id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
11357229|NCT03102645|12554012|FG000|STARTED|Overall Study||8
11357230|NCT03102645|12554013|FG001|STARTED|Overall Study||8
11357231|NCT03102645|12554012|FG000|COMPLETED|Overall Study||8
11357232|NCT03102645|12554013|FG001|COMPLETED|Overall Study||8
11357233|NCT03102645|12554012|FG000|NOT COMPLETED|Overall Study||0
11357234|NCT03102645|12554013|FG001|NOT COMPLETED|Overall Study||0
11357235|NCT03102710|12554023|FG000|STARTED|Overall Study||28
11357236|NCT03102710|12554024|FG001|STARTED|Overall Study||30
11357237|NCT03102710|12554025|FG002|STARTED|Overall Study||27
11357238|NCT03102710|12554023|FG000|COMPLETED|Overall Study||27
11357239|NCT03102710|12554024|FG001|COMPLETED|Overall Study||27
11357240|NCT03102710|12554025|FG002|COMPLETED|Overall Study||27
11357241|NCT03102710|12554023|FG000|NOT COMPLETED|Overall Study||1
11357242|NCT03102710|12554024|FG001|NOT COMPLETED|Overall Study||3
11357243|NCT03102710|12554025|FG002|NOT COMPLETED|Overall Study||0
11357244|NCT03102736|12554035|FG000|STARTED|Overall Study||7
11357245|NCT03102736|12554036|FG001|STARTED|Overall Study||9
11357246|NCT03102736|12554035|FG000|COMPLETED|Overall Study||7
11357247|NCT03102736|12554036|FG001|COMPLETED|Overall Study||9
11357248|NCT03102736|12554035|FG000|NOT COMPLETED|Overall Study||0
11357249|NCT03102736|12554036|FG001|NOT COMPLETED|Overall Study||0
11357250|NCT03102762|12554044|FG000|STARTED|Overall Study||35
11357251|NCT03102762|12554045|FG001|STARTED|Overall Study||35
11357252|NCT03102762|12554044|FG000|COMPLETED|Overall Study||34
11357253|NCT03102762|12554045|FG001|COMPLETED|Overall Study||35
11357254|NCT03102762|12554044|FG000|NOT COMPLETED|Overall Study||1
11357255|NCT03102762|12554045|FG001|NOT COMPLETED|Overall Study||0
11357256|NCT03102879|12554054|FG000|STARTED|Overall Study||18
11357257|NCT03102879|12554055|FG001|STARTED|Overall Study||18
11357258|NCT03102879|12554054|FG000|COMPLETED|Overall Study||18
11357259|NCT03102879|12554055|FG001|COMPLETED|Overall Study||18
11357260|NCT03102879|12554054|FG000|NOT COMPLETED|Overall Study||0
11357261|NCT03102879|12554055|FG001|NOT COMPLETED|Overall Study||0
11357262|NCT03102918|12554067|FG000|STARTED|Overall Study||5
11357263|NCT03102918|12554068|FG001|STARTED|Overall Study||5
11357264|NCT03102918|12554067|FG000|COMPLETED|Overall Study||4
11357265|NCT03102918|12554068|FG001|COMPLETED|Overall Study||5
11357266|NCT03102918|12554067|FG000|NOT COMPLETED|Overall Study||1
11357267|NCT03102918|12554068|FG001|NOT COMPLETED|Overall Study||0
11357268|NCT03103061|12554074|FG000|STARTED|Overall Study||24
11357269|NCT03103061|12554074|FG000|COMPLETED|Overall Study||24
11357270|NCT03103061|12554074|FG000|NOT COMPLETED|Overall Study||0
11237781|NCT02067676|12429527|FG000|STARTED|Overall Study||8
11237782|NCT02067676|12429528|FG001|STARTED|Overall Study||8
11237783|NCT02067676|12429529|FG002|STARTED|Overall Study||8
11237784|NCT02067676|12429530|FG003|STARTED|Overall Study||8
11237785|NCT02067676|12429531|FG004|STARTED|Overall Study||8
11237786|NCT02067676|12429532|FG005|STARTED|Overall Study||8
11237787|NCT02067676|12429527|FG000|COMPLETED|Overall Study||7
11237788|NCT02067676|12429528|FG001|COMPLETED|Overall Study||8
11237789|NCT02067676|12429529|FG002|COMPLETED|Overall Study||8
11237790|NCT02067676|12429530|FG003|COMPLETED|Overall Study||8
11237791|NCT02067676|12429531|FG004|COMPLETED|Overall Study||8
11237792|NCT02067676|12429532|FG005|COMPLETED|Overall Study||8
11237793|NCT02067676|12429527|FG000|NOT COMPLETED|Overall Study||1
11237794|NCT02067676|12429528|FG001|NOT COMPLETED|Overall Study||0
11237795|NCT02067676|12429529|FG002|NOT COMPLETED|Overall Study||0
11237796|NCT02067676|12429530|FG003|NOT COMPLETED|Overall Study||0
11237797|NCT02067676|12429531|FG004|NOT COMPLETED|Overall Study||0
11237798|NCT02067676|12429532|FG005|NOT COMPLETED|Overall Study||0
11237799|NCT02067728|12429553|FG000|STARTED|Baseline - 1 Month Follow up Survey||220
11237800|NCT02067728|12429554|FG001|STARTED|Baseline - 1 Month Follow up Survey||210
11237801|NCT02067728|12429553|FG000|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
11237802|NCT02067728|12429554|FG001|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
11237803|NCT02067728|12429553|FG000|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
11237804|NCT02067728|12429554|FG001|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
11237805|NCT02067728|12429553|FG000|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
11237806|NCT02067728|12429554|FG001|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
11237807|NCT02067728|12429553|FG000|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
11237808|NCT02067728|12429554|FG001|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
11237809|NCT02067728|12429553|FG000|NOT COMPLETED|6 Month Follow up Survey||48
11237810|NCT02067728|12429554|FG001|NOT COMPLETED|6 Month Follow up Survey||60
11237811|NCT02067728|12429553|FG000|STARTED|6 Month Measurements||220
11237812|NCT02067728|12429554|FG001|STARTED|6 Month Measurements||210
11237813|NCT02067728|12429553|FG000|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
11237814|NCT02067728|12429554|FG001|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
11237815|NCT02067728|12429553|FG000|NOT COMPLETED|6 Month Measurements||114
11237816|NCT02067728|12429554|FG001|NOT COMPLETED|6 Month Measurements||97
11237817|NCT02067806|12429560|FG000|STARTED|Overall Study||394
11237818|NCT02067806|12429560|FG000|COMPLETED|Overall Study||387
11237819|NCT02067806|12429560|FG000|NOT COMPLETED|Overall Study||7
11237820|NCT02067858|12429565|FG000|STARTED|Overall Study||6
11237821|NCT02067858|12429565|FG000|COMPLETED|Overall Study||6
11237822|NCT02067858|12429565|FG000|NOT COMPLETED|Overall Study||0
11237823|NCT02068027|12429571|FG000|STARTED|Overall Study||130
11237824|NCT02068027|12429572|FG001|STARTED|Overall Study||130
11237825|NCT02068027|12429571|FG000|COMPLETED|Overall Study||117
11237826|NCT02068027|12429572|FG001|COMPLETED|Overall Study||114
11237827|NCT02068027|12429571|FG000|NOT COMPLETED|Overall Study||13
11237828|NCT02068027|12429572|FG001|NOT COMPLETED|Overall Study||16
11237829|NCT02068118|12429580|FG000|STARTED|18-month Comparative Study Period||455
11237830|NCT02068118|12429581|FG001|STARTED|18-month Comparative Study Period||482
11237831|NCT02068118|12429580|FG000|COMPLETED|18-month Comparative Study Period||327
11237832|NCT02068118|12429581|FG001|COMPLETED|18-month Comparative Study Period||305
11237833|NCT02068118|12429580|FG000|NOT COMPLETED|18-month Comparative Study Period||128
11237834|NCT02068118|12429581|FG001|NOT COMPLETED|18-month Comparative Study Period||177
11237835|NCT02068118|12429580|FG000|STARTED|Extension Period|Standard Care/Tele-cardiology : Patients entered Period 2 if they wished and consented|7
11237836|NCT02068118|12429581|FG001|STARTED|Extension Period|Tele-cardiology/Tele-cardiology : Patients entered Period 2 if they wished and consented|13
11237837|NCT02068118|12429580|FG000|COMPLETED|Extension Period||5
11237838|NCT02068118|12429581|FG001|COMPLETED|Extension Period||10
11237839|NCT02068118|12429580|FG000|NOT COMPLETED|Extension Period||2
11237840|NCT02068118|12429581|FG001|NOT COMPLETED|Extension Period||3
11237841|NCT02068157|12429589|FG000|STARTED|Overall Study||3
11237842|NCT02068157|12429589|FG000|COMPLETED|Overall Study||3
11237843|NCT02068157|12429589|FG000|NOT COMPLETED|Overall Study||0
11237844|NCT02068222|12429593|FG000|STARTED|Overall Study||10
11237845|NCT02068222|12429593|FG000|COMPLETED|Overall Study||9
11237846|NCT02068222|12429593|FG000|NOT COMPLETED|Overall Study||1
11237847|NCT02068352|12429600|FG000|STARTED|Overall Study||41
11237848|NCT02068352|12429601|FG001|STARTED|Overall Study||43
11237849|NCT02068352|12429602|FG002|STARTED|Overall Study||37
11237850|NCT02068352|12429600|FG000|COMPLETED|Overall Study||31
11237851|NCT02068352|12429601|FG001|COMPLETED|Overall Study||35
11237852|NCT02068352|12429602|FG002|COMPLETED|Overall Study||28
11237853|NCT02068352|12429600|FG000|NOT COMPLETED|Overall Study||10
11237854|NCT02068352|12429601|FG001|NOT COMPLETED|Overall Study||8
11237855|NCT02068352|12429602|FG002|NOT COMPLETED|Overall Study||9
11237856|NCT02068443|12429613|FG000|STARTED|Overall Study||71
11237857|NCT02068443|12429614|FG001|STARTED|Overall Study||152
11237858|NCT02068443|12429615|FG002|STARTED|Overall Study||151
11237859|NCT02068443|12429613|FG000|COMPLETED|Overall Study||64
11237860|NCT02068443|12429614|FG001|COMPLETED|Overall Study||146
11237861|NCT02068443|12429615|FG002|COMPLETED|Overall Study||148
11237862|NCT02068443|12429613|FG000|NOT COMPLETED|Overall Study||7
11237863|NCT02068443|12429614|FG001|NOT COMPLETED|Overall Study||6
11237864|NCT02068443|12429615|FG002|NOT COMPLETED|Overall Study||3
11237865|NCT02068495|12429623|FG000|STARTED|Overall Study||3409
11237866|NCT02068495|12429623|FG000|COMPLETED|Overall Study||3300
11237867|NCT02068495|12429623|FG000|NOT COMPLETED|Overall Study||109
11237868|NCT02068508|12429627|FG000|STARTED|Overall Study||1067
11237869|NCT02068508|12429627|FG000|COMPLETED|Overall Study||1035
11237870|NCT02068508|12429627|FG000|NOT COMPLETED|Overall Study||32
11237871|NCT02068599|12429634|FG000|STARTED|Overall Study||130
11237872|NCT02068599|12429635|FG001|STARTED|Overall Study||129
11237873|NCT02068599|12429636|FG002|STARTED|Overall Study||130
11237874|NCT02068599|12429634|FG000|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
11237875|NCT02068599|12429635|FG001|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
11237876|NCT02068599|12429636|FG002|Safety Analysis Set|Overall Study||130
11237877|NCT02068599|12429634|FG000|Full Analysis Set|Overall Study||129
11237878|NCT02068599|12429635|FG001|Full Analysis Set|Overall Study||128
11237879|NCT02068599|12429636|FG002|Full Analysis Set|Overall Study||130
11237880|NCT02068599|12429634|FG000|COMPLETED|Overall Study||119
11237881|NCT02068599|12429635|FG001|COMPLETED|Overall Study||119
11237882|NCT02068599|12429636|FG002|COMPLETED|Overall Study||117
11237883|NCT02068599|12429634|FG000|NOT COMPLETED|Overall Study||11
11237884|NCT02068599|12429635|FG001|NOT COMPLETED|Overall Study||10
11237885|NCT02068599|12429636|FG002|NOT COMPLETED|Overall Study||13
11237886|NCT02068729|12429644|FG000|STARTED|Overall Study||131
11237887|NCT02068729|12429644|FG000|COMPLETED|Overall Study||56
11237888|NCT02068729|12429644|FG000|NOT COMPLETED|Overall Study||75
11237889|NCT02068768|12429703|FG000|STARTED|Overall Study||13
11237890|NCT02068768|12429703|FG000|COMPLETED|Overall Study||6
11237891|NCT02068768|12429703|FG000|NOT COMPLETED|Overall Study||7
11237892|NCT02068820|12429709|FG000|STARTED|Overall Study||20
11237893|NCT02068820|12429710|FG001|STARTED|Overall Study||180
11237894|NCT02068820|12429709|FG000|COMPLETED|Overall Study||20
11237895|NCT02068820|12429710|FG001|COMPLETED|Overall Study||180
11237896|NCT02068820|12429709|FG000|NOT COMPLETED|Overall Study||0
11237897|NCT02068820|12429710|FG001|NOT COMPLETED|Overall Study||0
11237898|NCT02068846|12429723|FG000|STARTED|Overall Study||9
11237899|NCT02068846|12429724|FG001|STARTED|Overall Study||8
11237900|NCT02068846|12429723|FG000|COMPLETED|Overall Study||8
11237901|NCT02068846|12429724|FG001|COMPLETED|Overall Study||7
11237902|NCT02068846|12429723|FG000|NOT COMPLETED|Overall Study||1
11237903|NCT02068846|12429724|FG001|NOT COMPLETED|Overall Study||1
11237904|NCT02069015|12429732|FG000|STARTED|Overall Study|Baseline and enrollment at Emergency Department (ED)|71
11237905|NCT02069015|12429733|FG001|STARTED|Overall Study||68
11237906|NCT02069015|12429732|FG000|7 Day|Overall Study|7 day post ED discharge at Clinical Research Center (CRC)|44
11237907|NCT02069015|12429733|FG001|7 Day|Overall Study|7 day post ED discharge at CRC|45
11237908|NCT02069015|12429732|FG000|30 Day|Overall Study|30 day post-discharge at CRC|38
11237909|NCT02069015|12429733|FG001|30 Day|Overall Study|30 day post-discharge at CRC|43
11237910|NCT02069015|12429732|FG000|90 Day|Overall Study|90 day post ED discharge at CRC|32
11237911|NCT02069015|12429733|FG001|90 Day|Overall Study|90 day post ED discharge|35
11237912|NCT02069015|12429732|FG000|COMPLETED|Overall Study|180 post ED discharge at CRC|31
11237913|NCT02069015|12429733|FG001|COMPLETED|Overall Study|180 day post ED discharge at CRC|35
11237914|NCT02069015|12429732|FG000|NOT COMPLETED|Overall Study||40
11237915|NCT02069015|12429733|FG001|NOT COMPLETED|Overall Study||33
11237916|NCT02069041|12429740|FG000|STARTED|Overall Study||8
11237917|NCT02069041|12429740|FG000|Received at Least One Dose of Study Drug|Overall Study||8
11237918|NCT02069041|12429740|FG000|COMPLETED|Overall Study||8
11237919|NCT02069041|12429740|FG000|NOT COMPLETED|Overall Study||0
11237920|NCT02069093|12429744|FG000|STARTED|Overall Study||86
11237921|NCT02069093|12429744|FG000|Pharmacokinetic Analysis Set|Overall Study||50
11237922|NCT02069093|12429744|FG000|COMPLETED|Overall Study||56
11237923|NCT02069093|12429744|FG000|NOT COMPLETED|Overall Study||30
11237924|NCT02069119|12429752|FG000|STARTED|Overall Study||20
11237925|NCT02069119|12429753|FG001|STARTED|Overall Study||4
11237926|NCT02069119|12429754|FG002|STARTED|Overall Study||20
11237927|NCT02069119|12429755|FG003|STARTED|Overall Study||4
11357271|NCT03103100|12554081|FG000|STARTED|Overall Study||25
11357272|NCT03103100|12554082|FG001|STARTED|Overall Study||25
11357273|NCT03103100|12554083|FG002|STARTED|Overall Study||25
11357274|NCT03103100|12554081|FG000|COMPLETED|Overall Study||23
11357275|NCT03103100|12554082|FG001|COMPLETED|Overall Study||25
11357276|NCT03103100|12554083|FG002|COMPLETED|Overall Study||23
11357277|NCT03103100|12554081|FG000|NOT COMPLETED|Overall Study||2
11357278|NCT03103100|12554082|FG001|NOT COMPLETED|Overall Study||0
11357279|NCT03103100|12554083|FG002|NOT COMPLETED|Overall Study||2
11357280|NCT03103282|12554091|FG000|STARTED|Overall Study||65
11357281|NCT03103282|12554091|FG000|COMPLETED|Overall Study||65
11357282|NCT03103282|12554091|FG000|NOT COMPLETED|Overall Study||0
11357283|NCT03103438|12554102|FG000|STARTED|Overall Study||1
11357284|NCT03103438|12554103|FG001|STARTED|Overall Study||3
11357285|NCT03103438|12554104|FG002|STARTED|Overall Study||3
11357286|NCT03103438|12554105|FG003|STARTED|Overall Study||3
11357287|NCT03103438|12554106|FG004|STARTED|Overall Study||3
11357288|NCT03103438|12554107|FG005|STARTED|Overall Study||3
11357289|NCT03103438|12554108|FG006|STARTED|Overall Study||3
11357290|NCT03103438|12554102|FG000|COMPLETED|Overall Study||1
11001691|NCT00705432|12179018|FG000|STARTED|Treatment Period||311
11237928|NCT02069119|12429752|FG000|COMPLETED|Overall Study||20
11237929|NCT02069119|12429753|FG001|COMPLETED|Overall Study||4
11357291|NCT03103438|12554103|FG001|COMPLETED|Overall Study||3
11357292|NCT03103438|12554104|FG002|COMPLETED|Overall Study||3
11357293|NCT03103438|12554105|FG003|COMPLETED|Overall Study||3
11357294|NCT03103438|12554106|FG004|COMPLETED|Overall Study||3
11357295|NCT03103438|12554107|FG005|COMPLETED|Overall Study||3
11357296|NCT03103438|12554108|FG006|COMPLETED|Overall Study||3
11357297|NCT03103438|12554102|FG000|NOT COMPLETED|Overall Study||0
11357298|NCT03103438|12554103|FG001|NOT COMPLETED|Overall Study||0
11357299|NCT03103438|12554104|FG002|NOT COMPLETED|Overall Study||0
11357300|NCT03103438|12554105|FG003|NOT COMPLETED|Overall Study||0
11357301|NCT03103438|12554106|FG004|NOT COMPLETED|Overall Study||0
11357302|NCT03103438|12554107|FG005|NOT COMPLETED|Overall Study||0
11357303|NCT03103438|12554108|FG006|NOT COMPLETED|Overall Study||0
11357304|NCT03103503|12554124|FG000|STARTED|Overall Study||901
11357305|NCT03103503|12554124|FG000|COMPLETED|Overall Study||0
11357306|NCT03103503|12554124|FG000|NOT COMPLETED|Overall Study||901
11357307|NCT03103763|12554131|FG000|STARTED|Overall Study||44
11357308|NCT03103763|12554132|FG001|STARTED|Overall Study||44
11357309|NCT03103763|12554133|FG002|STARTED|Overall Study||44
11357310|NCT03103763|12554131|FG000|COMPLETED|Overall Study||29
11357311|NCT03103763|12554132|FG001|COMPLETED|Overall Study||36
11357312|NCT03103763|12554133|FG002|COMPLETED|Overall Study||37
11357313|NCT03103763|12554131|FG000|NOT COMPLETED|Overall Study||15
11357314|NCT03103763|12554132|FG001|NOT COMPLETED|Overall Study||8
11357315|NCT03103763|12554133|FG002|NOT COMPLETED|Overall Study||7
11357316|NCT03103906|12554143|FG000|STARTED|Overall Study||40
11357317|NCT03103906|12554144|FG001|STARTED|Overall Study||42
11357318|NCT03103906|12554143|FG000|COMPLETED|Overall Study||36
11357319|NCT03103906|12554144|FG001|COMPLETED|Overall Study||39
11357320|NCT03103906|12554143|FG000|NOT COMPLETED|Overall Study||4
11357321|NCT03103906|12554144|FG001|NOT COMPLETED|Overall Study||3
11357322|NCT03103919|12554152|FG000|STARTED|Overall Study||20
11357323|NCT03103919|12554153|FG001|STARTED|Overall Study||19
11357324|NCT03103919|12554152|FG000|COMPLETED|Overall Study||18
11357325|NCT03103919|12554153|FG001|COMPLETED|Overall Study||17
11357326|NCT03103919|12554152|FG000|NOT COMPLETED|Overall Study||2
11357327|NCT03103919|12554153|FG001|NOT COMPLETED|Overall Study||2
11357328|NCT03104192|12554165|FG000|STARTED|Overall Study||9
11357329|NCT03104192|12554166|FG001|STARTED|Overall Study||27
11357330|NCT03104192|12554167|FG002|STARTED|Overall Study||16
11357331|NCT03104192|12554168|FG003|STARTED|Overall Study||17
11357332|NCT03104192|12554165|FG000|COMPLETED|Overall Study||9
11357333|NCT03104192|12554166|FG001|COMPLETED|Overall Study||23
11357334|NCT03104192|12554167|FG002|COMPLETED|Overall Study||14
11357335|NCT03104192|12554168|FG003|COMPLETED|Overall Study||14
11357336|NCT03104192|12554165|FG000|NOT COMPLETED|Overall Study||0
11357337|NCT03104192|12554166|FG001|NOT COMPLETED|Overall Study||4
11357338|NCT03104192|12554167|FG002|NOT COMPLETED|Overall Study||2
11357339|NCT03104192|12554168|FG003|NOT COMPLETED|Overall Study||3
11357340|NCT03104322|12554184|FG000|STARTED|Overall Study||7
11357341|NCT03104322|12554184|FG000|COMPLETED|Overall Study||6
11357342|NCT03104322|12554184|FG000|NOT COMPLETED|Overall Study||1
11357343|NCT03104647|12554188|FG000|STARTED|Overall Study||20
11357344|NCT03104647|12554188|FG000|COMPLETED|Overall Study||20
11357345|NCT03104647|12554188|FG000|NOT COMPLETED|Overall Study||0
11357346|NCT03104725|12554194|FG000|STARTED|Overall Study||2
11357347|NCT03104725|12554195|FG001|STARTED|Overall Study||4
11357348|NCT03104725|12554194|FG000|COMPLETED|Overall Study||2
11357349|NCT03104725|12554195|FG001|COMPLETED|Overall Study||4
11357350|NCT03104725|12554194|FG000|NOT COMPLETED|Overall Study||0
11357351|NCT03104725|12554195|FG001|NOT COMPLETED|Overall Study||0
11357352|NCT03104738|12554203|FG000|STARTED|Overall Study||20
11357353|NCT03104738|12554204|FG001|STARTED|Overall Study||20
11357354|NCT03104738|12554203|FG000|COMPLETED|Overall Study||20
11357355|NCT03104738|12554204|FG001|COMPLETED|Overall Study||20
11357356|NCT03104738|12554203|FG000|NOT COMPLETED|Overall Study||0
11357357|NCT03104738|12554204|FG001|NOT COMPLETED|Overall Study||0
11357358|NCT03104816|12554213|FG000|STARTED|Overall Study||11
11357359|NCT03104816|12554214|FG001|STARTED|Overall Study||11
11357360|NCT03104816|12554215|FG002|STARTED|Overall Study||6
11357361|NCT03104816|12554213|FG000|COMPLETED|Overall Study||9
11357362|NCT03104816|12554214|FG001|COMPLETED|Overall Study||9
11357363|NCT03104816|12554215|FG002|COMPLETED|Overall Study||4
11357364|NCT03104816|12554213|FG000|NOT COMPLETED|Overall Study||2
11357365|NCT03104816|12554214|FG001|NOT COMPLETED|Overall Study||2
11001692|NCT00705432|12179019|FG001|STARTED|Treatment Period||316
11357366|NCT03104816|12554215|FG002|NOT COMPLETED|Overall Study||2
11357367|NCT03104985|12554225|FG000|STARTED|Overall Study||34
11357368|NCT03104985|12554226|FG001|STARTED|Overall Study||34
11357369|NCT03104985|12554225|FG000|COMPLETED|Overall Study||34
11357370|NCT03104985|12554226|FG001|COMPLETED|Overall Study||34
11357371|NCT03104985|12554225|FG000|NOT COMPLETED|Overall Study||0
11357372|NCT03104985|12554226|FG001|NOT COMPLETED|Overall Study||0
11357373|NCT03105297|12554232|FG000|STARTED|Baseline Phase (Day 1)||91
11357374|NCT03105297|12554232|FG000|COMPLETED|Baseline Phase (Day 1)||70
11357375|NCT03105297|12554232|FG000|NOT COMPLETED|Baseline Phase (Day 1)||21
11357376|NCT03105297|12554232|FG000|STARTED|Active Phase (Day 2-29)||70
11357377|NCT03105297|12554232|FG000|COMPLETED|Active Phase (Day 2-29)||70
11357378|NCT03105297|12554232|FG000|NOT COMPLETED|Active Phase (Day 2-29)||0
11357379|NCT03105297|12554232|FG000|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56
11357380|NCT03105297|12554232|FG000|Treated|Nasal Resistance Phase (Day 30, 31)||55
11357381|NCT03105297|12554232|FG000|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48
11357382|NCT03105297|12554232|FG000|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8
11357383|NCT03105362|12554243|FG000|STARTED|Overall Study||4
11357384|NCT03105362|12554243|FG000|Completed 1 Week of Study|Overall Study||4
11357385|NCT03105362|12554243|FG000|Completed 2 Weeks of Study|Overall Study||3
11357386|NCT03105362|12554243|FG000|Completed 2 Week Questionaire|Overall Study||2
11357387|NCT03105362|12554243|FG000|COMPLETED|Overall Study||2
11357388|NCT03105362|12554243|FG000|NOT COMPLETED|Overall Study||2
11357389|NCT03105479|12554250|FG000|STARTED|Overall Study||1
11357390|NCT03105479|12554251|FG001|STARTED|Overall Study||0
11357391|NCT03105479|12554252|FG002|STARTED|Overall Study||0
11357392|NCT03105479|12554253|FG003|STARTED|Overall Study||0
11357393|NCT03105479|12554254|FG004|STARTED|Overall Study||0
11357394|NCT03105479|12554255|FG005|STARTED|Overall Study||0
11357395|NCT03105479|12554256|FG006|STARTED|Overall Study||0
11357396|NCT03105479|12554250|FG000|COMPLETED|Overall Study||1
11357397|NCT03105479|12554251|FG001|COMPLETED|Overall Study||0
11357398|NCT03105479|12554252|FG002|COMPLETED|Overall Study||0
11357399|NCT03105479|12554253|FG003|COMPLETED|Overall Study||0
11357400|NCT03105479|12554254|FG004|COMPLETED|Overall Study||0
11357401|NCT03105479|12554255|FG005|COMPLETED|Overall Study||0
11357402|NCT03105479|12554256|FG006|COMPLETED|Overall Study||0
11357403|NCT03105479|12554250|FG000|NOT COMPLETED|Overall Study||0
11357404|NCT03105479|12554251|FG001|NOT COMPLETED|Overall Study||0
11357405|NCT03105479|12554252|FG002|NOT COMPLETED|Overall Study||0
11357406|NCT03105479|12554253|FG003|NOT COMPLETED|Overall Study||0
11357407|NCT03105479|12554254|FG004|NOT COMPLETED|Overall Study||0
11357408|NCT03105479|12554255|FG005|NOT COMPLETED|Overall Study||0
11357409|NCT03105479|12554256|FG006|NOT COMPLETED|Overall Study||0
11357410|NCT03106077|12554263|FG000|STARTED|Overall Study||96
11357411|NCT03106077|12554264|FG001|STARTED|Overall Study||0
11357412|NCT03106077|12554263|FG000|COMPLETED|Overall Study||2
11357413|NCT03106077|12554264|FG001|COMPLETED|Overall Study||0
11357414|NCT03106077|12554263|FG000|NOT COMPLETED|Overall Study||94
11357415|NCT03106077|12554264|FG001|NOT COMPLETED|Overall Study||0
11357416|NCT03106337|12554269|FG000|STARTED|Overall Study||35
11357417|NCT03106337|12554269|FG000|COMPLETED|Overall Study||35
11357418|NCT03106337|12554269|FG000|NOT COMPLETED|Overall Study||0
11357419|NCT03106636|12554276|FG000|STARTED|Overall Study||226
11357420|NCT03106636|12554277|FG001|STARTED|Overall Study||190
11357421|NCT03106636|12554276|FG000|COMPLETED|Overall Study||182
11357422|NCT03106636|12554277|FG001|COMPLETED|Overall Study||164
11357423|NCT03106636|12554276|FG000|NOT COMPLETED|Overall Study||44
11357424|NCT03106636|12554277|FG001|NOT COMPLETED|Overall Study||26
11357425|NCT03106753|12554285|FG000|STARTED|Overall Study||17
11357426|NCT03106753|12554286|FG001|STARTED|Overall Study||17
11357427|NCT03106753|12554285|FG000|COMPLETED|Overall Study||17
11357428|NCT03106753|12554286|FG001|COMPLETED|Overall Study||16
11357429|NCT03106753|12554285|FG000|NOT COMPLETED|Overall Study||0
11357430|NCT03106753|12554286|FG001|NOT COMPLETED|Overall Study||1
11357431|NCT03106844|12554294|FG000|STARTED|Overall Study||50
11357432|NCT03106844|12554294|FG000|COMPLETED|Overall Study||49
11357433|NCT03106844|12554294|FG000|NOT COMPLETED|Overall Study||1
11357434|NCT03106870|12554300|FG000|STARTED|Overall Study||31
11357435|NCT03106870|12554301|FG001|STARTED|Overall Study||31
11357436|NCT03106870|12554300|FG000|COMPLETED|Overall Study||31
11357437|NCT03106870|12554301|FG001|COMPLETED|Overall Study||31
11357438|NCT03106870|12554300|FG000|NOT COMPLETED|Overall Study||0
11357439|NCT03106870|12554301|FG001|NOT COMPLETED|Overall Study||0
11357440|NCT03107026|12554310|FG000|STARTED|Overall Study||163
11357441|NCT03107026|12554311|FG001|STARTED|Overall Study||161
11357442|NCT03107026|12554312|FG002|STARTED|Overall Study||162
11357443|NCT03107026|12554310|FG000|COMPLETED|Overall Study||131
11357444|NCT03107026|12554311|FG001|COMPLETED|Overall Study||123
11357445|NCT03107026|12554312|FG002|COMPLETED|Overall Study||106
11357446|NCT03107026|12554310|FG000|NOT COMPLETED|Overall Study||32
11357447|NCT03107026|12554311|FG001|NOT COMPLETED|Overall Study||38
11357448|NCT03107026|12554312|FG002|NOT COMPLETED|Overall Study||56
11357449|NCT03107052|12554323|FG000|STARTED|Overall Study||145
11357450|NCT03107052|12554324|FG001|STARTED|Overall Study||60
11357451|NCT03107052|12554325|FG002|STARTED|Overall Study||70
11357452|NCT03107052|12554323|FG000|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|144
11357453|NCT03107052|12554324|FG001|Safety Analysis Set|Overall Study||60
11357454|NCT03107052|12554325|FG002|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|71
11357455|NCT03107052|12554323|FG000|COMPLETED|Overall Study||26
11357456|NCT03107052|12554324|FG001|COMPLETED|Overall Study||14
11357457|NCT03107052|12554325|FG002|COMPLETED|Overall Study||29
11357458|NCT03107052|12554323|FG000|NOT COMPLETED|Overall Study||119
11357459|NCT03107052|12554324|FG001|NOT COMPLETED|Overall Study||46
11357460|NCT03107052|12554325|FG002|NOT COMPLETED|Overall Study||41
11357461|NCT03107091|12554333|FG000|STARTED|Overall Study||6
11357462|NCT03107091|12554333|FG000|COMPLETED|Overall Study||5
11357463|NCT03107091|12554333|FG000|NOT COMPLETED|Overall Study||1
11357464|NCT03107377|12554340|FG000|STARTED|Overall Study||426
11357465|NCT03107377|12554341|FG001|STARTED|Overall Study||434
11357466|NCT03107377|12554340|FG000|COMPLETED|Overall Study||335
11357467|NCT03107377|12554341|FG001|COMPLETED|Overall Study||335
11357468|NCT03107377|12554340|FG000|NOT COMPLETED|Overall Study||91
11357469|NCT03107377|12554341|FG001|NOT COMPLETED|Overall Study||99
11357470|NCT03107715|12554349|FG000|STARTED|Overall Study||132
11357471|NCT03107715|12554350|FG001|STARTED|Overall Study||111
11357472|NCT03107715|12554349|FG000|COMPLETED|Overall Study||128
11357473|NCT03107715|12554350|FG001|COMPLETED|Overall Study||104
11357474|NCT03107715|12554349|FG000|NOT COMPLETED|Overall Study||4
11357475|NCT03107715|12554350|FG001|NOT COMPLETED|Overall Study||7
11357476|NCT03107754|12554358|FG000|STARTED|Overall Study||48
11357477|NCT03107754|12554359|FG001|STARTED|Overall Study||50
11357478|NCT03107754|12554358|FG000|COMPLETED|Overall Study||48
11357479|NCT03107754|12554359|FG001|COMPLETED|Overall Study||50
11357480|NCT03107754|12554358|FG000|NOT COMPLETED|Overall Study||0
11357481|NCT03107754|12554359|FG001|NOT COMPLETED|Overall Study||0
11357482|NCT03107793|12554365|FG000|STARTED|Induction Period (16 Weeks)||500
11357483|NCT03107793|12554366|FG001|STARTED|Induction Period (16 Weeks)||0
11357484|NCT03107793|12554367|FG002|STARTED|Induction Period (16 Weeks)||0
11357485|NCT03107793|12554365|FG000|COMPLETED|Induction Period (16 Weeks)||490
11357486|NCT03107793|12554366|FG001|COMPLETED|Induction Period (16 Weeks)||0
11357487|NCT03107793|12554367|FG002|COMPLETED|Induction Period (16 Weeks)||0
11357488|NCT03107793|12554365|FG000|NOT COMPLETED|Induction Period (16 Weeks)||10
11357489|NCT03107793|12554366|FG001|NOT COMPLETED|Induction Period (16 Weeks)||0
11357490|NCT03107793|12554367|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
11357491|NCT03107793|12554365|FG000|STARTED|Maintenance Period (16-48 Week)||0
11357492|NCT03107793|12554366|FG001|STARTED|Maintenance Period (16-48 Week)||220
11001693|NCT00705432|12179020|FG002|STARTED|Treatment Period||311
11001694|NCT00705432|12179021|FG003|STARTED|Treatment Period||52
11001695|NCT00705432|12179022|FG004|STARTED|Treatment Period||52
11001696|NCT00705432|12179023|FG005|STARTED|Treatment Period||55
11001697|NCT00705432|12179018|FG000|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
11001698|NCT00705432|12179019|FG001|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
11001699|NCT00705432|12179020|FG002|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
11001700|NCT00705432|12179021|FG003|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
11001701|NCT00705432|12179022|FG004|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
11001702|NCT00705432|12179023|FG005|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
11001703|NCT00705432|12179018|FG000|COMPLETED|Treatment Period||148
11001704|NCT00705432|12179019|FG001|COMPLETED|Treatment Period||205
11001705|NCT00705432|12179020|FG002|COMPLETED|Treatment Period||190
11001706|NCT00705432|12179021|FG003|COMPLETED|Treatment Period||11
11001707|NCT00705432|12179022|FG004|COMPLETED|Treatment Period||24
11001708|NCT00705432|12179023|FG005|COMPLETED|Treatment Period||25
11001709|NCT00705432|12179018|FG000|NOT COMPLETED|Treatment Period||163
11001710|NCT00705432|12179019|FG001|NOT COMPLETED|Treatment Period||111
11001711|NCT00705432|12179020|FG002|NOT COMPLETED|Treatment Period||121
11001712|NCT00705432|12179021|FG003|NOT COMPLETED|Treatment Period||41
11001713|NCT00705432|12179022|FG004|NOT COMPLETED|Treatment Period||28
11001714|NCT00705432|12179023|FG005|NOT COMPLETED|Treatment Period||30
11001715|NCT00705432|12179018|FG000|STARTED|Follow-up Period (Upto Week 72)||278
11001716|NCT00705432|12179019|FG001|STARTED|Follow-up Period (Upto Week 72)||295
11001717|NCT00705432|12179020|FG002|STARTED|Follow-up Period (Upto Week 72)||291
11001718|NCT00705432|12179021|FG003|STARTED|Follow-up Period (Upto Week 72)||42
11001719|NCT00705432|12179022|FG004|STARTED|Follow-up Period (Upto Week 72)||44
11001720|NCT00705432|12179023|FG005|STARTED|Follow-up Period (Upto Week 72)||53
11001721|NCT00705432|12179018|FG000|COMPLETED|Follow-up Period (Upto Week 72)||207
11001722|NCT00705432|12179019|FG001|COMPLETED|Follow-up Period (Upto Week 72)||252
11001723|NCT00705432|12179020|FG002|COMPLETED|Follow-up Period (Upto Week 72)||266
11357493|NCT03107793|12554367|FG002|STARTED|Maintenance Period (16-48 Week)||221
11357494|NCT03107793|12554365|FG000|COMPLETED|Maintenance Period (16-48 Week)||0
11357495|NCT03107793|12554366|FG001|COMPLETED|Maintenance Period (16-48 Week)||174
11357496|NCT03107793|12554367|FG002|COMPLETED|Maintenance Period (16-48 Week)||193
11357497|NCT03107793|12554365|FG000|NOT COMPLETED|Maintenance Period (16-48 Week)||0
11357498|NCT03107793|12554366|FG001|NOT COMPLETED|Maintenance Period (16-48 Week)||46
11357499|NCT03107793|12554367|FG002|NOT COMPLETED|Maintenance Period (16-48 Week)||28
11001724|NCT00705432|12179021|FG003|COMPLETED|Follow-up Period (Upto Week 72)||28
11001725|NCT00705432|12179022|FG004|COMPLETED|Follow-up Period (Upto Week 72)||38
11001726|NCT00705432|12179023|FG005|COMPLETED|Follow-up Period (Upto Week 72)||46
11001727|NCT00705432|12179018|FG000|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
11001728|NCT00705432|12179019|FG001|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
11001729|NCT00705432|12179020|FG002|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
11357500|NCT03108027|12554374|FG000|STARTED|Period 1||7
11357501|NCT03108027|12554375|FG001|STARTED|Period 1||6
11357502|NCT03108027|12554376|FG002|STARTED|Period 1||6
11357503|NCT03108027|12554377|FG003|STARTED|Period 1||6
11357504|NCT03108027|12554378|FG004|STARTED|Period 1||6
11357505|NCT03108027|12554379|FG005|STARTED|Period 1||6
11357506|NCT03108027|12554374|FG000|COMPLETED|Period 1||7
11357507|NCT03108027|12554375|FG001|COMPLETED|Period 1||6
11357508|NCT03108027|12554376|FG002|COMPLETED|Period 1||6
11357509|NCT03108027|12554377|FG003|COMPLETED|Period 1||4
11357510|NCT03108027|12554378|FG004|COMPLETED|Period 1||6
11357511|NCT03108027|12554379|FG005|COMPLETED|Period 1||6
11357512|NCT03108027|12554374|FG000|NOT COMPLETED|Period 1||0
11357513|NCT03108027|12554375|FG001|NOT COMPLETED|Period 1||0
11357514|NCT03108027|12554376|FG002|NOT COMPLETED|Period 1||0
11357515|NCT03108027|12554377|FG003|NOT COMPLETED|Period 1||2
11357516|NCT03108027|12554378|FG004|NOT COMPLETED|Period 1||0
11357517|NCT03108027|12554379|FG005|NOT COMPLETED|Period 1||0
11357518|NCT03108027|12554374|FG000|STARTED|Period 2||7
11357519|NCT03108027|12554375|FG001|STARTED|Period 2||6
11357520|NCT03108027|12554376|FG002|STARTED|Period 2||6
11357521|NCT03108027|12554377|FG003|STARTED|Period 2||4
11357522|NCT03108027|12554378|FG004|STARTED|Period 2||6
11357523|NCT03108027|12554379|FG005|STARTED|Period 2||6
11357524|NCT03108027|12554374|FG000|COMPLETED|Period 2||7
11357525|NCT03108027|12554375|FG001|COMPLETED|Period 2||6
11357526|NCT03108027|12554376|FG002|COMPLETED|Period 2||6
11357527|NCT03108027|12554377|FG003|COMPLETED|Period 2||4
11357528|NCT03108027|12554378|FG004|COMPLETED|Period 2||6
11357529|NCT03108027|12554379|FG005|COMPLETED|Period 2||6
11357530|NCT03108027|12554374|FG000|NOT COMPLETED|Period 2||0
11357531|NCT03108027|12554375|FG001|NOT COMPLETED|Period 2||0
11357532|NCT03108027|12554376|FG002|NOT COMPLETED|Period 2||0
11357533|NCT03108027|12554377|FG003|NOT COMPLETED|Period 2||0
11357534|NCT03108027|12554378|FG004|NOT COMPLETED|Period 2||0
11357535|NCT03108027|12554379|FG005|NOT COMPLETED|Period 2||0
11357536|NCT03108027|12554374|FG000|STARTED|Period 3||7
11357537|NCT03108027|12554375|FG001|STARTED|Period 3||6
11357538|NCT03108027|12554376|FG002|STARTED|Period 3||6
11357539|NCT03108027|12554377|FG003|STARTED|Period 3||4
11357540|NCT03108027|12554378|FG004|STARTED|Period 3||6
11357541|NCT03108027|12554379|FG005|STARTED|Period 3||6
11357542|NCT03108027|12554374|FG000|COMPLETED|Period 3||7
11357543|NCT03108027|12554375|FG001|COMPLETED|Period 3||5
11357544|NCT03108027|12554376|FG002|COMPLETED|Period 3||6
11357545|NCT03108027|12554377|FG003|COMPLETED|Period 3||4
11357546|NCT03108027|12554378|FG004|COMPLETED|Period 3||6
11357547|NCT03108027|12554379|FG005|COMPLETED|Period 3||6
11357548|NCT03108027|12554374|FG000|NOT COMPLETED|Period 3||0
11357549|NCT03108027|12554375|FG001|NOT COMPLETED|Period 3||1
11357550|NCT03108027|12554376|FG002|NOT COMPLETED|Period 3||0
11357551|NCT03108027|12554377|FG003|NOT COMPLETED|Period 3||0
11357552|NCT03108027|12554378|FG004|NOT COMPLETED|Period 3||0
11357553|NCT03108027|12554379|FG005|NOT COMPLETED|Period 3||0
11357554|NCT03108157|12554389|FG000|STARTED|Overall Study||176
11357555|NCT03108157|12554390|FG001|STARTED|Overall Study||176
11357556|NCT03108157|12554389|FG000|COMPLETED|Overall Study||161
11357557|NCT03108157|12554390|FG001|COMPLETED|Overall Study||172
11357558|NCT03108157|12554389|FG000|NOT COMPLETED|Overall Study||15
11357559|NCT03108157|12554390|FG001|NOT COMPLETED|Overall Study||4
11357560|NCT03108469|12554399|FG000|STARTED|Overall Study||15
11357561|NCT03108469|12554400|FG001|STARTED|Overall Study||15
11357562|NCT03108469|12554399|FG000|COMPLETED|Overall Study||11
11357563|NCT03108469|12554400|FG001|COMPLETED|Overall Study||11
11357564|NCT03108469|12554399|FG000|NOT COMPLETED|Overall Study||4
11357565|NCT03108469|12554400|FG001|NOT COMPLETED|Overall Study||4
11357566|NCT03108482|12554410|FG000|STARTED|Overall Study||183
11357567|NCT03108482|12554411|FG001|STARTED|Overall Study||183
11357568|NCT03108482|12554412|FG002|STARTED|Overall Study||182
11357569|NCT03108482|12554413|FG003|STARTED|Overall Study||89
11357570|NCT03108482|12554410|FG000|COMPLETED|Overall Study||183
11357571|NCT03108482|12554411|FG001|COMPLETED|Overall Study||179
11357572|NCT03108482|12554412|FG002|COMPLETED|Overall Study||180
11001730|NCT00705432|12179021|FG003|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
11001731|NCT00705432|12179022|FG004|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
11001732|NCT00705432|12179023|FG005|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
11001733|NCT00705484|12179036|FG000|STARTED|Overall Study|Number Enrolled|1059
11001734|NCT00705484|12179037|FG001|STARTED|Overall Study|Number Enrolled|1180
11001735|NCT00705484|12179036|FG000|Follow-up Period|Overall Study||1059
11001736|NCT00705484|12179037|FG001|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
11001737|NCT00705484|12179036|FG000|COMPLETED|Overall Study||677
11001738|NCT00705484|12179037|FG001|COMPLETED|Overall Study||772
11001739|NCT00705484|12179036|FG000|NOT COMPLETED|Overall Study||382
11001740|NCT00705484|12179037|FG001|NOT COMPLETED|Overall Study||408
11357573|NCT03108482|12554413|FG003|COMPLETED|Overall Study||86
11357574|NCT03108482|12554410|FG000|NOT COMPLETED|Overall Study||0
11357575|NCT03108482|12554411|FG001|NOT COMPLETED|Overall Study||4
11357576|NCT03108482|12554412|FG002|NOT COMPLETED|Overall Study||2
11001741|NCT00705523|12179047|FG000|STARTED|Overall Study||19
11001742|NCT00705523|12179048|FG001|STARTED|Overall Study||21
11001743|NCT00705523|12179047|FG000|COMPLETED|Overall Study||17
11001744|NCT00705523|12179048|FG001|COMPLETED|Overall Study||18
11357577|NCT03108482|12554413|FG003|NOT COMPLETED|Overall Study||3
11357578|NCT03108521|12554425|FG000|STARTED|Overall Study||83
11357579|NCT03108521|12554426|FG001|STARTED|Overall Study||36
11357580|NCT03108521|12554425|FG000|COMPLETED|Overall Study||71
11357581|NCT03108521|12554426|FG001|COMPLETED|Overall Study||36
11357582|NCT03108521|12554425|FG000|NOT COMPLETED|Overall Study||12
11357583|NCT03108521|12554426|FG001|NOT COMPLETED|Overall Study||0
11357584|NCT03109015|12554438|FG000|STARTED|Overall Study||4
11357585|NCT03109015|12554439|FG001|STARTED|Overall Study||3
11357586|NCT03109015|12554438|FG000|COMPLETED|Overall Study||4
11357587|NCT03109015|12554439|FG001|COMPLETED|Overall Study||3
11357588|NCT03109015|12554438|FG000|NOT COMPLETED|Overall Study||0
11357589|NCT03109015|12554439|FG001|NOT COMPLETED|Overall Study||0
11357590|NCT03109184|12554447|FG000|STARTED|Overall Study||60
11357591|NCT03109184|12554448|FG001|STARTED|Overall Study||59
11357592|NCT03109184|12554447|FG000|COMPLETED|Overall Study||53
11357593|NCT03109184|12554448|FG001|COMPLETED|Overall Study||52
11357594|NCT03109184|12554447|FG000|NOT COMPLETED|Overall Study||7
11357595|NCT03109184|12554448|FG001|NOT COMPLETED|Overall Study||7
11357596|NCT03109769|12554456|FG000|STARTED|Overall Study||22
11357597|NCT03109769|12554457|FG001|STARTED|Overall Study||22
11357598|NCT03109769|12554456|FG000|COMPLETED|Overall Study||22
11357599|NCT03109769|12554457|FG001|COMPLETED|Overall Study||22
11357600|NCT03109769|12554456|FG000|NOT COMPLETED|Overall Study||0
11357601|NCT03109769|12554457|FG001|NOT COMPLETED|Overall Study||0
11357602|NCT03109951|12554463|FG000|STARTED|Overall Study||187
11357603|NCT03109951|12554463|FG000|COMPLETED|Overall Study||187
11357604|NCT03109951|12554463|FG000|NOT COMPLETED|Overall Study||0
11357605|NCT03110003|12554469|FG000|STARTED|Overall Study||21
11357606|NCT03110003|12554470|FG001|STARTED|Overall Study||24
11357607|NCT03110003|12554469|FG000|COMPLETED|Overall Study||21
11357608|NCT03110003|12554470|FG001|COMPLETED|Overall Study||24
11357609|NCT03110003|12554469|FG000|NOT COMPLETED|Overall Study||0
11357610|NCT03110003|12554470|FG001|NOT COMPLETED|Overall Study||0
11357611|NCT03110029|12554478|FG000|STARTED|Overall Study||7
11357612|NCT03110029|12554479|FG001|STARTED|Overall Study||6
11357613|NCT03110029|12554478|FG000|COMPLETED|Overall Study||6
11357614|NCT03110029|12554479|FG001|COMPLETED|Overall Study||5
11357615|NCT03110029|12554478|FG000|NOT COMPLETED|Overall Study||1
11357616|NCT03110029|12554479|FG001|NOT COMPLETED|Overall Study||1
11357617|NCT03110185|12554487|FG000|STARTED|Overall Study||27
11357618|NCT03110185|12554488|FG001|STARTED|Overall Study||64
11357619|NCT03110185|12554487|FG000|COMPLETED|Overall Study||17
11357620|NCT03110185|12554488|FG001|COMPLETED|Overall Study||33
11357621|NCT03110185|12554487|FG000|NOT COMPLETED|Overall Study||10
11357622|NCT03110185|12554488|FG001|NOT COMPLETED|Overall Study||31
11357623|NCT03110458|12554500|FG000|STARTED|Overall Study||37
11357624|NCT03110458|12554501|FG001|STARTED|Overall Study||36
11357625|NCT03110458|12554502|FG002|STARTED|Overall Study||34
11357626|NCT03110458|12554500|FG000|COMPLETED|Overall Study||31
11357627|NCT03110458|12554501|FG001|COMPLETED|Overall Study||32
11357628|NCT03110458|12554502|FG002|COMPLETED|Overall Study||31
11357629|NCT03110458|12554500|FG000|NOT COMPLETED|Overall Study||6
11357630|NCT03110458|12554501|FG001|NOT COMPLETED|Overall Study||4
11357631|NCT03110458|12554502|FG002|NOT COMPLETED|Overall Study||3
11357632|NCT03110471|12554512|FG000|STARTED|Overall Study||30
11357633|NCT03110471|12554513|FG001|STARTED|Overall Study||30
11357634|NCT03110471|12554512|FG000|COMPLETED|Overall Study||30
11357635|NCT03110471|12554513|FG001|COMPLETED|Overall Study||30
11357636|NCT03110471|12554512|FG000|NOT COMPLETED|Overall Study||0
11357637|NCT03110471|12554513|FG001|NOT COMPLETED|Overall Study||0
11357638|NCT03110562|12554519|FG000|STARTED|Overall Study||195
11357639|NCT03110562|12554520|FG001|STARTED|Overall Study||207
11357640|NCT03110562|12554519|FG000|Treated|Overall Study||195
11357641|NCT03110562|12554520|FG001|Treated|Overall Study||204
11357642|NCT03110562|12554519|FG000|COMPLETED|Overall Study||0
11357643|NCT03110562|12554520|FG001|COMPLETED|Overall Study||0
11357644|NCT03110562|12554519|FG000|NOT COMPLETED|Overall Study||195
11357645|NCT03110562|12554520|FG001|NOT COMPLETED|Overall Study||207
11357646|NCT03110601|12554526|FG000|STARTED|Conventional SCS Parameters||25
11357647|NCT03110601|12554526|FG000|COMPLETED|Conventional SCS Parameters||24
11357648|NCT03110601|12554526|FG000|NOT COMPLETED|Conventional SCS Parameters||1
11357649|NCT03110601|12554526|FG000|STARTED|Washout Period||24
11357650|NCT03110601|12554526|FG000|COMPLETED|Washout Period||23
11357651|NCT03110601|12554526|FG000|NOT COMPLETED|Washout Period||1
11357652|NCT03110601|12554526|FG000|STARTED|Stimgenics SCS Parameters||23
11357653|NCT03110601|12554526|FG000|COMPLETED|Stimgenics SCS Parameters||20
11357654|NCT03110601|12554526|FG000|NOT COMPLETED|Stimgenics SCS Parameters||3
11357655|NCT03110692|12554535|FG000|STARTED|Overall Study||679
11357656|NCT03110692|12554536|FG001|STARTED|Overall Study||509
11357657|NCT03110692|12554535|FG000|COMPLETED|Overall Study||679
11357658|NCT03110692|12554536|FG001|COMPLETED|Overall Study||509
11357659|NCT03110692|12554535|FG000|NOT COMPLETED|Overall Study||0
11357660|NCT03110692|12554536|FG001|NOT COMPLETED|Overall Study||0
11357661|NCT03110770|12554547|FG000|STARTED|Overall Study||30
11357662|NCT03110770|12554548|FG001|STARTED|Overall Study||30
11357663|NCT03110770|12554549|FG002|STARTED|Overall Study||30
11357664|NCT03110770|12554550|FG003|STARTED|Overall Study||1170
11357665|NCT03110770|12554551|FG004|STARTED|Overall Study||1168
11357666|NCT03110770|12554547|FG000|Received First Product Administration|Overall Study||30
11357667|NCT03110770|12554548|FG001|Received First Product Administration|Overall Study||30
11357668|NCT03110770|12554549|FG002|Received First Product Administration|Overall Study||30
11357669|NCT03110770|12554550|FG003|Received First Product Administration|Overall Study||1162
11357670|NCT03110770|12554551|FG004|Received First Product Administration|Overall Study||1161
11357671|NCT03110770|12554547|FG000|Received Second Product Administration|Overall Study||30
11357672|NCT03110770|12554548|FG001|Received Second Product Administration|Overall Study||29
11357673|NCT03110770|12554549|FG002|Received Second Product Administration|Overall Study||29
11357674|NCT03110770|12554550|FG003|Received Second Product Administration|Overall Study||1126
11357675|NCT03110770|12554551|FG004|Received Second Product Administration|Overall Study||1127
11357676|NCT03110770|12554547|FG000|Received Third Product Administration|Overall Study||29
11357677|NCT03110770|12554548|FG001|Received Third Product Administration|Overall Study||27
11357678|NCT03110770|12554549|FG002|Received Third Product Administration|Overall Study||28
11357679|NCT03110770|12554550|FG003|Received Third Product Administration|Overall Study||1107
11357680|NCT03110770|12554551|FG004|Received Third Product Administration|Overall Study||1107
11357681|NCT03110770|12554547|FG000|COMPLETED|Overall Study||24
11357682|NCT03110770|12554548|FG001|COMPLETED|Overall Study||30
11357683|NCT03110770|12554549|FG002|COMPLETED|Overall Study||28
11357684|NCT03110770|12554550|FG003|COMPLETED|Overall Study||1037
11357685|NCT03110770|12554551|FG004|COMPLETED|Overall Study||1045
11357686|NCT03110770|12554547|FG000|NOT COMPLETED|Overall Study||6
11357687|NCT03110770|12554548|FG001|NOT COMPLETED|Overall Study||0
11357688|NCT03110770|12554549|FG002|NOT COMPLETED|Overall Study||2
11357689|NCT03110770|12554550|FG003|NOT COMPLETED|Overall Study||133
11357690|NCT03110770|12554551|FG004|NOT COMPLETED|Overall Study||123
11357691|NCT03111108|12554567|FG000|STARTED|Overall Study||53
11357692|NCT03111108|12554568|FG001|STARTED|Overall Study||64
11357693|NCT03111108|12554567|FG000|COMPLETED|Overall Study||52
11357694|NCT03111108|12554568|FG001|COMPLETED|Overall Study||63
11357695|NCT03111108|12554567|FG000|NOT COMPLETED|Overall Study||1
11357696|NCT03111108|12554568|FG001|NOT COMPLETED|Overall Study||1
11357697|NCT03111316|12554578|FG000|STARTED|Overall Study||26
11357698|NCT03111316|12554579|FG001|STARTED|Overall Study||24
11357699|NCT03111316|12554580|FG002|STARTED|Overall Study||25
11357700|NCT03111316|12554581|FG003|STARTED|Overall Study||25
11357701|NCT03111316|12554578|FG000|COMPLETED|Overall Study||26
11357702|NCT03111316|12554579|FG001|COMPLETED|Overall Study||24
11357703|NCT03111316|12554580|FG002|COMPLETED|Overall Study||25
11357704|NCT03111316|12554581|FG003|COMPLETED|Overall Study||25
11357705|NCT03111316|12554578|FG000|NOT COMPLETED|Overall Study||0
11357706|NCT03111316|12554579|FG001|NOT COMPLETED|Overall Study||0
11357707|NCT03111316|12554580|FG002|NOT COMPLETED|Overall Study||0
11357708|NCT03111316|12554581|FG003|NOT COMPLETED|Overall Study||0
11357709|NCT03111381|12554593|FG000|STARTED|Overall Study||46
11357710|NCT03111381|12554594|FG001|STARTED|Overall Study||48
11357711|NCT03111381|12554593|FG000|COMPLETED|Overall Study||46
11357712|NCT03111381|12554594|FG001|COMPLETED|Overall Study||48
11357713|NCT03111381|12554593|FG000|NOT COMPLETED|Overall Study||0
11357714|NCT03111381|12554594|FG001|NOT COMPLETED|Overall Study||0
11357715|NCT03111407|12554602|FG000|STARTED|Overall Study||45
11357716|NCT03111407|12554603|FG001|STARTED|Overall Study||27
11357717|NCT03111407|12554602|FG000|COMPLETED|Overall Study||44
11357718|NCT03111407|12554603|FG001|COMPLETED|Overall Study||26
11357719|NCT03111407|12554602|FG000|NOT COMPLETED|Overall Study||1
11357720|NCT03111407|12554603|FG001|NOT COMPLETED|Overall Study||1
11357721|NCT03111550|12554613|FG000|STARTED|Overall Study|First eye|77
11357722|NCT03111550|12554614|FG001|STARTED|Overall Study|First eye|73
11357723|NCT03111550|12554615|FG002|STARTED|Overall Study|First eye|79
11357724|NCT03111550|12554613|FG000|COMPLETED|Overall Study||73
11357725|NCT03111550|12554614|FG001|COMPLETED|Overall Study||71
11357726|NCT03111550|12554615|FG002|COMPLETED|Overall Study||76
11357727|NCT03111550|12554613|FG000|NOT COMPLETED|Overall Study||4
11357728|NCT03111550|12554614|FG001|NOT COMPLETED|Overall Study||2
11357729|NCT03111550|12554615|FG002|NOT COMPLETED|Overall Study||3
11357730|NCT03111628|12554623|FG000|STARTED|Overall Study||18
11357731|NCT03111628|12554623|FG000|COMPLETED|Overall Study||18
11357732|NCT03111628|12554623|FG000|NOT COMPLETED|Overall Study||0
11357733|NCT03111940|12554630|FG000|STARTED|Overall Study||21
11357734|NCT03111940|12554631|FG001|STARTED|Overall Study||14
11357735|NCT03111940|12554630|FG000|COMPLETED|Overall Study||21
11357736|NCT03111940|12554631|FG001|COMPLETED|Overall Study||14
11357737|NCT03111940|12554630|FG000|NOT COMPLETED|Overall Study||0
11357738|NCT03111940|12554631|FG001|NOT COMPLETED|Overall Study||0
11357739|NCT03112473|12554643|FG000|STARTED|Overall Study||30
11357740|NCT03112473|12554644|FG001|STARTED|Overall Study||30
11357741|NCT03112473|12554645|FG002|STARTED|Overall Study||30
11357742|NCT03112473|12554646|FG003|STARTED|Overall Study||30
11357743|NCT03112473|12554643|FG000|COMPLETED|Overall Study||30
11357744|NCT03112473|12554644|FG001|COMPLETED|Overall Study||30
11357745|NCT03112473|12554645|FG002|COMPLETED|Overall Study||30
11357746|NCT03112473|12554646|FG003|COMPLETED|Overall Study||30
11357747|NCT03112473|12554643|FG000|NOT COMPLETED|Overall Study||0
11357748|NCT03112473|12554644|FG001|NOT COMPLETED|Overall Study||0
11357749|NCT03112473|12554645|FG002|NOT COMPLETED|Overall Study||0
11357750|NCT03112473|12554646|FG003|NOT COMPLETED|Overall Study||0
11357751|NCT03112863|12554661|FG000|STARTED|Overall Study||21
11357752|NCT03112863|12554662|FG001|STARTED|Overall Study||23
11357753|NCT03112863|12554661|FG000|COMPLETED|Overall Study||21
11357754|NCT03112863|12554662|FG001|COMPLETED|Overall Study||23
11357755|NCT03112863|12554661|FG000|NOT COMPLETED|Overall Study||0
11357756|NCT03112863|12554662|FG001|NOT COMPLETED|Overall Study||0
11357757|NCT03113656|12554670|FG000|STARTED|Overall Study||9
11357758|NCT03113656|12554671|FG001|STARTED|Overall Study||7
11357759|NCT03113656|12554670|FG000|COMPLETED|Overall Study||9
11357760|NCT03113656|12554671|FG001|COMPLETED|Overall Study||7
11357761|NCT03113656|12554670|FG000|NOT COMPLETED|Overall Study||0
11357762|NCT03113656|12554671|FG001|NOT COMPLETED|Overall Study||0
11357763|NCT03113916|12554679|FG000|STARTED|Overall Study||99
11357764|NCT03113916|12554680|FG001|STARTED|Overall Study||96
11357765|NCT03113916|12554679|FG000|COMPLETED|Overall Study||88
11357766|NCT03113916|12554680|FG001|COMPLETED|Overall Study||84
11357767|NCT03113916|12554679|FG000|NOT COMPLETED|Overall Study||11
11357768|NCT03113916|12554680|FG001|NOT COMPLETED|Overall Study||12
11357769|NCT03114124|12554693|FG000|STARTED|Overall Study||15
11357770|NCT03114124|12554694|FG001|STARTED|Overall Study||15
11357771|NCT03114124|12554693|FG000|COMPLETED|Overall Study||15
11357772|NCT03114124|12554694|FG001|COMPLETED|Overall Study||15
11357773|NCT03114124|12554693|FG000|NOT COMPLETED|Overall Study||0
11357774|NCT03114124|12554694|FG001|NOT COMPLETED|Overall Study||0
11357775|NCT03114488|12554700|FG000|STARTED|Time Period 1||19
11357776|NCT03114488|12554701|FG001|STARTED|Time Period 1||22
11357777|NCT03114488|12554700|FG000|COMPLETED|Time Period 1||19
11357778|NCT03114488|12554701|FG001|COMPLETED|Time Period 1||22
11357779|NCT03114488|12554700|FG000|NOT COMPLETED|Time Period 1||0
11357780|NCT03114488|12554701|FG001|NOT COMPLETED|Time Period 1||0
11357781|NCT03114488|12554700|FG000|STARTED|Time Period 2||19
11357782|NCT03114488|12554701|FG001|STARTED|Time Period 2||22
11357783|NCT03114488|12554700|FG000|COMPLETED|Time Period 2||18
11357784|NCT03114488|12554701|FG001|COMPLETED|Time Period 2||19
11357785|NCT03114488|12554700|FG000|NOT COMPLETED|Time Period 2||1
11357786|NCT03114488|12554701|FG001|NOT COMPLETED|Time Period 2||3
11357787|NCT03114657|12554713|FG000|STARTED|Overall Study||399
11357788|NCT03114657|12554714|FG001|STARTED|Overall Study||407
11357789|NCT03114657|12554713|FG000|COMPLETED|Overall Study||0
11357790|NCT03114657|12554714|FG001|COMPLETED|Overall Study||0
11357791|NCT03114657|12554713|FG000|NOT COMPLETED|Overall Study||399
11357792|NCT03114657|12554714|FG001|NOT COMPLETED|Overall Study||407
11357793|NCT03114683|12554721|FG000|STARTED|Overall Study||96
11357794|NCT03114683|12554721|FG000|COMPLETED|Overall Study||52
11357795|NCT03114683|12554721|FG000|NOT COMPLETED|Overall Study||44
11357796|NCT03114969|12554734|FG000|STARTED|Overall Study||50
11357797|NCT03114969|12554735|FG001|STARTED|Overall Study||50
11357798|NCT03114969|12554736|FG002|STARTED|Overall Study||50
11357799|NCT03114969|12554737|FG003|STARTED|Overall Study||50
11357800|NCT03114969|12554738|FG004|STARTED|Overall Study||51
11357801|NCT03114969|12554739|FG005|STARTED|Overall Study||49
11357802|NCT03114969|12554740|FG006|STARTED|Overall Study||50
11357803|NCT03114969|12554741|FG007|STARTED|Overall Study||50
11357804|NCT03114969|12554742|FG008|STARTED|Overall Study||50
11357805|NCT03114969|12554734|FG000|COMPLETED|Overall Study||50
11357806|NCT03114969|12554735|FG001|COMPLETED|Overall Study||50
11357807|NCT03114969|12554736|FG002|COMPLETED|Overall Study||46
11357808|NCT03114969|12554737|FG003|COMPLETED|Overall Study||48
11357809|NCT03114969|12554738|FG004|COMPLETED|Overall Study||51
11357810|NCT03114969|12554739|FG005|COMPLETED|Overall Study||48
11357811|NCT03114969|12554740|FG006|COMPLETED|Overall Study||49
11357812|NCT03114969|12554741|FG007|COMPLETED|Overall Study||50
11357813|NCT03114969|12554742|FG008|COMPLETED|Overall Study||48
11357814|NCT03114969|12554734|FG000|NOT COMPLETED|Overall Study||0
11357815|NCT03114969|12554735|FG001|NOT COMPLETED|Overall Study||0
11357816|NCT03114969|12554736|FG002|NOT COMPLETED|Overall Study||4
11357817|NCT03114969|12554737|FG003|NOT COMPLETED|Overall Study||2
11357818|NCT03114969|12554738|FG004|NOT COMPLETED|Overall Study||0
11357819|NCT03114969|12554739|FG005|NOT COMPLETED|Overall Study||1
11357820|NCT03114969|12554740|FG006|NOT COMPLETED|Overall Study||1
11357821|NCT03114969|12554741|FG007|NOT COMPLETED|Overall Study||0
11357822|NCT03114969|12554742|FG008|NOT COMPLETED|Overall Study||2
11357823|NCT03114995|12554772|FG000|STARTED|Overall Study||31
11357824|NCT03114995|12554773|FG001|STARTED|Overall Study||31
11357825|NCT03114995|12554774|FG002|STARTED|Overall Study||78
11357826|NCT03114995|12554772|FG000|COMPLETED|Overall Study||30
11357827|NCT03114995|12554773|FG001|COMPLETED|Overall Study||30
11357828|NCT03114995|12554774|FG002|COMPLETED|Overall Study||78
11357829|NCT03114995|12554772|FG000|NOT COMPLETED|Overall Study||1
11357830|NCT03114995|12554773|FG001|NOT COMPLETED|Overall Study||1
11357831|NCT03114995|12554774|FG002|NOT COMPLETED|Overall Study||0
11357832|NCT03115112|12554784|FG000|STARTED|Overall Study||192
11357833|NCT03115112|12554785|FG001|STARTED|Overall Study||194
11357834|NCT03115112|12554784|FG000|Intention-to-treat|Overall Study||191
11357835|NCT03115112|12554785|FG001|Intention-to-treat|Overall Study||193
11357836|NCT03115112|12554784|FG000|COMPLETED|Overall Study||180
11357837|NCT03115112|12554785|FG001|COMPLETED|Overall Study||189
11357838|NCT03115112|12554784|FG000|NOT COMPLETED|Overall Study||12
11357839|NCT03115112|12554785|FG001|NOT COMPLETED|Overall Study||5
11357840|NCT03115177|12554795|FG000|STARTED|Overall Study||27
11357841|NCT03115177|12554796|FG001|STARTED|Overall Study||29
11357842|NCT03115177|12554795|FG000|COMPLETED|Overall Study||27
11357843|NCT03115177|12554796|FG001|COMPLETED|Overall Study||29
11357844|NCT03115177|12554795|FG000|NOT COMPLETED|Overall Study||0
11357845|NCT03115177|12554796|FG001|NOT COMPLETED|Overall Study||0
11357846|NCT03115411|12554802|FG000|STARTED|Overall Study||23
11357847|NCT03115411|12554802|FG000|COMPLETED|Overall Study||23
11357848|NCT03115411|12554802|FG000|NOT COMPLETED|Overall Study||0
11357849|NCT03115476|12554809|FG000|STARTED|Main Trials (LP0084-119x)||407
11357850|NCT03115476|12554810|FG001|STARTED|Main Trials (LP0084-119x)||418
11357851|NCT03115476|12554811|FG002|STARTED|Main Trials (LP0084-119x)||409
11357852|NCT03115476|12554809|FG000|COMPLETED|Main Trials (LP0084-119x)||407
11357853|NCT03115476|12554810|FG001|COMPLETED|Main Trials (LP0084-119x)||418
11357854|NCT03115476|12554811|FG002|COMPLETED|Main Trials (LP0084-119x)||409
11357855|NCT03115476|12554809|FG000|NOT COMPLETED|Main Trials (LP0084-119x)||0
11357856|NCT03115476|12554810|FG001|NOT COMPLETED|Main Trials (LP0084-119x)||0
11357857|NCT03115476|12554811|FG002|NOT COMPLETED|Main Trials (LP0084-119x)||0
11357858|NCT03115476|12554809|FG000|STARTED|LP0084-1369||191
11357859|NCT03115476|12554810|FG001|STARTED|LP0084-1369||210
11357860|NCT03115476|12554811|FG002|STARTED|LP0084-1369||162
11357861|NCT03115476|12554809|FG000|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
11357862|NCT03115476|12554810|FG001|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
11357863|NCT03115476|12554811|FG002|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
11357864|NCT03115476|12554809|FG000|NOT COMPLETED|LP0084-1369||191
11357865|NCT03115476|12554810|FG001|NOT COMPLETED|LP0084-1369||210
11357866|NCT03115476|12554811|FG002|NOT COMPLETED|LP0084-1369||162
11357867|NCT03115580|12554821|FG000|STARTED|Overall Study||35
11357868|NCT03115580|12554822|FG001|STARTED|Overall Study||36
11357869|NCT03115580|12554821|FG000|COMPLETED|Overall Study||35
11357870|NCT03115580|12554822|FG001|COMPLETED|Overall Study||36
11357871|NCT03115580|12554821|FG000|NOT COMPLETED|Overall Study||0
11237930|NCT02069119|12429754|FG002|COMPLETED|Overall Study||20
11237931|NCT02069119|12429755|FG003|COMPLETED|Overall Study||4
11237932|NCT02069119|12429752|FG000|NOT COMPLETED|Overall Study||0
11237933|NCT02069119|12429753|FG001|NOT COMPLETED|Overall Study||0
11237934|NCT02069119|12429754|FG002|NOT COMPLETED|Overall Study||0
11237935|NCT02069119|12429755|FG003|NOT COMPLETED|Overall Study||0
11237936|NCT02069184|12429769|FG000|STARTED|Overall Study||33
11237937|NCT02069184|12429770|FG001|STARTED|Overall Study||33
11357872|NCT03115580|12554822|FG001|NOT COMPLETED|Overall Study||0
11357873|NCT03115801|12554830|FG000|STARTED|Overall Study||4
11357874|NCT03115801|12554831|FG001|STARTED|Overall Study||2
11357875|NCT03115801|12554830|FG000|COMPLETED|Overall Study||1
11357876|NCT03115801|12554831|FG001|COMPLETED|Overall Study||0
11237938|NCT02069184|12429769|FG000|COMPLETED|Overall Study||27
11237939|NCT02069184|12429770|FG001|COMPLETED|Overall Study||31
11237940|NCT02069184|12429769|FG000|NOT COMPLETED|Overall Study||6
11237941|NCT02069184|12429770|FG001|NOT COMPLETED|Overall Study||2
11237942|NCT02069353|12429776|FG000|STARTED|Overall Study||4
11237943|NCT02069353|12429776|FG000|COMPLETED|Overall Study||4
11237944|NCT02069353|12429776|FG000|NOT COMPLETED|Overall Study||0
11237945|NCT02069379|12429782|FG000|STARTED|Baseline Measurements||30
11237946|NCT02069379|12429783|FG001|STARTED|Baseline Measurements||4
11237947|NCT02069379|12429784|FG002|STARTED|Baseline Measurements||2
11237948|NCT02069379|12429785|FG003|STARTED|Baseline Measurements||6
11237949|NCT02069379|12429782|FG000|Baseline Measurements Taken|Baseline Measurements||30
11237950|NCT02069379|12429783|FG001|Baseline Measurements Taken|Baseline Measurements||4
11237951|NCT02069379|12429784|FG002|Baseline Measurements Taken|Baseline Measurements||2
11237952|NCT02069379|12429785|FG003|Baseline Measurements Taken|Baseline Measurements||6
11237953|NCT02069379|12429782|FG000|COMPLETED|Baseline Measurements||27
11237954|NCT02069379|12429783|FG001|COMPLETED|Baseline Measurements||4
11237955|NCT02069379|12429784|FG002|COMPLETED|Baseline Measurements||2
11237956|NCT02069379|12429785|FG003|COMPLETED|Baseline Measurements||4
11237957|NCT02069379|12429782|FG000|NOT COMPLETED|Baseline Measurements||3
11237958|NCT02069379|12429783|FG001|NOT COMPLETED|Baseline Measurements||0
11237959|NCT02069379|12429784|FG002|NOT COMPLETED|Baseline Measurements||0
11237960|NCT02069379|12429785|FG003|NOT COMPLETED|Baseline Measurements||2
11237961|NCT02069379|12429782|FG000|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
11237962|NCT02069379|12429783|FG001|STARTED|First Treatment Arm||4
11357877|NCT03115801|12554830|FG000|NOT COMPLETED|Overall Study||3
11357878|NCT03115801|12554831|FG001|NOT COMPLETED|Overall Study||2
11357879|NCT03115827|12554837|FG000|STARTED|Overall Study||15
11357880|NCT03115827|12554837|FG000|COMPLETED|Overall Study||12
11357881|NCT03115827|12554837|FG000|NOT COMPLETED|Overall Study||3
11357882|NCT03116152|12554843|FG000|STARTED|Overall Study||95
11357883|NCT03116152|12554844|FG001|STARTED|Overall Study||95
11357884|NCT03116152|12554843|FG000|Treated|Overall Study||94
11357885|NCT03116152|12554844|FG001|Treated|Overall Study||87
11357886|NCT03116152|12554843|FG000|COMPLETED|Overall Study||4
11357887|NCT03116152|12554844|FG001|COMPLETED|Overall Study||0
11357888|NCT03116152|12554843|FG000|NOT COMPLETED|Overall Study||91
11357889|NCT03116152|12554844|FG001|NOT COMPLETED|Overall Study||95
11357890|NCT03116230|12554852|FG000|STARTED|Overall Study||19
11357891|NCT03116230|12554853|FG001|STARTED|Overall Study||19
11357892|NCT03116230|12554852|FG000|COMPLETED|Overall Study||15
11357893|NCT03116230|12554853|FG001|COMPLETED|Overall Study||17
11357894|NCT03116230|12554852|FG000|NOT COMPLETED|Overall Study||4
11357895|NCT03116230|12554853|FG001|NOT COMPLETED|Overall Study||2
11357896|NCT03116698|12554863|FG000|STARTED|Overall Study||62
11357897|NCT03116698|12554864|FG001|STARTED|Overall Study||57
11357898|NCT03116698|12554865|FG002|STARTED|Overall Study||62
11357899|NCT03116698|12554866|FG003|STARTED|Overall Study||57
11357900|NCT03116698|12554863|FG000|COMPLETED|Overall Study||56
11357901|NCT03116698|12554864|FG001|COMPLETED|Overall Study||51
11357902|NCT03116698|12554865|FG002|COMPLETED|Overall Study||54
11357903|NCT03116698|12554866|FG003|COMPLETED|Overall Study||55
11357904|NCT03116698|12554863|FG000|NOT COMPLETED|Overall Study||6
11357905|NCT03116698|12554864|FG001|NOT COMPLETED|Overall Study||6
11357906|NCT03116698|12554865|FG002|NOT COMPLETED|Overall Study||8
11357907|NCT03116698|12554866|FG003|NOT COMPLETED|Overall Study||2
11357908|NCT03116828|12554878|FG000|STARTED|Overall Study||44
11357909|NCT03116828|12554879|FG001|STARTED|Overall Study||58
11357910|NCT03116828|12554878|FG000|COMPLETED|Overall Study||36
11357911|NCT03116828|12554879|FG001|COMPLETED|Overall Study||37
11357912|NCT03116828|12554878|FG000|NOT COMPLETED|Overall Study||8
11357913|NCT03116828|12554879|FG001|NOT COMPLETED|Overall Study||21
11357914|NCT03116841|12554885|FG000|STARTED|Overall Study||3
11357915|NCT03116841|12554885|FG000|COMPLETED|Overall Study||3
11357916|NCT03116841|12554885|FG000|NOT COMPLETED|Overall Study||0
11357917|NCT03117140|12554893|FG000|STARTED|Overall Study||40
11357918|NCT03117140|12554894|FG001|STARTED|Overall Study||40
11357919|NCT03117140|12554895|FG002|STARTED|Overall Study||40
11357920|NCT03117140|12554896|FG003|STARTED|Overall Study||40
11357921|NCT03117140|12554893|FG000|COMPLETED|Overall Study||40
11357922|NCT03117140|12554894|FG001|COMPLETED|Overall Study||40
11357923|NCT03117140|12554895|FG002|COMPLETED|Overall Study||40
11357924|NCT03117140|12554896|FG003|COMPLETED|Overall Study||40
11357925|NCT03117140|12554893|FG000|NOT COMPLETED|Overall Study||0
11357926|NCT03117140|12554894|FG001|NOT COMPLETED|Overall Study||0
11357927|NCT03117140|12554895|FG002|NOT COMPLETED|Overall Study||0
11357928|NCT03117140|12554896|FG003|NOT COMPLETED|Overall Study||0
11357929|NCT03117361|12554909|FG000|STARTED|Overall Study||10
11357930|NCT03117361|12554909|FG000|COMPLETED|Overall Study||0
11357931|NCT03117361|12554909|FG000|NOT COMPLETED|Overall Study||10
11237963|NCT02069379|12429784|FG002|STARTED|First Treatment Arm||2
11357932|NCT03117517|12554915|FG000|STARTED|Overall Study||53
11357933|NCT03117517|12554916|FG001|STARTED|Overall Study||53
11357934|NCT03117517|12554915|FG000|COMPLETED|Overall Study||48
11357935|NCT03117517|12554916|FG001|COMPLETED|Overall Study||49
11357936|NCT03117517|12554915|FG000|NOT COMPLETED|Overall Study||5
11357937|NCT03117517|12554916|FG001|NOT COMPLETED|Overall Study||4
11357938|NCT03117569|12554928|FG000|STARTED|Overall Study||127
11357939|NCT03117569|12554929|FG001|STARTED|Overall Study||253
11357940|NCT03117569|12554928|FG000|COMPLETED|Overall Study||123
11357941|NCT03117569|12554929|FG001|COMPLETED|Overall Study||241
11357942|NCT03117569|12554928|FG000|NOT COMPLETED|Overall Study||4
11357943|NCT03117569|12554929|FG001|NOT COMPLETED|Overall Study||12
11357944|NCT03117634|12554941|FG000|STARTED|Overall Study||41
11357945|NCT03117634|12554942|FG001|STARTED|Overall Study||13
11357946|NCT03117634|12554941|FG000|COMPLETED|Overall Study||39
11357947|NCT03117634|12554942|FG001|COMPLETED|Overall Study||13
11357948|NCT03117634|12554941|FG000|NOT COMPLETED|Overall Study||2
11357949|NCT03117634|12554942|FG001|NOT COMPLETED|Overall Study||0
11357950|NCT03117738|12554950|FG000|STARTED|Overall Study||11
11357951|NCT03117738|12554951|FG001|STARTED|Overall Study||10
11357952|NCT03117738|12554950|FG000|COMPLETED|Overall Study||7
11357953|NCT03117738|12554951|FG001|COMPLETED|Overall Study||5
11357954|NCT03117738|12554950|FG000|NOT COMPLETED|Overall Study||4
11357955|NCT03117738|12554951|FG001|NOT COMPLETED|Overall Study||5
11357956|NCT03118297|12554959|FG000|STARTED|Overall Study||32
11357957|NCT03118297|12554960|FG001|STARTED|Overall Study||33
11357958|NCT03118297|12554959|FG000|COMPLETED|Overall Study||32
11357959|NCT03118297|12554960|FG001|COMPLETED|Overall Study||31
11357960|NCT03118297|12554959|FG000|NOT COMPLETED|Overall Study||0
11357961|NCT03118297|12554960|FG001|NOT COMPLETED|Overall Study||2
11357962|NCT03118466|12554966|FG000|STARTED|Overall Study||40
11357963|NCT03118466|12554966|FG000|COMPLETED|Overall Study||40
11357964|NCT03118466|12554966|FG000|NOT COMPLETED|Overall Study||0
11357965|NCT03118518|12554972|FG000|STARTED|Overall Study||108
11357966|NCT03118518|12554973|FG001|STARTED|Overall Study||102
11357967|NCT03118518|12554972|FG000|Subject Treated According to Randomization Assignment|Overall Study||104
11357968|NCT03118518|12554973|FG001|Subject Treated According to Randomization Assignment|Overall Study||99
11357969|NCT03118518|12554972|FG000|COMPLETED|Overall Study||102
11357970|NCT03118518|12554973|FG001|COMPLETED|Overall Study||91
11357971|NCT03118518|12554972|FG000|NOT COMPLETED|Overall Study||6
11357972|NCT03118518|12554973|FG001|NOT COMPLETED|Overall Study||11
11357973|NCT03118596|12554981|FG000|STARTED|Overall Study||90
11357974|NCT03118596|12554982|FG001|STARTED|Overall Study||90
11357975|NCT03118596|12554981|FG000|Treated|Overall Study||2
11357976|NCT03118596|12554982|FG001|Treated|Overall Study||0
11357977|NCT03118596|12554981|FG000|Failed|Overall Study||0
11357978|NCT03118596|12554982|FG001|Failed|Overall Study||4
11357979|NCT03118596|12554981|FG000|COMPLETED|Overall Study||90
11357980|NCT03118596|12554982|FG001|COMPLETED|Overall Study||86
11357981|NCT03118596|12554981|FG000|NOT COMPLETED|Overall Study||0
11357982|NCT03118596|12554982|FG001|NOT COMPLETED|Overall Study||4
11357983|NCT03118739|12554990|FG000|STARTED|Overall Study||32
11357984|NCT03118739|12554991|FG001|STARTED|Overall Study||28
11357985|NCT03118739|12554990|FG000|Completed 12 Weeks of Treatment|Overall Study||26
11357986|NCT03118739|12554991|FG001|Completed 12 Weeks of Treatment|Overall Study||25
11357987|NCT03118739|12554990|FG000|Completed 24 Weeks of Treatment|Overall Study||24
11357988|NCT03118739|12554991|FG001|Completed 24 Weeks of Treatment|Overall Study||25
11357989|NCT03118739|12554990|FG000|COMPLETED|Overall Study||25
11357990|NCT03118739|12554991|FG001|COMPLETED|Overall Study||24
11357991|NCT03118739|12554990|FG000|NOT COMPLETED|Overall Study||7
11357992|NCT03118739|12554991|FG001|NOT COMPLETED|Overall Study||4
11357993|NCT03118765|12555002|FG000|STARTED|Overall Study||30
11357994|NCT03118765|12555003|FG001|STARTED|Overall Study||32
11357995|NCT03118765|12555004|FG002|STARTED|Overall Study||31
11357996|NCT03118765|12555005|FG003|STARTED|Overall Study||32
11357997|NCT03118765|12555006|FG004|STARTED|Overall Study||30
11357998|NCT03118765|12555002|FG000|COMPLETED|Overall Study||26
11357999|NCT03118765|12555003|FG001|COMPLETED|Overall Study||30
11358000|NCT03118765|12555004|FG002|COMPLETED|Overall Study||26
11358001|NCT03118765|12555005|FG003|COMPLETED|Overall Study||29
11358002|NCT03118765|12555006|FG004|COMPLETED|Overall Study||28
11358003|NCT03118765|12555002|FG000|NOT COMPLETED|Overall Study||4
11358004|NCT03118765|12555003|FG001|NOT COMPLETED|Overall Study||2
11358005|NCT03118765|12555004|FG002|NOT COMPLETED|Overall Study||5
11358006|NCT03118765|12555005|FG003|NOT COMPLETED|Overall Study||3
11358007|NCT03118765|12555006|FG004|NOT COMPLETED|Overall Study||2
11358008|NCT03118843|12555019|FG000|STARTED|Overall Study||31
11358009|NCT03118843|12555019|FG000|COMPLETED|Overall Study||31
11358010|NCT03118843|12555019|FG000|NOT COMPLETED|Overall Study||0
11358011|NCT03118934|12555026|FG000|STARTED|Overall Study||34
11358012|NCT03118934|12555027|FG001|STARTED|Overall Study||31
11358013|NCT03118934|12555028|FG002|STARTED|Overall Study||34
11358014|NCT03118934|12555029|FG003|STARTED|Overall Study||29
11358015|NCT03118934|12555030|FG004|STARTED|Overall Study||29
11358016|NCT03118934|12555031|FG005|STARTED|Overall Study||25
11358017|NCT03118934|12555026|FG000|Safety Analysis Set|Overall Study||34
11358018|NCT03118934|12555027|FG001|Safety Analysis Set|Overall Study||29
11358019|NCT03118934|12555028|FG002|Safety Analysis Set|Overall Study||34
11358020|NCT03118934|12555029|FG003|Safety Analysis Set|Overall Study||29
11358021|NCT03118934|12555030|FG004|Safety Analysis Set|Overall Study||26
11358022|NCT03118934|12555031|FG005|Safety Analysis Set|Overall Study||25
11358023|NCT03118934|12555026|FG000|COMPLETED|Overall Study||34
11358024|NCT03118934|12555027|FG001|COMPLETED|Overall Study||30
11358025|NCT03118934|12555028|FG002|COMPLETED|Overall Study||33
11358026|NCT03118934|12555029|FG003|COMPLETED|Overall Study||28
11358027|NCT03118934|12555030|FG004|COMPLETED|Overall Study||27
11358028|NCT03118934|12555031|FG005|COMPLETED|Overall Study||23
11358029|NCT03118934|12555026|FG000|NOT COMPLETED|Overall Study||0
11358030|NCT03118934|12555027|FG001|NOT COMPLETED|Overall Study||1
11358031|NCT03118934|12555028|FG002|NOT COMPLETED|Overall Study||1
11358032|NCT03118934|12555029|FG003|NOT COMPLETED|Overall Study||1
11358033|NCT03118934|12555030|FG004|NOT COMPLETED|Overall Study||2
11358034|NCT03118934|12555031|FG005|NOT COMPLETED|Overall Study||2
11358035|NCT03118947|12555041|FG000|STARTED|Overall Study||78
11358036|NCT03118947|12555041|FG000|COMPLETED|Overall Study||49
11358037|NCT03118947|12555041|FG000|NOT COMPLETED|Overall Study||29
11358038|NCT03119025|12555045|FG000|STARTED|Overall Study||10
11358039|NCT03119025|12555045|FG000|COMPLETED|Overall Study||10
11358040|NCT03119025|12555045|FG000|NOT COMPLETED|Overall Study||0
11358041|NCT03119168|12555051|FG000|STARTED|Overall Study||129
11358042|NCT03119168|12555052|FG001|STARTED|Overall Study||139
11358043|NCT03119168|12555051|FG000|COMPLETED|Overall Study||129
11358044|NCT03119168|12555052|FG001|COMPLETED|Overall Study||139
11358045|NCT03119168|12555051|FG000|NOT COMPLETED|Overall Study||0
11358046|NCT03119168|12555052|FG001|NOT COMPLETED|Overall Study||0
11358047|NCT03119181|12555062|FG000|STARTED|Overall Study||19
11358048|NCT03119181|12555063|FG001|STARTED|Overall Study||21
11358049|NCT03119181|12555062|FG000|COMPLETED|Overall Study||19
11358050|NCT03119181|12555063|FG001|COMPLETED|Overall Study||21
11358051|NCT03119181|12555062|FG000|NOT COMPLETED|Overall Study||0
11358052|NCT03119181|12555063|FG001|NOT COMPLETED|Overall Study||0
11358053|NCT03119389|12555071|FG000|STARTED|Overall Study||6791
11358054|NCT03119389|12555072|FG001|STARTED|Overall Study||7627
11358055|NCT03119389|12555071|FG000|COMPLETED|Overall Study||6791
11358056|NCT03119389|12555072|FG001|COMPLETED|Overall Study||7627
11358057|NCT03119389|12555071|FG000|NOT COMPLETED|Overall Study||0
11358058|NCT03119389|12555072|FG001|NOT COMPLETED|Overall Study||0
11358059|NCT03119571|12555082|FG000|STARTED|Overall Study||31
11358060|NCT03119571|12555083|FG001|STARTED|Overall Study||34
11358061|NCT03119571|12555082|FG000|COMPLETED|Overall Study||31
11358062|NCT03119571|12555083|FG001|COMPLETED|Overall Study||34
11358063|NCT03119571|12555082|FG000|NOT COMPLETED|Overall Study||0
11358064|NCT03119571|12555083|FG001|NOT COMPLETED|Overall Study||0
11358065|NCT03119610|12555091|FG000|STARTED|Overall Study||13
11358066|NCT03119610|12555092|FG001|STARTED|Overall Study||10
11358067|NCT03119610|12555091|FG000|COMPLETED|Overall Study||12
11358068|NCT03119610|12555092|FG001|COMPLETED|Overall Study||9
11358069|NCT03119610|12555091|FG000|NOT COMPLETED|Overall Study||1
11358070|NCT03119610|12555092|FG001|NOT COMPLETED|Overall Study||1
11358071|NCT03119649|12555103|FG000|STARTED|Overall Study||11
11358072|NCT03119649|12555104|FG001|STARTED|Overall Study||10
11358073|NCT03119649|12555105|FG002|STARTED|Overall Study||10
11358074|NCT03119649|12555106|FG003|STARTED|Overall Study||14
11001745|NCT00705523|12179047|FG000|NOT COMPLETED|Overall Study||2
11001746|NCT00705523|12179048|FG001|NOT COMPLETED|Overall Study||3
11001747|NCT00705536|12179056|FG000|STARTED|Start Period 1||6
11001748|NCT00705536|12179057|FG001|STARTED|Start Period 1||6
11001749|NCT00705536|12179058|FG002|STARTED|Start Period 1||7
11001750|NCT00705536|12179059|FG003|STARTED|Start Period 1||7
11001751|NCT00705536|12179056|FG000|Received at Least 1 Dose of Study Drug|Start Period 1||6
11001752|NCT00705536|12179057|FG001|Received at Least 1 Dose of Study Drug|Start Period 1||6
11001753|NCT00705536|12179058|FG002|Received at Least 1 Dose of Study Drug|Start Period 1||7
11001754|NCT00705536|12179059|FG003|Received at Least 1 Dose of Study Drug|Start Period 1||7
11001755|NCT00705536|12179056|FG000|COMPLETED|Start Period 1||6
11001756|NCT00705536|12179057|FG001|COMPLETED|Start Period 1||6
11001757|NCT00705536|12179058|FG002|COMPLETED|Start Period 1||7
11001758|NCT00705536|12179059|FG003|COMPLETED|Start Period 1||6
11001759|NCT00705536|12179056|FG000|NOT COMPLETED|Start Period 1||0
11001760|NCT00705536|12179057|FG001|NOT COMPLETED|Start Period 1||0
11001761|NCT00705536|12179058|FG002|NOT COMPLETED|Start Period 1||0
11001762|NCT00705536|12179059|FG003|NOT COMPLETED|Start Period 1||1
11001763|NCT00705536|12179056|FG000|STARTED|Washout Period of at Least 6 Days||6
11001764|NCT00705536|12179057|FG001|STARTED|Washout Period of at Least 6 Days||6
11001765|NCT00705536|12179058|FG002|STARTED|Washout Period of at Least 6 Days||7
11001766|NCT00705536|12179059|FG003|STARTED|Washout Period of at Least 6 Days||6
11001767|NCT00705536|12179056|FG000|COMPLETED|Washout Period of at Least 6 Days||6
11001768|NCT00705536|12179057|FG001|COMPLETED|Washout Period of at Least 6 Days||6
11001769|NCT00705536|12179058|FG002|COMPLETED|Washout Period of at Least 6 Days||7
11001770|NCT00705536|12179059|FG003|COMPLETED|Washout Period of at Least 6 Days||6
11001771|NCT00705536|12179056|FG000|NOT COMPLETED|Washout Period of at Least 6 Days||0
11001772|NCT00705536|12179057|FG001|NOT COMPLETED|Washout Period of at Least 6 Days||0
11001773|NCT00705536|12179058|FG002|NOT COMPLETED|Washout Period of at Least 6 Days||0
11001774|NCT00705536|12179059|FG003|NOT COMPLETED|Washout Period of at Least 6 Days||0
11001775|NCT00705536|12179056|FG000|STARTED|Start Period 2||6
11001776|NCT00705536|12179057|FG001|STARTED|Start Period 2||6
11001777|NCT00705536|12179058|FG002|STARTED|Start Period 2||7
11001778|NCT00705536|12179059|FG003|STARTED|Start Period 2||6
11001779|NCT00705536|12179056|FG000|COMPLETED|Start Period 2||6
11001780|NCT00705536|12179057|FG001|COMPLETED|Start Period 2||6
11001781|NCT00705536|12179058|FG002|COMPLETED|Start Period 2||7
11001782|NCT00705536|12179059|FG003|COMPLETED|Start Period 2||6
11001783|NCT00705536|12179056|FG000|NOT COMPLETED|Start Period 2||0
11001784|NCT00705536|12179057|FG001|NOT COMPLETED|Start Period 2||0
11001785|NCT00705536|12179058|FG002|NOT COMPLETED|Start Period 2||0
11001786|NCT00705536|12179059|FG003|NOT COMPLETED|Start Period 2||0
11001787|NCT00705536|12179056|FG000|STARTED|Completed Study||6
11001788|NCT00705536|12179057|FG001|STARTED|Completed Study||6
11001789|NCT00705536|12179058|FG002|STARTED|Completed Study||7
11001790|NCT00705536|12179059|FG003|STARTED|Completed Study||6
11001791|NCT00705536|12179056|FG000|COMPLETED|Completed Study||6
11001792|NCT00705536|12179057|FG001|COMPLETED|Completed Study||6
11001793|NCT00705536|12179058|FG002|COMPLETED|Completed Study||7
11001794|NCT00705536|12179059|FG003|COMPLETED|Completed Study||6
11001795|NCT00705536|12179056|FG000|NOT COMPLETED|Completed Study||0
11001796|NCT00705536|12179057|FG001|NOT COMPLETED|Completed Study||0
11001797|NCT00705536|12179058|FG002|NOT COMPLETED|Completed Study||0
11001798|NCT00705536|12179059|FG003|NOT COMPLETED|Completed Study||0
11001799|NCT00705575|12179080|FG000|STARTED|Overall Study||349
11001800|NCT00705575|12179081|FG001|STARTED|Overall Study||339
11001801|NCT00705575|12179080|FG000|COMPLETED|Overall Study||326
11001802|NCT00705575|12179081|FG001|COMPLETED|Overall Study||293
11001803|NCT00705575|12179080|FG000|NOT COMPLETED|Overall Study||23
11001804|NCT00705575|12179081|FG001|NOT COMPLETED|Overall Study||46
11001805|NCT00705614|12179089|FG000|STARTED|Initial Intervention||1541
11001806|NCT00705614|12179090|FG001|STARTED|Initial Intervention||1121
11001807|NCT00705614|12179089|FG000|COMPLETED|Initial Intervention||1023
11001808|NCT00705614|12179090|FG001|COMPLETED|Initial Intervention||800
11001809|NCT00705614|12179089|FG000|NOT COMPLETED|Initial Intervention||518
11001810|NCT00705614|12179090|FG001|NOT COMPLETED|Initial Intervention||321
11001811|NCT00705614|12179089|FG000|STARTED|Switch to Remicade||0
11001812|NCT00705614|12179090|FG001|STARTED|Switch to Remicade||298
11001813|NCT00705614|12179089|FG000|COMPLETED|Switch to Remicade||0
11001814|NCT00705614|12179090|FG001|COMPLETED|Switch to Remicade||249
11001815|NCT00705614|12179089|FG000|NOT COMPLETED|Switch to Remicade||0
11001816|NCT00705614|12179090|FG001|NOT COMPLETED|Switch to Remicade||49
11001817|NCT00705653|12179098|FG000|STARTED|Overall Study||46
11001818|NCT00705653|12179098|FG000|COMPLETED|Overall Study||46
11001819|NCT00705653|12179098|FG000|NOT COMPLETED|Overall Study||0
11001820|NCT00705666|12179102|FG000|STARTED|Overall Study||789
11001821|NCT00705666|12179102|FG000|COMPLETED|Overall Study||450
11001822|NCT00705666|12179102|FG000|NOT COMPLETED|Overall Study||339
11001823|NCT00705679|12179111|FG000|STARTED|Overall Study||1007
11001824|NCT00705679|12179112|FG001|STARTED|Overall Study||1003
11001825|NCT00705679|12179113|FG002|STARTED|Overall Study||1009
11001826|NCT00705679|12179114|FG003|STARTED|Overall Study||1007
11001827|NCT00705679|12179115|FG004|STARTED|Overall Study||1003
11001828|NCT00705679|12179111|FG000|COMPLETED|Overall Study||942
11001829|NCT00705679|12179112|FG001|COMPLETED|Overall Study||864
11001830|NCT00705679|12179113|FG002|COMPLETED|Overall Study||894
11001831|NCT00705679|12179114|FG003|COMPLETED|Overall Study||927
11001832|NCT00705679|12179115|FG004|COMPLETED|Overall Study||934
11001833|NCT00705679|12179111|FG000|NOT COMPLETED|Overall Study||65
11001834|NCT00705679|12179112|FG001|NOT COMPLETED|Overall Study||139
11001835|NCT00705679|12179113|FG002|NOT COMPLETED|Overall Study||115
11001836|NCT00705679|12179114|FG003|NOT COMPLETED|Overall Study||80
11001837|NCT00705679|12179115|FG004|NOT COMPLETED|Overall Study||69
11001838|NCT00705718|12179134|FG000|STARTED|Overall Study||44
11001839|NCT00705718|12179135|FG001|STARTED|Overall Study||150
11001840|NCT00705718|12179134|FG000|1 Month Follow up|Overall Study|1 Death|43
11001841|NCT00705718|12179135|FG001|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
11001842|NCT00705718|12179134|FG000|6 Month Follow up|Overall Study|3 Deaths|40
11001843|NCT00705718|12179135|FG001|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
11001844|NCT00705718|12179134|FG000|12 Month Follow up|Overall Study|2 Deaths|37
11001845|NCT00705718|12179135|FG001|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
11001846|NCT00705718|12179134|FG000|COMPLETED|Overall Study||37
11001847|NCT00705718|12179135|FG001|COMPLETED|Overall Study||128
11001848|NCT00705718|12179134|FG000|NOT COMPLETED|Overall Study||7
11001849|NCT00705718|12179135|FG001|NOT COMPLETED|Overall Study||22
11001850|NCT00705757|12179144|FG000|STARTED|Overall Study||32
11001851|NCT00705757|12179145|FG001|STARTED|Overall Study||29
11001852|NCT00705757|12179146|FG002|STARTED|Overall Study||28
11001853|NCT00705757|12179144|FG000|COMPLETED|Overall Study||19
11001854|NCT00705757|12179145|FG001|COMPLETED|Overall Study||21
11001855|NCT00705757|12179146|FG002|COMPLETED|Overall Study||17
11001856|NCT00705757|12179144|FG000|NOT COMPLETED|Overall Study||13
11001857|NCT00705757|12179145|FG001|NOT COMPLETED|Overall Study||8
11001858|NCT00705757|12179146|FG002|NOT COMPLETED|Overall Study||11
11001859|NCT00705783|12179156|FG000|STARTED|Conversion Phase||633
11001860|NCT00705783|12179157|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
11001861|NCT00705783|12179158|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
11001862|NCT00705783|12179156|FG000|Received Study Medication|Conversion Phase||632
11058403|NCT01003990|12240249|FG000|COMPLETED|Overall Study||367
11119557|NCT01331083|12304519|FG000|STARTED|Overall Study||43
11119558|NCT01331083|12304520|FG001|STARTED|Overall Study||25
11119559|NCT01331083|12304519|FG000|COMPLETED|Overall Study||43
11119560|NCT01331083|12304520|FG001|COMPLETED|Overall Study||25
11119561|NCT01331083|12304519|FG000|NOT COMPLETED|Overall Study||0
11119562|NCT01331083|12304520|FG001|NOT COMPLETED|Overall Study||0
11119563|NCT01331109|12304526|FG000|STARTED|Overall Study||57
11119564|NCT01331109|12304526|FG000|COMPLETED|Overall Study||0
11119565|NCT01331109|12304526|FG000|NOT COMPLETED|Overall Study||57
11119566|NCT01331161|12304532|FG000|STARTED|Overall Study||44
11119567|NCT01331161|12304533|FG001|STARTED|Overall Study||33
11119568|NCT01331161|12304532|FG000|COMPLETED|Overall Study||43
11119569|NCT01331161|12304533|FG001|COMPLETED|Overall Study||31
11119570|NCT01331161|12304532|FG000|NOT COMPLETED|Overall Study||1
11119571|NCT01331161|12304533|FG001|NOT COMPLETED|Overall Study||2
11119572|NCT01331213|12304543|FG000|STARTED|Overall Study||8
11119573|NCT01331213|12304544|FG001|STARTED|Overall Study||10
11119574|NCT01331213|12304543|FG000|COMPLETED|Overall Study||8
11119575|NCT01331213|12304544|FG001|COMPLETED|Overall Study||10
11119576|NCT01331213|12304543|FG000|NOT COMPLETED|Overall Study||0
11119577|NCT01331213|12304544|FG001|NOT COMPLETED|Overall Study||0
11119578|NCT01331239|12304552|FG000|STARTED|Part I: Core Study||12
11119579|NCT01331239|12304553|FG001|STARTED|Part I: Core Study||0
11119580|NCT01331239|12304554|FG002|STARTED|Part I: Core Study||0
11119581|NCT01331239|12304552|FG000|COMPLETED|Part I: Core Study||12
11119582|NCT01331239|12304553|FG001|COMPLETED|Part I: Core Study||0
11119583|NCT01331239|12304554|FG002|COMPLETED|Part I: Core Study||0
11119584|NCT01331239|12304552|FG000|NOT COMPLETED|Part I: Core Study||0
11119585|NCT01331239|12304553|FG001|NOT COMPLETED|Part I: Core Study||0
11119586|NCT01331239|12304554|FG002|NOT COMPLETED|Part I: Core Study||0
11119587|NCT01331239|12304552|FG000|STARTED|Part II: Core Study||0
11119588|NCT01331239|12304553|FG001|STARTED|Part II: Core Study||15
11119589|NCT01331239|12304554|FG002|STARTED|Part II: Core Study||4
11119590|NCT01331239|12304552|FG000|COMPLETED|Part II: Core Study||0
11119591|NCT01331239|12304553|FG001|COMPLETED|Part II: Core Study||7
11119592|NCT01331239|12304554|FG002|COMPLETED|Part II: Core Study||3
11119593|NCT01331239|12304552|FG000|NOT COMPLETED|Part II: Core Study||0
11119594|NCT01331239|12304553|FG001|NOT COMPLETED|Part II: Core Study||8
11119595|NCT01331239|12304554|FG002|NOT COMPLETED|Part II: Core Study||1
11119596|NCT01331291|12304572|FG000|STARTED|Overall Study||2
11119597|NCT01331291|12304573|FG001|STARTED|Overall Study||9
11119598|NCT01331291|12304572|FG000|COMPLETED|Overall Study||0
11119599|NCT01331291|12304573|FG001|COMPLETED|Overall Study||0
11119600|NCT01331291|12304572|FG000|NOT COMPLETED|Overall Study||2
11119601|NCT01331291|12304573|FG001|NOT COMPLETED|Overall Study||9
11119602|NCT01331304|12304580|FG000|STARTED|Overall Study||240
11119603|NCT01331304|12304581|FG001|STARTED|Overall Study||242
11119604|NCT01331304|12304580|FG000|COMPLETED|Overall Study||182
11119605|NCT01331304|12304581|FG001|COMPLETED|Overall Study||182
11119606|NCT01331304|12304580|FG000|NOT COMPLETED|Overall Study||58
11119607|NCT01331304|12304581|FG001|NOT COMPLETED|Overall Study||60
11001863|NCT00705783|12179157|FG001|Received Study Medication|Conversion Phase||0
11001864|NCT00705783|12179158|FG002|Received Study Medication|Conversion Phase||0
11001865|NCT00705783|12179156|FG000|COMPLETED|Conversion Phase||500
11001866|NCT00705783|12179157|FG001|COMPLETED|Conversion Phase||0
11001867|NCT00705783|12179158|FG002|COMPLETED|Conversion Phase||0
11001868|NCT00705783|12179156|FG000|NOT COMPLETED|Conversion Phase||133
11001869|NCT00705783|12179157|FG001|NOT COMPLETED|Conversion Phase||0
11001870|NCT00705783|12179158|FG002|NOT COMPLETED|Conversion Phase||0
11001871|NCT00705783|12179156|FG000|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
11001872|NCT00705783|12179157|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
11001873|NCT00705783|12179158|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
11001874|NCT00705783|12179156|FG000|Received Study Medication|Oral Stabilization Phase||709
11001875|NCT00705783|12179157|FG001|Received Study Medication|Oral Stabilization Phase||0
11001876|NCT00705783|12179158|FG002|Received Study Medication|Oral Stabilization Phase||0
11001877|NCT00705783|12179156|FG000|COMPLETED|Oral Stabilization Phase||576
11001878|NCT00705783|12179157|FG001|COMPLETED|Oral Stabilization Phase||0
11001879|NCT00705783|12179158|FG002|COMPLETED|Oral Stabilization Phase||0
11001880|NCT00705783|12179156|FG000|NOT COMPLETED|Oral Stabilization Phase||134
11001881|NCT00705783|12179157|FG001|NOT COMPLETED|Oral Stabilization Phase||0
11001882|NCT00705783|12179158|FG002|NOT COMPLETED|Oral Stabilization Phase||0
11001883|NCT00705783|12179156|FG000|STARTED|Depot Stabilization Phase||576
11001884|NCT00705783|12179157|FG001|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
11001885|NCT00705783|12179158|FG002|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
11001886|NCT00705783|12179156|FG000|COMPLETED|Depot Stabilization Phase||403
11001887|NCT00705783|12179157|FG001|COMPLETED|Depot Stabilization Phase||0
11001888|NCT00705783|12179158|FG002|COMPLETED|Depot Stabilization Phase||0
11001889|NCT00705783|12179156|FG000|NOT COMPLETED|Depot Stabilization Phase||173
11001890|NCT00705783|12179157|FG001|NOT COMPLETED|Depot Stabilization Phase||0
11001891|NCT00705783|12179158|FG002|NOT COMPLETED|Depot Stabilization Phase||0
11001892|NCT00705783|12179156|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
11001893|NCT00705783|12179157|FG001|STARTED|Depot Maintenance Phase||269
11001894|NCT00705783|12179158|FG002|STARTED|Depot Maintenance Phase||134
11001895|NCT00705783|12179156|FG000|COMPLETED|Depot Maintenance Phase||0
11001896|NCT00705783|12179157|FG001|COMPLETED|Depot Maintenance Phase||23
11001897|NCT00705783|12179158|FG002|COMPLETED|Depot Maintenance Phase||3
11001898|NCT00705783|12179156|FG000|NOT COMPLETED|Depot Maintenance Phase||0
11001899|NCT00705783|12179157|FG001|NOT COMPLETED|Depot Maintenance Phase||246
11001900|NCT00705783|12179158|FG002|NOT COMPLETED|Depot Maintenance Phase||131
11001901|NCT00705874|12179174|FG000|STARTED|Overall Study||12
11001902|NCT00705874|12179175|FG001|STARTED|Overall Study||9
11001903|NCT00705874|12179176|FG002|STARTED|Overall Study||34
11001904|NCT00705874|12179177|FG003|STARTED|Overall Study||34
11001905|NCT00705874|12179178|FG004|STARTED|Overall Study||48
11001906|NCT00705874|12179179|FG005|STARTED|Overall Study||32
11001907|NCT00705874|12179180|FG006|STARTED|Overall Study||3
11001908|NCT00705874|12179174|FG000|COMPLETED|Overall Study||10
11001909|NCT00705874|12179175|FG001|COMPLETED|Overall Study||8
11001910|NCT00705874|12179176|FG002|COMPLETED|Overall Study||32
11001911|NCT00705874|12179177|FG003|COMPLETED|Overall Study||33
11001912|NCT00705874|12179178|FG004|COMPLETED|Overall Study||36
11001913|NCT00705874|12179179|FG005|COMPLETED|Overall Study||28
11001914|NCT00705874|12179180|FG006|COMPLETED|Overall Study||3
11001915|NCT00705874|12179174|FG000|NOT COMPLETED|Overall Study||2
11001916|NCT00705874|12179175|FG001|NOT COMPLETED|Overall Study||1
11001917|NCT00705874|12179176|FG002|NOT COMPLETED|Overall Study||2
11001918|NCT00705874|12179177|FG003|NOT COMPLETED|Overall Study||1
11001919|NCT00705874|12179178|FG004|NOT COMPLETED|Overall Study||12
11001920|NCT00705874|12179179|FG005|NOT COMPLETED|Overall Study||4
11001921|NCT00705874|12179180|FG006|NOT COMPLETED|Overall Study||0
11001922|NCT00705939|12179199|FG000|STARTED|Overall Study||12
11001923|NCT00705939|12179200|FG001|STARTED|Overall Study||14
11001924|NCT00705939|12179201|FG002|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
11001925|NCT00705939|12179199|FG000|COMPLETED|Overall Study||12
11001926|NCT00705939|12179200|FG001|COMPLETED|Overall Study||12
11001927|NCT00705939|12179201|FG002|COMPLETED|Overall Study||14
11001928|NCT00705939|12179199|FG000|NOT COMPLETED|Overall Study||0
11001929|NCT00705939|12179200|FG001|NOT COMPLETED|Overall Study||2
11001930|NCT00705939|12179201|FG002|NOT COMPLETED|Overall Study||4
11056226|NCT00993187|12237765|FG001|Received at Least 1 Dose of Study Drug|Overall Study||144
11056227|NCT00993187|12237764|FG000|COMPLETED|Overall Study||121
11056228|NCT00993187|12237765|FG001|COMPLETED|Overall Study||108
11056229|NCT00993187|12237764|FG000|NOT COMPLETED|Overall Study||26
11056230|NCT00993187|12237765|FG001|NOT COMPLETED|Overall Study||37
11056231|NCT00993200|12237773|FG000|STARTED|Overall Study||13
11056232|NCT00993200|12237774|FG001|STARTED|Overall Study||13
11056233|NCT00993200|12237773|FG000|COMPLETED|Overall Study||13
11056234|NCT00993200|12237774|FG001|COMPLETED|Overall Study||13
11056235|NCT00993200|12237773|FG000|NOT COMPLETED|Overall Study||0
11056236|NCT00993200|12237774|FG001|NOT COMPLETED|Overall Study||0
11056237|NCT00993226|12237785|FG000|STARTED|Overall Study||61
11056238|NCT00993226|12237786|FG001|STARTED|Overall Study||27
11056239|NCT00993226|12237787|FG002|STARTED|Overall Study||27
11056240|NCT00993226|12237785|FG000|COMPLETED|Overall Study||60
11056241|NCT00993226|12237786|FG001|COMPLETED|Overall Study||26
11056242|NCT00993226|12237787|FG002|COMPLETED|Overall Study||27
11056243|NCT00993226|12237785|FG000|NOT COMPLETED|Overall Study||1
11056244|NCT00993226|12237786|FG001|NOT COMPLETED|Overall Study||1
11056245|NCT00993226|12237787|FG002|NOT COMPLETED|Overall Study||0
11056246|NCT00993265|12237797|FG000|STARTED|Overall Study||20
11056247|NCT00993265|12237798|FG001|STARTED|Overall Study||19
11056248|NCT00993265|12237797|FG000|COMPLETED|Overall Study||16
11056249|NCT00993265|12237798|FG001|COMPLETED|Overall Study||19
11056250|NCT00993265|12237797|FG000|NOT COMPLETED|Overall Study||4
11056251|NCT00993265|12237798|FG001|NOT COMPLETED|Overall Study||0
11056252|NCT00993291|12237804|FG000|STARTED|Overall Study||20
11056253|NCT00993291|12237804|FG000|COMPLETED|Overall Study||19
11056254|NCT00993291|12237804|FG000|NOT COMPLETED|Overall Study||1
11056255|NCT00993317|12237810|FG000|STARTED|Overall Study||42
11056256|NCT00993317|12237811|FG001|STARTED|Overall Study||85
11056257|NCT00993317|12237810|FG000|COMPLETED|Overall Study||21
11056258|NCT00993317|12237811|FG001|COMPLETED|Overall Study||60
11056259|NCT00993317|12237810|FG000|NOT COMPLETED|Overall Study||21
11056260|NCT00993317|12237811|FG001|NOT COMPLETED|Overall Study||25
11056261|NCT00993421|12237824|FG000|STARTED|Overall Study||49
11056262|NCT00993421|12237825|FG001|STARTED|Overall Study||49
11056263|NCT00993421|12237826|FG002|STARTED|Overall Study||48
11056264|NCT00993421|12237827|FG003|STARTED|Overall Study||49
11056265|NCT00993421|12237828|FG004|STARTED|Overall Study||52
11056266|NCT00993421|12237829|FG005|STARTED|Overall Study||50
11056267|NCT00993421|12237830|FG006|STARTED|Overall Study||46
11056268|NCT00993421|12237824|FG000|COMPLETED|Overall Study||5
11056269|NCT00993421|12237825|FG001|COMPLETED|Overall Study||4
11056270|NCT00993421|12237826|FG002|COMPLETED|Overall Study||5
11056271|NCT00993421|12237827|FG003|COMPLETED|Overall Study||4
11056272|NCT00993421|12237828|FG004|COMPLETED|Overall Study||6
11001931|NCT00706004|12179210|FG000|STARTED|Overall Study||9
11001932|NCT00706004|12179210|FG000|COMPLETED|Overall Study||7
11001933|NCT00706004|12179210|FG000|NOT COMPLETED|Overall Study||2
11001934|NCT00706030|12179219|FG000|STARTED|Overall Study||6
11001935|NCT00706030|12179220|FG001|STARTED|Overall Study||6
11001936|NCT00706030|12179221|FG002|STARTED|Overall Study||64
11001937|NCT00706030|12179222|FG003|STARTED|Overall Study||16
11001938|NCT00706030|12179219|FG000|Treated|Overall Study||6
11001939|NCT00706030|12179220|FG001|Treated|Overall Study||6
11001940|NCT00706030|12179221|FG002|Treated|Overall Study||64
11001941|NCT00706030|12179222|FG003|Treated|Overall Study||15
11001942|NCT00706030|12179219|FG000|COMPLETED|Overall Study||0
11001943|NCT00706030|12179220|FG001|COMPLETED|Overall Study||0
11001944|NCT00706030|12179221|FG002|COMPLETED|Overall Study||4
11001945|NCT00706030|12179222|FG003|COMPLETED|Overall Study||0
11001946|NCT00706030|12179219|FG000|NOT COMPLETED|Overall Study||6
11001947|NCT00706030|12179220|FG001|NOT COMPLETED|Overall Study||6
11001948|NCT00706030|12179221|FG002|NOT COMPLETED|Overall Study||60
11001949|NCT00706030|12179222|FG003|NOT COMPLETED|Overall Study||16
11001950|NCT00706095|12179236|FG000|STARTED|Overall Study||6
11001951|NCT00706095|12179237|FG001|STARTED|Overall Study||7
11001952|NCT00706095|12179238|FG002|STARTED|Overall Study||5
11001953|NCT00706095|12179236|FG000|COMPLETED|Overall Study||0
11001954|NCT00706095|12179237|FG001|COMPLETED|Overall Study||0
11001955|NCT00706095|12179238|FG002|COMPLETED|Overall Study||0
11001956|NCT00706095|12179236|FG000|NOT COMPLETED|Overall Study||6
11001957|NCT00706095|12179237|FG001|NOT COMPLETED|Overall Study||7
11001958|NCT00706095|12179238|FG002|NOT COMPLETED|Overall Study||5
11001959|NCT00706121|12179250|FG000|STARTED|Overall Study||2039
11001960|NCT00706121|12179251|FG001|STARTED|Overall Study||2096
11001961|NCT00706121|12179252|FG002|STARTED|Overall Study||2030
11001962|NCT00706121|12179253|FG003|STARTED|Overall Study||1929
11001963|NCT00706121|12179250|FG000|COMPLETED|Overall Study||1643
11001964|NCT00706121|12179251|FG001|COMPLETED|Overall Study||1700
11001965|NCT00706121|12179252|FG002|COMPLETED|Overall Study||1626
11001966|NCT00706121|12179253|FG003|COMPLETED|Overall Study||1577
11001967|NCT00706121|12179250|FG000|NOT COMPLETED|Overall Study||396
11001968|NCT00706121|12179251|FG001|NOT COMPLETED|Overall Study||396
11001969|NCT00706121|12179252|FG002|NOT COMPLETED|Overall Study||404
11001970|NCT00706121|12179253|FG003|NOT COMPLETED|Overall Study||352
11001971|NCT00706134|12179275|FG000|STARTED|Overall Study||189
11001972|NCT00706134|12179276|FG001|STARTED|Overall Study||192
11001973|NCT00706134|12179277|FG002|STARTED|Overall Study||189
11001974|NCT00706134|12179278|FG003|STARTED|Overall Study||186
11001975|NCT00706134|12179275|FG000|Entered Double-blind Period|Overall Study||187
11001976|NCT00706134|12179276|FG001|Entered Double-blind Period|Overall Study||192
11001977|NCT00706134|12179277|FG002|Entered Double-blind Period|Overall Study||189
11001978|NCT00706134|12179278|FG003|Entered Double-blind Period|Overall Study||186
11001979|NCT00706134|12179275|FG000|COMPLETED|Overall Study||169
11001980|NCT00706134|12179276|FG001|COMPLETED|Overall Study||173
11001981|NCT00706134|12179277|FG002|COMPLETED|Overall Study||183
11001982|NCT00706134|12179278|FG003|COMPLETED|Overall Study||175
11001983|NCT00706134|12179275|FG000|NOT COMPLETED|Overall Study||20
11001984|NCT00706134|12179276|FG001|NOT COMPLETED|Overall Study||19
11001985|NCT00706134|12179277|FG002|NOT COMPLETED|Overall Study||6
11001986|NCT00706134|12179278|FG003|NOT COMPLETED|Overall Study||11
11001987|NCT00706238|12179288|FG000|STARTED|Overall Study||5
11001988|NCT00706238|12179288|FG000|COMPLETED|Overall Study||0
11001989|NCT00706238|12179288|FG000|NOT COMPLETED|Overall Study||5
11001990|NCT00706264|12179294|FG000|STARTED|Overall Study||193
11001991|NCT00706264|12179295|FG001|STARTED|Overall Study||192
11001992|NCT00706264|12179294|FG000|COMPLETED|Overall Study||190
11001993|NCT00706264|12179295|FG001|COMPLETED|Overall Study||190
11001994|NCT00706264|12179294|FG000|NOT COMPLETED|Overall Study||3
11001995|NCT00706264|12179295|FG001|NOT COMPLETED|Overall Study||2
11056273|NCT00993421|12237829|FG005|COMPLETED|Overall Study||4
11056274|NCT00993421|12237830|FG006|COMPLETED|Overall Study||4
11056275|NCT00993421|12237824|FG000|NOT COMPLETED|Overall Study||44
11056276|NCT00993421|12237825|FG001|NOT COMPLETED|Overall Study||45
11056277|NCT00993421|12237826|FG002|NOT COMPLETED|Overall Study||43
11056278|NCT00993421|12237827|FG003|NOT COMPLETED|Overall Study||45
11056279|NCT00993421|12237828|FG004|NOT COMPLETED|Overall Study||46
11056280|NCT00993421|12237829|FG005|NOT COMPLETED|Overall Study||46
11056281|NCT00993421|12237830|FG006|NOT COMPLETED|Overall Study||42
11056282|NCT00993473|12237848|FG000|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
11056283|NCT00993473|12237849|FG001|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
11056284|NCT00993473|12237848|FG000|COMPLETED|Overall Study||57
11056285|NCT00993473|12237849|FG001|COMPLETED|Overall Study||54
11056286|NCT00993473|12237848|FG000|NOT COMPLETED|Overall Study||4
11056287|NCT00993473|12237849|FG001|NOT COMPLETED|Overall Study||10
11056288|NCT00993499|12237861|FG000|STARTED|Run-in Period (8 Days)||13
11056289|NCT00993499|12237862|FG001|STARTED|Run-in Period (8 Days)||12
11056290|NCT00993499|12237863|FG002|STARTED|Run-in Period (8 Days)||10
11056291|NCT00993499|12237864|FG003|STARTED|Run-in Period (8 Days)||3
11056292|NCT00993499|12237865|FG004|STARTED|Run-in Period (8 Days)||3
11056293|NCT00993499|12237866|FG005|STARTED|Run-in Period (8 Days)||3
11056294|NCT00993499|12237861|FG000|COMPLETED|Run-in Period (8 Days)||12
11056295|NCT00993499|12237862|FG001|COMPLETED|Run-in Period (8 Days)||9
11056296|NCT00993499|12237863|FG002|COMPLETED|Run-in Period (8 Days)||9
11056297|NCT00993499|12237864|FG003|COMPLETED|Run-in Period (8 Days)||3
11056298|NCT00993499|12237865|FG004|COMPLETED|Run-in Period (8 Days)||3
11056299|NCT00993499|12237866|FG005|COMPLETED|Run-in Period (8 Days)||3
11056300|NCT00993499|12237861|FG000|NOT COMPLETED|Run-in Period (8 Days)||1
11056301|NCT00993499|12237862|FG001|NOT COMPLETED|Run-in Period (8 Days)||3
11056302|NCT00993499|12237863|FG002|NOT COMPLETED|Run-in Period (8 Days)||1
11056303|NCT00993499|12237864|FG003|NOT COMPLETED|Run-in Period (8 Days)||0
11056304|NCT00993499|12237865|FG004|NOT COMPLETED|Run-in Period (8 Days)||0
11056305|NCT00993499|12237866|FG005|NOT COMPLETED|Run-in Period (8 Days)||0
11056306|NCT00993499|12237861|FG000|STARTED|Discontinued Before Starting Course 3||12
11056307|NCT00993499|12237862|FG001|STARTED|Discontinued Before Starting Course 3||9
11056308|NCT00993499|12237863|FG002|STARTED|Discontinued Before Starting Course 3||9
11056309|NCT00993499|12237864|FG003|STARTED|Discontinued Before Starting Course 3||3
11056310|NCT00993499|12237865|FG004|STARTED|Discontinued Before Starting Course 3||3
11056311|NCT00993499|12237866|FG005|STARTED|Discontinued Before Starting Course 3||3
11056312|NCT00993499|12237861|FG000|COMPLETED|Discontinued Before Starting Course 3||8
11056313|NCT00993499|12237862|FG001|COMPLETED|Discontinued Before Starting Course 3||5
11001996|NCT00706342|12179303|FG000|STARTED|Overall Study||18
11001997|NCT00706342|12179303|FG000|COMPLETED|Overall Study||0
11001998|NCT00706342|12179303|FG000|NOT COMPLETED|Overall Study||18
11001999|NCT00706355|12179311|FG000|STARTED|Period 1: PF-04217903 50 mg||3
11002000|NCT00706355|12179312|FG001|STARTED|Period 1: PF-04217903 50 mg||0
11002001|NCT00706355|12179313|FG002|STARTED|Period 1: PF-04217903 50 mg||0
11002002|NCT00706355|12179314|FG003|STARTED|Period 1: PF-04217903 50 mg||0
11237964|NCT02069379|12429785|FG003|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
11237965|NCT02069379|12429782|FG000|COMPLETED|First Treatment Arm||0
11237966|NCT02069379|12429783|FG001|COMPLETED|First Treatment Arm||3
11237967|NCT02069379|12429784|FG002|COMPLETED|First Treatment Arm||1
11002003|NCT00706355|12179311|FG000|COMPLETED|Period 1: PF-04217903 50 mg||0
11002004|NCT00706355|12179312|FG001|COMPLETED|Period 1: PF-04217903 50 mg||0
11002005|NCT00706355|12179313|FG002|COMPLETED|Period 1: PF-04217903 50 mg||0
11002006|NCT00706355|12179314|FG003|COMPLETED|Period 1: PF-04217903 50 mg||0
11002007|NCT00706355|12179311|FG000|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
11002008|NCT00706355|12179312|FG001|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
11002009|NCT00706355|12179313|FG002|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
11002010|NCT00706355|12179314|FG003|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
11002011|NCT00706355|12179311|FG000|STARTED|Period 2: PF-04217903 100 mg||0
11002012|NCT00706355|12179312|FG001|STARTED|Period 2: PF-04217903 100 mg||7
11002013|NCT00706355|12179313|FG002|STARTED|Period 2: PF-04217903 100 mg||0
11002014|NCT00706355|12179314|FG003|STARTED|Period 2: PF-04217903 100 mg||0
11002015|NCT00706355|12179311|FG000|COMPLETED|Period 2: PF-04217903 100 mg||0
11002016|NCT00706355|12179312|FG001|COMPLETED|Period 2: PF-04217903 100 mg||0
11002017|NCT00706355|12179313|FG002|COMPLETED|Period 2: PF-04217903 100 mg||0
11002018|NCT00706355|12179314|FG003|COMPLETED|Period 2: PF-04217903 100 mg||0
11002019|NCT00706355|12179311|FG000|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
11002020|NCT00706355|12179312|FG001|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
11002021|NCT00706355|12179313|FG002|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
11002022|NCT00706355|12179314|FG003|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
11002023|NCT00706355|12179311|FG000|STARTED|Period 3: PF-04217903 200 mg||0
11002024|NCT00706355|12179312|FG001|STARTED|Period 3: PF-04217903 200 mg||0
11002025|NCT00706355|12179313|FG002|STARTED|Period 3: PF-04217903 200 mg||2
11002026|NCT00706355|12179314|FG003|STARTED|Period 3: PF-04217903 200 mg||0
11002027|NCT00706355|12179311|FG000|COMPLETED|Period 3: PF-04217903 200 mg||0
11002028|NCT00706355|12179312|FG001|COMPLETED|Period 3: PF-04217903 200 mg||0
11002029|NCT00706355|12179313|FG002|COMPLETED|Period 3: PF-04217903 200 mg||0
11002030|NCT00706355|12179314|FG003|COMPLETED|Period 3: PF-04217903 200 mg||0
11002031|NCT00706355|12179311|FG000|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
11002032|NCT00706355|12179312|FG001|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
11002033|NCT00706355|12179313|FG002|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
11002034|NCT00706355|12179314|FG003|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
11002035|NCT00706355|12179311|FG000|STARTED|Period 4: PF-04217903 150 mg||0
11002036|NCT00706355|12179312|FG001|STARTED|Period 4: PF-04217903 150 mg||0
11002037|NCT00706355|12179313|FG002|STARTED|Period 4: PF-04217903 150 mg||0
11002038|NCT00706355|12179314|FG003|STARTED|Period 4: PF-04217903 150 mg||4
11002039|NCT00706355|12179311|FG000|COMPLETED|Period 4: PF-04217903 150 mg||0
11002040|NCT00706355|12179312|FG001|COMPLETED|Period 4: PF-04217903 150 mg||0
11002041|NCT00706355|12179313|FG002|COMPLETED|Period 4: PF-04217903 150 mg||0
11002042|NCT00706355|12179314|FG003|COMPLETED|Period 4: PF-04217903 150 mg||0
11002043|NCT00706355|12179311|FG000|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
11058404|NCT01003990|12240250|FG001|COMPLETED|Overall Study||103
11002044|NCT00706355|12179312|FG001|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
11002045|NCT00706355|12179313|FG002|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
11002046|NCT00706355|12179314|FG003|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
11002047|NCT00706381|12179330|FG000|STARTED|Overall Study||10
11002048|NCT00706381|12179331|FG001|STARTED|Overall Study||6
11002049|NCT00706381|12179332|FG002|STARTED|Overall Study||6
11002050|NCT00706381|12179333|FG003|STARTED|Overall Study||9
11002051|NCT00706381|12179330|FG000|Intervention 1 (1 Day)|Overall Study||10
11002052|NCT00706381|12179331|FG001|Intervention 1 (1 Day)|Overall Study||6
11002053|NCT00706381|12179332|FG002|Intervention 1 (1 Day)|Overall Study||6
11002054|NCT00706381|12179333|FG003|Intervention 1 (1 Day)|Overall Study||9
11002055|NCT00706381|12179330|FG000|Intervention 2 (1 Day)|Overall Study||10
11002056|NCT00706381|12179331|FG001|Intervention 2 (1 Day)|Overall Study||6
11002057|NCT00706381|12179332|FG002|Intervention 2 (1 Day)|Overall Study||6
11002058|NCT00706381|12179333|FG003|Intervention 2 (1 Day)|Overall Study||9
11002059|NCT00706381|12179330|FG000|Intervention 3 (1 Day)|Overall Study||10
11002060|NCT00706381|12179331|FG001|Intervention 3 (1 Day)|Overall Study||6
11002061|NCT00706381|12179332|FG002|Intervention 3 (1 Day)|Overall Study||6
11002062|NCT00706381|12179333|FG003|Intervention 3 (1 Day)|Overall Study||9
11002063|NCT00706381|12179330|FG000|Intervention 4 (1 Day)|Overall Study||10
11002064|NCT00706381|12179331|FG001|Intervention 4 (1 Day)|Overall Study||5
11002065|NCT00706381|12179332|FG002|Intervention 4 (1 Day)|Overall Study||6
11002066|NCT00706381|12179333|FG003|Intervention 4 (1 Day)|Overall Study||9
11002067|NCT00706381|12179330|FG000|Intervention 5 (1 Day)|Overall Study||10
11002068|NCT00706381|12179331|FG001|Intervention 5 (1 Day)|Overall Study||5
11237968|NCT02069379|12429785|FG003|COMPLETED|First Treatment Arm||0
11002069|NCT00706381|12179332|FG002|Intervention 5 (1 Day)|Overall Study||5
11002070|NCT00706381|12179333|FG003|Intervention 5 (1 Day)|Overall Study||9
11002071|NCT00706381|12179330|FG000|COMPLETED|Overall Study||10
11002072|NCT00706381|12179331|FG001|COMPLETED|Overall Study||5
11002073|NCT00706381|12179332|FG002|COMPLETED|Overall Study||5
11002074|NCT00706381|12179333|FG003|COMPLETED|Overall Study||9
11002075|NCT00706381|12179330|FG000|NOT COMPLETED|Overall Study||0
11002076|NCT00706381|12179331|FG001|NOT COMPLETED|Overall Study||1
11002077|NCT00706381|12179332|FG002|NOT COMPLETED|Overall Study||1
11002078|NCT00706381|12179333|FG003|NOT COMPLETED|Overall Study||0
11002079|NCT00706394|12179346|FG000|STARTED|Overall Study||19
11002080|NCT00706394|12179346|FG000|COMPLETED|Overall Study||8
11002081|NCT00706394|12179346|FG000|NOT COMPLETED|Overall Study||11
11002082|NCT00706407|12179352|FG000|STARTED|Overall Study||42
11002083|NCT00706407|12179352|FG000|COMPLETED|Overall Study||33
11002084|NCT00706407|12179352|FG000|NOT COMPLETED|Overall Study||9
11002085|NCT00706433|12179363|FG000|STARTED|Overall Study||68
11002086|NCT00706433|12179364|FG001|STARTED|Overall Study||65
11002087|NCT00706433|12179365|FG002|STARTED|Overall Study||67
11002088|NCT00706433|12179366|FG003|STARTED|Overall Study||66
11002089|NCT00706433|12179363|FG000|COMPLETED|Overall Study||63
11002090|NCT00706433|12179364|FG001|COMPLETED|Overall Study||62
11002091|NCT00706433|12179365|FG002|COMPLETED|Overall Study||57
11002092|NCT00706433|12179366|FG003|COMPLETED|Overall Study||64
11002093|NCT00706433|12179363|FG000|NOT COMPLETED|Overall Study||5
11002094|NCT00706433|12179364|FG001|NOT COMPLETED|Overall Study||3
11002095|NCT00706433|12179365|FG002|NOT COMPLETED|Overall Study||10
11002096|NCT00706433|12179366|FG003|NOT COMPLETED|Overall Study||2
11002097|NCT00706446|12179382|FG000|STARTED|Overall Study||29
11002098|NCT00706446|12179383|FG001|STARTED|Overall Study||57
11002099|NCT00706446|12179384|FG002|STARTED|Overall Study||44
11002100|NCT00706446|12179385|FG003|STARTED|Overall Study||26
11002101|NCT00706446|12179386|FG004|STARTED|Overall Study||54
11002102|NCT00706446|12179387|FG005|STARTED|Overall Study||45
11002103|NCT00706446|12179382|FG000|COMPLETED|Overall Study||3
11002104|NCT00706446|12179383|FG001|COMPLETED|Overall Study||8
11002105|NCT00706446|12179384|FG002|COMPLETED|Overall Study||7
11002106|NCT00706446|12179385|FG003|COMPLETED|Overall Study||4
11002107|NCT00706446|12179386|FG004|COMPLETED|Overall Study||10
11002108|NCT00706446|12179387|FG005|COMPLETED|Overall Study||7
11002109|NCT00706446|12179382|FG000|NOT COMPLETED|Overall Study||26
11002110|NCT00706446|12179383|FG001|NOT COMPLETED|Overall Study||49
11002111|NCT00706446|12179384|FG002|NOT COMPLETED|Overall Study||37
11002112|NCT00706446|12179385|FG003|NOT COMPLETED|Overall Study||22
11002113|NCT00706446|12179386|FG004|NOT COMPLETED|Overall Study||44
11002114|NCT00706446|12179387|FG005|NOT COMPLETED|Overall Study||38
11002115|NCT00706485|12179401|FG000|STARTED|Overall Study||5
11002116|NCT00706485|12179401|FG000|COMPLETED|Overall Study||5
11002117|NCT00706485|12179401|FG000|NOT COMPLETED|Overall Study||0
11002118|NCT00706511|12179409|FG000|STARTED|Overall Study||10
11002119|NCT00706511|12179410|FG001|STARTED|Overall Study||4
11002120|NCT00706511|12179411|FG002|STARTED|Overall Study||3
11002121|NCT00706511|12179412|FG003|STARTED|Overall Study||10
11002122|NCT00706511|12179409|FG000|COMPLETED|Overall Study||9
11002123|NCT00706511|12179410|FG001|COMPLETED|Overall Study||4
11002124|NCT00706511|12179411|FG002|COMPLETED|Overall Study||3
11002125|NCT00706511|12179412|FG003|COMPLETED|Overall Study||10
11002126|NCT00706511|12179409|FG000|NOT COMPLETED|Overall Study||1
11002127|NCT00706511|12179410|FG001|NOT COMPLETED|Overall Study||0
11002128|NCT00706511|12179411|FG002|NOT COMPLETED|Overall Study||0
11002129|NCT00706511|12179412|FG003|NOT COMPLETED|Overall Study||0
11002130|NCT00706550|12179422|FG000|STARTED|Overall Study||43
11002131|NCT00706550|12179423|FG001|STARTED|Overall Study||64
11002132|NCT00706550|12179422|FG000|COMPLETED|Overall Study||36
11002133|NCT00706550|12179423|FG001|COMPLETED|Overall Study||36
11002134|NCT00706550|12179422|FG000|NOT COMPLETED|Overall Study||7
11002135|NCT00706550|12179423|FG001|NOT COMPLETED|Overall Study||28
11002136|NCT00706563|12179432|FG000|STARTED|Overall Study||61
11002137|NCT00706563|12179433|FG001|STARTED|Overall Study||59
11002138|NCT00706563|12179432|FG000|COMPLETED|Overall Study||61
11002139|NCT00706563|12179433|FG001|COMPLETED|Overall Study||59
11002140|NCT00706563|12179432|FG000|NOT COMPLETED|Overall Study||0
11002141|NCT00706563|12179433|FG001|NOT COMPLETED|Overall Study||0
11002142|NCT00706589|12179441|FG000|STARTED|Overall Study||32
11002143|NCT00706589|12179442|FG001|STARTED|Overall Study||29
11002144|NCT00706589|12179441|FG000|COMPLETED|Overall Study||29
11002145|NCT00706589|12179442|FG001|COMPLETED|Overall Study||25
11002146|NCT00706589|12179441|FG000|NOT COMPLETED|Overall Study||3
11002147|NCT00706589|12179442|FG001|NOT COMPLETED|Overall Study||4
11002148|NCT00706628|12179452|FG000|STARTED|Overall Study||47
11002149|NCT00706628|12179453|FG001|STARTED|Overall Study||21
11002150|NCT00706628|12179454|FG002|STARTED|Overall Study||16
11002151|NCT00706628|12179455|FG003|STARTED|Overall Study||3
11002152|NCT00706628|12179452|FG000|COMPLETED|Overall Study||0
11002153|NCT00706628|12179453|FG001|COMPLETED|Overall Study||0
11002154|NCT00706628|12179454|FG002|COMPLETED|Overall Study||0
11002155|NCT00706628|12179455|FG003|COMPLETED|Overall Study||0
11002156|NCT00706628|12179452|FG000|NOT COMPLETED|Overall Study||47
11002157|NCT00706628|12179453|FG001|NOT COMPLETED|Overall Study||21
11002158|NCT00706628|12179454|FG002|NOT COMPLETED|Overall Study||16
11002159|NCT00706628|12179455|FG003|NOT COMPLETED|Overall Study||3
11002160|NCT00706641|12179468|FG000|STARTED|Dasatinib Administration||25
11002161|NCT00706641|12179468|FG000|Toxicity Evaluation|Dasatinib Administration||24
11002162|NCT00706641|12179468|FG000|COMPLETED|Dasatinib Administration||23
11002163|NCT00706641|12179468|FG000|NOT COMPLETED|Dasatinib Administration||2
11002164|NCT00706641|12179468|FG000|STARTED|Radical Cystectomy||23
11002165|NCT00706641|12179468|FG000|COMPLETED|Radical Cystectomy||22
11002166|NCT00706641|12179468|FG000|NOT COMPLETED|Radical Cystectomy||1
11002167|NCT00706654|12179475|FG000|STARTED|Conversion Phase||709
11002168|NCT00706654|12179476|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
11002169|NCT00706654|12179477|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
11002170|NCT00706654|12179478|FG003|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
11002171|NCT00706654|12179475|FG000|COMPLETED|Conversion Phase||614
11002172|NCT00706654|12179476|FG001|COMPLETED|Conversion Phase||0
11002173|NCT00706654|12179477|FG002|COMPLETED|Conversion Phase||0
11002174|NCT00706654|12179478|FG003|COMPLETED|Conversion Phase||0
11002175|NCT00706654|12179475|FG000|NOT COMPLETED|Conversion Phase||95
11002176|NCT00706654|12179476|FG001|NOT COMPLETED|Conversion Phase||0
11002177|NCT00706654|12179477|FG002|NOT COMPLETED|Conversion Phase||0
11002178|NCT00706654|12179478|FG003|NOT COMPLETED|Conversion Phase||0
11002179|NCT00706654|12179475|FG000|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
11002180|NCT00706654|12179476|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
11002181|NCT00706654|12179477|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
11002182|NCT00706654|12179478|FG003|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
11002183|NCT00706654|12179475|FG000|COMPLETED|Oral Stabilization Phase||662
11002184|NCT00706654|12179476|FG001|COMPLETED|Oral Stabilization Phase||0
11002185|NCT00706654|12179477|FG002|COMPLETED|Oral Stabilization Phase||0
11002186|NCT00706654|12179478|FG003|COMPLETED|Oral Stabilization Phase||0
11002187|NCT00706654|12179475|FG000|NOT COMPLETED|Oral Stabilization Phase||180
11002188|NCT00706654|12179476|FG001|NOT COMPLETED|Oral Stabilization Phase||0
11002189|NCT00706654|12179477|FG002|NOT COMPLETED|Oral Stabilization Phase||0
11002190|NCT00706654|12179478|FG003|NOT COMPLETED|Oral Stabilization Phase||0
11002191|NCT00706654|12179475|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
11002192|NCT00706654|12179476|FG001|STARTED|Depot Maintenance Phase||265
11002193|NCT00706654|12179477|FG002|STARTED|Depot Maintenance Phase||266
11002194|NCT00706654|12179478|FG003|STARTED|Depot Maintenance Phase||131
11002195|NCT00706654|12179475|FG000|COMPLETED|Depot Maintenance Phase||0
11002196|NCT00706654|12179476|FG001|COMPLETED|Depot Maintenance Phase||196
11002197|NCT00706654|12179477|FG002|COMPLETED|Depot Maintenance Phase||178
11002198|NCT00706654|12179478|FG003|COMPLETED|Depot Maintenance Phase||61
11002199|NCT00706654|12179475|FG000|NOT COMPLETED|Depot Maintenance Phase||0
11002200|NCT00706654|12179476|FG001|NOT COMPLETED|Depot Maintenance Phase||69
11002201|NCT00706654|12179477|FG002|NOT COMPLETED|Depot Maintenance Phase||88
11002202|NCT00706654|12179478|FG003|NOT COMPLETED|Depot Maintenance Phase||70
11002203|NCT00706706|12179488|FG000|STARTED|Overall Study||105
11002204|NCT00706706|12179488|FG000|COMPLETED|Overall Study||0
11002205|NCT00706706|12179488|FG000|NOT COMPLETED|Overall Study||105
11002206|NCT00706719|12179495|FG000|STARTED|Overall Study||5
11002207|NCT00706719|12179496|FG001|STARTED|Overall Study||7
11002208|NCT00706719|12179497|FG002|STARTED|Overall Study||5
11002209|NCT00706719|12179495|FG000|COMPLETED|Overall Study||5
11002210|NCT00706719|12179496|FG001|COMPLETED|Overall Study||6
11002211|NCT00706719|12179497|FG002|COMPLETED|Overall Study||1
11002212|NCT00706719|12179495|FG000|NOT COMPLETED|Overall Study||0
11002213|NCT00706719|12179496|FG001|NOT COMPLETED|Overall Study||1
11002214|NCT00706719|12179497|FG002|NOT COMPLETED|Overall Study||4
11002215|NCT00706784|12179506|FG000|STARTED|Overall Study||3
11002216|NCT00706784|12179507|FG001|STARTED|Overall Study||3
11002217|NCT00706784|12179506|FG000|COMPLETED|Overall Study||3
11002218|NCT00706784|12179507|FG001|COMPLETED|Overall Study||3
11002219|NCT00706784|12179506|FG000|NOT COMPLETED|Overall Study||0
11002220|NCT00706784|12179507|FG001|NOT COMPLETED|Overall Study||0
11002221|NCT00706810|12179513|FG000|STARTED|Overall Study||8
11002222|NCT00706810|12179513|FG000|COMPLETED|Overall Study||7
11002223|NCT00706810|12179513|FG000|NOT COMPLETED|Overall Study||1
11002224|NCT00706823|12179520|FG000|STARTED|Overall Study||25
11002225|NCT00706823|12179521|FG001|STARTED|Overall Study||25
11002226|NCT00706823|12179520|FG000|COMPLETED|Overall Study||25
11002227|NCT00706823|12179521|FG001|COMPLETED|Overall Study||25
11002228|NCT00706823|12179520|FG000|NOT COMPLETED|Overall Study||0
11002229|NCT00706823|12179521|FG001|NOT COMPLETED|Overall Study||0
11002230|NCT00706836|12179527|FG000|STARTED|Overall Study||16
11002231|NCT00706836|12179527|FG000|COMPLETED|Overall Study||16
11002232|NCT00706836|12179527|FG000|NOT COMPLETED|Overall Study||0
11002233|NCT00706849|12179537|FG000|STARTED|Treatment Period||41
11002234|NCT00706849|12179538|FG001|STARTED|Treatment Period||83
11002235|NCT00706849|12179537|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
11002236|NCT00706849|12179538|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
11002237|NCT00706849|12179537|FG000|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
11002238|NCT00706849|12179538|FG001|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
11002239|NCT00706849|12179537|FG000|NOT COMPLETED|Treatment Period||0
11002240|NCT00706849|12179538|FG001|NOT COMPLETED|Treatment Period||10
11002241|NCT00706849|12179537|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
11002242|NCT00706849|12179538|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
11002243|NCT00706849|12179537|FG000|COMPLETED|Follow-up Period||3
11002244|NCT00706849|12179538|FG001|COMPLETED|Follow-up Period||25
11002245|NCT00706849|12179537|FG000|NOT COMPLETED|Follow-up Period||0
11002246|NCT00706849|12179538|FG001|NOT COMPLETED|Follow-up Period||3
11002247|NCT00706901|12179547|FG000|STARTED|Overall Study||59
11002248|NCT00706901|12179548|FG001|STARTED|Overall Study||62
11002249|NCT00706901|12179549|FG002|STARTED|Overall Study||59
11002250|NCT00706901|12179547|FG000|COMPLETED|Overall Study||51
11002251|NCT00706901|12179548|FG001|COMPLETED|Overall Study||57
11002252|NCT00706901|12179549|FG002|COMPLETED|Overall Study||51
11002253|NCT00706901|12179547|FG000|NOT COMPLETED|Overall Study||8
11002254|NCT00706901|12179548|FG001|NOT COMPLETED|Overall Study||5
11002255|NCT00706901|12179549|FG002|NOT COMPLETED|Overall Study||8
11002256|NCT00706914|12179561|FG000|STARTED|Overall Study||63
11002257|NCT00706914|12179562|FG001|STARTED|Overall Study||62
11002258|NCT00706914|12179563|FG002|STARTED|Overall Study||31
11002259|NCT00706914|12179561|FG000|COMPLETED|Overall Study||57
11002260|NCT00706914|12179562|FG001|COMPLETED|Overall Study||58
11002261|NCT00706914|12179563|FG002|COMPLETED|Overall Study||30
11002262|NCT00706914|12179561|FG000|NOT COMPLETED|Overall Study||6
11002263|NCT00706914|12179562|FG001|NOT COMPLETED|Overall Study||4
11002264|NCT00706914|12179563|FG002|NOT COMPLETED|Overall Study||1
11002265|NCT00706966|12179571|FG000|STARTED|Overall Study||10
11002266|NCT00706966|12179571|FG000|COMPLETED|Overall Study||9
11002267|NCT00706966|12179571|FG000|NOT COMPLETED|Overall Study||1
11002268|NCT00706979|12179605|FG000|STARTED|Overall Study||426
11002269|NCT00706979|12179606|FG001|STARTED|Overall Study||423
11002270|NCT00706979|12179605|FG000|COMPLETED|Overall Study||426
11002271|NCT00706979|12179606|FG001|COMPLETED|Overall Study||423
11002272|NCT00706979|12179605|FG000|NOT COMPLETED|Overall Study||0
11002273|NCT00706979|12179606|FG001|NOT COMPLETED|Overall Study||0
11002274|NCT00706992|12179619|FG000|STARTED|Overall Study||8
11002275|NCT00706992|12179620|FG001|STARTED|Overall Study||8
11002276|NCT00706992|12179621|FG002|STARTED|Overall Study||9
11002277|NCT00706992|12179622|FG003|STARTED|Overall Study||8
11002278|NCT00706992|12179623|FG004|STARTED|Overall Study||6
11002279|NCT00706992|12179624|FG005|STARTED|Overall Study||5
11002280|NCT00706992|12179625|FG006|STARTED|Overall Study||6
11002281|NCT00706992|12179619|FG000|COMPLETED|Overall Study||3
11002282|NCT00706992|12179620|FG001|COMPLETED|Overall Study||3
11002283|NCT00706992|12179621|FG002|COMPLETED|Overall Study||3
11002284|NCT00706992|12179622|FG003|COMPLETED|Overall Study||6
11002285|NCT00706992|12179623|FG004|COMPLETED|Overall Study||2
11002286|NCT00706992|12179624|FG005|COMPLETED|Overall Study||3
11002287|NCT00706992|12179625|FG006|COMPLETED|Overall Study||3
11002288|NCT00706992|12179619|FG000|NOT COMPLETED|Overall Study||5
11002289|NCT00706992|12179620|FG001|NOT COMPLETED|Overall Study||5
11002290|NCT00706992|12179621|FG002|NOT COMPLETED|Overall Study||6
11002291|NCT00706992|12179622|FG003|NOT COMPLETED|Overall Study||2
11002292|NCT00706992|12179623|FG004|NOT COMPLETED|Overall Study||4
11002293|NCT00706992|12179624|FG005|NOT COMPLETED|Overall Study||2
11002294|NCT00706992|12179625|FG006|NOT COMPLETED|Overall Study||3
11002295|NCT00707031|12179644|FG000|STARTED|Overall Study|Randomized|320
11119608|NCT01331681|12304591|FG000|STARTED|Overall Study|randomized|136
11119609|NCT01331681|12304592|FG001|STARTED|Overall Study|randomized|135
11119610|NCT01331681|12304593|FG002|STARTED|Overall Study|randomized|135
11119611|NCT01331681|12304591|FG000|Participants Received Treatment|Overall Study|safety population|136
11119612|NCT01331681|12304592|FG001|Participants Received Treatment|Overall Study|safety population|135
11119613|NCT01331681|12304593|FG002|Participants Received Treatment|Overall Study|safety population|133
11119614|NCT01331681|12304591|FG000|Completed Week 52|Overall Study||125
11119615|NCT01331681|12304592|FG001|Completed Week 52|Overall Study||121
11119616|NCT01331681|12304593|FG002|Completed Week 52|Overall Study||115
11119617|NCT01331681|12304591|FG000|Completed Week 100|Overall Study||115
11119618|NCT01331681|12304592|FG001|Completed Week 100|Overall Study||110
11119619|NCT01331681|12304593|FG002|Completed Week 100|Overall Study||105
11119620|NCT01331681|12304591|FG000|Completed Week 148|Overall Study||101
11119621|NCT01331681|12304592|FG001|Completed Week 148|Overall Study||101
11119622|NCT01331681|12304593|FG002|Completed Week 148|Overall Study||100
11119623|NCT01331681|12304591|FG000|COMPLETED|Overall Study|Completed Week 148|101
11119624|NCT01331681|12304592|FG001|COMPLETED|Overall Study|Completed Week 148|101
11119625|NCT01331681|12304593|FG002|COMPLETED|Overall Study|Completed Week 148|100
11119626|NCT01331681|12304591|FG000|NOT COMPLETED|Overall Study||35
11119627|NCT01331681|12304592|FG001|NOT COMPLETED|Overall Study||34
11119628|NCT01331681|12304593|FG002|NOT COMPLETED|Overall Study||35
11119629|NCT01331694|12304607|FG000|STARTED|Overall Study||16684
11119630|NCT01331694|12304608|FG001|STARTED|Overall Study||14449
11119631|NCT01331694|12304609|FG002|STARTED|Overall Study||12659
11119632|NCT01331694|12304610|FG003|STARTED|Overall Study||12595
11119633|NCT01331694|12304611|FG004|STARTED|Overall Study||10617
11002296|NCT00707031|12179645|FG001|STARTED|Overall Study||319
11002297|NCT00707031|12179644|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
11002298|NCT00707031|12179645|FG001|Treated/Safety Population|Overall Study||316
11002299|NCT00707031|12179644|FG000|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
11002300|NCT00707031|12179645|FG001|Modified Intent-to-Treat Population|Overall Study||315
11002301|NCT00707031|12179644|FG000|COMPLETED|Overall Study||216
11002302|NCT00707031|12179645|FG001|COMPLETED|Overall Study||220
11002303|NCT00707031|12179644|FG000|NOT COMPLETED|Overall Study||104
11002304|NCT00707031|12179645|FG001|NOT COMPLETED|Overall Study||99
11002305|NCT00707057|12179654|FG000|STARTED|Overall Study||169
11002306|NCT00707057|12179655|FG001|STARTED|Overall Study||87
11002307|NCT00707057|12179654|FG000|COMPLETED|Overall Study||161
11002308|NCT00707057|12179655|FG001|COMPLETED|Overall Study||83
11002309|NCT00707057|12179654|FG000|NOT COMPLETED|Overall Study||8
11002310|NCT00707057|12179655|FG001|NOT COMPLETED|Overall Study||4
11002311|NCT00707174|12179663|FG000|STARTED|Overall Study||46
11002312|NCT00707174|12179664|FG001|STARTED|Overall Study||44
11002313|NCT00707174|12179663|FG000|COMPLETED|Overall Study||41
11119634|NCT01331694|12304612|FG005|STARTED|Overall Study||9126
11119635|NCT01331694|12304607|FG000|COMPLETED|Overall Study||16684
11119636|NCT01331694|12304608|FG001|COMPLETED|Overall Study||14449
11119637|NCT01331694|12304609|FG002|COMPLETED|Overall Study||12659
11119638|NCT01331694|12304610|FG003|COMPLETED|Overall Study||12595
11119639|NCT01331694|12304611|FG004|COMPLETED|Overall Study||10617
11119640|NCT01331694|12304612|FG005|COMPLETED|Overall Study||9126
11119641|NCT01331694|12304607|FG000|NOT COMPLETED|Overall Study||0
11119642|NCT01331694|12304608|FG001|NOT COMPLETED|Overall Study||0
11119643|NCT01331694|12304609|FG002|NOT COMPLETED|Overall Study||0
11119644|NCT01331694|12304610|FG003|NOT COMPLETED|Overall Study||0
11119645|NCT01331694|12304611|FG004|NOT COMPLETED|Overall Study||0
11119646|NCT01331694|12304612|FG005|NOT COMPLETED|Overall Study||0
11119647|NCT01331824|12304626|FG000|STARTED|Overall Study||22
11119648|NCT01331824|12304626|FG000|COMPLETED|Overall Study||9
11119649|NCT01331824|12304626|FG000|NOT COMPLETED|Overall Study||13
11119650|NCT01331837|12304632|FG000|STARTED|Overall Study||1538
11119651|NCT01331837|12304633|FG001|STARTED|Overall Study||1542
11119652|NCT01331837|12304632|FG000|COMPLETED|Overall Study||1482
11119653|NCT01331837|12304633|FG001|COMPLETED|Overall Study||1475
11119654|NCT01331837|12304632|FG000|NOT COMPLETED|Overall Study||56
11119655|NCT01331837|12304633|FG001|NOT COMPLETED|Overall Study||67
11119656|NCT01332019|12304641|FG000|STARTED|Overall Study||530
11119657|NCT01332019|12304642|FG001|STARTED|Overall Study||547
11119658|NCT01332019|12304641|FG000|COMPLETED|Overall Study||417
11119659|NCT01332019|12304642|FG001|COMPLETED|Overall Study||425
11119660|NCT01332019|12304641|FG000|NOT COMPLETED|Overall Study||113
11119661|NCT01332019|12304642|FG001|NOT COMPLETED|Overall Study||122
11119662|NCT01332071|12304648|FG000|STARTED|Period 1||13
11119663|NCT01332071|12304649|FG001|STARTED|Period 1||13
11119664|NCT01332071|12304648|FG000|COMPLETED|Period 1||13
11119665|NCT01332071|12304649|FG001|COMPLETED|Period 1||13
11119666|NCT01332071|12304648|FG000|NOT COMPLETED|Period 1||0
11119667|NCT01332071|12304649|FG001|NOT COMPLETED|Period 1||0
11119668|NCT01332071|12304648|FG000|STARTED|7-Day Washout Period||13
11119669|NCT01332071|12304649|FG001|STARTED|7-Day Washout Period||13
11119670|NCT01332071|12304648|FG000|COMPLETED|7-Day Washout Period||13
11119671|NCT01332071|12304649|FG001|COMPLETED|7-Day Washout Period||13
11119672|NCT01332071|12304648|FG000|NOT COMPLETED|7-Day Washout Period||0
11119673|NCT01332071|12304649|FG001|NOT COMPLETED|7-Day Washout Period||0
11119674|NCT01332071|12304648|FG000|STARTED|Period 2||13
11119675|NCT01332071|12304649|FG001|STARTED|Period 2||13
11119676|NCT01332071|12304648|FG000|COMPLETED|Period 2||13
11119677|NCT01332071|12304649|FG001|COMPLETED|Period 2||13
11119678|NCT01332071|12304648|FG000|NOT COMPLETED|Period 2||0
11119679|NCT01332071|12304649|FG001|NOT COMPLETED|Period 2||0
11119680|NCT01332123|12304657|FG000|STARTED|Overall Study||10
11119681|NCT01332123|12304657|FG000|COMPLETED|Overall Study||10
11119682|NCT01332123|12304657|FG000|NOT COMPLETED|Overall Study||0
11119683|NCT01332149|12304664|FG000|STARTED|Overall Study|Assigned to study treatment.|314
11119684|NCT01332149|12304665|FG001|STARTED|Overall Study|Assigned to study treatment.|309
11119685|NCT01332149|12304664|FG000|Treated|Overall Study||313
11119686|NCT01332149|12304665|FG001|Treated|Overall Study||307
11119687|NCT01332149|12304664|FG000|COMPLETED|Overall Study||284
11119688|NCT01332149|12304665|FG001|COMPLETED|Overall Study||271
11119689|NCT01332149|12304664|FG000|NOT COMPLETED|Overall Study||30
11119690|NCT01332149|12304665|FG001|NOT COMPLETED|Overall Study||38
11119691|NCT01332188|12304675|FG000|STARTED|Overall Study||25
11119692|NCT01332188|12304676|FG001|STARTED|Overall Study||26
11119693|NCT01332188|12304677|FG002|STARTED|Overall Study||25
11119694|NCT01332188|12304678|FG003|STARTED|Overall Study||25
11119695|NCT01332188|12304675|FG000|COMPLETED|Overall Study||23
11119696|NCT01332188|12304676|FG001|COMPLETED|Overall Study||25
11119697|NCT01332188|12304677|FG002|COMPLETED|Overall Study||21
11119698|NCT01332188|12304678|FG003|COMPLETED|Overall Study||25
11119699|NCT01332188|12304675|FG000|NOT COMPLETED|Overall Study||2
11119700|NCT01332188|12304676|FG001|NOT COMPLETED|Overall Study||1
11119701|NCT01332188|12304677|FG002|NOT COMPLETED|Overall Study||4
11119702|NCT01332188|12304678|FG003|NOT COMPLETED|Overall Study||0
11119703|NCT01332227|12304690|FG000|STARTED|Overall Study|Participants who received treatment|72
11119704|NCT01332227|12304691|FG001|STARTED|Overall Study|Participants who received treatment|37
11119705|NCT01332227|12304690|FG000|COMPLETED|Overall Study||56
11119706|NCT01332227|12304691|FG001|COMPLETED|Overall Study||32
11119707|NCT01332227|12304690|FG000|NOT COMPLETED|Overall Study||16
11002314|NCT00707174|12179664|FG001|COMPLETED|Overall Study||37
11119708|NCT01332227|12304691|FG001|NOT COMPLETED|Overall Study||5
11119709|NCT01332253|12304699|FG000|STARTED|Overall Study||82
11119710|NCT01332253|12304700|FG001|STARTED|Overall Study||79
11119711|NCT01332253|12304699|FG000|COMPLETED|Overall Study||82
11119712|NCT01332253|12304700|FG001|COMPLETED|Overall Study||79
11119713|NCT01332253|12304699|FG000|NOT COMPLETED|Overall Study||0
11119714|NCT01332253|12304700|FG001|NOT COMPLETED|Overall Study||0
11119715|NCT01332292|12304706|FG000|STARTED|Treatment Period 1 (14 Days)||14
11119716|NCT01332292|12304707|FG001|STARTED|Treatment Period 1 (14 Days)||13
11119717|NCT01332292|12304706|FG000|COMPLETED|Treatment Period 1 (14 Days)||12
11119718|NCT01332292|12304707|FG001|COMPLETED|Treatment Period 1 (14 Days)||12
11119719|NCT01332292|12304706|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
11119720|NCT01332292|12304707|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
11119721|NCT01332292|12304706|FG000|STARTED|Washout Period (>=7 Days)||12
11119722|NCT01332292|12304707|FG001|STARTED|Washout Period (>=7 Days)||12
11119723|NCT01332292|12304706|FG000|COMPLETED|Washout Period (>=7 Days)||12
11119724|NCT01332292|12304707|FG001|COMPLETED|Washout Period (>=7 Days)||12
11119725|NCT01332292|12304706|FG000|NOT COMPLETED|Washout Period (>=7 Days)||0
11119726|NCT01332292|12304707|FG001|NOT COMPLETED|Washout Period (>=7 Days)||0
11119727|NCT01332292|12304706|FG000|STARTED|Treatment Period 2 (14 Days)||12
11119728|NCT01332292|12304707|FG001|STARTED|Treatment Period 2 (14 Days)||12
11119729|NCT01332292|12304706|FG000|COMPLETED|Treatment Period 2 (14 Days)||11
11119730|NCT01332292|12304707|FG001|COMPLETED|Treatment Period 2 (14 Days)||11
11119731|NCT01332292|12304706|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1
11119732|NCT01332292|12304707|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
11119733|NCT01332305|12304720|FG000|STARTED|Overall Study||41
11119734|NCT01332305|12304721|FG001|STARTED|Overall Study||48
11119735|NCT01332305|12304722|FG002|STARTED|Overall Study||45
11119736|NCT01332305|12304723|FG003|STARTED|Overall Study||38
11119737|NCT01332305|12304724|FG004|STARTED|Overall Study||45
11119738|NCT01332305|12304720|FG000|COMPLETED|Overall Study||31
11119739|NCT01332305|12304721|FG001|COMPLETED|Overall Study||34
11119740|NCT01332305|12304722|FG002|COMPLETED|Overall Study||31
11119741|NCT01332305|12304723|FG003|COMPLETED|Overall Study||30
11119742|NCT01332305|12304724|FG004|COMPLETED|Overall Study||33
11119743|NCT01332305|12304720|FG000|NOT COMPLETED|Overall Study||10
11119744|NCT01332305|12304721|FG001|NOT COMPLETED|Overall Study||14
11119745|NCT01332305|12304722|FG002|NOT COMPLETED|Overall Study||14
11119746|NCT01332305|12304723|FG003|NOT COMPLETED|Overall Study||8
11119747|NCT01332305|12304724|FG004|NOT COMPLETED|Overall Study||12
11119748|NCT01332318|12304740|FG000|STARTED|Overall Study||34
11119749|NCT01332318|12304741|FG001|STARTED|Overall Study||32
11119750|NCT01332318|12304742|FG002|STARTED|Overall Study||34
11119751|NCT01332318|12304743|FG003|STARTED|Overall Study||30
11119752|NCT01332318|12304740|FG000|COMPLETED|Overall Study||32
11119753|NCT01332318|12304741|FG001|COMPLETED|Overall Study||28
11119754|NCT01332318|12304742|FG002|COMPLETED|Overall Study||33
11119755|NCT01332318|12304743|FG003|COMPLETED|Overall Study||28
11119756|NCT01332318|12304740|FG000|NOT COMPLETED|Overall Study||2
11119757|NCT01332318|12304741|FG001|NOT COMPLETED|Overall Study||4
11119758|NCT01332318|12304742|FG002|NOT COMPLETED|Overall Study||1
11119759|NCT01332318|12304743|FG003|NOT COMPLETED|Overall Study||2
11119760|NCT01332331|12304756|FG000|STARTED|Overall Study||21
11119761|NCT01332331|12304757|FG001|STARTED|Overall Study||20
11119762|NCT01332331|12304756|FG000|COMPLETED|Overall Study||19
11119763|NCT01332331|12304757|FG001|COMPLETED|Overall Study||18
11119764|NCT01332331|12304756|FG000|NOT COMPLETED|Overall Study||2
11119765|NCT01332331|12304757|FG001|NOT COMPLETED|Overall Study||2
11119766|NCT01332357|12304764|FG000|STARTED|Overall Study||6139
11119767|NCT01332357|12304764|FG000|COMPLETED|Overall Study||6139
11119768|NCT01332357|12304764|FG000|NOT COMPLETED|Overall Study||0
11119769|NCT01332435|12304772|FG000|STARTED|Overall Study||1572
11119770|NCT01332435|12304773|FG001|STARTED|Overall Study||1064
11119771|NCT01332435|12304774|FG002|STARTED|Overall Study||2604
11119772|NCT01332435|12304775|FG003|STARTED|Overall Study||1656
11119773|NCT01332435|12304772|FG000|COMPLETED|Overall Study||1572
11119774|NCT01332435|12304773|FG001|COMPLETED|Overall Study||1064
11119775|NCT01332435|12304774|FG002|COMPLETED|Overall Study||2604
11119776|NCT01332435|12304775|FG003|COMPLETED|Overall Study||1656
11119777|NCT01332435|12304772|FG000|NOT COMPLETED|Overall Study||0
11119778|NCT01332435|12304773|FG001|NOT COMPLETED|Overall Study||0
11119779|NCT01332435|12304774|FG002|NOT COMPLETED|Overall Study||0
11119780|NCT01332435|12304775|FG003|NOT COMPLETED|Overall Study||0
11119781|NCT01332461|12304788|FG000|STARTED|Overall Study||1291
11119782|NCT01332461|12304789|FG001|STARTED|Overall Study||4386
11119783|NCT01332461|12304788|FG000|COMPLETED|Overall Study||1291
11119784|NCT01332461|12304789|FG001|COMPLETED|Overall Study||4386
11119785|NCT01332461|12304788|FG000|NOT COMPLETED|Overall Study||0
11119786|NCT01332461|12304789|FG001|NOT COMPLETED|Overall Study||0
11119787|NCT01332487|12304797|FG000|STARTED|Overall Study||5554
11119788|NCT01332487|12304798|FG001|STARTED|Overall Study||3063
11119789|NCT01332487|12304797|FG000|COMPLETED|Overall Study||5554
11237969|NCT02069379|12429782|FG000|NOT COMPLETED|First Treatment Arm||0
11119790|NCT01332487|12304798|FG001|COMPLETED|Overall Study||3063
11119791|NCT01332487|12304797|FG000|NOT COMPLETED|Overall Study||0
11119792|NCT01332487|12304798|FG001|NOT COMPLETED|Overall Study||0
11119793|NCT01332500|12304808|FG000|STARTED|Overall Study||13257
11119794|NCT01332500|12304809|FG001|STARTED|Overall Study||39771
11119795|NCT01332500|12304810|FG002|STARTED|Overall Study||2903
11119796|NCT01332500|12304811|FG003|STARTED|Overall Study||5806
11119797|NCT01332500|12304808|FG000|COMPLETED|Overall Study||13257
11119798|NCT01332500|12304809|FG001|COMPLETED|Overall Study||39771
11119799|NCT01332500|12304810|FG002|COMPLETED|Overall Study||2903
11237970|NCT02069379|12429783|FG001|NOT COMPLETED|First Treatment Arm||1
11119800|NCT01332500|12304811|FG003|COMPLETED|Overall Study||5806
11119801|NCT01332500|12304808|FG000|NOT COMPLETED|Overall Study||0
11119802|NCT01332500|12304809|FG001|NOT COMPLETED|Overall Study||0
11119803|NCT01332500|12304810|FG002|NOT COMPLETED|Overall Study||0
11119804|NCT01332500|12304811|FG003|NOT COMPLETED|Overall Study||0
11119805|NCT01332578|12304821|FG000|STARTED|Period I||12
11119806|NCT01332578|12304822|FG001|STARTED|Period I||13
11119807|NCT01332578|12304821|FG000|COMPLETED|Period I||12
11119808|NCT01332578|12304822|FG001|COMPLETED|Period I||13
11119809|NCT01332578|12304821|FG000|NOT COMPLETED|Period I||0
11119810|NCT01332578|12304822|FG001|NOT COMPLETED|Period I||0
11119811|NCT01332578|12304821|FG000|STARTED|Washout Period||12
11119812|NCT01332578|12304822|FG001|STARTED|Washout Period||13
11119813|NCT01332578|12304821|FG000|COMPLETED|Washout Period||12
11119814|NCT01332578|12304822|FG001|COMPLETED|Washout Period||13
11119815|NCT01332578|12304821|FG000|NOT COMPLETED|Washout Period||0
11119816|NCT01332578|12304822|FG001|NOT COMPLETED|Washout Period||0
11119817|NCT01332578|12304821|FG000|STARTED|Period II||12
11119818|NCT01332578|12304822|FG001|STARTED|Period II||13
11119819|NCT01332578|12304821|FG000|COMPLETED|Period II||12
11119820|NCT01332578|12304822|FG001|COMPLETED|Period II||13
11119821|NCT01332578|12304821|FG000|NOT COMPLETED|Period II||0
11119822|NCT01332578|12304822|FG001|NOT COMPLETED|Period II||0
11119823|NCT01332630|12304829|FG000|STARTED|Overall Study||24
11119824|NCT01332630|12304829|FG000|COMPLETED|Overall Study||21
11119825|NCT01332630|12304829|FG000|NOT COMPLETED|Overall Study||3
11119826|NCT01332721|12304833|FG000|STARTED|Overall Study||38
11119827|NCT01332721|12304833|FG000|COMPLETED|Overall Study||38
11119828|NCT01332721|12304833|FG000|NOT COMPLETED|Overall Study||0
11119829|NCT01332851|12304839|FG000|STARTED|Overall Study||124
11119830|NCT01332851|12304840|FG001|STARTED|Overall Study||123
11119831|NCT01332851|12304839|FG000|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
11119832|NCT01332851|12304840|FG001|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
11119833|NCT01332851|12304839|FG000|Completed Follow up 1|Overall Study||116
11119834|NCT01332851|12304840|FG001|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
11119835|NCT01332851|12304839|FG000|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
11119836|NCT01332851|12304840|FG001|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
11201813|NCT01835548|12392178|FG000|NOT COMPLETED|Dose Optimization Period||0
11002315|NCT00707174|12179663|FG000|NOT COMPLETED|Overall Study||5
11002316|NCT00707174|12179664|FG001|NOT COMPLETED|Overall Study||7
11002317|NCT00707239|12179673|FG000|STARTED|Overall Study||37
11002318|NCT00707239|12179674|FG001|STARTED|Overall Study||36
11002319|NCT00707239|12179675|FG002|STARTED|Overall Study||35
11002320|NCT00707239|12179673|FG000|Treated|Overall Study||36
11002321|NCT00707239|12179674|FG001|Treated|Overall Study||35
11002322|NCT00707239|12179675|FG002|Treated|Overall Study||34
11002323|NCT00707239|12179673|FG000|COMPLETED|Overall Study||18
11002324|NCT00707239|12179674|FG001|COMPLETED|Overall Study||25
11002325|NCT00707239|12179675|FG002|COMPLETED|Overall Study||21
11002326|NCT00707239|12179673|FG000|NOT COMPLETED|Overall Study||19
11002327|NCT00707239|12179674|FG001|NOT COMPLETED|Overall Study||11
11002328|NCT00707239|12179675|FG002|NOT COMPLETED|Overall Study||14
11002329|NCT00707343|12179686|FG000|STARTED|Overall Study||15
11002330|NCT00707343|12179686|FG000|COMPLETED|Overall Study||15
11002331|NCT00707343|12179686|FG000|NOT COMPLETED|Overall Study||0
11002332|NCT00707447|12179692|FG000|STARTED|Overall Study||89
11002333|NCT00707447|12179693|FG001|STARTED|Overall Study||93
11002334|NCT00707447|12179692|FG000|COMPLETED|Overall Study||81
11002335|NCT00707447|12179693|FG001|COMPLETED|Overall Study||85
11002336|NCT00707447|12179692|FG000|NOT COMPLETED|Overall Study||8
11002337|NCT00707447|12179693|FG001|NOT COMPLETED|Overall Study||8
11002338|NCT00707486|12179699|FG000|STARTED|Overall Study||72
11002339|NCT00707486|12179699|FG000|COMPLETED|Overall Study||71
11002340|NCT00707486|12179699|FG000|NOT COMPLETED|Overall Study||1
11002341|NCT00707577|12179707|FG000|STARTED|Overall Study||174
11002342|NCT00707577|12179708|FG001|STARTED|Overall Study||156
11002343|NCT00707577|12179707|FG000|COMPLETED|Overall Study||120
11002344|NCT00707577|12179708|FG001|COMPLETED|Overall Study||118
11237971|NCT02069379|12429784|FG002|NOT COMPLETED|First Treatment Arm||1
11119837|NCT01332851|12304839|FG000|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
11119838|NCT01332851|12304840|FG001|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
11119839|NCT01332851|12304839|FG000|COMPLETED|Overall Study||113
11119840|NCT01332851|12304840|FG001|COMPLETED|Overall Study||110
11119841|NCT01332851|12304839|FG000|NOT COMPLETED|Overall Study||11
11119842|NCT01332851|12304840|FG001|NOT COMPLETED|Overall Study||13
11201814|NCT01835548|12392179|FG001|NOT COMPLETED|Dose Optimization Period||0
11201815|NCT01835548|12392180|FG002|NOT COMPLETED|Dose Optimization Period||2
11201816|NCT01835548|12392178|FG000|STARTED|Dose Stabilization Period||0
11201817|NCT01835548|12392179|FG001|STARTED|Dose Stabilization Period||0
11201818|NCT01835548|12392180|FG002|STARTED|Dose Stabilization Period||85
11201819|NCT01835548|12392178|FG000|COMPLETED|Dose Stabilization Period||0
11201820|NCT01835548|12392179|FG001|COMPLETED|Dose Stabilization Period||0
11201821|NCT01835548|12392180|FG002|COMPLETED|Dose Stabilization Period||85
11201822|NCT01835548|12392178|FG000|NOT COMPLETED|Dose Stabilization Period||0
11201823|NCT01835548|12392179|FG001|NOT COMPLETED|Dose Stabilization Period||0
11237972|NCT02069379|12429785|FG003|NOT COMPLETED|First Treatment Arm||0
11237973|NCT02069379|12429782|FG000|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
11237974|NCT02069379|12429783|FG001|STARTED|Washout Period (4 Weeks)||3
11237975|NCT02069379|12429784|FG002|STARTED|Washout Period (4 Weeks)||1
11237976|NCT02069379|12429785|FG003|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
11237977|NCT02069379|12429782|FG000|COMPLETED|Washout Period (4 Weeks)||0
11237978|NCT02069379|12429783|FG001|COMPLETED|Washout Period (4 Weeks)||1
11237979|NCT02069379|12429784|FG002|COMPLETED|Washout Period (4 Weeks)||1
11237980|NCT02069379|12429785|FG003|COMPLETED|Washout Period (4 Weeks)||0
11237981|NCT02069379|12429782|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0
11237982|NCT02069379|12429783|FG001|NOT COMPLETED|Washout Period (4 Weeks)||2
11237983|NCT02069379|12429784|FG002|NOT COMPLETED|Washout Period (4 Weeks)||0
11237984|NCT02069379|12429785|FG003|NOT COMPLETED|Washout Period (4 Weeks)||0
11237985|NCT02069379|12429782|FG000|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
11237986|NCT02069379|12429783|FG001|STARTED|Second Treatment Arm||1
11237987|NCT02069379|12429784|FG002|STARTED|Second Treatment Arm||1
11237988|NCT02069379|12429785|FG003|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
11237989|NCT02069379|12429782|FG000|COMPLETED|Second Treatment Arm||0
11237990|NCT02069379|12429783|FG001|COMPLETED|Second Treatment Arm||1
11237991|NCT02069379|12429784|FG002|COMPLETED|Second Treatment Arm||0
11237992|NCT02069379|12429785|FG003|COMPLETED|Second Treatment Arm||0
11237993|NCT02069379|12429782|FG000|NOT COMPLETED|Second Treatment Arm||0
11237994|NCT02069379|12429783|FG001|NOT COMPLETED|Second Treatment Arm||0
11237995|NCT02069379|12429784|FG002|NOT COMPLETED|Second Treatment Arm||1
11237996|NCT02069379|12429785|FG003|NOT COMPLETED|Second Treatment Arm||0
11201824|NCT01835548|12392180|FG002|NOT COMPLETED|Dose Stabilization Period||0
11201825|NCT01835548|12392178|FG000|STARTED|Double-Blind Treatment Period||44
11201826|NCT01835548|12392179|FG001|STARTED|Double-Blind Treatment Period||41
11201827|NCT01835548|12392180|FG002|STARTED|Double-Blind Treatment Period||0
11201828|NCT01835548|12392178|FG000|COMPLETED|Double-Blind Treatment Period||44
11201829|NCT01835548|12392179|FG001|COMPLETED|Double-Blind Treatment Period||39
11201830|NCT01835548|12392180|FG002|COMPLETED|Double-Blind Treatment Period||0
11201831|NCT01835548|12392178|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
11201832|NCT01835548|12392179|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
11237997|NCT02069392|12429797|FG000|STARTED|Overall Study||14
11237998|NCT02069392|12429798|FG001|STARTED|Overall Study||17
11237999|NCT02069392|12429797|FG000|COMPLETED|Overall Study||10
11238000|NCT02069392|12429798|FG001|COMPLETED|Overall Study||15
11238001|NCT02069392|12429797|FG000|NOT COMPLETED|Overall Study||4
11238002|NCT02069392|12429798|FG001|NOT COMPLETED|Overall Study||2
11238003|NCT02069704|12429808|FG000|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69
11238004|NCT02069704|12429809|FG001|STARTED|Overall Study||71
11238005|NCT02069704|12429808|FG000|COMPLETED|Overall Study||69
11238006|NCT02069704|12429809|FG001|COMPLETED|Overall Study||71
11238007|NCT02069704|12429808|FG000|NOT COMPLETED|Overall Study||0
11238008|NCT02069704|12429809|FG001|NOT COMPLETED|Overall Study||0
11238009|NCT02069847|12429824|FG000|STARTED|Overall Study||22
11238010|NCT02069847|12429825|FG001|STARTED|Overall Study||68
11238011|NCT02069847|12429824|FG000|COMPLETED|Overall Study||22
11119843|NCT01332981|12304850|FG000|STARTED|Overall Study||220
11119844|NCT01332981|12304850|FG000|COMPLETED|Overall Study||220
11119845|NCT01332981|12304850|FG000|NOT COMPLETED|Overall Study||0
11119846|NCT01332994|12304857|FG000|STARTED|Overall Study||519
11119847|NCT01332994|12304857|FG000|Completed Week 16|Overall Study||463
11119848|NCT01332994|12304857|FG000|Completed Week 32 (TCZ/TCZ)|Overall Study||200
11119849|NCT01332994|12304857|FG000|Completed Week 32 (TCZ/RTX)|Overall Study||26
11119850|NCT01332994|12304857|FG000|Completed Week 66 (TCZ/RTX)|Overall Study||25
11119851|NCT01332994|12304857|FG000|COMPLETED|Overall Study||448
11119852|NCT01332994|12304857|FG000|NOT COMPLETED|Overall Study||71
11119853|NCT01333033|12304863|FG000|STARTED|Overall Study||72
11119854|NCT01333033|12304864|FG001|STARTED|Overall Study||39
11119855|NCT01333033|12304865|FG002|STARTED|Overall Study||64
11119856|NCT01333033|12304866|FG003|STARTED|Overall Study||50
11119857|NCT01333033|12304867|FG004|STARTED|Overall Study||14
11119858|NCT01333033|12304868|FG005|STARTED|Overall Study||18
11119859|NCT01333033|12304863|FG000|COMPLETED|Overall Study||72
11119860|NCT01333033|12304864|FG001|COMPLETED|Overall Study||39
11119861|NCT01333033|12304865|FG002|COMPLETED|Overall Study||64
11119862|NCT01333033|12304866|FG003|COMPLETED|Overall Study||50
11119863|NCT01333033|12304867|FG004|COMPLETED|Overall Study||0
11119864|NCT01333033|12304868|FG005|COMPLETED|Overall Study||0
11119865|NCT01333033|12304863|FG000|NOT COMPLETED|Overall Study||0
11119866|NCT01333033|12304864|FG001|NOT COMPLETED|Overall Study||0
11119867|NCT01333033|12304865|FG002|NOT COMPLETED|Overall Study||0
11119868|NCT01333033|12304866|FG003|NOT COMPLETED|Overall Study||0
11119869|NCT01333033|12304867|FG004|NOT COMPLETED|Overall Study||14
11119870|NCT01333033|12304868|FG005|NOT COMPLETED|Overall Study||18
11119871|NCT01333059|12304888|FG000|STARTED|Overall Study||14
11119872|NCT01333059|12304889|FG001|STARTED|Overall Study||11
11119873|NCT01333059|12304888|FG000|COMPLETED|Overall Study||8
11119874|NCT01333059|12304889|FG001|COMPLETED|Overall Study||8
11119875|NCT01333059|12304888|FG000|NOT COMPLETED|Overall Study||6
11119876|NCT01333059|12304889|FG001|NOT COMPLETED|Overall Study||3
11119877|NCT01333072|12304899|FG000|STARTED|Overall Study||30
11119878|NCT01333072|12304900|FG001|STARTED|Overall Study||31
11119879|NCT01333072|12304899|FG000|COMPLETED|Overall Study||24
11119880|NCT01333072|12304900|FG001|COMPLETED|Overall Study||27
11119881|NCT01333072|12304899|FG000|NOT COMPLETED|Overall Study||6
11119882|NCT01333072|12304900|FG001|NOT COMPLETED|Overall Study||4
11119883|NCT01333098|12304906|FG000|STARTED|Overall Study||15
11119884|NCT01333098|12304906|FG000|COMPLETED|Overall Study||12
11119885|NCT01333098|12304906|FG000|NOT COMPLETED|Overall Study||3
11119886|NCT01333111|12304915|FG000|STARTED|Overall Study||30
11119887|NCT01333111|12304916|FG001|STARTED|Overall Study||29
11119888|NCT01333111|12304917|FG002|STARTED|Overall Study||15
11119889|NCT01333111|12304915|FG000|COMPLETED|Overall Study||28
11119890|NCT01333111|12304916|FG001|COMPLETED|Overall Study||26
11119891|NCT01333111|12304917|FG002|COMPLETED|Overall Study||13
11119892|NCT01333111|12304915|FG000|NOT COMPLETED|Overall Study||2
11119893|NCT01333111|12304916|FG001|NOT COMPLETED|Overall Study||3
11119894|NCT01333111|12304917|FG002|NOT COMPLETED|Overall Study||2
11119895|NCT01333189|12304927|FG000|STARTED|Overall Study||13
11119896|NCT01333189|12304928|FG001|STARTED|Overall Study||13
11119897|NCT01333189|12304927|FG000|COMPLETED|Overall Study||11
11119898|NCT01333189|12304928|FG001|COMPLETED|Overall Study||11
11119899|NCT01333189|12304927|FG000|NOT COMPLETED|Overall Study||2
11119900|NCT01333189|12304928|FG001|NOT COMPLETED|Overall Study||2
11119901|NCT01333475|12304936|FG000|STARTED|Overall Study||12
11119902|NCT01333475|12304937|FG001|STARTED|Overall Study||9
11119903|NCT01333475|12304936|FG000|COMPLETED|Overall Study||10
11119904|NCT01333475|12304937|FG001|COMPLETED|Overall Study||6
11119905|NCT01333475|12304936|FG000|NOT COMPLETED|Overall Study||2
11119906|NCT01333475|12304937|FG001|NOT COMPLETED|Overall Study||3
11119907|NCT01333488|12304947|FG000|STARTED|Overall Study||2
11119908|NCT01333488|12304948|FG001|STARTED|Overall Study||1
11119909|NCT01333488|12304949|FG002|STARTED|Overall Study||3
11119910|NCT01333488|12304947|FG000|COMPLETED|Overall Study||2
11119911|NCT01333488|12304948|FG001|COMPLETED|Overall Study||1
11119912|NCT01333488|12304949|FG002|COMPLETED|Overall Study||3
11119913|NCT01333488|12304947|FG000|NOT COMPLETED|Overall Study||0
11119914|NCT01333488|12304948|FG001|NOT COMPLETED|Overall Study||0
11119915|NCT01333488|12304949|FG002|NOT COMPLETED|Overall Study||0
11119916|NCT01333501|12304960|FG000|STARTED|Overall Study||106
11119917|NCT01333501|12304961|FG001|STARTED|Overall Study||51
11119918|NCT01333501|12304960|FG000|Full Analysis Set (FAS)|Overall Study||80
11119919|NCT01333501|12304961|FG001|Full Analysis Set (FAS)|Overall Study||28
11119920|NCT01333501|12304960|FG000|Safety Population|Overall Study||104
11119921|NCT01333501|12304961|FG001|Safety Population|Overall Study||47
11119922|NCT01333501|12304960|FG000|COMPLETED|Overall Study||97
11119923|NCT01333501|12304961|FG001|COMPLETED|Overall Study||30
11119924|NCT01333501|12304960|FG000|NOT COMPLETED|Overall Study||9
11119925|NCT01333501|12304961|FG001|NOT COMPLETED|Overall Study||21
11119926|NCT01333527|12304969|FG000|STARTED|Overall Study||105
11119927|NCT01333527|12304970|FG001|STARTED|Overall Study||106
11119928|NCT01333527|12304969|FG000|COMPLETED|Overall Study||87
11119929|NCT01333527|12304970|FG001|COMPLETED|Overall Study||89
11119930|NCT01333527|12304969|FG000|NOT COMPLETED|Overall Study||18
11119931|NCT01333527|12304970|FG001|NOT COMPLETED|Overall Study||17
11119932|NCT01333592|12304978|FG000|STARTED|Overall Study||67
11119933|NCT01333592|12304979|FG001|STARTED|Overall Study||69
11119934|NCT01333592|12304978|FG000|COMPLETED|Overall Study||58
11119935|NCT01333592|12304979|FG001|COMPLETED|Overall Study||52
11119936|NCT01333592|12304978|FG000|NOT COMPLETED|Overall Study||9
11119937|NCT01333592|12304979|FG001|NOT COMPLETED|Overall Study||17
11119938|NCT01333722|12304987|FG000|STARTED|Overall Study||51
11119939|NCT01333722|12304988|FG001|STARTED|Overall Study||49
11119940|NCT01333722|12304987|FG000|COMPLETED|Overall Study||51
11119941|NCT01333722|12304988|FG001|COMPLETED|Overall Study||46
11119942|NCT01333722|12304987|FG000|NOT COMPLETED|Overall Study||0
11119943|NCT01333722|12304988|FG001|NOT COMPLETED|Overall Study||3
11119944|NCT01333813|12304996|FG000|STARTED|Overall Study||297
11119945|NCT01333813|12304996|FG000|COMPLETED|Overall Study||297
11119946|NCT01333813|12304996|FG000|NOT COMPLETED|Overall Study||0
11119947|NCT01333865|12305000|FG000|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
11119948|NCT01333865|12305000|FG000|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
11119949|NCT01333865|12305000|FG000|NOT COMPLETED|Overall Study||2
11119950|NCT01333956|12305008|FG000|STARTED|Overall Study||30
11119951|NCT01333956|12305009|FG001|STARTED|Overall Study||30
11119952|NCT01333956|12305010|FG002|STARTED|Overall Study||30
11119953|NCT01333956|12305011|FG003|STARTED|Overall Study||30
11119954|NCT01333956|12305008|FG000|COMPLETED|Overall Study||28
11119955|NCT01333956|12305009|FG001|COMPLETED|Overall Study||26
11119956|NCT01333956|12305010|FG002|COMPLETED|Overall Study||29
11119957|NCT01333956|12305011|FG003|COMPLETED|Overall Study||28
11119958|NCT01333956|12305008|FG000|NOT COMPLETED|Overall Study||2
11119959|NCT01333956|12305009|FG001|NOT COMPLETED|Overall Study||4
11119960|NCT01333956|12305010|FG002|NOT COMPLETED|Overall Study||1
11119961|NCT01333956|12305011|FG003|NOT COMPLETED|Overall Study||2
11119962|NCT01334086|12305022|FG000|STARTED|Overall Study||41
11119963|NCT01334086|12305022|FG000|COMPLETED|Overall Study||41
11119964|NCT01334086|12305022|FG000|NOT COMPLETED|Overall Study||0
11119965|NCT01334125|12305028|FG000|STARTED|Overall Study||15
11119966|NCT01334125|12305029|FG001|STARTED|Overall Study||13
11119967|NCT01334125|12305028|FG000|COMPLETED|Overall Study|3 subjects move to another city|12
11119968|NCT01334125|12305029|FG001|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
11119969|NCT01334125|12305028|FG000|NOT COMPLETED|Overall Study||3
11119970|NCT01334125|12305029|FG001|NOT COMPLETED|Overall Study||3
11119971|NCT01334216|12305038|FG000|STARTED|Overall Study||168
11119972|NCT01334216|12305039|FG001|STARTED|Overall Study||194
11119973|NCT01334216|12305038|FG000|COMPLETED|Overall Study||168
11119974|NCT01334216|12305039|FG001|COMPLETED|Overall Study||194
11119975|NCT01334216|12305038|FG000|NOT COMPLETED|Overall Study||0
11119976|NCT01334216|12305039|FG001|NOT COMPLETED|Overall Study||0
11119977|NCT01334229|12305047|FG000|STARTED|Overall Study||11
11119978|NCT01334229|12305048|FG001|STARTED|Overall Study||11
11119979|NCT01334229|12305047|FG000|COMPLETED|Overall Study||11
11119980|NCT01334229|12305048|FG001|COMPLETED|Overall Study||11
11119981|NCT01334229|12305047|FG000|NOT COMPLETED|Overall Study||0
11119982|NCT01334229|12305048|FG001|NOT COMPLETED|Overall Study||0
11119983|NCT01334515|12305056|FG000|STARTED|Overall Study||16
11119984|NCT01334515|12305057|FG001|STARTED|Overall Study||36
11119985|NCT01334515|12305056|FG000|COMPLETED|Overall Study||4
11119986|NCT01334515|12305057|FG001|COMPLETED|Overall Study||7
11119987|NCT01334515|12305056|FG000|NOT COMPLETED|Overall Study||12
11119988|NCT01334515|12305057|FG001|NOT COMPLETED|Overall Study||29
11119989|NCT01334554|12305065|FG000|STARTED|Overall Study||23
11119990|NCT01334554|12305066|FG001|STARTED|Overall Study||23
11119991|NCT01334554|12305065|FG000|COMPLETED|Overall Study||19
11119992|NCT01334554|12305066|FG001|COMPLETED|Overall Study||21
11119993|NCT01334554|12305065|FG000|NOT COMPLETED|Overall Study||4
11119994|NCT01334554|12305066|FG001|NOT COMPLETED|Overall Study||2
11119995|NCT01334710|12305074|FG000|STARTED|Overall Study||3
11119996|NCT01334710|12305074|FG000|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
11119997|NCT01334710|12305074|FG000|NOT COMPLETED|Overall Study||3
11119998|NCT01334723|12305081|FG000|STARTED|Overall Study||17293
11119999|NCT01334723|12305082|FG001|STARTED|Overall Study||17739
11120000|NCT01334723|12305081|FG000|COMPLETED|Overall Study||17293
11120001|NCT01334723|12305082|FG001|COMPLETED|Overall Study||17739
11120002|NCT01334723|12305081|FG000|NOT COMPLETED|Overall Study||0
11120003|NCT01334723|12305082|FG001|NOT COMPLETED|Overall Study||0
11120004|NCT01334827|12305102|FG000|STARTED|Overall Study||48
11120005|NCT01334827|12305102|FG000|COMPLETED|Overall Study||48
11120006|NCT01334827|12305102|FG000|NOT COMPLETED|Overall Study||0
11120007|NCT01334866|12305108|FG000|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
11120008|NCT01334866|12305108|FG000|COMPLETED|Overall Study||72
11120009|NCT01334866|12305108|FG000|NOT COMPLETED|Overall Study||19
11120010|NCT01334918|12305116|FG000|STARTED|Overall Study||63
11120011|NCT01334918|12305117|FG001|STARTED|Overall Study||61
11120012|NCT01334918|12305116|FG000|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
11120013|NCT01334918|12305117|FG001|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
11120014|NCT01334918|12305116|FG000|COMPLETED|Overall Study||55
11120015|NCT01334918|12305117|FG001|COMPLETED|Overall Study||60
11120016|NCT01334918|12305116|FG000|NOT COMPLETED|Overall Study||8
11120017|NCT01334918|12305117|FG001|NOT COMPLETED|Overall Study||1
11120018|NCT01334944|12305134|FG000|STARTED|Overall Study||11
11120019|NCT01334944|12305135|FG001|STARTED|Overall Study||139
11120020|NCT01334944|12305134|FG000|Received Singel Dose|Overall Study||1
11120021|NCT01334944|12305135|FG001|Received Singel Dose|Overall Study||96
11120022|NCT01334944|12305134|FG000|Received Multiple Doses|Overall Study||10
11120023|NCT01334944|12305135|FG001|Received Multiple Doses|Overall Study||43
11120024|NCT01334944|12305134|FG000|COMPLETED|Overall Study||11
11120025|NCT01334944|12305135|FG001|COMPLETED|Overall Study||139
11120026|NCT01334944|12305134|FG000|NOT COMPLETED|Overall Study||0
11120027|NCT01334944|12305135|FG001|NOT COMPLETED|Overall Study||0
11120028|NCT01334957|12305144|FG000|STARTED|Overall Study||300
11120029|NCT01334957|12305144|FG000|Received Single Dose|Overall Study||252
11120030|NCT01334957|12305144|FG000|Received Multiple Doses|Overall Study||48
11120031|NCT01334957|12305144|FG000|COMPLETED|Overall Study||300
11120032|NCT01334957|12305144|FG000|NOT COMPLETED|Overall Study||0
11120033|NCT01335009|12305150|FG000|STARTED|Overall Study||40
11120034|NCT01335009|12305151|FG001|STARTED|Overall Study||36
11120035|NCT01335009|12305150|FG000|COMPLETED|Overall Study||9
11120036|NCT01335009|12305151|FG001|COMPLETED|Overall Study||3
11120037|NCT01335009|12305150|FG000|NOT COMPLETED|Overall Study||31
11120038|NCT01335009|12305151|FG001|NOT COMPLETED|Overall Study||33
11120039|NCT01335061|12305157|FG000|STARTED|Overall Study||25
11120040|NCT01335061|12305157|FG000|COMPLETED|Overall Study||25
11120041|NCT01335061|12305157|FG000|NOT COMPLETED|Overall Study||0
11120042|NCT01335191|12305170|FG000|STARTED|Overall Study||16
11120043|NCT01335191|12305171|FG001|STARTED|Overall Study||11
11120044|NCT01335191|12305170|FG000|COMPLETED|Overall Study||16
11120045|NCT01335191|12305171|FG001|COMPLETED|Overall Study||11
11120046|NCT01335191|12305170|FG000|NOT COMPLETED|Overall Study||0
11120047|NCT01335191|12305171|FG001|NOT COMPLETED|Overall Study||0
11120048|NCT01335204|12305177|FG000|STARTED|Overall Study||4
11120049|NCT01335204|12305177|FG000|COMPLETED|Overall Study||4
11120050|NCT01335204|12305177|FG000|NOT COMPLETED|Overall Study||0
11120051|NCT01335230|12305185|FG000|STARTED|Overall Study|subjects|10
11120052|NCT01335230|12305186|FG001|STARTED|Overall Study|subjects|10
11120053|NCT01335230|12305187|FG002|STARTED|Overall Study|subjects|10
11120054|NCT01335230|12305188|FG003|STARTED|Overall Study|subjects|10
11120055|NCT01335230|12305185|FG000|COMPLETED|Overall Study|subjects|10
11120056|NCT01335230|12305186|FG001|COMPLETED|Overall Study|subjects|10
11120057|NCT01335230|12305187|FG002|COMPLETED|Overall Study|subjects|10
11120058|NCT01335230|12305188|FG003|COMPLETED|Overall Study|subjects|10
11120059|NCT01335230|12305185|FG000|NOT COMPLETED|Overall Study||0
11120060|NCT01335230|12305186|FG001|NOT COMPLETED|Overall Study||0
11120061|NCT01335230|12305187|FG002|NOT COMPLETED|Overall Study||0
11120062|NCT01335230|12305188|FG003|NOT COMPLETED|Overall Study||0
11120063|NCT01335308|12305201|FG000|STARTED|Overall Study||198
11120064|NCT01335308|12305202|FG001|STARTED|Overall Study||212
11120065|NCT01335308|12305203|FG002|STARTED|Overall Study||235
11120066|NCT01335308|12305201|FG000|COMPLETED|Overall Study||158
11120067|NCT01335308|12305202|FG001|COMPLETED|Overall Study||145
11120068|NCT01335308|12305203|FG002|COMPLETED|Overall Study||154
11120069|NCT01335308|12305201|FG000|NOT COMPLETED|Overall Study||40
11120070|NCT01335308|12305202|FG001|NOT COMPLETED|Overall Study||67
11120071|NCT01335308|12305203|FG002|NOT COMPLETED|Overall Study||81
11120072|NCT01335464|12305213|FG000|STARTED|Overall Study||206
11120073|NCT01335464|12305214|FG001|STARTED|Overall Study||309
11120074|NCT01335464|12305213|FG000|COMPLETED|Overall Study||174
11120075|NCT01335464|12305214|FG001|COMPLETED|Overall Study||260
11120076|NCT01335464|12305213|FG000|NOT COMPLETED|Overall Study||32
11120077|NCT01335464|12305214|FG001|NOT COMPLETED|Overall Study||49
11120078|NCT01335477|12305222|FG000|STARTED|Overall Study||220
11120079|NCT01335477|12305223|FG001|STARTED|Overall Study||331
11120080|NCT01335477|12305222|FG000|COMPLETED|Overall Study||179
11120081|NCT01335477|12305223|FG001|COMPLETED|Overall Study||272
11120082|NCT01335477|12305222|FG000|NOT COMPLETED|Overall Study||41
11120083|NCT01335477|12305223|FG001|NOT COMPLETED|Overall Study||59
11120084|NCT01335542|12305231|FG000|STARTED|Overall Study||45
11120085|NCT01335542|12305232|FG001|STARTED|Overall Study||45
11120086|NCT01335542|12305231|FG000|COMPLETED|Overall Study||45
11120087|NCT01335542|12305232|FG001|COMPLETED|Overall Study||45
11120088|NCT01335542|12305231|FG000|NOT COMPLETED|Overall Study||0
11120089|NCT01335542|12305232|FG001|NOT COMPLETED|Overall Study||0
11120090|NCT01335620|12305238|FG000|STARTED|Overall Study||19
11120091|NCT01335620|12305238|FG000|COMPLETED|Overall Study||19
11120092|NCT01335620|12305238|FG000|NOT COMPLETED|Overall Study||0
11120093|NCT01335698|12305247|FG000|STARTED|Treatment Stage 1||23
11120094|NCT01335698|12305248|FG001|STARTED|Treatment Stage 1||12
11120095|NCT01335698|12305249|FG002|STARTED|Treatment Stage 1||21
11120096|NCT01335698|12305250|FG003|STARTED|Treatment Stage 1||35
11120097|NCT01335698|12305251|FG004|STARTED|Treatment Stage 1||8
11120098|NCT01335698|12305247|FG000|COMPLETED|Treatment Stage 1||15
11120099|NCT01335698|12305248|FG001|COMPLETED|Treatment Stage 1||4
11120100|NCT01335698|12305249|FG002|COMPLETED|Treatment Stage 1||16
11120101|NCT01335698|12305250|FG003|COMPLETED|Treatment Stage 1||26
11120102|NCT01335698|12305251|FG004|COMPLETED|Treatment Stage 1||6
11120103|NCT01335698|12305247|FG000|NOT COMPLETED|Treatment Stage 1||8
11120104|NCT01335698|12305248|FG001|NOT COMPLETED|Treatment Stage 1||8
11120105|NCT01335698|12305249|FG002|NOT COMPLETED|Treatment Stage 1||5
11120106|NCT01335698|12305250|FG003|NOT COMPLETED|Treatment Stage 1||9
11120107|NCT01335698|12305251|FG004|NOT COMPLETED|Treatment Stage 1||2
11120108|NCT01335698|12305247|FG000|STARTED|Treatment Stage 2||15
11120109|NCT01335698|12305248|FG001|STARTED|Treatment Stage 2||4
11120110|NCT01335698|12305249|FG002|STARTED|Treatment Stage 2||16
11120111|NCT01335698|12305250|FG003|STARTED|Treatment Stage 2||26
11120112|NCT01335698|12305251|FG004|STARTED|Treatment Stage 2||6
11120113|NCT01335698|12305247|FG000|COMPLETED|Treatment Stage 2||4
11120114|NCT01335698|12305248|FG001|COMPLETED|Treatment Stage 2||1
11120115|NCT01335698|12305249|FG002|COMPLETED|Treatment Stage 2||11
11120116|NCT01335698|12305250|FG003|COMPLETED|Treatment Stage 2||18
11120117|NCT01335698|12305251|FG004|COMPLETED|Treatment Stage 2||5
11120118|NCT01335698|12305247|FG000|NOT COMPLETED|Treatment Stage 2||11
11120119|NCT01335698|12305248|FG001|NOT COMPLETED|Treatment Stage 2||3
11120120|NCT01335698|12305249|FG002|NOT COMPLETED|Treatment Stage 2||5
11120121|NCT01335698|12305250|FG003|NOT COMPLETED|Treatment Stage 2||8
11120122|NCT01335698|12305251|FG004|NOT COMPLETED|Treatment Stage 2||1
11120123|NCT01335724|12305267|FG000|STARTED|Overall Study||36
11120124|NCT01335724|12305268|FG001|STARTED|Overall Study||36
11120125|NCT01335724|12305267|FG000|COMPLETED|Overall Study||36
11120126|NCT01335724|12305268|FG001|COMPLETED|Overall Study||36
11120127|NCT01335724|12305267|FG000|NOT COMPLETED|Overall Study||0
11120128|NCT01335724|12305268|FG001|NOT COMPLETED|Overall Study||0
11120129|NCT01335750|12305274|FG000|STARTED|Overall Study||32
11120130|NCT01335750|12305274|FG000|COMPLETED|Overall Study||32
11120131|NCT01335750|12305274|FG000|NOT COMPLETED|Overall Study||0
11120132|NCT01335789|12305288|FG000|STARTED|Overall Study||8
11120133|NCT01335789|12305289|FG001|STARTED|Overall Study||8
11120134|NCT01335789|12305288|FG000|COMPLETED|Overall Study||8
11120135|NCT01335789|12305289|FG001|COMPLETED|Overall Study||8
11120136|NCT01335789|12305288|FG000|NOT COMPLETED|Overall Study||0
11120137|NCT01335789|12305289|FG001|NOT COMPLETED|Overall Study||0
11120138|NCT01335867|12305297|FG000|STARTED|Overall Study||16
11120139|NCT01335867|12305298|FG001|STARTED|Overall Study||16
11120140|NCT01335867|12305297|FG000|COMPLETED|Overall Study||9
11120141|NCT01335867|12305298|FG001|COMPLETED|Overall Study||12
11120142|NCT01335867|12305297|FG000|NOT COMPLETED|Overall Study||7
11120143|NCT01335867|12305298|FG001|NOT COMPLETED|Overall Study||4
11120144|NCT01335932|12305313|FG000|STARTED|Overall Study||84
11120145|NCT01335932|12305314|FG001|STARTED|Overall Study||76
11120146|NCT01335932|12305313|FG000|COMPLETED|Overall Study||84
11120147|NCT01335932|12305314|FG001|COMPLETED|Overall Study||72
11120148|NCT01335932|12305313|FG000|NOT COMPLETED|Overall Study||0
11120149|NCT01335932|12305314|FG001|NOT COMPLETED|Overall Study||4
11120150|NCT01335971|12305323|FG000|STARTED|Overall Study||31
11120151|NCT01335971|12305324|FG001|STARTED|Overall Study||29
11120152|NCT01335971|12305325|FG002|STARTED|Overall Study||29
11120153|NCT01335971|12305323|FG000|COMPLETED|Overall Study||29
11120154|NCT01335971|12305324|FG001|COMPLETED|Overall Study||28
11120155|NCT01335971|12305325|FG002|COMPLETED|Overall Study||28
11120156|NCT01335971|12305323|FG000|NOT COMPLETED|Overall Study||2
11120157|NCT01335971|12305324|FG001|NOT COMPLETED|Overall Study||1
11120158|NCT01335971|12305325|FG002|NOT COMPLETED|Overall Study||1
11120159|NCT01336023|12305336|FG000|STARTED|Week 0 to Week 26||414
11120160|NCT01336023|12305337|FG001|STARTED|Week 0 to Week 26||834
11120161|NCT01336023|12305338|FG002|STARTED|Week 0 to Week 26||415
11120162|NCT01336023|12305336|FG000|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
11120163|NCT01336023|12305337|FG001|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
11120164|NCT01336023|12305338|FG002|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
11120165|NCT01336023|12305336|FG000|COMPLETED|Week 0 to Week 26||366
11120166|NCT01336023|12305337|FG001|COMPLETED|Week 0 to Week 26||736
11120167|NCT01336023|12305338|FG002|COMPLETED|Week 0 to Week 26||342
11120168|NCT01336023|12305336|FG000|NOT COMPLETED|Week 0 to Week 26||48
11120169|NCT01336023|12305337|FG001|NOT COMPLETED|Week 0 to Week 26||98
11120170|NCT01336023|12305338|FG002|NOT COMPLETED|Week 0 to Week 26||73
11120171|NCT01336023|12305336|FG000|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
11120172|NCT01336023|12305337|FG001|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
11120173|NCT01336023|12305338|FG002|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
11120174|NCT01336023|12305336|FG000|COMPLETED|Week 27 to 52||305
11120175|NCT01336023|12305337|FG001|COMPLETED|Week 27 to 52||621
11120176|NCT01336023|12305338|FG002|COMPLETED|Week 27 to 52||285
11120177|NCT01336023|12305336|FG000|NOT COMPLETED|Week 27 to 52||28
11120178|NCT01336023|12305337|FG001|NOT COMPLETED|Week 27 to 52||44
11120179|NCT01336023|12305338|FG002|NOT COMPLETED|Week 27 to 52||28
11120180|NCT01336140|12305348|FG000|STARTED|Overall Study||150
11120181|NCT01336140|12305349|FG001|STARTED|Overall Study||150
11120182|NCT01336140|12305348|FG000|COMPLETED|Overall Study||150
11120183|NCT01336140|12305349|FG001|COMPLETED|Overall Study||150
11120184|NCT01336140|12305348|FG000|NOT COMPLETED|Overall Study||0
11120185|NCT01336140|12305349|FG001|NOT COMPLETED|Overall Study||0
11120186|NCT01336205|12305357|FG000|STARTED|Overall Study||563
11120187|NCT01336205|12305358|FG001|STARTED|Overall Study||281
11120188|NCT01336205|12305357|FG000|COMPLETED|Overall Study||330
11120189|NCT01336205|12305358|FG001|COMPLETED|Overall Study||192
11120190|NCT01336205|12305357|FG000|NOT COMPLETED|Overall Study||233
11120191|NCT01336205|12305358|FG001|NOT COMPLETED|Overall Study||89
11120192|NCT01336296|12305366|FG000|STARTED|Overall Study||40
11120193|NCT01336296|12305367|FG001|STARTED|Overall Study||21
11120194|NCT01336296|12305366|FG000|COMPLETED|Overall Study||35
11120195|NCT01336296|12305367|FG001|COMPLETED|Overall Study||17
11120196|NCT01336296|12305366|FG000|NOT COMPLETED|Overall Study||5
11120197|NCT01336296|12305367|FG001|NOT COMPLETED|Overall Study||4
11120198|NCT01336413|12305375|FG000|STARTED|Overall Study||27
11120199|NCT01336413|12305376|FG001|STARTED|Overall Study||26
11120200|NCT01336413|12305375|FG000|COMPLETED|Overall Study||26
11120201|NCT01336413|12305376|FG001|COMPLETED|Overall Study||18
11120202|NCT01336413|12305375|FG000|NOT COMPLETED|Overall Study||1
11120203|NCT01336413|12305376|FG001|NOT COMPLETED|Overall Study||8
11120204|NCT01336569|12305384|FG000|STARTED|Overall Study||49
11120205|NCT01336569|12305384|FG000|COMPLETED|Overall Study||45
11120206|NCT01336569|12305384|FG000|NOT COMPLETED|Overall Study||4
11120207|NCT01336608|12305391|FG000|STARTED|2-week, Single-blind Run-In Period||559
11120208|NCT01336608|12305392|FG001|STARTED|2-week, Single-blind Run-In Period||0
11120209|NCT01336608|12305393|FG002|STARTED|2-week, Single-blind Run-In Period||0
11120210|NCT01336608|12305394|FG003|STARTED|2-week, Single-blind Run-In Period||0
11120211|NCT01336608|12305391|FG000|COMPLETED|2-week, Single-blind Run-In Period||444
11120212|NCT01336608|12305392|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
11120213|NCT01336608|12305393|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
11120214|NCT01336608|12305394|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
11120215|NCT01336608|12305391|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||115
11120216|NCT01336608|12305392|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
11120217|NCT01336608|12305393|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
11120218|NCT01336608|12305394|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
11120219|NCT01336608|12305391|FG000|STARTED|24-week, Double-blind Treatment Period||0
11120220|NCT01336608|12305392|FG001|STARTED|24-week, Double-blind Treatment Period||141
11120221|NCT01336608|12305393|FG002|STARTED|24-week, Double-blind Treatment Period||154
11120222|NCT01336608|12305394|FG003|STARTED|24-week, Double-blind Treatment Period||135
11120223|NCT01336608|12305391|FG000|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
11120224|NCT01336608|12305392|FG001|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
11120225|NCT01336608|12305393|FG002|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
11120226|NCT01336608|12305394|FG003|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
11120227|NCT01336608|12305391|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
11120228|NCT01336608|12305392|FG001|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
11120229|NCT01336608|12305393|FG002|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
11120230|NCT01336608|12305394|FG003|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
11120231|NCT01336608|12305391|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
11120232|NCT01336608|12305392|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||44
11120233|NCT01336608|12305393|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||30
11120234|NCT01336608|12305394|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||24
11120235|NCT01336647|12305405|FG000|STARTED|Overall Study||46
11120236|NCT01336647|12305406|FG001|STARTED|Overall Study||49
11120237|NCT01336647|12305407|FG002|STARTED|Overall Study||47
11120238|NCT01336647|12305405|FG000|COMPLETED|Overall Study||42
11120239|NCT01336647|12305406|FG001|COMPLETED|Overall Study||48
11120240|NCT01336647|12305407|FG002|COMPLETED|Overall Study||44
11120241|NCT01336647|12305405|FG000|NOT COMPLETED|Overall Study||4
11120242|NCT01336647|12305406|FG001|NOT COMPLETED|Overall Study||1
11120243|NCT01336647|12305407|FG002|NOT COMPLETED|Overall Study||3
11120244|NCT01336712|12305417|FG000|STARTED|Overall Study||30
11120245|NCT01336712|12305417|FG000|COMPLETED|Overall Study||27
11120246|NCT01336712|12305417|FG000|NOT COMPLETED|Overall Study||3
11120247|NCT01336738|12305426|FG000|STARTED|Overall Study||52
11120248|NCT01336738|12305427|FG001|STARTED|Overall Study||54
11120249|NCT01336738|12305428|FG002|STARTED|Overall Study||53
11120250|NCT01336738|12305429|FG003|STARTED|Overall Study||54
11120251|NCT01336738|12305430|FG004|STARTED|Overall Study||53
11120252|NCT01336738|12305426|FG000|COMPLETED|Overall Study||45
11120253|NCT01336738|12305427|FG001|COMPLETED|Overall Study||45
11120254|NCT01336738|12305428|FG002|COMPLETED|Overall Study||45
11120255|NCT01336738|12305429|FG003|COMPLETED|Overall Study||47
11120256|NCT01336738|12305430|FG004|COMPLETED|Overall Study||43
11120257|NCT01336738|12305426|FG000|NOT COMPLETED|Overall Study||7
11120258|NCT01336738|12305427|FG001|NOT COMPLETED|Overall Study||9
11120259|NCT01336738|12305428|FG002|NOT COMPLETED|Overall Study||8
11120260|NCT01336738|12305429|FG003|NOT COMPLETED|Overall Study||7
11120261|NCT01336738|12305430|FG004|NOT COMPLETED|Overall Study||10
11120262|NCT01336764|12305444|FG000|STARTED|Overall Study||12
11120263|NCT01336764|12305445|FG001|STARTED|Overall Study||10
11120264|NCT01336764|12305444|FG000|COMPLETED|Overall Study||7
11120265|NCT01336764|12305445|FG001|COMPLETED|Overall Study||5
11120266|NCT01336764|12305444|FG000|NOT COMPLETED|Overall Study||5
11120267|NCT01336764|12305445|FG001|NOT COMPLETED|Overall Study||5
11120268|NCT01336803|12305451|FG000|STARTED|Overall Study||21
11120269|NCT01336803|12305451|FG000|Bone Sarcoma|Overall Study||10
11120270|NCT01336803|12305451|FG000|Osteomyelitis|Overall Study||4
11120271|NCT01336803|12305451|FG000|Lymphoma|Overall Study||7
11120272|NCT01336803|12305451|FG000|COMPLETED|Overall Study||21
11120273|NCT01336803|12305451|FG000|NOT COMPLETED|Overall Study||0
11120274|NCT01336894|12305465|FG000|STARTED|Protocol Interventions||4
11120275|NCT01336894|12305466|FG001|STARTED|Protocol Interventions||7
11120276|NCT01336894|12305465|FG000|COMPLETED|Protocol Interventions||4
11120277|NCT01336894|12305466|FG001|COMPLETED|Protocol Interventions||7
11120278|NCT01336894|12305465|FG000|NOT COMPLETED|Protocol Interventions||0
11120279|NCT01336894|12305466|FG001|NOT COMPLETED|Protocol Interventions||0
11120280|NCT01336894|12305465|FG000|STARTED|Follow-up||4
11120281|NCT01336894|12305466|FG001|STARTED|Follow-up||7
11120282|NCT01336894|12305465|FG000|COMPLETED|Follow-up||2
11120283|NCT01336894|12305466|FG001|COMPLETED|Follow-up||0
11120284|NCT01336894|12305465|FG000|NOT COMPLETED|Follow-up||2
11120285|NCT01336894|12305466|FG001|NOT COMPLETED|Follow-up||7
11120286|NCT01336933|12305472|FG000|STARTED|Overall Study||34
11120287|NCT01336933|12305472|FG000|COMPLETED|Overall Study||33
11120288|NCT01336933|12305472|FG000|NOT COMPLETED|Overall Study||1
11120289|NCT01336959|12305480|FG000|STARTED|Overall Study||8
11120290|NCT01336959|12305481|FG001|STARTED|Overall Study||42
11120291|NCT01336959|12305482|FG002|STARTED|Overall Study||41
11120292|NCT01336959|12305480|FG000|COMPLETED|Overall Study||8
11120293|NCT01336959|12305481|FG001|COMPLETED|Overall Study||37
11120294|NCT01336959|12305482|FG002|COMPLETED|Overall Study||40
11120295|NCT01336959|12305480|FG000|NOT COMPLETED|Overall Study||0
11120296|NCT01336959|12305481|FG001|NOT COMPLETED|Overall Study||5
11120297|NCT01336959|12305482|FG002|NOT COMPLETED|Overall Study||1
11120298|NCT01336972|12305496|FG000|STARTED|Overall Study||10
11120299|NCT01336972|12305497|FG001|STARTED|Overall Study||10
11120300|NCT01336972|12305498|FG002|STARTED|Overall Study||9
11120301|NCT01336972|12305496|FG000|COMPLETED|Overall Study||9
11120302|NCT01336972|12305497|FG001|COMPLETED|Overall Study||9
11120303|NCT01336972|12305498|FG002|COMPLETED|Overall Study||9
11120304|NCT01336972|12305496|FG000|NOT COMPLETED|Overall Study||1
11120305|NCT01336972|12305497|FG001|NOT COMPLETED|Overall Study||1
11120306|NCT01336972|12305498|FG002|NOT COMPLETED|Overall Study||0
11120307|NCT01337050|12305510|FG000|STARTED|Overall Study||4
11120308|NCT01337050|12305511|FG001|STARTED|Overall Study||13
11120309|NCT01337050|12305512|FG002|STARTED|Overall Study||19
11120310|NCT01337050|12305510|FG000|COMPLETED|Overall Study||0
11120311|NCT01337050|12305511|FG001|COMPLETED|Overall Study||0
11120312|NCT01337050|12305512|FG002|COMPLETED|Overall Study||0
11120313|NCT01337050|12305510|FG000|NOT COMPLETED|Overall Study||4
11120314|NCT01337050|12305511|FG001|NOT COMPLETED|Overall Study||13
11120315|NCT01337050|12305512|FG002|NOT COMPLETED|Overall Study||19
11120316|NCT01337076|12305521|FG000|STARTED|Overall Study|subjects implanted|21
11120317|NCT01337076|12305521|FG000|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
11120318|NCT01337076|12305521|FG000|NOT COMPLETED|Overall Study||2
11120319|NCT01337089|12305525|FG000|STARTED|Overall Study||660
11120320|NCT01337089|12305525|FG000|Received at Least 1 Dose of Study Drug|Overall Study||660
11120321|NCT01337089|12305525|FG000|Safety Population|Overall Study||660
11120322|NCT01337089|12305525|FG000|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
11120323|NCT01337089|12305525|FG000|COMPLETED|Overall Study||256
11120324|NCT01337089|12305525|FG000|NOT COMPLETED|Overall Study||404
11120325|NCT01337115|12305531|FG000|STARTED|Overall Study||25
11120326|NCT01337115|12305532|FG001|STARTED|Overall Study||25
11120327|NCT01337115|12305531|FG000|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
11120328|NCT01337115|12305532|FG001|COMPLETED|Overall Study||25
11120329|NCT01337115|12305531|FG000|NOT COMPLETED|Overall Study||2
11120330|NCT01337115|12305532|FG001|NOT COMPLETED|Overall Study||0
11120331|NCT01337167|12305542|FG000|STARTED|Infant Series||986
11120332|NCT01337167|12305543|FG001|STARTED|Infant Series||487
11120333|NCT01337167|12305542|FG000|COMPLETED|Infant Series||924
11120334|NCT01337167|12305543|FG001|COMPLETED|Infant Series||460
11120335|NCT01337167|12305542|FG000|NOT COMPLETED|Infant Series||62
11120336|NCT01337167|12305543|FG001|NOT COMPLETED|Infant Series||27
11120337|NCT01337167|12305542|FG000|STARTED|Interim Period||924
11120338|NCT01337167|12305543|FG001|STARTED|Interim Period||460
11120339|NCT01337167|12305542|FG000|COMPLETED|Interim Period||843
11120340|NCT01337167|12305543|FG001|COMPLETED|Interim Period||420
11120341|NCT01337167|12305542|FG000|NOT COMPLETED|Interim Period||81
11120342|NCT01337167|12305543|FG001|NOT COMPLETED|Interim Period||40
11120343|NCT01337167|12305542|FG000|STARTED|Toddler Vaccinations||843
11120344|NCT01337167|12305543|FG001|STARTED|Toddler Vaccinations||420
11120345|NCT01337167|12305542|FG000|COMPLETED|Toddler Vaccinations||829
11120346|NCT01337167|12305543|FG001|COMPLETED|Toddler Vaccinations||407
11120347|NCT01337167|12305542|FG000|NOT COMPLETED|Toddler Vaccinations||14
11120348|NCT01337167|12305543|FG001|NOT COMPLETED|Toddler Vaccinations||13
11120349|NCT01337297|12305551|FG000|STARTED|Overall Study||11
11120350|NCT01337297|12305552|FG001|STARTED|Overall Study||9
11120351|NCT01337297|12305551|FG000|COMPLETED|Overall Study||6
11120352|NCT01337297|12305552|FG001|COMPLETED|Overall Study||3
11120353|NCT01337297|12305551|FG000|NOT COMPLETED|Overall Study||5
11120354|NCT01337297|12305552|FG001|NOT COMPLETED|Overall Study||6
11120355|NCT01337336|12305560|FG000|STARTED|Overall Study||1078
11120356|NCT01337336|12305561|FG001|STARTED|Overall Study||2923
11120357|NCT01337336|12305560|FG000|COMPLETED|Overall Study||1078
11120358|NCT01337336|12305561|FG001|COMPLETED|Overall Study||2923
11120359|NCT01337336|12305560|FG000|NOT COMPLETED|Overall Study||0
11120360|NCT01337336|12305561|FG001|NOT COMPLETED|Overall Study||0
11120361|NCT01337596|12305576|FG000|STARTED|Overall Study||7
11002345|NCT00707577|12179707|FG000|NOT COMPLETED|Overall Study||54
11002346|NCT00707577|12179708|FG001|NOT COMPLETED|Overall Study||38
11002347|NCT00707655|12179716|FG000|STARTED|Overall Study||3
11002348|NCT00707655|12179717|FG001|STARTED|Overall Study||5
11002349|NCT00707655|12179716|FG000|COMPLETED|Overall Study||3
11002350|NCT00707655|12179717|FG001|COMPLETED|Overall Study||3
11002351|NCT00707655|12179716|FG000|NOT COMPLETED|Overall Study||0
11002352|NCT00707655|12179717|FG001|NOT COMPLETED|Overall Study||2
11002353|NCT00707746|12179727|FG000|STARTED|Treatment Period||12
11002354|NCT00707746|12179728|FG001|STARTED|Treatment Period||22
11002355|NCT00707746|12179727|FG000|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
11002356|NCT00707746|12179728|FG001|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
11002357|NCT00707746|12179727|FG000|COMPLETED|Treatment Period||10
11002358|NCT00707746|12179728|FG001|COMPLETED|Treatment Period||17
11002359|NCT00707746|12179727|FG000|NOT COMPLETED|Treatment Period||2
11120362|NCT01337596|12305577|FG001|STARTED|Overall Study||7
11120363|NCT01337596|12305578|FG002|STARTED|Overall Study||7
11120364|NCT01337596|12305579|FG003|STARTED|Overall Study||7
11120365|NCT01337596|12305580|FG004|STARTED|Overall Study||7
11120366|NCT01337596|12305581|FG005|STARTED|Overall Study||7
11120367|NCT01337596|12305582|FG006|STARTED|Overall Study||12
11120368|NCT01337596|12305583|FG007|STARTED|Overall Study||2
11120369|NCT01337596|12305584|FG008|STARTED|Overall Study||7
11120370|NCT01337596|12305576|FG000|Safety Population|Overall Study||7
11120371|NCT01337596|12305577|FG001|Safety Population|Overall Study||7
11120372|NCT01337596|12305578|FG002|Safety Population|Overall Study||7
11120373|NCT01337596|12305579|FG003|Safety Population|Overall Study||7
11120374|NCT01337596|12305580|FG004|Safety Population|Overall Study||7
11120375|NCT01337596|12305581|FG005|Safety Population|Overall Study||7
11120376|NCT01337596|12305582|FG006|Safety Population|Overall Study||12
11120377|NCT01337596|12305583|FG007|Safety Population|Overall Study||2
11120378|NCT01337596|12305584|FG008|Safety Population|Overall Study||7
11120379|NCT01337596|12305576|FG000|COMPLETED|Overall Study||7
11120380|NCT01337596|12305577|FG001|COMPLETED|Overall Study||7
11120381|NCT01337596|12305578|FG002|COMPLETED|Overall Study||7
11120382|NCT01337596|12305579|FG003|COMPLETED|Overall Study||7
11120383|NCT01337596|12305580|FG004|COMPLETED|Overall Study||5
11120384|NCT01337596|12305581|FG005|COMPLETED|Overall Study||7
11120385|NCT01337596|12305582|FG006|COMPLETED|Overall Study||12
11120386|NCT01337596|12305583|FG007|COMPLETED|Overall Study||2
11120387|NCT01337596|12305584|FG008|COMPLETED|Overall Study||7
11120388|NCT01337596|12305576|FG000|NOT COMPLETED|Overall Study||0
11120389|NCT01337596|12305577|FG001|NOT COMPLETED|Overall Study||0
11120390|NCT01337596|12305578|FG002|NOT COMPLETED|Overall Study||0
11120391|NCT01337596|12305579|FG003|NOT COMPLETED|Overall Study||0
11120392|NCT01337596|12305580|FG004|NOT COMPLETED|Overall Study||2
11120393|NCT01337596|12305581|FG005|NOT COMPLETED|Overall Study||0
11120394|NCT01337596|12305582|FG006|NOT COMPLETED|Overall Study||0
11120395|NCT01337596|12305583|FG007|NOT COMPLETED|Overall Study||0
11120396|NCT01337596|12305584|FG008|NOT COMPLETED|Overall Study||0
11120397|NCT01337635|12305609|FG000|STARTED|Overall Study||3
11120398|NCT01337635|12305610|FG001|STARTED|Overall Study||4
11120399|NCT01337635|12305609|FG000|COMPLETED|Overall Study||3
11120400|NCT01337635|12305610|FG001|COMPLETED|Overall Study||3
11120401|NCT01337635|12305609|FG000|NOT COMPLETED|Overall Study||0
11120402|NCT01337635|12305610|FG001|NOT COMPLETED|Overall Study||1
11120403|NCT01337674|12305618|FG000|STARTED|Treatment Period 1||6
11120404|NCT01337674|12305619|FG001|STARTED|Treatment Period 1|The discontinued participant was replaced|7
11120405|NCT01337674|12305620|FG002|STARTED|Treatment Period 1||6
11120406|NCT01337674|12305621|FG003|STARTED|Treatment Period 1|The discontinued participant was replaced|7
11120407|NCT01337674|12305618|FG000|COMPLETED|Treatment Period 1||6
11120408|NCT01337674|12305619|FG001|COMPLETED|Treatment Period 1||6
11120409|NCT01337674|12305620|FG002|COMPLETED|Treatment Period 1||6
11120410|NCT01337674|12305621|FG003|COMPLETED|Treatment Period 1||6
11120411|NCT01337674|12305618|FG000|NOT COMPLETED|Treatment Period 1||0
11120412|NCT01337674|12305619|FG001|NOT COMPLETED|Treatment Period 1||1
11120413|NCT01337674|12305620|FG002|NOT COMPLETED|Treatment Period 1||0
11120414|NCT01337674|12305621|FG003|NOT COMPLETED|Treatment Period 1||1
11120415|NCT01337674|12305618|FG000|STARTED|Two-week Washout Period||6
11120416|NCT01337674|12305619|FG001|STARTED|Two-week Washout Period||6
11120417|NCT01337674|12305620|FG002|STARTED|Two-week Washout Period||6
11120418|NCT01337674|12305621|FG003|STARTED|Two-week Washout Period||6
11120419|NCT01337674|12305618|FG000|COMPLETED|Two-week Washout Period||6
11120420|NCT01337674|12305619|FG001|COMPLETED|Two-week Washout Period||6
11120421|NCT01337674|12305620|FG002|COMPLETED|Two-week Washout Period||6
11120422|NCT01337674|12305621|FG003|COMPLETED|Two-week Washout Period||6
11120423|NCT01337674|12305618|FG000|NOT COMPLETED|Two-week Washout Period||0
11120424|NCT01337674|12305619|FG001|NOT COMPLETED|Two-week Washout Period||0
11120425|NCT01337674|12305620|FG002|NOT COMPLETED|Two-week Washout Period||0
11120426|NCT01337674|12305621|FG003|NOT COMPLETED|Two-week Washout Period||0
11120427|NCT01337674|12305618|FG000|STARTED|Treatment Period 2||6
11120428|NCT01337674|12305619|FG001|STARTED|Treatment Period 2||6
11120429|NCT01337674|12305620|FG002|STARTED|Treatment Period 2||6
11120430|NCT01337674|12305621|FG003|STARTED|Treatment Period 2||6
11120431|NCT01337674|12305618|FG000|COMPLETED|Treatment Period 2||6
11120432|NCT01337674|12305619|FG001|COMPLETED|Treatment Period 2||6
11120433|NCT01337674|12305620|FG002|COMPLETED|Treatment Period 2||5
11120434|NCT01337674|12305621|FG003|COMPLETED|Treatment Period 2||6
11120435|NCT01337674|12305618|FG000|NOT COMPLETED|Treatment Period 2||0
11120436|NCT01337674|12305619|FG001|NOT COMPLETED|Treatment Period 2||0
11120437|NCT01337674|12305620|FG002|NOT COMPLETED|Treatment Period 2||1
11120438|NCT01337674|12305621|FG003|NOT COMPLETED|Treatment Period 2||0
11120439|NCT01337687|12305636|FG000|STARTED|Overall Study||10
11120440|NCT01337687|12305637|FG001|STARTED|Overall Study||9
11120441|NCT01337687|12305636|FG000|COMPLETED|Overall Study||10
11120442|NCT01337687|12305637|FG001|COMPLETED|Overall Study||9
11120443|NCT01337687|12305636|FG000|NOT COMPLETED|Overall Study||0
11120444|NCT01337687|12305637|FG001|NOT COMPLETED|Overall Study||0
11120445|NCT01337700|12305645|FG000|STARTED|Overall Study||5
11120446|NCT01337700|12305646|FG001|STARTED|Overall Study||5
11120447|NCT01337700|12305645|FG000|COMPLETED|Overall Study||5
11120448|NCT01337700|12305646|FG001|COMPLETED|Overall Study||5
11120449|NCT01337700|12305645|FG000|NOT COMPLETED|Overall Study||0
11120450|NCT01337700|12305646|FG001|NOT COMPLETED|Overall Study||0
11120451|NCT01337739|12305654|FG000|STARTED|Overall Study||6
11120452|NCT01337739|12305655|FG001|STARTED|Overall Study||4
11120453|NCT01337739|12305654|FG000|COMPLETED|Overall Study||6
11120454|NCT01337739|12305655|FG001|COMPLETED|Overall Study||4
11120455|NCT01337739|12305654|FG000|NOT COMPLETED|Overall Study||0
11120456|NCT01337739|12305655|FG001|NOT COMPLETED|Overall Study||0
11120457|NCT01337960|12305664|FG000|STARTED|Overall Study||14
11120458|NCT01337960|12305665|FG001|STARTED|Overall Study||14
11120459|NCT01337960|12305666|FG002|STARTED|Overall Study||6
11120460|NCT01337960|12305664|FG000|COMPLETED|Overall Study||12
11120461|NCT01337960|12305665|FG001|COMPLETED|Overall Study||14
11120462|NCT01337960|12305666|FG002|COMPLETED|Overall Study||6
11120463|NCT01337960|12305664|FG000|NOT COMPLETED|Overall Study||2
11120464|NCT01337960|12305665|FG001|NOT COMPLETED|Overall Study||0
11120465|NCT01337960|12305666|FG002|NOT COMPLETED|Overall Study||0
11120466|NCT01337973|12305677|FG000|STARTED|Overall Study||60
11120467|NCT01337973|12305678|FG001|STARTED|Overall Study||60
11120468|NCT01337973|12305679|FG002|STARTED|Overall Study||60
11120469|NCT01337973|12305677|FG000|COMPLETED|Overall Study||44
11120470|NCT01337973|12305678|FG001|COMPLETED|Overall Study||45
11120471|NCT01337973|12305679|FG002|COMPLETED|Overall Study||49
11120472|NCT01337973|12305677|FG000|NOT COMPLETED|Overall Study||16
11120473|NCT01337973|12305678|FG001|NOT COMPLETED|Overall Study||15
11120474|NCT01337973|12305679|FG002|NOT COMPLETED|Overall Study||11
11120475|NCT01337986|12305689|FG000|STARTED|Overall Study||23
11120476|NCT01337986|12305690|FG001|STARTED|Overall Study||23
11120477|NCT01337986|12305689|FG000|COMPLETED|Overall Study||20
11120478|NCT01337986|12305690|FG001|COMPLETED|Overall Study||18
11120479|NCT01337986|12305689|FG000|NOT COMPLETED|Overall Study||3
11120480|NCT01337986|12305690|FG001|NOT COMPLETED|Overall Study||5
11120481|NCT01338012|12305712|FG000|STARTED|Overall Study||8
11120482|NCT01338012|12305712|FG000|COMPLETED|Overall Study||0
11120483|NCT01338012|12305712|FG000|NOT COMPLETED|Overall Study||8
11120484|NCT01338025|12305718|FG000|STARTED|Overall Study||16
11120485|NCT01338025|12305719|FG001|STARTED|Overall Study||17
11120486|NCT01338025|12305718|FG000|COMPLETED|Overall Study||5
11120487|NCT01338025|12305719|FG001|COMPLETED|Overall Study||6
11120488|NCT01338025|12305718|FG000|NOT COMPLETED|Overall Study||11
11120489|NCT01338025|12305719|FG001|NOT COMPLETED|Overall Study||11
11120490|NCT01338298|12305727|FG000|STARTED|Overall Study||24
11120491|NCT01338298|12305728|FG001|STARTED|Overall Study||18
11120492|NCT01338298|12305727|FG000|COMPLETED|Overall Study||20
11120493|NCT01338298|12305728|FG001|COMPLETED|Overall Study||15
11120494|NCT01338298|12305727|FG000|NOT COMPLETED|Overall Study||4
11120495|NCT01338298|12305728|FG001|NOT COMPLETED|Overall Study||3
11120496|NCT01338415|12305736|FG000|STARTED|Core + Extension||33
11120497|NCT01338415|12305737|FG001|STARTED|Core + Extension||31
11120498|NCT01338415|12305738|FG002|STARTED|Core + Extension||0
11120499|NCT01338415|12305736|FG000|Enrolled in FUTURE 3 Extension|Core + Extension||31
11120500|NCT01338415|12305737|FG001|Enrolled in FUTURE 3 Extension|Core + Extension||27
11120501|NCT01338415|12305738|FG002|Enrolled in FUTURE 3 Extension|Core + Extension||0
11120502|NCT01338415|12305736|FG000|COMPLETED|Core + Extension||23
11120503|NCT01338415|12305737|FG001|COMPLETED|Core + Extension||22
11120504|NCT01338415|12305738|FG002|COMPLETED|Core + Extension||0
11120505|NCT01338415|12305736|FG000|NOT COMPLETED|Core + Extension||10
11120506|NCT01338415|12305737|FG001|NOT COMPLETED|Core + Extension||9
11120507|NCT01338415|12305738|FG002|NOT COMPLETED|Core + Extension||0
11120508|NCT01338415|12305736|FG000|STARTED|Exceptional Use Treatment Period||0
11120509|NCT01338415|12305737|FG001|STARTED|Exceptional Use Treatment Period||0
11120510|NCT01338415|12305738|FG002|STARTED|Exceptional Use Treatment Period||10
11120511|NCT01338415|12305736|FG000|COMPLETED|Exceptional Use Treatment Period||0
11120512|NCT01338415|12305737|FG001|COMPLETED|Exceptional Use Treatment Period||0
11120513|NCT01338415|12305738|FG002|COMPLETED|Exceptional Use Treatment Period||4
11120514|NCT01338415|12305736|FG000|NOT COMPLETED|Exceptional Use Treatment Period||0
11120515|NCT01338415|12305737|FG001|NOT COMPLETED|Exceptional Use Treatment Period||0
11120516|NCT01338415|12305738|FG002|NOT COMPLETED|Exceptional Use Treatment Period||6
11120517|NCT01338493|12305746|FG000|STARTED|Enrolled||139
11120518|NCT01338493|12305746|FG000|COMPLETED|Enrolled||134
11120519|NCT01338493|12305746|FG000|NOT COMPLETED|Enrolled||5
11120520|NCT01338493|12305746|FG000|STARTED|Implant||134
11120521|NCT01338493|12305746|FG000|COMPLETED|Implant||134
11120522|NCT01338493|12305746|FG000|NOT COMPLETED|Implant||0
11120523|NCT01338493|12305746|FG000|STARTED|Discharge||134
11120524|NCT01338493|12305746|FG000|COMPLETED|Discharge||132
11120525|NCT01338493|12305746|FG000|NOT COMPLETED|Discharge||2
11120526|NCT01338493|12305746|FG000|STARTED|6 Months Follow up||132
11120527|NCT01338493|12305746|FG000|COMPLETED|6 Months Follow up||113
11120528|NCT01338493|12305746|FG000|NOT COMPLETED|6 Months Follow up||19
11120529|NCT01338493|12305746|FG000|STARTED|12 Months Follow up||113
11120530|NCT01338493|12305746|FG000|COMPLETED|12 Months Follow up||104
11120531|NCT01338493|12305746|FG000|NOT COMPLETED|12 Months Follow up||9
11120532|NCT01338493|12305746|FG000|STARTED|24 Months Follow up||104
11120533|NCT01338493|12305746|FG000|COMPLETED|24 Months Follow up||104
11120534|NCT01338493|12305746|FG000|NOT COMPLETED|24 Months Follow up||0
11120535|NCT01338506|12305752|FG000|STARTED|Overall Study||54
11120536|NCT01338506|12305753|FG001|STARTED|Overall Study||27
11120537|NCT01338506|12305752|FG000|COMPLETED|Overall Study||29
11120538|NCT01338506|12305753|FG001|COMPLETED|Overall Study||13
11120539|NCT01338506|12305752|FG000|NOT COMPLETED|Overall Study||25
11120540|NCT01338506|12305753|FG001|NOT COMPLETED|Overall Study||14
11120541|NCT01338610|12305766|FG000|STARTED|Overall Study||39
11120542|NCT01338610|12305767|FG001|STARTED|Overall Study||56
11120543|NCT01338610|12305768|FG002|STARTED|Overall Study||29
11120544|NCT01338610|12305766|FG000|COMPLETED|Overall Study||34
11120545|NCT01338610|12305767|FG001|COMPLETED|Overall Study||55
11120546|NCT01338610|12305768|FG002|COMPLETED|Overall Study||28
11120547|NCT01338610|12305766|FG000|NOT COMPLETED|Overall Study||5
11120548|NCT01338610|12305767|FG001|NOT COMPLETED|Overall Study||1
11120549|NCT01338610|12305768|FG002|NOT COMPLETED|Overall Study||1
11120550|NCT01338649|12305777|FG000|STARTED|Overall Study||13
11120551|NCT01338649|12305778|FG001|STARTED|Overall Study||14
11120552|NCT01338649|12305777|FG000|COMPLETED|Overall Study||13
11120553|NCT01338649|12305778|FG001|COMPLETED|Overall Study||14
11120554|NCT01338649|12305777|FG000|NOT COMPLETED|Overall Study||0
11120555|NCT01338649|12305778|FG001|NOT COMPLETED|Overall Study||0
11120556|NCT01338792|12305784|FG000|STARTED|Overall Study||47
11120557|NCT01338792|12305784|FG000|COMPLETED|Overall Study||43
11120558|NCT01338792|12305784|FG000|NOT COMPLETED|Overall Study||4
11120559|NCT01338818|12305788|FG000|STARTED|Overall Study||298
11120560|NCT01338818|12305788|FG000|COMPLETED|Overall Study||262
11120561|NCT01338818|12305788|FG000|NOT COMPLETED|Overall Study||36
11120562|NCT01338857|12305792|FG000|STARTED|Overall Study||12
11120563|NCT01338857|12305792|FG000|COMPLETED|Overall Study||1
11120564|NCT01338857|12305792|FG000|NOT COMPLETED|Overall Study||11
11201833|NCT01835548|12392180|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
11201834|NCT01835587|12392196|FG000|STARTED|Overall Study||3
11201835|NCT01835587|12392197|FG001|STARTED|Overall Study||4
11201836|NCT01835587|12392198|FG002|STARTED|Overall Study||4
11201837|NCT01835587|12392199|FG003|STARTED|Overall Study||19
11201838|NCT01835587|12392196|FG000|COMPLETED|Overall Study||1
11201839|NCT01835587|12392197|FG001|COMPLETED|Overall Study||0
11201840|NCT01835587|12392198|FG002|COMPLETED|Overall Study||2
11201841|NCT01835587|12392199|FG003|COMPLETED|Overall Study||10
11002360|NCT00707746|12179728|FG001|NOT COMPLETED|Treatment Period||5
11002361|NCT00707746|12179727|FG000|STARTED|Follow-up Period||12
11002362|NCT00707746|12179728|FG001|STARTED|Follow-up Period||21
11002363|NCT00707746|12179727|FG000|COMPLETED|Follow-up Period||12
11002364|NCT00707746|12179728|FG001|COMPLETED|Follow-up Period||21
11002365|NCT00707746|12179727|FG000|NOT COMPLETED|Follow-up Period||0
11002366|NCT00707746|12179728|FG001|NOT COMPLETED|Follow-up Period||0
11002367|NCT00707759|12179736|FG000|STARTED|Overall Study||14
11002368|NCT00707759|12179737|FG001|STARTED|Overall Study||14
11002369|NCT00707759|12179736|FG000|COMPLETED|Overall Study||12
11002370|NCT00707759|12179737|FG001|COMPLETED|Overall Study||12
11002371|NCT00707759|12179736|FG000|NOT COMPLETED|Overall Study||2
11002372|NCT00707759|12179737|FG001|NOT COMPLETED|Overall Study||2
11002373|NCT00707863|12179745|FG000|STARTED|Overall Study||6
11002374|NCT00707863|12179746|FG001|STARTED|Overall Study||11
11002375|NCT00707863|12179745|FG000|COMPLETED|Overall Study||6
11002376|NCT00707863|12179746|FG001|COMPLETED|Overall Study||8
11002377|NCT00707863|12179745|FG000|NOT COMPLETED|Overall Study||0
11002378|NCT00707863|12179746|FG001|NOT COMPLETED|Overall Study||3
11002379|NCT00707915|12179752|FG000|STARTED|Overall Study||30
11201842|NCT01835587|12392196|FG000|NOT COMPLETED|Overall Study||2
11201843|NCT01835587|12392197|FG001|NOT COMPLETED|Overall Study||4
11201844|NCT01835587|12392198|FG002|NOT COMPLETED|Overall Study||2
11201845|NCT01835587|12392199|FG003|NOT COMPLETED|Overall Study||9
11201846|NCT01835626|12392216|FG000|STARTED|Overall Study||24
11201847|NCT01835626|12392216|FG000|COMPLETED|Overall Study||17
11201848|NCT01835626|12392216|FG000|NOT COMPLETED|Overall Study||7
11201849|NCT01835743|12392222|FG000|STARTED|Overall Study||37
11201850|NCT01835743|12392223|FG001|STARTED|Overall Study||32
11201851|NCT01835743|12392222|FG000|COMPLETED|Overall Study||37
11201852|NCT01835743|12392223|FG001|COMPLETED|Overall Study||32
11201853|NCT01835743|12392222|FG000|NOT COMPLETED|Overall Study||0
11201854|NCT01835743|12392223|FG001|NOT COMPLETED|Overall Study||0
11201855|NCT01835756|12392231|FG000|STARTED|Overall Study||31
11201856|NCT01835756|12392232|FG001|STARTED|Overall Study||31
11201857|NCT01835756|12392231|FG000|COMPLETED|Overall Study||31
11201858|NCT01835756|12392232|FG001|COMPLETED|Overall Study||31
11201859|NCT01835756|12392231|FG000|NOT COMPLETED|Overall Study||0
11201860|NCT01835756|12392232|FG001|NOT COMPLETED|Overall Study||0
11201861|NCT01835899|12392243|FG000|STARTED|Overall Study||6
11201862|NCT01835899|12392244|FG001|STARTED|Overall Study||9
11201863|NCT01835899|12392245|FG002|STARTED|Overall Study||9
11201864|NCT01835899|12392243|FG000|COMPLETED|Overall Study||6
11201865|NCT01835899|12392244|FG001|COMPLETED|Overall Study||8
11201866|NCT01835899|12392245|FG002|COMPLETED|Overall Study||8
11201867|NCT01835899|12392243|FG000|NOT COMPLETED|Overall Study||0
11201868|NCT01835899|12392244|FG001|NOT COMPLETED|Overall Study||1
11201869|NCT01835899|12392245|FG002|NOT COMPLETED|Overall Study||1
11002380|NCT00707915|12179752|FG000|Effects of Discontinuing Benzodiazepine|Overall Study||30
11002381|NCT00707915|12179752|FG000|COMPLETED|Overall Study||30
11002382|NCT00707915|12179752|FG000|NOT COMPLETED|Overall Study||0
11002383|NCT00707954|12179761|FG000|STARTED|Overall Study||12
11002384|NCT00707954|12179762|FG001|STARTED|Overall Study||12
11002385|NCT00707954|12179763|FG002|STARTED|Overall Study||14
11201870|NCT01835912|12392255|FG000|STARTED|Overall Study||10
11201871|NCT01835912|12392255|FG000|Acute|Overall Study||10
11201872|NCT01835912|12392255|FG000|Acute Placebo|Overall Study||10
11201873|NCT01835912|12392255|FG000|Chronic|Overall Study||10
11201874|NCT01835912|12392255|FG000|Chronic Placebo|Overall Study||10
11201875|NCT01835912|12392255|FG000|COMPLETED|Overall Study||10
11120565|NCT01338870|12305802|FG000|STARTED|Overall Study||50
11120566|NCT01338870|12305803|FG001|STARTED|Overall Study||49
11120567|NCT01338870|12305804|FG002|STARTED|Overall Study||50
11120568|NCT01338870|12305805|FG003|STARTED|Overall Study||50
11120569|NCT01338870|12305806|FG004|STARTED|Overall Study||52
11120570|NCT01338870|12305807|FG005|STARTED|Overall Study||50
11120571|NCT01338870|12305802|FG000|COMPLETED|Overall Study||41
11120572|NCT01338870|12305803|FG001|COMPLETED|Overall Study||37
11120573|NCT01338870|12305804|FG002|COMPLETED|Overall Study||39
11120574|NCT01338870|12305805|FG003|COMPLETED|Overall Study||41
11120575|NCT01338870|12305806|FG004|COMPLETED|Overall Study||46
11120576|NCT01338870|12305807|FG005|COMPLETED|Overall Study||44
11120577|NCT01338870|12305802|FG000|NOT COMPLETED|Overall Study||9
11120578|NCT01338870|12305803|FG001|NOT COMPLETED|Overall Study||12
11120579|NCT01338870|12305804|FG002|NOT COMPLETED|Overall Study||11
11120580|NCT01338870|12305805|FG003|NOT COMPLETED|Overall Study||9
11120581|NCT01338870|12305806|FG004|NOT COMPLETED|Overall Study||6
11120582|NCT01338870|12305807|FG005|NOT COMPLETED|Overall Study||6
11120583|NCT01338987|12305826|FG000|STARTED|Overall Study||12
11120584|NCT01338987|12305827|FG001|STARTED|Overall Study||9
11120585|NCT01338987|12305828|FG002|STARTED|Overall Study||22
11120586|NCT01338987|12305829|FG003|STARTED|Overall Study||31
11120587|NCT01338987|12305830|FG004|STARTED|Overall Study||2
11120588|NCT01338987|12305826|FG000|COMPLETED|Overall Study||10
11120589|NCT01338987|12305827|FG001|COMPLETED|Overall Study||8
11120590|NCT01338987|12305828|FG002|COMPLETED|Overall Study||20
11120591|NCT01338987|12305829|FG003|COMPLETED|Overall Study||31
11120592|NCT01338987|12305830|FG004|COMPLETED|Overall Study||2
11120593|NCT01338987|12305826|FG000|NOT COMPLETED|Overall Study||2
11120594|NCT01338987|12305827|FG001|NOT COMPLETED|Overall Study||1
11120595|NCT01338987|12305828|FG002|NOT COMPLETED|Overall Study||2
11120596|NCT01338987|12305829|FG003|NOT COMPLETED|Overall Study||0
11120597|NCT01338987|12305830|FG004|NOT COMPLETED|Overall Study||0
11120598|NCT01339000|12305846|FG000|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
11120599|NCT01339000|12305847|FG001|STARTED|Overall Study||0
11120600|NCT01339000|12305846|FG000|COMPLETED|Overall Study||0
11120601|NCT01339000|12305847|FG001|COMPLETED|Overall Study||0
11120602|NCT01339000|12305846|FG000|NOT COMPLETED|Overall Study||1
11120603|NCT01339000|12305847|FG001|NOT COMPLETED|Overall Study||0
11120604|NCT01339013|12305856|FG000|STARTED|Overall Study||6
11120605|NCT01339013|12305856|FG000|COMPLETED|Overall Study||6
11120606|NCT01339013|12305856|FG000|NOT COMPLETED|Overall Study||0
11120607|NCT01339052|12305862|FG000|STARTED|Overall Study||15
11120608|NCT01339052|12305863|FG001|STARTED|Overall Study||50
11120609|NCT01339052|12305862|FG000|Measurable Disease|Overall Study||11
11120610|NCT01339052|12305863|FG001|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
11120611|NCT01339052|12305862|FG000|Evaluable Tumor Sample at Surgery|Overall Study||14
11238012|NCT02069847|12429825|FG001|COMPLETED|Overall Study||68
11120612|NCT01339052|12305863|FG001|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
11120613|NCT01339052|12305862|FG000|Evaluable Plasma Sample at Surgery|Overall Study||13
11120614|NCT01339052|12305863|FG001|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
11120615|NCT01339052|12305862|FG000|COMPLETED|Overall Study||0
11120616|NCT01339052|12305863|FG001|COMPLETED|Overall Study||0
11120617|NCT01339052|12305862|FG000|NOT COMPLETED|Overall Study||15
11120618|NCT01339052|12305863|FG001|NOT COMPLETED|Overall Study||50
11120619|NCT01339091|12305874|FG000|STARTED|Overall Study||288
11120620|NCT01339091|12305875|FG001|STARTED|Overall Study||285
11120621|NCT01339091|12305874|FG000|Safety Population|Overall Study||284
11120622|NCT01339091|12305875|FG001|Safety Population|Overall Study||284
11120623|NCT01339091|12305874|FG000|COMPLETED|Overall Study||261
11120624|NCT01339091|12305875|FG001|COMPLETED|Overall Study||257
11120625|NCT01339091|12305874|FG000|NOT COMPLETED|Overall Study||27
11120626|NCT01339091|12305875|FG001|NOT COMPLETED|Overall Study||28
11120627|NCT01339247|12305881|FG000|STARTED|Period 1||30
11120628|NCT01339247|12305882|FG001|STARTED|Period 1||30
11120629|NCT01339247|12305881|FG000|COMPLETED|Period 1||30
11120630|NCT01339247|12305882|FG001|COMPLETED|Period 1||30
11120631|NCT01339247|12305881|FG000|NOT COMPLETED|Period 1||0
11120632|NCT01339247|12305882|FG001|NOT COMPLETED|Period 1||0
11120633|NCT01339247|12305881|FG000|STARTED|Period 2||30
11120634|NCT01339247|12305882|FG001|STARTED|Period 2||30
11120635|NCT01339247|12305881|FG000|COMPLETED|Period 2||30
11120636|NCT01339247|12305882|FG001|COMPLETED|Period 2||30
11120637|NCT01339247|12305881|FG000|NOT COMPLETED|Period 2||0
11120638|NCT01339247|12305882|FG001|NOT COMPLETED|Period 2||0
11120639|NCT01339260|12305890|FG000|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
11120640|NCT01339260|12305891|FG001|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
11120641|NCT01339260|12305890|FG000|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
11120642|NCT01339260|12305891|FG001|Safety Population|Cycle 1|Patients receiving palonosetron|725
11120643|NCT01339260|12305890|FG000|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
11120644|NCT01339260|12305891|FG001|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
11120645|NCT01339260|12305890|FG000|COMPLETED|Cycle 1||719
11120646|NCT01339260|12305891|FG001|COMPLETED|Cycle 1||719
11120647|NCT01339260|12305890|FG000|NOT COMPLETED|Cycle 1||7
11120648|NCT01339260|12305891|FG001|NOT COMPLETED|Cycle 1||10
11120649|NCT01339260|12305890|FG000|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
11120650|NCT01339260|12305891|FG001|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
11120651|NCT01339260|12305890|FG000|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
11120652|NCT01339260|12305891|FG001|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
11120653|NCT01339260|12305890|FG000|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
11120654|NCT01339260|12305891|FG001|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
11120655|NCT01339260|12305890|FG000|NOT COMPLETED|Multi-cycle Extension||186
11120656|NCT01339260|12305891|FG001|NOT COMPLETED|Multi-cycle Extension||193
11120657|NCT01339273|12305901|FG000|STARTED|Overall Study||36
11120658|NCT01339273|12305902|FG001|STARTED|Overall Study||36
11120659|NCT01339273|12305901|FG000|COMPLETED|Overall Study||28
11120660|NCT01339273|12305902|FG001|COMPLETED|Overall Study||28
11120661|NCT01339273|12305901|FG000|NOT COMPLETED|Overall Study||8
11120662|NCT01339273|12305902|FG001|NOT COMPLETED|Overall Study||8
11120663|NCT01339299|12305910|FG000|STARTED|Overall Study||50
11120664|NCT01339299|12305911|FG001|STARTED|Overall Study||50
11120665|NCT01339299|12305910|FG000|COMPLETED|Overall Study||50
11120666|NCT01339299|12305911|FG001|COMPLETED|Overall Study||50
11120667|NCT01339299|12305910|FG000|NOT COMPLETED|Overall Study||0
11120668|NCT01339299|12305911|FG001|NOT COMPLETED|Overall Study||0
11201876|NCT01835912|12392255|FG000|NOT COMPLETED|Overall Study||0
11201877|NCT01836029|12392267|FG000|STARTED|Overall Study||100
11201878|NCT01836029|12392268|FG001|STARTED|Overall Study||95
11201879|NCT01836029|12392267|FG000|COMPLETED|Overall Study||100
11201880|NCT01836029|12392268|FG001|COMPLETED|Overall Study||95
11201881|NCT01836029|12392267|FG000|NOT COMPLETED|Overall Study||0
11201882|NCT01836029|12392268|FG001|NOT COMPLETED|Overall Study||0
11201883|NCT01836042|12392277|FG000|STARTED|Overall Study||51
11201884|NCT01836042|12392278|FG001|STARTED|Overall Study||35
11201885|NCT01836042|12392279|FG002|STARTED|Overall Study||22
11201886|NCT01836042|12392277|FG000|COMPLETED|Overall Study||51
11201887|NCT01836042|12392278|FG001|COMPLETED|Overall Study||35
11201888|NCT01836042|12392279|FG002|COMPLETED|Overall Study||22
11201889|NCT01836042|12392277|FG000|NOT COMPLETED|Overall Study||0
11201890|NCT01836042|12392278|FG001|NOT COMPLETED|Overall Study||0
11201891|NCT01836042|12392279|FG002|NOT COMPLETED|Overall Study||0
11201892|NCT01836133|12392287|FG000|STARTED|Overall Study||70
11201893|NCT01836133|12392287|FG000|COMPLETED|Overall Study||70
11201894|NCT01836133|12392287|FG000|NOT COMPLETED|Overall Study||0
11201895|NCT01836185|12392295|FG000|STARTED|Overall Study||10
11201896|NCT01836185|12392296|FG001|STARTED|Overall Study||8
11201897|NCT01836185|12392297|FG002|STARTED|Overall Study||8
11201898|NCT01836185|12392298|FG003|STARTED|Overall Study||6
11201899|NCT01836185|12392295|FG000|Received Single Dose of Study Treatment|Overall Study||10
11201900|NCT01836185|12392296|FG001|Received Single Dose of Study Treatment|Overall Study||8
11201901|NCT01836185|12392297|FG002|Received Single Dose of Study Treatment|Overall Study||8
11201902|NCT01836185|12392298|FG003|Received Single Dose of Study Treatment|Overall Study||6
11201903|NCT01836185|12392295|FG000|COMPLETED|Overall Study||10
11201904|NCT01836185|12392296|FG001|COMPLETED|Overall Study||8
11201905|NCT01836185|12392297|FG002|COMPLETED|Overall Study||8
11201906|NCT01836185|12392298|FG003|COMPLETED|Overall Study||6
11201907|NCT01836185|12392295|FG000|NOT COMPLETED|Overall Study||0
11201908|NCT01836185|12392296|FG001|NOT COMPLETED|Overall Study||0
11201909|NCT01836185|12392297|FG002|NOT COMPLETED|Overall Study||0
11201910|NCT01836185|12392298|FG003|NOT COMPLETED|Overall Study||0
11201911|NCT01836198|12392310|FG000|STARTED|Part A, Period 1||15
11238013|NCT02069847|12429824|FG000|NOT COMPLETED|Overall Study||0
11238014|NCT02069847|12429825|FG001|NOT COMPLETED|Overall Study||0
11238015|NCT02070237|12429832|FG000|STARTED|Overall Study||45
11238016|NCT02070237|12429833|FG001|STARTED|Overall Study||45
11238017|NCT02070237|12429832|FG000|COMPLETED|Overall Study||42
11238018|NCT02070237|12429833|FG001|COMPLETED|Overall Study||42
11238019|NCT02070237|12429832|FG000|NOT COMPLETED|Overall Study||3
11238020|NCT02070237|12429833|FG001|NOT COMPLETED|Overall Study||3
11238021|NCT02070276|12429842|FG000|STARTED|Overall Study||149
11238022|NCT02070276|12429843|FG001|STARTED|Overall Study||132
11238023|NCT02070276|12429844|FG002|STARTED|Overall Study||148
11238024|NCT02070276|12429842|FG000|COMPLETED|Overall Study||149
11238025|NCT02070276|12429843|FG001|COMPLETED|Overall Study||132
11238026|NCT02070276|12429844|FG002|COMPLETED|Overall Study||148
11238027|NCT02070276|12429842|FG000|NOT COMPLETED|Overall Study||0
11238028|NCT02070276|12429843|FG001|NOT COMPLETED|Overall Study||0
11238029|NCT02070276|12429844|FG002|NOT COMPLETED|Overall Study||0
11238030|NCT02070302|12429854|FG000|STARTED|Overall Study||5
11238031|NCT02070302|12429855|FG001|STARTED|Overall Study||5
11238032|NCT02070302|12429854|FG000|COMPLETED|Overall Study||5
11238033|NCT02070302|12429855|FG001|COMPLETED|Overall Study||5
11238034|NCT02070302|12429854|FG000|NOT COMPLETED|Overall Study||0
11238035|NCT02070302|12429855|FG001|NOT COMPLETED|Overall Study||0
11238036|NCT02070380|12429865|FG000|STARTED|First Injection||31
11238037|NCT02070380|12429866|FG001|STARTED|First Injection||39
11238038|NCT02070380|12429867|FG002|STARTED|First Injection||53
11238039|NCT02070380|12429868|FG003|STARTED|First Injection||54
11238040|NCT02070380|12429865|FG000|COMPLETED|First Injection||31
11238041|NCT02070380|12429866|FG001|COMPLETED|First Injection||39
11238042|NCT02070380|12429867|FG002|COMPLETED|First Injection||53
11238043|NCT02070380|12429868|FG003|COMPLETED|First Injection||54
11238044|NCT02070380|12429865|FG000|NOT COMPLETED|First Injection||0
11238045|NCT02070380|12429866|FG001|NOT COMPLETED|First Injection||0
11238046|NCT02070380|12429867|FG002|NOT COMPLETED|First Injection||0
11238047|NCT02070380|12429868|FG003|NOT COMPLETED|First Injection||0
11238048|NCT02070380|12429865|FG000|STARTED|Washout (no Second Injection/MRI)||31
11238049|NCT02070380|12429866|FG001|STARTED|Washout (no Second Injection/MRI)||39
11238050|NCT02070380|12429867|FG002|STARTED|Washout (no Second Injection/MRI)||53
11238051|NCT02070380|12429868|FG003|STARTED|Washout (no Second Injection/MRI)||54
11238052|NCT02070380|12429865|FG000|COMPLETED|Washout (no Second Injection/MRI)||31
11238053|NCT02070380|12429866|FG001|COMPLETED|Washout (no Second Injection/MRI)||34
11238054|NCT02070380|12429867|FG002|COMPLETED|Washout (no Second Injection/MRI)||51
11238055|NCT02070380|12429868|FG003|COMPLETED|Washout (no Second Injection/MRI)||51
11238056|NCT02070380|12429865|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||0
11238057|NCT02070380|12429866|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||5
11238058|NCT02070380|12429867|FG002|NOT COMPLETED|Washout (no Second Injection/MRI)||2
11238059|NCT02070380|12429868|FG003|NOT COMPLETED|Washout (no Second Injection/MRI)||3
11238060|NCT02070380|12429865|FG000|STARTED|Second Injection||31
11238061|NCT02070380|12429866|FG001|STARTED|Second Injection||34
11238062|NCT02070380|12429867|FG002|STARTED|Second Injection||51
11238063|NCT02070380|12429868|FG003|STARTED|Second Injection||51
11238064|NCT02070380|12429865|FG000|COMPLETED|Second Injection||31
11238065|NCT02070380|12429866|FG001|COMPLETED|Second Injection||32
11238066|NCT02070380|12429867|FG002|COMPLETED|Second Injection||50
11238067|NCT02070380|12429868|FG003|COMPLETED|Second Injection||46
11238068|NCT02070380|12429865|FG000|NOT COMPLETED|Second Injection||0
11238069|NCT02070380|12429866|FG001|NOT COMPLETED|Second Injection||2
11238070|NCT02070380|12429867|FG002|NOT COMPLETED|Second Injection||1
11238071|NCT02070380|12429868|FG003|NOT COMPLETED|Second Injection||5
11238072|NCT02070484|12429882|FG000|STARTED|Overall Study||3
11238073|NCT02070484|12429883|FG001|STARTED|Overall Study||3
11238074|NCT02070484|12429882|FG000|COMPLETED|Overall Study||2
11238075|NCT02070484|12429883|FG001|COMPLETED|Overall Study||3
11238076|NCT02070484|12429882|FG000|NOT COMPLETED|Overall Study||1
11238077|NCT02070484|12429883|FG001|NOT COMPLETED|Overall Study||0
11238078|NCT02070588|12429892|FG000|STARTED|Overall Study||86
11238079|NCT02070588|12429893|FG001|STARTED|Overall Study||26
11238080|NCT02070588|12429894|FG002|STARTED|Overall Study||0
11238081|NCT02070588|12429892|FG000|COMPLETED|Overall Study||47
11238082|NCT02070588|12429893|FG001|COMPLETED|Overall Study||25
11238083|NCT02070588|12429894|FG002|COMPLETED|Overall Study||0
11238084|NCT02070588|12429892|FG000|NOT COMPLETED|Overall Study||39
11238085|NCT02070588|12429893|FG001|NOT COMPLETED|Overall Study||1
11238086|NCT02070588|12429894|FG002|NOT COMPLETED|Overall Study||0
11238087|NCT02070640|12429904|FG000|STARTED|Overall Study||93
11238088|NCT02070640|12429905|FG001|STARTED|Overall Study||6
11238089|NCT02070640|12429904|FG000|COMPLETED|Overall Study||82
11238090|NCT02070640|12429905|FG001|COMPLETED|Overall Study||6
11238091|NCT02070640|12429904|FG000|NOT COMPLETED|Overall Study||11
11238092|NCT02070640|12429905|FG001|NOT COMPLETED|Overall Study||0
11238093|NCT02070692|12429914|FG000|STARTED|Overall Study||28
11238094|NCT02070692|12429915|FG001|STARTED|Overall Study||28
11238095|NCT02070692|12429914|FG000|COMPLETED|Overall Study||18
11238096|NCT02070692|12429915|FG001|COMPLETED|Overall Study||16
11238097|NCT02070692|12429914|FG000|NOT COMPLETED|Overall Study||10
11238098|NCT02070692|12429915|FG001|NOT COMPLETED|Overall Study||12
11238099|NCT02070744|12429925|FG000|STARTED|PC Phase (12 Weeks)||6
11238100|NCT02070744|12429926|FG001|STARTED|PC Phase (12 Weeks)||5
11238101|NCT02070744|12429927|FG002|STARTED|PC Phase (12 Weeks)||15
11238102|NCT02070744|12429928|FG003|STARTED|PC Phase (12 Weeks)||14
11238103|NCT02070744|12429929|FG004|STARTED|PC Phase (12 Weeks)||0
11238104|NCT02070744|12429925|FG000|Treated|PC Phase (12 Weeks)||6
11238105|NCT02070744|12429926|FG001|Treated|PC Phase (12 Weeks)||5
11238106|NCT02070744|12429927|FG002|Treated|PC Phase (12 Weeks)||15
11238107|NCT02070744|12429928|FG003|Treated|PC Phase (12 Weeks)||13
11238108|NCT02070744|12429929|FG004|Treated|PC Phase (12 Weeks)||0
11238109|NCT02070744|12429925|FG000|COMPLETED|PC Phase (12 Weeks)||6
11238110|NCT02070744|12429926|FG001|COMPLETED|PC Phase (12 Weeks)||5
11238111|NCT02070744|12429927|FG002|COMPLETED|PC Phase (12 Weeks)||15
11238112|NCT02070744|12429928|FG003|COMPLETED|PC Phase (12 Weeks)||13
11238113|NCT02070744|12429929|FG004|COMPLETED|PC Phase (12 Weeks)||0
11238114|NCT02070744|12429925|FG000|NOT COMPLETED|PC Phase (12 Weeks)||0
11238115|NCT02070744|12429926|FG001|NOT COMPLETED|PC Phase (12 Weeks)||0
11238116|NCT02070744|12429927|FG002|NOT COMPLETED|PC Phase (12 Weeks)||0
11238117|NCT02070744|12429928|FG003|NOT COMPLETED|PC Phase (12 Weeks)||1
11238118|NCT02070744|12429929|FG004|NOT COMPLETED|PC Phase (12 Weeks)||0
11238119|NCT02070744|12429925|FG000|STARTED|OLE Phase (48 Weeks)||0
11238120|NCT02070744|12429926|FG001|STARTED|OLE Phase (48 Weeks)||0
11238121|NCT02070744|12429927|FG002|STARTED|OLE Phase (48 Weeks)||0
11238122|NCT02070744|12429928|FG003|STARTED|OLE Phase (48 Weeks)||0
11238123|NCT02070744|12429929|FG004|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
11238124|NCT02070744|12429925|FG000|COMPLETED|OLE Phase (48 Weeks)||0
11238125|NCT02070744|12429926|FG001|COMPLETED|OLE Phase (48 Weeks)||0
11238126|NCT02070744|12429927|FG002|COMPLETED|OLE Phase (48 Weeks)||0
11238127|NCT02070744|12429928|FG003|COMPLETED|OLE Phase (48 Weeks)||0
11238128|NCT02070744|12429929|FG004|COMPLETED|OLE Phase (48 Weeks)||24
11238129|NCT02070744|12429925|FG000|NOT COMPLETED|OLE Phase (48 Weeks)||0
11238130|NCT02070744|12429926|FG001|NOT COMPLETED|OLE Phase (48 Weeks)||0
11238131|NCT02070744|12429927|FG002|NOT COMPLETED|OLE Phase (48 Weeks)||0
11238132|NCT02070744|12429928|FG003|NOT COMPLETED|OLE Phase (48 Weeks)||0
11238133|NCT02070744|12429929|FG004|NOT COMPLETED|OLE Phase (48 Weeks)||3
11238134|NCT02070757|12429946|FG000|STARTED|Overall Study||362
11238135|NCT02070757|12429947|FG001|STARTED|Overall Study||364
11238136|NCT02070757|12429946|FG000|Treated Participants|Overall Study||361
11238137|NCT02070757|12429947|FG001|Treated Participants|Overall Study||359
11238138|NCT02070757|12429946|FG000|COMPLETED|Overall Study||245
11238139|NCT02070757|12429947|FG001|COMPLETED|Overall Study||250
11238140|NCT02070757|12429946|FG000|NOT COMPLETED|Overall Study||117
11238141|NCT02070757|12429947|FG001|NOT COMPLETED|Overall Study||114
11238142|NCT02070965|12429956|FG000|STARTED|Overall Study||27
11238143|NCT02070965|12429957|FG001|STARTED|Overall Study||23
11238144|NCT02070965|12429958|FG002|STARTED|Overall Study||25
11238145|NCT02070965|12429956|FG000|COMPLETED|Overall Study||25
11238146|NCT02070965|12429957|FG001|COMPLETED|Overall Study||21
11238147|NCT02070965|12429958|FG002|COMPLETED|Overall Study||24
11238148|NCT02070965|12429956|FG000|NOT COMPLETED|Overall Study||2
11238149|NCT02070965|12429957|FG001|NOT COMPLETED|Overall Study||2
11238150|NCT02070965|12429958|FG002|NOT COMPLETED|Overall Study||1
11002386|NCT00707954|12179764|FG003|STARTED|Overall Study||13
11002387|NCT00707954|12179765|FG004|STARTED|Overall Study||10
11002388|NCT00707954|12179761|FG000|COMPLETED|Overall Study||12
11238151|NCT02070978|12429969|FG000|STARTED|Overall Study||83
11238152|NCT02070978|12429970|FG001|STARTED|Overall Study||82
11238153|NCT02070978|12429971|FG002|STARTED|Overall Study||88
11238154|NCT02070978|12429969|FG000|COMPLETED|Overall Study||36
11238155|NCT02070978|12429970|FG001|COMPLETED|Overall Study||29
11238156|NCT02070978|12429971|FG002|COMPLETED|Overall Study||35
11238157|NCT02070978|12429969|FG000|NOT COMPLETED|Overall Study||47
11238158|NCT02070978|12429970|FG001|NOT COMPLETED|Overall Study||53
11238159|NCT02070978|12429971|FG002|NOT COMPLETED|Overall Study||53
11238160|NCT02070991|12429981|FG000|STARTED|Overall Study||31
11238161|NCT02070991|12429982|FG001|STARTED|Overall Study||32
11238162|NCT02070991|12429981|FG000|COMPLETED|Overall Study||28
11238163|NCT02070991|12429982|FG001|COMPLETED|Overall Study||32
11238164|NCT02070991|12429981|FG000|NOT COMPLETED|Overall Study||3
11238165|NCT02070991|12429982|FG001|NOT COMPLETED|Overall Study||0
11238166|NCT02071082|12429990|FG000|STARTED|Overall Study||4
11238167|NCT02071082|12429991|FG001|STARTED|Overall Study||75
11238168|NCT02071082|12429990|FG000|COMPLETED|Overall Study||2
11238169|NCT02071082|12429991|FG001|COMPLETED|Overall Study||68
11238170|NCT02071082|12429990|FG000|NOT COMPLETED|Overall Study||2
11238171|NCT02071082|12429991|FG001|NOT COMPLETED|Overall Study||7
11238172|NCT02071095|12429999|FG000|STARTED|Overall Study||12
11238173|NCT02071095|12430000|FG001|STARTED|Overall Study||3
11238174|NCT02071095|12429999|FG000|COMPLETED|Overall Study||12
11238175|NCT02071095|12430000|FG001|COMPLETED|Overall Study||3
11238176|NCT02071095|12429999|FG000|NOT COMPLETED|Overall Study||0
11238177|NCT02071095|12430000|FG001|NOT COMPLETED|Overall Study||0
11238178|NCT02071108|12430006|FG000|STARTED|Overall Study||35
11238179|NCT02071108|12430006|FG000|COMPLETED|Overall Study||35
11238180|NCT02071108|12430006|FG000|NOT COMPLETED|Overall Study||0
11238181|NCT02071173|12430010|FG000|STARTED|Overall Study||2244
11238182|NCT02071173|12430010|FG000|Implanted/Attempted With a Study Device|Overall Study||2200
11238183|NCT02071173|12430010|FG000|RELIANCE 4-FRONT Endpoint Population|Overall Study|1507 with active fixation 4-FRONT lead, 37 with passive fixation 4-FRONT lead|1544
11238184|NCT02071173|12430010|FG000|ACUITY X4 Endpoint Population|Overall Study|536 with ACUITY X4 Spiral lead, 228 with ACUITY X4 Straight lead|764
11238185|NCT02071173|12430010|FG000|COMPLETED|Overall Study|Follow-up is ongoing. Data as of 5-Feb-2020.|409
11238186|NCT02071173|12430010|FG000|NOT COMPLETED|Overall Study||1835
11238187|NCT02071225|12430015|FG000|STARTED|Overall Study||72
11238188|NCT02071225|12430015|FG000|COMPLETED|Overall Study||42
11238189|NCT02071225|12430015|FG000|NOT COMPLETED|Overall Study||30
11238190|NCT02071290|12430021|FG000|STARTED|Overall Study||25
11238191|NCT02071290|12430022|FG001|STARTED|Overall Study||25
11238192|NCT02071290|12430021|FG000|COMPLETED|Overall Study||21
11238193|NCT02071290|12430022|FG001|COMPLETED|Overall Study||18
11238194|NCT02071290|12430021|FG000|NOT COMPLETED|Overall Study||4
11238195|NCT02071290|12430022|FG001|NOT COMPLETED|Overall Study||7
11238196|NCT02071420|12430030|FG000|STARTED|Overall Study||30
11238197|NCT02071420|12430031|FG001|STARTED|Overall Study||30
11238198|NCT02071420|12430030|FG000|COMPLETED|Overall Study||27
11238199|NCT02071420|12430031|FG001|COMPLETED|Overall Study||27
11238200|NCT02071420|12430030|FG000|NOT COMPLETED|Overall Study||3
11238201|NCT02071420|12430031|FG001|NOT COMPLETED|Overall Study||3
11238202|NCT02071706|12430037|FG000|STARTED|Overall Study||62
11238203|NCT02071706|12430037|FG000|COMPLETED|Overall Study||59
11238204|NCT02071706|12430037|FG000|NOT COMPLETED|Overall Study||3
11238205|NCT02071771|12430041|FG000|STARTED|Period 1: First 10 Days||41
11238206|NCT02071771|12430042|FG001|STARTED|Period 1: First 10 Days||39
11238207|NCT02071771|12430041|FG000|Dispensed|Period 1: First 10 Days||39
11238208|NCT02071771|12430042|FG001|Dispensed|Period 1: First 10 Days||39
11238209|NCT02071771|12430041|FG000|COMPLETED|Period 1: First 10 Days||39
11238210|NCT02071771|12430042|FG001|COMPLETED|Period 1: First 10 Days||39
11238211|NCT02071771|12430041|FG000|NOT COMPLETED|Period 1: First 10 Days||2
11238212|NCT02071771|12430042|FG001|NOT COMPLETED|Period 1: First 10 Days||0
11238213|NCT02071771|12430041|FG000|STARTED|Period 2: Second 10 Days||39
11238214|NCT02071771|12430042|FG001|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
11238215|NCT02071771|12430041|FG000|COMPLETED|Period 2: Second 10 Days||39
11238216|NCT02071771|12430042|FG001|COMPLETED|Period 2: Second 10 Days||38
11238217|NCT02071771|12430041|FG000|NOT COMPLETED|Period 2: Second 10 Days||0
11238218|NCT02071771|12430042|FG001|NOT COMPLETED|Period 2: Second 10 Days||0
11238219|NCT02071810|12430053|FG000|STARTED|Overall Study||6
11238220|NCT02071810|12430054|FG001|STARTED|Overall Study||6
11238221|NCT02071810|12430055|FG002|STARTED|Overall Study||6
11238222|NCT02071810|12430056|FG003|STARTED|Overall Study||7
11238223|NCT02071810|12430057|FG004|STARTED|Overall Study||9
11238224|NCT02071810|12430053|FG000|COMPLETED|Overall Study||6
11238225|NCT02071810|12430054|FG001|COMPLETED|Overall Study||6
11238226|NCT02071810|12430055|FG002|COMPLETED|Overall Study||6
11238227|NCT02071810|12430056|FG003|COMPLETED|Overall Study||6
11238228|NCT02071810|12430057|FG004|COMPLETED|Overall Study||8
11238229|NCT02071810|12430053|FG000|NOT COMPLETED|Overall Study||0
11238230|NCT02071810|12430054|FG001|NOT COMPLETED|Overall Study||0
11238231|NCT02071810|12430055|FG002|NOT COMPLETED|Overall Study||0
11238232|NCT02071810|12430056|FG003|NOT COMPLETED|Overall Study||1
11238233|NCT02071810|12430057|FG004|NOT COMPLETED|Overall Study||1
11238234|NCT02071823|12430071|FG000|STARTED|Overall Study||6
11238235|NCT02071823|12430072|FG001|STARTED|Overall Study||6
11238236|NCT02071823|12430071|FG000|COMPLETED|Overall Study||5
11238237|NCT02071823|12430072|FG001|COMPLETED|Overall Study||6
11238238|NCT02071823|12430071|FG000|NOT COMPLETED|Overall Study||1
11238239|NCT02071823|12430072|FG001|NOT COMPLETED|Overall Study||0
11238240|NCT02071849|12430080|FG000|STARTED|6-month Primary Endpoint||20
11238241|NCT02071849|12430080|FG000|COMPLETED|6-month Primary Endpoint||15
11238242|NCT02071849|12430080|FG000|NOT COMPLETED|6-month Primary Endpoint||5
11238243|NCT02071849|12430080|FG000|STARTED|2-year Extended Follow-up||15
11238244|NCT02071849|12430080|FG000|COMPLETED|2-year Extended Follow-up||14
11238245|NCT02071849|12430080|FG000|NOT COMPLETED|2-year Extended Follow-up||1
11238246|NCT02071914|12430087|FG000|STARTED|Overall Study||27
11238247|NCT02071914|12430088|FG001|STARTED|Overall Study||27
11238248|NCT02071914|12430089|FG002|STARTED|Overall Study||27
11238249|NCT02071914|12430087|FG000|COMPLETED|Overall Study||27
11238250|NCT02071914|12430088|FG001|COMPLETED|Overall Study||27
11238251|NCT02071914|12430089|FG002|COMPLETED|Overall Study||27
11238252|NCT02071914|12430087|FG000|NOT COMPLETED|Overall Study||0
11238253|NCT02071914|12430088|FG001|NOT COMPLETED|Overall Study||0
11238254|NCT02071914|12430089|FG002|NOT COMPLETED|Overall Study||0
11238255|NCT02072096|12430099|FG000|STARTED|Overall Study||99
11238256|NCT02072096|12430100|FG001|STARTED|Overall Study||93
11238257|NCT02072096|12430099|FG000|Received at Least One Dose of Study Drug|Overall Study||98
11238258|NCT02072096|12430100|FG001|Received at Least One Dose of Study Drug|Overall Study||93
11238259|NCT02072096|12430099|FG000|COMPLETED|Overall Study||14
11238260|NCT02072096|12430100|FG001|COMPLETED|Overall Study||15
11238261|NCT02072096|12430099|FG000|NOT COMPLETED|Overall Study||85
11238262|NCT02072096|12430100|FG001|NOT COMPLETED|Overall Study||78
11238263|NCT02072174|12430109|FG000|STARTED|Overall Study||290
11238264|NCT02072174|12430110|FG001|STARTED|Overall Study||279
11238265|NCT02072174|12430109|FG000|COMPLETED|Overall Study||258
11238266|NCT02072174|12430110|FG001|COMPLETED|Overall Study||240
11238267|NCT02072174|12430109|FG000|NOT COMPLETED|Overall Study||32
11238268|NCT02072174|12430110|FG001|NOT COMPLETED|Overall Study||39
11238269|NCT02072200|12430118|FG000|STARTED|Overall Study||147
11238270|NCT02072200|12430118|FG000|COMPLETED|Overall Study||145
11238271|NCT02072200|12430118|FG000|NOT COMPLETED|Overall Study||2
11238272|NCT02072226|12430124|FG000|STARTED|Overall Study||156
11238273|NCT02072226|12430125|FG001|STARTED|Overall Study||157
11238274|NCT02072226|12430124|FG000|COMPLETED|Overall Study||141
11238275|NCT02072226|12430125|FG001|COMPLETED|Overall Study||147
11238276|NCT02072226|12430124|FG000|NOT COMPLETED|Overall Study||15
11238277|NCT02072226|12430125|FG001|NOT COMPLETED|Overall Study||10
11238278|NCT02072421|12430131|FG000|STARTED|Overall Study||2879
11238279|NCT02072421|12430131|FG000|COMPLETED|Overall Study||2489
11238280|NCT02072421|12430131|FG000|NOT COMPLETED|Overall Study||390
11238281|NCT02072434|12430138|FG000|STARTED|Overall Study||1095
11238282|NCT02072434|12430139|FG001|STARTED|Overall Study||1104
11238283|NCT02072434|12430138|FG000|Intent to Treat Analysis Set|Overall Study||1095
11238284|NCT02072434|12430139|FG001|Intent to Treat Analysis Set|Overall Study||1104
11238285|NCT02072434|12430138|FG000|Received Study Drug|Overall Study||1067
11238286|NCT02072434|12430139|FG001|Received Study Drug|Overall Study||1082
11238287|NCT02072434|12430138|FG000|Safety Analysis Set|Overall Study||1067
11238288|NCT02072434|12430139|FG001|Safety Analysis Set|Overall Study||1082
11238289|NCT02072434|12430138|FG000|COMPLETED|Overall Study||1041
11238290|NCT02072434|12430139|FG001|COMPLETED|Overall Study||1014
11238291|NCT02072434|12430138|FG000|NOT COMPLETED|Overall Study||54
11238292|NCT02072434|12430139|FG001|NOT COMPLETED|Overall Study||90
11238293|NCT02072668|12430145|FG000|STARTED|First Intervention||7
11238294|NCT02072668|12430146|FG001|STARTED|First Intervention||7
11238295|NCT02072668|12430145|FG000|COMPLETED|First Intervention||7
11238296|NCT02072668|12430146|FG001|COMPLETED|First Intervention||7
11238297|NCT02072668|12430145|FG000|NOT COMPLETED|First Intervention||0
11238298|NCT02072668|12430146|FG001|NOT COMPLETED|First Intervention||0
11238299|NCT02072668|12430145|FG000|STARTED|Washout (2 Weeks)||7
11238300|NCT02072668|12430146|FG001|STARTED|Washout (2 Weeks)||7
11238301|NCT02072668|12430145|FG000|COMPLETED|Washout (2 Weeks)||7
11238302|NCT02072668|12430146|FG001|COMPLETED|Washout (2 Weeks)||7
11238303|NCT02072668|12430145|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11238304|NCT02072668|12430146|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11238305|NCT02072668|12430145|FG000|STARTED|Second Intervention||7
11238306|NCT02072668|12430146|FG001|STARTED|Second Intervention||7
11238307|NCT02072668|12430145|FG000|COMPLETED|Second Intervention||6
11238308|NCT02072668|12430146|FG001|COMPLETED|Second Intervention||7
11238309|NCT02072668|12430145|FG000|NOT COMPLETED|Second Intervention||1
11238310|NCT02072668|12430146|FG001|NOT COMPLETED|Second Intervention||0
11238311|NCT02072824|12430157|FG000|STARTED|Overall Study||71
11238312|NCT02072824|12430158|FG001|STARTED|Overall Study||34
11238313|NCT02072824|12430159|FG002|STARTED|Overall Study||70
11238314|NCT02072824|12430157|FG000|COMPLETED|Overall Study||69
11238315|NCT02072824|12430158|FG001|COMPLETED|Overall Study||33
11238316|NCT02072824|12430159|FG002|COMPLETED|Overall Study||67
11238317|NCT02072824|12430157|FG000|NOT COMPLETED|Overall Study||2
11238318|NCT02072824|12430158|FG001|NOT COMPLETED|Overall Study||1
11238319|NCT02072824|12430159|FG002|NOT COMPLETED|Overall Study||3
11238320|NCT02072928|12430167|FG000|STARTED|Overall Study||55
11238321|NCT02072928|12430167|FG000|COMPLETED|Overall Study||55
11238322|NCT02072928|12430167|FG000|NOT COMPLETED|Overall Study||0
11238323|NCT02072941|12430173|FG000|STARTED|Overall Study||219
11238324|NCT02072941|12430174|FG001|STARTED|Overall Study||226
11238325|NCT02072941|12430173|FG000|COMPLETED|Overall Study||181
11238326|NCT02072941|12430174|FG001|COMPLETED|Overall Study||197
11238327|NCT02072941|12430173|FG000|NOT COMPLETED|Overall Study||38
11238328|NCT02072941|12430174|FG001|NOT COMPLETED|Overall Study||29
11238329|NCT02072980|12430180|FG000|STARTED|Period 1, First Wear||7
11238330|NCT02072980|12430181|FG001|STARTED|Period 1, First Wear||8
11238331|NCT02072980|12430180|FG000|COMPLETED|Period 1, First Wear||7
11238332|NCT02072980|12430181|FG001|COMPLETED|Period 1, First Wear||8
11238333|NCT02072980|12430180|FG000|NOT COMPLETED|Period 1, First Wear||0
11238334|NCT02072980|12430181|FG001|NOT COMPLETED|Period 1, First Wear||0
11238335|NCT02072980|12430180|FG000|STARTED|Period 2, Second Wear||7
11238336|NCT02072980|12430181|FG001|STARTED|Period 2, Second Wear||8
11238337|NCT02072980|12430180|FG000|COMPLETED|Period 2, Second Wear||7
11238338|NCT02072980|12430181|FG001|COMPLETED|Period 2, Second Wear||7
11238339|NCT02072980|12430180|FG000|NOT COMPLETED|Period 2, Second Wear||0
11238340|NCT02072980|12430181|FG001|NOT COMPLETED|Period 2, Second Wear||1
11238341|NCT02073162|12430189|FG000|STARTED|Overall Study||1499
11238342|NCT02073162|12430190|FG001|STARTED|Overall Study||1501
11238343|NCT02073162|12430189|FG000|COMPLETED|Overall Study||1493
11238344|NCT02073162|12430190|FG001|COMPLETED|Overall Study||1490
11238345|NCT02073162|12430189|FG000|NOT COMPLETED|Overall Study||6
11238346|NCT02073162|12430190|FG001|NOT COMPLETED|Overall Study||11
11238347|NCT02073331|12430196|FG000|STARTED|Overall Study||1420
11238348|NCT02073331|12430196|FG000|COMPLETED|Overall Study||1420
11238349|NCT02073331|12430196|FG000|NOT COMPLETED|Overall Study||0
11238350|NCT02073435|12430202|FG000|STARTED|Overall Study||81
11238351|NCT02073435|12430203|FG001|STARTED|Overall Study||96
11238352|NCT02073435|12430202|FG000|COMPLETED|Overall Study||81
11238353|NCT02073435|12430203|FG001|COMPLETED|Overall Study||96
11238354|NCT02073435|12430202|FG000|NOT COMPLETED|Overall Study||0
11238355|NCT02073435|12430203|FG001|NOT COMPLETED|Overall Study||0
11238356|NCT02073448|12430212|FG000|STARTED|Overall Study||101
11238357|NCT02073448|12430213|FG001|STARTED|Overall Study||212
11238358|NCT02073448|12430214|FG002|STARTED|Overall Study||104
11238359|NCT02073448|12430212|FG000|COMPLETED|Overall Study||99
11238360|NCT02073448|12430213|FG001|COMPLETED|Overall Study||200
11238361|NCT02073448|12430214|FG002|COMPLETED|Overall Study||99
11238362|NCT02073448|12430212|FG000|NOT COMPLETED|Overall Study||2
11238363|NCT02073448|12430213|FG001|NOT COMPLETED|Overall Study||12
11238364|NCT02073448|12430214|FG002|NOT COMPLETED|Overall Study||5
11238365|NCT02073461|12430227|FG000|STARTED|Overall Study||79
11238366|NCT02073461|12430228|FG001|STARTED|Overall Study||78
11238367|NCT02073461|12430229|FG002|STARTED|Overall Study||79
11238368|NCT02073461|12430227|FG000|COMPLETED|Overall Study||75
11238369|NCT02073461|12430228|FG001|COMPLETED|Overall Study||77
11238370|NCT02073461|12430229|FG002|COMPLETED|Overall Study||78
11238371|NCT02073461|12430227|FG000|NOT COMPLETED|Overall Study||4
11238372|NCT02073461|12430228|FG001|NOT COMPLETED|Overall Study||1
11238373|NCT02073461|12430229|FG002|NOT COMPLETED|Overall Study||1
11238374|NCT02073487|12430239|FG000|STARTED|Overall Study||16
11238375|NCT02073487|12430240|FG001|STARTED|Overall Study||16
11238376|NCT02073487|12430239|FG000|COMPLETED|Overall Study||14
11238377|NCT02073487|12430240|FG001|COMPLETED|Overall Study||16
11238378|NCT02073487|12430239|FG000|NOT COMPLETED|Overall Study||2
11238379|NCT02073487|12430240|FG001|NOT COMPLETED|Overall Study||0
11238380|NCT02073643|12430247|FG000|STARTED|Overall Study||204
11238381|NCT02073643|12430247|FG000|COMPLETED|Overall Study||180
11238382|NCT02073643|12430247|FG000|NOT COMPLETED|Overall Study||24
11238383|NCT02073656|12430251|FG000|STARTED|Primary Study||335
11238384|NCT02073656|12430251|FG000|COMPLETED|Primary Study||327
11238385|NCT02073656|12430251|FG000|NOT COMPLETED|Primary Study||8
11238386|NCT02073656|12430251|FG000|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
11238387|NCT02073656|12430251|FG000|COMPLETED|Retreatment Substudy||9
11238388|NCT02073656|12430251|FG000|NOT COMPLETED|Retreatment Substudy||0
11238389|NCT02073682|12430259|FG000|STARTED|Overall Study||522
11238390|NCT02073682|12430260|FG001|STARTED|Overall Study||524
11238391|NCT02073682|12430259|FG000|COMPLETED|Overall Study||200
11238392|NCT02073682|12430260|FG001|COMPLETED|Overall Study||154
11238393|NCT02073682|12430259|FG000|NOT COMPLETED|Overall Study||322
11238394|NCT02073682|12430260|FG001|NOT COMPLETED|Overall Study||370
11238395|NCT02073747|12430268|FG000|STARTED|Overall Study||15
11238396|NCT02073747|12430269|FG001|STARTED|Overall Study||15
11238397|NCT02073747|12430268|FG000|COMPLETED|Overall Study||14
11238398|NCT02073747|12430269|FG001|COMPLETED|Overall Study||14
11238399|NCT02073747|12430268|FG000|NOT COMPLETED|Overall Study||1
11238400|NCT02073747|12430269|FG001|NOT COMPLETED|Overall Study||1
11238401|NCT02073929|12430277|FG000|STARTED|Overall Study||48
11238402|NCT02073929|12430278|FG001|STARTED|Overall Study||24
11238403|NCT02073929|12430277|FG000|COMPLETED|Overall Study||44
11238404|NCT02073929|12430278|FG001|COMPLETED|Overall Study||21
11238405|NCT02073929|12430277|FG000|NOT COMPLETED|Overall Study||4
11238406|NCT02073929|12430278|FG001|NOT COMPLETED|Overall Study||3
11238407|NCT02074059|12430290|FG000|STARTED|Overall Study||8
11238408|NCT02074059|12430291|FG001|STARTED|Overall Study||8
11238409|NCT02074059|12430292|FG002|STARTED|Overall Study||8
11238410|NCT02074059|12430293|FG003|STARTED|Overall Study||8
11238411|NCT02074059|12430294|FG004|STARTED|Overall Study||8
11238412|NCT02074059|12430295|FG005|STARTED|Overall Study||40
11238413|NCT02074059|12430290|FG000|COMPLETED|Overall Study||8
11238414|NCT02074059|12430291|FG001|COMPLETED|Overall Study||8
11238415|NCT02074059|12430292|FG002|COMPLETED|Overall Study||8
11238416|NCT02074059|12430293|FG003|COMPLETED|Overall Study||8
11238417|NCT02074059|12430294|FG004|COMPLETED|Overall Study||7
11238418|NCT02074059|12430295|FG005|COMPLETED|Overall Study||39
11238419|NCT02074059|12430290|FG000|NOT COMPLETED|Overall Study||0
11238420|NCT02074059|12430291|FG001|NOT COMPLETED|Overall Study||0
11238421|NCT02074059|12430292|FG002|NOT COMPLETED|Overall Study||0
11238422|NCT02074059|12430293|FG003|NOT COMPLETED|Overall Study||0
11238423|NCT02074059|12430294|FG004|NOT COMPLETED|Overall Study||1
11238424|NCT02074059|12430295|FG005|NOT COMPLETED|Overall Study||1
11238425|NCT02074345|12430310|FG000|STARTED|Overall Study||31
11238426|NCT02074345|12430310|FG000|COMPLETED|Overall Study||31
11238427|NCT02074345|12430310|FG000|NOT COMPLETED|Overall Study||0
11238428|NCT02074358|12430314|FG000|STARTED|Overall Study||3
11238429|NCT02074358|12430315|FG001|STARTED|Overall Study||3
11238430|NCT02074358|12430316|FG002|STARTED|Overall Study||2
11238431|NCT02074358|12430317|FG003|STARTED|Overall Study||2
11238432|NCT02074358|12430318|FG004|STARTED|Overall Study||3
11238433|NCT02074358|12430319|FG005|STARTED|Overall Study||2
11238434|NCT02074358|12430314|FG000|COMPLETED|Overall Study||3
11238435|NCT02074358|12430315|FG001|COMPLETED|Overall Study||3
11238436|NCT02074358|12430316|FG002|COMPLETED|Overall Study||2
11238437|NCT02074358|12430317|FG003|COMPLETED|Overall Study||2
11238438|NCT02074358|12430318|FG004|COMPLETED|Overall Study||3
11238439|NCT02074358|12430319|FG005|COMPLETED|Overall Study||2
11238440|NCT02074358|12430314|FG000|NOT COMPLETED|Overall Study||0
11238441|NCT02074358|12430315|FG001|NOT COMPLETED|Overall Study||0
11238442|NCT02074358|12430316|FG002|NOT COMPLETED|Overall Study||0
11238443|NCT02074358|12430317|FG003|NOT COMPLETED|Overall Study||0
11238444|NCT02074358|12430318|FG004|NOT COMPLETED|Overall Study||0
11238445|NCT02074358|12430319|FG005|NOT COMPLETED|Overall Study||0
11238446|NCT02074384|12430330|FG000|STARTED|Overall Study||74
11238447|NCT02074384|12430331|FG001|STARTED|Overall Study||70
11238448|NCT02074384|12430332|FG002|STARTED|Overall Study||17
11238449|NCT02074384|12430330|FG000|COMPLETED|Overall Study||74
11238450|NCT02074384|12430331|FG001|COMPLETED|Overall Study||70
11238451|NCT02074384|12430332|FG002|COMPLETED|Overall Study||17
11238452|NCT02074384|12430330|FG000|NOT COMPLETED|Overall Study||0
11238453|NCT02074384|12430331|FG001|NOT COMPLETED|Overall Study||0
11238454|NCT02074384|12430332|FG002|NOT COMPLETED|Overall Study||0
11238455|NCT02074514|12430344|FG000|STARTED|Overall Study||59
11238456|NCT02074514|12430345|FG001|STARTED|Overall Study||58
11238457|NCT02074514|12430344|FG000|COMPLETED|Overall Study||56
11238458|NCT02074514|12430345|FG001|COMPLETED|Overall Study||54
11238459|NCT02074514|12430344|FG000|NOT COMPLETED|Overall Study||3
11238460|NCT02074514|12430345|FG001|NOT COMPLETED|Overall Study||4
11238461|NCT02074553|12430357|FG000|STARTED|Intervention Period 1||12
11238462|NCT02074553|12430358|FG001|STARTED|Intervention Period 1||12
11238463|NCT02074553|12430359|FG002|STARTED|Intervention Period 1||12
11238464|NCT02074553|12430360|FG003|STARTED|Intervention Period 1||13
11238465|NCT02074553|12430361|FG004|STARTED|Intervention Period 1||12
11238466|NCT02074553|12430362|FG005|STARTED|Intervention Period 1||12
11238467|NCT02074553|12430363|FG006|STARTED|Intervention Period 1||12
11238468|NCT02074553|12430364|FG007|STARTED|Intervention Period 1||12
11238469|NCT02074553|12430357|FG000|COMPLETED|Intervention Period 1||12
11238470|NCT02074553|12430358|FG001|COMPLETED|Intervention Period 1||12
11238471|NCT02074553|12430359|FG002|COMPLETED|Intervention Period 1||12
11238472|NCT02074553|12430360|FG003|COMPLETED|Intervention Period 1||12
11238473|NCT02074553|12430361|FG004|COMPLETED|Intervention Period 1||12
11238474|NCT02074553|12430362|FG005|COMPLETED|Intervention Period 1||12
11238475|NCT02074553|12430363|FG006|COMPLETED|Intervention Period 1||12
11238476|NCT02074553|12430364|FG007|COMPLETED|Intervention Period 1||12
11238477|NCT02074553|12430357|FG000|NOT COMPLETED|Intervention Period 1||0
11238478|NCT02074553|12430358|FG001|NOT COMPLETED|Intervention Period 1||0
11238479|NCT02074553|12430359|FG002|NOT COMPLETED|Intervention Period 1||0
11238480|NCT02074553|12430360|FG003|NOT COMPLETED|Intervention Period 1||1
11238481|NCT02074553|12430361|FG004|NOT COMPLETED|Intervention Period 1||0
11238482|NCT02074553|12430362|FG005|NOT COMPLETED|Intervention Period 1||0
11238483|NCT02074553|12430363|FG006|NOT COMPLETED|Intervention Period 1||0
11238484|NCT02074553|12430364|FG007|NOT COMPLETED|Intervention Period 1||0
11238485|NCT02074553|12430357|FG000|STARTED|Washout Period 1||12
11238486|NCT02074553|12430358|FG001|STARTED|Washout Period 1||12
11238487|NCT02074553|12430359|FG002|STARTED|Washout Period 1||12
11238488|NCT02074553|12430360|FG003|STARTED|Washout Period 1||12
11238489|NCT02074553|12430361|FG004|STARTED|Washout Period 1||12
11238490|NCT02074553|12430362|FG005|STARTED|Washout Period 1||12
11238491|NCT02074553|12430363|FG006|STARTED|Washout Period 1||12
11238492|NCT02074553|12430364|FG007|STARTED|Washout Period 1||12
11238493|NCT02074553|12430357|FG000|COMPLETED|Washout Period 1||11
11238494|NCT02074553|12430358|FG001|COMPLETED|Washout Period 1||12
11238495|NCT02074553|12430359|FG002|COMPLETED|Washout Period 1||12
11238496|NCT02074553|12430360|FG003|COMPLETED|Washout Period 1||11
11238497|NCT02074553|12430361|FG004|COMPLETED|Washout Period 1||12
11238498|NCT02074553|12430362|FG005|COMPLETED|Washout Period 1||11
11238499|NCT02074553|12430363|FG006|COMPLETED|Washout Period 1||12
11238500|NCT02074553|12430364|FG007|COMPLETED|Washout Period 1||12
11238501|NCT02074553|12430357|FG000|NOT COMPLETED|Washout Period 1||1
11238502|NCT02074553|12430358|FG001|NOT COMPLETED|Washout Period 1||0
11238503|NCT02074553|12430359|FG002|NOT COMPLETED|Washout Period 1||0
11238504|NCT02074553|12430360|FG003|NOT COMPLETED|Washout Period 1||1
11238505|NCT02074553|12430361|FG004|NOT COMPLETED|Washout Period 1||0
11238506|NCT02074553|12430362|FG005|NOT COMPLETED|Washout Period 1||1
11238507|NCT02074553|12430363|FG006|NOT COMPLETED|Washout Period 1||0
11238508|NCT02074553|12430364|FG007|NOT COMPLETED|Washout Period 1||0
11238509|NCT02074553|12430357|FG000|STARTED|Intervention Period 2||11
11238510|NCT02074553|12430358|FG001|STARTED|Intervention Period 2||12
11238511|NCT02074553|12430359|FG002|STARTED|Intervention Period 2||12
11238512|NCT02074553|12430360|FG003|STARTED|Intervention Period 2||11
11238513|NCT02074553|12430361|FG004|STARTED|Intervention Period 2||12
11238514|NCT02074553|12430362|FG005|STARTED|Intervention Period 2||11
11238515|NCT02074553|12430363|FG006|STARTED|Intervention Period 2||12
11238516|NCT02074553|12430364|FG007|STARTED|Intervention Period 2||12
11238517|NCT02074553|12430357|FG000|COMPLETED|Intervention Period 2||11
11238518|NCT02074553|12430358|FG001|COMPLETED|Intervention Period 2||12
11238519|NCT02074553|12430359|FG002|COMPLETED|Intervention Period 2||12
11238520|NCT02074553|12430360|FG003|COMPLETED|Intervention Period 2||11
11238521|NCT02074553|12430361|FG004|COMPLETED|Intervention Period 2||12
11238522|NCT02074553|12430362|FG005|COMPLETED|Intervention Period 2||11
11238523|NCT02074553|12430363|FG006|COMPLETED|Intervention Period 2||12
11002389|NCT00707954|12179762|FG001|COMPLETED|Overall Study||12
11002390|NCT00707954|12179763|FG002|COMPLETED|Overall Study||14
11002391|NCT00707954|12179764|FG003|COMPLETED|Overall Study||13
11002392|NCT00707954|12179765|FG004|COMPLETED|Overall Study||9
11002393|NCT00707954|12179761|FG000|NOT COMPLETED|Overall Study||0
11002394|NCT00707954|12179762|FG001|NOT COMPLETED|Overall Study||0
11002395|NCT00707954|12179763|FG002|NOT COMPLETED|Overall Study||0
11238524|NCT02074553|12430364|FG007|COMPLETED|Intervention Period 2||12
11238525|NCT02074553|12430357|FG000|NOT COMPLETED|Intervention Period 2||0
11238526|NCT02074553|12430358|FG001|NOT COMPLETED|Intervention Period 2||0
11002396|NCT00707954|12179764|FG003|NOT COMPLETED|Overall Study||0
11002397|NCT00707954|12179765|FG004|NOT COMPLETED|Overall Study||1
11002398|NCT00707967|12179780|FG000|STARTED|Overall Study||22
11002399|NCT00707967|12179781|FG001|STARTED|Overall Study||8
11002400|NCT00707967|12179782|FG002|STARTED|Overall Study||7
11002401|NCT00707967|12179780|FG000|COMPLETED|Overall Study||22
11002402|NCT00707967|12179781|FG001|COMPLETED|Overall Study||8
11002403|NCT00707967|12179782|FG002|COMPLETED|Overall Study||7
11002404|NCT00707967|12179780|FG000|NOT COMPLETED|Overall Study||0
11002405|NCT00707967|12179781|FG001|NOT COMPLETED|Overall Study||0
11002406|NCT00707967|12179782|FG002|NOT COMPLETED|Overall Study||0
11238527|NCT02074553|12430359|FG002|NOT COMPLETED|Intervention Period 2||0
11238528|NCT02074553|12430360|FG003|NOT COMPLETED|Intervention Period 2||0
11238529|NCT02074553|12430361|FG004|NOT COMPLETED|Intervention Period 2||0
11238530|NCT02074553|12430362|FG005|NOT COMPLETED|Intervention Period 2||0
11238531|NCT02074553|12430363|FG006|NOT COMPLETED|Intervention Period 2||0
11238532|NCT02074553|12430364|FG007|NOT COMPLETED|Intervention Period 2||0
11238533|NCT02074553|12430357|FG000|STARTED|Washout Period 2||11
11238534|NCT02074553|12430358|FG001|STARTED|Washout Period 2||12
11238535|NCT02074553|12430359|FG002|STARTED|Washout Period 2||12
11238536|NCT02074553|12430360|FG003|STARTED|Washout Period 2||11
11238537|NCT02074553|12430361|FG004|STARTED|Washout Period 2||12
11238538|NCT02074553|12430362|FG005|STARTED|Washout Period 2||11
11238539|NCT02074553|12430363|FG006|STARTED|Washout Period 2||12
11238540|NCT02074553|12430364|FG007|STARTED|Washout Period 2||12
11238541|NCT02074553|12430357|FG000|COMPLETED|Washout Period 2||11
11238542|NCT02074553|12430358|FG001|COMPLETED|Washout Period 2||12
11238543|NCT02074553|12430359|FG002|COMPLETED|Washout Period 2||11
11238544|NCT02074553|12430360|FG003|COMPLETED|Washout Period 2||11
11238545|NCT02074553|12430361|FG004|COMPLETED|Washout Period 2||12
11238546|NCT02074553|12430362|FG005|COMPLETED|Washout Period 2||10
11238547|NCT02074553|12430363|FG006|COMPLETED|Washout Period 2||11
11238548|NCT02074553|12430364|FG007|COMPLETED|Washout Period 2||12
11238549|NCT02074553|12430357|FG000|NOT COMPLETED|Washout Period 2||0
11002407|NCT00707980|12179790|FG000|STARTED|Overall Study||836
11120669|NCT01339390|12305919|FG000|STARTED|Overall Study||1571
11120670|NCT01339390|12305920|FG001|STARTED|Overall Study||1598
11120671|NCT01339390|12305919|FG000|COMPLETED|Overall Study||1414
11120672|NCT01339390|12305920|FG001|COMPLETED|Overall Study||1442
11120673|NCT01339390|12305919|FG000|NOT COMPLETED|Overall Study||157
11120674|NCT01339390|12305920|FG001|NOT COMPLETED|Overall Study||156
11120675|NCT01339403|12305928|FG000|STARTED|Overall Study||24768
11002408|NCT00707980|12179790|FG000|Received Treatment|Overall Study||834
11002409|NCT00707980|12179790|FG000|COMPLETED|Overall Study||526
11002410|NCT00707980|12179790|FG000|NOT COMPLETED|Overall Study||310
11002411|NCT00707993|12179796|FG000|STARTED|Overall Study||222
11002412|NCT00707993|12179797|FG001|STARTED|Overall Study||219
11002413|NCT00707993|12179796|FG000|COMPLETED|Overall Study||133
11002414|NCT00707993|12179797|FG001|COMPLETED|Overall Study||125
11002415|NCT00707993|12179796|FG000|NOT COMPLETED|Overall Study||89
11002416|NCT00707993|12179797|FG001|NOT COMPLETED|Overall Study||94
11002417|NCT00708019|12179805|FG000|STARTED|Overall Study||92
11002418|NCT00708019|12179806|FG001|STARTED|Overall Study||93
11002419|NCT00708019|12179805|FG000|COMPLETED|Overall Study||77
11002420|NCT00708019|12179806|FG001|COMPLETED|Overall Study||78
11002421|NCT00708019|12179805|FG000|NOT COMPLETED|Overall Study||15
11002422|NCT00708019|12179806|FG001|NOT COMPLETED|Overall Study||15
11002423|NCT00708032|12179814|FG000|STARTED|Overall Study||36
11002424|NCT00708032|12179815|FG001|STARTED|Overall Study||38
11002425|NCT00708032|12179814|FG000|COMPLETED|Overall Study||26
11002426|NCT00708032|12179815|FG001|COMPLETED|Overall Study||22
11002427|NCT00708032|12179814|FG000|NOT COMPLETED|Overall Study||10
11002428|NCT00708032|12179815|FG001|NOT COMPLETED|Overall Study||16
11002429|NCT00708071|12179821|FG000|STARTED|Overall Study|Randomized and treated|45
11002430|NCT00708071|12179821|FG000|COMPLETED|Overall Study||45
11002431|NCT00708071|12179821|FG000|NOT COMPLETED|Overall Study||0
11002432|NCT00708097|12179855|FG000|STARTED|Period 1||11
11002433|NCT00708097|12179856|FG001|STARTED|Period 1||12
11002434|NCT00708097|12179857|FG002|STARTED|Period 1||12
11002435|NCT00708097|12179858|FG003|STARTED|Period 1||11
11002436|NCT00708097|12179859|FG004|STARTED|Period 1||11
11002437|NCT00708097|12179855|FG000|COMPLETED|Period 1||11
11002438|NCT00708097|12179856|FG001|COMPLETED|Period 1||11
11002439|NCT00708097|12179857|FG002|COMPLETED|Period 1||12
11002440|NCT00708097|12179858|FG003|COMPLETED|Period 1||9
11002441|NCT00708097|12179859|FG004|COMPLETED|Period 1||10
11002442|NCT00708097|12179855|FG000|NOT COMPLETED|Period 1||0
11002443|NCT00708097|12179856|FG001|NOT COMPLETED|Period 1||1
11002444|NCT00708097|12179857|FG002|NOT COMPLETED|Period 1||0
11002445|NCT00708097|12179858|FG003|NOT COMPLETED|Period 1||2
11002446|NCT00708097|12179859|FG004|NOT COMPLETED|Period 1||1
11002447|NCT00708097|12179855|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
11002448|NCT00708097|12179856|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
11002449|NCT00708097|12179857|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
11002450|NCT00708097|12179858|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
11002451|NCT00708097|12179859|FG004|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
11002452|NCT00708097|12179855|FG000|COMPLETED|Period 2||10
11002453|NCT00708097|12179856|FG001|COMPLETED|Period 2||11
11002454|NCT00708097|12179857|FG002|COMPLETED|Period 2||9
11002455|NCT00708097|12179858|FG003|COMPLETED|Period 2||10
11002456|NCT00708097|12179859|FG004|COMPLETED|Period 2||10
11002457|NCT00708097|12179855|FG000|NOT COMPLETED|Period 2||0
11002458|NCT00708097|12179856|FG001|NOT COMPLETED|Period 2||1
11002459|NCT00708097|12179857|FG002|NOT COMPLETED|Period 2||1
11002460|NCT00708097|12179858|FG003|NOT COMPLETED|Period 2||1
11002461|NCT00708097|12179859|FG004|NOT COMPLETED|Period 2||0
11002462|NCT00708097|12179855|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
11002463|NCT00708097|12179856|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
11002464|NCT00708097|12179857|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
11002465|NCT00708097|12179858|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
11002466|NCT00708097|12179859|FG004|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
11002467|NCT00708097|12179855|FG000|COMPLETED|Period 3||9
11002468|NCT00708097|12179856|FG001|COMPLETED|Period 3||11
11002469|NCT00708097|12179857|FG002|COMPLETED|Period 3||10
11002470|NCT00708097|12179858|FG003|COMPLETED|Period 3||10
11002471|NCT00708097|12179859|FG004|COMPLETED|Period 3||10
11002472|NCT00708097|12179855|FG000|NOT COMPLETED|Period 3||0
11002473|NCT00708097|12179856|FG001|NOT COMPLETED|Period 3||0
11002474|NCT00708097|12179857|FG002|NOT COMPLETED|Period 3||0
11002475|NCT00708097|12179858|FG003|NOT COMPLETED|Period 3||0
11002476|NCT00708097|12179859|FG004|NOT COMPLETED|Period 3||0
11002477|NCT00708097|12179855|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
11002478|NCT00708097|12179856|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
11002479|NCT00708097|12179857|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
11002480|NCT00708097|12179858|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
11002481|NCT00708097|12179859|FG004|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
11002482|NCT00708097|12179855|FG000|COMPLETED|Period 4||12
11002483|NCT00708097|12179856|FG001|COMPLETED|Period 4||9
11002484|NCT00708097|12179857|FG002|COMPLETED|Period 4||10
11002485|NCT00708097|12179858|FG003|COMPLETED|Period 4||11
11002486|NCT00708097|12179859|FG004|COMPLETED|Period 4||8
11002487|NCT00708097|12179855|FG000|NOT COMPLETED|Period 4||0
11002488|NCT00708097|12179856|FG001|NOT COMPLETED|Period 4||0
11002489|NCT00708097|12179857|FG002|NOT COMPLETED|Period 4||0
11002490|NCT00708097|12179858|FG003|NOT COMPLETED|Period 4||0
11002491|NCT00708097|12179859|FG004|NOT COMPLETED|Period 4||0
11002492|NCT00708097|12179855|FG000|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
11002493|NCT00708097|12179856|FG001|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
11002494|NCT00708097|12179857|FG002|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
11002495|NCT00708097|12179858|FG003|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
11002496|NCT00708097|12179859|FG004|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
11002497|NCT00708097|12179855|FG000|COMPLETED|Period 5||8
11002498|NCT00708097|12179856|FG001|COMPLETED|Period 5||9
11002499|NCT00708097|12179857|FG002|COMPLETED|Period 5||11
11002500|NCT00708097|12179858|FG003|COMPLETED|Period 5||10
11002501|NCT00708097|12179859|FG004|COMPLETED|Period 5||12
11002502|NCT00708097|12179855|FG000|NOT COMPLETED|Period 5||0
11002503|NCT00708097|12179856|FG001|NOT COMPLETED|Period 5||0
11002504|NCT00708097|12179857|FG002|NOT COMPLETED|Period 5||0
11002505|NCT00708097|12179858|FG003|NOT COMPLETED|Period 5||0
11002506|NCT00708097|12179859|FG004|NOT COMPLETED|Period 5||0
11002507|NCT00708110|12179880|FG000|STARTED|Overall Study||7
11002508|NCT00708110|12179881|FG001|STARTED|Overall Study||9
11002509|NCT00708110|12179882|FG002|STARTED|Overall Study||9
11002510|NCT00708110|12179883|FG003|STARTED|Overall Study||10
11002511|NCT00708110|12179880|FG000|COMPLETED|Overall Study||7
11002512|NCT00708110|12179881|FG001|COMPLETED|Overall Study||9
11002513|NCT00708110|12179882|FG002|COMPLETED|Overall Study||9
11002514|NCT00708110|12179883|FG003|COMPLETED|Overall Study||10
11002515|NCT00708110|12179880|FG000|NOT COMPLETED|Overall Study||0
11002516|NCT00708110|12179881|FG001|NOT COMPLETED|Overall Study||0
11002517|NCT00708110|12179882|FG002|NOT COMPLETED|Overall Study||0
11002518|NCT00708110|12179883|FG003|NOT COMPLETED|Overall Study||0
11002519|NCT00708123|12179893|FG000|STARTED|Period 1||12
11002520|NCT00708123|12179894|FG001|STARTED|Period 1||12
11002521|NCT00708123|12179895|FG002|STARTED|Period 1||12
11002522|NCT00708123|12179896|FG003|STARTED|Period 1||12
11002523|NCT00708123|12179897|FG004|STARTED|Period 1||12
11002524|NCT00708123|12179893|FG000|COMPLETED|Period 1||12
11002525|NCT00708123|12179894|FG001|COMPLETED|Period 1||11
11002526|NCT00708123|12179895|FG002|COMPLETED|Period 1||11
11002527|NCT00708123|12179896|FG003|COMPLETED|Period 1||11
11002528|NCT00708123|12179897|FG004|COMPLETED|Period 1||12
11002529|NCT00708123|12179893|FG000|NOT COMPLETED|Period 1||0
11002530|NCT00708123|12179894|FG001|NOT COMPLETED|Period 1||1
11002531|NCT00708123|12179895|FG002|NOT COMPLETED|Period 1||1
11002532|NCT00708123|12179896|FG003|NOT COMPLETED|Period 1||1
11002533|NCT00708123|12179897|FG004|NOT COMPLETED|Period 1||0
11002534|NCT00708123|12179893|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
11002535|NCT00708123|12179894|FG001|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
11002536|NCT00708123|12179895|FG002|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
11002537|NCT00708123|12179896|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
11002538|NCT00708123|12179897|FG004|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
11002539|NCT00708123|12179893|FG000|COMPLETED|Period 2||10
11002540|NCT00708123|12179894|FG001|COMPLETED|Period 2||12
11002541|NCT00708123|12179895|FG002|COMPLETED|Period 2||12
11002542|NCT00708123|12179896|FG003|COMPLETED|Period 2||10
11002543|NCT00708123|12179897|FG004|COMPLETED|Period 2||11
11002544|NCT00708123|12179893|FG000|NOT COMPLETED|Period 2||1
11002545|NCT00708123|12179894|FG001|NOT COMPLETED|Period 2||0
11002546|NCT00708123|12179895|FG002|NOT COMPLETED|Period 2||0
11120676|NCT01339403|12305929|FG001|STARTED|Overall Study||257600
11120677|NCT01339403|12305928|FG000|COMPLETED|Overall Study||24768
11002547|NCT00708123|12179896|FG003|NOT COMPLETED|Period 2||1
11120678|NCT01339403|12305929|FG001|COMPLETED|Overall Study||257600
11120679|NCT01339403|12305928|FG000|NOT COMPLETED|Overall Study||0
11002548|NCT00708123|12179897|FG004|NOT COMPLETED|Period 2||0
11002549|NCT00708123|12179893|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
11002550|NCT00708123|12179894|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
11002551|NCT00708123|12179895|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
11002552|NCT00708123|12179896|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
11002553|NCT00708123|12179897|FG004|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
11002554|NCT00708123|12179893|FG000|COMPLETED|Period 3||12
11002555|NCT00708123|12179894|FG001|COMPLETED|Period 3||10
11002556|NCT00708123|12179895|FG002|COMPLETED|Period 3||10
11002557|NCT00708123|12179896|FG003|COMPLETED|Period 3||11
11002558|NCT00708123|12179897|FG004|COMPLETED|Period 3||10
11002559|NCT00708123|12179893|FG000|NOT COMPLETED|Period 3||0
11002560|NCT00708123|12179894|FG001|NOT COMPLETED|Period 3||0
11002561|NCT00708123|12179895|FG002|NOT COMPLETED|Period 3||1
11002562|NCT00708123|12179896|FG003|NOT COMPLETED|Period 3||1
11002563|NCT00708123|12179897|FG004|NOT COMPLETED|Period 3||0
11002564|NCT00708123|12179893|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
11002565|NCT00708123|12179894|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
11002566|NCT00708123|12179895|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
11002567|NCT00708123|12179896|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
11002568|NCT00708123|12179897|FG004|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
11002569|NCT00708123|12179893|FG000|COMPLETED|Period 4||10
11002570|NCT00708123|12179894|FG001|COMPLETED|Period 4||11
11002571|NCT00708123|12179895|FG002|COMPLETED|Period 4||10
11002572|NCT00708123|12179896|FG003|COMPLETED|Period 4||10
11002573|NCT00708123|12179897|FG004|COMPLETED|Period 4||11
11002574|NCT00708123|12179893|FG000|NOT COMPLETED|Period 4||0
11002575|NCT00708123|12179894|FG001|NOT COMPLETED|Period 4||1
11002576|NCT00708123|12179895|FG002|NOT COMPLETED|Period 4||0
11120680|NCT01339403|12305929|FG001|NOT COMPLETED|Overall Study||0
11002577|NCT00708123|12179896|FG003|NOT COMPLETED|Period 4||0
11120681|NCT01339416|12305935|FG000|STARTED|Overall Study||8202
11120682|NCT01339416|12305935|FG000|COMPLETED|Overall Study||8202
11120683|NCT01339416|12305935|FG000|NOT COMPLETED|Overall Study||0
11120684|NCT01339429|12305939|FG000|STARTED|Overall Study||41
11120685|NCT01339429|12305939|FG000|COMPLETED|Overall Study||37
11120686|NCT01339429|12305939|FG000|NOT COMPLETED|Overall Study||4
11120687|NCT01339559|12305943|FG000|STARTED|Overall Study||766
11120688|NCT01339559|12305943|FG000|COMPLETED|Overall Study||368
11120689|NCT01339559|12305943|FG000|NOT COMPLETED|Overall Study||398
11120690|NCT01339832|12305948|FG000|STARTED|Overall Study||51
11120691|NCT01339832|12305948|FG000|COMPLETED|Overall Study||37
11120692|NCT01339832|12305948|FG000|NOT COMPLETED|Overall Study||14
11120693|NCT01339858|12305954|FG000|STARTED|Overall Study||30
11120694|NCT01339858|12305955|FG001|STARTED|Overall Study||30
11120695|NCT01339858|12305954|FG000|COMPLETED|Overall Study||14
11120696|NCT01339858|12305955|FG001|COMPLETED|Overall Study||18
11120697|NCT01339858|12305954|FG000|NOT COMPLETED|Overall Study||16
11120698|NCT01339858|12305955|FG001|NOT COMPLETED|Overall Study||12
11120699|NCT01339897|12305967|FG000|STARTED|Overall Study||7
11120700|NCT01339897|12305968|FG001|STARTED|Overall Study||6
11120701|NCT01339897|12305969|FG002|STARTED|Overall Study||6
11120702|NCT01339897|12305970|FG003|STARTED|Overall Study||6
11120703|NCT01339897|12305967|FG000|COMPLETED|Overall Study||6
11120704|NCT01339897|12305968|FG001|COMPLETED|Overall Study||6
11120705|NCT01339897|12305969|FG002|COMPLETED|Overall Study||6
11120706|NCT01339897|12305970|FG003|COMPLETED|Overall Study||5
11120707|NCT01339897|12305967|FG000|NOT COMPLETED|Overall Study||1
11120708|NCT01339897|12305968|FG001|NOT COMPLETED|Overall Study||0
11120709|NCT01339897|12305969|FG002|NOT COMPLETED|Overall Study||0
11120710|NCT01339897|12305970|FG003|NOT COMPLETED|Overall Study||1
11120711|NCT01339910|12305984|FG000|STARTED|Overall Study||135
11120712|NCT01339910|12305985|FG001|STARTED|Overall Study||137
11120713|NCT01339910|12305984|FG000|COMPLETED|Overall Study||132
11120714|NCT01339910|12305985|FG001|COMPLETED|Overall Study||133
11120715|NCT01339910|12305984|FG000|NOT COMPLETED|Overall Study||3
11120716|NCT01339910|12305985|FG001|NOT COMPLETED|Overall Study||4
11120717|NCT01339923|12305998|FG000|STARTED|Overall Study||253
11120718|NCT01339923|12305999|FG001|STARTED|Overall Study||250
11120719|NCT01339923|12306000|FG002|STARTED|Overall Study||251
11120720|NCT01339923|12306001|FG003|STARTED|Overall Study||104
11120721|NCT01339923|12306002|FG004|STARTED|Overall Study||300
11120722|NCT01339923|12306003|FG005|STARTED|Overall Study||126
11120723|NCT01339923|12306004|FG006|STARTED|Overall Study||125
11120724|NCT01339923|12305998|FG000|COMPLETED|Overall Study||239
11120725|NCT01339923|12305999|FG001|COMPLETED|Overall Study||234
11120726|NCT01339923|12306000|FG002|COMPLETED|Overall Study||243
11120727|NCT01339923|12306001|FG003|COMPLETED|Overall Study||100
11120728|NCT01339923|12306002|FG004|COMPLETED|Overall Study||295
11120729|NCT01339923|12306003|FG005|COMPLETED|Overall Study||117
11002578|NCT00708123|12179897|FG004|NOT COMPLETED|Period 4||0
11002579|NCT00708123|12179893|FG000|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
11002580|NCT00708123|12179894|FG001|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
11002581|NCT00708123|12179895|FG002|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
11002582|NCT00708123|12179896|FG003|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
11002583|NCT00708123|12179897|FG004|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
11002584|NCT00708123|12179893|FG000|COMPLETED|Period 5||10
11002585|NCT00708123|12179894|FG001|COMPLETED|Period 5||10
11002586|NCT00708123|12179895|FG002|COMPLETED|Period 5||11
11002587|NCT00708123|12179896|FG003|COMPLETED|Period 5||11
11002588|NCT00708123|12179897|FG004|COMPLETED|Period 5||10
11002589|NCT00708123|12179893|FG000|NOT COMPLETED|Period 5||0
11002590|NCT00708123|12179894|FG001|NOT COMPLETED|Period 5||0
11002591|NCT00708123|12179895|FG002|NOT COMPLETED|Period 5||0
11002592|NCT00708123|12179896|FG003|NOT COMPLETED|Period 5||0
11002593|NCT00708123|12179897|FG004|NOT COMPLETED|Period 5||0
11002594|NCT00708162|12179915|FG000|STARTED|Randomized Phase||361
11002595|NCT00708162|12179916|FG001|STARTED|Randomized Phase||363
11002596|NCT00708162|12179915|FG000|Randomized and Treated|Randomized Phase||354
11002597|NCT00708162|12179916|FG001|Randomized and Treated|Randomized Phase||358
11002598|NCT00708162|12179915|FG000|COMPLETED|Randomized Phase||205
11002599|NCT00708162|12179916|FG001|COMPLETED|Randomized Phase||209
11002600|NCT00708162|12179915|FG000|NOT COMPLETED|Randomized Phase||156
11002601|NCT00708162|12179916|FG001|NOT COMPLETED|Randomized Phase||154
11120730|NCT01339923|12306004|FG006|COMPLETED|Overall Study||111
11002602|NCT00708162|12179915|FG000|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
11002603|NCT00708162|12179916|FG001|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
11002604|NCT00708162|12179915|FG000|COMPLETED|Open-Label Phase||152
11002605|NCT00708162|12179916|FG001|COMPLETED|Open-Label Phase||121
11002606|NCT00708162|12179915|FG000|NOT COMPLETED|Open-Label Phase||44
11002607|NCT00708162|12179916|FG001|NOT COMPLETED|Open-Label Phase||30
11002608|NCT00708175|12179925|FG000|STARTED|Overall Study||78
11002609|NCT00708175|12179926|FG001|STARTED|Overall Study||78
11002610|NCT00708175|12179925|FG000|COMPLETED|Overall Study||60
11002611|NCT00708175|12179926|FG001|COMPLETED|Overall Study||57
11002612|NCT00708175|12179925|FG000|NOT COMPLETED|Overall Study||18
11002613|NCT00708175|12179926|FG001|NOT COMPLETED|Overall Study||21
11002614|NCT00708201|12179934|FG000|STARTED|Overall Study||137
11002615|NCT00708201|12179935|FG001|STARTED|Overall Study||143
11002616|NCT00708201|12179934|FG000|Received at Least 1 Dose of Study Drug|Overall Study||130
11002617|NCT00708201|12179935|FG001|Received at Least 1 Dose of Study Drug|Overall Study||137
11002618|NCT00708201|12179934|FG000|COMPLETED|Overall Study||130
11002619|NCT00708201|12179935|FG001|COMPLETED|Overall Study||137
11002620|NCT00708201|12179934|FG000|NOT COMPLETED|Overall Study||7
11002621|NCT00708201|12179935|FG001|NOT COMPLETED|Overall Study||6
11002622|NCT00708214|12179944|FG000|STARTED|Overall Study||7
11002623|NCT00708214|12179945|FG001|STARTED|Overall Study||13
11002624|NCT00708214|12179946|FG002|STARTED|Overall Study||8
11002625|NCT00708214|12179944|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
11002626|NCT00708214|12179945|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
11002627|NCT00708214|12179946|FG002|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
11002628|NCT00708214|12179944|FG000|NOT COMPLETED|Overall Study||7
11002629|NCT00708214|12179945|FG001|NOT COMPLETED|Overall Study||13
11002630|NCT00708214|12179946|FG002|NOT COMPLETED|Overall Study||8
11002631|NCT00708227|12179963|FG000|STARTED|Overall Study||19
11002632|NCT00708227|12179964|FG001|STARTED|Overall Study||26
11002633|NCT00708227|12179965|FG002|STARTED|Overall Study||18
11002634|NCT00708227|12179966|FG003|STARTED|Overall Study||25
11002635|NCT00708227|12179963|FG000|COMPLETED|Overall Study||18
11002636|NCT00708227|12179964|FG001|COMPLETED|Overall Study||21
11002637|NCT00708227|12179965|FG002|COMPLETED|Overall Study||17
11002638|NCT00708227|12179966|FG003|COMPLETED|Overall Study||22
11002639|NCT00708227|12179963|FG000|NOT COMPLETED|Overall Study||1
11002640|NCT00708227|12179964|FG001|NOT COMPLETED|Overall Study||5
11002641|NCT00708227|12179965|FG002|NOT COMPLETED|Overall Study||1
11002642|NCT00708227|12179966|FG003|NOT COMPLETED|Overall Study||3
11002643|NCT00708305|12179996|FG000|STARTED|Period 1||16
11002644|NCT00708305|12179997|FG001|STARTED|Period 1||16
11002645|NCT00708305|12179998|FG002|STARTED|Period 1||17
11002646|NCT00708305|12179999|FG003|STARTED|Period 1||16
11002647|NCT00708305|12179996|FG000|COMPLETED|Period 1||15
11002648|NCT00708305|12179997|FG001|COMPLETED|Period 1||16
11002649|NCT00708305|12179998|FG002|COMPLETED|Period 1||16
11002650|NCT00708305|12179999|FG003|COMPLETED|Period 1||14
11002651|NCT00708305|12179996|FG000|NOT COMPLETED|Period 1||1
11002652|NCT00708305|12179997|FG001|NOT COMPLETED|Period 1||0
11002653|NCT00708305|12179998|FG002|NOT COMPLETED|Period 1||1
11002654|NCT00708305|12179999|FG003|NOT COMPLETED|Period 1||2
11002655|NCT00708305|12179996|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
11002656|NCT00708305|12179997|FG001|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
11002657|NCT00708305|12179998|FG002|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
11002658|NCT00708305|12179999|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
11002659|NCT00708305|12179996|FG000|COMPLETED|Period 2||14
11002660|NCT00708305|12179997|FG001|COMPLETED|Period 2||13
11002661|NCT00708305|12179998|FG002|COMPLETED|Period 2||16
11002662|NCT00708305|12179999|FG003|COMPLETED|Period 2||14
11002663|NCT00708305|12179996|FG000|NOT COMPLETED|Period 2||1
11002664|NCT00708305|12179997|FG001|NOT COMPLETED|Period 2||2
11002665|NCT00708305|12179998|FG002|NOT COMPLETED|Period 2||0
11002666|NCT00708305|12179999|FG003|NOT COMPLETED|Period 2||1
11002667|NCT00708305|12179996|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
11002668|NCT00708305|12179997|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
11002669|NCT00708305|12179998|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
11002670|NCT00708305|12179999|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
11002671|NCT00708305|12179996|FG000|COMPLETED|Period 3||14
11002672|NCT00708305|12179997|FG001|COMPLETED|Period 3||12
11002673|NCT00708305|12179998|FG002|COMPLETED|Period 3||14
11002674|NCT00708305|12179999|FG003|COMPLETED|Period 3||14
11002675|NCT00708305|12179996|FG000|NOT COMPLETED|Period 3||1
11002676|NCT00708305|12179997|FG001|NOT COMPLETED|Period 3||2
11002677|NCT00708305|12179998|FG002|NOT COMPLETED|Period 3||0
11002678|NCT00708305|12179999|FG003|NOT COMPLETED|Period 3||0
11002679|NCT00708305|12179996|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
11002680|NCT00708305|12179997|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
11002681|NCT00708305|12179998|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
11002682|NCT00708305|12179999|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
11002683|NCT00708305|12179996|FG000|COMPLETED|Period 4||12
11002684|NCT00708305|12179997|FG001|COMPLETED|Period 4||14
11002685|NCT00708305|12179998|FG002|COMPLETED|Period 4||14
11002686|NCT00708305|12179999|FG003|COMPLETED|Period 4||14
11002687|NCT00708305|12179996|FG000|NOT COMPLETED|Period 4||0
11002688|NCT00708305|12179997|FG001|NOT COMPLETED|Period 4||0
11002689|NCT00708305|12179998|FG002|NOT COMPLETED|Period 4||0
11002690|NCT00708305|12179999|FG003|NOT COMPLETED|Period 4||0
11002691|NCT00708422|12180014|FG000|STARTED|Overall Study||116
11002692|NCT00708422|12180015|FG001|STARTED|Overall Study||115
11002693|NCT00708422|12180014|FG000|COMPLETED|Overall Study||112
11002694|NCT00708422|12180015|FG001|COMPLETED|Overall Study||114
11002695|NCT00708422|12180014|FG000|NOT COMPLETED|Overall Study||4
11002696|NCT00708422|12180015|FG001|NOT COMPLETED|Overall Study||1
11002697|NCT00708435|12180023|FG000|STARTED|Overall Study||107
11002698|NCT00708435|12180024|FG001|STARTED|Overall Study||109
11002699|NCT00708435|12180023|FG000|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
11002700|NCT00708435|12180024|FG001|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
11002701|NCT00708435|12180023|FG000|NOT COMPLETED|Overall Study||25
11002702|NCT00708435|12180024|FG001|NOT COMPLETED|Overall Study||17
11002703|NCT00708461|12180034|FG000|STARTED|Overall Study||752
11002704|NCT00708461|12180035|FG001|STARTED|Overall Study||995
11002705|NCT00708461|12180034|FG000|COMPLETED|Overall Study||611
11002706|NCT00708461|12180035|FG001|COMPLETED|Overall Study||795
11002707|NCT00708461|12180034|FG000|NOT COMPLETED|Overall Study||141
11002708|NCT00708461|12180035|FG001|NOT COMPLETED|Overall Study||200
11002709|NCT00708500|12180044|FG000|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
11002710|NCT00708500|12180045|FG001|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
11002711|NCT00708500|12180046|FG002|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
11002712|NCT00708500|12180044|FG000|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
11002713|NCT00708500|12180045|FG001|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
11002714|NCT00708500|12180046|FG002|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
11002715|NCT00708500|12180044|FG000|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
11002716|NCT00708500|12180045|FG001|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
11002717|NCT00708500|12180046|FG002|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
11002718|NCT00708500|12180044|FG000|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
11002719|NCT00708500|12180045|FG001|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
11002720|NCT00708500|12180046|FG002|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
11002721|NCT00708500|12180044|FG000|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
11002722|NCT00708500|12180045|FG001|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
11002723|NCT00708500|12180046|FG002|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
11002724|NCT00708500|12180044|FG000|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
11002725|NCT00708500|12180045|FG001|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
11002726|NCT00708500|12180046|FG002|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
11002727|NCT00708500|12180044|FG000|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
11002728|NCT00708500|12180045|FG001|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
11002729|NCT00708500|12180046|FG002|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
11002730|NCT00708500|12180044|FG000|STARTED|FOLLOWUP||77
11002731|NCT00708500|12180045|FG001|STARTED|FOLLOWUP||151
11002732|NCT00708500|12180046|FG002|STARTED|FOLLOWUP||158
11002733|NCT00708500|12180044|FG000|COMPLETED|FOLLOWUP||37
11002734|NCT00708500|12180045|FG001|COMPLETED|FOLLOWUP||136
11002735|NCT00708500|12180046|FG002|COMPLETED|FOLLOWUP||143
11002736|NCT00708500|12180044|FG000|NOT COMPLETED|FOLLOWUP||40
11002737|NCT00708500|12180045|FG001|NOT COMPLETED|FOLLOWUP||15
11002738|NCT00708500|12180046|FG002|NOT COMPLETED|FOLLOWUP||15
11002739|NCT00708526|12180056|FG000|STARTED|Wake up After Anesthesia||11
11002740|NCT00708526|12180057|FG001|STARTED|Wake up After Anesthesia||11
11002741|NCT00708526|12180056|FG000|COMPLETED|Wake up After Anesthesia||11
11002742|NCT00708526|12180057|FG001|COMPLETED|Wake up After Anesthesia||11
11002743|NCT00708526|12180056|FG000|NOT COMPLETED|Wake up After Anesthesia||0
11002744|NCT00708526|12180057|FG001|NOT COMPLETED|Wake up After Anesthesia||0
11120731|NCT01339923|12305998|FG000|NOT COMPLETED|Overall Study||14
11120732|NCT01339923|12305999|FG001|NOT COMPLETED|Overall Study||16
11238550|NCT02074553|12430358|FG001|NOT COMPLETED|Washout Period 2||0
11002745|NCT00708526|12180056|FG000|STARTED|Return of Cognitive Function||11
11120733|NCT01339923|12306000|FG002|NOT COMPLETED|Overall Study||8
11120734|NCT01339923|12306001|FG003|NOT COMPLETED|Overall Study||4
11120735|NCT01339923|12306002|FG004|NOT COMPLETED|Overall Study||5
11120736|NCT01339923|12306003|FG005|NOT COMPLETED|Overall Study||9
11120737|NCT01339923|12306004|FG006|NOT COMPLETED|Overall Study||14
11002746|NCT00708526|12180057|FG001|STARTED|Return of Cognitive Function||11
11002747|NCT00708526|12180056|FG000|COMPLETED|Return of Cognitive Function||11
11002748|NCT00708526|12180057|FG001|COMPLETED|Return of Cognitive Function||11
11002749|NCT00708526|12180056|FG000|NOT COMPLETED|Return of Cognitive Function||0
11002750|NCT00708526|12180057|FG001|NOT COMPLETED|Return of Cognitive Function||0
11002751|NCT00708552|12180067|FG000|STARTED|Overall Study||145
11002752|NCT00708552|12180068|FG001|STARTED|Overall Study||145
11002753|NCT00708552|12180069|FG002|STARTED|Overall Study||133
11002754|NCT00708552|12180070|FG003|STARTED|Overall Study||151
11002755|NCT00708552|12180067|FG000|COMPLETED|Overall Study||118
11002756|NCT00708552|12180068|FG001|COMPLETED|Overall Study||127
11120738|NCT01339936|12306033|FG000|STARTED|Overall Study|plus 2 screen failures|38
11120739|NCT01339936|12306033|FG000|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
11120740|NCT01339936|12306033|FG000|NOT COMPLETED|Overall Study||2
11120741|NCT01340014|12306039|FG000|STARTED|Period 1, First 7 Days||55
11002757|NCT00708552|12180069|FG002|COMPLETED|Overall Study||118
11002758|NCT00708552|12180070|FG003|COMPLETED|Overall Study||130
11002759|NCT00708552|12180067|FG000|NOT COMPLETED|Overall Study||27
11002760|NCT00708552|12180068|FG001|NOT COMPLETED|Overall Study||18
11002761|NCT00708552|12180069|FG002|NOT COMPLETED|Overall Study||15
11002762|NCT00708552|12180070|FG003|NOT COMPLETED|Overall Study||21
11120742|NCT01340014|12306040|FG001|STARTED|Period 1, First 7 Days||57
11002763|NCT00708643|12180086|FG000|STARTED|Overall Study||40
11002764|NCT00708643|12180087|FG001|STARTED|Overall Study||40
11002765|NCT00708643|12180086|FG000|COMPLETED|Overall Study||40
11002766|NCT00708643|12180087|FG001|COMPLETED|Overall Study||39
11002767|NCT00708643|12180086|FG000|NOT COMPLETED|Overall Study||0
11238551|NCT02074553|12430359|FG002|NOT COMPLETED|Washout Period 2||1
11002768|NCT00708643|12180087|FG001|NOT COMPLETED|Overall Study||1
11002769|NCT00708682|12180093|FG000|STARTED|Infant Series||225
11002770|NCT00708682|12180093|FG000|Vaccinated Dose 1|Infant Series||223
11002771|NCT00708682|12180093|FG000|Vaccinated Dose 2|Infant Series||214
11002772|NCT00708682|12180093|FG000|Vaccinated Dose 3|Infant Series||194
11002773|NCT00708682|12180093|FG000|COMPLETED|Infant Series||192
11002774|NCT00708682|12180093|FG000|NOT COMPLETED|Infant Series||33
11002775|NCT00708682|12180093|FG000|STARTED|After Infant Series||192
11002776|NCT00708682|12180093|FG000|COMPLETED|After Infant Series||191
11002777|NCT00708682|12180093|FG000|NOT COMPLETED|After Infant Series||1
11002778|NCT00708682|12180093|FG000|STARTED|Toddler Dose||191
11002779|NCT00708682|12180093|FG000|COMPLETED|Toddler Dose||183
11002780|NCT00708682|12180093|FG000|NOT COMPLETED|Toddler Dose||8
11002781|NCT00708708|12180099|FG000|STARTED|Overall Study||955
11002782|NCT00708708|12180099|FG000|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
11002783|NCT00708708|12180099|FG000|NOT COMPLETED|Overall Study||742
11002784|NCT00708721|12180106|FG000|STARTED|Overall Study||2
11002785|NCT00708721|12180107|FG001|STARTED|Overall Study||4
11002786|NCT00708721|12180108|FG002|STARTED|Overall Study||3
11002787|NCT00708721|12180109|FG003|STARTED|Overall Study||2
11002788|NCT00708721|12180106|FG000|COMPLETED|Overall Study||2
11002789|NCT00708721|12180107|FG001|COMPLETED|Overall Study||4
11002790|NCT00708721|12180108|FG002|COMPLETED|Overall Study||3
11002791|NCT00708721|12180109|FG003|COMPLETED|Overall Study||2
11002792|NCT00708721|12180106|FG000|NOT COMPLETED|Overall Study||0
11002793|NCT00708721|12180107|FG001|NOT COMPLETED|Overall Study||0
11002794|NCT00708721|12180108|FG002|NOT COMPLETED|Overall Study||0
11002795|NCT00708721|12180109|FG003|NOT COMPLETED|Overall Study||0
11002796|NCT00708851|12180120|FG000|STARTED|Overall Study||12
11002797|NCT00708851|12180120|FG000|COMPLETED|Overall Study||12
11002798|NCT00708851|12180120|FG000|NOT COMPLETED|Overall Study||0
11002799|NCT00708877|12180126|FG000|STARTED|Overall Study||5
11002800|NCT00708877|12180126|FG000|COMPLETED|Overall Study||5
11002801|NCT00708877|12180126|FG000|NOT COMPLETED|Overall Study||0
11002802|NCT00708942|12180135|FG000|STARTED|Overall Study||47
11002803|NCT00708942|12180136|FG001|STARTED|Overall Study||12
11002804|NCT00708942|12180137|FG002|STARTED|Overall Study||11
11002805|NCT00708942|12180138|FG003|STARTED|Overall Study||10
11002806|NCT00708942|12180139|FG004|STARTED|Overall Study||3
11002807|NCT00708942|12180135|FG000|COMPLETED|Overall Study||40
11002808|NCT00708942|12180136|FG001|COMPLETED|Overall Study||11
11002809|NCT00708942|12180137|FG002|COMPLETED|Overall Study||9
11002810|NCT00708942|12180138|FG003|COMPLETED|Overall Study||10
11002811|NCT00708942|12180139|FG004|COMPLETED|Overall Study||2
11002812|NCT00708942|12180135|FG000|NOT COMPLETED|Overall Study||7
11002813|NCT00708942|12180136|FG001|NOT COMPLETED|Overall Study||1
11002814|NCT00708942|12180137|FG002|NOT COMPLETED|Overall Study||2
11002815|NCT00708942|12180138|FG003|NOT COMPLETED|Overall Study||0
11002816|NCT00708942|12180139|FG004|NOT COMPLETED|Overall Study||1
11002817|NCT00709059|12180151|FG000|STARTED|Overall Study||538
11002818|NCT00709059|12180151|FG000|COMPLETED|Overall Study||444
11002819|NCT00709059|12180151|FG000|NOT COMPLETED|Overall Study||94
11002820|NCT00709098|12180158|FG000|STARTED|Double-blind Period||25
11002821|NCT00709098|12180159|FG001|STARTED|Double-blind Period||24
11002822|NCT00709098|12180160|FG002|STARTED|Double-blind Period||0
11002823|NCT00709098|12180158|FG000|COMPLETED|Double-blind Period||19
11002824|NCT00709098|12180159|FG001|COMPLETED|Double-blind Period||16
11002825|NCT00709098|12180160|FG002|COMPLETED|Double-blind Period||0
11002826|NCT00709098|12180158|FG000|NOT COMPLETED|Double-blind Period||6
11002827|NCT00709098|12180159|FG001|NOT COMPLETED|Double-blind Period||8
11002828|NCT00709098|12180160|FG002|NOT COMPLETED|Double-blind Period||0
11002829|NCT00709098|12180158|FG000|STARTED|Open-label Period||0
11002830|NCT00709098|12180159|FG001|STARTED|Open-label Period||0
11002831|NCT00709098|12180160|FG002|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
11002832|NCT00709098|12180158|FG000|COMPLETED|Open-label Period||0
11002833|NCT00709098|12180159|FG001|COMPLETED|Open-label Period||0
11002834|NCT00709098|12180160|FG002|COMPLETED|Open-label Period||18
11002835|NCT00709098|12180158|FG000|NOT COMPLETED|Open-label Period||0
11002836|NCT00709098|12180159|FG001|NOT COMPLETED|Open-label Period||0
11002837|NCT00709098|12180160|FG002|NOT COMPLETED|Open-label Period||14
11002838|NCT00709111|12180169|FG000|STARTED|Overall Study||34
11002839|NCT00709111|12180169|FG000|Week 22/24|Overall Study||33
11002840|NCT00709111|12180169|FG000|COMPLETED|Overall Study||32
11002841|NCT00709111|12180169|FG000|NOT COMPLETED|Overall Study||2
11002842|NCT00709124|12180175|FG000|STARTED|Overall Study||16
11002843|NCT00709124|12180176|FG001|STARTED|Overall Study||18
11002844|NCT00709124|12180175|FG000|COMPLETED|Overall Study||12
11002845|NCT00709124|12180176|FG001|COMPLETED|Overall Study||17
11002846|NCT00709124|12180175|FG000|NOT COMPLETED|Overall Study||4
11002847|NCT00709124|12180176|FG001|NOT COMPLETED|Overall Study||1
11002848|NCT00709202|12180188|FG000|STARTED|Overall Study||19
11002849|NCT00709202|12180189|FG001|STARTED|Overall Study||21
11002850|NCT00709202|12180188|FG000|COMPLETED|Overall Study||13
11002851|NCT00709202|12180189|FG001|COMPLETED|Overall Study||15
11002852|NCT00709202|12180188|FG000|NOT COMPLETED|Overall Study||6
11002853|NCT00709202|12180189|FG001|NOT COMPLETED|Overall Study||6
11002854|NCT00709228|12180196|FG000|STARTED|Overall Study||496
11002855|NCT00709228|12180196|FG000|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
11002856|NCT00709228|12180196|FG000|NOT COMPLETED|Overall Study||332
11002857|NCT00709306|12180204|FG000|STARTED|Overall Study||48
11002858|NCT00709306|12180205|FG001|STARTED|Overall Study||44
11002859|NCT00709306|12180206|FG002|STARTED|Overall Study||58
11002860|NCT00709306|12180207|FG003|STARTED|Overall Study||47
11002861|NCT00709306|12180204|FG000|COMPLETED|Overall Study||39
11002862|NCT00709306|12180205|FG001|COMPLETED|Overall Study||30
11002863|NCT00709306|12180206|FG002|COMPLETED|Overall Study||48
11002864|NCT00709306|12180207|FG003|COMPLETED|Overall Study||37
11002865|NCT00709306|12180204|FG000|NOT COMPLETED|Overall Study||9
11002866|NCT00709306|12180205|FG001|NOT COMPLETED|Overall Study||14
11002867|NCT00709306|12180206|FG002|NOT COMPLETED|Overall Study||10
11002868|NCT00709306|12180207|FG003|NOT COMPLETED|Overall Study||10
11002869|NCT00709319|12180217|FG000|STARTED|Overall Study||87
11002870|NCT00709319|12180217|FG000|COMPLETED|Overall Study||81
11002871|NCT00709319|12180217|FG000|NOT COMPLETED|Overall Study||6
11002872|NCT00709592|12180223|FG000|STARTED|Overall Study||19
11002873|NCT00709592|12180224|FG001|STARTED|Overall Study||23
11002874|NCT00709592|12180223|FG000|COMPLETED|Overall Study||19
11002875|NCT00709592|12180224|FG001|COMPLETED|Overall Study||22
11002876|NCT00709592|12180223|FG000|NOT COMPLETED|Overall Study||0
11002877|NCT00709592|12180224|FG001|NOT COMPLETED|Overall Study||1
11002878|NCT00709618|12180230|FG000|STARTED|Overall Study||44
11002879|NCT00709618|12180230|FG000|COMPLETED|Overall Study||14
11002880|NCT00709618|12180230|FG000|NOT COMPLETED|Overall Study||30
11002881|NCT00709696|12180236|FG000|STARTED|Overall Study||4
11002882|NCT00709696|12180237|FG001|STARTED|Overall Study||3
11002883|NCT00709696|12180236|FG000|COMPLETED|Overall Study||4
11002884|NCT00709696|12180237|FG001|COMPLETED|Overall Study||3
11002885|NCT00709696|12180236|FG000|NOT COMPLETED|Overall Study||0
11002886|NCT00709696|12180237|FG001|NOT COMPLETED|Overall Study||0
11002887|NCT00709722|12180243|FG000|STARTED|Overall Study||21
11002888|NCT00709722|12180243|FG000|COMPLETED|Overall Study||20
11002889|NCT00709722|12180243|FG000|NOT COMPLETED|Overall Study||1
11002890|NCT00709735|12180249|FG000|STARTED|Overall Study||11
11002891|NCT00709735|12180250|FG001|STARTED|Overall Study||12
11002892|NCT00709735|12180249|FG000|COMPLETED|Overall Study||8
11002893|NCT00709735|12180250|FG001|COMPLETED|Overall Study||10
11002894|NCT00709735|12180249|FG000|NOT COMPLETED|Overall Study||3
11002895|NCT00709735|12180250|FG001|NOT COMPLETED|Overall Study||2
11002896|NCT00709761|12180256|FG000|STARTED|Overall Study||60
11002897|NCT00709761|12180256|FG000|COMPLETED|Overall Study||33
11002898|NCT00709761|12180256|FG000|NOT COMPLETED|Overall Study||27
11002899|NCT00709826|12180262|FG000|STARTED|Overall Study||70
11002900|NCT00709826|12180263|FG001|STARTED|Overall Study||39
11002901|NCT00709826|12180262|FG000|COMPLETED|Overall Study||68
11002902|NCT00709826|12180263|FG001|COMPLETED|Overall Study||38
11002903|NCT00709826|12180262|FG000|NOT COMPLETED|Overall Study||2
11002904|NCT00709826|12180263|FG001|NOT COMPLETED|Overall Study||1
11002905|NCT00709852|12180269|FG000|STARTED|Period 1||228
11002906|NCT00709852|12180270|FG001|STARTED|Period 1||174
11002907|NCT00709852|12180269|FG000|COMPLETED|Period 1||220
11002908|NCT00709852|12180270|FG001|COMPLETED|Period 1||171
11002909|NCT00709852|12180269|FG000|NOT COMPLETED|Period 1||8
11002910|NCT00709852|12180270|FG001|NOT COMPLETED|Period 1||3
11002911|NCT00709852|12180269|FG000|STARTED|Period 2||220
11002912|NCT00709852|12180270|FG001|STARTED|Period 2||171
11002913|NCT00709852|12180269|FG000|COMPLETED|Period 2||211
11002914|NCT00709852|12180270|FG001|COMPLETED|Period 2||169
11002915|NCT00709852|12180269|FG000|NOT COMPLETED|Period 2||9
11002916|NCT00709852|12180270|FG001|NOT COMPLETED|Period 2||2
11002917|NCT00709878|12180289|FG000|STARTED|Overall Study||8
11002918|NCT00709878|12180290|FG001|STARTED|Overall Study||8
11002919|NCT00709878|12180291|FG002|STARTED|Overall Study||8
11002920|NCT00709878|12180292|FG003|STARTED|Overall Study||8
11002921|NCT00709878|12180289|FG000|COMPLETED|Overall Study||8
11002922|NCT00709878|12180290|FG001|COMPLETED|Overall Study||8
11002923|NCT00709878|12180291|FG002|COMPLETED|Overall Study||8
11002924|NCT00709878|12180292|FG003|COMPLETED|Overall Study||8
11002925|NCT00709878|12180289|FG000|NOT COMPLETED|Overall Study||0
11002926|NCT00709878|12180290|FG001|NOT COMPLETED|Overall Study||0
11002927|NCT00709878|12180291|FG002|NOT COMPLETED|Overall Study||0
11002928|NCT00709878|12180292|FG003|NOT COMPLETED|Overall Study||0
11002929|NCT00709891|12180302|FG000|STARTED|Baseline, Cross-sectional Phase||47208
11002930|NCT00709891|12180302|FG000|COMPLETED|Baseline, Cross-sectional Phase||45758
11002931|NCT00709891|12180302|FG000|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
11002932|NCT00709891|12180302|FG000|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
11002933|NCT00709891|12180302|FG000|COMPLETED|Longitudinal Follow-up Phase||5020
11002934|NCT00709891|12180302|FG000|NOT COMPLETED|Longitudinal Follow-up Phase||4982
11002935|NCT00709956|12180308|FG000|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
11002936|NCT00709956|12180309|FG001|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
11002937|NCT00709956|12180308|FG000|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
11002938|NCT00709956|12180309|FG001|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
11002939|NCT00709956|12180308|FG000|COMPLETED|Overall Study||30
11002940|NCT00709956|12180309|FG001|COMPLETED|Overall Study||33
11002941|NCT00709956|12180308|FG000|NOT COMPLETED|Overall Study||3
11002942|NCT00709956|12180309|FG001|NOT COMPLETED|Overall Study||4
11002943|NCT00709995|12180319|FG000|STARTED|Overall Study||11
11002944|NCT00709995|12180320|FG001|STARTED|Overall Study||6
11002945|NCT00709995|12180319|FG000|Progressive Disease|Overall Study||6
11002946|NCT00709995|12180320|FG001|Progressive Disease|Overall Study||1
11002947|NCT00709995|12180319|FG000|COMPLETED|Overall Study||6
11002948|NCT00709995|12180320|FG001|COMPLETED|Overall Study||1
11002949|NCT00709995|12180319|FG000|NOT COMPLETED|Overall Study||5
11002950|NCT00709995|12180320|FG001|NOT COMPLETED|Overall Study||5
11002951|NCT00710021|12180332|FG000|STARTED|Overall Study||19
11002952|NCT00710021|12180333|FG001|STARTED|Overall Study||19
11002953|NCT00710021|12180334|FG002|STARTED|Overall Study||19
11002954|NCT00710021|12180332|FG000|Modified Intent-to-Treat (mITT)|Overall Study||19
11002955|NCT00710021|12180333|FG001|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
11002956|NCT00710021|12180334|FG002|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
11002957|NCT00710021|12180332|FG000|COMPLETED|Overall Study||18
11002958|NCT00710021|12180333|FG001|COMPLETED|Overall Study||16
11002959|NCT00710021|12180334|FG002|COMPLETED|Overall Study||18
11002960|NCT00710021|12180332|FG000|NOT COMPLETED|Overall Study||1
11002961|NCT00710021|12180333|FG001|NOT COMPLETED|Overall Study||3
11002962|NCT00710021|12180334|FG002|NOT COMPLETED|Overall Study||1
11002963|NCT00710034|12180345|FG000|STARTED|Completed 6 Weeks of Treatment||195
11002964|NCT00710034|12180346|FG001|STARTED|Completed 6 Weeks of Treatment||196
11002965|NCT00710034|12180345|FG000|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
11002966|NCT00710034|12180346|FG001|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
11002967|NCT00710034|12180345|FG000|NOT COMPLETED|Completed 6 Weeks of Treatment||41
11002968|NCT00710034|12180346|FG001|NOT COMPLETED|Completed 6 Weeks of Treatment||47
11002969|NCT00710034|12180345|FG000|STARTED|Completed 12 Weeks of Treatment||154
11002970|NCT00710034|12180346|FG001|STARTED|Completed 12 Weeks of Treatment||149
11002971|NCT00710034|12180345|FG000|COMPLETED|Completed 12 Weeks of Treatment||141
11002972|NCT00710034|12180346|FG001|COMPLETED|Completed 12 Weeks of Treatment||138
11002973|NCT00710034|12180345|FG000|NOT COMPLETED|Completed 12 Weeks of Treatment||13
11002974|NCT00710034|12180346|FG001|NOT COMPLETED|Completed 12 Weeks of Treatment||11
11002975|NCT00710203|12180352|FG000|STARTED|Overall Study||10
11002976|NCT00710203|12180352|FG000|COMPLETED|Overall Study||10
11002977|NCT00710203|12180352|FG000|NOT COMPLETED|Overall Study||0
11002978|NCT00710385|12180362|FG000|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
11002979|NCT00710385|12180362|FG000|COMPLETED|Overall Study||12
11002980|NCT00710385|12180362|FG000|NOT COMPLETED|Overall Study||5
11002981|NCT00710424|12180374|FG000|STARTED|Overall Study||149
11002982|NCT00710424|12180375|FG001|STARTED|Overall Study||148
11002983|NCT00710424|12180374|FG000|COMPLETED|Overall Study||105
11002984|NCT00710424|12180375|FG001|COMPLETED|Overall Study||125
11002985|NCT00710424|12180374|FG000|NOT COMPLETED|Overall Study||44
11002986|NCT00710424|12180375|FG001|NOT COMPLETED|Overall Study||23
11002987|NCT00710554|12180383|FG000|STARTED|Overall Study||128
11002988|NCT00710554|12180384|FG001|STARTED|Overall Study||118
11002989|NCT00710554|12180383|FG000|COMPLETED|Overall Study||79
11002990|NCT00710554|12180384|FG001|COMPLETED|Overall Study||94
11002991|NCT00710554|12180383|FG000|NOT COMPLETED|Overall Study||49
11002992|NCT00710554|12180384|FG001|NOT COMPLETED|Overall Study||24
11002993|NCT00710593|12180392|FG000|STARTED|Overall Study||69
11002994|NCT00710593|12180393|FG001|STARTED|Overall Study||30
11002995|NCT00710593|12180392|FG000|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
11002996|NCT00710593|12180393|FG001|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
11002997|NCT00710593|12180392|FG000|NOT COMPLETED|Overall Study||15
11002998|NCT00710593|12180393|FG001|NOT COMPLETED|Overall Study||5
11002999|NCT00710606|12180417|FG000|STARTED|Overall Study||20
11003000|NCT00710606|12180418|FG001|STARTED|Overall Study||20
11003001|NCT00710606|12180417|FG000|COMPLETED|Overall Study||20
11003002|NCT00710606|12180418|FG001|COMPLETED|Overall Study||18
11003003|NCT00710606|12180417|FG000|NOT COMPLETED|Overall Study||0
11003004|NCT00710606|12180418|FG001|NOT COMPLETED|Overall Study||2
11003005|NCT00710684|12180429|FG000|STARTED|Overall Study||225
11003006|NCT00710684|12180430|FG001|STARTED|Overall Study||221
11003007|NCT00710684|12180431|FG002|STARTED|Overall Study||236
11003008|NCT00710684|12180429|FG000|COMPLETED|Overall Study||151
11003009|NCT00710684|12180430|FG001|COMPLETED|Overall Study||147
11003010|NCT00710684|12180431|FG002|COMPLETED|Overall Study||172
11003011|NCT00710684|12180429|FG000|NOT COMPLETED|Overall Study||74
11003012|NCT00710684|12180430|FG001|NOT COMPLETED|Overall Study||74
11003013|NCT00710684|12180431|FG002|NOT COMPLETED|Overall Study||64
11003014|NCT00710749|12180445|FG000|STARTED|Clinic Baseline Recording||30
11003015|NCT00710749|12180446|FG001|STARTED|Clinic Baseline Recording||30
11003016|NCT00710749|12180445|FG000|COMPLETED|Clinic Baseline Recording||30
11003017|NCT00710749|12180446|FG001|COMPLETED|Clinic Baseline Recording||30
11003018|NCT00710749|12180445|FG000|NOT COMPLETED|Clinic Baseline Recording||0
11003019|NCT00710749|12180446|FG001|NOT COMPLETED|Clinic Baseline Recording||0
11003020|NCT00710749|12180445|FG000|STARTED|First Intervention||30
11003021|NCT00710749|12180446|FG001|STARTED|First Intervention||30
11003022|NCT00710749|12180445|FG000|COMPLETED|First Intervention||29
11003023|NCT00710749|12180446|FG001|COMPLETED|First Intervention||30
11003024|NCT00710749|12180445|FG000|NOT COMPLETED|First Intervention||1
11003025|NCT00710749|12180446|FG001|NOT COMPLETED|First Intervention||0
11003026|NCT00710749|12180445|FG000|STARTED|Second Intervention||29
11003027|NCT00710749|12180446|FG001|STARTED|Second Intervention||30
11003028|NCT00710749|12180445|FG000|COMPLETED|Second Intervention||29
11003029|NCT00710749|12180446|FG001|COMPLETED|Second Intervention||30
11003030|NCT00710749|12180445|FG000|NOT COMPLETED|Second Intervention||0
11003031|NCT00710749|12180446|FG001|NOT COMPLETED|Second Intervention||0
11003032|NCT00710762|12180456|FG000|STARTED|Overall Study||44
11003033|NCT00710762|12180457|FG001|STARTED|Overall Study||40
11003034|NCT00710762|12180456|FG000|COMPLETED|Overall Study||5
11003035|NCT00710762|12180457|FG001|COMPLETED|Overall Study||0
11003036|NCT00710762|12180456|FG000|NOT COMPLETED|Overall Study||39
11003037|NCT00710762|12180457|FG001|NOT COMPLETED|Overall Study||40
11056314|NCT00993499|12237863|FG002|COMPLETED|Discontinued Before Starting Course 3||6
11056315|NCT00993499|12237864|FG003|COMPLETED|Discontinued Before Starting Course 3||2
11056316|NCT00993499|12237865|FG004|COMPLETED|Discontinued Before Starting Course 3||3
11056317|NCT00993499|12237866|FG005|COMPLETED|Discontinued Before Starting Course 3||3
11120743|NCT01340014|12306039|FG000|COMPLETED|Period 1, First 7 Days||53
11120744|NCT01340014|12306040|FG001|COMPLETED|Period 1, First 7 Days||57
11120745|NCT01340014|12306039|FG000|NOT COMPLETED|Period 1, First 7 Days||2
11120746|NCT01340014|12306040|FG001|NOT COMPLETED|Period 1, First 7 Days||0
11120747|NCT01340014|12306039|FG000|STARTED|Period 2, Second 7 Days||53
11120748|NCT01340014|12306040|FG001|STARTED|Period 2, Second 7 Days||57
11120749|NCT01340014|12306039|FG000|COMPLETED|Period 2, Second 7 Days||53
11120750|NCT01340014|12306040|FG001|COMPLETED|Period 2, Second 7 Days||56
11120751|NCT01340014|12306039|FG000|NOT COMPLETED|Period 2, Second 7 Days||0
11120752|NCT01340014|12306040|FG001|NOT COMPLETED|Period 2, Second 7 Days||1
11120753|NCT01340027|12306058|FG000|STARTED|Overall Study||81
11056318|NCT00993499|12237861|FG000|NOT COMPLETED|Discontinued Before Starting Course 3||4
11056319|NCT00993499|12237862|FG001|NOT COMPLETED|Discontinued Before Starting Course 3||4
11056320|NCT00993499|12237863|FG002|NOT COMPLETED|Discontinued Before Starting Course 3||3
11056321|NCT00993499|12237864|FG003|NOT COMPLETED|Discontinued Before Starting Course 3||1
11056322|NCT00993499|12237865|FG004|NOT COMPLETED|Discontinued Before Starting Course 3||0
11056323|NCT00993499|12237866|FG005|NOT COMPLETED|Discontinued Before Starting Course 3||0
11056324|NCT00993499|12237861|FG000|STARTED|Discontinued After Starting Course 3||12
11056325|NCT00993499|12237862|FG001|STARTED|Discontinued After Starting Course 3||9
11056326|NCT00993499|12237863|FG002|STARTED|Discontinued After Starting Course 3||9
11056327|NCT00993499|12237864|FG003|STARTED|Discontinued After Starting Course 3||3
11056328|NCT00993499|12237865|FG004|STARTED|Discontinued After Starting Course 3||3
11056329|NCT00993499|12237866|FG005|STARTED|Discontinued After Starting Course 3||3
11056330|NCT00993499|12237861|FG000|COMPLETED|Discontinued After Starting Course 3||4
11120754|NCT01340027|12306059|FG001|STARTED|Overall Study||78
11120755|NCT01340027|12306060|FG002|STARTED|Overall Study||79
11003038|NCT00710814|12180465|FG000|STARTED|Overall Study||15
11003039|NCT00710814|12180466|FG001|STARTED|Overall Study||16
11003040|NCT00710814|12180465|FG000|COMPLETED|Overall Study||14
11003041|NCT00710814|12180466|FG001|COMPLETED|Overall Study||13
11003042|NCT00710814|12180465|FG000|NOT COMPLETED|Overall Study||1
11003043|NCT00710814|12180466|FG001|NOT COMPLETED|Overall Study||3
11003044|NCT00710840|12180474|FG000|STARTED|Overall Study||22
11003045|NCT00710840|12180475|FG001|STARTED|Overall Study||22
11003046|NCT00710840|12180474|FG000|COMPLETED|Overall Study||22
11003047|NCT00710840|12180475|FG001|COMPLETED|Overall Study||19
11003048|NCT00710840|12180474|FG000|NOT COMPLETED|Overall Study||0
11003049|NCT00710840|12180475|FG001|NOT COMPLETED|Overall Study||3
11003050|NCT00710866|12180483|FG000|STARTED|Overall Study||133
11003051|NCT00710866|12180484|FG001|STARTED|Overall Study||134
11003052|NCT00710866|12180483|FG000|COMPLETED|Overall Study||124
11003053|NCT00710866|12180484|FG001|COMPLETED|Overall Study||128
11003054|NCT00710866|12180483|FG000|NOT COMPLETED|Overall Study||9
11003055|NCT00710866|12180484|FG001|NOT COMPLETED|Overall Study||6
11003056|NCT00710879|12180492|FG000|STARTED|Overall Study||60
11003057|NCT00710879|12180493|FG001|STARTED|Overall Study||117
11003058|NCT00710879|12180492|FG000|COMPLETED|Overall Study||58
11003059|NCT00710879|12180493|FG001|COMPLETED|Overall Study||113
11003060|NCT00710879|12180492|FG000|NOT COMPLETED|Overall Study||2
11003061|NCT00710879|12180493|FG001|NOT COMPLETED|Overall Study||4
11003062|NCT00710905|12180499|FG000|STARTED|Overall Study||50
11003063|NCT00710905|12180499|FG000|COMPLETED|Overall Study||34
11003064|NCT00710905|12180499|FG000|NOT COMPLETED|Overall Study||16
11003065|NCT00710931|12180503|FG000|STARTED|Overall Study||34
11003066|NCT00710931|12180503|FG000|COMPLETED|Overall Study||29
11003067|NCT00710931|12180503|FG000|NOT COMPLETED|Overall Study||5
11003068|NCT00710944|12180510|FG000|STARTED|Overall Study||55
11003069|NCT00710944|12180511|FG001|STARTED|Overall Study||58
11003070|NCT00710944|12180512|FG002|STARTED|Overall Study||19
11003071|NCT00710944|12180510|FG000|COMPLETED|Overall Study||45
11003072|NCT00710944|12180511|FG001|COMPLETED|Overall Study||49
11003073|NCT00710944|12180512|FG002|COMPLETED|Overall Study||17
11003074|NCT00710944|12180510|FG000|NOT COMPLETED|Overall Study||10
11003075|NCT00710944|12180511|FG001|NOT COMPLETED|Overall Study||9
11003076|NCT00710944|12180512|FG002|NOT COMPLETED|Overall Study||2
11003077|NCT00710996|12180523|FG000|STARTED|Overall Study||17
11003078|NCT00710996|12180524|FG001|STARTED|Overall Study||20
11003079|NCT00710996|12180525|FG002|STARTED|Overall Study||21
11003080|NCT00710996|12180523|FG000|COMPLETED|Overall Study||16
11003081|NCT00710996|12180524|FG001|COMPLETED|Overall Study||16
11003082|NCT00710996|12180525|FG002|COMPLETED|Overall Study||21
11003083|NCT00710996|12180523|FG000|NOT COMPLETED|Overall Study||1
11003084|NCT00710996|12180524|FG001|NOT COMPLETED|Overall Study||4
11003085|NCT00710996|12180525|FG002|NOT COMPLETED|Overall Study||0
11003086|NCT00711009|12180535|FG000|STARTED|Overall Study||105
11003087|NCT00711009|12180536|FG001|STARTED|Overall Study||101
11003088|NCT00711009|12180535|FG000|COMPLETED|Overall Study||90
11003089|NCT00711009|12180536|FG001|COMPLETED|Overall Study||82
11003090|NCT00711009|12180535|FG000|NOT COMPLETED|Overall Study||15
11003091|NCT00711009|12180536|FG001|NOT COMPLETED|Overall Study||19
11003092|NCT00711022|12180542|FG000|STARTED|Overall Study||51
11003093|NCT00711022|12180542|FG000|COMPLETED|Overall Study||40
11003094|NCT00711022|12180542|FG000|NOT COMPLETED|Overall Study||11
11003095|NCT00711100|12180546|FG000|STARTED|Overall Study||104
11003096|NCT00711100|12180546|FG000|COMPLETED|Overall Study||91
11003097|NCT00711100|12180546|FG000|NOT COMPLETED|Overall Study||13
11003098|NCT00711113|12180562|FG000|STARTED|Overall Study||47
11003099|NCT00711113|12180562|FG000|COMPLETED|Overall Study||36
11003100|NCT00711113|12180562|FG000|NOT COMPLETED|Overall Study||11
11003101|NCT00711191|12180569|FG000|STARTED|Overall Study||3
11003102|NCT00711191|12180570|FG001|STARTED|Overall Study||6
11003103|NCT00711191|12180571|FG002|STARTED|Overall Study||13
11003104|NCT00711191|12180569|FG000|COMPLETED|Overall Study||0
11003105|NCT00711191|12180570|FG001|COMPLETED|Overall Study||1
11003106|NCT00711191|12180571|FG002|COMPLETED|Overall Study||1
11003107|NCT00711191|12180569|FG000|NOT COMPLETED|Overall Study||3
11003108|NCT00711191|12180570|FG001|NOT COMPLETED|Overall Study||5
11003109|NCT00711191|12180571|FG002|NOT COMPLETED|Overall Study||12
11003110|NCT00711243|12180588|FG000|STARTED|Registed and Started Treatment||3
11003111|NCT00711243|12180589|FG001|STARTED|Registed and Started Treatment||3
11003112|NCT00711243|12180590|FG002|STARTED|Registed and Started Treatment||3
11003113|NCT00711243|12180591|FG003|STARTED|Registed and Started Treatment||3
11003114|NCT00711243|12180592|FG004|STARTED|Registed and Started Treatment||3
11003115|NCT00711243|12180593|FG005|STARTED|Registed and Started Treatment||44
11003116|NCT00711243|12180588|FG000|Registered to Study|Registed and Started Treatment||3
11003117|NCT00711243|12180589|FG001|Registered to Study|Registed and Started Treatment||3
11003118|NCT00711243|12180590|FG002|Registered to Study|Registed and Started Treatment||3
11003119|NCT00711243|12180591|FG003|Registered to Study|Registed and Started Treatment||3
11003120|NCT00711243|12180592|FG004|Registered to Study|Registed and Started Treatment||3
11003121|NCT00711243|12180593|FG005|Registered to Study|Registed and Started Treatment||44
11003122|NCT00711243|12180588|FG000|Started Treatment|Registed and Started Treatment||3
11003123|NCT00711243|12180589|FG001|Started Treatment|Registed and Started Treatment||3
11003124|NCT00711243|12180590|FG002|Started Treatment|Registed and Started Treatment||3
11003125|NCT00711243|12180591|FG003|Started Treatment|Registed and Started Treatment||3
11003126|NCT00711243|12180592|FG004|Started Treatment|Registed and Started Treatment||3
11003127|NCT00711243|12180593|FG005|Started Treatment|Registed and Started Treatment||43
11003128|NCT00711243|12180588|FG000|COMPLETED|Registed and Started Treatment||3
11003129|NCT00711243|12180589|FG001|COMPLETED|Registed and Started Treatment||3
11003130|NCT00711243|12180590|FG002|COMPLETED|Registed and Started Treatment||3
11003131|NCT00711243|12180591|FG003|COMPLETED|Registed and Started Treatment||3
11003132|NCT00711243|12180592|FG004|COMPLETED|Registed and Started Treatment||3
11003133|NCT00711243|12180593|FG005|COMPLETED|Registed and Started Treatment||43
11003134|NCT00711243|12180588|FG000|NOT COMPLETED|Registed and Started Treatment||0
11003135|NCT00711243|12180589|FG001|NOT COMPLETED|Registed and Started Treatment||0
11003136|NCT00711243|12180590|FG002|NOT COMPLETED|Registed and Started Treatment||0
11003137|NCT00711243|12180591|FG003|NOT COMPLETED|Registed and Started Treatment||0
11003138|NCT00711243|12180592|FG004|NOT COMPLETED|Registed and Started Treatment||0
11003139|NCT00711243|12180593|FG005|NOT COMPLETED|Registed and Started Treatment||1
11003140|NCT00711243|12180588|FG000|STARTED|Reached First Response/4 Cycles||3
11120756|NCT01340027|12306061|FG003|STARTED|Overall Study||79
11120757|NCT01340027|12306062|FG004|STARTED|Overall Study||156
11120758|NCT01340027|12306063|FG005|STARTED|Overall Study||78
11120759|NCT01340027|12306064|FG006|STARTED|Overall Study||149
11120760|NCT01340027|12306065|FG007|STARTED|Overall Study||149
11120761|NCT01340027|12306066|FG008|STARTED|Overall Study||144
11120762|NCT01340027|12306067|FG009|STARTED|Overall Study||152
11120763|NCT01340027|12306068|FG010|STARTED|Overall Study||81
11120764|NCT01340027|12306069|FG011|STARTED|Overall Study||81
11120765|NCT01340027|12306058|FG000|Received Treatment|Overall Study||81
11120766|NCT01340027|12306059|FG001|Received Treatment|Overall Study||78
11003141|NCT00711243|12180589|FG001|STARTED|Reached First Response/4 Cycles||3
11003142|NCT00711243|12180590|FG002|STARTED|Reached First Response/4 Cycles||3
11003143|NCT00711243|12180591|FG003|STARTED|Reached First Response/4 Cycles||3
11003144|NCT00711243|12180592|FG004|STARTED|Reached First Response/4 Cycles||3
11120767|NCT01340027|12306060|FG002|Received Treatment|Overall Study||78
11120768|NCT01340027|12306061|FG003|Received Treatment|Overall Study||79
11120769|NCT01340027|12306062|FG004|Received Treatment|Overall Study||156
11003145|NCT00711243|12180593|FG005|STARTED|Reached First Response/4 Cycles||43
11003146|NCT00711243|12180588|FG000|COMPLETED|Reached First Response/4 Cycles||3
11003147|NCT00711243|12180589|FG001|COMPLETED|Reached First Response/4 Cycles||3
11003148|NCT00711243|12180590|FG002|COMPLETED|Reached First Response/4 Cycles||3
11003149|NCT00711243|12180591|FG003|COMPLETED|Reached First Response/4 Cycles||2
11003150|NCT00711243|12180592|FG004|COMPLETED|Reached First Response/4 Cycles||3
11003151|NCT00711243|12180593|FG005|COMPLETED|Reached First Response/4 Cycles||41
11003152|NCT00711243|12180588|FG000|NOT COMPLETED|Reached First Response/4 Cycles||0
11003153|NCT00711243|12180589|FG001|NOT COMPLETED|Reached First Response/4 Cycles||0
11003154|NCT00711243|12180590|FG002|NOT COMPLETED|Reached First Response/4 Cycles||0
11003155|NCT00711243|12180591|FG003|NOT COMPLETED|Reached First Response/4 Cycles||1
11003156|NCT00711243|12180592|FG004|NOT COMPLETED|Reached First Response/4 Cycles||0
11003157|NCT00711243|12180593|FG005|NOT COMPLETED|Reached First Response/4 Cycles||2
11003158|NCT00711243|12180588|FG000|STARTED|Treated Cycle 5 After First Response||3
11003159|NCT00711243|12180589|FG001|STARTED|Treated Cycle 5 After First Response||3
11003160|NCT00711243|12180590|FG002|STARTED|Treated Cycle 5 After First Response||3
11003161|NCT00711243|12180591|FG003|STARTED|Treated Cycle 5 After First Response||2
11003162|NCT00711243|12180592|FG004|STARTED|Treated Cycle 5 After First Response||3
11003163|NCT00711243|12180593|FG005|STARTED|Treated Cycle 5 After First Response||41
11003164|NCT00711243|12180588|FG000|COMPLETED|Treated Cycle 5 After First Response||2
11003165|NCT00711243|12180589|FG001|COMPLETED|Treated Cycle 5 After First Response||1
11003166|NCT00711243|12180590|FG002|COMPLETED|Treated Cycle 5 After First Response||3
11003167|NCT00711243|12180591|FG003|COMPLETED|Treated Cycle 5 After First Response||2
11003168|NCT00711243|12180592|FG004|COMPLETED|Treated Cycle 5 After First Response||2
11003169|NCT00711243|12180593|FG005|COMPLETED|Treated Cycle 5 After First Response||37
11003170|NCT00711243|12180588|FG000|NOT COMPLETED|Treated Cycle 5 After First Response||1
11003171|NCT00711243|12180589|FG001|NOT COMPLETED|Treated Cycle 5 After First Response||2
11003172|NCT00711243|12180590|FG002|NOT COMPLETED|Treated Cycle 5 After First Response||0
11003173|NCT00711243|12180591|FG003|NOT COMPLETED|Treated Cycle 5 After First Response||0
11003174|NCT00711243|12180592|FG004|NOT COMPLETED|Treated Cycle 5 After First Response||1
11003175|NCT00711243|12180593|FG005|NOT COMPLETED|Treated Cycle 5 After First Response||4
11003176|NCT00711243|12180588|FG000|STARTED|Follow up Every 3 Months Until Death||3
11003177|NCT00711243|12180589|FG001|STARTED|Follow up Every 3 Months Until Death||3
11003178|NCT00711243|12180590|FG002|STARTED|Follow up Every 3 Months Until Death||3
11003179|NCT00711243|12180591|FG003|STARTED|Follow up Every 3 Months Until Death||3
11003180|NCT00711243|12180592|FG004|STARTED|Follow up Every 3 Months Until Death||3
11003181|NCT00711243|12180593|FG005|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
11003182|NCT00711243|12180588|FG000|COMPLETED|Follow up Every 3 Months Until Death||3
11003183|NCT00711243|12180589|FG001|COMPLETED|Follow up Every 3 Months Until Death||3
11003184|NCT00711243|12180590|FG002|COMPLETED|Follow up Every 3 Months Until Death||3
11003185|NCT00711243|12180591|FG003|COMPLETED|Follow up Every 3 Months Until Death||3
11003186|NCT00711243|12180592|FG004|COMPLETED|Follow up Every 3 Months Until Death||3
11003187|NCT00711243|12180593|FG005|COMPLETED|Follow up Every 3 Months Until Death||37
11003188|NCT00711243|12180588|FG000|NOT COMPLETED|Follow up Every 3 Months Until Death||0
11003189|NCT00711243|12180589|FG001|NOT COMPLETED|Follow up Every 3 Months Until Death||0
11003190|NCT00711243|12180590|FG002|NOT COMPLETED|Follow up Every 3 Months Until Death||0
11003191|NCT00711243|12180591|FG003|NOT COMPLETED|Follow up Every 3 Months Until Death||0
11003192|NCT00711243|12180592|FG004|NOT COMPLETED|Follow up Every 3 Months Until Death||0
11003193|NCT00711243|12180593|FG005|NOT COMPLETED|Follow up Every 3 Months Until Death||2
11003194|NCT00711347|12180611|FG000|STARTED|Overall Study||14
11003195|NCT00711347|12180612|FG001|STARTED|Overall Study||14
11003196|NCT00711347|12180611|FG000|COMPLETED|Overall Study||14
11003197|NCT00711347|12180612|FG001|COMPLETED|Overall Study||14
11003198|NCT00711347|12180611|FG000|NOT COMPLETED|Overall Study||0
11003199|NCT00711347|12180612|FG001|NOT COMPLETED|Overall Study||0
11003200|NCT00711412|12180618|FG000|STARTED|Induction Treatment||44
11003201|NCT00711412|12180618|FG000|Registered to Study|Induction Treatment||44
11003202|NCT00711412|12180618|FG000|Started Induction Treatment|Induction Treatment||43
11003203|NCT00711412|12180618|FG000|COMPLETED|Induction Treatment||40
11003204|NCT00711412|12180618|FG000|NOT COMPLETED|Induction Treatment||4
11003205|NCT00711412|12180618|FG000|STARTED|Evaluated for Combination Treatment||40
11003206|NCT00711412|12180618|FG000|COMPLETED|Evaluated for Combination Treatment||34
11003207|NCT00711412|12180618|FG000|NOT COMPLETED|Evaluated for Combination Treatment||6
11003208|NCT00711412|12180618|FG000|STARTED|Combination Treatment||34
11003209|NCT00711412|12180618|FG000|COMPLETED|Combination Treatment||33
11003210|NCT00711412|12180618|FG000|NOT COMPLETED|Combination Treatment||1
11003211|NCT00711412|12180618|FG000|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
11003212|NCT00711412|12180618|FG000|COMPLETED|Evaluation for Response and Surgery||28
11003213|NCT00711412|12180618|FG000|NOT COMPLETED|Evaluation for Response and Surgery||6
11003214|NCT00711412|12180618|FG000|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
11003215|NCT00711412|12180618|FG000|COMPLETED|Survival Follow up Until Death||26
11003216|NCT00711412|12180618|FG000|NOT COMPLETED|Survival Follow up Until Death||12
11003217|NCT00711425|12180623|FG000|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
11003218|NCT00711425|12180623|FG000|COMPLETED|Overall Study||41
11003219|NCT00711425|12180623|FG000|NOT COMPLETED|Overall Study||4
11003220|NCT00711464|12180627|FG000|STARTED|Overall Study||29
11003221|NCT00711464|12180627|FG000|COMPLETED|Overall Study||29
11003222|NCT00711464|12180627|FG000|NOT COMPLETED|Overall Study||0
11003223|NCT00711477|12180639|FG000|STARTED|Overall Study||23
11003224|NCT00711477|12180640|FG001|STARTED|Overall Study||23
11003225|NCT00711477|12180639|FG000|COMPLETED|Overall Study||20
11003226|NCT00711477|12180640|FG001|COMPLETED|Overall Study||20
11003227|NCT00711477|12180639|FG000|NOT COMPLETED|Overall Study||3
11120770|NCT01340027|12306063|FG005|Received Treatment|Overall Study||78
11120771|NCT01340027|12306064|FG006|Received Treatment|Overall Study||149
11120772|NCT01340027|12306065|FG007|Received Treatment|Overall Study||149
11120773|NCT01340027|12306066|FG008|Received Treatment|Overall Study||144
11120774|NCT01340027|12306067|FG009|Received Treatment|Overall Study||152
11120775|NCT01340027|12306068|FG010|Received Treatment|Overall Study||81
11120776|NCT01340027|12306069|FG011|Received Treatment|Overall Study||81
11120777|NCT01340027|12306058|FG000|COMPLETED|Overall Study||76
11120778|NCT01340027|12306059|FG001|COMPLETED|Overall Study||71
11120779|NCT01340027|12306060|FG002|COMPLETED|Overall Study||75
11120780|NCT01340027|12306061|FG003|COMPLETED|Overall Study||75
11120781|NCT01340027|12306062|FG004|COMPLETED|Overall Study||146
11120782|NCT01340027|12306063|FG005|COMPLETED|Overall Study||74
11120783|NCT01340027|12306064|FG006|COMPLETED|Overall Study||142
11120784|NCT01340027|12306065|FG007|COMPLETED|Overall Study||142
11120785|NCT01340027|12306066|FG008|COMPLETED|Overall Study||136
11120786|NCT01340027|12306067|FG009|COMPLETED|Overall Study||146
11120787|NCT01340027|12306068|FG010|COMPLETED|Overall Study||79
11120788|NCT01340027|12306069|FG011|COMPLETED|Overall Study||77
11120789|NCT01340027|12306058|FG000|NOT COMPLETED|Overall Study||5
11120790|NCT01340027|12306059|FG001|NOT COMPLETED|Overall Study||7
11120791|NCT01340027|12306060|FG002|NOT COMPLETED|Overall Study||4
11120792|NCT01340027|12306061|FG003|NOT COMPLETED|Overall Study||4
11120793|NCT01340027|12306062|FG004|NOT COMPLETED|Overall Study||10
11120794|NCT01340027|12306063|FG005|NOT COMPLETED|Overall Study||4
11120795|NCT01340027|12306064|FG006|NOT COMPLETED|Overall Study||7
11120796|NCT01340027|12306065|FG007|NOT COMPLETED|Overall Study||7
11120797|NCT01340027|12306066|FG008|NOT COMPLETED|Overall Study||8
11120798|NCT01340027|12306067|FG009|NOT COMPLETED|Overall Study||6
11120799|NCT01340027|12306068|FG010|NOT COMPLETED|Overall Study||2
11120800|NCT01340027|12306069|FG011|NOT COMPLETED|Overall Study||4
11120801|NCT01340053|12306099|FG000|STARTED|Overall Study||47
11120802|NCT01340053|12306100|FG001|STARTED|Overall Study||46
11120803|NCT01340053|12306101|FG002|STARTED|Overall Study||47
11120804|NCT01340053|12306102|FG003|STARTED|Overall Study||46
11120805|NCT01340053|12306099|FG000|COMPLETED|Overall Study||43
11120806|NCT01340053|12306100|FG001|COMPLETED|Overall Study||44
11120807|NCT01340053|12306101|FG002|COMPLETED|Overall Study||43
11120808|NCT01340053|12306102|FG003|COMPLETED|Overall Study||43
11120809|NCT01340053|12306099|FG000|NOT COMPLETED|Overall Study||4
11120810|NCT01340053|12306100|FG001|NOT COMPLETED|Overall Study||2
11120811|NCT01340053|12306101|FG002|NOT COMPLETED|Overall Study||4
11238552|NCT02074553|12430360|FG003|NOT COMPLETED|Washout Period 2||0
11238553|NCT02074553|12430361|FG004|NOT COMPLETED|Washout Period 2||0
11238554|NCT02074553|12430362|FG005|NOT COMPLETED|Washout Period 2||1
11238555|NCT02074553|12430363|FG006|NOT COMPLETED|Washout Period 2||1
11238556|NCT02074553|12430364|FG007|NOT COMPLETED|Washout Period 2||0
11238557|NCT02074553|12430357|FG000|STARTED|Intervention Period 3||11
11238558|NCT02074553|12430358|FG001|STARTED|Intervention Period 3||12
11238559|NCT02074553|12430359|FG002|STARTED|Intervention Period 3||11
11238560|NCT02074553|12430360|FG003|STARTED|Intervention Period 3||11
11238561|NCT02074553|12430361|FG004|STARTED|Intervention Period 3||12
11238562|NCT02074553|12430362|FG005|STARTED|Intervention Period 3||10
11238563|NCT02074553|12430363|FG006|STARTED|Intervention Period 3||11
11003228|NCT00711477|12180640|FG001|NOT COMPLETED|Overall Study||3
11003229|NCT00711490|12180648|FG000|STARTED|Overall Study||5
11003230|NCT00711490|12180648|FG000|COMPLETED|Overall Study||5
11003231|NCT00711490|12180648|FG000|NOT COMPLETED|Overall Study||0
11003232|NCT00711516|12180655|FG000|STARTED|Overall Study||21
11003233|NCT00711516|12180656|FG001|STARTED|Overall Study||19
11003234|NCT00711516|12180655|FG000|COMPLETED|Overall Study||20
11003235|NCT00711516|12180656|FG001|COMPLETED|Overall Study||16
11003236|NCT00711516|12180655|FG000|NOT COMPLETED|Overall Study||1
11003237|NCT00711516|12180656|FG001|NOT COMPLETED|Overall Study||3
11003238|NCT00711529|12180664|FG000|STARTED|Overall Study||13
11003239|NCT00711529|12180665|FG001|STARTED|Overall Study||14
11003240|NCT00711529|12180664|FG000|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
11003241|NCT00711529|12180665|FG001|COMPLETED|Overall Study||8
11003242|NCT00711529|12180664|FG000|NOT COMPLETED|Overall Study||4
11003243|NCT00711529|12180665|FG001|NOT COMPLETED|Overall Study||6
11003244|NCT00711594|12180675|FG000|STARTED|Overall Study||3
11003245|NCT00711594|12180676|FG001|STARTED|Overall Study||3
11003246|NCT00711594|12180677|FG002|STARTED|Overall Study||6
11003247|NCT00711594|12180678|FG003|STARTED|Overall Study||62
11003248|NCT00711594|12180675|FG000|COMPLETED|Overall Study||0
11003249|NCT00711594|12180676|FG001|COMPLETED|Overall Study||0
11003250|NCT00711594|12180677|FG002|COMPLETED|Overall Study||0
11003251|NCT00711594|12180678|FG003|COMPLETED|Overall Study||0
11003252|NCT00711594|12180675|FG000|NOT COMPLETED|Overall Study||3
11003253|NCT00711594|12180676|FG001|NOT COMPLETED|Overall Study||3
11003254|NCT00711594|12180677|FG002|NOT COMPLETED|Overall Study||6
11003255|NCT00711594|12180678|FG003|NOT COMPLETED|Overall Study||62
11003256|NCT00711646|12180692|FG000|STARTED|Overall Study||124
11003257|NCT00711646|12180693|FG001|STARTED|Overall Study||65
11120812|NCT01340053|12306102|FG003|NOT COMPLETED|Overall Study||3
11120813|NCT01340066|12306114|FG000|STARTED|Placebo Run in Period||94
11120814|NCT01340066|12306115|FG001|STARTED|Placebo Run in Period||0
11120815|NCT01340066|12306116|FG002|STARTED|Placebo Run in Period||0
11120816|NCT01340066|12306114|FG000|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
11120817|NCT01340066|12306115|FG001|COMPLETED|Placebo Run in Period||0
11120818|NCT01340066|12306116|FG002|COMPLETED|Placebo Run in Period||0
11120819|NCT01340066|12306114|FG000|NOT COMPLETED|Placebo Run in Period||27
11238564|NCT02074553|12430364|FG007|STARTED|Intervention Period 3||12
11238565|NCT02074553|12430357|FG000|COMPLETED|Intervention Period 3||11
11238566|NCT02074553|12430358|FG001|COMPLETED|Intervention Period 3||12
11003258|NCT00711646|12180692|FG000|COMPLETED|Overall Study||112
11003259|NCT00711646|12180693|FG001|COMPLETED|Overall Study||62
11003260|NCT00711646|12180692|FG000|NOT COMPLETED|Overall Study||12
11003261|NCT00711646|12180693|FG001|NOT COMPLETED|Overall Study||3
11003262|NCT00711711|12180701|FG000|STARTED|Overall Study||30
11003263|NCT00711711|12180702|FG001|STARTED|Overall Study||30
11003264|NCT00711711|12180701|FG000|Second Postsurgical Day|Overall Study||30
11003265|NCT00711711|12180702|FG001|Second Postsurgical Day|Overall Study||30
11003266|NCT00711711|12180701|FG000|Seventh Postsurgical Day|Overall Study||29
11003267|NCT00711711|12180702|FG001|Seventh Postsurgical Day|Overall Study||27
11003268|NCT00711711|12180701|FG000|COMPLETED|Overall Study||29
11003269|NCT00711711|12180702|FG001|COMPLETED|Overall Study||24
11003270|NCT00711711|12180701|FG000|NOT COMPLETED|Overall Study||1
11003271|NCT00711711|12180702|FG001|NOT COMPLETED|Overall Study||6
11003272|NCT00711802|12180718|FG000|STARTED|Overall Study||75
11003273|NCT00711802|12180719|FG001|STARTED|Overall Study||38
11003274|NCT00711802|12180720|FG002|STARTED|Overall Study||75
11003275|NCT00711802|12180721|FG003|STARTED|Overall Study||38
11003276|NCT00711802|12180722|FG004|STARTED|Overall Study||83
11003277|NCT00711802|12180723|FG005|STARTED|Overall Study||42
11003278|NCT00711802|12180724|FG006|STARTED|Overall Study||30
11003279|NCT00711802|12180725|FG007|STARTED|Overall Study||15
11003280|NCT00711802|12180718|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73
11003281|NCT00711802|12180719|FG001|Received at Least 1 Dose of Study Drug|Overall Study||37
11003282|NCT00711802|12180720|FG002|Received at Least 1 Dose of Study Drug|Overall Study||73
11003283|NCT00711802|12180721|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38
11003284|NCT00711802|12180722|FG004|Received at Least 1 Dose of Study Drug|Overall Study||81
11003285|NCT00711802|12180723|FG005|Received at Least 1 Dose of Study Drug|Overall Study||42
11003286|NCT00711802|12180724|FG006|Received at Least 1 Dose of Study Drug|Overall Study||30
11003287|NCT00711802|12180725|FG007|Received at Least 1 Dose of Study Drug|Overall Study||15
11003288|NCT00711802|12180718|FG000|COMPLETED|Overall Study||73
11003289|NCT00711802|12180719|FG001|COMPLETED|Overall Study||32
11003290|NCT00711802|12180720|FG002|COMPLETED|Overall Study||69
11003291|NCT00711802|12180721|FG003|COMPLETED|Overall Study||35
11003292|NCT00711802|12180722|FG004|COMPLETED|Overall Study||69
11003293|NCT00711802|12180723|FG005|COMPLETED|Overall Study||34
11003294|NCT00711802|12180724|FG006|COMPLETED|Overall Study||25
11003295|NCT00711802|12180725|FG007|COMPLETED|Overall Study||13
11003296|NCT00711802|12180718|FG000|NOT COMPLETED|Overall Study||2
11003297|NCT00711802|12180719|FG001|NOT COMPLETED|Overall Study||6
11003298|NCT00711802|12180720|FG002|NOT COMPLETED|Overall Study||6
11003299|NCT00711802|12180721|FG003|NOT COMPLETED|Overall Study||3
11003300|NCT00711802|12180722|FG004|NOT COMPLETED|Overall Study||14
11003301|NCT00711802|12180723|FG005|NOT COMPLETED|Overall Study||8
11003302|NCT00711802|12180724|FG006|NOT COMPLETED|Overall Study||5
11003303|NCT00711802|12180725|FG007|NOT COMPLETED|Overall Study||2
11003304|NCT00711828|12180746|FG000|STARTED|Overall Study||21
11003305|NCT00711828|12180746|FG000|COMPLETED|Overall Study||21
11003306|NCT00711828|12180746|FG000|NOT COMPLETED|Overall Study||0
11003307|NCT00711867|12180752|FG000|STARTED|Overall Study||30
11003308|NCT00711867|12180753|FG001|STARTED|Overall Study||25
11003309|NCT00711867|12180752|FG000|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
11003310|NCT00711867|12180753|FG001|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
11003311|NCT00711867|12180752|FG000|NOT COMPLETED|Overall Study||5
11003312|NCT00711867|12180753|FG001|NOT COMPLETED|Overall Study||4
11003313|NCT00711880|12180761|FG000|STARTED|Overall Study||63
11003314|NCT00711880|12180762|FG001|STARTED|Overall Study||62
11003315|NCT00711880|12180761|FG000|COMPLETED|Overall Study||50
11003316|NCT00711880|12180762|FG001|COMPLETED|Overall Study||55
11003317|NCT00711880|12180761|FG000|NOT COMPLETED|Overall Study||13
11003318|NCT00711880|12180762|FG001|NOT COMPLETED|Overall Study||7
11003319|NCT00711958|12180770|FG000|STARTED|Overall Study||74
11003320|NCT00711958|12180771|FG001|STARTED|Overall Study||40
11003321|NCT00711958|12180770|FG000|COMPLETED|Overall Study||41
11003322|NCT00711958|12180771|FG001|COMPLETED|Overall Study||17
11003323|NCT00711958|12180770|FG000|NOT COMPLETED|Overall Study||33
11003324|NCT00711958|12180771|FG001|NOT COMPLETED|Overall Study||23
11003325|NCT00711971|12180780|FG000|STARTED|Overall Study||42
11003326|NCT00711971|12180781|FG001|STARTED|Overall Study||42
11003327|NCT00711971|12180782|FG002|STARTED|Overall Study||42
11003328|NCT00711971|12180780|FG000|COMPLETED|Overall Study||39
11003329|NCT00711971|12180781|FG001|COMPLETED|Overall Study||38
11003330|NCT00711971|12180782|FG002|COMPLETED|Overall Study||41
11003331|NCT00711971|12180780|FG000|NOT COMPLETED|Overall Study||3
11003332|NCT00711971|12180781|FG001|NOT COMPLETED|Overall Study||4
11003333|NCT00711971|12180782|FG002|NOT COMPLETED|Overall Study||1
11003334|NCT00711997|12180796|FG000|STARTED|Overall Study||3
11003335|NCT00711997|12180797|FG001|STARTED|Overall Study||6
11003336|NCT00711997|12180796|FG000|COMPLETED|Overall Study||3
11003337|NCT00711997|12180797|FG001|COMPLETED|Overall Study||6
11003338|NCT00711997|12180796|FG000|NOT COMPLETED|Overall Study||0
11003339|NCT00711997|12180797|FG001|NOT COMPLETED|Overall Study||0
11003340|NCT00712010|12180805|FG000|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
11003341|NCT00712010|12180805|FG000|COMPLETED|1st Protein Testing (1 Day)||24
11003342|NCT00712010|12180805|FG000|NOT COMPLETED|1st Protein Testing (1 Day)||0
11003343|NCT00712010|12180805|FG000|STARTED|Washout (7 Days)||24
11003344|NCT00712010|12180805|FG000|COMPLETED|Washout (7 Days)||24
11003345|NCT00712010|12180805|FG000|NOT COMPLETED|Washout (7 Days)||0
11003346|NCT00712010|12180805|FG000|STARTED|2nd Protein Testing (1 Day)||24
11003347|NCT00712010|12180805|FG000|COMPLETED|2nd Protein Testing (1 Day)||24
11003348|NCT00712010|12180805|FG000|NOT COMPLETED|2nd Protein Testing (1 Day)||0
11003349|NCT00712010|12180805|FG000|STARTED|Washout (7 Days)||24
11003350|NCT00712010|12180805|FG000|COMPLETED|Washout (7 Days)||24
11003351|NCT00712010|12180805|FG000|NOT COMPLETED|Washout (7 Days)||0
11003352|NCT00712010|12180805|FG000|STARTED|3rd Protein Testing (1 Day)||24
11003353|NCT00712010|12180805|FG000|COMPLETED|3rd Protein Testing (1 Day)||24
11003354|NCT00712010|12180805|FG000|NOT COMPLETED|3rd Protein Testing (1 Day)||0
11003355|NCT00712010|12180805|FG000|STARTED|Washout (7 Days)||24
11003356|NCT00712010|12180805|FG000|COMPLETED|Washout (7 Days)||24
11003357|NCT00712010|12180805|FG000|NOT COMPLETED|Washout (7 Days)||0
11003358|NCT00712010|12180805|FG000|STARTED|4th Protein Testing (1 Day)||24
11003359|NCT00712010|12180805|FG000|COMPLETED|4th Protein Testing (1 Day)||24
11003360|NCT00712010|12180805|FG000|NOT COMPLETED|4th Protein Testing (1 Day)||0
11003361|NCT00712010|12180805|FG000|STARTED|Washout (7 Days)||24
11003362|NCT00712010|12180805|FG000|COMPLETED|Washout (7 Days)||23
11003363|NCT00712010|12180805|FG000|NOT COMPLETED|Washout (7 Days)||1
11003364|NCT00712010|12180805|FG000|STARTED|5th Protein Testing (1 Day)||23
11003365|NCT00712010|12180805|FG000|COMPLETED|5th Protein Testing (1 Day)||23
11003366|NCT00712010|12180805|FG000|NOT COMPLETED|5th Protein Testing (1 Day)||0
11003367|NCT00712010|12180805|FG000|STARTED|Washout (7 Days)||23
11003368|NCT00712010|12180805|FG000|COMPLETED|Washout (7 Days)||23
11003369|NCT00712010|12180805|FG000|NOT COMPLETED|Washout (7 Days)||0
11003370|NCT00712010|12180805|FG000|STARTED|6th Protein Testing (1 Day)||23
11003371|NCT00712010|12180805|FG000|COMPLETED|6th Protein Testing (1 Day)||23
11003372|NCT00712010|12180805|FG000|NOT COMPLETED|6th Protein Testing (1 Day)||0
11120820|NCT01340066|12306115|FG001|NOT COMPLETED|Placebo Run in Period||0
11120821|NCT01340066|12306116|FG002|NOT COMPLETED|Placebo Run in Period||0
11120822|NCT01340066|12306114|FG000|STARTED|5 Week Double Blind Randomization Period||0
11120823|NCT01340066|12306115|FG001|STARTED|5 Week Double Blind Randomization Period||33
11120824|NCT01340066|12306116|FG002|STARTED|5 Week Double Blind Randomization Period||34
11120825|NCT01340066|12306114|FG000|COMPLETED|5 Week Double Blind Randomization Period||0
11120826|NCT01340066|12306115|FG001|COMPLETED|5 Week Double Blind Randomization Period||28
11120827|NCT01340066|12306116|FG002|COMPLETED|5 Week Double Blind Randomization Period||31
11120828|NCT01340066|12306114|FG000|NOT COMPLETED|5 Week Double Blind Randomization Period||0
11120829|NCT01340066|12306115|FG001|NOT COMPLETED|5 Week Double Blind Randomization Period||5
11120830|NCT01340066|12306116|FG002|NOT COMPLETED|5 Week Double Blind Randomization Period||3
11120831|NCT01340144|12306125|FG000|STARTED|Overall Study||625
11120832|NCT01340144|12306126|FG001|STARTED|Overall Study||625
11120833|NCT01340144|12306125|FG000|COMPLETED|Overall Study||553
11120834|NCT01340144|12306126|FG001|COMPLETED|Overall Study||567
11120835|NCT01340144|12306125|FG000|NOT COMPLETED|Overall Study||72
11120836|NCT01340144|12306126|FG001|NOT COMPLETED|Overall Study||58
11120837|NCT01340196|12306132|FG000|STARTED|Treat. Period 1 (Tenofovir)||16
11120838|NCT01340196|12306132|FG000|COMPLETED|Treat. Period 1 (Tenofovir)||16
11120839|NCT01340196|12306132|FG000|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
11120840|NCT01340196|12306132|FG000|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
11003373|NCT00712010|12180805|FG000|STARTED|Washout (7 Days)||23
11003374|NCT00712010|12180805|FG000|COMPLETED|Washout (7 Days)||23
11003375|NCT00712010|12180805|FG000|NOT COMPLETED|Washout (7 Days)||0
11003376|NCT00712010|12180805|FG000|STARTED|7th and Last Protein Testing (1 Day)||23
11003377|NCT00712010|12180805|FG000|COMPLETED|7th and Last Protein Testing (1 Day)||23
11003378|NCT00712010|12180805|FG000|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
11003379|NCT00712075|12180824|FG000|STARTED|Overall Study||22
11120841|NCT01340196|12306132|FG000|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
11003380|NCT00712075|12180825|FG001|STARTED|Overall Study||30
11003381|NCT00712075|12180826|FG002|STARTED|Overall Study||25
11003382|NCT00712075|12180824|FG000|COMPLETED|Overall Study||17
11003383|NCT00712075|12180825|FG001|COMPLETED|Overall Study||26
11003384|NCT00712075|12180826|FG002|COMPLETED|Overall Study||14
11003385|NCT00712075|12180824|FG000|NOT COMPLETED|Overall Study||5
11003386|NCT00712075|12180825|FG001|NOT COMPLETED|Overall Study||4
11003387|NCT00712075|12180826|FG002|NOT COMPLETED|Overall Study||11
11003388|NCT00712166|12180836|FG000|STARTED|Overall Study||81
11003389|NCT00712166|12180837|FG001|STARTED|Overall Study||76
11120842|NCT01340196|12306132|FG000|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
11003390|NCT00712166|12180836|FG000|COMPLETED|Overall Study||81
11003391|NCT00712166|12180837|FG001|COMPLETED|Overall Study||75
11003392|NCT00712166|12180836|FG000|NOT COMPLETED|Overall Study||0
11003393|NCT00712166|12180837|FG001|NOT COMPLETED|Overall Study||1
11003394|NCT00712179|12180845|FG000|STARTED|Overall Study||49
11003395|NCT00712179|12180845|FG000|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
11003396|NCT00712179|12180845|FG000|NOT COMPLETED|Overall Study||12
11003397|NCT00712244|12180853|FG000|STARTED|Overall Study||29
11003398|NCT00712244|12180854|FG001|STARTED|Overall Study||29
11003399|NCT00712244|12180855|FG002|STARTED|Overall Study||27
11003400|NCT00712244|12180856|FG003|STARTED|Overall Study||27
11003401|NCT00712244|12180853|FG000|COMPLETED|Overall Study||25
11003402|NCT00712244|12180854|FG001|COMPLETED|Overall Study||28
11003403|NCT00712244|12180855|FG002|COMPLETED|Overall Study||25
11003404|NCT00712244|12180856|FG003|COMPLETED|Overall Study||26
11003405|NCT00712244|12180853|FG000|NOT COMPLETED|Overall Study||4
11003406|NCT00712244|12180854|FG001|NOT COMPLETED|Overall Study||1
11003407|NCT00712244|12180855|FG002|NOT COMPLETED|Overall Study||2
11003408|NCT00712244|12180856|FG003|NOT COMPLETED|Overall Study||1
11003409|NCT00712270|12180869|FG000|STARTED|Overall Study||21
11003410|NCT00712270|12180869|FG000|COMPLETED|Overall Study||7
11003411|NCT00712270|12180869|FG000|NOT COMPLETED|Overall Study||14
11003412|NCT00712296|12180883|FG000|STARTED|Phase I ( 1 Week)||12
11003413|NCT00712296|12180884|FG001|STARTED|Phase I ( 1 Week)||8
11003414|NCT00712296|12180885|FG002|STARTED|Phase I ( 1 Week)||0
11003415|NCT00712296|12180886|FG003|STARTED|Phase I ( 1 Week)||0
11003416|NCT00712296|12180887|FG004|STARTED|Phase I ( 1 Week)||0
11003417|NCT00712296|12180883|FG000|COMPLETED|Phase I ( 1 Week)||12
11003418|NCT00712296|12180884|FG001|COMPLETED|Phase I ( 1 Week)||8
11003419|NCT00712296|12180885|FG002|COMPLETED|Phase I ( 1 Week)||0
11003420|NCT00712296|12180886|FG003|COMPLETED|Phase I ( 1 Week)||0
11003421|NCT00712296|12180887|FG004|COMPLETED|Phase I ( 1 Week)||0
11003422|NCT00712296|12180883|FG000|NOT COMPLETED|Phase I ( 1 Week)||0
11003423|NCT00712296|12180884|FG001|NOT COMPLETED|Phase I ( 1 Week)||0
11003424|NCT00712296|12180885|FG002|NOT COMPLETED|Phase I ( 1 Week)||0
11003425|NCT00712296|12180886|FG003|NOT COMPLETED|Phase I ( 1 Week)||0
11003426|NCT00712296|12180887|FG004|NOT COMPLETED|Phase I ( 1 Week)||0
11003427|NCT00712296|12180883|FG000|STARTED|Phase II (28 Weeks)||0
11003428|NCT00712296|12180884|FG001|STARTED|Phase II (28 Weeks)||0
11003429|NCT00712296|12180885|FG002|STARTED|Phase II (28 Weeks)||15
11003430|NCT00712296|12180886|FG003|STARTED|Phase II (28 Weeks)||16
11003431|NCT00712296|12180887|FG004|STARTED|Phase II (28 Weeks)||15
11003432|NCT00712296|12180883|FG000|COMPLETED|Phase II (28 Weeks)||0
11003433|NCT00712296|12180884|FG001|COMPLETED|Phase II (28 Weeks)||0
11003434|NCT00712296|12180885|FG002|COMPLETED|Phase II (28 Weeks)|ASHMI/Placebo was discontinued on 9/29/10.20 participants were re-randomized into the Phase II.|2
11003435|NCT00712296|12180886|FG003|COMPLETED|Phase II (28 Weeks)||1
11003436|NCT00712296|12180887|FG004|COMPLETED|Phase II (28 Weeks)||3
11003437|NCT00712296|12180883|FG000|NOT COMPLETED|Phase II (28 Weeks)||0
11003438|NCT00712296|12180884|FG001|NOT COMPLETED|Phase II (28 Weeks)||0
11003439|NCT00712296|12180885|FG002|NOT COMPLETED|Phase II (28 Weeks)||13
11003440|NCT00712296|12180886|FG003|NOT COMPLETED|Phase II (28 Weeks)||15
11003441|NCT00712296|12180887|FG004|NOT COMPLETED|Phase II (28 Weeks)||12
11003442|NCT00712335|12180923|FG000|STARTED|Overall Study||8
11003443|NCT00712335|12180924|FG001|STARTED|Overall Study||32
11003444|NCT00712335|12180925|FG002|STARTED|Overall Study||11
11003445|NCT00712335|12180926|FG003|STARTED|Overall Study||24
11003446|NCT00712335|12180927|FG004|STARTED|Overall Study||30
11003447|NCT00712335|12180923|FG000|COMPLETED|Overall Study||5
11003448|NCT00712335|12180924|FG001|COMPLETED|Overall Study||15
11003449|NCT00712335|12180925|FG002|COMPLETED|Overall Study||6
11003450|NCT00712335|12180926|FG003|COMPLETED|Overall Study||19
11003451|NCT00712335|12180927|FG004|COMPLETED|Overall Study||30
11003452|NCT00712335|12180923|FG000|NOT COMPLETED|Overall Study||3
11003453|NCT00712335|12180924|FG001|NOT COMPLETED|Overall Study||17
11003454|NCT00712335|12180925|FG002|NOT COMPLETED|Overall Study||5
11003455|NCT00712335|12180926|FG003|NOT COMPLETED|Overall Study||5
11003456|NCT00712335|12180927|FG004|NOT COMPLETED|Overall Study||0
11003457|NCT00712348|12180939|FG000|STARTED|Overall Study||31
11003458|NCT00712348|12180939|FG000|COMPLETED|Overall Study||30
11003459|NCT00712348|12180939|FG000|NOT COMPLETED|Overall Study||1
11003460|NCT00712530|12180946|FG000|STARTED|Overall Study||3
11003461|NCT00712530|12180947|FG001|STARTED|Overall Study||3
11003462|NCT00712530|12180948|FG002|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
11003463|NCT00712530|12180946|FG000|COMPLETED|Overall Study||3
11003464|NCT00712530|12180947|FG001|COMPLETED|Overall Study||3
11003465|NCT00712530|12180948|FG002|COMPLETED|Overall Study||3
11003466|NCT00712530|12180946|FG000|NOT COMPLETED|Overall Study||0
11003467|NCT00712530|12180947|FG001|NOT COMPLETED|Overall Study||0
11003468|NCT00712530|12180948|FG002|NOT COMPLETED|Overall Study||0
11003469|NCT00712543|12180958|FG000|STARTED|Day 1-7||23
11003470|NCT00712543|12180959|FG001|STARTED|Day 1-7||27
11003471|NCT00712543|12180958|FG000|COMPLETED|Day 1-7||23
11003472|NCT00712543|12180959|FG001|COMPLETED|Day 1-7||27
11003473|NCT00712543|12180958|FG000|NOT COMPLETED|Day 1-7||0
11003474|NCT00712543|12180959|FG001|NOT COMPLETED|Day 1-7||0
11003475|NCT00712543|12180958|FG000|STARTED|Day 8-14||23
11003476|NCT00712543|12180959|FG001|STARTED|Day 8-14||27
11003477|NCT00712543|12180958|FG000|COMPLETED|Day 8-14||23
11003478|NCT00712543|12180959|FG001|COMPLETED|Day 8-14||25
11003479|NCT00712543|12180958|FG000|NOT COMPLETED|Day 8-14||0
11003480|NCT00712543|12180959|FG001|NOT COMPLETED|Day 8-14||2
11003481|NCT00712673|12180968|FG000|STARTED|Overall Study|Randomized.|85
11003482|NCT00712673|12180969|FG001|STARTED|Overall Study||85
11003483|NCT00712673|12180970|FG002|STARTED|Overall Study||255
11003484|NCT00712673|12180971|FG003|STARTED|Overall Study||255
11056331|NCT00993499|12237862|FG001|COMPLETED|Discontinued After Starting Course 3||4
11003485|NCT00712673|12180968|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
11003486|NCT00712673|12180969|FG001|Safety Population|Overall Study||85
11003487|NCT00712673|12180970|FG002|Safety Population|Overall Study||255
11003488|NCT00712673|12180971|FG003|Safety Population|Overall Study||255
11003489|NCT00712673|12180968|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
11003490|NCT00712673|12180969|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||85
11003491|NCT00712673|12180970|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||255
11003492|NCT00712673|12180971|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||255
11003493|NCT00712673|12180968|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
11003494|NCT00712673|12180969|FG001|Subgroup for Standardized Meal Test|Overall Study||0
11003495|NCT00712673|12180970|FG002|Subgroup for Standardized Meal Test|Overall Study||255
11003496|NCT00712673|12180971|FG003|Subgroup for Standardized Meal Test|Overall Study||0
11003497|NCT00712673|12180968|FG000|COMPLETED|Overall Study||64
11003498|NCT00712673|12180969|FG001|COMPLETED|Overall Study||64
11003499|NCT00712673|12180970|FG002|COMPLETED|Overall Study||198
11003500|NCT00712673|12180971|FG003|COMPLETED|Overall Study||185
11003501|NCT00712673|12180968|FG000|NOT COMPLETED|Overall Study||21
11003502|NCT00712673|12180969|FG001|NOT COMPLETED|Overall Study||21
11003503|NCT00712673|12180970|FG002|NOT COMPLETED|Overall Study||57
11003504|NCT00712673|12180971|FG003|NOT COMPLETED|Overall Study||70
11003505|NCT00712712|12180990|FG000|STARTED|Overall Study||78
11003506|NCT00712712|12180990|FG000|COMPLETED|Overall Study||55
11003507|NCT00712712|12180990|FG000|NOT COMPLETED|Overall Study||23
11003508|NCT00712725|12181002|FG000|STARTED|Overall Study||169
11003509|NCT00712725|12181003|FG001|STARTED|Overall Study||39
11003510|NCT00712725|12181004|FG002|STARTED|Overall Study||57
11003511|NCT00712725|12181005|FG003|STARTED|Overall Study||84
11003512|NCT00712725|12181006|FG004|STARTED|Overall Study||86
11003513|NCT00712725|12181007|FG005|STARTED|Overall Study||84
11003514|NCT00712725|12181008|FG006|STARTED|Overall Study||83
11003515|NCT00712725|12181009|FG007|STARTED|Overall Study||74
11003516|NCT00712725|12181002|FG000|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
11003517|NCT00712725|12181003|FG001|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
11003518|NCT00712725|12181004|FG002|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
11003519|NCT00712725|12181005|FG003|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
11003520|NCT00712725|12181006|FG004|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
11003521|NCT00712725|12181007|FG005|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
11003522|NCT00712725|12181008|FG006|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
11003523|NCT00712725|12181009|FG007|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
11003524|NCT00712725|12181002|FG000|NOT COMPLETED|Overall Study||29
11003525|NCT00712725|12181003|FG001|NOT COMPLETED|Overall Study||6
11003526|NCT00712725|12181004|FG002|NOT COMPLETED|Overall Study||10
11003527|NCT00712725|12181005|FG003|NOT COMPLETED|Overall Study||17
11003528|NCT00712725|12181006|FG004|NOT COMPLETED|Overall Study||19
11003529|NCT00712725|12181007|FG005|NOT COMPLETED|Overall Study||16
11003530|NCT00712725|12181008|FG006|NOT COMPLETED|Overall Study||22
11003531|NCT00712725|12181009|FG007|NOT COMPLETED|Overall Study||11
11003532|NCT00712920|12181030|FG000|STARTED|Overall Study||192
11003533|NCT00712920|12181031|FG001|STARTED|Overall Study|3 subjects were randomized in error|197
11003534|NCT00712920|12181032|FG002|STARTED|Overall Study||192
11003535|NCT00712920|12181030|FG000|COMPLETED|Overall Study||175
11003536|NCT00712920|12181031|FG001|COMPLETED|Overall Study||180
11003537|NCT00712920|12181032|FG002|COMPLETED|Overall Study||180
11003538|NCT00712920|12181030|FG000|NOT COMPLETED|Overall Study||17
11003539|NCT00712920|12181031|FG001|NOT COMPLETED|Overall Study||17
11003540|NCT00712920|12181032|FG002|NOT COMPLETED|Overall Study||12
11003541|NCT00712959|12181042|FG000|STARTED|Overall Study||361
11003542|NCT00712959|12181043|FG001|STARTED|Overall Study||407
11003543|NCT00712959|12181042|FG000|COMPLETED|Overall Study||342
11003544|NCT00712959|12181043|FG001|COMPLETED|Overall Study||404
11003545|NCT00712959|12181042|FG000|NOT COMPLETED|Overall Study||19
11003546|NCT00712959|12181043|FG001|NOT COMPLETED|Overall Study||3
11003547|NCT00712985|12181049|FG000|STARTED|Overall Study||18
11003548|NCT00712985|12181049|FG000|COMPLETED|Overall Study||13
11003549|NCT00712985|12181049|FG000|NOT COMPLETED|Overall Study||5
11003550|NCT00713219|12181053|FG000|STARTED|Overall Study||14
11003551|NCT00713219|12181053|FG000|COMPLETED|Overall Study||12
11003552|NCT00713219|12181053|FG000|NOT COMPLETED|Overall Study||2
11003553|NCT00713284|12181057|FG000|STARTED|Overall Study|29 participants were screened but only 13 eligible for conversion and continue in the study.|29
11003554|NCT00713284|12181057|FG000|COMPLETED|Overall Study||13
11003555|NCT00713284|12181057|FG000|NOT COMPLETED|Overall Study||16
11003556|NCT00713310|12181063|FG000|STARTED|Overall Study||41
11003557|NCT00713310|12181064|FG001|STARTED|Overall Study||42
11003558|NCT00713310|12181063|FG000|mITT Population|Overall Study||41
11003559|NCT00713310|12181064|FG001|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
11003560|NCT00713310|12181063|FG000|COMPLETED|Overall Study||36
11003561|NCT00713310|12181064|FG001|COMPLETED|Overall Study||36
11003562|NCT00713310|12181063|FG000|NOT COMPLETED|Overall Study||5
11003563|NCT00713310|12181064|FG001|NOT COMPLETED|Overall Study||6
11003564|NCT00713323|12181070|FG000|STARTED|Overall Study||380
11003565|NCT00713323|12181070|FG000|COMPLETED|Overall Study||234
11003566|NCT00713323|12181070|FG000|NOT COMPLETED|Overall Study||146
11003567|NCT00713349|12181074|FG000|STARTED|Overall Study||25
11003568|NCT00713349|12181074|FG000|COMPLETED|Overall Study||24
11003569|NCT00713349|12181074|FG000|NOT COMPLETED|Overall Study||1
11003570|NCT00713427|12181080|FG000|STARTED|Overall Study||70
11003571|NCT00713427|12181080|FG000|COMPLETED|Overall Study||66
11003572|NCT00713427|12181080|FG000|NOT COMPLETED|Overall Study||4
11003573|NCT00713479|12181084|FG000|STARTED|First Medication Condition||6
11003574|NCT00713479|12181085|FG001|STARTED|First Medication Condition||6
11003575|NCT00713479|12181084|FG000|COMPLETED|First Medication Condition||2
11003576|NCT00713479|12181085|FG001|COMPLETED|First Medication Condition||6
11003577|NCT00713479|12181084|FG000|NOT COMPLETED|First Medication Condition||4
11003578|NCT00713479|12181085|FG001|NOT COMPLETED|First Medication Condition||0
11003579|NCT00713479|12181084|FG000|STARTED|Washout||2
11003580|NCT00713479|12181085|FG001|STARTED|Washout||6
11003581|NCT00713479|12181084|FG000|COMPLETED|Washout||2
11003582|NCT00713479|12181085|FG001|COMPLETED|Washout||6
11003583|NCT00713479|12181084|FG000|NOT COMPLETED|Washout||0
11003584|NCT00713479|12181085|FG001|NOT COMPLETED|Washout||0
11003585|NCT00713479|12181084|FG000|STARTED|Next Medication Condition||2
11003586|NCT00713479|12181085|FG001|STARTED|Next Medication Condition||6
11003587|NCT00713479|12181084|FG000|COMPLETED|Next Medication Condition||2
11003588|NCT00713479|12181085|FG001|COMPLETED|Next Medication Condition||6
11003589|NCT00713479|12181084|FG000|NOT COMPLETED|Next Medication Condition||0
11003590|NCT00713479|12181085|FG001|NOT COMPLETED|Next Medication Condition||0
11003591|NCT00713544|12181099|FG000|STARTED|Overall Study||52
11003592|NCT00713544|12181100|FG001|STARTED|Overall Study||52
11003593|NCT00713544|12181101|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
11003594|NCT00713544|12181102|FG003|STARTED|Overall Study||76
11003595|NCT00713544|12181103|FG004|STARTED|Overall Study||65
11003596|NCT00713544|12181104|FG005|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
11003597|NCT00713544|12181099|FG000|COMPLETED|Overall Study||45
11003598|NCT00713544|12181100|FG001|COMPLETED|Overall Study||46
11003599|NCT00713544|12181101|FG002|COMPLETED|Overall Study||41
11003600|NCT00713544|12181102|FG003|COMPLETED|Overall Study||66
11003601|NCT00713544|12181103|FG004|COMPLETED|Overall Study||57
11003602|NCT00713544|12181104|FG005|COMPLETED|Overall Study||67
11003603|NCT00713544|12181099|FG000|NOT COMPLETED|Overall Study||7
11003604|NCT00713544|12181100|FG001|NOT COMPLETED|Overall Study||6
11003605|NCT00713544|12181101|FG002|NOT COMPLETED|Overall Study||11
11003606|NCT00713544|12181102|FG003|NOT COMPLETED|Overall Study||10
11003607|NCT00713544|12181103|FG004|NOT COMPLETED|Overall Study||8
11003608|NCT00713544|12181104|FG005|NOT COMPLETED|Overall Study||9
11003609|NCT00713583|12181120|FG000|STARTED|Overall Study||45
11003610|NCT00713583|12181121|FG001|STARTED|Overall Study||40
11003611|NCT00713583|12181120|FG000|COMPLETED|Overall Study||45
11003612|NCT00713583|12181121|FG001|COMPLETED|Overall Study||40
11003613|NCT00713583|12181120|FG000|NOT COMPLETED|Overall Study||0
11003614|NCT00713583|12181121|FG001|NOT COMPLETED|Overall Study||0
11003615|NCT00713609|12181133|FG000|STARTED|Overall Study||106
11003616|NCT00713609|12181134|FG001|STARTED|Overall Study||105
11003617|NCT00713609|12181135|FG002|STARTED|Overall Study||107
11003618|NCT00713609|12181136|FG003|STARTED|Overall Study||108
11003619|NCT00713609|12181137|FG004|STARTED|Overall Study||106
11003620|NCT00713609|12181138|FG005|STARTED|Overall Study||55
11003621|NCT00713609|12181133|FG000|COMPLETED|Overall Study||85
11003622|NCT00713609|12181134|FG001|COMPLETED|Overall Study||90
11003623|NCT00713609|12181135|FG002|COMPLETED|Overall Study||92
11003624|NCT00713609|12181136|FG003|COMPLETED|Overall Study||99
11003625|NCT00713609|12181137|FG004|COMPLETED|Overall Study||87
11003626|NCT00713609|12181138|FG005|COMPLETED|Overall Study||47
11003627|NCT00713609|12181133|FG000|NOT COMPLETED|Overall Study||21
11003628|NCT00713609|12181134|FG001|NOT COMPLETED|Overall Study||15
11003629|NCT00713609|12181135|FG002|NOT COMPLETED|Overall Study||15
11003630|NCT00713609|12181136|FG003|NOT COMPLETED|Overall Study||9
11003631|NCT00713609|12181137|FG004|NOT COMPLETED|Overall Study||19
11003632|NCT00713609|12181138|FG005|NOT COMPLETED|Overall Study||8
11003633|NCT00713648|12181152|FG000|STARTED|Overall Study||41
11003634|NCT00713648|12181152|FG000|COMPLETED|Overall Study||33
11003635|NCT00713648|12181152|FG000|NOT COMPLETED|Overall Study||8
11003636|NCT00713661|12181160|FG000|STARTED|Overall Study||7
11003637|NCT00713661|12181161|FG001|STARTED|Overall Study||9
11003638|NCT00713661|12181162|FG002|STARTED|Overall Study||4
11003639|NCT00713661|12181163|FG003|STARTED|Overall Study||5
11003640|NCT00713661|12181160|FG000|COMPLETED|Overall Study||7
11003641|NCT00713661|12181161|FG001|COMPLETED|Overall Study||9
11003642|NCT00713661|12181162|FG002|COMPLETED|Overall Study||4
11003643|NCT00713661|12181163|FG003|COMPLETED|Overall Study||5
11003644|NCT00713661|12181160|FG000|NOT COMPLETED|Overall Study||0
11003645|NCT00713661|12181161|FG001|NOT COMPLETED|Overall Study||0
11003646|NCT00713661|12181162|FG002|NOT COMPLETED|Overall Study||0
11003647|NCT00713661|12181163|FG003|NOT COMPLETED|Overall Study||0
11003648|NCT00713700|12181173|FG000|STARTED|Overall Study||192
11003649|NCT00713700|12181173|FG000|COMPLETED|Overall Study||188
11003650|NCT00713700|12181173|FG000|NOT COMPLETED|Overall Study||4
11003651|NCT00713817|12181179|FG000|STARTED|Overall Study||10
11003652|NCT00713817|12181180|FG001|STARTED|Overall Study||9
11003653|NCT00713817|12181179|FG000|COMPLETED|Overall Study||10
11003654|NCT00713817|12181180|FG001|COMPLETED|Overall Study||9
11003655|NCT00713817|12181179|FG000|NOT COMPLETED|Overall Study||0
11003656|NCT00713817|12181180|FG001|NOT COMPLETED|Overall Study||0
11003657|NCT00713830|12181188|FG000|STARTED|Overall Study|Randomized.|286
11003658|NCT00713830|12181189|FG001|STARTED|Overall Study||573
11003659|NCT00713830|12181188|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
11003660|NCT00713830|12181189|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||570
11003661|NCT00713830|12181188|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
11003662|NCT00713830|12181189|FG001|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
11003663|NCT00713830|12181188|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
11003664|NCT00713830|12181189|FG001|Subgroup for Standardized Meal Test|Overall Study||313
11003665|NCT00713830|12181188|FG000|COMPLETED|Overall Study||204
11003666|NCT00713830|12181189|FG001|COMPLETED|Overall Study||396
11003667|NCT00713830|12181188|FG000|NOT COMPLETED|Overall Study||82
11003668|NCT00713830|12181189|FG001|NOT COMPLETED|Overall Study||177
11003669|NCT00714051|12181197|FG000|STARTED|Overall Study||27
11003670|NCT00714051|12181198|FG001|STARTED|Overall Study||28
11003671|NCT00714051|12181197|FG000|COMPLETED|Overall Study||26
11003672|NCT00714051|12181198|FG001|COMPLETED|Overall Study||27
11003673|NCT00714051|12181197|FG000|NOT COMPLETED|Overall Study||1
11003674|NCT00714051|12181198|FG001|NOT COMPLETED|Overall Study||1
11003675|NCT00714168|12181206|FG000|STARTED|Overall Study||165
11003676|NCT00714168|12181207|FG001|STARTED|Overall Study||198
11003677|NCT00714168|12181206|FG000|COMPLETED|Overall Study||121
11003678|NCT00714168|12181207|FG001|COMPLETED|Overall Study||139
11003679|NCT00714168|12181206|FG000|NOT COMPLETED|Overall Study||44
11003680|NCT00714168|12181207|FG001|NOT COMPLETED|Overall Study||59
11003681|NCT00714233|12181217|FG000|STARTED|Overall Study||10
11003682|NCT00714233|12181218|FG001|STARTED|Overall Study||11
11003683|NCT00714233|12181219|FG002|STARTED|Overall Study||11
11003684|NCT00714233|12181220|FG003|STARTED|Overall Study||10
11003685|NCT00714233|12181217|FG000|COMPLETED|Overall Study||6
11003686|NCT00714233|12181218|FG001|COMPLETED|Overall Study||10
11003687|NCT00714233|12181219|FG002|COMPLETED|Overall Study||10
11003688|NCT00714233|12181220|FG003|COMPLETED|Overall Study||6
11003689|NCT00714233|12181217|FG000|NOT COMPLETED|Overall Study||4
11003690|NCT00714233|12181218|FG001|NOT COMPLETED|Overall Study||1
11003691|NCT00714233|12181219|FG002|NOT COMPLETED|Overall Study||1
11003692|NCT00714233|12181220|FG003|NOT COMPLETED|Overall Study||4
11003693|NCT00714259|12181235|FG000|STARTED|Overall Study||5
11003694|NCT00714259|12181235|FG000|COMPLETED|Overall Study||3
11003695|NCT00714259|12181235|FG000|NOT COMPLETED|Overall Study||2
11003696|NCT00714272|12181241|FG000|STARTED|Overall Study||2
11003697|NCT00714272|12181242|FG001|STARTED|Overall Study||2
11003698|NCT00714272|12181241|FG000|COMPLETED|Overall Study||2
11003699|NCT00714272|12181242|FG001|COMPLETED|Overall Study||2
11003700|NCT00714272|12181241|FG000|NOT COMPLETED|Overall Study||0
11003701|NCT00714272|12181242|FG001|NOT COMPLETED|Overall Study||0
11003702|NCT00714285|12181252|FG000|STARTED|Overall Study||105
11003703|NCT00714285|12181253|FG001|STARTED|Overall Study||105
11003704|NCT00714285|12181254|FG002|STARTED|Overall Study||105
11003705|NCT00714285|12181255|FG003|STARTED|Overall Study||105
11003706|NCT00714285|12181252|FG000|COMPLETED|Overall Study|Completed upto Day 180|105
11003707|NCT00714285|12181253|FG001|COMPLETED|Overall Study|Completed upto Day 180|102
11003708|NCT00714285|12181254|FG002|COMPLETED|Overall Study|Completed upto Day 180|105
11003709|NCT00714285|12181255|FG003|COMPLETED|Overall Study|Completed upto Day 180|104
11003710|NCT00714285|12181252|FG000|NOT COMPLETED|Overall Study||0
11003711|NCT00714285|12181253|FG001|NOT COMPLETED|Overall Study||3
11003712|NCT00714285|12181254|FG002|NOT COMPLETED|Overall Study||0
11003713|NCT00714285|12181255|FG003|NOT COMPLETED|Overall Study||1
11003714|NCT00714311|12181269|FG000|STARTED|Overall Study||52
11003715|NCT00714311|12181270|FG001|STARTED|Overall Study||52
11003716|NCT00714311|12181269|FG000|COMPLETED|Overall Study||39
11003717|NCT00714311|12181270|FG001|COMPLETED|Overall Study||30
11003718|NCT00714311|12181269|FG000|NOT COMPLETED|Overall Study||13
11003719|NCT00714311|12181270|FG001|NOT COMPLETED|Overall Study||22
11003720|NCT00714389|12181276|FG000|STARTED|Overall Study||12
11003721|NCT00714389|12181276|FG000|COMPLETED|Overall Study||12
11003722|NCT00714389|12181276|FG000|NOT COMPLETED|Overall Study||0
11003723|NCT00714415|12181282|FG000|STARTED|Overall Study||25
11003724|NCT00714415|12181283|FG001|STARTED|Overall Study||55
11003725|NCT00714415|12181282|FG000|COMPLETED|Overall Study||23
11003726|NCT00714415|12181283|FG001|COMPLETED|Overall Study||55
11003727|NCT00714415|12181282|FG000|NOT COMPLETED|Overall Study||2
11120843|NCT01340196|12306132|FG000|STARTED|Treat. Period 3 (Faldaprevir)||16
11120844|NCT01340196|12306132|FG000|COMPLETED|Treat. Period 3 (Faldaprevir)||14
11003728|NCT00714415|12181283|FG001|NOT COMPLETED|Overall Study||0
11003729|NCT00714493|12181289|FG000|STARTED|Overall Study||203
11003730|NCT00714493|12181289|FG000|COMPLETED|Overall Study||154
11003731|NCT00714493|12181289|FG000|NOT COMPLETED|Overall Study||49
11003732|NCT00714571|12181299|FG000|STARTED|Stage 1||12
11003733|NCT00714571|12181300|FG001|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
11003734|NCT00714571|12181301|FG002|STARTED|Stage 1||11
11003735|NCT00714571|12181302|FG003|STARTED|Stage 1||14
11003736|NCT00714571|12181303|FG004|STARTED|Stage 1||0
11120845|NCT01340196|12306132|FG000|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
11120846|NCT01340209|12306144|FG000|STARTED|Overall Study||57
11120847|NCT01340209|12306145|FG001|STARTED|Overall Study||114
11120848|NCT01340209|12306146|FG002|STARTED|Overall Study||114
11120849|NCT01340209|12306144|FG000|COMPLETED|Overall Study||52
11120850|NCT01340209|12306145|FG001|COMPLETED|Overall Study||106
11120851|NCT01340209|12306146|FG002|COMPLETED|Overall Study||106
11120852|NCT01340209|12306144|FG000|NOT COMPLETED|Overall Study||5
11120853|NCT01340209|12306145|FG001|NOT COMPLETED|Overall Study||8
11120854|NCT01340209|12306146|FG002|NOT COMPLETED|Overall Study||8
11120855|NCT01340300|12306158|FG000|STARTED|Overall Study||35
11120856|NCT01340300|12306159|FG001|STARTED|Overall Study||35
11120857|NCT01340300|12306160|FG002|STARTED|Overall Study||35
11120858|NCT01340300|12306161|FG003|STARTED|Overall Study||34
11003737|NCT00714571|12181304|FG005|STARTED|Stage 1||0
11003738|NCT00714571|12181299|FG000|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
11003739|NCT00714571|12181300|FG001|COMPLETED|Stage 1||15
11003740|NCT00714571|12181301|FG002|COMPLETED|Stage 1||10
11003741|NCT00714571|12181302|FG003|COMPLETED|Stage 1||14
11003742|NCT00714571|12181303|FG004|COMPLETED|Stage 1||0
11003743|NCT00714571|12181304|FG005|COMPLETED|Stage 1||0
11003744|NCT00714571|12181299|FG000|NOT COMPLETED|Stage 1||0
11003745|NCT00714571|12181300|FG001|NOT COMPLETED|Stage 1||0
11003746|NCT00714571|12181301|FG002|NOT COMPLETED|Stage 1||1
11003747|NCT00714571|12181302|FG003|NOT COMPLETED|Stage 1||0
11003748|NCT00714571|12181303|FG004|NOT COMPLETED|Stage 1||0
11003749|NCT00714571|12181304|FG005|NOT COMPLETED|Stage 1||0
11003750|NCT00714571|12181299|FG000|STARTED|Stage 2||0
11003751|NCT00714571|12181300|FG001|STARTED|Stage 2||0
11003752|NCT00714571|12181301|FG002|STARTED|Stage 2||0
11003753|NCT00714571|12181302|FG003|STARTED|Stage 2||0
11003754|NCT00714571|12181303|FG004|STARTED|Stage 2||15
11003755|NCT00714571|12181304|FG005|STARTED|Stage 2||15
11003756|NCT00714571|12181299|FG000|COMPLETED|Stage 2||0
11003757|NCT00714571|12181300|FG001|COMPLETED|Stage 2||0
11003758|NCT00714571|12181301|FG002|COMPLETED|Stage 2||0
11003759|NCT00714571|12181302|FG003|COMPLETED|Stage 2||0
11003760|NCT00714571|12181303|FG004|COMPLETED|Stage 2||15
11003761|NCT00714571|12181304|FG005|COMPLETED|Stage 2||15
11003762|NCT00714571|12181299|FG000|NOT COMPLETED|Stage 2||0
11003763|NCT00714571|12181300|FG001|NOT COMPLETED|Stage 2||0
11003764|NCT00714571|12181301|FG002|NOT COMPLETED|Stage 2||0
11003765|NCT00714571|12181302|FG003|NOT COMPLETED|Stage 2||0
11003766|NCT00714571|12181303|FG004|NOT COMPLETED|Stage 2||0
11120859|NCT01340300|12306158|FG000|Baseline Blood Sample|Overall Study||33
11120860|NCT01340300|12306159|FG001|Baseline Blood Sample|Overall Study||34
11003767|NCT00714571|12181304|FG005|NOT COMPLETED|Stage 2||0
11003768|NCT00714688|12181321|FG000|STARTED|Overall Study||97
11003769|NCT00714688|12181322|FG001|STARTED|Overall Study||90
11003770|NCT00714688|12181323|FG002|STARTED|Overall Study||92
11003771|NCT00714688|12181321|FG000|COMPLETED|Overall Study||68
11003772|NCT00714688|12181322|FG001|COMPLETED|Overall Study||55
11003773|NCT00714688|12181323|FG002|COMPLETED|Overall Study||55
11003774|NCT00714688|12181321|FG000|NOT COMPLETED|Overall Study||29
11003775|NCT00714688|12181322|FG001|NOT COMPLETED|Overall Study||35
11003776|NCT00714688|12181323|FG002|NOT COMPLETED|Overall Study||37
11003777|NCT00714714|12181331|FG000|STARTED|Overall Study||25
11003778|NCT00714714|12181331|FG000|COMPLETED|Overall Study||24
11003779|NCT00714714|12181331|FG000|NOT COMPLETED|Overall Study||1
11003780|NCT00714753|12181337|FG000|STARTED|Overall Study||5
11003781|NCT00714753|12181337|FG000|HDR Brachytherapy|Overall Study||5
11003782|NCT00714753|12181337|FG000|External Beam Radiotherapy (EBRT)|Overall Study||1
11003783|NCT00714753|12181337|FG000|COMPLETED|Overall Study||5
11003784|NCT00714753|12181337|FG000|NOT COMPLETED|Overall Study||0
11003785|NCT00714792|12181343|FG000|STARTED|Overall Study||10
11003786|NCT00714792|12181344|FG001|STARTED|Overall Study||8
11003787|NCT00714792|12181343|FG000|COMPLETED|Overall Study||10
11003788|NCT00714792|12181344|FG001|COMPLETED|Overall Study||8
11003789|NCT00714792|12181343|FG000|NOT COMPLETED|Overall Study||0
11003790|NCT00714792|12181344|FG001|NOT COMPLETED|Overall Study||0
11003791|NCT00714870|12181352|FG000|STARTED|Overall Study||49
11003792|NCT00714870|12181353|FG001|STARTED|Overall Study||27
11003793|NCT00714870|12181352|FG000|COMPLETED|Overall Study||22
11003794|NCT00714870|12181353|FG001|COMPLETED|Overall Study||22
11003795|NCT00714870|12181352|FG000|NOT COMPLETED|Overall Study||27
11003796|NCT00714870|12181353|FG001|NOT COMPLETED|Overall Study||5
11003797|NCT00715026|12181359|FG000|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
11003798|NCT00715026|12181359|FG000|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
11003799|NCT00715026|12181359|FG000|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
11120861|NCT01340300|12306160|FG002|Baseline Blood Sample|Overall Study||32
11120862|NCT01340300|12306161|FG003|Baseline Blood Sample|Overall Study||29
11120863|NCT01340300|12306158|FG000|Follow-up Blood Sample|Overall Study||25
11120864|NCT01340300|12306159|FG001|Follow-up Blood Sample|Overall Study||26
11003800|NCT00715026|12181359|FG000|NOT COMPLETED|Overall Study||10
11003801|NCT00715078|12181366|FG000|STARTED|Overall Study||41
11003802|NCT00715078|12181367|FG001|STARTED|Overall Study||40
11003803|NCT00715078|12181368|FG002|STARTED|Overall Study||41
11003804|NCT00715078|12181366|FG000|Received ≥ 1 Study Infusion|Overall Study||40
11003805|NCT00715078|12181367|FG001|Received ≥ 1 Study Infusion|Overall Study||40
11003806|NCT00715078|12181368|FG002|Received ≥ 1 Study Infusion|Overall Study||39
11003807|NCT00715078|12181366|FG000|Received ≥ 1 Leukapheresis|Overall Study||40
11003808|NCT00715078|12181367|FG001|Received ≥ 1 Leukapheresis|Overall Study||40
11003809|NCT00715078|12181368|FG002|Received ≥ 1 Leukapheresis|Overall Study||40
11003810|NCT00715078|12181366|FG000|COMPLETED|Overall Study||11
11003811|NCT00715078|12181367|FG001|COMPLETED|Overall Study||4
11003812|NCT00715078|12181368|FG002|COMPLETED|Overall Study||3
11003813|NCT00715078|12181366|FG000|NOT COMPLETED|Overall Study||30
11003814|NCT00715078|12181367|FG001|NOT COMPLETED|Overall Study||36
11003815|NCT00715078|12181368|FG002|NOT COMPLETED|Overall Study||38
11003816|NCT00715104|12181379|FG000|STARTED|Overall Study||18
11003817|NCT00715104|12181380|FG001|STARTED|Overall Study||16
11003818|NCT00715104|12181381|FG002|STARTED|Overall Study||8
11003819|NCT00715104|12181379|FG000|COMPLETED|Overall Study||18
11003820|NCT00715104|12181380|FG001|COMPLETED|Overall Study||16
11003821|NCT00715104|12181381|FG002|COMPLETED|Overall Study||8
11003822|NCT00715104|12181379|FG000|NOT COMPLETED|Overall Study||0
11003823|NCT00715104|12181380|FG001|NOT COMPLETED|Overall Study||0
11003824|NCT00715104|12181381|FG002|NOT COMPLETED|Overall Study||0
11003825|NCT00715117|12181425|FG000|STARTED|Overall Study||6
11003826|NCT00715117|12181426|FG001|STARTED|Overall Study||6
11003827|NCT00715117|12181425|FG000|Completion fo 8 Week Study|Overall Study||6
11003828|NCT00715117|12181426|FG001|Completion fo 8 Week Study|Overall Study||6
11003829|NCT00715117|12181425|FG000|COMPLETED|Overall Study||6
11003830|NCT00715117|12181426|FG001|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
11003831|NCT00715117|12181425|FG000|NOT COMPLETED|Overall Study||0
11003832|NCT00715117|12181426|FG001|NOT COMPLETED|Overall Study||1
11003833|NCT00715208|12181439|FG000|STARTED|Overall Study||7
11003834|NCT00715208|12181440|FG001|STARTED|Overall Study||48
11003835|NCT00715208|12181439|FG000|COMPLETED|Overall Study||6
11003836|NCT00715208|12181440|FG001|COMPLETED|Overall Study||39
11003837|NCT00715208|12181439|FG000|NOT COMPLETED|Overall Study||1
11003838|NCT00715208|12181440|FG001|NOT COMPLETED|Overall Study||9
11003839|NCT00715299|12181446|FG000|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
11003840|NCT00715299|12181446|FG000|COMPLETED|Overall Study||30
11003841|NCT00715299|12181446|FG000|NOT COMPLETED|Overall Study||6
11003842|NCT00715390|12181450|FG000|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
11003843|NCT00715390|12181450|FG000|Eligible|Overall Study||234
11003844|NCT00715390|12181450|FG000|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
11003845|NCT00715390|12181450|FG000|NOT COMPLETED|Overall Study||0
11003846|NCT00715403|12181461|FG000|STARTED|Overall Study||1
11003847|NCT00715403|12181462|FG001|STARTED|Overall Study||1
11003848|NCT00715403|12181463|FG002|STARTED|Overall Study||4
11003849|NCT00715403|12181464|FG003|STARTED|Overall Study||9
11003850|NCT00715403|12181465|FG004|STARTED|Overall Study||6
11003851|NCT00715403|12181466|FG005|STARTED|Overall Study||19
11003852|NCT00715403|12181467|FG006|STARTED|Overall Study||1
11003853|NCT00715403|12181461|FG000|COMPLETED|Overall Study||0
11003854|NCT00715403|12181462|FG001|COMPLETED|Overall Study||0
11003855|NCT00715403|12181463|FG002|COMPLETED|Overall Study||0
11003856|NCT00715403|12181464|FG003|COMPLETED|Overall Study||0
11003857|NCT00715403|12181465|FG004|COMPLETED|Overall Study||0
11003858|NCT00715403|12181466|FG005|COMPLETED|Overall Study||0
11003859|NCT00715403|12181467|FG006|COMPLETED|Overall Study||0
11003860|NCT00715403|12181461|FG000|NOT COMPLETED|Overall Study||1
11003861|NCT00715403|12181462|FG001|NOT COMPLETED|Overall Study||1
11003862|NCT00715403|12181463|FG002|NOT COMPLETED|Overall Study||4
11003863|NCT00715403|12181464|FG003|NOT COMPLETED|Overall Study||9
11003864|NCT00715403|12181465|FG004|NOT COMPLETED|Overall Study||6
11003865|NCT00715403|12181466|FG005|NOT COMPLETED|Overall Study||19
11003866|NCT00715403|12181467|FG006|NOT COMPLETED|Overall Study||1
11003867|NCT00715429|12181485|FG000|STARTED|Overall Study||7
11003868|NCT00715429|12181486|FG001|STARTED|Overall Study||7
11003869|NCT00715429|12181485|FG000|COMPLETED|Overall Study||7
11003870|NCT00715429|12181486|FG001|COMPLETED|Overall Study||6
11003871|NCT00715429|12181485|FG000|NOT COMPLETED|Overall Study||0
11003872|NCT00715429|12181486|FG001|NOT COMPLETED|Overall Study||1
11003873|NCT00715520|12181495|FG000|STARTED|Overall Study||20
11003874|NCT00715520|12181496|FG001|STARTED|Overall Study||10
11003875|NCT00715520|12181497|FG002|STARTED|Overall Study||3
11003876|NCT00715520|12181495|FG000|COMPLETED|Overall Study||10
11003877|NCT00715520|12181496|FG001|COMPLETED|Overall Study||9
11003878|NCT00715520|12181497|FG002|COMPLETED|Overall Study||1
11003879|NCT00715520|12181495|FG000|NOT COMPLETED|Overall Study||10
11003880|NCT00715520|12181496|FG001|NOT COMPLETED|Overall Study||1
11003881|NCT00715520|12181497|FG002|NOT COMPLETED|Overall Study||2
11003882|NCT00715559|12181505|FG000|STARTED|Overall Study||3
11003883|NCT00715559|12181505|FG000|COMPLETED|Overall Study||2
11003884|NCT00715559|12181505|FG000|NOT COMPLETED|Overall Study||1
11003885|NCT00715624|12181511|FG000|STARTED|Overall Study|Randomized|167
11003886|NCT00715624|12181512|FG001|STARTED|Overall Study||329
11003887|NCT00715624|12181511|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
11003888|NCT00715624|12181512|FG001|Treated/Safety Population|Overall Study||328
11003889|NCT00715624|12181511|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
11003890|NCT00715624|12181512|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||327
11003891|NCT00715624|12181511|FG000|COMPLETED|Overall Study||115
11003892|NCT00715624|12181512|FG001|COMPLETED|Overall Study||213
11003893|NCT00715624|12181511|FG000|NOT COMPLETED|Overall Study||52
11003894|NCT00715624|12181512|FG001|NOT COMPLETED|Overall Study||116
11003895|NCT00715650|12181520|FG000|STARTED|Intervention||47
11003896|NCT00715650|12181521|FG001|STARTED|Intervention||45
11003897|NCT00715650|12181520|FG000|Received Any Session|Intervention||39
11003898|NCT00715650|12181521|FG001|Received Any Session|Intervention||38
11003899|NCT00715650|12181520|FG000|Attended ≥ 2 Sessions|Intervention||36
11003900|NCT00715650|12181521|FG001|Attended ≥ 2 Sessions|Intervention||33
11003901|NCT00715650|12181520|FG000|Attended ≥ 3 Sessions|Intervention||23
11003902|NCT00715650|12181521|FG001|Attended ≥ 3 Sessions|Intervention||17
11003903|NCT00715650|12181520|FG000|COMPLETED|Intervention||42
11003904|NCT00715650|12181521|FG001|COMPLETED|Intervention||42
11003905|NCT00715650|12181520|FG000|NOT COMPLETED|Intervention||5
11003906|NCT00715650|12181521|FG001|NOT COMPLETED|Intervention||3
11003907|NCT00715650|12181520|FG000|STARTED|Follow-up||42
11003908|NCT00715650|12181521|FG001|STARTED|Follow-up||42
11003909|NCT00715650|12181520|FG000|Completed Month 1 Follow-up|Follow-up||40
11003910|NCT00715650|12181521|FG001|Completed Month 1 Follow-up|Follow-up||38
11003911|NCT00715650|12181520|FG000|Completed Month 3 Follow-up|Follow-up||35
11003912|NCT00715650|12181521|FG001|Completed Month 3 Follow-up|Follow-up||40
11003913|NCT00715650|12181520|FG000|Completed Month 6 Follow-up|Follow-up||29
11003914|NCT00715650|12181521|FG001|Completed Month 6 Follow-up|Follow-up||37
11003915|NCT00715650|12181520|FG000|COMPLETED|Follow-up||29
11003916|NCT00715650|12181521|FG001|COMPLETED|Follow-up||37
11003917|NCT00715650|12181520|FG000|NOT COMPLETED|Follow-up||13
11003918|NCT00715650|12181521|FG001|NOT COMPLETED|Follow-up||5
11003919|NCT00715676|12181530|FG000|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
11003920|NCT00715676|12181531|FG001|STARTED|Overall Study||54
11003921|NCT00715676|12181532|FG002|STARTED|Overall Study||53
11003922|NCT00715676|12181530|FG000|COMPLETED|Overall Study||43
11003923|NCT00715676|12181531|FG001|COMPLETED|Overall Study||43
11003924|NCT00715676|12181532|FG002|COMPLETED|Overall Study||21
11003925|NCT00715676|12181530|FG000|NOT COMPLETED|Overall Study||6
11003926|NCT00715676|12181531|FG001|NOT COMPLETED|Overall Study||11
11003927|NCT00715676|12181532|FG002|NOT COMPLETED|Overall Study||32
11003928|NCT00715728|12181542|FG000|STARTED|Overall Study||14
11003929|NCT00715728|12181543|FG001|STARTED|Overall Study||14
11003930|NCT00715728|12181542|FG000|COMPLETED|Overall Study||14
11003931|NCT00715728|12181543|FG001|COMPLETED|Overall Study||14
11003932|NCT00715728|12181542|FG000|NOT COMPLETED|Overall Study||0
11003933|NCT00715728|12181543|FG001|NOT COMPLETED|Overall Study||0
11003934|NCT00715741|12181555|FG000|STARTED|Overall Study||25
11003935|NCT00715741|12181556|FG001|STARTED|Overall Study||25
11003936|NCT00715741|12181557|FG002|STARTED|Overall Study||25
11003937|NCT00715741|12181558|FG003|STARTED|Overall Study||25
11003938|NCT00715741|12181555|FG000|COMPLETED|Overall Study||25
11003939|NCT00715741|12181556|FG001|COMPLETED|Overall Study||25
11003940|NCT00715741|12181557|FG002|COMPLETED|Overall Study||25
11003941|NCT00715741|12181558|FG003|COMPLETED|Overall Study||25
11003942|NCT00715741|12181555|FG000|NOT COMPLETED|Overall Study||0
11003943|NCT00715741|12181556|FG001|NOT COMPLETED|Overall Study||0
11003944|NCT00715741|12181557|FG002|NOT COMPLETED|Overall Study||0
11003945|NCT00715741|12181558|FG003|NOT COMPLETED|Overall Study||0
11003946|NCT00715754|12181568|FG000|STARTED|Overall Study||47
11003947|NCT00715754|12181568|FG000|COMPLETED|Overall Study||47
11003948|NCT00715754|12181568|FG000|NOT COMPLETED|Overall Study||0
11003949|NCT00715793|12181572|FG000|STARTED|Phase 1 RP2D DAC + TMZ||4
11003950|NCT00715793|12181573|FG001|STARTED|Phase 1 RP2D DAC + TMZ||6
11003951|NCT00715793|12181572|FG000|COMPLETED|Phase 1 RP2D DAC + TMZ||3
11003952|NCT00715793|12181573|FG001|COMPLETED|Phase 1 RP2D DAC + TMZ||6
11003953|NCT00715793|12181572|FG000|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
11003954|NCT00715793|12181573|FG001|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
11003955|NCT00715793|12181572|FG000|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
11003956|NCT00715793|12181573|FG001|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
11003957|NCT00715793|12181572|FG000|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
11003958|NCT00715793|12181573|FG001|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
11003959|NCT00715793|12181572|FG000|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
11003960|NCT00715793|12181573|FG001|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
11003961|NCT00715884|12181582|FG000|STARTED|Overall Study||452
11003962|NCT00715884|12181583|FG001|STARTED|Overall Study||226
11003963|NCT00715884|12181582|FG000|COMPLETED|Overall Study||444
11003964|NCT00715884|12181583|FG001|COMPLETED|Overall Study||225
11003965|NCT00715884|12181582|FG000|NOT COMPLETED|Overall Study||8
11003966|NCT00715884|12181583|FG001|NOT COMPLETED|Overall Study||1
11003967|NCT00715910|12181593|FG000|STARTED|Year 1||433
11003968|NCT00715910|12181594|FG001|STARTED|Year 1||147
11003969|NCT00715910|12181595|FG002|STARTED|Year 1||68
11003970|NCT00715910|12181596|FG003|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
11003971|NCT00715910|12181597|FG004|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
11003972|NCT00715910|12181598|FG005|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
11003973|NCT00715910|12181593|FG000|COMPLETED|Year 1||433
11003974|NCT00715910|12181594|FG001|COMPLETED|Year 1||147
11003975|NCT00715910|12181595|FG002|COMPLETED|Year 1||68
11003976|NCT00715910|12181596|FG003|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
11003977|NCT00715910|12181597|FG004|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
11003978|NCT00715910|12181598|FG005|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
11003979|NCT00715910|12181593|FG000|NOT COMPLETED|Year 1||0
11003980|NCT00715910|12181594|FG001|NOT COMPLETED|Year 1||0
11003981|NCT00715910|12181595|FG002|NOT COMPLETED|Year 1||0
11003982|NCT00715910|12181596|FG003|NOT COMPLETED|Year 1||0
11003983|NCT00715910|12181597|FG004|NOT COMPLETED|Year 1||0
11003984|NCT00715910|12181598|FG005|NOT COMPLETED|Year 1||0
11003985|NCT00715910|12181593|FG000|STARTED|Year 3||345
11003986|NCT00715910|12181594|FG001|STARTED|Year 3||86
11003987|NCT00715910|12181595|FG002|STARTED|Year 3||56
11003988|NCT00715910|12181596|FG003|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
11003989|NCT00715910|12181597|FG004|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
11003990|NCT00715910|12181598|FG005|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
11003991|NCT00715910|12181593|FG000|COMPLETED|Year 3||345
11003992|NCT00715910|12181594|FG001|COMPLETED|Year 3||86
11003993|NCT00715910|12181595|FG002|COMPLETED|Year 3||56
11003994|NCT00715910|12181596|FG003|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
11003995|NCT00715910|12181597|FG004|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
11003996|NCT00715910|12181598|FG005|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
11003997|NCT00715910|12181593|FG000|NOT COMPLETED|Year 3||0
11003998|NCT00715910|12181594|FG001|NOT COMPLETED|Year 3||0
11003999|NCT00715910|12181595|FG002|NOT COMPLETED|Year 3||0
11004000|NCT00715910|12181596|FG003|NOT COMPLETED|Year 3||0
11004001|NCT00715910|12181597|FG004|NOT COMPLETED|Year 3||0
11004002|NCT00715910|12181598|FG005|NOT COMPLETED|Year 3||0
11004003|NCT00715910|12181593|FG000|STARTED|Year 5||218
11004004|NCT00715910|12181594|FG001|STARTED|Year 5||56
11004005|NCT00715910|12181595|FG002|STARTED|Year 5||38
11004006|NCT00715910|12181596|FG003|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
11004007|NCT00715910|12181597|FG004|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
11004008|NCT00715910|12181598|FG005|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
11004009|NCT00715910|12181593|FG000|COMPLETED|Year 5||218
11004010|NCT00715910|12181594|FG001|COMPLETED|Year 5||56
11004011|NCT00715910|12181595|FG002|COMPLETED|Year 5||38
11004012|NCT00715910|12181596|FG003|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
11004013|NCT00715910|12181597|FG004|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
11004014|NCT00715910|12181598|FG005|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
11004015|NCT00715910|12181593|FG000|NOT COMPLETED|Year 5||0
11004016|NCT00715910|12181594|FG001|NOT COMPLETED|Year 5||0
11004017|NCT00715910|12181595|FG002|NOT COMPLETED|Year 5||0
11004018|NCT00715910|12181596|FG003|NOT COMPLETED|Year 5||0
11004019|NCT00715910|12181597|FG004|NOT COMPLETED|Year 5||0
11004020|NCT00715910|12181598|FG005|NOT COMPLETED|Year 5||0
11004021|NCT00715910|12181593|FG000|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
11004022|NCT00715910|12181594|FG001|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
11004023|NCT00715910|12181595|FG002|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
11004024|NCT00715910|12181596|FG003|STARTED|Booster and ESFU Phase||183
11004025|NCT00715910|12181597|FG004|STARTED|Booster and ESFU Phase||38
11004026|NCT00715910|12181598|FG005|STARTED|Booster and ESFU Phase||101
11004027|NCT00715910|12181593|FG000|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
11004028|NCT00715910|12181594|FG001|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
11004029|NCT00715910|12181595|FG002|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
11004030|NCT00715910|12181596|FG003|COMPLETED|Booster and ESFU Phase||172
11004031|NCT00715910|12181597|FG004|COMPLETED|Booster and ESFU Phase||36
11004032|NCT00715910|12181598|FG005|COMPLETED|Booster and ESFU Phase||88
11004033|NCT00715910|12181593|FG000|NOT COMPLETED|Booster and ESFU Phase||0
11004034|NCT00715910|12181594|FG001|NOT COMPLETED|Booster and ESFU Phase||0
11004035|NCT00715910|12181595|FG002|NOT COMPLETED|Booster and ESFU Phase||0
11004036|NCT00715910|12181596|FG003|NOT COMPLETED|Booster and ESFU Phase||11
11004037|NCT00715910|12181597|FG004|NOT COMPLETED|Booster and ESFU Phase||2
11004038|NCT00715910|12181598|FG005|NOT COMPLETED|Booster and ESFU Phase||13
11056332|NCT00993499|12237863|FG002|COMPLETED|Discontinued After Starting Course 3||3
11056333|NCT00993499|12237864|FG003|COMPLETED|Discontinued After Starting Course 3||1
11056334|NCT00993499|12237865|FG004|COMPLETED|Discontinued After Starting Course 3||0
11056335|NCT00993499|12237866|FG005|COMPLETED|Discontinued After Starting Course 3||0
11056336|NCT00993499|12237861|FG000|NOT COMPLETED|Discontinued After Starting Course 3||8
11056337|NCT00993499|12237862|FG001|NOT COMPLETED|Discontinued After Starting Course 3||5
11056338|NCT00993499|12237863|FG002|NOT COMPLETED|Discontinued After Starting Course 3||6
11056339|NCT00993499|12237864|FG003|NOT COMPLETED|Discontinued After Starting Course 3||2
11056340|NCT00993499|12237865|FG004|NOT COMPLETED|Discontinued After Starting Course 3||3
11056341|NCT00993499|12237866|FG005|NOT COMPLETED|Discontinued After Starting Course 3||3
11056342|NCT00993616|12237880|FG000|STARTED|Overall Study||29
11056343|NCT00993616|12237880|FG000|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
11056344|NCT00993616|12237880|FG000|NOT COMPLETED|Overall Study||2
11056345|NCT00993655|12237893|FG000|STARTED|Overall Study||101
11056346|NCT00993655|12237894|FG001|STARTED|Overall Study||72
11056347|NCT00993655|12237895|FG002|STARTED|Overall Study||102
11056348|NCT00993655|12237893|FG000|COMPLETED|Overall Study||101
11056349|NCT00993655|12237894|FG001|COMPLETED|Overall Study||72
11056350|NCT00993655|12237895|FG002|COMPLETED|Overall Study||102
11056351|NCT00993655|12237893|FG000|NOT COMPLETED|Overall Study||0
11056352|NCT00993655|12237894|FG001|NOT COMPLETED|Overall Study||0
11056353|NCT00993655|12237895|FG002|NOT COMPLETED|Overall Study||0
11056354|NCT00993668|12237908|FG000|STARTED|Single-Blind Period||114
11056355|NCT00993668|12237909|FG001|STARTED|Single-Blind Period||110
11056356|NCT00993668|12237908|FG000|COMPLETED|Single-Blind Period||110
11056357|NCT00993668|12237909|FG001|COMPLETED|Single-Blind Period||107
11056358|NCT00993668|12237908|FG000|NOT COMPLETED|Single-Blind Period||4
11056359|NCT00993668|12237909|FG001|NOT COMPLETED|Single-Blind Period||3
11056360|NCT00993668|12237908|FG000|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
11056361|NCT00993668|12237909|FG001|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
11056362|NCT00993668|12237908|FG000|COMPLETED|Open-Label Period||86
11056363|NCT00993668|12237909|FG001|COMPLETED|Open-Label Period||91
11056364|NCT00993668|12237908|FG000|NOT COMPLETED|Open-Label Period||23
11056365|NCT00993668|12237909|FG001|NOT COMPLETED|Open-Label Period||15
11056366|NCT00993798|12237919|FG000|STARTED|Overall Study||53
11056367|NCT00993798|12237920|FG001|STARTED|Overall Study||25
11056368|NCT00993798|12237921|FG002|STARTED|Overall Study||29
11056369|NCT00993798|12237922|FG003|STARTED|Overall Study||0
11056370|NCT00993798|12237923|FG004|STARTED|Overall Study||0
11056371|NCT00993798|12237919|FG000|COMPLETED|Overall Study||53
11056372|NCT00993798|12237920|FG001|COMPLETED|Overall Study||25
11056373|NCT00993798|12237921|FG002|COMPLETED|Overall Study||29
11056374|NCT00993798|12237922|FG003|COMPLETED|Overall Study||0
11056375|NCT00993798|12237923|FG004|COMPLETED|Overall Study||0
11056376|NCT00993798|12237919|FG000|NOT COMPLETED|Overall Study||0
11056377|NCT00993798|12237920|FG001|NOT COMPLETED|Overall Study||0
11056378|NCT00993798|12237921|FG002|NOT COMPLETED|Overall Study||0
11056379|NCT00993798|12237922|FG003|NOT COMPLETED|Overall Study||0
11056380|NCT00993798|12237923|FG004|NOT COMPLETED|Overall Study||0
11056381|NCT00993824|12237933|FG000|STARTED|Overall Study||11
11056382|NCT00993824|12237934|FG001|STARTED|Overall Study||10
11056383|NCT00993824|12237933|FG000|COMPLETED|Overall Study||11
11056384|NCT00993824|12237934|FG001|COMPLETED|Overall Study||10
11056385|NCT00993824|12237933|FG000|NOT COMPLETED|Overall Study||0
11056386|NCT00993824|12237934|FG001|NOT COMPLETED|Overall Study||0
11004039|NCT00715949|12181614|FG000|STARTED|Overall Study|4 dropped because could not finish first test|120
11004040|NCT00715949|12181614|FG000|COMPLETED|Overall Study|116 patients completed first test|116
11004041|NCT00715949|12181614|FG000|NOT COMPLETED|Overall Study||4
11004042|NCT00715962|12181620|FG000|STARTED|Overall Study||50
11004043|NCT00715962|12181621|FG001|STARTED|Overall Study||50
11004044|NCT00715962|12181620|FG000|COMPLETED|Overall Study||44
11004045|NCT00715962|12181621|FG001|COMPLETED|Overall Study||48
11004046|NCT00715962|12181620|FG000|NOT COMPLETED|Overall Study||6
11004047|NCT00715962|12181621|FG001|NOT COMPLETED|Overall Study||2
11004048|NCT00716079|12181630|FG000|STARTED|Overall Study||1403
11004049|NCT00716079|12181631|FG001|STARTED|Overall Study||1436
11004050|NCT00716079|12181630|FG000|COMPLETED|Overall Study||1394
11004051|NCT00716079|12181631|FG001|COMPLETED|Overall Study||1421
11004052|NCT00716079|12181630|FG000|NOT COMPLETED|Overall Study||9
11004053|NCT00716079|12181631|FG001|NOT COMPLETED|Overall Study||15
11004054|NCT00716092|12181640|FG000|STARTED|Overall Study||40
11004055|NCT00716092|12181641|FG001|STARTED|Overall Study||40
11004056|NCT00716092|12181642|FG002|STARTED|Overall Study||41
11004057|NCT00716092|12181640|FG000|COMPLETED|Overall Study||38
11004058|NCT00716092|12181641|FG001|COMPLETED|Overall Study||39
11004059|NCT00716092|12181642|FG002|COMPLETED|Overall Study||41
11004060|NCT00716092|12181640|FG000|NOT COMPLETED|Overall Study||2
11004061|NCT00716092|12181641|FG001|NOT COMPLETED|Overall Study||1
11004062|NCT00716092|12181642|FG002|NOT COMPLETED|Overall Study||0
11004063|NCT00716144|12181654|FG000|STARTED|Overall Study||41
11004064|NCT00716144|12181655|FG001|STARTED|Overall Study||45
11004065|NCT00716144|12181656|FG002|STARTED|Overall Study||45
11004066|NCT00716144|12181657|FG003|STARTED|Overall Study||45
11004067|NCT00716144|12181654|FG000|COMPLETED|Overall Study||32
11004068|NCT00716144|12181655|FG001|COMPLETED|Overall Study||38
11004069|NCT00716144|12181656|FG002|COMPLETED|Overall Study||33
11004070|NCT00716144|12181657|FG003|COMPLETED|Overall Study||33
11004071|NCT00716144|12181654|FG000|NOT COMPLETED|Overall Study||9
11004072|NCT00716144|12181655|FG001|NOT COMPLETED|Overall Study||7
11004073|NCT00716144|12181656|FG002|NOT COMPLETED|Overall Study||12
11004074|NCT00716144|12181657|FG003|NOT COMPLETED|Overall Study||12
11004075|NCT00716274|12181670|FG000|STARTED|Study Period II (16-Weeks)||45
11004076|NCT00716274|12181671|FG001|STARTED|Study Period II (16-Weeks)||44
11004077|NCT00716274|12181672|FG002|STARTED|Study Period II (16-Weeks)||0
11004078|NCT00716274|12181673|FG003|STARTED|Study Period II (16-Weeks)||0
11004079|NCT00716274|12181674|FG004|STARTED|Study Period II (16-Weeks)||0
11004080|NCT00716274|12181675|FG005|STARTED|Study Period II (16-Weeks)||21
11004081|NCT00716274|12181670|FG000|COMPLETED|Study Period II (16-Weeks)||36
11004082|NCT00716274|12181671|FG001|COMPLETED|Study Period II (16-Weeks)||35
11004083|NCT00716274|12181672|FG002|COMPLETED|Study Period II (16-Weeks)||0
11004084|NCT00716274|12181673|FG003|COMPLETED|Study Period II (16-Weeks)||0
11004085|NCT00716274|12181674|FG004|COMPLETED|Study Period II (16-Weeks)||0
11004086|NCT00716274|12181675|FG005|COMPLETED|Study Period II (16-Weeks)||19
11004087|NCT00716274|12181670|FG000|NOT COMPLETED|Study Period II (16-Weeks)||9
11004088|NCT00716274|12181671|FG001|NOT COMPLETED|Study Period II (16-Weeks)||9
11004089|NCT00716274|12181672|FG002|NOT COMPLETED|Study Period II (16-Weeks)||0
11004090|NCT00716274|12181673|FG003|NOT COMPLETED|Study Period II (16-Weeks)||0
11004091|NCT00716274|12181674|FG004|NOT COMPLETED|Study Period II (16-Weeks)||0
11004092|NCT00716274|12181675|FG005|NOT COMPLETED|Study Period II (16-Weeks)||2
11004093|NCT00716274|12181670|FG000|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
11004094|NCT00716274|12181671|FG001|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
11004095|NCT00716274|12181672|FG002|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
11004096|NCT00716274|12181673|FG003|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
11004097|NCT00716274|12181674|FG004|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
11004098|NCT00716274|12181675|FG005|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
11004099|NCT00716274|12181670|FG000|COMPLETED|Study Period III (16-Weeks)||0
11004100|NCT00716274|12181671|FG001|COMPLETED|Study Period III (16-Weeks)||0
11004101|NCT00716274|12181672|FG002|COMPLETED|Study Period III (16-Weeks)||16
11004102|NCT00716274|12181673|FG003|COMPLETED|Study Period III (16-Weeks)||17
11004103|NCT00716274|12181674|FG004|COMPLETED|Study Period III (16-Weeks)||32
11004104|NCT00716274|12181675|FG005|COMPLETED|Study Period III (16-Weeks)||19
11004105|NCT00716274|12181670|FG000|NOT COMPLETED|Study Period III (16-Weeks)||0
11004106|NCT00716274|12181671|FG001|NOT COMPLETED|Study Period III (16-Weeks)||0
11004107|NCT00716274|12181672|FG002|NOT COMPLETED|Study Period III (16-Weeks)||2
11004108|NCT00716274|12181673|FG003|NOT COMPLETED|Study Period III (16-Weeks)||1
11004109|NCT00716274|12181674|FG004|NOT COMPLETED|Study Period III (16-Weeks)||3
11004110|NCT00716274|12181675|FG005|NOT COMPLETED|Study Period III (16-Weeks)||0
11004111|NCT00716417|12181702|FG000|STARTED|Overall Study||3
11004112|NCT00716417|12181703|FG001|STARTED|Overall Study||6
11004113|NCT00716417|12181704|FG002|STARTED|Overall Study||5
11004114|NCT00716417|12181705|FG003|STARTED|Overall Study||11
11004115|NCT00716417|12181706|FG004|STARTED|Overall Study||1
11004116|NCT00716417|12181707|FG005|STARTED|Overall Study||3
11004117|NCT00716417|12181708|FG006|STARTED|Overall Study||7
11004118|NCT00716417|12181709|FG007|STARTED|Overall Study||3
11004119|NCT00716417|12181710|FG008|STARTED|Overall Study||5
11004120|NCT00716417|12181711|FG009|STARTED|Overall Study||3
11004121|NCT00716417|12181702|FG000|COMPLETED|Overall Study||0
11004122|NCT00716417|12181703|FG001|COMPLETED|Overall Study||0
11004123|NCT00716417|12181704|FG002|COMPLETED|Overall Study||0
11004124|NCT00716417|12181705|FG003|COMPLETED|Overall Study||0
11004125|NCT00716417|12181706|FG004|COMPLETED|Overall Study||0
11004126|NCT00716417|12181707|FG005|COMPLETED|Overall Study||0
11004127|NCT00716417|12181708|FG006|COMPLETED|Overall Study||0
11004128|NCT00716417|12181709|FG007|COMPLETED|Overall Study||0
11004129|NCT00716417|12181710|FG008|COMPLETED|Overall Study||0
11004130|NCT00716417|12181711|FG009|COMPLETED|Overall Study||0
11004131|NCT00716417|12181702|FG000|NOT COMPLETED|Overall Study||3
11004132|NCT00716417|12181703|FG001|NOT COMPLETED|Overall Study||6
11004133|NCT00716417|12181704|FG002|NOT COMPLETED|Overall Study||5
11004134|NCT00716417|12181705|FG003|NOT COMPLETED|Overall Study||11
11004135|NCT00716417|12181706|FG004|NOT COMPLETED|Overall Study||1
11004136|NCT00716417|12181707|FG005|NOT COMPLETED|Overall Study||3
11004137|NCT00716417|12181708|FG006|NOT COMPLETED|Overall Study||7
11004138|NCT00716417|12181709|FG007|NOT COMPLETED|Overall Study||3
11004139|NCT00716417|12181710|FG008|NOT COMPLETED|Overall Study||5
11004140|NCT00716417|12181711|FG009|NOT COMPLETED|Overall Study||3
11004141|NCT00716456|12181738|FG000|STARTED|Overall Study||3
11004142|NCT00716456|12181739|FG001|STARTED|Overall Study||5
11004143|NCT00716456|12181740|FG002|STARTED|Overall Study||13
11004144|NCT00716456|12181738|FG000|COMPLETED|Overall Study||3
11004145|NCT00716456|12181739|FG001|COMPLETED|Overall Study||3
11004146|NCT00716456|12181740|FG002|COMPLETED|Overall Study||13
11004147|NCT00716456|12181738|FG000|NOT COMPLETED|Overall Study||0
11004148|NCT00716456|12181739|FG001|NOT COMPLETED|Overall Study||2
11004149|NCT00716456|12181740|FG002|NOT COMPLETED|Overall Study||0
11004150|NCT00716482|12181748|FG000|STARTED|Overall Study||1681
11004151|NCT00716482|12181748|FG000|COMPLETED|Overall Study||1562
11004152|NCT00716482|12181748|FG000|NOT COMPLETED|Overall Study||119
11004153|NCT00716586|12181758|FG000|STARTED|Overall Study||44
11004154|NCT00716586|12181758|FG000|COMPLETED|Overall Study||44
11004155|NCT00716586|12181758|FG000|NOT COMPLETED|Overall Study||0
11004156|NCT00716625|12181763|FG000|STARTED|Overall Study||1674
11004157|NCT00716625|12181763|FG000|COMPLETED|Overall Study||1673
11004158|NCT00716625|12181763|FG000|NOT COMPLETED|Overall Study||1
11004159|NCT00716742|12181784|FG000|STARTED|Baseline||364
11004160|NCT00716742|12181785|FG001|STARTED|Baseline||370
11004161|NCT00716742|12181786|FG002|STARTED|Baseline||365
11004162|NCT00716742|12181784|FG000|COMPLETED|Baseline||347
11004163|NCT00716742|12181785|FG001|COMPLETED|Baseline||356
11004164|NCT00716742|12181786|FG002|COMPLETED|Baseline||352
11004165|NCT00716742|12181784|FG000|NOT COMPLETED|Baseline||17
11004166|NCT00716742|12181785|FG001|NOT COMPLETED|Baseline||14
11004167|NCT00716742|12181786|FG002|NOT COMPLETED|Baseline||13
11004168|NCT00716742|12181784|FG000|STARTED|1 Year Follow-up||347
11004169|NCT00716742|12181785|FG001|STARTED|1 Year Follow-up||356
11004170|NCT00716742|12181786|FG002|STARTED|1 Year Follow-up||352
11004171|NCT00716742|12181784|FG000|COMPLETED|1 Year Follow-up||160
11004172|NCT00716742|12181785|FG001|COMPLETED|1 Year Follow-up||163
11004173|NCT00716742|12181786|FG002|COMPLETED|1 Year Follow-up||152
11004174|NCT00716742|12181784|FG000|NOT COMPLETED|1 Year Follow-up||187
11004175|NCT00716742|12181785|FG001|NOT COMPLETED|1 Year Follow-up||193
11004176|NCT00716742|12181786|FG002|NOT COMPLETED|1 Year Follow-up||200
11004177|NCT00716742|12181784|FG000|STARTED|2 Year Follow-up||160
11004178|NCT00716742|12181785|FG001|STARTED|2 Year Follow-up||163
11004179|NCT00716742|12181786|FG002|STARTED|2 Year Follow-up||152
11004180|NCT00716742|12181784|FG000|COMPLETED|2 Year Follow-up||56
11120865|NCT01340300|12306160|FG002|Follow-up Blood Sample|Overall Study||19
11004181|NCT00716742|12181785|FG001|COMPLETED|2 Year Follow-up||67
11004182|NCT00716742|12181786|FG002|COMPLETED|2 Year Follow-up||50
11004183|NCT00716742|12181784|FG000|NOT COMPLETED|2 Year Follow-up||104
11004184|NCT00716742|12181785|FG001|NOT COMPLETED|2 Year Follow-up||96
11004185|NCT00716742|12181786|FG002|NOT COMPLETED|2 Year Follow-up||102
11004186|NCT00716742|12181784|FG000|STARTED|3 Year Follow-up||56
11004187|NCT00716742|12181785|FG001|STARTED|3 Year Follow-up||67
11004188|NCT00716742|12181786|FG002|STARTED|3 Year Follow-up||50
11004189|NCT00716742|12181784|FG000|COMPLETED|3 Year Follow-up||26
11004190|NCT00716742|12181785|FG001|COMPLETED|3 Year Follow-up||35
11004191|NCT00716742|12181786|FG002|COMPLETED|3 Year Follow-up||29
11004192|NCT00716742|12181784|FG000|NOT COMPLETED|3 Year Follow-up||30
11004193|NCT00716742|12181785|FG001|NOT COMPLETED|3 Year Follow-up||32
11004194|NCT00716742|12181786|FG002|NOT COMPLETED|3 Year Follow-up||21
11004195|NCT00716820|12181794|FG000|STARTED|Overall Study||472
11004196|NCT00716820|12181794|FG000|COMPLETED|Overall Study||472
11004197|NCT00716820|12181794|FG000|NOT COMPLETED|Overall Study||0
11004198|NCT00716859|12181821|FG000|STARTED|Overall Study||70
11004199|NCT00716859|12181822|FG001|STARTED|Overall Study||69
11004200|NCT00716859|12181821|FG000|Received Treatment|Overall Study||69
11004201|NCT00716859|12181822|FG001|Received Treatment|Overall Study||68
11004202|NCT00716859|12181821|FG000|COMPLETED|Overall Study||61
11004203|NCT00716859|12181822|FG001|COMPLETED|Overall Study||64
11004204|NCT00716859|12181821|FG000|NOT COMPLETED|Overall Study||9
11004205|NCT00716859|12181822|FG001|NOT COMPLETED|Overall Study||5
11004206|NCT00716963|12181828|FG000|STARTED|Overall Study||2
11004207|NCT00716963|12181829|FG001|STARTED|Overall Study||1
11004208|NCT00716963|12181830|FG002|STARTED|Overall Study||1
11004209|NCT00716963|12181831|FG003|STARTED|Overall Study||1
11004210|NCT00716963|12181832|FG004|STARTED|Overall Study||1
11004211|NCT00716963|12181833|FG005|STARTED|Overall Study||1
11004212|NCT00716963|12181828|FG000|COMPLETED|Overall Study||1
11004213|NCT00716963|12181829|FG001|COMPLETED|Overall Study||1
11004214|NCT00716963|12181830|FG002|COMPLETED|Overall Study||1
11004215|NCT00716963|12181831|FG003|COMPLETED|Overall Study||1
11004216|NCT00716963|12181832|FG004|COMPLETED|Overall Study||1
11004217|NCT00716963|12181833|FG005|COMPLETED|Overall Study||1
11004218|NCT00716963|12181828|FG000|NOT COMPLETED|Overall Study||1
11004219|NCT00716963|12181829|FG001|NOT COMPLETED|Overall Study||0
11004220|NCT00716963|12181830|FG002|NOT COMPLETED|Overall Study||0
11004221|NCT00716963|12181831|FG003|NOT COMPLETED|Overall Study||0
11004222|NCT00716963|12181832|FG004|NOT COMPLETED|Overall Study||0
11004223|NCT00716963|12181833|FG005|NOT COMPLETED|Overall Study||0
11004224|NCT00716976|12181843|FG000|STARTED|Overall Study||65
11004225|NCT00716976|12181844|FG001|STARTED|Overall Study||66
11004226|NCT00716976|12181843|FG000|COMPLETED|Overall Study||45
11004227|NCT00716976|12181844|FG001|COMPLETED|Overall Study||57
11004228|NCT00716976|12181843|FG000|NOT COMPLETED|Overall Study||20
11004229|NCT00716976|12181844|FG001|NOT COMPLETED|Overall Study||9
11004230|NCT00717041|12181852|FG000|STARTED|Overall Study||1206
11004231|NCT00717041|12181852|FG000|COMPLETED|Overall Study||1206
11004232|NCT00717041|12181852|FG000|NOT COMPLETED|Overall Study||0
11004233|NCT00717054|12181860|FG000|STARTED|Overall Study||58
11004234|NCT00717054|12181861|FG001|STARTED|Overall Study||57
11004235|NCT00717054|12181860|FG000|COMPLETED|Overall Study||58
11004236|NCT00717054|12181861|FG001|COMPLETED|Overall Study||57
11004237|NCT00717054|12181860|FG000|NOT COMPLETED|Overall Study||0
11004238|NCT00717054|12181861|FG001|NOT COMPLETED|Overall Study||0
11004239|NCT00717067|12181873|FG000|STARTED|Part 1a: Normal/Mild/Moderate Group||6
11004240|NCT00717067|12181874|FG001|STARTED|Part 1a: Normal/Mild/Moderate Group||6
11004241|NCT00717067|12181875|FG002|STARTED|Part 1a: Normal/Mild/Moderate Group||6
11004242|NCT00717067|12181876|FG003|STARTED|Part 1a: Normal/Mild/Moderate Group||0
11004243|NCT00717067|12181877|FG004|STARTED|Part 1a: Normal/Mild/Moderate Group||0
11004244|NCT00717067|12181873|FG000|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
11004245|NCT00717067|12181874|FG001|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
11004246|NCT00717067|12181875|FG002|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
11004247|NCT00717067|12181876|FG003|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
11004248|NCT00717067|12181877|FG004|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
11004249|NCT00717067|12181873|FG000|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
11004250|NCT00717067|12181874|FG001|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
11004251|NCT00717067|12181875|FG002|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
11004252|NCT00717067|12181876|FG003|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
11004253|NCT00717067|12181877|FG004|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
11004254|NCT00717067|12181873|FG000|STARTED|Part 1b: Severe Renal Impairment||0
11004255|NCT00717067|12181874|FG001|STARTED|Part 1b: Severe Renal Impairment||0
11004256|NCT00717067|12181875|FG002|STARTED|Part 1b: Severe Renal Impairment||0
11004257|NCT00717067|12181876|FG003|STARTED|Part 1b: Severe Renal Impairment||6
11004258|NCT00717067|12181877|FG004|STARTED|Part 1b: Severe Renal Impairment||0
11004259|NCT00717067|12181873|FG000|COMPLETED|Part 1b: Severe Renal Impairment||0
11004260|NCT00717067|12181874|FG001|COMPLETED|Part 1b: Severe Renal Impairment||0
11004261|NCT00717067|12181875|FG002|COMPLETED|Part 1b: Severe Renal Impairment||0
11004262|NCT00717067|12181876|FG003|COMPLETED|Part 1b: Severe Renal Impairment||6
11004263|NCT00717067|12181877|FG004|COMPLETED|Part 1b: Severe Renal Impairment||0
11004264|NCT00717067|12181873|FG000|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
11004265|NCT00717067|12181874|FG001|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
11004266|NCT00717067|12181875|FG002|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
11004267|NCT00717067|12181876|FG003|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
11004268|NCT00717067|12181877|FG004|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
11004269|NCT00717067|12181873|FG000|STARTED|Part 2: End Stage Renal Disease||0
11004270|NCT00717067|12181874|FG001|STARTED|Part 2: End Stage Renal Disease||0
11004271|NCT00717067|12181875|FG002|STARTED|Part 2: End Stage Renal Disease||0
11004272|NCT00717067|12181876|FG003|STARTED|Part 2: End Stage Renal Disease||0
11004273|NCT00717067|12181877|FG004|STARTED|Part 2: End Stage Renal Disease||6
11004274|NCT00717067|12181873|FG000|COMPLETED|Part 2: End Stage Renal Disease||0
11004275|NCT00717067|12181874|FG001|COMPLETED|Part 2: End Stage Renal Disease||0
11004276|NCT00717067|12181875|FG002|COMPLETED|Part 2: End Stage Renal Disease||0
11004277|NCT00717067|12181876|FG003|COMPLETED|Part 2: End Stage Renal Disease||0
11004278|NCT00717067|12181877|FG004|COMPLETED|Part 2: End Stage Renal Disease||6
11004279|NCT00717067|12181873|FG000|NOT COMPLETED|Part 2: End Stage Renal Disease||0
11004280|NCT00717067|12181874|FG001|NOT COMPLETED|Part 2: End Stage Renal Disease||0
11004281|NCT00717067|12181875|FG002|NOT COMPLETED|Part 2: End Stage Renal Disease||0
11004282|NCT00717067|12181876|FG003|NOT COMPLETED|Part 2: End Stage Renal Disease||0
11004283|NCT00717067|12181877|FG004|NOT COMPLETED|Part 2: End Stage Renal Disease||0
11004284|NCT00717093|12181901|FG000|STARTED|Overall Study||214
11004285|NCT00717093|12181902|FG001|STARTED|Overall Study||218
11004286|NCT00717093|12181901|FG000|Received Treatment|Overall Study||213
11004287|NCT00717093|12181902|FG001|Received Treatment|Overall Study||218
11004288|NCT00717093|12181901|FG000|COMPLETED|Overall Study||170
11004289|NCT00717093|12181902|FG001|COMPLETED|Overall Study||170
11120866|NCT01340300|12306161|FG003|Follow-up Blood Sample|Overall Study||18
11120867|NCT01340300|12306158|FG000|COMPLETED|Overall Study||26
11120868|NCT01340300|12306159|FG001|COMPLETED|Overall Study||26
11120869|NCT01340300|12306160|FG002|COMPLETED|Overall Study||20
11004290|NCT00717093|12181901|FG000|NOT COMPLETED|Overall Study||44
11004291|NCT00717093|12181902|FG001|NOT COMPLETED|Overall Study||48
11004292|NCT00717197|12181908|FG000|STARTED|Overall Study||30
11004293|NCT00717197|12181908|FG000|COMPLETED|Overall Study||23
11004294|NCT00717197|12181908|FG000|NOT COMPLETED|Overall Study||7
11004295|NCT00717236|12181914|FG000|STARTED|Double-Blind Period||851
11004296|NCT00717236|12181915|FG001|STARTED|Double-Blind Period||212
11004297|NCT00717236|12181914|FG000|COMPLETED|Double-Blind Period||771
11004298|NCT00717236|12181915|FG001|COMPLETED|Double-Blind Period||184
11004299|NCT00717236|12181914|FG000|NOT COMPLETED|Double-Blind Period||80
11004300|NCT00717236|12181915|FG001|NOT COMPLETED|Double-Blind Period||28
11004301|NCT00717236|12181914|FG000|STARTED|Open-Label Period||771
11004302|NCT00717236|12181915|FG001|STARTED|Open-Label Period||184
11004303|NCT00717236|12181914|FG000|COMPLETED|Open-Label Period||646
11004304|NCT00717236|12181915|FG001|COMPLETED|Open-Label Period||163
11004305|NCT00717236|12181914|FG000|NOT COMPLETED|Open-Label Period||125
11004306|NCT00717236|12181915|FG001|NOT COMPLETED|Open-Label Period||21
11004307|NCT00717249|12181925|FG000|STARTED|Overall Study||326
11004308|NCT00717249|12181926|FG001|STARTED|Overall Study||165
11004309|NCT00717249|12181925|FG000|COMPLETED|Overall Study||304
11004310|NCT00717249|12181926|FG001|COMPLETED|Overall Study||150
11004311|NCT00717249|12181925|FG000|NOT COMPLETED|Overall Study||22
11004312|NCT00717249|12181926|FG001|NOT COMPLETED|Overall Study||15
11004313|NCT00717288|12181935|FG000|STARTED|Overall Study||28
11004314|NCT00717288|12181936|FG001|STARTED|Overall Study||29
11004315|NCT00717288|12181937|FG002|STARTED|Overall Study||25
11004316|NCT00717288|12181935|FG000|COMPLETED|Overall Study||28
11120870|NCT01340300|12306161|FG003|COMPLETED|Overall Study||20
11120871|NCT01340300|12306158|FG000|NOT COMPLETED|Overall Study||9
11120872|NCT01340300|12306159|FG001|NOT COMPLETED|Overall Study||9
11004317|NCT00717288|12181936|FG001|COMPLETED|Overall Study||29
11004318|NCT00717288|12181937|FG002|COMPLETED|Overall Study||25
11120873|NCT01340300|12306160|FG002|NOT COMPLETED|Overall Study||15
11120874|NCT01340300|12306161|FG003|NOT COMPLETED|Overall Study||14
11004319|NCT00717288|12181935|FG000|NOT COMPLETED|Overall Study||0
11004320|NCT00717288|12181936|FG001|NOT COMPLETED|Overall Study||0
11004321|NCT00717288|12181937|FG002|NOT COMPLETED|Overall Study||0
11004322|NCT00717314|12181953|FG000|STARTED|Overall Study||43
11004323|NCT00717314|12181954|FG001|STARTED|Overall Study||44
11004324|NCT00717314|12181953|FG000|COMPLETED|Overall Study||37
11120875|NCT01340482|12306174|FG000|STARTED|Overall Study||27
11120876|NCT01340482|12306175|FG001|STARTED|Overall Study||1
11120877|NCT01340482|12306176|FG002|STARTED|Overall Study||1
11120878|NCT01340482|12306174|FG000|COMPLETED|Overall Study||25
11120879|NCT01340482|12306175|FG001|COMPLETED|Overall Study||1
11120880|NCT01340482|12306176|FG002|COMPLETED|Overall Study||1
11120881|NCT01340482|12306174|FG000|NOT COMPLETED|Overall Study||2
11120882|NCT01340482|12306175|FG001|NOT COMPLETED|Overall Study||0
11120883|NCT01340482|12306176|FG002|NOT COMPLETED|Overall Study||0
11120884|NCT01340495|12306186|FG000|STARTED|Overall Study||70
11120885|NCT01340495|12306186|FG000|COMPLETED|Overall Study||69
11120886|NCT01340495|12306186|FG000|NOT COMPLETED|Overall Study||1
11120887|NCT01340586|12306192|FG000|STARTED|Overall Study||8
11120888|NCT01340586|12306193|FG001|STARTED|Overall Study||8
11120889|NCT01340586|12306192|FG000|COMPLETED|Overall Study||8
11120890|NCT01340586|12306193|FG001|COMPLETED|Overall Study||8
11120891|NCT01340586|12306192|FG000|NOT COMPLETED|Overall Study||0
11120892|NCT01340586|12306193|FG001|NOT COMPLETED|Overall Study||0
11120893|NCT01340625|12306206|FG000|STARTED|First Intervention||18
11120894|NCT01340625|12306207|FG001|STARTED|First Intervention||18
11120895|NCT01340625|12306206|FG000|COMPLETED|First Intervention||17
11120896|NCT01340625|12306207|FG001|COMPLETED|First Intervention||18
11120897|NCT01340625|12306206|FG000|NOT COMPLETED|First Intervention||1
11120898|NCT01340625|12306207|FG001|NOT COMPLETED|First Intervention||0
11120899|NCT01340625|12306206|FG000|STARTED|Washout Period of 28 Days||17
11120900|NCT01340625|12306207|FG001|STARTED|Washout Period of 28 Days||18
11120901|NCT01340625|12306206|FG000|COMPLETED|Washout Period of 28 Days||16
11120902|NCT01340625|12306207|FG001|COMPLETED|Washout Period of 28 Days||18
11120903|NCT01340625|12306206|FG000|NOT COMPLETED|Washout Period of 28 Days||1
11120904|NCT01340625|12306207|FG001|NOT COMPLETED|Washout Period of 28 Days||0
11120905|NCT01340625|12306206|FG000|STARTED|Second Intervention||16
11120906|NCT01340625|12306207|FG001|STARTED|Second Intervention||18
11120907|NCT01340625|12306206|FG000|COMPLETED|Second Intervention||16
11120908|NCT01340625|12306207|FG001|COMPLETED|Second Intervention||18
11120909|NCT01340625|12306206|FG000|NOT COMPLETED|Second Intervention||0
11120910|NCT01340625|12306207|FG001|NOT COMPLETED|Second Intervention||0
11120911|NCT01340651|12306213|FG000|STARTED|Overall Study||41
11120912|NCT01340651|12306213|FG000|COMPLETED|Overall Study||24
11120913|NCT01340651|12306213|FG000|NOT COMPLETED|Overall Study||17
11120914|NCT01340664|12306222|FG000|STARTED|Overall Study||93
11120915|NCT01340664|12306223|FG001|STARTED|Overall Study||93
11120916|NCT01340664|12306224|FG002|STARTED|Overall Study||93
11120917|NCT01340664|12306222|FG000|COMPLETED|Overall Study||86
11120918|NCT01340664|12306223|FG001|COMPLETED|Overall Study||85
11120919|NCT01340664|12306224|FG002|COMPLETED|Overall Study||80
11120920|NCT01340664|12306222|FG000|NOT COMPLETED|Overall Study||7
11120921|NCT01340664|12306223|FG001|NOT COMPLETED|Overall Study||8
11120922|NCT01340664|12306224|FG002|NOT COMPLETED|Overall Study||13
11120923|NCT01340768|12306234|FG000|STARTED|Overall Study||436
11004325|NCT00717314|12181954|FG001|COMPLETED|Overall Study||34
11120924|NCT01340768|12306235|FG001|STARTED|Overall Study||434
11120925|NCT01340768|12306234|FG000|COMPLETED|Overall Study||419
11120926|NCT01340768|12306235|FG001|COMPLETED|Overall Study||429
11120927|NCT01340768|12306234|FG000|NOT COMPLETED|Overall Study||17
11120928|NCT01340768|12306235|FG001|NOT COMPLETED|Overall Study||5
11120929|NCT01340794|12306243|FG000|STARTED|Overall Study||2
11120930|NCT01340794|12306244|FG001|STARTED|Overall Study||5
11120931|NCT01340794|12306243|FG000|COMPLETED|Overall Study||2
11120932|NCT01340794|12306244|FG001|COMPLETED|Overall Study||4
11120933|NCT01340794|12306243|FG000|NOT COMPLETED|Overall Study||0
11120934|NCT01340794|12306244|FG001|NOT COMPLETED|Overall Study||1
11120935|NCT01340872|12306254|FG000|STARTED|Double-blind Phase||64
11120936|NCT01340872|12306255|FG001|STARTED|Double-blind Phase||64
11120937|NCT01340872|12306256|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
11004326|NCT00717314|12181953|FG000|NOT COMPLETED|Overall Study||6
11004327|NCT00717314|12181954|FG001|NOT COMPLETED|Overall Study||10
11004328|NCT00717366|12181962|FG000|STARTED|Core Study Period (20 Weeks)||16
11004329|NCT00717366|12181963|FG001|STARTED|Core Study Period (20 Weeks)||48
11004330|NCT00717366|12181962|FG000|COMPLETED|Core Study Period (20 Weeks)||12
11004331|NCT00717366|12181963|FG001|COMPLETED|Core Study Period (20 Weeks)||35
11004332|NCT00717366|12181962|FG000|NOT COMPLETED|Core Study Period (20 Weeks)||4
11004333|NCT00717366|12181963|FG001|NOT COMPLETED|Core Study Period (20 Weeks)||13
11004334|NCT00717366|12181962|FG000|STARTED|Extension Period (52 Weeks)||9
11004335|NCT00717366|12181963|FG001|STARTED|Extension Period (52 Weeks)||28
11120938|NCT01340872|12306257|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
11004336|NCT00717366|12181962|FG000|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
11004337|NCT00717366|12181963|FG001|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
11004338|NCT00717366|12181962|FG000|COMPLETED|Extension Period (52 Weeks)||5
11004339|NCT00717366|12181963|FG001|COMPLETED|Extension Period (52 Weeks)||12
11004340|NCT00717366|12181962|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4
11004341|NCT00717366|12181963|FG001|NOT COMPLETED|Extension Period (52 Weeks)||16
11004342|NCT00717405|12181969|FG000|STARTED|Overall Study||52
11004343|NCT00717405|12181969|FG000|COMPLETED|Overall Study||52
11004344|NCT00717405|12181969|FG000|NOT COMPLETED|Overall Study||0
11004345|NCT00717418|12181977|FG000|STARTED|Baseline||180
11004346|NCT00717418|12181978|FG001|STARTED|Baseline||74
11004347|NCT00717418|12181979|FG002|STARTED|Baseline||508
11004348|NCT00717418|12181980|FG003|STARTED|Baseline||19
11004349|NCT00717418|12181977|FG000|COMPLETED|Baseline||180
11004350|NCT00717418|12181978|FG001|COMPLETED|Baseline||74
11004351|NCT00717418|12181979|FG002|COMPLETED|Baseline||508
11004352|NCT00717418|12181980|FG003|COMPLETED|Baseline||4
11004353|NCT00717418|12181977|FG000|NOT COMPLETED|Baseline||0
11004354|NCT00717418|12181978|FG001|NOT COMPLETED|Baseline||0
11004355|NCT00717418|12181979|FG002|NOT COMPLETED|Baseline||0
11004356|NCT00717418|12181980|FG003|NOT COMPLETED|Baseline||15
11004357|NCT00717418|12181977|FG000|STARTED|1-Year Follow-Up||180
11004358|NCT00717418|12181978|FG001|STARTED|1-Year Follow-Up||74
11004359|NCT00717418|12181979|FG002|STARTED|1-Year Follow-Up||508
11004360|NCT00717418|12181980|FG003|STARTED|1-Year Follow-Up||4
11004361|NCT00717418|12181977|FG000|COMPLETED|1-Year Follow-Up||33
11004362|NCT00717418|12181978|FG001|COMPLETED|1-Year Follow-Up||23
11004363|NCT00717418|12181979|FG002|COMPLETED|1-Year Follow-Up||74
11004364|NCT00717418|12181980|FG003|COMPLETED|1-Year Follow-Up||0
11004365|NCT00717418|12181977|FG000|NOT COMPLETED|1-Year Follow-Up||147
11004366|NCT00717418|12181978|FG001|NOT COMPLETED|1-Year Follow-Up||51
11004367|NCT00717418|12181979|FG002|NOT COMPLETED|1-Year Follow-Up||434
11004368|NCT00717418|12181980|FG003|NOT COMPLETED|1-Year Follow-Up||4
11004369|NCT00717522|12181984|FG000|STARTED|Overall Study||7
11004370|NCT00717522|12181984|FG000|COMPLETED|Overall Study||0
11004371|NCT00717522|12181984|FG000|NOT COMPLETED|Overall Study||7
11004372|NCT00717574|12181990|FG000|STARTED|Overall Study||16
11004373|NCT00717574|12181991|FG001|STARTED|Overall Study||16
11004374|NCT00717574|12181990|FG000|COMPLETED|Overall Study||14
11004375|NCT00717574|12181991|FG001|COMPLETED|Overall Study||14
11004376|NCT00717574|12181990|FG000|NOT COMPLETED|Overall Study||2
11004377|NCT00717574|12181991|FG001|NOT COMPLETED|Overall Study||2
11004378|NCT00717626|12181997|FG000|STARTED|Overall Study||14
11004379|NCT00717626|12181997|FG000|COMPLETED|Overall Study||14
11004380|NCT00717626|12181997|FG000|NOT COMPLETED|Overall Study||0
11004381|NCT00717756|12182001|FG000|STARTED|Overall Study||41
11004382|NCT00717756|12182001|FG000|COMPLETED|Overall Study||40
11004383|NCT00717756|12182001|FG000|NOT COMPLETED|Overall Study||1
11004384|NCT00717769|12182008|FG000|STARTED|Overall Study||120
11004385|NCT00717769|12182009|FG001|STARTED|Overall Study||120
11004386|NCT00717769|12182010|FG002|STARTED|Overall Study||30
11004387|NCT00717769|12182008|FG000|COMPLETED|Overall Study||104
11004388|NCT00717769|12182009|FG001|COMPLETED|Overall Study||102
11004389|NCT00717769|12182010|FG002|COMPLETED|Overall Study||19
11004390|NCT00717769|12182008|FG000|NOT COMPLETED|Overall Study||16
11004391|NCT00717769|12182009|FG001|NOT COMPLETED|Overall Study||18
11004392|NCT00717769|12182010|FG002|NOT COMPLETED|Overall Study||11
11120939|NCT01340872|12306254|FG000|COMPLETED|Double-blind Phase||55
11120940|NCT01340872|12306255|FG001|COMPLETED|Double-blind Phase||53
11004393|NCT00717860|12182022|FG000|STARTED|Overall Study||61
11004394|NCT00717860|12182023|FG001|STARTED|Overall Study||60
11004395|NCT00717860|12182022|FG000|COMPLETED|Overall Study||34
11004396|NCT00717860|12182023|FG001|COMPLETED|Overall Study||32
11004397|NCT00717860|12182022|FG000|NOT COMPLETED|Overall Study||27
11004398|NCT00717860|12182023|FG001|NOT COMPLETED|Overall Study||28
11004399|NCT00717873|12182031|FG000|STARTED|Overall Study||46
11004400|NCT00717873|12182032|FG001|STARTED|Overall Study||59
11120941|NCT01340872|12306256|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
11120942|NCT01340872|12306257|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
11120943|NCT01340872|12306254|FG000|NOT COMPLETED|Double-blind Phase||9
11120944|NCT01340872|12306255|FG001|NOT COMPLETED|Double-blind Phase||11
11120945|NCT01340872|12306256|FG002|NOT COMPLETED|Double-blind Phase||0
11120946|NCT01340872|12306257|FG003|NOT COMPLETED|Double-blind Phase||0
11120947|NCT01340872|12306254|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0
11120948|NCT01340872|12306255|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0
11120949|NCT01340872|12306256|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
11201912|NCT01836198|12392311|FG001|STARTED|Part A, Period 1||15
11004401|NCT00717873|12182031|FG000|COMPLETED|Overall Study||46
11004402|NCT00717873|12182032|FG001|COMPLETED|Overall Study||59
11004403|NCT00717873|12182031|FG000|NOT COMPLETED|Overall Study||0
11004404|NCT00717873|12182032|FG001|NOT COMPLETED|Overall Study||0
11004405|NCT00717886|12182038|FG000|STARTED|Overall Study||13
11004406|NCT00717886|12182038|FG000|COMPLETED|Overall Study||9
11004407|NCT00717886|12182038|FG000|NOT COMPLETED|Overall Study||4
11004408|NCT00717912|12182042|FG000|STARTED|Overall Study||1
11004409|NCT00717912|12182043|FG001|STARTED|Overall Study||1
11004410|NCT00717912|12182044|FG002|STARTED|Overall Study||1
11004411|NCT00717912|12182045|FG003|STARTED|Overall Study||1
11004412|NCT00717912|12182046|FG004|STARTED|Overall Study||1
11004413|NCT00717912|12182047|FG005|STARTED|Overall Study||1
11004414|NCT00717912|12182042|FG000|COMPLETED|Overall Study||1
11004415|NCT00717912|12182043|FG001|COMPLETED|Overall Study||1
11004416|NCT00717912|12182044|FG002|COMPLETED|Overall Study||1
11004417|NCT00717912|12182045|FG003|COMPLETED|Overall Study||1
11004418|NCT00717912|12182046|FG004|COMPLETED|Overall Study||1
11004419|NCT00717912|12182047|FG005|COMPLETED|Overall Study||1
11004420|NCT00717912|12182042|FG000|NOT COMPLETED|Overall Study||0
11004421|NCT00717912|12182043|FG001|NOT COMPLETED|Overall Study||0
11004422|NCT00717912|12182044|FG002|NOT COMPLETED|Overall Study||0
11004423|NCT00717912|12182045|FG003|NOT COMPLETED|Overall Study||0
11004424|NCT00717912|12182046|FG004|NOT COMPLETED|Overall Study||0
11004425|NCT00717912|12182047|FG005|NOT COMPLETED|Overall Study||0
11004426|NCT00717977|12182056|FG000|STARTED|Overall Study||74
11004427|NCT00717977|12182056|FG000|COMPLETED|Overall Study||74
11004428|NCT00717977|12182056|FG000|NOT COMPLETED|Overall Study||0
11004429|NCT00718042|12182066|FG000|STARTED|ABBOTT PRISM Chagas Testing||16313
11004430|NCT00718042|12182067|FG001|STARTED|ABBOTT PRISM Chagas Testing||289
11004431|NCT00718042|12182068|FG002|STARTED|ABBOTT PRISM Chagas Testing||525
11004432|NCT00718042|12182069|FG003|STARTED|ABBOTT PRISM Chagas Testing||110
11004433|NCT00718042|12182070|FG004|STARTED|ABBOTT PRISM Chagas Testing||25549
11004434|NCT00718042|12182071|FG005|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
11004435|NCT00718042|12182066|FG000|COMPLETED|ABBOTT PRISM Chagas Testing||16249
11004436|NCT00718042|12182067|FG001|COMPLETED|ABBOTT PRISM Chagas Testing||287
11004437|NCT00718042|12182068|FG002|COMPLETED|ABBOTT PRISM Chagas Testing||524
11004438|NCT00718042|12182069|FG003|COMPLETED|ABBOTT PRISM Chagas Testing||110
11004439|NCT00718042|12182070|FG004|COMPLETED|ABBOTT PRISM Chagas Testing||25511
11004440|NCT00718042|12182071|FG005|COMPLETED|ABBOTT PRISM Chagas Testing||0
11004441|NCT00718042|12182066|FG000|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
11004442|NCT00718042|12182067|FG001|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
11004443|NCT00718042|12182068|FG002|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
11004444|NCT00718042|12182069|FG003|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
11004445|NCT00718042|12182070|FG004|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
11004446|NCT00718042|12182071|FG005|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
11004447|NCT00718042|12182066|FG000|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
11004448|NCT00718042|12182067|FG001|STARTED|ESA Chagas Testing||287
11004449|NCT00718042|12182068|FG002|STARTED|ESA Chagas Testing||524
11004450|NCT00718042|12182069|FG003|STARTED|ESA Chagas Testing||110
11004451|NCT00718042|12182070|FG004|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
11004452|NCT00718042|12182071|FG005|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
11004453|NCT00718042|12182066|FG000|COMPLETED|ESA Chagas Testing||36
11004454|NCT00718042|12182067|FG001|COMPLETED|ESA Chagas Testing||287
11004455|NCT00718042|12182068|FG002|COMPLETED|ESA Chagas Testing||524
11004456|NCT00718042|12182069|FG003|COMPLETED|ESA Chagas Testing||110
11004457|NCT00718042|12182070|FG004|COMPLETED|ESA Chagas Testing||43
11004458|NCT00718042|12182071|FG005|COMPLETED|ESA Chagas Testing||330
11004459|NCT00718042|12182066|FG000|NOT COMPLETED|ESA Chagas Testing||0
11004460|NCT00718042|12182067|FG001|NOT COMPLETED|ESA Chagas Testing||0
11004461|NCT00718042|12182068|FG002|NOT COMPLETED|ESA Chagas Testing||0
11004462|NCT00718042|12182069|FG003|NOT COMPLETED|ESA Chagas Testing||0
11004463|NCT00718042|12182070|FG004|NOT COMPLETED|ESA Chagas Testing||0
11004464|NCT00718042|12182071|FG005|NOT COMPLETED|ESA Chagas Testing||0
11004465|NCT00718042|12182066|FG000|STARTED|Donor Follow-up||36
11004466|NCT00718042|12182067|FG001|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
11004467|NCT00718042|12182068|FG002|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
11056387|NCT00993915|12237942|FG000|STARTED|Overall Study||687
11004468|NCT00718042|12182069|FG003|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
11004469|NCT00718042|12182070|FG004|STARTED|Donor Follow-up||43
11004470|NCT00718042|12182071|FG005|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
11004471|NCT00718042|12182066|FG000|COMPLETED|Donor Follow-up||23
11004472|NCT00718042|12182067|FG001|COMPLETED|Donor Follow-up||0
11004473|NCT00718042|12182068|FG002|COMPLETED|Donor Follow-up||0
11004474|NCT00718042|12182069|FG003|COMPLETED|Donor Follow-up||0
11004475|NCT00718042|12182070|FG004|COMPLETED|Donor Follow-up||24
11004476|NCT00718042|12182071|FG005|COMPLETED|Donor Follow-up||0
11004477|NCT00718042|12182066|FG000|NOT COMPLETED|Donor Follow-up||13
11004478|NCT00718042|12182067|FG001|NOT COMPLETED|Donor Follow-up||0
11004479|NCT00718042|12182068|FG002|NOT COMPLETED|Donor Follow-up||0
11004480|NCT00718042|12182069|FG003|NOT COMPLETED|Donor Follow-up||0
11004481|NCT00718042|12182070|FG004|NOT COMPLETED|Donor Follow-up||19
11004482|NCT00718042|12182071|FG005|NOT COMPLETED|Donor Follow-up||0
11004483|NCT00718081|12182086|FG000|STARTED|Overall Study||29
11004484|NCT00718081|12182087|FG001|STARTED|Overall Study||29
11004485|NCT00718081|12182088|FG002|STARTED|Overall Study||30
11120950|NCT01340872|12306257|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
11120951|NCT01340872|12306254|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
11120952|NCT01340872|12306255|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
11120953|NCT01340872|12306256|FG002|COMPLETED|Open-label Phase||37
11120954|NCT01340872|12306257|FG003|COMPLETED|Open-label Phase||36
11120955|NCT01340872|12306254|FG000|NOT COMPLETED|Open-label Phase||0
11120956|NCT01340872|12306255|FG001|NOT COMPLETED|Open-label Phase||0
11120957|NCT01340872|12306256|FG002|NOT COMPLETED|Open-label Phase||13
11120958|NCT01340872|12306257|FG003|NOT COMPLETED|Open-label Phase||11
11120959|NCT01340898|12306272|FG000|STARTED|Primary Phase||376
11238567|NCT02074553|12430359|FG002|COMPLETED|Intervention Period 3||11
11238568|NCT02074553|12430360|FG003|COMPLETED|Intervention Period 3||11
11238569|NCT02074553|12430361|FG004|COMPLETED|Intervention Period 3||12
11238570|NCT02074553|12430362|FG005|COMPLETED|Intervention Period 3||10
11238571|NCT02074553|12430363|FG006|COMPLETED|Intervention Period 3||11
11238572|NCT02074553|12430364|FG007|COMPLETED|Intervention Period 3||12
11238573|NCT02074553|12430357|FG000|NOT COMPLETED|Intervention Period 3||0
11238574|NCT02074553|12430358|FG001|NOT COMPLETED|Intervention Period 3||0
11238575|NCT02074553|12430359|FG002|NOT COMPLETED|Intervention Period 3||0
11238576|NCT02074553|12430360|FG003|NOT COMPLETED|Intervention Period 3||0
11238577|NCT02074553|12430361|FG004|NOT COMPLETED|Intervention Period 3||0
11004486|NCT00718081|12182086|FG000|COMPLETED|Overall Study||22
11004487|NCT00718081|12182087|FG001|COMPLETED|Overall Study||25
11004488|NCT00718081|12182088|FG002|COMPLETED|Overall Study||9
11004489|NCT00718081|12182086|FG000|NOT COMPLETED|Overall Study||7
11004490|NCT00718081|12182087|FG001|NOT COMPLETED|Overall Study||4
11004491|NCT00718081|12182088|FG002|NOT COMPLETED|Overall Study||21
11004492|NCT00718094|12182098|FG000|STARTED|Overall Study||15
11004493|NCT00718094|12182099|FG001|STARTED|Overall Study||5
11004494|NCT00718094|12182098|FG000|COMPLETED|Overall Study||15
11004495|NCT00718094|12182099|FG001|COMPLETED|Overall Study||5
11004496|NCT00718094|12182098|FG000|NOT COMPLETED|Overall Study||0
11004497|NCT00718094|12182099|FG001|NOT COMPLETED|Overall Study||0
11004498|NCT00718120|12182107|FG000|STARTED|Overall Study||55
11004499|NCT00718120|12182108|FG001|STARTED|Overall Study||55
11004500|NCT00718120|12182107|FG000|COMPLETED|Overall Study||55
11004501|NCT00718120|12182108|FG001|COMPLETED|Overall Study||55
11120960|NCT01340898|12306273|FG001|STARTED|Primary Phase||187
11120961|NCT01340898|12306274|FG002|STARTED|Primary Phase||187
11004502|NCT00718120|12182107|FG000|NOT COMPLETED|Overall Study||0
11004503|NCT00718120|12182108|FG001|NOT COMPLETED|Overall Study||0
11004504|NCT00718159|12182121|FG000|STARTED|Overall Study||3
11004505|NCT00718159|12182122|FG001|STARTED|Overall Study||3
11004506|NCT00718159|12182123|FG002|STARTED|Overall Study||3
11004507|NCT00718159|12182124|FG003|STARTED|Overall Study||4
11004508|NCT00718159|12182125|FG004|STARTED|Overall Study||8
11004509|NCT00718159|12182126|FG005|STARTED|Overall Study||1
11004510|NCT00718159|12182127|FG006|STARTED|Overall Study||1
11004511|NCT00718159|12182121|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11004512|NCT00718159|12182122|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
11004513|NCT00718159|12182123|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
11004514|NCT00718159|12182124|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
11004515|NCT00718159|12182125|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
11004516|NCT00718159|12182126|FG005|Received at Least 1 Dose of Study Drug|Overall Study||1
11004517|NCT00718159|12182127|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1
11004518|NCT00718159|12182121|FG000|COMPLETED|Overall Study||0
11004519|NCT00718159|12182122|FG001|COMPLETED|Overall Study||0
11004520|NCT00718159|12182123|FG002|COMPLETED|Overall Study||0
11004521|NCT00718159|12182124|FG003|COMPLETED|Overall Study||0
11004522|NCT00718159|12182125|FG004|COMPLETED|Overall Study||0
11004523|NCT00718159|12182126|FG005|COMPLETED|Overall Study||0
11004524|NCT00718159|12182127|FG006|COMPLETED|Overall Study||0
11238578|NCT02074553|12430362|FG005|NOT COMPLETED|Intervention Period 3||0
11238579|NCT02074553|12430363|FG006|NOT COMPLETED|Intervention Period 3||0
11238580|NCT02074553|12430364|FG007|NOT COMPLETED|Intervention Period 3||0
11238581|NCT02074553|12430357|FG000|STARTED|Washout Period 3||11
11004525|NCT00718159|12182121|FG000|NOT COMPLETED|Overall Study||3
11004526|NCT00718159|12182122|FG001|NOT COMPLETED|Overall Study||3
11004527|NCT00718159|12182123|FG002|NOT COMPLETED|Overall Study||3
11004528|NCT00718159|12182124|FG003|NOT COMPLETED|Overall Study||4
11004529|NCT00718159|12182125|FG004|NOT COMPLETED|Overall Study||8
11004530|NCT00718159|12182126|FG005|NOT COMPLETED|Overall Study||1
11004531|NCT00718159|12182127|FG006|NOT COMPLETED|Overall Study||1
11004532|NCT00718237|12182145|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
11004533|NCT00718237|12182146|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
11004534|NCT00718237|12182145|FG000|Vaccinated at Visit 1|Overall Study||380
11004535|NCT00718237|12182146|FG001|Vaccinated at Visit 1|Overall Study||381
11004536|NCT00718237|12182145|FG000|Vaccinated at Visit 2|Overall Study||373
11004537|NCT00718237|12182146|FG001|Vaccinated at Visit 2|Overall Study||374
11004538|NCT00718237|12182145|FG000|Vaccinated at Visit 3|Overall Study||371
11004539|NCT00718237|12182146|FG001|Vaccinated at Visit 3|Overall Study||369
11004540|NCT00718237|12182145|FG000|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
11004541|NCT00718237|12182146|FG001|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
11120962|NCT01340898|12306272|FG000|COMPLETED|Primary Phase||360
11120963|NCT01340898|12306273|FG001|COMPLETED|Primary Phase||178
11120964|NCT01340898|12306274|FG002|COMPLETED|Primary Phase||181
11120965|NCT01340898|12306272|FG000|NOT COMPLETED|Primary Phase||16
11120966|NCT01340898|12306273|FG001|NOT COMPLETED|Primary Phase||9
11120967|NCT01340898|12306274|FG002|NOT COMPLETED|Primary Phase||6
11120968|NCT01340898|12306272|FG000|STARTED|Booster Phase||342
11120969|NCT01340898|12306273|FG001|STARTED|Booster Phase||166
11004542|NCT00718237|12182145|FG000|NOT COMPLETED|Overall Study||13
11004543|NCT00718237|12182146|FG001|NOT COMPLETED|Overall Study||15
11004544|NCT00718302|12182156|FG000|STARTED|Overall Study||119
11004545|NCT00718302|12182157|FG001|STARTED|Overall Study||114
11004546|NCT00718302|12182156|FG000|COMPLETED|Overall Study||119
11004547|NCT00718302|12182157|FG001|COMPLETED|Overall Study||114
11004548|NCT00718302|12182156|FG000|NOT COMPLETED|Overall Study||0
11004549|NCT00718302|12182157|FG001|NOT COMPLETED|Overall Study||0
11004550|NCT00718315|12182168|FG000|STARTED|Overall Study||67
11004551|NCT00718315|12182169|FG001|STARTED|Overall Study||67
11004552|NCT00718315|12182170|FG002|STARTED|Overall Study||67
11004553|NCT00718315|12182168|FG000|COMPLETED|Overall Study||48
11004554|NCT00718315|12182169|FG001|COMPLETED|Overall Study||45
11004555|NCT00718315|12182170|FG002|COMPLETED|Overall Study||46
11004556|NCT00718315|12182168|FG000|NOT COMPLETED|Overall Study||19
11004557|NCT00718315|12182169|FG001|NOT COMPLETED|Overall Study||22
11004558|NCT00718315|12182170|FG002|NOT COMPLETED|Overall Study||21
11004559|NCT00718328|12182180|FG000|STARTED|Overall Study||1
11004560|NCT00718328|12182181|FG001|STARTED|Overall Study||0
11004561|NCT00718328|12182180|FG000|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
11004562|NCT00718328|12182181|FG001|COMPLETED|Overall Study|Terminated due to poor enrollment|0
11004563|NCT00718328|12182180|FG000|NOT COMPLETED|Overall Study||1
11004564|NCT00718328|12182181|FG001|NOT COMPLETED|Overall Study||0
11004565|NCT00718419|12182189|FG000|STARTED|Overall Study||14
11004566|NCT00718419|12182190|FG001|STARTED|Overall Study||42
11004567|NCT00718419|12182189|FG000|Received at Least One Dose of Study Drug|Overall Study||14
11004568|NCT00718419|12182190|FG001|Received at Least One Dose of Study Drug|Overall Study||42
11004569|NCT00718419|12182189|FG000|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|1
11004570|NCT00718419|12182190|FG001|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|3
11004571|NCT00718419|12182189|FG000|NOT COMPLETED|Overall Study||13
11004572|NCT00718419|12182190|FG001|NOT COMPLETED|Overall Study||39
11004573|NCT00718510|12182198|FG000|STARTED|First Intervention (3 Weeks)||7
11004574|NCT00718510|12182199|FG001|STARTED|First Intervention (3 Weeks)||8
11004575|NCT00718510|12182198|FG000|Received Intervention|First Intervention (3 Weeks)||7
11004576|NCT00718510|12182199|FG001|Received Intervention|First Intervention (3 Weeks)||7
11004577|NCT00718510|12182198|FG000|COMPLETED|First Intervention (3 Weeks)||7
11004578|NCT00718510|12182199|FG001|COMPLETED|First Intervention (3 Weeks)||7
11004579|NCT00718510|12182198|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
11004580|NCT00718510|12182199|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
11004581|NCT00718510|12182198|FG000|STARTED|Washout (5 Days)||7
11004582|NCT00718510|12182199|FG001|STARTED|Washout (5 Days)||7
11004583|NCT00718510|12182198|FG000|COMPLETED|Washout (5 Days)||7
11004584|NCT00718510|12182199|FG001|COMPLETED|Washout (5 Days)||7
11004585|NCT00718510|12182198|FG000|NOT COMPLETED|Washout (5 Days)||0
11004586|NCT00718510|12182199|FG001|NOT COMPLETED|Washout (5 Days)||0
11004587|NCT00718510|12182198|FG000|STARTED|Second Intervention (3 Weeks)||7
11004588|NCT00718510|12182199|FG001|STARTED|Second Intervention (3 Weeks)||7
11004589|NCT00718510|12182198|FG000|COMPLETED|Second Intervention (3 Weeks)||6
11004590|NCT00718510|12182199|FG001|COMPLETED|Second Intervention (3 Weeks)||7
11120970|NCT01340898|12306274|FG002|STARTED|Booster Phase||170
11120971|NCT01340898|12306272|FG000|COMPLETED|Booster Phase||332
11120972|NCT01340898|12306273|FG001|COMPLETED|Booster Phase||164
11120973|NCT01340898|12306274|FG002|COMPLETED|Booster Phase||163
11120974|NCT01340898|12306272|FG000|NOT COMPLETED|Booster Phase||10
11120975|NCT01340898|12306273|FG001|NOT COMPLETED|Booster Phase||2
11120976|NCT01340898|12306274|FG002|NOT COMPLETED|Booster Phase||7
11120977|NCT01340937|12306288|FG000|STARTED|Period 1: Infant Series||800
11120978|NCT01340937|12306289|FG001|STARTED|Period 1: Infant Series||797
11120979|NCT01340937|12306290|FG002|STARTED|Period 1: Infant Series||809
11120980|NCT01340937|12306291|FG003|STARTED|Period 1: Infant Series||402
11120981|NCT01340937|12306288|FG000|COMPLETED|Period 1: Infant Series||742
11120982|NCT01340937|12306289|FG001|COMPLETED|Period 1: Infant Series||737
11120983|NCT01340937|12306290|FG002|COMPLETED|Period 1: Infant Series||753
11120984|NCT01340937|12306291|FG003|COMPLETED|Period 1: Infant Series||370
11120985|NCT01340937|12306288|FG000|NOT COMPLETED|Period 1: Infant Series||58
11120986|NCT01340937|12306289|FG001|NOT COMPLETED|Period 1: Infant Series||60
11120987|NCT01340937|12306290|FG002|NOT COMPLETED|Period 1: Infant Series||56
11238582|NCT02074553|12430358|FG001|STARTED|Washout Period 3||12
11004591|NCT00718510|12182198|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
11004592|NCT00718510|12182199|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
11004593|NCT00718523|12182207|FG000|STARTED|Overall Study||84
11004594|NCT00718523|12182208|FG001|STARTED|Overall Study||86
11004595|NCT00718523|12182207|FG000|COMPLETED|Overall Study||66
11004596|NCT00718523|12182208|FG001|COMPLETED|Overall Study||62
11120988|NCT01340937|12306291|FG003|NOT COMPLETED|Period 1: Infant Series||32
11120989|NCT01340937|12306288|FG000|STARTED|Period 2: Interim Period||742
11120990|NCT01340937|12306289|FG001|STARTED|Period 2: Interim Period||737
11238583|NCT02074553|12430359|FG002|STARTED|Washout Period 3||11
11004597|NCT00718523|12182207|FG000|NOT COMPLETED|Overall Study||18
11004598|NCT00718523|12182208|FG001|NOT COMPLETED|Overall Study||24
11120991|NCT01340937|12306290|FG002|STARTED|Period 2: Interim Period||753
11120992|NCT01340937|12306291|FG003|STARTED|Period 2: Interim Period||370
11120993|NCT01340937|12306288|FG000|COMPLETED|Period 2: Interim Period||675
11120994|NCT01340937|12306289|FG001|COMPLETED|Period 2: Interim Period||658
11120995|NCT01340937|12306290|FG002|COMPLETED|Period 2: Interim Period||669
11120996|NCT01340937|12306291|FG003|COMPLETED|Period 2: Interim Period||329
11120997|NCT01340937|12306288|FG000|NOT COMPLETED|Period 2: Interim Period||67
11120998|NCT01340937|12306289|FG001|NOT COMPLETED|Period 2: Interim Period||79
11120999|NCT01340937|12306290|FG002|NOT COMPLETED|Period 2: Interim Period||84
11121000|NCT01340937|12306291|FG003|NOT COMPLETED|Period 2: Interim Period||41
11121001|NCT01340937|12306288|FG000|STARTED|Period 3: Toddler Vaccinations||675
11121002|NCT01340937|12306289|FG001|STARTED|Period 3: Toddler Vaccinations||658
11121003|NCT01340937|12306290|FG002|STARTED|Period 3: Toddler Vaccinations||669
11121004|NCT01340937|12306291|FG003|STARTED|Period 3: Toddler Vaccinations||329
11121005|NCT01340937|12306288|FG000|COMPLETED|Period 3: Toddler Vaccinations||666
11121006|NCT01340937|12306289|FG001|COMPLETED|Period 3: Toddler Vaccinations||641
11121007|NCT01340937|12306290|FG002|COMPLETED|Period 3: Toddler Vaccinations||660
11121008|NCT01340937|12306291|FG003|COMPLETED|Period 3: Toddler Vaccinations||319
11121009|NCT01340937|12306288|FG000|NOT COMPLETED|Period 3: Toddler Vaccinations||9
11121010|NCT01340937|12306289|FG001|NOT COMPLETED|Period 3: Toddler Vaccinations||17
11121011|NCT01340937|12306290|FG002|NOT COMPLETED|Period 3: Toddler Vaccinations||9
11121012|NCT01340937|12306291|FG003|NOT COMPLETED|Period 3: Toddler Vaccinations||10
11121013|NCT01340976|12306313|FG000|STARTED|Overall Study||4
11121014|NCT01340976|12306314|FG001|STARTED|Overall Study||3
11121015|NCT01340976|12306315|FG002|STARTED|Overall Study||7
11121016|NCT01340976|12306316|FG003|STARTED|Overall Study||5
11121017|NCT01340976|12306317|FG004|STARTED|Overall Study||7
11121018|NCT01340976|12306318|FG005|STARTED|Overall Study||7
11121019|NCT01340976|12306313|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
11121020|NCT01340976|12306314|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
11121021|NCT01340976|12306315|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
11121022|NCT01340976|12306316|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
11004599|NCT00718549|12182214|FG000|STARTED|Induction Phase||128
11121023|NCT01340976|12306317|FG004|Received at Least 1 Dose of Study Drug|Overall Study||7
11121024|NCT01340976|12306318|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7
11121025|NCT01340976|12306313|FG000|COMPLETED|Overall Study||0
11121026|NCT01340976|12306314|FG001|COMPLETED|Overall Study||1
11121027|NCT01340976|12306315|FG002|COMPLETED|Overall Study||4
11121028|NCT01340976|12306316|FG003|COMPLETED|Overall Study||2
11121029|NCT01340976|12306317|FG004|COMPLETED|Overall Study||5
11121030|NCT01340976|12306318|FG005|COMPLETED|Overall Study||6
11121031|NCT01340976|12306313|FG000|NOT COMPLETED|Overall Study||4
11121032|NCT01340976|12306314|FG001|NOT COMPLETED|Overall Study||2
11121033|NCT01340976|12306315|FG002|NOT COMPLETED|Overall Study||3
11121034|NCT01340976|12306316|FG003|NOT COMPLETED|Overall Study||3
11121035|NCT01340976|12306317|FG004|NOT COMPLETED|Overall Study||2
11121036|NCT01340976|12306318|FG005|NOT COMPLETED|Overall Study||1
11121037|NCT01341067|12306338|FG000|STARTED|Overall Study||30
11121038|NCT01341067|12306338|FG000|COMPLETED|Overall Study||26
11121039|NCT01341067|12306338|FG000|NOT COMPLETED|Overall Study||4
11121040|NCT01341301|12306342|FG000|STARTED|Overall Study||25
11121041|NCT01341301|12306342|FG000|COMPLETED|Overall Study||25
11121042|NCT01341301|12306342|FG000|NOT COMPLETED|Overall Study||0
11121043|NCT01341457|12306350|FG000|STARTED|Overall Study||7
11121044|NCT01341457|12306351|FG001|STARTED|Overall Study||10
11121045|NCT01341457|12306350|FG000|Received at Least One Dose of Study Drug|Overall Study||7
11121046|NCT01341457|12306351|FG001|Received at Least One Dose of Study Drug|Overall Study||10
11121047|NCT01341457|12306350|FG000|COMPLETED|Overall Study||5
11121048|NCT01341457|12306351|FG001|COMPLETED|Overall Study||10
11121049|NCT01341457|12306350|FG000|NOT COMPLETED|Overall Study||2
11121050|NCT01341457|12306351|FG001|NOT COMPLETED|Overall Study||0
11121051|NCT01341470|12306364|FG000|STARTED|Overall Study||6
11121052|NCT01341470|12306365|FG001|STARTED|Overall Study||9
11121053|NCT01341470|12306366|FG002|STARTED|Overall Study||10
11121054|NCT01341470|12306367|FG003|STARTED|Overall Study||10
11121055|NCT01341470|12306368|FG004|STARTED|Overall Study||2
11121056|NCT01341470|12306369|FG005|STARTED|Overall Study||10
11121057|NCT01341470|12306364|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
11121058|NCT01341470|12306365|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9
11121059|NCT01341470|12306366|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10
11121060|NCT01341470|12306367|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
11121061|NCT01341470|12306368|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2
11121062|NCT01341470|12306369|FG005|Received at Least 1 Dose of Study Drug|Overall Study||10
11121063|NCT01341470|12306364|FG000|COMPLETED|Overall Study||6
11121064|NCT01341470|12306365|FG001|COMPLETED|Overall Study||9
11121065|NCT01341470|12306366|FG002|COMPLETED|Overall Study||9
11121066|NCT01341470|12306367|FG003|COMPLETED|Overall Study||9
11121067|NCT01341470|12306368|FG004|COMPLETED|Overall Study||2
11121068|NCT01341470|12306369|FG005|COMPLETED|Overall Study||9
11121069|NCT01341470|12306364|FG000|NOT COMPLETED|Overall Study||0
11121070|NCT01341470|12306365|FG001|NOT COMPLETED|Overall Study||0
11121071|NCT01341470|12306366|FG002|NOT COMPLETED|Overall Study||1
11121072|NCT01341470|12306367|FG003|NOT COMPLETED|Overall Study||1
11121073|NCT01341470|12306368|FG004|NOT COMPLETED|Overall Study||0
11121074|NCT01341470|12306369|FG005|NOT COMPLETED|Overall Study||1
11121075|NCT01341639|12306387|FG000|STARTED|Infant Series||628
11121076|NCT01341639|12306388|FG001|STARTED|Infant Series||622
11121077|NCT01341639|12306387|FG000|Site 0048 Excluded|Infant Series||611
11121078|NCT01341639|12306388|FG001|Site 0048 Excluded|Infant Series||606
11121079|NCT01341639|12306387|FG000|Treated|Infant Series||610
11121080|NCT01341639|12306388|FG001|Treated|Infant Series||605
11121081|NCT01341639|12306387|FG000|COMPLETED|Infant Series||599
11121082|NCT01341639|12306388|FG001|COMPLETED|Infant Series||590
11121083|NCT01341639|12306387|FG000|NOT COMPLETED|Infant Series||29
11121084|NCT01341639|12306388|FG001|NOT COMPLETED|Infant Series||32
11121085|NCT01341639|12306387|FG000|STARTED|Interim Period||599
11121086|NCT01341639|12306388|FG001|STARTED|Interim Period||590
11121087|NCT01341639|12306387|FG000|COMPLETED|Interim Period||591
11121088|NCT01341639|12306388|FG001|COMPLETED|Interim Period||581
11121089|NCT01341639|12306387|FG000|NOT COMPLETED|Interim Period||8
11121090|NCT01341639|12306388|FG001|NOT COMPLETED|Interim Period||9
11121091|NCT01341639|12306387|FG000|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590
11121092|NCT01341639|12306388|FG001|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582
11121093|NCT01341639|12306387|FG000|COMPLETED|Toddler Dose||539
11121094|NCT01341639|12306388|FG001|COMPLETED|Toddler Dose||548
11121095|NCT01341639|12306387|FG000|NOT COMPLETED|Toddler Dose||51
11121096|NCT01341639|12306388|FG001|NOT COMPLETED|Toddler Dose||34
11121097|NCT01341639|12306387|FG000|STARTED|Post-Treatment||539
11121098|NCT01341639|12306388|FG001|STARTED|Post-Treatment||548
11121099|NCT01341639|12306387|FG000|COMPLETED|Post-Treatment||539
11121100|NCT01341639|12306388|FG001|COMPLETED|Post-Treatment||545
11121101|NCT01341639|12306387|FG000|NOT COMPLETED|Post-Treatment||0
11121102|NCT01341639|12306388|FG001|NOT COMPLETED|Post-Treatment||3
11121103|NCT01341652|12306396|FG000|STARTED|Overall Study||49
11121104|NCT01341652|12306397|FG001|STARTED|Overall Study||50
11121105|NCT01341652|12306396|FG000|COMPLETED|Overall Study||49
11121106|NCT01341652|12306397|FG001|COMPLETED|Overall Study||48
11121107|NCT01341652|12306396|FG000|NOT COMPLETED|Overall Study||0
11121108|NCT01341652|12306397|FG001|NOT COMPLETED|Overall Study||2
11121109|NCT01341730|12306405|FG000|STARTED|Overall Study||20
11121110|NCT01341730|12306406|FG001|STARTED|Overall Study||21
11121111|NCT01341730|12306405|FG000|COMPLETED|Overall Study||16
11121112|NCT01341730|12306406|FG001|COMPLETED|Overall Study||17
11121113|NCT01341730|12306405|FG000|NOT COMPLETED|Overall Study||4
11121114|NCT01341730|12306406|FG001|NOT COMPLETED|Overall Study||4
11121115|NCT01341782|12306416|FG000|STARTED|Overall Study||127
11121116|NCT01341782|12306417|FG001|STARTED|Overall Study||128
11121117|NCT01341782|12306416|FG000|COMPLETED|Overall Study||112
11121118|NCT01341782|12306417|FG001|COMPLETED|Overall Study||114
11121119|NCT01341782|12306416|FG000|NOT COMPLETED|Overall Study||15
11121120|NCT01341782|12306417|FG001|NOT COMPLETED|Overall Study||14
11121121|NCT01341912|12306423|FG000|STARTED|Overall Study||3
11121122|NCT01341912|12306423|FG000|COMPLETED|Overall Study||3
11121123|NCT01341912|12306423|FG000|NOT COMPLETED|Overall Study||0
11121124|NCT01341977|12306429|FG000|STARTED|Overall Study||288
11121125|NCT01341977|12306430|FG001|STARTED|Overall Study||285
11121126|NCT01341977|12306429|FG000|COMPLETED|Overall Study||274
11121127|NCT01341977|12306430|FG001|COMPLETED|Overall Study||270
11121128|NCT01341977|12306429|FG000|NOT COMPLETED|Overall Study||14
11238584|NCT02074553|12430360|FG003|STARTED|Washout Period 3||11
11238585|NCT02074553|12430361|FG004|STARTED|Washout Period 3||12
11238586|NCT02074553|12430362|FG005|STARTED|Washout Period 3||10
11238587|NCT02074553|12430363|FG006|STARTED|Washout Period 3||11
11238588|NCT02074553|12430364|FG007|STARTED|Washout Period 3||12
11238589|NCT02074553|12430357|FG000|COMPLETED|Washout Period 3||11
11238590|NCT02074553|12430358|FG001|COMPLETED|Washout Period 3||12
11238591|NCT02074553|12430359|FG002|COMPLETED|Washout Period 3||11
11238592|NCT02074553|12430360|FG003|COMPLETED|Washout Period 3||11
11238593|NCT02074553|12430361|FG004|COMPLETED|Washout Period 3||12
11238594|NCT02074553|12430362|FG005|COMPLETED|Washout Period 3||10
11238595|NCT02074553|12430363|FG006|COMPLETED|Washout Period 3||11
11238596|NCT02074553|12430364|FG007|COMPLETED|Washout Period 3||11
11238597|NCT02074553|12430357|FG000|NOT COMPLETED|Washout Period 3||0
11238598|NCT02074553|12430358|FG001|NOT COMPLETED|Washout Period 3||0
11238599|NCT02074553|12430359|FG002|NOT COMPLETED|Washout Period 3||0
11238600|NCT02074553|12430360|FG003|NOT COMPLETED|Washout Period 3||0
11238601|NCT02074553|12430361|FG004|NOT COMPLETED|Washout Period 3||0
11238602|NCT02074553|12430362|FG005|NOT COMPLETED|Washout Period 3||0
11238603|NCT02074553|12430363|FG006|NOT COMPLETED|Washout Period 3||0
11238604|NCT02074553|12430364|FG007|NOT COMPLETED|Washout Period 3||1
11238605|NCT02074553|12430357|FG000|STARTED|Intervention Period 4||11
11238606|NCT02074553|12430358|FG001|STARTED|Intervention Period 4||12
11238607|NCT02074553|12430359|FG002|STARTED|Intervention Period 4||11
11238608|NCT02074553|12430360|FG003|STARTED|Intervention Period 4||11
11238609|NCT02074553|12430361|FG004|STARTED|Intervention Period 4||12
11238610|NCT02074553|12430362|FG005|STARTED|Intervention Period 4||10
11238611|NCT02074553|12430363|FG006|STARTED|Intervention Period 4||11
11238612|NCT02074553|12430364|FG007|STARTED|Intervention Period 4||11
11238613|NCT02074553|12430357|FG000|COMPLETED|Intervention Period 4||11
11238614|NCT02074553|12430358|FG001|COMPLETED|Intervention Period 4||12
11238615|NCT02074553|12430359|FG002|COMPLETED|Intervention Period 4||11
11238616|NCT02074553|12430360|FG003|COMPLETED|Intervention Period 4||11
11238617|NCT02074553|12430361|FG004|COMPLETED|Intervention Period 4||12
11238618|NCT02074553|12430362|FG005|COMPLETED|Intervention Period 4||10
11121129|NCT01341977|12306430|FG001|NOT COMPLETED|Overall Study||15
11121130|NCT01341990|12306438|FG000|STARTED|Overall Study||35
11121131|NCT01341990|12306439|FG001|STARTED|Overall Study||33
11238619|NCT02074553|12430363|FG006|COMPLETED|Intervention Period 4||11
11238620|NCT02074553|12430364|FG007|COMPLETED|Intervention Period 4||11
11121132|NCT01341990|12306438|FG000|COMPLETED|Overall Study||32
11121133|NCT01341990|12306439|FG001|COMPLETED|Overall Study||32
11121134|NCT01341990|12306438|FG000|NOT COMPLETED|Overall Study||3
11121135|NCT01341990|12306439|FG001|NOT COMPLETED|Overall Study||1
11121136|NCT01342029|12306445|FG000|STARTED|Period 1||70
11121137|NCT01342029|12306446|FG001|STARTED|Period 1||72
11121138|NCT01342029|12306445|FG000|Dropout|Period 1||3
11121139|NCT01342029|12306446|FG001|Dropout|Period 1||1
11121140|NCT01342029|12306445|FG000|COMPLETED|Period 1||67
11121141|NCT01342029|12306446|FG001|COMPLETED|Period 1||71
11121142|NCT01342029|12306445|FG000|NOT COMPLETED|Period 1||3
11121143|NCT01342029|12306446|FG001|NOT COMPLETED|Period 1||1
11121144|NCT01342029|12306445|FG000|STARTED|Washout||67
11121145|NCT01342029|12306446|FG001|STARTED|Washout||71
11121146|NCT01342029|12306445|FG000|COMPLETED|Washout||67
11121147|NCT01342029|12306446|FG001|COMPLETED|Washout||67
11121148|NCT01342029|12306445|FG000|NOT COMPLETED|Washout||0
11121149|NCT01342029|12306446|FG001|NOT COMPLETED|Washout||4
11121150|NCT01342029|12306445|FG000|STARTED|Period 2||67
11121151|NCT01342029|12306446|FG001|STARTED|Period 2||67
11121152|NCT01342029|12306445|FG000|Dropout|Period 2||2
11121153|NCT01342029|12306446|FG001|Dropout|Period 2||0
11121154|NCT01342029|12306445|FG000|COMPLETED|Period 2||65
11121155|NCT01342029|12306446|FG001|COMPLETED|Period 2||67
11121156|NCT01342029|12306445|FG000|NOT COMPLETED|Period 2||2
11121157|NCT01342029|12306446|FG001|NOT COMPLETED|Period 2||0
11121158|NCT01342081|12306457|FG000|STARTED|Overall Study||161
11121159|NCT01342081|12306458|FG001|STARTED|Overall Study||164
11121160|NCT01342081|12306459|FG002|STARTED|Overall Study||164
11121161|NCT01342081|12306457|FG000|COMPLETED|Overall Study||159
11121162|NCT01342081|12306458|FG001|COMPLETED|Overall Study||162
11121163|NCT01342081|12306459|FG002|COMPLETED|Overall Study||163
11121164|NCT01342081|12306457|FG000|NOT COMPLETED|Overall Study||2
11121165|NCT01342081|12306458|FG001|NOT COMPLETED|Overall Study||2
11121166|NCT01342081|12306459|FG002|NOT COMPLETED|Overall Study||1
11121167|NCT01342094|12306469|FG000|STARTED|Overall Study||82
11121168|NCT01342094|12306470|FG001|STARTED|Overall Study||84
11121169|NCT01342094|12306469|FG000|COMPLETED|Overall Study||77
11121170|NCT01342094|12306470|FG001|COMPLETED|Overall Study||81
11121171|NCT01342094|12306469|FG000|NOT COMPLETED|Overall Study||5
11121172|NCT01342094|12306470|FG001|NOT COMPLETED|Overall Study||3
11121173|NCT01342107|12306478|FG000|STARTED|Overall Study||34
11121174|NCT01342107|12306479|FG001|STARTED|Overall Study||32
11121175|NCT01342107|12306478|FG000|COMPLETED|Overall Study||34
11121176|NCT01342107|12306479|FG001|COMPLETED|Overall Study||32
11121177|NCT01342107|12306478|FG000|NOT COMPLETED|Overall Study||0
11121178|NCT01342107|12306479|FG001|NOT COMPLETED|Overall Study||0
11121179|NCT01342172|12306485|FG000|STARTED|Overall Study||9
11121180|NCT01342172|12306485|FG000|COMPLETED|Overall Study||9
11121181|NCT01342172|12306485|FG000|NOT COMPLETED|Overall Study||0
11121182|NCT01342211|12306495|FG000|STARTED|Overall Study||19
11121183|NCT01342211|12306496|FG001|STARTED|Overall Study||19
11121184|NCT01342211|12306497|FG002|STARTED|Overall Study||18
11121185|NCT01342211|12306498|FG003|STARTED|Overall Study||19
11121186|NCT01342211|12306499|FG004|STARTED|Overall Study||18
11121187|NCT01342211|12306495|FG000|Treated|Overall Study||19
11121188|NCT01342211|12306496|FG001|Treated|Overall Study||17
11121189|NCT01342211|12306497|FG002|Treated|Overall Study||18
11121190|NCT01342211|12306498|FG003|Treated|Overall Study||19
11121191|NCT01342211|12306499|FG004|Treated|Overall Study||17
11121192|NCT01342211|12306495|FG000|COMPLETED|Overall Study||19
11121193|NCT01342211|12306496|FG001|COMPLETED|Overall Study||17
11121194|NCT01342211|12306497|FG002|COMPLETED|Overall Study||18
11121195|NCT01342211|12306498|FG003|COMPLETED|Overall Study||17
11121196|NCT01342211|12306499|FG004|COMPLETED|Overall Study||16
11121197|NCT01342211|12306495|FG000|NOT COMPLETED|Overall Study||0
11121198|NCT01342211|12306496|FG001|NOT COMPLETED|Overall Study||2
11121199|NCT01342211|12306497|FG002|NOT COMPLETED|Overall Study||0
11121200|NCT01342211|12306498|FG003|NOT COMPLETED|Overall Study||2
11121201|NCT01342211|12306499|FG004|NOT COMPLETED|Overall Study||2
11121202|NCT01342341|12306517|FG000|STARTED|Overall Study||24
11121203|NCT01342341|12306518|FG001|STARTED|Overall Study||24
11121204|NCT01342341|12306517|FG000|COMPLETED|Overall Study||20
11121205|NCT01342341|12306518|FG001|COMPLETED|Overall Study||20
11121206|NCT01342341|12306517|FG000|NOT COMPLETED|Overall Study||4
11121207|NCT01342341|12306518|FG001|NOT COMPLETED|Overall Study||4
11121208|NCT01342367|12306526|FG000|STARTED|Overall Study||32
11121209|NCT01342367|12306527|FG001|STARTED|Overall Study||42
11121210|NCT01342367|12306526|FG000|COMPLETED|Overall Study||30
11121211|NCT01342367|12306527|FG001|COMPLETED|Overall Study||40
11121212|NCT01342367|12306526|FG000|NOT COMPLETED|Overall Study||2
11121213|NCT01342367|12306527|FG001|NOT COMPLETED|Overall Study||2
11121214|NCT01342445|12306535|FG000|STARTED|Overall Study||26
11121215|NCT01342445|12306536|FG001|STARTED|Overall Study||24
11121216|NCT01342445|12306535|FG000|COMPLETED|Overall Study||26
11121217|NCT01342445|12306536|FG001|COMPLETED|Overall Study||22
11121218|NCT01342445|12306535|FG000|NOT COMPLETED|Overall Study||0
11121219|NCT01342445|12306536|FG001|NOT COMPLETED|Overall Study||2
11121220|NCT01342458|12306548|FG000|STARTED|Overall Study||28
11121221|NCT01342458|12306549|FG001|STARTED|Overall Study||28
11121222|NCT01342458|12306548|FG000|COMPLETED|Overall Study||26
11121223|NCT01342458|12306549|FG001|COMPLETED|Overall Study||24
11121224|NCT01342458|12306548|FG000|NOT COMPLETED|Overall Study||2
11121225|NCT01342458|12306549|FG001|NOT COMPLETED|Overall Study||4
11121226|NCT01342471|12306571|FG000|STARTED|Overall Study||29
11121227|NCT01342471|12306572|FG001|STARTED|Overall Study||29
11121228|NCT01342471|12306571|FG000|COMPLETED|Overall Study||24
11121229|NCT01342471|12306572|FG001|COMPLETED|Overall Study||23
11121230|NCT01342471|12306571|FG000|NOT COMPLETED|Overall Study||5
11121231|NCT01342471|12306572|FG001|NOT COMPLETED|Overall Study||6
11121232|NCT01342484|12306581|FG000|STARTED|Overall Study||15
11121233|NCT01342484|12306582|FG001|STARTED|Overall Study||10
11121234|NCT01342484|12306583|FG002|STARTED|Overall Study||14
11121235|NCT01342484|12306581|FG000|COMPLETED|Overall Study||13
11121236|NCT01342484|12306582|FG001|COMPLETED|Overall Study||10
11121237|NCT01342484|12306583|FG002|COMPLETED|Overall Study||13
11121238|NCT01342484|12306581|FG000|NOT COMPLETED|Overall Study||2
11121239|NCT01342484|12306582|FG001|NOT COMPLETED|Overall Study||0
11121240|NCT01342484|12306583|FG002|NOT COMPLETED|Overall Study||1
11121241|NCT01342510|12306595|FG000|STARTED|Overall Study||50
11121242|NCT01342510|12306596|FG001|STARTED|Overall Study||50
11121243|NCT01342510|12306597|FG002|STARTED|Overall Study||50
11121244|NCT01342510|12306598|FG003|STARTED|Overall Study||50
11121245|NCT01342510|12306595|FG000|COMPLETED|Overall Study||38
11121246|NCT01342510|12306596|FG001|COMPLETED|Overall Study||44
11121247|NCT01342510|12306597|FG002|COMPLETED|Overall Study||37
11121248|NCT01342510|12306598|FG003|COMPLETED|Overall Study||39
11121249|NCT01342510|12306595|FG000|NOT COMPLETED|Overall Study||12
11121250|NCT01342510|12306596|FG001|NOT COMPLETED|Overall Study||6
11121251|NCT01342510|12306597|FG002|NOT COMPLETED|Overall Study||13
11121252|NCT01342510|12306598|FG003|NOT COMPLETED|Overall Study||11
11121253|NCT01342523|12306644|FG000|STARTED|Overall Study||35
11121254|NCT01342523|12306645|FG001|STARTED|Overall Study||32
11121255|NCT01342523|12306646|FG002|STARTED|Overall Study||36
11121256|NCT01342523|12306647|FG003|STARTED|Overall Study||33
11121257|NCT01342523|12306648|FG004|STARTED|Overall Study||36
11121258|NCT01342523|12306649|FG005|STARTED|Overall Study||36
11121259|NCT01342523|12306650|FG006|STARTED|Overall Study||22
11121260|NCT01342523|12306651|FG007|STARTED|Overall Study||27
11121261|NCT01342523|12306652|FG008|STARTED|Overall Study||28
11121262|NCT01342523|12306653|FG009|STARTED|Overall Study||28
11121263|NCT01342523|12306654|FG010|STARTED|Overall Study||38
11121264|NCT01342523|12306655|FG011|STARTED|Overall Study||38
11121265|NCT01342523|12306656|FG012|STARTED|Overall Study||39
11121266|NCT01342523|12306657|FG013|STARTED|Overall Study||38
11121267|NCT01342523|12306658|FG014|STARTED|Overall Study||38
11121268|NCT01342523|12306659|FG015|STARTED|Overall Study||32
11121269|NCT01342523|12306660|FG016|STARTED|Overall Study||29
11121270|NCT01342523|12306661|FG017|STARTED|Overall Study||27
11121271|NCT01342523|12306662|FG018|STARTED|Overall Study||21
11121272|NCT01342523|12306663|FG019|STARTED|Overall Study||27
11121273|NCT01342523|12306664|FG020|STARTED|Overall Study||29
11121274|NCT01342523|12306665|FG021|STARTED|Overall Study||30
11121275|NCT01342523|12306666|FG022|STARTED|Overall Study||36
11121276|NCT01342523|12306667|FG023|STARTED|Overall Study||36
11121277|NCT01342523|12306668|FG024|STARTED|Overall Study||37
11121278|NCT01342523|12306669|FG025|STARTED|Overall Study||38
11121279|NCT01342523|12306670|FG026|STARTED|Overall Study||34
11121280|NCT01342523|12306671|FG027|STARTED|Overall Study||31
11121281|NCT01342523|12306672|FG028|STARTED|Overall Study||35
11121282|NCT01342523|12306673|FG029|STARTED|Overall Study||29
11121283|NCT01342523|12306674|FG030|STARTED|Overall Study||31
11121284|NCT01342523|12306675|FG031|STARTED|Overall Study||28
11121285|NCT01342523|12306644|FG000|COMPLETED|Overall Study||34
11121286|NCT01342523|12306645|FG001|COMPLETED|Overall Study||32
11121287|NCT01342523|12306646|FG002|COMPLETED|Overall Study||36
11121288|NCT01342523|12306647|FG003|COMPLETED|Overall Study||32
11121289|NCT01342523|12306648|FG004|COMPLETED|Overall Study||36
11121290|NCT01342523|12306649|FG005|COMPLETED|Overall Study||36
11121291|NCT01342523|12306650|FG006|COMPLETED|Overall Study||22
11121292|NCT01342523|12306651|FG007|COMPLETED|Overall Study||27
11121293|NCT01342523|12306652|FG008|COMPLETED|Overall Study||28
11121294|NCT01342523|12306653|FG009|COMPLETED|Overall Study||28
11121295|NCT01342523|12306654|FG010|COMPLETED|Overall Study||38
11121296|NCT01342523|12306655|FG011|COMPLETED|Overall Study||36
11121297|NCT01342523|12306656|FG012|COMPLETED|Overall Study||39
11121298|NCT01342523|12306657|FG013|COMPLETED|Overall Study||36
11121299|NCT01342523|12306658|FG014|COMPLETED|Overall Study||37
11121300|NCT01342523|12306659|FG015|COMPLETED|Overall Study||32
11121301|NCT01342523|12306660|FG016|COMPLETED|Overall Study||28
11121302|NCT01342523|12306661|FG017|COMPLETED|Overall Study||27
11121303|NCT01342523|12306662|FG018|COMPLETED|Overall Study||21
11121304|NCT01342523|12306663|FG019|COMPLETED|Overall Study||27
11121305|NCT01342523|12306664|FG020|COMPLETED|Overall Study||29
11121306|NCT01342523|12306665|FG021|COMPLETED|Overall Study||30
11121307|NCT01342523|12306666|FG022|COMPLETED|Overall Study||36
11121308|NCT01342523|12306667|FG023|COMPLETED|Overall Study||35
11121309|NCT01342523|12306668|FG024|COMPLETED|Overall Study||36
11121310|NCT01342523|12306669|FG025|COMPLETED|Overall Study||36
11121311|NCT01342523|12306670|FG026|COMPLETED|Overall Study||33
11121312|NCT01342523|12306671|FG027|COMPLETED|Overall Study||30
11238621|NCT02074553|12430357|FG000|NOT COMPLETED|Intervention Period 4||0
11238622|NCT02074553|12430358|FG001|NOT COMPLETED|Intervention Period 4||0
11238623|NCT02074553|12430359|FG002|NOT COMPLETED|Intervention Period 4||0
11238624|NCT02074553|12430360|FG003|NOT COMPLETED|Intervention Period 4||0
11238625|NCT02074553|12430361|FG004|NOT COMPLETED|Intervention Period 4||0
11238626|NCT02074553|12430362|FG005|NOT COMPLETED|Intervention Period 4||0
11238627|NCT02074553|12430363|FG006|NOT COMPLETED|Intervention Period 4||0
11238628|NCT02074553|12430364|FG007|NOT COMPLETED|Intervention Period 4||0
11238629|NCT02074709|12430384|FG000|STARTED|Overall Study||30
11238630|NCT02074709|12430385|FG001|STARTED|Overall Study||30
11238631|NCT02074709|12430384|FG000|COMPLETED|Overall Study||29
11004600|NCT00718549|12182215|FG001|STARTED|Induction Phase||0
11004601|NCT00718549|12182216|FG002|STARTED|Induction Phase||0
11004602|NCT00718549|12182214|FG000|COMPLETED|Induction Phase||66
11238632|NCT02074709|12430385|FG001|COMPLETED|Overall Study||29
11358075|NCT03119649|12555107|FG004|STARTED|Overall Study||14
11358076|NCT03119649|12555103|FG000|COMPLETED|Overall Study||11
11358077|NCT03119649|12555104|FG001|COMPLETED|Overall Study||10
11358078|NCT03119649|12555105|FG002|COMPLETED|Overall Study||10
11358079|NCT03119649|12555106|FG003|COMPLETED|Overall Study||14
11238633|NCT02074709|12430384|FG000|NOT COMPLETED|Overall Study||1
11004603|NCT00718549|12182215|FG001|COMPLETED|Induction Phase||0
11121313|NCT01342523|12306672|FG028|COMPLETED|Overall Study||34
11121314|NCT01342523|12306673|FG029|COMPLETED|Overall Study||28
11121315|NCT01342523|12306674|FG030|COMPLETED|Overall Study||30
11121316|NCT01342523|12306675|FG031|COMPLETED|Overall Study||27
11121317|NCT01342523|12306644|FG000|NOT COMPLETED|Overall Study||1
11121318|NCT01342523|12306645|FG001|NOT COMPLETED|Overall Study||0
11121319|NCT01342523|12306646|FG002|NOT COMPLETED|Overall Study||0
11121320|NCT01342523|12306647|FG003|NOT COMPLETED|Overall Study||1
11121321|NCT01342523|12306648|FG004|NOT COMPLETED|Overall Study||0
11121322|NCT01342523|12306649|FG005|NOT COMPLETED|Overall Study||0
11121323|NCT01342523|12306650|FG006|NOT COMPLETED|Overall Study||0
11121324|NCT01342523|12306651|FG007|NOT COMPLETED|Overall Study||0
11121325|NCT01342523|12306652|FG008|NOT COMPLETED|Overall Study||0
11121326|NCT01342523|12306653|FG009|NOT COMPLETED|Overall Study||0
11121327|NCT01342523|12306654|FG010|NOT COMPLETED|Overall Study||0
11121328|NCT01342523|12306655|FG011|NOT COMPLETED|Overall Study||2
11121329|NCT01342523|12306656|FG012|NOT COMPLETED|Overall Study||0
11121330|NCT01342523|12306657|FG013|NOT COMPLETED|Overall Study||2
11121331|NCT01342523|12306658|FG014|NOT COMPLETED|Overall Study||1
11121332|NCT01342523|12306659|FG015|NOT COMPLETED|Overall Study||0
11121333|NCT01342523|12306660|FG016|NOT COMPLETED|Overall Study||1
11121334|NCT01342523|12306661|FG017|NOT COMPLETED|Overall Study||0
11121335|NCT01342523|12306662|FG018|NOT COMPLETED|Overall Study||0
11121336|NCT01342523|12306663|FG019|NOT COMPLETED|Overall Study||0
11121337|NCT01342523|12306664|FG020|NOT COMPLETED|Overall Study||0
11121338|NCT01342523|12306665|FG021|NOT COMPLETED|Overall Study||0
11121339|NCT01342523|12306666|FG022|NOT COMPLETED|Overall Study||0
11121340|NCT01342523|12306667|FG023|NOT COMPLETED|Overall Study||1
11121341|NCT01342523|12306668|FG024|NOT COMPLETED|Overall Study||1
11121342|NCT01342523|12306669|FG025|NOT COMPLETED|Overall Study||2
11121343|NCT01342523|12306670|FG026|NOT COMPLETED|Overall Study||1
11121344|NCT01342523|12306671|FG027|NOT COMPLETED|Overall Study||1
11121345|NCT01342523|12306672|FG028|NOT COMPLETED|Overall Study||1
11121346|NCT01342523|12306673|FG029|NOT COMPLETED|Overall Study||1
11121347|NCT01342523|12306674|FG030|NOT COMPLETED|Overall Study||1
11121348|NCT01342523|12306675|FG031|NOT COMPLETED|Overall Study||1
11121349|NCT01342549|12306690|FG000|STARTED|Overall Study||31
11121350|NCT01342549|12306691|FG001|STARTED|Overall Study||31
11121351|NCT01342549|12306690|FG000|COMPLETED|Overall Study||31
11121352|NCT01342549|12306691|FG001|COMPLETED|Overall Study||31
11121353|NCT01342549|12306690|FG000|NOT COMPLETED|Overall Study||0
11121354|NCT01342549|12306691|FG001|NOT COMPLETED|Overall Study||0
11121355|NCT01342640|12306697|FG000|STARTED|Overall Study||70
11121356|NCT01342640|12306697|FG000|COMPLETED|Overall Study||29
11121357|NCT01342640|12306697|FG000|NOT COMPLETED|Overall Study||41
11121358|NCT01342666|12306703|FG000|STARTED|Overall Study||26
11121359|NCT01342666|12306704|FG001|STARTED|Overall Study||24
11121360|NCT01342666|12306703|FG000|COMPLETED|Overall Study||26
11121361|NCT01342666|12306704|FG001|COMPLETED|Overall Study||24
11121362|NCT01342666|12306703|FG000|NOT COMPLETED|Overall Study||0
11121363|NCT01342666|12306704|FG001|NOT COMPLETED|Overall Study||0
11121364|NCT01342757|12306710|FG000|STARTED|Overall Study||12
11121365|NCT01342757|12306710|FG000|COMPLETED|Overall Study||12
11121366|NCT01342757|12306710|FG000|NOT COMPLETED|Overall Study||0
11121367|NCT01342770|12306714|FG000|STARTED|Overall Study||6
11121368|NCT01342770|12306714|FG000|COMPLETED|Overall Study||6
11121369|NCT01342770|12306714|FG000|NOT COMPLETED|Overall Study||0
11121370|NCT01342796|12306720|FG000|STARTED|Overall Study||43
11121371|NCT01342796|12306721|FG001|STARTED|Overall Study||41
11121372|NCT01342796|12306720|FG000|COMPLETED|Overall Study||40
11121373|NCT01342796|12306721|FG001|COMPLETED|Overall Study||38
11121374|NCT01342796|12306720|FG000|NOT COMPLETED|Overall Study||3
11121375|NCT01342796|12306721|FG001|NOT COMPLETED|Overall Study||3
11121376|NCT01342887|12306727|FG000|STARTED|Overall Study||6
11121377|NCT01342887|12306727|FG000|COMPLETED|Overall Study||4
11121378|NCT01342887|12306727|FG000|NOT COMPLETED|Overall Study||2
11121379|NCT01342913|12306733|FG000|STARTED|2-week Run-in Period||702
11004604|NCT00718549|12182216|FG002|COMPLETED|Induction Phase||0
11004605|NCT00718549|12182214|FG000|NOT COMPLETED|Induction Phase||62
11004606|NCT00718549|12182215|FG001|NOT COMPLETED|Induction Phase||0
11004607|NCT00718549|12182216|FG002|NOT COMPLETED|Induction Phase||0
11004608|NCT00718549|12182214|FG000|STARTED|Maintenance/ Observation Phase||0
11121380|NCT01342913|12306734|FG001|STARTED|2-week Run-in Period||0
11121381|NCT01342913|12306735|FG002|STARTED|2-week Run-in Period||0
11121382|NCT01342913|12306733|FG000|COMPLETED|2-week Run-in Period||528
11121383|NCT01342913|12306734|FG001|COMPLETED|2-week Run-in Period||0
11121384|NCT01342913|12306735|FG002|COMPLETED|2-week Run-in Period||0
11121385|NCT01342913|12306733|FG000|NOT COMPLETED|2-week Run-in Period||174
11121386|NCT01342913|12306734|FG001|NOT COMPLETED|2-week Run-in Period||0
11121387|NCT01342913|12306735|FG002|NOT COMPLETED|2-week Run-in Period||0
11121388|NCT01342913|12306733|FG000|STARTED|Double-Blind Treatment Period||0
11121389|NCT01342913|12306734|FG001|STARTED|Double-Blind Treatment Period||262
11121390|NCT01342913|12306735|FG002|STARTED|Double-Blind Treatment Period||266
11121391|NCT01342913|12306733|FG000|COMPLETED|Double-Blind Treatment Period||0
11121392|NCT01342913|12306734|FG001|COMPLETED|Double-Blind Treatment Period||246
11121393|NCT01342913|12306735|FG002|COMPLETED|Double-Blind Treatment Period||243
11121394|NCT01342913|12306733|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
11121395|NCT01342913|12306734|FG001|NOT COMPLETED|Double-Blind Treatment Period||16
11121396|NCT01342913|12306735|FG002|NOT COMPLETED|Double-Blind Treatment Period||23
11121397|NCT01342926|12306745|FG000|STARTED|Overall Study||46
11121398|NCT01342926|12306746|FG001|STARTED|Overall Study||46
11121399|NCT01342926|12306747|FG002|STARTED|Overall Study||48
11121400|NCT01342926|12306748|FG003|STARTED|Overall Study||51
11121401|NCT01342926|12306745|FG000|COMPLETED|Overall Study||37
11121402|NCT01342926|12306746|FG001|COMPLETED|Overall Study||31
11121403|NCT01342926|12306747|FG002|COMPLETED|Overall Study||34
11121404|NCT01342926|12306748|FG003|COMPLETED|Overall Study||39
11121405|NCT01342926|12306745|FG000|NOT COMPLETED|Overall Study||9
11121406|NCT01342926|12306746|FG001|NOT COMPLETED|Overall Study||15
11121407|NCT01342926|12306747|FG002|NOT COMPLETED|Overall Study||14
11121408|NCT01342926|12306748|FG003|NOT COMPLETED|Overall Study||12
11121409|NCT01342965|12306760|FG000|STARTED|Overall Study||110
11121410|NCT01342965|12306761|FG001|STARTED|Overall Study||107
11121411|NCT01342965|12306760|FG000|Received Treatment|Overall Study||110
11121412|NCT01342965|12306761|FG001|Received Treatment|Overall Study||104
11121413|NCT01342965|12306760|FG000|COMPLETED|Overall Study||1
11121414|NCT01342965|12306761|FG001|COMPLETED|Overall Study||0
11121415|NCT01342965|12306760|FG000|NOT COMPLETED|Overall Study||109
11121416|NCT01342965|12306761|FG001|NOT COMPLETED|Overall Study||107
11121417|NCT01343004|12306770|FG000|STARTED|Overall Study||821
11121418|NCT01343004|12306771|FG001|STARTED|Overall Study||824
11121419|NCT01343004|12306772|FG002|STARTED|Overall Study||818
11121420|NCT01343004|12306770|FG000|COMPLETED|Overall Study||637
11121421|NCT01343004|12306771|FG001|COMPLETED|Overall Study||606
11121422|NCT01343004|12306772|FG002|COMPLETED|Overall Study||658
11121423|NCT01343004|12306770|FG000|NOT COMPLETED|Overall Study||184
11121424|NCT01343004|12306771|FG001|NOT COMPLETED|Overall Study||218
11121425|NCT01343004|12306772|FG002|NOT COMPLETED|Overall Study||160
11121426|NCT01343043|12306784|FG000|STARTED|Overall Study||15
11121427|NCT01343043|12306785|FG001|STARTED|Overall Study||14
11121428|NCT01343043|12306786|FG002|STARTED|Overall Study||5
11121429|NCT01343043|12306787|FG003|STARTED|Overall Study||16
11121430|NCT01343043|12306784|FG000|Received T-cell Infusion|Overall Study||12
11121431|NCT01343043|12306785|FG001|Received T-cell Infusion|Overall Study||13
11121432|NCT01343043|12306786|FG002|Received T-cell Infusion|Overall Study||5
11121433|NCT01343043|12306787|FG003|Received T-cell Infusion|Overall Study||15
11121434|NCT01343043|12306784|FG000|COMPLETED|Overall Study||12
11121435|NCT01343043|12306785|FG001|COMPLETED|Overall Study||13
11121436|NCT01343043|12306786|FG002|COMPLETED|Overall Study||5
11121437|NCT01343043|12306787|FG003|COMPLETED|Overall Study||15
11121438|NCT01343043|12306784|FG000|NOT COMPLETED|Overall Study||3
11121439|NCT01343043|12306785|FG001|NOT COMPLETED|Overall Study||1
11121440|NCT01343043|12306786|FG002|NOT COMPLETED|Overall Study||0
11121441|NCT01343043|12306787|FG003|NOT COMPLETED|Overall Study||1
11121442|NCT01343056|12306804|FG000|STARTED|Overall Study||35
11121443|NCT01343056|12306805|FG001|STARTED|Overall Study||36
11121444|NCT01343056|12306806|FG002|STARTED|Overall Study||32
11121445|NCT01343056|12306807|FG003|STARTED|Overall Study||38
11121446|NCT01343056|12306804|FG000|COMPLETED|Overall Study||28
11121447|NCT01343056|12306805|FG001|COMPLETED|Overall Study||31
11121448|NCT01343056|12306806|FG002|COMPLETED|Overall Study||29
11121449|NCT01343056|12306807|FG003|COMPLETED|Overall Study||29
11121450|NCT01343056|12306804|FG000|NOT COMPLETED|Overall Study||7
11121451|NCT01343056|12306805|FG001|NOT COMPLETED|Overall Study||5
11121452|NCT01343056|12306806|FG002|NOT COMPLETED|Overall Study||3
11121453|NCT01343056|12306807|FG003|NOT COMPLETED|Overall Study||9
11121454|NCT01343082|12306821|FG000|STARTED|The run-in Period||51
11121455|NCT01343082|12306822|FG001|STARTED|The run-in Period||49
11121456|NCT01343082|12306823|FG002|STARTED|The run-in Period||48
11121457|NCT01343082|12306821|FG000|COMPLETED|The run-in Period||48
11121458|NCT01343082|12306822|FG001|COMPLETED|The run-in Period||45
11121459|NCT01343082|12306823|FG002|COMPLETED|The run-in Period||43
11121460|NCT01343082|12306821|FG000|NOT COMPLETED|The run-in Period||3
11121461|NCT01343082|12306822|FG001|NOT COMPLETED|The run-in Period||4
11121462|NCT01343082|12306823|FG002|NOT COMPLETED|The run-in Period||5
11121463|NCT01343082|12306821|FG000|STARTED|Treatment Period , Switched to DE-111||48
11121464|NCT01343082|12306822|FG001|STARTED|Treatment Period , Switched to DE-111||45
11121465|NCT01343082|12306823|FG002|STARTED|Treatment Period , Switched to DE-111||43
11121466|NCT01343082|12306821|FG000|COMPLETED|Treatment Period , Switched to DE-111||43
11121467|NCT01343082|12306822|FG001|COMPLETED|Treatment Period , Switched to DE-111||36
11121468|NCT01343082|12306823|FG002|COMPLETED|Treatment Period , Switched to DE-111||31
11121469|NCT01343082|12306821|FG000|NOT COMPLETED|Treatment Period , Switched to DE-111||5
11121470|NCT01343082|12306822|FG001|NOT COMPLETED|Treatment Period , Switched to DE-111||9
11121471|NCT01343082|12306823|FG002|NOT COMPLETED|Treatment Period , Switched to DE-111||12
11121472|NCT01343095|12306830|FG000|STARTED|Overall Study||2
11121473|NCT01343095|12306831|FG001|STARTED|Overall Study||3
11121474|NCT01343095|12306832|FG002|STARTED|Overall Study||3
11121475|NCT01343095|12306830|FG000|COMPLETED|Overall Study||2
11121476|NCT01343095|12306831|FG001|COMPLETED|Overall Study||3
11121477|NCT01343095|12306832|FG002|COMPLETED|Overall Study||3
11121478|NCT01343095|12306830|FG000|NOT COMPLETED|Overall Study||0
11121479|NCT01343095|12306831|FG001|NOT COMPLETED|Overall Study||0
11121480|NCT01343095|12306832|FG002|NOT COMPLETED|Overall Study||0
11121481|NCT01343160|12306842|FG000|STARTED|Overall Study||36
11121482|NCT01343160|12306842|FG000|COMPLETED|Overall Study||31
11121483|NCT01343160|12306842|FG000|NOT COMPLETED|Overall Study||5
11121484|NCT01343251|12306849|FG000|STARTED|Overall Study||16
11121485|NCT01343251|12306850|FG001|STARTED|Overall Study||17
11121486|NCT01343251|12306849|FG000|COMPLETED|Overall Study||16
11121487|NCT01343251|12306850|FG001|COMPLETED|Overall Study||17
11121488|NCT01343251|12306849|FG000|NOT COMPLETED|Overall Study||0
11121489|NCT01343251|12306850|FG001|NOT COMPLETED|Overall Study||0
11121490|NCT01343277|12306861|FG000|STARTED|Overall Study||384
11121491|NCT01343277|12306862|FG001|STARTED|Overall Study||193
11121492|NCT01343277|12306861|FG000|Treated|Overall Study||378
11121493|NCT01343277|12306862|FG001|Treated|Overall Study||172
11121494|NCT01343277|12306861|FG000|COMPLETED|Overall Study||0
11121495|NCT01343277|12306862|FG001|COMPLETED|Overall Study||0
11238634|NCT02074709|12430385|FG001|NOT COMPLETED|Overall Study||1
11238635|NCT02074735|12430393|FG000|STARTED|Overall Study||29
11121496|NCT01343277|12306861|FG000|NOT COMPLETED|Overall Study||384
11121497|NCT01343277|12306862|FG001|NOT COMPLETED|Overall Study||193
11121498|NCT01343368|12306870|FG000|STARTED|Overall Study||9
11121499|NCT01343368|12306871|FG001|STARTED|Overall Study||10
11121500|NCT01343368|12306870|FG000|COMPLETED|Overall Study||7
11121501|NCT01343368|12306871|FG001|COMPLETED|Overall Study||10
11121502|NCT01343368|12306870|FG000|NOT COMPLETED|Overall Study||2
11121503|NCT01343368|12306871|FG001|NOT COMPLETED|Overall Study||0
11121504|NCT01343407|12306877|FG000|STARTED|First Treatment Period (Part 2)||2
11121505|NCT01343407|12306878|FG001|STARTED|First Treatment Period (Part 2)||2
11121506|NCT01343407|12306879|FG002|STARTED|First Treatment Period (Part 2)||3
11121507|NCT01343407|12306880|FG003|STARTED|First Treatment Period (Part 2)||3
11121508|NCT01343407|12306881|FG004|STARTED|First Treatment Period (Part 2)||3
11121509|NCT01343407|12306882|FG005|STARTED|First Treatment Period (Part 2)||3
11121510|NCT01343407|12306877|FG000|COMPLETED|First Treatment Period (Part 2)||2
11121511|NCT01343407|12306878|FG001|COMPLETED|First Treatment Period (Part 2)||2
11121512|NCT01343407|12306879|FG002|COMPLETED|First Treatment Period (Part 2)||3
11121513|NCT01343407|12306880|FG003|COMPLETED|First Treatment Period (Part 2)||3
11121514|NCT01343407|12306881|FG004|COMPLETED|First Treatment Period (Part 2)||3
11121515|NCT01343407|12306882|FG005|COMPLETED|First Treatment Period (Part 2)||3
11121516|NCT01343407|12306877|FG000|NOT COMPLETED|First Treatment Period (Part 2)||0
11121517|NCT01343407|12306878|FG001|NOT COMPLETED|First Treatment Period (Part 2)||0
11121518|NCT01343407|12306879|FG002|NOT COMPLETED|First Treatment Period (Part 2)||0
11121519|NCT01343407|12306880|FG003|NOT COMPLETED|First Treatment Period (Part 2)||0
11121520|NCT01343407|12306881|FG004|NOT COMPLETED|First Treatment Period (Part 2)||0
11121521|NCT01343407|12306882|FG005|NOT COMPLETED|First Treatment Period (Part 2)||0
11121522|NCT01343407|12306877|FG000|STARTED|First Washout (Part 2)||2
11121523|NCT01343407|12306878|FG001|STARTED|First Washout (Part 2)||2
11121524|NCT01343407|12306879|FG002|STARTED|First Washout (Part 2)||3
11121525|NCT01343407|12306880|FG003|STARTED|First Washout (Part 2)||3
11121526|NCT01343407|12306881|FG004|STARTED|First Washout (Part 2)||3
11121527|NCT01343407|12306882|FG005|STARTED|First Washout (Part 2)||3
11121528|NCT01343407|12306877|FG000|COMPLETED|First Washout (Part 2)||2
11121529|NCT01343407|12306878|FG001|COMPLETED|First Washout (Part 2)||2
11121530|NCT01343407|12306879|FG002|COMPLETED|First Washout (Part 2)||3
11121531|NCT01343407|12306880|FG003|COMPLETED|First Washout (Part 2)||3
11121532|NCT01343407|12306881|FG004|COMPLETED|First Washout (Part 2)||3
11121533|NCT01343407|12306882|FG005|COMPLETED|First Washout (Part 2)||3
11121534|NCT01343407|12306877|FG000|NOT COMPLETED|First Washout (Part 2)||0
11121535|NCT01343407|12306878|FG001|NOT COMPLETED|First Washout (Part 2)||0
11121536|NCT01343407|12306879|FG002|NOT COMPLETED|First Washout (Part 2)||0
11121537|NCT01343407|12306880|FG003|NOT COMPLETED|First Washout (Part 2)||0
11121538|NCT01343407|12306881|FG004|NOT COMPLETED|First Washout (Part 2)||0
11121539|NCT01343407|12306882|FG005|NOT COMPLETED|First Washout (Part 2)||0
11121540|NCT01343407|12306877|FG000|STARTED|Second Treatment Period (Part 2)||2
11121541|NCT01343407|12306878|FG001|STARTED|Second Treatment Period (Part 2)||2
11121542|NCT01343407|12306879|FG002|STARTED|Second Treatment Period (Part 2)||3
11121543|NCT01343407|12306880|FG003|STARTED|Second Treatment Period (Part 2)||3
11121544|NCT01343407|12306881|FG004|STARTED|Second Treatment Period (Part 2)||3
11121545|NCT01343407|12306882|FG005|STARTED|Second Treatment Period (Part 2)||3
11121546|NCT01343407|12306877|FG000|COMPLETED|Second Treatment Period (Part 2)||2
11121547|NCT01343407|12306878|FG001|COMPLETED|Second Treatment Period (Part 2)||2
11121548|NCT01343407|12306879|FG002|COMPLETED|Second Treatment Period (Part 2)||2
11121549|NCT01343407|12306880|FG003|COMPLETED|Second Treatment Period (Part 2)||3
11121550|NCT01343407|12306881|FG004|COMPLETED|Second Treatment Period (Part 2)||3
11121551|NCT01343407|12306882|FG005|COMPLETED|Second Treatment Period (Part 2)||3
11121552|NCT01343407|12306877|FG000|NOT COMPLETED|Second Treatment Period (Part 2)||0
11121553|NCT01343407|12306878|FG001|NOT COMPLETED|Second Treatment Period (Part 2)||0
11121554|NCT01343407|12306879|FG002|NOT COMPLETED|Second Treatment Period (Part 2)||1
11121555|NCT01343407|12306880|FG003|NOT COMPLETED|Second Treatment Period (Part 2)||0
11121556|NCT01343407|12306881|FG004|NOT COMPLETED|Second Treatment Period (Part 2)||0
11121557|NCT01343407|12306882|FG005|NOT COMPLETED|Second Treatment Period (Part 2)||0
11121558|NCT01343407|12306877|FG000|STARTED|Second Washout (Part 2)||2
11121559|NCT01343407|12306878|FG001|STARTED|Second Washout (Part 2)||2
11121560|NCT01343407|12306879|FG002|STARTED|Second Washout (Part 2)||2
11121561|NCT01343407|12306880|FG003|STARTED|Second Washout (Part 2)||3
11121562|NCT01343407|12306881|FG004|STARTED|Second Washout (Part 2)||3
11121563|NCT01343407|12306882|FG005|STARTED|Second Washout (Part 2)||3
11121564|NCT01343407|12306877|FG000|COMPLETED|Second Washout (Part 2)||2
11121565|NCT01343407|12306878|FG001|COMPLETED|Second Washout (Part 2)||2
11121566|NCT01343407|12306879|FG002|COMPLETED|Second Washout (Part 2)||1
11121567|NCT01343407|12306880|FG003|COMPLETED|Second Washout (Part 2)||3
11121568|NCT01343407|12306881|FG004|COMPLETED|Second Washout (Part 2)||3
11121569|NCT01343407|12306882|FG005|COMPLETED|Second Washout (Part 2)||3
11121570|NCT01343407|12306877|FG000|NOT COMPLETED|Second Washout (Part 2)||0
11121571|NCT01343407|12306878|FG001|NOT COMPLETED|Second Washout (Part 2)||0
11121572|NCT01343407|12306879|FG002|NOT COMPLETED|Second Washout (Part 2)||1
11121573|NCT01343407|12306880|FG003|NOT COMPLETED|Second Washout (Part 2)||0
11121574|NCT01343407|12306881|FG004|NOT COMPLETED|Second Washout (Part 2)||0
11121575|NCT01343407|12306882|FG005|NOT COMPLETED|Second Washout (Part 2)||0
11121576|NCT01343407|12306877|FG000|STARTED|Third Treatment Period (Part 2)||2
11121577|NCT01343407|12306878|FG001|STARTED|Third Treatment Period (Part 2)||2
11121578|NCT01343407|12306879|FG002|STARTED|Third Treatment Period (Part 2)||1
11121579|NCT01343407|12306880|FG003|STARTED|Third Treatment Period (Part 2)||3
11121580|NCT01343407|12306881|FG004|STARTED|Third Treatment Period (Part 2)||3
11121581|NCT01343407|12306882|FG005|STARTED|Third Treatment Period (Part 2)||3
11121582|NCT01343407|12306877|FG000|COMPLETED|Third Treatment Period (Part 2)||2
11121583|NCT01343407|12306878|FG001|COMPLETED|Third Treatment Period (Part 2)||2
11121584|NCT01343407|12306879|FG002|COMPLETED|Third Treatment Period (Part 2)||1
11121585|NCT01343407|12306880|FG003|COMPLETED|Third Treatment Period (Part 2)||3
11121586|NCT01343407|12306881|FG004|COMPLETED|Third Treatment Period (Part 2)||3
11121587|NCT01343407|12306882|FG005|COMPLETED|Third Treatment Period (Part 2)||3
11121588|NCT01343407|12306877|FG000|NOT COMPLETED|Third Treatment Period (Part 2)||0
11121589|NCT01343407|12306878|FG001|NOT COMPLETED|Third Treatment Period (Part 2)||0
11121590|NCT01343407|12306879|FG002|NOT COMPLETED|Third Treatment Period (Part 2)||0
11121591|NCT01343407|12306880|FG003|NOT COMPLETED|Third Treatment Period (Part 2)||0
11121592|NCT01343407|12306881|FG004|NOT COMPLETED|Third Treatment Period (Part 2)||0
11121593|NCT01343407|12306882|FG005|NOT COMPLETED|Third Treatment Period (Part 2)||0
11121594|NCT01343485|12306892|FG000|STARTED|Overall Study||185
11121595|NCT01343485|12306893|FG001|STARTED|Overall Study||180
11121596|NCT01343485|12306892|FG000|COMPLETED|Overall Study||36
11121597|NCT01343485|12306893|FG001|COMPLETED|Overall Study||46
11121598|NCT01343485|12306892|FG000|NOT COMPLETED|Overall Study||149
11121599|NCT01343485|12306893|FG001|NOT COMPLETED|Overall Study||134
11121600|NCT01343667|12306901|FG000|STARTED|Overall Study||425
11121601|NCT01343667|12306902|FG001|STARTED|Overall Study||972
11121602|NCT01343667|12306901|FG000|COMPLETED|Overall Study||413
11121603|NCT01343667|12306902|FG001|COMPLETED|Overall Study||916
11121604|NCT01343667|12306901|FG000|NOT COMPLETED|Overall Study||12
11121605|NCT01343667|12306902|FG001|NOT COMPLETED|Overall Study||56
11121606|NCT01343693|12306908|FG000|STARTED|Overall Study||119
11121607|NCT01343693|12306908|FG000|COMPLETED|Overall Study||110
11121608|NCT01343693|12306908|FG000|NOT COMPLETED|Overall Study||9
11121609|NCT01343823|12306916|FG000|STARTED|Overall Study||20
11121610|NCT01343823|12306917|FG001|STARTED|Overall Study||20
11121611|NCT01343823|12306918|FG002|STARTED|Overall Study||19
11121612|NCT01343823|12306919|FG003|STARTED|Overall Study||20
11121613|NCT01343823|12306916|FG000|COMPLETED|Overall Study||18
11121614|NCT01343823|12306917|FG001|COMPLETED|Overall Study||20
11121615|NCT01343823|12306918|FG002|COMPLETED|Overall Study||19
11121616|NCT01343823|12306919|FG003|COMPLETED|Overall Study||19
11121617|NCT01343823|12306916|FG000|NOT COMPLETED|Overall Study||2
11121618|NCT01343823|12306917|FG001|NOT COMPLETED|Overall Study||0
11121619|NCT01343823|12306918|FG002|NOT COMPLETED|Overall Study||0
11121620|NCT01343823|12306919|FG003|NOT COMPLETED|Overall Study||1
11121621|NCT01343888|12306932|FG000|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
11121622|NCT01343888|12306933|FG001|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
11121623|NCT01343888|12306934|FG002|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
11121624|NCT01343888|12306932|FG000|COMPLETED|Overall Study||234
11121625|NCT01343888|12306933|FG001|COMPLETED|Overall Study||222
11121626|NCT01343888|12306934|FG002|COMPLETED|Overall Study||110
11121627|NCT01343888|12306932|FG000|NOT COMPLETED|Overall Study||25
11121628|NCT01343888|12306933|FG001|NOT COMPLETED|Overall Study||39
11121629|NCT01343888|12306934|FG002|NOT COMPLETED|Overall Study||22
11121630|NCT01343901|12306942|FG000|STARTED|Overall Study||210
11121631|NCT01343901|12306942|FG000|Efficacy Population|Overall Study||205
11121632|NCT01343901|12306942|FG000|COMPLETED|Overall Study||97
11121633|NCT01343901|12306942|FG000|NOT COMPLETED|Overall Study||113
11121634|NCT01344057|12306946|FG000|STARTED|Overall Study||63
11121635|NCT01344057|12306946|FG000|COMPLETED|Overall Study||62
11121636|NCT01344057|12306946|FG000|NOT COMPLETED|Overall Study||1
11121637|NCT01344161|12306952|FG000|STARTED|Overall Study||43
11121638|NCT01344161|12306953|FG001|STARTED|Overall Study||42
11121639|NCT01344161|12306952|FG000|COMPLETED|Overall Study||38
11121640|NCT01344161|12306953|FG001|COMPLETED|Overall Study||39
11121641|NCT01344161|12306952|FG000|NOT COMPLETED|Overall Study||5
11121642|NCT01344161|12306953|FG001|NOT COMPLETED|Overall Study||3
11121643|NCT01344226|12306959|FG000|STARTED|Overall Study||49
11121644|NCT01344226|12306959|FG000|COMPLETED|Overall Study||41
11121645|NCT01344226|12306959|FG000|NOT COMPLETED|Overall Study||8
11121646|NCT01344356|12306965|FG000|STARTED|Overall Study||1
11121647|NCT01344356|12306966|FG001|STARTED|Overall Study||18
11121648|NCT01344356|12306965|FG000|COMPLETED|Overall Study||1
11121649|NCT01344356|12306966|FG001|COMPLETED|Overall Study||9
11121650|NCT01344356|12306965|FG000|NOT COMPLETED|Overall Study||0
11121651|NCT01344356|12306966|FG001|NOT COMPLETED|Overall Study||9
11121652|NCT01344369|12306976|FG000|STARTED|First Intervention||18
11121653|NCT01344369|12306977|FG001|STARTED|First Intervention||18
11121654|NCT01344369|12306976|FG000|COMPLETED|First Intervention||18
11121655|NCT01344369|12306977|FG001|COMPLETED|First Intervention||18
11121656|NCT01344369|12306976|FG000|NOT COMPLETED|First Intervention||0
11121657|NCT01344369|12306977|FG001|NOT COMPLETED|First Intervention||0
11121658|NCT01344369|12306976|FG000|STARTED|Washout of 28 Days||18
11121659|NCT01344369|12306977|FG001|STARTED|Washout of 28 Days||18
11121660|NCT01344369|12306976|FG000|COMPLETED|Washout of 28 Days||17
11121661|NCT01344369|12306977|FG001|COMPLETED|Washout of 28 Days||17
11121662|NCT01344369|12306976|FG000|NOT COMPLETED|Washout of 28 Days||1
11121663|NCT01344369|12306977|FG001|NOT COMPLETED|Washout of 28 Days||1
11121664|NCT01344369|12306976|FG000|STARTED|Second Intervention||17
11121665|NCT01344369|12306977|FG001|STARTED|Second Intervention||17
11121666|NCT01344369|12306976|FG000|COMPLETED|Second Intervention||17
11121667|NCT01344369|12306977|FG001|COMPLETED|Second Intervention||16
11121668|NCT01344369|12306976|FG000|NOT COMPLETED|Second Intervention||0
11121669|NCT01344369|12306977|FG001|NOT COMPLETED|Second Intervention||1
11121670|NCT01344447|12306983|FG000|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
11121671|NCT01344447|12306983|FG000|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
11121672|NCT01344447|12306983|FG000|COMPLETED|Overall Study||471
11121673|NCT01344447|12306983|FG000|NOT COMPLETED|Overall Study||8
11121674|NCT01344460|12306991|FG000|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
11121675|NCT01344460|12306991|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
11121676|NCT01344460|12306991|FG000|COMPLETED|Overall Study||312
11121677|NCT01344460|12306991|FG000|NOT COMPLETED|Overall Study||3
11121678|NCT01344538|12307001|FG000|STARTED|Overall Study||16
11121679|NCT01344538|12307002|FG001|STARTED|Overall Study||17
11121680|NCT01344538|12307001|FG000|COMPLETED|Overall Study||14
11121681|NCT01344538|12307002|FG001|COMPLETED|Overall Study||16
11121682|NCT01344538|12307001|FG000|NOT COMPLETED|Overall Study||2
11121683|NCT01344538|12307002|FG001|NOT COMPLETED|Overall Study||1
11121684|NCT01344616|12307010|FG000|STARTED|Overall Study||244
11121685|NCT01344616|12307011|FG001|STARTED|Overall Study||238
11121686|NCT01344616|12307010|FG000|COMPLETED|Overall Study||209
11121687|NCT01344616|12307011|FG001|COMPLETED|Overall Study||194
11121688|NCT01344616|12307010|FG000|NOT COMPLETED|Overall Study||35
11121689|NCT01344616|12307011|FG001|NOT COMPLETED|Overall Study||44
11121690|NCT01344629|12307019|FG000|STARTED|Crossover Period 1||32
11121691|NCT01344629|12307020|FG001|STARTED|Crossover Period 1||32
11121692|NCT01344629|12307019|FG000|COMPLETED|Crossover Period 1||32
11121693|NCT01344629|12307020|FG001|COMPLETED|Crossover Period 1||32
11121694|NCT01344629|12307019|FG000|NOT COMPLETED|Crossover Period 1||0
11121695|NCT01344629|12307020|FG001|NOT COMPLETED|Crossover Period 1||0
11121696|NCT01344629|12307019|FG000|STARTED|Crossover Period 2||32
11121697|NCT01344629|12307020|FG001|STARTED|Crossover Period 2||32
11121698|NCT01344629|12307019|FG000|COMPLETED|Crossover Period 2||32
11121699|NCT01344629|12307020|FG001|COMPLETED|Crossover Period 2||31
11121700|NCT01344629|12307019|FG000|NOT COMPLETED|Crossover Period 2||0
11121701|NCT01344629|12307020|FG001|NOT COMPLETED|Crossover Period 2||1
11121702|NCT01344629|12307019|FG000|STARTED|Crossover Period 3||32
11121703|NCT01344629|12307020|FG001|STARTED|Crossover Period 3||31
11121704|NCT01344629|12307019|FG000|COMPLETED|Crossover Period 3||32
11121705|NCT01344629|12307020|FG001|COMPLETED|Crossover Period 3||31
11121706|NCT01344629|12307019|FG000|NOT COMPLETED|Crossover Period 3||0
11121707|NCT01344629|12307020|FG001|NOT COMPLETED|Crossover Period 3||0
11121708|NCT01344629|12307019|FG000|STARTED|Crossover Period 4||32
11121709|NCT01344629|12307020|FG001|STARTED|Crossover Period 4||31
11121710|NCT01344629|12307019|FG000|COMPLETED|Crossover Period 4||32
11121711|NCT01344629|12307020|FG001|COMPLETED|Crossover Period 4||31
11121712|NCT01344629|12307019|FG000|NOT COMPLETED|Crossover Period 4||0
11121713|NCT01344629|12307020|FG001|NOT COMPLETED|Crossover Period 4||0
11121714|NCT01344759|12307028|FG000|STARTED|Overall Study||30
11121715|NCT01344759|12307029|FG001|STARTED|Overall Study||30
11121716|NCT01344759|12307028|FG000|COMPLETED|Overall Study||30
11121717|NCT01344759|12307029|FG001|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
11121718|NCT01344759|12307028|FG000|NOT COMPLETED|Overall Study||0
11121719|NCT01344759|12307029|FG001|NOT COMPLETED|Overall Study||2
11121720|NCT01344824|12307041|FG000|STARTED|Overall Study||38
11121721|NCT01344824|12307041|FG000|COMPLETED|Overall Study||1
11121722|NCT01344824|12307041|FG000|NOT COMPLETED|Overall Study||37
11121723|NCT01344876|12307046|FG000|STARTED|Overall Study||4
11121724|NCT01344876|12307047|FG001|STARTED|Overall Study||3
11121725|NCT01344876|12307048|FG002|STARTED|Overall Study||4
11121726|NCT01344876|12307049|FG003|STARTED|Overall Study||6
11121727|NCT01344876|12307050|FG004|STARTED|Overall Study||3
11121728|NCT01344876|12307046|FG000|COMPLETED|Overall Study||3
11121729|NCT01344876|12307047|FG001|COMPLETED|Overall Study||3
11121730|NCT01344876|12307048|FG002|COMPLETED|Overall Study||3
11121731|NCT01344876|12307049|FG003|COMPLETED|Overall Study||3
11121732|NCT01344876|12307050|FG004|COMPLETED|Overall Study||2
11121733|NCT01344876|12307046|FG000|NOT COMPLETED|Overall Study||1
11121734|NCT01344876|12307047|FG001|NOT COMPLETED|Overall Study||0
11121735|NCT01344876|12307048|FG002|NOT COMPLETED|Overall Study||1
11121736|NCT01344876|12307049|FG003|NOT COMPLETED|Overall Study||3
11121737|NCT01344876|12307050|FG004|NOT COMPLETED|Overall Study||1
11121738|NCT01345019|12307065|FG000|STARTED|Blinded Treatment Phase||859
11121739|NCT01345019|12307066|FG001|STARTED|Blinded Treatment Phase||859
11121740|NCT01345019|12307065|FG000|Received Treatment|Blinded Treatment Phase||852
11121741|NCT01345019|12307066|FG001|Received Treatment|Blinded Treatment Phase||850
11121742|NCT01345019|12307065|FG000|COMPLETED|Blinded Treatment Phase||541
11121743|NCT01345019|12307066|FG001|COMPLETED|Blinded Treatment Phase||555
11121744|NCT01345019|12307065|FG000|NOT COMPLETED|Blinded Treatment Phase||318
11121745|NCT01345019|12307066|FG001|NOT COMPLETED|Blinded Treatment Phase||304
11121746|NCT01345019|12307065|FG000|STARTED|Open Label Treatment Phase||418
11121747|NCT01345019|12307066|FG001|STARTED|Open Label Treatment Phase||426
11121748|NCT01345019|12307065|FG000|COMPLETED|Open Label Treatment Phase||227
11121749|NCT01345019|12307066|FG001|COMPLETED|Open Label Treatment Phase||233
11121750|NCT01345019|12307065|FG000|NOT COMPLETED|Open Label Treatment Phase||191
11121751|NCT01345019|12307066|FG001|NOT COMPLETED|Open Label Treatment Phase||193
11121752|NCT01345058|12307076|FG000|STARTED|Overall Study||20
11121753|NCT01345058|12307077|FG001|STARTED|Overall Study||36
11238636|NCT02074735|12430394|FG001|STARTED|Overall Study||33
11238637|NCT02074735|12430393|FG000|COMPLETED|Overall Study||26
11121754|NCT01345058|12307076|FG000|Received Lacosamide|Overall Study||19
11121755|NCT01345058|12307077|FG001|Received Lacosamide|Overall Study||0
11121756|NCT01345058|12307076|FG000|COMPLETED|Overall Study||15
11121757|NCT01345058|12307077|FG001|COMPLETED|Overall Study||36
11121758|NCT01345058|12307076|FG000|NOT COMPLETED|Overall Study||5
11121759|NCT01345058|12307077|FG001|NOT COMPLETED|Overall Study||0
11121760|NCT01345123|12307086|FG000|STARTED|Overall Study||3323
11121761|NCT01345123|12307087|FG001|STARTED|Overall Study||3311
11121762|NCT01345123|12307088|FG002|STARTED|Overall Study||3291
11121763|NCT01345123|12307086|FG000|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
11121764|NCT01345123|12307087|FG001|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
11121765|NCT01345123|12307088|FG002|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
11121766|NCT01345123|12307086|FG000|NOT COMPLETED|Overall Study||79
11121767|NCT01345123|12307087|FG001|NOT COMPLETED|Overall Study||85
11121768|NCT01345123|12307088|FG002|NOT COMPLETED|Overall Study||88
11121769|NCT01345162|12307099|FG000|STARTED|Overall Study||100
11121770|NCT01345162|12307100|FG001|STARTED|Overall Study||100
11121771|NCT01345162|12307099|FG000|COMPLETED|Overall Study||98
11121772|NCT01345162|12307100|FG001|COMPLETED|Overall Study||96
11121773|NCT01345162|12307099|FG000|NOT COMPLETED|Overall Study||2
11121774|NCT01345162|12307100|FG001|NOT COMPLETED|Overall Study||4
11121775|NCT01345188|12307106|FG000|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
11121776|NCT01345188|12307106|FG000|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
11121777|NCT01345188|12307106|FG000|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
11121778|NCT01345188|12307106|FG000|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
11121779|NCT01345188|12307106|FG000|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
11121780|NCT01345188|12307106|FG000|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
11201913|NCT01836198|12392312|FG002|STARTED|Part A, Period 1||0
11201914|NCT01836198|12392310|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
11201915|NCT01836198|12392311|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
11201916|NCT01836198|12392312|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
11201917|NCT01836198|12392310|FG000|COMPLETED|Part A, Period 1||15
11201918|NCT01836198|12392311|FG001|COMPLETED|Part A, Period 1||15
11201919|NCT01836198|12392312|FG002|COMPLETED|Part A, Period 1||0
11121781|NCT01345253|12307115|FG000|STARTED|Double-blind (DB) Phase (52 Weeks)||226
11121782|NCT01345253|12307116|FG001|STARTED|Double-blind (DB) Phase (52 Weeks)||451
11121783|NCT01345253|12307115|FG000|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170
11121784|NCT01345253|12307116|FG001|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372
11121785|NCT01345253|12307115|FG000|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56
11121786|NCT01345253|12307116|FG001|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79
11121787|NCT01345253|12307115|FG000|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134
11121788|NCT01345253|12307116|FG001|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290
11121789|NCT01345253|12307115|FG000|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69
11121790|NCT01345253|12307116|FG001|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146
11121791|NCT01345253|12307115|FG000|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65
11121792|NCT01345253|12307116|FG001|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144
11121793|NCT01345292|12307127|FG000|STARTED|Overall Study||75
11121794|NCT01345292|12307128|FG001|STARTED|Overall Study||76
11121795|NCT01345292|12307129|FG002|STARTED|Overall Study||75
11121796|NCT01345292|12307127|FG000|COMPLETED|Overall Study||73
11121797|NCT01345292|12307128|FG001|COMPLETED|Overall Study||76
11121798|NCT01345292|12307129|FG002|COMPLETED|Overall Study||74
11121799|NCT01345292|12307127|FG000|NOT COMPLETED|Overall Study||2
11121800|NCT01345292|12307128|FG001|NOT COMPLETED|Overall Study||0
11121801|NCT01345292|12307129|FG002|NOT COMPLETED|Overall Study||1
11121802|NCT01345318|12307137|FG000|STARTED|Overall Study||191
11121803|NCT01345318|12307137|FG000|COMPLETED|Overall Study||111
11121804|NCT01345318|12307137|FG000|NOT COMPLETED|Overall Study||80
11121805|NCT01345513|12307142|FG000|STARTED|Overall Study||50
11121806|NCT01345513|12307142|FG000|COMPLETED|Overall Study||50
11121807|NCT01345513|12307142|FG000|NOT COMPLETED|Overall Study||0
11121808|NCT01345591|12307146|FG000|STARTED|Overall Study||20
11121809|NCT01345591|12307146|FG000|COMPLETED|Overall Study||19
11121810|NCT01345591|12307146|FG000|NOT COMPLETED|Overall Study||1
11121811|NCT01345630|12307157|FG000|STARTED|Overall Study||396
11238638|NCT02074735|12430394|FG001|COMPLETED|Overall Study||29
11238639|NCT02074735|12430393|FG000|NOT COMPLETED|Overall Study||3
11238640|NCT02074735|12430394|FG001|NOT COMPLETED|Overall Study||4
11238641|NCT02074982|12430402|FG000|STARTED|Overall Study||337
11238642|NCT02074982|12430403|FG001|STARTED|Overall Study||339
11238643|NCT02074982|12430402|FG000|Full Analysis Set (FAS)|Overall Study||336
11238644|NCT02074982|12430403|FG001|Full Analysis Set (FAS)|Overall Study||339
11238645|NCT02074982|12430402|FG000|Safety Set (SF)|Overall Study||335
11238646|NCT02074982|12430403|FG001|Safety Set (SF)|Overall Study||336
11238647|NCT02074982|12430402|FG000|COMPLETED|Overall Study||286
11238648|NCT02074982|12430403|FG001|COMPLETED|Overall Study||285
11238649|NCT02074982|12430402|FG000|NOT COMPLETED|Overall Study||51
11121812|NCT01345630|12307158|FG001|STARTED|Overall Study||401
11121813|NCT01345630|12307157|FG000|COMPLETED|Overall Study||35
11121814|NCT01345630|12307158|FG001|COMPLETED|Overall Study||42
11121815|NCT01345630|12307157|FG000|NOT COMPLETED|Overall Study||361
11121816|NCT01345630|12307158|FG001|NOT COMPLETED|Overall Study||359
11121817|NCT01345669|12307170|FG000|STARTED|Overall Study||411
11121818|NCT01345669|12307171|FG001|STARTED|Overall Study||206
11121819|NCT01345669|12307170|FG000|COMPLETED|Overall Study||124
11121820|NCT01345669|12307171|FG001|COMPLETED|Overall Study||87
11121821|NCT01345669|12307170|FG000|NOT COMPLETED|Overall Study||287
11121822|NCT01345669|12307171|FG001|NOT COMPLETED|Overall Study||119
11238650|NCT02074982|12430403|FG001|NOT COMPLETED|Overall Study||54
11238651|NCT02074995|12430409|FG000|STARTED|Overall Study||1
11238652|NCT02074995|12430410|FG001|STARTED|Overall Study||0
11238653|NCT02074995|12430411|FG002|STARTED|Overall Study||0
11238654|NCT02074995|12430409|FG000|COMPLETED|Overall Study||1
11238655|NCT02074995|12430410|FG001|COMPLETED|Overall Study||0
11238656|NCT02074995|12430411|FG002|COMPLETED|Overall Study||0
11238657|NCT02074995|12430409|FG000|NOT COMPLETED|Overall Study||0
11238658|NCT02074995|12430410|FG001|NOT COMPLETED|Overall Study||0
11238659|NCT02074995|12430411|FG002|NOT COMPLETED|Overall Study||0
11238660|NCT02075008|12430415|FG000|STARTED|Overall Study||270
11238661|NCT02075008|12430415|FG000|COMPLETED|Overall Study||94
11238662|NCT02075008|12430415|FG000|NOT COMPLETED|Overall Study||176
11238663|NCT02075047|12430421|FG000|STARTED|Treatment Phase (4 Weeks)||86
11121823|NCT01345682|12307179|FG000|STARTED|Overall Study|Randomised|322
11238664|NCT02075047|12430422|FG001|STARTED|Treatment Phase (4 Weeks)||85
11238665|NCT02075047|12430421|FG000|COMPLETED|Treatment Phase (4 Weeks)||63
11238666|NCT02075047|12430422|FG001|COMPLETED|Treatment Phase (4 Weeks)||75
11238667|NCT02075047|12430421|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||23
11238668|NCT02075047|12430422|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||10
11238669|NCT02075047|12430421|FG000|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|86
11121824|NCT01345682|12307180|FG001|STARTED|Overall Study|Randomised|161
11121825|NCT01345682|12307179|FG000|COMPLETED|Overall Study||0
11121826|NCT01345682|12307180|FG001|COMPLETED|Overall Study||0
11121827|NCT01345682|12307179|FG000|NOT COMPLETED|Overall Study||322
11121828|NCT01345682|12307180|FG001|NOT COMPLETED|Overall Study||161
11121829|NCT01345721|12307189|FG000|STARTED|Overall Study||74
11121830|NCT01345721|12307190|FG001|STARTED|Overall Study||66
11121831|NCT01345721|12307191|FG002|STARTED|Overall Study||65
11004609|NCT00718549|12182215|FG001|STARTED|Maintenance/ Observation Phase||33
11004610|NCT00718549|12182216|FG002|STARTED|Maintenance/ Observation Phase||33
11121832|NCT01345721|12307189|FG000|COMPLETED|Overall Study||74
11121833|NCT01345721|12307190|FG001|COMPLETED|Overall Study||66
11121834|NCT01345721|12307191|FG002|COMPLETED|Overall Study||65
11121835|NCT01345721|12307189|FG000|NOT COMPLETED|Overall Study||0
11121836|NCT01345721|12307190|FG001|NOT COMPLETED|Overall Study||0
11121837|NCT01345721|12307191|FG002|NOT COMPLETED|Overall Study||0
11121838|NCT01345929|12307205|FG000|STARTED|Overall Study||533
11121839|NCT01345929|12307206|FG001|STARTED|Overall Study||535
11121840|NCT01345929|12307205|FG000|COMPLETED|Overall Study||512
11121841|NCT01345929|12307206|FG001|COMPLETED|Overall Study||516
11121842|NCT01345929|12307205|FG000|NOT COMPLETED|Overall Study||21
11121843|NCT01345929|12307206|FG001|NOT COMPLETED|Overall Study||19
11121844|NCT01346059|12307214|FG000|STARTED|Overall Study||1
11121845|NCT01346059|12307215|FG001|STARTED|Overall Study||1
11121846|NCT01346059|12307214|FG000|COMPLETED|Overall Study||0
11121847|NCT01346059|12307215|FG001|COMPLETED|Overall Study||1
11121848|NCT01346059|12307214|FG000|NOT COMPLETED|Overall Study||1
11121849|NCT01346059|12307215|FG001|NOT COMPLETED|Overall Study||0
11121850|NCT01346072|12307223|FG000|STARTED|Overall Study||11
11121851|NCT01346072|12307224|FG001|STARTED|Overall Study||10
11121852|NCT01346072|12307223|FG000|COMPLETED|Overall Study||11
11121853|NCT01346072|12307224|FG001|COMPLETED|Overall Study||10
11121854|NCT01346072|12307223|FG000|NOT COMPLETED|Overall Study||0
11121855|NCT01346072|12307224|FG001|NOT COMPLETED|Overall Study||0
11121856|NCT01346085|12307230|FG000|STARTED|Overall Study||10
11121857|NCT01346085|12307230|FG000|COMPLETED|Overall Study||10
11121858|NCT01346085|12307230|FG000|NOT COMPLETED|Overall Study||0
11121859|NCT01346176|12307237|FG000|STARTED|Recruited||49
11121860|NCT01346176|12307238|FG001|STARTED|Recruited||40
11121861|NCT01346176|12307239|FG002|STARTED|Recruited||43
11121862|NCT01346176|12307237|FG000|COMPLETED|Recruited||48
11121863|NCT01346176|12307238|FG001|COMPLETED|Recruited||40
11121864|NCT01346176|12307239|FG002|COMPLETED|Recruited||43
11121865|NCT01346176|12307237|FG000|NOT COMPLETED|Recruited||1
11121866|NCT01346176|12307238|FG001|NOT COMPLETED|Recruited||0
11121867|NCT01346176|12307239|FG002|NOT COMPLETED|Recruited||0
11121868|NCT01346176|12307237|FG000|STARTED|Completed Advance Directive||48
11121869|NCT01346176|12307238|FG001|STARTED|Completed Advance Directive||40
11121870|NCT01346176|12307239|FG002|STARTED|Completed Advance Directive||43
11121871|NCT01346176|12307237|FG000|COMPLETED|Completed Advance Directive||35
11121872|NCT01346176|12307238|FG001|COMPLETED|Completed Advance Directive||26
11121873|NCT01346176|12307239|FG002|COMPLETED|Completed Advance Directive||33
11004611|NCT00718549|12182214|FG000|COMPLETED|Maintenance/ Observation Phase||0
11004612|NCT00718549|12182215|FG001|COMPLETED|Maintenance/ Observation Phase||5
11004613|NCT00718549|12182216|FG002|COMPLETED|Maintenance/ Observation Phase||3
11004614|NCT00718549|12182214|FG000|NOT COMPLETED|Maintenance/ Observation Phase||0
11004615|NCT00718549|12182215|FG001|NOT COMPLETED|Maintenance/ Observation Phase||28
11343930|NCT02957305|12541225|FG001|COMPLETED|Overall Study||105
11121874|NCT01346176|12307237|FG000|NOT COMPLETED|Completed Advance Directive||13
11121875|NCT01346176|12307238|FG001|NOT COMPLETED|Completed Advance Directive||14
11121876|NCT01346176|12307239|FG002|NOT COMPLETED|Completed Advance Directive||10
11121877|NCT01346176|12307237|FG000|STARTED|Completed Satisfaction Survey||35
11121878|NCT01346176|12307238|FG001|STARTED|Completed Satisfaction Survey||26
11121879|NCT01346176|12307239|FG002|STARTED|Completed Satisfaction Survey||33
11121880|NCT01346176|12307237|FG000|COMPLETED|Completed Satisfaction Survey||29
11121881|NCT01346176|12307238|FG001|COMPLETED|Completed Satisfaction Survey||22
11121882|NCT01346176|12307239|FG002|COMPLETED|Completed Satisfaction Survey||27
11121883|NCT01346176|12307237|FG000|NOT COMPLETED|Completed Satisfaction Survey||6
11121884|NCT01346176|12307238|FG001|NOT COMPLETED|Completed Satisfaction Survey||4
11121885|NCT01346176|12307239|FG002|NOT COMPLETED|Completed Satisfaction Survey||6
11121886|NCT01346189|12307251|FG000|STARTED|Overall Study||433
11121887|NCT01346189|12307252|FG001|STARTED|Overall Study||358
11121888|NCT01346189|12307253|FG002|STARTED|Overall Study||346
11121889|NCT01346189|12307254|FG003|STARTED|Overall Study||366
11121890|NCT01346189|12307251|FG000|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
11121891|NCT01346189|12307252|FG001|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
11121892|NCT01346189|12307253|FG002|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
11121893|NCT01346189|12307254|FG003|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
11121894|NCT01346189|12307251|FG000|NOT COMPLETED|Overall Study||16
11121895|NCT01346189|12307252|FG001|NOT COMPLETED|Overall Study||17
11121896|NCT01346189|12307253|FG002|NOT COMPLETED|Overall Study||14
11121897|NCT01346189|12307254|FG003|NOT COMPLETED|Overall Study||11
11121898|NCT01346267|12307266|FG000|STARTED|Overall Study||93
11121899|NCT01346267|12307267|FG001|STARTED|Overall Study||94
11121900|NCT01346267|12307266|FG000|COMPLETED|Overall Study||70
11121901|NCT01346267|12307267|FG001|COMPLETED|Overall Study||67
11121902|NCT01346267|12307266|FG000|NOT COMPLETED|Overall Study||23
11121903|NCT01346267|12307267|FG001|NOT COMPLETED|Overall Study||27
11121904|NCT01346293|12307275|FG000|STARTED|Overall Study||2743
11121905|NCT01346293|12307276|FG001|STARTED|Overall Study||629
11121906|NCT01346293|12307275|FG000|COMPLETED|Overall Study||2676
11121907|NCT01346293|12307276|FG001|COMPLETED|Overall Study||608
11121908|NCT01346293|12307275|FG000|NOT COMPLETED|Overall Study||67
11121909|NCT01346293|12307276|FG001|NOT COMPLETED|Overall Study||21
11121910|NCT01346371|12307286|FG000|STARTED|Overall Study||20
11121911|NCT01346371|12307287|FG001|STARTED|Overall Study||20
11121912|NCT01346371|12307286|FG000|COMPLETED|Overall Study||18
11121913|NCT01346371|12307287|FG001|COMPLETED|Overall Study||20
11121914|NCT01346371|12307286|FG000|NOT COMPLETED|Overall Study||2
11121915|NCT01346371|12307287|FG001|NOT COMPLETED|Overall Study||0
11121916|NCT01346397|12307295|FG000|STARTED|Overall Study||85
11121917|NCT01346397|12307296|FG001|STARTED|Overall Study||85
11121918|NCT01346397|12307295|FG000|COMPLETED|Overall Study||85
11121919|NCT01346397|12307296|FG001|COMPLETED|Overall Study||85
11121920|NCT01346397|12307295|FG000|NOT COMPLETED|Overall Study||0
11121921|NCT01346397|12307296|FG001|NOT COMPLETED|Overall Study||0
11121922|NCT01346410|12307302|FG000|STARTED|Overall Study||1
11121923|NCT01346410|12307302|FG000|COMPLETED|Overall Study||0
11121924|NCT01346410|12307302|FG000|NOT COMPLETED|Overall Study||1
11121925|NCT01346475|12307308|FG000|STARTED|First Intervention||22
11121926|NCT01346475|12307309|FG001|STARTED|First Intervention||28
11121927|NCT01346475|12307308|FG000|COMPLETED|First Intervention||18
11121928|NCT01346475|12307309|FG001|COMPLETED|First Intervention||25
11121929|NCT01346475|12307308|FG000|NOT COMPLETED|First Intervention||4
11121930|NCT01346475|12307309|FG001|NOT COMPLETED|First Intervention||3
11121931|NCT01346475|12307308|FG000|STARTED|Second Intervention||18
11121932|NCT01346475|12307309|FG001|STARTED|Second Intervention||25
11121933|NCT01346475|12307308|FG000|COMPLETED|Second Intervention||18
11121934|NCT01346475|12307309|FG001|COMPLETED|Second Intervention||25
11121935|NCT01346475|12307308|FG000|NOT COMPLETED|Second Intervention||0
11121936|NCT01346475|12307309|FG001|NOT COMPLETED|Second Intervention||0
11121937|NCT01346488|12307315|FG000|STARTED|Overall Study||1968
11121938|NCT01346488|12307315|FG000|COMPLETED|Overall Study||1262
11121939|NCT01346488|12307315|FG000|NOT COMPLETED|Overall Study||706
11121940|NCT01346501|12307321|FG000|STARTED|Overall Study||79
11121941|NCT01346501|12307322|FG001|STARTED|Overall Study||93
11121942|NCT01346501|12307321|FG000|COMPLETED|Overall Study||68
11121943|NCT01346501|12307322|FG001|COMPLETED|Overall Study||80
11121944|NCT01346501|12307321|FG000|NOT COMPLETED|Overall Study||11
11121945|NCT01346501|12307322|FG001|NOT COMPLETED|Overall Study||13
11121946|NCT01346514|12307332|FG000|STARTED|Overall Study||91
11121947|NCT01346514|12307333|FG001|STARTED|Overall Study||90
11121948|NCT01346514|12307332|FG000|3 Month Assessment|Overall Study||83
11121949|NCT01346514|12307333|FG001|3 Month Assessment|Overall Study||68
11121950|NCT01346514|12307332|FG000|6 Month Assessment|Overall Study||74
11121951|NCT01346514|12307333|FG001|6 Month Assessment|Overall Study||61
11121952|NCT01346514|12307332|FG000|9 Month Assessment|Overall Study||67
11121953|NCT01346514|12307333|FG001|9 Month Assessment|Overall Study||59
11121954|NCT01346514|12307332|FG000|12 Month Assessment|Overall Study||62
11121955|NCT01346514|12307333|FG001|12 Month Assessment|Overall Study||53
11121956|NCT01346514|12307332|FG000|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
11121957|NCT01346514|12307333|FG001|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
11121958|NCT01346514|12307332|FG000|NOT COMPLETED|Overall Study||29
11121959|NCT01346514|12307333|FG001|NOT COMPLETED|Overall Study||37
11121960|NCT01346540|12307343|FG000|STARTED|Overall Study||4
11121961|NCT01346540|12307344|FG001|STARTED|Overall Study||12
11121962|NCT01346540|12307343|FG000|COMPLETED|Overall Study||1
11121963|NCT01346540|12307344|FG001|COMPLETED|Overall Study||0
11121964|NCT01346540|12307343|FG000|NOT COMPLETED|Overall Study||3
11121965|NCT01346540|12307344|FG001|NOT COMPLETED|Overall Study||12
11121966|NCT01346592|12307354|FG000|STARTED|Overall Study||3136
11121967|NCT01346592|12307355|FG001|STARTED|Overall Study||1478
11121968|NCT01346592|12307356|FG002|STARTED|Overall Study||1486
11121969|NCT01346592|12307354|FG000|COMPLETED|Overall Study||2983
11121970|NCT01346592|12307355|FG001|COMPLETED|Overall Study||1389
11121971|NCT01346592|12307356|FG002|COMPLETED|Overall Study||1408
11121972|NCT01346592|12307354|FG000|NOT COMPLETED|Overall Study||153
11121973|NCT01346592|12307355|FG001|NOT COMPLETED|Overall Study||89
11121974|NCT01346592|12307356|FG002|NOT COMPLETED|Overall Study||78
11121975|NCT01346683|12307381|FG000|STARTED|Overall Study||45
11121976|NCT01346683|12307381|FG000|COMPLETED|Overall Study||45
11121977|NCT01346683|12307381|FG000|NOT COMPLETED|Overall Study||0
11121978|NCT01346696|12307385|FG000|STARTED|Overall Study||45
11121979|NCT01346696|12307385|FG000|COMPLETED|Overall Study||44
11121980|NCT01346696|12307385|FG000|NOT COMPLETED|Overall Study||1
11121981|NCT01346774|12307391|FG000|STARTED|Overall Study||80
11121982|NCT01346774|12307392|FG001|STARTED|Overall Study||80
11121983|NCT01346774|12307391|FG000|COMPLETED|Overall Study||67
11121984|NCT01346774|12307392|FG001|COMPLETED|Overall Study||63
11121985|NCT01346774|12307391|FG000|NOT COMPLETED|Overall Study||13
11121986|NCT01346774|12307392|FG001|NOT COMPLETED|Overall Study||17
11121987|NCT01346839|12307400|FG000|STARTED|Overall Study||683
11121988|NCT01346839|12307401|FG001|STARTED|Overall Study||573
11121989|NCT01346839|12307400|FG000|COMPLETED|Overall Study||369
11121990|NCT01346839|12307401|FG001|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
11121991|NCT01346839|12307400|FG000|NOT COMPLETED|Overall Study||314
11121992|NCT01346839|12307401|FG001|NOT COMPLETED|Overall Study||209
11121993|NCT01346852|12307409|FG000|STARTED|Overall Study||41753
11121994|NCT01346852|12307410|FG001|STARTED|Overall Study||59684
11121995|NCT01346852|12307409|FG000|COMPLETED|Overall Study||41753
11121996|NCT01346852|12307410|FG001|COMPLETED|Overall Study||59684
11121997|NCT01346852|12307409|FG000|NOT COMPLETED|Overall Study||0
11121998|NCT01346852|12307410|FG001|NOT COMPLETED|Overall Study||0
11121999|NCT01346969|12307420|FG000|STARTED|Overall Study||28
11122000|NCT01346969|12307421|FG001|STARTED|Overall Study||14
11122001|NCT01346969|12307422|FG002|STARTED|Overall Study||13
11122002|NCT01346969|12307423|FG003|STARTED|Overall Study||13
11122003|NCT01346969|12307420|FG000|Safety Population|Overall Study||27
11122004|NCT01346969|12307421|FG001|Safety Population|Overall Study||14
11122005|NCT01346969|12307422|FG002|Safety Population|Overall Study||13
11122006|NCT01346969|12307423|FG003|Safety Population|Overall Study||13
11122007|NCT01346969|12307420|FG000|COMPLETED|Overall Study||26
11122008|NCT01346969|12307421|FG001|COMPLETED|Overall Study||14
11122009|NCT01346969|12307422|FG002|COMPLETED|Overall Study||10
11122010|NCT01346969|12307423|FG003|COMPLETED|Overall Study||12
11122011|NCT01346969|12307420|FG000|NOT COMPLETED|Overall Study||2
11122012|NCT01346969|12307421|FG001|NOT COMPLETED|Overall Study||0
11122013|NCT01346969|12307422|FG002|NOT COMPLETED|Overall Study||3
11122014|NCT01346969|12307423|FG003|NOT COMPLETED|Overall Study||1
11122015|NCT01347008|12307435|FG000|STARTED|Overall Study||21
11122016|NCT01347008|12307436|FG001|STARTED|Overall Study||20
11122017|NCT01347008|12307435|FG000|COMPLETED|Overall Study||21
11338912|NCT02906813|12536280|FG001|STARTED|Washout Period 2 (at Least 3 Days)||3
11122018|NCT01347008|12307436|FG001|COMPLETED|Overall Study||20
11122019|NCT01347008|12307435|FG000|NOT COMPLETED|Overall Study||0
11122020|NCT01347008|12307436|FG001|NOT COMPLETED|Overall Study||0
11122021|NCT01347034|12307444|FG000|STARTED|Overall Study||6
11122022|NCT01347034|12307445|FG001|STARTED|Overall Study||14
11122023|NCT01347034|12307444|FG000|COMPLETED|Overall Study||6
11122024|NCT01347034|12307445|FG001|COMPLETED|Overall Study||14
11122025|NCT01347034|12307444|FG000|NOT COMPLETED|Overall Study||0
11122026|NCT01347034|12307445|FG001|NOT COMPLETED|Overall Study||0
11122027|NCT01347060|12307453|FG000|STARTED|Overall Study||9868
11122028|NCT01347060|12307454|FG001|STARTED|Overall Study||7580
11122029|NCT01347060|12307453|FG000|COMPLETED|Overall Study||9868
11122030|NCT01347060|12307454|FG001|COMPLETED|Overall Study||7580
11122031|NCT01347060|12307453|FG000|NOT COMPLETED|Overall Study||0
11122032|NCT01347060|12307454|FG001|NOT COMPLETED|Overall Study||0
11122033|NCT01347073|12307460|FG000|STARTED|Overall Study||23
11122034|NCT01347073|12307460|FG000|COMPLETED|Overall Study||21
11122035|NCT01347073|12307460|FG000|NOT COMPLETED|Overall Study||2
11122036|NCT01347086|12307480|FG000|STARTED|Overall Study||2
11122037|NCT01347086|12307481|FG001|STARTED|Overall Study||6
11122038|NCT01347086|12307482|FG002|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
11122039|NCT01347086|12307483|FG003|STARTED|Overall Study||6
11122040|NCT01347086|12307484|FG004|STARTED|Overall Study||6
11122041|NCT01347086|12307485|FG005|STARTED|Overall Study||6
11122042|NCT01347086|12307486|FG006|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
11122043|NCT01347086|12307487|FG007|STARTED|Overall Study|One subject was not treated.|7
11122044|NCT01347086|12307488|FG008|STARTED|Overall Study||6
11122045|NCT01347086|12307489|FG009|STARTED|Overall Study|One subject was not treated.|7
11122046|NCT01347086|12307480|FG000|COMPLETED|Overall Study||2
11122047|NCT01347086|12307481|FG001|COMPLETED|Overall Study||6
11122048|NCT01347086|12307482|FG002|COMPLETED|Overall Study||6
11122049|NCT01347086|12307483|FG003|COMPLETED|Overall Study||6
11122050|NCT01347086|12307484|FG004|COMPLETED|Overall Study||6
11122051|NCT01347086|12307485|FG005|COMPLETED|Overall Study||6
11122052|NCT01347086|12307486|FG006|COMPLETED|Overall Study||6
11122053|NCT01347086|12307487|FG007|COMPLETED|Overall Study||6
11122054|NCT01347086|12307488|FG008|COMPLETED|Overall Study||6
11122055|NCT01347086|12307489|FG009|COMPLETED|Overall Study||6
11122056|NCT01347086|12307480|FG000|NOT COMPLETED|Overall Study||0
11122057|NCT01347086|12307481|FG001|NOT COMPLETED|Overall Study||0
11122058|NCT01347086|12307482|FG002|NOT COMPLETED|Overall Study||1
11122059|NCT01347086|12307483|FG003|NOT COMPLETED|Overall Study||0
11122060|NCT01347086|12307484|FG004|NOT COMPLETED|Overall Study||0
11122061|NCT01347086|12307485|FG005|NOT COMPLETED|Overall Study||0
11122062|NCT01347086|12307486|FG006|NOT COMPLETED|Overall Study||1
11122063|NCT01347086|12307487|FG007|NOT COMPLETED|Overall Study||1
11122064|NCT01347086|12307488|FG008|NOT COMPLETED|Overall Study||0
11122065|NCT01347086|12307489|FG009|NOT COMPLETED|Overall Study||1
11122066|NCT01347112|12307523|FG000|STARTED|Overall Study||16
11338913|NCT02906813|12536281|FG002|STARTED|Washout Period 2 (at Least 3 Days)||3
11122067|NCT01347112|12307524|FG001|STARTED|Overall Study||17
11122068|NCT01347112|12307523|FG000|COMPLETED|Overall Study||12
11122069|NCT01347112|12307524|FG001|COMPLETED|Overall Study||5
11122070|NCT01347112|12307523|FG000|NOT COMPLETED|Overall Study||4
11122071|NCT01347112|12307524|FG001|NOT COMPLETED|Overall Study||12
11122072|NCT01347255|12307531|FG000|STARTED|Overall Study||24
11122073|NCT01347255|12307531|FG000|COMPLETED|Overall Study||24
11122074|NCT01347255|12307531|FG000|NOT COMPLETED|Overall Study||0
11122075|NCT01347307|12307540|FG000|STARTED|Overall Study||3
11122076|NCT01347307|12307541|FG001|STARTED|Overall Study||33
11122077|NCT01347307|12307540|FG000|COMPLETED|Overall Study||3
11122078|NCT01347307|12307541|FG001|COMPLETED|Overall Study||28
11122079|NCT01347307|12307540|FG000|NOT COMPLETED|Overall Study||0
11122080|NCT01347307|12307541|FG001|NOT COMPLETED|Overall Study||5
11122081|NCT01347333|12307549|FG000|STARTED|Overall Study||23
11122082|NCT01347333|12307550|FG001|STARTED|Overall Study|No participants were enrolled in the Primary Liver Tumor arm.|0
11122083|NCT01347333|12307549|FG000|COMPLETED|Overall Study||23
11122084|NCT01347333|12307550|FG001|COMPLETED|Overall Study||0
11122085|NCT01347333|12307549|FG000|NOT COMPLETED|Overall Study||0
11122086|NCT01347333|12307550|FG001|NOT COMPLETED|Overall Study||0
11122087|NCT01347541|12307558|FG000|STARTED|Overall Study||3
11122088|NCT01347541|12307559|FG001|STARTED|Overall Study||1
11122089|NCT01347541|12307558|FG000|COMPLETED|Overall Study||3
11122090|NCT01347541|12307559|FG001|COMPLETED|Overall Study||1
11122091|NCT01347541|12307558|FG000|NOT COMPLETED|Overall Study||0
11122092|NCT01347541|12307559|FG001|NOT COMPLETED|Overall Study||0
11122093|NCT01347554|12307567|FG000|STARTED|Overall Study||237
11122094|NCT01347554|12307568|FG001|STARTED|Overall Study||242
11122095|NCT01347554|12307567|FG000|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
11122096|NCT01347554|12307568|FG001|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
11122097|NCT01347554|12307567|FG000|NOT COMPLETED|Overall Study||7
11122098|NCT01347554|12307568|FG001|NOT COMPLETED|Overall Study||11
11122099|NCT01347580|12307576|FG000|STARTED|Overall Study|based on randomized treatment|909
11122100|NCT01347580|12307577|FG001|STARTED|Overall Study|based on randomized treatment|953
11122101|NCT01347580|12307576|FG000|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
11122102|NCT01347580|12307577|FG001|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
11122103|NCT01347580|12307576|FG000|Safety Population|Overall Study|based on actual treatment|908
11122104|NCT01347580|12307577|FG001|Safety Population|Overall Study|based on actual treatment|950
11122105|NCT01347580|12307576|FG000|COMPLETED|Overall Study|based on randomized treatment|844
11122106|NCT01347580|12307577|FG001|COMPLETED|Overall Study|based on randomized treatment|897
11122107|NCT01347580|12307576|FG000|NOT COMPLETED|Overall Study||65
11122108|NCT01347580|12307577|FG001|NOT COMPLETED|Overall Study||56
11122109|NCT01347710|12307583|FG000|STARTED|Overall Study||795
11122110|NCT01347710|12307583|FG000|COMPLETED|Overall Study||764
11122111|NCT01347710|12307583|FG000|NOT COMPLETED|Overall Study||31
11122112|NCT01347762|12307595|FG000|STARTED|Overall Study||10
11122113|NCT01347762|12307596|FG001|STARTED|Overall Study||8
11122114|NCT01347762|12307597|FG002|STARTED|Overall Study||16
11122115|NCT01347762|12307598|FG003|STARTED|Overall Study||18
11122116|NCT01347762|12307595|FG000|COMPLETED|Overall Study||6
11122117|NCT01347762|12307596|FG001|COMPLETED|Overall Study||6
11122118|NCT01347762|12307597|FG002|COMPLETED|Overall Study||7
11122119|NCT01347762|12307598|FG003|COMPLETED|Overall Study||10
11122120|NCT01347762|12307595|FG000|NOT COMPLETED|Overall Study||4
11122121|NCT01347762|12307596|FG001|NOT COMPLETED|Overall Study||2
11122122|NCT01347762|12307597|FG002|NOT COMPLETED|Overall Study||9
11122123|NCT01347762|12307598|FG003|NOT COMPLETED|Overall Study||8
11122124|NCT01347788|12307608|FG000|STARTED|Overall Study||11
11122125|NCT01347788|12307609|FG001|STARTED|Overall Study||10
11122126|NCT01347788|12307610|FG002|STARTED|Overall Study||13
11122127|NCT01347788|12307608|FG000|COMPLETED|Overall Study||11
11122128|NCT01347788|12307609|FG001|COMPLETED|Overall Study||10
11122129|NCT01347788|12307610|FG002|COMPLETED|Overall Study||13
11122130|NCT01347788|12307608|FG000|NOT COMPLETED|Overall Study||0
11004616|NCT00718549|12182216|FG002|NOT COMPLETED|Maintenance/ Observation Phase||30
11004617|NCT00718666|12182232|FG000|STARTED|Persistence Phase Year 1||118
11004618|NCT00718666|12182233|FG001|STARTED|Persistence Phase Year 1||130
11004619|NCT00718666|12182234|FG002|STARTED|Persistence Phase Year 1||0
11004620|NCT00718666|12182232|FG000|COMPLETED|Persistence Phase Year 1||118
11122131|NCT01347788|12307609|FG001|NOT COMPLETED|Overall Study||0
11122132|NCT01347788|12307610|FG002|NOT COMPLETED|Overall Study||0
11122133|NCT01347866|12307635|FG000|STARTED|Overall Study||5
11122134|NCT01347866|12307636|FG001|STARTED|Overall Study||1
11122135|NCT01347866|12307637|FG002|STARTED|Overall Study||1
11122136|NCT01347866|12307638|FG003|STARTED|Overall Study||7
11122137|NCT01347866|12307639|FG004|STARTED|Overall Study||7
11122138|NCT01347866|12307640|FG005|STARTED|Overall Study||3
11122139|NCT01347866|12307641|FG006|STARTED|Overall Study||6
11122140|NCT01347866|12307642|FG007|STARTED|Overall Study||4
11122141|NCT01347866|12307643|FG008|STARTED|Overall Study||31
11122142|NCT01347866|12307644|FG009|STARTED|Overall Study||7
11122143|NCT01347866|12307645|FG010|STARTED|Overall Study||3
11122144|NCT01347866|12307646|FG011|STARTED|Overall Study||4
11122145|NCT01347866|12307647|FG012|STARTED|Overall Study||7
11122146|NCT01347866|12307648|FG013|STARTED|Overall Study||7
11122147|NCT01347866|12307649|FG014|STARTED|Overall Study||3
11122148|NCT01347866|12307650|FG015|STARTED|Overall Study||4
11122149|NCT01347866|12307651|FG016|STARTED|Overall Study||2
11122150|NCT01347866|12307635|FG000|COMPLETED|Overall Study||0
11122151|NCT01347866|12307636|FG001|COMPLETED|Overall Study||0
11122152|NCT01347866|12307637|FG002|COMPLETED|Overall Study||0
11122153|NCT01347866|12307638|FG003|COMPLETED|Overall Study||0
11122154|NCT01347866|12307639|FG004|COMPLETED|Overall Study||0
11122155|NCT01347866|12307640|FG005|COMPLETED|Overall Study||0
11122156|NCT01347866|12307641|FG006|COMPLETED|Overall Study||0
11122157|NCT01347866|12307642|FG007|COMPLETED|Overall Study||0
11122158|NCT01347866|12307643|FG008|COMPLETED|Overall Study||0
11122159|NCT01347866|12307644|FG009|COMPLETED|Overall Study||0
11122160|NCT01347866|12307645|FG010|COMPLETED|Overall Study||0
11122161|NCT01347866|12307646|FG011|COMPLETED|Overall Study||0
11122162|NCT01347866|12307647|FG012|COMPLETED|Overall Study||0
11122163|NCT01347866|12307648|FG013|COMPLETED|Overall Study||0
11122164|NCT01347866|12307649|FG014|COMPLETED|Overall Study||0
11122165|NCT01347866|12307650|FG015|COMPLETED|Overall Study||0
11122166|NCT01347866|12307651|FG016|COMPLETED|Overall Study||0
11122167|NCT01347866|12307635|FG000|NOT COMPLETED|Overall Study||5
11122168|NCT01347866|12307636|FG001|NOT COMPLETED|Overall Study||1
11122169|NCT01347866|12307637|FG002|NOT COMPLETED|Overall Study||1
11122170|NCT01347866|12307638|FG003|NOT COMPLETED|Overall Study||7
11122171|NCT01347866|12307639|FG004|NOT COMPLETED|Overall Study||7
11122172|NCT01347866|12307640|FG005|NOT COMPLETED|Overall Study||3
11122173|NCT01347866|12307641|FG006|NOT COMPLETED|Overall Study||6
11122174|NCT01347866|12307642|FG007|NOT COMPLETED|Overall Study||4
11122175|NCT01347866|12307643|FG008|NOT COMPLETED|Overall Study||31
11122176|NCT01347866|12307644|FG009|NOT COMPLETED|Overall Study||7
11122177|NCT01347866|12307645|FG010|NOT COMPLETED|Overall Study||3
11122178|NCT01347866|12307646|FG011|NOT COMPLETED|Overall Study||4
11122179|NCT01347866|12307647|FG012|NOT COMPLETED|Overall Study||7
11122180|NCT01347866|12307648|FG013|NOT COMPLETED|Overall Study||7
11122181|NCT01347866|12307649|FG014|NOT COMPLETED|Overall Study||3
11122182|NCT01347866|12307650|FG015|NOT COMPLETED|Overall Study||4
11122183|NCT01347866|12307651|FG016|NOT COMPLETED|Overall Study||2
11122184|NCT01347879|12307724|FG000|STARTED|Overall Study||53
11122185|NCT01347879|12307725|FG001|STARTED|Overall Study||100
11122186|NCT01347879|12307724|FG000|COMPLETED|Overall Study||46
11122187|NCT01347879|12307725|FG001|COMPLETED|Overall Study||83
11122188|NCT01347879|12307724|FG000|NOT COMPLETED|Overall Study||7
11122189|NCT01347879|12307725|FG001|NOT COMPLETED|Overall Study||17
11122190|NCT01347931|12307731|FG000|STARTED|Standard Oxygen Therapy||30
11122191|NCT01347931|12307731|FG000|COMPLETED|Standard Oxygen Therapy||29
11122192|NCT01347931|12307731|FG000|NOT COMPLETED|Standard Oxygen Therapy||1
11122193|NCT01347931|12307731|FG000|STARTED|NIOV System||29
11122194|NCT01347931|12307731|FG000|COMPLETED|NIOV System||29
11122195|NCT01347931|12307731|FG000|NOT COMPLETED|NIOV System||0
11122196|NCT01348087|12307737|FG000|STARTED|Overall Study||148
11122197|NCT01348087|12307737|FG000|COMPLETED|Overall Study||0
11122198|NCT01348087|12307737|FG000|NOT COMPLETED|Overall Study||148
11122199|NCT01348100|12307758|FG000|STARTED|Overall Study||2
11122200|NCT01348100|12307759|FG001|STARTED|Overall Study||2
11122201|NCT01348100|12307760|FG002|STARTED|Overall Study||15
11122202|NCT01348100|12307761|FG003|STARTED|Overall Study||15
11122203|NCT01348100|12307762|FG004|STARTED|Overall Study||15
11122204|NCT01348100|12307763|FG005|STARTED|Overall Study||16
11122205|NCT01348100|12307764|FG006|STARTED|Overall Study||16
11122206|NCT01348100|12307758|FG000|COMPLETED|Overall Study||2
11122207|NCT01348100|12307759|FG001|COMPLETED|Overall Study||2
11122208|NCT01348100|12307760|FG002|COMPLETED|Overall Study||13
11122209|NCT01348100|12307761|FG003|COMPLETED|Overall Study||14
11122210|NCT01348100|12307762|FG004|COMPLETED|Overall Study||14
11122211|NCT01348100|12307763|FG005|COMPLETED|Overall Study||14
11122212|NCT01348100|12307764|FG006|COMPLETED|Overall Study||13
11122213|NCT01348100|12307758|FG000|NOT COMPLETED|Overall Study||0
11122214|NCT01348100|12307759|FG001|NOT COMPLETED|Overall Study||0
11122215|NCT01348100|12307760|FG002|NOT COMPLETED|Overall Study||2
11122216|NCT01348100|12307761|FG003|NOT COMPLETED|Overall Study||1
11122217|NCT01348100|12307762|FG004|NOT COMPLETED|Overall Study||1
11122218|NCT01348100|12307763|FG005|NOT COMPLETED|Overall Study||2
11122219|NCT01348100|12307764|FG006|NOT COMPLETED|Overall Study||3
11122220|NCT01348139|12307785|FG000|STARTED|Period 1||5
11122221|NCT01348139|12307786|FG001|STARTED|Period 1||4
11122222|NCT01348139|12307787|FG002|STARTED|Period 1||4
11122223|NCT01348139|12307788|FG003|STARTED|Period 1||4
11122224|NCT01348139|12307789|FG004|STARTED|Period 1||5
11122225|NCT01348139|12307790|FG005|STARTED|Period 1||4
11122226|NCT01348139|12307785|FG000|COMPLETED|Period 1||4
11122227|NCT01348139|12307786|FG001|COMPLETED|Period 1||4
11122228|NCT01348139|12307787|FG002|COMPLETED|Period 1||4
11122229|NCT01348139|12307788|FG003|COMPLETED|Period 1||4
11122230|NCT01348139|12307789|FG004|COMPLETED|Period 1||5
11122231|NCT01348139|12307790|FG005|COMPLETED|Period 1||4
11122232|NCT01348139|12307785|FG000|NOT COMPLETED|Period 1||1
11122233|NCT01348139|12307786|FG001|NOT COMPLETED|Period 1||0
11122234|NCT01348139|12307787|FG002|NOT COMPLETED|Period 1||0
11122235|NCT01348139|12307788|FG003|NOT COMPLETED|Period 1||0
11122236|NCT01348139|12307789|FG004|NOT COMPLETED|Period 1||0
11122237|NCT01348139|12307790|FG005|NOT COMPLETED|Period 1||0
11122238|NCT01348139|12307785|FG000|STARTED|Period 2||4
11122239|NCT01348139|12307786|FG001|STARTED|Period 2||4
11122240|NCT01348139|12307787|FG002|STARTED|Period 2||4
11122241|NCT01348139|12307788|FG003|STARTED|Period 2||4
11122242|NCT01348139|12307789|FG004|STARTED|Period 2||5
11122243|NCT01348139|12307790|FG005|STARTED|Period 2||4
11122244|NCT01348139|12307785|FG000|COMPLETED|Period 2||4
11122245|NCT01348139|12307786|FG001|COMPLETED|Period 2||4
11122246|NCT01348139|12307787|FG002|COMPLETED|Period 2||4
11122247|NCT01348139|12307788|FG003|COMPLETED|Period 2||4
11122248|NCT01348139|12307789|FG004|COMPLETED|Period 2||5
11122249|NCT01348139|12307790|FG005|COMPLETED|Period 2||4
11122250|NCT01348139|12307785|FG000|NOT COMPLETED|Period 2||0
11122251|NCT01348139|12307786|FG001|NOT COMPLETED|Period 2||0
11122252|NCT01348139|12307787|FG002|NOT COMPLETED|Period 2||0
11122253|NCT01348139|12307788|FG003|NOT COMPLETED|Period 2||0
11122254|NCT01348139|12307789|FG004|NOT COMPLETED|Period 2||0
11122255|NCT01348139|12307790|FG005|NOT COMPLETED|Period 2||0
11122256|NCT01348139|12307785|FG000|STARTED|Period 3||4
11122257|NCT01348139|12307786|FG001|STARTED|Period 3||4
11122258|NCT01348139|12307787|FG002|STARTED|Period 3||4
11122259|NCT01348139|12307788|FG003|STARTED|Period 3||4
11122260|NCT01348139|12307789|FG004|STARTED|Period 3||5
11122261|NCT01348139|12307790|FG005|STARTED|Period 3||4
11122262|NCT01348139|12307785|FG000|COMPLETED|Period 3||4
11122263|NCT01348139|12307786|FG001|COMPLETED|Period 3||4
11122264|NCT01348139|12307787|FG002|COMPLETED|Period 3||4
11122265|NCT01348139|12307788|FG003|COMPLETED|Period 3||4
11122266|NCT01348139|12307789|FG004|COMPLETED|Period 3||5
11122267|NCT01348139|12307790|FG005|COMPLETED|Period 3||4
11122268|NCT01348139|12307785|FG000|NOT COMPLETED|Period 3||0
11122269|NCT01348139|12307786|FG001|NOT COMPLETED|Period 3||0
11122270|NCT01348139|12307787|FG002|NOT COMPLETED|Period 3||0
11122271|NCT01348139|12307788|FG003|NOT COMPLETED|Period 3||0
11122272|NCT01348139|12307789|FG004|NOT COMPLETED|Period 3||0
11122273|NCT01348139|12307790|FG005|NOT COMPLETED|Period 3||0
11122274|NCT01348139|12307785|FG000|STARTED|Period 4||4
11122275|NCT01348139|12307786|FG001|STARTED|Period 4||4
11122276|NCT01348139|12307787|FG002|STARTED|Period 4||4
11122277|NCT01348139|12307788|FG003|STARTED|Period 4||4
11122278|NCT01348139|12307789|FG004|STARTED|Period 4||5
11122279|NCT01348139|12307790|FG005|STARTED|Period 4||4
11122280|NCT01348139|12307785|FG000|COMPLETED|Period 4||4
11122281|NCT01348139|12307786|FG001|COMPLETED|Period 4||4
11122282|NCT01348139|12307787|FG002|COMPLETED|Period 4||4
11122283|NCT01348139|12307788|FG003|COMPLETED|Period 4||4
11122284|NCT01348139|12307789|FG004|COMPLETED|Period 4||5
11122285|NCT01348139|12307790|FG005|COMPLETED|Period 4||4
11122286|NCT01348139|12307785|FG000|NOT COMPLETED|Period 4||0
11122287|NCT01348139|12307786|FG001|NOT COMPLETED|Period 4||0
11122288|NCT01348139|12307787|FG002|NOT COMPLETED|Period 4||0
11122289|NCT01348139|12307788|FG003|NOT COMPLETED|Period 4||0
11122290|NCT01348139|12307789|FG004|NOT COMPLETED|Period 4||0
11122291|NCT01348139|12307790|FG005|NOT COMPLETED|Period 4||0
11122292|NCT01348139|12307785|FG000|STARTED|Period 5||4
11122293|NCT01348139|12307786|FG001|STARTED|Period 5||4
11122294|NCT01348139|12307787|FG002|STARTED|Period 5||4
11122295|NCT01348139|12307788|FG003|STARTED|Period 5||4
11122296|NCT01348139|12307789|FG004|STARTED|Period 5||5
11122297|NCT01348139|12307790|FG005|STARTED|Period 5||4
11122298|NCT01348139|12307785|FG000|COMPLETED|Period 5||4
11122299|NCT01348139|12307786|FG001|COMPLETED|Period 5||4
11122300|NCT01348139|12307787|FG002|COMPLETED|Period 5||4
11122301|NCT01348139|12307788|FG003|COMPLETED|Period 5||4
11122302|NCT01348139|12307789|FG004|COMPLETED|Period 5||5
11122303|NCT01348139|12307790|FG005|COMPLETED|Period 5||4
11122304|NCT01348139|12307785|FG000|NOT COMPLETED|Period 5||0
11122305|NCT01348139|12307786|FG001|NOT COMPLETED|Period 5||0
11122306|NCT01348139|12307787|FG002|NOT COMPLETED|Period 5||0
11122307|NCT01348139|12307788|FG003|NOT COMPLETED|Period 5||0
11122308|NCT01348139|12307789|FG004|NOT COMPLETED|Period 5||0
11122309|NCT01348139|12307790|FG005|NOT COMPLETED|Period 5||0
11122310|NCT01348139|12307785|FG000|STARTED|Period 6||4
11122311|NCT01348139|12307786|FG001|STARTED|Period 6||4
11122312|NCT01348139|12307787|FG002|STARTED|Period 6||4
11122313|NCT01348139|12307788|FG003|STARTED|Period 6||4
11122314|NCT01348139|12307789|FG004|STARTED|Period 6||5
11122315|NCT01348139|12307790|FG005|STARTED|Period 6||4
11122316|NCT01348139|12307785|FG000|COMPLETED|Period 6||4
11122317|NCT01348139|12307786|FG001|COMPLETED|Period 6||4
11122318|NCT01348139|12307787|FG002|COMPLETED|Period 6||4
11122319|NCT01348139|12307788|FG003|COMPLETED|Period 6||4
11122320|NCT01348139|12307789|FG004|COMPLETED|Period 6||5
11122321|NCT01348139|12307790|FG005|COMPLETED|Period 6||4
11122322|NCT01348139|12307785|FG000|NOT COMPLETED|Period 6||0
11122323|NCT01348139|12307786|FG001|NOT COMPLETED|Period 6||0
11122324|NCT01348139|12307787|FG002|NOT COMPLETED|Period 6||0
11122325|NCT01348139|12307788|FG003|NOT COMPLETED|Period 6||0
11122326|NCT01348139|12307789|FG004|NOT COMPLETED|Period 6||0
11122327|NCT01348139|12307790|FG005|NOT COMPLETED|Period 6||0
11122328|NCT01348165|12307811|FG000|STARTED|Overall Study||10
11122329|NCT01348165|12307812|FG001|STARTED|Overall Study||5
11122330|NCT01348165|12307813|FG002|STARTED|Overall Study||6
11122331|NCT01348165|12307814|FG003|STARTED|Overall Study||6
11122332|NCT01348165|12307815|FG004|STARTED|Overall Study||6
11122333|NCT01348165|12307816|FG005|STARTED|Overall Study||1
11122334|NCT01348165|12307817|FG006|STARTED|Overall Study||6
11122335|NCT01348165|12307811|FG000|COMPLETED|Overall Study||10
11122336|NCT01348165|12307812|FG001|COMPLETED|Overall Study||5
11122337|NCT01348165|12307813|FG002|COMPLETED|Overall Study||6
11122338|NCT01348165|12307814|FG003|COMPLETED|Overall Study||6
11122339|NCT01348165|12307815|FG004|COMPLETED|Overall Study||6
11122340|NCT01348165|12307816|FG005|COMPLETED|Overall Study||1
11122341|NCT01348165|12307817|FG006|COMPLETED|Overall Study||5
11122342|NCT01348165|12307811|FG000|NOT COMPLETED|Overall Study||0
11122343|NCT01348165|12307812|FG001|NOT COMPLETED|Overall Study||0
11122344|NCT01348165|12307813|FG002|NOT COMPLETED|Overall Study||0
11122345|NCT01348165|12307814|FG003|NOT COMPLETED|Overall Study||0
11122346|NCT01348165|12307815|FG004|NOT COMPLETED|Overall Study||0
11122347|NCT01348165|12307816|FG005|NOT COMPLETED|Overall Study||0
11122348|NCT01348165|12307817|FG006|NOT COMPLETED|Overall Study||1
11122349|NCT01348347|12307840|FG000|STARTED|Overall Study||3
11122350|NCT01348347|12307841|FG001|STARTED|Overall Study||6
11122351|NCT01348347|12307842|FG002|STARTED|Overall Study||6
11122352|NCT01348347|12307840|FG000|COMPLETED|Overall Study||0
11122353|NCT01348347|12307841|FG001|COMPLETED|Overall Study||0
11122354|NCT01348347|12307842|FG002|COMPLETED|Overall Study||0
11122355|NCT01348347|12307840|FG000|NOT COMPLETED|Overall Study||3
11122356|NCT01348347|12307841|FG001|NOT COMPLETED|Overall Study||6
11122357|NCT01348347|12307842|FG002|NOT COMPLETED|Overall Study||6
11122358|NCT01348425|12307853|FG000|STARTED|Overall Study||31
11122359|NCT01348425|12307854|FG001|STARTED|Overall Study||14
11122360|NCT01348425|12307853|FG000|COMPLETED|Overall Study||30
11122361|NCT01348425|12307854|FG001|COMPLETED|Overall Study||13
11122362|NCT01348425|12307853|FG000|NOT COMPLETED|Overall Study||1
11122363|NCT01348425|12307854|FG001|NOT COMPLETED|Overall Study||1
11122364|NCT01348490|12307859|FG000|STARTED|Overall Study||66
11122365|NCT01348490|12307859|FG000|COMPLETED|Overall Study||42
11122366|NCT01348490|12307859|FG000|NOT COMPLETED|Overall Study||24
11122367|NCT01348542|12307882|FG000|STARTED|Overall Study||13
11122368|NCT01348542|12307883|FG001|STARTED|Overall Study||11
11004621|NCT00718666|12182233|FG001|COMPLETED|Persistence Phase Year 1||130
11004622|NCT00718666|12182234|FG002|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
11004623|NCT00718666|12182232|FG000|NOT COMPLETED|Persistence Phase Year 1||0
11004624|NCT00718666|12182233|FG001|NOT COMPLETED|Persistence Phase Year 1||0
11122369|NCT01348542|12307882|FG000|COMPLETED|Overall Study||10
11122370|NCT01348542|12307883|FG001|COMPLETED|Overall Study||11
11122371|NCT01348542|12307882|FG000|NOT COMPLETED|Overall Study||3
11122372|NCT01348542|12307883|FG001|NOT COMPLETED|Overall Study||0
11122373|NCT01348607|12307892|FG000|STARTED|Overall Study||1
11122374|NCT01348607|12307893|FG001|STARTED|Overall Study||0
11122375|NCT01348607|12307894|FG002|STARTED|Overall Study||0
11122376|NCT01348607|12307892|FG000|COMPLETED|Overall Study||1
11122377|NCT01348607|12307893|FG001|COMPLETED|Overall Study||0
11122378|NCT01348607|12307894|FG002|COMPLETED|Overall Study||0
11122379|NCT01348607|12307892|FG000|NOT COMPLETED|Overall Study||0
11122380|NCT01348607|12307893|FG001|NOT COMPLETED|Overall Study||0
11122381|NCT01348607|12307894|FG002|NOT COMPLETED|Overall Study||0
11122382|NCT01348698|12307902|FG000|STARTED|Overall Study||74
11122383|NCT01348698|12307902|FG000|COMPLETED|Overall Study||2
11122384|NCT01348698|12307902|FG000|NOT COMPLETED|Overall Study||72
11122385|NCT01348763|12307906|FG000|STARTED|With Tenofovir/Emtricitabine (10 Days)||13
11122386|NCT01348763|12307906|FG000|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11
11122387|NCT01348763|12307906|FG000|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2
11122388|NCT01348763|12307906|FG000|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11
11122389|NCT01348763|12307906|FG000|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11
11122390|NCT01348763|12307906|FG000|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0
11122391|NCT01348776|12307910|FG000|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
11122392|NCT01348776|12307910|FG000|COMPLETED|Overall Study||84
11122393|NCT01348776|12307910|FG000|NOT COMPLETED|Overall Study||3
11122394|NCT01348789|12307923|FG000|STARTED|Overall Study||37
11122395|NCT01348789|12307923|FG000|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
11122396|NCT01348789|12307923|FG000|NOT COMPLETED|Overall Study||4
11122397|NCT01348828|12307934|FG000|STARTED|Overall Study||49
11122398|NCT01348828|12307934|FG000|COMPLETED|Overall Study||16
11122399|NCT01348828|12307934|FG000|NOT COMPLETED|Overall Study||33
11122400|NCT01348854|12307940|FG000|STARTED|Overall Study|53 eyes of 34 participants|34
11122401|NCT01348854|12307941|FG001|STARTED|Overall Study|10 eyes of 6 participants|6
11122402|NCT01348854|12307940|FG000|COMPLETED|Overall Study|47 eyes of 31 participants|31
11122403|NCT01348854|12307941|FG001|COMPLETED|Overall Study|9 eyes of 5 participants|5
11122404|NCT01348854|12307940|FG000|NOT COMPLETED|Overall Study||3
11122405|NCT01348854|12307941|FG001|NOT COMPLETED|Overall Study||1
11122406|NCT01349036|12307949|FG000|STARTED|Overall Study||14
11122407|NCT01349036|12307950|FG001|STARTED|Overall Study||24
11122408|NCT01349036|12307949|FG000|COMPLETED|Overall Study||0
11122409|NCT01349036|12307950|FG001|COMPLETED|Overall Study||0
11122410|NCT01349036|12307949|FG000|NOT COMPLETED|Overall Study||14
11122411|NCT01349036|12307950|FG001|NOT COMPLETED|Overall Study||24
11122412|NCT01349049|12307969|FG000|STARTED|Overall Study||3
11122413|NCT01349049|12307970|FG001|STARTED|Overall Study||7
11122414|NCT01349049|12307971|FG002|STARTED|Overall Study||3
11122415|NCT01349049|12307972|FG003|STARTED|Overall Study||3
11122416|NCT01349049|12307973|FG004|STARTED|Overall Study||3
11122417|NCT01349049|12307974|FG005|STARTED|Overall Study||6
11122418|NCT01349049|12307975|FG006|STARTED|Overall Study||5
11122419|NCT01349049|12307976|FG007|STARTED|Overall Study||4
11122420|NCT01349049|12307977|FG008|STARTED|Overall Study||56
11122421|NCT01349049|12307969|FG000|COMPLETED|Overall Study||0
11122422|NCT01349049|12307970|FG001|COMPLETED|Overall Study||0
11122423|NCT01349049|12307971|FG002|COMPLETED|Overall Study||0
11122424|NCT01349049|12307972|FG003|COMPLETED|Overall Study||0
11122425|NCT01349049|12307973|FG004|COMPLETED|Overall Study||0
11122426|NCT01349049|12307974|FG005|COMPLETED|Overall Study||0
11122427|NCT01349049|12307975|FG006|COMPLETED|Overall Study||0
11122428|NCT01349049|12307976|FG007|COMPLETED|Overall Study||0
11122429|NCT01349049|12307977|FG008|COMPLETED|Overall Study||1
11122430|NCT01349049|12307969|FG000|NOT COMPLETED|Overall Study||3
11122431|NCT01349049|12307970|FG001|NOT COMPLETED|Overall Study||7
11122432|NCT01349049|12307971|FG002|NOT COMPLETED|Overall Study||3
11122433|NCT01349049|12307972|FG003|NOT COMPLETED|Overall Study||3
11122434|NCT01349049|12307973|FG004|NOT COMPLETED|Overall Study||3
11122435|NCT01349049|12307974|FG005|NOT COMPLETED|Overall Study||6
11122436|NCT01349049|12307975|FG006|NOT COMPLETED|Overall Study||5
11122437|NCT01349049|12307976|FG007|NOT COMPLETED|Overall Study||4
11122438|NCT01349049|12307977|FG008|NOT COMPLETED|Overall Study||55
11122439|NCT01349114|12308011|FG000|STARTED|Overall Study||10
11122440|NCT01349114|12308012|FG001|STARTED|Overall Study||11
11122441|NCT01349114|12308011|FG000|COMPLETED|Overall Study||10
11122442|NCT01349114|12308012|FG001|COMPLETED|Overall Study||11
11122443|NCT01349114|12308011|FG000|NOT COMPLETED|Overall Study||0
11122444|NCT01349114|12308012|FG001|NOT COMPLETED|Overall Study||0
11122445|NCT01349140|12308020|FG000|STARTED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
11122446|NCT01349140|12308020|FG000|COMPLETED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
11122447|NCT01349140|12308020|FG000|NOT COMPLETED|Overall Study||0
11122448|NCT01349192|12308026|FG000|STARTED|Overall Study||24
11122449|NCT01349192|12308027|FG001|STARTED|Overall Study||23
11122450|NCT01349192|12308026|FG000|Evaluable for Primary Endpoint|Overall Study||22
11122451|NCT01349192|12308027|FG001|Evaluable for Primary Endpoint|Overall Study||19
11122452|NCT01349192|12308026|FG000|Withdrawals|Overall Study||3
11122453|NCT01349192|12308027|FG001|Withdrawals|Overall Study||6
11122454|NCT01349192|12308026|FG000|COMPLETED|Overall Study||21
11122455|NCT01349192|12308027|FG001|COMPLETED|Overall Study||17
11122456|NCT01349192|12308026|FG000|NOT COMPLETED|Overall Study||3
11122457|NCT01349192|12308027|FG001|NOT COMPLETED|Overall Study||6
11122458|NCT01349231|12308035|FG000|STARTED|Overall Study||10
11122459|NCT01349231|12308035|FG000|COMPLETED|Overall Study||10
11122460|NCT01349231|12308035|FG000|NOT COMPLETED|Overall Study||0
11122461|NCT01349465|12308041|FG000|STARTED|Overall Study||200
11122462|NCT01349465|12308042|FG001|STARTED|Overall Study||49
11122463|NCT01349465|12308041|FG000|COMPLETED|Overall Study||182
11122464|NCT01349465|12308042|FG001|COMPLETED|Overall Study||27
11122465|NCT01349465|12308041|FG000|NOT COMPLETED|Overall Study||18
11122466|NCT01349465|12308042|FG001|NOT COMPLETED|Overall Study||22
11122467|NCT01349491|12308052|FG000|STARTED|Overall Study||5
11122468|NCT01349491|12308053|FG001|STARTED|Overall Study||5
11122469|NCT01349491|12308052|FG000|COMPLETED|Overall Study||5
11122470|NCT01349491|12308053|FG001|COMPLETED|Overall Study||5
11122471|NCT01349491|12308052|FG000|NOT COMPLETED|Overall Study||0
11122472|NCT01349491|12308053|FG001|NOT COMPLETED|Overall Study||0
11122473|NCT01349569|12308059|FG000|STARTED|Overall Study||16
11122474|NCT01349569|12308059|FG000|COMPLETED|Overall Study||12
11122475|NCT01349569|12308059|FG000|NOT COMPLETED|Overall Study||4
11122476|NCT01349660|12308069|FG000|STARTED|Overall Study||6
11122477|NCT01349660|12308070|FG001|STARTED|Overall Study||6
11122478|NCT01349660|12308071|FG002|STARTED|Overall Study||76
11122479|NCT01349660|12308069|FG000|COMPLETED|Overall Study||0
11122480|NCT01349660|12308070|FG001|COMPLETED|Overall Study||0
11122481|NCT01349660|12308071|FG002|COMPLETED|Overall Study||0
11122482|NCT01349660|12308069|FG000|NOT COMPLETED|Overall Study||6
11122483|NCT01349660|12308070|FG001|NOT COMPLETED|Overall Study||6
11122484|NCT01349660|12308071|FG002|NOT COMPLETED|Overall Study||76
11122485|NCT01349673|12308086|FG000|STARTED|Overall Study||114
11122486|NCT01349673|12308086|FG000|Participants Entered Cycle 1|Overall Study||114
11122487|NCT01349673|12308086|FG000|Participants Entered Cycle 2|Overall Study||65
11122488|NCT01349673|12308086|FG000|Participants Entered Cycle 3|Overall Study||41
11122489|NCT01349673|12308086|FG000|Participants Entered Cycle 4|Overall Study||22
11122490|NCT01349673|12308086|FG000|Participants Entered Cycle 5|Overall Study||12
11122491|NCT01349673|12308086|FG000|Participants Entered Cycle 6|Overall Study||5
11122492|NCT01349673|12308086|FG000|Participants Entered Cycle 7|Overall Study||3
11122493|NCT01349673|12308086|FG000|Participants Entered Cycle 8|Overall Study||1
11122494|NCT01349673|12308086|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||114
11122495|NCT01349673|12308086|FG000|COMPLETED|Overall Study||0
11122496|NCT01349673|12308086|FG000|NOT COMPLETED|Overall Study||114
11122497|NCT01349790|12308090|FG000|STARTED|Overall Study||40
11122498|NCT01349790|12308090|FG000|COMPLETED|Overall Study||31
11122499|NCT01349790|12308090|FG000|NOT COMPLETED|Overall Study||9
11122500|NCT01349803|12308098|FG000|STARTED|Overall Study||60
11122501|NCT01349803|12308099|FG001|STARTED|Overall Study||58
11122502|NCT01349803|12308100|FG002|STARTED|Overall Study||60
11122503|NCT01349803|12308101|FG003|STARTED|Overall Study||59
11122504|NCT01349803|12308098|FG000|COMPLETED|Overall Study||59
11122505|NCT01349803|12308099|FG001|COMPLETED|Overall Study||57
11122506|NCT01349803|12308100|FG002|COMPLETED|Overall Study||57
11122507|NCT01349803|12308101|FG003|COMPLETED|Overall Study||57
11122508|NCT01349803|12308098|FG000|NOT COMPLETED|Overall Study||1
11122509|NCT01349803|12308099|FG001|NOT COMPLETED|Overall Study||1
11122510|NCT01349803|12308100|FG002|NOT COMPLETED|Overall Study||3
11122511|NCT01349803|12308101|FG003|NOT COMPLETED|Overall Study||2
11122512|NCT01349816|12308119|FG000|STARTED|Overall Study||185
11122513|NCT01349816|12308119|FG000|GP MDI 36 µg|Overall Study||61
11122514|NCT01349816|12308119|FG000|GFF MDI 36/7.2 µg|Overall Study||58
11122515|NCT01349816|12308119|FG000|GFF MDI 36/9.6 µg|Overall Study||56
11122516|NCT01349816|12308119|FG000|GFF MDI 18/9.6 µg|Overall Study||57
11122517|NCT01349816|12308119|FG000|GFF MDI 9/9.6 µg|Overall Study||57
11122518|NCT01349816|12308119|FG000|FF MDI 9.6 µg|Overall Study||61
11122519|NCT01349816|12308119|FG000|COMPLETED|Overall Study||155
11122520|NCT01349816|12308119|FG000|NOT COMPLETED|Overall Study||30
11122521|NCT01349829|12308135|FG000|STARTED|Overall Study||126
11122522|NCT01349829|12308136|FG001|STARTED|Overall Study||125
11122523|NCT01349829|12308135|FG000|COMPLETED|Overall Study||117
11122524|NCT01349829|12308136|FG001|COMPLETED|Overall Study||102
11122525|NCT01349829|12308135|FG000|NOT COMPLETED|Overall Study||9
11122526|NCT01349829|12308136|FG001|NOT COMPLETED|Overall Study||23
11122527|NCT01349920|12308144|FG000|STARTED|Overall Study||15
11122528|NCT01349920|12308144|FG000|COMPLETED|Overall Study||15
11122529|NCT01349920|12308144|FG000|NOT COMPLETED|Overall Study||0
11122530|NCT01349933|12308150|FG000|STARTED|Overall Study||21
11122531|NCT01349933|12308150|FG000|COMPLETED|Overall Study||21
11122532|NCT01349933|12308150|FG000|NOT COMPLETED|Overall Study||0
11122533|NCT01349972|12308156|FG000|STARTED|Overall Study||114
11122534|NCT01349972|12308157|FG001|STARTED|Overall Study||58
11122535|NCT01349972|12308156|FG000|COMPLETED|Overall Study||109
11122536|NCT01349972|12308157|FG001|COMPLETED|Overall Study||56
11122537|NCT01349972|12308156|FG000|NOT COMPLETED|Overall Study||5
11122538|NCT01349972|12308157|FG001|NOT COMPLETED|Overall Study||2
11122539|NCT01350102|12308167|FG000|STARTED|Overall Study||0
11122540|NCT01350102|12308168|FG001|STARTED|Overall Study||1
11122541|NCT01350102|12308169|FG002|STARTED|Overall Study||1
11122542|NCT01350102|12308170|FG003|STARTED|Overall Study||0
11122543|NCT01350102|12308167|FG000|COMPLETED|Overall Study||0
11122544|NCT01350102|12308168|FG001|COMPLETED|Overall Study||1
11122545|NCT01350102|12308169|FG002|COMPLETED|Overall Study||0
11122546|NCT01350102|12308170|FG003|COMPLETED|Overall Study||0
11122547|NCT01350102|12308167|FG000|NOT COMPLETED|Overall Study||0
11122548|NCT01350102|12308168|FG001|NOT COMPLETED|Overall Study||0
11122549|NCT01350102|12308169|FG002|NOT COMPLETED|Overall Study||1
11122550|NCT01350102|12308170|FG003|NOT COMPLETED|Overall Study||0
11122551|NCT01350115|12308182|FG000|STARTED|Core Study (All Patients)||8
11122552|NCT01350115|12308183|FG001|STARTED|Core Study (All Patients)||2
11122553|NCT01350115|12308182|FG000|Safety Anlysis Set|Core Study (All Patients)||8
11122554|NCT01350115|12308183|FG001|Safety Anlysis Set|Core Study (All Patients)||2
11122555|NCT01350115|12308182|FG000|Pharmacodynamic Set|Core Study (All Patients)||7
11122556|NCT01350115|12308183|FG001|Pharmacodynamic Set|Core Study (All Patients)||2
11122557|NCT01350115|12308182|FG000|COMPLETED|Core Study (All Patients)||8
11122558|NCT01350115|12308183|FG001|COMPLETED|Core Study (All Patients)||2
11122559|NCT01350115|12308182|FG000|NOT COMPLETED|Core Study (All Patients)||0
11122560|NCT01350115|12308183|FG001|NOT COMPLETED|Core Study (All Patients)||0
11122561|NCT01350115|12308182|FG000|STARTED|Long Term Follow-Up (All Patients)||8
11122562|NCT01350115|12308183|FG001|STARTED|Long Term Follow-Up (All Patients)||2
11122563|NCT01350115|12308182|FG000|COMPLETED|Long Term Follow-Up (All Patients)||7
11122564|NCT01350115|12308183|FG001|COMPLETED|Long Term Follow-Up (All Patients)||0
11122565|NCT01350115|12308182|FG000|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
11122566|NCT01350115|12308183|FG001|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
11122567|NCT01350128|12308191|FG000|STARTED|Overall Study||103
11122568|NCT01350128|12308191|FG000|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
11122569|NCT01350128|12308191|FG000|GP MDI 18 µg BID|Overall Study||49
11122570|NCT01350128|12308191|FG000|GP MDI 9 µg BID|Overall Study||49
11122571|NCT01350128|12308191|FG000|GP MDI 4.6 µg BID|Overall Study||45
11122572|NCT01350128|12308191|FG000|Placebo MDI BID|Overall Study||48
11122573|NCT01350128|12308191|FG000|Atrovent HFA 34 µg BID|Overall Study||48
11122574|NCT01350128|12308191|FG000|COMPLETED|Overall Study||89
11122575|NCT01350128|12308191|FG000|NOT COMPLETED|Overall Study||14
11122576|NCT01350141|12308208|FG000|STARTED|Overall Study||15
11122577|NCT01350141|12308209|FG001|STARTED|Overall Study||15
11122578|NCT01350141|12308210|FG002|STARTED|Overall Study||16
11122579|NCT01350141|12308208|FG000|Treated|Overall Study||14
11122580|NCT01350141|12308209|FG001|Treated|Overall Study||15
11122581|NCT01350141|12308210|FG002|Treated|Overall Study||16
11122582|NCT01350141|12308208|FG000|COMPLETED|Overall Study||12
11122583|NCT01350141|12308209|FG001|COMPLETED|Overall Study||15
11122584|NCT01350141|12308210|FG002|COMPLETED|Overall Study||15
11122585|NCT01350141|12308208|FG000|NOT COMPLETED|Overall Study||3
11122586|NCT01350141|12308209|FG001|NOT COMPLETED|Overall Study||0
11122587|NCT01350141|12308210|FG002|NOT COMPLETED|Overall Study||1
11122588|NCT01350245|12308220|FG000|STARTED|Overall Study||28
11122589|NCT01350245|12308220|FG000|COMPLETED|Overall Study||28
11122590|NCT01350245|12308220|FG000|NOT COMPLETED|Overall Study||0
11122591|NCT01350271|12308227|FG000|STARTED|Overall Study||70
11122592|NCT01350271|12308228|FG001|STARTED|Overall Study||70
11122593|NCT01350271|12308229|FG002|STARTED|Overall Study||74
11122594|NCT01350271|12308227|FG000|COMPLETED|Overall Study||49
11122595|NCT01350271|12308228|FG001|COMPLETED|Overall Study||53
11122596|NCT01350271|12308229|FG002|COMPLETED|Overall Study||48
11122597|NCT01350271|12308227|FG000|NOT COMPLETED|Overall Study||21
11122598|NCT01350271|12308228|FG001|NOT COMPLETED|Overall Study||17
11122599|NCT01350271|12308229|FG002|NOT COMPLETED|Overall Study||26
11122600|NCT01350336|12308240|FG000|STARTED|Overall Study||284
11122601|NCT01350336|12308240|FG000|COMPLETED|Overall Study||227
11122602|NCT01350336|12308240|FG000|NOT COMPLETED|Overall Study||57
11122603|NCT01350388|12308291|FG000|STARTED|Overall Study||40
11122604|NCT01350388|12308292|FG001|STARTED|Overall Study||40
11122605|NCT01350388|12308291|FG000|COMPLETED|Overall Study||37
11122606|NCT01350388|12308292|FG001|COMPLETED|Overall Study||39
11122607|NCT01350388|12308291|FG000|NOT COMPLETED|Overall Study||3
11122608|NCT01350388|12308292|FG001|NOT COMPLETED|Overall Study||1
11122609|NCT01350401|12308298|FG000|STARTED|Overall Study||4
11122610|NCT01350401|12308298|FG000|COMPLETED|Overall Study||4
11122611|NCT01350401|12308298|FG000|NOT COMPLETED|Overall Study||0
11122612|NCT01350414|12308306|FG000|STARTED|Overall Study||181
11122613|NCT01350414|12308306|FG000|Year 2|Overall Study||165
11122614|NCT01350414|12308306|FG000|Year 3|Overall Study||162
11122615|NCT01350414|12308306|FG000|Year 4|Overall Study||159
11122616|NCT01350414|12308306|FG000|Year 5|Overall Study||162
11122617|NCT01350414|12308306|FG000|COMPLETED|Overall Study||162
11122618|NCT01350414|12308306|FG000|NOT COMPLETED|Overall Study||19
11122619|NCT01350453|12308318|FG000|STARTED|Overall Study||11
11122620|NCT01350453|12308319|FG001|STARTED|Overall Study||8
11122621|NCT01350453|12308318|FG000|COMPLETED|Overall Study||9
11122622|NCT01350453|12308319|FG001|COMPLETED|Overall Study||7
11122623|NCT01350453|12308318|FG000|NOT COMPLETED|Overall Study||2
11122624|NCT01350453|12308319|FG001|NOT COMPLETED|Overall Study||1
11122625|NCT01350479|12308329|FG000|STARTED|Overall Study||94
11122626|NCT01350479|12308330|FG001|STARTED|Overall Study||106
11122627|NCT01350479|12308329|FG000|COMPLETED|Overall Study||94
11122628|NCT01350479|12308330|FG001|COMPLETED|Overall Study||106
11122629|NCT01350479|12308329|FG000|NOT COMPLETED|Overall Study||0
11122630|NCT01350479|12308330|FG001|NOT COMPLETED|Overall Study||0
11122631|NCT01350492|12308338|FG000|STARTED|Intervention||28
11122632|NCT01350492|12308339|FG001|STARTED|Intervention||26
11122633|NCT01350492|12308338|FG000|6-week MRI Scan|Intervention||24
11122634|NCT01350492|12308339|FG001|6-week MRI Scan|Intervention||22
11122635|NCT01350492|12308338|FG000|11-week MRI Scan|Intervention||23
11122636|NCT01350492|12308339|FG001|11-week MRI Scan|Intervention||21
11122637|NCT01350492|12308338|FG000|COMPLETED|Intervention||23
11122638|NCT01350492|12308339|FG001|COMPLETED|Intervention||20
11122639|NCT01350492|12308338|FG000|NOT COMPLETED|Intervention||5
11122640|NCT01350492|12308339|FG001|NOT COMPLETED|Intervention||6
11122641|NCT01350492|12308338|FG000|STARTED|Post Intervention Follow-Up||23
11122642|NCT01350492|12308339|FG001|STARTED|Post Intervention Follow-Up||20
11122643|NCT01350492|12308338|FG000|6-month MRI Scan|Post Intervention Follow-Up||20
11122644|NCT01350492|12308339|FG001|6-month MRI Scan|Post Intervention Follow-Up||20
11122645|NCT01350492|12308338|FG000|COMPLETED|Post Intervention Follow-Up||17
11122646|NCT01350492|12308339|FG001|COMPLETED|Post Intervention Follow-Up||18
11122647|NCT01350492|12308338|FG000|NOT COMPLETED|Post Intervention Follow-Up||6
11122648|NCT01350492|12308339|FG001|NOT COMPLETED|Post Intervention Follow-Up||2
11122649|NCT01350505|12308345|FG000|STARTED|Overall Study||21
11122650|NCT01350505|12308345|FG000|COMPLETED|Overall Study||17
11122651|NCT01350505|12308345|FG000|NOT COMPLETED|Overall Study||4
11122652|NCT01350544|12308351|FG000|STARTED|Overall Study||108
11122653|NCT01350544|12308352|FG001|STARTED|Overall Study||108
11122654|NCT01350544|12308351|FG000|COMPLETED|Overall Study||85
11122655|NCT01350544|12308352|FG001|COMPLETED|Overall Study||86
11122656|NCT01350544|12308351|FG000|NOT COMPLETED|Overall Study||23
11238670|NCT02075047|12430422|FG001|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|85
11238671|NCT02075047|12430421|FG000|COMPLETED|Follow up Phase (5 Weeks)||60
11238672|NCT02075047|12430422|FG001|COMPLETED|Follow up Phase (5 Weeks)||72
11238673|NCT02075047|12430421|FG000|NOT COMPLETED|Follow up Phase (5 Weeks)||26
11238674|NCT02075047|12430422|FG001|NOT COMPLETED|Follow up Phase (5 Weeks)||13
11238675|NCT02075073|12430431|FG000|STARTED|Overall Study||36
11238676|NCT02075073|12430432|FG001|STARTED|Overall Study||37
11238677|NCT02075073|12430433|FG002|STARTED|Overall Study||36
11238678|NCT02075073|12430431|FG000|COMPLETED|Overall Study||36
11238679|NCT02075073|12430432|FG001|COMPLETED|Overall Study||36
11238680|NCT02075073|12430433|FG002|COMPLETED|Overall Study||36
11238681|NCT02075073|12430431|FG000|NOT COMPLETED|Overall Study||0
11238682|NCT02075073|12430432|FG001|NOT COMPLETED|Overall Study||1
11238683|NCT02075073|12430433|FG002|NOT COMPLETED|Overall Study||0
11238684|NCT02075125|12430443|FG000|STARTED|Overall Study||19
11238685|NCT02075125|12430444|FG001|STARTED|Overall Study||20
11238686|NCT02075125|12430443|FG000|COMPLETED|Overall Study||19
11238687|NCT02075125|12430444|FG001|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
11238688|NCT02075125|12430443|FG000|NOT COMPLETED|Overall Study||0
11238689|NCT02075125|12430444|FG001|NOT COMPLETED|Overall Study||1
11238690|NCT02075203|12430453|FG000|STARTED|Overall Study||330
11238691|NCT02075203|12430454|FG001|STARTED|Overall Study||330
11122657|NCT01350544|12308352|FG001|NOT COMPLETED|Overall Study||22
11122658|NCT01350804|12308362|FG000|STARTED|Core Study||138
11122659|NCT01350804|12308363|FG001|STARTED|Core Study||137
11122660|NCT01350804|12308364|FG002|STARTED|Core Study||138
11122661|NCT01350804|12308365|FG003|STARTED|Core Study||138
11122662|NCT01350804|12308362|FG000|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
11122663|NCT01350804|12308363|FG001|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
11122664|NCT01350804|12308364|FG002|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
11122665|NCT01350804|12308365|FG003|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
11122666|NCT01350804|12308362|FG000|Tratment Switch to AIN457 at Week 16|Core Study||0
11122667|NCT01350804|12308363|FG001|Tratment Switch to AIN457 at Week 16|Core Study||0
11122668|NCT01350804|12308364|FG002|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
11122669|NCT01350804|12308365|FG003|Tratment Switch to AIN457 at Week 16|Core Study||0
11122670|NCT01350804|12308362|FG000|Treatment Switch to AIN457 at Week 24|Core Study||0
11122671|NCT01350804|12308363|FG001|Treatment Switch to AIN457 at Week 24|Core Study||0
11122672|NCT01350804|12308364|FG002|Treatment Switch to AIN457 at Week 24|Core Study||45
11122673|NCT01350804|12308365|FG003|Treatment Switch to AIN457 at Week 24|Core Study||37
11122674|NCT01350804|12308362|FG000|Full Analysis Set|Core Study||138
11122675|NCT01350804|12308363|FG001|Full Analysis Set|Core Study||137
11122676|NCT01350804|12308364|FG002|Full Analysis Set|Core Study||138
11122677|NCT01350804|12308365|FG003|Full Analysis Set|Core Study||138
11122678|NCT01350804|12308362|FG000|COMPLETED|Core Study||97
11122679|NCT01350804|12308363|FG001|COMPLETED|Core Study||90
11122680|NCT01350804|12308364|FG002|COMPLETED|Core Study||91
11122681|NCT01350804|12308365|FG003|COMPLETED|Core Study||112
11122682|NCT01350804|12308362|FG000|NOT COMPLETED|Core Study||41
11122683|NCT01350804|12308363|FG001|NOT COMPLETED|Core Study||47
11122684|NCT01350804|12308364|FG002|NOT COMPLETED|Core Study||47
11122685|NCT01350804|12308365|FG003|NOT COMPLETED|Core Study||26
11122686|NCT01350804|12308362|FG000|STARTED|Extension Study, Weeks 52 - 260||80
11122687|NCT01350804|12308363|FG001|STARTED|Extension Study, Weeks 52 - 260||79
11122688|NCT01350804|12308364|FG002|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
11122689|NCT01350804|12308365|FG003|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
11122690|NCT01350804|12308362|FG000|COMPLETED|Extension Study, Weeks 52 - 260||0
11122691|NCT01350804|12308363|FG001|COMPLETED|Extension Study, Weeks 52 - 260||0
11122692|NCT01350804|12308364|FG002|COMPLETED|Extension Study, Weeks 52 - 260||0
11122693|NCT01350804|12308365|FG003|COMPLETED|Extension Study, Weeks 52 - 260||0
11122694|NCT01350804|12308362|FG000|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
11122695|NCT01350804|12308363|FG001|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
11122696|NCT01350804|12308364|FG002|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
11122697|NCT01350804|12308365|FG003|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
11122698|NCT01350947|12308385|FG000|STARTED|Overall Study||11
11122699|NCT01350947|12308385|FG000|COMPLETED|Overall Study||11
11122700|NCT01350947|12308385|FG000|NOT COMPLETED|Overall Study||0
11201920|NCT01836198|12392310|FG000|NOT COMPLETED|Part A, Period 1||0
11201921|NCT01836198|12392311|FG001|NOT COMPLETED|Part A, Period 1||0
11201922|NCT01836198|12392312|FG002|NOT COMPLETED|Part A, Period 1||0
11201923|NCT01836198|12392310|FG000|STARTED|Part A, Period 2||15
11201924|NCT01836198|12392311|FG001|STARTED|Part A, Period 2||15
11201925|NCT01836198|12392312|FG002|STARTED|Part A, Period 2||0
11201926|NCT01836198|12392310|FG000|Completed Part A, Entered Part B|Part A, Period 2||6
11201927|NCT01836198|12392311|FG001|Completed Part A, Entered Part B|Part A, Period 2||6
11201928|NCT01836198|12392312|FG002|Completed Part A, Entered Part B|Part A, Period 2||0
11201929|NCT01836198|12392310|FG000|COMPLETED|Part A, Period 2||15
11201930|NCT01836198|12392311|FG001|COMPLETED|Part A, Period 2||14
11201931|NCT01836198|12392312|FG002|COMPLETED|Part A, Period 2||0
11201932|NCT01836198|12392310|FG000|NOT COMPLETED|Part A, Period 2||0
11201933|NCT01836198|12392311|FG001|NOT COMPLETED|Part A, Period 2||1
11201934|NCT01836198|12392312|FG002|NOT COMPLETED|Part A, Period 2||0
11201935|NCT01836198|12392310|FG000|STARTED|Part B||0
11201936|NCT01836198|12392311|FG001|STARTED|Part B||0
11201937|NCT01836198|12392312|FG002|STARTED|Part B||12
11201938|NCT01836198|12392310|FG000|Received at Least 1 Dose of Study Drug|Part B||0
11201939|NCT01836198|12392311|FG001|Received at Least 1 Dose of Study Drug|Part B||0
11201940|NCT01836198|12392312|FG002|Received at Least 1 Dose of Study Drug|Part B||12
11201941|NCT01836198|12392310|FG000|COMPLETED|Part B||0
11201942|NCT01836198|12392311|FG001|COMPLETED|Part B||0
11201943|NCT01836198|12392312|FG002|COMPLETED|Part B||12
11201944|NCT01836198|12392310|FG000|NOT COMPLETED|Part B||0
11201945|NCT01836198|12392311|FG001|NOT COMPLETED|Part B||0
11201946|NCT01836198|12392312|FG002|NOT COMPLETED|Part B||0
11201947|NCT01836276|12392330|FG000|STARTED|Overall Study||224
11201948|NCT01836276|12392331|FG001|STARTED|Overall Study||225
11201949|NCT01836276|12392330|FG000|Week 4|Overall Study||198
11201950|NCT01836276|12392331|FG001|Week 4|Overall Study||186
11201951|NCT01836276|12392330|FG000|Week 12|Overall Study||183
11201952|NCT01836276|12392331|FG001|Week 12|Overall Study||165
11201953|NCT01836276|12392330|FG000|COMPLETED|Overall Study||196
11201954|NCT01836276|12392331|FG001|COMPLETED|Overall Study||174
11201955|NCT01836276|12392330|FG000|NOT COMPLETED|Overall Study||28
11201956|NCT01836276|12392331|FG001|NOT COMPLETED|Overall Study||51
11122701|NCT01350973|12308392|FG000|STARTED|Overall Study||206
11122702|NCT01350973|12308393|FG001|STARTED|Overall Study||210
11122703|NCT01350973|12308394|FG002|STARTED|Overall Study||195
11122704|NCT01350973|12308392|FG000|Received Treatment|Overall Study||205
11122705|NCT01350973|12308393|FG001|Received Treatment|Overall Study||210
11122706|NCT01350973|12308394|FG002|Received Treatment|Overall Study||195
11122707|NCT01350973|12308392|FG000|COMPLETED|Overall Study||200
11122708|NCT01350973|12308393|FG001|COMPLETED|Overall Study||202
11122709|NCT01350973|12308394|FG002|COMPLETED|Overall Study||187
11122710|NCT01350973|12308392|FG000|NOT COMPLETED|Overall Study||6
11122711|NCT01350973|12308393|FG001|NOT COMPLETED|Overall Study||8
11122712|NCT01350973|12308394|FG002|NOT COMPLETED|Overall Study||8
11122713|NCT01350999|12308405|FG000|STARTED|Overall Study||165
11122714|NCT01350999|12308406|FG001|STARTED|Overall Study||171
11122715|NCT01350999|12308407|FG002|STARTED|Overall Study||167
11122716|NCT01350999|12308405|FG000|Treated|Overall Study||165
11122717|NCT01350999|12308406|FG001|Treated|Overall Study||171
11122718|NCT01350999|12308407|FG002|Treated|Overall Study||167
11122719|NCT01350999|12308405|FG000|COMPLETED|Overall Study||157
11122720|NCT01350999|12308406|FG001|COMPLETED|Overall Study||157
11122721|NCT01350999|12308407|FG002|COMPLETED|Overall Study||146
11122722|NCT01350999|12308405|FG000|NOT COMPLETED|Overall Study||8
11122723|NCT01350999|12308406|FG001|NOT COMPLETED|Overall Study||14
11122724|NCT01350999|12308407|FG002|NOT COMPLETED|Overall Study||21
11122725|NCT01351025|12308417|FG000|STARTED|Week 0 - 20||46
11122726|NCT01351025|12308418|FG001|STARTED|Week 0 - 20||48
11122727|NCT01351025|12308417|FG000|COMPLETED|Week 0 - 20||43
11122728|NCT01351025|12308418|FG001|COMPLETED|Week 0 - 20||47
11122729|NCT01351025|12308417|FG000|NOT COMPLETED|Week 0 - 20||3
11122730|NCT01351025|12308418|FG001|NOT COMPLETED|Week 0 - 20||1
11122731|NCT01351025|12308417|FG000|STARTED|Week 20 - 24||43
11122732|NCT01351025|12308418|FG001|STARTED|Week 20 - 24||47
11122733|NCT01351025|12308417|FG000|COMPLETED|Week 20 - 24||43
11122734|NCT01351025|12308418|FG001|COMPLETED|Week 20 - 24||47
11122735|NCT01351025|12308417|FG000|NOT COMPLETED|Week 20 - 24||0
11122736|NCT01351025|12308418|FG001|NOT COMPLETED|Week 20 - 24||0
11122737|NCT01351025|12308417|FG000|STARTED|Week 24 - 44||43
11122738|NCT01351025|12308418|FG001|STARTED|Week 24 - 44||47
11122739|NCT01351025|12308417|FG000|COMPLETED|Week 24 - 44||42
11122740|NCT01351025|12308418|FG001|COMPLETED|Week 24 - 44||43
11122741|NCT01351025|12308417|FG000|NOT COMPLETED|Week 24 - 44||1
11122742|NCT01351025|12308418|FG001|NOT COMPLETED|Week 24 - 44||4
11122743|NCT01351025|12308417|FG000|STARTED|Week 44 - 48||42
11122744|NCT01351025|12308418|FG001|STARTED|Week 44 - 48||43
11122745|NCT01351025|12308417|FG000|COMPLETED|Week 44 - 48||42
11122746|NCT01351025|12308418|FG001|COMPLETED|Week 44 - 48||43
11122747|NCT01351025|12308417|FG000|NOT COMPLETED|Week 44 - 48||0
11122748|NCT01351025|12308418|FG001|NOT COMPLETED|Week 44 - 48||0
11122749|NCT01351064|12308432|FG000|STARTED|Overall Study||42
11122750|NCT01351064|12308433|FG001|STARTED|Overall Study||42
11122751|NCT01351064|12308432|FG000|COMPLETED|Overall Study||42
11122752|NCT01351064|12308433|FG001|COMPLETED|Overall Study||42
11122753|NCT01351064|12308432|FG000|NOT COMPLETED|Overall Study||0
11122754|NCT01351064|12308433|FG001|NOT COMPLETED|Overall Study||0
11238692|NCT02075203|12430455|FG002|STARTED|Overall Study||329
11122755|NCT01351077|12308441|FG000|STARTED|Overall Study||180
11122756|NCT01351077|12308442|FG001|STARTED|Overall Study||180
11122757|NCT01351077|12308441|FG000|COMPLETED|Overall Study||180
11122758|NCT01351077|12308442|FG001|COMPLETED|Overall Study||180
11122759|NCT01351077|12308441|FG000|NOT COMPLETED|Overall Study||0
11122760|NCT01351077|12308442|FG001|NOT COMPLETED|Overall Study||0
11122761|NCT01351090|12308451|FG000|STARTED|Overall Study||43
11122762|NCT01351090|12308452|FG001|STARTED|Overall Study||42
11122763|NCT01351090|12308453|FG002|STARTED|Overall Study||42
11122764|NCT01351090|12308451|FG000|COMPLETED|Overall Study||32
11122765|NCT01351090|12308452|FG001|COMPLETED|Overall Study||31
11122766|NCT01351090|12308453|FG002|COMPLETED|Overall Study||36
11122767|NCT01351090|12308451|FG000|NOT COMPLETED|Overall Study||11
11122768|NCT01351090|12308452|FG001|NOT COMPLETED|Overall Study||11
11122769|NCT01351090|12308453|FG002|NOT COMPLETED|Overall Study||6
11122770|NCT01351337|12308461|FG000|STARTED|Overall Study||58
11122771|NCT01351337|12308461|FG000|COMPLETED|Overall Study||58
11122772|NCT01351337|12308461|FG000|NOT COMPLETED|Overall Study||0
11122773|NCT01351350|12308471|FG000|STARTED|Overall Study||8
11122774|NCT01351350|12308472|FG001|STARTED|Overall Study||29
11122775|NCT01351350|12308473|FG002|STARTED|Overall Study||11
11122776|NCT01351350|12308474|FG003|STARTED|Overall Study||13
11122777|NCT01351350|12308475|FG004|STARTED|Overall Study||7
11238693|NCT02075203|12430453|FG000|COMPLETED|Overall Study||327
11238694|NCT02075203|12430454|FG001|COMPLETED|Overall Study||330
11238695|NCT02075203|12430455|FG002|COMPLETED|Overall Study||328
11238696|NCT02075203|12430453|FG000|NOT COMPLETED|Overall Study||3
11238697|NCT02075203|12430454|FG001|NOT COMPLETED|Overall Study||0
11238698|NCT02075203|12430455|FG002|NOT COMPLETED|Overall Study||1
11238699|NCT02075255|12430466|FG000|STARTED|Overall Study||72
11238700|NCT02075255|12430467|FG001|STARTED|Overall Study||73
11238701|NCT02075255|12430468|FG002|STARTED|Overall Study||75
11238702|NCT02075255|12430466|FG000|COMPLETED|Overall Study||68
11238703|NCT02075255|12430467|FG001|COMPLETED|Overall Study||69
11238704|NCT02075255|12430468|FG002|COMPLETED|Overall Study||72
11238705|NCT02075255|12430466|FG000|NOT COMPLETED|Overall Study||4
11238706|NCT02075255|12430467|FG001|NOT COMPLETED|Overall Study||4
11122778|NCT01351350|12308471|FG000|Treated|Overall Study||8
11122779|NCT01351350|12308472|FG001|Treated|Overall Study||29
11238707|NCT02075255|12430468|FG002|NOT COMPLETED|Overall Study||3
11238708|NCT02075463|12430476|FG000|STARTED|Overall Study||15
11238709|NCT02075463|12430476|FG000|COMPLETED|Overall Study||7
11238710|NCT02075463|12430476|FG000|NOT COMPLETED|Overall Study||8
11238711|NCT02075476|12430483|FG000|STARTED|Overall Study||20
11238712|NCT02075476|12430484|FG001|STARTED|Overall Study||20
11238713|NCT02075476|12430483|FG000|COMPLETED|Overall Study||17
11238714|NCT02075476|12430484|FG001|COMPLETED|Overall Study||15
11238715|NCT02075476|12430483|FG000|NOT COMPLETED|Overall Study||3
11238716|NCT02075476|12430484|FG001|NOT COMPLETED|Overall Study||5
11238717|NCT02075515|12430493|FG000|STARTED|Overall Study||218
11238718|NCT02075515|12430494|FG001|STARTED|Overall Study||217
11238719|NCT02075515|12430495|FG002|STARTED|Overall Study||216
11238720|NCT02075515|12430493|FG000|COMPLETED|Overall Study||214
11238721|NCT02075515|12430494|FG001|COMPLETED|Overall Study||212
11238722|NCT02075515|12430495|FG002|COMPLETED|Overall Study||208
11238723|NCT02075515|12430493|FG000|NOT COMPLETED|Overall Study||4
11238724|NCT02075515|12430494|FG001|NOT COMPLETED|Overall Study||5
11238725|NCT02075515|12430495|FG002|NOT COMPLETED|Overall Study||8
11238726|NCT02075541|12430506|FG000|STARTED|Overall Study||73
11238727|NCT02075541|12430507|FG001|STARTED|Overall Study||72
11238728|NCT02075541|12430506|FG000|COMPLETED|Overall Study||69
11238729|NCT02075541|12430507|FG001|COMPLETED|Overall Study||64
11238730|NCT02075541|12430506|FG000|NOT COMPLETED|Overall Study||4
11238731|NCT02075541|12430507|FG001|NOT COMPLETED|Overall Study||8
11338914|NCT02906813|12536279|FG000|COMPLETED|Washout Period 2 (at Least 3 Days)||3
11338915|NCT02906813|12536280|FG001|COMPLETED|Washout Period 2 (at Least 3 Days)||3
11338916|NCT02906813|12536281|FG002|COMPLETED|Washout Period 2 (at Least 3 Days)||3
11338917|NCT02906813|12536279|FG000|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
11338918|NCT02906813|12536280|FG001|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
11338919|NCT02906813|12536281|FG002|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
11338920|NCT02906813|12536279|FG000|STARTED|Intervention Period 3 (3 Days)||3
11338921|NCT02906813|12536280|FG001|STARTED|Intervention Period 3 (3 Days)||3
11338922|NCT02906813|12536281|FG002|STARTED|Intervention Period 3 (3 Days)||3
11338923|NCT02906813|12536279|FG000|COMPLETED|Intervention Period 3 (3 Days)||3
11338924|NCT02906813|12536280|FG001|COMPLETED|Intervention Period 3 (3 Days)||3
11338925|NCT02906813|12536281|FG002|COMPLETED|Intervention Period 3 (3 Days)||3
11338926|NCT02906813|12536279|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11338927|NCT02906813|12536280|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11338928|NCT02906813|12536281|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11338929|NCT02906917|12536291|FG000|STARTED|Initiation Period (Week 0-26)||267
11338930|NCT02906917|12536292|FG001|STARTED|Initiation Period (Week 0-26)||265
11338931|NCT02906917|12536291|FG000|Exposed|Initiation Period (Week 0-26)||265
11338932|NCT02906917|12536292|FG001|Exposed|Initiation Period (Week 0-26)||263
11338933|NCT02906917|12536291|FG000|COMPLETED|Initiation Period (Week 0-26)||261
11338934|NCT02906917|12536292|FG001|COMPLETED|Initiation Period (Week 0-26)||254
11338935|NCT02906917|12536291|FG000|NOT COMPLETED|Initiation Period (Week 0-26)||6
11338936|NCT02906917|12536292|FG001|NOT COMPLETED|Initiation Period (Week 0-26)||11
11338937|NCT02906917|12536291|FG000|STARTED|Intensification Period (Week 26-38)||261
11338938|NCT02906917|12536292|FG001|STARTED|Intensification Period (Week 26-38)||254
11338939|NCT02906917|12536291|FG000|COMPLETED|Intensification Period (Week 26-38)||252
11338940|NCT02906917|12536292|FG001|COMPLETED|Intensification Period (Week 26-38)||247
11338941|NCT02906917|12536291|FG000|NOT COMPLETED|Intensification Period (Week 26-38)||9
11338942|NCT02906917|12536292|FG001|NOT COMPLETED|Intensification Period (Week 26-38)||7
11122780|NCT01351350|12308473|FG002|Treated|Overall Study||10
11338943|NCT02907073|12536301|FG000|STARTED|Overall Study||8
11338944|NCT02907073|12536302|FG001|STARTED|Overall Study||0
11338945|NCT02907073|12536303|FG002|STARTED|Overall Study||0
11338946|NCT02907073|12536301|FG000|COMPLETED|Overall Study||8
11338947|NCT02907073|12536302|FG001|COMPLETED|Overall Study||0
11338948|NCT02907073|12536303|FG002|COMPLETED|Overall Study||0
11338949|NCT02907073|12536301|FG000|NOT COMPLETED|Overall Study||0
11122781|NCT01351350|12308474|FG003|Treated|Overall Study||13
11122782|NCT01351350|12308475|FG004|Treated|Overall Study||7
11122783|NCT01351350|12308471|FG000|Dose-escalation Evaluable|Overall Study||7
11122784|NCT01351350|12308472|FG001|Dose-escalation Evaluable|Overall Study||23
11122785|NCT01351350|12308473|FG002|Dose-escalation Evaluable|Overall Study||10
11122786|NCT01351350|12308474|FG003|Dose-escalation Evaluable|Overall Study||0
11122787|NCT01351350|12308475|FG004|Dose-escalation Evaluable|Overall Study||0
11122788|NCT01351350|12308471|FG000|COMPLETED|Overall Study||0
11122789|NCT01351350|12308472|FG001|COMPLETED|Overall Study||0
11122790|NCT01351350|12308473|FG002|COMPLETED|Overall Study||0
11122791|NCT01351350|12308474|FG003|COMPLETED|Overall Study||0
11122792|NCT01351350|12308475|FG004|COMPLETED|Overall Study||0
11122793|NCT01351350|12308471|FG000|NOT COMPLETED|Overall Study||8
11122794|NCT01351350|12308472|FG001|NOT COMPLETED|Overall Study||29
11122795|NCT01351350|12308473|FG002|NOT COMPLETED|Overall Study||11
11122796|NCT01351350|12308474|FG003|NOT COMPLETED|Overall Study||13
11122797|NCT01351350|12308475|FG004|NOT COMPLETED|Overall Study||7
11122798|NCT01351376|12308502|FG000|STARTED|Overall Study||10
11122799|NCT01351376|12308503|FG001|STARTED|Overall Study||11
11122800|NCT01351376|12308502|FG000|COMPLETED|Overall Study||10
11122801|NCT01351376|12308503|FG001|COMPLETED|Overall Study||11
11122802|NCT01351376|12308502|FG000|NOT COMPLETED|Overall Study||0
11122803|NCT01351376|12308503|FG001|NOT COMPLETED|Overall Study||0
11122804|NCT01351415|12308511|FG000|STARTED|Overall Study||245
11122805|NCT01351415|12308512|FG001|STARTED|Overall Study||240
11122806|NCT01351415|12308511|FG000|Treated Participants|Overall Study||243
11122807|NCT01351415|12308512|FG001|Treated Participants|Overall Study||232
11122808|NCT01351415|12308511|FG000|COMPLETED|Overall Study||0
11122809|NCT01351415|12308512|FG001|COMPLETED|Overall Study||0
11122810|NCT01351415|12308511|FG000|NOT COMPLETED|Overall Study||245
11122811|NCT01351415|12308512|FG001|NOT COMPLETED|Overall Study||240
11122812|NCT01351480|12308518|FG000|STARTED|Overall Study||34
11122813|NCT01351480|12308518|FG000|COMPLETED|Overall Study||26
11122814|NCT01351480|12308518|FG000|NOT COMPLETED|Overall Study||8
11122815|NCT01351506|12308524|FG000|STARTED|Overall Study||602
11122816|NCT01351506|12308524|FG000|COMPLETED|Overall Study||465
11122817|NCT01351506|12308524|FG000|NOT COMPLETED|Overall Study||137
11122818|NCT01351623|12308530|FG000|STARTED|Overall Study||44
11122819|NCT01351623|12308530|FG000|COMPLETED|Overall Study||35
11238732|NCT02075554|12430513|FG000|STARTED|Overall Study||58
11238733|NCT02075554|12430513|FG000|COMPLETED|Overall Study||43
11238734|NCT02075554|12430513|FG000|NOT COMPLETED|Overall Study||15
11122820|NCT01351623|12308530|FG000|NOT COMPLETED|Overall Study||9
11122821|NCT01351740|12308536|FG000|STARTED|Overall Study||25
11122822|NCT01351740|12308537|FG001|STARTED|Overall Study||25
11122823|NCT01351740|12308536|FG000|COMPLETED|Overall Study||23
11122824|NCT01351740|12308537|FG001|COMPLETED|Overall Study||19
11122825|NCT01351740|12308536|FG000|NOT COMPLETED|Overall Study||2
11122826|NCT01351740|12308537|FG001|NOT COMPLETED|Overall Study||6
11122827|NCT01351753|12308550|FG000|STARTED|Overall Study||22
11122828|NCT01351753|12308551|FG001|STARTED|Overall Study||20
11122829|NCT01351753|12308552|FG002|STARTED|Overall Study||21
11122830|NCT01351753|12308553|FG003|STARTED|Overall Study||21
11122831|NCT01351753|12308554|FG004|STARTED|Overall Study||21
11122832|NCT01351753|12308555|FG005|STARTED|Overall Study||23
11122833|NCT01351753|12308550|FG000|COMPLETED|Overall Study||15
11122834|NCT01351753|12308551|FG001|COMPLETED|Overall Study||13
11122835|NCT01351753|12308552|FG002|COMPLETED|Overall Study||14
11122836|NCT01351753|12308553|FG003|COMPLETED|Overall Study||21
11122837|NCT01351753|12308554|FG004|COMPLETED|Overall Study||14
11122838|NCT01351753|12308555|FG005|COMPLETED|Overall Study||22
11122839|NCT01351753|12308550|FG000|NOT COMPLETED|Overall Study||7
11122840|NCT01351753|12308551|FG001|NOT COMPLETED|Overall Study||7
11122841|NCT01351753|12308552|FG002|NOT COMPLETED|Overall Study||7
11122842|NCT01351753|12308553|FG003|NOT COMPLETED|Overall Study||0
11122843|NCT01351753|12308554|FG004|NOT COMPLETED|Overall Study||7
11122844|NCT01351753|12308555|FG005|NOT COMPLETED|Overall Study||1
11122845|NCT01352117|12308573|FG000|STARTED|Overall Study||96
11122846|NCT01352117|12308574|FG001|STARTED|Overall Study||96
11122847|NCT01352117|12308573|FG000|Entered Step 2 to Initiate Delayed ET|Overall Study||32
11122848|NCT01352117|12308574|FG001|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
11122849|NCT01352117|12308573|FG000|Study Week 48 Data Potential|Overall Study||80
11238735|NCT02075606|12430517|FG000|STARTED|Overall Study||50
11238736|NCT02075606|12430517|FG000|COMPLETED|Overall Study||40
11238737|NCT02075606|12430517|FG000|NOT COMPLETED|Overall Study||10
11238738|NCT02075632|12430528|FG000|STARTED|Overall Study||162
11238739|NCT02075632|12430529|FG001|STARTED|Overall Study||148
11238740|NCT02075632|12430528|FG000|COMPLETED|Overall Study||161
11238741|NCT02075632|12430529|FG001|COMPLETED|Overall Study||143
11238742|NCT02075632|12430528|FG000|NOT COMPLETED|Overall Study||1
11238743|NCT02075632|12430529|FG001|NOT COMPLETED|Overall Study||5
11238744|NCT02075658|12430537|FG000|STARTED|Overall Study||30
11238745|NCT02075658|12430538|FG001|STARTED|Overall Study||30
11238746|NCT02075658|12430537|FG000|COMPLETED|Overall Study||28
11122850|NCT01352117|12308574|FG001|Study Week 48 Data Potential|Overall Study||83
11122851|NCT01352117|12308573|FG000|Study Week 96 Data Potential|Overall Study||58
11122852|NCT01352117|12308574|FG001|Study Week 96 Data Potential|Overall Study||61
11122853|NCT01352117|12308573|FG000|COMPLETED|Overall Study||75
11122854|NCT01352117|12308574|FG001|COMPLETED|Overall Study||72
11122855|NCT01352117|12308573|FG000|NOT COMPLETED|Overall Study||21
11122856|NCT01352117|12308574|FG001|NOT COMPLETED|Overall Study||24
11122857|NCT01352182|12308585|FG000|STARTED|Overall Study||8
11122858|NCT01352182|12308586|FG001|STARTED|Overall Study||4
11122859|NCT01352182|12308585|FG000|COMPLETED|Overall Study||8
11122860|NCT01352182|12308586|FG001|COMPLETED|Overall Study||4
11122861|NCT01352182|12308585|FG000|NOT COMPLETED|Overall Study||0
11122862|NCT01352182|12308586|FG001|NOT COMPLETED|Overall Study||0
11122863|NCT01352221|12308596|FG000|STARTED|Double-blind Phase||64
11122864|NCT01352221|12308597|FG001|STARTED|Double-blind Phase||64
11122865|NCT01352221|12308598|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
11122866|NCT01352221|12308599|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
11122867|NCT01352221|12308596|FG000|COMPLETED|Double-blind Phase||55
11122868|NCT01352221|12308597|FG001|COMPLETED|Double-blind Phase||53
11122869|NCT01352221|12308598|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
11238747|NCT02075658|12430538|FG001|COMPLETED|Overall Study||28
11238748|NCT02075658|12430537|FG000|NOT COMPLETED|Overall Study||2
11004625|NCT00718666|12182234|FG002|NOT COMPLETED|Persistence Phase Year 1||0
11004626|NCT00718666|12182232|FG000|STARTED|Persistence Phase Year 3||98
11004627|NCT00718666|12182233|FG001|STARTED|Persistence Phase Year 3||104
11004628|NCT00718666|12182234|FG002|STARTED|Persistence Phase Year 3||0
11004629|NCT00718666|12182232|FG000|COMPLETED|Persistence Phase Year 3||98
11004630|NCT00718666|12182233|FG001|COMPLETED|Persistence Phase Year 3||104
11004631|NCT00718666|12182234|FG002|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
11004632|NCT00718666|12182232|FG000|NOT COMPLETED|Persistence Phase Year 3||0
11004633|NCT00718666|12182233|FG001|NOT COMPLETED|Persistence Phase Year 3||0
11004634|NCT00718666|12182234|FG002|NOT COMPLETED|Persistence Phase Year 3||0
11004635|NCT00718666|12182232|FG000|STARTED|Persistence Phase Year 5||70
11004636|NCT00718666|12182233|FG001|STARTED|Persistence Phase Year 5||82
11004637|NCT00718666|12182234|FG002|STARTED|Persistence Phase Year 5||0
11004638|NCT00718666|12182232|FG000|COMPLETED|Persistence Phase Year 5||70
11004639|NCT00718666|12182233|FG001|COMPLETED|Persistence Phase Year 5||82
11004640|NCT00718666|12182234|FG002|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
11004641|NCT00718666|12182232|FG000|NOT COMPLETED|Persistence Phase Year 5||0
11004642|NCT00718666|12182233|FG001|NOT COMPLETED|Persistence Phase Year 5||0
11004643|NCT00718666|12182234|FG002|NOT COMPLETED|Persistence Phase Year 5||0
11004644|NCT00718666|12182232|FG000|STARTED|Booster Phase Year 5||38
11004645|NCT00718666|12182233|FG001|STARTED|Booster Phase Year 5||46
11004646|NCT00718666|12182234|FG002|STARTED|Booster Phase Year 5||100
11004647|NCT00718666|12182232|FG000|COMPLETED|Booster Phase Year 5||36
11004648|NCT00718666|12182233|FG001|COMPLETED|Booster Phase Year 5||46
11004649|NCT00718666|12182234|FG002|COMPLETED|Booster Phase Year 5||94
11004650|NCT00718666|12182232|FG000|NOT COMPLETED|Booster Phase Year 5||2
11004651|NCT00718666|12182233|FG001|NOT COMPLETED|Booster Phase Year 5||0
11004652|NCT00718666|12182234|FG002|NOT COMPLETED|Booster Phase Year 5||6
11004653|NCT00718718|12182259|FG000|STARTED|Prior to Week 12||19
11004654|NCT00718718|12182260|FG001|STARTED|Prior to Week 12||0
11004655|NCT00718718|12182261|FG002|STARTED|Prior to Week 12||17
11004656|NCT00718718|12182262|FG003|STARTED|Prior to Week 12||0
11004657|NCT00718718|12182263|FG004|STARTED|Prior to Week 12||30
11004658|NCT00718718|12182264|FG005|STARTED|Prior to Week 12||0
11004659|NCT00718718|12182265|FG006|STARTED|Prior to Week 12||30
11004660|NCT00718718|12182266|FG007|STARTED|Prior to Week 12||30
11004661|NCT00718718|12182267|FG008|STARTED|Prior to Week 12||30
11004662|NCT00718718|12182268|FG009|STARTED|Prior to Week 12||31
11004663|NCT00718718|12182259|FG000|COMPLETED|Prior to Week 12||18
11004664|NCT00718718|12182260|FG001|COMPLETED|Prior to Week 12||0
11004665|NCT00718718|12182261|FG002|COMPLETED|Prior to Week 12||16
11004666|NCT00718718|12182262|FG003|COMPLETED|Prior to Week 12||0
11004667|NCT00718718|12182263|FG004|COMPLETED|Prior to Week 12||27
11004668|NCT00718718|12182264|FG005|COMPLETED|Prior to Week 12||0
11004669|NCT00718718|12182265|FG006|COMPLETED|Prior to Week 12||29
11004670|NCT00718718|12182266|FG007|COMPLETED|Prior to Week 12||28
11004671|NCT00718718|12182267|FG008|COMPLETED|Prior to Week 12||28
11004672|NCT00718718|12182268|FG009|COMPLETED|Prior to Week 12||31
11004673|NCT00718718|12182259|FG000|NOT COMPLETED|Prior to Week 12||1
11004674|NCT00718718|12182260|FG001|NOT COMPLETED|Prior to Week 12||0
11004675|NCT00718718|12182261|FG002|NOT COMPLETED|Prior to Week 12||1
11004676|NCT00718718|12182262|FG003|NOT COMPLETED|Prior to Week 12||0
11004677|NCT00718718|12182263|FG004|NOT COMPLETED|Prior to Week 12||3
11004678|NCT00718718|12182264|FG005|NOT COMPLETED|Prior to Week 12||0
11004679|NCT00718718|12182265|FG006|NOT COMPLETED|Prior to Week 12||1
11004680|NCT00718718|12182266|FG007|NOT COMPLETED|Prior to Week 12||2
11004681|NCT00718718|12182267|FG008|NOT COMPLETED|Prior to Week 12||2
11004682|NCT00718718|12182268|FG009|NOT COMPLETED|Prior to Week 12||0
11004683|NCT00718718|12182259|FG000|STARTED|Week 12 to End of Study||0
11004684|NCT00718718|12182260|FG001|STARTED|Week 12 to End of Study||18
11004685|NCT00718718|12182261|FG002|STARTED|Week 12 to End of Study||0
11004686|NCT00718718|12182262|FG003|STARTED|Week 12 to End of Study||16
11004687|NCT00718718|12182263|FG004|STARTED|Week 12 to End of Study||0
11004688|NCT00718718|12182264|FG005|STARTED|Week 12 to End of Study||27
11004689|NCT00718718|12182265|FG006|STARTED|Week 12 to End of Study||29
11004690|NCT00718718|12182266|FG007|STARTED|Week 12 to End of Study||28
11004691|NCT00718718|12182267|FG008|STARTED|Week 12 to End of Study||28
11004692|NCT00718718|12182268|FG009|STARTED|Week 12 to End of Study||31
11004693|NCT00718718|12182259|FG000|Treated|Week 12 to End of Study||0
11004694|NCT00718718|12182260|FG001|Treated|Week 12 to End of Study||18
11004695|NCT00718718|12182261|FG002|Treated|Week 12 to End of Study||0
11004696|NCT00718718|12182262|FG003|Treated|Week 12 to End of Study||16
11004697|NCT00718718|12182263|FG004|Treated|Week 12 to End of Study||0
11004698|NCT00718718|12182264|FG005|Treated|Week 12 to End of Study||26
11004699|NCT00718718|12182265|FG006|Treated|Week 12 to End of Study||29
11004700|NCT00718718|12182266|FG007|Treated|Week 12 to End of Study||28
11004701|NCT00718718|12182267|FG008|Treated|Week 12 to End of Study||28
11004702|NCT00718718|12182268|FG009|Treated|Week 12 to End of Study||31
11004703|NCT00718718|12182259|FG000|COMPLETED|Week 12 to End of Study||0
11004704|NCT00718718|12182260|FG001|COMPLETED|Week 12 to End of Study||17
11004705|NCT00718718|12182261|FG002|COMPLETED|Week 12 to End of Study||0
11004706|NCT00718718|12182262|FG003|COMPLETED|Week 12 to End of Study||15
11004707|NCT00718718|12182263|FG004|COMPLETED|Week 12 to End of Study||0
11004708|NCT00718718|12182264|FG005|COMPLETED|Week 12 to End of Study||24
11004709|NCT00718718|12182265|FG006|COMPLETED|Week 12 to End of Study||27
11004710|NCT00718718|12182266|FG007|COMPLETED|Week 12 to End of Study||27
11004711|NCT00718718|12182267|FG008|COMPLETED|Week 12 to End of Study||27
11004712|NCT00718718|12182268|FG009|COMPLETED|Week 12 to End of Study||31
11004713|NCT00718718|12182259|FG000|NOT COMPLETED|Week 12 to End of Study||0
11004714|NCT00718718|12182260|FG001|NOT COMPLETED|Week 12 to End of Study||1
11004715|NCT00718718|12182261|FG002|NOT COMPLETED|Week 12 to End of Study||0
11004716|NCT00718718|12182262|FG003|NOT COMPLETED|Week 12 to End of Study||1
11004717|NCT00718718|12182263|FG004|NOT COMPLETED|Week 12 to End of Study||0
11004718|NCT00718718|12182264|FG005|NOT COMPLETED|Week 12 to End of Study||3
11004719|NCT00718718|12182265|FG006|NOT COMPLETED|Week 12 to End of Study||2
11004720|NCT00718718|12182266|FG007|NOT COMPLETED|Week 12 to End of Study||1
11004721|NCT00718718|12182267|FG008|NOT COMPLETED|Week 12 to End of Study||1
11004722|NCT00718718|12182268|FG009|NOT COMPLETED|Week 12 to End of Study||0
11004723|NCT00718770|12182294|FG000|STARTED|Overall Study||10
11004724|NCT00718770|12182294|FG000|COMPLETED|Overall Study||2
11004725|NCT00718770|12182294|FG000|NOT COMPLETED|Overall Study||8
11004726|NCT00718809|12182300|FG000|STARTED|Overall Study||12
11004727|NCT00718809|12182301|FG001|STARTED|Overall Study||9
11004728|NCT00718809|12182300|FG000|COMPLETED|Overall Study||0
11004729|NCT00718809|12182301|FG001|COMPLETED|Overall Study||0
11004730|NCT00718809|12182300|FG000|NOT COMPLETED|Overall Study||12
11004731|NCT00718809|12182301|FG001|NOT COMPLETED|Overall Study||9
11004732|NCT00718861|12182309|FG000|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
11004733|NCT00718861|12182310|FG001|STARTED|Overall Study||95
11004734|NCT00718861|12182309|FG000|Safety Set|Overall Study|3 patients randomized but never received study drug|92
11004735|NCT00718861|12182310|FG001|Safety Set|Overall Study||95
11004736|NCT00718861|12182309|FG000|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
11004737|NCT00718861|12182310|FG001|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
11004738|NCT00718861|12182309|FG000|COMPLETED|Overall Study||74
11004739|NCT00718861|12182310|FG001|COMPLETED|Overall Study||77
11004740|NCT00718861|12182309|FG000|NOT COMPLETED|Overall Study||21
11004741|NCT00718861|12182310|FG001|NOT COMPLETED|Overall Study||18
11004742|NCT00718887|12182318|FG000|STARTED|Overall Study|Participants who received treatment.|89
11004743|NCT00718887|12182319|FG001|STARTED|Overall Study|Participants who received treatment.|77
11004744|NCT00718887|12182318|FG000|COMPLETED|Overall Study|Continued in study after 48 weeks|84
11004745|NCT00718887|12182319|FG001|COMPLETED|Overall Study||68
11004746|NCT00718887|12182318|FG000|NOT COMPLETED|Overall Study||5
11004747|NCT00718887|12182319|FG001|NOT COMPLETED|Overall Study||9
11004748|NCT00719043|12182338|FG000|STARTED|Overall Study||120
11004749|NCT00719043|12182339|FG001|STARTED|Overall Study||121
11004750|NCT00719043|12182340|FG002|STARTED|Overall Study||119
11004751|NCT00719043|12182341|FG003|STARTED|Overall Study||119
11004752|NCT00719043|12182342|FG004|STARTED|Overall Study||122
11004753|NCT00719043|12182343|FG005|STARTED|Overall Study||120
11004754|NCT00719043|12182344|FG006|STARTED|Overall Study||120
11004755|NCT00719043|12182338|FG000|COMPLETED|Overall Study|Up to Day 909|88
11004756|NCT00719043|12182339|FG001|COMPLETED|Overall Study|Up to Day 909|96
11004757|NCT00719043|12182340|FG002|COMPLETED|Overall Study|Up to Day 909|99
11004758|NCT00719043|12182341|FG003|COMPLETED|Overall Study|Up to Day 909|96
11004759|NCT00719043|12182342|FG004|COMPLETED|Overall Study|Up to Day 909|95
11004760|NCT00719043|12182343|FG005|COMPLETED|Overall Study|Up to Day 909|86
11004761|NCT00719043|12182344|FG006|COMPLETED|Overall Study|Up to Day 909|92
11004762|NCT00719043|12182338|FG000|NOT COMPLETED|Overall Study||32
11004763|NCT00719043|12182339|FG001|NOT COMPLETED|Overall Study||25
11004764|NCT00719043|12182340|FG002|NOT COMPLETED|Overall Study||20
11004765|NCT00719043|12182341|FG003|NOT COMPLETED|Overall Study||23
11004766|NCT00719043|12182342|FG004|NOT COMPLETED|Overall Study||27
11004767|NCT00719043|12182343|FG005|NOT COMPLETED|Overall Study||34
11004768|NCT00719043|12182344|FG006|NOT COMPLETED|Overall Study||28
11004769|NCT00719134|12182372|FG000|STARTED|Overall Study||76
11004770|NCT00719134|12182372|FG000|COMPLETED|Overall Study||66
11004771|NCT00719134|12182372|FG000|NOT COMPLETED|Overall Study||10
11004772|NCT00719160|12182377|FG000|STARTED|Overall Study||6
11004773|NCT00719160|12182378|FG001|STARTED|Overall Study||6
11004774|NCT00719160|12182377|FG000|COMPLETED|Overall Study||6
11004775|NCT00719160|12182378|FG001|COMPLETED|Overall Study||6
11004776|NCT00719160|12182377|FG000|NOT COMPLETED|Overall Study||0
11004777|NCT00719160|12182378|FG001|NOT COMPLETED|Overall Study||0
11004778|NCT00719186|12182387|FG000|STARTED|Overall Study||376
11004779|NCT00719186|12182388|FG001|STARTED|Overall Study||374
11004780|NCT00719186|12182387|FG000|COMPLETED|Overall Study||376
11004781|NCT00719186|12182388|FG001|COMPLETED|Overall Study||374
11004782|NCT00719186|12182387|FG000|NOT COMPLETED|Overall Study||0
11004783|NCT00719186|12182388|FG001|NOT COMPLETED|Overall Study||0
11004784|NCT00719212|12182394|FG000|STARTED|Overall Study||61
11004785|NCT00719212|12182394|FG000|COMPLETED|Overall Study||17
11004786|NCT00719212|12182394|FG000|NOT COMPLETED|Overall Study||44
11004787|NCT00719264|12182400|FG000|STARTED|Overall Study||182
11004788|NCT00719264|12182401|FG001|STARTED|Overall Study||183
11004789|NCT00719264|12182400|FG000|Full Analysis Set|Overall Study||182
11004790|NCT00719264|12182401|FG001|Full Analysis Set|Overall Study||183
11004791|NCT00719264|12182400|FG000|Safety Set|Overall Study||180
11004792|NCT00719264|12182401|FG001|Safety Set|Overall Study||181
11004793|NCT00719264|12182400|FG000|COMPLETED|Overall Study||0
11004794|NCT00719264|12182401|FG001|COMPLETED|Overall Study||0
11004795|NCT00719264|12182400|FG000|NOT COMPLETED|Overall Study||182
11004796|NCT00719264|12182401|FG001|NOT COMPLETED|Overall Study||183
11004797|NCT00719329|12182410|FG000|STARTED|Overall Study||705
11004798|NCT00719329|12182411|FG001|STARTED|Overall Study||571
11004799|NCT00719329|12182412|FG002|STARTED|Overall Study||647
11004800|NCT00719329|12182410|FG000|Day 1 Swab|Overall Study||705
11004801|NCT00719329|12182411|FG001|Day 1 Swab|Overall Study||569
11004802|NCT00719329|12182412|FG002|Day 1 Swab|Overall Study||646
11004803|NCT00719329|12182410|FG000|Day 3 Swab|Overall Study||614
11004804|NCT00719329|12182411|FG001|Day 3 Swab|Overall Study||501
11004805|NCT00719329|12182412|FG002|Day 3 Swab|Overall Study||578
11004806|NCT00719329|12182410|FG000|Day 7 Swab|Overall Study||593
11004807|NCT00719329|12182411|FG001|Day 7 Swab|Overall Study||467
11004808|NCT00719329|12182412|FG002|Day 7 Swab|Overall Study||561
11004809|NCT00719329|12182410|FG000|COMPLETED|Overall Study||705
11004810|NCT00719329|12182411|FG001|COMPLETED|Overall Study||569
11004811|NCT00719329|12182412|FG002|COMPLETED|Overall Study||646
11004812|NCT00719329|12182410|FG000|NOT COMPLETED|Overall Study||0
11004813|NCT00719329|12182411|FG001|NOT COMPLETED|Overall Study||2
11004814|NCT00719329|12182412|FG002|NOT COMPLETED|Overall Study||1
11004815|NCT00719355|12182425|FG000|STARTED|Overall Study||51
11004816|NCT00719355|12182426|FG001|STARTED|Overall Study||52
11004817|NCT00719355|12182425|FG000|Completed 6 Weeks|Overall Study||49
11004818|NCT00719355|12182426|FG001|Completed 6 Weeks|Overall Study||48
11004819|NCT00719355|12182425|FG000|Completed 12 Weeks|Overall Study||43
11004820|NCT00719355|12182426|FG001|Completed 12 Weeks|Overall Study||46
11004821|NCT00719355|12182425|FG000|Completed 24 Weeks|Overall Study||34
11004822|NCT00719355|12182426|FG001|Completed 24 Weeks|Overall Study||43
11004823|NCT00719355|12182425|FG000|Completed 32 Weeks|Overall Study||33
11004824|NCT00719355|12182426|FG001|Completed 32 Weeks|Overall Study||39
11004825|NCT00719355|12182425|FG000|COMPLETED|Overall Study||33
11004826|NCT00719355|12182426|FG001|COMPLETED|Overall Study||39
11004827|NCT00719355|12182425|FG000|NOT COMPLETED|Overall Study||18
11004828|NCT00719355|12182426|FG001|NOT COMPLETED|Overall Study||13
11004829|NCT00719472|12182432|FG000|STARTED|Enrolled in Study||451
11004830|NCT00719472|12182432|FG000|COMPLETED|Enrolled in Study||425
11004831|NCT00719472|12182432|FG000|NOT COMPLETED|Enrolled in Study||26
11004832|NCT00719472|12182432|FG000|STARTED|Received Cycle 1 Treatment||425
11004833|NCT00719472|12182432|FG000|COMPLETED|Received Cycle 1 Treatment||372
11004834|NCT00719472|12182432|FG000|NOT COMPLETED|Received Cycle 1 Treatment||53
11004835|NCT00719472|12182432|FG000|STARTED|Received Cycle 2 Treatment||372
11004836|NCT00719472|12182432|FG000|COMPLETED|Received Cycle 2 Treatment||304
11004837|NCT00719472|12182432|FG000|NOT COMPLETED|Received Cycle 2 Treatment||68
11004838|NCT00719537|12182438|FG000|STARTED|Overall Study||2
11004839|NCT00719537|12182439|FG001|STARTED|Overall Study||1
11004840|NCT00719537|12182438|FG000|COMPLETED|Overall Study||1
11004841|NCT00719537|12182439|FG001|COMPLETED|Overall Study||0
11004842|NCT00719537|12182438|FG000|NOT COMPLETED|Overall Study||1
11004843|NCT00719537|12182439|FG001|NOT COMPLETED|Overall Study||1
11004844|NCT00719563|12182447|FG000|STARTED|Overall Study||171
11004845|NCT00719563|12182448|FG001|STARTED|Overall Study||170
11238749|NCT02075658|12430538|FG001|NOT COMPLETED|Overall Study||2
11238750|NCT02076022|12430546|FG000|STARTED|Overall Study||7
11238751|NCT02076022|12430547|FG001|STARTED|Overall Study||3
11238752|NCT02076022|12430546|FG000|COMPLETED|Overall Study||5
11238753|NCT02076022|12430547|FG001|COMPLETED|Overall Study||3
11238754|NCT02076022|12430546|FG000|NOT COMPLETED|Overall Study||2
11238755|NCT02076022|12430547|FG001|NOT COMPLETED|Overall Study||0
11238756|NCT02076100|12430560|FG000|STARTED|Overall Study||3
11238757|NCT02076100|12430561|FG001|STARTED|Overall Study||3
11238758|NCT02076100|12430562|FG002|STARTED|Overall Study||3
11004846|NCT00719563|12182447|FG000|COMPLETED|Overall Study||133
11004847|NCT00719563|12182448|FG001|COMPLETED|Overall Study||128
11004848|NCT00719563|12182447|FG000|NOT COMPLETED|Overall Study||38
11238759|NCT02076100|12430563|FG003|STARTED|Overall Study||3
11238760|NCT02076100|12430564|FG004|STARTED|Overall Study||3
11238761|NCT02076100|12430565|FG005|STARTED|Overall Study||3
11238762|NCT02076100|12430566|FG006|STARTED|Overall Study||4
11238763|NCT02076100|12430560|FG000|COMPLETED|Overall Study||3
11238764|NCT02076100|12430561|FG001|COMPLETED|Overall Study||3
11238765|NCT02076100|12430562|FG002|COMPLETED|Overall Study||3
11238766|NCT02076100|12430563|FG003|COMPLETED|Overall Study||3
11238767|NCT02076100|12430564|FG004|COMPLETED|Overall Study||3
11238768|NCT02076100|12430565|FG005|COMPLETED|Overall Study||3
11238769|NCT02076100|12430566|FG006|COMPLETED|Overall Study||4
11238770|NCT02076100|12430560|FG000|NOT COMPLETED|Overall Study||0
11238771|NCT02076100|12430561|FG001|NOT COMPLETED|Overall Study||0
11238772|NCT02076100|12430562|FG002|NOT COMPLETED|Overall Study||0
11238773|NCT02076100|12430563|FG003|NOT COMPLETED|Overall Study||0
11238774|NCT02076100|12430564|FG004|NOT COMPLETED|Overall Study||0
11238775|NCT02076100|12430565|FG005|NOT COMPLETED|Overall Study||0
11238776|NCT02076100|12430566|FG006|NOT COMPLETED|Overall Study||0
11238777|NCT02076152|12430588|FG000|STARTED|Overall Study||2
11238778|NCT02076152|12430589|FG001|STARTED|Overall Study||9
11238779|NCT02076152|12430588|FG000|COMPLETED|Overall Study||2
11238780|NCT02076152|12430589|FG001|COMPLETED|Overall Study||9
11238781|NCT02076152|12430588|FG000|NOT COMPLETED|Overall Study||0
11238782|NCT02076152|12430589|FG001|NOT COMPLETED|Overall Study||0
11238783|NCT02076165|12430596|FG000|STARTED|Overall Study||74
11238784|NCT02076165|12430597|FG001|STARTED|Overall Study||75
11238785|NCT02076165|12430596|FG000|COMPLETED|Overall Study||66
11238786|NCT02076165|12430597|FG001|COMPLETED|Overall Study||69
11238787|NCT02076165|12430596|FG000|NOT COMPLETED|Overall Study||8
11238788|NCT02076165|12430597|FG001|NOT COMPLETED|Overall Study||6
11238789|NCT02076243|12430603|FG000|STARTED|Overall Study||2
11238790|NCT02076243|12430603|FG000|COMPLETED|Overall Study||0
11238791|NCT02076243|12430603|FG000|NOT COMPLETED|Overall Study||2
11238792|NCT02076321|12430609|FG000|STARTED|Overall Study||51
11238793|NCT02076321|12430610|FG001|STARTED|Overall Study||51
11238794|NCT02076321|12430609|FG000|COMPLETED|Overall Study||46
11238795|NCT02076321|12430610|FG001|COMPLETED|Overall Study||49
11238796|NCT02076321|12430609|FG000|NOT COMPLETED|Overall Study||5
11238797|NCT02076321|12430610|FG001|NOT COMPLETED|Overall Study||2
11238798|NCT02076334|12430620|FG000|STARTED|Overall Study||21
11238799|NCT02076334|12430621|FG001|STARTED|Overall Study||21
11238800|NCT02076334|12430622|FG002|STARTED|Overall Study||21
11238801|NCT02076334|12430623|FG003|STARTED|Overall Study||21
11238802|NCT02076334|12430620|FG000|COMPLETED|Overall Study||20
11238803|NCT02076334|12430621|FG001|COMPLETED|Overall Study||20
11004849|NCT00719563|12182448|FG001|NOT COMPLETED|Overall Study||42
11004850|NCT00719576|12182457|FG000|STARTED|Overall Study||72
11004851|NCT00719576|12182458|FG001|STARTED|Overall Study||72
11004852|NCT00719576|12182457|FG000|COMPLETED|Overall Study||70
11004853|NCT00719576|12182458|FG001|COMPLETED|Overall Study||67
11004854|NCT00719576|12182457|FG000|NOT COMPLETED|Overall Study||2
11004855|NCT00719576|12182458|FG001|NOT COMPLETED|Overall Study||5
11004856|NCT00719615|12182469|FG000|STARTED|Overall Study||42
11004857|NCT00719615|12182470|FG001|STARTED|Overall Study||45
11004858|NCT00719615|12182471|FG002|STARTED|Overall Study||24
11004859|NCT00719615|12182469|FG000|COMPLETED|Overall Study||42
11004860|NCT00719615|12182470|FG001|COMPLETED|Overall Study||45
11004861|NCT00719615|12182471|FG002|COMPLETED|Overall Study||24
11004862|NCT00719615|12182469|FG000|NOT COMPLETED|Overall Study||0
11004863|NCT00719615|12182470|FG001|NOT COMPLETED|Overall Study||0
11004864|NCT00719615|12182471|FG002|NOT COMPLETED|Overall Study||0
11004865|NCT00719680|12182479|FG000|STARTED|Overall Study||21
11004866|NCT00719680|12182479|FG000|COMPLETED|Overall Study||16
11004867|NCT00719680|12182479|FG000|NOT COMPLETED|Overall Study||5
11004868|NCT00719706|12182485|FG000|STARTED|Overall Study||20
11004869|NCT00719706|12182486|FG001|STARTED|Overall Study||20
11004870|NCT00719706|12182485|FG000|COMPLETED|Overall Study||11
11004871|NCT00719706|12182486|FG001|COMPLETED|Overall Study||14
11238804|NCT02076334|12430622|FG002|COMPLETED|Overall Study||20
11238805|NCT02076334|12430623|FG003|COMPLETED|Overall Study||20
11238806|NCT02076334|12430620|FG000|NOT COMPLETED|Overall Study||1
11238807|NCT02076334|12430621|FG001|NOT COMPLETED|Overall Study||1
11238808|NCT02076334|12430622|FG002|NOT COMPLETED|Overall Study||1
11238809|NCT02076334|12430623|FG003|NOT COMPLETED|Overall Study||1
11238810|NCT02076399|12430635|FG000|STARTED|Overall Study||51
11238811|NCT02076399|12430636|FG001|STARTED|Overall Study||25
11238812|NCT02076399|12430635|FG000|COMPLETED|Overall Study||12
11238813|NCT02076399|12430636|FG001|COMPLETED|Overall Study||1
11238814|NCT02076399|12430635|FG000|NOT COMPLETED|Overall Study||39
11238815|NCT02076399|12430636|FG001|NOT COMPLETED|Overall Study||24
11238816|NCT02076412|12430644|FG000|STARTED|Overall Study||50
11238817|NCT02076412|12430645|FG001|STARTED|Overall Study||24
11238818|NCT02076412|12430644|FG000|COMPLETED|Overall Study||13
11238819|NCT02076412|12430645|FG001|COMPLETED|Overall Study||2
11238820|NCT02076412|12430644|FG000|NOT COMPLETED|Overall Study||37
11238821|NCT02076412|12430645|FG001|NOT COMPLETED|Overall Study||22
11238822|NCT02076425|12430653|FG000|STARTED|Overall Study||114
11004872|NCT00719706|12182485|FG000|NOT COMPLETED|Overall Study||9
11238823|NCT02076425|12430654|FG001|STARTED|Overall Study||115
11004873|NCT00719706|12182486|FG001|NOT COMPLETED|Overall Study||6
11004874|NCT00719732|12182492|FG000|STARTED|Overall Study||218
11238824|NCT02076425|12430653|FG000|COMPLETED|Overall Study||100
11004875|NCT00719732|12182492|FG000|COMPLETED|Overall Study||196
11004876|NCT00719732|12182492|FG000|NOT COMPLETED|Overall Study||22
11004877|NCT00719810|12182499|FG000|STARTED|Overall Study||49
11004878|NCT00719810|12182500|FG001|STARTED|Overall Study||51
11004879|NCT00719810|12182501|FG002|STARTED|Overall Study||50
11004880|NCT00719810|12182499|FG000|COMPLETED|Overall Study||46
11004881|NCT00719810|12182500|FG001|COMPLETED|Overall Study||47
11004882|NCT00719810|12182501|FG002|COMPLETED|Overall Study||42
11004883|NCT00719810|12182499|FG000|NOT COMPLETED|Overall Study||3
11004884|NCT00719810|12182500|FG001|NOT COMPLETED|Overall Study||4
11004885|NCT00719810|12182501|FG002|NOT COMPLETED|Overall Study||8
11004886|NCT00719849|12182511|FG000|STARTED|Overall Study||4
11004887|NCT00719849|12182512|FG001|STARTED|Overall Study||9
11004888|NCT00719849|12182511|FG000|COMPLETED|Overall Study||4
11004889|NCT00719849|12182512|FG001|COMPLETED|Overall Study||8
11004890|NCT00719849|12182511|FG000|NOT COMPLETED|Overall Study||0
11004891|NCT00719849|12182512|FG001|NOT COMPLETED|Overall Study||1
11004892|NCT00719862|12182520|FG000|STARTED|Overall Study||242
11004893|NCT00719862|12182521|FG001|STARTED|Overall Study|1 subject was randomized in error|239
11004894|NCT00719862|12182520|FG000|COMPLETED|Overall Study||234
11004895|NCT00719862|12182521|FG001|COMPLETED|Overall Study||233
11004896|NCT00719862|12182520|FG000|NOT COMPLETED|Overall Study||8
11004897|NCT00719862|12182521|FG001|NOT COMPLETED|Overall Study||6
11004898|NCT00719901|12182527|FG000|STARTED|Overall Study||11
11004899|NCT00719901|12182527|FG000|COMPLETED|Overall Study||0
11004900|NCT00719901|12182527|FG000|NOT COMPLETED|Overall Study||11
11004901|NCT00719953|12182531|FG000|STARTED|Overall Study||30
11004902|NCT00719953|12182531|FG000|COMPLETED|Overall Study||26
11004903|NCT00719953|12182531|FG000|NOT COMPLETED|Overall Study||4
11004904|NCT00720057|12182537|FG000|STARTED|Overall Study||153
11004905|NCT00720057|12182538|FG001|STARTED|Overall Study||159
11004906|NCT00720057|12182537|FG000|COMPLETED|Overall Study||152
11004907|NCT00720057|12182538|FG001|COMPLETED|Overall Study||156
11004908|NCT00720057|12182537|FG000|NOT COMPLETED|Overall Study||1
11004909|NCT00720057|12182538|FG001|NOT COMPLETED|Overall Study||3
11004910|NCT00720096|12182546|FG000|STARTED|Overall Study||2
11004911|NCT00720096|12182547|FG001|STARTED|Overall Study||2
11004912|NCT00720096|12182546|FG000|COMPLETED|Overall Study||2
11004913|NCT00720096|12182547|FG001|COMPLETED|Overall Study||0
11004914|NCT00720096|12182546|FG000|NOT COMPLETED|Overall Study||0
11004915|NCT00720096|12182547|FG001|NOT COMPLETED|Overall Study||2
11004916|NCT00720109|12182553|FG000|STARTED|Induction Period||63
11004917|NCT00720109|12182554|FG001|STARTED|Induction Period||0
11004918|NCT00720109|12182555|FG002|STARTED|Induction Period||0
11004919|NCT00720109|12182553|FG000|COMPLETED|Induction Period||57
11004920|NCT00720109|12182554|FG001|COMPLETED|Induction Period||0
11004921|NCT00720109|12182555|FG002|COMPLETED|Induction Period||0
11004922|NCT00720109|12182553|FG000|NOT COMPLETED|Induction Period||6
11004923|NCT00720109|12182554|FG001|NOT COMPLETED|Induction Period||0
11004924|NCT00720109|12182555|FG002|NOT COMPLETED|Induction Period||0
11004925|NCT00720109|12182553|FG000|STARTED|Risk Stratification Period||0
11004926|NCT00720109|12182554|FG001|STARTED|Risk Stratification Period||48
11004927|NCT00720109|12182555|FG002|STARTED|Risk Stratification Period||9
11004928|NCT00720109|12182553|FG000|COMPLETED|Risk Stratification Period||0
11004929|NCT00720109|12182554|FG001|COMPLETED|Risk Stratification Period||33
11004930|NCT00720109|12182555|FG002|COMPLETED|Risk Stratification Period||1
11004931|NCT00720109|12182553|FG000|NOT COMPLETED|Risk Stratification Period||0
11004932|NCT00720109|12182554|FG001|NOT COMPLETED|Risk Stratification Period||15
11004933|NCT00720109|12182555|FG002|NOT COMPLETED|Risk Stratification Period||8
11004934|NCT00720122|12182564|FG000|STARTED|Overall Study||28
11004935|NCT00720122|12182564|FG000|COMPLETED|Overall Study||19
11004936|NCT00720122|12182564|FG000|NOT COMPLETED|Overall Study||9
11004937|NCT00720213|12182568|FG000|STARTED|Screening Phase With Diagnostic PSG||44
11004938|NCT00720213|12182569|FG001|STARTED|Screening Phase With Diagnostic PSG||0
11004939|NCT00720213|12182570|FG002|STARTED|Screening Phase With Diagnostic PSG||0
11004940|NCT00720213|12182568|FG000|COMPLETED|Screening Phase With Diagnostic PSG||37
11004941|NCT00720213|12182569|FG001|COMPLETED|Screening Phase With Diagnostic PSG||0
11004942|NCT00720213|12182570|FG002|COMPLETED|Screening Phase With Diagnostic PSG||0
11004943|NCT00720213|12182568|FG000|NOT COMPLETED|Screening Phase With Diagnostic PSG||7
11004944|NCT00720213|12182569|FG001|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
11004945|NCT00720213|12182570|FG002|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
11004946|NCT00720213|12182568|FG000|STARTED|Treatment Period||0
11004947|NCT00720213|12182569|FG001|STARTED|Treatment Period||20
11004948|NCT00720213|12182570|FG002|STARTED|Treatment Period||17
11004949|NCT00720213|12182568|FG000|COMPLETED|Treatment Period||0
11004950|NCT00720213|12182569|FG001|COMPLETED|Treatment Period||20
11004951|NCT00720213|12182570|FG002|COMPLETED|Treatment Period||17
11004952|NCT00720213|12182568|FG000|NOT COMPLETED|Treatment Period||0
11004953|NCT00720213|12182569|FG001|NOT COMPLETED|Treatment Period||0
11004954|NCT00720213|12182570|FG002|NOT COMPLETED|Treatment Period||0
11004955|NCT00720226|12182580|FG000|STARTED|Overall Study||54
11004956|NCT00720226|12182581|FG001|STARTED|Overall Study||52
11004957|NCT00720226|12182580|FG000|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
11004958|NCT00720226|12182581|FG001|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
11004959|NCT00720226|12182580|FG000|NOT COMPLETED|Overall Study||7
11004960|NCT00720226|12182581|FG001|NOT COMPLETED|Overall Study||4
11004961|NCT00720278|12182590|FG000|STARTED|Overall Study|1 subject was randomized in error|178
11004962|NCT00720278|12182591|FG001|STARTED|Overall Study|1 subject was randomized in error|170
11004963|NCT00720278|12182592|FG002|STARTED|Overall Study|1 subject was randomized in error|178
11004964|NCT00720278|12182590|FG000|COMPLETED|Overall Study||171
11004965|NCT00720278|12182591|FG001|COMPLETED|Overall Study||166
11004966|NCT00720278|12182592|FG002|COMPLETED|Overall Study||172
11004967|NCT00720278|12182590|FG000|NOT COMPLETED|Overall Study||7
11004968|NCT00720278|12182591|FG001|NOT COMPLETED|Overall Study||4
11004969|NCT00720278|12182592|FG002|NOT COMPLETED|Overall Study||6
11004970|NCT00720330|12182603|FG000|STARTED|Overall Study||5
11004971|NCT00720330|12182604|FG001|STARTED|Overall Study||4
11004972|NCT00720330|12182605|FG002|STARTED|Overall Study||3
11004973|NCT00720330|12182603|FG000|COMPLETED|Overall Study||5
11004974|NCT00720330|12182604|FG001|COMPLETED|Overall Study||4
11004975|NCT00720330|12182605|FG002|COMPLETED|Overall Study||3
11004976|NCT00720330|12182603|FG000|NOT COMPLETED|Overall Study||0
11004977|NCT00720330|12182604|FG001|NOT COMPLETED|Overall Study||0
11004978|NCT00720330|12182605|FG002|NOT COMPLETED|Overall Study||0
11004979|NCT00720356|12182613|FG000|STARTED|Registration to Study||115
11004980|NCT00720356|12182613|FG000|Completed Registration Step 1|Registration to Study||115
11004981|NCT00720356|12182613|FG000|Completed Registration Step 2|Registration to Study||48
11004982|NCT00720356|12182613|FG000|COMPLETED|Registration to Study||48
11004983|NCT00720356|12182613|FG000|NOT COMPLETED|Registration to Study||67
11004984|NCT00720356|12182613|FG000|STARTED|Reached 1st Response/2 Cycles||48
11004985|NCT00720356|12182613|FG000|COMPLETED|Reached 1st Response/2 Cycles||46
11004986|NCT00720356|12182613|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2
11004987|NCT00720356|12182613|FG000|STARTED|Went on to be Treated Cycle 3||46
11004988|NCT00720356|12182613|FG000|COMPLETED|Went on to be Treated Cycle 3||44
11004989|NCT00720356|12182613|FG000|NOT COMPLETED|Went on to be Treated Cycle 3||2
11004990|NCT00720356|12182613|FG000|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
11004991|NCT00720356|12182613|FG000|COMPLETED|Follow up Until Death||43
11004992|NCT00720356|12182613|FG000|NOT COMPLETED|Follow up Until Death||5
11004993|NCT00720369|12182619|FG000|STARTED|Overall Study||11
11004994|NCT00720369|12182620|FG001|STARTED|Overall Study||8
11004995|NCT00720369|12182619|FG000|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
11004996|NCT00720369|12182620|FG001|COMPLETED|Overall Study||8
11004997|NCT00720369|12182619|FG000|NOT COMPLETED|Overall Study||1
11004998|NCT00720369|12182620|FG001|NOT COMPLETED|Overall Study||0
11004999|NCT00720382|12182630|FG000|STARTED|Overall Study||466
11005000|NCT00720382|12182631|FG001|STARTED|Overall Study||237
11005001|NCT00720382|12182630|FG000|COMPLETED|Overall Study||290
11005002|NCT00720382|12182631|FG001|COMPLETED|Overall Study||178
11005003|NCT00720382|12182630|FG000|NOT COMPLETED|Overall Study||176
11005004|NCT00720382|12182631|FG001|NOT COMPLETED|Overall Study||59
11005005|NCT00720434|12182641|FG000|STARTED|Double-Blind Period (Week 1-4)||10
11005006|NCT00720434|12182642|FG001|STARTED|Double-Blind Period (Week 1-4)||9
11005007|NCT00720434|12182643|FG002|STARTED|Double-Blind Period (Week 1-4)||8
11005008|NCT00720434|12182644|FG003|STARTED|Double-Blind Period (Week 1-4)||8
11005009|NCT00720434|12182641|FG000|COMPLETED|Double-Blind Period (Week 1-4)||10
11005010|NCT00720434|12182642|FG001|COMPLETED|Double-Blind Period (Week 1-4)||8
11005011|NCT00720434|12182643|FG002|COMPLETED|Double-Blind Period (Week 1-4)||8
11005012|NCT00720434|12182644|FG003|COMPLETED|Double-Blind Period (Week 1-4)||8
11005013|NCT00720434|12182641|FG000|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
11005014|NCT00720434|12182642|FG001|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
11005015|NCT00720434|12182643|FG002|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
11005016|NCT00720434|12182644|FG003|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
11005017|NCT00720434|12182641|FG000|STARTED|Open-Label Period (Week 5-72)||10
11005018|NCT00720434|12182642|FG001|STARTED|Open-Label Period (Week 5-72)||8
11005019|NCT00720434|12182643|FG002|STARTED|Open-Label Period (Week 5-72)||8
11005020|NCT00720434|12182644|FG003|STARTED|Open-Label Period (Week 5-72)||8
11005021|NCT00720434|12182641|FG000|COMPLETED|Open-Label Period (Week 5-72)||4
11005022|NCT00720434|12182642|FG001|COMPLETED|Open-Label Period (Week 5-72)||5
11005023|NCT00720434|12182643|FG002|COMPLETED|Open-Label Period (Week 5-72)||4
11005024|NCT00720434|12182644|FG003|COMPLETED|Open-Label Period (Week 5-72)||4
11005025|NCT00720434|12182641|FG000|NOT COMPLETED|Open-Label Period (Week 5-72)||6
11005026|NCT00720434|12182642|FG001|NOT COMPLETED|Open-Label Period (Week 5-72)||3
11005027|NCT00720434|12182643|FG002|NOT COMPLETED|Open-Label Period (Week 5-72)||4
11005028|NCT00720434|12182644|FG003|NOT COMPLETED|Open-Label Period (Week 5-72)||4
11005029|NCT00720473|12182656|FG000|STARTED|Overall Study||45
11005030|NCT00720473|12182657|FG001|STARTED|Overall Study||24
11005031|NCT00720473|12182656|FG000|COMPLETED|Overall Study||15
11005032|NCT00720473|12182657|FG001|COMPLETED|Overall Study||16
11005033|NCT00720473|12182656|FG000|NOT COMPLETED|Overall Study||30
11005034|NCT00720473|12182657|FG001|NOT COMPLETED|Overall Study||8
11005035|NCT00720499|12182664|FG000|STARTED|Treatment Period 1 (4 Weeks)||69
11005036|NCT00720499|12182665|FG001|STARTED|Treatment Period 1 (4 Weeks)||72
11005037|NCT00720499|12182664|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||66
11005038|NCT00720499|12182665|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||70
11005039|NCT00720499|12182664|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
11005040|NCT00720499|12182665|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
11005041|NCT00720499|12182664|FG000|STARTED|Washout Period (2 Weeks)||66
11005042|NCT00720499|12182665|FG001|STARTED|Washout Period (2 Weeks)||70
11005043|NCT00720499|12182664|FG000|COMPLETED|Washout Period (2 Weeks)||66
11005044|NCT00720499|12182665|FG001|COMPLETED|Washout Period (2 Weeks)||70
11005045|NCT00720499|12182664|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
11005046|NCT00720499|12182665|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
11005047|NCT00720499|12182664|FG000|STARTED|Treatment Period 2 (4 Weeks)||66
11005048|NCT00720499|12182665|FG001|STARTED|Treatment Period 2 (4 Weeks)||70
11005049|NCT00720499|12182664|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||64
11005050|NCT00720499|12182665|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||67
11005051|NCT00720499|12182664|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
11005052|NCT00720499|12182665|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
11005053|NCT00720629|12182672|FG000|STARTED|Overall Study||8
11005054|NCT00720629|12182672|FG000|COMPLETED|Overall Study||8
11005055|NCT00720629|12182672|FG000|NOT COMPLETED|Overall Study||0
11005056|NCT00720759|12182682|FG000|STARTED|Overall Study||6
11005057|NCT00720759|12182683|FG001|STARTED|Overall Study||6
11005058|NCT00720759|12182684|FG002|STARTED|Overall Study||6
11005059|NCT00720759|12182685|FG003|STARTED|Overall Study||6
11005060|NCT00720759|12182682|FG000|COMPLETED|Overall Study||6
11005061|NCT00720759|12182683|FG001|COMPLETED|Overall Study||5
11005062|NCT00720759|12182684|FG002|COMPLETED|Overall Study||5
11005063|NCT00720759|12182685|FG003|COMPLETED|Overall Study||6
11005064|NCT00720759|12182682|FG000|NOT COMPLETED|Overall Study||0
11005065|NCT00720759|12182683|FG001|NOT COMPLETED|Overall Study||1
11005066|NCT00720759|12182684|FG002|NOT COMPLETED|Overall Study||1
11005067|NCT00720759|12182685|FG003|NOT COMPLETED|Overall Study||0
11005068|NCT00720798|12182695|FG000|STARTED|Overall Study||2067
11005069|NCT00720798|12182695|FG000|COMPLETED|Overall Study||1311
11005070|NCT00720798|12182695|FG000|NOT COMPLETED|Overall Study||756
11005071|NCT00720876|12182699|FG000|STARTED|Overall Study||30
11005072|NCT00720876|12182699|FG000|COMPLETED|Overall Study||28
11005073|NCT00720876|12182699|FG000|NOT COMPLETED|Overall Study||2
11005074|NCT00720941|12182705|FG000|STARTED|Overall Study||557
11005075|NCT00720941|12182706|FG001|STARTED|Overall Study||553
11005076|NCT00720941|12182705|FG000|Ongoing|Overall Study||34
11005077|NCT00720941|12182706|FG001|Ongoing|Overall Study||23
11005078|NCT00720941|12182705|FG000|COMPLETED|Overall Study||144
11005079|NCT00720941|12182706|FG001|COMPLETED|Overall Study||138
11005080|NCT00720941|12182705|FG000|NOT COMPLETED|Overall Study||413
11005081|NCT00720941|12182706|FG001|NOT COMPLETED|Overall Study||415
11005082|NCT00721110|12182716|FG000|STARTED|Overall Study||16
11005083|NCT00721110|12182717|FG001|STARTED|Overall Study||16
11005084|NCT00721110|12182718|FG002|STARTED|Overall Study||16
11005085|NCT00721110|12182719|FG003|STARTED|Overall Study||16
11005086|NCT00721110|12182716|FG000|COMPLETED|Overall Study||15
11005087|NCT00721110|12182717|FG001|COMPLETED|Overall Study||16
11005088|NCT00721110|12182718|FG002|COMPLETED|Overall Study||15
11005089|NCT00721110|12182719|FG003|COMPLETED|Overall Study||16
11005090|NCT00721110|12182716|FG000|NOT COMPLETED|Overall Study||1
11005091|NCT00721110|12182717|FG001|NOT COMPLETED|Overall Study||0
11005092|NCT00721110|12182718|FG002|NOT COMPLETED|Overall Study||1
11005093|NCT00721110|12182719|FG003|NOT COMPLETED|Overall Study||0
11005094|NCT00721123|12182729|FG000|STARTED|Overall Study||538
11005095|NCT00721123|12182729|FG000|COMPLETED|Overall Study||355
11122870|NCT01352221|12308599|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
11122871|NCT01352221|12308596|FG000|NOT COMPLETED|Double-blind Phase||9
11122872|NCT01352221|12308597|FG001|NOT COMPLETED|Double-blind Phase||11
11122873|NCT01352221|12308598|FG002|NOT COMPLETED|Double-blind Phase||0
11122874|NCT01352221|12308599|FG003|NOT COMPLETED|Double-blind Phase||0
11122875|NCT01352221|12308596|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0
11122876|NCT01352221|12308597|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0
11122877|NCT01352221|12308598|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
11122878|NCT01352221|12308599|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
11122879|NCT01352221|12308596|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
11122880|NCT01352221|12308597|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
11122881|NCT01352221|12308598|FG002|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
11122882|NCT01352221|12308599|FG003|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
11122883|NCT01352221|12308596|FG000|NOT COMPLETED|Open-label Phase||0
11122884|NCT01352221|12308597|FG001|NOT COMPLETED|Open-label Phase||0
11122885|NCT01352221|12308598|FG002|NOT COMPLETED|Open-label Phase||13
11122886|NCT01352221|12308599|FG003|NOT COMPLETED|Open-label Phase||11
11005096|NCT00721123|12182729|FG000|NOT COMPLETED|Overall Study||183
11005097|NCT00721136|12182753|FG000|STARTED|Overall Study||42
11005098|NCT00721136|12182754|FG001|STARTED|Overall Study||42
11005099|NCT00721136|12182755|FG002|STARTED|Overall Study||8
11005100|NCT00721136|12182756|FG003|STARTED|Overall Study||8
11005101|NCT00721136|12182753|FG000|COMPLETED|Overall Study||42
11005102|NCT00721136|12182754|FG001|COMPLETED|Overall Study||42
11005103|NCT00721136|12182755|FG002|COMPLETED|Overall Study||8
11005104|NCT00721136|12182756|FG003|COMPLETED|Overall Study||8
11122887|NCT01352286|12308611|FG000|STARTED|Overall Study||25
11122888|NCT01352286|12308611|FG000|Received T-cells|Overall Study||25
11122889|NCT01352286|12308611|FG000|COMPLETED|Overall Study||25
11122890|NCT01352286|12308611|FG000|NOT COMPLETED|Overall Study||0
11122891|NCT01352442|12308616|FG000|STARTED|Overall Study||151
11122892|NCT01352442|12308616|FG000|COMPLETED|Overall Study||139
11122893|NCT01352442|12308616|FG000|NOT COMPLETED|Overall Study||12
11122894|NCT01352468|12308622|FG000|STARTED|Overall Study||22
11122895|NCT01352468|12308623|FG001|STARTED|Overall Study||22
11122896|NCT01352468|12308622|FG000|COMPLETED|Overall Study||17
11122897|NCT01352468|12308623|FG001|COMPLETED|Overall Study||18
11122898|NCT01352468|12308622|FG000|NOT COMPLETED|Overall Study||5
11122899|NCT01352468|12308623|FG001|NOT COMPLETED|Overall Study||4
11122900|NCT01352507|12308631|FG000|STARTED|Treatment Period 1||190
11122901|NCT01352507|12308632|FG001|STARTED|Treatment Period 1||193
11122902|NCT01352507|12308631|FG000|Received Treatment|Treatment Period 1||182
11122903|NCT01352507|12308632|FG001|Received Treatment|Treatment Period 1||188
11122904|NCT01352507|12308631|FG000|COMPLETED|Treatment Period 1||176
11122905|NCT01352507|12308632|FG001|COMPLETED|Treatment Period 1||184
11122906|NCT01352507|12308631|FG000|NOT COMPLETED|Treatment Period 1||14
11122907|NCT01352507|12308632|FG001|NOT COMPLETED|Treatment Period 1||9
11122908|NCT01352507|12308631|FG000|STARTED|Washout Period||176
11122909|NCT01352507|12308632|FG001|STARTED|Washout Period||184
11122910|NCT01352507|12308631|FG000|COMPLETED|Washout Period||176
11122911|NCT01352507|12308632|FG001|COMPLETED|Washout Period||183
11122912|NCT01352507|12308631|FG000|NOT COMPLETED|Washout Period||0
11122913|NCT01352507|12308632|FG001|NOT COMPLETED|Washout Period||1
11122914|NCT01352507|12308631|FG000|STARTED|Treatment Period 2||176
11122915|NCT01352507|12308632|FG001|STARTED|Treatment Period 2||183
11122916|NCT01352507|12308631|FG000|Received Treatment|Treatment Period 2||173
11122917|NCT01352507|12308632|FG001|Received Treatment|Treatment Period 2||181
11122918|NCT01352507|12308631|FG000|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
11122919|NCT01352507|12308632|FG001|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
11122920|NCT01352507|12308631|FG000|NOT COMPLETED|Treatment Period 2||6
11122921|NCT01352507|12308632|FG001|NOT COMPLETED|Treatment Period 2||3
11122922|NCT01352507|12308631|FG000|STARTED|Extension Phase||164
11122923|NCT01352507|12308632|FG001|STARTED|Extension Phase||173
11122924|NCT01352507|12308631|FG000|COMPLETED|Extension Phase||164
11122925|NCT01352507|12308632|FG001|COMPLETED|Extension Phase||173
11122926|NCT01352507|12308631|FG000|NOT COMPLETED|Extension Phase||0
11122927|NCT01352507|12308632|FG001|NOT COMPLETED|Extension Phase||0
11122928|NCT01352546|12308644|FG000|STARTED|Overall Study||31
11122929|NCT01352546|12308644|FG000|COMPLETED|Overall Study||31
11122930|NCT01352546|12308644|FG000|NOT COMPLETED|Overall Study||0
11122931|NCT01352585|12308650|FG000|STARTED|Overall Study||23
11122932|NCT01352585|12308651|FG001|STARTED|Overall Study||24
11122933|NCT01352585|12308650|FG000|COMPLETED|Overall Study||15
11122934|NCT01352585|12308651|FG001|COMPLETED|Overall Study||21
11122935|NCT01352585|12308650|FG000|NOT COMPLETED|Overall Study||8
11122936|NCT01352585|12308651|FG001|NOT COMPLETED|Overall Study||3
11122937|NCT01352598|12308658|FG000|STARTED|Overall Study||84
11122938|NCT01352598|12308658|FG000|COMPLETED|Overall Study||72
11122939|NCT01352598|12308658|FG000|NOT COMPLETED|Overall Study||12
11122940|NCT01352637|12308666|FG000|STARTED|Exposure Therapy||97
11122941|NCT01352637|12308667|FG001|STARTED|Exposure Therapy||95
11122942|NCT01352637|12308668|FG002|STARTED|Exposure Therapy||0
11122943|NCT01352637|12308669|FG003|STARTED|Exposure Therapy||0
11122944|NCT01352637|12308666|FG000|COMPLETED|Exposure Therapy||70
11122945|NCT01352637|12308667|FG001|COMPLETED|Exposure Therapy||62
11122946|NCT01352637|12308668|FG002|COMPLETED|Exposure Therapy||0
11122947|NCT01352637|12308669|FG003|COMPLETED|Exposure Therapy||0
11122948|NCT01352637|12308666|FG000|NOT COMPLETED|Exposure Therapy||27
11122949|NCT01352637|12308667|FG001|NOT COMPLETED|Exposure Therapy||33
11122950|NCT01352637|12308668|FG002|NOT COMPLETED|Exposure Therapy||0
11122951|NCT01352637|12308669|FG003|NOT COMPLETED|Exposure Therapy||0
11122952|NCT01352637|12308666|FG000|STARTED|Drug||0
11122953|NCT01352637|12308667|FG001|STARTED|Drug||0
11122954|NCT01352637|12308668|FG002|STARTED|Drug||95
11122955|NCT01352637|12308669|FG003|STARTED|Drug||97
11122956|NCT01352637|12308666|FG000|COMPLETED|Drug||0
11122957|NCT01352637|12308667|FG001|COMPLETED|Drug||0
11122958|NCT01352637|12308668|FG002|COMPLETED|Drug||70
11122959|NCT01352637|12308669|FG003|COMPLETED|Drug||62
11122960|NCT01352637|12308666|FG000|NOT COMPLETED|Drug||0
11122961|NCT01352637|12308667|FG001|NOT COMPLETED|Drug||0
11122962|NCT01352637|12308668|FG002|NOT COMPLETED|Drug||25
11122963|NCT01352637|12308669|FG003|NOT COMPLETED|Drug||35
11122964|NCT01352715|12308681|FG000|STARTED|Overall Study||260
11122965|NCT01352715|12308682|FG001|STARTED|Overall Study||255
11122966|NCT01352715|12308681|FG000|COMPLETED|Overall Study||215
11122967|NCT01352715|12308682|FG001|COMPLETED|Overall Study||209
11122968|NCT01352715|12308681|FG000|NOT COMPLETED|Overall Study||45
11122969|NCT01352715|12308682|FG001|NOT COMPLETED|Overall Study||46
11122970|NCT01352741|12308688|FG000|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
11122971|NCT01352741|12308689|FG001|STARTED|Open-label Tapentadol Titration Period||0
11122972|NCT01352741|12308688|FG000|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
11122973|NCT01352741|12308689|FG001|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
11122974|NCT01352741|12308688|FG000|Full Analysis Set|Open-label Tapentadol Titration Period||436
11122975|NCT01352741|12308689|FG001|Full Analysis Set|Open-label Tapentadol Titration Period||0
11122976|NCT01352741|12308688|FG000|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
11122977|NCT01352741|12308689|FG001|COMPLETED|Open-label Tapentadol Titration Period||0
11122978|NCT01352741|12308688|FG000|NOT COMPLETED|Open-label Tapentadol Titration Period||73
11122979|NCT01352741|12308689|FG001|NOT COMPLETED|Open-label Tapentadol Titration Period||0
11122980|NCT01352741|12308688|FG000|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
11122981|NCT01352741|12308689|FG001|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
11122982|NCT01352741|12308688|FG000|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
11122983|NCT01352741|12308689|FG001|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
11122984|NCT01352741|12308688|FG000|No Pain Assessments Available|Double-blind Comparative Period||2
11122985|NCT01352741|12308689|FG001|No Pain Assessments Available|Double-blind Comparative Period||2
11122986|NCT01352741|12308688|FG000|Full Analysis Set|Double-blind Comparative Period||152
11122987|NCT01352741|12308689|FG001|Full Analysis Set|Double-blind Comparative Period||157
11122988|NCT01352741|12308688|FG000|Major Protocol Deviations|Double-blind Comparative Period||13
11122989|NCT01352741|12308689|FG001|Major Protocol Deviations|Double-blind Comparative Period||8
11122990|NCT01352741|12308688|FG000|Per Protocol Set|Double-blind Comparative Period||139
11122991|NCT01352741|12308689|FG001|Per Protocol Set|Double-blind Comparative Period||149
11122992|NCT01352741|12308688|FG000|painDetect Per Protocol Set|Double-blind Comparative Period||109
11122993|NCT01352741|12308689|FG001|painDetect Per Protocol Set|Double-blind Comparative Period||127
11122994|NCT01352741|12308688|FG000|SF-12 Per Protocol Set|Double-blind Comparative Period||131
11122995|NCT01352741|12308689|FG001|SF-12 Per Protocol Set|Double-blind Comparative Period||143
11122996|NCT01352741|12308688|FG000|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
11122997|NCT01352741|12308689|FG001|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
11122998|NCT01352741|12308688|FG000|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
11122999|NCT01352741|12308689|FG001|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
11123000|NCT01352741|12308688|FG000|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
11123001|NCT01352741|12308689|FG001|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
11123002|NCT01352741|12308688|FG000|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
11123003|NCT01352741|12308689|FG001|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
11123004|NCT01352741|12308688|FG000|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
11123005|NCT01352741|12308689|FG001|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
11123006|NCT01352741|12308688|FG000|COMPLETED|Double-blind Comparative Period||126
11123007|NCT01352741|12308689|FG001|COMPLETED|Double-blind Comparative Period||133
11123008|NCT01352741|12308688|FG000|NOT COMPLETED|Double-blind Comparative Period||28
11123009|NCT01352741|12308689|FG001|NOT COMPLETED|Double-blind Comparative Period||26
11123010|NCT01352741|12308688|FG000|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
11123011|NCT01352741|12308689|FG001|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
11123012|NCT01352741|12308688|FG000|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
11123013|NCT01352741|12308689|FG001|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
11123014|NCT01352741|12308688|FG000|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
11123015|NCT01352741|12308689|FG001|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
11123016|NCT01352741|12308688|FG000|COMPLETED|Open-Label Tapentadol Continuation Arm||51
11123017|NCT01352741|12308689|FG001|COMPLETED|Open-Label Tapentadol Continuation Arm||0
11123018|NCT01352741|12308688|FG000|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
11123019|NCT01352741|12308689|FG001|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
11123020|NCT01352741|12308688|FG000|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
11123021|NCT01352741|12308689|FG001|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
11123022|NCT01352741|12308688|FG000|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
11123023|NCT01352741|12308689|FG001|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
11123024|NCT01352741|12308688|FG000|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
11123025|NCT01352741|12308689|FG001|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
11123026|NCT01352793|12308711|FG000|STARTED|Overall Study||3804
11123027|NCT01352793|12308712|FG001|STARTED|Overall Study||1908
11123028|NCT01352793|12308711|FG000|Vaccination 1|Overall Study||3796
11123029|NCT01352793|12308712|FG001|Vaccination 1|Overall Study||1908
11123030|NCT01352793|12308711|FG000|Vaccination 2|Overall Study||3530
11123031|NCT01352793|12308712|FG001|Vaccination 2|Overall Study||1806
11123032|NCT01352793|12308711|FG000|Vaccination 3|Overall Study||3314
11123033|NCT01352793|12308712|FG001|Vaccination 3|Overall Study||1710
11123034|NCT01352793|12308711|FG000|COMPLETED|Overall Study||3219
11123035|NCT01352793|12308712|FG001|COMPLETED|Overall Study||1663
11123036|NCT01352793|12308711|FG000|NOT COMPLETED|Overall Study||585
11123037|NCT01352793|12308712|FG001|NOT COMPLETED|Overall Study||245
11123038|NCT01352845|12308720|FG000|STARTED|Overall Study||2471
11123039|NCT01352845|12308721|FG001|STARTED|Overall Study||822
11123040|NCT01352845|12308720|FG000|COMPLETED|Overall Study||1800
11123041|NCT01352845|12308721|FG001|COMPLETED|Overall Study||619
11123042|NCT01352845|12308720|FG000|NOT COMPLETED|Overall Study||671
11123043|NCT01352845|12308721|FG001|NOT COMPLETED|Overall Study||203
11123044|NCT01353079|12308729|FG000|STARTED|Overall Study||218
11123045|NCT01353079|12308730|FG001|STARTED|Overall Study||211
11123046|NCT01353079|12308729|FG000|COMPLETED|Overall Study||191
11123047|NCT01353079|12308730|FG001|COMPLETED|Overall Study||190
11123048|NCT01353079|12308729|FG000|NOT COMPLETED|Overall Study||27
11123049|NCT01353079|12308730|FG001|NOT COMPLETED|Overall Study||21
11123050|NCT01353144|12308740|FG000|STARTED|Overall Study||89
11123051|NCT01353144|12308741|FG001|STARTED|Overall Study||89
11123052|NCT01353144|12308740|FG000|COMPLETED|Overall Study||80
11123053|NCT01353144|12308741|FG001|COMPLETED|Overall Study||81
11123054|NCT01353144|12308740|FG000|NOT COMPLETED|Overall Study||9
11123055|NCT01353144|12308741|FG001|NOT COMPLETED|Overall Study||8
11123056|NCT01353196|12308751|FG000|STARTED|Overall Study||100
11123057|NCT01353196|12308752|FG001|STARTED|Overall Study||70
11123058|NCT01353196|12308751|FG000|COMPLETED|Overall Study||71
11123059|NCT01353196|12308752|FG001|COMPLETED|Overall Study||59
11123060|NCT01353196|12308751|FG000|NOT COMPLETED|Overall Study||29
11123061|NCT01353196|12308752|FG001|NOT COMPLETED|Overall Study||11
11123062|NCT01353222|12308760|FG000|STARTED|Overall Study||70
11123063|NCT01353222|12308761|FG001|STARTED|Overall Study||72
11123064|NCT01353222|12308760|FG000|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
11238825|NCT02076425|12430654|FG001|COMPLETED|Overall Study||91
11238826|NCT02076425|12430653|FG000|NOT COMPLETED|Overall Study||14
11238827|NCT02076425|12430654|FG001|NOT COMPLETED|Overall Study||24
11123065|NCT01353222|12308761|FG001|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
11123066|NCT01353222|12308760|FG000|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
11123067|NCT01353222|12308761|FG001|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
11123068|NCT01353222|12308760|FG000|COMPLETED|Overall Study||0
11123069|NCT01353222|12308761|FG001|COMPLETED|Overall Study||0
11123070|NCT01353222|12308760|FG000|NOT COMPLETED|Overall Study||70
11123071|NCT01353222|12308761|FG001|NOT COMPLETED|Overall Study||72
11123072|NCT01353274|12308767|FG000|STARTED|Overall Study||1157
11123073|NCT01353274|12308767|FG000|COMPLETED|Overall Study||1129
11123074|NCT01353274|12308767|FG000|NOT COMPLETED|Overall Study||28
11123075|NCT01353495|12308773|FG000|STARTED|Overall Study||19
11123076|NCT01353495|12308774|FG001|STARTED|Overall Study||20
11123077|NCT01353495|12308773|FG000|COMPLETED|Overall Study||19
11123078|NCT01353495|12308774|FG001|COMPLETED|Overall Study||20
11123079|NCT01353495|12308773|FG000|NOT COMPLETED|Overall Study||0
11123080|NCT01353495|12308774|FG001|NOT COMPLETED|Overall Study||0
11123081|NCT01353508|12308784|FG000|STARTED|Period 1 - First Intervention (7 Days)||8
11123082|NCT01353508|12308785|FG001|STARTED|Period 1 - First Intervention (7 Days)||8
11123083|NCT01353508|12308786|FG002|STARTED|Period 1 - First Intervention (7 Days)||8
11123084|NCT01353508|12308787|FG003|STARTED|Period 1 - First Intervention (7 Days)||8
11123085|NCT01353508|12308784|FG000|COMPLETED|Period 1 - First Intervention (7 Days)||8
11123086|NCT01353508|12308785|FG001|COMPLETED|Period 1 - First Intervention (7 Days)||8
11123087|NCT01353508|12308786|FG002|COMPLETED|Period 1 - First Intervention (7 Days)||8
11123088|NCT01353508|12308787|FG003|COMPLETED|Period 1 - First Intervention (7 Days)||7
11123089|NCT01353508|12308784|FG000|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
11123090|NCT01353508|12308785|FG001|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
11123091|NCT01353508|12308786|FG002|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
11123092|NCT01353508|12308787|FG003|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
11123093|NCT01353508|12308784|FG000|STARTED|Period 2 - Second Intervention (7 Days)||8
11123094|NCT01353508|12308785|FG001|STARTED|Period 2 - Second Intervention (7 Days)||8
11123095|NCT01353508|12308786|FG002|STARTED|Period 2 - Second Intervention (7 Days)||8
11123096|NCT01353508|12308787|FG003|STARTED|Period 2 - Second Intervention (7 Days)||7
11123097|NCT01353508|12308784|FG000|COMPLETED|Period 2 - Second Intervention (7 Days)||7
11123098|NCT01353508|12308785|FG001|COMPLETED|Period 2 - Second Intervention (7 Days)||8
11123099|NCT01353508|12308786|FG002|COMPLETED|Period 2 - Second Intervention (7 Days)||8
11123100|NCT01353508|12308787|FG003|COMPLETED|Period 2 - Second Intervention (7 Days)||7
11123101|NCT01353508|12308784|FG000|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
11123102|NCT01353508|12308785|FG001|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
11123103|NCT01353508|12308786|FG002|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
11123104|NCT01353508|12308787|FG003|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
11123105|NCT01353586|12308799|FG000|STARTED|Overall Study||167
11123106|NCT01353586|12308800|FG001|STARTED|Overall Study||19
11123107|NCT01353586|12308799|FG000|Participated in Workflow Phase|Overall Study||20
11123108|NCT01353586|12308800|FG001|Participated in Workflow Phase|Overall Study||0
11123109|NCT01353586|12308799|FG000|Participated in Roll-in Phase|Overall Study||22
11123110|NCT01353586|12308800|FG001|Participated in Roll-in Phase|Overall Study||0
11123111|NCT01353586|12308799|FG000|Participated in SNA Substudy|Overall Study||19
11123112|NCT01353586|12308800|FG001|Participated in SNA Substudy|Overall Study||19
11123113|NCT01353586|12308799|FG000|COMPLETED|Overall Study||160
11123114|NCT01353586|12308800|FG001|COMPLETED|Overall Study||17
11123115|NCT01353586|12308799|FG000|NOT COMPLETED|Overall Study||7
11123116|NCT01353586|12308800|FG001|NOT COMPLETED|Overall Study||2
11123117|NCT01353664|12308809|FG000|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
11123118|NCT01353664|12308809|FG000|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
11123119|NCT01353664|12308809|FG000|NOT COMPLETED|Overall Study||19
11123120|NCT01353703|12308815|FG000|STARTED|Overall Study||112
11123121|NCT01353703|12308816|FG001|STARTED|Overall Study||112
11123122|NCT01353703|12308815|FG000|COMPLETED|Overall Study||111
11123123|NCT01353703|12308816|FG001|COMPLETED|Overall Study||112
11123124|NCT01353703|12308815|FG000|NOT COMPLETED|Overall Study||1
11123125|NCT01353703|12308816|FG001|NOT COMPLETED|Overall Study||0
11123126|NCT01353859|12308824|FG000|STARTED|Overall Study||39
11123127|NCT01353859|12308824|FG000|COMPLETED|Overall Study||35
11123128|NCT01353859|12308824|FG000|NOT COMPLETED|Overall Study||4
11123129|NCT01353898|12308834|FG000|STARTED|Overall Study||2
11123130|NCT01353898|12308835|FG001|STARTED|Overall Study||2
11123131|NCT01353898|12308836|FG002|STARTED|Overall Study||2
11123132|NCT01353898|12308837|FG003|STARTED|Overall Study||2
11123133|NCT01353898|12308838|FG004|STARTED|Overall Study||2
11123134|NCT01353898|12308839|FG005|STARTED|Overall Study||2
11123135|NCT01353898|12308834|FG000|COMPLETED|Overall Study||2
11123136|NCT01353898|12308835|FG001|COMPLETED|Overall Study||2
11123137|NCT01353898|12308836|FG002|COMPLETED|Overall Study||2
11123138|NCT01353898|12308837|FG003|COMPLETED|Overall Study||2
11123139|NCT01353898|12308838|FG004|COMPLETED|Overall Study||2
11123140|NCT01353898|12308839|FG005|COMPLETED|Overall Study||1
11123141|NCT01353898|12308834|FG000|NOT COMPLETED|Overall Study||0
11123142|NCT01353898|12308835|FG001|NOT COMPLETED|Overall Study||0
11123143|NCT01353898|12308836|FG002|NOT COMPLETED|Overall Study||0
11123144|NCT01353898|12308837|FG003|NOT COMPLETED|Overall Study||0
11123145|NCT01353898|12308838|FG004|NOT COMPLETED|Overall Study||0
11123146|NCT01353898|12308839|FG005|NOT COMPLETED|Overall Study||1
11123147|NCT01353911|12308861|FG000|STARTED|Overall Study||36
11123148|NCT01353911|12308862|FG001|STARTED|Overall Study||66
11123149|NCT01353911|12308863|FG002|STARTED|Overall Study||68
11123150|NCT01353911|12308864|FG003|STARTED|Overall Study||24
11123151|NCT01353911|12308865|FG004|STARTED|Overall Study||29
11123152|NCT01353911|12308866|FG005|STARTED|Overall Study||43
11123153|NCT01353911|12308867|FG006|STARTED|Overall Study||36
11123154|NCT01353911|12308868|FG007|STARTED|Overall Study||66
11123155|NCT01353911|12308861|FG000|COMPLETED|Overall Study||28
11123156|NCT01353911|12308862|FG001|COMPLETED|Overall Study||57
11123157|NCT01353911|12308863|FG002|COMPLETED|Overall Study||59
11123158|NCT01353911|12308864|FG003|COMPLETED|Overall Study||22
11123159|NCT01353911|12308865|FG004|COMPLETED|Overall Study||23
11123160|NCT01353911|12308866|FG005|COMPLETED|Overall Study||36
11123161|NCT01353911|12308867|FG006|COMPLETED|Overall Study||30
11123162|NCT01353911|12308868|FG007|COMPLETED|Overall Study||51
11123163|NCT01353911|12308861|FG000|NOT COMPLETED|Overall Study||8
11123164|NCT01353911|12308862|FG001|NOT COMPLETED|Overall Study||9
11123165|NCT01353911|12308863|FG002|NOT COMPLETED|Overall Study||9
11123166|NCT01353911|12308864|FG003|NOT COMPLETED|Overall Study||2
11123167|NCT01353911|12308865|FG004|NOT COMPLETED|Overall Study||6
11123168|NCT01353911|12308866|FG005|NOT COMPLETED|Overall Study||7
11123169|NCT01353911|12308867|FG006|NOT COMPLETED|Overall Study||6
11123170|NCT01353911|12308868|FG007|NOT COMPLETED|Overall Study||15
11123171|NCT01353963|12308886|FG000|STARTED|Overall Study||13
11123172|NCT01353963|12308886|FG000|COMPLETED|Overall Study||11
11123173|NCT01353963|12308886|FG000|NOT COMPLETED|Overall Study||2
11123174|NCT01353976|12308892|FG000|STARTED|Overall Study||130
11123175|NCT01353976|12308893|FG001|STARTED|Overall Study||134
11123176|NCT01353976|12308892|FG000|COMPLETED|Overall Study||82
11123177|NCT01353976|12308893|FG001|COMPLETED|Overall Study||83
11123178|NCT01353976|12308892|FG000|NOT COMPLETED|Overall Study||48
11123179|NCT01353976|12308893|FG001|NOT COMPLETED|Overall Study||51
11123180|NCT01354015|12308901|FG000|STARTED|Overall Study||50
11123181|NCT01354015|12308902|FG001|STARTED|Overall Study||48
11123182|NCT01354015|12308901|FG000|COMPLETED|Overall Study||44
11123183|NCT01354015|12308902|FG001|COMPLETED|Overall Study||43
11123184|NCT01354015|12308901|FG000|NOT COMPLETED|Overall Study||6
11123185|NCT01354015|12308902|FG001|NOT COMPLETED|Overall Study||5
11123186|NCT01354028|12308908|FG000|STARTED|Overall Study||15
11123187|NCT01354028|12308909|FG001|STARTED|Overall Study||15
11123188|NCT01354028|12308908|FG000|COMPLETED|Overall Study||13
11123189|NCT01354028|12308909|FG001|COMPLETED|Overall Study||10
11123190|NCT01354028|12308908|FG000|NOT COMPLETED|Overall Study||2
11123191|NCT01354028|12308909|FG001|NOT COMPLETED|Overall Study||5
11123192|NCT01354106|12308921|FG000|STARTED|Overall Study||26
11123193|NCT01354106|12308921|FG000|COMPLETED|Overall Study||24
11123194|NCT01354106|12308921|FG000|NOT COMPLETED|Overall Study||2
11123195|NCT01354132|12308929|FG000|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
11123196|NCT01354132|12308930|FG001|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
11123197|NCT01354132|12308929|FG000|COMPLETED|Randomization||31
11123198|NCT01354132|12308930|FG001|COMPLETED|Randomization||30
11123199|NCT01354132|12308929|FG000|NOT COMPLETED|Randomization||1
11123200|NCT01354132|12308930|FG001|NOT COMPLETED|Randomization||1
11123201|NCT01354132|12308929|FG000|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
11123202|NCT01354132|12308930|FG001|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
11123203|NCT01354132|12308929|FG000|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
11123204|NCT01354132|12308930|FG001|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
11123205|NCT01354132|12308929|FG000|Stopped After First Visit|Double Blind (Visits 1-7)||3
11123206|NCT01354132|12308930|FG001|Stopped After First Visit|Double Blind (Visits 1-7)||2
11123207|NCT01354132|12308929|FG000|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
11123208|NCT01354132|12308930|FG001|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
11123209|NCT01354132|12308929|FG000|COMPLETED|Double Blind (Visits 1-7)||22
11123210|NCT01354132|12308930|FG001|COMPLETED|Double Blind (Visits 1-7)||19
11123211|NCT01354132|12308929|FG000|NOT COMPLETED|Double Blind (Visits 1-7)||9
11123212|NCT01354132|12308930|FG001|NOT COMPLETED|Double Blind (Visits 1-7)||11
11123213|NCT01354132|12308929|FG000|STARTED|1 Month Post Study Medication||22
11123214|NCT01354132|12308930|FG001|STARTED|1 Month Post Study Medication||19
11123215|NCT01354132|12308929|FG000|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
11123216|NCT01354132|12308930|FG001|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
11123217|NCT01354132|12308929|FG000|COMPLETED|1 Month Post Study Medication||21
11123218|NCT01354132|12308930|FG001|COMPLETED|1 Month Post Study Medication||16
11123219|NCT01354132|12308929|FG000|NOT COMPLETED|1 Month Post Study Medication||1
11123220|NCT01354132|12308930|FG001|NOT COMPLETED|1 Month Post Study Medication||3
11123221|NCT01354145|12308941|FG000|STARTED|Overall Study||97
11123222|NCT01354145|12308942|FG001|STARTED|Overall Study||97
11123223|NCT01354145|12308941|FG000|COMPLETED|Overall Study||58
11123224|NCT01354145|12308942|FG001|COMPLETED|Overall Study||63
11123225|NCT01354145|12308941|FG000|NOT COMPLETED|Overall Study||39
11123226|NCT01354145|12308942|FG001|NOT COMPLETED|Overall Study||34
11123227|NCT01354197|12308950|FG000|STARTED|Overall Study||4652
11123228|NCT01354197|12308950|FG000|COMPLETED|Overall Study||4652
11123229|NCT01354197|12308950|FG000|NOT COMPLETED|Overall Study||0
11123230|NCT01354223|12308957|FG000|STARTED|Overall Study||60
11123231|NCT01354223|12308958|FG001|STARTED|Overall Study||30
11123232|NCT01354223|12308957|FG000|COMPLETED|Overall Study||57
11123233|NCT01354223|12308958|FG001|COMPLETED|Overall Study||29
11123234|NCT01354223|12308957|FG000|NOT COMPLETED|Overall Study||3
11123235|NCT01354223|12308958|FG001|NOT COMPLETED|Overall Study||1
11123236|NCT01354314|12308968|FG000|STARTED|Overall Study||12
11123237|NCT01354314|12308969|FG001|STARTED|Overall Study||11
11123238|NCT01354314|12308970|FG002|STARTED|Overall Study||11
11123239|NCT01354314|12308971|FG003|STARTED|Overall Study||11
11123240|NCT01354314|12308968|FG000|Completed (ITT)|Overall Study||11
11123241|NCT01354314|12308969|FG001|Completed (ITT)|Overall Study||11
11123242|NCT01354314|12308970|FG002|Completed (ITT)|Overall Study||9
11123243|NCT01354314|12308971|FG003|Completed (ITT)|Overall Study||10
11123244|NCT01354314|12308968|FG000|COMPLETED|Overall Study||6
11123245|NCT01354314|12308969|FG001|COMPLETED|Overall Study||8
11123246|NCT01354314|12308970|FG002|COMPLETED|Overall Study||3
11123247|NCT01354314|12308971|FG003|COMPLETED|Overall Study||5
11123248|NCT01354314|12308968|FG000|NOT COMPLETED|Overall Study||6
11123249|NCT01354314|12308969|FG001|NOT COMPLETED|Overall Study||3
11123250|NCT01354314|12308970|FG002|NOT COMPLETED|Overall Study||8
11123251|NCT01354314|12308971|FG003|NOT COMPLETED|Overall Study||6
11123252|NCT01354444|12308985|FG000|STARTED|Overall Study||14
11123253|NCT01354444|12308986|FG001|STARTED|Overall Study||15
11123254|NCT01354444|12308985|FG000|COMPLETED|Overall Study||6
11123255|NCT01354444|12308986|FG001|COMPLETED|Overall Study||11
11123256|NCT01354444|12308985|FG000|NOT COMPLETED|Overall Study||8
11123257|NCT01354444|12308986|FG001|NOT COMPLETED|Overall Study||4
11123258|NCT01354496|12308996|FG000|STARTED|Period 1||6
11123259|NCT01354496|12308997|FG001|STARTED|Period 1||6
11123260|NCT01354496|12308998|FG002|STARTED|Period 1||6
11123261|NCT01354496|12308999|FG003|STARTED|Period 1||6
11123262|NCT01354496|12309000|FG004|STARTED|Period 1||5
11123263|NCT01354496|12309001|FG005|STARTED|Period 1||6
11123264|NCT01354496|12308996|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
11123265|NCT01354496|12308997|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
11123266|NCT01354496|12308998|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
11123267|NCT01354496|12308999|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
11201957|NCT01836458|12392341|FG000|STARTED|Overall Study||7
11123268|NCT01354496|12309000|FG004|Received at Least 1 Dose of Study Drug|Period 1||5
11123269|NCT01354496|12309001|FG005|Received at Least 1 Dose of Study Drug|Period 1||6
11123270|NCT01354496|12308996|FG000|COMPLETED|Period 1||6
11123271|NCT01354496|12308997|FG001|COMPLETED|Period 1||6
11123272|NCT01354496|12308998|FG002|COMPLETED|Period 1||4
11123273|NCT01354496|12308999|FG003|COMPLETED|Period 1||6
11123274|NCT01354496|12309000|FG004|COMPLETED|Period 1||5
11123275|NCT01354496|12309001|FG005|COMPLETED|Period 1||6
11123276|NCT01354496|12308996|FG000|NOT COMPLETED|Period 1||0
11123277|NCT01354496|12308997|FG001|NOT COMPLETED|Period 1||0
11123278|NCT01354496|12308998|FG002|NOT COMPLETED|Period 1||2
11123279|NCT01354496|12308999|FG003|NOT COMPLETED|Period 1||0
11123280|NCT01354496|12309000|FG004|NOT COMPLETED|Period 1||0
11123281|NCT01354496|12309001|FG005|NOT COMPLETED|Period 1||0
11123282|NCT01354496|12308996|FG000|STARTED|Washout (at Least 14 Days)||6
11123283|NCT01354496|12308997|FG001|STARTED|Washout (at Least 14 Days)||6
11123284|NCT01354496|12308998|FG002|STARTED|Washout (at Least 14 Days)||4
11123285|NCT01354496|12308999|FG003|STARTED|Washout (at Least 14 Days)||6
11123286|NCT01354496|12309000|FG004|STARTED|Washout (at Least 14 Days)||5
11123287|NCT01354496|12309001|FG005|STARTED|Washout (at Least 14 Days)||6
11123288|NCT01354496|12308996|FG000|COMPLETED|Washout (at Least 14 Days)||6
11123289|NCT01354496|12308997|FG001|COMPLETED|Washout (at Least 14 Days)||6
11123290|NCT01354496|12308998|FG002|COMPLETED|Washout (at Least 14 Days)||4
11123291|NCT01354496|12308999|FG003|COMPLETED|Washout (at Least 14 Days)||6
11123292|NCT01354496|12309000|FG004|COMPLETED|Washout (at Least 14 Days)||5
11123293|NCT01354496|12309001|FG005|COMPLETED|Washout (at Least 14 Days)||6
11123294|NCT01354496|12308996|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
11123295|NCT01354496|12308997|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
11123296|NCT01354496|12308998|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
11123297|NCT01354496|12308999|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0
11123298|NCT01354496|12309000|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0
11123299|NCT01354496|12309001|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0
11123300|NCT01354496|12308996|FG000|STARTED|Period 2||6
11123301|NCT01354496|12308997|FG001|STARTED|Period 2||6
11123302|NCT01354496|12308998|FG002|STARTED|Period 2||4
11123303|NCT01354496|12308999|FG003|STARTED|Period 2||6
11123304|NCT01354496|12309000|FG004|STARTED|Period 2||5
11123305|NCT01354496|12309001|FG005|STARTED|Period 2||6
11123306|NCT01354496|12308996|FG000|COMPLETED|Period 2||6
11123307|NCT01354496|12308997|FG001|COMPLETED|Period 2||6
11123308|NCT01354496|12308998|FG002|COMPLETED|Period 2||4
11123309|NCT01354496|12308999|FG003|COMPLETED|Period 2||5
11123310|NCT01354496|12309000|FG004|COMPLETED|Period 2||5
11123311|NCT01354496|12309001|FG005|COMPLETED|Period 2||6
11123312|NCT01354496|12308996|FG000|NOT COMPLETED|Period 2||0
11123313|NCT01354496|12308997|FG001|NOT COMPLETED|Period 2||0
11123314|NCT01354496|12308998|FG002|NOT COMPLETED|Period 2||0
11123315|NCT01354496|12308999|FG003|NOT COMPLETED|Period 2||1
11123316|NCT01354496|12309000|FG004|NOT COMPLETED|Period 2||0
11123317|NCT01354496|12309001|FG005|NOT COMPLETED|Period 2||0
11123318|NCT01354496|12308996|FG000|STARTED|Washout (at Least 14 Days)||6
11123319|NCT01354496|12308997|FG001|STARTED|Washout (at Least 14 Days)||6
11123320|NCT01354496|12308998|FG002|STARTED|Washout (at Least 14 Days)||4
11123321|NCT01354496|12308999|FG003|STARTED|Washout (at Least 14 Days)||5
11123322|NCT01354496|12309000|FG004|STARTED|Washout (at Least 14 Days)||5
11123323|NCT01354496|12309001|FG005|STARTED|Washout (at Least 14 Days)||6
11123324|NCT01354496|12308996|FG000|COMPLETED|Washout (at Least 14 Days)||6
11123325|NCT01354496|12308997|FG001|COMPLETED|Washout (at Least 14 Days)||5
11123326|NCT01354496|12308998|FG002|COMPLETED|Washout (at Least 14 Days)||4
11123327|NCT01354496|12308999|FG003|COMPLETED|Washout (at Least 14 Days)||4
11123328|NCT01354496|12309000|FG004|COMPLETED|Washout (at Least 14 Days)||5
11123329|NCT01354496|12309001|FG005|COMPLETED|Washout (at Least 14 Days)||6
11123330|NCT01354496|12308996|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
11123331|NCT01354496|12308997|FG001|NOT COMPLETED|Washout (at Least 14 Days)||1
11123332|NCT01354496|12308998|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
11123333|NCT01354496|12308999|FG003|NOT COMPLETED|Washout (at Least 14 Days)||1
11123334|NCT01354496|12309000|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0
11123335|NCT01354496|12309001|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0
11123336|NCT01354496|12308996|FG000|STARTED|Period 3||6
11123337|NCT01354496|12308997|FG001|STARTED|Period 3||5
11123338|NCT01354496|12308998|FG002|STARTED|Period 3||4
11123339|NCT01354496|12308999|FG003|STARTED|Period 3||4
11123340|NCT01354496|12309000|FG004|STARTED|Period 3||5
11123341|NCT01354496|12309001|FG005|STARTED|Period 3||6
11123342|NCT01354496|12308996|FG000|COMPLETED|Period 3||6
11123343|NCT01354496|12308997|FG001|COMPLETED|Period 3||5
11123344|NCT01354496|12308998|FG002|COMPLETED|Period 3||4
11123345|NCT01354496|12308999|FG003|COMPLETED|Period 3||4
11123346|NCT01354496|12309000|FG004|COMPLETED|Period 3||5
11123347|NCT01354496|12309001|FG005|COMPLETED|Period 3||6
11123348|NCT01354496|12308996|FG000|NOT COMPLETED|Period 3||0
11123349|NCT01354496|12308997|FG001|NOT COMPLETED|Period 3||0
11123350|NCT01354496|12308998|FG002|NOT COMPLETED|Period 3||0
11123351|NCT01354496|12308999|FG003|NOT COMPLETED|Period 3||0
11123352|NCT01354496|12309000|FG004|NOT COMPLETED|Period 3||0
11123353|NCT01354496|12309001|FG005|NOT COMPLETED|Period 3||0
11123354|NCT01354652|12309025|FG000|STARTED|Overall Study||3
11123355|NCT01354652|12309026|FG001|STARTED|Overall Study||2
11123356|NCT01354652|12309027|FG002|STARTED|Overall Study||0
11123357|NCT01354652|12309025|FG000|COMPLETED|Overall Study||0
11123358|NCT01354652|12309026|FG001|COMPLETED|Overall Study||0
11123359|NCT01354652|12309027|FG002|COMPLETED|Overall Study||0
11123360|NCT01354652|12309025|FG000|NOT COMPLETED|Overall Study||3
11123361|NCT01354652|12309026|FG001|NOT COMPLETED|Overall Study||2
11123362|NCT01354652|12309027|FG002|NOT COMPLETED|Overall Study||0
11123363|NCT01354691|12309038|FG000|STARTED|Overall Study||101
11123364|NCT01354691|12309039|FG001|STARTED|Overall Study||99
11123365|NCT01354691|12309038|FG000|ITT|Overall Study||99
11123366|NCT01354691|12309039|FG001|ITT|Overall Study||96
11123367|NCT01354691|12309038|FG000|PP|Overall Study||79
11123368|NCT01354691|12309039|FG001|PP|Overall Study||75
11123369|NCT01354691|12309038|FG000|COMPLETED|Overall Study||80
11123370|NCT01354691|12309039|FG001|COMPLETED|Overall Study||77
11123371|NCT01354691|12309038|FG000|NOT COMPLETED|Overall Study||21
11123372|NCT01354691|12309039|FG001|NOT COMPLETED|Overall Study||22
11123373|NCT01354899|12309045|FG000|STARTED|Overall Study||24
11123374|NCT01354899|12309045|FG000|COMPLETED|Overall Study||21
11123375|NCT01354899|12309045|FG000|NOT COMPLETED|Overall Study||3
11123376|NCT01354938|12309049|FG000|STARTED|Overall Study||220
11123377|NCT01354938|12309049|FG000|COMPLETED|Overall Study||219
11123378|NCT01354938|12309049|FG000|NOT COMPLETED|Overall Study||1
11123379|NCT01354964|12309055|FG000|STARTED|Overall Study||11
11123380|NCT01354964|12309056|FG001|STARTED|Overall Study||8
11123381|NCT01354964|12309055|FG000|COMPLETED|Overall Study||7
11123382|NCT01354964|12309056|FG001|COMPLETED|Overall Study||7
11123383|NCT01354964|12309055|FG000|NOT COMPLETED|Overall Study||4
11123384|NCT01354964|12309056|FG001|NOT COMPLETED|Overall Study||1
11123385|NCT01354990|12309064|FG000|STARTED|Overall Study||2974
11123386|NCT01354990|12309064|FG000|COMPLETED|Overall Study||2974
11123387|NCT01354990|12309064|FG000|NOT COMPLETED|Overall Study||0
11123388|NCT01355068|12309068|FG000|STARTED|First Intervention Period||13
11123389|NCT01355068|12309069|FG001|STARTED|First Intervention Period||13
11123390|NCT01355068|12309068|FG000|COMPLETED|First Intervention Period||13
11123391|NCT01355068|12309069|FG001|COMPLETED|First Intervention Period||11
11123392|NCT01355068|12309068|FG000|NOT COMPLETED|First Intervention Period||0
11123393|NCT01355068|12309069|FG001|NOT COMPLETED|First Intervention Period||2
11123394|NCT01355068|12309068|FG000|STARTED|Washout Period (at Least 7 Days)||13
11123395|NCT01355068|12309069|FG001|STARTED|Washout Period (at Least 7 Days)||11
11123396|NCT01355068|12309068|FG000|COMPLETED|Washout Period (at Least 7 Days)||13
11123397|NCT01355068|12309069|FG001|COMPLETED|Washout Period (at Least 7 Days)||11
11123398|NCT01355068|12309068|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11123399|NCT01355068|12309069|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11123400|NCT01355068|12309068|FG000|STARTED|Second Intervention Period||13
11123401|NCT01355068|12309069|FG001|STARTED|Second Intervention Period||11
11123402|NCT01355068|12309068|FG000|COMPLETED|Second Intervention Period||13
11123403|NCT01355068|12309069|FG001|COMPLETED|Second Intervention Period||11
11123404|NCT01355068|12309068|FG000|NOT COMPLETED|Second Intervention Period||0
11123405|NCT01355068|12309069|FG001|NOT COMPLETED|Second Intervention Period||0
11123406|NCT01355081|12309078|FG000|STARTED|Overall Study||119
11123407|NCT01355081|12309079|FG001|STARTED|Overall Study||123
11123408|NCT01355081|12309080|FG002|STARTED|Overall Study||124
11123409|NCT01355081|12309078|FG000|COMPLETED|Overall Study||112
11123410|NCT01355081|12309079|FG001|COMPLETED|Overall Study||113
11123411|NCT01355081|12309080|FG002|COMPLETED|Overall Study||113
11123412|NCT01355081|12309078|FG000|NOT COMPLETED|Overall Study||7
11123413|NCT01355081|12309079|FG001|NOT COMPLETED|Overall Study||10
11123414|NCT01355081|12309080|FG002|NOT COMPLETED|Overall Study||11
11123415|NCT01355159|12309090|FG000|STARTED|Overall Study||1228
11123416|NCT01355159|12309091|FG001|STARTED|Overall Study||1236
11123417|NCT01355159|12309090|FG000|COMPLETED|Overall Study||1144
11123418|NCT01355159|12309091|FG001|COMPLETED|Overall Study||1157
11123419|NCT01355159|12309090|FG000|NOT COMPLETED|Overall Study||84
11123420|NCT01355159|12309091|FG001|NOT COMPLETED|Overall Study||79
11123421|NCT01355224|12309101|FG000|STARTED|Overall Study||198
11123422|NCT01355224|12309102|FG001|STARTED|Overall Study||203
11123423|NCT01355224|12309103|FG002|STARTED|Overall Study||196
11123424|NCT01355224|12309104|FG003|STARTED|Overall Study||201
11123425|NCT01355224|12309101|FG000|Competed Baseline|Overall Study||191
11123426|NCT01355224|12309102|FG001|Competed Baseline|Overall Study||200
11123427|NCT01355224|12309103|FG002|Competed Baseline|Overall Study||193
11123428|NCT01355224|12309104|FG003|Competed Baseline|Overall Study||193
11123429|NCT01355224|12309101|FG000|COMPLETED|Overall Study||167
11123430|NCT01355224|12309102|FG001|COMPLETED|Overall Study||180
11123431|NCT01355224|12309103|FG002|COMPLETED|Overall Study||177
11123432|NCT01355224|12309104|FG003|COMPLETED|Overall Study||172
11123433|NCT01355224|12309101|FG000|NOT COMPLETED|Overall Study||31
11123434|NCT01355224|12309102|FG001|NOT COMPLETED|Overall Study||23
11123435|NCT01355224|12309103|FG002|NOT COMPLETED|Overall Study||19
11123436|NCT01355224|12309104|FG003|NOT COMPLETED|Overall Study||29
11123437|NCT01355289|12309126|FG000|STARTED|Core Study||17
11123438|NCT01355289|12309127|FG001|STARTED|Core Study||16
11123439|NCT01355289|12309128|FG002|STARTED|Core Study||18
11123440|NCT01355289|12309129|FG003|STARTED|Core Study||14
11123441|NCT01355289|12309130|FG004|STARTED|Core Study||0
11123442|NCT01355289|12309126|FG000|COMPLETED|Core Study||16
11123443|NCT01355289|12309127|FG001|COMPLETED|Core Study||16
11123444|NCT01355289|12309128|FG002|COMPLETED|Core Study||18
11123445|NCT01355289|12309129|FG003|COMPLETED|Core Study||12
11123446|NCT01355289|12309130|FG004|COMPLETED|Core Study||0
11123447|NCT01355289|12309126|FG000|NOT COMPLETED|Core Study||1
11123448|NCT01355289|12309127|FG001|NOT COMPLETED|Core Study||0
11123449|NCT01355289|12309128|FG002|NOT COMPLETED|Core Study||0
11123450|NCT01355289|12309129|FG003|NOT COMPLETED|Core Study||2
11123451|NCT01355289|12309130|FG004|NOT COMPLETED|Core Study||0
11123452|NCT01355289|12309126|FG000|STARTED|Open Label Extension||0
11123453|NCT01355289|12309127|FG001|STARTED|Open Label Extension||0
11123454|NCT01355289|12309128|FG002|STARTED|Open Label Extension||0
11123455|NCT01355289|12309129|FG003|STARTED|Open Label Extension||0
11123456|NCT01355289|12309130|FG004|STARTED|Open Label Extension||62
11123457|NCT01355289|12309126|FG000|COMPLETED|Open Label Extension||0
11123458|NCT01355289|12309127|FG001|COMPLETED|Open Label Extension||0
11123459|NCT01355289|12309128|FG002|COMPLETED|Open Label Extension||0
11123460|NCT01355289|12309129|FG003|COMPLETED|Open Label Extension||0
11123461|NCT01355289|12309130|FG004|COMPLETED|Open Label Extension||28
11123462|NCT01355289|12309126|FG000|NOT COMPLETED|Open Label Extension||0
11123463|NCT01355289|12309127|FG001|NOT COMPLETED|Open Label Extension||0
11123464|NCT01355289|12309128|FG002|NOT COMPLETED|Open Label Extension||0
11123465|NCT01355289|12309129|FG003|NOT COMPLETED|Open Label Extension||0
11123466|NCT01355289|12309130|FG004|NOT COMPLETED|Open Label Extension||34
11123467|NCT01355302|12309143|FG000|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
11123468|NCT01355302|12309144|FG001|STARTED|Phase 1b||0
11123469|NCT01355302|12309145|FG002|STARTED|Phase 1b||0
11123470|NCT01355302|12309143|FG000|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
11123471|NCT01355302|12309144|FG001|COMPLETED|Phase 1b||0
11123472|NCT01355302|12309145|FG002|COMPLETED|Phase 1b||0
11123473|NCT01355302|12309143|FG000|NOT COMPLETED|Phase 1b||6
11123474|NCT01355302|12309144|FG001|NOT COMPLETED|Phase 1b||0
11123475|NCT01355302|12309145|FG002|NOT COMPLETED|Phase 1b||0
11123476|NCT01355302|12309143|FG000|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
11123477|NCT01355302|12309144|FG001|STARTED|Phase 2|The study was terminated prior to enrollment|0
11123478|NCT01355302|12309145|FG002|STARTED|Phase 2|The study was terminated prior to enrollment|0
11123479|NCT01355302|12309143|FG000|COMPLETED|Phase 2||0
11123480|NCT01355302|12309144|FG001|COMPLETED|Phase 2||0
11123481|NCT01355302|12309145|FG002|COMPLETED|Phase 2||0
11123482|NCT01355302|12309143|FG000|NOT COMPLETED|Phase 2||0
11123483|NCT01355302|12309144|FG001|NOT COMPLETED|Phase 2||0
11123484|NCT01355302|12309145|FG002|NOT COMPLETED|Phase 2||0
11123485|NCT01355419|12309153|FG000|STARTED|Overall Study||150
11123486|NCT01355419|12309153|FG000|COMPLETED|Overall Study||142
11123487|NCT01355419|12309153|FG000|NOT COMPLETED|Overall Study||8
11123488|NCT01355458|12309159|FG000|STARTED|Overall Study||129
11123489|NCT01355458|12309160|FG001|STARTED|Overall Study||131
11123490|NCT01355458|12309159|FG000|COMPLETED|Overall Study||127
11123491|NCT01355458|12309160|FG001|COMPLETED|Overall Study||127
11123492|NCT01355458|12309159|FG000|NOT COMPLETED|Overall Study||2
11123493|NCT01355458|12309160|FG001|NOT COMPLETED|Overall Study||4
11123494|NCT01355471|12309168|FG000|STARTED|Overall Study||148
11123495|NCT01355471|12309169|FG001|STARTED|Overall Study||145
11123496|NCT01355471|12309168|FG000|COMPLETED|Overall Study||141
11123497|NCT01355471|12309169|FG001|COMPLETED|Overall Study||142
11123498|NCT01355471|12309168|FG000|NOT COMPLETED|Overall Study||7
11123499|NCT01355471|12309169|FG001|NOT COMPLETED|Overall Study||3
11123500|NCT01355484|12309177|FG000|STARTED|Overall Study||160
11123501|NCT01355484|12309178|FG001|STARTED|Overall Study||161
11123502|NCT01355484|12309177|FG000|COMPLETED|Overall Study||109
11123503|NCT01355484|12309178|FG001|COMPLETED|Overall Study||107
11123504|NCT01355484|12309177|FG000|NOT COMPLETED|Overall Study||51
11123505|NCT01355484|12309178|FG001|NOT COMPLETED|Overall Study||54
11123506|NCT01355497|12309186|FG000|STARTED|Overall Study||165
11123507|NCT01355497|12309187|FG001|STARTED|Overall Study||165
11123508|NCT01355497|12309186|FG000|COMPLETED|Overall Study||99
11123509|NCT01355497|12309187|FG001|COMPLETED|Overall Study||102
11123510|NCT01355497|12309186|FG000|NOT COMPLETED|Overall Study||66
11123511|NCT01355497|12309187|FG001|NOT COMPLETED|Overall Study||63
11123512|NCT01355523|12309195|FG000|STARTED|Overall Study||28
11123513|NCT01355523|12309196|FG001|STARTED|Overall Study||26
11123514|NCT01355523|12309195|FG000|COMPLETED|Overall Study||27
11123515|NCT01355523|12309196|FG001|COMPLETED|Overall Study||16
11123516|NCT01355523|12309195|FG000|NOT COMPLETED|Overall Study||1
11123517|NCT01355523|12309196|FG001|NOT COMPLETED|Overall Study||10
11123518|NCT01355575|12309202|FG000|STARTED|Overall Study||15
11123519|NCT01355575|12309202|FG000|COMPLETED|Overall Study||13
11123520|NCT01355575|12309202|FG000|NOT COMPLETED|Overall Study||2
11123521|NCT01355588|12309214|FG000|STARTED|First Intervention (Day 1)||4
11123522|NCT01355588|12309215|FG001|STARTED|First Intervention (Day 1)||4
11123523|NCT01355588|12309216|FG002|STARTED|First Intervention (Day 1)||4
11123524|NCT01355588|12309217|FG003|STARTED|First Intervention (Day 1)||4
11123525|NCT01355588|12309214|FG000|COMPLETED|First Intervention (Day 1)||4
11123526|NCT01355588|12309215|FG001|COMPLETED|First Intervention (Day 1)||4
11123527|NCT01355588|12309216|FG002|COMPLETED|First Intervention (Day 1)||4
11123528|NCT01355588|12309217|FG003|COMPLETED|First Intervention (Day 1)||4
11123529|NCT01355588|12309214|FG000|NOT COMPLETED|First Intervention (Day 1)||0
11123530|NCT01355588|12309215|FG001|NOT COMPLETED|First Intervention (Day 1)||0
11123531|NCT01355588|12309216|FG002|NOT COMPLETED|First Intervention (Day 1)||0
11123532|NCT01355588|12309217|FG003|NOT COMPLETED|First Intervention (Day 1)||0
11123533|NCT01355588|12309214|FG000|STARTED|Washout (3-7 Days)||4
11123534|NCT01355588|12309215|FG001|STARTED|Washout (3-7 Days)||4
11123535|NCT01355588|12309216|FG002|STARTED|Washout (3-7 Days)||4
11123536|NCT01355588|12309217|FG003|STARTED|Washout (3-7 Days)||4
11123537|NCT01355588|12309214|FG000|COMPLETED|Washout (3-7 Days)||4
11123538|NCT01355588|12309215|FG001|COMPLETED|Washout (3-7 Days)||4
11123539|NCT01355588|12309216|FG002|COMPLETED|Washout (3-7 Days)||4
11123540|NCT01355588|12309217|FG003|COMPLETED|Washout (3-7 Days)||4
11123541|NCT01355588|12309214|FG000|NOT COMPLETED|Washout (3-7 Days)||0
11123542|NCT01355588|12309215|FG001|NOT COMPLETED|Washout (3-7 Days)||0
11123543|NCT01355588|12309216|FG002|NOT COMPLETED|Washout (3-7 Days)||0
11123544|NCT01355588|12309217|FG003|NOT COMPLETED|Washout (3-7 Days)||0
11123545|NCT01355588|12309214|FG000|STARTED|Second Intervention (After Washout)||4
11123546|NCT01355588|12309215|FG001|STARTED|Second Intervention (After Washout)||4
11123547|NCT01355588|12309216|FG002|STARTED|Second Intervention (After Washout)||4
11123548|NCT01355588|12309217|FG003|STARTED|Second Intervention (After Washout)||4
11123549|NCT01355588|12309214|FG000|COMPLETED|Second Intervention (After Washout)||4
11123550|NCT01355588|12309215|FG001|COMPLETED|Second Intervention (After Washout)||4
11123551|NCT01355588|12309216|FG002|COMPLETED|Second Intervention (After Washout)||4
11123552|NCT01355588|12309217|FG003|COMPLETED|Second Intervention (After Washout)||4
11123553|NCT01355588|12309214|FG000|NOT COMPLETED|Second Intervention (After Washout)||0
11123554|NCT01355588|12309215|FG001|NOT COMPLETED|Second Intervention (After Washout)||0
11123555|NCT01355588|12309216|FG002|NOT COMPLETED|Second Intervention (After Washout)||0
11123556|NCT01355588|12309217|FG003|NOT COMPLETED|Second Intervention (After Washout)||0
11123557|NCT01355588|12309214|FG000|STARTED|Washout (3-7 Days)||4
11123558|NCT01355588|12309215|FG001|STARTED|Washout (3-7 Days)||4
11123559|NCT01355588|12309216|FG002|STARTED|Washout (3-7 Days)||4
11123560|NCT01355588|12309217|FG003|STARTED|Washout (3-7 Days)||4
11123561|NCT01355588|12309214|FG000|COMPLETED|Washout (3-7 Days)||4
11123562|NCT01355588|12309215|FG001|COMPLETED|Washout (3-7 Days)||4
11123563|NCT01355588|12309216|FG002|COMPLETED|Washout (3-7 Days)||4
11123564|NCT01355588|12309217|FG003|COMPLETED|Washout (3-7 Days)||4
11123565|NCT01355588|12309214|FG000|NOT COMPLETED|Washout (3-7 Days)||0
11123566|NCT01355588|12309215|FG001|NOT COMPLETED|Washout (3-7 Days)||0
11123567|NCT01355588|12309216|FG002|NOT COMPLETED|Washout (3-7 Days)||0
11123568|NCT01355588|12309217|FG003|NOT COMPLETED|Washout (3-7 Days)||0
11123569|NCT01355588|12309214|FG000|STARTED|Third Intervention (After Washout)||4
11123570|NCT01355588|12309215|FG001|STARTED|Third Intervention (After Washout)||4
11123571|NCT01355588|12309216|FG002|STARTED|Third Intervention (After Washout)||4
11123572|NCT01355588|12309217|FG003|STARTED|Third Intervention (After Washout)||4
11123573|NCT01355588|12309214|FG000|COMPLETED|Third Intervention (After Washout)||4
11123574|NCT01355588|12309215|FG001|COMPLETED|Third Intervention (After Washout)||4
11123575|NCT01355588|12309216|FG002|COMPLETED|Third Intervention (After Washout)||4
11123576|NCT01355588|12309217|FG003|COMPLETED|Third Intervention (After Washout)||4
11123577|NCT01355588|12309214|FG000|NOT COMPLETED|Third Intervention (After Washout)||0
11123578|NCT01355588|12309215|FG001|NOT COMPLETED|Third Intervention (After Washout)||0
11123579|NCT01355588|12309216|FG002|NOT COMPLETED|Third Intervention (After Washout)||0
11123580|NCT01355588|12309217|FG003|NOT COMPLETED|Third Intervention (After Washout)||0
11123581|NCT01355588|12309214|FG000|STARTED|Washout (3-7 Days)||4
11123582|NCT01355588|12309215|FG001|STARTED|Washout (3-7 Days)||4
11123583|NCT01355588|12309216|FG002|STARTED|Washout (3-7 Days)||4
11123584|NCT01355588|12309217|FG003|STARTED|Washout (3-7 Days)||4
11123585|NCT01355588|12309214|FG000|COMPLETED|Washout (3-7 Days)||4
11123586|NCT01355588|12309215|FG001|COMPLETED|Washout (3-7 Days)||4
11123587|NCT01355588|12309216|FG002|COMPLETED|Washout (3-7 Days)||4
11123588|NCT01355588|12309217|FG003|COMPLETED|Washout (3-7 Days)||4
11123589|NCT01355588|12309214|FG000|NOT COMPLETED|Washout (3-7 Days)||0
11123590|NCT01355588|12309215|FG001|NOT COMPLETED|Washout (3-7 Days)||0
11123591|NCT01355588|12309216|FG002|NOT COMPLETED|Washout (3-7 Days)||0
11123592|NCT01355588|12309217|FG003|NOT COMPLETED|Washout (3-7 Days)||0
11123593|NCT01355588|12309214|FG000|STARTED|Fourth Intervention (After Washout)||4
11123594|NCT01355588|12309215|FG001|STARTED|Fourth Intervention (After Washout)||4
11123595|NCT01355588|12309216|FG002|STARTED|Fourth Intervention (After Washout)||4
11123596|NCT01355588|12309217|FG003|STARTED|Fourth Intervention (After Washout)||4
11123597|NCT01355588|12309214|FG000|COMPLETED|Fourth Intervention (After Washout)||4
11123598|NCT01355588|12309215|FG001|COMPLETED|Fourth Intervention (After Washout)||4
11123599|NCT01355588|12309216|FG002|COMPLETED|Fourth Intervention (After Washout)||4
11123600|NCT01355588|12309217|FG003|COMPLETED|Fourth Intervention (After Washout)||4
11123601|NCT01355588|12309214|FG000|NOT COMPLETED|Fourth Intervention (After Washout)||0
11123602|NCT01355588|12309215|FG001|NOT COMPLETED|Fourth Intervention (After Washout)||0
11123603|NCT01355588|12309216|FG002|NOT COMPLETED|Fourth Intervention (After Washout)||0
11123604|NCT01355588|12309217|FG003|NOT COMPLETED|Fourth Intervention (After Washout)||0
11123605|NCT01355627|12309229|FG000|STARTED|Overall Study||362
11123606|NCT01355627|12309230|FG001|STARTED|Overall Study||364
11123607|NCT01355627|12309229|FG000|Safety Analysis Set|Overall Study||362
11123608|NCT01355627|12309230|FG001|Safety Analysis Set|Overall Study||364
11123609|NCT01355627|12309229|FG000|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
11123610|NCT01355627|12309230|FG001|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
11123611|NCT01355627|12309229|FG000|COMPLETED|Overall Study||329
11123612|NCT01355627|12309230|FG001|COMPLETED|Overall Study||326
11123613|NCT01355627|12309229|FG000|NOT COMPLETED|Overall Study||33
11123614|NCT01355627|12309230|FG001|NOT COMPLETED|Overall Study||38
11123615|NCT01355705|12309236|FG000|STARTED|Overall Study||14
11123616|NCT01355705|12309236|FG000|COMPLETED|Overall Study||14
11123617|NCT01355705|12309236|FG000|NOT COMPLETED|Overall Study||0
11123618|NCT01355796|12309241|FG000|STARTED|Overall Study||15
11123619|NCT01355796|12309242|FG001|STARTED|Overall Study||15
11123620|NCT01355796|12309241|FG000|First Intervention for 14 Days|Overall Study||15
11123621|NCT01355796|12309242|FG001|First Intervention for 14 Days|Overall Study||15
11123622|NCT01355796|12309241|FG000|Washout Period for 7 Days|Overall Study||15
11123623|NCT01355796|12309242|FG001|Washout Period for 7 Days|Overall Study||15
11123624|NCT01355796|12309241|FG000|Second Intervention for 14 Days|Overall Study||15
11123625|NCT01355796|12309242|FG001|Second Intervention for 14 Days|Overall Study||15
11123626|NCT01355796|12309241|FG000|COMPLETED|Overall Study||15
11123627|NCT01355796|12309242|FG001|COMPLETED|Overall Study||15
11123628|NCT01355796|12309241|FG000|NOT COMPLETED|Overall Study||0
11123629|NCT01355796|12309242|FG001|NOT COMPLETED|Overall Study||0
11123630|NCT01355978|12309248|FG000|STARTED|Overall Study||22
11123631|NCT01355978|12309248|FG000|COMPLETED|Overall Study||18
11123632|NCT01355978|12309248|FG000|NOT COMPLETED|Overall Study||4
11123633|NCT01356147|12309254|FG000|STARTED|Overall Study||5
11123634|NCT01356147|12309255|FG001|STARTED|Overall Study||6
11123635|NCT01356147|12309254|FG000|COMPLETED|Overall Study||5
11123636|NCT01356147|12309255|FG001|COMPLETED|Overall Study||6
11123637|NCT01356147|12309254|FG000|NOT COMPLETED|Overall Study||0
11123638|NCT01356147|12309255|FG001|NOT COMPLETED|Overall Study||0
11123639|NCT01356277|12309263|FG000|STARTED|Run-in||81
11123640|NCT01356277|12309264|FG001|STARTED|Run-in||88
11123641|NCT01356277|12309263|FG000|COMPLETED|Run-in||76
11123642|NCT01356277|12309264|FG001|COMPLETED|Run-in||88
11123643|NCT01356277|12309263|FG000|NOT COMPLETED|Run-in||5
11123644|NCT01356277|12309264|FG001|NOT COMPLETED|Run-in||0
11123645|NCT01356277|12309263|FG000|STARTED|Intervention Interval||76
11123646|NCT01356277|12309264|FG001|STARTED|Intervention Interval||88
11123647|NCT01356277|12309263|FG000|COMPLETED|Intervention Interval||66
11123648|NCT01356277|12309264|FG001|COMPLETED|Intervention Interval||81
11123649|NCT01356277|12309263|FG000|NOT COMPLETED|Intervention Interval||10
11123650|NCT01356277|12309264|FG001|NOT COMPLETED|Intervention Interval||7
11123651|NCT01356407|12309274|FG000|STARTED|Overall Study||150
11123652|NCT01356407|12309275|FG001|STARTED|Overall Study||150
11123653|NCT01356407|12309274|FG000|COMPLETED|Overall Study||144
11123654|NCT01356407|12309275|FG001|COMPLETED|Overall Study||146
11123655|NCT01356407|12309274|FG000|NOT COMPLETED|Overall Study||6
11123656|NCT01356407|12309275|FG001|NOT COMPLETED|Overall Study||4
11123657|NCT01356498|12309287|FG000|STARTED|Overall Study||35
11123658|NCT01356498|12309288|FG001|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
11123659|NCT01356498|12309289|FG002|STARTED|Overall Study||23
11123660|NCT01356498|12309290|FG003|STARTED|Overall Study||22
11123661|NCT01356498|12309291|FG004|STARTED|Overall Study||28
11123662|NCT01356498|12309292|FG005|STARTED|Overall Study||16
11123663|NCT01356498|12309287|FG000|COMPLETED|Overall Study||24
11123664|NCT01356498|12309288|FG001|COMPLETED|Overall Study||17
11123665|NCT01356498|12309289|FG002|COMPLETED|Overall Study||11
11123666|NCT01356498|12309290|FG003|COMPLETED|Overall Study||8
11123667|NCT01356498|12309291|FG004|COMPLETED|Overall Study||8
11123668|NCT01356498|12309292|FG005|COMPLETED|Overall Study||2
11123669|NCT01356498|12309287|FG000|NOT COMPLETED|Overall Study||11
11123670|NCT01356498|12309288|FG001|NOT COMPLETED|Overall Study||8
11123671|NCT01356498|12309289|FG002|NOT COMPLETED|Overall Study||12
11123672|NCT01356498|12309290|FG003|NOT COMPLETED|Overall Study||14
11123673|NCT01356498|12309291|FG004|NOT COMPLETED|Overall Study||20
11123674|NCT01356498|12309292|FG005|NOT COMPLETED|Overall Study||14
11123675|NCT01356589|12309312|FG000|STARTED|Overall Study||1288
11123676|NCT01356589|12309312|FG000|Treated|Overall Study||1285
11123677|NCT01356589|12309312|FG000|COMPLETED|Overall Study||1283
11123678|NCT01356589|12309312|FG000|NOT COMPLETED|Overall Study||5
11123679|NCT01356602|12309319|FG000|STARTED|Overall Study||133
11123680|NCT01356602|12309320|FG001|STARTED|Overall Study||132
11123681|NCT01356602|12309321|FG002|STARTED|Overall Study||132
11123682|NCT01356602|12309319|FG000|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
11123683|NCT01356602|12309320|FG001|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
11123684|NCT01356602|12309321|FG002|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
11123685|NCT01356602|12309319|FG000|Full Analysis Set|Overall Study||131
11123686|NCT01356602|12309320|FG001|Full Analysis Set|Overall Study||129
11238828|NCT02076776|12430663|FG000|STARTED|Overall Study||6
11238829|NCT02076776|12430664|FG001|STARTED|Overall Study||8
11238830|NCT02076776|12430665|FG002|STARTED|Overall Study||6
11238831|NCT02076776|12430663|FG000|COMPLETED|Overall Study||5
11238832|NCT02076776|12430664|FG001|COMPLETED|Overall Study||6
11238833|NCT02076776|12430665|FG002|COMPLETED|Overall Study||6
11238834|NCT02076776|12430663|FG000|NOT COMPLETED|Overall Study||1
11238835|NCT02076776|12430664|FG001|NOT COMPLETED|Overall Study||2
11238836|NCT02076776|12430665|FG002|NOT COMPLETED|Overall Study||0
11238837|NCT02076919|12430685|FG000|STARTED|Overall Study||24
11238838|NCT02076919|12430686|FG001|STARTED|Overall Study||8
11238839|NCT02076919|12430687|FG002|STARTED|Overall Study||36
11238840|NCT02076919|12430688|FG003|STARTED|Overall Study||12
11238841|NCT02076919|12430685|FG000|COMPLETED|Overall Study||24
11238842|NCT02076919|12430686|FG001|COMPLETED|Overall Study||8
11238843|NCT02076919|12430687|FG002|COMPLETED|Overall Study||36
11238844|NCT02076919|12430688|FG003|COMPLETED|Overall Study||12
11238845|NCT02076919|12430685|FG000|NOT COMPLETED|Overall Study||0
11238846|NCT02076919|12430686|FG001|NOT COMPLETED|Overall Study||0
11238847|NCT02076919|12430687|FG002|NOT COMPLETED|Overall Study||0
11238848|NCT02076919|12430688|FG003|NOT COMPLETED|Overall Study||0
11238849|NCT02076997|12430715|FG000|STARTED|Overall Study||23
11238850|NCT02076997|12430715|FG000|COMPLETED|Overall Study||22
11238851|NCT02076997|12430715|FG000|NOT COMPLETED|Overall Study||1
11238852|NCT02077140|12430724|FG000|STARTED|Overall Study||36
11238853|NCT02077140|12430725|FG001|STARTED|Overall Study||36
11238854|NCT02077140|12430726|FG002|STARTED|Overall Study||36
11238855|NCT02077140|12430727|FG003|STARTED|Overall Study||36
11238856|NCT02077140|12430728|FG004|STARTED|Overall Study||48
11238857|NCT02077140|12430724|FG000|COMPLETED|Overall Study||32
11238858|NCT02077140|12430725|FG001|COMPLETED|Overall Study||34
11238859|NCT02077140|12430726|FG002|COMPLETED|Overall Study||34
11238860|NCT02077140|12430727|FG003|COMPLETED|Overall Study||32
11238861|NCT02077140|12430728|FG004|COMPLETED|Overall Study||43
11238862|NCT02077140|12430724|FG000|NOT COMPLETED|Overall Study||4
11238863|NCT02077140|12430725|FG001|NOT COMPLETED|Overall Study||2
11238864|NCT02077140|12430726|FG002|NOT COMPLETED|Overall Study||2
11238865|NCT02077140|12430727|FG003|NOT COMPLETED|Overall Study||4
11238866|NCT02077140|12430728|FG004|NOT COMPLETED|Overall Study||5
11238867|NCT02077374|12430745|FG000|STARTED|Overall Study||19
11238868|NCT02077374|12430746|FG001|STARTED|Overall Study||19
11238869|NCT02077374|12430745|FG000|COMPLETED|Overall Study||19
11238870|NCT02077374|12430746|FG001|COMPLETED|Overall Study||17
11238871|NCT02077374|12430745|FG000|NOT COMPLETED|Overall Study||0
11238872|NCT02077374|12430746|FG001|NOT COMPLETED|Overall Study||2
11123687|NCT01356602|12309321|FG002|Full Analysis Set|Overall Study||129
11123688|NCT01356602|12309319|FG000|COMPLETED|Overall Study||124
11123689|NCT01356602|12309320|FG001|COMPLETED|Overall Study||117
11123690|NCT01356602|12309321|FG002|COMPLETED|Overall Study||108
11123691|NCT01356602|12309319|FG000|NOT COMPLETED|Overall Study||9
11123692|NCT01356602|12309320|FG001|NOT COMPLETED|Overall Study||15
11123693|NCT01356602|12309321|FG002|NOT COMPLETED|Overall Study||24
11238873|NCT02077465|12430757|FG000|STARTED|Overall Study||8
11238874|NCT02077465|12430758|FG001|STARTED|Overall Study||3
11238875|NCT02077465|12430757|FG000|COMPLETED|Overall Study||7
11238876|NCT02077465|12430758|FG001|COMPLETED|Overall Study||2
11238877|NCT02077465|12430757|FG000|NOT COMPLETED|Overall Study||1
11238878|NCT02077465|12430758|FG001|NOT COMPLETED|Overall Study||1
11238879|NCT02078102|12430766|FG000|STARTED|Overall Study||25
11238880|NCT02078102|12430767|FG001|STARTED|Overall Study||13
11123694|NCT01356628|12309329|FG000|STARTED|Overall Study||23
11123695|NCT01356628|12309329|FG000|COMPLETED|Overall Study||23
11123696|NCT01356628|12309329|FG000|NOT COMPLETED|Overall Study||0
11123697|NCT01356940|12309335|FG000|STARTED|First Intervention (28 Days)||22
11123698|NCT01356940|12309336|FG001|STARTED|First Intervention (28 Days)||21
11123699|NCT01356940|12309335|FG000|COMPLETED|First Intervention (28 Days)||21
11123700|NCT01356940|12309336|FG001|COMPLETED|First Intervention (28 Days)||21
11123701|NCT01356940|12309335|FG000|NOT COMPLETED|First Intervention (28 Days)||1
11123702|NCT01356940|12309336|FG001|NOT COMPLETED|First Intervention (28 Days)||0
11123703|NCT01356940|12309335|FG000|STARTED|Washout (14 Days)||21
11123704|NCT01356940|12309336|FG001|STARTED|Washout (14 Days)||21
11123705|NCT01356940|12309335|FG000|COMPLETED|Washout (14 Days)||21
11123706|NCT01356940|12309336|FG001|COMPLETED|Washout (14 Days)||21
11123707|NCT01356940|12309335|FG000|NOT COMPLETED|Washout (14 Days)||0
11123708|NCT01356940|12309336|FG001|NOT COMPLETED|Washout (14 Days)||0
11123709|NCT01356940|12309335|FG000|STARTED|Second Intervention (28 Days)||21
11123710|NCT01356940|12309336|FG001|STARTED|Second Intervention (28 Days)||21
11123711|NCT01356940|12309335|FG000|COMPLETED|Second Intervention (28 Days)||20
11123712|NCT01356940|12309336|FG001|COMPLETED|Second Intervention (28 Days)||21
11123713|NCT01356940|12309335|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
11123714|NCT01356940|12309336|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
11123715|NCT01356966|12309346|FG000|STARTED|Overall Study||18
11123716|NCT01356966|12309347|FG001|STARTED|Overall Study||14
11123717|NCT01356966|12309346|FG000|COMPLETED|Overall Study||16
11123718|NCT01356966|12309347|FG001|COMPLETED|Overall Study||12
11123719|NCT01356966|12309346|FG000|NOT COMPLETED|Overall Study||2
11123720|NCT01356966|12309347|FG001|NOT COMPLETED|Overall Study||2
11123721|NCT01357135|12309356|FG000|STARTED|Overall Study||1874
11123722|NCT01357135|12309357|FG001|STARTED|Overall Study||733
11123723|NCT01357135|12309358|FG002|STARTED|Overall Study||846
11123724|NCT01357135|12309356|FG000|COMPLETED|Overall Study||1276
11123725|NCT01357135|12309357|FG001|COMPLETED|Overall Study||510
11123726|NCT01357135|12309358|FG002|COMPLETED|Overall Study||583
11123727|NCT01357135|12309356|FG000|NOT COMPLETED|Overall Study||598
11123728|NCT01357135|12309357|FG001|NOT COMPLETED|Overall Study||223
11123729|NCT01357135|12309358|FG002|NOT COMPLETED|Overall Study||263
11123730|NCT01357148|12309365|FG000|STARTED|Overall Study||143
11123731|NCT01357148|12309365|FG000|COMPLETED|Overall Study||143
11123732|NCT01357148|12309365|FG000|NOT COMPLETED|Overall Study||0
11123733|NCT01357161|12309373|FG000|STARTED|Part 1 (Open Label Run-in)||15
11123734|NCT01357161|12309374|FG001|STARTED|Part 1 (Open Label Run-in)||0
11123735|NCT01357161|12309375|FG002|STARTED|Part 1 (Open Label Run-in)||0
11123736|NCT01357161|12309373|FG000|COMPLETED|Part 1 (Open Label Run-in)||0
11123737|NCT01357161|12309374|FG001|COMPLETED|Part 1 (Open Label Run-in)||0
11123738|NCT01357161|12309375|FG002|COMPLETED|Part 1 (Open Label Run-in)||0
11123739|NCT01357161|12309373|FG000|NOT COMPLETED|Part 1 (Open Label Run-in)||15
11123740|NCT01357161|12309374|FG001|NOT COMPLETED|Part 1 (Open Label Run-in)||0
11123741|NCT01357161|12309375|FG002|NOT COMPLETED|Part 1 (Open Label Run-in)||0
11123742|NCT01357161|12309373|FG000|STARTED|Part 2 (Double-Blind Comparison)||0
11123743|NCT01357161|12309374|FG001|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
11123744|NCT01357161|12309375|FG002|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
11123745|NCT01357161|12309373|FG000|Treated|Part 2 (Double-Blind Comparison)||0
11123746|NCT01357161|12309374|FG001|Treated|Part 2 (Double-Blind Comparison)||59
11123747|NCT01357161|12309375|FG002|Treated|Part 2 (Double-Blind Comparison)||60
11123748|NCT01357161|12309373|FG000|COMPLETED|Part 2 (Double-Blind Comparison)||0
11123749|NCT01357161|12309374|FG001|COMPLETED|Part 2 (Double-Blind Comparison)||0
11123750|NCT01357161|12309375|FG002|COMPLETED|Part 2 (Double-Blind Comparison)||0
11123751|NCT01357161|12309373|FG000|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
11123752|NCT01357161|12309374|FG001|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
11123753|NCT01357161|12309375|FG002|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
11123754|NCT01357239|12309387|FG000|STARTED|Stratum: All Patients||31
11123755|NCT01357239|12309388|FG001|STARTED|Stratum: All Patients||27
11123756|NCT01357239|12309389|FG002|STARTED|Stratum: All Patients||39
11123757|NCT01357239|12309390|FG003|STARTED|Stratum: All Patients||42
11123758|NCT01357239|12309387|FG000|COMPLETED|Stratum: All Patients||31
11123759|NCT01357239|12309388|FG001|COMPLETED|Stratum: All Patients||27
11123760|NCT01357239|12309389|FG002|COMPLETED|Stratum: All Patients||37
11123761|NCT01357239|12309390|FG003|COMPLETED|Stratum: All Patients||40
11123762|NCT01357239|12309387|FG000|NOT COMPLETED|Stratum: All Patients||0
11123763|NCT01357239|12309388|FG001|NOT COMPLETED|Stratum: All Patients||0
11123764|NCT01357239|12309389|FG002|NOT COMPLETED|Stratum: All Patients||2
11123765|NCT01357239|12309390|FG003|NOT COMPLETED|Stratum: All Patients||2
11123766|NCT01357239|12309387|FG000|STARTED|Stratum I: Fully-Methylated||8
11123767|NCT01357239|12309388|FG001|STARTED|Stratum I: Fully-Methylated||6
11123768|NCT01357239|12309389|FG002|STARTED|Stratum I: Fully-Methylated||17
11123769|NCT01357239|12309390|FG003|STARTED|Stratum I: Fully-Methylated||22
11123770|NCT01357239|12309387|FG000|COMPLETED|Stratum I: Fully-Methylated||8
11123771|NCT01357239|12309388|FG001|COMPLETED|Stratum I: Fully-Methylated||6
11123772|NCT01357239|12309389|FG002|COMPLETED|Stratum I: Fully-Methylated||16
11123773|NCT01357239|12309390|FG003|COMPLETED|Stratum I: Fully-Methylated||22
11123774|NCT01357239|12309387|FG000|NOT COMPLETED|Stratum I: Fully-Methylated||0
11123775|NCT01357239|12309388|FG001|NOT COMPLETED|Stratum I: Fully-Methylated||0
11123776|NCT01357239|12309389|FG002|NOT COMPLETED|Stratum I: Fully-Methylated||1
11123777|NCT01357239|12309390|FG003|NOT COMPLETED|Stratum I: Fully-Methylated||0
11123778|NCT01357239|12309387|FG000|STARTED|Stratum II: Partially-Methylated||23
11123779|NCT01357239|12309388|FG001|STARTED|Stratum II: Partially-Methylated||21
11123780|NCT01357239|12309389|FG002|STARTED|Stratum II: Partially-Methylated||22
11123781|NCT01357239|12309390|FG003|STARTED|Stratum II: Partially-Methylated||20
11123782|NCT01357239|12309387|FG000|COMPLETED|Stratum II: Partially-Methylated||23
11123783|NCT01357239|12309388|FG001|COMPLETED|Stratum II: Partially-Methylated||21
11123784|NCT01357239|12309389|FG002|COMPLETED|Stratum II: Partially-Methylated||21
11123785|NCT01357239|12309390|FG003|COMPLETED|Stratum II: Partially-Methylated||18
11123786|NCT01357239|12309387|FG000|NOT COMPLETED|Stratum II: Partially-Methylated||0
11123787|NCT01357239|12309388|FG001|NOT COMPLETED|Stratum II: Partially-Methylated||0
11123788|NCT01357239|12309389|FG002|NOT COMPLETED|Stratum II: Partially-Methylated||1
11123789|NCT01357239|12309390|FG003|NOT COMPLETED|Stratum II: Partially-Methylated||2
11123790|NCT01357356|12309407|FG000|STARTED|Overall Study||188
11123791|NCT01357356|12309408|FG001|STARTED|Overall Study||188
11123792|NCT01357356|12309409|FG002|STARTED|Overall Study||186
11123793|NCT01357356|12309410|FG003|STARTED|Overall Study||188
11123794|NCT01357356|12309407|FG000|COMPLETED|Overall Study||166
11123795|NCT01357356|12309408|FG001|COMPLETED|Overall Study||163
11123796|NCT01357356|12309409|FG002|COMPLETED|Overall Study||158
11123797|NCT01357356|12309410|FG003|COMPLETED|Overall Study||171
11123798|NCT01357356|12309407|FG000|NOT COMPLETED|Overall Study||22
11123799|NCT01357356|12309408|FG001|NOT COMPLETED|Overall Study||25
11123800|NCT01357356|12309409|FG002|NOT COMPLETED|Overall Study||28
11123801|NCT01357356|12309410|FG003|NOT COMPLETED|Overall Study||17
11123802|NCT01357512|12309424|FG000|STARTED|Overall Study||65
11123803|NCT01357512|12309425|FG001|STARTED|Overall Study||65
11123804|NCT01357512|12309424|FG000|COMPLETED|Overall Study||53
11123805|NCT01357512|12309425|FG001|COMPLETED|Overall Study||60
11123806|NCT01357512|12309424|FG000|NOT COMPLETED|Overall Study||12
11123807|NCT01357512|12309425|FG001|NOT COMPLETED|Overall Study||5
11123808|NCT01357525|12309431|FG000|STARTED|Overall Study||50
11123809|NCT01357525|12309431|FG000|COMPLETED|Overall Study||49
11123810|NCT01357525|12309431|FG000|NOT COMPLETED|Overall Study||1
11123811|NCT01357551|12309437|FG000|STARTED|Overall Study||110
11123812|NCT01357551|12309438|FG001|STARTED|Overall Study||112
11123813|NCT01357551|12309437|FG000|COMPLETED|Overall Study||88
11123814|NCT01357551|12309438|FG001|COMPLETED|Overall Study||101
11123815|NCT01357551|12309437|FG000|NOT COMPLETED|Overall Study||22
11123816|NCT01357551|12309438|FG001|NOT COMPLETED|Overall Study||11
11123817|NCT01357564|12309449|FG000|STARTED|Short-term (4-month) Follow up||154
11123818|NCT01357564|12309450|FG001|STARTED|Short-term (4-month) Follow up||168
11123819|NCT01357564|12309449|FG000|COMPLETED|Short-term (4-month) Follow up||106
11123820|NCT01357564|12309450|FG001|COMPLETED|Short-term (4-month) Follow up||118
11123821|NCT01357564|12309449|FG000|NOT COMPLETED|Short-term (4-month) Follow up||48
11123822|NCT01357564|12309450|FG001|NOT COMPLETED|Short-term (4-month) Follow up||50
11123823|NCT01357564|12309449|FG000|STARTED|Long-term (8-month) Follow-up||106
11123824|NCT01357564|12309450|FG001|STARTED|Long-term (8-month) Follow-up||118
11123825|NCT01357564|12309449|FG000|COMPLETED|Long-term (8-month) Follow-up||104
11123826|NCT01357564|12309450|FG001|COMPLETED|Long-term (8-month) Follow-up||102
11123827|NCT01357564|12309449|FG000|NOT COMPLETED|Long-term (8-month) Follow-up||2
11123828|NCT01357564|12309450|FG001|NOT COMPLETED|Long-term (8-month) Follow-up||16
11123829|NCT01357577|12309460|FG000|STARTED|Overall Study||64
11123830|NCT01357577|12309461|FG001|STARTED|Overall Study||65
11123831|NCT01357577|12309460|FG000|Post-Treatment Assessment Completed|Overall Study||24
11123832|NCT01357577|12309461|FG001|Post-Treatment Assessment Completed|Overall Study||39
11123833|NCT01357577|12309460|FG000|COMPLETED|Overall Study||27
11123834|NCT01357577|12309461|FG001|COMPLETED|Overall Study||39
11123835|NCT01357577|12309460|FG000|NOT COMPLETED|Overall Study||37
11123836|NCT01357577|12309461|FG001|NOT COMPLETED|Overall Study||26
11123837|NCT01357616|12309470|FG000|STARTED|Overall Study||166
11123838|NCT01357616|12309471|FG001|STARTED|Overall Study||162
11123839|NCT01357616|12309470|FG000|COMPLETED|Overall Study||156
11123840|NCT01357616|12309471|FG001|COMPLETED|Overall Study||153
11123841|NCT01357616|12309470|FG000|NOT COMPLETED|Overall Study||10
11123842|NCT01357616|12309471|FG001|NOT COMPLETED|Overall Study||9
11123843|NCT01357655|12309479|FG000|STARTED|Overall Study||66
11123844|NCT01357655|12309480|FG001|STARTED|Overall Study||0
11123845|NCT01357655|12309479|FG000|COMPLETED|Overall Study||0
11123846|NCT01357655|12309480|FG001|COMPLETED|Overall Study||0
11123847|NCT01357655|12309479|FG000|NOT COMPLETED|Overall Study||66
11123848|NCT01357655|12309480|FG001|NOT COMPLETED|Overall Study||0
11201958|NCT01836458|12392342|FG001|STARTED|Overall Study||4
11201959|NCT01836458|12392343|FG002|STARTED|Overall Study||7
11201960|NCT01836458|12392344|FG003|STARTED|Overall Study||7
11201961|NCT01836458|12392341|FG000|COMPLETED|Overall Study||4
11201962|NCT01836458|12392342|FG001|COMPLETED|Overall Study||2
11201963|NCT01836458|12392343|FG002|COMPLETED|Overall Study||2
11201964|NCT01836458|12392344|FG003|COMPLETED|Overall Study||1
11201965|NCT01836458|12392341|FG000|NOT COMPLETED|Overall Study||3
11201966|NCT01836458|12392342|FG001|NOT COMPLETED|Overall Study||2
11201967|NCT01836458|12392343|FG002|NOT COMPLETED|Overall Study||5
11201968|NCT01836458|12392344|FG003|NOT COMPLETED|Overall Study||6
11201969|NCT01836471|12392359|FG000|STARTED|Overall Study||93
11201970|NCT01836471|12392360|FG001|STARTED|Overall Study||94
11201971|NCT01836471|12392361|FG002|STARTED|Overall Study||51
11201972|NCT01836471|12392362|FG003|STARTED|Overall Study||42
11201973|NCT01836471|12392363|FG004|STARTED|Overall Study||54
11201974|NCT01836471|12392359|FG000|COMPLETED|Overall Study||82
11201975|NCT01836471|12392360|FG001|COMPLETED|Overall Study||85
11201976|NCT01836471|12392361|FG002|COMPLETED|Overall Study||49
11201977|NCT01836471|12392362|FG003|COMPLETED|Overall Study||40
11201978|NCT01836471|12392363|FG004|COMPLETED|Overall Study||49
11201979|NCT01836471|12392359|FG000|NOT COMPLETED|Overall Study||11
11201980|NCT01836471|12392360|FG001|NOT COMPLETED|Overall Study||9
11201981|NCT01836471|12392361|FG002|NOT COMPLETED|Overall Study||2
11201982|NCT01836471|12392362|FG003|NOT COMPLETED|Overall Study||2
11201983|NCT01836471|12392363|FG004|NOT COMPLETED|Overall Study||5
11201984|NCT01836523|12392380|FG000|STARTED|Overall Study||351
11201985|NCT01836523|12392381|FG001|STARTED|Overall Study||350
11201986|NCT01836523|12392382|FG002|STARTED|Overall Study||349
11201987|NCT01836523|12392383|FG003|STARTED|Overall Study||348
11201988|NCT01836523|12392380|FG000|Exposed|Overall Study||350
11201989|NCT01836523|12392381|FG001|Exposed|Overall Study||348
11201990|NCT01836523|12392382|FG002|Exposed|Overall Study||347
11201991|NCT01836523|12392383|FG003|Exposed|Overall Study||348
11201992|NCT01836523|12392380|FG000|COMPLETED|Overall Study||300
11201993|NCT01836523|12392381|FG001|COMPLETED|Overall Study||265
11201994|NCT01836523|12392382|FG002|COMPLETED|Overall Study||258
11201995|NCT01836523|12392383|FG003|COMPLETED|Overall Study||274
11201996|NCT01836523|12392380|FG000|NOT COMPLETED|Overall Study||51
11201997|NCT01836523|12392381|FG001|NOT COMPLETED|Overall Study||85
11201998|NCT01836523|12392382|FG002|NOT COMPLETED|Overall Study||91
11201999|NCT01836523|12392383|FG003|NOT COMPLETED|Overall Study||74
11202000|NCT01836549|12392399|FG000|STARTED|Overall Study||1
11202001|NCT01836549|12392400|FG001|STARTED|Overall Study||1
11202002|NCT01836549|12392401|FG002|STARTED|Overall Study||1
11202003|NCT01836549|12392402|FG003|STARTED|Overall Study||9
11202004|NCT01836549|12392403|FG004|STARTED|Overall Study||18
11202005|NCT01836549|12392404|FG005|STARTED|Overall Study||4
11202006|NCT01836549|12392405|FG006|STARTED|Overall Study||9
11202007|NCT01836549|12392399|FG000|COMPLETED|Overall Study||1
11202008|NCT01836549|12392400|FG001|COMPLETED|Overall Study||1
11202009|NCT01836549|12392401|FG002|COMPLETED|Overall Study||0
11202010|NCT01836549|12392402|FG003|COMPLETED|Overall Study||8
11202011|NCT01836549|12392403|FG004|COMPLETED|Overall Study||18
11202012|NCT01836549|12392404|FG005|COMPLETED|Overall Study||4
11202013|NCT01836549|12392405|FG006|COMPLETED|Overall Study||8
11202014|NCT01836549|12392399|FG000|NOT COMPLETED|Overall Study||0
11202015|NCT01836549|12392400|FG001|NOT COMPLETED|Overall Study||0
11202016|NCT01836549|12392401|FG002|NOT COMPLETED|Overall Study||1
11202017|NCT01836549|12392402|FG003|NOT COMPLETED|Overall Study||1
11202018|NCT01836549|12392403|FG004|NOT COMPLETED|Overall Study||0
11202019|NCT01836549|12392404|FG005|NOT COMPLETED|Overall Study||0
11202020|NCT01836549|12392405|FG006|NOT COMPLETED|Overall Study||1
11202021|NCT01837069|12392423|FG000|STARTED|Overall Study||103
11202022|NCT01837069|12392424|FG001|STARTED|Overall Study||95
11202023|NCT01837069|12392423|FG000|COMPLETED|Overall Study||103
11202024|NCT01837069|12392424|FG001|COMPLETED|Overall Study||95
11202025|NCT01837069|12392423|FG000|NOT COMPLETED|Overall Study||0
11202026|NCT01837069|12392424|FG001|NOT COMPLETED|Overall Study||0
11202027|NCT01837524|12392432|FG000|STARTED|Overall Study||28
11202028|NCT01837524|12392433|FG001|STARTED|Overall Study||27
11202029|NCT01837524|12392432|FG000|COMPLETED|Overall Study||25
11202030|NCT01837524|12392433|FG001|COMPLETED|Overall Study||25
11202031|NCT01837524|12392432|FG000|NOT COMPLETED|Overall Study||3
11202032|NCT01837524|12392433|FG001|NOT COMPLETED|Overall Study||2
11202033|NCT01837537|12392439|FG000|STARTED|Overall Study||90
11202034|NCT01837537|12392439|FG000|COMPLETED|Overall Study||90
11202035|NCT01837537|12392439|FG000|NOT COMPLETED|Overall Study||0
11202036|NCT01837550|12392445|FG000|STARTED|T0-T1, 5 Weeks||37
11202037|NCT01837550|12392446|FG001|STARTED|T0-T1, 5 Weeks||37
11202038|NCT01837550|12392445|FG000|COMPLETED|T0-T1, 5 Weeks||37
11202039|NCT01837550|12392446|FG001|COMPLETED|T0-T1, 5 Weeks||37
11202040|NCT01837550|12392445|FG000|NOT COMPLETED|T0-T1, 5 Weeks||0
11202041|NCT01837550|12392446|FG001|NOT COMPLETED|T0-T1, 5 Weeks||0
11202042|NCT01837550|12392445|FG000|STARTED|T0-T2, 6 Months Follow-up||37
11202043|NCT01837550|12392446|FG001|STARTED|T0-T2, 6 Months Follow-up||37
11202044|NCT01837550|12392445|FG000|COMPLETED|T0-T2, 6 Months Follow-up||37
11202045|NCT01837550|12392446|FG001|COMPLETED|T0-T2, 6 Months Follow-up||37
11202046|NCT01837550|12392445|FG000|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
11202047|NCT01837550|12392446|FG001|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
11123849|NCT01357720|12309487|FG000|STARTED|Overall Study||200
11123850|NCT01357720|12309488|FG001|STARTED|Overall Study||200
11123851|NCT01357720|12309487|FG000|COMPLETED|Overall Study||198
11123852|NCT01357720|12309488|FG001|COMPLETED|Overall Study||195
11123853|NCT01357720|12309487|FG000|NOT COMPLETED|Overall Study||2
11123854|NCT01357720|12309488|FG001|NOT COMPLETED|Overall Study||5
11123855|NCT01357850|12309498|FG000|STARTED|Overall Study||30
11123856|NCT01357850|12309499|FG001|STARTED|Overall Study||12
11123857|NCT01357850|12309500|FG002|STARTED|Overall Study||13
11123858|NCT01357850|12309501|FG003|STARTED|Overall Study||27
11123859|NCT01357850|12309498|FG000|COMPLETED|Overall Study||29
11123860|NCT01357850|12309499|FG001|COMPLETED|Overall Study||12
11123861|NCT01357850|12309500|FG002|COMPLETED|Overall Study||13
11123862|NCT01357850|12309501|FG003|COMPLETED|Overall Study||27
11123863|NCT01357850|12309498|FG000|NOT COMPLETED|Overall Study||1
11123864|NCT01357850|12309499|FG001|NOT COMPLETED|Overall Study||0
11123865|NCT01357850|12309500|FG002|NOT COMPLETED|Overall Study||0
11123866|NCT01357850|12309501|FG003|NOT COMPLETED|Overall Study||0
11123867|NCT01357889|12309514|FG000|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
11123868|NCT01357889|12309515|FG001|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
11123869|NCT01357889|12309514|FG000|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
11123870|NCT01357889|12309515|FG001|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
11123871|NCT01357889|12309514|FG000|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
11123872|NCT01357889|12309515|FG001|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
11123873|NCT01357889|12309514|FG000|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
11123874|NCT01357889|12309515|FG001|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
11123875|NCT01357889|12309514|FG000|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
11123876|NCT01357889|12309515|FG001|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
11123877|NCT01357889|12309514|FG000|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
11123878|NCT01357889|12309515|FG001|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
11123879|NCT01357889|12309514|FG000|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
11123880|NCT01357889|12309515|FG001|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
11123881|NCT01357889|12309514|FG000|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
11123882|NCT01357889|12309515|FG001|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
11123883|NCT01357889|12309514|FG000|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
11123884|NCT01357889|12309515|FG001|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
11123885|NCT01357915|12309525|FG000|STARTED|Overall Study||30
11123886|NCT01357915|12309526|FG001|STARTED|Overall Study||17
11123887|NCT01357915|12309525|FG000|COMPLETED|Overall Study||27
11123888|NCT01357915|12309526|FG001|COMPLETED|Overall Study||17
11123889|NCT01357915|12309525|FG000|NOT COMPLETED|Overall Study||3
11123890|NCT01357915|12309526|FG001|NOT COMPLETED|Overall Study||0
11123891|NCT01358175|12309535|FG000|STARTED|Overall Study||124
11123892|NCT01358175|12309536|FG001|STARTED|Overall Study||125
11123893|NCT01358175|12309537|FG002|STARTED|Overall Study||122
11123894|NCT01358175|12309535|FG000|COMPLETED|Overall Study||103
11123895|NCT01358175|12309536|FG001|COMPLETED|Overall Study||97
11123896|NCT01358175|12309537|FG002|COMPLETED|Overall Study||90
11123897|NCT01358175|12309535|FG000|NOT COMPLETED|Overall Study||21
11123898|NCT01358175|12309536|FG001|NOT COMPLETED|Overall Study||28
11123899|NCT01358175|12309537|FG002|NOT COMPLETED|Overall Study||32
11123900|NCT01358266|12309552|FG000|STARTED|Double-Masked Period||208
11123901|NCT01358266|12309553|FG001|STARTED|Double-Masked Period||208
11123902|NCT01358266|12309554|FG002|STARTED|Double-Masked Period||176
11123903|NCT01358266|12309552|FG000|COMPLETED|Double-Masked Period||175
11123904|NCT01358266|12309553|FG001|COMPLETED|Double-Masked Period||162
11123905|NCT01358266|12309554|FG002|COMPLETED|Double-Masked Period||137
11123906|NCT01358266|12309552|FG000|NOT COMPLETED|Double-Masked Period||33
11123907|NCT01358266|12309553|FG001|NOT COMPLETED|Double-Masked Period||46
11123908|NCT01358266|12309554|FG002|NOT COMPLETED|Double-Masked Period||39
11123909|NCT01358266|12309552|FG000|STARTED|Open-Label Period||119
11123910|NCT01358266|12309553|FG001|STARTED|Open-Label Period||102
11123911|NCT01358266|12309554|FG002|STARTED|Open-Label Period||114
11123912|NCT01358266|12309552|FG000|COMPLETED|Open-Label Period||63
11123913|NCT01358266|12309553|FG001|COMPLETED|Open-Label Period||58
11123914|NCT01358266|12309554|FG002|COMPLETED|Open-Label Period||44
11123915|NCT01358266|12309552|FG000|NOT COMPLETED|Open-Label Period||56
11123916|NCT01358266|12309553|FG001|NOT COMPLETED|Open-Label Period||44
11123917|NCT01358266|12309554|FG002|NOT COMPLETED|Open-Label Period||70
11123918|NCT01358331|12309569|FG000|STARTED|Overall Study||2
11123919|NCT01358331|12309570|FG001|STARTED|Overall Study||3
11123920|NCT01358331|12309571|FG002|STARTED|Overall Study||4
11123921|NCT01358331|12309572|FG003|STARTED|Overall Study||3
11123922|NCT01358331|12309573|FG004|STARTED|Overall Study||7
11123923|NCT01358331|12309574|FG005|STARTED|Overall Study||6
11123924|NCT01358331|12309569|FG000|COMPLETED|Overall Study||0
11123925|NCT01358331|12309570|FG001|COMPLETED|Overall Study||0
11123926|NCT01358331|12309571|FG002|COMPLETED|Overall Study||0
11123927|NCT01358331|12309572|FG003|COMPLETED|Overall Study||0
11123928|NCT01358331|12309573|FG004|COMPLETED|Overall Study||0
11123929|NCT01358331|12309574|FG005|COMPLETED|Overall Study||0
11123930|NCT01358331|12309569|FG000|NOT COMPLETED|Overall Study||2
11123931|NCT01358331|12309570|FG001|NOT COMPLETED|Overall Study||3
11123932|NCT01358331|12309571|FG002|NOT COMPLETED|Overall Study||4
11123933|NCT01358331|12309572|FG003|NOT COMPLETED|Overall Study||3
11123934|NCT01358331|12309573|FG004|NOT COMPLETED|Overall Study||7
11123935|NCT01358331|12309574|FG005|NOT COMPLETED|Overall Study||6
11123936|NCT01358357|12309590|FG000|STARTED|Open Label Phase||0
11123937|NCT01358357|12309591|FG001|STARTED|Open Label Phase||0
11123938|NCT01358357|12309592|FG002|STARTED|Open Label Phase||965
11123939|NCT01358357|12309590|FG000|COMPLETED|Open Label Phase||0
11123940|NCT01358357|12309591|FG001|COMPLETED|Open Label Phase||0
11123941|NCT01358357|12309592|FG002|COMPLETED|Open Label Phase||503
11123942|NCT01358357|12309590|FG000|NOT COMPLETED|Open Label Phase||0
11123943|NCT01358357|12309591|FG001|NOT COMPLETED|Open Label Phase||0
11123944|NCT01358357|12309592|FG002|NOT COMPLETED|Open Label Phase||462
11123945|NCT01358357|12309590|FG000|STARTED|Double-Blind Phase||246
11123946|NCT01358357|12309591|FG001|STARTED|Double-Blind Phase||250
11123947|NCT01358357|12309592|FG002|STARTED|Double-Blind Phase||0
11123948|NCT01358357|12309590|FG000|COMPLETED|Double-Blind Phase||166
11123949|NCT01358357|12309591|FG001|COMPLETED|Double-Blind Phase||150
11123950|NCT01358357|12309592|FG002|COMPLETED|Double-Blind Phase||0
11123951|NCT01358357|12309590|FG000|NOT COMPLETED|Double-Blind Phase||80
11123952|NCT01358357|12309591|FG001|NOT COMPLETED|Double-Blind Phase||100
11123953|NCT01358357|12309592|FG002|NOT COMPLETED|Double-Blind Phase||0
11123954|NCT01358526|12309601|FG000|STARTED|Open-label Titration Period||1095
11123955|NCT01358526|12309602|FG001|STARTED|Open-label Titration Period||0
11123956|NCT01358526|12309603|FG002|STARTED|Open-label Titration Period||0
11123957|NCT01358526|12309601|FG000|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
11123958|NCT01358526|12309602|FG001|COMPLETED|Open-label Titration Period||0
11123959|NCT01358526|12309603|FG002|COMPLETED|Open-label Titration Period||0
11123960|NCT01358526|12309601|FG000|NOT COMPLETED|Open-label Titration Period||494
11123961|NCT01358526|12309602|FG001|NOT COMPLETED|Open-label Titration Period||0
11123962|NCT01358526|12309603|FG002|NOT COMPLETED|Open-label Titration Period||0
11123963|NCT01358526|12309601|FG000|STARTED|Double-blind Phase||0
11123964|NCT01358526|12309602|FG001|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
11123965|NCT01358526|12309603|FG002|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
11123966|NCT01358526|12309601|FG000|COMPLETED|Double-blind Phase||0
11123967|NCT01358526|12309602|FG001|COMPLETED|Double-blind Phase||218
11123968|NCT01358526|12309603|FG002|COMPLETED|Double-blind Phase||181
11123969|NCT01358526|12309601|FG000|NOT COMPLETED|Double-blind Phase||0
11123970|NCT01358526|12309602|FG001|NOT COMPLETED|Double-blind Phase||80
11123971|NCT01358526|12309603|FG002|NOT COMPLETED|Double-blind Phase||121
11123972|NCT01358578|12309614|FG000|STARTED|Induction Period||327
11123973|NCT01358578|12309615|FG001|STARTED|Induction Period||327
11123974|NCT01358578|12309616|FG002|STARTED|Induction Period||326
11123975|NCT01358578|12309617|FG003|STARTED|Induction Period||326
11123976|NCT01358578|12309618|FG004|STARTED|Induction Period|These groups are populated after the induction period|0
11123977|NCT01358578|12309619|FG005|STARTED|Induction Period|These groups are populated after the induction period|0
11123978|NCT01358578|12309614|FG000|COMPLETED|Induction Period||315
11123979|NCT01358578|12309615|FG001|COMPLETED|Induction Period||312
11123980|NCT01358578|12309616|FG002|COMPLETED|Induction Period||301
11123981|NCT01358578|12309617|FG003|COMPLETED|Induction Period||305
11123982|NCT01358578|12309618|FG004|COMPLETED|Induction Period|These groups are populated after the induction period|0
11123983|NCT01358578|12309619|FG005|COMPLETED|Induction Period|These groups are populated after the induction period|0
11123984|NCT01358578|12309614|FG000|NOT COMPLETED|Induction Period||12
11123985|NCT01358578|12309615|FG001|NOT COMPLETED|Induction Period||15
11123986|NCT01358578|12309616|FG002|NOT COMPLETED|Induction Period||25
11123987|NCT01358578|12309617|FG003|NOT COMPLETED|Induction Period||21
11123988|NCT01358578|12309618|FG004|NOT COMPLETED|Induction Period||0
11123989|NCT01358578|12309619|FG005|NOT COMPLETED|Induction Period||0
11123990|NCT01358578|12309614|FG000|STARTED|Maintenance Period||315
11123991|NCT01358578|12309615|FG001|STARTED|Maintenance Period||312
11123992|NCT01358578|12309616|FG002|STARTED|Maintenance Period||17
11123993|NCT01358578|12309617|FG003|STARTED|Maintenance Period||305
11123994|NCT01358578|12309618|FG004|STARTED|Maintenance Period||142
11123995|NCT01358578|12309619|FG005|STARTED|Maintenance Period||142
11123996|NCT01358578|12309614|FG000|COMPLETED|Maintenance Period||276
11123997|NCT01358578|12309615|FG001|COMPLETED|Maintenance Period||290
11123998|NCT01358578|12309616|FG002|COMPLETED|Maintenance Period||15
11123999|NCT01358578|12309617|FG003|COMPLETED|Maintenance Period||263
11124000|NCT01358578|12309618|FG004|COMPLETED|Maintenance Period||125
11124001|NCT01358578|12309619|FG005|COMPLETED|Maintenance Period||131
11124002|NCT01358578|12309614|FG000|NOT COMPLETED|Maintenance Period||39
11124003|NCT01358578|12309615|FG001|NOT COMPLETED|Maintenance Period||22
11124004|NCT01358578|12309616|FG002|NOT COMPLETED|Maintenance Period||2
11124005|NCT01358578|12309617|FG003|NOT COMPLETED|Maintenance Period||42
11124006|NCT01358578|12309618|FG004|NOT COMPLETED|Maintenance Period||17
11124007|NCT01358578|12309619|FG005|NOT COMPLETED|Maintenance Period||11
11124008|NCT01358578|12309614|FG000|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
11124009|NCT01358578|12309615|FG001|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
11124010|NCT01358578|12309616|FG002|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
11124011|NCT01358578|12309617|FG003|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
11124012|NCT01358578|12309618|FG004|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
11124013|NCT01358578|12309619|FG005|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
11124014|NCT01358578|12309614|FG000|COMPLETED|Follow-up Period||138
11124015|NCT01358578|12309615|FG001|COMPLETED|Follow-up Period||119
11124016|NCT01358578|12309616|FG002|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
11124017|NCT01358578|12309617|FG003|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
11124018|NCT01358578|12309618|FG004|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
11124019|NCT01358578|12309619|FG005|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
11124020|NCT01358578|12309614|FG000|NOT COMPLETED|Follow-up Period||10
11124021|NCT01358578|12309615|FG001|NOT COMPLETED|Follow-up Period||6
11124022|NCT01358578|12309616|FG002|NOT COMPLETED|Follow-up Period||5
11124023|NCT01358578|12309617|FG003|NOT COMPLETED|Follow-up Period||19
11124024|NCT01358578|12309618|FG004|NOT COMPLETED|Follow-up Period||0
11124025|NCT01358578|12309619|FG005|NOT COMPLETED|Follow-up Period||0
11124026|NCT01358708|12309649|FG000|STARTED|Double-Blind Treatment Phase||13
11124027|NCT01358708|12309650|FG001|STARTED|Double-Blind Treatment Phase||13
11124028|NCT01358708|12309649|FG000|Randomized|Double-Blind Treatment Phase||13
11124029|NCT01358708|12309650|FG001|Randomized|Double-Blind Treatment Phase||13
11124030|NCT01358708|12309649|FG000|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
11124031|NCT01358708|12309650|FG001|Received Study Medication|Double-Blind Treatment Phase||13
11124032|NCT01358708|12309649|FG000|COMPLETED|Double-Blind Treatment Phase||10
11124033|NCT01358708|12309650|FG001|COMPLETED|Double-Blind Treatment Phase||13
11124034|NCT01358708|12309649|FG000|NOT COMPLETED|Double-Blind Treatment Phase||3
11124035|NCT01358708|12309650|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0
11124036|NCT01358708|12309649|FG000|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
11124037|NCT01358708|12309650|FG001|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
11124038|NCT01358708|12309649|FG000|COMPLETED|Open-Label Treatment Phase||5
11124039|NCT01358708|12309650|FG001|COMPLETED|Open-Label Treatment Phase||12
11124040|NCT01358708|12309649|FG000|NOT COMPLETED|Open-Label Treatment Phase||0
11124041|NCT01358708|12309650|FG001|NOT COMPLETED|Open-Label Treatment Phase||0
11124042|NCT01358721|12309664|FG000|STARTED|Overall Study||22
11124043|NCT01358721|12309665|FG001|STARTED|Overall Study||22
11124044|NCT01358721|12309666|FG002|STARTED|Overall Study||23
11124045|NCT01358721|12309667|FG003|STARTED|Overall Study||24
11124046|NCT01358721|12309664|FG000|COMPLETED|Overall Study||1
11124047|NCT01358721|12309665|FG001|COMPLETED|Overall Study||0
11124048|NCT01358721|12309666|FG002|COMPLETED|Overall Study||1
11124049|NCT01358721|12309667|FG003|COMPLETED|Overall Study||0
11124050|NCT01358721|12309664|FG000|NOT COMPLETED|Overall Study||21
11124051|NCT01358721|12309665|FG001|NOT COMPLETED|Overall Study||22
11124052|NCT01358721|12309666|FG002|NOT COMPLETED|Overall Study||22
11124053|NCT01358721|12309667|FG003|NOT COMPLETED|Overall Study||24
11124054|NCT01358734|12309680|FG000|STARTED|Overall Study||15
11124055|NCT01358734|12309681|FG001|STARTED|Overall Study||39
11124056|NCT01358734|12309682|FG002|STARTED|Overall Study||34
11124057|NCT01358734|12309680|FG000|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
11124058|NCT01358734|12309681|FG001|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
11124059|NCT01358734|12309682|FG002|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
11124060|NCT01358734|12309680|FG000|COMPLETED|Overall Study||0
11124061|NCT01358734|12309681|FG001|COMPLETED|Overall Study||0
11124062|NCT01358734|12309682|FG002|COMPLETED|Overall Study||0
11124063|NCT01358734|12309680|FG000|NOT COMPLETED|Overall Study||15
11124064|NCT01358734|12309681|FG001|NOT COMPLETED|Overall Study||39
11124065|NCT01358734|12309682|FG002|NOT COMPLETED|Overall Study||34
11124066|NCT01358760|12309693|FG000|STARTED|Overall Study||152
11124067|NCT01358760|12309694|FG001|STARTED|Overall Study||148
11124068|NCT01358760|12309695|FG002|STARTED|Overall Study||150
11124069|NCT01358760|12309693|FG000|Safety Population|Overall Study||150
11124070|NCT01358760|12309694|FG001|Safety Population|Overall Study||143
11124071|NCT01358760|12309695|FG002|Safety Population|Overall Study||148
11124072|NCT01358760|12309693|FG000|ITT Population|Overall Study||139
11124073|NCT01358760|12309694|FG001|ITT Population|Overall Study||134
11124074|NCT01358760|12309695|FG002|ITT Population|Overall Study||134
11124075|NCT01358760|12309693|FG000|COMPLETED|Overall Study||130
11124076|NCT01358760|12309694|FG001|COMPLETED|Overall Study||128
11124077|NCT01358760|12309695|FG002|COMPLETED|Overall Study||125
11124078|NCT01358760|12309693|FG000|NOT COMPLETED|Overall Study||22
11124079|NCT01358760|12309694|FG001|NOT COMPLETED|Overall Study||20
11124080|NCT01358760|12309695|FG002|NOT COMPLETED|Overall Study||25
11124081|NCT01358825|12309705|FG000|STARTED|Overall Study||12
11124082|NCT01358825|12309706|FG001|STARTED|Overall Study||46
11124083|NCT01358825|12309705|FG000|COMPLETED|Overall Study||12
11124084|NCT01358825|12309706|FG001|COMPLETED|Overall Study||45
11124085|NCT01358825|12309705|FG000|NOT COMPLETED|Overall Study||0
11124086|NCT01358825|12309706|FG001|NOT COMPLETED|Overall Study||1
11124087|NCT01358864|12309720|FG000|STARTED|Overall Study||49
11124088|NCT01358864|12309721|FG001|STARTED|Overall Study||99
11124089|NCT01358864|12309722|FG002|STARTED|Overall Study||103
11124090|NCT01358864|12309723|FG003|STARTED|Overall Study||29
11124091|NCT01358864|12309724|FG004|STARTED|Overall Study||57
11124092|NCT01358864|12309725|FG005|STARTED|Overall Study||55
11124093|NCT01358864|12309726|FG006|STARTED|Overall Study||146
11124094|NCT01358864|12309727|FG007|STARTED|Overall Study||140
11124095|NCT01358864|12309720|FG000|COMPLETED|Overall Study||18
11124096|NCT01358864|12309721|FG001|COMPLETED|Overall Study||86
11124097|NCT01358864|12309722|FG002|COMPLETED|Overall Study||87
11124098|NCT01358864|12309723|FG003|COMPLETED|Overall Study||10
11124099|NCT01358864|12309724|FG004|COMPLETED|Overall Study||46
11124100|NCT01358864|12309725|FG005|COMPLETED|Overall Study||42
11124101|NCT01358864|12309726|FG006|COMPLETED|Overall Study||81
11124102|NCT01358864|12309727|FG007|COMPLETED|Overall Study||85
11124103|NCT01358864|12309720|FG000|NOT COMPLETED|Overall Study||31
11124104|NCT01358864|12309721|FG001|NOT COMPLETED|Overall Study||13
11124105|NCT01358864|12309722|FG002|NOT COMPLETED|Overall Study||16
11124106|NCT01358864|12309723|FG003|NOT COMPLETED|Overall Study||19
11124107|NCT01358864|12309724|FG004|NOT COMPLETED|Overall Study||11
11124108|NCT01358864|12309725|FG005|NOT COMPLETED|Overall Study||13
11124109|NCT01358864|12309726|FG006|NOT COMPLETED|Overall Study||65
11124110|NCT01358864|12309727|FG007|NOT COMPLETED|Overall Study||55
11124111|NCT01358968|12309747|FG000|STARTED|Period 1||20
11124112|NCT01358968|12309748|FG001|STARTED|Period 1||0
11124113|NCT01358968|12309749|FG002|STARTED|Period 1||0
11124114|NCT01358968|12309750|FG003|STARTED|Period 1||0
11124115|NCT01358968|12309747|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
11124116|NCT01358968|12309748|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
11124117|NCT01358968|12309749|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
11124118|NCT01358968|12309750|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
11124119|NCT01358968|12309747|FG000|COMPLETED|Period 1||20
11124120|NCT01358968|12309748|FG001|COMPLETED|Period 1||0
11124121|NCT01358968|12309749|FG002|COMPLETED|Period 1||0
11124122|NCT01358968|12309750|FG003|COMPLETED|Period 1||0
11124123|NCT01358968|12309747|FG000|NOT COMPLETED|Period 1||0
11124124|NCT01358968|12309748|FG001|NOT COMPLETED|Period 1||0
11124125|NCT01358968|12309749|FG002|NOT COMPLETED|Period 1||0
11124126|NCT01358968|12309750|FG003|NOT COMPLETED|Period 1||0
11124127|NCT01358968|12309747|FG000|STARTED|Period 2||0
11124128|NCT01358968|12309748|FG001|STARTED|Period 2||20
11124129|NCT01358968|12309749|FG002|STARTED|Period 2||0
11124130|NCT01358968|12309750|FG003|STARTED|Period 2||0
11124131|NCT01358968|12309747|FG000|Received at Least 1 Dose of Study Drug|Period 2||0
11124132|NCT01358968|12309748|FG001|Received at Least 1 Dose of Study Drug|Period 2||19
11124133|NCT01358968|12309749|FG002|Received at Least 1 Dose of Study Drug|Period 2||0
11124134|NCT01358968|12309750|FG003|Received at Least 1 Dose of Study Drug|Period 2||0
11124135|NCT01358968|12309747|FG000|COMPLETED|Period 2||0
11124136|NCT01358968|12309748|FG001|COMPLETED|Period 2||19
11124137|NCT01358968|12309749|FG002|COMPLETED|Period 2||0
11124138|NCT01358968|12309750|FG003|COMPLETED|Period 2||0
11124139|NCT01358968|12309747|FG000|NOT COMPLETED|Period 2||0
11124140|NCT01358968|12309748|FG001|NOT COMPLETED|Period 2||1
11124141|NCT01358968|12309749|FG002|NOT COMPLETED|Period 2||0
11124142|NCT01358968|12309750|FG003|NOT COMPLETED|Period 2||0
11124143|NCT01358968|12309747|FG000|STARTED|Continued Access Phase||0
11124144|NCT01358968|12309748|FG001|STARTED|Continued Access Phase||0
11124145|NCT01358968|12309749|FG002|STARTED|Continued Access Phase||12
11124146|NCT01358968|12309750|FG003|STARTED|Continued Access Phase||7
11124147|NCT01358968|12309747|FG000|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
11124148|NCT01358968|12309748|FG001|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
11124149|NCT01358968|12309749|FG002|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
11124150|NCT01358968|12309750|FG003|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
11124151|NCT01358968|12309747|FG000|COMPLETED|Continued Access Phase||0
11124152|NCT01358968|12309748|FG001|COMPLETED|Continued Access Phase||0
11124153|NCT01358968|12309749|FG002|COMPLETED|Continued Access Phase||0
11124154|NCT01358968|12309750|FG003|COMPLETED|Continued Access Phase||0
11124155|NCT01358968|12309747|FG000|NOT COMPLETED|Continued Access Phase||0
11124156|NCT01358968|12309748|FG001|NOT COMPLETED|Continued Access Phase||0
11124157|NCT01358968|12309749|FG002|NOT COMPLETED|Continued Access Phase||12
11124158|NCT01358968|12309750|FG003|NOT COMPLETED|Continued Access Phase||7
11124159|NCT01358981|12309767|FG000|STARTED|Period 1||2
11124160|NCT01358981|12309768|FG001|STARTED|Period 1||2
11124161|NCT01358981|12309769|FG002|STARTED|Period 1||2
11124162|NCT01358981|12309770|FG003|STARTED|Period 1||2
11124163|NCT01358981|12309771|FG004|STARTED|Period 1||3
11124164|NCT01358981|12309772|FG005|STARTED|Period 1||3
11124165|NCT01358981|12309773|FG006|STARTED|Period 1||3
11124166|NCT01358981|12309767|FG000|Received at Least 1dose of Study Drug|Period 1||2
11124167|NCT01358981|12309768|FG001|Received at Least 1dose of Study Drug|Period 1||2
11124168|NCT01358981|12309769|FG002|Received at Least 1dose of Study Drug|Period 1||2
11124169|NCT01358981|12309770|FG003|Received at Least 1dose of Study Drug|Period 1||2
11124170|NCT01358981|12309771|FG004|Received at Least 1dose of Study Drug|Period 1||3
11124171|NCT01358981|12309772|FG005|Received at Least 1dose of Study Drug|Period 1||3
11124172|NCT01358981|12309773|FG006|Received at Least 1dose of Study Drug|Period 1||3
11124173|NCT01358981|12309767|FG000|COMPLETED|Period 1||2
11124174|NCT01358981|12309768|FG001|COMPLETED|Period 1||2
11124175|NCT01358981|12309769|FG002|COMPLETED|Period 1||2
11124176|NCT01358981|12309770|FG003|COMPLETED|Period 1||1
11124177|NCT01358981|12309771|FG004|COMPLETED|Period 1||3
11124178|NCT01358981|12309772|FG005|COMPLETED|Period 1||3
11124179|NCT01358981|12309773|FG006|COMPLETED|Period 1||3
11124180|NCT01358981|12309767|FG000|NOT COMPLETED|Period 1||0
11124181|NCT01358981|12309768|FG001|NOT COMPLETED|Period 1||0
11124182|NCT01358981|12309769|FG002|NOT COMPLETED|Period 1||0
11124183|NCT01358981|12309770|FG003|NOT COMPLETED|Period 1||1
11124184|NCT01358981|12309771|FG004|NOT COMPLETED|Period 1||0
11124185|NCT01358981|12309772|FG005|NOT COMPLETED|Period 1||0
11124186|NCT01358981|12309773|FG006|NOT COMPLETED|Period 1||0
11124187|NCT01358981|12309767|FG000|STARTED|Period 2||2
11124188|NCT01358981|12309768|FG001|STARTED|Period 2||2
11124189|NCT01358981|12309769|FG002|STARTED|Period 2||2
11124190|NCT01358981|12309770|FG003|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2
11124191|NCT01358981|12309771|FG004|STARTED|Period 2||3
11124192|NCT01358981|12309772|FG005|STARTED|Period 2||3
11124193|NCT01358981|12309773|FG006|STARTED|Period 2||3
11124194|NCT01358981|12309767|FG000|COMPLETED|Period 2||2
11124195|NCT01358981|12309768|FG001|COMPLETED|Period 2||2
11124196|NCT01358981|12309769|FG002|COMPLETED|Period 2||2
11124197|NCT01358981|12309770|FG003|COMPLETED|Period 2||2
11124198|NCT01358981|12309771|FG004|COMPLETED|Period 2||3
11124199|NCT01358981|12309772|FG005|COMPLETED|Period 2||3
11124200|NCT01358981|12309773|FG006|COMPLETED|Period 2||3
11124201|NCT01358981|12309767|FG000|NOT COMPLETED|Period 2||0
11124202|NCT01358981|12309768|FG001|NOT COMPLETED|Period 2||0
11124203|NCT01358981|12309769|FG002|NOT COMPLETED|Period 2||0
11124204|NCT01358981|12309770|FG003|NOT COMPLETED|Period 2||0
11124205|NCT01358981|12309771|FG004|NOT COMPLETED|Period 2||0
11124206|NCT01358981|12309772|FG005|NOT COMPLETED|Period 2||0
11124207|NCT01358981|12309773|FG006|NOT COMPLETED|Period 2||0
11124208|NCT01358981|12309767|FG000|STARTED|Period 3||2
11124209|NCT01358981|12309768|FG001|STARTED|Period 3||2
11124210|NCT01358981|12309769|FG002|STARTED|Period 3||2
11124211|NCT01358981|12309770|FG003|STARTED|Period 3||2
11124212|NCT01358981|12309771|FG004|STARTED|Period 3||3
11124213|NCT01358981|12309772|FG005|STARTED|Period 3||3
11124214|NCT01358981|12309773|FG006|STARTED|Period 3||3
11124215|NCT01358981|12309767|FG000|COMPLETED|Period 3||2
11124216|NCT01358981|12309768|FG001|COMPLETED|Period 3||2
11124217|NCT01358981|12309769|FG002|COMPLETED|Period 3||2
11124218|NCT01358981|12309770|FG003|COMPLETED|Period 3||2
11124219|NCT01358981|12309771|FG004|COMPLETED|Period 3||3
11124220|NCT01358981|12309772|FG005|COMPLETED|Period 3||3
11124221|NCT01358981|12309773|FG006|COMPLETED|Period 3||3
11124222|NCT01358981|12309767|FG000|NOT COMPLETED|Period 3||0
11124223|NCT01358981|12309768|FG001|NOT COMPLETED|Period 3||0
11124224|NCT01358981|12309769|FG002|NOT COMPLETED|Period 3||0
11124225|NCT01358981|12309770|FG003|NOT COMPLETED|Period 3||0
11124226|NCT01358981|12309771|FG004|NOT COMPLETED|Period 3||0
11124227|NCT01358981|12309772|FG005|NOT COMPLETED|Period 3||0
11124228|NCT01358981|12309773|FG006|NOT COMPLETED|Period 3||0
11005105|NCT00721136|12182753|FG000|NOT COMPLETED|Overall Study||0
11005106|NCT00721136|12182754|FG001|NOT COMPLETED|Overall Study||0
11005107|NCT00721136|12182755|FG002|NOT COMPLETED|Overall Study||0
11124229|NCT01358981|12309767|FG000|STARTED|Period 4||2
11124230|NCT01358981|12309768|FG001|STARTED|Period 4||2
11124231|NCT01358981|12309769|FG002|STARTED|Period 4||2
11124232|NCT01358981|12309770|FG003|STARTED|Period 4||2
11124233|NCT01358981|12309771|FG004|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
11124234|NCT01358981|12309772|FG005|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
11124235|NCT01358981|12309773|FG006|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
11124236|NCT01358981|12309767|FG000|COMPLETED|Period 4||2
11124237|NCT01358981|12309768|FG001|COMPLETED|Period 4||2
11124238|NCT01358981|12309769|FG002|COMPLETED|Period 4||2
11124239|NCT01358981|12309770|FG003|COMPLETED|Period 4||2
11124240|NCT01358981|12309771|FG004|COMPLETED|Period 4||0
11124241|NCT01358981|12309772|FG005|COMPLETED|Period 4||0
11124242|NCT01358981|12309773|FG006|COMPLETED|Period 4||0
11005108|NCT00721136|12182756|FG003|NOT COMPLETED|Overall Study||0
11056388|NCT00993915|12237942|FG000|COMPLETED|Overall Study||678
11056389|NCT00993915|12237942|FG000|NOT COMPLETED|Overall Study||9
11056390|NCT00993928|12237948|FG000|STARTED|Overall Study||48
11056391|NCT00993928|12237949|FG001|STARTED|Overall Study||45
11056392|NCT00993928|12237948|FG000|COMPLETED|Overall Study||43
11056393|NCT00993928|12237949|FG001|COMPLETED|Overall Study||38
11056394|NCT00993928|12237948|FG000|NOT COMPLETED|Overall Study||5
11056395|NCT00993928|12237949|FG001|NOT COMPLETED|Overall Study||7
11056396|NCT00993954|12237961|FG000|STARTED|Overall Study||145
11056397|NCT00993954|12237962|FG001|STARTED|Overall Study||123
11056398|NCT00993954|12237961|FG000|COMPLETED|Overall Study||124
11056399|NCT00993954|12237962|FG001|COMPLETED|Overall Study||121
11056400|NCT00993954|12237961|FG000|NOT COMPLETED|Overall Study||21
11056401|NCT00993954|12237962|FG001|NOT COMPLETED|Overall Study||2
11056402|NCT00993967|12237968|FG000|STARTED|Overall Study||200
11056403|NCT00993967|12237968|FG000|COMPLETED|Overall Study||139
11056404|NCT00993967|12237968|FG000|NOT COMPLETED|Overall Study||61
11056405|NCT00994110|12237974|FG000|STARTED|Overall Study||217
11056406|NCT00994110|12237975|FG001|STARTED|Overall Study||222
11056407|NCT00994110|12237974|FG000|COMPLETED|Overall Study||152
11056408|NCT00994110|12237975|FG001|COMPLETED|Overall Study||148
11056409|NCT00994110|12237974|FG000|NOT COMPLETED|Overall Study||65
11056410|NCT00994110|12237975|FG001|NOT COMPLETED|Overall Study||74
11056411|NCT00994123|12237984|FG000|STARTED|Overall Study||33
11056412|NCT00994123|12237985|FG001|STARTED|Overall Study||85
11056413|NCT00994123|12237986|FG002|STARTED|Overall Study||44
11056414|NCT00994123|12237984|FG000|COMPLETED|Overall Study||33
11056415|NCT00994123|12237985|FG001|COMPLETED|Overall Study||85
11056416|NCT00994123|12237986|FG002|COMPLETED|Overall Study||44
11056417|NCT00994123|12237984|FG000|NOT COMPLETED|Overall Study||0
11056418|NCT00994123|12237985|FG001|NOT COMPLETED|Overall Study||0
11056419|NCT00994123|12237986|FG002|NOT COMPLETED|Overall Study||0
11056420|NCT00994175|12238005|FG000|STARTED|First Intervention||6
11056421|NCT00994175|12238006|FG001|STARTED|First Intervention||9
11056422|NCT00994175|12238005|FG000|COMPLETED|First Intervention||4
11056423|NCT00994175|12238006|FG001|COMPLETED|First Intervention||8
11056424|NCT00994175|12238005|FG000|NOT COMPLETED|First Intervention||2
11056425|NCT00994175|12238006|FG001|NOT COMPLETED|First Intervention||1
11056426|NCT00994175|12238005|FG000|STARTED|Second Intervention||4
11124243|NCT01358981|12309767|FG000|NOT COMPLETED|Period 4||0
11124244|NCT01358981|12309768|FG001|NOT COMPLETED|Period 4||0
11124245|NCT01358981|12309769|FG002|NOT COMPLETED|Period 4||0
11124246|NCT01358981|12309770|FG003|NOT COMPLETED|Period 4||0
11124247|NCT01358981|12309771|FG004|NOT COMPLETED|Period 4||0
11124248|NCT01358981|12309772|FG005|NOT COMPLETED|Period 4||0
11124249|NCT01358981|12309773|FG006|NOT COMPLETED|Period 4||0
11124250|NCT01359007|12309798|FG000|STARTED|Overall Study||5
11124251|NCT01359007|12309798|FG000|COMPLETED|Overall Study||3
11124252|NCT01359007|12309798|FG000|NOT COMPLETED|Overall Study||2
11124253|NCT01359046|12309805|FG000|STARTED|Overall Study||144
11124254|NCT01359046|12309806|FG001|STARTED|Overall Study||144
11124255|NCT01359046|12309805|FG000|COMPLETED|Overall Study||137
11124256|NCT01359046|12309806|FG001|COMPLETED|Overall Study||127
11124257|NCT01359046|12309805|FG000|NOT COMPLETED|Overall Study||7
11124258|NCT01359046|12309806|FG001|NOT COMPLETED|Overall Study||17
11124259|NCT01359111|12309812|FG000|STARTED|Overall Study||20
11124260|NCT01359111|12309812|FG000|COMPLETED|Overall Study||20
11124261|NCT01359111|12309812|FG000|NOT COMPLETED|Overall Study||0
11124262|NCT01359150|12309820|FG000|STARTED|Overall Study||112
11124263|NCT01359150|12309821|FG001|STARTED|Overall Study||111
11124264|NCT01359150|12309820|FG000|COMPLETED|Overall Study||105
11124265|NCT01359150|12309821|FG001|COMPLETED|Overall Study||106
11124266|NCT01359150|12309820|FG000|NOT COMPLETED|Overall Study||7
11124267|NCT01359150|12309821|FG001|NOT COMPLETED|Overall Study||5
11124268|NCT01359371|12309827|FG000|STARTED|Overall Study||131
11124269|NCT01359371|12309827|FG000|COMPLETED|Overall Study||131
11124270|NCT01359371|12309827|FG000|NOT COMPLETED|Overall Study||0
11124271|NCT01359410|12309838|FG000|STARTED|Overall Study||54
11124272|NCT01359410|12309839|FG001|STARTED|Overall Study||46
11056427|NCT00994175|12238006|FG001|STARTED|Second Intervention||8
11056428|NCT00994175|12238005|FG000|COMPLETED|Second Intervention||4
11056429|NCT00994175|12238006|FG001|COMPLETED|Second Intervention||8
11056430|NCT00994175|12238005|FG000|NOT COMPLETED|Second Intervention||0
11056431|NCT00994175|12238006|FG001|NOT COMPLETED|Second Intervention||0
11056432|NCT00994214|12238016|FG000|STARTED|ITT (Intention-to-Treat) - Part A||19
11056433|NCT00994214|12238017|FG001|STARTED|ITT (Intention-to-Treat) - Part A||19
11056434|NCT00994214|12238018|FG002|STARTED|ITT (Intention-to-Treat) - Part A||18
11056435|NCT00994214|12238019|FG003|STARTED|ITT (Intention-to-Treat) - Part A||20
11124273|NCT01359410|12309838|FG000|COMPLETED|Overall Study||54
11124274|NCT01359410|12309839|FG001|COMPLETED|Overall Study||46
11124275|NCT01359410|12309838|FG000|NOT COMPLETED|Overall Study||0
11124276|NCT01359410|12309839|FG001|NOT COMPLETED|Overall Study||0
11124277|NCT01359449|12309847|FG000|STARTED|Overall Study||61
11124278|NCT01359449|12309848|FG001|STARTED|Overall Study||62
11124279|NCT01359449|12309847|FG000|COMPLETED|Overall Study||57
11056436|NCT00994214|12238016|FG000|COMPLETED|ITT (Intention-to-Treat) - Part A||5
11056437|NCT00994214|12238017|FG001|COMPLETED|ITT (Intention-to-Treat) - Part A||6
11124280|NCT01359449|12309848|FG001|COMPLETED|Overall Study||58
11124281|NCT01359449|12309847|FG000|NOT COMPLETED|Overall Study||4
11124282|NCT01359449|12309848|FG001|NOT COMPLETED|Overall Study||4
11124283|NCT01359644|12309864|FG000|STARTED|Treatment Period||15
11124284|NCT01359644|12309865|FG001|STARTED|Treatment Period||16
11124285|NCT01359644|12309866|FG002|STARTED|Treatment Period||14
11124286|NCT01359644|12309867|FG003|STARTED|Treatment Period||14
11124287|NCT01359644|12309868|FG004|STARTED|Treatment Period||15
11124288|NCT01359644|12309869|FG005|STARTED|Treatment Period||14
11124289|NCT01359644|12309870|FG006|STARTED|Treatment Period||41
11124290|NCT01359644|12309871|FG007|STARTED|Treatment Period||41
11124291|NCT01359644|12309872|FG008|STARTED|Treatment Period||21
11124292|NCT01359644|12309873|FG009|STARTED|Treatment Period||20
11124293|NCT01359644|12309864|FG000|COMPLETED|Treatment Period||15
11124294|NCT01359644|12309865|FG001|COMPLETED|Treatment Period||15
11124295|NCT01359644|12309866|FG002|COMPLETED|Treatment Period||13
11124296|NCT01359644|12309867|FG003|COMPLETED|Treatment Period||14
11124297|NCT01359644|12309868|FG004|COMPLETED|Treatment Period||15
11124298|NCT01359644|12309869|FG005|COMPLETED|Treatment Period||12
11124299|NCT01359644|12309870|FG006|COMPLETED|Treatment Period||41
11124300|NCT01359644|12309871|FG007|COMPLETED|Treatment Period||41
11124301|NCT01359644|12309872|FG008|COMPLETED|Treatment Period||21
11124302|NCT01359644|12309873|FG009|COMPLETED|Treatment Period||20
11124303|NCT01359644|12309864|FG000|NOT COMPLETED|Treatment Period||0
11124304|NCT01359644|12309865|FG001|NOT COMPLETED|Treatment Period||1
11124305|NCT01359644|12309866|FG002|NOT COMPLETED|Treatment Period||1
11124306|NCT01359644|12309867|FG003|NOT COMPLETED|Treatment Period||0
11124307|NCT01359644|12309868|FG004|NOT COMPLETED|Treatment Period||0
11124308|NCT01359644|12309869|FG005|NOT COMPLETED|Treatment Period||2
11124309|NCT01359644|12309870|FG006|NOT COMPLETED|Treatment Period||0
11124310|NCT01359644|12309871|FG007|NOT COMPLETED|Treatment Period||0
11124311|NCT01359644|12309872|FG008|NOT COMPLETED|Treatment Period||0
11124312|NCT01359644|12309873|FG009|NOT COMPLETED|Treatment Period||0
11124313|NCT01359644|12309864|FG000|STARTED|Follow-up Period||15
11124314|NCT01359644|12309865|FG001|STARTED|Follow-up Period||16
11124315|NCT01359644|12309866|FG002|STARTED|Follow-up Period||14
11124316|NCT01359644|12309867|FG003|STARTED|Follow-up Period||14
11124317|NCT01359644|12309868|FG004|STARTED|Follow-up Period||15
11124318|NCT01359644|12309869|FG005|STARTED|Follow-up Period||13
11124319|NCT01359644|12309870|FG006|STARTED|Follow-up Period||41
11124320|NCT01359644|12309871|FG007|STARTED|Follow-up Period||41
11124321|NCT01359644|12309872|FG008|STARTED|Follow-up Period||21
11124322|NCT01359644|12309873|FG009|STARTED|Follow-up Period||20
11124323|NCT01359644|12309864|FG000|COMPLETED|Follow-up Period||15
11124324|NCT01359644|12309865|FG001|COMPLETED|Follow-up Period||16
11124325|NCT01359644|12309866|FG002|COMPLETED|Follow-up Period||14
11124326|NCT01359644|12309867|FG003|COMPLETED|Follow-up Period||14
11124327|NCT01359644|12309868|FG004|COMPLETED|Follow-up Period||15
11124328|NCT01359644|12309869|FG005|COMPLETED|Follow-up Period||12
11124329|NCT01359644|12309870|FG006|COMPLETED|Follow-up Period||40
11124330|NCT01359644|12309871|FG007|COMPLETED|Follow-up Period||39
11124331|NCT01359644|12309872|FG008|COMPLETED|Follow-up Period||21
11124332|NCT01359644|12309873|FG009|COMPLETED|Follow-up Period||20
11124333|NCT01359644|12309864|FG000|NOT COMPLETED|Follow-up Period||0
11124334|NCT01359644|12309865|FG001|NOT COMPLETED|Follow-up Period||0
11124335|NCT01359644|12309866|FG002|NOT COMPLETED|Follow-up Period||0
11124336|NCT01359644|12309867|FG003|NOT COMPLETED|Follow-up Period||0
11124337|NCT01359644|12309868|FG004|NOT COMPLETED|Follow-up Period||0
11124338|NCT01359644|12309869|FG005|NOT COMPLETED|Follow-up Period||1
11124339|NCT01359644|12309870|FG006|NOT COMPLETED|Follow-up Period||1
11124340|NCT01359644|12309871|FG007|NOT COMPLETED|Follow-up Period||2
11124341|NCT01359644|12309872|FG008|NOT COMPLETED|Follow-up Period||0
11124342|NCT01359644|12309873|FG009|NOT COMPLETED|Follow-up Period||0
11124343|NCT01359735|12309908|FG000|STARTED|Overall Study||4
11124344|NCT01359735|12309909|FG001|STARTED|Overall Study||4
11124345|NCT01359735|12309908|FG000|COMPLETED|Overall Study||4
11124346|NCT01359735|12309909|FG001|COMPLETED|Overall Study||4
11124347|NCT01359735|12309908|FG000|NOT COMPLETED|Overall Study||0
11124348|NCT01359735|12309909|FG001|NOT COMPLETED|Overall Study||0
11124349|NCT01359748|12309919|FG000|STARTED|Overall Study||48
11124350|NCT01359748|12309920|FG001|STARTED|Overall Study||20
11124351|NCT01359748|12309921|FG002|STARTED|Overall Study||10
11124352|NCT01359748|12309922|FG003|STARTED|Overall Study||11
11124353|NCT01359748|12309919|FG000|COMPLETED|Overall Study||48
11124354|NCT01359748|12309920|FG001|COMPLETED|Overall Study||20
11124355|NCT01359748|12309921|FG002|COMPLETED|Overall Study||10
11124356|NCT01359748|12309922|FG003|COMPLETED|Overall Study||11
11124357|NCT01359748|12309919|FG000|NOT COMPLETED|Overall Study||0
11124358|NCT01359748|12309920|FG001|NOT COMPLETED|Overall Study||0
11124359|NCT01359748|12309921|FG002|NOT COMPLETED|Overall Study||0
11124360|NCT01359748|12309922|FG003|NOT COMPLETED|Overall Study||0
11124361|NCT01359904|12309932|FG000|STARTED|Overall Study||15
11124362|NCT01359904|12309933|FG001|STARTED|Overall Study||19
11124363|NCT01359904|12309932|FG000|COMPLETED|Overall Study||14
11124364|NCT01359904|12309933|FG001|COMPLETED|Overall Study||19
11124365|NCT01359904|12309932|FG000|NOT COMPLETED|Overall Study||1
11124366|NCT01359904|12309933|FG001|NOT COMPLETED|Overall Study||0
11124367|NCT01359943|12309942|FG000|STARTED|Double-blind (Weeks 0 - 16)||88
11124368|NCT01359943|12309943|FG001|STARTED|Double-blind (Weeks 0 - 16)||89
11124369|NCT01359943|12309944|FG002|STARTED|Double-blind (Weeks 0 - 16)||44
11124370|NCT01359943|12309942|FG000|COMPLETED|Double-blind (Weeks 0 - 16)||86
11124371|NCT01359943|12309943|FG001|COMPLETED|Double-blind (Weeks 0 - 16)||85
11124372|NCT01359943|12309944|FG002|COMPLETED|Double-blind (Weeks 0 - 16)||44
11124373|NCT01359943|12309942|FG000|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
11124374|NCT01359943|12309943|FG001|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
11124375|NCT01359943|12309944|FG002|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
11124376|NCT01359943|12309942|FG000|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
11124377|NCT01359943|12309943|FG001|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
11124378|NCT01359943|12309944|FG002|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
11124379|NCT01359943|12309942|FG000|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
11124380|NCT01359943|12309943|FG001|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
11124381|NCT01359943|12309944|FG002|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
11124382|NCT01359943|12309942|FG000|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
11124383|NCT01359943|12309943|FG001|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
11124384|NCT01359943|12309944|FG002|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
11124385|NCT01359943|12309942|FG000|STARTED|Follow-up (Weeks 52 - 60)||86
11124386|NCT01359943|12309943|FG001|STARTED|Follow-up (Weeks 52 - 60)||84
11124387|NCT01359943|12309944|FG002|STARTED|Follow-up (Weeks 52 - 60)||44
11124388|NCT01359943|12309942|FG000|COMPLETED|Follow-up (Weeks 52 - 60)||78
11124389|NCT01359943|12309943|FG001|COMPLETED|Follow-up (Weeks 52 - 60)||69
11124390|NCT01359943|12309944|FG002|COMPLETED|Follow-up (Weeks 52 - 60)||36
11124391|NCT01359943|12309942|FG000|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
11124392|NCT01359943|12309943|FG001|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
11124393|NCT01359943|12309944|FG002|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
11124394|NCT01359956|12309958|FG000|STARTED|Overall Study||67
11124395|NCT01359956|12309959|FG001|STARTED|Overall Study||69
11124396|NCT01359956|12309960|FG002|STARTED|Overall Study||71
11124397|NCT01359956|12309961|FG003|STARTED|Overall Study||62
11124398|NCT01359956|12309958|FG000|COMPLETED|Overall Study||6
11124399|NCT01359956|12309959|FG001|COMPLETED|Overall Study||5
11124400|NCT01359956|12309960|FG002|COMPLETED|Overall Study||4
11124401|NCT01359956|12309961|FG003|COMPLETED|Overall Study||4
11124402|NCT01359956|12309958|FG000|NOT COMPLETED|Overall Study||61
11124403|NCT01359956|12309959|FG001|NOT COMPLETED|Overall Study||64
11124404|NCT01359956|12309960|FG002|NOT COMPLETED|Overall Study||67
11124405|NCT01359956|12309961|FG003|NOT COMPLETED|Overall Study||58
11124406|NCT01360021|12309974|FG000|STARTED|Overall Study|Patients randomized|71
11124407|NCT01360021|12309975|FG001|STARTED|Overall Study|Patients randomized|71
11124408|NCT01360021|12309976|FG002|STARTED|Overall Study|Patients randomized|72
11124409|NCT01360021|12309974|FG000|COMPLETED|Overall Study|Patients who completed study|63
11124410|NCT01360021|12309975|FG001|COMPLETED|Overall Study|Patients who completed study|67
11124411|NCT01360021|12309976|FG002|COMPLETED|Overall Study|Patients who completed study|65
11124412|NCT01360021|12309974|FG000|NOT COMPLETED|Overall Study||8
11124413|NCT01360021|12309975|FG001|NOT COMPLETED|Overall Study||4
11124414|NCT01360021|12309976|FG002|NOT COMPLETED|Overall Study||7
11124415|NCT01360229|12309986|FG000|STARTED|Overall Study||47
11124416|NCT01360229|12309987|FG001|STARTED|Overall Study||47
11124417|NCT01360229|12309986|FG000|COMPLETED|Overall Study||44
11124418|NCT01360229|12309987|FG001|COMPLETED|Overall Study||45
11124419|NCT01360229|12309986|FG000|NOT COMPLETED|Overall Study||3
11124420|NCT01360229|12309987|FG001|NOT COMPLETED|Overall Study||2
11124421|NCT01360398|12309993|FG000|STARTED|Overall Study||127
11124422|NCT01360398|12309993|FG000|COMPLETED|Overall Study||105
11124423|NCT01360398|12309993|FG000|NOT COMPLETED|Overall Study||22
11124424|NCT01360450|12309999|FG000|STARTED|Overall Study||6
11124425|NCT01360450|12310000|FG001|STARTED|Overall Study||6
11124426|NCT01360450|12309999|FG000|Completed Treatment|Overall Study||6
11124427|NCT01360450|12310000|FG001|Completed Treatment|Overall Study||6
11124428|NCT01360450|12309999|FG000|COMPLETED|Overall Study||6
11124429|NCT01360450|12310000|FG001|COMPLETED|Overall Study||6
11124430|NCT01360450|12309999|FG000|NOT COMPLETED|Overall Study||0
11124431|NCT01360450|12310000|FG001|NOT COMPLETED|Overall Study||0
11124432|NCT01360554|12310009|FG000|STARTED|Overall Study|Three participants were randomized but not treated.|439
11124433|NCT01360554|12310010|FG001|STARTED|Overall Study|Three participants were randomized but not treated.|439
11124434|NCT01360554|12310009|FG000|Treated|Overall Study||436
11124435|NCT01360554|12310010|FG001|Treated|Overall Study||436
11124436|NCT01360554|12310009|FG000|COMPLETED|Overall Study||0
11124437|NCT01360554|12310010|FG001|COMPLETED|Overall Study||0
11124438|NCT01360554|12310009|FG000|NOT COMPLETED|Overall Study||439
11124439|NCT01360554|12310010|FG001|NOT COMPLETED|Overall Study||439
11124440|NCT01360632|12310019|FG000|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
11124441|NCT01360632|12310020|FG001|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
11124442|NCT01360632|12310021|FG002|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
11124443|NCT01360632|12310022|FG003|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
11124444|NCT01360632|12310023|FG004|STARTED|Phase A (8 Weeks)||0
11124445|NCT01360632|12310019|FG000|COMPLETED|Phase A (8 Weeks)||1277
11124446|NCT01360632|12310020|FG001|COMPLETED|Phase A (8 Weeks)||0
11124447|NCT01360632|12310021|FG002|COMPLETED|Phase A (8 Weeks)||0
11124448|NCT01360632|12310022|FG003|COMPLETED|Phase A (8 Weeks)||0
11124449|NCT01360632|12310023|FG004|COMPLETED|Phase A (8 Weeks)||0
11124450|NCT01360632|12310019|FG000|NOT COMPLETED|Phase A (8 Weeks)||255
11124451|NCT01360632|12310020|FG001|NOT COMPLETED|Phase A (8 Weeks)||0
11124452|NCT01360632|12310021|FG002|NOT COMPLETED|Phase A (8 Weeks)||0
11124453|NCT01360632|12310022|FG003|NOT COMPLETED|Phase A (8 Weeks)||0
11124454|NCT01360632|12310023|FG004|NOT COMPLETED|Phase A (8 Weeks)||0
11124455|NCT01360632|12310019|FG000|STARTED|Phase B (6 Weeks)||0
11124456|NCT01360632|12310020|FG001|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
11124457|NCT01360632|12310021|FG002|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
11124458|NCT01360632|12310022|FG003|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
11124459|NCT01360632|12310023|FG004|STARTED|Phase B (6 Weeks)||0
11124460|NCT01360632|12310019|FG000|COMPLETED|Phase B (6 Weeks)||0
11124461|NCT01360632|12310020|FG001|COMPLETED|Phase B (6 Weeks)||216
11124462|NCT01360632|12310021|FG002|COMPLETED|Phase B (6 Weeks)||210
11124463|NCT01360632|12310022|FG003|COMPLETED|Phase B (6 Weeks)||208
11124464|NCT01360632|12310023|FG004|COMPLETED|Phase B (6 Weeks)||0
11124465|NCT01360632|12310019|FG000|NOT COMPLETED|Phase B (6 Weeks)||0
11124466|NCT01360632|12310020|FG001|NOT COMPLETED|Phase B (6 Weeks)||10
11124467|NCT01360632|12310021|FG002|NOT COMPLETED|Phase B (6 Weeks)||20
11124468|NCT01360632|12310022|FG003|NOT COMPLETED|Phase B (6 Weeks)||13
11124469|NCT01360632|12310023|FG004|NOT COMPLETED|Phase B (6 Weeks)||0
11124470|NCT01360632|12310019|FG000|STARTED|Phase A+||0
11124471|NCT01360632|12310020|FG001|STARTED|Phase A+||0
11124472|NCT01360632|12310021|FG002|STARTED|Phase A+||0
11124473|NCT01360632|12310022|FG003|STARTED|Phase A+||0
11124474|NCT01360632|12310023|FG004|STARTED|Phase A+||600
11124475|NCT01360632|12310019|FG000|COMPLETED|Phase A+||0
11124476|NCT01360632|12310020|FG001|COMPLETED|Phase A+||0
11124477|NCT01360632|12310021|FG002|COMPLETED|Phase A+||0
11124478|NCT01360632|12310022|FG003|COMPLETED|Phase A+||0
11124479|NCT01360632|12310023|FG004|COMPLETED|Phase A+||575
11124480|NCT01360632|12310019|FG000|NOT COMPLETED|Phase A+||0
11124481|NCT01360632|12310020|FG001|NOT COMPLETED|Phase A+||0
11124482|NCT01360632|12310021|FG002|NOT COMPLETED|Phase A+||0
11358080|NCT03119649|12555107|FG004|COMPLETED|Overall Study||14
11124483|NCT01360632|12310022|FG003|NOT COMPLETED|Phase A+||0
11358081|NCT03119649|12555103|FG000|NOT COMPLETED|Overall Study||0
11124484|NCT01360632|12310023|FG004|NOT COMPLETED|Phase A+||25
11124485|NCT01360645|12310033|FG000|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
11124486|NCT01360645|12310034|FG001|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
11124487|NCT01360645|12310035|FG002|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
11124488|NCT01360645|12310036|FG003|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
11124489|NCT01360645|12310033|FG000|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
11124490|NCT01360645|12310034|FG001|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
11124491|NCT01360645|12310035|FG002|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
11124492|NCT01360645|12310036|FG003|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
11124493|NCT01360645|12310033|FG000|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
11124494|NCT01360645|12310034|FG001|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
11124495|NCT01360645|12310035|FG002|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
11124496|NCT01360645|12310036|FG003|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
11124497|NCT01360645|12310033|FG000|STARTED|Phase B (6 Weeks)||0
11124498|NCT01360645|12310034|FG001|STARTED|Phase B (6 Weeks)||188
11124499|NCT01360645|12310035|FG002|STARTED|Phase B (6 Weeks)||191
11124500|NCT01360645|12310036|FG003|STARTED|Phase B (6 Weeks)||0
11124501|NCT01360645|12310033|FG000|COMPLETED|Phase B (6 Weeks)||0
11124502|NCT01360645|12310034|FG001|COMPLETED|Phase B (6 Weeks)||174
11124503|NCT01360645|12310035|FG002|COMPLETED|Phase B (6 Weeks)||178
11124504|NCT01360645|12310036|FG003|COMPLETED|Phase B (6 Weeks)||0
11124505|NCT01360645|12310033|FG000|NOT COMPLETED|Phase B (6 Weeks)||0
11124506|NCT01360645|12310034|FG001|NOT COMPLETED|Phase B (6 Weeks)||14
11124507|NCT01360645|12310035|FG002|NOT COMPLETED|Phase B (6 Weeks)||13
11124508|NCT01360645|12310036|FG003|NOT COMPLETED|Phase B (6 Weeks)||0
11124509|NCT01360645|12310033|FG000|STARTED|Phase A+||0
11124510|NCT01360645|12310034|FG001|STARTED|Phase A+||0
11124511|NCT01360645|12310035|FG002|STARTED|Phase A+||0
11124512|NCT01360645|12310036|FG003|STARTED|Phase A+||331
11124513|NCT01360645|12310033|FG000|COMPLETED|Phase A+||0
11124514|NCT01360645|12310034|FG001|COMPLETED|Phase A+||0
11124515|NCT01360645|12310035|FG002|COMPLETED|Phase A+||0
11124516|NCT01360645|12310036|FG003|COMPLETED|Phase A+||307
11124517|NCT01360645|12310033|FG000|NOT COMPLETED|Phase A+||0
11124518|NCT01360645|12310034|FG001|NOT COMPLETED|Phase A+||0
11124519|NCT01360645|12310035|FG002|NOT COMPLETED|Phase A+||0
11124520|NCT01360645|12310036|FG003|NOT COMPLETED|Phase A+||24
11124521|NCT01360762|12310042|FG000|STARTED|Main Study Period (12-month Treatment)||74
11124522|NCT01360762|12310042|FG000|COMPLETED|Main Study Period (12-month Treatment)||45
11124523|NCT01360762|12310042|FG000|NOT COMPLETED|Main Study Period (12-month Treatment)||29
11124524|NCT01360762|12310042|FG000|STARTED|Whole Study Period||74
11124525|NCT01360762|12310042|FG000|COMPLETED|Whole Study Period||38
11124526|NCT01360762|12310042|FG000|NOT COMPLETED|Whole Study Period||36
11124527|NCT01360840|12310049|FG000|STARTED|Overall Study||60
11124528|NCT01360840|12310050|FG001|STARTED|Overall Study||60
11124529|NCT01360840|12310051|FG002|STARTED|Overall Study||60
11124530|NCT01360840|12310049|FG000|COMPLETED|Overall Study||50
11124531|NCT01360840|12310050|FG001|COMPLETED|Overall Study||50
11124532|NCT01360840|12310051|FG002|COMPLETED|Overall Study||51
11124533|NCT01360840|12310049|FG000|NOT COMPLETED|Overall Study||10
11124534|NCT01360840|12310050|FG001|NOT COMPLETED|Overall Study||10
11124535|NCT01360840|12310051|FG002|NOT COMPLETED|Overall Study||9
11124536|NCT01360866|12310065|FG000|STARTED|Overall Study||516
11124537|NCT01360866|12310066|FG001|STARTED|Overall Study||707
11124538|NCT01360866|12310067|FG002|STARTED|Overall Study||1645
11124539|NCT01360866|12310068|FG003|STARTED|Overall Study||76
11124540|NCT01360866|12310065|FG000|COMPLETED|Overall Study||295
11124541|NCT01360866|12310066|FG001|COMPLETED|Overall Study||420
11124542|NCT01360866|12310067|FG002|COMPLETED|Overall Study||1126
11124543|NCT01360866|12310068|FG003|COMPLETED|Overall Study||54
11124544|NCT01360866|12310065|FG000|NOT COMPLETED|Overall Study||221
11124545|NCT01360866|12310066|FG001|NOT COMPLETED|Overall Study||287
11124546|NCT01360866|12310067|FG002|NOT COMPLETED|Overall Study||519
11124547|NCT01360866|12310068|FG003|NOT COMPLETED|Overall Study||22
11124548|NCT01360996|12310081|FG000|STARTED|Overall Study||20
11124549|NCT01360996|12310082|FG001|STARTED|Overall Study||21
11124550|NCT01360996|12310083|FG002|STARTED|Overall Study||23
11124551|NCT01360996|12310081|FG000|COMPLETED|Overall Study||14
11124552|NCT01360996|12310082|FG001|COMPLETED|Overall Study||18
11124553|NCT01360996|12310083|FG002|COMPLETED|Overall Study||21
11124554|NCT01360996|12310081|FG000|NOT COMPLETED|Overall Study||6
11124555|NCT01360996|12310082|FG001|NOT COMPLETED|Overall Study||3
11124556|NCT01360996|12310083|FG002|NOT COMPLETED|Overall Study||2
11124557|NCT01361009|12310090|FG000|STARTED|Overall Study||2017
11124558|NCT01361009|12310090|FG000|COMPLETED|Overall Study||1901
11124559|NCT01361009|12310090|FG000|NOT COMPLETED|Overall Study||116
11124560|NCT01361048|12310097|FG000|STARTED|Overall Study||20
11124561|NCT01361048|12310098|FG001|STARTED|Overall Study||10
11124562|NCT01361048|12310099|FG002|STARTED|Overall Study||10
11124563|NCT01361048|12310097|FG000|COMPLETED|Overall Study||20
11124564|NCT01361048|12310098|FG001|COMPLETED|Overall Study||10
11124565|NCT01361048|12310099|FG002|COMPLETED|Overall Study||9
11124566|NCT01361048|12310097|FG000|NOT COMPLETED|Overall Study||0
11124567|NCT01361048|12310098|FG001|NOT COMPLETED|Overall Study||0
11124568|NCT01361048|12310099|FG002|NOT COMPLETED|Overall Study||1
11238881|NCT02078102|12430766|FG000|COMPLETED|Overall Study||23
11238882|NCT02078102|12430767|FG001|COMPLETED|Overall Study||12
11238883|NCT02078102|12430766|FG000|NOT COMPLETED|Overall Study||2
11238884|NCT02078102|12430767|FG001|NOT COMPLETED|Overall Study||1
11238885|NCT02078180|12430774|FG000|STARTED|Overall Study||34
11238886|NCT02078180|12430774|FG000|IR75|Overall Study||30
11238887|NCT02078180|12430774|FG000|IR100|Overall Study||31
11124569|NCT01361113|12310110|FG000|STARTED|Overall Study||21
11124570|NCT01361113|12310110|FG000|COMPLETED|Overall Study||21
11124571|NCT01361113|12310110|FG000|NOT COMPLETED|Overall Study||0
11124572|NCT01361126|12310118|FG000|STARTED|Overall Study||13
11124573|NCT01361126|12310119|FG001|STARTED|Overall Study||4
11124574|NCT01361126|12310118|FG000|COMPLETED|Overall Study||13
11124575|NCT01361126|12310119|FG001|COMPLETED|Overall Study||2
11124576|NCT01361126|12310118|FG000|NOT COMPLETED|Overall Study||0
11124577|NCT01361126|12310119|FG001|NOT COMPLETED|Overall Study||2
11124578|NCT01361178|12310128|FG000|STARTED|Overall Study||122
11124579|NCT01361178|12310129|FG001|STARTED|Overall Study||11
11124580|NCT01361178|12310128|FG000|COMPLETED|Overall Study||109
11124581|NCT01361178|12310129|FG001|COMPLETED|Overall Study||11
11124582|NCT01361178|12310128|FG000|NOT COMPLETED|Overall Study||13
11124583|NCT01361178|12310129|FG001|NOT COMPLETED|Overall Study||0
11124584|NCT01361217|12310135|FG000|STARTED|Overall Study||10
11124585|NCT01361217|12310135|FG000|COMPLETED|Overall Study||10
11238888|NCT02078180|12430774|FG000|SR100|Overall Study||31
11124586|NCT01361217|12310135|FG000|NOT COMPLETED|Overall Study||0
11124587|NCT01361308|12310143|FG000|STARTED|Overall Study||306
11124588|NCT01361308|12310144|FG001|STARTED|Overall Study||308
11124589|NCT01361308|12310143|FG000|COMPLETED|Overall Study||271
11124590|NCT01361308|12310144|FG001|COMPLETED|Overall Study||278
11124591|NCT01361308|12310143|FG000|NOT COMPLETED|Overall Study||35
11124592|NCT01361308|12310144|FG001|NOT COMPLETED|Overall Study||30
11124593|NCT01361464|12310150|FG000|STARTED|Overall Study||21
11124594|NCT01361464|12310150|FG000|COMPLETED|Overall Study||18
11124595|NCT01361464|12310150|FG000|NOT COMPLETED|Overall Study||3
11124596|NCT01361568|12310160|FG000|STARTED|Overall Study||71
11124597|NCT01361568|12310161|FG001|STARTED|Overall Study||71
11124598|NCT01361568|12310162|FG002|STARTED|Overall Study||20
11124599|NCT01361568|12310163|FG003|STARTED|Overall Study||21
11124600|NCT01361568|12310164|FG004|STARTED|Overall Study||7
11124601|NCT01361568|12310165|FG005|STARTED|Overall Study||13
11124602|NCT01361568|12310160|FG000|COMPLETED|Overall Study||69
11124603|NCT01361568|12310161|FG001|COMPLETED|Overall Study||70
11124604|NCT01361568|12310162|FG002|COMPLETED|Overall Study||20
11124605|NCT01361568|12310163|FG003|COMPLETED|Overall Study||21
11124606|NCT01361568|12310164|FG004|COMPLETED|Overall Study||6
11124607|NCT01361568|12310165|FG005|COMPLETED|Overall Study||11
11124608|NCT01361568|12310160|FG000|NOT COMPLETED|Overall Study||2
11124609|NCT01361568|12310161|FG001|NOT COMPLETED|Overall Study||1
11124610|NCT01361568|12310162|FG002|NOT COMPLETED|Overall Study||0
11124611|NCT01361568|12310163|FG003|NOT COMPLETED|Overall Study||0
11124612|NCT01361568|12310164|FG004|NOT COMPLETED|Overall Study||1
11124613|NCT01361568|12310165|FG005|NOT COMPLETED|Overall Study||2
11124614|NCT01361594|12310182|FG000|STARTED|Overall Study||152
11124615|NCT01361594|12310183|FG001|STARTED|Overall Study||153
11124616|NCT01361594|12310182|FG000|COMPLETED|Overall Study||151
11124617|NCT01361594|12310183|FG001|COMPLETED|Overall Study||151
11124618|NCT01361594|12310182|FG000|NOT COMPLETED|Overall Study||1
11124619|NCT01361594|12310183|FG001|NOT COMPLETED|Overall Study||2
11124620|NCT01361607|12310191|FG000|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
11124621|NCT01361607|12310192|FG001|STARTED|Overall Study||199
11124622|NCT01361607|12310191|FG000|Received at Least 1 Dose of Study Drug|Overall Study||198
11124623|NCT01361607|12310192|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199
11124624|NCT01361607|12310191|FG000|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
11124625|NCT01361607|12310192|FG001|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
11124626|NCT01361607|12310191|FG000|ITT Population|Overall Study||198
11124627|NCT01361607|12310192|FG001|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
11124628|NCT01361607|12310191|FG000|COMPLETED|Overall Study||136
11124629|NCT01361607|12310192|FG001|COMPLETED|Overall Study||158
11124630|NCT01361607|12310191|FG000|NOT COMPLETED|Overall Study||64
11124631|NCT01361607|12310192|FG001|NOT COMPLETED|Overall Study||41
11124632|NCT01361620|12310199|FG000|STARTED|Overall Study||132
11124633|NCT01361620|12310199|FG000|COMPLETED|Overall Study||132
11124634|NCT01361620|12310199|FG000|NOT COMPLETED|Overall Study||0
11124635|NCT01361633|12310205|FG000|STARTED|Overall Study||25
11124636|NCT01361633|12310206|FG001|STARTED|Overall Study||26
11124637|NCT01361633|12310205|FG000|COMPLETED|Overall Study||19
11124638|NCT01361633|12310206|FG001|COMPLETED|Overall Study||23
11124639|NCT01361633|12310205|FG000|NOT COMPLETED|Overall Study||6
11124640|NCT01361633|12310206|FG001|NOT COMPLETED|Overall Study||3
11124641|NCT01361711|12310214|FG000|STARTED|Trial Entry (Registration)||53
11124642|NCT01361711|12310214|FG000|Received Dose of Study Drug|Trial Entry (Registration)||52
11124643|NCT01361711|12310214|FG000|COMPLETED|Trial Entry (Registration)||52
11124644|NCT01361711|12310214|FG000|NOT COMPLETED|Trial Entry (Registration)||1
11124645|NCT01361711|12310214|FG000|STARTED|Week 9 Bone Marrow Response Assessment||52
11124646|NCT01361711|12310214|FG000|COMPLETED|Week 9 Bone Marrow Response Assessment||51
11124647|NCT01361711|12310214|FG000|NOT COMPLETED|Week 9 Bone Marrow Response Assessment||1
11124648|NCT01361711|12310214|FG000|STARTED|Continued Treatment After 9 Weeks||51
11124649|NCT01361711|12310214|FG000|COMPLETED|Continued Treatment After 9 Weeks||44
11124650|NCT01361711|12310214|FG000|NOT COMPLETED|Continued Treatment After 9 Weeks||7
11124651|NCT01361711|12310214|FG000|STARTED|Continued Treatment After 12 Weeks||44
11124652|NCT01361711|12310214|FG000|COMPLETED|Continued Treatment After 12 Weeks||41
11124653|NCT01361711|12310214|FG000|NOT COMPLETED|Continued Treatment After 12 Weeks||3
11124654|NCT01361711|12310214|FG000|STARTED|Completed Week 18 of Treatment||41
11124655|NCT01361711|12310214|FG000|COMPLETED|Completed Week 18 of Treatment||30
11124656|NCT01361711|12310214|FG000|NOT COMPLETED|Completed Week 18 of Treatment||11
11124657|NCT01361711|12310214|FG000|STARTED|10 Year Follow-up|All patients who receive at least one dose of study drug go into follow-up.|52
11124658|NCT01361711|12310214|FG000|COMPLETED|10 Year Follow-up||2
11124659|NCT01361711|12310214|FG000|NOT COMPLETED|10 Year Follow-up||50
11124660|NCT01361854|12310218|FG000|STARTED|Day 1||51
11124661|NCT01361854|12310219|FG001|STARTED|Day 1||51
11124662|NCT01361854|12310218|FG000|COMPLETED|Day 1||47
11124663|NCT01361854|12310219|FG001|COMPLETED|Day 1||48
11124664|NCT01361854|12310218|FG000|NOT COMPLETED|Day 1||4
11124665|NCT01361854|12310219|FG001|NOT COMPLETED|Day 1||3
11124666|NCT01361854|12310218|FG000|STARTED|Wash-out, Maximum 2 Weeks||47
11238889|NCT02078180|12430774|FG000|SR150|Overall Study||32
11238890|NCT02078180|12430774|FG000|XL 150|Overall Study||31
11238891|NCT02078180|12430774|FG000|XL 300|Overall Study||32
11238892|NCT02078180|12430774|FG000|COMPLETED|Overall Study||29
11238893|NCT02078180|12430774|FG000|NOT COMPLETED|Overall Study||5
11238894|NCT02078193|12430783|FG000|STARTED|Overall Study||3
11238895|NCT02078193|12430783|FG000|COMPLETED|Overall Study||3
11238896|NCT02078193|12430783|FG000|NOT COMPLETED|Overall Study||0
11238897|NCT02078219|12430793|FG000|STARTED|Overall Study||41
11238898|NCT02078219|12430794|FG001|STARTED|Overall Study||40
11238899|NCT02078219|12430795|FG002|STARTED|Overall Study||41
11238900|NCT02078219|12430796|FG003|STARTED|Overall Study||41
11238901|NCT02078219|12430797|FG004|STARTED|Overall Study||41
11238902|NCT02078219|12430793|FG000|COMPLETED|Overall Study||38
11238903|NCT02078219|12430794|FG001|COMPLETED|Overall Study||36
11238904|NCT02078219|12430795|FG002|COMPLETED|Overall Study||35
11238905|NCT02078219|12430796|FG003|COMPLETED|Overall Study||37
11238906|NCT02078219|12430797|FG004|COMPLETED|Overall Study||39
11238907|NCT02078219|12430793|FG000|NOT COMPLETED|Overall Study||3
11238908|NCT02078219|12430794|FG001|NOT COMPLETED|Overall Study||4
11238909|NCT02078219|12430795|FG002|NOT COMPLETED|Overall Study||6
11238910|NCT02078219|12430796|FG003|NOT COMPLETED|Overall Study||4
11238911|NCT02078219|12430797|FG004|NOT COMPLETED|Overall Study||2
11238912|NCT02078284|12430814|FG000|STARTED|Overall Study||5
11238913|NCT02078284|12430815|FG001|STARTED|Overall Study||7
11238914|NCT02078284|12430816|FG002|STARTED|Overall Study||6
11238915|NCT02078284|12430817|FG003|STARTED|Overall Study||6
11238916|NCT02078284|12430818|FG004|STARTED|Overall Study||4
11238917|NCT02078284|12430814|FG000|COMPLETED|Overall Study||5
11238918|NCT02078284|12430815|FG001|COMPLETED|Overall Study||7
11238919|NCT02078284|12430816|FG002|COMPLETED|Overall Study||6
11238920|NCT02078284|12430817|FG003|COMPLETED|Overall Study||6
11238921|NCT02078284|12430818|FG004|COMPLETED|Overall Study||4
11238922|NCT02078284|12430814|FG000|NOT COMPLETED|Overall Study||0
11238923|NCT02078284|12430815|FG001|NOT COMPLETED|Overall Study||0
11238924|NCT02078284|12430816|FG002|NOT COMPLETED|Overall Study||0
11238925|NCT02078284|12430817|FG003|NOT COMPLETED|Overall Study||0
11238926|NCT02078284|12430818|FG004|NOT COMPLETED|Overall Study||0
11124667|NCT01361854|12310219|FG001|STARTED|Wash-out, Maximum 2 Weeks||48
11124668|NCT01361854|12310218|FG000|COMPLETED|Wash-out, Maximum 2 Weeks||47
11124669|NCT01361854|12310219|FG001|COMPLETED|Wash-out, Maximum 2 Weeks||48
11124670|NCT01361854|12310218|FG000|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
11124671|NCT01361854|12310219|FG001|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
11124672|NCT01361854|12310218|FG000|STARTED|Second Intervention||47
11124673|NCT01361854|12310219|FG001|STARTED|Second Intervention||48
11124674|NCT01361854|12310218|FG000|COMPLETED|Second Intervention||47
11124675|NCT01361854|12310219|FG001|COMPLETED|Second Intervention||48
11124676|NCT01361854|12310218|FG000|NOT COMPLETED|Second Intervention||0
11124677|NCT01361854|12310219|FG001|NOT COMPLETED|Second Intervention||0
11124678|NCT01361867|12310225|FG000|STARTED|Overall Study||15
11124679|NCT01361867|12310225|FG000|COMPLETED|Overall Study||15
11124680|NCT01361867|12310225|FG000|NOT COMPLETED|Overall Study||0
11124681|NCT01361919|12310232|FG000|STARTED|Overall Study||100
11124682|NCT01361919|12310233|FG001|STARTED|Overall Study||100
11238927|NCT02078492|12430833|FG000|STARTED|Overall Study||80
11238928|NCT02078492|12430834|FG001|STARTED|Overall Study||80
11238929|NCT02078492|12430835|FG002|STARTED|Overall Study||80
11238930|NCT02078492|12430833|FG000|COMPLETED|Overall Study||80
11238931|NCT02078492|12430834|FG001|COMPLETED|Overall Study||80
11238932|NCT02078492|12430835|FG002|COMPLETED|Overall Study||80
11238933|NCT02078492|12430833|FG000|NOT COMPLETED|Overall Study||0
11238934|NCT02078492|12430834|FG001|NOT COMPLETED|Overall Study||0
11238935|NCT02078492|12430835|FG002|NOT COMPLETED|Overall Study||0
11238936|NCT02078557|12430843|FG000|STARTED|Overall Study||4
11238937|NCT02078557|12430843|FG000|COMPLETED|Overall Study||4
11238938|NCT02078557|12430843|FG000|NOT COMPLETED|Overall Study||0
11238939|NCT02078713|12430851|FG000|STARTED|Overall Study||407
11238940|NCT02078713|12430852|FG001|STARTED|Overall Study||351
11124683|NCT01361919|12310234|FG002|STARTED|Overall Study||98
11124684|NCT01361919|12310232|FG000|COMPLETED|Overall Study||90
11124685|NCT01361919|12310233|FG001|COMPLETED|Overall Study||88
11124686|NCT01361919|12310234|FG002|COMPLETED|Overall Study||88
11124687|NCT01361919|12310232|FG000|NOT COMPLETED|Overall Study||10
11124688|NCT01361919|12310233|FG001|NOT COMPLETED|Overall Study||12
11124689|NCT01361919|12310234|FG002|NOT COMPLETED|Overall Study||10
11124690|NCT01362049|12310246|FG000|STARTED|Follow-Up at 7 Weeks||26
11124691|NCT01362049|12310247|FG001|STARTED|Follow-Up at 7 Weeks||19
11124692|NCT01362049|12310248|FG002|STARTED|Follow-Up at 7 Weeks||32
11124693|NCT01362049|12310249|FG003|STARTED|Follow-Up at 7 Weeks||25
11124694|NCT01362049|12310246|FG000|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
11124695|NCT01362049|12310247|FG001|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
11124696|NCT01362049|12310248|FG002|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
11124697|NCT01362049|12310249|FG003|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
11124698|NCT01362049|12310246|FG000|COMPLETED|Follow-Up at 7 Weeks||23
11124699|NCT01362049|12310247|FG001|COMPLETED|Follow-Up at 7 Weeks||16
11124700|NCT01362049|12310248|FG002|COMPLETED|Follow-Up at 7 Weeks||30
11124701|NCT01362049|12310249|FG003|COMPLETED|Follow-Up at 7 Weeks||24
11124702|NCT01362049|12310246|FG000|NOT COMPLETED|Follow-Up at 7 Weeks||3
11124703|NCT01362049|12310247|FG001|NOT COMPLETED|Follow-Up at 7 Weeks||3
11124704|NCT01362049|12310248|FG002|NOT COMPLETED|Follow-Up at 7 Weeks||2
11124705|NCT01362049|12310249|FG003|NOT COMPLETED|Follow-Up at 7 Weeks||1
11124706|NCT01362049|12310246|FG000|STARTED|Follow-Up at 52 Weeks (12 Months)||23
11124707|NCT01362049|12310247|FG001|STARTED|Follow-Up at 52 Weeks (12 Months)||16
11124708|NCT01362049|12310248|FG002|STARTED|Follow-Up at 52 Weeks (12 Months)||30
11124709|NCT01362049|12310249|FG003|STARTED|Follow-Up at 52 Weeks (12 Months)||24
11124710|NCT01362049|12310246|FG000|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
11124711|NCT01362049|12310247|FG001|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
11124712|NCT01362049|12310248|FG002|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
11124713|NCT01362049|12310249|FG003|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
11124714|NCT01362049|12310246|FG000|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
11124715|NCT01362049|12310247|FG001|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
11124716|NCT01362049|12310248|FG002|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
11124717|NCT01362049|12310249|FG003|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
11124718|NCT01362062|12310265|FG000|STARTED|Overall Study||48
11124719|NCT01362062|12310266|FG001|STARTED|Overall Study||62
11124720|NCT01362062|12310265|FG000|COMPLETED|Overall Study||22
11124721|NCT01362062|12310266|FG001|COMPLETED|Overall Study||62
11124722|NCT01362062|12310265|FG000|NOT COMPLETED|Overall Study||26
11124723|NCT01362062|12310266|FG001|NOT COMPLETED|Overall Study||0
11124724|NCT01362127|12310273|FG000|STARTED|Overall Study||90
11124725|NCT01362127|12310274|FG001|STARTED|Overall Study||91
11124726|NCT01362127|12310273|FG000|COMPLETED|Overall Study||90
11124727|NCT01362127|12310274|FG001|COMPLETED|Overall Study||91
11124728|NCT01362127|12310273|FG000|NOT COMPLETED|Overall Study||0
11124729|NCT01362127|12310274|FG001|NOT COMPLETED|Overall Study||0
11124730|NCT01362140|12310282|FG000|STARTED|Overall Study||49
11124731|NCT01362140|12310283|FG001|STARTED|Overall Study||98
11124732|NCT01362140|12310282|FG000|Received Treatment|Overall Study||49
11124733|NCT01362140|12310283|FG001|Received Treatment|Overall Study||97
11124734|NCT01362140|12310282|FG000|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
11124735|NCT01362140|12310283|FG001|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
11124736|NCT01362140|12310282|FG000|NOT COMPLETED|Overall Study||10
11124737|NCT01362140|12310283|FG001|NOT COMPLETED|Overall Study||11
11124738|NCT01362192|12310289|FG000|STARTED|Overall Study||20
11124739|NCT01362192|12310289|FG000|COMPLETED|Overall Study||16
11124740|NCT01362192|12310289|FG000|NOT COMPLETED|Overall Study||4
11124741|NCT01362205|12310295|FG000|STARTED|Overall Study||22
11124742|NCT01362205|12310296|FG001|STARTED|Overall Study||27
11124743|NCT01362205|12310295|FG000|COMPLETED|Overall Study||22
11124744|NCT01362205|12310296|FG001|COMPLETED|Overall Study||27
11124745|NCT01362205|12310295|FG000|NOT COMPLETED|Overall Study||0
11124746|NCT01362205|12310296|FG001|NOT COMPLETED|Overall Study||0
11124747|NCT01362244|12310304|FG000|STARTED|Overall Study||54
11124748|NCT01362244|12310305|FG001|STARTED|Overall Study||51
11124749|NCT01362244|12310304|FG000|COMPLETED|Overall Study||22
11124750|NCT01362244|12310305|FG001|COMPLETED|Overall Study||19
11124751|NCT01362244|12310304|FG000|NOT COMPLETED|Overall Study||32
11124752|NCT01362244|12310305|FG001|NOT COMPLETED|Overall Study||32
11124753|NCT01362270|12310313|FG000|STARTED|Overall Study||7
11124754|NCT01362270|12310314|FG001|STARTED|Overall Study||8
11124755|NCT01362270|12310313|FG000|COMPLETED|Overall Study||5
11124756|NCT01362270|12310314|FG001|COMPLETED|Overall Study||6
11124757|NCT01362270|12310313|FG000|NOT COMPLETED|Overall Study||2
11124758|NCT01362270|12310314|FG001|NOT COMPLETED|Overall Study||2
11124759|NCT01362296|12310322|FG000|STARTED|Randomized Phase (RP)||87
11124760|NCT01362296|12310323|FG001|STARTED|Randomized Phase (RP)||43
11124761|NCT01362296|12310324|FG002|STARTED|Randomized Phase (RP)||0
11124762|NCT01362296|12310325|FG003|STARTED|Randomized Phase (RP)||0
11124763|NCT01362296|12310322|FG000|COMPLETED|Randomized Phase (RP)||0
11124764|NCT01362296|12310323|FG001|COMPLETED|Randomized Phase (RP)||0
11124765|NCT01362296|12310324|FG002|COMPLETED|Randomized Phase (RP)||0
11124766|NCT01362296|12310325|FG003|COMPLETED|Randomized Phase (RP)||0
11124767|NCT01362296|12310322|FG000|NOT COMPLETED|Randomized Phase (RP)||87
11124768|NCT01362296|12310323|FG001|NOT COMPLETED|Randomized Phase (RP)||43
11124769|NCT01362296|12310324|FG002|NOT COMPLETED|Randomized Phase (RP)||0
11124770|NCT01362296|12310325|FG003|NOT COMPLETED|Randomized Phase (RP)||0
11124771|NCT01362296|12310322|FG000|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
11124772|NCT01362296|12310323|FG001|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
11124773|NCT01362296|12310324|FG002|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
11124774|NCT01362296|12310325|FG003|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
11124775|NCT01362296|12310322|FG000|COMPLETED|Crossover Phase||0
11124776|NCT01362296|12310323|FG001|COMPLETED|Crossover Phase||0
11124777|NCT01362296|12310324|FG002|COMPLETED|Crossover Phase||0
11124778|NCT01362296|12310325|FG003|COMPLETED|Crossover Phase||0
11124779|NCT01362296|12310322|FG000|NOT COMPLETED|Crossover Phase||0
11124780|NCT01362296|12310323|FG001|NOT COMPLETED|Crossover Phase||0
11124781|NCT01362296|12310324|FG002|NOT COMPLETED|Crossover Phase||23
11124782|NCT01362296|12310325|FG003|NOT COMPLETED|Crossover Phase||2
11124783|NCT01362322|12310337|FG000|STARTED|Overall Study||335
11124784|NCT01362322|12310338|FG001|STARTED|Overall Study||336
11124785|NCT01362322|12310337|FG000|COMPLETED|Overall Study||330
11124786|NCT01362322|12310338|FG001|COMPLETED|Overall Study||329
11124787|NCT01362322|12310337|FG000|NOT COMPLETED|Overall Study||5
11124788|NCT01362322|12310338|FG001|NOT COMPLETED|Overall Study||7
11124789|NCT01362348|12310344|FG000|STARTED|Overall Study||19
11124790|NCT01362348|12310344|FG000|COMPLETED|Overall Study||5
11124791|NCT01362348|12310344|FG000|NOT COMPLETED|Overall Study||14
11124792|NCT01362439|12310348|FG000|STARTED|Overall Study||133
11124793|NCT01362439|12310348|FG000|COMPLETED|Overall Study||118
11124794|NCT01362439|12310348|FG000|NOT COMPLETED|Overall Study||15
11124795|NCT01362491|12310356|FG000|STARTED|Overall Study||91
11124796|NCT01362491|12310357|FG001|STARTED|Overall Study||89
11124797|NCT01362491|12310358|FG002|STARTED|Overall Study||46
11124798|NCT01362491|12310356|FG000|COMPLETED|Overall Study||90
11124799|NCT01362491|12310357|FG001|COMPLETED|Overall Study||89
11124800|NCT01362491|12310358|FG002|COMPLETED|Overall Study||46
11124801|NCT01362491|12310356|FG000|NOT COMPLETED|Overall Study||1
11124802|NCT01362491|12310357|FG001|NOT COMPLETED|Overall Study||0
11124803|NCT01362491|12310358|FG002|NOT COMPLETED|Overall Study||0
11124804|NCT01362517|12310367|FG000|STARTED|Overall Study||131
11124805|NCT01362517|12310367|FG000|COMPLETED|Overall Study||129
11124806|NCT01362517|12310367|FG000|NOT COMPLETED|Overall Study||2
11124807|NCT01362530|12310376|FG000|STARTED|Base Study (Cycle 1)||155
11124808|NCT01362530|12310377|FG001|STARTED|Base Study (Cycle 1)||152
11124809|NCT01362530|12310376|FG000|Received Study Treatment|Base Study (Cycle 1)||152
11124810|NCT01362530|12310377|FG001|Received Study Treatment|Base Study (Cycle 1)||150
11124811|NCT01362530|12310376|FG000|COMPLETED|Base Study (Cycle 1)||150
11124812|NCT01362530|12310377|FG001|COMPLETED|Base Study (Cycle 1)||149
11124813|NCT01362530|12310376|FG000|NOT COMPLETED|Base Study (Cycle 1)||5
11124814|NCT01362530|12310377|FG001|NOT COMPLETED|Base Study (Cycle 1)||3
11124815|NCT01362530|12310376|FG000|STARTED|Optional Extension (Cycles 2-6)||171
11124816|NCT01362530|12310377|FG001|STARTED|Optional Extension (Cycles 2-6)||0
11124817|NCT01362530|12310376|FG000|COMPLETED|Optional Extension (Cycles 2-6)||46
11124818|NCT01362530|12310377|FG001|COMPLETED|Optional Extension (Cycles 2-6)||0
11124819|NCT01362530|12310376|FG000|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
11124820|NCT01362530|12310377|FG001|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
11124821|NCT01362608|12310386|FG000|STARTED|Overall Study||67
11124822|NCT01362608|12310387|FG001|STARTED|Overall Study||69
11124823|NCT01362608|12310386|FG000|COMPLETED|Overall Study||63
11124824|NCT01362608|12310387|FG001|COMPLETED|Overall Study||61
11124825|NCT01362608|12310386|FG000|NOT COMPLETED|Overall Study||4
11124826|NCT01362608|12310387|FG001|NOT COMPLETED|Overall Study||8
11124827|NCT01362686|12310396|FG000|STARTED|Overall Study||67
11124828|NCT01362686|12310397|FG001|STARTED|Overall Study||66
11124829|NCT01362686|12310398|FG002|STARTED|Overall Study||63
11124830|NCT01362686|12310396|FG000|COMPLETED|Overall Study||59
11124831|NCT01362686|12310397|FG001|COMPLETED|Overall Study||54
11124832|NCT01362686|12310398|FG002|COMPLETED|Overall Study||53
11124833|NCT01362686|12310396|FG000|NOT COMPLETED|Overall Study||8
11124834|NCT01362686|12310397|FG001|NOT COMPLETED|Overall Study||12
11124835|NCT01362686|12310398|FG002|NOT COMPLETED|Overall Study||10
11124836|NCT01362790|12310412|FG000|STARTED|Pilot Phase & Phase 2||11
11124837|NCT01362790|12310413|FG001|STARTED|Pilot Phase & Phase 2||8
11124838|NCT01362790|12310414|FG002|STARTED|Pilot Phase & Phase 2||7
11124839|NCT01362790|12310415|FG003|STARTED|Pilot Phase & Phase 2||15
11124840|NCT01362790|12310416|FG004|STARTED|Pilot Phase & Phase 2||0
11124841|NCT01362790|12310417|FG005|STARTED|Pilot Phase & Phase 2||4
11124842|NCT01362790|12310418|FG006|STARTED|Pilot Phase & Phase 2||0
11124843|NCT01362790|12310412|FG000|COMPLETED|Pilot Phase & Phase 2||1
11124844|NCT01362790|12310413|FG001|COMPLETED|Pilot Phase & Phase 2||0
11124845|NCT01362790|12310414|FG002|COMPLETED|Pilot Phase & Phase 2||2
11124846|NCT01362790|12310415|FG003|COMPLETED|Pilot Phase & Phase 2||1
11124847|NCT01362790|12310416|FG004|COMPLETED|Pilot Phase & Phase 2||0
11124848|NCT01362790|12310417|FG005|COMPLETED|Pilot Phase & Phase 2||0
11124849|NCT01362790|12310418|FG006|COMPLETED|Pilot Phase & Phase 2||0
11124850|NCT01362790|12310412|FG000|NOT COMPLETED|Pilot Phase & Phase 2||10
11124851|NCT01362790|12310413|FG001|NOT COMPLETED|Pilot Phase & Phase 2||8
11124852|NCT01362790|12310414|FG002|NOT COMPLETED|Pilot Phase & Phase 2||5
11124853|NCT01362790|12310415|FG003|NOT COMPLETED|Pilot Phase & Phase 2||14
11124854|NCT01362790|12310416|FG004|NOT COMPLETED|Pilot Phase & Phase 2||0
11124855|NCT01362790|12310417|FG005|NOT COMPLETED|Pilot Phase & Phase 2||4
11124856|NCT01362790|12310418|FG006|NOT COMPLETED|Pilot Phase & Phase 2||0
11124857|NCT01362790|12310412|FG000|STARTED|Dose De-escalation of Regimen A||0
11124858|NCT01362790|12310413|FG001|STARTED|Dose De-escalation of Regimen A||0
11124859|NCT01362790|12310414|FG002|STARTED|Dose De-escalation of Regimen A||0
11124860|NCT01362790|12310415|FG003|STARTED|Dose De-escalation of Regimen A||0
11124861|NCT01362790|12310416|FG004|STARTED|Dose De-escalation of Regimen A||8
11124862|NCT01362790|12310417|FG005|STARTED|Dose De-escalation of Regimen A||0
11124863|NCT01362790|12310418|FG006|STARTED|Dose De-escalation of Regimen A||0
11124864|NCT01362790|12310412|FG000|COMPLETED|Dose De-escalation of Regimen A||0
11124865|NCT01362790|12310413|FG001|COMPLETED|Dose De-escalation of Regimen A||0
11124866|NCT01362790|12310414|FG002|COMPLETED|Dose De-escalation of Regimen A||0
11124867|NCT01362790|12310415|FG003|COMPLETED|Dose De-escalation of Regimen A||0
11124868|NCT01362790|12310416|FG004|COMPLETED|Dose De-escalation of Regimen A||2
11124869|NCT01362790|12310417|FG005|COMPLETED|Dose De-escalation of Regimen A||0
11124870|NCT01362790|12310418|FG006|COMPLETED|Dose De-escalation of Regimen A||0
11124871|NCT01362790|12310412|FG000|NOT COMPLETED|Dose De-escalation of Regimen A||0
11124872|NCT01362790|12310413|FG001|NOT COMPLETED|Dose De-escalation of Regimen A||0
11124873|NCT01362790|12310414|FG002|NOT COMPLETED|Dose De-escalation of Regimen A||0
11124874|NCT01362790|12310415|FG003|NOT COMPLETED|Dose De-escalation of Regimen A||0
11124875|NCT01362790|12310416|FG004|NOT COMPLETED|Dose De-escalation of Regimen A||6
11124876|NCT01362790|12310417|FG005|NOT COMPLETED|Dose De-escalation of Regimen A||0
11124877|NCT01362790|12310418|FG006|NOT COMPLETED|Dose De-escalation of Regimen A||0
11124878|NCT01362894|12310438|FG000|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
11238941|NCT02078713|12430853|FG002|STARTED|Overall Study||15
11238942|NCT02078713|12430854|FG003|STARTED|Overall Study||13
11238943|NCT02078713|12430851|FG000|COMPLETED|Overall Study||355
11238944|NCT02078713|12430852|FG001|COMPLETED|Overall Study||290
11238945|NCT02078713|12430853|FG002|COMPLETED|Overall Study||15
11238946|NCT02078713|12430854|FG003|COMPLETED|Overall Study||13
11238947|NCT02078713|12430851|FG000|NOT COMPLETED|Overall Study||52
11238948|NCT02078713|12430852|FG001|NOT COMPLETED|Overall Study||61
11238949|NCT02078713|12430853|FG002|NOT COMPLETED|Overall Study||0
11238950|NCT02078713|12430854|FG003|NOT COMPLETED|Overall Study||0
11238951|NCT02078726|12430868|FG000|STARTED|Overall Study||64
11238952|NCT02078726|12430869|FG001|STARTED|Overall Study||36
11124879|NCT01362894|12310439|FG001|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
11124880|NCT01362894|12310438|FG000|COMPLETED|Period One, 1 Week||119
11124881|NCT01362894|12310439|FG001|COMPLETED|Period One, 1 Week||117
11124882|NCT01362894|12310438|FG000|NOT COMPLETED|Period One, 1 Week||0
11124883|NCT01362894|12310439|FG001|NOT COMPLETED|Period One, 1 Week||0
11124884|NCT01362894|12310438|FG000|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
11124885|NCT01362894|12310439|FG001|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
11124886|NCT01362894|12310438|FG000|COMPLETED|Period Two, 1 Week||118
11124887|NCT01362894|12310439|FG001|COMPLETED|Period Two, 1 Week||115
11124888|NCT01362894|12310438|FG000|NOT COMPLETED|Period Two, 1 Week||0
11238953|NCT02078726|12430868|FG000|COMPLETED|Overall Study||64
11124889|NCT01362894|12310439|FG001|NOT COMPLETED|Period Two, 1 Week||0
11124890|NCT01362907|12310445|FG000|STARTED|Period 1, One Week||20
11124891|NCT01362907|12310446|FG001|STARTED|Period 1, One Week||20
11124892|NCT01362907|12310445|FG000|COMPLETED|Period 1, One Week||20
11238954|NCT02078726|12430869|FG001|COMPLETED|Overall Study||36
11238955|NCT02078726|12430868|FG000|NOT COMPLETED|Overall Study||0
11124893|NCT01362907|12310446|FG001|COMPLETED|Period 1, One Week||20
11124894|NCT01362907|12310445|FG000|NOT COMPLETED|Period 1, One Week||0
11124895|NCT01362907|12310446|FG001|NOT COMPLETED|Period 1, One Week||0
11124896|NCT01362907|12310445|FG000|STARTED|Period 2, One Week||20
11124897|NCT01362907|12310446|FG001|STARTED|Period 2, One Week||20
11124898|NCT01362907|12310445|FG000|COMPLETED|Period 2, One Week||20
11124899|NCT01362907|12310446|FG001|COMPLETED|Period 2, One Week||20
11124900|NCT01362907|12310445|FG000|NOT COMPLETED|Period 2, One Week||0
11124901|NCT01362907|12310446|FG001|NOT COMPLETED|Period 2, One Week||0
11124902|NCT01362946|12310452|FG000|STARTED|First Behavior Modification Block||24
11124903|NCT01362946|12310453|FG001|STARTED|First Behavior Modification Block||24
11124904|NCT01362946|12310452|FG000|COMPLETED|First Behavior Modification Block||24
11124905|NCT01362946|12310453|FG001|COMPLETED|First Behavior Modification Block||24
11124906|NCT01362946|12310452|FG000|NOT COMPLETED|First Behavior Modification Block||0
11124907|NCT01362946|12310453|FG001|NOT COMPLETED|First Behavior Modification Block||0
11124908|NCT01362946|12310452|FG000|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
11124909|NCT01362946|12310453|FG001|STARTED|Second Behavior Modification Block||24
11124910|NCT01362946|12310452|FG000|COMPLETED|Second Behavior Modification Block||23
11124911|NCT01362946|12310453|FG001|COMPLETED|Second Behavior Modification Block||24
11124912|NCT01362946|12310452|FG000|NOT COMPLETED|Second Behavior Modification Block||0
11124913|NCT01362946|12310453|FG001|NOT COMPLETED|Second Behavior Modification Block||0
11124914|NCT01362959|12310461|FG000|STARTED|Overall Study||21
11124915|NCT01362959|12310462|FG001|STARTED|Overall Study||26
11124916|NCT01362959|12310461|FG000|COMPLETED|Overall Study||21
11124917|NCT01362959|12310462|FG001|COMPLETED|Overall Study||26
11124918|NCT01362959|12310461|FG000|NOT COMPLETED|Overall Study||0
11124919|NCT01362959|12310462|FG001|NOT COMPLETED|Overall Study||0
11124920|NCT01363011|12310470|FG000|STARTED|Main Study||33
11124921|NCT01363011|12310471|FG001|STARTED|Main Study||73
11124922|NCT01363011|12310470|FG000|COMPLETED|Main Study||29
11124923|NCT01363011|12310471|FG001|COMPLETED|Main Study||64
11124924|NCT01363011|12310470|FG000|NOT COMPLETED|Main Study||4
11124925|NCT01363011|12310471|FG001|NOT COMPLETED|Main Study||9
11124926|NCT01363011|12310470|FG000|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
11124927|NCT01363011|12310471|FG001|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
11124928|NCT01363011|12310470|FG000|COMPLETED|Extension Phase||13
11124929|NCT01363011|12310471|FG001|COMPLETED|Extension Phase||41
11124930|NCT01363011|12310470|FG000|NOT COMPLETED|Extension Phase||5
11124931|NCT01363011|12310471|FG001|NOT COMPLETED|Extension Phase||8
11124932|NCT01363050|12310477|FG000|STARTED|Overall Study||15
11124933|NCT01363050|12310477|FG000|COMPLETED|Overall Study||15
11124934|NCT01363050|12310477|FG000|NOT COMPLETED|Overall Study||0
11124935|NCT01363076|12310485|FG000|STARTED|Overall Study||7
11124936|NCT01363076|12310486|FG001|STARTED|Overall Study||13
11124937|NCT01363076|12310485|FG000|COMPLETED|Overall Study||7
11124938|NCT01363076|12310486|FG001|COMPLETED|Overall Study||12
11124939|NCT01363076|12310485|FG000|NOT COMPLETED|Overall Study||0
11124940|NCT01363076|12310486|FG001|NOT COMPLETED|Overall Study||1
11124941|NCT01363128|12310492|FG000|STARTED|Overall Study||69
11124942|NCT01363128|12310492|FG000|COMPLETED|Overall Study||69
11124943|NCT01363128|12310492|FG000|NOT COMPLETED|Overall Study||0
11124944|NCT01363258|12310498|FG000|STARTED|Overall Study||54
11124945|NCT01363258|12310499|FG001|STARTED|Overall Study||46
11124946|NCT01363258|12310498|FG000|COMPLETED|Overall Study||54
11124947|NCT01363258|12310499|FG001|COMPLETED|Overall Study||46
11124948|NCT01363258|12310498|FG000|NOT COMPLETED|Overall Study||0
11124949|NCT01363258|12310499|FG001|NOT COMPLETED|Overall Study||0
11124950|NCT01363297|12310510|FG000|STARTED|Overall Study||3
11124951|NCT01363297|12310511|FG001|STARTED|Overall Study||12
11124952|NCT01363297|12310512|FG002|STARTED|Overall Study||9
11124953|NCT01363297|12310513|FG003|STARTED|Overall Study||13
11124954|NCT01363297|12310514|FG004|STARTED|Overall Study||35
11124955|NCT01363297|12310510|FG000|COMPLETED|Overall Study||0
11124956|NCT01363297|12310511|FG001|COMPLETED|Overall Study||6
11124957|NCT01363297|12310512|FG002|COMPLETED|Overall Study||3
11124958|NCT01363297|12310513|FG003|COMPLETED|Overall Study||3
11124959|NCT01363297|12310514|FG004|COMPLETED|Overall Study||4
11124960|NCT01363297|12310510|FG000|NOT COMPLETED|Overall Study||3
11124961|NCT01363297|12310511|FG001|NOT COMPLETED|Overall Study||6
11124962|NCT01363297|12310512|FG002|NOT COMPLETED|Overall Study||6
11124963|NCT01363297|12310513|FG003|NOT COMPLETED|Overall Study||10
11124964|NCT01363297|12310514|FG004|NOT COMPLETED|Overall Study||31
11124965|NCT01363349|12310533|FG000|STARTED|Overall Study||133
11124966|NCT01363349|12310534|FG001|STARTED|Overall Study||136
11124967|NCT01363349|12310533|FG000|Randomized|Overall Study||133
11124968|NCT01363349|12310534|FG001|Randomized|Overall Study||136
11124969|NCT01363349|12310533|FG000|COMPLETED|Overall Study||66
11124970|NCT01363349|12310534|FG001|COMPLETED|Overall Study||66
11124971|NCT01363349|12310533|FG000|NOT COMPLETED|Overall Study||67
11124972|NCT01363349|12310534|FG001|NOT COMPLETED|Overall Study||70
11124973|NCT01363388|12310543|FG000|STARTED|Overall Study||23
11124974|NCT01363388|12310544|FG001|STARTED|Overall Study||22
11124975|NCT01363388|12310545|FG002|STARTED|Overall Study||22
11124976|NCT01363388|12310543|FG000|COMPLETED|Overall Study||18
11124977|NCT01363388|12310544|FG001|COMPLETED|Overall Study||19
11124978|NCT01363388|12310545|FG002|COMPLETED|Overall Study||18
11124979|NCT01363388|12310543|FG000|NOT COMPLETED|Overall Study||5
11124980|NCT01363388|12310544|FG001|NOT COMPLETED|Overall Study||3
11124981|NCT01363388|12310545|FG002|NOT COMPLETED|Overall Study||4
11124982|NCT01363440|12310556|FG000|STARTED|Overall Study|randomized|156
11124983|NCT01363440|12310557|FG001|STARTED|Overall Study|randomized|156
11124984|NCT01363440|12310558|FG002|STARTED|Overall Study|randomized|154
11124985|NCT01363440|12310556|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
11124986|NCT01363440|12310557|FG001|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
11124987|NCT01363440|12310558|FG002|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
11124988|NCT01363440|12310556|FG000|Completed Week 52|Overall Study||145
11124989|NCT01363440|12310557|FG001|Completed Week 52|Overall Study||146
11124990|NCT01363440|12310558|FG002|Completed Week 52|Overall Study||144
11124991|NCT01363440|12310556|FG000|Completed Week 100|Overall Study||133
11124992|NCT01363440|12310557|FG001|Completed Week 100|Overall Study||125
11124993|NCT01363440|12310558|FG002|Completed Week 100|Overall Study||127
11124994|NCT01363440|12310556|FG000|COMPLETED|Overall Study|Completed Week 100|133
11124995|NCT01363440|12310557|FG001|COMPLETED|Overall Study|Completed Week 100|125
11124996|NCT01363440|12310558|FG002|COMPLETED|Overall Study|Completed Week 100|127
11124997|NCT01363440|12310556|FG000|NOT COMPLETED|Overall Study||23
11124998|NCT01363440|12310557|FG001|NOT COMPLETED|Overall Study||31
11124999|NCT01363440|12310558|FG002|NOT COMPLETED|Overall Study||27
11125000|NCT01363479|12310571|FG000|STARTED|Overall Study|number of randomised patients|371
11125001|NCT01363479|12310572|FG001|STARTED|Overall Study|number of randomised patients|372
11125002|NCT01363479|12310571|FG000|COMPLETED|Overall Study||359
11125003|NCT01363479|12310572|FG001|COMPLETED|Overall Study||351
11125004|NCT01363479|12310571|FG000|NOT COMPLETED|Overall Study||12
11125005|NCT01363479|12310572|FG001|NOT COMPLETED|Overall Study||21
11125006|NCT01363492|12310578|FG000|STARTED|Overall Study||14
11125007|NCT01363492|12310578|FG000|COMPLETED|Overall Study||14
11125008|NCT01363492|12310578|FG000|NOT COMPLETED|Overall Study||0
11125009|NCT01363661|12310586|FG000|STARTED|Overall Study||32
11125010|NCT01363661|12310587|FG001|STARTED|Overall Study||32
11125011|NCT01363661|12310586|FG000|COMPLETED|Overall Study||18
11125012|NCT01363661|12310587|FG001|COMPLETED|Overall Study||28
11125013|NCT01363661|12310586|FG000|NOT COMPLETED|Overall Study||14
11125014|NCT01363661|12310587|FG001|NOT COMPLETED|Overall Study||4
11125015|NCT01363700|12310596|FG000|STARTED|Epinastine vs Placebo Period1||43
11125016|NCT01363700|12310597|FG001|STARTED|Epinastine vs Placebo Period1||22
11125017|NCT01363700|12310598|FG002|STARTED|Epinastine vs Placebo Period1||22
11125018|NCT01363700|12310599|FG003|STARTED|Epinastine vs Placebo Period1|No Allocation|0
11125019|NCT01363700|12310600|FG004|STARTED|Epinastine vs Placebo Period1|No Allocation|0
11125020|NCT01363700|12310596|FG000|COMPLETED|Epinastine vs Placebo Period1||43
11125021|NCT01363700|12310597|FG001|COMPLETED|Epinastine vs Placebo Period1||21
11125022|NCT01363700|12310598|FG002|COMPLETED|Epinastine vs Placebo Period1||22
11125023|NCT01363700|12310599|FG003|COMPLETED|Epinastine vs Placebo Period1||0
11125024|NCT01363700|12310600|FG004|COMPLETED|Epinastine vs Placebo Period1||0
11125025|NCT01363700|12310596|FG000|NOT COMPLETED|Epinastine vs Placebo Period1||0
11125026|NCT01363700|12310597|FG001|NOT COMPLETED|Epinastine vs Placebo Period1||1
11125027|NCT01363700|12310598|FG002|NOT COMPLETED|Epinastine vs Placebo Period1||0
11125028|NCT01363700|12310599|FG003|NOT COMPLETED|Epinastine vs Placebo Period1||0
11125029|NCT01363700|12310600|FG004|NOT COMPLETED|Epinastine vs Placebo Period1||0
11125030|NCT01363700|12310596|FG000|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
11125031|NCT01363700|12310597|FG001|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
11125032|NCT01363700|12310598|FG002|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
11125033|NCT01363700|12310599|FG003|STARTED|Epinastine vs Olopatadine Period2||43
11125034|NCT01363700|12310600|FG004|STARTED|Epinastine vs Olopatadine Period2||43
11125035|NCT01363700|12310596|FG000|COMPLETED|Epinastine vs Olopatadine Period2||0
11125036|NCT01363700|12310597|FG001|COMPLETED|Epinastine vs Olopatadine Period2||0
11125037|NCT01363700|12310598|FG002|COMPLETED|Epinastine vs Olopatadine Period2||0
11125038|NCT01363700|12310599|FG003|COMPLETED|Epinastine vs Olopatadine Period2||43
11125039|NCT01363700|12310600|FG004|COMPLETED|Epinastine vs Olopatadine Period2||43
11125040|NCT01363700|12310596|FG000|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
11125041|NCT01363700|12310597|FG001|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
11125042|NCT01363700|12310598|FG002|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
11125043|NCT01363700|12310599|FG003|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
11125044|NCT01363700|12310600|FG004|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
11125045|NCT01363713|12310611|FG000|STARTED|Overall Study|Assessed for eligibility|130
11125046|NCT01363713|12310611|FG000|ALLOCATED|Overall Study||130
11125047|NCT01363713|12310611|FG000|COMPLETED|Overall Study|Analysed (n=130)|124
11125048|NCT01363713|12310611|FG000|NOT COMPLETED|Overall Study||6
11125049|NCT01363765|12310617|FG000|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
11125050|NCT01363765|12310618|FG001|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
11125051|NCT01363765|12310617|FG000|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
11125052|NCT01363765|12310618|FG001|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
11125053|NCT01363765|12310617|FG000|NOT COMPLETED|Overall Study||5800
11125054|NCT01363765|12310618|FG001|NOT COMPLETED|Overall Study||4731
11125055|NCT01363843|12310626|FG000|STARTED|Overall Study||39
11125056|NCT01363843|12310626|FG000|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
11125057|NCT01363843|12310626|FG000|NOT COMPLETED|Overall Study||1
11125058|NCT01363908|12310633|FG000|STARTED|Screening/Enrollment||14
11125059|NCT01363908|12310634|FG001|STARTED|Screening/Enrollment||16
11125060|NCT01363908|12310633|FG000|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
11125061|NCT01363908|12310634|FG001|COMPLETED|Screening/Enrollment||16
11125062|NCT01363908|12310633|FG000|NOT COMPLETED|Screening/Enrollment||1
11125063|NCT01363908|12310634|FG001|NOT COMPLETED|Screening/Enrollment||0
11125064|NCT01363908|12310633|FG000|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
11125065|NCT01363908|12310634|FG001|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
11125066|NCT01363908|12310633|FG000|COMPLETED|Pharmacokinetic (PK) Phase||8
11125067|NCT01363908|12310634|FG001|COMPLETED|Pharmacokinetic (PK) Phase||8
11125068|NCT01363908|12310633|FG000|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
11125069|NCT01363908|12310634|FG001|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
11202048|NCT01837654|12392454|FG000|STARTED|Overall Study||11
11125070|NCT01363908|12310633|FG000|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
11125071|NCT01363908|12310634|FG001|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
11125072|NCT01363908|12310633|FG000|COMPLETED|Chronic Dosing (CD) Phase||3
11125073|NCT01363908|12310634|FG001|COMPLETED|Chronic Dosing (CD) Phase||10
11125074|NCT01363908|12310633|FG000|NOT COMPLETED|Chronic Dosing (CD) Phase||10
11125075|NCT01363908|12310634|FG001|NOT COMPLETED|Chronic Dosing (CD) Phase||6
11125076|NCT01363986|12310640|FG000|STARTED|Overall Study||3
11125077|NCT01363986|12310640|FG000|COMPLETED|Overall Study||2
11125078|NCT01363986|12310640|FG000|NOT COMPLETED|Overall Study||1
11125079|NCT01363999|12310644|FG000|STARTED|A: RO5317116/F01 Bilayer Tablet||24
11125080|NCT01363999|12310644|FG000|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24
11125081|NCT01363999|12310644|FG000|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0
11125082|NCT01363999|12310644|FG000|STARTED|B: RO5317116/F03 Bilayer Tablet||24
11125083|NCT01363999|12310644|FG000|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24
11125084|NCT01363999|12310644|FG000|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0
11125085|NCT01363999|12310644|FG000|STARTED|C: RO5317116/ F04 Active-coated Tablet||24
11125086|NCT01363999|12310644|FG000|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24
11125087|NCT01363999|12310644|FG000|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0
11125088|NCT01363999|12310644|FG000|STARTED|D: RO4607381/ F49 Tablet||24
11125089|NCT01363999|12310644|FG000|COMPLETED|D: RO4607381/ F49 Tablet||24
11125090|NCT01363999|12310644|FG000|NOT COMPLETED|D: RO4607381/ F49 Tablet||0
11202049|NCT01837654|12392455|FG001|STARTED|Overall Study||11
11202050|NCT01837654|12392454|FG000|COMPLETED|Overall Study||11
11202051|NCT01837654|12392455|FG001|COMPLETED|Overall Study||11
11202052|NCT01837654|12392454|FG000|NOT COMPLETED|Overall Study||0
11202053|NCT01837654|12392455|FG001|NOT COMPLETED|Overall Study||0
11202054|NCT01837680|12392463|FG000|STARTED|Overall Study||52
11202055|NCT01837680|12392464|FG001|STARTED|Overall Study||53
11202056|NCT01837680|12392463|FG000|COMPLETED|Overall Study||42
11202057|NCT01837680|12392464|FG001|COMPLETED|Overall Study||45
11202058|NCT01837680|12392463|FG000|NOT COMPLETED|Overall Study||10
11202059|NCT01837680|12392464|FG001|NOT COMPLETED|Overall Study||8
11202060|NCT01837719|12392470|FG000|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
11202061|NCT01837719|12392470|FG000|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
11202062|NCT01837719|12392470|FG000|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
11202063|NCT01837719|12392470|FG000|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
11202064|NCT01837719|12392470|FG000|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
11202065|NCT01837719|12392470|FG000|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
11202066|NCT01837719|12392470|FG000|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
11202067|NCT01837719|12392470|FG000|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
11202068|NCT01837719|12392470|FG000|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
11202069|NCT01837719|12392470|FG000|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
11202070|NCT01837719|12392470|FG000|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
11202071|NCT01837719|12392470|FG000|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
11202072|NCT01837719|12392470|FG000|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
11202073|NCT01837719|12392470|FG000|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
11202074|NCT01837719|12392470|FG000|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
11202075|NCT01837797|12392488|FG000|STARTED|Period 1||129
11202076|NCT01837797|12392489|FG001|STARTED|Period 1||0
11202077|NCT01837797|12392490|FG002|STARTED|Period 1||0
11202078|NCT01837797|12392491|FG003|STARTED|Period 1||0
11202079|NCT01837797|12392492|FG004|STARTED|Period 1||0
11202080|NCT01837797|12392488|FG000|COMPLETED|Period 1||27
11202081|NCT01837797|12392489|FG001|COMPLETED|Period 1||0
11202082|NCT01837797|12392490|FG002|COMPLETED|Period 1||0
11202083|NCT01837797|12392491|FG003|COMPLETED|Period 1||0
11202084|NCT01837797|12392492|FG004|COMPLETED|Period 1||0
11202085|NCT01837797|12392488|FG000|NOT COMPLETED|Period 1||102
11202086|NCT01837797|12392489|FG001|NOT COMPLETED|Period 1||0
11202087|NCT01837797|12392490|FG002|NOT COMPLETED|Period 1||0
11202088|NCT01837797|12392491|FG003|NOT COMPLETED|Period 1||0
11238956|NCT02078726|12430869|FG001|NOT COMPLETED|Overall Study||0
11238957|NCT02078752|12430885|FG000|STARTED|Overall Study||3
11202089|NCT01837797|12392492|FG004|NOT COMPLETED|Period 1||0
11202090|NCT01837797|12392488|FG000|STARTED|Period 2||0
11202091|NCT01837797|12392489|FG001|STARTED|Period 2||6
11202092|NCT01837797|12392490|FG002|STARTED|Period 2||3
11202093|NCT01837797|12392491|FG003|STARTED|Period 2||6
11202094|NCT01837797|12392492|FG004|STARTED|Period 2||0
11202095|NCT01837797|12392488|FG000|COMPLETED|Period 2||0
11202096|NCT01837797|12392489|FG001|COMPLETED|Period 2||1
11202097|NCT01837797|12392490|FG002|COMPLETED|Period 2||1
11202098|NCT01837797|12392491|FG003|COMPLETED|Period 2||1
11202099|NCT01837797|12392492|FG004|COMPLETED|Period 2||0
11202100|NCT01837797|12392488|FG000|NOT COMPLETED|Period 2||0
11202101|NCT01837797|12392489|FG001|NOT COMPLETED|Period 2||5
11202102|NCT01837797|12392490|FG002|NOT COMPLETED|Period 2||2
11202103|NCT01837797|12392491|FG003|NOT COMPLETED|Period 2||5
11202104|NCT01837797|12392492|FG004|NOT COMPLETED|Period 2||0
11202105|NCT01837797|12392488|FG000|STARTED|Period 3||0
11202106|NCT01837797|12392489|FG001|STARTED|Period 3||0
11202107|NCT01837797|12392490|FG002|STARTED|Period 3||0
11202108|NCT01837797|12392491|FG003|STARTED|Period 3||0
11202109|NCT01837797|12392492|FG004|STARTED|Period 3||47
11125091|NCT01364090|12310654|FG000|STARTED|Overall Study||61
11125092|NCT01364090|12310655|FG001|STARTED|Overall Study||26
11125093|NCT01364090|12310656|FG002|STARTED|Overall Study||6
11125094|NCT01364090|12310654|FG000|COMPLETED|Overall Study||58
11125095|NCT01364090|12310655|FG001|COMPLETED|Overall Study||12
11125096|NCT01364090|12310656|FG002|COMPLETED|Overall Study||0
11125097|NCT01364090|12310654|FG000|NOT COMPLETED|Overall Study||3
11125098|NCT01364090|12310655|FG001|NOT COMPLETED|Overall Study||14
11125099|NCT01364090|12310656|FG002|NOT COMPLETED|Overall Study||6
11125100|NCT01364207|12310664|FG000|STARTED|First Visit (~1.5-2 Hours)||54
11125101|NCT01364207|12310665|FG001|STARTED|First Visit (~1.5-2 Hours)||58
11125102|NCT01364207|12310664|FG000|COMPLETED|First Visit (~1.5-2 Hours)||54
11125103|NCT01364207|12310665|FG001|COMPLETED|First Visit (~1.5-2 Hours)||58
11125104|NCT01364207|12310664|FG000|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
11125105|NCT01364207|12310665|FG001|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
11125106|NCT01364207|12310664|FG000|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
11125107|NCT01364207|12310665|FG001|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
11125108|NCT01364207|12310664|FG000|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
11125109|NCT01364207|12310665|FG001|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
11125110|NCT01364207|12310664|FG000|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
11125111|NCT01364207|12310665|FG001|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
11125112|NCT01364207|12310664|FG000|STARTED|Second Visit (~1.5-2 Hours)||52
11125113|NCT01364207|12310665|FG001|STARTED|Second Visit (~1.5-2 Hours)||54
11125114|NCT01364207|12310664|FG000|COMPLETED|Second Visit (~1.5-2 Hours)||52
11125115|NCT01364207|12310665|FG001|COMPLETED|Second Visit (~1.5-2 Hours)||54
11125116|NCT01364207|12310664|FG000|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
11125117|NCT01364207|12310665|FG001|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
11125118|NCT01364233|12310671|FG000|STARTED|Overall Study||10
11125119|NCT01364233|12310671|FG000|COMPLETED|Overall Study||9
11125120|NCT01364233|12310671|FG000|NOT COMPLETED|Overall Study||1
11125121|NCT01364259|12310677|FG000|STARTED|Overall Study||9
11125122|NCT01364259|12310678|FG001|STARTED|Overall Study||8
11125123|NCT01364259|12310677|FG000|COMPLETED|Overall Study||9
11125124|NCT01364259|12310678|FG001|COMPLETED|Overall Study||8
11125125|NCT01364259|12310677|FG000|NOT COMPLETED|Overall Study||0
11125126|NCT01364259|12310678|FG001|NOT COMPLETED|Overall Study||0
11125127|NCT01364298|12310686|FG000|STARTED|Overall Study||176
11125128|NCT01364298|12310687|FG001|STARTED|Overall Study||177
11125129|NCT01364298|12310686|FG000|Treated|Overall Study||174
11125130|NCT01364298|12310687|FG001|Treated|Overall Study||174
11125131|NCT01364298|12310686|FG000|COMPLETED|Overall Study||162
11125132|NCT01364298|12310687|FG001|COMPLETED|Overall Study||154
11125133|NCT01364298|12310686|FG000|NOT COMPLETED|Overall Study||14
11125134|NCT01364298|12310687|FG001|NOT COMPLETED|Overall Study||23
11125135|NCT01364389|12310696|FG000|STARTED|Overall Study||5
11125136|NCT01364389|12310697|FG001|STARTED|Overall Study||6
11125137|NCT01364389|12310698|FG002|STARTED|Overall Study||5
11125138|NCT01364389|12310696|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||5
11125139|NCT01364389|12310697|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||6
11125140|NCT01364389|12310698|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
11125141|NCT01364389|12310696|FG000|COMPLETED|Overall Study||3
11125142|NCT01364389|12310697|FG001|COMPLETED|Overall Study||5
11125143|NCT01364389|12310698|FG002|COMPLETED|Overall Study||4
11125144|NCT01364389|12310696|FG000|NOT COMPLETED|Overall Study||2
11125145|NCT01364389|12310697|FG001|NOT COMPLETED|Overall Study||1
11125146|NCT01364389|12310698|FG002|NOT COMPLETED|Overall Study||1
11125147|NCT01364428|12310708|FG000|STARTED|Overall Study||186
11125148|NCT01364428|12310709|FG001|STARTED|Overall Study||187
11125149|NCT01364428|12310708|FG000|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
11125150|NCT01364428|12310709|FG001|Exposed|Overall Study||187
11125151|NCT01364428|12310708|FG000|COMPLETED|Overall Study||166
11125152|NCT01364428|12310709|FG001|COMPLETED|Overall Study||172
11125153|NCT01364428|12310708|FG000|NOT COMPLETED|Overall Study||20
11125154|NCT01364428|12310709|FG001|NOT COMPLETED|Overall Study||15
11125155|NCT01364467|12310717|FG000|STARTED|Overall Study||10
11125156|NCT01364467|12310718|FG001|STARTED|Overall Study||20
11125157|NCT01364467|12310717|FG000|COMPLETED|Overall Study||9
11125158|NCT01364467|12310718|FG001|COMPLETED|Overall Study||18
11125159|NCT01364467|12310717|FG000|NOT COMPLETED|Overall Study||1
11125160|NCT01364467|12310718|FG001|NOT COMPLETED|Overall Study||2
11125161|NCT01364558|12310724|FG000|STARTED|Dose One||8
11125162|NCT01364558|12310725|FG001|STARTED|Dose One||8
11125163|NCT01364558|12310726|FG002|STARTED|Dose One||8
11125164|NCT01364558|12310724|FG000|COMPLETED|Dose One||8
11125165|NCT01364558|12310725|FG001|COMPLETED|Dose One||8
11125166|NCT01364558|12310726|FG002|COMPLETED|Dose One||8
11125167|NCT01364558|12310724|FG000|NOT COMPLETED|Dose One||0
11125168|NCT01364558|12310725|FG001|NOT COMPLETED|Dose One||0
11125169|NCT01364558|12310726|FG002|NOT COMPLETED|Dose One||0
11125170|NCT01364558|12310724|FG000|STARTED|Dose Two||8
11125171|NCT01364558|12310725|FG001|STARTED|Dose Two||8
11125172|NCT01364558|12310726|FG002|STARTED|Dose Two||8
11125173|NCT01364558|12310724|FG000|COMPLETED|Dose Two||8
11125174|NCT01364558|12310725|FG001|COMPLETED|Dose Two||8
11125175|NCT01364558|12310726|FG002|COMPLETED|Dose Two||8
11125176|NCT01364558|12310724|FG000|NOT COMPLETED|Dose Two||0
11125177|NCT01364558|12310725|FG001|NOT COMPLETED|Dose Two||0
11125178|NCT01364558|12310726|FG002|NOT COMPLETED|Dose Two||0
11125179|NCT01364558|12310724|FG000|STARTED|Dose Three||8
11125180|NCT01364558|12310725|FG001|STARTED|Dose Three||8
11125181|NCT01364558|12310726|FG002|STARTED|Dose Three||8
11125182|NCT01364558|12310724|FG000|COMPLETED|Dose Three||8
11125183|NCT01364558|12310725|FG001|COMPLETED|Dose Three||8
11125184|NCT01364558|12310726|FG002|COMPLETED|Dose Three||8
11125185|NCT01364558|12310724|FG000|NOT COMPLETED|Dose Three||0
11125186|NCT01364558|12310725|FG001|NOT COMPLETED|Dose Three||0
11125187|NCT01364558|12310726|FG002|NOT COMPLETED|Dose Three||0
11125188|NCT01364584|12310736|FG000|STARTED|Overall Study||11
11125189|NCT01364584|12310737|FG001|STARTED|Overall Study||12
11125190|NCT01364584|12310736|FG000|COMPLETED|Overall Study||11
11125191|NCT01364584|12310737|FG001|COMPLETED|Overall Study||12
11125192|NCT01364584|12310736|FG000|NOT COMPLETED|Overall Study||0
11125193|NCT01364584|12310737|FG001|NOT COMPLETED|Overall Study||0
11125194|NCT01364623|12310748|FG000|STARTED|Single Dose||8
11125195|NCT01364623|12310749|FG001|STARTED|Single Dose||8
11125196|NCT01364623|12310750|FG002|STARTED|Single Dose||8
11125197|NCT01364623|12310751|FG003|STARTED|Single Dose||0
11125198|NCT01364623|12310748|FG000|COMPLETED|Single Dose||8
11125199|NCT01364623|12310749|FG001|COMPLETED|Single Dose||8
11125200|NCT01364623|12310750|FG002|COMPLETED|Single Dose||8
11125201|NCT01364623|12310751|FG003|COMPLETED|Single Dose||0
11125202|NCT01364623|12310748|FG000|NOT COMPLETED|Single Dose||0
11125203|NCT01364623|12310749|FG001|NOT COMPLETED|Single Dose||0
11125204|NCT01364623|12310750|FG002|NOT COMPLETED|Single Dose||0
11125205|NCT01364623|12310751|FG003|NOT COMPLETED|Single Dose||0
11125206|NCT01364623|12310748|FG000|STARTED|Multiple Dose||0
11125207|NCT01364623|12310749|FG001|STARTED|Multiple Dose||0
11125208|NCT01364623|12310750|FG002|STARTED|Multiple Dose||0
11125209|NCT01364623|12310751|FG003|STARTED|Multiple Dose||8
11125210|NCT01364623|12310748|FG000|COMPLETED|Multiple Dose||0
11125211|NCT01364623|12310749|FG001|COMPLETED|Multiple Dose||0
11125212|NCT01364623|12310750|FG002|COMPLETED|Multiple Dose||0
11125213|NCT01364623|12310751|FG003|COMPLETED|Multiple Dose||8
11125214|NCT01364623|12310748|FG000|NOT COMPLETED|Multiple Dose||0
11125215|NCT01364623|12310749|FG001|NOT COMPLETED|Multiple Dose||0
11125216|NCT01364623|12310750|FG002|NOT COMPLETED|Multiple Dose||0
11125217|NCT01364623|12310751|FG003|NOT COMPLETED|Multiple Dose||0
11125218|NCT01364649|12310768|FG000|STARTED|Overall Study||225
11125219|NCT01364649|12310769|FG001|STARTED|Overall Study||222
11125220|NCT01364649|12310768|FG000|COMPLETED|Overall Study||169
11125221|NCT01364649|12310769|FG001|COMPLETED|Overall Study||179
11125222|NCT01364649|12310768|FG000|NOT COMPLETED|Overall Study||56
11125223|NCT01364649|12310769|FG001|NOT COMPLETED|Overall Study||43
11125224|NCT01364727|12310775|FG000|STARTED|Overall Study||35
11125225|NCT01364727|12310775|FG000|COMPLETED|Overall Study||33
11125226|NCT01364727|12310775|FG000|NOT COMPLETED|Overall Study||2
11125227|NCT01364740|12310781|FG000|STARTED|Overall Study||10
11125228|NCT01364740|12310781|FG000|COMPLETED|Overall Study||10
11125229|NCT01364740|12310781|FG000|NOT COMPLETED|Overall Study||0
11125230|NCT01364870|12310789|FG000|STARTED|Overall Study||122
11125231|NCT01364870|12310790|FG001|STARTED|Overall Study||123
11125232|NCT01364870|12310791|FG002|STARTED|Overall Study||72
11125233|NCT01364870|12310789|FG000|COMPLETED|Overall Study||100
11125234|NCT01364870|12310790|FG001|COMPLETED|Overall Study||93
11125235|NCT01364870|12310791|FG002|COMPLETED|Overall Study||58
11125236|NCT01364870|12310789|FG000|NOT COMPLETED|Overall Study||22
11125237|NCT01364870|12310790|FG001|NOT COMPLETED|Overall Study||30
11125238|NCT01364870|12310791|FG002|NOT COMPLETED|Overall Study||14
11125239|NCT01364896|12310799|FG000|STARTED|Overall Study||46
11125240|NCT01364896|12310799|FG000|COMPLETED|Overall Study||46
11125241|NCT01364896|12310799|FG000|NOT COMPLETED|Overall Study||0
11125242|NCT01364922|12310806|FG000|STARTED|Open-label (OL) Period||168
11125243|NCT01364922|12310807|FG001|STARTED|Open-label (OL) Period||0
11125244|NCT01364922|12310808|FG002|STARTED|Open-label (OL) Period||0
11125245|NCT01364922|12310806|FG000|COMPLETED|Open-label (OL) Period||146
11125246|NCT01364922|12310807|FG001|COMPLETED|Open-label (OL) Period||0
11125247|NCT01364922|12310808|FG002|COMPLETED|Open-label (OL) Period||0
11125248|NCT01364922|12310806|FG000|NOT COMPLETED|Open-label (OL) Period||22
11125249|NCT01364922|12310807|FG001|NOT COMPLETED|Open-label (OL) Period||0
11125250|NCT01364922|12310808|FG002|NOT COMPLETED|Open-label (OL) Period||0
11125251|NCT01364922|12310806|FG000|STARTED|Double-Blind (DB) Period||0
11125252|NCT01364922|12310807|FG001|STARTED|Double-Blind (DB) Period||99
11125253|NCT01364922|12310808|FG002|STARTED|Double-Blind (DB) Period||47
11125254|NCT01364922|12310806|FG000|COMPLETED|Double-Blind (DB) Period||0
11125255|NCT01364922|12310807|FG001|COMPLETED|Double-Blind (DB) Period||94
11125256|NCT01364922|12310808|FG002|COMPLETED|Double-Blind (DB) Period||42
11125257|NCT01364922|12310806|FG000|NOT COMPLETED|Double-Blind (DB) Period||0
11125258|NCT01364922|12310807|FG001|NOT COMPLETED|Double-Blind (DB) Period||5
11125259|NCT01364922|12310808|FG002|NOT COMPLETED|Double-Blind (DB) Period||5
11125260|NCT01365039|12310817|FG000|STARTED|Overall Study||86
11125261|NCT01365039|12310818|FG001|STARTED|Overall Study||87
11125262|NCT01365039|12310817|FG000|COMPLETED|Overall Study||85
11125263|NCT01365039|12310818|FG001|COMPLETED|Overall Study||87
11125264|NCT01365039|12310817|FG000|NOT COMPLETED|Overall Study||1
11125265|NCT01365039|12310818|FG001|NOT COMPLETED|Overall Study||0
11125266|NCT01365052|12310827|FG000|STARTED|Overall Study||217
11125267|NCT01365052|12310828|FG001|STARTED|Overall Study||109
11125268|NCT01365052|12310827|FG000|COMPLETED|Overall Study||213
11125269|NCT01365052|12310828|FG001|COMPLETED|Overall Study||105
11125270|NCT01365052|12310827|FG000|NOT COMPLETED|Overall Study||4
11125271|NCT01365052|12310828|FG001|NOT COMPLETED|Overall Study||4
11125272|NCT01365091|12310838|FG000|STARTED|Period 1||28
11125273|NCT01365091|12310839|FG001|STARTED|Period 1||28
11125274|NCT01365091|12310840|FG002|STARTED|Period 1||28
11125275|NCT01365091|12310841|FG003|STARTED|Period 1||28
11125276|NCT01365091|12310838|FG000|COMPLETED|Period 1||26
11125277|NCT01365091|12310839|FG001|COMPLETED|Period 1||26
11125278|NCT01365091|12310840|FG002|COMPLETED|Period 1||25
11125279|NCT01365091|12310841|FG003|COMPLETED|Period 1||25
11125280|NCT01365091|12310838|FG000|NOT COMPLETED|Period 1||2
11125281|NCT01365091|12310839|FG001|NOT COMPLETED|Period 1||2
11125282|NCT01365091|12310840|FG002|NOT COMPLETED|Period 1||3
11125283|NCT01365091|12310841|FG003|NOT COMPLETED|Period 1||3
11125284|NCT01365091|12310838|FG000|STARTED|Period 2||26
11125285|NCT01365091|12310839|FG001|STARTED|Period 2||26
11125286|NCT01365091|12310840|FG002|STARTED|Period 2||25
11125287|NCT01365091|12310841|FG003|STARTED|Period 2||25
11125288|NCT01365091|12310838|FG000|COMPLETED|Period 2||25
11125289|NCT01365091|12310839|FG001|COMPLETED|Period 2||26
11125290|NCT01365091|12310840|FG002|COMPLETED|Period 2||24
11125291|NCT01365091|12310841|FG003|COMPLETED|Period 2||25
11125292|NCT01365091|12310838|FG000|NOT COMPLETED|Period 2||1
11125293|NCT01365091|12310839|FG001|NOT COMPLETED|Period 2||0
11125294|NCT01365091|12310840|FG002|NOT COMPLETED|Period 2||1
11125295|NCT01365091|12310841|FG003|NOT COMPLETED|Period 2||0
11125296|NCT01365130|12310865|FG000|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
11125297|NCT01365130|12310865|FG000|COMPLETED|Overall Study||13
11125298|NCT01365130|12310865|FG000|NOT COMPLETED|Overall Study||2
11125299|NCT01365273|12310871|FG000|STARTED|Overall Study||22
11125300|NCT01365273|12310872|FG001|STARTED|Overall Study||21
11125301|NCT01365273|12310871|FG000|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
11125302|NCT01365273|12310872|FG001|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
11125303|NCT01365273|12310871|FG000|COMPLETED|Overall Study||20
11125304|NCT01365273|12310872|FG001|COMPLETED|Overall Study||20
11125305|NCT01365273|12310871|FG000|NOT COMPLETED|Overall Study||2
11125306|NCT01365273|12310872|FG001|NOT COMPLETED|Overall Study||1
11125307|NCT01365455|12310881|FG000|STARTED|Induction Period||245
11125308|NCT01365455|12310882|FG001|STARTED|Induction Period||245
11125309|NCT01365455|12310883|FG002|STARTED|Induction Period||248
11125310|NCT01365455|12310884|FG003|STARTED|Induction Period||0
11125311|NCT01365455|12310885|FG004|STARTED|Induction Period||0
11125312|NCT01365455|12310881|FG000|COMPLETED|Induction Period||230
11125313|NCT01365455|12310882|FG001|COMPLETED|Induction Period||238
11125314|NCT01365455|12310883|FG002|COMPLETED|Induction Period||232
11125315|NCT01365455|12310884|FG003|COMPLETED|Induction Period||0
11238958|NCT02078752|12430886|FG001|STARTED|Overall Study||13
11125316|NCT01365455|12310885|FG004|COMPLETED|Induction Period||0
11125317|NCT01365455|12310881|FG000|NOT COMPLETED|Induction Period||15
11125318|NCT01365455|12310882|FG001|NOT COMPLETED|Induction Period||7
11125319|NCT01365455|12310883|FG002|NOT COMPLETED|Induction Period||16
11125320|NCT01365455|12310884|FG003|NOT COMPLETED|Induction Period||0
11125321|NCT01365455|12310885|FG004|NOT COMPLETED|Induction Period||0
11125322|NCT01365455|12310881|FG000|STARTED|Maintenance Period||230
11125323|NCT01365455|12310882|FG001|STARTED|Maintenance Period||238
11125324|NCT01365455|12310883|FG002|STARTED|Maintenance Period||18
11125325|NCT01365455|12310884|FG003|STARTED|Maintenance Period||109
11125326|NCT01365455|12310885|FG004|STARTED|Maintenance Period||105
11125327|NCT01365455|12310881|FG000|COMPLETED|Maintenance Period||201
11125328|NCT01365455|12310882|FG001|COMPLETED|Maintenance Period||215
11125329|NCT01365455|12310883|FG002|COMPLETED|Maintenance Period||15
11125330|NCT01365455|12310884|FG003|COMPLETED|Maintenance Period||100
11125331|NCT01365455|12310885|FG004|COMPLETED|Maintenance Period||92
11125332|NCT01365455|12310881|FG000|NOT COMPLETED|Maintenance Period||29
11125333|NCT01365455|12310882|FG001|NOT COMPLETED|Maintenance Period||23
11125334|NCT01365455|12310883|FG002|NOT COMPLETED|Maintenance Period||3
11125335|NCT01365455|12310884|FG003|NOT COMPLETED|Maintenance Period||9
11125336|NCT01365455|12310885|FG004|NOT COMPLETED|Maintenance Period||13
11125337|NCT01365455|12310881|FG000|STARTED|Follow-up Period||58
11125338|NCT01365455|12310882|FG001|STARTED|Follow-up Period||47
11125339|NCT01365455|12310883|FG002|STARTED|Follow-up Period||18
11125340|NCT01365455|12310884|FG003|STARTED|Follow-up Period||0
11125341|NCT01365455|12310885|FG004|STARTED|Follow-up Period||0
11125342|NCT01365455|12310881|FG000|COMPLETED|Follow-up Period||58
11125343|NCT01365455|12310882|FG001|COMPLETED|Follow-up Period||47
11125344|NCT01365455|12310883|FG002|COMPLETED|Follow-up Period||18
11125345|NCT01365455|12310884|FG003|COMPLETED|Follow-up Period||0
11125346|NCT01365455|12310885|FG004|COMPLETED|Follow-up Period||0
11125347|NCT01365455|12310881|FG000|NOT COMPLETED|Follow-up Period||0
11125348|NCT01365455|12310882|FG001|NOT COMPLETED|Follow-up Period||0
11125349|NCT01365455|12310883|FG002|NOT COMPLETED|Follow-up Period||0
11125350|NCT01365455|12310884|FG003|NOT COMPLETED|Follow-up Period||0
11125351|NCT01365455|12310885|FG004|NOT COMPLETED|Follow-up Period||0
11125352|NCT01365468|12310905|FG000|STARTED|Overall Study||4
11125353|NCT01365468|12310906|FG001|STARTED|Overall Study||5
11125354|NCT01365468|12310905|FG000|COMPLETED|Overall Study||0
11125355|NCT01365468|12310906|FG001|COMPLETED|Overall Study||5
11125356|NCT01365468|12310905|FG000|NOT COMPLETED|Overall Study||4
11125357|NCT01365468|12310906|FG001|NOT COMPLETED|Overall Study||0
11125358|NCT01365481|12310917|FG000|STARTED|Overall Study||23
11125359|NCT01365481|12310918|FG001|STARTED|Overall Study||52
11125360|NCT01365481|12310919|FG002|STARTED|Overall Study||18
11125361|NCT01365481|12310920|FG003|STARTED|Overall Study||57
11125362|NCT01365481|12310917|FG000|COMPLETED|Overall Study||16
11125363|NCT01365481|12310918|FG001|COMPLETED|Overall Study||37
11125364|NCT01365481|12310919|FG002|COMPLETED|Overall Study||14
11125365|NCT01365481|12310920|FG003|COMPLETED|Overall Study||50
11125366|NCT01365481|12310917|FG000|NOT COMPLETED|Overall Study||7
11125367|NCT01365481|12310918|FG001|NOT COMPLETED|Overall Study||15
11125368|NCT01365481|12310919|FG002|NOT COMPLETED|Overall Study||4
11125369|NCT01365481|12310920|FG003|NOT COMPLETED|Overall Study||7
11125370|NCT01365494|12310932|FG000|STARTED|Overall Study||126
11125371|NCT01365494|12310933|FG001|STARTED|Overall Study||124
11125372|NCT01365494|12310932|FG000|COMPLETED|Overall Study||124
11125373|NCT01365494|12310933|FG001|COMPLETED|Overall Study||121
11125374|NCT01365494|12310932|FG000|NOT COMPLETED|Overall Study||2
11125375|NCT01365494|12310933|FG001|NOT COMPLETED|Overall Study||3
11125376|NCT01365507|12310942|FG000|STARTED|Overall Study||136
11125377|NCT01365507|12310943|FG001|STARTED|Overall Study||140
11125378|NCT01365507|12310942|FG000|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
11125379|NCT01365507|12310943|FG001|Exposed|Overall Study||140
11125380|NCT01365507|12310942|FG000|COMPLETED|Overall Study||127
11125381|NCT01365507|12310943|FG001|COMPLETED|Overall Study||131
11125382|NCT01365507|12310942|FG000|NOT COMPLETED|Overall Study||9
11125383|NCT01365507|12310943|FG001|NOT COMPLETED|Overall Study||9
11125384|NCT01365546|12310949|FG000|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
11125385|NCT01365546|12310949|FG000|COMPLETED|Overall Study||30
11125386|NCT01365546|12310949|FG000|NOT COMPLETED|Overall Study||11
11125387|NCT01365585|12310957|FG000|STARTED|Overall Study||227
11125388|NCT01365585|12310957|FG000|COMPLETED|Overall Study||227
11125389|NCT01365585|12310957|FG000|NOT COMPLETED|Overall Study||0
11125390|NCT01365611|12310961|FG000|STARTED|Overall Study||36
11125391|NCT01365611|12310961|FG000|COMPLETED|Overall Study||36
11125392|NCT01365611|12310961|FG000|NOT COMPLETED|Overall Study||0
11125393|NCT01365624|12310969|FG000|STARTED|Overall Study||15
11125394|NCT01365624|12310970|FG001|STARTED|Overall Study||15
11125395|NCT01365624|12310969|FG000|COMPLETED|Overall Study||15
11125396|NCT01365624|12310970|FG001|COMPLETED|Overall Study||15
11125397|NCT01365624|12310969|FG000|NOT COMPLETED|Overall Study||0
11125398|NCT01365624|12310970|FG001|NOT COMPLETED|Overall Study||0
11125399|NCT01365650|12310976|FG000|STARTED|Treatment A||24
11125400|NCT01365650|12310976|FG000|COMPLETED|Treatment A||24
11125401|NCT01365650|12310976|FG000|NOT COMPLETED|Treatment A||0
11125402|NCT01365650|12310976|FG000|STARTED|Treatment B||24
11125403|NCT01365650|12310976|FG000|COMPLETED|Treatment B||24
11125404|NCT01365650|12310976|FG000|NOT COMPLETED|Treatment B||0
11125405|NCT01365650|12310976|FG000|STARTED|Treatment C||24
11125406|NCT01365650|12310976|FG000|COMPLETED|Treatment C||24
11125407|NCT01365650|12310976|FG000|NOT COMPLETED|Treatment C||0
11125408|NCT01365793|12310988|FG000|STARTED|Overall Study||344
11125409|NCT01365793|12310989|FG001|STARTED|Overall Study||351
11125410|NCT01365793|12310990|FG002|STARTED|Overall Study||345
11125411|NCT01365793|12310991|FG003|STARTED|Overall Study||349
11125412|NCT01365793|12310988|FG000|COMPLETED|Overall Study||342
11125413|NCT01365793|12310989|FG001|COMPLETED|Overall Study||344
11125414|NCT01365793|12310990|FG002|COMPLETED|Overall Study||338
11125415|NCT01365793|12310991|FG003|COMPLETED|Overall Study||347
11125416|NCT01365793|12310988|FG000|NOT COMPLETED|Overall Study||2
11125417|NCT01365793|12310989|FG001|NOT COMPLETED|Overall Study||7
11125418|NCT01365793|12310990|FG002|NOT COMPLETED|Overall Study||7
11125419|NCT01365793|12310991|FG003|NOT COMPLETED|Overall Study||2
11125420|NCT01365819|12311003|FG000|STARTED|Overall Study||25
11125421|NCT01365819|12311004|FG001|STARTED|Overall Study||27
11125422|NCT01365819|12311003|FG000|COMPLETED|Overall Study||12
11125423|NCT01365819|12311004|FG001|COMPLETED|Overall Study||14
11125424|NCT01365819|12311003|FG000|NOT COMPLETED|Overall Study||13
11125425|NCT01365819|12311004|FG001|NOT COMPLETED|Overall Study||13
11125426|NCT01365845|12311010|FG000|STARTED|Induction Phase||18
11125427|NCT01365845|12311011|FG001|STARTED|Induction Phase||0
11125428|NCT01365845|12311012|FG002|STARTED|Induction Phase||0
11125429|NCT01365845|12311010|FG000|COMPLETED|Induction Phase||18
11125430|NCT01365845|12311011|FG001|COMPLETED|Induction Phase||0
11125431|NCT01365845|12311012|FG002|COMPLETED|Induction Phase||0
11125432|NCT01365845|12311010|FG000|NOT COMPLETED|Induction Phase||0
11125433|NCT01365845|12311011|FG001|NOT COMPLETED|Induction Phase||0
11125434|NCT01365845|12311012|FG002|NOT COMPLETED|Induction Phase||0
11125435|NCT01365845|12311010|FG000|STARTED|Treatment Phase||0
11125436|NCT01365845|12311011|FG001|STARTED|Treatment Phase||0
11125437|NCT01365845|12311012|FG002|STARTED|Treatment Phase||18
11125438|NCT01365845|12311010|FG000|COMPLETED|Treatment Phase||0
11125439|NCT01365845|12311011|FG001|COMPLETED|Treatment Phase||0
11125440|NCT01365845|12311012|FG002|COMPLETED|Treatment Phase||18
11125441|NCT01365845|12311010|FG000|NOT COMPLETED|Treatment Phase||0
11125442|NCT01365845|12311011|FG001|NOT COMPLETED|Treatment Phase||0
11125443|NCT01365845|12311012|FG002|NOT COMPLETED|Treatment Phase||0
11125444|NCT01365910|12311017|FG000|STARTED|Overall Study||30
11125445|NCT01365910|12311017|FG000|COMPLETED|Overall Study||0
11125446|NCT01365910|12311017|FG000|NOT COMPLETED|Overall Study||30
11125447|NCT01366196|12311023|FG000|STARTED|Overall Study||43
11125448|NCT01366196|12311024|FG001|STARTED|Overall Study||43
11238959|NCT02078752|12430887|FG002|STARTED|Overall Study||2
11238960|NCT02078752|12430888|FG003|STARTED|Overall Study||7
11238961|NCT02078752|12430889|FG004|STARTED|Overall Study||3
11238962|NCT02078752|12430890|FG005|STARTED|Overall Study||9
11238963|NCT02078752|12430891|FG006|STARTED|Overall Study||3
11238964|NCT02078752|12430892|FG007|STARTED|Overall Study||6
11238965|NCT02078752|12430893|FG008|STARTED|Overall Study||2
11238966|NCT02078752|12430894|FG009|STARTED|Overall Study||12
11238967|NCT02078752|12430885|FG000|COMPLETED|Overall Study||1
11238968|NCT02078752|12430886|FG001|COMPLETED|Overall Study||6
11238969|NCT02078752|12430887|FG002|COMPLETED|Overall Study||1
11238970|NCT02078752|12430888|FG003|COMPLETED|Overall Study||5
11238971|NCT02078752|12430889|FG004|COMPLETED|Overall Study||2
11238972|NCT02078752|12430890|FG005|COMPLETED|Overall Study||5
11238973|NCT02078752|12430891|FG006|COMPLETED|Overall Study||1
11238974|NCT02078752|12430892|FG007|COMPLETED|Overall Study||3
11238975|NCT02078752|12430893|FG008|COMPLETED|Overall Study||2
11238976|NCT02078752|12430894|FG009|COMPLETED|Overall Study||2
11125449|NCT01366196|12311023|FG000|COMPLETED|Overall Study||43
11125450|NCT01366196|12311024|FG001|COMPLETED|Overall Study||43
11125451|NCT01366196|12311023|FG000|NOT COMPLETED|Overall Study||0
11125452|NCT01366196|12311024|FG001|NOT COMPLETED|Overall Study||0
11125453|NCT01366209|12311032|FG000|STARTED|Overall Study||278
11125454|NCT01366209|12311033|FG001|STARTED|Overall Study||277
11125455|NCT01366209|12311032|FG000|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
11125456|NCT01366209|12311033|FG001|COMPLETED|Overall Study||241
11125457|NCT01366209|12311032|FG000|NOT COMPLETED|Overall Study||35
11125458|NCT01366209|12311033|FG001|NOT COMPLETED|Overall Study||36
11125459|NCT01366417|12311039|FG000|STARTED|Overall Study||43
11125460|NCT01366417|12311039|FG000|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
11125461|NCT01366417|12311039|FG000|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
11125462|NCT01366417|12311039|FG000|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
11125463|NCT01366417|12311039|FG000|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
11125464|NCT01366417|12311039|FG000|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
11125465|NCT01366417|12311039|FG000|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
11125466|NCT01366417|12311039|FG000|COMPLETED|Overall Study|25 subjects included in the analysis|25
11125467|NCT01366417|12311039|FG000|NOT COMPLETED|Overall Study||18
11125468|NCT01366443|12311044|FG000|STARTED|Overall Study||288
11125469|NCT01366443|12311044|FG000|COMPLETED|Overall Study||285
11125470|NCT01366443|12311044|FG000|NOT COMPLETED|Overall Study||3
11125471|NCT01366495|12311053|FG000|STARTED|Testing Study||0
11125472|NCT01366495|12311054|FG001|STARTED|Testing Study||0
11125473|NCT01366495|12311055|FG002|STARTED|Testing Study||349
11125474|NCT01366495|12311056|FG003|STARTED|Testing Study||348
11125475|NCT01366495|12311053|FG000|COMPLETED|Testing Study||0
11125476|NCT01366495|12311054|FG001|COMPLETED|Testing Study||0
11125477|NCT01366495|12311055|FG002|COMPLETED|Testing Study||349
11125478|NCT01366495|12311056|FG003|COMPLETED|Testing Study||348
11125479|NCT01366495|12311053|FG000|NOT COMPLETED|Testing Study||0
11125480|NCT01366495|12311054|FG001|NOT COMPLETED|Testing Study||0
11125481|NCT01366495|12311055|FG002|NOT COMPLETED|Testing Study||0
11125482|NCT01366495|12311056|FG003|NOT COMPLETED|Testing Study||0
11125483|NCT01366495|12311053|FG000|STARTED|HIV Study||50
11125484|NCT01366495|12311054|FG001|STARTED|HIV Study||50
11125485|NCT01366495|12311055|FG002|STARTED|HIV Study||0
11125486|NCT01366495|12311056|FG003|STARTED|HIV Study||0
11125487|NCT01366495|12311053|FG000|COMPLETED|HIV Study||49
11125488|NCT01366495|12311054|FG001|COMPLETED|HIV Study||50
11125489|NCT01366495|12311055|FG002|COMPLETED|HIV Study||0
11125490|NCT01366495|12311056|FG003|COMPLETED|HIV Study||0
11125491|NCT01366495|12311053|FG000|NOT COMPLETED|HIV Study||1
11125492|NCT01366495|12311054|FG001|NOT COMPLETED|HIV Study||0
11125493|NCT01366495|12311055|FG002|NOT COMPLETED|HIV Study||0
11125494|NCT01366495|12311056|FG003|NOT COMPLETED|HIV Study||0
11125495|NCT01366521|12311070|FG000|STARTED|Overall Study||21
11125496|NCT01366521|12311071|FG001|STARTED|Overall Study||15
11125497|NCT01366521|12311072|FG002|STARTED|Overall Study||23
11238977|NCT02078752|12430885|FG000|NOT COMPLETED|Overall Study||2
11238978|NCT02078752|12430886|FG001|NOT COMPLETED|Overall Study||7
11238979|NCT02078752|12430887|FG002|NOT COMPLETED|Overall Study||1
11238980|NCT02078752|12430888|FG003|NOT COMPLETED|Overall Study||2
11125498|NCT01366521|12311073|FG003|STARTED|Overall Study||11
11125499|NCT01366521|12311070|FG000|COMPLETED|Overall Study||20
11125500|NCT01366521|12311071|FG001|COMPLETED|Overall Study||14
11125501|NCT01366521|12311072|FG002|COMPLETED|Overall Study||21
11125502|NCT01366521|12311073|FG003|COMPLETED|Overall Study||11
11125503|NCT01366521|12311070|FG000|NOT COMPLETED|Overall Study||1
11125504|NCT01366521|12311071|FG001|NOT COMPLETED|Overall Study||1
11125505|NCT01366521|12311072|FG002|NOT COMPLETED|Overall Study||2
11125506|NCT01366521|12311073|FG003|NOT COMPLETED|Overall Study||0
11125507|NCT01366534|12311088|FG000|STARTED|Overall Study||28
11125508|NCT01366534|12311089|FG001|STARTED|Overall Study||27
11125509|NCT01366534|12311090|FG002|STARTED|Overall Study||12
11125510|NCT01366534|12311088|FG000|COMPLETED|Overall Study||26
11125511|NCT01366534|12311089|FG001|COMPLETED|Overall Study||25
11125512|NCT01366534|12311090|FG002|COMPLETED|Overall Study||12
11125513|NCT01366534|12311088|FG000|NOT COMPLETED|Overall Study||2
11238981|NCT02078752|12430889|FG004|NOT COMPLETED|Overall Study||1
11238982|NCT02078752|12430890|FG005|NOT COMPLETED|Overall Study||4
11238983|NCT02078752|12430891|FG006|NOT COMPLETED|Overall Study||2
11238984|NCT02078752|12430892|FG007|NOT COMPLETED|Overall Study||3
11238985|NCT02078752|12430893|FG008|NOT COMPLETED|Overall Study||0
11238986|NCT02078752|12430894|FG009|NOT COMPLETED|Overall Study||10
11238987|NCT02078817|12430925|FG000|STARTED|Overall Study||14
11238988|NCT02078817|12430925|FG000|COMPLETED|Overall Study||13
11238989|NCT02078817|12430925|FG000|NOT COMPLETED|Overall Study||1
11238990|NCT02078882|12430929|FG000|STARTED|Overall Study||16
11238991|NCT02078882|12430929|FG000|COMPLETED|Overall Study||16
11238992|NCT02078882|12430929|FG000|NOT COMPLETED|Overall Study||0
11238993|NCT02078960|12430936|FG000|STARTED|Treatment Period||2
11238994|NCT02078960|12430937|FG001|STARTED|Treatment Period||4
11238995|NCT02078960|12430938|FG002|STARTED|Treatment Period||4
11238996|NCT02078960|12430936|FG000|COMPLETED|Treatment Period||0
11238997|NCT02078960|12430937|FG001|COMPLETED|Treatment Period||1
11238998|NCT02078960|12430938|FG002|COMPLETED|Treatment Period||1
11238999|NCT02078960|12430936|FG000|NOT COMPLETED|Treatment Period||2
11239000|NCT02078960|12430937|FG001|NOT COMPLETED|Treatment Period||3
11239001|NCT02078960|12430938|FG002|NOT COMPLETED|Treatment Period||3
11239002|NCT02078960|12430936|FG000|STARTED|Follow-up Period||2
11239003|NCT02078960|12430937|FG001|STARTED|Follow-up Period||2
11239004|NCT02078960|12430938|FG002|STARTED|Follow-up Period||1
11239005|NCT02078960|12430936|FG000|COMPLETED|Follow-up Period||0
11239006|NCT02078960|12430937|FG001|COMPLETED|Follow-up Period||1
11239007|NCT02078960|12430938|FG002|COMPLETED|Follow-up Period||1
11239008|NCT02078960|12430936|FG000|NOT COMPLETED|Follow-up Period||2
11239009|NCT02078960|12430937|FG001|NOT COMPLETED|Follow-up Period||1
11125514|NCT01366534|12311089|FG001|NOT COMPLETED|Overall Study||2
11125515|NCT01366534|12311090|FG002|NOT COMPLETED|Overall Study||0
11125516|NCT01366638|12311101|FG000|STARTED|Overall Study||24
11125517|NCT01366638|12311102|FG001|STARTED|Overall Study||29
11125518|NCT01366638|12311103|FG002|STARTED|Overall Study||26
11125519|NCT01366638|12311101|FG000|COMPLETED|Overall Study||23
11125520|NCT01366638|12311102|FG001|COMPLETED|Overall Study||29
11125521|NCT01366638|12311103|FG002|COMPLETED|Overall Study||20
11125522|NCT01366638|12311101|FG000|NOT COMPLETED|Overall Study||1
11125523|NCT01366638|12311102|FG001|NOT COMPLETED|Overall Study||0
11125524|NCT01366638|12311103|FG002|NOT COMPLETED|Overall Study||6
11125525|NCT01366846|12311115|FG000|STARTED|Overall Study||235
11125526|NCT01366846|12311116|FG001|STARTED|Overall Study||228
11239010|NCT02078960|12430938|FG002|NOT COMPLETED|Follow-up Period||0
11239011|NCT02079025|12430950|FG000|STARTED|Overall Study||839
11239012|NCT02079025|12430951|FG001|STARTED|Overall Study||837
11239013|NCT02079025|12430950|FG000|COMPLETED|Overall Study||839
11239014|NCT02079025|12430951|FG001|COMPLETED|Overall Study||837
11239015|NCT02079025|12430950|FG000|NOT COMPLETED|Overall Study||0
11239016|NCT02079025|12430951|FG001|NOT COMPLETED|Overall Study||0
11239017|NCT02079038|12430960|FG000|STARTED|Modified Intent to Treat Population||112
11239018|NCT02079038|12430961|FG001|STARTED|Modified Intent to Treat Population||56
11239019|NCT02079038|12430960|FG000|COMPLETED|Modified Intent to Treat Population||105
11239020|NCT02079038|12430961|FG001|COMPLETED|Modified Intent to Treat Population||51
11239021|NCT02079038|12430960|FG000|NOT COMPLETED|Modified Intent to Treat Population||7
11005109|NCT00721149|12182770|FG000|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
11005110|NCT00721149|12182770|FG000|COMPLETED|Overall Study||9
11005111|NCT00721149|12182770|FG000|NOT COMPLETED|Overall Study||1
11005112|NCT00721162|12182774|FG000|STARTED|Overall Study||60
11005113|NCT00721162|12182774|FG000|Received Any Amount of Study Drug|Overall Study||60
11005114|NCT00721162|12182774|FG000|COMPLETED|Overall Study||60
11239022|NCT02079038|12430961|FG001|NOT COMPLETED|Modified Intent to Treat Population||5
11239023|NCT02079038|12430960|FG000|STARTED|Completed 6 Months||105
11239024|NCT02079038|12430961|FG001|STARTED|Completed 6 Months||51
11239025|NCT02079038|12430960|FG000|COMPLETED|Completed 6 Months||103
11239026|NCT02079038|12430961|FG001|COMPLETED|Completed 6 Months||50
11239027|NCT02079038|12430960|FG000|NOT COMPLETED|Completed 6 Months||2
11239028|NCT02079038|12430961|FG001|NOT COMPLETED|Completed 6 Months||1
11239029|NCT02079077|12430969|FG000|STARTED|Overall Study||43
11239030|NCT02079077|12430970|FG001|STARTED|Overall Study||48
11239031|NCT02079077|12430969|FG000|COMPLETED|Overall Study||37
11239032|NCT02079077|12430970|FG001|COMPLETED|Overall Study||39
11239033|NCT02079077|12430969|FG000|NOT COMPLETED|Overall Study||6
11239034|NCT02079077|12430970|FG001|NOT COMPLETED|Overall Study||9
11239035|NCT02079246|12430976|FG000|STARTED|OLEX||1463
11239036|NCT02079246|12430977|FG001|STARTED|OLEX||0
11239037|NCT02079246|12430976|FG000|COMPLETED|OLEX||1235
11239038|NCT02079246|12430977|FG001|COMPLETED|OLEX||0
11005115|NCT00721162|12182774|FG000|NOT COMPLETED|Overall Study||0
11005116|NCT00721175|12182780|FG000|STARTED|Overall Study||54
11239039|NCT02079246|12430976|FG000|NOT COMPLETED|OLEX||228
11239040|NCT02079246|12430977|FG001|NOT COMPLETED|OLEX||0
11239041|NCT02079246|12430976|FG000|STARTED|OLEX-MEM||0
11239042|NCT02079246|12430977|FG001|STARTED|OLEX-MEM||101
11239043|NCT02079246|12430976|FG000|COMPLETED|OLEX-MEM||0
11239044|NCT02079246|12430977|FG001|COMPLETED|OLEX-MEM||82
11239045|NCT02079246|12430976|FG000|NOT COMPLETED|OLEX-MEM||0
11239046|NCT02079246|12430977|FG001|NOT COMPLETED|OLEX-MEM||19
11239047|NCT02079311|12430988|FG000|STARTED|Overall Study||28
11239048|NCT02079311|12430989|FG001|STARTED|Overall Study||27
11239049|NCT02079311|12430988|FG000|COMPLETED|Overall Study||28
11239050|NCT02079311|12430989|FG001|COMPLETED|Overall Study||26
11239051|NCT02079311|12430988|FG000|NOT COMPLETED|Overall Study||0
11005117|NCT00721175|12182781|FG001|STARTED|Overall Study||54
11005118|NCT00721175|12182780|FG000|COMPLETED|Overall Study||54
11005119|NCT00721175|12182781|FG001|COMPLETED|Overall Study||54
11005120|NCT00721175|12182780|FG000|NOT COMPLETED|Overall Study||0
11005121|NCT00721175|12182781|FG001|NOT COMPLETED|Overall Study||0
11005122|NCT00721188|12182787|FG000|STARTED|Overall Study||11
11005123|NCT00721188|12182787|FG000|COMPLETED|Overall Study||11
11005124|NCT00721188|12182787|FG000|NOT COMPLETED|Overall Study||0
11005125|NCT00721214|12182791|FG000|STARTED|Overall Study||16
11005126|NCT00721214|12182791|FG000|COMPLETED|Overall Study||12
11005127|NCT00721214|12182791|FG000|NOT COMPLETED|Overall Study||4
11005128|NCT00721227|12182797|FG000|STARTED|Overall Study||9
11005129|NCT00721227|12182798|FG001|STARTED|Overall Study||6
11005130|NCT00721227|12182797|FG000|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
11005131|NCT00721227|12182798|FG001|COMPLETED|Overall Study||6
11005132|NCT00721227|12182797|FG000|NOT COMPLETED|Overall Study||4
11005133|NCT00721227|12182798|FG001|NOT COMPLETED|Overall Study||0
11005134|NCT00721253|12182806|FG000|STARTED|Overall Study||20
11005135|NCT00721253|12182807|FG001|STARTED|Overall Study||22
11005136|NCT00721253|12182808|FG002|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
11005137|NCT00721253|12182806|FG000|COMPLETED|Overall Study||20
11239052|NCT02079311|12430989|FG001|NOT COMPLETED|Overall Study||1
11125527|NCT01366846|12311117|FG002|STARTED|Overall Study||47
11125528|NCT01366846|12311118|FG003|STARTED|Overall Study||46
11125529|NCT01366846|12311115|FG000|COMPLETED|Overall Study||232
11125530|NCT01366846|12311116|FG001|COMPLETED|Overall Study||224
11125531|NCT01366846|12311117|FG002|COMPLETED|Overall Study||46
11125532|NCT01366846|12311118|FG003|COMPLETED|Overall Study||45
11125533|NCT01366846|12311115|FG000|NOT COMPLETED|Overall Study||3
11125534|NCT01366846|12311116|FG001|NOT COMPLETED|Overall Study||4
11125535|NCT01366846|12311117|FG002|NOT COMPLETED|Overall Study||1
11125536|NCT01366846|12311118|FG003|NOT COMPLETED|Overall Study||1
11125537|NCT01366872|12311131|FG000|STARTED|Overall Study||50
11125538|NCT01366872|12311131|FG000|COMPLETED|Overall Study||50
11125539|NCT01366872|12311131|FG000|NOT COMPLETED|Overall Study||0
11125540|NCT01366885|12311135|FG000|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
11125541|NCT01366885|12311135|FG000|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
11125542|NCT01366885|12311135|FG000|NOT COMPLETED|Overall Study||1
11125543|NCT01366976|12311141|FG000|STARTED|Overall Study||30
11125544|NCT01366976|12311142|FG001|STARTED|Overall Study||30
11125545|NCT01366976|12311141|FG000|COMPLETED|Overall Study||30
11125546|NCT01366976|12311142|FG001|COMPLETED|Overall Study||30
11125547|NCT01366976|12311141|FG000|NOT COMPLETED|Overall Study||0
11125548|NCT01366976|12311142|FG001|NOT COMPLETED|Overall Study||0
11125549|NCT01367080|12311150|FG000|STARTED|1st Administration||6
11125550|NCT01367080|12311151|FG001|STARTED|1st Administration||6
11125551|NCT01367080|12311150|FG000|COMPLETED|1st Administration||6
11125552|NCT01367080|12311151|FG001|COMPLETED|1st Administration||6
11125553|NCT01367080|12311150|FG000|NOT COMPLETED|1st Administration||0
11125554|NCT01367080|12311151|FG001|NOT COMPLETED|1st Administration||0
11239053|NCT02079519|12430995|FG000|STARTED|Overall Study||10
11005138|NCT00721253|12182807|FG001|COMPLETED|Overall Study||22
11005139|NCT00721253|12182808|FG002|COMPLETED|Overall Study||0
11239054|NCT02079519|12430995|FG000|COMPLETED|Overall Study||0
11125555|NCT01367080|12311150|FG000|STARTED|2nd Administration||6
11125556|NCT01367080|12311151|FG001|STARTED|2nd Administration||6
11125557|NCT01367080|12311150|FG000|COMPLETED|2nd Administration||6
11125558|NCT01367080|12311151|FG001|COMPLETED|2nd Administration||6
11125559|NCT01367080|12311150|FG000|NOT COMPLETED|2nd Administration||0
11125560|NCT01367080|12311151|FG001|NOT COMPLETED|2nd Administration||0
11125561|NCT01367119|12311161|FG000|STARTED|Overall Study||21
11125562|NCT01367119|12311162|FG001|STARTED|Overall Study||17
11125563|NCT01367119|12311161|FG000|COMPLETED|Overall Study||19
11125564|NCT01367119|12311162|FG001|COMPLETED|Overall Study||16
11125565|NCT01367119|12311161|FG000|NOT COMPLETED|Overall Study||2
11125566|NCT01367119|12311162|FG001|NOT COMPLETED|Overall Study||1
11125567|NCT01367158|12311179|FG000|STARTED|Overall Study||25
11125568|NCT01367158|12311180|FG001|STARTED|Overall Study||49
11125569|NCT01367158|12311181|FG002|STARTED|Overall Study||24
11125570|NCT01367158|12311182|FG003|STARTED|Overall Study||49
11125571|NCT01367158|12311183|FG004|STARTED|Overall Study||25
11125572|NCT01367158|12311184|FG005|STARTED|Overall Study||48
11125573|NCT01367158|12311185|FG006|STARTED|Overall Study||25
11125574|NCT01367158|12311186|FG007|STARTED|Overall Study||49
11125575|NCT01367158|12311187|FG008|STARTED|Overall Study||23
11125576|NCT01367158|12311188|FG009|STARTED|Overall Study||50
11125577|NCT01367158|12311189|FG010|STARTED|Overall Study||73
11125578|NCT01367158|12311179|FG000|COMPLETED|Overall Study||25
11125579|NCT01367158|12311180|FG001|COMPLETED|Overall Study||46
11125580|NCT01367158|12311181|FG002|COMPLETED|Overall Study||23
11125581|NCT01367158|12311182|FG003|COMPLETED|Overall Study||48
11125582|NCT01367158|12311183|FG004|COMPLETED|Overall Study||23
11125583|NCT01367158|12311184|FG005|COMPLETED|Overall Study||46
11125584|NCT01367158|12311185|FG006|COMPLETED|Overall Study||25
11125585|NCT01367158|12311186|FG007|COMPLETED|Overall Study||47
11125586|NCT01367158|12311187|FG008|COMPLETED|Overall Study||23
11125587|NCT01367158|12311188|FG009|COMPLETED|Overall Study||50
11125588|NCT01367158|12311189|FG010|COMPLETED|Overall Study||72
11125589|NCT01367158|12311179|FG000|NOT COMPLETED|Overall Study||0
11125590|NCT01367158|12311180|FG001|NOT COMPLETED|Overall Study||3
11125591|NCT01367158|12311181|FG002|NOT COMPLETED|Overall Study||1
11125592|NCT01367158|12311182|FG003|NOT COMPLETED|Overall Study||1
11125593|NCT01367158|12311183|FG004|NOT COMPLETED|Overall Study||2
11125594|NCT01367158|12311184|FG005|NOT COMPLETED|Overall Study||2
11125595|NCT01367158|12311185|FG006|NOT COMPLETED|Overall Study||0
11125596|NCT01367158|12311186|FG007|NOT COMPLETED|Overall Study||2
11125597|NCT01367158|12311187|FG008|NOT COMPLETED|Overall Study||0
11125598|NCT01367158|12311188|FG009|NOT COMPLETED|Overall Study||0
11125599|NCT01367158|12311189|FG010|NOT COMPLETED|Overall Study||1
11125600|NCT01367236|12311226|FG000|STARTED|Overall Study||30
11125601|NCT01367236|12311227|FG001|STARTED|Overall Study||30
11125602|NCT01367236|12311226|FG000|COMPLETED|Overall Study||27
11125603|NCT01367236|12311227|FG001|COMPLETED|Overall Study||29
11125604|NCT01367236|12311226|FG000|NOT COMPLETED|Overall Study||3
11125605|NCT01367236|12311227|FG001|NOT COMPLETED|Overall Study||1
11125606|NCT01367249|12311235|FG000|STARTED|Overall Study||222
11125607|NCT01367249|12311236|FG001|STARTED|Overall Study||218
11125608|NCT01367249|12311235|FG000|COMPLETED|Overall Study||213
11125609|NCT01367249|12311236|FG001|COMPLETED|Overall Study||202
11125610|NCT01367249|12311235|FG000|NOT COMPLETED|Overall Study||9
11125611|NCT01367249|12311236|FG001|NOT COMPLETED|Overall Study||16
11125612|NCT01367262|12311242|FG000|STARTED|Overall Study||6
11125613|NCT01367262|12311242|FG000|COMPLETED|Overall Study||6
11125614|NCT01367262|12311242|FG000|NOT COMPLETED|Overall Study||0
11125615|NCT01367275|12311246|FG000|STARTED|Overall Study||8
11125616|NCT01367275|12311246|FG000|COMPLETED|Overall Study||5
11125617|NCT01367275|12311246|FG000|NOT COMPLETED|Overall Study||3
11125618|NCT01367444|12311257|FG000|STARTED|Overall Study||4
11125619|NCT01367444|12311258|FG001|STARTED|Overall Study||4
11125620|NCT01367444|12311259|FG002|STARTED|Overall Study||4
11125621|NCT01367444|12311260|FG003|STARTED|Overall Study||4
11125622|NCT01367444|12311261|FG004|STARTED|Overall Study||6
11125623|NCT01367444|12311262|FG005|STARTED|Overall Study||4
11125624|NCT01367444|12311263|FG006|STARTED|Overall Study||1
11125625|NCT01367444|12311257|FG000|COMPLETED|Overall Study||4
11125626|NCT01367444|12311258|FG001|COMPLETED|Overall Study||4
11125627|NCT01367444|12311259|FG002|COMPLETED|Overall Study||4
11125628|NCT01367444|12311260|FG003|COMPLETED|Overall Study||4
11125629|NCT01367444|12311261|FG004|COMPLETED|Overall Study||6
11125630|NCT01367444|12311262|FG005|COMPLETED|Overall Study||4
11125631|NCT01367444|12311263|FG006|COMPLETED|Overall Study||1
11125632|NCT01367444|12311257|FG000|NOT COMPLETED|Overall Study||0
11125633|NCT01367444|12311258|FG001|NOT COMPLETED|Overall Study||0
11125634|NCT01367444|12311259|FG002|NOT COMPLETED|Overall Study||0
11125635|NCT01367444|12311260|FG003|NOT COMPLETED|Overall Study||0
11125636|NCT01367444|12311261|FG004|NOT COMPLETED|Overall Study||0
11125637|NCT01367444|12311262|FG005|NOT COMPLETED|Overall Study||0
11125638|NCT01367444|12311263|FG006|NOT COMPLETED|Overall Study||0
11125639|NCT01367457|12311282|FG000|STARTED|Overall Study||193
11125640|NCT01367457|12311283|FG001|STARTED|Overall Study||23
11125641|NCT01367457|12311284|FG002|STARTED|Overall Study||26
11125642|NCT01367457|12311282|FG000|COMPLETED|Overall Study||5
11125643|NCT01367457|12311283|FG001|COMPLETED|Overall Study||23
11125644|NCT01367457|12311284|FG002|COMPLETED|Overall Study||26
11125645|NCT01367457|12311282|FG000|NOT COMPLETED|Overall Study||188
11125646|NCT01367457|12311283|FG001|NOT COMPLETED|Overall Study||0
11125647|NCT01367457|12311284|FG002|NOT COMPLETED|Overall Study||0
11125648|NCT01367665|12311294|FG000|STARTED|Overall Study||1119
11125649|NCT01367665|12311295|FG001|STARTED|Overall Study||96
11125650|NCT01367665|12311294|FG000|COMPLETED|Overall Study||677
11125651|NCT01367665|12311295|FG001|COMPLETED|Overall Study||41
11125652|NCT01367665|12311294|FG000|NOT COMPLETED|Overall Study||442
11125653|NCT01367665|12311295|FG001|NOT COMPLETED|Overall Study||55
11125654|NCT01367704|12311304|FG000|STARTED|Overall Study||998
11125655|NCT01367704|12311305|FG001|STARTED|Overall Study||1008
11125656|NCT01367704|12311304|FG000|COMPLETED|Overall Study||951
11125657|NCT01367704|12311305|FG001|COMPLETED|Overall Study||847
11125658|NCT01367704|12311304|FG000|NOT COMPLETED|Overall Study||47
11125659|NCT01367704|12311305|FG001|NOT COMPLETED|Overall Study||161
11125660|NCT01367834|12311313|FG000|STARTED|Overall Study||11
11125661|NCT01367834|12311314|FG001|STARTED|Overall Study||6
11125662|NCT01367834|12311313|FG000|COMPLETED|Overall Study||9
11125663|NCT01367834|12311314|FG001|COMPLETED|Overall Study||3
11125664|NCT01367834|12311313|FG000|NOT COMPLETED|Overall Study||2
11125665|NCT01367834|12311314|FG001|NOT COMPLETED|Overall Study||3
11125666|NCT01367847|12311322|FG000|STARTED|Overall Study||10
11125667|NCT01367847|12311323|FG001|STARTED|Overall Study||9
11125668|NCT01367847|12311322|FG000|COMPLETED|Overall Study||8
11125669|NCT01367847|12311323|FG001|COMPLETED|Overall Study||7
11125670|NCT01367847|12311322|FG000|NOT COMPLETED|Overall Study||2
11125671|NCT01367847|12311323|FG001|NOT COMPLETED|Overall Study||2
11125672|NCT01367860|12311332|FG000|STARTED|Overall Study||20
11125673|NCT01367860|12311333|FG001|STARTED|Overall Study||20
11125674|NCT01367860|12311332|FG000|COMPLETED|Overall Study||20
11125675|NCT01367860|12311333|FG001|COMPLETED|Overall Study||20
11125676|NCT01367860|12311332|FG000|NOT COMPLETED|Overall Study||0
11125677|NCT01367860|12311333|FG001|NOT COMPLETED|Overall Study||0
11125678|NCT01367886|12311339|FG000|STARTED|Overall Study||21
11125679|NCT01367886|12311339|FG000|COMPLETED|Overall Study||14
11125680|NCT01367886|12311339|FG000|NOT COMPLETED|Overall Study||7
11125681|NCT01368042|12311344|FG000|STARTED|Overall Study||265
11125682|NCT01368042|12311344|FG000|COMPLETED|Overall Study||235
11125683|NCT01368042|12311344|FG000|NOT COMPLETED|Overall Study||30
11125684|NCT01368081|12311361|FG000|STARTED|Overall Study||136
11125685|NCT01368081|12311362|FG001|STARTED|Overall Study||137
11125686|NCT01368081|12311363|FG002|STARTED|Overall Study||63
11125687|NCT01368081|12311364|FG003|STARTED|Overall Study||68
11125688|NCT01368081|12311365|FG004|STARTED|Overall Study||65
11125689|NCT01368081|12311366|FG005|STARTED|Overall Study||137
11125690|NCT01368081|12311367|FG006|STARTED|Overall Study||136
11125691|NCT01368081|12311368|FG007|STARTED|Overall Study||69
11125692|NCT01368081|12311369|FG008|STARTED|Overall Study||70
11125693|NCT01368081|12311370|FG009|STARTED|Overall Study||68
11125694|NCT01368081|12311371|FG010|STARTED|Overall Study||71
11125695|NCT01368081|12311372|FG011|STARTED|Overall Study||70
11125696|NCT01368081|12311373|FG012|STARTED|Overall Study||70
11125697|NCT01368081|12311361|FG000|COMPLETED|Overall Study||126
11125698|NCT01368081|12311362|FG001|COMPLETED|Overall Study||128
11125699|NCT01368081|12311363|FG002|COMPLETED|Overall Study||59
11125700|NCT01368081|12311364|FG003|COMPLETED|Overall Study||63
11125701|NCT01368081|12311365|FG004|COMPLETED|Overall Study||63
11125702|NCT01368081|12311366|FG005|COMPLETED|Overall Study||127
11125703|NCT01368081|12311367|FG006|COMPLETED|Overall Study||124
11125704|NCT01368081|12311368|FG007|COMPLETED|Overall Study||62
11125705|NCT01368081|12311369|FG008|COMPLETED|Overall Study||62
11125706|NCT01368081|12311370|FG009|COMPLETED|Overall Study||58
11125707|NCT01368081|12311371|FG010|COMPLETED|Overall Study||62
11125708|NCT01368081|12311372|FG011|COMPLETED|Overall Study||67
11125709|NCT01368081|12311373|FG012|COMPLETED|Overall Study||63
11125710|NCT01368081|12311361|FG000|NOT COMPLETED|Overall Study||10
11125711|NCT01368081|12311362|FG001|NOT COMPLETED|Overall Study||9
11125712|NCT01368081|12311363|FG002|NOT COMPLETED|Overall Study||4
11125713|NCT01368081|12311364|FG003|NOT COMPLETED|Overall Study||5
11125714|NCT01368081|12311365|FG004|NOT COMPLETED|Overall Study||2
11125715|NCT01368081|12311366|FG005|NOT COMPLETED|Overall Study||10
11125716|NCT01368081|12311367|FG006|NOT COMPLETED|Overall Study||12
11125717|NCT01368081|12311368|FG007|NOT COMPLETED|Overall Study||7
11125718|NCT01368081|12311369|FG008|NOT COMPLETED|Overall Study||8
11125719|NCT01368081|12311370|FG009|NOT COMPLETED|Overall Study||10
11125720|NCT01368081|12311371|FG010|NOT COMPLETED|Overall Study||9
11125721|NCT01368081|12311372|FG011|NOT COMPLETED|Overall Study||3
11125722|NCT01368081|12311373|FG012|NOT COMPLETED|Overall Study||7
11125723|NCT01368211|12311403|FG000|STARTED|First Platelets Transfusion||8
11125724|NCT01368211|12311404|FG001|STARTED|First Platelets Transfusion||7
11125725|NCT01368211|12311403|FG000|COMPLETED|First Platelets Transfusion||8
11125726|NCT01368211|12311404|FG001|COMPLETED|First Platelets Transfusion||7
11125727|NCT01368211|12311403|FG000|NOT COMPLETED|First Platelets Transfusion||0
11125728|NCT01368211|12311404|FG001|NOT COMPLETED|First Platelets Transfusion||0
11125729|NCT01368211|12311403|FG000|STARTED|Second Platelets Transfusion||8
11125730|NCT01368211|12311404|FG001|STARTED|Second Platelets Transfusion||7
11125731|NCT01368211|12311403|FG000|COMPLETED|Second Platelets Transfusion||7
11125732|NCT01368211|12311404|FG001|COMPLETED|Second Platelets Transfusion||5
11125733|NCT01368211|12311403|FG000|NOT COMPLETED|Second Platelets Transfusion||1
11125734|NCT01368211|12311404|FG001|NOT COMPLETED|Second Platelets Transfusion||2
11125735|NCT01368263|12311413|FG000|STARTED|Overall Study||6
11125736|NCT01368263|12311414|FG001|STARTED|Overall Study||1
11125737|NCT01368263|12311415|FG002|STARTED|Overall Study||1
11125738|NCT01368263|12311413|FG000|COMPLETED|Overall Study||6
11125739|NCT01368263|12311414|FG001|COMPLETED|Overall Study||1
11125740|NCT01368263|12311415|FG002|COMPLETED|Overall Study||1
11125741|NCT01368263|12311413|FG000|NOT COMPLETED|Overall Study||0
11125742|NCT01368263|12311414|FG001|NOT COMPLETED|Overall Study||0
11125743|NCT01368263|12311415|FG002|NOT COMPLETED|Overall Study||0
11125744|NCT01368276|12311425|FG000|STARTED|Overall Study||3
11125745|NCT01368276|12311426|FG001|STARTED|Overall Study||28
11125746|NCT01368276|12311425|FG000|COMPLETED|Overall Study||2
11125747|NCT01368276|12311426|FG001|COMPLETED|Overall Study||18
11125748|NCT01368276|12311425|FG000|NOT COMPLETED|Overall Study||1
11125749|NCT01368276|12311426|FG001|NOT COMPLETED|Overall Study||10
11125750|NCT01368406|12311434|FG000|STARTED|Overall Study||81
11125751|NCT01368406|12311435|FG001|STARTED|Overall Study||79
11125752|NCT01368406|12311434|FG000|COMPLETED|Overall Study||60
11125753|NCT01368406|12311435|FG001|COMPLETED|Overall Study||66
11125754|NCT01368406|12311434|FG000|NOT COMPLETED|Overall Study||21
11125755|NCT01368406|12311435|FG001|NOT COMPLETED|Overall Study||13
11125756|NCT01368432|12311443|FG000|STARTED|Overall Study||6
11125757|NCT01368432|12311444|FG001|STARTED|Overall Study||8
11125758|NCT01368432|12311443|FG000|COMPLETED|Overall Study||6
11125759|NCT01368432|12311444|FG001|COMPLETED|Overall Study||7
11125760|NCT01368432|12311443|FG000|NOT COMPLETED|Overall Study||0
11125761|NCT01368432|12311444|FG001|NOT COMPLETED|Overall Study||1
11125762|NCT01368536|12311467|FG000|STARTED|Overall Study||138
11125763|NCT01368536|12311468|FG001|STARTED|Overall Study||137
11125764|NCT01368536|12311469|FG002|STARTED|Overall Study||142
11125765|NCT01368536|12311467|FG000|Full Analysis Set|Overall Study||138
11125766|NCT01368536|12311468|FG001|Full Analysis Set|Overall Study||137
11125767|NCT01368536|12311469|FG002|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
11125768|NCT01368536|12311467|FG000|COMPLETED|Overall Study||87
11125769|NCT01368536|12311468|FG001|COMPLETED|Overall Study||78
11125770|NCT01368536|12311469|FG002|COMPLETED|Overall Study||83
11125771|NCT01368536|12311467|FG000|NOT COMPLETED|Overall Study||51
11125772|NCT01368536|12311468|FG001|NOT COMPLETED|Overall Study||59
11125773|NCT01368536|12311469|FG002|NOT COMPLETED|Overall Study||59
11125774|NCT01368562|12311478|FG000|STARTED|Overall Study||26
11125775|NCT01368562|12311478|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25
11125776|NCT01368562|12311478|FG000|COMPLETED|Overall Study||7
11125777|NCT01368562|12311478|FG000|NOT COMPLETED|Overall Study||19
11125778|NCT01368614|12311482|FG000|STARTED|Screening Period||90
11125779|NCT01368614|12311483|FG001|STARTED|Screening Period||0
11125780|NCT01368614|12311484|FG002|STARTED|Screening Period||0
11125781|NCT01368614|12311485|FG003|STARTED|Screening Period||0
11125782|NCT01368614|12311482|FG000|COMPLETED|Screening Period||32
11125783|NCT01368614|12311483|FG001|COMPLETED|Screening Period||0
11125784|NCT01368614|12311484|FG002|COMPLETED|Screening Period||0
11125785|NCT01368614|12311485|FG003|COMPLETED|Screening Period||0
11125786|NCT01368614|12311482|FG000|NOT COMPLETED|Screening Period||58
11125787|NCT01368614|12311483|FG001|NOT COMPLETED|Screening Period||0
11125788|NCT01368614|12311484|FG002|NOT COMPLETED|Screening Period||0
11125789|NCT01368614|12311485|FG003|NOT COMPLETED|Screening Period||0
11125790|NCT01368614|12311482|FG000|STARTED|Study Period||0
11125791|NCT01368614|12311483|FG001|STARTED|Study Period||11
11125792|NCT01368614|12311484|FG002|STARTED|Study Period||10
11125793|NCT01368614|12311485|FG003|STARTED|Study Period||11
11125794|NCT01368614|12311482|FG000|COMPLETED|Study Period||0
11125795|NCT01368614|12311483|FG001|COMPLETED|Study Period||10
11125796|NCT01368614|12311484|FG002|COMPLETED|Study Period||8
11125797|NCT01368614|12311485|FG003|COMPLETED|Study Period||8
11125798|NCT01368614|12311482|FG000|NOT COMPLETED|Study Period||0
11125799|NCT01368614|12311483|FG001|NOT COMPLETED|Study Period||1
11125800|NCT01368614|12311484|FG002|NOT COMPLETED|Study Period||2
11125801|NCT01368614|12311485|FG003|NOT COMPLETED|Study Period||3
11125802|NCT01368653|12311495|FG000|STARTED|Overall Study||47
11125803|NCT01368653|12311496|FG001|STARTED|Overall Study||46
11125804|NCT01368653|12311495|FG000|Completed 4-week Follow-up|Overall Study||44
11125805|NCT01368653|12311496|FG001|Completed 4-week Follow-up|Overall Study||37
11125806|NCT01368653|12311495|FG000|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
11125807|NCT01368653|12311496|FG001|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
11125808|NCT01368653|12311495|FG000|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
11125809|NCT01368653|12311496|FG001|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
11125810|NCT01368653|12311495|FG000|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
11125811|NCT01368653|12311496|FG001|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
11125812|NCT01368653|12311495|FG000|Randomized to Advice Only in Phase 2|Overall Study||10
11125813|NCT01368653|12311496|FG001|Randomized to Advice Only in Phase 2|Overall Study||10
11125814|NCT01368653|12311495|FG000|COMPLETED|Overall Study||41
11125815|NCT01368653|12311496|FG001|COMPLETED|Overall Study||37
11125816|NCT01368653|12311495|FG000|NOT COMPLETED|Overall Study||6
11125817|NCT01368653|12311496|FG001|NOT COMPLETED|Overall Study||9
11125818|NCT01368809|12311511|FG000|STARTED|Overall Study||50
11125819|NCT01368809|12311512|FG001|STARTED|Overall Study||50
11125820|NCT01368809|12311511|FG000|COMPLETED|Overall Study||50
11125821|NCT01368809|12311512|FG001|COMPLETED|Overall Study||50
11125822|NCT01368809|12311511|FG000|NOT COMPLETED|Overall Study||0
11125823|NCT01368809|12311512|FG001|NOT COMPLETED|Overall Study||0
11125824|NCT01368835|12311520|FG000|STARTED|Overall Study|103 Subjects Enrolled|103
11125825|NCT01368835|12311520|FG000|COMPLETED|Overall Study||70
11125826|NCT01368835|12311520|FG000|NOT COMPLETED|Overall Study||33
11125827|NCT01368874|12311528|FG000|STARTED|Overall Study||34
11125828|NCT01368874|12311529|FG001|STARTED|Overall Study||5
11125829|NCT01368874|12311530|FG002|STARTED|Overall Study||25
11125830|NCT01368874|12311528|FG000|COMPLETED|Overall Study||31
11125831|NCT01368874|12311529|FG001|COMPLETED|Overall Study||5
11125832|NCT01368874|12311530|FG002|COMPLETED|Overall Study||24
11125833|NCT01368874|12311528|FG000|NOT COMPLETED|Overall Study||3
11125834|NCT01368874|12311529|FG001|NOT COMPLETED|Overall Study||0
11239055|NCT02079519|12430995|FG000|NOT COMPLETED|Overall Study||10
11239056|NCT02079532|12430999|FG000|STARTED|Overall Study||302
11239057|NCT02079532|12430999|FG000|COMPLETED|Overall Study||273
11239058|NCT02079532|12430999|FG000|NOT COMPLETED|Overall Study||29
11239059|NCT02079610|12431005|FG000|STARTED|Overall Study||19
11239060|NCT02079610|12431006|FG001|STARTED|Overall Study||17
11239061|NCT02079610|12431005|FG000|COMPLETED|Overall Study||18
11239062|NCT02079610|12431006|FG001|COMPLETED|Overall Study||16
11239063|NCT02079610|12431005|FG000|NOT COMPLETED|Overall Study||1
11239064|NCT02079610|12431006|FG001|NOT COMPLETED|Overall Study||1
11239065|NCT02079636|12431027|FG000|STARTED|Overall Study||8
11239066|NCT02079636|12431028|FG001|STARTED|Overall Study||15
11239067|NCT02079636|12431029|FG002|STARTED|Overall Study||3
11239068|NCT02079636|12431030|FG003|STARTED|Overall Study||21
11239069|NCT02079636|12431031|FG004|STARTED|Overall Study||4
11239070|NCT02079636|12431032|FG005|STARTED|Overall Study||19
11239071|NCT02079636|12431033|FG006|STARTED|Overall Study||12
11239072|NCT02079636|12431034|FG007|STARTED|Overall Study||4
11239073|NCT02079636|12431035|FG008|STARTED|Overall Study||3
11239074|NCT02079636|12431036|FG009|STARTED|Overall Study||9
11239075|NCT02079636|12431037|FG010|STARTED|Overall Study||10
11239076|NCT02079636|12431038|FG011|STARTED|Overall Study||6
11239077|NCT02079636|12431039|FG012|STARTED|Overall Study||8
11239078|NCT02079636|12431040|FG013|STARTED|Overall Study||3
11239079|NCT02079636|12431041|FG014|STARTED|Overall Study||17
11239080|NCT02079636|12431027|FG000|Received at Least One Dose of Study Drug|Overall Study||8
11239081|NCT02079636|12431028|FG001|Received at Least One Dose of Study Drug|Overall Study||15
11239082|NCT02079636|12431029|FG002|Received at Least One Dose of Study Drug|Overall Study||3
11239083|NCT02079636|12431030|FG003|Received at Least One Dose of Study Drug|Overall Study||21
11239084|NCT02079636|12431031|FG004|Received at Least One Dose of Study Drug|Overall Study||4
11239085|NCT02079636|12431032|FG005|Received at Least One Dose of Study Drug|Overall Study||19
11239086|NCT02079636|12431033|FG006|Received at Least One Dose of Study Drug|Overall Study||12
11239087|NCT02079636|12431034|FG007|Received at Least One Dose of Study Drug|Overall Study||4
11239088|NCT02079636|12431035|FG008|Received at Least One Dose of Study Drug|Overall Study||3
11239089|NCT02079636|12431036|FG009|Received at Least One Dose of Study Drug|Overall Study||9
11125835|NCT01368874|12311530|FG002|NOT COMPLETED|Overall Study||1
11125836|NCT01368900|12311572|FG000|STARTED|Overall Study||68
11125837|NCT01368900|12311572|FG000|COMPLETED|Overall Study||61
11125838|NCT01368900|12311572|FG000|NOT COMPLETED|Overall Study||7
11125839|NCT01368965|12311578|FG000|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
11125840|NCT01368965|12311578|FG000|Subject Withdrawal Prior to Treatment|Overall Study||2
11125841|NCT01368965|12311578|FG000|COMPLETED|Overall Study||40
11125842|NCT01368965|12311578|FG000|NOT COMPLETED|Overall Study||12
11125843|NCT01369030|12311584|FG000|STARTED|Overall Study||594
11125844|NCT01369030|12311584|FG000|COMPLETED|Overall Study||554
11125845|NCT01369030|12311584|FG000|NOT COMPLETED|Overall Study||40
11125846|NCT01369069|12311590|FG000|STARTED|Overall Study||581
11125847|NCT01369069|12311591|FG001|STARTED|Overall Study||570
11125848|NCT01369069|12311590|FG000|COMPLETED|Overall Study||564
11125849|NCT01369069|12311591|FG001|COMPLETED|Overall Study||554
11125850|NCT01369069|12311590|FG000|NOT COMPLETED|Overall Study||17
11125851|NCT01369069|12311591|FG001|NOT COMPLETED|Overall Study||16
11125852|NCT01369108|12311597|FG000|STARTED|Overall Study|120 teeth|60
11125853|NCT01369108|12311597|FG000|COMPLETED|Overall Study||49
11125854|NCT01369108|12311597|FG000|NOT COMPLETED|Overall Study||11
11125855|NCT01369225|12311608|FG000|STARTED|Overall Study||6
11125856|NCT01369225|12311609|FG001|STARTED|Overall Study||3
11125857|NCT01369225|12311610|FG002|STARTED|Overall Study||12
11125858|NCT01369225|12311611|FG003|STARTED|Overall Study||10
11125859|NCT01369225|12311612|FG004|STARTED|Overall Study||12
11125860|NCT01369225|12311613|FG005|STARTED|Overall Study||9
11125861|NCT01369225|12311608|FG000|COMPLETED|Overall Study||4
11125862|NCT01369225|12311609|FG001|COMPLETED|Overall Study||3
11125863|NCT01369225|12311610|FG002|COMPLETED|Overall Study||9
11125864|NCT01369225|12311611|FG003|COMPLETED|Overall Study||8
11125865|NCT01369225|12311612|FG004|COMPLETED|Overall Study||10
11125866|NCT01369225|12311613|FG005|COMPLETED|Overall Study||9
11125867|NCT01369225|12311608|FG000|NOT COMPLETED|Overall Study||2
11125868|NCT01369225|12311609|FG001|NOT COMPLETED|Overall Study||0
11125869|NCT01369225|12311610|FG002|NOT COMPLETED|Overall Study||3
11125870|NCT01369225|12311611|FG003|NOT COMPLETED|Overall Study||2
11125871|NCT01369225|12311612|FG004|NOT COMPLETED|Overall Study||2
11125872|NCT01369225|12311613|FG005|NOT COMPLETED|Overall Study||0
11125873|NCT01369329|12311630|FG000|STARTED|Overall Study||256
11125874|NCT01369329|12311631|FG001|STARTED|Overall Study||254
11125875|NCT01369329|12311632|FG002|STARTED|Overall Study||259
11125876|NCT01369329|12311630|FG000|COMPLETED|Overall Study||244
11125877|NCT01369329|12311631|FG001|COMPLETED|Overall Study||243
11125878|NCT01369329|12311632|FG002|COMPLETED|Overall Study||245
11125879|NCT01369329|12311630|FG000|NOT COMPLETED|Overall Study||12
11125880|NCT01369329|12311631|FG001|NOT COMPLETED|Overall Study||11
11125881|NCT01369329|12311632|FG002|NOT COMPLETED|Overall Study||14
11125882|NCT01369342|12311643|FG000|STARTED|Overall Study||214
11125883|NCT01369342|12311644|FG001|STARTED|Overall Study||213
11125884|NCT01369342|12311645|FG002|STARTED|Overall Study||213
11125885|NCT01369342|12311643|FG000|COMPLETED|Overall Study||201
11125886|NCT01369342|12311644|FG001|COMPLETED|Overall Study||204
11125887|NCT01369342|12311645|FG002|COMPLETED|Overall Study||210
11125888|NCT01369342|12311643|FG000|NOT COMPLETED|Overall Study||13
11125889|NCT01369342|12311644|FG001|NOT COMPLETED|Overall Study||9
11125890|NCT01369342|12311645|FG002|NOT COMPLETED|Overall Study||3
11125891|NCT01369355|12311659|FG000|STARTED|Week 0 - Week 44 (Maintenance)||133
11125892|NCT01369355|12311660|FG001|STARTED|Week 0 - Week 44 (Maintenance)||132
11125893|NCT01369355|12311661|FG002|STARTED|Week 0 - Week 44 (Maintenance)||132
11125894|NCT01369355|12311662|FG003|STARTED|Week 0 - Week 44 (Maintenance)||123
11125895|NCT01369355|12311663|FG004|STARTED|Week 0 - Week 44 (Maintenance)||285
11125896|NCT01369355|12311664|FG005|STARTED|Week 0 - Week 44 (Maintenance)||476
11125897|NCT01369355|12311665|FG006|STARTED|Week 0 - Week 44 (Maintenance)||0
11125898|NCT01369355|12311666|FG007|STARTED|Week 0 - Week 44 (Maintenance)||0
11125899|NCT01369355|12311667|FG008|STARTED|Week 0 - Week 44 (Maintenance)||0
11125900|NCT01369355|12311659|FG000|COMPLETED|Week 0 - Week 44 (Maintenance)||102
11125901|NCT01369355|12311660|FG001|COMPLETED|Week 0 - Week 44 (Maintenance)||103
11125902|NCT01369355|12311661|FG002|COMPLETED|Week 0 - Week 44 (Maintenance)||101
11125903|NCT01369355|12311662|FG003|COMPLETED|Week 0 - Week 44 (Maintenance)||93
11125904|NCT01369355|12311663|FG004|COMPLETED|Week 0 - Week 44 (Maintenance)||131
11125905|NCT01369355|12311664|FG005|COMPLETED|Week 0 - Week 44 (Maintenance)||204
11125906|NCT01369355|12311665|FG006|COMPLETED|Week 0 - Week 44 (Maintenance)||0
11125907|NCT01369355|12311666|FG007|COMPLETED|Week 0 - Week 44 (Maintenance)||0
11125908|NCT01369355|12311667|FG008|COMPLETED|Week 0 - Week 44 (Maintenance)||0
11125909|NCT01369355|12311659|FG000|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
11125910|NCT01369355|12311660|FG001|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||29
11125911|NCT01369355|12311661|FG002|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
11125912|NCT01369355|12311662|FG003|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||30
11125913|NCT01369355|12311663|FG004|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||154
11125914|NCT01369355|12311664|FG005|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||272
11125915|NCT01369355|12311665|FG006|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
11125916|NCT01369355|12311666|FG007|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
11125917|NCT01369355|12311667|FG008|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
11125918|NCT01369355|12311659|FG000|STARTED|Long-term Extension (Week 44-272)||0
11125919|NCT01369355|12311660|FG001|STARTED|Long-term Extension (Week 44-272)||0
11125920|NCT01369355|12311661|FG002|STARTED|Long-term Extension (Week 44-272)||0
11125921|NCT01369355|12311662|FG003|STARTED|Long-term Extension (Week 44-272)||0
11125922|NCT01369355|12311663|FG004|STARTED|Long-term Extension (Week 44-272)||0
11125923|NCT01369355|12311664|FG005|STARTED|Long-term Extension (Week 44-272)||0
11125924|NCT01369355|12311665|FG006|STARTED|Long-term Extension (Week 44-272)||151
11125925|NCT01369355|12311666|FG007|STARTED|Long-term Extension (Week 44-272)||213
11125926|NCT01369355|12311667|FG008|STARTED|Long-term Extension (Week 44-272)||354
11125927|NCT01369355|12311659|FG000|COMPLETED|Long-term Extension (Week 44-272)||0
11125928|NCT01369355|12311660|FG001|COMPLETED|Long-term Extension (Week 44-272)||0
11125929|NCT01369355|12311661|FG002|COMPLETED|Long-term Extension (Week 44-272)||0
11125930|NCT01369355|12311662|FG003|COMPLETED|Long-term Extension (Week 44-272)||0
11125931|NCT01369355|12311663|FG004|COMPLETED|Long-term Extension (Week 44-272)||0
11125932|NCT01369355|12311664|FG005|COMPLETED|Long-term Extension (Week 44-272)||0
11125933|NCT01369355|12311665|FG006|COMPLETED|Long-term Extension (Week 44-272)||0
11125934|NCT01369355|12311666|FG007|COMPLETED|Long-term Extension (Week 44-272)||107
11125935|NCT01369355|12311667|FG008|COMPLETED|Long-term Extension (Week 44-272)||183
11125936|NCT01369355|12311659|FG000|NOT COMPLETED|Long-term Extension (Week 44-272)||0
11125937|NCT01369355|12311660|FG001|NOT COMPLETED|Long-term Extension (Week 44-272)||0
11125938|NCT01369355|12311661|FG002|NOT COMPLETED|Long-term Extension (Week 44-272)||0
11125939|NCT01369355|12311662|FG003|NOT COMPLETED|Long-term Extension (Week 44-272)||0
11125940|NCT01369355|12311663|FG004|NOT COMPLETED|Long-term Extension (Week 44-272)||0
11125941|NCT01369355|12311664|FG005|NOT COMPLETED|Long-term Extension (Week 44-272)||0
11125942|NCT01369355|12311665|FG006|NOT COMPLETED|Long-term Extension (Week 44-272)||151
11125943|NCT01369355|12311666|FG007|NOT COMPLETED|Long-term Extension (Week 44-272)||106
11125944|NCT01369355|12311667|FG008|NOT COMPLETED|Long-term Extension (Week 44-272)||171
11125945|NCT01369433|12311686|FG000|STARTED|Overall Study||209
11125946|NCT01369433|12311687|FG001|STARTED|Overall Study||16
11125947|NCT01369433|12311686|FG000|COMPLETED|Overall Study||0
11125948|NCT01369433|12311687|FG001|COMPLETED|Overall Study||0
11125949|NCT01369433|12311686|FG000|NOT COMPLETED|Overall Study||209
11125950|NCT01369433|12311687|FG001|NOT COMPLETED|Overall Study||16
11125951|NCT01369485|12311695|FG000|STARTED|Randomized Phase (Day 0 to Week 12)||80
11125952|NCT01369485|12311696|FG001|STARTED|Randomized Phase (Day 0 to Week 12)||83
11125953|NCT01369485|12311695|FG000|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
11125954|NCT01369485|12311696|FG001|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
11125955|NCT01369485|12311695|FG000|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
11125956|NCT01369485|12311696|FG001|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
11125957|NCT01369485|12311695|FG000|STARTED|Open Label Phase (Week 12 to Month 12)||57
11125958|NCT01369485|12311696|FG001|STARTED|Open Label Phase (Week 12 to Month 12)||66
11125959|NCT01369485|12311695|FG000|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
11125960|NCT01369485|12311696|FG001|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
11125961|NCT01369485|12311695|FG000|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
11125962|NCT01369485|12311696|FG001|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
11125963|NCT01369498|12311714|FG000|STARTED|Overall Study||12
11125964|NCT01369498|12311715|FG001|STARTED|Overall Study||12
11125965|NCT01369498|12311716|FG002|STARTED|Overall Study||15
11125966|NCT01369498|12311717|FG003|STARTED|Overall Study||15
11125967|NCT01369498|12311714|FG000|COMPLETED|Overall Study||0
11125968|NCT01369498|12311715|FG001|COMPLETED|Overall Study||0
11125969|NCT01369498|12311716|FG002|COMPLETED|Overall Study||0
11125970|NCT01369498|12311717|FG003|COMPLETED|Overall Study||0
11125971|NCT01369498|12311714|FG000|NOT COMPLETED|Overall Study||12
11125972|NCT01369498|12311715|FG001|NOT COMPLETED|Overall Study||12
11125973|NCT01369498|12311716|FG002|NOT COMPLETED|Overall Study||15
11125974|NCT01369498|12311717|FG003|NOT COMPLETED|Overall Study||15
11125975|NCT01369511|12311732|FG000|STARTED|Overall Study||98
11125976|NCT01369511|12311733|FG001|STARTED|Overall Study||104
11125977|NCT01369511|12311734|FG002|STARTED|Overall Study||98
11125978|NCT01369511|12311735|FG003|STARTED|Overall Study||100
11125979|NCT01369511|12311732|FG000|Received at Least 1 Dose of Study Drug|Overall Study||98
11125980|NCT01369511|12311733|FG001|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
11125981|NCT01369511|12311734|FG002|Received at Least 1 Dose of Study Drug|Overall Study||98
11125982|NCT01369511|12311735|FG003|Received at Least 1 Dose of Study Drug|Overall Study||100
11125983|NCT01369511|12311732|FG000|COMPLETED|Overall Study||85
11125984|NCT01369511|12311733|FG001|COMPLETED|Overall Study||91
11125985|NCT01369511|12311734|FG002|COMPLETED|Overall Study||87
11125986|NCT01369511|12311735|FG003|COMPLETED|Overall Study||89
11125987|NCT01369511|12311732|FG000|NOT COMPLETED|Overall Study||13
11125988|NCT01369511|12311733|FG001|NOT COMPLETED|Overall Study||13
11125989|NCT01369511|12311734|FG002|NOT COMPLETED|Overall Study||11
11125990|NCT01369511|12311735|FG003|NOT COMPLETED|Overall Study||11
11125991|NCT01369615|12311747|FG000|STARTED|Overall Study||9
11125992|NCT01369615|12311748|FG001|STARTED|Overall Study||14
11125993|NCT01369615|12311747|FG000|COMPLETED|Overall Study||9
11125994|NCT01369615|12311748|FG001|COMPLETED|Overall Study||12
11125995|NCT01369615|12311747|FG000|NOT COMPLETED|Overall Study||0
11125996|NCT01369615|12311748|FG001|NOT COMPLETED|Overall Study||2
11125997|NCT01369680|12311758|FG000|STARTED|Overall Study||3
11125998|NCT01369680|12311759|FG001|STARTED|Overall Study||3
11125999|NCT01369680|12311760|FG002|STARTED|Overall Study||3
11126000|NCT01369680|12311761|FG003|STARTED|Overall Study||3
11126001|NCT01369680|12311758|FG000|COMPLETED|Overall Study||3
11126002|NCT01369680|12311759|FG001|COMPLETED|Overall Study||3
11126003|NCT01369680|12311760|FG002|COMPLETED|Overall Study||2
11126004|NCT01369680|12311761|FG003|COMPLETED|Overall Study||1
11126005|NCT01369680|12311758|FG000|NOT COMPLETED|Overall Study||0
11126006|NCT01369680|12311759|FG001|NOT COMPLETED|Overall Study||0
11126007|NCT01369680|12311760|FG002|NOT COMPLETED|Overall Study||1
11126008|NCT01369680|12311761|FG003|NOT COMPLETED|Overall Study||2
11126009|NCT01369706|12311782|FG000|STARTED|Overall Study||388
11126010|NCT01369706|12311782|FG000|COMPLETED|Overall Study||388
11126011|NCT01369706|12311782|FG000|NOT COMPLETED|Overall Study||0
11126012|NCT01369732|12311788|FG000|STARTED|Overall Study||33
11126013|NCT01369732|12311789|FG001|STARTED|Overall Study||33
11126014|NCT01369732|12311788|FG000|COMPLETED|Overall Study||29
11126015|NCT01369732|12311789|FG001|COMPLETED|Overall Study||31
11126016|NCT01369732|12311788|FG000|NOT COMPLETED|Overall Study||4
11126017|NCT01369732|12311789|FG001|NOT COMPLETED|Overall Study||2
11126018|NCT01369745|12311800|FG000|STARTED|Overall Study||32
11126019|NCT01369745|12311801|FG001|STARTED|Overall Study||41
11126020|NCT01369745|12311802|FG002|STARTED|Overall Study||18
11126021|NCT01369745|12311803|FG003|STARTED|Overall Study||84
11126022|NCT01369745|12311804|FG004|STARTED|Overall Study||83
11126023|NCT01369745|12311800|FG000|COMPLETED|Overall Study||25
11126024|NCT01369745|12311801|FG001|COMPLETED|Overall Study||28
11126025|NCT01369745|12311802|FG002|COMPLETED|Overall Study||16
11126026|NCT01369745|12311803|FG003|COMPLETED|Overall Study||64
11126027|NCT01369745|12311804|FG004|COMPLETED|Overall Study||65
11126028|NCT01369745|12311800|FG000|NOT COMPLETED|Overall Study||7
11126029|NCT01369745|12311801|FG001|NOT COMPLETED|Overall Study||13
11126030|NCT01369745|12311802|FG002|NOT COMPLETED|Overall Study||2
11126031|NCT01369745|12311803|FG003|NOT COMPLETED|Overall Study||20
11126032|NCT01369745|12311804|FG004|NOT COMPLETED|Overall Study||18
11126033|NCT01369758|12311816|FG000|STARTED|Overall Study||290
11126034|NCT01369758|12311816|FG000|COMPLETED|Overall Study||290
11126035|NCT01369758|12311816|FG000|NOT COMPLETED|Overall Study||0
11126036|NCT01369784|12311820|FG000|STARTED|Overall Study||158
11126037|NCT01369784|12311820|FG000|COMPLETED|Overall Study||146
11126038|NCT01369784|12311820|FG000|NOT COMPLETED|Overall Study||12
11126039|NCT01369849|12311827|FG000|STARTED|Overall Study||6
11126040|NCT01369849|12311828|FG001|STARTED|Overall Study||4
11126041|NCT01369849|12311829|FG002|STARTED|Overall Study||5
11126042|NCT01369849|12311827|FG000|COMPLETED|Overall Study||6
11126043|NCT01369849|12311828|FG001|COMPLETED|Overall Study||3
11126044|NCT01369849|12311829|FG002|COMPLETED|Overall Study||4
11126045|NCT01369849|12311827|FG000|NOT COMPLETED|Overall Study||0
11126046|NCT01369849|12311828|FG001|NOT COMPLETED|Overall Study||1
11126047|NCT01369849|12311829|FG002|NOT COMPLETED|Overall Study||1
11126048|NCT01369875|12311841|FG000|STARTED|Overall Study||1
11126049|NCT01369875|12311842|FG001|STARTED|Overall Study||1
11126050|NCT01369875|12311841|FG000|COMPLETED|Overall Study||1
11126051|NCT01369875|12311842|FG001|COMPLETED|Overall Study||1
11126052|NCT01369875|12311841|FG000|NOT COMPLETED|Overall Study||0
11126053|NCT01369875|12311842|FG001|NOT COMPLETED|Overall Study||0
11126054|NCT01369888|12311852|FG000|STARTED|Overall Study||1
11126055|NCT01369888|12311853|FG001|STARTED|Overall Study||2
11126056|NCT01369888|12311854|FG002|STARTED|Overall Study||0
11126057|NCT01369888|12311855|FG003|STARTED|Overall Study||0
11126058|NCT01369888|12311852|FG000|COMPLETED|Overall Study||1
11126059|NCT01369888|12311853|FG001|COMPLETED|Overall Study||2
11126060|NCT01369888|12311854|FG002|COMPLETED|Overall Study||0
11126061|NCT01369888|12311855|FG003|COMPLETED|Overall Study||0
11126062|NCT01369888|12311852|FG000|NOT COMPLETED|Overall Study||0
11126063|NCT01369888|12311853|FG001|NOT COMPLETED|Overall Study||0
11126064|NCT01369888|12311854|FG002|NOT COMPLETED|Overall Study||0
11126065|NCT01369888|12311855|FG003|NOT COMPLETED|Overall Study||0
11202110|NCT01837797|12392488|FG000|COMPLETED|Period 3||0
11202111|NCT01837797|12392489|FG001|COMPLETED|Period 3||0
11202112|NCT01837797|12392490|FG002|COMPLETED|Period 3||0
11202113|NCT01837797|12392491|FG003|COMPLETED|Period 3||0
11202114|NCT01837797|12392492|FG004|COMPLETED|Period 3||24
11202115|NCT01837797|12392488|FG000|NOT COMPLETED|Period 3||0
11202116|NCT01837797|12392489|FG001|NOT COMPLETED|Period 3||0
11202117|NCT01837797|12392490|FG002|NOT COMPLETED|Period 3||0
11202118|NCT01837797|12392491|FG003|NOT COMPLETED|Period 3||0
11202119|NCT01837797|12392492|FG004|NOT COMPLETED|Period 3||23
11202120|NCT01837823|12392500|FG000|STARTED|Overall Study||91
11202121|NCT01837823|12392500|FG000|COMPLETED|Overall Study||85
11202122|NCT01837823|12392500|FG000|NOT COMPLETED|Overall Study||6
11202123|NCT01837901|12392511|FG000|STARTED|Overall Study||22
11202124|NCT01837901|12392512|FG001|STARTED|Overall Study||21
11202125|NCT01837901|12392513|FG002|STARTED|Overall Study||20
11202126|NCT01837901|12392511|FG000|COMPLETED|Overall Study||20
11202127|NCT01837901|12392512|FG001|COMPLETED|Overall Study||15
11202128|NCT01837901|12392513|FG002|COMPLETED|Overall Study||17
11202129|NCT01837901|12392511|FG000|NOT COMPLETED|Overall Study||2
11202130|NCT01837901|12392512|FG001|NOT COMPLETED|Overall Study||6
11202131|NCT01837901|12392513|FG002|NOT COMPLETED|Overall Study||3
11202132|NCT01837966|12392523|FG000|STARTED|Overall Study||47
11202133|NCT01837966|12392524|FG001|STARTED|Overall Study||46
11202134|NCT01837966|12392523|FG000|COMPLETED|Overall Study||45
11202135|NCT01837966|12392524|FG001|COMPLETED|Overall Study||45
11202136|NCT01837966|12392523|FG000|NOT COMPLETED|Overall Study||2
11202137|NCT01837966|12392524|FG001|NOT COMPLETED|Overall Study||1
11202138|NCT01838044|12392532|FG000|STARTED|Overall Study||89
11202139|NCT01838044|12392533|FG001|STARTED|Overall Study||91
11202140|NCT01838044|12392532|FG000|COMPLETED|Overall Study||81
11202141|NCT01838044|12392533|FG001|COMPLETED|Overall Study||75
11202142|NCT01838044|12392532|FG000|NOT COMPLETED|Overall Study||8
11202143|NCT01838044|12392533|FG001|NOT COMPLETED|Overall Study||16
11202144|NCT01838200|12392542|FG000|STARTED|Overall Study||3
11202145|NCT01838200|12392543|FG001|STARTED|Overall Study||2
11202146|NCT01838200|12392542|FG000|COMPLETED|Overall Study||0
11202147|NCT01838200|12392543|FG001|COMPLETED|Overall Study||0
11202148|NCT01838200|12392542|FG000|NOT COMPLETED|Overall Study||3
11202149|NCT01838200|12392543|FG001|NOT COMPLETED|Overall Study||2
11202150|NCT01838213|12392551|FG000|STARTED|Overall Study||247
11202151|NCT01838213|12392552|FG001|STARTED|Overall Study||453
11202152|NCT01838213|12392551|FG000|COMPLETED|Overall Study||81
11202153|NCT01838213|12392552|FG001|COMPLETED|Overall Study||262
11202154|NCT01838213|12392551|FG000|NOT COMPLETED|Overall Study||166
11202155|NCT01838213|12392552|FG001|NOT COMPLETED|Overall Study||191
11126066|NCT01370005|12311864|FG000|STARTED|Overall Study||272
11126067|NCT01370005|12311865|FG001|STARTED|Overall Study||276
11126068|NCT01370005|12311866|FG002|STARTED|Overall Study||277
11126069|NCT01370005|12311864|FG000|COMPLETED|Overall Study||256
11126070|NCT01370005|12311865|FG001|COMPLETED|Overall Study||265
11126071|NCT01370005|12311866|FG002|COMPLETED|Overall Study||266
11126072|NCT01370005|12311864|FG000|NOT COMPLETED|Overall Study||16
11126073|NCT01370005|12311865|FG001|NOT COMPLETED|Overall Study||11
11126074|NCT01370005|12311866|FG002|NOT COMPLETED|Overall Study||11
11126075|NCT01370018|12311874|FG000|STARTED|Overall Study||4
11126076|NCT01370018|12311874|FG000|COMPLETED|Overall Study||3
11126077|NCT01370018|12311874|FG000|NOT COMPLETED|Overall Study||1
11126078|NCT01370083|12311880|FG000|STARTED|Overall Study||7
11126079|NCT01370083|12311881|FG001|STARTED|Overall Study||7
11126080|NCT01370083|12311880|FG000|COMPLETED|Overall Study||5
11126081|NCT01370083|12311881|FG001|COMPLETED|Overall Study||6
11126082|NCT01370083|12311880|FG000|NOT COMPLETED|Overall Study||2
11126083|NCT01370083|12311881|FG001|NOT COMPLETED|Overall Study||1
11126084|NCT01370174|12311891|FG000|STARTED|Overall Study||25
11126085|NCT01370174|12311892|FG001|STARTED|Overall Study||26
11126086|NCT01370174|12311893|FG002|STARTED|Overall Study||25
11126087|NCT01370174|12311894|FG003|STARTED|Overall Study||26
11126088|NCT01370174|12311891|FG000|COMPLETED|Overall Study||18
11126089|NCT01370174|12311892|FG001|COMPLETED|Overall Study||15
11126090|NCT01370174|12311893|FG002|COMPLETED|Overall Study||13
11126091|NCT01370174|12311894|FG003|COMPLETED|Overall Study||17
11126092|NCT01370174|12311891|FG000|NOT COMPLETED|Overall Study||7
11126093|NCT01370174|12311892|FG001|NOT COMPLETED|Overall Study||11
11126094|NCT01370174|12311893|FG002|NOT COMPLETED|Overall Study||12
11126095|NCT01370174|12311894|FG003|NOT COMPLETED|Overall Study||9
11126096|NCT01370213|12311907|FG000|STARTED|Overall Study||7
11126097|NCT01370213|12311908|FG001|STARTED|Overall Study||17
11126098|NCT01370213|12311909|FG002|STARTED|Overall Study||1
11126099|NCT01370213|12311907|FG000|COMPLETED|Overall Study||6
11126100|NCT01370213|12311908|FG001|COMPLETED|Overall Study||15
11126101|NCT01370213|12311909|FG002|COMPLETED|Overall Study||1
11126102|NCT01370213|12311907|FG000|NOT COMPLETED|Overall Study||1
11126103|NCT01370213|12311908|FG001|NOT COMPLETED|Overall Study||2
11126104|NCT01370213|12311909|FG002|NOT COMPLETED|Overall Study||0
11126105|NCT01370265|12311916|FG000|STARTED|Resting Myocardial Blood Flow (MBF)||6
11126106|NCT01370265|12311917|FG001|STARTED|Resting Myocardial Blood Flow (MBF)||6
11126107|NCT01370265|12311916|FG000|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
11126108|NCT01370265|12311917|FG001|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
11126109|NCT01370265|12311916|FG000|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
11126110|NCT01370265|12311917|FG001|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
11126111|NCT01370265|12311916|FG000|STARTED|Washout Period (50-minute Period Decay)||6
11126112|NCT01370265|12311917|FG001|STARTED|Washout Period (50-minute Period Decay)||6
11126113|NCT01370265|12311916|FG000|COMPLETED|Washout Period (50-minute Period Decay)||6
11126114|NCT01370265|12311917|FG001|COMPLETED|Washout Period (50-minute Period Decay)||6
11126115|NCT01370265|12311916|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
11126116|NCT01370265|12311917|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
11126117|NCT01370265|12311916|FG000|STARTED|First Intervention||6
11126118|NCT01370265|12311917|FG001|STARTED|First Intervention||6
11126119|NCT01370265|12311916|FG000|COMPLETED|First Intervention||5
11126120|NCT01370265|12311917|FG001|COMPLETED|First Intervention||5
11126121|NCT01370265|12311916|FG000|NOT COMPLETED|First Intervention||1
11126122|NCT01370265|12311917|FG001|NOT COMPLETED|First Intervention||1
11126123|NCT01370265|12311916|FG000|STARTED|Washout Period (50-minute Period Decay)||5
11126124|NCT01370265|12311917|FG001|STARTED|Washout Period (50-minute Period Decay)||5
11126125|NCT01370265|12311916|FG000|COMPLETED|Washout Period (50-minute Period Decay)||5
11126126|NCT01370265|12311917|FG001|COMPLETED|Washout Period (50-minute Period Decay)||5
11126127|NCT01370265|12311916|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
11126128|NCT01370265|12311917|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
11126129|NCT01370265|12311916|FG000|STARTED|Second Intervention||5
11126130|NCT01370265|12311917|FG001|STARTED|Second Intervention||5
11126131|NCT01370265|12311916|FG000|COMPLETED|Second Intervention||5
11126132|NCT01370265|12311917|FG001|COMPLETED|Second Intervention||5
11126133|NCT01370265|12311916|FG000|NOT COMPLETED|Second Intervention||0
11126134|NCT01370265|12311917|FG001|NOT COMPLETED|Second Intervention||0
11126135|NCT01370317|12311926|FG000|STARTED|Overall Study||18
11126136|NCT01370317|12311927|FG001|STARTED|Overall Study||9
11126137|NCT01370317|12311926|FG000|COMPLETED|Overall Study||17
11126138|NCT01370317|12311927|FG001|COMPLETED|Overall Study||8
11126139|NCT01370317|12311926|FG000|NOT COMPLETED|Overall Study||1
11126140|NCT01370317|12311927|FG001|NOT COMPLETED|Overall Study||1
11126141|NCT01370356|12311935|FG000|STARTED|Overall Study||751
11126142|NCT01370356|12311936|FG001|STARTED|Overall Study||742
11126143|NCT01370356|12311935|FG000|COMPLETED|Overall Study||559
11126144|NCT01370356|12311936|FG001|COMPLETED|Overall Study||515
11126145|NCT01370356|12311935|FG000|NOT COMPLETED|Overall Study||192
11126146|NCT01370356|12311936|FG001|NOT COMPLETED|Overall Study||227
11126147|NCT01370369|12311942|FG000|STARTED|Overall Study||20
11126148|NCT01370369|12311942|FG000|COMPLETED|Overall Study||20
11126149|NCT01370369|12311942|FG000|NOT COMPLETED|Overall Study||0
11126150|NCT01370408|12311955|FG000|STARTED|Overall Study||85
11126151|NCT01370408|12311955|FG000|COMPLETED|Overall Study||76
11126152|NCT01370408|12311955|FG000|NOT COMPLETED|Overall Study||9
11126153|NCT01370460|12311961|FG000|STARTED|Overall Study||50
11126154|NCT01370460|12311962|FG001|STARTED|Overall Study||51
11126155|NCT01370460|12311961|FG000|COMPLETED|Overall Study||50
11126156|NCT01370460|12311962|FG001|COMPLETED|Overall Study||51
11126157|NCT01370460|12311961|FG000|NOT COMPLETED|Overall Study||0
11126158|NCT01370460|12311962|FG001|NOT COMPLETED|Overall Study||0
11126159|NCT01370499|12311971|FG000|STARTED|Overall Study||195
11126160|NCT01370499|12311972|FG001|STARTED|Overall Study||93
11126161|NCT01370499|12311971|FG000|Entered Abrupt Discontinuation Phase|Overall Study||188
11126162|NCT01370499|12311972|FG001|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
11126163|NCT01370499|12311971|FG000|Received at Least 1 Dose of Study Drug|Overall Study||195
11126164|NCT01370499|12311972|FG001|Received at Least 1 Dose of Study Drug|Overall Study||92
11126165|NCT01370499|12311971|FG000|COMPLETED|Overall Study||84
11126166|NCT01370499|12311972|FG001|COMPLETED|Overall Study||49
11126167|NCT01370499|12311971|FG000|NOT COMPLETED|Overall Study||111
11126168|NCT01370499|12311972|FG001|NOT COMPLETED|Overall Study||44
11126169|NCT01370525|12311982|FG000|STARTED|Overall Study||171
11126170|NCT01370525|12311983|FG001|STARTED|Overall Study||169
11126171|NCT01370525|12311982|FG000|Patients Who Received Treatment|Overall Study||168
11126172|NCT01370525|12311983|FG001|Patients Who Received Treatment|Overall Study||163
11126173|NCT01370525|12311982|FG000|Patients Who Completed Treatment|Overall Study||163
11126174|NCT01370525|12311983|FG001|Patients Who Completed Treatment|Overall Study||158
11126175|NCT01370525|12311982|FG000|COMPLETED|Overall Study||163
11126176|NCT01370525|12311983|FG001|COMPLETED|Overall Study||158
11126177|NCT01370525|12311982|FG000|NOT COMPLETED|Overall Study||8
11126178|NCT01370525|12311983|FG001|NOT COMPLETED|Overall Study||11
11126179|NCT01370538|12311991|FG000|STARTED|Overall Study||170
11126180|NCT01370538|12311992|FG001|STARTED|Overall Study||171
11126181|NCT01370538|12311991|FG000|Patients Who Received Treatment|Overall Study||165
11126182|NCT01370538|12311992|FG001|Patients Who Received Treatment|Overall Study||161
11126183|NCT01370538|12311991|FG000|Patients Who Completed Treatment|Overall Study||151
11126184|NCT01370538|12311992|FG001|Patients Who Completed Treatment|Overall Study||152
11126185|NCT01370538|12311991|FG000|COMPLETED|Overall Study||151
11126186|NCT01370538|12311992|FG001|COMPLETED|Overall Study||152
11126187|NCT01370538|12311991|FG000|NOT COMPLETED|Overall Study||19
11126188|NCT01370538|12311992|FG001|NOT COMPLETED|Overall Study||19
11126189|NCT01370564|12311998|FG000|STARTED|Overall Study||21
11126190|NCT01370564|12311998|FG000|COMPLETED|Overall Study||21
11126191|NCT01370564|12311998|FG000|NOT COMPLETED|Overall Study||0
11126192|NCT01370616|12312004|FG000|STARTED|Overall Study|Participants randomized|282
11126193|NCT01370616|12312005|FG001|STARTED|Overall Study|Participants randomized|283
11126194|NCT01370616|12312004|FG000|Treated|Overall Study||275
11126195|NCT01370616|12312005|FG001|Treated|Overall Study||275
11126196|NCT01370616|12312004|FG000|COMPLETED|Overall Study||220
11126197|NCT01370616|12312005|FG001|COMPLETED|Overall Study||216
11126198|NCT01370616|12312004|FG000|NOT COMPLETED|Overall Study||62
11126199|NCT01370616|12312005|FG001|NOT COMPLETED|Overall Study||67
11126200|NCT01370629|12312011|FG000|STARTED|Overall Study||2015
11126201|NCT01370629|12312011|FG000|COMPLETED|Overall Study||2009
11126202|NCT01370629|12312011|FG000|NOT COMPLETED|Overall Study||6
11126203|NCT01370642|12312018|FG000|STARTED|Overall Study||98
11126204|NCT01370642|12312019|FG001|STARTED|Overall Study||98
11126205|NCT01370642|12312020|FG002|STARTED|Overall Study||98
11126206|NCT01370642|12312018|FG000|FAS Population|Overall Study||98
11126207|NCT01370642|12312019|FG001|FAS Population|Overall Study||97
11126208|NCT01370642|12312020|FG002|FAS Population|Overall Study||98
11126209|NCT01370642|12312018|FG000|COMPLETED|Overall Study||90
11126210|NCT01370642|12312019|FG001|COMPLETED|Overall Study||92
11126211|NCT01370642|12312020|FG002|COMPLETED|Overall Study||69
11126212|NCT01370642|12312018|FG000|NOT COMPLETED|Overall Study||8
11126213|NCT01370642|12312019|FG001|NOT COMPLETED|Overall Study||6
11126214|NCT01370642|12312020|FG002|NOT COMPLETED|Overall Study||29
11126215|NCT01370655|12312040|FG000|STARTED|Period 1||7
11126216|NCT01370655|12312041|FG001|STARTED|Period 1||7
11126217|NCT01370655|12312042|FG002|STARTED|Period 1||3
11126218|NCT01370655|12312043|FG003|STARTED|Period 1||3
11126219|NCT01370655|12312044|FG004|STARTED|Period 1||3
11126220|NCT01370655|12312045|FG005|STARTED|Period 1||4
11126221|NCT01370655|12312046|FG006|STARTED|Period 1||4
11126222|NCT01370655|12312047|FG007|STARTED|Period 1||4
11126223|NCT01370655|12312048|FG008|STARTED|Period 1||3
11126224|NCT01370655|12312049|FG009|STARTED|Period 1||2
11126225|NCT01370655|12312050|FG010|STARTED|Period 1||3
11126226|NCT01370655|12312051|FG011|STARTED|Period 1||3
11126227|NCT01370655|12312040|FG000|COMPLETED|Period 1||5
11126228|NCT01370655|12312041|FG001|COMPLETED|Period 1||7
11126229|NCT01370655|12312042|FG002|COMPLETED|Period 1||3
11126230|NCT01370655|12312043|FG003|COMPLETED|Period 1||3
11126231|NCT01370655|12312044|FG004|COMPLETED|Period 1||3
11126232|NCT01370655|12312045|FG005|COMPLETED|Period 1||4
11126233|NCT01370655|12312046|FG006|COMPLETED|Period 1||3
11126234|NCT01370655|12312047|FG007|COMPLETED|Period 1||4
11126235|NCT01370655|12312048|FG008|COMPLETED|Period 1||3
11126236|NCT01370655|12312049|FG009|COMPLETED|Period 1||2
11126237|NCT01370655|12312050|FG010|COMPLETED|Period 1||3
11126238|NCT01370655|12312051|FG011|COMPLETED|Period 1||3
11126239|NCT01370655|12312040|FG000|NOT COMPLETED|Period 1||2
11126240|NCT01370655|12312041|FG001|NOT COMPLETED|Period 1||0
11126241|NCT01370655|12312042|FG002|NOT COMPLETED|Period 1||0
11126242|NCT01370655|12312043|FG003|NOT COMPLETED|Period 1||0
11126243|NCT01370655|12312044|FG004|NOT COMPLETED|Period 1||0
11126244|NCT01370655|12312045|FG005|NOT COMPLETED|Period 1||0
11126245|NCT01370655|12312046|FG006|NOT COMPLETED|Period 1||1
11126246|NCT01370655|12312047|FG007|NOT COMPLETED|Period 1||0
11126247|NCT01370655|12312048|FG008|NOT COMPLETED|Period 1||0
11126248|NCT01370655|12312049|FG009|NOT COMPLETED|Period 1||0
11126249|NCT01370655|12312050|FG010|NOT COMPLETED|Period 1||0
11126250|NCT01370655|12312051|FG011|NOT COMPLETED|Period 1||0
11126251|NCT01370655|12312040|FG000|STARTED|Period 2||5
11126252|NCT01370655|12312041|FG001|STARTED|Period 2||7
11126253|NCT01370655|12312042|FG002|STARTED|Period 2||3
11126254|NCT01370655|12312043|FG003|STARTED|Period 2||3
11126255|NCT01370655|12312044|FG004|STARTED|Period 2||3
11126256|NCT01370655|12312045|FG005|STARTED|Period 2||4
11126257|NCT01370655|12312046|FG006|STARTED|Period 2||3
11126258|NCT01370655|12312047|FG007|STARTED|Period 2||4
11126259|NCT01370655|12312048|FG008|STARTED|Period 2||3
11126260|NCT01370655|12312049|FG009|STARTED|Period 2||2
11126261|NCT01370655|12312050|FG010|STARTED|Period 2||3
11126262|NCT01370655|12312051|FG011|STARTED|Period 2||3
11126263|NCT01370655|12312040|FG000|COMPLETED|Period 2||5
11126264|NCT01370655|12312041|FG001|COMPLETED|Period 2||7
11126265|NCT01370655|12312042|FG002|COMPLETED|Period 2||1
11126266|NCT01370655|12312043|FG003|COMPLETED|Period 2||3
11126267|NCT01370655|12312044|FG004|COMPLETED|Period 2||2
11126268|NCT01370655|12312045|FG005|COMPLETED|Period 2||4
11126269|NCT01370655|12312046|FG006|COMPLETED|Period 2||2
11126270|NCT01370655|12312047|FG007|COMPLETED|Period 2||3
11126271|NCT01370655|12312048|FG008|COMPLETED|Period 2||1
11126272|NCT01370655|12312049|FG009|COMPLETED|Period 2||2
11126273|NCT01370655|12312050|FG010|COMPLETED|Period 2||2
11126274|NCT01370655|12312051|FG011|COMPLETED|Period 2||3
11126275|NCT01370655|12312040|FG000|NOT COMPLETED|Period 2||0
11126276|NCT01370655|12312041|FG001|NOT COMPLETED|Period 2||0
11126277|NCT01370655|12312042|FG002|NOT COMPLETED|Period 2||2
11126278|NCT01370655|12312043|FG003|NOT COMPLETED|Period 2||0
11126279|NCT01370655|12312044|FG004|NOT COMPLETED|Period 2||1
11126280|NCT01370655|12312045|FG005|NOT COMPLETED|Period 2||0
11126281|NCT01370655|12312046|FG006|NOT COMPLETED|Period 2||1
11126282|NCT01370655|12312047|FG007|NOT COMPLETED|Period 2||1
11126283|NCT01370655|12312048|FG008|NOT COMPLETED|Period 2||2
11126284|NCT01370655|12312049|FG009|NOT COMPLETED|Period 2||0
11126285|NCT01370655|12312050|FG010|NOT COMPLETED|Period 2||1
11126286|NCT01370655|12312051|FG011|NOT COMPLETED|Period 2||0
11126287|NCT01370694|12312061|FG000|STARTED|Overall Study||7
11126288|NCT01370694|12312061|FG000|COMPLETED|Overall Study||1
11126289|NCT01370694|12312061|FG000|NOT COMPLETED|Overall Study||6
11126290|NCT01370733|12312067|FG000|STARTED|Overall Study||103
11126291|NCT01370733|12312068|FG001|STARTED|Overall Study||99
11126292|NCT01370733|12312067|FG000|COMPLETED|Overall Study||86
11126293|NCT01370733|12312068|FG001|COMPLETED|Overall Study||77
11126294|NCT01370733|12312067|FG000|NOT COMPLETED|Overall Study||17
11126295|NCT01370733|12312068|FG001|NOT COMPLETED|Overall Study||22
11126296|NCT01370837|12312077|FG000|STARTED|Overall Study||12
11126297|NCT01370837|12312078|FG001|STARTED|Overall Study||12
11126298|NCT01370837|12312079|FG002|STARTED|Overall Study||17
11126299|NCT01370837|12312077|FG000|COMPLETED|Overall Study||12
11126300|NCT01370837|12312078|FG001|COMPLETED|Overall Study||12
11126301|NCT01370837|12312079|FG002|COMPLETED|Overall Study||17
11126302|NCT01370837|12312077|FG000|NOT COMPLETED|Overall Study||0
11126303|NCT01370837|12312078|FG001|NOT COMPLETED|Overall Study||0
11126304|NCT01370837|12312079|FG002|NOT COMPLETED|Overall Study||0
11126305|NCT01370863|12312089|FG000|STARTED|Overall Study||34
11126306|NCT01370863|12312090|FG001|STARTED|Overall Study||33
11126307|NCT01370863|12312089|FG000|COMPLETED|Overall Study||32
11126308|NCT01370863|12312090|FG001|COMPLETED|Overall Study||30
11126309|NCT01370863|12312089|FG000|NOT COMPLETED|Overall Study||2
11126310|NCT01370863|12312090|FG001|NOT COMPLETED|Overall Study||3
11126311|NCT01371006|12312098|FG000|STARTED|Overall Study||14
11126312|NCT01371006|12312099|FG001|STARTED|Overall Study||15
11126313|NCT01371006|12312098|FG000|COMPLETED|Overall Study||13
11126314|NCT01371006|12312099|FG001|COMPLETED|Overall Study||15
11126315|NCT01371006|12312098|FG000|NOT COMPLETED|Overall Study||1
11126316|NCT01371006|12312099|FG001|NOT COMPLETED|Overall Study||0
11126317|NCT01371032|12312127|FG000|STARTED|Overall Study||14
11126318|NCT01371032|12312128|FG001|STARTED|Overall Study||14
11126319|NCT01371032|12312127|FG000|COMPLETED|Overall Study||14
11126320|NCT01371032|12312128|FG001|COMPLETED|Overall Study||14
11126321|NCT01371032|12312127|FG000|NOT COMPLETED|Overall Study||0
11126322|NCT01371032|12312128|FG001|NOT COMPLETED|Overall Study||0
11126323|NCT01371110|12312138|FG000|STARTED|Overall Study||1
11126324|NCT01371110|12312139|FG001|STARTED|Overall Study||2
11126325|NCT01371110|12312138|FG000|COMPLETED|Overall Study||1
11126326|NCT01371110|12312139|FG001|COMPLETED|Overall Study||2
11239090|NCT02079636|12431037|FG010|Received at Least One Dose of Study Drug|Overall Study||10
11239091|NCT02079636|12431038|FG011|Received at Least One Dose of Study Drug|Overall Study||6
11239092|NCT02079636|12431039|FG012|Received at Least One Dose of Study Drug|Overall Study||8
11239093|NCT02079636|12431040|FG013|Received at Least One Dose of Study Drug|Overall Study||3
11239094|NCT02079636|12431041|FG014|Received at Least One Dose of Study Drug|Overall Study||17
11239095|NCT02079636|12431027|FG000|COMPLETED|Overall Study||5
11126327|NCT01371110|12312138|FG000|NOT COMPLETED|Overall Study||0
11126328|NCT01371110|12312139|FG001|NOT COMPLETED|Overall Study||0
11126329|NCT01371539|12312145|FG000|STARTED|Period One: One Week||53
11126330|NCT01371539|12312146|FG001|STARTED|Period One: One Week||51
11126331|NCT01371539|12312145|FG000|COMPLETED|Period One: One Week||53
11126332|NCT01371539|12312146|FG001|COMPLETED|Period One: One Week||50
11239096|NCT02079636|12431028|FG001|COMPLETED|Overall Study||13
11239097|NCT02079636|12431029|FG002|COMPLETED|Overall Study||3
11239098|NCT02079636|12431030|FG003|COMPLETED|Overall Study||9
11239099|NCT02079636|12431031|FG004|COMPLETED|Overall Study||2
11239100|NCT02079636|12431032|FG005|COMPLETED|Overall Study||13
11239101|NCT02079636|12431033|FG006|COMPLETED|Overall Study||11
11239102|NCT02079636|12431034|FG007|COMPLETED|Overall Study||3
11239103|NCT02079636|12431035|FG008|COMPLETED|Overall Study||3
11239104|NCT02079636|12431036|FG009|COMPLETED|Overall Study||6
11239105|NCT02079636|12431037|FG010|COMPLETED|Overall Study||8
11239106|NCT02079636|12431038|FG011|COMPLETED|Overall Study||4
11239107|NCT02079636|12431039|FG012|COMPLETED|Overall Study||5
11239108|NCT02079636|12431040|FG013|COMPLETED|Overall Study||3
11126333|NCT01371539|12312145|FG000|NOT COMPLETED|Period One: One Week||0
11126334|NCT01371539|12312146|FG001|NOT COMPLETED|Period One: One Week||1
11126335|NCT01371539|12312145|FG000|STARTED|Period Two: One Week||53
11126336|NCT01371539|12312146|FG001|STARTED|Period Two: One Week||50
11126337|NCT01371539|12312145|FG000|COMPLETED|Period Two: One Week||53
11126338|NCT01371539|12312146|FG001|COMPLETED|Period Two: One Week||47
11126339|NCT01371539|12312145|FG000|NOT COMPLETED|Period Two: One Week||0
11126340|NCT01371539|12312146|FG001|NOT COMPLETED|Period Two: One Week||3
11239109|NCT02079636|12431041|FG014|COMPLETED|Overall Study||12
11126341|NCT01371552|12312152|FG000|STARTED|Part 1, First 3 Days||19
11126342|NCT01371552|12312153|FG001|STARTED|Part 1, First 3 Days||17
11126343|NCT01371552|12312154|FG002|STARTED|Part 1, First 3 Days||20
11126344|NCT01371552|12312155|FG003|STARTED|Part 1, First 3 Days||20
11126345|NCT01371552|12312156|FG004|STARTED|Part 1, First 3 Days||15
11126346|NCT01371552|12312157|FG005|STARTED|Part 1, First 3 Days||18
11126347|NCT01371552|12312152|FG000|COMPLETED|Part 1, First 3 Days||19
11126348|NCT01371552|12312153|FG001|COMPLETED|Part 1, First 3 Days||17
11126349|NCT01371552|12312154|FG002|COMPLETED|Part 1, First 3 Days||19
11126350|NCT01371552|12312155|FG003|COMPLETED|Part 1, First 3 Days||20
11126351|NCT01371552|12312156|FG004|COMPLETED|Part 1, First 3 Days||15
11126352|NCT01371552|12312157|FG005|COMPLETED|Part 1, First 3 Days||18
11126353|NCT01371552|12312152|FG000|NOT COMPLETED|Part 1, First 3 Days||0
11126354|NCT01371552|12312153|FG001|NOT COMPLETED|Part 1, First 3 Days||0
11126355|NCT01371552|12312154|FG002|NOT COMPLETED|Part 1, First 3 Days||1
11126356|NCT01371552|12312155|FG003|NOT COMPLETED|Part 1, First 3 Days||0
11126357|NCT01371552|12312156|FG004|NOT COMPLETED|Part 1, First 3 Days||0
11126358|NCT01371552|12312157|FG005|NOT COMPLETED|Part 1, First 3 Days||0
11126359|NCT01371552|12312152|FG000|STARTED|Part 1, Second 3 Days||19
11126360|NCT01371552|12312153|FG001|STARTED|Part 1, Second 3 Days||17
11126361|NCT01371552|12312154|FG002|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
11126362|NCT01371552|12312155|FG003|STARTED|Part 1, Second 3 Days||20
11126363|NCT01371552|12312156|FG004|STARTED|Part 1, Second 3 Days||15
11126364|NCT01371552|12312157|FG005|STARTED|Part 1, Second 3 Days||18
11126365|NCT01371552|12312152|FG000|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
11126366|NCT01371552|12312153|FG001|COMPLETED|Part 1, Second 3 Days||17
11126367|NCT01371552|12312154|FG002|COMPLETED|Part 1, Second 3 Days||18
11126368|NCT01371552|12312155|FG003|COMPLETED|Part 1, Second 3 Days||20
11126369|NCT01371552|12312156|FG004|COMPLETED|Part 1, Second 3 Days||15
11126370|NCT01371552|12312157|FG005|COMPLETED|Part 1, Second 3 Days||18
11126371|NCT01371552|12312152|FG000|NOT COMPLETED|Part 1, Second 3 Days||1
11126372|NCT01371552|12312153|FG001|NOT COMPLETED|Part 1, Second 3 Days||0
11126373|NCT01371552|12312154|FG002|NOT COMPLETED|Part 1, Second 3 Days||0
11126374|NCT01371552|12312155|FG003|NOT COMPLETED|Part 1, Second 3 Days||0
11126375|NCT01371552|12312156|FG004|NOT COMPLETED|Part 1, Second 3 Days||0
11126376|NCT01371552|12312157|FG005|NOT COMPLETED|Part 1, Second 3 Days||0
11126377|NCT01371552|12312152|FG000|STARTED|Part 1, Third 3 Days||19
11126378|NCT01371552|12312153|FG001|STARTED|Part 1, Third 3 Days||17
11126379|NCT01371552|12312154|FG002|STARTED|Part 1, Third 3 Days||18
11126380|NCT01371552|12312155|FG003|STARTED|Part 1, Third 3 Days||20
11126381|NCT01371552|12312156|FG004|STARTED|Part 1, Third 3 Days||15
11126382|NCT01371552|12312157|FG005|STARTED|Part 1, Third 3 Days||18
11126383|NCT01371552|12312152|FG000|COMPLETED|Part 1, Third 3 Days||19
11126384|NCT01371552|12312153|FG001|COMPLETED|Part 1, Third 3 Days||17
11126385|NCT01371552|12312154|FG002|COMPLETED|Part 1, Third 3 Days||18
11126386|NCT01371552|12312155|FG003|COMPLETED|Part 1, Third 3 Days||20
11126387|NCT01371552|12312156|FG004|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
11126388|NCT01371552|12312157|FG005|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
11126389|NCT01371552|12312152|FG000|NOT COMPLETED|Part 1, Third 3 Days||0
11126390|NCT01371552|12312153|FG001|NOT COMPLETED|Part 1, Third 3 Days||0
11126391|NCT01371552|12312154|FG002|NOT COMPLETED|Part 1, Third 3 Days||0
11126392|NCT01371552|12312155|FG003|NOT COMPLETED|Part 1, Third 3 Days||0
11126393|NCT01371552|12312156|FG004|NOT COMPLETED|Part 1, Third 3 Days||1
11126394|NCT01371552|12312157|FG005|NOT COMPLETED|Part 1, Third 3 Days||1
11126395|NCT01371552|12312152|FG000|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
11126396|NCT01371552|12312153|FG001|STARTED|Part 2, One Week||17
11126397|NCT01371552|12312154|FG002|STARTED|Part 2, One Week||18
11126398|NCT01371552|12312155|FG003|STARTED|Part 2, One Week||20
11126399|NCT01371552|12312156|FG004|STARTED|Part 2, One Week||15
11126400|NCT01371552|12312157|FG005|STARTED|Part 2, One Week||18
11126401|NCT01371552|12312152|FG000|COMPLETED|Part 2, One Week||18
11126402|NCT01371552|12312153|FG001|COMPLETED|Part 2, One Week||17
11126403|NCT01371552|12312154|FG002|COMPLETED|Part 2, One Week||18
11126404|NCT01371552|12312155|FG003|COMPLETED|Part 2, One Week||20
11126405|NCT01371552|12312156|FG004|COMPLETED|Part 2, One Week||15
11126406|NCT01371552|12312157|FG005|COMPLETED|Part 2, One Week||18
11126407|NCT01371552|12312152|FG000|NOT COMPLETED|Part 2, One Week||0
11126408|NCT01371552|12312153|FG001|NOT COMPLETED|Part 2, One Week||0
11126409|NCT01371552|12312154|FG002|NOT COMPLETED|Part 2, One Week||0
11126410|NCT01371552|12312155|FG003|NOT COMPLETED|Part 2, One Week||0
11126411|NCT01371552|12312156|FG004|NOT COMPLETED|Part 2, One Week||0
11126412|NCT01371552|12312157|FG005|NOT COMPLETED|Part 2, One Week||0
11126413|NCT01371565|12312166|FG000|STARTED|Overall Study||4
11126414|NCT01371565|12312166|FG000|COMPLETED|Overall Study||1
11126415|NCT01371565|12312166|FG000|NOT COMPLETED|Overall Study||3
11126416|NCT01371643|12312172|FG000|STARTED|Overall Study||15
11126417|NCT01371643|12312173|FG001|STARTED|Overall Study||26
11126418|NCT01371643|12312172|FG000|COMPLETED|Overall Study||12
11126419|NCT01371643|12312173|FG001|COMPLETED|Overall Study||26
11126420|NCT01371643|12312172|FG000|NOT COMPLETED|Overall Study||3
11126421|NCT01371643|12312173|FG001|NOT COMPLETED|Overall Study||0
11126422|NCT01371656|12312181|FG000|STARTED|Overall Study||314
11126423|NCT01371656|12312182|FG001|STARTED|Overall Study||310
11126424|NCT01371656|12312181|FG000|COMPLETED|Overall Study||250
11126425|NCT01371656|12312182|FG001|COMPLETED|Overall Study||296
11126426|NCT01371656|12312181|FG000|NOT COMPLETED|Overall Study||64
11126427|NCT01371656|12312182|FG001|NOT COMPLETED|Overall Study||14
11126428|NCT01371708|12312191|FG000|STARTED|Overall Study||92
11126429|NCT01371708|12312192|FG001|STARTED|Overall Study||93
11126430|NCT01371708|12312193|FG002|STARTED|Overall Study||98
11126431|NCT01371708|12312191|FG000|Received Treatment|Overall Study||91
11126432|NCT01371708|12312192|FG001|Received Treatment|Overall Study||93
11126433|NCT01371708|12312193|FG002|Received Treatment|Overall Study||97
11126434|NCT01371708|12312191|FG000|COMPLETED|Overall Study||66
11126435|NCT01371708|12312192|FG001|COMPLETED|Overall Study||63
11126436|NCT01371708|12312193|FG002|COMPLETED|Overall Study||59
11126437|NCT01371708|12312191|FG000|NOT COMPLETED|Overall Study||26
11126438|NCT01371708|12312192|FG001|NOT COMPLETED|Overall Study||30
11126439|NCT01371708|12312193|FG002|NOT COMPLETED|Overall Study||39
11126440|NCT01371721|12312206|FG000|STARTED|Overall Study||88
11126441|NCT01371721|12312207|FG001|STARTED|Overall Study||89
11126442|NCT01371721|12312208|FG002|STARTED|Overall Study||92
11126443|NCT01371721|12312206|FG000|Treated|Overall Study||87
11126444|NCT01371721|12312207|FG001|Treated|Overall Study||89
11126445|NCT01371721|12312208|FG002|Treated|Overall Study||92
11126446|NCT01371721|12312206|FG000|COMPLETED|Overall Study||59
11126447|NCT01371721|12312207|FG001|COMPLETED|Overall Study||65
11126448|NCT01371721|12312208|FG002|COMPLETED|Overall Study||62
11126449|NCT01371721|12312206|FG000|NOT COMPLETED|Overall Study||29
11126450|NCT01371721|12312207|FG001|NOT COMPLETED|Overall Study||24
11126451|NCT01371721|12312208|FG002|NOT COMPLETED|Overall Study||30
11126452|NCT01371734|12312221|FG000|STARTED|Overall Study||120
11126453|NCT01371734|12312222|FG001|STARTED|Overall Study||122
11126454|NCT01371734|12312223|FG002|STARTED|Overall Study||121
11126455|NCT01371734|12312221|FG000|COMPLETED|Overall Study||97
11126456|NCT01371734|12312222|FG001|COMPLETED|Overall Study||103
11126457|NCT01371734|12312223|FG002|COMPLETED|Overall Study||104
11126458|NCT01371734|12312221|FG000|NOT COMPLETED|Overall Study||23
11126459|NCT01371734|12312222|FG001|NOT COMPLETED|Overall Study||19
11126460|NCT01371734|12312223|FG002|NOT COMPLETED|Overall Study||17
11126461|NCT01371747|12312237|FG000|STARTED|Overall Study||74
11126462|NCT01371747|12312238|FG001|STARTED|Overall Study||74
11126463|NCT01371747|12312239|FG002|STARTED|Overall Study||74
11126464|NCT01371747|12312240|FG003|STARTED|Overall Study||26
11126465|NCT01371747|12312241|FG004|STARTED|Overall Study||28
11126466|NCT01371747|12312242|FG005|STARTED|Overall Study||30
11126467|NCT01371747|12312237|FG000|COMPLETED|Overall Study||56
11126468|NCT01371747|12312238|FG001|COMPLETED|Overall Study||51
11126469|NCT01371747|12312239|FG002|COMPLETED|Overall Study||50
11126470|NCT01371747|12312240|FG003|COMPLETED|Overall Study||17
11126471|NCT01371747|12312241|FG004|COMPLETED|Overall Study||21
11126472|NCT01371747|12312242|FG005|COMPLETED|Overall Study||16
11126473|NCT01371747|12312237|FG000|NOT COMPLETED|Overall Study||18
11239110|NCT02079636|12431027|FG000|NOT COMPLETED|Overall Study||3
11239111|NCT02079636|12431028|FG001|NOT COMPLETED|Overall Study||2
11239112|NCT02079636|12431029|FG002|NOT COMPLETED|Overall Study||0
11239113|NCT02079636|12431030|FG003|NOT COMPLETED|Overall Study||12
11239114|NCT02079636|12431031|FG004|NOT COMPLETED|Overall Study||2
11239115|NCT02079636|12431032|FG005|NOT COMPLETED|Overall Study||6
11239116|NCT02079636|12431033|FG006|NOT COMPLETED|Overall Study||1
11239117|NCT02079636|12431034|FG007|NOT COMPLETED|Overall Study||1
11239118|NCT02079636|12431035|FG008|NOT COMPLETED|Overall Study||0
11239119|NCT02079636|12431036|FG009|NOT COMPLETED|Overall Study||3
11239120|NCT02079636|12431037|FG010|NOT COMPLETED|Overall Study||2
11239121|NCT02079636|12431038|FG011|NOT COMPLETED|Overall Study||2
11239122|NCT02079636|12431039|FG012|NOT COMPLETED|Overall Study||3
11239123|NCT02079636|12431040|FG013|NOT COMPLETED|Overall Study||0
11239124|NCT02079636|12431041|FG014|NOT COMPLETED|Overall Study||5
11239125|NCT02079649|12431109|FG000|STARTED|Overall Study||42
11239126|NCT02079649|12431110|FG001|STARTED|Overall Study||41
11239127|NCT02079649|12431111|FG002|STARTED|Overall Study||41
11239128|NCT02079649|12431112|FG003|STARTED|Overall Study||40
11239129|NCT02079649|12431109|FG000|Treated|Overall Study||41
11239130|NCT02079649|12431110|FG001|Treated|Overall Study||41
11239131|NCT02079649|12431111|FG002|Treated|Overall Study||40
11239132|NCT02079649|12431112|FG003|Treated|Overall Study||40
11239133|NCT02079649|12431109|FG000|COMPLETED|Overall Study||41
11239134|NCT02079649|12431110|FG001|COMPLETED|Overall Study||41
11239135|NCT02079649|12431111|FG002|COMPLETED|Overall Study||40
11239136|NCT02079649|12431112|FG003|COMPLETED|Overall Study||38
11239137|NCT02079649|12431109|FG000|NOT COMPLETED|Overall Study||1
11239138|NCT02079649|12431110|FG001|NOT COMPLETED|Overall Study||0
11239139|NCT02079649|12431111|FG002|NOT COMPLETED|Overall Study||1
11239140|NCT02079649|12431112|FG003|NOT COMPLETED|Overall Study||2
11239141|NCT02079805|12431125|FG000|STARTED|Overall Study||16
11239142|NCT02079805|12431126|FG001|STARTED|Overall Study||17
11239143|NCT02079805|12431125|FG000|COMPLETED|Overall Study||16
11239144|NCT02079805|12431126|FG001|COMPLETED|Overall Study||15
11239145|NCT02079805|12431125|FG000|NOT COMPLETED|Overall Study||0
11126474|NCT01371747|12312238|FG001|NOT COMPLETED|Overall Study||23
11126475|NCT01371747|12312239|FG002|NOT COMPLETED|Overall Study||24
11126476|NCT01371747|12312240|FG003|NOT COMPLETED|Overall Study||9
11126477|NCT01371747|12312241|FG004|NOT COMPLETED|Overall Study||7
11126478|NCT01371747|12312242|FG005|NOT COMPLETED|Overall Study||14
11126479|NCT01371786|12312259|FG000|STARTED|Overall Study||7
11126480|NCT01371786|12312260|FG001|STARTED|Overall Study||7
11126481|NCT01371786|12312259|FG000|COMPLETED|Overall Study||7
11126482|NCT01371786|12312260|FG001|COMPLETED|Overall Study||7
11126483|NCT01371786|12312259|FG000|NOT COMPLETED|Overall Study||0
11126484|NCT01371786|12312260|FG001|NOT COMPLETED|Overall Study||0
11126485|NCT01371825|12312266|FG000|STARTED|Overall Study||9
11126486|NCT01371825|12312266|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9
11126487|NCT01371825|12312266|FG000|COMPLETED|Overall Study||5
11126488|NCT01371825|12312266|FG000|NOT COMPLETED|Overall Study||4
11126489|NCT01371838|12312272|FG000|STARTED|Overall Study||381
11126490|NCT01371838|12312273|FG001|STARTED|Overall Study||383
11126491|NCT01371838|12312272|FG000|COMPLETED|Overall Study||332
11126492|NCT01371838|12312273|FG001|COMPLETED|Overall Study||317
11126493|NCT01371838|12312272|FG000|NOT COMPLETED|Overall Study||49
11126494|NCT01371838|12312273|FG001|NOT COMPLETED|Overall Study||66
11126495|NCT01371851|12312281|FG000|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
11126496|NCT01371851|12312282|FG001|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
11126497|NCT01371851|12312281|FG000|COMPLETED|Overall Study||3
11126498|NCT01371851|12312282|FG001|COMPLETED|Overall Study||2
11126499|NCT01371851|12312281|FG000|NOT COMPLETED|Overall Study||8
11126500|NCT01371851|12312282|FG001|NOT COMPLETED|Overall Study||9
11126501|NCT01371877|12312290|FG000|STARTED|Overall Study||21
11126502|NCT01371877|12312291|FG001|STARTED|Overall Study||21
11126503|NCT01371877|12312290|FG000|COMPLETED|Overall Study||21
11126504|NCT01371877|12312291|FG001|COMPLETED|Overall Study||17
11126505|NCT01371877|12312290|FG000|NOT COMPLETED|Overall Study||0
11126506|NCT01371877|12312291|FG001|NOT COMPLETED|Overall Study||4
11126507|NCT01371994|12312299|FG000|STARTED|Overall Study||320
11126508|NCT01371994|12312300|FG001|STARTED|Overall Study||320
11126509|NCT01371994|12312299|FG000|Received Treatment|Overall Study||310
11126510|NCT01371994|12312300|FG001|Received Treatment|Overall Study||313
11126511|NCT01371994|12312299|FG000|COMPLETED|Overall Study||263
11126512|NCT01371994|12312300|FG001|COMPLETED|Overall Study||278
11126513|NCT01371994|12312299|FG000|NOT COMPLETED|Overall Study||57
11126514|NCT01371994|12312300|FG001|NOT COMPLETED|Overall Study||42
11126515|NCT01372085|12312316|FG000|STARTED|First Intervention (Period 1)||8
11126516|NCT01372085|12312317|FG001|STARTED|First Intervention (Period 1)||2
11126517|NCT01372085|12312318|FG002|STARTED|First Intervention (Period 1)||2
11126518|NCT01372085|12312319|FG003|STARTED|First Intervention (Period 1)||1
11126519|NCT01372085|12312320|FG004|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3
11126520|NCT01372085|12312321|FG005|STARTED|First Intervention (Period 1)||5
11126521|NCT01372085|12312322|FG006|STARTED|First Intervention (Period 1)||3
11126522|NCT01372085|12312323|FG007|STARTED|First Intervention (Period 1)||1
11126523|NCT01372085|12312324|FG008|STARTED|First Intervention (Period 1)||1
11126524|NCT01372085|12312325|FG009|STARTED|First Intervention (Period 1)||0
11126525|NCT01372085|12312316|FG000|COMPLETED|First Intervention (Period 1)||8
11126526|NCT01372085|12312317|FG001|COMPLETED|First Intervention (Period 1)||2
11126527|NCT01372085|12312318|FG002|COMPLETED|First Intervention (Period 1)||2
11126528|NCT01372085|12312319|FG003|COMPLETED|First Intervention (Period 1)||1
11126529|NCT01372085|12312320|FG004|COMPLETED|First Intervention (Period 1)||3
11126530|NCT01372085|12312321|FG005|COMPLETED|First Intervention (Period 1)||5
11126531|NCT01372085|12312322|FG006|COMPLETED|First Intervention (Period 1)||3
11126532|NCT01372085|12312323|FG007|COMPLETED|First Intervention (Period 1)||1
11126533|NCT01372085|12312324|FG008|COMPLETED|First Intervention (Period 1)||1
11126534|NCT01372085|12312325|FG009|COMPLETED|First Intervention (Period 1)||0
11126535|NCT01372085|12312316|FG000|NOT COMPLETED|First Intervention (Period 1)||0
11126536|NCT01372085|12312317|FG001|NOT COMPLETED|First Intervention (Period 1)||0
11126537|NCT01372085|12312318|FG002|NOT COMPLETED|First Intervention (Period 1)||0
11126538|NCT01372085|12312319|FG003|NOT COMPLETED|First Intervention (Period 1)||0
11126539|NCT01372085|12312320|FG004|NOT COMPLETED|First Intervention (Period 1)||0
11126540|NCT01372085|12312321|FG005|NOT COMPLETED|First Intervention (Period 1)||0
11126541|NCT01372085|12312322|FG006|NOT COMPLETED|First Intervention (Period 1)||0
11126542|NCT01372085|12312323|FG007|NOT COMPLETED|First Intervention (Period 1)||0
11126543|NCT01372085|12312324|FG008|NOT COMPLETED|First Intervention (Period 1)||0
11126544|NCT01372085|12312325|FG009|NOT COMPLETED|First Intervention (Period 1)||0
11126545|NCT01372085|12312316|FG000|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
11126546|NCT01372085|12312317|FG001|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
11126547|NCT01372085|12312318|FG002|STARTED|Washout Period 1||2
11126548|NCT01372085|12312319|FG003|STARTED|Washout Period 1||1
11126549|NCT01372085|12312320|FG004|STARTED|Washout Period 1||3
11126550|NCT01372085|12312321|FG005|STARTED|Washout Period 1||5
11126551|NCT01372085|12312322|FG006|STARTED|Washout Period 1||3
11126552|NCT01372085|12312323|FG007|STARTED|Washout Period 1||1
11126553|NCT01372085|12312324|FG008|STARTED|Washout Period 1||1
11126554|NCT01372085|12312325|FG009|STARTED|Washout Period 1||0
11126555|NCT01372085|12312316|FG000|COMPLETED|Washout Period 1||0
11126556|NCT01372085|12312317|FG001|COMPLETED|Washout Period 1||0
11126557|NCT01372085|12312318|FG002|COMPLETED|Washout Period 1||2
11126558|NCT01372085|12312319|FG003|COMPLETED|Washout Period 1||1
11126559|NCT01372085|12312320|FG004|COMPLETED|Washout Period 1||3
11126560|NCT01372085|12312321|FG005|COMPLETED|Washout Period 1||5
11126561|NCT01372085|12312322|FG006|COMPLETED|Washout Period 1||3
11126562|NCT01372085|12312323|FG007|COMPLETED|Washout Period 1||1
11126563|NCT01372085|12312324|FG008|COMPLETED|Washout Period 1||1
11126564|NCT01372085|12312325|FG009|COMPLETED|Washout Period 1||0
11126565|NCT01372085|12312316|FG000|NOT COMPLETED|Washout Period 1||0
11126566|NCT01372085|12312317|FG001|NOT COMPLETED|Washout Period 1||0
11126567|NCT01372085|12312318|FG002|NOT COMPLETED|Washout Period 1||0
11126568|NCT01372085|12312319|FG003|NOT COMPLETED|Washout Period 1||0
11126569|NCT01372085|12312320|FG004|NOT COMPLETED|Washout Period 1||0
11126570|NCT01372085|12312321|FG005|NOT COMPLETED|Washout Period 1||0
11126571|NCT01372085|12312322|FG006|NOT COMPLETED|Washout Period 1||0
11126572|NCT01372085|12312323|FG007|NOT COMPLETED|Washout Period 1||0
11126573|NCT01372085|12312324|FG008|NOT COMPLETED|Washout Period 1||0
11126574|NCT01372085|12312325|FG009|NOT COMPLETED|Washout Period 1||0
11126575|NCT01372085|12312316|FG000|STARTED|Second Intervention (Period 2)||0
11126576|NCT01372085|12312317|FG001|STARTED|Second Intervention (Period 2)||0
11126577|NCT01372085|12312318|FG002|STARTED|Second Intervention (Period 2)||2
11126578|NCT01372085|12312319|FG003|STARTED|Second Intervention (Period 2)||1
11126579|NCT01372085|12312320|FG004|STARTED|Second Intervention (Period 2)||3
11126580|NCT01372085|12312321|FG005|STARTED|Second Intervention (Period 2)||5
11126581|NCT01372085|12312322|FG006|STARTED|Second Intervention (Period 2)||3
11126582|NCT01372085|12312323|FG007|STARTED|Second Intervention (Period 2)||1
11126583|NCT01372085|12312324|FG008|STARTED|Second Intervention (Period 2)||1
11126584|NCT01372085|12312325|FG009|STARTED|Second Intervention (Period 2)||0
11126585|NCT01372085|12312316|FG000|COMPLETED|Second Intervention (Period 2)||0
11126586|NCT01372085|12312317|FG001|COMPLETED|Second Intervention (Period 2)||0
11126587|NCT01372085|12312318|FG002|COMPLETED|Second Intervention (Period 2)||2
11126588|NCT01372085|12312319|FG003|COMPLETED|Second Intervention (Period 2)||1
11126589|NCT01372085|12312320|FG004|COMPLETED|Second Intervention (Period 2)||3
11126590|NCT01372085|12312321|FG005|COMPLETED|Second Intervention (Period 2)||5
11126591|NCT01372085|12312322|FG006|COMPLETED|Second Intervention (Period 2)||3
11126592|NCT01372085|12312323|FG007|COMPLETED|Second Intervention (Period 2)||1
11126593|NCT01372085|12312324|FG008|COMPLETED|Second Intervention (Period 2)||1
11126594|NCT01372085|12312325|FG009|COMPLETED|Second Intervention (Period 2)||0
11126595|NCT01372085|12312316|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
11126596|NCT01372085|12312317|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
11126597|NCT01372085|12312318|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
11126598|NCT01372085|12312319|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
11126599|NCT01372085|12312320|FG004|NOT COMPLETED|Second Intervention (Period 2)||0
11126600|NCT01372085|12312321|FG005|NOT COMPLETED|Second Intervention (Period 2)||0
11126601|NCT01372085|12312322|FG006|NOT COMPLETED|Second Intervention (Period 2)||0
11126602|NCT01372085|12312323|FG007|NOT COMPLETED|Second Intervention (Period 2)||0
11126603|NCT01372085|12312324|FG008|NOT COMPLETED|Second Intervention (Period 2)||0
11126604|NCT01372085|12312325|FG009|NOT COMPLETED|Second Intervention (Period 2)||0
11126605|NCT01372085|12312316|FG000|STARTED|Washout Period 2||0
11126606|NCT01372085|12312317|FG001|STARTED|Washout Period 2||0
11126607|NCT01372085|12312318|FG002|STARTED|Washout Period 2||2
11126608|NCT01372085|12312319|FG003|STARTED|Washout Period 2||1
11126609|NCT01372085|12312320|FG004|STARTED|Washout Period 2||3
11126610|NCT01372085|12312321|FG005|STARTED|Washout Period 2||5
11126611|NCT01372085|12312322|FG006|STARTED|Washout Period 2||3
11126612|NCT01372085|12312323|FG007|STARTED|Washout Period 2||1
11126613|NCT01372085|12312324|FG008|STARTED|Washout Period 2||1
11126614|NCT01372085|12312325|FG009|STARTED|Washout Period 2||0
11126615|NCT01372085|12312316|FG000|COMPLETED|Washout Period 2||0
11126616|NCT01372085|12312317|FG001|COMPLETED|Washout Period 2||0
11126617|NCT01372085|12312318|FG002|COMPLETED|Washout Period 2||2
11126618|NCT01372085|12312319|FG003|COMPLETED|Washout Period 2||1
11126619|NCT01372085|12312320|FG004|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2
11126620|NCT01372085|12312321|FG005|COMPLETED|Washout Period 2||5
11126621|NCT01372085|12312322|FG006|COMPLETED|Washout Period 2||3
11126622|NCT01372085|12312323|FG007|COMPLETED|Washout Period 2||1
11126623|NCT01372085|12312324|FG008|COMPLETED|Washout Period 2||1
11126624|NCT01372085|12312325|FG009|COMPLETED|Washout Period 2||0
11126625|NCT01372085|12312316|FG000|NOT COMPLETED|Washout Period 2||0
11126626|NCT01372085|12312317|FG001|NOT COMPLETED|Washout Period 2||0
11126627|NCT01372085|12312318|FG002|NOT COMPLETED|Washout Period 2||0
11126628|NCT01372085|12312319|FG003|NOT COMPLETED|Washout Period 2||0
11126629|NCT01372085|12312320|FG004|NOT COMPLETED|Washout Period 2||1
11126630|NCT01372085|12312321|FG005|NOT COMPLETED|Washout Period 2||0
11126631|NCT01372085|12312322|FG006|NOT COMPLETED|Washout Period 2||0
11126632|NCT01372085|12312323|FG007|NOT COMPLETED|Washout Period 2||0
11126633|NCT01372085|12312324|FG008|NOT COMPLETED|Washout Period 2||0
11126634|NCT01372085|12312325|FG009|NOT COMPLETED|Washout Period 2||0
11126635|NCT01372085|12312316|FG000|STARTED|Third Intervention (Period 3)||0
11126636|NCT01372085|12312317|FG001|STARTED|Third Intervention (Period 3)||0
11126637|NCT01372085|12312318|FG002|STARTED|Third Intervention (Period 3)||2
11126638|NCT01372085|12312319|FG003|STARTED|Third Intervention (Period 3)||1
11126639|NCT01372085|12312320|FG004|STARTED|Third Intervention (Period 3)||2
11126640|NCT01372085|12312321|FG005|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7
11126641|NCT01372085|12312322|FG006|STARTED|Third Intervention (Period 3)||3
11126642|NCT01372085|12312323|FG007|STARTED|Third Intervention (Period 3)||1
11126643|NCT01372085|12312324|FG008|STARTED|Third Intervention (Period 3)||1
11126644|NCT01372085|12312325|FG009|STARTED|Third Intervention (Period 3)||0
11126645|NCT01372085|12312316|FG000|COMPLETED|Third Intervention (Period 3)||0
11126646|NCT01372085|12312317|FG001|COMPLETED|Third Intervention (Period 3)||0
11126647|NCT01372085|12312318|FG002|COMPLETED|Third Intervention (Period 3)||2
11126648|NCT01372085|12312319|FG003|COMPLETED|Third Intervention (Period 3)||1
11126649|NCT01372085|12312320|FG004|COMPLETED|Third Intervention (Period 3)||2
11126650|NCT01372085|12312321|FG005|COMPLETED|Third Intervention (Period 3)||7
11126651|NCT01372085|12312322|FG006|COMPLETED|Third Intervention (Period 3)||3
11126652|NCT01372085|12312323|FG007|COMPLETED|Third Intervention (Period 3)||1
11126653|NCT01372085|12312324|FG008|COMPLETED|Third Intervention (Period 3)||1
11126654|NCT01372085|12312325|FG009|COMPLETED|Third Intervention (Period 3)||0
11126655|NCT01372085|12312316|FG000|NOT COMPLETED|Third Intervention (Period 3)||0
11126656|NCT01372085|12312317|FG001|NOT COMPLETED|Third Intervention (Period 3)||0
11126657|NCT01372085|12312318|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
11126658|NCT01372085|12312319|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
11126659|NCT01372085|12312320|FG004|NOT COMPLETED|Third Intervention (Period 3)||0
11126660|NCT01372085|12312321|FG005|NOT COMPLETED|Third Intervention (Period 3)||0
11126661|NCT01372085|12312322|FG006|NOT COMPLETED|Third Intervention (Period 3)||0
11126662|NCT01372085|12312323|FG007|NOT COMPLETED|Third Intervention (Period 3)||0
11126663|NCT01372085|12312324|FG008|NOT COMPLETED|Third Intervention (Period 3)||0
11126664|NCT01372085|12312325|FG009|NOT COMPLETED|Third Intervention (Period 3)||0
11126665|NCT01372085|12312316|FG000|STARTED|Washout Period 3||0
11126666|NCT01372085|12312317|FG001|STARTED|Washout Period 3||0
11126667|NCT01372085|12312318|FG002|STARTED|Washout Period 3||2
11126668|NCT01372085|12312319|FG003|STARTED|Washout Period 3||1
11126669|NCT01372085|12312320|FG004|STARTED|Washout Period 3||2
11126670|NCT01372085|12312321|FG005|STARTED|Washout Period 3||7
11126671|NCT01372085|12312322|FG006|STARTED|Washout Period 3||3
11126672|NCT01372085|12312323|FG007|STARTED|Washout Period 3||1
11126673|NCT01372085|12312324|FG008|STARTED|Washout Period 3||1
11126674|NCT01372085|12312325|FG009|STARTED|Washout Period 3||0
11126675|NCT01372085|12312316|FG000|COMPLETED|Washout Period 3||0
11126676|NCT01372085|12312317|FG001|COMPLETED|Washout Period 3||0
11126677|NCT01372085|12312318|FG002|COMPLETED|Washout Period 3||2
11126678|NCT01372085|12312319|FG003|COMPLETED|Washout Period 3||1
11126679|NCT01372085|12312320|FG004|COMPLETED|Washout Period 3||2
11126680|NCT01372085|12312321|FG005|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5
11126681|NCT01372085|12312322|FG006|COMPLETED|Washout Period 3||3
11126682|NCT01372085|12312323|FG007|COMPLETED|Washout Period 3||1
11126683|NCT01372085|12312324|FG008|COMPLETED|Washout Period 3||1
11126684|NCT01372085|12312325|FG009|COMPLETED|Washout Period 3||0
11126685|NCT01372085|12312316|FG000|NOT COMPLETED|Washout Period 3||0
11126686|NCT01372085|12312317|FG001|NOT COMPLETED|Washout Period 3||0
11126687|NCT01372085|12312318|FG002|NOT COMPLETED|Washout Period 3||0
11126688|NCT01372085|12312319|FG003|NOT COMPLETED|Washout Period 3||0
11126689|NCT01372085|12312320|FG004|NOT COMPLETED|Washout Period 3||0
11126690|NCT01372085|12312321|FG005|NOT COMPLETED|Washout Period 3||2
11126691|NCT01372085|12312322|FG006|NOT COMPLETED|Washout Period 3||0
11126692|NCT01372085|12312323|FG007|NOT COMPLETED|Washout Period 3||0
11126693|NCT01372085|12312324|FG008|NOT COMPLETED|Washout Period 3||0
11126694|NCT01372085|12312325|FG009|NOT COMPLETED|Washout Period 3||0
11126695|NCT01372085|12312316|FG000|STARTED|Forth Intervention (Period 4a/4b)||0
11126696|NCT01372085|12312317|FG001|STARTED|Forth Intervention (Period 4a/4b)||0
11126697|NCT01372085|12312318|FG002|STARTED|Forth Intervention (Period 4a/4b)||2
11126698|NCT01372085|12312319|FG003|STARTED|Forth Intervention (Period 4a/4b)||1
11126699|NCT01372085|12312320|FG004|STARTED|Forth Intervention (Period 4a/4b)||2
11126700|NCT01372085|12312321|FG005|STARTED|Forth Intervention (Period 4a/4b)||5
11126701|NCT01372085|12312322|FG006|STARTED|Forth Intervention (Period 4a/4b)||3
11126702|NCT01372085|12312323|FG007|STARTED|Forth Intervention (Period 4a/4b)||1
11126703|NCT01372085|12312324|FG008|STARTED|Forth Intervention (Period 4a/4b)||1
11126704|NCT01372085|12312325|FG009|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1
11126705|NCT01372085|12312316|FG000|COMPLETED|Forth Intervention (Period 4a/4b)||0
11126706|NCT01372085|12312317|FG001|COMPLETED|Forth Intervention (Period 4a/4b)||0
11126707|NCT01372085|12312318|FG002|COMPLETED|Forth Intervention (Period 4a/4b)||2
11126708|NCT01372085|12312319|FG003|COMPLETED|Forth Intervention (Period 4a/4b)||1
11126709|NCT01372085|12312320|FG004|COMPLETED|Forth Intervention (Period 4a/4b)||2
11126710|NCT01372085|12312321|FG005|COMPLETED|Forth Intervention (Period 4a/4b)||5
11126711|NCT01372085|12312322|FG006|COMPLETED|Forth Intervention (Period 4a/4b)||3
11126712|NCT01372085|12312323|FG007|COMPLETED|Forth Intervention (Period 4a/4b)||1
11126713|NCT01372085|12312324|FG008|COMPLETED|Forth Intervention (Period 4a/4b)||1
11126714|NCT01372085|12312325|FG009|COMPLETED|Forth Intervention (Period 4a/4b)||1
11126715|NCT01372085|12312316|FG000|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
11126716|NCT01372085|12312317|FG001|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
11126717|NCT01372085|12312318|FG002|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
11126718|NCT01372085|12312319|FG003|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
11126719|NCT01372085|12312320|FG004|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
11126720|NCT01372085|12312321|FG005|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
11126721|NCT01372085|12312322|FG006|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
11126722|NCT01372085|12312323|FG007|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
11126723|NCT01372085|12312324|FG008|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
11126724|NCT01372085|12312325|FG009|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
11126725|NCT01372150|12312352|FG000|STARTED|Overall Study||112
11126726|NCT01372150|12312353|FG001|STARTED|Overall Study||113
11126727|NCT01372150|12312354|FG002|STARTED|Overall Study||115
11126728|NCT01372150|12312352|FG000|Treated|Overall Study||112
11126729|NCT01372150|12312353|FG001|Treated|Overall Study||112
11126730|NCT01372150|12312354|FG002|Treated|Overall Study||115
11126731|NCT01372150|12312352|FG000|COMPLETED|Overall Study||99
11126732|NCT01372150|12312353|FG001|COMPLETED|Overall Study||99
11126733|NCT01372150|12312354|FG002|COMPLETED|Overall Study||99
11126734|NCT01372150|12312352|FG000|NOT COMPLETED|Overall Study||13
11126735|NCT01372150|12312353|FG001|NOT COMPLETED|Overall Study||14
11126736|NCT01372150|12312354|FG002|NOT COMPLETED|Overall Study||16
11126737|NCT01372202|12312365|FG000|STARTED|Overall Study||13
11126738|NCT01372202|12312366|FG001|STARTED|Overall Study||9
11126739|NCT01372202|12312367|FG002|STARTED|Overall Study||9
11126740|NCT01372202|12312365|FG000|COMPLETED|Overall Study||13
11126741|NCT01372202|12312366|FG001|COMPLETED|Overall Study||9
11126742|NCT01372202|12312367|FG002|COMPLETED|Overall Study||9
11126743|NCT01372202|12312365|FG000|NOT COMPLETED|Overall Study||0
11126744|NCT01372202|12312366|FG001|NOT COMPLETED|Overall Study||0
11126745|NCT01372202|12312367|FG002|NOT COMPLETED|Overall Study||0
11126746|NCT01372384|12312380|FG000|STARTED|Overall Study||6
11126747|NCT01372384|12312380|FG000|COMPLETED|Overall Study||3
11126748|NCT01372384|12312380|FG000|NOT COMPLETED|Overall Study||3
11126749|NCT01372410|12312384|FG000|STARTED|Treatment Period 1 (7 Days)||20
11126750|NCT01372410|12312385|FG001|STARTED|Treatment Period 1 (7 Days)||21
11126751|NCT01372410|12312386|FG002|STARTED|Treatment Period 1 (7 Days)||19
11126752|NCT01372410|12312387|FG003|STARTED|Treatment Period 1 (7 Days)||20
11126753|NCT01372410|12312388|FG004|STARTED|Treatment Period 1 (7 Days)||21
11126754|NCT01372410|12312389|FG005|STARTED|Treatment Period 1 (7 Days)||21
11126755|NCT01372410|12312390|FG006|STARTED|Treatment Period 1 (7 Days)||22
11126756|NCT01372410|12312391|FG007|STARTED|Treatment Period 1 (7 Days)||19
11126757|NCT01372410|12312384|FG000|COMPLETED|Treatment Period 1 (7 Days)||19
11126758|NCT01372410|12312385|FG001|COMPLETED|Treatment Period 1 (7 Days)||19
11126759|NCT01372410|12312386|FG002|COMPLETED|Treatment Period 1 (7 Days)||19
11126760|NCT01372410|12312387|FG003|COMPLETED|Treatment Period 1 (7 Days)||20
11126761|NCT01372410|12312388|FG004|COMPLETED|Treatment Period 1 (7 Days)||19
11126762|NCT01372410|12312389|FG005|COMPLETED|Treatment Period 1 (7 Days)||21
11126763|NCT01372410|12312390|FG006|COMPLETED|Treatment Period 1 (7 Days)||20
11126764|NCT01372410|12312391|FG007|COMPLETED|Treatment Period 1 (7 Days)||19
11126765|NCT01372410|12312384|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||1
11126766|NCT01372410|12312385|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||2
11126767|NCT01372410|12312386|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0
11126768|NCT01372410|12312387|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||0
11126769|NCT01372410|12312388|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||2
11126770|NCT01372410|12312389|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0
11126771|NCT01372410|12312390|FG006|NOT COMPLETED|Treatment Period 1 (7 Days)||2
11126772|NCT01372410|12312391|FG007|NOT COMPLETED|Treatment Period 1 (7 Days)||0
11126773|NCT01372410|12312384|FG000|STARTED|Washout Period 1 (10-14 Days)||19
11126774|NCT01372410|12312385|FG001|STARTED|Washout Period 1 (10-14 Days)||19
11126775|NCT01372410|12312386|FG002|STARTED|Washout Period 1 (10-14 Days)||19
11126776|NCT01372410|12312387|FG003|STARTED|Washout Period 1 (10-14 Days)||20
11126777|NCT01372410|12312388|FG004|STARTED|Washout Period 1 (10-14 Days)||19
11126778|NCT01372410|12312389|FG005|STARTED|Washout Period 1 (10-14 Days)||21
11126779|NCT01372410|12312390|FG006|STARTED|Washout Period 1 (10-14 Days)||20
11126780|NCT01372410|12312391|FG007|STARTED|Washout Period 1 (10-14 Days)||19
11126781|NCT01372410|12312384|FG000|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
11126782|NCT01372410|12312385|FG001|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
11126783|NCT01372410|12312386|FG002|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
11126784|NCT01372410|12312387|FG003|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
11126785|NCT01372410|12312388|FG004|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
11126786|NCT01372410|12312389|FG005|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
11126787|NCT01372410|12312390|FG006|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
11126788|NCT01372410|12312391|FG007|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
11126789|NCT01372410|12312384|FG000|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
11126790|NCT01372410|12312385|FG001|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
11126791|NCT01372410|12312386|FG002|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
11126792|NCT01372410|12312387|FG003|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
11126793|NCT01372410|12312388|FG004|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
11126794|NCT01372410|12312389|FG005|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
11126795|NCT01372410|12312390|FG006|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
11126796|NCT01372410|12312391|FG007|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
11126797|NCT01372410|12312384|FG000|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
11126798|NCT01372410|12312385|FG001|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
11126799|NCT01372410|12312386|FG002|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
11126800|NCT01372410|12312387|FG003|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
11126801|NCT01372410|12312388|FG004|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
11126802|NCT01372410|12312389|FG005|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
11126803|NCT01372410|12312390|FG006|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
11126804|NCT01372410|12312391|FG007|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
11126805|NCT01372410|12312384|FG000|COMPLETED|Treatment Period 2 (7 Days)||19
11126806|NCT01372410|12312385|FG001|COMPLETED|Treatment Period 2 (7 Days)||21
11126807|NCT01372410|12312386|FG002|COMPLETED|Treatment Period 2 (7 Days)||22
11126808|NCT01372410|12312387|FG003|COMPLETED|Treatment Period 2 (7 Days)||17
11126809|NCT01372410|12312388|FG004|COMPLETED|Treatment Period 2 (7 Days)||19
11126810|NCT01372410|12312389|FG005|COMPLETED|Treatment Period 2 (7 Days)||16
11126811|NCT01372410|12312390|FG006|COMPLETED|Treatment Period 2 (7 Days)||21
11126812|NCT01372410|12312391|FG007|COMPLETED|Treatment Period 2 (7 Days)||19
11126813|NCT01372410|12312384|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
11126814|NCT01372410|12312385|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0
11126815|NCT01372410|12312386|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||0
11126816|NCT01372410|12312387|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0
11126817|NCT01372410|12312388|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0
11126818|NCT01372410|12312389|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||0
11126819|NCT01372410|12312390|FG006|NOT COMPLETED|Treatment Period 2 (7 Days)||0
11126820|NCT01372410|12312391|FG007|NOT COMPLETED|Treatment Period 2 (7 Days)||0
11126821|NCT01372410|12312384|FG000|STARTED|Washout Period 2 (10-14 Days)||19
11126822|NCT01372410|12312385|FG001|STARTED|Washout Period 2 (10-14 Days)||21
11126823|NCT01372410|12312386|FG002|STARTED|Washout Period 2 (10-14 Days)||22
11126824|NCT01372410|12312387|FG003|STARTED|Washout Period 2 (10-14 Days)||17
11126825|NCT01372410|12312388|FG004|STARTED|Washout Period 2 (10-14 Days)||19
11126826|NCT01372410|12312389|FG005|STARTED|Washout Period 2 (10-14 Days)||16
11126827|NCT01372410|12312390|FG006|STARTED|Washout Period 2 (10-14 Days)||21
11126828|NCT01372410|12312391|FG007|STARTED|Washout Period 2 (10-14 Days)||19
11126829|NCT01372410|12312384|FG000|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
11126830|NCT01372410|12312385|FG001|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
11126831|NCT01372410|12312386|FG002|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
11126832|NCT01372410|12312387|FG003|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
11126833|NCT01372410|12312388|FG004|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
11126834|NCT01372410|12312389|FG005|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
11126835|NCT01372410|12312390|FG006|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
11126836|NCT01372410|12312391|FG007|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
11126837|NCT01372410|12312384|FG000|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
11126838|NCT01372410|12312385|FG001|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
11126839|NCT01372410|12312386|FG002|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
11126840|NCT01372410|12312387|FG003|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
11126841|NCT01372410|12312388|FG004|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
11126842|NCT01372410|12312389|FG005|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
11126843|NCT01372410|12312390|FG006|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
11126844|NCT01372410|12312391|FG007|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
11126845|NCT01372410|12312384|FG000|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
11126846|NCT01372410|12312385|FG001|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
11126847|NCT01372410|12312386|FG002|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
11126848|NCT01372410|12312387|FG003|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
11126849|NCT01372410|12312388|FG004|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
11126850|NCT01372410|12312389|FG005|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
11126851|NCT01372410|12312390|FG006|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
11126852|NCT01372410|12312391|FG007|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
11126853|NCT01372410|12312384|FG000|COMPLETED|Treatment Period 3 (7 Days)||21
11126854|NCT01372410|12312385|FG001|COMPLETED|Treatment Period 3 (7 Days)||18
11126855|NCT01372410|12312386|FG002|COMPLETED|Treatment Period 3 (7 Days)||15
11126856|NCT01372410|12312387|FG003|COMPLETED|Treatment Period 3 (7 Days)||22
11126857|NCT01372410|12312388|FG004|COMPLETED|Treatment Period 3 (7 Days)||20
11126858|NCT01372410|12312389|FG005|COMPLETED|Treatment Period 3 (7 Days)||18
11126859|NCT01372410|12312390|FG006|COMPLETED|Treatment Period 3 (7 Days)||15
11126860|NCT01372410|12312391|FG007|COMPLETED|Treatment Period 3 (7 Days)||18
11126861|NCT01372410|12312384|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
11126862|NCT01372410|12312385|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0
11126863|NCT01372410|12312386|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||1
11126864|NCT01372410|12312387|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0
11126865|NCT01372410|12312388|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0
11126866|NCT01372410|12312389|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||1
11126867|NCT01372410|12312390|FG006|NOT COMPLETED|Treatment Period 3 (7 Days)||0
11126868|NCT01372410|12312391|FG007|NOT COMPLETED|Treatment Period 3 (7 Days)||0
11126869|NCT01372462|12312410|FG000|STARTED|NIOV - Room Air||15
11126870|NCT01372462|12312410|FG000|COMPLETED|NIOV - Room Air||15
11126871|NCT01372462|12312410|FG000|NOT COMPLETED|NIOV - Room Air||0
11126872|NCT01372462|12312410|FG000|STARTED|NIOV - Oxygen||15
11126873|NCT01372462|12312410|FG000|COMPLETED|NIOV - Oxygen||15
11126874|NCT01372462|12312410|FG000|NOT COMPLETED|NIOV - Oxygen||0
11126875|NCT01372462|12312410|FG000|STARTED|Oxygen Nasal Cannula||15
11126876|NCT01372462|12312410|FG000|COMPLETED|Oxygen Nasal Cannula||15
11126877|NCT01372462|12312410|FG000|NOT COMPLETED|Oxygen Nasal Cannula||0
11126878|NCT01372462|12312410|FG000|STARTED|No Treatment Control||15
11126879|NCT01372462|12312410|FG000|COMPLETED|No Treatment Control||15
11126880|NCT01372462|12312410|FG000|NOT COMPLETED|No Treatment Control||0
11126881|NCT01372501|12312420|FG000|STARTED|Overall Study||19
11126882|NCT01372501|12312420|FG000|COMPLETED|Overall Study||14
11126883|NCT01372501|12312420|FG000|NOT COMPLETED|Overall Study||5
11126884|NCT01372605|12312427|FG000|STARTED|Overall Study||149
11126885|NCT01372605|12312428|FG001|STARTED|Overall Study||155
11126886|NCT01372605|12312427|FG000|COMPLETED|Overall Study||137
11126887|NCT01372605|12312428|FG001|COMPLETED|Overall Study||145
11126888|NCT01372605|12312427|FG000|NOT COMPLETED|Overall Study||12
11126889|NCT01372605|12312428|FG001|NOT COMPLETED|Overall Study||10
11126890|NCT01372748|12312436|FG000|STARTED|Overall Study||11045
11126891|NCT01372748|12312437|FG001|STARTED|Overall Study||12642
11126892|NCT01372748|12312436|FG000|COMPLETED|Overall Study|defined as having vital status|11022
11126893|NCT01372748|12312437|FG001|COMPLETED|Overall Study|defined as having vital status|12603
11126894|NCT01372748|12312436|FG000|NOT COMPLETED|Overall Study||23
11126895|NCT01372748|12312437|FG001|NOT COMPLETED|Overall Study||39
11126896|NCT01372813|12312443|FG000|STARTED|Overall Study||3
11126897|NCT01372813|12312443|FG000|COMPLETED|Overall Study||3
11126898|NCT01372813|12312443|FG000|NOT COMPLETED|Overall Study||0
11126899|NCT01372878|12312447|FG000|STARTED|Overall Study||884
11126900|NCT01372878|12312447|FG000|COMPLETED|Overall Study||700
11126901|NCT01372878|12312447|FG000|NOT COMPLETED|Overall Study||184
11126902|NCT01372995|12312454|FG000|STARTED|Overall Study||10
11126903|NCT01372995|12312455|FG001|STARTED|Overall Study||10
11126904|NCT01372995|12312456|FG002|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
11126905|NCT01372995|12312454|FG000|COMPLETED|Overall Study||10
11126906|NCT01372995|12312455|FG001|COMPLETED|Overall Study||9
11126907|NCT01372995|12312456|FG002|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
11126908|NCT01372995|12312454|FG000|NOT COMPLETED|Overall Study||0
11126909|NCT01372995|12312455|FG001|NOT COMPLETED|Overall Study||1
11126910|NCT01372995|12312456|FG002|NOT COMPLETED|Overall Study||1
11126911|NCT01373164|12312469|FG000|STARTED|Overall Study||5
11126912|NCT01373164|12312470|FG001|STARTED|Overall Study||4
11126913|NCT01373164|12312471|FG002|STARTED|Overall Study||5
11126914|NCT01373164|12312472|FG003|STARTED|Overall Study||104
11126915|NCT01373164|12312473|FG004|STARTED|Overall Study||52
11126916|NCT01373164|12312469|FG000|Received at Least One Dose|Overall Study||5
11126917|NCT01373164|12312470|FG001|Received at Least One Dose|Overall Study||4
11126918|NCT01373164|12312471|FG002|Received at Least One Dose|Overall Study||5
11126919|NCT01373164|12312472|FG003|Received at Least One Dose|Overall Study||103
11126920|NCT01373164|12312473|FG004|Received at Least One Dose|Overall Study||52
11126921|NCT01373164|12312469|FG000|COMPLETED|Overall Study||5
11126922|NCT01373164|12312470|FG001|COMPLETED|Overall Study||3
11126923|NCT01373164|12312471|FG002|COMPLETED|Overall Study||4
11126924|NCT01373164|12312472|FG003|COMPLETED|Overall Study||92
11126925|NCT01373164|12312473|FG004|COMPLETED|Overall Study||50
11126926|NCT01373164|12312469|FG000|NOT COMPLETED|Overall Study||0
11126927|NCT01373164|12312470|FG001|NOT COMPLETED|Overall Study||1
11126928|NCT01373164|12312471|FG002|NOT COMPLETED|Overall Study||1
11126929|NCT01373164|12312472|FG003|NOT COMPLETED|Overall Study||12
11126930|NCT01373164|12312473|FG004|NOT COMPLETED|Overall Study||2
11126931|NCT01373229|12312488|FG000|STARTED|Overall Study||15
11126932|NCT01373229|12312488|FG000|COMPLETED|Overall Study||9
11126933|NCT01373229|12312488|FG000|NOT COMPLETED|Overall Study||6
11126934|NCT01373242|12312492|FG000|STARTED|Overall Study||54
11126935|NCT01373242|12312492|FG000|COMPLETED|Overall Study||38
11126936|NCT01373242|12312492|FG000|NOT COMPLETED|Overall Study||16
11126937|NCT01373294|12312500|FG000|STARTED|Overall Study||15
11126938|NCT01373294|12312501|FG001|STARTED|Overall Study||2
11126939|NCT01373294|12312500|FG000|COMPLETED|Overall Study||14
11126940|NCT01373294|12312501|FG001|COMPLETED|Overall Study||2
11126941|NCT01373294|12312500|FG000|NOT COMPLETED|Overall Study||1
11126942|NCT01373294|12312501|FG001|NOT COMPLETED|Overall Study||0
11126943|NCT01373346|12312507|FG000|STARTED|Overall Study||15
11126944|NCT01373346|12312507|FG000|COMPLETED|Overall Study||14
11126945|NCT01373346|12312507|FG000|NOT COMPLETED|Overall Study||1
11126946|NCT01373450|12312516|FG000|STARTED|Crossover Period 1||2
11126947|NCT01373450|12312517|FG001|STARTED|Crossover Period 1||2
11126948|NCT01373450|12312518|FG002|STARTED|Crossover Period 1||2
11126949|NCT01373450|12312519|FG003|STARTED|Crossover Period 1||2
11126950|NCT01373450|12312520|FG004|STARTED|Crossover Period 1||2
11126951|NCT01373450|12312521|FG005|STARTED|Crossover Period 1||2
11126952|NCT01373450|12312516|FG000|COMPLETED|Crossover Period 1||2
11126953|NCT01373450|12312517|FG001|COMPLETED|Crossover Period 1||2
11126954|NCT01373450|12312518|FG002|COMPLETED|Crossover Period 1||2
11126955|NCT01373450|12312519|FG003|COMPLETED|Crossover Period 1||2
11126956|NCT01373450|12312520|FG004|COMPLETED|Crossover Period 1||2
11126957|NCT01373450|12312521|FG005|COMPLETED|Crossover Period 1||2
11126958|NCT01373450|12312516|FG000|NOT COMPLETED|Crossover Period 1||0
11126959|NCT01373450|12312517|FG001|NOT COMPLETED|Crossover Period 1||0
11126960|NCT01373450|12312518|FG002|NOT COMPLETED|Crossover Period 1||0
11126961|NCT01373450|12312519|FG003|NOT COMPLETED|Crossover Period 1||0
11126962|NCT01373450|12312520|FG004|NOT COMPLETED|Crossover Period 1||0
11126963|NCT01373450|12312521|FG005|NOT COMPLETED|Crossover Period 1||0
11126964|NCT01373450|12312516|FG000|STARTED|7 Day Wash-out||2
11126965|NCT01373450|12312517|FG001|STARTED|7 Day Wash-out||2
11126966|NCT01373450|12312518|FG002|STARTED|7 Day Wash-out||2
11126967|NCT01373450|12312519|FG003|STARTED|7 Day Wash-out||2
11126968|NCT01373450|12312520|FG004|STARTED|7 Day Wash-out||2
11126969|NCT01373450|12312521|FG005|STARTED|7 Day Wash-out||2
11126970|NCT01373450|12312516|FG000|COMPLETED|7 Day Wash-out||2
11126971|NCT01373450|12312517|FG001|COMPLETED|7 Day Wash-out||2
11126972|NCT01373450|12312518|FG002|COMPLETED|7 Day Wash-out||2
11126973|NCT01373450|12312519|FG003|COMPLETED|7 Day Wash-out||2
11126974|NCT01373450|12312520|FG004|COMPLETED|7 Day Wash-out||2
11126975|NCT01373450|12312521|FG005|COMPLETED|7 Day Wash-out||2
11126976|NCT01373450|12312516|FG000|NOT COMPLETED|7 Day Wash-out||0
11126977|NCT01373450|12312517|FG001|NOT COMPLETED|7 Day Wash-out||0
11126978|NCT01373450|12312518|FG002|NOT COMPLETED|7 Day Wash-out||0
11126979|NCT01373450|12312519|FG003|NOT COMPLETED|7 Day Wash-out||0
11126980|NCT01373450|12312520|FG004|NOT COMPLETED|7 Day Wash-out||0
11126981|NCT01373450|12312521|FG005|NOT COMPLETED|7 Day Wash-out||0
11126982|NCT01373450|12312516|FG000|STARTED|Crossover Period 2||2
11126983|NCT01373450|12312517|FG001|STARTED|Crossover Period 2||2
11126984|NCT01373450|12312518|FG002|STARTED|Crossover Period 2||2
11126985|NCT01373450|12312519|FG003|STARTED|Crossover Period 2||2
11126986|NCT01373450|12312520|FG004|STARTED|Crossover Period 2||2
11239146|NCT02079805|12431126|FG001|NOT COMPLETED|Overall Study||2
11239147|NCT02079844|12431135|FG000|STARTED|Treatment Period 1||6
11239148|NCT02079844|12431136|FG001|STARTED|Treatment Period 1||7
11239149|NCT02079844|12431137|FG002|STARTED|Treatment Period 1||7
11239150|NCT02079844|12431135|FG000|COMPLETED|Treatment Period 1||6
11239151|NCT02079844|12431136|FG001|COMPLETED|Treatment Period 1||7
11239152|NCT02079844|12431137|FG002|COMPLETED|Treatment Period 1||5
11239153|NCT02079844|12431135|FG000|NOT COMPLETED|Treatment Period 1||0
11239154|NCT02079844|12431136|FG001|NOT COMPLETED|Treatment Period 1||0
11239155|NCT02079844|12431137|FG002|NOT COMPLETED|Treatment Period 1||2
11126987|NCT01373450|12312521|FG005|STARTED|Crossover Period 2||2
11126988|NCT01373450|12312516|FG000|COMPLETED|Crossover Period 2||2
11126989|NCT01373450|12312517|FG001|COMPLETED|Crossover Period 2||2
11126990|NCT01373450|12312518|FG002|COMPLETED|Crossover Period 2||2
11126991|NCT01373450|12312519|FG003|COMPLETED|Crossover Period 2||2
11126992|NCT01373450|12312520|FG004|COMPLETED|Crossover Period 2||2
11126993|NCT01373450|12312521|FG005|COMPLETED|Crossover Period 2||2
11126994|NCT01373450|12312516|FG000|NOT COMPLETED|Crossover Period 2||0
11126995|NCT01373450|12312517|FG001|NOT COMPLETED|Crossover Period 2||0
11239156|NCT02079844|12431135|FG000|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
11126996|NCT01373450|12312518|FG002|NOT COMPLETED|Crossover Period 2||0
11126997|NCT01373450|12312519|FG003|NOT COMPLETED|Crossover Period 2||0
11126998|NCT01373450|12312520|FG004|NOT COMPLETED|Crossover Period 2||0
11126999|NCT01373450|12312521|FG005|NOT COMPLETED|Crossover Period 2||0
11127000|NCT01373450|12312516|FG000|STARTED|7 Day Wash-out||2
11127001|NCT01373450|12312517|FG001|STARTED|7 Day Wash-out||2
11127002|NCT01373450|12312518|FG002|STARTED|7 Day Wash-out||2
11127003|NCT01373450|12312519|FG003|STARTED|7 Day Wash-out||2
11127004|NCT01373450|12312520|FG004|STARTED|7 Day Wash-out||2
11127005|NCT01373450|12312521|FG005|STARTED|7 Day Wash-out||2
11127006|NCT01373450|12312516|FG000|COMPLETED|7 Day Wash-out||2
11127007|NCT01373450|12312517|FG001|COMPLETED|7 Day Wash-out||2
11127008|NCT01373450|12312518|FG002|COMPLETED|7 Day Wash-out||2
11127009|NCT01373450|12312519|FG003|COMPLETED|7 Day Wash-out||2
11127010|NCT01373450|12312520|FG004|COMPLETED|7 Day Wash-out||2
11127011|NCT01373450|12312521|FG005|COMPLETED|7 Day Wash-out||2
11127012|NCT01373450|12312516|FG000|NOT COMPLETED|7 Day Wash-out||0
11127013|NCT01373450|12312517|FG001|NOT COMPLETED|7 Day Wash-out||0
11127014|NCT01373450|12312518|FG002|NOT COMPLETED|7 Day Wash-out||0
11127015|NCT01373450|12312519|FG003|NOT COMPLETED|7 Day Wash-out||0
11127016|NCT01373450|12312520|FG004|NOT COMPLETED|7 Day Wash-out||0
11127017|NCT01373450|12312521|FG005|NOT COMPLETED|7 Day Wash-out||0
11127018|NCT01373450|12312516|FG000|STARTED|Crossover Period 3||2
11127019|NCT01373450|12312517|FG001|STARTED|Crossover Period 3||2
11127020|NCT01373450|12312518|FG002|STARTED|Crossover Period 3||2
11127021|NCT01373450|12312519|FG003|STARTED|Crossover Period 3||2
11127022|NCT01373450|12312520|FG004|STARTED|Crossover Period 3||2
11127023|NCT01373450|12312521|FG005|STARTED|Crossover Period 3||2
11127024|NCT01373450|12312516|FG000|COMPLETED|Crossover Period 3||2
11127025|NCT01373450|12312517|FG001|COMPLETED|Crossover Period 3||2
11127026|NCT01373450|12312518|FG002|COMPLETED|Crossover Period 3||2
11127027|NCT01373450|12312519|FG003|COMPLETED|Crossover Period 3||2
11127028|NCT01373450|12312520|FG004|COMPLETED|Crossover Period 3||2
11127029|NCT01373450|12312521|FG005|COMPLETED|Crossover Period 3||2
11127030|NCT01373450|12312516|FG000|NOT COMPLETED|Crossover Period 3||0
11127031|NCT01373450|12312517|FG001|NOT COMPLETED|Crossover Period 3||0
11127032|NCT01373450|12312518|FG002|NOT COMPLETED|Crossover Period 3||0
11127033|NCT01373450|12312519|FG003|NOT COMPLETED|Crossover Period 3||0
11127034|NCT01373450|12312520|FG004|NOT COMPLETED|Crossover Period 3||0
11127035|NCT01373450|12312521|FG005|NOT COMPLETED|Crossover Period 3||0
11127036|NCT01373450|12312516|FG000|STARTED|7 Day Wash-out||2
11127037|NCT01373450|12312517|FG001|STARTED|7 Day Wash-out||2
11127038|NCT01373450|12312518|FG002|STARTED|7 Day Wash-out||2
11127039|NCT01373450|12312519|FG003|STARTED|7 Day Wash-out||2
11127040|NCT01373450|12312520|FG004|STARTED|7 Day Wash-out||2
11127041|NCT01373450|12312521|FG005|STARTED|7 Day Wash-out||2
11127042|NCT01373450|12312516|FG000|COMPLETED|7 Day Wash-out||2
11127043|NCT01373450|12312517|FG001|COMPLETED|7 Day Wash-out||2
11127044|NCT01373450|12312518|FG002|COMPLETED|7 Day Wash-out||2
11127045|NCT01373450|12312519|FG003|COMPLETED|7 Day Wash-out||2
11127046|NCT01373450|12312520|FG004|COMPLETED|7 Day Wash-out||2
11127047|NCT01373450|12312521|FG005|COMPLETED|7 Day Wash-out||2
11127048|NCT01373450|12312516|FG000|NOT COMPLETED|7 Day Wash-out||0
11127049|NCT01373450|12312517|FG001|NOT COMPLETED|7 Day Wash-out||0
11127050|NCT01373450|12312518|FG002|NOT COMPLETED|7 Day Wash-out||0
11127051|NCT01373450|12312519|FG003|NOT COMPLETED|7 Day Wash-out||0
11127052|NCT01373450|12312520|FG004|NOT COMPLETED|7 Day Wash-out||0
11127053|NCT01373450|12312521|FG005|NOT COMPLETED|7 Day Wash-out||0
11127054|NCT01373450|12312516|FG000|STARTED|Crossover Period 4||2
11127055|NCT01373450|12312517|FG001|STARTED|Crossover Period 4||2
11127056|NCT01373450|12312518|FG002|STARTED|Crossover Period 4||2
11127057|NCT01373450|12312519|FG003|STARTED|Crossover Period 4||2
11127058|NCT01373450|12312520|FG004|STARTED|Crossover Period 4||2
11127059|NCT01373450|12312521|FG005|STARTED|Crossover Period 4||2
11127060|NCT01373450|12312516|FG000|COMPLETED|Crossover Period 4||2
11127061|NCT01373450|12312517|FG001|COMPLETED|Crossover Period 4||2
11127062|NCT01373450|12312518|FG002|COMPLETED|Crossover Period 4||2
11127063|NCT01373450|12312519|FG003|COMPLETED|Crossover Period 4||2
11127064|NCT01373450|12312520|FG004|COMPLETED|Crossover Period 4||2
11127065|NCT01373450|12312521|FG005|COMPLETED|Crossover Period 4||2
11127066|NCT01373450|12312516|FG000|NOT COMPLETED|Crossover Period 4||0
11127067|NCT01373450|12312517|FG001|NOT COMPLETED|Crossover Period 4||0
11127068|NCT01373450|12312518|FG002|NOT COMPLETED|Crossover Period 4||0
11127069|NCT01373450|12312519|FG003|NOT COMPLETED|Crossover Period 4||0
11127070|NCT01373450|12312520|FG004|NOT COMPLETED|Crossover Period 4||0
11127071|NCT01373450|12312521|FG005|NOT COMPLETED|Crossover Period 4||0
11127072|NCT01373489|12312537|FG000|STARTED|Overall Study||59
11127073|NCT01373489|12312538|FG001|STARTED|Overall Study||54
11127074|NCT01373489|12312537|FG000|COMPLETED|Overall Study||44
11127075|NCT01373489|12312538|FG001|COMPLETED|Overall Study||41
11127076|NCT01373489|12312537|FG000|NOT COMPLETED|Overall Study||15
11127077|NCT01373489|12312538|FG001|NOT COMPLETED|Overall Study||13
11127078|NCT01373580|12312544|FG000|STARTED|Overall Study||373
11127079|NCT01373580|12312544|FG000|COMPLETED|Overall Study||317
11127080|NCT01373580|12312544|FG000|NOT COMPLETED|Overall Study||56
11127081|NCT01373671|12312548|FG000|STARTED|Overall Study||764
11127082|NCT01373671|12312548|FG000|COMPLETED|Overall Study||672
11127083|NCT01373671|12312548|FG000|NOT COMPLETED|Overall Study||92
11127084|NCT01373918|12312555|FG000|STARTED|Overall Study||20
11127085|NCT01373918|12312556|FG001|STARTED|Overall Study||16
11127086|NCT01373918|12312555|FG000|COMPLETED|Overall Study||20
11127087|NCT01373918|12312556|FG001|COMPLETED|Overall Study||15
11127088|NCT01373918|12312555|FG000|NOT COMPLETED|Overall Study||0
11127089|NCT01373918|12312556|FG001|NOT COMPLETED|Overall Study||1
11127090|NCT01373931|12312564|FG000|STARTED|Lead-in Period||10
11127091|NCT01373931|12312565|FG001|STARTED|Lead-in Period||10
11127092|NCT01373931|12312564|FG000|Received at Least 1 Dose of Study Drug|Lead-in Period||8
11127093|NCT01373931|12312565|FG001|Received at Least 1 Dose of Study Drug|Lead-in Period||10
11127094|NCT01373931|12312564|FG000|COMPLETED|Lead-in Period||8
11127095|NCT01373931|12312565|FG001|COMPLETED|Lead-in Period||10
11127096|NCT01373931|12312564|FG000|NOT COMPLETED|Lead-in Period||2
11127097|NCT01373931|12312565|FG001|NOT COMPLETED|Lead-in Period||0
11127098|NCT01373931|12312564|FG000|STARTED|Period 1||8
11127099|NCT01373931|12312565|FG001|STARTED|Period 1||10
11127100|NCT01373931|12312564|FG000|COMPLETED|Period 1||6
11127101|NCT01373931|12312565|FG001|COMPLETED|Period 1||8
11127102|NCT01373931|12312564|FG000|NOT COMPLETED|Period 1||2
11127103|NCT01373931|12312565|FG001|NOT COMPLETED|Period 1||2
11127104|NCT01373931|12312564|FG000|STARTED|Period 2||6
11127105|NCT01373931|12312565|FG001|STARTED|Period 2||8
11127106|NCT01373931|12312564|FG000|COMPLETED|Period 2||6
11127107|NCT01373931|12312565|FG001|COMPLETED|Period 2||8
11127108|NCT01373931|12312564|FG000|NOT COMPLETED|Period 2||0
11127109|NCT01373931|12312565|FG001|NOT COMPLETED|Period 2||0
11127110|NCT01374087|12312574|FG000|STARTED|Overall Study||16
11127111|NCT01374087|12312575|FG001|STARTED|Overall Study||15
11127112|NCT01374087|12312574|FG000|COMPLETED|Overall Study||0
11127113|NCT01374087|12312575|FG001|COMPLETED|Overall Study||0
11127114|NCT01374087|12312574|FG000|NOT COMPLETED|Overall Study||16
11127115|NCT01374087|12312575|FG001|NOT COMPLETED|Overall Study||15
11127116|NCT01374178|12312581|FG000|STARTED|Period 1 (up to 24 Hours After Dosing)||11
11127117|NCT01374178|12312582|FG001|STARTED|Period 1 (up to 24 Hours After Dosing)||5
11127118|NCT01374178|12312581|FG000|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
11127119|NCT01374178|12312582|FG001|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
11127120|NCT01374178|12312581|FG000|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
11127121|NCT01374178|12312582|FG001|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
11127122|NCT01374178|12312581|FG000|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
11127123|NCT01374178|12312582|FG001|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
11127124|NCT01374178|12312581|FG000|STARTED|Washout Period of at Least 7 Days||11
11127125|NCT01374178|12312582|FG001|STARTED|Washout Period of at Least 7 Days||5
11127126|NCT01374178|12312581|FG000|COMPLETED|Washout Period of at Least 7 Days||10
11127127|NCT01374178|12312582|FG001|COMPLETED|Washout Period of at Least 7 Days||5
11127128|NCT01374178|12312581|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1
11127129|NCT01374178|12312582|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
11127130|NCT01374178|12312581|FG000|STARTED|Period 2 (up to 24 Hours After Dosing)||10
11127131|NCT01374178|12312582|FG001|STARTED|Period 2 (up to 24 Hours After Dosing)||5
11127132|NCT01374178|12312581|FG000|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
11127133|NCT01374178|12312582|FG001|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
11127134|NCT01374178|12312581|FG000|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
11127135|NCT01374178|12312582|FG001|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
11127136|NCT01374217|12312588|FG000|STARTED|Overall Study||13
11127137|NCT01374217|12312588|FG000|COMPLETED|Overall Study||0
11127138|NCT01374217|12312588|FG000|NOT COMPLETED|Overall Study||13
11127139|NCT01374269|12312594|FG000|STARTED|Overall Study||46
11127140|NCT01374269|12312595|FG001|STARTED|Overall Study||44
11127141|NCT01374269|12312594|FG000|COMPLETED|Overall Study||40
11127142|NCT01374269|12312595|FG001|COMPLETED|Overall Study||39
11127143|NCT01374269|12312594|FG000|NOT COMPLETED|Overall Study||6
11127144|NCT01374269|12312595|FG001|NOT COMPLETED|Overall Study||5
11127145|NCT01374425|12312603|FG000|STARTED|Overall Study||188
11127146|NCT01374425|12312604|FG001|STARTED|Overall Study||188
11127147|NCT01374425|12312603|FG000|COMPLETED|Overall Study||0
11127148|NCT01374425|12312604|FG001|COMPLETED|Overall Study||0
11127149|NCT01374425|12312603|FG000|NOT COMPLETED|Overall Study||188
11127150|NCT01374425|12312604|FG001|NOT COMPLETED|Overall Study||188
11127151|NCT01374438|12312633|FG000|STARTED|Overall Study||16
11127152|NCT01374438|12312634|FG001|STARTED|Overall Study||13
11127153|NCT01374438|12312633|FG000|COMPLETED|Overall Study||16
11127154|NCT01374438|12312634|FG001|COMPLETED|Overall Study||13
11127155|NCT01374438|12312633|FG000|NOT COMPLETED|Overall Study||0
11127156|NCT01374438|12312634|FG001|NOT COMPLETED|Overall Study||0
11127157|NCT01374451|12312642|FG000|STARTED|Overall Study||79
11127158|NCT01374451|12312643|FG001|STARTED|Overall Study||81
11127159|NCT01374451|12312642|FG000|COMPLETED|Overall Study||78
11127160|NCT01374451|12312643|FG001|COMPLETED|Overall Study||81
11127161|NCT01374451|12312642|FG000|NOT COMPLETED|Overall Study||1
11127162|NCT01374451|12312643|FG001|NOT COMPLETED|Overall Study||0
11127163|NCT01374490|12312649|FG000|STARTED|Overall Study||250
11127164|NCT01374490|12312649|FG000|COMPLETED|Overall Study||190
11127165|NCT01374490|12312649|FG000|NOT COMPLETED|Overall Study||60
11127166|NCT01374568|12312655|FG000|STARTED|Overall Study||2
11127167|NCT01374568|12312656|FG001|STARTED|Overall Study||3
11127168|NCT01374568|12312655|FG000|COMPLETED|Overall Study||2
11127169|NCT01374568|12312656|FG001|COMPLETED|Overall Study||1
11127170|NCT01374568|12312655|FG000|NOT COMPLETED|Overall Study||0
11127171|NCT01374568|12312656|FG001|NOT COMPLETED|Overall Study||2
11127172|NCT01374802|12312662|FG000|STARTED|Overall Study||14
11127173|NCT01374802|12312662|FG000|COMPLETED|Overall Study||14
11127174|NCT01374802|12312662|FG000|NOT COMPLETED|Overall Study||0
11127175|NCT01374906|12312670|FG000|STARTED|Overall Study||74
11127176|NCT01374906|12312671|FG001|STARTED|Overall Study||76
11127177|NCT01374906|12312670|FG000|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
11127178|NCT01374906|12312671|FG001|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
11127179|NCT01374906|12312670|FG000|Completed Core Phase|Overall Study||50
11127180|NCT01374906|12312671|FG001|Completed Core Phase|Overall Study||54
11127181|NCT01374906|12312670|FG000|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
11127182|NCT01374906|12312671|FG001|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
11127183|NCT01374906|12312670|FG000|Completed Core Phase/Entered Ext. Phase|Overall Study||40
11127184|NCT01374906|12312671|FG001|Completed Core Phase/Entered Ext. Phase|Overall Study||41
11127185|NCT01374906|12312670|FG000|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
11127186|NCT01374906|12312671|FG001|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
11127187|NCT01374906|12312670|FG000|Completed Extension Phase|Overall Study||24
11127188|NCT01374906|12312671|FG001|Completed Extension Phase|Overall Study||15
11127189|NCT01374906|12312670|FG000|COMPLETED|Overall Study||34
11127190|NCT01374906|12312671|FG001|COMPLETED|Overall Study||28
11127191|NCT01374906|12312670|FG000|NOT COMPLETED|Overall Study||40
11127192|NCT01374906|12312671|FG001|NOT COMPLETED|Overall Study||48
11127193|NCT01374919|12312681|FG000|STARTED|Overall Study||60
11127194|NCT01374919|12312681|FG000|COMPLETED|Overall Study||58
11127195|NCT01374919|12312681|FG000|NOT COMPLETED|Overall Study||2
11127196|NCT01374971|12312685|FG000|STARTED|Overall Study||12
11127197|NCT01374971|12312685|FG000|COMPLETED|Overall Study||11
11127198|NCT01374971|12312685|FG000|NOT COMPLETED|Overall Study||1
11127199|NCT01375010|12312691|FG000|STARTED|Overall Study||43
11127200|NCT01375010|12312692|FG001|STARTED|Overall Study||42
11127201|NCT01375010|12312691|FG000|COMPLETED|Overall Study||31
11127202|NCT01375010|12312692|FG001|COMPLETED|Overall Study||38
11127203|NCT01375010|12312691|FG000|NOT COMPLETED|Overall Study||12
11127204|NCT01375010|12312692|FG001|NOT COMPLETED|Overall Study||4
11127205|NCT01375049|12312698|FG000|STARTED|Overall Study||105
11127206|NCT01375049|12312698|FG000|COMPLETED|Overall Study||55
11127207|NCT01375049|12312698|FG000|NOT COMPLETED|Overall Study||50
11127208|NCT01375075|12312712|FG000|STARTED|Overall Study||27
11127209|NCT01375075|12312713|FG001|STARTED|Overall Study||28
11127210|NCT01375075|12312714|FG002|STARTED|Overall Study||27
11127211|NCT01375075|12312715|FG003|STARTED|Overall Study||28
11127212|NCT01375075|12312716|FG004|STARTED|Overall Study||27
11239157|NCT02079844|12431136|FG001|STARTED|Treatment Period 2||7
11239158|NCT02079844|12431137|FG002|STARTED|Treatment Period 2||5
11239159|NCT02079844|12431135|FG000|COMPLETED|Treatment Period 2||5
11239160|NCT02079844|12431136|FG001|COMPLETED|Treatment Period 2||6
11239161|NCT02079844|12431137|FG002|COMPLETED|Treatment Period 2||5
11239162|NCT02079844|12431135|FG000|NOT COMPLETED|Treatment Period 2||0
11239163|NCT02079844|12431136|FG001|NOT COMPLETED|Treatment Period 2||1
11239164|NCT02079844|12431137|FG002|NOT COMPLETED|Treatment Period 2||0
11239165|NCT02079844|12431135|FG000|STARTED|Treatment Period 3||5
11239166|NCT02079844|12431136|FG001|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
11239167|NCT02079844|12431137|FG002|STARTED|Treatment Period 3||5
11239168|NCT02079844|12431135|FG000|COMPLETED|Treatment Period 3||5
11239169|NCT02079844|12431136|FG001|COMPLETED|Treatment Period 3||5
11239170|NCT02079844|12431137|FG002|COMPLETED|Treatment Period 3||5
11239171|NCT02079844|12431135|FG000|NOT COMPLETED|Treatment Period 3||0
11239172|NCT02079844|12431136|FG001|NOT COMPLETED|Treatment Period 3||0
11239173|NCT02079844|12431137|FG002|NOT COMPLETED|Treatment Period 3||0
11239174|NCT02079909|12431151|FG000|STARTED|Overall Study||158
11239175|NCT02079909|12431152|FG001|STARTED|Overall Study||166
11239176|NCT02079909|12431153|FG002|STARTED|Overall Study||158
11239177|NCT02079909|12431151|FG000|COMPLETED|Overall Study||120
11239178|NCT02079909|12431152|FG001|COMPLETED|Overall Study||117
11239179|NCT02079909|12431153|FG002|COMPLETED|Overall Study||140
11239180|NCT02079909|12431151|FG000|NOT COMPLETED|Overall Study||38
11239181|NCT02079909|12431152|FG001|NOT COMPLETED|Overall Study||49
11239182|NCT02079909|12431153|FG002|NOT COMPLETED|Overall Study||18
11239183|NCT02079987|12431163|FG000|STARTED|Overall Study||557
11239184|NCT02079987|12431164|FG001|STARTED|Overall Study||544
11239185|NCT02079987|12431163|FG000|COMPLETED|Overall Study||557
11127213|NCT01375075|12312717|FG005|STARTED|Overall Study||28
11127214|NCT01375075|12312712|FG000|Received at Least One Dose of Study Drug|Overall Study||27
11239186|NCT02079987|12431164|FG001|COMPLETED|Overall Study||544
11239187|NCT02079987|12431163|FG000|NOT COMPLETED|Overall Study||0
11239188|NCT02079987|12431164|FG001|NOT COMPLETED|Overall Study||0
11127215|NCT01375075|12312713|FG001|Received at Least One Dose of Study Drug|Overall Study||28
11127216|NCT01375075|12312714|FG002|Received at Least One Dose of Study Drug|Overall Study||27
11127217|NCT01375075|12312715|FG003|Received at Least One Dose of Study Drug|Overall Study||28
11127218|NCT01375075|12312716|FG004|Received at Least One Dose of Study Drug|Overall Study||27
11127219|NCT01375075|12312717|FG005|Received at Least One Dose of Study Drug|Overall Study||28
11127220|NCT01375075|12312712|FG000|COMPLETED|Overall Study||26
11127221|NCT01375075|12312713|FG001|COMPLETED|Overall Study||27
11127222|NCT01375075|12312714|FG002|COMPLETED|Overall Study||24
11127223|NCT01375075|12312715|FG003|COMPLETED|Overall Study||27
11127224|NCT01375075|12312716|FG004|COMPLETED|Overall Study||27
11127225|NCT01375075|12312717|FG005|COMPLETED|Overall Study||25
11239189|NCT02080091|12431171|FG000|STARTED|Overall Study||25
11127226|NCT01375075|12312712|FG000|NOT COMPLETED|Overall Study||1
11127227|NCT01375075|12312713|FG001|NOT COMPLETED|Overall Study||1
11127228|NCT01375075|12312714|FG002|NOT COMPLETED|Overall Study||3
11127229|NCT01375075|12312715|FG003|NOT COMPLETED|Overall Study||1
11127230|NCT01375075|12312716|FG004|NOT COMPLETED|Overall Study||0
11127231|NCT01375075|12312717|FG005|NOT COMPLETED|Overall Study||3
11127232|NCT01375127|12312741|FG000|STARTED|Overall Study||1
11127233|NCT01375127|12312742|FG001|STARTED|Overall Study||1
11127234|NCT01375127|12312743|FG002|STARTED|Overall Study||40
11127235|NCT01375127|12312744|FG003|STARTED|Overall Study||33
11127236|NCT01375127|12312745|FG004|STARTED|Overall Study||5
11127237|NCT01375127|12312746|FG005|STARTED|Overall Study||3
11127238|NCT01375127|12312741|FG000|COMPLETED|Overall Study||1
11127239|NCT01375127|12312742|FG001|COMPLETED|Overall Study||1
11127240|NCT01375127|12312743|FG002|COMPLETED|Overall Study||40
11127241|NCT01375127|12312744|FG003|COMPLETED|Overall Study||33
11127242|NCT01375127|12312745|FG004|COMPLETED|Overall Study||5
11127243|NCT01375127|12312746|FG005|COMPLETED|Overall Study||3
11127244|NCT01375127|12312741|FG000|NOT COMPLETED|Overall Study||0
11127245|NCT01375127|12312742|FG001|NOT COMPLETED|Overall Study||0
11127246|NCT01375127|12312743|FG002|NOT COMPLETED|Overall Study||0
11127247|NCT01375127|12312744|FG003|NOT COMPLETED|Overall Study||0
11127248|NCT01375127|12312745|FG004|NOT COMPLETED|Overall Study||0
11127249|NCT01375127|12312746|FG005|NOT COMPLETED|Overall Study||0
11127250|NCT01375140|12312760|FG000|STARTED|Overall Study||31
11127251|NCT01375140|12312760|FG000|COMPLETED|Overall Study||31
11127252|NCT01375140|12312760|FG000|NOT COMPLETED|Overall Study||0
11127253|NCT01375205|12312766|FG000|STARTED|Overall Study||54
11127254|NCT01375205|12312767|FG001|STARTED|Overall Study||46
11127255|NCT01375205|12312766|FG000|COMPLETED|Overall Study||33
11127256|NCT01375205|12312767|FG001|COMPLETED|Overall Study||33
11127257|NCT01375205|12312766|FG000|NOT COMPLETED|Overall Study||21
11127258|NCT01375205|12312767|FG001|NOT COMPLETED|Overall Study||13
11127259|NCT01375374|12312773|FG000|STARTED|Overall Study||11
11127260|NCT01375374|12312773|FG000|COMPLETED|Overall Study||10
11127261|NCT01375374|12312773|FG000|NOT COMPLETED|Overall Study||1
11127262|NCT01375491|12312780|FG000|STARTED|Overall Study||11
11127263|NCT01375491|12312781|FG001|STARTED|Overall Study||13
11127264|NCT01375491|12312782|FG002|STARTED|Overall Study||15
11127265|NCT01375491|12312780|FG000|COMPLETED|Overall Study||9
11127266|NCT01375491|12312781|FG001|COMPLETED|Overall Study||12
11127267|NCT01375491|12312782|FG002|COMPLETED|Overall Study||15
11127268|NCT01375491|12312780|FG000|NOT COMPLETED|Overall Study||2
11127269|NCT01375491|12312781|FG001|NOT COMPLETED|Overall Study||1
11127270|NCT01375491|12312782|FG002|NOT COMPLETED|Overall Study||0
11127271|NCT01375569|12312789|FG000|STARTED|Overall Study||11
11127272|NCT01375569|12312789|FG000|COMPLETED|Overall Study||11
11127273|NCT01375569|12312789|FG000|NOT COMPLETED|Overall Study||0
11127274|NCT01375608|12312793|FG000|STARTED|Overall Study||10
11127275|NCT01375608|12312793|FG000|COMPLETED|Overall Study||8
11127276|NCT01375608|12312793|FG000|NOT COMPLETED|Overall Study||2
11127277|NCT01375660|12312799|FG000|STARTED|Overall Study||102
11127278|NCT01375660|12312800|FG001|STARTED|Overall Study||103
11127279|NCT01375660|12312799|FG000|COMPLETED|Overall Study||86
11127280|NCT01375660|12312800|FG001|COMPLETED|Overall Study||87
11127281|NCT01375660|12312799|FG000|NOT COMPLETED|Overall Study||16
11127282|NCT01375660|12312800|FG001|NOT COMPLETED|Overall Study||16
11127283|NCT01375673|12312809|FG000|STARTED|Overall Study||7
11127284|NCT01375673|12312810|FG001|STARTED|Overall Study||7
11127285|NCT01375673|12312809|FG000|COMPLETED|Overall Study||7
11127286|NCT01375673|12312810|FG001|COMPLETED|Overall Study||6
11127287|NCT01375673|12312809|FG000|NOT COMPLETED|Overall Study||0
11127288|NCT01375673|12312810|FG001|NOT COMPLETED|Overall Study||1
11127289|NCT01375751|12312819|FG000|STARTED|Overall Study||56
11127290|NCT01375751|12312820|FG001|STARTED|Overall Study||56
11127291|NCT01375751|12312821|FG002|STARTED|Overall Study||56
11127292|NCT01375751|12312819|FG000|Received Treatment|Overall Study||56
11127293|NCT01375751|12312820|FG001|Received Treatment|Overall Study||55
11127294|NCT01375751|12312821|FG002|Received Treatment|Overall Study||56
11127295|NCT01375751|12312819|FG000|COMPLETED|Overall Study||56
11127296|NCT01375751|12312820|FG001|COMPLETED|Overall Study||55
11127297|NCT01375751|12312821|FG002|COMPLETED|Overall Study||56
11127298|NCT01375751|12312819|FG000|NOT COMPLETED|Overall Study||0
11127299|NCT01375751|12312820|FG001|NOT COMPLETED|Overall Study||1
11127300|NCT01375751|12312821|FG002|NOT COMPLETED|Overall Study||0
11127301|NCT01375764|12312834|FG000|STARTED|Overall Study||33
11127302|NCT01375764|12312835|FG001|STARTED|Overall Study||31
11127303|NCT01375764|12312836|FG002|STARTED|Overall Study||32
11127304|NCT01375764|12312837|FG003|STARTED|Overall Study||32
11127305|NCT01375764|12312838|FG004|STARTED|Overall Study||32
11127306|NCT01375764|12312834|FG000|Received Treatment|Overall Study||32
11127307|NCT01375764|12312835|FG001|Received Treatment|Overall Study||30
11127308|NCT01375764|12312836|FG002|Received Treatment|Overall Study||32
11127309|NCT01375764|12312837|FG003|Received Treatment|Overall Study||31
11127310|NCT01375764|12312838|FG004|Received Treatment|Overall Study||32
11127311|NCT01375764|12312834|FG000|COMPLETED|Overall Study||31
11127312|NCT01375764|12312835|FG001|COMPLETED|Overall Study||30
11127313|NCT01375764|12312836|FG002|COMPLETED|Overall Study||32
11127314|NCT01375764|12312837|FG003|COMPLETED|Overall Study||31
11127315|NCT01375764|12312838|FG004|COMPLETED|Overall Study||31
11127316|NCT01375764|12312834|FG000|NOT COMPLETED|Overall Study||2
11127317|NCT01375764|12312835|FG001|NOT COMPLETED|Overall Study||1
11127318|NCT01375764|12312836|FG002|NOT COMPLETED|Overall Study||0
11127319|NCT01375764|12312837|FG003|NOT COMPLETED|Overall Study||1
11127320|NCT01375764|12312838|FG004|NOT COMPLETED|Overall Study||1
11127321|NCT01375777|12312859|FG000|STARTED|Overall Study||46
11127322|NCT01375777|12312860|FG001|STARTED|Overall Study||45
11127323|NCT01375777|12312861|FG002|STARTED|Overall Study||46
11127324|NCT01375777|12312862|FG003|STARTED|Overall Study||45
11127325|NCT01375777|12312863|FG004|STARTED|Overall Study||46
11127326|NCT01375777|12312864|FG005|STARTED|Overall Study||45
11127327|NCT01375777|12312865|FG006|STARTED|Overall Study||46
11127328|NCT01375777|12312866|FG007|STARTED|Overall Study||46
11127329|NCT01375777|12312867|FG008|STARTED|Overall Study||46
11127330|NCT01375777|12312859|FG000|Received Treatment|Overall Study||45
11127331|NCT01375777|12312860|FG001|Received Treatment|Overall Study||45
11127332|NCT01375777|12312861|FG002|Received Treatment|Overall Study||45
11127333|NCT01375777|12312862|FG003|Received Treatment|Overall Study||45
11127334|NCT01375777|12312863|FG004|Received Treatment|Overall Study||46
11127335|NCT01375777|12312864|FG005|Received Treatment|Overall Study||45
11127336|NCT01375777|12312865|FG006|Received Treatment|Overall Study||45
11127337|NCT01375777|12312866|FG007|Received Treatment|Overall Study||45
11127338|NCT01375777|12312867|FG008|Received Treatment|Overall Study||45
11127339|NCT01375777|12312859|FG000|COMPLETED|Overall Study||44
11127340|NCT01375777|12312860|FG001|COMPLETED|Overall Study||42
11127341|NCT01375777|12312861|FG002|COMPLETED|Overall Study||45
11127342|NCT01375777|12312862|FG003|COMPLETED|Overall Study||45
11127343|NCT01375777|12312863|FG004|COMPLETED|Overall Study||45
11127344|NCT01375777|12312864|FG005|COMPLETED|Overall Study||44
11127345|NCT01375777|12312865|FG006|COMPLETED|Overall Study||44
11127346|NCT01375777|12312866|FG007|COMPLETED|Overall Study||44
11127347|NCT01375777|12312867|FG008|COMPLETED|Overall Study||44
11127348|NCT01375777|12312859|FG000|NOT COMPLETED|Overall Study||2
11127349|NCT01375777|12312860|FG001|NOT COMPLETED|Overall Study||3
11127350|NCT01375777|12312861|FG002|NOT COMPLETED|Overall Study||1
11127351|NCT01375777|12312862|FG003|NOT COMPLETED|Overall Study||0
11127352|NCT01375777|12312863|FG004|NOT COMPLETED|Overall Study||1
11127353|NCT01375777|12312864|FG005|NOT COMPLETED|Overall Study||1
11127354|NCT01375777|12312865|FG006|NOT COMPLETED|Overall Study||2
11127355|NCT01375777|12312866|FG007|NOT COMPLETED|Overall Study||2
11127356|NCT01375777|12312867|FG008|NOT COMPLETED|Overall Study||2
11127357|NCT01375946|12312887|FG000|STARTED|Overall Study||4
11127358|NCT01375946|12312888|FG001|STARTED|Overall Study||4
11127359|NCT01375946|12312889|FG002|STARTED|Overall Study||4
11127360|NCT01375946|12312890|FG003|STARTED|Overall Study||4
11127361|NCT01375946|12312891|FG004|STARTED|Overall Study||4
11127362|NCT01375946|12312892|FG005|STARTED|Overall Study||4
11127363|NCT01375946|12312887|FG000|COMPLETED|Overall Study||4
11127364|NCT01375946|12312888|FG001|COMPLETED|Overall Study||4
11127365|NCT01375946|12312889|FG002|COMPLETED|Overall Study||4
11127366|NCT01375946|12312890|FG003|COMPLETED|Overall Study||4
11127367|NCT01375946|12312891|FG004|COMPLETED|Overall Study||4
11127368|NCT01375946|12312892|FG005|COMPLETED|Overall Study||4
11127369|NCT01375946|12312887|FG000|NOT COMPLETED|Overall Study||0
11127370|NCT01375946|12312888|FG001|NOT COMPLETED|Overall Study||0
11127371|NCT01375946|12312889|FG002|NOT COMPLETED|Overall Study||0
11127372|NCT01375946|12312890|FG003|NOT COMPLETED|Overall Study||0
11127373|NCT01375946|12312891|FG004|NOT COMPLETED|Overall Study||0
11127374|NCT01375946|12312892|FG005|NOT COMPLETED|Overall Study||0
11127375|NCT01376037|12312898|FG000|STARTED|Overall Study||31
11127376|NCT01376037|12312899|FG001|STARTED|Overall Study||31
11127377|NCT01376037|12312898|FG000|COMPLETED|Overall Study||31
11127378|NCT01376037|12312899|FG001|COMPLETED|Overall Study||29
11127379|NCT01376037|12312898|FG000|NOT COMPLETED|Overall Study||0
11127380|NCT01376037|12312899|FG001|NOT COMPLETED|Overall Study||2
11127381|NCT01376050|12312907|FG000|STARTED|Overall Study||13
11127382|NCT01376050|12312908|FG001|STARTED|Overall Study||11
11127383|NCT01376050|12312907|FG000|COMPLETED|Overall Study||13
11127384|NCT01376050|12312908|FG001|COMPLETED|Overall Study||11
11127385|NCT01376050|12312907|FG000|NOT COMPLETED|Overall Study||0
11127386|NCT01376050|12312908|FG001|NOT COMPLETED|Overall Study||0
11127387|NCT01376089|12312916|FG000|STARTED|Overall Study||151
11127388|NCT01376089|12312917|FG001|STARTED|Overall Study||148
11127389|NCT01376089|12312916|FG000|COMPLETED|Overall Study||148
11127390|NCT01376089|12312917|FG001|COMPLETED|Overall Study||144
11127391|NCT01376089|12312916|FG000|NOT COMPLETED|Overall Study||3
11127392|NCT01376089|12312917|FG001|NOT COMPLETED|Overall Study||4
11127393|NCT01376167|12312930|FG000|STARTED|Overall Study||133
11127394|NCT01376167|12312931|FG001|STARTED|Overall Study||260
11127395|NCT01376167|12312932|FG002|STARTED|Overall Study||129
11127396|NCT01376167|12312930|FG000|COMPLETED|Overall Study||129
11127397|NCT01376167|12312931|FG001|COMPLETED|Overall Study||250
11127398|NCT01376167|12312932|FG002|COMPLETED|Overall Study||123
11127399|NCT01376167|12312930|FG000|NOT COMPLETED|Overall Study||4
11127400|NCT01376167|12312931|FG001|NOT COMPLETED|Overall Study||10
11239190|NCT02080091|12431171|FG000|COMPLETED|Overall Study||0
11127401|NCT01376167|12312932|FG002|NOT COMPLETED|Overall Study||6
11127402|NCT01376245|12312947|FG000|STARTED|2-wk Single-blind Placebo Run-in Period||744
11127403|NCT01376245|12312948|FG001|STARTED|2-wk Single-blind Placebo Run-in Period||0
11127404|NCT01376245|12312949|FG002|STARTED|2-wk Single-blind Placebo Run-in Period||0
11127405|NCT01376245|12312950|FG003|STARTED|2-wk Single-blind Placebo Run-in Period||0
11127406|NCT01376245|12312951|FG004|STARTED|2-wk Single-blind Placebo Run-in Period||0
11127407|NCT01376245|12312947|FG000|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
11127408|NCT01376245|12312948|FG001|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
11127409|NCT01376245|12312949|FG002|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
11127410|NCT01376245|12312950|FG003|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
11127411|NCT01376245|12312951|FG004|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
11127412|NCT01376245|12312947|FG000|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
11127413|NCT01376245|12312948|FG001|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
11127414|NCT01376245|12312949|FG002|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
11127415|NCT01376245|12312950|FG003|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
11127416|NCT01376245|12312951|FG004|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
11127417|NCT01376245|12312947|FG000|STARTED|24-week, Double-blind Treatment Period||0
11127418|NCT01376245|12312948|FG001|STARTED|24-week, Double-blind Treatment Period||162
11127419|NCT01376245|12312949|FG002|STARTED|24-week, Double-blind Treatment Period||160
11127420|NCT01376245|12312950|FG003|STARTED|24-week, Double-blind Treatment Period||161
11127421|NCT01376245|12312951|FG004|STARTED|24-week, Double-blind Treatment Period||160
11127422|NCT01376245|12312947|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
11127423|NCT01376245|12312948|FG001|COMPLETED|24-week, Double-blind Treatment Period||130
11127424|NCT01376245|12312949|FG002|COMPLETED|24-week, Double-blind Treatment Period||135
11127425|NCT01376245|12312950|FG003|COMPLETED|24-week, Double-blind Treatment Period||138
11127426|NCT01376245|12312951|FG004|COMPLETED|24-week, Double-blind Treatment Period||134
11127427|NCT01376245|12312947|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
11127428|NCT01376245|12312948|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||32
11127429|NCT01376245|12312949|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||25
11127430|NCT01376245|12312950|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||23
11127431|NCT01376245|12312951|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||26
11127432|NCT01376297|12312963|FG000|STARTED|Overall Study|number of randomised patients|309
11127433|NCT01376297|12312964|FG001|STARTED|Overall Study|number of randomised patients|104
11127434|NCT01376297|12312963|FG000|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
11127435|NCT01376297|12312964|FG001|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
11127436|NCT01376297|12312963|FG000|NOT COMPLETED|Overall Study||128
11127437|NCT01376297|12312964|FG001|NOT COMPLETED|Overall Study||49
11127438|NCT01376310|12312972|FG000|STARTED|Overall Study||126
11127439|NCT01376310|12312973|FG001|STARTED|Overall Study||33
11239191|NCT02080091|12431171|FG000|NOT COMPLETED|Overall Study||25
11239192|NCT02080195|12431175|FG000|STARTED|Overall Study||1
11127440|NCT01376310|12312972|FG000|COMPLETED|Overall Study||90
11127441|NCT01376310|12312973|FG001|COMPLETED|Overall Study||22
11127442|NCT01376310|12312972|FG000|NOT COMPLETED|Overall Study||36
11127443|NCT01376310|12312973|FG001|NOT COMPLETED|Overall Study||11
11202156|NCT01838226|12392560|FG000|STARTED|Overall Study||202
11202157|NCT01838226|12392561|FG001|STARTED|Overall Study||199
11202158|NCT01838226|12392560|FG000|COMPLETED|Overall Study||126
11202159|NCT01838226|12392561|FG001|COMPLETED|Overall Study||128
11202160|NCT01838226|12392560|FG000|NOT COMPLETED|Overall Study||76
11202161|NCT01838226|12392561|FG001|NOT COMPLETED|Overall Study||71
11202162|NCT01838304|12392569|FG000|STARTED|Overall Study||20
11202163|NCT01838304|12392570|FG001|STARTED|Overall Study||20
11202164|NCT01838304|12392569|FG000|COMPLETED|Overall Study||19
11202165|NCT01838304|12392570|FG001|COMPLETED|Overall Study||20
11202166|NCT01838304|12392569|FG000|NOT COMPLETED|Overall Study||1
11202167|NCT01838304|12392570|FG001|NOT COMPLETED|Overall Study||0
11202168|NCT01838317|12392578|FG000|STARTED|Overall Study||9
11202169|NCT01838317|12392579|FG001|STARTED|Overall Study||5
11202170|NCT01838317|12392578|FG000|COMPLETED|Overall Study||9
11202171|NCT01838317|12392579|FG001|COMPLETED|Overall Study||5
11202172|NCT01838317|12392578|FG000|NOT COMPLETED|Overall Study||0
11127444|NCT01376349|12312982|FG000|STARTED|Raondomized Treatment||147
11127445|NCT01376349|12312983|FG001|STARTED|Raondomized Treatment||149
11127446|NCT01376349|12312984|FG002|STARTED|Raondomized Treatment||147
11127447|NCT01376349|12312982|FG000|COMPLETED|Raondomized Treatment||123
11127448|NCT01376349|12312983|FG001|COMPLETED|Raondomized Treatment||114
11127449|NCT01376349|12312984|FG002|COMPLETED|Raondomized Treatment||118
11127450|NCT01376349|12312982|FG000|NOT COMPLETED|Raondomized Treatment||24
11127451|NCT01376349|12312983|FG001|NOT COMPLETED|Raondomized Treatment||35
11127452|NCT01376349|12312984|FG002|NOT COMPLETED|Raondomized Treatment||29
11127453|NCT01376349|12312982|FG000|STARTED|Optional Continuation Phase||0
11127454|NCT01376349|12312983|FG001|STARTED|Optional Continuation Phase||0
11127455|NCT01376349|12312984|FG002|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
11127456|NCT01376349|12312982|FG000|COMPLETED|Optional Continuation Phase||0
11127457|NCT01376349|12312983|FG001|COMPLETED|Optional Continuation Phase||0
11127458|NCT01376349|12312984|FG002|COMPLETED|Optional Continuation Phase||94
11127459|NCT01376349|12312982|FG000|NOT COMPLETED|Optional Continuation Phase||0
11127460|NCT01376349|12312983|FG001|NOT COMPLETED|Optional Continuation Phase||0
11127461|NCT01376349|12312984|FG002|NOT COMPLETED|Optional Continuation Phase||0
11127462|NCT01376362|12312993|FG000|STARTED|Overall Study||5
11127463|NCT01376362|12312993|FG000|COMPLETED|Overall Study||5
11127464|NCT01376362|12312993|FG000|NOT COMPLETED|Overall Study||0
11127465|NCT01376388|12312997|FG000|STARTED|Overall Study||130
11127466|NCT01376388|12312997|FG000|COMPLETED|Overall Study||112
11127467|NCT01376388|12312997|FG000|NOT COMPLETED|Overall Study||18
11127468|NCT01376557|12313006|FG000|STARTED|Overall Study||59
11127469|NCT01376557|12313007|FG001|STARTED|Overall Study||60
11239193|NCT02080195|12431175|FG000|COMPLETED|Overall Study||1
11239194|NCT02080195|12431175|FG000|NOT COMPLETED|Overall Study||0
11239195|NCT02080273|12431182|FG000|STARTED|Overall Study||45
11127470|NCT01376557|12313008|FG002|STARTED|Overall Study||60
11127471|NCT01376557|12313009|FG003|STARTED|Overall Study||60
11127472|NCT01376557|12313010|FG004|STARTED|Overall Study||60
11127473|NCT01376557|12313006|FG000|COMPLETED|Overall Study||51
11127474|NCT01376557|12313007|FG001|COMPLETED|Overall Study||54
11127475|NCT01376557|12313008|FG002|COMPLETED|Overall Study||55
11127476|NCT01376557|12313009|FG003|COMPLETED|Overall Study||54
11127477|NCT01376557|12313010|FG004|COMPLETED|Overall Study||53
11127478|NCT01376557|12313006|FG000|NOT COMPLETED|Overall Study||8
11127479|NCT01376557|12313007|FG001|NOT COMPLETED|Overall Study||6
11127480|NCT01376557|12313008|FG002|NOT COMPLETED|Overall Study||5
11127481|NCT01376557|12313009|FG003|NOT COMPLETED|Overall Study||6
11127482|NCT01376557|12313010|FG004|NOT COMPLETED|Overall Study||7
11127483|NCT01376700|12313022|FG000|STARTED|Overall Study||19
11127484|NCT01376700|12313022|FG000|COMPLETED|Overall Study||3
11127485|NCT01376700|12313022|FG000|NOT COMPLETED|Overall Study||16
11127486|NCT01376804|12313029|FG000|STARTED|Treatment Period||57
11127487|NCT01376804|12313029|FG000|Received Study Drug|Treatment Period||56
11127488|NCT01376804|12313029|FG000|COMPLETED|Treatment Period||49
11127489|NCT01376804|12313029|FG000|NOT COMPLETED|Treatment Period||8
11127490|NCT01376804|12313029|FG000|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
11127491|NCT01376804|12313029|FG000|COMPLETED|Follow-up Period||55
11127492|NCT01376804|12313029|FG000|NOT COMPLETED|Follow-up Period||0
11127493|NCT01376908|12313035|FG000|STARTED|Overall Study||27
11127494|NCT01376908|12313036|FG001|STARTED|Overall Study||29
11127495|NCT01376908|12313035|FG000|COMPLETED|Overall Study||25
11127496|NCT01376908|12313036|FG001|COMPLETED|Overall Study||26
11127497|NCT01376908|12313035|FG000|NOT COMPLETED|Overall Study||2
11127498|NCT01376908|12313036|FG001|NOT COMPLETED|Overall Study||3
11127499|NCT01377012|12313052|FG000|STARTED|Core Study||210
11127500|NCT01377012|12313053|FG001|STARTED|Core Study||213
11127501|NCT01377012|12313054|FG002|STARTED|Core Study||214
11127502|NCT01377012|12313052|FG000|wk16 Re-randomized to AIN 75mg NR|Core Study||0
11127503|NCT01377012|12313053|FG001|wk16 Re-randomized to AIN 75mg NR|Core Study||0
11127504|NCT01377012|12313054|FG002|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
11127505|NCT01377012|12313052|FG000|wk16 Re-randomized to AIN 150mg NR|Core Study||0
11127506|NCT01377012|12313053|FG001|wk16 Re-randomized to AIN 150mg NR|Core Study||0
11127507|NCT01377012|12313054|FG002|wk16 Re-randomized to AIN 150mg NR|Core Study||53
11127508|NCT01377012|12313052|FG000|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
11127509|NCT01377012|12313053|FG001|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
11127510|NCT01377012|12313054|FG002|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
11127511|NCT01377012|12313052|FG000|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
11127512|NCT01377012|12313053|FG001|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
11127513|NCT01377012|12313054|FG002|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
11127514|NCT01377012|12313052|FG000|COMPLETED|Core Study||76
11127515|NCT01377012|12313053|FG001|COMPLETED|Core Study||81
11127516|NCT01377012|12313054|FG002|COMPLETED|Core Study||80
11127517|NCT01377012|12313052|FG000|NOT COMPLETED|Core Study||134
11127518|NCT01377012|12313053|FG001|NOT COMPLETED|Core Study||132
11127519|NCT01377012|12313054|FG002|NOT COMPLETED|Core Study||134
11127520|NCT01377012|12313052|FG000|STARTED|Extension Study, Weeks 104-260||57
11127521|NCT01377012|12313053|FG001|STARTED|Extension Study, Weeks 104-260||71
11127522|NCT01377012|12313054|FG002|STARTED|Extension Study, Weeks 104-260||68
11127523|NCT01377012|12313052|FG000|COMPLETED|Extension Study, Weeks 104-260||0
11127524|NCT01377012|12313053|FG001|COMPLETED|Extension Study, Weeks 104-260||0
11127525|NCT01377012|12313054|FG002|COMPLETED|Extension Study, Weeks 104-260||0
11127526|NCT01377012|12313052|FG000|NOT COMPLETED|Extension Study, Weeks 104-260||57
11127527|NCT01377012|12313053|FG001|NOT COMPLETED|Extension Study, Weeks 104-260||71
11127528|NCT01377012|12313054|FG002|NOT COMPLETED|Extension Study, Weeks 104-260||68
11127529|NCT01377194|12313065|FG000|STARTED|Overall Study||186
11127530|NCT01377194|12313066|FG001|STARTED|Overall Study||188
11127531|NCT01377194|12313067|FG002|STARTED|Overall Study||188
11127532|NCT01377194|12313065|FG000|COMPLETED|Overall Study||154
11127533|NCT01377194|12313066|FG001|COMPLETED|Overall Study||145
11127534|NCT01377194|12313067|FG002|COMPLETED|Overall Study||142
11127535|NCT01377194|12313065|FG000|NOT COMPLETED|Overall Study||32
11127536|NCT01377194|12313066|FG001|NOT COMPLETED|Overall Study||43
11127537|NCT01377194|12313067|FG002|NOT COMPLETED|Overall Study||46
11127538|NCT01377233|12313083|FG000|STARTED|Open-label||46
11127539|NCT01377233|12313084|FG001|STARTED|Open-label||0
11127540|NCT01377233|12313085|FG002|STARTED|Open-label||0
11127541|NCT01377233|12313086|FG003|STARTED|Open-label||0
11127542|NCT01377233|12313087|FG004|STARTED|Open-label||0
11127543|NCT01377233|12313083|FG000|COMPLETED|Open-label||42
11127544|NCT01377233|12313084|FG001|COMPLETED|Open-label||0
11127545|NCT01377233|12313085|FG002|COMPLETED|Open-label||0
11127546|NCT01377233|12313086|FG003|COMPLETED|Open-label||0
11127547|NCT01377233|12313087|FG004|COMPLETED|Open-label||0
11127548|NCT01377233|12313083|FG000|NOT COMPLETED|Open-label||4
11127549|NCT01377233|12313084|FG001|NOT COMPLETED|Open-label||0
11127550|NCT01377233|12313085|FG002|NOT COMPLETED|Open-label||0
11127551|NCT01377233|12313086|FG003|NOT COMPLETED|Open-label||0
11127552|NCT01377233|12313087|FG004|NOT COMPLETED|Open-label||0
11127553|NCT01377233|12313083|FG000|STARTED|Double-blind||0
11127554|NCT01377233|12313084|FG001|STARTED|Double-blind||11
11127555|NCT01377233|12313085|FG002|STARTED|Double-blind||10
11127556|NCT01377233|12313086|FG003|STARTED|Double-blind||11
11127557|NCT01377233|12313087|FG004|STARTED|Double-blind||10
11127558|NCT01377233|12313083|FG000|COMPLETED|Double-blind||0
11127559|NCT01377233|12313084|FG001|COMPLETED|Double-blind||10
11127560|NCT01377233|12313085|FG002|COMPLETED|Double-blind||8
11127561|NCT01377233|12313086|FG003|COMPLETED|Double-blind||7
11127562|NCT01377233|12313087|FG004|COMPLETED|Double-blind||8
11127563|NCT01377233|12313083|FG000|NOT COMPLETED|Double-blind||0
11127564|NCT01377233|12313084|FG001|NOT COMPLETED|Double-blind||1
11127565|NCT01377233|12313085|FG002|NOT COMPLETED|Double-blind||2
11127566|NCT01377233|12313086|FG003|NOT COMPLETED|Double-blind||4
11127567|NCT01377233|12313087|FG004|NOT COMPLETED|Double-blind||2
11127568|NCT01377389|12313103|FG000|STARTED|Overall Study||30
11127569|NCT01377389|12313103|FG000|COMPLETED|Overall Study||27
11127570|NCT01377389|12313103|FG000|NOT COMPLETED|Overall Study||3
11127571|NCT01377402|12313107|FG000|STARTED|Overall Study||982
11127572|NCT01377402|12313107|FG000|COMPLETED|Overall Study||982
11127573|NCT01377402|12313107|FG000|NOT COMPLETED|Overall Study||0
11127574|NCT01377467|12313115|FG000|STARTED|Overall Study||46
11127575|NCT01377467|12313116|FG001|STARTED|Overall Study||44
11127576|NCT01377467|12313115|FG000|COMPLETED|Overall Study||46
11127577|NCT01377467|12313116|FG001|COMPLETED|Overall Study||44
11127578|NCT01377467|12313115|FG000|NOT COMPLETED|Overall Study||0
11127579|NCT01377467|12313116|FG001|NOT COMPLETED|Overall Study||0
11127580|NCT01377480|12313126|FG000|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
11127581|NCT01377480|12313127|FG001|STARTED|Overall Study||30
11127582|NCT01377480|12313128|FG002|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
11127583|NCT01377480|12313129|FG003|STARTED|Overall Study||30
11239196|NCT02080273|12431183|FG001|STARTED|Overall Study||45
11239197|NCT02080273|12431184|FG002|STARTED|Overall Study||45
11239198|NCT02080273|12431182|FG000|COMPLETED|Overall Study||45
11239199|NCT02080273|12431183|FG001|COMPLETED|Overall Study||45
11239200|NCT02080273|12431184|FG002|COMPLETED|Overall Study||45
11239201|NCT02080273|12431182|FG000|NOT COMPLETED|Overall Study||0
11239202|NCT02080273|12431183|FG001|NOT COMPLETED|Overall Study||0
11239203|NCT02080273|12431184|FG002|NOT COMPLETED|Overall Study||0
11239204|NCT02080312|12431192|FG000|STARTED|Overall Study||6
11239205|NCT02080312|12431192|FG000|COMPLETED|Overall Study||6
11239206|NCT02080312|12431192|FG000|NOT COMPLETED|Overall Study||0
11239207|NCT02080364|12431201|FG000|STARTED|Baseline Period||197
11239208|NCT02080364|12431202|FG001|STARTED|Baseline Period||208
11239209|NCT02080364|12431203|FG002|STARTED|Baseline Period||247
11239210|NCT02080364|12431204|FG003|STARTED|Baseline Period||228
11239211|NCT02080364|12431201|FG000|COMPLETED|Baseline Period||195
11239212|NCT02080364|12431202|FG001|COMPLETED|Baseline Period||206
11239213|NCT02080364|12431203|FG002|COMPLETED|Baseline Period||246
11239214|NCT02080364|12431204|FG003|COMPLETED|Baseline Period||228
11239215|NCT02080364|12431201|FG000|NOT COMPLETED|Baseline Period||2
11239216|NCT02080364|12431202|FG001|NOT COMPLETED|Baseline Period||2
11239217|NCT02080364|12431203|FG002|NOT COMPLETED|Baseline Period||1
11239218|NCT02080364|12431204|FG003|NOT COMPLETED|Baseline Period||0
11239219|NCT02080364|12431201|FG000|STARTED|Treatment Period||195
11239220|NCT02080364|12431202|FG001|STARTED|Treatment Period||206
11239221|NCT02080364|12431203|FG002|STARTED|Treatment Period||246
11239222|NCT02080364|12431204|FG003|STARTED|Treatment Period||228
11239223|NCT02080364|12431201|FG000|COMPLETED|Treatment Period||148
11239224|NCT02080364|12431202|FG001|COMPLETED|Treatment Period||157
11239225|NCT02080364|12431203|FG002|COMPLETED|Treatment Period||9
11127584|NCT01377480|12313126|FG000|COMPLETED|Overall Study||32
11127585|NCT01377480|12313127|FG001|COMPLETED|Overall Study||29
11127586|NCT01377480|12313128|FG002|COMPLETED|Overall Study||18
11127587|NCT01377480|12313129|FG003|COMPLETED|Overall Study||19
11239226|NCT02080364|12431204|FG003|COMPLETED|Treatment Period||4
11239227|NCT02080364|12431201|FG000|NOT COMPLETED|Treatment Period||47
11239228|NCT02080364|12431202|FG001|NOT COMPLETED|Treatment Period||49
11239229|NCT02080364|12431203|FG002|NOT COMPLETED|Treatment Period||237
11239230|NCT02080364|12431204|FG003|NOT COMPLETED|Treatment Period||224
11338950|NCT02907073|12536302|FG001|NOT COMPLETED|Overall Study||0
11338951|NCT02907073|12536303|FG002|NOT COMPLETED|Overall Study||0
11338952|NCT02907177|12536313|FG000|STARTED|Overall Study||68
11338953|NCT02907177|12536314|FG001|STARTED|Overall Study||68
11338954|NCT02907177|12536313|FG000|Treated|Overall Study||67
11338955|NCT02907177|12536314|FG001|Treated|Overall Study||68
11338956|NCT02907177|12536313|FG000|Randomized Analysis Set|Overall Study||68
11338957|NCT02907177|12536314|FG001|Randomized Analysis Set|Overall Study||68
11338958|NCT02907177|12536313|FG000|COMPLETED|Overall Study||0
11338959|NCT02907177|12536314|FG001|COMPLETED|Overall Study||0
11338960|NCT02907177|12536313|FG000|NOT COMPLETED|Overall Study||68
11338961|NCT02907177|12536314|FG001|NOT COMPLETED|Overall Study||68
11338962|NCT02907216|12536322|FG000|STARTED|Overall Study||147
11338963|NCT02907216|12536323|FG001|STARTED|Overall Study||145
11338964|NCT02907216|12536322|FG000|COMPLETED|Overall Study||146
11338965|NCT02907216|12536323|FG001|COMPLETED|Overall Study||144
11338966|NCT02907216|12536322|FG000|NOT COMPLETED|Overall Study||1
11338967|NCT02907216|12536323|FG001|NOT COMPLETED|Overall Study||1
11338968|NCT02907268|12536331|FG000|STARTED|Overall Study||5
11338969|NCT02907268|12536332|FG001|STARTED|Overall Study||5
11338970|NCT02907268|12536331|FG000|COMPLETED|Overall Study||5
11338971|NCT02907268|12536332|FG001|COMPLETED|Overall Study||5
11338972|NCT02907268|12536331|FG000|NOT COMPLETED|Overall Study||0
11127588|NCT01377480|12313126|FG000|NOT COMPLETED|Overall Study||0
11127589|NCT01377480|12313127|FG001|NOT COMPLETED|Overall Study||1
11127590|NCT01377480|12313128|FG002|NOT COMPLETED|Overall Study||10
11127591|NCT01377480|12313129|FG003|NOT COMPLETED|Overall Study||11
11127592|NCT01377584|12313145|FG000|STARTED|Overall Study||8
11127593|NCT01377584|12313146|FG001|STARTED|Overall Study||8
11127594|NCT01377584|12313147|FG002|STARTED|Overall Study||10
11127595|NCT01377584|12313148|FG003|STARTED|Overall Study||10
11127596|NCT01377584|12313149|FG004|STARTED|Overall Study||12
11127597|NCT01377584|12313150|FG005|STARTED|Overall Study||12
11127598|NCT01377584|12313145|FG000|COMPLETED|Overall Study||5
11127599|NCT01377584|12313146|FG001|COMPLETED|Overall Study||5
11127600|NCT01377584|12313147|FG002|COMPLETED|Overall Study||6
11127601|NCT01377584|12313148|FG003|COMPLETED|Overall Study||6
11127602|NCT01377584|12313149|FG004|COMPLETED|Overall Study||9
11127603|NCT01377584|12313150|FG005|COMPLETED|Overall Study||9
11127604|NCT01377584|12313145|FG000|NOT COMPLETED|Overall Study||3
11127605|NCT01377584|12313146|FG001|NOT COMPLETED|Overall Study||3
11127606|NCT01377584|12313147|FG002|NOT COMPLETED|Overall Study||4
11127607|NCT01377584|12313148|FG003|NOT COMPLETED|Overall Study||4
11127608|NCT01377584|12313149|FG004|NOT COMPLETED|Overall Study||3
11127609|NCT01377584|12313150|FG005|NOT COMPLETED|Overall Study||3
11127610|NCT01377623|12313169|FG000|STARTED|Overall Study||33
11127611|NCT01377623|12313170|FG001|STARTED|Overall Study||33
11127612|NCT01377623|12313169|FG000|COMPLETED|Overall Study||26
11127613|NCT01377623|12313170|FG001|COMPLETED|Overall Study||28
11127614|NCT01377623|12313169|FG000|NOT COMPLETED|Overall Study||7
11127615|NCT01377623|12313170|FG001|NOT COMPLETED|Overall Study||5
11127616|NCT01377636|12313176|FG000|STARTED|Overall Study||20
11127617|NCT01377636|12313176|FG000|COMPLETED|Overall Study||20
11127618|NCT01377636|12313176|FG000|NOT COMPLETED|Overall Study||0
11127619|NCT01377844|12313184|FG000|STARTED|Overall Study||145
11127620|NCT01377844|12313185|FG001|STARTED|Overall Study||143
11127621|NCT01377844|12313184|FG000|Safety Population|Overall Study||145
11127622|NCT01377844|12313185|FG001|Safety Population|Overall Study||141
11127623|NCT01377844|12313184|FG000|COMPLETED|Overall Study||109
11127624|NCT01377844|12313185|FG001|COMPLETED|Overall Study||108
11127625|NCT01377844|12313184|FG000|NOT COMPLETED|Overall Study||36
11127626|NCT01377844|12313185|FG001|NOT COMPLETED|Overall Study||35
11127627|NCT01377922|12313194|FG000|STARTED|Overall Study||22
11127628|NCT01377922|12313195|FG001|STARTED|Overall Study||16
11127629|NCT01377922|12313194|FG000|COMPLETED|Overall Study||21
11127630|NCT01377922|12313195|FG001|COMPLETED|Overall Study||16
11127631|NCT01377922|12313194|FG000|NOT COMPLETED|Overall Study||1
11127632|NCT01377922|12313195|FG001|NOT COMPLETED|Overall Study||0
11127633|NCT01377987|12313201|FG000|STARTED|First Intervention (7 Days)||14
11127634|NCT01377987|12313202|FG001|STARTED|First Intervention (7 Days)||15
11127635|NCT01377987|12313201|FG000|COMPLETED|First Intervention (7 Days)||14
11127636|NCT01377987|12313202|FG001|COMPLETED|First Intervention (7 Days)||15
11127637|NCT01377987|12313201|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11127638|NCT01377987|12313202|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11127639|NCT01377987|12313201|FG000|STARTED|Washout (7 Days)||14
11127640|NCT01377987|12313202|FG001|STARTED|Washout (7 Days)||15
11127641|NCT01377987|12313201|FG000|COMPLETED|Washout (7 Days)||13
11127642|NCT01377987|12313202|FG001|COMPLETED|Washout (7 Days)||14
11127643|NCT01377987|12313201|FG000|NOT COMPLETED|Washout (7 Days)||1
11127644|NCT01377987|12313202|FG001|NOT COMPLETED|Washout (7 Days)||1
11127645|NCT01377987|12313201|FG000|STARTED|Second Intervention (7 Days)||13
11127646|NCT01377987|12313202|FG001|STARTED|Second Intervention (7 Days)||14
11127647|NCT01377987|12313201|FG000|COMPLETED|Second Intervention (7 Days)||13
11127648|NCT01377987|12313202|FG001|COMPLETED|Second Intervention (7 Days)||14
11127649|NCT01377987|12313201|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
11127650|NCT01377987|12313202|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11127651|NCT01378065|12313208|FG000|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
11127652|NCT01378065|12313208|FG000|6 Week|Overall Study||30
11127653|NCT01378065|12313208|FG000|3 Months|Overall Study||30
11127654|NCT01378065|12313208|FG000|6 Months|Overall Study||30
11127655|NCT01378065|12313208|FG000|12 Months|Overall Study||30
11127656|NCT01378065|12313208|FG000|COMPLETED|Overall Study||30
11127657|NCT01378065|12313208|FG000|NOT COMPLETED|Overall Study||0
11127658|NCT01378104|12313214|FG000|STARTED|Overall Study||92
11127659|NCT01378104|12313215|FG001|STARTED|Overall Study||86
11127660|NCT01378104|12313214|FG000|COMPLETED|Overall Study||65
11127661|NCT01378104|12313215|FG001|COMPLETED|Overall Study||60
11127662|NCT01378104|12313214|FG000|NOT COMPLETED|Overall Study||27
11127663|NCT01378104|12313215|FG001|NOT COMPLETED|Overall Study||26
11127664|NCT01378117|12313226|FG000|STARTED|Overall Study||31
11127665|NCT01378117|12313227|FG001|STARTED|Overall Study||30
11127666|NCT01378117|12313228|FG002|STARTED|Overall Study||29
11127667|NCT01378117|12313226|FG000|COMPLETED|Overall Study||27
11127668|NCT01378117|12313227|FG001|COMPLETED|Overall Study||29
11127669|NCT01378117|12313228|FG002|COMPLETED|Overall Study||26
11127670|NCT01378117|12313226|FG000|NOT COMPLETED|Overall Study||4
11127671|NCT01378117|12313227|FG001|NOT COMPLETED|Overall Study||1
11127672|NCT01378117|12313228|FG002|NOT COMPLETED|Overall Study||3
11127673|NCT01378195|12313243|FG000|STARTED|Overall Study||75
11127674|NCT01378195|12313244|FG001|STARTED|Overall Study||75
11127675|NCT01378195|12313243|FG000|COMPLETED|Overall Study||46
11127676|NCT01378195|12313244|FG001|COMPLETED|Overall Study||57
11127677|NCT01378195|12313243|FG000|NOT COMPLETED|Overall Study||29
11127678|NCT01378195|12313244|FG001|NOT COMPLETED|Overall Study||18
11127679|NCT01378221|12313252|FG000|STARTED|Overall Study||36
11127680|NCT01378221|12313253|FG001|STARTED|Overall Study||39
11127681|NCT01378221|12313252|FG000|COMPLETED|Overall Study||29
11127682|NCT01378221|12313253|FG001|COMPLETED|Overall Study||30
11127683|NCT01378221|12313252|FG000|NOT COMPLETED|Overall Study||7
11127684|NCT01378221|12313253|FG001|NOT COMPLETED|Overall Study||9
11127685|NCT01378273|12313261|FG000|STARTED|Overall Study||464
11127686|NCT01378273|12313262|FG001|STARTED|Overall Study||477
11127687|NCT01378273|12313261|FG000|COMPLETED|Overall Study||460
11127688|NCT01378273|12313262|FG001|COMPLETED|Overall Study||476
11127689|NCT01378273|12313261|FG000|NOT COMPLETED|Overall Study||4
11127690|NCT01378273|12313262|FG001|NOT COMPLETED|Overall Study||1
11127691|NCT01378299|12313272|FG000|STARTED|Overall Study||105
11127692|NCT01378299|12313272|FG000|BMI group1|Overall Study||38
11127693|NCT01378299|12313272|FG000|BMI Group 2|Overall Study||40
11127694|NCT01378299|12313272|FG000|BMI Group 3|Overall Study||27
11127695|NCT01378299|12313272|FG000|COMPLETED|Overall Study||74
11127696|NCT01378299|12313272|FG000|NOT COMPLETED|Overall Study||31
11127697|NCT01378325|12313304|FG000|STARTED|Overall Study||40
11127698|NCT01378325|12313305|FG001|STARTED|Overall Study||40
11127699|NCT01378325|12313304|FG000|COMPLETED|Overall Study||40
11127700|NCT01378325|12313305|FG001|COMPLETED|Overall Study||39
11127701|NCT01378325|12313304|FG000|NOT COMPLETED|Overall Study||0
11127702|NCT01378325|12313305|FG001|NOT COMPLETED|Overall Study||1
11127703|NCT01378377|12313314|FG000|STARTED|Overall Study||4
11127704|NCT01378377|12313315|FG001|STARTED|Overall Study||23
11127705|NCT01378377|12313316|FG002|STARTED|Overall Study||6
11127706|NCT01378377|12313314|FG000|COMPLETED|Overall Study||4
11127707|NCT01378377|12313315|FG001|COMPLETED|Overall Study||23
11127708|NCT01378377|12313316|FG002|COMPLETED|Overall Study||6
11127709|NCT01378377|12313314|FG000|NOT COMPLETED|Overall Study||0
11127710|NCT01378377|12313315|FG001|NOT COMPLETED|Overall Study||0
11127711|NCT01378377|12313316|FG002|NOT COMPLETED|Overall Study||0
11127712|NCT01378416|12313329|FG000|STARTED|Overall Study||16
11127713|NCT01378416|12313329|FG000|COMPLETED|Overall Study||16
11127714|NCT01378416|12313329|FG000|NOT COMPLETED|Overall Study||0
11127715|NCT01378429|12313335|FG000|STARTED|Overall Study||42
11127716|NCT01378429|12313336|FG001|STARTED|Overall Study||47
11127717|NCT01378429|12313335|FG000|COMPLETED|Overall Study||41
11127718|NCT01378429|12313336|FG001|COMPLETED|Overall Study||47
11127719|NCT01378429|12313335|FG000|NOT COMPLETED|Overall Study||1
11127720|NCT01378429|12313336|FG001|NOT COMPLETED|Overall Study||0
11127721|NCT01378520|12313345|FG000|STARTED|First Intervention (Day 2-3)||10
11127722|NCT01378520|12313346|FG001|STARTED|First Intervention (Day 2-3)||10
11127723|NCT01378520|12313345|FG000|COMPLETED|First Intervention (Day 2-3)||10
11127724|NCT01378520|12313346|FG001|COMPLETED|First Intervention (Day 2-3)||10
11127725|NCT01378520|12313345|FG000|NOT COMPLETED|First Intervention (Day 2-3)||0
11127726|NCT01378520|12313346|FG001|NOT COMPLETED|First Intervention (Day 2-3)||0
11127727|NCT01378520|12313345|FG000|STARTED|Second Intervention (Day 4-6)||10
11127728|NCT01378520|12313346|FG001|STARTED|Second Intervention (Day 4-6)||10
11127729|NCT01378520|12313345|FG000|COMPLETED|Second Intervention (Day 4-6)||10
11127730|NCT01378520|12313346|FG001|COMPLETED|Second Intervention (Day 4-6)||10
11127731|NCT01378520|12313345|FG000|NOT COMPLETED|Second Intervention (Day 4-6)||0
11127732|NCT01378520|12313346|FG001|NOT COMPLETED|Second Intervention (Day 4-6)||0
11127733|NCT01378858|12313354|FG000|STARTED|Overall Study||50
11127734|NCT01378858|12313355|FG001|STARTED|Overall Study||50
11127735|NCT01378858|12313354|FG000|COMPLETED|Overall Study||46
11127736|NCT01378858|12313355|FG001|COMPLETED|Overall Study||46
11127737|NCT01378858|12313354|FG000|NOT COMPLETED|Overall Study||4
11127738|NCT01378858|12313355|FG001|NOT COMPLETED|Overall Study||4
11127739|NCT01378962|12313361|FG000|STARTED|Overall Study||50
11127740|NCT01378962|12313361|FG000|COMPLETED|Overall Study||33
11127741|NCT01378962|12313361|FG000|NOT COMPLETED|Overall Study||17
11127742|NCT01378975|12313367|FG000|STARTED|Overall Study||90
11127743|NCT01378975|12313368|FG001|STARTED|Overall Study||56
11127744|NCT01378975|12313367|FG000|COMPLETED|Overall Study||4
11127745|NCT01378975|12313368|FG001|COMPLETED|Overall Study||6
11127746|NCT01378975|12313367|FG000|NOT COMPLETED|Overall Study||86
11127747|NCT01378975|12313368|FG001|NOT COMPLETED|Overall Study||50
11127748|NCT01378988|12313377|FG000|STARTED|Overall Study||2
11127749|NCT01378988|12313378|FG001|STARTED|Overall Study||3
11127750|NCT01378988|12313377|FG000|COMPLETED|Overall Study||2
11127751|NCT01378988|12313378|FG001|COMPLETED|Overall Study||3
11127752|NCT01378988|12313377|FG000|NOT COMPLETED|Overall Study||0
11127753|NCT01378988|12313378|FG001|NOT COMPLETED|Overall Study||0
11127754|NCT01379183|12313386|FG000|STARTED|Overall Study||19
11127755|NCT01379183|12313387|FG001|STARTED|Overall Study||21
11127756|NCT01379183|12313386|FG000|COMPLETED|Overall Study||19
11127757|NCT01379183|12313387|FG001|COMPLETED|Overall Study||21
11127758|NCT01379183|12313386|FG000|NOT COMPLETED|Overall Study||0
11127759|NCT01379183|12313387|FG001|NOT COMPLETED|Overall Study||0
11127760|NCT01379222|12313395|FG000|STARTED|Overall Study||178
11127761|NCT01379222|12313395|FG000|COMPLETED|Overall Study||105
11127762|NCT01379222|12313395|FG000|NOT COMPLETED|Overall Study||73
11127763|NCT01379508|12313403|FG000|STARTED|Treatment to Week 104||99
11127764|NCT01379508|12313404|FG001|STARTED|Treatment to Week 104||22
11127765|NCT01379508|12313405|FG002|STARTED|Treatment to Week 104||109
11127766|NCT01379508|12313406|FG003|STARTED|Treatment to Week 104||11
11127767|NCT01379508|12313403|FG000|Completed Wk 24|Treatment to Week 104||93
11127768|NCT01379508|12313404|FG001|Completed Wk 24|Treatment to Week 104||22
11127769|NCT01379508|12313405|FG002|Completed Wk 24|Treatment to Week 104||107
11127770|NCT01379508|12313406|FG003|Completed Wk 24|Treatment to Week 104||11
11127771|NCT01379508|12313403|FG000|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
11127772|NCT01379508|12313404|FG001|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
11127773|NCT01379508|12313405|FG002|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
11127774|NCT01379508|12313406|FG003|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
11127775|NCT01379508|12313403|FG000|COMPLETED|Treatment to Week 104||80
11127776|NCT01379508|12313404|FG001|COMPLETED|Treatment to Week 104||19
11127777|NCT01379508|12313405|FG002|COMPLETED|Treatment to Week 104||96
11127778|NCT01379508|12313406|FG003|COMPLETED|Treatment to Week 104||11
11127779|NCT01379508|12313403|FG000|NOT COMPLETED|Treatment to Week 104||19
11127780|NCT01379508|12313404|FG001|NOT COMPLETED|Treatment to Week 104||3
11127781|NCT01379508|12313405|FG002|NOT COMPLETED|Treatment to Week 104||13
11127782|NCT01379508|12313406|FG003|NOT COMPLETED|Treatment to Week 104||0
11127783|NCT01379508|12313403|FG000|STARTED|Extension Period Weeks 109-156||64
11127784|NCT01379508|12313404|FG001|STARTED|Extension Period Weeks 109-156||17
11127785|NCT01379508|12313405|FG002|STARTED|Extension Period Weeks 109-156||79
11127786|NCT01379508|12313406|FG003|STARTED|Extension Period Weeks 109-156||10
11127787|NCT01379508|12313403|FG000|COMPLETED|Extension Period Weeks 109-156||45
11127788|NCT01379508|12313404|FG001|COMPLETED|Extension Period Weeks 109-156||14
11127789|NCT01379508|12313405|FG002|COMPLETED|Extension Period Weeks 109-156||65
11127790|NCT01379508|12313406|FG003|COMPLETED|Extension Period Weeks 109-156||10
11127791|NCT01379508|12313403|FG000|NOT COMPLETED|Extension Period Weeks 109-156||19
11127792|NCT01379508|12313404|FG001|NOT COMPLETED|Extension Period Weeks 109-156||3
11127793|NCT01379508|12313405|FG002|NOT COMPLETED|Extension Period Weeks 109-156||14
11127794|NCT01379508|12313406|FG003|NOT COMPLETED|Extension Period Weeks 109-156||0
11127795|NCT01379521|12313422|FG000|STARTED|Overall Study -Treatment Period||33
11127796|NCT01379521|12313423|FG001|STARTED|Overall Study -Treatment Period||26
11127797|NCT01379521|12313422|FG000|COMPLETED|Overall Study -Treatment Period||0
11127798|NCT01379521|12313423|FG001|COMPLETED|Overall Study -Treatment Period||0
11127799|NCT01379521|12313422|FG000|NOT COMPLETED|Overall Study -Treatment Period||33
11127800|NCT01379521|12313423|FG001|NOT COMPLETED|Overall Study -Treatment Period||26
11127801|NCT01379521|12313422|FG000|STARTED|Post-Treatment Evaluations||25
11127802|NCT01379521|12313423|FG001|STARTED|Post-Treatment Evaluations||21
11127803|NCT01379521|12313422|FG000|COMPLETED|Post-Treatment Evaluations||0
11127804|NCT01379521|12313423|FG001|COMPLETED|Post-Treatment Evaluations||0
11127805|NCT01379521|12313422|FG000|NOT COMPLETED|Post-Treatment Evaluations||25
11127806|NCT01379521|12313423|FG001|NOT COMPLETED|Post-Treatment Evaluations||21
11127807|NCT01379534|12313431|FG000|STARTED|Treatment Phase||22
11127808|NCT01379534|12313432|FG001|STARTED|Treatment Phase||31
11127809|NCT01379534|12313431|FG000|COMPLETED|Treatment Phase||0
11127810|NCT01379534|12313432|FG001|COMPLETED|Treatment Phase||0
11127811|NCT01379534|12313431|FG000|NOT COMPLETED|Treatment Phase||22
11127812|NCT01379534|12313432|FG001|NOT COMPLETED|Treatment Phase||31
11127813|NCT01379534|12313431|FG000|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
11127814|NCT01379534|12313432|FG001|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
11127815|NCT01379534|12313431|FG000|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
11127816|NCT01379534|12313432|FG001|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
11127817|NCT01379534|12313431|FG000|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
11127818|NCT01379534|12313432|FG001|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
11127819|NCT01379573|12313438|FG000|STARTED|Overall Study||74
11127820|NCT01379573|12313438|FG000|COMPLETED|Overall Study||63
11127821|NCT01379573|12313438|FG000|NOT COMPLETED|Overall Study||11
11127822|NCT01379625|12313444|FG000|STARTED|Overall Study||16
11127823|NCT01379625|12313445|FG001|STARTED|Overall Study||16
11127824|NCT01379625|12313444|FG000|COMPLETED|Overall Study||16
11127825|NCT01379625|12313445|FG001|COMPLETED|Overall Study||16
11127826|NCT01379625|12313444|FG000|NOT COMPLETED|Overall Study||0
11127827|NCT01379625|12313445|FG001|NOT COMPLETED|Overall Study||0
11127828|NCT01379651|12313453|FG000|STARTED|Overall Study||10
11127829|NCT01379651|12313454|FG001|STARTED|Overall Study||10
11127830|NCT01379651|12313453|FG000|COMPLETED|Overall Study||10
11127831|NCT01379651|12313454|FG001|COMPLETED|Overall Study||10
11127832|NCT01379651|12313453|FG000|NOT COMPLETED|Overall Study||0
11127833|NCT01379651|12313454|FG001|NOT COMPLETED|Overall Study||0
11127834|NCT01379664|12313462|FG000|STARTED|Overall Study||714
11127835|NCT01379664|12313463|FG001|STARTED|Overall Study||870
11127836|NCT01379664|12313462|FG000|COMPLETED|Overall Study||714
11127837|NCT01379664|12313463|FG001|COMPLETED|Overall Study||870
11127838|NCT01379664|12313462|FG000|NOT COMPLETED|Overall Study||0
11127839|NCT01379664|12313463|FG001|NOT COMPLETED|Overall Study||0
11127840|NCT01379703|12313469|FG000|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
11127841|NCT01379703|12313470|FG001|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
11127842|NCT01379703|12313471|FG002|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
11127843|NCT01379703|12313469|FG000|COMPLETED|Study Start Through 9 Months||62
11127844|NCT01379703|12313470|FG001|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
11127845|NCT01379703|12313471|FG002|COMPLETED|Study Start Through 9 Months||873
11127846|NCT01379703|12313469|FG000|NOT COMPLETED|Study Start Through 9 Months||4
11127847|NCT01379703|12313470|FG001|NOT COMPLETED|Study Start Through 9 Months||122
11127848|NCT01379703|12313471|FG002|NOT COMPLETED|Study Start Through 9 Months||143
11127849|NCT01379703|12313469|FG000|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
11127850|NCT01379703|12313470|FG001|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
11127851|NCT01379703|12313471|FG002|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
11127852|NCT01379703|12313469|FG000|COMPLETED|9 Months Through 18 Months||0
11127853|NCT01379703|12313470|FG001|COMPLETED|9 Months Through 18 Months||854
11127854|NCT01379703|12313471|FG002|COMPLETED|9 Months Through 18 Months||0
11127855|NCT01379703|12313469|FG000|NOT COMPLETED|9 Months Through 18 Months||0
11127856|NCT01379703|12313470|FG001|NOT COMPLETED|9 Months Through 18 Months||230
11127857|NCT01379703|12313471|FG002|NOT COMPLETED|9 Months Through 18 Months||0
11127858|NCT01379768|12313483|FG000|STARTED|Overall Study||23
11127859|NCT01379768|12313484|FG001|STARTED|Overall Study||22
11127860|NCT01379768|12313485|FG002|STARTED|Overall Study||20
11127861|NCT01379768|12313483|FG000|COMPLETED|Overall Study||20
11127862|NCT01379768|12313484|FG001|COMPLETED|Overall Study||21
11127863|NCT01379768|12313485|FG002|COMPLETED|Overall Study||20
11127864|NCT01379768|12313483|FG000|NOT COMPLETED|Overall Study||3
11127865|NCT01379768|12313484|FG001|NOT COMPLETED|Overall Study||1
11127866|NCT01379768|12313485|FG002|NOT COMPLETED|Overall Study||0
11127867|NCT01379924|12313495|FG000|STARTED|Baseline||72
11127868|NCT01379924|12313496|FG001|STARTED|Baseline||68
11127869|NCT01379924|12313495|FG000|COMPLETED|Baseline||72
11127870|NCT01379924|12313496|FG001|COMPLETED|Baseline||68
11127871|NCT01379924|12313495|FG000|NOT COMPLETED|Baseline||0
11127872|NCT01379924|12313496|FG001|NOT COMPLETED|Baseline||0
11127873|NCT01379924|12313495|FG000|STARTED|12-month Assessment||72
11127874|NCT01379924|12313496|FG001|STARTED|12-month Assessment||68
11127875|NCT01379924|12313495|FG000|COMPLETED|12-month Assessment||62
11127876|NCT01379924|12313496|FG001|COMPLETED|12-month Assessment||55
11127877|NCT01379924|12313495|FG000|NOT COMPLETED|12-month Assessment||10
11127878|NCT01379924|12313496|FG001|NOT COMPLETED|12-month Assessment||13
11127879|NCT01379924|12313495|FG000|STARTED|24-month Assessment||62
11127880|NCT01379924|12313496|FG001|STARTED|24-month Assessment||55
11127881|NCT01379924|12313495|FG000|COMPLETED|24-month Assessment||55
11127882|NCT01379924|12313496|FG001|COMPLETED|24-month Assessment||52
11127883|NCT01379924|12313495|FG000|NOT COMPLETED|24-month Assessment||7
11127884|NCT01379924|12313496|FG001|NOT COMPLETED|24-month Assessment||3
11127885|NCT01379924|12313495|FG000|STARTED|36-month Assessment||55
11127886|NCT01379924|12313496|FG001|STARTED|36-month Assessment||52
11127887|NCT01379924|12313495|FG000|COMPLETED|36-month Assessment||52
11127888|NCT01379924|12313496|FG001|COMPLETED|36-month Assessment||48
11127889|NCT01379924|12313495|FG000|NOT COMPLETED|36-month Assessment||3
11127890|NCT01379924|12313496|FG001|NOT COMPLETED|36-month Assessment||4
11127891|NCT01379937|12313509|FG000|STARTED|Overall Study||156
11127892|NCT01379937|12313510|FG001|STARTED|Overall Study||156
11127893|NCT01379937|12313511|FG002|STARTED|Overall Study||104
11127894|NCT01379937|12313512|FG003|STARTED|Overall Study||104
11127895|NCT01379937|12313509|FG000|COMPLETED|Overall Study||155
11127896|NCT01379937|12313510|FG001|COMPLETED|Overall Study||153
11127897|NCT01379937|12313511|FG002|COMPLETED|Overall Study||102
11127898|NCT01379937|12313512|FG003|COMPLETED|Overall Study||103
11127899|NCT01379937|12313509|FG000|NOT COMPLETED|Overall Study||1
11127900|NCT01379937|12313510|FG001|NOT COMPLETED|Overall Study||3
11127901|NCT01379937|12313511|FG002|NOT COMPLETED|Overall Study||2
11127902|NCT01379937|12313512|FG003|NOT COMPLETED|Overall Study||1
11127903|NCT01379963|12313527|FG000|STARTED|Overall Study||780
11127904|NCT01379963|12313527|FG000|COMPLETED|Overall Study||780
11127905|NCT01379963|12313527|FG000|NOT COMPLETED|Overall Study||0
11127906|NCT01380080|12313533|FG000|STARTED|Overall Study||424
11127907|NCT01380080|12313534|FG001|STARTED|Overall Study||426
11127908|NCT01380080|12313533|FG000|COMPLETED|Overall Study||339
11127909|NCT01380080|12313534|FG001|COMPLETED|Overall Study||343
11127910|NCT01380080|12313533|FG000|NOT COMPLETED|Overall Study||85
11127911|NCT01380080|12313534|FG001|NOT COMPLETED|Overall Study||83
11127912|NCT01380093|12313540|FG000|STARTED|Naloxone Challenge Phase||80
11127913|NCT01380093|12313541|FG001|STARTED|Naloxone Challenge Phase||0
11127914|NCT01380093|12313542|FG002|STARTED|Naloxone Challenge Phase||0
11127915|NCT01380093|12313543|FG003|STARTED|Naloxone Challenge Phase||0
11127916|NCT01380093|12313544|FG004|STARTED|Naloxone Challenge Phase||0
11239231|NCT02080455|12431216|FG000|STARTED|Overall Study||16
11239232|NCT02080455|12431217|FG001|STARTED|Overall Study||16
11239233|NCT02080455|12431216|FG000|COMPLETED|Overall Study||16
11239234|NCT02080455|12431217|FG001|COMPLETED|Overall Study||16
11239235|NCT02080455|12431216|FG000|NOT COMPLETED|Overall Study||0
11239236|NCT02080455|12431217|FG001|NOT COMPLETED|Overall Study||0
11239237|NCT02080468|12431233|FG000|STARTED|Overall Study||16
11239238|NCT02080468|12431234|FG001|STARTED|Overall Study||16
11239239|NCT02080468|12431233|FG000|COMPLETED|Overall Study||14
11239240|NCT02080468|12431234|FG001|COMPLETED|Overall Study||14
11239241|NCT02080468|12431233|FG000|NOT COMPLETED|Overall Study||2
11239242|NCT02080468|12431234|FG001|NOT COMPLETED|Overall Study||2
11239243|NCT02080481|12431249|FG000|STARTED|Overall Study||68
11127917|NCT01380093|12313545|FG005|STARTED|Naloxone Challenge Phase||0
11127918|NCT01380093|12313546|FG006|STARTED|Naloxone Challenge Phase||0
11127919|NCT01380093|12313547|FG007|STARTED|Naloxone Challenge Phase||0
11127920|NCT01380093|12313548|FG008|STARTED|Naloxone Challenge Phase||0
11127921|NCT01380093|12313540|FG000|TREATED|Naloxone Challenge Phase||59
11127922|NCT01380093|12313541|FG001|TREATED|Naloxone Challenge Phase||0
11127923|NCT01380093|12313542|FG002|TREATED|Naloxone Challenge Phase||0
11127924|NCT01380093|12313543|FG003|TREATED|Naloxone Challenge Phase||0
11127925|NCT01380093|12313544|FG004|TREATED|Naloxone Challenge Phase||0
11127926|NCT01380093|12313545|FG005|TREATED|Naloxone Challenge Phase||0
11127927|NCT01380093|12313546|FG006|TREATED|Naloxone Challenge Phase||0
11127928|NCT01380093|12313547|FG007|TREATED|Naloxone Challenge Phase||0
11127929|NCT01380093|12313548|FG008|TREATED|Naloxone Challenge Phase||0
11127930|NCT01380093|12313540|FG000|COMPLETED|Naloxone Challenge Phase||59
11127931|NCT01380093|12313541|FG001|COMPLETED|Naloxone Challenge Phase||0
11127932|NCT01380093|12313542|FG002|COMPLETED|Naloxone Challenge Phase||0
11127933|NCT01380093|12313543|FG003|COMPLETED|Naloxone Challenge Phase||0
11127934|NCT01380093|12313544|FG004|COMPLETED|Naloxone Challenge Phase||0
11127935|NCT01380093|12313545|FG005|COMPLETED|Naloxone Challenge Phase||0
11127936|NCT01380093|12313546|FG006|COMPLETED|Naloxone Challenge Phase||0
11127937|NCT01380093|12313547|FG007|COMPLETED|Naloxone Challenge Phase||0
11127938|NCT01380093|12313548|FG008|COMPLETED|Naloxone Challenge Phase||0
11127939|NCT01380093|12313540|FG000|NOT COMPLETED|Naloxone Challenge Phase||21
11127940|NCT01380093|12313541|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
11127941|NCT01380093|12313542|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
11127942|NCT01380093|12313543|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
11127943|NCT01380093|12313544|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
11127944|NCT01380093|12313545|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
11127945|NCT01380093|12313546|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
11127946|NCT01380093|12313547|FG007|NOT COMPLETED|Naloxone Challenge Phase||0
11127947|NCT01380093|12313548|FG008|NOT COMPLETED|Naloxone Challenge Phase||0
11127948|NCT01380093|12313540|FG000|STARTED|Drug Discrimination Phase: Day 1||0
11127949|NCT01380093|12313541|FG001|STARTED|Drug Discrimination Phase: Day 1||30
11127950|NCT01380093|12313542|FG002|STARTED|Drug Discrimination Phase: Day 1||29
11127951|NCT01380093|12313543|FG003|STARTED|Drug Discrimination Phase: Day 1||0
11127952|NCT01380093|12313544|FG004|STARTED|Drug Discrimination Phase: Day 1||0
11127953|NCT01380093|12313545|FG005|STARTED|Drug Discrimination Phase: Day 1||0
11127954|NCT01380093|12313546|FG006|STARTED|Drug Discrimination Phase: Day 1||0
11127955|NCT01380093|12313547|FG007|STARTED|Drug Discrimination Phase: Day 1||0
11127956|NCT01380093|12313548|FG008|STARTED|Drug Discrimination Phase: Day 1||0
11127957|NCT01380093|12313540|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
11127958|NCT01380093|12313541|FG001|COMPLETED|Drug Discrimination Phase: Day 1||29
11127959|NCT01380093|12313542|FG002|COMPLETED|Drug Discrimination Phase: Day 1||29
11127960|NCT01380093|12313543|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
11127961|NCT01380093|12313544|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
11127962|NCT01380093|12313545|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
11127963|NCT01380093|12313546|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
11127964|NCT01380093|12313547|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0
11127965|NCT01380093|12313548|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0
11127966|NCT01380093|12313540|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11127967|NCT01380093|12313541|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
11127968|NCT01380093|12313542|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11127969|NCT01380093|12313543|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11127970|NCT01380093|12313544|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11127971|NCT01380093|12313545|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11127972|NCT01380093|12313546|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11127973|NCT01380093|12313547|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11239244|NCT02080481|12431250|FG001|STARTED|Overall Study||67
11239245|NCT02080481|12431249|FG000|COMPLETED|Overall Study||67
11239246|NCT02080481|12431250|FG001|COMPLETED|Overall Study||67
11239247|NCT02080481|12431249|FG000|NOT COMPLETED|Overall Study||1
11127974|NCT01380093|12313548|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11127975|NCT01380093|12313540|FG000|STARTED|Drug Discrimination Phase: Day 2||0
11127976|NCT01380093|12313541|FG001|STARTED|Drug Discrimination Phase: Day 2||29
11127977|NCT01380093|12313542|FG002|STARTED|Drug Discrimination Phase: Day 2||29
11127978|NCT01380093|12313543|FG003|STARTED|Drug Discrimination Phase: Day 2||0
11127979|NCT01380093|12313544|FG004|STARTED|Drug Discrimination Phase: Day 2||0
11127980|NCT01380093|12313545|FG005|STARTED|Drug Discrimination Phase: Day 2||0
11127981|NCT01380093|12313546|FG006|STARTED|Drug Discrimination Phase: Day 2||0
11127982|NCT01380093|12313547|FG007|STARTED|Drug Discrimination Phase: Day 2||0
11127983|NCT01380093|12313548|FG008|STARTED|Drug Discrimination Phase: Day 2||0
11127984|NCT01380093|12313540|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
11127985|NCT01380093|12313541|FG001|COMPLETED|Drug Discrimination Phase: Day 2||20
11127986|NCT01380093|12313542|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16
11127987|NCT01380093|12313543|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
11127988|NCT01380093|12313544|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
11127989|NCT01380093|12313545|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
11127990|NCT01380093|12313546|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
11127991|NCT01380093|12313547|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0
11127992|NCT01380093|12313548|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0
11127993|NCT01380093|12313540|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11127994|NCT01380093|12313541|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
11127995|NCT01380093|12313542|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
11127996|NCT01380093|12313543|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11127997|NCT01380093|12313544|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11127998|NCT01380093|12313545|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11127999|NCT01380093|12313546|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11128000|NCT01380093|12313547|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11128001|NCT01380093|12313548|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11128002|NCT01380093|12313540|FG000|STARTED|Treatment Phase: First Intervention||0
11128003|NCT01380093|12313541|FG001|STARTED|Treatment Phase: First Intervention||0
11128004|NCT01380093|12313542|FG002|STARTED|Treatment Phase: First Intervention||0
11128005|NCT01380093|12313543|FG003|STARTED|Treatment Phase: First Intervention||6
11128006|NCT01380093|12313544|FG004|STARTED|Treatment Phase: First Intervention||6
11128007|NCT01380093|12313545|FG005|STARTED|Treatment Phase: First Intervention||6
11128008|NCT01380093|12313546|FG006|STARTED|Treatment Phase: First Intervention||6
11128009|NCT01380093|12313547|FG007|STARTED|Treatment Phase: First Intervention||6
11128010|NCT01380093|12313548|FG008|STARTED|Treatment Phase: First Intervention||6
11128011|NCT01380093|12313540|FG000|COMPLETED|Treatment Phase: First Intervention||0
11128012|NCT01380093|12313541|FG001|COMPLETED|Treatment Phase: First Intervention||0
11128013|NCT01380093|12313542|FG002|COMPLETED|Treatment Phase: First Intervention||0
11128014|NCT01380093|12313543|FG003|COMPLETED|Treatment Phase: First Intervention||6
11128015|NCT01380093|12313544|FG004|COMPLETED|Treatment Phase: First Intervention||6
11128016|NCT01380093|12313545|FG005|COMPLETED|Treatment Phase: First Intervention||6
11128017|NCT01380093|12313546|FG006|COMPLETED|Treatment Phase: First Intervention||6
11128018|NCT01380093|12313547|FG007|COMPLETED|Treatment Phase: First Intervention||6
11128019|NCT01380093|12313548|FG008|COMPLETED|Treatment Phase: First Intervention||6
11128020|NCT01380093|12313540|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
11128021|NCT01380093|12313541|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
11128022|NCT01380093|12313542|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
11128023|NCT01380093|12313543|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
11128024|NCT01380093|12313544|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
11128025|NCT01380093|12313545|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
11128026|NCT01380093|12313546|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0
11128027|NCT01380093|12313547|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0
11128028|NCT01380093|12313548|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0
11128029|NCT01380093|12313540|FG000|STARTED|Treatment Phase: Washout Period||0
11128030|NCT01380093|12313541|FG001|STARTED|Treatment Phase: Washout Period||0
11128031|NCT01380093|12313542|FG002|STARTED|Treatment Phase: Washout Period||0
11128032|NCT01380093|12313543|FG003|STARTED|Treatment Phase: Washout Period||6
11128033|NCT01380093|12313544|FG004|STARTED|Treatment Phase: Washout Period||6
11128034|NCT01380093|12313545|FG005|STARTED|Treatment Phase: Washout Period||6
11128035|NCT01380093|12313546|FG006|STARTED|Treatment Phase: Washout Period||6
11128036|NCT01380093|12313547|FG007|STARTED|Treatment Phase: Washout Period||6
11128037|NCT01380093|12313548|FG008|STARTED|Treatment Phase: Washout Period||6
11128038|NCT01380093|12313540|FG000|COMPLETED|Treatment Phase: Washout Period||0
11128039|NCT01380093|12313541|FG001|COMPLETED|Treatment Phase: Washout Period||0
11128040|NCT01380093|12313542|FG002|COMPLETED|Treatment Phase: Washout Period||0
11128041|NCT01380093|12313543|FG003|COMPLETED|Treatment Phase: Washout Period||6
11128042|NCT01380093|12313544|FG004|COMPLETED|Treatment Phase: Washout Period||6
11128043|NCT01380093|12313545|FG005|COMPLETED|Treatment Phase: Washout Period||6
11128044|NCT01380093|12313546|FG006|COMPLETED|Treatment Phase: Washout Period||6
11128045|NCT01380093|12313547|FG007|COMPLETED|Treatment Phase: Washout Period||6
11128046|NCT01380093|12313548|FG008|COMPLETED|Treatment Phase: Washout Period||6
11128047|NCT01380093|12313540|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0
11128048|NCT01380093|12313541|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0
11128049|NCT01380093|12313542|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0
11128050|NCT01380093|12313543|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0
11128051|NCT01380093|12313544|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0
11128052|NCT01380093|12313545|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0
11128053|NCT01380093|12313546|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0
11128054|NCT01380093|12313547|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0
11128055|NCT01380093|12313548|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0
11128056|NCT01380093|12313540|FG000|STARTED|Treatment Phase: Second Intervention||0
11128057|NCT01380093|12313541|FG001|STARTED|Treatment Phase: Second Intervention||0
11128058|NCT01380093|12313542|FG002|STARTED|Treatment Phase: Second Intervention||0
11128059|NCT01380093|12313543|FG003|STARTED|Treatment Phase: Second Intervention||6
11128060|NCT01380093|12313544|FG004|STARTED|Treatment Phase: Second Intervention||6
11128061|NCT01380093|12313545|FG005|STARTED|Treatment Phase: Second Intervention||6
11128062|NCT01380093|12313546|FG006|STARTED|Treatment Phase: Second Intervention||6
11128063|NCT01380093|12313547|FG007|STARTED|Treatment Phase: Second Intervention||6
11128064|NCT01380093|12313548|FG008|STARTED|Treatment Phase: Second Intervention||6
11128065|NCT01380093|12313540|FG000|COMPLETED|Treatment Phase: Second Intervention||0
11128066|NCT01380093|12313541|FG001|COMPLETED|Treatment Phase: Second Intervention||0
11128067|NCT01380093|12313542|FG002|COMPLETED|Treatment Phase: Second Intervention||0
11128068|NCT01380093|12313543|FG003|COMPLETED|Treatment Phase: Second Intervention||5
11128069|NCT01380093|12313544|FG004|COMPLETED|Treatment Phase: Second Intervention||6
11128070|NCT01380093|12313545|FG005|COMPLETED|Treatment Phase: Second Intervention||6
11128071|NCT01380093|12313546|FG006|COMPLETED|Treatment Phase: Second Intervention||6
11128072|NCT01380093|12313547|FG007|COMPLETED|Treatment Phase: Second Intervention||6
11128073|NCT01380093|12313548|FG008|COMPLETED|Treatment Phase: Second Intervention||6
11128074|NCT01380093|12313540|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
11128075|NCT01380093|12313541|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
11128076|NCT01380093|12313542|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
11128077|NCT01380093|12313543|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||1
11128078|NCT01380093|12313544|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
11128079|NCT01380093|12313545|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
11128080|NCT01380093|12313546|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
11128081|NCT01380093|12313547|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||0
11128082|NCT01380093|12313548|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0
11128083|NCT01380093|12313540|FG000|STARTED|Treatment Phase: Washout Period||0
11128084|NCT01380093|12313541|FG001|STARTED|Treatment Phase: Washout Period||0
11128085|NCT01380093|12313542|FG002|STARTED|Treatment Phase: Washout Period||0
11128086|NCT01380093|12313543|FG003|STARTED|Treatment Phase: Washout Period||5
11128087|NCT01380093|12313544|FG004|STARTED|Treatment Phase: Washout Period||6
11128088|NCT01380093|12313545|FG005|STARTED|Treatment Phase: Washout Period||6
11128089|NCT01380093|12313546|FG006|STARTED|Treatment Phase: Washout Period||6
11128090|NCT01380093|12313547|FG007|STARTED|Treatment Phase: Washout Period||6
11128091|NCT01380093|12313548|FG008|STARTED|Treatment Phase: Washout Period||6
11128092|NCT01380093|12313540|FG000|COMPLETED|Treatment Phase: Washout Period||0
11128093|NCT01380093|12313541|FG001|COMPLETED|Treatment Phase: Washout Period||0
11128094|NCT01380093|12313542|FG002|COMPLETED|Treatment Phase: Washout Period||0
11128095|NCT01380093|12313543|FG003|COMPLETED|Treatment Phase: Washout Period||5
11128096|NCT01380093|12313544|FG004|COMPLETED|Treatment Phase: Washout Period||6
11128097|NCT01380093|12313545|FG005|COMPLETED|Treatment Phase: Washout Period||6
11128098|NCT01380093|12313546|FG006|COMPLETED|Treatment Phase: Washout Period||6
11128099|NCT01380093|12313547|FG007|COMPLETED|Treatment Phase: Washout Period||6
11128100|NCT01380093|12313548|FG008|COMPLETED|Treatment Phase: Washout Period||6
11128101|NCT01380093|12313540|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0
11128102|NCT01380093|12313541|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0
11128103|NCT01380093|12313542|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0
11128104|NCT01380093|12313543|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0
11128105|NCT01380093|12313544|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0
11128106|NCT01380093|12313545|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0
11128107|NCT01380093|12313546|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0
11128108|NCT01380093|12313547|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0
11128109|NCT01380093|12313548|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0
11128110|NCT01380093|12313540|FG000|STARTED|Treatment Phase: Third Intervention||0
11128111|NCT01380093|12313541|FG001|STARTED|Treatment Phase: Third Intervention||0
11128112|NCT01380093|12313542|FG002|STARTED|Treatment Phase: Third Intervention||0
11128113|NCT01380093|12313543|FG003|STARTED|Treatment Phase: Third Intervention||5
11128114|NCT01380093|12313544|FG004|STARTED|Treatment Phase: Third Intervention||6
11128115|NCT01380093|12313545|FG005|STARTED|Treatment Phase: Third Intervention||6
11128116|NCT01380093|12313546|FG006|STARTED|Treatment Phase: Third Intervention||6
11128117|NCT01380093|12313547|FG007|STARTED|Treatment Phase: Third Intervention||6
11128118|NCT01380093|12313548|FG008|STARTED|Treatment Phase: Third Intervention||6
11128119|NCT01380093|12313540|FG000|COMPLETED|Treatment Phase: Third Intervention||0
11128120|NCT01380093|12313541|FG001|COMPLETED|Treatment Phase: Third Intervention||0
11128121|NCT01380093|12313542|FG002|COMPLETED|Treatment Phase: Third Intervention||0
11128122|NCT01380093|12313543|FG003|COMPLETED|Treatment Phase: Third Intervention||5
11128123|NCT01380093|12313544|FG004|COMPLETED|Treatment Phase: Third Intervention||6
11128124|NCT01380093|12313545|FG005|COMPLETED|Treatment Phase: Third Intervention||6
11128125|NCT01380093|12313546|FG006|COMPLETED|Treatment Phase: Third Intervention||6
11128126|NCT01380093|12313547|FG007|COMPLETED|Treatment Phase: Third Intervention||6
11128127|NCT01380093|12313548|FG008|COMPLETED|Treatment Phase: Third Intervention||4
11128128|NCT01380093|12313540|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
11128129|NCT01380093|12313541|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
11128130|NCT01380093|12313542|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
11128131|NCT01380093|12313543|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
11128132|NCT01380093|12313544|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
11128133|NCT01380093|12313545|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0
11128134|NCT01380093|12313546|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0
11128135|NCT01380093|12313547|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0
11128136|NCT01380093|12313548|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||2
11128137|NCT01380106|12313564|FG000|STARTED|Overall Study||16
11128138|NCT01380106|12313565|FG001|STARTED|Overall Study||17
11128139|NCT01380106|12313564|FG000|COMPLETED|Overall Study||16
11128140|NCT01380106|12313565|FG001|COMPLETED|Overall Study||17
11128141|NCT01380106|12313564|FG000|NOT COMPLETED|Overall Study||0
11128142|NCT01380106|12313565|FG001|NOT COMPLETED|Overall Study||0
11128143|NCT01380145|12313571|FG000|STARTED|Overall Study||13
11128144|NCT01380145|12313571|FG000|COMPLETED|Overall Study||9
11128145|NCT01380145|12313571|FG000|NOT COMPLETED|Overall Study||4
11128146|NCT01380184|12313577|FG000|STARTED|Part 1 (19 Days)||15
11128147|NCT01380184|12313577|FG000|COMPLETED|Part 1 (19 Days)||14
11128148|NCT01380184|12313577|FG000|NOT COMPLETED|Part 1 (19 Days)||1
11128149|NCT01380184|12313577|FG000|STARTED|Washout Period (≥2 Days)||14
11128150|NCT01380184|12313577|FG000|COMPLETED|Washout Period (≥2 Days)||14
11128151|NCT01380184|12313577|FG000|NOT COMPLETED|Washout Period (≥2 Days)||0
11128152|NCT01380184|12313577|FG000|STARTED|Part 2||14
11128153|NCT01380184|12313577|FG000|COMPLETED|Part 2||0
11128154|NCT01380184|12313577|FG000|NOT COMPLETED|Part 2||14
11128155|NCT01380197|12313583|FG000|STARTED|Overall Study||20
11128156|NCT01380197|12313584|FG001|STARTED|Overall Study||20
11128157|NCT01380197|12313583|FG000|COMPLETED|Overall Study||20
11128158|NCT01380197|12313584|FG001|COMPLETED|Overall Study||20
11239248|NCT02080481|12431250|FG001|NOT COMPLETED|Overall Study||0
11128159|NCT01380197|12313583|FG000|NOT COMPLETED|Overall Study||0
11128160|NCT01380197|12313584|FG001|NOT COMPLETED|Overall Study||0
11128161|NCT01380327|12313593|FG000|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
11128162|NCT01380327|12313594|FG001|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
11128163|NCT01380327|12313595|FG002|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
11128164|NCT01380327|12313593|FG000|COMPLETED|Overall Study||27
11128165|NCT01380327|12313594|FG001|COMPLETED|Overall Study||28
11128166|NCT01380327|12313595|FG002|COMPLETED|Overall Study||21
11128167|NCT01380327|12313593|FG000|NOT COMPLETED|Overall Study||3
11128168|NCT01380327|12313594|FG001|NOT COMPLETED|Overall Study||3
11128169|NCT01380327|12313595|FG002|NOT COMPLETED|Overall Study||7
11128170|NCT01380366|12313603|FG000|STARTED|Overall Study||15
11128171|NCT01380366|12313603|FG000|COMPLETED|Overall Study||15
11128172|NCT01380366|12313603|FG000|NOT COMPLETED|Overall Study||0
11128173|NCT01380379|12313608|FG000|STARTED|Overall Study||9
11128174|NCT01380379|12313608|FG000|COMPLETED|Overall Study||8
11128175|NCT01380379|12313608|FG000|NOT COMPLETED|Overall Study||1
11128176|NCT01380535|12313614|FG000|STARTED|Overall Study||29
11128177|NCT01380535|12313615|FG001|STARTED|Overall Study||31
11128178|NCT01380535|12313614|FG000|Baseline Population|Overall Study||29
11128179|NCT01380535|12313615|FG001|Baseline Population|Overall Study||31
11128180|NCT01380535|12313614|FG000|Safety Population|Overall Study||28
11128181|NCT01380535|12313615|FG001|Safety Population|Overall Study||28
11128182|NCT01380535|12313614|FG000|Intent-to-treat Population|Overall Study||29
11128183|NCT01380535|12313615|FG001|Intent-to-treat Population|Overall Study||24
11128184|NCT01380535|12313614|FG000|COMPLETED|Overall Study||22
11128185|NCT01380535|12313615|FG001|COMPLETED|Overall Study||16
11128186|NCT01380535|12313614|FG000|NOT COMPLETED|Overall Study||7
11128187|NCT01380535|12313615|FG001|NOT COMPLETED|Overall Study||15
11128188|NCT01380639|12313623|FG000|STARTED|Overall Study||42
11128189|NCT01380639|12313624|FG001|STARTED|Overall Study||40
11128190|NCT01380639|12313623|FG000|COMPLETED|Overall Study||36
11128191|NCT01380639|12313624|FG001|COMPLETED|Overall Study||36
11128192|NCT01380639|12313623|FG000|NOT COMPLETED|Overall Study||6
11128193|NCT01380639|12313624|FG001|NOT COMPLETED|Overall Study||4
11128194|NCT01380691|12313630|FG000|STARTED|Period 1||7
11128195|NCT01380691|12313631|FG001|STARTED|Period 1||7
11128196|NCT01380691|12313632|FG002|STARTED|Period 1||7
11128197|NCT01380691|12313633|FG003|STARTED|Period 1||7
11128198|NCT01380691|12313630|FG000|COMPLETED|Period 1||7
11128199|NCT01380691|12313631|FG001|COMPLETED|Period 1||7
11128200|NCT01380691|12313632|FG002|COMPLETED|Period 1||7
11128201|NCT01380691|12313633|FG003|COMPLETED|Period 1||7
11128202|NCT01380691|12313630|FG000|NOT COMPLETED|Period 1||0
11128203|NCT01380691|12313631|FG001|NOT COMPLETED|Period 1||0
11128204|NCT01380691|12313632|FG002|NOT COMPLETED|Period 1||0
11128205|NCT01380691|12313633|FG003|NOT COMPLETED|Period 1||0
11128206|NCT01380691|12313630|FG000|STARTED|Washout (7 Days)||7
11128207|NCT01380691|12313631|FG001|STARTED|Washout (7 Days)||7
11128208|NCT01380691|12313632|FG002|STARTED|Washout (7 Days)||7
11239249|NCT02080507|12431258|FG000|STARTED|Overall Study||5
11128209|NCT01380691|12313633|FG003|STARTED|Washout (7 Days)||7
11128210|NCT01380691|12313630|FG000|COMPLETED|Washout (7 Days)||7
11128211|NCT01380691|12313631|FG001|COMPLETED|Washout (7 Days)||7
11128212|NCT01380691|12313632|FG002|COMPLETED|Washout (7 Days)||6
11128213|NCT01380691|12313633|FG003|COMPLETED|Washout (7 Days)||6
11128214|NCT01380691|12313630|FG000|NOT COMPLETED|Washout (7 Days)||0
11128215|NCT01380691|12313631|FG001|NOT COMPLETED|Washout (7 Days)||0
11128216|NCT01380691|12313632|FG002|NOT COMPLETED|Washout (7 Days)||1
11128217|NCT01380691|12313633|FG003|NOT COMPLETED|Washout (7 Days)||1
11128218|NCT01380691|12313630|FG000|STARTED|Period 2||7
11128219|NCT01380691|12313631|FG001|STARTED|Period 2||7
11128220|NCT01380691|12313632|FG002|STARTED|Period 2||6
11128221|NCT01380691|12313633|FG003|STARTED|Period 2||6
11128222|NCT01380691|12313630|FG000|COMPLETED|Period 2||7
11128223|NCT01380691|12313631|FG001|COMPLETED|Period 2||7
11128224|NCT01380691|12313632|FG002|COMPLETED|Period 2||6
11128225|NCT01380691|12313633|FG003|COMPLETED|Period 2||6
11128226|NCT01380691|12313630|FG000|NOT COMPLETED|Period 2||0
11128227|NCT01380691|12313631|FG001|NOT COMPLETED|Period 2||0
11128228|NCT01380691|12313632|FG002|NOT COMPLETED|Period 2||0
11128229|NCT01380691|12313633|FG003|NOT COMPLETED|Period 2||0
11128230|NCT01380730|12313652|FG000|STARTED|Overall Study||78
11128231|NCT01380730|12313653|FG001|STARTED|Overall Study||79
11128232|NCT01380730|12313654|FG002|STARTED|Overall Study||79
11128233|NCT01380730|12313655|FG003|STARTED|Overall Study||79
11128234|NCT01380730|12313656|FG004|STARTED|Overall Study||78
11128235|NCT01380730|12313657|FG005|STARTED|Overall Study||79
11128236|NCT01380730|12313658|FG006|STARTED|Overall Study||79
11128237|NCT01380730|12313659|FG007|STARTED|Overall Study||80
11128238|NCT01380730|12313652|FG000|Received Treatment|Overall Study||78
11128239|NCT01380730|12313653|FG001|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
11128240|NCT01380730|12313654|FG002|Received Treatment|Overall Study||79
11128241|NCT01380730|12313655|FG003|Received Treatment|Overall Study||79
11128242|NCT01380730|12313656|FG004|Received Treatment|Overall Study||78
11128243|NCT01380730|12313657|FG005|Received Treatment|Overall Study||79
11128244|NCT01380730|12313658|FG006|Received Treatment|Overall Study||79
11128245|NCT01380730|12313659|FG007|Received Treatment|Overall Study||80
11128246|NCT01380730|12313652|FG000|COMPLETED|Overall Study||78
11128247|NCT01380730|12313653|FG001|COMPLETED|Overall Study||79
11128248|NCT01380730|12313654|FG002|COMPLETED|Overall Study||79
11128249|NCT01380730|12313655|FG003|COMPLETED|Overall Study||79
11128250|NCT01380730|12313656|FG004|COMPLETED|Overall Study||77
11128251|NCT01380730|12313657|FG005|COMPLETED|Overall Study||79
11128252|NCT01380730|12313658|FG006|COMPLETED|Overall Study||79
11128253|NCT01380730|12313659|FG007|COMPLETED|Overall Study||80
11128254|NCT01380730|12313652|FG000|NOT COMPLETED|Overall Study||0
11128255|NCT01380730|12313653|FG001|NOT COMPLETED|Overall Study||0
11128256|NCT01380730|12313654|FG002|NOT COMPLETED|Overall Study||0
11128257|NCT01380730|12313655|FG003|NOT COMPLETED|Overall Study||0
11128258|NCT01380730|12313656|FG004|NOT COMPLETED|Overall Study||1
11128259|NCT01380730|12313657|FG005|NOT COMPLETED|Overall Study||0
11128260|NCT01380730|12313658|FG006|NOT COMPLETED|Overall Study||0
11128261|NCT01380730|12313659|FG007|NOT COMPLETED|Overall Study||0
11128262|NCT01380743|12313681|FG000|STARTED|Overall Study||6
11128263|NCT01380743|12313682|FG001|STARTED|Overall Study||6
11128264|NCT01380743|12313683|FG002|STARTED|Overall Study||6
11128265|NCT01380743|12313684|FG003|STARTED|Overall Study||7
11128266|NCT01380743|12313681|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
11128267|NCT01380743|12313682|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
11239250|NCT02080507|12431259|FG001|STARTED|Overall Study||7
11239251|NCT02080507|12431258|FG000|COMPLETED|Overall Study||5
11239252|NCT02080507|12431259|FG001|COMPLETED|Overall Study||7
11239253|NCT02080507|12431258|FG000|NOT COMPLETED|Overall Study||0
11239254|NCT02080507|12431259|FG001|NOT COMPLETED|Overall Study||0
11239255|NCT02080546|12431267|FG000|STARTED|Overall Study||57
11239256|NCT02080546|12431268|FG001|STARTED|Overall Study||63
11239257|NCT02080546|12431267|FG000|COMPLETED|Overall Study||49
11239258|NCT02080546|12431268|FG001|COMPLETED|Overall Study||52
11239259|NCT02080546|12431267|FG000|NOT COMPLETED|Overall Study||8
11239260|NCT02080546|12431268|FG001|NOT COMPLETED|Overall Study||11
11239261|NCT02080637|12431276|FG000|STARTED|Overall Study||13
11239262|NCT02080637|12431277|FG001|STARTED|Overall Study||3
11239263|NCT02080637|12431276|FG000|COMPLETED|Overall Study||13
11239264|NCT02080637|12431277|FG001|COMPLETED|Overall Study||3
11239265|NCT02080637|12431276|FG000|NOT COMPLETED|Overall Study||0
11239266|NCT02080637|12431277|FG001|NOT COMPLETED|Overall Study||0
11128268|NCT01380743|12313683|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11128269|NCT01380743|12313684|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
11128270|NCT01380743|12313681|FG000|COMPLETED|Overall Study||6
11128271|NCT01380743|12313682|FG001|COMPLETED|Overall Study||6
11128272|NCT01380743|12313683|FG002|COMPLETED|Overall Study||6
11128273|NCT01380743|12313684|FG003|COMPLETED|Overall Study||7
11128274|NCT01380743|12313681|FG000|NOT COMPLETED|Overall Study||0
11128275|NCT01380743|12313682|FG001|NOT COMPLETED|Overall Study||0
11128276|NCT01380743|12313683|FG002|NOT COMPLETED|Overall Study||0
11128277|NCT01380743|12313684|FG003|NOT COMPLETED|Overall Study||0
11128278|NCT01380769|12313696|FG000|STARTED|Overall Study||100
11128279|NCT01380769|12313697|FG001|STARTED|Overall Study||57
11128280|NCT01380769|12313696|FG000|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
11202173|NCT01838317|12392579|FG001|NOT COMPLETED|Overall Study||0
11239267|NCT02080780|12431283|FG000|STARTED|Overall Study||24
11239268|NCT02080780|12431283|FG000|COMPLETED|Overall Study||24
11239269|NCT02080780|12431283|FG000|NOT COMPLETED|Overall Study||0
11239270|NCT02080819|12431293|FG000|STARTED|Overall Study||63
11239271|NCT02080819|12431294|FG001|STARTED|Overall Study||35
11239272|NCT02080819|12431295|FG002|STARTED|Overall Study||33
11239273|NCT02080819|12431293|FG000|COMPLETED|Overall Study||38
11239274|NCT02080819|12431294|FG001|COMPLETED|Overall Study||9
11239275|NCT02080819|12431295|FG002|COMPLETED|Overall Study||11
11239276|NCT02080819|12431293|FG000|NOT COMPLETED|Overall Study||25
11239277|NCT02080819|12431294|FG001|NOT COMPLETED|Overall Study||26
11239278|NCT02080819|12431295|FG002|NOT COMPLETED|Overall Study||22
11239279|NCT02080832|12431306|FG000|STARTED|Overall Study||15
11239280|NCT02080832|12431307|FG001|STARTED|Overall Study||17
11239281|NCT02080832|12431308|FG002|STARTED|Overall Study||22
11239282|NCT02080832|12431306|FG000|COMPLETED|Overall Study||6
11239283|NCT02080832|12431307|FG001|COMPLETED|Overall Study||5
11239284|NCT02080832|12431308|FG002|COMPLETED|Overall Study||6
11239285|NCT02080832|12431306|FG000|NOT COMPLETED|Overall Study||9
11239286|NCT02080832|12431307|FG001|NOT COMPLETED|Overall Study||12
11239287|NCT02080832|12431308|FG002|NOT COMPLETED|Overall Study||16
11239288|NCT02080871|12431318|FG000|STARTED|Overall Study||134
11239289|NCT02080871|12431318|FG000|COMPLETED|Overall Study||132
11239290|NCT02080871|12431318|FG000|NOT COMPLETED|Overall Study||2
11239291|NCT02081001|12431324|FG000|STARTED|Overall Study||2
11239292|NCT02081001|12431325|FG001|STARTED|Overall Study||1
11239293|NCT02081001|12431326|FG002|STARTED|Overall Study||2
11239294|NCT02081001|12431327|FG003|STARTED|Overall Study||1
11239295|NCT02081001|12431328|FG004|STARTED|Overall Study||3
11239296|NCT02081001|12431329|FG005|STARTED|Overall Study||1
11239297|NCT02081001|12431330|FG006|STARTED|Overall Study||2
11239298|NCT02081001|12431331|FG007|STARTED|Overall Study||1
11239299|NCT02081001|12431332|FG008|STARTED|Overall Study||2
11239300|NCT02081001|12431333|FG009|STARTED|Overall Study||1
11239301|NCT02081001|12431334|FG010|STARTED|Overall Study||2
11239302|NCT02081001|12431335|FG011|STARTED|Overall Study||1
11239303|NCT02081001|12431324|FG000|COMPLETED|Overall Study||2
11239304|NCT02081001|12431325|FG001|COMPLETED|Overall Study||1
11239305|NCT02081001|12431326|FG002|COMPLETED|Overall Study||2
11239306|NCT02081001|12431327|FG003|COMPLETED|Overall Study||1
11239307|NCT02081001|12431328|FG004|COMPLETED|Overall Study||2
11239308|NCT02081001|12431329|FG005|COMPLETED|Overall Study||1
11239309|NCT02081001|12431330|FG006|COMPLETED|Overall Study||2
11239310|NCT02081001|12431331|FG007|COMPLETED|Overall Study||1
11239311|NCT02081001|12431332|FG008|COMPLETED|Overall Study||2
11239312|NCT02081001|12431333|FG009|COMPLETED|Overall Study||1
11239313|NCT02081001|12431334|FG010|COMPLETED|Overall Study||2
11239314|NCT02081001|12431335|FG011|COMPLETED|Overall Study||1
11239315|NCT02081001|12431324|FG000|NOT COMPLETED|Overall Study||0
11239316|NCT02081001|12431325|FG001|NOT COMPLETED|Overall Study||0
11239317|NCT02081001|12431326|FG002|NOT COMPLETED|Overall Study||0
11239318|NCT02081001|12431327|FG003|NOT COMPLETED|Overall Study||0
11239319|NCT02081001|12431328|FG004|NOT COMPLETED|Overall Study||1
11239320|NCT02081001|12431329|FG005|NOT COMPLETED|Overall Study||0
11239321|NCT02081001|12431330|FG006|NOT COMPLETED|Overall Study||0
11239322|NCT02081001|12431331|FG007|NOT COMPLETED|Overall Study||0
11239323|NCT02081001|12431332|FG008|NOT COMPLETED|Overall Study||0
11239324|NCT02081001|12431333|FG009|NOT COMPLETED|Overall Study||0
11239325|NCT02081001|12431334|FG010|NOT COMPLETED|Overall Study||0
11239326|NCT02081001|12431335|FG011|NOT COMPLETED|Overall Study||0
11239327|NCT02081014|12431346|FG000|STARTED|Overall Study||2
11239328|NCT02081014|12431347|FG001|STARTED|Overall Study||2
11239329|NCT02081014|12431348|FG002|STARTED|Overall Study||2
11239330|NCT02081014|12431349|FG003|STARTED|Overall Study||2
11239331|NCT02081014|12431350|FG004|STARTED|Overall Study||2
11239332|NCT02081014|12431351|FG005|STARTED|Overall Study||2
11239333|NCT02081014|12431346|FG000|COMPLETED|Overall Study||2
11239334|NCT02081014|12431347|FG001|COMPLETED|Overall Study||2
11239335|NCT02081014|12431348|FG002|COMPLETED|Overall Study||2
11239336|NCT02081014|12431349|FG003|COMPLETED|Overall Study||2
11239337|NCT02081014|12431350|FG004|COMPLETED|Overall Study||2
11239338|NCT02081014|12431351|FG005|COMPLETED|Overall Study||2
11239339|NCT02081014|12431346|FG000|NOT COMPLETED|Overall Study||0
11239340|NCT02081014|12431347|FG001|NOT COMPLETED|Overall Study||0
11239341|NCT02081014|12431348|FG002|NOT COMPLETED|Overall Study||0
11239342|NCT02081014|12431349|FG003|NOT COMPLETED|Overall Study||0
11239343|NCT02081014|12431350|FG004|NOT COMPLETED|Overall Study||0
11239344|NCT02081014|12431351|FG005|NOT COMPLETED|Overall Study||0
11239345|NCT02081079|12431372|FG000|STARTED|Overall Study||44
11239346|NCT02081079|12431373|FG001|STARTED|Overall Study||41
11239347|NCT02081079|12431372|FG000|COMPLETED|Overall Study||40
11239348|NCT02081079|12431373|FG001|COMPLETED|Overall Study||39
11239349|NCT02081079|12431372|FG000|NOT COMPLETED|Overall Study||4
11239350|NCT02081079|12431373|FG001|NOT COMPLETED|Overall Study||2
11239351|NCT02081196|12431383|FG000|STARTED|Overall Study|Treatment on one flank. Contralateral flank was untreated control.|45
11239352|NCT02081196|12431383|FG000|Untreated Control Flank|Overall Study||45
11239353|NCT02081196|12431383|FG000|COMPLETED|Overall Study|One (1) subject was lost to FU.|44
11239354|NCT02081196|12431383|FG000|NOT COMPLETED|Overall Study||1
11239355|NCT02081248|12431391|FG000|STARTED|Overall Study||98
11239356|NCT02081248|12431392|FG001|STARTED|Overall Study||100
11239357|NCT02081248|12431391|FG000|COMPLETED|Overall Study||76
11239358|NCT02081248|12431392|FG001|COMPLETED|Overall Study||87
11239359|NCT02081248|12431391|FG000|NOT COMPLETED|Overall Study||22
11239360|NCT02081248|12431392|FG001|NOT COMPLETED|Overall Study||13
11239361|NCT02081365|12431400|FG000|STARTED|Overall Study||74
11239362|NCT02081365|12431401|FG001|STARTED|Overall Study||77
11239363|NCT02081365|12431400|FG000|Received Allocated Intervention|Overall Study||46
11239364|NCT02081365|12431401|FG001|Received Allocated Intervention|Overall Study||59
11239365|NCT02081365|12431400|FG000|COMPLETED|Overall Study||44
11239366|NCT02081365|12431401|FG001|COMPLETED|Overall Study||54
11239367|NCT02081365|12431400|FG000|NOT COMPLETED|Overall Study||30
11239368|NCT02081365|12431401|FG001|NOT COMPLETED|Overall Study||23
11239369|NCT02081417|12431409|FG000|STARTED|Overall Study|Randomized to intervention|163
11239370|NCT02081417|12431410|FG001|STARTED|Overall Study||166
11239371|NCT02081417|12431409|FG000|1st Interview Completed|Overall Study||146
11239372|NCT02081417|12431410|FG001|1st Interview Completed|Overall Study||145
11239373|NCT02081417|12431409|FG000|3-Month Follow-Up|Overall Study||94
11239374|NCT02081417|12431410|FG001|3-Month Follow-Up|Overall Study||95
11239375|NCT02081417|12431409|FG000|6-Month Follow-Up|Overall Study||82
11239376|NCT02081417|12431410|FG001|6-Month Follow-Up|Overall Study||92
11239377|NCT02081417|12431409|FG000|COMPLETED|Overall Study||107
11239378|NCT02081417|12431410|FG001|COMPLETED|Overall Study||115
11239379|NCT02081417|12431409|FG000|NOT COMPLETED|Overall Study||56
11239380|NCT02081417|12431410|FG001|NOT COMPLETED|Overall Study||51
11239381|NCT02081443|12431418|FG000|STARTED|Overall Study||30
11239382|NCT02081443|12431419|FG001|STARTED|Overall Study||30
11239383|NCT02081443|12431418|FG000|COMPLETED|Overall Study||30
11239384|NCT02081443|12431419|FG001|COMPLETED|Overall Study||30
11239385|NCT02081443|12431418|FG000|NOT COMPLETED|Overall Study||0
11239386|NCT02081443|12431419|FG001|NOT COMPLETED|Overall Study||0
11239387|NCT02081456|12431427|FG000|STARTED|Overall Study||11
11239388|NCT02081456|12431428|FG001|STARTED|Overall Study||12
11239389|NCT02081456|12431427|FG000|COMPLETED|Overall Study||11
11239390|NCT02081456|12431428|FG001|COMPLETED|Overall Study||12
11239391|NCT02081456|12431427|FG000|NOT COMPLETED|Overall Study||0
11239392|NCT02081456|12431428|FG001|NOT COMPLETED|Overall Study||0
11239393|NCT02081534|12431441|FG000|STARTED|Overall Study||23
11239394|NCT02081534|12431442|FG001|STARTED|Overall Study||21
11239395|NCT02081534|12431443|FG002|STARTED|Overall Study||23
11239396|NCT02081534|12431444|FG003|STARTED|Overall Study||26
11239397|NCT02081534|12431445|FG004|STARTED|Overall Study||22
11239398|NCT02081534|12431446|FG005|STARTED|Overall Study||21
11239399|NCT02081534|12431447|FG006|STARTED|Overall Study||26
11239400|NCT02081534|12431441|FG000|COMPLETED|Overall Study||18
11239401|NCT02081534|12431442|FG001|COMPLETED|Overall Study||13
11239402|NCT02081534|12431443|FG002|COMPLETED|Overall Study||19
11239403|NCT02081534|12431444|FG003|COMPLETED|Overall Study||13
11239404|NCT02081534|12431445|FG004|COMPLETED|Overall Study||18
11239405|NCT02081534|12431446|FG005|COMPLETED|Overall Study||12
11239406|NCT02081534|12431447|FG006|COMPLETED|Overall Study||22
11239407|NCT02081534|12431441|FG000|NOT COMPLETED|Overall Study||5
11239408|NCT02081534|12431442|FG001|NOT COMPLETED|Overall Study||8
11239409|NCT02081534|12431443|FG002|NOT COMPLETED|Overall Study||4
11239410|NCT02081534|12431444|FG003|NOT COMPLETED|Overall Study||13
11239411|NCT02081534|12431445|FG004|NOT COMPLETED|Overall Study||4
11239412|NCT02081534|12431446|FG005|NOT COMPLETED|Overall Study||9
11239413|NCT02081534|12431447|FG006|NOT COMPLETED|Overall Study||4
11239414|NCT02081573|12431463|FG000|STARTED|Overall Study||10
11239415|NCT02081573|12431463|FG000|COMPLETED|Overall Study||10
11239416|NCT02081573|12431463|FG000|NOT COMPLETED|Overall Study||0
11239417|NCT02081586|12431471|FG000|STARTED|Overall Study||3
11239418|NCT02081586|12431472|FG001|STARTED|Overall Study||3
11239419|NCT02081586|12431473|FG002|STARTED|Overall Study||4
11239420|NCT02081586|12431474|FG003|STARTED|Overall Study||3
11239421|NCT02081586|12431471|FG000|COMPLETED|Overall Study||3
11239422|NCT02081586|12431472|FG001|COMPLETED|Overall Study||2
11239423|NCT02081586|12431473|FG002|COMPLETED|Overall Study||3
11239424|NCT02081586|12431474|FG003|COMPLETED|Overall Study||2
11239425|NCT02081586|12431471|FG000|NOT COMPLETED|Overall Study||0
11239426|NCT02081586|12431472|FG001|NOT COMPLETED|Overall Study||1
11239427|NCT02081586|12431473|FG002|NOT COMPLETED|Overall Study||1
11239428|NCT02081586|12431474|FG003|NOT COMPLETED|Overall Study||1
11239429|NCT02081599|12431488|FG000|STARTED|Period 1：Double-blind Period||71
11239430|NCT02081599|12431489|FG001|STARTED|Period 1：Double-blind Period||77
11239431|NCT02081599|12431488|FG000|COMPLETED|Period 1：Double-blind Period||63
11239432|NCT02081599|12431489|FG001|COMPLETED|Period 1：Double-blind Period||75
11239433|NCT02081599|12431488|FG000|NOT COMPLETED|Period 1：Double-blind Period||8
11239434|NCT02081599|12431489|FG001|NOT COMPLETED|Period 1：Double-blind Period||2
11239435|NCT02081599|12431488|FG000|STARTED|Period 2：Open-label Period||63
11239436|NCT02081599|12431489|FG001|STARTED|Period 2：Open-label Period||75
11239437|NCT02081599|12431488|FG000|COMPLETED|Period 2：Open-label Period||57
11239438|NCT02081599|12431489|FG001|COMPLETED|Period 2：Open-label Period||71
11239439|NCT02081599|12431488|FG000|NOT COMPLETED|Period 2：Open-label Period||6
11239440|NCT02081599|12431489|FG001|NOT COMPLETED|Period 2：Open-label Period||4
11239441|NCT02081638|12431499|FG000|STARTED|Overall Study||26
11239442|NCT02081638|12431500|FG001|STARTED|Overall Study||27
11239443|NCT02081638|12431499|FG000|COMPLETED|Overall Study||24
11239444|NCT02081638|12431500|FG001|COMPLETED|Overall Study||20
11239445|NCT02081638|12431499|FG000|NOT COMPLETED|Overall Study||2
11239446|NCT02081638|12431500|FG001|NOT COMPLETED|Overall Study||7
11239447|NCT02081677|12431514|FG000|STARTED|Overall Study||19
11239448|NCT02081677|12431515|FG001|STARTED|Overall Study||19
11239449|NCT02081677|12431516|FG002|STARTED|Overall Study||19
11239450|NCT02081677|12431517|FG003|STARTED|Overall Study||19
11239451|NCT02081677|12431514|FG000|COMPLETED|Overall Study||18
11239452|NCT02081677|12431515|FG001|COMPLETED|Overall Study||18
11239453|NCT02081677|12431516|FG002|COMPLETED|Overall Study||17
11239454|NCT02081677|12431517|FG003|COMPLETED|Overall Study||19
11239455|NCT02081677|12431514|FG000|NOT COMPLETED|Overall Study||1
11239456|NCT02081677|12431515|FG001|NOT COMPLETED|Overall Study||1
11239457|NCT02081677|12431516|FG002|NOT COMPLETED|Overall Study||2
11239458|NCT02081677|12431517|FG003|NOT COMPLETED|Overall Study||0
11239459|NCT02081690|12431527|FG000|STARTED|Overall Study||88
11239460|NCT02081690|12431527|FG000|COMPLETED|Overall Study||81
11239461|NCT02081690|12431527|FG000|NOT COMPLETED|Overall Study||7
11239462|NCT02081807|12431539|FG000|STARTED|Overall Study||7668
11239463|NCT02081807|12431540|FG001|STARTED|Overall Study||26149
11239464|NCT02081807|12431541|FG002|STARTED|Overall Study||14852
11239465|NCT02081807|12431542|FG003|STARTED|Overall Study||9112
11239466|NCT02081807|12431543|FG004|STARTED|Overall Study||27456
11239467|NCT02081807|12431544|FG005|STARTED|Overall Study||76055
11239468|NCT02081807|12431545|FG006|STARTED|Overall Study||40207
11239469|NCT02081807|12431546|FG007|STARTED|Overall Study||19729
11239470|NCT02081807|12431539|FG000|COMPLETED|Overall Study||7668
11239471|NCT02081807|12431540|FG001|COMPLETED|Overall Study||26149
11239472|NCT02081807|12431541|FG002|COMPLETED|Overall Study||14852
11239473|NCT02081807|12431542|FG003|COMPLETED|Overall Study||9112
11239474|NCT02081807|12431543|FG004|COMPLETED|Overall Study||27456
11239475|NCT02081807|12431544|FG005|COMPLETED|Overall Study||76055
11239476|NCT02081807|12431545|FG006|COMPLETED|Overall Study||40207
11239477|NCT02081807|12431546|FG007|COMPLETED|Overall Study||19729
11128281|NCT01380769|12313697|FG001|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
11128282|NCT01380769|12313696|FG000|NOT COMPLETED|Overall Study||9
11128283|NCT01380769|12313697|FG001|NOT COMPLETED|Overall Study||14
11128284|NCT01380782|12313705|FG000|STARTED|Overall Study||12
11128285|NCT01380782|12313706|FG001|STARTED|Overall Study||10
11128286|NCT01380782|12313707|FG002|STARTED|Overall Study||11
11128287|NCT01380782|12313708|FG003|STARTED|Overall Study||4
11128288|NCT01380782|12313705|FG000|COMPLETED|Overall Study||0
11128289|NCT01380782|12313706|FG001|COMPLETED|Overall Study||0
11128290|NCT01380782|12313707|FG002|COMPLETED|Overall Study||0
11128291|NCT01380782|12313708|FG003|COMPLETED|Overall Study||0
11128292|NCT01380782|12313705|FG000|NOT COMPLETED|Overall Study||12
11128293|NCT01380782|12313706|FG001|NOT COMPLETED|Overall Study||10
11128294|NCT01380782|12313707|FG002|NOT COMPLETED|Overall Study||11
11128295|NCT01380782|12313708|FG003|NOT COMPLETED|Overall Study||4
11239478|NCT02081807|12431539|FG000|NOT COMPLETED|Overall Study||0
11239479|NCT02081807|12431540|FG001|NOT COMPLETED|Overall Study||0
11239480|NCT02081807|12431541|FG002|NOT COMPLETED|Overall Study||0
11239481|NCT02081807|12431542|FG003|NOT COMPLETED|Overall Study||0
11239482|NCT02081807|12431543|FG004|NOT COMPLETED|Overall Study||0
11239483|NCT02081807|12431544|FG005|NOT COMPLETED|Overall Study||0
11239484|NCT02081807|12431545|FG006|NOT COMPLETED|Overall Study||0
11239485|NCT02081807|12431546|FG007|NOT COMPLETED|Overall Study||0
11239486|NCT02081846|12431576|FG000|STARTED|Overall Study||751
11239487|NCT02081846|12431577|FG001|STARTED|Overall Study||749
11239488|NCT02081846|12431576|FG000|COMPLETED|Overall Study||749
11239489|NCT02081846|12431577|FG001|COMPLETED|Overall Study||749
11239490|NCT02081846|12431576|FG000|NOT COMPLETED|Overall Study||2
11239491|NCT02081846|12431577|FG001|NOT COMPLETED|Overall Study||0
11239492|NCT02081859|12431585|FG000|STARTED|Overall Study||150
11239493|NCT02081859|12431586|FG001|STARTED|Overall Study||150
11239494|NCT02081859|12431585|FG000|COMPLETED|Overall Study||116
11239495|NCT02081859|12431586|FG001|COMPLETED|Overall Study||119
11239496|NCT02081859|12431585|FG000|NOT COMPLETED|Overall Study||34
11239497|NCT02081859|12431586|FG001|NOT COMPLETED|Overall Study||31
11239498|NCT02081950|12431592|FG000|STARTED|Treatment Period 1||14
11239499|NCT02081950|12431592|FG000|COMPLETED|Treatment Period 1||14
11239500|NCT02081950|12431592|FG000|NOT COMPLETED|Treatment Period 1||0
11239501|NCT02081950|12431592|FG000|STARTED|Treatment Period 2||14
11239502|NCT02081950|12431592|FG000|COMPLETED|Treatment Period 2||14
11239503|NCT02081950|12431592|FG000|NOT COMPLETED|Treatment Period 2||0
11239504|NCT02081963|12431600|FG000|STARTED|Overall Study||79
11239505|NCT02081963|12431601|FG001|STARTED|Overall Study||73
11239506|NCT02081963|12431600|FG000|COMPLETED|Overall Study||74
11239507|NCT02081963|12431601|FG001|COMPLETED|Overall Study||69
11239508|NCT02081963|12431600|FG000|NOT COMPLETED|Overall Study||5
11239509|NCT02081963|12431601|FG001|NOT COMPLETED|Overall Study||4
11239510|NCT02082119|12431607|FG000|STARTED|Overall Study||82
11239511|NCT02082119|12431607|FG000|COMPLETED|Overall Study||82
11239512|NCT02082119|12431607|FG000|NOT COMPLETED|Overall Study||0
11239513|NCT02082145|12431613|FG000|STARTED|Overall Study||5
11239514|NCT02082145|12431614|FG001|STARTED|Overall Study||9
11239515|NCT02082145|12431613|FG000|COMPLETED|Overall Study||5
11239516|NCT02082145|12431614|FG001|COMPLETED|Overall Study||9
11239517|NCT02082145|12431613|FG000|NOT COMPLETED|Overall Study||0
11239518|NCT02082145|12431614|FG001|NOT COMPLETED|Overall Study||0
11239519|NCT02082158|12431628|FG000|STARTED|Overall Study||66
11239520|NCT02082158|12431629|FG001|STARTED|Overall Study||61
11239521|NCT02082158|12431630|FG002|STARTED|Overall Study||52
11128296|NCT01380834|12313722|FG000|STARTED|Overall Study||42
11239522|NCT02082158|12431631|FG003|STARTED|Overall Study||72
11239523|NCT02082158|12431632|FG004|STARTED|Overall Study||68
11239524|NCT02082158|12431633|FG005|STARTED|Overall Study||63
11239525|NCT02082158|12431628|FG000|COMPLETED|Overall Study||58
11239526|NCT02082158|12431629|FG001|COMPLETED|Overall Study||53
11239527|NCT02082158|12431630|FG002|COMPLETED|Overall Study||38
11239528|NCT02082158|12431631|FG003|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
11239529|NCT02082158|12431632|FG004|COMPLETED|Overall Study||64
11239530|NCT02082158|12431633|FG005|COMPLETED|Overall Study||56
11239531|NCT02082158|12431628|FG000|NOT COMPLETED|Overall Study||8
11239532|NCT02082158|12431629|FG001|NOT COMPLETED|Overall Study||8
11239533|NCT02082158|12431630|FG002|NOT COMPLETED|Overall Study||14
11239534|NCT02082158|12431631|FG003|NOT COMPLETED|Overall Study||4
11128297|NCT01380834|12313723|FG001|STARTED|Overall Study||42
11128298|NCT01380834|12313722|FG000|COMPLETED|Overall Study||41
11239535|NCT02082158|12431632|FG004|NOT COMPLETED|Overall Study||4
11239536|NCT02082158|12431633|FG005|NOT COMPLETED|Overall Study||7
11239537|NCT02082184|12431655|FG000|STARTED|Overall Study||149
11128299|NCT01380834|12313723|FG001|COMPLETED|Overall Study||42
11128300|NCT01380834|12313722|FG000|NOT COMPLETED|Overall Study||1
11128301|NCT01380834|12313723|FG001|NOT COMPLETED|Overall Study||0
11128302|NCT01380899|12313732|FG000|STARTED|Overall Study||34
11128303|NCT01380899|12313733|FG001|STARTED|Overall Study||33
11128304|NCT01380899|12313734|FG002|STARTED|Overall Study||20
11128305|NCT01380899|12313732|FG000|COMPLETED|Overall Study||34
11128306|NCT01380899|12313733|FG001|COMPLETED|Overall Study||33
11128307|NCT01380899|12313734|FG002|COMPLETED|Overall Study||20
11128308|NCT01380899|12313732|FG000|NOT COMPLETED|Overall Study||0
11128309|NCT01380899|12313733|FG001|NOT COMPLETED|Overall Study||0
11128310|NCT01380899|12313734|FG002|NOT COMPLETED|Overall Study||0
11128311|NCT01380990|12313744|FG000|STARTED|Overall Study||20
11128312|NCT01380990|12313745|FG001|STARTED|Overall Study||16
11128313|NCT01380990|12313744|FG000|COMPLETED|Overall Study||19
11128314|NCT01380990|12313745|FG001|COMPLETED|Overall Study||15
11128315|NCT01380990|12313744|FG000|NOT COMPLETED|Overall Study||1
11128316|NCT01380990|12313745|FG001|NOT COMPLETED|Overall Study||1
11128317|NCT01381016|12313757|FG000|STARTED|Overall Study||13
11128318|NCT01381016|12313758|FG001|STARTED|Overall Study||17
11128319|NCT01381016|12313757|FG000|COMPLETED|Overall Study||10
11128320|NCT01381016|12313758|FG001|COMPLETED|Overall Study||11
11128321|NCT01381016|12313757|FG000|NOT COMPLETED|Overall Study||3
11128322|NCT01381016|12313758|FG001|NOT COMPLETED|Overall Study||6
11128323|NCT01381068|12313768|FG000|STARTED|Overall Study||25
11128324|NCT01381068|12313769|FG001|STARTED|Overall Study||24
11128325|NCT01381068|12313768|FG000|COMPLETED|Overall Study||24
11128326|NCT01381068|12313769|FG001|COMPLETED|Overall Study||24
11128327|NCT01381068|12313768|FG000|NOT COMPLETED|Overall Study||1
11128328|NCT01381068|12313769|FG001|NOT COMPLETED|Overall Study||0
11128329|NCT01381120|12313777|FG000|STARTED|Overall Study||50
11128330|NCT01381120|12313778|FG001|STARTED|Overall Study||27
11128331|NCT01381120|12313777|FG000|COMPLETED|Overall Study||39
11128332|NCT01381120|12313778|FG001|COMPLETED|Overall Study||18
11128333|NCT01381120|12313777|FG000|NOT COMPLETED|Overall Study||11
11128334|NCT01381120|12313778|FG001|NOT COMPLETED|Overall Study||9
11128335|NCT01381172|12313786|FG000|STARTED|Overall Study||74
11128336|NCT01381172|12313787|FG001|STARTED|Overall Study||86
11128337|NCT01381172|12313786|FG000|COMPLETED|Overall Study||64
11128338|NCT01381172|12313787|FG001|COMPLETED|Overall Study||73
11128339|NCT01381172|12313786|FG000|NOT COMPLETED|Overall Study||10
11128340|NCT01381172|12313787|FG001|NOT COMPLETED|Overall Study||13
11128341|NCT01381406|12313795|FG000|STARTED|Overall Study||2481
11128342|NCT01381406|12313796|FG001|STARTED|Overall Study||852
11128343|NCT01381406|12313795|FG000|COMPLETED|Overall Study||2481
11128344|NCT01381406|12313796|FG001|COMPLETED|Overall Study||852
11128345|NCT01381406|12313795|FG000|NOT COMPLETED|Overall Study||0
11128346|NCT01381406|12313796|FG001|NOT COMPLETED|Overall Study||0
11128347|NCT01381471|12313802|FG000|STARTED|Overall Study||11060
11128348|NCT01381471|12313802|FG000|COMPLETED|Overall Study||11060
11128349|NCT01381471|12313802|FG000|NOT COMPLETED|Overall Study||0
11128350|NCT01381549|12313809|FG000|STARTED|Overall Study||6
11128351|NCT01381549|12313810|FG001|STARTED|Overall Study||8
11128352|NCT01381549|12313811|FG002|STARTED|Overall Study||6
11128353|NCT01381549|12313809|FG000|COMPLETED|Overall Study||6
11128354|NCT01381549|12313810|FG001|COMPLETED|Overall Study||8
11128355|NCT01381549|12313811|FG002|COMPLETED|Overall Study||5
11128356|NCT01381549|12313809|FG000|NOT COMPLETED|Overall Study||0
11128357|NCT01381549|12313810|FG001|NOT COMPLETED|Overall Study||0
11128358|NCT01381549|12313811|FG002|NOT COMPLETED|Overall Study||1
11128359|NCT01381562|12313823|FG000|STARTED|Overall Study||5
11128360|NCT01381562|12313824|FG001|STARTED|Overall Study||4
11128361|NCT01381562|12313825|FG002|STARTED|Overall Study||5
11128362|NCT01381562|12313823|FG000|COMPLETED|Overall Study||5
11128363|NCT01381562|12313824|FG001|COMPLETED|Overall Study||3
11128364|NCT01381562|12313825|FG002|COMPLETED|Overall Study||5
11128365|NCT01381562|12313823|FG000|NOT COMPLETED|Overall Study||0
11128366|NCT01381562|12313824|FG001|NOT COMPLETED|Overall Study||1
11128367|NCT01381562|12313825|FG002|NOT COMPLETED|Overall Study||0
11128368|NCT01381575|12313836|FG000|STARTED|Overall Study||550
11128369|NCT01381575|12313837|FG001|STARTED|Overall Study||482
11128370|NCT01381575|12313838|FG002|STARTED|Overall Study||415
11128371|NCT01381575|12313836|FG000|COMPLETED|Overall Study||524
11128372|NCT01381575|12313837|FG001|COMPLETED|Overall Study||443
11128373|NCT01381575|12313838|FG002|COMPLETED|Overall Study||395
11128374|NCT01381575|12313836|FG000|NOT COMPLETED|Overall Study||26
11128375|NCT01381575|12313837|FG001|NOT COMPLETED|Overall Study||39
11128376|NCT01381575|12313838|FG002|NOT COMPLETED|Overall Study||20
11128377|NCT01381692|12313849|FG000|STARTED|Overall Study||7
11128378|NCT01381692|12313850|FG001|STARTED|Overall Study||2
11128379|NCT01381692|12313851|FG002|STARTED|Overall Study||0
11128380|NCT01381692|12313852|FG003|STARTED|Overall Study||0
11128381|NCT01381692|12313853|FG004|STARTED|Overall Study||0
11128382|NCT01381692|12313854|FG005|STARTED|Overall Study||0
11128383|NCT01381692|12313849|FG000|COMPLETED|Overall Study||6
11128384|NCT01381692|12313850|FG001|COMPLETED|Overall Study||2
11128385|NCT01381692|12313851|FG002|COMPLETED|Overall Study||0
11128386|NCT01381692|12313852|FG003|COMPLETED|Overall Study||0
11128387|NCT01381692|12313853|FG004|COMPLETED|Overall Study||0
11128388|NCT01381692|12313854|FG005|COMPLETED|Overall Study||0
11239538|NCT02082184|12431656|FG001|STARTED|Overall Study||75
11239539|NCT02082184|12431655|FG000|COMPLETED|Overall Study||139
11239540|NCT02082184|12431656|FG001|COMPLETED|Overall Study||62
11239541|NCT02082184|12431655|FG000|NOT COMPLETED|Overall Study||10
11128389|NCT01381692|12313849|FG000|NOT COMPLETED|Overall Study||1
11128390|NCT01381692|12313850|FG001|NOT COMPLETED|Overall Study||0
11128391|NCT01381692|12313851|FG002|NOT COMPLETED|Overall Study||0
11128392|NCT01381692|12313852|FG003|NOT COMPLETED|Overall Study||0
11128393|NCT01381692|12313853|FG004|NOT COMPLETED|Overall Study||0
11128394|NCT01381692|12313854|FG005|NOT COMPLETED|Overall Study||0
11128395|NCT01381718|12313864|FG000|STARTED|Overall Study||56
11128396|NCT01381718|12313865|FG001|STARTED|Overall Study||56
11128397|NCT01381718|12313864|FG000|COMPLETED|Overall Study||51
11128398|NCT01381718|12313865|FG001|COMPLETED|Overall Study||43
11128399|NCT01381718|12313864|FG000|NOT COMPLETED|Overall Study||5
11128400|NCT01381718|12313865|FG001|NOT COMPLETED|Overall Study||13
11128401|NCT01381861|12313871|FG000|STARTED|Overall Study||23
11128402|NCT01381861|12313871|FG000|COMPLETED|Overall Study||23
11239542|NCT02082184|12431656|FG001|NOT COMPLETED|Overall Study||13
11239543|NCT02082210|12431668|FG000|STARTED|Overall Study||3
11239544|NCT02082210|12431669|FG001|STARTED|Overall Study||3
11239545|NCT02082210|12431670|FG002|STARTED|Overall Study||16
11239546|NCT02082210|12431671|FG003|STARTED|Overall Study||45
11239547|NCT02082210|12431672|FG004|STARTED|Overall Study||15
11239548|NCT02082210|12431673|FG005|STARTED|Overall Study||15
11239549|NCT02082210|12431668|FG000|Received at Least One Dose of Study Drug|Overall Study||3
11239550|NCT02082210|12431669|FG001|Received at Least One Dose of Study Drug|Overall Study||3
11239551|NCT02082210|12431670|FG002|Received at Least One Dose of Study Drug|Overall Study||16
11239552|NCT02082210|12431671|FG003|Received at Least One Dose of Study Drug|Overall Study||45
11239553|NCT02082210|12431672|FG004|Received at Least One Dose of Study Drug|Overall Study||15
11239554|NCT02082210|12431673|FG005|Received at Least One Dose of Study Drug|Overall Study||15
11239555|NCT02082210|12431668|FG000|COMPLETED|Overall Study||3
11239556|NCT02082210|12431669|FG001|COMPLETED|Overall Study||3
11239557|NCT02082210|12431670|FG002|COMPLETED|Overall Study||13
11239558|NCT02082210|12431671|FG003|COMPLETED|Overall Study||39
11239559|NCT02082210|12431672|FG004|COMPLETED|Overall Study||12
11239560|NCT02082210|12431673|FG005|COMPLETED|Overall Study||13
11239561|NCT02082210|12431668|FG000|NOT COMPLETED|Overall Study||0
11128403|NCT01381861|12313871|FG000|NOT COMPLETED|Overall Study||0
11128404|NCT01381874|12313878|FG000|STARTED|Overall Study||102
11128405|NCT01381874|12313879|FG001|STARTED|Overall Study||89
11128406|NCT01381874|12313880|FG002|STARTED|Overall Study||106
11128407|NCT01381874|12313878|FG000|Treated|Overall Study||102
11128408|NCT01381874|12313879|FG001|Treated|Overall Study||87
11128409|NCT01381874|12313880|FG002|Treated|Overall Study||104
11128410|NCT01381874|12313878|FG000|COMPLETED|Overall Study||25
11128411|NCT01381874|12313879|FG001|COMPLETED|Overall Study||26
11128412|NCT01381874|12313880|FG002|COMPLETED|Overall Study||30
11128413|NCT01381874|12313878|FG000|NOT COMPLETED|Overall Study||77
11128414|NCT01381874|12313879|FG001|NOT COMPLETED|Overall Study||63
11128415|NCT01381874|12313880|FG002|NOT COMPLETED|Overall Study||76
11128416|NCT01381900|12313891|FG000|STARTED|Overall Study||226
11128417|NCT01381900|12313892|FG001|STARTED|Overall Study||223
11128418|NCT01381900|12313893|FG002|STARTED|Overall Study||227
11128419|NCT01381900|12313891|FG000|COMPLETED|Overall Study||217
11128420|NCT01381900|12313892|FG001|COMPLETED|Overall Study||214
11128421|NCT01381900|12313893|FG002|COMPLETED|Overall Study||215
11128422|NCT01381900|12313891|FG000|NOT COMPLETED|Overall Study||9
11128423|NCT01381900|12313892|FG001|NOT COMPLETED|Overall Study||9
11128424|NCT01381900|12313893|FG002|NOT COMPLETED|Overall Study||12
11128425|NCT01381926|12313903|FG000|STARTED|Low/High Dose of 1st Treatment (2months)||5
11128426|NCT01381926|12313904|FG001|STARTED|Low/High Dose of 1st Treatment (2months)||5
11128427|NCT01381926|12313903|FG000|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
11128428|NCT01381926|12313904|FG001|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
11128429|NCT01381926|12313903|FG000|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
11128430|NCT01381926|12313904|FG001|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
11128431|NCT01381926|12313903|FG000|STARTED|Low/High Dose of 2nd Treatment (2months)||3
11239562|NCT02082210|12431669|FG001|NOT COMPLETED|Overall Study||0
11128432|NCT01381926|12313904|FG001|STARTED|Low/High Dose of 2nd Treatment (2months)||4
11128433|NCT01381926|12313903|FG000|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
11239563|NCT02082210|12431670|FG002|NOT COMPLETED|Overall Study||3
11239564|NCT02082210|12431671|FG003|NOT COMPLETED|Overall Study||6
11239565|NCT02082210|12431672|FG004|NOT COMPLETED|Overall Study||3
11128434|NCT01381926|12313904|FG001|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
11128435|NCT01381926|12313903|FG000|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
11128436|NCT01381926|12313904|FG001|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
11128437|NCT01381952|12313912|FG000|STARTED|Overall Study||20
11239566|NCT02082210|12431673|FG005|NOT COMPLETED|Overall Study||2
11239567|NCT02082262|12431699|FG000|STARTED|Overall Study||140
11239568|NCT02082262|12431699|FG000|COMPLETED|Overall Study||89
11239569|NCT02082262|12431699|FG000|NOT COMPLETED|Overall Study||51
11239570|NCT02082288|12431703|FG000|STARTED|Overall Study||243
11239571|NCT02082288|12431703|FG000|COMPLETED|Overall Study||243
11128438|NCT01381952|12313912|FG000|Collected Dose and Image Information|Overall Study||20
11128439|NCT01381952|12313912|FG000|COMPLETED|Overall Study||20
11128440|NCT01381952|12313912|FG000|NOT COMPLETED|Overall Study||0
11128441|NCT01382108|12313920|FG000|STARTED|Overall Study||20
11128442|NCT01382108|12313921|FG001|STARTED|Overall Study||19
11128443|NCT01382108|12313920|FG000|COMPLETED|Overall Study||20
11128444|NCT01382108|12313921|FG001|COMPLETED|Overall Study||19
11128445|NCT01382108|12313920|FG000|NOT COMPLETED|Overall Study||0
11128446|NCT01382108|12313921|FG001|NOT COMPLETED|Overall Study||0
11128447|NCT01382186|12313930|FG000|STARTED|Overall Study||33
11128448|NCT01382186|12313931|FG001|STARTED|Overall Study||819
11128449|NCT01382186|12313930|FG000|COMPLETED|Overall Study||32
11128450|NCT01382186|12313931|FG001|COMPLETED|Overall Study||819
11128451|NCT01382186|12313930|FG000|NOT COMPLETED|Overall Study||1
11128452|NCT01382186|12313931|FG001|NOT COMPLETED|Overall Study||0
11128453|NCT01382212|12313940|FG000|STARTED|Overall Study||13
11128454|NCT01382212|12313940|FG000|COMPLETED|Overall Study||11
11128455|NCT01382212|12313940|FG000|NOT COMPLETED|Overall Study||2
11128456|NCT01382225|12313946|FG000|STARTED|Overall Study||725
11128457|NCT01382225|12313947|FG001|STARTED|Overall Study||729
11128458|NCT01382225|12313946|FG000|COMPLETED|Overall Study||711
11128459|NCT01382225|12313947|FG001|COMPLETED|Overall Study||722
11128460|NCT01382225|12313946|FG000|NOT COMPLETED|Overall Study||14
11128461|NCT01382225|12313947|FG001|NOT COMPLETED|Overall Study||7
11128462|NCT01382251|12313955|FG000|STARTED|Overall Study||123
11128463|NCT01382251|12313956|FG001|STARTED|Overall Study||123
11128464|NCT01382251|12313955|FG000|COMPLETED|Overall Study||102
11128465|NCT01382251|12313956|FG001|COMPLETED|Overall Study||102
11128466|NCT01382251|12313955|FG000|NOT COMPLETED|Overall Study||21
11128467|NCT01382251|12313956|FG001|NOT COMPLETED|Overall Study||21
11128468|NCT01382303|12313963|FG000|STARTED|Overall Study||87
11128469|NCT01382303|12313964|FG001|STARTED|Overall Study||87
11128470|NCT01382303|12313963|FG000|COMPLETED|Overall Study||52
11128471|NCT01382303|12313964|FG001|COMPLETED|Overall Study||70
11128472|NCT01382303|12313963|FG000|NOT COMPLETED|Overall Study||35
11128473|NCT01382303|12313964|FG001|NOT COMPLETED|Overall Study||17
11128474|NCT01382446|12313972|FG000|STARTED|Overall Study||33
11128475|NCT01382446|12313973|FG001|STARTED|Overall Study||33
11128476|NCT01382446|12313972|FG000|COMPLETED|Overall Study||30
11128477|NCT01382446|12313973|FG001|COMPLETED|Overall Study||29
11128478|NCT01382446|12313972|FG000|NOT COMPLETED|Overall Study||3
11128479|NCT01382446|12313973|FG001|NOT COMPLETED|Overall Study||4
11128480|NCT01382602|12313981|FG000|STARTED|Overall Study||93
11128481|NCT01382602|12313982|FG001|STARTED|Overall Study||50
11128482|NCT01382602|12313981|FG000|COMPLETED|Overall Study||93
11128483|NCT01382602|12313982|FG001|COMPLETED|Overall Study||46
11128484|NCT01382602|12313981|FG000|NOT COMPLETED|Overall Study||0
11128485|NCT01382602|12313982|FG001|NOT COMPLETED|Overall Study||4
11128486|NCT01382719|12313992|FG000|STARTED|Overall Study||98
11128487|NCT01382719|12313993|FG001|STARTED|Overall Study||100
11128488|NCT01382719|12313994|FG002|STARTED|Overall Study||100
11128489|NCT01382719|12313995|FG003|STARTED|Overall Study||99
11128490|NCT01382719|12313992|FG000|Subjects Not Dosed|Overall Study||1
11128491|NCT01382719|12313993|FG001|Subjects Not Dosed|Overall Study||0
11128492|NCT01382719|12313994|FG002|Subjects Not Dosed|Overall Study||1
11128493|NCT01382719|12313995|FG003|Subjects Not Dosed|Overall Study||1
11128494|NCT01382719|12313992|FG000|COMPLETED|Overall Study||80
11128495|NCT01382719|12313993|FG001|COMPLETED|Overall Study||81
11128496|NCT01382719|12313994|FG002|COMPLETED|Overall Study||66
11128497|NCT01382719|12313995|FG003|COMPLETED|Overall Study||66
11128498|NCT01382719|12313992|FG000|NOT COMPLETED|Overall Study||18
11128499|NCT01382719|12313993|FG001|NOT COMPLETED|Overall Study||19
11128500|NCT01382719|12313994|FG002|NOT COMPLETED|Overall Study||34
11128501|NCT01382719|12313995|FG003|NOT COMPLETED|Overall Study||33
11128502|NCT01382901|12314007|FG000|STARTED|Overall Study||24
11128503|NCT01382901|12314008|FG001|STARTED|Overall Study||21
11128504|NCT01382901|12314007|FG000|COMPLETED|Overall Study||7
11128505|NCT01382901|12314008|FG001|COMPLETED|Overall Study||7
11128506|NCT01382901|12314007|FG000|NOT COMPLETED|Overall Study||17
11128507|NCT01382901|12314008|FG001|NOT COMPLETED|Overall Study||14
11128508|NCT01382940|12314014|FG000|STARTED|Overall Study||351
11128509|NCT01382940|12314014|FG000|Received Day 1 Infusion|Overall Study||351
11128510|NCT01382940|12314014|FG000|Received Day 15 Infusions|Overall Study||341
11239572|NCT02082288|12431703|FG000|NOT COMPLETED|Overall Study||0
11128511|NCT01382940|12314014|FG000|Received Day 168 Infusion|Overall Study||290
11128512|NCT01382940|12314014|FG000|Received Day 182 Infusion|Overall Study||278
11128513|NCT01382940|12314014|FG000|COMPLETED|Overall Study||278
11128514|NCT01382940|12314014|FG000|NOT COMPLETED|Overall Study||73
11128515|NCT01383005|12314020|FG000|STARTED|Overall Study||34
11128516|NCT01383005|12314021|FG001|STARTED|Overall Study||60
11128517|NCT01383005|12314020|FG000|COMPLETED|Overall Study||34
11128518|NCT01383005|12314021|FG001|COMPLETED|Overall Study||60
11128519|NCT01383005|12314020|FG000|NOT COMPLETED|Overall Study||0
11128520|NCT01383005|12314021|FG001|NOT COMPLETED|Overall Study||0
11128521|NCT01383018|12314027|FG000|STARTED|Overall Study||1457
11128522|NCT01383018|12314027|FG000|COMPLETED|Overall Study||1082
11128523|NCT01383018|12314027|FG000|NOT COMPLETED|Overall Study||375
11128524|NCT01383096|12314044|FG000|STARTED|First Intervention (8 Days)||19
11128525|NCT01383096|12314045|FG001|STARTED|First Intervention (8 Days)||17
11128526|NCT01383096|12314046|FG002|STARTED|First Intervention (8 Days)||16
11128527|NCT01383096|12314044|FG000|COMPLETED|First Intervention (8 Days)||19
11128528|NCT01383096|12314045|FG001|COMPLETED|First Intervention (8 Days)||17
11128529|NCT01383096|12314046|FG002|COMPLETED|First Intervention (8 Days)||16
11128530|NCT01383096|12314044|FG000|NOT COMPLETED|First Intervention (8 Days)||0
11128531|NCT01383096|12314045|FG001|NOT COMPLETED|First Intervention (8 Days)||0
11128532|NCT01383096|12314046|FG002|NOT COMPLETED|First Intervention (8 Days)||0
11128533|NCT01383096|12314044|FG000|STARTED|Second Intervention (8 Days)||19
11128534|NCT01383096|12314045|FG001|STARTED|Second Intervention (8 Days)||17
11128535|NCT01383096|12314046|FG002|STARTED|Second Intervention (8 Days)||16
11128536|NCT01383096|12314044|FG000|COMPLETED|Second Intervention (8 Days)||19
11239573|NCT02082340|12431709|FG000|STARTED|Overall Study||194
11239574|NCT02082340|12431710|FG001|STARTED|Overall Study||198
11239575|NCT02082340|12431709|FG000|COMPLETED|Overall Study||193
11239576|NCT02082340|12431710|FG001|COMPLETED|Overall Study||197
11239577|NCT02082340|12431709|FG000|NOT COMPLETED|Overall Study||1
11239578|NCT02082340|12431710|FG001|NOT COMPLETED|Overall Study||1
11239579|NCT02082392|12431718|FG000|STARTED|Overall Study||2
11239580|NCT02082392|12431719|FG001|STARTED|Overall Study||1
11239581|NCT02082392|12431718|FG000|COMPLETED|Overall Study||2
11239582|NCT02082392|12431719|FG001|COMPLETED|Overall Study||1
11239583|NCT02082392|12431718|FG000|NOT COMPLETED|Overall Study||0
11239584|NCT02082392|12431719|FG001|NOT COMPLETED|Overall Study||0
11239585|NCT02082483|12431727|FG000|STARTED|Overall Study||71
11239586|NCT02082483|12431728|FG001|STARTED|Overall Study||73
11239587|NCT02082483|12431727|FG000|COMPLETED|Overall Study||65
11239588|NCT02082483|12431728|FG001|COMPLETED|Overall Study||67
11239589|NCT02082483|12431727|FG000|NOT COMPLETED|Overall Study||6
11239590|NCT02082483|12431728|FG001|NOT COMPLETED|Overall Study||6
11239591|NCT02082522|12431737|FG000|STARTED|Overall Study||15
11239592|NCT02082522|12431738|FG001|STARTED|Overall Study||13
11239593|NCT02082522|12431737|FG000|COMPLETED|Overall Study||0
11239594|NCT02082522|12431738|FG001|COMPLETED|Overall Study||0
11239595|NCT02082522|12431737|FG000|NOT COMPLETED|Overall Study||15
11239596|NCT02082522|12431738|FG001|NOT COMPLETED|Overall Study||13
11239597|NCT02082678|12431746|FG000|STARTED|Overall Study||35
11239598|NCT02082678|12431747|FG001|STARTED|Overall Study||35
11239599|NCT02082678|12431746|FG000|COMPLETED|Overall Study||23
11239600|NCT02082678|12431747|FG001|COMPLETED|Overall Study||21
11239601|NCT02082678|12431746|FG000|NOT COMPLETED|Overall Study||12
11239602|NCT02082678|12431747|FG001|NOT COMPLETED|Overall Study||14
11128537|NCT01383096|12314045|FG001|COMPLETED|Second Intervention (8 Days)||16
11128538|NCT01383096|12314046|FG002|COMPLETED|Second Intervention (8 Days)||14
11128539|NCT01383096|12314044|FG000|NOT COMPLETED|Second Intervention (8 Days)||0
11128540|NCT01383096|12314045|FG001|NOT COMPLETED|Second Intervention (8 Days)||1
11128541|NCT01383096|12314046|FG002|NOT COMPLETED|Second Intervention (8 Days)||2
11128542|NCT01383096|12314044|FG000|STARTED|Third Intervention (8 Days)||19
11128543|NCT01383096|12314045|FG001|STARTED|Third Intervention (8 Days)||16
11128544|NCT01383096|12314046|FG002|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
11128545|NCT01383096|12314044|FG000|COMPLETED|Third Intervention (8 Days)||15
11128546|NCT01383096|12314045|FG001|COMPLETED|Third Intervention (8 Days)||12
11128547|NCT01383096|12314046|FG002|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
11128548|NCT01383096|12314044|FG000|NOT COMPLETED|Third Intervention (8 Days)||4
11128549|NCT01383096|12314045|FG001|NOT COMPLETED|Third Intervention (8 Days)||4
11128550|NCT01383096|12314046|FG002|NOT COMPLETED|Third Intervention (8 Days)||0
11128551|NCT01383096|12314044|FG000|STARTED|Fourth Intervention (8 Days)||15
11128552|NCT01383096|12314045|FG001|STARTED|Fourth Intervention (8 Days)||12
11128553|NCT01383096|12314046|FG002|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
11128554|NCT01383096|12314044|FG000|COMPLETED|Fourth Intervention (8 Days)||13
11128555|NCT01383096|12314045|FG001|COMPLETED|Fourth Intervention (8 Days)||12
11128556|NCT01383096|12314046|FG002|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
11128557|NCT01383096|12314044|FG000|NOT COMPLETED|Fourth Intervention (8 Days)||2
11128558|NCT01383096|12314045|FG001|NOT COMPLETED|Fourth Intervention (8 Days)||0
11128559|NCT01383096|12314046|FG002|NOT COMPLETED|Fourth Intervention (8 Days)||0
11128560|NCT01383096|12314044|FG000|STARTED|Fifth Intervention (8 Days)||13
11128561|NCT01383096|12314045|FG001|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
11128562|NCT01383096|12314046|FG002|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
11128563|NCT01383096|12314044|FG000|COMPLETED|Fifth Intervention (8 Days)||11
11128564|NCT01383096|12314045|FG001|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
11128565|NCT01383096|12314046|FG002|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
11128566|NCT01383096|12314044|FG000|NOT COMPLETED|Fifth Intervention (8 Days)||2
11128567|NCT01383096|12314045|FG001|NOT COMPLETED|Fifth Intervention (8 Days)||0
11128568|NCT01383096|12314046|FG002|NOT COMPLETED|Fifth Intervention (8 Days)||0
11128569|NCT01383161|12314085|FG000|STARTED|Overall Study||25
11128570|NCT01383161|12314086|FG001|STARTED|Overall Study||21
11128571|NCT01383161|12314085|FG000|COMPLETED|Overall Study||20
11128572|NCT01383161|12314086|FG001|COMPLETED|Overall Study||17
11128573|NCT01383161|12314085|FG000|NOT COMPLETED|Overall Study||5
11128574|NCT01383161|12314086|FG001|NOT COMPLETED|Overall Study||4
11202174|NCT01838447|12392587|FG000|STARTED|Overall Study||22
11202175|NCT01838447|12392588|FG001|STARTED|Overall Study||24
11202176|NCT01838447|12392587|FG000|COMPLETED|Overall Study||20
11202177|NCT01838447|12392588|FG001|COMPLETED|Overall Study||21
11202178|NCT01838447|12392587|FG000|NOT COMPLETED|Overall Study||2
11202179|NCT01838447|12392588|FG001|NOT COMPLETED|Overall Study||3
11202180|NCT01838499|12392596|FG000|STARTED|Overall Study||55
11202181|NCT01838499|12392597|FG001|STARTED|Overall Study||54
11202182|NCT01838499|12392596|FG000|COMPLETED|Overall Study||31
11202183|NCT01838499|12392597|FG001|COMPLETED|Overall Study||37
11202184|NCT01838499|12392596|FG000|NOT COMPLETED|Overall Study||24
11202185|NCT01838499|12392597|FG001|NOT COMPLETED|Overall Study||17
11202186|NCT01838551|12392603|FG000|STARTED|Overall Study|94 subjects were enrolled and received at least 1 dose of levoketoconazole|94
11202187|NCT01838551|12392603|FG000|COMPLETED|Overall Study|46 subjects completed the Extended Evaluation phase|46
11202188|NCT01838551|12392603|FG000|NOT COMPLETED|Overall Study||48
11202189|NCT01838590|12392611|FG000|STARTED|Overall Study||52
11202190|NCT01838590|12392612|FG001|STARTED|Overall Study||51
11202191|NCT01838590|12392611|FG000|COMPLETED|Overall Study||40
11202192|NCT01838590|12392612|FG001|COMPLETED|Overall Study||46
11005140|NCT00721253|12182806|FG000|NOT COMPLETED|Overall Study||0
11005141|NCT00721253|12182807|FG001|NOT COMPLETED|Overall Study||0
11005142|NCT00721253|12182808|FG002|NOT COMPLETED|Overall Study||0
11202193|NCT01838590|12392611|FG000|NOT COMPLETED|Overall Study||12
11202194|NCT01838590|12392612|FG001|NOT COMPLETED|Overall Study||5
11202195|NCT01838616|12392624|FG000|STARTED|Titration Period||130
11202196|NCT01838616|12392625|FG001|STARTED|Titration Period||128
11202197|NCT01838616|12392624|FG000|No Post Baseline Pain Intensity Values|Titration Period||0
11202198|NCT01838616|12392625|FG001|No Post Baseline Pain Intensity Values|Titration Period||2
11202199|NCT01838616|12392624|FG000|Major Protocol Deviations|Titration Period||13
11202200|NCT01838616|12392625|FG001|Major Protocol Deviations|Titration Period||16
11202201|NCT01838616|12392624|FG000|Switched to Pick-up Arm|Titration Period||0
11202202|NCT01838616|12392625|FG001|Switched to Pick-up Arm|Titration Period||43
11239603|NCT02082717|12431755|FG000|STARTED|Overall Study||8
11239604|NCT02082717|12431756|FG001|STARTED|Overall Study||9
11128575|NCT01383174|12314094|FG000|STARTED|Baseline Assessment||76
11128576|NCT01383174|12314095|FG001|STARTED|Baseline Assessment||75
11128577|NCT01383174|12314094|FG000|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
11128578|NCT01383174|12314095|FG001|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
11128579|NCT01383174|12314094|FG000|NOT COMPLETED|Baseline Assessment||0
11128580|NCT01383174|12314095|FG001|NOT COMPLETED|Baseline Assessment||0
11128581|NCT01383174|12314094|FG000|STARTED|3 Month Assessment||76
11128582|NCT01383174|12314095|FG001|STARTED|3 Month Assessment||75
11128583|NCT01383174|12314094|FG000|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
11239605|NCT02082717|12431755|FG000|COMPLETED|Overall Study||8
11128584|NCT01383174|12314095|FG001|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
11128585|NCT01383174|12314094|FG000|NOT COMPLETED|3 Month Assessment||6
11128586|NCT01383174|12314095|FG001|NOT COMPLETED|3 Month Assessment||1
11128587|NCT01383174|12314094|FG000|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
11128588|NCT01383174|12314095|FG001|STARTED|6 Month Assessment||74
11128589|NCT01383174|12314094|FG000|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
11128590|NCT01383174|12314095|FG001|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
11128591|NCT01383174|12314094|FG000|NOT COMPLETED|6 Month Assessment||5
11128592|NCT01383174|12314095|FG001|NOT COMPLETED|6 Month Assessment||1
11128593|NCT01383200|12314103|FG000|STARTED|Overall Study||5
11128594|NCT01383200|12314104|FG001|STARTED|Overall Study||6
11128595|NCT01383200|12314103|FG000|COMPLETED|Overall Study||5
11128596|NCT01383200|12314104|FG001|COMPLETED|Overall Study||6
11128597|NCT01383200|12314103|FG000|NOT COMPLETED|Overall Study||0
11128598|NCT01383200|12314104|FG001|NOT COMPLETED|Overall Study||0
11128599|NCT01383213|12314112|FG000|STARTED|Overall Study||40
11128600|NCT01383213|12314113|FG001|STARTED|Overall Study||41
11128601|NCT01383213|12314112|FG000|COMPLETED|Overall Study||40
11128602|NCT01383213|12314113|FG001|COMPLETED|Overall Study||41
11128603|NCT01383213|12314112|FG000|NOT COMPLETED|Overall Study||0
11128604|NCT01383213|12314113|FG001|NOT COMPLETED|Overall Study||0
11128605|NCT01383317|12314121|FG000|STARTED|Overall Study||29
11128606|NCT01383317|12314122|FG001|STARTED|Overall Study||35
11128607|NCT01383317|12314121|FG000|COMPLETED|Overall Study||26
11128608|NCT01383317|12314122|FG001|COMPLETED|Overall Study||33
11128609|NCT01383317|12314121|FG000|NOT COMPLETED|Overall Study||3
11128610|NCT01383317|12314122|FG001|NOT COMPLETED|Overall Study||2
11128611|NCT01383356|12314128|FG000|STARTED|Period 1|Entered and treated.|29
11128612|NCT01383356|12314129|FG001|STARTED|Period 1|Entered and treated.|29
11128613|NCT01383356|12314128|FG000|COMPLETED|Period 1|Completed period 1.|21
11128614|NCT01383356|12314129|FG001|COMPLETED|Period 1|Completed period 1.|23
11128615|NCT01383356|12314128|FG000|NOT COMPLETED|Period 1||8
11128616|NCT01383356|12314129|FG001|NOT COMPLETED|Period 1||6
11128617|NCT01383356|12314128|FG000|STARTED|Washout Period (at Least 35 Days)||21
11128618|NCT01383356|12314129|FG001|STARTED|Washout Period (at Least 35 Days)||23
11128619|NCT01383356|12314128|FG000|COMPLETED|Washout Period (at Least 35 Days)||21
11128620|NCT01383356|12314129|FG001|COMPLETED|Washout Period (at Least 35 Days)||23
11128621|NCT01383356|12314128|FG000|NOT COMPLETED|Washout Period (at Least 35 Days)||0
11128622|NCT01383356|12314129|FG001|NOT COMPLETED|Washout Period (at Least 35 Days)||0
11128623|NCT01383356|12314128|FG000|STARTED|Period 2|Entered and treated.|21
11128624|NCT01383356|12314129|FG001|STARTED|Period 2|Entered and treated.|23
11128625|NCT01383356|12314128|FG000|COMPLETED|Period 2|Completed period 2.|21
11128626|NCT01383356|12314129|FG001|COMPLETED|Period 2|Completed period 2.|23
11128627|NCT01383356|12314128|FG000|NOT COMPLETED|Period 2||0
11128628|NCT01383356|12314129|FG001|NOT COMPLETED|Period 2||0
11128629|NCT01383421|12314135|FG000|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
11128630|NCT01383421|12314135|FG000|COMPLETED|Overall Study||679
11128631|NCT01383421|12314135|FG000|NOT COMPLETED|Overall Study||346
11128632|NCT01383486|12314143|FG000|STARTED|Overall Study|Number of participants who were provided with investigational products|253
11128633|NCT01383486|12314143|FG000|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
11128634|NCT01383486|12314143|FG000|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
11128635|NCT01383486|12314143|FG000|NOT COMPLETED|Overall Study||18
11128636|NCT01383499|12314148|FG000|STARTED|Period 1 (4 Weeks)||27
11128637|NCT01383499|12314149|FG001|STARTED|Period 1 (4 Weeks)||24
11128638|NCT01383499|12314150|FG002|STARTED|Period 1 (4 Weeks)||25
11128639|NCT01383499|12314151|FG003|STARTED|Period 1 (4 Weeks)||25
11128640|NCT01383499|12314148|FG000|COMPLETED|Period 1 (4 Weeks)||26
11128641|NCT01383499|12314149|FG001|COMPLETED|Period 1 (4 Weeks)||24
11128642|NCT01383499|12314150|FG002|COMPLETED|Period 1 (4 Weeks)||25
11128643|NCT01383499|12314151|FG003|COMPLETED|Period 1 (4 Weeks)||25
11128644|NCT01383499|12314148|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1
11128645|NCT01383499|12314149|FG001|NOT COMPLETED|Period 1 (4 Weeks)||0
11128646|NCT01383499|12314150|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0
11128647|NCT01383499|12314151|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
11128648|NCT01383499|12314148|FG000|STARTED|Period 2 (4 Weeks)||26
11128649|NCT01383499|12314149|FG001|STARTED|Period 2 (4 Weeks)||24
11128650|NCT01383499|12314150|FG002|STARTED|Period 2 (4 Weeks)||25
11128651|NCT01383499|12314151|FG003|STARTED|Period 2 (4 Weeks)||25
11128652|NCT01383499|12314148|FG000|COMPLETED|Period 2 (4 Weeks)||26
11128653|NCT01383499|12314149|FG001|COMPLETED|Period 2 (4 Weeks)||24
11128654|NCT01383499|12314150|FG002|COMPLETED|Period 2 (4 Weeks)||25
11128655|NCT01383499|12314151|FG003|COMPLETED|Period 2 (4 Weeks)||25
11128656|NCT01383499|12314148|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
11128657|NCT01383499|12314149|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
11128658|NCT01383499|12314150|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
11128659|NCT01383499|12314151|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
11128660|NCT01383499|12314148|FG000|STARTED|Period 3 (4 Weeks)||26
11128661|NCT01383499|12314149|FG001|STARTED|Period 3 (4 Weeks)||24
11128662|NCT01383499|12314150|FG002|STARTED|Period 3 (4 Weeks)||25
11128663|NCT01383499|12314151|FG003|STARTED|Period 3 (4 Weeks)||25
11128664|NCT01383499|12314148|FG000|COMPLETED|Period 3 (4 Weeks)||26
11128665|NCT01383499|12314149|FG001|COMPLETED|Period 3 (4 Weeks)||24
11128666|NCT01383499|12314150|FG002|COMPLETED|Period 3 (4 Weeks)||25
11128667|NCT01383499|12314151|FG003|COMPLETED|Period 3 (4 Weeks)||25
11128668|NCT01383499|12314148|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
11128669|NCT01383499|12314149|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
11128670|NCT01383499|12314150|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
11128671|NCT01383499|12314151|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
11128672|NCT01383616|12314166|FG000|STARTED|Overall Study||40
11128673|NCT01383616|12314167|FG001|STARTED|Overall Study||44
11128674|NCT01383616|12314166|FG000|COMPLETED|Overall Study||23
11128675|NCT01383616|12314167|FG001|COMPLETED|Overall Study||21
11128676|NCT01383616|12314166|FG000|NOT COMPLETED|Overall Study||17
11128677|NCT01383616|12314167|FG001|NOT COMPLETED|Overall Study||23
11239606|NCT02082717|12431756|FG001|COMPLETED|Overall Study||9
11239607|NCT02082717|12431755|FG000|NOT COMPLETED|Overall Study||0
11239608|NCT02082717|12431756|FG001|NOT COMPLETED|Overall Study||0
11128678|NCT01383707|12314177|FG000|STARTED|Overall Study||77
11128679|NCT01383707|12314177|FG000|COMPLETED|Overall Study||5
11128680|NCT01383707|12314177|FG000|NOT COMPLETED|Overall Study||72
11128681|NCT01383720|12314181|FG000|STARTED|Overall Study||11
11128682|NCT01383720|12314181|FG000|Primary Endpoint (Discharge/7 Days)|Overall Study||11
11128683|NCT01383720|12314181|FG000|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
11128684|NCT01383720|12314181|FG000|NOT COMPLETED|Overall Study||0
11128685|NCT01383759|12314187|FG000|STARTED|Overall Study||19
11128686|NCT01383759|12314188|FG001|STARTED|Overall Study||1
11128687|NCT01383759|12314187|FG000|COMPLETED|Overall Study||19
11128688|NCT01383759|12314188|FG001|COMPLETED|Overall Study||1
11128689|NCT01383759|12314187|FG000|NOT COMPLETED|Overall Study||0
11128690|NCT01383759|12314188|FG001|NOT COMPLETED|Overall Study||0
11128691|NCT01383928|12314197|FG000|STARTED|Overall Study||7
11128692|NCT01383928|12314198|FG001|STARTED|Overall Study||7
11128693|NCT01383928|12314199|FG002|STARTED|Overall Study||50
11128694|NCT01383928|12314197|FG000|COMPLETED|Overall Study||2
11128695|NCT01383928|12314198|FG001|COMPLETED|Overall Study||0
11128696|NCT01383928|12314199|FG002|COMPLETED|Overall Study||10
11128697|NCT01383928|12314197|FG000|NOT COMPLETED|Overall Study||5
11128698|NCT01383928|12314198|FG001|NOT COMPLETED|Overall Study||7
11128699|NCT01383928|12314199|FG002|NOT COMPLETED|Overall Study||40
11128700|NCT01383954|12314209|FG000|STARTED|Overall Study||52
11128701|NCT01383954|12314209|FG000|Safety Population: Received Treatment|Overall Study||48
11128702|NCT01383954|12314209|FG000|COMPLETED|Overall Study||38
11128703|NCT01383954|12314209|FG000|NOT COMPLETED|Overall Study||14
11128704|NCT01383993|12314216|FG000|STARTED|Overall Study||15
11128705|NCT01383993|12314217|FG001|STARTED|Overall Study||4
11128706|NCT01383993|12314218|FG002|STARTED|Overall Study||2
11128707|NCT01383993|12314216|FG000|COMPLETED|Overall Study||12
11128708|NCT01383993|12314217|FG001|COMPLETED|Overall Study||3
11128709|NCT01383993|12314218|FG002|COMPLETED|Overall Study||1
11128710|NCT01383993|12314216|FG000|NOT COMPLETED|Overall Study||3
11128711|NCT01383993|12314217|FG001|NOT COMPLETED|Overall Study||1
11128712|NCT01383993|12314218|FG002|NOT COMPLETED|Overall Study||1
11128713|NCT01384019|12314229|FG000|STARTED|Overall Study||65
11128714|NCT01384019|12314230|FG001|STARTED|Overall Study||61
11128715|NCT01384019|12314229|FG000|COMPLETED|Overall Study||55
11128716|NCT01384019|12314230|FG001|COMPLETED|Overall Study||55
11128717|NCT01384019|12314229|FG000|NOT COMPLETED|Overall Study||10
11128718|NCT01384019|12314230|FG001|NOT COMPLETED|Overall Study||6
11128719|NCT01384292|12314239|FG000|STARTED|Part A||5
11128720|NCT01384292|12314240|FG001|STARTED|Part A||5
11128721|NCT01384292|12314241|FG002|STARTED|Part A||4
11128722|NCT01384292|12314239|FG000|COMPLETED|Part A||5
11128723|NCT01384292|12314240|FG001|COMPLETED|Part A||5
11239609|NCT02082769|12431769|FG000|STARTED|Overall Study||168
11239610|NCT02082769|12431770|FG001|STARTED|Overall Study||168
11239611|NCT02082769|12431771|FG002|STARTED|Overall Study||168
11239612|NCT02082769|12431769|FG000|COMPLETED|Overall Study||144
11239613|NCT02082769|12431770|FG001|COMPLETED|Overall Study||141
11239614|NCT02082769|12431771|FG002|COMPLETED|Overall Study||132
11239615|NCT02082769|12431769|FG000|NOT COMPLETED|Overall Study||24
11239616|NCT02082769|12431770|FG001|NOT COMPLETED|Overall Study||27
11239617|NCT02082769|12431771|FG002|NOT COMPLETED|Overall Study||36
11128724|NCT01384292|12314241|FG002|COMPLETED|Part A||4
11128725|NCT01384292|12314239|FG000|NOT COMPLETED|Part A||0
11128726|NCT01384292|12314240|FG001|NOT COMPLETED|Part A||0
11128727|NCT01384292|12314241|FG002|NOT COMPLETED|Part A||0
11128728|NCT01384292|12314239|FG000|STARTED|Part B||3
11128729|NCT01384292|12314240|FG001|STARTED|Part B||6
11128730|NCT01384292|12314241|FG002|STARTED|Part B||0
11128731|NCT01384292|12314239|FG000|COMPLETED|Part B||2
11128732|NCT01384292|12314240|FG001|COMPLETED|Part B||6
11239618|NCT02082912|12431781|FG000|STARTED|Overall Study||7
11128733|NCT01384292|12314241|FG002|COMPLETED|Part B||0
11128734|NCT01384292|12314239|FG000|NOT COMPLETED|Part B||1
11128735|NCT01384292|12314240|FG001|NOT COMPLETED|Part B||0
11128736|NCT01384292|12314241|FG002|NOT COMPLETED|Part B||0
11128737|NCT01384539|12314253|FG000|STARTED|Overall Study||64
11128738|NCT01384539|12314254|FG001|STARTED|Overall Study||64
11128739|NCT01384539|12314253|FG000|COMPLETED|Overall Study||58
11239619|NCT02082912|12431782|FG001|STARTED|Overall Study||7
11239620|NCT02082912|12431781|FG000|COMPLETED|Overall Study||7
11128740|NCT01384539|12314254|FG001|COMPLETED|Overall Study||57
11128741|NCT01384539|12314253|FG000|NOT COMPLETED|Overall Study||6
11128742|NCT01384539|12314254|FG001|NOT COMPLETED|Overall Study||7
11128743|NCT01384591|12314263|FG000|STARTED|Overall Study||2
11128744|NCT01384591|12314264|FG001|STARTED|Overall Study||2
11128745|NCT01384591|12314265|FG002|STARTED|Overall Study||2
11128746|NCT01384591|12314263|FG000|COMPLETED|Overall Study||2
11128747|NCT01384591|12314264|FG001|COMPLETED|Overall Study||2
11128748|NCT01384591|12314265|FG002|COMPLETED|Overall Study||2
11128749|NCT01384591|12314263|FG000|NOT COMPLETED|Overall Study||0
11128750|NCT01384591|12314264|FG001|NOT COMPLETED|Overall Study||0
11128751|NCT01384591|12314265|FG002|NOT COMPLETED|Overall Study||0
11128752|NCT01384734|12314278|FG000|STARTED|Overall Study||50
11128753|NCT01384734|12314279|FG001|STARTED|Overall Study||49
11128754|NCT01384734|12314280|FG002|STARTED|Overall Study||51
11128755|NCT01384734|12314281|FG003|STARTED|Overall Study||50
11128756|NCT01384734|12314282|FG004|STARTED|Overall Study||51
11128757|NCT01384734|12314278|FG000|COMPLETED|Overall Study||33
11128758|NCT01384734|12314279|FG001|COMPLETED|Overall Study||25
11128759|NCT01384734|12314280|FG002|COMPLETED|Overall Study||28
11128760|NCT01384734|12314281|FG003|COMPLETED|Overall Study||22
11128761|NCT01384734|12314282|FG004|COMPLETED|Overall Study||22
11128762|NCT01384734|12314278|FG000|NOT COMPLETED|Overall Study||17
11128763|NCT01384734|12314279|FG001|NOT COMPLETED|Overall Study||24
11128764|NCT01384734|12314280|FG002|NOT COMPLETED|Overall Study||23
11128765|NCT01384734|12314281|FG003|NOT COMPLETED|Overall Study||28
11128766|NCT01384734|12314282|FG004|NOT COMPLETED|Overall Study||29
11128767|NCT01384760|12314293|FG000|STARTED|Overall Study||61
11128768|NCT01384760|12314294|FG001|STARTED|Overall Study||43
11128769|NCT01384760|12314293|FG000|Randomized|Overall Study||61
11128770|NCT01384760|12314294|FG001|Randomized|Overall Study||43
11128771|NCT01384760|12314293|FG000|COMPLETED|Overall Study||45
11128772|NCT01384760|12314294|FG001|COMPLETED|Overall Study||37
11128773|NCT01384760|12314293|FG000|NOT COMPLETED|Overall Study||16
11128774|NCT01384760|12314294|FG001|NOT COMPLETED|Overall Study||6
11128775|NCT01384877|12314302|FG000|STARTED|Treatment 1||17
11128776|NCT01384877|12314303|FG001|STARTED|Treatment 1||15
11128777|NCT01384877|12314302|FG000|COMPLETED|Treatment 1||17
11128778|NCT01384877|12314303|FG001|COMPLETED|Treatment 1||15
11128779|NCT01384877|12314302|FG000|NOT COMPLETED|Treatment 1||0
11128780|NCT01384877|12314303|FG001|NOT COMPLETED|Treatment 1||0
11128781|NCT01384877|12314302|FG000|STARTED|Treatment 2|1 Patient died between treatment periods|16
11128782|NCT01384877|12314303|FG001|STARTED|Treatment 2|2 Patients died between treatment periods|13
11128783|NCT01384877|12314302|FG000|COMPLETED|Treatment 2||14
11128784|NCT01384877|12314303|FG001|COMPLETED|Treatment 2||11
11128785|NCT01384877|12314302|FG000|NOT COMPLETED|Treatment 2||2
11128786|NCT01384877|12314303|FG001|NOT COMPLETED|Treatment 2||2
11128787|NCT01385098|12314309|FG000|STARTED|Overall Study||37
11128788|NCT01385098|12314309|FG000|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
11128789|NCT01385098|12314309|FG000|NOT COMPLETED|Overall Study||14
11128790|NCT01385137|12314317|FG000|STARTED|Evaluable at Baseline||131
11128791|NCT01385137|12314318|FG001|STARTED|Evaluable at Baseline||131
11128792|NCT01385137|12314317|FG000|COMPLETED|Evaluable at Baseline||122
11128793|NCT01385137|12314318|FG001|COMPLETED|Evaluable at Baseline||127
11128794|NCT01385137|12314317|FG000|NOT COMPLETED|Evaluable at Baseline||9
11128795|NCT01385137|12314318|FG001|NOT COMPLETED|Evaluable at Baseline||4
11128796|NCT01385137|12314317|FG000|STARTED|Evaluable for Primary Endpoint||131
11128797|NCT01385137|12314318|FG001|STARTED|Evaluable for Primary Endpoint||131
11128798|NCT01385137|12314317|FG000|COMPLETED|Evaluable for Primary Endpoint||102
11128799|NCT01385137|12314318|FG001|COMPLETED|Evaluable for Primary Endpoint||107
11128800|NCT01385137|12314317|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||29
11128801|NCT01385137|12314318|FG001|NOT COMPLETED|Evaluable for Primary Endpoint||24
11128802|NCT01385189|12314329|FG000|STARTED|Overall Study||12
11128803|NCT01385189|12314330|FG001|STARTED|Overall Study||12
11128804|NCT01385189|12314331|FG002|STARTED|Overall Study||4
11128805|NCT01385189|12314332|FG003|STARTED|Overall Study||4
11239621|NCT02082912|12431782|FG001|COMPLETED|Overall Study||6
11239622|NCT02082912|12431781|FG000|NOT COMPLETED|Overall Study||0
11239623|NCT02082912|12431782|FG001|NOT COMPLETED|Overall Study||1
11239624|NCT02082977|12431798|FG000|STARTED|Part 1 (Up to 3.2 Years)||2
11239625|NCT02082977|12431799|FG001|STARTED|Part 1 (Up to 3.2 Years)||1
11239626|NCT02082977|12431800|FG002|STARTED|Part 1 (Up to 3.2 Years)||1
11239627|NCT02082977|12431801|FG003|STARTED|Part 1 (Up to 3.2 Years)||1
11128806|NCT01385189|12314333|FG004|STARTED|Overall Study||8
11128807|NCT01385189|12314329|FG000|COMPLETED|Overall Study||11
11128808|NCT01385189|12314330|FG001|COMPLETED|Overall Study||11
11128809|NCT01385189|12314331|FG002|COMPLETED|Overall Study||4
11128810|NCT01385189|12314332|FG003|COMPLETED|Overall Study||3
11128811|NCT01385189|12314333|FG004|COMPLETED|Overall Study||6
11128812|NCT01385189|12314329|FG000|NOT COMPLETED|Overall Study||1
11128813|NCT01385189|12314330|FG001|NOT COMPLETED|Overall Study||1
11128814|NCT01385189|12314331|FG002|NOT COMPLETED|Overall Study||0
11239628|NCT02082977|12431802|FG004|STARTED|Part 1 (Up to 3.2 Years)||3
11239629|NCT02082977|12431803|FG005|STARTED|Part 1 (Up to 3.2 Years)||4
11239630|NCT02082977|12431804|FG006|STARTED|Part 1 (Up to 3.2 Years)||10
11128815|NCT01385189|12314332|FG003|NOT COMPLETED|Overall Study||1
11128816|NCT01385189|12314333|FG004|NOT COMPLETED|Overall Study||2
11128817|NCT01385202|12314352|FG000|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
11128818|NCT01385202|12314352|FG000|Study Catheter Inserted|Overall Study||161
11128819|NCT01385202|12314352|FG000|Undergoing Ablation|Overall Study||160
11128820|NCT01385202|12314352|FG000|COMPLETED|Overall Study||154
11128821|NCT01385202|12314352|FG000|NOT COMPLETED|Overall Study||18
11128822|NCT01385293|12314358|FG000|STARTED|Overall Study||30
11128823|NCT01385293|12314358|FG000|COMPLETED|Overall Study||30
11128824|NCT01385293|12314358|FG000|NOT COMPLETED|Overall Study||0
11128825|NCT01385306|12314362|FG000|STARTED|Overall Study||6
11128826|NCT01385306|12314362|FG000|COMPLETED|Overall Study||6
11128827|NCT01385306|12314362|FG000|NOT COMPLETED|Overall Study||0
11128828|NCT01385371|12314368|FG000|STARTED|Overall Study||752
11128829|NCT01385371|12314369|FG001|STARTED|Overall Study||749
11128830|NCT01385371|12314368|FG000|COMPLETED|Overall Study||603
11128831|NCT01385371|12314369|FG001|COMPLETED|Overall Study||652
11128832|NCT01385371|12314368|FG000|NOT COMPLETED|Overall Study||149
11128833|NCT01385371|12314369|FG001|NOT COMPLETED|Overall Study||97
11128834|NCT01385566|12314381|FG000|STARTED|Overall Study||52
11128835|NCT01385566|12314382|FG001|STARTED|Overall Study||34
11128836|NCT01385566|12314383|FG002|STARTED|Overall Study||34
11128837|NCT01385566|12314384|FG003|STARTED|Overall Study||35
11128838|NCT01385566|12314385|FG004|STARTED|Overall Study||34
11128839|NCT01385566|12314386|FG005|STARTED|Overall Study||34
11128840|NCT01385566|12314381|FG000|COMPLETED|Overall Study||51
11128841|NCT01385566|12314382|FG001|COMPLETED|Overall Study||34
11128842|NCT01385566|12314383|FG002|COMPLETED|Overall Study||34
11128843|NCT01385566|12314384|FG003|COMPLETED|Overall Study||34
11128844|NCT01385566|12314385|FG004|COMPLETED|Overall Study||34
11128845|NCT01385566|12314386|FG005|COMPLETED|Overall Study||34
11128846|NCT01385566|12314381|FG000|NOT COMPLETED|Overall Study||1
11128847|NCT01385566|12314382|FG001|NOT COMPLETED|Overall Study||0
11128848|NCT01385566|12314383|FG002|NOT COMPLETED|Overall Study||0
11128849|NCT01385566|12314384|FG003|NOT COMPLETED|Overall Study||1
11128850|NCT01385566|12314385|FG004|NOT COMPLETED|Overall Study||0
11128851|NCT01385566|12314386|FG005|NOT COMPLETED|Overall Study||0
11128852|NCT01385579|12314404|FG000|STARTED|Overall Study||98
11128853|NCT01385579|12314405|FG001|STARTED|Overall Study||104
11128854|NCT01385579|12314404|FG000|COMPLETED|Overall Study||98
11128855|NCT01385579|12314405|FG001|COMPLETED|Overall Study||104
11128856|NCT01385579|12314404|FG000|NOT COMPLETED|Overall Study||0
11128857|NCT01385579|12314405|FG001|NOT COMPLETED|Overall Study||0
11128858|NCT01385644|12314413|FG000|STARTED|Overall Study||4
11128859|NCT01385644|12314414|FG001|STARTED|Overall Study||4
11128860|NCT01385644|12314413|FG000|COMPLETED|Overall Study||4
11128861|NCT01385644|12314414|FG001|COMPLETED|Overall Study||4
11128862|NCT01385644|12314413|FG000|NOT COMPLETED|Overall Study||0
11128863|NCT01385644|12314414|FG001|NOT COMPLETED|Overall Study||0
11128864|NCT01385696|12314420|FG000|STARTED|Overall Study||66
11128865|NCT01385696|12314421|FG001|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
11128866|NCT01385696|12314420|FG000|COMPLETED|Overall Study||66
11128867|NCT01385696|12314421|FG001|COMPLETED|Overall Study||64
11128868|NCT01385696|12314420|FG000|NOT COMPLETED|Overall Study||0
11128869|NCT01385696|12314421|FG001|NOT COMPLETED|Overall Study||0
11128870|NCT01385748|12314431|FG000|STARTED|Overall Study||56
11128871|NCT01385748|12314432|FG001|STARTED|Overall Study||65
11128872|NCT01385748|12314433|FG002|STARTED|Overall Study||62
11128873|NCT01385748|12314431|FG000|COMPLETED|Overall Study||41
11128874|NCT01385748|12314432|FG001|COMPLETED|Overall Study||51
11128875|NCT01385748|12314433|FG002|COMPLETED|Overall Study||49
11239631|NCT02082977|12431805|FG007|STARTED|Part 1 (Up to 3.2 Years)||12
11239632|NCT02082977|12431806|FG008|STARTED|Part 1 (Up to 3.2 Years)||7
11128876|NCT01385748|12314431|FG000|NOT COMPLETED|Overall Study||15
11128877|NCT01385748|12314432|FG001|NOT COMPLETED|Overall Study||14
11128878|NCT01385748|12314433|FG002|NOT COMPLETED|Overall Study||13
11128879|NCT01385995|12314447|FG000|STARTED|Period 1, 2 Months||25
11128880|NCT01385995|12314448|FG001|STARTED|Period 1, 2 Months||25
11128881|NCT01385995|12314447|FG000|COMPLETED|Period 1, 2 Months||24
11128882|NCT01385995|12314448|FG001|COMPLETED|Period 1, 2 Months||25
11128883|NCT01385995|12314447|FG000|NOT COMPLETED|Period 1, 2 Months||1
11128884|NCT01385995|12314448|FG001|NOT COMPLETED|Period 1, 2 Months||0
11128885|NCT01385995|12314447|FG000|STARTED|Washout Period, 1 Month||24
11128886|NCT01385995|12314448|FG001|STARTED|Washout Period, 1 Month||25
11128887|NCT01385995|12314447|FG000|COMPLETED|Washout Period, 1 Month||24
11128888|NCT01385995|12314448|FG001|COMPLETED|Washout Period, 1 Month||25
11128889|NCT01385995|12314447|FG000|NOT COMPLETED|Washout Period, 1 Month||0
11128890|NCT01385995|12314448|FG001|NOT COMPLETED|Washout Period, 1 Month||0
11128891|NCT01385995|12314447|FG000|STARTED|Period 2, 2 Months||24
11128892|NCT01385995|12314448|FG001|STARTED|Period 2, 2 Months||25
11128893|NCT01385995|12314447|FG000|COMPLETED|Period 2, 2 Months||24
11128894|NCT01385995|12314448|FG001|COMPLETED|Period 2, 2 Months||25
11128895|NCT01385995|12314447|FG000|NOT COMPLETED|Period 2, 2 Months||0
11128896|NCT01385995|12314448|FG001|NOT COMPLETED|Period 2, 2 Months||0
11128897|NCT01386008|12314456|FG000|STARTED|Overall Study||20
11128898|NCT01386008|12314456|FG000|COMPLETED|Overall Study||0
11128899|NCT01386008|12314456|FG000|NOT COMPLETED|Overall Study||20
11128900|NCT01386528|12314460|FG000|STARTED|Overall Study||13
11128901|NCT01386528|12314460|FG000|COMPLETED|Overall Study||13
11239633|NCT02082977|12431807|FG009|STARTED|Part 1 (Up to 3.2 Years)||0
11128902|NCT01386528|12314460|FG000|NOT COMPLETED|Overall Study||0
11128903|NCT01386554|12314467|FG000|STARTED|Overall Study||4
11128904|NCT01386554|12314468|FG001|STARTED|Overall Study||35
11128905|NCT01386554|12314469|FG002|STARTED|Overall Study||21
11128906|NCT01386554|12314467|FG000|COMPLETED|Overall Study||1
11128907|NCT01386554|12314468|FG001|COMPLETED|Overall Study||26
11128908|NCT01386554|12314469|FG002|COMPLETED|Overall Study||15
11128909|NCT01386554|12314467|FG000|NOT COMPLETED|Overall Study||3
11128910|NCT01386554|12314468|FG001|NOT COMPLETED|Overall Study||9
11128911|NCT01386554|12314469|FG002|NOT COMPLETED|Overall Study||6
11128912|NCT01386606|12314483|FG000|STARTED|Overall Study||16
11128913|NCT01386606|12314484|FG001|STARTED|Overall Study||14
11128914|NCT01386606|12314485|FG002|STARTED|Overall Study||16
11128915|NCT01386606|12314486|FG003|STARTED|Overall Study||14
11128916|NCT01386606|12314483|FG000|COMPLETED|Overall Study||12
11128917|NCT01386606|12314484|FG001|COMPLETED|Overall Study||10
11128918|NCT01386606|12314485|FG002|COMPLETED|Overall Study||13
11128919|NCT01386606|12314486|FG003|COMPLETED|Overall Study||13
11128920|NCT01386606|12314483|FG000|NOT COMPLETED|Overall Study||4
11128921|NCT01386606|12314484|FG001|NOT COMPLETED|Overall Study||4
11128922|NCT01386606|12314485|FG002|NOT COMPLETED|Overall Study||3
11128923|NCT01386606|12314486|FG003|NOT COMPLETED|Overall Study||1
11128924|NCT01386632|12314502|FG000|STARTED|Overall Study||25
11128925|NCT01386632|12314503|FG001|STARTED|Overall Study||25
11128926|NCT01386632|12314502|FG000|COMPLETED|Overall Study||20
11128927|NCT01386632|12314503|FG001|COMPLETED|Overall Study||21
11128928|NCT01386632|12314502|FG000|NOT COMPLETED|Overall Study||5
11128929|NCT01386632|12314503|FG001|NOT COMPLETED|Overall Study||4
11128930|NCT01386645|12314512|FG000|STARTED|Overall Study||18
11128931|NCT01386645|12314513|FG001|STARTED|Overall Study||19
11128932|NCT01386645|12314514|FG002|STARTED|Overall Study||19
11128933|NCT01386645|12314512|FG000|COMPLETED|Overall Study||18
11128934|NCT01386645|12314513|FG001|COMPLETED|Overall Study||18
11128935|NCT01386645|12314514|FG002|COMPLETED|Overall Study||17
11128936|NCT01386645|12314512|FG000|NOT COMPLETED|Overall Study||0
11128937|NCT01386645|12314513|FG001|NOT COMPLETED|Overall Study||1
11128938|NCT01386645|12314514|FG002|NOT COMPLETED|Overall Study||2
11128939|NCT01386788|12314522|FG000|STARTED|Overall Study||102
11128940|NCT01386788|12314522|FG000|COMPLETED|Overall Study||100
11128941|NCT01386788|12314522|FG000|NOT COMPLETED|Overall Study||2
11128942|NCT01386944|12314526|FG000|STARTED|Overall Study||102
11128943|NCT01386944|12314526|FG000|COMPLETED|Overall Study||46
11128944|NCT01386944|12314526|FG000|NOT COMPLETED|Overall Study||56
11239634|NCT02082977|12431798|FG000|COMPLETED|Part 1 (Up to 3.2 Years)||1
11239635|NCT02082977|12431799|FG001|COMPLETED|Part 1 (Up to 3.2 Years)||1
11239636|NCT02082977|12431800|FG002|COMPLETED|Part 1 (Up to 3.2 Years)||1
11239637|NCT02082977|12431801|FG003|COMPLETED|Part 1 (Up to 3.2 Years)||1
11239638|NCT02082977|12431802|FG004|COMPLETED|Part 1 (Up to 3.2 Years)||2
11239639|NCT02082977|12431803|FG005|COMPLETED|Part 1 (Up to 3.2 Years)||1
11239640|NCT02082977|12431804|FG006|COMPLETED|Part 1 (Up to 3.2 Years)||4
11239641|NCT02082977|12431805|FG007|COMPLETED|Part 1 (Up to 3.2 Years)||7
11239642|NCT02082977|12431806|FG008|COMPLETED|Part 1 (Up to 3.2 Years)||4
11239643|NCT02082977|12431807|FG009|COMPLETED|Part 1 (Up to 3.2 Years)||0
11239644|NCT02082977|12431798|FG000|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
11239645|NCT02082977|12431799|FG001|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
11239646|NCT02082977|12431800|FG002|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
11239647|NCT02082977|12431801|FG003|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
11239648|NCT02082977|12431802|FG004|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
11239649|NCT02082977|12431803|FG005|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
11239650|NCT02082977|12431804|FG006|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6
11239651|NCT02082977|12431805|FG007|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5
11239652|NCT02082977|12431806|FG008|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
11128945|NCT01386970|12314532|FG000|STARTED|Overall Study||20
11128946|NCT01386970|12314533|FG001|STARTED|Overall Study||23
11128947|NCT01386970|12314532|FG000|COMPLETED|Overall Study||16
11128948|NCT01386970|12314533|FG001|COMPLETED|Overall Study||21
11128949|NCT01386970|12314532|FG000|NOT COMPLETED|Overall Study||4
11239653|NCT02082977|12431807|FG009|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
11239654|NCT02082977|12431798|FG000|STARTED|Part 2 (Up to 3.2 Years)||0
11239655|NCT02082977|12431799|FG001|STARTED|Part 2 (Up to 3.2 Years)||0
11239656|NCT02082977|12431800|FG002|STARTED|Part 2 (Up to 3.2 Years)||0
11239657|NCT02082977|12431801|FG003|STARTED|Part 2 (Up to 3.2 Years)||0
11128950|NCT01386970|12314533|FG001|NOT COMPLETED|Overall Study||2
11128951|NCT01386983|12314543|FG000|STARTED|Overall Study||264
11128952|NCT01386983|12314544|FG001|STARTED|Overall Study||68
11128953|NCT01386983|12314543|FG000|COMPLETED|Overall Study||264
11128954|NCT01386983|12314544|FG001|COMPLETED|Overall Study||68
11128955|NCT01386983|12314543|FG000|NOT COMPLETED|Overall Study||0
11128956|NCT01386983|12314544|FG001|NOT COMPLETED|Overall Study||0
11128957|NCT01387022|12314552|FG000|STARTED|Overall Study||29
11128958|NCT01387022|12314553|FG001|STARTED|Overall Study||30
11128959|NCT01387022|12314552|FG000|COMPLETED|Overall Study||28
11128960|NCT01387022|12314553|FG001|COMPLETED|Overall Study||26
11128961|NCT01387022|12314552|FG000|NOT COMPLETED|Overall Study||1
11128962|NCT01387022|12314553|FG001|NOT COMPLETED|Overall Study||4
11128963|NCT01387074|12314559|FG000|STARTED|Overall Study||108
11128964|NCT01387074|12314559|FG000|COMPLETED|Overall Study||100
11128965|NCT01387074|12314559|FG000|NOT COMPLETED|Overall Study||8
11128966|NCT01387139|12314565|FG000|STARTED|Overall Study||99
11128967|NCT01387139|12314566|FG001|STARTED|Overall Study||84
11128968|NCT01387139|12314565|FG000|COMPLETED|Overall Study||99
11128969|NCT01387139|12314566|FG001|COMPLETED|Overall Study||84
11128970|NCT01387139|12314565|FG000|NOT COMPLETED|Overall Study||0
11128971|NCT01387139|12314566|FG001|NOT COMPLETED|Overall Study||0
11128972|NCT01387178|12314574|FG000|STARTED|Overall Study||11582
11128973|NCT01387178|12314575|FG001|STARTED|Overall Study||10641
11128974|NCT01387178|12314574|FG000|COMPLETED|Overall Study||11582
11128975|NCT01387178|12314575|FG001|COMPLETED|Overall Study||10641
11128976|NCT01387178|12314574|FG000|NOT COMPLETED|Overall Study||0
11128977|NCT01387178|12314575|FG001|NOT COMPLETED|Overall Study||0
11128978|NCT01387230|12314585|FG000|STARTED|Overall Study||68
11128979|NCT01387230|12314586|FG001|STARTED|Overall Study||69
11128980|NCT01387230|12314587|FG002|STARTED|Overall Study||69
11128981|NCT01387230|12314585|FG000|COMPLETED|Overall Study||50
11128982|NCT01387230|12314586|FG001|COMPLETED|Overall Study||62
11128983|NCT01387230|12314587|FG002|COMPLETED|Overall Study||56
11128984|NCT01387230|12314585|FG000|NOT COMPLETED|Overall Study||18
11128985|NCT01387230|12314586|FG001|NOT COMPLETED|Overall Study||7
11128986|NCT01387230|12314587|FG002|NOT COMPLETED|Overall Study||13
11128987|NCT01387269|12314597|FG000|STARTED|Overall Study||323
11128988|NCT01387269|12314598|FG001|STARTED|Overall Study||161
11128989|NCT01387269|12314597|FG000|ITT Population|Overall Study||323
11128990|NCT01387269|12314598|FG001|ITT Population|Overall Study||161
11128991|NCT01387269|12314597|FG000|MITT Population|Overall Study||284
11128992|NCT01387269|12314598|FG001|MITT Population|Overall Study||141
11128993|NCT01387269|12314597|FG000|Safety Population|Overall Study||320
11128994|NCT01387269|12314598|FG001|Safety Population|Overall Study||161
11128995|NCT01387269|12314597|FG000|COMPLETED|Overall Study||231
11128996|NCT01387269|12314598|FG001|COMPLETED|Overall Study||121
11128997|NCT01387269|12314597|FG000|NOT COMPLETED|Overall Study||92
11128998|NCT01387269|12314598|FG001|NOT COMPLETED|Overall Study||40
11128999|NCT01387282|12314606|FG000|STARTED|Overall Study||330
11129000|NCT01387282|12314607|FG001|STARTED|Overall Study||165
11129001|NCT01387282|12314606|FG000|ITT Population|Overall Study||330
11129002|NCT01387282|12314607|FG001|ITT Population|Overall Study||165
11129003|NCT01387282|12314606|FG000|MITT Population|Overall Study||268
11129004|NCT01387282|12314607|FG001|MITT Population|Overall Study||136
11129005|NCT01387282|12314606|FG000|Safety Population|Overall Study||330
11129006|NCT01387282|12314607|FG001|Safety Population|Overall Study||161
11129007|NCT01387282|12314606|FG000|COMPLETED|Overall Study||233
11129008|NCT01387282|12314607|FG001|COMPLETED|Overall Study||118
11129009|NCT01387282|12314606|FG000|NOT COMPLETED|Overall Study||97
11129010|NCT01387282|12314607|FG001|NOT COMPLETED|Overall Study||47
11129011|NCT01387347|12314615|FG000|STARTED|Overall Study||36
11129012|NCT01387347|12314616|FG001|STARTED|Overall Study||36
11129013|NCT01387347|12314615|FG000|COMPLETED|Overall Study||34
11129014|NCT01387347|12314616|FG001|COMPLETED|Overall Study||35
11129015|NCT01387347|12314615|FG000|NOT COMPLETED|Overall Study||2
11129016|NCT01387347|12314616|FG001|NOT COMPLETED|Overall Study||1
11129017|NCT01387464|12314628|FG000|STARTED|Overall Study||30
11129018|NCT01387464|12314629|FG001|STARTED|Overall Study||30
11129019|NCT01387464|12314628|FG000|Safety Population|Overall Study||30
11129020|NCT01387464|12314629|FG001|Safety Population|Overall Study||29
11129021|NCT01387464|12314628|FG000|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
11129022|NCT01387464|12314629|FG001|Per-Protocol Population|Overall Study||29
11129023|NCT01387464|12314628|FG000|COMPLETED|Overall Study||29
11129024|NCT01387464|12314629|FG001|COMPLETED|Overall Study||29
11129025|NCT01387464|12314628|FG000|NOT COMPLETED|Overall Study||1
11129026|NCT01387464|12314629|FG001|NOT COMPLETED|Overall Study||1
11129027|NCT01387516|12314639|FG000|STARTED|Overall Study||80
11129028|NCT01387516|12314640|FG001|STARTED|Overall Study||68
11129029|NCT01387516|12314641|FG002|STARTED|Overall Study||79
11129030|NCT01387516|12314642|FG003|STARTED|Overall Study||69
11129031|NCT01387516|12314639|FG000|COMPLETED|Overall Study||75
11129032|NCT01387516|12314640|FG001|COMPLETED|Overall Study||63
11129033|NCT01387516|12314641|FG002|COMPLETED|Overall Study||75
11129034|NCT01387516|12314642|FG003|COMPLETED|Overall Study||65
11129035|NCT01387516|12314639|FG000|NOT COMPLETED|Overall Study||5
11129036|NCT01387516|12314640|FG001|NOT COMPLETED|Overall Study||5
11129037|NCT01387516|12314641|FG002|NOT COMPLETED|Overall Study||4
11129038|NCT01387516|12314642|FG003|NOT COMPLETED|Overall Study||4
11129039|NCT01387542|12314652|FG000|STARTED|Overall Study||40
11129040|NCT01387542|12314652|FG000|Treated|Overall Study||38
11129041|NCT01387542|12314652|FG000|COMPLETED|Overall Study||32
11129042|NCT01387542|12314652|FG000|NOT COMPLETED|Overall Study||8
11129043|NCT01387581|12314659|FG000|STARTED|Overall Study||108
11129044|NCT01387581|12314660|FG001|STARTED|Overall Study||107
11129045|NCT01387581|12314661|FG002|STARTED|Overall Study||12
11129046|NCT01387581|12314659|FG000|COMPLETED|Overall Study||101
11129047|NCT01387581|12314660|FG001|COMPLETED|Overall Study||101
11129048|NCT01387581|12314661|FG002|COMPLETED|Overall Study||9
11129049|NCT01387581|12314659|FG000|NOT COMPLETED|Overall Study||7
11129050|NCT01387581|12314660|FG001|NOT COMPLETED|Overall Study||6
11129051|NCT01387581|12314661|FG002|NOT COMPLETED|Overall Study||3
11129052|NCT01387594|12314671|FG000|STARTED|Overall Study||10
11129053|NCT01387594|12314672|FG001|STARTED|Overall Study||39
11129054|NCT01387594|12314671|FG000|COMPLETED|Overall Study||10
11129055|NCT01387594|12314672|FG001|COMPLETED|Overall Study||36
11129056|NCT01387594|12314671|FG000|NOT COMPLETED|Overall Study||0
11129057|NCT01387594|12314672|FG001|NOT COMPLETED|Overall Study||3
11129058|NCT01387607|12314683|FG000|STARTED|Overall Study||173
11129059|NCT01387607|12314684|FG001|STARTED|Overall Study||170
11129060|NCT01387607|12314683|FG000|Received Treatment|Overall Study||170
11129061|NCT01387607|12314684|FG001|Received Treatment|Overall Study||164
11129062|NCT01387607|12314683|FG000|COMPLETED|Overall Study||122
11129063|NCT01387607|12314684|FG001|COMPLETED|Overall Study||125
11129064|NCT01387607|12314683|FG000|NOT COMPLETED|Overall Study||51
11129065|NCT01387607|12314684|FG001|NOT COMPLETED|Overall Study||45
11129066|NCT01387672|12314696|FG000|STARTED|Overall Study||39
11129067|NCT01387672|12314697|FG001|STARTED|Overall Study||38
11129068|NCT01387672|12314698|FG002|STARTED|Overall Study||38
11129069|NCT01387672|12314699|FG003|STARTED|Overall Study||39
11129070|NCT01387672|12314700|FG004|STARTED|Overall Study||38
11129071|NCT01387672|12314701|FG005|STARTED|Overall Study||37
11129072|NCT01387672|12314696|FG000|COMPLETED|Overall Study||32
11129073|NCT01387672|12314697|FG001|COMPLETED|Overall Study||31
11129074|NCT01387672|12314698|FG002|COMPLETED|Overall Study||33
11129075|NCT01387672|12314699|FG003|COMPLETED|Overall Study||35
11129076|NCT01387672|12314700|FG004|COMPLETED|Overall Study||34
11129077|NCT01387672|12314701|FG005|COMPLETED|Overall Study||37
11129078|NCT01387672|12314696|FG000|NOT COMPLETED|Overall Study||7
11129079|NCT01387672|12314697|FG001|NOT COMPLETED|Overall Study||7
11129080|NCT01387672|12314698|FG002|NOT COMPLETED|Overall Study||5
11129081|NCT01387672|12314699|FG003|NOT COMPLETED|Overall Study||4
11129082|NCT01387672|12314700|FG004|NOT COMPLETED|Overall Study||4
11129083|NCT01387672|12314701|FG005|NOT COMPLETED|Overall Study||0
11129084|NCT01387737|12314718|FG000|STARTED|Overall Study||584
11129085|NCT01387737|12314719|FG001|STARTED|Overall Study||715
11129086|NCT01387737|12314718|FG000|COMPLETED|Overall Study||532
11129087|NCT01387737|12314719|FG001|COMPLETED|Overall Study||641
11129088|NCT01387737|12314718|FG000|NOT COMPLETED|Overall Study||52
11129089|NCT01387737|12314719|FG001|NOT COMPLETED|Overall Study||74
11129090|NCT01387789|12314725|FG000|STARTED|Overall Study||71
11129091|NCT01387789|12314725|FG000|COMPLETED|Overall Study||63
11129092|NCT01387789|12314725|FG000|NOT COMPLETED|Overall Study||8
11129093|NCT01387815|12314731|FG000|STARTED|Overall Study||302
11129094|NCT01387815|12314732|FG001|STARTED|Overall Study||293
11129095|NCT01387815|12314731|FG000|COMPLETED|Overall Study||162
11129096|NCT01387815|12314732|FG001|COMPLETED|Overall Study||189
11129097|NCT01387815|12314731|FG000|NOT COMPLETED|Overall Study||140
11129098|NCT01387815|12314732|FG001|NOT COMPLETED|Overall Study||104
11129099|NCT01387932|12314740|FG000|STARTED|Randomized and Treated||118
11129100|NCT01387932|12314741|FG001|STARTED|Randomized and Treated||117
11129101|NCT01387932|12314740|FG000|COMPLETED|Randomized and Treated||111
11129102|NCT01387932|12314741|FG001|COMPLETED|Randomized and Treated||113
11129103|NCT01387932|12314740|FG000|NOT COMPLETED|Randomized and Treated||7
11129104|NCT01387932|12314741|FG001|NOT COMPLETED|Randomized and Treated||4
11129105|NCT01387932|12314740|FG000|STARTED|Completion of TACE Cycle||111
11129106|NCT01387932|12314741|FG001|STARTED|Completion of TACE Cycle||113
11129107|NCT01387932|12314740|FG000|COMPLETED|Completion of TACE Cycle||111
11129108|NCT01387932|12314741|FG001|COMPLETED|Completion of TACE Cycle||113
11129109|NCT01387932|12314740|FG000|NOT COMPLETED|Completion of TACE Cycle||0
11129110|NCT01387932|12314741|FG001|NOT COMPLETED|Completion of TACE Cycle||0
11129111|NCT01387932|12314740|FG000|STARTED|Survival Follow-up||111
11129112|NCT01387932|12314741|FG001|STARTED|Survival Follow-up||113
11129113|NCT01387932|12314740|FG000|COMPLETED|Survival Follow-up||27
11129114|NCT01387932|12314741|FG001|COMPLETED|Survival Follow-up||23
11129115|NCT01387932|12314740|FG000|NOT COMPLETED|Survival Follow-up||84
11129116|NCT01387932|12314741|FG001|NOT COMPLETED|Survival Follow-up||90
11129117|NCT01388166|12314749|FG000|STARTED|Overall Study||1253
11129118|NCT01388166|12314749|FG000|COMPLETED|Overall Study||1194
11129119|NCT01388166|12314749|FG000|NOT COMPLETED|Overall Study||59
11129120|NCT01388335|12314753|FG000|STARTED|Period 1||13
11129121|NCT01388335|12314753|FG000|Received at Least 1 Dose of Study Drug|Period 1||13
11129122|NCT01388335|12314753|FG000|COMPLETED|Period 1||12
11129123|NCT01388335|12314753|FG000|NOT COMPLETED|Period 1||1
11129124|NCT01388335|12314753|FG000|STARTED|Period 2||12
11129125|NCT01388335|12314753|FG000|Received at Least 1 Dose of Study Drug|Period 2||12
11129126|NCT01388335|12314753|FG000|COMPLETED|Period 2|Only 6 participants who completed Period 2 entered Safety Extension.|9
11129127|NCT01388335|12314753|FG000|NOT COMPLETED|Period 2||3
11129128|NCT01388335|12314753|FG000|STARTED|Safety Extension|Six completed Period 2 and 1 participant who discontinued Period 2 entered Safety Extension.|7
11129129|NCT01388335|12314753|FG000|COMPLETED|Safety Extension||0
11129130|NCT01388335|12314753|FG000|NOT COMPLETED|Safety Extension||7
11129131|NCT01388361|12314768|FG000|STARTED|Overall Study||236
11129132|NCT01388361|12314769|FG001|STARTED|Overall Study||88
11129133|NCT01388361|12314770|FG002|STARTED|Overall Study||89
11129134|NCT01388361|12314768|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
11129135|NCT01388361|12314769|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
11129136|NCT01388361|12314770|FG002|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
11129137|NCT01388361|12314768|FG000|COMPLETED|Overall Study||224
11129138|NCT01388361|12314769|FG001|COMPLETED|Overall Study||76
11129139|NCT01388361|12314770|FG002|COMPLETED|Overall Study||75
11129140|NCT01388361|12314768|FG000|NOT COMPLETED|Overall Study||12
11129141|NCT01388361|12314769|FG001|NOT COMPLETED|Overall Study||12
11129142|NCT01388361|12314770|FG002|NOT COMPLETED|Overall Study||14
11129143|NCT01388478|12314778|FG000|STARTED|Overall Study||20
11129144|NCT01388478|12314778|FG000|COMPLETED|Overall Study||15
11129145|NCT01388478|12314778|FG000|NOT COMPLETED|Overall Study||5
11129146|NCT01388530|12314782|FG000|STARTED|Overall Study||25
11129147|NCT01388530|12314782|FG000|COMPLETED|Overall Study||20
11129148|NCT01388530|12314782|FG000|NOT COMPLETED|Overall Study||5
11129149|NCT01388543|12314788|FG000|STARTED|Day 7, Primary End Point||15
11129150|NCT01388543|12314789|FG001|STARTED|Day 7, Primary End Point||16
11129151|NCT01388543|12314788|FG000|COMPLETED|Day 7, Primary End Point||15
11129152|NCT01388543|12314789|FG001|COMPLETED|Day 7, Primary End Point||16
11129153|NCT01388543|12314788|FG000|NOT COMPLETED|Day 7, Primary End Point||0
11129154|NCT01388543|12314789|FG001|NOT COMPLETED|Day 7, Primary End Point||0
11129155|NCT01388543|12314788|FG000|STARTED|Day 14||15
11129156|NCT01388543|12314789|FG001|STARTED|Day 14||16
11129157|NCT01388543|12314788|FG000|COMPLETED|Day 14||14
11129158|NCT01388543|12314789|FG001|COMPLETED|Day 14||12
11239658|NCT02082977|12431802|FG004|STARTED|Part 2 (Up to 3.2 Years)||0
11239659|NCT02082977|12431803|FG005|STARTED|Part 2 (Up to 3.2 Years)||0
11239660|NCT02082977|12431804|FG006|STARTED|Part 2 (Up to 3.2 Years)||0
11239661|NCT02082977|12431805|FG007|STARTED|Part 2 (Up to 3.2 Years)||0
11129159|NCT01388543|12314788|FG000|NOT COMPLETED|Day 14||1
11129160|NCT01388543|12314789|FG001|NOT COMPLETED|Day 14||4
11129161|NCT01388647|12314797|FG000|STARTED|Overall Study||6
11129162|NCT01388647|12314798|FG001|STARTED|Overall Study||6
11129163|NCT01388647|12314797|FG000|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
11129164|NCT01388647|12314798|FG001|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
11129165|NCT01388647|12314797|FG000|NOT COMPLETED|Overall Study||1
11129166|NCT01388647|12314798|FG001|NOT COMPLETED|Overall Study||2
11129167|NCT01388777|12314805|FG000|STARTED|Overall Study||1
11129168|NCT01388777|12314805|FG000|Cryoablation|Overall Study||1
11129169|NCT01388777|12314805|FG000|COMPLETED|Overall Study||1
11129170|NCT01388777|12314805|FG000|NOT COMPLETED|Overall Study||0
11129171|NCT01388790|12314809|FG000|STARTED|Overall Study||40
11129172|NCT01388790|12314809|FG000|COMPLETED|Overall Study||32
11129173|NCT01388790|12314809|FG000|NOT COMPLETED|Overall Study||8
11129174|NCT01388816|12314817|FG000|STARTED|Overall Study||45
11129175|NCT01388816|12314818|FG001|STARTED|Overall Study||43
11129176|NCT01388816|12314819|FG002|STARTED|Overall Study||44
11129177|NCT01388816|12314820|FG003|STARTED|Overall Study||44
11129178|NCT01388816|12314817|FG000|COMPLETED|Overall Study||43
11129179|NCT01388816|12314818|FG001|COMPLETED|Overall Study||39
11129180|NCT01388816|12314819|FG002|COMPLETED|Overall Study||41
11129181|NCT01388816|12314820|FG003|COMPLETED|Overall Study||44
11129182|NCT01388816|12314817|FG000|NOT COMPLETED|Overall Study||2
11129183|NCT01388816|12314818|FG001|NOT COMPLETED|Overall Study||4
11129184|NCT01388816|12314819|FG002|NOT COMPLETED|Overall Study||3
11129185|NCT01388816|12314820|FG003|NOT COMPLETED|Overall Study||0
11129186|NCT01388907|12314835|FG000|STARTED|Overall Study||33
11129187|NCT01388907|12314836|FG001|STARTED|Overall Study||28
11129188|NCT01388907|12314835|FG000|COMPLETED|Overall Study||31
11129189|NCT01388907|12314836|FG001|COMPLETED|Overall Study||28
11129190|NCT01388907|12314835|FG000|NOT COMPLETED|Overall Study||2
11129191|NCT01388907|12314836|FG001|NOT COMPLETED|Overall Study||0
11129192|NCT01388946|12314846|FG000|STARTED|Overall Study||55
11129193|NCT01388946|12314847|FG001|STARTED|Overall Study||55
11129194|NCT01388946|12314846|FG000|COMPLETED|Overall Study||49
11129195|NCT01388946|12314847|FG001|COMPLETED|Overall Study||52
11129196|NCT01388946|12314846|FG000|NOT COMPLETED|Overall Study||6
11129197|NCT01388946|12314847|FG001|NOT COMPLETED|Overall Study||3
11129198|NCT01388985|12314855|FG000|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
11129199|NCT01388985|12314856|FG001|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
11129200|NCT01388985|12314855|FG000|Primary Vaccination Period|Overall Study||231
11129201|NCT01388985|12314856|FG001|Primary Vaccination Period|Overall Study||238
11129202|NCT01388985|12314855|FG000|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200
11129203|NCT01388985|12314856|FG001|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211
11129204|NCT01388985|12314855|FG000|NOT COMPLETED|Overall Study||49
11129205|NCT01388985|12314856|FG001|NOT COMPLETED|Overall Study||38
11129206|NCT01389076|12314862|FG000|STARTED|Overall Study||22
11129207|NCT01389076|12314862|FG000|COMPLETED|Overall Study||22
11129208|NCT01389076|12314862|FG000|NOT COMPLETED|Overall Study||0
11129209|NCT01389102|12314872|FG000|STARTED|Overall Study||75
11129210|NCT01389102|12314873|FG001|STARTED|Overall Study||76
11129211|NCT01389102|12314874|FG002|STARTED|Overall Study||77
11129212|NCT01389102|12314875|FG003|STARTED|Overall Study||76
11129213|NCT01389102|12314876|FG004|STARTED|Overall Study||74
11129214|NCT01389102|12314877|FG005|STARTED|Overall Study||76
11129215|NCT01389102|12314872|FG000|COMPLETED|Overall Study||57
11129216|NCT01389102|12314873|FG001|COMPLETED|Overall Study||64
11129217|NCT01389102|12314874|FG002|COMPLETED|Overall Study||58
11129218|NCT01389102|12314875|FG003|COMPLETED|Overall Study||69
11129219|NCT01389102|12314876|FG004|COMPLETED|Overall Study||61
11129220|NCT01389102|12314877|FG005|COMPLETED|Overall Study||68
11129221|NCT01389102|12314872|FG000|NOT COMPLETED|Overall Study||18
11129222|NCT01389102|12314873|FG001|NOT COMPLETED|Overall Study||12
11129223|NCT01389102|12314874|FG002|NOT COMPLETED|Overall Study||19
11129224|NCT01389102|12314875|FG003|NOT COMPLETED|Overall Study||7
11129225|NCT01389102|12314876|FG004|NOT COMPLETED|Overall Study||13
11129226|NCT01389102|12314877|FG005|NOT COMPLETED|Overall Study||8
11129227|NCT01389128|12314899|FG000|STARTED|Overall Study||40
11129228|NCT01389128|12314900|FG001|STARTED|Overall Study||40
11129229|NCT01389128|12314899|FG000|COMPLETED|Overall Study||35
11129230|NCT01389128|12314900|FG001|COMPLETED|Overall Study||34
11129231|NCT01389128|12314899|FG000|NOT COMPLETED|Overall Study||5
11129232|NCT01389128|12314900|FG001|NOT COMPLETED|Overall Study||6
11129233|NCT01389232|12314910|FG000|STARTED|Overall Study||100
11129234|NCT01389232|12314910|FG000|COMPLETED|Overall Study||81
11129235|NCT01389232|12314910|FG000|NOT COMPLETED|Overall Study||19
11129236|NCT01389245|12314924|FG000|STARTED|Overall Study||42
11129237|NCT01389245|12314924|FG000|COMPLETED|Overall Study||27
11129238|NCT01389245|12314924|FG000|NOT COMPLETED|Overall Study||15
11129239|NCT01389258|12314928|FG000|STARTED|Overall Study||45
11239662|NCT02082977|12431806|FG008|STARTED|Part 2 (Up to 3.2 Years)||0
11239663|NCT02082977|12431807|FG009|STARTED|Part 2 (Up to 3.2 Years)||0
11239664|NCT02082977|12431798|FG000|COMPLETED|Part 2 (Up to 3.2 Years)||0
11239665|NCT02082977|12431799|FG001|COMPLETED|Part 2 (Up to 3.2 Years)||0
11239666|NCT02082977|12431800|FG002|COMPLETED|Part 2 (Up to 3.2 Years)||0
11239667|NCT02082977|12431801|FG003|COMPLETED|Part 2 (Up to 3.2 Years)||0
11239668|NCT02082977|12431802|FG004|COMPLETED|Part 2 (Up to 3.2 Years)||0
11239669|NCT02082977|12431803|FG005|COMPLETED|Part 2 (Up to 3.2 Years)||0
11239670|NCT02082977|12431804|FG006|COMPLETED|Part 2 (Up to 3.2 Years)||0
11129240|NCT01389258|12314928|FG000|COMPLETED|Overall Study||40
11129241|NCT01389258|12314928|FG000|NOT COMPLETED|Overall Study||5
11129242|NCT01389284|12314935|FG000|STARTED|Overall Study||120
11129243|NCT01389284|12314936|FG001|STARTED|Overall Study||120
11129244|NCT01389284|12314937|FG002|STARTED|Overall Study||60
11129245|NCT01389284|12314935|FG000|COMPLETED|Overall Study||120
11129246|NCT01389284|12314936|FG001|COMPLETED|Overall Study||120
11129247|NCT01389284|12314937|FG002|COMPLETED|Overall Study||60
11129248|NCT01389284|12314935|FG000|NOT COMPLETED|Overall Study||0
11129249|NCT01389284|12314936|FG001|NOT COMPLETED|Overall Study||0
11129250|NCT01389284|12314937|FG002|NOT COMPLETED|Overall Study||0
11129251|NCT01389323|12314945|FG000|STARTED|Treatment Period (up to 48 Weeks)||246
11129252|NCT01389323|12314945|FG000|COMPLETED|Treatment Period (up to 48 Weeks)||151
11129253|NCT01389323|12314945|FG000|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
11129254|NCT01389323|12314945|FG000|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
11129255|NCT01389323|12314945|FG000|COMPLETED|Follow-up Period (up to 48 Weeks)||184
11129256|NCT01389323|12314945|FG000|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
11129257|NCT01389596|12314959|FG000|STARTED|Overall Study||104
11129258|NCT01389596|12314960|FG001|STARTED|Overall Study||97
11129259|NCT01389596|12314961|FG002|STARTED|Overall Study||94
11129260|NCT01389596|12314959|FG000|COMPLETED|Overall Study||94
11129261|NCT01389596|12314960|FG001|COMPLETED|Overall Study||81
11129262|NCT01389596|12314961|FG002|COMPLETED|Overall Study||84
11129263|NCT01389596|12314959|FG000|NOT COMPLETED|Overall Study||10
11129264|NCT01389596|12314960|FG001|NOT COMPLETED|Overall Study||16
11129265|NCT01389596|12314961|FG002|NOT COMPLETED|Overall Study||10
11129266|NCT01389752|12314969|FG000|STARTED|Study Period 1||11
11129267|NCT01389752|12314970|FG001|STARTED|Study Period 1||11
11129268|NCT01389752|12314969|FG000|COMPLETED|Study Period 1||11
11129269|NCT01389752|12314970|FG001|COMPLETED|Study Period 1||9
11129270|NCT01389752|12314969|FG000|NOT COMPLETED|Study Period 1||0
11129271|NCT01389752|12314970|FG001|NOT COMPLETED|Study Period 1||2
11129272|NCT01389752|12314969|FG000|STARTED|Study Period 2||11
11239671|NCT02082977|12431805|FG007|COMPLETED|Part 2 (Up to 3.2 Years)||0
11239672|NCT02082977|12431806|FG008|COMPLETED|Part 2 (Up to 3.2 Years)||0
11239673|NCT02082977|12431807|FG009|COMPLETED|Part 2 (Up to 3.2 Years)||0
11239674|NCT02082977|12431798|FG000|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
11129273|NCT01389752|12314970|FG001|STARTED|Study Period 2||9
11129274|NCT01389752|12314969|FG000|COMPLETED|Study Period 2||10
11129275|NCT01389752|12314970|FG001|COMPLETED|Study Period 2||9
11129276|NCT01389752|12314969|FG000|NOT COMPLETED|Study Period 2||1
11129277|NCT01389752|12314970|FG001|NOT COMPLETED|Study Period 2||0
11129278|NCT01389765|12314977|FG000|STARTED|First Intervention (Day 1)||12
11129279|NCT01389765|12314978|FG001|STARTED|First Intervention (Day 1)||12
11129280|NCT01389765|12314977|FG000|COMPLETED|First Intervention (Day 1)||12
11129281|NCT01389765|12314978|FG001|COMPLETED|First Intervention (Day 1)||12
11129282|NCT01389765|12314977|FG000|NOT COMPLETED|First Intervention (Day 1)||0
11129283|NCT01389765|12314978|FG001|NOT COMPLETED|First Intervention (Day 1)||0
11129284|NCT01389765|12314977|FG000|STARTED|Washout Period (7 Days)||12
11129285|NCT01389765|12314978|FG001|STARTED|Washout Period (7 Days)||12
11129286|NCT01389765|12314977|FG000|COMPLETED|Washout Period (7 Days)||12
11129287|NCT01389765|12314978|FG001|COMPLETED|Washout Period (7 Days)||12
11129288|NCT01389765|12314977|FG000|NOT COMPLETED|Washout Period (7 Days)||0
11129289|NCT01389765|12314978|FG001|NOT COMPLETED|Washout Period (7 Days)||0
11129290|NCT01389765|12314977|FG000|STARTED|Second Intervention (Day 1)||12
11129291|NCT01389765|12314978|FG001|STARTED|Second Intervention (Day 1)||12
11129292|NCT01389765|12314977|FG000|COMPLETED|Second Intervention (Day 1)||12
11129293|NCT01389765|12314978|FG001|COMPLETED|Second Intervention (Day 1)||12
11129294|NCT01389765|12314977|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
11129295|NCT01389765|12314978|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
11129296|NCT01389856|12314986|FG000|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
11129297|NCT01389856|12314987|FG001|STARTED|Overall Study|Randomized and treated.|8
11129298|NCT01389856|12314986|FG000|COMPLETED|Overall Study||13
11129299|NCT01389856|12314987|FG001|COMPLETED|Overall Study||8
11129300|NCT01389856|12314986|FG000|NOT COMPLETED|Overall Study||0
11129301|NCT01389856|12314987|FG001|NOT COMPLETED|Overall Study||0
11129302|NCT01389882|12314995|FG000|STARTED|Overall Study||13
11129303|NCT01389882|12314996|FG001|STARTED|Overall Study||11
11129304|NCT01389882|12314995|FG000|COMPLETED|Overall Study||12
11129305|NCT01389882|12314996|FG001|COMPLETED|Overall Study||7
11129306|NCT01389882|12314995|FG000|NOT COMPLETED|Overall Study||1
11129307|NCT01389882|12314996|FG001|NOT COMPLETED|Overall Study||4
11129308|NCT01389973|12315002|FG000|STARTED|Overall Study||20
11129309|NCT01389973|12315002|FG000|COMPLETED|Overall Study||0
11129310|NCT01389973|12315002|FG000|NOT COMPLETED|Overall Study||20
11129311|NCT01390038|12315006|FG000|STARTED|Overall Study||157
11129312|NCT01390038|12315006|FG000|COMPLETED|Overall Study||149
11129313|NCT01390038|12315006|FG000|NOT COMPLETED|Overall Study||8
11129314|NCT01390064|12315012|FG000|STARTED|Overall Study||3
11129315|NCT01390064|12315013|FG001|STARTED|Overall Study||3
11129316|NCT01390064|12315012|FG000|COMPLETED|Overall Study||3
11129317|NCT01390064|12315013|FG001|COMPLETED|Overall Study||3
11129318|NCT01390064|12315012|FG000|NOT COMPLETED|Overall Study||0
11129319|NCT01390064|12315013|FG001|NOT COMPLETED|Overall Study||0
11129320|NCT01390077|12315019|FG000|STARTED|Overall Study||8
11129321|NCT01390077|12315019|FG000|Treatment|Overall Study||7
11129322|NCT01390077|12315019|FG000|COMPLETED|Overall Study||7
11129323|NCT01390077|12315019|FG000|NOT COMPLETED|Overall Study||1
11129324|NCT01390220|12315028|FG000|STARTED|Test Dose Phase||292
11129325|NCT01390220|12315029|FG001|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
11129326|NCT01390220|12315030|FG002|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
11129327|NCT01390220|12315028|FG000|COMPLETED|Test Dose Phase||201
11129328|NCT01390220|12315029|FG001|COMPLETED|Test Dose Phase||0
11129329|NCT01390220|12315030|FG002|COMPLETED|Test Dose Phase||0
11129330|NCT01390220|12315028|FG000|NOT COMPLETED|Test Dose Phase||91
11129331|NCT01390220|12315029|FG001|NOT COMPLETED|Test Dose Phase||0
11129332|NCT01390220|12315030|FG002|NOT COMPLETED|Test Dose Phase||0
11129333|NCT01390220|12315028|FG000|STARTED|Comparative Phase|This arm not applicable in CP|0
11129334|NCT01390220|12315029|FG001|STARTED|Comparative Phase||134
11129335|NCT01390220|12315030|FG002|STARTED|Comparative Phase||67
11129336|NCT01390220|12315028|FG000|COMPLETED|Comparative Phase|This arm not applicable in CP|0
11129337|NCT01390220|12315029|FG001|COMPLETED|Comparative Phase||133
11129338|NCT01390220|12315030|FG002|COMPLETED|Comparative Phase||67
11129339|NCT01390220|12315028|FG000|NOT COMPLETED|Comparative Phase||0
11129340|NCT01390220|12315029|FG001|NOT COMPLETED|Comparative Phase||1
11129341|NCT01390220|12315030|FG002|NOT COMPLETED|Comparative Phase||0
11129342|NCT01390233|12315042|FG000|STARTED|Overall Study||35
11129343|NCT01390233|12315043|FG001|STARTED|Overall Study||31
11129344|NCT01390233|12315044|FG002|STARTED|Overall Study||36
11129345|NCT01390233|12315042|FG000|COMPLETED|Overall Study||30
11129346|NCT01390233|12315043|FG001|COMPLETED|Overall Study||29
11129347|NCT01390233|12315044|FG002|COMPLETED|Overall Study||30
11129348|NCT01390233|12315042|FG000|NOT COMPLETED|Overall Study||5
11129349|NCT01390233|12315043|FG001|NOT COMPLETED|Overall Study||2
11129350|NCT01390233|12315044|FG002|NOT COMPLETED|Overall Study||6
11129351|NCT01390246|12315054|FG000|STARTED|Overall Study||30
11129352|NCT01390246|12315055|FG001|STARTED|Overall Study||35
11129353|NCT01390246|12315054|FG000|Visit 2: Quit Day|Overall Study||24
11129354|NCT01390246|12315055|FG001|Visit 2: Quit Day|Overall Study||24
11129355|NCT01390246|12315054|FG000|Visit 6: End of Treatment|Overall Study||15
11129356|NCT01390246|12315055|FG001|Visit 6: End of Treatment|Overall Study||15
11129357|NCT01390246|12315054|FG000|Visit 7: 36-38 Weeks Gestation|Overall Study||10
11129358|NCT01390246|12315055|FG001|Visit 7: 36-38 Weeks Gestation|Overall Study||10
11129359|NCT01390246|12315054|FG000|COMPLETED|Overall Study||10
11129360|NCT01390246|12315055|FG001|COMPLETED|Overall Study||10
11129361|NCT01390246|12315054|FG000|NOT COMPLETED|Overall Study||20
11129362|NCT01390246|12315055|FG001|NOT COMPLETED|Overall Study||25
11129363|NCT01390259|12315061|FG000|STARTED|Overall Study||5
11129364|NCT01390259|12315062|FG001|STARTED|Overall Study||6
11129365|NCT01390259|12315061|FG000|COMPLETED|Overall Study||5
11129366|NCT01390259|12315062|FG001|COMPLETED|Overall Study||6
11129367|NCT01390259|12315061|FG000|NOT COMPLETED|Overall Study||0
11129368|NCT01390259|12315062|FG001|NOT COMPLETED|Overall Study||0
11129369|NCT01390272|12315069|FG000|STARTED|Overall Study||192
11129370|NCT01390272|12315070|FG001|STARTED|Overall Study||193
11129371|NCT01390272|12315069|FG000|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162
11129372|NCT01390272|12315070|FG001|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171
11129373|NCT01390272|12315069|FG000|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139
11129374|NCT01390272|12315070|FG001|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159
11129375|NCT01390272|12315069|FG000|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155
11129376|NCT01390272|12315070|FG001|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160
11129377|NCT01390272|12315069|FG000|COMPLETED|Overall Study||175
11129378|NCT01390272|12315070|FG001|COMPLETED|Overall Study||178
11239675|NCT02082977|12431799|FG001|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
11239676|NCT02082977|12431800|FG002|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
11239677|NCT02082977|12431801|FG003|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
11239678|NCT02082977|12431802|FG004|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
11129379|NCT01390272|12315069|FG000|NOT COMPLETED|Overall Study||17
11129380|NCT01390272|12315070|FG001|NOT COMPLETED|Overall Study||15
11129381|NCT01390298|12315076|FG000|STARTED|Overall Study||55
11129382|NCT01390298|12315076|FG000|COMPLETED|Overall Study||31
11129383|NCT01390298|12315076|FG000|NOT COMPLETED|Overall Study||24
11202203|NCT01838616|12392624|FG000|Full Analysis Set|Titration Period||130
11202204|NCT01838616|12392625|FG001|Full Analysis Set|Titration Period||128
11202205|NCT01838616|12392624|FG000|Per Protocol Set|Titration Period||117
11202206|NCT01838616|12392625|FG001|Per Protocol Set|Titration Period||112
11202207|NCT01838616|12392624|FG000|COMPLETED|Titration Period||100
11202208|NCT01838616|12392625|FG001|COMPLETED|Titration Period||62
11202209|NCT01838616|12392624|FG000|NOT COMPLETED|Titration Period||30
11202210|NCT01838616|12392625|FG001|NOT COMPLETED|Titration Period||66
11239679|NCT02082977|12431803|FG005|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
11239680|NCT02082977|12431804|FG006|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
11239681|NCT02082977|12431805|FG007|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
11239682|NCT02082977|12431806|FG008|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
11239683|NCT02082977|12431807|FG009|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
11239684|NCT02083107|12431842|FG000|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
11239685|NCT02083107|12431843|FG001|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
11239686|NCT02083107|12431844|FG002|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
11239687|NCT02083107|12431842|FG000|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
11239688|NCT02083107|12431843|FG001|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
11239689|NCT02083107|12431844|FG002|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
11239690|NCT02083107|12431842|FG000|NOT COMPLETED|Overall Study||0
11239691|NCT02083107|12431843|FG001|NOT COMPLETED|Overall Study||0
11239692|NCT02083107|12431844|FG002|NOT COMPLETED|Overall Study||0
11338973|NCT02907268|12536332|FG001|NOT COMPLETED|Overall Study||0
11338974|NCT02907463|12536337|FG000|STARTED|Overall Study||280
11338975|NCT02907463|12536337|FG000|Enrolled Cohort|Overall Study||280
11338976|NCT02907463|12536337|FG000|Per Protocol Cohort|Overall Study||276
11338977|NCT02907463|12536337|FG000|COMPLETED|Overall Study||243
11338978|NCT02907463|12536337|FG000|NOT COMPLETED|Overall Study||37
11338979|NCT02907489|12536351|FG000|STARTED|Overall Study||42
11338980|NCT02907489|12536352|FG001|STARTED|Overall Study||42
11338981|NCT02907489|12536351|FG000|COMPLETED|Overall Study||40
11338982|NCT02907489|12536352|FG001|COMPLETED|Overall Study||41
11338983|NCT02907489|12536351|FG000|NOT COMPLETED|Overall Study||2
11338984|NCT02907489|12536352|FG001|NOT COMPLETED|Overall Study||1
11338985|NCT02907619|12536361|FG000|STARTED|Overall Study||19
11338986|NCT02907619|12536362|FG001|STARTED|Overall Study||20
11338987|NCT02907619|12536363|FG002|STARTED|Overall Study||20
11338988|NCT02907619|12536361|FG000|Received Treatment|Overall Study||19
11338989|NCT02907619|12536362|FG001|Received Treatment|Overall Study||20
11338990|NCT02907619|12536363|FG002|Received Treatment|Overall Study||20
11338991|NCT02907619|12536361|FG000|COMPLETED|Overall Study||0
11338992|NCT02907619|12536362|FG001|COMPLETED|Overall Study||0
11202211|NCT01838616|12392624|FG000|STARTED|Continuation Period||100
11239693|NCT02083185|12431855|FG000|STARTED|Overall Study||56
11239694|NCT02083185|12431856|FG001|STARTED|Overall Study||56
11239695|NCT02083185|12431857|FG002|STARTED|Overall Study||24
11239696|NCT02083185|12431855|FG000|Safety Population|Overall Study||56
11239697|NCT02083185|12431856|FG001|Safety Population|Overall Study||54
11239698|NCT02083185|12431857|FG002|Safety Population|Overall Study||24
11239699|NCT02083185|12431855|FG000|COMPLETED|Overall Study||36
11129384|NCT01390389|12315082|FG000|STARTED|Overall Study||10
11129385|NCT01390389|12315083|FG001|STARTED|Overall Study||9
11129386|NCT01390389|12315082|FG000|COMPLETED|Overall Study||6
11129387|NCT01390389|12315083|FG001|COMPLETED|Overall Study||8
11129388|NCT01390389|12315082|FG000|NOT COMPLETED|Overall Study||4
11129389|NCT01390389|12315083|FG001|NOT COMPLETED|Overall Study||1
11129390|NCT01390402|12315093|FG000|STARTED|Overall Study||6
11129391|NCT01390402|12315093|FG000|COMPLETED|Overall Study||1
11129392|NCT01390402|12315093|FG000|NOT COMPLETED|Overall Study||5
11129393|NCT01390428|12315103|FG000|STARTED|Overall Study||8
11129394|NCT01390428|12315104|FG001|STARTED|Overall Study||8
11129395|NCT01390428|12315105|FG002|STARTED|Overall Study||9
11129396|NCT01390428|12315106|FG003|STARTED|Overall Study||9
11129397|NCT01390428|12315107|FG004|STARTED|Overall Study||8
11129398|NCT01390428|12315108|FG005|STARTED|Overall Study||8
11129399|NCT01390428|12315103|FG000|COMPLETED|Overall Study||8
11129400|NCT01390428|12315104|FG001|COMPLETED|Overall Study||8
11129401|NCT01390428|12315105|FG002|COMPLETED|Overall Study||8
11129402|NCT01390428|12315106|FG003|COMPLETED|Overall Study||9
11129403|NCT01390428|12315107|FG004|COMPLETED|Overall Study||7
11129404|NCT01390428|12315108|FG005|COMPLETED|Overall Study||8
11129405|NCT01390428|12315103|FG000|NOT COMPLETED|Overall Study||0
11129406|NCT01390428|12315104|FG001|NOT COMPLETED|Overall Study||0
11129407|NCT01390428|12315105|FG002|NOT COMPLETED|Overall Study||1
11129408|NCT01390428|12315106|FG003|NOT COMPLETED|Overall Study||0
11129409|NCT01390428|12315107|FG004|NOT COMPLETED|Overall Study||1
11129410|NCT01390428|12315108|FG005|NOT COMPLETED|Overall Study||0
11129411|NCT01390441|12315127|FG000|STARTED|Treatment Period||23
11129412|NCT01390441|12315128|FG001|STARTED|Treatment Period||22
11129413|NCT01390441|12315129|FG002|STARTED|Treatment Period||18
11129414|NCT01390441|12315130|FG003|STARTED|Treatment Period||19
11129415|NCT01390441|12315131|FG004|STARTED|Treatment Period||18
11129416|NCT01390441|12315127|FG000|COMPLETED|Treatment Period||22
11129417|NCT01390441|12315128|FG001|COMPLETED|Treatment Period||21
11129418|NCT01390441|12315129|FG002|COMPLETED|Treatment Period||8
11129419|NCT01390441|12315130|FG003|COMPLETED|Treatment Period||6
11129420|NCT01390441|12315131|FG004|COMPLETED|Treatment Period||7
11129421|NCT01390441|12315127|FG000|NOT COMPLETED|Treatment Period||1
11129422|NCT01390441|12315128|FG001|NOT COMPLETED|Treatment Period||1
11129423|NCT01390441|12315129|FG002|NOT COMPLETED|Treatment Period||10
11129424|NCT01390441|12315130|FG003|NOT COMPLETED|Treatment Period||13
11129425|NCT01390441|12315131|FG004|NOT COMPLETED|Treatment Period||11
11129426|NCT01390441|12315127|FG000|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
11129427|NCT01390441|12315128|FG001|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
11129428|NCT01390441|12315129|FG002|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
11129429|NCT01390441|12315130|FG003|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
11129430|NCT01390441|12315131|FG004|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
11129431|NCT01390441|12315127|FG000|COMPLETED|Extension Period||12
11129432|NCT01390441|12315128|FG001|COMPLETED|Extension Period||12
11129433|NCT01390441|12315129|FG002|COMPLETED|Extension Period||1
11129434|NCT01390441|12315130|FG003|COMPLETED|Extension Period||0
11129435|NCT01390441|12315131|FG004|COMPLETED|Extension Period||3
11129436|NCT01390441|12315127|FG000|NOT COMPLETED|Extension Period||3
11129437|NCT01390441|12315128|FG001|NOT COMPLETED|Extension Period||1
11129438|NCT01390441|12315129|FG002|NOT COMPLETED|Extension Period||0
11129439|NCT01390441|12315130|FG003|NOT COMPLETED|Extension Period||1
11129440|NCT01390441|12315131|FG004|NOT COMPLETED|Extension Period||0
11129441|NCT01390584|12315171|FG000|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||4
11129442|NCT01390584|12315172|FG001|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
11129443|NCT01390584|12315173|FG002|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
11129444|NCT01390584|12315171|FG000|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||4
11129445|NCT01390584|12315172|FG001|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
11129446|NCT01390584|12315173|FG002|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
11129447|NCT01390584|12315171|FG000|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
11129448|NCT01390584|12315172|FG001|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
11129449|NCT01390584|12315173|FG002|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
11129450|NCT01390584|12315171|FG000|STARTED|Step 2: ABVD or BEACOPP Then INRT||4
11129451|NCT01390584|12315172|FG001|STARTED|Step 2: ABVD or BEACOPP Then INRT||1
11129452|NCT01390584|12315173|FG002|STARTED|Step 2: ABVD or BEACOPP Then INRT||0
11129453|NCT01390584|12315171|FG000|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||4
11129454|NCT01390584|12315172|FG001|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||1
11129455|NCT01390584|12315173|FG002|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
11129456|NCT01390584|12315171|FG000|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
11129457|NCT01390584|12315172|FG001|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
11129458|NCT01390584|12315173|FG002|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
11239700|NCT02083185|12431856|FG001|COMPLETED|Overall Study||27
11129459|NCT01390649|12315182|FG000|STARTED|Overall Study|Subjects treated with Privigen|57
11129460|NCT01390649|12315182|FG000|COMPLETED|Overall Study||56
11129461|NCT01390649|12315182|FG000|NOT COMPLETED|Overall Study||1
11129462|NCT01390779|12315186|FG000|STARTED|Overall Study||33
11129463|NCT01390779|12315186|FG000|COMPLETED|Overall Study||32
11129464|NCT01390779|12315186|FG000|NOT COMPLETED|Overall Study||1
11129465|NCT01390818|12315205|FG000|STARTED|Overall Study||3
11129466|NCT01390818|12315206|FG001|STARTED|Overall Study||3
11129467|NCT01390818|12315207|FG002|STARTED|Overall Study||3
11129468|NCT01390818|12315208|FG003|STARTED|Overall Study||4
11129469|NCT01390818|12315209|FG004|STARTED|Overall Study||4
11129470|NCT01390818|12315210|FG005|STARTED|Overall Study||3
11129471|NCT01390818|12315211|FG006|STARTED|Overall Study||19
11129472|NCT01390818|12315212|FG007|STARTED|Overall Study||14
11129473|NCT01390818|12315213|FG008|STARTED|Overall Study||3
11129474|NCT01390818|12315214|FG009|STARTED|Overall Study||3
11129475|NCT01390818|12315215|FG010|STARTED|Overall Study||4
11129476|NCT01390818|12315216|FG011|STARTED|Overall Study||26
11129477|NCT01390818|12315217|FG012|STARTED|Overall Study||24
11129478|NCT01390818|12315218|FG013|STARTED|Overall Study||18
11129479|NCT01390818|12315219|FG014|STARTED|Overall Study||15
11129480|NCT01390818|12315205|FG000|COMPLETED|Overall Study||3
11129481|NCT01390818|12315206|FG001|COMPLETED|Overall Study||3
11129482|NCT01390818|12315207|FG002|COMPLETED|Overall Study||3
11129483|NCT01390818|12315208|FG003|COMPLETED|Overall Study||4
11129484|NCT01390818|12315209|FG004|COMPLETED|Overall Study||4
11129485|NCT01390818|12315210|FG005|COMPLETED|Overall Study||3
11129486|NCT01390818|12315211|FG006|COMPLETED|Overall Study||19
11129487|NCT01390818|12315212|FG007|COMPLETED|Overall Study||14
11129488|NCT01390818|12315213|FG008|COMPLETED|Overall Study||3
11129489|NCT01390818|12315214|FG009|COMPLETED|Overall Study||3
11129490|NCT01390818|12315215|FG010|COMPLETED|Overall Study||4
11129491|NCT01390818|12315216|FG011|COMPLETED|Overall Study||26
11129492|NCT01390818|12315217|FG012|COMPLETED|Overall Study||24
11129493|NCT01390818|12315218|FG013|COMPLETED|Overall Study||18
11129494|NCT01390818|12315219|FG014|COMPLETED|Overall Study||15
11129495|NCT01390818|12315205|FG000|NOT COMPLETED|Overall Study||0
11129496|NCT01390818|12315206|FG001|NOT COMPLETED|Overall Study||0
11129497|NCT01390818|12315207|FG002|NOT COMPLETED|Overall Study||0
11129498|NCT01390818|12315208|FG003|NOT COMPLETED|Overall Study||0
11129499|NCT01390818|12315209|FG004|NOT COMPLETED|Overall Study||0
11129500|NCT01390818|12315210|FG005|NOT COMPLETED|Overall Study||0
11129501|NCT01390818|12315211|FG006|NOT COMPLETED|Overall Study||0
11129502|NCT01390818|12315212|FG007|NOT COMPLETED|Overall Study||0
11129503|NCT01390818|12315213|FG008|NOT COMPLETED|Overall Study||0
11129504|NCT01390818|12315214|FG009|NOT COMPLETED|Overall Study||0
11129505|NCT01390818|12315215|FG010|NOT COMPLETED|Overall Study||0
11129506|NCT01390818|12315216|FG011|NOT COMPLETED|Overall Study||0
11129507|NCT01390818|12315217|FG012|NOT COMPLETED|Overall Study||0
11129508|NCT01390818|12315218|FG013|NOT COMPLETED|Overall Study||0
11129509|NCT01390818|12315219|FG014|NOT COMPLETED|Overall Study||0
11129510|NCT01390844|12315323|FG000|STARTED|Treatment Phase||133
11129511|NCT01390844|12315324|FG001|STARTED|Treatment Phase||65
11129512|NCT01390844|12315325|FG002|STARTED|Treatment Phase||57
11129513|NCT01390844|12315326|FG003|STARTED|Treatment Phase||27
11129514|NCT01390844|12315323|FG000|Followed Good Clinical Practice (GCP)|Treatment Phase||133
11129515|NCT01390844|12315324|FG001|Followed Good Clinical Practice (GCP)|Treatment Phase||65
11129516|NCT01390844|12315325|FG002|Followed Good Clinical Practice (GCP)|Treatment Phase||47
11129517|NCT01390844|12315326|FG003|Followed Good Clinical Practice (GCP)|Treatment Phase||24
11129518|NCT01390844|12315323|FG000|COMPLETED|Treatment Phase||93
11129519|NCT01390844|12315324|FG001|COMPLETED|Treatment Phase||37
11129520|NCT01390844|12315325|FG002|COMPLETED|Treatment Phase||26
11129521|NCT01390844|12315326|FG003|COMPLETED|Treatment Phase||8
11129522|NCT01390844|12315323|FG000|NOT COMPLETED|Treatment Phase||40
11129523|NCT01390844|12315324|FG001|NOT COMPLETED|Treatment Phase||28
11129524|NCT01390844|12315325|FG002|NOT COMPLETED|Treatment Phase||31
11129525|NCT01390844|12315326|FG003|NOT COMPLETED|Treatment Phase||19
11129526|NCT01390844|12315323|FG000|STARTED|Follow-Up Phase||93
11129527|NCT01390844|12315324|FG001|STARTED|Follow-Up Phase||37
11129528|NCT01390844|12315325|FG002|STARTED|Follow-Up Phase||26
11129529|NCT01390844|12315326|FG003|STARTED|Follow-Up Phase||8
11129530|NCT01390844|12315323|FG000|COMPLETED|Follow-Up Phase||92
11129531|NCT01390844|12315324|FG001|COMPLETED|Follow-Up Phase||36
11129532|NCT01390844|12315325|FG002|COMPLETED|Follow-Up Phase||25
11129533|NCT01390844|12315326|FG003|COMPLETED|Follow-Up Phase||8
11129534|NCT01390844|12315323|FG000|NOT COMPLETED|Follow-Up Phase||1
11129535|NCT01390844|12315324|FG001|NOT COMPLETED|Follow-Up Phase||1
11129536|NCT01390844|12315325|FG002|NOT COMPLETED|Follow-Up Phase||1
11129537|NCT01390844|12315326|FG003|NOT COMPLETED|Follow-Up Phase||0
11129538|NCT01390857|12315336|FG000|STARTED|Overall Study||379
11129539|NCT01390857|12315336|FG000|COMPLETED|Overall Study||369
11129540|NCT01390857|12315336|FG000|NOT COMPLETED|Overall Study||10
11239701|NCT02083185|12431857|FG002|COMPLETED|Overall Study||17
11239702|NCT02083185|12431855|FG000|NOT COMPLETED|Overall Study||20
11239703|NCT02083185|12431856|FG001|NOT COMPLETED|Overall Study||29
11239704|NCT02083185|12431857|FG002|NOT COMPLETED|Overall Study||7
11239705|NCT02083263|12431867|FG000|STARTED|Overall Study||16
11239706|NCT02083263|12431868|FG001|STARTED|Overall Study||16
11239707|NCT02083263|12431867|FG000|COMPLETED|Overall Study||16
11129541|NCT01390870|12315340|FG000|STARTED|Overall Study||400
11239708|NCT02083263|12431868|FG001|COMPLETED|Overall Study||16
11239709|NCT02083263|12431867|FG000|NOT COMPLETED|Overall Study||0
11239710|NCT02083263|12431868|FG001|NOT COMPLETED|Overall Study||0
11239711|NCT02083380|12431877|FG000|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
11239712|NCT02083380|12431878|FG001|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
11239713|NCT02083380|12431879|FG002|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
11239714|NCT02083380|12431877|FG000|COMPLETED|Overall Study||57
11239715|NCT02083380|12431878|FG001|COMPLETED|Overall Study||56
11239716|NCT02083380|12431879|FG002|COMPLETED|Overall Study||65
11239717|NCT02083380|12431877|FG000|NOT COMPLETED|Overall Study||91
11239718|NCT02083380|12431878|FG001|NOT COMPLETED|Overall Study||95
11129542|NCT01390870|12315340|FG000|COMPLETED|Overall Study||400
11129543|NCT01390870|12315340|FG000|NOT COMPLETED|Overall Study||0
11129544|NCT01390909|12315350|FG000|STARTED|Overall Study||3454
11129545|NCT01390909|12315351|FG001|STARTED|Overall Study||3552
11129546|NCT01390909|12315352|FG002|STARTED|Overall Study||3552
11129547|NCT01390909|12315353|FG003|STARTED|Overall Study||602
11129548|NCT01390909|12315354|FG004|STARTED|Overall Study||613
11129549|NCT01390909|12315355|FG005|STARTED|Overall Study||613
11129550|NCT01390909|12315350|FG000|Participants in Subgroup|Overall Study||0
11129551|NCT01390909|12315351|FG001|Participants in Subgroup|Overall Study||3454
11129552|NCT01390909|12315352|FG002|Participants in Subgroup|Overall Study||0
11129553|NCT01390909|12315353|FG003|Participants in Subgroup|Overall Study||0
11129554|NCT01390909|12315354|FG004|Participants in Subgroup|Overall Study||602
11129555|NCT01390909|12315355|FG005|Participants in Subgroup|Overall Study||0
11129556|NCT01390909|12315350|FG000|COMPLETED|Overall Study||3454
11129557|NCT01390909|12315351|FG001|COMPLETED|Overall Study||3552
11129558|NCT01390909|12315352|FG002|COMPLETED|Overall Study||3552
11129559|NCT01390909|12315353|FG003|COMPLETED|Overall Study||602
11239719|NCT02083380|12431879|FG002|NOT COMPLETED|Overall Study||84
11239720|NCT02083406|12431895|FG000|STARTED|Overall Study||7
11239721|NCT02083406|12431896|FG001|STARTED|Overall Study||8
11239722|NCT02083406|12431897|FG002|STARTED|Overall Study||7
11239723|NCT02083406|12431895|FG000|COMPLETED|Overall Study||7
11239724|NCT02083406|12431896|FG001|COMPLETED|Overall Study||8
11129560|NCT01390909|12315354|FG004|COMPLETED|Overall Study||613
11129561|NCT01390909|12315355|FG005|COMPLETED|Overall Study||613
11129562|NCT01390909|12315350|FG000|NOT COMPLETED|Overall Study||0
11129563|NCT01390909|12315351|FG001|NOT COMPLETED|Overall Study||0
11129564|NCT01390909|12315352|FG002|NOT COMPLETED|Overall Study||0
11129565|NCT01390909|12315353|FG003|NOT COMPLETED|Overall Study||0
11129566|NCT01390909|12315354|FG004|NOT COMPLETED|Overall Study||0
11129567|NCT01390909|12315355|FG005|NOT COMPLETED|Overall Study||0
11129568|NCT01390948|12315376|FG000|STARTED|Overall Study||59
11129569|NCT01390948|12315377|FG001|STARTED|Overall Study||62
11129570|NCT01390948|12315378|FG002|STARTED|Overall Study||3
11129571|NCT01390948|12315376|FG000|Treated|Overall Study||56
11129572|NCT01390948|12315377|FG001|Treated|Overall Study||60
11129573|NCT01390948|12315378|FG002|Treated|Overall Study||3
11129574|NCT01390948|12315376|FG000|COMPLETED|Overall Study||44
11129575|NCT01390948|12315377|FG001|COMPLETED|Overall Study||44
11129576|NCT01390948|12315378|FG002|COMPLETED|Overall Study||2
11129577|NCT01390948|12315376|FG000|NOT COMPLETED|Overall Study||15
11129578|NCT01390948|12315377|FG001|NOT COMPLETED|Overall Study||18
11129579|NCT01390948|12315378|FG002|NOT COMPLETED|Overall Study||1
11129580|NCT01391000|12315387|FG000|STARTED|Overall Study||35
11129581|NCT01391000|12315388|FG001|STARTED|Overall Study||35
11129582|NCT01391000|12315387|FG000|COMPLETED|Overall Study||33
11239725|NCT02083406|12431897|FG002|COMPLETED|Overall Study||7
11239726|NCT02083406|12431895|FG000|NOT COMPLETED|Overall Study||0
11239727|NCT02083406|12431896|FG001|NOT COMPLETED|Overall Study||0
11239728|NCT02083406|12431897|FG002|NOT COMPLETED|Overall Study||0
11239729|NCT02083653|12431908|FG000|STARTED|Overall Study||83
11239730|NCT02083653|12431909|FG001|STARTED|Overall Study||86
11239731|NCT02083653|12431910|FG002|STARTED|Overall Study||85
11239732|NCT02083653|12431908|FG000|COMPLETED|Overall Study||1
11239733|NCT02083653|12431909|FG001|COMPLETED|Overall Study||1
11239734|NCT02083653|12431910|FG002|COMPLETED|Overall Study||1
11239735|NCT02083653|12431908|FG000|NOT COMPLETED|Overall Study||82
11239736|NCT02083653|12431909|FG001|NOT COMPLETED|Overall Study||85
11239737|NCT02083653|12431910|FG002|NOT COMPLETED|Overall Study||84
11239738|NCT02083679|12431922|FG000|STARTED|Overall Study||3
11239739|NCT02083679|12431923|FG001|STARTED|Overall Study||6
11239740|NCT02083679|12431924|FG002|STARTED|Overall Study||3
11239741|NCT02083679|12431925|FG003|STARTED|Overall Study||3
11239742|NCT02083679|12431922|FG000|COMPLETED|Overall Study||3
11239743|NCT02083679|12431923|FG001|COMPLETED|Overall Study||6
11129583|NCT01391000|12315388|FG001|COMPLETED|Overall Study||35
11129584|NCT01391000|12315387|FG000|NOT COMPLETED|Overall Study||2
11129585|NCT01391000|12315388|FG001|NOT COMPLETED|Overall Study||0
11129586|NCT01391013|12315396|FG000|STARTED|Overall Study||15
11129587|NCT01391013|12315397|FG001|STARTED|Overall Study||15
11129588|NCT01391013|12315396|FG000|COMPLETED|Overall Study||15
11239744|NCT02083679|12431924|FG002|COMPLETED|Overall Study||3
11239745|NCT02083679|12431925|FG003|COMPLETED|Overall Study||3
11239746|NCT02083679|12431922|FG000|NOT COMPLETED|Overall Study||0
11239747|NCT02083679|12431923|FG001|NOT COMPLETED|Overall Study||0
11239748|NCT02083679|12431924|FG002|NOT COMPLETED|Overall Study||0
11129589|NCT01391013|12315397|FG001|COMPLETED|Overall Study||15
11129590|NCT01391013|12315396|FG000|NOT COMPLETED|Overall Study||0
11129591|NCT01391013|12315397|FG001|NOT COMPLETED|Overall Study||0
11129592|NCT01391130|12315405|FG000|STARTED|Overall Study||73
11129593|NCT01391130|12315406|FG001|STARTED|Overall Study||37
11239749|NCT02083679|12431925|FG003|NOT COMPLETED|Overall Study||0
11239750|NCT02083783|12431937|FG000|STARTED|Overall Study||52
11239751|NCT02083783|12431938|FG001|STARTED|Overall Study||48
11239752|NCT02083783|12431937|FG000|COMPLETED|Overall Study||51
11239753|NCT02083783|12431938|FG001|COMPLETED|Overall Study||48
11239754|NCT02083783|12431937|FG000|NOT COMPLETED|Overall Study||1
11239755|NCT02083783|12431938|FG001|NOT COMPLETED|Overall Study||0
11239756|NCT02083809|12431948|FG000|STARTED|Overall Study||82
11239757|NCT02083809|12431949|FG001|STARTED|Overall Study||84
11239758|NCT02083809|12431948|FG000|COMPLETED|Overall Study||78
11239759|NCT02083809|12431949|FG001|COMPLETED|Overall Study||82
11239760|NCT02083809|12431948|FG000|NOT COMPLETED|Overall Study||4
11239761|NCT02083809|12431949|FG001|NOT COMPLETED|Overall Study||2
11239762|NCT02083861|12431957|FG000|STARTED|Overall Study||57
11239763|NCT02083861|12431958|FG001|STARTED|Overall Study||36
11239764|NCT02083861|12431957|FG000|Treated|Overall Study||55
11239765|NCT02083861|12431958|FG001|Treated|Overall Study||35
11239766|NCT02083861|12431957|FG000|COMPLETED|Overall Study||51
11239767|NCT02083861|12431958|FG001|COMPLETED|Overall Study||33
11239768|NCT02083861|12431957|FG000|NOT COMPLETED|Overall Study||6
11239769|NCT02083861|12431958|FG001|NOT COMPLETED|Overall Study||3
11239770|NCT02083926|12431968|FG000|STARTED|Overall Study||9
11239771|NCT02083926|12431969|FG001|STARTED|Overall Study||9
11239772|NCT02083926|12431968|FG000|COMPLETED|Overall Study||8
11239773|NCT02083926|12431969|FG001|COMPLETED|Overall Study||9
11239774|NCT02083926|12431968|FG000|NOT COMPLETED|Overall Study||1
11239775|NCT02083926|12431969|FG001|NOT COMPLETED|Overall Study||0
11239776|NCT02083965|12431978|FG000|STARTED|PK Period 1||10
11239777|NCT02083965|12431979|FG001|STARTED|PK Period 1||9
11239778|NCT02083965|12431978|FG000|COMPLETED|PK Period 1||10
11239779|NCT02083965|12431979|FG001|COMPLETED|PK Period 1||9
11239780|NCT02083965|12431978|FG000|NOT COMPLETED|PK Period 1||0
11239781|NCT02083965|12431979|FG001|NOT COMPLETED|PK Period 1||0
11239782|NCT02083965|12431978|FG000|STARTED|Washout Period||10
11239783|NCT02083965|12431979|FG001|STARTED|Washout Period||9
11239784|NCT02083965|12431978|FG000|COMPLETED|Washout Period||10
11239785|NCT02083965|12431979|FG001|COMPLETED|Washout Period||9
11239786|NCT02083965|12431978|FG000|NOT COMPLETED|Washout Period||0
11239787|NCT02083965|12431979|FG001|NOT COMPLETED|Washout Period||0
11239788|NCT02083965|12431978|FG000|STARTED|PK Period 2||10
11239789|NCT02083965|12431979|FG001|STARTED|PK Period 2||9
11239790|NCT02083965|12431978|FG000|COMPLETED|PK Period 2||10
11239791|NCT02083965|12431979|FG001|COMPLETED|PK Period 2||9
11239792|NCT02083965|12431978|FG000|NOT COMPLETED|PK Period 2||0
11239793|NCT02083965|12431979|FG001|NOT COMPLETED|PK Period 2||0
11239794|NCT02083965|12431978|FG000|STARTED|Treatment Period||10
11239795|NCT02083965|12431979|FG001|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
11239796|NCT02083965|12431978|FG000|COMPLETED|Treatment Period||9
11239797|NCT02083965|12431979|FG001|COMPLETED|Treatment Period||8
11239798|NCT02083965|12431978|FG000|NOT COMPLETED|Treatment Period||1
11239799|NCT02083965|12431979|FG001|NOT COMPLETED|Treatment Period||0
11239800|NCT02084056|12431989|FG000|STARTED|Treatment Period 1 (4 Days)||28
11239801|NCT02084056|12431990|FG001|STARTED|Treatment Period 1 (4 Days)||30
11239802|NCT02084056|12431991|FG002|STARTED|Treatment Period 1 (4 Days)||8
11239803|NCT02084056|12431992|FG003|STARTED|Treatment Period 1 (4 Days)||8
11239804|NCT02084056|12431989|FG000|COMPLETED|Treatment Period 1 (4 Days)||27
11239805|NCT02084056|12431990|FG001|COMPLETED|Treatment Period 1 (4 Days)||30
11239806|NCT02084056|12431991|FG002|COMPLETED|Treatment Period 1 (4 Days)||8
11239807|NCT02084056|12431992|FG003|COMPLETED|Treatment Period 1 (4 Days)||8
11239808|NCT02084056|12431989|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||1
11239809|NCT02084056|12431990|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11239810|NCT02084056|12431991|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11239811|NCT02084056|12431992|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11239812|NCT02084056|12431989|FG000|STARTED|Washout Period 1 (35 Days)||27
11239813|NCT02084056|12431990|FG001|STARTED|Washout Period 1 (35 Days)||30
11239814|NCT02084056|12431991|FG002|STARTED|Washout Period 1 (35 Days)||8
11239815|NCT02084056|12431992|FG003|STARTED|Washout Period 1 (35 Days)||8
11239816|NCT02084056|12431989|FG000|COMPLETED|Washout Period 1 (35 Days)||26
11239817|NCT02084056|12431990|FG001|COMPLETED|Washout Period 1 (35 Days)||30
11239818|NCT02084056|12431991|FG002|COMPLETED|Washout Period 1 (35 Days)||8
11239819|NCT02084056|12431992|FG003|COMPLETED|Washout Period 1 (35 Days)||8
11239820|NCT02084056|12431989|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||1
11239821|NCT02084056|12431990|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0
11239822|NCT02084056|12431991|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||0
11239823|NCT02084056|12431992|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||0
11239824|NCT02084056|12431989|FG000|STARTED|Treatment Period 2 (4 Days)||26
11239825|NCT02084056|12431990|FG001|STARTED|Treatment Period 2 (4 Days)||30
11239826|NCT02084056|12431991|FG002|STARTED|Treatment Period 2 (4 Days)||8
11239827|NCT02084056|12431992|FG003|STARTED|Treatment Period 2 (4 Days)||8
11239828|NCT02084056|12431989|FG000|COMPLETED|Treatment Period 2 (4 Days)||26
11239829|NCT02084056|12431990|FG001|COMPLETED|Treatment Period 2 (4 Days)||30
11239830|NCT02084056|12431991|FG002|COMPLETED|Treatment Period 2 (4 Days)||8
11239831|NCT02084056|12431992|FG003|COMPLETED|Treatment Period 2 (4 Days)||8
11239832|NCT02084056|12431989|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11239833|NCT02084056|12431990|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11239834|NCT02084056|12431991|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11239835|NCT02084056|12431992|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11239836|NCT02084069|12432004|FG000|STARTED|Overall Study||29
11129594|NCT01391130|12315405|FG000|Received At Least One Dose of Study Drug|Overall Study||72
11129595|NCT01391130|12315406|FG001|Received At Least One Dose of Study Drug|Overall Study||36
11129596|NCT01391130|12315405|FG000|COMPLETED|Overall Study||67
11129597|NCT01391130|12315406|FG001|COMPLETED|Overall Study||31
11129598|NCT01391130|12315405|FG000|NOT COMPLETED|Overall Study||6
11129599|NCT01391130|12315406|FG001|NOT COMPLETED|Overall Study||6
11129600|NCT01391273|12315414|FG000|STARTED|Overall Study||88
11129601|NCT01391273|12315415|FG001|STARTED|Overall Study||85
11129602|NCT01391273|12315414|FG000|COMPLETED|Overall Study||84
11129603|NCT01391273|12315415|FG001|COMPLETED|Overall Study||83
11129604|NCT01391273|12315414|FG000|NOT COMPLETED|Overall Study||4
11129605|NCT01391273|12315415|FG001|NOT COMPLETED|Overall Study||2
11129606|NCT01391286|12315423|FG000|STARTED|Overall Study||18
11129607|NCT01391286|12315424|FG001|STARTED|Overall Study||18
11129608|NCT01391286|12315423|FG000|COMPLETED|Overall Study||18
11129609|NCT01391286|12315424|FG001|COMPLETED|Overall Study||18
11129610|NCT01391286|12315423|FG000|NOT COMPLETED|Overall Study||0
11129611|NCT01391286|12315424|FG001|NOT COMPLETED|Overall Study||0
11129612|NCT01391299|12315433|FG000|STARTED|Overall Study||57
11129613|NCT01391299|12315434|FG001|STARTED|Overall Study||60
11129614|NCT01391299|12315435|FG002|STARTED|Overall Study||58
11129615|NCT01391299|12315433|FG000|COMPLETED|Overall Study||57
11129616|NCT01391299|12315434|FG001|COMPLETED|Overall Study||59
11129617|NCT01391299|12315435|FG002|COMPLETED|Overall Study||56
11129618|NCT01391299|12315433|FG000|NOT COMPLETED|Overall Study||0
11129619|NCT01391299|12315434|FG001|NOT COMPLETED|Overall Study||1
11129620|NCT01391299|12315435|FG002|NOT COMPLETED|Overall Study||2
11129621|NCT01391312|12315445|FG000|STARTED|Overall Study||20
11129622|NCT01391312|12315446|FG001|STARTED|Overall Study||20
11129623|NCT01391312|12315445|FG000|COMPLETED|Overall Study||18
11129624|NCT01391312|12315446|FG001|COMPLETED|Overall Study||19
11129625|NCT01391312|12315445|FG000|NOT COMPLETED|Overall Study||2
11129626|NCT01391312|12315446|FG001|NOT COMPLETED|Overall Study||1
11129627|NCT01391325|12315452|FG000|STARTED|Overall Study||1732
11129628|NCT01391325|12315452|FG000|COMPLETED|Overall Study||1238
11129629|NCT01391325|12315452|FG000|NOT COMPLETED|Overall Study||494
11129630|NCT01391364|12315458|FG000|STARTED|Overall Study||222
11129631|NCT01391364|12315459|FG001|STARTED|Overall Study||216
11129632|NCT01391364|12315458|FG000|COMPLETED|Overall Study||217
11129633|NCT01391364|12315459|FG001|COMPLETED|Overall Study||214
11129634|NCT01391364|12315458|FG000|NOT COMPLETED|Overall Study||5
11129635|NCT01391364|12315459|FG001|NOT COMPLETED|Overall Study||2
11129636|NCT01391468|12315467|FG000|STARTED|Overall Study||24
11129637|NCT01391468|12315468|FG001|STARTED|Overall Study||23
11129638|NCT01391468|12315467|FG000|COMPLETED|Overall Study||18
11129639|NCT01391468|12315468|FG001|COMPLETED|Overall Study||21
11129640|NCT01391468|12315467|FG000|NOT COMPLETED|Overall Study||6
11129641|NCT01391468|12315468|FG001|NOT COMPLETED|Overall Study||2
11129642|NCT01391507|12315483|FG000|STARTED|Overall Study||10
11129643|NCT01391507|12315484|FG001|STARTED|Overall Study||8
11129644|NCT01391507|12315485|FG002|STARTED|Overall Study||6
11129645|NCT01391507|12315486|FG003|STARTED|Overall Study||12
11129646|NCT01391507|12315483|FG000|COMPLETED|Overall Study||6
11129647|NCT01391507|12315484|FG001|COMPLETED|Overall Study||4
11129648|NCT01391507|12315485|FG002|COMPLETED|Overall Study||2
11129649|NCT01391507|12315486|FG003|COMPLETED|Overall Study||5
11129650|NCT01391507|12315483|FG000|NOT COMPLETED|Overall Study||4
11129651|NCT01391507|12315484|FG001|NOT COMPLETED|Overall Study||4
11129652|NCT01391507|12315485|FG002|NOT COMPLETED|Overall Study||4
11129653|NCT01391507|12315486|FG003|NOT COMPLETED|Overall Study||7
11129654|NCT01391546|12315498|FG000|STARTED|Overall Study||177
11129655|NCT01391546|12315499|FG001|STARTED|Overall Study||177
11129656|NCT01391546|12315498|FG000|Vaccinated|Overall Study||176
11129657|NCT01391546|12315499|FG001|Vaccinated|Overall Study||177
11129658|NCT01391546|12315498|FG000|COMPLETED|Overall Study||176
11129659|NCT01391546|12315499|FG001|COMPLETED|Overall Study||177
11129660|NCT01391546|12315498|FG000|NOT COMPLETED|Overall Study||1
11129661|NCT01391546|12315499|FG001|NOT COMPLETED|Overall Study||0
11129662|NCT01391559|12315506|FG000|STARTED|First Intervention||10
11129663|NCT01391559|12315507|FG001|STARTED|First Intervention||10
11129664|NCT01391559|12315506|FG000|COMPLETED|First Intervention||10
11129665|NCT01391559|12315507|FG001|COMPLETED|First Intervention||10
11129666|NCT01391559|12315506|FG000|NOT COMPLETED|First Intervention||0
11129667|NCT01391559|12315507|FG001|NOT COMPLETED|First Intervention||0
11129668|NCT01391559|12315506|FG000|STARTED|Second Intervention||10
11129669|NCT01391559|12315507|FG001|STARTED|Second Intervention||10
11129670|NCT01391559|12315506|FG000|COMPLETED|Second Intervention||10
11129671|NCT01391559|12315507|FG001|COMPLETED|Second Intervention||10
11129672|NCT01391559|12315506|FG000|NOT COMPLETED|Second Intervention||0
11129673|NCT01391559|12315507|FG001|NOT COMPLETED|Second Intervention||0
11129674|NCT01391611|12315513|FG000|STARTED|Overall Study||25
11129675|NCT01391611|12315513|FG000|COMPLETED|Overall Study||3
11129676|NCT01391611|12315513|FG000|NOT COMPLETED|Overall Study||22
11129677|NCT01391663|12315521|FG000|STARTED|Overall Study||12
11129678|NCT01391663|12315522|FG001|STARTED|Overall Study||12
11129679|NCT01391663|12315523|FG002|STARTED|Overall Study||12
11129680|NCT01391663|12315524|FG003|STARTED|Overall Study||12
11129681|NCT01391663|12315521|FG000|COMPLETED|Overall Study||12
11129682|NCT01391663|12315522|FG001|COMPLETED|Overall Study||12
11129683|NCT01391663|12315523|FG002|COMPLETED|Overall Study||11
11239837|NCT02084069|12432005|FG001|STARTED|Overall Study||29
11129684|NCT01391663|12315524|FG003|COMPLETED|Overall Study||12
11129685|NCT01391663|12315521|FG000|NOT COMPLETED|Overall Study||0
11129686|NCT01391663|12315522|FG001|NOT COMPLETED|Overall Study||0
11129687|NCT01391663|12315523|FG002|NOT COMPLETED|Overall Study||1
11129688|NCT01391663|12315524|FG003|NOT COMPLETED|Overall Study||0
11129689|NCT01391793|12315536|FG000|STARTED|Overall Study||271
11129690|NCT01391793|12315537|FG001|STARTED|Overall Study||275
11129691|NCT01391793|12315536|FG000|Had a Positive Urine Culture|Overall Study||197
11129692|NCT01391793|12315537|FG001|Had a Positive Urine Culture|Overall Study||188
11129693|NCT01391793|12315536|FG000|COMPLETED|Overall Study||124
11129694|NCT01391793|12315537|FG001|COMPLETED|Overall Study||131
11129695|NCT01391793|12315536|FG000|NOT COMPLETED|Overall Study||147
11129696|NCT01391793|12315537|FG001|NOT COMPLETED|Overall Study||144
11129697|NCT01391819|12315543|FG000|STARTED|Overall Study||2116
11129698|NCT01391819|12315543|FG000|COMPLETED|Overall Study||1714
11129699|NCT01391819|12315543|FG000|NOT COMPLETED|Overall Study||402
11129700|NCT01391832|12315552|FG000|STARTED|Overall Study||49
11129701|NCT01391832|12315553|FG001|STARTED|Overall Study||54
11239838|NCT02084069|12432004|FG000|COMPLETED|Overall Study||29
11239839|NCT02084069|12432005|FG001|COMPLETED|Overall Study||29
11239840|NCT02084069|12432004|FG000|NOT COMPLETED|Overall Study||0
11239841|NCT02084069|12432005|FG001|NOT COMPLETED|Overall Study||0
11239842|NCT02084082|12432013|FG000|STARTED|Treatment Period 1 (4 Days)||26
11239843|NCT02084082|12432014|FG001|STARTED|Treatment Period 1 (4 Days)||26
11239844|NCT02084082|12432015|FG002|STARTED|Treatment Period 1 (4 Days)||8
11239845|NCT02084082|12432016|FG003|STARTED|Treatment Period 1 (4 Days)||8
11239846|NCT02084082|12432013|FG000|COMPLETED|Treatment Period 1 (4 Days)||26
11239847|NCT02084082|12432014|FG001|COMPLETED|Treatment Period 1 (4 Days)||26
11239848|NCT02084082|12432015|FG002|COMPLETED|Treatment Period 1 (4 Days)||8
11129702|NCT01391832|12315552|FG000|1 Month Follow-Up|Overall Study||30
11129703|NCT01391832|12315553|FG001|1 Month Follow-Up|Overall Study||31
11129704|NCT01391832|12315552|FG000|3 Month Follow-Up|Overall Study||28
11129705|NCT01391832|12315553|FG001|3 Month Follow-Up|Overall Study||29
11129706|NCT01391832|12315552|FG000|COMPLETED|Overall Study||28
11129707|NCT01391832|12315553|FG001|COMPLETED|Overall Study||31
11129708|NCT01391832|12315552|FG000|NOT COMPLETED|Overall Study||21
11129709|NCT01391832|12315553|FG001|NOT COMPLETED|Overall Study||23
11129710|NCT01391858|12315561|FG000|STARTED|Overall Study||25
11129711|NCT01391858|12315562|FG001|STARTED|Overall Study||24
11129712|NCT01391858|12315561|FG000|COMPLETED|Overall Study||23
11129713|NCT01391858|12315562|FG001|COMPLETED|Overall Study||24
11129714|NCT01391858|12315561|FG000|NOT COMPLETED|Overall Study||2
11129715|NCT01391858|12315562|FG001|NOT COMPLETED|Overall Study||0
11129716|NCT01392053|12315570|FG000|STARTED|Overall Study||23
11129717|NCT01392053|12315571|FG001|STARTED|Overall Study||23
11129718|NCT01392053|12315570|FG000|COMPLETED|Overall Study||23
11129719|NCT01392053|12315571|FG001|COMPLETED|Overall Study||23
11129720|NCT01392053|12315570|FG000|NOT COMPLETED|Overall Study||0
11129721|NCT01392053|12315571|FG001|NOT COMPLETED|Overall Study||0
11129722|NCT01392183|12315579|FG000|STARTED|First Drug Administration||35
11129723|NCT01392183|12315580|FG001|STARTED|First Drug Administration||34
11129724|NCT01392183|12315579|FG000|Eligible to Cross Over to 2nd Drug|First Drug Administration||29
11129725|NCT01392183|12315580|FG001|Eligible to Cross Over to 2nd Drug|First Drug Administration||31
11129726|NCT01392183|12315579|FG000|COMPLETED|First Drug Administration||21
11129727|NCT01392183|12315580|FG001|COMPLETED|First Drug Administration||15
11129728|NCT01392183|12315579|FG000|NOT COMPLETED|First Drug Administration||14
11129729|NCT01392183|12315580|FG001|NOT COMPLETED|First Drug Administration||19
11129730|NCT01392183|12315579|FG000|STARTED|Second Drug Administration||21
11129731|NCT01392183|12315580|FG001|STARTED|Second Drug Administration||15
11129732|NCT01392183|12315579|FG000|Treatment Ended: Progression|Second Drug Administration||18
11129733|NCT01392183|12315580|FG001|Treatment Ended: Progression|Second Drug Administration||11
11129734|NCT01392183|12315579|FG000|Treatment Ended: Adverse Events|Second Drug Administration||1
11129735|NCT01392183|12315580|FG001|Treatment Ended: Adverse Events|Second Drug Administration||2
11129736|NCT01392183|12315579|FG000|Treatment Ended: Participant Withdrew|Second Drug Administration||2
11129737|NCT01392183|12315580|FG001|Treatment Ended: Participant Withdrew|Second Drug Administration||1
11129738|NCT01392183|12315579|FG000|Treatment Ended: Death|Second Drug Administration||0
11129739|NCT01392183|12315580|FG001|Treatment Ended: Death|Second Drug Administration||1
11239849|NCT02084082|12432016|FG003|COMPLETED|Treatment Period 1 (4 Days)||8
11239850|NCT02084082|12432013|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11239851|NCT02084082|12432014|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11129740|NCT01392183|12315579|FG000|COMPLETED|Second Drug Administration||21
11129741|NCT01392183|12315580|FG001|COMPLETED|Second Drug Administration||15
11129742|NCT01392183|12315579|FG000|NOT COMPLETED|Second Drug Administration||0
11239852|NCT02084082|12432015|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11239853|NCT02084082|12432016|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11239854|NCT02084082|12432013|FG000|STARTED|Washout Period 1 (35 Days)||26
11129743|NCT01392183|12315580|FG001|NOT COMPLETED|Second Drug Administration||0
11129744|NCT01392300|12315590|FG000|STARTED|Main Period (MP)||210
11129745|NCT01392300|12315591|FG001|STARTED|Main Period (MP)||107
11129746|NCT01392300|12315592|FG002|STARTED|Main Period (MP)||0
11129747|NCT01392300|12315590|FG000|COMPLETED|Main Period (MP)||199
11129748|NCT01392300|12315591|FG001|COMPLETED|Main Period (MP)||100
11129749|NCT01392300|12315592|FG002|COMPLETED|Main Period (MP)||0
11129750|NCT01392300|12315590|FG000|NOT COMPLETED|Main Period (MP)||11
11129751|NCT01392300|12315591|FG001|NOT COMPLETED|Main Period (MP)||7
11129752|NCT01392300|12315592|FG002|NOT COMPLETED|Main Period (MP)||0
11129753|NCT01392300|12315590|FG000|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
11129754|NCT01392300|12315591|FG001|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
11129755|NCT01392300|12315592|FG002|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
11129756|NCT01392300|12315590|FG000|COMPLETED|Open Label Extension (OLEX) Period||0
11129757|NCT01392300|12315591|FG001|COMPLETED|Open Label Extension (OLEX) Period||0
11129758|NCT01392300|12315592|FG002|COMPLETED|Open Label Extension (OLEX) Period||248
11129759|NCT01392300|12315590|FG000|NOT COMPLETED|Open Label Extension (OLEX) Period||0
11129760|NCT01392300|12315591|FG001|NOT COMPLETED|Open Label Extension (OLEX) Period||0
11129761|NCT01392300|12315592|FG002|NOT COMPLETED|Open Label Extension (OLEX) Period||51
11129762|NCT01392326|12315602|FG000|STARTED|Overall Study||202
11129763|NCT01392326|12315603|FG001|STARTED|Overall Study||202
11129764|NCT01392326|12315604|FG002|STARTED|Overall Study||202
11129765|NCT01392326|12315602|FG000|COMPLETED|Overall Study||155
11129766|NCT01392326|12315603|FG001|COMPLETED|Overall Study||167
11129767|NCT01392326|12315604|FG002|COMPLETED|Overall Study||154
11129768|NCT01392326|12315602|FG000|NOT COMPLETED|Overall Study||47
11129769|NCT01392326|12315603|FG001|NOT COMPLETED|Overall Study||35
11129770|NCT01392326|12315604|FG002|NOT COMPLETED|Overall Study||48
11129771|NCT01392378|12315617|FG000|STARTED|Infant Series||173
11129772|NCT01392378|12315618|FG001|STARTED|Infant Series||176
11129773|NCT01392378|12315619|FG002|STARTED|Infant Series||172
11129774|NCT01392378|12315620|FG003|STARTED|Infant Series||177
11129775|NCT01392378|12315621|FG004|STARTED|Infant Series||210
11129776|NCT01392378|12315617|FG000|Vaccinated Dose 1|Infant Series||173
11129777|NCT01392378|12315618|FG001|Vaccinated Dose 1|Infant Series||176
11129778|NCT01392378|12315619|FG002|Vaccinated Dose 1|Infant Series||172
11129779|NCT01392378|12315620|FG003|Vaccinated Dose 1|Infant Series||177
11129780|NCT01392378|12315621|FG004|Vaccinated Dose 1|Infant Series||210
11129781|NCT01392378|12315617|FG000|Vaccinated Dose 2|Infant Series||171
11129782|NCT01392378|12315618|FG001|Vaccinated Dose 2|Infant Series||174
11129783|NCT01392378|12315619|FG002|Vaccinated Dose 2|Infant Series||172
11129784|NCT01392378|12315620|FG003|Vaccinated Dose 2|Infant Series||177
11129785|NCT01392378|12315621|FG004|Vaccinated Dose 2|Infant Series||210
11129786|NCT01392378|12315617|FG000|Vaccinated Dose 3|Infant Series||170
11129787|NCT01392378|12315618|FG001|Vaccinated Dose 3|Infant Series||174
11129788|NCT01392378|12315619|FG002|Vaccinated Dose 3|Infant Series||172
11129789|NCT01392378|12315620|FG003|Vaccinated Dose 3|Infant Series||176
11129790|NCT01392378|12315621|FG004|Vaccinated Dose 3|Infant Series||210
11129791|NCT01392378|12315617|FG000|COMPLETED|Infant Series||169
11129792|NCT01392378|12315618|FG001|COMPLETED|Infant Series||174
11129793|NCT01392378|12315619|FG002|COMPLETED|Infant Series||172
11129794|NCT01392378|12315620|FG003|COMPLETED|Infant Series||175
11129795|NCT01392378|12315621|FG004|COMPLETED|Infant Series||210
11129796|NCT01392378|12315617|FG000|NOT COMPLETED|Infant Series||4
11129797|NCT01392378|12315618|FG001|NOT COMPLETED|Infant Series||2
11129798|NCT01392378|12315619|FG002|NOT COMPLETED|Infant Series||0
11129799|NCT01392378|12315620|FG003|NOT COMPLETED|Infant Series||2
11129800|NCT01392378|12315621|FG004|NOT COMPLETED|Infant Series||0
11129801|NCT01392378|12315617|FG000|STARTED|After Infant Series||169
11129802|NCT01392378|12315618|FG001|STARTED|After Infant Series||174
11129803|NCT01392378|12315619|FG002|STARTED|After Infant Series||172
11129804|NCT01392378|12315620|FG003|STARTED|After Infant Series||175
11129805|NCT01392378|12315621|FG004|STARTED|After Infant Series||210
11129806|NCT01392378|12315617|FG000|COMPLETED|After Infant Series||169
11129807|NCT01392378|12315618|FG001|COMPLETED|After Infant Series||173
11129808|NCT01392378|12315619|FG002|COMPLETED|After Infant Series||170
11129809|NCT01392378|12315620|FG003|COMPLETED|After Infant Series||175
11129810|NCT01392378|12315621|FG004|COMPLETED|After Infant Series||209
11129811|NCT01392378|12315617|FG000|NOT COMPLETED|After Infant Series||0
11129812|NCT01392378|12315618|FG001|NOT COMPLETED|After Infant Series||1
11129813|NCT01392378|12315619|FG002|NOT COMPLETED|After Infant Series||2
11129814|NCT01392378|12315620|FG003|NOT COMPLETED|After Infant Series||0
11129815|NCT01392378|12315621|FG004|NOT COMPLETED|After Infant Series||1
11239855|NCT02084082|12432014|FG001|STARTED|Washout Period 1 (35 Days)||26
11239856|NCT02084082|12432015|FG002|STARTED|Washout Period 1 (35 Days)||8
11129816|NCT01392378|12315617|FG000|STARTED|Toddler Dose||169
11129817|NCT01392378|12315618|FG001|STARTED|Toddler Dose||173
11129818|NCT01392378|12315619|FG002|STARTED|Toddler Dose||170
11129819|NCT01392378|12315620|FG003|STARTED|Toddler Dose||175
11129820|NCT01392378|12315621|FG004|STARTED|Toddler Dose||209
11129821|NCT01392378|12315617|FG000|COMPLETED|Toddler Dose||169
11129822|NCT01392378|12315618|FG001|COMPLETED|Toddler Dose||172
11239857|NCT02084082|12432016|FG003|STARTED|Washout Period 1 (35 Days)||8
11239858|NCT02084082|12432013|FG000|COMPLETED|Washout Period 1 (35 Days)||26
11239859|NCT02084082|12432014|FG001|COMPLETED|Washout Period 1 (35 Days)||26
11129823|NCT01392378|12315619|FG002|COMPLETED|Toddler Dose||170
11129824|NCT01392378|12315620|FG003|COMPLETED|Toddler Dose||173
11129825|NCT01392378|12315621|FG004|COMPLETED|Toddler Dose||208
11129826|NCT01392378|12315617|FG000|NOT COMPLETED|Toddler Dose||0
11129827|NCT01392378|12315618|FG001|NOT COMPLETED|Toddler Dose||1
11129828|NCT01392378|12315619|FG002|NOT COMPLETED|Toddler Dose||0
11129829|NCT01392378|12315620|FG003|NOT COMPLETED|Toddler Dose||2
11129830|NCT01392378|12315621|FG004|NOT COMPLETED|Toddler Dose||1
11129831|NCT01392443|12315643|FG000|STARTED|Overall Study||120
11129832|NCT01392443|12315643|FG000|COMPLETED|Overall Study||52
11129833|NCT01392443|12315643|FG000|NOT COMPLETED|Overall Study||68
11129834|NCT01392469|12315647|FG000|STARTED|Overall Study||21
11129835|NCT01392469|12315647|FG000|COMPLETED|Overall Study||17
11129836|NCT01392469|12315647|FG000|NOT COMPLETED|Overall Study||4
11129837|NCT01392495|12315662|FG000|STARTED|Overall Study||17
11129838|NCT01392495|12315662|FG000|Received 200 mg|Overall Study||4
11129839|NCT01392495|12315662|FG000|Received 400 mg|Overall Study||13
11129840|NCT01392495|12315662|FG000|COMPLETED|Overall Study||1
11129841|NCT01392495|12315662|FG000|NOT COMPLETED|Overall Study||16
11129842|NCT01392547|12315668|FG000|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
11129843|NCT01392547|12315668|FG000|COMPLETED|Overall Study||64
11129844|NCT01392547|12315668|FG000|NOT COMPLETED|Overall Study||8
11129845|NCT01392560|12315674|FG000|STARTED|Overall Study||52
11129846|NCT01392560|12315674|FG000|COMPLETED|Overall Study||40
11129847|NCT01392560|12315674|FG000|NOT COMPLETED|Overall Study||12
11129848|NCT01392573|12315682|FG000|STARTED|Overall Study||207
11129849|NCT01392573|12315683|FG001|STARTED|Overall Study||206
11129850|NCT01392573|12315682|FG000|Exposed|Overall Study||207
11129851|NCT01392573|12315683|FG001|Exposed|Overall Study||206
11129852|NCT01392573|12315682|FG000|COMPLETED|Overall Study||175
11129853|NCT01392573|12315683|FG001|COMPLETED|Overall Study||171
11129854|NCT01392573|12315682|FG000|NOT COMPLETED|Overall Study||32
11129855|NCT01392573|12315683|FG001|NOT COMPLETED|Overall Study||35
11129856|NCT01392625|12315691|FG000|STARTED|Overall Study||18
11129857|NCT01392625|12315692|FG001|STARTED|Overall Study||19
11129858|NCT01392625|12315691|FG000|COMPLETED|Overall Study||16
11129859|NCT01392625|12315692|FG001|COMPLETED|Overall Study||18
11129860|NCT01392625|12315691|FG000|NOT COMPLETED|Overall Study||2
11129861|NCT01392625|12315692|FG001|NOT COMPLETED|Overall Study||1
11239860|NCT02084082|12432015|FG002|COMPLETED|Washout Period 1 (35 Days)||7
11005143|NCT00721279|12182816|FG000|STARTED|Overall Study||452
11005144|NCT00721279|12182817|FG001|STARTED|Overall Study||97
11005145|NCT00721279|12182816|FG000|COMPLETED|Overall Study||416
11005146|NCT00721279|12182817|FG001|COMPLETED|Overall Study||73
11129862|NCT01392677|12315700|FG000|STARTED|Overall Study||109
11129863|NCT01392677|12315701|FG001|STARTED|Overall Study||109
11129864|NCT01392677|12315700|FG000|COMPLETED|Overall Study||101
11129865|NCT01392677|12315701|FG001|COMPLETED|Overall Study||101
11129866|NCT01392677|12315700|FG000|NOT COMPLETED|Overall Study||8
11129867|NCT01392677|12315701|FG001|NOT COMPLETED|Overall Study||8
11129868|NCT01392703|12315707|FG000|STARTED|Day 1||26
11129869|NCT01392703|12315708|FG001|STARTED|Day 1||26
11129870|NCT01392703|12315709|FG002|STARTED|Day 1||26
11129871|NCT01392703|12315707|FG000|COMPLETED|Day 1||26
11129872|NCT01392703|12315708|FG001|COMPLETED|Day 1||26
11129873|NCT01392703|12315709|FG002|COMPLETED|Day 1||26
11129874|NCT01392703|12315707|FG000|NOT COMPLETED|Day 1||0
11129875|NCT01392703|12315708|FG001|NOT COMPLETED|Day 1||0
11129876|NCT01392703|12315709|FG002|NOT COMPLETED|Day 1||0
11129877|NCT01392703|12315707|FG000|STARTED|Day 5||26
11129878|NCT01392703|12315708|FG001|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
11129879|NCT01392703|12315709|FG002|STARTED|Day 5||26
11129880|NCT01392703|12315707|FG000|COMPLETED|Day 5||26
11129881|NCT01392703|12315708|FG001|COMPLETED|Day 5||25
11005147|NCT00721279|12182816|FG000|NOT COMPLETED|Overall Study||36
11005148|NCT00721279|12182817|FG001|NOT COMPLETED|Overall Study||24
11005149|NCT00721357|12182826|FG000|STARTED|Overall Study||15
11005150|NCT00721357|12182827|FG001|STARTED|Overall Study||15
11129882|NCT01392703|12315709|FG002|COMPLETED|Day 5||26
11129883|NCT01392703|12315707|FG000|NOT COMPLETED|Day 5||0
11129884|NCT01392703|12315708|FG001|NOT COMPLETED|Day 5||0
11129885|NCT01392703|12315709|FG002|NOT COMPLETED|Day 5||0
11129886|NCT01392703|12315707|FG000|STARTED|Day 9||26
11129887|NCT01392703|12315708|FG001|STARTED|Day 9||26
11129888|NCT01392703|12315709|FG002|STARTED|Day 9||25
11129889|NCT01392703|12315707|FG000|COMPLETED|Day 9||26
11129890|NCT01392703|12315708|FG001|COMPLETED|Day 9||26
11129891|NCT01392703|12315709|FG002|COMPLETED|Day 9||25
11129892|NCT01392703|12315707|FG000|NOT COMPLETED|Day 9||0
11129893|NCT01392703|12315708|FG001|NOT COMPLETED|Day 9||0
11129894|NCT01392703|12315709|FG002|NOT COMPLETED|Day 9||0
11129895|NCT01392742|12315719|FG000|STARTED|Overall Study||443
11129896|NCT01392742|12315719|FG000|COMPLETED|Overall Study||242
11129897|NCT01392742|12315719|FG000|NOT COMPLETED|Overall Study||201
11129898|NCT01392859|12315723|FG000|STARTED|Overall Study||15
11129899|NCT01392859|12315724|FG001|STARTED|Overall Study||13
11129900|NCT01392859|12315725|FG002|STARTED|Overall Study||183
11129901|NCT01392859|12315723|FG000|Wash Out 3-7 Days|Overall Study||15
11129902|NCT01392859|12315724|FG001|Wash Out 3-7 Days|Overall Study||13
11129903|NCT01392859|12315725|FG002|Wash Out 3-7 Days|Overall Study||0
11129904|NCT01392859|12315723|FG000|COMPLETED|Overall Study||13
11129905|NCT01392859|12315724|FG001|COMPLETED|Overall Study||13
11129906|NCT01392859|12315725|FG002|COMPLETED|Overall Study||183
11129907|NCT01392859|12315723|FG000|NOT COMPLETED|Overall Study||2
11129908|NCT01392859|12315724|FG001|NOT COMPLETED|Overall Study||0
11129909|NCT01392859|12315725|FG002|NOT COMPLETED|Overall Study||0
11129910|NCT01392963|12315733|FG000|STARTED|Week 0 (First Intervention)||11
11129911|NCT01392963|12315734|FG001|STARTED|Week 0 (First Intervention)||19
11129912|NCT01392963|12315733|FG000|COMPLETED|Week 0 (First Intervention)||11
11129913|NCT01392963|12315734|FG001|COMPLETED|Week 0 (First Intervention)||17
11129914|NCT01392963|12315733|FG000|NOT COMPLETED|Week 0 (First Intervention)||0
11129915|NCT01392963|12315734|FG001|NOT COMPLETED|Week 0 (First Intervention)||2
11129916|NCT01392963|12315733|FG000|STARTED|Week 12 (Second Intervention)||11
11129917|NCT01392963|12315734|FG001|STARTED|Week 12 (Second Intervention)||17
11129918|NCT01392963|12315733|FG000|COMPLETED|Week 12 (Second Intervention)||11
11129919|NCT01392963|12315734|FG001|COMPLETED|Week 12 (Second Intervention)||17
11129920|NCT01392963|12315733|FG000|NOT COMPLETED|Week 12 (Second Intervention)||0
11129921|NCT01392963|12315734|FG001|NOT COMPLETED|Week 12 (Second Intervention)||0
11129922|NCT01392963|12315733|FG000|STARTED|Week 24 Follow-up||11
11129923|NCT01392963|12315734|FG001|STARTED|Week 24 Follow-up||17
11129924|NCT01392963|12315733|FG000|COMPLETED|Week 24 Follow-up||9
11129925|NCT01392963|12315734|FG001|COMPLETED|Week 24 Follow-up||17
11129926|NCT01392963|12315733|FG000|NOT COMPLETED|Week 24 Follow-up||2
11129927|NCT01392963|12315734|FG001|NOT COMPLETED|Week 24 Follow-up||0
11129928|NCT01392989|12315742|FG000|STARTED|Total Lymphoid Irradiation (TLI)||44
11129929|NCT01392989|12315742|FG000|COMPLETED|Total Lymphoid Irradiation (TLI)||44
11129930|NCT01392989|12315742|FG000|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0
11129931|NCT01392989|12315742|FG000|STARTED|CIK Cell Infusion||31
11129932|NCT01392989|12315742|FG000|COMPLETED|CIK Cell Infusion||31
11129933|NCT01392989|12315742|FG000|NOT COMPLETED|CIK Cell Infusion||0
11129934|NCT01393106|12315747|FG000|STARTED|Overall Study||25
11129935|NCT01393106|12315747|FG000|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
11129936|NCT01393106|12315747|FG000|NOT COMPLETED|Overall Study||5
11129937|NCT01393132|12315753|FG000|STARTED|Overall Study||6
11129938|NCT01393132|12315754|FG001|STARTED|Overall Study||3
11129939|NCT01393132|12315753|FG000|COMPLETED|Overall Study||6
11129940|NCT01393132|12315754|FG001|COMPLETED|Overall Study||3
11129941|NCT01393132|12315753|FG000|NOT COMPLETED|Overall Study||0
11129942|NCT01393132|12315754|FG001|NOT COMPLETED|Overall Study||0
11129943|NCT01393158|12315764|FG000|STARTED|Overall Study||6
11129944|NCT01393158|12315765|FG001|STARTED|Overall Study||10
11129945|NCT01393158|12315764|FG000|COMPLETED|Overall Study||5
11129946|NCT01393158|12315765|FG001|COMPLETED|Overall Study||10
11129947|NCT01393158|12315764|FG000|NOT COMPLETED|Overall Study||1
11129948|NCT01393158|12315765|FG001|NOT COMPLETED|Overall Study||0
11129949|NCT01393301|12315779|FG000|STARTED|Overall Study||26
11129950|NCT01393301|12315780|FG001|STARTED|Overall Study||27
11129951|NCT01393301|12315779|FG000|COMPLETED|Overall Study||17
11129952|NCT01393301|12315780|FG001|COMPLETED|Overall Study||24
11129953|NCT01393301|12315779|FG000|NOT COMPLETED|Overall Study||9
11129954|NCT01393301|12315780|FG001|NOT COMPLETED|Overall Study||3
11129955|NCT01393392|12315788|FG000|STARTED|Overall Study||44
11129956|NCT01393392|12315789|FG001|STARTED|Overall Study||43
11129957|NCT01393392|12315788|FG000|COMPLETED|Overall Study||33
11129958|NCT01393392|12315789|FG001|COMPLETED|Overall Study||24
11129959|NCT01393392|12315788|FG000|NOT COMPLETED|Overall Study||11
11129960|NCT01393392|12315789|FG001|NOT COMPLETED|Overall Study||19
11129961|NCT01393405|12315795|FG000|STARTED|Induction Period (week1-16)||179
11129962|NCT01393405|12315796|FG001|STARTED|Induction Period (week1-16)||0
11129963|NCT01393405|12315797|FG002|STARTED|Induction Period (week1-16)||0
11129964|NCT01393405|12315795|FG000|COMPLETED|Induction Period (week1-16)||84
11239861|NCT02084082|12432016|FG003|COMPLETED|Washout Period 1 (35 Days)||6
11239862|NCT02084082|12432013|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||0
11239863|NCT02084082|12432014|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0
11239864|NCT02084082|12432015|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||1
11239865|NCT02084082|12432016|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||2
11239866|NCT02084082|12432013|FG000|STARTED|Treatment Period 2 (4 Days)||26
11239867|NCT02084082|12432014|FG001|STARTED|Treatment Period 2 (4 Days)||26
11239868|NCT02084082|12432015|FG002|STARTED|Treatment Period 2 (4 Days)||7
11239869|NCT02084082|12432016|FG003|STARTED|Treatment Period 2 (4 Days)||6
11239870|NCT02084082|12432013|FG000|COMPLETED|Treatment Period 2 (4 Days)||26
11239871|NCT02084082|12432014|FG001|COMPLETED|Treatment Period 2 (4 Days)||26
11239872|NCT02084082|12432015|FG002|COMPLETED|Treatment Period 2 (4 Days)||7
11239873|NCT02084082|12432016|FG003|COMPLETED|Treatment Period 2 (4 Days)||6
11239874|NCT02084082|12432013|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11239875|NCT02084082|12432014|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11239876|NCT02084082|12432015|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11239877|NCT02084082|12432016|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11239878|NCT02084134|12432028|FG000|STARTED|Overall Study||23
11239879|NCT02084134|12432029|FG001|STARTED|Overall Study||20
11239880|NCT02084134|12432028|FG000|COMPLETED|Overall Study||19
11239881|NCT02084134|12432029|FG001|COMPLETED|Overall Study||17
11239882|NCT02084134|12432028|FG000|NOT COMPLETED|Overall Study||4
11239883|NCT02084134|12432029|FG001|NOT COMPLETED|Overall Study||3
11239884|NCT02084160|12432035|FG000|STARTED|Overall Study||579
11239885|NCT02084160|12432035|FG000|COMPLETED|Overall Study||579
11239886|NCT02084160|12432035|FG000|NOT COMPLETED|Overall Study||0
11239887|NCT02084238|12432039|FG000|STARTED|Overall Study||40
11239888|NCT02084238|12432039|FG000|COMPLETED|Overall Study||38
11239889|NCT02084238|12432039|FG000|NOT COMPLETED|Overall Study||2
11239890|NCT02084511|12432054|FG000|STARTED|Overall Study||20
11239891|NCT02084511|12432055|FG001|STARTED|Overall Study||20
11239892|NCT02084511|12432056|FG002|STARTED|Overall Study||20
11239893|NCT02084511|12432057|FG003|STARTED|Overall Study||20
11239894|NCT02084511|12432054|FG000|COMPLETED|Overall Study||20
11239895|NCT02084511|12432055|FG001|COMPLETED|Overall Study||20
11239896|NCT02084511|12432056|FG002|COMPLETED|Overall Study||20
11239897|NCT02084511|12432057|FG003|COMPLETED|Overall Study||20
11239898|NCT02084511|12432054|FG000|NOT COMPLETED|Overall Study||0
11239899|NCT02084511|12432055|FG001|NOT COMPLETED|Overall Study||0
11239900|NCT02084511|12432056|FG002|NOT COMPLETED|Overall Study||0
11239901|NCT02084511|12432057|FG003|NOT COMPLETED|Overall Study||0
11239902|NCT02084628|12432067|FG000|STARTED|Overall Study||1
11239903|NCT02084628|12432067|FG000|COMPLETED|Overall Study||1
11239904|NCT02084628|12432067|FG000|NOT COMPLETED|Overall Study||0
11239905|NCT02084706|12432073|FG000|STARTED|Overall Study||29
11239906|NCT02084706|12432074|FG001|STARTED|Overall Study||31
11239907|NCT02084706|12432073|FG000|COMPLETED|Overall Study||29
11239908|NCT02084706|12432074|FG001|COMPLETED|Overall Study||31
11239909|NCT02084706|12432073|FG000|NOT COMPLETED|Overall Study||0
11239910|NCT02084706|12432074|FG001|NOT COMPLETED|Overall Study||0
11239911|NCT02084797|12432080|FG000|STARTED|Overall Study||10
11239912|NCT02084797|12432080|FG000|COMPLETED|Overall Study||10
11239913|NCT02084797|12432080|FG000|NOT COMPLETED|Overall Study||0
11239914|NCT02085070|12432086|FG000|STARTED|Overall Study||23
11239915|NCT02085070|12432087|FG001|STARTED|Overall Study||42
11239916|NCT02085070|12432086|FG000|COMPLETED|Overall Study||23
11239917|NCT02085070|12432087|FG001|COMPLETED|Overall Study||42
11239918|NCT02085070|12432086|FG000|NOT COMPLETED|Overall Study||0
11239919|NCT02085070|12432087|FG001|NOT COMPLETED|Overall Study||0
11239920|NCT02085135|12432095|FG000|STARTED|Overall Study||34
11239921|NCT02085135|12432096|FG001|STARTED|Overall Study||32
11239922|NCT02085135|12432095|FG000|COMPLETED|Overall Study||23
11239923|NCT02085135|12432096|FG001|COMPLETED|Overall Study||23
11239924|NCT02085135|12432095|FG000|NOT COMPLETED|Overall Study||11
11239925|NCT02085135|12432096|FG001|NOT COMPLETED|Overall Study||9
11239926|NCT02085161|12432106|FG000|STARTED|Overall Study||76
11239927|NCT02085161|12432107|FG001|STARTED|Overall Study||76
11239928|NCT02085161|12432108|FG002|STARTED|Overall Study||76
11239929|NCT02085161|12432109|FG003|STARTED|Overall Study||76
11239930|NCT02085161|12432106|FG000|COMPLETED|Overall Study||64
11239931|NCT02085161|12432107|FG001|COMPLETED|Overall Study||66
11239932|NCT02085161|12432108|FG002|COMPLETED|Overall Study||71
11239933|NCT02085161|12432109|FG003|COMPLETED|Overall Study||66
11239934|NCT02085161|12432106|FG000|NOT COMPLETED|Overall Study||12
11129965|NCT01393405|12315796|FG001|COMPLETED|Induction Period (week1-16)||0
11129966|NCT01393405|12315797|FG002|COMPLETED|Induction Period (week1-16)||0
11239935|NCT02085161|12432107|FG001|NOT COMPLETED|Overall Study||10
11239936|NCT02085161|12432108|FG002|NOT COMPLETED|Overall Study||5
11239937|NCT02085161|12432109|FG003|NOT COMPLETED|Overall Study||10
11239938|NCT02085252|12432122|FG000|STARTED|Overall Study||58
11129967|NCT01393405|12315795|FG000|NOT COMPLETED|Induction Period (week1-16)||95
11129968|NCT01393405|12315796|FG001|NOT COMPLETED|Induction Period (week1-16)||0
11239939|NCT02085252|12432123|FG001|STARTED|Overall Study||57
11239940|NCT02085252|12432122|FG000|COMPLETED|Overall Study||57
11239941|NCT02085252|12432123|FG001|COMPLETED|Overall Study||53
11239942|NCT02085252|12432122|FG000|NOT COMPLETED|Overall Study||1
11239943|NCT02085252|12432123|FG001|NOT COMPLETED|Overall Study||4
11239944|NCT02085356|12432133|FG000|STARTED|Overall Study||577
11239945|NCT02085356|12432134|FG001|STARTED|Overall Study||348
11358082|NCT03119649|12555104|FG001|NOT COMPLETED|Overall Study||0
11358083|NCT03119649|12555105|FG002|NOT COMPLETED|Overall Study||0
11358084|NCT03119649|12555106|FG003|NOT COMPLETED|Overall Study||0
11358085|NCT03119649|12555107|FG004|NOT COMPLETED|Overall Study||0
11129969|NCT01393405|12315797|FG002|NOT COMPLETED|Induction Period (week1-16)||0
11129970|NCT01393405|12315795|FG000|STARTED|Maintenance Period Week||0
11129971|NCT01393405|12315796|FG001|STARTED|Maintenance Period Week||44
11129972|NCT01393405|12315797|FG002|STARTED|Maintenance Period Week||40
11129973|NCT01393405|12315795|FG000|COMPLETED|Maintenance Period Week||0
11129974|NCT01393405|12315796|FG001|COMPLETED|Maintenance Period Week||15
11129975|NCT01393405|12315797|FG002|COMPLETED|Maintenance Period Week||16
11129976|NCT01393405|12315795|FG000|NOT COMPLETED|Maintenance Period Week||0
11129977|NCT01393405|12315796|FG001|NOT COMPLETED|Maintenance Period Week||29
11129978|NCT01393405|12315797|FG002|NOT COMPLETED|Maintenance Period Week||24
11129979|NCT01393444|12315807|FG000|STARTED|Overall Study||6
11129980|NCT01393444|12315807|FG000|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
11129981|NCT01393444|12315807|FG000|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
11129982|NCT01393444|12315807|FG000|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
11129983|NCT01393444|12315807|FG000|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
11129984|NCT01393444|12315807|FG000|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
11129985|NCT01393444|12315807|FG000|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
11129986|NCT01393444|12315807|FG000|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
11129987|NCT01393444|12315807|FG000|NOT COMPLETED|Overall Study||3
11129988|NCT01393457|12315815|FG000|STARTED|Overall Study||26
11129989|NCT01393457|12315816|FG001|STARTED|Overall Study||26
11129990|NCT01393457|12315817|FG002|STARTED|Overall Study||31
11129991|NCT01393457|12315818|FG003|STARTED|Overall Study||27
11129992|NCT01393457|12315815|FG000|COMPLETED|Overall Study||14
11129993|NCT01393457|12315816|FG001|COMPLETED|Overall Study||14
11129994|NCT01393457|12315817|FG002|COMPLETED|Overall Study||16
11129995|NCT01393457|12315818|FG003|COMPLETED|Overall Study||15
11129996|NCT01393457|12315815|FG000|NOT COMPLETED|Overall Study||12
11129997|NCT01393457|12315816|FG001|NOT COMPLETED|Overall Study||12
11129998|NCT01393457|12315817|FG002|NOT COMPLETED|Overall Study||15
11129999|NCT01393457|12315818|FG003|NOT COMPLETED|Overall Study||12
11130000|NCT01393600|12315828|FG000|STARTED|Treatment Period 1 (Day 1 to 14)||9
11130001|NCT01393600|12315829|FG001|STARTED|Treatment Period 1 (Day 1 to 14)||8
11130002|NCT01393600|12315830|FG002|STARTED|Treatment Period 1 (Day 1 to 14)||10
11130003|NCT01393600|12315831|FG003|STARTED|Treatment Period 1 (Day 1 to 14)||10
11130004|NCT01393600|12315828|FG000|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
11130005|NCT01393600|12315829|FG001|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
11130006|NCT01393600|12315830|FG002|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
11130007|NCT01393600|12315831|FG003|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
11130008|NCT01393600|12315828|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
11130009|NCT01393600|12315829|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
11130010|NCT01393600|12315830|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
11130011|NCT01393600|12315831|FG003|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
11130012|NCT01393600|12315828|FG000|STARTED|Treatment Period 2 (Day 15 to 28)||9
11130013|NCT01393600|12315829|FG001|STARTED|Treatment Period 2 (Day 15 to 28)||7
11130014|NCT01393600|12315830|FG002|STARTED|Treatment Period 2 (Day 15 to 28)||9
11130015|NCT01393600|12315831|FG003|STARTED|Treatment Period 2 (Day 15 to 28)||9
11130016|NCT01393600|12315828|FG000|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
11130017|NCT01393600|12315829|FG001|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
11130018|NCT01393600|12315830|FG002|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
11130019|NCT01393600|12315831|FG003|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
11130020|NCT01393600|12315828|FG000|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
11130021|NCT01393600|12315829|FG001|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
11130022|NCT01393600|12315830|FG002|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
11239946|NCT02085356|12432135|FG002|STARTED|Overall Study||681
11239947|NCT02085356|12432136|FG003|STARTED|Overall Study||361
11358086|NCT03119688|12555123|FG000|STARTED|Overall Study||48
11358087|NCT03119688|12555123|FG000|COMPLETED|Overall Study||44
11358088|NCT03119688|12555123|FG000|NOT COMPLETED|Overall Study||4
11358089|NCT03119701|12555142|FG000|STARTED|6-day Dosing||29
11130023|NCT01393600|12315831|FG003|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
11130024|NCT01393600|12315828|FG000|STARTED|Follow-up Period (Day 29 to 35)||9
11130025|NCT01393600|12315829|FG001|STARTED|Follow-up Period (Day 29 to 35)||7
11130026|NCT01393600|12315830|FG002|STARTED|Follow-up Period (Day 29 to 35)||7
11130027|NCT01393600|12315831|FG003|STARTED|Follow-up Period (Day 29 to 35)||8
11130028|NCT01393600|12315828|FG000|COMPLETED|Follow-up Period (Day 29 to 35)||9
11130029|NCT01393600|12315829|FG001|COMPLETED|Follow-up Period (Day 29 to 35)||7
11130030|NCT01393600|12315830|FG002|COMPLETED|Follow-up Period (Day 29 to 35)||6
11130031|NCT01393600|12315831|FG003|COMPLETED|Follow-up Period (Day 29 to 35)||8
11130032|NCT01393600|12315828|FG000|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
11130033|NCT01393600|12315829|FG001|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
11130034|NCT01393600|12315830|FG002|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
11130035|NCT01393600|12315831|FG003|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
11130036|NCT01393613|12315847|FG000|STARTED|Overall Study||120
11130037|NCT01393613|12315848|FG001|STARTED|Overall Study||186
11130038|NCT01393613|12315849|FG002|STARTED|Overall Study||184
11130039|NCT01393613|12315850|FG003|STARTED|Overall Study||184
11130040|NCT01393613|12315847|FG000|COMPLETED|Overall Study||81
11130041|NCT01393613|12315848|FG001|COMPLETED|Overall Study||129
11130042|NCT01393613|12315849|FG002|COMPLETED|Overall Study||130
11130043|NCT01393613|12315850|FG003|COMPLETED|Overall Study||118
11130044|NCT01393613|12315847|FG000|NOT COMPLETED|Overall Study||39
11130045|NCT01393613|12315848|FG001|NOT COMPLETED|Overall Study||57
11130046|NCT01393613|12315849|FG002|NOT COMPLETED|Overall Study||54
11130047|NCT01393613|12315850|FG003|NOT COMPLETED|Overall Study||66
11130048|NCT01393626|12315866|FG000|STARTED|Overall Study||91
11130049|NCT01393626|12315867|FG001|STARTED|Overall Study||86
11130050|NCT01393626|12315868|FG002|STARTED|Overall Study||86
11130051|NCT01393626|12315869|FG003|STARTED|Overall Study||16
11130052|NCT01393626|12315866|FG000|COMPLETED|Overall Study||73
11130053|NCT01393626|12315867|FG001|COMPLETED|Overall Study||74
11130054|NCT01393626|12315868|FG002|COMPLETED|Overall Study||74
11130055|NCT01393626|12315869|FG003|COMPLETED|Overall Study||15
11130056|NCT01393626|12315866|FG000|NOT COMPLETED|Overall Study||18
11130057|NCT01393626|12315867|FG001|NOT COMPLETED|Overall Study||12
11130058|NCT01393626|12315868|FG002|NOT COMPLETED|Overall Study||12
11130059|NCT01393626|12315869|FG003|NOT COMPLETED|Overall Study||1
11130060|NCT01393704|12315888|FG000|STARTED|Overall Study||76
11130061|NCT01393704|12315889|FG001|STARTED|Overall Study||76
11130062|NCT01393704|12315888|FG000|COMPLETED|Overall Study||76
11130063|NCT01393704|12315889|FG001|COMPLETED|Overall Study||76
11130064|NCT01393704|12315888|FG000|NOT COMPLETED|Overall Study||0
11130065|NCT01393704|12315889|FG001|NOT COMPLETED|Overall Study||0
11130066|NCT01393717|12315895|FG000|STARTED|Overall Study||37
11130067|NCT01393717|12315896|FG001|STARTED|Overall Study||20
11130068|NCT01393717|12315895|FG000|COMPLETED|Overall Study||37
11239948|NCT02085356|12432133|FG000|COMPLETED|Overall Study||577
11239949|NCT02085356|12432134|FG001|COMPLETED|Overall Study||348
11239950|NCT02085356|12432135|FG002|COMPLETED|Overall Study||681
11239951|NCT02085356|12432136|FG003|COMPLETED|Overall Study||361
11239952|NCT02085356|12432133|FG000|NOT COMPLETED|Overall Study||0
11239953|NCT02085356|12432134|FG001|NOT COMPLETED|Overall Study||0
11130069|NCT01393717|12315896|FG001|COMPLETED|Overall Study||20
11130070|NCT01393717|12315895|FG000|NOT COMPLETED|Overall Study||0
11130071|NCT01393717|12315896|FG001|NOT COMPLETED|Overall Study||0
11130072|NCT01393730|12315906|FG000|STARTED|Overall Study||40
11130073|NCT01393730|12315906|FG000|Treated|Overall Study||38
11130074|NCT01393730|12315906|FG000|Evaluable AR Amplification|Overall Study||21
11130075|NCT01393730|12315906|FG000|Evaluable AR Mutation|Overall Study||14
11130076|NCT01393730|12315906|FG000|COMPLETED|Overall Study||34
11130077|NCT01393730|12315906|FG000|NOT COMPLETED|Overall Study||6
11130078|NCT01393743|12315912|FG000|STARTED|Core Study|Treated|82
11130079|NCT01393743|12315913|FG001|STARTED|Core Study|Treated|81
11130080|NCT01393743|12315914|FG002|STARTED|Core Study||0
11130081|NCT01393743|12315912|FG000|COMPLETED|Core Study||72
11130082|NCT01393743|12315913|FG001|COMPLETED|Core Study||68
11130083|NCT01393743|12315914|FG002|COMPLETED|Core Study||0
11130084|NCT01393743|12315912|FG000|NOT COMPLETED|Core Study||10
11130085|NCT01393743|12315913|FG001|NOT COMPLETED|Core Study||13
11130086|NCT01393743|12315914|FG002|NOT COMPLETED|Core Study||0
11130087|NCT01393743|12315912|FG000|STARTED|Extension Phase||0
11130088|NCT01393743|12315913|FG001|STARTED|Extension Phase||0
11130089|NCT01393743|12315914|FG002|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
11130090|NCT01393743|12315912|FG000|COMPLETED|Extension Phase||0
11130091|NCT01393743|12315913|FG001|COMPLETED|Extension Phase||0
11130092|NCT01393743|12315914|FG002|COMPLETED|Extension Phase||78
11130093|NCT01393743|12315912|FG000|NOT COMPLETED|Extension Phase||0
11130094|NCT01393743|12315913|FG001|NOT COMPLETED|Extension Phase||0
11130095|NCT01393743|12315914|FG002|NOT COMPLETED|Extension Phase||60
11130096|NCT01393821|12315927|FG000|STARTED|Overall Study||14
11130097|NCT01393821|12315928|FG001|STARTED|Overall Study||13
11239954|NCT02085356|12432135|FG002|NOT COMPLETED|Overall Study||0
11239955|NCT02085356|12432136|FG003|NOT COMPLETED|Overall Study||0
11130098|NCT01393821|12315927|FG000|COMPLETED|Overall Study||9
11130099|NCT01393821|12315928|FG001|COMPLETED|Overall Study||10
11130100|NCT01393821|12315927|FG000|NOT COMPLETED|Overall Study||5
11130101|NCT01393821|12315928|FG001|NOT COMPLETED|Overall Study||3
11130102|NCT01393899|12315937|FG000|STARTED|Overall Study||59
11130103|NCT01393899|12315938|FG001|STARTED|Overall Study||60
11130104|NCT01393899|12315939|FG002|STARTED|Overall Study||61
11130105|NCT01393899|12315937|FG000|COMPLETED|Overall Study||27
11130106|NCT01393899|12315938|FG001|COMPLETED|Overall Study||32
11130107|NCT01393899|12315939|FG002|COMPLETED|Overall Study||38
11130108|NCT01393899|12315937|FG000|NOT COMPLETED|Overall Study||32
11130109|NCT01393899|12315938|FG001|NOT COMPLETED|Overall Study||28
11130110|NCT01393899|12315939|FG002|NOT COMPLETED|Overall Study||23
11130111|NCT01393964|12315952|FG000|STARTED|Overall Study||8
11130112|NCT01393964|12315953|FG001|STARTED|Overall Study||9
11130113|NCT01393964|12315954|FG002|STARTED|Overall Study||9
11130114|NCT01393964|12315952|FG000|COMPLETED|Overall Study|Completed=treatment on-going|0
11130115|NCT01393964|12315953|FG001|COMPLETED|Overall Study|Completed=treatment on-going|0
11130116|NCT01393964|12315954|FG002|COMPLETED|Overall Study|Completed=treatment on-going|0
11130117|NCT01393964|12315952|FG000|NOT COMPLETED|Overall Study||8
11130118|NCT01393964|12315953|FG001|NOT COMPLETED|Overall Study||9
11130119|NCT01393964|12315954|FG002|NOT COMPLETED|Overall Study||9
11130120|NCT01393990|12315986|FG000|STARTED|Overall Study||4
11130121|NCT01393990|12315987|FG001|STARTED|Overall Study||3
11130122|NCT01393990|12315988|FG002|STARTED|Overall Study||3
11130123|NCT01393990|12315989|FG003|STARTED|Overall Study||3
11130124|NCT01393990|12315990|FG004|STARTED|Overall Study||5
11130125|NCT01393990|12315991|FG005|STARTED|Overall Study||3
11130126|NCT01393990|12315992|FG006|STARTED|Overall Study||3
11130127|NCT01393990|12315993|FG007|STARTED|Overall Study||7
11130128|NCT01393990|12315994|FG008|STARTED|Overall Study||6
11130129|NCT01393990|12315995|FG009|STARTED|Overall Study||3
11130130|NCT01393990|12315996|FG010|STARTED|Overall Study||3
11130131|NCT01393990|12315997|FG011|STARTED|Overall Study||3
11130132|NCT01393990|12315998|FG012|STARTED|Overall Study||3
11130133|NCT01393990|12315999|FG013|STARTED|Overall Study||5
11130134|NCT01393990|12316000|FG014|STARTED|Overall Study||18
11130135|NCT01393990|12316001|FG015|STARTED|Overall Study||8
11130136|NCT01393990|12316002|FG016|STARTED|Overall Study||3
11130137|NCT01393990|12316003|FG017|STARTED|Overall Study||6
11130138|NCT01393990|12315986|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
11130139|NCT01393990|12315987|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
11130140|NCT01393990|12315988|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
11130141|NCT01393990|12315989|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
11130142|NCT01393990|12315990|FG004|Received at Least 1 Dose of Study Drug|Overall Study||5
11130143|NCT01393990|12315991|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
11130144|NCT01393990|12315992|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
11130145|NCT01393990|12315993|FG007|Received at Least 1 Dose of Study Drug|Overall Study||7
11130146|NCT01393990|12315994|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6
11130147|NCT01393990|12315995|FG009|Received at Least 1 Dose of Study Drug|Overall Study||3
11130148|NCT01393990|12315996|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
11130149|NCT01393990|12315997|FG011|Received at Least 1 Dose of Study Drug|Overall Study||3
11130150|NCT01393990|12315998|FG012|Received at Least 1 Dose of Study Drug|Overall Study||3
11130151|NCT01393990|12315999|FG013|Received at Least 1 Dose of Study Drug|Overall Study||5
11130152|NCT01393990|12316000|FG014|Received at Least 1 Dose of Study Drug|Overall Study||18
11130153|NCT01393990|12316001|FG015|Received at Least 1 Dose of Study Drug|Overall Study||8
11130154|NCT01393990|12316002|FG016|Received at Least 1 Dose of Study Drug|Overall Study||3
11130155|NCT01393990|12316003|FG017|Received at Least 1 Dose of Study Drug|Overall Study||6
11130156|NCT01393990|12315986|FG000|COMPLETED|Overall Study||3
11130157|NCT01393990|12315987|FG001|COMPLETED|Overall Study||3
11130158|NCT01393990|12315988|FG002|COMPLETED|Overall Study||3
11130159|NCT01393990|12315989|FG003|COMPLETED|Overall Study||2
11130160|NCT01393990|12315990|FG004|COMPLETED|Overall Study||3
11130161|NCT01393990|12315991|FG005|COMPLETED|Overall Study||2
11130162|NCT01393990|12315992|FG006|COMPLETED|Overall Study||2
11130163|NCT01393990|12315993|FG007|COMPLETED|Overall Study||6
11130164|NCT01393990|12315994|FG008|COMPLETED|Overall Study||3
11130165|NCT01393990|12315995|FG009|COMPLETED|Overall Study||2
11130166|NCT01393990|12315996|FG010|COMPLETED|Overall Study||3
11130167|NCT01393990|12315997|FG011|COMPLETED|Overall Study||3
11130168|NCT01393990|12315998|FG012|COMPLETED|Overall Study||3
11130169|NCT01393990|12315999|FG013|COMPLETED|Overall Study||3
11130170|NCT01393990|12316000|FG014|COMPLETED|Overall Study||9
11130171|NCT01393990|12316001|FG015|COMPLETED|Overall Study||5
11130172|NCT01393990|12316002|FG016|COMPLETED|Overall Study||3
11130173|NCT01393990|12316003|FG017|COMPLETED|Overall Study||6
11130174|NCT01393990|12315986|FG000|NOT COMPLETED|Overall Study||1
11130175|NCT01393990|12315987|FG001|NOT COMPLETED|Overall Study||0
11130176|NCT01393990|12315988|FG002|NOT COMPLETED|Overall Study||0
11130177|NCT01393990|12315989|FG003|NOT COMPLETED|Overall Study||1
11130178|NCT01393990|12315990|FG004|NOT COMPLETED|Overall Study||2
11130179|NCT01393990|12315991|FG005|NOT COMPLETED|Overall Study||1
11130180|NCT01393990|12315992|FG006|NOT COMPLETED|Overall Study||1
11130181|NCT01393990|12315993|FG007|NOT COMPLETED|Overall Study||1
11130182|NCT01393990|12315994|FG008|NOT COMPLETED|Overall Study||3
11130183|NCT01393990|12315995|FG009|NOT COMPLETED|Overall Study||1
11130184|NCT01393990|12315996|FG010|NOT COMPLETED|Overall Study||0
11130185|NCT01393990|12315997|FG011|NOT COMPLETED|Overall Study||0
11130186|NCT01393990|12315998|FG012|NOT COMPLETED|Overall Study||0
11130187|NCT01393990|12315999|FG013|NOT COMPLETED|Overall Study||2
11130188|NCT01393990|12316000|FG014|NOT COMPLETED|Overall Study||9
11130189|NCT01393990|12316001|FG015|NOT COMPLETED|Overall Study||3
11130190|NCT01393990|12316002|FG016|NOT COMPLETED|Overall Study||0
11130191|NCT01393990|12316003|FG017|NOT COMPLETED|Overall Study||0
11130192|NCT01394003|12316060|FG000|STARTED|Overall Study||3
11130193|NCT01394003|12316061|FG001|STARTED|Overall Study||8
11130194|NCT01394003|12316062|FG002|STARTED|Overall Study||3
11130195|NCT01394003|12316063|FG003|STARTED|Overall Study||6
11130196|NCT01394003|12316064|FG004|STARTED|Overall Study||3
11130197|NCT01394003|12316065|FG005|STARTED|Overall Study||3
11130198|NCT01394003|12316066|FG006|STARTED|Overall Study||6
11130199|NCT01394003|12316067|FG007|STARTED|Overall Study||2
11130200|NCT01394003|12316060|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11130201|NCT01394003|12316061|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
11130202|NCT01394003|12316062|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
11130203|NCT01394003|12316063|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
11130204|NCT01394003|12316064|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
11130205|NCT01394003|12316065|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
11130206|NCT01394003|12316066|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
11239956|NCT02085447|12432146|FG000|STARTED|Overall Study||30
11239957|NCT02085447|12432146|FG000|COMPLETED|Overall Study||26
11239958|NCT02085447|12432146|FG000|NOT COMPLETED|Overall Study||4
11130207|NCT01394003|12316067|FG007|Received at Least 1 Dose of Study Drug|Overall Study||2
11130208|NCT01394003|12316060|FG000|COMPLETED|Overall Study||3
11130209|NCT01394003|12316061|FG001|COMPLETED|Overall Study||8
11130210|NCT01394003|12316062|FG002|COMPLETED|Overall Study||3
11130211|NCT01394003|12316063|FG003|COMPLETED|Overall Study||6
11130212|NCT01394003|12316064|FG004|COMPLETED|Overall Study||3
11130213|NCT01394003|12316065|FG005|COMPLETED|Overall Study||3
11130214|NCT01394003|12316066|FG006|COMPLETED|Overall Study||6
11130215|NCT01394003|12316067|FG007|COMPLETED|Overall Study||2
11130216|NCT01394003|12316060|FG000|NOT COMPLETED|Overall Study||0
11130217|NCT01394003|12316061|FG001|NOT COMPLETED|Overall Study||0
11130218|NCT01394003|12316062|FG002|NOT COMPLETED|Overall Study||0
11130219|NCT01394003|12316063|FG003|NOT COMPLETED|Overall Study||0
11130220|NCT01394003|12316064|FG004|NOT COMPLETED|Overall Study||0
11130221|NCT01394003|12316065|FG005|NOT COMPLETED|Overall Study||0
11130222|NCT01394003|12316066|FG006|NOT COMPLETED|Overall Study||0
11130223|NCT01394003|12316067|FG007|NOT COMPLETED|Overall Study||0
11130224|NCT01394081|12316093|FG000|STARTED|Overall Study||101
11130225|NCT01394081|12316094|FG001|STARTED|Overall Study||102
11130226|NCT01394081|12316093|FG000|COMPLETED|Overall Study||101
11130227|NCT01394081|12316094|FG001|COMPLETED|Overall Study||102
11130228|NCT01394081|12316093|FG000|NOT COMPLETED|Overall Study||0
11130229|NCT01394081|12316094|FG001|NOT COMPLETED|Overall Study||0
11130230|NCT01394159|12316104|FG000|STARTED|Overall Study||28
11130231|NCT01394159|12316105|FG001|STARTED|Overall Study||28
11130232|NCT01394159|12316104|FG000|COMPLETED|Overall Study||28
11130233|NCT01394159|12316105|FG001|COMPLETED|Overall Study||28
11130234|NCT01394159|12316104|FG000|NOT COMPLETED|Overall Study||0
11130235|NCT01394159|12316105|FG001|NOT COMPLETED|Overall Study||0
11130236|NCT01394185|12316111|FG000|STARTED|Overall Study||8
11130237|NCT01394185|12316112|FG001|STARTED|Overall Study||2
11130238|NCT01394185|12316113|FG002|STARTED|Overall Study||2
11130239|NCT01394185|12316114|FG003|STARTED|Overall Study||4
11130240|NCT01394185|12316115|FG004|STARTED|Overall Study||6
11130241|NCT01394185|12316116|FG005|STARTED|Overall Study||3
11130242|NCT01394185|12316111|FG000|COMPLETED|Overall Study||2
11130243|NCT01394185|12316112|FG001|COMPLETED|Overall Study||2
11130244|NCT01394185|12316113|FG002|COMPLETED|Overall Study||2
11130245|NCT01394185|12316114|FG003|COMPLETED|Overall Study||3
11130246|NCT01394185|12316115|FG004|COMPLETED|Overall Study||2
11130247|NCT01394185|12316116|FG005|COMPLETED|Overall Study||2
11130248|NCT01394185|12316111|FG000|NOT COMPLETED|Overall Study||6
11130249|NCT01394185|12316112|FG001|NOT COMPLETED|Overall Study||0
11130250|NCT01394185|12316113|FG002|NOT COMPLETED|Overall Study||0
11130251|NCT01394185|12316114|FG003|NOT COMPLETED|Overall Study||1
11130252|NCT01394185|12316115|FG004|NOT COMPLETED|Overall Study||4
11130253|NCT01394185|12316116|FG005|NOT COMPLETED|Overall Study||1
11130254|NCT01394250|12316126|FG000|STARTED|Randomization and IV Placement Attempt||134
11130255|NCT01394250|12316127|FG001|STARTED|Randomization and IV Placement Attempt||134
11130256|NCT01394250|12316126|FG000|COMPLETED|Randomization and IV Placement Attempt||120
11130257|NCT01394250|12316127|FG001|COMPLETED|Randomization and IV Placement Attempt||121
11239959|NCT02085460|12432154|FG000|STARTED|Overall Study||31
11239960|NCT02085460|12432155|FG001|STARTED|Overall Study||32
11239961|NCT02085460|12432156|FG002|STARTED|Overall Study||31
11239962|NCT02085460|12432154|FG000|COMPLETED|Overall Study||17
11239963|NCT02085460|12432155|FG001|COMPLETED|Overall Study||24
11239964|NCT02085460|12432156|FG002|COMPLETED|Overall Study||21
11130258|NCT01394250|12316126|FG000|NOT COMPLETED|Randomization and IV Placement Attempt||14
11130259|NCT01394250|12316127|FG001|NOT COMPLETED|Randomization and IV Placement Attempt||13
11130260|NCT01394250|12316126|FG000|STARTED|Successful IV Placement & Follow-Up||120
11130261|NCT01394250|12316127|FG001|STARTED|Successful IV Placement & Follow-Up||121
11130262|NCT01394250|12316126|FG000|COMPLETED|Successful IV Placement & Follow-Up||114
11130263|NCT01394250|12316127|FG001|COMPLETED|Successful IV Placement & Follow-Up||110
11239965|NCT02085460|12432154|FG000|NOT COMPLETED|Overall Study||14
11239966|NCT02085460|12432155|FG001|NOT COMPLETED|Overall Study||8
11239967|NCT02085460|12432156|FG002|NOT COMPLETED|Overall Study||10
11239968|NCT02085473|12432168|FG000|STARTED|Overall Study||15
11239969|NCT02085473|12432169|FG001|STARTED|Overall Study||15
11239970|NCT02085473|12432170|FG002|STARTED|Overall Study||15
11130264|NCT01394250|12316126|FG000|NOT COMPLETED|Successful IV Placement & Follow-Up||6
11130265|NCT01394250|12316127|FG001|NOT COMPLETED|Successful IV Placement & Follow-Up||11
11130266|NCT01394276|12316133|FG000|STARTED|Overall Study||322
11130267|NCT01394276|12316133|FG000|COMPLETED|Overall Study||260
11130268|NCT01394276|12316133|FG000|NOT COMPLETED|Overall Study||62
11130269|NCT01394510|12316142|FG000|STARTED|Overall Study||13
11130270|NCT01394510|12316142|FG000|COMPLETED|Overall Study||13
11130271|NCT01394510|12316142|FG000|NOT COMPLETED|Overall Study||0
11130272|NCT01394523|12316149|FG000|STARTED|Overall Study||13
11130273|NCT01394523|12316150|FG001|STARTED|Overall Study||13
11130274|NCT01394523|12316151|FG002|STARTED|Overall Study||13
11130275|NCT01394523|12316149|FG000|COMPLETED|Overall Study||12
11130276|NCT01394523|12316150|FG001|COMPLETED|Overall Study||13
11130277|NCT01394523|12316151|FG002|COMPLETED|Overall Study||13
11130278|NCT01394523|12316149|FG000|NOT COMPLETED|Overall Study||1
11130279|NCT01394523|12316150|FG001|NOT COMPLETED|Overall Study||0
11130280|NCT01394523|12316151|FG002|NOT COMPLETED|Overall Study||0
11130281|NCT01394614|12316161|FG000|STARTED|Overall Study||8
11130282|NCT01394614|12316162|FG001|STARTED|Overall Study||16
11130283|NCT01394614|12316161|FG000|COMPLETED|Overall Study||8
11130284|NCT01394614|12316162|FG001|COMPLETED|Overall Study||16
11130285|NCT01394614|12316161|FG000|NOT COMPLETED|Overall Study||0
11130286|NCT01394614|12316162|FG001|NOT COMPLETED|Overall Study||0
11130287|NCT01394627|12316168|FG000|STARTED|First Intervention (1 Day)||8
11130288|NCT01394627|12316169|FG001|STARTED|First Intervention (1 Day)||13
11130289|NCT01394627|12316168|FG000|COMPLETED|First Intervention (1 Day)||8
11130290|NCT01394627|12316169|FG001|COMPLETED|First Intervention (1 Day)||12
11130291|NCT01394627|12316168|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11130292|NCT01394627|12316169|FG001|NOT COMPLETED|First Intervention (1 Day)||1
11130293|NCT01394627|12316168|FG000|STARTED|Washout (1-3 Months)||8
11130294|NCT01394627|12316169|FG001|STARTED|Washout (1-3 Months)||12
11130295|NCT01394627|12316168|FG000|COMPLETED|Washout (1-3 Months)||7
11130296|NCT01394627|12316169|FG001|COMPLETED|Washout (1-3 Months)||12
11130297|NCT01394627|12316168|FG000|NOT COMPLETED|Washout (1-3 Months)||1
11130298|NCT01394627|12316169|FG001|NOT COMPLETED|Washout (1-3 Months)||0
11130299|NCT01394627|12316168|FG000|STARTED|Second Intervention (1 Day)||7
11130300|NCT01394627|12316169|FG001|STARTED|Second Intervention (1 Day)||12
11130301|NCT01394627|12316168|FG000|COMPLETED|Second Intervention (1 Day)||7
11130302|NCT01394627|12316169|FG001|COMPLETED|Second Intervention (1 Day)||12
11130303|NCT01394627|12316168|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11130304|NCT01394627|12316169|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11130305|NCT01394692|12316177|FG000|STARTED|Overall Study||29
11130306|NCT01394692|12316178|FG001|STARTED|Overall Study||29
11130307|NCT01394692|12316177|FG000|COMPLETED|Overall Study||29
11130308|NCT01394692|12316178|FG001|COMPLETED|Overall Study||29
11130309|NCT01394692|12316177|FG000|NOT COMPLETED|Overall Study||0
11130310|NCT01394692|12316178|FG001|NOT COMPLETED|Overall Study||0
11130311|NCT01394705|12316186|FG000|STARTED|Overall Study||21
11130312|NCT01394705|12316187|FG001|STARTED|Overall Study||21
11130313|NCT01394705|12316186|FG000|COMPLETED|Overall Study||19
11130314|NCT01394705|12316187|FG001|COMPLETED|Overall Study||19
11130315|NCT01394705|12316186|FG000|NOT COMPLETED|Overall Study||2
11130316|NCT01394705|12316187|FG001|NOT COMPLETED|Overall Study||2
11130317|NCT01394718|12316196|FG000|STARTED|Overall Study||30
11130318|NCT01394718|12316197|FG001|STARTED|Overall Study||30
11130319|NCT01394718|12316196|FG000|COMPLETED|Overall Study||28
11130320|NCT01394718|12316197|FG001|COMPLETED|Overall Study||29
11130321|NCT01394718|12316196|FG000|NOT COMPLETED|Overall Study||2
11239971|NCT02085473|12432171|FG003|STARTED|Overall Study||15
11239972|NCT02085473|12432168|FG000|COMPLETED|Overall Study||15
11239973|NCT02085473|12432169|FG001|COMPLETED|Overall Study||15
11239974|NCT02085473|12432170|FG002|COMPLETED|Overall Study||15
11239975|NCT02085473|12432171|FG003|COMPLETED|Overall Study||15
11239976|NCT02085473|12432168|FG000|NOT COMPLETED|Overall Study||0
11239977|NCT02085473|12432169|FG001|NOT COMPLETED|Overall Study||0
11239978|NCT02085473|12432170|FG002|NOT COMPLETED|Overall Study||0
11130322|NCT01394718|12316197|FG001|NOT COMPLETED|Overall Study||1
11130323|NCT01394939|12316207|FG000|STARTED|Overall Study||4
11239979|NCT02085473|12432171|FG003|NOT COMPLETED|Overall Study||0
11239980|NCT02085551|12432181|FG000|STARTED|Overall Study||85
11239981|NCT02085551|12432181|FG000|COMPLETED|Overall Study||85
11130324|NCT01394939|12316208|FG001|STARTED|Overall Study||25
11130325|NCT01394939|12316209|FG002|STARTED|Overall Study||4
11130326|NCT01394939|12316210|FG003|STARTED|Overall Study||17
11130327|NCT01394939|12316207|FG000|COMPLETED|Overall Study||3
11130328|NCT01394939|12316208|FG001|COMPLETED|Overall Study||15
11130329|NCT01394939|12316209|FG002|COMPLETED|Overall Study||4
11130330|NCT01394939|12316210|FG003|COMPLETED|Overall Study||10
11130331|NCT01394939|12316207|FG000|NOT COMPLETED|Overall Study||1
11130332|NCT01394939|12316208|FG001|NOT COMPLETED|Overall Study||10
11130333|NCT01394939|12316209|FG002|NOT COMPLETED|Overall Study||0
11130334|NCT01394939|12316210|FG003|NOT COMPLETED|Overall Study||7
11130335|NCT01394952|12316222|FG000|STARTED|Overall Study||4952
11130336|NCT01394952|12316223|FG001|STARTED|Overall Study||4949
11130337|NCT01394952|12316222|FG000|Received at Least One Dose of Study Drug|Overall Study||4949
11130338|NCT01394952|12316223|FG001|Received at Least One Dose of Study Drug|Overall Study||4943
11239982|NCT02085551|12432181|FG000|NOT COMPLETED|Overall Study||0
11239983|NCT02085720|12432185|FG000|STARTED|Overall Study||819
11239984|NCT02085720|12432185|FG000|COMPLETED|Overall Study||819
11239985|NCT02085720|12432185|FG000|NOT COMPLETED|Overall Study||0
11130339|NCT01394952|12316222|FG000|COMPLETED|Overall Study||4935
11130340|NCT01394952|12316223|FG001|COMPLETED|Overall Study||4932
11130341|NCT01394952|12316222|FG000|NOT COMPLETED|Overall Study||17
11130342|NCT01394952|12316223|FG001|NOT COMPLETED|Overall Study||17
11130343|NCT01394978|12316232|FG000|STARTED|Overall Study||168
11130344|NCT01394978|12316233|FG001|STARTED|Overall Study||276
11130345|NCT01394978|12316232|FG000|COMPLETED|Overall Study||147
11130346|NCT01394978|12316233|FG001|COMPLETED|Overall Study||245
11130347|NCT01394978|12316232|FG000|NOT COMPLETED|Overall Study||21
11130348|NCT01394978|12316233|FG001|NOT COMPLETED|Overall Study||31
11130349|NCT01394991|12316242|FG000|STARTED|Overall Study||242
11130350|NCT01394991|12316243|FG001|STARTED|Overall Study||262
11130351|NCT01394991|12316242|FG000|COMPLETED|Overall Study||183
11130352|NCT01394991|12316243|FG001|COMPLETED|Overall Study||190
11130353|NCT01394991|12316242|FG000|NOT COMPLETED|Overall Study||59
11130354|NCT01394991|12316243|FG001|NOT COMPLETED|Overall Study||72
11130355|NCT01395017|12316251|FG000|STARTED|Overall Study||100
11130356|NCT01395017|12316252|FG001|STARTED|Overall Study||102
11239986|NCT02085785|12432195|FG000|STARTED|Overall Study||7
11239987|NCT02085785|12432196|FG001|STARTED|Overall Study||8
11239988|NCT02085785|12432195|FG000|COMPLETED|Overall Study||5
11239989|NCT02085785|12432196|FG001|COMPLETED|Overall Study||6
11239990|NCT02085785|12432195|FG000|NOT COMPLETED|Overall Study||2
11239991|NCT02085785|12432196|FG001|NOT COMPLETED|Overall Study||2
11239992|NCT02085980|12432204|FG000|STARTED|Overall Study||30
11239993|NCT02085980|12432204|FG000|COMPLETED|Overall Study||27
11239994|NCT02085980|12432204|FG000|NOT COMPLETED|Overall Study||3
11239995|NCT02086110|12432210|FG000|STARTED|Overall Study||5
11239996|NCT02086110|12432211|FG001|STARTED|Overall Study||6
11239997|NCT02086110|12432210|FG000|COMPLETED|Overall Study||4
11239998|NCT02086110|12432211|FG001|COMPLETED|Overall Study||5
11239999|NCT02086110|12432210|FG000|NOT COMPLETED|Overall Study||1
11240000|NCT02086110|12432211|FG001|NOT COMPLETED|Overall Study||1
11240001|NCT02086162|12432220|FG000|STARTED|Overall Study||78
11240002|NCT02086162|12432221|FG001|STARTED|Overall Study||84
11240003|NCT02086162|12432220|FG000|COMPLETED|Overall Study||68
11240004|NCT02086162|12432221|FG001|COMPLETED|Overall Study||77
11240005|NCT02086162|12432220|FG000|NOT COMPLETED|Overall Study||10
11240006|NCT02086162|12432221|FG001|NOT COMPLETED|Overall Study||7
11240007|NCT02086331|12432231|FG000|STARTED|Overall Study||5
11240008|NCT02086331|12432231|FG000|COMPLETED|Overall Study||5
11240009|NCT02086331|12432231|FG000|NOT COMPLETED|Overall Study||0
11240010|NCT02086500|12432246|FG000|STARTED|Overall Study||447
11240011|NCT02086500|12432247|FG001|STARTED|Overall Study||456
11240012|NCT02086500|12432246|FG000|COMPLETED|Overall Study||447
11240013|NCT02086500|12432247|FG001|COMPLETED|Overall Study||456
11240014|NCT02086500|12432246|FG000|NOT COMPLETED|Overall Study||0
11240015|NCT02086500|12432247|FG001|NOT COMPLETED|Overall Study||0
11240016|NCT02086565|12432255|FG000|STARTED|Overall Study||151
11240017|NCT02086565|12432256|FG001|STARTED|Overall Study||150
11240018|NCT02086565|12432255|FG000|COMPLETED|Overall Study||135
11240019|NCT02086565|12432256|FG001|COMPLETED|Overall Study||138
11240020|NCT02086565|12432255|FG000|NOT COMPLETED|Overall Study||16
11240021|NCT02086565|12432256|FG001|NOT COMPLETED|Overall Study||12
11240022|NCT02086591|12432262|FG000|STARTED|Overall Study||7
11240023|NCT02086591|12432262|FG000|COMPLETED|Overall Study||2
11240024|NCT02086591|12432262|FG000|NOT COMPLETED|Overall Study||5
11240025|NCT02086682|12432268|FG000|STARTED|Overall Study||156
11240026|NCT02086682|12432269|FG001|STARTED|Overall Study||182
11240027|NCT02086682|12432268|FG000|COMPLETED|Overall Study||156
11240028|NCT02086682|12432269|FG001|COMPLETED|Overall Study||182
11240029|NCT02086682|12432268|FG000|NOT COMPLETED|Overall Study||0
11240030|NCT02086682|12432269|FG001|NOT COMPLETED|Overall Study||0
11240031|NCT02086708|12432275|FG000|STARTED|Overall Study||24
11240032|NCT02086708|12432275|FG000|COMPLETED|Overall Study||24
11240033|NCT02086708|12432275|FG000|NOT COMPLETED|Overall Study||0
11240034|NCT02086786|12432289|FG000|STARTED|Overall Study||35
11240035|NCT02086786|12432290|FG001|STARTED|Overall Study||35
11240036|NCT02086786|12432289|FG000|COMPLETED|Overall Study||17
11240037|NCT02086786|12432290|FG001|COMPLETED|Overall Study||19
11240038|NCT02086786|12432289|FG000|NOT COMPLETED|Overall Study||18
11240039|NCT02086786|12432290|FG001|NOT COMPLETED|Overall Study||16
11240040|NCT02086968|12432300|FG000|STARTED|Overall Study||100
11240041|NCT02086968|12432301|FG001|STARTED|Overall Study||98
11240042|NCT02086968|12432300|FG000|COMPLETED|Overall Study||92
11240043|NCT02086968|12432301|FG001|COMPLETED|Overall Study||85
11240044|NCT02086968|12432300|FG000|NOT COMPLETED|Overall Study||8
11240045|NCT02086968|12432301|FG001|NOT COMPLETED|Overall Study||13
11240046|NCT02087046|12432307|FG000|STARTED|Overall Study||127
11240047|NCT02087046|12432307|FG000|Primary Endpoint|Overall Study||121
11240048|NCT02087046|12432307|FG000|COMPLETED|Overall Study||116
11240049|NCT02087046|12432307|FG000|NOT COMPLETED|Overall Study||11
11240050|NCT02087059|12432312|FG000|STARTED|Overall Study||51
11358090|NCT03119701|12555143|FG001|STARTED|6-day Dosing||11
11130357|NCT01395017|12316251|FG000|Treated|Overall Study||98
11130358|NCT01395017|12316252|FG001|Treated|Overall Study||101
11130359|NCT01395017|12316251|FG000|COMPLETED|Overall Study||0
11240051|NCT02087059|12432312|FG000|COMPLETED|Overall Study||44
11240052|NCT02087059|12432312|FG000|NOT COMPLETED|Overall Study||7
11240053|NCT02087085|12432318|FG000|STARTED|Overall Study||154
11240054|NCT02087085|12432319|FG001|STARTED|Overall Study||156
11240055|NCT02087085|12432318|FG000|COMPLETED|Overall Study||34
11240056|NCT02087085|12432319|FG001|COMPLETED|Overall Study||40
11240057|NCT02087085|12432318|FG000|NOT COMPLETED|Overall Study||120
11130360|NCT01395017|12316252|FG001|COMPLETED|Overall Study||0
11130361|NCT01395017|12316251|FG000|NOT COMPLETED|Overall Study||100
11130362|NCT01395017|12316252|FG001|NOT COMPLETED|Overall Study||102
11130363|NCT01395030|12316259|FG000|STARTED|Overall Study||64
11130364|NCT01395030|12316259|FG000|Complete FCH PET/CT|Overall Study||57
11130365|NCT01395030|12316259|FG000|Adequate Tissue for Analysis|Overall Study||50
11130366|NCT01395030|12316259|FG000|COMPLETED|Overall Study||57
11130367|NCT01395030|12316259|FG000|NOT COMPLETED|Overall Study||7
11130368|NCT01395043|12316265|FG000|STARTED|Overall Study||15
11130369|NCT01395043|12316265|FG000|COMPLETED|Overall Study||15
11130370|NCT01395043|12316265|FG000|NOT COMPLETED|Overall Study||0
11130371|NCT01395277|12316272|FG000|STARTED|Overall Study||15
11130372|NCT01395277|12316273|FG001|STARTED|Overall Study||15
11130373|NCT01395277|12316272|FG000|COMPLETED|Overall Study||15
11130374|NCT01395277|12316273|FG001|COMPLETED|Overall Study||15
11130375|NCT01395277|12316272|FG000|NOT COMPLETED|Overall Study||0
11130376|NCT01395277|12316273|FG001|NOT COMPLETED|Overall Study||0
11130377|NCT01395316|12316281|FG000|STARTED|Overall Study||8
11130378|NCT01395316|12316281|FG000|COMPLETED|Overall Study||5
11130379|NCT01395316|12316281|FG000|NOT COMPLETED|Overall Study||3
11130380|NCT01395329|12316288|FG000|STARTED|Overall Study||14
11130381|NCT01395329|12316289|FG001|STARTED|Overall Study||14
11130382|NCT01395329|12316290|FG002|STARTED|Overall Study||14
11130383|NCT01395329|12316288|FG000|COMPLETED|Overall Study||14
11130384|NCT01395329|12316289|FG001|COMPLETED|Overall Study||14
11130385|NCT01395329|12316290|FG002|COMPLETED|Overall Study||14
11130386|NCT01395329|12316288|FG000|NOT COMPLETED|Overall Study||0
11130387|NCT01395329|12316289|FG001|NOT COMPLETED|Overall Study||0
11130388|NCT01395329|12316290|FG002|NOT COMPLETED|Overall Study||0
11130389|NCT01395368|12316301|FG000|STARTED|Overall Study||108
11130390|NCT01395368|12316301|FG000|COMPLETED|Overall Study||92
11130391|NCT01395368|12316301|FG000|NOT COMPLETED|Overall Study||16
11130392|NCT01395394|12316308|FG000|STARTED|Baseline Study Visit||4
11130393|NCT01395394|12316309|FG001|STARTED|Baseline Study Visit||3
11130394|NCT01395394|12316310|FG002|STARTED|Baseline Study Visit||5
11130395|NCT01395394|12316308|FG000|COMPLETED|Baseline Study Visit||3
11130396|NCT01395394|12316309|FG001|COMPLETED|Baseline Study Visit||3
11130397|NCT01395394|12316310|FG002|COMPLETED|Baseline Study Visit||5
11130398|NCT01395394|12316308|FG000|NOT COMPLETED|Baseline Study Visit||1
11130399|NCT01395394|12316309|FG001|NOT COMPLETED|Baseline Study Visit||0
11130400|NCT01395394|12316310|FG002|NOT COMPLETED|Baseline Study Visit||0
11130401|NCT01395394|12316308|FG000|STARTED|Study Visit 2 (Non-responders Only)||3
11130402|NCT01395394|12316309|FG001|STARTED|Study Visit 2 (Non-responders Only)||0
11130403|NCT01395394|12316310|FG002|STARTED|Study Visit 2 (Non-responders Only)||0
11130404|NCT01395394|12316308|FG000|COMPLETED|Study Visit 2 (Non-responders Only)||3
11130405|NCT01395394|12316309|FG001|COMPLETED|Study Visit 2 (Non-responders Only)||0
11130406|NCT01395394|12316310|FG002|COMPLETED|Study Visit 2 (Non-responders Only)||0
11130407|NCT01395394|12316308|FG000|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
11130408|NCT01395394|12316309|FG001|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
11130409|NCT01395394|12316310|FG002|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
11130410|NCT01395524|12316321|FG000|STARTED|Overall Study||97
11130411|NCT01395524|12316322|FG001|STARTED|Overall Study||99
11130412|NCT01395524|12316323|FG002|STARTED|Overall Study||106
11130413|NCT01395524|12316321|FG000|COMPLETED|Overall Study||79
11130414|NCT01395524|12316322|FG001|COMPLETED|Overall Study||83
11130415|NCT01395524|12316323|FG002|COMPLETED|Overall Study||89
11130416|NCT01395524|12316321|FG000|NOT COMPLETED|Overall Study||18
11130417|NCT01395524|12316322|FG001|NOT COMPLETED|Overall Study||16
11130418|NCT01395524|12316323|FG002|NOT COMPLETED|Overall Study||17
11130419|NCT01395537|12316331|FG000|STARTED|Phase I||13
11130420|NCT01395537|12316331|FG000|COMPLETED|Phase I||13
11130421|NCT01395537|12316331|FG000|NOT COMPLETED|Phase I||0
11130422|NCT01395537|12316331|FG000|STARTED|Phase II||1
11130423|NCT01395537|12316331|FG000|COMPLETED|Phase II||1
11130424|NCT01395537|12316331|FG000|NOT COMPLETED|Phase II||0
11130425|NCT01395758|12316337|FG000|STARTED|Open-label Treatment Period||51
11130426|NCT01395758|12316338|FG001|STARTED|Open-label Treatment Period||45
11130427|NCT01395758|12316339|FG002|STARTED|Open-label Treatment Period||0
11130428|NCT01395758|12316337|FG000|COMPLETED|Open-label Treatment Period||47
11130429|NCT01395758|12316338|FG001|COMPLETED|Open-label Treatment Period||45
11130430|NCT01395758|12316339|FG002|COMPLETED|Open-label Treatment Period||0
11130431|NCT01395758|12316337|FG000|NOT COMPLETED|Open-label Treatment Period||4
11130432|NCT01395758|12316338|FG001|NOT COMPLETED|Open-label Treatment Period||0
11130433|NCT01395758|12316339|FG002|NOT COMPLETED|Open-label Treatment Period||0
11130434|NCT01395758|12316337|FG000|STARTED|Crossover Period||0
11130435|NCT01395758|12316338|FG001|STARTED|Crossover Period||0
11130436|NCT01395758|12316339|FG002|STARTED|Crossover Period||26
11130437|NCT01395758|12316337|FG000|COMPLETED|Crossover Period||0
11130438|NCT01395758|12316338|FG001|COMPLETED|Crossover Period||0
11130439|NCT01395758|12316339|FG002|COMPLETED|Crossover Period||26
11130440|NCT01395758|12316337|FG000|NOT COMPLETED|Crossover Period||0
11130441|NCT01395758|12316338|FG001|NOT COMPLETED|Crossover Period||0
11130442|NCT01395758|12316339|FG002|NOT COMPLETED|Crossover Period||0
11130443|NCT01395784|12316346|FG000|STARTED|Overall Study||32
11130444|NCT01395784|12316346|FG000|COMPLETED|Overall Study||17
11130445|NCT01395784|12316346|FG000|NOT COMPLETED|Overall Study||15
11130446|NCT01395797|12316356|FG000|STARTED|Overall Study||19
11130447|NCT01395797|12316357|FG001|STARTED|Overall Study||4
11130448|NCT01395797|12316358|FG002|STARTED|Overall Study||18
11130449|NCT01395797|12316359|FG003|STARTED|Overall Study||15
11130450|NCT01395797|12316360|FG004|STARTED|Overall Study||9
11130451|NCT01395797|12316361|FG005|STARTED|Overall Study||17
11130452|NCT01395797|12316356|FG000|COMPLETED|Overall Study||16
11130453|NCT01395797|12316357|FG001|COMPLETED|Overall Study||3
11130454|NCT01395797|12316358|FG002|COMPLETED|Overall Study||14
11130455|NCT01395797|12316359|FG003|COMPLETED|Overall Study||13
11130456|NCT01395797|12316360|FG004|COMPLETED|Overall Study||7
11130457|NCT01395797|12316361|FG005|COMPLETED|Overall Study||14
11130458|NCT01395797|12316356|FG000|NOT COMPLETED|Overall Study||3
11130459|NCT01395797|12316357|FG001|NOT COMPLETED|Overall Study||1
11130460|NCT01395797|12316358|FG002|NOT COMPLETED|Overall Study||4
11130461|NCT01395797|12316359|FG003|NOT COMPLETED|Overall Study||2
11130462|NCT01395797|12316360|FG004|NOT COMPLETED|Overall Study||2
11130463|NCT01395797|12316361|FG005|NOT COMPLETED|Overall Study||3
11130464|NCT01395810|12316385|FG000|STARTED|Overall Study||18
11130465|NCT01395810|12316386|FG001|STARTED|Overall Study||48
11130466|NCT01395810|12316387|FG002|STARTED|Overall Study||0
11130467|NCT01395810|12316388|FG003|STARTED|Overall Study||5
11130468|NCT01395810|12316385|FG000|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
11130469|NCT01395810|12316386|FG001|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
11130470|NCT01395810|12316387|FG002|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
11130471|NCT01395810|12316388|FG003|After Switching the Arms|Overall Study||5
11130472|NCT01395810|12316385|FG000|COMPLETED|Overall Study||16
11130473|NCT01395810|12316386|FG001|COMPLETED|Overall Study||44
11130474|NCT01395810|12316387|FG002|COMPLETED|Overall Study||0
11130475|NCT01395810|12316388|FG003|COMPLETED|Overall Study||5
11130476|NCT01395810|12316385|FG000|NOT COMPLETED|Overall Study||2
11130477|NCT01395810|12316386|FG001|NOT COMPLETED|Overall Study||4
11130478|NCT01395810|12316387|FG002|NOT COMPLETED|Overall Study||0
11130479|NCT01395810|12316388|FG003|NOT COMPLETED|Overall Study||0
11202212|NCT01838616|12392625|FG001|STARTED|Continuation Period||62
11202213|NCT01838616|12392624|FG000|Switched to Pick-up Arm|Continuation Period||0
11202214|NCT01838616|12392625|FG001|Switched to Pick-up Arm|Continuation Period||7
11202215|NCT01838616|12392624|FG000|COMPLETED|Continuation Period||86
11202216|NCT01838616|12392625|FG001|COMPLETED|Continuation Period||48
11202217|NCT01838616|12392624|FG000|NOT COMPLETED|Continuation Period||14
11202218|NCT01838616|12392625|FG001|NOT COMPLETED|Continuation Period||14
11202219|NCT01838616|12392624|FG000|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
11202220|NCT01838616|12392625|FG001|STARTED|Pick-up Arm||0
11202221|NCT01838616|12392624|FG000|Full Analysis Set|Pick-up Arm||49
11202222|NCT01838616|12392625|FG001|Full Analysis Set|Pick-up Arm||0
11202223|NCT01838616|12392624|FG000|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
11202224|NCT01838616|12392625|FG001|COMPLETED|Pick-up Arm||0
11202225|NCT01838616|12392624|FG000|NOT COMPLETED|Pick-up Arm||15
11202226|NCT01838616|12392625|FG001|NOT COMPLETED|Pick-up Arm||0
11202227|NCT01838642|12392636|FG000|STARTED|Overall Study||3
11202228|NCT01838642|12392636|FG000|COMPLETED|Overall Study||2
11202229|NCT01838642|12392636|FG000|NOT COMPLETED|Overall Study||1
11205176|NCT01857869|12395949|FG009|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
11205177|NCT01857869|12395940|FG000|COMPLETED|Primary/Challenge Phase||29
11205178|NCT01857869|12395941|FG001|COMPLETED|Primary/Challenge Phase||16
11205179|NCT01857869|12395942|FG002|COMPLETED|Primary/Challenge Phase||12
11205180|NCT01857869|12395943|FG003|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
11205181|NCT01857869|12395944|FG004|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
11205182|NCT01857869|12395945|FG005|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
11205183|NCT01857869|12395946|FG006|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
11205184|NCT01857869|12395947|FG007|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
11205265|NCT01858363|12396008|FG001|12-month Vist|Overall Study||61
11130480|NCT01395823|12316401|FG000|STARTED|Overall Study||137
11130481|NCT01395823|12316402|FG001|STARTED|Overall Study||139
11130482|NCT01395823|12316401|FG000|COMPLETED|Overall Study||122
11130483|NCT01395823|12316402|FG001|COMPLETED|Overall Study||130
11130484|NCT01395823|12316401|FG000|NOT COMPLETED|Overall Study||15
11130485|NCT01395823|12316402|FG001|NOT COMPLETED|Overall Study||9
11130486|NCT01395888|12316410|FG000|STARTED|2-week Run-in Period||279
11130487|NCT01395888|12316411|FG001|STARTED|2-week Run-in Period||0
11130488|NCT01395888|12316412|FG002|STARTED|2-week Run-in Period||0
11130489|NCT01395888|12316410|FG000|COMPLETED|2-week Run-in Period||257
11130490|NCT01395888|12316411|FG001|COMPLETED|2-week Run-in Period||0
11130491|NCT01395888|12316412|FG002|COMPLETED|2-week Run-in Period||0
11130492|NCT01395888|12316410|FG000|NOT COMPLETED|2-week Run-in Period||22
11130493|NCT01395888|12316411|FG001|NOT COMPLETED|2-week Run-in Period||0
11130494|NCT01395888|12316412|FG002|NOT COMPLETED|2-week Run-in Period||0
11130495|NCT01395888|12316410|FG000|STARTED|Treatment Period (TP)||0
11130496|NCT01395888|12316411|FG001|STARTED|Treatment Period (TP)||127
11130497|NCT01395888|12316412|FG002|STARTED|Treatment Period (TP)||130
11130498|NCT01395888|12316410|FG000|Completed the Treatment Period|Treatment Period (TP)||0
11130499|NCT01395888|12316411|FG001|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
11130500|NCT01395888|12316412|FG002|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
11130501|NCT01395888|12316410|FG000|COMPLETED|Treatment Period (TP)||0
11130502|NCT01395888|12316411|FG001|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
11130503|NCT01395888|12316412|FG002|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
11130504|NCT01395888|12316410|FG000|NOT COMPLETED|Treatment Period (TP)||0
11130505|NCT01395888|12316411|FG001|NOT COMPLETED|Treatment Period (TP)||15
11130506|NCT01395888|12316412|FG002|NOT COMPLETED|Treatment Period (TP)||17
11130507|NCT01395901|12316420|FG000|STARTED|Overall Study|Randomized Population|336
11130508|NCT01395901|12316421|FG001|STARTED|Overall Study|Randomized Population|334
11130509|NCT01395901|12316420|FG000|COMPLETED|Overall Study|Treated patients completing the study|326
11130510|NCT01395901|12316421|FG001|COMPLETED|Overall Study|Treated patients completing the study|329
11130511|NCT01395901|12316420|FG000|NOT COMPLETED|Overall Study||10
11130512|NCT01395901|12316421|FG001|NOT COMPLETED|Overall Study||5
11130513|NCT01395914|12316429|FG000|STARTED|Overall Study||345
11130514|NCT01395914|12316430|FG001|STARTED|Overall Study||168
11130515|NCT01395914|12316429|FG000|ITT Population|Overall Study||345
11130516|NCT01395914|12316430|FG001|ITT Population|Overall Study||168
11130517|NCT01395914|12316429|FG000|Safety Population|Overall Study||343
11130518|NCT01395914|12316430|FG001|Safety Population|Overall Study||167
11130519|NCT01395914|12316429|FG000|COMPLETED|Overall Study||273
11130520|NCT01395914|12316430|FG001|COMPLETED|Overall Study||131
11130521|NCT01395914|12316429|FG000|NOT COMPLETED|Overall Study||72
11130522|NCT01395914|12316430|FG001|NOT COMPLETED|Overall Study||37
11130523|NCT01395966|12316439|FG000|STARTED|Overall Study||109
11130524|NCT01395966|12316440|FG001|STARTED|Overall Study||110
11130525|NCT01395966|12316441|FG002|STARTED|Overall Study||112
11130526|NCT01395966|12316439|FG000|COMPLETED|Overall Study||99
11130527|NCT01395966|12316440|FG001|COMPLETED|Overall Study||91
11130528|NCT01395966|12316441|FG002|COMPLETED|Overall Study||104
11130529|NCT01395966|12316439|FG000|NOT COMPLETED|Overall Study||10
11130530|NCT01395966|12316440|FG001|NOT COMPLETED|Overall Study||19
11130531|NCT01395966|12316441|FG002|NOT COMPLETED|Overall Study||8
11130532|NCT01396005|12316451|FG000|STARTED|Overall Study||10
11130533|NCT01396005|12316452|FG001|STARTED|Overall Study||11
11130534|NCT01396005|12316451|FG000|COMPLETED|Overall Study||10
11130535|NCT01396005|12316452|FG001|COMPLETED|Overall Study||9
11130536|NCT01396005|12316451|FG000|NOT COMPLETED|Overall Study||0
11130537|NCT01396005|12316452|FG001|NOT COMPLETED|Overall Study||2
11130538|NCT01396044|12316462|FG000|STARTED|Overall Study||125
11130539|NCT01396044|12316463|FG001|STARTED|Overall Study||171
11130540|NCT01396044|12316462|FG000|COMPLETED|Overall Study||125
11130541|NCT01396044|12316463|FG001|COMPLETED|Overall Study||171
11130542|NCT01396044|12316462|FG000|NOT COMPLETED|Overall Study||0
11130543|NCT01396044|12316463|FG001|NOT COMPLETED|Overall Study||0
11130544|NCT01396057|12316471|FG000|STARTED|Overall Study||126
11130545|NCT01396057|12316472|FG001|STARTED|Overall Study||118
11130546|NCT01396057|12316471|FG000|COMPLETED|Overall Study||115
11130547|NCT01396057|12316472|FG001|COMPLETED|Overall Study||100
11130548|NCT01396057|12316471|FG000|NOT COMPLETED|Overall Study||11
11130549|NCT01396057|12316472|FG001|NOT COMPLETED|Overall Study||18
11130550|NCT01396070|12316478|FG000|STARTED|Overall Study||36
11130551|NCT01396070|12316478|FG000|COMPLETED|Overall Study||17
11130552|NCT01396070|12316478|FG000|NOT COMPLETED|Overall Study||19
11130553|NCT01396083|12316485|FG000|STARTED|Overall Study||124
11130554|NCT01396083|12316486|FG001|STARTED|Overall Study||119
11130555|NCT01396083|12316485|FG000|COMPLETED|Overall Study||113
11130556|NCT01396083|12316486|FG001|COMPLETED|Overall Study||72
11130557|NCT01396083|12316485|FG000|NOT COMPLETED|Overall Study||11
11130558|NCT01396083|12316486|FG001|NOT COMPLETED|Overall Study||47
11130559|NCT01396148|12316492|FG000|STARTED|Overall Study||6
11130560|NCT01396148|12316492|FG000|COMPLETED|Overall Study||5
11130561|NCT01396148|12316492|FG000|NOT COMPLETED|Overall Study||1
11130562|NCT01396161|12316505|FG000|STARTED|Overall Study||12
11130563|NCT01396161|12316506|FG001|STARTED|Overall Study||5
11130564|NCT01396161|12316507|FG002|STARTED|Overall Study||9
11130565|NCT01396161|12316508|FG003|STARTED|Overall Study||9
11130566|NCT01396161|12316509|FG004|STARTED|Overall Study||9
11130567|NCT01396161|12316510|FG005|STARTED|Overall Study||9
11130568|NCT01396161|12316511|FG006|STARTED|Overall Study||11
11130569|NCT01396161|12316505|FG000|COMPLETED|Overall Study||12
11130570|NCT01396161|12316506|FG001|COMPLETED|Overall Study||5
11130571|NCT01396161|12316507|FG002|COMPLETED|Overall Study||9
11130572|NCT01396161|12316508|FG003|COMPLETED|Overall Study||9
11130573|NCT01396161|12316509|FG004|COMPLETED|Overall Study||8
11130574|NCT01396161|12316510|FG005|COMPLETED|Overall Study||9
11130575|NCT01396161|12316511|FG006|COMPLETED|Overall Study||10
11130576|NCT01396161|12316505|FG000|NOT COMPLETED|Overall Study||0
11130577|NCT01396161|12316506|FG001|NOT COMPLETED|Overall Study||0
11130578|NCT01396161|12316507|FG002|NOT COMPLETED|Overall Study||0
11130579|NCT01396161|12316508|FG003|NOT COMPLETED|Overall Study||0
11130580|NCT01396161|12316509|FG004|NOT COMPLETED|Overall Study||1
11130581|NCT01396161|12316510|FG005|NOT COMPLETED|Overall Study||0
11130582|NCT01396161|12316511|FG006|NOT COMPLETED|Overall Study||1
11130583|NCT01396187|12316537|FG000|STARTED|Overall Study||8
11130584|NCT01396187|12316538|FG001|STARTED|Overall Study||12
11130585|NCT01396187|12316539|FG002|STARTED|Overall Study||10
11130586|NCT01396187|12316540|FG003|STARTED|Overall Study||10
11130587|NCT01396187|12316541|FG004|STARTED|Overall Study||10
11130588|NCT01396187|12316537|FG000|COMPLETED|Overall Study||7
11130589|NCT01396187|12316538|FG001|COMPLETED|Overall Study||9
11130590|NCT01396187|12316539|FG002|COMPLETED|Overall Study||9
11130591|NCT01396187|12316540|FG003|COMPLETED|Overall Study||10
11130592|NCT01396187|12316541|FG004|COMPLETED|Overall Study||9
11130593|NCT01396187|12316537|FG000|NOT COMPLETED|Overall Study||1
11130594|NCT01396187|12316538|FG001|NOT COMPLETED|Overall Study||3
11130595|NCT01396187|12316539|FG002|NOT COMPLETED|Overall Study||1
11130596|NCT01396187|12316540|FG003|NOT COMPLETED|Overall Study||0
11130597|NCT01396187|12316541|FG004|NOT COMPLETED|Overall Study||1
11130598|NCT01396226|12316559|FG000|STARTED|Overall Study||12
11130599|NCT01396226|12316560|FG001|STARTED|Overall Study||6
11130600|NCT01396226|12316559|FG000|Patients Who Received Treatment|Overall Study||12
11130601|NCT01396226|12316560|FG001|Patients Who Received Treatment|Overall Study||6
11130602|NCT01396226|12316559|FG000|Patients Who Completed Treatment|Overall Study||12
11130603|NCT01396226|12316560|FG001|Patients Who Completed Treatment|Overall Study||6
11130604|NCT01396226|12316559|FG000|COMPLETED|Overall Study||12
11130605|NCT01396226|12316560|FG001|COMPLETED|Overall Study||6
11130606|NCT01396226|12316559|FG000|NOT COMPLETED|Overall Study||0
11130607|NCT01396226|12316560|FG001|NOT COMPLETED|Overall Study||0
11130608|NCT01396239|12316569|FG000|STARTED|Overall Study||4
11130609|NCT01396239|12316570|FG001|STARTED|Overall Study||2
11130610|NCT01396239|12316571|FG002|STARTED|Overall Study||4
11130611|NCT01396239|12316572|FG003|STARTED|Overall Study||2
11130612|NCT01396239|12316569|FG000|COMPLETED|Overall Study||4
11130613|NCT01396239|12316570|FG001|COMPLETED|Overall Study||2
11130614|NCT01396239|12316571|FG002|COMPLETED|Overall Study||4
11130615|NCT01396239|12316572|FG003|COMPLETED|Overall Study||2
11130616|NCT01396239|12316569|FG000|NOT COMPLETED|Overall Study||0
11130617|NCT01396239|12316570|FG001|NOT COMPLETED|Overall Study||0
11130618|NCT01396239|12316571|FG002|NOT COMPLETED|Overall Study||0
11130619|NCT01396239|12316572|FG003|NOT COMPLETED|Overall Study||0
11130620|NCT01396265|12316589|FG000|STARTED|Afatinib||22
11130621|NCT01396265|12316589|FG000|COMPLETED|Afatinib||22
11130622|NCT01396265|12316589|FG000|NOT COMPLETED|Afatinib||0
11130623|NCT01396265|12316589|FG000|STARTED|Washout||22
11130624|NCT01396265|12316589|FG000|COMPLETED|Washout||22
11130625|NCT01396265|12316589|FG000|NOT COMPLETED|Washout||0
11130626|NCT01396265|12316589|FG000|STARTED|Rifa+Afatinib||22
11130627|NCT01396265|12316589|FG000|COMPLETED|Rifa+Afatinib||21
11130628|NCT01396265|12316589|FG000|NOT COMPLETED|Rifa+Afatinib||1
11130629|NCT01396317|12316597|FG000|STARTED|Overall Study||10
11130630|NCT01396317|12316598|FG001|STARTED|Overall Study||10
11130631|NCT01396317|12316597|FG000|COMPLETED|Overall Study||9
11130632|NCT01396317|12316598|FG001|COMPLETED|Overall Study||10
11130633|NCT01396317|12316597|FG000|NOT COMPLETED|Overall Study||1
11130634|NCT01396317|12316598|FG001|NOT COMPLETED|Overall Study||0
11130635|NCT01396382|12316606|FG000|STARTED|Overall Study||97
11130636|NCT01396382|12316606|FG000|COMPLETED|Overall Study||97
11130637|NCT01396382|12316606|FG000|NOT COMPLETED|Overall Study||0
11130638|NCT01396395|12316613|FG000|STARTED|Overall Study||200
11130639|NCT01396395|12316614|FG001|STARTED|Overall Study||202
11130640|NCT01396395|12316613|FG000|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
11130641|NCT01396395|12316614|FG001|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
11130642|NCT01396395|12316613|FG000|COMPLETED|Overall Study||160
11130643|NCT01396395|12316614|FG001|COMPLETED|Overall Study||175
11130644|NCT01396395|12316613|FG000|NOT COMPLETED|Overall Study||40
11130645|NCT01396395|12316614|FG001|NOT COMPLETED|Overall Study||27
11130646|NCT01396421|12316626|FG000|STARTED|Overall Study||180
11130647|NCT01396421|12316627|FG001|STARTED|Overall Study||182
11130648|NCT01396421|12316628|FG002|STARTED|Overall Study||90
11130649|NCT01396421|12316629|FG003|STARTED|Overall Study||184
11130650|NCT01396421|12316626|FG000|COMPLETED|Overall Study||121
11130651|NCT01396421|12316627|FG001|COMPLETED|Overall Study||124
11130652|NCT01396421|12316628|FG002|COMPLETED|Overall Study||56
11130653|NCT01396421|12316629|FG003|COMPLETED|Overall Study||109
11130654|NCT01396421|12316626|FG000|NOT COMPLETED|Overall Study||59
11130655|NCT01396421|12316627|FG001|NOT COMPLETED|Overall Study||58
11130656|NCT01396421|12316628|FG002|NOT COMPLETED|Overall Study||34
11130657|NCT01396421|12316629|FG003|NOT COMPLETED|Overall Study||75
11130658|NCT01396434|12316656|FG000|STARTED|Overall Study||2817
11130659|NCT01396434|12316657|FG001|STARTED|Overall Study||175
11130660|NCT01396434|12316658|FG002|STARTED|Overall Study||14
11130661|NCT01396434|12316656|FG000|COMPLETED|Overall Study||2806
11130662|NCT01396434|12316657|FG001|COMPLETED|Overall Study||175
11130663|NCT01396434|12316658|FG002|COMPLETED|Overall Study||14
11130664|NCT01396434|12316656|FG000|NOT COMPLETED|Overall Study||11
11130665|NCT01396434|12316657|FG001|NOT COMPLETED|Overall Study||0
11130666|NCT01396434|12316658|FG002|NOT COMPLETED|Overall Study||0
11130667|NCT01396447|12316670|FG000|STARTED|Overall Study||148
11130668|NCT01396447|12316671|FG001|STARTED|Overall Study||143
11130669|NCT01396447|12316672|FG002|STARTED|Overall Study||147
11130670|NCT01396447|12316673|FG003|STARTED|Overall Study||146
11130671|NCT01396447|12316670|FG000|Received Treatment|Overall Study||145
11130672|NCT01396447|12316671|FG001|Received Treatment|Overall Study||141
11130673|NCT01396447|12316672|FG002|Received Treatment|Overall Study||146
11358091|NCT03119701|12555142|FG000|COMPLETED|6-day Dosing||22
11130674|NCT01396447|12316673|FG003|Received Treatment|Overall Study||146
11130675|NCT01396447|12316670|FG000|COMPLETED|Overall Study||105
11130676|NCT01396447|12316671|FG001|COMPLETED|Overall Study||103
11130677|NCT01396447|12316672|FG002|COMPLETED|Overall Study||117
11130678|NCT01396447|12316673|FG003|COMPLETED|Overall Study||94
11130679|NCT01396447|12316670|FG000|NOT COMPLETED|Overall Study||43
11130680|NCT01396447|12316671|FG001|NOT COMPLETED|Overall Study||40
11130681|NCT01396447|12316672|FG002|NOT COMPLETED|Overall Study||30
11130682|NCT01396447|12316673|FG003|NOT COMPLETED|Overall Study||52
11130683|NCT01396486|12316686|FG000|STARTED|Overall Study||20
11130684|NCT01396486|12316687|FG001|STARTED|Overall Study||19
11130685|NCT01396486|12316688|FG002|STARTED|Overall Study||22
11130686|NCT01396486|12316686|FG000|Exposed|Overall Study||19
11130687|NCT01396486|12316687|FG001|Exposed|Overall Study||16
11130688|NCT01396486|12316688|FG002|Exposed|Overall Study||17
11130689|NCT01396486|12316686|FG000|COMPLETED|Overall Study||10
11130690|NCT01396486|12316687|FG001|COMPLETED|Overall Study||7
11130691|NCT01396486|12316688|FG002|COMPLETED|Overall Study||10
11130692|NCT01396486|12316686|FG000|NOT COMPLETED|Overall Study||10
11130693|NCT01396486|12316687|FG001|NOT COMPLETED|Overall Study||12
11130694|NCT01396486|12316688|FG002|NOT COMPLETED|Overall Study||12
11130695|NCT01396512|12316698|FG000|STARTED|Overall Study||137
11130696|NCT01396512|12316699|FG001|STARTED|Overall Study||137
11130697|NCT01396512|12316698|FG000|COMPLETED|Overall Study||137
11130698|NCT01396512|12316699|FG001|COMPLETED|Overall Study||136
11130699|NCT01396512|12316698|FG000|NOT COMPLETED|Overall Study||0
11130700|NCT01396512|12316699|FG001|NOT COMPLETED|Overall Study||1
11130701|NCT01396525|12316705|FG000|STARTED|Overall Study||153
11130702|NCT01396525|12316705|FG000|COMPLETED|Overall Study||127
11130703|NCT01396525|12316705|FG000|NOT COMPLETED|Overall Study||26
11130704|NCT01396551|12316713|FG000|STARTED|Overall Study||69
11130705|NCT01396551|12316713|FG000|COMPLETED|Overall Study||69
11130706|NCT01396551|12316713|FG000|NOT COMPLETED|Overall Study||0
11130707|NCT01396837|12316717|FG000|STARTED|Overall Study||20
11130708|NCT01396837|12316717|FG000|COMPLETED|Overall Study||16
11130709|NCT01396837|12316717|FG000|NOT COMPLETED|Overall Study||4
11130710|NCT01397071|12316721|FG000|STARTED|Consumption of Beef Patty Alone||11
11130711|NCT01397071|12316721|FG000|COMPLETED|Consumption of Beef Patty Alone||11
11130712|NCT01397071|12316721|FG000|NOT COMPLETED|Consumption of Beef Patty Alone||0
11130713|NCT01397071|12316721|FG000|STARTED|Consumption of Beef Patty With Avocado||11
11130714|NCT01397071|12316721|FG000|COMPLETED|Consumption of Beef Patty With Avocado||11
11130715|NCT01397071|12316721|FG000|NOT COMPLETED|Consumption of Beef Patty With Avocado||0
11130716|NCT01397084|12316729|FG000|STARTED|Overall Study||108
11130717|NCT01397084|12316729|FG000|COMPLETED|Overall Study||100
11130718|NCT01397084|12316729|FG000|NOT COMPLETED|Overall Study||8
11130719|NCT01397253|12316735|FG000|STARTED|Overall Study||443
11130720|NCT01397253|12316736|FG001|STARTED|Overall Study||392
11130721|NCT01397253|12316735|FG000|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
11130722|NCT01397253|12316736|FG001|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
11130723|NCT01397253|12316735|FG000|NOT COMPLETED|Overall Study||126
11130724|NCT01397253|12316736|FG001|NOT COMPLETED|Overall Study||149
11130725|NCT01397409|12316752|FG000|STARTED|Stage 1||9
11130726|NCT01397409|12316753|FG001|STARTED|Stage 1||6
11130727|NCT01397409|12316754|FG002|STARTED|Stage 1||6
11130728|NCT01397409|12316755|FG003|STARTED|Stage 1||3
11130729|NCT01397409|12316756|FG004|STARTED|Stage 1||0
11130730|NCT01397409|12316757|FG005|STARTED|Stage 1||0
11130731|NCT01397409|12316758|FG006|STARTED|Stage 1||0
11130732|NCT01397409|12316759|FG007|STARTED|Stage 1||0
11130733|NCT01397409|12316760|FG008|STARTED|Stage 1||0
11130734|NCT01397409|12316761|FG009|STARTED|Stage 1||0
11130735|NCT01397409|12316752|FG000|COMPLETED|Stage 1||9
11130736|NCT01397409|12316753|FG001|COMPLETED|Stage 1||6
11130737|NCT01397409|12316754|FG002|COMPLETED|Stage 1||6
11130738|NCT01397409|12316755|FG003|COMPLETED|Stage 1||3
11130739|NCT01397409|12316756|FG004|COMPLETED|Stage 1||0
11130740|NCT01397409|12316757|FG005|COMPLETED|Stage 1||0
11130741|NCT01397409|12316758|FG006|COMPLETED|Stage 1||0
11130742|NCT01397409|12316759|FG007|COMPLETED|Stage 1||0
11130743|NCT01397409|12316760|FG008|COMPLETED|Stage 1||0
11130744|NCT01397409|12316761|FG009|COMPLETED|Stage 1||0
11130745|NCT01397409|12316752|FG000|NOT COMPLETED|Stage 1||0
11130746|NCT01397409|12316753|FG001|NOT COMPLETED|Stage 1||0
11130747|NCT01397409|12316754|FG002|NOT COMPLETED|Stage 1||0
11130748|NCT01397409|12316755|FG003|NOT COMPLETED|Stage 1||0
11130749|NCT01397409|12316756|FG004|NOT COMPLETED|Stage 1||0
11130750|NCT01397409|12316757|FG005|NOT COMPLETED|Stage 1||0
11130751|NCT01397409|12316758|FG006|NOT COMPLETED|Stage 1||0
11130752|NCT01397409|12316759|FG007|NOT COMPLETED|Stage 1||0
11130753|NCT01397409|12316760|FG008|NOT COMPLETED|Stage 1||0
11130754|NCT01397409|12316761|FG009|NOT COMPLETED|Stage 1||0
11130755|NCT01397409|12316752|FG000|STARTED|Stage 2||0
11130756|NCT01397409|12316753|FG001|STARTED|Stage 2||0
11130757|NCT01397409|12316754|FG002|STARTED|Stage 2||0
11130758|NCT01397409|12316755|FG003|STARTED|Stage 2||0
11130759|NCT01397409|12316756|FG004|STARTED|Stage 2||67
11130760|NCT01397409|12316757|FG005|STARTED|Stage 2||58
11130761|NCT01397409|12316758|FG006|STARTED|Stage 2||58
11130762|NCT01397409|12316759|FG007|STARTED|Stage 2||0
11130763|NCT01397409|12316760|FG008|STARTED|Stage 2||0
11130764|NCT01397409|12316761|FG009|STARTED|Stage 2||0
11130765|NCT01397409|12316752|FG000|COMPLETED|Stage 2||0
11130766|NCT01397409|12316753|FG001|COMPLETED|Stage 2||0
11130767|NCT01397409|12316754|FG002|COMPLETED|Stage 2||0
11130768|NCT01397409|12316755|FG003|COMPLETED|Stage 2||0
11130769|NCT01397409|12316756|FG004|COMPLETED|Stage 2||59
11130770|NCT01397409|12316757|FG005|COMPLETED|Stage 2||54
11130771|NCT01397409|12316758|FG006|COMPLETED|Stage 2||58
11130772|NCT01397409|12316759|FG007|COMPLETED|Stage 2||0
11130773|NCT01397409|12316760|FG008|COMPLETED|Stage 2||0
11130774|NCT01397409|12316761|FG009|COMPLETED|Stage 2||0
11130775|NCT01397409|12316752|FG000|NOT COMPLETED|Stage 2||0
11130776|NCT01397409|12316753|FG001|NOT COMPLETED|Stage 2||0
11240058|NCT02087085|12432319|FG001|NOT COMPLETED|Overall Study||116
11240059|NCT02087150|12432328|FG000|STARTED|Overall Study||81
11240060|NCT02087150|12432329|FG001|STARTED|Overall Study||162
11240061|NCT02087150|12432330|FG002|STARTED|Overall Study||80
11130777|NCT01397409|12316754|FG002|NOT COMPLETED|Stage 2||0
11130778|NCT01397409|12316755|FG003|NOT COMPLETED|Stage 2||0
11130779|NCT01397409|12316756|FG004|NOT COMPLETED|Stage 2||8
11130780|NCT01397409|12316757|FG005|NOT COMPLETED|Stage 2||4
11130781|NCT01397409|12316758|FG006|NOT COMPLETED|Stage 2||0
11130782|NCT01397409|12316759|FG007|NOT COMPLETED|Stage 2||0
11130783|NCT01397409|12316760|FG008|NOT COMPLETED|Stage 2||0
11130784|NCT01397409|12316761|FG009|NOT COMPLETED|Stage 2||0
11130785|NCT01397409|12316752|FG000|STARTED|Stage 3||0
11130786|NCT01397409|12316753|FG001|STARTED|Stage 3||0
11130787|NCT01397409|12316754|FG002|STARTED|Stage 3||0
11240062|NCT02087150|12432328|FG000|Had a Lead-in or Randomized ETBC Proc|Overall Study||80
11240063|NCT02087150|12432329|FG001|Had a Lead-in or Randomized ETBC Proc|Overall Study||149
11240064|NCT02087150|12432330|FG002|Had a Lead-in or Randomized ETBC Proc|Overall Study||0
11240065|NCT02087150|12432328|FG000|Received a Crossover MM ETBC Procedure|Overall Study||0
11240066|NCT02087150|12432329|FG001|Received a Crossover MM ETBC Procedure|Overall Study||0
11240067|NCT02087150|12432330|FG002|Received a Crossover MM ETBC Procedure|Overall Study||70
11240068|NCT02087150|12432328|FG000|COMPLETED|Overall Study||71
11240069|NCT02087150|12432329|FG001|COMPLETED|Overall Study||128
11240070|NCT02087150|12432330|FG002|COMPLETED|Overall Study||69
11240071|NCT02087150|12432328|FG000|NOT COMPLETED|Overall Study||10
11240072|NCT02087150|12432329|FG001|NOT COMPLETED|Overall Study||34
11240073|NCT02087150|12432330|FG002|NOT COMPLETED|Overall Study||11
11240074|NCT02087163|12432339|FG000|STARTED|Overall Study||90
11240075|NCT02087163|12432339|FG000|COMPLETED|Overall Study||73
11240076|NCT02087163|12432339|FG000|NOT COMPLETED|Overall Study||17
11240077|NCT02087176|12432343|FG000|STARTED|Overall Study||32
11240078|NCT02087176|12432343|FG000|COMPLETED|Overall Study|The sponsor terminated the study early.|0
11240079|NCT02087176|12432343|FG000|NOT COMPLETED|Overall Study||32
11240080|NCT02087241|12432351|FG000|STARTED|Overall Study||3
11240081|NCT02087241|12432352|FG001|STARTED|Overall Study||3
11240082|NCT02087241|12432353|FG002|STARTED|Overall Study||1
11240083|NCT02087241|12432354|FG003|STARTED|Overall Study||7
11130788|NCT01397409|12316755|FG003|STARTED|Stage 3||0
11240084|NCT02087241|12432351|FG000|COMPLETED|Overall Study||0
11240085|NCT02087241|12432352|FG001|COMPLETED|Overall Study||0
11240086|NCT02087241|12432353|FG002|COMPLETED|Overall Study||0
11130789|NCT01397409|12316756|FG004|STARTED|Stage 3||0
11130790|NCT01397409|12316757|FG005|STARTED|Stage 3||0
11130791|NCT01397409|12316758|FG006|STARTED|Stage 3||0
11130792|NCT01397409|12316759|FG007|STARTED|Stage 3||23
11130793|NCT01397409|12316760|FG008|STARTED|Stage 3||25
11130794|NCT01397409|12316761|FG009|STARTED|Stage 3||16
11130795|NCT01397409|12316752|FG000|COMPLETED|Stage 3||0
11130796|NCT01397409|12316753|FG001|COMPLETED|Stage 3||0
11130797|NCT01397409|12316754|FG002|COMPLETED|Stage 3||0
11130798|NCT01397409|12316755|FG003|COMPLETED|Stage 3||0
11130799|NCT01397409|12316756|FG004|COMPLETED|Stage 3||0
11130800|NCT01397409|12316757|FG005|COMPLETED|Stage 3||0
11130801|NCT01397409|12316758|FG006|COMPLETED|Stage 3||0
11130802|NCT01397409|12316759|FG007|COMPLETED|Stage 3||21
11130803|NCT01397409|12316760|FG008|COMPLETED|Stage 3||25
11130804|NCT01397409|12316761|FG009|COMPLETED|Stage 3||16
11130805|NCT01397409|12316752|FG000|NOT COMPLETED|Stage 3||0
11130806|NCT01397409|12316753|FG001|NOT COMPLETED|Stage 3||0
11130807|NCT01397409|12316754|FG002|NOT COMPLETED|Stage 3||0
11130808|NCT01397409|12316755|FG003|NOT COMPLETED|Stage 3||0
11130809|NCT01397409|12316756|FG004|NOT COMPLETED|Stage 3||0
11130810|NCT01397409|12316757|FG005|NOT COMPLETED|Stage 3||0
11130811|NCT01397409|12316758|FG006|NOT COMPLETED|Stage 3||0
11130812|NCT01397409|12316759|FG007|NOT COMPLETED|Stage 3||2
11130813|NCT01397409|12316760|FG008|NOT COMPLETED|Stage 3||0
11130814|NCT01397409|12316761|FG009|NOT COMPLETED|Stage 3||0
11130815|NCT01397422|12316788|FG000|STARTED|Overall Study||22
11130816|NCT01397422|12316789|FG001|STARTED|Overall Study||20
11130817|NCT01397422|12316790|FG002|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
11130818|NCT01397422|12316791|FG003|STARTED|Overall Study||20
11130819|NCT01397422|12316788|FG000|COMPLETED|Overall Study||20
11130820|NCT01397422|12316789|FG001|COMPLETED|Overall Study||17
11130821|NCT01397422|12316790|FG002|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
11130822|NCT01397422|12316791|FG003|COMPLETED|Overall Study||12
11130823|NCT01397422|12316788|FG000|NOT COMPLETED|Overall Study||2
11130824|NCT01397422|12316789|FG001|NOT COMPLETED|Overall Study||3
11130825|NCT01397422|12316790|FG002|NOT COMPLETED|Overall Study||3
11130826|NCT01397422|12316791|FG003|NOT COMPLETED|Overall Study||8
11130827|NCT01397448|12316806|FG000|STARTED|Overall Study||156
11130828|NCT01397448|12316807|FG001|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
11130829|NCT01397448|12316808|FG002|STARTED|Overall Study||158
11130830|NCT01397448|12316806|FG000|COMPLETED|Overall Study||138
11130831|NCT01397448|12316807|FG001|COMPLETED|Overall Study||142
11130832|NCT01397448|12316808|FG002|COMPLETED|Overall Study||140
11130833|NCT01397448|12316806|FG000|NOT COMPLETED|Overall Study||18
11130834|NCT01397448|12316807|FG001|NOT COMPLETED|Overall Study||15
11130835|NCT01397448|12316808|FG002|NOT COMPLETED|Overall Study||18
11130836|NCT01397461|12316819|FG000|STARTED|Overall Study||155
11130837|NCT01397461|12316820|FG001|STARTED|Overall Study||156
11130838|NCT01397461|12316821|FG002|STARTED|Overall Study||154
11130839|NCT01397461|12316819|FG000|COMPLETED|Overall Study||153
11130840|NCT01397461|12316820|FG001|COMPLETED|Overall Study||150
11130841|NCT01397461|12316821|FG002|COMPLETED|Overall Study||152
11130842|NCT01397461|12316819|FG000|NOT COMPLETED|Overall Study||2
11130843|NCT01397461|12316820|FG001|NOT COMPLETED|Overall Study||6
11130844|NCT01397461|12316821|FG002|NOT COMPLETED|Overall Study||2
11130845|NCT01397591|12316829|FG000|STARTED|Overall Study||2
11130846|NCT01397591|12316829|FG000|COMPLETED|Overall Study||2
11130847|NCT01397591|12316829|FG000|NOT COMPLETED|Overall Study||0
11130848|NCT01397617|12316837|FG000|STARTED|Overall Study||64
11130849|NCT01397617|12316838|FG001|STARTED|Overall Study||53
11130850|NCT01397617|12316839|FG002|STARTED|Overall Study||60
11130851|NCT01397617|12316837|FG000|COMPLETED|Overall Study||33
11130852|NCT01397617|12316838|FG001|COMPLETED|Overall Study||30
11130853|NCT01397617|12316839|FG002|COMPLETED|Overall Study||31
11130854|NCT01397617|12316837|FG000|NOT COMPLETED|Overall Study||31
11130855|NCT01397617|12316838|FG001|NOT COMPLETED|Overall Study||23
11130856|NCT01397617|12316839|FG002|NOT COMPLETED|Overall Study||29
11130857|NCT01397656|12316852|FG000|STARTED|Overall Study||33
11130858|NCT01397656|12316853|FG001|STARTED|Overall Study||30
11130859|NCT01397656|12316852|FG000|COMPLETED|Overall Study||33
11130860|NCT01397656|12316853|FG001|COMPLETED|Overall Study||30
11130861|NCT01397656|12316852|FG000|NOT COMPLETED|Overall Study||0
11130862|NCT01397656|12316853|FG001|NOT COMPLETED|Overall Study||0
11130863|NCT01397747|12316861|FG000|STARTED|Overall Study||11016
11130864|NCT01397747|12316861|FG000|COMPLETED|Overall Study||9989
11130865|NCT01397747|12316861|FG000|NOT COMPLETED|Overall Study||1027
11130866|NCT01397786|12316869|FG000|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
11130867|NCT01397786|12316870|FG001|STARTED|Phase A||0
11130868|NCT01397786|12316871|FG002|STARTED|Phase A||227
11130869|NCT01397786|12316869|FG000|COMPLETED|Phase A||12
11130870|NCT01397786|12316870|FG001|COMPLETED|Phase A||0
11130871|NCT01397786|12316871|FG002|COMPLETED|Phase A||199
11130872|NCT01397786|12316869|FG000|NOT COMPLETED|Phase A||0
11130873|NCT01397786|12316870|FG001|NOT COMPLETED|Phase A||0
11130874|NCT01397786|12316871|FG002|NOT COMPLETED|Phase A||28
11130875|NCT01397786|12316869|FG000|STARTED|Phase B||611
11130876|NCT01397786|12316870|FG001|STARTED|Phase B||204
11130877|NCT01397786|12316871|FG002|STARTED|Phase B||229
11130878|NCT01397786|12316869|FG000|COMPLETED|Phase B||308
11130879|NCT01397786|12316870|FG001|COMPLETED|Phase B||109
11130880|NCT01397786|12316871|FG002|COMPLETED|Phase B||91
11130881|NCT01397786|12316869|FG000|NOT COMPLETED|Phase B||303
11130882|NCT01397786|12316870|FG001|NOT COMPLETED|Phase B||95
11130883|NCT01397786|12316871|FG002|NOT COMPLETED|Phase B||138
11130884|NCT01397825|12316887|FG000|STARTED|Overall Study||13
11130885|NCT01397825|12316888|FG001|STARTED|Overall Study||4
11130886|NCT01397825|12316889|FG002|STARTED|Overall Study||25
11130887|NCT01397825|12316890|FG003|STARTED|Overall Study||3
11130888|NCT01397825|12316891|FG004|STARTED|Overall Study||0
11130889|NCT01397825|12316887|FG000|COMPLETED|Overall Study||0
11130890|NCT01397825|12316888|FG001|COMPLETED|Overall Study||0
11130891|NCT01397825|12316889|FG002|COMPLETED|Overall Study||0
11130892|NCT01397825|12316890|FG003|COMPLETED|Overall Study||0
11130893|NCT01397825|12316891|FG004|COMPLETED|Overall Study||0
11130894|NCT01397825|12316887|FG000|NOT COMPLETED|Overall Study||13
11130895|NCT01397825|12316888|FG001|NOT COMPLETED|Overall Study||4
11130896|NCT01397825|12316889|FG002|NOT COMPLETED|Overall Study||25
11130897|NCT01397825|12316890|FG003|NOT COMPLETED|Overall Study||3
11130898|NCT01397825|12316891|FG004|NOT COMPLETED|Overall Study||0
11130899|NCT01397851|12316907|FG000|STARTED|Overall Study||41634
11130900|NCT01397851|12316908|FG001|STARTED|Overall Study||39963
11130901|NCT01397851|12316907|FG000|COMPLETED|Overall Study||41555
11130902|NCT01397851|12316908|FG001|COMPLETED|Overall Study||39917
11130903|NCT01397851|12316907|FG000|NOT COMPLETED|Overall Study||79
11130904|NCT01397851|12316908|FG001|NOT COMPLETED|Overall Study||46
11130905|NCT01397890|12316916|FG000|STARTED|Overall Study||287
11130906|NCT01397890|12316917|FG001|STARTED|Overall Study||291
11130907|NCT01397890|12316916|FG000|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
11130908|NCT01397890|12316917|FG001|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
11130909|NCT01397890|12316916|FG000|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
11130910|NCT01397890|12316917|FG001|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
11130911|NCT01397890|12316916|FG000|COMPLETED|Overall Study||264
11130912|NCT01397890|12316917|FG001|COMPLETED|Overall Study||260
11130913|NCT01397890|12316916|FG000|NOT COMPLETED|Overall Study||23
11130914|NCT01397890|12316917|FG001|NOT COMPLETED|Overall Study||31
11130915|NCT01398059|12316923|FG000|STARTED|Overall Study||4
11130916|NCT01398059|12316924|FG001|STARTED|Overall Study||3
11130917|NCT01398059|12316925|FG002|STARTED|Overall Study||4
11130918|NCT01398059|12316926|FG003|STARTED|Overall Study||2
11130919|NCT01398059|12316927|FG004|STARTED|Overall Study||4
11130920|NCT01398059|12316928|FG005|STARTED|Overall Study||2
11130921|NCT01398059|12316923|FG000|COMPLETED|Overall Study||4
11130922|NCT01398059|12316924|FG001|COMPLETED|Overall Study||3
11130923|NCT01398059|12316925|FG002|COMPLETED|Overall Study||4
11130924|NCT01398059|12316926|FG003|COMPLETED|Overall Study||2
11130925|NCT01398059|12316927|FG004|COMPLETED|Overall Study||4
11130926|NCT01398059|12316928|FG005|COMPLETED|Overall Study||2
11130927|NCT01398059|12316923|FG000|NOT COMPLETED|Overall Study||0
11130928|NCT01398059|12316924|FG001|NOT COMPLETED|Overall Study||0
11130929|NCT01398059|12316925|FG002|NOT COMPLETED|Overall Study||0
11130930|NCT01398059|12316926|FG003|NOT COMPLETED|Overall Study||0
11130931|NCT01398059|12316927|FG004|NOT COMPLETED|Overall Study||0
11130932|NCT01398059|12316928|FG005|NOT COMPLETED|Overall Study||0
11130933|NCT01398176|12316938|FG000|STARTED|Overall Study||26
11130934|NCT01398176|12316939|FG001|STARTED|Overall Study||25
11130935|NCT01398176|12316938|FG000|COMPLETED|Overall Study||23
11130936|NCT01398176|12316939|FG001|COMPLETED|Overall Study||19
11130937|NCT01398176|12316938|FG000|NOT COMPLETED|Overall Study||3
11130938|NCT01398176|12316939|FG001|NOT COMPLETED|Overall Study||6
11130939|NCT01398280|12316947|FG000|STARTED|Overall Study||11
11130940|NCT01398280|12316948|FG001|STARTED|Overall Study||4
11130941|NCT01398280|12316947|FG000|COMPLETED|Overall Study||7
11130942|NCT01398280|12316948|FG001|COMPLETED|Overall Study||4
11130943|NCT01398280|12316947|FG000|NOT COMPLETED|Overall Study||4
11130944|NCT01398280|12316948|FG001|NOT COMPLETED|Overall Study||0
11130945|NCT01398358|12316957|FG000|STARTED|Overall Study||218
11130946|NCT01398358|12316958|FG001|STARTED|Overall Study||224
11130947|NCT01398358|12316959|FG002|STARTED|Overall Study||255
11130948|NCT01398358|12316957|FG000|COMPLETED|Overall Study||203
11130949|NCT01398358|12316958|FG001|COMPLETED|Overall Study||201
11130950|NCT01398358|12316959|FG002|COMPLETED|Overall Study||234
11130951|NCT01398358|12316957|FG000|NOT COMPLETED|Overall Study||15
11130952|NCT01398358|12316958|FG001|NOT COMPLETED|Overall Study||23
11130953|NCT01398358|12316959|FG002|NOT COMPLETED|Overall Study||21
11130954|NCT01398410|12316969|FG000|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
11130955|NCT01398410|12316970|FG001|STARTED|Overall Study||204
11130956|NCT01398410|12316969|FG000|COMPLETED|Overall Study||143
11130957|NCT01398410|12316970|FG001|COMPLETED|Overall Study||148
11130958|NCT01398410|12316969|FG000|NOT COMPLETED|Overall Study||58
11130959|NCT01398410|12316970|FG001|NOT COMPLETED|Overall Study||56
11130960|NCT01398475|12316976|FG000|STARTED|Overall Study||4
11130961|NCT01398475|12316977|FG001|STARTED|Overall Study||3
11130962|NCT01398475|12316978|FG002|STARTED|Overall Study||4
11130963|NCT01398475|12316979|FG003|STARTED|Overall Study||4
11130964|NCT01398475|12316976|FG000|Received First Intervention|Overall Study||4
11130965|NCT01398475|12316977|FG001|Received First Intervention|Overall Study||3
11130966|NCT01398475|12316978|FG002|Received First Intervention|Overall Study||4
11130967|NCT01398475|12316979|FG003|Received First Intervention|Overall Study||4
11130968|NCT01398475|12316976|FG000|Received Second Intervention|Overall Study||4
11130969|NCT01398475|12316977|FG001|Received Second Intervention|Overall Study||3
11130970|NCT01398475|12316978|FG002|Received Second Intervention|Overall Study||4
11130971|NCT01398475|12316979|FG003|Received Second Intervention|Overall Study||4
11130972|NCT01398475|12316976|FG000|Received Third Intervention|Overall Study||4
11130973|NCT01398475|12316977|FG001|Received Third Intervention|Overall Study||3
11130974|NCT01398475|12316978|FG002|Received Third Intervention|Overall Study||4
11130975|NCT01398475|12316979|FG003|Received Third Intervention|Overall Study||4
11130976|NCT01398475|12316976|FG000|Received Fourth Intervention|Overall Study||4
11130977|NCT01398475|12316977|FG001|Received Fourth Intervention|Overall Study||3
11130978|NCT01398475|12316978|FG002|Received Fourth Intervention|Overall Study||4
11130979|NCT01398475|12316979|FG003|Received Fourth Intervention|Overall Study||4
11130980|NCT01398475|12316976|FG000|COMPLETED|Overall Study||4
11130981|NCT01398475|12316977|FG001|COMPLETED|Overall Study||3
11240087|NCT02087241|12432354|FG003|COMPLETED|Overall Study||0
11240088|NCT02087241|12432351|FG000|NOT COMPLETED|Overall Study||3
11240089|NCT02087241|12432352|FG001|NOT COMPLETED|Overall Study||3
11240090|NCT02087241|12432353|FG002|NOT COMPLETED|Overall Study||1
11240091|NCT02087241|12432354|FG003|NOT COMPLETED|Overall Study||7
11240092|NCT02087306|12432371|FG000|STARTED|Overall Study||65
11130982|NCT01398475|12316978|FG002|COMPLETED|Overall Study||4
11130983|NCT01398475|12316979|FG003|COMPLETED|Overall Study||4
11130984|NCT01398475|12316976|FG000|NOT COMPLETED|Overall Study||0
11130985|NCT01398475|12316977|FG001|NOT COMPLETED|Overall Study||0
11130986|NCT01398475|12316978|FG002|NOT COMPLETED|Overall Study||0
11130987|NCT01398475|12316979|FG003|NOT COMPLETED|Overall Study||0
11130988|NCT01398514|12316991|FG000|STARTED|Overall Study||26
11130989|NCT01398514|12316992|FG001|STARTED|Overall Study||26
11130990|NCT01398514|12316991|FG000|COMPLETED|Overall Study||18
11130991|NCT01398514|12316992|FG001|COMPLETED|Overall Study||20
11130992|NCT01398514|12316991|FG000|NOT COMPLETED|Overall Study||8
11130993|NCT01398514|12316992|FG001|NOT COMPLETED|Overall Study||6
11240093|NCT02087306|12432372|FG001|STARTED|Overall Study||93
11240094|NCT02087306|12432373|FG002|STARTED|Overall Study||43
11240095|NCT02087306|12432371|FG000|COMPLETED|Overall Study||29
11130994|NCT01398566|12317000|FG000|STARTED|Overall Study|20 enrolled|20
11130995|NCT01398566|12317000|FG000|COMPLETED|Overall Study||20
11130996|NCT01398566|12317000|FG000|NOT COMPLETED|Overall Study||0
11130997|NCT01398787|12317004|FG000|STARTED|Overall Study||198
11130998|NCT01398787|12317004|FG000|COMPLETED|Overall Study||197
11130999|NCT01398787|12317004|FG000|NOT COMPLETED|Overall Study||1
11131000|NCT01398943|12317012|FG000|STARTED|First Intervention (1 Day)||15
11131001|NCT01398943|12317013|FG001|STARTED|First Intervention (1 Day)||15
11131002|NCT01398943|12317014|FG002|STARTED|First Intervention (1 Day)||15
11131003|NCT01398943|12317015|FG003|STARTED|First Intervention (1 Day)||15
11131004|NCT01398943|12317012|FG000|COMPLETED|First Intervention (1 Day)||15
11131005|NCT01398943|12317013|FG001|COMPLETED|First Intervention (1 Day)||15
11131006|NCT01398943|12317014|FG002|COMPLETED|First Intervention (1 Day)||15
11131007|NCT01398943|12317015|FG003|COMPLETED|First Intervention (1 Day)||15
11131008|NCT01398943|12317012|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11240096|NCT02087306|12432372|FG001|COMPLETED|Overall Study||29
11240097|NCT02087306|12432373|FG002|COMPLETED|Overall Study||16
11240098|NCT02087306|12432371|FG000|NOT COMPLETED|Overall Study||36
11240099|NCT02087306|12432372|FG001|NOT COMPLETED|Overall Study||64
11240100|NCT02087306|12432373|FG002|NOT COMPLETED|Overall Study||27
11240101|NCT02087514|12432386|FG000|STARTED|Overall Study||10
11240102|NCT02087514|12432387|FG001|STARTED|Overall Study||10
11131009|NCT01398943|12317013|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11131010|NCT01398943|12317014|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11131011|NCT01398943|12317015|FG003|NOT COMPLETED|First Intervention (1 Day)||0
11131012|NCT01398943|12317012|FG000|STARTED|Washout (2-7 Days)||15
11131013|NCT01398943|12317013|FG001|STARTED|Washout (2-7 Days)||15
11131014|NCT01398943|12317014|FG002|STARTED|Washout (2-7 Days)||15
11131015|NCT01398943|12317015|FG003|STARTED|Washout (2-7 Days)||15
11131016|NCT01398943|12317012|FG000|COMPLETED|Washout (2-7 Days)||15
11131017|NCT01398943|12317013|FG001|COMPLETED|Washout (2-7 Days)||15
11131018|NCT01398943|12317014|FG002|COMPLETED|Washout (2-7 Days)||15
11131019|NCT01398943|12317015|FG003|COMPLETED|Washout (2-7 Days)||15
11131020|NCT01398943|12317012|FG000|NOT COMPLETED|Washout (2-7 Days)||0
11131021|NCT01398943|12317013|FG001|NOT COMPLETED|Washout (2-7 Days)||0
11131022|NCT01398943|12317014|FG002|NOT COMPLETED|Washout (2-7 Days)||0
11131023|NCT01398943|12317015|FG003|NOT COMPLETED|Washout (2-7 Days)||0
11131024|NCT01398943|12317012|FG000|STARTED|Second Intervention (1 Day)||15
11131025|NCT01398943|12317013|FG001|STARTED|Second Intervention (1 Day)||15
11131026|NCT01398943|12317014|FG002|STARTED|Second Intervention (1 Day)||15
11131027|NCT01398943|12317015|FG003|STARTED|Second Intervention (1 Day)||15
11131028|NCT01398943|12317012|FG000|COMPLETED|Second Intervention (1 Day)||15
11131029|NCT01398943|12317013|FG001|COMPLETED|Second Intervention (1 Day)||15
11131030|NCT01398943|12317014|FG002|COMPLETED|Second Intervention (1 Day)||15
11131031|NCT01398943|12317015|FG003|COMPLETED|Second Intervention (1 Day)||15
11131032|NCT01398943|12317012|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11131033|NCT01398943|12317013|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11131034|NCT01398943|12317014|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11131035|NCT01398943|12317015|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
11131036|NCT01398956|12317023|FG000|STARTED|Overall Study||44
11131037|NCT01398956|12317023|FG000|COMPLETED|Overall Study||34
11131038|NCT01398956|12317023|FG000|NOT COMPLETED|Overall Study||10
11131039|NCT01398982|12317030|FG000|STARTED|Overall Study||44
11131040|NCT01398982|12317031|FG001|STARTED|Overall Study||49
11131041|NCT01398982|12317030|FG000|COMPLETED|Overall Study||38
11131042|NCT01398982|12317031|FG001|COMPLETED|Overall Study||47
11131043|NCT01398982|12317030|FG000|NOT COMPLETED|Overall Study||6
11131044|NCT01398982|12317031|FG001|NOT COMPLETED|Overall Study||2
11131045|NCT01399008|12317040|FG000|STARTED|Overall Study||35
11131046|NCT01399008|12317041|FG001|STARTED|Overall Study||32
11240103|NCT02087514|12432388|FG002|STARTED|Overall Study||10
11240104|NCT02087514|12432389|FG003|STARTED|Overall Study||10
11240105|NCT02087514|12432390|FG004|STARTED|Overall Study||10
11240106|NCT02087514|12432391|FG005|STARTED|Overall Study||10
11240107|NCT02087514|12432386|FG000|COMPLETED|Overall Study||8
11131047|NCT01399008|12317042|FG002|STARTED|Overall Study||33
11131048|NCT01399008|12317040|FG000|COMPLETED|Overall Study||32
11131049|NCT01399008|12317041|FG001|COMPLETED|Overall Study||27
11131050|NCT01399008|12317042|FG002|COMPLETED|Overall Study||31
11131051|NCT01399008|12317040|FG000|NOT COMPLETED|Overall Study||3
11131052|NCT01399008|12317041|FG001|NOT COMPLETED|Overall Study||5
11131053|NCT01399008|12317042|FG002|NOT COMPLETED|Overall Study||2
11131054|NCT01399047|12317052|FG000|STARTED|Overall Study||10
11131055|NCT01399047|12317053|FG001|STARTED|Overall Study||9
11131056|NCT01399047|12317052|FG000|COMPLETED|Overall Study||10
11131057|NCT01399047|12317053|FG001|COMPLETED|Overall Study||8
11131058|NCT01399047|12317052|FG000|NOT COMPLETED|Overall Study||0
11131059|NCT01399047|12317053|FG001|NOT COMPLETED|Overall Study||1
11131060|NCT01399099|12317061|FG000|STARTED|Overall Study||67
11131061|NCT01399099|12317061|FG000|6 Months|Overall Study||47
11131062|NCT01399099|12317061|FG000|COMPLETED|Overall Study||36
11131063|NCT01399099|12317061|FG000|NOT COMPLETED|Overall Study||31
11131064|NCT01399125|12317068|FG000|STARTED|Overall Study||248
11131065|NCT01399125|12317069|FG001|STARTED|Overall Study||253
11131066|NCT01399125|12317068|FG000|Per Protocol (PP) Population|Overall Study||192
11131067|NCT01399125|12317069|FG001|Per Protocol (PP) Population|Overall Study||188
11131068|NCT01399125|12317068|FG000|COMPLETED|Overall Study||197
11131069|NCT01399125|12317069|FG001|COMPLETED|Overall Study||193
11131070|NCT01399125|12317068|FG000|NOT COMPLETED|Overall Study||51
11131071|NCT01399125|12317069|FG001|NOT COMPLETED|Overall Study||60
11131072|NCT01399190|12317075|FG000|STARTED|Overall Study||68
11131073|NCT01399190|12317075|FG000|Included in Final Analysis|Overall Study||63
11131074|NCT01399190|12317075|FG000|Evaluable for Primary Endpoint Analysis|Overall Study||60
11131075|NCT01399190|12317075|FG000|COMPLETED|Overall Study||48
11131076|NCT01399190|12317075|FG000|NOT COMPLETED|Overall Study||20
11131077|NCT01399229|12317079|FG000|STARTED|Overall Study||20
11131078|NCT01399229|12317080|FG001|STARTED|Overall Study||5
11131079|NCT01399229|12317081|FG002|STARTED|Overall Study||5
11131080|NCT01399229|12317079|FG000|COMPLETED|Overall Study||20
11131081|NCT01399229|12317080|FG001|COMPLETED|Overall Study||5
11131082|NCT01399229|12317081|FG002|COMPLETED|Overall Study||5
11131083|NCT01399229|12317079|FG000|NOT COMPLETED|Overall Study||0
11131084|NCT01399229|12317080|FG001|NOT COMPLETED|Overall Study||0
11131085|NCT01399229|12317081|FG002|NOT COMPLETED|Overall Study||0
11131086|NCT01399268|12317087|FG000|STARTED|Overall Study||15
11131087|NCT01399268|12317088|FG001|STARTED|Overall Study||15
11131088|NCT01399268|12317087|FG000|COMPLETED|Overall Study||15
11131089|NCT01399268|12317088|FG001|COMPLETED|Overall Study||15
11131090|NCT01399268|12317087|FG000|NOT COMPLETED|Overall Study||0
11131091|NCT01399268|12317088|FG001|NOT COMPLETED|Overall Study||0
11240108|NCT02087514|12432387|FG001|COMPLETED|Overall Study||10
11240109|NCT02087514|12432388|FG002|COMPLETED|Overall Study||7
11240110|NCT02087514|12432389|FG003|COMPLETED|Overall Study||8
11240111|NCT02087514|12432390|FG004|COMPLETED|Overall Study||10
11240112|NCT02087514|12432391|FG005|COMPLETED|Overall Study||9
11131092|NCT01399593|12317096|FG000|STARTED|Overall Study||51
11131093|NCT01399593|12317097|FG001|STARTED|Overall Study||51
11131094|NCT01399593|12317096|FG000|COMPLETED|Overall Study||48
11131095|NCT01399593|12317097|FG001|COMPLETED|Overall Study||49
11131096|NCT01399593|12317096|FG000|NOT COMPLETED|Overall Study||3
11131097|NCT01399593|12317097|FG001|NOT COMPLETED|Overall Study||2
11131098|NCT01399619|12317105|FG000|STARTED|Overall Study||123
11131099|NCT01399619|12317106|FG001|STARTED|Overall Study||84
11131100|NCT01399619|12317107|FG002|STARTED|Overall Study||86
11131101|NCT01399619|12317108|FG003|STARTED|Overall Study||17
11131102|NCT01399619|12317105|FG000|COMPLETED|Overall Study||98
11131103|NCT01399619|12317106|FG001|COMPLETED|Overall Study||84
11131104|NCT01399619|12317107|FG002|COMPLETED|Overall Study||74
11131105|NCT01399619|12317108|FG003|COMPLETED|Overall Study||0
11131106|NCT01399619|12317105|FG000|NOT COMPLETED|Overall Study||25
11131107|NCT01399619|12317106|FG001|NOT COMPLETED|Overall Study||0
11131108|NCT01399619|12317107|FG002|NOT COMPLETED|Overall Study||12
11131109|NCT01399619|12317108|FG003|NOT COMPLETED|Overall Study||17
11131110|NCT01399697|12317126|FG000|STARTED|Overall Study||96
11131111|NCT01399697|12317127|FG001|STARTED|Overall Study||83
11131112|NCT01399697|12317128|FG002|STARTED|Overall Study||82
11131113|NCT01399697|12317126|FG000|COMPLETED|Overall Study||55
11131114|NCT01399697|12317127|FG001|COMPLETED|Overall Study||80
11240113|NCT02087514|12432386|FG000|NOT COMPLETED|Overall Study||2
11240114|NCT02087514|12432387|FG001|NOT COMPLETED|Overall Study||0
11131115|NCT01399697|12317128|FG002|COMPLETED|Overall Study||78
11131116|NCT01399697|12317126|FG000|NOT COMPLETED|Overall Study||41
11131117|NCT01399697|12317127|FG001|NOT COMPLETED|Overall Study||3
11131118|NCT01399697|12317128|FG002|NOT COMPLETED|Overall Study||4
11131119|NCT01399723|12317141|FG000|STARTED|Overall Study||263
11131120|NCT01399723|12317142|FG001|STARTED|Overall Study||264
11131121|NCT01399723|12317141|FG000|COMPLETED|Overall Study||263
11131122|NCT01399723|12317142|FG001|COMPLETED|Overall Study||263
11131123|NCT01399723|12317141|FG000|NOT COMPLETED|Overall Study||0
11131124|NCT01399723|12317142|FG001|NOT COMPLETED|Overall Study||1
11240115|NCT02087514|12432388|FG002|NOT COMPLETED|Overall Study||3
11131125|NCT01399736|12317151|FG000|STARTED|Overall Study||295
11131126|NCT01399736|12317152|FG001|STARTED|Overall Study||590
11131127|NCT01399736|12317151|FG000|COMPLETED|Overall Study||291
11131128|NCT01399736|12317152|FG001|COMPLETED|Overall Study||586
11131129|NCT01399736|12317151|FG000|NOT COMPLETED|Overall Study||4
11131130|NCT01399736|12317152|FG001|NOT COMPLETED|Overall Study||4
11131131|NCT01399788|12317166|FG000|STARTED|First Intervention Period||18
11131132|NCT01399788|12317167|FG001|STARTED|First Intervention Period||18
11131133|NCT01399788|12317166|FG000|COMPLETED|First Intervention Period||17
11131134|NCT01399788|12317167|FG001|COMPLETED|First Intervention Period||18
11131135|NCT01399788|12317166|FG000|NOT COMPLETED|First Intervention Period||1
11131136|NCT01399788|12317167|FG001|NOT COMPLETED|First Intervention Period||0
11131137|NCT01399788|12317166|FG000|STARTED|Washout Period (at Least 1 Week)||17
11131138|NCT01399788|12317167|FG001|STARTED|Washout Period (at Least 1 Week)||18
11131139|NCT01399788|12317166|FG000|COMPLETED|Washout Period (at Least 1 Week)||17
11131140|NCT01399788|12317167|FG001|COMPLETED|Washout Period (at Least 1 Week)||18
11131141|NCT01399788|12317166|FG000|NOT COMPLETED|Washout Period (at Least 1 Week)||0
11131142|NCT01399788|12317167|FG001|NOT COMPLETED|Washout Period (at Least 1 Week)||0
11131143|NCT01399788|12317166|FG000|STARTED|Second Intervention Period||17
11131144|NCT01399788|12317167|FG001|STARTED|Second Intervention Period||18
11131145|NCT01399788|12317166|FG000|COMPLETED|Second Intervention Period||17
11131146|NCT01399788|12317167|FG001|COMPLETED|Second Intervention Period||18
11131147|NCT01399788|12317166|FG000|NOT COMPLETED|Second Intervention Period||0
11131148|NCT01399788|12317167|FG001|NOT COMPLETED|Second Intervention Period||0
11131149|NCT01399827|12317175|FG000|STARTED|Overall Study||1
11131150|NCT01399827|12317176|FG001|STARTED|Overall Study||1
11131151|NCT01399827|12317175|FG000|COMPLETED|Overall Study||1
11131152|NCT01399827|12317176|FG001|COMPLETED|Overall Study||1
11131153|NCT01399827|12317175|FG000|NOT COMPLETED|Overall Study||0
11131154|NCT01399827|12317176|FG001|NOT COMPLETED|Overall Study||0
11131155|NCT01399866|12317184|FG000|STARTED|Overall Study||32
11131156|NCT01399866|12317185|FG001|STARTED|Overall Study||30
11131157|NCT01399866|12317184|FG000|COMPLETED|Overall Study||28
11131158|NCT01399866|12317185|FG001|COMPLETED|Overall Study||28
11131159|NCT01399866|12317184|FG000|NOT COMPLETED|Overall Study||4
11131160|NCT01399866|12317185|FG001|NOT COMPLETED|Overall Study||2
11131161|NCT01399905|12317193|FG000|STARTED|Overall Study||7
11131162|NCT01399905|12317194|FG001|STARTED|Overall Study||7
11131163|NCT01399905|12317193|FG000|COMPLETED|Overall Study|Subject withdrew from the study before receiving treatment.|6
11131164|NCT01399905|12317194|FG001|COMPLETED|Overall Study|Subject was treated at least one dose of carbidopa before withdrawing from the study.|6
11131165|NCT01399905|12317193|FG000|NOT COMPLETED|Overall Study||1
11131166|NCT01399905|12317194|FG001|NOT COMPLETED|Overall Study||1
11131167|NCT01400113|12317207|FG000|STARTED|Overall Study||60
11131168|NCT01400113|12317208|FG001|STARTED|Overall Study||60
11131169|NCT01400113|12317207|FG000|COMPLETED|Overall Study||59
11131170|NCT01400113|12317208|FG001|COMPLETED|Overall Study||59
11131171|NCT01400113|12317207|FG000|NOT COMPLETED|Overall Study||1
11131172|NCT01400113|12317208|FG001|NOT COMPLETED|Overall Study||1
11131173|NCT01400139|12317214|FG000|STARTED|HYD Core Study||922
11131174|NCT01400139|12317214|FG000|COMPLETED|HYD Core Study||410
11240116|NCT02087514|12432389|FG003|NOT COMPLETED|Overall Study||2
11240117|NCT02087514|12432390|FG004|NOT COMPLETED|Overall Study||0
11240118|NCT02087514|12432391|FG005|NOT COMPLETED|Overall Study||1
11240119|NCT02087670|12432407|FG000|STARTED|Overall Study||20
11240120|NCT02087670|12432408|FG001|STARTED|Overall Study||22
11240121|NCT02087670|12432407|FG000|COMPLETED|Overall Study||17
11240122|NCT02087670|12432408|FG001|COMPLETED|Overall Study||20
11240123|NCT02087670|12432407|FG000|NOT COMPLETED|Overall Study||3
11240124|NCT02087670|12432408|FG001|NOT COMPLETED|Overall Study||2
11240125|NCT02087748|12432414|FG000|STARTED|Overall Study||24
11240126|NCT02087748|12432414|FG000|COMPLETED|Overall Study||24
11240127|NCT02087748|12432414|FG000|NOT COMPLETED|Overall Study||0
11240128|NCT02087774|12432424|FG000|STARTED|Overall Study||150
11131175|NCT01400139|12317214|FG000|NOT COMPLETED|HYD Core Study||512
11131176|NCT01400139|12317214|FG000|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
11131177|NCT01400139|12317214|FG000|COMPLETED|HYD Extension Period||83
11131178|NCT01400139|12317214|FG000|NOT COMPLETED|HYD Extension Period||23
11131179|NCT01400243|12317222|FG000|STARTED|Overall Study||64
11131180|NCT01400243|12317223|FG001|STARTED|Overall Study||63
11131181|NCT01400243|12317222|FG000|COMPLETED|Overall Study||56
11131182|NCT01400243|12317223|FG001|COMPLETED|Overall Study||52
11131183|NCT01400243|12317222|FG000|NOT COMPLETED|Overall Study||8
11131184|NCT01400243|12317223|FG001|NOT COMPLETED|Overall Study||11
11131185|NCT01400412|12317233|FG000|STARTED|Overall Study||130
11131186|NCT01400412|12317234|FG001|STARTED|Overall Study||132
11240129|NCT02087774|12432425|FG001|STARTED|Overall Study||150
11240130|NCT02087774|12432424|FG000|COMPLETED|Overall Study||142
11240131|NCT02087774|12432425|FG001|COMPLETED|Overall Study||130
11240132|NCT02087774|12432424|FG000|NOT COMPLETED|Overall Study||8
11131187|NCT01400412|12317233|FG000|COMPLETED|Overall Study||120
11131188|NCT01400412|12317234|FG001|COMPLETED|Overall Study||115
11131189|NCT01400412|12317233|FG000|NOT COMPLETED|Overall Study||10
11131190|NCT01400412|12317234|FG001|NOT COMPLETED|Overall Study||17
11131191|NCT01400425|12317242|FG000|STARTED|Overall Study||239
11131192|NCT01400425|12317242|FG000|COMPLETED|Overall Study||229
11131193|NCT01400425|12317242|FG000|NOT COMPLETED|Overall Study||10
11131194|NCT01400451|12317251|FG000|STARTED|28 Day Lead In With Vemurafenib Alone||6
11131195|NCT01400451|12317252|FG001|STARTED|28 Day Lead In With Vemurafenib Alone||4
11131196|NCT01400451|12317253|FG002|STARTED|28 Day Lead In With Vemurafenib Alone||2
11131197|NCT01400451|12317251|FG000|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
11131198|NCT01400451|12317252|FG001|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
11131199|NCT01400451|12317253|FG002|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
11131200|NCT01400451|12317251|FG000|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
11131201|NCT01400451|12317252|FG001|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
11131202|NCT01400451|12317253|FG002|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
11131203|NCT01400451|12317251|FG000|STARTED|Combination Treatment (or Intended)||6
11131204|NCT01400451|12317252|FG001|STARTED|Combination Treatment (or Intended)||4
11131205|NCT01400451|12317253|FG002|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
11131206|NCT01400451|12317251|FG000|COMPLETED|Combination Treatment (or Intended)||0
11131207|NCT01400451|12317252|FG001|COMPLETED|Combination Treatment (or Intended)||0
11131208|NCT01400451|12317253|FG002|COMPLETED|Combination Treatment (or Intended)||0
11131209|NCT01400451|12317251|FG000|NOT COMPLETED|Combination Treatment (or Intended)||6
11131210|NCT01400451|12317252|FG001|NOT COMPLETED|Combination Treatment (or Intended)||4
11131211|NCT01400451|12317253|FG002|NOT COMPLETED|Combination Treatment (or Intended)||2
11131212|NCT01400477|12317268|FG000|STARTED|Overall Study||40
11131213|NCT01400477|12317269|FG001|STARTED|Overall Study||40
11131214|NCT01400477|12317268|FG000|COMPLETED|Overall Study||38
11131215|NCT01400477|12317269|FG001|COMPLETED|Overall Study||40
11131216|NCT01400477|12317268|FG000|NOT COMPLETED|Overall Study||2
11131217|NCT01400477|12317269|FG001|NOT COMPLETED|Overall Study||0
11131218|NCT01400503|12317275|FG000|STARTED|Overall Study||60
11131219|NCT01400503|12317275|FG000|COMPLETED|Overall Study||0
11131220|NCT01400503|12317275|FG000|NOT COMPLETED|Overall Study||60
11131221|NCT01400516|12317281|FG000|STARTED|Primary Trial||12
11131222|NCT01400516|12317282|FG001|STARTED|Primary Trial||14
11131223|NCT01400516|12317281|FG000|COMPLETED|Primary Trial||12
11131224|NCT01400516|12317282|FG001|COMPLETED|Primary Trial||12
11131225|NCT01400516|12317281|FG000|NOT COMPLETED|Primary Trial||0
11131226|NCT01400516|12317282|FG001|NOT COMPLETED|Primary Trial||2
11131227|NCT01400516|12317281|FG000|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
11131228|NCT01400516|12317282|FG001|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
11131229|NCT01400516|12317281|FG000|COMPLETED|Extension Trial||6
11131230|NCT01400516|12317282|FG001|COMPLETED|Extension Trial||7
11131231|NCT01400516|12317281|FG000|NOT COMPLETED|Extension Trial||0
11131232|NCT01400516|12317282|FG001|NOT COMPLETED|Extension Trial||0
11131233|NCT01400698|12317292|FG000|STARTED|Overall Study||23
11131234|NCT01400698|12317293|FG001|STARTED|Overall Study||23
11131235|NCT01400698|12317294|FG002|STARTED|Overall Study||2
11131236|NCT01400698|12317295|FG003|STARTED|Overall Study||14
11131237|NCT01400698|12317296|FG004|STARTED|Overall Study||14
11131238|NCT01400698|12317297|FG005|STARTED|Overall Study||15
11131239|NCT01400698|12317292|FG000|COMPLETED|Overall Study||8
11131240|NCT01400698|12317293|FG001|COMPLETED|Overall Study||12
11131241|NCT01400698|12317294|FG002|COMPLETED|Overall Study||0
11131242|NCT01400698|12317295|FG003|COMPLETED|Overall Study||6
11131243|NCT01400698|12317296|FG004|COMPLETED|Overall Study||7
11131244|NCT01400698|12317297|FG005|COMPLETED|Overall Study||9
11131245|NCT01400698|12317292|FG000|NOT COMPLETED|Overall Study||15
11131246|NCT01400698|12317293|FG001|NOT COMPLETED|Overall Study||11
11131247|NCT01400698|12317294|FG002|NOT COMPLETED|Overall Study||2
11131248|NCT01400698|12317295|FG003|NOT COMPLETED|Overall Study||8
11131249|NCT01400698|12317296|FG004|NOT COMPLETED|Overall Study||7
11131250|NCT01400698|12317297|FG005|NOT COMPLETED|Overall Study||6
11131251|NCT01400815|12317309|FG000|STARTED|Overall Study||118
11131252|NCT01400815|12317310|FG001|STARTED|Overall Study||116
11131253|NCT01400815|12317309|FG000|COMPLETED|Overall Study||80
11131254|NCT01400815|12317310|FG001|COMPLETED|Overall Study||95
11131255|NCT01400815|12317309|FG000|NOT COMPLETED|Overall Study||38
11131256|NCT01400815|12317310|FG001|NOT COMPLETED|Overall Study||21
11131257|NCT01400841|12317316|FG000|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
11131258|NCT01400841|12317316|FG000|COMPLETED|Initial Study Phase (6 Months)||15
11131259|NCT01400841|12317316|FG000|NOT COMPLETED|Initial Study Phase (6 Months)||1
11131260|NCT01400841|12317316|FG000|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
11131261|NCT01400841|12317316|FG000|COMPLETED|Extended Study Phase (2 Years)||11
11131262|NCT01400841|12317316|FG000|NOT COMPLETED|Extended Study Phase (2 Years)||2
11131263|NCT01400880|12317320|FG000|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
11131264|NCT01400880|12317320|FG000|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
11131265|NCT01400880|12317320|FG000|NOT COMPLETED|Overall Study||2
11131266|NCT01400893|12317326|FG000|STARTED|Overall Study||69
11131267|NCT01400893|12317327|FG001|STARTED|Overall Study||65
11240133|NCT02087774|12432425|FG001|NOT COMPLETED|Overall Study||20
11240134|NCT02087904|12432435|FG000|STARTED|Overall Study||85
11240135|NCT02087904|12432436|FG001|STARTED|Overall Study||89
11240136|NCT02087904|12432437|FG002|STARTED|Overall Study||87
11240137|NCT02087904|12432438|FG003|STARTED|Overall Study||89
11131268|NCT01400893|12317326|FG000|COMPLETED|Overall Study||42
11131269|NCT01400893|12317327|FG001|COMPLETED|Overall Study||38
11131270|NCT01400893|12317326|FG000|NOT COMPLETED|Overall Study||27
11131271|NCT01400893|12317327|FG001|NOT COMPLETED|Overall Study||27
11131272|NCT01400906|12317335|FG000|STARTED|Treatment Period 1||6
11131273|NCT01400906|12317336|FG001|STARTED|Treatment Period 1||6
11131274|NCT01400906|12317337|FG002|STARTED|Treatment Period 1||6
11131275|NCT01400906|12317338|FG003|STARTED|Treatment Period 1||6
11131276|NCT01400906|12317339|FG004|STARTED|Treatment Period 1||6
11131277|NCT01400906|12317340|FG005|STARTED|Treatment Period 1||5
11131278|NCT01400906|12317335|FG000|COMPLETED|Treatment Period 1||6
11131279|NCT01400906|12317336|FG001|COMPLETED|Treatment Period 1||6
11131280|NCT01400906|12317337|FG002|COMPLETED|Treatment Period 1||6
11131281|NCT01400906|12317338|FG003|COMPLETED|Treatment Period 1||6
11131282|NCT01400906|12317339|FG004|COMPLETED|Treatment Period 1||6
11131283|NCT01400906|12317340|FG005|COMPLETED|Treatment Period 1||5
11131284|NCT01400906|12317335|FG000|NOT COMPLETED|Treatment Period 1||0
11131285|NCT01400906|12317336|FG001|NOT COMPLETED|Treatment Period 1||0
11240138|NCT02087904|12432435|FG000|COMPLETED|Overall Study||60
11240139|NCT02087904|12432436|FG001|COMPLETED|Overall Study||70
11240140|NCT02087904|12432437|FG002|COMPLETED|Overall Study||65
11131286|NCT01400906|12317337|FG002|NOT COMPLETED|Treatment Period 1||0
11131287|NCT01400906|12317338|FG003|NOT COMPLETED|Treatment Period 1||0
11131288|NCT01400906|12317339|FG004|NOT COMPLETED|Treatment Period 1||0
11131289|NCT01400906|12317340|FG005|NOT COMPLETED|Treatment Period 1||0
11131290|NCT01400906|12317335|FG000|STARTED|Washout Period 1||6
11131291|NCT01400906|12317336|FG001|STARTED|Washout Period 1||6
11131292|NCT01400906|12317337|FG002|STARTED|Washout Period 1||6
11131293|NCT01400906|12317338|FG003|STARTED|Washout Period 1||6
11131294|NCT01400906|12317339|FG004|STARTED|Washout Period 1||6
11131295|NCT01400906|12317340|FG005|STARTED|Washout Period 1||5
11131296|NCT01400906|12317335|FG000|COMPLETED|Washout Period 1||6
11131297|NCT01400906|12317336|FG001|COMPLETED|Washout Period 1||6
11131298|NCT01400906|12317337|FG002|COMPLETED|Washout Period 1||6
11131299|NCT01400906|12317338|FG003|COMPLETED|Washout Period 1||6
11131300|NCT01400906|12317339|FG004|COMPLETED|Washout Period 1||6
11131301|NCT01400906|12317340|FG005|COMPLETED|Washout Period 1||5
11131302|NCT01400906|12317335|FG000|NOT COMPLETED|Washout Period 1||0
11131303|NCT01400906|12317336|FG001|NOT COMPLETED|Washout Period 1||0
11131304|NCT01400906|12317337|FG002|NOT COMPLETED|Washout Period 1||0
11131305|NCT01400906|12317338|FG003|NOT COMPLETED|Washout Period 1||0
11131306|NCT01400906|12317339|FG004|NOT COMPLETED|Washout Period 1||0
11131307|NCT01400906|12317340|FG005|NOT COMPLETED|Washout Period 1||0
11131308|NCT01400906|12317335|FG000|STARTED|Treatment Period 2||6
11131309|NCT01400906|12317336|FG001|STARTED|Treatment Period 2||6
11131310|NCT01400906|12317337|FG002|STARTED|Treatment Period 2||6
11131311|NCT01400906|12317338|FG003|STARTED|Treatment Period 2||6
11131312|NCT01400906|12317339|FG004|STARTED|Treatment Period 2||6
11131313|NCT01400906|12317340|FG005|STARTED|Treatment Period 2||5
11131314|NCT01400906|12317335|FG000|COMPLETED|Treatment Period 2||6
11131315|NCT01400906|12317336|FG001|COMPLETED|Treatment Period 2||6
11131316|NCT01400906|12317337|FG002|COMPLETED|Treatment Period 2||6
11131317|NCT01400906|12317338|FG003|COMPLETED|Treatment Period 2||6
11131318|NCT01400906|12317339|FG004|COMPLETED|Treatment Period 2||6
11131319|NCT01400906|12317340|FG005|COMPLETED|Treatment Period 2||5
11131320|NCT01400906|12317335|FG000|NOT COMPLETED|Treatment Period 2||0
11131321|NCT01400906|12317336|FG001|NOT COMPLETED|Treatment Period 2||0
11131322|NCT01400906|12317337|FG002|NOT COMPLETED|Treatment Period 2||0
11131323|NCT01400906|12317338|FG003|NOT COMPLETED|Treatment Period 2||0
11240141|NCT02087904|12432438|FG003|COMPLETED|Overall Study||64
11240142|NCT02087904|12432435|FG000|NOT COMPLETED|Overall Study||25
11240143|NCT02087904|12432436|FG001|NOT COMPLETED|Overall Study||19
11240144|NCT02087904|12432437|FG002|NOT COMPLETED|Overall Study||22
11240145|NCT02087904|12432438|FG003|NOT COMPLETED|Overall Study||25
11131324|NCT01400906|12317339|FG004|NOT COMPLETED|Treatment Period 2||0
11131325|NCT01400906|12317340|FG005|NOT COMPLETED|Treatment Period 2||0
11131326|NCT01400906|12317335|FG000|STARTED|Washout Period 2||6
11131327|NCT01400906|12317336|FG001|STARTED|Washout Period 2||6
11131328|NCT01400906|12317337|FG002|STARTED|Washout Period 2||6
11131329|NCT01400906|12317338|FG003|STARTED|Washout Period 2||6
11131330|NCT01400906|12317339|FG004|STARTED|Washout Period 2||6
11131331|NCT01400906|12317340|FG005|STARTED|Washout Period 2||5
11131332|NCT01400906|12317335|FG000|COMPLETED|Washout Period 2||6
11131333|NCT01400906|12317336|FG001|COMPLETED|Washout Period 2||6
11240146|NCT02087943|12432451|FG000|STARTED|Placebo-Controlled Phase Week 0-12||64
11240147|NCT02087943|12432452|FG001|STARTED|Placebo-Controlled Phase Week 0-12||58
11131334|NCT01400906|12317337|FG002|COMPLETED|Washout Period 2||6
11131335|NCT01400906|12317338|FG003|COMPLETED|Washout Period 2||6
11131336|NCT01400906|12317339|FG004|COMPLETED|Washout Period 2||6
11131337|NCT01400906|12317340|FG005|COMPLETED|Washout Period 2||5
11131338|NCT01400906|12317335|FG000|NOT COMPLETED|Washout Period 2||0
11131339|NCT01400906|12317336|FG001|NOT COMPLETED|Washout Period 2||0
11131340|NCT01400906|12317337|FG002|NOT COMPLETED|Washout Period 2||0
11131341|NCT01400906|12317338|FG003|NOT COMPLETED|Washout Period 2||0
11131342|NCT01400906|12317339|FG004|NOT COMPLETED|Washout Period 2||0
11131343|NCT01400906|12317340|FG005|NOT COMPLETED|Washout Period 2||0
11131344|NCT01400906|12317335|FG000|STARTED|Treatment Period 3||6
11131345|NCT01400906|12317336|FG001|STARTED|Treatment Period 3||6
11131346|NCT01400906|12317337|FG002|STARTED|Treatment Period 3||6
11131347|NCT01400906|12317338|FG003|STARTED|Treatment Period 3||6
11131348|NCT01400906|12317339|FG004|STARTED|Treatment Period 3||6
11131349|NCT01400906|12317340|FG005|STARTED|Treatment Period 3||5
11131350|NCT01400906|12317335|FG000|COMPLETED|Treatment Period 3||6
11131351|NCT01400906|12317336|FG001|COMPLETED|Treatment Period 3||6
11131352|NCT01400906|12317337|FG002|COMPLETED|Treatment Period 3||6
11131353|NCT01400906|12317338|FG003|COMPLETED|Treatment Period 3||6
11131354|NCT01400906|12317339|FG004|COMPLETED|Treatment Period 3||6
11131355|NCT01400906|12317340|FG005|COMPLETED|Treatment Period 3||5
11131356|NCT01400906|12317335|FG000|NOT COMPLETED|Treatment Period 3||0
11131357|NCT01400906|12317336|FG001|NOT COMPLETED|Treatment Period 3||0
11131358|NCT01400906|12317337|FG002|NOT COMPLETED|Treatment Period 3||0
11131359|NCT01400906|12317338|FG003|NOT COMPLETED|Treatment Period 3||0
11131360|NCT01400906|12317339|FG004|NOT COMPLETED|Treatment Period 3||0
11131361|NCT01400906|12317340|FG005|NOT COMPLETED|Treatment Period 3||0
11131362|NCT01400919|12317348|FG000|STARTED|Overall Study||75
11131363|NCT01400919|12317348|FG000|COMPLETED|Overall Study||67
11131364|NCT01400919|12317348|FG000|NOT COMPLETED|Overall Study||8
11131365|NCT01400932|12317354|FG000|STARTED|Overall Study||178
11131366|NCT01400932|12317355|FG001|STARTED|Overall Study||182
11131367|NCT01400932|12317354|FG000|COMPLETED|Overall Study||164
11131368|NCT01400932|12317355|FG001|COMPLETED|Overall Study||167
11131369|NCT01400932|12317354|FG000|NOT COMPLETED|Overall Study||14
11131370|NCT01400932|12317355|FG001|NOT COMPLETED|Overall Study||15
11131371|NCT01400958|12317363|FG000|STARTED|Overall Study||3
11131372|NCT01400958|12317364|FG001|STARTED|Overall Study||3
11131373|NCT01400958|12317363|FG000|COMPLETED|Overall Study||2
11131374|NCT01400958|12317364|FG001|COMPLETED|Overall Study||1
11131375|NCT01400958|12317363|FG000|NOT COMPLETED|Overall Study||1
11131376|NCT01400958|12317364|FG001|NOT COMPLETED|Overall Study||2
11131377|NCT01400971|12317370|FG000|STARTED|Overall Study||4299
11131378|NCT01400971|12317370|FG000|Complete Treatment Data|Overall Study||2528
11131379|NCT01400971|12317370|FG000|COMPLETED|Overall Study||3382
11131380|NCT01400971|12317370|FG000|NOT COMPLETED|Overall Study||917
11131381|NCT01401010|12317376|FG000|STARTED|Overall Study||6
11131382|NCT01401010|12317377|FG001|STARTED|Overall Study||6
11131383|NCT01401010|12317376|FG000|COMPLETED|Overall Study||5
11131384|NCT01401010|12317377|FG001|COMPLETED|Overall Study||6
11131385|NCT01401010|12317376|FG000|NOT COMPLETED|Overall Study||1
11131386|NCT01401010|12317377|FG001|NOT COMPLETED|Overall Study||0
11131387|NCT01401023|12317388|FG000|STARTED|Overall Study||10
11131388|NCT01401023|12317388|FG000|COMPLETED|Overall Study||10
11131389|NCT01401023|12317388|FG000|NOT COMPLETED|Overall Study||0
11131390|NCT01401062|12317396|FG000|STARTED|Overall Study||11
11240148|NCT02087943|12432453|FG002|STARTED|Placebo-Controlled Phase Week 0-12||63
11240149|NCT02087943|12432454|FG003|STARTED|Placebo-Controlled Phase Week 0-12||0
11131391|NCT01401062|12317397|FG001|STARTED|Overall Study||12
11131392|NCT01401062|12317396|FG000|COMPLETED|Overall Study||0
11131393|NCT01401062|12317397|FG001|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
11131394|NCT01401062|12317396|FG000|NOT COMPLETED|Overall Study||11
11131395|NCT01401062|12317397|FG001|NOT COMPLETED|Overall Study||8
11131396|NCT01401101|12317405|FG000|STARTED|Overall Study||206
11131397|NCT01401101|12317406|FG001|STARTED|Overall Study||198
11131398|NCT01401101|12317405|FG000|COMPLETED|Overall Study||184
11131399|NCT01401101|12317406|FG001|COMPLETED|Overall Study||171
11131400|NCT01401101|12317405|FG000|NOT COMPLETED|Overall Study||22
11131401|NCT01401101|12317406|FG001|NOT COMPLETED|Overall Study||27
11131402|NCT01401153|12317414|FG000|STARTED|First Test Day||66
11131403|NCT01401153|12317415|FG001|STARTED|First Test Day||55
11131404|NCT01401153|12317414|FG000|COMPLETED|First Test Day||65
11131405|NCT01401153|12317415|FG001|COMPLETED|First Test Day||45
11131406|NCT01401153|12317414|FG000|NOT COMPLETED|First Test Day||1
11131407|NCT01401153|12317415|FG001|NOT COMPLETED|First Test Day||10
11131408|NCT01401153|12317414|FG000|STARTED|Second Test Day||45
11131409|NCT01401153|12317415|FG001|STARTED|Second Test Day||65
11131410|NCT01401153|12317414|FG000|COMPLETED|Second Test Day||45
11131411|NCT01401153|12317415|FG001|COMPLETED|Second Test Day||60
11131412|NCT01401153|12317414|FG000|NOT COMPLETED|Second Test Day||0
11131413|NCT01401153|12317415|FG001|NOT COMPLETED|Second Test Day||5
11131414|NCT01401166|12317424|FG000|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
11131415|NCT01401166|12317425|FG001|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
11131416|NCT01401166|12317426|FG002|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
11131417|NCT01401166|12317427|FG003|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
11131418|NCT01401166|12317424|FG000|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
11131419|NCT01401166|12317425|FG001|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
11131420|NCT01401166|12317426|FG002|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
11131421|NCT01401166|12317427|FG003|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
11131422|NCT01401166|12317424|FG000|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
11131423|NCT01401166|12317425|FG001|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
11131424|NCT01401166|12317426|FG002|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
11131425|NCT01401166|12317427|FG003|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
11131426|NCT01401166|12317424|FG000|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
11131427|NCT01401166|12317425|FG001|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
11131428|NCT01401166|12317426|FG002|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
11131429|NCT01401166|12317427|FG003|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
11131430|NCT01401166|12317424|FG000|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
11131431|NCT01401166|12317425|FG001|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
11131432|NCT01401166|12317426|FG002|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
11131433|NCT01401166|12317427|FG003|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
11131434|NCT01401166|12317424|FG000|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
11131435|NCT01401166|12317425|FG001|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
11131436|NCT01401166|12317426|FG002|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
11131437|NCT01401166|12317427|FG003|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
11131438|NCT01401166|12317424|FG000|STARTED|Continuation Treatment (Cycles 9 to 18)||113
11131439|NCT01401166|12317425|FG001|STARTED|Continuation Treatment (Cycles 9 to 18)||116
11131440|NCT01401166|12317426|FG002|STARTED|Continuation Treatment (Cycles 9 to 18)||107
11131441|NCT01401166|12317427|FG003|STARTED|Continuation Treatment (Cycles 9 to 18)||105
11131442|NCT01401166|12317424|FG000|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
11131443|NCT01401166|12317425|FG001|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
11131444|NCT01401166|12317426|FG002|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
11131445|NCT01401166|12317427|FG003|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
11131446|NCT01401166|12317424|FG000|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
11131447|NCT01401166|12317425|FG001|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
11131448|NCT01401166|12317426|FG002|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
11131449|NCT01401166|12317427|FG003|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
11131450|NCT01401166|12317424|FG000|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
11131451|NCT01401166|12317425|FG001|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
11131452|NCT01401166|12317426|FG002|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
11131453|NCT01401166|12317427|FG003|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
11131454|NCT01401166|12317424|FG000|COMPLETED|Safety Follow-Up Period||99
11131455|NCT01401166|12317425|FG001|COMPLETED|Safety Follow-Up Period||106
11131456|NCT01401166|12317426|FG002|COMPLETED|Safety Follow-Up Period||104
11131457|NCT01401166|12317427|FG003|COMPLETED|Safety Follow-Up Period||100
11131458|NCT01401166|12317424|FG000|NOT COMPLETED|Safety Follow-Up Period||25
11131459|NCT01401166|12317425|FG001|NOT COMPLETED|Safety Follow-Up Period||18
11131460|NCT01401166|12317426|FG002|NOT COMPLETED|Safety Follow-Up Period||17
11131461|NCT01401166|12317427|FG003|NOT COMPLETED|Safety Follow-Up Period||19
11131462|NCT01401257|12317448|FG000|STARTED|Overall Study||21
11131463|NCT01401257|12317449|FG001|STARTED|Overall Study||21
11131464|NCT01401257|12317450|FG002|STARTED|Overall Study||19
11131465|NCT01401257|12317451|FG003|STARTED|Overall Study||19
11131466|NCT01401257|12317448|FG000|COMPLETED|Overall Study||21
11131467|NCT01401257|12317449|FG001|COMPLETED|Overall Study||19
11131468|NCT01401257|12317450|FG002|COMPLETED|Overall Study||16
11131469|NCT01401257|12317451|FG003|COMPLETED|Overall Study||17
11131470|NCT01401257|12317448|FG000|NOT COMPLETED|Overall Study||0
11131471|NCT01401257|12317449|FG001|NOT COMPLETED|Overall Study||2
11131472|NCT01401257|12317450|FG002|NOT COMPLETED|Overall Study||3
11131473|NCT01401257|12317451|FG003|NOT COMPLETED|Overall Study||2
11131474|NCT01401283|12317463|FG000|STARTED|Overall Study||89
11131475|NCT01401283|12317464|FG001|STARTED|Overall Study||91
11131476|NCT01401283|12317463|FG000|COMPLETED|Overall Study||79
11131477|NCT01401283|12317464|FG001|COMPLETED|Overall Study||81
11131478|NCT01401283|12317463|FG000|NOT COMPLETED|Overall Study||10
11131479|NCT01401283|12317464|FG001|NOT COMPLETED|Overall Study||10
11131480|NCT01401322|12317470|FG000|STARTED|Overall Study||5
11240150|NCT02087943|12432455|FG004|STARTED|Placebo-Controlled Phase Week 0-12||0
11338993|NCT02907619|12536363|FG002|COMPLETED|Overall Study||0
11131481|NCT01401322|12317470|FG000|COMPLETED|Overall Study||3
11131482|NCT01401322|12317470|FG000|NOT COMPLETED|Overall Study||2
11131483|NCT01401361|12317474|FG000|STARTED|Overall Study||150
11131484|NCT01401361|12317474|FG000|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
11131485|NCT01401361|12317474|FG000|NOT COMPLETED|Overall Study||28
11131486|NCT01401452|12317478|FG000|STARTED|Overall Study||246
11131487|NCT01401452|12317478|FG000|Visit 1 (Baseline)|Overall Study||246
11131488|NCT01401452|12317478|FG000|Visit 2 (1 Month)|Overall Study||225
11131489|NCT01401452|12317478|FG000|Visit 3 (3 Months)|Overall Study||217
11131490|NCT01401452|12317478|FG000|Visit 4 (6 Months)|Overall Study||172
11131491|NCT01401452|12317478|FG000|Visit 5 (9 Months)|Overall Study||175
11131492|NCT01401452|12317478|FG000|COMPLETED|Overall Study||174
11131493|NCT01401452|12317478|FG000|NOT COMPLETED|Overall Study||72
11202230|NCT01838655|12392641|FG000|STARTED|Overall Study||5
11202231|NCT01838655|12392641|FG000|COMPLETED|Overall Study||5
11202232|NCT01838655|12392641|FG000|NOT COMPLETED|Overall Study||0
11202233|NCT01838681|12392645|FG000|STARTED|Period A||1986
11202234|NCT01838681|12392646|FG001|STARTED|Period A||0
11202235|NCT01838681|12392647|FG002|STARTED|Period A||0
11202236|NCT01838681|12392648|FG003|STARTED|Period A||0
11202237|NCT01838681|12392645|FG000|COMPLETED|Period A||1661
11202238|NCT01838681|12392646|FG001|COMPLETED|Period A||0
11202239|NCT01838681|12392647|FG002|COMPLETED|Period A||0
11202240|NCT01838681|12392648|FG003|COMPLETED|Period A||0
11202241|NCT01838681|12392645|FG000|NOT COMPLETED|Period A||325
11202242|NCT01838681|12392646|FG001|NOT COMPLETED|Period A||0
11202243|NCT01838681|12392647|FG002|NOT COMPLETED|Period A||0
11240151|NCT02087943|12432451|FG000|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
11240152|NCT02087943|12432452|FG001|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
11240153|NCT02087943|12432453|FG002|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
11240154|NCT02087943|12432454|FG003|Safety Population|Placebo-Controlled Phase Week 0-12||0
11240155|NCT02087943|12432455|FG004|Safety Population|Placebo-Controlled Phase Week 0-12||0
11240156|NCT02087943|12432451|FG000|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
11240157|NCT02087943|12432452|FG001|COMPLETED|Placebo-Controlled Phase Week 0-12||46
11240158|NCT02087943|12432453|FG002|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
11240159|NCT02087943|12432454|FG003|COMPLETED|Placebo-Controlled Phase Week 0-12||0
11240160|NCT02087943|12432455|FG004|COMPLETED|Placebo-Controlled Phase Week 0-12||0
11240161|NCT02087943|12432451|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
11240162|NCT02087943|12432452|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
11240163|NCT02087943|12432453|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
11240164|NCT02087943|12432454|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
11240165|NCT02087943|12432455|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
11240166|NCT02087943|12432451|FG000|STARTED|Active Treatment Phase Week 12-24||0
11240167|NCT02087943|12432452|FG001|STARTED|Active Treatment Phase Week 12-24||46
11240168|NCT02087943|12432453|FG002|STARTED|Active Treatment Phase Week 12-24||49
11240169|NCT02087943|12432454|FG003|STARTED|Active Treatment Phase Week 12-24||24
11240170|NCT02087943|12432455|FG004|STARTED|Active Treatment Phase Week 12-24||23
11240171|NCT02087943|12432451|FG000|COMPLETED|Active Treatment Phase Week 12-24||0
11240172|NCT02087943|12432452|FG001|COMPLETED|Active Treatment Phase Week 12-24||42
11240173|NCT02087943|12432453|FG002|COMPLETED|Active Treatment Phase Week 12-24||44
11240174|NCT02087943|12432454|FG003|COMPLETED|Active Treatment Phase Week 12-24||22
11240175|NCT02087943|12432455|FG004|COMPLETED|Active Treatment Phase Week 12-24||21
11240176|NCT02087943|12432451|FG000|NOT COMPLETED|Active Treatment Phase Week 12-24||0
11240177|NCT02087943|12432452|FG001|NOT COMPLETED|Active Treatment Phase Week 12-24||4
11240178|NCT02087943|12432453|FG002|NOT COMPLETED|Active Treatment Phase Week 12-24||5
11240179|NCT02087943|12432454|FG003|NOT COMPLETED|Active Treatment Phase Week 12-24||2
11240180|NCT02087943|12432455|FG004|NOT COMPLETED|Active Treatment Phase Week 12-24||2
11202244|NCT01838681|12392648|FG003|NOT COMPLETED|Period A||0
11202245|NCT01838681|12392645|FG000|STARTED|Period B/A+||0
11240181|NCT02087943|12432451|FG000|STARTED|Observational Follow-up Phase Week 24-30||0
11240182|NCT02087943|12432452|FG001|STARTED|Observational Follow-up Phase Week 24-30||46
11240183|NCT02087943|12432453|FG002|STARTED|Observational Follow-up Phase Week 24-30||48
11240184|NCT02087943|12432454|FG003|STARTED|Observational Follow-up Phase Week 24-30||24
11240185|NCT02087943|12432455|FG004|STARTED|Observational Follow-up Phase Week 24-30||23
11202246|NCT01838681|12392646|FG001|STARTED|Period B/A+||442
11202247|NCT01838681|12392647|FG002|STARTED|Period B/A+||444
11202248|NCT01838681|12392648|FG003|STARTED|Period B/A+||770
11202249|NCT01838681|12392645|FG000|COMPLETED|Period B/A+||0
11202250|NCT01838681|12392646|FG001|COMPLETED|Period B/A+||380
11202251|NCT01838681|12392647|FG002|COMPLETED|Period B/A+||349
11202252|NCT01838681|12392648|FG003|COMPLETED|Period B/A+||653
11202253|NCT01838681|12392645|FG000|NOT COMPLETED|Period B/A+||0
11131494|NCT01401465|12317484|FG000|STARTED|Treatment Period 1||165
11131495|NCT01401465|12317485|FG001|STARTED|Treatment Period 1||162
11131496|NCT01401465|12317484|FG000|COMPLETED|Treatment Period 1||150
11131497|NCT01401465|12317485|FG001|COMPLETED|Treatment Period 1||146
11131498|NCT01401465|12317484|FG000|NOT COMPLETED|Treatment Period 1||15
11131499|NCT01401465|12317485|FG001|NOT COMPLETED|Treatment Period 1||16
11131500|NCT01401465|12317484|FG000|STARTED|Washout||150
11131501|NCT01401465|12317485|FG001|STARTED|Washout||146
11131502|NCT01401465|12317484|FG000|COMPLETED|Washout||150
11131503|NCT01401465|12317485|FG001|COMPLETED|Washout||146
11131504|NCT01401465|12317484|FG000|NOT COMPLETED|Washout||0
11131505|NCT01401465|12317485|FG001|NOT COMPLETED|Washout||0
11131506|NCT01401465|12317484|FG000|STARTED|Treatment Period 2||150
11131507|NCT01401465|12317485|FG001|STARTED|Treatment Period 2||146
11131508|NCT01401465|12317484|FG000|COMPLETED|Treatment Period 2||150
11131509|NCT01401465|12317485|FG001|COMPLETED|Treatment Period 2||144
11131510|NCT01401465|12317484|FG000|NOT COMPLETED|Treatment Period 2||0
11131511|NCT01401465|12317485|FG001|NOT COMPLETED|Treatment Period 2||2
11131512|NCT01401478|12317494|FG000|STARTED|Overall Study||86
11131513|NCT01401478|12317494|FG000|COMPLETED|Overall Study||55
11131514|NCT01401478|12317494|FG000|NOT COMPLETED|Overall Study||31
11131515|NCT01401517|12317501|FG000|STARTED|Overall Study||18
11131516|NCT01401517|12317502|FG001|STARTED|Overall Study||19
11131517|NCT01401517|12317503|FG002|STARTED|Overall Study||18
11131518|NCT01401517|12317501|FG000|COMPLETED|Overall Study||15
11131519|NCT01401517|12317502|FG001|COMPLETED|Overall Study||17
11240186|NCT02087943|12432451|FG000|COMPLETED|Observational Follow-up Phase Week 24-30||0
11240187|NCT02087943|12432452|FG001|COMPLETED|Observational Follow-up Phase Week 24-30||46
11240188|NCT02087943|12432453|FG002|COMPLETED|Observational Follow-up Phase Week 24-30||45
11240189|NCT02087943|12432454|FG003|COMPLETED|Observational Follow-up Phase Week 24-30||23
11240190|NCT02087943|12432455|FG004|COMPLETED|Observational Follow-up Phase Week 24-30||22
11240191|NCT02087943|12432451|FG000|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
11240192|NCT02087943|12432452|FG001|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
11131520|NCT01401517|12317503|FG002|COMPLETED|Overall Study||15
11131521|NCT01401517|12317501|FG000|NOT COMPLETED|Overall Study||3
11131522|NCT01401517|12317502|FG001|NOT COMPLETED|Overall Study||2
11131523|NCT01401517|12317503|FG002|NOT COMPLETED|Overall Study||3
11131524|NCT01401530|12317514|FG000|STARTED|Overall Study||3
11131525|NCT01401530|12317515|FG001|STARTED|Overall Study||7
11131526|NCT01401530|12317516|FG002|STARTED|Overall Study||3
11131527|NCT01401530|12317514|FG000|COMPLETED|Overall Study||0
11131528|NCT01401530|12317515|FG001|COMPLETED|Overall Study||1
11131529|NCT01401530|12317516|FG002|COMPLETED|Overall Study||0
11131530|NCT01401530|12317514|FG000|NOT COMPLETED|Overall Study||3
11131531|NCT01401530|12317515|FG001|NOT COMPLETED|Overall Study||6
11131532|NCT01401530|12317516|FG002|NOT COMPLETED|Overall Study||3
11131533|NCT01401543|12317526|FG000|STARTED|First Intervention||6
11131534|NCT01401543|12317527|FG001|STARTED|First Intervention||6
11131535|NCT01401543|12317528|FG002|STARTED|First Intervention||6
11131536|NCT01401543|12317529|FG003|STARTED|First Intervention||6
11131537|NCT01401543|12317526|FG000|COMPLETED|First Intervention||6
11131538|NCT01401543|12317527|FG001|COMPLETED|First Intervention||6
11131539|NCT01401543|12317528|FG002|COMPLETED|First Intervention||6
11131540|NCT01401543|12317529|FG003|COMPLETED|First Intervention||6
11131541|NCT01401543|12317526|FG000|NOT COMPLETED|First Intervention||0
11131542|NCT01401543|12317527|FG001|NOT COMPLETED|First Intervention||0
11131543|NCT01401543|12317528|FG002|NOT COMPLETED|First Intervention||0
11131544|NCT01401543|12317529|FG003|NOT COMPLETED|First Intervention||0
11131545|NCT01401543|12317526|FG000|STARTED|First Washout Period of 1 Week||6
11131546|NCT01401543|12317527|FG001|STARTED|First Washout Period of 1 Week||6
11131547|NCT01401543|12317528|FG002|STARTED|First Washout Period of 1 Week||6
11131548|NCT01401543|12317529|FG003|STARTED|First Washout Period of 1 Week||6
11131549|NCT01401543|12317526|FG000|COMPLETED|First Washout Period of 1 Week||6
11131550|NCT01401543|12317527|FG001|COMPLETED|First Washout Period of 1 Week||6
11131551|NCT01401543|12317528|FG002|COMPLETED|First Washout Period of 1 Week||6
11131552|NCT01401543|12317529|FG003|COMPLETED|First Washout Period of 1 Week||6
11131553|NCT01401543|12317526|FG000|NOT COMPLETED|First Washout Period of 1 Week||0
11131554|NCT01401543|12317527|FG001|NOT COMPLETED|First Washout Period of 1 Week||0
11131555|NCT01401543|12317528|FG002|NOT COMPLETED|First Washout Period of 1 Week||0
11131556|NCT01401543|12317529|FG003|NOT COMPLETED|First Washout Period of 1 Week||0
11131557|NCT01401543|12317526|FG000|STARTED|Second Intervention||6
11131558|NCT01401543|12317527|FG001|STARTED|Second Intervention||6
11131559|NCT01401543|12317528|FG002|STARTED|Second Intervention||6
11131560|NCT01401543|12317529|FG003|STARTED|Second Intervention||6
11240193|NCT02087943|12432453|FG002|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
11240194|NCT02087943|12432454|FG003|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
11131561|NCT01401543|12317526|FG000|COMPLETED|Second Intervention||6
11131562|NCT01401543|12317527|FG001|COMPLETED|Second Intervention||6
11131563|NCT01401543|12317528|FG002|COMPLETED|Second Intervention||6
11131564|NCT01401543|12317529|FG003|COMPLETED|Second Intervention||6
11131565|NCT01401543|12317526|FG000|NOT COMPLETED|Second Intervention||0
11131566|NCT01401543|12317527|FG001|NOT COMPLETED|Second Intervention||0
11131567|NCT01401543|12317528|FG002|NOT COMPLETED|Second Intervention||0
11131568|NCT01401543|12317529|FG003|NOT COMPLETED|Second Intervention||0
11131569|NCT01401543|12317526|FG000|STARTED|Second Washout Period of 1 Week||6
11131570|NCT01401543|12317527|FG001|STARTED|Second Washout Period of 1 Week||6
11131571|NCT01401543|12317528|FG002|STARTED|Second Washout Period of 1 Week||6
11131572|NCT01401543|12317529|FG003|STARTED|Second Washout Period of 1 Week||6
11131573|NCT01401543|12317526|FG000|COMPLETED|Second Washout Period of 1 Week||6
11131574|NCT01401543|12317527|FG001|COMPLETED|Second Washout Period of 1 Week||6
11131575|NCT01401543|12317528|FG002|COMPLETED|Second Washout Period of 1 Week||6
11131576|NCT01401543|12317529|FG003|COMPLETED|Second Washout Period of 1 Week||6
11131577|NCT01401543|12317526|FG000|NOT COMPLETED|Second Washout Period of 1 Week||0
11131578|NCT01401543|12317527|FG001|NOT COMPLETED|Second Washout Period of 1 Week||0
11131579|NCT01401543|12317528|FG002|NOT COMPLETED|Second Washout Period of 1 Week||0
11131580|NCT01401543|12317529|FG003|NOT COMPLETED|Second Washout Period of 1 Week||0
11131581|NCT01401543|12317526|FG000|STARTED|Third Intervention||6
11131582|NCT01401543|12317527|FG001|STARTED|Third Intervention||6
11131583|NCT01401543|12317528|FG002|STARTED|Third Intervention||6
11131584|NCT01401543|12317529|FG003|STARTED|Third Intervention||6
11131585|NCT01401543|12317526|FG000|COMPLETED|Third Intervention||6
11131586|NCT01401543|12317527|FG001|COMPLETED|Third Intervention||6
11131587|NCT01401543|12317528|FG002|COMPLETED|Third Intervention||6
11131588|NCT01401543|12317529|FG003|COMPLETED|Third Intervention||6
11131589|NCT01401543|12317526|FG000|NOT COMPLETED|Third Intervention||0
11131590|NCT01401543|12317527|FG001|NOT COMPLETED|Third Intervention||0
11131591|NCT01401543|12317528|FG002|NOT COMPLETED|Third Intervention||0
11131592|NCT01401543|12317529|FG003|NOT COMPLETED|Third Intervention||0
11131593|NCT01401543|12317526|FG000|STARTED|Third Washout Period of 1 Week||6
11131594|NCT01401543|12317527|FG001|STARTED|Third Washout Period of 1 Week||6
11131595|NCT01401543|12317528|FG002|STARTED|Third Washout Period of 1 Week||6
11131596|NCT01401543|12317529|FG003|STARTED|Third Washout Period of 1 Week||6
11131597|NCT01401543|12317526|FG000|COMPLETED|Third Washout Period of 1 Week||6
11131598|NCT01401543|12317527|FG001|COMPLETED|Third Washout Period of 1 Week||6
11131599|NCT01401543|12317528|FG002|COMPLETED|Third Washout Period of 1 Week||6
11131600|NCT01401543|12317529|FG003|COMPLETED|Third Washout Period of 1 Week||6
11131601|NCT01401543|12317526|FG000|NOT COMPLETED|Third Washout Period of 1 Week||0
11131602|NCT01401543|12317527|FG001|NOT COMPLETED|Third Washout Period of 1 Week||0
11131603|NCT01401543|12317528|FG002|NOT COMPLETED|Third Washout Period of 1 Week||0
11131604|NCT01401543|12317529|FG003|NOT COMPLETED|Third Washout Period of 1 Week||0
11131605|NCT01401543|12317526|FG000|STARTED|Fourth Intervention||6
11131606|NCT01401543|12317527|FG001|STARTED|Fourth Intervention||6
11131607|NCT01401543|12317528|FG002|STARTED|Fourth Intervention||6
11131608|NCT01401543|12317529|FG003|STARTED|Fourth Intervention||6
11131609|NCT01401543|12317526|FG000|COMPLETED|Fourth Intervention||6
11131610|NCT01401543|12317527|FG001|COMPLETED|Fourth Intervention||6
11131611|NCT01401543|12317528|FG002|COMPLETED|Fourth Intervention||6
11131612|NCT01401543|12317529|FG003|COMPLETED|Fourth Intervention||6
11131613|NCT01401543|12317526|FG000|NOT COMPLETED|Fourth Intervention||0
11131614|NCT01401543|12317527|FG001|NOT COMPLETED|Fourth Intervention||0
11131615|NCT01401543|12317528|FG002|NOT COMPLETED|Fourth Intervention||0
11131616|NCT01401543|12317529|FG003|NOT COMPLETED|Fourth Intervention||0
11131617|NCT01401582|12317545|FG000|STARTED|Overall Study||226
11131618|NCT01401582|12317546|FG001|STARTED|Overall Study||408
11131619|NCT01401582|12317545|FG000|Baseline Completed|Overall Study||168
11131620|NCT01401582|12317546|FG001|Baseline Completed|Overall Study||348
11131621|NCT01401582|12317545|FG000|COMPLETED|Overall Study||116
11131622|NCT01401582|12317546|FG001|COMPLETED|Overall Study||291
11131623|NCT01401582|12317545|FG000|NOT COMPLETED|Overall Study||110
11131624|NCT01401582|12317546|FG001|NOT COMPLETED|Overall Study||117
11131625|NCT01401595|12317557|FG000|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
11131626|NCT01401595|12317558|FG001|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
11131627|NCT01401595|12317557|FG000|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
11131628|NCT01401595|12317558|FG001|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
11131629|NCT01401595|12317557|FG000|NOT COMPLETED|Recruitment and Screening||43
11131630|NCT01401595|12317558|FG001|NOT COMPLETED|Recruitment and Screening||2
11131631|NCT01401595|12317557|FG000|STARTED|Imaging and Treatment (for NE Arm)||32
11131632|NCT01401595|12317558|FG001|STARTED|Imaging and Treatment (for NE Arm)||10
11131633|NCT01401595|12317557|FG000|COMPLETED|Imaging and Treatment (for NE Arm)||18
11131634|NCT01401595|12317558|FG001|COMPLETED|Imaging and Treatment (for NE Arm)||10
11131635|NCT01401595|12317557|FG000|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
11131636|NCT01401595|12317558|FG001|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
11131637|NCT01401647|12317568|FG000|STARTED|Overall Study||972
11131638|NCT01401647|12317569|FG001|STARTED|Overall Study||993
11131639|NCT01401647|12317570|FG002|STARTED|Overall Study||1059
11131640|NCT01401647|12317568|FG000|COMPLETED|Overall Study||968
11131641|NCT01401647|12317569|FG001|COMPLETED|Overall Study||985
11131642|NCT01401647|12317570|FG002|COMPLETED|Overall Study||1056
11131643|NCT01401647|12317568|FG000|NOT COMPLETED|Overall Study||4
11131644|NCT01401647|12317569|FG001|NOT COMPLETED|Overall Study||8
11131645|NCT01401647|12317570|FG002|NOT COMPLETED|Overall Study||3
11131646|NCT01401699|12317578|FG000|STARTED|Overall Study||109
11131647|NCT01401699|12317578|FG000|COMPLETED|Overall Study||109
11131648|NCT01401699|12317578|FG000|NOT COMPLETED|Overall Study||0
11131649|NCT01401842|12317584|FG000|STARTED|Overall Study||298
11131650|NCT01401842|12317585|FG001|STARTED|Overall Study||284
11131651|NCT01401842|12317584|FG000|COMPLETED|Overall Study||230
11131652|NCT01401842|12317585|FG001|COMPLETED|Overall Study||217
11131653|NCT01401842|12317584|FG000|NOT COMPLETED|Overall Study||68
11131654|NCT01401842|12317585|FG001|NOT COMPLETED|Overall Study||67
11131655|NCT01401907|12317593|FG000|STARTED|Overall Study||175
11131656|NCT01401907|12317594|FG001|STARTED|Overall Study||175
11131657|NCT01401907|12317593|FG000|12 Week Outcomes|Overall Study||148
11131658|NCT01401907|12317594|FG001|12 Week Outcomes|Overall Study||153
11131659|NCT01401907|12317593|FG000|COMPLETED|Overall Study||118
11131660|NCT01401907|12317594|FG001|COMPLETED|Overall Study||124
11131661|NCT01401907|12317593|FG000|NOT COMPLETED|Overall Study||57
11131662|NCT01401907|12317594|FG001|NOT COMPLETED|Overall Study||51
11131663|NCT01401959|12317605|FG000|STARTED|Enrolled||54
11131664|NCT01401959|12317606|FG001|STARTED|Enrolled||42
11131665|NCT01401959|12317607|FG002|STARTED|Enrolled||31
11131666|NCT01401959|12317605|FG000|COMPLETED|Enrolled||53
11131667|NCT01401959|12317606|FG001|COMPLETED|Enrolled||42
11131668|NCT01401959|12317607|FG002|COMPLETED|Enrolled||31
11131669|NCT01401959|12317605|FG000|NOT COMPLETED|Enrolled||1
11131670|NCT01401959|12317606|FG001|NOT COMPLETED|Enrolled||0
11131671|NCT01401959|12317607|FG002|NOT COMPLETED|Enrolled||0
11131672|NCT01401959|12317605|FG000|STARTED|Treated||53
11131673|NCT01401959|12317606|FG001|STARTED|Treated||42
11131674|NCT01401959|12317607|FG002|STARTED|Treated||31
11131675|NCT01401959|12317605|FG000|COMPLETED|Treated||46
11131676|NCT01401959|12317606|FG001|COMPLETED|Treated||34
11131677|NCT01401959|12317607|FG002|COMPLETED|Treated||26
11131678|NCT01401959|12317605|FG000|NOT COMPLETED|Treated||7
11131679|NCT01401959|12317606|FG001|NOT COMPLETED|Treated||8
11131680|NCT01401959|12317607|FG002|NOT COMPLETED|Treated||5
11131681|NCT01402011|12317620|FG000|STARTED|Delayed Treatment Period||29
11131682|NCT01402011|12317621|FG001|STARTED|Delayed Treatment Period||23
11131683|NCT01402011|12317622|FG002|STARTED|Delayed Treatment Period||26
11131684|NCT01402011|12317620|FG000|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
11131685|NCT01402011|12317621|FG001|COMPLETED|Delayed Treatment Period||23
11131686|NCT01402011|12317622|FG002|COMPLETED|Delayed Treatment Period||26
11131687|NCT01402011|12317620|FG000|NOT COMPLETED|Delayed Treatment Period||1
11131688|NCT01402011|12317621|FG001|NOT COMPLETED|Delayed Treatment Period||0
11131689|NCT01402011|12317622|FG002|NOT COMPLETED|Delayed Treatment Period||0
11131690|NCT01402011|12317620|FG000|STARTED|Active Treatment Period||28
11131691|NCT01402011|12317621|FG001|STARTED|Active Treatment Period||23
11005151|NCT00721357|12182826|FG000|COMPLETED|Overall Study||15
11005152|NCT00721357|12182827|FG001|COMPLETED|Overall Study||15
11005153|NCT00721357|12182826|FG000|NOT COMPLETED|Overall Study||0
11131692|NCT01402011|12317622|FG002|STARTED|Active Treatment Period||26
11131693|NCT01402011|12317620|FG000|COMPLETED|Active Treatment Period||27
11131694|NCT01402011|12317621|FG001|COMPLETED|Active Treatment Period||20
11131695|NCT01402011|12317622|FG002|COMPLETED|Active Treatment Period||26
11131696|NCT01402011|12317620|FG000|NOT COMPLETED|Active Treatment Period||1
11131697|NCT01402011|12317621|FG001|NOT COMPLETED|Active Treatment Period||3
11005154|NCT00721357|12182827|FG001|NOT COMPLETED|Overall Study||0
11131698|NCT01402011|12317622|FG002|NOT COMPLETED|Active Treatment Period||0
11131699|NCT01402011|12317620|FG000|STARTED|Nine Month Follow-up||27
11131700|NCT01402011|12317621|FG001|STARTED|Nine Month Follow-up||20
11131701|NCT01402011|12317622|FG002|STARTED|Nine Month Follow-up||26
11131702|NCT01402011|12317620|FG000|COMPLETED|Nine Month Follow-up||27
11131703|NCT01402011|12317621|FG001|COMPLETED|Nine Month Follow-up||19
11131704|NCT01402011|12317622|FG002|COMPLETED|Nine Month Follow-up||26
11240195|NCT02087943|12432455|FG004|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
11240196|NCT02087956|12432469|FG000|STARTED|Overall Study||111
11240197|NCT02087956|12432470|FG001|STARTED|Overall Study||112
11240198|NCT02087956|12432469|FG000|COMPLETED|Overall Study||105
11240199|NCT02087956|12432470|FG001|COMPLETED|Overall Study||107
11240200|NCT02087956|12432469|FG000|NOT COMPLETED|Overall Study||6
11240201|NCT02087956|12432470|FG001|NOT COMPLETED|Overall Study||5
11240202|NCT02087995|12432478|FG000|STARTED|Overall Study||51
11240203|NCT02087995|12432478|FG000|COMPLETED|Overall Study||51
11240204|NCT02087995|12432478|FG000|NOT COMPLETED|Overall Study||0
11240205|NCT02088034|12432485|FG000|STARTED|Overall Study||33
11240206|NCT02088034|12432486|FG001|STARTED|Overall Study||30
11240207|NCT02088034|12432487|FG002|STARTED|Overall Study||29
11240208|NCT02088034|12432485|FG000|COMPLETED|Overall Study||30
11240209|NCT02088034|12432486|FG001|COMPLETED|Overall Study||28
11240210|NCT02088034|12432487|FG002|COMPLETED|Overall Study||27
11240211|NCT02088034|12432485|FG000|NOT COMPLETED|Overall Study||3
11240212|NCT02088034|12432486|FG001|NOT COMPLETED|Overall Study||2
11240213|NCT02088034|12432487|FG002|NOT COMPLETED|Overall Study||2
11240214|NCT02088047|12432497|FG000|STARTED|Overall Study||3
11131705|NCT01402011|12317620|FG000|NOT COMPLETED|Nine Month Follow-up||0
11131706|NCT01402011|12317621|FG001|NOT COMPLETED|Nine Month Follow-up||1
11131707|NCT01402011|12317622|FG002|NOT COMPLETED|Nine Month Follow-up||0
11131708|NCT01402050|12317635|FG000|STARTED|Overall Study||185
11131709|NCT01402050|12317636|FG001|STARTED|Overall Study||191
11131710|NCT01402050|12317635|FG000|COMPLETED|Overall Study||185
11131711|NCT01402050|12317636|FG001|COMPLETED|Overall Study||191
11131712|NCT01402050|12317635|FG000|NOT COMPLETED|Overall Study||0
11005155|NCT00721396|12182839|FG000|STARTED|Overall Study||627
11131713|NCT01402050|12317636|FG001|NOT COMPLETED|Overall Study||0
11131714|NCT01402063|12317644|FG000|STARTED|Overall Study||42
11131715|NCT01402063|12317645|FG001|STARTED|Overall Study||21
11131716|NCT01402063|12317644|FG000|COMPLETED|Overall Study||39
11131717|NCT01402063|12317645|FG001|COMPLETED|Overall Study||18
11131718|NCT01402063|12317644|FG000|NOT COMPLETED|Overall Study||3
11240215|NCT02088047|12432498|FG001|STARTED|Overall Study||1
11240216|NCT02088047|12432497|FG000|COMPLETED|Overall Study||2
11240217|NCT02088047|12432498|FG001|COMPLETED|Overall Study||1
11240218|NCT02088047|12432497|FG000|NOT COMPLETED|Overall Study||1
11240219|NCT02088047|12432498|FG001|NOT COMPLETED|Overall Study||0
11240220|NCT02088073|12432509|FG000|STARTED|Acute Phase||258
11240221|NCT02088073|12432510|FG001|STARTED|Acute Phase||0
11240222|NCT02088073|12432511|FG002|STARTED|Acute Phase||0
11240223|NCT02088073|12432512|FG003|STARTED|Acute Phase||0
11131719|NCT01402063|12317645|FG001|NOT COMPLETED|Overall Study||3
11131720|NCT01402102|12317653|FG000|STARTED|Overall Study||30
11131721|NCT01402102|12317654|FG001|STARTED|Overall Study||30
11131722|NCT01402102|12317653|FG000|COMPLETED|Overall Study||28
11131723|NCT01402102|12317654|FG001|COMPLETED|Overall Study||27
11131724|NCT01402102|12317653|FG000|NOT COMPLETED|Overall Study||2
11131725|NCT01402102|12317654|FG001|NOT COMPLETED|Overall Study||3
11131726|NCT01402115|12317664|FG000|STARTED|Overall Study||30
11131727|NCT01402115|12317665|FG001|STARTED|Overall Study||30
11131728|NCT01402115|12317664|FG000|COMPLETED|Overall Study||29
11131729|NCT01402115|12317665|FG001|COMPLETED|Overall Study||29
11131730|NCT01402115|12317664|FG000|NOT COMPLETED|Overall Study||1
11131731|NCT01402115|12317665|FG001|NOT COMPLETED|Overall Study||1
11131732|NCT01402128|12317673|FG000|STARTED|Overall Study||40
11131733|NCT01402128|12317674|FG001|STARTED|Overall Study||40
11131734|NCT01402128|12317673|FG000|COMPLETED|Overall Study||39
11131735|NCT01402128|12317674|FG001|COMPLETED|Overall Study||40
11131736|NCT01402128|12317673|FG000|NOT COMPLETED|Overall Study||1
11131737|NCT01402128|12317674|FG001|NOT COMPLETED|Overall Study||0
11131738|NCT01402141|12317682|FG000|STARTED|Overall Study||30
11131739|NCT01402141|12317683|FG001|STARTED|Overall Study||30
11131740|NCT01402141|12317682|FG000|COMPLETED|Overall Study||29
11131741|NCT01402141|12317683|FG001|COMPLETED|Overall Study||28
11131742|NCT01402141|12317682|FG000|NOT COMPLETED|Overall Study||1
11131743|NCT01402141|12317683|FG001|NOT COMPLETED|Overall Study||2
11131744|NCT01402284|12317690|FG000|STARTED|Overall Study||45
11131745|NCT01402284|12317690|FG000|COMPLETED|Overall Study||31
11131746|NCT01402284|12317690|FG000|NOT COMPLETED|Overall Study||14
11131747|NCT01402375|12317700|FG000|STARTED|Overall Study||120
11131748|NCT01402375|12317701|FG001|STARTED|Overall Study||120
11131749|NCT01402375|12317702|FG002|STARTED|Overall Study||120
11131750|NCT01402375|12317703|FG003|STARTED|Overall Study||120
11131751|NCT01402375|12317704|FG004|STARTED|Overall Study||120
11131752|NCT01402375|12317705|FG005|STARTED|Overall Study||120
11131753|NCT01402375|12317700|FG000|COMPLETED|Overall Study||120
11131754|NCT01402375|12317701|FG001|COMPLETED|Overall Study||120
11131755|NCT01402375|12317702|FG002|COMPLETED|Overall Study||120
11131756|NCT01402375|12317703|FG003|COMPLETED|Overall Study||120
11131757|NCT01402375|12317704|FG004|COMPLETED|Overall Study||120
11131758|NCT01402375|12317705|FG005|COMPLETED|Overall Study||120
11131759|NCT01402375|12317700|FG000|NOT COMPLETED|Overall Study||0
11131760|NCT01402375|12317701|FG001|NOT COMPLETED|Overall Study||0
11131761|NCT01402375|12317702|FG002|NOT COMPLETED|Overall Study||0
11131762|NCT01402375|12317703|FG003|NOT COMPLETED|Overall Study||0
11131763|NCT01402375|12317704|FG004|NOT COMPLETED|Overall Study||0
11131764|NCT01402375|12317705|FG005|NOT COMPLETED|Overall Study||0
11131765|NCT01402427|12317721|FG000|STARTED|Overall Study||297
11240224|NCT02088073|12432513|FG004|STARTED|Acute Phase||0
11240225|NCT02088073|12432509|FG000|COMPLETED|Acute Phase||251
11240226|NCT02088073|12432510|FG001|COMPLETED|Acute Phase||0
11240227|NCT02088073|12432511|FG002|COMPLETED|Acute Phase||0
11240228|NCT02088073|12432512|FG003|COMPLETED|Acute Phase||0
11131766|NCT01402427|12317722|FG001|STARTED|Overall Study||294
11131767|NCT01402427|12317721|FG000|COMPLETED|Overall Study||297
11240229|NCT02088073|12432513|FG004|COMPLETED|Acute Phase||0
11240230|NCT02088073|12432509|FG000|NOT COMPLETED|Acute Phase||7
11240231|NCT02088073|12432510|FG001|NOT COMPLETED|Acute Phase||0
11240232|NCT02088073|12432511|FG002|NOT COMPLETED|Acute Phase||0
11240233|NCT02088073|12432512|FG003|NOT COMPLETED|Acute Phase||0
11240234|NCT02088073|12432513|FG004|NOT COMPLETED|Acute Phase||0
11240235|NCT02088073|12432509|FG000|STARTED|Maintanance Phase||0
11131768|NCT01402427|12317722|FG001|COMPLETED|Overall Study||294
11131769|NCT01402427|12317721|FG000|NOT COMPLETED|Overall Study||0
11131770|NCT01402427|12317722|FG001|NOT COMPLETED|Overall Study||0
11131771|NCT01402492|12317731|FG000|STARTED|Overall Study||100
11131772|NCT01402492|12317732|FG001|STARTED|Overall Study||100
11131773|NCT01402492|12317733|FG002|STARTED|Overall Study||102
11131774|NCT01402492|12317731|FG000|COMPLETED|Overall Study||79
11131775|NCT01402492|12317732|FG001|COMPLETED|Overall Study||83
11131776|NCT01402492|12317733|FG002|COMPLETED|Overall Study||86
11131777|NCT01402492|12317731|FG000|NOT COMPLETED|Overall Study||21
11131778|NCT01402492|12317732|FG001|NOT COMPLETED|Overall Study||17
11131779|NCT01402492|12317733|FG002|NOT COMPLETED|Overall Study||16
11240236|NCT02088073|12432510|FG001|STARTED|Maintanance Phase||85
11240237|NCT02088073|12432511|FG002|STARTED|Maintanance Phase||45
11240238|NCT02088073|12432512|FG003|STARTED|Maintanance Phase||51
11240239|NCT02088073|12432513|FG004|STARTED|Maintanance Phase||56
11240240|NCT02088073|12432509|FG000|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
11240241|NCT02088073|12432510|FG001|COMPLETED|Maintanance Phase||75
11240242|NCT02088073|12432511|FG002|COMPLETED|Maintanance Phase||40
11240243|NCT02088073|12432512|FG003|COMPLETED|Maintanance Phase||44
11240244|NCT02088073|12432513|FG004|COMPLETED|Maintanance Phase||49
11240245|NCT02088073|12432509|FG000|NOT COMPLETED|Maintanance Phase||0
11240246|NCT02088073|12432510|FG001|NOT COMPLETED|Maintanance Phase||10
11240247|NCT02088073|12432511|FG002|NOT COMPLETED|Maintanance Phase||5
11240248|NCT02088073|12432512|FG003|NOT COMPLETED|Maintanance Phase||7
11240249|NCT02088073|12432513|FG004|NOT COMPLETED|Maintanance Phase||7
11131780|NCT01402544|12317741|FG000|STARTED|Overall Study||12
11131781|NCT01402544|12317741|FG000|COMPLETED|Overall Study||6
11131782|NCT01402544|12317741|FG000|NOT COMPLETED|Overall Study||6
11131783|NCT01402570|12317745|FG000|STARTED|Overall Study||20
11131784|NCT01402570|12317745|FG000|COMPLETED|Overall Study||19
11131785|NCT01402570|12317745|FG000|NOT COMPLETED|Overall Study||1
11131786|NCT01402700|12317750|FG000|STARTED|Overall Study||75
11131787|NCT01402700|12317750|FG000|COMPLETED|Overall Study||68
11131788|NCT01402700|12317750|FG000|NOT COMPLETED|Overall Study||7
11131789|NCT01402817|12317754|FG000|STARTED|Overall Study||19
11131790|NCT01402817|12317754|FG000|COMPLETED|Overall Study||8
11131791|NCT01402817|12317754|FG000|NOT COMPLETED|Overall Study||11
11131792|NCT01402869|12317762|FG000|STARTED|Overall Study||30
11131793|NCT01402869|12317763|FG001|STARTED|Overall Study||30
11131794|NCT01402869|12317764|FG002|STARTED|Overall Study||31
11131795|NCT01402869|12317762|FG000|COMPLETED|Overall Study||30
11131796|NCT01402869|12317763|FG001|COMPLETED|Overall Study||30
11131797|NCT01402869|12317764|FG002|COMPLETED|Overall Study||30
11131798|NCT01402869|12317762|FG000|NOT COMPLETED|Overall Study||0
11131799|NCT01402869|12317763|FG001|NOT COMPLETED|Overall Study||0
11131800|NCT01402869|12317764|FG002|NOT COMPLETED|Overall Study||1
11131801|NCT01402947|12317774|FG000|STARTED|First Intervention||15
11131802|NCT01402947|12317775|FG001|STARTED|First Intervention||15
11131803|NCT01402947|12317774|FG000|COMPLETED|First Intervention||15
11131804|NCT01402947|12317775|FG001|COMPLETED|First Intervention||14
11131805|NCT01402947|12317774|FG000|NOT COMPLETED|First Intervention||0
11131806|NCT01402947|12317775|FG001|NOT COMPLETED|First Intervention||1
11131807|NCT01402947|12317774|FG000|STARTED|Second Intervention||15
11131808|NCT01402947|12317775|FG001|STARTED|Second Intervention||14
11131809|NCT01402947|12317774|FG000|COMPLETED|Second Intervention||15
11131810|NCT01402947|12317775|FG001|COMPLETED|Second Intervention||14
11131811|NCT01402947|12317774|FG000|NOT COMPLETED|Second Intervention||0
11131812|NCT01402947|12317775|FG001|NOT COMPLETED|Second Intervention||0
11131813|NCT01402986|12317785|FG000|STARTED|Overall Study||76
11131814|NCT01402986|12317786|FG001|STARTED|Overall Study||150
11131815|NCT01402986|12317787|FG002|STARTED|Overall Study||75
11131816|NCT01402986|12317788|FG003|STARTED|Overall Study||151
11131817|NCT01402986|12317785|FG000|COMPLETED|Overall Study||67
11131818|NCT01402986|12317786|FG001|COMPLETED|Overall Study||135
11131819|NCT01402986|12317787|FG002|COMPLETED|Overall Study||67
11131820|NCT01402986|12317788|FG003|COMPLETED|Overall Study||129
11131821|NCT01402986|12317785|FG000|NOT COMPLETED|Overall Study||9
11131822|NCT01402986|12317786|FG001|NOT COMPLETED|Overall Study||15
11131823|NCT01402986|12317787|FG002|NOT COMPLETED|Overall Study||8
11131824|NCT01402986|12317788|FG003|NOT COMPLETED|Overall Study||22
11131825|NCT01403051|12317800|FG000|STARTED|Overall Study||81
11131826|NCT01403051|12317801|FG001|STARTED|Overall Study||86
11131827|NCT01403051|12317800|FG000|Initiated Study Treatment|Overall Study||81
11240250|NCT02088177|12432526|FG000|STARTED|Overall Study||12
11240251|NCT02088177|12432526|FG000|COMPLETED|Overall Study||9
11240252|NCT02088177|12432526|FG000|NOT COMPLETED|Overall Study||3
11240253|NCT02088216|12432532|FG000|STARTED|Overall Study||81
11131828|NCT01403051|12317801|FG001|Initiated Study Treatment|Overall Study||86
11131829|NCT01403051|12317800|FG000|COMPLETED|Overall Study||71
11131830|NCT01403051|12317801|FG001|COMPLETED|Overall Study||80
11131831|NCT01403051|12317800|FG000|NOT COMPLETED|Overall Study||10
11131832|NCT01403051|12317801|FG001|NOT COMPLETED|Overall Study||6
11131833|NCT01403064|12317812|FG000|STARTED|Overall Study||24
11131834|NCT01403064|12317813|FG001|STARTED|Overall Study||7
11240254|NCT02088216|12432533|FG001|STARTED|Overall Study||80
11240255|NCT02088216|12432532|FG000|COMPLETED|Overall Study||69
11240256|NCT02088216|12432533|FG001|COMPLETED|Overall Study||70
11240257|NCT02088216|12432532|FG000|NOT COMPLETED|Overall Study||12
11131835|NCT01403064|12317814|FG002|STARTED|Overall Study||23
11131836|NCT01403064|12317815|FG003|STARTED|Overall Study||22
11131837|NCT01403064|12317812|FG000|COMPLETED|Overall Study||23
11131838|NCT01403064|12317813|FG001|COMPLETED|Overall Study||7
11131839|NCT01403064|12317814|FG002|COMPLETED|Overall Study||19
11131840|NCT01403064|12317815|FG003|COMPLETED|Overall Study||19
11131841|NCT01403064|12317812|FG000|NOT COMPLETED|Overall Study||1
11131842|NCT01403064|12317813|FG001|NOT COMPLETED|Overall Study||0
11131843|NCT01403064|12317814|FG002|NOT COMPLETED|Overall Study||4
11131844|NCT01403064|12317815|FG003|NOT COMPLETED|Overall Study||3
11131845|NCT01403090|12317830|FG000|STARTED|Overall Study||8
11131846|NCT01403090|12317830|FG000|COMPLETED|Overall Study||8
11131847|NCT01403090|12317830|FG000|NOT COMPLETED|Overall Study||0
11131848|NCT01403116|12317836|FG000|STARTED|Overall Study||161
11131849|NCT01403116|12317837|FG001|STARTED|Overall Study||160
11131850|NCT01403116|12317836|FG000|Randomized|Overall Study||162
11131851|NCT01403116|12317837|FG001|Randomized|Overall Study||163
11131852|NCT01403116|12317836|FG000|Randomized in Error/ No Treatment Recvd|Overall Study||1
11131853|NCT01403116|12317837|FG001|Randomized in Error/ No Treatment Recvd|Overall Study||3
11131854|NCT01403116|12317836|FG000|COMPLETED|Overall Study||129
11131855|NCT01403116|12317837|FG001|COMPLETED|Overall Study||133
11240258|NCT02088216|12432533|FG001|NOT COMPLETED|Overall Study||10
11240259|NCT02088385|12432541|FG000|STARTED|Overall Study||10
11240260|NCT02088385|12432542|FG001|STARTED|Overall Study||10
11240261|NCT02088385|12432541|FG000|COMPLETED|Overall Study||10
11240262|NCT02088385|12432542|FG001|COMPLETED|Overall Study||10
11240263|NCT02088385|12432541|FG000|NOT COMPLETED|Overall Study||0
11240264|NCT02088385|12432542|FG001|NOT COMPLETED|Overall Study||0
11240265|NCT02088541|12432553|FG000|STARTED|Overall Study||71
11240266|NCT02088541|12432554|FG001|STARTED|Overall Study||27
11240267|NCT02088541|12432555|FG002|STARTED|Overall Study||117
11240268|NCT02088541|12432556|FG003|STARTED|Overall Study||44
11240269|NCT02088541|12432557|FG004|STARTED|Overall Study||58
11240270|NCT02088541|12432553|FG000|Safety Population|Overall Study||71
11240271|NCT02088541|12432554|FG001|Safety Population|Overall Study||27
11240272|NCT02088541|12432555|FG002|Safety Population|Overall Study||115
11240273|NCT02088541|12432556|FG003|Safety Population|Overall Study||39
11240274|NCT02088541|12432557|FG004|Safety Population|Overall Study||45
11240275|NCT02088541|12432553|FG000|Intent-to-treat (ITT) Population|Overall Study||0
11131856|NCT01403116|12317836|FG000|NOT COMPLETED|Overall Study||32
11131857|NCT01403116|12317837|FG001|NOT COMPLETED|Overall Study||27
11131858|NCT01403246|12317843|FG000|STARTED|Overall Study||9
11131859|NCT01403246|12317843|FG000|COMPLETED|Overall Study||9
11131860|NCT01403246|12317843|FG000|NOT COMPLETED|Overall Study||0
11131861|NCT01403376|12317850|FG000|STARTED|Overall Study||41
11131862|NCT01403376|12317851|FG001|STARTED|Overall Study||41
11131863|NCT01403376|12317852|FG002|STARTED|Overall Study||46
11131864|NCT01403376|12317850|FG000|COMPLETED|Overall Study||41
11131865|NCT01403376|12317851|FG001|COMPLETED|Overall Study||41
11131866|NCT01403376|12317852|FG002|COMPLETED|Overall Study||46
11131867|NCT01403376|12317850|FG000|NOT COMPLETED|Overall Study||0
11131868|NCT01403376|12317851|FG001|NOT COMPLETED|Overall Study||0
11131869|NCT01403376|12317852|FG002|NOT COMPLETED|Overall Study||0
11131870|NCT01403441|12317860|FG000|STARTED|Overall Study||3
11131871|NCT01403441|12317860|FG000|COMPLETED|Overall Study||3
11131872|NCT01403441|12317860|FG000|NOT COMPLETED|Overall Study||0
11131873|NCT01403584|12317866|FG000|STARTED|First Intervention (1 Night)||11
11131874|NCT01403584|12317867|FG001|STARTED|First Intervention (1 Night)||10
11131875|NCT01403584|12317866|FG000|COMPLETED|First Intervention (1 Night)||11
11131876|NCT01403584|12317867|FG001|COMPLETED|First Intervention (1 Night)||10
11131877|NCT01403584|12317866|FG000|NOT COMPLETED|First Intervention (1 Night)||0
11131878|NCT01403584|12317867|FG001|NOT COMPLETED|First Intervention (1 Night)||0
11131879|NCT01403584|12317866|FG000|STARTED|Second Intervention(1 Night)||10
11131880|NCT01403584|12317867|FG001|STARTED|Second Intervention(1 Night)||11
11131881|NCT01403584|12317866|FG000|COMPLETED|Second Intervention(1 Night)||10
11131882|NCT01403584|12317867|FG001|COMPLETED|Second Intervention(1 Night)||11
11131883|NCT01403584|12317866|FG000|NOT COMPLETED|Second Intervention(1 Night)||0
11131884|NCT01403584|12317867|FG001|NOT COMPLETED|Second Intervention(1 Night)||0
11131885|NCT01403610|12317877|FG000|STARTED|Overall Study||5
11131886|NCT01403610|12317878|FG001|STARTED|Overall Study||6
11131887|NCT01403610|12317879|FG002|STARTED|Overall Study||4
11131888|NCT01403610|12317880|FG003|STARTED|Overall Study||13
11131889|NCT01403610|12317877|FG000|COMPLETED|Overall Study||3
11131890|NCT01403610|12317878|FG001|COMPLETED|Overall Study||3
11131891|NCT01403610|12317879|FG002|COMPLETED|Overall Study||4
11131892|NCT01403610|12317880|FG003|COMPLETED|Overall Study||13
11240276|NCT02088541|12432554|FG001|Intent-to-treat (ITT) Population|Overall Study||0
11240277|NCT02088541|12432555|FG002|Intent-to-treat (ITT) Population|Overall Study|1 randomized to Selinexor 60mg (PV>=5) but treated with physician choice 2, counted under this arm.|118
11131893|NCT01403610|12317877|FG000|NOT COMPLETED|Overall Study||2
11131894|NCT01403610|12317878|FG001|NOT COMPLETED|Overall Study||3
11131895|NCT01403610|12317879|FG002|NOT COMPLETED|Overall Study||0
11131896|NCT01403610|12317880|FG003|NOT COMPLETED|Overall Study||0
11131897|NCT01403805|12317892|FG000|STARTED|Overall Study||94
11131898|NCT01403805|12317893|FG001|STARTED|Overall Study||105
11131899|NCT01403805|12317892|FG000|Pneumonia Diagnosis|Overall Study||21
11131900|NCT01403805|12317893|FG001|Pneumonia Diagnosis|Overall Study||2
11131901|NCT01403805|12317892|FG000|COMPLETED|Overall Study||94
11131902|NCT01403805|12317893|FG001|COMPLETED|Overall Study||98
11131903|NCT01403805|12317892|FG000|NOT COMPLETED|Overall Study||0
11131904|NCT01403805|12317893|FG001|NOT COMPLETED|Overall Study||7
11131905|NCT01403987|12317906|FG000|STARTED|Overall Study||34
11131906|NCT01403987|12317907|FG001|STARTED|Overall Study||34
11131907|NCT01403987|12317908|FG002|STARTED|Overall Study||68
11131908|NCT01403987|12317906|FG000|COMPLETED|Overall Study||16
11131909|NCT01403987|12317907|FG001|COMPLETED|Overall Study||17
11131910|NCT01403987|12317908|FG002|COMPLETED|Overall Study||50
11131911|NCT01403987|12317906|FG000|NOT COMPLETED|Overall Study||18
11131912|NCT01403987|12317907|FG001|NOT COMPLETED|Overall Study||17
11131913|NCT01403987|12317908|FG002|NOT COMPLETED|Overall Study||18
11131914|NCT01404039|12317925|FG000|STARTED|Overall Study||5
11131915|NCT01404039|12317926|FG001|STARTED|Overall Study||5
11131916|NCT01404039|12317927|FG002|STARTED|Overall Study||5
11240278|NCT02088541|12432556|FG003|Intent-to-treat (ITT) Population|Overall Study||0
11131917|NCT01404039|12317928|FG003|STARTED|Overall Study||10
11131918|NCT01404039|12317929|FG004|STARTED|Overall Study||10
11131919|NCT01404039|12317930|FG005|STARTED|Overall Study||10
11131920|NCT01404039|12317931|FG006|STARTED|Overall Study||10
11131921|NCT01404039|12317932|FG007|STARTED|Overall Study||15
11131922|NCT01404039|12317933|FG008|STARTED|Overall Study||15
11131923|NCT01404039|12317934|FG009|STARTED|Overall Study||15
11131924|NCT01404039|12317935|FG010|STARTED|Overall Study||15
11131925|NCT01404039|12317936|FG011|STARTED|Overall Study||0
11131926|NCT01404039|12317937|FG012|STARTED|Overall Study||0
11131927|NCT01404039|12317925|FG000|COMPLETED|Overall Study||4
11131928|NCT01404039|12317926|FG001|COMPLETED|Overall Study||5
11131929|NCT01404039|12317927|FG002|COMPLETED|Overall Study||5
11131930|NCT01404039|12317928|FG003|COMPLETED|Overall Study||10
11131931|NCT01404039|12317929|FG004|COMPLETED|Overall Study||10
11131932|NCT01404039|12317930|FG005|COMPLETED|Overall Study||10
11131933|NCT01404039|12317931|FG006|COMPLETED|Overall Study||10
11131934|NCT01404039|12317932|FG007|COMPLETED|Overall Study||15
11131935|NCT01404039|12317933|FG008|COMPLETED|Overall Study||15
11131936|NCT01404039|12317934|FG009|COMPLETED|Overall Study||14
11131937|NCT01404039|12317935|FG010|COMPLETED|Overall Study||14
11131938|NCT01404039|12317936|FG011|COMPLETED|Overall Study||0
11131939|NCT01404039|12317937|FG012|COMPLETED|Overall Study||0
11240279|NCT02088541|12432557|FG004|Intent-to-treat (ITT) Population|Overall Study||57
11240280|NCT02088541|12432553|FG000|COMPLETED|Overall Study||0
11240281|NCT02088541|12432554|FG001|COMPLETED|Overall Study||0
11240282|NCT02088541|12432555|FG002|COMPLETED|Overall Study||0
11240283|NCT02088541|12432556|FG003|COMPLETED|Overall Study||0
11131940|NCT01404039|12317925|FG000|NOT COMPLETED|Overall Study||1
11131941|NCT01404039|12317926|FG001|NOT COMPLETED|Overall Study||0
11131942|NCT01404039|12317927|FG002|NOT COMPLETED|Overall Study||0
11131943|NCT01404039|12317928|FG003|NOT COMPLETED|Overall Study||0
11131944|NCT01404039|12317929|FG004|NOT COMPLETED|Overall Study||0
11131945|NCT01404039|12317930|FG005|NOT COMPLETED|Overall Study||0
11131946|NCT01404039|12317931|FG006|NOT COMPLETED|Overall Study||0
11131947|NCT01404039|12317932|FG007|NOT COMPLETED|Overall Study||0
11131948|NCT01404039|12317933|FG008|NOT COMPLETED|Overall Study||0
11131949|NCT01404039|12317934|FG009|NOT COMPLETED|Overall Study||1
11131950|NCT01404039|12317935|FG010|NOT COMPLETED|Overall Study||1
11131951|NCT01404039|12317936|FG011|NOT COMPLETED|Overall Study||0
11131952|NCT01404039|12317937|FG012|NOT COMPLETED|Overall Study||0
11131953|NCT01404078|12317963|FG000|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
11131954|NCT01404078|12317964|FG001|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
11131955|NCT01404078|12317963|FG000|COMPLETED|Overall Study||243
11131956|NCT01404078|12317964|FG001|COMPLETED|Overall Study||237
11131957|NCT01404078|12317963|FG000|NOT COMPLETED|Overall Study||18
11131958|NCT01404078|12317964|FG001|NOT COMPLETED|Overall Study||20
11131959|NCT01404208|12317972|FG000|STARTED|Overall Study||70
11131960|NCT01404208|12317973|FG001|STARTED|Overall Study||72
11131961|NCT01404208|12317972|FG000|COMPLETED|Overall Study||67
11131962|NCT01404208|12317973|FG001|COMPLETED|Overall Study||72
11131963|NCT01404208|12317972|FG000|NOT COMPLETED|Overall Study||3
11131964|NCT01404208|12317973|FG001|NOT COMPLETED|Overall Study||0
11131965|NCT01404234|12317979|FG000|STARTED|Overall Study||61
11240284|NCT02088541|12432557|FG004|COMPLETED|Overall Study||0
11240285|NCT02088541|12432553|FG000|NOT COMPLETED|Overall Study||71
11240286|NCT02088541|12432554|FG001|NOT COMPLETED|Overall Study||27
11131966|NCT01404234|12317979|FG000|COMPLETED|Overall Study||59
11131967|NCT01404234|12317979|FG000|NOT COMPLETED|Overall Study||2
11131968|NCT01404260|12317985|FG000|STARTED|Overall Study||109
11131969|NCT01404260|12317986|FG001|STARTED|Overall Study||110
11131970|NCT01404260|12317985|FG000|COMPLETED|Overall Study||106
11131971|NCT01404260|12317986|FG001|COMPLETED|Overall Study||101
11131972|NCT01404260|12317985|FG000|NOT COMPLETED|Overall Study||3
11131973|NCT01404260|12317986|FG001|NOT COMPLETED|Overall Study||9
11131974|NCT01404325|12317994|FG000|STARTED|Overall Study||67
11131975|NCT01404325|12317995|FG001|STARTED|Overall Study||63
11240287|NCT02088541|12432555|FG002|NOT COMPLETED|Overall Study||117
11240288|NCT02088541|12432556|FG003|NOT COMPLETED|Overall Study||44
11240289|NCT02088541|12432557|FG004|NOT COMPLETED|Overall Study||58
11240290|NCT02088697|12432569|FG000|STARTED|Period I||25
11240291|NCT02088697|12432570|FG001|STARTED|Period I||25
11240292|NCT02088697|12432569|FG000|COMPLETED|Period I||24
11131976|NCT01404325|12317994|FG000|COMPLETED|Overall Study||63
11131977|NCT01404325|12317995|FG001|COMPLETED|Overall Study||61
11131978|NCT01404325|12317994|FG000|NOT COMPLETED|Overall Study||4
11131979|NCT01404325|12317995|FG001|NOT COMPLETED|Overall Study||2
11131980|NCT01404429|12318003|FG000|STARTED|Overall Study||47
11131981|NCT01404429|12318004|FG001|STARTED|Overall Study||53
11131982|NCT01404429|12318003|FG000|COMPLETED|Overall Study||38
11131983|NCT01404429|12318004|FG001|COMPLETED|Overall Study||46
11131984|NCT01404429|12318003|FG000|NOT COMPLETED|Overall Study||9
11131985|NCT01404429|12318004|FG001|NOT COMPLETED|Overall Study||7
11131986|NCT01404559|12318014|FG000|STARTED|Overall Study||5
11131987|NCT01404559|12318015|FG001|STARTED|Overall Study||5
11131988|NCT01404559|12318016|FG002|STARTED|Overall Study||4
11131989|NCT01404559|12318017|FG003|STARTED|Overall Study||14
11131990|NCT01404559|12318014|FG000|COMPLETED|Overall Study||5
11131991|NCT01404559|12318015|FG001|COMPLETED|Overall Study||5
11131992|NCT01404559|12318016|FG002|COMPLETED|Overall Study||4
11131993|NCT01404559|12318017|FG003|COMPLETED|Overall Study||14
11131994|NCT01404559|12318014|FG000|NOT COMPLETED|Overall Study||0
11131995|NCT01404559|12318015|FG001|NOT COMPLETED|Overall Study||0
11131996|NCT01404559|12318016|FG002|NOT COMPLETED|Overall Study||0
11131997|NCT01404559|12318017|FG003|NOT COMPLETED|Overall Study||0
11131998|NCT01404572|12318024|FG000|STARTED|Overall Study||4
11131999|NCT01404572|12318025|FG001|STARTED|Overall Study||4
11132000|NCT01404572|12318026|FG002|STARTED|Overall Study||4
11132001|NCT01404572|12318024|FG000|COMPLETED|Overall Study||4
11132002|NCT01404572|12318025|FG001|COMPLETED|Overall Study||4
11132003|NCT01404572|12318026|FG002|COMPLETED|Overall Study||4
11132004|NCT01404572|12318024|FG000|NOT COMPLETED|Overall Study||0
11132005|NCT01404572|12318025|FG001|NOT COMPLETED|Overall Study||0
11132006|NCT01404572|12318026|FG002|NOT COMPLETED|Overall Study||0
11132007|NCT01404611|12318040|FG000|STARTED|Overall Study||112
11132008|NCT01404611|12318041|FG001|STARTED|Overall Study||108
11132009|NCT01404611|12318042|FG002|STARTED|Overall Study||111
11132010|NCT01404611|12318040|FG000|COMPLETED|Overall Study||104
11132011|NCT01404611|12318041|FG001|COMPLETED|Overall Study||89
11132012|NCT01404611|12318042|FG002|COMPLETED|Overall Study||106
11132013|NCT01404611|12318040|FG000|NOT COMPLETED|Overall Study||8
11132014|NCT01404611|12318041|FG001|NOT COMPLETED|Overall Study||19
11132015|NCT01404611|12318042|FG002|NOT COMPLETED|Overall Study||5
11132016|NCT01404650|12318050|FG000|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
11132017|NCT01404650|12318050|FG000|COMPLETED|Overall Study||25
11132018|NCT01404650|12318050|FG000|NOT COMPLETED|Overall Study||0
11132019|NCT01404832|12318054|FG000|STARTED|Overall Study||21
11132020|NCT01404832|12318054|FG000|COMPLETED|Overall Study||21
11132021|NCT01404832|12318054|FG000|NOT COMPLETED|Overall Study||0
11132022|NCT01404923|12318060|FG000|STARTED|Overall Study||222
11132023|NCT01404923|12318061|FG001|STARTED|Overall Study||214
11132024|NCT01404923|12318060|FG000|COMPLETED|Overall Study||199
11132025|NCT01404923|12318061|FG001|COMPLETED|Overall Study||197
11132026|NCT01404923|12318060|FG000|NOT COMPLETED|Overall Study||23
11132027|NCT01404923|12318061|FG001|NOT COMPLETED|Overall Study||17
11132028|NCT01404936|12318067|FG000|STARTED|Overall Study||30
11132029|NCT01404936|12318067|FG000|COMPLETED|Overall Study||30
11132030|NCT01404936|12318067|FG000|NOT COMPLETED|Overall Study||0
11132031|NCT01404949|12318071|FG000|STARTED|Overall Study||17
11132032|NCT01404949|12318071|FG000|COMPLETED|Overall Study||16
11240293|NCT02088697|12432570|FG001|COMPLETED|Period I||21
11240294|NCT02088697|12432569|FG000|NOT COMPLETED|Period I||1
11240295|NCT02088697|12432570|FG001|NOT COMPLETED|Period I||4
11240296|NCT02088697|12432569|FG000|STARTED|Wash-out Period (at Least 10 Days)||24
11240297|NCT02088697|12432570|FG001|STARTED|Wash-out Period (at Least 10 Days)||21
11240298|NCT02088697|12432569|FG000|COMPLETED|Wash-out Period (at Least 10 Days)||23
11240299|NCT02088697|12432570|FG001|COMPLETED|Wash-out Period (at Least 10 Days)||21
11240300|NCT02088697|12432569|FG000|NOT COMPLETED|Wash-out Period (at Least 10 Days)||1
11240301|NCT02088697|12432570|FG001|NOT COMPLETED|Wash-out Period (at Least 10 Days)||0
11132033|NCT01404949|12318071|FG000|NOT COMPLETED|Overall Study||1
11132034|NCT01404988|12318078|FG000|STARTED|Overall Study||33
11132035|NCT01404988|12318079|FG001|STARTED|Overall Study||33
11132036|NCT01404988|12318080|FG002|STARTED|Overall Study||33
11132037|NCT01404988|12318078|FG000|COMPLETED|Overall Study||27
11132038|NCT01404988|12318079|FG001|COMPLETED|Overall Study||29
11132039|NCT01404988|12318080|FG002|COMPLETED|Overall Study||30
11132040|NCT01404988|12318078|FG000|NOT COMPLETED|Overall Study||6
11132041|NCT01404988|12318079|FG001|NOT COMPLETED|Overall Study||4
11132042|NCT01404988|12318080|FG002|NOT COMPLETED|Overall Study||3
11132043|NCT01405027|12318093|FG000|STARTED|Overall Study||84
11132044|NCT01405027|12318094|FG001|STARTED|Overall Study||113
11132045|NCT01405027|12318093|FG000|COMPLETED|Overall Study||52
11132046|NCT01405027|12318094|FG001|COMPLETED|Overall Study||62
11132047|NCT01405027|12318093|FG000|NOT COMPLETED|Overall Study||32
11132048|NCT01405027|12318094|FG001|NOT COMPLETED|Overall Study||51
11132049|NCT01405053|12318104|FG000|STARTED|Overall Study||25
11132050|NCT01405053|12318105|FG001|STARTED|Overall Study||12
11132051|NCT01405053|12318104|FG000|COMPLETED|Overall Study||15
11132052|NCT01405053|12318105|FG001|COMPLETED|Overall Study||4
11132053|NCT01405053|12318104|FG000|NOT COMPLETED|Overall Study||10
11132054|NCT01405053|12318105|FG001|NOT COMPLETED|Overall Study||8
11132055|NCT01405196|12318115|FG000|STARTED|Overall Study||45
11132056|NCT01405196|12318116|FG001|STARTED|Overall Study||47
11132057|NCT01405196|12318117|FG002|STARTED|Overall Study||46
11132058|NCT01405196|12318118|FG003|STARTED|Overall Study||45
11132059|NCT01405196|12318115|FG000|COMPLETED|Overall Study||34
11132060|NCT01405196|12318116|FG001|COMPLETED|Overall Study||35
11132061|NCT01405196|12318117|FG002|COMPLETED|Overall Study||23
11132062|NCT01405196|12318118|FG003|COMPLETED|Overall Study||36
11132063|NCT01405196|12318115|FG000|NOT COMPLETED|Overall Study||11
11132064|NCT01405196|12318116|FG001|NOT COMPLETED|Overall Study||12
11132065|NCT01405196|12318117|FG002|NOT COMPLETED|Overall Study||23
11132066|NCT01405196|12318118|FG003|NOT COMPLETED|Overall Study||9
11132067|NCT01405313|12318129|FG000|STARTED|Overall Study||21
11132068|NCT01405313|12318129|FG000|COMPLETED|Overall Study||21
11132069|NCT01405313|12318129|FG000|NOT COMPLETED|Overall Study||0
11132070|NCT01405456|12318139|FG000|STARTED|Overall Study||25
11132071|NCT01405456|12318140|FG001|STARTED|Overall Study||21
11132072|NCT01405456|12318139|FG000|COMPLETED|Overall Study||22
11132073|NCT01405456|12318140|FG001|COMPLETED|Overall Study||20
11132074|NCT01405456|12318139|FG000|NOT COMPLETED|Overall Study||3
11132075|NCT01405456|12318140|FG001|NOT COMPLETED|Overall Study||1
11132076|NCT01405469|12318146|FG000|STARTED|Overall Study||16
11132077|NCT01405469|12318146|FG000|COMPLETED|Overall Study||16
11132078|NCT01405469|12318146|FG000|NOT COMPLETED|Overall Study||0
11132079|NCT01405508|12318155|FG000|STARTED|Overall Study||26
11132080|NCT01405508|12318156|FG001|STARTED|Overall Study||26
11132081|NCT01405508|12318157|FG002|STARTED|Overall Study||27
11132082|NCT01405508|12318158|FG003|STARTED|Overall Study||26
11132083|NCT01405508|12318155|FG000|COMPLETED|Overall Study||25
11132084|NCT01405508|12318156|FG001|COMPLETED|Overall Study||25
11132085|NCT01405508|12318157|FG002|COMPLETED|Overall Study||27
11132086|NCT01405508|12318158|FG003|COMPLETED|Overall Study||26
11132087|NCT01405508|12318155|FG000|NOT COMPLETED|Overall Study||1
11132088|NCT01405508|12318156|FG001|NOT COMPLETED|Overall Study||1
11132089|NCT01405508|12318157|FG002|NOT COMPLETED|Overall Study||0
11132090|NCT01405508|12318158|FG003|NOT COMPLETED|Overall Study||0
11132091|NCT01405560|12318168|FG000|STARTED|Overall Study||42
11132092|NCT01405560|12318168|FG000|COMPLETED|Overall Study||41
11132093|NCT01405560|12318168|FG000|NOT COMPLETED|Overall Study||1
11132094|NCT01405742|12318172|FG000|STARTED|Overall Study||2
11132095|NCT01405742|12318173|FG001|STARTED|Overall Study||2
11132096|NCT01405742|12318172|FG000|COMPLETED|Overall Study||1
11132097|NCT01405742|12318173|FG001|COMPLETED|Overall Study||2
11132098|NCT01405742|12318172|FG000|NOT COMPLETED|Overall Study||1
11132099|NCT01405742|12318173|FG001|NOT COMPLETED|Overall Study||0
11132100|NCT01405768|12318181|FG000|STARTED|Overall Study||28
11132101|NCT01405768|12318182|FG001|STARTED|Overall Study||28
11132102|NCT01405768|12318181|FG000|COMPLETED|Overall Study||24
11132103|NCT01405768|12318182|FG001|COMPLETED|Overall Study||28
11132104|NCT01405768|12318181|FG000|NOT COMPLETED|Overall Study||4
11132105|NCT01405768|12318182|FG001|NOT COMPLETED|Overall Study||0
11132106|NCT01405794|12318188|FG000|STARTED|First Dose Placebo (14 Days)||12
11132107|NCT01405794|12318188|FG000|COMPLETED|First Dose Placebo (14 Days)||12
11132108|NCT01405794|12318188|FG000|NOT COMPLETED|First Dose Placebo (14 Days)||0
11132109|NCT01405794|12318188|FG000|STARTED|72 hr Washout||12
11132110|NCT01405794|12318188|FG000|COMPLETED|72 hr Washout||12
11132111|NCT01405794|12318188|FG000|NOT COMPLETED|72 hr Washout||0
11132112|NCT01405794|12318188|FG000|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
11132113|NCT01405794|12318188|FG000|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
11132114|NCT01405794|12318188|FG000|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
11132115|NCT01405820|12318200|FG000|STARTED|Randomized Treatment Period||54
11132116|NCT01405820|12318201|FG001|STARTED|Randomized Treatment Period||45
11132117|NCT01405820|12318202|FG002|STARTED|Randomized Treatment Period||52
11132118|NCT01405820|12318203|FG003|STARTED|Randomized Treatment Period||54
11132119|NCT01405820|12318204|FG004|STARTED|Randomized Treatment Period||47
11132120|NCT01405820|12318205|FG005|STARTED|Randomized Treatment Period||38
11132121|NCT01405820|12318200|FG000|Safety Population|Randomized Treatment Period||54
11132122|NCT01405820|12318201|FG001|Safety Population|Randomized Treatment Period||45
11132123|NCT01405820|12318202|FG002|Safety Population|Randomized Treatment Period||52
11132124|NCT01405820|12318203|FG003|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
11132125|NCT01405820|12318204|FG004|Safety Population|Randomized Treatment Period||47
11132126|NCT01405820|12318205|FG005|Safety Population|Randomized Treatment Period||38
11132127|NCT01405820|12318200|FG000|COMPLETED|Randomized Treatment Period||43
11132128|NCT01405820|12318201|FG001|COMPLETED|Randomized Treatment Period||35
11132129|NCT01405820|12318202|FG002|COMPLETED|Randomized Treatment Period||9
11132130|NCT01405820|12318203|FG003|COMPLETED|Randomized Treatment Period||3
11132131|NCT01405820|12318204|FG004|COMPLETED|Randomized Treatment Period||2
11132132|NCT01405820|12318205|FG005|COMPLETED|Randomized Treatment Period||1
11132133|NCT01405820|12318200|FG000|NOT COMPLETED|Randomized Treatment Period||11
11132134|NCT01405820|12318201|FG001|NOT COMPLETED|Randomized Treatment Period||10
11132135|NCT01405820|12318202|FG002|NOT COMPLETED|Randomized Treatment Period||43
11132136|NCT01405820|12318203|FG003|NOT COMPLETED|Randomized Treatment Period||51
11132137|NCT01405820|12318204|FG004|NOT COMPLETED|Randomized Treatment Period||45
11132138|NCT01405820|12318205|FG005|NOT COMPLETED|Randomized Treatment Period||37
11132139|NCT01405820|12318200|FG000|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
11132140|NCT01405820|12318201|FG001|STARTED|Open-Label Treatment Period||35
11132141|NCT01405820|12318202|FG002|STARTED|Open-Label Treatment Period||42
11132142|NCT01405820|12318203|FG003|STARTED|Open-Label Treatment Period||42
11132143|NCT01405820|12318204|FG004|STARTED|Open-Label Treatment Period||42
11132144|NCT01405820|12318205|FG005|STARTED|Open-Label Treatment Period||32
11132145|NCT01405820|12318200|FG000|COMPLETED|Open-Label Treatment Period||40
11132146|NCT01405820|12318201|FG001|COMPLETED|Open-Label Treatment Period||33
11132147|NCT01405820|12318202|FG002|COMPLETED|Open-Label Treatment Period||39
11132148|NCT01405820|12318203|FG003|COMPLETED|Open-Label Treatment Period||37
11132149|NCT01405820|12318204|FG004|COMPLETED|Open-Label Treatment Period||40
11132150|NCT01405820|12318205|FG005|COMPLETED|Open-Label Treatment Period||30
11132151|NCT01405820|12318200|FG000|NOT COMPLETED|Open-Label Treatment Period||4
11132152|NCT01405820|12318201|FG001|NOT COMPLETED|Open-Label Treatment Period||2
11132153|NCT01405820|12318202|FG002|NOT COMPLETED|Open-Label Treatment Period||3
11132154|NCT01405820|12318203|FG003|NOT COMPLETED|Open-Label Treatment Period||5
11132155|NCT01405820|12318204|FG004|NOT COMPLETED|Open-Label Treatment Period||2
11132156|NCT01405820|12318205|FG005|NOT COMPLETED|Open-Label Treatment Period||2
11132157|NCT01405898|12318227|FG000|STARTED|Overall Study||34
11132158|NCT01405898|12318228|FG001|STARTED|Overall Study||34
11132159|NCT01405898|12318227|FG000|COMPLETED|Overall Study||32
11132160|NCT01405898|12318228|FG001|COMPLETED|Overall Study||32
11132161|NCT01405898|12318227|FG000|NOT COMPLETED|Overall Study||2
11132162|NCT01405898|12318228|FG001|NOT COMPLETED|Overall Study||2
11132163|NCT01405911|12318237|FG000|STARTED|Overall Study||83
11132164|NCT01405911|12318238|FG001|STARTED|Overall Study||82
11132165|NCT01405911|12318239|FG002|STARTED|Overall Study||77
11132166|NCT01405911|12318237|FG000|Treated|Overall Study||82
11132167|NCT01405911|12318238|FG001|Treated|Overall Study|1 participant received study drug but was discontinued due to pre-treatment lab AE.|82
11132168|NCT01405911|12318239|FG002|Treated|Overall Study||77
11132169|NCT01405911|12318237|FG000|COMPLETED|Overall Study||79
11132170|NCT01405911|12318238|FG001|COMPLETED|Overall Study||79
11132171|NCT01405911|12318239|FG002|COMPLETED|Overall Study||76
11132172|NCT01405911|12318237|FG000|NOT COMPLETED|Overall Study||4
11132173|NCT01405911|12318238|FG001|NOT COMPLETED|Overall Study||3
11132174|NCT01405911|12318239|FG002|NOT COMPLETED|Overall Study||1
11132175|NCT01405924|12318247|FG000|STARTED|Overall Study||111
11132176|NCT01405924|12318247|FG000|COMPLETED|Overall Study||101
11132177|NCT01405924|12318247|FG000|NOT COMPLETED|Overall Study||10
11132178|NCT01405937|12318255|FG000|STARTED|Overall Study||25
11132179|NCT01405937|12318256|FG001|STARTED|Overall Study||26
11132180|NCT01405937|12318255|FG000|COMPLETED|Overall Study||25
11132181|NCT01405937|12318256|FG001|COMPLETED|Overall Study||26
11132182|NCT01405937|12318255|FG000|NOT COMPLETED|Overall Study||0
11132183|NCT01405937|12318256|FG001|NOT COMPLETED|Overall Study||0
11132184|NCT01405950|12318264|FG000|STARTED|Overall Study||8
11132185|NCT01405950|12318265|FG001|STARTED|Overall Study||2
11132186|NCT01405950|12318266|FG002|STARTED|Overall Study||0
11132187|NCT01405950|12318267|FG003|STARTED|Overall Study||0
11132188|NCT01405950|12318264|FG000|COMPLETED|Overall Study||7
11132189|NCT01405950|12318265|FG001|COMPLETED|Overall Study||2
11132190|NCT01405950|12318266|FG002|COMPLETED|Overall Study||0
11132191|NCT01405950|12318267|FG003|COMPLETED|Overall Study||0
11132192|NCT01405950|12318264|FG000|NOT COMPLETED|Overall Study||1
11132193|NCT01405950|12318265|FG001|NOT COMPLETED|Overall Study||0
11132194|NCT01405950|12318266|FG002|NOT COMPLETED|Overall Study||0
11132195|NCT01405950|12318267|FG003|NOT COMPLETED|Overall Study||0
11132196|NCT01406015|12318277|FG000|STARTED|Overall Study||19
11132197|NCT01406015|12318278|FG001|STARTED|Overall Study||19
11132198|NCT01406015|12318277|FG000|COMPLETED|Overall Study||16
11132199|NCT01406015|12318278|FG001|COMPLETED|Overall Study||16
11132200|NCT01406015|12318277|FG000|NOT COMPLETED|Overall Study||3
11132201|NCT01406015|12318278|FG001|NOT COMPLETED|Overall Study||3
11132202|NCT01406223|12318288|FG000|STARTED|Overall Study||18
11132203|NCT01406223|12318289|FG001|STARTED|Overall Study||19
11132204|NCT01406223|12318290|FG002|STARTED|Overall Study||20
11132205|NCT01406223|12318291|FG003|STARTED|Overall Study||19
11132206|NCT01406223|12318288|FG000|COMPLETED|Overall Study||6
11132207|NCT01406223|12318289|FG001|COMPLETED|Overall Study||7
11132208|NCT01406223|12318290|FG002|COMPLETED|Overall Study||2
11132209|NCT01406223|12318291|FG003|COMPLETED|Overall Study||3
11132210|NCT01406223|12318288|FG000|NOT COMPLETED|Overall Study||12
11132211|NCT01406223|12318289|FG001|NOT COMPLETED|Overall Study||12
11132212|NCT01406223|12318290|FG002|NOT COMPLETED|Overall Study||18
11132213|NCT01406223|12318291|FG003|NOT COMPLETED|Overall Study||16
11132214|NCT01406444|12318304|FG000|STARTED|Overall Study||33
11132215|NCT01406444|12318305|FG001|STARTED|Overall Study||33
11132216|NCT01406444|12318306|FG002|STARTED|Overall Study||16
11132217|NCT01406444|12318304|FG000|COMPLETED|Overall Study||23
11132218|NCT01406444|12318305|FG001|COMPLETED|Overall Study||24
11132219|NCT01406444|12318306|FG002|COMPLETED|Overall Study||14
11132220|NCT01406444|12318304|FG000|NOT COMPLETED|Overall Study||10
11132221|NCT01406444|12318305|FG001|NOT COMPLETED|Overall Study||9
11132222|NCT01406444|12318306|FG002|NOT COMPLETED|Overall Study||2
11132223|NCT01406574|12318314|FG000|STARTED|Overall Study||7
11132224|NCT01406574|12318315|FG001|STARTED|Overall Study||4
11132225|NCT01406574|12318316|FG002|STARTED|Overall Study||7
11132226|NCT01406574|12318317|FG003|STARTED|Overall Study||5
11132227|NCT01406574|12318314|FG000|COMPLETED|Overall Study||6
11132228|NCT01406574|12318315|FG001|COMPLETED|Overall Study||3
11132229|NCT01406574|12318316|FG002|COMPLETED|Overall Study||6
11132230|NCT01406574|12318317|FG003|COMPLETED|Overall Study||1
11132231|NCT01406574|12318314|FG000|NOT COMPLETED|Overall Study||1
11132232|NCT01406574|12318315|FG001|NOT COMPLETED|Overall Study||1
11132233|NCT01406574|12318316|FG002|NOT COMPLETED|Overall Study||1
11132234|NCT01406574|12318317|FG003|NOT COMPLETED|Overall Study||4
11132235|NCT01406652|12318330|FG000|STARTED|Overall Study||109
11132236|NCT01406652|12318331|FG001|STARTED|Overall Study||115
11132237|NCT01406652|12318330|FG000|COMPLETED|Overall Study||89
11132238|NCT01406652|12318331|FG001|COMPLETED|Overall Study||95
11132239|NCT01406652|12318330|FG000|NOT COMPLETED|Overall Study||20
11132240|NCT01406652|12318331|FG001|NOT COMPLETED|Overall Study||20
11132241|NCT01406717|12318341|FG000|STARTED|Overall Study||180
11132242|NCT01406717|12318342|FG001|STARTED|Overall Study||180
11132243|NCT01406717|12318341|FG000|COMPLETED|Overall Study||137
11132244|NCT01406717|12318342|FG001|COMPLETED|Overall Study||149
11132245|NCT01406717|12318341|FG000|NOT COMPLETED|Overall Study||43
11132246|NCT01406717|12318342|FG001|NOT COMPLETED|Overall Study||31
11132247|NCT01406795|12318358|FG000|STARTED|Overall Study||1
11132248|NCT01406795|12318358|FG000|COMPLETED|Overall Study||0
11132249|NCT01406795|12318358|FG000|NOT COMPLETED|Overall Study||1
11132250|NCT01406873|12318364|FG000|STARTED|Overall Study||21
11132251|NCT01406873|12318365|FG001|STARTED|Overall Study||21
11132252|NCT01406873|12318364|FG000|COMPLETED|Overall Study||20
11132253|NCT01406873|12318365|FG001|COMPLETED|Overall Study||20
11132254|NCT01406873|12318364|FG000|NOT COMPLETED|Overall Study||1
11132255|NCT01406873|12318365|FG001|NOT COMPLETED|Overall Study||1
11132256|NCT01406938|12318383|FG000|STARTED|Induction Period||482
11132257|NCT01406938|12318384|FG001|STARTED|Induction Period||484
11132258|NCT01406938|12318385|FG002|STARTED|Induction Period||0
11132259|NCT01406938|12318386|FG003|STARTED|Induction Period||0
11132260|NCT01406938|12318387|FG004|STARTED|Induction Period||0
11132261|NCT01406938|12318388|FG005|STARTED|Induction Period||0
11132262|NCT01406938|12318383|FG000|FAS:Patients Assigned Study Treatment|Induction Period||482
11132263|NCT01406938|12318384|FG001|FAS:Patients Assigned Study Treatment|Induction Period||483
11132264|NCT01406938|12318385|FG002|FAS:Patients Assigned Study Treatment|Induction Period||0
11132265|NCT01406938|12318386|FG003|FAS:Patients Assigned Study Treatment|Induction Period||0
11132266|NCT01406938|12318387|FG004|FAS:Patients Assigned Study Treatment|Induction Period||0
11132267|NCT01406938|12318388|FG005|FAS:Patients Assigned Study Treatment|Induction Period||0
11132268|NCT01406938|12318383|FG000|COMPLETED|Induction Period||464
11132269|NCT01406938|12318384|FG001|COMPLETED|Induction Period||464
11132270|NCT01406938|12318385|FG002|COMPLETED|Induction Period||0
11132271|NCT01406938|12318386|FG003|COMPLETED|Induction Period||0
11132272|NCT01406938|12318387|FG004|COMPLETED|Induction Period||0
11132273|NCT01406938|12318388|FG005|COMPLETED|Induction Period||0
11132274|NCT01406938|12318383|FG000|NOT COMPLETED|Induction Period||18
11132275|NCT01406938|12318384|FG001|NOT COMPLETED|Induction Period||20
11132276|NCT01406938|12318385|FG002|NOT COMPLETED|Induction Period||0
11132277|NCT01406938|12318386|FG003|NOT COMPLETED|Induction Period||0
11132278|NCT01406938|12318387|FG004|NOT COMPLETED|Induction Period||0
11132279|NCT01406938|12318388|FG005|NOT COMPLETED|Induction Period||0
11132280|NCT01406938|12318383|FG000|STARTED|Maintenance Period||0
11132281|NCT01406938|12318384|FG001|STARTED|Maintenance Period||0
11132282|NCT01406938|12318385|FG002|STARTED|Maintenance Period||203
11132283|NCT01406938|12318386|FG003|STARTED|Maintenance Period||217
11132284|NCT01406938|12318387|FG004|STARTED|Maintenance Period||206
11132285|NCT01406938|12318388|FG005|STARTED|Maintenance Period||217
11132286|NCT01406938|12318383|FG000|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
11132287|NCT01406938|12318384|FG001|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
11132288|NCT01406938|12318385|FG002|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
11132289|NCT01406938|12318386|FG003|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
11132290|NCT01406938|12318387|FG004|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
11132291|NCT01406938|12318388|FG005|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
11132292|NCT01406938|12318383|FG000|COMPLETED|Maintenance Period||0
11240302|NCT02088697|12432569|FG000|STARTED|Period II||23
11240303|NCT02088697|12432570|FG001|STARTED|Period II||21
11240304|NCT02088697|12432569|FG000|COMPLETED|Period II||23
11240305|NCT02088697|12432570|FG001|COMPLETED|Period II||21
11240306|NCT02088697|12432569|FG000|NOT COMPLETED|Period II||0
11240307|NCT02088697|12432570|FG001|NOT COMPLETED|Period II||0
11240308|NCT02088788|12432578|FG000|STARTED|Overall Study||135
11240309|NCT02088788|12432579|FG001|STARTED|Overall Study||130
11240310|NCT02088788|12432578|FG000|COMPLETED|Overall Study||105
11240311|NCT02088788|12432579|FG001|COMPLETED|Overall Study||89
11132293|NCT01406938|12318384|FG001|COMPLETED|Maintenance Period||0
11132294|NCT01406938|12318385|FG002|COMPLETED|Maintenance Period||186
11132295|NCT01406938|12318386|FG003|COMPLETED|Maintenance Period||199
11132296|NCT01406938|12318387|FG004|COMPLETED|Maintenance Period||181
11240312|NCT02088788|12432578|FG000|NOT COMPLETED|Overall Study||30
11240313|NCT02088788|12432579|FG001|NOT COMPLETED|Overall Study||41
11240314|NCT02088905|12432587|FG000|STARTED|Overall Study||13
11132297|NCT01406938|12318388|FG005|COMPLETED|Maintenance Period||201
11132298|NCT01406938|12318383|FG000|NOT COMPLETED|Maintenance Period||0
11132299|NCT01406938|12318384|FG001|NOT COMPLETED|Maintenance Period||0
11132300|NCT01406938|12318385|FG002|NOT COMPLETED|Maintenance Period||17
11132301|NCT01406938|12318386|FG003|NOT COMPLETED|Maintenance Period||18
11132302|NCT01406938|12318387|FG004|NOT COMPLETED|Maintenance Period||25
11132303|NCT01406938|12318388|FG005|NOT COMPLETED|Maintenance Period||16
11132304|NCT01406938|12318383|FG000|STARTED|Follow up||26
11132305|NCT01406938|12318384|FG001|STARTED|Follow up||23
11132306|NCT01406938|12318385|FG002|STARTED|Follow up||40
11132307|NCT01406938|12318386|FG003|STARTED|Follow up||39
11132308|NCT01406938|12318387|FG004|STARTED|Follow up||40
11132309|NCT01406938|12318388|FG005|STARTED|Follow up||35
11132310|NCT01406938|12318383|FG000|COMPLETED|Follow up||18
11132311|NCT01406938|12318384|FG001|COMPLETED|Follow up||18
11132312|NCT01406938|12318385|FG002|COMPLETED|Follow up||32
11132313|NCT01406938|12318386|FG003|COMPLETED|Follow up||36
11132314|NCT01406938|12318387|FG004|COMPLETED|Follow up||31
11132315|NCT01406938|12318388|FG005|COMPLETED|Follow up||32
11132316|NCT01406938|12318383|FG000|NOT COMPLETED|Follow up||8
11132317|NCT01406938|12318384|FG001|NOT COMPLETED|Follow up||5
11132318|NCT01406938|12318385|FG002|NOT COMPLETED|Follow up||8
11132319|NCT01406938|12318386|FG003|NOT COMPLETED|Follow up||3
11132320|NCT01406938|12318387|FG004|NOT COMPLETED|Follow up||9
11132321|NCT01406938|12318388|FG005|NOT COMPLETED|Follow up||3
11132322|NCT01406990|12318408|FG000|STARTED|Overall Study||15
11132323|NCT01406990|12318408|FG000|COMPLETED|Overall Study||15
11132324|NCT01406990|12318408|FG000|NOT COMPLETED|Overall Study||0
11132325|NCT01407068|12318412|FG000|STARTED|Overall Study||60
11132326|NCT01407068|12318412|FG000|COMPLETED|Overall Study||60
11132327|NCT01407068|12318412|FG000|NOT COMPLETED|Overall Study||0
11132328|NCT01407094|12318421|FG000|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
11132329|NCT01407094|12318422|FG001|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
11132330|NCT01407094|12318423|FG002|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
11132331|NCT01407094|12318421|FG000|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
11132332|NCT01407094|12318422|FG001|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
11132333|NCT01407094|12318423|FG002|COMPLETED|Stage 1||0
11132334|NCT01407094|12318421|FG000|NOT COMPLETED|Stage 1||34
11132335|NCT01407094|12318422|FG001|NOT COMPLETED|Stage 1||27
11132336|NCT01407094|12318423|FG002|NOT COMPLETED|Stage 1||0
11132337|NCT01407094|12318421|FG000|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
11132338|NCT01407094|12318422|FG001|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
11132339|NCT01407094|12318423|FG002|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
11132340|NCT01407094|12318421|FG000|COMPLETED|Stage 2||113
11132341|NCT01407094|12318422|FG001|COMPLETED|Stage 2||35
11132342|NCT01407094|12318423|FG002|COMPLETED|Stage 2||38
11132343|NCT01407094|12318421|FG000|NOT COMPLETED|Stage 2||21
11132344|NCT01407094|12318422|FG001|NOT COMPLETED|Stage 2||11
11132345|NCT01407094|12318423|FG002|NOT COMPLETED|Stage 2||15
11132346|NCT01407107|12318434|FG000|STARTED|Overall Study||7
11132347|NCT01407107|12318435|FG001|STARTED|Overall Study||3
11132348|NCT01407107|12318436|FG002|STARTED|Overall Study||3
11132349|NCT01407107|12318434|FG000|COMPLETED|Overall Study||7
11132350|NCT01407107|12318435|FG001|COMPLETED|Overall Study||3
11132351|NCT01407107|12318436|FG002|COMPLETED|Overall Study||3
11132352|NCT01407107|12318434|FG000|NOT COMPLETED|Overall Study||0
11132353|NCT01407107|12318435|FG001|NOT COMPLETED|Overall Study||0
11132354|NCT01407107|12318436|FG002|NOT COMPLETED|Overall Study||0
11132355|NCT01407276|12318452|FG000|STARTED|Overall Study||6
11132356|NCT01407276|12318453|FG001|STARTED|Overall Study||6
11132357|NCT01407276|12318454|FG002|STARTED|Overall Study||6
11132358|NCT01407276|12318455|FG003|STARTED|Overall Study||6
11132359|NCT01407276|12318456|FG004|STARTED|Overall Study||6
11240315|NCT02088905|12432588|FG001|STARTED|Overall Study||10
11132360|NCT01407276|12318457|FG005|STARTED|Overall Study||6
11132361|NCT01407276|12318458|FG006|STARTED|Overall Study||6
11132362|NCT01407276|12318459|FG007|STARTED|Overall Study||7
11132363|NCT01407276|12318452|FG000|COMPLETED|Overall Study||6
11132364|NCT01407276|12318453|FG001|COMPLETED|Overall Study||6
11132365|NCT01407276|12318454|FG002|COMPLETED|Overall Study||6
11132366|NCT01407276|12318455|FG003|COMPLETED|Overall Study||6
11132367|NCT01407276|12318456|FG004|COMPLETED|Overall Study||6
11132368|NCT01407276|12318457|FG005|COMPLETED|Overall Study||6
11132369|NCT01407276|12318458|FG006|COMPLETED|Overall Study||6
11132370|NCT01407276|12318459|FG007|COMPLETED|Overall Study||6
11132371|NCT01407276|12318452|FG000|NOT COMPLETED|Overall Study||0
11132372|NCT01407276|12318453|FG001|NOT COMPLETED|Overall Study||0
11132373|NCT01407276|12318454|FG002|NOT COMPLETED|Overall Study||0
11132374|NCT01407276|12318455|FG003|NOT COMPLETED|Overall Study||0
11132375|NCT01407276|12318456|FG004|NOT COMPLETED|Overall Study||0
11132376|NCT01407276|12318457|FG005|NOT COMPLETED|Overall Study||0
11132377|NCT01407276|12318458|FG006|NOT COMPLETED|Overall Study||0
11132378|NCT01407276|12318459|FG007|NOT COMPLETED|Overall Study||1
11132379|NCT01407354|12318484|FG000|STARTED|First Intervention||20
11132380|NCT01407354|12318485|FG001|STARTED|First Intervention||17
11132381|NCT01407354|12318484|FG000|COMPLETED|First Intervention||18
11132382|NCT01407354|12318485|FG001|COMPLETED|First Intervention||15
11132383|NCT01407354|12318484|FG000|NOT COMPLETED|First Intervention||2
11132384|NCT01407354|12318485|FG001|NOT COMPLETED|First Intervention||2
11240316|NCT02088905|12432587|FG000|Week 9|Overall Study||10
11132385|NCT01407354|12318484|FG000|STARTED|Second Intervention||18
11132386|NCT01407354|12318485|FG001|STARTED|Second Intervention||15
11132387|NCT01407354|12318484|FG000|COMPLETED|Second Intervention||18
11132388|NCT01407354|12318485|FG001|COMPLETED|Second Intervention||13
11132389|NCT01407354|12318484|FG000|NOT COMPLETED|Second Intervention||0
11132390|NCT01407354|12318485|FG001|NOT COMPLETED|Second Intervention||2
11132391|NCT01407367|12318494|FG000|STARTED|Overall Study||108
11132392|NCT01407367|12318495|FG001|STARTED|Overall Study||242
11132393|NCT01407367|12318494|FG000|COMPLETED|Overall Study||68
11132394|NCT01407367|12318495|FG001|COMPLETED|Overall Study||164
11132395|NCT01407367|12318494|FG000|NOT COMPLETED|Overall Study||40
11132396|NCT01407367|12318495|FG001|NOT COMPLETED|Overall Study||78
11132397|NCT01407523|12318504|FG000|STARTED|Overall Study||16
11132398|NCT01407523|12318504|FG000|COMPLETED|Overall Study||16
11132399|NCT01407523|12318504|FG000|NOT COMPLETED|Overall Study||0
11132400|NCT01407575|12318510|FG000|STARTED|Overall Study||7
11132401|NCT01407575|12318511|FG001|STARTED|Overall Study||6
11132402|NCT01407575|12318510|FG000|COMPLETED|Overall Study||5
11132403|NCT01407575|12318511|FG001|COMPLETED|Overall Study||5
11132404|NCT01407575|12318510|FG000|NOT COMPLETED|Overall Study||2
11132405|NCT01407575|12318511|FG001|NOT COMPLETED|Overall Study||1
11132406|NCT01407926|12318519|FG000|STARTED|Overall Study||142
11132407|NCT01407926|12318519|FG000|COMPLETED|Overall Study||87
11132408|NCT01407926|12318519|FG000|NOT COMPLETED|Overall Study||55
11132409|NCT01407952|12318526|FG000|STARTED|Overall Study||297
11132410|NCT01407952|12318527|FG001|STARTED|Overall Study||303
11132411|NCT01407952|12318526|FG000|COMPLETED|Overall Study||251
11132412|NCT01407952|12318527|FG001|COMPLETED|Overall Study||266
11132413|NCT01407952|12318526|FG000|NOT COMPLETED|Overall Study||46
11132414|NCT01407952|12318527|FG001|NOT COMPLETED|Overall Study||37
11132415|NCT01408030|12318537|FG000|STARTED|Treatment Phase (on Drug)||29
11132416|NCT01408030|12318538|FG001|STARTED|Treatment Phase (on Drug)||31
11132417|NCT01408030|12318539|FG002|STARTED|Treatment Phase (on Drug)||33
11132418|NCT01408030|12318540|FG003|STARTED|Treatment Phase (on Drug)||28
11132419|NCT01408030|12318537|FG000|COMPLETED|Treatment Phase (on Drug)||26
11132420|NCT01408030|12318538|FG001|COMPLETED|Treatment Phase (on Drug)||24
11132421|NCT01408030|12318539|FG002|COMPLETED|Treatment Phase (on Drug)||32
11132422|NCT01408030|12318540|FG003|COMPLETED|Treatment Phase (on Drug)||25
11132423|NCT01408030|12318537|FG000|NOT COMPLETED|Treatment Phase (on Drug)||3
11132424|NCT01408030|12318538|FG001|NOT COMPLETED|Treatment Phase (on Drug)||7
11132425|NCT01408030|12318539|FG002|NOT COMPLETED|Treatment Phase (on Drug)||1
11132426|NCT01408030|12318540|FG003|NOT COMPLETED|Treatment Phase (on Drug)||3
11132427|NCT01408030|12318537|FG000|STARTED|Observation Phase (Off Drug)||26
11132428|NCT01408030|12318538|FG001|STARTED|Observation Phase (Off Drug)||24
11132429|NCT01408030|12318539|FG002|STARTED|Observation Phase (Off Drug)||32
11132430|NCT01408030|12318540|FG003|STARTED|Observation Phase (Off Drug)||25
11132431|NCT01408030|12318537|FG000|COMPLETED|Observation Phase (Off Drug)||22
11132432|NCT01408030|12318538|FG001|COMPLETED|Observation Phase (Off Drug)||18
11132433|NCT01408030|12318539|FG002|COMPLETED|Observation Phase (Off Drug)||26
11132434|NCT01408030|12318540|FG003|COMPLETED|Observation Phase (Off Drug)||21
11132435|NCT01408030|12318537|FG000|NOT COMPLETED|Observation Phase (Off Drug)||4
11132436|NCT01408030|12318538|FG001|NOT COMPLETED|Observation Phase (Off Drug)||6
11132437|NCT01408030|12318539|FG002|NOT COMPLETED|Observation Phase (Off Drug)||6
11132438|NCT01408030|12318540|FG003|NOT COMPLETED|Observation Phase (Off Drug)||4
11132439|NCT01408043|12318550|FG000|STARTED|Overall Study||25
11132440|NCT01408043|12318550|FG000|COMPLETED|Overall Study||24
11132441|NCT01408043|12318550|FG000|NOT COMPLETED|Overall Study||1
11240317|NCT02088905|12432588|FG001|Week 9|Overall Study||9
11132442|NCT01408147|12318556|FG000|STARTED|Overall Study|174 participants|174
11132443|NCT01408147|12318557|FG001|STARTED|Overall Study|197 participants|197
11132444|NCT01408147|12318556|FG000|COMPLETED|Overall Study|1 clinic withdrew due to low census|174
11132445|NCT01408147|12318557|FG001|COMPLETED|Overall Study||196
11132446|NCT01408147|12318556|FG000|NOT COMPLETED|Overall Study||0
11132447|NCT01408147|12318557|FG001|NOT COMPLETED|Overall Study||1
11132448|NCT01408277|12318565|FG000|STARTED|Overall Study||28
11132449|NCT01408277|12318566|FG001|STARTED|Overall Study||27
11240318|NCT02088905|12432587|FG000|COMPLETED|Overall Study||8
11240319|NCT02088905|12432588|FG001|COMPLETED|Overall Study||9
11132450|NCT01408277|12318565|FG000|COMPLETED|Overall Study||20
11132451|NCT01408277|12318566|FG001|COMPLETED|Overall Study||23
11132452|NCT01408277|12318565|FG000|NOT COMPLETED|Overall Study||8
11132453|NCT01408277|12318566|FG001|NOT COMPLETED|Overall Study||4
11132454|NCT01408303|12318575|FG000|STARTED|Overall Study||215
11132455|NCT01408303|12318576|FG001|STARTED|Overall Study||216
11132456|NCT01408303|12318577|FG002|STARTED|Overall Study||216
11132457|NCT01408303|12318575|FG000|COMPLETED|Overall Study||209
11132458|NCT01408303|12318576|FG001|COMPLETED|Overall Study||204
11132459|NCT01408303|12318577|FG002|COMPLETED|Overall Study||210
11132460|NCT01408303|12318575|FG000|NOT COMPLETED|Overall Study||6
11132461|NCT01408303|12318576|FG001|NOT COMPLETED|Overall Study||12
11132462|NCT01408303|12318577|FG002|NOT COMPLETED|Overall Study||6
11132463|NCT01408329|12318587|FG000|STARTED|Overall Study||13
11132464|NCT01408329|12318588|FG001|STARTED|Overall Study||15
11132465|NCT01408329|12318587|FG000|COMPLETED|Overall Study||10
11132466|NCT01408329|12318588|FG001|COMPLETED|Overall Study||11
11132467|NCT01408329|12318587|FG000|NOT COMPLETED|Overall Study||3
11132468|NCT01408329|12318588|FG001|NOT COMPLETED|Overall Study||4
11202254|NCT01838681|12392646|FG001|NOT COMPLETED|Period B/A+||62
11202255|NCT01838681|12392647|FG002|NOT COMPLETED|Period B/A+||95
11240320|NCT02088905|12432587|FG000|NOT COMPLETED|Overall Study||5
11132469|NCT01408459|12318596|FG000|STARTED|Overall Study||22
11132470|NCT01408459|12318597|FG001|STARTED|Overall Study||15
11132471|NCT01408459|12318596|FG000|COMPLETED|Overall Study||21
11132472|NCT01408459|12318597|FG001|COMPLETED|Overall Study||14
11132473|NCT01408459|12318596|FG000|NOT COMPLETED|Overall Study||1
11132474|NCT01408459|12318597|FG001|NOT COMPLETED|Overall Study||1
11132475|NCT01408485|12318604|FG000|STARTED|Overall Study||200
11132476|NCT01408485|12318604|FG000|COMPLETED|Overall Study||179
11132477|NCT01408485|12318604|FG000|NOT COMPLETED|Overall Study||21
11132478|NCT01408537|12318608|FG000|STARTED|Overall Study||152
11132479|NCT01408537|12318608|FG000|COMPLETED|Overall Study||144
11132480|NCT01408537|12318608|FG000|NOT COMPLETED|Overall Study||8
11240321|NCT02088905|12432588|FG001|NOT COMPLETED|Overall Study||1
11240322|NCT02089113|12432596|FG000|STARTED|Overall Study||161
11240323|NCT02089113|12432597|FG001|STARTED|Overall Study||80
11240324|NCT02089113|12432596|FG000|COMPLETED|Overall Study||160
11240325|NCT02089113|12432597|FG001|COMPLETED|Overall Study||80
11240326|NCT02089113|12432596|FG000|NOT COMPLETED|Overall Study||1
11240327|NCT02089113|12432597|FG001|NOT COMPLETED|Overall Study||0
11240328|NCT02089191|12432603|FG000|STARTED|Period 1, First 12 Hours||16
11240329|NCT02089191|12432604|FG001|STARTED|Period 1, First 12 Hours||15
11240330|NCT02089191|12432603|FG000|COMPLETED|Period 1, First 12 Hours||16
11240331|NCT02089191|12432604|FG001|COMPLETED|Period 1, First 12 Hours||15
11240332|NCT02089191|12432603|FG000|NOT COMPLETED|Period 1, First 12 Hours||0
11132481|NCT01408563|12318623|FG000|STARTED|Overall Study||33
11132482|NCT01408563|12318623|FG000|Received Transplant|Overall Study||31
11132483|NCT01408563|12318623|FG000|COMPLETED|Overall Study||31
11132484|NCT01408563|12318623|FG000|NOT COMPLETED|Overall Study||2
11132485|NCT01408576|12318630|FG000|STARTED|Overall Study||244
11132486|NCT01408576|12318631|FG001|STARTED|Overall Study||498
11132487|NCT01408576|12318632|FG002|STARTED|Overall Study||508
11132488|NCT01408576|12318630|FG000|COMPLETED|Overall Study||56
11132489|NCT01408576|12318631|FG001|COMPLETED|Overall Study||0
11132490|NCT01408576|12318632|FG002|COMPLETED|Overall Study||0
11132491|NCT01408576|12318630|FG000|NOT COMPLETED|Overall Study||188
11132492|NCT01408576|12318631|FG001|NOT COMPLETED|Overall Study||498
11132493|NCT01408576|12318632|FG002|NOT COMPLETED|Overall Study||508
11132494|NCT01408628|12318652|FG000|STARTED|Consented||51
11132495|NCT01408628|12318652|FG000|COMPLETED|Consented||39
11132496|NCT01408628|12318652|FG000|NOT COMPLETED|Consented||12
11132497|NCT01408628|12318652|FG000|STARTED|Started Classes/Intervention||39
11132498|NCT01408628|12318652|FG000|COMPLETED|Started Classes/Intervention||39
11132499|NCT01408628|12318652|FG000|NOT COMPLETED|Started Classes/Intervention||0
11132500|NCT01408628|12318652|FG000|STARTED|Completed 6 Month Follow-Up||39
11240333|NCT02089191|12432604|FG001|NOT COMPLETED|Period 1, First 12 Hours||0
11240334|NCT02089191|12432603|FG000|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
11240335|NCT02089191|12432604|FG001|STARTED|Period 2, Second 12 Hours||15
11240336|NCT02089191|12432603|FG000|COMPLETED|Period 2, Second 12 Hours||15
11240337|NCT02089191|12432604|FG001|COMPLETED|Period 2, Second 12 Hours||15
11240338|NCT02089191|12432603|FG000|NOT COMPLETED|Period 2, Second 12 Hours||0
11240339|NCT02089191|12432604|FG001|NOT COMPLETED|Period 2, Second 12 Hours||0
11240340|NCT02089230|12432613|FG000|STARTED|Overall Study||3
11240341|NCT02089230|12432614|FG001|STARTED|Overall Study||4
11240342|NCT02089230|12432615|FG002|STARTED|Overall Study||12
11240343|NCT02089230|12432613|FG000|COMPLETED|Overall Study||3
11240344|NCT02089230|12432614|FG001|COMPLETED|Overall Study||4
11240345|NCT02089230|12432615|FG002|COMPLETED|Overall Study||6
11240346|NCT02089230|12432613|FG000|NOT COMPLETED|Overall Study||0
11132501|NCT01408628|12318652|FG000|COMPLETED|Completed 6 Month Follow-Up||25
11132502|NCT01408628|12318652|FG000|NOT COMPLETED|Completed 6 Month Follow-Up||14
11132503|NCT01408706|12318659|FG000|STARTED|Overall Study||30
11132504|NCT01408706|12318660|FG001|STARTED|Overall Study||30
11132505|NCT01408706|12318659|FG000|COMPLETED|Overall Study||29
11132506|NCT01408706|12318660|FG001|COMPLETED|Overall Study||30
11132507|NCT01408706|12318659|FG000|NOT COMPLETED|Overall Study||1
11132508|NCT01408706|12318660|FG001|NOT COMPLETED|Overall Study||0
11132509|NCT01408719|12318688|FG000|STARTED|First Intervention (35 Days)||2
11240347|NCT02089230|12432614|FG001|NOT COMPLETED|Overall Study||0
11240348|NCT02089230|12432615|FG002|NOT COMPLETED|Overall Study||6
11240349|NCT02089334|12432627|FG000|STARTED|Overall Study||3
11240350|NCT02089334|12432628|FG001|STARTED|Overall Study||4
11240351|NCT02089334|12432629|FG002|STARTED|Overall Study||4
11240352|NCT02089334|12432630|FG003|STARTED|Overall Study||13
11240353|NCT02089334|12432627|FG000|Received Study Drug|Overall Study||3
11240354|NCT02089334|12432628|FG001|Received Study Drug|Overall Study||4
11240355|NCT02089334|12432629|FG002|Received Study Drug|Overall Study||3
11240356|NCT02089334|12432630|FG003|Received Study Drug|Overall Study||11
11240357|NCT02089334|12432627|FG000|COMPLETED|Overall Study||3
11240358|NCT02089334|12432628|FG001|COMPLETED|Overall Study||4
11240359|NCT02089334|12432629|FG002|COMPLETED|Overall Study||3
11240360|NCT02089334|12432630|FG003|COMPLETED|Overall Study||6
11240361|NCT02089334|12432627|FG000|NOT COMPLETED|Overall Study||0
11240362|NCT02089334|12432628|FG001|NOT COMPLETED|Overall Study||0
11240363|NCT02089334|12432629|FG002|NOT COMPLETED|Overall Study||1
11132510|NCT01408719|12318689|FG001|STARTED|First Intervention (35 Days)||3
11132511|NCT01408719|12318690|FG002|STARTED|First Intervention (35 Days)||2
11132512|NCT01408719|12318691|FG003|STARTED|First Intervention (35 Days)||2
11132513|NCT01408719|12318692|FG004|STARTED|First Intervention (35 Days)||4
11132514|NCT01408719|12318693|FG005|STARTED|First Intervention (35 Days)||3
11132515|NCT01408719|12318694|FG006|STARTED|First Intervention (35 Days)||2
11132516|NCT01408719|12318695|FG007|STARTED|First Intervention (35 Days)||3
11132517|NCT01408719|12318696|FG008|STARTED|First Intervention (35 Days)||2
11132518|NCT01408719|12318697|FG009|STARTED|First Intervention (35 Days)||1
11132519|NCT01408719|12318698|FG010|STARTED|First Intervention (35 Days)||2
11132520|NCT01408719|12318699|FG011|STARTED|First Intervention (35 Days)||2
11132521|NCT01408719|12318700|FG012|STARTED|First Intervention (35 Days)||2
11132522|NCT01408719|12318701|FG013|STARTED|First Intervention (35 Days)||5
11132523|NCT01408719|12318702|FG014|STARTED|First Intervention (35 Days)||1
11132524|NCT01408719|12318703|FG015|STARTED|First Intervention (35 Days)||2
11132525|NCT01408719|12318704|FG016|STARTED|First Intervention (35 Days)||3
11132526|NCT01408719|12318705|FG017|STARTED|First Intervention (35 Days)||2
11132527|NCT01408719|12318706|FG018|STARTED|First Intervention (35 Days)||1
11132528|NCT01408719|12318707|FG019|STARTED|First Intervention (35 Days)||1
11132529|NCT01408719|12318688|FG000|COMPLETED|First Intervention (35 Days)||2
11132530|NCT01408719|12318689|FG001|COMPLETED|First Intervention (35 Days)||3
11132531|NCT01408719|12318690|FG002|COMPLETED|First Intervention (35 Days)||1
11132532|NCT01408719|12318691|FG003|COMPLETED|First Intervention (35 Days)||2
11132533|NCT01408719|12318692|FG004|COMPLETED|First Intervention (35 Days)||3
11132534|NCT01408719|12318693|FG005|COMPLETED|First Intervention (35 Days)||3
11132535|NCT01408719|12318694|FG006|COMPLETED|First Intervention (35 Days)||2
11132536|NCT01408719|12318695|FG007|COMPLETED|First Intervention (35 Days)||3
11132537|NCT01408719|12318696|FG008|COMPLETED|First Intervention (35 Days)||1
11132538|NCT01408719|12318697|FG009|COMPLETED|First Intervention (35 Days)||1
11132539|NCT01408719|12318698|FG010|COMPLETED|First Intervention (35 Days)||2
11132540|NCT01408719|12318699|FG011|COMPLETED|First Intervention (35 Days)||2
11132541|NCT01408719|12318700|FG012|COMPLETED|First Intervention (35 Days)||2
11132542|NCT01408719|12318701|FG013|COMPLETED|First Intervention (35 Days)||4
11132543|NCT01408719|12318702|FG014|COMPLETED|First Intervention (35 Days)||1
11132544|NCT01408719|12318703|FG015|COMPLETED|First Intervention (35 Days)||2
11132545|NCT01408719|12318704|FG016|COMPLETED|First Intervention (35 Days)||2
11132546|NCT01408719|12318705|FG017|COMPLETED|First Intervention (35 Days)||2
11132547|NCT01408719|12318706|FG018|COMPLETED|First Intervention (35 Days)||0
11132548|NCT01408719|12318707|FG019|COMPLETED|First Intervention (35 Days)||1
11132549|NCT01408719|12318688|FG000|NOT COMPLETED|First Intervention (35 Days)||0
11240364|NCT02089334|12432630|FG003|NOT COMPLETED|Overall Study||7
11240365|NCT02089347|12432645|FG000|STARTED|Overall Study||356
11132550|NCT01408719|12318689|FG001|NOT COMPLETED|First Intervention (35 Days)||0
11132551|NCT01408719|12318690|FG002|NOT COMPLETED|First Intervention (35 Days)||1
11132552|NCT01408719|12318691|FG003|NOT COMPLETED|First Intervention (35 Days)||0
11132553|NCT01408719|12318692|FG004|NOT COMPLETED|First Intervention (35 Days)||1
11132554|NCT01408719|12318693|FG005|NOT COMPLETED|First Intervention (35 Days)||0
11132555|NCT01408719|12318694|FG006|NOT COMPLETED|First Intervention (35 Days)||0
11132556|NCT01408719|12318695|FG007|NOT COMPLETED|First Intervention (35 Days)||0
11132557|NCT01408719|12318696|FG008|NOT COMPLETED|First Intervention (35 Days)||1
11005156|NCT00721396|12182840|FG001|STARTED|Overall Study||628
11005157|NCT00721396|12182841|FG002|STARTED|Overall Study||318
11005158|NCT00721396|12182842|FG003|STARTED|Overall Study||312
11005159|NCT00721396|12182839|FG000|COMPLETED|Overall Study||597
11005160|NCT00721396|12182840|FG001|COMPLETED|Overall Study||592
11005161|NCT00721396|12182841|FG002|COMPLETED|Overall Study||308
11132558|NCT01408719|12318697|FG009|NOT COMPLETED|First Intervention (35 Days)||0
11240366|NCT02089347|12432646|FG001|STARTED|Overall Study||178
11240367|NCT02089347|12432645|FG000|COMPLETED|Overall Study||355
11132559|NCT01408719|12318698|FG010|NOT COMPLETED|First Intervention (35 Days)||0
11240368|NCT02089347|12432646|FG001|COMPLETED|Overall Study||178
11240369|NCT02089347|12432645|FG000|NOT COMPLETED|Overall Study||1
11240370|NCT02089347|12432646|FG001|NOT COMPLETED|Overall Study||0
11240371|NCT02089464|12432654|FG000|STARTED|Overall Study||132
11240372|NCT02089464|12432655|FG001|STARTED|Overall Study||67
11132560|NCT01408719|12318699|FG011|NOT COMPLETED|First Intervention (35 Days)||0
11132561|NCT01408719|12318700|FG012|NOT COMPLETED|First Intervention (35 Days)||0
11132562|NCT01408719|12318701|FG013|NOT COMPLETED|First Intervention (35 Days)||1
11132563|NCT01408719|12318702|FG014|NOT COMPLETED|First Intervention (35 Days)||0
11132564|NCT01408719|12318703|FG015|NOT COMPLETED|First Intervention (35 Days)||0
11132565|NCT01408719|12318704|FG016|NOT COMPLETED|First Intervention (35 Days)||1
11132566|NCT01408719|12318705|FG017|NOT COMPLETED|First Intervention (35 Days)||0
11132567|NCT01408719|12318706|FG018|NOT COMPLETED|First Intervention (35 Days)||1
11132568|NCT01408719|12318707|FG019|NOT COMPLETED|First Intervention (35 Days)||0
11240373|NCT02089464|12432654|FG000|COMPLETED|Overall Study||104
11132569|NCT01408719|12318688|FG000|STARTED|Washout Period (28 Days)||2
11132570|NCT01408719|12318689|FG001|STARTED|Washout Period (28 Days)||3
11132571|NCT01408719|12318690|FG002|STARTED|Washout Period (28 Days)||1
11132572|NCT01408719|12318691|FG003|STARTED|Washout Period (28 Days)||2
11132573|NCT01408719|12318692|FG004|STARTED|Washout Period (28 Days)||3
11132574|NCT01408719|12318693|FG005|STARTED|Washout Period (28 Days)||3
11132575|NCT01408719|12318694|FG006|STARTED|Washout Period (28 Days)||2
11132576|NCT01408719|12318695|FG007|STARTED|Washout Period (28 Days)||3
11132577|NCT01408719|12318696|FG008|STARTED|Washout Period (28 Days)||1
11132578|NCT01408719|12318697|FG009|STARTED|Washout Period (28 Days)||1
11132579|NCT01408719|12318698|FG010|STARTED|Washout Period (28 Days)||2
11132580|NCT01408719|12318699|FG011|STARTED|Washout Period (28 Days)||2
11132581|NCT01408719|12318700|FG012|STARTED|Washout Period (28 Days)||2
11132582|NCT01408719|12318701|FG013|STARTED|Washout Period (28 Days)||4
11132583|NCT01408719|12318702|FG014|STARTED|Washout Period (28 Days)||1
11132584|NCT01408719|12318703|FG015|STARTED|Washout Period (28 Days)||2
11132585|NCT01408719|12318704|FG016|STARTED|Washout Period (28 Days)||2
11132586|NCT01408719|12318705|FG017|STARTED|Washout Period (28 Days)||2
11132587|NCT01408719|12318706|FG018|STARTED|Washout Period (28 Days)||0
11132588|NCT01408719|12318707|FG019|STARTED|Washout Period (28 Days)||1
11132589|NCT01408719|12318688|FG000|COMPLETED|Washout Period (28 Days)||2
11132590|NCT01408719|12318689|FG001|COMPLETED|Washout Period (28 Days)||3
11132591|NCT01408719|12318690|FG002|COMPLETED|Washout Period (28 Days)||1
11132592|NCT01408719|12318691|FG003|COMPLETED|Washout Period (28 Days)||2
11132593|NCT01408719|12318692|FG004|COMPLETED|Washout Period (28 Days)||3
11132594|NCT01408719|12318693|FG005|COMPLETED|Washout Period (28 Days)||3
11132595|NCT01408719|12318694|FG006|COMPLETED|Washout Period (28 Days)||2
11132596|NCT01408719|12318695|FG007|COMPLETED|Washout Period (28 Days)||3
11132597|NCT01408719|12318696|FG008|COMPLETED|Washout Period (28 Days)||1
11132598|NCT01408719|12318697|FG009|COMPLETED|Washout Period (28 Days)||1
11132599|NCT01408719|12318698|FG010|COMPLETED|Washout Period (28 Days)||2
11132600|NCT01408719|12318699|FG011|COMPLETED|Washout Period (28 Days)||2
11132601|NCT01408719|12318700|FG012|COMPLETED|Washout Period (28 Days)||2
11132602|NCT01408719|12318701|FG013|COMPLETED|Washout Period (28 Days)||4
11132603|NCT01408719|12318702|FG014|COMPLETED|Washout Period (28 Days)||1
11132604|NCT01408719|12318703|FG015|COMPLETED|Washout Period (28 Days)||2
11132605|NCT01408719|12318704|FG016|COMPLETED|Washout Period (28 Days)||2
11132606|NCT01408719|12318705|FG017|COMPLETED|Washout Period (28 Days)||2
11132607|NCT01408719|12318706|FG018|COMPLETED|Washout Period (28 Days)||0
11132608|NCT01408719|12318707|FG019|COMPLETED|Washout Period (28 Days)||1
11132609|NCT01408719|12318688|FG000|NOT COMPLETED|Washout Period (28 Days)||0
11132610|NCT01408719|12318689|FG001|NOT COMPLETED|Washout Period (28 Days)||0
11132611|NCT01408719|12318690|FG002|NOT COMPLETED|Washout Period (28 Days)||0
11132612|NCT01408719|12318691|FG003|NOT COMPLETED|Washout Period (28 Days)||0
11240374|NCT02089464|12432655|FG001|COMPLETED|Overall Study||51
11240375|NCT02089464|12432654|FG000|NOT COMPLETED|Overall Study||28
11240376|NCT02089464|12432655|FG001|NOT COMPLETED|Overall Study||16
11240377|NCT02089659|12432663|FG000|STARTED|Overall Study||8
11240378|NCT02089659|12432664|FG001|STARTED|Overall Study||8
11240379|NCT02089659|12432665|FG002|STARTED|Overall Study||0
11240380|NCT02089659|12432663|FG000|COMPLETED|Overall Study||8
11132613|NCT01408719|12318692|FG004|NOT COMPLETED|Washout Period (28 Days)||0
11132614|NCT01408719|12318693|FG005|NOT COMPLETED|Washout Period (28 Days)||0
11132615|NCT01408719|12318694|FG006|NOT COMPLETED|Washout Period (28 Days)||0
11132616|NCT01408719|12318695|FG007|NOT COMPLETED|Washout Period (28 Days)||0
11132617|NCT01408719|12318696|FG008|NOT COMPLETED|Washout Period (28 Days)||0
11132618|NCT01408719|12318697|FG009|NOT COMPLETED|Washout Period (28 Days)||0
11132619|NCT01408719|12318698|FG010|NOT COMPLETED|Washout Period (28 Days)||0
11132620|NCT01408719|12318699|FG011|NOT COMPLETED|Washout Period (28 Days)||0
11132621|NCT01408719|12318700|FG012|NOT COMPLETED|Washout Period (28 Days)||0
11132622|NCT01408719|12318701|FG013|NOT COMPLETED|Washout Period (28 Days)||0
11132623|NCT01408719|12318702|FG014|NOT COMPLETED|Washout Period (28 Days)||0
11132624|NCT01408719|12318703|FG015|NOT COMPLETED|Washout Period (28 Days)||0
11132625|NCT01408719|12318704|FG016|NOT COMPLETED|Washout Period (28 Days)||0
11240381|NCT02089659|12432664|FG001|COMPLETED|Overall Study||8
11240382|NCT02089659|12432665|FG002|COMPLETED|Overall Study||0
11240383|NCT02089659|12432663|FG000|NOT COMPLETED|Overall Study||0
11240384|NCT02089659|12432664|FG001|NOT COMPLETED|Overall Study||0
11240385|NCT02089659|12432665|FG002|NOT COMPLETED|Overall Study||0
11240386|NCT02089737|12432671|FG000|STARTED|Overall Study||3091
11132626|NCT01408719|12318705|FG017|NOT COMPLETED|Washout Period (28 Days)||0
11132627|NCT01408719|12318706|FG018|NOT COMPLETED|Washout Period (28 Days)||0
11132628|NCT01408719|12318707|FG019|NOT COMPLETED|Washout Period (28 Days)||0
11132629|NCT01408719|12318688|FG000|STARTED|Second Intervention (35 Days)||2
11132630|NCT01408719|12318689|FG001|STARTED|Second Intervention (35 Days)||3
11132631|NCT01408719|12318690|FG002|STARTED|Second Intervention (35 Days)||1
11132632|NCT01408719|12318691|FG003|STARTED|Second Intervention (35 Days)||2
11132633|NCT01408719|12318692|FG004|STARTED|Second Intervention (35 Days)||3
11132634|NCT01408719|12318693|FG005|STARTED|Second Intervention (35 Days)||3
11132635|NCT01408719|12318694|FG006|STARTED|Second Intervention (35 Days)||2
11132636|NCT01408719|12318695|FG007|STARTED|Second Intervention (35 Days)||3
11132637|NCT01408719|12318696|FG008|STARTED|Second Intervention (35 Days)||1
11132638|NCT01408719|12318697|FG009|STARTED|Second Intervention (35 Days)||1
11132639|NCT01408719|12318698|FG010|STARTED|Second Intervention (35 Days)||2
11240387|NCT02089737|12432671|FG000|COMPLETED|Overall Study||3085
11132640|NCT01408719|12318699|FG011|STARTED|Second Intervention (35 Days)||2
11132641|NCT01408719|12318700|FG012|STARTED|Second Intervention (35 Days)||2
11132642|NCT01408719|12318701|FG013|STARTED|Second Intervention (35 Days)||4
11132643|NCT01408719|12318702|FG014|STARTED|Second Intervention (35 Days)||1
11132644|NCT01408719|12318703|FG015|STARTED|Second Intervention (35 Days)||2
11132645|NCT01408719|12318704|FG016|STARTED|Second Intervention (35 Days)||2
11132646|NCT01408719|12318705|FG017|STARTED|Second Intervention (35 Days)||2
11132647|NCT01408719|12318706|FG018|STARTED|Second Intervention (35 Days)||0
11132648|NCT01408719|12318707|FG019|STARTED|Second Intervention (35 Days)||1
11132649|NCT01408719|12318688|FG000|COMPLETED|Second Intervention (35 Days)||2
11132650|NCT01408719|12318689|FG001|COMPLETED|Second Intervention (35 Days)||3
11132651|NCT01408719|12318690|FG002|COMPLETED|Second Intervention (35 Days)||1
11132652|NCT01408719|12318691|FG003|COMPLETED|Second Intervention (35 Days)||2
11132653|NCT01408719|12318692|FG004|COMPLETED|Second Intervention (35 Days)||3
11132654|NCT01408719|12318693|FG005|COMPLETED|Second Intervention (35 Days)||3
11132655|NCT01408719|12318694|FG006|COMPLETED|Second Intervention (35 Days)||2
11132656|NCT01408719|12318695|FG007|COMPLETED|Second Intervention (35 Days)||3
11132657|NCT01408719|12318696|FG008|COMPLETED|Second Intervention (35 Days)||1
11132658|NCT01408719|12318697|FG009|COMPLETED|Second Intervention (35 Days)||1
11132659|NCT01408719|12318698|FG010|COMPLETED|Second Intervention (35 Days)||2
11132660|NCT01408719|12318699|FG011|COMPLETED|Second Intervention (35 Days)||2
11132661|NCT01408719|12318700|FG012|COMPLETED|Second Intervention (35 Days)||2
11132662|NCT01408719|12318701|FG013|COMPLETED|Second Intervention (35 Days)||3
11132663|NCT01408719|12318702|FG014|COMPLETED|Second Intervention (35 Days)||1
11132664|NCT01408719|12318703|FG015|COMPLETED|Second Intervention (35 Days)||2
11132665|NCT01408719|12318704|FG016|COMPLETED|Second Intervention (35 Days)||2
11132666|NCT01408719|12318705|FG017|COMPLETED|Second Intervention (35 Days)||2
11132667|NCT01408719|12318706|FG018|COMPLETED|Second Intervention (35 Days)||0
11132668|NCT01408719|12318707|FG019|COMPLETED|Second Intervention (35 Days)||1
11132669|NCT01408719|12318688|FG000|NOT COMPLETED|Second Intervention (35 Days)||0
11132670|NCT01408719|12318689|FG001|NOT COMPLETED|Second Intervention (35 Days)||0
11132671|NCT01408719|12318690|FG002|NOT COMPLETED|Second Intervention (35 Days)||0
11358092|NCT03119701|12555143|FG001|COMPLETED|6-day Dosing||8
11132672|NCT01408719|12318691|FG003|NOT COMPLETED|Second Intervention (35 Days)||0
11132673|NCT01408719|12318692|FG004|NOT COMPLETED|Second Intervention (35 Days)||0
11132674|NCT01408719|12318693|FG005|NOT COMPLETED|Second Intervention (35 Days)||0
11132675|NCT01408719|12318694|FG006|NOT COMPLETED|Second Intervention (35 Days)||0
11132676|NCT01408719|12318695|FG007|NOT COMPLETED|Second Intervention (35 Days)||0
11132677|NCT01408719|12318696|FG008|NOT COMPLETED|Second Intervention (35 Days)||0
11132678|NCT01408719|12318697|FG009|NOT COMPLETED|Second Intervention (35 Days)||0
11132679|NCT01408719|12318698|FG010|NOT COMPLETED|Second Intervention (35 Days)||0
11132680|NCT01408719|12318699|FG011|NOT COMPLETED|Second Intervention (35 Days)||0
11132681|NCT01408719|12318700|FG012|NOT COMPLETED|Second Intervention (35 Days)||0
11132682|NCT01408719|12318701|FG013|NOT COMPLETED|Second Intervention (35 Days)||1
11132683|NCT01408719|12318702|FG014|NOT COMPLETED|Second Intervention (35 Days)||0
11132684|NCT01408719|12318703|FG015|NOT COMPLETED|Second Intervention (35 Days)||0
11132685|NCT01408719|12318704|FG016|NOT COMPLETED|Second Intervention (35 Days)||0
11132686|NCT01408719|12318705|FG017|NOT COMPLETED|Second Intervention (35 Days)||0
11132687|NCT01408719|12318706|FG018|NOT COMPLETED|Second Intervention (35 Days)||0
11132688|NCT01408719|12318707|FG019|NOT COMPLETED|Second Intervention (35 Days)||0
11240388|NCT02089737|12432671|FG000|NOT COMPLETED|Overall Study||6
11240389|NCT02089997|12432676|FG000|STARTED|Overall Study||3304
11240390|NCT02089997|12432676|FG000|COMPLETED|Overall Study||3058
11240391|NCT02089997|12432676|FG000|NOT COMPLETED|Overall Study||246
11240392|NCT02090075|12432682|FG000|STARTED|Overall Study||33
11240393|NCT02090075|12432683|FG001|STARTED|Overall Study||33
11240394|NCT02090075|12432682|FG000|COMPLETED|Overall Study||26
11240395|NCT02090075|12432683|FG001|COMPLETED|Overall Study||30
11240396|NCT02090075|12432682|FG000|NOT COMPLETED|Overall Study||7
11240397|NCT02090075|12432683|FG001|NOT COMPLETED|Overall Study||3
11240398|NCT02090088|12432689|FG000|STARTED|Overall Study||4
11240399|NCT02090088|12432689|FG000|Gave Birth|Overall Study||4
11240400|NCT02090088|12432689|FG000|COMPLETED|Overall Study||4
11240401|NCT02090088|12432689|FG000|NOT COMPLETED|Overall Study||0
11240402|NCT02090283|12432697|FG000|STARTED|Overall Study||17
11240403|NCT02090283|12432698|FG001|STARTED|Overall Study||15
11240404|NCT02090283|12432699|FG002|STARTED|Overall Study||10
11240405|NCT02090283|12432697|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||17
11240406|NCT02090283|12432698|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||15
11240407|NCT02090283|12432699|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||10
11240408|NCT02090283|12432697|FG000|COMPLETED|Overall Study||0
11240409|NCT02090283|12432698|FG001|COMPLETED|Overall Study||0
11240410|NCT02090283|12432699|FG002|COMPLETED|Overall Study||0
11240411|NCT02090283|12432697|FG000|NOT COMPLETED|Overall Study||17
11240412|NCT02090283|12432698|FG001|NOT COMPLETED|Overall Study||15
11240413|NCT02090283|12432699|FG002|NOT COMPLETED|Overall Study||10
11240414|NCT02090374|12432715|FG000|STARTED|Overall Study||8
11240415|NCT02090374|12432716|FG001|STARTED|Overall Study||4
11240416|NCT02090374|12432717|FG002|STARTED|Overall Study||4
11240417|NCT02090374|12432718|FG003|STARTED|Overall Study||9
11132689|NCT01408719|12318688|FG000|STARTED|Washout Period (28 Days)||2
11132690|NCT01408719|12318689|FG001|STARTED|Washout Period (28 Days)||3
11132691|NCT01408719|12318690|FG002|STARTED|Washout Period (28 Days)||1
11132692|NCT01408719|12318691|FG003|STARTED|Washout Period (28 Days)||2
11132693|NCT01408719|12318692|FG004|STARTED|Washout Period (28 Days)||3
11132694|NCT01408719|12318693|FG005|STARTED|Washout Period (28 Days)||3
11132695|NCT01408719|12318694|FG006|STARTED|Washout Period (28 Days)||2
11132696|NCT01408719|12318695|FG007|STARTED|Washout Period (28 Days)||3
11132697|NCT01408719|12318696|FG008|STARTED|Washout Period (28 Days)||1
11132698|NCT01408719|12318697|FG009|STARTED|Washout Period (28 Days)||1
11240418|NCT02090374|12432719|FG004|STARTED|Overall Study||35
11240419|NCT02090374|12432720|FG005|STARTED|Overall Study||15
11240420|NCT02090374|12432721|FG006|STARTED|Overall Study||16
11240421|NCT02090374|12432722|FG007|STARTED|Overall Study||2
11132699|NCT01408719|12318698|FG010|STARTED|Washout Period (28 Days)||2
11132700|NCT01408719|12318699|FG011|STARTED|Washout Period (28 Days)||2
11132701|NCT01408719|12318700|FG012|STARTED|Washout Period (28 Days)||2
11132702|NCT01408719|12318701|FG013|STARTED|Washout Period (28 Days)||3
11132703|NCT01408719|12318702|FG014|STARTED|Washout Period (28 Days)||1
11132704|NCT01408719|12318703|FG015|STARTED|Washout Period (28 Days)||1
11132705|NCT01408719|12318704|FG016|STARTED|Washout Period (28 Days)||2
11132706|NCT01408719|12318705|FG017|STARTED|Washout Period (28 Days)||2
11132707|NCT01408719|12318706|FG018|STARTED|Washout Period (28 Days)||0
11132708|NCT01408719|12318707|FG019|STARTED|Washout Period (28 Days)||1
11132709|NCT01408719|12318688|FG000|COMPLETED|Washout Period (28 Days)||2
11132710|NCT01408719|12318689|FG001|COMPLETED|Washout Period (28 Days)||3
11132711|NCT01408719|12318690|FG002|COMPLETED|Washout Period (28 Days)||1
11132712|NCT01408719|12318691|FG003|COMPLETED|Washout Period (28 Days)||2
11132713|NCT01408719|12318692|FG004|COMPLETED|Washout Period (28 Days)||3
11132714|NCT01408719|12318693|FG005|COMPLETED|Washout Period (28 Days)||3
11132715|NCT01408719|12318694|FG006|COMPLETED|Washout Period (28 Days)||2
11132716|NCT01408719|12318695|FG007|COMPLETED|Washout Period (28 Days)||3
11132717|NCT01408719|12318696|FG008|COMPLETED|Washout Period (28 Days)||1
11132718|NCT01408719|12318697|FG009|COMPLETED|Washout Period (28 Days)||1
11132719|NCT01408719|12318698|FG010|COMPLETED|Washout Period (28 Days)||2
11132720|NCT01408719|12318699|FG011|COMPLETED|Washout Period (28 Days)||2
11132721|NCT01408719|12318700|FG012|COMPLETED|Washout Period (28 Days)||2
11132722|NCT01408719|12318701|FG013|COMPLETED|Washout Period (28 Days)||3
11132723|NCT01408719|12318702|FG014|COMPLETED|Washout Period (28 Days)||1
11132724|NCT01408719|12318703|FG015|COMPLETED|Washout Period (28 Days)||1
11132725|NCT01408719|12318704|FG016|COMPLETED|Washout Period (28 Days)||2
11132726|NCT01408719|12318705|FG017|COMPLETED|Washout Period (28 Days)||2
11132727|NCT01408719|12318706|FG018|COMPLETED|Washout Period (28 Days)||0
11132728|NCT01408719|12318707|FG019|COMPLETED|Washout Period (28 Days)||1
11132729|NCT01408719|12318688|FG000|NOT COMPLETED|Washout Period (28 Days)||0
11132730|NCT01408719|12318689|FG001|NOT COMPLETED|Washout Period (28 Days)||0
11132731|NCT01408719|12318690|FG002|NOT COMPLETED|Washout Period (28 Days)||0
11132732|NCT01408719|12318691|FG003|NOT COMPLETED|Washout Period (28 Days)||0
11132733|NCT01408719|12318692|FG004|NOT COMPLETED|Washout Period (28 Days)||0
11132734|NCT01408719|12318693|FG005|NOT COMPLETED|Washout Period (28 Days)||0
11132735|NCT01408719|12318694|FG006|NOT COMPLETED|Washout Period (28 Days)||0
11132736|NCT01408719|12318695|FG007|NOT COMPLETED|Washout Period (28 Days)||0
11132737|NCT01408719|12318696|FG008|NOT COMPLETED|Washout Period (28 Days)||0
11132738|NCT01408719|12318697|FG009|NOT COMPLETED|Washout Period (28 Days)||0
11132739|NCT01408719|12318698|FG010|NOT COMPLETED|Washout Period (28 Days)||0
11132740|NCT01408719|12318699|FG011|NOT COMPLETED|Washout Period (28 Days)||0
11132741|NCT01408719|12318700|FG012|NOT COMPLETED|Washout Period (28 Days)||0
11132742|NCT01408719|12318701|FG013|NOT COMPLETED|Washout Period (28 Days)||0
11132743|NCT01408719|12318702|FG014|NOT COMPLETED|Washout Period (28 Days)||0
11132744|NCT01408719|12318703|FG015|NOT COMPLETED|Washout Period (28 Days)||0
11132745|NCT01408719|12318704|FG016|NOT COMPLETED|Washout Period (28 Days)||0
11132746|NCT01408719|12318705|FG017|NOT COMPLETED|Washout Period (28 Days)||0
11132747|NCT01408719|12318706|FG018|NOT COMPLETED|Washout Period (28 Days)||0
11132748|NCT01408719|12318707|FG019|NOT COMPLETED|Washout Period (28 Days)||0
11132749|NCT01408719|12318688|FG000|STARTED|Third Intervention (35 Days)||2
11132750|NCT01408719|12318689|FG001|STARTED|Third Intervention (35 Days)||3
11132751|NCT01408719|12318690|FG002|STARTED|Third Intervention (35 Days)||1
11132752|NCT01408719|12318691|FG003|STARTED|Third Intervention (35 Days)||2
11132753|NCT01408719|12318692|FG004|STARTED|Third Intervention (35 Days)||3
11132754|NCT01408719|12318693|FG005|STARTED|Third Intervention (35 Days)||3
11132755|NCT01408719|12318694|FG006|STARTED|Third Intervention (35 Days)||2
11132756|NCT01408719|12318695|FG007|STARTED|Third Intervention (35 Days)||3
11132757|NCT01408719|12318696|FG008|STARTED|Third Intervention (35 Days)||1
11132758|NCT01408719|12318697|FG009|STARTED|Third Intervention (35 Days)||1
11132759|NCT01408719|12318698|FG010|STARTED|Third Intervention (35 Days)||2
11132760|NCT01408719|12318699|FG011|STARTED|Third Intervention (35 Days)||2
11132761|NCT01408719|12318700|FG012|STARTED|Third Intervention (35 Days)||2
11132762|NCT01408719|12318701|FG013|STARTED|Third Intervention (35 Days)||3
11132763|NCT01408719|12318702|FG014|STARTED|Third Intervention (35 Days)||1
11132764|NCT01408719|12318703|FG015|STARTED|Third Intervention (35 Days)||1
11132765|NCT01408719|12318704|FG016|STARTED|Third Intervention (35 Days)||2
11132766|NCT01408719|12318705|FG017|STARTED|Third Intervention (35 Days)||2
11132767|NCT01408719|12318706|FG018|STARTED|Third Intervention (35 Days)||0
11132768|NCT01408719|12318707|FG019|STARTED|Third Intervention (35 Days)||1
11132769|NCT01408719|12318688|FG000|COMPLETED|Third Intervention (35 Days)||2
11132770|NCT01408719|12318689|FG001|COMPLETED|Third Intervention (35 Days)||3
11132771|NCT01408719|12318690|FG002|COMPLETED|Third Intervention (35 Days)||1
11132772|NCT01408719|12318691|FG003|COMPLETED|Third Intervention (35 Days)||2
11132773|NCT01408719|12318692|FG004|COMPLETED|Third Intervention (35 Days)||3
11132774|NCT01408719|12318693|FG005|COMPLETED|Third Intervention (35 Days)||3
11132775|NCT01408719|12318694|FG006|COMPLETED|Third Intervention (35 Days)||2
11132776|NCT01408719|12318695|FG007|COMPLETED|Third Intervention (35 Days)||2
11132777|NCT01408719|12318696|FG008|COMPLETED|Third Intervention (35 Days)||1
11132778|NCT01408719|12318697|FG009|COMPLETED|Third Intervention (35 Days)||1
11132779|NCT01408719|12318698|FG010|COMPLETED|Third Intervention (35 Days)||2
11132780|NCT01408719|12318699|FG011|COMPLETED|Third Intervention (35 Days)||2
11132781|NCT01408719|12318700|FG012|COMPLETED|Third Intervention (35 Days)||2
11132782|NCT01408719|12318701|FG013|COMPLETED|Third Intervention (35 Days)||3
11132783|NCT01408719|12318702|FG014|COMPLETED|Third Intervention (35 Days)||1
11132784|NCT01408719|12318703|FG015|COMPLETED|Third Intervention (35 Days)||1
11132785|NCT01408719|12318704|FG016|COMPLETED|Third Intervention (35 Days)||2
11132786|NCT01408719|12318705|FG017|COMPLETED|Third Intervention (35 Days)||2
11132787|NCT01408719|12318706|FG018|COMPLETED|Third Intervention (35 Days)||0
11132788|NCT01408719|12318707|FG019|COMPLETED|Third Intervention (35 Days)||1
11132789|NCT01408719|12318688|FG000|NOT COMPLETED|Third Intervention (35 Days)||0
11132790|NCT01408719|12318689|FG001|NOT COMPLETED|Third Intervention (35 Days)||0
11132791|NCT01408719|12318690|FG002|NOT COMPLETED|Third Intervention (35 Days)||0
11132792|NCT01408719|12318691|FG003|NOT COMPLETED|Third Intervention (35 Days)||0
11132793|NCT01408719|12318692|FG004|NOT COMPLETED|Third Intervention (35 Days)||0
11132794|NCT01408719|12318693|FG005|NOT COMPLETED|Third Intervention (35 Days)||0
11132795|NCT01408719|12318694|FG006|NOT COMPLETED|Third Intervention (35 Days)||0
11132796|NCT01408719|12318695|FG007|NOT COMPLETED|Third Intervention (35 Days)||1
11132797|NCT01408719|12318696|FG008|NOT COMPLETED|Third Intervention (35 Days)||0
11132798|NCT01408719|12318697|FG009|NOT COMPLETED|Third Intervention (35 Days)||0
11132799|NCT01408719|12318698|FG010|NOT COMPLETED|Third Intervention (35 Days)||0
11132800|NCT01408719|12318699|FG011|NOT COMPLETED|Third Intervention (35 Days)||0
11132801|NCT01408719|12318700|FG012|NOT COMPLETED|Third Intervention (35 Days)||0
11132802|NCT01408719|12318701|FG013|NOT COMPLETED|Third Intervention (35 Days)||0
11132803|NCT01408719|12318702|FG014|NOT COMPLETED|Third Intervention (35 Days)||0
11132804|NCT01408719|12318703|FG015|NOT COMPLETED|Third Intervention (35 Days)||0
11132805|NCT01408719|12318704|FG016|NOT COMPLETED|Third Intervention (35 Days)||0
11132806|NCT01408719|12318705|FG017|NOT COMPLETED|Third Intervention (35 Days)||0
11132807|NCT01408719|12318706|FG018|NOT COMPLETED|Third Intervention (35 Days)||0
11132808|NCT01408719|12318707|FG019|NOT COMPLETED|Third Intervention (35 Days)||0
11132809|NCT01408719|12318688|FG000|STARTED|Washout Period (28 Days)||2
11132810|NCT01408719|12318689|FG001|STARTED|Washout Period (28 Days)||3
11132811|NCT01408719|12318690|FG002|STARTED|Washout Period (28 Days)||1
11132812|NCT01408719|12318691|FG003|STARTED|Washout Period (28 Days)||2
11132813|NCT01408719|12318692|FG004|STARTED|Washout Period (28 Days)||3
11132814|NCT01408719|12318693|FG005|STARTED|Washout Period (28 Days)||3
11132815|NCT01408719|12318694|FG006|STARTED|Washout Period (28 Days)||2
11132816|NCT01408719|12318695|FG007|STARTED|Washout Period (28 Days)||2
11132817|NCT01408719|12318696|FG008|STARTED|Washout Period (28 Days)||1
11132818|NCT01408719|12318697|FG009|STARTED|Washout Period (28 Days)||1
11132819|NCT01408719|12318698|FG010|STARTED|Washout Period (28 Days)||2
11132820|NCT01408719|12318699|FG011|STARTED|Washout Period (28 Days)||2
11132821|NCT01408719|12318700|FG012|STARTED|Washout Period (28 Days)||1
11132822|NCT01408719|12318701|FG013|STARTED|Washout Period (28 Days)||3
11132823|NCT01408719|12318702|FG014|STARTED|Washout Period (28 Days)||1
11132824|NCT01408719|12318703|FG015|STARTED|Washout Period (28 Days)||1
11132825|NCT01408719|12318704|FG016|STARTED|Washout Period (28 Days)||2
11132826|NCT01408719|12318705|FG017|STARTED|Washout Period (28 Days)||2
11132827|NCT01408719|12318706|FG018|STARTED|Washout Period (28 Days)||0
11132828|NCT01408719|12318707|FG019|STARTED|Washout Period (28 Days)||1
11132829|NCT01408719|12318688|FG000|COMPLETED|Washout Period (28 Days)||2
11132830|NCT01408719|12318689|FG001|COMPLETED|Washout Period (28 Days)||3
11132831|NCT01408719|12318690|FG002|COMPLETED|Washout Period (28 Days)||1
11132832|NCT01408719|12318691|FG003|COMPLETED|Washout Period (28 Days)||2
11132833|NCT01408719|12318692|FG004|COMPLETED|Washout Period (28 Days)||3
11132834|NCT01408719|12318693|FG005|COMPLETED|Washout Period (28 Days)||3
11132835|NCT01408719|12318694|FG006|COMPLETED|Washout Period (28 Days)||2
11132836|NCT01408719|12318695|FG007|COMPLETED|Washout Period (28 Days)||2
11132837|NCT01408719|12318696|FG008|COMPLETED|Washout Period (28 Days)||1
11132838|NCT01408719|12318697|FG009|COMPLETED|Washout Period (28 Days)||1
11132839|NCT01408719|12318698|FG010|COMPLETED|Washout Period (28 Days)||2
11132840|NCT01408719|12318699|FG011|COMPLETED|Washout Period (28 Days)||2
11132841|NCT01408719|12318700|FG012|COMPLETED|Washout Period (28 Days)||1
11132842|NCT01408719|12318701|FG013|COMPLETED|Washout Period (28 Days)||3
11132843|NCT01408719|12318702|FG014|COMPLETED|Washout Period (28 Days)||1
11132844|NCT01408719|12318703|FG015|COMPLETED|Washout Period (28 Days)||1
11240422|NCT02090374|12432715|FG000|COMPLETED|Overall Study||8
11240423|NCT02090374|12432716|FG001|COMPLETED|Overall Study||4
11240424|NCT02090374|12432717|FG002|COMPLETED|Overall Study||4
11240425|NCT02090374|12432718|FG003|COMPLETED|Overall Study||9
11240426|NCT02090374|12432719|FG004|COMPLETED|Overall Study||35
11132845|NCT01408719|12318704|FG016|COMPLETED|Washout Period (28 Days)||2
11132846|NCT01408719|12318705|FG017|COMPLETED|Washout Period (28 Days)||2
11132847|NCT01408719|12318706|FG018|COMPLETED|Washout Period (28 Days)||0
11132848|NCT01408719|12318707|FG019|COMPLETED|Washout Period (28 Days)||1
11132849|NCT01408719|12318688|FG000|NOT COMPLETED|Washout Period (28 Days)||0
11132850|NCT01408719|12318689|FG001|NOT COMPLETED|Washout Period (28 Days)||0
11132851|NCT01408719|12318690|FG002|NOT COMPLETED|Washout Period (28 Days)||0
11132852|NCT01408719|12318691|FG003|NOT COMPLETED|Washout Period (28 Days)||0
11132853|NCT01408719|12318692|FG004|NOT COMPLETED|Washout Period (28 Days)||0
11132854|NCT01408719|12318693|FG005|NOT COMPLETED|Washout Period (28 Days)||0
11132855|NCT01408719|12318694|FG006|NOT COMPLETED|Washout Period (28 Days)||0
11240427|NCT02090374|12432720|FG005|COMPLETED|Overall Study||15
11132856|NCT01408719|12318695|FG007|NOT COMPLETED|Washout Period (28 Days)||0
11132857|NCT01408719|12318696|FG008|NOT COMPLETED|Washout Period (28 Days)||0
11132858|NCT01408719|12318697|FG009|NOT COMPLETED|Washout Period (28 Days)||0
11132859|NCT01408719|12318698|FG010|NOT COMPLETED|Washout Period (28 Days)||0
11132860|NCT01408719|12318699|FG011|NOT COMPLETED|Washout Period (28 Days)||0
11132861|NCT01408719|12318700|FG012|NOT COMPLETED|Washout Period (28 Days)||0
11132862|NCT01408719|12318701|FG013|NOT COMPLETED|Washout Period (28 Days)||0
11132863|NCT01408719|12318702|FG014|NOT COMPLETED|Washout Period (28 Days)||0
11132864|NCT01408719|12318703|FG015|NOT COMPLETED|Washout Period (28 Days)||0
11132865|NCT01408719|12318704|FG016|NOT COMPLETED|Washout Period (28 Days)||0
11132866|NCT01408719|12318705|FG017|NOT COMPLETED|Washout Period (28 Days)||0
11132867|NCT01408719|12318706|FG018|NOT COMPLETED|Washout Period (28 Days)||0
11132868|NCT01408719|12318707|FG019|NOT COMPLETED|Washout Period (28 Days)||0
11132869|NCT01408719|12318688|FG000|STARTED|Fourth Intervention (35 Days)||2
11132870|NCT01408719|12318689|FG001|STARTED|Fourth Intervention (35 Days)||3
11132871|NCT01408719|12318690|FG002|STARTED|Fourth Intervention (35 Days)||1
11132872|NCT01408719|12318691|FG003|STARTED|Fourth Intervention (35 Days)||2
11132873|NCT01408719|12318692|FG004|STARTED|Fourth Intervention (35 Days)||3
11132874|NCT01408719|12318693|FG005|STARTED|Fourth Intervention (35 Days)||3
11132875|NCT01408719|12318694|FG006|STARTED|Fourth Intervention (35 Days)||2
11132876|NCT01408719|12318695|FG007|STARTED|Fourth Intervention (35 Days)||2
11132877|NCT01408719|12318696|FG008|STARTED|Fourth Intervention (35 Days)||1
11132878|NCT01408719|12318697|FG009|STARTED|Fourth Intervention (35 Days)||1
11132879|NCT01408719|12318698|FG010|STARTED|Fourth Intervention (35 Days)||2
11132880|NCT01408719|12318699|FG011|STARTED|Fourth Intervention (35 Days)||2
11132881|NCT01408719|12318700|FG012|STARTED|Fourth Intervention (35 Days)||1
11132882|NCT01408719|12318701|FG013|STARTED|Fourth Intervention (35 Days)||3
11132883|NCT01408719|12318702|FG014|STARTED|Fourth Intervention (35 Days)||1
11132884|NCT01408719|12318703|FG015|STARTED|Fourth Intervention (35 Days)||1
11132885|NCT01408719|12318704|FG016|STARTED|Fourth Intervention (35 Days)||2
11132886|NCT01408719|12318705|FG017|STARTED|Fourth Intervention (35 Days)||2
11132887|NCT01408719|12318706|FG018|STARTED|Fourth Intervention (35 Days)||0
11132888|NCT01408719|12318707|FG019|STARTED|Fourth Intervention (35 Days)||1
11132889|NCT01408719|12318688|FG000|COMPLETED|Fourth Intervention (35 Days)||2
11132890|NCT01408719|12318689|FG001|COMPLETED|Fourth Intervention (35 Days)||3
11132891|NCT01408719|12318690|FG002|COMPLETED|Fourth Intervention (35 Days)||1
11132892|NCT01408719|12318691|FG003|COMPLETED|Fourth Intervention (35 Days)||2
11132893|NCT01408719|12318692|FG004|COMPLETED|Fourth Intervention (35 Days)||3
11132894|NCT01408719|12318693|FG005|COMPLETED|Fourth Intervention (35 Days)||3
11132895|NCT01408719|12318694|FG006|COMPLETED|Fourth Intervention (35 Days)||2
11132896|NCT01408719|12318695|FG007|COMPLETED|Fourth Intervention (35 Days)||2
11132897|NCT01408719|12318696|FG008|COMPLETED|Fourth Intervention (35 Days)||1
11132898|NCT01408719|12318697|FG009|COMPLETED|Fourth Intervention (35 Days)||1
11132899|NCT01408719|12318698|FG010|COMPLETED|Fourth Intervention (35 Days)||2
11240428|NCT02090374|12432721|FG006|COMPLETED|Overall Study||16
11240429|NCT02090374|12432722|FG007|COMPLETED|Overall Study||2
11240430|NCT02090374|12432715|FG000|NOT COMPLETED|Overall Study||0
11132900|NCT01408719|12318699|FG011|COMPLETED|Fourth Intervention (35 Days)||2
11132901|NCT01408719|12318700|FG012|COMPLETED|Fourth Intervention (35 Days)||1
11132902|NCT01408719|12318701|FG013|COMPLETED|Fourth Intervention (35 Days)||3
11132903|NCT01408719|12318702|FG014|COMPLETED|Fourth Intervention (35 Days)||1
11132904|NCT01408719|12318703|FG015|COMPLETED|Fourth Intervention (35 Days)||1
11132905|NCT01408719|12318704|FG016|COMPLETED|Fourth Intervention (35 Days)||2
11132906|NCT01408719|12318705|FG017|COMPLETED|Fourth Intervention (35 Days)||2
11132907|NCT01408719|12318706|FG018|COMPLETED|Fourth Intervention (35 Days)||0
11132908|NCT01408719|12318707|FG019|COMPLETED|Fourth Intervention (35 Days)||1
11132909|NCT01408719|12318688|FG000|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132910|NCT01408719|12318689|FG001|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132911|NCT01408719|12318690|FG002|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132912|NCT01408719|12318691|FG003|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132913|NCT01408719|12318692|FG004|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132914|NCT01408719|12318693|FG005|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132915|NCT01408719|12318694|FG006|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132916|NCT01408719|12318695|FG007|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132917|NCT01408719|12318696|FG008|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132918|NCT01408719|12318697|FG009|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132919|NCT01408719|12318698|FG010|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132920|NCT01408719|12318699|FG011|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132921|NCT01408719|12318700|FG012|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132922|NCT01408719|12318701|FG013|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132923|NCT01408719|12318702|FG014|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132924|NCT01408719|12318703|FG015|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132925|NCT01408719|12318704|FG016|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132926|NCT01408719|12318705|FG017|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132927|NCT01408719|12318706|FG018|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132928|NCT01408719|12318707|FG019|NOT COMPLETED|Fourth Intervention (35 Days)||0
11132929|NCT01408732|12318717|FG000|STARTED|Overall Study||9
11132930|NCT01408732|12318718|FG001|STARTED|Overall Study||9
11132931|NCT01408732|12318717|FG000|COMPLETED|Overall Study||7
11132932|NCT01408732|12318718|FG001|COMPLETED|Overall Study||7
11132933|NCT01408732|12318717|FG000|NOT COMPLETED|Overall Study||2
11132934|NCT01408732|12318718|FG001|NOT COMPLETED|Overall Study||2
11132935|NCT01408862|12318724|FG000|STARTED|Overall Study||20
11132936|NCT01408862|12318724|FG000|COMPLETED|Overall Study||20
11132937|NCT01408862|12318724|FG000|NOT COMPLETED|Overall Study||0
11132938|NCT01408888|12318729|FG000|STARTED|First Intervention||18
11132939|NCT01408888|12318730|FG001|STARTED|First Intervention||11
11132940|NCT01408888|12318729|FG000|Received at Least 1 Dose of Drug|First Intervention||18
11132941|NCT01408888|12318730|FG001|Received at Least 1 Dose of Drug|First Intervention||11
11132942|NCT01408888|12318729|FG000|COMPLETED|First Intervention||18
11132943|NCT01408888|12318730|FG001|COMPLETED|First Intervention||8
11132944|NCT01408888|12318729|FG000|NOT COMPLETED|First Intervention||0
11132945|NCT01408888|12318730|FG001|NOT COMPLETED|First Intervention||3
11132946|NCT01408888|12318729|FG000|STARTED|Washout of at Least 21 Days||18
11132947|NCT01408888|12318730|FG001|STARTED|Washout of at Least 21 Days||8
11132948|NCT01408888|12318729|FG000|COMPLETED|Washout of at Least 21 Days||18
11132949|NCT01408888|12318730|FG001|COMPLETED|Washout of at Least 21 Days||8
11132950|NCT01408888|12318729|FG000|NOT COMPLETED|Washout of at Least 21 Days||0
11132951|NCT01408888|12318730|FG001|NOT COMPLETED|Washout of at Least 21 Days||0
11132952|NCT01408888|12318729|FG000|STARTED|Second Intervention||18
11132953|NCT01408888|12318730|FG001|STARTED|Second Intervention||8
11132954|NCT01408888|12318729|FG000|COMPLETED|Second Intervention||16
11132955|NCT01408888|12318730|FG001|COMPLETED|Second Intervention||8
11132956|NCT01408888|12318729|FG000|NOT COMPLETED|Second Intervention||2
11132957|NCT01408888|12318730|FG001|NOT COMPLETED|Second Intervention||0
11132958|NCT01408901|12318750|FG000|STARTED|6-Week Follow-Up||53
11132959|NCT01408901|12318751|FG001|STARTED|6-Week Follow-Up||53
11132960|NCT01408901|12318752|FG002|STARTED|6-Week Follow-Up||53
11132961|NCT01408901|12318753|FG003|STARTED|6-Week Follow-Up||51
11132962|NCT01408901|12318750|FG000|COMPLETED|6-Week Follow-Up||50
11132963|NCT01408901|12318751|FG001|COMPLETED|6-Week Follow-Up||51
11132964|NCT01408901|12318752|FG002|COMPLETED|6-Week Follow-Up||50
11132965|NCT01408901|12318753|FG003|COMPLETED|6-Week Follow-Up||47
11132966|NCT01408901|12318750|FG000|NOT COMPLETED|6-Week Follow-Up||3
11132967|NCT01408901|12318751|FG001|NOT COMPLETED|6-Week Follow-Up||2
11132968|NCT01408901|12318752|FG002|NOT COMPLETED|6-Week Follow-Up||3
11132969|NCT01408901|12318753|FG003|NOT COMPLETED|6-Week Follow-Up||4
11132970|NCT01408901|12318750|FG000|STARTED|12-Week Follow-Up (Primary Endpoint)||50
11132971|NCT01408901|12318751|FG001|STARTED|12-Week Follow-Up (Primary Endpoint)||52
11132972|NCT01408901|12318752|FG002|STARTED|12-Week Follow-Up (Primary Endpoint)||50
11132973|NCT01408901|12318753|FG003|STARTED|12-Week Follow-Up (Primary Endpoint)||49
11132974|NCT01408901|12318750|FG000|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49
11132975|NCT01408901|12318751|FG001|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
11132976|NCT01408901|12318752|FG002|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
11132977|NCT01408901|12318753|FG003|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46
11132978|NCT01408901|12318750|FG000|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1
11132979|NCT01408901|12318751|FG001|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2
11132980|NCT01408901|12318752|FG002|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0
11132981|NCT01408901|12318753|FG003|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3
11132982|NCT01408901|12318750|FG000|STARTED|26-Week Follow-Up||49
11132983|NCT01408901|12318751|FG001|STARTED|26-Week Follow-Up||52
11132984|NCT01408901|12318752|FG002|STARTED|26-Week Follow-Up||50
11132985|NCT01408901|12318753|FG003|STARTED|26-Week Follow-Up||47
11132986|NCT01408901|12318750|FG000|COMPLETED|26-Week Follow-Up||48
11132987|NCT01408901|12318751|FG001|COMPLETED|26-Week Follow-Up||50
11132988|NCT01408901|12318752|FG002|COMPLETED|26-Week Follow-Up||50
11132989|NCT01408901|12318753|FG003|COMPLETED|26-Week Follow-Up||46
11132990|NCT01408901|12318750|FG000|NOT COMPLETED|26-Week Follow-Up||1
11132991|NCT01408901|12318751|FG001|NOT COMPLETED|26-Week Follow-Up||2
11132992|NCT01408901|12318752|FG002|NOT COMPLETED|26-Week Follow-Up||0
11132993|NCT01408901|12318753|FG003|NOT COMPLETED|26-Week Follow-Up||1
11132994|NCT01408914|12318768|FG000|STARTED|Overall Study||60
11132995|NCT01408914|12318769|FG001|STARTED|Overall Study||60
11132996|NCT01408914|12318770|FG002|STARTED|Overall Study||60
11132997|NCT01408914|12318768|FG000|COMPLETED|Overall Study||48
11132998|NCT01408914|12318769|FG001|COMPLETED|Overall Study||48
11132999|NCT01408914|12318770|FG002|COMPLETED|Overall Study||47
11133000|NCT01408914|12318768|FG000|NOT COMPLETED|Overall Study||12
11133001|NCT01408914|12318769|FG001|NOT COMPLETED|Overall Study||12
11133002|NCT01408914|12318770|FG002|NOT COMPLETED|Overall Study||13
11133003|NCT01408992|12318778|FG000|STARTED|Overall Study||558
11133004|NCT01408992|12318778|FG000|COMPLETED|Overall Study||558
11133005|NCT01408992|12318778|FG000|NOT COMPLETED|Overall Study||0
11133006|NCT01409096|12318792|FG000|STARTED|Overall Study||40
11133007|NCT01409096|12318793|FG001|STARTED|Overall Study||40
11133008|NCT01409096|12318792|FG000|COMPLETED|Overall Study||38
11133009|NCT01409096|12318793|FG001|COMPLETED|Overall Study||35
11133010|NCT01409096|12318792|FG000|NOT COMPLETED|Overall Study||2
11133011|NCT01409096|12318793|FG001|NOT COMPLETED|Overall Study||5
11133012|NCT01409213|12318799|FG000|STARTED|Overall Study||1523
11133013|NCT01409213|12318799|FG000|COMPLETED|Overall Study||1523
11133014|NCT01409213|12318799|FG000|NOT COMPLETED|Overall Study||0
11133015|NCT01409239|12318805|FG000|STARTED|Overall Study||16
11133016|NCT01409239|12318806|FG001|STARTED|Overall Study||17
11133017|NCT01409239|12318805|FG000|COMPLETED|Overall Study||16
11133018|NCT01409239|12318806|FG001|COMPLETED|Overall Study||17
11133019|NCT01409239|12318805|FG000|NOT COMPLETED|Overall Study||0
11133020|NCT01409239|12318806|FG001|NOT COMPLETED|Overall Study||0
11133021|NCT01409291|12318814|FG000|STARTED|Overall Study||36
11133022|NCT01409291|12318815|FG001|STARTED|Overall Study||28
11133023|NCT01409291|12318814|FG000|COMPLETED|Overall Study||29
11133024|NCT01409291|12318815|FG001|COMPLETED|Overall Study||19
11133025|NCT01409291|12318814|FG000|NOT COMPLETED|Overall Study||7
11133026|NCT01409291|12318815|FG001|NOT COMPLETED|Overall Study||9
11133027|NCT01409382|12318823|FG000|STARTED|Overall Study||240
11133028|NCT01409382|12318824|FG001|STARTED|Overall Study||240
11133029|NCT01409382|12318823|FG000|COMPLETED|Overall Study||159
11133030|NCT01409382|12318824|FG001|COMPLETED|Overall Study||160
11133031|NCT01409382|12318823|FG000|NOT COMPLETED|Overall Study||81
11133032|NCT01409382|12318824|FG001|NOT COMPLETED|Overall Study||80
11133033|NCT01409434|12318834|FG000|STARTED|Overall Study||44
11133034|NCT01409434|12318834|FG000|COMPLETED|Overall Study||40
11133035|NCT01409434|12318834|FG000|NOT COMPLETED|Overall Study||4
11133036|NCT01409564|12318840|FG000|STARTED|Overall Study||23
11133037|NCT01409564|12318841|FG001|STARTED|Overall Study||23
11133038|NCT01409564|12318840|FG000|COMPLETED|Overall Study||18
11133039|NCT01409564|12318841|FG001|COMPLETED|Overall Study||18
11133040|NCT01409564|12318840|FG000|NOT COMPLETED|Overall Study||5
11133041|NCT01409564|12318841|FG001|NOT COMPLETED|Overall Study||5
11133042|NCT01409707|12318854|FG000|STARTED|Overall Study||41
11133043|NCT01409707|12318855|FG001|STARTED|Overall Study||45
11133044|NCT01409707|12318856|FG002|STARTED|Overall Study||40
11133045|NCT01409707|12318854|FG000|COMPLETED|Overall Study||36
11133046|NCT01409707|12318855|FG001|COMPLETED|Overall Study||28
11133047|NCT01409707|12318856|FG002|COMPLETED|Overall Study||24
11133048|NCT01409707|12318854|FG000|NOT COMPLETED|Overall Study||5
11133049|NCT01409707|12318855|FG001|NOT COMPLETED|Overall Study||17
11133050|NCT01409707|12318856|FG002|NOT COMPLETED|Overall Study||16
11133051|NCT01409811|12318863|FG000|STARTED|Overall Study||9
11133052|NCT01409811|12318863|FG000|COMPLETED|Overall Study||8
11133053|NCT01409811|12318863|FG000|NOT COMPLETED|Overall Study||1
11133054|NCT01409837|12318869|FG000|STARTED|Overall Study||17
11133055|NCT01409837|12318870|FG001|STARTED|Overall Study||16
11133056|NCT01409837|12318869|FG000|6th Week|Overall Study||17
11133057|NCT01409837|12318870|FG001|6th Week|Overall Study||16
11133058|NCT01409837|12318869|FG000|12th Week|Overall Study|Moved away to another location|16
11133059|NCT01409837|12318870|FG001|12th Week|Overall Study||16
11133060|NCT01409837|12318869|FG000|24th Week|Overall Study||16
11133061|NCT01409837|12318870|FG001|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
11133062|NCT01409837|12318869|FG000|48th Week|Overall Study|Lost to follow-up|15
11133063|NCT01409837|12318870|FG001|48th Week|Overall Study||15
11133064|NCT01409837|12318869|FG000|96th Week|Overall Study||15
11133065|NCT01409837|12318870|FG001|96th Week|Overall Study||15
11133066|NCT01409837|12318869|FG000|102nd Week|Overall Study||15
11133067|NCT01409837|12318870|FG001|102nd Week|Overall Study|Married another wife|14
11133068|NCT01409837|12318869|FG000|114th Week|Overall Study||15
11133069|NCT01409837|12318870|FG001|114th Week|Overall Study||14
11133070|NCT01409837|12318869|FG000|138th Week|Overall Study||15
11133071|NCT01409837|12318870|FG001|138th Week|Overall Study||14
11133072|NCT01409837|12318869|FG000|186th Week|Overall Study|Moved away to another location|14
11133073|NCT01409837|12318870|FG001|186th Week|Overall Study||14
11133074|NCT01409837|12318869|FG000|282nd Week|Overall Study||14
11133075|NCT01409837|12318870|FG001|282nd Week|Overall Study||14
11133076|NCT01409837|12318869|FG000|COMPLETED|Overall Study||14
11133077|NCT01409837|12318870|FG001|COMPLETED|Overall Study||14
11133078|NCT01409837|12318869|FG000|NOT COMPLETED|Overall Study||3
11133079|NCT01409837|12318870|FG001|NOT COMPLETED|Overall Study||2
11133080|NCT01409915|12318880|FG000|STARTED|Overall Study||21
11133081|NCT01409915|12318881|FG001|STARTED|Overall Study||23
11133082|NCT01409915|12318880|FG000|COMPLETED|Overall Study||20
11133083|NCT01409915|12318881|FG001|COMPLETED|Overall Study||20
11133084|NCT01409915|12318880|FG000|NOT COMPLETED|Overall Study||1
11133085|NCT01409915|12318881|FG001|NOT COMPLETED|Overall Study||3
11133086|NCT01409928|12318887|FG000|STARTED|Overall Study||16
11133087|NCT01409928|12318887|FG000|COMPLETED|Overall Study||4
11133088|NCT01409928|12318887|FG000|NOT COMPLETED|Overall Study||12
11133089|NCT01409993|12318893|FG000|STARTED|Overall Study||25
11133090|NCT01409993|12318894|FG001|STARTED|Overall Study||26
11133091|NCT01409993|12318895|FG002|STARTED|Overall Study||14
11133092|NCT01409993|12318896|FG003|STARTED|Overall Study||13
11133093|NCT01409993|12318893|FG000|COMPLETED|Overall Study||21
11240431|NCT02090374|12432716|FG001|NOT COMPLETED|Overall Study||0
11240432|NCT02090374|12432717|FG002|NOT COMPLETED|Overall Study||0
11240433|NCT02090374|12432718|FG003|NOT COMPLETED|Overall Study||0
11240434|NCT02090374|12432719|FG004|NOT COMPLETED|Overall Study||0
11133094|NCT01409993|12318894|FG001|COMPLETED|Overall Study||21
11133095|NCT01409993|12318895|FG002|COMPLETED|Overall Study||11
11133096|NCT01409993|12318896|FG003|COMPLETED|Overall Study||8
11133097|NCT01409993|12318893|FG000|NOT COMPLETED|Overall Study||4
11133098|NCT01409993|12318894|FG001|NOT COMPLETED|Overall Study||5
11133099|NCT01409993|12318895|FG002|NOT COMPLETED|Overall Study||3
11133100|NCT01409993|12318896|FG003|NOT COMPLETED|Overall Study||5
11133101|NCT01410058|12318912|FG000|STARTED|Washout Day 0||13
11133102|NCT01410058|12318913|FG001|STARTED|Washout Day 0||6
11133103|NCT01410058|12318912|FG000|COMPLETED|Washout Day 0||13
11133104|NCT01410058|12318913|FG001|COMPLETED|Washout Day 0||6
11133105|NCT01410058|12318912|FG000|NOT COMPLETED|Washout Day 0||0
11133106|NCT01410058|12318913|FG001|NOT COMPLETED|Washout Day 0||0
11133107|NCT01410058|12318912|FG000|STARTED|Baseline Day 22||13
11133108|NCT01410058|12318913|FG001|STARTED|Baseline Day 22||6
11133109|NCT01410058|12318912|FG000|COMPLETED|Baseline Day 22||13
11133110|NCT01410058|12318913|FG001|COMPLETED|Baseline Day 22||6
11240435|NCT02090374|12432720|FG005|NOT COMPLETED|Overall Study||0
11240436|NCT02090374|12432721|FG006|NOT COMPLETED|Overall Study||0
11240437|NCT02090374|12432722|FG007|NOT COMPLETED|Overall Study||0
11240438|NCT02090413|12432743|FG000|STARTED|Overall Study||81
11133111|NCT01410058|12318912|FG000|NOT COMPLETED|Baseline Day 22||0
11133112|NCT01410058|12318913|FG001|NOT COMPLETED|Baseline Day 22||0
11133113|NCT01410058|12318912|FG000|STARTED|Day 35||13
11133114|NCT01410058|12318913|FG001|STARTED|Day 35||6
11133115|NCT01410058|12318912|FG000|COMPLETED|Day 35||13
11133116|NCT01410058|12318913|FG001|COMPLETED|Day 35||6
11133117|NCT01410058|12318912|FG000|NOT COMPLETED|Day 35||0
11133118|NCT01410058|12318913|FG001|NOT COMPLETED|Day 35||0
11133119|NCT01410084|12318923|FG000|STARTED|Overall Study||38
11133120|NCT01410084|12318924|FG001|STARTED|Overall Study||30
11133121|NCT01410084|12318923|FG000|COMPLETED|Overall Study||37
11133122|NCT01410084|12318924|FG001|COMPLETED|Overall Study||27
11005162|NCT00721396|12182842|FG003|COMPLETED|Overall Study||302
11133123|NCT01410084|12318923|FG000|NOT COMPLETED|Overall Study||1
11133124|NCT01410084|12318924|FG001|NOT COMPLETED|Overall Study||3
11133125|NCT01410097|12318932|FG000|STARTED|Overall Study||556
11133126|NCT01410097|12318933|FG001|STARTED|Overall Study||533
11133127|NCT01410097|12318932|FG000|COMPLETED|Overall Study||551
11133128|NCT01410097|12318933|FG001|COMPLETED|Overall Study||530
11133129|NCT01410097|12318932|FG000|NOT COMPLETED|Overall Study||5
11240439|NCT02090413|12432744|FG001|STARTED|Overall Study||80
11133130|NCT01410097|12318933|FG001|NOT COMPLETED|Overall Study||3
11133131|NCT01410110|12318941|FG000|STARTED|Overall Study||24
11133132|NCT01410110|12318942|FG001|STARTED|Overall Study||24
11133133|NCT01410110|12318941|FG000|Randomization|Overall Study||24
11133134|NCT01410110|12318942|FG001|Randomization|Overall Study||24
11133135|NCT01410110|12318941|FG000|3 Months (End of Intervention)|Overall Study||20
11133136|NCT01410110|12318942|FG001|3 Months (End of Intervention)|Overall Study||22
11133137|NCT01410110|12318941|FG000|6 Month Follow-up|Overall Study||20
11133138|NCT01410110|12318942|FG001|6 Month Follow-up|Overall Study||22
11133139|NCT01410110|12318941|FG000|COMPLETED|Overall Study||20
11133140|NCT01410110|12318942|FG001|COMPLETED|Overall Study||22
11133141|NCT01410110|12318941|FG000|NOT COMPLETED|Overall Study||4
11133142|NCT01410110|12318942|FG001|NOT COMPLETED|Overall Study||2
11133143|NCT01410227|12318948|FG000|STARTED|Overall Study||8
11133144|NCT01410227|12318949|FG001|STARTED|Overall Study||8
11133145|NCT01410227|12318950|FG002|STARTED|Overall Study||15
11133146|NCT01410227|12318951|FG003|STARTED|Overall Study||6
11133147|NCT01410227|12318948|FG000|COMPLETED|Overall Study||4
11133148|NCT01410227|12318949|FG001|COMPLETED|Overall Study||8
11133149|NCT01410227|12318950|FG002|COMPLETED|Overall Study||13
11133150|NCT01410227|12318951|FG003|COMPLETED|Overall Study||5
11133151|NCT01410227|12318948|FG000|NOT COMPLETED|Overall Study||4
11133152|NCT01410227|12318949|FG001|NOT COMPLETED|Overall Study||0
11133153|NCT01410227|12318950|FG002|NOT COMPLETED|Overall Study||2
11133154|NCT01410227|12318951|FG003|NOT COMPLETED|Overall Study||1
11133155|NCT01410240|12318964|FG000|STARTED|Overall Study||53
11133156|NCT01410240|12318965|FG001|STARTED|Overall Study||53
11133157|NCT01410240|12318966|FG002|STARTED|Overall Study||12
11133158|NCT01410240|12318964|FG000|COMPLETED|Overall Study||52
11133159|NCT01410240|12318965|FG001|COMPLETED|Overall Study||52
11133160|NCT01410240|12318966|FG002|COMPLETED|Overall Study||10
11133161|NCT01410240|12318964|FG000|NOT COMPLETED|Overall Study||1
11133162|NCT01410240|12318965|FG001|NOT COMPLETED|Overall Study||1
11133163|NCT01410240|12318966|FG002|NOT COMPLETED|Overall Study||2
11133164|NCT01410344|12318975|FG000|STARTED|Overall Study||20
11133165|NCT01410344|12318975|FG000|COMPLETED|Overall Study||17
11133166|NCT01410344|12318975|FG000|NOT COMPLETED|Overall Study||3
11133167|NCT01410357|12318983|FG000|STARTED|Overall Study||100
11133168|NCT01410357|12318984|FG001|STARTED|Overall Study||100
11133169|NCT01410357|12318983|FG000|COMPLETED|Overall Study||74
11133170|NCT01410357|12318984|FG001|COMPLETED|Overall Study||76
11133171|NCT01410357|12318983|FG000|NOT COMPLETED|Overall Study||26
11133172|NCT01410357|12318984|FG001|NOT COMPLETED|Overall Study||24
11133173|NCT01410409|12318994|FG000|STARTED|Overall Study||50
11133174|NCT01410409|12318995|FG001|STARTED|Overall Study||50
11133175|NCT01410409|12318994|FG000|COMPLETED|Overall Study||49
11133176|NCT01410409|12318995|FG001|COMPLETED|Overall Study||46
11133177|NCT01410409|12318994|FG000|NOT COMPLETED|Overall Study||1
11133178|NCT01410409|12318995|FG001|NOT COMPLETED|Overall Study||4
11133179|NCT01410448|12319003|FG000|STARTED|Overall Study||193
11133180|NCT01410448|12319004|FG001|STARTED|Overall Study||190
11133181|NCT01410448|12319003|FG000|Intent-to Treat (ITT) Analysis Set|Overall Study||193
11133182|NCT01410448|12319004|FG001|Intent-to Treat (ITT) Analysis Set|Overall Study||190
11133183|NCT01410448|12319003|FG000|Modified ITT Analysis Set|Overall Study||161
11133184|NCT01410448|12319004|FG001|Modified ITT Analysis Set|Overall Study||149
11133185|NCT01410448|12319003|FG000|COMPLETED|Overall Study||181
11133186|NCT01410448|12319004|FG001|COMPLETED|Overall Study||155
11133187|NCT01410448|12319003|FG000|NOT COMPLETED|Overall Study||12
11133188|NCT01410448|12319004|FG001|NOT COMPLETED|Overall Study||35
11133189|NCT01410474|12319012|FG000|STARTED|Overall Study||173
11133190|NCT01410474|12319013|FG001|STARTED|Overall Study||168
11133191|NCT01410474|12319012|FG000|COMPLETED|Overall Study||173
11133192|NCT01410474|12319013|FG001|COMPLETED|Overall Study||167
11133193|NCT01410474|12319012|FG000|NOT COMPLETED|Overall Study||0
11133194|NCT01410474|12319013|FG001|NOT COMPLETED|Overall Study||1
11133195|NCT01410552|12319026|FG000|STARTED|Overall Study||1013
11133196|NCT01410552|12319026|FG000|COMPLETED|Overall Study||877
11133197|NCT01410552|12319026|FG000|NOT COMPLETED|Overall Study||136
11133198|NCT01410565|12319032|FG000|STARTED|Open Label Phase Apaziquone||0
11133199|NCT01410565|12319033|FG001|STARTED|Open Label Phase Apaziquone||0
11133200|NCT01410565|12319034|FG002|STARTED|Open Label Phase Apaziquone||66
11133201|NCT01410565|12319032|FG000|COMPLETED|Open Label Phase Apaziquone||0
11133202|NCT01410565|12319033|FG001|COMPLETED|Open Label Phase Apaziquone||0
11133203|NCT01410565|12319034|FG002|COMPLETED|Open Label Phase Apaziquone||58
11133204|NCT01410565|12319032|FG000|NOT COMPLETED|Open Label Phase Apaziquone||0
11133205|NCT01410565|12319033|FG001|NOT COMPLETED|Open Label Phase Apaziquone||0
11133206|NCT01410565|12319034|FG002|NOT COMPLETED|Open Label Phase Apaziquone||8
11133207|NCT01410565|12319032|FG000|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
11133208|NCT01410565|12319033|FG001|STARTED|Double Blind Phase||15
11133209|NCT01410565|12319034|FG002|STARTED|Double Blind Phase||0
11133210|NCT01410565|12319032|FG000|COMPLETED|Double Blind Phase||0
11133211|NCT01410565|12319033|FG001|COMPLETED|Double Blind Phase||0
11133212|NCT01410565|12319034|FG002|COMPLETED|Double Blind Phase||0
11133213|NCT01410565|12319032|FG000|NOT COMPLETED|Double Blind Phase||13
11133214|NCT01410565|12319033|FG001|NOT COMPLETED|Double Blind Phase||15
11133215|NCT01410565|12319034|FG002|NOT COMPLETED|Double Blind Phase||0
11133216|NCT01410604|12319042|FG000|STARTED|Overall Study||15
11133217|NCT01410604|12319043|FG001|STARTED|Overall Study||16
11133218|NCT01410604|12319042|FG000|COMPLETED|Overall Study||12
11133219|NCT01410604|12319043|FG001|COMPLETED|Overall Study||14
11133220|NCT01410604|12319042|FG000|NOT COMPLETED|Overall Study||3
11133221|NCT01410604|12319043|FG001|NOT COMPLETED|Overall Study||2
11133222|NCT01410773|12319049|FG000|STARTED|Overall Study||110
11133223|NCT01410773|12319049|FG000|COMPLETED|Overall Study||110
11133224|NCT01410773|12319049|FG000|NOT COMPLETED|Overall Study||0
11133225|NCT01410812|12319056|FG000|STARTED|Overall Study||75
11133226|NCT01410812|12319057|FG001|STARTED|Overall Study||75
11133227|NCT01410812|12319058|FG002|STARTED|Overall Study||76
11133228|NCT01410812|12319056|FG000|COMPLETED|Overall Study||75
11133229|NCT01410812|12319057|FG001|COMPLETED|Overall Study||75
11133230|NCT01410812|12319058|FG002|COMPLETED|Overall Study||76
11133231|NCT01410812|12319056|FG000|NOT COMPLETED|Overall Study||0
11005163|NCT00721396|12182839|FG000|NOT COMPLETED|Overall Study||30
11005164|NCT00721396|12182840|FG001|NOT COMPLETED|Overall Study||36
11005165|NCT00721396|12182841|FG002|NOT COMPLETED|Overall Study||10
11005166|NCT00721396|12182842|FG003|NOT COMPLETED|Overall Study||10
11005167|NCT00721409|12182860|FG000|STARTED|Overall Study||12
11005168|NCT00721409|12182861|FG001|STARTED|Overall Study||84
11005169|NCT00721409|12182862|FG002|STARTED|Overall Study||81
11005170|NCT00721409|12182860|FG000|Treated|Overall Study||12
11005171|NCT00721409|12182861|FG001|Treated|Overall Study||83
11005172|NCT00721409|12182862|FG002|Treated|Overall Study||77
11005173|NCT00721409|12182860|FG000|COMPLETED|Overall Study||0
11133232|NCT01410812|12319057|FG001|NOT COMPLETED|Overall Study||0
11133233|NCT01410812|12319058|FG002|NOT COMPLETED|Overall Study||0
11133234|NCT01411085|12319066|FG000|STARTED|Overall Study||10
11133235|NCT01411085|12319066|FG000|COMPLETED|Overall Study||7
11133236|NCT01411085|12319066|FG000|NOT COMPLETED|Overall Study||3
11133237|NCT01411137|12319070|FG000|STARTED|Part 1: Dose Conversion||43
11133238|NCT01411137|12319070|FG000|COMPLETED|Part 1: Dose Conversion||33
11133239|NCT01411137|12319070|FG000|NOT COMPLETED|Part 1: Dose Conversion||10
11133240|NCT01411137|12319070|FG000|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
11133241|NCT01411137|12319070|FG000|COMPLETED|Part 2: Open-Label Extension||25
11133242|NCT01411137|12319070|FG000|NOT COMPLETED|Part 2: Open-Label Extension||7
11133243|NCT01411137|12319070|FG000|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
11133244|NCT01411137|12319070|FG000|COMPLETED|Part 3: Open-Label Extension||12
11133245|NCT01411137|12319070|FG000|NOT COMPLETED|Part 3: Open-Label Extension||0
11133246|NCT01411215|12319087|FG000|STARTED|Overall Study||69
11133247|NCT01411215|12319088|FG001|STARTED|Overall Study||91
11133248|NCT01411215|12319087|FG000|Treated|Overall Study||69
11133249|NCT01411215|12319088|FG001|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
11133250|NCT01411215|12319087|FG000|COMPLETED|Overall Study||3
11133251|NCT01411215|12319088|FG001|COMPLETED|Overall Study||7
11133252|NCT01411215|12319087|FG000|NOT COMPLETED|Overall Study||66
11133253|NCT01411215|12319088|FG001|NOT COMPLETED|Overall Study||84
11133254|NCT01411228|12319097|FG000|STARTED|Overall Study||5
11133255|NCT01411228|12319098|FG001|STARTED|Overall Study||5
11133256|NCT01411228|12319099|FG002|STARTED|Overall Study||5
11133257|NCT01411228|12319097|FG000|COMPLETED|Overall Study||4
11133258|NCT01411228|12319098|FG001|COMPLETED|Overall Study||5
11133259|NCT01411228|12319099|FG002|COMPLETED|Overall Study||4
11133260|NCT01411228|12319097|FG000|NOT COMPLETED|Overall Study||1
11133261|NCT01411228|12319098|FG001|NOT COMPLETED|Overall Study||0
11133262|NCT01411228|12319099|FG002|NOT COMPLETED|Overall Study||1
11133263|NCT01411319|12319107|FG000|STARTED|Overall Study||25
11133264|NCT01411319|12319107|FG000|COMPLETED|Overall Study||24
11133265|NCT01411319|12319107|FG000|NOT COMPLETED|Overall Study||1
11133266|NCT01411488|12319113|FG000|STARTED|Overall Study||41
11133267|NCT01411488|12319114|FG001|STARTED|Overall Study||38
11133268|NCT01411488|12319113|FG000|COMPLETED|Overall Study||41
11133269|NCT01411488|12319114|FG001|COMPLETED|Overall Study||38
11133270|NCT01411488|12319113|FG000|NOT COMPLETED|Overall Study||0
11133271|NCT01411488|12319114|FG001|NOT COMPLETED|Overall Study||0
11133272|NCT01411501|12319124|FG000|STARTED|Overall Study||168
11133273|NCT01411501|12319125|FG001|STARTED|Overall Study||172
11133274|NCT01411501|12319126|FG002|STARTED|Overall Study||165
11133275|NCT01411501|12319127|FG003|STARTED|Overall Study||170
11133276|NCT01411501|12319124|FG000|COMPLETED|Overall Study||158
11133277|NCT01411501|12319125|FG001|COMPLETED|Overall Study||166
11133278|NCT01411501|12319126|FG002|COMPLETED|Overall Study||159
11133279|NCT01411501|12319127|FG003|COMPLETED|Overall Study||163
11133280|NCT01411501|12319124|FG000|NOT COMPLETED|Overall Study||10
11133281|NCT01411501|12319125|FG001|NOT COMPLETED|Overall Study||6
11133282|NCT01411501|12319126|FG002|NOT COMPLETED|Overall Study||6
11133283|NCT01411501|12319127|FG003|NOT COMPLETED|Overall Study||7
11133284|NCT01411527|12319139|FG000|STARTED|Overall Study||1864
11133285|NCT01411527|12319140|FG001|STARTED|Overall Study||93
11133286|NCT01411527|12319139|FG000|COMPLETED|Overall Study||1864
11133287|NCT01411527|12319140|FG001|COMPLETED|Overall Study||93
11133288|NCT01411527|12319139|FG000|NOT COMPLETED|Overall Study||0
11133289|NCT01411527|12319140|FG001|NOT COMPLETED|Overall Study||0
11133290|NCT01411592|12319147|FG000|STARTED|Overall Study||14
11133291|NCT01411592|12319148|FG001|STARTED|Overall Study||16
11133292|NCT01411592|12319147|FG000|5-Year Time Frame|Overall Study||14
11133293|NCT01411592|12319148|FG001|5-Year Time Frame|Overall Study||16
11133294|NCT01411592|12319147|FG000|COMPLETED|Overall Study||14
11133295|NCT01411592|12319148|FG001|COMPLETED|Overall Study||16
11133296|NCT01411592|12319147|FG000|NOT COMPLETED|Overall Study||0
11133297|NCT01411592|12319148|FG001|NOT COMPLETED|Overall Study||0
11133298|NCT01411696|12319154|FG000|STARTED|Overall Study||289
11133299|NCT01411696|12319154|FG000|COMPLETED|Overall Study||289
11133300|NCT01411696|12319154|FG000|NOT COMPLETED|Overall Study||0
11133301|NCT01411774|12319160|FG000|STARTED|Overall Study||72
11133302|NCT01411774|12319161|FG001|STARTED|Overall Study||70
11133303|NCT01411774|12319160|FG000|COMPLETED|Overall Study||72
11133304|NCT01411774|12319161|FG001|COMPLETED|Overall Study||67
11133305|NCT01411774|12319160|FG000|NOT COMPLETED|Overall Study||0
11133306|NCT01411774|12319161|FG001|NOT COMPLETED|Overall Study||3
11133307|NCT01411839|12319169|FG000|STARTED|Overall Study||20
11133308|NCT01411839|12319170|FG001|STARTED|Overall Study||20
11133309|NCT01411839|12319169|FG000|COMPLETED|Overall Study||16
11133310|NCT01411839|12319170|FG001|COMPLETED|Overall Study||17
11133311|NCT01411839|12319169|FG000|NOT COMPLETED|Overall Study||4
11133312|NCT01411839|12319170|FG001|NOT COMPLETED|Overall Study||3
11133313|NCT01411852|12319178|FG000|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
11133314|NCT01411852|12319179|FG001|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
11133315|NCT01411852|12319178|FG000|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
11133316|NCT01411852|12319179|FG001|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
11133317|NCT01411852|12319178|FG000|NOT COMPLETED|Prehospital Intervention Phase||12
11133318|NCT01411852|12319179|FG001|NOT COMPLETED|Prehospital Intervention Phase||7
11133319|NCT01411852|12319178|FG000|STARTED|Hospital Intervention Phase||83
11133320|NCT01411852|12319179|FG001|STARTED|Hospital Intervention Phase||89
11133321|NCT01411852|12319178|FG000|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
11133322|NCT01411852|12319179|FG001|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
11133323|NCT01411852|12319178|FG000|NOT COMPLETED|Hospital Intervention Phase||24
11133324|NCT01411852|12319179|FG001|NOT COMPLETED|Hospital Intervention Phase||18
11133325|NCT01411891|12319189|FG000|STARTED|Overall Study||50
11133326|NCT01411891|12319190|FG001|STARTED|Overall Study||50
11133327|NCT01411891|12319189|FG000|COMPLETED|Overall Study||47
11133328|NCT01411891|12319190|FG001|COMPLETED|Overall Study||48
11133329|NCT01411891|12319189|FG000|NOT COMPLETED|Overall Study||3
11133330|NCT01411891|12319190|FG001|NOT COMPLETED|Overall Study||2
11133331|NCT01411917|12319198|FG000|STARTED|Overall Study||32
11133332|NCT01411917|12319199|FG001|STARTED|Overall Study||37
11133333|NCT01411917|12319198|FG000|COMPLETED|Overall Study||32
11133334|NCT01411917|12319199|FG001|COMPLETED|Overall Study||36
11133335|NCT01411917|12319198|FG000|NOT COMPLETED|Overall Study||0
11133336|NCT01411917|12319199|FG001|NOT COMPLETED|Overall Study||1
11133337|NCT01411995|12319207|FG000|STARTED|Overall Study||100
11133338|NCT01411995|12319208|FG001|STARTED|Overall Study||100
11133339|NCT01411995|12319207|FG000|COMPLETED|Overall Study||100
11133340|NCT01411995|12319208|FG001|COMPLETED|Overall Study||99
11133341|NCT01411995|12319207|FG000|NOT COMPLETED|Overall Study||0
11133342|NCT01411995|12319208|FG001|NOT COMPLETED|Overall Study||1
11133343|NCT01412021|12319214|FG000|STARTED|Overall Study||375
11133344|NCT01412021|12319214|FG000|Case Report Forms Locked|Overall Study||368
11133345|NCT01412021|12319214|FG000|COMPLETED|Overall Study||356
11133346|NCT01412021|12319214|FG000|NOT COMPLETED|Overall Study||19
11133347|NCT01412060|12319218|FG000|STARTED|Open-label Run-in Period (RIP)||765
11133348|NCT01412060|12319219|FG001|STARTED|Open-label Run-in Period (RIP)||0
11133349|NCT01412060|12319220|FG002|STARTED|Open-label Run-in Period (RIP)||0
11133350|NCT01412060|12319218|FG000|COMPLETED|Open-label Run-in Period (RIP)||418
11133351|NCT01412060|12319219|FG001|COMPLETED|Open-label Run-in Period (RIP)||0
11133352|NCT01412060|12319220|FG002|COMPLETED|Open-label Run-in Period (RIP)||0
11133353|NCT01412060|12319218|FG000|NOT COMPLETED|Open-label Run-in Period (RIP)||347
11133354|NCT01412060|12319219|FG001|NOT COMPLETED|Open-label Run-in Period (RIP)||0
11133355|NCT01412060|12319220|FG002|NOT COMPLETED|Open-label Run-in Period (RIP)||0
11133356|NCT01412060|12319218|FG000|STARTED|Period Between RIP and SP||418
11133357|NCT01412060|12319219|FG001|STARTED|Period Between RIP and SP||0
11133358|NCT01412060|12319220|FG002|STARTED|Period Between RIP and SP||0
11133359|NCT01412060|12319218|FG000|COMPLETED|Period Between RIP and SP||364
11133360|NCT01412060|12319219|FG001|COMPLETED|Period Between RIP and SP||0
11133361|NCT01412060|12319220|FG002|COMPLETED|Period Between RIP and SP||0
11133362|NCT01412060|12319218|FG000|NOT COMPLETED|Period Between RIP and SP||54
11133363|NCT01412060|12319219|FG001|NOT COMPLETED|Period Between RIP and SP||0
11133364|NCT01412060|12319220|FG002|NOT COMPLETED|Period Between RIP and SP||0
11133365|NCT01412060|12319218|FG000|STARTED|Open-label Stabilization Period (SP)||364
11133366|NCT01412060|12319219|FG001|STARTED|Open-label Stabilization Period (SP)||0
11133367|NCT01412060|12319220|FG002|STARTED|Open-label Stabilization Period (SP)||0
11133368|NCT01412060|12319218|FG000|COMPLETED|Open-label Stabilization Period (SP)||264
11133369|NCT01412060|12319219|FG001|COMPLETED|Open-label Stabilization Period (SP)||0
11133370|NCT01412060|12319220|FG002|COMPLETED|Open-label Stabilization Period (SP)||0
11133371|NCT01412060|12319218|FG000|NOT COMPLETED|Open-label Stabilization Period (SP)||100
11133372|NCT01412060|12319219|FG001|NOT COMPLETED|Open-label Stabilization Period (SP)||0
11133373|NCT01412060|12319220|FG002|NOT COMPLETED|Open-label Stabilization Period (SP)||0
11133374|NCT01412060|12319218|FG000|STARTED|Period Between SP and DBP||264
11240440|NCT02090413|12432745|FG002|STARTED|Overall Study||80
11133375|NCT01412060|12319219|FG001|STARTED|Period Between SP and DBP||0
11133376|NCT01412060|12319220|FG002|STARTED|Period Between SP and DBP||0
11133377|NCT01412060|12319218|FG000|COMPLETED|Period Between SP and DBP||200
11133378|NCT01412060|12319219|FG001|COMPLETED|Period Between SP and DBP||0
11133379|NCT01412060|12319220|FG002|COMPLETED|Period Between SP and DBP||0
11133380|NCT01412060|12319218|FG000|NOT COMPLETED|Period Between SP and DBP||64
11133381|NCT01412060|12319219|FG001|NOT COMPLETED|Period Between SP and DBP||0
11133382|NCT01412060|12319220|FG002|NOT COMPLETED|Period Between SP and DBP||0
11133383|NCT01412060|12319218|FG000|STARTED|Double-blind Treatment Phase (DBP)||0
11133384|NCT01412060|12319219|FG001|STARTED|Double-blind Treatment Phase (DBP)||99
11133385|NCT01412060|12319220|FG002|STARTED|Double-blind Treatment Phase (DBP)||101
11133386|NCT01412060|12319218|FG000|COMPLETED|Double-blind Treatment Phase (DBP)||0
11133387|NCT01412060|12319219|FG001|COMPLETED|Double-blind Treatment Phase (DBP)||16
11133388|NCT01412060|12319220|FG002|COMPLETED|Double-blind Treatment Phase (DBP)||18
11133389|NCT01412060|12319218|FG000|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
11133390|NCT01412060|12319219|FG001|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
11133391|NCT01412060|12319220|FG002|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
11133392|NCT01412086|12319230|FG000|STARTED|Overall Study||112
11133393|NCT01412086|12319230|FG000|COMPLETED|Overall Study||112
11133394|NCT01412086|12319230|FG000|NOT COMPLETED|Overall Study||0
11133395|NCT01412151|12319234|FG000|STARTED|Week 0 - 306 - Treatment Period||10
11133396|NCT01412151|12319234|FG000|COMPLETED|Week 0 - 306 - Treatment Period||5
11133397|NCT01412151|12319234|FG000|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
11133398|NCT01412151|12319234|FG000|STARTED|Week 306 - 310 - Washout Period||5
11133399|NCT01412151|12319234|FG000|COMPLETED|Week 306 - 310 - Washout Period||3
11133400|NCT01412151|12319234|FG000|NOT COMPLETED|Week 306 - 310 - Washout Period||2
11133401|NCT01412164|12319240|FG000|STARTED|Overall Study||730
11133402|NCT01412164|12319240|FG000|COMPLETED|Overall Study||683
11133403|NCT01412164|12319240|FG000|NOT COMPLETED|Overall Study||47
11133404|NCT01412229|12319244|FG000|STARTED|Overall Study||39
11133405|NCT01412229|12319244|FG000|COMPLETED|Overall Study||38
11133406|NCT01412229|12319244|FG000|NOT COMPLETED|Overall Study||1
11133407|NCT01412281|12319253|FG000|STARTED|Overall Study||110
11133408|NCT01412281|12319254|FG001|STARTED|Overall Study||110
11133409|NCT01412281|12319255|FG002|STARTED|Overall Study||110
11133410|NCT01412281|12319256|FG003|STARTED|Overall Study||110
11133411|NCT01412281|12319253|FG000|COMPLETED|Overall Study||110
11133412|NCT01412281|12319254|FG001|COMPLETED|Overall Study||110
11133413|NCT01412281|12319255|FG002|COMPLETED|Overall Study||110
11133414|NCT01412281|12319256|FG003|COMPLETED|Overall Study||110
11133415|NCT01412281|12319253|FG000|NOT COMPLETED|Overall Study||0
11133416|NCT01412281|12319254|FG001|NOT COMPLETED|Overall Study||0
11133417|NCT01412281|12319255|FG002|NOT COMPLETED|Overall Study||0
11133418|NCT01412281|12319256|FG003|NOT COMPLETED|Overall Study||0
11133419|NCT01412372|12319268|FG000|STARTED|Overall Study||30
11133420|NCT01412372|12319269|FG001|STARTED|Overall Study||31
11133421|NCT01412372|12319268|FG000|COMPLETED|Overall Study||26
11133422|NCT01412372|12319269|FG001|COMPLETED|Overall Study||28
11133423|NCT01412372|12319268|FG000|NOT COMPLETED|Overall Study||4
11133424|NCT01412372|12319269|FG001|NOT COMPLETED|Overall Study||3
11133425|NCT01412424|12319275|FG000|STARTED|Core Treatment Period||155
11133426|NCT01412424|12319275|FG000|COMPLETED|Core Treatment Period||102
11133427|NCT01412424|12319275|FG000|NOT COMPLETED|Core Treatment Period||53
11133428|NCT01412424|12319275|FG000|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
11133429|NCT01412424|12319275|FG000|COMPLETED|Extension Treatment Period||82
11133430|NCT01412424|12319275|FG000|NOT COMPLETED|Extension Treatment Period||6
11133431|NCT01412541|12319287|FG000|STARTED|Overall Study||372
11133432|NCT01412541|12319288|FG001|STARTED|Overall Study||160
11133433|NCT01412541|12319287|FG000|COMPLETED|Overall Study||246
11133434|NCT01412541|12319288|FG001|COMPLETED|Overall Study||117
11133435|NCT01412541|12319287|FG000|NOT COMPLETED|Overall Study||126
11133436|NCT01412541|12319288|FG001|NOT COMPLETED|Overall Study||43
11133437|NCT01412554|12319297|FG000|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103
11133438|NCT01412554|12319297|FG000|COMPLETED|Overall Study||103
11133439|NCT01412554|12319297|FG000|NOT COMPLETED|Overall Study||0
11133440|NCT01412710|12319303|FG000|STARTED|Overall Study||50
11133441|NCT01412710|12319304|FG001|STARTED|Overall Study||27
11133442|NCT01412710|12319303|FG000|COMPLETED|Overall Study||46
11133443|NCT01412710|12319304|FG001|COMPLETED|Overall Study||22
11133444|NCT01412710|12319303|FG000|NOT COMPLETED|Overall Study||4
11133445|NCT01412710|12319304|FG001|NOT COMPLETED|Overall Study||5
11133446|NCT01412801|12319316|FG000|STARTED|Overall Study||91
11133447|NCT01412801|12319317|FG001|STARTED|Overall Study||89
11133448|NCT01412801|12319318|FG002|STARTED|Overall Study||90
11133449|NCT01412801|12319319|FG003|STARTED|Overall Study||91
11133450|NCT01412801|12319320|FG004|STARTED|Overall Study||88
11133451|NCT01412801|12319321|FG005|STARTED|Overall Study||87
11133452|NCT01412801|12319316|FG000|COMPLETED|Overall Study||87
11133453|NCT01412801|12319317|FG001|COMPLETED|Overall Study||84
11133454|NCT01412801|12319318|FG002|COMPLETED|Overall Study||83
11133455|NCT01412801|12319319|FG003|COMPLETED|Overall Study||87
11133456|NCT01412801|12319320|FG004|COMPLETED|Overall Study||85
11133457|NCT01412801|12319321|FG005|COMPLETED|Overall Study||84
11133458|NCT01412801|12319316|FG000|NOT COMPLETED|Overall Study||4
11240441|NCT02090413|12432743|FG000|COMPLETED|Overall Study||62
11240442|NCT02090413|12432744|FG001|COMPLETED|Overall Study||60
11240443|NCT02090413|12432745|FG002|COMPLETED|Overall Study||57
11240444|NCT02090413|12432743|FG000|NOT COMPLETED|Overall Study||19
11240445|NCT02090413|12432744|FG001|NOT COMPLETED|Overall Study||20
11240446|NCT02090413|12432745|FG002|NOT COMPLETED|Overall Study||23
11240447|NCT02090426|12432756|FG000|STARTED|Overall Study||401
11240448|NCT02090426|12432757|FG001|STARTED|Overall Study||399
11240449|NCT02090426|12432756|FG000|Analysis Population|Overall Study||389
11240450|NCT02090426|12432757|FG001|Analysis Population|Overall Study||393
11240451|NCT02090426|12432756|FG000|COMPLETED|Overall Study||389
11240452|NCT02090426|12432757|FG001|COMPLETED|Overall Study||393
11240453|NCT02090426|12432756|FG000|NOT COMPLETED|Overall Study||12
11240454|NCT02090426|12432757|FG001|NOT COMPLETED|Overall Study||6
11240455|NCT02090634|12432765|FG000|STARTED|Overall Study||30
11240456|NCT02090634|12432766|FG001|STARTED|Overall Study||28
11240457|NCT02090634|12432765|FG000|COMPLETED|Overall Study||25
11240458|NCT02090634|12432766|FG001|COMPLETED|Overall Study||25
11240459|NCT02090634|12432765|FG000|NOT COMPLETED|Overall Study||5
11240460|NCT02090634|12432766|FG001|NOT COMPLETED|Overall Study||3
11240461|NCT02090725|12432772|FG000|STARTED|Overall Study||4
11240462|NCT02090725|12432772|FG000|COMPLETED|Overall Study||0
11240463|NCT02090725|12432772|FG000|NOT COMPLETED|Overall Study||4
11240464|NCT02090764|12432778|FG000|STARTED|Overall Study||206
11240465|NCT02090764|12432779|FG001|STARTED|Overall Study||206
11240466|NCT02090764|12432778|FG000|COMPLETED|Overall Study||200
11240467|NCT02090764|12432779|FG001|COMPLETED|Overall Study||186
11240468|NCT02090764|12432778|FG000|NOT COMPLETED|Overall Study||6
11240469|NCT02090764|12432779|FG001|NOT COMPLETED|Overall Study||20
11240470|NCT02090777|12432785|FG000|STARTED|Overall Study||4
11240471|NCT02090777|12432785|FG000|COMPLETED|Overall Study||4
11240472|NCT02090777|12432785|FG000|NOT COMPLETED|Overall Study||0
11240473|NCT02090855|12432789|FG000|STARTED|Overall Study||108
11240474|NCT02090855|12432789|FG000|COMPLETED|Overall Study||106
11240475|NCT02090855|12432789|FG000|NOT COMPLETED|Overall Study||2
11133459|NCT01412801|12319317|FG001|NOT COMPLETED|Overall Study||5
11133460|NCT01412801|12319318|FG002|NOT COMPLETED|Overall Study||7
11133461|NCT01412801|12319319|FG003|NOT COMPLETED|Overall Study||4
11133462|NCT01412801|12319320|FG004|NOT COMPLETED|Overall Study||3
11133463|NCT01412801|12319321|FG005|NOT COMPLETED|Overall Study||3
11133464|NCT01412866|12319346|FG000|STARTED|Overall Study||58
11133465|NCT01412866|12319347|FG001|STARTED|Overall Study||66
11133466|NCT01412866|12319346|FG000|COMPLETED|Overall Study||57
11133467|NCT01412866|12319347|FG001|COMPLETED|Overall Study||64
11133468|NCT01412866|12319346|FG000|NOT COMPLETED|Overall Study||1
11133469|NCT01412866|12319347|FG001|NOT COMPLETED|Overall Study||2
11240476|NCT02090894|12432796|FG000|STARTED|Overall Study||11
11240477|NCT02090894|12432796|FG000|COMPLETED|Overall Study||11
11133470|NCT01412879|12319355|FG000|STARTED|Initial Registration (Induction Therapy)||18
11133471|NCT01412879|12319356|FG001|STARTED|Initial Registration (Induction Therapy)||35
11133472|NCT01412879|12319357|FG002|STARTED|Initial Registration (Induction Therapy)||0
11133473|NCT01412879|12319355|FG000|Treatment Started|Initial Registration (Induction Therapy)||17
11133474|NCT01412879|12319356|FG001|Treatment Started|Initial Registration (Induction Therapy)||35
11133475|NCT01412879|12319357|FG002|Treatment Started|Initial Registration (Induction Therapy)||0
11133476|NCT01412879|12319355|FG000|COMPLETED|Initial Registration (Induction Therapy)||5
11133477|NCT01412879|12319356|FG001|COMPLETED|Initial Registration (Induction Therapy)||27
11133478|NCT01412879|12319357|FG002|COMPLETED|Initial Registration (Induction Therapy)||0
11133479|NCT01412879|12319355|FG000|NOT COMPLETED|Initial Registration (Induction Therapy)||13
11133480|NCT01412879|12319356|FG001|NOT COMPLETED|Initial Registration (Induction Therapy)||8
11133481|NCT01412879|12319357|FG002|NOT COMPLETED|Initial Registration (Induction Therapy)||0
11133482|NCT01412879|12319355|FG000|STARTED|Consolidation Therapy||0
11133483|NCT01412879|12319356|FG001|STARTED|Consolidation Therapy||0
11133484|NCT01412879|12319357|FG002|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
11133485|NCT01412879|12319355|FG000|COMPLETED|Consolidation Therapy||0
11133486|NCT01412879|12319356|FG001|COMPLETED|Consolidation Therapy||0
11133487|NCT01412879|12319357|FG002|COMPLETED|Consolidation Therapy||26
11133488|NCT01412879|12319355|FG000|NOT COMPLETED|Consolidation Therapy||0
11133489|NCT01412879|12319356|FG001|NOT COMPLETED|Consolidation Therapy||0
11133490|NCT01412879|12319357|FG002|NOT COMPLETED|Consolidation Therapy||0
11133491|NCT01412918|12319369|FG000|STARTED|Overall Study||20
11133492|NCT01412918|12319370|FG001|STARTED|Overall Study||1
11133493|NCT01412918|12319369|FG000|COMPLETED|Overall Study||20
11133494|NCT01412918|12319370|FG001|COMPLETED|Overall Study||1
11133495|NCT01412918|12319369|FG000|NOT COMPLETED|Overall Study||0
11133496|NCT01412918|12319370|FG001|NOT COMPLETED|Overall Study||0
11133497|NCT01412944|12319379|FG000|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
11133498|NCT01412944|12319380|FG001|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
11133499|NCT01412944|12319381|FG002|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
11133500|NCT01412944|12319382|FG003|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
11133501|NCT01412944|12319383|FG004|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
11133502|NCT01412944|12319384|FG005|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
11133503|NCT01412944|12319379|FG000|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
11133504|NCT01412944|12319380|FG001|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
11133505|NCT01412944|12319381|FG002|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
11133506|NCT01412944|12319382|FG003|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
11240478|NCT02090894|12432796|FG000|NOT COMPLETED|Overall Study||0
11240479|NCT02090959|12432800|FG000|STARTED|Overall Study||219
11133507|NCT01412944|12319383|FG004|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
11133508|NCT01412944|12319384|FG005|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
11133509|NCT01412944|12319379|FG000|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
11133510|NCT01412944|12319380|FG001|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
11133511|NCT01412944|12319381|FG002|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
11133512|NCT01412944|12319382|FG003|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
11133513|NCT01412944|12319383|FG004|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
11133514|NCT01412944|12319384|FG005|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
11133515|NCT01412944|12319379|FG000|STARTED|IV: Per CAIN457A2307||21
11133516|NCT01412944|12319380|FG001|STARTED|IV: Per CAIN457A2307||22
11133517|NCT01412944|12319381|FG002|STARTED|IV: Per CAIN457A2307||0
11133518|NCT01412944|12319382|FG003|STARTED|IV: Per CAIN457A2307||0
11133519|NCT01412944|12319383|FG004|STARTED|IV: Per CAIN457A2307||0
11133520|NCT01412944|12319384|FG005|STARTED|IV: Per CAIN457A2307||0
11133521|NCT01412944|12319379|FG000|COMPLETED|IV: Per CAIN457A2307||20
11133522|NCT01412944|12319380|FG001|COMPLETED|IV: Per CAIN457A2307||20
11133523|NCT01412944|12319381|FG002|COMPLETED|IV: Per CAIN457A2307||0
11133524|NCT01412944|12319382|FG003|COMPLETED|IV: Per CAIN457A2307||0
11133525|NCT01412944|12319383|FG004|COMPLETED|IV: Per CAIN457A2307||0
11133526|NCT01412944|12319384|FG005|COMPLETED|IV: Per CAIN457A2307||0
11133527|NCT01412944|12319379|FG000|NOT COMPLETED|IV: Per CAIN457A2307||1
11133528|NCT01412944|12319380|FG001|NOT COMPLETED|IV: Per CAIN457A2307||2
11133529|NCT01412944|12319381|FG002|NOT COMPLETED|IV: Per CAIN457A2307||0
11133530|NCT01412944|12319382|FG003|NOT COMPLETED|IV: Per CAIN457A2307||0
11133531|NCT01412944|12319383|FG004|NOT COMPLETED|IV: Per CAIN457A2307||0
11133532|NCT01412944|12319384|FG005|NOT COMPLETED|IV: Per CAIN457A2307||0
11133533|NCT01412944|12319379|FG000|STARTED|Entire: IV + Maintenance||0
11133534|NCT01412944|12319380|FG001|STARTED|Entire: IV + Maintenance||0
11133535|NCT01412944|12319381|FG002|STARTED|Entire: IV + Maintenance||15
11133536|NCT01412944|12319382|FG003|STARTED|Entire: IV + Maintenance||6
11133537|NCT01412944|12319383|FG004|STARTED|Entire: IV + Maintenance||14
11133538|NCT01412944|12319384|FG005|STARTED|Entire: IV + Maintenance||8
11133539|NCT01412944|12319379|FG000|COMPLETED|Entire: IV + Maintenance||0
11133540|NCT01412944|12319380|FG001|COMPLETED|Entire: IV + Maintenance||0
11133541|NCT01412944|12319381|FG002|COMPLETED|Entire: IV + Maintenance||14
11133542|NCT01412944|12319382|FG003|COMPLETED|Entire: IV + Maintenance||5
11133543|NCT01412944|12319383|FG004|COMPLETED|Entire: IV + Maintenance||11
11133544|NCT01412944|12319384|FG005|COMPLETED|Entire: IV + Maintenance||6
11133545|NCT01412944|12319379|FG000|NOT COMPLETED|Entire: IV + Maintenance||0
11133546|NCT01412944|12319380|FG001|NOT COMPLETED|Entire: IV + Maintenance||0
11133547|NCT01412944|12319381|FG002|NOT COMPLETED|Entire: IV + Maintenance||1
11133548|NCT01412944|12319382|FG003|NOT COMPLETED|Entire: IV + Maintenance||1
11133549|NCT01412944|12319383|FG004|NOT COMPLETED|Entire: IV + Maintenance||3
11133550|NCT01412944|12319384|FG005|NOT COMPLETED|Entire: IV + Maintenance||2
11133551|NCT01412944|12319379|FG000|STARTED|Entire: IV + Maintenance||21
11133552|NCT01412944|12319380|FG001|STARTED|Entire: IV + Maintenance||22
11133553|NCT01412944|12319381|FG002|STARTED|Entire: IV + Maintenance||0
11133554|NCT01412944|12319382|FG003|STARTED|Entire: IV + Maintenance||0
11133555|NCT01412944|12319383|FG004|STARTED|Entire: IV + Maintenance||0
11133556|NCT01412944|12319384|FG005|STARTED|Entire: IV + Maintenance||0
11133557|NCT01412944|12319379|FG000|COMPLETED|Entire: IV + Maintenance||19
11133558|NCT01412944|12319380|FG001|COMPLETED|Entire: IV + Maintenance||17
11133559|NCT01412944|12319381|FG002|COMPLETED|Entire: IV + Maintenance||0
11133560|NCT01412944|12319382|FG003|COMPLETED|Entire: IV + Maintenance||0
11133561|NCT01412944|12319383|FG004|COMPLETED|Entire: IV + Maintenance||0
11133562|NCT01412944|12319384|FG005|COMPLETED|Entire: IV + Maintenance||0
11133563|NCT01412944|12319379|FG000|NOT COMPLETED|Entire: IV + Maintenance||2
11133564|NCT01412944|12319380|FG001|NOT COMPLETED|Entire: IV + Maintenance||5
11133565|NCT01412944|12319381|FG002|NOT COMPLETED|Entire: IV + Maintenance||0
11133566|NCT01412944|12319382|FG003|NOT COMPLETED|Entire: IV + Maintenance||0
11133567|NCT01412944|12319383|FG004|NOT COMPLETED|Entire: IV + Maintenance||0
11133568|NCT01412944|12319384|FG005|NOT COMPLETED|Entire: IV + Maintenance||0
11133569|NCT01412944|12319379|FG000|STARTED|Follow-up||0
11133570|NCT01412944|12319380|FG001|STARTED|Follow-up||0
11133571|NCT01412944|12319381|FG002|STARTED|Follow-up||2
11133572|NCT01412944|12319382|FG003|STARTED|Follow-up||1
11133573|NCT01412944|12319383|FG004|STARTED|Follow-up||2
11133574|NCT01412944|12319384|FG005|STARTED|Follow-up||0
11133575|NCT01412944|12319379|FG000|COMPLETED|Follow-up||0
11133576|NCT01412944|12319380|FG001|COMPLETED|Follow-up||0
11133577|NCT01412944|12319381|FG002|COMPLETED|Follow-up||2
11133578|NCT01412944|12319382|FG003|COMPLETED|Follow-up||1
11133579|NCT01412944|12319383|FG004|COMPLETED|Follow-up||2
11133580|NCT01412944|12319384|FG005|COMPLETED|Follow-up||0
11133581|NCT01412944|12319379|FG000|NOT COMPLETED|Follow-up||0
11133582|NCT01412944|12319380|FG001|NOT COMPLETED|Follow-up||0
11133583|NCT01412944|12319381|FG002|NOT COMPLETED|Follow-up||0
11133584|NCT01412944|12319382|FG003|NOT COMPLETED|Follow-up||0
11133585|NCT01412944|12319383|FG004|NOT COMPLETED|Follow-up||0
11133586|NCT01412944|12319384|FG005|NOT COMPLETED|Follow-up||0
11133587|NCT01412957|12319402|FG000|STARTED|Overall Study||189
11133588|NCT01412957|12319403|FG001|STARTED|Overall Study||188
11133589|NCT01412957|12319402|FG000|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
11133590|NCT01412957|12319403|FG001|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
11133591|NCT01412957|12319402|FG000|NOT COMPLETED|Overall Study||149
11133592|NCT01412957|12319403|FG001|NOT COMPLETED|Overall Study||157
11133593|NCT01412983|12319409|FG000|STARTED|1st Period||50
11133594|NCT01412983|12319410|FG001|STARTED|1st Period||50
11133595|NCT01412983|12319409|FG000|COMPLETED|1st Period||50
11133596|NCT01412983|12319410|FG001|COMPLETED|1st Period||46
11133597|NCT01412983|12319409|FG000|NOT COMPLETED|1st Period||0
11133598|NCT01412983|12319410|FG001|NOT COMPLETED|1st Period||4
11133599|NCT01412983|12319409|FG000|STARTED|2nd Period||50
11133600|NCT01412983|12319410|FG001|STARTED|2nd Period||46
11133601|NCT01412983|12319409|FG000|COMPLETED|2nd Period||50
11133602|NCT01412983|12319410|FG001|COMPLETED|2nd Period||46
11133603|NCT01412983|12319409|FG000|NOT COMPLETED|2nd Period||0
11133604|NCT01412983|12319410|FG001|NOT COMPLETED|2nd Period||0
11133605|NCT01413087|12319419|FG000|STARTED|Overall Study||6
11133606|NCT01413087|12319420|FG001|STARTED|Overall Study||6
11133607|NCT01413087|12319419|FG000|COMPLETED|Overall Study||6
11133608|NCT01413087|12319420|FG001|COMPLETED|Overall Study||6
11133609|NCT01413087|12319419|FG000|NOT COMPLETED|Overall Study||0
11133610|NCT01413087|12319420|FG001|NOT COMPLETED|Overall Study||0
11133611|NCT01413178|12319428|FG000|STARTED|Overall Study||105
11133612|NCT01413178|12319429|FG001|STARTED|Overall Study||100
11133613|NCT01413178|12319428|FG000|COMPLETED|Overall Study||104
11133614|NCT01413178|12319429|FG001|COMPLETED|Overall Study||98
11133615|NCT01413178|12319428|FG000|NOT COMPLETED|Overall Study||1
11133616|NCT01413178|12319429|FG001|NOT COMPLETED|Overall Study||2
11133617|NCT01413191|12319435|FG000|STARTED|Overall Study||18
11133618|NCT01413191|12319435|FG000|COMPLETED|Overall Study||7
11133619|NCT01413191|12319435|FG000|NOT COMPLETED|Overall Study||11
11133620|NCT01413204|12319442|FG000|STARTED|Overall Study||90
11133621|NCT01413204|12319443|FG001|STARTED|Overall Study||89
11133622|NCT01413204|12319444|FG002|STARTED|Overall Study||93
11133623|NCT01413204|12319442|FG000|COMPLETED|Overall Study||84
11133624|NCT01413204|12319443|FG001|COMPLETED|Overall Study||83
11133625|NCT01413204|12319444|FG002|COMPLETED|Overall Study||74
11133626|NCT01413204|12319442|FG000|NOT COMPLETED|Overall Study||6
11133627|NCT01413204|12319443|FG001|NOT COMPLETED|Overall Study||6
11133628|NCT01413204|12319444|FG002|NOT COMPLETED|Overall Study||19
11133629|NCT01413360|12319452|FG000|STARTED|Overall Study||10
11133630|NCT01413360|12319452|FG000|COMPLETED|Overall Study||7
11133631|NCT01413360|12319452|FG000|NOT COMPLETED|Overall Study||3
11133632|NCT01413503|12319456|FG000|STARTED|Overall Study||50
11133633|NCT01413503|12319456|FG000|COMPLETED|Overall Study||49
11133634|NCT01413503|12319456|FG000|NOT COMPLETED|Overall Study||1
11133635|NCT01413516|12319462|FG000|STARTED|Overall Study||8
11133636|NCT01413516|12319463|FG001|STARTED|Overall Study||9
11240480|NCT02090959|12432800|FG000|As-treated Population|Overall Study||218
11240481|NCT02090959|12432800|FG000|COMPLETED|Overall Study||68
11240482|NCT02090959|12432800|FG000|NOT COMPLETED|Overall Study||151
11240483|NCT02091089|12432804|FG000|STARTED|Overall Study||20
11240484|NCT02091089|12432804|FG000|COMPLETED|Overall Study||18
11240485|NCT02091089|12432804|FG000|NOT COMPLETED|Overall Study||2
11240486|NCT02091102|12432808|FG000|STARTED|Overall Study||20
11240487|NCT02091102|12432808|FG000|COMPLETED|Overall Study||20
11133637|NCT01413516|12319462|FG000|COMPLETED|Overall Study||8
11133638|NCT01413516|12319463|FG001|COMPLETED|Overall Study||9
11133639|NCT01413516|12319462|FG000|NOT COMPLETED|Overall Study||0
11133640|NCT01413516|12319463|FG001|NOT COMPLETED|Overall Study||0
11133641|NCT01413542|12319471|FG000|STARTED|Overall Study||6
11133642|NCT01413542|12319472|FG001|STARTED|Overall Study||6
11133643|NCT01413542|12319473|FG002|STARTED|Overall Study||9
11133644|NCT01413542|12319474|FG003|STARTED|Overall Study||8
11133645|NCT01413542|12319471|FG000|COMPLETED|Overall Study||5
11133646|NCT01413542|12319472|FG001|COMPLETED|Overall Study||6
11133647|NCT01413542|12319473|FG002|COMPLETED|Overall Study||6
11133648|NCT01413542|12319474|FG003|COMPLETED|Overall Study||7
11133649|NCT01413542|12319471|FG000|NOT COMPLETED|Overall Study||1
11133650|NCT01413542|12319472|FG001|NOT COMPLETED|Overall Study||0
11133651|NCT01413542|12319473|FG002|NOT COMPLETED|Overall Study||3
11133652|NCT01413542|12319474|FG003|NOT COMPLETED|Overall Study||1
11133653|NCT01413750|12319490|FG000|STARTED|Overall Study||6
11133654|NCT01413750|12319491|FG001|STARTED|Overall Study||6
11133655|NCT01413750|12319492|FG002|STARTED|Overall Study||4
11133656|NCT01413750|12319493|FG003|STARTED|Overall Study||7
11133657|NCT01413750|12319490|FG000|COMPLETED|Overall Study||6
11133658|NCT01413750|12319491|FG001|COMPLETED|Overall Study||6
11240488|NCT02091102|12432808|FG000|NOT COMPLETED|Overall Study||0
11240489|NCT02091167|12432814|FG000|STARTED|Overall Study||19
11240490|NCT02091167|12432815|FG001|STARTED|Overall Study||16
11240491|NCT02091167|12432814|FG000|COMPLETED|Overall Study||19
11240492|NCT02091167|12432815|FG001|COMPLETED|Overall Study||14
11240493|NCT02091167|12432814|FG000|NOT COMPLETED|Overall Study||0
11133659|NCT01413750|12319492|FG002|COMPLETED|Overall Study||4
11133660|NCT01413750|12319493|FG003|COMPLETED|Overall Study||7
11240494|NCT02091167|12432815|FG001|NOT COMPLETED|Overall Study||2
11240495|NCT02091284|12432823|FG000|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26
11240496|NCT02091284|12432824|FG001|STARTED|Overall Study|One subject from this group discontinued the protocol|23
11240497|NCT02091284|12432823|FG000|COMPLETED|Overall Study||23
11240498|NCT02091284|12432824|FG001|COMPLETED|Overall Study||22
11240499|NCT02091284|12432823|FG000|NOT COMPLETED|Overall Study||3
11240500|NCT02091284|12432824|FG001|NOT COMPLETED|Overall Study||1
11240501|NCT02091362|12432834|FG000|STARTED|Period 1||133
11240502|NCT02091362|12432835|FG001|STARTED|Period 1||137
11240503|NCT02091362|12432834|FG000|COMPLETED|Period 1||128
11240504|NCT02091362|12432835|FG001|COMPLETED|Period 1||133
11240505|NCT02091362|12432834|FG000|NOT COMPLETED|Period 1||5
11240506|NCT02091362|12432835|FG001|NOT COMPLETED|Period 1||4
11240507|NCT02091362|12432834|FG000|STARTED|Wash-out||128
11240508|NCT02091362|12432835|FG001|STARTED|Wash-out||133
11240509|NCT02091362|12432834|FG000|COMPLETED|Wash-out||127
11240510|NCT02091362|12432835|FG001|COMPLETED|Wash-out||130
11240511|NCT02091362|12432834|FG000|NOT COMPLETED|Wash-out||1
11240512|NCT02091362|12432835|FG001|NOT COMPLETED|Wash-out||3
11240513|NCT02091362|12432834|FG000|STARTED|Period 2||127
11240514|NCT02091362|12432835|FG001|STARTED|Period 2||130
11240515|NCT02091362|12432834|FG000|COMPLETED|Period 2||125
11240516|NCT02091362|12432835|FG001|COMPLETED|Period 2||128
11240517|NCT02091362|12432834|FG000|NOT COMPLETED|Period 2||2
11240518|NCT02091362|12432835|FG001|NOT COMPLETED|Period 2||2
11240519|NCT02091414|12432845|FG000|STARTED|Overall Study||36
11240520|NCT02091414|12432845|FG000|COMPLETED|Overall Study||32
11240521|NCT02091414|12432845|FG000|NOT COMPLETED|Overall Study||4
11240522|NCT02091440|12432849|FG000|STARTED|Overall Study||6
11240523|NCT02091440|12432849|FG000|Primary Endpoint (Success at 180 Days)|Overall Study||6
11240524|NCT02091440|12432849|FG000|Overall Survival at 180 Days|Overall Study||6
11240525|NCT02091440|12432849|FG000|COMPLETED|Overall Study||4
11240526|NCT02091440|12432849|FG000|NOT COMPLETED|Overall Study||2
11240527|NCT02091466|12432855|FG000|STARTED|Overall Study||20
11240528|NCT02091466|12432856|FG001|STARTED|Overall Study||20
11240529|NCT02091466|12432855|FG000|COMPLETED|Overall Study||20
11240530|NCT02091466|12432856|FG001|COMPLETED|Overall Study||20
11240531|NCT02091466|12432855|FG000|NOT COMPLETED|Overall Study||0
11240532|NCT02091466|12432856|FG001|NOT COMPLETED|Overall Study||0
11240533|NCT02091531|12432862|FG000|STARTED|Overall Study||9
11240534|NCT02091531|12432862|FG000|COMPLETED|Overall Study||9
11240535|NCT02091531|12432862|FG000|NOT COMPLETED|Overall Study||0
11338994|NCT02907619|12536361|FG000|NOT COMPLETED|Overall Study||19
11338995|NCT02907619|12536362|FG001|NOT COMPLETED|Overall Study||20
11338996|NCT02907619|12536363|FG002|NOT COMPLETED|Overall Study||20
11338997|NCT02907814|12536375|FG000|STARTED|Overall Study||6
11338998|NCT02907814|12536376|FG001|STARTED|Overall Study||0
11133661|NCT01413750|12319490|FG000|NOT COMPLETED|Overall Study||0
11133662|NCT01413750|12319491|FG001|NOT COMPLETED|Overall Study||0
11133663|NCT01413750|12319492|FG002|NOT COMPLETED|Overall Study||0
11133664|NCT01413750|12319493|FG003|NOT COMPLETED|Overall Study||0
11133665|NCT01413958|12319506|FG000|STARTED|Overall Study||288
11133666|NCT01413958|12319507|FG001|STARTED|Overall Study||287
11133667|NCT01413958|12319506|FG000|COMPLETED|Overall Study||288
11133668|NCT01413958|12319507|FG001|COMPLETED|Overall Study||286
11133669|NCT01413958|12319506|FG000|NOT COMPLETED|Overall Study||0
11133670|NCT01413958|12319507|FG001|NOT COMPLETED|Overall Study||1
11133671|NCT01414010|12319518|FG000|STARTED|Overall Study||8
11133672|NCT01414010|12319519|FG001|STARTED|Overall Study||8
11133673|NCT01414010|12319520|FG002|STARTED|Overall Study||8
11133674|NCT01414010|12319521|FG003|STARTED|Overall Study||8
11133675|NCT01414010|12319518|FG000|COMPLETED|Overall Study||6
11133676|NCT01414010|12319519|FG001|COMPLETED|Overall Study||8
11133677|NCT01414010|12319520|FG002|COMPLETED|Overall Study||8
11133678|NCT01414010|12319521|FG003|COMPLETED|Overall Study||8
11133679|NCT01414010|12319518|FG000|NOT COMPLETED|Overall Study||2
11133680|NCT01414010|12319519|FG001|NOT COMPLETED|Overall Study||0
11133681|NCT01414010|12319520|FG002|NOT COMPLETED|Overall Study||0
11133682|NCT01414010|12319521|FG003|NOT COMPLETED|Overall Study||0
11133683|NCT01414036|12319539|FG000|STARTED|Received Allocated Intervention||23
11133684|NCT01414036|12319540|FG001|STARTED|Received Allocated Intervention||24
11133685|NCT01414036|12319539|FG000|COMPLETED|Received Allocated Intervention||23
11133686|NCT01414036|12319540|FG001|COMPLETED|Received Allocated Intervention||11
11133687|NCT01414036|12319539|FG000|NOT COMPLETED|Received Allocated Intervention||0
11133688|NCT01414036|12319540|FG001|NOT COMPLETED|Received Allocated Intervention||13
11133689|NCT01414036|12319539|FG000|STARTED|Completed 3 Month Survey||23
11133690|NCT01414036|12319540|FG001|STARTED|Completed 3 Month Survey||24
11133691|NCT01414036|12319539|FG000|COMPLETED|Completed 3 Month Survey||14
11133692|NCT01414036|12319540|FG001|COMPLETED|Completed 3 Month Survey||19
11133693|NCT01414036|12319539|FG000|NOT COMPLETED|Completed 3 Month Survey||9
11133694|NCT01414036|12319540|FG001|NOT COMPLETED|Completed 3 Month Survey||5
11133695|NCT01414075|12319550|FG000|STARTED|Overall Study||24
11133696|NCT01414075|12319551|FG001|STARTED|Overall Study||12
11133697|NCT01414075|12319552|FG002|STARTED|Overall Study||12
11133698|NCT01414075|12319553|FG003|STARTED|Overall Study||12
11133699|NCT01414075|12319550|FG000|Efficacy Evaluable (EE) Population|Overall Study||23
11133700|NCT01414075|12319551|FG001|Efficacy Evaluable (EE) Population|Overall Study||12
11133701|NCT01414075|12319552|FG002|Efficacy Evaluable (EE) Population|Overall Study||10
11133702|NCT01414075|12319553|FG003|Efficacy Evaluable (EE) Population|Overall Study||10
11133703|NCT01414075|12319550|FG000|COMPLETED|Overall Study||21
11133704|NCT01414075|12319551|FG001|COMPLETED|Overall Study||12
11133705|NCT01414075|12319552|FG002|COMPLETED|Overall Study||10
11133706|NCT01414075|12319553|FG003|COMPLETED|Overall Study||10
11133707|NCT01414075|12319550|FG000|NOT COMPLETED|Overall Study||3
11133708|NCT01414075|12319551|FG001|NOT COMPLETED|Overall Study||0
11133709|NCT01414075|12319552|FG002|NOT COMPLETED|Overall Study||2
11133710|NCT01414075|12319553|FG003|NOT COMPLETED|Overall Study||2
11133711|NCT01414114|12319563|FG000|STARTED|Overall Study||37
11133712|NCT01414114|12319563|FG000|COMPLETED|Overall Study|Completed 12-week treatment period|32
11133713|NCT01414114|12319563|FG000|NOT COMPLETED|Overall Study||5
11133714|NCT01414153|12319573|FG000|STARTED|Overall Study||38
11133715|NCT01414153|12319574|FG001|STARTED|Overall Study||40
11133716|NCT01414153|12319575|FG002|STARTED|Overall Study||39
11133717|NCT01414153|12319576|FG003|STARTED|Overall Study||41
11133718|NCT01414153|12319573|FG000|COMPLETED|Overall Study||30
11133719|NCT01414153|12319574|FG001|COMPLETED|Overall Study||38
11133720|NCT01414153|12319575|FG002|COMPLETED|Overall Study||35
11133721|NCT01414153|12319576|FG003|COMPLETED|Overall Study||37
11133722|NCT01414153|12319573|FG000|NOT COMPLETED|Overall Study||8
11133723|NCT01414153|12319574|FG001|NOT COMPLETED|Overall Study||2
11133724|NCT01414153|12319575|FG002|NOT COMPLETED|Overall Study||4
11133725|NCT01414153|12319576|FG003|NOT COMPLETED|Overall Study||4
11133726|NCT01414205|12319588|FG000|STARTED|Overall Study||41
11133727|NCT01414205|12319589|FG001|STARTED|Overall Study||39
11133728|NCT01414205|12319588|FG000|Received Study Drug|Overall Study||40
11133729|NCT01414205|12319589|FG001|Received Study Drug|Overall Study||38
11133730|NCT01414205|12319588|FG000|COMPLETED|Overall Study||34
11133731|NCT01414205|12319589|FG001|COMPLETED|Overall Study||32
11133732|NCT01414205|12319588|FG000|NOT COMPLETED|Overall Study||7
11133733|NCT01414205|12319589|FG001|NOT COMPLETED|Overall Study||7
11133734|NCT01414244|12319597|FG000|STARTED|Overall Study||54
11133735|NCT01414244|12319598|FG001|STARTED|Overall Study||52
11133736|NCT01414244|12319597|FG000|COMPLETED|Overall Study||54
11133737|NCT01414244|12319598|FG001|COMPLETED|Overall Study||52
11133738|NCT01414244|12319597|FG000|NOT COMPLETED|Overall Study||0
11133739|NCT01414244|12319598|FG001|NOT COMPLETED|Overall Study||0
11133740|NCT01414257|12319604|FG000|STARTED|Overall Study||2860
11133741|NCT01414257|12319604|FG000|COMPLETED|Overall Study||2838
11133742|NCT01414257|12319604|FG000|NOT COMPLETED|Overall Study||22
11133743|NCT01414413|12319610|FG000|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
11133744|NCT01414413|12319611|FG001|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
11133745|NCT01414413|12319610|FG000|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
11133746|NCT01414413|12319611|FG001|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
11133747|NCT01414413|12319610|FG000|NOT COMPLETED|Overall Study||0
11133748|NCT01414413|12319611|FG001|NOT COMPLETED|Overall Study||0
11133749|NCT01414426|12319619|FG000|STARTED|Overall Study||10
11133750|NCT01414426|12319620|FG001|STARTED|Overall Study||10
11133751|NCT01414426|12319619|FG000|COMPLETED|Overall Study||9
11005174|NCT00721409|12182861|FG001|COMPLETED|Overall Study||2
11005175|NCT00721409|12182862|FG002|COMPLETED|Overall Study||2
11005176|NCT00721409|12182860|FG000|NOT COMPLETED|Overall Study||12
11005177|NCT00721409|12182861|FG001|NOT COMPLETED|Overall Study||82
11005178|NCT00721409|12182862|FG002|NOT COMPLETED|Overall Study||79
11133752|NCT01414426|12319620|FG001|COMPLETED|Overall Study||8
11133753|NCT01414426|12319619|FG000|NOT COMPLETED|Overall Study||1
11133754|NCT01414426|12319620|FG001|NOT COMPLETED|Overall Study||2
11133755|NCT01414634|12319626|FG000|STARTED|Overall Study||1
11133756|NCT01414634|12319627|FG001|STARTED|Overall Study||1
11133757|NCT01414634|12319628|FG002|STARTED|Overall Study||1
11133758|NCT01414634|12319629|FG003|STARTED|Overall Study||1
11133759|NCT01414634|12319630|FG004|STARTED|Overall Study||1
11005179|NCT00721500|12182886|FG000|STARTED|Period One||6
11005180|NCT00721500|12182887|FG001|STARTED|Period One||7
11133760|NCT01414634|12319631|FG005|STARTED|Overall Study||2
11133761|NCT01414634|12319632|FG006|STARTED|Overall Study||1
11133762|NCT01414634|12319633|FG007|STARTED|Overall Study||1
11133763|NCT01414634|12319626|FG000|COMPLETED|Overall Study||1
11133764|NCT01414634|12319627|FG001|COMPLETED|Overall Study||1
11133765|NCT01414634|12319628|FG002|COMPLETED|Overall Study||1
11133766|NCT01414634|12319629|FG003|COMPLETED|Overall Study||1
11133767|NCT01414634|12319630|FG004|COMPLETED|Overall Study||1
11133768|NCT01414634|12319631|FG005|COMPLETED|Overall Study||2
11133769|NCT01414634|12319632|FG006|COMPLETED|Overall Study||1
11133770|NCT01414634|12319633|FG007|COMPLETED|Overall Study||1
11133771|NCT01414634|12319626|FG000|NOT COMPLETED|Overall Study||0
11133772|NCT01414634|12319627|FG001|NOT COMPLETED|Overall Study||0
11133773|NCT01414634|12319628|FG002|NOT COMPLETED|Overall Study||0
11133774|NCT01414634|12319629|FG003|NOT COMPLETED|Overall Study||0
11133775|NCT01414634|12319630|FG004|NOT COMPLETED|Overall Study||0
11133776|NCT01414634|12319631|FG005|NOT COMPLETED|Overall Study||0
11133777|NCT01414634|12319632|FG006|NOT COMPLETED|Overall Study||0
11133778|NCT01414634|12319633|FG007|NOT COMPLETED|Overall Study||0
11133779|NCT01414738|12319644|FG000|STARTED|Overall Study||49
11133780|NCT01414738|12319644|FG000|Follow-up (3 Months)|Overall Study||18
11133781|NCT01414738|12319644|FG000|Follow-up (6 Months)|Overall Study||8
11133782|NCT01414738|12319644|FG000|Follow-up (9 Months)|Overall Study||5
11133783|NCT01414738|12319644|FG000|COMPLETED|Overall Study||5
11133784|NCT01414738|12319644|FG000|NOT COMPLETED|Overall Study||44
11202256|NCT01838681|12392648|FG003|NOT COMPLETED|Period B/A+||117
11202257|NCT01838694|12392656|FG000|STARTED|Overall Study||8
11202258|NCT01838694|12392657|FG001|STARTED|Overall Study||22
11202259|NCT01838694|12392656|FG000|COMPLETED|Overall Study||8
11202260|NCT01838694|12392657|FG001|COMPLETED|Overall Study||21
11202261|NCT01838694|12392656|FG000|NOT COMPLETED|Overall Study||0
11202262|NCT01838694|12392657|FG001|NOT COMPLETED|Overall Study||1
11202263|NCT01838785|12392666|FG000|STARTED|Overall Study||25
11202264|NCT01838785|12392666|FG000|COMPLETED|Overall Study||25
11202265|NCT01838785|12392666|FG000|NOT COMPLETED|Overall Study||0
11202266|NCT01838863|12392672|FG000|STARTED|Overall Study||75
11202267|NCT01838863|12392673|FG001|STARTED|Overall Study||69
11202268|NCT01838863|12392672|FG000|COMPLETED|Overall Study||65
11202269|NCT01838863|12392673|FG001|COMPLETED|Overall Study||60
11202270|NCT01838863|12392672|FG000|NOT COMPLETED|Overall Study||10
11202271|NCT01838863|12392673|FG001|NOT COMPLETED|Overall Study||9
11202272|NCT01838876|12392679|FG000|STARTED|Overall Study||442
11202273|NCT01838876|12392679|FG000|Safety Population; Received Study Drug|Overall Study||345
11202274|NCT01838876|12392679|FG000|Entered Safety Follow-up Period|Overall Study||287
11202275|NCT01838876|12392679|FG000|COMPLETED|Overall Study||209
11202276|NCT01838876|12392679|FG000|NOT COMPLETED|Overall Study||233
11202277|NCT01838941|12392685|FG000|STARTED|Overall Study||12
11240536|NCT02091726|12432866|FG000|STARTED|Overall Study||110
11240537|NCT02091726|12432866|FG000|1 Week Followup|Overall Study||110
11240538|NCT02091726|12432866|FG000|4 Week Followup|Overall Study||104
11240539|NCT02091726|12432866|FG000|COMPLETED|Overall Study||104
11240540|NCT02091726|12432866|FG000|NOT COMPLETED|Overall Study||6
11240541|NCT02091739|12432873|FG000|STARTED|MP: 16 Weeks||36
11005181|NCT00721500|12182888|FG002|STARTED|Period One||6
11005182|NCT00721500|12182889|FG003|STARTED|Period One||6
11005183|NCT00721500|12182886|FG000|COMPLETED|Period One||6
11202278|NCT01838941|12392685|FG000|COMPLETED|Overall Study||10
11202279|NCT01838941|12392685|FG000|NOT COMPLETED|Overall Study||2
11202280|NCT01838980|12392690|FG000|STARTED|Overall Study||15
11202281|NCT01838980|12392690|FG000|COMPLETED|Overall Study||15
11202282|NCT01838980|12392690|FG000|NOT COMPLETED|Overall Study||0
11202283|NCT01839058|12392696|FG000|STARTED|Overall Study||21
11202284|NCT01839058|12392697|FG001|STARTED|Overall Study||19
11202285|NCT01839058|12392696|FG000|COMPLETED|Overall Study||17
11202286|NCT01839058|12392697|FG001|COMPLETED|Overall Study||16
11202287|NCT01839058|12392696|FG000|NOT COMPLETED|Overall Study||4
11202288|NCT01839058|12392697|FG001|NOT COMPLETED|Overall Study||3
11202289|NCT01839110|12392706|FG000|STARTED|Overall Study||7
11202290|NCT01839110|12392707|FG001|STARTED|Overall Study||6
11240542|NCT02091739|12432874|FG001|STARTED|MP: 16 Weeks||74
11202291|NCT01839110|12392708|FG002|STARTED|Overall Study||9
11202292|NCT01839110|12392706|FG000|COMPLETED|Overall Study||4
11202293|NCT01839110|12392707|FG001|COMPLETED|Overall Study||4
11202294|NCT01839110|12392708|FG002|COMPLETED|Overall Study||6
11202295|NCT01839110|12392706|FG000|NOT COMPLETED|Overall Study||3
11202296|NCT01839110|12392707|FG001|NOT COMPLETED|Overall Study||2
11202297|NCT01839110|12392708|FG002|NOT COMPLETED|Overall Study||3
11202298|NCT01839188|12392716|FG000|STARTED|Overall Study||385
11202299|NCT01839188|12392716|FG000|Treated|Overall Study||385
11202300|NCT01839188|12392716|FG000|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384
11202301|NCT01839188|12392716|FG000|NOT COMPLETED|Overall Study||1
11202302|NCT01839279|12392728|FG000|STARTED|Overall Study||72
11202303|NCT01839279|12392729|FG001|STARTED|Overall Study||32
11202304|NCT01839279|12392730|FG002|STARTED|Overall Study||32
11202305|NCT01839279|12392728|FG000|QT/QTc Analysis Set|Overall Study||72
11202306|NCT01839279|12392729|FG001|QT/QTc Analysis Set|Overall Study||32
11202307|NCT01839279|12392730|FG002|QT/QTc Analysis Set|Overall Study||32
11202308|NCT01839279|12392728|FG000|PK Analysis Set|Overall Study||70
11202309|NCT01839279|12392729|FG001|PK Analysis Set|Overall Study||0
11202310|NCT01839279|12392730|FG002|PK Analysis Set|Overall Study||0
11202311|NCT01839279|12392728|FG000|Moxifloxacin/Placebo Analysis Set|Overall Study||0
11202312|NCT01839279|12392729|FG001|Moxifloxacin/Placebo Analysis Set|Overall Study||31
11202313|NCT01839279|12392730|FG002|Moxifloxacin/Placebo Analysis Set|Overall Study||30
11202314|NCT01839279|12392728|FG000|PK/QTc Analysis Set|Overall Study||70
11202315|NCT01839279|12392729|FG001|PK/QTc Analysis Set|Overall Study||0
11202316|NCT01839279|12392730|FG002|PK/QTc Analysis Set|Overall Study||0
11202317|NCT01839279|12392728|FG000|COMPLETED|Overall Study||59
11202318|NCT01839279|12392729|FG001|COMPLETED|Overall Study||30
11202319|NCT01839279|12392730|FG002|COMPLETED|Overall Study||30
11202320|NCT01839279|12392728|FG000|NOT COMPLETED|Overall Study||13
11202321|NCT01839279|12392729|FG001|NOT COMPLETED|Overall Study||2
11202322|NCT01839279|12392730|FG002|NOT COMPLETED|Overall Study||2
11202323|NCT01839318|12392745|FG000|STARTED|Period 1, First Day of Wear||4
11202324|NCT01839318|12392746|FG001|STARTED|Period 1, First Day of Wear||4
11202325|NCT01839318|12392747|FG002|STARTED|Period 1, First Day of Wear||5
11202326|NCT01839318|12392748|FG003|STARTED|Period 1, First Day of Wear||6
11202327|NCT01839318|12392749|FG004|STARTED|Period 1, First Day of Wear||7
11202328|NCT01839318|12392750|FG005|STARTED|Period 1, First Day of Wear||2
11202329|NCT01839318|12392745|FG000|COMPLETED|Period 1, First Day of Wear||4
11202330|NCT01839318|12392746|FG001|COMPLETED|Period 1, First Day of Wear||4
11202331|NCT01839318|12392747|FG002|COMPLETED|Period 1, First Day of Wear||5
11202332|NCT01839318|12392748|FG003|COMPLETED|Period 1, First Day of Wear||6
11240543|NCT02091739|12432875|FG002|STARTED|MP: 16 Weeks||74
11005184|NCT00721500|12182887|FG001|COMPLETED|Period One||7
11133785|NCT01414855|12319648|FG000|STARTED|Overall Study||100
11133786|NCT01414855|12319648|FG000|COMPLETED|Overall Study||71
11133787|NCT01414855|12319648|FG000|NOT COMPLETED|Overall Study||29
11133788|NCT01415232|12319652|FG000|STARTED|Overall Study||160
11133789|NCT01415232|12319652|FG000|COMPLETED|Overall Study||160
11133790|NCT01415232|12319652|FG000|NOT COMPLETED|Overall Study||0
11133791|NCT01415349|12319656|FG000|STARTED|Treatment Period 1||21
11133792|NCT01415349|12319657|FG001|STARTED|Treatment Period 1||21
11133793|NCT01415349|12319656|FG000|COMPLETED|Treatment Period 1||21
11133794|NCT01415349|12319657|FG001|COMPLETED|Treatment Period 1||19
11133795|NCT01415349|12319656|FG000|NOT COMPLETED|Treatment Period 1||0
11133796|NCT01415349|12319657|FG001|NOT COMPLETED|Treatment Period 1||2
11133797|NCT01415349|12319656|FG000|STARTED|Treatment Period 2||21
11133798|NCT01415349|12319657|FG001|STARTED|Treatment Period 2||19
11133799|NCT01415349|12319656|FG000|COMPLETED|Treatment Period 2||21
11133800|NCT01415349|12319657|FG001|COMPLETED|Treatment Period 2||19
11133801|NCT01415349|12319656|FG000|NOT COMPLETED|Treatment Period 2||0
11133802|NCT01415349|12319657|FG001|NOT COMPLETED|Treatment Period 2||0
11133803|NCT01415401|12319663|FG000|STARTED|Overall Study||54
11133804|NCT01415401|12319663|FG000|COMPLETED|Overall Study||47
11133805|NCT01415401|12319663|FG000|NOT COMPLETED|Overall Study||7
11133806|NCT01415427|12319671|FG000|STARTED|Overall Study||29
11133807|NCT01415427|12319672|FG001|STARTED|Overall Study||29
11133808|NCT01415427|12319673|FG002|STARTED|Overall Study||59
11133809|NCT01415427|12319674|FG003|STARTED|Overall Study||56
11133810|NCT01415427|12319671|FG000|COMPLETED|Overall Study||0
11133811|NCT01415427|12319672|FG001|COMPLETED|Overall Study||0
11133812|NCT01415427|12319673|FG002|COMPLETED|Overall Study||1
11133813|NCT01415427|12319674|FG003|COMPLETED|Overall Study||0
11133814|NCT01415427|12319671|FG000|NOT COMPLETED|Overall Study||29
11133815|NCT01415427|12319672|FG001|NOT COMPLETED|Overall Study||29
11133816|NCT01415427|12319673|FG002|NOT COMPLETED|Overall Study||58
11133817|NCT01415427|12319674|FG003|NOT COMPLETED|Overall Study||56
11133818|NCT01415453|12319686|FG000|STARTED|Overall Study||1
11133819|NCT01415453|12319686|FG000|Imaging Study|Overall Study||1
11133820|NCT01415453|12319686|FG000|COMPLETED|Overall Study||1
11133821|NCT01415453|12319686|FG000|NOT COMPLETED|Overall Study||0
11133822|NCT01415518|12319692|FG000|STARTED|Overall Study||292
11133823|NCT01415518|12319693|FG001|STARTED|Overall Study||292
11133824|NCT01415518|12319692|FG000|Patients Who Received Study Treatment|Overall Study||290
11133825|NCT01415518|12319693|FG001|Patients Who Received Study Treatment|Overall Study||292
11133826|NCT01415518|12319692|FG000|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
11133827|NCT01415518|12319693|FG001|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
11133828|NCT01415518|12319692|FG000|COMPLETED|Overall Study||276
11133829|NCT01415518|12319693|FG001|COMPLETED|Overall Study||261
11133830|NCT01415518|12319692|FG000|NOT COMPLETED|Overall Study||16
11133831|NCT01415518|12319693|FG001|NOT COMPLETED|Overall Study||31
11133832|NCT01415531|12319701|FG000|STARTED|Overall Study||214
11133833|NCT01415531|12319702|FG001|STARTED|Overall Study||427
11133834|NCT01415531|12319701|FG000|COMPLETED|Overall Study||189
11133835|NCT01415531|12319702|FG001|COMPLETED|Overall Study||390
11133836|NCT01415531|12319701|FG000|NOT COMPLETED|Overall Study||25
11133837|NCT01415531|12319702|FG001|NOT COMPLETED|Overall Study||37
11133838|NCT01415583|12319710|FG000|STARTED|Overall Study||157
11133839|NCT01415583|12319711|FG001|STARTED|Overall Study||157
11133840|NCT01415583|12319710|FG000|COMPLETED|Overall Study||157
11133841|NCT01415583|12319711|FG001|COMPLETED|Overall Study||157
11133842|NCT01415583|12319710|FG000|NOT COMPLETED|Overall Study||0
11133843|NCT01415583|12319711|FG001|NOT COMPLETED|Overall Study||0
11133844|NCT01415908|12319719|FG000|STARTED|Overall Study||11
11133845|NCT01415908|12319720|FG001|STARTED|Overall Study||4
11133846|NCT01415908|12319719|FG000|COMPLETED|Overall Study||10
11133847|NCT01415908|12319720|FG001|COMPLETED|Overall Study||4
11133848|NCT01415908|12319719|FG000|NOT COMPLETED|Overall Study||1
11133849|NCT01415908|12319720|FG001|NOT COMPLETED|Overall Study||0
11133850|NCT01415921|12319728|FG000|STARTED|Overall Study||16
11133851|NCT01415921|12319729|FG001|STARTED|Overall Study||17
11133852|NCT01415921|12319728|FG000|COMPLETED|Overall Study||13
11133853|NCT01415921|12319729|FG001|COMPLETED|Overall Study||14
11133854|NCT01415921|12319728|FG000|NOT COMPLETED|Overall Study||3
11133855|NCT01415921|12319729|FG001|NOT COMPLETED|Overall Study||3
11133856|NCT01415934|12319737|FG000|STARTED|Overall Study||192
11133857|NCT01415934|12319738|FG001|STARTED|Overall Study||189
11133858|NCT01415934|12319737|FG000|COMPLETED|Overall Study||189
11133859|NCT01415934|12319738|FG001|COMPLETED|Overall Study||182
11133860|NCT01415934|12319737|FG000|NOT COMPLETED|Overall Study||3
11133861|NCT01415934|12319738|FG001|NOT COMPLETED|Overall Study||7
11133862|NCT01415960|12319744|FG000|STARTED|Overall Study||163
11133863|NCT01415960|12319744|FG000|ITT|Overall Study||161
11133864|NCT01415960|12319744|FG000|PK Subgroup|Overall Study||30
11133865|NCT01415960|12319744|FG000|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
11133866|NCT01415960|12319744|FG000|NOT COMPLETED|Overall Study||12
11133867|NCT01416025|12319750|FG000|STARTED|Overall Study||14
11133868|NCT01416025|12319751|FG001|STARTED|Overall Study||15
11240544|NCT02091739|12432876|FG003|STARTED|MP: 16 Weeks||0
11240545|NCT02091739|12432877|FG004|STARTED|MP: 16 Weeks||0
11133869|NCT01416025|12319750|FG000|COMPLETED|Overall Study||14
11133870|NCT01416025|12319751|FG001|COMPLETED|Overall Study||15
11133871|NCT01416025|12319750|FG000|NOT COMPLETED|Overall Study||0
11240546|NCT02091739|12432873|FG000|COMPLETED|MP: 16 Weeks||32
11240547|NCT02091739|12432874|FG001|COMPLETED|MP: 16 Weeks||69
11240548|NCT02091739|12432875|FG002|COMPLETED|MP: 16 Weeks||72
11240549|NCT02091739|12432876|FG003|COMPLETED|MP: 16 Weeks||0
11240550|NCT02091739|12432877|FG004|COMPLETED|MP: 16 Weeks||0
11240551|NCT02091739|12432873|FG000|NOT COMPLETED|MP: 16 Weeks||4
11240552|NCT02091739|12432874|FG001|NOT COMPLETED|MP: 16 Weeks||5
11240553|NCT02091739|12432875|FG002|NOT COMPLETED|MP: 16 Weeks||2
11240554|NCT02091739|12432876|FG003|NOT COMPLETED|MP: 16 Weeks||0
11240555|NCT02091739|12432877|FG004|NOT COMPLETED|MP: 16 Weeks||0
11240556|NCT02091739|12432873|FG000|STARTED|EP: 48 Weeks||0
11240557|NCT02091739|12432874|FG001|STARTED|EP: 48 Weeks||0
11240558|NCT02091739|12432875|FG002|STARTED|EP: 48 Weeks||0
11240559|NCT02091739|12432876|FG003|STARTED|EP: 48 Weeks||84
11240560|NCT02091739|12432877|FG004|STARTED|EP: 48 Weeks||89
11240561|NCT02091739|12432873|FG000|COMPLETED|EP: 48 Weeks||0
11240562|NCT02091739|12432874|FG001|COMPLETED|EP: 48 Weeks||0
11240563|NCT02091739|12432875|FG002|COMPLETED|EP: 48 Weeks||0
11240564|NCT02091739|12432876|FG003|COMPLETED|EP: 48 Weeks||76
11240565|NCT02091739|12432877|FG004|COMPLETED|EP: 48 Weeks||75
11240566|NCT02091739|12432873|FG000|NOT COMPLETED|EP: 48 Weeks||0
11240567|NCT02091739|12432874|FG001|NOT COMPLETED|EP: 48 Weeks||0
11240568|NCT02091739|12432875|FG002|NOT COMPLETED|EP: 48 Weeks||0
11240569|NCT02091739|12432876|FG003|NOT COMPLETED|EP: 48 Weeks||8
11240570|NCT02091739|12432877|FG004|NOT COMPLETED|EP: 48 Weeks||14
11240571|NCT02091778|12432887|FG000|STARTED|Overall Study||21
11240572|NCT02091778|12432887|FG000|COMPLETED|Overall Study||20
11240573|NCT02091778|12432887|FG000|NOT COMPLETED|Overall Study||1
11240574|NCT02091856|12432894|FG000|STARTED|Active Intervention Interval||34
11240575|NCT02091856|12432895|FG001|STARTED|Active Intervention Interval||19
11240576|NCT02091856|12432896|FG002|STARTED|Active Intervention Interval||26
11240577|NCT02091856|12432894|FG000|COMPLETED|Active Intervention Interval||15
11240578|NCT02091856|12432895|FG001|COMPLETED|Active Intervention Interval||12
11240579|NCT02091856|12432896|FG002|COMPLETED|Active Intervention Interval||19
11240580|NCT02091856|12432894|FG000|NOT COMPLETED|Active Intervention Interval||19
11133872|NCT01416025|12319751|FG001|NOT COMPLETED|Overall Study||0
11133873|NCT01416129|12319759|FG000|STARTED|Control Condition: Ischial Containment||5
11133874|NCT01416129|12319760|FG001|STARTED|Control Condition: Ischial Containment||5
11133875|NCT01416129|12319759|FG000|COMPLETED|Control Condition: Ischial Containment||5
11133876|NCT01416129|12319760|FG001|COMPLETED|Control Condition: Ischial Containment||5
11133877|NCT01416129|12319759|FG000|NOT COMPLETED|Control Condition: Ischial Containment||0
11240581|NCT02091856|12432895|FG001|NOT COMPLETED|Active Intervention Interval||7
11240582|NCT02091856|12432896|FG002|NOT COMPLETED|Active Intervention Interval||7
11240583|NCT02091856|12432894|FG000|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
11005185|NCT00721500|12182888|FG002|COMPLETED|Period One||6
11133878|NCT01416129|12319760|FG001|NOT COMPLETED|Control Condition: Ischial Containment||0
11133879|NCT01416129|12319759|FG000|STARTED|Experimental Condition: Brimless||5
11133880|NCT01416129|12319760|FG001|STARTED|Experimental Condition: Brimless||5
11133881|NCT01416129|12319759|FG000|COMPLETED|Experimental Condition: Brimless||5
11133882|NCT01416129|12319760|FG001|COMPLETED|Experimental Condition: Brimless||5
11133883|NCT01416129|12319759|FG000|NOT COMPLETED|Experimental Condition: Brimless||0
11133884|NCT01416129|12319760|FG001|NOT COMPLETED|Experimental Condition: Brimless||0
11133885|NCT01416142|12319766|FG000|STARTED|Cross Over at Movie Intermission||32
11133886|NCT01416142|12319767|FG001|STARTED|Cross Over at Movie Intermission||31
11133887|NCT01416142|12319768|FG002|STARTED|Cross Over at Movie Intermission||0
11133888|NCT01416142|12319766|FG000|COMPLETED|Cross Over at Movie Intermission||32
11133889|NCT01416142|12319767|FG001|COMPLETED|Cross Over at Movie Intermission||31
11133890|NCT01416142|12319768|FG002|COMPLETED|Cross Over at Movie Intermission||0
11133891|NCT01416142|12319766|FG000|NOT COMPLETED|Cross Over at Movie Intermission||0
11133892|NCT01416142|12319767|FG001|NOT COMPLETED|Cross Over at Movie Intermission||0
11133893|NCT01416142|12319768|FG002|NOT COMPLETED|Cross Over at Movie Intermission||0
11133894|NCT01416142|12319766|FG000|STARTED|PureVision2 HD||0
11133895|NCT01416142|12319767|FG001|STARTED|PureVision2 HD||0
11133896|NCT01416142|12319768|FG002|STARTED|PureVision2 HD||63
11133897|NCT01416142|12319766|FG000|COMPLETED|PureVision2 HD||0
11133898|NCT01416142|12319767|FG001|COMPLETED|PureVision2 HD||0
11133899|NCT01416142|12319768|FG002|COMPLETED|PureVision2 HD||62
11133900|NCT01416142|12319766|FG000|NOT COMPLETED|PureVision2 HD||0
11133901|NCT01416142|12319767|FG001|NOT COMPLETED|PureVision2 HD||0
11133902|NCT01416142|12319768|FG002|NOT COMPLETED|PureVision2 HD||1
11133903|NCT01416155|12319776|FG000|STARTED|Overall Study||97
11133904|NCT01416155|12319776|FG000|COMPLETED|Overall Study||39
11133905|NCT01416155|12319776|FG000|NOT COMPLETED|Overall Study||58
11133906|NCT01416181|12319782|FG000|STARTED|Part 1||449
11133907|NCT01416181|12319783|FG001|STARTED|Part 1||440
11133908|NCT01416181|12319782|FG000|Withdrew Prior to Dosing|Part 1||0
11133909|NCT01416181|12319783|FG001|Withdrew Prior to Dosing|Part 1||1
11133910|NCT01416181|12319782|FG000|COMPLETED|Part 1|Completed Study through Week 108|312
11133911|NCT01416181|12319783|FG001|COMPLETED|Part 1|Completed Study through Week 108|326
11133912|NCT01416181|12319782|FG000|NOT COMPLETED|Part 1||137
11133913|NCT01416181|12319783|FG001|NOT COMPLETED|Part 1||114
11133914|NCT01416181|12319782|FG000|STARTED|Part 2||274
11133915|NCT01416181|12319783|FG001|STARTED|Part 2||292
11133916|NCT01416181|12319782|FG000|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
11133917|NCT01416181|12319783|FG001|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
11133918|NCT01416181|12319782|FG000|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
11133919|NCT01416181|12319783|FG001|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
11133920|NCT01416181|12319782|FG000|Completed Treatment for > 96 Weeks|Part 2||1
11133921|NCT01416181|12319783|FG001|Completed Treatment for > 96 Weeks|Part 2||0
11133922|NCT01416181|12319782|FG000|COMPLETED|Part 2||3
11133923|NCT01416181|12319783|FG001|COMPLETED|Part 2||6
11133924|NCT01416181|12319782|FG000|NOT COMPLETED|Part 2||271
11133925|NCT01416181|12319783|FG001|NOT COMPLETED|Part 2||286
11133926|NCT01416194|12319792|FG000|STARTED|Overall Study||1111
11133927|NCT01416194|12319793|FG001|STARTED|Overall Study||2720
11133928|NCT01416194|12319794|FG002|STARTED|Overall Study||6666
11133929|NCT01416194|12319792|FG000|COMPLETED|Overall Study||1111
11133930|NCT01416194|12319793|FG001|COMPLETED|Overall Study||2720
11133931|NCT01416194|12319794|FG002|COMPLETED|Overall Study||6666
11133932|NCT01416194|12319792|FG000|NOT COMPLETED|Overall Study||0
11133933|NCT01416194|12319793|FG001|NOT COMPLETED|Overall Study||0
11133934|NCT01416194|12319794|FG002|NOT COMPLETED|Overall Study||0
11133935|NCT01416389|12319806|FG000|STARTED|Overall Study||26
11133936|NCT01416389|12319807|FG001|STARTED|Overall Study||13
11133937|NCT01416389|12319806|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
11133938|NCT01416389|12319807|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
11133939|NCT01416389|12319806|FG000|COMPLETED|Overall Study||23
11133940|NCT01416389|12319807|FG001|COMPLETED|Overall Study||13
11133941|NCT01416389|12319806|FG000|NOT COMPLETED|Overall Study||3
11133942|NCT01416389|12319807|FG001|NOT COMPLETED|Overall Study||0
11133943|NCT01416441|12319815|FG000|STARTED|Overall Study||170
11133944|NCT01416441|12319815|FG000|COMPLETED|Overall Study||89
11133945|NCT01416441|12319815|FG000|NOT COMPLETED|Overall Study||81
11133946|NCT01416571|12319819|FG000|STARTED|Overall Study||78
11133947|NCT01416571|12319819|FG000|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
11133948|NCT01416571|12319819|FG000|NOT COMPLETED|Overall Study||2
11133949|NCT01416584|12319826|FG000|STARTED|Overall Study||30
11133950|NCT01416584|12319827|FG001|STARTED|Overall Study||35
11133951|NCT01416584|12319828|FG002|STARTED|Overall Study||33
11133952|NCT01416584|12319826|FG000|COMPLETED|Overall Study||27
11240584|NCT02091856|12432895|FG001|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
11005186|NCT00721500|12182889|FG003|COMPLETED|Period One||6
11133953|NCT01416584|12319827|FG001|COMPLETED|Overall Study||33
11240585|NCT02091856|12432896|FG002|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
11240586|NCT02091856|12432894|FG000|COMPLETED|Follow-up Assessment||10
11240587|NCT02091856|12432895|FG001|COMPLETED|Follow-up Assessment||9
11240588|NCT02091856|12432896|FG002|COMPLETED|Follow-up Assessment||0
11240589|NCT02091856|12432894|FG000|NOT COMPLETED|Follow-up Assessment||5
11240590|NCT02091856|12432895|FG001|NOT COMPLETED|Follow-up Assessment||3
11133954|NCT01416584|12319828|FG002|COMPLETED|Overall Study||32
11133955|NCT01416584|12319826|FG000|NOT COMPLETED|Overall Study||3
11133956|NCT01416584|12319827|FG001|NOT COMPLETED|Overall Study||2
11133957|NCT01416584|12319828|FG002|NOT COMPLETED|Overall Study||1
11133958|NCT01416610|12319842|FG000|STARTED|Overall Study||88
11133959|NCT01416610|12319842|FG000|Intention to Treat|Overall Study||88
11133960|NCT01416610|12319842|FG000|Safety Population|Overall Study||86
11133961|NCT01416610|12319842|FG000|Per Protocol|Overall Study||83
11133962|NCT01416610|12319842|FG000|Completed Treatment|Overall Study||47
11133963|NCT01416610|12319842|FG000|Completed Follow-up|Overall Study||45
11133964|NCT01416610|12319842|FG000|COMPLETED|Overall Study||45
11240591|NCT02091856|12432896|FG002|NOT COMPLETED|Follow-up Assessment||0
11240592|NCT02091869|12432906|FG000|STARTED|Overall Study||17
11240593|NCT02091869|12432907|FG001|STARTED|Overall Study||17
11240594|NCT02091869|12432906|FG000|COMPLETED|Overall Study||17
11240595|NCT02091869|12432907|FG001|COMPLETED|Overall Study||14
11240596|NCT02091869|12432906|FG000|NOT COMPLETED|Overall Study||0
11240597|NCT02091869|12432907|FG001|NOT COMPLETED|Overall Study||3
11240598|NCT02091882|12432913|FG000|STARTED|Overall Study||30
11240599|NCT02091882|12432913|FG000|COMPLETED|Overall Study||30
11240600|NCT02091882|12432913|FG000|NOT COMPLETED|Overall Study||0
11133965|NCT01416610|12319842|FG000|NOT COMPLETED|Overall Study||43
11133966|NCT01416805|12319852|FG000|STARTED|Overall Study||49
11133967|NCT01416805|12319853|FG001|STARTED|Overall Study||51
11133968|NCT01416805|12319852|FG000|COMPLETED|Overall Study||45
11133969|NCT01416805|12319853|FG001|COMPLETED|Overall Study||47
11133970|NCT01416805|12319852|FG000|NOT COMPLETED|Overall Study||4
11133971|NCT01416805|12319853|FG001|NOT COMPLETED|Overall Study||4
11133972|NCT01416987|12319859|FG000|STARTED|Overall Study||600
11133973|NCT01416987|12319859|FG000|COMPLETED|Overall Study||600
11133974|NCT01416987|12319859|FG000|NOT COMPLETED|Overall Study||0
11133975|NCT01417000|12319865|FG000|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
11133976|NCT01417000|12319866|FG001|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
11133977|NCT01417000|12319865|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
11133978|NCT01417000|12319866|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
11133979|NCT01417000|12319865|FG000|NOT COMPLETED|Overall Study||61
11133980|NCT01417000|12319866|FG001|NOT COMPLETED|Overall Study||29
11133981|NCT01417026|12319874|FG000|STARTED|Overall Study||16
11133982|NCT01417026|12319875|FG001|STARTED|Overall Study||13
11133983|NCT01417026|12319874|FG000|COMPLETED|Overall Study||14
11133984|NCT01417026|12319875|FG001|COMPLETED|Overall Study||13
11133985|NCT01417026|12319874|FG000|NOT COMPLETED|Overall Study||2
11133986|NCT01417026|12319875|FG001|NOT COMPLETED|Overall Study||0
11133987|NCT01417078|12319881|FG000|STARTED|Overall Study||31
11133988|NCT01417078|12319881|FG000|COMPLETED|Overall Study||30
11133989|NCT01417078|12319881|FG000|NOT COMPLETED|Overall Study||1
11133990|NCT01417104|12319889|FG000|STARTED|Overall Study||34
11133991|NCT01417104|12319890|FG001|STARTED|Overall Study||37
11133992|NCT01417104|12319889|FG000|COMPLETED|Overall Study||28
11133993|NCT01417104|12319890|FG001|COMPLETED|Overall Study||35
11133994|NCT01417104|12319889|FG000|NOT COMPLETED|Overall Study||6
11133995|NCT01417104|12319890|FG001|NOT COMPLETED|Overall Study||2
11133996|NCT01417156|12319896|FG000|STARTED|Overall Study||20
11133997|NCT01417156|12319896|FG000|COMPLETED|Overall Study||6
11133998|NCT01417156|12319896|FG000|NOT COMPLETED|Overall Study||14
11133999|NCT01417195|12319902|FG000|STARTED|Overall Study||60
11134000|NCT01417195|12319903|FG001|STARTED|Overall Study||62
11134001|NCT01417195|12319902|FG000|COMPLETED|Overall Study||57
11134002|NCT01417195|12319903|FG001|COMPLETED|Overall Study||61
11134003|NCT01417195|12319902|FG000|NOT COMPLETED|Overall Study||3
11240601|NCT02091921|12432917|FG000|STARTED|Overall Study||53
11240602|NCT02091921|12432917|FG000|COMPLETED|Overall Study||50
11240603|NCT02091921|12432917|FG000|NOT COMPLETED|Overall Study||3
11240604|NCT02091986|12432927|FG000|STARTED|Overall Study||92
11134004|NCT01417195|12319903|FG001|NOT COMPLETED|Overall Study||1
11240605|NCT02091986|12432928|FG001|STARTED|Overall Study||95
11240606|NCT02091986|12432929|FG002|STARTED|Overall Study||92
11240607|NCT02091986|12432927|FG000|COMPLETED|Overall Study||85
11240608|NCT02091986|12432928|FG001|COMPLETED|Overall Study||84
11240609|NCT02091986|12432929|FG002|COMPLETED|Overall Study||84
11005187|NCT00721500|12182886|FG000|NOT COMPLETED|Period One||0
11134005|NCT01417455|12319918|FG000|STARTED|Overall Study||16
11134006|NCT01417455|12319919|FG001|STARTED|Overall Study||16
11134007|NCT01417455|12319920|FG002|STARTED|Overall Study||17
11134008|NCT01417455|12319921|FG003|STARTED|Overall Study||17
11134009|NCT01417455|12319922|FG004|STARTED|Overall Study||30
11134010|NCT01417455|12319923|FG005|STARTED|Overall Study||13
11134011|NCT01417455|12319924|FG006|STARTED|Overall Study||13
11134012|NCT01417455|12319925|FG007|STARTED|Overall Study||25
11134013|NCT01417455|12319918|FG000|COMPLETED|Overall Study||16
11134014|NCT01417455|12319919|FG001|COMPLETED|Overall Study||16
11134015|NCT01417455|12319920|FG002|COMPLETED|Overall Study||17
11134016|NCT01417455|12319921|FG003|COMPLETED|Overall Study||17
11134017|NCT01417455|12319922|FG004|COMPLETED|Overall Study||30
11134018|NCT01417455|12319923|FG005|COMPLETED|Overall Study||13
11134019|NCT01417455|12319924|FG006|COMPLETED|Overall Study||13
11134020|NCT01417455|12319925|FG007|COMPLETED|Overall Study||25
11134021|NCT01417455|12319918|FG000|NOT COMPLETED|Overall Study||0
11134022|NCT01417455|12319919|FG001|NOT COMPLETED|Overall Study||0
11134023|NCT01417455|12319920|FG002|NOT COMPLETED|Overall Study||0
11134024|NCT01417455|12319921|FG003|NOT COMPLETED|Overall Study||0
11134025|NCT01417455|12319922|FG004|NOT COMPLETED|Overall Study||0
11134026|NCT01417455|12319923|FG005|NOT COMPLETED|Overall Study||0
11134027|NCT01417455|12319924|FG006|NOT COMPLETED|Overall Study||0
11134028|NCT01417455|12319925|FG007|NOT COMPLETED|Overall Study||0
11134029|NCT01417481|12319945|FG000|STARTED|First Intervention (8 Weeks)||8
11134030|NCT01417481|12319946|FG001|STARTED|First Intervention (8 Weeks)||7
11134031|NCT01417481|12319945|FG000|COMPLETED|First Intervention (8 Weeks)||8
11134032|NCT01417481|12319946|FG001|COMPLETED|First Intervention (8 Weeks)||5
11134033|NCT01417481|12319945|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
11134034|NCT01417481|12319946|FG001|NOT COMPLETED|First Intervention (8 Weeks)||2
11134035|NCT01417481|12319945|FG000|STARTED|Washout (2 Weeks)||8
11134036|NCT01417481|12319946|FG001|STARTED|Washout (2 Weeks)||5
11134037|NCT01417481|12319945|FG000|COMPLETED|Washout (2 Weeks)||8
11134038|NCT01417481|12319946|FG001|COMPLETED|Washout (2 Weeks)||5
11134039|NCT01417481|12319945|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11134040|NCT01417481|12319946|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11134041|NCT01417481|12319945|FG000|STARTED|Second Period (8 Weeks)||8
11134042|NCT01417481|12319946|FG001|STARTED|Second Period (8 Weeks)||5
11134043|NCT01417481|12319945|FG000|COMPLETED|Second Period (8 Weeks)||8
11134044|NCT01417481|12319946|FG001|COMPLETED|Second Period (8 Weeks)||5
11134045|NCT01417481|12319945|FG000|NOT COMPLETED|Second Period (8 Weeks)||0
11134046|NCT01417481|12319946|FG001|NOT COMPLETED|Second Period (8 Weeks)||0
11134047|NCT01417741|12319954|FG000|STARTED|Overall Study||75
11134048|NCT01417741|12319955|FG001|STARTED|Overall Study||86
11134049|NCT01417741|12319954|FG000|COMPLETED|Overall Study||75
11134050|NCT01417741|12319955|FG001|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86
11134051|NCT01417741|12319954|FG000|NOT COMPLETED|Overall Study||0
11134052|NCT01417741|12319955|FG001|NOT COMPLETED|Overall Study||0
11134053|NCT01417780|12319964|FG000|STARTED|Overall Study||15
11134054|NCT01417780|12319965|FG001|STARTED|Overall Study||17
11134055|NCT01417780|12319966|FG002|STARTED|Overall Study||11
11134056|NCT01417780|12319964|FG000|COMPLETED|Overall Study||14
11134057|NCT01417780|12319965|FG001|COMPLETED|Overall Study||14
11134058|NCT01417780|12319966|FG002|COMPLETED|Overall Study||9
11134059|NCT01417780|12319964|FG000|NOT COMPLETED|Overall Study||1
11134060|NCT01417780|12319965|FG001|NOT COMPLETED|Overall Study||3
11134061|NCT01417780|12319966|FG002|NOT COMPLETED|Overall Study||2
11134062|NCT01417936|12319974|FG000|STARTED|Overall Study||26
11134063|NCT01417936|12319974|FG000|COMPLETED|Overall Study||26
11134064|NCT01417936|12319974|FG000|NOT COMPLETED|Overall Study||0
11134065|NCT01418001|12319978|FG000|STARTED|Overall Study||5
11134066|NCT01418001|12319978|FG000|COMPLETED|Overall Study||5
11134067|NCT01418001|12319978|FG000|NOT COMPLETED|Overall Study||0
11134068|NCT01418209|12319986|FG000|STARTED|Overall Study||97
11134069|NCT01418209|12319987|FG001|STARTED|Overall Study||96
11134070|NCT01418209|12319988|FG002|STARTED|Overall Study||146
11134071|NCT01418209|12319986|FG000|COMPLETED|Overall Study||95
11134072|NCT01418209|12319987|FG001|COMPLETED|Overall Study||93
11134073|NCT01418209|12319988|FG002|COMPLETED|Overall Study||142
11134074|NCT01418209|12319986|FG000|NOT COMPLETED|Overall Study||2
11134075|NCT01418209|12319987|FG001|NOT COMPLETED|Overall Study||3
11134076|NCT01418209|12319988|FG002|NOT COMPLETED|Overall Study||4
11134077|NCT01418339|12319998|FG000|STARTED|Overall Study||90
11134078|NCT01418339|12319999|FG001|STARTED|Overall Study||45
11134079|NCT01418339|12319998|FG000|COMPLETED|Overall Study||78
11134080|NCT01418339|12319999|FG001|COMPLETED|Overall Study||35
11134081|NCT01418339|12319998|FG000|NOT COMPLETED|Overall Study||12
11134082|NCT01418339|12319999|FG001|NOT COMPLETED|Overall Study||10
11134083|NCT01418352|12320009|FG000|STARTED|Overall Study||20
11134084|NCT01418352|12320010|FG001|STARTED|Overall Study||21
11134085|NCT01418352|12320011|FG002|STARTED|Overall Study||21
11134086|NCT01418352|12320012|FG003|STARTED|Overall Study||21
11134087|NCT01418352|12320009|FG000|COMPLETED|Overall Study||17
11134088|NCT01418352|12320010|FG001|COMPLETED|Overall Study||17
11134089|NCT01418352|12320011|FG002|COMPLETED|Overall Study||16
11134090|NCT01418352|12320012|FG003|COMPLETED|Overall Study||18
11134091|NCT01418352|12320009|FG000|NOT COMPLETED|Overall Study||3
11134092|NCT01418352|12320010|FG001|NOT COMPLETED|Overall Study||4
11134093|NCT01418352|12320011|FG002|NOT COMPLETED|Overall Study||5
11134094|NCT01418352|12320012|FG003|NOT COMPLETED|Overall Study||3
11134095|NCT01418365|12320024|FG000|STARTED|First Intervention||15
11134096|NCT01418365|12320025|FG001|STARTED|First Intervention||15
11134097|NCT01418365|12320024|FG000|COMPLETED|First Intervention||14
11134098|NCT01418365|12320025|FG001|COMPLETED|First Intervention||14
11134099|NCT01418365|12320024|FG000|NOT COMPLETED|First Intervention||1
11134100|NCT01418365|12320025|FG001|NOT COMPLETED|First Intervention||1
11134101|NCT01418365|12320024|FG000|STARTED|Second Intervention||14
11134102|NCT01418365|12320025|FG001|STARTED|Second Intervention||14
11134103|NCT01418365|12320024|FG000|COMPLETED|Second Intervention||14
11005188|NCT00721500|12182887|FG001|NOT COMPLETED|Period One||0
11134104|NCT01418365|12320025|FG001|COMPLETED|Second Intervention||13
11134105|NCT01418365|12320024|FG000|NOT COMPLETED|Second Intervention||0
11134106|NCT01418365|12320025|FG001|NOT COMPLETED|Second Intervention||1
11134107|NCT01418378|12320033|FG000|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90
11134108|NCT01418378|12320034|FG001|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88
11134109|NCT01418378|12320033|FG000|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90
11134110|NCT01418378|12320034|FG001|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88
11134111|NCT01418378|12320033|FG000|COMPLETED|Overall Study||89
11134112|NCT01418378|12320034|FG001|COMPLETED|Overall Study||83
11134113|NCT01418378|12320033|FG000|NOT COMPLETED|Overall Study||1
11134114|NCT01418378|12320034|FG001|NOT COMPLETED|Overall Study||5
11134115|NCT01418482|12320040|FG000|STARTED|Overall Study||15
11134116|NCT01418482|12320040|FG000|COMPLETED|Overall Study||15
11134117|NCT01418482|12320040|FG000|NOT COMPLETED|Overall Study||0
11134118|NCT01418703|12320046|FG000|STARTED|Overall Study||13
11134119|NCT01418703|12320047|FG001|STARTED|Overall Study||13
11134120|NCT01418703|12320048|FG002|STARTED|Overall Study||6
11134121|NCT01418703|12320049|FG003|STARTED|Overall Study||6
11134122|NCT01418703|12320046|FG000|COMPLETED|Overall Study||13
11134123|NCT01418703|12320047|FG001|COMPLETED|Overall Study||13
11134124|NCT01418703|12320048|FG002|COMPLETED|Overall Study||6
11134125|NCT01418703|12320049|FG003|COMPLETED|Overall Study||6
11134126|NCT01418703|12320046|FG000|NOT COMPLETED|Overall Study||0
11134127|NCT01418703|12320047|FG001|NOT COMPLETED|Overall Study||0
11134128|NCT01418703|12320048|FG002|NOT COMPLETED|Overall Study||0
11134129|NCT01418703|12320049|FG003|NOT COMPLETED|Overall Study||0
11134130|NCT01418937|12320056|FG000|STARTED|Overall Study||164
11134131|NCT01418937|12320056|FG000|COMPLETED|Overall Study||156
11134132|NCT01418937|12320056|FG000|NOT COMPLETED|Overall Study||8
11134133|NCT01419015|12320060|FG000|STARTED|Overall Study||17
11134134|NCT01419015|12320060|FG000|COMPLETED|Overall Study||15
11134135|NCT01419015|12320060|FG000|NOT COMPLETED|Overall Study||2
11134136|NCT01419028|12320064|FG000|STARTED|Overall Study||48
11134137|NCT01419028|12320064|FG000|COMPLETED|Overall Study||48
11134138|NCT01419028|12320064|FG000|NOT COMPLETED|Overall Study||0
11134139|NCT01419171|12320068|FG000|STARTED|Overall Study||328
11134140|NCT01419171|12320068|FG000|COMPLETED|Overall Study||328
11134141|NCT01419171|12320068|FG000|NOT COMPLETED|Overall Study||0
11134142|NCT01419184|12320074|FG000|STARTED|Overall Study||128
11134143|NCT01419184|12320075|FG001|STARTED|Overall Study||121
11134144|NCT01419184|12320074|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118
11134145|NCT01419184|12320075|FG001|Received at Least 1 Dose of Study Drug|Overall Study||106
11134146|NCT01419184|12320074|FG000|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
11134147|NCT01419184|12320075|FG001|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
11134148|NCT01419184|12320074|FG000|NOT COMPLETED|Overall Study||10
11134149|NCT01419184|12320075|FG001|NOT COMPLETED|Overall Study||15
11134150|NCT01419197|12320083|FG000|STARTED|Overall Study||404
11134151|NCT01419197|12320084|FG001|STARTED|Overall Study||198
11134152|NCT01419197|12320083|FG000|Switched to Trastuzumab Emtansine|Overall Study||0
11134153|NCT01419197|12320084|FG001|Switched to Trastuzumab Emtansine|Overall Study||94
11134154|NCT01419197|12320083|FG000|COMPLETED|Overall Study||0
11134155|NCT01419197|12320084|FG001|COMPLETED|Overall Study||0
11134156|NCT01419197|12320083|FG000|NOT COMPLETED|Overall Study||404
11134157|NCT01419197|12320084|FG001|NOT COMPLETED|Overall Study||198
11134158|NCT01419236|12320093|FG000|STARTED|Overall Study||36
11134159|NCT01419236|12320094|FG001|STARTED|Overall Study||40
11134160|NCT01419236|12320093|FG000|Received at Least 1 Dose of Study Drug|Overall Study||35
11134161|NCT01419236|12320094|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
11005189|NCT00721500|12182888|FG002|NOT COMPLETED|Period One||0
11005190|NCT00721500|12182889|FG003|NOT COMPLETED|Period One||0
11005191|NCT00721500|12182886|FG000|STARTED|Period Two||6
11005192|NCT00721500|12182887|FG001|STARTED|Period Two||7
11005193|NCT00721500|12182888|FG002|STARTED|Period Two||6
11240610|NCT02091986|12432927|FG000|NOT COMPLETED|Overall Study||7
11240611|NCT02091986|12432928|FG001|NOT COMPLETED|Overall Study||11
11240612|NCT02091986|12432929|FG002|NOT COMPLETED|Overall Study||8
11240613|NCT02092025|12432937|FG000|STARTED|Overall Study||3437
11240614|NCT02092025|12432937|FG000|COMPLETED|Overall Study||3369
11240615|NCT02092025|12432937|FG000|NOT COMPLETED|Overall Study||68
11240616|NCT02092116|12432943|FG000|STARTED|Overall Study||6
11240617|NCT02092116|12432944|FG001|STARTED|Overall Study||20
11240618|NCT02092116|12432943|FG000|COMPLETED|Overall Study||6
11240619|NCT02092116|12432944|FG001|COMPLETED|Overall Study||16
11240620|NCT02092116|12432943|FG000|NOT COMPLETED|Overall Study||0
11240621|NCT02092116|12432944|FG001|NOT COMPLETED|Overall Study||4
11240622|NCT02092168|12432952|FG000|STARTED|Overall Study||12
11134162|NCT01419236|12320093|FG000|COMPLETED|Overall Study||31
11134163|NCT01419236|12320094|FG001|COMPLETED|Overall Study||35
11134164|NCT01419236|12320093|FG000|NOT COMPLETED|Overall Study||5
11134165|NCT01419236|12320094|FG001|NOT COMPLETED|Overall Study||5
11134166|NCT01419249|12320102|FG000|STARTED|Overall Study||318
11134167|NCT01419249|12320103|FG001|STARTED|Overall Study||140
11134168|NCT01419249|12320102|FG000|COMPLETED|Overall Study||318
11134169|NCT01419249|12320103|FG001|COMPLETED|Overall Study||140
11134170|NCT01419249|12320102|FG000|NOT COMPLETED|Overall Study||0
11134171|NCT01419249|12320103|FG001|NOT COMPLETED|Overall Study||0
11134172|NCT01419275|12320110|FG000|STARTED|Overall Study||126
11134173|NCT01419275|12320110|FG000|COMPLETED|Overall Study||126
11134174|NCT01419275|12320110|FG000|NOT COMPLETED|Overall Study||0
11134175|NCT01419314|12320116|FG000|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
11134176|NCT01419314|12320117|FG001|STARTED|Start of Study|No comfort issues reported.|22
11134177|NCT01419314|12320116|FG000|COMPLETED|Start of Study||23
11134178|NCT01419314|12320117|FG001|COMPLETED|Start of Study||22
11134179|NCT01419314|12320116|FG000|NOT COMPLETED|Start of Study||0
11134180|NCT01419314|12320117|FG001|NOT COMPLETED|Start of Study||0
11134181|NCT01419314|12320116|FG000|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
11134182|NCT01419314|12320117|FG001|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
11134183|NCT01419314|12320116|FG000|COMPLETED|Follow-up at Week 3 of the Trial||17
11134184|NCT01419314|12320117|FG001|COMPLETED|Follow-up at Week 3 of the Trial||21
11134185|NCT01419314|12320116|FG000|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
11134186|NCT01419314|12320117|FG001|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
11134187|NCT01419314|12320116|FG000|STARTED|Follow-up at Week 6 of the Trial||17
11134188|NCT01419314|12320117|FG001|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
11134189|NCT01419314|12320116|FG000|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
11134190|NCT01419314|12320117|FG001|COMPLETED|Follow-up at Week 6 of the Trial||19
11134191|NCT01419314|12320116|FG000|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
11134192|NCT01419314|12320117|FG001|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
11134193|NCT01419535|12320129|FG000|STARTED|Overall Study||9
11134194|NCT01419535|12320130|FG001|STARTED|Overall Study||10
11134195|NCT01419535|12320129|FG000|COMPLETED|Overall Study||8
11134196|NCT01419535|12320130|FG001|COMPLETED|Overall Study||8
11134197|NCT01419535|12320129|FG000|NOT COMPLETED|Overall Study||1
11134198|NCT01419535|12320130|FG001|NOT COMPLETED|Overall Study||2
11134199|NCT01419626|12320139|FG000|STARTED|Overall Study||46
11134200|NCT01419626|12320140|FG001|STARTED|Overall Study||47
11134201|NCT01419626|12320141|FG002|STARTED|Overall Study||47
11134202|NCT01419626|12320139|FG000|COMPLETED|Overall Study||42
11134203|NCT01419626|12320140|FG001|COMPLETED|Overall Study||44
11134204|NCT01419626|12320141|FG002|COMPLETED|Overall Study||44
11134205|NCT01419626|12320139|FG000|NOT COMPLETED|Overall Study||4
11134206|NCT01419626|12320140|FG001|NOT COMPLETED|Overall Study||3
11134207|NCT01419626|12320141|FG002|NOT COMPLETED|Overall Study||3
11134208|NCT01419639|12320149|FG000|STARTED|Overall Study||10
11134209|NCT01419639|12320149|FG000|COMPLETED|Overall Study||9
11134210|NCT01419639|12320149|FG000|NOT COMPLETED|Overall Study||1
11134211|NCT01419665|12320155|FG000|STARTED|Combination Treatment||312
11134212|NCT01419665|12320156|FG001|STARTED|Combination Treatment||315
11240623|NCT02092168|12432953|FG001|STARTED|Overall Study||12
11005194|NCT00721500|12182889|FG003|STARTED|Period Two||6
11005195|NCT00721500|12182886|FG000|COMPLETED|Period Two||6
11005196|NCT00721500|12182887|FG001|COMPLETED|Period Two||7
11134213|NCT01419665|12320155|FG000|COMPLETED|Combination Treatment||274
11134214|NCT01419665|12320156|FG001|COMPLETED|Combination Treatment||274
11134215|NCT01419665|12320155|FG000|NOT COMPLETED|Combination Treatment||38
11134216|NCT01419665|12320156|FG001|NOT COMPLETED|Combination Treatment||41
11134217|NCT01419665|12320155|FG000|STARTED|Maintenance Treatment and/or Follow up||254
11134218|NCT01419665|12320156|FG001|STARTED|Maintenance Treatment and/or Follow up||252
11134219|NCT01419665|12320155|FG000|COMPLETED|Maintenance Treatment and/or Follow up||132
11134220|NCT01419665|12320156|FG001|COMPLETED|Maintenance Treatment and/or Follow up||150
11005197|NCT00721500|12182888|FG002|COMPLETED|Period Two||6
11005198|NCT00721500|12182889|FG003|COMPLETED|Period Two||6
11005199|NCT00721500|12182886|FG000|NOT COMPLETED|Period Two||0
11005200|NCT00721500|12182887|FG001|NOT COMPLETED|Period Two||0
11005201|NCT00721500|12182888|FG002|NOT COMPLETED|Period Two||0
11005202|NCT00721500|12182889|FG003|NOT COMPLETED|Period Two||0
11005203|NCT00721500|12182886|FG000|STARTED|Period Three||6
11005204|NCT00721500|12182887|FG001|STARTED|Period Three||7
11005205|NCT00721500|12182888|FG002|STARTED|Period Three||6
11134221|NCT01419665|12320155|FG000|NOT COMPLETED|Maintenance Treatment and/or Follow up||122
11134222|NCT01419665|12320156|FG001|NOT COMPLETED|Maintenance Treatment and/or Follow up||102
11134223|NCT01419665|12320155|FG000|STARTED|Open Label Phase||44
11134224|NCT01419665|12320156|FG001|STARTED|Open Label Phase||39
11134225|NCT01419665|12320155|FG000|COMPLETED|Open Label Phase||43
11134226|NCT01419665|12320156|FG001|COMPLETED|Open Label Phase||38
11134227|NCT01419665|12320155|FG000|NOT COMPLETED|Open Label Phase||1
11134228|NCT01419665|12320156|FG001|NOT COMPLETED|Open Label Phase||1
11134229|NCT01419717|12320164|FG000|STARTED|Overall Study||129
11134230|NCT01419717|12320164|FG000|Received Denosumab|Overall Study||128
11134231|NCT01419717|12320164|FG000|COMPLETED|Overall Study||4
11134232|NCT01419717|12320164|FG000|NOT COMPLETED|Overall Study||125
11134233|NCT01419769|12320168|FG000|STARTED|Overall Study||33
11134234|NCT01419769|12320168|FG000|COMPLETED|Overall Study||29
11134235|NCT01419769|12320168|FG000|NOT COMPLETED|Overall Study||4
11134236|NCT01419795|12320174|FG000|STARTED|Overall Study||3
11134237|NCT01419795|12320175|FG001|STARTED|Overall Study||0
11134238|NCT01419795|12320174|FG000|COMPLETED|Overall Study||3
11005206|NCT00721500|12182889|FG003|STARTED|Period Three||6
11134239|NCT01419795|12320175|FG001|COMPLETED|Overall Study||0
11134240|NCT01419795|12320174|FG000|NOT COMPLETED|Overall Study||0
11134241|NCT01419795|12320175|FG001|NOT COMPLETED|Overall Study||0
11134242|NCT01419977|12320183|FG000|STARTED|Overall Study||16
11134243|NCT01419977|12320184|FG001|STARTED|Overall Study||13
11134244|NCT01419977|12320183|FG000|COMPLETED|Overall Study||16
11240624|NCT02092168|12432952|FG000|COMPLETED|Overall Study||12
11240625|NCT02092168|12432953|FG001|COMPLETED|Overall Study||12
11240626|NCT02092168|12432952|FG000|NOT COMPLETED|Overall Study||0
11134245|NCT01419977|12320184|FG001|COMPLETED|Overall Study||13
11134246|NCT01419977|12320183|FG000|NOT COMPLETED|Overall Study||0
11134247|NCT01419977|12320184|FG001|NOT COMPLETED|Overall Study||0
11240627|NCT02092168|12432953|FG001|NOT COMPLETED|Overall Study||0
11240628|NCT02092181|12432961|FG000|STARTED|Overall Study||15
11240629|NCT02092181|12432962|FG001|STARTED|Overall Study||15
11240630|NCT02092181|12432961|FG000|COMPLETED|Overall Study||12
11134248|NCT01420016|12320192|FG000|STARTED|Primary Analysis||6970
11134249|NCT01420016|12320193|FG001|STARTED|Primary Analysis||6411
11134250|NCT01420016|12320194|FG002|STARTED|Primary Analysis||0
11134251|NCT01420016|12320195|FG003|STARTED|Primary Analysis||0
11134252|NCT01420016|12320192|FG000|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
11134253|NCT01420016|12320193|FG001|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
11134254|NCT01420016|12320194|FG002|COMPLETED|Primary Analysis||0
11134255|NCT01420016|12320195|FG003|COMPLETED|Primary Analysis||0
11134256|NCT01420016|12320192|FG000|NOT COMPLETED|Primary Analysis||2927
11134257|NCT01420016|12320193|FG001|NOT COMPLETED|Primary Analysis||2540
11134258|NCT01420016|12320194|FG002|NOT COMPLETED|Primary Analysis||0
11134259|NCT01420016|12320195|FG003|NOT COMPLETED|Primary Analysis||0
11134260|NCT01420016|12320192|FG000|STARTED|Safety Analysis||0
11134261|NCT01420016|12320193|FG001|STARTED|Safety Analysis||0
11134262|NCT01420016|12320194|FG002|STARTED|Safety Analysis||6392
11134263|NCT01420016|12320195|FG003|STARTED|Safety Analysis||5159
11134264|NCT01420016|12320192|FG000|COMPLETED|Safety Analysis||0
11134265|NCT01420016|12320193|FG001|COMPLETED|Safety Analysis||0
11134266|NCT01420016|12320194|FG002|COMPLETED|Safety Analysis||6392
11134267|NCT01420016|12320195|FG003|COMPLETED|Safety Analysis||5159
11134268|NCT01420016|12320192|FG000|NOT COMPLETED|Safety Analysis||0
11134269|NCT01420016|12320193|FG001|NOT COMPLETED|Safety Analysis||0
11134270|NCT01420016|12320194|FG002|NOT COMPLETED|Safety Analysis||0
11134271|NCT01420016|12320195|FG003|NOT COMPLETED|Safety Analysis||0
11134272|NCT01420068|12320203|FG000|STARTED|Overall Study||51
11134273|NCT01420068|12320204|FG001|STARTED|Overall Study||55
11134274|NCT01420068|12320203|FG000|COMPLETED|Overall Study||49
11134275|NCT01420068|12320204|FG001|COMPLETED|Overall Study||50
11134276|NCT01420068|12320203|FG000|NOT COMPLETED|Overall Study||2
11134277|NCT01420068|12320204|FG001|NOT COMPLETED|Overall Study||5
11134278|NCT01420081|12320219|FG000|STARTED|Overall Study||3
11134279|NCT01420081|12320220|FG001|STARTED|Overall Study||1
11134280|NCT01420081|12320221|FG002|STARTED|Overall Study||11
11134281|NCT01420081|12320222|FG003|STARTED|Overall Study||3
11134282|NCT01420081|12320223|FG004|STARTED|Overall Study||20
11134283|NCT01420081|12320224|FG005|STARTED|Overall Study||20
11005207|NCT00721500|12182886|FG000|COMPLETED|Period Three||6
11005208|NCT00721500|12182887|FG001|COMPLETED|Period Three||7
11134284|NCT01420081|12320225|FG006|STARTED|Overall Study||3
11134285|NCT01420081|12320226|FG007|STARTED|Overall Study||3
11134286|NCT01420081|12320227|FG008|STARTED|Overall Study||3
11134287|NCT01420081|12320219|FG000|COMPLETED|Overall Study||0
11134288|NCT01420081|12320220|FG001|COMPLETED|Overall Study||0
11134289|NCT01420081|12320221|FG002|COMPLETED|Overall Study||0
11134290|NCT01420081|12320222|FG003|COMPLETED|Overall Study||0
11134291|NCT01420081|12320223|FG004|COMPLETED|Overall Study||0
11134292|NCT01420081|12320224|FG005|COMPLETED|Overall Study||0
11134293|NCT01420081|12320225|FG006|COMPLETED|Overall Study||0
11134294|NCT01420081|12320226|FG007|COMPLETED|Overall Study||0
11134295|NCT01420081|12320227|FG008|COMPLETED|Overall Study||0
11134296|NCT01420081|12320219|FG000|NOT COMPLETED|Overall Study||3
11134297|NCT01420081|12320220|FG001|NOT COMPLETED|Overall Study||1
11134298|NCT01420081|12320221|FG002|NOT COMPLETED|Overall Study||11
11134299|NCT01420081|12320222|FG003|NOT COMPLETED|Overall Study||3
11134300|NCT01420081|12320223|FG004|NOT COMPLETED|Overall Study||20
11134301|NCT01420081|12320224|FG005|NOT COMPLETED|Overall Study||20
11134302|NCT01420081|12320225|FG006|NOT COMPLETED|Overall Study||3
11134303|NCT01420081|12320226|FG007|NOT COMPLETED|Overall Study||3
11134304|NCT01420081|12320227|FG008|NOT COMPLETED|Overall Study||3
11134305|NCT01420146|12320243|FG000|STARTED|Overall Study||20
11134306|NCT01420146|12320243|FG000|COMPLETED|Overall Study||20
11240631|NCT02092181|12432962|FG001|COMPLETED|Overall Study||14
11240632|NCT02092181|12432961|FG000|NOT COMPLETED|Overall Study||3
11240633|NCT02092181|12432962|FG001|NOT COMPLETED|Overall Study||1
11240634|NCT02092220|12432968|FG000|STARTED|Period 1||21
11134307|NCT01420146|12320243|FG000|NOT COMPLETED|Overall Study||0
11134308|NCT01420289|12320249|FG000|STARTED|Overall Study||18
11134309|NCT01420289|12320250|FG001|STARTED|Overall Study||16
11134310|NCT01420289|12320249|FG000|COMPLETED|Overall Study||18
11134311|NCT01420289|12320250|FG001|COMPLETED|Overall Study||16
11134312|NCT01420289|12320249|FG000|NOT COMPLETED|Overall Study||0
11134313|NCT01420289|12320250|FG001|NOT COMPLETED|Overall Study||0
11134314|NCT01420536|12320258|FG000|STARTED|Period 1 (30 Days)||22
11134315|NCT01420536|12320259|FG001|STARTED|Period 1 (30 Days)||22
11134316|NCT01420536|12320258|FG000|COMPLETED|Period 1 (30 Days)|Participants declined to participate further before changing interventions.|19
11134317|NCT01420536|12320259|FG001|COMPLETED|Period 1 (30 Days)||22
11134318|NCT01420536|12320258|FG000|NOT COMPLETED|Period 1 (30 Days)||3
11134319|NCT01420536|12320259|FG001|NOT COMPLETED|Period 1 (30 Days)||0
11134320|NCT01420536|12320258|FG000|STARTED|Period 2 (30 Days)||19
11134321|NCT01420536|12320259|FG001|STARTED|Period 2 (30 Days)||22
11134322|NCT01420536|12320258|FG000|COMPLETED|Period 2 (30 Days)||19
11134323|NCT01420536|12320259|FG001|COMPLETED|Period 2 (30 Days)||22
11134324|NCT01420536|12320258|FG000|NOT COMPLETED|Period 2 (30 Days)||0
11134325|NCT01420536|12320259|FG001|NOT COMPLETED|Period 2 (30 Days)||0
11134326|NCT01420549|12320269|FG000|STARTED|Overall Study||66
11134327|NCT01420549|12320270|FG001|STARTED|Overall Study||63
11134328|NCT01420549|12320269|FG000|COMPLETED|Overall Study||59
11134329|NCT01420549|12320270|FG001|COMPLETED|Overall Study||58
11134330|NCT01420549|12320269|FG000|NOT COMPLETED|Overall Study||7
11134331|NCT01420549|12320270|FG001|NOT COMPLETED|Overall Study||5
11134332|NCT01420627|12320276|FG000|STARTED|Adagen Lead-in Period||7
11134333|NCT01420627|12320276|FG000|COMPLETED|Adagen Lead-in Period||7
11134334|NCT01420627|12320276|FG000|NOT COMPLETED|Adagen Lead-in Period||0
11134335|NCT01420627|12320276|FG000|STARTED|EZN-2279 Treatment Period||7
11134336|NCT01420627|12320276|FG000|COMPLETED|EZN-2279 Treatment Period||6
11134337|NCT01420627|12320276|FG000|NOT COMPLETED|EZN-2279 Treatment Period||1
11134338|NCT01420627|12320276|FG000|STARTED|EZN-2279 Maintenance Period||6
11134339|NCT01420627|12320276|FG000|COMPLETED|EZN-2279 Maintenance Period||6
11134340|NCT01420627|12320276|FG000|NOT COMPLETED|EZN-2279 Maintenance Period||0
11134341|NCT01420653|12320288|FG000|STARTED|Overall Study||110
11134342|NCT01420653|12320289|FG001|STARTED|Overall Study||111
11134343|NCT01420653|12320290|FG002|STARTED|Overall Study||112
11134344|NCT01420653|12320291|FG003|STARTED|Overall Study||75
11134345|NCT01420653|12320288|FG000|COMPLETED|Overall Study||107
11134346|NCT01420653|12320289|FG001|COMPLETED|Overall Study||108
11134347|NCT01420653|12320290|FG002|COMPLETED|Overall Study||108
11134348|NCT01420653|12320291|FG003|COMPLETED|Overall Study||68
11134349|NCT01420653|12320288|FG000|NOT COMPLETED|Overall Study||3
11134350|NCT01420653|12320289|FG001|NOT COMPLETED|Overall Study||3
11134351|NCT01420653|12320290|FG002|NOT COMPLETED|Overall Study||4
11134352|NCT01420653|12320291|FG003|NOT COMPLETED|Overall Study||7
11134353|NCT01420679|12320303|FG000|STARTED|Overall Study||14
11134354|NCT01420679|12320304|FG001|STARTED|Overall Study||7
11134355|NCT01420679|12320303|FG000|COMPLETED|Overall Study||0
11134356|NCT01420679|12320304|FG001|COMPLETED|Overall Study||0
11134357|NCT01420679|12320303|FG000|NOT COMPLETED|Overall Study||14
11134358|NCT01420679|12320304|FG001|NOT COMPLETED|Overall Study||7
11134359|NCT01420848|12320313|FG000|STARTED|Overall Study||24
11134360|NCT01420848|12320314|FG001|STARTED|Overall Study||25
11134361|NCT01420848|12320315|FG002|STARTED|Overall Study||22
11134362|NCT01420848|12320313|FG000|COMPLETED|Overall Study||24
11134363|NCT01420848|12320314|FG001|COMPLETED|Overall Study||25
11134364|NCT01420848|12320315|FG002|COMPLETED|Overall Study||22
11134365|NCT01420848|12320313|FG000|NOT COMPLETED|Overall Study||0
11134366|NCT01420848|12320314|FG001|NOT COMPLETED|Overall Study||0
11134367|NCT01420848|12320315|FG002|NOT COMPLETED|Overall Study||0
11134368|NCT01421017|12320326|FG000|STARTED|Overall Study||12
11134369|NCT01421017|12320327|FG001|STARTED|Overall Study||12
11134370|NCT01421017|12320328|FG002|STARTED|Overall Study||7
11134371|NCT01421017|12320326|FG000|COMPLETED|Overall Study||10
11134372|NCT01421017|12320327|FG001|COMPLETED|Overall Study||6
11134373|NCT01421017|12320328|FG002|COMPLETED|Overall Study||4
11134374|NCT01421017|12320326|FG000|NOT COMPLETED|Overall Study||2
11134375|NCT01421017|12320327|FG001|NOT COMPLETED|Overall Study||6
11134376|NCT01421017|12320328|FG002|NOT COMPLETED|Overall Study||3
11134377|NCT01421134|12320338|FG000|STARTED|Overall Study||109
11134378|NCT01421134|12320339|FG001|STARTED|Overall Study||102
11134379|NCT01421134|12320338|FG000|COMPLETED|Overall Study||102
11134380|NCT01421134|12320339|FG001|COMPLETED|Overall Study||87
11134381|NCT01421134|12320338|FG000|NOT COMPLETED|Overall Study||7
11134382|NCT01421134|12320339|FG001|NOT COMPLETED|Overall Study||15
11134383|NCT01421147|12320347|FG000|STARTED|Treatment Period||269
11134384|NCT01421147|12320348|FG001|STARTED|Treatment Period||267
11134385|NCT01421147|12320347|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||268
11134386|NCT01421147|12320348|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||267
11134387|NCT01421147|12320347|FG000|COMPLETED|Treatment Period||253
11134388|NCT01421147|12320348|FG001|COMPLETED|Treatment Period||256
11134389|NCT01421147|12320347|FG000|NOT COMPLETED|Treatment Period||16
11134390|NCT01421147|12320348|FG001|NOT COMPLETED|Treatment Period||11
11134391|NCT01421147|12320347|FG000|STARTED|Extension Period||253
11134392|NCT01421147|12320348|FG001|STARTED|Extension Period||256
11134393|NCT01421147|12320347|FG000|COMPLETED|Extension Period||245
11134394|NCT01421147|12320348|FG001|COMPLETED|Extension Period||245
11134395|NCT01421147|12320347|FG000|NOT COMPLETED|Extension Period||8
11134396|NCT01421147|12320348|FG001|NOT COMPLETED|Extension Period||11
11134397|NCT01421186|12320359|FG000|STARTED|Overall Study||31
11134398|NCT01421186|12320360|FG001|STARTED|Overall Study||4
11134399|NCT01421186|12320361|FG002|STARTED|Overall Study||18
11134400|NCT01421186|12320362|FG003|STARTED|Overall Study||21
11134401|NCT01421186|12320363|FG004|STARTED|Overall Study||17
11134402|NCT01421186|12320359|FG000|COMPLETED|Overall Study||31
11134403|NCT01421186|12320360|FG001|COMPLETED|Overall Study||4
11134404|NCT01421186|12320361|FG002|COMPLETED|Overall Study||18
11134405|NCT01421186|12320362|FG003|COMPLETED|Overall Study||21
11134406|NCT01421186|12320363|FG004|COMPLETED|Overall Study||17
11134407|NCT01421186|12320359|FG000|NOT COMPLETED|Overall Study||0
11134408|NCT01421186|12320360|FG001|NOT COMPLETED|Overall Study||0
11134409|NCT01421186|12320361|FG002|NOT COMPLETED|Overall Study||0
11134410|NCT01421186|12320362|FG003|NOT COMPLETED|Overall Study||0
11134411|NCT01421186|12320363|FG004|NOT COMPLETED|Overall Study||0
11134412|NCT01421225|12320383|FG000|STARTED|Overall Study||4
11134413|NCT01421225|12320384|FG001|STARTED|Overall Study||6
11134414|NCT01421225|12320383|FG000|COMPLETED|Overall Study||4
11134415|NCT01421225|12320384|FG001|COMPLETED|Overall Study||5
11134416|NCT01421225|12320383|FG000|NOT COMPLETED|Overall Study||0
11134417|NCT01421225|12320384|FG001|NOT COMPLETED|Overall Study||1
11134418|NCT01421277|12320393|FG000|STARTED|Overall Study||25
11134419|NCT01421277|12320394|FG001|STARTED|Overall Study||191
11134420|NCT01421277|12320393|FG000|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
11134421|NCT01421277|12320394|FG001|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
11134422|NCT01421277|12320393|FG000|NOT COMPLETED|Overall Study||0
11134423|NCT01421277|12320394|FG001|NOT COMPLETED|Overall Study||92
11134424|NCT01421303|12320400|FG000|STARTED|Overall Study||80
11134425|NCT01421303|12320400|FG000|COMPLETED|Overall Study||58
11134426|NCT01421303|12320400|FG000|NOT COMPLETED|Overall Study||22
11134427|NCT01421342|12320407|FG000|STARTED|Acute Treatment Phase (12 Weeks)||511
11134428|NCT01421342|12320408|FG001|STARTED|Acute Treatment Phase (12 Weeks)||506
11134429|NCT01421342|12320409|FG002|STARTED|Acute Treatment Phase (12 Weeks)||505
11134430|NCT01421342|12320407|FG000|COMPLETED|Acute Treatment Phase (12 Weeks)||353
11134431|NCT01421342|12320408|FG001|COMPLETED|Acute Treatment Phase (12 Weeks)||378
11134432|NCT01421342|12320409|FG002|COMPLETED|Acute Treatment Phase (12 Weeks)||406
11134433|NCT01421342|12320407|FG000|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
11134434|NCT01421342|12320408|FG001|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
11134435|NCT01421342|12320409|FG002|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
11134436|NCT01421342|12320407|FG000|STARTED|Completed to Week 12 But Then Withdrawn||353
11134437|NCT01421342|12320408|FG001|STARTED|Completed to Week 12 But Then Withdrawn||378
11134438|NCT01421342|12320409|FG002|STARTED|Completed to Week 12 But Then Withdrawn||406
11134439|NCT01421342|12320407|FG000|COMPLETED|Completed to Week 12 But Then Withdrawn||204
11134440|NCT01421342|12320408|FG001|COMPLETED|Completed to Week 12 But Then Withdrawn||253
11134441|NCT01421342|12320409|FG002|COMPLETED|Completed to Week 12 But Then Withdrawn||268
11134442|NCT01421342|12320407|FG000|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
11134443|NCT01421342|12320408|FG001|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
11134444|NCT01421342|12320409|FG002|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
11134445|NCT01421342|12320407|FG000|STARTED|Continuation of Treatment (Week 12 - 36)||204
11134446|NCT01421342|12320408|FG001|STARTED|Continuation of Treatment (Week 12 - 36)||253
11134447|NCT01421342|12320409|FG002|STARTED|Continuation of Treatment (Week 12 - 36)||268
11134448|NCT01421342|12320407|FG000|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
11134449|NCT01421342|12320408|FG001|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
11134450|NCT01421342|12320409|FG002|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
11134451|NCT01421342|12320407|FG000|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
11134452|NCT01421342|12320408|FG001|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
11134453|NCT01421342|12320409|FG002|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
11134454|NCT01421355|12320417|FG000|STARTED|Overall Study||21
11134455|NCT01421355|12320417|FG000|COMPLETED|Overall Study||15
11134456|NCT01421355|12320417|FG000|NOT COMPLETED|Overall Study||6
11134457|NCT01421459|12320423|FG000|STARTED|Overall Study||379
11134458|NCT01421459|12320424|FG001|STARTED|Overall Study||380
11134459|NCT01421459|12320423|FG000|Received at Least 1 Dose of Study Drug|Overall Study||376
11134460|NCT01421459|12320424|FG001|Received at Least 1 Dose of Study Drug|Overall Study||380
11134461|NCT01421459|12320423|FG000|COMPLETED|Overall Study||334
11134462|NCT01421459|12320424|FG001|COMPLETED|Overall Study||328
11134463|NCT01421459|12320423|FG000|NOT COMPLETED|Overall Study||45
11134464|NCT01421459|12320424|FG001|NOT COMPLETED|Overall Study||52
11134465|NCT01421472|12320434|FG000|STARTED|Overall Study||67
11134466|NCT01421472|12320435|FG001|STARTED|Overall Study||33
11134467|NCT01421472|12320436|FG002|STARTED|Overall Study||64
11134468|NCT01421472|12320437|FG003|STARTED|Overall Study||32
11134469|NCT01421472|12320434|FG000|COMPLETED|Overall Study||67
11134470|NCT01421472|12320435|FG001|COMPLETED|Overall Study||33
11134471|NCT01421472|12320436|FG002|COMPLETED|Overall Study||64
11134472|NCT01421472|12320437|FG003|COMPLETED|Overall Study||32
11134473|NCT01421472|12320434|FG000|NOT COMPLETED|Overall Study||0
11134474|NCT01421472|12320435|FG001|NOT COMPLETED|Overall Study||0
11134475|NCT01421472|12320436|FG002|NOT COMPLETED|Overall Study||0
11134476|NCT01421472|12320437|FG003|NOT COMPLETED|Overall Study||0
11134477|NCT01421498|12320449|FG000|STARTED|Overall Study||293
11134478|NCT01421498|12320450|FG001|STARTED|Overall Study||295
11134479|NCT01421498|12320449|FG000|COMPLETED|Overall Study||281
11134480|NCT01421498|12320450|FG001|COMPLETED|Overall Study||284
11134481|NCT01421498|12320449|FG000|NOT COMPLETED|Overall Study||12
11134482|NCT01421498|12320450|FG001|NOT COMPLETED|Overall Study||11
11134483|NCT01421511|12320458|FG000|STARTED|Overall Study||332
11134484|NCT01421511|12320459|FG001|STARTED|Overall Study||334
11134485|NCT01421511|12320458|FG000|COMPLETED|Overall Study||313
11134486|NCT01421511|12320459|FG001|COMPLETED|Overall Study||306
11134487|NCT01421511|12320458|FG000|NOT COMPLETED|Overall Study||19
11134488|NCT01421511|12320459|FG001|NOT COMPLETED|Overall Study||28
11134489|NCT01421589|12320466|FG000|STARTED|Overall Study||15
11134490|NCT01421589|12320466|FG000|COMPLETED|Overall Study||15
11134491|NCT01421589|12320466|FG000|NOT COMPLETED|Overall Study||0
11134492|NCT01421641|12320473|FG000|STARTED|Overall Study||37
11134493|NCT01421641|12320474|FG001|STARTED|Overall Study||37
11134494|NCT01421641|12320473|FG000|COMPLETED|Overall Study||35
11134495|NCT01421641|12320474|FG001|COMPLETED|Overall Study||35
11134496|NCT01421641|12320473|FG000|NOT COMPLETED|Overall Study||2
11005209|NCT00721500|12182888|FG002|COMPLETED|Period Three||6
11005210|NCT00721500|12182889|FG003|COMPLETED|Period Three||6
11005211|NCT00721500|12182886|FG000|NOT COMPLETED|Period Three||0
11005212|NCT00721500|12182887|FG001|NOT COMPLETED|Period Three||0
11005213|NCT00721500|12182888|FG002|NOT COMPLETED|Period Three||0
11005214|NCT00721500|12182889|FG003|NOT COMPLETED|Period Three||0
11005215|NCT00721513|12182901|FG000|STARTED|Overall Study||20
11005216|NCT00721513|12182901|FG000|COMPLETED|Overall Study||20
11005217|NCT00721513|12182901|FG000|NOT COMPLETED|Overall Study||0
11005218|NCT00721539|12182905|FG000|STARTED|Overall Study||9
11005219|NCT00721539|12182905|FG000|COMPLETED|Overall Study||9
11005220|NCT00721539|12182905|FG000|NOT COMPLETED|Overall Study||0
11005221|NCT00721578|12182909|FG000|STARTED|Overall Study||12
11005222|NCT00721578|12182910|FG001|STARTED|Overall Study||11
11134497|NCT01421641|12320474|FG001|NOT COMPLETED|Overall Study||2
11134498|NCT01421654|12320482|FG000|STARTED|Overall Study||11
11134499|NCT01421654|12320483|FG001|STARTED|Overall Study||9
11134500|NCT01421654|12320482|FG000|COMPLETED|Overall Study||11
11134501|NCT01421654|12320483|FG001|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
11134502|NCT01421654|12320482|FG000|NOT COMPLETED|Overall Study||0
11134503|NCT01421654|12320483|FG001|NOT COMPLETED|Overall Study||0
11134504|NCT01421667|12320493|FG000|STARTED|Overall Study||35
11134505|NCT01421667|12320494|FG001|STARTED|Overall Study||68
11134506|NCT01421667|12320495|FG002|STARTED|Overall Study||53
11134507|NCT01421667|12320496|FG003|STARTED|Overall Study||16
11134508|NCT01421667|12320493|FG000|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
11134509|NCT01421667|12320494|FG001|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
11134510|NCT01421667|12320495|FG002|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
11134511|NCT01421667|12320496|FG003|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
11005223|NCT00721578|12182909|FG000|COMPLETED|Overall Study||10
11134512|NCT01421667|12320493|FG000|NOT COMPLETED|Overall Study||0
11134513|NCT01421667|12320494|FG001|NOT COMPLETED|Overall Study||2
11134514|NCT01421667|12320495|FG002|NOT COMPLETED|Overall Study||2
11134515|NCT01421667|12320496|FG003|NOT COMPLETED|Overall Study||1
11134516|NCT01421719|12320514|FG000|STARTED|Overall Study||20
11134517|NCT01421719|12320514|FG000|COMPLETED|Overall Study||16
11134518|NCT01421719|12320514|FG000|NOT COMPLETED|Overall Study||4
11134519|NCT01422070|12320521|FG000|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
11134520|NCT01422070|12320522|FG001|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
11134521|NCT01422070|12320521|FG000|COMPLETED|Overall Study||5031
11005224|NCT00721578|12182910|FG001|COMPLETED|Overall Study||9
11134522|NCT01422070|12320522|FG001|COMPLETED|Overall Study||803
11134523|NCT01422070|12320521|FG000|NOT COMPLETED|Overall Study||0
11134524|NCT01422070|12320522|FG001|NOT COMPLETED|Overall Study||0
11134525|NCT01422135|12320527|FG000|STARTED|Overall Study||4
11134526|NCT01422135|12320528|FG001|STARTED|Overall Study||4
11134527|NCT01422135|12320529|FG002|STARTED|Overall Study||4
11134528|NCT01422135|12320530|FG003|STARTED|Overall Study||4
11134529|NCT01422135|12320531|FG004|STARTED|Overall Study||4
11134530|NCT01422135|12320532|FG005|STARTED|Overall Study||4
11134531|NCT01422135|12320527|FG000|COMPLETED|Overall Study||4
11134532|NCT01422135|12320528|FG001|COMPLETED|Overall Study||4
11134533|NCT01422135|12320529|FG002|COMPLETED|Overall Study||3
11134534|NCT01422135|12320530|FG003|COMPLETED|Overall Study||4
11134535|NCT01422135|12320531|FG004|COMPLETED|Overall Study||4
11134536|NCT01422135|12320532|FG005|COMPLETED|Overall Study||3
11134537|NCT01422135|12320527|FG000|NOT COMPLETED|Overall Study||0
11134538|NCT01422135|12320528|FG001|NOT COMPLETED|Overall Study||0
11134539|NCT01422135|12320529|FG002|NOT COMPLETED|Overall Study||1
11134540|NCT01422135|12320530|FG003|NOT COMPLETED|Overall Study||0
11134541|NCT01422135|12320531|FG004|NOT COMPLETED|Overall Study||0
11134542|NCT01422135|12320532|FG005|NOT COMPLETED|Overall Study||1
11134543|NCT01422161|12320540|FG000|STARTED|Overall Study||10
11134544|NCT01422161|12320541|FG001|STARTED|Overall Study||6
11134545|NCT01422161|12320540|FG000|COMPLETED|Overall Study||10
11134546|NCT01422161|12320541|FG001|COMPLETED|Overall Study||6
11134547|NCT01422161|12320540|FG000|NOT COMPLETED|Overall Study||0
11134548|NCT01422161|12320541|FG001|NOT COMPLETED|Overall Study||0
11134549|NCT01422187|12320558|FG000|STARTED|Overall Study||8
11134550|NCT01422187|12320559|FG001|STARTED|Overall Study||9
11134551|NCT01422187|12320560|FG002|STARTED|Overall Study||2
11134552|NCT01422187|12320558|FG000|COMPLETED|Overall Study||7
11134553|NCT01422187|12320559|FG001|COMPLETED|Overall Study||8
11134554|NCT01422187|12320560|FG002|COMPLETED|Overall Study||2
11134555|NCT01422187|12320558|FG000|NOT COMPLETED|Overall Study||1
11134556|NCT01422187|12320559|FG001|NOT COMPLETED|Overall Study||1
11005225|NCT00721578|12182909|FG000|NOT COMPLETED|Overall Study||2
11005226|NCT00721578|12182910|FG001|NOT COMPLETED|Overall Study||2
11005227|NCT00721617|12182916|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12
11005228|NCT00721617|12182916|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
11134557|NCT01422187|12320560|FG002|NOT COMPLETED|Overall Study||0
11134558|NCT01422200|12320570|FG000|STARTED|Overall Study||11
11134559|NCT01422200|12320571|FG001|STARTED|Overall Study||11
11134560|NCT01422200|12320570|FG000|COMPLETED|Overall Study||11
11134561|NCT01422200|12320571|FG001|COMPLETED|Overall Study||11
11134562|NCT01422200|12320570|FG000|NOT COMPLETED|Overall Study||0
11134563|NCT01422200|12320571|FG001|NOT COMPLETED|Overall Study||0
11134564|NCT01422213|12320582|FG000|STARTED|Overall Study||196
11134565|NCT01422213|12320583|FG001|STARTED|Overall Study||195
11134566|NCT01422213|12320584|FG002|STARTED|Overall Study||207
11134567|NCT01422213|12320582|FG000|COMPLETED|Overall Study||163
11134568|NCT01422213|12320583|FG001|COMPLETED|Overall Study||173
11134569|NCT01422213|12320584|FG002|COMPLETED|Overall Study||178
11134570|NCT01422213|12320582|FG000|NOT COMPLETED|Overall Study||33
11134571|NCT01422213|12320583|FG001|NOT COMPLETED|Overall Study||22
11134572|NCT01422213|12320584|FG002|NOT COMPLETED|Overall Study||29
11134573|NCT01422226|12320594|FG000|STARTED|Overall Study||1
11134574|NCT01422226|12320595|FG001|STARTED|Overall Study||2
11134575|NCT01422226|12320594|FG000|COMPLETED|Overall Study||1
11134576|NCT01422226|12320595|FG001|COMPLETED|Overall Study||2
11134577|NCT01422226|12320594|FG000|NOT COMPLETED|Overall Study||0
11134578|NCT01422226|12320595|FG001|NOT COMPLETED|Overall Study||0
11134579|NCT01422239|12320603|FG000|STARTED|Overall Study||14
11134580|NCT01422239|12320604|FG001|STARTED|Overall Study||6
11134581|NCT01422239|12320603|FG000|COMPLETED|Overall Study||10
11134582|NCT01422239|12320604|FG001|COMPLETED|Overall Study||3
11240635|NCT02092220|12432969|FG001|STARTED|Period 1||22
11240636|NCT02092220|12432968|FG000|COMPLETED|Period 1||21
11240637|NCT02092220|12432969|FG001|COMPLETED|Period 1||20
11240638|NCT02092220|12432968|FG000|NOT COMPLETED|Period 1||0
11240639|NCT02092220|12432969|FG001|NOT COMPLETED|Period 1||2
11240640|NCT02092220|12432968|FG000|STARTED|Period 2||21
11240641|NCT02092220|12432969|FG001|STARTED|Period 2||20
11240642|NCT02092220|12432968|FG000|COMPLETED|Period 2||20
11240643|NCT02092220|12432969|FG001|COMPLETED|Period 2||19
11240644|NCT02092220|12432968|FG000|NOT COMPLETED|Period 2||1
11240645|NCT02092220|12432969|FG001|NOT COMPLETED|Period 2||1
11240646|NCT02092285|12432977|FG000|STARTED|Induction Phase||205
11240647|NCT02092285|12432977|FG000|COMPLETED|Induction Phase||170
11240648|NCT02092285|12432977|FG000|NOT COMPLETED|Induction Phase||35
11240649|NCT02092285|12432977|FG000|STARTED|Maintenance Phase & Follow-up||170
11240650|NCT02092285|12432977|FG000|COMPLETED|Maintenance Phase & Follow-up||60
11134583|NCT01422239|12320603|FG000|NOT COMPLETED|Overall Study||4
11134584|NCT01422239|12320604|FG001|NOT COMPLETED|Overall Study||3
11202333|NCT01839318|12392749|FG004|COMPLETED|Period 1, First Day of Wear||7
11202334|NCT01839318|12392750|FG005|COMPLETED|Period 1, First Day of Wear||2
11202335|NCT01839318|12392745|FG000|NOT COMPLETED|Period 1, First Day of Wear||0
11202336|NCT01839318|12392746|FG001|NOT COMPLETED|Period 1, First Day of Wear||0
11202337|NCT01839318|12392747|FG002|NOT COMPLETED|Period 1, First Day of Wear||0
11202338|NCT01839318|12392748|FG003|NOT COMPLETED|Period 1, First Day of Wear||0
11202339|NCT01839318|12392749|FG004|NOT COMPLETED|Period 1, First Day of Wear||0
11202340|NCT01839318|12392750|FG005|NOT COMPLETED|Period 1, First Day of Wear||0
11202341|NCT01839318|12392745|FG000|STARTED|Period 2, Second Day of Wear||4
11202342|NCT01839318|12392746|FG001|STARTED|Period 2, Second Day of Wear||4
11202343|NCT01839318|12392747|FG002|STARTED|Period 2, Second Day of Wear||5
11202344|NCT01839318|12392748|FG003|STARTED|Period 2, Second Day of Wear||6
11134585|NCT01422304|12320612|FG000|STARTED|Overall Study|Randomized|598
11134586|NCT01422304|12320613|FG001|STARTED|Overall Study|Randomized|600
11134587|NCT01422304|12320612|FG000|Treated|Overall Study||595
11134588|NCT01422304|12320613|FG001|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
11134589|NCT01422304|12320612|FG000|COMPLETED|Overall Study||574
11134590|NCT01422304|12320613|FG001|COMPLETED|Overall Study||563
11134591|NCT01422304|12320612|FG000|NOT COMPLETED|Overall Study||24
11134592|NCT01422304|12320613|FG001|NOT COMPLETED|Overall Study||37
11134593|NCT01422356|12320619|FG000|STARTED|Overall Study||200
11134594|NCT01422356|12320619|FG000|COMPLETED|Overall Study||169
11134595|NCT01422356|12320619|FG000|NOT COMPLETED|Overall Study||31
11134596|NCT01422369|12320623|FG000|STARTED|NK-104 4mg QD||28
11134597|NCT01422369|12320623|FG000|COMPLETED|NK-104 4mg QD||28
11134598|NCT01422369|12320623|FG000|NOT COMPLETED|NK-104 4mg QD||0
11134599|NCT01422369|12320623|FG000|STARTED|Prezista 800mg/100mg QD||28
11134600|NCT01422369|12320623|FG000|COMPLETED|Prezista 800mg/100mg QD||28
11134601|NCT01422369|12320623|FG000|NOT COMPLETED|Prezista 800mg/100mg QD||0
11134602|NCT01422369|12320623|FG000|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
11240651|NCT02092285|12432977|FG000|NOT COMPLETED|Maintenance Phase & Follow-up||110
11134603|NCT01422369|12320623|FG000|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
11134604|NCT01422369|12320623|FG000|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
11134605|NCT01422382|12320628|FG000|STARTED|NK-104 4mg Once Daily (QD)||28
11134606|NCT01422382|12320628|FG000|COMPLETED|NK-104 4mg Once Daily (QD)||28
11134607|NCT01422382|12320628|FG000|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
11134608|NCT01422382|12320628|FG000|STARTED|Diltiazem 240 mg QD||28
11134609|NCT01422382|12320628|FG000|COMPLETED|Diltiazem 240 mg QD||28
11134610|NCT01422382|12320628|FG000|NOT COMPLETED|Diltiazem 240 mg QD||0
11134611|NCT01422382|12320628|FG000|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
11134612|NCT01422382|12320628|FG000|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
11134613|NCT01422382|12320628|FG000|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
11134614|NCT01422408|12320632|FG000|STARTED|Overall Study||34
11240652|NCT02092298|12432981|FG000|STARTED|Overall Study||19
11240653|NCT02092298|12432981|FG000|COMPLETED|Overall Study||19
11134615|NCT01422408|12320632|FG000|COMPLETED|Overall Study||30
11134616|NCT01422408|12320632|FG000|NOT COMPLETED|Overall Study||4
11134617|NCT01422434|12320639|FG000|STARTED|Overall Study||227
11134618|NCT01422434|12320640|FG001|STARTED|Overall Study||226
11134619|NCT01422434|12320641|FG002|STARTED|Overall Study||223
11134620|NCT01422434|12320639|FG000|COMPLETED|Overall Study||216
11134621|NCT01422434|12320640|FG001|COMPLETED|Overall Study||221
11134622|NCT01422434|12320641|FG002|COMPLETED|Overall Study||217
11134623|NCT01422434|12320639|FG000|NOT COMPLETED|Overall Study||11
11134624|NCT01422434|12320640|FG001|NOT COMPLETED|Overall Study||5
11134625|NCT01422434|12320641|FG002|NOT COMPLETED|Overall Study||6
11134626|NCT01422538|12320652|FG000|STARTED|Overall Study||10
11134627|NCT01422538|12320653|FG001|STARTED|Overall Study||10
11134628|NCT01422538|12320654|FG002|STARTED|Overall Study||10
11134629|NCT01422538|12320652|FG000|COMPLETED|Overall Study||10
11134630|NCT01422538|12320653|FG001|COMPLETED|Overall Study||8
11134631|NCT01422538|12320654|FG002|COMPLETED|Overall Study||8
11134632|NCT01422538|12320652|FG000|NOT COMPLETED|Overall Study||0
11134633|NCT01422538|12320653|FG001|NOT COMPLETED|Overall Study||2
11134634|NCT01422538|12320654|FG002|NOT COMPLETED|Overall Study||2
11134635|NCT01422720|12320663|FG000|STARTED|Overall Study||72
11134636|NCT01422720|12320663|FG000|Safety Set|Overall Study||72
11134637|NCT01422720|12320663|FG000|Full Analysis Set (FAS)|Overall Study||71
11134638|NCT01422720|12320663|FG000|Per-Protocol Set (PPS)|Overall Study||55
11134639|NCT01422720|12320663|FG000|COMPLETED|Overall Study||50
11134640|NCT01422720|12320663|FG000|NOT COMPLETED|Overall Study||22
11134641|NCT01422824|12320671|FG000|STARTED|Overall Study||185
11134642|NCT01422824|12320671|FG000|Treated|Overall Study||184
11134643|NCT01422824|12320671|FG000|COMPLETED|Overall Study||147
11134644|NCT01422824|12320671|FG000|NOT COMPLETED|Overall Study||38
11134645|NCT01422850|12320675|FG000|STARTED|Overall Study||21
11134646|NCT01422850|12320675|FG000|Week 4 - First Treatment|Overall Study||21
11134647|NCT01422850|12320675|FG000|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
11134648|NCT01422850|12320675|FG000|Week 9 - Second Treatment|Overall Study||20
11134649|NCT01422850|12320675|FG000|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
11134650|NCT01422850|12320675|FG000|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
11134651|NCT01422850|12320675|FG000|COMPLETED|Overall Study||18
11134652|NCT01422850|12320675|FG000|NOT COMPLETED|Overall Study||3
11134653|NCT01422876|12320691|FG000|STARTED|Week 24||137
11134654|NCT01422876|12320692|FG001|STARTED|Week 24||136
11134655|NCT01422876|12320693|FG002|STARTED|Week 24||141
11134656|NCT01422876|12320694|FG003|STARTED|Week 24||140
11134657|NCT01422876|12320695|FG004|STARTED|Week 24||132
11134658|NCT01422876|12320696|FG005|STARTED|Week 24||137
11134659|NCT01422876|12320697|FG006|STARTED|Week 24||136
11134660|NCT01422876|12320698|FG007|STARTED|Week 24||135
11134661|NCT01422876|12320699|FG008|STARTED|Week 24||134
11134662|NCT01422876|12320700|FG009|STARTED|Week 24||135
11134663|NCT01422876|12320691|FG000|COMPLETED|Week 24||131
11134664|NCT01422876|12320692|FG001|COMPLETED|Week 24||133
11134665|NCT01422876|12320693|FG002|COMPLETED|Week 24||136
11134666|NCT01422876|12320694|FG003|COMPLETED|Week 24||132
11134667|NCT01422876|12320695|FG004|COMPLETED|Week 24||125
11134668|NCT01422876|12320696|FG005|COMPLETED|Week 24||131
11134669|NCT01422876|12320697|FG006|COMPLETED|Week 24||130
11134670|NCT01422876|12320698|FG007|COMPLETED|Week 24||128
11134671|NCT01422876|12320699|FG008|COMPLETED|Week 24||128
11134672|NCT01422876|12320700|FG009|COMPLETED|Week 24||125
11134673|NCT01422876|12320691|FG000|NOT COMPLETED|Week 24||6
11134674|NCT01422876|12320692|FG001|NOT COMPLETED|Week 24||3
11134675|NCT01422876|12320693|FG002|NOT COMPLETED|Week 24||5
11134676|NCT01422876|12320694|FG003|NOT COMPLETED|Week 24||8
11134677|NCT01422876|12320695|FG004|NOT COMPLETED|Week 24||7
11134678|NCT01422876|12320696|FG005|NOT COMPLETED|Week 24||6
11134679|NCT01422876|12320697|FG006|NOT COMPLETED|Week 24||6
11134680|NCT01422876|12320698|FG007|NOT COMPLETED|Week 24||7
11134681|NCT01422876|12320699|FG008|NOT COMPLETED|Week 24||6
11134682|NCT01422876|12320700|FG009|NOT COMPLETED|Week 24||10
11134683|NCT01422876|12320691|FG000|STARTED|Week 52||137
11134684|NCT01422876|12320692|FG001|STARTED|Week 52||136
11134685|NCT01422876|12320693|FG002|STARTED|Week 52||141
11134686|NCT01422876|12320694|FG003|STARTED|Week 52||140
11134687|NCT01422876|12320695|FG004|STARTED|Week 52||132
11134688|NCT01422876|12320696|FG005|STARTED|Week 52||137
11134689|NCT01422876|12320697|FG006|STARTED|Week 52||136
11134690|NCT01422876|12320698|FG007|STARTED|Week 52||135
11134691|NCT01422876|12320699|FG008|STARTED|Week 52||134
11134692|NCT01422876|12320700|FG009|STARTED|Week 52||135
11134693|NCT01422876|12320691|FG000|COMPLETED|Week 52||125
11134694|NCT01422876|12320692|FG001|COMPLETED|Week 52||126
11134695|NCT01422876|12320693|FG002|COMPLETED|Week 52||128
11134696|NCT01422876|12320694|FG003|COMPLETED|Week 52||122
11134697|NCT01422876|12320695|FG004|COMPLETED|Week 52||117
11134698|NCT01422876|12320696|FG005|COMPLETED|Week 52||120
11134699|NCT01422876|12320697|FG006|COMPLETED|Week 52||120
11134700|NCT01422876|12320698|FG007|COMPLETED|Week 52||112
11134701|NCT01422876|12320699|FG008|COMPLETED|Week 52||113
11134702|NCT01422876|12320700|FG009|COMPLETED|Week 52||118
11134703|NCT01422876|12320691|FG000|NOT COMPLETED|Week 52||12
11134704|NCT01422876|12320692|FG001|NOT COMPLETED|Week 52||10
11134705|NCT01422876|12320693|FG002|NOT COMPLETED|Week 52||13
11134706|NCT01422876|12320694|FG003|NOT COMPLETED|Week 52||18
11134707|NCT01422876|12320695|FG004|NOT COMPLETED|Week 52||15
11134708|NCT01422876|12320696|FG005|NOT COMPLETED|Week 52||17
11134709|NCT01422876|12320697|FG006|NOT COMPLETED|Week 52||16
11134710|NCT01422876|12320698|FG007|NOT COMPLETED|Week 52||23
11134711|NCT01422876|12320699|FG008|NOT COMPLETED|Week 52||21
11134712|NCT01422876|12320700|FG009|NOT COMPLETED|Week 52||17
11134713|NCT01422889|12320718|FG000|STARTED|Overall Study||1120
11134714|NCT01422889|12320718|FG000|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
11134715|NCT01422889|12320718|FG000|NOT COMPLETED|Overall Study||9
11134716|NCT01422915|12320722|FG000|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
11134717|NCT01422915|12320722|FG000|COMPLETED|Overall Study||3
11134718|NCT01422915|12320722|FG000|NOT COMPLETED|Overall Study||1
11134719|NCT01423084|12320729|FG000|STARTED|Overall Study||170
11134720|NCT01423084|12320730|FG001|STARTED|Overall Study||174
11134721|NCT01423084|12320729|FG000|COMPLETED|Overall Study||168
11134722|NCT01423084|12320730|FG001|COMPLETED|Overall Study||170
11134723|NCT01423084|12320729|FG000|NOT COMPLETED|Overall Study||2
11134724|NCT01423084|12320730|FG001|NOT COMPLETED|Overall Study||4
11134725|NCT01423162|12320739|FG000|STARTED|Overall Study||11
11134726|NCT01423162|12320740|FG001|STARTED|Overall Study||9
11134727|NCT01423162|12320739|FG000|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
11134728|NCT01423162|12320740|FG001|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
11134729|NCT01423162|12320739|FG000|NOT COMPLETED|Overall Study||0
11134730|NCT01423162|12320740|FG001|NOT COMPLETED|Overall Study||0
11134731|NCT01423253|12320746|FG000|STARTED|Overall Study||48
11134732|NCT01423253|12320746|FG000|COMPLETED|Overall Study||39
11134733|NCT01423253|12320746|FG000|NOT COMPLETED|Overall Study||9
11134734|NCT01423604|12320753|FG000|STARTED|Safety Run-In||9
11134735|NCT01423604|12320754|FG001|STARTED|Safety Run-In||0
11134736|NCT01423604|12320753|FG000|COMPLETED|Safety Run-In||0
11134737|NCT01423604|12320754|FG001|COMPLETED|Safety Run-In||0
11134738|NCT01423604|12320753|FG000|NOT COMPLETED|Safety Run-In||9
11134739|NCT01423604|12320754|FG001|NOT COMPLETED|Safety Run-In||0
11134740|NCT01423604|12320753|FG000|STARTED|Randomized||64
11134741|NCT01423604|12320754|FG001|STARTED|Randomized||63
11134742|NCT01423604|12320753|FG000|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
11134743|NCT01423604|12320754|FG001|COMPLETED|Randomized||0
11134744|NCT01423604|12320753|FG000|NOT COMPLETED|Randomized||63
11134745|NCT01423604|12320754|FG001|NOT COMPLETED|Randomized||63
11134746|NCT01423617|12320763|FG000|STARTED|Overall Study||46
11134747|NCT01423617|12320764|FG001|STARTED|Overall Study||46
11134748|NCT01423617|12320763|FG000|COMPLETED|Overall Study||46
11134749|NCT01423617|12320764|FG001|COMPLETED|Overall Study||45
11134750|NCT01423617|12320763|FG000|NOT COMPLETED|Overall Study||0
11134751|NCT01423617|12320764|FG001|NOT COMPLETED|Overall Study||1
11134752|NCT01423760|12320772|FG000|STARTED|Overall Study||14
11134753|NCT01423760|12320773|FG001|STARTED|Overall Study||13
11134754|NCT01423760|12320772|FG000|Number of Tecemotide Subjects|Overall Study||12
11134755|NCT01423760|12320773|FG001|Number of Tecemotide Subjects|Overall Study||8
11134756|NCT01423760|12320772|FG000|Number of Non-treatment Subjects|Overall Study||2
11134757|NCT01423760|12320773|FG001|Number of Non-treatment Subjects|Overall Study||5
11134758|NCT01423760|12320772|FG000|Safety Analysis Set|Overall Study||12
11134759|NCT01423760|12320773|FG001|Safety Analysis Set|Overall Study||8
11134760|NCT01423760|12320772|FG000|COMPLETED|Overall Study||14
11134761|NCT01423760|12320773|FG001|COMPLETED|Overall Study||13
11134762|NCT01423760|12320772|FG000|NOT COMPLETED|Overall Study||0
11134763|NCT01423760|12320773|FG001|NOT COMPLETED|Overall Study||0
11134764|NCT01423773|12320779|FG000|STARTED|Period One, 2 Days||10
11134765|NCT01423773|12320780|FG001|STARTED|Period One, 2 Days||10
11134766|NCT01423773|12320779|FG000|COMPLETED|Period One, 2 Days||10
11134767|NCT01423773|12320780|FG001|COMPLETED|Period One, 2 Days||10
11134768|NCT01423773|12320779|FG000|NOT COMPLETED|Period One, 2 Days||0
11134769|NCT01423773|12320780|FG001|NOT COMPLETED|Period One, 2 Days||0
11134770|NCT01423773|12320779|FG000|STARTED|Period 2, 2 Days||10
11134771|NCT01423773|12320780|FG001|STARTED|Period 2, 2 Days||10
11134772|NCT01423773|12320779|FG000|COMPLETED|Period 2, 2 Days||10
11134773|NCT01423773|12320780|FG001|COMPLETED|Period 2, 2 Days||10
11134774|NCT01423773|12320779|FG000|NOT COMPLETED|Period 2, 2 Days||0
11134775|NCT01423773|12320780|FG001|NOT COMPLETED|Period 2, 2 Days||0
11134776|NCT01423812|12320788|FG000|STARTED|Overall Study||30
11134777|NCT01423812|12320789|FG001|STARTED|Overall Study||30
11134778|NCT01423812|12320788|FG000|COMPLETED|Overall Study||27
11134779|NCT01423812|12320789|FG001|COMPLETED|Overall Study||26
11134780|NCT01423812|12320788|FG000|NOT COMPLETED|Overall Study||3
11134781|NCT01423812|12320789|FG001|NOT COMPLETED|Overall Study||4
11240654|NCT02092298|12432981|FG000|NOT COMPLETED|Overall Study||0
11240655|NCT02092311|12432987|FG000|STARTED|Overall Study||285
11240656|NCT02092311|12432988|FG001|STARTED|Overall Study||285
11240657|NCT02092311|12432987|FG000|COMPLETED|Overall Study||285
11240658|NCT02092311|12432988|FG001|COMPLETED|Overall Study||285
11240659|NCT02092311|12432987|FG000|NOT COMPLETED|Overall Study||0
11240660|NCT02092311|12432988|FG001|NOT COMPLETED|Overall Study||0
11240661|NCT02092324|12432996|FG000|STARTED|Overall Study||51
11240662|NCT02092324|12432996|FG000|End of Cycle 6|Overall Study|This study has an accrual goal of 25 evaluable subjects who reach cycle 7, week 1.|25
11240663|NCT02092324|12432996|FG000|Wildtype CSF3R|Overall Study||23
11240664|NCT02092324|12432996|FG000|Mutant CSF3R|Overall Study||26
11240665|NCT02092324|12432996|FG000|COMPLETED|Overall Study||32
11240666|NCT02092324|12432996|FG000|NOT COMPLETED|Overall Study||19
11240667|NCT02092350|12433005|FG000|STARTED|Overall Study||123
11240668|NCT02092350|12433006|FG001|STARTED|Overall Study||114
11240669|NCT02092350|12433005|FG000|COMPLETED|Overall Study||113
11134782|NCT01423916|12320800|FG000|STARTED|Overall Study||74
11134783|NCT01423916|12320801|FG001|STARTED|Overall Study||73
11134784|NCT01423916|12320802|FG002|STARTED|Overall Study||71
11134785|NCT01423916|12320800|FG000|COMPLETED|Overall Study||63
11134786|NCT01423916|12320801|FG001|COMPLETED|Overall Study||53
11134787|NCT01423916|12320802|FG002|COMPLETED|Overall Study||64
11134788|NCT01423916|12320800|FG000|NOT COMPLETED|Overall Study||11
11134789|NCT01423916|12320801|FG001|NOT COMPLETED|Overall Study||20
11134790|NCT01423916|12320802|FG002|NOT COMPLETED|Overall Study||7
11134791|NCT01424033|12320821|FG000|STARTED|Overall Study||5
11134792|NCT01424033|12320821|FG000|COMPLETED|Overall Study||0
11134793|NCT01424033|12320821|FG000|NOT COMPLETED|Overall Study||5
11134794|NCT01424072|12320828|FG000|STARTED|Overall Study||27
11134795|NCT01424072|12320829|FG001|STARTED|Overall Study||26
11005229|NCT00721617|12182916|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
11005230|NCT00721617|12182916|FG000|STARTED|4 Hours Into Saline Infusion||12
11005231|NCT00721617|12182916|FG000|COMPLETED|4 Hours Into Saline Infusion||12
11005232|NCT00721617|12182916|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0
11005233|NCT00721617|12182916|FG000|STARTED|8 Hours Into Saline Infusion||12
11134796|NCT01424072|12320830|FG002|STARTED|Overall Study||22
11134797|NCT01424072|12320828|FG000|COMPLETED|Overall Study||27
11134798|NCT01424072|12320829|FG001|COMPLETED|Overall Study||26
11134799|NCT01424072|12320830|FG002|COMPLETED|Overall Study||22
11134800|NCT01424072|12320828|FG000|NOT COMPLETED|Overall Study||0
11134801|NCT01424072|12320829|FG001|NOT COMPLETED|Overall Study||0
11134802|NCT01424072|12320830|FG002|NOT COMPLETED|Overall Study||0
11134803|NCT01424189|12320840|FG000|STARTED|Overall Study||386
11134804|NCT01424189|12320841|FG001|STARTED|Overall Study||188
11134805|NCT01424189|12320840|FG000|COMPLETED|Overall Study||373
11134806|NCT01424189|12320841|FG001|COMPLETED|Overall Study||182
11134807|NCT01424189|12320840|FG000|NOT COMPLETED|Overall Study||13
11134808|NCT01424189|12320841|FG001|NOT COMPLETED|Overall Study||6
11134809|NCT01424215|12320849|FG000|STARTED|Overall Study||50
11134810|NCT01424215|12320850|FG001|STARTED|Overall Study||50
11134811|NCT01424215|12320849|FG000|COMPLETED|Overall Study||50
11134812|NCT01424215|12320850|FG001|COMPLETED|Overall Study||50
11134813|NCT01424215|12320849|FG000|NOT COMPLETED|Overall Study||0
11134814|NCT01424215|12320850|FG001|NOT COMPLETED|Overall Study||0
11134815|NCT01424228|12320858|FG000|STARTED|Overall Study||182
11134816|NCT01424228|12320859|FG001|STARTED|Overall Study||182
11134817|NCT01424228|12320858|FG000|COMPLETED|Overall Study||126
11134818|NCT01424228|12320859|FG001|COMPLETED|Overall Study||135
11134819|NCT01424228|12320858|FG000|NOT COMPLETED|Overall Study||56
11134820|NCT01424228|12320859|FG001|NOT COMPLETED|Overall Study||47
11134821|NCT01424293|12320865|FG000|STARTED|Overall Study||7
11134822|NCT01424293|12320865|FG000|COMPLETED|Overall Study||7
11134823|NCT01424293|12320865|FG000|NOT COMPLETED|Overall Study||0
11134824|NCT01424306|12320869|FG000|STARTED|Overall Study||4
11134825|NCT01424306|12320870|FG001|STARTED|Overall Study||4
11134826|NCT01424306|12320871|FG002|STARTED|Overall Study||3
11134827|NCT01424306|12320872|FG003|STARTED|Overall Study||3
11134828|NCT01424306|12320873|FG004|STARTED|Overall Study||5
11134829|NCT01424306|12320874|FG005|STARTED|Overall Study||6
11134830|NCT01424306|12320869|FG000|COMPLETED|Overall Study||4
11240670|NCT02092350|12433006|FG001|COMPLETED|Overall Study||102
11134831|NCT01424306|12320870|FG001|COMPLETED|Overall Study||4
11134832|NCT01424306|12320871|FG002|COMPLETED|Overall Study||3
11134833|NCT01424306|12320872|FG003|COMPLETED|Overall Study||3
11134834|NCT01424306|12320873|FG004|COMPLETED|Overall Study||4
11005234|NCT00721617|12182916|FG000|COMPLETED|8 Hours Into Saline Infusion||12
11005235|NCT00721617|12182916|FG000|NOT COMPLETED|8 Hours Into Saline Infusion||0
11005236|NCT00721617|12182916|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
11005237|NCT00721617|12182916|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
11005238|NCT00721617|12182916|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
11005239|NCT00721617|12182916|FG000|STARTED|4 Hours Into Intralipid Infusion||12
11005240|NCT00721617|12182916|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12
11134835|NCT01424306|12320874|FG005|COMPLETED|Overall Study||6
11134836|NCT01424306|12320869|FG000|NOT COMPLETED|Overall Study||0
11134837|NCT01424306|12320870|FG001|NOT COMPLETED|Overall Study||0
11005241|NCT00721617|12182916|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
11134838|NCT01424306|12320871|FG002|NOT COMPLETED|Overall Study||0
11134839|NCT01424306|12320872|FG003|NOT COMPLETED|Overall Study||0
11134840|NCT01424306|12320873|FG004|NOT COMPLETED|Overall Study||1
11134841|NCT01424306|12320874|FG005|NOT COMPLETED|Overall Study||0
11134842|NCT01424397|12320918|FG000|STARTED|Period-1 (8 Days)||7
11134843|NCT01424397|12320919|FG001|STARTED|Period-1 (8 Days)||8
11134844|NCT01424397|12320920|FG002|STARTED|Period-1 (8 Days)||8
11134845|NCT01424397|12320921|FG003|STARTED|Period-1 (8 Days)||8
11134846|NCT01424397|12320922|FG004|STARTED|Period-1 (8 Days)||8
11134847|NCT01424397|12320923|FG005|STARTED|Period-1 (8 Days)||8
11134848|NCT01424397|12320924|FG006|STARTED|Period-1 (8 Days)||4
11134849|NCT01424397|12320925|FG007|STARTED|Period-1 (8 Days)||4
11005242|NCT00721617|12182916|FG000|STARTED|8 Hours Into Intralipid Infusion||12
11134850|NCT01424397|12320926|FG008|STARTED|Period-1 (8 Days)||4
11134851|NCT01424397|12320927|FG009|STARTED|Period-1 (8 Days)||3
11005243|NCT00721617|12182916|FG000|COMPLETED|8 Hours Into Intralipid Infusion||12
11005244|NCT00721617|12182916|FG000|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
11134852|NCT01424397|12320928|FG010|STARTED|Period-1 (8 Days)||4
11134853|NCT01424397|12320929|FG011|STARTED|Period-1 (8 Days)||4
11134854|NCT01424397|12320918|FG000|COMPLETED|Period-1 (8 Days)||7
11134855|NCT01424397|12320919|FG001|COMPLETED|Period-1 (8 Days)||8
11134856|NCT01424397|12320920|FG002|COMPLETED|Period-1 (8 Days)||8
11134857|NCT01424397|12320921|FG003|COMPLETED|Period-1 (8 Days)||8
11134858|NCT01424397|12320922|FG004|COMPLETED|Period-1 (8 Days)||8
11134859|NCT01424397|12320923|FG005|COMPLETED|Period-1 (8 Days)||8
11134860|NCT01424397|12320924|FG006|COMPLETED|Period-1 (8 Days)||4
11134861|NCT01424397|12320925|FG007|COMPLETED|Period-1 (8 Days)||4
11134862|NCT01424397|12320926|FG008|COMPLETED|Period-1 (8 Days)||4
11134863|NCT01424397|12320927|FG009|COMPLETED|Period-1 (8 Days)||3
11134864|NCT01424397|12320928|FG010|COMPLETED|Period-1 (8 Days)||4
11134865|NCT01424397|12320929|FG011|COMPLETED|Period-1 (8 Days)||4
11134866|NCT01424397|12320918|FG000|NOT COMPLETED|Period-1 (8 Days)||0
11134867|NCT01424397|12320919|FG001|NOT COMPLETED|Period-1 (8 Days)||0
11134868|NCT01424397|12320920|FG002|NOT COMPLETED|Period-1 (8 Days)||0
11134869|NCT01424397|12320921|FG003|NOT COMPLETED|Period-1 (8 Days)||0
11134870|NCT01424397|12320922|FG004|NOT COMPLETED|Period-1 (8 Days)||0
11134871|NCT01424397|12320923|FG005|NOT COMPLETED|Period-1 (8 Days)||0
11134872|NCT01424397|12320924|FG006|NOT COMPLETED|Period-1 (8 Days)||0
11134873|NCT01424397|12320925|FG007|NOT COMPLETED|Period-1 (8 Days)||0
11134874|NCT01424397|12320926|FG008|NOT COMPLETED|Period-1 (8 Days)||0
11134875|NCT01424397|12320927|FG009|NOT COMPLETED|Period-1 (8 Days)||0
11134876|NCT01424397|12320928|FG010|NOT COMPLETED|Period-1 (8 Days)||0
11134877|NCT01424397|12320929|FG011|NOT COMPLETED|Period-1 (8 Days)||0
11134878|NCT01424397|12320918|FG000|STARTED|Washout Period-1 (14-20 Days)||7
11134879|NCT01424397|12320919|FG001|STARTED|Washout Period-1 (14-20 Days)||8
11134880|NCT01424397|12320920|FG002|STARTED|Washout Period-1 (14-20 Days)||8
11134881|NCT01424397|12320921|FG003|STARTED|Washout Period-1 (14-20 Days)||8
11134882|NCT01424397|12320922|FG004|STARTED|Washout Period-1 (14-20 Days)||8
11134883|NCT01424397|12320923|FG005|STARTED|Washout Period-1 (14-20 Days)||8
11134884|NCT01424397|12320924|FG006|STARTED|Washout Period-1 (14-20 Days)||4
11134885|NCT01424397|12320925|FG007|STARTED|Washout Period-1 (14-20 Days)||4
11134886|NCT01424397|12320926|FG008|STARTED|Washout Period-1 (14-20 Days)||4
11134887|NCT01424397|12320927|FG009|STARTED|Washout Period-1 (14-20 Days)||3
11134888|NCT01424397|12320928|FG010|STARTED|Washout Period-1 (14-20 Days)||4
11134889|NCT01424397|12320929|FG011|STARTED|Washout Period-1 (14-20 Days)||4
11134890|NCT01424397|12320918|FG000|COMPLETED|Washout Period-1 (14-20 Days)||7
11134891|NCT01424397|12320919|FG001|COMPLETED|Washout Period-1 (14-20 Days)||8
11134892|NCT01424397|12320920|FG002|COMPLETED|Washout Period-1 (14-20 Days)||8
11134893|NCT01424397|12320921|FG003|COMPLETED|Washout Period-1 (14-20 Days)||8
11134894|NCT01424397|12320922|FG004|COMPLETED|Washout Period-1 (14-20 Days)||8
11134895|NCT01424397|12320923|FG005|COMPLETED|Washout Period-1 (14-20 Days)||8
11134896|NCT01424397|12320924|FG006|COMPLETED|Washout Period-1 (14-20 Days)||4
11134897|NCT01424397|12320925|FG007|COMPLETED|Washout Period-1 (14-20 Days)||4
11134898|NCT01424397|12320926|FG008|COMPLETED|Washout Period-1 (14-20 Days)||4
11134899|NCT01424397|12320927|FG009|COMPLETED|Washout Period-1 (14-20 Days)||3
11134900|NCT01424397|12320928|FG010|COMPLETED|Washout Period-1 (14-20 Days)||4
11134901|NCT01424397|12320929|FG011|COMPLETED|Washout Period-1 (14-20 Days)||4
11134902|NCT01424397|12320918|FG000|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
11134903|NCT01424397|12320919|FG001|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
11134904|NCT01424397|12320920|FG002|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
11134905|NCT01424397|12320921|FG003|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
11134906|NCT01424397|12320922|FG004|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
11134907|NCT01424397|12320923|FG005|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
11134908|NCT01424397|12320924|FG006|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
11134909|NCT01424397|12320925|FG007|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
11134910|NCT01424397|12320926|FG008|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
11134911|NCT01424397|12320927|FG009|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
11134912|NCT01424397|12320928|FG010|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
11240671|NCT02092350|12433005|FG000|NOT COMPLETED|Overall Study||10
11240672|NCT02092350|12433006|FG001|NOT COMPLETED|Overall Study||12
11240673|NCT02092389|12433014|FG000|STARTED|Overall Study||10
11134913|NCT01424397|12320929|FG011|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
11134914|NCT01424397|12320918|FG000|STARTED|Period-2 (8 Days)||7
11134915|NCT01424397|12320919|FG001|STARTED|Period-2 (8 Days)||8
11134916|NCT01424397|12320920|FG002|STARTED|Period-2 (8 Days)||8
11134917|NCT01424397|12320921|FG003|STARTED|Period-2 (8 Days)||8
11240674|NCT02092389|12433014|FG000|COMPLETED|Overall Study||4
11240675|NCT02092389|12433014|FG000|NOT COMPLETED|Overall Study||6
11240676|NCT02092415|12433018|FG000|STARTED|Overall Study||10
11240677|NCT02092415|12433018|FG000|COMPLETED|Overall Study||10
11240678|NCT02092415|12433018|FG000|NOT COMPLETED|Overall Study||0
11240679|NCT02092441|12433025|FG000|STARTED|Overall Study||37
11005245|NCT00721617|12182916|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
11134918|NCT01424397|12320922|FG004|STARTED|Period-2 (8 Days)||8
11134919|NCT01424397|12320923|FG005|STARTED|Period-2 (8 Days)||8
11134920|NCT01424397|12320924|FG006|STARTED|Period-2 (8 Days)||4
11134921|NCT01424397|12320925|FG007|STARTED|Period-2 (8 Days)||4
11134922|NCT01424397|12320926|FG008|STARTED|Period-2 (8 Days)||4
11134923|NCT01424397|12320927|FG009|STARTED|Period-2 (8 Days)||3
11134924|NCT01424397|12320928|FG010|STARTED|Period-2 (8 Days)||4
11134925|NCT01424397|12320929|FG011|STARTED|Period-2 (8 Days)||4
11134926|NCT01424397|12320918|FG000|COMPLETED|Period-2 (8 Days)||7
11134927|NCT01424397|12320919|FG001|COMPLETED|Period-2 (8 Days)||8
11134928|NCT01424397|12320920|FG002|COMPLETED|Period-2 (8 Days)||7
11005246|NCT00721617|12182916|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
11134929|NCT01424397|12320921|FG003|COMPLETED|Period-2 (8 Days)||8
11134930|NCT01424397|12320922|FG004|COMPLETED|Period-2 (8 Days)||8
11134931|NCT01424397|12320923|FG005|COMPLETED|Period-2 (8 Days)||8
11134932|NCT01424397|12320924|FG006|COMPLETED|Period-2 (8 Days)||4
11134933|NCT01424397|12320925|FG007|COMPLETED|Period-2 (8 Days)||4
11134934|NCT01424397|12320926|FG008|COMPLETED|Period-2 (8 Days)||4
11134935|NCT01424397|12320927|FG009|COMPLETED|Period-2 (8 Days)||3
11134936|NCT01424397|12320928|FG010|COMPLETED|Period-2 (8 Days)||4
11134937|NCT01424397|12320929|FG011|COMPLETED|Period-2 (8 Days)||4
11134938|NCT01424397|12320918|FG000|NOT COMPLETED|Period-2 (8 Days)||0
11134939|NCT01424397|12320919|FG001|NOT COMPLETED|Period-2 (8 Days)||0
11134940|NCT01424397|12320920|FG002|NOT COMPLETED|Period-2 (8 Days)||1
11134941|NCT01424397|12320921|FG003|NOT COMPLETED|Period-2 (8 Days)||0
11134942|NCT01424397|12320922|FG004|NOT COMPLETED|Period-2 (8 Days)||0
11134943|NCT01424397|12320923|FG005|NOT COMPLETED|Period-2 (8 Days)||0
11134944|NCT01424397|12320924|FG006|NOT COMPLETED|Period-2 (8 Days)||0
11134945|NCT01424397|12320925|FG007|NOT COMPLETED|Period-2 (8 Days)||0
11134946|NCT01424397|12320926|FG008|NOT COMPLETED|Period-2 (8 Days)||0
11134947|NCT01424397|12320927|FG009|NOT COMPLETED|Period-2 (8 Days)||0
11134948|NCT01424397|12320928|FG010|NOT COMPLETED|Period-2 (8 Days)||0
11134949|NCT01424397|12320929|FG011|NOT COMPLETED|Period-2 (8 Days)||0
11134950|NCT01424397|12320918|FG000|STARTED|Washout Period-2 (14-20 Days)||7
11134951|NCT01424397|12320919|FG001|STARTED|Washout Period-2 (14-20 Days)||8
11134952|NCT01424397|12320920|FG002|STARTED|Washout Period-2 (14-20 Days)||7
11134953|NCT01424397|12320921|FG003|STARTED|Washout Period-2 (14-20 Days)||8
11134954|NCT01424397|12320922|FG004|STARTED|Washout Period-2 (14-20 Days)||8
11134955|NCT01424397|12320923|FG005|STARTED|Washout Period-2 (14-20 Days)||8
11134956|NCT01424397|12320924|FG006|STARTED|Washout Period-2 (14-20 Days)||4
11134957|NCT01424397|12320925|FG007|STARTED|Washout Period-2 (14-20 Days)||4
11134958|NCT01424397|12320926|FG008|STARTED|Washout Period-2 (14-20 Days)||4
11134959|NCT01424397|12320927|FG009|STARTED|Washout Period-2 (14-20 Days)||3
11134960|NCT01424397|12320928|FG010|STARTED|Washout Period-2 (14-20 Days)||4
11134961|NCT01424397|12320929|FG011|STARTED|Washout Period-2 (14-20 Days)||4
11134962|NCT01424397|12320918|FG000|COMPLETED|Washout Period-2 (14-20 Days)||7
11240680|NCT02092441|12433026|FG001|STARTED|Overall Study||43
11240681|NCT02092441|12433025|FG000|COMPLETED|Overall Study||37
11134963|NCT01424397|12320919|FG001|COMPLETED|Washout Period-2 (14-20 Days)||8
11134964|NCT01424397|12320920|FG002|COMPLETED|Washout Period-2 (14-20 Days)||7
11134965|NCT01424397|12320921|FG003|COMPLETED|Washout Period-2 (14-20 Days)||8
11134966|NCT01424397|12320922|FG004|COMPLETED|Washout Period-2 (14-20 Days)||8
11134967|NCT01424397|12320923|FG005|COMPLETED|Washout Period-2 (14-20 Days)||8
11134968|NCT01424397|12320924|FG006|COMPLETED|Washout Period-2 (14-20 Days)||4
11134969|NCT01424397|12320925|FG007|COMPLETED|Washout Period-2 (14-20 Days)||4
11134970|NCT01424397|12320926|FG008|COMPLETED|Washout Period-2 (14-20 Days)||4
11134971|NCT01424397|12320927|FG009|COMPLETED|Washout Period-2 (14-20 Days)||3
11134972|NCT01424397|12320928|FG010|COMPLETED|Washout Period-2 (14-20 Days)||4
11134973|NCT01424397|12320929|FG011|COMPLETED|Washout Period-2 (14-20 Days)||4
11134974|NCT01424397|12320918|FG000|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
11134975|NCT01424397|12320919|FG001|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
11134976|NCT01424397|12320920|FG002|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
11134977|NCT01424397|12320921|FG003|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
11134978|NCT01424397|12320922|FG004|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
11134979|NCT01424397|12320923|FG005|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
11134980|NCT01424397|12320924|FG006|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
11134981|NCT01424397|12320925|FG007|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
11134982|NCT01424397|12320926|FG008|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
11134983|NCT01424397|12320927|FG009|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
11134984|NCT01424397|12320928|FG010|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
11134985|NCT01424397|12320929|FG011|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
11134986|NCT01424397|12320918|FG000|STARTED|Period-3 (8 Days)||7
11134987|NCT01424397|12320919|FG001|STARTED|Period-3 (8 Days)||8
11134988|NCT01424397|12320920|FG002|STARTED|Period-3 (8 Days)||7
11134989|NCT01424397|12320921|FG003|STARTED|Period-3 (8 Days)||8
11134990|NCT01424397|12320922|FG004|STARTED|Period-3 (8 Days)||8
11134991|NCT01424397|12320923|FG005|STARTED|Period-3 (8 Days)||8
11134992|NCT01424397|12320924|FG006|STARTED|Period-3 (8 Days)||4
11134993|NCT01424397|12320925|FG007|STARTED|Period-3 (8 Days)||4
11134994|NCT01424397|12320926|FG008|STARTED|Period-3 (8 Days)||4
11240682|NCT02092441|12433026|FG001|COMPLETED|Overall Study||43
11058405|NCT01003990|12240251|FG002|COMPLETED|Overall Study||53
11134995|NCT01424397|12320927|FG009|STARTED|Period-3 (8 Days)||3
11134996|NCT01424397|12320928|FG010|STARTED|Period-3 (8 Days)||4
11134997|NCT01424397|12320929|FG011|STARTED|Period-3 (8 Days)||4
11134998|NCT01424397|12320918|FG000|COMPLETED|Period-3 (8 Days)||7
11134999|NCT01424397|12320919|FG001|COMPLETED|Period-3 (8 Days)||8
11135000|NCT01424397|12320920|FG002|COMPLETED|Period-3 (8 Days)||7
11240683|NCT02092441|12433025|FG000|NOT COMPLETED|Overall Study||0
11135001|NCT01424397|12320921|FG003|COMPLETED|Period-3 (8 Days)||8
11135002|NCT01424397|12320922|FG004|COMPLETED|Period-3 (8 Days)||8
11135003|NCT01424397|12320923|FG005|COMPLETED|Period-3 (8 Days)||8
11135004|NCT01424397|12320924|FG006|COMPLETED|Period-3 (8 Days)||4
11135005|NCT01424397|12320925|FG007|COMPLETED|Period-3 (8 Days)||4
11135006|NCT01424397|12320926|FG008|COMPLETED|Period-3 (8 Days)||4
11135007|NCT01424397|12320927|FG009|COMPLETED|Period-3 (8 Days)||3
11135008|NCT01424397|12320928|FG010|COMPLETED|Period-3 (8 Days)||4
11135009|NCT01424397|12320929|FG011|COMPLETED|Period-3 (8 Days)||4
11135010|NCT01424397|12320918|FG000|NOT COMPLETED|Period-3 (8 Days)||0
11135011|NCT01424397|12320919|FG001|NOT COMPLETED|Period-3 (8 Days)||0
11135012|NCT01424397|12320920|FG002|NOT COMPLETED|Period-3 (8 Days)||0
11135013|NCT01424397|12320921|FG003|NOT COMPLETED|Period-3 (8 Days)||0
11135014|NCT01424397|12320922|FG004|NOT COMPLETED|Period-3 (8 Days)||0
11135015|NCT01424397|12320923|FG005|NOT COMPLETED|Period-3 (8 Days)||0
11135016|NCT01424397|12320924|FG006|NOT COMPLETED|Period-3 (8 Days)||0
11135017|NCT01424397|12320925|FG007|NOT COMPLETED|Period-3 (8 Days)||0
11135018|NCT01424397|12320926|FG008|NOT COMPLETED|Period-3 (8 Days)||0
11135019|NCT01424397|12320927|FG009|NOT COMPLETED|Period-3 (8 Days)||0
11135020|NCT01424397|12320928|FG010|NOT COMPLETED|Period-3 (8 Days)||0
11135021|NCT01424397|12320929|FG011|NOT COMPLETED|Period-3 (8 Days)||0
11135022|NCT01424501|12320949|FG000|STARTED|Overall Study||7
11135023|NCT01424501|12320950|FG001|STARTED|Overall Study||6
11135024|NCT01424501|12320951|FG002|STARTED|Overall Study||24
11135025|NCT01424501|12320952|FG003|STARTED|Overall Study||25
11135026|NCT01424501|12320953|FG004|STARTED|Overall Study||40
11135027|NCT01424501|12320954|FG005|STARTED|Overall Study||40
11135028|NCT01424501|12320949|FG000|COMPLETED|Overall Study||6
11135029|NCT01424501|12320950|FG001|COMPLETED|Overall Study||5
11135030|NCT01424501|12320951|FG002|COMPLETED|Overall Study||22
11135031|NCT01424501|12320952|FG003|COMPLETED|Overall Study||25
11135032|NCT01424501|12320953|FG004|COMPLETED|Overall Study||40
11135033|NCT01424501|12320954|FG005|COMPLETED|Overall Study||40
11135034|NCT01424501|12320949|FG000|NOT COMPLETED|Overall Study||1
11135035|NCT01424501|12320950|FG001|NOT COMPLETED|Overall Study||1
11135036|NCT01424501|12320951|FG002|NOT COMPLETED|Overall Study||2
11135037|NCT01424501|12320952|FG003|NOT COMPLETED|Overall Study||0
11135038|NCT01424501|12320953|FG004|NOT COMPLETED|Overall Study||0
11135039|NCT01424501|12320954|FG005|NOT COMPLETED|Overall Study||0
11135040|NCT01424514|12320969|FG000|STARTED|Period 1:Intervention Period 1 (14 Days)||20
11058406|NCT01003990|12240249|FG000|NOT COMPLETED|Overall Study||92
11058407|NCT01003990|12240250|FG001|NOT COMPLETED|Overall Study||51
11058408|NCT01003990|12240251|FG002|NOT COMPLETED|Overall Study||43
11058409|NCT01004003|12240268|FG000|STARTED|Overall Study||6
11058410|NCT01004003|12240269|FG001|STARTED|Overall Study||3
11058411|NCT01004003|12240270|FG002|STARTED|Overall Study||4
11058412|NCT01004003|12240271|FG003|STARTED|Overall Study||3
11058413|NCT01004003|12240272|FG004|STARTED|Overall Study||4
11058414|NCT01004003|12240273|FG005|STARTED|Overall Study||4
11058415|NCT01004003|12240274|FG006|STARTED|Overall Study||8
11058416|NCT01004003|12240275|FG007|STARTED|Overall Study||62
11058417|NCT01004003|12240276|FG008|STARTED|Overall Study||31
11058418|NCT01004003|12240268|FG000|COMPLETED|Overall Study||0
11058419|NCT01004003|12240269|FG001|COMPLETED|Overall Study||0
11058420|NCT01004003|12240270|FG002|COMPLETED|Overall Study||0
11058421|NCT01004003|12240271|FG003|COMPLETED|Overall Study||0
11058422|NCT01004003|12240272|FG004|COMPLETED|Overall Study||0
11058423|NCT01004003|12240273|FG005|COMPLETED|Overall Study||0
11058424|NCT01004003|12240274|FG006|COMPLETED|Overall Study||0
11058425|NCT01004003|12240275|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
11058426|NCT01004003|12240276|FG008|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
11135041|NCT01424514|12320970|FG001|STARTED|Period 1:Intervention Period 1 (14 Days)||20
11135042|NCT01424514|12320969|FG000|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
11135043|NCT01424514|12320970|FG001|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
11135044|NCT01424514|12320969|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
11135045|NCT01424514|12320970|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
11135046|NCT01424514|12320969|FG000|STARTED|Period 2:Washout Period (4 Weeks)||19
11135047|NCT01424514|12320970|FG001|STARTED|Period 2:Washout Period (4 Weeks)||19
11135048|NCT01424514|12320969|FG000|COMPLETED|Period 2:Washout Period (4 Weeks)||19
11135049|NCT01424514|12320970|FG001|COMPLETED|Period 2:Washout Period (4 Weeks)||19
11135050|NCT01424514|12320969|FG000|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
11135051|NCT01424514|12320970|FG001|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
11135052|NCT01424514|12320969|FG000|STARTED|Period 3:Intervention Period 2 (14 Days)||19
11135053|NCT01424514|12320970|FG001|STARTED|Period 3:Intervention Period 2 (14 Days)||19
11240684|NCT02092441|12433026|FG001|NOT COMPLETED|Overall Study||0
11135054|NCT01424514|12320969|FG000|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
11135055|NCT01424514|12320970|FG001|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
11135056|NCT01424514|12320969|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
11135057|NCT01424514|12320970|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
11135058|NCT01424566|12320981|FG000|STARTED|Single-blind Treatment||406
11135059|NCT01424566|12320982|FG001|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
11135060|NCT01424566|12320983|FG002|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
11135061|NCT01424566|12320981|FG000|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
11240685|NCT02092467|12433035|FG000|STARTED|Overall Study||1457
11240686|NCT02092467|12433036|FG001|STARTED|Overall Study||1457
11135062|NCT01424566|12320982|FG001|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
11135063|NCT01424566|12320983|FG002|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
11135064|NCT01424566|12320981|FG000|Single-blind Safety Population|Single-blind Treatment||404
11135065|NCT01424566|12320982|FG001|Single-blind Safety Population|Single-blind Treatment||0
11135066|NCT01424566|12320983|FG002|Single-blind Safety Population|Single-blind Treatment||0
11135067|NCT01424566|12320981|FG000|Met Randomization Criteria|Single-blind Treatment||206
11135068|NCT01424566|12320982|FG001|Met Randomization Criteria|Single-blind Treatment||0
11135069|NCT01424566|12320983|FG002|Met Randomization Criteria|Single-blind Treatment||0
11135070|NCT01424566|12320981|FG000|COMPLETED|Single-blind Treatment||206
11135071|NCT01424566|12320982|FG001|COMPLETED|Single-blind Treatment||0
11135072|NCT01424566|12320983|FG002|COMPLETED|Single-blind Treatment||0
11135073|NCT01424566|12320981|FG000|NOT COMPLETED|Single-blind Treatment||200
11005247|NCT00721617|12182916|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
11005248|NCT00721617|12182916|FG000|STARTED|4 Hours Into Dextrose Infusion||12
11005249|NCT00721617|12182916|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12
11005250|NCT00721617|12182916|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
11005251|NCT00721617|12182916|FG000|STARTED|8 Hours Into Dextrose Infusion||12
11005252|NCT00721617|12182916|FG000|COMPLETED|8 Hours Into Dextrose Infusion||12
11005253|NCT00721617|12182916|FG000|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
11005254|NCT00721617|12182916|FG000|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
11005255|NCT00721617|12182916|FG000|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
11005256|NCT00721617|12182916|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
11005257|NCT00721617|12182916|FG000|STARTED|4 Hours Into Intralipid/Dextrose||12
11005258|NCT00721617|12182916|FG000|COMPLETED|4 Hours Into Intralipid/Dextrose||12
11005259|NCT00721617|12182916|FG000|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
11005260|NCT00721617|12182916|FG000|STARTED|8 Hours Into Intralipid/Dextrose||12
11005261|NCT00721617|12182916|FG000|COMPLETED|8 Hours Into Intralipid/Dextrose||12
11135074|NCT01424566|12320982|FG001|NOT COMPLETED|Single-blind Treatment||0
11135075|NCT01424566|12320983|FG002|NOT COMPLETED|Single-blind Treatment||0
11135076|NCT01424566|12320981|FG000|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
11135077|NCT01424566|12320982|FG001|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
11135078|NCT01424566|12320983|FG002|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
11135079|NCT01424566|12320981|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
11135080|NCT01424566|12320982|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
11135081|NCT01424566|12320983|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
11135082|NCT01424566|12320981|FG000|Randomized Safety Population|Double-blind Treatment||0
11135083|NCT01424566|12320982|FG001|Randomized Safety Population|Double-blind Treatment||103
11135084|NCT01424566|12320983|FG002|Randomized Safety Population|Double-blind Treatment||103
11135085|NCT01424566|12320981|FG000|ITT Population|Double-blind Treatment||0
11135086|NCT01424566|12320982|FG001|ITT Population|Double-blind Treatment||103
11135087|NCT01424566|12320983|FG002|ITT Population|Double-blind Treatment||103
11135088|NCT01424566|12320981|FG000|COMPLETED|Double-blind Treatment||0
11135089|NCT01424566|12320982|FG001|COMPLETED|Double-blind Treatment||78
11135090|NCT01424566|12320983|FG002|COMPLETED|Double-blind Treatment||88
11135091|NCT01424566|12320981|FG000|NOT COMPLETED|Double-blind Treatment||0
11135092|NCT01424566|12320982|FG001|NOT COMPLETED|Double-blind Treatment||25
11135093|NCT01424566|12320983|FG002|NOT COMPLETED|Double-blind Treatment||15
11240687|NCT02092467|12433037|FG002|STARTED|Overall Study||1458
11240688|NCT02092467|12433035|FG000|Treated|Overall Study||1455
11240689|NCT02092467|12433036|FG001|Treated|Overall Study||1456
11240690|NCT02092467|12433037|FG002|Treated|Overall Study||1451
11240691|NCT02092467|12433035|FG000|COMPLETED|Overall Study||1053
11240692|NCT02092467|12433036|FG001|COMPLETED|Overall Study||998
11240693|NCT02092467|12433037|FG002|COMPLETED|Overall Study||1060
11240694|NCT02092467|12433035|FG000|NOT COMPLETED|Overall Study||404
11240695|NCT02092467|12433036|FG001|NOT COMPLETED|Overall Study||459
11240696|NCT02092467|12433037|FG002|NOT COMPLETED|Overall Study||398
11005262|NCT00721617|12182916|FG000|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
11005263|NCT00721630|12182921|FG000|STARTED|Overall Study||24
11135094|NCT01424644|12320992|FG000|STARTED|Overall Study||402
11135095|NCT01424644|12320993|FG001|STARTED|Overall Study||399
11135096|NCT01424644|12320992|FG000|COMPLETED|Overall Study||369
11135097|NCT01424644|12320993|FG001|COMPLETED|Overall Study||372
11135098|NCT01424644|12320992|FG000|NOT COMPLETED|Overall Study||33
11135099|NCT01424644|12320993|FG001|NOT COMPLETED|Overall Study||27
11135100|NCT01424670|12321001|FG000|STARTED|6-Month Intensive Period (182 Days)||341
11135101|NCT01424670|12321002|FG001|STARTED|6-Month Intensive Period (182 Days)||170
11135102|NCT01424670|12321001|FG000|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341
11135103|NCT01424670|12321002|FG001|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170
11135104|NCT01424670|12321001|FG000|COMPLETED|6-Month Intensive Period (182 Days)||322
11135105|NCT01424670|12321002|FG001|COMPLETED|6-Month Intensive Period (182 Days)||156
11135106|NCT01424670|12321001|FG000|NOT COMPLETED|6-Month Intensive Period (182 Days)||19
11135107|NCT01424670|12321002|FG001|NOT COMPLETED|6-Month Intensive Period (182 Days)||14
11135108|NCT01424670|12321001|FG000|STARTED|Continuation Period||322
11135109|NCT01424670|12321002|FG001|STARTED|Continuation Period||156
11135110|NCT01424670|12321001|FG000|COMPLETED|Continuation Period||288
11240697|NCT02092610|12433049|FG000|STARTED|Overall Study||25
11135111|NCT01424670|12321002|FG001|COMPLETED|Continuation Period||142
11135112|NCT01424670|12321001|FG000|NOT COMPLETED|Continuation Period||34
11135113|NCT01424670|12321002|FG001|NOT COMPLETED|Continuation Period||14
11135114|NCT01424722|12321010|FG000|STARTED|Overall Study||2258
11240698|NCT02092610|12433050|FG001|STARTED|Overall Study||52
11135115|NCT01424722|12321010|FG000|COMPLETED|Overall Study||0
11135116|NCT01424722|12321010|FG000|NOT COMPLETED|Overall Study||2258
11135117|NCT01424813|12321016|FG000|STARTED|Overall Study||79
11135118|NCT01424813|12321017|FG001|STARTED|Overall Study||79
11135119|NCT01424813|12321016|FG000|Treated|Overall Study|Safety set and full analysis set|79
11135120|NCT01424813|12321017|FG001|Treated|Overall Study|Safety set and full analysis set|78
11135121|NCT01424813|12321016|FG000|COMPLETED|Overall Study||74
11135122|NCT01424813|12321017|FG001|COMPLETED|Overall Study||77
11135123|NCT01424813|12321016|FG000|NOT COMPLETED|Overall Study||5
11135124|NCT01424813|12321017|FG001|NOT COMPLETED|Overall Study||2
11135125|NCT01424930|12321025|FG000|STARTED|Overall Study||7
11135126|NCT01424930|12321026|FG001|STARTED|Overall Study||18
11135127|NCT01424930|12321025|FG000|Completed Food Safety Evaluation|Overall Study||6
11135128|NCT01424930|12321026|FG001|Completed Food Safety Evaluation|Overall Study||18
11135129|NCT01424930|12321025|FG000|COMPLETED|Overall Study||3
11135130|NCT01424930|12321026|FG001|COMPLETED|Overall Study||4
11135131|NCT01424930|12321025|FG000|NOT COMPLETED|Overall Study||4
11135132|NCT01424930|12321026|FG001|NOT COMPLETED|Overall Study||14
11135133|NCT01424943|12321034|FG000|STARTED|Overall Study||25
11135134|NCT01424943|12321035|FG001|STARTED|Overall Study||24
11135135|NCT01424943|12321034|FG000|COMPLETED|Overall Study||12
11135136|NCT01424943|12321035|FG001|COMPLETED|Overall Study||23
11135137|NCT01424943|12321034|FG000|NOT COMPLETED|Overall Study||13
11135138|NCT01424943|12321035|FG001|NOT COMPLETED|Overall Study||1
11135139|NCT01425190|12321044|FG000|STARTED|Overall Study||16
11135140|NCT01425190|12321045|FG001|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
11135141|NCT01425190|12321046|FG002|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
11135142|NCT01425190|12321044|FG000|COMPLETED|Overall Study||15
11135143|NCT01425190|12321045|FG001|COMPLETED|Overall Study||0
11135144|NCT01425190|12321046|FG002|COMPLETED|Overall Study||0
11135145|NCT01425190|12321044|FG000|NOT COMPLETED|Overall Study||1
11240699|NCT02092610|12433049|FG000|COMPLETED|Overall Study||17
11240700|NCT02092610|12433050|FG001|COMPLETED|Overall Study||40
11240701|NCT02092610|12433049|FG000|NOT COMPLETED|Overall Study||8
11240702|NCT02092610|12433050|FG001|NOT COMPLETED|Overall Study||12
11240703|NCT02092649|12433058|FG000|STARTED|Overall Study|13 participants recruited|13
11240704|NCT02092649|12433059|FG001|STARTED|Overall Study|13 participants recruited|13
11240705|NCT02092649|12433058|FG000|COMPLETED|Overall Study|13 participants finished study|13
11240706|NCT02092649|12433059|FG001|COMPLETED|Overall Study|13 participants finished study|13
11240707|NCT02092649|12433058|FG000|NOT COMPLETED|Overall Study||0
11240708|NCT02092649|12433059|FG001|NOT COMPLETED|Overall Study||0
11240709|NCT02092662|12433067|FG000|STARTED|Overall Study||38
11240710|NCT02092662|12433068|FG001|STARTED|Overall Study||19
11240711|NCT02092662|12433067|FG000|Recruited|Overall Study||38
11240712|NCT02092662|12433068|FG001|Recruited|Overall Study||19
11240713|NCT02092662|12433067|FG000|COMPLETED|Overall Study||25
11240714|NCT02092662|12433068|FG001|COMPLETED|Overall Study||19
11240715|NCT02092662|12433067|FG000|NOT COMPLETED|Overall Study||13
11240716|NCT02092662|12433068|FG001|NOT COMPLETED|Overall Study||0
11240717|NCT02092857|12433078|FG000|STARTED|Overall Study||30
11240718|NCT02092857|12433079|FG001|STARTED|Overall Study||30
11005264|NCT00721630|12182921|FG000|COMPLETED|Overall Study||23
11005265|NCT00721630|12182921|FG000|NOT COMPLETED|Overall Study||1
11240719|NCT02092857|12433080|FG002|STARTED|Overall Study||29
11240720|NCT02092857|12433078|FG000|COMPLETED|Overall Study||20
11240721|NCT02092857|12433079|FG001|COMPLETED|Overall Study||18
11240722|NCT02092857|12433080|FG002|COMPLETED|Overall Study||16
11240723|NCT02092857|12433078|FG000|NOT COMPLETED|Overall Study||10
11240724|NCT02092857|12433079|FG001|NOT COMPLETED|Overall Study||12
11240725|NCT02092857|12433080|FG002|NOT COMPLETED|Overall Study||13
11240726|NCT02092909|12433092|FG000|STARTED|Overall Study||6
11240727|NCT02092909|12433093|FG001|STARTED|Overall Study||5
11240728|NCT02092909|12433094|FG002|STARTED|Overall Study||14
11240729|NCT02092909|12433095|FG003|STARTED|Overall Study||6
11240730|NCT02092909|12433092|FG000|COMPLETED|Overall Study||5
11240731|NCT02092909|12433093|FG001|COMPLETED|Overall Study||2
11240732|NCT02092909|12433094|FG002|COMPLETED|Overall Study||5
11240733|NCT02092909|12433095|FG003|COMPLETED|Overall Study||0
11240734|NCT02092909|12433092|FG000|NOT COMPLETED|Overall Study||1
11240735|NCT02092909|12433093|FG001|NOT COMPLETED|Overall Study||3
11240736|NCT02092909|12433094|FG002|NOT COMPLETED|Overall Study||9
11240737|NCT02092909|12433095|FG003|NOT COMPLETED|Overall Study||6
11240738|NCT02092961|12433108|FG000|STARTED|Overall Study|Patients who received treatment|33
11240739|NCT02092961|12433109|FG001|STARTED|Overall Study|Patients who received treatment|28
11135146|NCT01425190|12321045|FG001|NOT COMPLETED|Overall Study||0
11135147|NCT01425190|12321046|FG002|NOT COMPLETED|Overall Study||0
11135148|NCT01425203|12321056|FG000|STARTED|Treatment Phase||159
11135149|NCT01425203|12321057|FG001|STARTED|Treatment Phase||79
11240740|NCT02092961|12433110|FG002|STARTED|Overall Study|Patients who received treatment|29
11240741|NCT02092961|12433108|FG000|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
11240742|NCT02092961|12433109|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
11240743|NCT02092961|12433110|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
11135150|NCT01425203|12321058|FG002|STARTED|Treatment Phase||0
11135151|NCT01425203|12321056|FG000|Treated (FAS)|Treatment Phase||159
11135152|NCT01425203|12321057|FG001|Treated (FAS)|Treatment Phase||78
11135153|NCT01425203|12321058|FG002|Treated (FAS)|Treatment Phase||0
11135154|NCT01425203|12321056|FG000|COMPLETED|Treatment Phase||132
11135155|NCT01425203|12321057|FG001|COMPLETED|Treatment Phase||42
11135156|NCT01425203|12321058|FG002|COMPLETED|Treatment Phase||0
11135157|NCT01425203|12321056|FG000|NOT COMPLETED|Treatment Phase||27
11135158|NCT01425203|12321057|FG001|NOT COMPLETED|Treatment Phase||37
11135159|NCT01425203|12321058|FG002|NOT COMPLETED|Treatment Phase||0
11135160|NCT01425203|12321056|FG000|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
11135161|NCT01425203|12321057|FG001|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
11135162|NCT01425203|12321058|FG002|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
11135163|NCT01425203|12321056|FG000|COMPLETED|Crossover Phase||0
11135164|NCT01425203|12321057|FG001|COMPLETED|Crossover Phase||0
11135165|NCT01425203|12321058|FG002|COMPLETED|Crossover Phase||21
11135166|NCT01425203|12321056|FG000|NOT COMPLETED|Crossover Phase||0
11135167|NCT01425203|12321057|FG001|NOT COMPLETED|Crossover Phase||0
11135168|NCT01425203|12321058|FG002|NOT COMPLETED|Crossover Phase||6
11135169|NCT01425203|12321056|FG000|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
11135170|NCT01425203|12321057|FG001|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
11135171|NCT01425203|12321058|FG002|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
11135172|NCT01425203|12321056|FG000|COMPLETED|Follow-up Phase||153
11135173|NCT01425203|12321057|FG001|COMPLETED|Follow-up Phase||49
11135174|NCT01425203|12321058|FG002|COMPLETED|Follow-up Phase||27
11005266|NCT00721734|12182930|FG000|STARTED|Overall Study||12
11005267|NCT00721734|12182931|FG001|STARTED|Overall Study||12
11005268|NCT00721734|12182932|FG002|STARTED|Overall Study||10
11005269|NCT00721734|12182933|FG003|STARTED|Overall Study||8
11005270|NCT00721734|12182934|FG004|STARTED|Overall Study||8
11005271|NCT00721734|12182930|FG000|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
11005272|NCT00721734|12182931|FG001|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
11005273|NCT00721734|12182932|FG002|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
11005274|NCT00721734|12182933|FG003|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
11005275|NCT00721734|12182934|FG004|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
11005276|NCT00721734|12182930|FG000|NOT COMPLETED|Overall Study||8
11005277|NCT00721734|12182931|FG001|NOT COMPLETED|Overall Study||12
11005278|NCT00721734|12182932|FG002|NOT COMPLETED|Overall Study||8
11005279|NCT00721734|12182933|FG003|NOT COMPLETED|Overall Study||6
11005280|NCT00721734|12182934|FG004|NOT COMPLETED|Overall Study||6
11005281|NCT00721799|12182946|FG000|STARTED|Overall Study||33
11005282|NCT00721799|12182946|FG000|Recieved FLT PET Scan 1|Overall Study||26
11135175|NCT01425203|12321056|FG000|NOT COMPLETED|Follow-up Phase||0
11135176|NCT01425203|12321057|FG001|NOT COMPLETED|Follow-up Phase||0
11135177|NCT01425203|12321058|FG002|NOT COMPLETED|Follow-up Phase||0
11240744|NCT02092961|12433108|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
11240745|NCT02092961|12433109|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
11240746|NCT02092961|12433110|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
11240747|NCT02092961|12433108|FG000|NOT COMPLETED|Overall Study||21
11135178|NCT01425229|12321066|FG000|STARTED|Bosentan Single Dose||16
11135179|NCT01425229|12321066|FG000|COMPLETED|Bosentan Single Dose||16
11135180|NCT01425229|12321066|FG000|NOT COMPLETED|Bosentan Single Dose||0
11135181|NCT01425229|12321066|FG000|STARTED|Bosentan Steady-state||16
11135182|NCT01425229|12321066|FG000|COMPLETED|Bosentan Steady-state||16
11135183|NCT01425229|12321066|FG000|NOT COMPLETED|Bosentan Steady-state||0
11135184|NCT01425229|12321066|FG000|STARTED|Bosentan During Clarithromycin||16
11135185|NCT01425229|12321066|FG000|COMPLETED|Bosentan During Clarithromycin||16
11135186|NCT01425229|12321066|FG000|NOT COMPLETED|Bosentan During Clarithromycin||0
11135187|NCT01425268|12321076|FG000|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
11135188|NCT01425268|12321077|FG001|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
11135189|NCT01425268|12321076|FG000|COMPLETED|Overall Study||98
11135190|NCT01425268|12321077|FG001|COMPLETED|Overall Study||52
11135191|NCT01425268|12321076|FG000|NOT COMPLETED|Overall Study||8
11135192|NCT01425268|12321077|FG001|NOT COMPLETED|Overall Study||0
11135193|NCT01425307|12321085|FG000|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
11135194|NCT01425307|12321086|FG001|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
11135195|NCT01425307|12321085|FG000|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
11135196|NCT01425307|12321086|FG001|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
11135197|NCT01425307|12321085|FG000|NOT COMPLETED|Overall Study||19
11135198|NCT01425307|12321086|FG001|NOT COMPLETED|Overall Study||19
11135199|NCT01425359|12321096|FG000|STARTED|Overall Study||476
11135200|NCT01425359|12321097|FG001|STARTED|Overall Study||473
11135201|NCT01425359|12321096|FG000|COMPLETED|Overall Study||457
11135202|NCT01425359|12321097|FG001|COMPLETED|Overall Study||451
11135203|NCT01425359|12321096|FG000|NOT COMPLETED|Overall Study||19
11135204|NCT01425359|12321097|FG001|NOT COMPLETED|Overall Study||22
11135205|NCT01425463|12321106|FG000|STARTED|Overall Study||130
11135206|NCT01425463|12321107|FG001|STARTED|Overall Study||126
11135207|NCT01425463|12321106|FG000|Safety Set|Overall Study||126
11135208|NCT01425463|12321107|FG001|Safety Set|Overall Study||122
11135209|NCT01425463|12321106|FG000|Full Analysis Set|Overall Study||122
11135210|NCT01425463|12321107|FG001|Full Analysis Set|Overall Study||116
11135211|NCT01425463|12321106|FG000|COMPLETED|Overall Study||106
11135212|NCT01425463|12321107|FG001|COMPLETED|Overall Study||102
11135213|NCT01425463|12321106|FG000|NOT COMPLETED|Overall Study||24
11135214|NCT01425463|12321107|FG001|NOT COMPLETED|Overall Study||24
11135215|NCT01425528|12321115|FG000|STARTED|Overall Study||6
11135216|NCT01425528|12321116|FG001|STARTED|Overall Study||6
11135217|NCT01425528|12321115|FG000|COMPLETED|Overall Study||5
11135218|NCT01425528|12321116|FG001|COMPLETED|Overall Study||5
11135219|NCT01425528|12321115|FG000|NOT COMPLETED|Overall Study||1
11135220|NCT01425528|12321116|FG001|NOT COMPLETED|Overall Study||1
11135221|NCT01425281|12321124|FG000|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335
11135222|NCT01425281|12321125|FG001|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166
11135223|NCT01425281|12321124|FG000|COMPLETED|At 30-day Clinical Follow-up||334
11135224|NCT01425281|12321125|FG001|COMPLETED|At 30-day Clinical Follow-up||166
11135225|NCT01425281|12321124|FG000|NOT COMPLETED|At 30-day Clinical Follow-up||1
11135226|NCT01425281|12321125|FG001|NOT COMPLETED|At 30-day Clinical Follow-up||0
11135227|NCT01425281|12321124|FG000|STARTED|At 180-day Clinical Follow-up||334
11135228|NCT01425281|12321125|FG001|STARTED|At 180-day Clinical Follow-up||166
11135229|NCT01425281|12321124|FG000|COMPLETED|At 180-day Clinical Follow-up||331
11135230|NCT01425281|12321125|FG001|COMPLETED|At 180-day Clinical Follow-up||165
11135231|NCT01425281|12321124|FG000|NOT COMPLETED|At 180-day Clinical Follow-up||3
11135232|NCT01425281|12321125|FG001|NOT COMPLETED|At 180-day Clinical Follow-up||1
11135233|NCT01425281|12321124|FG000|STARTED|At 1-year Clinical Follow-up||331
11135234|NCT01425281|12321125|FG001|STARTED|At 1-year Clinical Follow-up||165
11135235|NCT01425281|12321124|FG000|COMPLETED|At 1-year Clinical Follow-up||329
11135236|NCT01425281|12321125|FG001|COMPLETED|At 1-year Clinical Follow-up||164
11135237|NCT01425281|12321124|FG000|NOT COMPLETED|At 1-year Clinical Follow-up||2
11135238|NCT01425281|12321125|FG001|NOT COMPLETED|At 1-year Clinical Follow-up||1
11135239|NCT01425281|12321124|FG000|STARTED|At 2-year Clinical Follow-up||329
11135240|NCT01425281|12321125|FG001|STARTED|At 2-year Clinical Follow-up||164
11135241|NCT01425281|12321124|FG000|COMPLETED|At 2-year Clinical Follow-up||323
11135242|NCT01425281|12321125|FG001|COMPLETED|At 2-year Clinical Follow-up||163
11202345|NCT01839318|12392749|FG004|STARTED|Period 2, Second Day of Wear||7
11135243|NCT01425281|12321124|FG000|NOT COMPLETED|At 2-year Clinical Follow-up||6
11135244|NCT01425281|12321125|FG001|NOT COMPLETED|At 2-year Clinical Follow-up||1
11135245|NCT01425281|12321124|FG000|STARTED|At 3-year Clinical Follow-up||323
11135246|NCT01425281|12321125|FG001|STARTED|At 3-year Clinical Follow-up||163
11135247|NCT01425281|12321124|FG000|COMPLETED|At 3-year Clinical Follow-up||318
11135248|NCT01425281|12321125|FG001|COMPLETED|At 3-year Clinical Follow-up||157
11135249|NCT01425281|12321124|FG000|NOT COMPLETED|At 3-year Clinical Follow-up||5
11135250|NCT01425281|12321125|FG001|NOT COMPLETED|At 3-year Clinical Follow-up||6
11135251|NCT01425281|12321124|FG000|STARTED|At 4-year Clinical Follow-up||318
11135252|NCT01425281|12321125|FG001|STARTED|At 4-year Clinical Follow-up||157
11135253|NCT01425281|12321124|FG000|COMPLETED|At 4-year Clinical Follow-up||288
11135254|NCT01425281|12321125|FG001|COMPLETED|At 4-year Clinical Follow-up||136
11135255|NCT01425281|12321124|FG000|NOT COMPLETED|At 4-year Clinical Follow-up||30
11135256|NCT01425281|12321125|FG001|NOT COMPLETED|At 4-year Clinical Follow-up||21
11135257|NCT01425281|12321124|FG000|STARTED|At 5-year Clinical Follow-up||288
11135258|NCT01425281|12321125|FG001|STARTED|At 5-year Clinical Follow-up||136
11135259|NCT01425281|12321124|FG000|COMPLETED|At 5-year Clinical Follow-up||256
11135260|NCT01425281|12321125|FG001|COMPLETED|At 5-year Clinical Follow-up||125
11135261|NCT01425281|12321124|FG000|NOT COMPLETED|At 5-year Clinical Follow-up||32
11135262|NCT01425281|12321125|FG001|NOT COMPLETED|At 5-year Clinical Follow-up||11
11135263|NCT01425632|12321135|FG000|STARTED|Overall Study||161
11135264|NCT01425632|12321136|FG001|STARTED|Overall Study||166
11135265|NCT01425632|12321137|FG002|STARTED|Overall Study||163
11135266|NCT01425632|12321135|FG000|COMPLETED|Overall Study||160
11135267|NCT01425632|12321136|FG001|COMPLETED|Overall Study||165
11135268|NCT01425632|12321137|FG002|COMPLETED|Overall Study||159
11135269|NCT01425632|12321135|FG000|NOT COMPLETED|Overall Study||1
11135270|NCT01425632|12321136|FG001|NOT COMPLETED|Overall Study||1
11135271|NCT01425632|12321137|FG002|NOT COMPLETED|Overall Study||4
11135272|NCT01425723|12321147|FG000|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
11135273|NCT01425723|12321148|FG001|STARTED|Overall Study||93
11135274|NCT01425723|12321147|FG000|Weekly Prophylaxis|Overall Study||23
11135275|NCT01425723|12321148|FG001|Weekly Prophylaxis|Overall Study||51
11135276|NCT01425723|12321147|FG000|Individualized Prophylaxis|Overall Study||5
11135277|NCT01425723|12321148|FG001|Individualized Prophylaxis|Overall Study||31
11135278|NCT01425723|12321147|FG000|Personalized Prophylaxis|Overall Study||2
11135279|NCT01425723|12321148|FG001|Personalized Prophylaxis|Overall Study||17
11135280|NCT01425723|12321147|FG000|Episodic|Overall Study||0
11135281|NCT01425723|12321148|FG001|Episodic|Overall Study||15
11135282|NCT01425723|12321147|FG000|Surgery Subgroup|Overall Study||1
11135283|NCT01425723|12321148|FG001|Surgery Subgroup|Overall Study||15
11135284|NCT01425723|12321147|FG000|COMPLETED|Overall Study||23
11135285|NCT01425723|12321148|FG001|COMPLETED|Overall Study||75
11135286|NCT01425723|12321147|FG000|NOT COMPLETED|Overall Study||4
11135287|NCT01425723|12321148|FG001|NOT COMPLETED|Overall Study||18
11135288|NCT01425749|12321165|FG000|STARTED|Overall Study||13
11135289|NCT01425749|12321166|FG001|STARTED|Overall Study||12
11135290|NCT01425749|12321165|FG000|COMPLETED|Overall Study||13
11135291|NCT01425749|12321166|FG001|COMPLETED|Overall Study||11
11135292|NCT01425749|12321165|FG000|NOT COMPLETED|Overall Study||0
11135293|NCT01425749|12321166|FG001|NOT COMPLETED|Overall Study||1
11135294|NCT01425801|12321175|FG000|STARTED|Period 1||9
11135295|NCT01425801|12321176|FG001|STARTED|Period 1||9
11135296|NCT01425801|12321177|FG002|STARTED|Period 1||9
11135297|NCT01425801|12321178|FG003|STARTED|Period 1||12
11135298|NCT01425801|12321179|FG004|STARTED|Period 1||13
11135299|NCT01425801|12321180|FG005|STARTED|Period 1||10
11135300|NCT01425801|12321175|FG000|COMPLETED|Period 1||9
11135301|NCT01425801|12321176|FG001|COMPLETED|Period 1||9
11135302|NCT01425801|12321177|FG002|COMPLETED|Period 1||9
11135303|NCT01425801|12321178|FG003|COMPLETED|Period 1||12
11135304|NCT01425801|12321179|FG004|COMPLETED|Period 1||12
11135305|NCT01425801|12321180|FG005|COMPLETED|Period 1||10
11135306|NCT01425801|12321175|FG000|NOT COMPLETED|Period 1||0
11135307|NCT01425801|12321176|FG001|NOT COMPLETED|Period 1||0
11135308|NCT01425801|12321177|FG002|NOT COMPLETED|Period 1||0
11135309|NCT01425801|12321178|FG003|NOT COMPLETED|Period 1||0
11135310|NCT01425801|12321179|FG004|NOT COMPLETED|Period 1||1
11135311|NCT01425801|12321180|FG005|NOT COMPLETED|Period 1||0
11135312|NCT01425801|12321175|FG000|STARTED|Period 2||9
11135313|NCT01425801|12321176|FG001|STARTED|Period 2||9
11135314|NCT01425801|12321177|FG002|STARTED|Period 2||9
11135315|NCT01425801|12321178|FG003|STARTED|Period 2||12
11135316|NCT01425801|12321179|FG004|STARTED|Period 2||12
11135317|NCT01425801|12321180|FG005|STARTED|Period 2||10
11135318|NCT01425801|12321175|FG000|COMPLETED|Period 2||9
11135319|NCT01425801|12321176|FG001|COMPLETED|Period 2||9
11135320|NCT01425801|12321177|FG002|COMPLETED|Period 2||9
11135321|NCT01425801|12321178|FG003|COMPLETED|Period 2||12
11135322|NCT01425801|12321179|FG004|COMPLETED|Period 2||11
11135323|NCT01425801|12321180|FG005|COMPLETED|Period 2||10
11135324|NCT01425801|12321175|FG000|NOT COMPLETED|Period 2||0
11135325|NCT01425801|12321176|FG001|NOT COMPLETED|Period 2||0
11135326|NCT01425801|12321177|FG002|NOT COMPLETED|Period 2||0
11135327|NCT01425801|12321178|FG003|NOT COMPLETED|Period 2||0
11135328|NCT01425801|12321179|FG004|NOT COMPLETED|Period 2||1
11135329|NCT01425801|12321180|FG005|NOT COMPLETED|Period 2||0
11135330|NCT01425801|12321175|FG000|STARTED|Period 3||9
11135331|NCT01425801|12321176|FG001|STARTED|Period 3||9
11135332|NCT01425801|12321177|FG002|STARTED|Period 3||9
11135333|NCT01425801|12321178|FG003|STARTED|Period 3||12
11135334|NCT01425801|12321179|FG004|STARTED|Period 3||11
11135335|NCT01425801|12321180|FG005|STARTED|Period 3||10
11135336|NCT01425801|12321175|FG000|COMPLETED|Period 3||9
11135337|NCT01425801|12321176|FG001|COMPLETED|Period 3||9
11135338|NCT01425801|12321177|FG002|COMPLETED|Period 3||8
11135339|NCT01425801|12321178|FG003|COMPLETED|Period 3||12
11135340|NCT01425801|12321179|FG004|COMPLETED|Period 3||11
11135341|NCT01425801|12321180|FG005|COMPLETED|Period 3||10
11135342|NCT01425801|12321175|FG000|NOT COMPLETED|Period 3||0
11135343|NCT01425801|12321176|FG001|NOT COMPLETED|Period 3||0
11135344|NCT01425801|12321177|FG002|NOT COMPLETED|Period 3||1
11135345|NCT01425801|12321178|FG003|NOT COMPLETED|Period 3||0
11135346|NCT01425801|12321179|FG004|NOT COMPLETED|Period 3||0
11135347|NCT01425801|12321180|FG005|NOT COMPLETED|Period 3||0
11135348|NCT01425801|12321175|FG000|STARTED|Period 4||9
11135349|NCT01425801|12321176|FG001|STARTED|Period 4||9
11135350|NCT01425801|12321177|FG002|STARTED|Period 4||8
11135351|NCT01425801|12321178|FG003|STARTED|Period 4||12
11135352|NCT01425801|12321179|FG004|STARTED|Period 4||11
11135353|NCT01425801|12321180|FG005|STARTED|Period 4||10
11135354|NCT01425801|12321175|FG000|COMPLETED|Period 4||9
11135355|NCT01425801|12321176|FG001|COMPLETED|Period 4||9
11135356|NCT01425801|12321177|FG002|COMPLETED|Period 4||7
11135357|NCT01425801|12321178|FG003|COMPLETED|Period 4||12
11135358|NCT01425801|12321179|FG004|COMPLETED|Period 4||11
11135359|NCT01425801|12321180|FG005|COMPLETED|Period 4||10
11135360|NCT01425801|12321175|FG000|NOT COMPLETED|Period 4||0
11135361|NCT01425801|12321176|FG001|NOT COMPLETED|Period 4||0
11135362|NCT01425801|12321177|FG002|NOT COMPLETED|Period 4||1
11135363|NCT01425801|12321178|FG003|NOT COMPLETED|Period 4||0
11135364|NCT01425801|12321179|FG004|NOT COMPLETED|Period 4||0
11135365|NCT01425801|12321180|FG005|NOT COMPLETED|Period 4||0
11135366|NCT01425801|12321175|FG000|STARTED|Period 5||9
11135367|NCT01425801|12321176|FG001|STARTED|Period 5||9
11135368|NCT01425801|12321177|FG002|STARTED|Period 5||7
11135369|NCT01425801|12321178|FG003|STARTED|Period 5||12
11135370|NCT01425801|12321179|FG004|STARTED|Period 5||11
11135371|NCT01425801|12321180|FG005|STARTED|Period 5||10
11135372|NCT01425801|12321175|FG000|COMPLETED|Period 5||9
11135373|NCT01425801|12321176|FG001|COMPLETED|Period 5||9
11135374|NCT01425801|12321177|FG002|COMPLETED|Period 5||7
11135375|NCT01425801|12321178|FG003|COMPLETED|Period 5||12
11135376|NCT01425801|12321179|FG004|COMPLETED|Period 5||11
11135377|NCT01425801|12321180|FG005|COMPLETED|Period 5||10
11135378|NCT01425801|12321175|FG000|NOT COMPLETED|Period 5||0
11135379|NCT01425801|12321176|FG001|NOT COMPLETED|Period 5||0
11135380|NCT01425801|12321177|FG002|NOT COMPLETED|Period 5||0
11135381|NCT01425801|12321178|FG003|NOT COMPLETED|Period 5||0
11135382|NCT01425801|12321179|FG004|NOT COMPLETED|Period 5||0
11135383|NCT01425801|12321180|FG005|NOT COMPLETED|Period 5||0
11135384|NCT01425801|12321175|FG000|STARTED|Period 6||9
11135385|NCT01425801|12321176|FG001|STARTED|Period 6||9
11135386|NCT01425801|12321177|FG002|STARTED|Period 6||7
11135387|NCT01425801|12321178|FG003|STARTED|Period 6||12
11135388|NCT01425801|12321179|FG004|STARTED|Period 6||11
11135389|NCT01425801|12321180|FG005|STARTED|Period 6||10
11135390|NCT01425801|12321175|FG000|COMPLETED|Period 6||9
11135391|NCT01425801|12321176|FG001|COMPLETED|Period 6||9
11135392|NCT01425801|12321177|FG002|COMPLETED|Period 6||7
11135393|NCT01425801|12321178|FG003|COMPLETED|Period 6||12
11135394|NCT01425801|12321179|FG004|COMPLETED|Period 6||11
11135395|NCT01425801|12321180|FG005|COMPLETED|Period 6||10
11135396|NCT01425801|12321175|FG000|NOT COMPLETED|Period 6||0
11135397|NCT01425801|12321176|FG001|NOT COMPLETED|Period 6||0
11135398|NCT01425801|12321177|FG002|NOT COMPLETED|Period 6||0
11135399|NCT01425801|12321178|FG003|NOT COMPLETED|Period 6||0
11135400|NCT01425801|12321179|FG004|NOT COMPLETED|Period 6||0
11135401|NCT01425801|12321180|FG005|NOT COMPLETED|Period 6||0
11135402|NCT01425814|12321194|FG000|STARTED|Period 1||12
11135403|NCT01425814|12321195|FG001|STARTED|Period 1||11
11135404|NCT01425814|12321196|FG002|STARTED|Period 1||12
11135405|NCT01425814|12321197|FG003|STARTED|Period 1||10
11135406|NCT01425814|12321198|FG004|STARTED|Period 1||12
11135407|NCT01425814|12321199|FG005|STARTED|Period 1||13
11135408|NCT01425814|12321194|FG000|COMPLETED|Period 1||12
11135409|NCT01425814|12321195|FG001|COMPLETED|Period 1||10
11135410|NCT01425814|12321196|FG002|COMPLETED|Period 1||12
11135411|NCT01425814|12321197|FG003|COMPLETED|Period 1||10
11135412|NCT01425814|12321198|FG004|COMPLETED|Period 1||12
11135413|NCT01425814|12321199|FG005|COMPLETED|Period 1||13
11135414|NCT01425814|12321194|FG000|NOT COMPLETED|Period 1||0
11135415|NCT01425814|12321195|FG001|NOT COMPLETED|Period 1||1
11135416|NCT01425814|12321196|FG002|NOT COMPLETED|Period 1||0
11135417|NCT01425814|12321197|FG003|NOT COMPLETED|Period 1||0
11135418|NCT01425814|12321198|FG004|NOT COMPLETED|Period 1||0
11135419|NCT01425814|12321199|FG005|NOT COMPLETED|Period 1||0
11135420|NCT01425814|12321194|FG000|STARTED|Period 2||12
11135421|NCT01425814|12321195|FG001|STARTED|Period 2||10
11135422|NCT01425814|12321196|FG002|STARTED|Period 2||12
11135423|NCT01425814|12321197|FG003|STARTED|Period 2||10
11135424|NCT01425814|12321198|FG004|STARTED|Period 2||12
11135425|NCT01425814|12321199|FG005|STARTED|Period 2||13
11135426|NCT01425814|12321194|FG000|COMPLETED|Period 2||12
11135427|NCT01425814|12321195|FG001|COMPLETED|Period 2||9
11135428|NCT01425814|12321196|FG002|COMPLETED|Period 2||12
11135429|NCT01425814|12321197|FG003|COMPLETED|Period 2||10
11135430|NCT01425814|12321198|FG004|COMPLETED|Period 2||12
11135431|NCT01425814|12321199|FG005|COMPLETED|Period 2||13
11135432|NCT01425814|12321194|FG000|NOT COMPLETED|Period 2||0
11135433|NCT01425814|12321195|FG001|NOT COMPLETED|Period 2||1
11135434|NCT01425814|12321196|FG002|NOT COMPLETED|Period 2||0
11135435|NCT01425814|12321197|FG003|NOT COMPLETED|Period 2||0
11135436|NCT01425814|12321198|FG004|NOT COMPLETED|Period 2||0
11135437|NCT01425814|12321199|FG005|NOT COMPLETED|Period 2||0
11135438|NCT01425814|12321194|FG000|STARTED|Period 3||12
11135439|NCT01425814|12321195|FG001|STARTED|Period 3||9
11135440|NCT01425814|12321196|FG002|STARTED|Period 3||12
11135441|NCT01425814|12321197|FG003|STARTED|Period 3||10
11135442|NCT01425814|12321198|FG004|STARTED|Period 3||12
11135443|NCT01425814|12321199|FG005|STARTED|Period 3||13
11135444|NCT01425814|12321194|FG000|COMPLETED|Period 3||12
11135445|NCT01425814|12321195|FG001|COMPLETED|Period 3||9
11135446|NCT01425814|12321196|FG002|COMPLETED|Period 3||12
11135447|NCT01425814|12321197|FG003|COMPLETED|Period 3||10
11135448|NCT01425814|12321198|FG004|COMPLETED|Period 3||12
11135449|NCT01425814|12321199|FG005|COMPLETED|Period 3||12
11135450|NCT01425814|12321194|FG000|NOT COMPLETED|Period 3||0
11135451|NCT01425814|12321195|FG001|NOT COMPLETED|Period 3||0
11135452|NCT01425814|12321196|FG002|NOT COMPLETED|Period 3||0
11135453|NCT01425814|12321197|FG003|NOT COMPLETED|Period 3||0
11135454|NCT01425814|12321198|FG004|NOT COMPLETED|Period 3||0
11135455|NCT01425814|12321199|FG005|NOT COMPLETED|Period 3||1
11135456|NCT01425814|12321194|FG000|STARTED|Period 4||12
11135457|NCT01425814|12321195|FG001|STARTED|Period 4||9
11135458|NCT01425814|12321196|FG002|STARTED|Period 4||12
11135459|NCT01425814|12321197|FG003|STARTED|Period 4||10
11135460|NCT01425814|12321198|FG004|STARTED|Period 4||12
11135461|NCT01425814|12321199|FG005|STARTED|Period 4||12
11135462|NCT01425814|12321194|FG000|COMPLETED|Period 4||11
11135463|NCT01425814|12321195|FG001|COMPLETED|Period 4||9
11135464|NCT01425814|12321196|FG002|COMPLETED|Period 4||11
11135465|NCT01425814|12321197|FG003|COMPLETED|Period 4||10
11135466|NCT01425814|12321198|FG004|COMPLETED|Period 4||12
11135467|NCT01425814|12321199|FG005|COMPLETED|Period 4||12
11135468|NCT01425814|12321194|FG000|NOT COMPLETED|Period 4||1
11135469|NCT01425814|12321195|FG001|NOT COMPLETED|Period 4||0
11135470|NCT01425814|12321196|FG002|NOT COMPLETED|Period 4||1
11135471|NCT01425814|12321197|FG003|NOT COMPLETED|Period 4||0
11135472|NCT01425814|12321198|FG004|NOT COMPLETED|Period 4||0
11135473|NCT01425814|12321199|FG005|NOT COMPLETED|Period 4||0
11135474|NCT01425814|12321194|FG000|STARTED|Period 5||11
11135475|NCT01425814|12321195|FG001|STARTED|Period 5||9
11135476|NCT01425814|12321196|FG002|STARTED|Period 5||11
11135477|NCT01425814|12321197|FG003|STARTED|Period 5||10
11135478|NCT01425814|12321198|FG004|STARTED|Period 5||12
11135479|NCT01425814|12321199|FG005|STARTED|Period 5||12
11135480|NCT01425814|12321194|FG000|COMPLETED|Period 5||11
11135481|NCT01425814|12321195|FG001|COMPLETED|Period 5||9
11135482|NCT01425814|12321196|FG002|COMPLETED|Period 5||10
11135483|NCT01425814|12321197|FG003|COMPLETED|Period 5||10
11135484|NCT01425814|12321198|FG004|COMPLETED|Period 5||12
11135485|NCT01425814|12321199|FG005|COMPLETED|Period 5||11
11135486|NCT01425814|12321194|FG000|NOT COMPLETED|Period 5||0
11135487|NCT01425814|12321195|FG001|NOT COMPLETED|Period 5||0
11135488|NCT01425814|12321196|FG002|NOT COMPLETED|Period 5||1
11135489|NCT01425814|12321197|FG003|NOT COMPLETED|Period 5||0
11135490|NCT01425814|12321198|FG004|NOT COMPLETED|Period 5||0
11135491|NCT01425814|12321199|FG005|NOT COMPLETED|Period 5||1
11135492|NCT01425853|12321215|FG000|STARTED|Overall Study||304
11135493|NCT01425853|12321216|FG001|STARTED|Overall Study||302
11135494|NCT01425853|12321215|FG000|Safety Population|Overall Study||304
11135495|NCT01425853|12321216|FG001|Safety Population|Overall Study||299
11135496|NCT01425853|12321215|FG000|Per Protocol (PP)|Overall Study||264
11135497|NCT01425853|12321216|FG001|Per Protocol (PP)|Overall Study||258
11135498|NCT01425853|12321215|FG000|COMPLETED|Overall Study||240
11135499|NCT01425853|12321216|FG001|COMPLETED|Overall Study||225
11135500|NCT01425853|12321215|FG000|NOT COMPLETED|Overall Study||64
11135501|NCT01425853|12321216|FG001|NOT COMPLETED|Overall Study||77
11135502|NCT01425879|12321223|FG000|STARTED|Overall Study||8
11135503|NCT01425879|12321223|FG000|COMPLETED|Overall Study||8
11135504|NCT01425879|12321223|FG000|NOT COMPLETED|Overall Study||0
11135505|NCT01426009|12321227|FG000|STARTED|Period 1-First Intervention (7 Days)||139
11135506|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
11135507|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
11135508|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
11135509|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
11135510|NCT01426009|12321227|FG000|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
11135511|NCT01426009|12321227|FG000|Placebo|Period 1-First Intervention (7 Days)||24
11135512|NCT01426009|12321227|FG000|COMPLETED|Period 1-First Intervention (7 Days)||137
11135513|NCT01426009|12321227|FG000|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
11135514|NCT01426009|12321227|FG000|STARTED|Washout 1||137
11135515|NCT01426009|12321227|FG000|COMPLETED|Washout 1||135
11135516|NCT01426009|12321227|FG000|NOT COMPLETED|Washout 1||2
11135517|NCT01426009|12321227|FG000|STARTED|Period 2-Second Intervention (7 Days)||135
11135518|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
11135519|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
11135520|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
11135521|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
11135522|NCT01426009|12321227|FG000|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
11135523|NCT01426009|12321227|FG000|Placebo|Period 2-Second Intervention (7 Days)||21
11135524|NCT01426009|12321227|FG000|COMPLETED|Period 2-Second Intervention (7 Days)||130
11135525|NCT01426009|12321227|FG000|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
11135526|NCT01426009|12321227|FG000|STARTED|Washout 2||130
11135527|NCT01426009|12321227|FG000|COMPLETED|Washout 2||129
11135528|NCT01426009|12321227|FG000|NOT COMPLETED|Washout 2||1
11135529|NCT01426009|12321227|FG000|STARTED|Period 3-Third Intervention (7 Days)||129
11135530|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
11135531|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
11135532|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
11135533|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
11135534|NCT01426009|12321227|FG000|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
11135535|NCT01426009|12321227|FG000|Placebo|Period 3-Third Intervention (7 Days)||22
11135536|NCT01426009|12321227|FG000|COMPLETED|Period 3-Third Intervention (7 Days)||129
11135537|NCT01426009|12321227|FG000|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
11135538|NCT01426009|12321227|FG000|STARTED|Washout 3||129
11135539|NCT01426009|12321227|FG000|COMPLETED|Washout 3||128
11135540|NCT01426009|12321227|FG000|NOT COMPLETED|Washout 3||1
11135541|NCT01426009|12321227|FG000|STARTED|Period 4-Fourth Intervention (7 Days)||128
11135542|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
11135543|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
11135544|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
11135545|NCT01426009|12321227|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
11135546|NCT01426009|12321227|FG000|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
11135547|NCT01426009|12321227|FG000|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
11135548|NCT01426009|12321227|FG000|Placebo|Period 4-Fourth Intervention (7 Days)||10
11135549|NCT01426009|12321227|FG000|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
11135550|NCT01426009|12321227|FG000|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
11135551|NCT01426009|12321227|FG000|STARTED|Washout 4||127
11135552|NCT01426009|12321227|FG000|COMPLETED|Washout 4||126
11135553|NCT01426009|12321227|FG000|NOT COMPLETED|Washout 4||1
11135554|NCT01426191|12321243|FG000|STARTED|Overall Study||2032
11135555|NCT01426191|12321243|FG000|COMPLETED|Overall Study||2032
11135556|NCT01426191|12321243|FG000|NOT COMPLETED|Overall Study||0
11135557|NCT01426217|12321249|FG000|STARTED|Overall Study||314
11135558|NCT01426217|12321250|FG001|STARTED|Overall Study||280
11135559|NCT01426217|12321249|FG000|COMPLETED|Overall Study||306
11135560|NCT01426217|12321250|FG001|COMPLETED|Overall Study||266
11135561|NCT01426217|12321249|FG000|NOT COMPLETED|Overall Study||8
11135562|NCT01426217|12321250|FG001|NOT COMPLETED|Overall Study||14
11135563|NCT01426230|12321258|FG000|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
11135564|NCT01426230|12321259|FG001|STARTED|Overall Study||111
11135565|NCT01426230|12321258|FG000|COMPLETED|Overall Study||55
11135566|NCT01426230|12321259|FG001|COMPLETED|Overall Study||84
11135567|NCT01426230|12321258|FG000|NOT COMPLETED|Overall Study||31
11135568|NCT01426230|12321259|FG001|NOT COMPLETED|Overall Study||27
11135569|NCT01426347|12321266|FG000|STARTED|Overall Study||41
11135570|NCT01426347|12321267|FG001|STARTED|Overall Study||42
11135571|NCT01426347|12321266|FG000|COMPLETED|Overall Study||34
11135572|NCT01426347|12321267|FG001|COMPLETED|Overall Study||39
11135573|NCT01426347|12321266|FG000|NOT COMPLETED|Overall Study||7
11135574|NCT01426347|12321267|FG001|NOT COMPLETED|Overall Study||3
11135575|NCT01426360|12321275|FG000|STARTED|Overall Study||38
11135576|NCT01426360|12321276|FG001|STARTED|Overall Study||41
11135577|NCT01426360|12321275|FG000|COMPLETED|Overall Study||38
11135578|NCT01426360|12321276|FG001|COMPLETED|Overall Study||41
11135579|NCT01426360|12321275|FG000|NOT COMPLETED|Overall Study||0
11135580|NCT01426360|12321276|FG001|NOT COMPLETED|Overall Study||0
11135581|NCT01426373|12321282|FG000|STARTED|Overall Study||165
11135582|NCT01426373|12321282|FG000|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
11135583|NCT01426373|12321282|FG000|NOT COMPLETED|Overall Study||34
11135584|NCT01426386|12321294|FG000|STARTED|Overall Study||42
11135585|NCT01426386|12321295|FG001|STARTED|Overall Study||45
11135586|NCT01426386|12321296|FG002|STARTED|Overall Study||44
11135587|NCT01426386|12321297|FG003|STARTED|Overall Study||44
11135588|NCT01426386|12321298|FG004|STARTED|Overall Study||47
11135589|NCT01426386|12321299|FG005|STARTED|Overall Study||43
11135590|NCT01426386|12321294|FG000|COMPLETED|Overall Study||39
11135591|NCT01426386|12321295|FG001|COMPLETED|Overall Study||39
11135592|NCT01426386|12321296|FG002|COMPLETED|Overall Study||42
11135593|NCT01426386|12321297|FG003|COMPLETED|Overall Study||44
11135594|NCT01426386|12321298|FG004|COMPLETED|Overall Study||43
11135595|NCT01426386|12321299|FG005|COMPLETED|Overall Study||42
11135596|NCT01426386|12321294|FG000|NOT COMPLETED|Overall Study||3
11135597|NCT01426386|12321295|FG001|NOT COMPLETED|Overall Study||6
11135598|NCT01426386|12321296|FG002|NOT COMPLETED|Overall Study||2
11135599|NCT01426386|12321297|FG003|NOT COMPLETED|Overall Study||0
11135600|NCT01426386|12321298|FG004|NOT COMPLETED|Overall Study||4
11135601|NCT01426386|12321299|FG005|NOT COMPLETED|Overall Study||1
11135602|NCT01426412|12321322|FG000|STARTED|Overall Study||6
11135603|NCT01426412|12321323|FG001|STARTED|Overall Study||6
11135604|NCT01426412|12321324|FG002|STARTED|Overall Study||6
11135605|NCT01426412|12321325|FG003|STARTED|Overall Study||6
11135606|NCT01426412|12321326|FG004|STARTED|Overall Study||6
11135607|NCT01426412|12321327|FG005|STARTED|Overall Study||6
11135608|NCT01426412|12321328|FG006|STARTED|Overall Study||6
11135609|NCT01426412|12321329|FG007|STARTED|Overall Study||10
11135610|NCT01426412|12321330|FG008|STARTED|Overall Study||17
11135611|NCT01426412|12321322|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
11135612|NCT01426412|12321323|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
11135613|NCT01426412|12321324|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11135614|NCT01426412|12321325|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
11135615|NCT01426412|12321326|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
11135616|NCT01426412|12321327|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
11135617|NCT01426412|12321328|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
11135618|NCT01426412|12321329|FG007|Received at Least 1 Dose of Study Drug|Overall Study||10
11135619|NCT01426412|12321330|FG008|Received at Least 1 Dose of Study Drug|Overall Study||17
11135620|NCT01426412|12321322|FG000|COMPLETED|Overall Study||5
11135621|NCT01426412|12321323|FG001|COMPLETED|Overall Study||6
11240748|NCT02092961|12433109|FG001|NOT COMPLETED|Overall Study||14
11240749|NCT02092961|12433110|FG002|NOT COMPLETED|Overall Study||16
11240750|NCT02092987|12433121|FG000|STARTED|Overall Study||110
11240751|NCT02092987|12433122|FG001|STARTED|Overall Study||111
11240752|NCT02092987|12433121|FG000|COMPLETED|Overall Study||106
11240753|NCT02092987|12433122|FG001|COMPLETED|Overall Study||103
11240754|NCT02092987|12433121|FG000|NOT COMPLETED|Overall Study||4
11240755|NCT02092987|12433122|FG001|NOT COMPLETED|Overall Study||8
11240756|NCT02093026|12433131|FG000|STARTED|Overall Study||465
11240757|NCT02093026|12433131|FG000|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
11240758|NCT02093026|12433131|FG000|NOT COMPLETED|Overall Study||193
11240759|NCT02093221|12433141|FG000|STARTED|Overall Study||15
11240760|NCT02093221|12433142|FG001|STARTED|Overall Study||16
11240761|NCT02093221|12433143|FG002|STARTED|Overall Study||15
11240762|NCT02093221|12433144|FG003|STARTED|Overall Study||15
11240763|NCT02093221|12433145|FG004|STARTED|Overall Study||15
11240764|NCT02093221|12433141|FG000|COMPLETED|Overall Study||5
11135622|NCT01426412|12321324|FG002|COMPLETED|Overall Study||6
11135623|NCT01426412|12321325|FG003|COMPLETED|Overall Study||6
11135624|NCT01426412|12321326|FG004|COMPLETED|Overall Study||5
11135625|NCT01426412|12321327|FG005|COMPLETED|Overall Study||6
11135626|NCT01426412|12321328|FG006|COMPLETED|Overall Study||6
11135627|NCT01426412|12321329|FG007|COMPLETED|Overall Study||7
11135628|NCT01426412|12321330|FG008|COMPLETED|Overall Study||16
11135629|NCT01426412|12321322|FG000|NOT COMPLETED|Overall Study||1
11135630|NCT01426412|12321323|FG001|NOT COMPLETED|Overall Study||0
11135631|NCT01426412|12321324|FG002|NOT COMPLETED|Overall Study||0
11135632|NCT01426412|12321325|FG003|NOT COMPLETED|Overall Study||0
11135633|NCT01426412|12321326|FG004|NOT COMPLETED|Overall Study||1
11135634|NCT01426412|12321327|FG005|NOT COMPLETED|Overall Study||0
11135635|NCT01426412|12321328|FG006|NOT COMPLETED|Overall Study||0
11135636|NCT01426412|12321329|FG007|NOT COMPLETED|Overall Study||3
11135637|NCT01426412|12321330|FG008|NOT COMPLETED|Overall Study||1
11135638|NCT01426425|12321361|FG000|STARTED|Overall Study||572
11135639|NCT01426425|12321361|FG000|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
11135640|NCT01426425|12321361|FG000|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
11135641|NCT01426425|12321361|FG000|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
11135642|NCT01426425|12321361|FG000|NOT COMPLETED|Overall Study||175
11135643|NCT01426438|12321368|FG000|STARTED|Overall Study||50
11135644|NCT01426438|12321369|FG001|STARTED|Overall Study||49
11135645|NCT01426438|12321368|FG000|COMPLETED|Overall Study||35
11135646|NCT01426438|12321369|FG001|COMPLETED|Overall Study||39
11135647|NCT01426438|12321368|FG000|NOT COMPLETED|Overall Study||15
11135648|NCT01426438|12321369|FG001|NOT COMPLETED|Overall Study||10
11135649|NCT01426581|12321377|FG000|STARTED|Overall Study||62
11135650|NCT01426581|12321378|FG001|STARTED|Overall Study||58
11135651|NCT01426581|12321377|FG000|COMPLETED|Overall Study||62
11135652|NCT01426581|12321378|FG001|COMPLETED|Overall Study||58
11135653|NCT01426581|12321377|FG000|NOT COMPLETED|Overall Study||0
11135654|NCT01426581|12321378|FG001|NOT COMPLETED|Overall Study||0
11135655|NCT01426763|12321388|FG000|STARTED|Overall Study||6
11135656|NCT01426763|12321389|FG001|STARTED|Overall Study||6
11135657|NCT01426763|12321388|FG000|COMPLETED|Overall Study||6
11135658|NCT01426763|12321389|FG001|COMPLETED|Overall Study||6
11135659|NCT01426763|12321388|FG000|NOT COMPLETED|Overall Study||0
11135660|NCT01426763|12321389|FG001|NOT COMPLETED|Overall Study||0
11135661|NCT01426789|12321399|FG000|STARTED|Part 1||68
11135662|NCT01426789|12321400|FG001|STARTED|Part 1||32
11135663|NCT01426789|12321401|FG002|STARTED|Part 1||0
11135664|NCT01426789|12321402|FG003|STARTED|Part 1||0
11135665|NCT01426789|12321403|FG004|STARTED|Part 1||0
11135666|NCT01426789|12321404|FG005|STARTED|Part 1||0
11135667|NCT01426789|12321399|FG000|COMPLETED|Part 1||62
11135668|NCT01426789|12321400|FG001|COMPLETED|Part 1||28
11135669|NCT01426789|12321401|FG002|COMPLETED|Part 1||0
11135670|NCT01426789|12321402|FG003|COMPLETED|Part 1||0
11135671|NCT01426789|12321403|FG004|COMPLETED|Part 1||0
11135672|NCT01426789|12321404|FG005|COMPLETED|Part 1||0
11135673|NCT01426789|12321399|FG000|NOT COMPLETED|Part 1||6
11135674|NCT01426789|12321400|FG001|NOT COMPLETED|Part 1||4
11135675|NCT01426789|12321401|FG002|NOT COMPLETED|Part 1||0
11135676|NCT01426789|12321402|FG003|NOT COMPLETED|Part 1||0
11135677|NCT01426789|12321403|FG004|NOT COMPLETED|Part 1||0
11135678|NCT01426789|12321404|FG005|NOT COMPLETED|Part 1||0
11135679|NCT01426789|12321399|FG000|STARTED|Part 2||0
11135680|NCT01426789|12321400|FG001|STARTED|Part 2||0
11135681|NCT01426789|12321401|FG002|STARTED|Part 2||49
11135682|NCT01426789|12321402|FG003|STARTED|Part 2||13
11135683|NCT01426789|12321403|FG004|STARTED|Part 2||27
11135684|NCT01426789|12321404|FG005|STARTED|Part 2||1
11135685|NCT01426789|12321399|FG000|COMPLETED|Part 2||0
11135686|NCT01426789|12321400|FG001|COMPLETED|Part 2||0
11135687|NCT01426789|12321401|FG002|COMPLETED|Part 2||34
11135688|NCT01426789|12321402|FG003|COMPLETED|Part 2||12
11135689|NCT01426789|12321403|FG004|COMPLETED|Part 2||19
11135690|NCT01426789|12321404|FG005|COMPLETED|Part 2||1
11135691|NCT01426789|12321399|FG000|NOT COMPLETED|Part 2||0
11135692|NCT01426789|12321400|FG001|NOT COMPLETED|Part 2||0
11135693|NCT01426789|12321401|FG002|NOT COMPLETED|Part 2||15
11135694|NCT01426789|12321402|FG003|NOT COMPLETED|Part 2||1
11135695|NCT01426789|12321403|FG004|NOT COMPLETED|Part 2||8
11135696|NCT01426789|12321404|FG005|NOT COMPLETED|Part 2||0
11135697|NCT01426828|12321414|FG000|STARTED|Overall Study Evaluations||22
11135698|NCT01426828|12321415|FG001|STARTED|Overall Study Evaluations||18
11135699|NCT01426828|12321414|FG000|COMPLETED|Overall Study Evaluations||17
11135700|NCT01426828|12321415|FG001|COMPLETED|Overall Study Evaluations||15
11135701|NCT01426828|12321414|FG000|NOT COMPLETED|Overall Study Evaluations||5
11135702|NCT01426828|12321415|FG001|NOT COMPLETED|Overall Study Evaluations||3
11135703|NCT01426828|12321414|FG000|STARTED|Immune Response Analysis||17
11135704|NCT01426828|12321415|FG001|STARTED|Immune Response Analysis||15
11135705|NCT01426828|12321414|FG000|COMPLETED|Immune Response Analysis||8
11135706|NCT01426828|12321415|FG001|COMPLETED|Immune Response Analysis||8
11135707|NCT01426828|12321414|FG000|NOT COMPLETED|Immune Response Analysis||9
11135708|NCT01426828|12321415|FG001|NOT COMPLETED|Immune Response Analysis||7
11135709|NCT01426854|12321423|FG000|STARTED|Overall Study||131
11135710|NCT01426854|12321424|FG001|STARTED|Overall Study||129
11135711|NCT01426854|12321423|FG000|COMPLETED|Overall Study||119
11135712|NCT01426854|12321424|FG001|COMPLETED|Overall Study||98
11135713|NCT01426854|12321423|FG000|NOT COMPLETED|Overall Study||12
11135714|NCT01426854|12321424|FG001|NOT COMPLETED|Overall Study||31
11135715|NCT01426867|12321433|FG000|STARTED|Overall Study||33
11135716|NCT01426867|12321434|FG001|STARTED|Overall Study||34
11135717|NCT01426867|12321435|FG002|STARTED|Overall Study||34
11135718|NCT01426867|12321433|FG000|COMPLETED|Overall Study||33
11135719|NCT01426867|12321434|FG001|COMPLETED|Overall Study||34
11135720|NCT01426867|12321435|FG002|COMPLETED|Overall Study||34
11135721|NCT01426867|12321433|FG000|NOT COMPLETED|Overall Study||0
11135722|NCT01426867|12321434|FG001|NOT COMPLETED|Overall Study||0
11135723|NCT01426867|12321435|FG002|NOT COMPLETED|Overall Study||0
11135724|NCT01426958|12321443|FG000|STARTED|Overall Study||24
11135725|NCT01426958|12321443|FG000|COMPLETED|Overall Study||22
11135726|NCT01426958|12321443|FG000|NOT COMPLETED|Overall Study||2
11135727|NCT01427296|12321453|FG000|STARTED|Overall Study||1041
11135728|NCT01427296|12321454|FG001|STARTED|Overall Study||1051
11135729|NCT01427296|12321453|FG000|COMPLETED|Overall Study||1041
11135730|NCT01427296|12321454|FG001|COMPLETED|Overall Study||1051
11135731|NCT01427296|12321453|FG000|NOT COMPLETED|Overall Study||0
11135732|NCT01427296|12321454|FG001|NOT COMPLETED|Overall Study||0
11135733|NCT01427309|12321464|FG000|STARTED|Overall Study||7253
11135734|NCT01427309|12321465|FG001|STARTED|Overall Study||7244
11135735|NCT01427309|12321466|FG002|STARTED|Overall Study||8737
11135736|NCT01427309|12321467|FG003|STARTED|Overall Study||8749
11135737|NCT01427309|12321464|FG000|COMPLETED|Overall Study||6881
11135738|NCT01427309|12321465|FG001|COMPLETED|Overall Study||6837
11135739|NCT01427309|12321466|FG002|COMPLETED|Overall Study||8376
11135740|NCT01427309|12321467|FG003|COMPLETED|Overall Study||8373
11135741|NCT01427309|12321464|FG000|NOT COMPLETED|Overall Study||372
11135742|NCT01427309|12321465|FG001|NOT COMPLETED|Overall Study||407
11135743|NCT01427309|12321466|FG002|NOT COMPLETED|Overall Study||361
11135744|NCT01427309|12321467|FG003|NOT COMPLETED|Overall Study||376
11135745|NCT01427504|12321483|FG000|STARTED|Overall Study||4
11135746|NCT01427504|12321484|FG001|STARTED|Overall Study||3
11135747|NCT01427504|12321485|FG002|STARTED|Overall Study||4
11135748|NCT01427504|12321486|FG003|STARTED|Overall Study||6
11135749|NCT01427504|12321487|FG004|STARTED|Overall Study||3
11135750|NCT01427504|12321488|FG005|STARTED|Overall Study||6
11135751|NCT01427504|12321483|FG000|Received Boceprevir|Overall Study||4
11135752|NCT01427504|12321484|FG001|Received Boceprevir|Overall Study||3
11135753|NCT01427504|12321485|FG002|Received Boceprevir|Overall Study||3
11135754|NCT01427504|12321486|FG003|Received Boceprevir|Overall Study||5
11135755|NCT01427504|12321487|FG004|Received Boceprevir|Overall Study||2
11135756|NCT01427504|12321488|FG005|Received Boceprevir|Overall Study||4
11135757|NCT01427504|12321483|FG000|Received Etravirine|Overall Study||4
11135758|NCT01427504|12321484|FG001|Received Etravirine|Overall Study||2
11135759|NCT01427504|12321485|FG002|Received Etravirine|Overall Study||4
11135760|NCT01427504|12321486|FG003|Received Etravirine|Overall Study||6
11135761|NCT01427504|12321487|FG004|Received Etravirine|Overall Study||2
11135762|NCT01427504|12321488|FG005|Received Etravirine|Overall Study||4
11135763|NCT01427504|12321483|FG000|Received Combination|Overall Study||4
11135764|NCT01427504|12321484|FG001|Received Combination|Overall Study||3
11135765|NCT01427504|12321485|FG002|Received Combination|Overall Study||3
11135766|NCT01427504|12321486|FG003|Received Combination|Overall Study||6
11135767|NCT01427504|12321487|FG004|Received Combination|Overall Study||3
11135768|NCT01427504|12321488|FG005|Received Combination|Overall Study||6
11135769|NCT01427504|12321483|FG000|COMPLETED|Overall Study||4
11135770|NCT01427504|12321484|FG001|COMPLETED|Overall Study||2
11135771|NCT01427504|12321485|FG002|COMPLETED|Overall Study||3
11135772|NCT01427504|12321486|FG003|COMPLETED|Overall Study||5
11135773|NCT01427504|12321487|FG004|COMPLETED|Overall Study||2
11135774|NCT01427504|12321488|FG005|COMPLETED|Overall Study||4
11135775|NCT01427504|12321483|FG000|NOT COMPLETED|Overall Study||0
11135776|NCT01427504|12321484|FG001|NOT COMPLETED|Overall Study||1
11135777|NCT01427504|12321485|FG002|NOT COMPLETED|Overall Study||1
11135778|NCT01427504|12321486|FG003|NOT COMPLETED|Overall Study||1
11135779|NCT01427504|12321487|FG004|NOT COMPLETED|Overall Study||1
11135780|NCT01427504|12321488|FG005|NOT COMPLETED|Overall Study||2
11135781|NCT01427517|12321508|FG000|STARTED|Overall Study||3
11135782|NCT01427517|12321509|FG001|STARTED|Overall Study||3
11135783|NCT01427517|12321510|FG002|STARTED|Overall Study||3
11135784|NCT01427517|12321508|FG000|COMPLETED|Overall Study||3
11135785|NCT01427517|12321509|FG001|COMPLETED|Overall Study||3
11135786|NCT01427517|12321510|FG002|COMPLETED|Overall Study||3
11135787|NCT01427517|12321508|FG000|NOT COMPLETED|Overall Study||0
11135788|NCT01427517|12321509|FG001|NOT COMPLETED|Overall Study||0
11135789|NCT01427517|12321510|FG002|NOT COMPLETED|Overall Study||0
11135790|NCT01427595|12321518|FG000|STARTED|Overall Study||25
11135791|NCT01427595|12321518|FG000|COMPLETED|Overall Study||12
11135792|NCT01427595|12321518|FG000|NOT COMPLETED|Overall Study||13
11135793|NCT01427608|12321524|FG000|STARTED|Overall Study||64
11135794|NCT01427608|12321525|FG001|STARTED|Overall Study||62
11135795|NCT01427608|12321524|FG000|COMPLETED|Overall Study||43
11135796|NCT01427608|12321525|FG001|COMPLETED|Overall Study||24
11135797|NCT01427608|12321524|FG000|NOT COMPLETED|Overall Study||21
11135798|NCT01427608|12321525|FG001|NOT COMPLETED|Overall Study||38
11135799|NCT01427738|12321535|FG000|STARTED|Overall Study||110
11135800|NCT01427738|12321536|FG001|STARTED|Overall Study||111
11135801|NCT01427738|12321535|FG000|COMPLETED|Overall Study||91
11135802|NCT01427738|12321536|FG001|COMPLETED|Overall Study||90
11135803|NCT01427738|12321535|FG000|NOT COMPLETED|Overall Study||19
11135804|NCT01427738|12321536|FG001|NOT COMPLETED|Overall Study||21
11135805|NCT01427751|12321544|FG000|STARTED|Overall Study||154
11240765|NCT02093221|12433142|FG001|COMPLETED|Overall Study||8
11240766|NCT02093221|12433143|FG002|COMPLETED|Overall Study||6
11240767|NCT02093221|12433144|FG003|COMPLETED|Overall Study||7
11240768|NCT02093221|12433145|FG004|COMPLETED|Overall Study||7
11240769|NCT02093221|12433141|FG000|NOT COMPLETED|Overall Study||10
11240770|NCT02093221|12433142|FG001|NOT COMPLETED|Overall Study||8
11240771|NCT02093221|12433143|FG002|NOT COMPLETED|Overall Study||9
11240772|NCT02093221|12433144|FG003|NOT COMPLETED|Overall Study||8
11240773|NCT02093221|12433145|FG004|NOT COMPLETED|Overall Study||8
11240774|NCT02093234|12433160|FG000|STARTED|Overall Study||56
11240775|NCT02093234|12433161|FG001|STARTED|Overall Study||56
11240776|NCT02093234|12433162|FG002|STARTED|Overall Study||54
11240777|NCT02093234|12433160|FG000|COMPLETED|Overall Study||53
11240778|NCT02093234|12433161|FG001|COMPLETED|Overall Study||52
11240779|NCT02093234|12433162|FG002|COMPLETED|Overall Study||50
11240780|NCT02093234|12433160|FG000|NOT COMPLETED|Overall Study||3
11240781|NCT02093234|12433161|FG001|NOT COMPLETED|Overall Study||4
11240782|NCT02093234|12433162|FG002|NOT COMPLETED|Overall Study||4
11240783|NCT02093351|12433173|FG000|STARTED|Part A||30
11240784|NCT02093351|12433174|FG001|STARTED|Part A||23
11240785|NCT02093351|12433175|FG002|STARTED|Part A||26
11240786|NCT02093351|12433176|FG003|STARTED|Part A||0
11240787|NCT02093351|12433173|FG000|Completing Treatment Period 1|Part A||29
11240788|NCT02093351|12433174|FG001|Completing Treatment Period 1|Part A||22
11240789|NCT02093351|12433175|FG002|Completing Treatment Period 1|Part A||23
11240790|NCT02093351|12433176|FG003|Completing Treatment Period 1|Part A||0
11240791|NCT02093351|12433173|FG000|Completing Treatment Period 2|Part A||29
11240792|NCT02093351|12433174|FG001|Completing Treatment Period 2|Part A||21
11135806|NCT01427751|12321545|FG001|STARTED|Overall Study||153
11135807|NCT01427751|12321544|FG000|COMPLETED|Overall Study||112
11240793|NCT02093351|12433175|FG002|Completing Treatment Period 2|Part A||23
11240794|NCT02093351|12433176|FG003|Completing Treatment Period 2|Part A||0
11135808|NCT01427751|12321545|FG001|COMPLETED|Overall Study||139
11135809|NCT01427751|12321544|FG000|NOT COMPLETED|Overall Study||42
11135810|NCT01427751|12321545|FG001|NOT COMPLETED|Overall Study||14
11135811|NCT01427803|12321553|FG000|STARTED|Overall Study||526
11135812|NCT01427803|12321554|FG001|STARTED|Overall Study||252
11135813|NCT01427803|12321553|FG000|Purchased Product|Overall Study|Only 516 participants used e-diary|525
11135814|NCT01427803|12321554|FG001|Purchased Product|Overall Study||252
11135815|NCT01427803|12321553|FG000|Baseline Assessment|Overall Study||516
11135816|NCT01427803|12321554|FG001|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
11135817|NCT01427803|12321553|FG000|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
11135818|NCT01427803|12321554|FG001|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
11135819|NCT01427803|12321553|FG000|COMPLETED|Overall Study||463
11135820|NCT01427803|12321554|FG001|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
11135821|NCT01427803|12321553|FG000|NOT COMPLETED|Overall Study||63
11135822|NCT01427803|12321554|FG001|NOT COMPLETED|Overall Study||26
11135823|NCT01427881|12321558|FG000|STARTED|Overall Study||43
11135824|NCT01427881|12321558|FG000|COMPLETED|Overall Study||43
11135825|NCT01427881|12321558|FG000|NOT COMPLETED|Overall Study||0
11135826|NCT01427907|12321564|FG000|STARTED|Overall Study|Randomized|20
11135827|NCT01427907|12321565|FG001|STARTED|Overall Study|Randomized|18
11135828|NCT01427907|12321564|FG000|COMPLETED|Overall Study|Completed study|17
11135829|NCT01427907|12321565|FG001|COMPLETED|Overall Study|Completed study|14
11135830|NCT01427907|12321564|FG000|NOT COMPLETED|Overall Study||3
11135831|NCT01427907|12321565|FG001|NOT COMPLETED|Overall Study||4
11135832|NCT01427920|12321573|FG000|STARTED|Overall Study||174
11135833|NCT01427920|12321574|FG001|STARTED|Overall Study||174
11135834|NCT01427920|12321573|FG000|Exposed|Overall Study||174
11135835|NCT01427920|12321574|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
11135836|NCT01427920|12321573|FG000|COMPLETED|Overall Study||165
11135837|NCT01427920|12321574|FG001|COMPLETED|Overall Study||157
11135838|NCT01427920|12321573|FG000|NOT COMPLETED|Overall Study||9
11135839|NCT01427920|12321574|FG001|NOT COMPLETED|Overall Study||17
11135840|NCT01427933|12321582|FG000|STARTED|Overall Study||71
11135841|NCT01427933|12321583|FG001|STARTED|Overall Study||70
11135842|NCT01427933|12321582|FG000|Received at Least 1 Dose of Study Drug|Overall Study||69
11135843|NCT01427933|12321583|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65
11135844|NCT01427933|12321582|FG000|COMPLETED|Overall Study||63
11135845|NCT01427933|12321583|FG001|COMPLETED|Overall Study||57
11135846|NCT01427933|12321582|FG000|NOT COMPLETED|Overall Study||8
11135847|NCT01427933|12321583|FG001|NOT COMPLETED|Overall Study||13
11135848|NCT01427972|12321602|FG000|STARTED|Treatment Period 1 (21 Days)||3
11135849|NCT01427972|12321603|FG001|STARTED|Treatment Period 1 (21 Days)||4
11135850|NCT01427972|12321604|FG002|STARTED|Treatment Period 1 (21 Days)||4
11135851|NCT01427972|12321605|FG003|STARTED|Treatment Period 1 (21 Days)||3
11135852|NCT01427972|12321606|FG004|STARTED|Treatment Period 1 (21 Days)||4
11135853|NCT01427972|12321607|FG005|STARTED|Treatment Period 1 (21 Days)||3
11135854|NCT01427972|12321608|FG006|STARTED|Treatment Period 1 (21 Days)||3
11135855|NCT01427972|12321609|FG007|STARTED|Treatment Period 1 (21 Days)||5
11135856|NCT01427972|12321610|FG008|STARTED|Treatment Period 1 (21 Days)||3
11135857|NCT01427972|12321611|FG009|STARTED|Treatment Period 1 (21 Days)||3
11135858|NCT01427972|12321612|FG010|STARTED|Treatment Period 1 (21 Days)||3
11135859|NCT01427972|12321613|FG011|STARTED|Treatment Period 1 (21 Days)||4
11135860|NCT01427972|12321602|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
11135861|NCT01427972|12321603|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
11135862|NCT01427972|12321604|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
11135863|NCT01427972|12321605|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
11135864|NCT01427972|12321606|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
11202346|NCT01839318|12392750|FG005|STARTED|Period 2, Second Day of Wear||2
11202347|NCT01839318|12392745|FG000|COMPLETED|Period 2, Second Day of Wear||4
11202348|NCT01839318|12392746|FG001|COMPLETED|Period 2, Second Day of Wear||4
11202349|NCT01839318|12392747|FG002|COMPLETED|Period 2, Second Day of Wear||5
11202350|NCT01839318|12392748|FG003|COMPLETED|Period 2, Second Day of Wear||6
11202351|NCT01839318|12392749|FG004|COMPLETED|Period 2, Second Day of Wear||7
11202352|NCT01839318|12392750|FG005|COMPLETED|Period 2, Second Day of Wear||2
11202353|NCT01839318|12392745|FG000|NOT COMPLETED|Period 2, Second Day of Wear||0
11202354|NCT01839318|12392746|FG001|NOT COMPLETED|Period 2, Second Day of Wear||0
11202355|NCT01839318|12392747|FG002|NOT COMPLETED|Period 2, Second Day of Wear||0
11202356|NCT01839318|12392748|FG003|NOT COMPLETED|Period 2, Second Day of Wear||0
11202357|NCT01839318|12392749|FG004|NOT COMPLETED|Period 2, Second Day of Wear||0
11135865|NCT01427972|12321607|FG005|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
11135866|NCT01427972|12321608|FG006|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
11135867|NCT01427972|12321609|FG007|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5
11135868|NCT01427972|12321610|FG008|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
11135869|NCT01427972|12321611|FG009|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
11135870|NCT01427972|12321612|FG010|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
11135871|NCT01427972|12321613|FG011|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
11135872|NCT01427972|12321602|FG000|COMPLETED|Treatment Period 1 (21 Days)||3
11135873|NCT01427972|12321603|FG001|COMPLETED|Treatment Period 1 (21 Days)||4
11135874|NCT01427972|12321604|FG002|COMPLETED|Treatment Period 1 (21 Days)||4
11135875|NCT01427972|12321605|FG003|COMPLETED|Treatment Period 1 (21 Days)||3
11135876|NCT01427972|12321606|FG004|COMPLETED|Treatment Period 1 (21 Days)||4
11135877|NCT01427972|12321607|FG005|COMPLETED|Treatment Period 1 (21 Days)||3
11135878|NCT01427972|12321608|FG006|COMPLETED|Treatment Period 1 (21 Days)||3
11135879|NCT01427972|12321609|FG007|COMPLETED|Treatment Period 1 (21 Days)||4
11135880|NCT01427972|12321610|FG008|COMPLETED|Treatment Period 1 (21 Days)||3
11135881|NCT01427972|12321611|FG009|COMPLETED|Treatment Period 1 (21 Days)||3
11135882|NCT01427972|12321612|FG010|COMPLETED|Treatment Period 1 (21 Days)||3
11135883|NCT01427972|12321613|FG011|COMPLETED|Treatment Period 1 (21 Days)||4
11135884|NCT01427972|12321602|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11135885|NCT01427972|12321603|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11135886|NCT01427972|12321604|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11135887|NCT01427972|12321605|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11135888|NCT01427972|12321606|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11135889|NCT01427972|12321607|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11135890|NCT01427972|12321608|FG006|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11135891|NCT01427972|12321609|FG007|NOT COMPLETED|Treatment Period 1 (21 Days)||1
11135892|NCT01427972|12321610|FG008|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11135893|NCT01427972|12321611|FG009|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11135894|NCT01427972|12321612|FG010|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11135895|NCT01427972|12321613|FG011|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11135896|NCT01427972|12321602|FG000|STARTED|Washout (at Least 28 Days)||3
11135897|NCT01427972|12321603|FG001|STARTED|Washout (at Least 28 Days)||4
11135898|NCT01427972|12321604|FG002|STARTED|Washout (at Least 28 Days)||4
11135899|NCT01427972|12321605|FG003|STARTED|Washout (at Least 28 Days)||3
11135900|NCT01427972|12321606|FG004|STARTED|Washout (at Least 28 Days)||4
11135901|NCT01427972|12321607|FG005|STARTED|Washout (at Least 28 Days)||3
11135902|NCT01427972|12321608|FG006|STARTED|Washout (at Least 28 Days)||3
11135903|NCT01427972|12321609|FG007|STARTED|Washout (at Least 28 Days)||4
11135904|NCT01427972|12321610|FG008|STARTED|Washout (at Least 28 Days)||3
11135905|NCT01427972|12321611|FG009|STARTED|Washout (at Least 28 Days)||3
11135906|NCT01427972|12321612|FG010|STARTED|Washout (at Least 28 Days)||3
11135907|NCT01427972|12321613|FG011|STARTED|Washout (at Least 28 Days)||4
11135908|NCT01427972|12321602|FG000|COMPLETED|Washout (at Least 28 Days)||3
11135909|NCT01427972|12321603|FG001|COMPLETED|Washout (at Least 28 Days)||4
11135910|NCT01427972|12321604|FG002|COMPLETED|Washout (at Least 28 Days)||4
11135911|NCT01427972|12321605|FG003|COMPLETED|Washout (at Least 28 Days)||3
11135912|NCT01427972|12321606|FG004|COMPLETED|Washout (at Least 28 Days)||4
11135913|NCT01427972|12321607|FG005|COMPLETED|Washout (at Least 28 Days)||1
11135914|NCT01427972|12321608|FG006|COMPLETED|Washout (at Least 28 Days)||3
11135915|NCT01427972|12321609|FG007|COMPLETED|Washout (at Least 28 Days)||4
11135916|NCT01427972|12321610|FG008|COMPLETED|Washout (at Least 28 Days)||3
11135917|NCT01427972|12321611|FG009|COMPLETED|Washout (at Least 28 Days)||3
11135918|NCT01427972|12321612|FG010|COMPLETED|Washout (at Least 28 Days)||3
11135919|NCT01427972|12321613|FG011|COMPLETED|Washout (at Least 28 Days)||4
11135920|NCT01427972|12321602|FG000|NOT COMPLETED|Washout (at Least 28 Days)||0
11135921|NCT01427972|12321603|FG001|NOT COMPLETED|Washout (at Least 28 Days)||0
11135922|NCT01427972|12321604|FG002|NOT COMPLETED|Washout (at Least 28 Days)||0
11135923|NCT01427972|12321605|FG003|NOT COMPLETED|Washout (at Least 28 Days)||0
11135924|NCT01427972|12321606|FG004|NOT COMPLETED|Washout (at Least 28 Days)||0
11135925|NCT01427972|12321607|FG005|NOT COMPLETED|Washout (at Least 28 Days)||2
11240795|NCT02093351|12433173|FG000|Completing Treatment Period 3|Part A||28
11240796|NCT02093351|12433174|FG001|Completing Treatment Period 3|Part A||21
11240797|NCT02093351|12433175|FG002|Completing Treatment Period 3|Part A||23
11240798|NCT02093351|12433176|FG003|Completing Treatment Period 3|Part A||0
11240799|NCT02093351|12433173|FG000|COMPLETED|Part A||28
11240800|NCT02093351|12433174|FG001|COMPLETED|Part A||21
11240801|NCT02093351|12433175|FG002|COMPLETED|Part A||23
11240802|NCT02093351|12433176|FG003|COMPLETED|Part A||0
11240803|NCT02093351|12433173|FG000|NOT COMPLETED|Part A||2
11240804|NCT02093351|12433174|FG001|NOT COMPLETED|Part A||2
11240805|NCT02093351|12433175|FG002|NOT COMPLETED|Part A||3
11240806|NCT02093351|12433176|FG003|NOT COMPLETED|Part A||0
11240807|NCT02093351|12433173|FG000|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
11240808|NCT02093351|12433174|FG001|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
11240809|NCT02093351|12433175|FG002|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
11240810|NCT02093351|12433176|FG003|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69
11240811|NCT02093351|12433173|FG000|COMPLETED|Part B||0
11240812|NCT02093351|12433174|FG001|COMPLETED|Part B||0
11240813|NCT02093351|12433175|FG002|COMPLETED|Part B||0
11240814|NCT02093351|12433176|FG003|COMPLETED|Part B||6
11240815|NCT02093351|12433173|FG000|NOT COMPLETED|Part B||0
11240816|NCT02093351|12433174|FG001|NOT COMPLETED|Part B||0
11240817|NCT02093351|12433175|FG002|NOT COMPLETED|Part B||0
11240818|NCT02093351|12433176|FG003|NOT COMPLETED|Part B||63
11240819|NCT02093390|12433193|FG000|STARTED|Overall Study||20
11135926|NCT01427972|12321608|FG006|NOT COMPLETED|Washout (at Least 28 Days)||0
11135927|NCT01427972|12321609|FG007|NOT COMPLETED|Washout (at Least 28 Days)||0
11135928|NCT01427972|12321610|FG008|NOT COMPLETED|Washout (at Least 28 Days)||0
11135929|NCT01427972|12321611|FG009|NOT COMPLETED|Washout (at Least 28 Days)||0
11135930|NCT01427972|12321612|FG010|NOT COMPLETED|Washout (at Least 28 Days)||0
11135931|NCT01427972|12321613|FG011|NOT COMPLETED|Washout (at Least 28 Days)||0
11135932|NCT01427972|12321602|FG000|STARTED|Treatment Period 2 (21 Days)||3
11135933|NCT01427972|12321603|FG001|STARTED|Treatment Period 2 (21 Days)||4
11135934|NCT01427972|12321604|FG002|STARTED|Treatment Period 2 (21 Days)||4
11135935|NCT01427972|12321605|FG003|STARTED|Treatment Period 2 (21 Days)||3
11240820|NCT02093390|12433194|FG001|STARTED|Overall Study||20
11240821|NCT02093390|12433193|FG000|COMPLETED|Overall Study||20
11135936|NCT01427972|12321606|FG004|STARTED|Treatment Period 2 (21 Days)||4
11135937|NCT01427972|12321607|FG005|STARTED|Treatment Period 2 (21 Days)||1
11135938|NCT01427972|12321608|FG006|STARTED|Treatment Period 2 (21 Days)||3
11135939|NCT01427972|12321609|FG007|STARTED|Treatment Period 2 (21 Days)||4
11135940|NCT01427972|12321610|FG008|STARTED|Treatment Period 2 (21 Days)||3
11135941|NCT01427972|12321611|FG009|STARTED|Treatment Period 2 (21 Days)||3
11135942|NCT01427972|12321612|FG010|STARTED|Treatment Period 2 (21 Days)||3
11135943|NCT01427972|12321613|FG011|STARTED|Treatment Period 2 (21 Days)||4
11135944|NCT01427972|12321602|FG000|COMPLETED|Treatment Period 2 (21 Days)||3
11135945|NCT01427972|12321603|FG001|COMPLETED|Treatment Period 2 (21 Days)||3
11135946|NCT01427972|12321604|FG002|COMPLETED|Treatment Period 2 (21 Days)||4
11135947|NCT01427972|12321605|FG003|COMPLETED|Treatment Period 2 (21 Days)||3
11135948|NCT01427972|12321606|FG004|COMPLETED|Treatment Period 2 (21 Days)||4
11135949|NCT01427972|12321607|FG005|COMPLETED|Treatment Period 2 (21 Days)||1
11135950|NCT01427972|12321608|FG006|COMPLETED|Treatment Period 2 (21 Days)||3
11135951|NCT01427972|12321609|FG007|COMPLETED|Treatment Period 2 (21 Days)||4
11135952|NCT01427972|12321610|FG008|COMPLETED|Treatment Period 2 (21 Days)||3
11135953|NCT01427972|12321611|FG009|COMPLETED|Treatment Period 2 (21 Days)||3
11135954|NCT01427972|12321612|FG010|COMPLETED|Treatment Period 2 (21 Days)||3
11135955|NCT01427972|12321613|FG011|COMPLETED|Treatment Period 2 (21 Days)||4
11135956|NCT01427972|12321602|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11135957|NCT01427972|12321603|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||1
11135958|NCT01427972|12321604|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11135959|NCT01427972|12321605|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11135960|NCT01427972|12321606|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11135961|NCT01427972|12321607|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11135962|NCT01427972|12321608|FG006|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11135963|NCT01427972|12321609|FG007|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11135964|NCT01427972|12321610|FG008|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11135965|NCT01427972|12321611|FG009|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11135966|NCT01427972|12321612|FG010|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11135967|NCT01427972|12321613|FG011|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11135968|NCT01428063|12321626|FG000|STARTED|Overall Study||99
11135969|NCT01428063|12321627|FG001|STARTED|Overall Study||122
11135970|NCT01428063|12321628|FG002|STARTED|Overall Study||6
11135971|NCT01428063|12321626|FG000|COMPLETED|Overall Study||89
11135972|NCT01428063|12321627|FG001|COMPLETED|Overall Study||112
11135973|NCT01428063|12321628|FG002|COMPLETED|Overall Study||5
11135974|NCT01428063|12321626|FG000|NOT COMPLETED|Overall Study||10
11135975|NCT01428063|12321627|FG001|NOT COMPLETED|Overall Study||10
11135976|NCT01428063|12321628|FG002|NOT COMPLETED|Overall Study||1
11135977|NCT01428076|12321649|FG000|STARTED|Overall Study||9
11135978|NCT01428076|12321650|FG001|STARTED|Overall Study||12
11135979|NCT01428076|12321649|FG000|COMPLETED|Overall Study||9
11135980|NCT01428076|12321650|FG001|COMPLETED|Overall Study||11
11135981|NCT01428076|12321649|FG000|NOT COMPLETED|Overall Study||0
11135982|NCT01428076|12321650|FG001|NOT COMPLETED|Overall Study||1
11005283|NCT00721799|12182946|FG000|Received FLT PET Scan #2|Overall Study||25
11005284|NCT00721799|12182946|FG000|COMPLETED|Overall Study||25
11135983|NCT01428115|12321658|FG000|STARTED|Overall Study||83
11135984|NCT01428115|12321658|FG000|COMPLETED|Overall Study||62
11135985|NCT01428115|12321658|FG000|NOT COMPLETED|Overall Study||21
11135986|NCT01428128|12321663|FG000|STARTED|Overall Study||50
11135987|NCT01428128|12321663|FG000|COMPLETED|Overall Study||33
11135988|NCT01428128|12321663|FG000|NOT COMPLETED|Overall Study||17
11135989|NCT01428193|12321668|FG000|STARTED|Overall Study||4
11135990|NCT01428193|12321668|FG000|COMPLETED|Overall Study||2
11135991|NCT01428193|12321668|FG000|NOT COMPLETED|Overall Study||2
11135992|NCT01428219|12321672|FG000|STARTED|Overall Study||25
11135993|NCT01428219|12321672|FG000|COMPLETED|Overall Study||22
11135994|NCT01428219|12321672|FG000|NOT COMPLETED|Overall Study||3
11135995|NCT01428245|12321676|FG000|STARTED|Overall Study||1
11135996|NCT01428245|12321676|FG000|COMPLETED|Overall Study||1
11135997|NCT01428245|12321676|FG000|NOT COMPLETED|Overall Study||0
11135998|NCT01428258|12321682|FG000|STARTED|Intervention 1||17
11135999|NCT01428258|12321683|FG001|STARTED|Intervention 1||15
11136000|NCT01428258|12321682|FG000|COMPLETED|Intervention 1||15
11136001|NCT01428258|12321683|FG001|COMPLETED|Intervention 1||15
11136002|NCT01428258|12321682|FG000|NOT COMPLETED|Intervention 1||2
11136003|NCT01428258|12321683|FG001|NOT COMPLETED|Intervention 1||0
11136004|NCT01428258|12321682|FG000|STARTED|Intervention 2||15
11136005|NCT01428258|12321683|FG001|STARTED|Intervention 2||15
11136006|NCT01428258|12321682|FG000|COMPLETED|Intervention 2||15
11136007|NCT01428258|12321683|FG001|COMPLETED|Intervention 2||15
11136008|NCT01428258|12321682|FG000|NOT COMPLETED|Intervention 2||0
11136009|NCT01428258|12321683|FG001|NOT COMPLETED|Intervention 2||0
11136010|NCT01428336|12321699|FG000|STARTED|Overall Study||10
11136011|NCT01428336|12321700|FG001|STARTED|Overall Study||12
11136012|NCT01428336|12321699|FG000|COMPLETED|Overall Study||10
11136013|NCT01428336|12321700|FG001|COMPLETED|Overall Study||12
11136014|NCT01428336|12321699|FG000|NOT COMPLETED|Overall Study||0
11136015|NCT01428336|12321700|FG001|NOT COMPLETED|Overall Study||0
11136016|NCT01428453|12321711|FG000|STARTED|Overall Study||62
11136017|NCT01428453|12321712|FG001|STARTED|Overall Study||61
11136018|NCT01428453|12321711|FG000|COMPLETED|Overall Study||56
11136019|NCT01428453|12321712|FG001|COMPLETED|Overall Study||52
11136020|NCT01428453|12321711|FG000|NOT COMPLETED|Overall Study||6
11136021|NCT01428453|12321712|FG001|NOT COMPLETED|Overall Study||9
11136022|NCT01428583|12321720|FG000|STARTED|Overall Study||395
11136023|NCT01428583|12321720|FG000|COMPLETED|Overall Study||158
11136024|NCT01428583|12321720|FG000|NOT COMPLETED|Overall Study||237
11136025|NCT01428661|12321727|FG000|STARTED|Double-Masked Phase||254
11136026|NCT01428661|12321728|FG001|STARTED|Double-Masked Phase||253
11136027|NCT01428661|12321729|FG002|STARTED|Double-Masked Phase|Does not apply.|0
11136028|NCT01428661|12321727|FG000|COMPLETED|Double-Masked Phase||197
11136029|NCT01428661|12321728|FG001|COMPLETED|Double-Masked Phase||204
11136030|NCT01428661|12321729|FG002|COMPLETED|Double-Masked Phase|Does not apply.|0
11136031|NCT01428661|12321727|FG000|NOT COMPLETED|Double-Masked Phase||57
11136032|NCT01428661|12321728|FG001|NOT COMPLETED|Double-Masked Phase||49
11136033|NCT01428661|12321729|FG002|NOT COMPLETED|Double-Masked Phase||0
11136034|NCT01428661|12321727|FG000|STARTED|Open Label Extension|Does not apply.|0
11136035|NCT01428661|12321728|FG001|STARTED|Open Label Extension|Does not apply.|0
11136036|NCT01428661|12321729|FG002|STARTED|Open Label Extension||339
11136037|NCT01428661|12321727|FG000|COMPLETED|Open Label Extension|Does not apply.|0
11136038|NCT01428661|12321728|FG001|COMPLETED|Open Label Extension|Does not apply.|0
11136039|NCT01428661|12321729|FG002|COMPLETED|Open Label Extension||19
11136040|NCT01428661|12321727|FG000|NOT COMPLETED|Open Label Extension||0
11136041|NCT01428661|12321728|FG001|NOT COMPLETED|Open Label Extension||0
11136042|NCT01428661|12321729|FG002|NOT COMPLETED|Open Label Extension||320
11136043|NCT01428713|12321737|FG000|STARTED|Overall Study||9
11136044|NCT01428713|12321738|FG001|STARTED|Overall Study||8
11136045|NCT01428713|12321737|FG000|COMPLETED|Overall Study||6
11136046|NCT01428713|12321738|FG001|COMPLETED|Overall Study||3
11136047|NCT01428713|12321737|FG000|NOT COMPLETED|Overall Study||3
11136048|NCT01428713|12321738|FG001|NOT COMPLETED|Overall Study||5
11202358|NCT01839318|12392750|FG005|NOT COMPLETED|Period 2, Second Day of Wear||0
11202359|NCT01839318|12392745|FG000|STARTED|Period 3, Third Day of Wear||4
11202360|NCT01839318|12392746|FG001|STARTED|Period 3, Third Day of Wear||4
11202361|NCT01839318|12392747|FG002|STARTED|Period 3, Third Day of Wear||5
11202362|NCT01839318|12392748|FG003|STARTED|Period 3, Third Day of Wear||6
11202363|NCT01839318|12392749|FG004|STARTED|Period 3, Third Day of Wear||7
11136049|NCT01428765|12321744|FG000|STARTED|Overall Study||1063
11136050|NCT01428765|12321744|FG000|COMPLETED|Overall Study||1063
11136051|NCT01428765|12321744|FG000|NOT COMPLETED|Overall Study||0
11136052|NCT01428882|12321750|FG000|STARTED|Overall Study||67
11136053|NCT01428882|12321751|FG001|STARTED|Overall Study||68
11136054|NCT01428882|12321750|FG000|COMPLETED|Overall Study||61
11136055|NCT01428882|12321751|FG001|COMPLETED|Overall Study||58
11136056|NCT01428882|12321750|FG000|NOT COMPLETED|Overall Study||6
11136057|NCT01428882|12321751|FG001|NOT COMPLETED|Overall Study||10
11136058|NCT01429051|12321757|FG000|STARTED|Titration Phase||45
11136059|NCT01429051|12321757|FG000|COMPLETED|Titration Phase||33
11136060|NCT01429051|12321757|FG000|NOT COMPLETED|Titration Phase||12
11136061|NCT01429051|12321757|FG000|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
11136062|NCT01429051|12321757|FG000|COMPLETED|Efficacy Phase||13
11136063|NCT01429051|12321757|FG000|NOT COMPLETED|Efficacy Phase||2
11136064|NCT01429051|12321757|FG000|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
11136065|NCT01429051|12321757|FG000|COMPLETED|Tolerability Phase||16
11136066|NCT01429051|12321757|FG000|NOT COMPLETED|Tolerability Phase||15
11136067|NCT01429064|12321772|FG000|STARTED|Overall Study||19
11136068|NCT01429064|12321773|FG001|STARTED|Overall Study||22
11136069|NCT01429064|12321774|FG002|STARTED|Overall Study||19
11136070|NCT01429064|12321775|FG003|STARTED|Overall Study||16
11136071|NCT01429064|12321772|FG000|COMPLETED|Overall Study||19
11136072|NCT01429064|12321773|FG001|COMPLETED|Overall Study||22
11136073|NCT01429064|12321774|FG002|COMPLETED|Overall Study||19
11136074|NCT01429064|12321775|FG003|COMPLETED|Overall Study||16
11136075|NCT01429064|12321772|FG000|NOT COMPLETED|Overall Study||0
11136076|NCT01429064|12321773|FG001|NOT COMPLETED|Overall Study||0
11136077|NCT01429064|12321774|FG002|NOT COMPLETED|Overall Study||0
11136078|NCT01429064|12321775|FG003|NOT COMPLETED|Overall Study||0
11136079|NCT01429077|12321787|FG000|STARTED|Overall Study||19
11136080|NCT01429077|12321788|FG001|STARTED|Overall Study||17
11136081|NCT01429077|12321787|FG000|Completed 6-week Intervention|Overall Study||19
11136082|NCT01429077|12321788|FG001|Completed 6-week Intervention|Overall Study||17
11136083|NCT01429077|12321787|FG000|COMPLETED|Overall Study||19
11136084|NCT01429077|12321788|FG001|COMPLETED|Overall Study||14
11136085|NCT01429077|12321787|FG000|NOT COMPLETED|Overall Study||0
11136086|NCT01429077|12321788|FG001|NOT COMPLETED|Overall Study||3
11136087|NCT01429259|12321794|FG000|STARTED|Overall Study||30
11136088|NCT01429259|12321794|FG000|COMPLETED|Overall Study||30
11136089|NCT01429259|12321794|FG000|NOT COMPLETED|Overall Study||0
11136090|NCT01429272|12321802|FG000|STARTED|Overall Study||30
11136091|NCT01429272|12321803|FG001|STARTED|Overall Study||31
11136092|NCT01429272|12321804|FG002|STARTED|Overall Study||19
11136093|NCT01429272|12321805|FG003|STARTED|Overall Study||19
11136094|NCT01429272|12321802|FG000|COMPLETED|Overall Study||24
11136095|NCT01429272|12321803|FG001|COMPLETED|Overall Study||22
11136096|NCT01429272|12321804|FG002|COMPLETED|Overall Study||15
11136097|NCT01429272|12321805|FG003|COMPLETED|Overall Study||14
11136098|NCT01429272|12321802|FG000|NOT COMPLETED|Overall Study||6
11136099|NCT01429272|12321803|FG001|NOT COMPLETED|Overall Study||9
11136100|NCT01429272|12321804|FG002|NOT COMPLETED|Overall Study||4
11136101|NCT01429272|12321805|FG003|NOT COMPLETED|Overall Study||5
11136102|NCT01429285|12321817|FG000|STARTED|Overall Study||175
11136103|NCT01429285|12321818|FG001|STARTED|Overall Study||175
11136104|NCT01429285|12321817|FG000|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
11136105|NCT01429285|12321818|FG001|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
11136106|NCT01429285|12321817|FG000|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
11136107|NCT01429285|12321818|FG001|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
11136108|NCT01429285|12321817|FG000|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
11136109|NCT01429285|12321818|FG001|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
11136110|NCT01429285|12321817|FG000|COMPLETED|Overall Study||153
11136111|NCT01429285|12321818|FG001|COMPLETED|Overall Study||166
11136112|NCT01429285|12321817|FG000|NOT COMPLETED|Overall Study||22
11136113|NCT01429285|12321818|FG001|NOT COMPLETED|Overall Study||9
11136114|NCT01429298|12321826|FG000|STARTED|Overall Study||175
11136115|NCT01429298|12321827|FG001|STARTED|Overall Study||175
11136116|NCT01429298|12321826|FG000|Given IV Opioids|Overall Study|4 never given IV opioids|171
11136117|NCT01429298|12321827|FG001|Given IV Opioids|Overall Study|6 never given IV opioids|169
11136118|NCT01429298|12321826|FG000|COMPLETED|Overall Study||171
11136119|NCT01429298|12321827|FG001|COMPLETED|Overall Study||169
11136120|NCT01429298|12321826|FG000|NOT COMPLETED|Overall Study||4
11136121|NCT01429298|12321827|FG001|NOT COMPLETED|Overall Study||6
11136122|NCT01429350|12321835|FG000|STARTED|Overall Study||53
11136123|NCT01429350|12321836|FG001|STARTED|Overall Study||55
11136124|NCT01429350|12321835|FG000|As-Treated|Overall Study||62
11136125|NCT01429350|12321836|FG001|As-Treated|Overall Study||43
11136126|NCT01429350|12321835|FG000|Per Protocol|Overall Study||41
11136127|NCT01429350|12321836|FG001|Per Protocol|Overall Study||37
11136128|NCT01429350|12321835|FG000|90 Day|Overall Study||46
11136129|NCT01429350|12321836|FG001|90 Day|Overall Study||50
11136130|NCT01429350|12321835|FG000|COMPLETED|Overall Study||46
11136131|NCT01429350|12321836|FG001|COMPLETED|Overall Study||50
11136132|NCT01429350|12321835|FG000|NOT COMPLETED|Overall Study||7
11136133|NCT01429350|12321836|FG001|NOT COMPLETED|Overall Study||5
11136134|NCT01429441|12321844|FG000|STARTED|Overall Study||146
11136135|NCT01429441|12321845|FG001|STARTED|Overall Study||74
11136136|NCT01429441|12321844|FG000|COMPLETED|Overall Study||108
11136137|NCT01429441|12321845|FG001|COMPLETED|Overall Study||51
11136138|NCT01429441|12321844|FG000|NOT COMPLETED|Overall Study||38
11136139|NCT01429441|12321845|FG001|NOT COMPLETED|Overall Study||23
11136140|NCT01429454|12321853|FG000|STARTED|Overall Study||62
11136141|NCT01429454|12321854|FG001|STARTED|Overall Study||65
11136142|NCT01429454|12321853|FG000|COMPLETED|Overall Study||35
11136143|NCT01429454|12321854|FG001|COMPLETED|Overall Study||35
11136144|NCT01429454|12321853|FG000|NOT COMPLETED|Overall Study||27
11136145|NCT01429454|12321854|FG001|NOT COMPLETED|Overall Study||30
11136146|NCT01429532|12321864|FG000|STARTED|Overall Study||40
11136147|NCT01429532|12321865|FG001|STARTED|Overall Study||40
11136148|NCT01429532|12321866|FG002|STARTED|Overall Study||40
11136149|NCT01429532|12321864|FG000|COMPLETED|Overall Study||40
11136150|NCT01429532|12321865|FG001|COMPLETED|Overall Study||40
11136151|NCT01429532|12321866|FG002|COMPLETED|Overall Study||40
11136152|NCT01429532|12321864|FG000|NOT COMPLETED|Overall Study||0
11136153|NCT01429532|12321865|FG001|NOT COMPLETED|Overall Study||0
11136154|NCT01429532|12321866|FG002|NOT COMPLETED|Overall Study||0
11136155|NCT01429584|12321876|FG000|STARTED|Overall Study||15
11136156|NCT01429584|12321877|FG001|STARTED|Overall Study||15
11136157|NCT01429584|12321876|FG000|COMPLETED|Overall Study||14
11136158|NCT01429584|12321877|FG001|COMPLETED|Overall Study||14
11136159|NCT01429584|12321876|FG000|NOT COMPLETED|Overall Study||1
11136160|NCT01429584|12321877|FG001|NOT COMPLETED|Overall Study||1
11136161|NCT01429623|12321885|FG000|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
11136162|NCT01429623|12321886|FG001|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
11136163|NCT01429623|12321885|FG000|Converted to Alzheimer's|Overall Study|14 of 99|14
11136164|NCT01429623|12321886|FG001|Converted to Alzheimer's|Overall Study|21 of 103|21
11136165|NCT01429623|12321885|FG000|COMPLETED|Overall Study||51
11136166|NCT01429623|12321886|FG001|COMPLETED|Overall Study||48
11136167|NCT01429623|12321885|FG000|NOT COMPLETED|Overall Study||51
11136168|NCT01429623|12321886|FG001|NOT COMPLETED|Overall Study||59
11136169|NCT01429792|12321892|FG000|STARTED|Overall Study||1013
11136170|NCT01429792|12321892|FG000|Genotype 1|Overall Study||687
11136171|NCT01429792|12321892|FG000|Genotype 2 & 3|Overall Study||305
11136172|NCT01429792|12321892|FG000|Genotype 4|Overall Study||5
11136173|NCT01429792|12321892|FG000|COMPLETED|Overall Study||607
11136174|NCT01429792|12321892|FG000|NOT COMPLETED|Overall Study||406
11136175|NCT01429987|12321900|FG000|STARTED|Overall Study||238
11136176|NCT01429987|12321901|FG001|STARTED|Overall Study||238
11136177|NCT01429987|12321902|FG002|STARTED|Overall Study||238
11136178|NCT01429987|12321903|FG003|STARTED|Overall Study||237
11136179|NCT01429987|12321900|FG000|COMPLETED|Overall Study||189
11136180|NCT01429987|12321901|FG001|COMPLETED|Overall Study||176
11136181|NCT01429987|12321902|FG002|COMPLETED|Overall Study||202
11136182|NCT01429987|12321903|FG003|COMPLETED|Overall Study||171
11136183|NCT01429987|12321900|FG000|NOT COMPLETED|Overall Study||49
11136184|NCT01429987|12321901|FG001|NOT COMPLETED|Overall Study||62
11136185|NCT01429987|12321902|FG002|NOT COMPLETED|Overall Study||36
11136186|NCT01429987|12321903|FG003|NOT COMPLETED|Overall Study||66
11136187|NCT01430091|12321913|FG000|STARTED|Overall Study||18
11136188|NCT01430091|12321913|FG000|COMPLETED|Overall Study||18
11136189|NCT01430091|12321913|FG000|NOT COMPLETED|Overall Study||0
11136190|NCT01430104|12321927|FG000|STARTED|14-Day Lead-In Period||30
11136191|NCT01430104|12321927|FG000|COMPLETED|14-Day Lead-In Period||30
11136192|NCT01430104|12321927|FG000|NOT COMPLETED|14-Day Lead-In Period||0
11136193|NCT01430104|12321927|FG000|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
11136194|NCT01430104|12321927|FG000|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
11136195|NCT01430104|12321927|FG000|COMPLETED|28-Day Teriparatide Treatment Period||28
11136196|NCT01430104|12321927|FG000|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
11136197|NCT01430130|12321934|FG000|STARTED|Overall Study||12
11136198|NCT01430130|12321934|FG000|COMPLETED|Overall Study||10
11136199|NCT01430130|12321934|FG000|NOT COMPLETED|Overall Study||2
11136200|NCT01430169|12321940|FG000|STARTED|Overall Study||20
11136201|NCT01430169|12321940|FG000|COMPLETED|Overall Study||20
11136202|NCT01430169|12321940|FG000|NOT COMPLETED|Overall Study||0
11136203|NCT01430182|12321946|FG000|STARTED|Overall Study||9
11136204|NCT01430182|12321947|FG001|STARTED|Overall Study||8
11136205|NCT01430182|12321946|FG000|COMPLETED|Overall Study||9
11136206|NCT01430182|12321947|FG001|COMPLETED|Overall Study||8
11136207|NCT01430182|12321946|FG000|NOT COMPLETED|Overall Study||0
11136208|NCT01430182|12321947|FG001|NOT COMPLETED|Overall Study||0
11136209|NCT01430299|12321955|FG000|STARTED|Overall Study||20
11136210|NCT01430299|12321956|FG001|STARTED|Overall Study||23
11136211|NCT01430299|12321955|FG000|COMPLETED|Overall Study||16
11136212|NCT01430299|12321956|FG001|COMPLETED|Overall Study||21
11136213|NCT01430299|12321955|FG000|NOT COMPLETED|Overall Study||4
11136214|NCT01430299|12321956|FG001|NOT COMPLETED|Overall Study||2
11136215|NCT01430325|12321966|FG000|STARTED|Overall Study||10
11136216|NCT01430325|12321967|FG001|STARTED|Overall Study||12
11136217|NCT01430325|12321968|FG002|STARTED|Overall Study||8
11136218|NCT01430325|12321969|FG003|STARTED|Overall Study||12
11136219|NCT01430325|12321966|FG000|COMPLETED|Overall Study||10
11136220|NCT01430325|12321967|FG001|COMPLETED|Overall Study||12
11136221|NCT01430325|12321968|FG002|COMPLETED|Overall Study||8
11136222|NCT01430325|12321969|FG003|COMPLETED|Overall Study||12
11136223|NCT01430325|12321966|FG000|NOT COMPLETED|Overall Study||0
11136224|NCT01430325|12321967|FG001|NOT COMPLETED|Overall Study||0
11136225|NCT01430325|12321968|FG002|NOT COMPLETED|Overall Study||0
11136226|NCT01430325|12321969|FG003|NOT COMPLETED|Overall Study||0
11136227|NCT01430403|12321982|FG000|STARTED|Overall Study|Intent-to-treat|259
11136228|NCT01430403|12321983|FG001|STARTED|Overall Study|Intent-to-treat|130
11136229|NCT01430403|12321984|FG002|STARTED|Overall Study|Intent-to-treat|89
11136230|NCT01430403|12321982|FG000|COMPLETED|Overall Study||242
11136231|NCT01430403|12321983|FG001|COMPLETED|Overall Study||121
11136232|NCT01430403|12321984|FG002|COMPLETED|Overall Study||81
11136233|NCT01430403|12321982|FG000|NOT COMPLETED|Overall Study||17
11136234|NCT01430403|12321983|FG001|NOT COMPLETED|Overall Study||9
11136235|NCT01430403|12321984|FG002|NOT COMPLETED|Overall Study||8
11136236|NCT01430442|12322005|FG000|STARTED|Overall Study||85
11136237|NCT01430442|12322006|FG001|STARTED|Overall Study||68
11136238|NCT01430442|12322007|FG002|STARTED|Overall Study||91
11136239|NCT01430442|12322008|FG003|STARTED|Overall Study||90
11136240|NCT01430442|12322009|FG004|STARTED|Overall Study||121
11136241|NCT01430442|12322010|FG005|STARTED|Overall Study||92
11136242|NCT01430442|12322011|FG006|STARTED|Overall Study||229
11136243|NCT01430442|12322012|FG007|STARTED|Overall Study||109
11136244|NCT01430442|12322005|FG000|COMPLETED|Overall Study||72
11136245|NCT01430442|12322006|FG001|COMPLETED|Overall Study||62
11136246|NCT01430442|12322007|FG002|COMPLETED|Overall Study||86
11136247|NCT01430442|12322008|FG003|COMPLETED|Overall Study||86
11136248|NCT01430442|12322009|FG004|COMPLETED|Overall Study||112
11136249|NCT01430442|12322010|FG005|COMPLETED|Overall Study||84
11136250|NCT01430442|12322011|FG006|COMPLETED|Overall Study||210
11136251|NCT01430442|12322012|FG007|COMPLETED|Overall Study||100
11136252|NCT01430442|12322005|FG000|NOT COMPLETED|Overall Study||13
11136253|NCT01430442|12322006|FG001|NOT COMPLETED|Overall Study||6
11136254|NCT01430442|12322007|FG002|NOT COMPLETED|Overall Study||5
11136255|NCT01430442|12322008|FG003|NOT COMPLETED|Overall Study||4
11136256|NCT01430442|12322009|FG004|NOT COMPLETED|Overall Study||9
11136257|NCT01430442|12322010|FG005|NOT COMPLETED|Overall Study||8
11136258|NCT01430442|12322011|FG006|NOT COMPLETED|Overall Study||19
11136259|NCT01430442|12322012|FG007|NOT COMPLETED|Overall Study||9
11136260|NCT01430455|12322030|FG000|STARTED|Overall Study||7
11136261|NCT01430455|12322030|FG000|COMPLETED|Overall Study||5
11136262|NCT01430455|12322030|FG000|NOT COMPLETED|Overall Study||2
11136263|NCT01430468|12322036|FG000|STARTED|Overall Study||22
11136264|NCT01430468|12322037|FG001|STARTED|Overall Study||22
11136265|NCT01430468|12322036|FG000|COMPLETED|Overall Study||15
11136266|NCT01430468|12322037|FG001|COMPLETED|Overall Study||16
11136267|NCT01430468|12322036|FG000|NOT COMPLETED|Overall Study||7
11136268|NCT01430468|12322037|FG001|NOT COMPLETED|Overall Study||6
11136269|NCT01430559|12322045|FG000|STARTED|Overall Study||146
11136270|NCT01430559|12322046|FG001|STARTED|Overall Study||147
11136271|NCT01430559|12322045|FG000|Treated|Overall Study||143
11136272|NCT01430559|12322046|FG001|Treated|Overall Study||144
11136273|NCT01430559|12322045|FG000|COMPLETED|Overall Study||126
11136274|NCT01430559|12322046|FG001|COMPLETED|Overall Study||135
11136275|NCT01430559|12322045|FG000|NOT COMPLETED|Overall Study||20
11136276|NCT01430559|12322046|FG001|NOT COMPLETED|Overall Study||12
11136277|NCT01430585|12322057|FG000|STARTED|Overall Study||14
11136278|NCT01430585|12322057|FG000|COMPLETED|Overall Study||0
11136279|NCT01430585|12322057|FG000|NOT COMPLETED|Overall Study||14
11136280|NCT01430611|12322069|FG000|STARTED|Overall Study||332
11136281|NCT01430611|12322070|FG001|STARTED|Overall Study||333
11136282|NCT01430611|12322069|FG000|COMPLETED|Overall Study||315
11136283|NCT01430611|12322070|FG001|COMPLETED|Overall Study||318
11136284|NCT01430611|12322069|FG000|NOT COMPLETED|Overall Study||17
11136285|NCT01430611|12322070|FG001|NOT COMPLETED|Overall Study||15
11136286|NCT01430624|12322079|FG000|STARTED|Overall Study|Initial potential eligible screened enrolled|82
11136287|NCT01430624|12322080|FG001|STARTED|Overall Study||82
11136288|NCT01430624|12322081|FG002|STARTED|Overall Study||81
11136289|NCT01430624|12322079|FG000|Eligible Baseline Completes|Overall Study||77
11136290|NCT01430624|12322080|FG001|Eligible Baseline Completes|Overall Study||77
11136291|NCT01430624|12322081|FG002|Eligible Baseline Completes|Overall Study||79
11136292|NCT01430624|12322079|FG000|COMPLETED|Overall Study|Completed one or more follow-ups|54
11136293|NCT01430624|12322080|FG001|COMPLETED|Overall Study|Completed one or more follow-ups|48
11136294|NCT01430624|12322081|FG002|COMPLETED|Overall Study|Completed one or more follow-ups|52
11136295|NCT01430624|12322079|FG000|NOT COMPLETED|Overall Study||28
11136296|NCT01430624|12322080|FG001|NOT COMPLETED|Overall Study||34
11136297|NCT01430624|12322081|FG002|NOT COMPLETED|Overall Study||29
11136298|NCT01430741|12322097|FG000|STARTED|Overall Study||22
11136299|NCT01430741|12322098|FG001|STARTED|Overall Study||87
11136300|NCT01430741|12322099|FG002|STARTED|Overall Study||47
11136301|NCT01430741|12322100|FG003|STARTED|Overall Study||81
11136302|NCT01430741|12322097|FG000|COMPLETED|Overall Study||22
11136303|NCT01430741|12322098|FG001|COMPLETED|Overall Study||87
11136304|NCT01430741|12322099|FG002|COMPLETED|Overall Study||37
11136305|NCT01430741|12322100|FG003|COMPLETED|Overall Study||81
11136306|NCT01430741|12322097|FG000|NOT COMPLETED|Overall Study||0
11136307|NCT01430741|12322098|FG001|NOT COMPLETED|Overall Study||0
11136308|NCT01430741|12322099|FG002|NOT COMPLETED|Overall Study||10
11136309|NCT01430741|12322100|FG003|NOT COMPLETED|Overall Study||0
11136310|NCT01430754|12322113|FG000|STARTED|Run-In Phase||57
11136311|NCT01430754|12322114|FG001|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
11136312|NCT01430754|12322113|FG000|Entrained - After Run-In Phase|Run-In Phase||24
11136313|NCT01430754|12322114|FG001|Entrained - After Run-In Phase|Run-In Phase||0
11136314|NCT01430754|12322113|FG000|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
11136315|NCT01430754|12322114|FG001|COMPLETED|Run-In Phase||0
11136316|NCT01430754|12322113|FG000|NOT COMPLETED|Run-In Phase||37
11136317|NCT01430754|12322114|FG001|NOT COMPLETED|Run-In Phase||0
11136318|NCT01430754|12322113|FG000|STARTED|Randomized Phase||10
11240822|NCT02093390|12433194|FG001|COMPLETED|Overall Study||19
11240823|NCT02093390|12433193|FG000|NOT COMPLETED|Overall Study||0
11240824|NCT02093390|12433194|FG001|NOT COMPLETED|Overall Study||1
11240825|NCT02093520|12433203|FG000|STARTED|Overall Study||149
11136319|NCT01430754|12322114|FG001|STARTED|Randomized Phase||10
11136320|NCT01430754|12322113|FG000|COMPLETED|Randomized Phase||10
11136321|NCT01430754|12322114|FG001|COMPLETED|Randomized Phase||10
11136322|NCT01430754|12322113|FG000|NOT COMPLETED|Randomized Phase||0
11136323|NCT01430754|12322114|FG001|NOT COMPLETED|Randomized Phase||0
11136324|NCT01430819|12322124|FG000|STARTED|Overall Study||150
11240826|NCT02093520|12433204|FG001|STARTED|Overall Study||153
11240827|NCT02093520|12433203|FG000|COMPLETED|Overall Study||143
11240828|NCT02093520|12433204|FG001|COMPLETED|Overall Study||131
11136325|NCT01430819|12322125|FG001|STARTED|Overall Study||150
11136326|NCT01430819|12322124|FG000|COMPLETED|Overall Study||150
11136327|NCT01430819|12322125|FG001|COMPLETED|Overall Study||150
11136328|NCT01430819|12322124|FG000|NOT COMPLETED|Overall Study||0
11136329|NCT01430819|12322125|FG001|NOT COMPLETED|Overall Study||0
11136330|NCT01431014|12322133|FG000|STARTED|Overall Study||34
11136331|NCT01431014|12322134|FG001|STARTED|Overall Study||34
11136332|NCT01431014|12322133|FG000|COMPLETED|Overall Study||31
11136333|NCT01431014|12322134|FG001|COMPLETED|Overall Study||25
11136334|NCT01431014|12322133|FG000|NOT COMPLETED|Overall Study||3
11136335|NCT01431014|12322134|FG001|NOT COMPLETED|Overall Study||9
11136336|NCT01431079|12322142|FG000|STARTED|Overall Study||45
11136337|NCT01431079|12322143|FG001|STARTED|Overall Study||45
11136338|NCT01431079|12322142|FG000|Post-test|Overall Study||45
11136339|NCT01431079|12322143|FG001|Post-test|Overall Study||45
11136340|NCT01431079|12322142|FG000|COMPLETED|Overall Study||10
11136341|NCT01431079|12322143|FG001|COMPLETED|Overall Study||6
11136342|NCT01431079|12322142|FG000|NOT COMPLETED|Overall Study||35
11136343|NCT01431079|12322143|FG001|NOT COMPLETED|Overall Study||39
11136344|NCT01431105|12322173|FG000|STARTED|Overall Study||34
11136345|NCT01431105|12322173|FG000|COMPLETED|Overall Study||34
11136346|NCT01431105|12322173|FG000|NOT COMPLETED|Overall Study||0
11136347|NCT01431131|12322179|FG000|STARTED|Overall Study||12
11136348|NCT01431131|12322180|FG001|STARTED|Overall Study||12
11136349|NCT01431131|12322179|FG000|COMPLETED|Overall Study||12
11136350|NCT01431131|12322180|FG001|COMPLETED|Overall Study||12
11136351|NCT01431131|12322179|FG000|NOT COMPLETED|Overall Study||0
11136352|NCT01431131|12322180|FG001|NOT COMPLETED|Overall Study||0
11136353|NCT01431144|12322188|FG000|STARTED|Overall Study||13
11136354|NCT01431144|12322189|FG001|STARTED|Overall Study||14
11136355|NCT01431144|12322188|FG000|COMPLETED|Overall Study||11
11136356|NCT01431144|12322189|FG001|COMPLETED|Overall Study||14
11136357|NCT01431144|12322188|FG000|NOT COMPLETED|Overall Study||2
11136358|NCT01431144|12322189|FG001|NOT COMPLETED|Overall Study||0
11136359|NCT01431170|12322197|FG000|STARTED|Overall Study||12
11136360|NCT01431170|12322198|FG001|STARTED|Overall Study||12
11136361|NCT01431170|12322197|FG000|COMPLETED|Overall Study||9
11136362|NCT01431170|12322198|FG001|COMPLETED|Overall Study||11
11136363|NCT01431170|12322197|FG000|NOT COMPLETED|Overall Study||3
11136364|NCT01431170|12322198|FG001|NOT COMPLETED|Overall Study||1
11136365|NCT01431209|12322216|FG000|STARTED|Overall Study||47
11136366|NCT01431209|12322217|FG001|STARTED|Overall Study||13
11136367|NCT01431209|12322216|FG000|COMPLETED|Overall Study||43
11136368|NCT01431209|12322217|FG001|COMPLETED|Overall Study||12
11136369|NCT01431209|12322216|FG000|NOT COMPLETED|Overall Study||4
11136370|NCT01431209|12322217|FG001|NOT COMPLETED|Overall Study||1
11136371|NCT01431274|12322228|FG000|STARTED|Overall Study||528
11136372|NCT01431274|12322229|FG001|STARTED|Overall Study||525
11136373|NCT01431274|12322230|FG002|STARTED|Overall Study||527
11136374|NCT01431274|12322231|FG003|STARTED|Overall Study||522
11136375|NCT01431274|12322232|FG004|STARTED|Overall Study||522
11136376|NCT01431274|12322228|FG000|COMPLETED|Overall Study||431
11136377|NCT01431274|12322229|FG001|COMPLETED|Overall Study||448
11136378|NCT01431274|12322230|FG002|COMPLETED|Overall Study||455
11136379|NCT01431274|12322231|FG003|COMPLETED|Overall Study||462
11136380|NCT01431274|12322232|FG004|COMPLETED|Overall Study||466
11136381|NCT01431274|12322228|FG000|NOT COMPLETED|Overall Study||97
11136382|NCT01431274|12322229|FG001|NOT COMPLETED|Overall Study||77
11136383|NCT01431274|12322230|FG002|NOT COMPLETED|Overall Study||72
11136384|NCT01431274|12322231|FG003|NOT COMPLETED|Overall Study||60
11136385|NCT01431274|12322232|FG004|NOT COMPLETED|Overall Study||56
11136386|NCT01431287|12322249|FG000|STARTED|Overall Study|started are actually the randomized|510
11136387|NCT01431287|12322250|FG001|STARTED|Overall Study||507
11136388|NCT01431287|12322251|FG002|STARTED|Overall Study||507
11136389|NCT01431287|12322252|FG003|STARTED|Overall Study||508
11136390|NCT01431287|12322253|FG004|STARTED|Overall Study||507
11136391|NCT01431287|12322249|FG000|COMPLETED|Overall Study||412
11136392|NCT01431287|12322250|FG001|COMPLETED|Overall Study||409
11136393|NCT01431287|12322251|FG002|COMPLETED|Overall Study||410
11136394|NCT01431287|12322252|FG003|COMPLETED|Overall Study||445
11136395|NCT01431287|12322253|FG004|COMPLETED|Overall Study||430
11136396|NCT01431287|12322249|FG000|NOT COMPLETED|Overall Study||98
11136397|NCT01431287|12322250|FG001|NOT COMPLETED|Overall Study||98
11136398|NCT01431287|12322251|FG002|NOT COMPLETED|Overall Study||97
11136399|NCT01431287|12322252|FG003|NOT COMPLETED|Overall Study||63
11136400|NCT01431287|12322253|FG004|NOT COMPLETED|Overall Study||77
11136401|NCT01431300|12322268|FG000|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
11136402|NCT01431300|12322269|FG001|STARTED|Overall Study||10
11136403|NCT01431300|12322270|FG002|STARTED|Overall Study||10
11136404|NCT01431300|12322268|FG000|COMPLETED|Overall Study||10
11136405|NCT01431300|12322269|FG001|COMPLETED|Overall Study||10
11136406|NCT01431300|12322270|FG002|COMPLETED|Overall Study||10
11136407|NCT01431300|12322268|FG000|NOT COMPLETED|Overall Study||1
11136408|NCT01431300|12322269|FG001|NOT COMPLETED|Overall Study||0
11136409|NCT01431300|12322270|FG002|NOT COMPLETED|Overall Study||0
11136410|NCT01431313|12322281|FG000|STARTED|Overall Study||20
11136411|NCT01431313|12322282|FG001|STARTED|Overall Study||20
11136412|NCT01431313|12322283|FG002|STARTED|Overall Study||8
11136413|NCT01431313|12322281|FG000|COMPLETED|Overall Study||20
11136414|NCT01431313|12322282|FG001|COMPLETED|Overall Study||20
11136415|NCT01431313|12322283|FG002|COMPLETED|Overall Study||8
11136416|NCT01431313|12322281|FG000|NOT COMPLETED|Overall Study||0
11136417|NCT01431313|12322282|FG001|NOT COMPLETED|Overall Study||0
11136418|NCT01431313|12322283|FG002|NOT COMPLETED|Overall Study||0
11136419|NCT01431339|12322294|FG000|STARTED|Overall Study||371
11136420|NCT01431339|12322295|FG001|STARTED|Overall Study||368
11136421|NCT01431339|12322294|FG000|Safety Population|Overall Study||368
11136422|NCT01431339|12322295|FG001|Safety Population|Overall Study||367
11136423|NCT01431339|12322294|FG000|COMPLETED|Overall Study||332
11136424|NCT01431339|12322295|FG001|COMPLETED|Overall Study||333
11136425|NCT01431339|12322294|FG000|NOT COMPLETED|Overall Study||39
11136426|NCT01431339|12322295|FG001|NOT COMPLETED|Overall Study||35
11136427|NCT01431391|12322303|FG000|STARTED|Overall Study||34
11136428|NCT01431391|12322304|FG001|STARTED|Overall Study||34
11136429|NCT01431391|12322303|FG000|Received ≥1 Leaukapheresis|Overall Study||34
11136430|NCT01431391|12322304|FG001|Received ≥1 Leaukapheresis|Overall Study||34
11136431|NCT01431391|12322303|FG000|COMPLETED|Overall Study||26
11136432|NCT01431391|12322304|FG001|COMPLETED|Overall Study||30
11136433|NCT01431391|12322303|FG000|NOT COMPLETED|Overall Study||8
11136434|NCT01431391|12322304|FG001|NOT COMPLETED|Overall Study||4
11136435|NCT01431521|12322315|FG000|STARTED|Overall Study||10
11136436|NCT01431521|12322316|FG001|STARTED|Overall Study||5
11136437|NCT01431521|12322317|FG002|STARTED|Overall Study||11
11136438|NCT01431521|12322318|FG003|STARTED|Overall Study||5
11136439|NCT01431521|12322315|FG000|Treated|Overall Study||10
11136440|NCT01431521|12322316|FG001|Treated|Overall Study||5
11136441|NCT01431521|12322317|FG002|Treated|Overall Study||10
11136442|NCT01431521|12322318|FG003|Treated|Overall Study||5
11136443|NCT01431521|12322315|FG000|COMPLETED|Overall Study||10
11136444|NCT01431521|12322316|FG001|COMPLETED|Overall Study||5
11136445|NCT01431521|12322317|FG002|COMPLETED|Overall Study||10
11136446|NCT01431521|12322318|FG003|COMPLETED|Overall Study||5
11136447|NCT01431521|12322315|FG000|NOT COMPLETED|Overall Study||0
11136448|NCT01431521|12322316|FG001|NOT COMPLETED|Overall Study||0
11136449|NCT01431521|12322317|FG002|NOT COMPLETED|Overall Study||1
11136450|NCT01431521|12322318|FG003|NOT COMPLETED|Overall Study||0
11136451|NCT01431534|12322330|FG000|STARTED|Treatment Phase||4
11136452|NCT01431534|12322331|FG001|STARTED|Treatment Phase||3
11136453|NCT01431534|12322332|FG002|STARTED|Treatment Phase||13
11136454|NCT01431534|12322330|FG000|COMPLETED|Treatment Phase||0
11136455|NCT01431534|12322331|FG001|COMPLETED|Treatment Phase||0
11136456|NCT01431534|12322332|FG002|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2
11136457|NCT01431534|12322330|FG000|NOT COMPLETED|Treatment Phase||4
11136458|NCT01431534|12322331|FG001|NOT COMPLETED|Treatment Phase||3
11136459|NCT01431534|12322332|FG002|NOT COMPLETED|Treatment Phase||11
11136460|NCT01431534|12322330|FG000|STARTED|Extension Phase|No participants continued in Extension Phase.|0
11136461|NCT01431534|12322331|FG001|STARTED|Extension Phase|No participants continued in Extension Phase.|0
11136462|NCT01431534|12322332|FG002|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2
11136463|NCT01431534|12322330|FG000|COMPLETED|Extension Phase||0
11136464|NCT01431534|12322331|FG001|COMPLETED|Extension Phase||0
11136465|NCT01431534|12322332|FG002|COMPLETED|Extension Phase||2
11136466|NCT01431534|12322330|FG000|NOT COMPLETED|Extension Phase||0
11136467|NCT01431534|12322331|FG001|NOT COMPLETED|Extension Phase||0
11136468|NCT01431534|12322332|FG002|NOT COMPLETED|Extension Phase||0
11136469|NCT01431573|12322340|FG000|STARTED|Overall Study||8
11136470|NCT01431573|12322340|FG000|COMPLETED|Overall Study||8
11136471|NCT01431573|12322340|FG000|NOT COMPLETED|Overall Study||0
11136472|NCT01431638|12322347|FG000|STARTED|Overall Study||133
11136473|NCT01431638|12322348|FG001|STARTED|Overall Study||132
11136474|NCT01431638|12322349|FG002|STARTED|Overall Study||132
11136475|NCT01431638|12322347|FG000|Completed Core Study|Overall Study||124
11136476|NCT01431638|12322348|FG001|Completed Core Study|Overall Study||117
11136477|NCT01431638|12322349|FG002|Completed Core Study|Overall Study||108
11136478|NCT01431638|12322347|FG000|Entered Extension 1 Study|Overall Study||85
11136479|NCT01431638|12322348|FG001|Entered Extension 1 Study|Overall Study||71
11136480|NCT01431638|12322349|FG002|Entered Extension 1 Study|Overall Study||76
11136481|NCT01431638|12322347|FG000|COMPLETED|Overall Study||67
11136482|NCT01431638|12322348|FG001|COMPLETED|Overall Study||61
11136483|NCT01431638|12322349|FG002|COMPLETED|Overall Study||70
11136484|NCT01431638|12322347|FG000|NOT COMPLETED|Overall Study||66
11136485|NCT01431638|12322348|FG001|NOT COMPLETED|Overall Study||71
11136486|NCT01431638|12322349|FG002|NOT COMPLETED|Overall Study||62
11136487|NCT01431703|12322357|FG000|STARTED|Overall Study||326
11136488|NCT01431703|12322357|FG000|COMPLETED|Overall Study||326
11136489|NCT01431703|12322357|FG000|NOT COMPLETED|Overall Study||0
11136490|NCT01431716|12322361|FG000|STARTED|Overall Study||42
11136491|NCT01431716|12322361|FG000|COMPLETED|Overall Study||41
11136492|NCT01431716|12322361|FG000|NOT COMPLETED|Overall Study||1
11136493|NCT01431794|12322370|FG000|STARTED|Overall Study||13
11136494|NCT01431794|12322371|FG001|STARTED|Overall Study|not started due to early study's termination|0
11240829|NCT02093520|12433203|FG000|NOT COMPLETED|Overall Study||6
11240830|NCT02093520|12433204|FG001|NOT COMPLETED|Overall Study||22
11240831|NCT02093663|12433210|FG000|STARTED|Double Blind Acute Phase (8 Weeks)||27
11240832|NCT02093663|12433211|FG001|STARTED|Double Blind Acute Phase (8 Weeks)||26
11240833|NCT02093663|12433212|FG002|STARTED|Double Blind Acute Phase (8 Weeks)||0
11240834|NCT02093663|12433213|FG003|STARTED|Double Blind Acute Phase (8 Weeks)||0
11240835|NCT02093663|12433214|FG004|STARTED|Double Blind Acute Phase (8 Weeks)||0
11240836|NCT02093663|12433210|FG000|COMPLETED|Double Blind Acute Phase (8 Weeks)||19
11240837|NCT02093663|12433211|FG001|COMPLETED|Double Blind Acute Phase (8 Weeks)||22
11240838|NCT02093663|12433212|FG002|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
11240839|NCT02093663|12433213|FG003|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
11240840|NCT02093663|12433214|FG004|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
11136495|NCT01431794|12322372|FG002|STARTED|Overall Study|not started due to early study's termination|0
11136496|NCT01431794|12322373|FG003|STARTED|Overall Study|not started due to early study's termination|0
11136497|NCT01431794|12322374|FG004|STARTED|Overall Study|not started due to early study's termination|0
11136498|NCT01431794|12322370|FG000|COMPLETED|Overall Study||13
11136499|NCT01431794|12322371|FG001|COMPLETED|Overall Study|not started due to early study's termination|0
11136500|NCT01431794|12322372|FG002|COMPLETED|Overall Study|not started due to early study's termination|0
11136501|NCT01431794|12322373|FG003|COMPLETED|Overall Study|not started due to early study's termination|0
11136502|NCT01431794|12322374|FG004|COMPLETED|Overall Study|not started due to early study's termination|0
11136503|NCT01431794|12322370|FG000|NOT COMPLETED|Overall Study||0
11136504|NCT01431794|12322371|FG001|NOT COMPLETED|Overall Study||0
11136505|NCT01431794|12322372|FG002|NOT COMPLETED|Overall Study||0
11136506|NCT01431794|12322373|FG003|NOT COMPLETED|Overall Study||0
11136507|NCT01431794|12322374|FG004|NOT COMPLETED|Overall Study||0
11136508|NCT01431846|12322389|FG000|STARTED|Overall Study||8
11136509|NCT01431846|12322390|FG001|STARTED|Overall Study||3
11136510|NCT01431846|12322391|FG002|STARTED|Overall Study||8
11136511|NCT01431846|12322389|FG000|COMPLETED|Overall Study||8
11136512|NCT01431846|12322390|FG001|COMPLETED|Overall Study||3
11136513|NCT01431846|12322391|FG002|COMPLETED|Overall Study||8
11136514|NCT01431846|12322389|FG000|NOT COMPLETED|Overall Study||0
11136515|NCT01431846|12322390|FG001|NOT COMPLETED|Overall Study||0
11136516|NCT01431846|12322391|FG002|NOT COMPLETED|Overall Study||0
11136517|NCT01431950|12322401|FG000|STARTED|Overall Study||119
11136518|NCT01431950|12322402|FG001|STARTED|Overall Study||119
11136519|NCT01431950|12322401|FG000|COMPLETED|Overall Study||100
11136520|NCT01431950|12322402|FG001|COMPLETED|Overall Study||104
11136521|NCT01431950|12322401|FG000|NOT COMPLETED|Overall Study||19
11136522|NCT01431950|12322402|FG001|NOT COMPLETED|Overall Study||15
11136523|NCT01431963|12322408|FG000|STARTED|Overall Study||67
11136524|NCT01431963|12322408|FG000|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
11136525|NCT01431963|12322408|FG000|Received Treatment|Overall Study||65
11136526|NCT01431963|12322408|FG000|Complete EP (6 Weeks)|Overall Study||52
11136527|NCT01431963|12322408|FG000|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
11136528|NCT01431963|12322408|FG000|Complete MP (24 Weeks)|Overall Study||42
11136529|NCT01431963|12322408|FG000|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
11136530|NCT01431963|12322408|FG000|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
11136531|NCT01431963|12322408|FG000|COMPLETED|Overall Study||32
11136532|NCT01431963|12322408|FG000|NOT COMPLETED|Overall Study||35
11136533|NCT01431976|12322412|FG000|STARTED|Overall Study||20
11136534|NCT01431976|12322412|FG000|COMPLETED|Overall Study||6
11136535|NCT01431976|12322412|FG000|NOT COMPLETED|Overall Study||14
11136536|NCT01431989|12322416|FG000|STARTED|Period 1||14
11136537|NCT01431989|12322417|FG001|STARTED|Period 1||14
11136538|NCT01431989|12322416|FG000|COMPLETED|Period 1||14
11136539|NCT01431989|12322417|FG001|COMPLETED|Period 1||14
11136540|NCT01431989|12322416|FG000|NOT COMPLETED|Period 1||0
11136541|NCT01431989|12322417|FG001|NOT COMPLETED|Period 1||0
11136542|NCT01431989|12322416|FG000|STARTED|14-Day Washout Period||14
11136543|NCT01431989|12322417|FG001|STARTED|14-Day Washout Period||14
11136544|NCT01431989|12322416|FG000|COMPLETED|14-Day Washout Period||14
11136545|NCT01431989|12322417|FG001|COMPLETED|14-Day Washout Period||14
11136546|NCT01431989|12322416|FG000|NOT COMPLETED|14-Day Washout Period||0
11136547|NCT01431989|12322417|FG001|NOT COMPLETED|14-Day Washout Period||0
11136548|NCT01431989|12322416|FG000|STARTED|Period 2||14
11136549|NCT01431989|12322417|FG001|STARTED|Period 2||14
11136550|NCT01431989|12322416|FG000|COMPLETED|Period 2||14
11136551|NCT01431989|12322417|FG001|COMPLETED|Period 2||14
11136552|NCT01431989|12322416|FG000|NOT COMPLETED|Period 2||0
11136553|NCT01431989|12322417|FG001|NOT COMPLETED|Period 2||0
11136554|NCT01432015|12322425|FG000|STARTED|Overall Study||10
11136555|NCT01432015|12322426|FG001|STARTED|Overall Study||10
11136556|NCT01432015|12322425|FG000|COMPLETED|Overall Study||10
11136557|NCT01432015|12322426|FG001|COMPLETED|Overall Study||10
11136558|NCT01432015|12322425|FG000|NOT COMPLETED|Overall Study||0
11136559|NCT01432015|12322426|FG001|NOT COMPLETED|Overall Study||0
11136560|NCT01432145|12322432|FG000|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74
11136561|NCT01432145|12322432|FG000|COMPLETED|Overall Study||67
11136562|NCT01432145|12322432|FG000|NOT COMPLETED|Overall Study||7
11136563|NCT01432171|12322438|FG000|STARTED|Overall Study||18
11136564|NCT01432171|12322439|FG001|STARTED|Overall Study||19
11136565|NCT01432171|12322438|FG000|COMPLETED|Overall Study||4
11136566|NCT01432171|12322439|FG001|COMPLETED|Overall Study||8
11136567|NCT01432171|12322438|FG000|NOT COMPLETED|Overall Study||14
11136568|NCT01432171|12322439|FG001|NOT COMPLETED|Overall Study||11
11136569|NCT01432236|12322447|FG000|STARTED|Overall Study||96
11136570|NCT01432236|12322448|FG001|STARTED|Overall Study||97
11136571|NCT01432236|12322447|FG000|COMPLETED|Overall Study||70
11136572|NCT01432236|12322448|FG001|COMPLETED|Overall Study||79
11136573|NCT01432236|12322447|FG000|NOT COMPLETED|Overall Study||26
11136574|NCT01432236|12322448|FG001|NOT COMPLETED|Overall Study||18
11136575|NCT01432262|12322463|FG000|STARTED|Overall Study||162
11136576|NCT01432262|12322464|FG001|STARTED|Overall Study||162
11136577|NCT01432262|12322463|FG000|Vaccinated|Overall Study||162
11136578|NCT01432262|12322464|FG001|Vaccinated|Overall Study||161
11240841|NCT02093663|12433210|FG000|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8
11136579|NCT01432262|12322463|FG000|COMPLETED|Overall Study||160
11136580|NCT01432262|12322464|FG001|COMPLETED|Overall Study||161
11136581|NCT01432262|12322463|FG000|NOT COMPLETED|Overall Study||2
11136582|NCT01432262|12322464|FG001|NOT COMPLETED|Overall Study||1
11136583|NCT01432275|12322470|FG000|STARTED|First BG Meter System (7 Days)||90
11136584|NCT01432275|12322471|FG001|STARTED|First BG Meter System (7 Days)||87
11136585|NCT01432275|12322470|FG000|COMPLETED|First BG Meter System (7 Days)||90
11136586|NCT01432275|12322471|FG001|COMPLETED|First BG Meter System (7 Days)||84
11136587|NCT01432275|12322470|FG000|NOT COMPLETED|First BG Meter System (7 Days)||0
11136588|NCT01432275|12322471|FG001|NOT COMPLETED|First BG Meter System (7 Days)||3
11136589|NCT01432275|12322470|FG000|STARTED|Second BG Meter System (7 Days)||90
11136590|NCT01432275|12322471|FG001|STARTED|Second BG Meter System (7 Days)||84
11136591|NCT01432275|12322470|FG000|COMPLETED|Second BG Meter System (7 Days)||88
11136592|NCT01432275|12322471|FG001|COMPLETED|Second BG Meter System (7 Days)||81
11136593|NCT01432275|12322470|FG000|NOT COMPLETED|Second BG Meter System (7 Days)||2
11136594|NCT01432275|12322471|FG001|NOT COMPLETED|Second BG Meter System (7 Days)||3
11136595|NCT01432275|12322470|FG000|STARTED|ADC With Calculator (10 Days)||88
11136596|NCT01432275|12322471|FG001|STARTED|ADC With Calculator (10 Days)||81
11136597|NCT01432275|12322470|FG000|COMPLETED|ADC With Calculator (10 Days)||85
11136598|NCT01432275|12322471|FG001|COMPLETED|ADC With Calculator (10 Days)||79
11136599|NCT01432275|12322470|FG000|NOT COMPLETED|ADC With Calculator (10 Days)||3
11136600|NCT01432275|12322471|FG001|NOT COMPLETED|ADC With Calculator (10 Days)||2
11136601|NCT01432327|12322481|FG000|STARTED|Baseline||56
11136602|NCT01432327|12322482|FG001|STARTED|Baseline||57
11136603|NCT01432327|12322483|FG002|STARTED|Baseline||57
11136604|NCT01432327|12322484|FG003|STARTED|Baseline||57
11136605|NCT01432327|12322481|FG000|COMPLETED|Baseline||56
11136606|NCT01432327|12322482|FG001|COMPLETED|Baseline||57
11136607|NCT01432327|12322483|FG002|COMPLETED|Baseline||57
11136608|NCT01432327|12322484|FG003|COMPLETED|Baseline||57
11136609|NCT01432327|12322481|FG000|NOT COMPLETED|Baseline||0
11136610|NCT01432327|12322482|FG001|NOT COMPLETED|Baseline||0
11136611|NCT01432327|12322483|FG002|NOT COMPLETED|Baseline||0
11136612|NCT01432327|12322484|FG003|NOT COMPLETED|Baseline||0
11136613|NCT01432327|12322481|FG000|STARTED|Posttest 3 Months||56
11136614|NCT01432327|12322482|FG001|STARTED|Posttest 3 Months||57
11136615|NCT01432327|12322483|FG002|STARTED|Posttest 3 Months||57
11136616|NCT01432327|12322484|FG003|STARTED|Posttest 3 Months||57
11136617|NCT01432327|12322481|FG000|COMPLETED|Posttest 3 Months||52
11136618|NCT01432327|12322482|FG001|COMPLETED|Posttest 3 Months||55
11136619|NCT01432327|12322483|FG002|COMPLETED|Posttest 3 Months||55
11136620|NCT01432327|12322484|FG003|COMPLETED|Posttest 3 Months||56
11136621|NCT01432327|12322481|FG000|NOT COMPLETED|Posttest 3 Months||4
11136622|NCT01432327|12322482|FG001|NOT COMPLETED|Posttest 3 Months||2
11136623|NCT01432327|12322483|FG002|NOT COMPLETED|Posttest 3 Months||2
11136624|NCT01432327|12322484|FG003|NOT COMPLETED|Posttest 3 Months||1
11136625|NCT01432327|12322481|FG000|STARTED|Posttest 6 Months||52
11136626|NCT01432327|12322482|FG001|STARTED|Posttest 6 Months||55
11136627|NCT01432327|12322483|FG002|STARTED|Posttest 6 Months||55
11136628|NCT01432327|12322484|FG003|STARTED|Posttest 6 Months||56
11136629|NCT01432327|12322481|FG000|COMPLETED|Posttest 6 Months||52
11136630|NCT01432327|12322482|FG001|COMPLETED|Posttest 6 Months||55
11136631|NCT01432327|12322483|FG002|COMPLETED|Posttest 6 Months||50
11136632|NCT01432327|12322484|FG003|COMPLETED|Posttest 6 Months||54
11136633|NCT01432327|12322481|FG000|NOT COMPLETED|Posttest 6 Months||0
11136634|NCT01432327|12322482|FG001|NOT COMPLETED|Posttest 6 Months||0
11136635|NCT01432327|12322483|FG002|NOT COMPLETED|Posttest 6 Months||5
11136636|NCT01432327|12322484|FG003|NOT COMPLETED|Posttest 6 Months||2
11136637|NCT01432327|12322481|FG000|STARTED|Posttest 1 Year||52
11136638|NCT01432327|12322482|FG001|STARTED|Posttest 1 Year||55
11136639|NCT01432327|12322483|FG002|STARTED|Posttest 1 Year||50
11136640|NCT01432327|12322484|FG003|STARTED|Posttest 1 Year||54
11136641|NCT01432327|12322481|FG000|COMPLETED|Posttest 1 Year||28
11136642|NCT01432327|12322482|FG001|COMPLETED|Posttest 1 Year||27
11136643|NCT01432327|12322483|FG002|COMPLETED|Posttest 1 Year||30
11136644|NCT01432327|12322484|FG003|COMPLETED|Posttest 1 Year||31
11136645|NCT01432327|12322481|FG000|NOT COMPLETED|Posttest 1 Year||24
11136646|NCT01432327|12322482|FG001|NOT COMPLETED|Posttest 1 Year||28
11136647|NCT01432327|12322483|FG002|NOT COMPLETED|Posttest 1 Year||20
11136648|NCT01432327|12322484|FG003|NOT COMPLETED|Posttest 1 Year||23
11136649|NCT01432366|12322494|FG000|STARTED|Overall Study||460
11136650|NCT01432366|12322494|FG000|COMPLETED|Overall Study||392
11136651|NCT01432366|12322494|FG000|NOT COMPLETED|Overall Study||68
11136652|NCT01432379|12322498|FG000|STARTED|Overall Study||1168
11136653|NCT01432379|12322498|FG000|COMPLETED|Overall Study||783
11136654|NCT01432379|12322498|FG000|NOT COMPLETED|Overall Study||385
11136655|NCT01432405|12322504|FG000|STARTED|Overall Study||12
11136656|NCT01432405|12322505|FG001|STARTED|Overall Study||12
11136657|NCT01432405|12322504|FG000|COMPLETED|Overall Study||11
11136658|NCT01432405|12322505|FG001|COMPLETED|Overall Study||10
11136659|NCT01432405|12322504|FG000|NOT COMPLETED|Overall Study||1
11136660|NCT01432405|12322505|FG001|NOT COMPLETED|Overall Study||2
11136661|NCT01432444|12322511|FG000|STARTED|Tolerability/Cross-titration Phase||325
11136662|NCT01432444|12322512|FG001|STARTED|Tolerability/Cross-titration Phase||0
11136663|NCT01432444|12322513|FG002|STARTED|Tolerability/Cross-titration Phase||0
11136664|NCT01432444|12322511|FG000|COMPLETED|Tolerability/Cross-titration Phase||265
11136665|NCT01432444|12322512|FG001|COMPLETED|Tolerability/Cross-titration Phase||0
11136666|NCT01432444|12322513|FG002|COMPLETED|Tolerability/Cross-titration Phase||0
11136667|NCT01432444|12322511|FG000|NOT COMPLETED|Tolerability/Cross-titration Phase||60
11136668|NCT01432444|12322512|FG001|NOT COMPLETED|Tolerability/Cross-titration Phase||0
11136669|NCT01432444|12322513|FG002|NOT COMPLETED|Tolerability/Cross-titration Phase||0
11136670|NCT01432444|12322511|FG000|STARTED|Treatment Phase||0
11136671|NCT01432444|12322512|FG001|STARTED|Treatment Phase||433
11136672|NCT01432444|12322513|FG002|STARTED|Treatment Phase||0
11136673|NCT01432444|12322511|FG000|COMPLETED|Treatment Phase||0
11136674|NCT01432444|12322512|FG001|COMPLETED|Treatment Phase||293
11136675|NCT01432444|12322513|FG002|COMPLETED|Treatment Phase||0
11136676|NCT01432444|12322511|FG000|NOT COMPLETED|Treatment Phase||0
11136677|NCT01432444|12322512|FG001|NOT COMPLETED|Treatment Phase||140
11136678|NCT01432444|12322513|FG002|NOT COMPLETED|Treatment Phase||0
11136679|NCT01432444|12322511|FG000|STARTED|Extension Phase||0
11136680|NCT01432444|12322512|FG001|STARTED|Extension Phase||0
11136681|NCT01432444|12322513|FG002|STARTED|Extension Phase||192
11136682|NCT01432444|12322511|FG000|COMPLETED|Extension Phase||0
11136683|NCT01432444|12322512|FG001|COMPLETED|Extension Phase||0
11136684|NCT01432444|12322513|FG002|COMPLETED|Extension Phase||0
11136685|NCT01432444|12322511|FG000|NOT COMPLETED|Extension Phase||0
11136686|NCT01432444|12322512|FG001|NOT COMPLETED|Extension Phase||0
11136687|NCT01432444|12322513|FG002|NOT COMPLETED|Extension Phase||192
11136688|NCT01432457|12322521|FG000|STARTED|Overall Study||306
11136689|NCT01432457|12322522|FG001|STARTED|Overall Study||306
11136690|NCT01432457|12322523|FG002|STARTED|Overall Study||312
11136691|NCT01432457|12322521|FG000|COMPLETED|Overall Study||269
11136692|NCT01432457|12322522|FG001|COMPLETED|Overall Study||258
11136693|NCT01432457|12322523|FG002|COMPLETED|Overall Study||253
11136694|NCT01432457|12322521|FG000|NOT COMPLETED|Overall Study||37
11136695|NCT01432457|12322522|FG001|NOT COMPLETED|Overall Study||48
11240842|NCT02093663|12433211|FG001|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4
11240843|NCT02093663|12433212|FG002|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
11240844|NCT02093663|12433213|FG003|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
11240845|NCT02093663|12433214|FG004|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
11240846|NCT02093663|12433210|FG000|STARTED|Open Label Acute Phase (8 Weeks)||0
11240847|NCT02093663|12433211|FG001|STARTED|Open Label Acute Phase (8 Weeks)||0
11240848|NCT02093663|12433212|FG002|STARTED|Open Label Acute Phase (8 Weeks)||18
11240849|NCT02093663|12433213|FG003|STARTED|Open Label Acute Phase (8 Weeks)||0
11240850|NCT02093663|12433214|FG004|STARTED|Open Label Acute Phase (8 Weeks)||0
11240851|NCT02093663|12433210|FG000|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
11240852|NCT02093663|12433211|FG001|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
11240853|NCT02093663|12433212|FG002|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18
11240854|NCT02093663|12433213|FG003|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
11240855|NCT02093663|12433214|FG004|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
11240856|NCT02093663|12433210|FG000|COMPLETED|Open Label Acute Phase (8 Weeks)||0
11240857|NCT02093663|12433211|FG001|COMPLETED|Open Label Acute Phase (8 Weeks)||0
11240858|NCT02093663|12433212|FG002|COMPLETED|Open Label Acute Phase (8 Weeks)||12
11240859|NCT02093663|12433213|FG003|COMPLETED|Open Label Acute Phase (8 Weeks)||0
11240860|NCT02093663|12433214|FG004|COMPLETED|Open Label Acute Phase (8 Weeks)||0
11240861|NCT02093663|12433210|FG000|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
11240862|NCT02093663|12433211|FG001|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
11240863|NCT02093663|12433212|FG002|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6
11240864|NCT02093663|12433213|FG003|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
11240865|NCT02093663|12433214|FG004|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
11240866|NCT02093663|12433210|FG000|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
11136696|NCT01432457|12322523|FG002|NOT COMPLETED|Overall Study||59
11136697|NCT01432535|12322534|FG000|STARTED|Overall Study||12
11136698|NCT01432535|12322535|FG001|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
11136699|NCT01432535|12322536|FG002|STARTED|Overall Study||6
11136700|NCT01432535|12322534|FG000|COMPLETED|Overall Study||12
11136701|NCT01432535|12322535|FG001|COMPLETED|Overall Study||7
11136702|NCT01432535|12322536|FG002|COMPLETED|Overall Study||6
11136703|NCT01432535|12322534|FG000|NOT COMPLETED|Overall Study||0
11240867|NCT02093663|12433211|FG001|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
11240868|NCT02093663|12433212|FG002|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
11240869|NCT02093663|12433213|FG003|STARTED|Double Blind Maintenance Phase(26 Weeks)||42
11240870|NCT02093663|12433214|FG004|STARTED|Double Blind Maintenance Phase(26 Weeks)||45
11240871|NCT02093663|12433210|FG000|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
11240872|NCT02093663|12433211|FG001|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
11240873|NCT02093663|12433212|FG002|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
11240874|NCT02093663|12433213|FG003|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
11240875|NCT02093663|12433214|FG004|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
11240876|NCT02093663|12433210|FG000|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
11136704|NCT01432535|12322535|FG001|NOT COMPLETED|Overall Study||0
11136705|NCT01432535|12322536|FG002|NOT COMPLETED|Overall Study||0
11136706|NCT01432561|12322544|FG000|STARTED|Overall Study||8
11240877|NCT02093663|12433211|FG001|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
11240878|NCT02093663|12433212|FG002|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
11338999|NCT02907814|12536375|FG000|COMPLETED|Overall Study||0
11136707|NCT01432561|12322544|FG000|COMPLETED|Overall Study||8
11136708|NCT01432561|12322544|FG000|NOT COMPLETED|Overall Study||0
11136709|NCT01432574|12322548|FG000|STARTED|Overall Study||150
11136710|NCT01432574|12322548|FG000|COMPLETED|Overall Study||147
11136711|NCT01432574|12322548|FG000|NOT COMPLETED|Overall Study||3
11136712|NCT01432600|12322557|FG000|STARTED|Overall Study||10
11136713|NCT01432600|12322558|FG001|STARTED|Overall Study||36
11136714|NCT01432600|12322559|FG002|STARTED|Overall Study||34
11136715|NCT01432600|12322557|FG000|COMPLETED|Overall Study||10
11136716|NCT01432600|12322558|FG001|COMPLETED|Overall Study||35
11136717|NCT01432600|12322559|FG002|COMPLETED|Overall Study||33
11136718|NCT01432600|12322557|FG000|NOT COMPLETED|Overall Study||0
11136719|NCT01432600|12322558|FG001|NOT COMPLETED|Overall Study||1
11136720|NCT01432600|12322559|FG002|NOT COMPLETED|Overall Study||1
11136721|NCT01432626|12322569|FG000|STARTED|Overall Study||10
11136722|NCT01432626|12322569|FG000|COMPLETED|Overall Study|Completed both images|3
11136723|NCT01432626|12322569|FG000|NOT COMPLETED|Overall Study||7
11136724|NCT01432730|12322573|FG000|STARTED|Period 1||12
11136725|NCT01432730|12322574|FG001|STARTED|Period 1||12
11136726|NCT01432730|12322573|FG000|COMPLETED|Period 1||10
11136727|NCT01432730|12322574|FG001|COMPLETED|Period 1||12
11136728|NCT01432730|12322573|FG000|NOT COMPLETED|Period 1||2
11136729|NCT01432730|12322574|FG001|NOT COMPLETED|Period 1||0
11136730|NCT01432730|12322573|FG000|STARTED|Period 2||10
11136731|NCT01432730|12322574|FG001|STARTED|Period 2||12
11136732|NCT01432730|12322573|FG000|COMPLETED|Period 2||10
11136733|NCT01432730|12322574|FG001|COMPLETED|Period 2||8
11136734|NCT01432730|12322573|FG000|NOT COMPLETED|Period 2||0
11136735|NCT01432730|12322574|FG001|NOT COMPLETED|Period 2||4
11136736|NCT01432756|12322584|FG000|STARTED|Overall Study||32
11136737|NCT01432756|12322585|FG001|STARTED|Overall Study||34
11136738|NCT01432756|12322586|FG002|STARTED|Overall Study||32
11136739|NCT01432756|12322587|FG003|STARTED|Overall Study||34
11136740|NCT01432756|12322584|FG000|COMPLETED|Overall Study||31
11136741|NCT01432756|12322585|FG001|COMPLETED|Overall Study||34
11136742|NCT01432756|12322586|FG002|COMPLETED|Overall Study||30
11136743|NCT01432756|12322587|FG003|COMPLETED|Overall Study||33
11136744|NCT01432756|12322584|FG000|NOT COMPLETED|Overall Study||1
11136745|NCT01432756|12322585|FG001|NOT COMPLETED|Overall Study||0
11136746|NCT01432756|12322586|FG002|NOT COMPLETED|Overall Study||2
11136747|NCT01432756|12322587|FG003|NOT COMPLETED|Overall Study||1
11136748|NCT01432886|12322597|FG000|STARTED|Overall Study||6
11136749|NCT01432886|12322598|FG001|STARTED|Overall Study||6
11136750|NCT01432886|12322597|FG000|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
11136751|NCT01432886|12322598|FG001|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
11136752|NCT01432886|12322597|FG000|NOT COMPLETED|Overall Study||0
11136753|NCT01432886|12322598|FG001|NOT COMPLETED|Overall Study||0
11136754|NCT01432938|12322605|FG000|STARTED|First Intervention||14
11136755|NCT01432938|12322606|FG001|STARTED|First Intervention||14
11136756|NCT01432938|12322605|FG000|Received at Least 1 Dose of Study Drug|First Intervention||14
11136757|NCT01432938|12322606|FG001|Received at Least 1 Dose of Study Drug|First Intervention||14
11136758|NCT01432938|12322605|FG000|COMPLETED|First Intervention||12
11136759|NCT01432938|12322606|FG001|COMPLETED|First Intervention||14
11136760|NCT01432938|12322605|FG000|NOT COMPLETED|First Intervention||2
11136761|NCT01432938|12322606|FG001|NOT COMPLETED|First Intervention||0
11136762|NCT01432938|12322605|FG000|STARTED|Washout Period of at Least 24 Days||12
11136763|NCT01432938|12322606|FG001|STARTED|Washout Period of at Least 24 Days||14
11136764|NCT01432938|12322605|FG000|COMPLETED|Washout Period of at Least 24 Days||12
11136765|NCT01432938|12322606|FG001|COMPLETED|Washout Period of at Least 24 Days||14
11136766|NCT01432938|12322605|FG000|NOT COMPLETED|Washout Period of at Least 24 Days||0
11136767|NCT01432938|12322606|FG001|NOT COMPLETED|Washout Period of at Least 24 Days||0
11136768|NCT01432938|12322605|FG000|STARTED|Second Intervention||12
11136769|NCT01432938|12322606|FG001|STARTED|Second Intervention||14
11136770|NCT01432938|12322605|FG000|COMPLETED|Second Intervention||11
11136771|NCT01432938|12322606|FG001|COMPLETED|Second Intervention||14
11136772|NCT01432938|12322605|FG000|NOT COMPLETED|Second Intervention||1
11136773|NCT01432938|12322606|FG001|NOT COMPLETED|Second Intervention||0
11136774|NCT01432951|12322613|FG000|STARTED|Treatment Phase (Day 1 to 30)||26
11136775|NCT01432951|12322613|FG000|Received at Least One Dose of Study Drug|Treatment Phase (Day 1 to 30)||25
11136776|NCT01432951|12322613|FG000|PK Sampling (no Dosing) Days 15-17|Treatment Phase (Day 1 to 30)||23
11136777|NCT01432951|12322613|FG000|Progressive Disease|Treatment Phase (Day 1 to 30)||10
11136778|NCT01432951|12322613|FG000|COMPLETED|Treatment Phase (Day 1 to 30)||25
11136779|NCT01432951|12322613|FG000|NOT COMPLETED|Treatment Phase (Day 1 to 30)||1
11136780|NCT01432951|12322613|FG000|STARTED|Safety Extension Day 30 to End of Study|Participants had the option to continue on to safety extension period.|15
11136781|NCT01432951|12322613|FG000|COMPLETED|Safety Extension Day 30 to End of Study||15
11136782|NCT01432951|12322613|FG000|NOT COMPLETED|Safety Extension Day 30 to End of Study||0
11136783|NCT01433016|12322618|FG000|STARTED|Overall Study||20
11136784|NCT01433016|12322618|FG000|COMPLETED|Overall Study||20
11136785|NCT01433016|12322618|FG000|NOT COMPLETED|Overall Study||0
11136786|NCT01433042|12322622|FG000|STARTED|Overall Study||225
11136787|NCT01433042|12322622|FG000|COMPLETED|Overall Study||224
11136788|NCT01433042|12322622|FG000|NOT COMPLETED|Overall Study||1
11136789|NCT01433055|12322628|FG000|STARTED|Overall Study||29
11136790|NCT01433055|12322629|FG001|STARTED|Overall Study||23
11136791|NCT01433055|12322628|FG000|COMPLETED|Overall Study||27
11136792|NCT01433055|12322629|FG001|COMPLETED|Overall Study||23
11136793|NCT01433055|12322628|FG000|NOT COMPLETED|Overall Study||2
11136794|NCT01433055|12322629|FG001|NOT COMPLETED|Overall Study||0
11136795|NCT01433081|12322637|FG000|STARTED|Overall Study||25
11136796|NCT01433081|12322638|FG001|STARTED|Overall Study||25
11136797|NCT01433081|12322637|FG000|COMPLETED|Overall Study||23
11136798|NCT01433081|12322638|FG001|COMPLETED|Overall Study||23
11136799|NCT01433081|12322637|FG000|NOT COMPLETED|Overall Study||2
11136800|NCT01433081|12322638|FG001|NOT COMPLETED|Overall Study||2
11136801|NCT01433107|12322647|FG000|STARTED|Overall Study||145
11136802|NCT01433107|12322648|FG001|STARTED|Overall Study||145
11136803|NCT01433107|12322647|FG000|COMPLETED|Overall Study||118
11136804|NCT01433107|12322648|FG001|COMPLETED|Overall Study||128
11136805|NCT01433107|12322647|FG000|NOT COMPLETED|Overall Study||27
11136806|NCT01433107|12322648|FG001|NOT COMPLETED|Overall Study||17
11136807|NCT01433159|12322656|FG000|STARTED|Overall Study||9
11136808|NCT01433159|12322657|FG001|STARTED|Overall Study||10
11136809|NCT01433159|12322656|FG000|COMPLETED|Overall Study||7
11136810|NCT01433159|12322657|FG001|COMPLETED|Overall Study||9
11136811|NCT01433159|12322656|FG000|NOT COMPLETED|Overall Study||2
11136812|NCT01433159|12322657|FG001|NOT COMPLETED|Overall Study||1
11136813|NCT01433172|12322666|FG000|STARTED|Overall Study||3
11136814|NCT01433172|12322667|FG001|STARTED|Overall Study||37
11136815|NCT01433172|12322668|FG002|STARTED|Overall Study||33
11136816|NCT01433172|12322666|FG000|COMPLETED|Overall Study||3
11136817|NCT01433172|12322667|FG001|COMPLETED|Overall Study||34
11136818|NCT01433172|12322668|FG002|COMPLETED|Overall Study||32
11136819|NCT01433172|12322666|FG000|NOT COMPLETED|Overall Study||0
11136820|NCT01433172|12322667|FG001|NOT COMPLETED|Overall Study||3
11136821|NCT01433172|12322668|FG002|NOT COMPLETED|Overall Study||1
11136822|NCT01433250|12322678|FG000|STARTED|Overall Study||22
11136823|NCT01433250|12322679|FG001|STARTED|Overall Study||17
11136824|NCT01433250|12322678|FG000|COMPLETED|Overall Study||19
11136825|NCT01433250|12322679|FG001|COMPLETED|Overall Study||14
11136826|NCT01433250|12322678|FG000|NOT COMPLETED|Overall Study||3
11136827|NCT01433250|12322679|FG001|NOT COMPLETED|Overall Study||3
11136828|NCT01433263|12322687|FG000|STARTED|Overall Study||29
11136829|NCT01433263|12322688|FG001|STARTED|Overall Study||28
11136830|NCT01433263|12322687|FG000|COMPLETED|Overall Study||10
11136831|NCT01433263|12322688|FG001|COMPLETED|Overall Study||16
11136832|NCT01433263|12322687|FG000|NOT COMPLETED|Overall Study||19
11136833|NCT01433263|12322688|FG001|NOT COMPLETED|Overall Study||12
11136834|NCT01433354|12322697|FG000|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
11136835|NCT01433354|12322697|FG000|COMPLETED|Overall Study||0
11136836|NCT01433354|12322697|FG000|NOT COMPLETED|Overall Study||119
11136837|NCT01433549|12322711|FG000|STARTED|Phase 1: First Study Product||12
11136838|NCT01433549|12322712|FG001|STARTED|Phase 1: First Study Product||13
11136839|NCT01433549|12322711|FG000|COMPLETED|Phase 1: First Study Product||12
11136840|NCT01433549|12322712|FG001|COMPLETED|Phase 1: First Study Product||13
11136841|NCT01433549|12322711|FG000|NOT COMPLETED|Phase 1: First Study Product||0
11136842|NCT01433549|12322712|FG001|NOT COMPLETED|Phase 1: First Study Product||0
11136843|NCT01433549|12322711|FG000|STARTED|Phase 2: Second Study Product||12
11136844|NCT01433549|12322712|FG001|STARTED|Phase 2: Second Study Product||13
11136845|NCT01433549|12322711|FG000|COMPLETED|Phase 2: Second Study Product||12
11136846|NCT01433549|12322712|FG001|COMPLETED|Phase 2: Second Study Product||12
11136847|NCT01433549|12322711|FG000|NOT COMPLETED|Phase 2: Second Study Product||0
11136848|NCT01433549|12322712|FG001|NOT COMPLETED|Phase 2: Second Study Product||1
11136849|NCT01433731|12322722|FG000|STARTED|Overall Study||3
11136850|NCT01433731|12322723|FG001|STARTED|Overall Study||5
11136851|NCT01433731|12322724|FG002|STARTED|Overall Study||5
11136852|NCT01433731|12322725|FG003|STARTED|Overall Study||5
11136853|NCT01433731|12322722|FG000|COMPLETED|Overall Study||3
11136854|NCT01433731|12322723|FG001|COMPLETED|Overall Study||5
11136855|NCT01433731|12322724|FG002|COMPLETED|Overall Study||5
11136856|NCT01433731|12322725|FG003|COMPLETED|Overall Study||5
11136857|NCT01433731|12322722|FG000|NOT COMPLETED|Overall Study||0
11136858|NCT01433731|12322723|FG001|NOT COMPLETED|Overall Study||0
11136859|NCT01433731|12322724|FG002|NOT COMPLETED|Overall Study||0
11136860|NCT01433731|12322725|FG003|NOT COMPLETED|Overall Study||0
11136861|NCT01433913|12322735|FG000|STARTED|Overall Study||10
11136862|NCT01433913|12322736|FG001|STARTED|Overall Study||10
11136863|NCT01433913|12322735|FG000|COMPLETED|Overall Study||9
11136864|NCT01433913|12322736|FG001|COMPLETED|Overall Study||10
11136865|NCT01433913|12322735|FG000|NOT COMPLETED|Overall Study||1
11136866|NCT01433913|12322736|FG001|NOT COMPLETED|Overall Study||0
11136867|NCT01433978|12322745|FG000|STARTED|Core Study||11
11136868|NCT01433978|12322746|FG001|STARTED|Core Study||12
11136869|NCT01433978|12322747|FG002|STARTED|Core Study||0
11136870|NCT01433978|12322745|FG000|COMPLETED|Core Study||0
11136871|NCT01433978|12322746|FG001|COMPLETED|Core Study||1
11136872|NCT01433978|12322747|FG002|COMPLETED|Core Study||0
11136873|NCT01433978|12322745|FG000|NOT COMPLETED|Core Study||11
11136874|NCT01433978|12322746|FG001|NOT COMPLETED|Core Study||11
11136875|NCT01433978|12322747|FG002|NOT COMPLETED|Core Study||0
11136876|NCT01433978|12322745|FG000|STARTED|Extension Phase||0
11136877|NCT01433978|12322746|FG001|STARTED|Extension Phase||0
11136878|NCT01433978|12322747|FG002|STARTED|Extension Phase||6
11136879|NCT01433978|12322745|FG000|COMPLETED|Extension Phase||0
11136880|NCT01433978|12322746|FG001|COMPLETED|Extension Phase||0
11136881|NCT01433978|12322747|FG002|COMPLETED|Extension Phase||0
11136882|NCT01433978|12322745|FG000|NOT COMPLETED|Extension Phase||0
11136883|NCT01433978|12322746|FG001|NOT COMPLETED|Extension Phase||0
11136884|NCT01433978|12322747|FG002|NOT COMPLETED|Extension Phase||6
11136885|NCT01433991|12322758|FG000|STARTED|Pretreatment Phase (Single Agent Run-in)||5
11136886|NCT01433991|12322759|FG001|STARTED|Pretreatment Phase (Single Agent Run-in)||3
11136887|NCT01433991|12322760|FG002|STARTED|Pretreatment Phase (Single Agent Run-in)||14
11136888|NCT01433991|12322761|FG003|STARTED|Pretreatment Phase (Single Agent Run-in)||8
11136889|NCT01433991|12322758|FG000|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
11136890|NCT01433991|12322759|FG001|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
11136891|NCT01433991|12322760|FG002|COMPLETED|Pretreatment Phase (Single Agent Run-in)||14
11136892|NCT01433991|12322761|FG003|COMPLETED|Pretreatment Phase (Single Agent Run-in)||8
11136893|NCT01433991|12322758|FG000|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||2
11136894|NCT01433991|12322759|FG001|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
11136895|NCT01433991|12322760|FG002|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
11136896|NCT01433991|12322761|FG003|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
11136897|NCT01433991|12322758|FG000|STARTED|Treatment Phase (Combination Agent)||3
11136898|NCT01433991|12322759|FG001|STARTED|Treatment Phase (Combination Agent)||3
11136899|NCT01433991|12322760|FG002|STARTED|Treatment Phase (Combination Agent)||14
11136900|NCT01433991|12322761|FG003|STARTED|Treatment Phase (Combination Agent)||8
11136901|NCT01433991|12322758|FG000|COMPLETED|Treatment Phase (Combination Agent)||1
11136902|NCT01433991|12322759|FG001|COMPLETED|Treatment Phase (Combination Agent)||2
11136903|NCT01433991|12322760|FG002|COMPLETED|Treatment Phase (Combination Agent)||8
11136904|NCT01433991|12322761|FG003|COMPLETED|Treatment Phase (Combination Agent)||2
11136905|NCT01433991|12322758|FG000|NOT COMPLETED|Treatment Phase (Combination Agent)||2
11136906|NCT01433991|12322759|FG001|NOT COMPLETED|Treatment Phase (Combination Agent)||1
11136907|NCT01433991|12322760|FG002|NOT COMPLETED|Treatment Phase (Combination Agent)||6
11136908|NCT01433991|12322761|FG003|NOT COMPLETED|Treatment Phase (Combination Agent)||6
11136909|NCT01434030|12322777|FG000|STARTED|Overall Study||57
11136910|NCT01434030|12322777|FG000|COMPLETED|Overall Study||56
11136911|NCT01434030|12322777|FG000|NOT COMPLETED|Overall Study||1
11136912|NCT01434121|12322785|FG000|STARTED|Overall Study||8
11136913|NCT01434121|12322786|FG001|STARTED|Overall Study||8
11136914|NCT01434121|12322787|FG002|STARTED|Overall Study||8
11136915|NCT01434121|12322785|FG000|COMPLETED|Overall Study||8
11136916|NCT01434121|12322786|FG001|COMPLETED|Overall Study||8
11136917|NCT01434121|12322787|FG002|COMPLETED|Overall Study||8
11136918|NCT01434121|12322785|FG000|NOT COMPLETED|Overall Study||0
11136919|NCT01434121|12322786|FG001|NOT COMPLETED|Overall Study||0
11136920|NCT01434121|12322787|FG002|NOT COMPLETED|Overall Study||0
11136921|NCT01434186|12322800|FG000|STARTED|Overall Study||2
11136922|NCT01434186|12322801|FG001|STARTED|Overall Study||4
11136923|NCT01434186|12322800|FG000|COMPLETED|Overall Study||2
11136924|NCT01434186|12322801|FG001|COMPLETED|Overall Study||4
11136925|NCT01434186|12322800|FG000|NOT COMPLETED|Overall Study||0
11136926|NCT01434186|12322801|FG001|NOT COMPLETED|Overall Study||0
11202364|NCT01839318|12392750|FG005|STARTED|Period 3, Third Day of Wear||2
11202365|NCT01839318|12392745|FG000|COMPLETED|Period 3, Third Day of Wear||4
11202366|NCT01839318|12392746|FG001|COMPLETED|Period 3, Third Day of Wear||4
11202367|NCT01839318|12392747|FG002|COMPLETED|Period 3, Third Day of Wear||5
11202368|NCT01839318|12392748|FG003|COMPLETED|Period 3, Third Day of Wear||6
11202369|NCT01839318|12392749|FG004|COMPLETED|Period 3, Third Day of Wear||7
11202370|NCT01839318|12392750|FG005|COMPLETED|Period 3, Third Day of Wear||2
11202371|NCT01839318|12392745|FG000|NOT COMPLETED|Period 3, Third Day of Wear||0
11202372|NCT01839318|12392746|FG001|NOT COMPLETED|Period 3, Third Day of Wear||0
11202373|NCT01839318|12392747|FG002|NOT COMPLETED|Period 3, Third Day of Wear||0
11202374|NCT01839318|12392748|FG003|NOT COMPLETED|Period 3, Third Day of Wear||0
11202375|NCT01839318|12392749|FG004|NOT COMPLETED|Period 3, Third Day of Wear||0
11202376|NCT01839318|12392750|FG005|NOT COMPLETED|Period 3, Third Day of Wear||0
11202377|NCT01839487|12392760|FG000|STARTED|Run-in Phase (Maximum Exposure:295 Days)||16
11202378|NCT01839487|12392761|FG001|STARTED|Run-in Phase (Maximum Exposure:295 Days)||7
11202379|NCT01839487|12392762|FG002|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
11202380|NCT01839487|12392763|FG003|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
11202381|NCT01839487|12392764|FG004|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
11202382|NCT01839487|12392765|FG005|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
11205266|NCT01858363|12396007|FG000|24-month Visit|Overall Study||184
11136927|NCT01434342|12322809|FG000|STARTED|Overall Study||98
11136928|NCT01434342|12322810|FG001|STARTED|Overall Study||48
11136929|NCT01434342|12322809|FG000|COMPLETED|Overall Study||50
11136930|NCT01434342|12322810|FG001|COMPLETED|Overall Study||31
11136931|NCT01434342|12322809|FG000|NOT COMPLETED|Overall Study||48
11136932|NCT01434342|12322810|FG001|NOT COMPLETED|Overall Study||17
11136933|NCT01434472|12322816|FG000|STARTED|Overall Study||20
11136934|NCT01434472|12322816|FG000|COMPLETED|Overall Study||20
11136935|NCT01434472|12322816|FG000|NOT COMPLETED|Overall Study||0
11136936|NCT01434641|12322820|FG000|STARTED|Overall Study||102
11136937|NCT01434641|12322820|FG000|COMPLETED|Overall Study||102
11136938|NCT01434641|12322820|FG000|NOT COMPLETED|Overall Study||0
11136939|NCT01434654|12322826|FG000|STARTED|Overall Study||7
11136940|NCT01434654|12322827|FG001|STARTED|Overall Study||12
11136941|NCT01434654|12322826|FG000|COMPLETED|Overall Study||5
11136942|NCT01434654|12322827|FG001|COMPLETED|Overall Study||12
11136943|NCT01434654|12322826|FG000|NOT COMPLETED|Overall Study||2
11136944|NCT01434654|12322827|FG001|NOT COMPLETED|Overall Study||0
11136945|NCT01434667|12322837|FG000|STARTED|Overall Study||39
11136946|NCT01434667|12322838|FG001|STARTED|Overall Study||75
11136947|NCT01434667|12322837|FG000|COMPLETED|Overall Study||34
11136948|NCT01434667|12322838|FG001|COMPLETED|Overall Study||65
11136949|NCT01434667|12322837|FG000|NOT COMPLETED|Overall Study||5
11136950|NCT01434667|12322838|FG001|NOT COMPLETED|Overall Study||10
11136951|NCT01434680|12322848|FG000|STARTED|Overall Study||299
11136952|NCT01434680|12322849|FG001|STARTED|Overall Study||268
11136953|NCT01434680|12322850|FG002|STARTED|Overall Study||306
11136954|NCT01434680|12322851|FG003|STARTED|Overall Study||119
11136955|NCT01434680|12322848|FG000|COMPLETED|Overall Study||296
11136956|NCT01434680|12322849|FG001|COMPLETED|Overall Study||266
11136957|NCT01434680|12322850|FG002|COMPLETED|Overall Study||304
11136958|NCT01434680|12322851|FG003|COMPLETED|Overall Study||119
11136959|NCT01434680|12322848|FG000|NOT COMPLETED|Overall Study||3
11136960|NCT01434680|12322849|FG001|NOT COMPLETED|Overall Study||2
11136961|NCT01434680|12322850|FG002|NOT COMPLETED|Overall Study||2
11136962|NCT01434680|12322851|FG003|NOT COMPLETED|Overall Study||0
11136963|NCT01434693|12322865|FG000|STARTED|Overall Study||9
11136964|NCT01434693|12322866|FG001|STARTED|Overall Study||9
11136965|NCT01434693|12322867|FG002|STARTED|Overall Study||9
11136966|NCT01434693|12322868|FG003|STARTED|Overall Study||9
11136967|NCT01434693|12322865|FG000|COMPLETED|Overall Study||6
11136968|NCT01434693|12322866|FG001|COMPLETED|Overall Study||9
11136969|NCT01434693|12322867|FG002|COMPLETED|Overall Study||8
11136970|NCT01434693|12322868|FG003|COMPLETED|Overall Study||8
11136971|NCT01434693|12322865|FG000|NOT COMPLETED|Overall Study||3
11136972|NCT01434693|12322866|FG001|NOT COMPLETED|Overall Study||0
11136973|NCT01434693|12322867|FG002|NOT COMPLETED|Overall Study||1
11136974|NCT01434693|12322868|FG003|NOT COMPLETED|Overall Study||1
11136975|NCT01434810|12322880|FG000|STARTED|Overall Study||224
11136976|NCT01434810|12322881|FG001|STARTED|Overall Study||223
11136977|NCT01434810|12322880|FG000|COMPLETED|Overall Study||201
11136978|NCT01434810|12322881|FG001|COMPLETED|Overall Study||213
11136979|NCT01434810|12322880|FG000|NOT COMPLETED|Overall Study||23
11136980|NCT01434810|12322881|FG001|NOT COMPLETED|Overall Study||10
11136981|NCT01434823|12322889|FG000|STARTED|Overall Study||824
11136982|NCT01434823|12322890|FG001|STARTED|Overall Study||785
11136983|NCT01434823|12322889|FG000|COMPLETED|Overall Study||820
11136984|NCT01434823|12322890|FG001|COMPLETED|Overall Study||778
11136985|NCT01434823|12322889|FG000|NOT COMPLETED|Overall Study||4
11136986|NCT01434823|12322890|FG001|NOT COMPLETED|Overall Study||7
11136987|NCT01435018|12322900|FG000|STARTED|Overall Study||135
11136988|NCT01435018|12322901|FG001|STARTED|Overall Study||60
11136989|NCT01435018|12322902|FG002|STARTED|Overall Study||139
11136990|NCT01435018|12322900|FG000|COMPLETED|Overall Study||88
11136991|NCT01435018|12322901|FG001|COMPLETED|Overall Study||26
11136992|NCT01435018|12322902|FG002|COMPLETED|Overall Study||98
11136993|NCT01435018|12322900|FG000|NOT COMPLETED|Overall Study||47
11136994|NCT01435018|12322901|FG001|NOT COMPLETED|Overall Study||34
11136995|NCT01435018|12322902|FG002|NOT COMPLETED|Overall Study||41
11136996|NCT01435031|12322912|FG000|STARTED|ITT at 1 Month|ITT population|222
11136997|NCT01435031|12322912|FG000|COMPLETED|ITT at 1 Month||216
11136998|NCT01435031|12322912|FG000|NOT COMPLETED|ITT at 1 Month||6
11136999|NCT01435031|12322912|FG000|STARTED|ITT at 6 Months||216
11137000|NCT01435031|12322912|FG000|COMPLETED|ITT at 6 Months||211
11137001|NCT01435031|12322912|FG000|NOT COMPLETED|ITT at 6 Months||5
11137002|NCT01435031|12322912|FG000|STARTED|ITT at 1 Year||211
11137003|NCT01435031|12322912|FG000|COMPLETED|ITT at 1 Year||202
11137004|NCT01435031|12322912|FG000|NOT COMPLETED|ITT at 1 Year||9
11240879|NCT02093663|12433213|FG003|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12
11240880|NCT02093663|12433214|FG004|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15
11240881|NCT02093663|12433210|FG000|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
11240882|NCT02093663|12433211|FG001|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
11240883|NCT02093663|12433212|FG002|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
11240884|NCT02093663|12433213|FG003|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
11240885|NCT02093663|12433214|FG004|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
11240886|NCT02093663|12433210|FG000|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
11240887|NCT02093663|12433211|FG001|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
11240888|NCT02093663|12433212|FG002|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
11339000|NCT02907814|12536376|FG001|COMPLETED|Overall Study||0
11240889|NCT02093663|12433213|FG003|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32
11240890|NCT02093663|12433214|FG004|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34
11240891|NCT02093663|12433210|FG000|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
11240892|NCT02093663|12433211|FG001|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
11240893|NCT02093663|12433212|FG002|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
11240894|NCT02093663|12433213|FG003|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10
11240895|NCT02093663|12433214|FG004|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11
11240896|NCT02093702|12433233|FG000|STARTED|Overall Study||2
11137005|NCT01435031|12322912|FG000|STARTED|ITT at 2 Years||202
11137006|NCT01435031|12322912|FG000|COMPLETED|ITT at 2 Years||189
11137007|NCT01435031|12322912|FG000|NOT COMPLETED|ITT at 2 Years||13
11137008|NCT01435031|12322912|FG000|STARTED|ITT at 3 Years||189
11137009|NCT01435031|12322912|FG000|COMPLETED|ITT at 3 Years||178
11137010|NCT01435031|12322912|FG000|NOT COMPLETED|ITT at 3 Years||11
11137011|NCT01435031|12322912|FG000|STARTED|ITT at 4 Years||178
11137012|NCT01435031|12322912|FG000|COMPLETED|ITT at 4 Years||171
11137013|NCT01435031|12322912|FG000|NOT COMPLETED|ITT at 4 Years||7
11137014|NCT01435122|12322916|FG000|STARTED|Overall Study||30
11137015|NCT01435122|12322916|FG000|COMPLETED|Overall Study||22
11137016|NCT01435122|12322916|FG000|NOT COMPLETED|Overall Study||8
11137017|NCT01435174|12322920|FG000|STARTED|Overall Study||17
11137018|NCT01435174|12322920|FG000|COMPLETED|Overall Study||8
11137019|NCT01435174|12322920|FG000|NOT COMPLETED|Overall Study||9
11137020|NCT01435265|12322926|FG000|STARTED|Overall Study||3
11137021|NCT01435265|12322927|FG001|STARTED|Overall Study||4
11137022|NCT01435265|12322926|FG000|COMPLETED|Overall Study||3
11137023|NCT01435265|12322927|FG001|COMPLETED|Overall Study||3
11137024|NCT01435265|12322926|FG000|NOT COMPLETED|Overall Study||0
11137025|NCT01435265|12322927|FG001|NOT COMPLETED|Overall Study||1
11137026|NCT01435304|12322935|FG000|STARTED|Overall Study||50
11137027|NCT01435304|12322936|FG001|STARTED|Overall Study||50
11137028|NCT01435304|12322935|FG000|COMPLETED|Overall Study||50
11240897|NCT02093702|12433234|FG001|STARTED|Overall Study||3
11240898|NCT02093702|12433233|FG000|COMPLETED|Overall Study||2
11240899|NCT02093702|12433234|FG001|COMPLETED|Overall Study||3
11240900|NCT02093702|12433233|FG000|NOT COMPLETED|Overall Study||0
11240901|NCT02093702|12433234|FG001|NOT COMPLETED|Overall Study||0
11240902|NCT02093793|12433244|FG000|STARTED|Overall Study||98
11240903|NCT02093793|12433245|FG001|STARTED|Overall Study||90
11240904|NCT02093793|12433246|FG002|STARTED|Overall Study||68
11137029|NCT01435304|12322936|FG001|COMPLETED|Overall Study||50
11137030|NCT01435304|12322935|FG000|NOT COMPLETED|Overall Study||0
11137031|NCT01435304|12322936|FG001|NOT COMPLETED|Overall Study||0
11137032|NCT01435356|12322944|FG000|STARTED|Overall Study||48
11137033|NCT01435356|12322945|FG001|STARTED|Overall Study||29
11137034|NCT01435356|12322944|FG000|COMPLETED|Overall Study||16
11137035|NCT01435356|12322945|FG001|COMPLETED|Overall Study||5
11137036|NCT01435356|12322944|FG000|NOT COMPLETED|Overall Study||32
11137037|NCT01435356|12322945|FG001|NOT COMPLETED|Overall Study||24
11137038|NCT01435382|12322955|FG000|STARTED|Overall Study||12
11137039|NCT01435382|12322956|FG001|STARTED|Overall Study||13
11137040|NCT01435382|12322957|FG002|STARTED|Overall Study||13
11137041|NCT01435382|12322958|FG003|STARTED|Overall Study||11
11137042|NCT01435382|12322955|FG000|COMPLETED|Overall Study||11
11137043|NCT01435382|12322956|FG001|COMPLETED|Overall Study||11
11137044|NCT01435382|12322957|FG002|COMPLETED|Overall Study||12
11137045|NCT01435382|12322958|FG003|COMPLETED|Overall Study||10
11137046|NCT01435382|12322955|FG000|NOT COMPLETED|Overall Study||1
11137047|NCT01435382|12322956|FG001|NOT COMPLETED|Overall Study||2
11137048|NCT01435382|12322957|FG002|NOT COMPLETED|Overall Study||1
11137049|NCT01435382|12322958|FG003|NOT COMPLETED|Overall Study||1
11137050|NCT01435460|12322976|FG000|STARTED|Overall Study||151
11137051|NCT01435460|12322977|FG001|STARTED|Overall Study||149
11137052|NCT01435460|12322976|FG000|COMPLETED|Overall Study||140
11137053|NCT01435460|12322977|FG001|COMPLETED|Overall Study||143
11137054|NCT01435460|12322976|FG000|NOT COMPLETED|Overall Study||11
11137055|NCT01435460|12322977|FG001|NOT COMPLETED|Overall Study||6
11137056|NCT01435512|12322985|FG000|STARTED|Overall Study||67
11137057|NCT01435512|12322986|FG001|STARTED|Overall Study||68
11137058|NCT01435512|12322985|FG000|COMPLETED|Overall Study||67
11137059|NCT01435512|12322986|FG001|COMPLETED|Overall Study||68
11137060|NCT01435512|12322985|FG000|NOT COMPLETED|Overall Study||0
11137061|NCT01435512|12322986|FG001|NOT COMPLETED|Overall Study||0
11137062|NCT01435577|12322994|FG000|STARTED|Overall Study||64
11137063|NCT01435577|12322995|FG001|STARTED|Overall Study||65
11137064|NCT01435577|12322994|FG000|COMPLETED|Overall Study||47
11137065|NCT01435577|12322995|FG001|COMPLETED|Overall Study||13
11137066|NCT01435577|12322994|FG000|NOT COMPLETED|Overall Study||17
11137067|NCT01435577|12322995|FG001|NOT COMPLETED|Overall Study||52
11137068|NCT01435603|12323007|FG000|STARTED|Overall Study||167
11137069|NCT01435603|12323008|FG001|STARTED|Overall Study||164
11137070|NCT01435603|12323007|FG000|COMPLETED|Overall Study||128
11137071|NCT01435603|12323008|FG001|COMPLETED|Overall Study||129
11137072|NCT01435603|12323007|FG000|NOT COMPLETED|Overall Study||39
11137073|NCT01435603|12323008|FG001|NOT COMPLETED|Overall Study||35
11137074|NCT01435616|12323016|FG000|STARTED|Overall Study||1003
11137075|NCT01435616|12323017|FG001|STARTED|Overall Study||535
11137076|NCT01435616|12323016|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1003
11137077|NCT01435616|12323017|FG001|Received at Least 1 Dose of Study Drug|Overall Study||535
11240905|NCT02093793|12433244|FG000|COMPLETED|Overall Study||91
11240906|NCT02093793|12433245|FG001|COMPLETED|Overall Study||80
11137078|NCT01435616|12323016|FG000|COMPLETED|Overall Study||832
11137079|NCT01435616|12323017|FG001|COMPLETED|Overall Study||455
11137080|NCT01435616|12323016|FG000|NOT COMPLETED|Overall Study||171
11137081|NCT01435616|12323017|FG001|NOT COMPLETED|Overall Study||80
11137082|NCT01435655|12323025|FG000|STARTED|Overall Study||10
11137083|NCT01435655|12323025|FG000|COMPLETED|Overall Study||7
11137084|NCT01435655|12323025|FG000|NOT COMPLETED|Overall Study||3
11137085|NCT01435759|12323034|FG000|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
11137086|NCT01435759|12323035|FG001|STARTED|Antidepressant Lead-in Phase||0
11137087|NCT01435759|12323036|FG002|STARTED|Antidepressant Lead-in Phase||0
11137088|NCT01435759|12323037|FG003|STARTED|Antidepressant Lead-in Phase||0
11137089|NCT01435759|12323038|FG004|STARTED|Antidepressant Lead-in Phase||0
11137090|NCT01435759|12323039|FG005|STARTED|Antidepressant Lead-in Phase||0
11137091|NCT01435759|12323034|FG000|COMPLETED|Antidepressant Lead-in Phase||855
11137092|NCT01435759|12323035|FG001|COMPLETED|Antidepressant Lead-in Phase||0
11137093|NCT01435759|12323036|FG002|COMPLETED|Antidepressant Lead-in Phase||0
11137094|NCT01435759|12323037|FG003|COMPLETED|Antidepressant Lead-in Phase||0
11137095|NCT01435759|12323038|FG004|COMPLETED|Antidepressant Lead-in Phase||0
11137096|NCT01435759|12323039|FG005|COMPLETED|Antidepressant Lead-in Phase||0
11137097|NCT01435759|12323034|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||342
11137098|NCT01435759|12323035|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0
11137099|NCT01435759|12323036|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0
11137100|NCT01435759|12323037|FG003|NOT COMPLETED|Antidepressant Lead-in Phase||0
11137101|NCT01435759|12323038|FG004|NOT COMPLETED|Antidepressant Lead-in Phase||0
11137102|NCT01435759|12323039|FG005|NOT COMPLETED|Antidepressant Lead-in Phase||0
11137103|NCT01435759|12323034|FG000|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
11137104|NCT01435759|12323035|FG001|STARTED|Double-blind Phase||78
11137105|NCT01435759|12323036|FG002|STARTED|Double-blind Phase|One subject was not dosed.|78
11137106|NCT01435759|12323037|FG003|STARTED|Double-blind Phase|Two subjects were not dosed.|78
11137107|NCT01435759|12323038|FG004|STARTED|Double-blind Phase||78
11137108|NCT01435759|12323039|FG005|STARTED|Double-blind Phase||80
11137109|NCT01435759|12323034|FG000|COMPLETED|Double-blind Phase||397
11137110|NCT01435759|12323035|FG001|COMPLETED|Double-blind Phase||71
11137111|NCT01435759|12323036|FG002|COMPLETED|Double-blind Phase||71
11137112|NCT01435759|12323037|FG003|COMPLETED|Double-blind Phase||69
11137113|NCT01435759|12323038|FG004|COMPLETED|Double-blind Phase||69
11137114|NCT01435759|12323039|FG005|COMPLETED|Double-blind Phase||71
11137115|NCT01435759|12323034|FG000|NOT COMPLETED|Double-blind Phase||66
11137116|NCT01435759|12323035|FG001|NOT COMPLETED|Double-blind Phase||7
11137117|NCT01435759|12323036|FG002|NOT COMPLETED|Double-blind Phase||7
11137118|NCT01435759|12323037|FG003|NOT COMPLETED|Double-blind Phase||9
11137119|NCT01435759|12323038|FG004|NOT COMPLETED|Double-blind Phase||9
11137120|NCT01435759|12323039|FG005|NOT COMPLETED|Double-blind Phase||9
11137121|NCT01435772|12323054|FG000|STARTED|Overall Study||3
11137122|NCT01435772|12323055|FG001|STARTED|Overall Study||3
11137123|NCT01435772|12323056|FG002|STARTED|Overall Study||15
11137124|NCT01435772|12323054|FG000|COMPLETED|Overall Study||0
11137125|NCT01435772|12323055|FG001|COMPLETED|Overall Study||0
11137126|NCT01435772|12323056|FG002|COMPLETED|Overall Study||0
11137127|NCT01435772|12323054|FG000|NOT COMPLETED|Overall Study||3
11137128|NCT01435772|12323055|FG001|NOT COMPLETED|Overall Study||3
11137129|NCT01435772|12323056|FG002|NOT COMPLETED|Overall Study||15
11137130|NCT01435798|12323065|FG000|STARTED|Overall Study|Crossover design|26
11137131|NCT01435798|12323065|FG000|0% MTD|Overall Study||25
11137132|NCT01435798|12323065|FG000|25% MTD|Overall Study||26
11137133|NCT01435798|12323065|FG000|50% MTD|Overall Study||25
11137134|NCT01435798|12323065|FG000|100% MTD|Overall Study||25
11137135|NCT01435798|12323065|FG000|COMPLETED|Overall Study|Crossover design|25
11137136|NCT01435798|12323065|FG000|NOT COMPLETED|Overall Study||1
11137137|NCT01435824|12323075|FG000|STARTED|First Intervention||8
11137138|NCT01435824|12323076|FG001|STARTED|First Intervention||8
11137139|NCT01435824|12323075|FG000|COMPLETED|First Intervention||8
11240907|NCT02093793|12433246|FG002|COMPLETED|Overall Study||65
11240908|NCT02093793|12433244|FG000|NOT COMPLETED|Overall Study||7
11240909|NCT02093793|12433245|FG001|NOT COMPLETED|Overall Study||10
11137140|NCT01435824|12323076|FG001|COMPLETED|First Intervention||8
11137141|NCT01435824|12323075|FG000|NOT COMPLETED|First Intervention||0
11137142|NCT01435824|12323076|FG001|NOT COMPLETED|First Intervention||0
11137143|NCT01435824|12323075|FG000|STARTED|Washout of 1-2 Weeks||8
11137144|NCT01435824|12323076|FG001|STARTED|Washout of 1-2 Weeks||8
11137145|NCT01435824|12323075|FG000|COMPLETED|Washout of 1-2 Weeks||8
11137146|NCT01435824|12323076|FG001|COMPLETED|Washout of 1-2 Weeks||8
11137147|NCT01435824|12323075|FG000|NOT COMPLETED|Washout of 1-2 Weeks||0
11137148|NCT01435824|12323076|FG001|NOT COMPLETED|Washout of 1-2 Weeks||0
11137149|NCT01435824|12323075|FG000|STARTED|Second Intervention||8
11137150|NCT01435824|12323076|FG001|STARTED|Second Intervention||8
11137151|NCT01435824|12323075|FG000|COMPLETED|Second Intervention||8
11137152|NCT01435824|12323076|FG001|COMPLETED|Second Intervention||8
11137153|NCT01435824|12323075|FG000|NOT COMPLETED|Second Intervention||0
11137154|NCT01435824|12323076|FG001|NOT COMPLETED|Second Intervention||0
11137155|NCT01435928|12323084|FG000|STARTED|Open Label Phase - up to 24 Weeks||676
11137156|NCT01435928|12323085|FG001|STARTED|Open Label Phase - up to 24 Weeks||0
11137157|NCT01435928|12323086|FG002|STARTED|Open Label Phase - up to 24 Weeks||0
11137158|NCT01435928|12323084|FG000|COMPLETED|Open Label Phase - up to 24 Weeks||287
11137159|NCT01435928|12323085|FG001|COMPLETED|Open Label Phase - up to 24 Weeks||0
11137160|NCT01435928|12323086|FG002|COMPLETED|Open Label Phase - up to 24 Weeks||0
11137161|NCT01435928|12323084|FG000|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
11137162|NCT01435928|12323085|FG001|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
11137163|NCT01435928|12323086|FG002|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
11137164|NCT01435928|12323084|FG000|STARTED|Double Blind Phase - 28 Weeks||0
11137165|NCT01435928|12323085|FG001|STARTED|Double Blind Phase - 28 Weeks||144
11137166|NCT01435928|12323086|FG002|STARTED|Double Blind Phase - 28 Weeks||141
11137167|NCT01435928|12323084|FG000|COMPLETED|Double Blind Phase - 28 Weeks||0
11137168|NCT01435928|12323085|FG001|COMPLETED|Double Blind Phase - 28 Weeks||28
11137169|NCT01435928|12323086|FG002|COMPLETED|Double Blind Phase - 28 Weeks||20
11137170|NCT01435928|12323084|FG000|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
11137171|NCT01435928|12323085|FG001|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
11137172|NCT01435928|12323086|FG002|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
11137173|NCT01436006|12323093|FG000|STARTED|Overall Study||6700
11137174|NCT01436006|12323093|FG000|COMPLETED|Overall Study||6663
11137175|NCT01436006|12323093|FG000|NOT COMPLETED|Overall Study||37
11137176|NCT01436045|12323105|FG000|STARTED|Overall Study||6
11137177|NCT01436045|12323106|FG001|STARTED|Overall Study||6
11137178|NCT01436045|12323105|FG000|COMPLETED|Overall Study||6
11137179|NCT01436045|12323106|FG001|COMPLETED|Overall Study||6
11137180|NCT01436045|12323105|FG000|NOT COMPLETED|Overall Study||0
11137181|NCT01436045|12323106|FG001|NOT COMPLETED|Overall Study||0
11137182|NCT01436071|12323114|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|124
11137183|NCT01436071|12323115|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|124
11240910|NCT02093793|12433246|FG002|NOT COMPLETED|Overall Study||3
11240911|NCT02093819|12433262|FG000|STARTED|Overall Study||15
11240912|NCT02093819|12433263|FG001|STARTED|Overall Study||6
11137184|NCT01436071|12323114|FG000|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
11137185|NCT01436071|12323115|FG001|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
11137186|NCT01436071|12323114|FG000|COMPLETED|Overall Study||98
11137187|NCT01436071|12323115|FG001|COMPLETED|Overall Study||110
11137188|NCT01436071|12323114|FG000|NOT COMPLETED|Overall Study||26
11137189|NCT01436071|12323115|FG001|NOT COMPLETED|Overall Study||14
11137190|NCT01436110|12323124|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|116
11137191|NCT01436110|12323125|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|117
11137192|NCT01436110|12323126|FG002|STARTED|Overall Study|These participants were randomized to trial medication.|118
11137193|NCT01436110|12323124|FG000|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
11137194|NCT01436110|12323125|FG001|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
11137195|NCT01436110|12323126|FG002|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
11137196|NCT01436110|12323124|FG000|COMPLETED|Overall Study||77
11137197|NCT01436110|12323125|FG001|COMPLETED|Overall Study||91
11137198|NCT01436110|12323126|FG002|COMPLETED|Overall Study||95
11137199|NCT01436110|12323124|FG000|NOT COMPLETED|Overall Study||39
11137200|NCT01436110|12323125|FG001|NOT COMPLETED|Overall Study||26
11137201|NCT01436110|12323126|FG002|NOT COMPLETED|Overall Study||23
11137202|NCT01436149|12323136|FG000|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
11137203|NCT01436149|12323137|FG001|STARTED|Antidepressant Lead-in Phase||0
11137204|NCT01436149|12323138|FG002|STARTED|Antidepressant Lead-in Phase||0
11137205|NCT01436149|12323136|FG000|COMPLETED|Antidepressant Lead-in Phase||896
11137206|NCT01436149|12323137|FG001|COMPLETED|Antidepressant Lead-in Phase||0
11137207|NCT01436149|12323138|FG002|COMPLETED|Antidepressant Lead-in Phase||0
11137208|NCT01436149|12323136|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||366
11137209|NCT01436149|12323137|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0
11137210|NCT01436149|12323138|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0
11137211|NCT01436149|12323136|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
11137212|NCT01436149|12323137|FG001|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
11137213|NCT01436149|12323138|FG002|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
11137214|NCT01436149|12323136|FG000|COMPLETED|Randomized Phase||415
11137215|NCT01436149|12323137|FG001|COMPLETED|Randomized Phase||164
11137216|NCT01436149|12323138|FG002|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
11137217|NCT01436149|12323136|FG000|NOT COMPLETED|Randomized Phase||77
11137218|NCT01436149|12323137|FG001|NOT COMPLETED|Randomized Phase||38
11137219|NCT01436149|12323138|FG002|NOT COMPLETED|Randomized Phase||42
11137220|NCT01436162|12323146|FG000|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
11137221|NCT01436162|12323147|FG001|STARTED|Single-blind Lead-in Phase||0
11137222|NCT01436162|12323148|FG002|STARTED|Single-blind Lead-in Phase||0
11137223|NCT01436162|12323146|FG000|COMPLETED|Single-blind Lead-in Phase||823
11137224|NCT01436162|12323147|FG001|COMPLETED|Single-blind Lead-in Phase||0
11137225|NCT01436162|12323148|FG002|COMPLETED|Single-blind Lead-in Phase||0
11137226|NCT01436162|12323146|FG000|NOT COMPLETED|Single-blind Lead-in Phase||282
11137227|NCT01436162|12323147|FG001|NOT COMPLETED|Single-blind Lead-in Phase||0
11240913|NCT02093819|12433264|FG002|STARTED|Overall Study||10
11137228|NCT01436162|12323148|FG002|NOT COMPLETED|Single-blind Lead-in Phase||0
11137229|NCT01436162|12323146|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
11137230|NCT01436162|12323147|FG001|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
11137231|NCT01436162|12323148|FG002|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
11137232|NCT01436162|12323146|FG000|COMPLETED|Randomized Phase||353
11137233|NCT01436162|12323147|FG001|COMPLETED|Randomized Phase||181
11137234|NCT01436162|12323148|FG002|COMPLETED|Randomized Phase||189
11137235|NCT01436162|12323146|FG000|NOT COMPLETED|Randomized Phase||44
11137236|NCT01436162|12323147|FG001|NOT COMPLETED|Randomized Phase||31
11137237|NCT01436162|12323148|FG002|NOT COMPLETED|Randomized Phase||25
11137238|NCT01436175|12323156|FG000|STARTED|Overall Study||1570
11137239|NCT01436175|12323156|FG000|COMPLETED|Overall Study||300
11137240|NCT01436175|12323156|FG000|NOT COMPLETED|Overall Study||1270
11137241|NCT01436201|12323161|FG000|STARTED|Overall Study||24
11137242|NCT01436201|12323161|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24
11137243|NCT01436201|12323161|FG000|COMPLETED|Overall Study||20
11137244|NCT01436201|12323161|FG000|NOT COMPLETED|Overall Study||4
11137245|NCT01436266|12323169|FG000|STARTED|Overall Study||1
11137246|NCT01436266|12323170|FG001|STARTED|Overall Study||1
11137247|NCT01436266|12323169|FG000|COMPLETED|Overall Study||1
11137248|NCT01436266|12323170|FG001|COMPLETED|Overall Study||1
11137249|NCT01436266|12323169|FG000|NOT COMPLETED|Overall Study||0
11137250|NCT01436266|12323170|FG001|NOT COMPLETED|Overall Study||0
11137251|NCT01436279|12323178|FG000|STARTED|Overall Study||30
11137252|NCT01436279|12323179|FG001|STARTED|Overall Study||20
11137253|NCT01436279|12323178|FG000|COMPLETED|Overall Study||30
11137254|NCT01436279|12323179|FG001|COMPLETED|Overall Study||20
11137255|NCT01436279|12323178|FG000|NOT COMPLETED|Overall Study||0
11137256|NCT01436279|12323179|FG001|NOT COMPLETED|Overall Study||0
11137257|NCT01436305|12323190|FG000|STARTED|Overall Study||6
11137258|NCT01436305|12323191|FG001|STARTED|Overall Study||6
11137259|NCT01436305|12323192|FG002|STARTED|Overall Study||7
11137260|NCT01436305|12323190|FG000|COMPLETED|Overall Study||4
11137261|NCT01436305|12323191|FG001|COMPLETED|Overall Study||2
11137262|NCT01436305|12323192|FG002|COMPLETED|Overall Study||7
11137263|NCT01436305|12323190|FG000|NOT COMPLETED|Overall Study||2
11137264|NCT01436305|12323191|FG001|NOT COMPLETED|Overall Study||4
11137265|NCT01436305|12323192|FG002|NOT COMPLETED|Overall Study||0
11137266|NCT01436357|12323202|FG000|STARTED|Overall Study||274
11137267|NCT01436357|12323203|FG001|STARTED|Overall Study||274
11137268|NCT01436357|12323202|FG000|Stage 1|Overall Study||49
11137269|NCT01436357|12323203|FG001|Stage 1|Overall Study||48
11137270|NCT01436357|12323202|FG000|Stage 2|Overall Study||225
11137271|NCT01436357|12323203|FG001|Stage 2|Overall Study||226
11137272|NCT01436357|12323202|FG000|COMPLETED|Overall Study||152
11137273|NCT01436357|12323203|FG001|COMPLETED|Overall Study||146
11137274|NCT01436357|12323202|FG000|NOT COMPLETED|Overall Study||122
11137275|NCT01436357|12323203|FG001|NOT COMPLETED|Overall Study||128
11137276|NCT01436370|12323217|FG000|STARTED|Overall Study||6
11137277|NCT01436370|12323218|FG001|STARTED|Overall Study||6
11137278|NCT01436370|12323219|FG002|STARTED|Overall Study||10
11137279|NCT01436370|12323220|FG003|STARTED|Overall Study||10
11137280|NCT01436370|12323221|FG004|STARTED|Overall Study||19
11137281|NCT01436370|12323222|FG005|STARTED|Overall Study||19
11137282|NCT01436370|12323223|FG006|STARTED|Overall Study||16
11137283|NCT01436370|12323224|FG007|STARTED|Overall Study||16
11137284|NCT01436370|12323217|FG000|COMPLETED|Overall Study||6
11137285|NCT01436370|12323218|FG001|COMPLETED|Overall Study||6
11137286|NCT01436370|12323219|FG002|COMPLETED|Overall Study||10
11137287|NCT01436370|12323220|FG003|COMPLETED|Overall Study||10
11137288|NCT01436370|12323221|FG004|COMPLETED|Overall Study||18
11137289|NCT01436370|12323222|FG005|COMPLETED|Overall Study||19
11137290|NCT01436370|12323223|FG006|COMPLETED|Overall Study||16
11137291|NCT01436370|12323224|FG007|COMPLETED|Overall Study||16
11137292|NCT01436370|12323217|FG000|NOT COMPLETED|Overall Study||0
11137293|NCT01436370|12323218|FG001|NOT COMPLETED|Overall Study||0
11137294|NCT01436370|12323219|FG002|NOT COMPLETED|Overall Study||0
11137295|NCT01436370|12323220|FG003|NOT COMPLETED|Overall Study||0
11137296|NCT01436370|12323221|FG004|NOT COMPLETED|Overall Study||1
11137297|NCT01436370|12323222|FG005|NOT COMPLETED|Overall Study||0
11137298|NCT01436370|12323223|FG006|NOT COMPLETED|Overall Study||0
11137299|NCT01436370|12323224|FG007|NOT COMPLETED|Overall Study||0
11137300|NCT01436435|12323250|FG000|STARTED|Overall Study||241
11137301|NCT01436435|12323250|FG000|COMPLETED|Overall Study||177
11137302|NCT01436435|12323250|FG000|NOT COMPLETED|Overall Study||64
11137303|NCT01436500|12323256|FG000|STARTED|Overall Study||12
11137304|NCT01436500|12323257|FG001|STARTED|Overall Study||12
11137305|NCT01436500|12323258|FG002|STARTED|Overall Study||12
11137306|NCT01436500|12323259|FG003|STARTED|Overall Study||6
11137307|NCT01436500|12323260|FG004|STARTED|Overall Study||13
11137308|NCT01436500|12323256|FG000|COMPLETED|Overall Study||9
11137309|NCT01436500|12323257|FG001|COMPLETED|Overall Study||9
11137310|NCT01436500|12323258|FG002|COMPLETED|Overall Study||7
11137311|NCT01436500|12323259|FG003|COMPLETED|Overall Study||5
11137312|NCT01436500|12323260|FG004|COMPLETED|Overall Study||9
11137313|NCT01436500|12323256|FG000|NOT COMPLETED|Overall Study||3
11137314|NCT01436500|12323257|FG001|NOT COMPLETED|Overall Study||3
11137315|NCT01436500|12323258|FG002|NOT COMPLETED|Overall Study||5
11137316|NCT01436500|12323259|FG003|NOT COMPLETED|Overall Study||1
11137317|NCT01436500|12323260|FG004|NOT COMPLETED|Overall Study||4
11137318|NCT01436526|12323275|FG000|STARTED|Period 1||14
11137319|NCT01436526|12323276|FG001|STARTED|Period 1||14
11137320|NCT01436526|12323275|FG000|Participants Received Treatment|Period 1||14
11137321|NCT01436526|12323276|FG001|Participants Received Treatment|Period 1||14
11137322|NCT01436526|12323275|FG000|COMPLETED|Period 1||14
11137323|NCT01436526|12323276|FG001|COMPLETED|Period 1||14
11137324|NCT01436526|12323275|FG000|NOT COMPLETED|Period 1||0
11137325|NCT01436526|12323276|FG001|NOT COMPLETED|Period 1||0
11137326|NCT01436526|12323275|FG000|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
11137327|NCT01436526|12323276|FG001|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
11137328|NCT01436526|12323275|FG000|Participants Received Treatment|Period 2||13
11137329|NCT01436526|12323276|FG001|Participants Received Treatment|Period 2||13
11137330|NCT01436526|12323275|FG000|COMPLETED|Period 2||13
11137331|NCT01436526|12323276|FG001|COMPLETED|Period 2||13
11137332|NCT01436526|12323275|FG000|NOT COMPLETED|Period 2||0
11137333|NCT01436526|12323276|FG001|NOT COMPLETED|Period 2||0
11137334|NCT01436643|12323285|FG000|STARTED|2-week Pre-treatment||0
11137335|NCT01436643|12323286|FG001|STARTED|2-week Pre-treatment||0
11137336|NCT01436643|12323287|FG002|STARTED|2-week Pre-treatment||0
11137337|NCT01436643|12323288|FG003|STARTED|2-week Pre-treatment||54
11137338|NCT01436643|12323285|FG000|COMPLETED|2-week Pre-treatment||0
11137339|NCT01436643|12323286|FG001|COMPLETED|2-week Pre-treatment||0
11137340|NCT01436643|12323287|FG002|COMPLETED|2-week Pre-treatment||0
11137341|NCT01436643|12323288|FG003|COMPLETED|2-week Pre-treatment||44
11137342|NCT01436643|12323285|FG000|NOT COMPLETED|2-week Pre-treatment||0
11137343|NCT01436643|12323286|FG001|NOT COMPLETED|2-week Pre-treatment||0
11137344|NCT01436643|12323287|FG002|NOT COMPLETED|2-week Pre-treatment||0
11137345|NCT01436643|12323288|FG003|NOT COMPLETED|2-week Pre-treatment||10
11137346|NCT01436643|12323285|FG000|STARTED|Core Phase (16 Weeks)||17
11137347|NCT01436643|12323286|FG001|STARTED|Core Phase (16 Weeks)||15
11137348|NCT01436643|12323287|FG002|STARTED|Core Phase (16 Weeks)||20
11137349|NCT01436643|12323288|FG003|STARTED|Core Phase (16 Weeks)||0
11137350|NCT01436643|12323285|FG000|COMPLETED|Core Phase (16 Weeks)||16
11137351|NCT01436643|12323286|FG001|COMPLETED|Core Phase (16 Weeks)||11
11137352|NCT01436643|12323287|FG002|COMPLETED|Core Phase (16 Weeks)||17
11137353|NCT01436643|12323288|FG003|COMPLETED|Core Phase (16 Weeks)||0
11137354|NCT01436643|12323285|FG000|NOT COMPLETED|Core Phase (16 Weeks)||1
11137355|NCT01436643|12323286|FG001|NOT COMPLETED|Core Phase (16 Weeks)||4
11137356|NCT01436643|12323287|FG002|NOT COMPLETED|Core Phase (16 Weeks)||3
11137357|NCT01436643|12323288|FG003|NOT COMPLETED|Core Phase (16 Weeks)||0
11137358|NCT01436799|12323300|FG000|STARTED|Overall Study||20
11137359|NCT01436799|12323301|FG001|STARTED|Overall Study||20
11137360|NCT01436799|12323300|FG000|COMPLETED|Overall Study||20
11137361|NCT01436799|12323301|FG001|COMPLETED|Overall Study||20
11137362|NCT01436799|12323300|FG000|NOT COMPLETED|Overall Study||0
11137363|NCT01436799|12323301|FG001|NOT COMPLETED|Overall Study||0
11137364|NCT01437098|12323307|FG000|STARTED|Overall Study||55
11137365|NCT01437098|12323307|FG000|30 Days|Overall Study||51
11137366|NCT01437098|12323307|FG000|6 Months|Overall Study||47
11137367|NCT01437098|12323307|FG000|12 Months|Overall Study||45
11137368|NCT01437098|12323307|FG000|24 Months|Overall Study||42
11137369|NCT01437098|12323307|FG000|36 Months|Overall Study||36
11137370|NCT01437098|12323307|FG000|COMPLETED|Overall Study||42
11137371|NCT01437098|12323307|FG000|NOT COMPLETED|Overall Study||13
11137372|NCT01437124|12323319|FG000|STARTED|Overall Study||83
11137373|NCT01437124|12323319|FG000|COMPLETED|Overall Study||83
11137374|NCT01437124|12323319|FG000|NOT COMPLETED|Overall Study||0
11137375|NCT01437267|12323329|FG000|STARTED|Overall Study||20
11137376|NCT01437267|12323330|FG001|STARTED|Overall Study||20
11137377|NCT01437267|12323331|FG002|STARTED|Overall Study||20
11137378|NCT01437267|12323332|FG003|STARTED|Overall Study||20
11137379|NCT01437267|12323333|FG004|STARTED|Overall Study||20
11137380|NCT01437267|12323334|FG005|STARTED|Overall Study||20
11137381|NCT01437267|12323329|FG000|COMPLETED|Overall Study||20
11137382|NCT01437267|12323330|FG001|COMPLETED|Overall Study||19
11137383|NCT01437267|12323331|FG002|COMPLETED|Overall Study||20
11137384|NCT01437267|12323332|FG003|COMPLETED|Overall Study||19
11137385|NCT01437267|12323333|FG004|COMPLETED|Overall Study||20
11137386|NCT01437267|12323334|FG005|COMPLETED|Overall Study||20
11137387|NCT01437267|12323329|FG000|NOT COMPLETED|Overall Study||0
11137388|NCT01437267|12323330|FG001|NOT COMPLETED|Overall Study||1
11137389|NCT01437267|12323331|FG002|NOT COMPLETED|Overall Study||0
11137390|NCT01437267|12323332|FG003|NOT COMPLETED|Overall Study||1
11137391|NCT01437267|12323333|FG004|NOT COMPLETED|Overall Study||0
11137392|NCT01437267|12323334|FG005|NOT COMPLETED|Overall Study||0
11137393|NCT01437319|12323348|FG000|STARTED|Phase I||282
11137394|NCT01437319|12323349|FG001|STARTED|Phase I||0
11137395|NCT01437319|12323350|FG002|STARTED|Phase I||0
11137396|NCT01437319|12323348|FG000|COMPLETED|Phase I||227
11137397|NCT01437319|12323349|FG001|COMPLETED|Phase I||0
11137398|NCT01437319|12323350|FG002|COMPLETED|Phase I||0
11137399|NCT01437319|12323348|FG000|NOT COMPLETED|Phase I||55
11137400|NCT01437319|12323349|FG001|NOT COMPLETED|Phase I||0
11137401|NCT01437319|12323350|FG002|NOT COMPLETED|Phase I||0
11137402|NCT01437319|12323348|FG000|STARTED|Phase II||0
11137403|NCT01437319|12323349|FG001|STARTED|Phase II||115
11137404|NCT01437319|12323350|FG002|STARTED|Phase II||112
11137405|NCT01437319|12323348|FG000|COMPLETED|Phase II||0
11137406|NCT01437319|12323349|FG001|COMPLETED|Phase II||71
11137407|NCT01437319|12323350|FG002|COMPLETED|Phase II||75
11137408|NCT01437319|12323348|FG000|NOT COMPLETED|Phase II||0
11137409|NCT01437319|12323349|FG001|NOT COMPLETED|Phase II||44
11005285|NCT00721799|12182946|FG000|NOT COMPLETED|Overall Study||8
11005286|NCT00721955|12182953|FG000|STARTED|Overall Study||105
11137410|NCT01437319|12323350|FG002|NOT COMPLETED|Phase II||37
11137411|NCT01437397|12323364|FG000|STARTED|Overall Study||338
11137412|NCT01437397|12323365|FG001|STARTED|Overall Study||338
11137413|NCT01437397|12323366|FG002|STARTED|Overall Study||340
11137414|NCT01437397|12323367|FG003|STARTED|Overall Study||339
11137415|NCT01437397|12323368|FG004|STARTED|Overall Study||337
11137416|NCT01437397|12323364|FG000|COMPLETED|Overall Study||272
11137417|NCT01437397|12323365|FG001|COMPLETED|Overall Study||276
11137418|NCT01437397|12323366|FG002|COMPLETED|Overall Study||268
11137419|NCT01437397|12323367|FG003|COMPLETED|Overall Study||270
11137420|NCT01437397|12323368|FG004|COMPLETED|Overall Study||236
11137421|NCT01437397|12323364|FG000|NOT COMPLETED|Overall Study||66
11137422|NCT01437397|12323365|FG001|NOT COMPLETED|Overall Study||62
11137423|NCT01437397|12323366|FG002|NOT COMPLETED|Overall Study||72
11137424|NCT01437397|12323367|FG003|NOT COMPLETED|Overall Study||69
11137425|NCT01437397|12323368|FG004|NOT COMPLETED|Overall Study||101
11137426|NCT01437449|12323380|FG000|STARTED|Overall Study||27
11137427|NCT01437449|12323380|FG000|COMPLETED|Overall Study||27
11137428|NCT01437449|12323380|FG000|NOT COMPLETED|Overall Study||0
11137429|NCT01437488|12323384|FG000|STARTED|Overall Study||14
11137430|NCT01437488|12323384|FG000|COMPLETED|Overall Study||14
11137431|NCT01437488|12323384|FG000|NOT COMPLETED|Overall Study||0
11137432|NCT01437501|12323393|FG000|STARTED|Overall Study||148
11137433|NCT01437501|12323394|FG001|STARTED|Overall Study||143
11137434|NCT01437501|12323393|FG000|COMPLETED|Overall Study||135
11137435|NCT01437501|12323394|FG001|COMPLETED|Overall Study||132
11137436|NCT01437501|12323393|FG000|NOT COMPLETED|Overall Study||13
11137437|NCT01437501|12323394|FG001|NOT COMPLETED|Overall Study||11
11137438|NCT01437540|12323404|FG000|STARTED|Overall Study||392
11137439|NCT01437540|12323405|FG001|STARTED|Overall Study||198
11137440|NCT01437540|12323404|FG000|COMPLETED|Overall Study||265
11137441|NCT01437540|12323405|FG001|COMPLETED|Overall Study||133
11137442|NCT01437540|12323404|FG000|NOT COMPLETED|Overall Study||127
11137443|NCT01437540|12323405|FG001|NOT COMPLETED|Overall Study||65
11137444|NCT01437605|12323413|FG000|STARTED|Overall Study||9
11137445|NCT01437605|12323414|FG001|STARTED|Overall Study||5
11137446|NCT01437605|12323413|FG000|COMPLETED|Overall Study||9
11137447|NCT01437605|12323414|FG001|COMPLETED|Overall Study||5
11137448|NCT01437605|12323413|FG000|NOT COMPLETED|Overall Study||0
11137449|NCT01437605|12323414|FG001|NOT COMPLETED|Overall Study||0
11137450|NCT01437852|12323420|FG000|STARTED|Overall Study||30
11137451|NCT01437852|12323420|FG000|Received StrataGraft Skin Tissue|Overall Study||30
11137452|NCT01437852|12323420|FG000|Received Autograft|Overall Study||30
11137453|NCT01437852|12323420|FG000|COMPLETED|Overall Study||30
11137454|NCT01437852|12323420|FG000|NOT COMPLETED|Overall Study||0
11137455|NCT01437878|12323427|FG000|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
11137456|NCT01437878|12323428|FG001|STARTED|Overall Study||1
11137457|NCT01437878|12323427|FG000|COMPLETED|Overall Study||0
11137458|NCT01437878|12323428|FG001|COMPLETED|Overall Study||1
11137459|NCT01437878|12323427|FG000|NOT COMPLETED|Overall Study||1
11137460|NCT01437878|12323428|FG001|NOT COMPLETED|Overall Study||0
11137461|NCT01437943|12323436|FG000|STARTED|Overall Study||7
11137462|NCT01437943|12323437|FG001|STARTED|Overall Study||3
11137463|NCT01437943|12323436|FG000|COMPLETED|Overall Study||0
11137464|NCT01437943|12323437|FG001|COMPLETED|Overall Study||1
11137465|NCT01437943|12323436|FG000|NOT COMPLETED|Overall Study||7
11137466|NCT01437943|12323437|FG001|NOT COMPLETED|Overall Study||2
11137467|NCT01437995|12323446|FG000|STARTED|Overall Study||151
11137468|NCT01437995|12323447|FG001|STARTED|Overall Study||149
11137469|NCT01437995|12323448|FG002|STARTED|Overall Study||155
11137470|NCT01437995|12323446|FG000|Included in Treatment Failure Analysis|Overall Study||150
11137471|NCT01437995|12323447|FG001|Included in Treatment Failure Analysis|Overall Study||146
11137472|NCT01437995|12323448|FG002|Included in Treatment Failure Analysis|Overall Study||151
11137473|NCT01437995|12323446|FG000|COMPLETED|Overall Study||140
11137474|NCT01437995|12323447|FG001|COMPLETED|Overall Study||131
11137475|NCT01437995|12323448|FG002|COMPLETED|Overall Study||135
11137476|NCT01437995|12323446|FG000|NOT COMPLETED|Overall Study||11
11137477|NCT01437995|12323447|FG001|NOT COMPLETED|Overall Study||18
11137478|NCT01437995|12323448|FG002|NOT COMPLETED|Overall Study||20
11137479|NCT01438008|12323458|FG000|STARTED|Overall Study||4
11137480|NCT01438008|12323459|FG001|STARTED|Overall Study||5
11137481|NCT01438008|12323458|FG000|COMPLETED|Overall Study||4
11137482|NCT01438008|12323459|FG001|COMPLETED|Overall Study||5
11137483|NCT01438008|12323458|FG000|NOT COMPLETED|Overall Study||0
11137484|NCT01438008|12323459|FG001|NOT COMPLETED|Overall Study||0
11137485|NCT01438060|12323467|FG000|STARTED|Acute Phase: Double-blind, 10 Weeks||102
11137486|NCT01438060|12323468|FG001|STARTED|Acute Phase: Double-blind, 10 Weeks||106
11137487|NCT01438060|12323467|FG000|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
11137488|NCT01438060|12323468|FG001|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
11137489|NCT01438060|12323467|FG000|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
11137490|NCT01438060|12323468|FG001|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
11137491|NCT01438060|12323467|FG000|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
11137492|NCT01438060|12323468|FG001|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
11137493|NCT01438060|12323467|FG000|COMPLETED|Extension Phase: Week 10 to Week 130||22
11137494|NCT01438060|12323468|FG001|COMPLETED|Extension Phase: Week 10 to Week 130||25
11137495|NCT01438060|12323467|FG000|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
11137496|NCT01438060|12323468|FG001|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
11137497|NCT01438060|12323467|FG000|STARTED|On Study Beyond Week 140||0
11137498|NCT01438060|12323468|FG001|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
11137499|NCT01438060|12323467|FG000|COMPLETED|On Study Beyond Week 140||0
11137500|NCT01438060|12323468|FG001|COMPLETED|On Study Beyond Week 140||1
11137501|NCT01438060|12323467|FG000|NOT COMPLETED|On Study Beyond Week 140||0
11137502|NCT01438060|12323468|FG001|NOT COMPLETED|On Study Beyond Week 140||8
11137503|NCT01438151|12323479|FG000|STARTED|Overall Study||11
11137504|NCT01438151|12323479|FG000|COMPLETED|Overall Study||3
11137505|NCT01438151|12323479|FG000|NOT COMPLETED|Overall Study||8
11137506|NCT01438177|12323483|FG000|STARTED|Overall Study||11
11137507|NCT01438177|12323483|FG000|COMPLETED|Overall Study|Patients who were off due to disease progression|9
11137508|NCT01438177|12323483|FG000|NOT COMPLETED|Overall Study||2
11137509|NCT01438229|12323487|FG000|STARTED|Overall Study||47
11137510|NCT01438229|12323487|FG000|Excluded Due to Renal Artery Anatomy|Overall Study||1
11137511|NCT01438229|12323487|FG000|Underwent Procedure|Overall Study||46
11137512|NCT01438229|12323487|FG000|COMPLETED|Overall Study||44
11137513|NCT01438229|12323487|FG000|NOT COMPLETED|Overall Study||3
11137514|NCT01438294|12323493|FG000|STARTED|Overall Study||16
11137515|NCT01438294|12323494|FG001|STARTED|Overall Study||20
11137516|NCT01438294|12323493|FG000|COMPLETED|Overall Study||13
11137517|NCT01438294|12323494|FG001|COMPLETED|Overall Study||13
11137518|NCT01438294|12323493|FG000|NOT COMPLETED|Overall Study||3
11137519|NCT01438294|12323494|FG001|NOT COMPLETED|Overall Study||7
11137520|NCT01438307|12323502|FG000|STARTED|Overall Study||14
11137521|NCT01438307|12323503|FG001|STARTED|Overall Study||14
11137522|NCT01438307|12323502|FG000|COMPLETED|Overall Study||13
11137523|NCT01438307|12323503|FG001|COMPLETED|Overall Study||13
11240914|NCT02093819|12433265|FG003|STARTED|Overall Study||6
11240915|NCT02093819|12433266|FG004|STARTED|Overall Study||6
11240916|NCT02093819|12433267|FG005|STARTED|Overall Study||6
11240917|NCT02093819|12433268|FG006|STARTED|Overall Study||5
11240918|NCT02093819|12433269|FG007|STARTED|Overall Study||6
11240919|NCT02093819|12433262|FG000|COMPLETED|Overall Study||15
11240920|NCT02093819|12433263|FG001|COMPLETED|Overall Study||6
11240921|NCT02093819|12433264|FG002|COMPLETED|Overall Study||10
11240922|NCT02093819|12433265|FG003|COMPLETED|Overall Study||6
11240923|NCT02093819|12433266|FG004|COMPLETED|Overall Study||6
11240924|NCT02093819|12433267|FG005|COMPLETED|Overall Study||6
11240925|NCT02093819|12433268|FG006|COMPLETED|Overall Study||5
11240926|NCT02093819|12433269|FG007|COMPLETED|Overall Study||6
11240927|NCT02093819|12433262|FG000|NOT COMPLETED|Overall Study||0
11240928|NCT02093819|12433263|FG001|NOT COMPLETED|Overall Study||0
11240929|NCT02093819|12433264|FG002|NOT COMPLETED|Overall Study||0
11240930|NCT02093819|12433265|FG003|NOT COMPLETED|Overall Study||0
11240931|NCT02093819|12433266|FG004|NOT COMPLETED|Overall Study||0
11240932|NCT02093819|12433267|FG005|NOT COMPLETED|Overall Study||0
11240933|NCT02093819|12433268|FG006|NOT COMPLETED|Overall Study||0
11240934|NCT02093819|12433269|FG007|NOT COMPLETED|Overall Study||0
11240935|NCT02093897|12433296|FG000|STARTED|Overall Study||84
11240936|NCT02093897|12433296|FG000|COMPLETED|Overall Study||65
11240937|NCT02093897|12433296|FG000|NOT COMPLETED|Overall Study||19
11240938|NCT02093923|12433312|FG000|STARTED|Overall Study||4
11240939|NCT02093923|12433313|FG001|STARTED|Overall Study||4
11137524|NCT01438307|12323502|FG000|NOT COMPLETED|Overall Study||1
11137525|NCT01438307|12323503|FG001|NOT COMPLETED|Overall Study||1
11137526|NCT01438411|12323509|FG000|STARTED|Overall Study||53
11137527|NCT01438411|12323509|FG000|COMPLETED|Overall Study||40
11137528|NCT01438411|12323509|FG000|NOT COMPLETED|Overall Study||13
11137529|NCT01438424|12323513|FG000|STARTED|Overall Study|Received treatment|1051
11137530|NCT01438424|12323513|FG000|COMPLETED|Overall Study|Completed treatment|634
11137531|NCT01438424|12323513|FG000|NOT COMPLETED|Overall Study||417
11137532|NCT01438476|12323529|FG000|STARTED|Overall Study||116
11137533|NCT01438476|12323530|FG001|STARTED|Overall Study||45
11137534|NCT01438476|12323529|FG000|COMPLETED|Overall Study||106
11137535|NCT01438476|12323530|FG001|COMPLETED|Overall Study||34
11137536|NCT01438476|12323529|FG000|NOT COMPLETED|Overall Study||10
11137537|NCT01438476|12323530|FG001|NOT COMPLETED|Overall Study||11
11137538|NCT01438489|12323539|FG000|STARTED|Overall Study||103
11137539|NCT01438489|12323540|FG001|STARTED|Overall Study||100
11137540|NCT01438489|12323541|FG002|STARTED|Overall Study||104
11240940|NCT02093923|12433314|FG002|STARTED|Overall Study||5
11240941|NCT02093923|12433315|FG003|STARTED|Overall Study||12
11240942|NCT02093923|12433316|FG004|STARTED|Overall Study||13
11240943|NCT02093923|12433312|FG000|Total Treated|Overall Study||4
11240944|NCT02093923|12433313|FG001|Total Treated|Overall Study||4
11240945|NCT02093923|12433314|FG002|Total Treated|Overall Study||5
11240946|NCT02093923|12433315|FG003|Total Treated|Overall Study||11
11240947|NCT02093923|12433316|FG004|Total Treated|Overall Study||13
11240948|NCT02093923|12433312|FG000|Treated - 1 Dose Only:|Overall Study||0
11240949|NCT02093923|12433313|FG001|Treated - 1 Dose Only:|Overall Study||0
11137541|NCT01438489|12323539|FG000|COMPLETED|Overall Study||77
11240950|NCT02093923|12433314|FG002|Treated - 1 Dose Only:|Overall Study||0
11240951|NCT02093923|12433315|FG003|Treated - 1 Dose Only:|Overall Study||1
11240952|NCT02093923|12433316|FG004|Treated - 1 Dose Only:|Overall Study||0
11240953|NCT02093923|12433312|FG000|Treated - 2 Doses:|Overall Study||4
11240954|NCT02093923|12433313|FG001|Treated - 2 Doses:|Overall Study||4
11240955|NCT02093923|12433314|FG002|Treated - 2 Doses:|Overall Study||5
11240956|NCT02093923|12433315|FG003|Treated - 2 Doses:|Overall Study||10
11240957|NCT02093923|12433316|FG004|Treated - 2 Doses:|Overall Study||13
11240958|NCT02093923|12433312|FG000|COMPLETED|Overall Study||4
11240959|NCT02093923|12433313|FG001|COMPLETED|Overall Study||4
11240960|NCT02093923|12433314|FG002|COMPLETED|Overall Study||5
11240961|NCT02093923|12433315|FG003|COMPLETED|Overall Study||10
11240962|NCT02093923|12433316|FG004|COMPLETED|Overall Study||13
11240963|NCT02093923|12433312|FG000|NOT COMPLETED|Overall Study||0
11240964|NCT02093923|12433313|FG001|NOT COMPLETED|Overall Study||0
11137542|NCT01438489|12323540|FG001|COMPLETED|Overall Study||84
11137543|NCT01438489|12323541|FG002|COMPLETED|Overall Study||85
11137544|NCT01438489|12323539|FG000|NOT COMPLETED|Overall Study||26
11137545|NCT01438489|12323540|FG001|NOT COMPLETED|Overall Study||16
11137546|NCT01438489|12323541|FG002|NOT COMPLETED|Overall Study||19
11137547|NCT01438541|12323551|FG000|STARTED|Overall Study||29
11137548|NCT01438541|12323551|FG000|COMPLETED|Overall Study||22
11137549|NCT01438541|12323551|FG000|NOT COMPLETED|Overall Study||7
11137550|NCT01438710|12323555|FG000|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
11137551|NCT01438710|12323556|FG001|STARTED|First Week of Treatment||44
11137552|NCT01438710|12323555|FG000|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
11137553|NCT01438710|12323556|FG001|COMPLETED|First Week of Treatment||41
11137554|NCT01438710|12323555|FG000|NOT COMPLETED|First Week of Treatment||0
11137555|NCT01438710|12323556|FG001|NOT COMPLETED|First Week of Treatment||3
11137556|NCT01438710|12323555|FG000|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
11137557|NCT01438710|12323556|FG001|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
11137558|NCT01438710|12323555|FG000|COMPLETED|Second Week of Treatment||40
11137559|NCT01438710|12323556|FG001|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
11137560|NCT01438710|12323555|FG000|NOT COMPLETED|Second Week of Treatment||1
11137561|NCT01438710|12323556|FG001|NOT COMPLETED|Second Week of Treatment||0
11137562|NCT01438814|12323563|FG000|STARTED|Overall Study||344
11137563|NCT01438814|12323564|FG001|STARTED|Overall Study||345
11137564|NCT01438814|12323563|FG000|COMPLETED|Overall Study||330
11137565|NCT01438814|12323564|FG001|COMPLETED|Overall Study||331
11137566|NCT01438814|12323563|FG000|NOT COMPLETED|Overall Study||14
11137567|NCT01438814|12323564|FG001|NOT COMPLETED|Overall Study||14
11137568|NCT01438840|12323572|FG000|STARTED|Core Study||17
11137569|NCT01438840|12323573|FG001|STARTED|Core Study||32
11137570|NCT01438840|12323574|FG002|STARTED|Core Study||0
11137571|NCT01438840|12323572|FG000|COMPLETED|Core Study||1
11137572|NCT01438840|12323573|FG001|COMPLETED|Core Study||22
11137573|NCT01438840|12323574|FG002|COMPLETED|Core Study||0
11137574|NCT01438840|12323572|FG000|NOT COMPLETED|Core Study||16
11137575|NCT01438840|12323573|FG001|NOT COMPLETED|Core Study||10
11137576|NCT01438840|12323574|FG002|NOT COMPLETED|Core Study||0
11137577|NCT01438840|12323572|FG000|STARTED|Extension Phase||0
11137578|NCT01438840|12323573|FG001|STARTED|Extension Phase||0
11137579|NCT01438840|12323574|FG002|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
11137580|NCT01438840|12323572|FG000|COMPLETED|Extension Phase||0
11137581|NCT01438840|12323573|FG001|COMPLETED|Extension Phase||0
11137582|NCT01438840|12323574|FG002|COMPLETED|Extension Phase||29
11137583|NCT01438840|12323572|FG000|NOT COMPLETED|Extension Phase||0
11137584|NCT01438840|12323573|FG001|NOT COMPLETED|Extension Phase||0
11137585|NCT01438840|12323574|FG002|NOT COMPLETED|Extension Phase||10
11137586|NCT01438957|12323586|FG000|STARTED|Overall Study||22
11137587|NCT01438957|12323587|FG001|STARTED|Overall Study||23
11137588|NCT01438957|12323588|FG002|STARTED|Overall Study||24
11137589|NCT01438957|12323589|FG003|STARTED|Overall Study||25
11137590|NCT01438957|12323590|FG004|STARTED|Overall Study||25
11137591|NCT01438957|12323586|FG000|COMPLETED|Overall Study||21
11137592|NCT01438957|12323587|FG001|COMPLETED|Overall Study||22
11137593|NCT01438957|12323588|FG002|COMPLETED|Overall Study||24
11137594|NCT01438957|12323589|FG003|COMPLETED|Overall Study||24
11137595|NCT01438957|12323590|FG004|COMPLETED|Overall Study||25
11137596|NCT01438957|12323586|FG000|NOT COMPLETED|Overall Study||1
11137597|NCT01438957|12323587|FG001|NOT COMPLETED|Overall Study||1
11137598|NCT01438957|12323588|FG002|NOT COMPLETED|Overall Study||0
11137599|NCT01438957|12323589|FG003|NOT COMPLETED|Overall Study||1
11137600|NCT01438957|12323590|FG004|NOT COMPLETED|Overall Study||0
11137601|NCT01438996|12323605|FG000|STARTED|Overall Study||18
11137602|NCT01438996|12323606|FG001|STARTED|Overall Study||13
11137603|NCT01438996|12323607|FG002|STARTED|Overall Study||20
11137604|NCT01438996|12323605|FG000|COMPLETED|Overall Study||14
11137605|NCT01438996|12323606|FG001|COMPLETED|Overall Study||12
11137606|NCT01438996|12323607|FG002|COMPLETED|Overall Study||20
11137607|NCT01438996|12323605|FG000|NOT COMPLETED|Overall Study||4
11137608|NCT01438996|12323606|FG001|NOT COMPLETED|Overall Study||1
11137609|NCT01438996|12323607|FG002|NOT COMPLETED|Overall Study||0
11137610|NCT01439009|12323617|FG000|STARTED|Overall Study||50
11137611|NCT01439009|12323618|FG001|STARTED|Overall Study||50
11137612|NCT01439009|12323617|FG000|COMPLETED|Overall Study||42
11240965|NCT02093923|12433314|FG002|NOT COMPLETED|Overall Study||0
11137613|NCT01439009|12323618|FG001|COMPLETED|Overall Study||47
11137614|NCT01439009|12323617|FG000|NOT COMPLETED|Overall Study||8
11137615|NCT01439009|12323618|FG001|NOT COMPLETED|Overall Study||3
11137616|NCT01439035|12323624|FG000|STARTED|Overall Study||6
11137617|NCT01439035|12323624|FG000|COMPLETED|Overall Study||6
11137618|NCT01439035|12323624|FG000|NOT COMPLETED|Overall Study||0
11137619|NCT01439074|12323630|FG000|STARTED|Overall Study||75
11137620|NCT01439074|12323631|FG001|STARTED|Overall Study||87
11137621|NCT01439074|12323630|FG000|COMPLETED|Overall Study||66
11137622|NCT01439074|12323631|FG001|COMPLETED|Overall Study||74
11137623|NCT01439074|12323630|FG000|NOT COMPLETED|Overall Study||9
11137624|NCT01439074|12323631|FG001|NOT COMPLETED|Overall Study||13
11137625|NCT01439087|12323637|FG000|STARTED|Overall Study||2
11137626|NCT01439087|12323637|FG000|COMPLETED|Overall Study||2
11137627|NCT01439087|12323637|FG000|NOT COMPLETED|Overall Study||0
11137628|NCT01439126|12323643|FG000|STARTED|Overall Study||68
11137629|NCT01439126|12323644|FG001|STARTED|Overall Study||67
11137630|NCT01439126|12323643|FG000|COMPLETED|Overall Study||37
11137631|NCT01439126|12323644|FG001|COMPLETED|Overall Study||25
11137632|NCT01439126|12323643|FG000|NOT COMPLETED|Overall Study||31
11137633|NCT01439126|12323644|FG001|NOT COMPLETED|Overall Study||42
11137634|NCT01439204|12323652|FG000|STARTED|Overall Study||36
11137635|NCT01439204|12323653|FG001|STARTED|Overall Study||36
11137636|NCT01439204|12323652|FG000|COMPLETED|Overall Study||32
11137637|NCT01439204|12323653|FG001|COMPLETED|Overall Study||33
11137638|NCT01439204|12323652|FG000|NOT COMPLETED|Overall Study||4
11137639|NCT01439204|12323653|FG001|NOT COMPLETED|Overall Study||3
11137640|NCT01439282|12323661|FG000|STARTED|Overall Study||67
11137641|NCT01439282|12323662|FG001|STARTED|Overall Study||10
11137642|NCT01439282|12323661|FG000|COMPLETED|Overall Study||59
11137643|NCT01439282|12323662|FG001|COMPLETED|Overall Study||9
11137644|NCT01439282|12323661|FG000|NOT COMPLETED|Overall Study||8
11137645|NCT01439282|12323662|FG001|NOT COMPLETED|Overall Study||1
11137646|NCT01439360|12323671|FG000|STARTED|Overall Study||6006
11137647|NCT01439360|12323672|FG001|STARTED|Overall Study||6012
11137648|NCT01439360|12323671|FG000|COMPLETED|Overall Study||5808
11137649|NCT01439360|12323672|FG001|COMPLETED|Overall Study||5804
11137650|NCT01439360|12323671|FG000|NOT COMPLETED|Overall Study||198
11137651|NCT01439360|12323672|FG001|NOT COMPLETED|Overall Study||208
11137652|NCT01439373|12323680|FG000|STARTED|Monotherapy (Day 1)||11
11137653|NCT01439373|12323681|FG001|STARTED|Monotherapy (Day 1)||5
11137654|NCT01439373|12323680|FG000|COMPLETED|Monotherapy (Day 1)||11
11137655|NCT01439373|12323681|FG001|COMPLETED|Monotherapy (Day 1)||4
11137656|NCT01439373|12323680|FG000|NOT COMPLETED|Monotherapy (Day 1)||0
11137657|NCT01439373|12323681|FG001|NOT COMPLETED|Monotherapy (Day 1)||1
11137658|NCT01439373|12323680|FG000|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
11137659|NCT01439373|12323681|FG001|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
11137660|NCT01439373|12323680|FG000|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
11137661|NCT01439373|12323681|FG001|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
11137662|NCT01439373|12323680|FG000|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
11137663|NCT01439373|12323681|FG001|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
11137664|NCT01439555|12323691|FG000|STARTED|Overall Study||11
11137665|NCT01439555|12323691|FG000|COMPLETED|Overall Study||10
11137666|NCT01439555|12323691|FG000|NOT COMPLETED|Overall Study||1
11137667|NCT01439568|12323697|FG000|STARTED|Overall Study||47
11137668|NCT01439568|12323698|FG001|STARTED|Overall Study||43
11137669|NCT01439568|12323697|FG000|Received at Least One Dose of Study Drug|Overall Study||47
11137670|NCT01439568|12323698|FG001|Received at Least One Dose of Study Drug|Overall Study||43
11137671|NCT01439568|12323697|FG000|COMPLETED|Overall Study||44
11137672|NCT01439568|12323698|FG001|COMPLETED|Overall Study||41
11137673|NCT01439568|12323697|FG000|NOT COMPLETED|Overall Study||3
11137674|NCT01439568|12323698|FG001|NOT COMPLETED|Overall Study||2
11137675|NCT01439581|12323706|FG000|STARTED|Overall Study||216
11137676|NCT01439581|12323707|FG001|STARTED|Overall Study||212
11137677|NCT01439581|12323706|FG000|COMPLETED|Overall Study||216
11137678|NCT01439581|12323707|FG001|COMPLETED|Overall Study||212
11137679|NCT01439581|12323706|FG000|NOT COMPLETED|Overall Study||0
11137680|NCT01439581|12323707|FG001|NOT COMPLETED|Overall Study||0
11137681|NCT01439594|12323713|FG000|STARTED|Overall Study||17
11137682|NCT01439594|12323713|FG000|COMPLETED|Overall Study||17
11137683|NCT01439594|12323713|FG000|NOT COMPLETED|Overall Study||0
11137684|NCT01439620|12323717|FG000|STARTED|Overall Study||7
11137685|NCT01439620|12323717|FG000|COMPLETED|Overall Study||7
11137686|NCT01439620|12323717|FG000|NOT COMPLETED|Overall Study||0
11137687|NCT01439633|12323721|FG000|STARTED|Overall Study||22
11137688|NCT01439633|12323721|FG000|COMPLETED|Overall Study||22
11137689|NCT01439633|12323721|FG000|NOT COMPLETED|Overall Study||0
11137690|NCT01439672|12323725|FG000|STARTED|Overall Study||35
11137691|NCT01439672|12323725|FG000|COMPLETED|Overall Study||11
11137692|NCT01439672|12323725|FG000|NOT COMPLETED|Overall Study||24
11137693|NCT01439711|12323729|FG000|STARTED|Overall Study||108
11137694|NCT01439711|12323729|FG000|COMPLETED|Overall Study||68
11137695|NCT01439711|12323729|FG000|NOT COMPLETED|Overall Study||40
11137696|NCT01439724|12323735|FG000|STARTED|Overall Study||47
11137697|NCT01439724|12323736|FG001|STARTED|Overall Study||47
11137698|NCT01439724|12323735|FG000|COMPLETED|Overall Study||38
11137699|NCT01439724|12323736|FG001|COMPLETED|Overall Study||39
11137700|NCT01439724|12323735|FG000|NOT COMPLETED|Overall Study||9
11137701|NCT01439724|12323736|FG001|NOT COMPLETED|Overall Study||8
11137702|NCT01439815|12323744|FG000|STARTED|Overall Study||11
11137703|NCT01439815|12323745|FG001|STARTED|Overall Study||11
11137704|NCT01439815|12323744|FG000|All Randomized Participant Population|Overall Study||11
11137705|NCT01439815|12323745|FG001|All Randomized Participant Population|Overall Study||11
11137706|NCT01439815|12323744|FG000|COMPLETED|Overall Study||11
11137707|NCT01439815|12323745|FG001|COMPLETED|Overall Study||9
11137708|NCT01439815|12323744|FG000|NOT COMPLETED|Overall Study||0
11137709|NCT01439815|12323745|FG001|NOT COMPLETED|Overall Study||2
11137710|NCT01439854|12323753|FG000|STARTED|Overall Study||8
11137711|NCT01439854|12323754|FG001|STARTED|Overall Study||10
11137712|NCT01439854|12323753|FG000|COMPLETED|Overall Study||8
11137713|NCT01439854|12323754|FG001|COMPLETED|Overall Study||10
11137714|NCT01439854|12323753|FG000|NOT COMPLETED|Overall Study||0
11137715|NCT01439854|12323754|FG001|NOT COMPLETED|Overall Study||0
11137716|NCT01439867|12323762|FG000|STARTED|Overall Study||8
11137717|NCT01439867|12323763|FG001|STARTED|Overall Study||10
11137718|NCT01439867|12323762|FG000|Received Treatment|Overall Study||7
11137719|NCT01439867|12323763|FG001|Received Treatment|Overall Study||10
11137720|NCT01439867|12323762|FG000|COMPLETED|Overall Study||2
11137721|NCT01439867|12323763|FG001|COMPLETED|Overall Study||2
11137722|NCT01439867|12323762|FG000|NOT COMPLETED|Overall Study||6
11137723|NCT01439867|12323763|FG001|NOT COMPLETED|Overall Study||8
11137724|NCT01439945|12323774|FG000|STARTED|Double-Blind Treatment Phase||97
11137725|NCT01439945|12323775|FG001|STARTED|Double-Blind Treatment Phase||96
11137726|NCT01439945|12323776|FG002|STARTED|Double-Blind Treatment Phase||48
11137727|NCT01439945|12323777|FG003|STARTED|Double-Blind Treatment Phase||48
11137728|NCT01439945|12323774|FG000|COMPLETED|Double-Blind Treatment Phase||93
11137729|NCT01439945|12323775|FG001|COMPLETED|Double-Blind Treatment Phase||91
11137730|NCT01439945|12323776|FG002|COMPLETED|Double-Blind Treatment Phase||45
11137731|NCT01439945|12323777|FG003|COMPLETED|Double-Blind Treatment Phase||46
11137732|NCT01439945|12323774|FG000|NOT COMPLETED|Double-Blind Treatment Phase||4
11137733|NCT01439945|12323775|FG001|NOT COMPLETED|Double-Blind Treatment Phase||5
11137734|NCT01439945|12323776|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3
11137735|NCT01439945|12323777|FG003|NOT COMPLETED|Double-Blind Treatment Phase||2
11137736|NCT01439945|12323774|FG000|STARTED|Optional Continuation Phase||72
11137737|NCT01439945|12323775|FG001|STARTED|Optional Continuation Phase||44
11137738|NCT01439945|12323776|FG002|STARTED|Optional Continuation Phase||0
11137739|NCT01439945|12323777|FG003|STARTED|Optional Continuation Phase||0
11137740|NCT01439945|12323774|FG000|COMPLETED|Optional Continuation Phase||72
11137741|NCT01439945|12323775|FG001|COMPLETED|Optional Continuation Phase||44
11137742|NCT01439945|12323776|FG002|COMPLETED|Optional Continuation Phase||0
11137743|NCT01439945|12323777|FG003|COMPLETED|Optional Continuation Phase||0
11137744|NCT01439945|12323774|FG000|NOT COMPLETED|Optional Continuation Phase||0
11137745|NCT01439945|12323775|FG001|NOT COMPLETED|Optional Continuation Phase||0
11137746|NCT01439945|12323776|FG002|NOT COMPLETED|Optional Continuation Phase||0
11137747|NCT01439945|12323777|FG003|NOT COMPLETED|Optional Continuation Phase||0
11137748|NCT01439971|12323793|FG000|STARTED|Overall Study||1
11137749|NCT01439971|12323794|FG001|STARTED|Overall Study||7
11137750|NCT01439971|12323795|FG002|STARTED|Overall Study||8
11137751|NCT01439971|12323796|FG003|STARTED|Overall Study||6
11137752|NCT01439971|12323797|FG004|STARTED|Overall Study||7
11137753|NCT01439971|12323793|FG000|Received Treatment|Overall Study||1
11137754|NCT01439971|12323794|FG001|Received Treatment|Overall Study||6
11137755|NCT01439971|12323795|FG002|Received Treatment|Overall Study||6
11137756|NCT01439971|12323796|FG003|Received Treatment|Overall Study||6
11137757|NCT01439971|12323797|FG004|Received Treatment|Overall Study||6
11137758|NCT01439971|12323793|FG000|COMPLETED|Overall Study||1
11137759|NCT01439971|12323794|FG001|COMPLETED|Overall Study||6
11137760|NCT01439971|12323795|FG002|COMPLETED|Overall Study||6
11137761|NCT01439971|12323796|FG003|COMPLETED|Overall Study||6
11137762|NCT01439971|12323797|FG004|COMPLETED|Overall Study||6
11137763|NCT01439971|12323793|FG000|NOT COMPLETED|Overall Study||0
11137764|NCT01439971|12323794|FG001|NOT COMPLETED|Overall Study||1
11137765|NCT01439971|12323795|FG002|NOT COMPLETED|Overall Study||2
11137766|NCT01439971|12323796|FG003|NOT COMPLETED|Overall Study||0
11137767|NCT01439971|12323797|FG004|NOT COMPLETED|Overall Study||1
11202383|NCT01839487|12392760|FG000|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
11202384|NCT01839487|12392761|FG001|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
11202385|NCT01839487|12392762|FG002|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
11202386|NCT01839487|12392763|FG003|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
11202387|NCT01839487|12392764|FG004|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
11202388|NCT01839487|12392765|FG005|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
11202389|NCT01839487|12392760|FG000|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||16
11202390|NCT01839487|12392761|FG001|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||7
11202391|NCT01839487|12392762|FG002|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
11202392|NCT01839487|12392763|FG003|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
11202393|NCT01839487|12392764|FG004|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
11137768|NCT01440049|12323809|FG000|STARTED|Overall Study||160
11137769|NCT01440049|12323809|FG000|COMPLETED|Overall Study||155
11137770|NCT01440049|12323809|FG000|NOT COMPLETED|Overall Study||5
11137771|NCT01440101|12323816|FG000|STARTED|Overall Study||12
11137772|NCT01440101|12323817|FG001|STARTED|Overall Study||47
11137773|NCT01440101|12323818|FG002|STARTED|Overall Study||47
11137774|NCT01440101|12323816|FG000|COMPLETED|Overall Study||10
11137775|NCT01440101|12323817|FG001|COMPLETED|Overall Study||43
11137776|NCT01440101|12323818|FG002|COMPLETED|Overall Study||46
11137777|NCT01440101|12323816|FG000|NOT COMPLETED|Overall Study||2
11137778|NCT01440101|12323817|FG001|NOT COMPLETED|Overall Study||4
11137779|NCT01440101|12323818|FG002|NOT COMPLETED|Overall Study||1
11137780|NCT01440283|12323827|FG000|STARTED|Overall Study||14
11137781|NCT01440283|12323827|FG000|COMPLETED|Overall Study||4
11137782|NCT01440283|12323827|FG000|NOT COMPLETED|Overall Study||10
11137783|NCT01440322|12323839|FG000|STARTED|Overall Study||97
11137784|NCT01440322|12323840|FG001|STARTED|Overall Study||50
11137785|NCT01440322|12323839|FG000|COMPLETED|Overall Study||90
11137786|NCT01440322|12323840|FG001|COMPLETED|Overall Study||49
11137787|NCT01440322|12323839|FG000|NOT COMPLETED|Overall Study||7
11137788|NCT01440322|12323840|FG001|NOT COMPLETED|Overall Study||1
11137789|NCT01440374|12323849|FG000|STARTED|Part 1: Open-label Phase||17
11137790|NCT01440374|12323850|FG001|STARTED|Part 1: Open-label Phase||0
11137791|NCT01440374|12323851|FG002|STARTED|Part 1: Open-label Phase||0
11137792|NCT01440374|12323852|FG003|STARTED|Part 1: Open-label Phase||0
11137793|NCT01440374|12323849|FG000|COMPLETED|Part 1: Open-label Phase||11
11137794|NCT01440374|12323850|FG001|COMPLETED|Part 1: Open-label Phase||0
11137795|NCT01440374|12323851|FG002|COMPLETED|Part 1: Open-label Phase||0
11137796|NCT01440374|12323852|FG003|COMPLETED|Part 1: Open-label Phase||0
11137797|NCT01440374|12323849|FG000|NOT COMPLETED|Part 1: Open-label Phase||6
11137798|NCT01440374|12323850|FG001|NOT COMPLETED|Part 1: Open-label Phase||0
11137799|NCT01440374|12323851|FG002|NOT COMPLETED|Part 1: Open-label Phase||0
11137800|NCT01440374|12323852|FG003|NOT COMPLETED|Part 1: Open-label Phase||0
11137801|NCT01440374|12323849|FG000|STARTED|Part 2; Double-blind Phase||0
11137802|NCT01440374|12323850|FG001|STARTED|Part 2; Double-blind Phase||47
11137803|NCT01440374|12323851|FG002|STARTED|Part 2; Double-blind Phase||98
11137804|NCT01440374|12323852|FG003|STARTED|Part 2; Double-blind Phase||0
11137805|NCT01440374|12323849|FG000|COMPLETED|Part 2; Double-blind Phase||0
11137806|NCT01440374|12323850|FG001|COMPLETED|Part 2; Double-blind Phase||27
11137807|NCT01440374|12323851|FG002|COMPLETED|Part 2; Double-blind Phase||43
11137808|NCT01440374|12323852|FG003|COMPLETED|Part 2; Double-blind Phase||0
11137809|NCT01440374|12323849|FG000|NOT COMPLETED|Part 2; Double-blind Phase||0
11137810|NCT01440374|12323850|FG001|NOT COMPLETED|Part 2; Double-blind Phase||20
11137811|NCT01440374|12323851|FG002|NOT COMPLETED|Part 2; Double-blind Phase||55
11137812|NCT01440374|12323852|FG003|NOT COMPLETED|Part 2; Double-blind Phase||0
11137813|NCT01440374|12323849|FG000|STARTED|Part 3: Extension||0
11137814|NCT01440374|12323850|FG001|STARTED|Part 3: Extension||0
11137815|NCT01440374|12323851|FG002|STARTED|Part 3: Extension||0
11137816|NCT01440374|12323852|FG003|STARTED|Part 3: Extension||59
11137817|NCT01440374|12323849|FG000|COMPLETED|Part 3: Extension||0
11137818|NCT01440374|12323850|FG001|COMPLETED|Part 3: Extension||0
11137819|NCT01440374|12323851|FG002|COMPLETED|Part 3: Extension||0
11137820|NCT01440374|12323852|FG003|COMPLETED|Part 3: Extension||27
11137821|NCT01440374|12323849|FG000|NOT COMPLETED|Part 3: Extension||0
11137822|NCT01440374|12323850|FG001|NOT COMPLETED|Part 3: Extension||0
11137823|NCT01440374|12323851|FG002|NOT COMPLETED|Part 3: Extension||0
11137824|NCT01440374|12323852|FG003|NOT COMPLETED|Part 3: Extension||32
11137825|NCT01440387|12323866|FG000|STARTED|Overall Study||56
11137826|NCT01440387|12323867|FG001|STARTED|Overall Study||56
11137827|NCT01440387|12323866|FG000|COMPLETED|Overall Study||56
11137828|NCT01440387|12323867|FG001|COMPLETED|Overall Study||56
11137829|NCT01440387|12323866|FG000|NOT COMPLETED|Overall Study||0
11137830|NCT01440387|12323867|FG001|NOT COMPLETED|Overall Study||0
11137831|NCT01440543|12323877|FG000|STARTED|Overall Study||106
11137832|NCT01440543|12323878|FG001|STARTED|Overall Study||105
11137833|NCT01440543|12323879|FG002|STARTED|Overall Study||102
11137834|NCT01440543|12323880|FG003|STARTED|Overall Study||107
11137835|NCT01440543|12323877|FG000|COMPLETED|Overall Study||102
11137836|NCT01440543|12323878|FG001|COMPLETED|Overall Study||101
11137837|NCT01440543|12323879|FG002|COMPLETED|Overall Study||100
11137838|NCT01440543|12323880|FG003|COMPLETED|Overall Study||101
11137839|NCT01440543|12323877|FG000|NOT COMPLETED|Overall Study||4
11137840|NCT01440543|12323878|FG001|NOT COMPLETED|Overall Study||4
11137841|NCT01440543|12323879|FG002|NOT COMPLETED|Overall Study||2
11137842|NCT01440543|12323880|FG003|NOT COMPLETED|Overall Study||6
11137843|NCT01440569|12323892|FG000|STARTED|Main Study||296
11137844|NCT01440569|12323893|FG001|STARTED|Main Study||18
11137845|NCT01440569|12323892|FG000|Enrolled and Treated|Main Study||295
11137846|NCT01440569|12323893|FG001|Enrolled and Treated|Main Study||18
11137847|NCT01440569|12323892|FG000|COMPLETED|Main Study||260
11137848|NCT01440569|12323893|FG001|COMPLETED|Main Study||14
11137849|NCT01440569|12323892|FG000|NOT COMPLETED|Main Study||36
11137850|NCT01440569|12323893|FG001|NOT COMPLETED|Main Study||4
11137851|NCT01440569|12323892|FG000|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
11137852|NCT01440569|12323893|FG001|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
11137853|NCT01440569|12323892|FG000|COMPLETED|Open-Label Rollover Phase||204
11137854|NCT01440569|12323893|FG001|COMPLETED|Open-Label Rollover Phase||7
11137855|NCT01440569|12323892|FG000|NOT COMPLETED|Open-Label Rollover Phase||47
11137856|NCT01440569|12323893|FG001|NOT COMPLETED|Open-Label Rollover Phase||6
11137857|NCT01440634|12323901|FG000|STARTED|Cross Sectional Phase||0
11137858|NCT01440634|12323902|FG001|STARTED|Cross Sectional Phase||347
11137859|NCT01440634|12323901|FG000|COMPLETED|Cross Sectional Phase||0
11137860|NCT01440634|12323902|FG001|COMPLETED|Cross Sectional Phase||347
11137861|NCT01440634|12323901|FG000|NOT COMPLETED|Cross Sectional Phase||0
11137862|NCT01440634|12323902|FG001|NOT COMPLETED|Cross Sectional Phase||0
11137863|NCT01440634|12323901|FG000|STARTED|Randomization Phase||30
11137864|NCT01440634|12323902|FG001|STARTED|Randomization Phase||24
11137865|NCT01440634|12323901|FG000|COMPLETED|Randomization Phase||24
11137866|NCT01440634|12323902|FG001|COMPLETED|Randomization Phase||14
11137867|NCT01440634|12323901|FG000|NOT COMPLETED|Randomization Phase||6
11137868|NCT01440634|12323902|FG001|NOT COMPLETED|Randomization Phase||10
11137869|NCT01440647|12323910|FG000|STARTED|Overall Study||16
11137870|NCT01440647|12323911|FG001|STARTED|Overall Study||18
11137871|NCT01440647|12323910|FG000|COMPLETED|Overall Study||14
11137872|NCT01440647|12323911|FG001|COMPLETED|Overall Study||15
11137873|NCT01440647|12323910|FG000|NOT COMPLETED|Overall Study||2
11137874|NCT01440647|12323911|FG001|NOT COMPLETED|Overall Study||3
11137875|NCT01440764|12323919|FG000|STARTED|Test Day 1||4
11137876|NCT01440764|12323920|FG001|STARTED|Test Day 1||2
11137877|NCT01440764|12323921|FG002|STARTED|Test Day 1||6
11137878|NCT01440764|12323922|FG003|STARTED|Test Day 1||1
11137879|NCT01440764|12323923|FG004|STARTED|Test Day 1||3
11137880|NCT01440764|12323924|FG005|STARTED|Test Day 1||5
11137881|NCT01440764|12323925|FG006|STARTED|Test Day 1||3
11137882|NCT01440764|12323919|FG000|COMPLETED|Test Day 1||4
11137883|NCT01440764|12323920|FG001|COMPLETED|Test Day 1||2
11137884|NCT01440764|12323921|FG002|COMPLETED|Test Day 1||6
11137885|NCT01440764|12323922|FG003|COMPLETED|Test Day 1||1
11137886|NCT01440764|12323923|FG004|COMPLETED|Test Day 1||3
11137887|NCT01440764|12323924|FG005|COMPLETED|Test Day 1||5
11137888|NCT01440764|12323925|FG006|COMPLETED|Test Day 1||3
11137889|NCT01440764|12323919|FG000|NOT COMPLETED|Test Day 1||0
11137890|NCT01440764|12323920|FG001|NOT COMPLETED|Test Day 1||0
11137891|NCT01440764|12323921|FG002|NOT COMPLETED|Test Day 1||0
11137892|NCT01440764|12323922|FG003|NOT COMPLETED|Test Day 1||0
11137893|NCT01440764|12323923|FG004|NOT COMPLETED|Test Day 1||0
11137894|NCT01440764|12323924|FG005|NOT COMPLETED|Test Day 1||0
11137895|NCT01440764|12323925|FG006|NOT COMPLETED|Test Day 1||0
11137896|NCT01440764|12323919|FG000|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
11137897|NCT01440764|12323920|FG001|STARTED|Test Day 2||2
11137898|NCT01440764|12323921|FG002|STARTED|Test Day 2||6
11137899|NCT01440764|12323922|FG003|STARTED|Test Day 2||1
11137900|NCT01440764|12323923|FG004|STARTED|Test Day 2||3
11137901|NCT01440764|12323924|FG005|STARTED|Test Day 2||5
11137902|NCT01440764|12323925|FG006|STARTED|Test Day 2||3
11137903|NCT01440764|12323919|FG000|COMPLETED|Test Day 2||3
11137904|NCT01440764|12323920|FG001|COMPLETED|Test Day 2||2
11137905|NCT01440764|12323921|FG002|COMPLETED|Test Day 2||6
11137906|NCT01440764|12323922|FG003|COMPLETED|Test Day 2||1
11137907|NCT01440764|12323923|FG004|COMPLETED|Test Day 2||3
11137908|NCT01440764|12323924|FG005|COMPLETED|Test Day 2||5
11137909|NCT01440764|12323925|FG006|COMPLETED|Test Day 2||3
11137910|NCT01440764|12323919|FG000|NOT COMPLETED|Test Day 2||0
11137911|NCT01440764|12323920|FG001|NOT COMPLETED|Test Day 2||0
11137912|NCT01440764|12323921|FG002|NOT COMPLETED|Test Day 2||0
11137913|NCT01440764|12323922|FG003|NOT COMPLETED|Test Day 2||0
11137914|NCT01440764|12323923|FG004|NOT COMPLETED|Test Day 2||0
11137915|NCT01440764|12323924|FG005|NOT COMPLETED|Test Day 2||0
11137916|NCT01440764|12323925|FG006|NOT COMPLETED|Test Day 2||0
11137917|NCT01440764|12323919|FG000|STARTED|Test Day 3||3
11137918|NCT01440764|12323920|FG001|STARTED|Test Day 3||2
11137919|NCT01440764|12323921|FG002|STARTED|Test Day 3||6
11137920|NCT01440764|12323922|FG003|STARTED|Test Day 3||1
11137921|NCT01440764|12323923|FG004|STARTED|Test Day 3||3
11137922|NCT01440764|12323924|FG005|STARTED|Test Day 3||5
11137923|NCT01440764|12323925|FG006|STARTED|Test Day 3||3
11137924|NCT01440764|12323919|FG000|COMPLETED|Test Day 3||3
11137925|NCT01440764|12323920|FG001|COMPLETED|Test Day 3||2
11137926|NCT01440764|12323921|FG002|COMPLETED|Test Day 3||6
11137927|NCT01440764|12323922|FG003|COMPLETED|Test Day 3||1
11137928|NCT01440764|12323923|FG004|COMPLETED|Test Day 3||3
11137929|NCT01440764|12323924|FG005|COMPLETED|Test Day 3||5
11137930|NCT01440764|12323925|FG006|COMPLETED|Test Day 3||3
11137931|NCT01440764|12323919|FG000|NOT COMPLETED|Test Day 3||0
11137932|NCT01440764|12323920|FG001|NOT COMPLETED|Test Day 3||0
11137933|NCT01440764|12323921|FG002|NOT COMPLETED|Test Day 3||0
11137934|NCT01440764|12323922|FG003|NOT COMPLETED|Test Day 3||0
11137935|NCT01440764|12323923|FG004|NOT COMPLETED|Test Day 3||0
11137936|NCT01440764|12323924|FG005|NOT COMPLETED|Test Day 3||0
11137937|NCT01440764|12323925|FG006|NOT COMPLETED|Test Day 3||0
11137938|NCT01440803|12323945|FG000|STARTED|Overall Study||13
11137939|NCT01440803|12323946|FG001|STARTED|Overall Study||28
11137940|NCT01440803|12323945|FG000|Period 1 - Forteo/Placebo|Overall Study||13
11137941|NCT01440803|12323946|FG001|Period 1 - Forteo/Placebo|Overall Study||28
11137942|NCT01440803|12323945|FG000|Period 2 - Forteo/Forteo|Overall Study||13
11137943|NCT01440803|12323946|FG001|Period 2 - Forteo/Forteo|Overall Study||28
11137944|NCT01440803|12323945|FG000|Period 3 - Forteo Open Label|Overall Study||13
11137945|NCT01440803|12323946|FG001|Period 3 - Forteo Open Label|Overall Study||27
11137946|NCT01440803|12323945|FG000|COMPLETED|Overall Study||11
11137947|NCT01440803|12323946|FG001|COMPLETED|Overall Study||24
11137948|NCT01440803|12323945|FG000|NOT COMPLETED|Overall Study||2
11137949|NCT01440803|12323946|FG001|NOT COMPLETED|Overall Study||4
11137950|NCT01440816|12323955|FG000|STARTED|Overall Study||3
11137951|NCT01440816|12323956|FG001|STARTED|Overall Study||12
11137952|NCT01440816|12323955|FG000|COMPLETED|Overall Study||2
11137953|NCT01440816|12323956|FG001|COMPLETED|Overall Study||1
11137954|NCT01440816|12323955|FG000|NOT COMPLETED|Overall Study||1
11137955|NCT01440816|12323956|FG001|NOT COMPLETED|Overall Study||11
11137956|NCT01440881|12323966|FG000|STARTED|Overall Study||14
11137957|NCT01440881|12323967|FG001|STARTED|Overall Study||15
11137958|NCT01440881|12323966|FG000|COMPLETED|Overall Study||14
11137959|NCT01440881|12323967|FG001|COMPLETED|Overall Study||14
11137960|NCT01440881|12323966|FG000|NOT COMPLETED|Overall Study||0
11137961|NCT01440881|12323967|FG001|NOT COMPLETED|Overall Study||1
11137962|NCT01440920|12323977|FG000|STARTED|Overall Study||3
11137963|NCT01440920|12323978|FG001|STARTED|Overall Study||3
11137964|NCT01440920|12323979|FG002|STARTED|Overall Study||3
11137965|NCT01440920|12323977|FG000|COMPLETED|Overall Study||3
11137966|NCT01440920|12323978|FG001|COMPLETED|Overall Study||3
11137967|NCT01440920|12323979|FG002|COMPLETED|Overall Study||3
11240966|NCT02093923|12433315|FG003|NOT COMPLETED|Overall Study||2
11240967|NCT02093923|12433316|FG004|NOT COMPLETED|Overall Study||0
11240968|NCT02093949|12433334|FG000|STARTED|Overall Study||105
11240969|NCT02093949|12433335|FG001|STARTED|Overall Study||47
11240970|NCT02093949|12433334|FG000|COMPLETED|Overall Study||105
11240971|NCT02093949|12433335|FG001|COMPLETED|Overall Study||47
11240972|NCT02093949|12433334|FG000|NOT COMPLETED|Overall Study||0
11240973|NCT02093949|12433335|FG001|NOT COMPLETED|Overall Study||0
11240974|NCT02093962|12433351|FG000|STARTED|Overall Study||134
11240975|NCT02093962|12433352|FG001|STARTED|Overall Study||131
11240976|NCT02093962|12433351|FG000|Received Treatment|Overall Study||130
11240977|NCT02093962|12433352|FG001|Received Treatment|Overall Study||130
11240978|NCT02093962|12433351|FG000|COMPLETED|Overall Study||0
11240979|NCT02093962|12433352|FG001|COMPLETED|Overall Study||0
11240980|NCT02093962|12433351|FG000|NOT COMPLETED|Overall Study||134
11240981|NCT02093962|12433352|FG001|NOT COMPLETED|Overall Study||131
11240982|NCT02094118|12433360|FG000|STARTED|Overall Study||85
11240983|NCT02094118|12433361|FG001|STARTED|Overall Study||86
11240984|NCT02094118|12433360|FG000|COMPLETED|Overall Study||73
11240985|NCT02094118|12433361|FG001|COMPLETED|Overall Study||81
11240986|NCT02094118|12433360|FG000|NOT COMPLETED|Overall Study||12
11240987|NCT02094118|12433361|FG001|NOT COMPLETED|Overall Study||5
11240988|NCT02094300|12433371|FG000|STARTED|Overall Study||26
11240989|NCT02094300|12433371|FG000|30 Days|Overall Study||24
11240990|NCT02094300|12433371|FG000|COMPLETED|Overall Study||6
11240991|NCT02094300|12433371|FG000|NOT COMPLETED|Overall Study||20
11240992|NCT02094326|12433375|FG000|STARTED|Overall Study||301
11240993|NCT02094326|12433375|FG000|COMPLETED|Overall Study||301
11240994|NCT02094326|12433375|FG000|NOT COMPLETED|Overall Study||0
11240995|NCT02094417|12433384|FG000|STARTED|Overall Study||7
11240996|NCT02094417|12433385|FG001|STARTED|Overall Study||9
11240997|NCT02094417|12433386|FG002|STARTED|Overall Study||9
11240998|NCT02094417|12433387|FG003|STARTED|Overall Study||10
11240999|NCT02094417|12433384|FG000|COMPLETED|Overall Study||2
11241000|NCT02094417|12433385|FG001|COMPLETED|Overall Study||1
11241001|NCT02094417|12433386|FG002|COMPLETED|Overall Study||4
11241002|NCT02094417|12433387|FG003|COMPLETED|Overall Study||3
11241003|NCT02094417|12433384|FG000|NOT COMPLETED|Overall Study||5
11241004|NCT02094417|12433385|FG001|NOT COMPLETED|Overall Study||8
11241005|NCT02094417|12433386|FG002|NOT COMPLETED|Overall Study||5
11241006|NCT02094417|12433387|FG003|NOT COMPLETED|Overall Study||7
11241007|NCT02094443|12433399|FG000|STARTED|Overall Study||26
11241008|NCT02094443|12433400|FG001|STARTED|Overall Study||26
11241009|NCT02094443|12433399|FG000|Completed at Week 12|Overall Study||0
11241010|NCT02094443|12433400|FG001|Completed at Week 12|Overall Study||1
11241011|NCT02094443|12433399|FG000|Completed at Week 24|Overall Study||11
11241012|NCT02094443|12433400|FG001|Completed at Week 24|Overall Study||8
11241013|NCT02094443|12433399|FG000|COMPLETED|Overall Study||11
11241014|NCT02094443|12433400|FG001|COMPLETED|Overall Study||9
11241015|NCT02094443|12433399|FG000|NOT COMPLETED|Overall Study||15
11241016|NCT02094443|12433400|FG001|NOT COMPLETED|Overall Study||17
11241017|NCT02094534|12433408|FG000|STARTED|Overall Study||15
11241018|NCT02094534|12433409|FG001|STARTED|Overall Study||10
11241019|NCT02094534|12433408|FG000|COMPLETED|Overall Study||15
11241020|NCT02094534|12433409|FG001|COMPLETED|Overall Study||10
11241021|NCT02094534|12433408|FG000|NOT COMPLETED|Overall Study||0
11241022|NCT02094534|12433409|FG001|NOT COMPLETED|Overall Study||0
11241023|NCT02094573|12433417|FG000|STARTED|Overall Study||112
11241024|NCT02094573|12433418|FG001|STARTED|Overall Study||110
11241025|NCT02094573|12433417|FG000|Treated|Overall Study||109
11241026|NCT02094573|12433418|FG001|Treated|Overall Study||110
11241027|NCT02094573|12433417|FG000|COMPLETED|Overall Study||0
11241028|NCT02094573|12433418|FG001|COMPLETED|Overall Study||0
11241029|NCT02094573|12433417|FG000|NOT COMPLETED|Overall Study||112
11241030|NCT02094573|12433418|FG001|NOT COMPLETED|Overall Study||110
11241031|NCT02094586|12433428|FG000|STARTED|Overall Study||927
11241032|NCT02094586|12433429|FG001|STARTED|Overall Study||933
11241033|NCT02094586|12433430|FG002|STARTED|Overall Study||935
11241034|NCT02094586|12433431|FG003|STARTED|Overall Study||351
11241035|NCT02094586|12433428|FG000|COMPLETED|Overall Study||848
11241036|NCT02094586|12433429|FG001|COMPLETED|Overall Study||866
11241037|NCT02094586|12433430|FG002|COMPLETED|Overall Study||876
11241038|NCT02094586|12433431|FG003|COMPLETED|Overall Study||331
11241039|NCT02094586|12433428|FG000|NOT COMPLETED|Overall Study||79
11241040|NCT02094586|12433429|FG001|NOT COMPLETED|Overall Study||67
11241041|NCT02094586|12433430|FG002|NOT COMPLETED|Overall Study||59
11241042|NCT02094586|12433431|FG003|NOT COMPLETED|Overall Study||20
11241043|NCT02094612|12433455|FG000|STARTED|Overall Study||112
11241044|NCT02094612|12433456|FG001|STARTED|Overall Study||95
11241045|NCT02094612|12433455|FG000|1 Month Follow up|Overall Study||67
11241046|NCT02094612|12433456|FG001|1 Month Follow up|Overall Study||50
11241047|NCT02094612|12433455|FG000|3 Month Follow up|Overall Study||50
11241048|NCT02094612|12433456|FG001|3 Month Follow up|Overall Study||43
11241049|NCT02094612|12433455|FG000|6 Month Follow up|Overall Study||33
11137968|NCT01440920|12323977|FG000|NOT COMPLETED|Overall Study||0
11137969|NCT01440920|12323978|FG001|NOT COMPLETED|Overall Study||0
11241050|NCT02094612|12433456|FG001|6 Month Follow up|Overall Study||25
11241051|NCT02094612|12433455|FG000|COMPLETED|Overall Study||33
11241052|NCT02094612|12433456|FG001|COMPLETED|Overall Study||25
11241053|NCT02094612|12433455|FG000|NOT COMPLETED|Overall Study||79
11241054|NCT02094612|12433456|FG001|NOT COMPLETED|Overall Study||70
11241055|NCT02094664|12433464|FG000|STARTED|Overall Study||16
11241056|NCT02094664|12433465|FG001|STARTED|Overall Study||16
11241057|NCT02094664|12433464|FG000|COMPLETED|Overall Study||16
11241058|NCT02094664|12433465|FG001|COMPLETED|Overall Study||16
11241059|NCT02094664|12433464|FG000|NOT COMPLETED|Overall Study||0
11241060|NCT02094664|12433465|FG001|NOT COMPLETED|Overall Study||0
11241061|NCT02094677|12433473|FG000|STARTED|Overall Study||43
11241062|NCT02094677|12433474|FG001|STARTED|Overall Study||31
11241063|NCT02094677|12433473|FG000|COMPLETED|Overall Study||40
11241064|NCT02094677|12433474|FG001|COMPLETED|Overall Study||30
11241065|NCT02094677|12433473|FG000|NOT COMPLETED|Overall Study||3
11241066|NCT02094677|12433474|FG001|NOT COMPLETED|Overall Study||1
11241067|NCT02094755|12433487|FG000|STARTED|Overall Study||100
11241068|NCT02094755|12433487|FG000|COMPLETED|Overall Study||100
11241069|NCT02094755|12433487|FG000|NOT COMPLETED|Overall Study||0
11241070|NCT02094872|12433491|FG000|STARTED|Overall Study||49
11241071|NCT02094872|12433491|FG000|Received Biopsy|Overall Study||37
11241072|NCT02094872|12433491|FG000|Received Tumor-board Recommendation|Overall Study|1 individual withdrew consent after biopsy.|36
11241073|NCT02094872|12433491|FG000|Received Targeted Therapy|Overall Study||20
11241074|NCT02094872|12433491|FG000|Received Standard of Care|Overall Study|7 standard-of-care patients crossed-over and received targeted therapy.|9
11241075|NCT02094872|12433491|FG000|Patients Treated With MEK162|Overall Study||20
11241076|NCT02094872|12433491|FG000|COMPLETED|Overall Study||20
11241077|NCT02094872|12433491|FG000|NOT COMPLETED|Overall Study||29
11241078|NCT02094885|12433497|FG000|STARTED|Overall Study||125
11241079|NCT02094885|12433498|FG001|STARTED|Overall Study||127
11241080|NCT02094885|12433497|FG000|COMPLETED|Overall Study||123
11241081|NCT02094885|12433498|FG001|COMPLETED|Overall Study||122
11241082|NCT02094885|12433497|FG000|NOT COMPLETED|Overall Study||2
11241083|NCT02094885|12433498|FG001|NOT COMPLETED|Overall Study||5
11241084|NCT02094898|12433504|FG000|STARTED|Overall Study||12
11241085|NCT02094898|12433504|FG000|COMPLETED|Overall Study||7
11241086|NCT02094898|12433504|FG000|NOT COMPLETED|Overall Study||5
11241087|NCT02094937|12433510|FG000|STARTED|8 Weeks in Period 1||430
11241088|NCT02094937|12433511|FG001|STARTED|8 Weeks in Period 1||0
11241089|NCT02094937|12433512|FG002|STARTED|8 Weeks in Period 1||0
11241090|NCT02094937|12433513|FG003|STARTED|8 Weeks in Period 1||0
11241091|NCT02094937|12433510|FG000|COMPLETED|8 Weeks in Period 1||370
11241092|NCT02094937|12433511|FG001|COMPLETED|8 Weeks in Period 1||0
11241093|NCT02094937|12433512|FG002|COMPLETED|8 Weeks in Period 1||0
11241094|NCT02094937|12433513|FG003|COMPLETED|8 Weeks in Period 1||0
11241095|NCT02094937|12433510|FG000|NOT COMPLETED|8 Weeks in Period 1||60
11241096|NCT02094937|12433511|FG001|NOT COMPLETED|8 Weeks in Period 1||0
11241097|NCT02094937|12433512|FG002|NOT COMPLETED|8 Weeks in Period 1||0
11137970|NCT01440920|12323979|FG002|NOT COMPLETED|Overall Study||0
11241098|NCT02094937|12433513|FG003|NOT COMPLETED|8 Weeks in Period 1||0
11241099|NCT02094937|12433510|FG000|STARTED|12 Weeks in Period 2||0
11241100|NCT02094937|12433511|FG001|STARTED|12 Weeks in Period 2||123
11241101|NCT02094937|12433512|FG002|STARTED|12 Weeks in Period 2||124
11241102|NCT02094937|12433513|FG003|STARTED|12 Weeks in Period 2||124
11241103|NCT02094937|12433510|FG000|COMPLETED|12 Weeks in Period 2||0
11241104|NCT02094937|12433511|FG001|COMPLETED|12 Weeks in Period 2||112
11241105|NCT02094937|12433512|FG002|COMPLETED|12 Weeks in Period 2||112
11241106|NCT02094937|12433513|FG003|COMPLETED|12 Weeks in Period 2||112
11241107|NCT02094937|12433510|FG000|NOT COMPLETED|12 Weeks in Period 2||0
11137971|NCT01440946|12323989|FG000|STARTED|Overall Study||15
11137972|NCT01440946|12323990|FG001|STARTED|Overall Study||15
11137973|NCT01440946|12323989|FG000|COMPLETED|Overall Study||13
11137974|NCT01440946|12323990|FG001|COMPLETED|Overall Study||14
11137975|NCT01440946|12323989|FG000|NOT COMPLETED|Overall Study||2
11137976|NCT01440946|12323990|FG001|NOT COMPLETED|Overall Study||1
11137977|NCT01440959|12323997|FG000|STARTED|Overall Study||30
11137978|NCT01440959|12323997|FG000|COMPLETED|Overall Study||30
11137979|NCT01440959|12323997|FG000|NOT COMPLETED|Overall Study||0
11137980|NCT01440972|12324003|FG000|STARTED|Overall Study||24
11137981|NCT01440972|12324004|FG001|STARTED|Overall Study||21
11137982|NCT01440972|12324003|FG000|COMPLETED|Overall Study||21
11137983|NCT01440972|12324004|FG001|COMPLETED|Overall Study||19
11137984|NCT01440972|12324003|FG000|NOT COMPLETED|Overall Study||3
11137985|NCT01440972|12324004|FG001|NOT COMPLETED|Overall Study||2
11137986|NCT01441037|12324010|FG000|STARTED|Overall Study||27
11137987|NCT01441037|12324010|FG000|COMPLETED|Overall Study||27
11137988|NCT01441037|12324010|FG000|NOT COMPLETED|Overall Study||0
11137989|NCT01441063|12324014|FG000|STARTED|Tocilizumab Alone||8
11137990|NCT01441063|12324014|FG000|COMPLETED|Tocilizumab Alone||5
11137991|NCT01441063|12324014|FG000|NOT COMPLETED|Tocilizumab Alone||3
11137992|NCT01441063|12324014|FG000|STARTED|Tocilizumab + Zidovudine /Valganciclovir||3
11137993|NCT01441063|12324014|FG000|COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||2
11137994|NCT01441063|12324014|FG000|NOT COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||1
11137995|NCT01441076|12324021|FG000|STARTED|Overall Study||6
11137996|NCT01441076|12324021|FG000|COMPLETED|Overall Study||4
11137997|NCT01441076|12324021|FG000|NOT COMPLETED|Overall Study||2
11137998|NCT01441102|12324025|FG000|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
11137999|NCT01441102|12324025|FG000|COMPLETED|Overall Study||4
11138000|NCT01441102|12324025|FG000|NOT COMPLETED|Overall Study||3
11138001|NCT01441180|12324032|FG000|STARTED|Overall Study||10
11138002|NCT01441180|12324033|FG001|STARTED|Overall Study||25
11138003|NCT01441180|12324034|FG002|STARTED|Overall Study||25
11138004|NCT01441180|12324032|FG000|COMPLETED|Overall Study||9
11138005|NCT01441180|12324033|FG001|COMPLETED|Overall Study||24
11138006|NCT01441180|12324034|FG002|COMPLETED|Overall Study||22
11138007|NCT01441180|12324032|FG000|NOT COMPLETED|Overall Study||1
11138008|NCT01441180|12324033|FG001|NOT COMPLETED|Overall Study||1
11138009|NCT01441180|12324034|FG002|NOT COMPLETED|Overall Study||3
11138010|NCT01441245|12324047|FG000|STARTED|Overall Study||30
11138011|NCT01441245|12324048|FG001|STARTED|Overall Study||27
11138012|NCT01441245|12324047|FG000|COMPLETED|Overall Study||30
11138013|NCT01441245|12324048|FG001|COMPLETED|Overall Study||27
11138014|NCT01441245|12324047|FG000|NOT COMPLETED|Overall Study||0
11138015|NCT01441245|12324048|FG001|NOT COMPLETED|Overall Study||0
11138016|NCT01441401|12324070|FG000|STARTED|Overall Study||82
11138017|NCT01441401|12324070|FG000|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
11138018|NCT01441401|12324070|FG000|NOT COMPLETED|Overall Study||0
11138019|NCT01441414|12324088|FG000|STARTED|Overall Study||18
11138020|NCT01441414|12324088|FG000|COMPLETED|Overall Study||3
11138021|NCT01441414|12324088|FG000|NOT COMPLETED|Overall Study||15
11138022|NCT01441440|12324107|FG000|STARTED|Overall Study|Safety analysis set|183
11138023|NCT01441440|12324108|FG001|STARTED|Overall Study|Safety analysis set|174
11138024|NCT01441440|12324109|FG002|STARTED|Overall Study|Safety analysis set|180
11138025|NCT01441440|12324107|FG000|COMPLETED|Overall Study||166
11138026|NCT01441440|12324108|FG001|COMPLETED|Overall Study||151
11138027|NCT01441440|12324109|FG002|COMPLETED|Overall Study||158
11138028|NCT01441440|12324107|FG000|NOT COMPLETED|Overall Study||17
11138029|NCT01441440|12324108|FG001|NOT COMPLETED|Overall Study||23
11138030|NCT01441440|12324109|FG002|NOT COMPLETED|Overall Study||22
11138031|NCT01441466|12324119|FG000|STARTED|Overall Study||37
11138032|NCT01441466|12324120|FG001|STARTED|Overall Study||11
11138033|NCT01441466|12324119|FG000|COMPLETED|Overall Study||37
11138034|NCT01441466|12324120|FG001|COMPLETED|Overall Study||11
11138035|NCT01441466|12324119|FG000|NOT COMPLETED|Overall Study||0
11138036|NCT01441466|12324120|FG001|NOT COMPLETED|Overall Study||0
11138037|NCT01441492|12324129|FG000|STARTED|Overall Study||197
11138038|NCT01441492|12324130|FG001|STARTED|Overall Study||202
11138039|NCT01441492|12324129|FG000|COMPLETED|Overall Study||170
11138040|NCT01441492|12324130|FG001|COMPLETED|Overall Study||174
11138041|NCT01441492|12324129|FG000|NOT COMPLETED|Overall Study||27
11138042|NCT01441492|12324130|FG001|NOT COMPLETED|Overall Study||28
11138043|NCT01441570|12324140|FG000|STARTED|Overall Study||6
11138044|NCT01441570|12324141|FG001|STARTED|Overall Study||5
11138045|NCT01441570|12324140|FG000|COMPLETED|Overall Study||6
11138046|NCT01441570|12324141|FG001|COMPLETED|Overall Study||5
11138047|NCT01441570|12324140|FG000|NOT COMPLETED|Overall Study||0
11138048|NCT01441570|12324141|FG001|NOT COMPLETED|Overall Study||0
11138049|NCT01441596|12324150|FG000|STARTED|Overall Study||40
11138050|NCT01441596|12324151|FG001|STARTED|Overall Study||38
11138051|NCT01441596|12324152|FG002|STARTED|Overall Study||43
11138052|NCT01441596|12324150|FG000|COMPLETED|Overall Study||36
11138053|NCT01441596|12324151|FG001|COMPLETED|Overall Study||35
11138054|NCT01441596|12324152|FG002|COMPLETED|Overall Study||39
11138055|NCT01441596|12324150|FG000|NOT COMPLETED|Overall Study||4
11138056|NCT01441596|12324151|FG001|NOT COMPLETED|Overall Study||3
11138057|NCT01441596|12324152|FG002|NOT COMPLETED|Overall Study||4
11138058|NCT01441635|12324170|FG000|STARTED|Overall Study||32
11138059|NCT01441635|12324171|FG001|STARTED|Overall Study||33
11138060|NCT01441635|12324172|FG002|STARTED|Overall Study||16
11138061|NCT01441635|12324173|FG003|STARTED|Overall Study||35
11138062|NCT01441635|12324174|FG004|STARTED|Overall Study||18
11138063|NCT01441635|12324175|FG005|STARTED|Overall Study||34
11138064|NCT01441635|12324176|FG006|STARTED|Overall Study||30
11138065|NCT01441635|12324177|FG007|STARTED|Overall Study||30
11138066|NCT01441635|12324178|FG008|STARTED|Overall Study||16
11138067|NCT01441635|12324179|FG009|STARTED|Overall Study||27
11138068|NCT01441635|12324170|FG000|COMPLETED|Overall Study||26
11138069|NCT01441635|12324171|FG001|COMPLETED|Overall Study||27
11138070|NCT01441635|12324172|FG002|COMPLETED|Overall Study||13
11138071|NCT01441635|12324173|FG003|COMPLETED|Overall Study||28
11138072|NCT01441635|12324174|FG004|COMPLETED|Overall Study||16
11138073|NCT01441635|12324175|FG005|COMPLETED|Overall Study||29
11241108|NCT02094937|12433511|FG001|NOT COMPLETED|12 Weeks in Period 2||11
11241109|NCT02094937|12433512|FG002|NOT COMPLETED|12 Weeks in Period 2||12
11241110|NCT02094937|12433513|FG003|NOT COMPLETED|12 Weeks in Period 2||12
11241111|NCT02095106|12433524|FG000|STARTED|First Intervention (14 Days)||14
11241112|NCT02095106|12433525|FG001|STARTED|First Intervention (14 Days)||13
11241113|NCT02095106|12433524|FG000|COMPLETED|First Intervention (14 Days)||14
11241114|NCT02095106|12433525|FG001|COMPLETED|First Intervention (14 Days)||13
11138074|NCT01441635|12324176|FG006|COMPLETED|Overall Study||24
11138075|NCT01441635|12324177|FG007|COMPLETED|Overall Study||26
11138076|NCT01441635|12324178|FG008|COMPLETED|Overall Study||14
11138077|NCT01441635|12324179|FG009|COMPLETED|Overall Study||25
11138078|NCT01441635|12324170|FG000|NOT COMPLETED|Overall Study||6
11138079|NCT01441635|12324171|FG001|NOT COMPLETED|Overall Study||6
11138080|NCT01441635|12324172|FG002|NOT COMPLETED|Overall Study||3
11138081|NCT01441635|12324173|FG003|NOT COMPLETED|Overall Study||7
11138082|NCT01441635|12324174|FG004|NOT COMPLETED|Overall Study||2
11138083|NCT01441635|12324175|FG005|NOT COMPLETED|Overall Study||5
11138084|NCT01441635|12324176|FG006|NOT COMPLETED|Overall Study||6
11138085|NCT01441635|12324177|FG007|NOT COMPLETED|Overall Study||4
11138086|NCT01441635|12324178|FG008|NOT COMPLETED|Overall Study||2
11138087|NCT01441635|12324179|FG009|NOT COMPLETED|Overall Study||2
11138088|NCT01441765|12324203|FG000|STARTED|Overall Study||11
11138089|NCT01441765|12324204|FG001|STARTED|Overall Study|not opened|0
11138090|NCT01441765|12324203|FG000|COMPLETED|Overall Study||10
11138091|NCT01441765|12324204|FG001|COMPLETED|Overall Study|not opened|0
11138092|NCT01441765|12324203|FG000|NOT COMPLETED|Overall Study||1
11138093|NCT01441765|12324204|FG001|NOT COMPLETED|Overall Study||0
11138094|NCT01441843|12324212|FG000|STARTED|Overall Study||200
11138095|NCT01441843|12324213|FG001|STARTED|Overall Study||200
11138096|NCT01441843|12324212|FG000|COMPLETED|Overall Study||188
11138097|NCT01441843|12324213|FG001|COMPLETED|Overall Study||195
11241115|NCT02095106|12433524|FG000|NOT COMPLETED|First Intervention (14 Days)||0
11241116|NCT02095106|12433525|FG001|NOT COMPLETED|First Intervention (14 Days)||0
11241117|NCT02095106|12433524|FG000|STARTED|Second Intervention (14 Days)||14
11241118|NCT02095106|12433525|FG001|STARTED|Second Intervention (14 Days)||13
11241119|NCT02095106|12433524|FG000|COMPLETED|Second Intervention (14 Days)||14
11241120|NCT02095106|12433525|FG001|COMPLETED|Second Intervention (14 Days)||12
11241121|NCT02095106|12433524|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
11241122|NCT02095106|12433525|FG001|NOT COMPLETED|Second Intervention (14 Days)||1
11241123|NCT02095145|12433537|FG000|STARTED|Overall Study||15
11241124|NCT02095145|12433538|FG001|STARTED|Overall Study||15
11241125|NCT02095145|12433537|FG000|COMPLETED|Overall Study||14
11241126|NCT02095145|12433538|FG001|COMPLETED|Overall Study||15
11241127|NCT02095145|12433537|FG000|NOT COMPLETED|Overall Study||1
11241128|NCT02095145|12433538|FG001|NOT COMPLETED|Overall Study||0
11241129|NCT02095158|12433546|FG000|STARTED|Overall Study||440
11241130|NCT02095158|12433546|FG000|COMPLETED|Overall Study||365
11241131|NCT02095158|12433546|FG000|NOT COMPLETED|Overall Study||75
11241132|NCT02095197|12433552|FG000|STARTED|Overall Study||40
11241133|NCT02095197|12433553|FG001|STARTED|Overall Study||39
11241134|NCT02095197|12433552|FG000|COMPLETED|Overall Study||40
11241135|NCT02095197|12433553|FG001|COMPLETED|Overall Study||36
11241136|NCT02095197|12433552|FG000|NOT COMPLETED|Overall Study||0
11241137|NCT02095197|12433553|FG001|NOT COMPLETED|Overall Study||3
11241138|NCT02095223|12433561|FG000|STARTED|Overall Study||2
11241139|NCT02095223|12433562|FG001|STARTED|Overall Study||2
11241140|NCT02095223|12433561|FG000|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
11241141|NCT02095223|12433562|FG001|COMPLETED|Overall Study||2
11241142|NCT02095223|12433561|FG000|NOT COMPLETED|Overall Study||1
11241143|NCT02095223|12433562|FG001|NOT COMPLETED|Overall Study||0
11241144|NCT02095340|12433571|FG000|STARTED|Overall Study|Mother (not the child) received the training.|51
11241145|NCT02095340|12433572|FG001|STARTED|Overall Study|Mother (not the child) received the training.|54
11241146|NCT02095340|12433573|FG002|STARTED|Overall Study||105
11241147|NCT02095340|12433571|FG000|COMPLETED|Overall Study||51
11241148|NCT02095340|12433572|FG001|COMPLETED|Overall Study||54
11241149|NCT02095340|12433573|FG002|COMPLETED|Overall Study||105
11241150|NCT02095340|12433571|FG000|NOT COMPLETED|Overall Study||0
11241151|NCT02095340|12433572|FG001|NOT COMPLETED|Overall Study||0
11241152|NCT02095340|12433573|FG002|NOT COMPLETED|Overall Study||0
11241153|NCT02095535|12433582|FG000|STARTED|Recruitment||20
11138098|NCT01441843|12324212|FG000|NOT COMPLETED|Overall Study||12
11138099|NCT01441843|12324213|FG001|NOT COMPLETED|Overall Study||5
11138100|NCT01441882|12324219|FG000|STARTED|Overall Study||19
11138101|NCT01441882|12324219|FG000|COMPLETED|Overall Study||13
11138102|NCT01441882|12324219|FG000|NOT COMPLETED|Overall Study||6
11138103|NCT01441960|12324223|FG000|STARTED|First Neuromuscular Blocking Agent:||26
11241154|NCT02095535|12433582|FG000|COMPLETED|Recruitment||18
11241155|NCT02095535|12433582|FG000|NOT COMPLETED|Recruitment||2
11241156|NCT02095535|12433582|FG000|STARTED|Analysis||18
11241157|NCT02095535|12433582|FG000|COMPLETED|Analysis||18
11138104|NCT01441960|12324224|FG001|STARTED|First Neuromuscular Blocking Agent:||19
11138105|NCT01441960|12324223|FG000|COMPLETED|First Neuromuscular Blocking Agent:||18
11138106|NCT01441960|12324224|FG001|COMPLETED|First Neuromuscular Blocking Agent:||13
11138107|NCT01441960|12324223|FG000|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
11138108|NCT01441960|12324224|FG001|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
11138109|NCT01441960|12324223|FG000|STARTED|Second Neuromuscular Blocking Agent||18
11138110|NCT01441960|12324224|FG001|STARTED|Second Neuromuscular Blocking Agent||13
11138111|NCT01441960|12324223|FG000|COMPLETED|Second Neuromuscular Blocking Agent||18
11138112|NCT01441960|12324224|FG001|COMPLETED|Second Neuromuscular Blocking Agent||13
11138113|NCT01441960|12324223|FG000|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
11138114|NCT01441960|12324224|FG001|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
11138115|NCT01441973|12324236|FG000|STARTED|Overall Study||15
11138116|NCT01441973|12324237|FG001|STARTED|Overall Study||16
11138117|NCT01441973|12324236|FG000|COMPLETED|Overall Study|Still receiving treatment|0
11138118|NCT01441973|12324237|FG001|COMPLETED|Overall Study|Still receiving treatment|0
11138119|NCT01441973|12324236|FG000|NOT COMPLETED|Overall Study||15
11138120|NCT01441973|12324237|FG001|NOT COMPLETED|Overall Study||16
11138121|NCT01442038|12324246|FG000|STARTED|Overall Study||1332
11138122|NCT01442038|12324247|FG001|STARTED|Overall Study||1319
11138123|NCT01442038|12324246|FG000|COMPLETED|Overall Study||1029
11138124|NCT01442038|12324247|FG001|COMPLETED|Overall Study||1040
11138125|NCT01442038|12324246|FG000|NOT COMPLETED|Overall Study||303
11138126|NCT01442038|12324247|FG001|NOT COMPLETED|Overall Study||279
11138127|NCT01442064|12324259|FG000|STARTED|Overall Study||97
11138128|NCT01442064|12324260|FG001|STARTED|Overall Study||103
11138129|NCT01442064|12324261|FG002|STARTED|Overall Study||104
11138130|NCT01442064|12324262|FG003|STARTED|Overall Study||98
11138131|NCT01442064|12324263|FG004|STARTED|Overall Study||107
11138132|NCT01442064|12324264|FG005|STARTED|Overall Study||99
11138133|NCT01442064|12324259|FG000|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
11138134|NCT01442064|12324260|FG001|Ranibizumab-Treated Subjects|Overall Study||103
11138135|NCT01442064|12324261|FG002|Ranibizumab-Treated Subjects|Overall Study||104
11138136|NCT01442064|12324262|FG003|Ranibizumab-Treated Subjects|Overall Study||96
11138137|NCT01442064|12324263|FG004|Ranibizumab-Treated Subjects|Overall Study||107
11138138|NCT01442064|12324264|FG005|Ranibizumab-Treated Subjects|Overall Study||99
11138139|NCT01442064|12324259|FG000|Received Study Drug in Extension Study|Overall Study||61
11138140|NCT01442064|12324260|FG001|Received Study Drug in Extension Study|Overall Study||70
11138141|NCT01442064|12324261|FG002|Received Study Drug in Extension Study|Overall Study||60
11138142|NCT01442064|12324262|FG003|Received Study Drug in Extension Study|Overall Study||70
11138143|NCT01442064|12324263|FG004|Received Study Drug in Extension Study|Overall Study||89
11138144|NCT01442064|12324264|FG005|Received Study Drug in Extension Study|Overall Study||81
11138145|NCT01442064|12324259|FG000|COMPLETED|Overall Study||0
11138146|NCT01442064|12324260|FG001|COMPLETED|Overall Study||2
11138147|NCT01442064|12324261|FG002|COMPLETED|Overall Study||0
11138148|NCT01442064|12324262|FG003|COMPLETED|Overall Study||0
11138149|NCT01442064|12324263|FG004|COMPLETED|Overall Study||1
11138150|NCT01442064|12324264|FG005|COMPLETED|Overall Study||0
11138151|NCT01442064|12324259|FG000|NOT COMPLETED|Overall Study||97
11138152|NCT01442064|12324260|FG001|NOT COMPLETED|Overall Study||101
11138153|NCT01442064|12324261|FG002|NOT COMPLETED|Overall Study||104
11138154|NCT01442064|12324262|FG003|NOT COMPLETED|Overall Study||98
11138155|NCT01442064|12324263|FG004|NOT COMPLETED|Overall Study||106
11138156|NCT01442064|12324264|FG005|NOT COMPLETED|Overall Study||99
11138157|NCT01442103|12324281|FG000|STARTED|Overall Study||10
11138158|NCT01442103|12324281|FG000|COMPLETED|Overall Study||8
11241158|NCT02095535|12433582|FG000|NOT COMPLETED|Analysis||0
11241159|NCT02095561|12433588|FG000|STARTED|Overall Study||3049
11241160|NCT02095561|12433589|FG001|STARTED|Overall Study||2964
11241161|NCT02095561|12433588|FG000|Self-testing Acceptability|Overall Study||2616
11138159|NCT01442103|12324281|FG000|NOT COMPLETED|Overall Study||2
11138160|NCT01442129|12324287|FG000|STARTED|Overall Study||20
11138161|NCT01442129|12324288|FG001|STARTED|Overall Study||10
11138162|NCT01442129|12324287|FG000|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
11138163|NCT01442129|12324288|FG001|COMPLETED|Overall Study||10
11138164|NCT01442129|12324287|FG000|NOT COMPLETED|Overall Study||0
11138165|NCT01442129|12324288|FG001|NOT COMPLETED|Overall Study||0
11138166|NCT01442155|12324294|FG000|STARTED|Overall Study||74
11241162|NCT02095561|12433589|FG001|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
11241163|NCT02095561|12433588|FG000|HPV Self-tested Women|Overall Study||2519
11241164|NCT02095561|12433589|FG001|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
11138167|NCT01442155|12324294|FG000|COMPLETED|Overall Study||9
11138168|NCT01442155|12324294|FG000|NOT COMPLETED|Overall Study||65
11138169|NCT01442181|12324300|FG000|STARTED|Overall Study||14
11138170|NCT01442181|12324301|FG001|STARTED|Overall Study||11
11138171|NCT01442181|12324300|FG000|COMPLETED|Overall Study||10
11138172|NCT01442181|12324301|FG001|COMPLETED|Overall Study||8
11138173|NCT01442181|12324300|FG000|NOT COMPLETED|Overall Study||4
11138174|NCT01442181|12324301|FG001|NOT COMPLETED|Overall Study||3
11138175|NCT01442376|12324311|FG000|STARTED|Overall Study|Randomized patients|169
11138176|NCT01442376|12324312|FG001|STARTED|Overall Study|Randomized patients|169
11138177|NCT01442376|12324313|FG002|STARTED|Overall Study|Randomized patients|164
11138178|NCT01442376|12324311|FG000|COMPLETED|Overall Study||166
11138179|NCT01442376|12324312|FG001|COMPLETED|Overall Study||160
11138180|NCT01442376|12324313|FG002|COMPLETED|Overall Study||159
11138181|NCT01442376|12324311|FG000|NOT COMPLETED|Overall Study||3
11138182|NCT01442376|12324312|FG001|NOT COMPLETED|Overall Study||9
11138183|NCT01442376|12324313|FG002|NOT COMPLETED|Overall Study||5
11138184|NCT01442493|12324323|FG000|STARTED|Overall Study||149
11138185|NCT01442493|12324324|FG001|STARTED|Overall Study||151
11138186|NCT01442493|12324323|FG000|COMPLETED|Overall Study||146
11138187|NCT01442493|12324324|FG001|COMPLETED|Overall Study||149
11138188|NCT01442493|12324323|FG000|NOT COMPLETED|Overall Study||3
11138189|NCT01442493|12324324|FG001|NOT COMPLETED|Overall Study||2
11138190|NCT01442675|12324330|FG000|STARTED|Overall Study||834
11138191|NCT01442675|12324330|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
11138192|NCT01442675|12324330|FG000|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
11138193|NCT01442675|12324330|FG000|COMPLETED|Overall Study||822
11138194|NCT01442675|12324330|FG000|NOT COMPLETED|Overall Study||12
11138195|NCT01442688|12324337|FG000|STARTED|First Intervention||31
11138196|NCT01442688|12324338|FG001|STARTED|First Intervention||31
11138197|NCT01442688|12324337|FG000|COMPLETED|First Intervention||29
11138198|NCT01442688|12324338|FG001|COMPLETED|First Intervention||31
11138199|NCT01442688|12324337|FG000|NOT COMPLETED|First Intervention||2
11138200|NCT01442688|12324338|FG001|NOT COMPLETED|First Intervention||0
11138201|NCT01442688|12324337|FG000|STARTED|Second Intervention||29
11138202|NCT01442688|12324338|FG001|STARTED|Second Intervention||31
11138203|NCT01442688|12324337|FG000|COMPLETED|Second Intervention||28
11138204|NCT01442688|12324338|FG001|COMPLETED|Second Intervention||31
11138205|NCT01442688|12324337|FG000|NOT COMPLETED|Second Intervention||1
11138206|NCT01442688|12324338|FG001|NOT COMPLETED|Second Intervention||0
11138207|NCT01442714|12324344|FG000|STARTED|Overall Study||33
11138208|NCT01442714|12324344|FG000|COMPLETED|Overall Study||21
11138209|NCT01442714|12324344|FG000|NOT COMPLETED|Overall Study||12
11138210|NCT01442779|12324350|FG000|STARTED|Overall Study||18
11138211|NCT01442779|12324350|FG000|COMPLETED|Overall Study||11
11138212|NCT01442779|12324350|FG000|NOT COMPLETED|Overall Study||7
11138213|NCT01442844|12324356|FG000|STARTED|Overall Study||1
11138214|NCT01442844|12324357|FG001|STARTED|Overall Study||2
11138215|NCT01442844|12324356|FG000|COMPLETED|Overall Study||1
11138216|NCT01442844|12324357|FG001|COMPLETED|Overall Study||2
11138217|NCT01442844|12324356|FG000|NOT COMPLETED|Overall Study||0
11138218|NCT01442844|12324357|FG001|NOT COMPLETED|Overall Study||0
11138219|NCT01443026|12324365|FG000|STARTED|Overall Study||29
11138220|NCT01443026|12324366|FG001|STARTED|Overall Study||37
11138221|NCT01443026|12324365|FG000|COMPLETED|Overall Study||26
11138222|NCT01443026|12324366|FG001|COMPLETED|Overall Study||32
11138223|NCT01443026|12324365|FG000|NOT COMPLETED|Overall Study||3
11138224|NCT01443026|12324366|FG001|NOT COMPLETED|Overall Study||5
11138225|NCT01443078|12324372|FG000|STARTED|Overall Study||42
11138226|NCT01443078|12324372|FG000|COMPLETED|Overall Study||13
11138227|NCT01443078|12324372|FG000|NOT COMPLETED|Overall Study||29
11138228|NCT01443130|12324382|FG000|STARTED|Overall Study||300
11138229|NCT01443130|12324383|FG001|STARTED|Overall Study||300
11138230|NCT01443130|12324384|FG002|STARTED|Overall Study||300
11138231|NCT01443130|12324385|FG003|STARTED|Overall Study||270
11138232|NCT01443130|12324386|FG004|STARTED|Overall Study||274
11138233|NCT01443130|12324387|FG005|STARTED|Overall Study||259
11138234|NCT01443130|12324382|FG000|COMPLETED|Overall Study||232
11138235|NCT01443130|12324383|FG001|COMPLETED|Overall Study||231
11138236|NCT01443130|12324384|FG002|COMPLETED|Overall Study||223
11138237|NCT01443130|12324385|FG003|COMPLETED|Overall Study||231
11138238|NCT01443130|12324386|FG004|COMPLETED|Overall Study||230
11138239|NCT01443130|12324387|FG005|COMPLETED|Overall Study||225
11138240|NCT01443130|12324382|FG000|NOT COMPLETED|Overall Study||68
11138241|NCT01443130|12324383|FG001|NOT COMPLETED|Overall Study||69
11138242|NCT01443130|12324384|FG002|NOT COMPLETED|Overall Study||77
11138243|NCT01443130|12324385|FG003|NOT COMPLETED|Overall Study||39
11138244|NCT01443130|12324386|FG004|NOT COMPLETED|Overall Study||44
11138245|NCT01443130|12324387|FG005|NOT COMPLETED|Overall Study||34
11138246|NCT01443364|12324401|FG000|STARTED|Overall Study||132
11138247|NCT01443364|12324401|FG000|COMPLETED|Overall Study||91
11138248|NCT01443364|12324401|FG000|NOT COMPLETED|Overall Study||41
11138249|NCT01443403|12324409|FG000|STARTED|Overall Study||61
11138250|NCT01443403|12324410|FG001|STARTED|Overall Study||61
11138251|NCT01443403|12324411|FG002|STARTED|Overall Study||61
11138252|NCT01443403|12324412|FG003|STARTED|Overall Study||61
11138253|NCT01443403|12324409|FG000|Received Treatment|Overall Study||61
11138254|NCT01443403|12324410|FG001|Received Treatment|Overall Study||61
11138255|NCT01443403|12324411|FG002|Received Treatment|Overall Study||60
11138256|NCT01443403|12324412|FG003|Received Treatment|Overall Study||61
11138257|NCT01443403|12324409|FG000|COMPLETED|Overall Study||55
11138258|NCT01443403|12324410|FG001|COMPLETED|Overall Study||55
11138259|NCT01443403|12324411|FG002|COMPLETED|Overall Study||54
11138260|NCT01443403|12324412|FG003|COMPLETED|Overall Study||52
11138261|NCT01443403|12324409|FG000|NOT COMPLETED|Overall Study||6
11138262|NCT01443403|12324410|FG001|NOT COMPLETED|Overall Study||6
11138263|NCT01443403|12324411|FG002|NOT COMPLETED|Overall Study||7
11138264|NCT01443403|12324412|FG003|NOT COMPLETED|Overall Study||9
11138265|NCT01443442|12324427|FG000|STARTED|Overall Study||12
11138266|NCT01443442|12324428|FG001|STARTED|Overall Study||11
11138267|NCT01443442|12324427|FG000|COMPLETED|Overall Study||12
11138268|NCT01443442|12324428|FG001|COMPLETED|Overall Study||11
11138269|NCT01443442|12324427|FG000|NOT COMPLETED|Overall Study||0
11138270|NCT01443442|12324428|FG001|NOT COMPLETED|Overall Study||0
11138271|NCT01443494|12324434|FG000|STARTED|Overall Study||19
11138272|NCT01443494|12324434|FG000|COMPLETED|Overall Study||19
11138273|NCT01443494|12324434|FG000|NOT COMPLETED|Overall Study||0
11138274|NCT01443546|12324441|FG000|STARTED|Overall Study||9
11138275|NCT01443546|12324442|FG001|STARTED|Overall Study||9
11138276|NCT01443546|12324443|FG002|STARTED|Overall Study||8
11138277|NCT01443546|12324441|FG000|COMPLETED|Overall Study||9
11138278|NCT01443546|12324442|FG001|COMPLETED|Overall Study||9
11138279|NCT01443546|12324443|FG002|COMPLETED|Overall Study||8
11138280|NCT01443546|12324441|FG000|NOT COMPLETED|Overall Study||0
11138281|NCT01443546|12324442|FG001|NOT COMPLETED|Overall Study||0
11138282|NCT01443546|12324443|FG002|NOT COMPLETED|Overall Study||0
11138283|NCT01443845|12324455|FG000|STARTED|Overall Study||1176
11138284|NCT01443845|12324456|FG001|STARTED|Overall Study||1178
11138285|NCT01443845|12324455|FG000|COMPLETED|Overall Study||922
11138286|NCT01443845|12324456|FG001|COMPLETED|Overall Study||841
11138287|NCT01443845|12324455|FG000|NOT COMPLETED|Overall Study||254
11138288|NCT01443845|12324456|FG001|NOT COMPLETED|Overall Study||337
11138289|NCT01443858|12324465|FG000|STARTED|Overall Study||25
11138290|NCT01443858|12324466|FG001|STARTED|Overall Study||25
11138291|NCT01443858|12324467|FG002|STARTED|Overall Study||25
11138292|NCT01443858|12324465|FG000|COMPLETED|Overall Study||10
11138293|NCT01443858|12324466|FG001|COMPLETED|Overall Study||12
11138294|NCT01443858|12324467|FG002|COMPLETED|Overall Study||18
11138295|NCT01443858|12324465|FG000|NOT COMPLETED|Overall Study||15
11138296|NCT01443858|12324466|FG001|NOT COMPLETED|Overall Study||13
11138297|NCT01443858|12324467|FG002|NOT COMPLETED|Overall Study||7
11138298|NCT01444027|12324478|FG000|STARTED|Overall Study||172
11138299|NCT01444027|12324479|FG001|STARTED|Overall Study||171
11138300|NCT01444027|12324480|FG002|STARTED|Overall Study||171
11138301|NCT01444027|12324478|FG000|Received Intervention as Assigned|Overall Study||168
11138302|NCT01444027|12324479|FG001|Received Intervention as Assigned|Overall Study||161
11138303|NCT01444027|12324480|FG002|Received Intervention as Assigned|Overall Study||147
11138304|NCT01444027|12324478|FG000|1 Month Follow-up|Overall Study||160
11138305|NCT01444027|12324479|FG001|1 Month Follow-up|Overall Study||159
11138306|NCT01444027|12324480|FG002|1 Month Follow-up|Overall Study||141
11138307|NCT01444027|12324478|FG000|3 Month Follow-up|Overall Study||142
11138308|NCT01444027|12324479|FG001|3 Month Follow-up|Overall Study||141
11138309|NCT01444027|12324480|FG002|3 Month Follow-up|Overall Study||133
11138310|NCT01444027|12324478|FG000|COMPLETED|Overall Study||142
11138311|NCT01444027|12324479|FG001|COMPLETED|Overall Study||141
11138312|NCT01444027|12324480|FG002|COMPLETED|Overall Study||133
11138313|NCT01444027|12324478|FG000|NOT COMPLETED|Overall Study||30
11138314|NCT01444027|12324479|FG001|NOT COMPLETED|Overall Study||30
11138315|NCT01444027|12324480|FG002|NOT COMPLETED|Overall Study||38
11138316|NCT01444287|12324488|FG000|STARTED|Period 1||22
11138317|NCT01444287|12324488|FG000|COMPLETED|Period 1||22
11138318|NCT01444287|12324488|FG000|NOT COMPLETED|Period 1||0
11138319|NCT01444287|12324488|FG000|STARTED|Period 2||22
11138320|NCT01444287|12324488|FG000|COMPLETED|Period 2||22
11138321|NCT01444287|12324488|FG000|NOT COMPLETED|Period 2||0
11138322|NCT01444287|12324488|FG000|STARTED|Period 3||22
11138323|NCT01444287|12324488|FG000|COMPLETED|Period 3||22
11138324|NCT01444287|12324488|FG000|NOT COMPLETED|Period 3||0
11138325|NCT01444287|12324488|FG000|STARTED|Period 4||22
11138326|NCT01444287|12324488|FG000|COMPLETED|Period 4||22
11138327|NCT01444287|12324488|FG000|NOT COMPLETED|Period 4||0
11138328|NCT01444300|12324504|FG000|STARTED|Overall Study||12
11138329|NCT01444300|12324505|FG001|STARTED|Overall Study||12
11138330|NCT01444300|12324504|FG000|COMPLETED|Overall Study||8
11138331|NCT01444300|12324505|FG001|COMPLETED|Overall Study||12
11138332|NCT01444300|12324504|FG000|NOT COMPLETED|Overall Study||4
11138333|NCT01444300|12324505|FG001|NOT COMPLETED|Overall Study||0
11138334|NCT01444378|12324512|FG000|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
11138335|NCT01444378|12324512|FG000|COMPLETED|Overall Study||124
11138336|NCT01444378|12324512|FG000|NOT COMPLETED|Overall Study||17
11138337|NCT01444391|12324519|FG000|STARTED|Overall Study||42
11138338|NCT01444391|12324519|FG000|COMPLETED|Overall Study||41
11138339|NCT01444391|12324519|FG000|NOT COMPLETED|Overall Study||1
11138340|NCT01444417|12324525|FG000|STARTED|Overall Study||20
11138341|NCT01444417|12324526|FG001|STARTED|Overall Study||42
11138342|NCT01444417|12324525|FG000|Received Treatment|Overall Study||19
11138343|NCT01444417|12324526|FG001|Received Treatment|Overall Study||42
11138344|NCT01444417|12324525|FG000|COMPLETED|Overall Study||18
11138345|NCT01444417|12324526|FG001|COMPLETED|Overall Study||41
11138346|NCT01444417|12324525|FG000|NOT COMPLETED|Overall Study||2
11138347|NCT01444417|12324526|FG001|NOT COMPLETED|Overall Study||1
11138348|NCT01444430|12324534|FG000|STARTED|Overall Study||5846
11138349|NCT01444430|12324535|FG001|STARTED|Overall Study||5847
11138350|NCT01444430|12324534|FG000|COMPLETED|Overall Study||5785
11138351|NCT01444430|12324535|FG001|COMPLETED|Overall Study||5766
11138352|NCT01444430|12324534|FG000|NOT COMPLETED|Overall Study||61
11138353|NCT01444430|12324535|FG001|NOT COMPLETED|Overall Study||81
11138354|NCT01444456|12324541|FG000|STARTED|Overall Study||1262
11138355|NCT01444456|12324541|FG000|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
11138356|NCT01444456|12324541|FG000|Received Darbepoetin Alfa|Overall Study||1134
11138357|NCT01444456|12324541|FG000|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
11138358|NCT01444456|12324541|FG000|NOT COMPLETED|Overall Study||285
11138359|NCT01444651|12324547|FG000|STARTED|Overall Study||36
11138360|NCT01444651|12324548|FG001|STARTED|Overall Study||37
11138361|NCT01444651|12324547|FG000|COMPLETED|Overall Study||25
11138362|NCT01444651|12324548|FG001|COMPLETED|Overall Study||28
11138363|NCT01444651|12324547|FG000|NOT COMPLETED|Overall Study||11
11138364|NCT01444651|12324548|FG001|NOT COMPLETED|Overall Study||9
11138365|NCT01444716|12324554|FG000|STARTED|Overall Study||34
11138366|NCT01444716|12324554|FG000|COMPLETED|Overall Study||34
11138367|NCT01444716|12324554|FG000|NOT COMPLETED|Overall Study||0
11138368|NCT01444742|12324558|FG000|STARTED|Overall Study||81
11138369|NCT01444742|12324558|FG000|COMPLETED|Overall Study||80
11138370|NCT01444742|12324558|FG000|NOT COMPLETED|Overall Study||1
11138371|NCT01444781|12324565|FG000|STARTED|Overall Study||416
11138372|NCT01444781|12324566|FG001|STARTED|Overall Study||415
11138373|NCT01444781|12324567|FG002|STARTED|Overall Study||275
11138374|NCT01444781|12324565|FG000|COMPLETED|Overall Study||413
11138375|NCT01444781|12324566|FG001|COMPLETED|Overall Study||411
11138376|NCT01444781|12324567|FG002|COMPLETED|Overall Study||272
11138377|NCT01444781|12324565|FG000|NOT COMPLETED|Overall Study||3
11138378|NCT01444781|12324566|FG001|NOT COMPLETED|Overall Study||4
11138379|NCT01444781|12324567|FG002|NOT COMPLETED|Overall Study||3
11138380|NCT01444898|12324582|FG000|STARTED|Overall Study||10
11138381|NCT01444898|12324582|FG000|COMPLETED|Overall Study||9
11138382|NCT01444898|12324582|FG000|NOT COMPLETED|Overall Study||1
11138383|NCT01444911|12324588|FG000|STARTED|Overall Study||16
11138384|NCT01444911|12324589|FG001|STARTED|Overall Study||13
11138385|NCT01444911|12324588|FG000|COMPLETED|Overall Study||8
11138386|NCT01444911|12324589|FG001|COMPLETED|Overall Study||13
11138387|NCT01444911|12324588|FG000|NOT COMPLETED|Overall Study||8
11138388|NCT01444911|12324589|FG001|NOT COMPLETED|Overall Study||0
11138389|NCT01444924|12324597|FG000|STARTED|Overall Study||31
11138390|NCT01444924|12324598|FG001|STARTED|Overall Study||33
11138391|NCT01444924|12324597|FG000|COMPLETED|Overall Study||31
11138392|NCT01444924|12324598|FG001|COMPLETED|Overall Study||33
11138393|NCT01444924|12324597|FG000|NOT COMPLETED|Overall Study||0
11138394|NCT01444924|12324598|FG001|NOT COMPLETED|Overall Study||0
11138395|NCT01445028|12324606|FG000|STARTED|Overall Study||58
11138396|NCT01445028|12324607|FG001|STARTED|Overall Study||54
11138397|NCT01445028|12324606|FG000|COMPLETED|Overall Study||58
11138398|NCT01445028|12324607|FG001|COMPLETED|Overall Study||51
11138399|NCT01445028|12324606|FG000|NOT COMPLETED|Overall Study||0
11138400|NCT01445028|12324607|FG001|NOT COMPLETED|Overall Study||3
11138401|NCT01445080|12324622|FG000|STARTED|Overall Study||7
11138402|NCT01445080|12324623|FG001|STARTED|Overall Study||5
11138403|NCT01445080|12324624|FG002|STARTED|Overall Study||12
11138404|NCT01445080|12324625|FG003|STARTED|Overall Study||8
11138405|NCT01445080|12324626|FG004|STARTED|Overall Study||4
11138406|NCT01445080|12324627|FG005|STARTED|Overall Study||9
11138407|NCT01445080|12324628|FG006|STARTED|Overall Study||2
11138408|NCT01445080|12324629|FG007|STARTED|Overall Study||5
11138409|NCT01445080|12324630|FG008|STARTED|Overall Study||18
11138410|NCT01445080|12324622|FG000|COMPLETED|Overall Study||0
11138411|NCT01445080|12324623|FG001|COMPLETED|Overall Study||0
11138412|NCT01445080|12324624|FG002|COMPLETED|Overall Study||0
11138413|NCT01445080|12324625|FG003|COMPLETED|Overall Study||0
11138414|NCT01445080|12324626|FG004|COMPLETED|Overall Study||0
11138415|NCT01445080|12324627|FG005|COMPLETED|Overall Study||0
11138416|NCT01445080|12324628|FG006|COMPLETED|Overall Study||0
11138417|NCT01445080|12324629|FG007|COMPLETED|Overall Study||0
11138418|NCT01445080|12324630|FG008|COMPLETED|Overall Study||0
11138419|NCT01445080|12324622|FG000|NOT COMPLETED|Overall Study||7
11138420|NCT01445080|12324623|FG001|NOT COMPLETED|Overall Study||5
11138421|NCT01445080|12324624|FG002|NOT COMPLETED|Overall Study||12
11138422|NCT01445080|12324625|FG003|NOT COMPLETED|Overall Study||8
11138423|NCT01445080|12324626|FG004|NOT COMPLETED|Overall Study||4
11138424|NCT01445080|12324627|FG005|NOT COMPLETED|Overall Study||9
11138425|NCT01445080|12324628|FG006|NOT COMPLETED|Overall Study||2
11138426|NCT01445080|12324629|FG007|NOT COMPLETED|Overall Study||5
11138427|NCT01445080|12324630|FG008|NOT COMPLETED|Overall Study||18
11138428|NCT01445171|12324665|FG000|STARTED|Overall Study||295
11138429|NCT01445171|12324665|FG000|Implanted With Study Device|Overall Study||287
11138430|NCT01445171|12324665|FG000|COMPLETED|Overall Study||200
11138431|NCT01445171|12324665|FG000|NOT COMPLETED|Overall Study||95
11138432|NCT01445301|12324674|FG000|STARTED|Overall Study||204
11138433|NCT01445301|12324675|FG001|STARTED|Overall Study||297
11138434|NCT01445301|12324676|FG002|STARTED|Overall Study||299
11138435|NCT01445301|12324674|FG000|COMPLETED|Overall Study||183
11138436|NCT01445301|12324675|FG001|COMPLETED|Overall Study||262
11138437|NCT01445301|12324676|FG002|COMPLETED|Overall Study||290
11138438|NCT01445301|12324674|FG000|NOT COMPLETED|Overall Study||21
11138439|NCT01445301|12324675|FG001|NOT COMPLETED|Overall Study||35
11138440|NCT01445301|12324676|FG002|NOT COMPLETED|Overall Study||9
11138441|NCT01445535|12324688|FG000|STARTED|Overall Study||3
11138442|NCT01445535|12324689|FG001|STARTED|Overall Study||3
11138443|NCT01445535|12324690|FG002|STARTED|Overall Study||3
11138444|NCT01445535|12324691|FG003|STARTED|Overall Study||6
11138445|NCT01445535|12324688|FG000|COMPLETED|Overall Study||2
11138446|NCT01445535|12324689|FG001|COMPLETED|Overall Study||3
11138447|NCT01445535|12324690|FG002|COMPLETED|Overall Study||2
11138448|NCT01445535|12324691|FG003|COMPLETED|Overall Study||4
11138449|NCT01445535|12324688|FG000|NOT COMPLETED|Overall Study||1
11138450|NCT01445535|12324689|FG001|NOT COMPLETED|Overall Study||0
11138451|NCT01445535|12324690|FG002|NOT COMPLETED|Overall Study||1
11138452|NCT01445535|12324691|FG003|NOT COMPLETED|Overall Study||2
11138453|NCT01445548|12324702|FG000|STARTED|Overall Study||6
11138454|NCT01445548|12324702|FG000|COMPLETED|Overall Study||5
11138455|NCT01445548|12324702|FG000|NOT COMPLETED|Overall Study||1
11138456|NCT01445613|12324706|FG000|STARTED|30-day Follow-up||1200
11138457|NCT01445613|12324706|FG000|COMPLETED|30-day Follow-up||1165
11138458|NCT01445613|12324706|FG000|NOT COMPLETED|30-day Follow-up||35
11138459|NCT01445613|12324706|FG000|STARTED|1-year Follow-up||1165
11138460|NCT01445613|12324706|FG000|COMPLETED|1-year Follow-up||1088
11138461|NCT01445613|12324706|FG000|NOT COMPLETED|1-year Follow-up||77
11138462|NCT01445626|12324716|FG000|STARTED|Overall Study||87
11138463|NCT01445626|12324716|FG000|COMPLETED|Overall Study||87
11138464|NCT01445626|12324716|FG000|NOT COMPLETED|Overall Study||0
11138465|NCT01445652|12324722|FG000|STARTED|Overall Study||57
11138466|NCT01445652|12324723|FG001|STARTED|Overall Study||53
11138467|NCT01445652|12324722|FG000|COMPLETED|Overall Study||47
11138468|NCT01445652|12324723|FG001|COMPLETED|Overall Study||50
11138469|NCT01445652|12324722|FG000|NOT COMPLETED|Overall Study||10
11138470|NCT01445652|12324723|FG001|NOT COMPLETED|Overall Study||3
11138471|NCT01445678|12324731|FG000|STARTED|Overall Study||482
11138472|NCT01445678|12324732|FG001|STARTED|Overall Study||497
11138473|NCT01445678|12324731|FG000|COMPLETED|Overall Study||452
11138474|NCT01445678|12324732|FG001|COMPLETED|Overall Study||476
11138475|NCT01445678|12324731|FG000|NOT COMPLETED|Overall Study||30
11138476|NCT01445678|12324732|FG001|NOT COMPLETED|Overall Study||21
11138477|NCT01445730|12324738|FG000|STARTED|Overall Study||82
11138478|NCT01445730|12324738|FG000|COMPLETED|Overall Study||71
11138479|NCT01445730|12324738|FG000|NOT COMPLETED|Overall Study||11
11138480|NCT01445769|12324742|FG000|STARTED|Overall Study||45
11138481|NCT01445769|12324742|FG000|COMPLETED|Overall Study||37
11138482|NCT01445769|12324742|FG000|NOT COMPLETED|Overall Study||8
11138483|NCT01445821|12324750|FG000|STARTED|Overall Study||22
11138484|NCT01445821|12324751|FG001|STARTED|Overall Study||22
11138485|NCT01445821|12324750|FG000|COMPLETED|Overall Study||22
11138486|NCT01445821|12324751|FG001|COMPLETED|Overall Study||22
11138487|NCT01445821|12324750|FG000|NOT COMPLETED|Overall Study||0
11138488|NCT01445821|12324751|FG001|NOT COMPLETED|Overall Study||0
11138489|NCT01445847|12324759|FG000|STARTED|Overall Study||50
11138490|NCT01445847|12324760|FG001|STARTED|Overall Study||50
11138491|NCT01445847|12324759|FG000|COMPLETED|Overall Study||36
11138492|NCT01445847|12324760|FG001|COMPLETED|Overall Study||36
11138493|NCT01445847|12324759|FG000|NOT COMPLETED|Overall Study||14
11138494|NCT01445847|12324760|FG001|NOT COMPLETED|Overall Study||14
11138495|NCT01445873|12324766|FG000|STARTED|Overall Study||36
11138496|NCT01445873|12324766|FG000|COMPLETED|Overall Study||36
11138497|NCT01445873|12324766|FG000|NOT COMPLETED|Overall Study||0
11138498|NCT01445886|12324770|FG000|STARTED|Overall Study||33
11138499|NCT01445886|12324770|FG000|COMPLETED|Overall Study||28
11138500|NCT01445886|12324770|FG000|NOT COMPLETED|Overall Study||5
11138501|NCT01445951|12324779|FG000|STARTED|Overall Study||174
11138502|NCT01445951|12324780|FG001|STARTED|Overall Study||174
11138503|NCT01445951|12324781|FG002|STARTED|Overall Study||170
11138504|NCT01445951|12324779|FG000|COMPLETED|Overall Study||130
11138505|NCT01445951|12324780|FG001|COMPLETED|Overall Study||138
11138506|NCT01445951|12324781|FG002|COMPLETED|Overall Study||151
11138507|NCT01445951|12324779|FG000|NOT COMPLETED|Overall Study||44
11138508|NCT01445951|12324780|FG001|NOT COMPLETED|Overall Study||36
11138509|NCT01445951|12324781|FG002|NOT COMPLETED|Overall Study||19
11138510|NCT01446003|12324789|FG000|STARTED|Period 1||16
11138511|NCT01446003|12324790|FG001|STARTED|Period 1||15
11138512|NCT01446003|12324789|FG000|COMPLETED|Period 1||14
11138513|NCT01446003|12324790|FG001|COMPLETED|Period 1||15
11138514|NCT01446003|12324789|FG000|NOT COMPLETED|Period 1||2
11138515|NCT01446003|12324790|FG001|NOT COMPLETED|Period 1||0
11138516|NCT01446003|12324789|FG000|STARTED|Period 2||14
11138517|NCT01446003|12324790|FG001|STARTED|Period 2||15
11138518|NCT01446003|12324789|FG000|COMPLETED|Period 2||13
11138519|NCT01446003|12324790|FG001|COMPLETED|Period 2||15
11138520|NCT01446003|12324789|FG000|NOT COMPLETED|Period 2||1
11138521|NCT01446003|12324790|FG001|NOT COMPLETED|Period 2||0
11138522|NCT01446042|12324799|FG000|STARTED|Overall Study||142
11138523|NCT01446042|12324800|FG001|STARTED|Overall Study||86
11138524|NCT01446042|12324801|FG002|STARTED|Overall Study||78
11138525|NCT01446042|12324799|FG000|COMPLETED|Overall Study||122
11138526|NCT01446042|12324800|FG001|COMPLETED|Overall Study||83
11138527|NCT01446042|12324801|FG002|COMPLETED|Overall Study||69
11138528|NCT01446042|12324799|FG000|NOT COMPLETED|Overall Study||20
11138529|NCT01446042|12324800|FG001|NOT COMPLETED|Overall Study||3
11138530|NCT01446042|12324801|FG002|NOT COMPLETED|Overall Study||9
11138531|NCT01446159|12324813|FG000|STARTED|Overall Study||3
11138532|NCT01446159|12324814|FG001|STARTED|Overall Study||3
11138533|NCT01446159|12324815|FG002|STARTED|Overall Study||92
11138534|NCT01446159|12324816|FG003|STARTED|Overall Study||85
11138535|NCT01446159|12324813|FG000|COMPLETED|Overall Study||0
11138536|NCT01446159|12324814|FG001|COMPLETED|Overall Study||0
11138537|NCT01446159|12324815|FG002|COMPLETED|Overall Study||21
11138538|NCT01446159|12324816|FG003|COMPLETED|Overall Study||23
11138539|NCT01446159|12324813|FG000|NOT COMPLETED|Overall Study||3
11138540|NCT01446159|12324814|FG001|NOT COMPLETED|Overall Study||3
11138541|NCT01446159|12324815|FG002|NOT COMPLETED|Overall Study||71
11138542|NCT01446159|12324816|FG003|NOT COMPLETED|Overall Study||62
11138543|NCT01446237|12324828|FG000|STARTED|Overall Study||125
11138544|NCT01446237|12324828|FG000|COMPLETED|Overall Study||115
11138545|NCT01446237|12324828|FG000|NOT COMPLETED|Overall Study||10
11138546|NCT01446289|12324836|FG000|STARTED|Overall Study||51
11138547|NCT01446289|12324837|FG001|STARTED|Overall Study||35
11138548|NCT01446289|12324838|FG002|STARTED|Overall Study||51
11138549|NCT01446289|12324839|FG003|STARTED|Overall Study||35
11138550|NCT01446289|12324836|FG000|COMPLETED|Overall Study||50
11138551|NCT01446289|12324837|FG001|COMPLETED|Overall Study||35
11138552|NCT01446289|12324838|FG002|COMPLETED|Overall Study||50
11138553|NCT01446289|12324839|FG003|COMPLETED|Overall Study||35
11138554|NCT01446289|12324836|FG000|NOT COMPLETED|Overall Study||1
11138555|NCT01446289|12324837|FG001|NOT COMPLETED|Overall Study||0
11138556|NCT01446289|12324838|FG002|NOT COMPLETED|Overall Study||1
11138557|NCT01446289|12324839|FG003|NOT COMPLETED|Overall Study||0
11138558|NCT01446419|12324853|FG000|STARTED|Overall Study||147
11138559|NCT01446419|12324854|FG001|STARTED|Overall Study||78
11138560|NCT01446419|12324853|FG000|3 Month Follow-up|Overall Study||146
11138561|NCT01446419|12324854|FG001|3 Month Follow-up|Overall Study||77
11138562|NCT01446419|12324853|FG000|6 Month Follow-up|Overall Study||144
11138563|NCT01446419|12324854|FG001|6 Month Follow-up|Overall Study||77
11138564|NCT01446419|12324853|FG000|12 Month Follow-up|Overall Study||142
11138565|NCT01446419|12324854|FG001|12 Month Follow-up|Overall Study||77
11138566|NCT01446419|12324853|FG000|COMPLETED|Overall Study||142
11138567|NCT01446419|12324854|FG001|COMPLETED|Overall Study||77
11138568|NCT01446419|12324853|FG000|NOT COMPLETED|Overall Study||5
11138569|NCT01446419|12324854|FG001|NOT COMPLETED|Overall Study||1
11138570|NCT01446666|12324860|FG000|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407
11138571|NCT01446666|12324860|FG000|COMPLETED|Overall Study||326
11138572|NCT01446666|12324860|FG000|NOT COMPLETED|Overall Study||81
11138573|NCT01446705|12324867|FG000|STARTED|Overall Study||50446
11138574|NCT01446705|12324868|FG001|STARTED|Overall Study||6627
11138575|NCT01446705|12324867|FG000|COMPLETED|Overall Study||50446
11138576|NCT01446705|12324868|FG001|COMPLETED|Overall Study||6627
11138577|NCT01446705|12324867|FG000|NOT COMPLETED|Overall Study||0
11138578|NCT01446705|12324868|FG001|NOT COMPLETED|Overall Study||0
11202394|NCT01839487|12392765|FG005|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
11202395|NCT01839487|12392760|FG000|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
11202396|NCT01839487|12392761|FG001|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
11202397|NCT01839487|12392762|FG002|STARTED|Phase 2 (Maximum Exposure:935 Days)||61
11202398|NCT01839487|12392763|FG003|STARTED|Phase 2 (Maximum Exposure:935 Days)||62
11202399|NCT01839487|12392764|FG004|STARTED|Phase 2 (Maximum Exposure:935 Days)||89
11202400|NCT01839487|12392765|FG005|STARTED|Phase 2 (Maximum Exposure:935 Days)||44
11202401|NCT01839487|12392760|FG000|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
11202402|NCT01839487|12392761|FG001|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
11202403|NCT01839487|12392762|FG002|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
11202404|NCT01839487|12392763|FG003|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
11202405|NCT01839487|12392764|FG004|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||1
11202406|NCT01839487|12392765|FG005|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
11202407|NCT01839487|12392760|FG000|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
11202408|NCT01839487|12392761|FG001|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
11202409|NCT01839487|12392762|FG002|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||61
11202410|NCT01839487|12392763|FG003|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||62
11202411|NCT01839487|12392764|FG004|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||88
11202412|NCT01839487|12392765|FG005|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||44
11202413|NCT01839604|12392778|FG000|STARTED|Overall Study||6
11202414|NCT01839604|12392779|FG001|STARTED|Overall Study||6
11202415|NCT01839604|12392780|FG002|STARTED|Overall Study||7
11202416|NCT01839604|12392781|FG003|STARTED|Overall Study||5
11202417|NCT01839604|12392782|FG004|STARTED|Overall Study||15
11202418|NCT01839604|12392778|FG000|COMPLETED|Overall Study||6
11202419|NCT01839604|12392779|FG001|COMPLETED|Overall Study||6
11202420|NCT01839604|12392780|FG002|COMPLETED|Overall Study||7
11202421|NCT01839604|12392781|FG003|COMPLETED|Overall Study||5
11202422|NCT01839604|12392782|FG004|COMPLETED|Overall Study||15
11202423|NCT01839604|12392778|FG000|NOT COMPLETED|Overall Study||0
11202424|NCT01839604|12392779|FG001|NOT COMPLETED|Overall Study||0
11005287|NCT00721955|12182954|FG001|STARTED|Overall Study||104
11005288|NCT00721955|12182955|FG002|STARTED|Overall Study||105
11202425|NCT01839604|12392780|FG002|NOT COMPLETED|Overall Study||0
11202426|NCT01839604|12392781|FG003|NOT COMPLETED|Overall Study||0
11202427|NCT01839604|12392782|FG004|NOT COMPLETED|Overall Study||0
11202428|NCT01839656|12392796|FG000|STARTED|Overall Study||5
11202429|NCT01839656|12392797|FG001|STARTED|Overall Study||16
11202430|NCT01839656|12392796|FG000|Completed Loading Dose Period|Overall Study||4
11202431|NCT01839656|12392797|FG001|Completed Loading Dose Period|Overall Study||15
11202432|NCT01839656|12392796|FG000|COMPLETED|Overall Study||2
11202433|NCT01839656|12392797|FG001|COMPLETED|Overall Study||0
11202434|NCT01839656|12392796|FG000|NOT COMPLETED|Overall Study||3
11241165|NCT02095561|12433588|FG000|HPV Tested at Health Centers|Overall Study||99
11241166|NCT02095561|12433589|FG001|HPV Tested at Health Centers|Overall Study||599
11241167|NCT02095561|12433588|FG000|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
11241168|NCT02095561|12433589|FG001|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
11202435|NCT01839656|12392797|FG001|NOT COMPLETED|Overall Study||16
11202436|NCT01839695|12392803|FG000|STARTED|Overall Study||9
11202437|NCT01839695|12392803|FG000|COMPLETED|Overall Study||9
11202438|NCT01839695|12392803|FG000|NOT COMPLETED|Overall Study||0
11202439|NCT01839708|12392809|FG000|STARTED|Overall Study||387
11202440|NCT01839708|12392810|FG001|STARTED|Overall Study||182
11202441|NCT01839708|12392809|FG000|COMPLETED|Overall Study||311
11202442|NCT01839708|12392810|FG001|COMPLETED|Overall Study||115
11202443|NCT01839708|12392809|FG000|NOT COMPLETED|Overall Study||76
11202444|NCT01839708|12392810|FG001|NOT COMPLETED|Overall Study||67
11202445|NCT01839799|12392818|FG000|STARTED|Overall Study||17
11202446|NCT01839799|12392819|FG001|STARTED|Overall Study||15
11202447|NCT01839799|12392818|FG000|COMPLETED|Overall Study||17
11202448|NCT01839799|12392819|FG001|COMPLETED|Overall Study||15
11202449|NCT01839799|12392818|FG000|NOT COMPLETED|Overall Study||0
11202450|NCT01839799|12392819|FG001|NOT COMPLETED|Overall Study||0
11202451|NCT01839916|12392825|FG000|STARTED|Overall Study||77
11202452|NCT01839916|12392825|FG000|COMPLETED|Overall Study||36
11202453|NCT01839916|12392825|FG000|NOT COMPLETED|Overall Study||41
11202454|NCT01840072|12392831|FG000|STARTED|Overall Study||2038
11202455|NCT01840072|12392832|FG001|STARTED|Overall Study||2033
11202456|NCT01840072|12392831|FG000|COMPLETED|Overall Study||2031
11202457|NCT01840072|12392832|FG001|COMPLETED|Overall Study||1986
11202458|NCT01840072|12392831|FG000|NOT COMPLETED|Overall Study||7
11202459|NCT01840072|12392832|FG001|NOT COMPLETED|Overall Study||47
11202460|NCT01840163|12392842|FG000|STARTED|First Follow up -Primary Outcome||267
11202461|NCT01840163|12392843|FG001|STARTED|First Follow up -Primary Outcome||270
11202462|NCT01840163|12392842|FG000|COMPLETED|First Follow up -Primary Outcome||248
11202463|NCT01840163|12392843|FG001|COMPLETED|First Follow up -Primary Outcome||254
11202464|NCT01840163|12392842|FG000|NOT COMPLETED|First Follow up -Primary Outcome||19
11202465|NCT01840163|12392843|FG001|NOT COMPLETED|First Follow up -Primary Outcome||16
11205252|NCT01858194|12395996|FG000|COMPLETED|Overall Study|All patients in Control arm completed.|8
11138579|NCT01446809|12324886|FG000|STARTED|Overall Study||14
11138580|NCT01446809|12324887|FG001|STARTED|Overall Study||7
11138581|NCT01446809|12324888|FG002|STARTED|Overall Study||2
11138582|NCT01446809|12324886|FG000|COMPLETED|Overall Study||14
11138583|NCT01446809|12324887|FG001|COMPLETED|Overall Study||7
11138584|NCT01446809|12324888|FG002|COMPLETED|Overall Study||0
11138585|NCT01446809|12324886|FG000|NOT COMPLETED|Overall Study||0
11138586|NCT01446809|12324887|FG001|NOT COMPLETED|Overall Study||0
11138587|NCT01446809|12324888|FG002|NOT COMPLETED|Overall Study||2
11138588|NCT01446874|12324900|FG000|STARTED|Overall Study||20
11138589|NCT01446874|12324901|FG001|STARTED|Overall Study||50
11138590|NCT01446874|12324902|FG002|STARTED|Overall Study||80
11138591|NCT01446874|12324900|FG000|COMPLETED|Overall Study||18
11138592|NCT01446874|12324901|FG001|COMPLETED|Overall Study||46
11138593|NCT01446874|12324902|FG002|COMPLETED|Overall Study||62
11138594|NCT01446874|12324900|FG000|NOT COMPLETED|Overall Study||2
11138595|NCT01446874|12324901|FG001|NOT COMPLETED|Overall Study||4
11138596|NCT01446874|12324902|FG002|NOT COMPLETED|Overall Study||18
11138597|NCT01446913|12324913|FG000|STARTED|Overall Study||86
11138598|NCT01446913|12324914|FG001|STARTED|Overall Study||82
11138599|NCT01446913|12324915|FG002|STARTED|Overall Study||84
11138600|NCT01446913|12324913|FG000|Patients With Sleep Study|Overall Study||53
11138601|NCT01446913|12324914|FG001|Patients With Sleep Study|Overall Study||56
11138602|NCT01446913|12324915|FG002|Patients With Sleep Study|Overall Study||29
11138603|NCT01446913|12324913|FG000|Patients With Sleep Apnea|Overall Study||39
11138604|NCT01446913|12324914|FG001|Patients With Sleep Apnea|Overall Study||45
11138605|NCT01446913|12324915|FG002|Patients With Sleep Apnea|Overall Study||21
11138606|NCT01446913|12324913|FG000|COMPLETED|Overall Study||77
11138607|NCT01446913|12324914|FG001|COMPLETED|Overall Study||73
11138608|NCT01446913|12324915|FG002|COMPLETED|Overall Study||73
11138609|NCT01446913|12324913|FG000|NOT COMPLETED|Overall Study||9
11138610|NCT01446913|12324914|FG001|NOT COMPLETED|Overall Study||9
11138611|NCT01446913|12324915|FG002|NOT COMPLETED|Overall Study||11
11138612|NCT01446965|12324931|FG000|STARTED|Randominization||1554
11138613|NCT01446965|12324932|FG001|STARTED|Randominization||794
11138614|NCT01446965|12324931|FG000|COMPLETED|Randominization||1524
11138615|NCT01446965|12324932|FG001|COMPLETED|Randominization||778
11138616|NCT01446965|12324931|FG000|NOT COMPLETED|Randominization||30
11138617|NCT01446965|12324932|FG001|NOT COMPLETED|Randominization||16
11138618|NCT01446965|12324931|FG000|STARTED|Participants Followed and Analyzed||1524
11138619|NCT01446965|12324932|FG001|STARTED|Participants Followed and Analyzed||778
11138620|NCT01446965|12324931|FG000|Received WCD|Participants Followed and Analyzed||1481
11138621|NCT01446965|12324932|FG001|Received WCD|Participants Followed and Analyzed||0
11138622|NCT01446965|12324931|FG000|Never Wore WCD|Participants Followed and Analyzed||43
11138623|NCT01446965|12324932|FG001|Never Wore WCD|Participants Followed and Analyzed||0
11138624|NCT01446965|12324931|FG000|Never Given WCD|Participants Followed and Analyzed||0
11138625|NCT01446965|12324932|FG001|Never Given WCD|Participants Followed and Analyzed||758
11138626|NCT01446965|12324931|FG000|Given WCD Out of Protocol|Participants Followed and Analyzed||0
11138627|NCT01446965|12324932|FG001|Given WCD Out of Protocol|Participants Followed and Analyzed||20
11138628|NCT01446965|12324931|FG000|COMPLETED|Participants Followed and Analyzed||1514
11138629|NCT01446965|12324932|FG001|COMPLETED|Participants Followed and Analyzed||766
11138630|NCT01446965|12324931|FG000|NOT COMPLETED|Participants Followed and Analyzed||10
11138631|NCT01446965|12324932|FG001|NOT COMPLETED|Participants Followed and Analyzed||12
11138632|NCT01447017|12324940|FG000|STARTED|Overall Study||45
11138633|NCT01447017|12324941|FG001|STARTED|Overall Study||24
11138634|NCT01447017|12324940|FG000|Performed Visit 2|Overall Study||43
11138635|NCT01447017|12324941|FG001|Performed Visit 2|Overall Study||24
11138636|NCT01447017|12324940|FG000|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
11138637|NCT01447017|12324941|FG001|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
11138638|NCT01447017|12324940|FG000|NOT COMPLETED|Overall Study||10
11138639|NCT01447017|12324941|FG001|NOT COMPLETED|Overall Study||10
11138640|NCT01447121|12324947|FG000|STARTED|Overall Study||118
11138641|NCT01447121|12324947|FG000|COMPLETED|Overall Study||118
11138642|NCT01447121|12324947|FG000|NOT COMPLETED|Overall Study||0
11138643|NCT01447225|12324956|FG000|STARTED|Overall Study||3
11138644|NCT01447225|12324957|FG001|STARTED|Overall Study||8
11138645|NCT01447225|12324958|FG002|STARTED|Overall Study||5
11138646|NCT01447225|12324959|FG003|STARTED|Overall Study||3
11138647|NCT01447225|12324960|FG004|STARTED|Overall Study||3
11138648|NCT01447225|12324961|FG005|STARTED|Overall Study||3
11138649|NCT01447225|12324962|FG006|STARTED|Overall Study||7
11138650|NCT01447225|12324963|FG007|STARTED|Overall Study||4
11138651|NCT01447225|12324964|FG008|STARTED|Overall Study||3
11138652|NCT01447225|12324965|FG009|STARTED|Overall Study||4
11138653|NCT01447225|12324956|FG000|COMPLETED|Overall Study||3
11138654|NCT01447225|12324957|FG001|COMPLETED|Overall Study||8
11138655|NCT01447225|12324958|FG002|COMPLETED|Overall Study||5
11138656|NCT01447225|12324959|FG003|COMPLETED|Overall Study||3
11138657|NCT01447225|12324960|FG004|COMPLETED|Overall Study||3
11138658|NCT01447225|12324961|FG005|COMPLETED|Overall Study||3
11138659|NCT01447225|12324962|FG006|COMPLETED|Overall Study||7
11138660|NCT01447225|12324963|FG007|COMPLETED|Overall Study||4
11138661|NCT01447225|12324964|FG008|COMPLETED|Overall Study||3
11138662|NCT01447225|12324965|FG009|COMPLETED|Overall Study||4
11138663|NCT01447225|12324956|FG000|NOT COMPLETED|Overall Study||0
11138664|NCT01447225|12324957|FG001|NOT COMPLETED|Overall Study||0
11138665|NCT01447225|12324958|FG002|NOT COMPLETED|Overall Study||0
11138666|NCT01447225|12324959|FG003|NOT COMPLETED|Overall Study||0
11138667|NCT01447225|12324960|FG004|NOT COMPLETED|Overall Study||0
11138668|NCT01447225|12324961|FG005|NOT COMPLETED|Overall Study||0
11138669|NCT01447225|12324962|FG006|NOT COMPLETED|Overall Study||0
11138670|NCT01447225|12324963|FG007|NOT COMPLETED|Overall Study||0
11138671|NCT01447225|12324964|FG008|NOT COMPLETED|Overall Study||0
11241169|NCT02095561|12433588|FG000|NOT COMPLETED|Overall Study||0
11241170|NCT02095561|12433589|FG001|NOT COMPLETED|Overall Study||0
11241171|NCT02095691|12433595|FG000|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
11241172|NCT02095691|12433595|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
11241173|NCT02095691|12433595|FG000|NOT COMPLETED|Overall Study||1
11241174|NCT02095873|12433613|FG000|STARTED|First Intervention (8 Weeks)||16
11241175|NCT02095873|12433614|FG001|STARTED|First Intervention (8 Weeks)||16
11241176|NCT02095873|12433613|FG000|COMPLETED|First Intervention (8 Weeks)||15
11241177|NCT02095873|12433614|FG001|COMPLETED|First Intervention (8 Weeks)||16
11241178|NCT02095873|12433613|FG000|NOT COMPLETED|First Intervention (8 Weeks)||1
11241179|NCT02095873|12433614|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
11241180|NCT02095873|12433613|FG000|STARTED|Second Intervention (8 Weeks)||15
11241181|NCT02095873|12433614|FG001|STARTED|Second Intervention (8 Weeks)||16
11241182|NCT02095873|12433613|FG000|COMPLETED|Second Intervention (8 Weeks)||13
11241183|NCT02095873|12433614|FG001|COMPLETED|Second Intervention (8 Weeks)||16
11241184|NCT02095873|12433613|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2
11241185|NCT02095873|12433614|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
11241186|NCT02095951|12433624|FG000|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
11241187|NCT02095951|12433625|FG001|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
11241188|NCT02095951|12433624|FG000|COMPLETED|Overall Study||4
11241189|NCT02095951|12433625|FG001|COMPLETED|Overall Study||8
11241190|NCT02095951|12433624|FG000|NOT COMPLETED|Overall Study||9
11241191|NCT02095951|12433625|FG001|NOT COMPLETED|Overall Study||6
11241192|NCT02096003|12433637|FG000|STARTED|Overall Study||40
11241193|NCT02096003|12433638|FG001|STARTED|Overall Study||40
11241194|NCT02096003|12433637|FG000|COMPLETED|Overall Study||38
11241195|NCT02096003|12433638|FG001|COMPLETED|Overall Study||37
11241196|NCT02096003|12433637|FG000|NOT COMPLETED|Overall Study||2
11241197|NCT02096003|12433638|FG001|NOT COMPLETED|Overall Study||3
11241198|NCT02096029|12433646|FG000|STARTED|Overall Study||652
11241199|NCT02096029|12433647|FG001|STARTED|Overall Study||593
11138672|NCT01447225|12324965|FG009|NOT COMPLETED|Overall Study||0
11138673|NCT01447407|12325001|FG000|STARTED|Overall Study||41
11138674|NCT01447407|12325002|FG001|STARTED|Overall Study||40
11138675|NCT01447407|12325003|FG002|STARTED|Overall Study||41
11138676|NCT01447407|12325004|FG003|STARTED|Overall Study||42
11138677|NCT01447407|12325001|FG000|COMPLETED|Overall Study||39
11138678|NCT01447407|12325002|FG001|COMPLETED|Overall Study||40
11138679|NCT01447407|12325003|FG002|COMPLETED|Overall Study||40
11138680|NCT01447407|12325004|FG003|COMPLETED|Overall Study||40
11138681|NCT01447407|12325001|FG000|NOT COMPLETED|Overall Study||2
11138682|NCT01447407|12325002|FG001|NOT COMPLETED|Overall Study||0
11138683|NCT01447407|12325003|FG002|NOT COMPLETED|Overall Study||1
11138684|NCT01447407|12325004|FG003|NOT COMPLETED|Overall Study||2
11138685|NCT01447420|12325017|FG000|STARTED|Overall Study||39
11138686|NCT01447420|12325018|FG001|STARTED|Overall Study||72
11138687|NCT01447420|12325019|FG002|STARTED|Overall Study||18
11138688|NCT01447420|12325017|FG000|COMPLETED|Overall Study||29
11138689|NCT01447420|12325018|FG001|COMPLETED|Overall Study||45
11138690|NCT01447420|12325019|FG002|COMPLETED|Overall Study||8
11138691|NCT01447420|12325017|FG000|NOT COMPLETED|Overall Study||10
11138692|NCT01447420|12325018|FG001|NOT COMPLETED|Overall Study||27
11138693|NCT01447420|12325019|FG002|NOT COMPLETED|Overall Study||10
11138694|NCT01447433|12325028|FG000|STARTED|Overall Study||26
11138695|NCT01447433|12325029|FG001|STARTED|Overall Study||27
11138696|NCT01447433|12325028|FG000|COMPLETED|Overall Study||22
11138697|NCT01447433|12325029|FG001|COMPLETED|Overall Study||21
11138698|NCT01447433|12325028|FG000|NOT COMPLETED|Overall Study||4
11138699|NCT01447433|12325029|FG001|NOT COMPLETED|Overall Study||6
11138700|NCT01447446|12325041|FG000|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
11138701|NCT01447446|12325042|FG001|STARTED|Overall Study||496
11138702|NCT01447446|12325043|FG002|STARTED|Overall Study||292
11138703|NCT01447446|12325044|FG003|STARTED|Overall Study||93
11138704|NCT01447446|12325045|FG004|STARTED|Overall Study||821
11138705|NCT01447446|12325046|FG005|STARTED|Overall Study||86
11138706|NCT01447446|12325041|FG000|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
11138707|NCT01447446|12325042|FG001|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
11138708|NCT01447446|12325043|FG002|COMPLETED|Overall Study||192
11138709|NCT01447446|12325044|FG003|COMPLETED|Overall Study||60
11138710|NCT01447446|12325045|FG004|COMPLETED|Overall Study||610
11138711|NCT01447446|12325046|FG005|COMPLETED|Overall Study||54
11138712|NCT01447446|12325041|FG000|NOT COMPLETED|Overall Study||722
11138713|NCT01447446|12325042|FG001|NOT COMPLETED|Overall Study||165
11138714|NCT01447446|12325043|FG002|NOT COMPLETED|Overall Study||100
11138715|NCT01447446|12325044|FG003|NOT COMPLETED|Overall Study||33
11138716|NCT01447446|12325045|FG004|NOT COMPLETED|Overall Study||211
11138717|NCT01447446|12325046|FG005|NOT COMPLETED|Overall Study||32
11138718|NCT01447511|12325071|FG000|STARTED|Control Period||8
11138719|NCT01447511|12325072|FG001|STARTED|Control Period||5
11138720|NCT01447511|12325073|FG002|STARTED|Control Period||9
11138721|NCT01447511|12325074|FG003|STARTED|Control Period||3
11138722|NCT01447511|12325075|FG004|STARTED|Control Period||4
11138723|NCT01447511|12325071|FG000|COMPLETED|Control Period||8
11138724|NCT01447511|12325072|FG001|COMPLETED|Control Period||5
11138725|NCT01447511|12325073|FG002|COMPLETED|Control Period||9
11138726|NCT01447511|12325074|FG003|COMPLETED|Control Period||3
11138727|NCT01447511|12325075|FG004|COMPLETED|Control Period||4
11138728|NCT01447511|12325071|FG000|NOT COMPLETED|Control Period||0
11138729|NCT01447511|12325072|FG001|NOT COMPLETED|Control Period||0
11138730|NCT01447511|12325073|FG002|NOT COMPLETED|Control Period||0
11138731|NCT01447511|12325074|FG003|NOT COMPLETED|Control Period||0
11138732|NCT01447511|12325075|FG004|NOT COMPLETED|Control Period||0
11138733|NCT01447511|12325071|FG000|STARTED|Fluconazole Period||8
11138734|NCT01447511|12325072|FG001|STARTED|Fluconazole Period||0
11138735|NCT01447511|12325073|FG002|STARTED|Fluconazole Period||9
11138736|NCT01447511|12325074|FG003|STARTED|Fluconazole Period||3
11138737|NCT01447511|12325075|FG004|STARTED|Fluconazole Period||4
11138738|NCT01447511|12325071|FG000|COMPLETED|Fluconazole Period||8
11138739|NCT01447511|12325072|FG001|COMPLETED|Fluconazole Period||0
11138740|NCT01447511|12325073|FG002|COMPLETED|Fluconazole Period||8
11138741|NCT01447511|12325074|FG003|COMPLETED|Fluconazole Period||3
11138742|NCT01447511|12325075|FG004|COMPLETED|Fluconazole Period||4
11138743|NCT01447511|12325071|FG000|NOT COMPLETED|Fluconazole Period||0
11138744|NCT01447511|12325072|FG001|NOT COMPLETED|Fluconazole Period||0
11138745|NCT01447511|12325073|FG002|NOT COMPLETED|Fluconazole Period||1
11138746|NCT01447511|12325074|FG003|NOT COMPLETED|Fluconazole Period||0
11138747|NCT01447511|12325075|FG004|NOT COMPLETED|Fluconazole Period||0
11138748|NCT01447511|12325071|FG000|STARTED|Rifampin Period||8
11138749|NCT01447511|12325072|FG001|STARTED|Rifampin Period||5
11138750|NCT01447511|12325073|FG002|STARTED|Rifampin Period||8
11138751|NCT01447511|12325074|FG003|STARTED|Rifampin Period||3
11138752|NCT01447511|12325075|FG004|STARTED|Rifampin Period||4
11138753|NCT01447511|12325071|FG000|COMPLETED|Rifampin Period||8
11138754|NCT01447511|12325072|FG001|COMPLETED|Rifampin Period||5
11138755|NCT01447511|12325073|FG002|COMPLETED|Rifampin Period||8
11138756|NCT01447511|12325074|FG003|COMPLETED|Rifampin Period||2
11138757|NCT01447511|12325075|FG004|COMPLETED|Rifampin Period||4
11138758|NCT01447511|12325071|FG000|NOT COMPLETED|Rifampin Period||0
11138759|NCT01447511|12325072|FG001|NOT COMPLETED|Rifampin Period||0
11138760|NCT01447511|12325073|FG002|NOT COMPLETED|Rifampin Period||0
11138761|NCT01447511|12325074|FG003|NOT COMPLETED|Rifampin Period||1
11138762|NCT01447511|12325075|FG004|NOT COMPLETED|Rifampin Period||0
11138763|NCT01447576|12325087|FG000|STARTED|Overall Study||1036
11138764|NCT01447576|12325087|FG000|COMPLETED|Overall Study||560
11138765|NCT01447576|12325087|FG000|NOT COMPLETED|Overall Study||476
11138766|NCT01447706|12325093|FG000|STARTED|Overall Study||140
11138767|NCT01447706|12325094|FG001|STARTED|Overall Study|3 patients enrolled but not dosed|83
11138768|NCT01447706|12325093|FG000|COMPLETED|Overall Study||140
11138769|NCT01447706|12325094|FG001|COMPLETED|Overall Study||80
11138770|NCT01447706|12325093|FG000|NOT COMPLETED|Overall Study||0
11138771|NCT01447706|12325094|FG001|NOT COMPLETED|Overall Study||3
11138772|NCT01447719|12325104|FG000|STARTED|Overall Study||152
11138773|NCT01447719|12325104|FG000|Valid AV-45 Scan Acquired|Overall Study||147
11241200|NCT02096029|12433646|FG000|COMPLETED|Overall Study||652
11241201|NCT02096029|12433647|FG001|COMPLETED|Overall Study||593
11241202|NCT02096029|12433646|FG000|NOT COMPLETED|Overall Study||0
11241203|NCT02096029|12433647|FG001|NOT COMPLETED|Overall Study||0
11241204|NCT02096081|12433655|FG000|STARTED|Overall Study||122
11241205|NCT02096081|12433656|FG001|STARTED|Overall Study||128
11241206|NCT02096081|12433655|FG000|COMPLETED|Overall Study||119
11241207|NCT02096081|12433656|FG001|COMPLETED|Overall Study||124
11241208|NCT02096081|12433655|FG000|NOT COMPLETED|Overall Study||3
11241209|NCT02096081|12433656|FG001|NOT COMPLETED|Overall Study||4
11241210|NCT02096107|12433664|FG000|STARTED|Overall Study||30
11241211|NCT02096107|12433665|FG001|STARTED|Overall Study||30
11241212|NCT02096107|12433664|FG000|COMPLETED|Overall Study||30
11241213|NCT02096107|12433665|FG001|COMPLETED|Overall Study||30
11241214|NCT02096107|12433664|FG000|NOT COMPLETED|Overall Study||0
11241215|NCT02096107|12433665|FG001|NOT COMPLETED|Overall Study||0
11241216|NCT02096263|12433674|FG000|STARTED|Overall Study||195
11241217|NCT02096263|12433675|FG001|STARTED|Overall Study||194
11241218|NCT02096263|12433676|FG002|STARTED|Overall Study||196
11241219|NCT02096263|12433674|FG000|COMPLETED|Overall Study||161
11241220|NCT02096263|12433675|FG001|COMPLETED|Overall Study||158
11241221|NCT02096263|12433676|FG002|COMPLETED|Overall Study||157
11241222|NCT02096263|12433674|FG000|NOT COMPLETED|Overall Study||34
11241223|NCT02096263|12433675|FG001|NOT COMPLETED|Overall Study||36
11241224|NCT02096263|12433676|FG002|NOT COMPLETED|Overall Study||39
11241225|NCT02096276|12433686|FG000|STARTED|Overall Study||250
11241226|NCT02096276|12433687|FG001|STARTED|Overall Study||55
11241227|NCT02096276|12433686|FG000|COMPLETED|Overall Study||250
11241228|NCT02096276|12433687|FG001|COMPLETED|Overall Study||55
11241229|NCT02096276|12433686|FG000|NOT COMPLETED|Overall Study||0
11241230|NCT02096276|12433687|FG001|NOT COMPLETED|Overall Study||0
11241231|NCT02096458|12433693|FG000|STARTED|Overall Study||8
11241232|NCT02096458|12433693|FG000|COMPLETED|Overall Study||8
11241233|NCT02096458|12433693|FG000|NOT COMPLETED|Overall Study||0
11241234|NCT02096471|12433697|FG000|STARTED|Overall Study||19
11241235|NCT02096471|12433697|FG000|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6
11241236|NCT02096471|12433697|FG000|NOT COMPLETED|Overall Study||13
11241237|NCT02096575|12433703|FG000|STARTED|Overall Study||68
11241238|NCT02096575|12433704|FG001|STARTED|Overall Study||67
11241239|NCT02096575|12433705|FG002|STARTED|Overall Study||5
11241240|NCT02096575|12433703|FG000|COMPLETED|Overall Study||68
11241241|NCT02096575|12433704|FG001|COMPLETED|Overall Study||67
11241242|NCT02096575|12433705|FG002|COMPLETED|Overall Study||0
11241243|NCT02096575|12433703|FG000|NOT COMPLETED|Overall Study||0
11241244|NCT02096575|12433704|FG001|NOT COMPLETED|Overall Study||0
11241245|NCT02096575|12433705|FG002|NOT COMPLETED|Overall Study||5
11241246|NCT02096679|12433712|FG000|STARTED|Overall Study||8
11241247|NCT02096679|12433712|FG000|COMPLETED|Overall Study||8
11241248|NCT02096679|12433712|FG000|NOT COMPLETED|Overall Study||0
11241249|NCT02096692|12433716|FG000|STARTED|Overall Study||154
11241250|NCT02096692|12433716|FG000|COMPLETED|Overall Study||150
11241251|NCT02096692|12433716|FG000|NOT COMPLETED|Overall Study||4
11241252|NCT02096705|12433722|FG000|STARTED|Treatment||133
11241253|NCT02096705|12433723|FG001|STARTED|Treatment||139
11241254|NCT02096705|12433722|FG000|COMPLETED|Treatment||124
11241255|NCT02096705|12433723|FG001|COMPLETED|Treatment||134
11241256|NCT02096705|12433722|FG000|NOT COMPLETED|Treatment||9
11241257|NCT02096705|12433723|FG001|NOT COMPLETED|Treatment||5
11241258|NCT02096705|12433722|FG000|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
11241259|NCT02096705|12433723|FG001|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
11241260|NCT02096705|12433722|FG000|COMPLETED|Follow-up||125
11241261|NCT02096705|12433723|FG001|COMPLETED|Follow-up||135
11241262|NCT02096705|12433722|FG000|NOT COMPLETED|Follow-up||4
11241263|NCT02096705|12433723|FG001|NOT COMPLETED|Follow-up||4
11241264|NCT02096718|12433732|FG000|STARTED|Overall Study||8
11241265|NCT02096718|12433733|FG001|STARTED|Overall Study||8
11241266|NCT02096718|12433734|FG002|STARTED|Overall Study||14
11138774|NCT01447719|12325104|FG000|Deceased <2 Years After AV-45 Scan|Overall Study||66
11138775|NCT01447719|12325104|FG000|COMPLETED|Overall Study||59
11138776|NCT01447719|12325104|FG000|NOT COMPLETED|Overall Study||93
11138777|NCT01447849|12325117|FG000|STARTED|First Intervention||10
11138778|NCT01447849|12325118|FG001|STARTED|First Intervention||10
11138779|NCT01447849|12325119|FG002|STARTED|First Intervention||10
11241267|NCT02096718|12433732|FG000|COMPLETED|Overall Study||8
11241268|NCT02096718|12433733|FG001|COMPLETED|Overall Study||8
11241269|NCT02096718|12433734|FG002|COMPLETED|Overall Study||14
11241270|NCT02096718|12433732|FG000|NOT COMPLETED|Overall Study||0
11241271|NCT02096718|12433733|FG001|NOT COMPLETED|Overall Study||0
11241272|NCT02096718|12433734|FG002|NOT COMPLETED|Overall Study||0
11241273|NCT02096731|12433745|FG000|STARTED|Overall Study||26442
11241274|NCT02096731|12433746|FG001|STARTED|Overall Study||88955
11241275|NCT02096731|12433745|FG000|COMPLETED|Overall Study||26442
11241276|NCT02096731|12433746|FG001|COMPLETED|Overall Study||88955
11138780|NCT01447849|12325120|FG003|STARTED|First Intervention||10
11138781|NCT01447849|12325117|FG000|COMPLETED|First Intervention||10
11138782|NCT01447849|12325118|FG001|COMPLETED|First Intervention||10
11138783|NCT01447849|12325119|FG002|COMPLETED|First Intervention||10
11138784|NCT01447849|12325120|FG003|COMPLETED|First Intervention||10
11138785|NCT01447849|12325117|FG000|NOT COMPLETED|First Intervention||0
11138786|NCT01447849|12325118|FG001|NOT COMPLETED|First Intervention||0
11138787|NCT01447849|12325119|FG002|NOT COMPLETED|First Intervention||0
11138788|NCT01447849|12325120|FG003|NOT COMPLETED|First Intervention||0
11138789|NCT01447849|12325117|FG000|STARTED|Washout Period for 1 Week||10
11138790|NCT01447849|12325118|FG001|STARTED|Washout Period for 1 Week||10
11138791|NCT01447849|12325119|FG002|STARTED|Washout Period for 1 Week||10
11138792|NCT01447849|12325120|FG003|STARTED|Washout Period for 1 Week||10
11138793|NCT01447849|12325117|FG000|COMPLETED|Washout Period for 1 Week||10
11138794|NCT01447849|12325118|FG001|COMPLETED|Washout Period for 1 Week||10
11138795|NCT01447849|12325119|FG002|COMPLETED|Washout Period for 1 Week||10
11138796|NCT01447849|12325120|FG003|COMPLETED|Washout Period for 1 Week||10
11138797|NCT01447849|12325117|FG000|NOT COMPLETED|Washout Period for 1 Week||0
11241277|NCT02096731|12433745|FG000|NOT COMPLETED|Overall Study||0
11241278|NCT02096731|12433746|FG001|NOT COMPLETED|Overall Study||0
11241279|NCT02096744|12433755|FG000|STARTED|Treatment Period 1(7 Days)||29
11138798|NCT01447849|12325118|FG001|NOT COMPLETED|Washout Period for 1 Week||0
11138799|NCT01447849|12325119|FG002|NOT COMPLETED|Washout Period for 1 Week||0
11138800|NCT01447849|12325120|FG003|NOT COMPLETED|Washout Period for 1 Week||0
11138801|NCT01447849|12325117|FG000|STARTED|Second Intervention||10
11138802|NCT01447849|12325118|FG001|STARTED|Second Intervention||10
11138803|NCT01447849|12325119|FG002|STARTED|Second Intervention||10
11138804|NCT01447849|12325120|FG003|STARTED|Second Intervention||10
11138805|NCT01447849|12325117|FG000|COMPLETED|Second Intervention||10
11138806|NCT01447849|12325118|FG001|COMPLETED|Second Intervention||10
11138807|NCT01447849|12325119|FG002|COMPLETED|Second Intervention||10
11138808|NCT01447849|12325120|FG003|COMPLETED|Second Intervention||10
11138809|NCT01447849|12325117|FG000|NOT COMPLETED|Second Intervention||0
11138810|NCT01447849|12325118|FG001|NOT COMPLETED|Second Intervention||0
11138811|NCT01447849|12325119|FG002|NOT COMPLETED|Second Intervention||0
11138812|NCT01447849|12325120|FG003|NOT COMPLETED|Second Intervention||0
11138813|NCT01447888|12325132|FG000|STARTED|Overall Study||45
11138814|NCT01447888|12325133|FG001|STARTED|Overall Study||55
11138815|NCT01447888|12325132|FG000|COMPLETED|Overall Study||45
11138816|NCT01447888|12325133|FG001|COMPLETED|Overall Study||55
11138817|NCT01447888|12325132|FG000|NOT COMPLETED|Overall Study||0
11138818|NCT01447888|12325133|FG001|NOT COMPLETED|Overall Study||0
11138819|NCT01447914|12325139|FG000|STARTED|Overall Study||16
11138820|NCT01447914|12325139|FG000|COMPLETED|Overall Study||16
11138821|NCT01447914|12325139|FG000|NOT COMPLETED|Overall Study||0
11138822|NCT01447927|12325145|FG000|STARTED|Overall Study||38
11138823|NCT01447927|12325146|FG001|STARTED|Overall Study||36
11138824|NCT01447927|12325145|FG000|COMPLETED|Overall Study||33
11138825|NCT01447927|12325146|FG001|COMPLETED|Overall Study||33
11241280|NCT02096744|12433756|FG001|STARTED|Treatment Period 1(7 Days)||29
11241281|NCT02096744|12433755|FG000|COMPLETED|Treatment Period 1(7 Days)||28
11241282|NCT02096744|12433756|FG001|COMPLETED|Treatment Period 1(7 Days)||28
11241283|NCT02096744|12433755|FG000|NOT COMPLETED|Treatment Period 1(7 Days)||1
11241284|NCT02096744|12433756|FG001|NOT COMPLETED|Treatment Period 1(7 Days)||1
11241285|NCT02096744|12433755|FG000|STARTED|Washout Period 1(7 Days)||28
11241286|NCT02096744|12433756|FG001|STARTED|Washout Period 1(7 Days)||28
11241287|NCT02096744|12433755|FG000|COMPLETED|Washout Period 1(7 Days)||28
11241288|NCT02096744|12433756|FG001|COMPLETED|Washout Period 1(7 Days)||28
11241289|NCT02096744|12433755|FG000|NOT COMPLETED|Washout Period 1(7 Days)||0
11241290|NCT02096744|12433756|FG001|NOT COMPLETED|Washout Period 1(7 Days)||0
11241291|NCT02096744|12433755|FG000|STARTED|Treatment Period 2 (7 Days)||28
11241292|NCT02096744|12433756|FG001|STARTED|Treatment Period 2 (7 Days)||28
11241293|NCT02096744|12433755|FG000|COMPLETED|Treatment Period 2 (7 Days)||28
11241294|NCT02096744|12433756|FG001|COMPLETED|Treatment Period 2 (7 Days)||28
11241295|NCT02096744|12433755|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
11241296|NCT02096744|12433756|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0
11241297|NCT02096744|12433755|FG000|STARTED|Washout Period 2 (3 Days)||28
11241298|NCT02096744|12433756|FG001|STARTED|Washout Period 2 (3 Days)||28
11241299|NCT02096744|12433755|FG000|COMPLETED|Washout Period 2 (3 Days)||28
11241300|NCT02096744|12433756|FG001|COMPLETED|Washout Period 2 (3 Days)||28
11241301|NCT02096744|12433755|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
11241302|NCT02096744|12433756|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
11241303|NCT02096744|12433755|FG000|STARTED|Treatment Period 3 (7 Days)||28
11138826|NCT01447927|12325145|FG000|NOT COMPLETED|Overall Study||5
11138827|NCT01447927|12325146|FG001|NOT COMPLETED|Overall Study||3
11138828|NCT01448044|12325154|FG000|STARTED|Treatment Period||82
11138829|NCT01448044|12325155|FG001|STARTED|Treatment Period||42
11138830|NCT01448044|12325154|FG000|COMPLETED|Treatment Period||59
11138831|NCT01448044|12325155|FG001|COMPLETED|Treatment Period||26
11138832|NCT01448044|12325154|FG000|NOT COMPLETED|Treatment Period||23
11138833|NCT01448044|12325155|FG001|NOT COMPLETED|Treatment Period||16
11205253|NCT01858194|12395997|FG001|COMPLETED|Overall Study||7
11205254|NCT01858194|12395996|FG000|NOT COMPLETED|Overall Study||0
11241304|NCT02096744|12433756|FG001|STARTED|Treatment Period 3 (7 Days)||28
11241305|NCT02096744|12433755|FG000|COMPLETED|Treatment Period 3 (7 Days)||28
11241306|NCT02096744|12433756|FG001|COMPLETED|Treatment Period 3 (7 Days)||27
11241307|NCT02096744|12433755|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
11138834|NCT01448044|12325154|FG000|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
11138835|NCT01448044|12325155|FG001|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
11138836|NCT01448044|12325154|FG000|COMPLETED|Follow Up Period||65
11138837|NCT01448044|12325155|FG001|COMPLETED|Follow Up Period||26
11138838|NCT01448044|12325154|FG000|NOT COMPLETED|Follow Up Period||12
11138839|NCT01448044|12325155|FG001|NOT COMPLETED|Follow Up Period||14
11138840|NCT01448057|12325163|FG000|STARTED|Overall Study||170
11138841|NCT01448057|12325164|FG001|STARTED|Overall Study||171
11138842|NCT01448057|12325163|FG000|COMPLETED|Overall Study||162
11138843|NCT01448057|12325164|FG001|COMPLETED|Overall Study||167
11138844|NCT01448057|12325163|FG000|NOT COMPLETED|Overall Study||8
11138845|NCT01448057|12325164|FG001|NOT COMPLETED|Overall Study||4
11138846|NCT01448213|12325172|FG000|STARTED|Overall Study||130
11138847|NCT01448213|12325173|FG001|STARTED|Overall Study||134
11138848|NCT01448213|12325172|FG000|COMPLETED|Overall Study||113
11138849|NCT01448213|12325173|FG001|COMPLETED|Overall Study||112
11138850|NCT01448213|12325172|FG000|NOT COMPLETED|Overall Study||17
11138851|NCT01448213|12325173|FG001|NOT COMPLETED|Overall Study||22
11138852|NCT01448356|12325179|FG000|STARTED|Overall Study||10
11138853|NCT01448356|12325179|FG000|COMPLETED|Overall Study|cross-over|10
11138854|NCT01448356|12325179|FG000|NOT COMPLETED|Overall Study||0
11138855|NCT01448421|12325184|FG000|STARTED|Overall Study||37
11138856|NCT01448421|12325184|FG000|COMPLETED|Overall Study||37
11138857|NCT01448421|12325184|FG000|NOT COMPLETED|Overall Study||0
11138858|NCT01448447|12325190|FG000|STARTED|Overall Study||20
11138859|NCT01448447|12325191|FG001|STARTED|Overall Study||0
11138860|NCT01448447|12325190|FG000|COMPLETED|Overall Study||20
11138861|NCT01448447|12325191|FG001|COMPLETED|Overall Study||0
11138862|NCT01448447|12325190|FG000|NOT COMPLETED|Overall Study||0
11138863|NCT01448447|12325191|FG001|NOT COMPLETED|Overall Study||0
11138864|NCT01448486|12325199|FG000|STARTED|Overall Study||3
11138865|NCT01448486|12325200|FG001|STARTED|Overall Study||3
11138866|NCT01448486|12325199|FG000|COMPLETED|Overall Study||3
11138867|NCT01448486|12325200|FG001|COMPLETED|Overall Study||3
11138868|NCT01448486|12325199|FG000|NOT COMPLETED|Overall Study||0
11138869|NCT01448486|12325200|FG001|NOT COMPLETED|Overall Study||0
11138870|NCT01448525|12325208|FG000|STARTED|Overall Study||44
11138871|NCT01448525|12325209|FG001|STARTED|Overall Study||44
11138872|NCT01448525|12325208|FG000|COMPLETED|Overall Study||43
11138873|NCT01448525|12325209|FG001|COMPLETED|Overall Study||42
11138874|NCT01448525|12325208|FG000|NOT COMPLETED|Overall Study||1
11138875|NCT01448525|12325209|FG001|NOT COMPLETED|Overall Study||2
11138876|NCT01448616|12325218|FG000|STARTED|Lead-In (Observational Phase)||73
11138877|NCT01448616|12325219|FG001|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
11138878|NCT01448616|12325220|FG002|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
11138879|NCT01448616|12325221|FG003|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
11138880|NCT01448616|12325218|FG000|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
11138881|NCT01448616|12325219|FG001|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
11138882|NCT01448616|12325220|FG002|COMPLETED|Lead-In (Observational Phase)||0
11138883|NCT01448616|12325221|FG003|COMPLETED|Lead-In (Observational Phase)||0
11138884|NCT01448616|12325218|FG000|NOT COMPLETED|Lead-In (Observational Phase)||9
11138885|NCT01448616|12325219|FG001|NOT COMPLETED|Lead-In (Observational Phase)||0
11138886|NCT01448616|12325220|FG002|NOT COMPLETED|Lead-In (Observational Phase)||0
11138887|NCT01448616|12325221|FG003|NOT COMPLETED|Lead-In (Observational Phase)||0
11138888|NCT01448616|12325218|FG000|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
11138889|NCT01448616|12325219|FG001|STARTED|Study Drug (Treatment Phase)||24
11138890|NCT01448616|12325220|FG002|STARTED|Study Drug (Treatment Phase)||27
11138891|NCT01448616|12325221|FG003|STARTED|Study Drug (Treatment Phase)||13
11138892|NCT01448616|12325218|FG000|COMPLETED|Study Drug (Treatment Phase)||0
11138893|NCT01448616|12325219|FG001|COMPLETED|Study Drug (Treatment Phase)||22
11138894|NCT01448616|12325220|FG002|COMPLETED|Study Drug (Treatment Phase)||23
11138895|NCT01448616|12325221|FG003|COMPLETED|Study Drug (Treatment Phase)||9
11138896|NCT01448616|12325218|FG000|NOT COMPLETED|Study Drug (Treatment Phase)||0
11138897|NCT01448616|12325219|FG001|NOT COMPLETED|Study Drug (Treatment Phase)||2
11138898|NCT01448616|12325220|FG002|NOT COMPLETED|Study Drug (Treatment Phase)||4
11138899|NCT01448616|12325221|FG003|NOT COMPLETED|Study Drug (Treatment Phase)||4
11138900|NCT01448707|12325236|FG000|STARTED|Overall Study||137
11138901|NCT01448707|12325237|FG001|STARTED|Overall Study||136
11138902|NCT01448707|12325236|FG000|COMPLETED|Overall Study||119
11138903|NCT01448707|12325237|FG001|COMPLETED|Overall Study||118
11138904|NCT01448707|12325236|FG000|NOT COMPLETED|Overall Study||18
11138905|NCT01448707|12325237|FG001|NOT COMPLETED|Overall Study||18
11138906|NCT01448824|12325251|FG000|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
11138907|NCT01448824|12325252|FG001|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
11138908|NCT01448824|12325253|FG002|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
11138909|NCT01448824|12325254|FG003|STARTED|Part 1 Period 1: Multiple Ascending Dose||10
11138910|NCT01448824|12325255|FG004|STARTED|Part 1 Period 1: Multiple Ascending Dose||16
11138911|NCT01448824|12325256|FG005|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
11138912|NCT01448824|12325257|FG006|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
11138913|NCT01448824|12325258|FG007|STARTED|Part 1 Period 1: Multiple Ascending Dose||0
11138914|NCT01448824|12325251|FG000|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
11138915|NCT01448824|12325252|FG001|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
11138916|NCT01448824|12325253|FG002|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
11138917|NCT01448824|12325254|FG003|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10
11138918|NCT01448824|12325255|FG004|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16
11138919|NCT01448824|12325256|FG005|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
11138920|NCT01448824|12325257|FG006|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
11138921|NCT01448824|12325258|FG007|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0
11138922|NCT01448824|12325251|FG000|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12
11138923|NCT01448824|12325252|FG001|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
11138924|NCT01448824|12325253|FG002|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
11138925|NCT01448824|12325254|FG003|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9
11138926|NCT01448824|12325255|FG004|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14
11138927|NCT01448824|12325256|FG005|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10
11138928|NCT01448824|12325257|FG006|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11
11138929|NCT01448824|12325258|FG007|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
11138930|NCT01448824|12325251|FG000|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
11138931|NCT01448824|12325252|FG001|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
11138932|NCT01448824|12325253|FG002|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
11138933|NCT01448824|12325254|FG003|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
11138934|NCT01448824|12325255|FG004|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
11138935|NCT01448824|12325256|FG005|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
11138936|NCT01448824|12325257|FG006|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
11138937|NCT01448824|12325258|FG007|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
11138938|NCT01448824|12325251|FG000|STARTED|Part 1: Washout Period||12
11138939|NCT01448824|12325252|FG001|STARTED|Part 1: Washout Period||4
11138940|NCT01448824|12325253|FG002|STARTED|Part 1: Washout Period||4
11138941|NCT01448824|12325254|FG003|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
11138942|NCT01448824|12325255|FG004|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0
11138943|NCT01448824|12325256|FG005|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0
11138944|NCT01448824|12325257|FG006|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0
11138945|NCT01448824|12325258|FG007|STARTED|Part 1: Washout Period||0
11138946|NCT01448824|12325251|FG000|COMPLETED|Part 1: Washout Period||11
11138947|NCT01448824|12325252|FG001|COMPLETED|Part 1: Washout Period||4
11138948|NCT01448824|12325253|FG002|COMPLETED|Part 1: Washout Period||4
11138949|NCT01448824|12325254|FG003|COMPLETED|Part 1: Washout Period||0
11138950|NCT01448824|12325255|FG004|COMPLETED|Part 1: Washout Period||0
11138951|NCT01448824|12325256|FG005|COMPLETED|Part 1: Washout Period||0
11138952|NCT01448824|12325257|FG006|COMPLETED|Part 1: Washout Period||0
11138953|NCT01448824|12325258|FG007|COMPLETED|Part 1: Washout Period||0
11138954|NCT01448824|12325251|FG000|NOT COMPLETED|Part 1: Washout Period||1
11138955|NCT01448824|12325252|FG001|NOT COMPLETED|Part 1: Washout Period||0
11138956|NCT01448824|12325253|FG002|NOT COMPLETED|Part 1: Washout Period||0
11138957|NCT01448824|12325254|FG003|NOT COMPLETED|Part 1: Washout Period||0
11138958|NCT01448824|12325255|FG004|NOT COMPLETED|Part 1: Washout Period||0
11138959|NCT01448824|12325256|FG005|NOT COMPLETED|Part 1: Washout Period||0
11138960|NCT01448824|12325257|FG006|NOT COMPLETED|Part 1: Washout Period||0
11138961|NCT01448824|12325258|FG007|NOT COMPLETED|Part 1: Washout Period||0
11138962|NCT01448824|12325251|FG000|STARTED|Part 1 Period 2: Multiple Ascending Dose||11
11138963|NCT01448824|12325252|FG001|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
11138964|NCT01448824|12325253|FG002|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
11138965|NCT01448824|12325254|FG003|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
11138966|NCT01448824|12325255|FG004|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0
11138967|NCT01448824|12325256|FG005|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0
11138968|NCT01448824|12325257|FG006|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0
11138969|NCT01448824|12325258|FG007|STARTED|Part 1 Period 2: Multiple Ascending Dose||0
11138970|NCT01448824|12325251|FG000|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11
11138971|NCT01448824|12325252|FG001|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
11138972|NCT01448824|12325253|FG002|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
11138973|NCT01448824|12325254|FG003|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
11138974|NCT01448824|12325255|FG004|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
11138975|NCT01448824|12325256|FG005|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
11138976|NCT01448824|12325257|FG006|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
11138977|NCT01448824|12325258|FG007|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
11138978|NCT01448824|12325251|FG000|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11
11138979|NCT01448824|12325252|FG001|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
11138980|NCT01448824|12325253|FG002|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
11138981|NCT01448824|12325254|FG003|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
11138982|NCT01448824|12325255|FG004|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
11138983|NCT01448824|12325256|FG005|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
11138984|NCT01448824|12325257|FG006|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
11138985|NCT01448824|12325258|FG007|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
11138986|NCT01448824|12325251|FG000|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
11138987|NCT01448824|12325252|FG001|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
11138988|NCT01448824|12325253|FG002|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
11138989|NCT01448824|12325254|FG003|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
11138990|NCT01448824|12325255|FG004|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
11138991|NCT01448824|12325256|FG005|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
11138992|NCT01448824|12325257|FG006|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
11138993|NCT01448824|12325258|FG007|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
11138994|NCT01448824|12325251|FG000|STARTED|Part 2 Period 1: Drug-drug Interaction||0
11138995|NCT01448824|12325252|FG001|STARTED|Part 2 Period 1: Drug-drug Interaction||0
11138996|NCT01448824|12325253|FG002|STARTED|Part 2 Period 1: Drug-drug Interaction||0
11138997|NCT01448824|12325254|FG003|STARTED|Part 2 Period 1: Drug-drug Interaction||0
11138998|NCT01448824|12325255|FG004|STARTED|Part 2 Period 1: Drug-drug Interaction||0
11138999|NCT01448824|12325256|FG005|STARTED|Part 2 Period 1: Drug-drug Interaction||0
11139000|NCT01448824|12325257|FG006|STARTED|Part 2 Period 1: Drug-drug Interaction||0
11139001|NCT01448824|12325258|FG007|STARTED|Part 2 Period 1: Drug-drug Interaction||12
11139002|NCT01448824|12325251|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
11139003|NCT01448824|12325252|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
11139004|NCT01448824|12325253|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
11139005|NCT01448824|12325254|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
11139006|NCT01448824|12325255|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
11139007|NCT01448824|12325256|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
11139008|NCT01448824|12325257|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
11139009|NCT01448824|12325258|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12
11139010|NCT01448824|12325251|FG000|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
11139011|NCT01448824|12325252|FG001|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
11139012|NCT01448824|12325253|FG002|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
11139013|NCT01448824|12325254|FG003|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
11139014|NCT01448824|12325255|FG004|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
11139015|NCT01448824|12325256|FG005|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
11139016|NCT01448824|12325257|FG006|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
11139017|NCT01448824|12325258|FG007|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11
11139018|NCT01448824|12325251|FG000|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
11139019|NCT01448824|12325252|FG001|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
11139020|NCT01448824|12325253|FG002|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
11139021|NCT01448824|12325254|FG003|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
11139022|NCT01448824|12325255|FG004|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
11139023|NCT01448824|12325256|FG005|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
11139024|NCT01448824|12325257|FG006|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
11139025|NCT01448824|12325258|FG007|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1
11139026|NCT01448824|12325251|FG000|STARTED|Part 2: Washout Period||0
11139027|NCT01448824|12325252|FG001|STARTED|Part 2: Washout Period||0
11139028|NCT01448824|12325253|FG002|STARTED|Part 2: Washout Period||0
11139029|NCT01448824|12325254|FG003|STARTED|Part 2: Washout Period||0
11139030|NCT01448824|12325255|FG004|STARTED|Part 2: Washout Period||0
11139031|NCT01448824|12325256|FG005|STARTED|Part 2: Washout Period||0
11139032|NCT01448824|12325257|FG006|STARTED|Part 2: Washout Period||0
11139033|NCT01448824|12325258|FG007|STARTED|Part 2: Washout Period||11
11139034|NCT01448824|12325251|FG000|COMPLETED|Part 2: Washout Period||0
11139035|NCT01448824|12325252|FG001|COMPLETED|Part 2: Washout Period||0
11139036|NCT01448824|12325253|FG002|COMPLETED|Part 2: Washout Period||0
11139037|NCT01448824|12325254|FG003|COMPLETED|Part 2: Washout Period||0
11139038|NCT01448824|12325255|FG004|COMPLETED|Part 2: Washout Period||0
11139039|NCT01448824|12325256|FG005|COMPLETED|Part 2: Washout Period||0
11139040|NCT01448824|12325257|FG006|COMPLETED|Part 2: Washout Period||0
11139041|NCT01448824|12325258|FG007|COMPLETED|Part 2: Washout Period||11
11139042|NCT01448824|12325251|FG000|NOT COMPLETED|Part 2: Washout Period||0
11139043|NCT01448824|12325252|FG001|NOT COMPLETED|Part 2: Washout Period||0
11139044|NCT01448824|12325253|FG002|NOT COMPLETED|Part 2: Washout Period||0
11139045|NCT01448824|12325254|FG003|NOT COMPLETED|Part 2: Washout Period||0
11139046|NCT01448824|12325255|FG004|NOT COMPLETED|Part 2: Washout Period||0
11139047|NCT01448824|12325256|FG005|NOT COMPLETED|Part 2: Washout Period||0
11139048|NCT01448824|12325257|FG006|NOT COMPLETED|Part 2: Washout Period||0
11139049|NCT01448824|12325258|FG007|NOT COMPLETED|Part 2: Washout Period||0
11139050|NCT01448824|12325251|FG000|STARTED|Part 2 Period 2: Drug-drug Interaction||0
11139051|NCT01448824|12325252|FG001|STARTED|Part 2 Period 2: Drug-drug Interaction||0
11139052|NCT01448824|12325253|FG002|STARTED|Part 2 Period 2: Drug-drug Interaction||0
11139053|NCT01448824|12325254|FG003|STARTED|Part 2 Period 2: Drug-drug Interaction||0
11139054|NCT01448824|12325255|FG004|STARTED|Part 2 Period 2: Drug-drug Interaction||0
11139055|NCT01448824|12325256|FG005|STARTED|Part 2 Period 2: Drug-drug Interaction||0
11139056|NCT01448824|12325257|FG006|STARTED|Part 2 Period 2: Drug-drug Interaction||0
11139057|NCT01448824|12325258|FG007|STARTED|Part 2 Period 2: Drug-drug Interaction||11
11139058|NCT01448824|12325251|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
11139059|NCT01448824|12325252|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
11139060|NCT01448824|12325253|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
11139061|NCT01448824|12325254|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
11139062|NCT01448824|12325255|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
11139063|NCT01448824|12325256|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
11139064|NCT01448824|12325257|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
11139065|NCT01448824|12325258|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11
11139066|NCT01448824|12325251|FG000|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
11139067|NCT01448824|12325252|FG001|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
11139068|NCT01448824|12325253|FG002|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
11139069|NCT01448824|12325254|FG003|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
11139070|NCT01448824|12325255|FG004|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
11139071|NCT01448824|12325256|FG005|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
11139072|NCT01448824|12325257|FG006|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
11139073|NCT01448824|12325258|FG007|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10
11139074|NCT01448824|12325251|FG000|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
11139075|NCT01448824|12325252|FG001|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
11139076|NCT01448824|12325253|FG002|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
11139077|NCT01448824|12325254|FG003|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
11139078|NCT01448824|12325255|FG004|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
11139079|NCT01448824|12325256|FG005|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
11139080|NCT01448824|12325257|FG006|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
11139081|NCT01448824|12325258|FG007|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8
11139082|NCT01448824|12325251|FG000|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
11139083|NCT01448824|12325252|FG001|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
11139084|NCT01448824|12325253|FG002|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
11139085|NCT01448824|12325254|FG003|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
11139086|NCT01448824|12325255|FG004|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
11139087|NCT01448824|12325256|FG005|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
11139088|NCT01448824|12325257|FG006|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
11139089|NCT01448824|12325258|FG007|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3
11139090|NCT01448850|12325288|FG000|STARTED|Overall Study||164
11139091|NCT01448850|12325289|FG001|STARTED|Overall Study||160
11139092|NCT01448850|12325288|FG000|COMPLETED|Overall Study||130
11139093|NCT01448850|12325289|FG001|COMPLETED|Overall Study||120
11139094|NCT01448850|12325288|FG000|NOT COMPLETED|Overall Study||34
11139095|NCT01448850|12325289|FG001|NOT COMPLETED|Overall Study||40
11139096|NCT01449006|12325298|FG000|STARTED|Overall Study||8
11139097|NCT01449006|12325299|FG001|STARTED|Overall Study||9
11139098|NCT01449006|12325298|FG000|COMPLETED|Overall Study||5
11139099|NCT01449006|12325299|FG001|COMPLETED|Overall Study||9
11139100|NCT01449006|12325298|FG000|NOT COMPLETED|Overall Study||3
11139101|NCT01449006|12325299|FG001|NOT COMPLETED|Overall Study||0
11139102|NCT01449240|12325305|FG000|STARTED|Overall Study||10
11139103|NCT01449240|12325305|FG000|COMPLETED|Overall Study||10
11139104|NCT01449240|12325305|FG000|NOT COMPLETED|Overall Study||0
11139105|NCT01449266|12325309|FG000|STARTED|Overall Study||10
11139106|NCT01449266|12325309|FG000|COMPLETED|Overall Study||10
11139107|NCT01449266|12325309|FG000|NOT COMPLETED|Overall Study||0
11139108|NCT01449279|12325313|FG000|STARTED|Overall Study||22
11139109|NCT01449279|12325313|FG000|COMPLETED|Overall Study||15
11139110|NCT01449279|12325313|FG000|NOT COMPLETED|Overall Study||7
11139111|NCT01449305|12325317|FG000|STARTED|Overall Study||44
11139112|NCT01449305|12325317|FG000|COMPLETED|Overall Study||42
11139113|NCT01449305|12325317|FG000|NOT COMPLETED|Overall Study||2
11139114|NCT01449370|12325346|FG000|STARTED|Overall Study||6
11139115|NCT01449370|12325347|FG001|STARTED|Overall Study||6
11139116|NCT01449370|12325348|FG002|STARTED|Overall Study||8
11139117|NCT01449370|12325349|FG003|STARTED|Overall Study||4
11139118|NCT01449370|12325350|FG004|STARTED|Overall Study||3
11139119|NCT01449370|12325351|FG005|STARTED|Overall Study||3
11139120|NCT01449370|12325352|FG006|STARTED|Overall Study||3
11139121|NCT01449370|12325353|FG007|STARTED|Overall Study||3
11139122|NCT01449370|12325354|FG008|STARTED|Overall Study||12
11139123|NCT01449370|12325355|FG009|STARTED|Overall Study||3
11139124|NCT01449370|12325356|FG010|STARTED|Overall Study||3
11139125|NCT01449370|12325357|FG011|STARTED|Overall Study||3
11139126|NCT01449370|12325358|FG012|STARTED|Overall Study||3
11139127|NCT01449370|12325359|FG013|STARTED|Overall Study||11
11139128|NCT01449370|12325360|FG014|STARTED|Overall Study||3
11139129|NCT01449370|12325361|FG015|STARTED|Overall Study||3
11139130|NCT01449370|12325362|FG016|STARTED|Overall Study||7
11139131|NCT01449370|12325363|FG017|STARTED|Overall Study||3
11139132|NCT01449370|12325364|FG018|STARTED|Overall Study||3
11139133|NCT01449370|12325365|FG019|STARTED|Overall Study||3
11139134|NCT01449370|12325366|FG020|STARTED|Overall Study||6
11139135|NCT01449370|12325367|FG021|STARTED|Overall Study||4
11139136|NCT01449370|12325368|FG022|STARTED|Overall Study||4
11139137|NCT01449370|12325369|FG023|STARTED|Overall Study||10
11139138|NCT01449370|12325370|FG024|STARTED|Overall Study||8
11139139|NCT01449370|12325346|FG000|COMPLETED|Overall Study||0
11139140|NCT01449370|12325347|FG001|COMPLETED|Overall Study||0
11139141|NCT01449370|12325348|FG002|COMPLETED|Overall Study||0
11139142|NCT01449370|12325349|FG003|COMPLETED|Overall Study||0
11139143|NCT01449370|12325350|FG004|COMPLETED|Overall Study||0
11139144|NCT01449370|12325351|FG005|COMPLETED|Overall Study||0
11139145|NCT01449370|12325352|FG006|COMPLETED|Overall Study||0
11139146|NCT01449370|12325353|FG007|COMPLETED|Overall Study||0
11139147|NCT01449370|12325354|FG008|COMPLETED|Overall Study||0
11139148|NCT01449370|12325355|FG009|COMPLETED|Overall Study||0
11139149|NCT01449370|12325356|FG010|COMPLETED|Overall Study||0
11139150|NCT01449370|12325357|FG011|COMPLETED|Overall Study||0
11139151|NCT01449370|12325358|FG012|COMPLETED|Overall Study||0
11139152|NCT01449370|12325359|FG013|COMPLETED|Overall Study||0
11139153|NCT01449370|12325360|FG014|COMPLETED|Overall Study||0
11139154|NCT01449370|12325361|FG015|COMPLETED|Overall Study||0
11139155|NCT01449370|12325362|FG016|COMPLETED|Overall Study||0
11139156|NCT01449370|12325363|FG017|COMPLETED|Overall Study||0
11139157|NCT01449370|12325364|FG018|COMPLETED|Overall Study||0
11139158|NCT01449370|12325365|FG019|COMPLETED|Overall Study||0
11139159|NCT01449370|12325366|FG020|COMPLETED|Overall Study||0
11139160|NCT01449370|12325367|FG021|COMPLETED|Overall Study||0
11139161|NCT01449370|12325368|FG022|COMPLETED|Overall Study||0
11139162|NCT01449370|12325369|FG023|COMPLETED|Overall Study||0
11139163|NCT01449370|12325370|FG024|COMPLETED|Overall Study||0
11139164|NCT01449370|12325346|FG000|NOT COMPLETED|Overall Study||6
11139165|NCT01449370|12325347|FG001|NOT COMPLETED|Overall Study||6
11139166|NCT01449370|12325348|FG002|NOT COMPLETED|Overall Study||8
11139167|NCT01449370|12325349|FG003|NOT COMPLETED|Overall Study||4
11139168|NCT01449370|12325350|FG004|NOT COMPLETED|Overall Study||3
11139169|NCT01449370|12325351|FG005|NOT COMPLETED|Overall Study||3
11139170|NCT01449370|12325352|FG006|NOT COMPLETED|Overall Study||3
11139171|NCT01449370|12325353|FG007|NOT COMPLETED|Overall Study||3
11139172|NCT01449370|12325354|FG008|NOT COMPLETED|Overall Study||12
11139173|NCT01449370|12325355|FG009|NOT COMPLETED|Overall Study||3
11139174|NCT01449370|12325356|FG010|NOT COMPLETED|Overall Study||3
11139175|NCT01449370|12325357|FG011|NOT COMPLETED|Overall Study||3
11139176|NCT01449370|12325358|FG012|NOT COMPLETED|Overall Study||3
11139177|NCT01449370|12325359|FG013|NOT COMPLETED|Overall Study||11
11139178|NCT01449370|12325360|FG014|NOT COMPLETED|Overall Study||3
11139179|NCT01449370|12325361|FG015|NOT COMPLETED|Overall Study||3
11139180|NCT01449370|12325362|FG016|NOT COMPLETED|Overall Study||7
11139181|NCT01449370|12325363|FG017|NOT COMPLETED|Overall Study||3
11139182|NCT01449370|12325364|FG018|NOT COMPLETED|Overall Study||3
11139183|NCT01449370|12325365|FG019|NOT COMPLETED|Overall Study||3
11139184|NCT01449370|12325366|FG020|NOT COMPLETED|Overall Study||6
11139185|NCT01449370|12325367|FG021|NOT COMPLETED|Overall Study||4
11139186|NCT01449370|12325368|FG022|NOT COMPLETED|Overall Study||4
11139187|NCT01449370|12325369|FG023|NOT COMPLETED|Overall Study||10
11139188|NCT01449370|12325370|FG024|NOT COMPLETED|Overall Study||8
11139189|NCT01449461|12325449|FG000|STARTED|Overall Study||6
11139190|NCT01449461|12325450|FG001|STARTED|Overall Study||18
11139191|NCT01449461|12325451|FG002|STARTED|Overall Study||18
11139192|NCT01449461|12325452|FG003|STARTED|Overall Study||32
11139193|NCT01449461|12325453|FG004|STARTED|Overall Study||48
11139194|NCT01449461|12325454|FG005|STARTED|Overall Study||15
11139195|NCT01449461|12325449|FG000|COMPLETED|Overall Study||0
11139196|NCT01449461|12325450|FG001|COMPLETED|Overall Study||0
11139197|NCT01449461|12325451|FG002|COMPLETED|Overall Study||0
11139198|NCT01449461|12325452|FG003|COMPLETED|Overall Study||0
11139199|NCT01449461|12325453|FG004|COMPLETED|Overall Study||0
11139200|NCT01449461|12325454|FG005|COMPLETED|Overall Study||0
11139201|NCT01449461|12325449|FG000|NOT COMPLETED|Overall Study||6
11139202|NCT01449461|12325450|FG001|NOT COMPLETED|Overall Study||18
11139203|NCT01449461|12325451|FG002|NOT COMPLETED|Overall Study||18
11139204|NCT01449461|12325452|FG003|NOT COMPLETED|Overall Study||32
11139205|NCT01449461|12325453|FG004|NOT COMPLETED|Overall Study||48
11139206|NCT01449461|12325454|FG005|NOT COMPLETED|Overall Study||15
11139207|NCT01449513|12325479|FG000|STARTED|Overall Study||16
11139208|NCT01449513|12325480|FG001|STARTED|Overall Study||8
11139209|NCT01449513|12325479|FG000|COMPLETED|Overall Study||16
11139210|NCT01449513|12325480|FG001|COMPLETED|Overall Study||8
11139211|NCT01449513|12325479|FG000|NOT COMPLETED|Overall Study||0
11139212|NCT01449513|12325480|FG001|NOT COMPLETED|Overall Study||0
11139213|NCT01449526|12325488|FG000|STARTED|Overall Study||83
11139214|NCT01449526|12325489|FG001|STARTED|Overall Study||83
11139215|NCT01449526|12325488|FG000|COMPLETED|Overall Study||81
11139216|NCT01449526|12325489|FG001|COMPLETED|Overall Study||77
11139217|NCT01449526|12325488|FG000|NOT COMPLETED|Overall Study||2
11139218|NCT01449526|12325489|FG001|NOT COMPLETED|Overall Study||6
11139219|NCT01449539|12325495|FG000|STARTED|Overall Study||8
11139220|NCT01449539|12325495|FG000|COMPLETED|Overall Study||4
11139221|NCT01449539|12325495|FG000|NOT COMPLETED|Overall Study||4
11139222|NCT01449630|12325508|FG000|STARTED|Period 1||2
11139223|NCT01449630|12325509|FG001|STARTED|Period 1||6
11139224|NCT01449630|12325510|FG002|STARTED|Period 1||2
11139225|NCT01449630|12325511|FG003|STARTED|Period 1||2
11139226|NCT01449630|12325512|FG004|STARTED|Period 1||5
11139227|NCT01449630|12325513|FG005|STARTED|Period 1||2
11139228|NCT01449630|12325514|FG006|STARTED|Period 1||2
11139229|NCT01449630|12325515|FG007|STARTED|Period 1||6
11139230|NCT01449630|12325516|FG008|STARTED|Period 1||2
11139231|NCT01449630|12325508|FG000|Received at Least 1 Dose|Period 1||2
11139232|NCT01449630|12325509|FG001|Received at Least 1 Dose|Period 1||6
11139233|NCT01449630|12325510|FG002|Received at Least 1 Dose|Period 1||2
11139234|NCT01449630|12325511|FG003|Received at Least 1 Dose|Period 1||2
11139235|NCT01449630|12325512|FG004|Received at Least 1 Dose|Period 1||5
11241308|NCT02096744|12433756|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||1
11241309|NCT02096835|12433767|FG000|STARTED|Overall Study||53
11241310|NCT02096835|12433768|FG001|STARTED|Overall Study||53
11241311|NCT02096835|12433769|FG002|STARTED|Overall Study||51
11241312|NCT02096835|12433767|FG000|COMPLETED|Overall Study||50
11241313|NCT02096835|12433768|FG001|COMPLETED|Overall Study||53
11139236|NCT01449630|12325513|FG005|Received at Least 1 Dose|Period 1||1
11139237|NCT01449630|12325514|FG006|Received at Least 1 Dose|Period 1||2
11139238|NCT01449630|12325515|FG007|Received at Least 1 Dose|Period 1||6
11139239|NCT01449630|12325516|FG008|Received at Least 1 Dose|Period 1||2
11139240|NCT01449630|12325508|FG000|COMPLETED|Period 1||1
11139241|NCT01449630|12325509|FG001|COMPLETED|Period 1||6
11139242|NCT01449630|12325510|FG002|COMPLETED|Period 1||2
11139243|NCT01449630|12325511|FG003|COMPLETED|Period 1||1
11139244|NCT01449630|12325512|FG004|COMPLETED|Period 1||5
11139245|NCT01449630|12325513|FG005|COMPLETED|Period 1||1
11139246|NCT01449630|12325514|FG006|COMPLETED|Period 1||2
11139247|NCT01449630|12325515|FG007|COMPLETED|Period 1||6
11139248|NCT01449630|12325516|FG008|COMPLETED|Period 1||2
11139249|NCT01449630|12325508|FG000|NOT COMPLETED|Period 1||1
11139250|NCT01449630|12325509|FG001|NOT COMPLETED|Period 1||0
11139251|NCT01449630|12325510|FG002|NOT COMPLETED|Period 1||0
11139252|NCT01449630|12325511|FG003|NOT COMPLETED|Period 1||1
11139253|NCT01449630|12325512|FG004|NOT COMPLETED|Period 1||0
11139254|NCT01449630|12325513|FG005|NOT COMPLETED|Period 1||1
11139255|NCT01449630|12325514|FG006|NOT COMPLETED|Period 1||0
11139256|NCT01449630|12325515|FG007|NOT COMPLETED|Period 1||0
11139257|NCT01449630|12325516|FG008|NOT COMPLETED|Period 1||0
11139258|NCT01449630|12325508|FG000|STARTED|Period 2||1
11139259|NCT01449630|12325509|FG001|STARTED|Period 2||6
11139260|NCT01449630|12325510|FG002|STARTED|Period 2||2
11139261|NCT01449630|12325511|FG003|STARTED|Period 2||1
11139262|NCT01449630|12325512|FG004|STARTED|Period 2||5
11139263|NCT01449630|12325513|FG005|STARTED|Period 2||1
11139264|NCT01449630|12325514|FG006|STARTED|Period 2||2
11139265|NCT01449630|12325515|FG007|STARTED|Period 2||6
11139266|NCT01449630|12325516|FG008|STARTED|Period 2||2
11139267|NCT01449630|12325508|FG000|COMPLETED|Period 2||1
11139268|NCT01449630|12325509|FG001|COMPLETED|Period 2||6
11139269|NCT01449630|12325510|FG002|COMPLETED|Period 2||2
11139270|NCT01449630|12325511|FG003|COMPLETED|Period 2||1
11139271|NCT01449630|12325512|FG004|COMPLETED|Period 2||5
11139272|NCT01449630|12325513|FG005|COMPLETED|Period 2||1
11139273|NCT01449630|12325514|FG006|COMPLETED|Period 2||1
11139274|NCT01449630|12325515|FG007|COMPLETED|Period 2||6
11139275|NCT01449630|12325516|FG008|COMPLETED|Period 2||2
11139276|NCT01449630|12325508|FG000|NOT COMPLETED|Period 2||0
11139277|NCT01449630|12325509|FG001|NOT COMPLETED|Period 2||0
11139278|NCT01449630|12325510|FG002|NOT COMPLETED|Period 2||0
11139279|NCT01449630|12325511|FG003|NOT COMPLETED|Period 2||0
11139280|NCT01449630|12325512|FG004|NOT COMPLETED|Period 2||0
11139281|NCT01449630|12325513|FG005|NOT COMPLETED|Period 2||0
11139282|NCT01449630|12325514|FG006|NOT COMPLETED|Period 2||1
11139283|NCT01449630|12325515|FG007|NOT COMPLETED|Period 2||0
11139284|NCT01449630|12325516|FG008|NOT COMPLETED|Period 2||0
11139285|NCT01449630|12325508|FG000|STARTED|Period 3||1
11139286|NCT01449630|12325509|FG001|STARTED|Period 3||6
11139287|NCT01449630|12325510|FG002|STARTED|Period 3||2
11139288|NCT01449630|12325511|FG003|STARTED|Period 3||1
11139289|NCT01449630|12325512|FG004|STARTED|Period 3||5
11139290|NCT01449630|12325513|FG005|STARTED|Period 3||1
11139291|NCT01449630|12325514|FG006|STARTED|Period 3||1
11139292|NCT01449630|12325515|FG007|STARTED|Period 3||6
11139293|NCT01449630|12325516|FG008|STARTED|Period 3||2
11139294|NCT01449630|12325508|FG000|COMPLETED|Period 3||1
11139295|NCT01449630|12325509|FG001|COMPLETED|Period 3||6
11139296|NCT01449630|12325510|FG002|COMPLETED|Period 3||2
11139297|NCT01449630|12325511|FG003|COMPLETED|Period 3||1
11139298|NCT01449630|12325512|FG004|COMPLETED|Period 3||5
11139299|NCT01449630|12325513|FG005|COMPLETED|Period 3||1
11241314|NCT02096835|12433769|FG002|COMPLETED|Overall Study||50
11139300|NCT01449630|12325514|FG006|COMPLETED|Period 3||1
11139301|NCT01449630|12325515|FG007|COMPLETED|Period 3||6
11139302|NCT01449630|12325516|FG008|COMPLETED|Period 3||2
11139303|NCT01449630|12325508|FG000|NOT COMPLETED|Period 3||0
11139304|NCT01449630|12325509|FG001|NOT COMPLETED|Period 3||0
11139305|NCT01449630|12325510|FG002|NOT COMPLETED|Period 3||0
11139306|NCT01449630|12325511|FG003|NOT COMPLETED|Period 3||0
11139307|NCT01449630|12325512|FG004|NOT COMPLETED|Period 3||0
11139308|NCT01449630|12325513|FG005|NOT COMPLETED|Period 3||0
11139309|NCT01449630|12325514|FG006|NOT COMPLETED|Period 3||0
11139310|NCT01449630|12325515|FG007|NOT COMPLETED|Period 3||0
11139311|NCT01449630|12325516|FG008|NOT COMPLETED|Period 3||0
11139312|NCT01449682|12325540|FG000|STARTED|Overall Study||5
11139313|NCT01449682|12325541|FG001|STARTED|Overall Study||5
11139314|NCT01449682|12325540|FG000|COMPLETED|Overall Study||4
11139315|NCT01449682|12325541|FG001|COMPLETED|Overall Study||4
11241315|NCT02096835|12433767|FG000|NOT COMPLETED|Overall Study||3
11241316|NCT02096835|12433768|FG001|NOT COMPLETED|Overall Study||0
11139316|NCT01449682|12325540|FG000|NOT COMPLETED|Overall Study||1
11139317|NCT01449682|12325541|FG001|NOT COMPLETED|Overall Study||1
11139318|NCT01449708|12325549|FG000|STARTED|Overall Study||61
11139319|NCT01449708|12325550|FG001|STARTED|Overall Study||63
11139320|NCT01449708|12325549|FG000|COMPLETED|Overall Study||59
11139321|NCT01449708|12325550|FG001|COMPLETED|Overall Study||60
11139322|NCT01449708|12325549|FG000|NOT COMPLETED|Overall Study||2
11139323|NCT01449708|12325550|FG001|NOT COMPLETED|Overall Study||3
11139324|NCT01449721|12325561|FG000|STARTED|Overall Study||112
11139325|NCT01449721|12325562|FG001|STARTED|Overall Study||30
11139326|NCT01449721|12325561|FG000|COMPLETED|Overall Study||112
11139327|NCT01449721|12325562|FG001|COMPLETED|Overall Study||28
11139328|NCT01449721|12325561|FG000|NOT COMPLETED|Overall Study||0
11139329|NCT01449721|12325562|FG001|NOT COMPLETED|Overall Study||2
11139330|NCT01449734|12325568|FG000|STARTED|Overall Study||215
11139331|NCT01449734|12325568|FG000|COMPLETED|Overall Study||215
11139332|NCT01449734|12325568|FG000|NOT COMPLETED|Overall Study||0
11139333|NCT01449747|12325574|FG000|STARTED|Overall Study||12
11139334|NCT01449747|12325575|FG001|STARTED|Overall Study||12
11139335|NCT01449747|12325574|FG000|COMPLETED|Overall Study||12
11139336|NCT01449747|12325575|FG001|COMPLETED|Overall Study||12
11139337|NCT01449747|12325574|FG000|NOT COMPLETED|Overall Study||0
11139338|NCT01449747|12325575|FG001|NOT COMPLETED|Overall Study||0
11139339|NCT01449812|12325584|FG000|STARTED|Overall Study||272
11139340|NCT01449812|12325585|FG001|STARTED|Overall Study||273
11139341|NCT01449812|12325586|FG002|STARTED|Overall Study||280
11139342|NCT01449812|12325584|FG000|COMPLETED|Overall Study||270
11139343|NCT01449812|12325585|FG001|COMPLETED|Overall Study||273
11139344|NCT01449812|12325586|FG002|COMPLETED|Overall Study||279
11139345|NCT01449812|12325584|FG000|NOT COMPLETED|Overall Study||2
11139346|NCT01449812|12325585|FG001|NOT COMPLETED|Overall Study||0
11139347|NCT01449812|12325586|FG002|NOT COMPLETED|Overall Study||1
11139348|NCT01449864|12325594|FG000|STARTED|Overall Study||22
11139349|NCT01449864|12325594|FG000|COMPLETED|Overall Study||17
11139350|NCT01449864|12325594|FG000|NOT COMPLETED|Overall Study||5
11139351|NCT01449929|12325600|FG000|STARTED|Randomization Phase 96 Week||242
11139352|NCT01449929|12325601|FG001|STARTED|Randomization Phase 96 Week||242
11139353|NCT01449929|12325602|FG002|STARTED|Randomization Phase 96 Week||0
11139354|NCT01449929|12325600|FG000|COMPLETED|Randomization Phase 96 Week||209
11139355|NCT01449929|12325601|FG001|COMPLETED|Randomization Phase 96 Week||189
11139356|NCT01449929|12325602|FG002|COMPLETED|Randomization Phase 96 Week||0
11139357|NCT01449929|12325600|FG000|NOT COMPLETED|Randomization Phase 96 Week||33
11139358|NCT01449929|12325601|FG001|NOT COMPLETED|Randomization Phase 96 Week||53
11139359|NCT01449929|12325602|FG002|NOT COMPLETED|Randomization Phase 96 Week||0
11139360|NCT01449929|12325600|FG000|STARTED|Extension Phase Approximately 3 Years||0
11139361|NCT01449929|12325601|FG001|STARTED|Extension Phase Approximately 3 Years||0
11139362|NCT01449929|12325602|FG002|STARTED|Extension Phase Approximately 3 Years||123
11139363|NCT01449929|12325600|FG000|COMPLETED|Extension Phase Approximately 3 Years||0
11139364|NCT01449929|12325601|FG001|COMPLETED|Extension Phase Approximately 3 Years||0
11139365|NCT01449929|12325602|FG002|COMPLETED|Extension Phase Approximately 3 Years||115
11139366|NCT01449929|12325600|FG000|NOT COMPLETED|Extension Phase Approximately 3 Years||0
11139367|NCT01449929|12325601|FG001|NOT COMPLETED|Extension Phase Approximately 3 Years||0
11139368|NCT01449929|12325602|FG002|NOT COMPLETED|Extension Phase Approximately 3 Years||8
11139369|NCT01449955|12325614|FG000|STARTED|Overall Study||28
11139370|NCT01449955|12325615|FG001|STARTED|Overall Study||26
11139371|NCT01449955|12325614|FG000|COMPLETED|Overall Study||27
11139372|NCT01449955|12325615|FG001|COMPLETED|Overall Study||24
11139373|NCT01449955|12325614|FG000|NOT COMPLETED|Overall Study||1
11139374|NCT01449955|12325615|FG001|NOT COMPLETED|Overall Study||2
11139375|NCT01450007|12325631|FG000|STARTED|Overall Study||44
11139376|NCT01450007|12325632|FG001|STARTED|Overall Study||42
11139377|NCT01450007|12325633|FG002|STARTED|Overall Study||44
11139378|NCT01450007|12325631|FG000|COMPLETED|Overall Study||42
11139379|NCT01450007|12325632|FG001|COMPLETED|Overall Study||37
11139380|NCT01450007|12325633|FG002|COMPLETED|Overall Study||41
11139381|NCT01450007|12325631|FG000|NOT COMPLETED|Overall Study||2
11139382|NCT01450007|12325632|FG001|NOT COMPLETED|Overall Study||5
11139383|NCT01450007|12325633|FG002|NOT COMPLETED|Overall Study||3
11139384|NCT01450098|12325643|FG000|STARTED|Period 1||8
11139385|NCT01450098|12325644|FG001|STARTED|Period 1||31
11139386|NCT01450098|12325643|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
11139387|NCT01450098|12325644|FG001|Received at Least 1 Dose of Study Drug|Period 1||31
11139388|NCT01450098|12325643|FG000|COMPLETED|Period 1||8
11139389|NCT01450098|12325644|FG001|COMPLETED|Period 1||31
11139390|NCT01450098|12325643|FG000|NOT COMPLETED|Period 1||0
11139391|NCT01450098|12325644|FG001|NOT COMPLETED|Period 1||0
11139392|NCT01450098|12325643|FG000|STARTED|Washout Period of at Least 14 Days||8
11139393|NCT01450098|12325644|FG001|STARTED|Washout Period of at Least 14 Days||31
11139394|NCT01450098|12325643|FG000|COMPLETED|Washout Period of at Least 14 Days||8
11139395|NCT01450098|12325644|FG001|COMPLETED|Washout Period of at Least 14 Days||31
11139396|NCT01450098|12325643|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
11139397|NCT01450098|12325644|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0
11139398|NCT01450098|12325643|FG000|STARTED|Period 2||8
11139399|NCT01450098|12325644|FG001|STARTED|Period 2||31
11139400|NCT01450098|12325643|FG000|Received at Least 1 Dose of Study Drug|Period 2||8
11139401|NCT01450098|12325644|FG001|Received at Least 1 Dose of Study Drug|Period 2||31
11139402|NCT01450098|12325643|FG000|COMPLETED|Period 2||8
11139403|NCT01450098|12325644|FG001|COMPLETED|Period 2||31
11139404|NCT01450098|12325643|FG000|NOT COMPLETED|Period 2||0
11139405|NCT01450098|12325644|FG001|NOT COMPLETED|Period 2||0
11139406|NCT01450098|12325643|FG000|STARTED|Washout of at Least 14 Days||8
11139407|NCT01450098|12325644|FG001|STARTED|Washout of at Least 14 Days||31
11139408|NCT01450098|12325643|FG000|COMPLETED|Washout of at Least 14 Days||8
11139409|NCT01450098|12325644|FG001|COMPLETED|Washout of at Least 14 Days||31
11139410|NCT01450098|12325643|FG000|NOT COMPLETED|Washout of at Least 14 Days||0
11139411|NCT01450098|12325644|FG001|NOT COMPLETED|Washout of at Least 14 Days||0
11139412|NCT01450098|12325643|FG000|STARTED|Period 3||8
11139413|NCT01450098|12325644|FG001|STARTED|Period 3||31
11139414|NCT01450098|12325643|FG000|Received at Least 1 Dose of Study Drug|Period 3||8
11139415|NCT01450098|12325644|FG001|Received at Least 1 Dose of Study Drug|Period 3||30
11139416|NCT01450098|12325643|FG000|COMPLETED|Period 3||8
11139417|NCT01450098|12325644|FG001|COMPLETED|Period 3||28
11139418|NCT01450098|12325643|FG000|NOT COMPLETED|Period 3||0
11139419|NCT01450098|12325644|FG001|NOT COMPLETED|Period 3||3
11139420|NCT01450137|12325659|FG000|STARTED|Up to Week 12||20
11139421|NCT01450137|12325660|FG001|STARTED|Up to Week 12||10
11139422|NCT01450137|12325659|FG000|COMPLETED|Up to Week 12||18
11139423|NCT01450137|12325660|FG001|COMPLETED|Up to Week 12||7
11139424|NCT01450137|12325659|FG000|NOT COMPLETED|Up to Week 12||2
11139425|NCT01450137|12325660|FG001|NOT COMPLETED|Up to Week 12||3
11139426|NCT01450137|12325659|FG000|STARTED|Week 12 to Study End||18
11139427|NCT01450137|12325660|FG001|STARTED|Week 12 to Study End||7
11139428|NCT01450137|12325659|FG000|COMPLETED|Week 12 to Study End||18
11139429|NCT01450137|12325660|FG001|COMPLETED|Week 12 to Study End||5
11139430|NCT01450137|12325659|FG000|NOT COMPLETED|Week 12 to Study End||0
11139431|NCT01450137|12325660|FG001|NOT COMPLETED|Week 12 to Study End||2
11139432|NCT01450189|12325669|FG000|STARTED|Overall Study||9
11139433|NCT01450189|12325670|FG001|STARTED|Overall Study||18
11139434|NCT01450189|12325671|FG002|STARTED|Overall Study||19
11139435|NCT01450189|12325669|FG000|COMPLETED|Overall Study||9
11139436|NCT01450189|12325670|FG001|COMPLETED|Overall Study||18
11139437|NCT01450189|12325671|FG002|COMPLETED|Overall Study||19
11139438|NCT01450189|12325669|FG000|NOT COMPLETED|Overall Study||0
11139439|NCT01450189|12325670|FG001|NOT COMPLETED|Overall Study||0
11139440|NCT01450189|12325671|FG002|NOT COMPLETED|Overall Study||0
11139441|NCT01450306|12325688|FG000|STARTED|Overall Study||10
11139442|NCT01450306|12325689|FG001|STARTED|Overall Study||10
11139443|NCT01450306|12325688|FG000|COMPLETED|Overall Study||10
11139444|NCT01450306|12325689|FG001|COMPLETED|Overall Study||10
11139445|NCT01450306|12325688|FG000|NOT COMPLETED|Overall Study||0
11139446|NCT01450306|12325689|FG001|NOT COMPLETED|Overall Study||0
11139447|NCT01450319|12325695|FG000|STARTED|Overall Study||70
11139448|NCT01450319|12325695|FG000|COMPLETED|Overall Study||70
11139449|NCT01450319|12325695|FG000|NOT COMPLETED|Overall Study||0
11139450|NCT01450397|12325699|FG000|STARTED|Overall Study||5
11139451|NCT01450397|12325699|FG000|COMPLETED|Overall Study||5
11139452|NCT01450397|12325699|FG000|NOT COMPLETED|Overall Study||0
11139453|NCT01450540|12325705|FG000|STARTED|Overall Study||123
11139454|NCT01450540|12325706|FG001|STARTED|Overall Study||118
11139455|NCT01450540|12325705|FG000|COMPLETED|Overall Study||101
11139456|NCT01450540|12325706|FG001|COMPLETED|Overall Study||82
11139457|NCT01450540|12325705|FG000|NOT COMPLETED|Overall Study||22
11139458|NCT01450540|12325706|FG001|NOT COMPLETED|Overall Study||36
11139459|NCT01450683|12325714|FG000|STARTED|Overall Study||4
11139460|NCT01450683|12325714|FG000|COMPLETED|Overall Study||2
11139461|NCT01450683|12325714|FG000|NOT COMPLETED|Overall Study||2
11139462|NCT01450696|12325720|FG000|STARTED|Overall Study||148
11139463|NCT01450696|12325721|FG001|STARTED|Overall Study||148
11139464|NCT01450696|12325720|FG000|Treated (Safety Population)|Overall Study||147
11139465|NCT01450696|12325721|FG001|Treated (Safety Population)|Overall Study||147
11139466|NCT01450696|12325720|FG000|COMPLETED|Overall Study||0
11139467|NCT01450696|12325721|FG001|COMPLETED|Overall Study||0
11139468|NCT01450696|12325720|FG000|NOT COMPLETED|Overall Study||148
11139469|NCT01450696|12325721|FG001|NOT COMPLETED|Overall Study||148
11139470|NCT01450761|12325729|FG000|STARTED|Randomization||566
11139471|NCT01450761|12325730|FG001|STARTED|Randomization||566
11139472|NCT01450761|12325729|FG000|COMPLETED|Randomization||562
11005289|NCT00721955|12182953|FG000|COMPLETED|Overall Study||105
11005290|NCT00721955|12182954|FG001|COMPLETED|Overall Study||104
11005291|NCT00721955|12182955|FG002|COMPLETED|Overall Study||103
11005292|NCT00721955|12182953|FG000|NOT COMPLETED|Overall Study||0
11005293|NCT00721955|12182954|FG001|NOT COMPLETED|Overall Study||0
11005294|NCT00721955|12182955|FG002|NOT COMPLETED|Overall Study||2
11005295|NCT00721968|12182965|FG000|STARTED|Overall Study||27
11005296|NCT00721968|12182966|FG001|STARTED|Overall Study||17
11005297|NCT00721968|12182965|FG000|COMPLETED|Overall Study||25
11005298|NCT00721968|12182966|FG001|COMPLETED|Overall Study||17
11139473|NCT01450761|12325730|FG001|COMPLETED|Randomization||561
11139474|NCT01450761|12325729|FG000|NOT COMPLETED|Randomization||4
11139475|NCT01450761|12325730|FG001|NOT COMPLETED|Randomization||5
11139476|NCT01450761|12325729|FG000|STARTED|Lead-in Chemotherapy||562
11139477|NCT01450761|12325730|FG001|STARTED|Lead-in Chemotherapy||561
11139478|NCT01450761|12325729|FG000|COMPLETED|Lead-in Chemotherapy||478
11139479|NCT01450761|12325730|FG001|COMPLETED|Lead-in Chemotherapy||476
11139480|NCT01450761|12325729|FG000|NOT COMPLETED|Lead-in Chemotherapy||84
11139481|NCT01450761|12325730|FG001|NOT COMPLETED|Lead-in Chemotherapy||85
11139482|NCT01450761|12325729|FG000|STARTED|Treatment With Blinded Study Therapy||478
11139483|NCT01450761|12325730|FG001|STARTED|Treatment With Blinded Study Therapy||476
11139484|NCT01450761|12325729|FG000|COMPLETED|Treatment With Blinded Study Therapy||0
11139485|NCT01450761|12325730|FG001|COMPLETED|Treatment With Blinded Study Therapy||0
11139486|NCT01450761|12325729|FG000|NOT COMPLETED|Treatment With Blinded Study Therapy||478
11139487|NCT01450761|12325730|FG001|NOT COMPLETED|Treatment With Blinded Study Therapy||476
11139488|NCT01450787|12325738|FG000|STARTED|Overall Study||38
11139489|NCT01450787|12325739|FG001|STARTED|Overall Study||25
11139490|NCT01450787|12325738|FG000|COMPLETED|Overall Study||38
11139491|NCT01450787|12325739|FG001|COMPLETED|Overall Study||25
11139492|NCT01450787|12325738|FG000|NOT COMPLETED|Overall Study||0
11139493|NCT01450787|12325739|FG001|NOT COMPLETED|Overall Study||0
11139494|NCT01450800|12325747|FG000|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
11139495|NCT01450800|12325748|FG001|STARTED|Overall Study|81 participants were randomized to placebo|81
11139496|NCT01450800|12325747|FG000|COMPLETED|Overall Study||81
11139497|NCT01450800|12325748|FG001|COMPLETED|Overall Study||78
11139498|NCT01450800|12325747|FG000|NOT COMPLETED|Overall Study||1
11139499|NCT01450800|12325748|FG001|NOT COMPLETED|Overall Study||3
11139500|NCT01450813|12325760|FG000|STARTED|Overall Study||20
11139501|NCT01450813|12325761|FG001|STARTED|Overall Study||20
11139502|NCT01450813|12325762|FG002|STARTED|Overall Study||20
11139503|NCT01450813|12325763|FG003|STARTED|Overall Study||20
11139504|NCT01450813|12325760|FG000|COMPLETED|Overall Study||19
11139505|NCT01450813|12325761|FG001|COMPLETED|Overall Study||19
11139506|NCT01450813|12325762|FG002|COMPLETED|Overall Study||20
11139507|NCT01450813|12325763|FG003|COMPLETED|Overall Study||17
11139508|NCT01450813|12325760|FG000|NOT COMPLETED|Overall Study||1
11139509|NCT01450813|12325761|FG001|NOT COMPLETED|Overall Study||1
11139510|NCT01450813|12325762|FG002|NOT COMPLETED|Overall Study||0
11139511|NCT01450813|12325763|FG003|NOT COMPLETED|Overall Study||3
11139512|NCT01450826|12325777|FG000|STARTED|Overall Study||70
11139513|NCT01450826|12325778|FG001|STARTED|Overall Study||66
11139514|NCT01450826|12325777|FG000|COMPLETED|Overall Study||70
11139515|NCT01450826|12325778|FG001|COMPLETED|Overall Study||66
11139516|NCT01450826|12325777|FG000|NOT COMPLETED|Overall Study||0
11139517|NCT01450826|12325778|FG001|NOT COMPLETED|Overall Study||0
11139518|NCT01450943|12325787|FG000|STARTED|Overall Study||28
11139519|NCT01450943|12325788|FG001|STARTED|Overall Study||42
11139520|NCT01450943|12325789|FG002|STARTED|Overall Study||48
11139521|NCT01450943|12325787|FG000|COMPLETED|Overall Study||26
11139522|NCT01450943|12325788|FG001|COMPLETED|Overall Study||35
11139523|NCT01450943|12325789|FG002|COMPLETED|Overall Study||42
11139524|NCT01450943|12325787|FG000|NOT COMPLETED|Overall Study||2
11139525|NCT01450943|12325788|FG001|NOT COMPLETED|Overall Study||7
11139526|NCT01450943|12325789|FG002|NOT COMPLETED|Overall Study||6
11139527|NCT01451164|12325805|FG000|STARTED|Overall Study||115
11139528|NCT01451164|12325806|FG001|STARTED|Overall Study||115
11139529|NCT01451164|12325807|FG002|STARTED|Overall Study||113
11139530|NCT01451164|12325808|FG003|STARTED|Overall Study||116
11139531|NCT01451164|12325805|FG000|COMPLETED|Overall Study||72
11139532|NCT01451164|12325806|FG001|COMPLETED|Overall Study||81
11139533|NCT01451164|12325807|FG002|COMPLETED|Overall Study||68
11139534|NCT01451164|12325808|FG003|COMPLETED|Overall Study||70
11139535|NCT01451164|12325805|FG000|NOT COMPLETED|Overall Study||43
11139536|NCT01451164|12325806|FG001|NOT COMPLETED|Overall Study||34
11139537|NCT01451164|12325807|FG002|NOT COMPLETED|Overall Study||45
11139538|NCT01451164|12325808|FG003|NOT COMPLETED|Overall Study||46
11139539|NCT01451203|12325820|FG000|STARTED|Double-blind Treatment Period||158
11139540|NCT01451203|12325821|FG001|STARTED|Double-blind Treatment Period||161
11139541|NCT01451203|12325820|FG000|Received Treatment|Double-blind Treatment Period||157
11139542|NCT01451203|12325821|FG001|Received Treatment|Double-blind Treatment Period||159
11139543|NCT01451203|12325820|FG000|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
11139544|NCT01451203|12325821|FG001|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
11139545|NCT01451203|12325820|FG000|COMPLETED|Double-blind Treatment Period||73
11139546|NCT01451203|12325821|FG001|COMPLETED|Double-blind Treatment Period||111
11139547|NCT01451203|12325820|FG000|NOT COMPLETED|Double-blind Treatment Period||85
11139548|NCT01451203|12325821|FG001|NOT COMPLETED|Double-blind Treatment Period||50
11139549|NCT01451203|12325820|FG000|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
11139550|NCT01451203|12325821|FG001|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
11139551|NCT01451203|12325820|FG000|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
11139552|NCT01451203|12325821|FG001|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
11139553|NCT01451203|12325820|FG000|COMPLETED|Post-treatment Period||57
11139554|NCT01451203|12325821|FG001|COMPLETED|Post-treatment Period||74
11005299|NCT00721968|12182965|FG000|NOT COMPLETED|Overall Study||2
11139555|NCT01451203|12325820|FG000|NOT COMPLETED|Post-treatment Period||14
11139556|NCT01451203|12325821|FG001|NOT COMPLETED|Post-treatment Period||34
11139557|NCT01451372|12325827|FG000|STARTED|Overall Study||69
11139558|NCT01451372|12325827|FG000|COMPLETED|Overall Study||69
11139559|NCT01451372|12325827|FG000|NOT COMPLETED|Overall Study||0
11139560|NCT01451385|12325831|FG000|STARTED|Overall Study||376
11139561|NCT01451385|12325831|FG000|COMPLETED|Overall Study||285
11139562|NCT01451385|12325831|FG000|NOT COMPLETED|Overall Study||91
11139563|NCT01451398|12325837|FG000|STARTED|Overall Study||177
11005300|NCT00721968|12182966|FG001|NOT COMPLETED|Overall Study||0
11005301|NCT00722007|12182972|FG000|STARTED|Overall Study||147
11005302|NCT00722007|12182972|FG000|COMPLETED|Overall Study||117
11005303|NCT00722007|12182972|FG000|NOT COMPLETED|Overall Study||30
11005304|NCT00722020|12182979|FG000|STARTED|Overall Study||19
11005305|NCT00722020|12182980|FG001|STARTED|Overall Study||24
11139564|NCT01451398|12325838|FG001|STARTED|Overall Study||176
11139565|NCT01451398|12325837|FG000|COMPLETED|Overall Study||150
11139566|NCT01451398|12325838|FG001|COMPLETED|Overall Study||139
11241317|NCT02096835|12433769|FG002|NOT COMPLETED|Overall Study||1
11241318|NCT02096861|12433781|FG000|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
11241319|NCT02096861|12433782|FG001|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
11241320|NCT02096861|12433783|FG002|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
11241321|NCT02096861|12433784|FG003|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
11241322|NCT02096861|12433781|FG000|Drug Switching at Week 30|Overall Study||48
11241323|NCT02096861|12433782|FG001|Drug Switching at Week 30|Overall Study||44
11241324|NCT02096861|12433783|FG002|Drug Switching at Week 30|Overall Study||41
11241325|NCT02096861|12433784|FG003|Drug Switching at Week 30|Overall Study||47
11241326|NCT02096861|12433781|FG000|COMPLETED|Overall Study||44
11241327|NCT02096861|12433782|FG001|COMPLETED|Overall Study||40
11241328|NCT02096861|12433783|FG002|COMPLETED|Overall Study||37
11241329|NCT02096861|12433784|FG003|COMPLETED|Overall Study||45
11241330|NCT02096861|12433781|FG000|NOT COMPLETED|Overall Study||12
11241331|NCT02096861|12433782|FG001|NOT COMPLETED|Overall Study||15
11241332|NCT02096861|12433783|FG002|NOT COMPLETED|Overall Study||17
11241333|NCT02096861|12433784|FG003|NOT COMPLETED|Overall Study||10
11241334|NCT02096900|12433798|FG000|STARTED|Overall Study|Allocated to Midazolam|42
11241335|NCT02096900|12433799|FG001|STARTED|Overall Study|Allocated to Zolpidem|44
11241336|NCT02096900|12433798|FG000|COMPLETED|Overall Study||38
11241337|NCT02096900|12433799|FG001|COMPLETED|Overall Study||42
11241338|NCT02096900|12433798|FG000|NOT COMPLETED|Overall Study||4
11241339|NCT02096900|12433799|FG001|NOT COMPLETED|Overall Study||2
11241340|NCT02096952|12433805|FG000|STARTED|Overall Study||15
11241341|NCT02096952|12433805|FG000|COMPLETED|Overall Study||14
11241342|NCT02096952|12433805|FG000|NOT COMPLETED|Overall Study||1
11241343|NCT02097030|12433811|FG000|STARTED|First Intervention (3 Days)||15
11241344|NCT02097030|12433812|FG001|STARTED|First Intervention (3 Days)||17
11241345|NCT02097030|12433811|FG000|COMPLETED|First Intervention (3 Days)||14
11241346|NCT02097030|12433812|FG001|COMPLETED|First Intervention (3 Days)||16
11241347|NCT02097030|12433811|FG000|NOT COMPLETED|First Intervention (3 Days)||1
11241348|NCT02097030|12433812|FG001|NOT COMPLETED|First Intervention (3 Days)||1
11241349|NCT02097030|12433811|FG000|STARTED|Second Intervention (3 Days)||14
11241350|NCT02097030|12433812|FG001|STARTED|Second Intervention (3 Days)||16
11241351|NCT02097030|12433811|FG000|COMPLETED|Second Intervention (3 Days)||14
11241352|NCT02097030|12433812|FG001|COMPLETED|Second Intervention (3 Days)||16
11241353|NCT02097030|12433811|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
11241354|NCT02097030|12433812|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
11241355|NCT02097056|12433822|FG000|STARTED|Overall Study||171
11241356|NCT02097056|12433822|FG000|ParticipantsTreated|Overall Study||170
11241357|NCT02097056|12433822|FG000|COMPLETED|Overall Study||113
11241358|NCT02097056|12433822|FG000|NOT COMPLETED|Overall Study||58
11241359|NCT02097108|12433826|FG000|STARTED|Overall Study||11
11241360|NCT02097108|12433826|FG000|COMPLETED|Overall Study||9
11241361|NCT02097108|12433826|FG000|NOT COMPLETED|Overall Study||2
11241362|NCT02097238|12433830|FG000|STARTED|Overall Study||19
11241363|NCT02097238|12433830|FG000|COMPLETED|Overall Study||0
11241364|NCT02097238|12433830|FG000|NOT COMPLETED|Overall Study||19
11241365|NCT02097277|12433840|FG000|STARTED|Overall Study||24
11241366|NCT02097277|12433841|FG001|STARTED|Overall Study||24
11241367|NCT02097277|12433842|FG002|STARTED|Overall Study||24
11241368|NCT02097277|12433843|FG003|STARTED|Overall Study||24
11241369|NCT02097277|12433844|FG004|STARTED|Overall Study||24
11241370|NCT02097277|12433840|FG000|COMPLETED|Overall Study||22
11241371|NCT02097277|12433841|FG001|COMPLETED|Overall Study||21
11241372|NCT02097277|12433842|FG002|COMPLETED|Overall Study||22
11241373|NCT02097277|12433843|FG003|COMPLETED|Overall Study||20
11241374|NCT02097277|12433844|FG004|COMPLETED|Overall Study||23
11241375|NCT02097277|12433840|FG000|NOT COMPLETED|Overall Study||2
11241376|NCT02097277|12433841|FG001|NOT COMPLETED|Overall Study||3
11241377|NCT02097277|12433842|FG002|NOT COMPLETED|Overall Study||2
11241378|NCT02097277|12433843|FG003|NOT COMPLETED|Overall Study||4
11241379|NCT02097277|12433844|FG004|NOT COMPLETED|Overall Study||1
11241380|NCT02097290|12433860|FG000|STARTED|Overall Study||210
11241381|NCT02097290|12433860|FG000|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
11241382|NCT02097290|12433860|FG000|NOT COMPLETED|Overall Study||17
11241383|NCT02097303|12433864|FG000|STARTED|Overall Study||36
11139567|NCT01451398|12325837|FG000|NOT COMPLETED|Overall Study||27
11139568|NCT01451398|12325838|FG001|NOT COMPLETED|Overall Study||37
11139569|NCT01451411|12325846|FG000|STARTED|Overall Study||3
11139570|NCT01451411|12325847|FG001|STARTED|Overall Study||1
11139571|NCT01451411|12325846|FG000|COMPLETED|Overall Study||3
11139572|NCT01451411|12325847|FG001|COMPLETED|Overall Study||1
11139573|NCT01451411|12325846|FG000|NOT COMPLETED|Overall Study||0
11139574|NCT01451411|12325847|FG001|NOT COMPLETED|Overall Study||0
11139575|NCT01451424|12325857|FG000|STARTED|Overall Study||9
11139576|NCT01451424|12325858|FG001|STARTED|Overall Study||9
11139577|NCT01451424|12325859|FG002|STARTED|Overall Study||12
11241384|NCT02097303|12433864|FG000|COMPLETED|Overall Study||31
11241385|NCT02097303|12433864|FG000|NOT COMPLETED|Overall Study||5
11241386|NCT02097472|12433876|FG000|STARTED|Received Vaccination 1||18
11139578|NCT01451424|12325860|FG003|STARTED|Overall Study||10
11139579|NCT01451424|12325857|FG000|COMPLETED|Overall Study||8
11139580|NCT01451424|12325858|FG001|COMPLETED|Overall Study||7
11139581|NCT01451424|12325859|FG002|COMPLETED|Overall Study||11
11139582|NCT01451424|12325860|FG003|COMPLETED|Overall Study||5
11139583|NCT01451424|12325857|FG000|NOT COMPLETED|Overall Study||1
11139584|NCT01451424|12325858|FG001|NOT COMPLETED|Overall Study||2
11139585|NCT01451424|12325859|FG002|NOT COMPLETED|Overall Study||1
11139586|NCT01451424|12325860|FG003|NOT COMPLETED|Overall Study||5
11139587|NCT01451437|12325884|FG000|STARTED|Overall Study||1
11139588|NCT01451437|12325885|FG001|STARTED|Overall Study||1
11139589|NCT01451437|12325886|FG002|STARTED|Overall Study||3
11139590|NCT01451437|12325887|FG003|STARTED|Overall Study||1
11139591|NCT01451437|12325888|FG004|STARTED|Overall Study||4
11139592|NCT01451437|12325889|FG005|STARTED|Overall Study||3
11139593|NCT01451437|12325890|FG006|STARTED|Overall Study||6
11139594|NCT01451437|12325891|FG007|STARTED|Overall Study||3
11139595|NCT01451437|12325892|FG008|STARTED|Overall Study||4
11139596|NCT01451437|12325884|FG000|COMPLETED|Overall Study||0
11139597|NCT01451437|12325885|FG001|COMPLETED|Overall Study||0
11139598|NCT01451437|12325886|FG002|COMPLETED|Overall Study||0
11139599|NCT01451437|12325887|FG003|COMPLETED|Overall Study||0
11139600|NCT01451437|12325888|FG004|COMPLETED|Overall Study||0
11139601|NCT01451437|12325889|FG005|COMPLETED|Overall Study||0
11139602|NCT01451437|12325890|FG006|COMPLETED|Overall Study||0
11139603|NCT01451437|12325891|FG007|COMPLETED|Overall Study||0
11139604|NCT01451437|12325892|FG008|COMPLETED|Overall Study||0
11139605|NCT01451437|12325884|FG000|NOT COMPLETED|Overall Study||1
11139606|NCT01451437|12325885|FG001|NOT COMPLETED|Overall Study||1
11139607|NCT01451437|12325886|FG002|NOT COMPLETED|Overall Study||3
11139608|NCT01451437|12325887|FG003|NOT COMPLETED|Overall Study||1
11139609|NCT01451437|12325888|FG004|NOT COMPLETED|Overall Study||4
11139610|NCT01451437|12325889|FG005|NOT COMPLETED|Overall Study||3
11139611|NCT01451437|12325890|FG006|NOT COMPLETED|Overall Study||6
11139612|NCT01451437|12325891|FG007|NOT COMPLETED|Overall Study||3
11139613|NCT01451437|12325892|FG008|NOT COMPLETED|Overall Study||4
11139614|NCT01451463|12325921|FG000|STARTED|Overall Study||11
11139615|NCT01451463|12325921|FG000|COMPLETED|Overall Study||11
11139616|NCT01451463|12325921|FG000|NOT COMPLETED|Overall Study||0
11139617|NCT01451541|12325933|FG000|STARTED|Overall Study||283
11139618|NCT01451541|12325934|FG001|STARTED|Overall Study||282
11139619|NCT01451541|12325935|FG002|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
11139620|NCT01451541|12325933|FG000|COMPLETED|Overall Study||247
11139621|NCT01451541|12325934|FG001|COMPLETED|Overall Study||257
11139622|NCT01451541|12325935|FG002|COMPLETED|Overall Study||254
11139623|NCT01451541|12325933|FG000|NOT COMPLETED|Overall Study||36
11139624|NCT01451541|12325934|FG001|NOT COMPLETED|Overall Study||25
11139625|NCT01451541|12325935|FG002|NOT COMPLETED|Overall Study||27
11139626|NCT01451554|12325947|FG000|STARTED|Overall Study||33
11139627|NCT01451554|12325948|FG001|STARTED|Overall Study||32
11139628|NCT01451554|12325947|FG000|COMPLETED|Overall Study||19
11139629|NCT01451554|12325948|FG001|COMPLETED|Overall Study||23
11139630|NCT01451554|12325947|FG000|NOT COMPLETED|Overall Study||14
11139631|NCT01451554|12325948|FG001|NOT COMPLETED|Overall Study||9
11139632|NCT01451606|12325956|FG000|STARTED|Overall Study||16
11139633|NCT01451606|12325957|FG001|STARTED|Overall Study||18
11139634|NCT01451606|12325956|FG000|COMPLETED|Overall Study||12
11139635|NCT01451606|12325957|FG001|COMPLETED|Overall Study||15
11139636|NCT01451606|12325956|FG000|NOT COMPLETED|Overall Study||4
11139637|NCT01451606|12325957|FG001|NOT COMPLETED|Overall Study||3
11139638|NCT01451632|12325965|FG000|STARTED|Overall Study||8
11139639|NCT01451632|12325966|FG001|STARTED|Overall Study||4
11139640|NCT01451632|12325967|FG002|STARTED|Overall Study||3
11139641|NCT01451632|12325968|FG003|STARTED|Overall Study||3
11139642|NCT01451632|12325969|FG004|STARTED|Overall Study||4
11139643|NCT01451632|12325970|FG005|STARTED|Overall Study||4
11139644|NCT01451632|12325971|FG006|STARTED|Overall Study||8
11139645|NCT01451632|12325972|FG007|STARTED|Overall Study||6
11139646|NCT01451632|12325973|FG008|STARTED|Overall Study||4
11139647|NCT01451632|12325974|FG009|STARTED|Overall Study||4
11139648|NCT01451632|12325965|FG000|COMPLETED|Overall Study||8
11139649|NCT01451632|12325966|FG001|COMPLETED|Overall Study||4
11139650|NCT01451632|12325967|FG002|COMPLETED|Overall Study||3
11139651|NCT01451632|12325968|FG003|COMPLETED|Overall Study||3
11139652|NCT01451632|12325969|FG004|COMPLETED|Overall Study||4
11139653|NCT01451632|12325970|FG005|COMPLETED|Overall Study||4
11139654|NCT01451632|12325971|FG006|COMPLETED|Overall Study||8
11139655|NCT01451632|12325972|FG007|COMPLETED|Overall Study||6
11139656|NCT01451632|12325973|FG008|COMPLETED|Overall Study||4
11139657|NCT01451632|12325974|FG009|COMPLETED|Overall Study||4
11139658|NCT01451632|12325965|FG000|NOT COMPLETED|Overall Study||0
11139659|NCT01451632|12325966|FG001|NOT COMPLETED|Overall Study||0
11139660|NCT01451632|12325967|FG002|NOT COMPLETED|Overall Study||0
11139661|NCT01451632|12325968|FG003|NOT COMPLETED|Overall Study||0
11139662|NCT01451632|12325969|FG004|NOT COMPLETED|Overall Study||0
11139663|NCT01451632|12325970|FG005|NOT COMPLETED|Overall Study||0
11139664|NCT01451632|12325971|FG006|NOT COMPLETED|Overall Study||0
11139665|NCT01451632|12325972|FG007|NOT COMPLETED|Overall Study||0
11139666|NCT01451632|12325973|FG008|NOT COMPLETED|Overall Study||0
11139667|NCT01451632|12325974|FG009|NOT COMPLETED|Overall Study||0
11139668|NCT01451645|12326001|FG000|STARTED|Overall Study||41
11139669|NCT01451645|12326002|FG001|STARTED|Overall Study||41
11139670|NCT01451645|12326001|FG000|COMPLETED|Overall Study||32
11139671|NCT01451645|12326002|FG001|COMPLETED|Overall Study||33
11139672|NCT01451645|12326001|FG000|NOT COMPLETED|Overall Study||9
11139673|NCT01451645|12326002|FG001|NOT COMPLETED|Overall Study||8
11139674|NCT01451749|12326010|FG000|STARTED|Overall Study||216
11139675|NCT01451749|12326011|FG001|STARTED|Overall Study||108
11139676|NCT01451749|12326010|FG000|COMPLETED|Overall Study||184
11139677|NCT01451749|12326011|FG001|COMPLETED|Overall Study||94
11139678|NCT01451749|12326010|FG000|NOT COMPLETED|Overall Study||32
11139679|NCT01451749|12326011|FG001|NOT COMPLETED|Overall Study||14
11139680|NCT01451762|12326022|FG000|STARTED|Overall Study||30
11139681|NCT01451762|12326023|FG001|STARTED|Overall Study||30
11139682|NCT01451762|12326024|FG002|STARTED|Overall Study||30
11139683|NCT01451762|12326022|FG000|COMPLETED|Overall Study||27
11139684|NCT01451762|12326023|FG001|COMPLETED|Overall Study||24
11139685|NCT01451762|12326024|FG002|COMPLETED|Overall Study||24
11139686|NCT01451762|12326022|FG000|NOT COMPLETED|Overall Study||3
11139687|NCT01451762|12326023|FG001|NOT COMPLETED|Overall Study||6
11139688|NCT01451762|12326024|FG002|NOT COMPLETED|Overall Study||6
11139689|NCT01451775|12326032|FG000|STARTED|Overall Study||3
11139690|NCT01451775|12326033|FG001|STARTED|Overall Study||3
11139691|NCT01451775|12326034|FG002|STARTED|Overall Study||3
11139692|NCT01451775|12326035|FG003|STARTED|Overall Study||3
11139693|NCT01451775|12326036|FG004|STARTED|Overall Study||3
11139694|NCT01451775|12326037|FG005|STARTED|Overall Study||3
11139695|NCT01451775|12326032|FG000|COMPLETED|Overall Study||3
11139696|NCT01451775|12326033|FG001|COMPLETED|Overall Study||3
11139697|NCT01451775|12326034|FG002|COMPLETED|Overall Study||3
11139698|NCT01451775|12326035|FG003|COMPLETED|Overall Study||3
11139699|NCT01451775|12326036|FG004|COMPLETED|Overall Study||3
11139700|NCT01451775|12326037|FG005|COMPLETED|Overall Study||3
11139701|NCT01451775|12326032|FG000|NOT COMPLETED|Overall Study||0
11139702|NCT01451775|12326033|FG001|NOT COMPLETED|Overall Study||0
11139703|NCT01451775|12326034|FG002|NOT COMPLETED|Overall Study||0
11139704|NCT01451775|12326035|FG003|NOT COMPLETED|Overall Study||0
11139705|NCT01451775|12326036|FG004|NOT COMPLETED|Overall Study||0
11139706|NCT01451775|12326037|FG005|NOT COMPLETED|Overall Study||0
11139707|NCT01451814|12326047|FG000|STARTED|Overall Study||35
11139708|NCT01451814|12326048|FG001|STARTED|Overall Study||31
11139709|NCT01451814|12326047|FG000|Attended a Session|Overall Study||35
11139710|NCT01451814|12326048|FG001|Attended a Session|Overall Study||31
11139711|NCT01451814|12326047|FG000|COMPLETED|Overall Study||29
11139712|NCT01451814|12326048|FG001|COMPLETED|Overall Study||26
11139713|NCT01451814|12326047|FG000|NOT COMPLETED|Overall Study||6
11139714|NCT01451814|12326048|FG001|NOT COMPLETED|Overall Study||5
11139715|NCT01451827|12326058|FG000|STARTED|Overall Study||45
11139716|NCT01451827|12326059|FG001|STARTED|Overall Study||45
11139717|NCT01451827|12326060|FG002|STARTED|Overall Study||44
11139718|NCT01451827|12326061|FG003|STARTED|Overall Study||43
11139719|NCT01451827|12326058|FG000|COMPLETED|Overall Study||42
11139720|NCT01451827|12326059|FG001|COMPLETED|Overall Study||40
11139721|NCT01451827|12326060|FG002|COMPLETED|Overall Study||42
11139722|NCT01451827|12326061|FG003|COMPLETED|Overall Study||39
11139723|NCT01451827|12326058|FG000|NOT COMPLETED|Overall Study||3
11139724|NCT01451827|12326059|FG001|NOT COMPLETED|Overall Study||5
11139725|NCT01451827|12326060|FG002|NOT COMPLETED|Overall Study||2
11139726|NCT01451827|12326061|FG003|NOT COMPLETED|Overall Study||4
11139727|NCT01451931|12326074|FG000|STARTED|Overall Study||909
11139728|NCT01451931|12326075|FG001|STARTED|Overall Study||901
11139729|NCT01451931|12326076|FG002|STARTED|Overall Study||966
11139730|NCT01451931|12326074|FG000|Baseline Data Collection|Overall Study||908
11139731|NCT01451931|12326075|FG001|Baseline Data Collection|Overall Study||893
11139732|NCT01451931|12326076|FG002|Baseline Data Collection|Overall Study||958
11139733|NCT01451931|12326074|FG000|6-month Follow up|Overall Study||876
11139734|NCT01451931|12326075|FG001|6-month Follow up|Overall Study||843
11139735|NCT01451931|12326076|FG002|6-month Follow up|Overall Study||923
11139736|NCT01451931|12326074|FG000|COMPLETED|Overall Study||876
11139737|NCT01451931|12326075|FG001|COMPLETED|Overall Study||843
11139738|NCT01451931|12326076|FG002|COMPLETED|Overall Study||923
11139739|NCT01451931|12326074|FG000|NOT COMPLETED|Overall Study||33
11139740|NCT01451931|12326075|FG001|NOT COMPLETED|Overall Study||58
11139741|NCT01451931|12326076|FG002|NOT COMPLETED|Overall Study||43
11139742|NCT01451983|12326089|FG000|STARTED|Overall Study||26
11139743|NCT01451983|12326090|FG001|STARTED|Overall Study||27
11139744|NCT01451983|12326091|FG002|STARTED|Overall Study||61
11139745|NCT01451983|12326092|FG003|STARTED|Overall Study||24
11139746|NCT01451983|12326089|FG000|COMPLETED|Overall Study||26
11139747|NCT01451983|12326090|FG001|COMPLETED|Overall Study||27
11139748|NCT01451983|12326091|FG002|COMPLETED|Overall Study||61
11139749|NCT01451983|12326092|FG003|COMPLETED|Overall Study||24
11139750|NCT01451983|12326089|FG000|NOT COMPLETED|Overall Study||0
11139751|NCT01451983|12326090|FG001|NOT COMPLETED|Overall Study||0
11139752|NCT01451983|12326091|FG002|NOT COMPLETED|Overall Study||0
11139753|NCT01451983|12326092|FG003|NOT COMPLETED|Overall Study||0
11139754|NCT01451996|12326106|FG000|STARTED|Overall Study||83
11139755|NCT01451996|12326107|FG001|STARTED|Overall Study||87
11139756|NCT01451996|12326108|FG002|STARTED|Overall Study||85
11139757|NCT01451996|12326109|FG003|STARTED|Overall Study||85
11139758|NCT01451996|12326106|FG000|COMPLETED|Overall Study||83
11139759|NCT01451996|12326107|FG001|COMPLETED|Overall Study||87
11139760|NCT01451996|12326108|FG002|COMPLETED|Overall Study||85
11139761|NCT01451996|12326109|FG003|COMPLETED|Overall Study||85
11139762|NCT01451996|12326106|FG000|NOT COMPLETED|Overall Study||0
11139763|NCT01451996|12326107|FG001|NOT COMPLETED|Overall Study||0
11139764|NCT01451996|12326108|FG002|NOT COMPLETED|Overall Study||0
11139765|NCT01451996|12326109|FG003|NOT COMPLETED|Overall Study||0
11139766|NCT01452126|12326119|FG000|STARTED|Overall Study||49
11139767|NCT01452126|12326119|FG000|COMPLETED|Overall Study||49
11139768|NCT01452126|12326119|FG000|NOT COMPLETED|Overall Study||0
11139769|NCT01452191|12326130|FG000|STARTED|Overall Study||373
11139770|NCT01452191|12326131|FG001|STARTED|Overall Study||369
11139771|NCT01452191|12326132|FG002|STARTED|Overall Study||370
11139772|NCT01452191|12326130|FG000|COMPLETED|Overall Study||241
11139773|NCT01452191|12326131|FG001|COMPLETED|Overall Study||252
11139774|NCT01452191|12326132|FG002|COMPLETED|Overall Study||258
11139775|NCT01452191|12326130|FG000|NOT COMPLETED|Overall Study||132
11139776|NCT01452191|12326131|FG001|NOT COMPLETED|Overall Study||117
11139777|NCT01452191|12326132|FG002|NOT COMPLETED|Overall Study||112
11139778|NCT01452269|12326142|FG000|STARTED|Overall Study||48
11139779|NCT01452269|12326143|FG001|STARTED|Overall Study||56
11139780|NCT01452269|12326142|FG000|COMPLETED|Overall Study||47
11139781|NCT01452269|12326143|FG001|COMPLETED|Overall Study||51
11139782|NCT01452269|12326142|FG000|NOT COMPLETED|Overall Study||1
11139783|NCT01452269|12326143|FG001|NOT COMPLETED|Overall Study||5
11139784|NCT01452347|12326151|FG000|STARTED|Overall Study||168
11139785|NCT01452347|12326152|FG001|STARTED|Overall Study||84
11139786|NCT01452347|12326151|FG000|COMPLETED|Overall Study||151
11241387|NCT02097472|12433877|FG001|STARTED|Received Vaccination 1||18
11241388|NCT02097472|12433878|FG002|STARTED|Received Vaccination 1||18
11241389|NCT02097472|12433879|FG003|STARTED|Received Vaccination 1||50
11241390|NCT02097472|12433880|FG004|STARTED|Received Vaccination 1||50
11241391|NCT02097472|12433881|FG005|STARTED|Received Vaccination 1||50
11241392|NCT02097472|12433882|FG006|STARTED|Received Vaccination 1||50
11241393|NCT02097472|12433883|FG007|STARTED|Received Vaccination 1||50
11241394|NCT02097472|12433876|FG000|COMPLETED|Received Vaccination 1||18
11241395|NCT02097472|12433877|FG001|COMPLETED|Received Vaccination 1||18
11241396|NCT02097472|12433878|FG002|COMPLETED|Received Vaccination 1||18
11241397|NCT02097472|12433879|FG003|COMPLETED|Received Vaccination 1||50
11241398|NCT02097472|12433880|FG004|COMPLETED|Received Vaccination 1||50
11241399|NCT02097472|12433881|FG005|COMPLETED|Received Vaccination 1||50
11241400|NCT02097472|12433882|FG006|COMPLETED|Received Vaccination 1||50
11241401|NCT02097472|12433883|FG007|COMPLETED|Received Vaccination 1||50
11241402|NCT02097472|12433876|FG000|NOT COMPLETED|Received Vaccination 1||0
11241403|NCT02097472|12433877|FG001|NOT COMPLETED|Received Vaccination 1||0
11241404|NCT02097472|12433878|FG002|NOT COMPLETED|Received Vaccination 1||0
11241405|NCT02097472|12433879|FG003|NOT COMPLETED|Received Vaccination 1||0
11241406|NCT02097472|12433880|FG004|NOT COMPLETED|Received Vaccination 1||0
11241407|NCT02097472|12433881|FG005|NOT COMPLETED|Received Vaccination 1||0
11241408|NCT02097472|12433882|FG006|NOT COMPLETED|Received Vaccination 1||0
11241409|NCT02097472|12433883|FG007|NOT COMPLETED|Received Vaccination 1||0
11241410|NCT02097472|12433876|FG000|STARTED|Received Vaccination 2||18
11241411|NCT02097472|12433877|FG001|STARTED|Received Vaccination 2||18
11241412|NCT02097472|12433878|FG002|STARTED|Received Vaccination 2||18
11241413|NCT02097472|12433879|FG003|STARTED|Received Vaccination 2||50
11241414|NCT02097472|12433880|FG004|STARTED|Received Vaccination 2||50
11241415|NCT02097472|12433881|FG005|STARTED|Received Vaccination 2||50
11241416|NCT02097472|12433882|FG006|STARTED|Received Vaccination 2||50
11241417|NCT02097472|12433883|FG007|STARTED|Received Vaccination 2||50
11241418|NCT02097472|12433876|FG000|COMPLETED|Received Vaccination 2||18
11241419|NCT02097472|12433877|FG001|COMPLETED|Received Vaccination 2||18
11241420|NCT02097472|12433878|FG002|COMPLETED|Received Vaccination 2||18
11241421|NCT02097472|12433879|FG003|COMPLETED|Received Vaccination 2||50
11241422|NCT02097472|12433880|FG004|COMPLETED|Received Vaccination 2||50
11241423|NCT02097472|12433881|FG005|COMPLETED|Received Vaccination 2||50
11241424|NCT02097472|12433882|FG006|COMPLETED|Received Vaccination 2||49
11241425|NCT02097472|12433883|FG007|COMPLETED|Received Vaccination 2||50
11241426|NCT02097472|12433876|FG000|NOT COMPLETED|Received Vaccination 2||0
11241427|NCT02097472|12433877|FG001|NOT COMPLETED|Received Vaccination 2||0
11241428|NCT02097472|12433878|FG002|NOT COMPLETED|Received Vaccination 2||0
11241429|NCT02097472|12433879|FG003|NOT COMPLETED|Received Vaccination 2||0
11139787|NCT01452347|12326152|FG001|COMPLETED|Overall Study||77
11139788|NCT01452347|12326151|FG000|NOT COMPLETED|Overall Study||17
11139789|NCT01452347|12326152|FG001|NOT COMPLETED|Overall Study||7
11139790|NCT01452412|12326162|FG000|STARTED|Overall Study||74
11139791|NCT01452412|12326163|FG001|STARTED|Overall Study||75
11139792|NCT01452412|12326162|FG000|COMPLETED|Overall Study||46
11139793|NCT01452412|12326163|FG001|COMPLETED|Overall Study||58
11241430|NCT02097472|12433880|FG004|NOT COMPLETED|Received Vaccination 2||0
11241431|NCT02097472|12433881|FG005|NOT COMPLETED|Received Vaccination 2||0
11139794|NCT01452412|12326162|FG000|NOT COMPLETED|Overall Study||28
11139795|NCT01452412|12326163|FG001|NOT COMPLETED|Overall Study||17
11139796|NCT01452425|12326169|FG000|STARTED|Overall Study||10
11139797|NCT01452425|12326169|FG000|COMPLETED|Overall Study||10
11139798|NCT01452425|12326169|FG000|NOT COMPLETED|Overall Study||0
11139799|NCT01452529|12326176|FG000|STARTED|Run-in Period||905
11139800|NCT01452529|12326177|FG001|STARTED|Run-in Period||0
11139801|NCT01452529|12326178|FG002|STARTED|Run-in Period||0
11139802|NCT01452529|12326176|FG000|COMPLETED|Run-in Period||592
11139803|NCT01452529|12326177|FG001|COMPLETED|Run-in Period||0
11139804|NCT01452529|12326178|FG002|COMPLETED|Run-in Period||0
11139805|NCT01452529|12326176|FG000|NOT COMPLETED|Run-in Period||313
11139806|NCT01452529|12326177|FG001|NOT COMPLETED|Run-in Period||0
11139807|NCT01452529|12326178|FG002|NOT COMPLETED|Run-in Period||0
11139808|NCT01452529|12326176|FG000|STARTED|Double-blind (DB) Period||0
11139809|NCT01452529|12326177|FG001|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
11139810|NCT01452529|12326178|FG002|STARTED|Double-blind (DB) Period||292
11139811|NCT01452529|12326176|FG000|COMPLETED|Double-blind (DB) Period||0
11139812|NCT01452529|12326177|FG001|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
11139813|NCT01452529|12326178|FG002|COMPLETED|Double-blind (DB) Period||210
11139814|NCT01452529|12326176|FG000|NOT COMPLETED|Double-blind (DB) Period||0
11139815|NCT01452529|12326177|FG001|NOT COMPLETED|Double-blind (DB) Period||67
11139816|NCT01452529|12326178|FG002|NOT COMPLETED|Double-blind (DB) Period||82
11139817|NCT01452789|12326187|FG000|STARTED|Overall Study||33
11139818|NCT01452789|12326188|FG001|STARTED|Overall Study||30
11139819|NCT01452789|12326187|FG000|COMPLETED|Overall Study||30
11139820|NCT01452789|12326188|FG001|COMPLETED|Overall Study||28
11139821|NCT01452789|12326187|FG000|NOT COMPLETED|Overall Study||3
11139822|NCT01452789|12326188|FG001|NOT COMPLETED|Overall Study||2
11139823|NCT01453023|12326194|FG000|STARTED|Treatment Period (TP) 1||13
11139824|NCT01453023|12326195|FG001|STARTED|Treatment Period (TP) 1||13
11139825|NCT01453023|12326194|FG000|COMPLETED|Treatment Period (TP) 1||12
11139826|NCT01453023|12326195|FG001|COMPLETED|Treatment Period (TP) 1||12
11139827|NCT01453023|12326194|FG000|NOT COMPLETED|Treatment Period (TP) 1||1
11139828|NCT01453023|12326195|FG001|NOT COMPLETED|Treatment Period (TP) 1||1
11139829|NCT01453023|12326194|FG000|STARTED|Washout Period||12
11139830|NCT01453023|12326195|FG001|STARTED|Washout Period||12
11139831|NCT01453023|12326194|FG000|COMPLETED|Washout Period||12
11139832|NCT01453023|12326195|FG001|COMPLETED|Washout Period||12
11139833|NCT01453023|12326194|FG000|NOT COMPLETED|Washout Period||0
11139834|NCT01453023|12326195|FG001|NOT COMPLETED|Washout Period||0
11139835|NCT01453023|12326194|FG000|STARTED|Treatment Period 2||12
11139836|NCT01453023|12326195|FG001|STARTED|Treatment Period 2||12
11139837|NCT01453023|12326194|FG000|COMPLETED|Treatment Period 2||12
11139838|NCT01453023|12326195|FG001|COMPLETED|Treatment Period 2||11
11139839|NCT01453023|12326194|FG000|NOT COMPLETED|Treatment Period 2||0
11139840|NCT01453023|12326195|FG001|NOT COMPLETED|Treatment Period 2||1
11139841|NCT01453036|12326204|FG000|STARTED|Overall Study||308
11139842|NCT01453036|12326205|FG001|STARTED|Overall Study||308
11139843|NCT01453036|12326206|FG002|STARTED|Overall Study||308
11139844|NCT01453036|12326204|FG000|COMPLETED|Overall Study||282
11139845|NCT01453036|12326205|FG001|COMPLETED|Overall Study||193
11139846|NCT01453036|12326206|FG002|COMPLETED|Overall Study||277
11139847|NCT01453036|12326204|FG000|NOT COMPLETED|Overall Study||26
11139848|NCT01453036|12326205|FG001|NOT COMPLETED|Overall Study||115
11139849|NCT01453036|12326206|FG002|NOT COMPLETED|Overall Study||31
11139850|NCT01453049|12326216|FG000|STARTED|Overall Study||42
11139851|NCT01453049|12326217|FG001|STARTED|Overall Study||44
11139852|NCT01453049|12326216|FG000|COMPLETED|Overall Study||1
11139853|NCT01453049|12326217|FG001|COMPLETED|Overall Study||2
11139854|NCT01453049|12326216|FG000|NOT COMPLETED|Overall Study||41
11139855|NCT01453049|12326217|FG001|NOT COMPLETED|Overall Study||42
11202466|NCT01840163|12392842|FG000|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
11202467|NCT01840163|12392843|FG001|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
11202468|NCT01840163|12392842|FG000|COMPLETED|Systemic Follow Up-secondary Outcome||174
11202469|NCT01840163|12392843|FG001|COMPLETED|Systemic Follow Up-secondary Outcome||191
11202470|NCT01840163|12392842|FG000|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
11202471|NCT01840163|12392843|FG001|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
11202472|NCT01840228|12392851|FG000|STARTED|Overall Study||19
11202473|NCT01840228|12392852|FG001|STARTED|Overall Study||19
11202474|NCT01840228|12392851|FG000|COMPLETED|Overall Study||18
11202475|NCT01840228|12392852|FG001|COMPLETED|Overall Study||18
11202476|NCT01840228|12392851|FG000|NOT COMPLETED|Overall Study||1
11202477|NCT01840228|12392852|FG001|NOT COMPLETED|Overall Study||1
11202478|NCT01840319|12392862|FG000|STARTED|Overall Study||156
11202479|NCT01840319|12392862|FG000|COMPLETED|Overall Study||156
11202480|NCT01840319|12392862|FG000|NOT COMPLETED|Overall Study||0
11241432|NCT02097472|12433882|FG006|NOT COMPLETED|Received Vaccination 2||1
11202481|NCT01840345|12392866|FG000|STARTED|Overall Study||11
11202482|NCT01840345|12392866|FG000|COMPLETED|Overall Study||10
11202483|NCT01840345|12392866|FG000|NOT COMPLETED|Overall Study||1
11202484|NCT01840410|12392872|FG000|STARTED|Overall Study||119
11202485|NCT01840410|12392873|FG001|STARTED|Overall Study||59
11202486|NCT01840410|12392872|FG000|Safety Set|Overall Study||119
11202487|NCT01840410|12392873|FG001|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
11202488|NCT01840410|12392872|FG000|Full Analysis Set|Overall Study||119
11202489|NCT01840410|12392873|FG001|Full Analysis Set|Overall Study||59
11202490|NCT01840410|12392872|FG000|COMPLETED|Overall Study||112
11202491|NCT01840410|12392873|FG001|COMPLETED|Overall Study||55
11202492|NCT01840410|12392872|FG000|NOT COMPLETED|Overall Study||7
11202493|NCT01840410|12392873|FG001|NOT COMPLETED|Overall Study||4
11202494|NCT01840579|12392891|FG000|STARTED|Overall Study||3
11202495|NCT01840579|12392892|FG001|STARTED|Overall Study||7
11202496|NCT01840579|12392893|FG002|STARTED|Overall Study||6
11202497|NCT01840579|12392894|FG003|STARTED|Overall Study||6
11202498|NCT01840579|12392895|FG004|STARTED|Overall Study||8
11202499|NCT01840579|12392896|FG005|STARTED|Overall Study||6
11202500|NCT01840579|12392897|FG006|STARTED|Overall Study||6
11139856|NCT01453075|12326225|FG000|STARTED|Overall Study||16
11139857|NCT01453075|12326226|FG001|STARTED|Overall Study||15
11139858|NCT01453075|12326225|FG000|COMPLETED|Overall Study||11
11139859|NCT01453075|12326226|FG001|COMPLETED|Overall Study||14
11139860|NCT01453075|12326225|FG000|NOT COMPLETED|Overall Study||5
11139861|NCT01453075|12326226|FG001|NOT COMPLETED|Overall Study||1
11139862|NCT01453153|12326235|FG000|STARTED|Overall Study||4
11139863|NCT01453153|12326236|FG001|STARTED|Overall Study||4
11139864|NCT01453153|12326237|FG002|STARTED|Overall Study||20
11139865|NCT01453153|12326235|FG000|COMPLETED|Overall Study||0
11139866|NCT01453153|12326236|FG001|COMPLETED|Overall Study||0
11139867|NCT01453153|12326237|FG002|COMPLETED|Overall Study||0
11139868|NCT01453153|12326235|FG000|NOT COMPLETED|Overall Study||4
11139869|NCT01453153|12326236|FG001|NOT COMPLETED|Overall Study||4
11139870|NCT01453153|12326237|FG002|NOT COMPLETED|Overall Study||20
11139871|NCT01453166|12326252|FG000|STARTED|Overall Study||42
11139872|NCT01453166|12326253|FG001|STARTED|Overall Study||41
11139873|NCT01453166|12326254|FG002|STARTED|Overall Study||39
11139874|NCT01453166|12326252|FG000|COMPLETED|Overall Study||40
11139875|NCT01453166|12326253|FG001|COMPLETED|Overall Study||39
11139876|NCT01453166|12326254|FG002|COMPLETED|Overall Study||38
11139877|NCT01453166|12326252|FG000|NOT COMPLETED|Overall Study||2
11139878|NCT01453166|12326253|FG001|NOT COMPLETED|Overall Study||2
11139879|NCT01453166|12326254|FG002|NOT COMPLETED|Overall Study||1
11241433|NCT02097472|12433883|FG007|NOT COMPLETED|Received Vaccination 2||0
11241434|NCT02097472|12433876|FG000|STARTED|Assessed for Immunogenicity||18
11241435|NCT02097472|12433877|FG001|STARTED|Assessed for Immunogenicity||18
11241436|NCT02097472|12433878|FG002|STARTED|Assessed for Immunogenicity||18
11241437|NCT02097472|12433879|FG003|STARTED|Assessed for Immunogenicity||50
11241438|NCT02097472|12433880|FG004|STARTED|Assessed for Immunogenicity||50
11241439|NCT02097472|12433881|FG005|STARTED|Assessed for Immunogenicity||50
11241440|NCT02097472|12433882|FG006|STARTED|Assessed for Immunogenicity||49
11241441|NCT02097472|12433883|FG007|STARTED|Assessed for Immunogenicity||50
11241442|NCT02097472|12433876|FG000|COMPLETED|Assessed for Immunogenicity||18
11241443|NCT02097472|12433877|FG001|COMPLETED|Assessed for Immunogenicity||18
11241444|NCT02097472|12433878|FG002|COMPLETED|Assessed for Immunogenicity||17
11241445|NCT02097472|12433879|FG003|COMPLETED|Assessed for Immunogenicity||48
11241446|NCT02097472|12433880|FG004|COMPLETED|Assessed for Immunogenicity||50
11241447|NCT02097472|12433881|FG005|COMPLETED|Assessed for Immunogenicity||48
11241448|NCT02097472|12433882|FG006|COMPLETED|Assessed for Immunogenicity||47
11241449|NCT02097472|12433883|FG007|COMPLETED|Assessed for Immunogenicity||49
11241450|NCT02097472|12433876|FG000|NOT COMPLETED|Assessed for Immunogenicity||0
11241451|NCT02097472|12433877|FG001|NOT COMPLETED|Assessed for Immunogenicity||0
11241452|NCT02097472|12433878|FG002|NOT COMPLETED|Assessed for Immunogenicity||1
11241453|NCT02097472|12433879|FG003|NOT COMPLETED|Assessed for Immunogenicity||2
11241454|NCT02097472|12433880|FG004|NOT COMPLETED|Assessed for Immunogenicity||0
11241455|NCT02097472|12433881|FG005|NOT COMPLETED|Assessed for Immunogenicity||2
11241456|NCT02097472|12433882|FG006|NOT COMPLETED|Assessed for Immunogenicity||2
11241457|NCT02097472|12433883|FG007|NOT COMPLETED|Assessed for Immunogenicity||1
11241458|NCT02097485|12433969|FG000|STARTED|Overall Study||25
11241459|NCT02097485|12433970|FG001|STARTED|Overall Study||25
11241460|NCT02097485|12433969|FG000|COMPLETED|Overall Study||25
11241461|NCT02097485|12433970|FG001|COMPLETED|Overall Study||25
11241462|NCT02097485|12433969|FG000|NOT COMPLETED|Overall Study||0
11241463|NCT02097485|12433970|FG001|NOT COMPLETED|Overall Study||0
11241464|NCT02097537|12433976|FG000|STARTED|Overall Study||10
11241465|NCT02097537|12433976|FG000|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
11241466|NCT02097537|12433976|FG000|Follow-Up|Overall Study||10
11241467|NCT02097537|12433976|FG000|COMPLETED|Overall Study||10
11241468|NCT02097537|12433976|FG000|NOT COMPLETED|Overall Study||0
11241469|NCT02097641|12433982|FG000|STARTED|Overall Study||40
11241470|NCT02097641|12433983|FG001|STARTED|Overall Study||20
11241471|NCT02097641|12433982|FG000|COMPLETED|Overall Study||40
11241472|NCT02097641|12433983|FG001|COMPLETED|Overall Study||20
11241473|NCT02097641|12433982|FG000|NOT COMPLETED|Overall Study||0
11139880|NCT01453205|12326265|FG000|STARTED|Overall Study||80
11139881|NCT01453205|12326266|FG001|STARTED|Overall Study||52
11139882|NCT01453205|12326267|FG002|STARTED|Overall Study||55
11139883|NCT01453205|12326265|FG000|COMPLETED|Overall Study||0
11139884|NCT01453205|12326266|FG001|COMPLETED|Overall Study||0
11139885|NCT01453205|12326267|FG002|COMPLETED|Overall Study||1
11139886|NCT01453205|12326265|FG000|NOT COMPLETED|Overall Study||80
11139887|NCT01453205|12326266|FG001|NOT COMPLETED|Overall Study||52
11139888|NCT01453205|12326267|FG002|NOT COMPLETED|Overall Study||54
11139889|NCT01453296|12326278|FG000|STARTED|Treatment Period 1||14
11139890|NCT01453296|12326279|FG001|STARTED|Treatment Period 1||14
11139891|NCT01453296|12326278|FG000|COMPLETED|Treatment Period 1||13
11139892|NCT01453296|12326279|FG001|COMPLETED|Treatment Period 1||13
11139893|NCT01453296|12326278|FG000|NOT COMPLETED|Treatment Period 1||1
11139894|NCT01453296|12326279|FG001|NOT COMPLETED|Treatment Period 1||1
11139895|NCT01453296|12326278|FG000|STARTED|Washout Period||13
11139896|NCT01453296|12326279|FG001|STARTED|Washout Period||13
11139897|NCT01453296|12326278|FG000|COMPLETED|Washout Period||13
11241474|NCT02097641|12433983|FG001|NOT COMPLETED|Overall Study||0
11339001|NCT02907814|12536375|FG000|NOT COMPLETED|Overall Study||6
11339002|NCT02907814|12536376|FG001|NOT COMPLETED|Overall Study||0
11339003|NCT02907892|12536384|FG000|STARTED|Overall Study||277
11339004|NCT02907892|12536385|FG001|STARTED|Overall Study||276
11339005|NCT02907892|12536384|FG000|COMPLETED|Overall Study||250
11139898|NCT01453296|12326279|FG001|COMPLETED|Washout Period||13
11139899|NCT01453296|12326278|FG000|NOT COMPLETED|Washout Period||0
11139900|NCT01453296|12326279|FG001|NOT COMPLETED|Washout Period||0
11139901|NCT01453296|12326278|FG000|STARTED|Treatment Period 2||13
11139902|NCT01453296|12326279|FG001|STARTED|Treatment Period 2||13
11139903|NCT01453296|12326278|FG000|COMPLETED|Treatment Period 2||11
11139904|NCT01453296|12326279|FG001|COMPLETED|Treatment Period 2||13
11139905|NCT01453296|12326278|FG000|NOT COMPLETED|Treatment Period 2||2
11139906|NCT01453296|12326279|FG001|NOT COMPLETED|Treatment Period 2||0
11139907|NCT01453348|12326288|FG000|STARTED|Overall Study||84
11139908|NCT01453348|12326289|FG001|STARTED|Overall Study||84
11139909|NCT01453348|12326290|FG002|STARTED|Overall Study||84
11139910|NCT01453348|12326288|FG000|COMPLETED|Overall Study||83
11139911|NCT01453348|12326289|FG001|COMPLETED|Overall Study||83
11139912|NCT01453348|12326290|FG002|COMPLETED|Overall Study||83
11139913|NCT01453348|12326288|FG000|NOT COMPLETED|Overall Study||1
11139914|NCT01453348|12326289|FG001|NOT COMPLETED|Overall Study||1
11139915|NCT01453348|12326290|FG002|NOT COMPLETED|Overall Study||1
11139916|NCT01453361|12326301|FG000|STARTED|Overall Study||18
11139917|NCT01453361|12326301|FG000|COMPLETED|Overall Study||2
11139918|NCT01453361|12326301|FG000|NOT COMPLETED|Overall Study||16
11139919|NCT01453374|12326305|FG000|STARTED|Overall Study||27
11139920|NCT01453374|12326305|FG000|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
11139921|NCT01453374|12326305|FG000|NOT COMPLETED|Overall Study||18
11139922|NCT01453387|12326313|FG000|STARTED|Overall Study||21
11139923|NCT01453387|12326314|FG001|STARTED|Overall Study||7
11139924|NCT01453387|12326313|FG000|COMPLETED|Overall Study||21
11139925|NCT01453387|12326314|FG001|COMPLETED|Overall Study||7
11139926|NCT01453387|12326313|FG000|NOT COMPLETED|Overall Study||0
11139927|NCT01453387|12326314|FG001|NOT COMPLETED|Overall Study||0
11139928|NCT01453413|12326337|FG000|STARTED|Overall Study||297
11139929|NCT01453413|12326337|FG000|COMPLETED|Overall Study||297
11139930|NCT01453413|12326337|FG000|NOT COMPLETED|Overall Study||0
11139931|NCT01453439|12326343|FG000|STARTED|Treatment Phase||61
11139932|NCT01453439|12326344|FG001|STARTED|Treatment Phase||59
11139933|NCT01453439|12326343|FG000|COMPLETED|Treatment Phase||44
11139934|NCT01453439|12326344|FG001|COMPLETED|Treatment Phase||48
11139935|NCT01453439|12326343|FG000|NOT COMPLETED|Treatment Phase||17
11139936|NCT01453439|12326344|FG001|NOT COMPLETED|Treatment Phase||11
11139937|NCT01453439|12326343|FG000|STARTED|Follow-up||44
11139938|NCT01453439|12326344|FG001|STARTED|Follow-up||48
11139939|NCT01453439|12326343|FG000|COMPLETED|Follow-up||39
11139940|NCT01453439|12326344|FG001|COMPLETED|Follow-up||37
11139941|NCT01453439|12326343|FG000|NOT COMPLETED|Follow-up||5
11139942|NCT01453439|12326344|FG001|NOT COMPLETED|Follow-up||11
11139943|NCT01453569|12326353|FG000|STARTED|Overall Study||86
11139944|NCT01453569|12326354|FG001|STARTED|Overall Study||84
11139945|NCT01453569|12326355|FG002|STARTED|Overall Study||85
11139946|NCT01453569|12326353|FG000|COMPLETED|Overall Study||75
11139947|NCT01453569|12326354|FG001|COMPLETED|Overall Study||70
11139948|NCT01453569|12326355|FG002|COMPLETED|Overall Study||78
11139949|NCT01453569|12326353|FG000|NOT COMPLETED|Overall Study||11
11139950|NCT01453569|12326354|FG001|NOT COMPLETED|Overall Study||14
11139951|NCT01453569|12326355|FG002|NOT COMPLETED|Overall Study||7
11139952|NCT01453595|12326366|FG000|STARTED|Overall Study||2
11139953|NCT01453595|12326367|FG001|STARTED|Overall Study||6
11139954|NCT01453595|12326368|FG002|STARTED|Overall Study||2
11139955|NCT01453595|12326366|FG000|COMPLETED|Overall Study||0
11139956|NCT01453595|12326367|FG001|COMPLETED|Overall Study||5
11139957|NCT01453595|12326368|FG002|COMPLETED|Overall Study||0
11139958|NCT01453595|12326366|FG000|NOT COMPLETED|Overall Study||2
11139959|NCT01453595|12326367|FG001|NOT COMPLETED|Overall Study||1
11139960|NCT01453595|12326368|FG002|NOT COMPLETED|Overall Study||2
11139961|NCT01453725|12326376|FG000|STARTED|Overall Study||98
11139962|NCT01453725|12326377|FG001|STARTED|Overall Study||100
11139963|NCT01453725|12326376|FG000|COMPLETED|Overall Study||85
11139964|NCT01453725|12326377|FG001|COMPLETED|Overall Study||89
11139965|NCT01453725|12326376|FG000|NOT COMPLETED|Overall Study||13
11139966|NCT01453725|12326377|FG001|NOT COMPLETED|Overall Study||11
11139967|NCT01453855|12326387|FG000|STARTED|Overall Study||442
11139968|NCT01453855|12326388|FG001|STARTED|Overall Study||422
11139969|NCT01453855|12326387|FG000|COMPLETED|Overall Study||432
11139970|NCT01453855|12326388|FG001|COMPLETED|Overall Study||408
11139971|NCT01453855|12326387|FG000|NOT COMPLETED|Overall Study||10
11139972|NCT01453855|12326388|FG001|NOT COMPLETED|Overall Study||14
11139973|NCT01453894|12326396|FG000|STARTED|Overall Study||225
11139974|NCT01453894|12326397|FG001|STARTED|Overall Study||225
11139975|NCT01453894|12326396|FG000|COMPLETED|Overall Study||225
11139976|NCT01453894|12326397|FG001|COMPLETED|Overall Study||225
11139977|NCT01453894|12326396|FG000|NOT COMPLETED|Overall Study||0
11139978|NCT01453894|12326397|FG001|NOT COMPLETED|Overall Study||0
11139979|NCT01453998|12326406|FG000|STARTED|Before Protocol Amendment 2||85
11139980|NCT01453998|12326407|FG001|STARTED|Before Protocol Amendment 2||88
11139981|NCT01453998|12326408|FG002|STARTED|Before Protocol Amendment 2||99
11139982|NCT01453998|12326406|FG000|COMPLETED|Before Protocol Amendment 2||85
11139983|NCT01453998|12326407|FG001|COMPLETED|Before Protocol Amendment 2||88
11139984|NCT01453998|12326408|FG002|COMPLETED|Before Protocol Amendment 2||99
11139985|NCT01453998|12326406|FG000|NOT COMPLETED|Before Protocol Amendment 2||0
11139986|NCT01453998|12326407|FG001|NOT COMPLETED|Before Protocol Amendment 2||0
11139987|NCT01453998|12326408|FG002|NOT COMPLETED|Before Protocol Amendment 2||0
11139988|NCT01453998|12326406|FG000|STARTED|After Protocol Amendment 2.||131
11139989|NCT01453998|12326407|FG001|STARTED|After Protocol Amendment 2.||130
11139990|NCT01453998|12326408|FG002|STARTED|After Protocol Amendment 2.||124
11139991|NCT01453998|12326406|FG000|COMPLETED|After Protocol Amendment 2.||130
11139992|NCT01453998|12326407|FG001|COMPLETED|After Protocol Amendment 2.||130
11139993|NCT01453998|12326408|FG002|COMPLETED|After Protocol Amendment 2.||124
11139994|NCT01453998|12326406|FG000|NOT COMPLETED|After Protocol Amendment 2.||1
11139995|NCT01453998|12326407|FG001|NOT COMPLETED|After Protocol Amendment 2.||0
11139996|NCT01453998|12326408|FG002|NOT COMPLETED|After Protocol Amendment 2.||0
11139997|NCT01454063|12326421|FG000|STARTED|Randomized||202
11139998|NCT01454063|12326422|FG001|STARTED|Randomized||203
11139999|NCT01454063|12326421|FG000|COMPLETED|Randomized||201
11140000|NCT01454063|12326422|FG001|COMPLETED|Randomized||201
11140001|NCT01454063|12326421|FG000|NOT COMPLETED|Randomized||1
11140002|NCT01454063|12326422|FG001|NOT COMPLETED|Randomized||2
11140003|NCT01454063|12326421|FG000|STARTED|Treated||201
11140004|NCT01454063|12326422|FG001|STARTED|Treated||201
11140005|NCT01454063|12326421|FG000|COMPLETED|Treated||199
11140006|NCT01454063|12326422|FG001|COMPLETED|Treated||201
11140007|NCT01454063|12326421|FG000|NOT COMPLETED|Treated||2
11140008|NCT01454063|12326422|FG001|NOT COMPLETED|Treated||0
11140009|NCT01454076|12326433|FG000|STARTED|Overall Study||29
11140010|NCT01454076|12326434|FG001|STARTED|Overall Study||20
11140011|NCT01454076|12326435|FG002|STARTED|Overall Study||24
11140012|NCT01454076|12326436|FG003|STARTED|Overall Study||18
11140013|NCT01454076|12326437|FG004|STARTED|Overall Study||21
11140014|NCT01454076|12326433|FG000|COMPLETED|Overall Study||16
11140015|NCT01454076|12326434|FG001|COMPLETED|Overall Study||14
11140016|NCT01454076|12326435|FG002|COMPLETED|Overall Study||15
11140017|NCT01454076|12326436|FG003|COMPLETED|Overall Study||16
11140018|NCT01454076|12326437|FG004|COMPLETED|Overall Study||15
11140019|NCT01454076|12326433|FG000|NOT COMPLETED|Overall Study||13
11140020|NCT01454076|12326434|FG001|NOT COMPLETED|Overall Study||6
11140021|NCT01454076|12326435|FG002|NOT COMPLETED|Overall Study||9
11140022|NCT01454076|12326436|FG003|NOT COMPLETED|Overall Study||2
11140023|NCT01454076|12326437|FG004|NOT COMPLETED|Overall Study||6
11140024|NCT01454102|12326474|FG000|STARTED|Overall Study||12
11140025|NCT01454102|12326475|FG001|STARTED|Overall Study||15
11140026|NCT01454102|12326476|FG002|STARTED|Overall Study||15
11140027|NCT01454102|12326477|FG003|STARTED|Overall Study||12
11140028|NCT01454102|12326478|FG004|STARTED|Overall Study||21
11140029|NCT01454102|12326479|FG005|STARTED|Overall Study||52
11140030|NCT01454102|12326480|FG006|STARTED|Overall Study||24
11140031|NCT01454102|12326481|FG007|STARTED|Overall Study||25
11140032|NCT01454102|12326482|FG008|STARTED|Overall Study||13
11140033|NCT01454102|12326483|FG009|STARTED|Overall Study||13
11140034|NCT01454102|12326484|FG010|STARTED|Overall Study||12
11140035|NCT01454102|12326485|FG011|STARTED|Overall Study||31
11140036|NCT01454102|12326486|FG012|STARTED|Overall Study||40
11140037|NCT01454102|12326487|FG013|STARTED|Overall Study||38
11140038|NCT01454102|12326488|FG014|STARTED|Overall Study||39
11140039|NCT01454102|12326489|FG015|STARTED|Overall Study||14
11140040|NCT01454102|12326474|FG000|COMPLETED|Overall Study||12
11140041|NCT01454102|12326475|FG001|COMPLETED|Overall Study||15
11140042|NCT01454102|12326476|FG002|COMPLETED|Overall Study||15
11140043|NCT01454102|12326477|FG003|COMPLETED|Overall Study||12
11140044|NCT01454102|12326478|FG004|COMPLETED|Overall Study||18
11140045|NCT01454102|12326479|FG005|COMPLETED|Overall Study||49
11140046|NCT01454102|12326480|FG006|COMPLETED|Overall Study||22
11140047|NCT01454102|12326481|FG007|COMPLETED|Overall Study||25
11140048|NCT01454102|12326482|FG008|COMPLETED|Overall Study||12
11140049|NCT01454102|12326483|FG009|COMPLETED|Overall Study||13
11140050|NCT01454102|12326484|FG010|COMPLETED|Overall Study||12
11140051|NCT01454102|12326485|FG011|COMPLETED|Overall Study||27
11140052|NCT01454102|12326486|FG012|COMPLETED|Overall Study||33
11140053|NCT01454102|12326487|FG013|COMPLETED|Overall Study||34
11140054|NCT01454102|12326488|FG014|COMPLETED|Overall Study||36
11140055|NCT01454102|12326489|FG015|COMPLETED|Overall Study||13
11140056|NCT01454102|12326474|FG000|NOT COMPLETED|Overall Study||0
11140057|NCT01454102|12326475|FG001|NOT COMPLETED|Overall Study||0
11140058|NCT01454102|12326476|FG002|NOT COMPLETED|Overall Study||0
11140059|NCT01454102|12326477|FG003|NOT COMPLETED|Overall Study||0
11140060|NCT01454102|12326478|FG004|NOT COMPLETED|Overall Study||3
11140061|NCT01454102|12326479|FG005|NOT COMPLETED|Overall Study||3
11140062|NCT01454102|12326480|FG006|NOT COMPLETED|Overall Study||2
11140063|NCT01454102|12326481|FG007|NOT COMPLETED|Overall Study||0
11140064|NCT01454102|12326482|FG008|NOT COMPLETED|Overall Study||1
11140065|NCT01454102|12326483|FG009|NOT COMPLETED|Overall Study||0
11140066|NCT01454102|12326484|FG010|NOT COMPLETED|Overall Study||0
11140067|NCT01454102|12326485|FG011|NOT COMPLETED|Overall Study||4
11140068|NCT01454102|12326486|FG012|NOT COMPLETED|Overall Study||7
11140069|NCT01454102|12326487|FG013|NOT COMPLETED|Overall Study||4
11140070|NCT01454102|12326488|FG014|NOT COMPLETED|Overall Study||3
11140071|NCT01454102|12326489|FG015|NOT COMPLETED|Overall Study||1
11140072|NCT01454258|12326524|FG000|STARTED|Overall Study||10100
11140073|NCT01454258|12326524|FG000|COMPLETED|Overall Study||9103
11140074|NCT01454258|12326524|FG000|NOT COMPLETED|Overall Study||997
11140075|NCT01454284|12326532|FG000|STARTED|Overall Study||664
11140076|NCT01454284|12326533|FG001|STARTED|Overall Study||450
11140077|NCT01454284|12326532|FG000|Received at Least 1 Dose of Study Drug|Overall Study||663
11140078|NCT01454284|12326533|FG001|Received at Least 1 Dose of Study Drug|Overall Study||449
11140079|NCT01454284|12326532|FG000|COMPLETED|Overall Study||548
11140080|NCT01454284|12326533|FG001|COMPLETED|Overall Study||377
11140081|NCT01454284|12326532|FG000|NOT COMPLETED|Overall Study||116
11140082|NCT01454284|12326533|FG001|NOT COMPLETED|Overall Study||73
11140083|NCT01454362|12326541|FG000|STARTED|Overall Study||28
11140084|NCT01454362|12326542|FG001|STARTED|Overall Study||23
11140085|NCT01454362|12326541|FG000|COMPLETED|Overall Study||28
11140086|NCT01454362|12326542|FG001|COMPLETED|Overall Study||23
11140087|NCT01454362|12326541|FG000|NOT COMPLETED|Overall Study||0
11140088|NCT01454362|12326542|FG001|NOT COMPLETED|Overall Study||0
11140089|NCT01454401|12326550|FG000|STARTED|Overall Study|ITT|44
11140090|NCT01454401|12326550|FG000|COMPLETED|Overall Study|Per Protocol (PP)|39
11140091|NCT01454401|12326550|FG000|NOT COMPLETED|Overall Study||5
11140092|NCT01454414|12326556|FG000|STARTED|Overall Study||79
11140093|NCT01454414|12326557|FG001|STARTED|Overall Study||80
11140094|NCT01454414|12326556|FG000|Baseline: Subjects That Sent Uniforms|Overall Study||67
11140095|NCT01454414|12326557|FG001|Baseline: Subjects That Sent Uniforms|Overall Study||66
11140096|NCT01454414|12326556|FG000|COMPLETED|Overall Study||66
11140097|NCT01454414|12326557|FG001|COMPLETED|Overall Study||64
11140098|NCT01454414|12326556|FG000|NOT COMPLETED|Overall Study||13
11140099|NCT01454414|12326557|FG001|NOT COMPLETED|Overall Study||16
11140100|NCT01454505|12326566|FG000|STARTED|Overall Study||35
11140101|NCT01454505|12326567|FG001|STARTED|Overall Study||15
11140102|NCT01454505|12326568|FG002|STARTED|Overall Study||40
11140103|NCT01454505|12326569|FG003|STARTED|Overall Study||20
11140104|NCT01454505|12326566|FG000|COMPLETED|Overall Study||35
11140105|NCT01454505|12326567|FG001|COMPLETED|Overall Study||15
11140106|NCT01454505|12326568|FG002|COMPLETED|Overall Study||40
11140107|NCT01454505|12326569|FG003|COMPLETED|Overall Study||20
11140108|NCT01454505|12326566|FG000|NOT COMPLETED|Overall Study||0
11140109|NCT01454505|12326567|FG001|NOT COMPLETED|Overall Study||0
11140110|NCT01454505|12326568|FG002|NOT COMPLETED|Overall Study||0
11140111|NCT01454505|12326569|FG003|NOT COMPLETED|Overall Study||0
11140112|NCT01454531|12326579|FG000|STARTED|Overall Study||196
11140113|NCT01454531|12326579|FG000|Subjects Treated|Overall Study||192
11140114|NCT01454531|12326579|FG000|COMPLETED|Overall Study||173
11140115|NCT01454531|12326579|FG000|NOT COMPLETED|Overall Study||23
11140116|NCT01454570|12326583|FG000|STARTED|Overall Study||19
11140117|NCT01454570|12326583|FG000|COMPLETED|Overall Study||10
11140118|NCT01454570|12326583|FG000|NOT COMPLETED|Overall Study||9
11140119|NCT01454583|12326590|FG000|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
11140120|NCT01454583|12326591|FG001|STARTED|1st Year||2696
11140121|NCT01454583|12326592|FG002|STARTED|1st Year||2113
11140122|NCT01454583|12326590|FG000|COMPLETED|1st Year||9120
11140123|NCT01454583|12326591|FG001|COMPLETED|1st Year||2378
11140124|NCT01454583|12326592|FG002|COMPLETED|1st Year||1933
11140125|NCT01454583|12326590|FG000|NOT COMPLETED|1st Year||1057
11140126|NCT01454583|12326591|FG001|NOT COMPLETED|1st Year||318
11140127|NCT01454583|12326592|FG002|NOT COMPLETED|1st Year||180
11140128|NCT01454583|12326590|FG000|STARTED|2nd Year||10177
11140129|NCT01454583|12326591|FG001|STARTED|2nd Year||2696
11140130|NCT01454583|12326592|FG002|STARTED|2nd Year||2113
11140131|NCT01454583|12326590|FG000|COMPLETED|2nd Year||6212
11140132|NCT01454583|12326591|FG001|COMPLETED|2nd Year||1647
11140133|NCT01454583|12326592|FG002|COMPLETED|2nd Year||1376
11140134|NCT01454583|12326590|FG000|NOT COMPLETED|2nd Year||3965
11140135|NCT01454583|12326591|FG001|NOT COMPLETED|2nd Year||1049
11140136|NCT01454583|12326592|FG002|NOT COMPLETED|2nd Year||737
11140137|NCT01454583|12326590|FG000|STARTED|3rd Year||3791
11140138|NCT01454583|12326591|FG001|STARTED|3rd Year||982
11140139|NCT01454583|12326592|FG002|STARTED|3rd Year||582
11140140|NCT01454583|12326590|FG000|COMPLETED|3rd Year||1832
11140141|NCT01454583|12326591|FG001|COMPLETED|3rd Year||470
11140142|NCT01454583|12326592|FG002|COMPLETED|3rd Year||285
11140143|NCT01454583|12326590|FG000|NOT COMPLETED|3rd Year||1959
11140144|NCT01454583|12326591|FG001|NOT COMPLETED|3rd Year||512
11140145|NCT01454583|12326592|FG002|NOT COMPLETED|3rd Year||297
11140146|NCT01454596|12326612|FG000|STARTED|Overall Study||1
11140147|NCT01454596|12326613|FG001|STARTED|Overall Study||1
11140148|NCT01454596|12326614|FG002|STARTED|Overall Study||1
11140149|NCT01454596|12326615|FG003|STARTED|Overall Study||1
11140150|NCT01454596|12326616|FG004|STARTED|Overall Study||1
11140151|NCT01454596|12326617|FG005|STARTED|Overall Study||1
11140152|NCT01454596|12326618|FG006|STARTED|Overall Study||1
11140153|NCT01454596|12326619|FG007|STARTED|Overall Study||3
11140154|NCT01454596|12326620|FG008|STARTED|Overall Study||3
11140155|NCT01454596|12326621|FG009|STARTED|Overall Study||3
11140156|NCT01454596|12326622|FG010|STARTED|Overall Study||1
11140157|NCT01454596|12326623|FG011|STARTED|Overall Study||1
11140158|NCT01454596|12326612|FG000|COMPLETED|Overall Study||1
11140159|NCT01454596|12326613|FG001|COMPLETED|Overall Study||1
11140160|NCT01454596|12326614|FG002|COMPLETED|Overall Study||1
11140161|NCT01454596|12326615|FG003|COMPLETED|Overall Study||1
11140162|NCT01454596|12326616|FG004|COMPLETED|Overall Study||1
11140163|NCT01454596|12326617|FG005|COMPLETED|Overall Study||1
11140164|NCT01454596|12326618|FG006|COMPLETED|Overall Study||1
11140165|NCT01454596|12326619|FG007|COMPLETED|Overall Study||3
11140166|NCT01454596|12326620|FG008|COMPLETED|Overall Study||3
11140167|NCT01454596|12326621|FG009|COMPLETED|Overall Study||2
11140168|NCT01454596|12326622|FG010|COMPLETED|Overall Study||0
11140169|NCT01454596|12326623|FG011|COMPLETED|Overall Study||1
11140170|NCT01454596|12326612|FG000|NOT COMPLETED|Overall Study||0
11140171|NCT01454596|12326613|FG001|NOT COMPLETED|Overall Study||0
11140172|NCT01454596|12326614|FG002|NOT COMPLETED|Overall Study||0
11140173|NCT01454596|12326615|FG003|NOT COMPLETED|Overall Study||0
11140174|NCT01454596|12326616|FG004|NOT COMPLETED|Overall Study||0
11140175|NCT01454596|12326617|FG005|NOT COMPLETED|Overall Study||0
11140176|NCT01454596|12326618|FG006|NOT COMPLETED|Overall Study||0
11140177|NCT01454596|12326619|FG007|NOT COMPLETED|Overall Study||0
11140178|NCT01454596|12326620|FG008|NOT COMPLETED|Overall Study||0
11140179|NCT01454596|12326621|FG009|NOT COMPLETED|Overall Study||1
11140180|NCT01454596|12326622|FG010|NOT COMPLETED|Overall Study||1
11140181|NCT01454596|12326623|FG011|NOT COMPLETED|Overall Study||0
11140182|NCT01454726|12326651|FG000|STARTED|Overall Study||16
11140183|NCT01454726|12326652|FG001|STARTED|Overall Study||11
11140184|NCT01454726|12326651|FG000|COMPLETED|Overall Study||16
11140185|NCT01454726|12326652|FG001|COMPLETED|Overall Study||10
11140186|NCT01454726|12326651|FG000|NOT COMPLETED|Overall Study||0
11140187|NCT01454726|12326652|FG001|NOT COMPLETED|Overall Study||1
11140188|NCT01454739|12326660|FG000|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
11140189|NCT01454739|12326661|FG001|STARTED|Overall Study||179
11140190|NCT01454739|12326660|FG000|Tailored Prophylaxis|Overall Study||59
11140191|NCT01454739|12326661|FG001|Tailored Prophylaxis|Overall Study||131
11140192|NCT01454739|12326660|FG000|Weekly Prophylaxis|Overall Study||0
11140193|NCT01454739|12326661|FG001|Weekly Prophylaxis|Overall Study||34
11140194|NCT01454739|12326660|FG000|Personalized Prophylaxis|Overall Study||3
11140195|NCT01454739|12326661|FG001|Personalized Prophylaxis|Overall Study||23
11140196|NCT01454739|12326660|FG000|Episodic|Overall Study||0
11140197|NCT01454739|12326661|FG001|Episodic|Overall Study||13
11140198|NCT01454739|12326660|FG000|Surgery Subgroup|Overall Study||2
11140199|NCT01454739|12326661|FG001|Surgery Subgroup|Overall Study||26
11140200|NCT01454739|12326660|FG000|COMPLETED|Overall Study||54
11140201|NCT01454739|12326661|FG001|COMPLETED|Overall Study||158
11140202|NCT01454739|12326660|FG000|NOT COMPLETED|Overall Study||7
11140203|NCT01454739|12326661|FG001|NOT COMPLETED|Overall Study||21
11140204|NCT01454778|12326674|FG000|STARTED|Overall Study||50
11140205|NCT01454778|12326674|FG000|COMPLETED|Overall Study||47
11140206|NCT01454778|12326674|FG000|NOT COMPLETED|Overall Study||3
11140207|NCT01454791|12326680|FG000|STARTED|Overall Study||20
11140208|NCT01454791|12326681|FG001|STARTED|Overall Study||20
11140209|NCT01454791|12326680|FG000|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
11140210|NCT01454791|12326681|FG001|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
11140211|NCT01454791|12326680|FG000|NOT COMPLETED|Overall Study||0
11140212|NCT01454791|12326681|FG001|NOT COMPLETED|Overall Study||0
11140213|NCT01454830|12326691|FG000|STARTED|Overall Study||61
11140214|NCT01454830|12326692|FG001|STARTED|Overall Study||57
11140215|NCT01454830|12326691|FG000|COMPLETED|Overall Study||30
11140216|NCT01454830|12326692|FG001|COMPLETED|Overall Study||30
11140217|NCT01454830|12326691|FG000|NOT COMPLETED|Overall Study||31
11140218|NCT01454830|12326692|FG001|NOT COMPLETED|Overall Study||27
11140219|NCT01454934|12326700|FG000|STARTED|Overall Study||270
11140220|NCT01454934|12326701|FG001|STARTED|Overall Study||270
11140221|NCT01454934|12326700|FG000|COMPLETED|Overall Study||0
11140222|NCT01454934|12326701|FG001|COMPLETED|Overall Study||0
11140223|NCT01454934|12326700|FG000|NOT COMPLETED|Overall Study||270
11140224|NCT01454934|12326701|FG001|NOT COMPLETED|Overall Study||270
11140225|NCT01454947|12326715|FG000|STARTED|Overall Study||27
11140226|NCT01454947|12326716|FG001|STARTED|Overall Study||42
11140227|NCT01454947|12326717|FG002|STARTED|Overall Study||35
11140228|NCT01454947|12326718|FG003|STARTED|Overall Study||20
11140229|NCT01454947|12326719|FG004|STARTED|Overall Study||34
11140230|NCT01454947|12326720|FG005|STARTED|Overall Study||35
11140231|NCT01454947|12326721|FG006|STARTED|Overall Study||27
11140232|NCT01454947|12326722|FG007|STARTED|Overall Study||28
11140233|NCT01454947|12326715|FG000|COMPLETED|Overall Study||24
11140234|NCT01454947|12326716|FG001|COMPLETED|Overall Study||38
11140235|NCT01454947|12326717|FG002|COMPLETED|Overall Study||32
11140236|NCT01454947|12326718|FG003|COMPLETED|Overall Study||19
11140237|NCT01454947|12326719|FG004|COMPLETED|Overall Study||33
11140238|NCT01454947|12326720|FG005|COMPLETED|Overall Study||32
11140239|NCT01454947|12326721|FG006|COMPLETED|Overall Study||26
11140240|NCT01454947|12326722|FG007|COMPLETED|Overall Study||23
11140241|NCT01454947|12326715|FG000|NOT COMPLETED|Overall Study||3
11140242|NCT01454947|12326716|FG001|NOT COMPLETED|Overall Study||4
11140243|NCT01454947|12326717|FG002|NOT COMPLETED|Overall Study||3
11140244|NCT01454947|12326718|FG003|NOT COMPLETED|Overall Study||1
11140245|NCT01454947|12326719|FG004|NOT COMPLETED|Overall Study||1
11140246|NCT01454947|12326720|FG005|NOT COMPLETED|Overall Study||3
11140247|NCT01454947|12326721|FG006|NOT COMPLETED|Overall Study||1
11140248|NCT01454947|12326722|FG007|NOT COMPLETED|Overall Study||5
11140249|NCT01455012|12326742|FG000|STARTED|Overall Study||41
11140250|NCT01455012|12326743|FG001|STARTED|Overall Study||40
11140251|NCT01455012|12326742|FG000|COMPLETED|Overall Study||30
11140252|NCT01455012|12326743|FG001|COMPLETED|Overall Study||36
11140253|NCT01455012|12326742|FG000|NOT COMPLETED|Overall Study||11
11140254|NCT01455012|12326743|FG001|NOT COMPLETED|Overall Study||4
11140255|NCT01455064|12326749|FG000|STARTED|Overall Study||31
11140256|NCT01455064|12326749|FG000|COMPLETED|Overall Study||30
11140257|NCT01455064|12326749|FG000|NOT COMPLETED|Overall Study||1
11140258|NCT01455181|12326753|FG000|STARTED|Overall Study||24
11140259|NCT01455181|12326753|FG000|COMPLETED|Overall Study||24
11140260|NCT01455181|12326753|FG000|NOT COMPLETED|Overall Study||0
11140261|NCT01455194|12326760|FG000|STARTED|Overall Study||153
11140262|NCT01455194|12326761|FG001|STARTED|Overall Study||120
11140263|NCT01455194|12326762|FG002|STARTED|Overall Study||122
11140264|NCT01455194|12326763|FG003|STARTED|Overall Study||125
11140265|NCT01455194|12326760|FG000|COMPLETED|Overall Study||0
11140266|NCT01455194|12326761|FG001|COMPLETED|Overall Study||89
11140267|NCT01455194|12326762|FG002|COMPLETED|Overall Study||92
11140268|NCT01455194|12326763|FG003|COMPLETED|Overall Study||97
11140269|NCT01455194|12326760|FG000|NOT COMPLETED|Overall Study||153
11140270|NCT01455194|12326761|FG001|NOT COMPLETED|Overall Study||31
11140271|NCT01455194|12326762|FG002|NOT COMPLETED|Overall Study||30
11140272|NCT01455194|12326763|FG003|NOT COMPLETED|Overall Study||28
11140273|NCT01455220|12326776|FG000|STARTED|Overall Study||45
11140274|NCT01455220|12326776|FG000|COMPLETED|Overall Study||15
11140275|NCT01455220|12326776|FG000|NOT COMPLETED|Overall Study||30
11140276|NCT01455415|12326785|FG000|STARTED|Period 1|Started=Treated|154
11140277|NCT01455415|12326786|FG001|STARTED|Period 1|Started=Treated|147
11140278|NCT01455415|12326785|FG000|COMPLETED|Period 1||135
11140279|NCT01455415|12326786|FG001|COMPLETED|Period 1||123
11140280|NCT01455415|12326785|FG000|NOT COMPLETED|Period 1||19
11140281|NCT01455415|12326786|FG001|NOT COMPLETED|Period 1||24
11140282|NCT01455415|12326785|FG000|STARTED|Washout||135
11140283|NCT01455415|12326786|FG001|STARTED|Washout||123
11140284|NCT01455415|12326785|FG000|COMPLETED|Washout||127
11140285|NCT01455415|12326786|FG001|COMPLETED|Washout||116
11140286|NCT01455415|12326785|FG000|NOT COMPLETED|Washout||8
11140287|NCT01455415|12326786|FG001|NOT COMPLETED|Washout||7
11140288|NCT01455415|12326785|FG000|STARTED|Period 2||127
11140289|NCT01455415|12326786|FG001|STARTED|Period 2||116
11140290|NCT01455415|12326785|FG000|COMPLETED|Period 2||114
11140291|NCT01455415|12326786|FG001|COMPLETED|Period 2||106
11140292|NCT01455415|12326785|FG000|NOT COMPLETED|Period 2||13
11140293|NCT01455415|12326786|FG001|NOT COMPLETED|Period 2||10
11140294|NCT01455415|12326785|FG000|STARTED|Follow-up||114
11140295|NCT01455415|12326786|FG001|STARTED|Follow-up||106
11140296|NCT01455415|12326785|FG000|COMPLETED|Follow-up||111
11140297|NCT01455415|12326786|FG001|COMPLETED|Follow-up||104
11140298|NCT01455415|12326785|FG000|NOT COMPLETED|Follow-up||3
11140299|NCT01455415|12326786|FG001|NOT COMPLETED|Follow-up||2
11140300|NCT01455428|12326794|FG000|STARTED|Overall Study||112
11140301|NCT01455428|12326795|FG001|STARTED|Overall Study||110
11140302|NCT01455428|12326794|FG000|Treated|Overall Study||111
11140303|NCT01455428|12326795|FG001|Treated|Overall Study||109
11140304|NCT01455428|12326794|FG000|COMPLETED|Overall Study||98
11140305|NCT01455428|12326795|FG001|COMPLETED|Overall Study||92
11140306|NCT01455428|12326794|FG000|NOT COMPLETED|Overall Study||14
11140307|NCT01455428|12326795|FG001|NOT COMPLETED|Overall Study||18
11140308|NCT01455519|12326803|FG000|STARTED|Overall Study||12
11140309|NCT01455519|12326804|FG001|STARTED|Overall Study||23
11140310|NCT01455519|12326803|FG000|COMPLETED|Overall Study||8
11140311|NCT01455519|12326804|FG001|COMPLETED|Overall Study||18
11140312|NCT01455519|12326803|FG000|NOT COMPLETED|Overall Study||4
11140313|NCT01455519|12326804|FG001|NOT COMPLETED|Overall Study||5
11140314|NCT01455545|12326810|FG000|STARTED|Overall Study||55
11140315|NCT01455545|12326811|FG001|STARTED|Overall Study||45
11140316|NCT01455545|12326810|FG000|COMPLETED|Overall Study||55
11140317|NCT01455545|12326811|FG001|COMPLETED|Overall Study||45
11140318|NCT01455545|12326810|FG000|NOT COMPLETED|Overall Study||0
11140319|NCT01455545|12326811|FG001|NOT COMPLETED|Overall Study||0
11140320|NCT01456000|12326828|FG000|STARTED|Overall Study||178
11140321|NCT01456000|12326829|FG001|STARTED|Overall Study||175
11140322|NCT01456000|12326828|FG000|COMPLETED|Overall Study||170
11140323|NCT01456000|12326829|FG001|COMPLETED|Overall Study||172
11140324|NCT01456000|12326828|FG000|NOT COMPLETED|Overall Study||8
11140325|NCT01456000|12326829|FG001|NOT COMPLETED|Overall Study||3
11140326|NCT01456039|12326838|FG000|STARTED|Phase 1 (First Step)||3
11140327|NCT01456039|12326839|FG001|STARTED|Phase 1 (First Step)||8
11140328|NCT01456039|12326840|FG002|STARTED|Phase 1 (First Step)||0
11140329|NCT01456039|12326838|FG000|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
11140330|NCT01456039|12326839|FG001|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
11140331|NCT01456039|12326840|FG002|COMPLETED|Phase 1 (First Step)||0
11140332|NCT01456039|12326838|FG000|NOT COMPLETED|Phase 1 (First Step)||2
11140333|NCT01456039|12326839|FG001|NOT COMPLETED|Phase 1 (First Step)||7
11140334|NCT01456039|12326840|FG002|NOT COMPLETED|Phase 1 (First Step)||0
11140335|NCT01456039|12326838|FG000|STARTED|Phase 2 (Second Step)||0
11140336|NCT01456039|12326839|FG001|STARTED|Phase 2 (Second Step)||0
11140337|NCT01456039|12326840|FG002|STARTED|Phase 2 (Second Step)||40
11140338|NCT01456039|12326838|FG000|COMPLETED|Phase 2 (Second Step)||0
11140339|NCT01456039|12326839|FG001|COMPLETED|Phase 2 (Second Step)||0
11140340|NCT01456039|12326840|FG002|COMPLETED|Phase 2 (Second Step)||7
11140341|NCT01456039|12326838|FG000|NOT COMPLETED|Phase 2 (Second Step)||0
11140342|NCT01456039|12326839|FG001|NOT COMPLETED|Phase 2 (Second Step)||0
11140343|NCT01456039|12326840|FG002|NOT COMPLETED|Phase 2 (Second Step)||33
11140344|NCT01456052|12326859|FG000|STARTED|Overall Study||10
11140345|NCT01456052|12326860|FG001|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
11140346|NCT01456052|12326861|FG002|STARTED|Overall Study||24
11140347|NCT01456052|12326859|FG000|COMPLETED|Overall Study||8
11140348|NCT01456052|12326860|FG001|COMPLETED|Overall Study||20
11140349|NCT01456052|12326861|FG002|COMPLETED|Overall Study||19
11140350|NCT01456052|12326859|FG000|NOT COMPLETED|Overall Study||2
11140351|NCT01456052|12326860|FG001|NOT COMPLETED|Overall Study||5
11140352|NCT01456052|12326861|FG002|NOT COMPLETED|Overall Study||5
11140353|NCT01456130|12326870|FG000|STARTED|Overall Study||67
11140354|NCT01456130|12326870|FG000|COMPLETED|Overall Study||57
11140355|NCT01456130|12326870|FG000|NOT COMPLETED|Overall Study||10
11140356|NCT01456143|12326874|FG000|STARTED|Overall Study||33
11140357|NCT01456143|12326874|FG000|COMPLETED|Overall Study||33
11140358|NCT01456143|12326874|FG000|NOT COMPLETED|Overall Study||0
11140359|NCT01456169|12326881|FG000|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
11140360|NCT01456169|12326882|FG001|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
11140361|NCT01456169|12326883|FG002|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
11140362|NCT01456169|12326881|FG000|COMPLETED|Overall Study||123
11140363|NCT01456169|12326882|FG001|COMPLETED|Overall Study||122
11140364|NCT01456169|12326883|FG002|COMPLETED|Overall Study||123
11140365|NCT01456169|12326881|FG000|NOT COMPLETED|Overall Study||10
11140366|NCT01456169|12326882|FG001|NOT COMPLETED|Overall Study||5
11140367|NCT01456169|12326883|FG002|NOT COMPLETED|Overall Study||12
11140368|NCT01456195|12326895|FG000|STARTED|Overall Study||143
11140369|NCT01456195|12326896|FG001|STARTED|Overall Study||137
11140370|NCT01456195|12326897|FG002|STARTED|Overall Study||141
11140371|NCT01456195|12326895|FG000|COMPLETED|Overall Study||132
11140372|NCT01456195|12326896|FG001|COMPLETED|Overall Study||127
11140373|NCT01456195|12326897|FG002|COMPLETED|Overall Study||127
11140374|NCT01456195|12326895|FG000|NOT COMPLETED|Overall Study||11
11140375|NCT01456195|12326896|FG001|NOT COMPLETED|Overall Study||10
11140376|NCT01456195|12326897|FG002|NOT COMPLETED|Overall Study||14
11140377|NCT01456221|12326907|FG000|STARTED|Overall Study||183
11140378|NCT01456221|12326908|FG001|STARTED|Overall Study||183
11140379|NCT01456221|12326907|FG000|COMPLETED|Overall Study||119
11140380|NCT01456221|12326908|FG001|COMPLETED|Overall Study||126
11140381|NCT01456221|12326907|FG000|NOT COMPLETED|Overall Study||64
11140382|NCT01456221|12326908|FG001|NOT COMPLETED|Overall Study||57
11140383|NCT01456299|12326917|FG000|STARTED|Overall Study||34
11140384|NCT01456299|12326918|FG001|STARTED|Overall Study||34
11140385|NCT01456299|12326919|FG002|STARTED|Overall Study||34
11140386|NCT01456299|12326917|FG000|COMPLETED|Overall Study||34
11140387|NCT01456299|12326918|FG001|COMPLETED|Overall Study||33
11140388|NCT01456299|12326919|FG002|COMPLETED|Overall Study||33
11140389|NCT01456299|12326917|FG000|NOT COMPLETED|Overall Study||0
11140390|NCT01456299|12326918|FG001|NOT COMPLETED|Overall Study||1
11140391|NCT01456299|12326919|FG002|NOT COMPLETED|Overall Study||1
11140392|NCT01456494|12326929|FG000|STARTED|Initial Inpatient Visit||24
11140393|NCT01456494|12326930|FG001|STARTED|Initial Inpatient Visit||26
11140394|NCT01456494|12326929|FG000|COMPLETED|Initial Inpatient Visit||24
11140395|NCT01456494|12326930|FG001|COMPLETED|Initial Inpatient Visit||26
11140396|NCT01456494|12326929|FG000|NOT COMPLETED|Initial Inpatient Visit||0
11140397|NCT01456494|12326930|FG001|NOT COMPLETED|Initial Inpatient Visit||0
11140398|NCT01456494|12326929|FG000|STARTED|Follow-Up Visit (Post 30-day Discharge)||24
11140399|NCT01456494|12326930|FG001|STARTED|Follow-Up Visit (Post 30-day Discharge)||26
11140400|NCT01456494|12326929|FG000|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19
11140401|NCT01456494|12326930|FG001|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20
11140402|NCT01456494|12326929|FG000|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5
11140403|NCT01456494|12326930|FG001|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6
11140404|NCT01456780|12326939|FG000|STARTED|Overall Study||20
11140405|NCT01456780|12326940|FG001|STARTED|Overall Study||20
11140406|NCT01456780|12326941|FG002|STARTED|Overall Study||20
11140407|NCT01456780|12326939|FG000|COMPLETED|Overall Study||17
11140408|NCT01456780|12326940|FG001|COMPLETED|Overall Study||17
11140409|NCT01456780|12326941|FG002|COMPLETED|Overall Study||20
11140410|NCT01456780|12326939|FG000|NOT COMPLETED|Overall Study||3
11140411|NCT01456780|12326940|FG001|NOT COMPLETED|Overall Study||3
11140412|NCT01456780|12326941|FG002|NOT COMPLETED|Overall Study||0
11140413|NCT01456897|12326951|FG000|STARTED|Overall Study||184
11140414|NCT01456897|12326952|FG001|STARTED|Overall Study||98
11140415|NCT01456897|12326951|FG000|COMPLETED|Overall Study||109
11140416|NCT01456897|12326952|FG001|COMPLETED|Overall Study||41
11140417|NCT01456897|12326951|FG000|NOT COMPLETED|Overall Study||75
11140418|NCT01456897|12326952|FG001|NOT COMPLETED|Overall Study||57
11140419|NCT01456936|12326962|FG000|STARTED|Overall Study||2037
11140420|NCT01456936|12326963|FG001|STARTED|Overall Study||2034
11140421|NCT01456936|12326964|FG002|STARTED|Overall Study||2038
11140422|NCT01456936|12326965|FG003|STARTED|Overall Study||2035
11140423|NCT01456936|12326962|FG000|Randomized and Treated|Overall Study||2016
11140424|NCT01456936|12326963|FG001|Randomized and Treated|Overall Study||2006
11140425|NCT01456936|12326964|FG002|Randomized and Treated|Overall Study||2022
11140426|NCT01456936|12326965|FG003|Randomized and Treated|Overall Study||2014
11140427|NCT01456936|12326962|FG000|COMPLETED|Overall Study||1598
11140428|NCT01456936|12326963|FG001|COMPLETED|Overall Study||1586
11140429|NCT01456936|12326964|FG002|COMPLETED|Overall Study||1557
11140430|NCT01456936|12326965|FG003|COMPLETED|Overall Study||1552
11140431|NCT01456936|12326962|FG000|NOT COMPLETED|Overall Study||439
11140432|NCT01456936|12326963|FG001|NOT COMPLETED|Overall Study||448
11140433|NCT01456936|12326964|FG002|NOT COMPLETED|Overall Study||481
11140434|NCT01456936|12326965|FG003|NOT COMPLETED|Overall Study||483
11140435|NCT01456949|12326975|FG000|STARTED|Enrollment||402
11140436|NCT01456949|12326975|FG000|Treated|Enrollment||359
11140437|NCT01456949|12326975|FG000|Modified Intent to Treat Group (mITT)|Enrollment||354
11140438|NCT01456949|12326975|FG000|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365
11140439|NCT01456949|12326975|FG000|NOT COMPLETED|Enrollment||37
11140440|NCT01456949|12326975|FG000|STARTED|Study Cryoablation Procedure & Follow-up||365
11140441|NCT01456949|12326975|FG000|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344
11202501|NCT01840579|12392898|FG007|STARTED|Overall Study||6
11140442|NCT01456949|12326975|FG000|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342
11140443|NCT01456949|12326975|FG000|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325
11140444|NCT01456949|12326975|FG000|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309
11140445|NCT01456949|12326975|FG000|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298
11140446|NCT01456949|12326975|FG000|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303
11140447|NCT01456949|12326975|FG000|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62
11140448|NCT01456962|12326981|FG000|STARTED|Overall Study||16
11140449|NCT01456962|12326982|FG001|STARTED|Overall Study||20
11140450|NCT01456962|12326981|FG000|COMPLETED|Overall Study||14
11140451|NCT01456962|12326982|FG001|COMPLETED|Overall Study||19
11140452|NCT01456962|12326981|FG000|NOT COMPLETED|Overall Study||2
11140453|NCT01456962|12326982|FG001|NOT COMPLETED|Overall Study||1
11140454|NCT01457014|12326988|FG000|STARTED|First Night||74
11140455|NCT01457014|12326989|FG001|STARTED|First Night||0
11140456|NCT01457014|12326990|FG002|STARTED|First Night||0
11140457|NCT01457014|12326991|FG003|STARTED|First Night||0
11140458|NCT01457014|12326988|FG000|COMPLETED|First Night||34
11140459|NCT01457014|12326989|FG001|COMPLETED|First Night||0
11140460|NCT01457014|12326990|FG002|COMPLETED|First Night||0
11140461|NCT01457014|12326991|FG003|COMPLETED|First Night||0
11140462|NCT01457014|12326988|FG000|NOT COMPLETED|First Night||40
11140463|NCT01457014|12326989|FG001|NOT COMPLETED|First Night||0
11140464|NCT01457014|12326990|FG002|NOT COMPLETED|First Night||0
11140465|NCT01457014|12326991|FG003|NOT COMPLETED|First Night||0
11140466|NCT01457014|12326988|FG000|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
11140467|NCT01457014|12326989|FG001|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
11140468|NCT01457014|12326990|FG002|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
11140469|NCT01457014|12326991|FG003|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
11140470|NCT01457014|12326988|FG000|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
11140471|NCT01457014|12326989|FG001|COMPLETED|Second Night||12
11140472|NCT01457014|12326990|FG002|COMPLETED|Second Night||11
11140473|NCT01457014|12326991|FG003|COMPLETED|Second Night||11
11140474|NCT01457014|12326988|FG000|NOT COMPLETED|Second Night||0
11140475|NCT01457014|12326989|FG001|NOT COMPLETED|Second Night||0
11140476|NCT01457014|12326990|FG002|NOT COMPLETED|Second Night||0
11140477|NCT01457014|12326991|FG003|NOT COMPLETED|Second Night||0
11140478|NCT01457014|12326988|FG000|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
11140479|NCT01457014|12326989|FG001|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
11140480|NCT01457014|12326990|FG002|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
11140481|NCT01457014|12326991|FG003|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
11140482|NCT01457014|12326988|FG000|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
11140483|NCT01457014|12326989|FG001|COMPLETED|Third Night||11
11140484|NCT01457014|12326990|FG002|COMPLETED|Third Night||11
11140485|NCT01457014|12326991|FG003|COMPLETED|Third Night||12
11140486|NCT01457014|12326988|FG000|NOT COMPLETED|Third Night||0
11140487|NCT01457014|12326989|FG001|NOT COMPLETED|Third Night||0
11140488|NCT01457014|12326990|FG002|NOT COMPLETED|Third Night||0
11140489|NCT01457014|12326991|FG003|NOT COMPLETED|Third Night||0
11140490|NCT01457014|12326988|FG000|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
11140491|NCT01457014|12326989|FG001|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
11140492|NCT01457014|12326990|FG002|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
11140493|NCT01457014|12326991|FG003|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
11140494|NCT01457014|12326988|FG000|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
11140495|NCT01457014|12326989|FG001|COMPLETED|Fourth Night||11
11140496|NCT01457014|12326990|FG002|COMPLETED|Fourth Night||12
11140497|NCT01457014|12326991|FG003|COMPLETED|Fourth Night||11
11140498|NCT01457014|12326988|FG000|NOT COMPLETED|Fourth Night||0
11140499|NCT01457014|12326989|FG001|NOT COMPLETED|Fourth Night||0
11140500|NCT01457014|12326990|FG002|NOT COMPLETED|Fourth Night||0
11140501|NCT01457014|12326991|FG003|NOT COMPLETED|Fourth Night||0
11140502|NCT01457118|12327003|FG000|STARTED|Overall Study||20
11140503|NCT01457118|12327004|FG001|STARTED|Overall Study||4
11140504|NCT01457118|12327005|FG002|STARTED|Overall Study||1
11140505|NCT01457118|12327006|FG003|STARTED|Overall Study||2
11140506|NCT01457118|12327003|FG000|COMPLETED|Overall Study||0
11140507|NCT01457118|12327004|FG001|COMPLETED|Overall Study||0
11140508|NCT01457118|12327005|FG002|COMPLETED|Overall Study||0
11140509|NCT01457118|12327006|FG003|COMPLETED|Overall Study||0
11140510|NCT01457118|12327003|FG000|NOT COMPLETED|Overall Study||20
11140511|NCT01457118|12327004|FG001|NOT COMPLETED|Overall Study||4
11140512|NCT01457118|12327005|FG002|NOT COMPLETED|Overall Study||1
11140513|NCT01457118|12327006|FG003|NOT COMPLETED|Overall Study||2
11140514|NCT01457196|12327016|FG000|STARTED|Overall Study||2074
11140515|NCT01457196|12327016|FG000|COMPLETED|Overall Study||2074
11140516|NCT01457196|12327016|FG000|NOT COMPLETED|Overall Study||0
11140517|NCT01457339|12327024|FG000|STARTED|Period 1 (50 mg)||7
11140518|NCT01457339|12327025|FG001|STARTED|Period 1 (50 mg)||24
11140519|NCT01457339|12327024|FG000|COMPLETED|Period 1 (50 mg)||7
11140520|NCT01457339|12327025|FG001|COMPLETED|Period 1 (50 mg)||24
11140521|NCT01457339|12327024|FG000|NOT COMPLETED|Period 1 (50 mg)||0
11140522|NCT01457339|12327025|FG001|NOT COMPLETED|Period 1 (50 mg)||0
11140523|NCT01457339|12327024|FG000|STARTED|Period 2 (70 mg)||7
11140524|NCT01457339|12327025|FG001|STARTED|Period 2 (70 mg)||24
11140525|NCT01457339|12327024|FG000|COMPLETED|Period 2 (70 mg)||7
11140526|NCT01457339|12327025|FG001|COMPLETED|Period 2 (70 mg)||24
11140527|NCT01457339|12327024|FG000|NOT COMPLETED|Period 2 (70 mg)||0
11140528|NCT01457339|12327025|FG001|NOT COMPLETED|Period 2 (70 mg)||0
11140529|NCT01457339|12327024|FG000|STARTED|Period 3 (100 mg)||7
11140530|NCT01457339|12327025|FG001|STARTED|Period 3 (100 mg)||24
11140531|NCT01457339|12327024|FG000|COMPLETED|Period 3 (100 mg)||7
11140532|NCT01457339|12327025|FG001|COMPLETED|Period 3 (100 mg)||23
11140533|NCT01457339|12327024|FG000|NOT COMPLETED|Period 3 (100 mg)||0
11140534|NCT01457339|12327025|FG001|NOT COMPLETED|Period 3 (100 mg)||1
11140535|NCT01457339|12327024|FG000|STARTED|Period 4 (150 mg)||7
11140536|NCT01457339|12327025|FG001|STARTED|Period 4 (150 mg)||23
11140537|NCT01457339|12327024|FG000|COMPLETED|Period 4 (150 mg)||7
11140538|NCT01457339|12327025|FG001|COMPLETED|Period 4 (150 mg)||23
11140539|NCT01457339|12327024|FG000|NOT COMPLETED|Period 4 (150 mg)||0
11140540|NCT01457339|12327025|FG001|NOT COMPLETED|Period 4 (150 mg)||0
11140541|NCT01457339|12327024|FG000|STARTED|Period 5 (200 mg)||7
11140542|NCT01457339|12327025|FG001|STARTED|Period 5 (200 mg)||23
11140543|NCT01457339|12327024|FG000|COMPLETED|Period 5 (200 mg)||7
11140544|NCT01457339|12327025|FG001|COMPLETED|Period 5 (200 mg)||22
11140545|NCT01457339|12327024|FG000|NOT COMPLETED|Period 5 (200 mg)||0
11140546|NCT01457339|12327025|FG001|NOT COMPLETED|Period 5 (200 mg)||1
11140547|NCT01457339|12327024|FG000|STARTED|Period 6 (250 mg)||7
11140548|NCT01457339|12327025|FG001|STARTED|Period 6 (250 mg)||22
11140549|NCT01457339|12327024|FG000|COMPLETED|Period 6 (250 mg)||6
11140550|NCT01457339|12327025|FG001|COMPLETED|Period 6 (250 mg)||21
11140551|NCT01457339|12327024|FG000|NOT COMPLETED|Period 6 (250 mg)||1
11140552|NCT01457339|12327025|FG001|NOT COMPLETED|Period 6 (250 mg)||1
11140553|NCT01457352|12327050|FG000|STARTED|Period 1||392
11140554|NCT01457352|12327051|FG001|STARTED|Period 1||0
11140555|NCT01457352|12327050|FG000|COMPLETED|Period 1||376
11140556|NCT01457352|12327051|FG001|COMPLETED|Period 1||0
11140557|NCT01457352|12327050|FG000|NOT COMPLETED|Period 1||16
11140558|NCT01457352|12327051|FG001|NOT COMPLETED|Period 1||0
11140559|NCT01457352|12327050|FG000|STARTED|Period 2||376
11140560|NCT01457352|12327051|FG001|STARTED|Period 2||0
11140561|NCT01457352|12327050|FG000|COMPLETED|Period 2||296
11140562|NCT01457352|12327051|FG001|COMPLETED|Period 2||0
11140563|NCT01457352|12327050|FG000|NOT COMPLETED|Period 2||80
11140564|NCT01457352|12327051|FG001|NOT COMPLETED|Period 2||0
11140565|NCT01457352|12327050|FG000|STARTED|Period 3||147
11140566|NCT01457352|12327051|FG001|STARTED|Period 3||149
11140567|NCT01457352|12327050|FG000|Randomization|Period 3||147
11140568|NCT01457352|12327051|FG001|Randomization|Period 3||149
11140569|NCT01457352|12327050|FG000|COMPLETED|Period 3||146
11140570|NCT01457352|12327051|FG001|COMPLETED|Period 3||144
11140571|NCT01457352|12327050|FG000|NOT COMPLETED|Period 3||1
11140572|NCT01457352|12327051|FG001|NOT COMPLETED|Period 3||5
11140573|NCT01457417|12327066|FG000|STARTED|Overall Study||3
11140574|NCT01457417|12327067|FG001|STARTED|Overall Study||3
11140575|NCT01457417|12327068|FG002|STARTED|Overall Study||4
11140576|NCT01457417|12327069|FG003|STARTED|Overall Study||3
11140577|NCT01457417|12327070|FG004|STARTED|Overall Study||19
11140578|NCT01457417|12327066|FG000|COMPLETED|Overall Study||3
11140579|NCT01457417|12327067|FG001|COMPLETED|Overall Study||3
11140580|NCT01457417|12327068|FG002|COMPLETED|Overall Study||4
11140581|NCT01457417|12327069|FG003|COMPLETED|Overall Study||3
11140582|NCT01457417|12327070|FG004|COMPLETED|Overall Study||19
11140583|NCT01457417|12327066|FG000|NOT COMPLETED|Overall Study||0
11140584|NCT01457417|12327067|FG001|NOT COMPLETED|Overall Study||0
11140585|NCT01457417|12327068|FG002|NOT COMPLETED|Overall Study||0
11140586|NCT01457417|12327069|FG003|NOT COMPLETED|Overall Study||0
11140587|NCT01457417|12327070|FG004|NOT COMPLETED|Overall Study||0
11140588|NCT01457430|12327084|FG000|STARTED|Overall Study||19
11140589|NCT01457430|12327084|FG000|COMPLETED|Overall Study||19
11140590|NCT01457430|12327084|FG000|NOT COMPLETED|Overall Study||0
11140591|NCT01457521|12327091|FG000|STARTED|Overall Study||123
11140592|NCT01457521|12327092|FG001|STARTED|Overall Study||127
11241475|NCT02097719|12433993|FG000|STARTED|Overall Study||49
11241476|NCT02097719|12433994|FG001|STARTED|Overall Study||51
11241477|NCT02097719|12433993|FG000|COMPLETED|Overall Study||46
11140593|NCT01457521|12327091|FG000|COMPLETED|Overall Study||111
11140594|NCT01457521|12327092|FG001|COMPLETED|Overall Study||117
11140595|NCT01457521|12327091|FG000|NOT COMPLETED|Overall Study||12
11140596|NCT01457521|12327092|FG001|NOT COMPLETED|Overall Study||10
11140597|NCT01457573|12327098|FG000|STARTED|Overall Study||10
11140598|NCT01457573|12327098|FG000|COMPLETED|Overall Study||10
11140599|NCT01457573|12327098|FG000|NOT COMPLETED|Overall Study||0
11140600|NCT01457703|12327105|FG000|STARTED|Overall Study||29
11140601|NCT01457703|12327106|FG001|STARTED|Overall Study||33
11140602|NCT01457703|12327105|FG000|COMPLETED|Overall Study||23
11140603|NCT01457703|12327106|FG001|COMPLETED|Overall Study||22
11140604|NCT01457703|12327105|FG000|NOT COMPLETED|Overall Study||6
11140605|NCT01457703|12327106|FG001|NOT COMPLETED|Overall Study||11
11140606|NCT01457846|12327116|FG000|STARTED|Overall Study||41
11140607|NCT01457846|12327117|FG001|STARTED|Overall Study||30
11241478|NCT02097719|12433994|FG001|COMPLETED|Overall Study||50
11241479|NCT02097719|12433993|FG000|NOT COMPLETED|Overall Study||3
11241480|NCT02097719|12433994|FG001|NOT COMPLETED|Overall Study||1
11241481|NCT02097732|12434002|FG000|STARTED|Overall Study||1
11241482|NCT02097732|12434003|FG001|STARTED|Overall Study||3
11241483|NCT02097732|12434002|FG000|COMPLETED|Overall Study||1
11241484|NCT02097732|12434003|FG001|COMPLETED|Overall Study||3
11241485|NCT02097732|12434002|FG000|NOT COMPLETED|Overall Study||0
11241486|NCT02097732|12434003|FG001|NOT COMPLETED|Overall Study||0
11241487|NCT02097745|12434010|FG000|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
11241488|NCT02097745|12434010|FG000|COMPLETED|Overall Study||157
11241489|NCT02097745|12434010|FG000|NOT COMPLETED|Overall Study||178
11241490|NCT02097823|12434019|FG000|STARTED|Overall Study||11
11241491|NCT02097823|12434020|FG001|STARTED|Overall Study||4
11241492|NCT02097823|12434019|FG000|COMPLETED|Overall Study||10
11241493|NCT02097823|12434020|FG001|COMPLETED|Overall Study||3
11241494|NCT02097823|12434019|FG000|NOT COMPLETED|Overall Study||1
11241495|NCT02097823|12434020|FG001|NOT COMPLETED|Overall Study||1
11241496|NCT02097849|12434029|FG000|STARTED|Overall Study||33
11241497|NCT02097849|12434030|FG001|STARTED|Overall Study||38
11241498|NCT02097849|12434029|FG000|COMPLETED|Overall Study||33
11241499|NCT02097849|12434030|FG001|COMPLETED|Overall Study||38
11241500|NCT02097849|12434029|FG000|NOT COMPLETED|Overall Study||0
11241501|NCT02097849|12434030|FG001|NOT COMPLETED|Overall Study||0
11241502|NCT02097992|12434040|FG000|STARTED|Treatment 1 (1 Day)||2
11241503|NCT02097992|12434041|FG001|STARTED|Treatment 1 (1 Day)||3
11241504|NCT02097992|12434042|FG002|STARTED|Treatment 1 (1 Day)||4
11241505|NCT02097992|12434043|FG003|STARTED|Treatment 1 (1 Day)||2
11241506|NCT02097992|12434040|FG000|COMPLETED|Treatment 1 (1 Day)||2
11241507|NCT02097992|12434041|FG001|COMPLETED|Treatment 1 (1 Day)||3
11241508|NCT02097992|12434042|FG002|COMPLETED|Treatment 1 (1 Day)||4
11241509|NCT02097992|12434043|FG003|COMPLETED|Treatment 1 (1 Day)||2
11241510|NCT02097992|12434040|FG000|NOT COMPLETED|Treatment 1 (1 Day)||0
11241511|NCT02097992|12434041|FG001|NOT COMPLETED|Treatment 1 (1 Day)||0
11241512|NCT02097992|12434042|FG002|NOT COMPLETED|Treatment 1 (1 Day)||0
11241513|NCT02097992|12434043|FG003|NOT COMPLETED|Treatment 1 (1 Day)||0
11241514|NCT02097992|12434040|FG000|STARTED|Treatment 2 (4 Weeks)||2
11241515|NCT02097992|12434041|FG001|STARTED|Treatment 2 (4 Weeks)||3
11241516|NCT02097992|12434042|FG002|STARTED|Treatment 2 (4 Weeks)||4
11241517|NCT02097992|12434043|FG003|STARTED|Treatment 2 (4 Weeks)||2
11241518|NCT02097992|12434040|FG000|COMPLETED|Treatment 2 (4 Weeks)||2
11241519|NCT02097992|12434041|FG001|COMPLETED|Treatment 2 (4 Weeks)||3
11241520|NCT02097992|12434042|FG002|COMPLETED|Treatment 2 (4 Weeks)||4
11241521|NCT02097992|12434043|FG003|COMPLETED|Treatment 2 (4 Weeks)||2
11241522|NCT02097992|12434040|FG000|NOT COMPLETED|Treatment 2 (4 Weeks)||0
11241523|NCT02097992|12434041|FG001|NOT COMPLETED|Treatment 2 (4 Weeks)||0
11241524|NCT02097992|12434042|FG002|NOT COMPLETED|Treatment 2 (4 Weeks)||0
11241525|NCT02097992|12434043|FG003|NOT COMPLETED|Treatment 2 (4 Weeks)||0
11241526|NCT02097992|12434040|FG000|STARTED|Washout (4 Weeks)||2
11241527|NCT02097992|12434041|FG001|STARTED|Washout (4 Weeks)||3
11241528|NCT02097992|12434042|FG002|STARTED|Washout (4 Weeks)||4
11241529|NCT02097992|12434043|FG003|STARTED|Washout (4 Weeks)||2
11241530|NCT02097992|12434040|FG000|COMPLETED|Washout (4 Weeks)||2
11241531|NCT02097992|12434041|FG001|COMPLETED|Washout (4 Weeks)||3
11241532|NCT02097992|12434042|FG002|COMPLETED|Washout (4 Weeks)||4
11241533|NCT02097992|12434043|FG003|COMPLETED|Washout (4 Weeks)||2
11241534|NCT02097992|12434040|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11241535|NCT02097992|12434041|FG001|NOT COMPLETED|Washout (4 Weeks)||0
11241536|NCT02097992|12434042|FG002|NOT COMPLETED|Washout (4 Weeks)||0
11241537|NCT02097992|12434043|FG003|NOT COMPLETED|Washout (4 Weeks)||0
11241538|NCT02097992|12434040|FG000|STARTED|Treatment 3 (4 Weeks)||2
11241539|NCT02097992|12434041|FG001|STARTED|Treatment 3 (4 Weeks)||3
11241540|NCT02097992|12434042|FG002|STARTED|Treatment 3 (4 Weeks)||4
11241541|NCT02097992|12434043|FG003|STARTED|Treatment 3 (4 Weeks)||2
11241542|NCT02097992|12434040|FG000|COMPLETED|Treatment 3 (4 Weeks)||2
11140608|NCT01457846|12327116|FG000|Received Treatment|Overall Study||40
11140609|NCT01457846|12327117|FG001|Received Treatment|Overall Study||27
11140610|NCT01457846|12327116|FG000|Did Not Receive Treatment|Overall Study||1
11140611|NCT01457846|12327117|FG001|Did Not Receive Treatment|Overall Study||3
11140612|NCT01457846|12327116|FG000|Ongoing Treatment at Data Cut-off|Overall Study||1
11140613|NCT01457846|12327117|FG001|Ongoing Treatment at Data Cut-off|Overall Study||1
11140614|NCT01457846|12327116|FG000|COMPLETED|Overall Study||0
11140615|NCT01457846|12327117|FG001|COMPLETED|Overall Study||0
11140616|NCT01457846|12327116|FG000|NOT COMPLETED|Overall Study||41
11140617|NCT01457846|12327117|FG001|NOT COMPLETED|Overall Study||30
11140618|NCT01457885|12327123|FG000|STARTED|Overall Study||74
11140619|NCT01457885|12327123|FG000|COMPLETED|Overall Study||74
11140620|NCT01457885|12327123|FG000|NOT COMPLETED|Overall Study||0
11140621|NCT01457924|12327132|FG000|STARTED|Treatment Phase (Weeks 0-24)||67
11241543|NCT02097992|12434041|FG001|COMPLETED|Treatment 3 (4 Weeks)||3
11241544|NCT02097992|12434042|FG002|COMPLETED|Treatment 3 (4 Weeks)||4
11241545|NCT02097992|12434043|FG003|COMPLETED|Treatment 3 (4 Weeks)||2
11241546|NCT02097992|12434040|FG000|NOT COMPLETED|Treatment 3 (4 Weeks)||0
11241547|NCT02097992|12434041|FG001|NOT COMPLETED|Treatment 3 (4 Weeks)||0
11241548|NCT02097992|12434042|FG002|NOT COMPLETED|Treatment 3 (4 Weeks)||0
11241549|NCT02097992|12434043|FG003|NOT COMPLETED|Treatment 3 (4 Weeks)||0
11241550|NCT02098109|12434053|FG000|STARTED|Overall Study||49
11140622|NCT01457924|12327133|FG001|STARTED|Treatment Phase (Weeks 0-24)||34
11140623|NCT01457924|12327134|FG002|STARTED|Treatment Phase (Weeks 0-24)||32
11140624|NCT01457924|12327135|FG003|STARTED|Treatment Phase (Weeks 0-24)||34
11140625|NCT01457924|12327136|FG004|STARTED|Treatment Phase (Weeks 0-24)||64
11140626|NCT01457924|12327132|FG000|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
11140627|NCT01457924|12327133|FG001|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
11140628|NCT01457924|12327134|FG002|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
11140629|NCT01457924|12327135|FG003|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
11140630|NCT01457924|12327136|FG004|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
11140631|NCT01457924|12327132|FG000|COMPLETED|Treatment Phase (Weeks 0-24)||64
11140632|NCT01457924|12327133|FG001|COMPLETED|Treatment Phase (Weeks 0-24)||29
11140633|NCT01457924|12327134|FG002|COMPLETED|Treatment Phase (Weeks 0-24)||30
11140634|NCT01457924|12327135|FG003|COMPLETED|Treatment Phase (Weeks 0-24)||33
11140635|NCT01457924|12327136|FG004|COMPLETED|Treatment Phase (Weeks 0-24)||58
11140636|NCT01457924|12327132|FG000|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
11140637|NCT01457924|12327133|FG001|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
11140638|NCT01457924|12327134|FG002|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
11140639|NCT01457924|12327135|FG003|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
11140640|NCT01457924|12327136|FG004|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
11140641|NCT01457924|12327132|FG000|STARTED|FUP (Weeks 24-48)||66
11140642|NCT01457924|12327133|FG001|STARTED|FUP (Weeks 24-48)||31
11140643|NCT01457924|12327134|FG002|STARTED|FUP (Weeks 24-48)||32
11140644|NCT01457924|12327135|FG003|STARTED|FUP (Weeks 24-48)||33
11140645|NCT01457924|12327136|FG004|STARTED|FUP (Weeks 24-48)||59
11140646|NCT01457924|12327132|FG000|COMPLETED|FUP (Weeks 24-48)||63
11140647|NCT01457924|12327133|FG001|COMPLETED|FUP (Weeks 24-48)||30
11140648|NCT01457924|12327134|FG002|COMPLETED|FUP (Weeks 24-48)||30
11140649|NCT01457924|12327135|FG003|COMPLETED|FUP (Weeks 24-48)||32
11140650|NCT01457924|12327136|FG004|COMPLETED|FUP (Weeks 24-48)||57
11140651|NCT01457924|12327132|FG000|NOT COMPLETED|FUP (Weeks 24-48)||3
11140652|NCT01457924|12327133|FG001|NOT COMPLETED|FUP (Weeks 24-48)||1
11140653|NCT01457924|12327134|FG002|NOT COMPLETED|FUP (Weeks 24-48)||2
11140654|NCT01457924|12327135|FG003|NOT COMPLETED|FUP (Weeks 24-48)||1
11140655|NCT01457924|12327136|FG004|NOT COMPLETED|FUP (Weeks 24-48)||2
11140656|NCT01457924|12327132|FG000|STARTED|Individualized FUP (Weeks 48+)||16
11140657|NCT01457924|12327133|FG001|STARTED|Individualized FUP (Weeks 48+)||18
11140658|NCT01457924|12327134|FG002|STARTED|Individualized FUP (Weeks 48+)||16
11140659|NCT01457924|12327135|FG003|STARTED|Individualized FUP (Weeks 48+)||20
11140660|NCT01457924|12327136|FG004|STARTED|Individualized FUP (Weeks 48+)||42
11140661|NCT01457924|12327132|FG000|COMPLETED|Individualized FUP (Weeks 48+)||11
11140662|NCT01457924|12327133|FG001|COMPLETED|Individualized FUP (Weeks 48+)||14
11140663|NCT01457924|12327134|FG002|COMPLETED|Individualized FUP (Weeks 48+)||12
11140664|NCT01457924|12327135|FG003|COMPLETED|Individualized FUP (Weeks 48+)||15
11140665|NCT01457924|12327136|FG004|COMPLETED|Individualized FUP (Weeks 48+)||36
11140666|NCT01457924|12327132|FG000|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
11140667|NCT01457924|12327133|FG001|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
11140668|NCT01457924|12327134|FG002|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
11140669|NCT01457924|12327135|FG003|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
11140670|NCT01457924|12327136|FG004|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
11140671|NCT01457950|12327150|FG000|STARTED|Double-Blind Phase||69
11140672|NCT01457950|12327151|FG001|STARTED|Double-Blind Phase||66
11140673|NCT01457950|12327152|FG002|STARTED|Double-Blind Phase||0
11140674|NCT01457950|12327153|FG003|STARTED|Double-Blind Phase||0
11140675|NCT01457950|12327150|FG000|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|62
11140676|NCT01457950|12327151|FG001|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|64
11140677|NCT01457950|12327152|FG002|Completed the 6 Month Assessment|Double-Blind Phase||0
11140678|NCT01457950|12327153|FG003|Completed the 6 Month Assessment|Double-Blind Phase||0
11140679|NCT01457950|12327150|FG000|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|60
11140680|NCT01457950|12327151|FG001|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|63
11140681|NCT01457950|12327152|FG002|COMPLETED|Double-Blind Phase||0
11140682|NCT01457950|12327153|FG003|COMPLETED|Double-Blind Phase||0
11140683|NCT01457950|12327150|FG000|NOT COMPLETED|Double-Blind Phase||9
11140684|NCT01457950|12327151|FG001|NOT COMPLETED|Double-Blind Phase||3
11140685|NCT01457950|12327152|FG002|NOT COMPLETED|Double-Blind Phase||0
11140686|NCT01457950|12327153|FG003|NOT COMPLETED|Double-Blind Phase||0
11140687|NCT01457950|12327150|FG000|STARTED|Open-Label Phase||0
11140688|NCT01457950|12327151|FG001|STARTED|Open-Label Phase||0
11140689|NCT01457950|12327152|FG002|STARTED|Open-Label Phase||60
11140690|NCT01457950|12327153|FG003|STARTED|Open-Label Phase||63
11140691|NCT01457950|12327150|FG000|COMPLETED|Open-Label Phase||0
11140692|NCT01457950|12327151|FG001|COMPLETED|Open-Label Phase||0
11140693|NCT01457950|12327152|FG002|COMPLETED|Open-Label Phase||58
11140694|NCT01457950|12327153|FG003|COMPLETED|Open-Label Phase||61
11140695|NCT01457950|12327150|FG000|NOT COMPLETED|Open-Label Phase||0
11140696|NCT01457950|12327151|FG001|NOT COMPLETED|Open-Label Phase||0
11140697|NCT01457950|12327152|FG002|NOT COMPLETED|Open-Label Phase||2
11140698|NCT01457950|12327153|FG003|NOT COMPLETED|Open-Label Phase||2
11140699|NCT01458106|12327166|FG000|STARTED|Overall Study||36
11241551|NCT02098109|12434054|FG001|STARTED|Overall Study||51
11241552|NCT02098109|12434053|FG000|COMPLETED|Overall Study||46
11241553|NCT02098109|12434054|FG001|COMPLETED|Overall Study||51
11140700|NCT01458106|12327167|FG001|STARTED|Overall Study||35
11140701|NCT01458106|12327166|FG000|PK Subgroup|Overall Study||25
11140702|NCT01458106|12327167|FG001|PK Subgroup|Overall Study||35
11140703|NCT01458106|12327166|FG000|Non-PK Subgroup|Overall Study||11
11140704|NCT01458106|12327167|FG001|Non-PK Subgroup|Overall Study||0
11140705|NCT01458106|12327166|FG000|COMPLETED|Overall Study||33
11140706|NCT01458106|12327167|FG001|COMPLETED|Overall Study||34
11140707|NCT01458106|12327166|FG000|NOT COMPLETED|Overall Study||3
11140708|NCT01458106|12327167|FG001|NOT COMPLETED|Overall Study||1
11140709|NCT01458119|12327176|FG000|STARTED|Overall Study||85
11140710|NCT01458119|12327176|FG000|Received at Least 1 Dose of Study Drug|Overall Study||85
11140711|NCT01458119|12327176|FG000|Safety Population|Overall Study||85
11140712|NCT01458119|12327176|FG000|Intent to Treat (ITT) Population|Overall Study||85
11140713|NCT01458119|12327176|FG000|ITT-Amenable Population|Overall Study||68
11140714|NCT01458119|12327176|FG000|COMPLETED|Overall Study||65
11140715|NCT01458119|12327176|FG000|NOT COMPLETED|Overall Study||20
11140716|NCT01458132|12327183|FG000|STARTED|Overall Study||15
11140717|NCT01458132|12327184|FG001|STARTED|Overall Study||4
11140718|NCT01458132|12327183|FG000|COMPLETED|Overall Study||0
11140719|NCT01458132|12327184|FG001|COMPLETED|Overall Study||1
11140720|NCT01458132|12327183|FG000|NOT COMPLETED|Overall Study||15
11140721|NCT01458132|12327184|FG001|NOT COMPLETED|Overall Study||3
11140722|NCT01458171|12327190|FG000|STARTED|Overall Study||23
11140723|NCT01458171|12327190|FG000|COMPLETED|Overall Study||22
11140724|NCT01458171|12327190|FG000|NOT COMPLETED|Overall Study||1
11140725|NCT01458210|12327196|FG000|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
11140726|NCT01458210|12327196|FG000|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
11140727|NCT01458210|12327196|FG000|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
11140728|NCT01458210|12327196|FG000|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
11140729|NCT01458210|12327196|FG000|STARTED|Ortho-Cyclen Alone (Period 1)||22
11140730|NCT01458210|12327196|FG000|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
11140731|NCT01458210|12327196|FG000|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
11140732|NCT01458210|12327196|FG000|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
11140733|NCT01458210|12327196|FG000|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
11140734|NCT01458210|12327196|FG000|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
11140735|NCT01458249|12327205|FG000|STARTED|Overall Study||52
11140736|NCT01458249|12327205|FG000|Participants Treated|Overall Study||51
11140737|NCT01458249|12327205|FG000|COMPLETED|Overall Study||44
11140738|NCT01458249|12327205|FG000|NOT COMPLETED|Overall Study||8
11140739|NCT01458275|12327213|FG000|STARTED|Overall Study||283
11140740|NCT01458275|12327214|FG001|STARTED|Overall Study||282
11140741|NCT01458275|12327215|FG002|STARTED|Overall Study||282
11140742|NCT01458275|12327213|FG000|COMPLETED|Overall Study||269
11140743|NCT01458275|12327214|FG001|COMPLETED|Overall Study||269
11140744|NCT01458275|12327215|FG002|COMPLETED|Overall Study||273
11140745|NCT01458275|12327213|FG000|NOT COMPLETED|Overall Study||14
11241554|NCT02098109|12434053|FG000|NOT COMPLETED|Overall Study||3
11140746|NCT01458275|12327214|FG001|NOT COMPLETED|Overall Study||13
11140747|NCT01458275|12327215|FG002|NOT COMPLETED|Overall Study||9
11140748|NCT01458288|12327225|FG000|STARTED|Overall Study||12
11140749|NCT01458288|12327225|FG000|COMPLETED|Overall Study||12
11140750|NCT01458288|12327225|FG000|NOT COMPLETED|Overall Study||0
11140751|NCT01458327|12327230|FG000|STARTED|Overall Study||3
11140752|NCT01458327|12327230|FG000|COMPLETED|Overall Study||3
11140753|NCT01458327|12327230|FG000|NOT COMPLETED|Overall Study||0
11140754|NCT01458392|12327238|FG000|STARTED|Overall Study||2
11140755|NCT01458392|12327239|FG001|STARTED|Overall Study||13
11140756|NCT01458392|12327240|FG002|STARTED|Overall Study||31
11140757|NCT01458392|12327238|FG000|COMPLETED|Overall Study||0
11140758|NCT01458392|12327239|FG001|COMPLETED|Overall Study||0
11140759|NCT01458392|12327240|FG002|COMPLETED|Overall Study||0
11140760|NCT01458392|12327238|FG000|NOT COMPLETED|Overall Study||2
11140761|NCT01458392|12327239|FG001|NOT COMPLETED|Overall Study||13
11140762|NCT01458392|12327240|FG002|NOT COMPLETED|Overall Study||31
11140763|NCT01458418|12327256|FG000|STARTED|Overall Study||0
11140764|NCT01458418|12327257|FG001|STARTED|Overall Study||0
11140765|NCT01458418|12327258|FG002|STARTED|Overall Study||0
11140766|NCT01458418|12327259|FG003|STARTED|Overall Study||4
11140767|NCT01458418|12327256|FG000|COMPLETED|Overall Study||0
11140768|NCT01458418|12327257|FG001|COMPLETED|Overall Study||0
11140769|NCT01458418|12327258|FG002|COMPLETED|Overall Study||0
11140770|NCT01458418|12327259|FG003|COMPLETED|Overall Study||4
11140771|NCT01458418|12327256|FG000|NOT COMPLETED|Overall Study||0
11140772|NCT01458418|12327257|FG001|NOT COMPLETED|Overall Study||0
11140773|NCT01458418|12327258|FG002|NOT COMPLETED|Overall Study||0
11140774|NCT01458418|12327259|FG003|NOT COMPLETED|Overall Study||0
11140775|NCT01458522|12327271|FG000|STARTED|Overall Study||37
11140776|NCT01458522|12327272|FG001|STARTED|Overall Study||37
11140777|NCT01458522|12327271|FG000|Received First Drug|Overall Study||35
11140778|NCT01458522|12327272|FG001|Received First Drug|Overall Study||35
11140779|NCT01458522|12327271|FG000|Crossover to Second Drug|Overall Study||15
11140780|NCT01458522|12327272|FG001|Crossover to Second Drug|Overall Study||10
11140781|NCT01458522|12327271|FG000|COMPLETED|Overall Study||34
11140782|NCT01458522|12327272|FG001|COMPLETED|Overall Study||26
11140783|NCT01458522|12327271|FG000|NOT COMPLETED|Overall Study||3
11140784|NCT01458522|12327272|FG001|NOT COMPLETED|Overall Study||11
11140785|NCT01458535|12327290|FG000|STARTED|Overall Study||10
11140786|NCT01458535|12327291|FG001|STARTED|Overall Study||10
11140787|NCT01458535|12327292|FG002|STARTED|Overall Study||10
11140788|NCT01458535|12327293|FG003|STARTED|Overall Study||10
11140789|NCT01458535|12327294|FG004|STARTED|Overall Study||10
11140790|NCT01458535|12327295|FG005|STARTED|Overall Study||11
11140791|NCT01458535|12327290|FG000|COMPLETED|Overall Study||10
11140792|NCT01458535|12327291|FG001|COMPLETED|Overall Study||8
11140793|NCT01458535|12327292|FG002|COMPLETED|Overall Study||8
11140794|NCT01458535|12327293|FG003|COMPLETED|Overall Study||6
11140795|NCT01458535|12327294|FG004|COMPLETED|Overall Study||6
11140796|NCT01458535|12327295|FG005|COMPLETED|Overall Study||7
11140797|NCT01458535|12327290|FG000|NOT COMPLETED|Overall Study||0
11140798|NCT01458535|12327291|FG001|NOT COMPLETED|Overall Study||2
11140799|NCT01458535|12327292|FG002|NOT COMPLETED|Overall Study||2
11140800|NCT01458535|12327293|FG003|NOT COMPLETED|Overall Study||4
11140801|NCT01458535|12327294|FG004|NOT COMPLETED|Overall Study||4
11140802|NCT01458535|12327295|FG005|NOT COMPLETED|Overall Study||4
11140803|NCT01458561|12327311|FG000|STARTED|Overall Study||0
11140804|NCT01458561|12327312|FG001|STARTED|Overall Study||1
11140805|NCT01458561|12327311|FG000|COMPLETED|Overall Study||0
11140806|NCT01458561|12327312|FG001|COMPLETED|Overall Study||1
11140807|NCT01458561|12327311|FG000|NOT COMPLETED|Overall Study||0
11140808|NCT01458561|12327312|FG001|NOT COMPLETED|Overall Study||0
11140809|NCT01458574|12327351|FG000|STARTED|Overall Study||198
11140810|NCT01458574|12327352|FG001|STARTED|Overall Study||197
11140811|NCT01458574|12327353|FG002|STARTED|Overall Study||198
11140812|NCT01458574|12327351|FG000|Treated|Overall Study||198
11140813|NCT01458574|12327352|FG001|Treated|Overall Study||196
11140814|NCT01458574|12327353|FG002|Treated|Overall Study||198
11140815|NCT01458574|12327351|FG000|COMPLETED|Overall Study||111
11140816|NCT01458574|12327352|FG001|COMPLETED|Overall Study||126
11140817|NCT01458574|12327353|FG002|COMPLETED|Overall Study||53
11140818|NCT01458574|12327351|FG000|NOT COMPLETED|Overall Study||87
11140819|NCT01458574|12327352|FG001|NOT COMPLETED|Overall Study||71
11140820|NCT01458574|12327353|FG002|NOT COMPLETED|Overall Study||145
11140821|NCT01458587|12327363|FG000|STARTED|Overall Study||35
11140822|NCT01458587|12327364|FG001|STARTED|Overall Study||35
11140823|NCT01458587|12327363|FG000|COMPLETED|Overall Study||34
11140824|NCT01458587|12327364|FG001|COMPLETED|Overall Study||35
11140825|NCT01458587|12327363|FG000|NOT COMPLETED|Overall Study||1
11140826|NCT01458587|12327364|FG001|NOT COMPLETED|Overall Study||0
11140827|NCT01458639|12327372|FG000|STARTED|Overall Study||18
11140828|NCT01458639|12327372|FG000|COMPLETED|Overall Study||12
11140829|NCT01458639|12327372|FG000|NOT COMPLETED|Overall Study||6
11140830|NCT01458951|12327379|FG000|STARTED|Overall Study||429
11140831|NCT01458951|12327380|FG001|STARTED|Overall Study||6
11140832|NCT01458951|12327381|FG002|STARTED|Overall Study||112
11140833|NCT01458951|12327379|FG000|COMPLETED|Overall Study||397
11140834|NCT01458951|12327380|FG001|COMPLETED|Overall Study||5
11140835|NCT01458951|12327381|FG002|COMPLETED|Overall Study||97
11140836|NCT01458951|12327379|FG000|NOT COMPLETED|Overall Study||32
11140837|NCT01458951|12327380|FG001|NOT COMPLETED|Overall Study||1
11140838|NCT01458951|12327381|FG002|NOT COMPLETED|Overall Study||15
11140839|NCT01458990|12327390|FG000|STARTED|Overall Study||45
11140840|NCT01458990|12327391|FG001|STARTED|Overall Study||15
11140841|NCT01458990|12327390|FG000|COMPLETED|Overall Study||45
11140842|NCT01458990|12327391|FG001|COMPLETED|Overall Study||15
11140843|NCT01458990|12327390|FG000|NOT COMPLETED|Overall Study||0
11140844|NCT01458990|12327391|FG001|NOT COMPLETED|Overall Study||0
11140845|NCT01459016|12327399|FG000|STARTED|Overall Study||56
11140846|NCT01459016|12327399|FG000|COMPLETED|Overall Study||41
11140847|NCT01459016|12327399|FG000|NOT COMPLETED|Overall Study||15
11140848|NCT01459068|12327405|FG000|STARTED|Overall Study||165
11140849|NCT01459068|12327406|FG001|STARTED|Overall Study||182
11140850|NCT01459068|12327405|FG000|COMPLETED|Overall Study||126
11140851|NCT01459068|12327406|FG001|COMPLETED|Overall Study||148
11140852|NCT01459068|12327405|FG000|NOT COMPLETED|Overall Study||39
11140853|NCT01459068|12327406|FG001|NOT COMPLETED|Overall Study||34
11140854|NCT01459588|12327416|FG000|STARTED|Overall Study||105
11140855|NCT01459588|12327417|FG001|STARTED|Overall Study||51
11140856|NCT01459588|12327418|FG002|STARTED|Overall Study||103
11140857|NCT01459588|12327419|FG003|STARTED|Overall Study||56
11140858|NCT01459588|12327416|FG000|COMPLETED|Overall Study||104
11140859|NCT01459588|12327417|FG001|COMPLETED|Overall Study||49
11140860|NCT01459588|12327418|FG002|COMPLETED|Overall Study||102
11140861|NCT01459588|12327419|FG003|COMPLETED|Overall Study||55
11140862|NCT01459588|12327416|FG000|NOT COMPLETED|Overall Study||1
11140863|NCT01459588|12327417|FG001|NOT COMPLETED|Overall Study||2
11140864|NCT01459588|12327418|FG002|NOT COMPLETED|Overall Study||1
11140865|NCT01459588|12327419|FG003|NOT COMPLETED|Overall Study||1
11140866|NCT01459614|12327431|FG000|STARTED|Overall Study||29
11140867|NCT01459614|12327432|FG001|STARTED|Overall Study||10
11140868|NCT01459614|12327431|FG000|COMPLETED|Overall Study||28
11140869|NCT01459614|12327432|FG001|COMPLETED|Overall Study||10
11140870|NCT01459614|12327431|FG000|NOT COMPLETED|Overall Study||1
11140871|NCT01459614|12327432|FG001|NOT COMPLETED|Overall Study||0
11140872|NCT01459653|12327438|FG000|STARTED|Overall Study||1496
11140873|NCT01459653|12327438|FG000|COMPLETED|Overall Study||828
11140874|NCT01459653|12327438|FG000|NOT COMPLETED|Overall Study||668
11140875|NCT01459705|12327512|FG000|STARTED|Overall Study||54
11140876|NCT01459705|12327513|FG001|STARTED|Overall Study||54
11140877|NCT01459705|12327514|FG002|STARTED|Overall Study||54
11140878|NCT01459705|12327512|FG000|COMPLETED|Overall Study||32
11140879|NCT01459705|12327513|FG001|COMPLETED|Overall Study||30
11140880|NCT01459705|12327514|FG002|COMPLETED|Overall Study||47
11140881|NCT01459705|12327512|FG000|NOT COMPLETED|Overall Study||22
11140882|NCT01459705|12327513|FG001|NOT COMPLETED|Overall Study||24
11140883|NCT01459705|12327514|FG002|NOT COMPLETED|Overall Study||7
11202502|NCT01840579|12392899|FG008|STARTED|Overall Study||6
11202503|NCT01840579|12392900|FG009|STARTED|Overall Study||3
11202504|NCT01840579|12392891|FG000|COMPLETED|Overall Study||0
11202505|NCT01840579|12392892|FG001|COMPLETED|Overall Study||0
11202506|NCT01840579|12392893|FG002|COMPLETED|Overall Study||4
11202507|NCT01840579|12392894|FG003|COMPLETED|Overall Study||3
11202508|NCT01840579|12392895|FG004|COMPLETED|Overall Study||4
11202509|NCT01840579|12392896|FG005|COMPLETED|Overall Study||2
11202510|NCT01840579|12392897|FG006|COMPLETED|Overall Study||4
11202511|NCT01840579|12392898|FG007|COMPLETED|Overall Study||3
11202512|NCT01840579|12392899|FG008|COMPLETED|Overall Study||3
11202513|NCT01840579|12392900|FG009|COMPLETED|Overall Study||0
11202514|NCT01840579|12392891|FG000|NOT COMPLETED|Overall Study||3
11202515|NCT01840579|12392892|FG001|NOT COMPLETED|Overall Study||7
11202516|NCT01840579|12392893|FG002|NOT COMPLETED|Overall Study||2
11202517|NCT01840579|12392894|FG003|NOT COMPLETED|Overall Study||3
11202518|NCT01840579|12392895|FG004|NOT COMPLETED|Overall Study||4
11202519|NCT01840579|12392896|FG005|NOT COMPLETED|Overall Study||4
11202520|NCT01840579|12392897|FG006|NOT COMPLETED|Overall Study||2
11202521|NCT01840579|12392898|FG007|NOT COMPLETED|Overall Study||3
11202522|NCT01840579|12392899|FG008|NOT COMPLETED|Overall Study||3
11202523|NCT01840579|12392900|FG009|NOT COMPLETED|Overall Study||3
11202524|NCT01840605|12392936|FG000|STARTED|Overall Study||151
11202525|NCT01840605|12392937|FG001|STARTED|Overall Study||152
11202526|NCT01840605|12392936|FG000|COMPLETED|Overall Study||149
11202527|NCT01840605|12392937|FG001|COMPLETED|Overall Study||150
11202528|NCT01840605|12392936|FG000|NOT COMPLETED|Overall Study||2
11202529|NCT01840605|12392937|FG001|NOT COMPLETED|Overall Study||2
11202530|NCT01840722|12392945|FG000|STARTED|Overall Study||201
11202531|NCT01840722|12392946|FG001|STARTED|Overall Study||199
11202532|NCT01840722|12392945|FG000|COMPLETED|Overall Study||201
11202533|NCT01840722|12392946|FG001|COMPLETED|Overall Study||130
11202534|NCT01840722|12392945|FG000|NOT COMPLETED|Overall Study||0
11202535|NCT01840722|12392946|FG001|NOT COMPLETED|Overall Study||69
11202536|NCT01840943|12392954|FG000|STARTED|Overall Study||14
11202537|NCT01840943|12392955|FG001|STARTED|Overall Study||12
11202538|NCT01840943|12392954|FG000|COMPLETED|Overall Study||1
11202539|NCT01840943|12392955|FG001|COMPLETED|Overall Study||0
11202540|NCT01840943|12392954|FG000|NOT COMPLETED|Overall Study||13
11202541|NCT01840943|12392955|FG001|NOT COMPLETED|Overall Study||12
11202542|NCT01841021|12392961|FG000|STARTED|Overall Study||1
11202543|NCT01841021|12392961|FG000|COMPLETED|Overall Study||1
11202544|NCT01841021|12392961|FG000|NOT COMPLETED|Overall Study||0
11202545|NCT01841047|12392965|FG000|STARTED|Overall Study||48
11202546|NCT01841047|12392965|FG000|COMPLETED|Overall Study||48
11202547|NCT01841047|12392965|FG000|NOT COMPLETED|Overall Study||0
11202548|NCT01841060|12392969|FG000|STARTED|Overall Study||42
11202549|NCT01841060|12392969|FG000|COMPLETED|Overall Study||32
11202550|NCT01841060|12392969|FG000|NOT COMPLETED|Overall Study||10
11202551|NCT01841073|12392975|FG000|STARTED|Overall Study||22
11202552|NCT01841073|12392976|FG001|STARTED|Overall Study||22
11202553|NCT01841073|12392975|FG000|COMPLETED|Overall Study||20
11202554|NCT01841073|12392976|FG001|COMPLETED|Overall Study||19
11202555|NCT01841073|12392975|FG000|NOT COMPLETED|Overall Study||2
11202556|NCT01841073|12392976|FG001|NOT COMPLETED|Overall Study||3
11202557|NCT01841216|12392986|FG000|STARTED|Overall Study||15
11202558|NCT01841216|12392987|FG001|STARTED|Overall Study||15
11202559|NCT01841216|12392986|FG000|COMPLETED|Overall Study||15
11202560|NCT01841216|12392987|FG001|COMPLETED|Overall Study||15
11202561|NCT01841216|12392986|FG000|NOT COMPLETED|Overall Study||0
11202562|NCT01841216|12392987|FG001|NOT COMPLETED|Overall Study||0
11202563|NCT01841281|12392995|FG000|STARTED|First Intervention (12 Weeks)||11
11202564|NCT01841281|12392996|FG001|STARTED|First Intervention (12 Weeks)||12
11202565|NCT01841281|12392997|FG002|STARTED|First Intervention (12 Weeks)||13
11202566|NCT01841281|12392998|FG003|STARTED|First Intervention (12 Weeks)||14
11202567|NCT01841281|12392995|FG000|COMPLETED|First Intervention (12 Weeks)||11
11202568|NCT01841281|12392996|FG001|COMPLETED|First Intervention (12 Weeks)||12
11202569|NCT01841281|12392997|FG002|COMPLETED|First Intervention (12 Weeks)||13
11202570|NCT01841281|12392998|FG003|COMPLETED|First Intervention (12 Weeks)||14
11202571|NCT01841281|12392995|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
11202572|NCT01841281|12392996|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
11202573|NCT01841281|12392997|FG002|NOT COMPLETED|First Intervention (12 Weeks)||0
11202574|NCT01841281|12392998|FG003|NOT COMPLETED|First Intervention (12 Weeks)||0
11202575|NCT01841281|12392995|FG000|STARTED|Washout (6 Weeks)||11
11202576|NCT01841281|12392996|FG001|STARTED|Washout (6 Weeks)||12
11202577|NCT01841281|12392997|FG002|STARTED|Washout (6 Weeks)||13
11140884|NCT01459718|12327522|FG000|STARTED|Overall Study||13
11140885|NCT01459718|12327522|FG000|Safety Analysis Set|Overall Study||13
11140886|NCT01459718|12327522|FG000|COMPLETED|Overall Study||10
11140887|NCT01459718|12327522|FG000|NOT COMPLETED|Overall Study||3
11140888|NCT01459783|12327528|FG000|STARTED|Baseline to 6 Months||71
11140889|NCT01459783|12327529|FG001|STARTED|Baseline to 6 Months||73
11140890|NCT01459783|12327528|FG000|COMPLETED|Baseline to 6 Months||39
11140891|NCT01459783|12327529|FG001|COMPLETED|Baseline to 6 Months||53
11140892|NCT01459783|12327528|FG000|NOT COMPLETED|Baseline to 6 Months||32
11140893|NCT01459783|12327529|FG001|NOT COMPLETED|Baseline to 6 Months||20
11140894|NCT01459783|12327528|FG000|STARTED|6 Months to 12 Months||39
11140895|NCT01459783|12327529|FG001|STARTED|6 Months to 12 Months||53
11140896|NCT01459783|12327528|FG000|COMPLETED|6 Months to 12 Months||20
11140897|NCT01459783|12327529|FG001|COMPLETED|6 Months to 12 Months||23
11140898|NCT01459783|12327528|FG000|NOT COMPLETED|6 Months to 12 Months||19
11140899|NCT01459783|12327529|FG001|NOT COMPLETED|6 Months to 12 Months||30
11140900|NCT01459796|12327537|FG000|STARTED|Overall Study||94
11140901|NCT01459796|12327538|FG001|STARTED|Overall Study||126
11140902|NCT01459796|12327537|FG000|COMPLETED|Overall Study||0
11140903|NCT01459796|12327538|FG001|COMPLETED|Overall Study||0
11140904|NCT01459796|12327537|FG000|NOT COMPLETED|Overall Study||94
11140905|NCT01459796|12327538|FG001|NOT COMPLETED|Overall Study||126
11140906|NCT01459913|12327548|FG000|STARTED|Overall Study||106
11140907|NCT01459913|12327549|FG001|STARTED|Overall Study||52
11140908|NCT01459913|12327550|FG002|STARTED|Overall Study||19
11140909|NCT01459913|12327551|FG003|STARTED|Overall Study||62
11140910|NCT01459913|12327548|FG000|COMPLETED|Overall Study||65
11140911|NCT01459913|12327549|FG001|COMPLETED|Overall Study||32
11140912|NCT01459913|12327550|FG002|COMPLETED|Overall Study||6
11140913|NCT01459913|12327551|FG003|COMPLETED|Overall Study||29
11140914|NCT01459913|12327548|FG000|NOT COMPLETED|Overall Study||41
11140915|NCT01459913|12327549|FG001|NOT COMPLETED|Overall Study||20
11140916|NCT01459913|12327550|FG002|NOT COMPLETED|Overall Study||13
11140917|NCT01459913|12327551|FG003|NOT COMPLETED|Overall Study||33
11140918|NCT01460225|12327563|FG000|STARTED|Overall Study|January 2009.|19
11140919|NCT01460225|12327563|FG000|COMPLETED|Overall Study|November 2010|19
11140920|NCT01460225|12327563|FG000|NOT COMPLETED|Overall Study||0
11140921|NCT01460290|12327568|FG000|STARTED|Overall Study||15
11140922|NCT01460290|12327568|FG000|COMPLETED|Overall Study||11
11140923|NCT01460290|12327568|FG000|NOT COMPLETED|Overall Study||4
11140924|NCT01460303|12327575|FG000|STARTED|Overall Study||25
11140925|NCT01460303|12327576|FG001|STARTED|Overall Study||24
11140926|NCT01460303|12327575|FG000|COMPLETED|Overall Study||25
11140927|NCT01460303|12327576|FG001|COMPLETED|Overall Study||24
11140928|NCT01460303|12327575|FG000|NOT COMPLETED|Overall Study||0
11140929|NCT01460303|12327576|FG001|NOT COMPLETED|Overall Study||0
11140930|NCT01460342|12327584|FG000|STARTED|Overall Study||304
11140931|NCT01460342|12327585|FG001|STARTED|Overall Study||306
11140932|NCT01460342|12327584|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304
11140933|NCT01460342|12327585|FG001|Received at Least 1 Dose of Study Drug|Overall Study||306
11140934|NCT01460342|12327584|FG000|COMPLETED|Overall Study||293
11140935|NCT01460342|12327585|FG001|COMPLETED|Overall Study||292
11140936|NCT01460342|12327584|FG000|NOT COMPLETED|Overall Study||11
11140937|NCT01460342|12327585|FG001|NOT COMPLETED|Overall Study||14
11140938|NCT01460368|12327593|FG000|STARTED|Part A||7
11140939|NCT01460368|12327594|FG001|STARTED|Part A||0
11140940|NCT01460368|12327595|FG002|STARTED|Part A||0
11140941|NCT01460368|12327596|FG003|STARTED|Part A||0
11140942|NCT01460368|12327597|FG004|STARTED|Part A||0
11140943|NCT01460368|12327598|FG005|STARTED|Part A||0
11140944|NCT01460368|12327599|FG006|STARTED|Part A||0
11140945|NCT01460368|12327593|FG000|Received at Least One Dose of Study Drug|Part A||7
11140946|NCT01460368|12327594|FG001|Received at Least One Dose of Study Drug|Part A||0
11140947|NCT01460368|12327595|FG002|Received at Least One Dose of Study Drug|Part A||0
11140948|NCT01460368|12327596|FG003|Received at Least One Dose of Study Drug|Part A||0
11140949|NCT01460368|12327597|FG004|Received at Least One Dose of Study Drug|Part A||0
11140950|NCT01460368|12327598|FG005|Received at Least One Dose of Study Drug|Part A||0
11140951|NCT01460368|12327599|FG006|Received at Least One Dose of Study Drug|Part A||0
11140952|NCT01460368|12327593|FG000|COMPLETED|Part A||7
11140953|NCT01460368|12327594|FG001|COMPLETED|Part A||0
11140954|NCT01460368|12327595|FG002|COMPLETED|Part A||0
11140955|NCT01460368|12327596|FG003|COMPLETED|Part A||0
11140956|NCT01460368|12327597|FG004|COMPLETED|Part A||0
11140957|NCT01460368|12327598|FG005|COMPLETED|Part A||0
11140958|NCT01460368|12327599|FG006|COMPLETED|Part A||0
11140959|NCT01460368|12327593|FG000|NOT COMPLETED|Part A||0
11140960|NCT01460368|12327594|FG001|NOT COMPLETED|Part A||0
11140961|NCT01460368|12327595|FG002|NOT COMPLETED|Part A||0
11140962|NCT01460368|12327596|FG003|NOT COMPLETED|Part A||0
11140963|NCT01460368|12327597|FG004|NOT COMPLETED|Part A||0
11140964|NCT01460368|12327598|FG005|NOT COMPLETED|Part A||0
11140965|NCT01460368|12327599|FG006|NOT COMPLETED|Part A||0
11140966|NCT01460368|12327593|FG000|STARTED|Part B: First Intervention (Period 1)||0
11140967|NCT01460368|12327594|FG001|STARTED|Part B: First Intervention (Period 1)||10
11140968|NCT01460368|12327595|FG002|STARTED|Part B: First Intervention (Period 1)||10
11140969|NCT01460368|12327596|FG003|STARTED|Part B: First Intervention (Period 1)||10
11140970|NCT01460368|12327597|FG004|STARTED|Part B: First Intervention (Period 1)||10
11140971|NCT01460368|12327598|FG005|STARTED|Part B: First Intervention (Period 1)||10
11140972|NCT01460368|12327599|FG006|STARTED|Part B: First Intervention (Period 1)||10
11140973|NCT01460368|12327593|FG000|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
11140974|NCT01460368|12327594|FG001|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
11140975|NCT01460368|12327595|FG002|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
11140976|NCT01460368|12327596|FG003|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
11140977|NCT01460368|12327597|FG004|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
11140978|NCT01460368|12327598|FG005|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
11140979|NCT01460368|12327599|FG006|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
11140980|NCT01460368|12327593|FG000|COMPLETED|Part B: First Intervention (Period 1)||0
11140981|NCT01460368|12327594|FG001|COMPLETED|Part B: First Intervention (Period 1)||10
11140982|NCT01460368|12327595|FG002|COMPLETED|Part B: First Intervention (Period 1)||10
11140983|NCT01460368|12327596|FG003|COMPLETED|Part B: First Intervention (Period 1)||10
11140984|NCT01460368|12327597|FG004|COMPLETED|Part B: First Intervention (Period 1)||9
11140985|NCT01460368|12327598|FG005|COMPLETED|Part B: First Intervention (Period 1)||10
11140986|NCT01460368|12327599|FG006|COMPLETED|Part B: First Intervention (Period 1)||10
11140987|NCT01460368|12327593|FG000|NOT COMPLETED|Part B: First Intervention (Period 1)||0
11140988|NCT01460368|12327594|FG001|NOT COMPLETED|Part B: First Intervention (Period 1)||0
11140989|NCT01460368|12327595|FG002|NOT COMPLETED|Part B: First Intervention (Period 1)||0
11140990|NCT01460368|12327596|FG003|NOT COMPLETED|Part B: First Intervention (Period 1)||0
11140991|NCT01460368|12327597|FG004|NOT COMPLETED|Part B: First Intervention (Period 1)||1
11140992|NCT01460368|12327598|FG005|NOT COMPLETED|Part B: First Intervention (Period 1)||0
11140993|NCT01460368|12327599|FG006|NOT COMPLETED|Part B: First Intervention (Period 1)||0
11140994|NCT01460368|12327593|FG000|STARTED|Part B: Washout (up to 15 Days)||0
11140995|NCT01460368|12327594|FG001|STARTED|Part B: Washout (up to 15 Days)||10
11140996|NCT01460368|12327595|FG002|STARTED|Part B: Washout (up to 15 Days)||10
11140997|NCT01460368|12327596|FG003|STARTED|Part B: Washout (up to 15 Days)||10
11140998|NCT01460368|12327597|FG004|STARTED|Part B: Washout (up to 15 Days)||9
11140999|NCT01460368|12327598|FG005|STARTED|Part B: Washout (up to 15 Days)||10
11141000|NCT01460368|12327599|FG006|STARTED|Part B: Washout (up to 15 Days)||10
11141001|NCT01460368|12327593|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0
11141002|NCT01460368|12327594|FG001|COMPLETED|Part B: Washout (up to 15 Days)||10
11141003|NCT01460368|12327595|FG002|COMPLETED|Part B: Washout (up to 15 Days)||10
11141004|NCT01460368|12327596|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10
11141005|NCT01460368|12327597|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9
11141006|NCT01460368|12327598|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10
11141007|NCT01460368|12327599|FG006|COMPLETED|Part B: Washout (up to 15 Days)||10
11141008|NCT01460368|12327593|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
11202578|NCT01841281|12392998|FG003|STARTED|Washout (6 Weeks)||14
11202579|NCT01841281|12392995|FG000|COMPLETED|Washout (6 Weeks)||9
11202580|NCT01841281|12392996|FG001|COMPLETED|Washout (6 Weeks)||9
11202581|NCT01841281|12392997|FG002|COMPLETED|Washout (6 Weeks)||10
11202582|NCT01841281|12392998|FG003|COMPLETED|Washout (6 Weeks)||13
11202583|NCT01841281|12392995|FG000|NOT COMPLETED|Washout (6 Weeks)||2
11202584|NCT01841281|12392996|FG001|NOT COMPLETED|Washout (6 Weeks)||3
11202585|NCT01841281|12392997|FG002|NOT COMPLETED|Washout (6 Weeks)||3
11202586|NCT01841281|12392998|FG003|NOT COMPLETED|Washout (6 Weeks)||1
11202587|NCT01841281|12392995|FG000|STARTED|Second Intervention (12 Weeks)||9
11241555|NCT02098109|12434054|FG001|NOT COMPLETED|Overall Study||0
11241556|NCT02098304|12434060|FG000|STARTED|Overall Study||42
11241557|NCT02098304|12434060|FG000|COMPLETED|Overall Study||42
11241558|NCT02098304|12434060|FG000|NOT COMPLETED|Overall Study||0
11241559|NCT02098369|12434069|FG000|STARTED|Overall Study||142
11241560|NCT02098369|12434070|FG001|STARTED|Overall Study||154
11241561|NCT02098369|12434071|FG002|STARTED|Overall Study||148
11241562|NCT02098369|12434069|FG000|COMPLETED|Overall Study||135
11241563|NCT02098369|12434070|FG001|COMPLETED|Overall Study||145
11241564|NCT02098369|12434071|FG002|COMPLETED|Overall Study||143
11241565|NCT02098369|12434069|FG000|NOT COMPLETED|Overall Study||7
11241566|NCT02098369|12434070|FG001|NOT COMPLETED|Overall Study||9
11241567|NCT02098369|12434071|FG002|NOT COMPLETED|Overall Study||5
11241568|NCT02098395|12434083|FG000|STARTED|Overall Study||212
11241569|NCT02098395|12434084|FG001|STARTED|Overall Study||209
11241570|NCT02098395|12434085|FG002|STARTED|Overall Study||207
11241571|NCT02098395|12434086|FG003|STARTED|Overall Study||207
11202588|NCT01841281|12392996|FG001|STARTED|Second Intervention (12 Weeks)||9
11202589|NCT01841281|12392997|FG002|STARTED|Second Intervention (12 Weeks)||10
11202590|NCT01841281|12392998|FG003|STARTED|Second Intervention (12 Weeks)||13
11202591|NCT01841281|12392995|FG000|COMPLETED|Second Intervention (12 Weeks)||9
11241572|NCT02098395|12434083|FG000|Exposed|Overall Study||211
11241573|NCT02098395|12434084|FG001|Exposed|Overall Study||209
11241574|NCT02098395|12434085|FG002|Exposed|Overall Study||206
11241575|NCT02098395|12434086|FG003|Exposed|Overall Study||206
11241576|NCT02098395|12434083|FG000|COMPLETED|Overall Study||186
11241577|NCT02098395|12434084|FG001|COMPLETED|Overall Study||177
11241578|NCT02098395|12434085|FG002|COMPLETED|Overall Study||165
11241579|NCT02098395|12434086|FG003|COMPLETED|Overall Study||180
11241580|NCT02098395|12434083|FG000|NOT COMPLETED|Overall Study||26
11241581|NCT02098395|12434084|FG001|NOT COMPLETED|Overall Study||32
11241582|NCT02098395|12434085|FG002|NOT COMPLETED|Overall Study||42
11241583|NCT02098395|12434086|FG003|NOT COMPLETED|Overall Study||27
11241584|NCT02098733|12434096|FG000|STARTED|Overall Study||1168
11241585|NCT02098733|12434096|FG000|COMPLETED|Overall Study||1158
11241586|NCT02098733|12434096|FG000|NOT COMPLETED|Overall Study||10
11241587|NCT02098746|12434100|FG000|STARTED|Overall Study||294
11241588|NCT02098746|12434100|FG000|COMPLETED|Overall Study||289
11241589|NCT02098746|12434100|FG000|NOT COMPLETED|Overall Study||5
11241590|NCT02098993|12434106|FG000|STARTED|Overall Study||4
11241591|NCT02098993|12434107|FG001|STARTED|Overall Study||3
11241592|NCT02098993|12434106|FG000|COMPLETED|Overall Study||4
11241593|NCT02098993|12434107|FG001|COMPLETED|Overall Study||3
11241594|NCT02098993|12434106|FG000|NOT COMPLETED|Overall Study||0
11358093|NCT03119701|12555142|FG000|NOT COMPLETED|6-day Dosing||7
11358094|NCT03119701|12555143|FG001|NOT COMPLETED|6-day Dosing||3
11358095|NCT03119701|12555142|FG000|STARTED|Mid-term (Final) Follow-up at D90|3 patients who discontinued study drug due to adverse events were also followed up.|25
11141009|NCT01460368|12327594|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
11141010|NCT01460368|12327595|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
11141011|NCT01460368|12327596|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
11141012|NCT01460368|12327597|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
11141013|NCT01460368|12327598|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
11141014|NCT01460368|12327599|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
11141015|NCT01460368|12327593|FG000|STARTED|Part B: Second Intervention (Period 2)||0
11141016|NCT01460368|12327594|FG001|STARTED|Part B: Second Intervention (Period 2)||10
11141017|NCT01460368|12327595|FG002|STARTED|Part B: Second Intervention (Period 2)||10
11141018|NCT01460368|12327596|FG003|STARTED|Part B: Second Intervention (Period 2)||10
11141019|NCT01460368|12327597|FG004|STARTED|Part B: Second Intervention (Period 2)||9
11358096|NCT03119701|12555143|FG001|STARTED|Mid-term (Final) Follow-up at D90|2 patients who did not receive 6 doses were also followed up.|10
11358097|NCT03119701|12555142|FG000|COMPLETED|Mid-term (Final) Follow-up at D90||22
11358098|NCT03119701|12555143|FG001|COMPLETED|Mid-term (Final) Follow-up at D90||9
11358099|NCT03119701|12555142|FG000|NOT COMPLETED|Mid-term (Final) Follow-up at D90||3
11358100|NCT03119701|12555143|FG001|NOT COMPLETED|Mid-term (Final) Follow-up at D90||1
11358101|NCT03119831|12555152|FG000|STARTED|Overall Study||14
11358102|NCT03119831|12555153|FG001|STARTED|Overall Study||14
11358103|NCT03119831|12555154|FG002|STARTED|Overall Study||14
11358104|NCT03119831|12555152|FG000|COMPLETED|Overall Study||14
11358105|NCT03119831|12555153|FG001|COMPLETED|Overall Study||14
11358106|NCT03119831|12555154|FG002|COMPLETED|Overall Study||14
11358107|NCT03119831|12555152|FG000|NOT COMPLETED|Overall Study||0
11141020|NCT01460368|12327598|FG005|STARTED|Part B: Second Intervention (Period 2)||10
11141021|NCT01460368|12327599|FG006|STARTED|Part B: Second Intervention (Period 2)||10
11141022|NCT01460368|12327593|FG000|COMPLETED|Part B: Second Intervention (Period 2)||0
11141023|NCT01460368|12327594|FG001|COMPLETED|Part B: Second Intervention (Period 2)||8
11141024|NCT01460368|12327595|FG002|COMPLETED|Part B: Second Intervention (Period 2)||10
11141025|NCT01460368|12327596|FG003|COMPLETED|Part B: Second Intervention (Period 2)||10
11141026|NCT01460368|12327597|FG004|COMPLETED|Part B: Second Intervention (Period 2)||9
11141027|NCT01460368|12327598|FG005|COMPLETED|Part B: Second Intervention (Period 2)||10
11141028|NCT01460368|12327599|FG006|COMPLETED|Part B: Second Intervention (Period 2)||9
11141029|NCT01460368|12327593|FG000|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
11141030|NCT01460368|12327594|FG001|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
11141031|NCT01460368|12327595|FG002|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
11141032|NCT01460368|12327596|FG003|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
11141033|NCT01460368|12327597|FG004|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
11141034|NCT01460368|12327598|FG005|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
11141035|NCT01460368|12327599|FG006|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
11141036|NCT01460368|12327593|FG000|STARTED|Part B: Washout (up to 15 Days)||0
11141037|NCT01460368|12327594|FG001|STARTED|Part B: Washout (up to 15 Days)||8
11141038|NCT01460368|12327595|FG002|STARTED|Part B: Washout (up to 15 Days)||10
11141039|NCT01460368|12327596|FG003|STARTED|Part B: Washout (up to 15 Days)||10
11141040|NCT01460368|12327597|FG004|STARTED|Part B: Washout (up to 15 Days)||9
11141041|NCT01460368|12327598|FG005|STARTED|Part B: Washout (up to 15 Days)||10
11141042|NCT01460368|12327599|FG006|STARTED|Part B: Washout (up to 15 Days)||9
11141043|NCT01460368|12327593|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0
11141044|NCT01460368|12327594|FG001|COMPLETED|Part B: Washout (up to 15 Days)||8
11141045|NCT01460368|12327595|FG002|COMPLETED|Part B: Washout (up to 15 Days)||9
11141046|NCT01460368|12327596|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10
11141047|NCT01460368|12327597|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9
11141048|NCT01460368|12327598|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10
11241595|NCT02098993|12434107|FG001|NOT COMPLETED|Overall Study||0
11241596|NCT02099006|12434113|FG000|STARTED|Overall Study||9
11241597|NCT02099006|12434113|FG000|Received Placebo|Overall Study||9
11141049|NCT01460368|12327599|FG006|COMPLETED|Part B: Washout (up to 15 Days)||9
11141050|NCT01460368|12327593|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
11141051|NCT01460368|12327594|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
11141052|NCT01460368|12327595|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
11141053|NCT01460368|12327596|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
11141054|NCT01460368|12327597|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
11141055|NCT01460368|12327598|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
11141056|NCT01460368|12327599|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
11141057|NCT01460368|12327593|FG000|STARTED|Part B: Third Interventions (Period 3)||0
11141058|NCT01460368|12327594|FG001|STARTED|Part B: Third Interventions (Period 3)||8
11141059|NCT01460368|12327595|FG002|STARTED|Part B: Third Interventions (Period 3)||9
11141060|NCT01460368|12327596|FG003|STARTED|Part B: Third Interventions (Period 3)||10
11141061|NCT01460368|12327597|FG004|STARTED|Part B: Third Interventions (Period 3)||9
11141062|NCT01460368|12327598|FG005|STARTED|Part B: Third Interventions (Period 3)||10
11141063|NCT01460368|12327599|FG006|STARTED|Part B: Third Interventions (Period 3)||9
11141064|NCT01460368|12327593|FG000|COMPLETED|Part B: Third Interventions (Period 3)||0
11141065|NCT01460368|12327594|FG001|COMPLETED|Part B: Third Interventions (Period 3)||8
11141066|NCT01460368|12327595|FG002|COMPLETED|Part B: Third Interventions (Period 3)||8
11141067|NCT01460368|12327596|FG003|COMPLETED|Part B: Third Interventions (Period 3)||9
11141068|NCT01460368|12327597|FG004|COMPLETED|Part B: Third Interventions (Period 3)||9
11141069|NCT01460368|12327598|FG005|COMPLETED|Part B: Third Interventions (Period 3)||9
11141070|NCT01460368|12327599|FG006|COMPLETED|Part B: Third Interventions (Period 3)||9
11141071|NCT01460368|12327593|FG000|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
11141072|NCT01460368|12327594|FG001|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
11141073|NCT01460368|12327595|FG002|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
11141074|NCT01460368|12327596|FG003|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
11141075|NCT01460368|12327597|FG004|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
11141076|NCT01460368|12327598|FG005|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
11141077|NCT01460368|12327599|FG006|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
11141078|NCT01460381|12327610|FG000|STARTED|Period 1 (Days 1-7)||7
11141079|NCT01460381|12327611|FG001|STARTED|Period 1 (Days 1-7)||11
11141080|NCT01460381|12327610|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
11141081|NCT01460381|12327611|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
11141082|NCT01460381|12327610|FG000|COMPLETED|Period 1 (Days 1-7)||7
11005306|NCT00722020|12182979|FG000|COMPLETED|Overall Study||19
11005307|NCT00722020|12182980|FG001|COMPLETED|Overall Study||24
11141083|NCT01460381|12327611|FG001|COMPLETED|Period 1 (Days 1-7)||11
11141084|NCT01460381|12327610|FG000|NOT COMPLETED|Period 1 (Days 1-7)||0
11141085|NCT01460381|12327611|FG001|NOT COMPLETED|Period 1 (Days 1-7)||0
11141086|NCT01460381|12327610|FG000|STARTED|Period 2 (Days 8-15)||7
11141087|NCT01460381|12327611|FG001|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
11141088|NCT01460381|12327610|FG000|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
11141089|NCT01460381|12327611|FG001|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
11141090|NCT01460381|12327610|FG000|NOT COMPLETED|Period 2 (Days 8-15)||1
11141091|NCT01460381|12327611|FG001|NOT COMPLETED|Period 2 (Days 8-15)||0
11141092|NCT01460407|12327619|FG000|STARTED|Period 1: Day 1 to Day 5||14
11141093|NCT01460407|12327620|FG001|STARTED|Period 1: Day 1 to Day 5||0
11141094|NCT01460407|12327619|FG000|COMPLETED|Period 1: Day 1 to Day 5||14
11141095|NCT01460407|12327620|FG001|COMPLETED|Period 1: Day 1 to Day 5||0
11141096|NCT01460407|12327619|FG000|NOT COMPLETED|Period 1: Day 1 to Day 5||0
11141097|NCT01460407|12327620|FG001|NOT COMPLETED|Period 1: Day 1 to Day 5||0
11141098|NCT01460407|12327619|FG000|STARTED|Period 2: Day 6 to Day 14||0
11141099|NCT01460407|12327620|FG001|STARTED|Period 2: Day 6 to Day 14||14
11141100|NCT01460407|12327619|FG000|COMPLETED|Period 2: Day 6 to Day 14||0
11141101|NCT01460407|12327620|FG001|COMPLETED|Period 2: Day 6 to Day 14||13
11141102|NCT01460407|12327619|FG000|NOT COMPLETED|Period 2: Day 6 to Day 14||0
11141103|NCT01460407|12327620|FG001|NOT COMPLETED|Period 2: Day 6 to Day 14||1
11141104|NCT01460446|12327629|FG000|STARTED|Overall Study||105
11141105|NCT01460446|12327630|FG001|STARTED|Overall Study||113
11141106|NCT01460446|12327629|FG000|COMPLETED|Overall Study||100
11141107|NCT01460446|12327630|FG001|COMPLETED|Overall Study||93
11141108|NCT01460446|12327629|FG000|NOT COMPLETED|Overall Study||5
11141109|NCT01460446|12327630|FG001|NOT COMPLETED|Overall Study||20
11141110|NCT01460628|12327637|FG000|STARTED|Overall Study||25
11141111|NCT01460628|12327637|FG000|COMPLETED|Overall Study||20
11141112|NCT01460628|12327637|FG000|NOT COMPLETED|Overall Study||5
11141113|NCT01460719|12327641|FG000|STARTED|Overall Study||80
11141114|NCT01460719|12327641|FG000|Vaccination 1 (Day 1)|Overall Study||80
11141115|NCT01460719|12327641|FG000|Vaccination 2 (~Day 30)|Overall Study||78
11141116|NCT01460719|12327641|FG000|Vaccination 3 (~Day 60)|Overall Study||78
11141117|NCT01460719|12327641|FG000|Vaccination 4 (~Day 90)|Overall Study||78
11141118|NCT01460719|12327641|FG000|COMPLETED|Overall Study||78
11141119|NCT01460719|12327641|FG000|NOT COMPLETED|Overall Study||2
11141120|NCT01460732|12327645|FG000|STARTED|Overall Study||81
11141121|NCT01460732|12327645|FG000|COMPLETED|Overall Study||81
11141122|NCT01460732|12327645|FG000|NOT COMPLETED|Overall Study||0
11141123|NCT01460875|12327651|FG000|STARTED|Overall Study||34
11141124|NCT01460875|12327651|FG000|COMPLETED|Overall Study||34
11005308|NCT00722020|12182979|FG000|NOT COMPLETED|Overall Study||0
11141125|NCT01460875|12327651|FG000|NOT COMPLETED|Overall Study||0
11141126|NCT01460901|12327655|FG000|STARTED|Overall Study|First enrollment|5
11141127|NCT01460901|12327655|FG000|tV-CTL Infusion|Overall Study||3
11141128|NCT01460901|12327655|FG000|COMPLETED|Overall Study|Follow-up completed|3
11141129|NCT01460901|12327655|FG000|NOT COMPLETED|Overall Study||2
11141130|NCT01460927|12327662|FG000|STARTED|Overall Study||25
11141131|NCT01460927|12327662|FG000|COMPLETED|Overall Study||25
11141132|NCT01460927|12327662|FG000|NOT COMPLETED|Overall Study||0
11141133|NCT01460940|12327670|FG000|STARTED|Overall Study||24
11141134|NCT01460940|12327670|FG000|COMPLETED|Overall Study||24
11141135|NCT01460940|12327670|FG000|NOT COMPLETED|Overall Study||0
11141136|NCT01461005|12327674|FG000|STARTED|Overall Study||1
11141137|NCT01461005|12327674|FG000|COMPLETED|Overall Study||0
11141138|NCT01461005|12327674|FG000|NOT COMPLETED|Overall Study||1
11141139|NCT01461044|12327681|FG000|STARTED|Overall Study||150
11141140|NCT01461044|12327682|FG001|STARTED|Overall Study||77
11141141|NCT01461044|12327681|FG000|Participants Alive at Inclusion|Overall Study||127
11141142|NCT01461044|12327682|FG001|Participants Alive at Inclusion|Overall Study||58
11141143|NCT01461044|12327681|FG000|COMPLETED|Overall Study||80
11141144|NCT01461044|12327682|FG001|COMPLETED|Overall Study||37
11141145|NCT01461044|12327681|FG000|NOT COMPLETED|Overall Study||70
11141146|NCT01461044|12327682|FG001|NOT COMPLETED|Overall Study||40
11141147|NCT01461057|12327693|FG000|STARTED|Overall Study||15
11141148|NCT01461057|12327694|FG001|STARTED|Overall Study||15
11141149|NCT01461057|12327693|FG000|COMPLETED|Overall Study||0
11141150|NCT01461057|12327694|FG001|COMPLETED|Overall Study||0
11141151|NCT01461057|12327693|FG000|NOT COMPLETED|Overall Study||15
11141152|NCT01461057|12327694|FG001|NOT COMPLETED|Overall Study||15
11141153|NCT01461096|12327702|FG000|STARTED|Overall Study||288
11141154|NCT01461096|12327703|FG001|STARTED|Overall Study||287
11141155|NCT01461096|12327702|FG000|Did Not Start Treatment|Overall Study||0
11141156|NCT01461096|12327703|FG001|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
11141157|NCT01461096|12327702|FG000|COMPLETED|Overall Study||226
11141158|NCT01461096|12327703|FG001|COMPLETED|Overall Study||226
11141159|NCT01461096|12327702|FG000|NOT COMPLETED|Overall Study||62
11141160|NCT01461096|12327703|FG001|NOT COMPLETED|Overall Study||61
11141161|NCT01461369|12327713|FG000|STARTED|Overall Study||104
11141162|NCT01461369|12327714|FG001|STARTED|Overall Study||98
11141163|NCT01461369|12327715|FG002|STARTED|Overall Study||103
11141164|NCT01461369|12327713|FG000|COMPLETED|Overall Study||91
11141165|NCT01461369|12327714|FG001|COMPLETED|Overall Study||81
11141166|NCT01461369|12327715|FG002|COMPLETED|Overall Study||86
11141167|NCT01461369|12327713|FG000|NOT COMPLETED|Overall Study||13
11141168|NCT01461369|12327714|FG001|NOT COMPLETED|Overall Study||17
11141169|NCT01461369|12327715|FG002|NOT COMPLETED|Overall Study||17
11141170|NCT01461473|12327725|FG000|STARTED|Overall Study||72
11141171|NCT01461473|12327726|FG001|STARTED|Overall Study||59
11141172|NCT01461473|12327725|FG000|COMPLETED|Overall Study||67
11141173|NCT01461473|12327726|FG001|COMPLETED|Overall Study||55
11141174|NCT01461473|12327725|FG000|NOT COMPLETED|Overall Study||5
11141175|NCT01461473|12327726|FG001|NOT COMPLETED|Overall Study||4
11141176|NCT01461499|12327734|FG000|STARTED|Overall Study||119
11141177|NCT01461499|12327735|FG001|STARTED|Overall Study||118
11141178|NCT01461499|12327734|FG000|COMPLETED|Overall Study||111
11141179|NCT01461499|12327735|FG001|COMPLETED|Overall Study||114
11141180|NCT01461499|12327734|FG000|NOT COMPLETED|Overall Study||8
11141181|NCT01461499|12327735|FG001|NOT COMPLETED|Overall Study||4
11141182|NCT01461538|12327746|FG000|STARTED|Overall Study||46
11141183|NCT01461538|12327747|FG001|STARTED|Overall Study||28
11141184|NCT01461538|12327748|FG002|STARTED|Overall Study||9
11141185|NCT01461538|12327746|FG000|COMPLETED|Overall Study||28
11141186|NCT01461538|12327747|FG001|COMPLETED|Overall Study||20
11141187|NCT01461538|12327748|FG002|COMPLETED|Overall Study||7
11141188|NCT01461538|12327746|FG000|NOT COMPLETED|Overall Study||18
11141189|NCT01461538|12327747|FG001|NOT COMPLETED|Overall Study||8
11141190|NCT01461538|12327748|FG002|NOT COMPLETED|Overall Study||2
11141191|NCT01461551|12327761|FG000|STARTED|Overall Study||35
11141192|NCT01461551|12327762|FG001|STARTED|Overall Study||35
11141193|NCT01461551|12327763|FG002|STARTED|Overall Study||35
11141194|NCT01461551|12327761|FG000|COMPLETED|Overall Study||33
11141195|NCT01461551|12327762|FG001|COMPLETED|Overall Study||34
11141196|NCT01461551|12327763|FG002|COMPLETED|Overall Study||33
11141197|NCT01461551|12327761|FG000|NOT COMPLETED|Overall Study||2
11141198|NCT01461551|12327762|FG001|NOT COMPLETED|Overall Study||1
11141199|NCT01461551|12327763|FG002|NOT COMPLETED|Overall Study||2
11141200|NCT01461655|12327771|FG000|STARTED|Overall Study||40
11141201|NCT01461655|12327771|FG000|COMPLETED|Overall Study||40
11141202|NCT01461655|12327771|FG000|NOT COMPLETED|Overall Study||0
11141203|NCT01461668|12327778|FG000|STARTED|Overall Study||27
11141204|NCT01461668|12327779|FG001|STARTED|Overall Study||26
11141205|NCT01461668|12327778|FG000|COMPLETED|Overall Study||25
11141206|NCT01461668|12327779|FG001|COMPLETED|Overall Study||25
11141207|NCT01461668|12327778|FG000|NOT COMPLETED|Overall Study||2
11141208|NCT01461668|12327779|FG001|NOT COMPLETED|Overall Study||1
11141209|NCT01461707|12327787|FG000|STARTED|Overall Study||15
11141210|NCT01461707|12327788|FG001|STARTED|Overall Study||15
11141211|NCT01461707|12327787|FG000|COMPLETED|Overall Study||14
11141212|NCT01461707|12327788|FG001|COMPLETED|Overall Study||15
11141213|NCT01461707|12327787|FG000|NOT COMPLETED|Overall Study||1
11141214|NCT01461707|12327788|FG001|NOT COMPLETED|Overall Study||0
11141215|NCT01461733|12327796|FG000|STARTED|Overall Study||12
11141216|NCT01461733|12327797|FG001|STARTED|Overall Study||12
11141217|NCT01461733|12327796|FG000|COMPLETED|Overall Study||8
11141218|NCT01461733|12327797|FG001|COMPLETED|Overall Study||8
11141219|NCT01461733|12327796|FG000|NOT COMPLETED|Overall Study||4
11141220|NCT01461733|12327797|FG001|NOT COMPLETED|Overall Study||4
11141221|NCT01461811|12327805|FG000|STARTED|Overall Study||95
11141222|NCT01461811|12327806|FG001|STARTED|Overall Study||49
11141223|NCT01461811|12327805|FG000|COMPLETED|Overall Study||91
11141224|NCT01461811|12327806|FG001|COMPLETED|Overall Study||46
11141225|NCT01461811|12327805|FG000|NOT COMPLETED|Overall Study||4
11141226|NCT01461811|12327806|FG001|NOT COMPLETED|Overall Study||3
11141227|NCT01461824|12327815|FG000|STARTED|Overall Study||12
11141228|NCT01461824|12327816|FG001|STARTED|Overall Study||11
11141229|NCT01461824|12327817|FG002|STARTED|Overall Study||11
11141230|NCT01461824|12327815|FG000|COMPLETED|Overall Study||10
11141231|NCT01461824|12327816|FG001|COMPLETED|Overall Study||7
11141232|NCT01461824|12327817|FG002|COMPLETED|Overall Study||8
11141233|NCT01461824|12327815|FG000|NOT COMPLETED|Overall Study||2
11141234|NCT01461824|12327816|FG001|NOT COMPLETED|Overall Study||4
11141235|NCT01461824|12327817|FG002|NOT COMPLETED|Overall Study||3
11141236|NCT01461863|12327827|FG000|STARTED|Overall Study||48
11141237|NCT01461863|12327828|FG001|STARTED|Overall Study||48
11141238|NCT01461863|12327827|FG000|COMPLETED|Overall Study||48
11141239|NCT01461863|12327828|FG001|COMPLETED|Overall Study||48
11141240|NCT01461863|12327827|FG000|NOT COMPLETED|Overall Study||0
11141241|NCT01461863|12327828|FG001|NOT COMPLETED|Overall Study||0
11141242|NCT01461928|12327836|FG000|STARTED|Induction (up to 8 Months)||692
11141243|NCT01461928|12327837|FG001|STARTED|Induction (up to 8 Months)||0
11141244|NCT01461928|12327838|FG002|STARTED|Induction (up to 8 Months)||0
11141245|NCT01461928|12327836|FG000|COMPLETED|Induction (up to 8 Months)||494
11141246|NCT01461928|12327837|FG001|COMPLETED|Induction (up to 8 Months)||0
11141247|NCT01461928|12327838|FG002|COMPLETED|Induction (up to 8 Months)||0
11141248|NCT01461928|12327836|FG000|NOT COMPLETED|Induction (up to 8 Months)||198
11141249|NCT01461928|12327837|FG001|NOT COMPLETED|Induction (up to 8 Months)||0
11141250|NCT01461928|12327838|FG002|NOT COMPLETED|Induction (up to 8 Months)||0
11141251|NCT01461928|12327836|FG000|STARTED|Maintenance I (24 Months)||494
11141252|NCT01461928|12327837|FG001|STARTED|Maintenance I (24 Months)||0
11141253|NCT01461928|12327838|FG002|STARTED|Maintenance I (24 Months)||0
11141254|NCT01461928|12327836|FG000|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276
11141255|NCT01461928|12327837|FG001|COMPLETED|Maintenance I (24 Months)||0
11141256|NCT01461928|12327838|FG002|COMPLETED|Maintenance I (24 Months)||0
11141257|NCT01461928|12327836|FG000|NOT COMPLETED|Maintenance I (24 Months)||218
11141258|NCT01461928|12327837|FG001|NOT COMPLETED|Maintenance I (24 Months)||0
11141259|NCT01461928|12327838|FG002|NOT COMPLETED|Maintenance I (24 Months)||0
11141260|NCT01461928|12327836|FG000|STARTED|Maintenance II (15 Months)||0
11141261|NCT01461928|12327837|FG001|STARTED|Maintenance II (15 Months)||138
11141262|NCT01461928|12327838|FG002|STARTED|Maintenance II (15 Months)||138
11141263|NCT01461928|12327836|FG000|COMPLETED|Maintenance II (15 Months)||0
11141264|NCT01461928|12327837|FG001|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115
11141265|NCT01461928|12327838|FG002|COMPLETED|Maintenance II (15 Months)||111
11141266|NCT01461928|12327836|FG000|NOT COMPLETED|Maintenance II (15 Months)||0
11141267|NCT01461928|12327837|FG001|NOT COMPLETED|Maintenance II (15 Months)||23
11141268|NCT01461928|12327838|FG002|NOT COMPLETED|Maintenance II (15 Months)||27
11141269|NCT01461980|12327852|FG000|STARTED|Overall Study||888
11141270|NCT01461980|12327853|FG001|STARTED|Overall Study||878
11141271|NCT01461980|12327854|FG002|STARTED|Overall Study||882
11141272|NCT01461980|12327852|FG000|Vaccination 1|Overall Study||884
11141273|NCT01461980|12327853|FG001|Vaccination 1|Overall Study||870
11141274|NCT01461980|12327854|FG002|Vaccination 1|Overall Study||875
11141275|NCT01461980|12327852|FG000|Vaccination 2|Overall Study||802
11141276|NCT01461980|12327853|FG001|Vaccination 2|Overall Study||819
11141277|NCT01461980|12327854|FG002|Vaccination 2|Overall Study||799
11141278|NCT01461980|12327852|FG000|Vaccination 3|Overall Study||757
11141279|NCT01461980|12327853|FG001|Vaccination 3|Overall Study||777
11141280|NCT01461980|12327854|FG002|Vaccination 3|Overall Study||748
11141281|NCT01461980|12327852|FG000|COMPLETED|Overall Study||722
11141282|NCT01461980|12327853|FG001|COMPLETED|Overall Study||733
11141283|NCT01461980|12327854|FG002|COMPLETED|Overall Study||717
11141284|NCT01461980|12327852|FG000|NOT COMPLETED|Overall Study||166
11141285|NCT01461980|12327853|FG001|NOT COMPLETED|Overall Study||145
11141286|NCT01461980|12327854|FG002|NOT COMPLETED|Overall Study||165
11141287|NCT01461993|12327866|FG000|STARTED|Overall Study||999
11141288|NCT01461993|12327867|FG001|STARTED|Overall Study||998
11141289|NCT01461993|12327868|FG002|STARTED|Overall Study||502
11141290|NCT01461993|12327866|FG000|COMPLETED|Overall Study||848
11141291|NCT01461993|12327867|FG001|COMPLETED|Overall Study||841
11141292|NCT01461993|12327868|FG002|COMPLETED|Overall Study||438
11141293|NCT01461993|12327866|FG000|NOT COMPLETED|Overall Study||151
11141294|NCT01461993|12327867|FG001|NOT COMPLETED|Overall Study||157
11141295|NCT01461993|12327868|FG002|NOT COMPLETED|Overall Study||64
11141296|NCT01462045|12327880|FG000|STARTED|Overall Study||11
11141297|NCT01462045|12327881|FG001|STARTED|Overall Study||11
11141298|NCT01462045|12327882|FG002|STARTED|Overall Study||7
11141299|NCT01462045|12327880|FG000|COMPLETED|Overall Study||11
11141300|NCT01462045|12327881|FG001|COMPLETED|Overall Study||10
11141301|NCT01462045|12327882|FG002|COMPLETED|Overall Study||7
11141302|NCT01462045|12327880|FG000|NOT COMPLETED|Overall Study||0
11141303|NCT01462045|12327881|FG001|NOT COMPLETED|Overall Study||1
11141304|NCT01462045|12327882|FG002|NOT COMPLETED|Overall Study||0
11141305|NCT01462084|12327890|FG000|STARTED|Overall Study||11
11141306|NCT01462084|12327891|FG001|STARTED|Overall Study||10
11141307|NCT01462084|12327890|FG000|Included for Analysis|Overall Study||9
11141308|NCT01462084|12327891|FG001|Included for Analysis|Overall Study||9
11141309|NCT01462084|12327890|FG000|COMPLETED|Overall Study||9
11141310|NCT01462084|12327891|FG001|COMPLETED|Overall Study||9
11141311|NCT01462084|12327890|FG000|NOT COMPLETED|Overall Study||2
11141312|NCT01462084|12327891|FG001|NOT COMPLETED|Overall Study||1
11141313|NCT01462110|12327900|FG000|STARTED|Overall Study||44
11141314|NCT01462110|12327901|FG001|STARTED|Overall Study||43
11141315|NCT01462110|12327900|FG000|COMPLETED|Overall Study||43
11141316|NCT01462110|12327901|FG001|COMPLETED|Overall Study||43
11141317|NCT01462110|12327900|FG000|NOT COMPLETED|Overall Study||1
11141318|NCT01462110|12327901|FG001|NOT COMPLETED|Overall Study||0
11141319|NCT01462162|12327907|FG000|STARTED|Overall Study||120
11141320|NCT01462162|12327907|FG000|COMPLETED|Overall Study||108
11141321|NCT01462162|12327907|FG000|NOT COMPLETED|Overall Study||12
11141322|NCT01462227|12327914|FG000|STARTED|First Assignment||4
11141323|NCT01462227|12327915|FG001|STARTED|First Assignment||2
11141324|NCT01462227|12327916|FG002|STARTED|First Assignment||6
11141325|NCT01462227|12327917|FG003|STARTED|First Assignment||5
11141326|NCT01462227|12327914|FG000|COMPLETED|First Assignment||4
11141327|NCT01462227|12327915|FG001|COMPLETED|First Assignment||2
11141328|NCT01462227|12327916|FG002|COMPLETED|First Assignment||6
11141329|NCT01462227|12327917|FG003|COMPLETED|First Assignment||5
11141330|NCT01462227|12327914|FG000|NOT COMPLETED|First Assignment||0
11141331|NCT01462227|12327915|FG001|NOT COMPLETED|First Assignment||0
11141332|NCT01462227|12327916|FG002|NOT COMPLETED|First Assignment||0
11141333|NCT01462227|12327917|FG003|NOT COMPLETED|First Assignment||0
11141334|NCT01462227|12327914|FG000|STARTED|Second Assignment||4
11141335|NCT01462227|12327915|FG001|STARTED|Second Assignment||2
11141336|NCT01462227|12327916|FG002|STARTED|Second Assignment||6
11141337|NCT01462227|12327917|FG003|STARTED|Second Assignment||5
11141338|NCT01462227|12327914|FG000|COMPLETED|Second Assignment||3
11141339|NCT01462227|12327915|FG001|COMPLETED|Second Assignment||1
11141340|NCT01462227|12327916|FG002|COMPLETED|Second Assignment||5
11141341|NCT01462227|12327917|FG003|COMPLETED|Second Assignment||5
11141342|NCT01462227|12327914|FG000|NOT COMPLETED|Second Assignment||1
11141343|NCT01462227|12327915|FG001|NOT COMPLETED|Second Assignment||1
11141344|NCT01462227|12327916|FG002|NOT COMPLETED|Second Assignment||1
11141345|NCT01462227|12327917|FG003|NOT COMPLETED|Second Assignment||0
11141346|NCT01462253|12327925|FG000|STARTED|Overall Study||35
11141347|NCT01462253|12327925|FG000|COMPLETED|Overall Study||27
11141348|NCT01462253|12327925|FG000|NOT COMPLETED|Overall Study||8
11141349|NCT01462266|12327931|FG000|STARTED|Overall Study||330
11141350|NCT01462266|12327932|FG001|STARTED|Overall Study||330
11141351|NCT01462266|12327931|FG000|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
11141352|NCT01462266|12327932|FG001|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
11141353|NCT01462266|12327931|FG000|COMPLETED|Overall Study||295
11141354|NCT01462266|12327932|FG001|COMPLETED|Overall Study||303
11141355|NCT01462266|12327931|FG000|NOT COMPLETED|Overall Study||35
11141356|NCT01462266|12327932|FG001|NOT COMPLETED|Overall Study||27
11141357|NCT01462279|12327938|FG000|STARTED|Overall Study||20
11141358|NCT01462279|12327938|FG000|COMPLETED|Overall Study||17
11141359|NCT01462279|12327938|FG000|NOT COMPLETED|Overall Study||3
11141360|NCT01462292|12327945|FG000|STARTED|Overall Study||16
11141361|NCT01462292|12327946|FG001|STARTED|Overall Study||17
11141362|NCT01462292|12327947|FG002|STARTED|Overall Study||18
11141363|NCT01462292|12327945|FG000|COMPLETED|Overall Study||16
11141364|NCT01462292|12327946|FG001|COMPLETED|Overall Study||17
11141365|NCT01462292|12327947|FG002|COMPLETED|Overall Study||18
11141366|NCT01462292|12327945|FG000|NOT COMPLETED|Overall Study||0
11141367|NCT01462292|12327946|FG001|NOT COMPLETED|Overall Study||0
11141368|NCT01462292|12327947|FG002|NOT COMPLETED|Overall Study||0
11141369|NCT01462305|12327960|FG000|STARTED|Overall Study||18
11141370|NCT01462305|12327961|FG001|STARTED|Overall Study||17
11141371|NCT01462305|12327960|FG000|COMPLETED|Overall Study||16
11141372|NCT01462305|12327961|FG001|COMPLETED|Overall Study||13
11141373|NCT01462305|12327960|FG000|NOT COMPLETED|Overall Study||2
11141374|NCT01462305|12327961|FG001|NOT COMPLETED|Overall Study||4
11141375|NCT01462318|12327969|FG000|STARTED|Main Study / TP-DI Study||113
11141376|NCT01462318|12327970|FG001|STARTED|Main Study / TP-DI Study||20
11141377|NCT01462318|12327971|FG002|STARTED|Main Study / TP-DI Study||0
11141378|NCT01462318|12327969|FG000|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
11141379|NCT01462318|12327970|FG001|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
11141380|NCT01462318|12327971|FG002|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
11141381|NCT01462318|12327969|FG000|COMPLETED|Main Study / TP-DI Study||105
11141382|NCT01462318|12327970|FG001|COMPLETED|Main Study / TP-DI Study||20
11141383|NCT01462318|12327971|FG002|COMPLETED|Main Study / TP-DI Study||0
11141384|NCT01462318|12327969|FG000|NOT COMPLETED|Main Study / TP-DI Study||8
11141385|NCT01462318|12327970|FG001|NOT COMPLETED|Main Study / TP-DI Study||0
11141386|NCT01462318|12327971|FG002|NOT COMPLETED|Main Study / TP-DI Study||0
11141387|NCT01462318|12327969|FG000|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
11141388|NCT01462318|12327970|FG001|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
11141389|NCT01462318|12327971|FG002|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
11141390|NCT01462318|12327969|FG000|COMPLETED|Extension Phase||0
11141391|NCT01462318|12327970|FG001|COMPLETED|Extension Phase||0
11141392|NCT01462318|12327971|FG002|COMPLETED|Extension Phase||70
11141393|NCT01462318|12327969|FG000|NOT COMPLETED|Extension Phase||0
11141394|NCT01462318|12327970|FG001|NOT COMPLETED|Extension Phase||0
11141395|NCT01462318|12327971|FG002|NOT COMPLETED|Extension Phase||45
11141396|NCT01462344|12327978|FG000|STARTED|Overall Study||3107
11141397|NCT01462344|12327979|FG001|STARTED|Overall Study||3101
11141398|NCT01462344|12327978|FG000|COMPLETED|Overall Study||2724
11141399|NCT01462344|12327979|FG001|COMPLETED|Overall Study||2751
11141400|NCT01462344|12327978|FG000|NOT COMPLETED|Overall Study||383
11141401|NCT01462344|12327979|FG001|NOT COMPLETED|Overall Study||350
11141402|NCT01462357|12327988|FG000|STARTED|Overall Study||359
11141403|NCT01462357|12327989|FG001|STARTED|Overall Study||358
11141404|NCT01462357|12327990|FG002|STARTED|Overall Study||358
11141405|NCT01462357|12327988|FG000|COMPLETED|Overall Study||351
11141406|NCT01462357|12327989|FG001|COMPLETED|Overall Study||339
11141407|NCT01462357|12327990|FG002|COMPLETED|Overall Study||346
11141408|NCT01462357|12327988|FG000|NOT COMPLETED|Overall Study||8
11141409|NCT01462357|12327989|FG001|NOT COMPLETED|Overall Study||19
11141410|NCT01462357|12327990|FG002|NOT COMPLETED|Overall Study||12
11141411|NCT01462435|12328002|FG000|STARTED|Overall Study||106
11141412|NCT01462435|12328003|FG001|STARTED|Overall Study||109
11141413|NCT01462435|12328004|FG002|STARTED|Overall Study||107
11141414|NCT01462435|12328005|FG003|STARTED|Overall Study||106
11141415|NCT01462435|12328002|FG000|COMPLETED|Overall Study||105
11141416|NCT01462435|12328003|FG001|COMPLETED|Overall Study||109
11141417|NCT01462435|12328004|FG002|COMPLETED|Overall Study||106
11141418|NCT01462435|12328005|FG003|COMPLETED|Overall Study||101
11141419|NCT01462435|12328002|FG000|NOT COMPLETED|Overall Study||1
11141420|NCT01462435|12328003|FG001|NOT COMPLETED|Overall Study||0
11141421|NCT01462435|12328004|FG002|NOT COMPLETED|Overall Study||1
11141422|NCT01462435|12328005|FG003|NOT COMPLETED|Overall Study||5
11141423|NCT01462565|12328015|FG000|STARTED|Overall Study||16
11141424|NCT01462565|12328015|FG000|COMPLETED|Overall Study||16
11141425|NCT01462565|12328015|FG000|NOT COMPLETED|Overall Study||0
11141426|NCT01462695|12328021|FG000|STARTED|Overall Study||17
11141427|NCT01462695|12328022|FG001|STARTED|Overall Study||13
11141428|NCT01462695|12328021|FG000|COMPLETED|Overall Study||0
11141429|NCT01462695|12328022|FG001|COMPLETED|Overall Study||0
11141430|NCT01462695|12328021|FG000|NOT COMPLETED|Overall Study||17
11141431|NCT01462695|12328022|FG001|NOT COMPLETED|Overall Study||13
11141432|NCT01462773|12328028|FG000|STARTED|Overall Study||16
11141433|NCT01462773|12328028|FG000|COMPLETED|Overall Study||16
11141434|NCT01462773|12328028|FG000|NOT COMPLETED|Overall Study||0
11141435|NCT01462812|12328035|FG000|STARTED|Overall Study||111
11141436|NCT01462812|12328036|FG001|STARTED|Overall Study||112
11141437|NCT01462812|12328035|FG000|COMPLETED|Overall Study||111
11141438|NCT01462812|12328036|FG001|COMPLETED|Overall Study||111
11141439|NCT01462812|12328035|FG000|NOT COMPLETED|Overall Study||0
11141440|NCT01462812|12328036|FG001|NOT COMPLETED|Overall Study||1
11141441|NCT01462877|12328042|FG000|STARTED|Overall Study||506
11141442|NCT01462877|12328042|FG000|Safety Set|Overall Study||492
11141443|NCT01462877|12328042|FG000|Full Analysis Set|Overall Study||468
11141444|NCT01462877|12328042|FG000|Per-protocol Set|Overall Study||364
11141445|NCT01462877|12328042|FG000|COMPLETED|Overall Study||435
11141446|NCT01462877|12328042|FG000|NOT COMPLETED|Overall Study||71
11141447|NCT01462929|12328049|FG000|STARTED|Overall Study||171
11141448|NCT01462929|12328050|FG001|STARTED|Overall Study||158
11141449|NCT01462929|12328051|FG002|STARTED|Overall Study||85
11141450|NCT01462929|12328049|FG000|COMPLETED|Overall Study||166
11141451|NCT01462929|12328050|FG001|COMPLETED|Overall Study||154
11141452|NCT01462929|12328051|FG002|COMPLETED|Overall Study||80
11141453|NCT01462929|12328049|FG000|NOT COMPLETED|Overall Study||5
11141454|NCT01462929|12328050|FG001|NOT COMPLETED|Overall Study||4
11141455|NCT01462929|12328051|FG002|NOT COMPLETED|Overall Study||5
11141456|NCT01462942|12328064|FG000|STARTED|Overall Study||194
11141457|NCT01462942|12328065|FG001|STARTED|Overall Study||385
11141458|NCT01462942|12328066|FG002|STARTED|Overall Study||381
11141459|NCT01462942|12328067|FG003|STARTED|Overall Study||385
11141460|NCT01462942|12328068|FG004|STARTED|Overall Study||384
11141461|NCT01462942|12328064|FG000|COMPLETED|Overall Study||160
11141462|NCT01462942|12328065|FG001|COMPLETED|Overall Study||351
11141463|NCT01462942|12328066|FG002|COMPLETED|Overall Study||341
11141464|NCT01462942|12328067|FG003|COMPLETED|Overall Study||335
11141465|NCT01462942|12328068|FG004|COMPLETED|Overall Study||339
11141466|NCT01462942|12328064|FG000|NOT COMPLETED|Overall Study||34
11141467|NCT01462942|12328065|FG001|NOT COMPLETED|Overall Study||34
11141468|NCT01462942|12328066|FG002|NOT COMPLETED|Overall Study||40
11141469|NCT01462942|12328067|FG003|NOT COMPLETED|Overall Study||50
11141470|NCT01462942|12328068|FG004|NOT COMPLETED|Overall Study||45
11141471|NCT01463007|12328080|FG000|STARTED|Overall Study||41
11141472|NCT01463007|12328080|FG000|COMPLETED|Overall Study||40
11141473|NCT01463007|12328080|FG000|NOT COMPLETED|Overall Study||1
11141474|NCT01463033|12328087|FG000|STARTED|Overall Study||66
11141475|NCT01463033|12328088|FG001|STARTED|Overall Study||60
11141476|NCT01463033|12328087|FG000|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
11141477|NCT01463033|12328088|FG001|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
11141478|NCT01463033|12328087|FG000|NOT COMPLETED|Overall Study||7
11141479|NCT01463033|12328088|FG001|NOT COMPLETED|Overall Study||6
11141480|NCT01463098|12328109|FG000|STARTED|Part A (11 Days)||16
11141481|NCT01463098|12328110|FG001|STARTED|Part A (11 Days)||6
11141482|NCT01463098|12328111|FG002|STARTED|Part A (11 Days)||6
11141483|NCT01463098|12328112|FG003|STARTED|Part A (11 Days)||6
11141484|NCT01463098|12328113|FG004|STARTED|Part A (11 Days)||6
11141485|NCT01463098|12328114|FG005|STARTED|Part A (11 Days)||6
11141486|NCT01463098|12328115|FG006|STARTED|Part A (11 Days)||6
11141487|NCT01463098|12328116|FG007|STARTED|Part A (11 Days)||6
11141488|NCT01463098|12328117|FG008|STARTED|Part A (11 Days)||6
11141489|NCT01463098|12328118|FG009|STARTED|Part A (11 Days)||0
11141490|NCT01463098|12328119|FG010|STARTED|Part A (11 Days)||0
11141491|NCT01463098|12328120|FG011|STARTED|Part A (11 Days)||0
11141492|NCT01463098|12328121|FG012|STARTED|Part A (11 Days)||0
11141493|NCT01463098|12328122|FG013|STARTED|Part A (11 Days)||0
11141494|NCT01463098|12328109|FG000|COMPLETED|Part A (11 Days)||14
11141495|NCT01463098|12328110|FG001|COMPLETED|Part A (11 Days)||6
11141496|NCT01463098|12328111|FG002|COMPLETED|Part A (11 Days)||6
11141497|NCT01463098|12328112|FG003|COMPLETED|Part A (11 Days)||6
11141498|NCT01463098|12328113|FG004|COMPLETED|Part A (11 Days)||5
11141499|NCT01463098|12328114|FG005|COMPLETED|Part A (11 Days)||6
11141500|NCT01463098|12328115|FG006|COMPLETED|Part A (11 Days)||6
11141501|NCT01463098|12328116|FG007|COMPLETED|Part A (11 Days)||6
11141502|NCT01463098|12328117|FG008|COMPLETED|Part A (11 Days)||5
11141503|NCT01463098|12328118|FG009|COMPLETED|Part A (11 Days)||0
11141504|NCT01463098|12328119|FG010|COMPLETED|Part A (11 Days)||0
11141505|NCT01463098|12328120|FG011|COMPLETED|Part A (11 Days)||0
11141506|NCT01463098|12328121|FG012|COMPLETED|Part A (11 Days)||0
11141507|NCT01463098|12328122|FG013|COMPLETED|Part A (11 Days)||0
11141508|NCT01463098|12328109|FG000|NOT COMPLETED|Part A (11 Days)||2
11141509|NCT01463098|12328110|FG001|NOT COMPLETED|Part A (11 Days)||0
11141510|NCT01463098|12328111|FG002|NOT COMPLETED|Part A (11 Days)||0
11141511|NCT01463098|12328112|FG003|NOT COMPLETED|Part A (11 Days)||0
11141512|NCT01463098|12328113|FG004|NOT COMPLETED|Part A (11 Days)||1
11141513|NCT01463098|12328114|FG005|NOT COMPLETED|Part A (11 Days)||0
11141514|NCT01463098|12328115|FG006|NOT COMPLETED|Part A (11 Days)||0
11141515|NCT01463098|12328116|FG007|NOT COMPLETED|Part A (11 Days)||0
11141516|NCT01463098|12328117|FG008|NOT COMPLETED|Part A (11 Days)||1
11141517|NCT01463098|12328118|FG009|NOT COMPLETED|Part A (11 Days)||0
11141518|NCT01463098|12328119|FG010|NOT COMPLETED|Part A (11 Days)||0
11141519|NCT01463098|12328120|FG011|NOT COMPLETED|Part A (11 Days)||0
11141520|NCT01463098|12328121|FG012|NOT COMPLETED|Part A (11 Days)||0
11141521|NCT01463098|12328122|FG013|NOT COMPLETED|Part A (11 Days)||0
11141522|NCT01463098|12328109|FG000|STARTED|Part B (11 Days)||0
11141523|NCT01463098|12328110|FG001|STARTED|Part B (11 Days)||0
11141524|NCT01463098|12328111|FG002|STARTED|Part B (11 Days)||0
11141525|NCT01463098|12328112|FG003|STARTED|Part B (11 Days)||0
11141526|NCT01463098|12328113|FG004|STARTED|Part B (11 Days)||0
11141527|NCT01463098|12328114|FG005|STARTED|Part B (11 Days)||0
11141528|NCT01463098|12328115|FG006|STARTED|Part B (11 Days)||0
11141529|NCT01463098|12328116|FG007|STARTED|Part B (11 Days)||0
11141530|NCT01463098|12328117|FG008|STARTED|Part B (11 Days)||0
11141531|NCT01463098|12328118|FG009|STARTED|Part B (11 Days)||12
11141532|NCT01463098|12328119|FG010|STARTED|Part B (11 Days)||11
11141533|NCT01463098|12328120|FG011|STARTED|Part B (11 Days)||13
11141534|NCT01463098|12328121|FG012|STARTED|Part B (11 Days)||10
11141535|NCT01463098|12328122|FG013|STARTED|Part B (11 Days)||12
11141536|NCT01463098|12328109|FG000|COMPLETED|Part B (11 Days)||0
11141537|NCT01463098|12328110|FG001|COMPLETED|Part B (11 Days)||0
11141538|NCT01463098|12328111|FG002|COMPLETED|Part B (11 Days)||0
11141539|NCT01463098|12328112|FG003|COMPLETED|Part B (11 Days)||0
11141540|NCT01463098|12328113|FG004|COMPLETED|Part B (11 Days)||0
11141541|NCT01463098|12328114|FG005|COMPLETED|Part B (11 Days)||0
11141542|NCT01463098|12328115|FG006|COMPLETED|Part B (11 Days)||0
11141543|NCT01463098|12328116|FG007|COMPLETED|Part B (11 Days)||0
11141544|NCT01463098|12328117|FG008|COMPLETED|Part B (11 Days)||0
11141545|NCT01463098|12328118|FG009|COMPLETED|Part B (11 Days)||12
11141546|NCT01463098|12328119|FG010|COMPLETED|Part B (11 Days)||11
11141547|NCT01463098|12328120|FG011|COMPLETED|Part B (11 Days)||12
11141548|NCT01463098|12328121|FG012|COMPLETED|Part B (11 Days)||10
11141549|NCT01463098|12328122|FG013|COMPLETED|Part B (11 Days)||12
11141550|NCT01463098|12328109|FG000|NOT COMPLETED|Part B (11 Days)||0
11141551|NCT01463098|12328110|FG001|NOT COMPLETED|Part B (11 Days)||0
11141552|NCT01463098|12328111|FG002|NOT COMPLETED|Part B (11 Days)||0
11141553|NCT01463098|12328112|FG003|NOT COMPLETED|Part B (11 Days)||0
11141554|NCT01463098|12328113|FG004|NOT COMPLETED|Part B (11 Days)||0
11141555|NCT01463098|12328114|FG005|NOT COMPLETED|Part B (11 Days)||0
11141556|NCT01463098|12328115|FG006|NOT COMPLETED|Part B (11 Days)||0
11141557|NCT01463098|12328116|FG007|NOT COMPLETED|Part B (11 Days)||0
11141558|NCT01463098|12328117|FG008|NOT COMPLETED|Part B (11 Days)||0
11141559|NCT01463098|12328118|FG009|NOT COMPLETED|Part B (11 Days)||0
11141560|NCT01463098|12328119|FG010|NOT COMPLETED|Part B (11 Days)||0
11141561|NCT01463098|12328120|FG011|NOT COMPLETED|Part B (11 Days)||1
11141562|NCT01463098|12328121|FG012|NOT COMPLETED|Part B (11 Days)||0
11141563|NCT01463098|12328122|FG013|NOT COMPLETED|Part B (11 Days)||0
11141564|NCT01463111|12328171|FG000|STARTED|Overall Study||26
11141565|NCT01463111|12328171|FG000|COMPLETED|Overall Study||17
11141566|NCT01463111|12328171|FG000|NOT COMPLETED|Overall Study||9
11141567|NCT01463202|12328177|FG000|STARTED|Overall Study||79
11141568|NCT01463202|12328178|FG001|STARTED|Overall Study||78
11141569|NCT01463202|12328177|FG000|COMPLETED|Overall Study||79
11141570|NCT01463202|12328178|FG001|COMPLETED|Overall Study||78
11141571|NCT01463202|12328177|FG000|NOT COMPLETED|Overall Study||0
11141572|NCT01463202|12328178|FG001|NOT COMPLETED|Overall Study||0
11141573|NCT01463267|12328188|FG000|STARTED|Overall Study||15
11141574|NCT01463267|12328189|FG001|STARTED|Overall Study||15
11141575|NCT01463267|12328190|FG002|STARTED|Overall Study||15
11141576|NCT01463267|12328191|FG003|STARTED|Overall Study||15
11141577|NCT01463267|12328188|FG000|COMPLETED|Overall Study||14
11141578|NCT01463267|12328189|FG001|COMPLETED|Overall Study||15
11141579|NCT01463267|12328190|FG002|COMPLETED|Overall Study||13
11141580|NCT01463267|12328191|FG003|COMPLETED|Overall Study||13
11141581|NCT01463267|12328188|FG000|NOT COMPLETED|Overall Study||1
11141582|NCT01463267|12328189|FG001|NOT COMPLETED|Overall Study||0
11141583|NCT01463267|12328190|FG002|NOT COMPLETED|Overall Study||2
11141584|NCT01463267|12328191|FG003|NOT COMPLETED|Overall Study||2
11141585|NCT01463306|12328204|FG000|STARTED|Overall Study||384
11141586|NCT01463306|12328205|FG001|STARTED|Overall Study||210
11141587|NCT01463306|12328206|FG002|STARTED|Overall Study||11
11141588|NCT01463306|12328204|FG000|COMPLETED|Overall Study||298
11141589|NCT01463306|12328205|FG001|COMPLETED|Overall Study||158
11141590|NCT01463306|12328206|FG002|COMPLETED|Overall Study||6
11141591|NCT01463306|12328204|FG000|NOT COMPLETED|Overall Study||86
11141592|NCT01463306|12328205|FG001|NOT COMPLETED|Overall Study||52
11141593|NCT01463306|12328206|FG002|NOT COMPLETED|Overall Study||5
11141594|NCT01463358|12328216|FG000|STARTED|Overall Study||49
11141595|NCT01463358|12328217|FG001|STARTED|Overall Study||52
11141596|NCT01463358|12328216|FG000|COMPLETED|Overall Study||46
11141597|NCT01463358|12328217|FG001|COMPLETED|Overall Study||47
11141598|NCT01463358|12328216|FG000|NOT COMPLETED|Overall Study||3
11141599|NCT01463358|12328217|FG001|NOT COMPLETED|Overall Study||5
11141600|NCT01463384|12328223|FG000|STARTED|Overall Study||13
11141601|NCT01463384|12328223|FG000|COMPLETED|Overall Study||13
11141602|NCT01463384|12328223|FG000|NOT COMPLETED|Overall Study||0
11141603|NCT01463527|12328231|FG000|STARTED|Overall Study||83
11141604|NCT01463527|12328232|FG001|STARTED|Overall Study||84
11141605|NCT01463527|12328231|FG000|COMPLETED|Overall Study||77
11141606|NCT01463527|12328232|FG001|COMPLETED|Overall Study||77
11141607|NCT01463527|12328231|FG000|NOT COMPLETED|Overall Study||6
11141608|NCT01463527|12328232|FG001|NOT COMPLETED|Overall Study||7
11141609|NCT01463631|12328242|FG000|STARTED|Overall Study||3
11141610|NCT01463631|12328243|FG001|STARTED|Overall Study||4
11141611|NCT01463631|12328244|FG002|STARTED|Overall Study||5
11141612|NCT01463631|12328245|FG003|STARTED|Overall Study||15
11141613|NCT01463631|12328242|FG000|Received at Least One Dose of Study Drug|Overall Study||3
11141614|NCT01463631|12328243|FG001|Received at Least One Dose of Study Drug|Overall Study||4
11141615|NCT01463631|12328244|FG002|Received at Least One Dose of Study Drug|Overall Study||5
11141616|NCT01463631|12328245|FG003|Received at Least One Dose of Study Drug|Overall Study||15
11141617|NCT01463631|12328242|FG000|COMPLETED|Overall Study||3
11141618|NCT01463631|12328243|FG001|COMPLETED|Overall Study||4
11141619|NCT01463631|12328244|FG002|COMPLETED|Overall Study||4
11141620|NCT01463631|12328245|FG003|COMPLETED|Overall Study||9
11141621|NCT01463631|12328242|FG000|NOT COMPLETED|Overall Study||0
11141622|NCT01463631|12328243|FG001|NOT COMPLETED|Overall Study||0
11141623|NCT01463631|12328244|FG002|NOT COMPLETED|Overall Study||1
11141624|NCT01463631|12328245|FG003|NOT COMPLETED|Overall Study||6
11141625|NCT01463683|12328260|FG000|STARTED|Overall Study||309
11141626|NCT01463683|12328261|FG001|STARTED|Overall Study||309
11141627|NCT01463683|12328262|FG002|STARTED|Overall Study||104
11141628|NCT01463683|12328260|FG000|Received Vaccination 1 (Day 1)|Overall Study||309
11141629|NCT01463683|12328261|FG001|Received Vaccination 1 (Day 1)|Overall Study||308
11141630|NCT01463683|12328262|FG002|Received Vaccination 1 (Day 1)|Overall Study||104
11141631|NCT01463683|12328260|FG000|Received Vaccination 2 (Month 1)|Overall Study||302
11141632|NCT01463683|12328261|FG001|Received Vaccination 2 (Month 1)|Overall Study||300
11141633|NCT01463683|12328262|FG002|Received Vaccination 2 (Month 1)|Overall Study||103
11141634|NCT01463683|12328260|FG000|Received Vaccination 3 (Month 6)|Overall Study||290
11141635|NCT01463683|12328261|FG001|Received Vaccination 3 (Month 6)|Overall Study||281
11141636|NCT01463683|12328262|FG002|Received Vaccination 3 (Month 6)|Overall Study||93
11141637|NCT01463683|12328260|FG000|COMPLETED|Overall Study||290
11141638|NCT01463683|12328261|FG001|COMPLETED|Overall Study||278
11141639|NCT01463683|12328262|FG002|COMPLETED|Overall Study||93
11141640|NCT01463683|12328260|FG000|NOT COMPLETED|Overall Study||19
11141641|NCT01463683|12328261|FG001|NOT COMPLETED|Overall Study||31
11141642|NCT01463683|12328262|FG002|NOT COMPLETED|Overall Study||11
11141643|NCT01463696|12328278|FG000|STARTED|Overall Study||1
11141644|NCT01463696|12328279|FG001|STARTED|Overall Study||6
11141645|NCT01463696|12328280|FG002|STARTED|Overall Study||3
11141646|NCT01463696|12328281|FG003|STARTED|Overall Study||7
11141647|NCT01463696|12328282|FG004|STARTED|Overall Study||3
11141648|NCT01463696|12328283|FG005|STARTED|Overall Study||6
11141649|NCT01463696|12328284|FG006|STARTED|Overall Study||16
11141650|NCT01463696|12328285|FG007|STARTED|Overall Study||6
11141651|NCT01463696|12328278|FG000|Treated|Overall Study||1
11141652|NCT01463696|12328279|FG001|Treated|Overall Study||6
11141653|NCT01463696|12328280|FG002|Treated|Overall Study||3
11141654|NCT01463696|12328281|FG003|Treated|Overall Study||7
11141655|NCT01463696|12328282|FG004|Treated|Overall Study||3
11141656|NCT01463696|12328283|FG005|Treated|Overall Study||6
11141657|NCT01463696|12328284|FG006|Treated|Overall Study||15
11141658|NCT01463696|12328285|FG007|Treated|Overall Study||6
11141659|NCT01463696|12328278|FG000|COMPLETED|Overall Study||1
11141660|NCT01463696|12328279|FG001|COMPLETED|Overall Study||4
11141661|NCT01463696|12328280|FG002|COMPLETED|Overall Study||2
11141662|NCT01463696|12328281|FG003|COMPLETED|Overall Study||3
11141663|NCT01463696|12328282|FG004|COMPLETED|Overall Study||2
11141664|NCT01463696|12328283|FG005|COMPLETED|Overall Study||3
11141665|NCT01463696|12328284|FG006|COMPLETED|Overall Study||6
11141666|NCT01463696|12328285|FG007|COMPLETED|Overall Study||2
11141667|NCT01463696|12328278|FG000|NOT COMPLETED|Overall Study||0
11141668|NCT01463696|12328279|FG001|NOT COMPLETED|Overall Study||2
11141669|NCT01463696|12328280|FG002|NOT COMPLETED|Overall Study||1
11141670|NCT01463696|12328281|FG003|NOT COMPLETED|Overall Study||4
11141671|NCT01463696|12328282|FG004|NOT COMPLETED|Overall Study||1
11141672|NCT01463696|12328283|FG005|NOT COMPLETED|Overall Study||3
11141673|NCT01463696|12328284|FG006|NOT COMPLETED|Overall Study||10
11141674|NCT01463696|12328285|FG007|NOT COMPLETED|Overall Study||4
11141675|NCT01463878|12328305|FG000|STARTED|Overall Study||9
11141676|NCT01463878|12328306|FG001|STARTED|Overall Study||9
11141677|NCT01463878|12328305|FG000|COMPLETED|Overall Study||7
11141678|NCT01463878|12328306|FG001|COMPLETED|Overall Study||7
11141679|NCT01463878|12328305|FG000|NOT COMPLETED|Overall Study||2
11141680|NCT01463878|12328306|FG001|NOT COMPLETED|Overall Study||2
11141681|NCT01463982|12328316|FG000|STARTED|Overall Study||3
11141682|NCT01463982|12328317|FG001|STARTED|Overall Study||8
11141683|NCT01463982|12328318|FG002|STARTED|Overall Study||4
11141684|NCT01463982|12328319|FG003|STARTED|Overall Study||6
11141685|NCT01463982|12328316|FG000|COMPLETED|Overall Study||3
11141686|NCT01463982|12328317|FG001|COMPLETED|Overall Study||7
11141687|NCT01463982|12328318|FG002|COMPLETED|Overall Study||2
11141688|NCT01463982|12328319|FG003|COMPLETED|Overall Study||6
11141689|NCT01463982|12328316|FG000|NOT COMPLETED|Overall Study||0
11141690|NCT01463982|12328317|FG001|NOT COMPLETED|Overall Study||1
11141691|NCT01463982|12328318|FG002|NOT COMPLETED|Overall Study||2
11141692|NCT01463982|12328319|FG003|NOT COMPLETED|Overall Study||0
11141693|NCT01464021|12328329|FG000|STARTED|Overall Study||26
11141694|NCT01464021|12328329|FG000|COMPLETED|Overall Study||0
11141695|NCT01464021|12328329|FG000|NOT COMPLETED|Overall Study||26
11141696|NCT01464190|12328335|FG000|STARTED|Overall Study||391
11141697|NCT01464190|12328336|FG001|STARTED|Overall Study||268
11141698|NCT01464190|12328335|FG000|COMPLETED|Overall Study||322
11141699|NCT01464190|12328336|FG001|COMPLETED|Overall Study||227
11141700|NCT01464190|12328335|FG000|NOT COMPLETED|Overall Study||69
11141701|NCT01464190|12328336|FG001|NOT COMPLETED|Overall Study||41
11141702|NCT01464229|12328344|FG000|STARTED|Overall Study||10
11141703|NCT01464229|12328345|FG001|STARTED|Overall Study||10
11141704|NCT01464229|12328344|FG000|COMPLETED|Overall Study||5
11141705|NCT01464229|12328345|FG001|COMPLETED|Overall Study||8
11141706|NCT01464229|12328344|FG000|NOT COMPLETED|Overall Study||5
11141707|NCT01464229|12328345|FG001|NOT COMPLETED|Overall Study||2
11141708|NCT01464255|12328353|FG000|STARTED|Overall Study||25
11141709|NCT01464255|12328354|FG001|STARTED|Overall Study||25
11141710|NCT01464255|12328353|FG000|COMPLETED|Overall Study||25
11141711|NCT01464255|12328354|FG001|COMPLETED|Overall Study||24
11141712|NCT01464255|12328353|FG000|NOT COMPLETED|Overall Study||0
11141713|NCT01464255|12328354|FG001|NOT COMPLETED|Overall Study||1
11141714|NCT01464307|12328363|FG000|STARTED|Main Period||144
11141715|NCT01464307|12328364|FG001|STARTED|Main Period||145
11141716|NCT01464307|12328363|FG000|Treated|Main Period||144
11141717|NCT01464307|12328364|FG001|Treated|Main Period||145
11141718|NCT01464307|12328363|FG000|COMPLETED|Main Period||129
11241598|NCT02099006|12434113|FG000|Received Amitriptyline/ Baclofen|Overall Study||7
11241599|NCT02099006|12434113|FG000|Received Ketoprofen|Overall Study||3
11241600|NCT02099006|12434113|FG000|Received Loperamide|Overall Study||7
11241601|NCT02099006|12434113|FG000|Received Ketamine|Overall Study||6
11241602|NCT02099006|12434113|FG000|Received Gabapentin|Overall Study||8
11241603|NCT02099006|12434113|FG000|COMPLETED|Overall Study||8
11241604|NCT02099006|12434113|FG000|NOT COMPLETED|Overall Study||1
11241605|NCT02099084|12434119|FG000|STARTED|First Intervention||4
11241606|NCT02099084|12434120|FG001|STARTED|First Intervention||4
11241607|NCT02099084|12434119|FG000|COMPLETED|First Intervention||4
11241608|NCT02099084|12434120|FG001|COMPLETED|First Intervention||4
11141719|NCT01464307|12328364|FG001|COMPLETED|Main Period||140
11141720|NCT01464307|12328363|FG000|NOT COMPLETED|Main Period||15
11141721|NCT01464307|12328364|FG001|NOT COMPLETED|Main Period||5
11141722|NCT01464307|12328363|FG000|STARTED|Open-Label Extension Period||269
11141723|NCT01464307|12328364|FG001|STARTED|Open-Label Extension Period||0
11141724|NCT01464307|12328363|FG000|Treated|Open-Label Extension Period||269
11141725|NCT01464307|12328364|FG001|Treated|Open-Label Extension Period||0
11141726|NCT01464307|12328363|FG000|COMPLETED|Open-Label Extension Period||218
11141727|NCT01464307|12328364|FG001|COMPLETED|Open-Label Extension Period||0
11141728|NCT01464307|12328363|FG000|NOT COMPLETED|Open-Label Extension Period||51
11141729|NCT01464307|12328364|FG001|NOT COMPLETED|Open-Label Extension Period||0
11141730|NCT01464333|12328371|FG000|STARTED|Overall Study||389
11141731|NCT01464333|12328371|FG000|COMPLETED|Overall Study||226
11241609|NCT02099084|12434119|FG000|NOT COMPLETED|First Intervention||0
11241610|NCT02099084|12434120|FG001|NOT COMPLETED|First Intervention||0
11241611|NCT02099084|12434119|FG000|STARTED|Washout Period of 14 Days||4
11241612|NCT02099084|12434120|FG001|STARTED|Washout Period of 14 Days||4
11241613|NCT02099084|12434119|FG000|COMPLETED|Washout Period of 14 Days||4
11241614|NCT02099084|12434120|FG001|COMPLETED|Washout Period of 14 Days||4
11241615|NCT02099084|12434119|FG000|NOT COMPLETED|Washout Period of 14 Days||0
11241616|NCT02099084|12434120|FG001|NOT COMPLETED|Washout Period of 14 Days||0
11241617|NCT02099084|12434119|FG000|STARTED|Second Intervention||4
11241618|NCT02099084|12434120|FG001|STARTED|Second Intervention||4
11241619|NCT02099084|12434119|FG000|COMPLETED|Second Intervention||4
11241620|NCT02099084|12434120|FG001|COMPLETED|Second Intervention||4
11241621|NCT02099084|12434119|FG000|NOT COMPLETED|Second Intervention||0
11241622|NCT02099084|12434120|FG001|NOT COMPLETED|Second Intervention||0
11241623|NCT02099110|12434131|FG000|STARTED|Overall Study||250
11241624|NCT02099110|12434132|FG001|STARTED|Overall Study||248
11241625|NCT02099110|12434133|FG002|STARTED|Overall Study||247
11241626|NCT02099110|12434134|FG003|STARTED|Overall Study||243
11241627|NCT02099110|12434135|FG004|STARTED|Overall Study||245
11241628|NCT02099110|12434131|FG000|Treated|Overall Study||250
11241629|NCT02099110|12434132|FG001|Treated|Overall Study||248
11241630|NCT02099110|12434133|FG002|Treated|Overall Study||247
11241631|NCT02099110|12434134|FG003|Treated|Overall Study||243
11241632|NCT02099110|12434135|FG004|Treated|Overall Study||244
11241633|NCT02099110|12434131|FG000|COMPLETED|Overall Study||226
11241634|NCT02099110|12434132|FG001|COMPLETED|Overall Study||217
11241635|NCT02099110|12434133|FG002|COMPLETED|Overall Study||219
11241636|NCT02099110|12434134|FG003|COMPLETED|Overall Study||221
11241637|NCT02099110|12434135|FG004|COMPLETED|Overall Study||218
11241638|NCT02099110|12434131|FG000|NOT COMPLETED|Overall Study||24
11241639|NCT02099110|12434132|FG001|NOT COMPLETED|Overall Study||31
11241640|NCT02099110|12434133|FG002|NOT COMPLETED|Overall Study||28
11241641|NCT02099110|12434134|FG003|NOT COMPLETED|Overall Study||22
11241642|NCT02099110|12434135|FG004|NOT COMPLETED|Overall Study||27
11241643|NCT02099266|12434147|FG000|STARTED|Overall Study||15
11241644|NCT02099266|12434147|FG000|COMPLETED|Overall Study||15
11241645|NCT02099266|12434147|FG000|NOT COMPLETED|Overall Study||0
11241646|NCT02099461|12434157|FG000|STARTED|Overall Study||27
11241647|NCT02099461|12434158|FG001|STARTED|Overall Study||27
11241648|NCT02099461|12434159|FG002|STARTED|Overall Study||28
11241649|NCT02099461|12434157|FG000|COMPLETED|Overall Study||27
11241650|NCT02099461|12434158|FG001|COMPLETED|Overall Study||27
11241651|NCT02099461|12434159|FG002|COMPLETED|Overall Study||28
11141732|NCT01464333|12328371|FG000|NOT COMPLETED|Overall Study||163
11141733|NCT01464346|12328375|FG000|STARTED|Overall Study||29
11141734|NCT01464346|12328376|FG001|STARTED|Overall Study||32
11141735|NCT01464346|12328377|FG002|STARTED|Overall Study||29
11141736|NCT01464346|12328375|FG000|COMPLETED|Overall Study||29
11141737|NCT01464346|12328376|FG001|COMPLETED|Overall Study||32
11141738|NCT01464346|12328377|FG002|COMPLETED|Overall Study||28
11141739|NCT01464346|12328375|FG000|NOT COMPLETED|Overall Study||0
11141740|NCT01464346|12328376|FG001|NOT COMPLETED|Overall Study||0
11141741|NCT01464346|12328377|FG002|NOT COMPLETED|Overall Study||1
11141742|NCT01464359|12328385|FG000|STARTED|Overall Study||3
11141743|NCT01464359|12328385|FG000|COMPLETED|Overall Study||3
11141744|NCT01464359|12328385|FG000|NOT COMPLETED|Overall Study||0
11141745|NCT01464424|12328389|FG000|STARTED|Period 1, First 6 Weeks||42
11141746|NCT01464424|12328390|FG001|STARTED|Period 1, First 6 Weeks||42
11141747|NCT01464424|12328389|FG000|COMPLETED|Period 1, First 6 Weeks||42
11141748|NCT01464424|12328390|FG001|COMPLETED|Period 1, First 6 Weeks||41
11141749|NCT01464424|12328389|FG000|NOT COMPLETED|Period 1, First 6 Weeks||0
11141750|NCT01464424|12328390|FG001|NOT COMPLETED|Period 1, First 6 Weeks||1
11141751|NCT01464424|12328389|FG000|STARTED|Period 2, Second 6 Weeks||42
11141752|NCT01464424|12328390|FG001|STARTED|Period 2, Second 6 Weeks||41
11241652|NCT02099461|12434157|FG000|NOT COMPLETED|Overall Study||0
11241653|NCT02099461|12434158|FG001|NOT COMPLETED|Overall Study||0
11241654|NCT02099461|12434159|FG002|NOT COMPLETED|Overall Study||0
11241655|NCT02099682|12434167|FG000|STARTED|Overall Study|Number of cases.|3366
11241656|NCT02099682|12434167|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
11241657|NCT02099682|12434167|FG000|COMPLETED|Overall Study||3255
11241658|NCT02099682|12434167|FG000|NOT COMPLETED|Overall Study||111
11241659|NCT02099708|12434171|FG000|STARTED|Overall Study|Number of cases.|3502
11241660|NCT02099708|12434171|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
11241661|NCT02099708|12434171|FG000|COMPLETED|Overall Study||3302
11241662|NCT02099708|12434171|FG000|NOT COMPLETED|Overall Study||200
11241663|NCT02099721|12434181|FG000|STARTED|Overall Study||1066
11241664|NCT02099721|12434182|FG001|STARTED|Overall Study||127
11241665|NCT02099721|12434183|FG002|STARTED|Overall Study||1068
11241666|NCT02099721|12434184|FG003|STARTED|Overall Study||845
11241667|NCT02099721|12434185|FG004|STARTED|Overall Study||331
11241668|NCT02099721|12434186|FG005|STARTED|Overall Study||452
11241669|NCT02099721|12434181|FG000|COMPLETED|Overall Study||990
11241670|NCT02099721|12434182|FG001|COMPLETED|Overall Study|Not implanted secondary patients were automatically exited.|0
11241671|NCT02099721|12434183|FG002|COMPLETED|Overall Study||983
11241672|NCT02099721|12434184|FG003|COMPLETED|Overall Study||774
11241673|NCT02099721|12434185|FG004|COMPLETED|Overall Study||304
11241674|NCT02099721|12434186|FG005|COMPLETED|Overall Study||432
11241675|NCT02099721|12434181|FG000|NOT COMPLETED|Overall Study||76
11241676|NCT02099721|12434182|FG001|NOT COMPLETED|Overall Study||127
11241677|NCT02099721|12434183|FG002|NOT COMPLETED|Overall Study||85
11241678|NCT02099721|12434184|FG003|NOT COMPLETED|Overall Study||71
11241679|NCT02099721|12434185|FG004|NOT COMPLETED|Overall Study||27
11241680|NCT02099721|12434186|FG005|NOT COMPLETED|Overall Study||20
11241681|NCT02099786|12434200|FG000|STARTED|Overall Study||24
11241682|NCT02099786|12434201|FG001|STARTED|Overall Study||23
11241683|NCT02099786|12434200|FG000|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24
11241684|NCT02099786|12434201|FG001|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23
11241685|NCT02099786|12434200|FG000|Program Eval 2|Overall Study|One month post randomization|23
11241686|NCT02099786|12434201|FG001|Program Eval 2|Overall Study|One month post randomization|19
11141753|NCT01464424|12328389|FG000|COMPLETED|Period 2, Second 6 Weeks||42
11141754|NCT01464424|12328390|FG001|COMPLETED|Period 2, Second 6 Weeks||41
11141755|NCT01464424|12328389|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0
11241687|NCT02099786|12434200|FG000|Program Eval 3|Overall Study|One year post randomization|21
11241688|NCT02099786|12434201|FG001|Program Eval 3|Overall Study|One year post randomization|15
11241689|NCT02099786|12434200|FG000|COMPLETED|Overall Study||21
11241690|NCT02099786|12434201|FG001|COMPLETED|Overall Study||15
11241691|NCT02099786|12434200|FG000|NOT COMPLETED|Overall Study||3
11241692|NCT02099786|12434201|FG001|NOT COMPLETED|Overall Study||8
11241693|NCT02099799|12434210|FG000|STARTED|Overall Study||75
11241694|NCT02099799|12434211|FG001|STARTED|Overall Study||78
11241695|NCT02099799|12434210|FG000|COMPLETED|Overall Study||60
11241696|NCT02099799|12434211|FG001|COMPLETED|Overall Study||54
11241697|NCT02099799|12434210|FG000|NOT COMPLETED|Overall Study||15
11241698|NCT02099799|12434211|FG001|NOT COMPLETED|Overall Study||24
11241699|NCT02099838|12434221|FG000|STARTED|Overall Study||47
11241700|NCT02099838|12434222|FG001|STARTED|Overall Study||51
11241701|NCT02099838|12434221|FG000|COMPLETED|Overall Study||43
11241702|NCT02099838|12434222|FG001|COMPLETED|Overall Study||49
11241703|NCT02099838|12434221|FG000|NOT COMPLETED|Overall Study||4
11241704|NCT02099838|12434222|FG001|NOT COMPLETED|Overall Study||2
11241705|NCT02100007|12434228|FG000|STARTED|Overall Study||46
11241706|NCT02100007|12434228|FG000|COMPLETED|Overall Study||46
11241707|NCT02100007|12434228|FG000|NOT COMPLETED|Overall Study||0
11241708|NCT02100072|12434233|FG000|STARTED|Overall Study||5
11241709|NCT02100072|12434233|FG000|COMPLETED|Overall Study||5
11241710|NCT02100072|12434233|FG000|NOT COMPLETED|Overall Study||0
11241711|NCT02100124|12434240|FG000|STARTED|Overall Study||329
11241712|NCT02100124|12434241|FG001|STARTED|Overall Study||329
11141756|NCT01464424|12328390|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0
11141757|NCT01464619|12328398|FG000|STARTED|Overall Study||32
11141758|NCT01464619|12328399|FG001|STARTED|Overall Study||29
11141759|NCT01464619|12328398|FG000|COMPLETED|Overall Study||29
11141760|NCT01464619|12328399|FG001|COMPLETED|Overall Study||25
11141761|NCT01464619|12328398|FG000|NOT COMPLETED|Overall Study||3
11141762|NCT01464619|12328399|FG001|NOT COMPLETED|Overall Study||4
11141763|NCT01464697|12328409|FG000|STARTED|Overall Study||93
11141764|NCT01464697|12328410|FG001|STARTED|Overall Study||96
11141765|NCT01464697|12328409|FG000|COMPLETED|Overall Study||90
11141766|NCT01464697|12328410|FG001|COMPLETED|Overall Study||86
11141767|NCT01464697|12328409|FG000|NOT COMPLETED|Overall Study||3
11141768|NCT01464697|12328410|FG001|NOT COMPLETED|Overall Study||10
11141769|NCT01464775|12328418|FG000|STARTED|Overall Study||123
11141770|NCT01464775|12328419|FG001|STARTED|Overall Study||44
11141771|NCT01464775|12328418|FG000|COMPLETED|Overall Study||112
11141772|NCT01464775|12328419|FG001|COMPLETED|Overall Study||38
11141773|NCT01464775|12328418|FG000|NOT COMPLETED|Overall Study||11
11141774|NCT01464775|12328419|FG001|NOT COMPLETED|Overall Study||6
11141775|NCT01464788|12328430|FG000|STARTED|Overall Study||30
11141776|NCT01464788|12328431|FG001|STARTED|Overall Study||31
11141777|NCT01464788|12328432|FG002|STARTED|Overall Study||29
11141778|NCT01464788|12328430|FG000|COMPLETED|Overall Study||30
11141779|NCT01464788|12328431|FG001|COMPLETED|Overall Study||29
11141780|NCT01464788|12328432|FG002|COMPLETED|Overall Study||29
11141781|NCT01464788|12328430|FG000|NOT COMPLETED|Overall Study||0
11141782|NCT01464788|12328431|FG001|NOT COMPLETED|Overall Study||2
11141783|NCT01464788|12328432|FG002|NOT COMPLETED|Overall Study||0
11141784|NCT01464827|12328456|FG000|STARTED|Overall Study||80
11141785|NCT01464827|12328457|FG001|STARTED|Overall Study||43
11141786|NCT01464827|12328458|FG002|STARTED|Overall Study||39
11141787|NCT01464827|12328459|FG003|STARTED|Overall Study||40
11141788|NCT01464827|12328460|FG004|STARTED|Overall Study||80
11141789|NCT01464827|12328461|FG005|STARTED|Overall Study||39
11141790|NCT01464827|12328462|FG006|STARTED|Overall Study||41
11141791|NCT01464827|12328463|FG007|STARTED|Overall Study||40
11141792|NCT01464827|12328464|FG008|STARTED|Overall Study||40
11141793|NCT01464827|12328465|FG009|STARTED|Overall Study||47
11141794|NCT01464827|12328466|FG010|STARTED|Overall Study||23
11141795|NCT01464827|12328467|FG011|STARTED|Overall Study||23
11141796|NCT01464827|12328468|FG012|STARTED|Overall Study||23
11141797|NCT01464827|12328469|FG013|STARTED|Overall Study||22
11141798|NCT01464827|12328456|FG000|Treated|Overall Study||80
11241713|NCT02100124|12434242|FG002|STARTED|Overall Study||326
11241714|NCT02100124|12434240|FG000|COMPLETED|Overall Study||323
11241715|NCT02100124|12434241|FG001|COMPLETED|Overall Study||318
11241716|NCT02100124|12434242|FG002|COMPLETED|Overall Study||323
11241717|NCT02100124|12434240|FG000|NOT COMPLETED|Overall Study||6
11241718|NCT02100124|12434241|FG001|NOT COMPLETED|Overall Study||11
11241719|NCT02100124|12434242|FG002|NOT COMPLETED|Overall Study||3
11241720|NCT02100189|12434250|FG000|STARTED|Overall Study||50
11241721|NCT02100189|12434250|FG000|COMPLETED|Overall Study||50
11141799|NCT01464827|12328457|FG001|Treated|Overall Study||41
11141800|NCT01464827|12328458|FG002|Treated|Overall Study||39
11141801|NCT01464827|12328459|FG003|Treated|Overall Study||40
11141802|NCT01464827|12328460|FG004|Treated|Overall Study||79
11141803|NCT01464827|12328461|FG005|Treated|Overall Study||39
11141804|NCT01464827|12328462|FG006|Treated|Overall Study||40
11141805|NCT01464827|12328463|FG007|Treated|Overall Study||40
11141806|NCT01464827|12328464|FG008|Treated|Overall Study||40
11141807|NCT01464827|12328465|FG009|Treated|Overall Study||45
11141808|NCT01464827|12328466|FG010|Treated|Overall Study||23
11141809|NCT01464827|12328467|FG011|Treated|Overall Study||22
11141810|NCT01464827|12328468|FG012|Treated|Overall Study||23
11141811|NCT01464827|12328469|FG013|Treated|Overall Study||20
11141812|NCT01464827|12328456|FG000|COMPLETED|Overall Study||77
11141813|NCT01464827|12328457|FG001|COMPLETED|Overall Study||36
11141814|NCT01464827|12328458|FG002|COMPLETED|Overall Study||39
11141815|NCT01464827|12328459|FG003|COMPLETED|Overall Study||36
11141816|NCT01464827|12328460|FG004|COMPLETED|Overall Study||72
11141817|NCT01464827|12328461|FG005|COMPLETED|Overall Study||38
11141818|NCT01464827|12328462|FG006|COMPLETED|Overall Study||37
11141819|NCT01464827|12328463|FG007|COMPLETED|Overall Study||37
11141820|NCT01464827|12328464|FG008|COMPLETED|Overall Study||37
11141821|NCT01464827|12328465|FG009|COMPLETED|Overall Study||44
11141822|NCT01464827|12328466|FG010|COMPLETED|Overall Study||21
11141823|NCT01464827|12328467|FG011|COMPLETED|Overall Study||21
11141824|NCT01464827|12328468|FG012|COMPLETED|Overall Study||21
11141825|NCT01464827|12328469|FG013|COMPLETED|Overall Study||19
11141826|NCT01464827|12328456|FG000|NOT COMPLETED|Overall Study||3
11141827|NCT01464827|12328457|FG001|NOT COMPLETED|Overall Study||7
11141828|NCT01464827|12328458|FG002|NOT COMPLETED|Overall Study||0
11141829|NCT01464827|12328459|FG003|NOT COMPLETED|Overall Study||4
11141830|NCT01464827|12328460|FG004|NOT COMPLETED|Overall Study||8
11141831|NCT01464827|12328461|FG005|NOT COMPLETED|Overall Study||1
11141832|NCT01464827|12328462|FG006|NOT COMPLETED|Overall Study||4
11141833|NCT01464827|12328463|FG007|NOT COMPLETED|Overall Study||3
11141834|NCT01464827|12328464|FG008|NOT COMPLETED|Overall Study||3
11141835|NCT01464827|12328465|FG009|NOT COMPLETED|Overall Study||3
11141836|NCT01464827|12328466|FG010|NOT COMPLETED|Overall Study||2
11141837|NCT01464827|12328467|FG011|NOT COMPLETED|Overall Study||2
11141838|NCT01464827|12328468|FG012|NOT COMPLETED|Overall Study||2
11141839|NCT01464827|12328469|FG013|NOT COMPLETED|Overall Study||3
11141840|NCT01464840|12328513|FG000|STARTED|Overall Study||10
11141841|NCT01464840|12328514|FG001|STARTED|Overall Study||10
11141842|NCT01464840|12328515|FG002|STARTED|Overall Study||10
11141843|NCT01464840|12328513|FG000|COMPLETED|Overall Study||10
11141844|NCT01464840|12328514|FG001|COMPLETED|Overall Study||10
11141845|NCT01464840|12328515|FG002|COMPLETED|Overall Study||10
11141846|NCT01464840|12328513|FG000|NOT COMPLETED|Overall Study||0
11241722|NCT02100189|12434250|FG000|NOT COMPLETED|Overall Study||0
11241723|NCT02100228|12434256|FG000|STARTED|Overall Study|735 treated with Apixaban|753
11241724|NCT02100228|12434257|FG001|STARTED|Overall Study|721 treated with Usual Care|747
11241725|NCT02100228|12434256|FG000|COMPLETED|Overall Study||678
11241726|NCT02100228|12434257|FG001|COMPLETED|Overall Study||657
11241727|NCT02100228|12434256|FG000|NOT COMPLETED|Overall Study||75
11241728|NCT02100228|12434257|FG001|NOT COMPLETED|Overall Study||90
11241729|NCT02100280|12434265|FG000|STARTED|Overall Study||48
11241730|NCT02100280|12434266|FG001|STARTED|Overall Study||48
11241731|NCT02100280|12434265|FG000|COMPLETED|Overall Study||44
11241732|NCT02100280|12434266|FG001|COMPLETED|Overall Study||44
11241733|NCT02100280|12434265|FG000|NOT COMPLETED|Overall Study||4
11241734|NCT02100280|12434266|FG001|NOT COMPLETED|Overall Study||4
11241735|NCT02100319|12434274|FG000|STARTED|Overall Study||387
11241736|NCT02100319|12434274|FG000|COMPLETED|Overall Study||371
11241737|NCT02100319|12434274|FG000|NOT COMPLETED|Overall Study||16
11241738|NCT02100410|12434278|FG000|STARTED|Exposure Pair 1, 30 Minutes||8
11241739|NCT02100410|12434279|FG001|STARTED|Exposure Pair 1, 30 Minutes||8
11241740|NCT02100410|12434280|FG002|STARTED|Exposure Pair 1, 30 Minutes||8
11241741|NCT02100410|12434281|FG003|STARTED|Exposure Pair 1, 30 Minutes||8
11241742|NCT02100410|12434282|FG004|STARTED|Exposure Pair 1, 30 Minutes||8
11241743|NCT02100410|12434283|FG005|STARTED|Exposure Pair 1, 30 Minutes||9
11241744|NCT02100410|12434278|FG000|COMPLETED|Exposure Pair 1, 30 Minutes||8
11241745|NCT02100410|12434279|FG001|COMPLETED|Exposure Pair 1, 30 Minutes||8
11241746|NCT02100410|12434280|FG002|COMPLETED|Exposure Pair 1, 30 Minutes||8
11241747|NCT02100410|12434281|FG003|COMPLETED|Exposure Pair 1, 30 Minutes||8
11241748|NCT02100410|12434282|FG004|COMPLETED|Exposure Pair 1, 30 Minutes||8
11241749|NCT02100410|12434283|FG005|COMPLETED|Exposure Pair 1, 30 Minutes||9
11241750|NCT02100410|12434278|FG000|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
11241751|NCT02100410|12434279|FG001|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
11241752|NCT02100410|12434280|FG002|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
11241753|NCT02100410|12434281|FG003|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
11241754|NCT02100410|12434282|FG004|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
11241755|NCT02100410|12434283|FG005|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
11241756|NCT02100410|12434278|FG000|STARTED|Exposure Pair 2, 30 Minutes||8
11241757|NCT02100410|12434279|FG001|STARTED|Exposure Pair 2, 30 Minutes||8
11241758|NCT02100410|12434280|FG002|STARTED|Exposure Pair 2, 30 Minutes||8
11241759|NCT02100410|12434281|FG003|STARTED|Exposure Pair 2, 30 Minutes||8
11241760|NCT02100410|12434282|FG004|STARTED|Exposure Pair 2, 30 Minutes||8
11241761|NCT02100410|12434283|FG005|STARTED|Exposure Pair 2, 30 Minutes||9
11141847|NCT01464840|12328514|FG001|NOT COMPLETED|Overall Study||0
11241762|NCT02100410|12434278|FG000|COMPLETED|Exposure Pair 2, 30 Minutes||8
11241763|NCT02100410|12434279|FG001|COMPLETED|Exposure Pair 2, 30 Minutes||8
11241764|NCT02100410|12434280|FG002|COMPLETED|Exposure Pair 2, 30 Minutes||8
11241765|NCT02100410|12434281|FG003|COMPLETED|Exposure Pair 2, 30 Minutes||8
11241766|NCT02100410|12434282|FG004|COMPLETED|Exposure Pair 2, 30 Minutes||8
11241767|NCT02100410|12434283|FG005|COMPLETED|Exposure Pair 2, 30 Minutes||9
11241768|NCT02100410|12434278|FG000|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
11241769|NCT02100410|12434279|FG001|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
11241770|NCT02100410|12434280|FG002|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
11241771|NCT02100410|12434281|FG003|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
11241772|NCT02100410|12434282|FG004|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
11241773|NCT02100410|12434283|FG005|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
11241774|NCT02100410|12434278|FG000|STARTED|Exposure Pair 3, 30 Minutes||8
11241775|NCT02100410|12434279|FG001|STARTED|Exposure Pair 3, 30 Minutes||8
11241776|NCT02100410|12434280|FG002|STARTED|Exposure Pair 3, 30 Minutes||8
11241777|NCT02100410|12434281|FG003|STARTED|Exposure Pair 3, 30 Minutes||8
11241778|NCT02100410|12434282|FG004|STARTED|Exposure Pair 3, 30 Minutes||8
11241779|NCT02100410|12434283|FG005|STARTED|Exposure Pair 3, 30 Minutes||9
11241780|NCT02100410|12434278|FG000|COMPLETED|Exposure Pair 3, 30 Minutes||8
11241781|NCT02100410|12434279|FG001|COMPLETED|Exposure Pair 3, 30 Minutes||8
11241782|NCT02100410|12434280|FG002|COMPLETED|Exposure Pair 3, 30 Minutes||8
11241783|NCT02100410|12434281|FG003|COMPLETED|Exposure Pair 3, 30 Minutes||8
11241784|NCT02100410|12434282|FG004|COMPLETED|Exposure Pair 3, 30 Minutes||8
11241785|NCT02100410|12434283|FG005|COMPLETED|Exposure Pair 3, 30 Minutes||9
11241786|NCT02100410|12434278|FG000|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
11241787|NCT02100410|12434279|FG001|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
11241788|NCT02100410|12434280|FG002|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
11241789|NCT02100410|12434281|FG003|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
11241790|NCT02100410|12434282|FG004|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
11241791|NCT02100410|12434283|FG005|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
11241792|NCT02100475|12434297|FG000|STARTED|Overall Study||16
11241793|NCT02100475|12434298|FG001|STARTED|Overall Study||15
11241794|NCT02100475|12434297|FG000|COMPLETED|Overall Study||14
11241795|NCT02100475|12434298|FG001|COMPLETED|Overall Study||13
11241796|NCT02100475|12434297|FG000|NOT COMPLETED|Overall Study||2
11241797|NCT02100475|12434298|FG001|NOT COMPLETED|Overall Study||2
11241798|NCT02100514|12434306|FG000|STARTED|Treatment Period||247
11241799|NCT02100514|12434307|FG001|STARTED|Treatment Period||499
11241800|NCT02100514|12434308|FG002|STARTED|Treatment Period||0
11241801|NCT02100514|12434309|FG003|STARTED|Treatment Period||0
11241802|NCT02100514|12434310|FG004|STARTED|Treatment Period||0
11241803|NCT02100514|12434306|FG000|COMPLETED|Treatment Period||218
11241804|NCT02100514|12434307|FG001|COMPLETED|Treatment Period||425
11241805|NCT02100514|12434308|FG002|COMPLETED|Treatment Period||0
11241806|NCT02100514|12434309|FG003|COMPLETED|Treatment Period||0
11241807|NCT02100514|12434310|FG004|COMPLETED|Treatment Period||0
11241808|NCT02100514|12434306|FG000|NOT COMPLETED|Treatment Period||29
11358108|NCT03119831|12555153|FG001|NOT COMPLETED|Overall Study||0
11241809|NCT02100514|12434307|FG001|NOT COMPLETED|Treatment Period||74
11241810|NCT02100514|12434308|FG002|NOT COMPLETED|Treatment Period||0
11241811|NCT02100514|12434309|FG003|NOT COMPLETED|Treatment Period||0
11241812|NCT02100514|12434310|FG004|NOT COMPLETED|Treatment Period||0
11241813|NCT02100514|12434306|FG000|STARTED|Extension Period||0
11241814|NCT02100514|12434307|FG001|STARTED|Extension Period||0
11241815|NCT02100514|12434308|FG002|STARTED|Extension Period||44
11241816|NCT02100514|12434309|FG003|STARTED|Extension Period||33
11241817|NCT02100514|12434310|FG004|STARTED|Extension Period||56
11241818|NCT02100514|12434306|FG000|COMPLETED|Extension Period||0
11241819|NCT02100514|12434307|FG001|COMPLETED|Extension Period||0
11241820|NCT02100514|12434308|FG002|COMPLETED|Extension Period||42
11241821|NCT02100514|12434309|FG003|COMPLETED|Extension Period||33
11241822|NCT02100514|12434310|FG004|COMPLETED|Extension Period||56
11241823|NCT02100514|12434306|FG000|NOT COMPLETED|Extension Period||0
11241824|NCT02100514|12434307|FG001|NOT COMPLETED|Extension Period||0
11241825|NCT02100514|12434308|FG002|NOT COMPLETED|Extension Period||2
11241826|NCT02100514|12434309|FG003|NOT COMPLETED|Extension Period||0
11241827|NCT02100514|12434310|FG004|NOT COMPLETED|Extension Period||0
11241828|NCT02100579|12434326|FG000|STARTED|Overall Study||20
11241829|NCT02100579|12434327|FG001|STARTED|Overall Study||20
11241830|NCT02100579|12434326|FG000|COMPLETED|Overall Study||20
11241831|NCT02100579|12434327|FG001|COMPLETED|Overall Study||20
11241832|NCT02100579|12434326|FG000|NOT COMPLETED|Overall Study||0
11241833|NCT02100579|12434327|FG001|NOT COMPLETED|Overall Study||0
11241834|NCT02100631|12434336|FG000|STARTED|Overall Study||299
11241835|NCT02100631|12434337|FG001|STARTED|Overall Study||99
11241836|NCT02100631|12434338|FG002|STARTED|Overall Study||2688
11241837|NCT02100631|12434336|FG000|COMPLETED|Overall Study||292
11241838|NCT02100631|12434337|FG001|COMPLETED|Overall Study||95
11241839|NCT02100631|12434338|FG002|COMPLETED|Overall Study||2688
11241840|NCT02100631|12434336|FG000|NOT COMPLETED|Overall Study||7
11241841|NCT02100631|12434337|FG001|NOT COMPLETED|Overall Study||4
11241842|NCT02100631|12434338|FG002|NOT COMPLETED|Overall Study||0
11241843|NCT02100644|12434346|FG000|STARTED|LTG Escalation Phase||33
11241844|NCT02100644|12434347|FG001|STARTED|LTG Escalation Phase||0
11241845|NCT02100644|12434348|FG002|STARTED|LTG Escalation Phase||0
11241846|NCT02100644|12434346|FG000|COMPLETED|LTG Escalation Phase||20
11241847|NCT02100644|12434347|FG001|COMPLETED|LTG Escalation Phase||0
11241848|NCT02100644|12434348|FG002|COMPLETED|LTG Escalation Phase||0
11241849|NCT02100644|12434346|FG000|NOT COMPLETED|LTG Escalation Phase||13
11241850|NCT02100644|12434347|FG001|NOT COMPLETED|LTG Escalation Phase||0
11241851|NCT02100644|12434348|FG002|NOT COMPLETED|LTG Escalation Phase||0
11241852|NCT02100644|12434346|FG000|STARTED|VPA Reduction Phase||0
11241853|NCT02100644|12434347|FG001|STARTED|VPA Reduction Phase||20
11241854|NCT02100644|12434348|FG002|STARTED|VPA Reduction Phase||0
11241855|NCT02100644|12434346|FG000|COMPLETED|VPA Reduction Phase||0
11241856|NCT02100644|12434347|FG001|COMPLETED|VPA Reduction Phase||20
11241857|NCT02100644|12434348|FG002|COMPLETED|VPA Reduction Phase||0
11241858|NCT02100644|12434346|FG000|NOT COMPLETED|VPA Reduction Phase||0
11241859|NCT02100644|12434347|FG001|NOT COMPLETED|VPA Reduction Phase||0
11241860|NCT02100644|12434348|FG002|NOT COMPLETED|VPA Reduction Phase||0
11241861|NCT02100644|12434346|FG000|STARTED|LTG and VPA Maintenance Phase||0
11241862|NCT02100644|12434347|FG001|STARTED|LTG and VPA Maintenance Phase||0
11241863|NCT02100644|12434348|FG002|STARTED|LTG and VPA Maintenance Phase||20
11241864|NCT02100644|12434346|FG000|COMPLETED|LTG and VPA Maintenance Phase||0
11241865|NCT02100644|12434347|FG001|COMPLETED|LTG and VPA Maintenance Phase||0
11241866|NCT02100644|12434348|FG002|COMPLETED|LTG and VPA Maintenance Phase||20
11241867|NCT02100644|12434346|FG000|NOT COMPLETED|LTG and VPA Maintenance Phase||0
11241868|NCT02100644|12434347|FG001|NOT COMPLETED|LTG and VPA Maintenance Phase||0
11241869|NCT02100644|12434348|FG002|NOT COMPLETED|LTG and VPA Maintenance Phase||0
11241870|NCT02100657|12434355|FG000|STARTED|Cohort 1: Dose Level 1||8
11241871|NCT02100657|12434356|FG001|STARTED|Cohort 1: Dose Level 1||0
11241872|NCT02100657|12434357|FG002|STARTED|Cohort 1: Dose Level 1||0
11241873|NCT02100657|12434355|FG000|COMPLETED|Cohort 1: Dose Level 1||0
11241874|NCT02100657|12434356|FG001|COMPLETED|Cohort 1: Dose Level 1||0
11241875|NCT02100657|12434357|FG002|COMPLETED|Cohort 1: Dose Level 1||0
11241876|NCT02100657|12434355|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||8
11241877|NCT02100657|12434356|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0
11241878|NCT02100657|12434357|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
11241879|NCT02100657|12434355|FG000|STARTED|Cohort 2: Dose Level 2||0
11241880|NCT02100657|12434356|FG001|STARTED|Cohort 2: Dose Level 2||4
11241881|NCT02100657|12434357|FG002|STARTED|Cohort 2: Dose Level 2||0
11241882|NCT02100657|12434355|FG000|COMPLETED|Cohort 2: Dose Level 2||0
11241883|NCT02100657|12434356|FG001|COMPLETED|Cohort 2: Dose Level 2||0
11241884|NCT02100657|12434357|FG002|COMPLETED|Cohort 2: Dose Level 2||0
11241885|NCT02100657|12434355|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
11241886|NCT02100657|12434356|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||4
11241887|NCT02100657|12434357|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0
11241888|NCT02100657|12434355|FG000|STARTED|Cohort 3: Dose Level 3||0
11241889|NCT02100657|12434356|FG001|STARTED|Cohort 3: Dose Level 3||0
11241890|NCT02100657|12434357|FG002|STARTED|Cohort 3: Dose Level 3||27
11241891|NCT02100657|12434355|FG000|COMPLETED|Cohort 3: Dose Level 3||0
11241892|NCT02100657|12434356|FG001|COMPLETED|Cohort 3: Dose Level 3||0
11241893|NCT02100657|12434357|FG002|COMPLETED|Cohort 3: Dose Level 3||0
11241894|NCT02100657|12434355|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
11241895|NCT02100657|12434356|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
11241896|NCT02100657|12434357|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||27
11241897|NCT02100670|12434370|FG000|STARTED|Overall Study||118
11241898|NCT02100670|12434371|FG001|STARTED|Overall Study||113
11241899|NCT02100670|12434372|FG002|STARTED|Overall Study||78
11241900|NCT02100670|12434373|FG003|STARTED|Overall Study||76
11241901|NCT02100670|12434370|FG000|COMPLETED|Overall Study||105
11241902|NCT02100670|12434371|FG001|COMPLETED|Overall Study||106
11241903|NCT02100670|12434372|FG002|COMPLETED|Overall Study||74
11241904|NCT02100670|12434373|FG003|COMPLETED|Overall Study||75
11241905|NCT02100670|12434370|FG000|NOT COMPLETED|Overall Study||13
11241906|NCT02100670|12434371|FG001|NOT COMPLETED|Overall Study||7
11241907|NCT02100670|12434372|FG002|NOT COMPLETED|Overall Study||4
11241908|NCT02100670|12434373|FG003|NOT COMPLETED|Overall Study||1
11241909|NCT02100696|12434396|FG000|STARTED|Induction Phase||130
11241910|NCT02100696|12434397|FG001|STARTED|Induction Phase||95
11241911|NCT02100696|12434398|FG002|STARTED|Induction Phase||384
11241912|NCT02100696|12434399|FG003|STARTED|Induction Phase||0
11241913|NCT02100696|12434400|FG004|STARTED|Induction Phase||0
11241914|NCT02100696|12434401|FG005|STARTED|Induction Phase||0
11241915|NCT02100696|12434396|FG000|COMPLETED|Induction Phase||115
11241916|NCT02100696|12434397|FG001|COMPLETED|Induction Phase||90
11241917|NCT02100696|12434398|FG002|COMPLETED|Induction Phase||358
11241918|NCT02100696|12434399|FG003|COMPLETED|Induction Phase||0
11241919|NCT02100696|12434400|FG004|COMPLETED|Induction Phase||0
11241920|NCT02100696|12434401|FG005|COMPLETED|Induction Phase||0
11241921|NCT02100696|12434396|FG000|NOT COMPLETED|Induction Phase||15
11241922|NCT02100696|12434397|FG001|NOT COMPLETED|Induction Phase||5
11241923|NCT02100696|12434398|FG002|NOT COMPLETED|Induction Phase||26
11241924|NCT02100696|12434399|FG003|NOT COMPLETED|Induction Phase||0
11241925|NCT02100696|12434400|FG004|NOT COMPLETED|Induction Phase||0
11241926|NCT02100696|12434401|FG005|NOT COMPLETED|Induction Phase||0
11241927|NCT02100696|12434396|FG000|STARTED|Maintenance Phase||0
11241928|NCT02100696|12434397|FG001|STARTED|Maintenance Phase||0
11241929|NCT02100696|12434398|FG002|STARTED|Maintenance Phase||0
11241930|NCT02100696|12434399|FG003|STARTED|Maintenance Phase||27
11241931|NCT02100696|12434400|FG004|STARTED|Maintenance Phase||115
11241932|NCT02100696|12434401|FG005|STARTED|Maintenance Phase||117
11241933|NCT02100696|12434396|FG000|COMPLETED|Maintenance Phase||0
11241934|NCT02100696|12434397|FG001|COMPLETED|Maintenance Phase||0
11241935|NCT02100696|12434398|FG002|COMPLETED|Maintenance Phase||0
11241936|NCT02100696|12434399|FG003|COMPLETED|Maintenance Phase||26
11241937|NCT02100696|12434400|FG004|COMPLETED|Maintenance Phase||106
11241938|NCT02100696|12434401|FG005|COMPLETED|Maintenance Phase||112
11241939|NCT02100696|12434396|FG000|NOT COMPLETED|Maintenance Phase||0
11241940|NCT02100696|12434397|FG001|NOT COMPLETED|Maintenance Phase||0
11241941|NCT02100696|12434398|FG002|NOT COMPLETED|Maintenance Phase||0
11241942|NCT02100696|12434399|FG003|NOT COMPLETED|Maintenance Phase||1
11241943|NCT02100696|12434400|FG004|NOT COMPLETED|Maintenance Phase||9
11241944|NCT02100696|12434401|FG005|NOT COMPLETED|Maintenance Phase||5
11241945|NCT02100748|12434434|FG000|STARTED|Overall Study||25
11241946|NCT02100748|12434435|FG001|STARTED|Overall Study||24
11241947|NCT02100748|12434436|FG002|STARTED|Overall Study||22
11241948|NCT02100748|12434437|FG003|STARTED|Overall Study||22
11241949|NCT02100748|12434438|FG004|STARTED|Overall Study||25
11241950|NCT02100748|12434439|FG005|STARTED|Overall Study||23
11241951|NCT02100748|12434440|FG006|STARTED|Overall Study||20
11241952|NCT02100748|12434441|FG007|STARTED|Overall Study||38
11241953|NCT02100748|12434442|FG008|STARTED|Overall Study||36
11241954|NCT02100748|12434443|FG009|STARTED|Overall Study||31
11241955|NCT02100748|12434444|FG010|STARTED|Overall Study||28
11241956|NCT02100748|12434445|FG011|STARTED|Overall Study||39
11241957|NCT02100748|12434434|FG000|COMPLETED|Overall Study||23
11241958|NCT02100748|12434435|FG001|COMPLETED|Overall Study||23
11241959|NCT02100748|12434436|FG002|COMPLETED|Overall Study||21
11241960|NCT02100748|12434437|FG003|COMPLETED|Overall Study||21
11241961|NCT02100748|12434438|FG004|COMPLETED|Overall Study||23
11241962|NCT02100748|12434439|FG005|COMPLETED|Overall Study||23
11241963|NCT02100748|12434440|FG006|COMPLETED|Overall Study||18
11241964|NCT02100748|12434441|FG007|COMPLETED|Overall Study||34
11241965|NCT02100748|12434442|FG008|COMPLETED|Overall Study||33
11241966|NCT02100748|12434443|FG009|COMPLETED|Overall Study||29
11241967|NCT02100748|12434444|FG010|COMPLETED|Overall Study||26
11241968|NCT02100748|12434445|FG011|COMPLETED|Overall Study||39
11241969|NCT02100748|12434434|FG000|NOT COMPLETED|Overall Study||2
11241970|NCT02100748|12434435|FG001|NOT COMPLETED|Overall Study||1
11241971|NCT02100748|12434436|FG002|NOT COMPLETED|Overall Study||1
11241972|NCT02100748|12434437|FG003|NOT COMPLETED|Overall Study||1
11241973|NCT02100748|12434438|FG004|NOT COMPLETED|Overall Study||2
11241974|NCT02100748|12434439|FG005|NOT COMPLETED|Overall Study||0
11241975|NCT02100748|12434440|FG006|NOT COMPLETED|Overall Study||2
11241976|NCT02100748|12434441|FG007|NOT COMPLETED|Overall Study||4
11241977|NCT02100748|12434442|FG008|NOT COMPLETED|Overall Study||3
11241978|NCT02100748|12434443|FG009|NOT COMPLETED|Overall Study||2
11241979|NCT02100748|12434444|FG010|NOT COMPLETED|Overall Study||2
11241980|NCT02100748|12434445|FG011|NOT COMPLETED|Overall Study||0
11241981|NCT02100813|12434479|FG000|STARTED|Overall Study||10
11241982|NCT02100813|12434480|FG001|STARTED|Overall Study||11
11241983|NCT02100813|12434481|FG002|STARTED|Overall Study||12
11241984|NCT02100813|12434482|FG003|STARTED|Overall Study||12
11241985|NCT02100813|12434483|FG004|STARTED|Overall Study||12
11241986|NCT02100813|12434484|FG005|STARTED|Overall Study||32
11241987|NCT02100813|12434485|FG006|STARTED|Overall Study||64
11241988|NCT02100813|12434486|FG007|STARTED|Overall Study||67
11241989|NCT02100813|12434479|FG000|COMPLETED|Overall Study||10
11241990|NCT02100813|12434480|FG001|COMPLETED|Overall Study||11
11241991|NCT02100813|12434481|FG002|COMPLETED|Overall Study||12
11241992|NCT02100813|12434482|FG003|COMPLETED|Overall Study||12
11241993|NCT02100813|12434483|FG004|COMPLETED|Overall Study||12
11241994|NCT02100813|12434484|FG005|COMPLETED|Overall Study||32
11241995|NCT02100813|12434485|FG006|COMPLETED|Overall Study||64
11241996|NCT02100813|12434486|FG007|COMPLETED|Overall Study||66
11241997|NCT02100813|12434479|FG000|NOT COMPLETED|Overall Study||0
11241998|NCT02100813|12434480|FG001|NOT COMPLETED|Overall Study||0
11241999|NCT02100813|12434481|FG002|NOT COMPLETED|Overall Study||0
11242000|NCT02100813|12434482|FG003|NOT COMPLETED|Overall Study||0
11242001|NCT02100813|12434483|FG004|NOT COMPLETED|Overall Study||0
11242002|NCT02100813|12434484|FG005|NOT COMPLETED|Overall Study||0
11242003|NCT02100813|12434485|FG006|NOT COMPLETED|Overall Study||0
11242004|NCT02100813|12434486|FG007|NOT COMPLETED|Overall Study||1
11242005|NCT02100826|12434504|FG000|STARTED|Period 1 (7 Days)||14
11242006|NCT02100826|12434505|FG001|STARTED|Period 1 (7 Days)||14
11242007|NCT02100826|12434504|FG000|COMPLETED|Period 1 (7 Days)||14
11242008|NCT02100826|12434505|FG001|COMPLETED|Period 1 (7 Days)||14
11242009|NCT02100826|12434504|FG000|NOT COMPLETED|Period 1 (7 Days)||0
11242010|NCT02100826|12434505|FG001|NOT COMPLETED|Period 1 (7 Days)||0
11242011|NCT02100826|12434504|FG000|STARTED|Washout Period (1 Day)||14
11242012|NCT02100826|12434505|FG001|STARTED|Washout Period (1 Day)||14
11242013|NCT02100826|12434504|FG000|COMPLETED|Washout Period (1 Day)||14
11242014|NCT02100826|12434505|FG001|COMPLETED|Washout Period (1 Day)||14
11242015|NCT02100826|12434504|FG000|NOT COMPLETED|Washout Period (1 Day)||0
11242016|NCT02100826|12434505|FG001|NOT COMPLETED|Washout Period (1 Day)||0
11242017|NCT02100826|12434504|FG000|STARTED|Period 2 (7 Days)||14
11242018|NCT02100826|12434505|FG001|STARTED|Period 2 (7 Days)||14
11242019|NCT02100826|12434504|FG000|COMPLETED|Period 2 (7 Days)||14
11242020|NCT02100826|12434505|FG001|COMPLETED|Period 2 (7 Days)||14
11242021|NCT02100826|12434504|FG000|NOT COMPLETED|Period 2 (7 Days)||0
11242022|NCT02100826|12434505|FG001|NOT COMPLETED|Period 2 (7 Days)||0
11242023|NCT02100839|12434513|FG000|STARTED|Single Ascending Dose||24
11242024|NCT02100839|12434514|FG001|STARTED|Single Ascending Dose||12
11242025|NCT02100839|12434513|FG000|COMPLETED|Single Ascending Dose||24
11242026|NCT02100839|12434514|FG001|COMPLETED|Single Ascending Dose||12
11242027|NCT02100839|12434513|FG000|NOT COMPLETED|Single Ascending Dose||0
11242028|NCT02100839|12434514|FG001|NOT COMPLETED|Single Ascending Dose||0
11242029|NCT02100839|12434513|FG000|STARTED|Multiple Ascending Dose||13
11242030|NCT02100839|12434514|FG001|STARTED|Multiple Ascending Dose||3
11242031|NCT02100839|12434513|FG000|COMPLETED|Multiple Ascending Dose||9
11242032|NCT02100839|12434514|FG001|COMPLETED|Multiple Ascending Dose||3
11242033|NCT02100839|12434513|FG000|NOT COMPLETED|Multiple Ascending Dose||4
11242034|NCT02100839|12434514|FG001|NOT COMPLETED|Multiple Ascending Dose||0
11242035|NCT02100930|12434520|FG000|STARTED|Overall Study||69
11242036|NCT02100930|12434520|FG000|COMPLETED|Overall Study||69
11242037|NCT02100930|12434520|FG000|NOT COMPLETED|Overall Study||0
11242038|NCT02100969|12434524|FG000|STARTED|Overall Study||23
11242039|NCT02100969|12434524|FG000|COMPLETED|Overall Study||22
11242040|NCT02100969|12434524|FG000|NOT COMPLETED|Overall Study||1
11242041|NCT02101008|12434529|FG000|STARTED|Overall Study||12
11242042|NCT02101008|12434529|FG000|COMPLETED|Overall Study||12
11242043|NCT02101008|12434529|FG000|NOT COMPLETED|Overall Study||0
11242044|NCT02101021|12434538|FG000|STARTED|Overall Study||7
11242045|NCT02101021|12434539|FG001|STARTED|Overall Study||4
11242046|NCT02101021|12434540|FG002|STARTED|Overall Study||7
11242047|NCT02101021|12434541|FG003|STARTED|Overall Study||3
11242048|NCT02101021|12434542|FG004|STARTED|Overall Study||4
11242049|NCT02101021|12434538|FG000|COMPLETED|Overall Study||0
11242050|NCT02101021|12434539|FG001|COMPLETED|Overall Study||0
11242051|NCT02101021|12434540|FG002|COMPLETED|Overall Study||0
11242052|NCT02101021|12434541|FG003|COMPLETED|Overall Study||0
11242053|NCT02101021|12434542|FG004|COMPLETED|Overall Study||0
11242054|NCT02101021|12434538|FG000|NOT COMPLETED|Overall Study||7
11242055|NCT02101021|12434539|FG001|NOT COMPLETED|Overall Study||4
11242056|NCT02101021|12434540|FG002|NOT COMPLETED|Overall Study||7
11242057|NCT02101021|12434541|FG003|NOT COMPLETED|Overall Study||3
11242058|NCT02101021|12434542|FG004|NOT COMPLETED|Overall Study||4
11242059|NCT02101060|12434556|FG000|STARTED|Overall Study||17
11242060|NCT02101060|12434557|FG001|STARTED|Overall Study||16
11242061|NCT02101060|12434556|FG000|COMPLETED|Overall Study||12
11242062|NCT02101060|12434557|FG001|COMPLETED|Overall Study||12
11242063|NCT02101060|12434556|FG000|NOT COMPLETED|Overall Study||5
11242064|NCT02101060|12434557|FG001|NOT COMPLETED|Overall Study||4
11242065|NCT02101112|12434563|FG000|STARTED|Overall Study||6
11242066|NCT02101112|12434564|FG001|STARTED|Overall Study||5
11242067|NCT02101112|12434565|FG002|STARTED|Overall Study||6
11242068|NCT02101112|12434566|FG003|STARTED|Overall Study||5
11242069|NCT02101112|12434567|FG004|STARTED|Overall Study||6
11242070|NCT02101112|12434568|FG005|STARTED|Overall Study||5
11242071|NCT02101112|12434563|FG000|COMPLETED|Overall Study||6
11242072|NCT02101112|12434564|FG001|COMPLETED|Overall Study||5
11242073|NCT02101112|12434565|FG002|COMPLETED|Overall Study||5
11242074|NCT02101112|12434566|FG003|COMPLETED|Overall Study||5
11242075|NCT02101112|12434567|FG004|COMPLETED|Overall Study||5
11242076|NCT02101112|12434568|FG005|COMPLETED|Overall Study||5
11242077|NCT02101112|12434563|FG000|NOT COMPLETED|Overall Study||0
11242078|NCT02101112|12434564|FG001|NOT COMPLETED|Overall Study||0
11242079|NCT02101112|12434565|FG002|NOT COMPLETED|Overall Study||1
11242080|NCT02101112|12434566|FG003|NOT COMPLETED|Overall Study||0
11242081|NCT02101112|12434567|FG004|NOT COMPLETED|Overall Study||1
11242082|NCT02101112|12434568|FG005|NOT COMPLETED|Overall Study||0
11242083|NCT02101190|12434580|FG000|STARTED|Overall Study||8
11242084|NCT02101190|12434581|FG001|STARTED|Overall Study||8
11242085|NCT02101190|12434580|FG000|COMPLETED|Overall Study||8
11242086|NCT02101190|12434581|FG001|COMPLETED|Overall Study||8
11242087|NCT02101190|12434580|FG000|NOT COMPLETED|Overall Study||0
11242088|NCT02101190|12434581|FG001|NOT COMPLETED|Overall Study||0
11242089|NCT02101281|12434589|FG000|STARTED|Overall Study||20
11242090|NCT02101281|12434590|FG001|STARTED|Overall Study||20
11242091|NCT02101281|12434589|FG000|COMPLETED|Overall Study||20
11242092|NCT02101281|12434590|FG001|COMPLETED|Overall Study||19
11242093|NCT02101281|12434589|FG000|NOT COMPLETED|Overall Study||0
11242094|NCT02101281|12434590|FG001|NOT COMPLETED|Overall Study||1
11242095|NCT02101294|12434602|FG000|STARTED|Overall Study||31
11242096|NCT02101294|12434602|FG000|COMPLETED|Overall Study||20
11242097|NCT02101294|12434602|FG000|NOT COMPLETED|Overall Study||11
11242098|NCT02101359|12434611|FG000|STARTED|Overall Study||295
11242099|NCT02101359|12434612|FG001|STARTED|Overall Study||296
11242100|NCT02101359|12434611|FG000|COMPLETED|Overall Study||266
11242101|NCT02101359|12434612|FG001|COMPLETED|Overall Study||277
11242102|NCT02101359|12434611|FG000|NOT COMPLETED|Overall Study||29
11242103|NCT02101359|12434612|FG001|NOT COMPLETED|Overall Study||19
11242104|NCT02101411|12434621|FG000|STARTED|Overall Study||111
11242105|NCT02101411|12434622|FG001|STARTED|Overall Study||109
11242106|NCT02101411|12434623|FG002|STARTED|Overall Study||114
11242107|NCT02101411|12434621|FG000|COMPLETED|Overall Study||107
11242108|NCT02101411|12434622|FG001|COMPLETED|Overall Study||102
11242109|NCT02101411|12434623|FG002|COMPLETED|Overall Study||104
11242110|NCT02101411|12434621|FG000|NOT COMPLETED|Overall Study||4
11242111|NCT02101411|12434622|FG001|NOT COMPLETED|Overall Study||7
11242112|NCT02101411|12434623|FG002|NOT COMPLETED|Overall Study||10
11242113|NCT02101437|12434635|FG000|STARTED|Overall Study||20
11242114|NCT02101437|12434636|FG001|STARTED|Overall Study||54
11242115|NCT02101437|12434637|FG002|STARTED|Overall Study||52
11242116|NCT02101437|12434638|FG003|STARTED|Overall Study||49
11242117|NCT02101437|12434635|FG000|COMPLETED|Overall Study||20
11242118|NCT02101437|12434636|FG001|COMPLETED|Overall Study||54
11242119|NCT02101437|12434637|FG002|COMPLETED|Overall Study||52
11242120|NCT02101437|12434638|FG003|COMPLETED|Overall Study||49
11242121|NCT02101437|12434635|FG000|NOT COMPLETED|Overall Study||0
11242122|NCT02101437|12434636|FG001|NOT COMPLETED|Overall Study||0
11242123|NCT02101437|12434637|FG002|NOT COMPLETED|Overall Study||0
11242124|NCT02101437|12434638|FG003|NOT COMPLETED|Overall Study||0
11242125|NCT02101515|12434650|FG000|STARTED|Overall Study||37
11242126|NCT02101515|12434651|FG001|STARTED|Overall Study||41
11242127|NCT02101515|12434650|FG000|COMPLETED|Overall Study||37
11242128|NCT02101515|12434651|FG001|COMPLETED|Overall Study||41
11242129|NCT02101515|12434650|FG000|NOT COMPLETED|Overall Study||0
11242130|NCT02101515|12434651|FG001|NOT COMPLETED|Overall Study||0
11242131|NCT02101554|12434660|FG000|STARTED|Overall Study||6
11242132|NCT02101554|12434661|FG001|STARTED|Overall Study||10
11242133|NCT02101554|12434662|FG002|STARTED|Overall Study||3
11242134|NCT02101554|12434660|FG000|COMPLETED|Overall Study||3
11242135|NCT02101554|12434661|FG001|COMPLETED|Overall Study||5
11242136|NCT02101554|12434662|FG002|COMPLETED|Overall Study||2
11242137|NCT02101554|12434660|FG000|NOT COMPLETED|Overall Study||3
11242138|NCT02101554|12434661|FG001|NOT COMPLETED|Overall Study||5
11242139|NCT02101554|12434662|FG002|NOT COMPLETED|Overall Study||1
11242140|NCT02101918|12434670|FG000|STARTED|Overall Study||22
11242141|NCT02101918|12434670|FG000|COMPLETED|Overall Study||22
11242142|NCT02101918|12434670|FG000|NOT COMPLETED|Overall Study||0
11242143|NCT02101983|12434676|FG000|STARTED|Overall Study||5
11242144|NCT02101983|12434677|FG001|STARTED|Overall Study||6
11242145|NCT02101983|12434676|FG000|COMPLETED|Overall Study||4
11242146|NCT02101983|12434677|FG001|COMPLETED|Overall Study||6
11242147|NCT02101983|12434676|FG000|NOT COMPLETED|Overall Study||1
11242148|NCT02101983|12434677|FG001|NOT COMPLETED|Overall Study||0
11242149|NCT02102100|12434685|FG000|STARTED|Overall Study||32
11242150|NCT02102100|12434686|FG001|STARTED|Overall Study||25
11242151|NCT02102100|12434685|FG000|COMPLETED|Overall Study||23
11242152|NCT02102100|12434686|FG001|COMPLETED|Overall Study||18
11242153|NCT02102100|12434685|FG000|NOT COMPLETED|Overall Study||9
11242154|NCT02102100|12434686|FG001|NOT COMPLETED|Overall Study||7
11242155|NCT02102204|12434692|FG000|STARTED|Overall Study||902
11242156|NCT02102204|12434692|FG000|Received Etelcalcetide|Overall Study||884
11242157|NCT02102204|12434692|FG000|COMPLETED|Overall Study||598
11242158|NCT02102204|12434692|FG000|NOT COMPLETED|Overall Study||304
11242159|NCT02102230|12434699|FG000|STARTED|Overall Study||42
11242160|NCT02102230|12434700|FG001|STARTED|Overall Study||28
11242161|NCT02102230|12434701|FG002|STARTED|Overall Study||41
11242162|NCT02102230|12434699|FG000|COMPLETED|Overall Study||25
11242163|NCT02102230|12434700|FG001|COMPLETED|Overall Study||11
11242164|NCT02102230|12434701|FG002|COMPLETED|Overall Study||24
11242165|NCT02102230|12434699|FG000|NOT COMPLETED|Overall Study||17
11242166|NCT02102230|12434700|FG001|NOT COMPLETED|Overall Study||17
11242167|NCT02102230|12434701|FG002|NOT COMPLETED|Overall Study||17
11242168|NCT02102399|12434712|FG000|STARTED|Overall Study||20
11242169|NCT02102399|12434713|FG001|STARTED|Overall Study||21
11242170|NCT02102399|12434712|FG000|COMPLETED|Overall Study||14
11242171|NCT02102399|12434713|FG001|COMPLETED|Overall Study||17
11242172|NCT02102399|12434712|FG000|NOT COMPLETED|Overall Study||6
11242173|NCT02102399|12434713|FG001|NOT COMPLETED|Overall Study||4
11242174|NCT02102464|12434726|FG000|STARTED|Randomized Study||29
11242175|NCT02102464|12434727|FG001|STARTED|Randomized Study||26
11242176|NCT02102464|12434728|FG002|STARTED|Randomized Study||0
11242177|NCT02102464|12434726|FG000|COMPLETED|Randomized Study||29
11242178|NCT02102464|12434727|FG001|COMPLETED|Randomized Study||25
11242179|NCT02102464|12434728|FG002|COMPLETED|Randomized Study||0
11242180|NCT02102464|12434726|FG000|NOT COMPLETED|Randomized Study||0
11242181|NCT02102464|12434727|FG001|NOT COMPLETED|Randomized Study||1
11242182|NCT02102464|12434728|FG002|NOT COMPLETED|Randomized Study||0
11242183|NCT02102464|12434726|FG000|STARTED|Crossover LipiFlow Treatment of Control||0
11242184|NCT02102464|12434727|FG001|STARTED|Crossover LipiFlow Treatment of Control||0
11242185|NCT02102464|12434728|FG002|STARTED|Crossover LipiFlow Treatment of Control||25
11242186|NCT02102464|12434726|FG000|COMPLETED|Crossover LipiFlow Treatment of Control||0
11242187|NCT02102464|12434727|FG001|COMPLETED|Crossover LipiFlow Treatment of Control||0
11242188|NCT02102464|12434728|FG002|COMPLETED|Crossover LipiFlow Treatment of Control||25
11242189|NCT02102464|12434726|FG000|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
11242190|NCT02102464|12434727|FG001|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
11242191|NCT02102464|12434728|FG002|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
11242192|NCT02102490|12434737|FG000|STARTED|Overall Study||132
11242193|NCT02102490|12434737|FG000|Received at Least 1 Dose of Study Drug|Overall Study||132
11242194|NCT02102490|12434737|FG000|COMPLETED|Overall Study||125
11242195|NCT02102490|12434737|FG000|NOT COMPLETED|Overall Study||7
11242196|NCT02102724|12434743|FG000|STARTED|Overall Study||18
11242197|NCT02102724|12434744|FG001|STARTED|Overall Study||19
11242198|NCT02102724|12434743|FG000|COMPLETED|Overall Study||16
11242199|NCT02102724|12434744|FG001|COMPLETED|Overall Study||18
11242200|NCT02102724|12434743|FG000|NOT COMPLETED|Overall Study||2
11242201|NCT02102724|12434744|FG001|NOT COMPLETED|Overall Study||1
11242202|NCT02102932|12434758|FG000|STARTED|Overall Study||12
11242203|NCT02102932|12434759|FG001|STARTED|Overall Study||12
11242204|NCT02102932|12434760|FG002|STARTED|Overall Study||12
11242205|NCT02102932|12434761|FG003|STARTED|Overall Study||12
11242206|NCT02102932|12434762|FG004|STARTED|Overall Study||12
11242207|NCT02102932|12434763|FG005|STARTED|Overall Study||12
11242208|NCT02102932|12434764|FG006|STARTED|Overall Study||12
11242209|NCT02102932|12434765|FG007|STARTED|Overall Study||12
11242210|NCT02102932|12434758|FG000|COMPLETED|Overall Study||12
11242211|NCT02102932|12434759|FG001|COMPLETED|Overall Study||12
11242212|NCT02102932|12434760|FG002|COMPLETED|Overall Study||12
11242213|NCT02102932|12434761|FG003|COMPLETED|Overall Study||12
11242214|NCT02102932|12434762|FG004|COMPLETED|Overall Study||12
11242215|NCT02102932|12434763|FG005|COMPLETED|Overall Study||12
11242216|NCT02102932|12434764|FG006|COMPLETED|Overall Study||12
11242217|NCT02102932|12434765|FG007|COMPLETED|Overall Study||12
11242218|NCT02102932|12434758|FG000|NOT COMPLETED|Overall Study||0
11242219|NCT02102932|12434759|FG001|NOT COMPLETED|Overall Study||0
11242220|NCT02102932|12434760|FG002|NOT COMPLETED|Overall Study||0
11242221|NCT02102932|12434761|FG003|NOT COMPLETED|Overall Study||0
11242222|NCT02102932|12434762|FG004|NOT COMPLETED|Overall Study||0
11242223|NCT02102932|12434763|FG005|NOT COMPLETED|Overall Study||0
11242224|NCT02102932|12434764|FG006|NOT COMPLETED|Overall Study||0
11242225|NCT02102932|12434765|FG007|NOT COMPLETED|Overall Study||0
11242226|NCT02103062|12434785|FG000|STARTED|Overall Study||18
11242227|NCT02103062|12434786|FG001|STARTED|Overall Study||23
11242228|NCT02103062|12434785|FG000|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
11242229|NCT02103062|12434786|FG001|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
11242230|NCT02103062|12434785|FG000|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
11242231|NCT02103062|12434786|FG001|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
11242232|NCT02103062|12434785|FG000|COMPLETED|Overall Study||0
11242233|NCT02103062|12434786|FG001|COMPLETED|Overall Study||0
11242234|NCT02103062|12434785|FG000|NOT COMPLETED|Overall Study||18
11242235|NCT02103062|12434786|FG001|NOT COMPLETED|Overall Study||23
11242236|NCT02103114|12434796|FG000|STARTED|Overall Study||20
11242237|NCT02103114|12434797|FG001|STARTED|Overall Study||20
11242238|NCT02103114|12434796|FG000|COMPLETED|Overall Study||20
11242239|NCT02103114|12434797|FG001|COMPLETED|Overall Study||19
11242240|NCT02103114|12434796|FG000|NOT COMPLETED|Overall Study||0
11242241|NCT02103114|12434797|FG001|NOT COMPLETED|Overall Study||1
11242242|NCT02103127|12434804|FG000|STARTED|Overall Study||20
11242243|NCT02103127|12434804|FG000|COMPLETED|Overall Study||17
11242244|NCT02103127|12434804|FG000|NOT COMPLETED|Overall Study||3
11242245|NCT02103153|12434808|FG000|STARTED|Overall Study||44
11242246|NCT02103153|12434808|FG000|COMPLETED|Overall Study||27
11242247|NCT02103153|12434808|FG000|NOT COMPLETED|Overall Study||17
11242248|NCT02103218|12434819|FG000|STARTED|Overall Study||51
11242249|NCT02103218|12434820|FG001|STARTED|Overall Study||59
11242250|NCT02103218|12434821|FG002|STARTED|Overall Study||48
11242251|NCT02103218|12434822|FG003|STARTED|Overall Study||54
11242252|NCT02103218|12434819|FG000|COMPLETED|Overall Study||46
11242253|NCT02103218|12434820|FG001|COMPLETED|Overall Study||51
11242254|NCT02103218|12434821|FG002|COMPLETED|Overall Study||44
11242255|NCT02103218|12434822|FG003|COMPLETED|Overall Study||47
11242256|NCT02103218|12434819|FG000|NOT COMPLETED|Overall Study||5
11242257|NCT02103218|12434820|FG001|NOT COMPLETED|Overall Study||8
11242258|NCT02103218|12434821|FG002|NOT COMPLETED|Overall Study||4
11242259|NCT02103218|12434822|FG003|NOT COMPLETED|Overall Study||7
11242260|NCT02103270|12434833|FG000|STARTED|Overall Study||60
11242261|NCT02103270|12434834|FG001|STARTED|Overall Study||35
11242262|NCT02103270|12434835|FG002|STARTED|Overall Study||25
11242263|NCT02103270|12434833|FG000|COMPLETED|Overall Study||51
11242264|NCT02103270|12434834|FG001|COMPLETED|Overall Study||29
11242265|NCT02103270|12434835|FG002|COMPLETED|Overall Study||1
11242266|NCT02103270|12434833|FG000|NOT COMPLETED|Overall Study||9
11242267|NCT02103270|12434834|FG001|NOT COMPLETED|Overall Study||6
11242268|NCT02103270|12434835|FG002|NOT COMPLETED|Overall Study||24
11242269|NCT02103309|12434846|FG000|STARTED|Overall Study||20
11242270|NCT02103309|12434847|FG001|STARTED|Overall Study||22
11242271|NCT02103309|12434846|FG000|COMPLETED|Overall Study||20
11242272|NCT02103309|12434847|FG001|COMPLETED|Overall Study||22
11242273|NCT02103309|12434846|FG000|NOT COMPLETED|Overall Study||0
11242274|NCT02103309|12434847|FG001|NOT COMPLETED|Overall Study||0
11242275|NCT02103439|12434855|FG000|STARTED|Overall Study||70
11242276|NCT02103439|12434856|FG001|STARTED|Overall Study||70
11242277|NCT02103439|12434855|FG000|COMPLETED|Overall Study||67
11242278|NCT02103439|12434856|FG001|COMPLETED|Overall Study||67
11242279|NCT02103439|12434855|FG000|NOT COMPLETED|Overall Study||3
11242280|NCT02103439|12434856|FG001|NOT COMPLETED|Overall Study||3
11242281|NCT02103478|12434873|FG000|STARTED|Overall Study||7
11242282|NCT02103478|12434874|FG001|STARTED|Overall Study||6
11242283|NCT02103478|12434875|FG002|STARTED|Overall Study||6
11242284|NCT02103478|12434876|FG003|STARTED|Overall Study||6
11242285|NCT02103478|12434877|FG004|STARTED|Overall Study||19
11242286|NCT02103478|12434878|FG005|STARTED|Overall Study||25
11242287|NCT02103478|12434879|FG006|STARTED|Overall Study||25
11242288|NCT02103478|12434880|FG007|STARTED|Overall Study||16
11242289|NCT02103478|12434881|FG008|STARTED|Overall Study||14
11242290|NCT02103478|12434873|FG000|COMPLETED|Overall Study||0
11242291|NCT02103478|12434874|FG001|COMPLETED|Overall Study||0
11242292|NCT02103478|12434875|FG002|COMPLETED|Overall Study||0
11242293|NCT02103478|12434876|FG003|COMPLETED|Overall Study||0
11242294|NCT02103478|12434877|FG004|COMPLETED|Overall Study||0
11242295|NCT02103478|12434878|FG005|COMPLETED|Overall Study||0
11242296|NCT02103478|12434879|FG006|COMPLETED|Overall Study||0
11242297|NCT02103478|12434880|FG007|COMPLETED|Overall Study||0
11242298|NCT02103478|12434881|FG008|COMPLETED|Overall Study||0
11242299|NCT02103478|12434873|FG000|NOT COMPLETED|Overall Study||7
11242300|NCT02103478|12434874|FG001|NOT COMPLETED|Overall Study||6
11242301|NCT02103478|12434875|FG002|NOT COMPLETED|Overall Study||6
11242302|NCT02103478|12434876|FG003|NOT COMPLETED|Overall Study||6
11242303|NCT02103478|12434877|FG004|NOT COMPLETED|Overall Study||19
11242304|NCT02103478|12434878|FG005|NOT COMPLETED|Overall Study||25
11242305|NCT02103478|12434879|FG006|NOT COMPLETED|Overall Study||25
11242306|NCT02103478|12434880|FG007|NOT COMPLETED|Overall Study||16
11242307|NCT02103478|12434881|FG008|NOT COMPLETED|Overall Study||14
11242308|NCT02103608|12434911|FG000|STARTED|Overall Study||17
11242309|NCT02103608|12434911|FG000|COMPLETED|Overall Study||15
11242310|NCT02103608|12434911|FG000|NOT COMPLETED|Overall Study||2
11242311|NCT02103816|12434915|FG000|STARTED|Overall Study||21
11242312|NCT02103816|12434915|FG000|COMPLETED|Overall Study||13
11242313|NCT02103816|12434915|FG000|NOT COMPLETED|Overall Study||8
11242314|NCT02103855|12434919|FG000|STARTED|Overall Study||6
11242315|NCT02103855|12434919|FG000|COMPLETED|Overall Study||4
11242316|NCT02103855|12434919|FG000|NOT COMPLETED|Overall Study||2
11242317|NCT02104141|12434923|FG000|STARTED|Overall Study||51
11242318|NCT02104141|12434923|FG000|COMPLETED|Overall Study||51
11242319|NCT02104141|12434923|FG000|NOT COMPLETED|Overall Study||0
11242320|NCT02104167|12434927|FG000|STARTED|Overall Study||110
11242321|NCT02104167|12434927|FG000|COMPLETED|Overall Study||110
11242322|NCT02104167|12434927|FG000|NOT COMPLETED|Overall Study||0
11242323|NCT02104219|12434931|FG000|STARTED|Overall Study||32
11242324|NCT02104219|12434931|FG000|COMPLETED|Overall Study||32
11242325|NCT02104219|12434931|FG000|NOT COMPLETED|Overall Study||0
11242326|NCT02104414|12434938|FG000|STARTED|Overall Study||5
11242327|NCT02104414|12434939|FG001|STARTED|Overall Study||4
11242328|NCT02104414|12434940|FG002|STARTED|Overall Study||2
11242329|NCT02104414|12434938|FG000|COMPLETED|Overall Study||5
11242330|NCT02104414|12434939|FG001|COMPLETED|Overall Study||4
11242331|NCT02104414|12434940|FG002|COMPLETED|Overall Study||2
11242332|NCT02104414|12434938|FG000|NOT COMPLETED|Overall Study||0
11242333|NCT02104414|12434939|FG001|NOT COMPLETED|Overall Study||0
11242334|NCT02104414|12434940|FG002|NOT COMPLETED|Overall Study||0
11242335|NCT02104427|12434948|FG000|STARTED|Overall Study||12
11242336|NCT02104427|12434948|FG000|COMPLETED|Overall Study||12
11242337|NCT02104427|12434948|FG000|NOT COMPLETED|Overall Study||0
11242338|NCT02104505|12434972|FG000|STARTED|First Intervention (14 Days)||12
11242339|NCT02104505|12434973|FG001|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
11242340|NCT02104505|12434972|FG000|COMPLETED|First Intervention (14 Days)||10
11242341|NCT02104505|12434973|FG001|COMPLETED|First Intervention (14 Days)||8
11242342|NCT02104505|12434972|FG000|NOT COMPLETED|First Intervention (14 Days)||2
11242343|NCT02104505|12434973|FG001|NOT COMPLETED|First Intervention (14 Days)||3
11242344|NCT02104505|12434972|FG000|STARTED|Washout (Minimum 3 Weeks)||10
11242345|NCT02104505|12434973|FG001|STARTED|Washout (Minimum 3 Weeks)||8
11242346|NCT02104505|12434972|FG000|COMPLETED|Washout (Minimum 3 Weeks)||10
11242347|NCT02104505|12434973|FG001|COMPLETED|Washout (Minimum 3 Weeks)||8
11242348|NCT02104505|12434972|FG000|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
11242349|NCT02104505|12434973|FG001|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
11242350|NCT02104505|12434972|FG000|STARTED|Second Intervention (14 Days)||10
11242351|NCT02104505|12434973|FG001|STARTED|Second Intervention (14 Days)||8
11242352|NCT02104505|12434972|FG000|COMPLETED|Second Intervention (14 Days)||8
11242353|NCT02104505|12434973|FG001|COMPLETED|Second Intervention (14 Days)||7
11242354|NCT02104505|12434972|FG000|NOT COMPLETED|Second Intervention (14 Days)||2
11242355|NCT02104505|12434973|FG001|NOT COMPLETED|Second Intervention (14 Days)||1
11242356|NCT02104557|12434980|FG000|STARTED|Overall Study||362
11242357|NCT02104557|12434980|FG000|Safety Population|Overall Study||337
11242358|NCT02104557|12434980|FG000|COMPLETED|Overall Study||185
11242359|NCT02104557|12434980|FG000|NOT COMPLETED|Overall Study||177
11242360|NCT02104583|12434989|FG000|STARTED|Overall Study||48
11242361|NCT02104583|12434990|FG001|STARTED|Overall Study||46
11242362|NCT02104583|12434991|FG002|STARTED|Overall Study||70
11242363|NCT02104583|12434992|FG003|STARTED|Overall Study||74
11242364|NCT02104583|12434993|FG004|STARTED|Overall Study||75
11242365|NCT02104583|12434989|FG000|COMPLETED|Overall Study||30
11242366|NCT02104583|12434990|FG001|COMPLETED|Overall Study||35
11242367|NCT02104583|12434991|FG002|COMPLETED|Overall Study||54
11242368|NCT02104583|12434992|FG003|COMPLETED|Overall Study||57
11242369|NCT02104583|12434993|FG004|COMPLETED|Overall Study||63
11242370|NCT02104583|12434989|FG000|NOT COMPLETED|Overall Study||18
11242371|NCT02104583|12434990|FG001|NOT COMPLETED|Overall Study||11
11242372|NCT02104583|12434991|FG002|NOT COMPLETED|Overall Study||16
11242373|NCT02104583|12434992|FG003|NOT COMPLETED|Overall Study||17
11242374|NCT02104583|12434993|FG004|NOT COMPLETED|Overall Study||12
11242375|NCT02104739|12435014|FG000|STARTED|First Intervention (1 Day)||2
11242376|NCT02104739|12435015|FG001|STARTED|First Intervention (1 Day)||5
11242377|NCT02104739|12435016|FG002|STARTED|First Intervention (1 Day)||2
11242378|NCT02104739|12435017|FG003|STARTED|First Intervention (1 Day)||8
11242379|NCT02104739|12435018|FG004|STARTED|First Intervention (1 Day)||0
11242380|NCT02104739|12435019|FG005|STARTED|First Intervention (1 Day)||3
11242381|NCT02104739|12435020|FG006|STARTED|First Intervention (1 Day)||0
11242382|NCT02104739|12435014|FG000|COMPLETED|First Intervention (1 Day)||2
11242383|NCT02104739|12435015|FG001|COMPLETED|First Intervention (1 Day)||4
11242384|NCT02104739|12435016|FG002|COMPLETED|First Intervention (1 Day)||2
11242385|NCT02104739|12435017|FG003|COMPLETED|First Intervention (1 Day)||7
11242386|NCT02104739|12435018|FG004|COMPLETED|First Intervention (1 Day)||0
11242387|NCT02104739|12435019|FG005|COMPLETED|First Intervention (1 Day)||3
11242388|NCT02104739|12435020|FG006|COMPLETED|First Intervention (1 Day)||0
11242389|NCT02104739|12435014|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11242390|NCT02104739|12435015|FG001|NOT COMPLETED|First Intervention (1 Day)||1
11242391|NCT02104739|12435016|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11242392|NCT02104739|12435017|FG003|NOT COMPLETED|First Intervention (1 Day)||1
11242393|NCT02104739|12435018|FG004|NOT COMPLETED|First Intervention (1 Day)||0
11242394|NCT02104739|12435019|FG005|NOT COMPLETED|First Intervention (1 Day)||0
11242395|NCT02104739|12435020|FG006|NOT COMPLETED|First Intervention (1 Day)||0
11242396|NCT02104739|12435014|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1
11242397|NCT02104739|12435015|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4
11242398|NCT02104739|12435016|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2
11242399|NCT02104739|12435017|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7
11242400|NCT02104739|12435018|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0
11242401|NCT02104739|12435019|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2
11242402|NCT02104739|12435020|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0
11242403|NCT02104739|12435014|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
11242404|NCT02104739|12435015|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
11242405|NCT02104739|12435016|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
11242406|NCT02104739|12435017|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
11242407|NCT02104739|12435018|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242408|NCT02104739|12435019|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
11242409|NCT02104739|12435020|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242410|NCT02104739|12435014|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242411|NCT02104739|12435015|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242412|NCT02104739|12435016|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242413|NCT02104739|12435017|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242414|NCT02104739|12435018|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242415|NCT02104739|12435019|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242416|NCT02104739|12435020|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242417|NCT02104739|12435014|FG000|STARTED|Second Intervention (1 Day)||1
11242418|NCT02104739|12435015|FG001|STARTED|Second Intervention (1 Day)||4
11242419|NCT02104739|12435016|FG002|STARTED|Second Intervention (1 Day)||2
11242420|NCT02104739|12435017|FG003|STARTED|Second Intervention (1 Day)||7
11242421|NCT02104739|12435018|FG004|STARTED|Second Intervention (1 Day)||0
11242422|NCT02104739|12435019|FG005|STARTED|Second Intervention (1 Day)||2
11242423|NCT02104739|12435020|FG006|STARTED|Second Intervention (1 Day)||0
11242424|NCT02104739|12435014|FG000|COMPLETED|Second Intervention (1 Day)||1
11242425|NCT02104739|12435015|FG001|COMPLETED|Second Intervention (1 Day)||4
11242426|NCT02104739|12435016|FG002|COMPLETED|Second Intervention (1 Day)||2
11242427|NCT02104739|12435017|FG003|COMPLETED|Second Intervention (1 Day)||7
11242428|NCT02104739|12435018|FG004|COMPLETED|Second Intervention (1 Day)||0
11242429|NCT02104739|12435019|FG005|COMPLETED|Second Intervention (1 Day)||2
11242430|NCT02104739|12435020|FG006|COMPLETED|Second Intervention (1 Day)||0
11242431|NCT02104739|12435014|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11242432|NCT02104739|12435015|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11242433|NCT02104739|12435016|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11242434|NCT02104739|12435017|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
11242435|NCT02104739|12435018|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
11242436|NCT02104739|12435019|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
11242437|NCT02104739|12435020|FG006|NOT COMPLETED|Second Intervention (1 Day)||0
11242438|NCT02104739|12435014|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1
11242439|NCT02104739|12435015|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4
11242440|NCT02104739|12435016|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2
11242441|NCT02104739|12435017|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7
11242442|NCT02104739|12435018|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0
11242443|NCT02104739|12435019|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2
11242444|NCT02104739|12435020|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0
11242445|NCT02104739|12435014|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
11242446|NCT02104739|12435015|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
11242447|NCT02104739|12435016|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
11242448|NCT02104739|12435017|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
11242449|NCT02104739|12435018|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242450|NCT02104739|12435019|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
11242451|NCT02104739|12435020|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242452|NCT02104739|12435014|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242453|NCT02104739|12435015|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242454|NCT02104739|12435016|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242455|NCT02104739|12435017|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242456|NCT02104739|12435018|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242457|NCT02104739|12435019|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242458|NCT02104739|12435020|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
11242459|NCT02104739|12435014|FG000|STARTED|Third Intervention (1 Day)||1
11242460|NCT02104739|12435015|FG001|STARTED|Third Intervention (1 Day)||4
11242461|NCT02104739|12435016|FG002|STARTED|Third Intervention (1 Day)||2
11242462|NCT02104739|12435017|FG003|STARTED|Third Intervention (1 Day)||7
11242463|NCT02104739|12435018|FG004|STARTED|Third Intervention (1 Day)||0
11242464|NCT02104739|12435019|FG005|STARTED|Third Intervention (1 Day)||2
11242465|NCT02104739|12435020|FG006|STARTED|Third Intervention (1 Day)||0
11242466|NCT02104739|12435014|FG000|COMPLETED|Third Intervention (1 Day)||1
11242467|NCT02104739|12435015|FG001|COMPLETED|Third Intervention (1 Day)||4
11242468|NCT02104739|12435016|FG002|COMPLETED|Third Intervention (1 Day)||2
11242469|NCT02104739|12435017|FG003|COMPLETED|Third Intervention (1 Day)||7
11242470|NCT02104739|12435018|FG004|COMPLETED|Third Intervention (1 Day)||0
11242471|NCT02104739|12435019|FG005|COMPLETED|Third Intervention (1 Day)||2
11242472|NCT02104739|12435020|FG006|COMPLETED|Third Intervention (1 Day)||0
11242473|NCT02104739|12435014|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11242474|NCT02104739|12435015|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11242475|NCT02104739|12435016|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
11242476|NCT02104739|12435017|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
11242477|NCT02104739|12435018|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
11242478|NCT02104739|12435019|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
11242479|NCT02104739|12435020|FG006|NOT COMPLETED|Third Intervention (1 Day)||0
11242480|NCT02104739|12435014|FG000|STARTED|Washout (Min of 10 and Max of 323 Days)||0
11242481|NCT02104739|12435015|FG001|STARTED|Washout (Min of 10 and Max of 323 Days)||0
11242482|NCT02104739|12435016|FG002|STARTED|Washout (Min of 10 and Max of 323 Days)||0
11242483|NCT02104739|12435017|FG003|STARTED|Washout (Min of 10 and Max of 323 Days)||0
11242484|NCT02104739|12435018|FG004|STARTED|Washout (Min of 10 and Max of 323 Days)||0
11242485|NCT02104739|12435019|FG005|STARTED|Washout (Min of 10 and Max of 323 Days)||0
11242486|NCT02104739|12435020|FG006|STARTED|Washout (Min of 10 and Max of 323 Days)||8
11242487|NCT02104739|12435014|FG000|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
11242488|NCT02104739|12435015|FG001|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
11242489|NCT02104739|12435016|FG002|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
11242490|NCT02104739|12435017|FG003|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
11242491|NCT02104739|12435018|FG004|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
11242492|NCT02104739|12435019|FG005|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
11242493|NCT02104739|12435020|FG006|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
11242494|NCT02104739|12435014|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
11242495|NCT02104739|12435015|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
11242496|NCT02104739|12435016|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
11242497|NCT02104739|12435017|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
11242498|NCT02104739|12435018|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
11242499|NCT02104739|12435019|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
11242500|NCT02104739|12435020|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
11242501|NCT02104739|12435014|FG000|STARTED|Extension Phase (6 Weeks)||0
11242502|NCT02104739|12435015|FG001|STARTED|Extension Phase (6 Weeks)||0
11242503|NCT02104739|12435016|FG002|STARTED|Extension Phase (6 Weeks)||0
11242504|NCT02104739|12435017|FG003|STARTED|Extension Phase (6 Weeks)||0
11242505|NCT02104739|12435018|FG004|STARTED|Extension Phase (6 Weeks)||0
11242506|NCT02104739|12435019|FG005|STARTED|Extension Phase (6 Weeks)||0
11242507|NCT02104739|12435020|FG006|STARTED|Extension Phase (6 Weeks)||8
11242508|NCT02104739|12435014|FG000|COMPLETED|Extension Phase (6 Weeks)||0
11242509|NCT02104739|12435015|FG001|COMPLETED|Extension Phase (6 Weeks)||0
11242510|NCT02104739|12435016|FG002|COMPLETED|Extension Phase (6 Weeks)||0
11242511|NCT02104739|12435017|FG003|COMPLETED|Extension Phase (6 Weeks)||0
11242512|NCT02104739|12435018|FG004|COMPLETED|Extension Phase (6 Weeks)||0
11242513|NCT02104739|12435019|FG005|COMPLETED|Extension Phase (6 Weeks)||0
11242514|NCT02104739|12435020|FG006|COMPLETED|Extension Phase (6 Weeks)||7
11242515|NCT02104739|12435014|FG000|NOT COMPLETED|Extension Phase (6 Weeks)||0
11242516|NCT02104739|12435015|FG001|NOT COMPLETED|Extension Phase (6 Weeks)||0
11242517|NCT02104739|12435016|FG002|NOT COMPLETED|Extension Phase (6 Weeks)||0
11242518|NCT02104739|12435017|FG003|NOT COMPLETED|Extension Phase (6 Weeks)||0
11242519|NCT02104739|12435018|FG004|NOT COMPLETED|Extension Phase (6 Weeks)||0
11242520|NCT02104739|12435019|FG005|NOT COMPLETED|Extension Phase (6 Weeks)||0
11242521|NCT02104739|12435020|FG006|NOT COMPLETED|Extension Phase (6 Weeks)||1
11242522|NCT02104752|12435032|FG000|STARTED|Overall Study||18
11242523|NCT02104752|12435033|FG001|STARTED|Overall Study||21
11242524|NCT02104752|12435032|FG000|COMPLETED|Overall Study||17
11242525|NCT02104752|12435033|FG001|COMPLETED|Overall Study||19
11242526|NCT02104752|12435032|FG000|NOT COMPLETED|Overall Study||1
11242527|NCT02104752|12435033|FG001|NOT COMPLETED|Overall Study||2
11242528|NCT02104765|12435046|FG000|STARTED|Overall Study||8
11242529|NCT02104765|12435047|FG001|STARTED|Overall Study||6
11242530|NCT02104765|12435048|FG002|STARTED|Overall Study||6
11242531|NCT02104765|12435049|FG003|STARTED|Overall Study||7
11242532|NCT02104765|12435050|FG004|STARTED|Overall Study||8
11242533|NCT02104765|12435051|FG005|STARTED|Overall Study||2
11242534|NCT02104765|12435052|FG006|STARTED|Overall Study||8
11242535|NCT02104765|12435046|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
11242536|NCT02104765|12435047|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
11242537|NCT02104765|12435048|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11242538|NCT02104765|12435049|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
11242539|NCT02104765|12435050|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
11242540|NCT02104765|12435051|FG005|Received at Least 1 Dose of Study Drug|Overall Study||2
11242541|NCT02104765|12435052|FG006|Received at Least 1 Dose of Study Drug|Overall Study||8
11242542|NCT02104765|12435046|FG000|COMPLETED|Overall Study||8
11242543|NCT02104765|12435047|FG001|COMPLETED|Overall Study||6
11242544|NCT02104765|12435048|FG002|COMPLETED|Overall Study||5
11242545|NCT02104765|12435049|FG003|COMPLETED|Overall Study||6
11242546|NCT02104765|12435050|FG004|COMPLETED|Overall Study||7
11242547|NCT02104765|12435051|FG005|COMPLETED|Overall Study||2
11242548|NCT02104765|12435052|FG006|COMPLETED|Overall Study||7
11242549|NCT02104765|12435046|FG000|NOT COMPLETED|Overall Study||0
11242550|NCT02104765|12435047|FG001|NOT COMPLETED|Overall Study||0
11242551|NCT02104765|12435048|FG002|NOT COMPLETED|Overall Study||1
11242552|NCT02104765|12435049|FG003|NOT COMPLETED|Overall Study||1
11242553|NCT02104765|12435050|FG004|NOT COMPLETED|Overall Study||1
11242554|NCT02104765|12435051|FG005|NOT COMPLETED|Overall Study||0
11242555|NCT02104765|12435052|FG006|NOT COMPLETED|Overall Study||1
11242556|NCT02104804|12435076|FG000|STARTED|Overall Study|Number of patients who were randomized|234
11242557|NCT02104804|12435077|FG001|STARTED|Overall Study|Number of patients who were randomized|232
11242558|NCT02104804|12435076|FG000|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
11242559|NCT02104804|12435077|FG001|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
11141848|NCT01464840|12328515|FG002|NOT COMPLETED|Overall Study||0
11141849|NCT01464879|12328523|FG000|STARTED|Overall Study||20
11141850|NCT01464879|12328523|FG000|Hand Application (2.50 mL)|Overall Study||20
11242560|NCT02104804|12435076|FG000|NOT COMPLETED|Overall Study||16
11242561|NCT02104804|12435077|FG001|NOT COMPLETED|Overall Study||19
11242562|NCT02104817|12435085|FG000|STARTED|Overall Study||6539
11242563|NCT02104817|12435086|FG001|STARTED|Overall Study||6539
11242564|NCT02104817|12435085|FG000|COMPLETED|Overall Study||80
11242565|NCT02104817|12435086|FG001|COMPLETED|Overall Study||92
11242566|NCT02104817|12435085|FG000|NOT COMPLETED|Overall Study||6459
11242567|NCT02104817|12435086|FG001|NOT COMPLETED|Overall Study||6447
11242568|NCT02104830|12435095|FG000|STARTED|Overall Study||42
11242569|NCT02104830|12435096|FG001|STARTED|Overall Study||43
11242570|NCT02104830|12435097|FG002|STARTED|Overall Study||43
11242571|NCT02104830|12435095|FG000|COMPLETED|Overall Study||38
11242572|NCT02104830|12435096|FG001|COMPLETED|Overall Study||36
11242573|NCT02104830|12435097|FG002|COMPLETED|Overall Study||36
11242574|NCT02104830|12435095|FG000|NOT COMPLETED|Overall Study||4
11242575|NCT02104830|12435096|FG001|NOT COMPLETED|Overall Study||7
11242576|NCT02104830|12435097|FG002|NOT COMPLETED|Overall Study||7
11242577|NCT02104895|12435107|FG000|STARTED|Overall Study||260
11242578|NCT02104895|12435108|FG001|STARTED|Overall Study||260
11242579|NCT02104895|12435107|FG000|COMPLETED|Overall Study||260
11242580|NCT02104895|12435108|FG001|COMPLETED|Overall Study||246
11242581|NCT02104895|12435107|FG000|NOT COMPLETED|Overall Study||0
11242582|NCT02104895|12435108|FG001|NOT COMPLETED|Overall Study||14
11242583|NCT02104947|12435116|FG000|STARTED|Overall Study||301
11242584|NCT02104947|12435117|FG001|STARTED|Overall Study||202
11242585|NCT02104947|12435116|FG000|COMPLETED|Overall Study||222
11242586|NCT02104947|12435117|FG001|COMPLETED|Overall Study||146
11242587|NCT02104947|12435116|FG000|NOT COMPLETED|Overall Study||79
11242588|NCT02104947|12435117|FG001|NOT COMPLETED|Overall Study||56
11141851|NCT01464879|12328523|FG000|Washout Period|Overall Study||20
11141852|NCT01464879|12328523|FG000|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
11141853|NCT01464879|12328523|FG000|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
11141854|NCT01464879|12328523|FG000|Applicator Application (3.75 mL)|Overall Study||18
11141855|NCT01464879|12328523|FG000|COMPLETED|Overall Study||18
11141856|NCT01464879|12328523|FG000|NOT COMPLETED|Overall Study||2
11141857|NCT01464931|12328535|FG000|STARTED|Overall Study||16
11141858|NCT01464931|12328536|FG001|STARTED|Overall Study||16
11141859|NCT01464931|12328535|FG000|COMPLETED|Overall Study||15
11141860|NCT01464931|12328536|FG001|COMPLETED|Overall Study||16
11242589|NCT02105012|12435127|FG000|STARTED|Overall Study||147
11242590|NCT02105012|12435127|FG000|BD MDI 320 µg|Overall Study||124
11242591|NCT02105012|12435127|FG000|BD MDI 160 µg|Overall Study||132
11242592|NCT02105012|12435127|FG000|BD MDI 80 µg|Overall Study||64
11242593|NCT02105012|12435127|FG000|BD MDI 40 µg|Overall Study||63
11242594|NCT02105012|12435127|FG000|Placebo MDI|Overall Study||127
11242595|NCT02105012|12435127|FG000|COMPLETED|Overall Study||114
11242596|NCT02105012|12435127|FG000|NOT COMPLETED|Overall Study||33
11242597|NCT02105246|12435141|FG000|STARTED|Overall Study||557
11242598|NCT02105246|12435142|FG001|STARTED|Overall Study||597
11242599|NCT02105246|12435141|FG000|COMPLETED|Overall Study||557
11242600|NCT02105246|12435142|FG001|COMPLETED|Overall Study||597
11242601|NCT02105246|12435141|FG000|NOT COMPLETED|Overall Study||0
11242602|NCT02105246|12435142|FG001|NOT COMPLETED|Overall Study||0
11242603|NCT02105272|12435154|FG000|STARTED|Overall Study||118
11242604|NCT02105272|12435155|FG001|STARTED|Overall Study||119
11358109|NCT03119831|12555154|FG002|NOT COMPLETED|Overall Study||0
11358110|NCT03120013|12555165|FG000|STARTED|First Intervention (2 Weeks)||10
11358111|NCT03120013|12555166|FG001|STARTED|First Intervention (2 Weeks)||11
11358112|NCT03120013|12555165|FG000|Received Intervention|First Intervention (2 Weeks)||10
11358113|NCT03120013|12555166|FG001|Received Intervention|First Intervention (2 Weeks)||11
11358114|NCT03120013|12555165|FG000|COMPLETED|First Intervention (2 Weeks)||10
11358115|NCT03120013|12555166|FG001|COMPLETED|First Intervention (2 Weeks)||10
11358116|NCT03120013|12555165|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
11358117|NCT03120013|12555166|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1
11358118|NCT03120013|12555165|FG000|STARTED|Washout (6 Months)||10
11358119|NCT03120013|12555166|FG001|STARTED|Washout (6 Months)||10
11358120|NCT03120013|12555165|FG000|COMPLETED|Washout (6 Months)||10
11358121|NCT03120013|12555166|FG001|COMPLETED|Washout (6 Months)||10
11358122|NCT03120013|12555165|FG000|NOT COMPLETED|Washout (6 Months)||0
11358123|NCT03120013|12555166|FG001|NOT COMPLETED|Washout (6 Months)||0
11358124|NCT03120013|12555165|FG000|STARTED|Second Intervention (2 Weeks)||10
11358125|NCT03120013|12555166|FG001|STARTED|Second Intervention (2 Weeks)||10
11358126|NCT03120013|12555165|FG000|COMPLETED|Second Intervention (2 Weeks)||10
11358127|NCT03120013|12555166|FG001|COMPLETED|Second Intervention (2 Weeks)||10
11358128|NCT03120013|12555165|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
11358129|NCT03120013|12555166|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
11358130|NCT03120351|12555174|FG000|STARTED|Overall Study||40
11358131|NCT03120351|12555175|FG001|STARTED|Overall Study||40
11358132|NCT03120351|12555174|FG000|COMPLETED|Overall Study||39
11358133|NCT03120351|12555175|FG001|COMPLETED|Overall Study||39
11358134|NCT03120351|12555174|FG000|NOT COMPLETED|Overall Study||1
11358135|NCT03120351|12555175|FG001|NOT COMPLETED|Overall Study||1
11358136|NCT03120520|12555185|FG000|STARTED|Overall Study||31
11358137|NCT03120520|12555186|FG001|STARTED|Overall Study||31
11358138|NCT03120520|12555187|FG002|STARTED|Overall Study||30
11358139|NCT03120520|12555188|FG003|STARTED|Overall Study||32
11358140|NCT03120520|12555185|FG000|COMPLETED|Overall Study||27
11358141|NCT03120520|12555186|FG001|COMPLETED|Overall Study||27
11358142|NCT03120520|12555187|FG002|COMPLETED|Overall Study||26
11358143|NCT03120520|12555188|FG003|COMPLETED|Overall Study||29
11358144|NCT03120520|12555185|FG000|NOT COMPLETED|Overall Study||4
11358145|NCT03120520|12555186|FG001|NOT COMPLETED|Overall Study||4
11358146|NCT03120520|12555187|FG002|NOT COMPLETED|Overall Study||4
11358147|NCT03120520|12555188|FG003|NOT COMPLETED|Overall Study||3
11358148|NCT03120832|12555201|FG000|STARTED|Overall Study||3
11358149|NCT03120832|12555202|FG001|STARTED|Overall Study||3
11358150|NCT03120832|12555203|FG002|STARTED|Overall Study||6
11358151|NCT03120832|12555201|FG000|COMPLETED|Overall Study||3
11358152|NCT03120832|12555202|FG001|COMPLETED|Overall Study||3
11358153|NCT03120832|12555203|FG002|COMPLETED|Overall Study||6
11358154|NCT03120832|12555201|FG000|NOT COMPLETED|Overall Study||0
11358155|NCT03120832|12555202|FG001|NOT COMPLETED|Overall Study||0
11358156|NCT03120832|12555203|FG002|NOT COMPLETED|Overall Study||0
11358157|NCT03121144|12555211|FG000|STARTED|Overall Study||34
11358158|NCT03121144|12555211|FG000|COMPLETED|Overall Study||34
11358159|NCT03121144|12555211|FG000|NOT COMPLETED|Overall Study||0
11358160|NCT03121365|12555217|FG000|STARTED|Baseline||55
11358161|NCT03121365|12555218|FG001|STARTED|Baseline||49
11358162|NCT03121365|12555217|FG000|COMPLETED|Baseline||54
11358163|NCT03121365|12555218|FG001|COMPLETED|Baseline||48
11358164|NCT03121365|12555217|FG000|NOT COMPLETED|Baseline||1
11358165|NCT03121365|12555218|FG001|NOT COMPLETED|Baseline||1
11358166|NCT03121365|12555217|FG000|STARTED|1 Months||54
11358167|NCT03121365|12555218|FG001|STARTED|1 Months||48
11358168|NCT03121365|12555217|FG000|COMPLETED|1 Months||52
11358169|NCT03121365|12555218|FG001|COMPLETED|1 Months||45
11358170|NCT03121365|12555217|FG000|NOT COMPLETED|1 Months||2
11358171|NCT03121365|12555218|FG001|NOT COMPLETED|1 Months||3
11358172|NCT03121365|12555217|FG000|STARTED|4 Months||54
11358173|NCT03121365|12555218|FG001|STARTED|4 Months||45
11358174|NCT03121365|12555217|FG000|COMPLETED|4 Months||51
11358175|NCT03121365|12555218|FG001|COMPLETED|4 Months||44
11358176|NCT03121365|12555217|FG000|NOT COMPLETED|4 Months||3
11358177|NCT03121365|12555218|FG001|NOT COMPLETED|4 Months||1
11358178|NCT03121365|12555217|FG000|STARTED|7 Months||54
11358179|NCT03121365|12555218|FG001|STARTED|7 Months||45
11358180|NCT03121365|12555217|FG000|COMPLETED|7 Months||44
11358181|NCT03121365|12555218|FG001|COMPLETED|7 Months||37
11358182|NCT03121365|12555217|FG000|NOT COMPLETED|7 Months||10
11358183|NCT03121365|12555218|FG001|NOT COMPLETED|7 Months||8
11358184|NCT03121612|12555228|FG000|STARTED|Overall Study||26
11242605|NCT02105272|12435154|FG000|COMPLETED|Overall Study||113
11242606|NCT02105272|12435155|FG001|COMPLETED|Overall Study||116
11242607|NCT02105272|12435154|FG000|NOT COMPLETED|Overall Study||5
11242608|NCT02105272|12435155|FG001|NOT COMPLETED|Overall Study||3
11242609|NCT02105285|12435164|FG000|STARTED|Overall Study||78
11242610|NCT02105285|12435165|FG001|STARTED|Overall Study||78
11242611|NCT02105285|12435166|FG002|STARTED|Overall Study||37
11242612|NCT02105285|12435164|FG000|COMPLETED|Overall Study||76
11242613|NCT02105285|12435165|FG001|COMPLETED|Overall Study||76
11242614|NCT02105285|12435166|FG002|COMPLETED|Overall Study||37
11242615|NCT02105285|12435164|FG000|NOT COMPLETED|Overall Study||2
11358185|NCT03121612|12555229|FG001|STARTED|Overall Study||25
11242616|NCT02105285|12435165|FG001|NOT COMPLETED|Overall Study||2
11242617|NCT02105285|12435166|FG002|NOT COMPLETED|Overall Study||0
11339006|NCT02907892|12536385|FG001|COMPLETED|Overall Study||236
11339007|NCT02907892|12536384|FG000|NOT COMPLETED|Overall Study||27
11339008|NCT02907892|12536385|FG001|NOT COMPLETED|Overall Study||40
11339009|NCT02907918|12536391|FG000|STARTED|Overall Study||26
11339010|NCT02907918|12536391|FG000|COMPLETED|Overall Study||26
11339011|NCT02907918|12536391|FG000|NOT COMPLETED|Overall Study||0
11339012|NCT02908100|12536401|FG000|STARTED|Overall Study||86
11339013|NCT02908100|12536402|FG001|STARTED|Overall Study||87
11339014|NCT02908100|12536403|FG002|STARTED|Overall Study||87
11339015|NCT02908100|12536401|FG000|COMPLETED|Overall Study||63
11339016|NCT02908100|12536402|FG001|COMPLETED|Overall Study||66
11339017|NCT02908100|12536403|FG002|COMPLETED|Overall Study||66
11339018|NCT02908100|12536401|FG000|NOT COMPLETED|Overall Study||23
11339019|NCT02908100|12536402|FG001|NOT COMPLETED|Overall Study||21
11339020|NCT02908100|12536403|FG002|NOT COMPLETED|Overall Study||21
11339021|NCT02908178|12536417|FG000|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409
11339022|NCT02908178|12536418|FG001|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106
11339023|NCT02908178|12536419|FG002|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992
11339024|NCT02908178|12536420|FG003|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784
11339025|NCT02908178|12536417|FG000|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409
11339026|NCT02908178|12536418|FG001|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718
11339027|NCT02908178|12536419|FG002|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992
11339028|NCT02908178|12536420|FG003|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965
11339029|NCT02908178|12536417|FG000|NOT COMPLETED|Overall Study||0
11339030|NCT02908178|12536418|FG001|NOT COMPLETED|Overall Study||8388
11339031|NCT02908178|12536419|FG002|NOT COMPLETED|Overall Study||0
11339032|NCT02908178|12536420|FG003|NOT COMPLETED|Overall Study||6819
11339033|NCT02908347|12536431|FG000|STARTED|Overall Study||23
11339034|NCT02908347|12536432|FG001|STARTED|Overall Study||23
11339035|NCT02908347|12536431|FG000|COMPLETED|Overall Study||22
11339036|NCT02908347|12536432|FG001|COMPLETED|Overall Study||22
11339037|NCT02908347|12536431|FG000|NOT COMPLETED|Overall Study||1
11339038|NCT02908347|12536432|FG001|NOT COMPLETED|Overall Study||1
11339039|NCT02908464|12536454|FG000|STARTED|Overall Study||22
11339040|NCT02908464|12536455|FG001|STARTED|Overall Study||23
11339041|NCT02908464|12536454|FG000|COMPLETED|Overall Study||20
11339042|NCT02908464|12536455|FG001|COMPLETED|Overall Study||20
11339043|NCT02908464|12536454|FG000|NOT COMPLETED|Overall Study||2
11339044|NCT02908464|12536455|FG001|NOT COMPLETED|Overall Study||3
11339045|NCT02908490|12536464|FG000|STARTED|Overall Study||12
11339046|NCT02908490|12536465|FG001|STARTED|Overall Study||13
11339047|NCT02908490|12536464|FG000|COMPLETED|Overall Study||10
11339048|NCT02908490|12536465|FG001|COMPLETED|Overall Study||11
11339049|NCT02908490|12536464|FG000|NOT COMPLETED|Overall Study||2
11339050|NCT02908490|12536465|FG001|NOT COMPLETED|Overall Study||2
11339051|NCT02908529|12536471|FG000|STARTED|Overall Study||10
11339052|NCT02908529|12536472|FG001|STARTED|Overall Study||12
11339053|NCT02908529|12536471|FG000|COMPLETED|Overall Study||10
11339054|NCT02908529|12536472|FG001|COMPLETED|Overall Study||10
11339055|NCT02908529|12536471|FG000|NOT COMPLETED|Overall Study||0
11339056|NCT02908529|12536472|FG001|NOT COMPLETED|Overall Study||2
11339057|NCT02908620|12536484|FG000|STARTED|Overall Study||10
11339058|NCT02908620|12536485|FG001|STARTED|Overall Study||10
11339059|NCT02908620|12536486|FG002|STARTED|Overall Study||10
11339060|NCT02908620|12536487|FG003|STARTED|Overall Study||10
11339061|NCT02908620|12536484|FG000|COMPLETED|Overall Study||10
11339062|NCT02908620|12536485|FG001|COMPLETED|Overall Study||10
11339063|NCT02908620|12536486|FG002|COMPLETED|Overall Study||10
11339064|NCT02908620|12536487|FG003|COMPLETED|Overall Study||10
11339065|NCT02908620|12536484|FG000|NOT COMPLETED|Overall Study||0
11339066|NCT02908620|12536485|FG001|NOT COMPLETED|Overall Study||0
11339067|NCT02908620|12536486|FG002|NOT COMPLETED|Overall Study||0
11339068|NCT02908620|12536487|FG003|NOT COMPLETED|Overall Study||0
11339069|NCT02908841|12536503|FG000|STARTED|Overall Study||10
11339070|NCT02908841|12536504|FG001|STARTED|Overall Study||12
11339071|NCT02908841|12536503|FG000|COMPLETED|Overall Study||6
11339072|NCT02908841|12536504|FG001|COMPLETED|Overall Study||12
11339073|NCT02908841|12536503|FG000|NOT COMPLETED|Overall Study||4
11339074|NCT02908841|12536504|FG001|NOT COMPLETED|Overall Study||0
11343931|NCT02957305|12541224|FG000|NOT COMPLETED|Overall Study||0
11343932|NCT02957305|12541225|FG001|NOT COMPLETED|Overall Study||0
11343933|NCT02957331|12541233|FG000|STARTED|Overall Study||14
11343934|NCT02957331|12541234|FG001|STARTED|Overall Study||12
11343935|NCT02957331|12541233|FG000|COMPLETED|Overall Study||13
11343936|NCT02957331|12541234|FG001|COMPLETED|Overall Study||12
11343937|NCT02957331|12541233|FG000|NOT COMPLETED|Overall Study||1
11343938|NCT02957331|12541234|FG001|NOT COMPLETED|Overall Study||0
11343939|NCT02957357|12541242|FG000|STARTED|Overall Study||10479
11343940|NCT02957357|12541243|FG001|STARTED|Overall Study||835
11343941|NCT02957357|12541242|FG000|COMPLETED|Overall Study||10479
11343942|NCT02957357|12541243|FG001|COMPLETED|Overall Study||835
11343943|NCT02957357|12541242|FG000|NOT COMPLETED|Overall Study||0
11343944|NCT02957357|12541243|FG001|NOT COMPLETED|Overall Study||0
11343945|NCT02957682|12541258|FG000|STARTED|Overall Study||1088
11343946|NCT02957682|12541259|FG001|STARTED|Overall Study||1088
11242618|NCT02105324|12435173|FG000|STARTED|Period 1||9
11242619|NCT02105324|12435174|FG001|STARTED|Period 1||10
11242620|NCT02105324|12435173|FG000|COMPLETED|Period 1||9
11242621|NCT02105324|12435174|FG001|COMPLETED|Period 1||10
11242622|NCT02105324|12435173|FG000|NOT COMPLETED|Period 1||0
11242623|NCT02105324|12435174|FG001|NOT COMPLETED|Period 1||0
11242624|NCT02105324|12435173|FG000|STARTED|Period 2||9
11242625|NCT02105324|12435174|FG001|STARTED|Period 2||10
11242626|NCT02105324|12435173|FG000|COMPLETED|Period 2||9
11242627|NCT02105324|12435174|FG001|COMPLETED|Period 2||10
11242628|NCT02105324|12435173|FG000|NOT COMPLETED|Period 2||0
11242629|NCT02105324|12435174|FG001|NOT COMPLETED|Period 2||0
11242630|NCT02105415|12435185|FG000|STARTED|Overall Study||76
11242631|NCT02105415|12435186|FG001|STARTED|Overall Study||84
11242632|NCT02105415|12435185|FG000|COMPLETED|Overall Study||73
11242633|NCT02105415|12435186|FG001|COMPLETED|Overall Study||79
11242634|NCT02105415|12435185|FG000|NOT COMPLETED|Overall Study||3
11242635|NCT02105415|12435186|FG001|NOT COMPLETED|Overall Study||5
11242636|NCT02105454|12435197|FG000|STARTED|Overall Study||79
11242637|NCT02105454|12435197|FG000|COMPLETED|Overall Study||78
11242638|NCT02105454|12435197|FG000|NOT COMPLETED|Overall Study||1
11242639|NCT02105467|12435203|FG000|STARTED|Period 1||316
11242640|NCT02105467|12435204|FG001|STARTED|Period 1||105
11242641|NCT02105467|12435203|FG000|COMPLETED|Period 1||314
11242642|NCT02105467|12435204|FG001|COMPLETED|Period 1||105
11242643|NCT02105467|12435203|FG000|NOT COMPLETED|Period 1||2
11242644|NCT02105467|12435204|FG001|NOT COMPLETED|Period 1||0
11242645|NCT02105467|12435203|FG000|STARTED|Period 2||314
11242646|NCT02105467|12435204|FG001|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
11242647|NCT02105467|12435203|FG000|COMPLETED|Period 2||312
11242648|NCT02105467|12435204|FG001|COMPLETED|Period 2||102
11242649|NCT02105467|12435203|FG000|NOT COMPLETED|Period 2||2
11242650|NCT02105467|12435204|FG001|NOT COMPLETED|Period 2||2
11242651|NCT02105467|12435203|FG000|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
11242652|NCT02105467|12435204|FG001|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
11242653|NCT02105467|12435203|FG000|COMPLETED|Period 3||0
11242654|NCT02105467|12435204|FG001|COMPLETED|Period 3||102
11242655|NCT02105467|12435203|FG000|NOT COMPLETED|Period 3||0
11242656|NCT02105467|12435204|FG001|NOT COMPLETED|Period 3||1
11242657|NCT02105558|12435213|FG000|STARTED|Overall Study||15
11242658|NCT02105558|12435214|FG001|STARTED|Overall Study||28
11242659|NCT02105558|12435213|FG000|COMPLETED|Overall Study||15
11242660|NCT02105558|12435214|FG001|COMPLETED|Overall Study||28
11242661|NCT02105558|12435213|FG000|NOT COMPLETED|Overall Study||0
11242662|NCT02105558|12435214|FG001|NOT COMPLETED|Overall Study||0
11242663|NCT02105662|12435220|FG000|STARTED|Overall Study||218
11242664|NCT02105662|12435220|FG000|COMPLETED|Overall Study||212
11242665|NCT02105662|12435220|FG000|NOT COMPLETED|Overall Study||6
11242666|NCT02105688|12435226|FG000|STARTED|Part A: Double-Blind||201
11242667|NCT02105688|12435227|FG001|STARTED|Part A: Double-Blind||100
11242668|NCT02105688|12435226|FG000|COMPLETED|Part A: Double-Blind|Completed Part A|181
11242669|NCT02105688|12435227|FG001|COMPLETED|Part A: Double-Blind|Completed Part A|83
11242670|NCT02105688|12435226|FG000|NOT COMPLETED|Part A: Double-Blind||20
11242671|NCT02105688|12435227|FG001|NOT COMPLETED|Part A: Double-Blind||17
11242672|NCT02105688|12435226|FG000|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|131
11242673|NCT02105688|12435227|FG001|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|68
11242674|NCT02105688|12435226|FG000|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|94
11242675|NCT02105688|12435227|FG001|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|48
11242676|NCT02105688|12435226|FG000|NOT COMPLETED|Part B: Observational Follow-up||37
11242677|NCT02105688|12435227|FG001|NOT COMPLETED|Part B: Observational Follow-up||20
11242678|NCT02105701|12435238|FG000|STARTED|Overall Study||105
11242679|NCT02105701|12435239|FG001|STARTED|Overall Study||104
11242680|NCT02105701|12435240|FG002|STARTED|Overall Study||105
11242681|NCT02105701|12435241|FG003|STARTED|Overall Study||106
11242682|NCT02105701|12435238|FG000|COMPLETED|Overall Study||101
11242683|NCT02105701|12435239|FG001|COMPLETED|Overall Study||103
11242684|NCT02105701|12435240|FG002|COMPLETED|Overall Study||102
11242685|NCT02105701|12435241|FG003|COMPLETED|Overall Study||104
11242686|NCT02105701|12435238|FG000|NOT COMPLETED|Overall Study||4
11242687|NCT02105701|12435239|FG001|NOT COMPLETED|Overall Study||1
11242688|NCT02105701|12435240|FG002|NOT COMPLETED|Overall Study||3
11242689|NCT02105701|12435241|FG003|NOT COMPLETED|Overall Study||2
11242690|NCT02105740|12435253|FG000|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
11242691|NCT02105740|12435254|FG001|STARTED|Overall Study|Application of EVA and HADS scales|12
11242692|NCT02105740|12435253|FG000|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
11242693|NCT02105740|12435254|FG001|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
11242694|NCT02105740|12435253|FG000|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
11242695|NCT02105740|12435254|FG001|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
11242696|NCT02105740|12435253|FG000|NOT COMPLETED|Overall Study||0
11242697|NCT02105740|12435254|FG001|NOT COMPLETED|Overall Study||1
11242698|NCT02105948|12435266|FG000|STARTED|Overall Study||229
11242699|NCT02105948|12435267|FG001|STARTED|Overall Study||233
11242700|NCT02105948|12435268|FG002|STARTED|Overall Study||190
11242701|NCT02105948|12435269|FG003|STARTED|Overall Study||184
11242702|NCT02105948|12435266|FG000|Completed Investigational Product (IP)|Overall Study||185
11242703|NCT02105948|12435267|FG001|Completed Investigational Product (IP)|Overall Study||203
11242704|NCT02105948|12435268|FG002|Completed Investigational Product (IP)|Overall Study||148
11242705|NCT02105948|12435269|FG003|Completed Investigational Product (IP)|Overall Study||149
11242706|NCT02105948|12435266|FG000|Not Completed IP|Overall Study||44
11242707|NCT02105948|12435267|FG001|Not Completed IP|Overall Study||30
11242708|NCT02105948|12435268|FG002|Not Completed IP|Overall Study||42
11242709|NCT02105948|12435269|FG003|Not Completed IP|Overall Study||35
11242710|NCT02105948|12435266|FG000|Withdrew IP Due to: Adverse Event|Overall Study||20
11242711|NCT02105948|12435267|FG001|Withdrew IP Due to: Adverse Event|Overall Study||16
11242712|NCT02105948|12435268|FG002|Withdrew IP Due to: Adverse Event|Overall Study||15
11242713|NCT02105948|12435269|FG003|Withdrew IP Due to: Adverse Event|Overall Study||13
11242714|NCT02105948|12435266|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
11242715|NCT02105948|12435267|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
11242716|NCT02105948|12435268|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
11242717|NCT02105948|12435269|FG003|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
11242718|NCT02105948|12435266|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||1
11242719|NCT02105948|12435267|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||3
11242720|NCT02105948|12435268|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||3
11242721|NCT02105948|12435269|FG003|Withdrew IP Due to: Protocol Deviation|Overall Study||0
11242722|NCT02105948|12435266|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
11242723|NCT02105948|12435267|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
11242724|NCT02105948|12435268|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
11242725|NCT02105948|12435269|FG003|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
11242726|NCT02105948|12435266|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
11242727|NCT02105948|12435267|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
11242728|NCT02105948|12435268|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
11242729|NCT02105948|12435269|FG003|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
11242730|NCT02105948|12435266|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2
11242731|NCT02105948|12435267|FG001|Withdrew IP Due to: Physician Decision|Overall Study||1
11242732|NCT02105948|12435268|FG002|Withdrew IP Due to: Physician Decision|Overall Study||4
11242733|NCT02105948|12435269|FG003|Withdrew IP Due to: Physician Decision|Overall Study||2
11242734|NCT02105948|12435266|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||0
11242735|NCT02105948|12435267|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||0
11242736|NCT02105948|12435268|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0
11242737|NCT02105948|12435269|FG003|Withdrew IP Due to: Stopping Criteria|Overall Study||1
11242738|NCT02105948|12435266|FG000|COMPLETED|Overall Study||202
11242739|NCT02105948|12435267|FG001|COMPLETED|Overall Study||213
11242740|NCT02105948|12435268|FG002|COMPLETED|Overall Study||162
11242741|NCT02105948|12435269|FG003|COMPLETED|Overall Study||157
11242742|NCT02105948|12435266|FG000|NOT COMPLETED|Overall Study||27
11242743|NCT02105948|12435267|FG001|NOT COMPLETED|Overall Study||20
11242744|NCT02105948|12435268|FG002|NOT COMPLETED|Overall Study||28
11242745|NCT02105948|12435269|FG003|NOT COMPLETED|Overall Study||27
11242746|NCT02105961|12435283|FG000|STARTED|Overall Study||226
11242747|NCT02105961|12435284|FG001|STARTED|Overall Study||223
11242748|NCT02105961|12435285|FG002|STARTED|Overall Study||225
11242749|NCT02105961|12435283|FG000|Completed Investigational Product (IP)|Overall Study||170
11242750|NCT02105961|12435284|FG001|Completed Investigational Product (IP)|Overall Study||196
11242751|NCT02105961|12435285|FG002|Completed Investigational Product (IP)|Overall Study||183
11242752|NCT02105961|12435283|FG000|Not Completed IP|Overall Study||56
11242753|NCT02105961|12435284|FG001|Not Completed IP|Overall Study||27
11242754|NCT02105961|12435285|FG002|Not Completed IP|Overall Study||42
11242755|NCT02105961|12435283|FG000|Withdrew IP Due to: Adverse Event|Overall Study||27
11242756|NCT02105961|12435284|FG001|Withdrew IP Due to: Adverse Event|Overall Study||9
11242757|NCT02105961|12435285|FG002|Withdrew IP Due to: Adverse Event|Overall Study||25
11242758|NCT02105961|12435283|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||1
11242759|NCT02105961|12435284|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||1
11242760|NCT02105961|12435285|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0
11242761|NCT02105961|12435283|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
11242762|NCT02105961|12435284|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
11242763|NCT02105961|12435285|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
11242764|NCT02105961|12435283|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||2
11242765|NCT02105961|12435284|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||0
11242766|NCT02105961|12435285|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||1
11242767|NCT02105961|12435283|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
11242768|NCT02105961|12435284|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
11242769|NCT02105961|12435285|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
11242770|NCT02105961|12435283|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2
11242771|NCT02105961|12435284|FG001|Withdrew IP Due to: Physician Decision|Overall Study||3
11242772|NCT02105961|12435285|FG002|Withdrew IP Due to: Physician Decision|Overall Study||1
11242773|NCT02105961|12435283|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
11242774|NCT02105961|12435284|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
11242775|NCT02105961|12435285|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
11242776|NCT02105961|12435283|FG000|Withdrew IP Due to: Site Closed|Overall Study||1
11242777|NCT02105961|12435284|FG001|Withdrew IP Due to: Site Closed|Overall Study||0
11242778|NCT02105961|12435285|FG002|Withdrew IP Due to: Site Closed|Overall Study||1
11242779|NCT02105961|12435283|FG000|COMPLETED|Overall Study||185
11242780|NCT02105961|12435284|FG001|COMPLETED|Overall Study||206
11242781|NCT02105961|12435285|FG002|COMPLETED|Overall Study||195
11242782|NCT02105961|12435283|FG000|NOT COMPLETED|Overall Study||41
11242783|NCT02105961|12435284|FG001|NOT COMPLETED|Overall Study||17
11242784|NCT02105961|12435285|FG002|NOT COMPLETED|Overall Study||30
11242785|NCT02105974|12435296|FG000|STARTED|2 Week Run-in Period||2423
11242786|NCT02105974|12435297|FG001|STARTED|2 Week Run-in Period||0
11242787|NCT02105974|12435298|FG002|STARTED|2 Week Run-in Period||0
11242788|NCT02105974|12435296|FG000|COMPLETED|2 Week Run-in Period||1622
11242789|NCT02105974|12435297|FG001|COMPLETED|2 Week Run-in Period||0
11242790|NCT02105974|12435298|FG002|COMPLETED|2 Week Run-in Period||0
11242791|NCT02105974|12435296|FG000|NOT COMPLETED|2 Week Run-in Period||801
11242792|NCT02105974|12435297|FG001|NOT COMPLETED|2 Week Run-in Period||0
11242793|NCT02105974|12435298|FG002|NOT COMPLETED|2 Week Run-in Period||0
11242794|NCT02105974|12435296|FG000|STARTED|12 Week (Wk) Treatment Period (TP)||0
11242795|NCT02105974|12435297|FG001|STARTED|12 Week (Wk) Treatment Period (TP)||806
11242796|NCT02105974|12435298|FG002|STARTED|12 Week (Wk) Treatment Period (TP)||814
11242797|NCT02105974|12435296|FG000|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
11242798|NCT02105974|12435297|FG001|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
11242799|NCT02105974|12435298|FG002|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
11242800|NCT02105974|12435296|FG000|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
11242801|NCT02105974|12435297|FG001|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
11242802|NCT02105974|12435298|FG002|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
11242803|NCT02105974|12435296|FG000|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
11242804|NCT02105974|12435297|FG001|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
11242805|NCT02105974|12435298|FG002|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
11242806|NCT02105987|12435306|FG000|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
11242807|NCT02105987|12435307|FG001|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
11242808|NCT02105987|12435308|FG002|STARTED|Early Switch Phase (24 Weeks)||0
11242809|NCT02105987|12435309|FG003|STARTED|Early Switch Phase (24 Weeks)||0
11242810|NCT02105987|12435310|FG004|STARTED|Early Switch Phase (24 Weeks)||0
11242811|NCT02105987|12435311|FG005|STARTED|Early Switch Phase (24 Weeks)||0
11242812|NCT02105987|12435306|FG000|COMPLETED|Early Switch Phase (24 Weeks)||239
11242813|NCT02105987|12435307|FG001|COMPLETED|Early Switch Phase (24 Weeks)||244
11242814|NCT02105987|12435308|FG002|COMPLETED|Early Switch Phase (24 Weeks)||0
11242815|NCT02105987|12435309|FG003|COMPLETED|Early Switch Phase (24 Weeks)||0
11242816|NCT02105987|12435310|FG004|COMPLETED|Early Switch Phase (24 Weeks)||0
11242817|NCT02105987|12435311|FG005|COMPLETED|Early Switch Phase (24 Weeks)||0
11242818|NCT02105987|12435306|FG000|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
11242819|NCT02105987|12435307|FG001|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
11242820|NCT02105987|12435308|FG002|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
11242821|NCT02105987|12435309|FG003|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
11242822|NCT02105987|12435310|FG004|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
11242823|NCT02105987|12435311|FG005|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
11242824|NCT02105987|12435306|FG000|STARTED|Late Switch Phase (24 Weeks)||0
11242825|NCT02105987|12435307|FG001|STARTED|Late Switch Phase (24 Weeks)||0
11242826|NCT02105987|12435308|FG002|STARTED|Late Switch Phase (24 Weeks)||275
11242827|NCT02105987|12435309|FG003|STARTED|Late Switch Phase (24 Weeks)||244
11242828|NCT02105987|12435310|FG004|STARTED|Late Switch Phase (24 Weeks)||0
11242829|NCT02105987|12435311|FG005|STARTED|Late Switch Phase (24 Weeks)||0
11242830|NCT02105987|12435306|FG000|COMPLETED|Late Switch Phase (24 Weeks)||0
11242831|NCT02105987|12435307|FG001|COMPLETED|Late Switch Phase (24 Weeks)||0
11242832|NCT02105987|12435308|FG002|COMPLETED|Late Switch Phase (24 Weeks)||230
11242833|NCT02105987|12435309|FG003|COMPLETED|Late Switch Phase (24 Weeks)||230
11242834|NCT02105987|12435310|FG004|COMPLETED|Late Switch Phase (24 Weeks)||0
11242835|NCT02105987|12435311|FG005|COMPLETED|Late Switch Phase (24 Weeks)||0
11242836|NCT02105987|12435306|FG000|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
11242837|NCT02105987|12435307|FG001|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
11242838|NCT02105987|12435308|FG002|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
11242839|NCT02105987|12435309|FG003|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
11242840|NCT02105987|12435310|FG004|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
11242841|NCT02105987|12435311|FG005|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
11242842|NCT02105987|12435306|FG000|STARTED|Continuation Phase||0
11242843|NCT02105987|12435307|FG001|STARTED|Continuation Phase||0
11242844|NCT02105987|12435308|FG002|STARTED|Continuation Phase||0
11242845|NCT02105987|12435309|FG003|STARTED|Continuation Phase||0
11242846|NCT02105987|12435310|FG004|STARTED|Continuation Phase||14
11242847|NCT02105987|12435311|FG005|STARTED|Continuation Phase||23
11242848|NCT02105987|12435306|FG000|COMPLETED|Continuation Phase||0
11242849|NCT02105987|12435307|FG001|COMPLETED|Continuation Phase||0
11242850|NCT02105987|12435308|FG002|COMPLETED|Continuation Phase||0
11242851|NCT02105987|12435309|FG003|COMPLETED|Continuation Phase||0
11242852|NCT02105987|12435310|FG004|COMPLETED|Continuation Phase||13
11242853|NCT02105987|12435311|FG005|COMPLETED|Continuation Phase||23
11242854|NCT02105987|12435306|FG000|NOT COMPLETED|Continuation Phase||0
11242855|NCT02105987|12435307|FG001|NOT COMPLETED|Continuation Phase||0
11242856|NCT02105987|12435308|FG002|NOT COMPLETED|Continuation Phase||0
11242857|NCT02105987|12435309|FG003|NOT COMPLETED|Continuation Phase||0
11242858|NCT02105987|12435310|FG004|NOT COMPLETED|Continuation Phase||1
11242859|NCT02105987|12435311|FG005|NOT COMPLETED|Continuation Phase||0
11242860|NCT02106065|12435320|FG000|STARTED|Overall Study||6
11242861|NCT02106065|12435321|FG001|STARTED|Overall Study||11
11242862|NCT02106065|12435322|FG002|STARTED|Overall Study||15
11242863|NCT02106065|12435320|FG000|6 Month Completion|Overall Study||3
11242864|NCT02106065|12435321|FG001|6 Month Completion|Overall Study||8
11242865|NCT02106065|12435322|FG002|6 Month Completion|Overall Study||5
11242866|NCT02106065|12435320|FG000|COMPLETED|Overall Study||3
11242867|NCT02106065|12435321|FG001|COMPLETED|Overall Study||8
11242868|NCT02106065|12435322|FG002|COMPLETED|Overall Study||5
11242869|NCT02106065|12435320|FG000|NOT COMPLETED|Overall Study||3
11242870|NCT02106065|12435321|FG001|NOT COMPLETED|Overall Study||3
11242871|NCT02106065|12435322|FG002|NOT COMPLETED|Overall Study||10
11242872|NCT02106156|12435333|FG000|STARTED|Overall Study||9620
11242873|NCT02106156|12435334|FG001|STARTED|Overall Study||90
11242874|NCT02106156|12435335|FG002|STARTED|Overall Study||518
11242875|NCT02106156|12435333|FG000|COMPLETED|Overall Study||7071
11242876|NCT02106156|12435334|FG001|COMPLETED|Overall Study||50
11242877|NCT02106156|12435335|FG002|COMPLETED|Overall Study||518
11242878|NCT02106156|12435333|FG000|NOT COMPLETED|Overall Study||2549
11242879|NCT02106156|12435334|FG001|NOT COMPLETED|Overall Study||40
11242880|NCT02106156|12435335|FG002|NOT COMPLETED|Overall Study||0
11242881|NCT02106325|12435344|FG000|STARTED|Phase 1||5
11242882|NCT02106325|12435345|FG001|STARTED|Phase 1||3
11242883|NCT02106325|12435344|FG000|COMPLETED|Phase 1||3
11242884|NCT02106325|12435345|FG001|COMPLETED|Phase 1||1
11242885|NCT02106325|12435344|FG000|NOT COMPLETED|Phase 1||2
11242886|NCT02106325|12435345|FG001|NOT COMPLETED|Phase 1||2
11242887|NCT02106325|12435344|FG000|STARTED|Phase 2||4
11242888|NCT02106325|12435345|FG001|STARTED|Phase 2||4
11242889|NCT02106325|12435344|FG000|COMPLETED|Phase 2||2
11242890|NCT02106325|12435345|FG001|COMPLETED|Phase 2||1
11242891|NCT02106325|12435344|FG000|NOT COMPLETED|Phase 2||2
11242892|NCT02106325|12435345|FG001|NOT COMPLETED|Phase 2||3
11242893|NCT02106325|12435344|FG000|STARTED|Phase 3||2
11242894|NCT02106325|12435345|FG001|STARTED|Phase 3||3
11242895|NCT02106325|12435344|FG000|COMPLETED|Phase 3||0
11242896|NCT02106325|12435345|FG001|COMPLETED|Phase 3||2
11242897|NCT02106325|12435344|FG000|NOT COMPLETED|Phase 3||2
11242898|NCT02106325|12435345|FG001|NOT COMPLETED|Phase 3||1
11242899|NCT02106390|12435354|FG000|STARTED|Overall Study||252
11242900|NCT02106390|12435355|FG001|STARTED|Overall Study||250
11242901|NCT02106390|12435356|FG002|STARTED|Overall Study||248
11242902|NCT02106390|12435354|FG000|COMPLETED|Overall Study||203
11242903|NCT02106390|12435355|FG001|COMPLETED|Overall Study||202
11242904|NCT02106390|12435356|FG002|COMPLETED|Overall Study||205
11242905|NCT02106390|12435354|FG000|NOT COMPLETED|Overall Study||49
11242906|NCT02106390|12435355|FG001|NOT COMPLETED|Overall Study||48
11242907|NCT02106390|12435356|FG002|NOT COMPLETED|Overall Study||43
11242908|NCT02106403|12435367|FG000|STARTED|Visit 1, Treatment Period 1||8
11242909|NCT02106403|12435368|FG001|STARTED|Visit 1, Treatment Period 1||8
11242910|NCT02106403|12435369|FG002|STARTED|Visit 1, Treatment Period 1||9
11242911|NCT02106403|12435370|FG003|STARTED|Visit 1, Treatment Period 1||8
11242912|NCT02106403|12435371|FG004|STARTED|Visit 1, Treatment Period 1||8
11242913|NCT02106403|12435372|FG005|STARTED|Visit 1, Treatment Period 1||9
11242914|NCT02106403|12435367|FG000|COMPLETED|Visit 1, Treatment Period 1||8
11242915|NCT02106403|12435368|FG001|COMPLETED|Visit 1, Treatment Period 1||8
11242916|NCT02106403|12435369|FG002|COMPLETED|Visit 1, Treatment Period 1||9
11242917|NCT02106403|12435370|FG003|COMPLETED|Visit 1, Treatment Period 1||8
11242918|NCT02106403|12435371|FG004|COMPLETED|Visit 1, Treatment Period 1||8
11242919|NCT02106403|12435372|FG005|COMPLETED|Visit 1, Treatment Period 1||9
11242920|NCT02106403|12435367|FG000|NOT COMPLETED|Visit 1, Treatment Period 1||0
11242921|NCT02106403|12435368|FG001|NOT COMPLETED|Visit 1, Treatment Period 1||0
11242922|NCT02106403|12435369|FG002|NOT COMPLETED|Visit 1, Treatment Period 1||0
11242923|NCT02106403|12435370|FG003|NOT COMPLETED|Visit 1, Treatment Period 1||0
11242924|NCT02106403|12435371|FG004|NOT COMPLETED|Visit 1, Treatment Period 1||0
11242925|NCT02106403|12435372|FG005|NOT COMPLETED|Visit 1, Treatment Period 1||0
11242926|NCT02106403|12435367|FG000|STARTED|Visit 1, Treatment Period 2||8
11242927|NCT02106403|12435368|FG001|STARTED|Visit 1, Treatment Period 2||8
11242928|NCT02106403|12435369|FG002|STARTED|Visit 1, Treatment Period 2||9
11242929|NCT02106403|12435370|FG003|STARTED|Visit 1, Treatment Period 2||8
11242930|NCT02106403|12435371|FG004|STARTED|Visit 1, Treatment Period 2||8
11242931|NCT02106403|12435372|FG005|STARTED|Visit 1, Treatment Period 2||9
11242932|NCT02106403|12435367|FG000|COMPLETED|Visit 1, Treatment Period 2||8
11242933|NCT02106403|12435368|FG001|COMPLETED|Visit 1, Treatment Period 2||8
11242934|NCT02106403|12435369|FG002|COMPLETED|Visit 1, Treatment Period 2||9
11242935|NCT02106403|12435370|FG003|COMPLETED|Visit 1, Treatment Period 2||8
11242936|NCT02106403|12435371|FG004|COMPLETED|Visit 1, Treatment Period 2||8
11242937|NCT02106403|12435372|FG005|COMPLETED|Visit 1, Treatment Period 2||9
11242938|NCT02106403|12435367|FG000|NOT COMPLETED|Visit 1, Treatment Period 2||0
11242939|NCT02106403|12435368|FG001|NOT COMPLETED|Visit 1, Treatment Period 2||0
11242940|NCT02106403|12435369|FG002|NOT COMPLETED|Visit 1, Treatment Period 2||0
11242941|NCT02106403|12435370|FG003|NOT COMPLETED|Visit 1, Treatment Period 2||0
11242942|NCT02106403|12435371|FG004|NOT COMPLETED|Visit 1, Treatment Period 2||0
11242943|NCT02106403|12435372|FG005|NOT COMPLETED|Visit 1, Treatment Period 2||0
11242944|NCT02106403|12435367|FG000|STARTED|Visit 1, Treatment Period 3||8
11242945|NCT02106403|12435368|FG001|STARTED|Visit 1, Treatment Period 3||8
11242946|NCT02106403|12435369|FG002|STARTED|Visit 1, Treatment Period 3||9
11242947|NCT02106403|12435370|FG003|STARTED|Visit 1, Treatment Period 3||8
11242948|NCT02106403|12435371|FG004|STARTED|Visit 1, Treatment Period 3||8
11242949|NCT02106403|12435372|FG005|STARTED|Visit 1, Treatment Period 3||9
11242950|NCT02106403|12435367|FG000|COMPLETED|Visit 1, Treatment Period 3||8
11242951|NCT02106403|12435368|FG001|COMPLETED|Visit 1, Treatment Period 3||8
11242952|NCT02106403|12435369|FG002|COMPLETED|Visit 1, Treatment Period 3||9
11242953|NCT02106403|12435370|FG003|COMPLETED|Visit 1, Treatment Period 3||8
11242954|NCT02106403|12435371|FG004|COMPLETED|Visit 1, Treatment Period 3||8
11242955|NCT02106403|12435372|FG005|COMPLETED|Visit 1, Treatment Period 3||9
11242956|NCT02106403|12435367|FG000|NOT COMPLETED|Visit 1, Treatment Period 3||0
11242957|NCT02106403|12435368|FG001|NOT COMPLETED|Visit 1, Treatment Period 3||0
11242958|NCT02106403|12435369|FG002|NOT COMPLETED|Visit 1, Treatment Period 3||0
11242959|NCT02106403|12435370|FG003|NOT COMPLETED|Visit 1, Treatment Period 3||0
11242960|NCT02106403|12435371|FG004|NOT COMPLETED|Visit 1, Treatment Period 3||0
11242961|NCT02106403|12435372|FG005|NOT COMPLETED|Visit 1, Treatment Period 3||0
11242962|NCT02106403|12435367|FG000|STARTED|Follow-Up Visit 2||8
11242963|NCT02106403|12435368|FG001|STARTED|Follow-Up Visit 2||8
11242964|NCT02106403|12435369|FG002|STARTED|Follow-Up Visit 2||9
11242965|NCT02106403|12435370|FG003|STARTED|Follow-Up Visit 2||8
11242966|NCT02106403|12435371|FG004|STARTED|Follow-Up Visit 2||8
11242967|NCT02106403|12435372|FG005|STARTED|Follow-Up Visit 2||9
11242968|NCT02106403|12435367|FG000|COMPLETED|Follow-Up Visit 2||8
11242969|NCT02106403|12435368|FG001|COMPLETED|Follow-Up Visit 2||8
11242970|NCT02106403|12435369|FG002|COMPLETED|Follow-Up Visit 2||9
11242971|NCT02106403|12435370|FG003|COMPLETED|Follow-Up Visit 2||8
11242972|NCT02106403|12435371|FG004|COMPLETED|Follow-Up Visit 2||8
11242973|NCT02106403|12435372|FG005|COMPLETED|Follow-Up Visit 2||9
11242974|NCT02106403|12435367|FG000|NOT COMPLETED|Follow-Up Visit 2||0
11242975|NCT02106403|12435368|FG001|NOT COMPLETED|Follow-Up Visit 2||0
11242976|NCT02106403|12435369|FG002|NOT COMPLETED|Follow-Up Visit 2||0
11242977|NCT02106403|12435370|FG003|NOT COMPLETED|Follow-Up Visit 2||0
11242978|NCT02106403|12435371|FG004|NOT COMPLETED|Follow-Up Visit 2||0
11242979|NCT02106403|12435372|FG005|NOT COMPLETED|Follow-Up Visit 2||0
11242980|NCT02106403|12435367|FG000|STARTED|Follow-Up Visit 3||8
11242981|NCT02106403|12435368|FG001|STARTED|Follow-Up Visit 3||8
11242982|NCT02106403|12435369|FG002|STARTED|Follow-Up Visit 3||9
11242983|NCT02106403|12435370|FG003|STARTED|Follow-Up Visit 3||8
11242984|NCT02106403|12435371|FG004|STARTED|Follow-Up Visit 3||8
11242985|NCT02106403|12435372|FG005|STARTED|Follow-Up Visit 3||9
11242986|NCT02106403|12435367|FG000|COMPLETED|Follow-Up Visit 3||8
11242987|NCT02106403|12435368|FG001|COMPLETED|Follow-Up Visit 3||8
11242988|NCT02106403|12435369|FG002|COMPLETED|Follow-Up Visit 3||9
11242989|NCT02106403|12435370|FG003|COMPLETED|Follow-Up Visit 3||8
11242990|NCT02106403|12435371|FG004|COMPLETED|Follow-Up Visit 3||8
11242991|NCT02106403|12435372|FG005|COMPLETED|Follow-Up Visit 3||8
11242992|NCT02106403|12435367|FG000|NOT COMPLETED|Follow-Up Visit 3||0
11242993|NCT02106403|12435368|FG001|NOT COMPLETED|Follow-Up Visit 3||0
11242994|NCT02106403|12435369|FG002|NOT COMPLETED|Follow-Up Visit 3||0
11242995|NCT02106403|12435370|FG003|NOT COMPLETED|Follow-Up Visit 3||0
11242996|NCT02106403|12435371|FG004|NOT COMPLETED|Follow-Up Visit 3||0
11242997|NCT02106403|12435372|FG005|NOT COMPLETED|Follow-Up Visit 3||1
11242998|NCT02106442|12435382|FG000|STARTED|Overall Study||579
11242999|NCT02106442|12435382|FG000|COMPLETED|Overall Study||542
11243000|NCT02106442|12435382|FG000|NOT COMPLETED|Overall Study||37
11243001|NCT02106455|12435386|FG000|STARTED|Overall Study||315
11243002|NCT02106455|12435386|FG000|COMPLETED|Overall Study||307
11243003|NCT02106455|12435386|FG000|NOT COMPLETED|Overall Study||8
11243004|NCT02106494|12435392|FG000|STARTED|Overall Study||471
11243005|NCT02106494|12435393|FG001|STARTED|Overall Study||471
11243006|NCT02106494|12435392|FG000|Safety Population|Overall Study||456
11243007|NCT02106494|12435393|FG001|Safety Population|Overall Study||459
11243008|NCT02106494|12435392|FG000|Efficacy Population|Overall Study||450
11243009|NCT02106494|12435393|FG001|Efficacy Population|Overall Study||452
11243010|NCT02106494|12435392|FG000|COMPLETED|Overall Study||445
11243011|NCT02106494|12435393|FG001|COMPLETED|Overall Study||446
11243012|NCT02106494|12435392|FG000|NOT COMPLETED|Overall Study||26
11243013|NCT02106494|12435393|FG001|NOT COMPLETED|Overall Study||25
11243014|NCT02106728|12435403|FG000|STARTED|Overall Study||70
11243015|NCT02106728|12435404|FG001|STARTED|Overall Study||47
11243016|NCT02106728|12435403|FG000|COMPLETED|Overall Study||70
11243017|NCT02106728|12435404|FG001|COMPLETED|Overall Study||47
11243018|NCT02106728|12435403|FG000|NOT COMPLETED|Overall Study||0
11243019|NCT02106728|12435404|FG001|NOT COMPLETED|Overall Study||0
11243020|NCT02106832|12435420|FG000|STARTED|Overall Study||171
11243021|NCT02106832|12435421|FG001|STARTED|Overall Study||176
11243022|NCT02106832|12435422|FG002|STARTED|Overall Study||86
11243023|NCT02106832|12435423|FG003|STARTED|Overall Study||88
11243024|NCT02106832|12435420|FG000|Participants Received Treatment|Overall Study||171
11243025|NCT02106832|12435421|FG001|Participants Received Treatment|Overall Study||174
11243026|NCT02106832|12435422|FG002|Participants Received Treatment|Overall Study||86
11243027|NCT02106832|12435423|FG003|Participants Received Treatment|Overall Study||88
11243028|NCT02106832|12435420|FG000|COMPLETED|Overall Study||148
11243029|NCT02106832|12435421|FG001|COMPLETED|Overall Study||151
11243030|NCT02106832|12435422|FG002|COMPLETED|Overall Study||70
11243031|NCT02106832|12435423|FG003|COMPLETED|Overall Study||73
11243032|NCT02106832|12435420|FG000|NOT COMPLETED|Overall Study||23
11243033|NCT02106832|12435421|FG001|NOT COMPLETED|Overall Study||25
11243034|NCT02106832|12435422|FG002|NOT COMPLETED|Overall Study||16
11243035|NCT02106832|12435423|FG003|NOT COMPLETED|Overall Study||15
11243036|NCT02106884|12435437|FG000|STARTED|Overall Study||72
11243037|NCT02106884|12435438|FG001|STARTED|Overall Study||74
11243038|NCT02106884|12435437|FG000|COMPLETED|Overall Study||72
11243039|NCT02106884|12435438|FG001|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73
11243040|NCT02106884|12435437|FG000|NOT COMPLETED|Overall Study||0
11243041|NCT02106884|12435438|FG001|NOT COMPLETED|Overall Study||1
11243042|NCT02106910|12435449|FG000|STARTED|Overall Study||49
11243043|NCT02106910|12435450|FG001|STARTED|Overall Study||89
11243044|NCT02106910|12435449|FG000|COMPLETED|Overall Study||48
11243045|NCT02106910|12435450|FG001|COMPLETED|Overall Study||88
11243046|NCT02106910|12435449|FG000|NOT COMPLETED|Overall Study||1
11243047|NCT02106910|12435450|FG001|NOT COMPLETED|Overall Study||1
11243048|NCT02106923|12435460|FG000|STARTED|Overall Study||12
11243049|NCT02106923|12435461|FG001|STARTED|Overall Study||12
11243050|NCT02106923|12435462|FG002|STARTED|Overall Study||12
11243051|NCT02106923|12435463|FG003|STARTED|Overall Study||12
11243052|NCT02106923|12435464|FG004|STARTED|Overall Study||12
11243053|NCT02106923|12435465|FG005|STARTED|Overall Study||12
11243054|NCT02106923|12435460|FG000|COMPLETED|Overall Study||12
11243055|NCT02106923|12435461|FG001|COMPLETED|Overall Study||12
11243056|NCT02106923|12435462|FG002|COMPLETED|Overall Study||12
11243057|NCT02106923|12435463|FG003|COMPLETED|Overall Study||12
11243058|NCT02106923|12435464|FG004|COMPLETED|Overall Study||12
11243059|NCT02106923|12435465|FG005|COMPLETED|Overall Study||11
11243060|NCT02106923|12435460|FG000|NOT COMPLETED|Overall Study||0
11243061|NCT02106923|12435461|FG001|NOT COMPLETED|Overall Study||0
11243062|NCT02106923|12435462|FG002|NOT COMPLETED|Overall Study||0
11243063|NCT02106923|12435463|FG003|NOT COMPLETED|Overall Study||0
11243064|NCT02106923|12435464|FG004|NOT COMPLETED|Overall Study||0
11243065|NCT02106923|12435465|FG005|NOT COMPLETED|Overall Study||1
11243066|NCT02106962|12435481|FG000|STARTED|Overall Study||8
11243067|NCT02106962|12435482|FG001|STARTED|Overall Study||9
11243068|NCT02106962|12435481|FG000|COMPLETED|Overall Study||8
11243069|NCT02106962|12435482|FG001|COMPLETED|Overall Study||9
11243070|NCT02106962|12435481|FG000|NOT COMPLETED|Overall Study||0
11243071|NCT02106962|12435482|FG001|NOT COMPLETED|Overall Study||0
11243072|NCT02106975|12435492|FG000|STARTED|Overall Study||84
11243073|NCT02106975|12435493|FG001|STARTED|Overall Study||83
11243074|NCT02106975|12435492|FG000|COMPLETED|Overall Study||59
11243075|NCT02106975|12435493|FG001|COMPLETED|Overall Study||44
11243076|NCT02106975|12435492|FG000|NOT COMPLETED|Overall Study||25
11243077|NCT02106975|12435493|FG001|NOT COMPLETED|Overall Study||39
11243078|NCT02107014|12435499|FG000|STARTED|Overall Study||9
11243079|NCT02107014|12435499|FG000|COMPLETED|Overall Study||8
11243080|NCT02107014|12435499|FG000|NOT COMPLETED|Overall Study||1
11243081|NCT02107092|12435503|FG000|STARTED|Overall Study||123
11243082|NCT02107092|12435503|FG000|COMPLETED|Overall Study||79
11243083|NCT02107092|12435503|FG000|NOT COMPLETED|Overall Study||44
11243084|NCT02107131|12435509|FG000|STARTED|Overall Study||20
11243085|NCT02107131|12435510|FG001|STARTED|Overall Study||20
11243086|NCT02107131|12435509|FG000|COMPLETED|Overall Study||12
11243087|NCT02107131|12435510|FG001|COMPLETED|Overall Study||11
11243088|NCT02107131|12435509|FG000|NOT COMPLETED|Overall Study||8
11243089|NCT02107131|12435510|FG001|NOT COMPLETED|Overall Study||9
11243090|NCT02107157|12435521|FG000|STARTED|Overall Study||11
11243091|NCT02107157|12435522|FG001|STARTED|Overall Study||12
11243092|NCT02107157|12435523|FG002|STARTED|Overall Study||4
11243093|NCT02107157|12435521|FG000|COMPLETED|Overall Study||6
11141861|NCT01464931|12328535|FG000|NOT COMPLETED|Overall Study||1
11141862|NCT01464931|12328536|FG001|NOT COMPLETED|Overall Study||0
11141863|NCT01464996|12328549|FG000|STARTED|Overall Study||24
11141864|NCT01464996|12328549|FG000|OptiBond XTR|Overall Study||23
11141865|NCT01464996|12328549|FG000|OptiBond FL|Overall Study||24
11141866|NCT01464996|12328549|FG000|COMPLETED|Overall Study||24
11141867|NCT01464996|12328549|FG000|NOT COMPLETED|Overall Study||0
11141868|NCT01465022|12328558|FG000|STARTED|Overall Study||64
11141869|NCT01465022|12328559|FG001|STARTED|Overall Study||63
11243094|NCT02107157|12435522|FG001|COMPLETED|Overall Study||11
11243095|NCT02107157|12435523|FG002|COMPLETED|Overall Study||4
11243096|NCT02107157|12435521|FG000|NOT COMPLETED|Overall Study||5
11243097|NCT02107157|12435522|FG001|NOT COMPLETED|Overall Study||1
11243098|NCT02107157|12435523|FG002|NOT COMPLETED|Overall Study||0
11243099|NCT02107196|12435533|FG000|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
11243100|NCT02107196|12435534|FG001|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
11243101|NCT02107196|12435533|FG000|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
11243102|NCT02107196|12435534|FG001|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
11243103|NCT02107196|12435533|FG000|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
11243104|NCT02107196|12435534|FG001|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
11243105|NCT02107196|12435533|FG000|COMPLETED|12-week Treatment Period||227
11243106|NCT02107196|12435534|FG001|COMPLETED|12-week Treatment Period||225
11243107|NCT02107196|12435533|FG000|NOT COMPLETED|12-week Treatment Period||44
11243108|NCT02107196|12435534|FG001|NOT COMPLETED|12-week Treatment Period||39
11243109|NCT02107196|12435533|FG000|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
11243110|NCT02107196|12435534|FG001|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
11243111|NCT02107196|12435533|FG000|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
11243112|NCT02107196|12435534|FG001|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
11243113|NCT02107196|12435533|FG000|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
11243114|NCT02107196|12435534|FG001|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
11243115|NCT02107196|12435533|FG000|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
11243116|NCT02107196|12435534|FG001|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
11243117|NCT02107196|12435533|FG000|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
11243118|NCT02107196|12435534|FG001|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
11243119|NCT02107274|12435542|FG000|STARTED|Treatment vs. Placebo||39
11243120|NCT02107274|12435543|FG001|STARTED|Treatment vs. Placebo||39
11243121|NCT02107274|12435542|FG000|COMPLETED|Treatment vs. Placebo||36
11243122|NCT02107274|12435543|FG001|COMPLETED|Treatment vs. Placebo||37
11243123|NCT02107274|12435542|FG000|NOT COMPLETED|Treatment vs. Placebo||3
11243124|NCT02107274|12435543|FG001|NOT COMPLETED|Treatment vs. Placebo||2
11243125|NCT02107274|12435542|FG000|STARTED|Control Phase||36
11243126|NCT02107274|12435543|FG001|STARTED|Control Phase||37
11243127|NCT02107274|12435542|FG000|COMPLETED|Control Phase||33
11243128|NCT02107274|12435543|FG001|COMPLETED|Control Phase||35
11243129|NCT02107274|12435542|FG000|NOT COMPLETED|Control Phase||3
11243130|NCT02107274|12435543|FG001|NOT COMPLETED|Control Phase||2
11243131|NCT02107300|12435551|FG000|STARTED|Overall Study||16
11243132|NCT02107300|12435552|FG001|STARTED|Overall Study||15
11243133|NCT02107300|12435551|FG000|COMPLETED|Overall Study||16
11243134|NCT02107300|12435552|FG001|COMPLETED|Overall Study||15
11243135|NCT02107300|12435551|FG000|NOT COMPLETED|Overall Study||0
11243136|NCT02107300|12435552|FG001|NOT COMPLETED|Overall Study||0
11243137|NCT02107313|12435558|FG000|STARTED|Overall Study||9
11243138|NCT02107313|12435559|FG001|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
11243139|NCT02107313|12435558|FG000|COMPLETED|Overall Study||9
11243140|NCT02107313|12435559|FG001|COMPLETED|Overall Study||8
11243141|NCT02107313|12435558|FG000|NOT COMPLETED|Overall Study||0
11243142|NCT02107313|12435559|FG001|NOT COMPLETED|Overall Study||1
11243143|NCT02107339|12435567|FG000|STARTED|Overall Study||63
11243144|NCT02107339|12435568|FG001|STARTED|Overall Study||57
11243145|NCT02107339|12435567|FG000|COMPLETED|Overall Study||62
11243146|NCT02107339|12435568|FG001|COMPLETED|Overall Study||53
11243147|NCT02107339|12435567|FG000|NOT COMPLETED|Overall Study||1
11243148|NCT02107339|12435568|FG001|NOT COMPLETED|Overall Study||4
11243149|NCT02107443|12435576|FG000|STARTED|Overall Study||296
11243150|NCT02107443|12435577|FG001|STARTED|Overall Study||250
11243151|NCT02107443|12435576|FG000|COMPLETED|Overall Study||198
11243152|NCT02107443|12435577|FG001|COMPLETED|Overall Study||167
11243153|NCT02107443|12435576|FG000|NOT COMPLETED|Overall Study||98
11243154|NCT02107443|12435577|FG001|NOT COMPLETED|Overall Study||83
11243155|NCT02107482|12435584|FG000|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
11243156|NCT02107482|12435584|FG000|COMPLETED|Overall Study||17
11243157|NCT02107482|12435584|FG000|NOT COMPLETED|Overall Study||4
11243158|NCT02107599|12435588|FG000|STARTED|Overall Study||96
11243159|NCT02107599|12435588|FG000|COMPLETED|Overall Study||96
11243160|NCT02107599|12435588|FG000|NOT COMPLETED|Overall Study||0
11243161|NCT02107703|12435597|FG000|STARTED|Overall Study||446
11141870|NCT01465022|12328560|FG002|STARTED|Overall Study||70
11141871|NCT01465022|12328558|FG000|COMPLETED|Overall Study||41
11243162|NCT02107703|12435598|FG001|STARTED|Overall Study||223
11243163|NCT02107703|12435597|FG000|Received at Least 1 Dose of Study Drug|Overall Study||441
11243164|NCT02107703|12435598|FG001|Received at Least 1 Dose of Study Drug|Overall Study||223
11243165|NCT02107703|12435597|FG000|COMPLETED|Overall Study||85
11243166|NCT02107703|12435598|FG001|COMPLETED|Overall Study||48
11243167|NCT02107703|12435597|FG000|NOT COMPLETED|Overall Study||361
11243168|NCT02107703|12435598|FG001|NOT COMPLETED|Overall Study||175
11243169|NCT02107859|12435607|FG000|STARTED|Overall Study||61
11243170|NCT02107859|12435607|FG000|As-treated Population|Overall Study||61
11243171|NCT02107859|12435607|FG000|Intent-to-treat (ITT) Population|Overall Study||60
11243172|NCT02107859|12435607|FG000|COMPLETED|Overall Study||0
11243173|NCT02107859|12435607|FG000|NOT COMPLETED|Overall Study||61
11243174|NCT02107898|12435613|FG000|STARTED|Overall Study|Randomized|72
11243175|NCT02107898|12435614|FG001|STARTED|Overall Study|Randomized|144
11243176|NCT02107898|12435613|FG000|Treated|Overall Study||72
11243177|NCT02107898|12435614|FG001|Treated|Overall Study||143
11243178|NCT02107898|12435613|FG000|COMPLETED|Overall Study||66
11243179|NCT02107898|12435614|FG001|COMPLETED|Overall Study||132
11243180|NCT02107898|12435613|FG000|NOT COMPLETED|Overall Study||6
11243181|NCT02107898|12435614|FG001|NOT COMPLETED|Overall Study||12
11243182|NCT02108171|12435622|FG000|STARTED|Overall Study||40
11243183|NCT02108171|12435623|FG001|STARTED|Overall Study||41
11243184|NCT02108171|12435622|FG000|COMPLETED|Overall Study||40
11243185|NCT02108171|12435623|FG001|COMPLETED|Overall Study||41
11243186|NCT02108171|12435622|FG000|NOT COMPLETED|Overall Study||0
11243187|NCT02108171|12435623|FG001|NOT COMPLETED|Overall Study||0
11243188|NCT02108223|12435633|FG000|STARTED|Overall Study||52
11243189|NCT02108223|12435634|FG001|STARTED|Overall Study||50
11243190|NCT02108223|12435635|FG002|STARTED|Overall Study||35
11243191|NCT02108223|12435633|FG000|COMPLETED|Overall Study||52
11243192|NCT02108223|12435634|FG001|COMPLETED|Overall Study||50
11243193|NCT02108223|12435635|FG002|COMPLETED|Overall Study||35
11243194|NCT02108223|12435633|FG000|NOT COMPLETED|Overall Study||0
11243195|NCT02108223|12435634|FG001|NOT COMPLETED|Overall Study||0
11243196|NCT02108223|12435635|FG002|NOT COMPLETED|Overall Study||0
11243197|NCT02108262|12435650|FG000|STARTED|Overall Study||9
11243198|NCT02108262|12435651|FG001|STARTED|Overall Study||419
11243199|NCT02108262|12435652|FG002|STARTED|Overall Study||421
11243200|NCT02108262|12435653|FG003|STARTED|Overall Study||418
11243201|NCT02108262|12435650|FG000|COMPLETED|Overall Study||9
11243202|NCT02108262|12435651|FG001|COMPLETED|Overall Study||375
11243203|NCT02108262|12435652|FG002|COMPLETED|Overall Study||379
11243204|NCT02108262|12435653|FG003|COMPLETED|Overall Study||376
11243205|NCT02108262|12435650|FG000|NOT COMPLETED|Overall Study||0
11243206|NCT02108262|12435651|FG001|NOT COMPLETED|Overall Study||44
11243207|NCT02108262|12435652|FG002|NOT COMPLETED|Overall Study||42
11243208|NCT02108262|12435653|FG003|NOT COMPLETED|Overall Study||42
11243209|NCT02108288|12435665|FG000|STARTED|Overall Study||10
11243210|NCT02108288|12435666|FG001|STARTED|Overall Study||10
11243211|NCT02108288|12435667|FG002|STARTED|Overall Study||10
11243212|NCT02108288|12435665|FG000|COMPLETED|Overall Study||10
11243213|NCT02108288|12435666|FG001|COMPLETED|Overall Study||10
11243214|NCT02108288|12435667|FG002|COMPLETED|Overall Study||10
11243215|NCT02108288|12435665|FG000|NOT COMPLETED|Overall Study||0
11243216|NCT02108288|12435666|FG001|NOT COMPLETED|Overall Study||0
11243217|NCT02108288|12435667|FG002|NOT COMPLETED|Overall Study||0
11243218|NCT02108457|12435677|FG000|STARTED|Overall Study||3
11243219|NCT02108457|12435678|FG001|STARTED|Overall Study||12
11243220|NCT02108457|12435677|FG000|COMPLETED|Overall Study||3
11243221|NCT02108457|12435678|FG001|COMPLETED|Overall Study||10
11243222|NCT02108457|12435677|FG000|NOT COMPLETED|Overall Study||0
11243223|NCT02108457|12435678|FG001|NOT COMPLETED|Overall Study||2
11243224|NCT02108522|12435684|FG000|STARTED|Screening Period||82
11243225|NCT02108522|12435684|FG000|COMPLETED|Screening Period||58
11243226|NCT02108522|12435684|FG000|NOT COMPLETED|Screening Period||24
11243227|NCT02108522|12435684|FG000|STARTED|Period 1: Initial Cohort||50
11243228|NCT02108522|12435684|FG000|COMPLETED|Period 1: Initial Cohort||28
11243229|NCT02108522|12435684|FG000|NOT COMPLETED|Period 1: Initial Cohort||22
11243230|NCT02108522|12435684|FG000|STARTED|Period 2: Expansion Cohort||8
11243231|NCT02108522|12435684|FG000|COMPLETED|Period 2: Expansion Cohort||2
11243232|NCT02108522|12435684|FG000|NOT COMPLETED|Period 2: Expansion Cohort||6
11243233|NCT02108600|12435690|FG000|STARTED|Overall Study||17
11243234|NCT02108600|12435691|FG001|STARTED|Overall Study||16
11243235|NCT02108600|12435690|FG000|COMPLETED|Overall Study||14
11243236|NCT02108600|12435691|FG001|COMPLETED|Overall Study|1 patient lost to follow up after the primary endpoint biopsy|15
11243237|NCT02108600|12435690|FG000|NOT COMPLETED|Overall Study||3
11243238|NCT02108600|12435691|FG001|NOT COMPLETED|Overall Study||1
11243239|NCT02108691|12435699|FG000|STARTED|Overall Study||40
11243240|NCT02108691|12435700|FG001|STARTED|Overall Study||40
11243241|NCT02108691|12435699|FG000|COMPLETED|Overall Study||32
11243242|NCT02108691|12435700|FG001|COMPLETED|Overall Study||31
11243243|NCT02108691|12435699|FG000|NOT COMPLETED|Overall Study||8
11243244|NCT02108691|12435700|FG001|NOT COMPLETED|Overall Study||9
11243245|NCT02108821|12435706|FG000|STARTED|Overall Study||23
11243246|NCT02108821|12435706|FG000|COMPLETED|Overall Study||23
11243247|NCT02108821|12435706|FG000|NOT COMPLETED|Overall Study||0
11243248|NCT02108912|12435714|FG000|STARTED|Overall Study||9
11243249|NCT02108912|12435715|FG001|STARTED|Overall Study||7
11243250|NCT02108912|12435714|FG000|COMPLETED|Overall Study||6
11243251|NCT02108912|12435715|FG001|COMPLETED|Overall Study||6
11243252|NCT02108912|12435714|FG000|NOT COMPLETED|Overall Study||3
11243253|NCT02108912|12435715|FG001|NOT COMPLETED|Overall Study||1
11243254|NCT02108951|12435721|FG000|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
11243255|NCT02108951|12435721|FG000|COMPLETED|Overall Study||4
11243256|NCT02108951|12435721|FG000|NOT COMPLETED|Overall Study||16
11243257|NCT02108977|12435727|FG000|STARTED|Overall Study||18
11243258|NCT02108977|12435728|FG001|STARTED|Overall Study||20
11243259|NCT02108977|12435727|FG000|COMPLETED|Overall Study||8
11243260|NCT02108977|12435728|FG001|COMPLETED|Overall Study||19
11243261|NCT02108977|12435727|FG000|NOT COMPLETED|Overall Study||10
11243262|NCT02108977|12435728|FG001|NOT COMPLETED|Overall Study||1
11243263|NCT02109029|12435739|FG000|STARTED|Part A||2
11243264|NCT02109029|12435740|FG001|STARTED|Part A||2
11243265|NCT02109029|12435741|FG002|STARTED|Part A||4
11243266|NCT02109029|12435742|FG003|STARTED|Part A||4
11243267|NCT02109029|12435743|FG004|STARTED|Part A||0
11243268|NCT02109029|12435744|FG005|STARTED|Part A||0
11243269|NCT02109029|12435739|FG000|Received One Dose of Study Drug|Part A||2
11243270|NCT02109029|12435740|FG001|Received One Dose of Study Drug|Part A||2
11243271|NCT02109029|12435741|FG002|Received One Dose of Study Drug|Part A||4
11243272|NCT02109029|12435742|FG003|Received One Dose of Study Drug|Part A||4
11243273|NCT02109029|12435743|FG004|Received One Dose of Study Drug|Part A||0
11243274|NCT02109029|12435744|FG005|Received One Dose of Study Drug|Part A||0
11243275|NCT02109029|12435739|FG000|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
11243276|NCT02109029|12435740|FG001|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
11243277|NCT02109029|12435741|FG002|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
11243278|NCT02109029|12435742|FG003|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
11243279|NCT02109029|12435743|FG004|COMPLETED|Part A||0
11243280|NCT02109029|12435744|FG005|COMPLETED|Part A||0
11243281|NCT02109029|12435739|FG000|NOT COMPLETED|Part A||0
11243282|NCT02109029|12435740|FG001|NOT COMPLETED|Part A||0
11243283|NCT02109029|12435741|FG002|NOT COMPLETED|Part A||0
11243284|NCT02109029|12435742|FG003|NOT COMPLETED|Part A||0
11243285|NCT02109029|12435743|FG004|NOT COMPLETED|Part A||0
11243286|NCT02109029|12435744|FG005|NOT COMPLETED|Part A||0
11243287|NCT02109029|12435739|FG000|STARTED|Part B||0
11243288|NCT02109029|12435740|FG001|STARTED|Part B||0
11243289|NCT02109029|12435741|FG002|STARTED|Part B||0
11243290|NCT02109029|12435742|FG003|STARTED|Part B||0
11243291|NCT02109029|12435743|FG004|STARTED|Part B|New participants entered Part B.|6
11243292|NCT02109029|12435744|FG005|STARTED|Part B|New participants entered Part B.|6
11243293|NCT02109029|12435739|FG000|Received at Least One Dose of Study Drug|Part B||0
11243294|NCT02109029|12435740|FG001|Received at Least One Dose of Study Drug|Part B||0
11243295|NCT02109029|12435741|FG002|Received at Least One Dose of Study Drug|Part B||0
11243296|NCT02109029|12435742|FG003|Received at Least One Dose of Study Drug|Part B||0
11243297|NCT02109029|12435743|FG004|Received at Least One Dose of Study Drug|Part B||6
11243298|NCT02109029|12435744|FG005|Received at Least One Dose of Study Drug|Part B||6
11243299|NCT02109029|12435739|FG000|COMPLETED|Part B||0
11243300|NCT02109029|12435740|FG001|COMPLETED|Part B||0
11243301|NCT02109029|12435741|FG002|COMPLETED|Part B||0
11243302|NCT02109029|12435742|FG003|COMPLETED|Part B||0
11243303|NCT02109029|12435743|FG004|COMPLETED|Part B||5
11243304|NCT02109029|12435744|FG005|COMPLETED|Part B||5
11243305|NCT02109029|12435739|FG000|NOT COMPLETED|Part B||0
11243306|NCT02109029|12435740|FG001|NOT COMPLETED|Part B||0
11243307|NCT02109029|12435741|FG002|NOT COMPLETED|Part B||0
11243308|NCT02109029|12435742|FG003|NOT COMPLETED|Part B||0
11243309|NCT02109029|12435743|FG004|NOT COMPLETED|Part B||1
11243310|NCT02109029|12435744|FG005|NOT COMPLETED|Part B||1
11243311|NCT02109042|12435755|FG000|STARTED|Overall Study||15
11243312|NCT02109042|12435755|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
11243313|NCT02109042|12435755|FG000|Received 180 mg Loading Dose|Overall Study||15
11243314|NCT02109042|12435755|FG000|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
11243315|NCT02109042|12435755|FG000|COMPLETED|Overall Study||0
11243316|NCT02109042|12435755|FG000|NOT COMPLETED|Overall Study||15
11243317|NCT02109107|12435760|FG000|STARTED|Overall Study||54
11243318|NCT02109107|12435760|FG000|COMPLETED|Overall Study||52
11243319|NCT02109107|12435760|FG000|NOT COMPLETED|Overall Study||2
11243320|NCT02109133|12435766|FG000|STARTED|Overall Study||33
11243321|NCT02109133|12435767|FG001|STARTED|Overall Study||34
11243322|NCT02109133|12435766|FG000|COMPLETED|Overall Study||32
11243323|NCT02109133|12435767|FG001|COMPLETED|Overall Study||34
11243324|NCT02109133|12435766|FG000|NOT COMPLETED|Overall Study||1
11243325|NCT02109133|12435767|FG001|NOT COMPLETED|Overall Study||0
11243326|NCT02109159|12435777|FG000|STARTED|Overall Study||4178
11243327|NCT02109159|12435778|FG001|STARTED|Overall Study||4175
11243328|NCT02109159|12435777|FG000|COMPLETED|Overall Study||4178
11243329|NCT02109159|12435778|FG001|COMPLETED|Overall Study||4175
11243330|NCT02109159|12435777|FG000|NOT COMPLETED|Overall Study||0
11243331|NCT02109159|12435778|FG001|NOT COMPLETED|Overall Study||0
11243332|NCT02109419|12435784|FG000|STARTED|Overall Study||57
11243333|NCT02109419|12435784|FG000|COMPLETED|Overall Study||57
11243334|NCT02109419|12435784|FG000|NOT COMPLETED|Overall Study||0
11243335|NCT02109432|12435790|FG000|STARTED|Overall Study||7
11243336|NCT02109432|12435790|FG000|COMPLETED|Overall Study||6
11243337|NCT02109432|12435790|FG000|NOT COMPLETED|Overall Study||1
11243338|NCT02109445|12435794|FG000|STARTED|Overall Study||3
11243339|NCT02109445|12435794|FG000|COMPLETED|Overall Study||0
11243340|NCT02109445|12435794|FG000|NOT COMPLETED|Overall Study||3
11243341|NCT02109458|12435798|FG000|STARTED|Overall Study||24
11243342|NCT02109458|12435798|FG000|COMPLETED|Overall Study||24
11243343|NCT02109458|12435798|FG000|NOT COMPLETED|Overall Study||0
11243344|NCT02109484|12435810|FG000|STARTED|Overall Study||5
11243345|NCT02109484|12435811|FG001|STARTED|Overall Study||13
11243346|NCT02109484|12435812|FG002|STARTED|Overall Study||12
11243347|NCT02109484|12435813|FG003|STARTED|Overall Study||12
11243348|NCT02109484|12435814|FG004|STARTED|Overall Study||50
11243349|NCT02109484|12435815|FG005|STARTED|Overall Study||12
11243350|NCT02109484|12435816|FG006|STARTED|Overall Study||50
11243351|NCT02109484|12435817|FG007|STARTED|Overall Study||50
11243352|NCT02109484|12435810|FG000|COMPLETED|Overall Study||5
11243353|NCT02109484|12435811|FG001|COMPLETED|Overall Study||13
11243354|NCT02109484|12435812|FG002|COMPLETED|Overall Study||12
11243355|NCT02109484|12435813|FG003|COMPLETED|Overall Study||11
11243356|NCT02109484|12435814|FG004|COMPLETED|Overall Study||46
11243357|NCT02109484|12435815|FG005|COMPLETED|Overall Study||11
11243358|NCT02109484|12435816|FG006|COMPLETED|Overall Study||47
11243359|NCT02109484|12435817|FG007|COMPLETED|Overall Study||47
11243360|NCT02109484|12435810|FG000|NOT COMPLETED|Overall Study||0
11243361|NCT02109484|12435811|FG001|NOT COMPLETED|Overall Study||0
11243362|NCT02109484|12435812|FG002|NOT COMPLETED|Overall Study||0
11243363|NCT02109484|12435813|FG003|NOT COMPLETED|Overall Study||1
11243364|NCT02109484|12435814|FG004|NOT COMPLETED|Overall Study||4
11243365|NCT02109484|12435815|FG005|NOT COMPLETED|Overall Study||1
11243366|NCT02109484|12435816|FG006|NOT COMPLETED|Overall Study||3
11243367|NCT02109484|12435817|FG007|NOT COMPLETED|Overall Study||3
11243368|NCT02109497|12435852|FG000|STARTED|Overall Study||18
11243369|NCT02109497|12435852|FG000|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
11243370|NCT02109497|12435852|FG000|NOT COMPLETED|Overall Study||1
11243371|NCT02109562|12435859|FG000|STARTED|Overall Study||116
11243372|NCT02109562|12435860|FG001|STARTED|Overall Study||119
11243373|NCT02109562|12435861|FG002|STARTED|Overall Study||119
11243374|NCT02109562|12435859|FG000|Safety|Overall Study||115
11243375|NCT02109562|12435860|FG001|Safety|Overall Study||117
11243376|NCT02109562|12435861|FG002|Safety|Overall Study||118
11243377|NCT02109562|12435859|FG000|Intent to Treat (ITT)|Overall Study||111
11243378|NCT02109562|12435860|FG001|Intent to Treat (ITT)|Overall Study||114
11243379|NCT02109562|12435861|FG002|Intent to Treat (ITT)|Overall Study||112
11243380|NCT02109562|12435859|FG000|COMPLETED|Overall Study||90
11243381|NCT02109562|12435860|FG001|COMPLETED|Overall Study||85
11243382|NCT02109562|12435861|FG002|COMPLETED|Overall Study||84
11243383|NCT02109562|12435859|FG000|NOT COMPLETED|Overall Study||26
11243384|NCT02109562|12435860|FG001|NOT COMPLETED|Overall Study||34
11243385|NCT02109562|12435861|FG002|NOT COMPLETED|Overall Study||35
11243386|NCT02109640|12435871|FG000|STARTED|Overall Study||27
11243387|NCT02109640|12435872|FG001|STARTED|Overall Study||23
11243388|NCT02109640|12435871|FG000|COMPLETED|Overall Study||27
11243389|NCT02109640|12435872|FG001|COMPLETED|Overall Study||23
11243390|NCT02109640|12435871|FG000|NOT COMPLETED|Overall Study||0
11243391|NCT02109640|12435872|FG001|NOT COMPLETED|Overall Study||0
11243392|NCT02109731|12435878|FG000|STARTED|Overall Study||15
11243393|NCT02109731|12435878|FG000|COMPLETED|Overall Study||15
11243394|NCT02109731|12435878|FG000|NOT COMPLETED|Overall Study||0
11243395|NCT02109939|12435884|FG000|STARTED|Overall Study||681
11243396|NCT02109939|12435885|FG001|STARTED|Overall Study||717
11243397|NCT02109939|12435884|FG000|COMPLETED|Overall Study||560
11243398|NCT02109939|12435885|FG001|COMPLETED|Overall Study||607
11243399|NCT02109939|12435884|FG000|NOT COMPLETED|Overall Study||121
11243400|NCT02109939|12435885|FG001|NOT COMPLETED|Overall Study||110
11243401|NCT02110095|12435895|FG000|STARTED|Overall Study||15
11243402|NCT02110095|12435895|FG000|COMPLETED|Overall Study||8
11243403|NCT02110095|12435895|FG000|NOT COMPLETED|Overall Study||7
11243404|NCT02110108|12435899|FG000|STARTED|Overall Study||10
11243405|NCT02110108|12435899|FG000|RevLite Single Wavelength|Overall Study||10
11243406|NCT02110108|12435899|FG000|RevLite Combo Wavelength|Overall Study||10
11243407|NCT02110108|12435899|FG000|COMPLETED|Overall Study||7
11243408|NCT02110108|12435899|FG000|NOT COMPLETED|Overall Study||3
11243409|NCT02110121|12435909|FG000|STARTED|Overall Study||58
11243410|NCT02110121|12435910|FG001|STARTED|Overall Study||5
11243411|NCT02110121|12435909|FG000|COMPLETED|Overall Study||42
11243412|NCT02110121|12435910|FG001|COMPLETED|Overall Study||5
11243413|NCT02110121|12435909|FG000|NOT COMPLETED|Overall Study||16
11243414|NCT02110121|12435910|FG001|NOT COMPLETED|Overall Study||0
11243415|NCT02110147|12435916|FG000|STARTED|Overall Study||4
11243416|NCT02110147|12435916|FG000|COMPLETED|Overall Study||4
11243417|NCT02110147|12435916|FG000|NOT COMPLETED|Overall Study||0
11243418|NCT02110225|12435923|FG000|STARTED|Overall Study||20
11243419|NCT02110225|12435924|FG001|STARTED|Overall Study||20
11243420|NCT02110225|12435925|FG002|STARTED|Overall Study||10
11243421|NCT02110225|12435923|FG000|COMPLETED|Overall Study||20
11243422|NCT02110225|12435924|FG001|COMPLETED|Overall Study||19
11243423|NCT02110225|12435925|FG002|COMPLETED|Overall Study||10
11243424|NCT02110225|12435923|FG000|NOT COMPLETED|Overall Study||0
11243425|NCT02110225|12435924|FG001|NOT COMPLETED|Overall Study||1
11243426|NCT02110225|12435925|FG002|NOT COMPLETED|Overall Study||0
11243427|NCT02110238|12435936|FG000|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
11243428|NCT02110238|12435937|FG001|STARTED|12 Week Pivotal Phase||209
11243429|NCT02110238|12435936|FG000|COMPLETED|12 Week Pivotal Phase||202
11243430|NCT02110238|12435937|FG001|COMPLETED|12 Week Pivotal Phase||200
11243431|NCT02110238|12435936|FG000|NOT COMPLETED|12 Week Pivotal Phase||10
11243432|NCT02110238|12435937|FG001|NOT COMPLETED|12 Week Pivotal Phase||9
11243433|NCT02110238|12435936|FG000|STARTED|14 Week Blinded Extension Phase||202
11243434|NCT02110238|12435937|FG001|STARTED|14 Week Blinded Extension Phase||200
11243435|NCT02110238|12435936|FG000|COMPLETED|14 Week Blinded Extension Phase||190
11243436|NCT02110238|12435937|FG001|COMPLETED|14 Week Blinded Extension Phase||188
11243437|NCT02110238|12435936|FG000|NOT COMPLETED|14 Week Blinded Extension Phase||12
11243438|NCT02110238|12435937|FG001|NOT COMPLETED|14 Week Blinded Extension Phase||12
11243439|NCT02110264|12435946|FG000|STARTED|Overall Study||53
11243440|NCT02110264|12435947|FG001|STARTED|Overall Study||50
11243441|NCT02110264|12435948|FG002|STARTED|Overall Study||48
11243442|NCT02110264|12435946|FG000|COMPLETED|Overall Study||35
11243443|NCT02110264|12435947|FG001|COMPLETED|Overall Study||38
11243444|NCT02110264|12435948|FG002|COMPLETED|Overall Study||39
11243445|NCT02110264|12435946|FG000|NOT COMPLETED|Overall Study||18
11243446|NCT02110264|12435947|FG001|NOT COMPLETED|Overall Study||12
11243447|NCT02110264|12435948|FG002|NOT COMPLETED|Overall Study||9
11243448|NCT02110381|12435958|FG000|STARTED|Single Modality||9
11243449|NCT02110381|12435959|FG001|STARTED|Single Modality||9
11243450|NCT02110381|12435958|FG000|COMPLETED|Single Modality||7
11243451|NCT02110381|12435959|FG001|COMPLETED|Single Modality||8
11243452|NCT02110381|12435958|FG000|NOT COMPLETED|Single Modality||2
11243453|NCT02110381|12435959|FG001|NOT COMPLETED|Single Modality||1
11243454|NCT02110381|12435958|FG000|STARTED|Dual Modality||7
11243455|NCT02110381|12435959|FG001|STARTED|Dual Modality||8
11243456|NCT02110381|12435958|FG000|Began Active Treatment|Dual Modality||7
11243457|NCT02110381|12435959|FG001|Began Active Treatment|Dual Modality||7
11243458|NCT02110381|12435958|FG000|COMPLETED|Dual Modality||5
11243459|NCT02110381|12435959|FG001|COMPLETED|Dual Modality||7
11243460|NCT02110381|12435958|FG000|NOT COMPLETED|Dual Modality||2
11243461|NCT02110381|12435959|FG001|NOT COMPLETED|Dual Modality||1
11243462|NCT02110485|12435968|FG000|STARTED|Overall Study||98
11243463|NCT02110485|12435969|FG001|STARTED|Overall Study||102
11243464|NCT02110485|12435968|FG000|COMPLETED|Overall Study||91
11243465|NCT02110485|12435969|FG001|COMPLETED|Overall Study||83
11243466|NCT02110485|12435968|FG000|NOT COMPLETED|Overall Study||7
11243467|NCT02110485|12435969|FG001|NOT COMPLETED|Overall Study||19
11243468|NCT02110693|12435975|FG000|STARTED|Overall Study||1026
11243469|NCT02110693|12435976|FG001|STARTED|Overall Study||1031
11243470|NCT02110693|12435975|FG000|COMPLETED|Overall Study||998
11243471|NCT02110693|12435976|FG001|COMPLETED|Overall Study||1002
11243472|NCT02110693|12435975|FG000|NOT COMPLETED|Overall Study||28
11243473|NCT02110693|12435976|FG001|NOT COMPLETED|Overall Study||29
11243474|NCT02110706|12435998|FG000|STARTED|Overall Study||25
11243475|NCT02110706|12435999|FG001|STARTED|Overall Study||27
11243476|NCT02110706|12435998|FG000|No. Completing Study Through Week 52|Overall Study||23
11243477|NCT02110706|12435999|FG001|No. Completing Study Through Week 52|Overall Study||24
11243478|NCT02110706|12435998|FG000|COMPLETED|Overall Study||20
11243479|NCT02110706|12435999|FG001|COMPLETED|Overall Study||23
11243480|NCT02110706|12435998|FG000|NOT COMPLETED|Overall Study||5
11243481|NCT02110706|12435999|FG001|NOT COMPLETED|Overall Study||4
11243482|NCT02110732|12436009|FG000|STARTED|Overall Study||20
11243483|NCT02110732|12436010|FG001|STARTED|Overall Study||20
11243484|NCT02110732|12436009|FG000|COMPLETED|Overall Study||14
11243485|NCT02110732|12436010|FG001|COMPLETED|Overall Study||17
11243486|NCT02110732|12436009|FG000|NOT COMPLETED|Overall Study||6
11243487|NCT02110732|12436010|FG001|NOT COMPLETED|Overall Study||3
11243488|NCT02110758|12436021|FG000|STARTED|Baseline: August 2011-July 2013||0
11243489|NCT02110758|12436022|FG001|STARTED|Baseline: August 2011-July 2013||0
11243490|NCT02110758|12436023|FG002|STARTED|Baseline: August 2011-July 2013||9832
11243491|NCT02110758|12436024|FG003|STARTED|Baseline: August 2011-July 2013||18994
11243492|NCT02110758|12436025|FG004|STARTED|Baseline: August 2011-July 2013||308
11243493|NCT02110758|12436021|FG000|COMPLETED|Baseline: August 2011-July 2013||0
11243494|NCT02110758|12436022|FG001|COMPLETED|Baseline: August 2011-July 2013||0
11243495|NCT02110758|12436023|FG002|COMPLETED|Baseline: August 2011-July 2013||9832
11243496|NCT02110758|12436024|FG003|COMPLETED|Baseline: August 2011-July 2013||18994
11243497|NCT02110758|12436025|FG004|COMPLETED|Baseline: August 2011-July 2013||308
11243498|NCT02110758|12436021|FG000|NOT COMPLETED|Baseline: August 2011-July 2013||0
11243499|NCT02110758|12436022|FG001|NOT COMPLETED|Baseline: August 2011-July 2013||0
11243500|NCT02110758|12436023|FG002|NOT COMPLETED|Baseline: August 2011-July 2013||0
11243501|NCT02110758|12436024|FG003|NOT COMPLETED|Baseline: August 2011-July 2013||0
11243502|NCT02110758|12436025|FG004|NOT COMPLETED|Baseline: August 2011-July 2013||0
11243503|NCT02110758|12436021|FG000|STARTED|Start-Up: August 2013-June 2014||175
11243504|NCT02110758|12436022|FG001|STARTED|Start-Up: August 2013-June 2014||431
11243505|NCT02110758|12436023|FG002|STARTED|Start-Up: August 2013-June 2014||8057
11243506|NCT02110758|12436024|FG003|STARTED|Start-Up: August 2013-June 2014||12883
11243507|NCT02110758|12436025|FG004|STARTED|Start-Up: August 2013-June 2014||0
11243508|NCT02110758|12436021|FG000|COMPLETED|Start-Up: August 2013-June 2014||175
11243509|NCT02110758|12436022|FG001|COMPLETED|Start-Up: August 2013-June 2014||431
11243510|NCT02110758|12436023|FG002|COMPLETED|Start-Up: August 2013-June 2014||8057
11243511|NCT02110758|12436024|FG003|COMPLETED|Start-Up: August 2013-June 2014||12883
11243512|NCT02110758|12436025|FG004|COMPLETED|Start-Up: August 2013-June 2014||0
11243513|NCT02110758|12436021|FG000|NOT COMPLETED|Start-Up: August 2013-June 2014||0
11343947|NCT02957682|12541258|FG000|Randomized and Treated|Overall Study||1085
11243514|NCT02110758|12436022|FG001|NOT COMPLETED|Start-Up: August 2013-June 2014||0
11358186|NCT03121612|12555228|FG000|COMPLETED|Overall Study||26
11358187|NCT03121612|12555229|FG001|COMPLETED|Overall Study||25
11358188|NCT03121612|12555228|FG000|NOT COMPLETED|Overall Study||0
11358189|NCT03121612|12555229|FG001|NOT COMPLETED|Overall Study||0
11358190|NCT03121820|12555239|FG000|STARTED|First Period||9
11358191|NCT03121820|12555240|FG001|STARTED|First Period||9
11358192|NCT03121820|12555239|FG000|COMPLETED|First Period||9
11358193|NCT03121820|12555240|FG001|COMPLETED|First Period||9
11358194|NCT03121820|12555239|FG000|NOT COMPLETED|First Period||0
11358195|NCT03121820|12555240|FG001|NOT COMPLETED|First Period||0
11358196|NCT03121820|12555239|FG000|STARTED|Second Period (After Washout)||9
11358197|NCT03121820|12555240|FG001|STARTED|Second Period (After Washout)||9
11358198|NCT03121820|12555239|FG000|COMPLETED|Second Period (After Washout)||9
11358199|NCT03121820|12555240|FG001|COMPLETED|Second Period (After Washout)||9
11358200|NCT03121820|12555239|FG000|NOT COMPLETED|Second Period (After Washout)||0
11358201|NCT03121820|12555240|FG001|NOT COMPLETED|Second Period (After Washout)||0
11358202|NCT03121950|12555248|FG000|STARTED|Overall Study||17
11358203|NCT03121950|12555249|FG001|STARTED|Overall Study||3
11358204|NCT03121950|12555248|FG000|COMPLETED|Overall Study||6
11358205|NCT03121950|12555249|FG001|COMPLETED|Overall Study||1
11358206|NCT03121950|12555248|FG000|NOT COMPLETED|Overall Study||11
11358207|NCT03121950|12555249|FG001|NOT COMPLETED|Overall Study||2
11358208|NCT03122145|12555259|FG000|STARTED|Overall Study|34 participants completed the first sub study under this IRB|37
11358209|NCT03122145|12555260|FG001|STARTED|Overall Study||12
11358210|NCT03122145|12555259|FG000|COMPLETED|Overall Study||34
11358211|NCT03122145|12555260|FG001|COMPLETED|Overall Study||12
11358212|NCT03122145|12555259|FG000|NOT COMPLETED|Overall Study||3
11358213|NCT03122145|12555260|FG001|NOT COMPLETED|Overall Study||0
11358214|NCT03122171|12555266|FG000|STARTED|Overall Study||6
11358215|NCT03122171|12555266|FG000|COMPLETED|Overall Study||5
11358216|NCT03122171|12555266|FG000|NOT COMPLETED|Overall Study||1
11358217|NCT03122184|12555272|FG000|STARTED|Overall Study||24
11358218|NCT03122184|12555273|FG001|STARTED|Overall Study||23
11358219|NCT03122184|12555272|FG000|COMPLETED|Overall Study||16
11358220|NCT03122184|12555273|FG001|COMPLETED|Overall Study||17
11358221|NCT03122184|12555272|FG000|NOT COMPLETED|Overall Study||8
11358222|NCT03122184|12555273|FG001|NOT COMPLETED|Overall Study||6
11358223|NCT03122223|12555283|FG000|STARTED|Overall Study||50
11358224|NCT03122223|12555284|FG001|STARTED|Overall Study||50
11358225|NCT03122223|12555285|FG002|STARTED|Overall Study||50
11358226|NCT03122223|12555286|FG003|STARTED|Overall Study||10
11358227|NCT03122223|12555283|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||49
11358228|NCT03122223|12555284|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||48
11358229|NCT03122223|12555285|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||47
11358230|NCT03122223|12555286|FG003|Month 6.5 Immunogenicity Cohort|Overall Study||8
11358231|NCT03122223|12555283|FG000|Month 12 Immunogenicity Cohort|Overall Study||47
11358232|NCT03122223|12555284|FG001|Month 12 Immunogenicity Cohort|Overall Study||45
11358233|NCT03122223|12555285|FG002|Month 12 Immunogenicity Cohort|Overall Study||46
11358234|NCT03122223|12555286|FG003|Month 12 Immunogenicity Cohort|Overall Study||10
11358235|NCT03122223|12555283|FG000|COMPLETED|Overall Study||47
11358236|NCT03122223|12555284|FG001|COMPLETED|Overall Study||45
11358237|NCT03122223|12555285|FG002|COMPLETED|Overall Study||46
11358238|NCT03122223|12555286|FG003|COMPLETED|Overall Study||10
11358239|NCT03122223|12555283|FG000|NOT COMPLETED|Overall Study||3
11358240|NCT03122223|12555284|FG001|NOT COMPLETED|Overall Study||5
11358241|NCT03122223|12555285|FG002|NOT COMPLETED|Overall Study||4
11358242|NCT03122223|12555286|FG003|NOT COMPLETED|Overall Study||0
11358243|NCT03122457|12555296|FG000|STARTED|Overall Study||22
11358244|NCT03122457|12555296|FG000|COMPLETED|Overall Study||16
11358245|NCT03122457|12555296|FG000|NOT COMPLETED|Overall Study||6
11358246|NCT03122535|12555300|FG000|STARTED|Overall Study||115
11358247|NCT03122535|12555301|FG001|STARTED|Overall Study||115
11358248|NCT03122535|12555300|FG000|3 Months|Overall Study||92
11358249|NCT03122535|12555301|FG001|3 Months|Overall Study||92
11358250|NCT03122535|12555300|FG000|12 Months|Overall Study||42
11358251|NCT03122535|12555301|FG001|12 Months|Overall Study||42
11243515|NCT02110758|12436023|FG002|NOT COMPLETED|Start-Up: August 2013-June 2014||0
11243516|NCT02110758|12436024|FG003|NOT COMPLETED|Start-Up: August 2013-June 2014||0
11243517|NCT02110758|12436025|FG004|NOT COMPLETED|Start-Up: August 2013-June 2014||0
11243518|NCT02110758|12436021|FG000|STARTED|Intervention: July 2014-December 2015||0
11243519|NCT02110758|12436022|FG001|STARTED|Intervention: July 2014-December 2015||0
11243520|NCT02110758|12436023|FG002|STARTED|Intervention: July 2014-December 2015||10106
11243521|NCT02110758|12436024|FG003|STARTED|Intervention: July 2014-December 2015||33012
11243522|NCT02110758|12436025|FG004|STARTED|Intervention: July 2014-December 2015||0
11243523|NCT02110758|12436021|FG000|COMPLETED|Intervention: July 2014-December 2015||0
11243524|NCT02110758|12436022|FG001|COMPLETED|Intervention: July 2014-December 2015||0
11243525|NCT02110758|12436023|FG002|COMPLETED|Intervention: July 2014-December 2015||10106
11243526|NCT02110758|12436024|FG003|COMPLETED|Intervention: July 2014-December 2015||33012
11243527|NCT02110758|12436025|FG004|COMPLETED|Intervention: July 2014-December 2015||0
11243528|NCT02110758|12436021|FG000|NOT COMPLETED|Intervention: July 2014-December 2015||0
11243529|NCT02110758|12436022|FG001|NOT COMPLETED|Intervention: July 2014-December 2015||0
11243530|NCT02110758|12436023|FG002|NOT COMPLETED|Intervention: July 2014-December 2015||0
11243531|NCT02110758|12436024|FG003|NOT COMPLETED|Intervention: July 2014-December 2015||0
11243532|NCT02110758|12436025|FG004|NOT COMPLETED|Intervention: July 2014-December 2015||0
11243533|NCT02110758|12436021|FG000|STARTED|Follow-Up: January-July 2016||81
11243534|NCT02110758|12436022|FG001|STARTED|Follow-Up: January-July 2016||179
11243535|NCT02110758|12436023|FG002|STARTED|Follow-Up: January-July 2016||6451
11243536|NCT02110758|12436024|FG003|STARTED|Follow-Up: January-July 2016||24392
11243537|NCT02110758|12436025|FG004|STARTED|Follow-Up: January-July 2016||349
11243538|NCT02110758|12436021|FG000|COMPLETED|Follow-Up: January-July 2016||81
11243539|NCT02110758|12436022|FG001|COMPLETED|Follow-Up: January-July 2016||179
11243540|NCT02110758|12436023|FG002|COMPLETED|Follow-Up: January-July 2016||6451
11243541|NCT02110758|12436024|FG003|COMPLETED|Follow-Up: January-July 2016||24392
11243542|NCT02110758|12436025|FG004|COMPLETED|Follow-Up: January-July 2016||349
11243543|NCT02110758|12436021|FG000|NOT COMPLETED|Follow-Up: January-July 2016||0
11243544|NCT02110758|12436022|FG001|NOT COMPLETED|Follow-Up: January-July 2016||0
11243545|NCT02110758|12436023|FG002|NOT COMPLETED|Follow-Up: January-July 2016||0
11243546|NCT02110758|12436024|FG003|NOT COMPLETED|Follow-Up: January-July 2016||0
11243547|NCT02110758|12436025|FG004|NOT COMPLETED|Follow-Up: January-July 2016||0
11243548|NCT02110901|12436039|FG000|STARTED|Overall Study||209
11243549|NCT02110901|12436040|FG001|STARTED|Overall Study||102
11243550|NCT02110901|12436039|FG000|COMPLETED|Overall Study||179
11243551|NCT02110901|12436040|FG001|COMPLETED|Overall Study||88
11243552|NCT02110901|12436039|FG000|NOT COMPLETED|Overall Study||30
11243553|NCT02110901|12436040|FG001|NOT COMPLETED|Overall Study||14
11243554|NCT02111083|12436049|FG000|STARTED|First Intervention (1 Day)||19
11243555|NCT02111083|12436050|FG001|STARTED|First Intervention (1 Day)||19
11243556|NCT02111083|12436049|FG000|COMPLETED|First Intervention (1 Day)||19
11243557|NCT02111083|12436050|FG001|COMPLETED|First Intervention (1 Day)||19
11243558|NCT02111083|12436049|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11243559|NCT02111083|12436050|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11243560|NCT02111083|12436049|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
11243561|NCT02111083|12436050|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
11243562|NCT02111083|12436049|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19
11243563|NCT02111083|12436050|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19
11243564|NCT02111083|12436049|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
11243565|NCT02111083|12436050|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
11243566|NCT02111083|12436049|FG000|STARTED|Second Intervention (1 Day)||19
11243567|NCT02111083|12436050|FG001|STARTED|Second Intervention (1 Day)||19
11243568|NCT02111083|12436049|FG000|COMPLETED|Second Intervention (1 Day)||19
11243569|NCT02111083|12436050|FG001|COMPLETED|Second Intervention (1 Day)||19
11243570|NCT02111083|12436049|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11243571|NCT02111083|12436050|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11243572|NCT02111083|12436049|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
11243573|NCT02111083|12436050|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
11243574|NCT02111083|12436049|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19
11243575|NCT02111083|12436050|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19
11243576|NCT02111083|12436049|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
11243577|NCT02111083|12436050|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
11243578|NCT02111083|12436049|FG000|STARTED|Third Intervention (1 Day)||19
11243579|NCT02111083|12436050|FG001|STARTED|Third Intervention (1 Day)||19
11243580|NCT02111083|12436049|FG000|COMPLETED|Third Intervention (1 Day)||19
11243581|NCT02111083|12436050|FG001|COMPLETED|Third Intervention (1 Day)||19
11243582|NCT02111083|12436049|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11243583|NCT02111083|12436050|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11243584|NCT02111083|12436049|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
11243585|NCT02111083|12436050|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
11243586|NCT02111083|12436049|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||18
11243587|NCT02111083|12436050|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||18
11243588|NCT02111083|12436049|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
11243589|NCT02111083|12436050|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
11243590|NCT02111083|12436049|FG000|STARTED|Fourth Intervention (1 Day)||18
11243591|NCT02111083|12436050|FG001|STARTED|Fourth Intervention (1 Day)||18
11243592|NCT02111083|12436049|FG000|COMPLETED|Fourth Intervention (1 Day)||18
11243593|NCT02111083|12436050|FG001|COMPLETED|Fourth Intervention (1 Day)||18
11243594|NCT02111083|12436049|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
11243595|NCT02111083|12436050|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
11243596|NCT02111096|12436059|FG000|STARTED|Overall Study||65
11243597|NCT02111096|12436060|FG001|STARTED|Overall Study||41
11243598|NCT02111096|12436061|FG002|STARTED|Overall Study||68
11243599|NCT02111096|12436059|FG000|Received at Least 1 Dose of Study Drug|Overall Study||65
11243600|NCT02111096|12436060|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
11243601|NCT02111096|12436061|FG002|Received at Least 1 Dose of Study Drug|Overall Study||68
11243602|NCT02111096|12436059|FG000|COMPLETED|Overall Study||1
11243603|NCT02111096|12436060|FG001|COMPLETED|Overall Study||0
11243604|NCT02111096|12436061|FG002|COMPLETED|Overall Study||2
11243605|NCT02111096|12436059|FG000|NOT COMPLETED|Overall Study||64
11243606|NCT02111096|12436060|FG001|NOT COMPLETED|Overall Study||41
11243607|NCT02111096|12436061|FG002|NOT COMPLETED|Overall Study||66
11243608|NCT02111174|12436074|FG000|STARTED|Treatment and Primary Outcome||18
11243609|NCT02111174|12436075|FG001|STARTED|Treatment and Primary Outcome||18
11243610|NCT02111174|12436074|FG000|COMPLETED|Treatment and Primary Outcome||15
11243611|NCT02111174|12436075|FG001|COMPLETED|Treatment and Primary Outcome||16
11243612|NCT02111174|12436074|FG000|NOT COMPLETED|Treatment and Primary Outcome||3
11243613|NCT02111174|12436075|FG001|NOT COMPLETED|Treatment and Primary Outcome||2
11243614|NCT02111174|12436074|FG000|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
11243615|NCT02111174|12436075|FG001|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
11243616|NCT02111174|12436074|FG000|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
11243617|NCT02111174|12436075|FG001|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
11243618|NCT02111174|12436074|FG000|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
11243619|NCT02111174|12436075|FG001|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
11243620|NCT02111174|12436074|FG000|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
11243621|NCT02111174|12436075|FG001|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
11243622|NCT02111187|12436083|FG000|STARTED|Overall Study||7
11243623|NCT02111187|12436084|FG001|STARTED|Overall Study||7
11243624|NCT02111187|12436083|FG000|COMPLETED|Overall Study||7
11243625|NCT02111187|12436084|FG001|COMPLETED|Overall Study||7
11243626|NCT02111187|12436083|FG000|NOT COMPLETED|Overall Study||0
11243627|NCT02111187|12436084|FG001|NOT COMPLETED|Overall Study||0
11243628|NCT02111200|12436094|FG000|STARTED|Overall Study||3
11243629|NCT02111200|12436095|FG001|STARTED|Overall Study||2
11243630|NCT02111200|12436096|FG002|STARTED|Overall Study||1
11243631|NCT02111200|12436097|FG003|STARTED|Overall Study||1
11243632|NCT02111200|12436094|FG000|COMPLETED|Overall Study||3
11243633|NCT02111200|12436095|FG001|COMPLETED|Overall Study||2
11243634|NCT02111200|12436096|FG002|COMPLETED|Overall Study||1
11243635|NCT02111200|12436097|FG003|COMPLETED|Overall Study||1
11243636|NCT02111200|12436094|FG000|NOT COMPLETED|Overall Study||0
11243637|NCT02111200|12436095|FG001|NOT COMPLETED|Overall Study||0
11243638|NCT02111200|12436096|FG002|NOT COMPLETED|Overall Study||0
11243639|NCT02111200|12436097|FG003|NOT COMPLETED|Overall Study||0
11243640|NCT02111213|12436107|FG000|STARTED|Overall Study||122
11243641|NCT02111213|12436108|FG001|STARTED|Overall Study||123
11243642|NCT02111213|12436107|FG000|COMPLETED|Overall Study||116
11243643|NCT02111213|12436108|FG001|COMPLETED|Overall Study||117
11243644|NCT02111213|12436107|FG000|NOT COMPLETED|Overall Study||6
11243645|NCT02111213|12436108|FG001|NOT COMPLETED|Overall Study||6
11243646|NCT02111252|12436114|FG000|STARTED|Overall Study||55
11243647|NCT02111252|12436114|FG000|COMPLETED|Overall Study||55
11243648|NCT02111252|12436114|FG000|NOT COMPLETED|Overall Study||0
11243649|NCT02111369|12436118|FG000|STARTED|Overall Study||18
11243650|NCT02111369|12436118|FG000|COMPLETED|Overall Study||15
11243651|NCT02111369|12436118|FG000|NOT COMPLETED|Overall Study||3
11243652|NCT02111447|12436126|FG000|STARTED|Overall Study||0
11243653|NCT02111447|12436127|FG001|STARTED|Overall Study||5
11243654|NCT02111447|12436128|FG002|STARTED|Overall Study||1
11243655|NCT02111447|12436129|FG003|STARTED|Overall Study||0
11243656|NCT02111447|12436126|FG000|COMPLETED|Overall Study||0
11243657|NCT02111447|12436127|FG001|COMPLETED|Overall Study||5
11243658|NCT02111447|12436128|FG002|COMPLETED|Overall Study||1
11243659|NCT02111447|12436129|FG003|COMPLETED|Overall Study||0
11243660|NCT02111447|12436126|FG000|NOT COMPLETED|Overall Study||0
11243661|NCT02111447|12436127|FG001|NOT COMPLETED|Overall Study||0
11243662|NCT02111447|12436128|FG002|NOT COMPLETED|Overall Study||0
11243663|NCT02111447|12436129|FG003|NOT COMPLETED|Overall Study||0
11243664|NCT02111564|12436141|FG000|STARTED|Overall Study||6007
11243665|NCT02111564|12436142|FG001|STARTED|Overall Study||6012
11243666|NCT02111564|12436141|FG000|Treated|Overall Study||5982
11243667|NCT02111564|12436142|FG001|Treated|Overall Study||5980
11243668|NCT02111564|12436141|FG000|COMPLETED|Overall Study||5876
11243669|NCT02111564|12436142|FG001|COMPLETED|Overall Study||5869
11243670|NCT02111564|12436141|FG000|NOT COMPLETED|Overall Study||131
11243671|NCT02111564|12436142|FG001|NOT COMPLETED|Overall Study||143
11243672|NCT02111577|12436150|FG000|STARTED|Overall Study||787
11243673|NCT02111577|12436151|FG001|STARTED|Overall Study||395
11243674|NCT02111577|12436150|FG000|COMPLETED|Overall Study||188
11243675|NCT02111577|12436151|FG001|COMPLETED|Overall Study||106
11243676|NCT02111577|12436150|FG000|NOT COMPLETED|Overall Study||599
11243677|NCT02111577|12436151|FG001|NOT COMPLETED|Overall Study||289
11243678|NCT02111603|12436159|FG000|STARTED|Overall Study||13
11243679|NCT02111603|12436159|FG000|COMPLETED|Overall Study||12
11243680|NCT02111603|12436159|FG000|NOT COMPLETED|Overall Study||1
11243681|NCT02111746|12436165|FG000|STARTED|Overall Study||172
11243682|NCT02111746|12436166|FG001|STARTED|Overall Study||171
11243683|NCT02111746|12436165|FG000|COMPLETED|Overall Study||169
11243684|NCT02111746|12436166|FG001|COMPLETED|Overall Study||169
11243685|NCT02111746|12436165|FG000|NOT COMPLETED|Overall Study||3
11243686|NCT02111746|12436166|FG001|NOT COMPLETED|Overall Study||2
11243687|NCT02111772|12436174|FG000|STARTED|Overall Study||12
11243688|NCT02111772|12436175|FG001|STARTED|Overall Study||14
11243689|NCT02111772|12436174|FG000|COMPLETED|Overall Study||12
11243690|NCT02111772|12436175|FG001|COMPLETED|Overall Study||14
11243691|NCT02111772|12436174|FG000|NOT COMPLETED|Overall Study||0
11243692|NCT02111772|12436175|FG001|NOT COMPLETED|Overall Study||0
11243693|NCT02111785|12436185|FG000|STARTED|Overall Study||3
11243694|NCT02111785|12436186|FG001|STARTED|Overall Study||5
11243695|NCT02111785|12436187|FG002|STARTED|Overall Study||1
11243696|NCT02111785|12436188|FG003|STARTED|Overall Study||1
11243697|NCT02111785|12436185|FG000|COMPLETED|Overall Study||3
11243698|NCT02111785|12436186|FG001|COMPLETED|Overall Study||4
11243699|NCT02111785|12436187|FG002|COMPLETED|Overall Study||1
11243700|NCT02111785|12436188|FG003|COMPLETED|Overall Study||1
11243701|NCT02111785|12436185|FG000|NOT COMPLETED|Overall Study||0
11243702|NCT02111785|12436186|FG001|NOT COMPLETED|Overall Study||1
11243703|NCT02111785|12436187|FG002|NOT COMPLETED|Overall Study||0
11243704|NCT02111785|12436188|FG003|NOT COMPLETED|Overall Study||0
11243705|NCT02111798|12436206|FG000|STARTED|Overall Study||31
11243706|NCT02111798|12436207|FG001|STARTED|Overall Study||32
11243707|NCT02111798|12436208|FG002|STARTED|Overall Study||10
11243708|NCT02111798|12436209|FG003|STARTED|Overall Study||10
11243709|NCT02111798|12436206|FG000|COMPLETED|Overall Study||20
11243710|NCT02111798|12436207|FG001|COMPLETED|Overall Study||16
11243711|NCT02111798|12436208|FG002|COMPLETED|Overall Study||10
11243712|NCT02111798|12436209|FG003|COMPLETED|Overall Study||7
11243713|NCT02111798|12436206|FG000|NOT COMPLETED|Overall Study||11
11243714|NCT02111798|12436207|FG001|NOT COMPLETED|Overall Study||16
11243715|NCT02111798|12436208|FG002|NOT COMPLETED|Overall Study||0
11243716|NCT02111798|12436209|FG003|NOT COMPLETED|Overall Study||3
11339075|NCT02908880|12536510|FG000|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263
11339076|NCT02908880|12536510|FG000|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236
11339077|NCT02908880|12536510|FG000|NOT COMPLETED|Overall Study||27
11339078|NCT02909101|12536516|FG000|STARTED|Overall Study||29
11339079|NCT02909101|12536517|FG001|STARTED|Overall Study||29
11339080|NCT02909101|12536516|FG000|COMPLETED|Overall Study||28
11339081|NCT02909101|12536517|FG001|COMPLETED|Overall Study||28
11339082|NCT02909101|12536516|FG000|NOT COMPLETED|Overall Study||1
11339083|NCT02909101|12536517|FG001|NOT COMPLETED|Overall Study||1
11339084|NCT02909140|12536526|FG000|STARTED|Overall Study||0
11339085|NCT02909140|12536527|FG001|STARTED|Overall Study||2
11339086|NCT02909140|12536528|FG002|STARTED|Overall Study||0
11339087|NCT02909140|12536526|FG000|COMPLETED|Overall Study||0
11339088|NCT02909140|12536527|FG001|COMPLETED|Overall Study||2
11339089|NCT02909140|12536528|FG002|COMPLETED|Overall Study||0
11339090|NCT02909140|12536526|FG000|NOT COMPLETED|Overall Study||0
11339091|NCT02909140|12536527|FG001|NOT COMPLETED|Overall Study||0
11339092|NCT02909140|12536528|FG002|NOT COMPLETED|Overall Study||0
11339093|NCT02909153|12536541|FG000|STARTED|Overall Study||6
11339094|NCT02909153|12536542|FG001|STARTED|Overall Study||6
11339095|NCT02909153|12536543|FG002|STARTED|Overall Study||6
11339096|NCT02909153|12536544|FG003|STARTED|Overall Study||6
11339097|NCT02909153|12536545|FG004|STARTED|Overall Study||6
11339098|NCT02909153|12536541|FG000|Triferic in Dianeal PD Solution|Overall Study||6
11339099|NCT02909153|12536542|FG001|Triferic in Dianeal PD Solution|Overall Study||6
11339100|NCT02909153|12536543|FG002|Triferic in Dianeal PD Solution|Overall Study||6
11339101|NCT02909153|12536544|FG003|Triferic in Dianeal PD Solution|Overall Study||0
11339102|NCT02909153|12536545|FG004|Triferic in Dianeal PD Solution|Overall Study||0
11339103|NCT02909153|12536541|FG000|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
11339104|NCT02909153|12536542|FG001|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5
11339105|NCT02909153|12536543|FG002|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
11339106|NCT02909153|12536544|FG003|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
11339107|NCT02909153|12536545|FG004|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
11339108|NCT02909153|12536541|FG000|Triferic in Extraneal PD Solution|Overall Study||0
11339109|NCT02909153|12536542|FG001|Triferic in Extraneal PD Solution|Overall Study||0
11339110|NCT02909153|12536543|FG002|Triferic in Extraneal PD Solution|Overall Study||0
11339111|NCT02909153|12536544|FG003|Triferic in Extraneal PD Solution|Overall Study||6
11339112|NCT02909153|12536545|FG004|Triferic in Extraneal PD Solution|Overall Study||6
11339113|NCT02909153|12536541|FG000|COMPLETED|Overall Study||6
11339114|NCT02909153|12536542|FG001|COMPLETED|Overall Study||5
11339115|NCT02909153|12536543|FG002|COMPLETED|Overall Study||6
11339116|NCT02909153|12536544|FG003|COMPLETED|Overall Study||6
11339117|NCT02909153|12536545|FG004|COMPLETED|Overall Study||6
11339118|NCT02909153|12536541|FG000|NOT COMPLETED|Overall Study||0
11339119|NCT02909153|12536542|FG001|NOT COMPLETED|Overall Study||1
11339120|NCT02909153|12536543|FG002|NOT COMPLETED|Overall Study||0
11339121|NCT02909153|12536544|FG003|NOT COMPLETED|Overall Study||0
11339122|NCT02909153|12536545|FG004|NOT COMPLETED|Overall Study||0
11339123|NCT02909439|12536559|FG000|STARTED|Overall Study||31
11339124|NCT02909439|12536560|FG001|STARTED|Overall Study||31
11339125|NCT02909439|12536559|FG000|COMPLETED|Overall Study||31
11339126|NCT02909439|12536560|FG001|COMPLETED|Overall Study||31
11339127|NCT02909439|12536559|FG000|NOT COMPLETED|Overall Study||0
11339128|NCT02909439|12536560|FG001|NOT COMPLETED|Overall Study||0
11339129|NCT02909504|12536566|FG000|STARTED|Overall Study||24
11339130|NCT02909504|12536566|FG000|COMPLETED|Overall Study||12
11339131|NCT02909504|12536566|FG000|NOT COMPLETED|Overall Study||12
11339132|NCT02909764|12536573|FG000|STARTED|Overall Study||19
11339133|NCT02909764|12536574|FG001|STARTED|Overall Study||20
11339134|NCT02909764|12536573|FG000|COMPLETED|Overall Study||19
11339135|NCT02909764|12536574|FG001|COMPLETED|Overall Study||20
11339136|NCT02909764|12536573|FG000|NOT COMPLETED|Overall Study||0
11339137|NCT02909764|12536574|FG001|NOT COMPLETED|Overall Study||0
11339138|NCT02909907|12536585|FG000|STARTED|Overall Study||10
11339139|NCT02909907|12536586|FG001|STARTED|Overall Study||10
11339140|NCT02909907|12536585|FG000|COMPLETED|Overall Study||10
11339141|NCT02909907|12536586|FG001|COMPLETED|Overall Study||9
11339142|NCT02909907|12536585|FG000|NOT COMPLETED|Overall Study||0
11339143|NCT02909907|12536586|FG001|NOT COMPLETED|Overall Study||1
11339144|NCT02909959|12536594|FG000|STARTED|Overall Study||24
11339145|NCT02909959|12536595|FG001|STARTED|Overall Study||24
11339146|NCT02909959|12536594|FG000|COMPLETED|Overall Study||24
11339147|NCT02909959|12536595|FG001|COMPLETED|Overall Study||24
11339148|NCT02909959|12536594|FG000|NOT COMPLETED|Overall Study||0
11339149|NCT02909959|12536595|FG001|NOT COMPLETED|Overall Study||0
11243717|NCT02111811|12436222|FG000|STARTED|Treatment Phase||139
11243718|NCT02111811|12436223|FG001|STARTED|Treatment Phase||114
11243719|NCT02111811|12436222|FG000|COMPLETED|Treatment Phase||115
11243720|NCT02111811|12436223|FG001|COMPLETED|Treatment Phase||96
11243721|NCT02111811|12436222|FG000|NOT COMPLETED|Treatment Phase||24
11243722|NCT02111811|12436223|FG001|NOT COMPLETED|Treatment Phase||18
11243723|NCT02111811|12436222|FG000|STARTED|Follow up Period (Aim 2)||139
11243724|NCT02111811|12436223|FG001|STARTED|Follow up Period (Aim 2)|All subjects were approached for followup, 1 patient completed the 2nd followup and not the first.|114
11243725|NCT02111811|12436222|FG000|COMPLETED|Follow up Period (Aim 2)||111
11243726|NCT02111811|12436223|FG001|COMPLETED|Follow up Period (Aim 2)||97
11243727|NCT02111811|12436222|FG000|NOT COMPLETED|Follow up Period (Aim 2)||28
11243728|NCT02111811|12436223|FG001|NOT COMPLETED|Follow up Period (Aim 2)||17
11243729|NCT02111863|12436229|FG000|STARTED|Overall Study||6
11243730|NCT02111863|12436229|FG000|COMPLETED|Overall Study||6
11243731|NCT02111863|12436229|FG000|NOT COMPLETED|Overall Study||0
11243732|NCT02111980|12436233|FG000|STARTED|Overall Study||50
11243733|NCT02111980|12436233|FG000|COMPLETED|Overall Study||50
11243734|NCT02111980|12436233|FG000|NOT COMPLETED|Overall Study||0
11243735|NCT02111993|12436242|FG000|STARTED|Overall Study||30
11243736|NCT02111993|12436243|FG001|STARTED|Overall Study||30
11243737|NCT02111993|12436242|FG000|COMPLETED|Overall Study||25
11243738|NCT02111993|12436243|FG001|COMPLETED|Overall Study||26
11243739|NCT02111993|12436242|FG000|NOT COMPLETED|Overall Study||5
11243740|NCT02111993|12436243|FG001|NOT COMPLETED|Overall Study||4
11243741|NCT02112045|12436253|FG000|STARTED|Overall Study||45
11243742|NCT02112045|12436254|FG001|STARTED|Overall Study||45
11243743|NCT02112045|12436253|FG000|COMPLETED|Overall Study||44
11243744|NCT02112045|12436254|FG001|COMPLETED|Overall Study||45
11243745|NCT02112045|12436253|FG000|NOT COMPLETED|Overall Study||1
11243746|NCT02112045|12436254|FG001|NOT COMPLETED|Overall Study||0
11243747|NCT02112370|12436262|FG000|STARTED|Overall Study||74
11243748|NCT02112370|12436263|FG001|STARTED|Overall Study||74
11243749|NCT02112370|12436262|FG000|COMPLETED|Overall Study||74
11243750|NCT02112370|12436263|FG001|COMPLETED|Overall Study||74
11243751|NCT02112370|12436262|FG000|NOT COMPLETED|Overall Study||0
11243752|NCT02112370|12436263|FG001|NOT COMPLETED|Overall Study||0
11243753|NCT02112448|12436271|FG000|STARTED|Overall Study||38
11243754|NCT02112448|12436272|FG001|STARTED|Overall Study||40
11243755|NCT02112448|12436271|FG000|COMPLETED|Overall Study||30
11243756|NCT02112448|12436272|FG001|COMPLETED|Overall Study||30
11243757|NCT02112448|12436271|FG000|NOT COMPLETED|Overall Study||8
11243758|NCT02112448|12436272|FG001|NOT COMPLETED|Overall Study||10
11243759|NCT02112838|12436283|FG000|STARTED|Overall Study||25
11243760|NCT02112838|12436284|FG001|STARTED|Overall Study||26
11243761|NCT02112838|12436285|FG002|STARTED|Overall Study||25
11243762|NCT02112838|12436283|FG000|COMPLETED|Overall Study||20
11243763|NCT02112838|12436284|FG001|COMPLETED|Overall Study||24
11243764|NCT02112838|12436285|FG002|COMPLETED|Overall Study||24
11243765|NCT02112838|12436283|FG000|NOT COMPLETED|Overall Study||5
11243766|NCT02112838|12436284|FG001|NOT COMPLETED|Overall Study||2
11243767|NCT02112838|12436285|FG002|NOT COMPLETED|Overall Study||1
11243768|NCT02112877|12436295|FG000|STARTED|Overall Study||30
11243769|NCT02112877|12436296|FG001|STARTED|Overall Study||170
11243770|NCT02112877|12436295|FG000|COMPLETED|Overall Study||28
11243771|NCT02112877|12436296|FG001|COMPLETED|Overall Study||157
11243772|NCT02112877|12436295|FG000|NOT COMPLETED|Overall Study||2
11243773|NCT02112877|12436296|FG001|NOT COMPLETED|Overall Study||13
11243774|NCT02112994|12436304|FG000|STARTED|Overall Study||6
11243775|NCT02112994|12436305|FG001|STARTED|Overall Study||16
11243776|NCT02112994|12436306|FG002|STARTED|Overall Study||9
11243777|NCT02112994|12436304|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
11243778|NCT02112994|12436305|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
11243779|NCT02112994|12436306|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
11243780|NCT02112994|12436304|FG000|Received 0.35 mg/kg QOW|Overall Study||0
11243781|NCT02112994|12436305|FG001|Received 0.35 mg/kg QOW|Overall Study||0
11243782|NCT02112994|12436306|FG002|Received 0.35 mg/kg QOW|Overall Study||1
11243783|NCT02112994|12436304|FG000|Received 1 mg/kg QOW|Overall Study||6
11243784|NCT02112994|12436305|FG001|Received 1 mg/kg QOW|Overall Study||16
11243785|NCT02112994|12436306|FG002|Received 1 mg/kg QOW|Overall Study||9
11243786|NCT02112994|12436304|FG000|Received 1 mg/kg QW|Overall Study||1
11243787|NCT02112994|12436305|FG001|Received 1 mg/kg QW|Overall Study||1
11243788|NCT02112994|12436306|FG002|Received 1 mg/kg QW|Overall Study||0
11243789|NCT02112994|12436304|FG000|Received 3 mg/kg QOW|Overall Study||3
11243790|NCT02112994|12436305|FG001|Received 3 mg/kg QOW|Overall Study||5
11243791|NCT02112994|12436306|FG002|Received 3 mg/kg QOW|Overall Study||3
11243792|NCT02112994|12436304|FG000|Received 3 mg/kg QW|Overall Study||2
11243793|NCT02112994|12436305|FG001|Received 3 mg/kg QW|Overall Study||1
11243794|NCT02112994|12436306|FG002|Received 3 mg/kg QW|Overall Study||1
11243795|NCT02112994|12436304|FG000|Completed 96-week Treatment Period|Overall Study||6
11243796|NCT02112994|12436305|FG001|Completed 96-week Treatment Period|Overall Study||14
11243797|NCT02112994|12436306|FG002|Completed 96-week Treatment Period|Overall Study||8
11243798|NCT02112994|12436304|FG000|COMPLETED|Overall Study||6
11243799|NCT02112994|12436305|FG001|COMPLETED|Overall Study||14
11243800|NCT02112994|12436306|FG002|COMPLETED|Overall Study||6
11243801|NCT02112994|12436304|FG000|NOT COMPLETED|Overall Study||0
11243802|NCT02112994|12436305|FG001|NOT COMPLETED|Overall Study||2
11243803|NCT02112994|12436306|FG002|NOT COMPLETED|Overall Study||3
11243804|NCT02113007|12436318|FG000|STARTED|Overall Study||2
11243805|NCT02113007|12436318|FG000|COMPLETED|Overall Study||0
11243806|NCT02113007|12436318|FG000|NOT COMPLETED|Overall Study||2
11243807|NCT02113124|12436324|FG000|STARTED|Overall Study||18
11243808|NCT02113124|12436325|FG001|STARTED|Overall Study||25
11243809|NCT02113124|12436324|FG000|COMPLETED|Overall Study||17
11243810|NCT02113124|12436325|FG001|COMPLETED|Overall Study||24
11243811|NCT02113124|12436324|FG000|NOT COMPLETED|Overall Study||1
11243812|NCT02113124|12436325|FG001|NOT COMPLETED|Overall Study||1
11243813|NCT02113189|12436334|FG000|STARTED|Overall Study||4
11243814|NCT02113189|12436335|FG001|STARTED|Overall Study||4
11243815|NCT02113189|12436336|FG002|STARTED|Overall Study||5
11243816|NCT02113189|12436334|FG000|COMPLETED|Overall Study||2
11243817|NCT02113189|12436335|FG001|COMPLETED|Overall Study||3
11243818|NCT02113189|12436336|FG002|COMPLETED|Overall Study||2
11243819|NCT02113189|12436334|FG000|NOT COMPLETED|Overall Study||2
11243820|NCT02113189|12436335|FG001|NOT COMPLETED|Overall Study||1
11243821|NCT02113189|12436336|FG002|NOT COMPLETED|Overall Study||3
11243822|NCT02113241|12436349|FG000|STARTED|Overall Study||12
11243823|NCT02113241|12436350|FG001|STARTED|Overall Study||12
11243824|NCT02113241|12436349|FG000|COMPLETED|Overall Study||12
11243825|NCT02113241|12436350|FG001|COMPLETED|Overall Study||11
11243826|NCT02113241|12436349|FG000|NOT COMPLETED|Overall Study||0
11243827|NCT02113241|12436350|FG001|NOT COMPLETED|Overall Study||1
11243828|NCT02113410|12436358|FG000|STARTED|Overall Study||65
11243829|NCT02113410|12436359|FG001|STARTED|Overall Study||66
11243830|NCT02113410|12436358|FG000|COMPLETED|Overall Study||49
11243831|NCT02113410|12436359|FG001|COMPLETED|Overall Study||63
11243832|NCT02113410|12436358|FG000|NOT COMPLETED|Overall Study||16
11243833|NCT02113410|12436359|FG001|NOT COMPLETED|Overall Study||3
11243834|NCT02113436|12436369|FG000|STARTED|Period 1: 8 Weeks||150
11243835|NCT02113436|12436370|FG001|STARTED|Period 1: 8 Weeks||150
11243836|NCT02113436|12436371|FG002|STARTED|Period 1: 8 Weeks||0
11243837|NCT02113436|12436372|FG003|STARTED|Period 1: 8 Weeks||0
11243838|NCT02113436|12436369|FG000|COMPLETED|Period 1: 8 Weeks||142
11243839|NCT02113436|12436370|FG001|COMPLETED|Period 1: 8 Weeks||148
11243840|NCT02113436|12436371|FG002|COMPLETED|Period 1: 8 Weeks||0
11243841|NCT02113436|12436372|FG003|COMPLETED|Period 1: 8 Weeks||0
11243842|NCT02113436|12436369|FG000|NOT COMPLETED|Period 1: 8 Weeks||8
11243843|NCT02113436|12436370|FG001|NOT COMPLETED|Period 1: 8 Weeks||2
11243844|NCT02113436|12436371|FG002|NOT COMPLETED|Period 1: 8 Weeks||0
11243845|NCT02113436|12436372|FG003|NOT COMPLETED|Period 1: 8 Weeks||0
11243846|NCT02113436|12436369|FG000|STARTED|Period 2: 16 Weeks||0
11243847|NCT02113436|12436370|FG001|STARTED|Period 2: 16 Weeks||0
11243848|NCT02113436|12436371|FG002|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|141
11243849|NCT02113436|12436372|FG003|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|147
11243850|NCT02113436|12436369|FG000|COMPLETED|Period 2: 16 Weeks||0
11243851|NCT02113436|12436370|FG001|COMPLETED|Period 2: 16 Weeks||0
11243852|NCT02113436|12436371|FG002|COMPLETED|Period 2: 16 Weeks||132
11243853|NCT02113436|12436372|FG003|COMPLETED|Period 2: 16 Weeks||136
11243854|NCT02113436|12436369|FG000|NOT COMPLETED|Period 2: 16 Weeks||0
11243855|NCT02113436|12436370|FG001|NOT COMPLETED|Period 2: 16 Weeks||0
11243856|NCT02113436|12436371|FG002|NOT COMPLETED|Period 2: 16 Weeks||9
11243857|NCT02113436|12436372|FG003|NOT COMPLETED|Period 2: 16 Weeks||11
11243858|NCT02113449|12436381|FG000|STARTED|Overall Study||147
11243859|NCT02113449|12436381|FG000|COMPLETED|Overall Study||143
11243860|NCT02113449|12436381|FG000|NOT COMPLETED|Overall Study||4
11243861|NCT02113579|12436391|FG000|STARTED|Overall Study||186
11243862|NCT02113579|12436392|FG001|STARTED|Overall Study||189
11243863|NCT02113579|12436391|FG000|COMPLETED|Overall Study||176
11243864|NCT02113579|12436392|FG001|COMPLETED|Overall Study||185
11243865|NCT02113579|12436391|FG000|NOT COMPLETED|Overall Study||10
11243866|NCT02113579|12436392|FG001|NOT COMPLETED|Overall Study||4
11243867|NCT02113956|12436400|FG000|STARTED|Intervention End (5 Weeks Post Baseline)||150
11243868|NCT02113956|12436401|FG001|STARTED|Intervention End (5 Weeks Post Baseline)||152
11243869|NCT02113956|12436400|FG000|COMPLETED|Intervention End (5 Weeks Post Baseline)||141
11243870|NCT02113956|12436401|FG001|COMPLETED|Intervention End (5 Weeks Post Baseline)||148
11243871|NCT02113956|12436400|FG000|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9
11243872|NCT02113956|12436401|FG001|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4
11243873|NCT02113956|12436400|FG000|STARTED|3 Month Post-intervention||141
11243874|NCT02113956|12436401|FG001|STARTED|3 Month Post-intervention||148
11243875|NCT02113956|12436400|FG000|COMPLETED|3 Month Post-intervention||137
11243876|NCT02113956|12436401|FG001|COMPLETED|3 Month Post-intervention||146
11243877|NCT02113956|12436400|FG000|NOT COMPLETED|3 Month Post-intervention||4
11243878|NCT02113956|12436401|FG001|NOT COMPLETED|3 Month Post-intervention||2
11243879|NCT02114151|12436407|FG000|STARTED|Overall Study||103
11243880|NCT02114151|12436407|FG000|COMPLETED|Overall Study||96
11243881|NCT02114151|12436407|FG000|NOT COMPLETED|Overall Study||7
11243882|NCT02114164|12436413|FG000|STARTED|Overall Study||50
11243883|NCT02114164|12436414|FG001|STARTED|Overall Study||50
11243884|NCT02114164|12436413|FG000|COMPLETED|Overall Study||50
11243885|NCT02114164|12436414|FG001|COMPLETED|Overall Study||50
11243886|NCT02114164|12436413|FG000|NOT COMPLETED|Overall Study||0
11243887|NCT02114164|12436414|FG001|NOT COMPLETED|Overall Study||0
11243888|NCT02114177|12436422|FG000|STARTED|Overall Study||155
11243889|NCT02114177|12436423|FG001|STARTED|Overall Study||155
11243890|NCT02114177|12436422|FG000|COMPLETED|Overall Study||146
11243891|NCT02114177|12436423|FG001|COMPLETED|Overall Study||151
11243892|NCT02114177|12436422|FG000|NOT COMPLETED|Overall Study||9
11243893|NCT02114177|12436423|FG001|NOT COMPLETED|Overall Study||4
11243894|NCT02114203|12436432|FG000|STARTED|Overall Study||7
11243895|NCT02114203|12436433|FG001|STARTED|Overall Study||16
11243896|NCT02114203|12436434|FG002|STARTED|Overall Study||7
11243897|NCT02114203|12436432|FG000|COMPLETED|Overall Study||7
11243898|NCT02114203|12436433|FG001|COMPLETED|Overall Study||14
11243899|NCT02114203|12436434|FG002|COMPLETED|Overall Study||7
11243900|NCT02114203|12436432|FG000|NOT COMPLETED|Overall Study||0
11243901|NCT02114203|12436433|FG001|NOT COMPLETED|Overall Study||2
11243902|NCT02114203|12436434|FG002|NOT COMPLETED|Overall Study||0
11243903|NCT02114216|12436445|FG000|STARTED|Overall Study||16
11243904|NCT02114216|12436446|FG001|STARTED|Overall Study||45
11243905|NCT02114216|12436447|FG002|STARTED|Overall Study||14
11243906|NCT02114216|12436445|FG000|COMPLETED|Overall Study||16
11243907|NCT02114216|12436446|FG001|COMPLETED|Overall Study||45
11243908|NCT02114216|12436447|FG002|COMPLETED|Overall Study||14
11243909|NCT02114216|12436445|FG000|NOT COMPLETED|Overall Study||0
11243910|NCT02114216|12436446|FG001|NOT COMPLETED|Overall Study||0
11243911|NCT02114216|12436447|FG002|NOT COMPLETED|Overall Study||0
11243912|NCT02114268|12436464|FG000|STARTED|Overall Study||34
11243913|NCT02114268|12436465|FG001|STARTED|Overall Study||6
11243914|NCT02114268|12436466|FG002|STARTED|Overall Study||6
11243915|NCT02114268|12436467|FG003|STARTED|Overall Study||6
11243916|NCT02114268|12436468|FG004|STARTED|Overall Study||6
11243917|NCT02114268|12436469|FG005|STARTED|Overall Study||78
11243918|NCT02114268|12436464|FG000|COMPLETED|Overall Study||28
11243919|NCT02114268|12436465|FG001|COMPLETED|Overall Study||5
11243920|NCT02114268|12436466|FG002|COMPLETED|Overall Study||5
11243921|NCT02114268|12436467|FG003|COMPLETED|Overall Study||6
11243922|NCT02114268|12436468|FG004|COMPLETED|Overall Study||6
11243923|NCT02114268|12436469|FG005|COMPLETED|Overall Study||75
11243924|NCT02114268|12436464|FG000|NOT COMPLETED|Overall Study||6
11243925|NCT02114268|12436465|FG001|NOT COMPLETED|Overall Study||1
11243926|NCT02114268|12436466|FG002|NOT COMPLETED|Overall Study||1
11243927|NCT02114268|12436467|FG003|NOT COMPLETED|Overall Study||0
11243928|NCT02114268|12436468|FG004|NOT COMPLETED|Overall Study||0
11243929|NCT02114268|12436469|FG005|NOT COMPLETED|Overall Study||3
11243930|NCT02114307|12436490|FG000|STARTED|Overall Study||11
11243931|NCT02114307|12436491|FG001|STARTED|Overall Study||11
11243932|NCT02114307|12436490|FG000|COMPLETED|Overall Study||10
11243933|NCT02114307|12436491|FG001|COMPLETED|Overall Study||11
11243934|NCT02114307|12436490|FG000|NOT COMPLETED|Overall Study||1
11243935|NCT02114307|12436491|FG001|NOT COMPLETED|Overall Study||0
11243936|NCT02114385|12436501|FG000|STARTED|Overall Study||249
11243937|NCT02114385|12436502|FG001|STARTED|Overall Study||251
11243938|NCT02114385|12436501|FG000|Vaccinated|Overall Study||249
11243939|NCT02114385|12436502|FG001|Vaccinated|Overall Study||251
11243940|NCT02114385|12436501|FG000|COMPLETED|Overall Study||246
11243941|NCT02114385|12436502|FG001|COMPLETED|Overall Study||243
11243942|NCT02114385|12436501|FG000|NOT COMPLETED|Overall Study||3
11243943|NCT02114385|12436502|FG001|NOT COMPLETED|Overall Study||8
11243944|NCT02114515|12436510|FG000|STARTED|Overall Study||511
11243945|NCT02114515|12436511|FG001|STARTED|Overall Study||518
11243946|NCT02114515|12436510|FG000|COMPLETED|Overall Study||378
11243947|NCT02114515|12436511|FG001|COMPLETED|Overall Study||368
11243948|NCT02114515|12436510|FG000|NOT COMPLETED|Overall Study||133
11243949|NCT02114515|12436511|FG001|NOT COMPLETED|Overall Study||150
11243950|NCT02114606|12436517|FG000|STARTED|Overall Study||86
11243951|NCT02114606|12436517|FG000|COMPLETED|Overall Study||80
11243952|NCT02114606|12436517|FG000|NOT COMPLETED|Overall Study||6
11243953|NCT02114684|12436523|FG000|STARTED|Overall Study||98
11243954|NCT02114684|12436524|FG001|STARTED|Overall Study||98
11243955|NCT02114684|12436523|FG000|COMPLETED|Overall Study||86
11243956|NCT02114684|12436524|FG001|COMPLETED|Overall Study||88
11243957|NCT02114684|12436523|FG000|NOT COMPLETED|Overall Study||12
11243958|NCT02114684|12436524|FG001|NOT COMPLETED|Overall Study||10
11243959|NCT02114879|12436536|FG000|STARTED|Overall Study||115
11243960|NCT02114879|12436537|FG001|STARTED|Overall Study||114
11243961|NCT02114879|12436536|FG000|COMPLETED|Overall Study||96
11243962|NCT02114879|12436537|FG001|COMPLETED|Overall Study||90
11243963|NCT02114879|12436536|FG000|NOT COMPLETED|Overall Study||19
11243964|NCT02114879|12436537|FG001|NOT COMPLETED|Overall Study||24
11243965|NCT02114892|12436545|FG000|STARTED|Overall Study||12
11243966|NCT02114892|12436546|FG001|STARTED|Overall Study||12
11243967|NCT02114892|12436545|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
11243968|NCT02114892|12436546|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
11243969|NCT02114892|12436545|FG000|NOT COMPLETED|Overall Study||1
11243970|NCT02114892|12436546|FG001|NOT COMPLETED|Overall Study||2
11243971|NCT02114931|12436554|FG000|STARTED|Overall Study||230
11243972|NCT02114931|12436555|FG001|STARTED|Overall Study||237
11243973|NCT02114931|12436554|FG000|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
11243974|NCT02114931|12436555|FG001|Received Treatment|Overall Study||237
11243975|NCT02114931|12436554|FG000|COMPLETED|Overall Study||205
11243976|NCT02114931|12436555|FG001|COMPLETED|Overall Study||207
11243977|NCT02114931|12436554|FG000|NOT COMPLETED|Overall Study||25
11243978|NCT02114931|12436555|FG001|NOT COMPLETED|Overall Study||30
11243979|NCT02115048|12436563|FG000|STARTED|Overall Study||23
11243980|NCT02115048|12436564|FG001|STARTED|Overall Study||21
11243981|NCT02115048|12436563|FG000|COMPLETED|Overall Study||23
11243982|NCT02115048|12436564|FG001|COMPLETED|Overall Study||21
11243983|NCT02115048|12436563|FG000|NOT COMPLETED|Overall Study||0
11243984|NCT02115048|12436564|FG001|NOT COMPLETED|Overall Study||0
11243985|NCT02115113|12436570|FG000|STARTED|Participants in Run-in Period||0
11243986|NCT02115113|12436571|FG001|STARTED|Participants in Run-in Period||0
11243987|NCT02115113|12436572|FG002|STARTED|Participants in Run-in Period||78
11005309|NCT00722020|12182980|FG001|NOT COMPLETED|Overall Study||0
11005310|NCT00722072|12182988|FG000|STARTED|Overall Study||12
11005311|NCT00722072|12182988|FG000|COMPLETED|Overall Study||9
11005312|NCT00722072|12182988|FG000|NOT COMPLETED|Overall Study||3
11005313|NCT00722111|12182994|FG000|STARTED|Overall Study||11
11005314|NCT00722111|12182995|FG001|STARTED|Overall Study||72
11005315|NCT00722111|12182994|FG000|COMPLETED|Overall Study||11
11005316|NCT00722111|12182995|FG001|COMPLETED|Overall Study||72
11005317|NCT00722111|12182994|FG000|NOT COMPLETED|Overall Study||0
11005318|NCT00722111|12182995|FG001|NOT COMPLETED|Overall Study||0
11005319|NCT00722124|12183004|FG000|STARTED|Overall Study||40
11005320|NCT00722124|12183005|FG001|STARTED|Overall Study||40
11005321|NCT00722124|12183006|FG002|STARTED|Overall Study||40
11005322|NCT00722124|12183004|FG000|COMPLETED|Overall Study||23
11005323|NCT00722124|12183005|FG001|COMPLETED|Overall Study||26
11005324|NCT00722124|12183006|FG002|COMPLETED|Overall Study||20
11005325|NCT00722124|12183004|FG000|NOT COMPLETED|Overall Study||17
11005326|NCT00722124|12183005|FG001|NOT COMPLETED|Overall Study||14
11005327|NCT00722124|12183006|FG002|NOT COMPLETED|Overall Study||20
11005328|NCT00722137|12183016|FG000|STARTED|Overall Study||244
11005329|NCT00722137|12183017|FG001|STARTED|Overall Study||243
11005330|NCT00722137|12183016|FG000|COMPLETED|Overall Study||199
11005331|NCT00722137|12183017|FG001|COMPLETED|Overall Study||195
11005332|NCT00722137|12183016|FG000|NOT COMPLETED|Overall Study||45
11005333|NCT00722137|12183017|FG001|NOT COMPLETED|Overall Study||48
11005334|NCT00722371|12183030|FG000|STARTED|Overall Study||231
11005335|NCT00722371|12183031|FG001|STARTED|Overall Study||230
11005336|NCT00722371|12183032|FG002|STARTED|Overall Study||233
11005337|NCT00722371|12183033|FG003|STARTED|Overall Study||230
11005338|NCT00722371|12183034|FG004|STARTED|Overall Study||230
11005339|NCT00722371|12183035|FG005|STARTED|Overall Study||231
11005340|NCT00722371|12183036|FG006|STARTED|Overall Study||230
11005341|NCT00722371|12183030|FG000|COMPLETED|Overall Study||175
11005342|NCT00722371|12183031|FG001|COMPLETED|Overall Study||158
11005343|NCT00722371|12183032|FG002|COMPLETED|Overall Study||168
11005344|NCT00722371|12183033|FG003|COMPLETED|Overall Study||167
11005345|NCT00722371|12183034|FG004|COMPLETED|Overall Study||182
11005346|NCT00722371|12183035|FG005|COMPLETED|Overall Study||178
11005347|NCT00722371|12183036|FG006|COMPLETED|Overall Study||179
11005348|NCT00722371|12183030|FG000|NOT COMPLETED|Overall Study||56
11005349|NCT00722371|12183031|FG001|NOT COMPLETED|Overall Study||72
11005350|NCT00722371|12183032|FG002|NOT COMPLETED|Overall Study||65
11005351|NCT00722371|12183033|FG003|NOT COMPLETED|Overall Study||63
11005352|NCT00722371|12183034|FG004|NOT COMPLETED|Overall Study||48
11005353|NCT00722371|12183035|FG005|NOT COMPLETED|Overall Study||53
11005354|NCT00722371|12183036|FG006|NOT COMPLETED|Overall Study||51
11005355|NCT00722423|12183054|FG000|STARTED|Overall Study||182
11005356|NCT00722423|12183055|FG001|STARTED|Overall Study||182
11243988|NCT02115113|12436570|FG000|COMPLETED|Participants in Run-in Period||0
11243989|NCT02115113|12436571|FG001|COMPLETED|Participants in Run-in Period||0
11243990|NCT02115113|12436572|FG002|COMPLETED|Participants in Run-in Period||68
11243991|NCT02115113|12436570|FG000|NOT COMPLETED|Participants in Run-in Period||0
11243992|NCT02115113|12436571|FG001|NOT COMPLETED|Participants in Run-in Period||0
11243993|NCT02115113|12436572|FG002|NOT COMPLETED|Participants in Run-in Period||10
11243994|NCT02115113|12436570|FG000|STARTED|Participants Randomized||24
11243995|NCT02115113|12436571|FG001|STARTED|Participants Randomized||26
11243996|NCT02115113|12436572|FG002|STARTED|Participants Randomized||0
11243997|NCT02115113|12436570|FG000|COMPLETED|Participants Randomized||22
11243998|NCT02115113|12436571|FG001|COMPLETED|Participants Randomized||26
11243999|NCT02115113|12436572|FG002|COMPLETED|Participants Randomized||0
11244000|NCT02115113|12436570|FG000|NOT COMPLETED|Participants Randomized||2
11244001|NCT02115113|12436571|FG001|NOT COMPLETED|Participants Randomized||0
11244002|NCT02115113|12436572|FG002|NOT COMPLETED|Participants Randomized||0
11244003|NCT02115139|12436581|FG000|STARTED|Overall Study||58
11244004|NCT02115139|12436581|FG000|COMPLETED|Overall Study||51
11244005|NCT02115139|12436581|FG000|NOT COMPLETED|Overall Study||7
11244006|NCT02115256|12436587|FG000|STARTED|Overall Study||3
11244007|NCT02115256|12436588|FG001|STARTED|Overall Study||3
11244008|NCT02115256|12436587|FG000|COMPLETED|Overall Study||3
11244009|NCT02115256|12436588|FG001|COMPLETED|Overall Study||2
11244010|NCT02115256|12436587|FG000|NOT COMPLETED|Overall Study||0
11244011|NCT02115256|12436588|FG001|NOT COMPLETED|Overall Study||1
11244012|NCT02115269|12436594|FG000|STARTED|Overall Study||759
11244013|NCT02115269|12436594|FG000|COMPLETED|Overall Study||702
11244014|NCT02115269|12436594|FG000|NOT COMPLETED|Overall Study||57
11244015|NCT02115282|12436611|FG000|STARTED|Overall Study||305
11244016|NCT02115282|12436612|FG001|STARTED|Overall Study||303
11244017|NCT02115282|12436611|FG000|Eligible|Overall Study||265
11244018|NCT02115282|12436612|FG001|Eligible|Overall Study||257
11244019|NCT02115282|12436611|FG000|Treated|Overall Study||296
11244020|NCT02115282|12436612|FG001|Treated|Overall Study||293
11244021|NCT02115282|12436611|FG000|COMPLETED|Overall Study||0
11244022|NCT02115282|12436612|FG001|COMPLETED|Overall Study||0
11244023|NCT02115282|12436611|FG000|NOT COMPLETED|Overall Study||305
11005357|NCT00722423|12183054|FG000|COMPLETED|Overall Study||182
11005358|NCT00722423|12183055|FG001|COMPLETED|Overall Study||181
11005359|NCT00722423|12183054|FG000|NOT COMPLETED|Overall Study||0
11244024|NCT02115282|12436612|FG001|NOT COMPLETED|Overall Study||303
11244025|NCT02115308|12436622|FG000|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
11244026|NCT02115308|12436623|FG001|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
11244027|NCT02115308|12436622|FG000|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
11244028|NCT02115308|12436623|FG001|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
11244029|NCT02115308|12436622|FG000|NOT COMPLETED|Overall Study||2
11244030|NCT02115308|12436623|FG001|NOT COMPLETED|Overall Study||2
11244031|NCT02115321|12436635|FG000|STARTED|Overall Study||30
11244032|NCT02115321|12436636|FG001|STARTED|Overall Study||10
11244033|NCT02115321|12436635|FG000|COMPLETED|Overall Study||29
11244034|NCT02115321|12436636|FG001|COMPLETED|Overall Study||10
11244035|NCT02115321|12436635|FG000|NOT COMPLETED|Overall Study||1
11244036|NCT02115321|12436636|FG001|NOT COMPLETED|Overall Study||0
11244037|NCT02115347|12436644|FG000|STARTED|Overall Study||8
11244038|NCT02115347|12436645|FG001|STARTED|Overall Study||8
11244039|NCT02115347|12436646|FG002|STARTED|Overall Study||0
11244040|NCT02115347|12436644|FG000|COMPLETED|Overall Study||8
11244041|NCT02115347|12436645|FG001|COMPLETED|Overall Study||8
11244042|NCT02115347|12436646|FG002|COMPLETED|Overall Study||0
11244043|NCT02115347|12436644|FG000|NOT COMPLETED|Overall Study||0
11244044|NCT02115347|12436645|FG001|NOT COMPLETED|Overall Study||0
11244045|NCT02115347|12436646|FG002|NOT COMPLETED|Overall Study||0
11244046|NCT02115386|12436652|FG000|STARTED|Overall Study||7
11244047|NCT02115386|12436652|FG000|COMPLETED|Overall Study||0
11244048|NCT02115386|12436652|FG000|NOT COMPLETED|Overall Study||7
11244049|NCT02115542|12436656|FG000|STARTED|Overall Study||39
11244050|NCT02115542|12436656|FG000|COMPLETED|Overall Study||39
11244051|NCT02115542|12436656|FG000|NOT COMPLETED|Overall Study||0
11244052|NCT02115581|12436662|FG000|STARTED|Overall Study||17
11244053|NCT02115581|12436663|FG001|STARTED|Overall Study||21
11244054|NCT02115581|12436662|FG000|COMPLETED|Overall Study||17
11244055|NCT02115581|12436663|FG001|COMPLETED|Overall Study||21
11244056|NCT02115581|12436662|FG000|NOT COMPLETED|Overall Study||0
11244057|NCT02115581|12436663|FG001|NOT COMPLETED|Overall Study||0
11244058|NCT02115607|12436669|FG000|STARTED|Overall Study||17
11244059|NCT02115607|12436669|FG000|COMPLETED|Overall Study||16
11244060|NCT02115607|12436669|FG000|NOT COMPLETED|Overall Study||1
11244061|NCT02115633|12436675|FG000|STARTED|Overall Study||15
11244062|NCT02115633|12436676|FG001|STARTED|Overall Study||16
11244063|NCT02115633|12436675|FG000|COMPLETED|Overall Study||15
11244064|NCT02115633|12436676|FG001|COMPLETED|Overall Study||16
11244065|NCT02115633|12436675|FG000|NOT COMPLETED|Overall Study||0
11244066|NCT02115633|12436676|FG001|NOT COMPLETED|Overall Study||0
11244067|NCT02115646|12436685|FG000|STARTED|Overall Study||29
11244068|NCT02115646|12436685|FG000|COMPLETED|Overall Study||22
11244069|NCT02115646|12436685|FG000|NOT COMPLETED|Overall Study||7
11244070|NCT02115750|12436696|FG000|STARTED|Part 1||323
11244071|NCT02115750|12436697|FG001|STARTED|Part 1||324
11244072|NCT02115750|12436696|FG000|COMPLETED|Part 1||301
11244073|NCT02115750|12436697|FG001|COMPLETED|Part 1||312
11244074|NCT02115750|12436696|FG000|NOT COMPLETED|Part 1||22
11244075|NCT02115750|12436697|FG001|NOT COMPLETED|Part 1||12
11244076|NCT02115750|12436696|FG000|STARTED|Part 2: All Subjects Receive CHS-0214||280
11244077|NCT02115750|12436697|FG001|STARTED|Part 2: All Subjects Receive CHS-0214||284
11244078|NCT02115750|12436696|FG000|COMPLETED|Part 2: All Subjects Receive CHS-0214||269
11244079|NCT02115750|12436697|FG001|COMPLETED|Part 2: All Subjects Receive CHS-0214||272
11244080|NCT02115750|12436696|FG000|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11
11244081|NCT02115750|12436697|FG001|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12
11244082|NCT02115815|12436712|FG000|STARTED|Overall Study||24
11244083|NCT02115815|12436713|FG001|STARTED|Overall Study||20
11244084|NCT02115815|12436714|FG002|STARTED|Overall Study||20
11244085|NCT02115815|12436715|FG003|STARTED|Overall Study||20
11244086|NCT02115815|12436716|FG004|STARTED|Overall Study||20
11244087|NCT02115815|12436717|FG005|STARTED|Overall Study||22
11244088|NCT02115815|12436718|FG006|STARTED|Overall Study||20
11244089|NCT02115815|12436712|FG000|COMPLETED|Overall Study||22
11244090|NCT02115815|12436713|FG001|COMPLETED|Overall Study||20
11244091|NCT02115815|12436714|FG002|COMPLETED|Overall Study||20
11244092|NCT02115815|12436715|FG003|COMPLETED|Overall Study||20
11244093|NCT02115815|12436716|FG004|COMPLETED|Overall Study||20
11244094|NCT02115815|12436717|FG005|COMPLETED|Overall Study||20
11244095|NCT02115815|12436718|FG006|COMPLETED|Overall Study||20
11244096|NCT02115815|12436712|FG000|NOT COMPLETED|Overall Study||2
11244097|NCT02115815|12436713|FG001|NOT COMPLETED|Overall Study||0
11244098|NCT02115815|12436714|FG002|NOT COMPLETED|Overall Study||0
11244099|NCT02115815|12436715|FG003|NOT COMPLETED|Overall Study||0
11244100|NCT02115815|12436716|FG004|NOT COMPLETED|Overall Study||0
11244101|NCT02115815|12436717|FG005|NOT COMPLETED|Overall Study||2
11244102|NCT02115815|12436718|FG006|NOT COMPLETED|Overall Study||0
11244103|NCT02115828|12436734|FG000|STARTED|Overall Study||9
11244104|NCT02115828|12436734|FG000|COMPLETED|Overall Study||9
11244105|NCT02115828|12436734|FG000|NOT COMPLETED|Overall Study||0
11244106|NCT02115984|12436740|FG000|STARTED|Overall Study||57
11244107|NCT02115984|12436741|FG001|STARTED|Overall Study||23
11244108|NCT02115984|12436740|FG000|COMPLETED|Overall Study||51
11244109|NCT02115984|12436741|FG001|COMPLETED|Overall Study||16
11244110|NCT02115984|12436740|FG000|NOT COMPLETED|Overall Study||6
11244111|NCT02115984|12436741|FG001|NOT COMPLETED|Overall Study||7
11244112|NCT02116205|12436751|FG000|STARTED|Overall Study||31
11244113|NCT02116205|12436752|FG001|STARTED|Overall Study||33
11244114|NCT02116205|12436753|FG002|STARTED|Overall Study||33
11244115|NCT02116205|12436754|FG003|STARTED|Overall Study||33
11244116|NCT02116205|12436751|FG000|COMPLETED|Overall Study||29
11244117|NCT02116205|12436752|FG001|COMPLETED|Overall Study||26
11244118|NCT02116205|12436753|FG002|COMPLETED|Overall Study||29
11244119|NCT02116205|12436754|FG003|COMPLETED|Overall Study||27
11244120|NCT02116205|12436751|FG000|NOT COMPLETED|Overall Study||2
11244121|NCT02116205|12436752|FG001|NOT COMPLETED|Overall Study||7
11244122|NCT02116205|12436753|FG002|NOT COMPLETED|Overall Study||4
11244123|NCT02116205|12436754|FG003|NOT COMPLETED|Overall Study||6
11244124|NCT02116309|12436766|FG000|STARTED|Overall Study||482
11244125|NCT02116309|12436767|FG001|STARTED|Overall Study||478
11244126|NCT02116309|12436766|FG000|COMPLETED|Overall Study||482
11244127|NCT02116309|12436767|FG001|COMPLETED|Overall Study||477
11244128|NCT02116309|12436766|FG000|NOT COMPLETED|Overall Study||0
11244129|NCT02116309|12436767|FG001|NOT COMPLETED|Overall Study||1
11244130|NCT02116322|12436773|FG000|STARTED|Overall Study||1
11244131|NCT02116322|12436773|FG000|COMPLETED|Overall Study||1
11244132|NCT02116322|12436773|FG000|NOT COMPLETED|Overall Study||0
11244133|NCT02116361|12436781|FG000|STARTED|Overall Study||69
11244134|NCT02116361|12436782|FG001|STARTED|Overall Study||65
11244135|NCT02116361|12436783|FG002|STARTED|Overall Study||59
11244136|NCT02116361|12436784|FG003|STARTED|Overall Study||65
11244137|NCT02116361|12436781|FG000|COMPLETED|Overall Study||38
11244138|NCT02116361|12436782|FG001|COMPLETED|Overall Study||34
11244139|NCT02116361|12436783|FG002|COMPLETED|Overall Study||33
11244140|NCT02116361|12436784|FG003|COMPLETED|Overall Study||34
11244141|NCT02116361|12436781|FG000|NOT COMPLETED|Overall Study||31
11244142|NCT02116361|12436782|FG001|NOT COMPLETED|Overall Study||31
11244143|NCT02116361|12436783|FG002|NOT COMPLETED|Overall Study||26
11244144|NCT02116361|12436784|FG003|NOT COMPLETED|Overall Study||31
11244145|NCT02116530|12436796|FG000|STARTED|Overall Study||192
11244146|NCT02116530|12436797|FG001|STARTED|Overall Study||188
11244147|NCT02116530|12436796|FG000|COMPLETED|Overall Study||183
11244148|NCT02116530|12436797|FG001|COMPLETED|Overall Study||184
11244149|NCT02116530|12436796|FG000|NOT COMPLETED|Overall Study||9
11244150|NCT02116530|12436797|FG001|NOT COMPLETED|Overall Study||4
11244151|NCT02116582|12436803|FG000|STARTED|Overall Study||215
11244152|NCT02116582|12436803|FG000|Treated|Overall Study||214
11244153|NCT02116582|12436803|FG000|COMPLETED|Overall Study||0
11244154|NCT02116582|12436803|FG000|NOT COMPLETED|Overall Study||215
11244155|NCT02116608|12436810|FG000|STARTED|Overall Study||9
11244156|NCT02116608|12436811|FG001|STARTED|Overall Study||9
11244157|NCT02116608|12436812|FG002|STARTED|Overall Study||8
11244158|NCT02116608|12436810|FG000|COMPLETED|Overall Study||9
11244159|NCT02116608|12436811|FG001|COMPLETED|Overall Study||7
11244160|NCT02116608|12436812|FG002|COMPLETED|Overall Study||7
11244161|NCT02116608|12436810|FG000|NOT COMPLETED|Overall Study||0
11244162|NCT02116608|12436811|FG001|NOT COMPLETED|Overall Study||2
11244163|NCT02116608|12436812|FG002|NOT COMPLETED|Overall Study||1
11244164|NCT02116621|12436822|FG000|STARTED|Baseline||108
11244165|NCT02116621|12436823|FG001|STARTED|Baseline||107
11244166|NCT02116621|12436822|FG000|Completed Baseline Visit|Baseline||108
11244167|NCT02116621|12436823|FG001|Completed Baseline Visit|Baseline||103
11244168|NCT02116621|12436822|FG000|Completed Intervention Period|Baseline||95
11244169|NCT02116621|12436823|FG001|Completed Intervention Period|Baseline||103
11244170|NCT02116621|12436822|FG000|COMPLETED|Baseline||108
11244171|NCT02116621|12436823|FG001|COMPLETED|Baseline||103
11244172|NCT02116621|12436822|FG000|NOT COMPLETED|Baseline||0
11244173|NCT02116621|12436823|FG001|NOT COMPLETED|Baseline||4
11244174|NCT02116621|12436822|FG000|STARTED|Three Month Follow-up||108
11244175|NCT02116621|12436823|FG001|STARTED|Three Month Follow-up||103
11244176|NCT02116621|12436822|FG000|COMPLETED|Three Month Follow-up||89
11244177|NCT02116621|12436823|FG001|COMPLETED|Three Month Follow-up||96
11244178|NCT02116621|12436822|FG000|NOT COMPLETED|Three Month Follow-up||19
11244179|NCT02116621|12436823|FG001|NOT COMPLETED|Three Month Follow-up||7
11244180|NCT02116621|12436822|FG000|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
11244181|NCT02116621|12436823|FG001|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
11244182|NCT02116621|12436822|FG000|COMPLETED|Six Month Follow-up||99
11244183|NCT02116621|12436823|FG001|COMPLETED|Six Month Follow-up||97
11244184|NCT02116621|12436822|FG000|NOT COMPLETED|Six Month Follow-up||4
11244185|NCT02116621|12436823|FG001|NOT COMPLETED|Six Month Follow-up||3
11244186|NCT02116621|12436822|FG000|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
11244187|NCT02116621|12436823|FG001|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
11244188|NCT02116621|12436822|FG000|COMPLETED|Twelve Month Follow-up||84
11244189|NCT02116621|12436823|FG001|COMPLETED|Twelve Month Follow-up||86
11244190|NCT02116621|12436822|FG000|NOT COMPLETED|Twelve Month Follow-up||16
11244191|NCT02116621|12436823|FG001|NOT COMPLETED|Twelve Month Follow-up||12
11244192|NCT02116660|12436831|FG000|STARTED|Overall Study||6
11244193|NCT02116660|12436832|FG001|STARTED|Overall Study||5
11244194|NCT02116660|12436831|FG000|COMPLETED|Overall Study||4
11244195|NCT02116660|12436832|FG001|COMPLETED|Overall Study||1
11244196|NCT02116660|12436831|FG000|NOT COMPLETED|Overall Study||2
11244197|NCT02116660|12436832|FG001|NOT COMPLETED|Overall Study||4
11244198|NCT02116777|12436847|FG000|STARTED|Overall Study||3
11244199|NCT02116777|12436848|FG001|STARTED|Overall Study||3
11244200|NCT02116777|12436849|FG002|STARTED|Overall Study||3
11244201|NCT02116777|12436850|FG003|STARTED|Overall Study||13
11244202|NCT02116777|12436851|FG004|STARTED|Overall Study||6
11244203|NCT02116777|12436852|FG005|STARTED|Overall Study||3
11244204|NCT02116777|12436853|FG006|STARTED|Overall Study||9
11244205|NCT02116777|12436847|FG000|COMPLETED|Overall Study||0
11244206|NCT02116777|12436848|FG001|COMPLETED|Overall Study||0
11244207|NCT02116777|12436849|FG002|COMPLETED|Overall Study||0
11244208|NCT02116777|12436850|FG003|COMPLETED|Overall Study||0
11244209|NCT02116777|12436851|FG004|COMPLETED|Overall Study||0
11244210|NCT02116777|12436852|FG005|COMPLETED|Overall Study||0
11244211|NCT02116777|12436853|FG006|COMPLETED|Overall Study||0
11244212|NCT02116777|12436847|FG000|NOT COMPLETED|Overall Study||3
11244213|NCT02116777|12436848|FG001|NOT COMPLETED|Overall Study||3
11244214|NCT02116777|12436849|FG002|NOT COMPLETED|Overall Study||3
11244215|NCT02116777|12436850|FG003|NOT COMPLETED|Overall Study||13
11244216|NCT02116777|12436851|FG004|NOT COMPLETED|Overall Study||6
11244217|NCT02116777|12436852|FG005|NOT COMPLETED|Overall Study||3
11244218|NCT02116777|12436853|FG006|NOT COMPLETED|Overall Study||9
11244219|NCT02116803|12436874|FG000|STARTED|Overall Study||10
11244220|NCT02116803|12436875|FG001|STARTED|Overall Study||2
11244221|NCT02116803|12436874|FG000|COMPLETED|Overall Study||0
11244222|NCT02116803|12436875|FG001|COMPLETED|Overall Study||0
11244223|NCT02116803|12436874|FG000|NOT COMPLETED|Overall Study||10
11244224|NCT02116803|12436875|FG001|NOT COMPLETED|Overall Study||2
11244225|NCT02116972|12436884|FG000|STARTED|Overall Study||102
11244226|NCT02116972|12436885|FG001|STARTED|Overall Study||104
11244227|NCT02116972|12436886|FG002|STARTED|Overall Study||104
11244228|NCT02116972|12436884|FG000|COMPLETED|Overall Study||83
11244229|NCT02116972|12436885|FG001|COMPLETED|Overall Study||87
11244230|NCT02116972|12436886|FG002|COMPLETED|Overall Study||85
11244231|NCT02116972|12436884|FG000|NOT COMPLETED|Overall Study||19
11244232|NCT02116972|12436885|FG001|NOT COMPLETED|Overall Study||17
11244233|NCT02116972|12436886|FG002|NOT COMPLETED|Overall Study||19
11244234|NCT02117024|12436898|FG000|STARTED|Overall Study||45
11244235|NCT02117024|12436899|FG001|STARTED|Overall Study||21
11244236|NCT02117024|12436898|FG000|COMPLETED|Overall Study||1
11244237|NCT02117024|12436899|FG001|COMPLETED|Overall Study||1
11244238|NCT02117024|12436898|FG000|NOT COMPLETED|Overall Study||44
11244239|NCT02117024|12436899|FG001|NOT COMPLETED|Overall Study||20
11244240|NCT02117193|12436905|FG000|STARTED|Overall Study||10
11244241|NCT02117193|12436905|FG000|Alcohol Intake + Normal Sleep|Overall Study||10
11244242|NCT02117193|12436905|FG000|Placebo Intake + Normal Sleep|Overall Study||10
11244243|NCT02117193|12436905|FG000|Alcohol Intake + Sleep Deprivation|Overall Study||10
11244244|NCT02117193|12436905|FG000|Placebo Intake + Sleep Deprivation|Overall Study||10
11244245|NCT02117193|12436905|FG000|COMPLETED|Overall Study||10
11244246|NCT02117193|12436905|FG000|NOT COMPLETED|Overall Study||0
11244247|NCT02117310|12436924|FG000|STARTED|Overall Study||5
11244248|NCT02117310|12436924|FG000|COMPLETED|Overall Study||5
11244249|NCT02117310|12436924|FG000|NOT COMPLETED|Overall Study||0
11244250|NCT02117349|12436930|FG000|STARTED|Overall Study||37
11244251|NCT02117349|12436931|FG001|STARTED|Overall Study||18
11244252|NCT02117349|12436930|FG000|Intent-to-treat Population|Overall Study||37
11244253|NCT02117349|12436931|FG001|Intent-to-treat Population|Overall Study||18
11244254|NCT02117349|12436930|FG000|Safety Population|Overall Study||36
11244255|NCT02117349|12436931|FG001|Safety Population|Overall Study||18
11244256|NCT02117349|12436930|FG000|Modified Intent-to-treat (mITT)|Overall Study||36
11244257|NCT02117349|12436931|FG001|Modified Intent-to-treat (mITT)|Overall Study||18
11244258|NCT02117349|12436930|FG000|COMPLETED|Overall Study||34
11244259|NCT02117349|12436931|FG001|COMPLETED|Overall Study||17
11244260|NCT02117349|12436930|FG000|NOT COMPLETED|Overall Study||3
11244261|NCT02117349|12436931|FG001|NOT COMPLETED|Overall Study||1
11244262|NCT02117414|12436939|FG000|STARTED|Overall Study|Subjects randomized to the MRI group.|175
11244263|NCT02117414|12436940|FG001|STARTED|Overall Study|Subjects randomized to the Control group.|88
11244264|NCT02117414|12436939|FG000|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
11244265|NCT02117414|12436940|FG001|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
11244266|NCT02117414|12436939|FG000|NOT COMPLETED|Overall Study||15
11244267|NCT02117414|12436940|FG001|NOT COMPLETED|Overall Study||6
11244268|NCT02117427|12436951|FG000|STARTED|Overall Study||6
11244269|NCT02117427|12436952|FG001|STARTED|Overall Study||5
11244270|NCT02117427|12436953|FG002|STARTED|Overall Study||0
11244271|NCT02117427|12436951|FG000|Run in Phase & Harvest|Overall Study||6
11244272|NCT02117427|12436952|FG001|Run in Phase & Harvest|Overall Study||4
11244273|NCT02117427|12436953|FG002|Run in Phase & Harvest|Overall Study||0
11244274|NCT02117427|12436951|FG000|Implantation & Efficacy|Overall Study||6
11244275|NCT02117427|12436952|FG001|Implantation & Efficacy|Overall Study||4
11244276|NCT02117427|12436953|FG002|Implantation & Efficacy|Overall Study||0
11244277|NCT02117427|12436951|FG000|Safety Follow-up|Overall Study||1
11244278|NCT02117427|12436952|FG001|Safety Follow-up|Overall Study||0
11244279|NCT02117427|12436953|FG002|Safety Follow-up|Overall Study||0
11244280|NCT02117427|12436951|FG000|Long Term Safety Follow-up|Overall Study||1
11244281|NCT02117427|12436952|FG001|Long Term Safety Follow-up|Overall Study||0
11244282|NCT02117427|12436953|FG002|Long Term Safety Follow-up|Overall Study||0
11244283|NCT02117427|12436951|FG000|COMPLETED|Overall Study||1
11244284|NCT02117427|12436952|FG001|COMPLETED|Overall Study||0
11244285|NCT02117427|12436953|FG002|COMPLETED|Overall Study||0
11244286|NCT02117427|12436951|FG000|NOT COMPLETED|Overall Study||5
11244287|NCT02117427|12436952|FG001|NOT COMPLETED|Overall Study||5
11244288|NCT02117427|12436953|FG002|NOT COMPLETED|Overall Study||0
11244289|NCT02117479|12436961|FG000|STARTED|Overall Study||161
11244290|NCT02117479|12436962|FG001|STARTED|Overall Study||160
11244291|NCT02117479|12436961|FG000|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
11244292|NCT02117479|12436962|FG001|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
11244293|NCT02117479|12436961|FG000|NOT COMPLETED|Overall Study||156
11244294|NCT02117479|12436962|FG001|NOT COMPLETED|Overall Study||156
11244295|NCT02117544|12436968|FG000|STARTED|Period 1||54
11244296|NCT02117544|12436969|FG001|STARTED|Period 1||55
11244297|NCT02117544|12436968|FG000|Treated|Period 1||52
11244298|NCT02117544|12436969|FG001|Treated|Period 1||55
11244299|NCT02117544|12436968|FG000|COMPLETED|Period 1||52
11244300|NCT02117544|12436969|FG001|COMPLETED|Period 1||55
11244301|NCT02117544|12436968|FG000|NOT COMPLETED|Period 1||2
11244302|NCT02117544|12436969|FG001|NOT COMPLETED|Period 1||0
11244303|NCT02117544|12436968|FG000|STARTED|Period 2||52
11244304|NCT02117544|12436969|FG001|STARTED|Period 2||55
11244305|NCT02117544|12436968|FG000|COMPLETED|Period 2||52
11244306|NCT02117544|12436969|FG001|COMPLETED|Period 2||55
11244307|NCT02117544|12436968|FG000|NOT COMPLETED|Period 2||0
11244308|NCT02117544|12436969|FG001|NOT COMPLETED|Period 2||0
11244309|NCT02117570|12436979|FG000|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
11244310|NCT02117570|12436980|FG001|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
11244311|NCT02117570|12436981|FG002|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
11244312|NCT02117570|12436979|FG000|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
11244313|NCT02117570|12436980|FG001|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
11244314|NCT02117570|12436981|FG002|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
11244315|NCT02117570|12436979|FG000|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
11244316|NCT02117570|12436980|FG001|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
11244317|NCT02117570|12436981|FG002|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
11244318|NCT02117570|12436979|FG000|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
11244319|NCT02117570|12436980|FG001|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
11244320|NCT02117570|12436981|FG002|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
11244321|NCT02117570|12436979|FG000|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
11244322|NCT02117570|12436980|FG001|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
11244323|NCT02117570|12436981|FG002|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
11244324|NCT02117570|12436979|FG000|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
11244325|NCT02117570|12436980|FG001|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
11244326|NCT02117570|12436981|FG002|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
11244327|NCT02117570|12436979|FG000|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
11244328|NCT02117570|12436980|FG001|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
11244329|NCT02117570|12436981|FG002|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
11244330|NCT02117570|12436979|FG000|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
11244331|NCT02117570|12436980|FG001|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
11244332|NCT02117570|12436981|FG002|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
11244333|NCT02117570|12436979|FG000|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
11244334|NCT02117570|12436980|FG001|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
11244335|NCT02117570|12436981|FG002|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
11244336|NCT02117570|12436979|FG000|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
11244337|NCT02117570|12436980|FG001|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
11244338|NCT02117570|12436981|FG002|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
11244339|NCT02117570|12436979|FG000|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
11244340|NCT02117570|12436980|FG001|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
11244341|NCT02117570|12436981|FG002|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
11244342|NCT02117570|12436979|FG000|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
11244343|NCT02117570|12436980|FG001|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
11244344|NCT02117570|12436981|FG002|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
11244345|NCT02117648|12436992|FG000|STARTED|Abemaciclib Alone Period 1||26
11244346|NCT02117648|12436992|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
11244347|NCT02117648|12436992|FG000|COMPLETED|Abemaciclib Alone Period 1||24
11244348|NCT02117648|12436992|FG000|NOT COMPLETED|Abemaciclib Alone Period 1||2
11244349|NCT02117648|12436992|FG000|STARTED|Abemaciclib + Clarithromycin Period 2||24
11244350|NCT02117648|12436992|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
11244351|NCT02117648|12436992|FG000|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
11244352|NCT02117648|12436992|FG000|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
11244353|NCT02117648|12436992|FG000|STARTED|Abemaciclib Safety-Extension Phase||20
11244354|NCT02117648|12436992|FG000|COMPLETED|Abemaciclib Safety-Extension Phase||0
11244355|NCT02117648|12436992|FG000|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
11244356|NCT02117687|12437002|FG000|STARTED|Overall Study||40
11244357|NCT02117687|12437003|FG001|STARTED|Overall Study||40
11244358|NCT02117687|12437002|FG000|COMPLETED|Overall Study||39
11244359|NCT02117687|12437003|FG001|COMPLETED|Overall Study||36
11244360|NCT02117687|12437002|FG000|NOT COMPLETED|Overall Study||1
11244361|NCT02117687|12437003|FG001|NOT COMPLETED|Overall Study||4
11244362|NCT02117713|12437009|FG000|STARTED|Week 48||34
11244363|NCT02117713|12437009|FG000|COMPLETED|Week 48||26
11244364|NCT02117713|12437009|FG000|NOT COMPLETED|Week 48||8
11244365|NCT02117713|12437009|FG000|STARTED|Long Term Follow-up Treatment||26
11244366|NCT02117713|12437009|FG000|COMPLETED|Long Term Follow-up Treatment||20
11244367|NCT02117713|12437009|FG000|NOT COMPLETED|Long Term Follow-up Treatment||6
11244368|NCT02117934|12437023|FG000|STARTED|Overall Study||5592
11358252|NCT03122535|12555300|FG000|COMPLETED|Overall Study||42
11358253|NCT03122535|12555301|FG001|COMPLETED|Overall Study||42
11358254|NCT03122535|12555300|FG000|NOT COMPLETED|Overall Study||73
11358255|NCT03122535|12555301|FG001|NOT COMPLETED|Overall Study||73
11358256|NCT03122548|12555307|FG000|STARTED|Overall Study||5
11358257|NCT03122548|12555307|FG000|COMPLETED|Overall Study||0
11358258|NCT03122548|12555307|FG000|NOT COMPLETED|Overall Study||5
11358259|NCT03122587|12555314|FG000|STARTED|Overall Study||13
11358260|NCT03122587|12555315|FG001|STARTED|Overall Study||12
11358261|NCT03122587|12555316|FG002|STARTED|Overall Study||13
11358262|NCT03122587|12555314|FG000|COMPLETED|Overall Study||11
11358263|NCT03122587|12555315|FG001|COMPLETED|Overall Study||10
11358264|NCT03122587|12555316|FG002|COMPLETED|Overall Study||12
11358265|NCT03122587|12555314|FG000|NOT COMPLETED|Overall Study||2
11358266|NCT03122587|12555315|FG001|NOT COMPLETED|Overall Study||2
11358267|NCT03122587|12555316|FG002|NOT COMPLETED|Overall Study||1
11358268|NCT03122860|12555330|FG000|STARTED|Overall Study||117
11358269|NCT03122860|12555331|FG001|STARTED|Overall Study||116
11358270|NCT03122860|12555332|FG002|STARTED|Overall Study||117
11358271|NCT03122860|12555333|FG003|STARTED|Overall Study||116
11358272|NCT03122860|12555334|FG004|STARTED|Overall Study||117
11358273|NCT03122860|12555335|FG005|STARTED|Overall Study||117
11358274|NCT03122860|12555330|FG000|Full Analysis Set|Overall Study||116
11358275|NCT03122860|12555331|FG001|Full Analysis Set|Overall Study||115
11358276|NCT03122860|12555332|FG002|Full Analysis Set|Overall Study||115
11358277|NCT03122860|12555333|FG003|Full Analysis Set|Overall Study||116
11358278|NCT03122860|12555334|FG004|Full Analysis Set|Overall Study||116
11358279|NCT03122860|12555335|FG005|Full Analysis Set|Overall Study||117
11358280|NCT03122860|12555330|FG000|COMPLETED|Overall Study||107
11358281|NCT03122860|12555331|FG001|COMPLETED|Overall Study||111
11358282|NCT03122860|12555332|FG002|COMPLETED|Overall Study||105
11358283|NCT03122860|12555333|FG003|COMPLETED|Overall Study||105
11358284|NCT03122860|12555334|FG004|COMPLETED|Overall Study||102
11358285|NCT03122860|12555335|FG005|COMPLETED|Overall Study||105
11358286|NCT03122860|12555330|FG000|NOT COMPLETED|Overall Study||10
11358287|NCT03122860|12555331|FG001|NOT COMPLETED|Overall Study||5
11358288|NCT03122860|12555332|FG002|NOT COMPLETED|Overall Study||12
11358289|NCT03122860|12555333|FG003|NOT COMPLETED|Overall Study||11
11358290|NCT03122860|12555334|FG004|NOT COMPLETED|Overall Study||15
11358291|NCT03122860|12555335|FG005|NOT COMPLETED|Overall Study||12
11358292|NCT03123055|12555350|FG000|STARTED|Overall Study||28
11358293|NCT03123055|12555350|FG000|COMPLETED|Overall Study||28
11244369|NCT02117934|12437024|FG001|STARTED|Overall Study||2782
11244370|NCT02117934|12437023|FG000|COMPLETED|Overall Study||5092
11244371|NCT02117934|12437024|FG001|COMPLETED|Overall Study||2567
11244372|NCT02117934|12437023|FG000|NOT COMPLETED|Overall Study||500
11244373|NCT02117934|12437024|FG001|NOT COMPLETED|Overall Study||215
11244374|NCT02117999|12437032|FG000|STARTED|Overall Study||20
11244375|NCT02117999|12437033|FG001|STARTED|Overall Study||10
11244376|NCT02117999|12437032|FG000|Mean Kmax Change in Corneal Topography|Overall Study||20
11244377|NCT02117999|12437033|FG001|Mean Kmax Change in Corneal Topography|Overall Study||10
11244378|NCT02117999|12437032|FG000|COMPLETED|Overall Study||20
11244379|NCT02117999|12437033|FG001|COMPLETED|Overall Study||10
11244380|NCT02117999|12437032|FG000|NOT COMPLETED|Overall Study||0
11244381|NCT02117999|12437033|FG001|NOT COMPLETED|Overall Study||0
11244382|NCT02118012|12437043|FG000|STARTED|Overall Study||12
11244383|NCT02118012|12437044|FG001|STARTED|Overall Study||12
11244384|NCT02118012|12437043|FG000|Day 5|Overall Study||12
11244385|NCT02118012|12437044|FG001|Day 5|Overall Study||11
11244386|NCT02118012|12437043|FG000|Day 14|Overall Study||12
11244387|NCT02118012|12437044|FG001|Day 14|Overall Study||10
11244388|NCT02118012|12437043|FG000|COMPLETED|Overall Study||12
11244389|NCT02118012|12437044|FG001|COMPLETED|Overall Study||10
11244390|NCT02118012|12437043|FG000|NOT COMPLETED|Overall Study||0
11244391|NCT02118012|12437044|FG001|NOT COMPLETED|Overall Study||2
11244392|NCT02118337|12437059|FG000|STARTED|Overall Study||4
11244393|NCT02118337|12437060|FG001|STARTED|Overall Study||5
11244394|NCT02118337|12437061|FG002|STARTED|Overall Study||3
11244395|NCT02118337|12437062|FG003|STARTED|Overall Study||3
11244396|NCT02118337|12437063|FG004|STARTED|Overall Study||9
11244397|NCT02118337|12437064|FG005|STARTED|Overall Study||6
11244398|NCT02118337|12437065|FG006|STARTED|Overall Study||4
11244399|NCT02118337|12437066|FG007|STARTED|Overall Study||42
11244400|NCT02118337|12437067|FG008|STARTED|Overall Study||21
11244401|NCT02118337|12437059|FG000|COMPLETED|Overall Study||0
11244402|NCT02118337|12437060|FG001|COMPLETED|Overall Study||0
11244403|NCT02118337|12437061|FG002|COMPLETED|Overall Study||0
11244404|NCT02118337|12437062|FG003|COMPLETED|Overall Study||0
11244405|NCT02118337|12437063|FG004|COMPLETED|Overall Study||0
11244406|NCT02118337|12437064|FG005|COMPLETED|Overall Study||0
11244407|NCT02118337|12437065|FG006|COMPLETED|Overall Study||0
11244408|NCT02118337|12437066|FG007|COMPLETED|Overall Study||0
11244409|NCT02118337|12437067|FG008|COMPLETED|Overall Study||0
11244410|NCT02118337|12437059|FG000|NOT COMPLETED|Overall Study||4
11244411|NCT02118337|12437060|FG001|NOT COMPLETED|Overall Study||5
11244412|NCT02118337|12437061|FG002|NOT COMPLETED|Overall Study||3
11244413|NCT02118337|12437062|FG003|NOT COMPLETED|Overall Study||3
11244414|NCT02118337|12437063|FG004|NOT COMPLETED|Overall Study||9
11244415|NCT02118337|12437064|FG005|NOT COMPLETED|Overall Study||6
11244416|NCT02118337|12437065|FG006|NOT COMPLETED|Overall Study||4
11244417|NCT02118337|12437066|FG007|NOT COMPLETED|Overall Study||42
11244418|NCT02118337|12437067|FG008|NOT COMPLETED|Overall Study||21
11244419|NCT02118428|12437093|FG000|STARTED|Overall Study||113
11244420|NCT02118428|12437094|FG001|STARTED|Overall Study||113
11244421|NCT02118428|12437095|FG002|STARTED|Overall Study||1
11244422|NCT02118428|12437093|FG000|Received Study Transfusion|Overall Study||111
11244423|NCT02118428|12437094|FG001|Received Study Transfusion|Overall Study||112
11244424|NCT02118428|12437095|FG002|Received Study Transfusion|Overall Study||0
11244425|NCT02118428|12437093|FG000|COMPLETED|Overall Study||100
11244426|NCT02118428|12437094|FG001|COMPLETED|Overall Study||104
11244427|NCT02118428|12437095|FG002|COMPLETED|Overall Study||0
11244428|NCT02118428|12437093|FG000|NOT COMPLETED|Overall Study||13
11244429|NCT02118428|12437094|FG001|NOT COMPLETED|Overall Study||9
11244430|NCT02118428|12437095|FG002|NOT COMPLETED|Overall Study||1
11244431|NCT02118441|12437103|FG000|STARTED|Overall Study||65
11244432|NCT02118441|12437104|FG001|STARTED|Overall Study||64
11244433|NCT02118441|12437103|FG000|COMPLETED|Overall Study||62
11244434|NCT02118441|12437104|FG001|COMPLETED|Overall Study||63
11244435|NCT02118441|12437103|FG000|NOT COMPLETED|Overall Study||3
11244436|NCT02118441|12437104|FG001|NOT COMPLETED|Overall Study||1
11244437|NCT02118597|12437111|FG000|STARTED|Overall Study||19
11244438|NCT02118597|12437111|FG000|COMPLETED|Overall Study||3
11244439|NCT02118597|12437111|FG000|NOT COMPLETED|Overall Study||16
11244440|NCT02118714|12437115|FG000|STARTED|Overall Study||20
11244441|NCT02118714|12437115|FG000|COMPLETED|Overall Study||17
11244442|NCT02118714|12437115|FG000|NOT COMPLETED|Overall Study||3
11244443|NCT02118766|12437121|FG000|STARTED|Overall Study||507
11244444|NCT02118766|12437122|FG001|STARTED|Overall Study||256
11244445|NCT02118766|12437121|FG000|Treated|Overall Study||503
11244446|NCT02118766|12437122|FG001|Treated|Overall Study||256
11244447|NCT02118766|12437121|FG000|COMPLETED|Overall Study||477
11244448|NCT02118766|12437122|FG001|COMPLETED|Overall Study||225
11244449|NCT02118766|12437121|FG000|NOT COMPLETED|Overall Study||30
11244450|NCT02118766|12437122|FG001|NOT COMPLETED|Overall Study||31
11244451|NCT02118792|12437130|FG000|STARTED|Overall Study||514
11244452|NCT02118792|12437131|FG001|STARTED|Overall Study||250
11244453|NCT02118792|12437130|FG000|Treated|Overall Study||513
11244454|NCT02118792|12437131|FG001|Treated|Overall Study||250
11244455|NCT02118792|12437130|FG000|COMPLETED|Overall Study||483
11244456|NCT02118792|12437131|FG001|COMPLETED|Overall Study||213
11244457|NCT02118792|12437130|FG000|NOT COMPLETED|Overall Study||31
11244458|NCT02118792|12437131|FG001|NOT COMPLETED|Overall Study||37
11244459|NCT02118831|12437142|FG000|STARTED|Overall Study||21
11244460|NCT02118831|12437143|FG001|STARTED|Overall Study||15
11244461|NCT02118831|12437144|FG002|STARTED|Overall Study||20
11244462|NCT02118831|12437142|FG000|COMPLETED|Overall Study||21
11244463|NCT02118831|12437143|FG001|COMPLETED|Overall Study||15
11244464|NCT02118831|12437144|FG002|COMPLETED|Overall Study||20
11244465|NCT02118831|12437142|FG000|NOT COMPLETED|Overall Study||0
11244466|NCT02118831|12437143|FG001|NOT COMPLETED|Overall Study||0
11244467|NCT02118831|12437144|FG002|NOT COMPLETED|Overall Study||0
11244468|NCT02118896|12437162|FG000|STARTED|Overall Study||47
11244469|NCT02118896|12437163|FG001|STARTED|Overall Study||47
11244470|NCT02118896|12437164|FG002|STARTED|Overall Study||67
11244471|NCT02118896|12437165|FG003|STARTED|Overall Study||79
11244472|NCT02118896|12437166|FG004|STARTED|Overall Study||130
11244473|NCT02118896|12437167|FG005|STARTED|Overall Study||191
11244474|NCT02118896|12437168|FG006|STARTED|Overall Study||85
11244475|NCT02118896|12437169|FG007|STARTED|Overall Study||107
11244476|NCT02118896|12437170|FG008|STARTED|Overall Study||88
11244477|NCT02118896|12437171|FG009|STARTED|Overall Study||9
11244478|NCT02118896|12437162|FG000|COMPLETED|Overall Study||30
11244479|NCT02118896|12437163|FG001|COMPLETED|Overall Study||32
11244480|NCT02118896|12437164|FG002|COMPLETED|Overall Study||53
11244481|NCT02118896|12437165|FG003|COMPLETED|Overall Study||55
11244482|NCT02118896|12437166|FG004|COMPLETED|Overall Study||113
11244483|NCT02118896|12437167|FG005|COMPLETED|Overall Study||163
11244484|NCT02118896|12437168|FG006|COMPLETED|Overall Study||83
11244485|NCT02118896|12437169|FG007|COMPLETED|Overall Study||105
11244486|NCT02118896|12437170|FG008|COMPLETED|Overall Study||84
11244487|NCT02118896|12437171|FG009|COMPLETED|Overall Study||7
11244488|NCT02118896|12437162|FG000|NOT COMPLETED|Overall Study||17
11244489|NCT02118896|12437163|FG001|NOT COMPLETED|Overall Study||15
11244490|NCT02118896|12437164|FG002|NOT COMPLETED|Overall Study||14
11244491|NCT02118896|12437165|FG003|NOT COMPLETED|Overall Study||24
11244492|NCT02118896|12437166|FG004|NOT COMPLETED|Overall Study||17
11244493|NCT02118896|12437167|FG005|NOT COMPLETED|Overall Study||28
11244494|NCT02118896|12437168|FG006|NOT COMPLETED|Overall Study||2
11244495|NCT02118896|12437169|FG007|NOT COMPLETED|Overall Study||2
11244496|NCT02118896|12437170|FG008|NOT COMPLETED|Overall Study||4
11244497|NCT02118896|12437171|FG009|NOT COMPLETED|Overall Study||2
11244498|NCT02118961|12437196|FG000|STARTED|Overall Study||224
11244499|NCT02118961|12437197|FG001|STARTED|Overall Study||222
11244500|NCT02118961|12437196|FG000|COMPLETED|Overall Study||223
11244501|NCT02118961|12437197|FG001|COMPLETED|Overall Study||222
11244502|NCT02118961|12437196|FG000|NOT COMPLETED|Overall Study||1
11244503|NCT02118961|12437197|FG001|NOT COMPLETED|Overall Study||0
11244504|NCT02119026|12437205|FG000|STARTED|1st-line Treatment||58
11244505|NCT02119026|12437206|FG001|STARTED|1st-line Treatment||62
11244506|NCT02119026|12437205|FG000|COMPLETED|1st-line Treatment||32
11244507|NCT02119026|12437206|FG001|COMPLETED|1st-line Treatment||24
11244508|NCT02119026|12437205|FG000|NOT COMPLETED|1st-line Treatment||26
11244509|NCT02119026|12437206|FG001|NOT COMPLETED|1st-line Treatment||38
11244510|NCT02119026|12437205|FG000|STARTED|2nd-line Treatment||32
11244511|NCT02119026|12437206|FG001|STARTED|2nd-line Treatment||24
11244512|NCT02119026|12437205|FG000|COMPLETED|2nd-line Treatment||23
11244513|NCT02119026|12437206|FG001|COMPLETED|2nd-line Treatment||22
11244514|NCT02119026|12437205|FG000|NOT COMPLETED|2nd-line Treatment||9
11244515|NCT02119026|12437206|FG001|NOT COMPLETED|2nd-line Treatment||2
11244516|NCT02119104|12437212|FG000|STARTED|Overall Study||1087
11244517|NCT02119104|12437212|FG000|COMPLETED|Overall Study||1071
11244518|NCT02119104|12437212|FG000|NOT COMPLETED|Overall Study||16
11244519|NCT02119156|12437219|FG000|STARTED|Treatment Phase (Up to 52 Weeks)||39
11244520|NCT02119156|12437220|FG001|STARTED|Treatment Phase (Up to 52 Weeks)||29
11244521|NCT02119156|12437221|FG002|STARTED|Treatment Phase (Up to 52 Weeks)||12
11244522|NCT02119156|12437219|FG000|COMPLETED|Treatment Phase (Up to 52 Weeks)||33
11244523|NCT02119156|12437220|FG001|COMPLETED|Treatment Phase (Up to 52 Weeks)||27
11244524|NCT02119156|12437221|FG002|COMPLETED|Treatment Phase (Up to 52 Weeks)||11
11244525|NCT02119156|12437219|FG000|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6
11244526|NCT02119156|12437220|FG001|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2
11244527|NCT02119156|12437221|FG002|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1
11244528|NCT02119156|12437219|FG000|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Long-term discontinuation participants were not allowed in Maintenance period|0
11244529|NCT02119156|12437220|FG001|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|16
11244530|NCT02119156|12437221|FG002|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|10
11244531|NCT02119156|12437219|FG000|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
11244532|NCT02119156|12437220|FG001|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6
11244533|NCT02119156|12437221|FG002|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3
11244534|NCT02119156|12437219|FG000|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
11244535|NCT02119156|12437220|FG001|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10
11244536|NCT02119156|12437221|FG002|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7
11244537|NCT02119260|12437243|FG000|STARTED|Overall Study||9
11244538|NCT02119260|12437244|FG001|STARTED|Overall Study||12
11244539|NCT02119260|12437245|FG002|STARTED|Overall Study||8
11244540|NCT02119260|12437246|FG003|STARTED|Overall Study||10
11244541|NCT02119260|12437247|FG004|STARTED|Overall Study||13
11244542|NCT02119260|12437248|FG005|STARTED|Overall Study||6
11244543|NCT02119260|12437249|FG006|STARTED|Overall Study||2
11244544|NCT02119260|12437243|FG000|COMPLETED|Overall Study||8
11244545|NCT02119260|12437244|FG001|COMPLETED|Overall Study||11
11244546|NCT02119260|12437245|FG002|COMPLETED|Overall Study||7
11244547|NCT02119260|12437246|FG003|COMPLETED|Overall Study||10
11244548|NCT02119260|12437247|FG004|COMPLETED|Overall Study||13
11244549|NCT02119260|12437248|FG005|COMPLETED|Overall Study||6
11244550|NCT02119260|12437249|FG006|COMPLETED|Overall Study||2
11244551|NCT02119260|12437243|FG000|NOT COMPLETED|Overall Study||1
11244552|NCT02119260|12437244|FG001|NOT COMPLETED|Overall Study||1
11244553|NCT02119260|12437245|FG002|NOT COMPLETED|Overall Study||1
11244554|NCT02119260|12437246|FG003|NOT COMPLETED|Overall Study||0
11244555|NCT02119260|12437247|FG004|NOT COMPLETED|Overall Study||0
11244556|NCT02119260|12437248|FG005|NOT COMPLETED|Overall Study||0
11244557|NCT02119260|12437249|FG006|NOT COMPLETED|Overall Study||0
11244558|NCT02119286|12437277|FG000|STARTED|Overall Study||206
11244559|NCT02119286|12437278|FG001|STARTED|Overall Study||206
11244560|NCT02119286|12437279|FG002|STARTED|Overall Study||207
11244561|NCT02119286|12437277|FG000|COMPLETED|Overall Study||180
11244562|NCT02119286|12437278|FG001|COMPLETED|Overall Study||195
11244563|NCT02119286|12437279|FG002|COMPLETED|Overall Study||200
11244564|NCT02119286|12437277|FG000|NOT COMPLETED|Overall Study||26
11244565|NCT02119286|12437278|FG001|NOT COMPLETED|Overall Study||11
11244566|NCT02119286|12437279|FG002|NOT COMPLETED|Overall Study||7
11244567|NCT02119299|12437287|FG000|STARTED|Overall Study||76
11244568|NCT02119299|12437287|FG000|COMPLETED|Overall Study||67
11244569|NCT02119299|12437287|FG000|NOT COMPLETED|Overall Study||9
11244570|NCT02119325|12437291|FG000|STARTED|Period 1||48
11244571|NCT02119325|12437292|FG001|STARTED|Period 1||48
11244572|NCT02119325|12437291|FG000|COMPLETED|Period 1||48
11244573|NCT02119325|12437292|FG001|COMPLETED|Period 1||48
11244574|NCT02119325|12437291|FG000|NOT COMPLETED|Period 1||0
11244575|NCT02119325|12437292|FG001|NOT COMPLETED|Period 1||0
11244576|NCT02119325|12437291|FG000|STARTED|Washout Period 1||48
11244577|NCT02119325|12437292|FG001|STARTED|Washout Period 1||48
11244578|NCT02119325|12437291|FG000|COMPLETED|Washout Period 1||48
11244579|NCT02119325|12437292|FG001|COMPLETED|Washout Period 1||47
11244580|NCT02119325|12437291|FG000|NOT COMPLETED|Washout Period 1||0
11244581|NCT02119325|12437292|FG001|NOT COMPLETED|Washout Period 1||1
11244582|NCT02119325|12437291|FG000|STARTED|Period 2||48
11244583|NCT02119325|12437292|FG001|STARTED|Period 2||47
11244584|NCT02119325|12437291|FG000|COMPLETED|Period 2||48
11244585|NCT02119325|12437292|FG001|COMPLETED|Period 2||47
11244586|NCT02119325|12437291|FG000|NOT COMPLETED|Period 2||0
11244587|NCT02119325|12437292|FG001|NOT COMPLETED|Period 2||0
11244588|NCT02119442|12437300|FG000|STARTED|Overall Study||90
11244589|NCT02119442|12437300|FG000|COMPLETED|Overall Study||90
11244590|NCT02119442|12437300|FG000|NOT COMPLETED|Overall Study||0
11244591|NCT02119455|12437306|FG000|STARTED|Overall Study||20
11244592|NCT02119455|12437307|FG001|STARTED|Overall Study||20
11244593|NCT02119455|12437306|FG000|COMPLETED|Overall Study||20
11244594|NCT02119455|12437307|FG001|COMPLETED|Overall Study||17
11244595|NCT02119455|12437306|FG000|NOT COMPLETED|Overall Study||0
11244596|NCT02119455|12437307|FG001|NOT COMPLETED|Overall Study||3
11244597|NCT02119650|12437315|FG000|STARTED|Overall Study||39
11244598|NCT02119650|12437316|FG001|STARTED|Overall Study||37
11244599|NCT02119650|12437315|FG000|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
11244600|NCT02119650|12437316|FG001|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
11244601|NCT02119650|12437315|FG000|NOT COMPLETED|Overall Study||25
11244602|NCT02119650|12437316|FG001|NOT COMPLETED|Overall Study||26
11244603|NCT02119663|12437324|FG000|STARTED|Overall Study||43
11244604|NCT02119663|12437325|FG001|STARTED|Overall Study||43
11244605|NCT02119663|12437324|FG000|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
11244606|NCT02119663|12437325|FG001|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
11244607|NCT02119663|12437324|FG000|NOT COMPLETED|Overall Study||40
11244608|NCT02119663|12437325|FG001|NOT COMPLETED|Overall Study||41
11339150|NCT02910011|12536601|FG000|STARTED|Overall Study||15
11339151|NCT02910011|12536601|FG000|COMPLETED|Overall Study||13
11339152|NCT02910011|12536601|FG000|NOT COMPLETED|Overall Study||2
11339153|NCT02910037|12536607|FG000|STARTED|Overall Study||214
11339154|NCT02910037|12536607|FG000|COMPLETED|Overall Study||204
11339155|NCT02910037|12536607|FG000|NOT COMPLETED|Overall Study||10
11339156|NCT02910063|12536627|FG000|STARTED|Phase 2||41
11339157|NCT02910063|12536628|FG001|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
11339158|NCT02910063|12536629|FG002|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
11339159|NCT02910063|12536627|FG000|Started Cycle 1|Phase 2||41
11339160|NCT02910063|12536628|FG001|Started Cycle 1|Phase 2||0
11339161|NCT02910063|12536629|FG002|Started Cycle 1|Phase 2||0
11339162|NCT02910063|12536627|FG000|Started Optional Cycle 2|Phase 2||4
11339163|NCT02910063|12536628|FG001|Started Optional Cycle 2|Phase 2||0
11339164|NCT02910063|12536629|FG002|Started Optional Cycle 2|Phase 2||0
11339165|NCT02910063|12536627|FG000|COMPLETED|Phase 2||13
11339166|NCT02910063|12536628|FG001|COMPLETED|Phase 2||0
11339167|NCT02910063|12536629|FG002|COMPLETED|Phase 2||0
11339168|NCT02910063|12536627|FG000|NOT COMPLETED|Phase 2||28
11339169|NCT02910063|12536628|FG001|NOT COMPLETED|Phase 2||0
11339170|NCT02910063|12536629|FG002|NOT COMPLETED|Phase 2||0
11339171|NCT02910063|12536627|FG000|STARTED|Phase 3|Participants in this Phase 2 arm were not included in the Phase 3 period.|0
11339172|NCT02910063|12536628|FG001|STARTED|Phase 3||0
11339173|NCT02910063|12536629|FG002|STARTED|Phase 3||0
11339174|NCT02910063|12536627|FG000|COMPLETED|Phase 3||0
11339175|NCT02910063|12536628|FG001|COMPLETED|Phase 3||0
11339176|NCT02910063|12536629|FG002|COMPLETED|Phase 3||0
11339177|NCT02910063|12536627|FG000|NOT COMPLETED|Phase 3||0
11339178|NCT02910063|12536628|FG001|NOT COMPLETED|Phase 3||0
11339179|NCT02910063|12536629|FG002|NOT COMPLETED|Phase 3||0
11339180|NCT02910089|12536640|FG000|STARTED|Overall Study|Patients allocated to intervention|700
11339181|NCT02910089|12536641|FG001|STARTED|Overall Study|Patients allocated to control|700
11339182|NCT02910089|12536640|FG000|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678
11339183|NCT02910089|12536641|FG001|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684
11339184|NCT02910089|12536640|FG000|NOT COMPLETED|Overall Study||22
11339185|NCT02910089|12536641|FG001|NOT COMPLETED|Overall Study||16
11339186|NCT02910102|12536649|FG000|STARTED|Overall Study||21
11339187|NCT02910102|12536650|FG001|STARTED|Overall Study||17
11339188|NCT02910102|12536649|FG000|Safety Population|Overall Study||21
11339189|NCT02910102|12536650|FG001|Safety Population|Overall Study||17
11339190|NCT02910102|12536649|FG000|Intent to Treat (ITT) Population|Overall Study||21
11339191|NCT02910102|12536650|FG001|Intent to Treat (ITT) Population|Overall Study||17
11339192|NCT02910102|12536649|FG000|Per-Protocol Population|Overall Study||20
11339193|NCT02910102|12536650|FG001|Per-Protocol Population|Overall Study||17
11339194|NCT02910102|12536649|FG000|COMPLETED|Overall Study||21
11339195|NCT02910102|12536650|FG001|COMPLETED|Overall Study||17
11339196|NCT02910102|12536649|FG000|NOT COMPLETED|Overall Study||0
11339197|NCT02910102|12536650|FG001|NOT COMPLETED|Overall Study||0
11339198|NCT02910167|12536661|FG000|STARTED|Overall Study||360
11339199|NCT02910167|12536661|FG000|COMPLETED|Overall Study||341
11339200|NCT02910167|12536661|FG000|NOT COMPLETED|Overall Study||19
11339201|NCT02910362|12536667|FG000|STARTED|Overall Study||8
11339202|NCT02910362|12536668|FG001|STARTED|Overall Study||7
11339203|NCT02910362|12536667|FG000|COMPLETED|Overall Study||8
11339204|NCT02910362|12536668|FG001|COMPLETED|Overall Study||7
11339205|NCT02910362|12536667|FG000|NOT COMPLETED|Overall Study||0
11339206|NCT02910362|12536668|FG001|NOT COMPLETED|Overall Study||0
11339207|NCT02910466|12536674|FG000|STARTED|Overall Study||39
11339208|NCT02910466|12536674|FG000|Safety Set|Overall Study||39
11339209|NCT02910466|12536674|FG000|Treated|Overall Study||36
11339210|NCT02910466|12536674|FG000|COMPLETED|Overall Study||0
11339211|NCT02910466|12536674|FG000|NOT COMPLETED|Overall Study||39
11339212|NCT02910674|12536678|FG000|STARTED|Overall Study||102
11339213|NCT02910674|12536678|FG000|COMPLETED|Overall Study||102
11244609|NCT02119676|12437335|FG000|STARTED|Overall Study||87
11244610|NCT02119676|12437336|FG001|STARTED|Overall Study||88
11244611|NCT02119676|12437337|FG002|STARTED|Overall Study||110
11244612|NCT02119676|12437338|FG003|STARTED|Overall Study||111
11244613|NCT02119676|12437335|FG000|Treated Patients|Overall Study||85
11244614|NCT02119676|12437336|FG001|Treated Patients|Overall Study||86
11244615|NCT02119676|12437337|FG002|Treated Patients|Overall Study||106
11244616|NCT02119676|12437338|FG003|Treated Patients|Overall Study||106
11244617|NCT02119676|12437335|FG000|COMPLETED|Overall Study||4
11244618|NCT02119676|12437336|FG001|COMPLETED|Overall Study||2
11244619|NCT02119676|12437337|FG002|COMPLETED|Overall Study||13
11244620|NCT02119676|12437338|FG003|COMPLETED|Overall Study||10
11244621|NCT02119676|12437335|FG000|NOT COMPLETED|Overall Study||83
11244622|NCT02119676|12437336|FG001|NOT COMPLETED|Overall Study||86
11244623|NCT02119676|12437337|FG002|NOT COMPLETED|Overall Study||97
11244624|NCT02119676|12437338|FG003|NOT COMPLETED|Overall Study||101
11244625|NCT02119819|12437354|FG000|STARTED|Overall Study||66
11244626|NCT02119819|12437355|FG001|STARTED|Overall Study||71
11244627|NCT02119819|12437356|FG002|STARTED|Overall Study||73
11244628|NCT02119819|12437357|FG003|STARTED|Overall Study||70
11244629|NCT02119819|12437358|FG004|STARTED|Overall Study||69
11244630|NCT02119819|12437359|FG005|STARTED|Overall Study||71
11244631|NCT02119819|12437354|FG000|COMPLETED|Overall Study||57
11244632|NCT02119819|12437355|FG001|COMPLETED|Overall Study||66
11244633|NCT02119819|12437356|FG002|COMPLETED|Overall Study||69
11244634|NCT02119819|12437357|FG003|COMPLETED|Overall Study||63
11244635|NCT02119819|12437358|FG004|COMPLETED|Overall Study||62
11244636|NCT02119819|12437359|FG005|COMPLETED|Overall Study||56
11244637|NCT02119819|12437354|FG000|NOT COMPLETED|Overall Study||9
11244638|NCT02119819|12437355|FG001|NOT COMPLETED|Overall Study||5
11244639|NCT02119819|12437356|FG002|NOT COMPLETED|Overall Study||4
11244640|NCT02119819|12437357|FG003|NOT COMPLETED|Overall Study||7
11244641|NCT02119819|12437358|FG004|NOT COMPLETED|Overall Study||7
11244642|NCT02119819|12437359|FG005|NOT COMPLETED|Overall Study||15
11244643|NCT02119871|12437375|FG000|STARTED|Overall Study||10
11244644|NCT02119871|12437376|FG001|STARTED|Overall Study||10
11244645|NCT02119871|12437375|FG000|COMPLETED|Overall Study||10
11244646|NCT02119871|12437376|FG001|COMPLETED|Overall Study||10
11244647|NCT02119871|12437375|FG000|NOT COMPLETED|Overall Study||0
11244648|NCT02119871|12437376|FG001|NOT COMPLETED|Overall Study||0
11244649|NCT02119936|12437382|FG000|STARTED|Overall Study||10
11244650|NCT02119936|12437382|FG000|COMPLETED|Overall Study||0
11244651|NCT02119936|12437382|FG000|NOT COMPLETED|Overall Study||10
11244652|NCT02120001|12437388|FG000|STARTED|Overall Study||17
11244653|NCT02120001|12437389|FG001|STARTED|Overall Study||19
11244654|NCT02120001|12437388|FG000|COMPLETED|Overall Study||17
11244655|NCT02120001|12437389|FG001|COMPLETED|Overall Study||19
11244656|NCT02120001|12437388|FG000|NOT COMPLETED|Overall Study||0
11244657|NCT02120001|12437389|FG001|NOT COMPLETED|Overall Study||0
11244658|NCT02120027|12437397|FG000|STARTED|Overall Study||277
11244659|NCT02120027|12437398|FG001|STARTED|Overall Study||279
11244660|NCT02120027|12437397|FG000|COMPLETED|Overall Study||161
11244661|NCT02120027|12437398|FG001|COMPLETED|Overall Study||160
11244662|NCT02120027|12437397|FG000|NOT COMPLETED|Overall Study||116
11244663|NCT02120027|12437398|FG001|NOT COMPLETED|Overall Study||119
11244664|NCT02120157|12437404|FG000|STARTED|Overall Study||32
11244665|NCT02120157|12437404|FG000|Completed 180 Days|Overall Study||30
11244666|NCT02120157|12437404|FG000|COMPLETED|Overall Study||24
11244667|NCT02120157|12437404|FG000|NOT COMPLETED|Overall Study||8
11244668|NCT02120261|12437412|FG000|STARTED|Overall Study||23
11244669|NCT02120261|12437413|FG001|STARTED|Overall Study||25
11244670|NCT02120261|12437412|FG000|COMPLETED|Overall Study||23
11244671|NCT02120261|12437413|FG001|COMPLETED|Overall Study||25
11244672|NCT02120261|12437412|FG000|NOT COMPLETED|Overall Study||0
11244673|NCT02120261|12437413|FG001|NOT COMPLETED|Overall Study||0
11244674|NCT02120287|12437419|FG000|STARTED|Overall Study||16
11244675|NCT02120287|12437419|FG000|COMPLETED|Overall Study||16
11244676|NCT02120287|12437419|FG000|NOT COMPLETED|Overall Study||0
11244677|NCT02120300|12437427|FG000|STARTED|Overall Study||101
11244678|NCT02120300|12437428|FG001|STARTED|Overall Study||5
11244679|NCT02120300|12437429|FG002|STARTED|Overall Study||10
11244680|NCT02120300|12437430|FG003|STARTED|Overall Study||6
11244681|NCT02120300|12437427|FG000|COMPLETED|Overall Study||98
11244682|NCT02120300|12437428|FG001|COMPLETED|Overall Study||5
11244683|NCT02120300|12437429|FG002|COMPLETED|Overall Study||10
11244684|NCT02120300|12437430|FG003|COMPLETED|Overall Study||5
11244685|NCT02120300|12437427|FG000|NOT COMPLETED|Overall Study||3
11244686|NCT02120300|12437428|FG001|NOT COMPLETED|Overall Study||0
11244687|NCT02120300|12437429|FG002|NOT COMPLETED|Overall Study||0
11244688|NCT02120300|12437430|FG003|NOT COMPLETED|Overall Study||1
11244689|NCT02120417|12437444|FG000|STARTED|Overall Study||76
11244690|NCT02120417|12437445|FG001|STARTED|Overall Study||73
11244691|NCT02120417|12437444|FG000|COMPLETED|Overall Study||16
11244692|NCT02120417|12437445|FG001|COMPLETED|Overall Study||5
11244693|NCT02120417|12437444|FG000|NOT COMPLETED|Overall Study||60
11244694|NCT02120417|12437445|FG001|NOT COMPLETED|Overall Study||68
11244695|NCT02120443|12437451|FG000|STARTED|Overall Study||43
11244696|NCT02120443|12437451|FG000|COMPLETED|Overall Study||43
11244697|NCT02120443|12437451|FG000|NOT COMPLETED|Overall Study||0
11244698|NCT02120456|12437464|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||12
11244699|NCT02120456|12437465|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||12
11244700|NCT02120456|12437466|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||12
11339214|NCT02910674|12536678|FG000|NOT COMPLETED|Overall Study||0
11244701|NCT02120456|12437467|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||12
11244702|NCT02120456|12437468|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||12
11244703|NCT02120456|12437469|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||9
11244704|NCT02120456|12437470|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||0
11244705|NCT02120456|12437471|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||0
11244706|NCT02120456|12437472|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||0
11244707|NCT02120456|12437464|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
11244708|NCT02120456|12437465|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
11244709|NCT02120456|12437466|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
11244710|NCT02120456|12437467|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
11244711|NCT02120456|12437468|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
11244712|NCT02120456|12437469|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9
11244713|NCT02120456|12437470|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11244714|NCT02120456|12437471|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11244715|NCT02120456|12437472|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11244716|NCT02120456|12437464|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11244717|NCT02120456|12437465|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11244718|NCT02120456|12437466|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11244719|NCT02120456|12437467|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11244720|NCT02120456|12437468|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11244721|NCT02120456|12437469|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11244722|NCT02120456|12437470|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11244723|NCT02120456|12437471|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11244724|NCT02120456|12437472|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11244725|NCT02120456|12437464|FG000|STARTED|Part 2 Double-blind Phase||0
11244726|NCT02120456|12437465|FG001|STARTED|Part 2 Double-blind Phase||0
11244727|NCT02120456|12437466|FG002|STARTED|Part 2 Double-blind Phase||0
11244728|NCT02120456|12437467|FG003|STARTED|Part 2 Double-blind Phase||0
11244729|NCT02120456|12437468|FG004|STARTED|Part 2 Double-blind Phase||0
11244730|NCT02120456|12437469|FG005|STARTED|Part 2 Double-blind Phase||0
11244731|NCT02120456|12437470|FG006|STARTED|Part 2 Double-blind Phase||32
11244732|NCT02120456|12437471|FG007|STARTED|Part 2 Double-blind Phase||60
11244733|NCT02120456|12437472|FG008|STARTED|Part 2 Double-blind Phase||63
11244734|NCT02120456|12437464|FG000|COMPLETED|Part 2 Double-blind Phase||0
11244735|NCT02120456|12437465|FG001|COMPLETED|Part 2 Double-blind Phase||0
11244736|NCT02120456|12437466|FG002|COMPLETED|Part 2 Double-blind Phase||0
11244737|NCT02120456|12437467|FG003|COMPLETED|Part 2 Double-blind Phase||0
11244738|NCT02120456|12437468|FG004|COMPLETED|Part 2 Double-blind Phase||0
11244739|NCT02120456|12437469|FG005|COMPLETED|Part 2 Double-blind Phase||0
11244740|NCT02120456|12437470|FG006|COMPLETED|Part 2 Double-blind Phase||30
11244741|NCT02120456|12437471|FG007|COMPLETED|Part 2 Double-blind Phase||60
11244742|NCT02120456|12437472|FG008|COMPLETED|Part 2 Double-blind Phase||62
11244743|NCT02120456|12437464|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0
11244744|NCT02120456|12437465|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0
11244745|NCT02120456|12437466|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0
11244746|NCT02120456|12437467|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0
11244747|NCT02120456|12437468|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0
11244748|NCT02120456|12437469|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0
11244749|NCT02120456|12437470|FG006|NOT COMPLETED|Part 2 Double-blind Phase||2
11244750|NCT02120456|12437471|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0
11244751|NCT02120456|12437472|FG008|NOT COMPLETED|Part 2 Double-blind Phase||1
11244752|NCT02120625|12437492|FG000|STARTED|Overall Study||8
11244753|NCT02120625|12437492|FG000|COMPLETED|Overall Study||6
11244754|NCT02120625|12437492|FG000|NOT COMPLETED|Overall Study||2
11244755|NCT02120664|12437501|FG000|STARTED|Overall Study||10
11244756|NCT02120664|12437502|FG001|STARTED|Overall Study||4
11244757|NCT02120664|12437503|FG002|STARTED|Overall Study||7
11244758|NCT02120664|12437504|FG003|STARTED|Overall Study||4
11244759|NCT02120664|12437505|FG004|STARTED|Overall Study||10
11244760|NCT02120664|12437501|FG000|COMPLETED|Overall Study||10
11244761|NCT02120664|12437502|FG001|COMPLETED|Overall Study||4
11244762|NCT02120664|12437503|FG002|COMPLETED|Overall Study||7
11244763|NCT02120664|12437504|FG003|COMPLETED|Overall Study||3
11244764|NCT02120664|12437505|FG004|COMPLETED|Overall Study||10
11244765|NCT02120664|12437501|FG000|NOT COMPLETED|Overall Study||0
11244766|NCT02120664|12437502|FG001|NOT COMPLETED|Overall Study||0
11244767|NCT02120664|12437503|FG002|NOT COMPLETED|Overall Study||0
11244768|NCT02120664|12437504|FG003|NOT COMPLETED|Overall Study||1
11244769|NCT02120664|12437505|FG004|NOT COMPLETED|Overall Study||0
11244770|NCT02120716|12437520|FG000|STARTED|Overall Study||31
11244771|NCT02120716|12437521|FG001|STARTED|Overall Study||19
11244772|NCT02120716|12437520|FG000|COMPLETED|Overall Study||30
11244773|NCT02120716|12437521|FG001|COMPLETED|Overall Study||19
11244774|NCT02120716|12437520|FG000|NOT COMPLETED|Overall Study||1
11244775|NCT02120716|12437521|FG001|NOT COMPLETED|Overall Study||0
11244776|NCT02120781|12437529|FG000|STARTED|Overall Study||15
11244777|NCT02120781|12437530|FG001|STARTED|Overall Study||6
11244778|NCT02120781|12437529|FG000|COMPLETED|Overall Study||11
11244779|NCT02120781|12437530|FG001|COMPLETED|Overall Study||5
11244780|NCT02120781|12437529|FG000|NOT COMPLETED|Overall Study||4
11244781|NCT02120781|12437530|FG001|NOT COMPLETED|Overall Study||1
11244782|NCT02120794|12437536|FG000|STARTED|Overall Study||194
11244783|NCT02120794|12437536|FG000|COMPLETED|Overall Study||136
11244784|NCT02120794|12437536|FG000|NOT COMPLETED|Overall Study||58
11244785|NCT02120833|12437542|FG000|STARTED|Overall Study||39
11244786|NCT02120833|12437543|FG001|STARTED|Overall Study||12
11244787|NCT02120833|12437542|FG000|COMPLETED|Overall Study||35
11244788|NCT02120833|12437543|FG001|COMPLETED|Overall Study||11
11244789|NCT02120833|12437542|FG000|NOT COMPLETED|Overall Study||4
11244790|NCT02120833|12437543|FG001|NOT COMPLETED|Overall Study||1
11244791|NCT02120898|12437552|FG000|STARTED|Overall Study||187
11244792|NCT02120898|12437553|FG001|STARTED|Overall Study||187
11244793|NCT02120898|12437554|FG002|STARTED|Overall Study||93
11244794|NCT02120898|12437552|FG000|Safety Population|Overall Study||187
11244795|NCT02120898|12437553|FG001|Safety Population|Overall Study||187
11244796|NCT02120898|12437554|FG002|Safety Population|Overall Study||93
11244797|NCT02120898|12437552|FG000|Intent-to-Treat (ITT) Population|Overall Study||183
11244798|NCT02120898|12437553|FG001|Intent-to-Treat (ITT) Population|Overall Study||185
11244799|NCT02120898|12437554|FG002|Intent-to-Treat (ITT) Population|Overall Study||93
11244800|NCT02120898|12437552|FG000|COMPLETED|Overall Study||178
11244801|NCT02120898|12437553|FG001|COMPLETED|Overall Study||181
11244802|NCT02120898|12437554|FG002|COMPLETED|Overall Study||89
11244803|NCT02120898|12437552|FG000|NOT COMPLETED|Overall Study||9
11244804|NCT02120898|12437553|FG001|NOT COMPLETED|Overall Study||6
11244805|NCT02120898|12437554|FG002|NOT COMPLETED|Overall Study||4
11244806|NCT02120924|12437565|FG000|STARTED|Overall Study||404
11244807|NCT02120924|12437566|FG001|STARTED|Overall Study||403
11244808|NCT02120924|12437567|FG002|STARTED|Overall Study||202
11244809|NCT02120924|12437565|FG000|COMPLETED|Overall Study||362
11244810|NCT02120924|12437566|FG001|COMPLETED|Overall Study||357
11244811|NCT02120924|12437567|FG002|COMPLETED|Overall Study||173
11244812|NCT02120924|12437565|FG000|NOT COMPLETED|Overall Study||42
11005360|NCT00722423|12183055|FG001|NOT COMPLETED|Overall Study||1
11005361|NCT00722436|12183065|FG000|STARTED|Overall Study||9
11005362|NCT00722436|12183066|FG001|STARTED|Overall Study||11
11005363|NCT00722436|12183065|FG000|COMPLETED|Overall Study||9
11005364|NCT00722436|12183066|FG001|COMPLETED|Overall Study||11
11244813|NCT02120924|12437566|FG001|NOT COMPLETED|Overall Study||46
11244814|NCT02120924|12437567|FG002|NOT COMPLETED|Overall Study||29
11244815|NCT02120950|12437578|FG000|STARTED|Overall Study||157
11244816|NCT02120950|12437579|FG001|STARTED|Overall Study||161
11244817|NCT02120950|12437580|FG002|STARTED|Overall Study||15
11244818|NCT02120950|12437578|FG000|COMPLETED|Overall Study|Completed Treatment (Week 96)|137
11244819|NCT02120950|12437579|FG001|COMPLETED|Overall Study|Completed Treatment (Week 96)|147
11244820|NCT02120950|12437580|FG002|COMPLETED|Overall Study||0
11244821|NCT02120950|12437578|FG000|NOT COMPLETED|Overall Study||20
11244822|NCT02120950|12437579|FG001|NOT COMPLETED|Overall Study||14
11244823|NCT02120950|12437580|FG002|NOT COMPLETED|Overall Study||15
11244824|NCT02121002|12437590|FG000|STARTED|Overall Study||392
11244825|NCT02121002|12437591|FG001|STARTED|Overall Study||393
11244826|NCT02121002|12437592|FG002|STARTED|Overall Study||391
11244827|NCT02121002|12437590|FG000|COMPLETED|Overall Study||385
11244828|NCT02121002|12437591|FG001|COMPLETED|Overall Study||389
11244829|NCT02121002|12437592|FG002|COMPLETED|Overall Study||381
11244830|NCT02121002|12437590|FG000|NOT COMPLETED|Overall Study||7
11244831|NCT02121002|12437591|FG001|NOT COMPLETED|Overall Study||4
11244832|NCT02121002|12437592|FG002|NOT COMPLETED|Overall Study||10
11244833|NCT02121041|12437602|FG000|STARTED|Overall Study||14
11244834|NCT02121041|12437603|FG001|STARTED|Overall Study||14
11244835|NCT02121041|12437602|FG000|COMPLETED|Overall Study||13
11244836|NCT02121041|12437603|FG001|COMPLETED|Overall Study||8
11244837|NCT02121041|12437602|FG000|NOT COMPLETED|Overall Study||1
11244838|NCT02121041|12437603|FG001|NOT COMPLETED|Overall Study||6
11244839|NCT02121067|12437609|FG000|STARTED|Overall Study||50
11244840|NCT02121067|12437609|FG000|COMPLETED|Overall Study||50
11244841|NCT02121067|12437609|FG000|NOT COMPLETED|Overall Study||0
11244842|NCT02121210|12437616|FG000|STARTED|Overall Study||65
11244843|NCT02121210|12437617|FG001|STARTED|Overall Study||67
11244844|NCT02121210|12437616|FG000|COMPLETED|Overall Study||58
11244845|NCT02121210|12437617|FG001|COMPLETED|Overall Study||58
11244846|NCT02121210|12437616|FG000|NOT COMPLETED|Overall Study||7
11244847|NCT02121210|12437617|FG001|NOT COMPLETED|Overall Study||9
11244848|NCT02121262|12437625|FG000|STARTED|Overall Study||139
11244849|NCT02121262|12437626|FG001|STARTED|Overall Study||145
11244850|NCT02121262|12437625|FG000|Treated|Overall Study||129
11244851|NCT02121262|12437626|FG001|Treated|Overall Study||145
11244852|NCT02121262|12437625|FG000|Modified Intent-to-treat Population|Overall Study||127
11244853|NCT02121262|12437626|FG001|Modified Intent-to-treat Population|Overall Study||145
11244854|NCT02121262|12437625|FG000|COMPLETED|Overall Study||108
11244855|NCT02121262|12437626|FG001|COMPLETED|Overall Study||135
11244856|NCT02121262|12437625|FG000|NOT COMPLETED|Overall Study||31
11244857|NCT02121262|12437626|FG001|NOT COMPLETED|Overall Study||10
11244858|NCT02121301|12437635|FG000|STARTED|Overall Study||30
11244859|NCT02121301|12437636|FG001|STARTED|Overall Study||30
11244860|NCT02121301|12437637|FG002|STARTED|Overall Study||31
11244861|NCT02121301|12437635|FG000|COMPLETED|Overall Study||29
11244862|NCT02121301|12437636|FG001|COMPLETED|Overall Study||26
11244863|NCT02121301|12437637|FG002|COMPLETED|Overall Study||30
11244864|NCT02121301|12437635|FG000|NOT COMPLETED|Overall Study||1
11244865|NCT02121301|12437636|FG001|NOT COMPLETED|Overall Study||4
11244866|NCT02121301|12437637|FG002|NOT COMPLETED|Overall Study||1
11244867|NCT02121392|12437647|FG000|STARTED|Prior to Intervention||83
11244868|NCT02121392|12437648|FG001|STARTED|Prior to Intervention||82
11244869|NCT02121392|12437647|FG000|COMPLETED|Prior to Intervention||35
11244870|NCT02121392|12437648|FG001|COMPLETED|Prior to Intervention||41
11244871|NCT02121392|12437647|FG000|NOT COMPLETED|Prior to Intervention||48
11244872|NCT02121392|12437648|FG001|NOT COMPLETED|Prior to Intervention||41
11244873|NCT02121392|12437647|FG000|STARTED|After Placement of AC Block vs Sham||35
11244874|NCT02121392|12437648|FG001|STARTED|After Placement of AC Block vs Sham||41
11244875|NCT02121392|12437647|FG000|COMPLETED|After Placement of AC Block vs Sham||32
11244876|NCT02121392|12437648|FG001|COMPLETED|After Placement of AC Block vs Sham||38
11244877|NCT02121392|12437647|FG000|NOT COMPLETED|After Placement of AC Block vs Sham||3
11244878|NCT02121392|12437648|FG001|NOT COMPLETED|After Placement of AC Block vs Sham||3
11244879|NCT02121418|12437654|FG000|STARTED|Overall Study||12
11244880|NCT02121418|12437654|FG000|COMPLETED|Overall Study||12
11244881|NCT02121418|12437654|FG000|NOT COMPLETED|Overall Study||0
11244882|NCT02121483|12437661|FG000|STARTED|Overall Study||9
11244883|NCT02121483|12437662|FG001|STARTED|Overall Study||8
11244884|NCT02121483|12437663|FG002|STARTED|Overall Study||10
11244885|NCT02121483|12437661|FG000|COMPLETED|Overall Study||9
11244886|NCT02121483|12437662|FG001|COMPLETED|Overall Study||8
11244887|NCT02121483|12437663|FG002|COMPLETED|Overall Study||10
11244888|NCT02121483|12437661|FG000|NOT COMPLETED|Overall Study||0
11244889|NCT02121483|12437662|FG001|NOT COMPLETED|Overall Study||0
11244890|NCT02121483|12437663|FG002|NOT COMPLETED|Overall Study||0
11244891|NCT02121509|12437673|FG000|STARTED|Treatment Period-1 (4 Days)||30
11244892|NCT02121509|12437674|FG001|STARTED|Treatment Period-1 (4 Days)||28
11244893|NCT02121509|12437675|FG002|STARTED|Treatment Period-1 (4 Days)||8
11244894|NCT02121509|12437676|FG003|STARTED|Treatment Period-1 (4 Days)||8
11244895|NCT02121509|12437673|FG000|COMPLETED|Treatment Period-1 (4 Days)||30
11244896|NCT02121509|12437674|FG001|COMPLETED|Treatment Period-1 (4 Days)||28
11244897|NCT02121509|12437675|FG002|COMPLETED|Treatment Period-1 (4 Days)||8
11244898|NCT02121509|12437676|FG003|COMPLETED|Treatment Period-1 (4 Days)||8
11244899|NCT02121509|12437673|FG000|NOT COMPLETED|Treatment Period-1 (4 Days)||0
11244900|NCT02121509|12437674|FG001|NOT COMPLETED|Treatment Period-1 (4 Days)||0
11244901|NCT02121509|12437675|FG002|NOT COMPLETED|Treatment Period-1 (4 Days)||0
11244902|NCT02121509|12437676|FG003|NOT COMPLETED|Treatment Period-1 (4 Days)||0
11244903|NCT02121509|12437673|FG000|STARTED|Washout Period (35 Days)||30
11244904|NCT02121509|12437674|FG001|STARTED|Washout Period (35 Days)||28
11244905|NCT02121509|12437675|FG002|STARTED|Washout Period (35 Days)||8
11244906|NCT02121509|12437676|FG003|STARTED|Washout Period (35 Days)||8
11244907|NCT02121509|12437673|FG000|COMPLETED|Washout Period (35 Days)||28
11244908|NCT02121509|12437674|FG001|COMPLETED|Washout Period (35 Days)||24
11244909|NCT02121509|12437675|FG002|COMPLETED|Washout Period (35 Days)||8
11244910|NCT02121509|12437676|FG003|COMPLETED|Washout Period (35 Days)||8
11244911|NCT02121509|12437673|FG000|NOT COMPLETED|Washout Period (35 Days)||2
11244912|NCT02121509|12437674|FG001|NOT COMPLETED|Washout Period (35 Days)||4
11244913|NCT02121509|12437675|FG002|NOT COMPLETED|Washout Period (35 Days)||0
11244914|NCT02121509|12437676|FG003|NOT COMPLETED|Washout Period (35 Days)||0
11244915|NCT02121509|12437673|FG000|STARTED|Treatment Period-2 (4 Days)||28
11244916|NCT02121509|12437674|FG001|STARTED|Treatment Period-2 (4 Days)||24
11244917|NCT02121509|12437675|FG002|STARTED|Treatment Period-2 (4 Days)||8
11244918|NCT02121509|12437676|FG003|STARTED|Treatment Period-2 (4 Days)||8
11244919|NCT02121509|12437673|FG000|COMPLETED|Treatment Period-2 (4 Days)||28
11244920|NCT02121509|12437674|FG001|COMPLETED|Treatment Period-2 (4 Days)||24
11244921|NCT02121509|12437675|FG002|COMPLETED|Treatment Period-2 (4 Days)||8
11244922|NCT02121509|12437676|FG003|COMPLETED|Treatment Period-2 (4 Days)||8
11244923|NCT02121509|12437673|FG000|NOT COMPLETED|Treatment Period-2 (4 Days)||0
11244924|NCT02121509|12437674|FG001|NOT COMPLETED|Treatment Period-2 (4 Days)||0
11244925|NCT02121509|12437675|FG002|NOT COMPLETED|Treatment Period-2 (4 Days)||0
11244926|NCT02121509|12437676|FG003|NOT COMPLETED|Treatment Period-2 (4 Days)||0
11244927|NCT02121522|12437686|FG000|STARTED|Overall Study||14
11244928|NCT02121522|12437686|FG000|COMPLETED|Overall Study||13
11244929|NCT02121522|12437686|FG000|NOT COMPLETED|Overall Study||1
11244930|NCT02121535|12437692|FG000|STARTED|Period 1 (8 Trial Days)||36
11244931|NCT02121535|12437693|FG001|STARTED|Period 1 (8 Trial Days)||36
11244932|NCT02121535|12437692|FG000|COMPLETED|Period 1 (8 Trial Days)||36
11244933|NCT02121535|12437693|FG001|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
11244934|NCT02121535|12437692|FG000|NOT COMPLETED|Period 1 (8 Trial Days)||0
11244935|NCT02121535|12437693|FG001|NOT COMPLETED|Period 1 (8 Trial Days)||1
11244936|NCT02121535|12437692|FG000|STARTED|Period 2 (8 Trial Days)||36
11244937|NCT02121535|12437693|FG001|STARTED|Period 2 (8 Trial Days)||35
11244938|NCT02121535|12437692|FG000|COMPLETED|Period 2 (8 Trial Days)||36
11244939|NCT02121535|12437693|FG001|COMPLETED|Period 2 (8 Trial Days)||35
11244940|NCT02121535|12437692|FG000|NOT COMPLETED|Period 2 (8 Trial Days)||0
11244941|NCT02121535|12437693|FG001|NOT COMPLETED|Period 2 (8 Trial Days)||0
11244942|NCT02121535|12437692|FG000|STARTED|Period 3 (8 Trial Days)||36
11244943|NCT02121535|12437693|FG001|STARTED|Period 3 (8 Trial Days)||35
11244944|NCT02121535|12437692|FG000|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
11244945|NCT02121535|12437693|FG001|COMPLETED|Period 3 (8 Trial Days)||35
11244946|NCT02121535|12437692|FG000|NOT COMPLETED|Period 3 (8 Trial Days)||1
11244947|NCT02121535|12437693|FG001|NOT COMPLETED|Period 3 (8 Trial Days)||0
11244948|NCT02121535|12437692|FG000|STARTED|Period 4 (8 Trial Days)||35
11244949|NCT02121535|12437693|FG001|STARTED|Period 4 (8 Trial Days)||35
11244950|NCT02121535|12437692|FG000|COMPLETED|Period 4 (8 Trial Days)||35
11244951|NCT02121535|12437693|FG001|COMPLETED|Period 4 (8 Trial Days)||35
11244952|NCT02121535|12437692|FG000|NOT COMPLETED|Period 4 (8 Trial Days)||0
11244953|NCT02121535|12437693|FG001|NOT COMPLETED|Period 4 (8 Trial Days)||0
11244954|NCT02121756|12437702|FG000|STARTED|Overall Study||21
11244955|NCT02121756|12437703|FG001|STARTED|Overall Study||19
11244956|NCT02121756|12437702|FG000|COMPLETED|Overall Study||15
11244957|NCT02121756|12437703|FG001|COMPLETED|Overall Study||17
11244958|NCT02121756|12437702|FG000|NOT COMPLETED|Overall Study||6
11244959|NCT02121756|12437703|FG001|NOT COMPLETED|Overall Study||2
11244960|NCT02121795|12437714|FG000|STARTED|Double-Blind Phase||334
11244961|NCT02121795|12437715|FG001|STARTED|Double-Blind Phase||334
11244962|NCT02121795|12437714|FG000|Safety Analysis Set|Double-Blind Phase||333
11244963|NCT02121795|12437715|FG001|Safety Analysis Set|Double-Blind Phase||330
11244964|NCT02121795|12437714|FG000|COMPLETED|Double-Blind Phase||296
11244965|NCT02121795|12437715|FG001|COMPLETED|Double-Blind Phase||300
11244966|NCT02121795|12437714|FG000|NOT COMPLETED|Double-Blind Phase||38
11244967|NCT02121795|12437715|FG001|NOT COMPLETED|Double-Blind Phase||34
11244968|NCT02121795|12437714|FG000|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|33
11244969|NCT02121795|12437715|FG001|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|31
11244970|NCT02121795|12437714|FG000|COMPLETED|Open-Label Phase||21
11244971|NCT02121795|12437715|FG001|COMPLETED|Open-Label Phase||21
11244972|NCT02121795|12437714|FG000|NOT COMPLETED|Open-Label Phase||12
11244973|NCT02121795|12437715|FG001|NOT COMPLETED|Open-Label Phase||10
11244974|NCT02121808|12437723|FG000|STARTED|Overall Study||20
11244975|NCT02121808|12437723|FG000|COMPLETED|Overall Study||17
11244976|NCT02121808|12437723|FG000|NOT COMPLETED|Overall Study||3
11244977|NCT02121834|12437739|FG000|STARTED|Overall Study||12
11244978|NCT02121834|12437740|FG001|STARTED|Overall Study||11
11244979|NCT02121834|12437741|FG002|STARTED|Overall Study||9
11244980|NCT02121834|12437742|FG003|STARTED|Overall Study||10
11244981|NCT02121834|12437743|FG004|STARTED|Overall Study||9
11244982|NCT02121834|12437744|FG005|STARTED|Overall Study||9
11244983|NCT02121834|12437745|FG006|STARTED|Overall Study||3
11244984|NCT02121834|12437739|FG000|Received at Least One Dose of Study Drug|Overall Study||12
11244985|NCT02121834|12437740|FG001|Received at Least One Dose of Study Drug|Overall Study||11
11244986|NCT02121834|12437741|FG002|Received at Least One Dose of Study Drug|Overall Study||9
11244987|NCT02121834|12437742|FG003|Received at Least One Dose of Study Drug|Overall Study||10
11244988|NCT02121834|12437743|FG004|Received at Least One Dose of Study Drug|Overall Study||9
11244989|NCT02121834|12437744|FG005|Received at Least One Dose of Study Drug|Overall Study||9
11244990|NCT02121834|12437745|FG006|Received at Least One Dose of Study Drug|Overall Study||3
11244991|NCT02121834|12437739|FG000|COMPLETED|Overall Study||12
11244992|NCT02121834|12437740|FG001|COMPLETED|Overall Study||9
11244993|NCT02121834|12437741|FG002|COMPLETED|Overall Study||7
11244994|NCT02121834|12437742|FG003|COMPLETED|Overall Study||10
11244995|NCT02121834|12437743|FG004|COMPLETED|Overall Study||9
11244996|NCT02121834|12437744|FG005|COMPLETED|Overall Study||9
11244997|NCT02121834|12437745|FG006|COMPLETED|Overall Study||3
11244998|NCT02121834|12437739|FG000|NOT COMPLETED|Overall Study||0
11244999|NCT02121834|12437740|FG001|NOT COMPLETED|Overall Study||2
11245000|NCT02121834|12437741|FG002|NOT COMPLETED|Overall Study||2
11245001|NCT02121834|12437742|FG003|NOT COMPLETED|Overall Study||0
11245002|NCT02121834|12437743|FG004|NOT COMPLETED|Overall Study||0
11245003|NCT02121834|12437744|FG005|NOT COMPLETED|Overall Study||0
11245004|NCT02121834|12437745|FG006|NOT COMPLETED|Overall Study||0
11245005|NCT02121847|12437771|FG000|STARTED|Overall Study||40
11245006|NCT02121847|12437771|FG000|COMPLETED|Overall Study||37
11245007|NCT02121847|12437771|FG000|NOT COMPLETED|Overall Study||3
11245008|NCT02121860|12437779|FG000|STARTED|Overall Study||8
11245009|NCT02121860|12437780|FG001|STARTED|Overall Study||12
11245010|NCT02121860|12437781|FG002|STARTED|Overall Study||8
11245011|NCT02121860|12437782|FG003|STARTED|Overall Study||8
11245012|NCT02121860|12437779|FG000|COMPLETED|Overall Study||8
11245013|NCT02121860|12437780|FG001|COMPLETED|Overall Study||12
11245014|NCT02121860|12437781|FG002|COMPLETED|Overall Study||8
11245015|NCT02121860|12437782|FG003|COMPLETED|Overall Study||8
11245016|NCT02121860|12437779|FG000|NOT COMPLETED|Overall Study||0
11245017|NCT02121860|12437780|FG001|NOT COMPLETED|Overall Study||0
11245018|NCT02121860|12437781|FG002|NOT COMPLETED|Overall Study||0
11245019|NCT02121860|12437782|FG003|NOT COMPLETED|Overall Study||0
11245020|NCT02121912|12437791|FG000|STARTED|Overall Study||25
11245021|NCT02121912|12437792|FG001|STARTED|Overall Study||25
11245022|NCT02121912|12437791|FG000|COMPLETED|Overall Study||21
11245023|NCT02121912|12437792|FG001|COMPLETED|Overall Study||25
11245024|NCT02121912|12437791|FG000|NOT COMPLETED|Overall Study||4
11245025|NCT02121912|12437792|FG001|NOT COMPLETED|Overall Study||0
11245026|NCT02122146|12437806|FG000|STARTED|Part 1: Dose Escalation||2
11245027|NCT02122146|12437807|FG001|STARTED|Part 1: Dose Escalation||2
11245028|NCT02122146|12437808|FG002|STARTED|Part 1: Dose Escalation||4
11245029|NCT02122146|12437809|FG003|STARTED|Part 1: Dose Escalation||4
11245030|NCT02122146|12437810|FG004|STARTED|Part 1: Dose Escalation||4
11245031|NCT02122146|12437811|FG005|STARTED|Part 1: Dose Escalation||6
11245032|NCT02122146|12437812|FG006|STARTED|Part 1: Dose Escalation||1
11245033|NCT02122146|12437813|FG007|STARTED|Part 1: Dose Escalation||8
11245034|NCT02122146|12437806|FG000|COMPLETED|Part 1: Dose Escalation||1
11245035|NCT02122146|12437807|FG001|COMPLETED|Part 1: Dose Escalation||1
11245036|NCT02122146|12437808|FG002|COMPLETED|Part 1: Dose Escalation||2
11245037|NCT02122146|12437809|FG003|COMPLETED|Part 1: Dose Escalation||3
11245038|NCT02122146|12437810|FG004|COMPLETED|Part 1: Dose Escalation||3
11245039|NCT02122146|12437811|FG005|COMPLETED|Part 1: Dose Escalation||5
11245040|NCT02122146|12437812|FG006|COMPLETED|Part 1: Dose Escalation||0
11245041|NCT02122146|12437813|FG007|COMPLETED|Part 1: Dose Escalation||6
11245042|NCT02122146|12437806|FG000|NOT COMPLETED|Part 1: Dose Escalation||1
11245043|NCT02122146|12437807|FG001|NOT COMPLETED|Part 1: Dose Escalation||1
11245044|NCT02122146|12437808|FG002|NOT COMPLETED|Part 1: Dose Escalation||2
11245045|NCT02122146|12437809|FG003|NOT COMPLETED|Part 1: Dose Escalation||1
11245046|NCT02122146|12437810|FG004|NOT COMPLETED|Part 1: Dose Escalation||1
11245047|NCT02122146|12437811|FG005|NOT COMPLETED|Part 1: Dose Escalation||1
11245048|NCT02122146|12437812|FG006|NOT COMPLETED|Part 1: Dose Escalation||1
11245049|NCT02122146|12437813|FG007|NOT COMPLETED|Part 1: Dose Escalation||2
11245050|NCT02122146|12437806|FG000|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
11245051|NCT02122146|12437807|FG001|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
11245052|NCT02122146|12437808|FG002|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
11245053|NCT02122146|12437809|FG003|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
11245054|NCT02122146|12437810|FG004|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
11245055|NCT02122146|12437811|FG005|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
11245056|NCT02122146|12437812|FG006|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
11245057|NCT02122146|12437813|FG007|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
11245058|NCT02122146|12437806|FG000|COMPLETED|Part 2: Maximum Tolerated Dose||0
11245059|NCT02122146|12437807|FG001|COMPLETED|Part 2: Maximum Tolerated Dose||0
11245060|NCT02122146|12437808|FG002|COMPLETED|Part 2: Maximum Tolerated Dose||0
11245061|NCT02122146|12437809|FG003|COMPLETED|Part 2: Maximum Tolerated Dose||0
11245062|NCT02122146|12437810|FG004|COMPLETED|Part 2: Maximum Tolerated Dose||0
11245063|NCT02122146|12437811|FG005|COMPLETED|Part 2: Maximum Tolerated Dose||0
11245064|NCT02122146|12437812|FG006|COMPLETED|Part 2: Maximum Tolerated Dose||0
11245065|NCT02122146|12437813|FG007|COMPLETED|Part 2: Maximum Tolerated Dose||0
11245066|NCT02122146|12437806|FG000|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
11245067|NCT02122146|12437807|FG001|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
11245068|NCT02122146|12437808|FG002|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
11245069|NCT02122146|12437809|FG003|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
11245070|NCT02122146|12437810|FG004|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
11245071|NCT02122146|12437811|FG005|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
11245072|NCT02122146|12437812|FG006|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
11141872|NCT01465022|12328559|FG001|COMPLETED|Overall Study||40
11141873|NCT01465022|12328560|FG002|COMPLETED|Overall Study||0
11141874|NCT01465022|12328558|FG000|NOT COMPLETED|Overall Study||23
11141875|NCT01465022|12328559|FG001|NOT COMPLETED|Overall Study||23
11141876|NCT01465022|12328560|FG002|NOT COMPLETED|Overall Study||70
11141877|NCT01465048|12328569|FG000|STARTED|Overall Study||6
11141878|NCT01465048|12328570|FG001|STARTED|Overall Study||6
11141879|NCT01465048|12328571|FG002|STARTED|Overall Study||6
11141880|NCT01465048|12328569|FG000|COMPLETED|Overall Study||6
11141881|NCT01465048|12328570|FG001|COMPLETED|Overall Study||6
11141882|NCT01465048|12328571|FG002|COMPLETED|Overall Study||6
11141883|NCT01465048|12328569|FG000|NOT COMPLETED|Overall Study||0
11141884|NCT01465048|12328570|FG001|NOT COMPLETED|Overall Study||0
11141885|NCT01465048|12328571|FG002|NOT COMPLETED|Overall Study||0
11141886|NCT01465178|12328581|FG000|STARTED|Overall Study||31
11141887|NCT01465178|12328582|FG001|STARTED|Overall Study||31
11141888|NCT01465178|12328581|FG000|COMPLETED|Overall Study||30
11141889|NCT01465178|12328582|FG001|COMPLETED|Overall Study||31
11141890|NCT01465178|12328581|FG000|NOT COMPLETED|Overall Study||1
11141891|NCT01465178|12328582|FG001|NOT COMPLETED|Overall Study||0
11141892|NCT01465191|12328591|FG000|STARTED|Overall Study||56
11141893|NCT01465191|12328592|FG001|STARTED|Overall Study||63
11141894|NCT01465191|12328593|FG002|STARTED|Overall Study||50
11141895|NCT01465191|12328591|FG000|COMPLETED|Overall Study||47
11141896|NCT01465191|12328592|FG001|COMPLETED|Overall Study||54
11141897|NCT01465191|12328593|FG002|COMPLETED|Overall Study||43
11141898|NCT01465191|12328591|FG000|NOT COMPLETED|Overall Study||9
11141899|NCT01465191|12328592|FG001|NOT COMPLETED|Overall Study||9
11141900|NCT01465191|12328593|FG002|NOT COMPLETED|Overall Study||7
11141901|NCT01465347|12328604|FG000|STARTED|Overall Study||3
11141902|NCT01465347|12328605|FG001|STARTED|Overall Study||56
11141903|NCT01465347|12328604|FG000|COMPLETED|Overall Study||2
11141904|NCT01465347|12328605|FG001|COMPLETED|Overall Study||53
11141905|NCT01465347|12328604|FG000|NOT COMPLETED|Overall Study||1
11141906|NCT01465347|12328605|FG001|NOT COMPLETED|Overall Study||3
11141907|NCT01465386|12328614|FG000|STARTED|Overall Study||6
11141908|NCT01465386|12328614|FG000|COMPLETED|Overall Study||2
11141909|NCT01465386|12328614|FG000|NOT COMPLETED|Overall Study||4
11141910|NCT01465412|12328622|FG000|STARTED|Overall Study||12
11141911|NCT01465412|12328623|FG001|STARTED|Overall Study||12
11141912|NCT01465412|12328624|FG002|STARTED|Overall Study||9
11141913|NCT01465412|12328625|FG003|STARTED|Overall Study||9
11141914|NCT01465412|12328622|FG000|COMPLETED|Overall Study||12
11141915|NCT01465412|12328623|FG001|COMPLETED|Overall Study||12
11141916|NCT01465412|12328624|FG002|COMPLETED|Overall Study||9
11141917|NCT01465412|12328625|FG003|COMPLETED|Overall Study||9
11141918|NCT01465412|12328622|FG000|NOT COMPLETED|Overall Study||0
11141919|NCT01465412|12328623|FG001|NOT COMPLETED|Overall Study||0
11141920|NCT01465412|12328624|FG002|NOT COMPLETED|Overall Study||0
11141921|NCT01465412|12328625|FG003|NOT COMPLETED|Overall Study||0
11141922|NCT01465464|12328637|FG000|STARTED|Overall Study||444
11141923|NCT01465464|12328638|FG001|STARTED|Overall Study||444
11141924|NCT01465464|12328637|FG000|COMPLETED|Overall Study||0
11141925|NCT01465464|12328638|FG001|COMPLETED|Overall Study||0
11141926|NCT01465464|12328637|FG000|NOT COMPLETED|Overall Study||444
11141927|NCT01465464|12328638|FG001|NOT COMPLETED|Overall Study||444
11202592|NCT01841281|12392996|FG001|COMPLETED|Second Intervention (12 Weeks)||6
11202593|NCT01841281|12392997|FG002|COMPLETED|Second Intervention (12 Weeks)||10
11202594|NCT01841281|12392998|FG003|COMPLETED|Second Intervention (12 Weeks)||13
11202595|NCT01841281|12392995|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
11202596|NCT01841281|12392996|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||3
11202597|NCT01841281|12392997|FG002|NOT COMPLETED|Second Intervention (12 Weeks)||0
11202598|NCT01841281|12392998|FG003|NOT COMPLETED|Second Intervention (12 Weeks)||0
11202599|NCT01841554|12393014|FG000|STARTED|Overall Study||61
11202600|NCT01841554|12393014|FG000|Implanted|Overall Study||60
11202601|NCT01841554|12393014|FG000|1 Year Follow Up|Overall Study||42
11202602|NCT01841554|12393014|FG000|COMPLETED|Overall Study||42
11202603|NCT01841554|12393014|FG000|NOT COMPLETED|Overall Study||19
11202604|NCT01841567|12393018|FG000|STARTED|Overall Study||60
11202605|NCT01841567|12393018|FG000|COMPLETED|Overall Study||57
11202606|NCT01841567|12393018|FG000|NOT COMPLETED|Overall Study||3
11202607|NCT01841593|12393024|FG000|STARTED|First Intervention (Days 1 to 7)||12
11245073|NCT02122146|12437813|FG007|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
11245074|NCT02122146|12437806|FG000|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
11245075|NCT02122146|12437807|FG001|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
11245076|NCT02122146|12437808|FG002|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
11245077|NCT02122146|12437809|FG003|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
11245078|NCT02122146|12437810|FG004|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
11245079|NCT02122146|12437811|FG005|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
11245080|NCT02122146|12437812|FG006|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
11245081|NCT02122146|12437813|FG007|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
11245082|NCT02122146|12437806|FG000|COMPLETED|Part 3: Expansion||0
11245083|NCT02122146|12437807|FG001|COMPLETED|Part 3: Expansion||0
11245084|NCT02122146|12437808|FG002|COMPLETED|Part 3: Expansion||0
11245085|NCT02122146|12437809|FG003|COMPLETED|Part 3: Expansion||0
11245086|NCT02122146|12437810|FG004|COMPLETED|Part 3: Expansion||0
11245087|NCT02122146|12437811|FG005|COMPLETED|Part 3: Expansion||0
11245088|NCT02122146|12437812|FG006|COMPLETED|Part 3: Expansion||0
11245089|NCT02122146|12437813|FG007|COMPLETED|Part 3: Expansion||0
11245090|NCT02122146|12437806|FG000|NOT COMPLETED|Part 3: Expansion||0
11245091|NCT02122146|12437807|FG001|NOT COMPLETED|Part 3: Expansion||0
11245092|NCT02122146|12437808|FG002|NOT COMPLETED|Part 3: Expansion||0
11245093|NCT02122146|12437809|FG003|NOT COMPLETED|Part 3: Expansion||0
11245094|NCT02122146|12437810|FG004|NOT COMPLETED|Part 3: Expansion||0
11245095|NCT02122146|12437811|FG005|NOT COMPLETED|Part 3: Expansion||0
11245096|NCT02122146|12437812|FG006|NOT COMPLETED|Part 3: Expansion||0
11245097|NCT02122146|12437813|FG007|NOT COMPLETED|Part 3: Expansion||0
11245098|NCT02122341|12437834|FG000|STARTED|Overall Study||17
11245099|NCT02122341|12437835|FG001|STARTED|Overall Study||18
11245100|NCT02122341|12437834|FG000|COMPLETED|Overall Study||17
11245101|NCT02122341|12437835|FG001|COMPLETED|Overall Study||18
11245102|NCT02122341|12437834|FG000|NOT COMPLETED|Overall Study||0
11245103|NCT02122341|12437835|FG001|NOT COMPLETED|Overall Study||0
11245104|NCT02122380|12437843|FG000|STARTED|First Intervention (30 Days)||11
11245105|NCT02122380|12437844|FG001|STARTED|First Intervention (30 Days)||12
11245106|NCT02122380|12437843|FG000|COMPLETED|First Intervention (30 Days)||10
11245107|NCT02122380|12437844|FG001|COMPLETED|First Intervention (30 Days)||11
11245108|NCT02122380|12437843|FG000|NOT COMPLETED|First Intervention (30 Days)||1
11245109|NCT02122380|12437844|FG001|NOT COMPLETED|First Intervention (30 Days)||1
11245110|NCT02122380|12437843|FG000|STARTED|Washout (8 Weeks)||10
11245111|NCT02122380|12437844|FG001|STARTED|Washout (8 Weeks)||11
11245112|NCT02122380|12437843|FG000|COMPLETED|Washout (8 Weeks)||9
11245113|NCT02122380|12437844|FG001|COMPLETED|Washout (8 Weeks)||9
11245114|NCT02122380|12437843|FG000|NOT COMPLETED|Washout (8 Weeks)||1
11202608|NCT01841593|12393025|FG001|STARTED|First Intervention (Days 1 to 7)||7
11202609|NCT01841593|12393024|FG000|COMPLETED|First Intervention (Days 1 to 7)||12
11202610|NCT01841593|12393025|FG001|COMPLETED|First Intervention (Days 1 to 7)||6
11202611|NCT01841593|12393024|FG000|NOT COMPLETED|First Intervention (Days 1 to 7)||0
11202612|NCT01841593|12393025|FG001|NOT COMPLETED|First Intervention (Days 1 to 7)||1
11245115|NCT02122380|12437844|FG001|NOT COMPLETED|Washout (8 Weeks)||2
11245116|NCT02122380|12437843|FG000|STARTED|Second Intervention (30 Days)||9
11245117|NCT02122380|12437844|FG001|STARTED|Second Intervention (30 Days)||9
11245118|NCT02122380|12437843|FG000|COMPLETED|Second Intervention (30 Days)||9
11245119|NCT02122380|12437844|FG001|COMPLETED|Second Intervention (30 Days)||7
11245120|NCT02122380|12437843|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
11245121|NCT02122380|12437844|FG001|NOT COMPLETED|Second Intervention (30 Days)||2
11245122|NCT02122406|12437851|FG000|STARTED|Overall Study||200
11245123|NCT02122406|12437851|FG000|COMPLETED|Overall Study||200
11245124|NCT02122406|12437851|FG000|NOT COMPLETED|Overall Study||0
11245125|NCT02122445|12437855|FG000|STARTED|Overall Study||20
11245126|NCT02122445|12437855|FG000|COMPLETED|Overall Study||20
11245127|NCT02122445|12437855|FG000|NOT COMPLETED|Overall Study||0
11245128|NCT02122471|12437862|FG000|STARTED|Overall Study||445
11245129|NCT02122471|12437863|FG001|STARTED|Overall Study||443
11245130|NCT02122471|12437864|FG002|STARTED|Overall Study||449
11245131|NCT02122471|12437862|FG000|COMPLETED|Overall Study||406
11245132|NCT02122471|12437863|FG001|COMPLETED|Overall Study||392
11245133|NCT02122471|12437864|FG002|COMPLETED|Overall Study||405
11245134|NCT02122471|12437862|FG000|NOT COMPLETED|Overall Study||39
11245135|NCT02122471|12437863|FG001|NOT COMPLETED|Overall Study||51
11245136|NCT02122471|12437864|FG002|NOT COMPLETED|Overall Study||44
11245137|NCT02122549|12437873|FG000|STARTED|Overall Study||59
11245138|NCT02122549|12437873|FG000|COMPLETED|Overall Study||59
11245139|NCT02122549|12437873|FG000|NOT COMPLETED|Overall Study||0
11245140|NCT02122770|12437881|FG000|STARTED|Part A: Drug-drug Interaction 2||13
11245141|NCT02122770|12437882|FG001|STARTED|Part A: Drug-drug Interaction 2||13
11245142|NCT02122770|12437883|FG002|STARTED|Part A: Drug-drug Interaction 2||6
11245143|NCT02122770|12437884|FG003|STARTED|Part A: Drug-drug Interaction 2||19
11245144|NCT02122770|12437885|FG004|STARTED|Part A: Drug-drug Interaction 2||0
11245145|NCT02122770|12437886|FG005|STARTED|Part A: Drug-drug Interaction 2||0
11245146|NCT02122770|12437881|FG000|COMPLETED|Part A: Drug-drug Interaction 2||9
11245147|NCT02122770|12437882|FG001|COMPLETED|Part A: Drug-drug Interaction 2||7
11245148|NCT02122770|12437883|FG002|COMPLETED|Part A: Drug-drug Interaction 2||4
11245149|NCT02122770|12437884|FG003|COMPLETED|Part A: Drug-drug Interaction 2||16
11245150|NCT02122770|12437885|FG004|COMPLETED|Part A: Drug-drug Interaction 2||0
11245151|NCT02122770|12437886|FG005|COMPLETED|Part A: Drug-drug Interaction 2||0
11245152|NCT02122770|12437881|FG000|NOT COMPLETED|Part A: Drug-drug Interaction 2||4
11245153|NCT02122770|12437882|FG001|NOT COMPLETED|Part A: Drug-drug Interaction 2||6
11245154|NCT02122770|12437883|FG002|NOT COMPLETED|Part A: Drug-drug Interaction 2||2
11245155|NCT02122770|12437884|FG003|NOT COMPLETED|Part A: Drug-drug Interaction 2||3
11245156|NCT02122770|12437885|FG004|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
11245157|NCT02122770|12437886|FG005|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
11245158|NCT02122770|12437881|FG000|STARTED|Part B: Standard of Care||0
11245159|NCT02122770|12437882|FG001|STARTED|Part B: Standard of Care||0
11245160|NCT02122770|12437883|FG002|STARTED|Part B: Standard of Care||0
11245161|NCT02122770|12437884|FG003|STARTED|Part B: Standard of Care||0
11245162|NCT02122770|12437885|FG004|STARTED|Part B: Standard of Care||23
11245163|NCT02122770|12437886|FG005|STARTED|Part B: Standard of Care||13
11245164|NCT02122770|12437881|FG000|COMPLETED|Part B: Standard of Care||0
11245165|NCT02122770|12437882|FG001|COMPLETED|Part B: Standard of Care||0
11245166|NCT02122770|12437883|FG002|COMPLETED|Part B: Standard of Care||0
11245167|NCT02122770|12437884|FG003|COMPLETED|Part B: Standard of Care||0
11245168|NCT02122770|12437885|FG004|COMPLETED|Part B: Standard of Care||0
11245169|NCT02122770|12437886|FG005|COMPLETED|Part B: Standard of Care||0
11245170|NCT02122770|12437881|FG000|NOT COMPLETED|Part B: Standard of Care||0
11245171|NCT02122770|12437882|FG001|NOT COMPLETED|Part B: Standard of Care||0
11245172|NCT02122770|12437883|FG002|NOT COMPLETED|Part B: Standard of Care||0
11245173|NCT02122770|12437884|FG003|NOT COMPLETED|Part B: Standard of Care||0
11245174|NCT02122770|12437885|FG004|NOT COMPLETED|Part B: Standard of Care||23
11245175|NCT02122770|12437886|FG005|NOT COMPLETED|Part B: Standard of Care||13
11245176|NCT02122783|12437911|FG000|STARTED|Overall Study||2
11245177|NCT02122783|12437912|FG001|STARTED|Overall Study||3
11245178|NCT02122783|12437911|FG000|COMPLETED|Overall Study||2
11245179|NCT02122783|12437912|FG001|COMPLETED|Overall Study||2
11245180|NCT02122783|12437911|FG000|NOT COMPLETED|Overall Study||0
11245181|NCT02122783|12437912|FG001|NOT COMPLETED|Overall Study||1
11245182|NCT02122796|12437923|FG000|STARTED|Visit 1||15
11245183|NCT02122796|12437924|FG001|STARTED|Visit 1||15
11245184|NCT02122796|12437923|FG000|COMPLETED|Visit 1||15
11245185|NCT02122796|12437924|FG001|COMPLETED|Visit 1||15
11245186|NCT02122796|12437923|FG000|NOT COMPLETED|Visit 1||0
11245187|NCT02122796|12437924|FG001|NOT COMPLETED|Visit 1||0
11245188|NCT02122796|12437923|FG000|STARTED|Visit 2||15
11245189|NCT02122796|12437924|FG001|STARTED|Visit 2||15
11245190|NCT02122796|12437923|FG000|COMPLETED|Visit 2||12
11245191|NCT02122796|12437924|FG001|COMPLETED|Visit 2||14
11245192|NCT02122796|12437923|FG000|NOT COMPLETED|Visit 2||3
11245193|NCT02122796|12437924|FG001|NOT COMPLETED|Visit 2||1
11245194|NCT02122887|12437933|FG000|STARTED|Overall Study||60
11245195|NCT02122887|12437934|FG001|STARTED|Overall Study||41
11245196|NCT02122887|12437933|FG000|COMPLETED|Overall Study||40
11245197|NCT02122887|12437934|FG001|COMPLETED|Overall Study||39
11245198|NCT02122887|12437933|FG000|NOT COMPLETED|Overall Study||20
11245199|NCT02122887|12437934|FG001|NOT COMPLETED|Overall Study||2
11245200|NCT02123017|12437943|FG000|STARTED|Overall Study||8
11245201|NCT02123017|12437944|FG001|STARTED|Overall Study||12
11245202|NCT02123017|12437945|FG002|STARTED|Overall Study||12
11245203|NCT02123017|12437943|FG000|COMPLETED|Overall Study||8
11245204|NCT02123017|12437944|FG001|COMPLETED|Overall Study||12
11245205|NCT02123017|12437945|FG002|COMPLETED|Overall Study||12
11245206|NCT02123017|12437943|FG000|NOT COMPLETED|Overall Study||0
11245207|NCT02123017|12437944|FG001|NOT COMPLETED|Overall Study||0
11245208|NCT02123017|12437945|FG002|NOT COMPLETED|Overall Study||0
11245209|NCT02123134|12437955|FG000|STARTED|Overall Study||28
11245210|NCT02123134|12437956|FG001|STARTED|Overall Study||27
11245211|NCT02123134|12437955|FG000|COMPLETED|Overall Study||25
11358294|NCT03123055|12555350|FG000|NOT COMPLETED|Overall Study||0
11358295|NCT03123068|12555357|FG000|STARTED|Overall Study||22
11358296|NCT03123068|12555358|FG001|STARTED|Overall Study||20
11358297|NCT03123068|12555357|FG000|COMPLETED|Overall Study||22
11358298|NCT03123068|12555358|FG001|COMPLETED|Overall Study||20
11358299|NCT03123068|12555357|FG000|NOT COMPLETED|Overall Study||0
11358300|NCT03123068|12555358|FG001|NOT COMPLETED|Overall Study||0
11358301|NCT03123120|12555366|FG000|STARTED|Overall Study||8
11358302|NCT03123120|12555367|FG001|STARTED|Overall Study||14
11358303|NCT03123120|12555366|FG000|Safety Analysis Set (SAF)|Overall Study||7
11358304|NCT03123120|12555367|FG001|Safety Analysis Set (SAF)|Overall Study||15
11358305|NCT03123120|12555366|FG000|COMPLETED|Overall Study||8
11358306|NCT03123120|12555367|FG001|COMPLETED|Overall Study||12
11358307|NCT03123120|12555366|FG000|NOT COMPLETED|Overall Study||0
11358308|NCT03123120|12555367|FG001|NOT COMPLETED|Overall Study||2
11358309|NCT03123263|12555375|FG000|STARTED|Overall Study||60
11358310|NCT03123263|12555375|FG000|COMPLETED|Overall Study||60
11358311|NCT03123263|12555375|FG000|NOT COMPLETED|Overall Study||0
11358312|NCT03123354|12555382|FG000|STARTED|Overall Study||44
11358313|NCT03123354|12555382|FG000|COMPLETED|Overall Study||38
11358314|NCT03123354|12555382|FG000|NOT COMPLETED|Overall Study||6
11358315|NCT03123471|12555388|FG000|STARTED|Placebo-controlled Phase||102
11358316|NCT03123471|12555389|FG001|STARTED|Placebo-controlled Phase||201
11358317|NCT03123471|12555388|FG000|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102
11358318|NCT03123471|12555389|FG001|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200
11358319|NCT03123471|12555388|FG000|COMPLETED|Placebo-controlled Phase||84
11358320|NCT03123471|12555389|FG001|COMPLETED|Placebo-controlled Phase||168
11358321|NCT03123471|12555388|FG000|NOT COMPLETED|Placebo-controlled Phase||18
11358322|NCT03123471|12555389|FG001|NOT COMPLETED|Placebo-controlled Phase||33
11358323|NCT03123471|12555388|FG000|STARTED|Apremilast Extension Phase||84
11358324|NCT03123471|12555389|FG001|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165
11005365|NCT00722436|12183065|FG000|NOT COMPLETED|Overall Study||0
11005366|NCT00722436|12183066|FG001|NOT COMPLETED|Overall Study||0
11005367|NCT00722553|12183072|FG000|STARTED|Overall Study||30
11005368|NCT00722553|12183072|FG000|COMPLETED|Overall Study||30
11005369|NCT00722553|12183072|FG000|NOT COMPLETED|Overall Study||0
11245212|NCT02123134|12437956|FG001|COMPLETED|Overall Study||24
11245213|NCT02123134|12437955|FG000|NOT COMPLETED|Overall Study||3
11245214|NCT02123134|12437956|FG001|NOT COMPLETED|Overall Study||3
11245215|NCT02123251|12437964|FG000|STARTED|Overall Study||159
11245216|NCT02123251|12437965|FG001|STARTED|Overall Study||161
11245217|NCT02123251|12437964|FG000|COMPLETED|Overall Study||125
11245218|NCT02123251|12437965|FG001|COMPLETED|Overall Study||131
11245219|NCT02123251|12437964|FG000|NOT COMPLETED|Overall Study||34
11245220|NCT02123251|12437965|FG001|NOT COMPLETED|Overall Study||30
11245221|NCT02123329|12437974|FG000|STARTED|3 Month Outcome Measure||147
11245222|NCT02123329|12437975|FG001|STARTED|3 Month Outcome Measure||167
11245223|NCT02123329|12437974|FG000|COMPLETED|3 Month Outcome Measure||98
11245224|NCT02123329|12437975|FG001|COMPLETED|3 Month Outcome Measure||101
11245225|NCT02123329|12437974|FG000|NOT COMPLETED|3 Month Outcome Measure||49
11245226|NCT02123329|12437975|FG001|NOT COMPLETED|3 Month Outcome Measure||66
11245227|NCT02123329|12437974|FG000|STARTED|6 Month Outcome Measure||147
11245228|NCT02123329|12437975|FG001|STARTED|6 Month Outcome Measure||167
11245229|NCT02123329|12437974|FG000|COMPLETED|6 Month Outcome Measure||99
11245230|NCT02123329|12437975|FG001|COMPLETED|6 Month Outcome Measure||100
11245231|NCT02123329|12437974|FG000|NOT COMPLETED|6 Month Outcome Measure||48
11245232|NCT02123329|12437975|FG001|NOT COMPLETED|6 Month Outcome Measure||67
11245233|NCT02123329|12437974|FG000|STARTED|12 Month Outcome Measure||147
11245234|NCT02123329|12437975|FG001|STARTED|12 Month Outcome Measure||167
11245235|NCT02123329|12437974|FG000|COMPLETED|12 Month Outcome Measure||83
11245236|NCT02123329|12437975|FG001|COMPLETED|12 Month Outcome Measure||88
11245237|NCT02123329|12437974|FG000|NOT COMPLETED|12 Month Outcome Measure||64
11245238|NCT02123329|12437975|FG001|NOT COMPLETED|12 Month Outcome Measure||79
11245239|NCT02123446|12437981|FG000|STARTED|Period 1 (7 Days)||14
11245240|NCT02123446|12437982|FG001|STARTED|Period 1 (7 Days)||14
11245241|NCT02123446|12437981|FG000|COMPLETED|Period 1 (7 Days)||14
11245242|NCT02123446|12437982|FG001|COMPLETED|Period 1 (7 Days)||14
11245243|NCT02123446|12437981|FG000|NOT COMPLETED|Period 1 (7 Days)||0
11245244|NCT02123446|12437982|FG001|NOT COMPLETED|Period 1 (7 Days)||0
11245245|NCT02123446|12437981|FG000|STARTED|Washout Period (1 Day)||14
11245246|NCT02123446|12437982|FG001|STARTED|Washout Period (1 Day)||14
11245247|NCT02123446|12437981|FG000|COMPLETED|Washout Period (1 Day)||13
11245248|NCT02123446|12437982|FG001|COMPLETED|Washout Period (1 Day)||14
11245249|NCT02123446|12437981|FG000|NOT COMPLETED|Washout Period (1 Day)||1
11245250|NCT02123446|12437982|FG001|NOT COMPLETED|Washout Period (1 Day)||0
11245251|NCT02123446|12437981|FG000|STARTED|Period 2 (7 Days)||13
11245252|NCT02123446|12437982|FG001|STARTED|Period 2 (7 Days)||14
11245253|NCT02123446|12437981|FG000|COMPLETED|Period 2 (7 Days)||13
11245254|NCT02123446|12437982|FG001|COMPLETED|Period 2 (7 Days)||14
11245255|NCT02123446|12437981|FG000|NOT COMPLETED|Period 2 (7 Days)||0
11245256|NCT02123446|12437982|FG001|NOT COMPLETED|Period 2 (7 Days)||0
11245257|NCT02123459|12437988|FG000|STARTED|Period 1 (7 Days)||14
11245258|NCT02123459|12437989|FG001|STARTED|Period 1 (7 Days)||14
11245259|NCT02123459|12437988|FG000|COMPLETED|Period 1 (7 Days)||14
11245260|NCT02123459|12437989|FG001|COMPLETED|Period 1 (7 Days)||14
11245261|NCT02123459|12437988|FG000|NOT COMPLETED|Period 1 (7 Days)||0
11245262|NCT02123459|12437989|FG001|NOT COMPLETED|Period 1 (7 Days)||0
11245263|NCT02123459|12437988|FG000|STARTED|Washout Period (1 Day)||14
11245264|NCT02123459|12437989|FG001|STARTED|Washout Period (1 Day)||14
11245265|NCT02123459|12437988|FG000|COMPLETED|Washout Period (1 Day)||13
11245266|NCT02123459|12437989|FG001|COMPLETED|Washout Period (1 Day)||14
11245267|NCT02123459|12437988|FG000|NOT COMPLETED|Washout Period (1 Day)||1
11245268|NCT02123459|12437989|FG001|NOT COMPLETED|Washout Period (1 Day)||0
11245269|NCT02123459|12437988|FG000|STARTED|Period 2 (7 Days)||13
11245270|NCT02123459|12437989|FG001|STARTED|Period 2 (7 Days)||14
11245271|NCT02123459|12437988|FG000|COMPLETED|Period 2 (7 Days)||13
11245272|NCT02123459|12437989|FG001|COMPLETED|Period 2 (7 Days)||14
11245273|NCT02123459|12437988|FG000|NOT COMPLETED|Period 2 (7 Days)||0
11245274|NCT02123459|12437989|FG001|NOT COMPLETED|Period 2 (7 Days)||0
11245275|NCT02123472|12437995|FG000|STARTED|Period 1 (7 Days)||14
11245276|NCT02123472|12437996|FG001|STARTED|Period 1 (7 Days)||14
11245277|NCT02123472|12437995|FG000|COMPLETED|Period 1 (7 Days)||14
11245278|NCT02123472|12437996|FG001|COMPLETED|Period 1 (7 Days)||14
11245279|NCT02123472|12437995|FG000|NOT COMPLETED|Period 1 (7 Days)||0
11245280|NCT02123472|12437996|FG001|NOT COMPLETED|Period 1 (7 Days)||0
11245281|NCT02123472|12437995|FG000|STARTED|Washout Period (1 Day)||14
11245282|NCT02123472|12437996|FG001|STARTED|Washout Period (1 Day)||14
11245283|NCT02123472|12437995|FG000|COMPLETED|Washout Period (1 Day)||14
11245284|NCT02123472|12437996|FG001|COMPLETED|Washout Period (1 Day)||14
11245285|NCT02123472|12437995|FG000|NOT COMPLETED|Washout Period (1 Day)||0
11245286|NCT02123472|12437996|FG001|NOT COMPLETED|Washout Period (1 Day)||0
11245287|NCT02123472|12437995|FG000|STARTED|Period 2 (7 Days)||14
11245288|NCT02123472|12437996|FG001|STARTED|Period 2 (7 Days)||14
11245289|NCT02123472|12437995|FG000|COMPLETED|Period 2 (7 Days)||14
11245290|NCT02123472|12437996|FG001|COMPLETED|Period 2 (7 Days)||13
11245291|NCT02123472|12437995|FG000|NOT COMPLETED|Period 2 (7 Days)||0
11245292|NCT02123472|12437996|FG001|NOT COMPLETED|Period 2 (7 Days)||1
11245293|NCT02123485|12438004|FG000|STARTED|Overall Study||18
11245294|NCT02123485|12438005|FG001|STARTED|Overall Study||17
11245295|NCT02123485|12438004|FG000|COMPLETED|Overall Study||17
11245296|NCT02123485|12438005|FG001|COMPLETED|Overall Study||17
11245297|NCT02123485|12438004|FG000|NOT COMPLETED|Overall Study||1
11245298|NCT02123485|12438005|FG001|NOT COMPLETED|Overall Study||0
11245299|NCT02123511|12438013|FG000|STARTED|Overall Study||18
11245300|NCT02123511|12438014|FG001|STARTED|Overall Study||16
11245301|NCT02123511|12438013|FG000|Eligible Patients|Overall Study||17
11245302|NCT02123511|12438014|FG001|Eligible Patients|Overall Study||15
11245303|NCT02123511|12438013|FG000|COMPLETED|Overall Study||16
11245304|NCT02123511|12438014|FG001|COMPLETED|Overall Study||12
11245305|NCT02123511|12438013|FG000|NOT COMPLETED|Overall Study||2
11245306|NCT02123511|12438014|FG001|NOT COMPLETED|Overall Study||4
11245307|NCT02123576|12438022|FG000|STARTED|Overall Study||6
11245308|NCT02123576|12438023|FG001|STARTED|Overall Study||6
11245309|NCT02123576|12438022|FG000|COMPLETED|Overall Study||5
11245310|NCT02123576|12438023|FG001|COMPLETED|Overall Study||6
11245311|NCT02123576|12438022|FG000|NOT COMPLETED|Overall Study||1
11245312|NCT02123576|12438023|FG001|NOT COMPLETED|Overall Study||0
11245313|NCT02123745|12438029|FG000|STARTED|Overall Study||71
11245314|NCT02123745|12438029|FG000|COMPLETED|Overall Study||71
11245315|NCT02123745|12438029|FG000|NOT COMPLETED|Overall Study||0
11245316|NCT02123797|12438035|FG000|STARTED|Baseline Intervention||178
11245317|NCT02123797|12438036|FG001|STARTED|Baseline Intervention||348
11245318|NCT02123797|12438037|FG002|STARTED|Baseline Intervention||100
11245319|NCT02123797|12438038|FG003|STARTED|Baseline Intervention||144
11245320|NCT02123797|12438039|FG004|STARTED|Baseline Intervention||11
11245321|NCT02123797|12438035|FG000|COMPLETED|Baseline Intervention||156
11245322|NCT02123797|12438036|FG001|COMPLETED|Baseline Intervention||306
11245323|NCT02123797|12438037|FG002|COMPLETED|Baseline Intervention||100
11245324|NCT02123797|12438038|FG003|COMPLETED|Baseline Intervention||144
11245325|NCT02123797|12438039|FG004|COMPLETED|Baseline Intervention||11
11245326|NCT02123797|12438035|FG000|NOT COMPLETED|Baseline Intervention||22
11245327|NCT02123797|12438036|FG001|NOT COMPLETED|Baseline Intervention||42
11245328|NCT02123797|12438037|FG002|NOT COMPLETED|Baseline Intervention||0
11245329|NCT02123797|12438038|FG003|NOT COMPLETED|Baseline Intervention||0
11245330|NCT02123797|12438039|FG004|NOT COMPLETED|Baseline Intervention||0
11245331|NCT02123797|12438035|FG000|STARTED|3-month Follow up (Cumulative Counts)||156
11245332|NCT02123797|12438036|FG001|STARTED|3-month Follow up (Cumulative Counts)||306
11245333|NCT02123797|12438037|FG002|STARTED|3-month Follow up (Cumulative Counts)||100
11245334|NCT02123797|12438038|FG003|STARTED|3-month Follow up (Cumulative Counts)||144
11245335|NCT02123797|12438039|FG004|STARTED|3-month Follow up (Cumulative Counts)|Clinical providers received 6 month follow-up rather than 3 month follow-up at this stage.|11
11245336|NCT02123797|12438035|FG000|COMPLETED|3-month Follow up (Cumulative Counts)||99
11245337|NCT02123797|12438036|FG001|COMPLETED|3-month Follow up (Cumulative Counts)||189
11245338|NCT02123797|12438037|FG002|COMPLETED|3-month Follow up (Cumulative Counts)||50
11245339|NCT02123797|12438038|FG003|COMPLETED|3-month Follow up (Cumulative Counts)||62
11245340|NCT02123797|12438039|FG004|COMPLETED|3-month Follow up (Cumulative Counts)||8
11245341|NCT02123797|12438035|FG000|NOT COMPLETED|3-month Follow up (Cumulative Counts)||57
11245342|NCT02123797|12438036|FG001|NOT COMPLETED|3-month Follow up (Cumulative Counts)||117
11245343|NCT02123797|12438037|FG002|NOT COMPLETED|3-month Follow up (Cumulative Counts)||50
11005370|NCT00722566|12183080|FG000|STARTED|Overall Study|One patient randomized and not dosed|148
11005371|NCT00722566|12183081|FG001|STARTED|Overall Study||74
11005372|NCT00722566|12183080|FG000|COMPLETED|Overall Study|Completed 8 cycles|81
11005373|NCT00722566|12183081|FG001|COMPLETED|Overall Study|Completed 8 cycles|39
11005374|NCT00722566|12183080|FG000|NOT COMPLETED|Overall Study||67
11245344|NCT02123797|12438038|FG003|NOT COMPLETED|3-month Follow up (Cumulative Counts)||82
11245345|NCT02123797|12438039|FG004|NOT COMPLETED|3-month Follow up (Cumulative Counts)||3
11245346|NCT02123797|12438035|FG000|STARTED|6-month Follow up (Cumulative Counts)||156
11245347|NCT02123797|12438036|FG001|STARTED|6-month Follow up (Cumulative Counts)||306
11245348|NCT02123797|12438037|FG002|STARTED|6-month Follow up (Cumulative Counts)||100
11245349|NCT02123797|12438038|FG003|STARTED|6-month Follow up (Cumulative Counts)||144
11245350|NCT02123797|12438039|FG004|STARTED|6-month Follow up (Cumulative Counts)|Clinical providers received 12 month follow-up rather than 6-month follow-up at this stage.|8
11245351|NCT02123797|12438035|FG000|COMPLETED|6-month Follow up (Cumulative Counts)||101
11245352|NCT02123797|12438036|FG001|COMPLETED|6-month Follow up (Cumulative Counts)||178
11245353|NCT02123797|12438037|FG002|COMPLETED|6-month Follow up (Cumulative Counts)||34
11245354|NCT02123797|12438038|FG003|COMPLETED|6-month Follow up (Cumulative Counts)||31
11245355|NCT02123797|12438039|FG004|COMPLETED|6-month Follow up (Cumulative Counts)||5
11245356|NCT02123797|12438035|FG000|NOT COMPLETED|6-month Follow up (Cumulative Counts)||55
11245357|NCT02123797|12438036|FG001|NOT COMPLETED|6-month Follow up (Cumulative Counts)||128
11245358|NCT02123797|12438037|FG002|NOT COMPLETED|6-month Follow up (Cumulative Counts)||66
11245359|NCT02123797|12438038|FG003|NOT COMPLETED|6-month Follow up (Cumulative Counts)||113
11245360|NCT02123797|12438039|FG004|NOT COMPLETED|6-month Follow up (Cumulative Counts)||3
11245361|NCT02123849|12438061|FG000|STARTED|Overall Study||27
11245362|NCT02123849|12438062|FG001|STARTED|Overall Study||27
11245363|NCT02123849|12438061|FG000|COMPLETED|Overall Study||23
11245364|NCT02123849|12438062|FG001|COMPLETED|Overall Study||18
11245365|NCT02123849|12438061|FG000|NOT COMPLETED|Overall Study||4
11245366|NCT02123849|12438062|FG001|NOT COMPLETED|Overall Study||9
11245367|NCT02123966|12438070|FG000|STARTED|Overall Study||10
11245368|NCT02123966|12438070|FG000|COMPLETED|Overall Study||9
11245369|NCT02123966|12438070|FG000|NOT COMPLETED|Overall Study||1
11245370|NCT02124018|12438077|FG000|STARTED|Overall Study||371
11245371|NCT02124018|12438078|FG001|STARTED|Overall Study||111
11245372|NCT02124018|12438079|FG002|STARTED|Overall Study||41
11245373|NCT02124018|12438077|FG000|COMPLETED|Overall Study||371
11245374|NCT02124018|12438078|FG001|COMPLETED|Overall Study||111
11245375|NCT02124018|12438079|FG002|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41
11245376|NCT02124018|12438077|FG000|NOT COMPLETED|Overall Study||0
11245377|NCT02124018|12438078|FG001|NOT COMPLETED|Overall Study||0
11245378|NCT02124018|12438079|FG002|NOT COMPLETED|Overall Study||0
11245379|NCT02124044|12438092|FG000|STARTED|Overall Study||20
11245380|NCT02124044|12438093|FG001|STARTED|Overall Study||10
11245381|NCT02124044|12438092|FG000|COMPLETED|Overall Study||20
11245382|NCT02124044|12438093|FG001|COMPLETED|Overall Study||9
11245383|NCT02124044|12438092|FG000|NOT COMPLETED|Overall Study||0
11245384|NCT02124044|12438093|FG001|NOT COMPLETED|Overall Study||1
11245385|NCT02124083|12438099|FG000|STARTED|Overall Study||12
11245386|NCT02124083|12438099|FG000|COMPLETED|Overall Study||11
11245387|NCT02124083|12438099|FG000|NOT COMPLETED|Overall Study||1
11245388|NCT02124122|12438105|FG000|STARTED|Overall Study||41
11245389|NCT02124122|12438106|FG001|STARTED|Overall Study||19
11245390|NCT02124122|12438105|FG000|COMPLETED|Overall Study||41
11245391|NCT02124122|12438106|FG001|COMPLETED|Overall Study||19
11245392|NCT02124122|12438105|FG000|NOT COMPLETED|Overall Study||0
11245393|NCT02124122|12438106|FG001|NOT COMPLETED|Overall Study||0
11245394|NCT02124161|12438114|FG000|STARTED|Overall Study||441
11245395|NCT02124161|12438115|FG001|STARTED|Overall Study||441
11245396|NCT02124161|12438114|FG000|Vaccination 1|Overall Study||439
11245397|NCT02124161|12438115|FG001|Vaccination 1|Overall Study||437
11245398|NCT02124161|12438114|FG000|Vaccination 2|Overall Study||431
11245399|NCT02124161|12438115|FG001|Vaccination 2|Overall Study||432
11245400|NCT02124161|12438114|FG000|COMPLETED|Overall Study||425
11245401|NCT02124161|12438115|FG001|COMPLETED|Overall Study||426
11245402|NCT02124161|12438114|FG000|NOT COMPLETED|Overall Study||16
11245403|NCT02124161|12438115|FG001|NOT COMPLETED|Overall Study||15
11245404|NCT02124265|12438128|FG000|STARTED|Overall Study||3
11245405|NCT02124265|12438128|FG000|COMPLETED|Overall Study||2
11245406|NCT02124265|12438128|FG000|NOT COMPLETED|Overall Study||1
11245407|NCT02124304|12438134|FG000|STARTED|Overall Study||15
11245408|NCT02124304|12438135|FG001|STARTED|Overall Study||15
11245409|NCT02124304|12438134|FG000|COMPLETED|Overall Study||15
11245410|NCT02124304|12438135|FG001|COMPLETED|Overall Study||15
11245411|NCT02124304|12438134|FG000|NOT COMPLETED|Overall Study||0
11245412|NCT02124304|12438135|FG001|NOT COMPLETED|Overall Study||0
11245413|NCT02124460|12438143|FG000|STARTED|Overall Study||361
11245414|NCT02124460|12438144|FG001|STARTED|Overall Study||360
11245415|NCT02124460|12438143|FG000|COMPLETED|Overall Study||328
11245416|NCT02124460|12438144|FG001|COMPLETED|Overall Study||336
11245417|NCT02124460|12438143|FG000|NOT COMPLETED|Overall Study||33
11245418|NCT02124460|12438144|FG001|NOT COMPLETED|Overall Study||24
11245419|NCT02124512|12438153|FG000|STARTED|Overall Study||6
11245420|NCT02124512|12438154|FG001|STARTED|Overall Study||6
11245421|NCT02124512|12438153|FG000|COMPLETED|Overall Study||6
11245422|NCT02124512|12438154|FG001|COMPLETED|Overall Study||6
11245423|NCT02124512|12438153|FG000|NOT COMPLETED|Overall Study||0
11245424|NCT02124512|12438154|FG001|NOT COMPLETED|Overall Study||0
11245425|NCT02124564|12438160|FG000|STARTED|Treatment Period||19
11245426|NCT02124564|12438160|FG000|Started Treatment Period|Treatment Period||19
11245427|NCT02124564|12438160|FG000|Started Titration Period|Treatment Period||19
11245428|NCT02124564|12438160|FG000|Started AED Withdrawal Period|Treatment Period||19
11245429|NCT02124564|12438160|FG000|Started Monotherapy Period|Treatment Period||17
11245430|NCT02124564|12438160|FG000|Started Evaluation Period|Treatment Period||17
11245431|NCT02124564|12438160|FG000|Started Follow-Up Period|Treatment Period||13
11245432|NCT02124564|12438160|FG000|COMPLETED|Treatment Period||12
11245433|NCT02124564|12438160|FG000|NOT COMPLETED|Treatment Period||7
11245434|NCT02124564|12438160|FG000|STARTED|Taper Period||2
11245435|NCT02124564|12438160|FG000|COMPLETED|Taper Period||2
11245436|NCT02124564|12438160|FG000|NOT COMPLETED|Taper Period||0
11245437|NCT02124603|12438165|FG000|STARTED|Overall Study||120
11245438|NCT02124603|12438165|FG000|COMPLETED|Overall Study||120
11245439|NCT02124603|12438165|FG000|NOT COMPLETED|Overall Study||0
11245440|NCT02124707|12438170|FG000|STARTED|Overall Study||14
11245441|NCT02124707|12438170|FG000|COMPLETED|Overall Study||7
11245442|NCT02124707|12438170|FG000|NOT COMPLETED|Overall Study||7
11245443|NCT02124746|12438178|FG000|STARTED|Overall Study||30
11245444|NCT02124746|12438179|FG001|STARTED|Overall Study||22
11245445|NCT02124746|12438180|FG002|STARTED|Overall Study||22
11245446|NCT02124746|12438178|FG000|COMPLETED|Overall Study||11
11245447|NCT02124746|12438179|FG001|COMPLETED|Overall Study||4
11245448|NCT02124746|12438180|FG002|COMPLETED|Overall Study||0
11245449|NCT02124746|12438178|FG000|NOT COMPLETED|Overall Study||19
11245450|NCT02124746|12438179|FG001|NOT COMPLETED|Overall Study||18
11245451|NCT02124746|12438180|FG002|NOT COMPLETED|Overall Study||22
11245452|NCT02124759|12438191|FG000|STARTED|Overall Study||6
11245453|NCT02124759|12438192|FG001|STARTED|Overall Study||7
11245454|NCT02124759|12438193|FG002|STARTED|Overall Study||7
11245455|NCT02124759|12438191|FG000|Subjects Randomized to Intervention|Overall Study||4
11245456|NCT02124759|12438192|FG001|Subjects Randomized to Intervention|Overall Study||5
11245457|NCT02124759|12438193|FG002|Subjects Randomized to Intervention|Overall Study||4
11245458|NCT02124759|12438191|FG000|Low Fat Diet|Overall Study|2 subjects did not complete and were withdrawn|4
11245459|NCT02124759|12438192|FG001|Low Fat Diet|Overall Study||4
11245460|NCT02124759|12438193|FG002|Low Fat Diet|Overall Study||4
11245461|NCT02124759|12438191|FG000|High Fat Diet|Overall Study|1 subject did not complete|2
11245462|NCT02124759|12438192|FG001|High Fat Diet|Overall Study|One subject withdrew (low fat diet had already been completed)|5
11245463|NCT02124759|12438193|FG002|High Fat Diet|Overall Study|One subject withdrew and did not complete the low fat diet|4
11245464|NCT02124759|12438191|FG000|COMPLETED|Overall Study||1
11245465|NCT02124759|12438192|FG001|COMPLETED|Overall Study||4
11245466|NCT02124759|12438193|FG002|COMPLETED|Overall Study||3
11245467|NCT02124759|12438191|FG000|NOT COMPLETED|Overall Study||5
11245468|NCT02124759|12438192|FG001|NOT COMPLETED|Overall Study||3
11245469|NCT02124759|12438193|FG002|NOT COMPLETED|Overall Study||4
11245470|NCT02124772|12438219|FG000|STARTED|Overall Study||3
11245471|NCT02124772|12438220|FG001|STARTED|Overall Study||19
11245472|NCT02124772|12438221|FG002|STARTED|Overall Study||12
11245473|NCT02124772|12438222|FG003|STARTED|Overall Study||16
11245474|NCT02124772|12438223|FG004|STARTED|Overall Study||11
11245475|NCT02124772|12438224|FG005|STARTED|Overall Study||10
11245476|NCT02124772|12438225|FG006|STARTED|Overall Study||10
11245477|NCT02124772|12438226|FG007|STARTED|Overall Study||10
11245478|NCT02124772|12438227|FG008|STARTED|Overall Study||3
11245479|NCT02124772|12438228|FG009|STARTED|Overall Study||9
11245480|NCT02124772|12438229|FG010|STARTED|Overall Study||6
11245481|NCT02124772|12438230|FG011|STARTED|Overall Study||20
11245482|NCT02124772|12438231|FG012|STARTED|Overall Study||10
11245483|NCT02124772|12438219|FG000|COMPLETED|Overall Study||0
11245484|NCT02124772|12438220|FG001|COMPLETED|Overall Study||5
11245485|NCT02124772|12438221|FG002|COMPLETED|Overall Study||6
11245486|NCT02124772|12438222|FG003|COMPLETED|Overall Study||3
11245487|NCT02124772|12438223|FG004|COMPLETED|Overall Study||2
11245488|NCT02124772|12438224|FG005|COMPLETED|Overall Study||2
11245489|NCT02124772|12438225|FG006|COMPLETED|Overall Study||2
11245490|NCT02124772|12438226|FG007|COMPLETED|Overall Study||1
11245491|NCT02124772|12438227|FG008|COMPLETED|Overall Study||2
11245492|NCT02124772|12438228|FG009|COMPLETED|Overall Study||2
11245493|NCT02124772|12438229|FG010|COMPLETED|Overall Study||4
11245494|NCT02124772|12438230|FG011|COMPLETED|Overall Study||14
11245495|NCT02124772|12438231|FG012|COMPLETED|Overall Study||8
11245496|NCT02124772|12438219|FG000|NOT COMPLETED|Overall Study||3
11245497|NCT02124772|12438220|FG001|NOT COMPLETED|Overall Study||14
11245498|NCT02124772|12438221|FG002|NOT COMPLETED|Overall Study||6
11245499|NCT02124772|12438222|FG003|NOT COMPLETED|Overall Study||13
11245500|NCT02124772|12438223|FG004|NOT COMPLETED|Overall Study||9
11245501|NCT02124772|12438224|FG005|NOT COMPLETED|Overall Study||8
11245502|NCT02124772|12438225|FG006|NOT COMPLETED|Overall Study||8
11245503|NCT02124772|12438226|FG007|NOT COMPLETED|Overall Study||9
11245504|NCT02124772|12438227|FG008|NOT COMPLETED|Overall Study||1
11245505|NCT02124772|12438228|FG009|NOT COMPLETED|Overall Study||7
11245506|NCT02124772|12438229|FG010|NOT COMPLETED|Overall Study||2
11245507|NCT02124772|12438230|FG011|NOT COMPLETED|Overall Study||6
11245508|NCT02124772|12438231|FG012|NOT COMPLETED|Overall Study||2
11245509|NCT02124798|12438283|FG000|STARTED|Overall Study||95
11245510|NCT02124798|12438283|FG000|COMPLETED|Overall Study||91
11245511|NCT02124798|12438283|FG000|NOT COMPLETED|Overall Study||4
11245512|NCT02124811|12438289|FG000|STARTED|Overall Study||5
11245513|NCT02124811|12438290|FG001|STARTED|Overall Study||5
11245514|NCT02124811|12438289|FG000|COMPLETED|Overall Study||2
11245515|NCT02124811|12438290|FG001|COMPLETED|Overall Study||3
11245516|NCT02124811|12438289|FG000|NOT COMPLETED|Overall Study||3
11245517|NCT02124811|12438290|FG001|NOT COMPLETED|Overall Study||2
11245518|NCT02124863|12438296|FG000|STARTED|Overall Study||67
11245519|NCT02124863|12438296|FG000|COMPLETED|Overall Study||50
11245520|NCT02124863|12438296|FG000|NOT COMPLETED|Overall Study||17
11245521|NCT02124889|12438304|FG000|STARTED|Overall Study||12
11245522|NCT02124889|12438305|FG001|STARTED|Overall Study||12
11245523|NCT02124889|12438304|FG000|COMPLETED|Overall Study||12
11245524|NCT02124889|12438305|FG001|COMPLETED|Overall Study||12
11245525|NCT02124889|12438304|FG000|NOT COMPLETED|Overall Study||0
11245526|NCT02124889|12438305|FG001|NOT COMPLETED|Overall Study||0
11245527|NCT02125279|12438311|FG000|STARTED|Overall Study||54
11245528|NCT02125279|12438311|FG000|COMPLETED|Overall Study||41
11245529|NCT02125279|12438311|FG000|NOT COMPLETED|Overall Study||13
11245530|NCT02125292|12438317|FG000|STARTED|First Intervention (1 Hour)||3
11245531|NCT02125292|12438318|FG001|STARTED|First Intervention (1 Hour)||3
11245532|NCT02125292|12438319|FG002|STARTED|First Intervention (1 Hour)||3
11245533|NCT02125292|12438320|FG003|STARTED|First Intervention (1 Hour)||3
11245534|NCT02125292|12438321|FG004|STARTED|First Intervention (1 Hour)||3
11245535|NCT02125292|12438322|FG005|STARTED|First Intervention (1 Hour)||3
11245536|NCT02125292|12438317|FG000|COMPLETED|First Intervention (1 Hour)||3
11245537|NCT02125292|12438318|FG001|COMPLETED|First Intervention (1 Hour)||3
11245538|NCT02125292|12438319|FG002|COMPLETED|First Intervention (1 Hour)||3
11245539|NCT02125292|12438320|FG003|COMPLETED|First Intervention (1 Hour)||3
11245540|NCT02125292|12438321|FG004|COMPLETED|First Intervention (1 Hour)||3
11245541|NCT02125292|12438322|FG005|COMPLETED|First Intervention (1 Hour)||3
11245542|NCT02125292|12438317|FG000|NOT COMPLETED|First Intervention (1 Hour)||0
11245543|NCT02125292|12438318|FG001|NOT COMPLETED|First Intervention (1 Hour)||0
11245544|NCT02125292|12438319|FG002|NOT COMPLETED|First Intervention (1 Hour)||0
11245545|NCT02125292|12438320|FG003|NOT COMPLETED|First Intervention (1 Hour)||0
11245546|NCT02125292|12438321|FG004|NOT COMPLETED|First Intervention (1 Hour)||0
11245547|NCT02125292|12438322|FG005|NOT COMPLETED|First Intervention (1 Hour)||0
11245548|NCT02125292|12438317|FG000|STARTED|Washout (2 Hours)||3
11245549|NCT02125292|12438318|FG001|STARTED|Washout (2 Hours)||3
11245550|NCT02125292|12438319|FG002|STARTED|Washout (2 Hours)||3
11245551|NCT02125292|12438320|FG003|STARTED|Washout (2 Hours)||3
11245552|NCT02125292|12438321|FG004|STARTED|Washout (2 Hours)||3
11245553|NCT02125292|12438322|FG005|STARTED|Washout (2 Hours)||3
11245554|NCT02125292|12438317|FG000|COMPLETED|Washout (2 Hours)||3
11245555|NCT02125292|12438318|FG001|COMPLETED|Washout (2 Hours)||3
11245556|NCT02125292|12438319|FG002|COMPLETED|Washout (2 Hours)||3
11245557|NCT02125292|12438320|FG003|COMPLETED|Washout (2 Hours)||3
11245558|NCT02125292|12438321|FG004|COMPLETED|Washout (2 Hours)||3
11245559|NCT02125292|12438322|FG005|COMPLETED|Washout (2 Hours)||3
11245560|NCT02125292|12438317|FG000|NOT COMPLETED|Washout (2 Hours)||0
11245561|NCT02125292|12438318|FG001|NOT COMPLETED|Washout (2 Hours)||0
11245562|NCT02125292|12438319|FG002|NOT COMPLETED|Washout (2 Hours)||0
11245563|NCT02125292|12438320|FG003|NOT COMPLETED|Washout (2 Hours)||0
11245564|NCT02125292|12438321|FG004|NOT COMPLETED|Washout (2 Hours)||0
11245565|NCT02125292|12438322|FG005|NOT COMPLETED|Washout (2 Hours)||0
11245566|NCT02125292|12438317|FG000|STARTED|Second Intervention (1 Hour)||3
11245567|NCT02125292|12438318|FG001|STARTED|Second Intervention (1 Hour)||3
11245568|NCT02125292|12438319|FG002|STARTED|Second Intervention (1 Hour)||3
11245569|NCT02125292|12438320|FG003|STARTED|Second Intervention (1 Hour)||3
11245570|NCT02125292|12438321|FG004|STARTED|Second Intervention (1 Hour)||3
11245571|NCT02125292|12438322|FG005|STARTED|Second Intervention (1 Hour)||3
11245572|NCT02125292|12438317|FG000|COMPLETED|Second Intervention (1 Hour)||3
11245573|NCT02125292|12438318|FG001|COMPLETED|Second Intervention (1 Hour)||3
11245574|NCT02125292|12438319|FG002|COMPLETED|Second Intervention (1 Hour)||3
11245575|NCT02125292|12438320|FG003|COMPLETED|Second Intervention (1 Hour)||3
11245576|NCT02125292|12438321|FG004|COMPLETED|Second Intervention (1 Hour)||3
11245577|NCT02125292|12438322|FG005|COMPLETED|Second Intervention (1 Hour)||3
11245578|NCT02125292|12438317|FG000|NOT COMPLETED|Second Intervention (1 Hour)||0
11245579|NCT02125292|12438318|FG001|NOT COMPLETED|Second Intervention (1 Hour)||0
11245580|NCT02125292|12438319|FG002|NOT COMPLETED|Second Intervention (1 Hour)||0
11245581|NCT02125292|12438320|FG003|NOT COMPLETED|Second Intervention (1 Hour)||0
11245582|NCT02125292|12438321|FG004|NOT COMPLETED|Second Intervention (1 Hour)||0
11245583|NCT02125292|12438322|FG005|NOT COMPLETED|Second Intervention (1 Hour)||0
11245584|NCT02125292|12438317|FG000|STARTED|Washout (2 Hours)||3
11245585|NCT02125292|12438318|FG001|STARTED|Washout (2 Hours)||3
11245586|NCT02125292|12438319|FG002|STARTED|Washout (2 Hours)||3
11245587|NCT02125292|12438320|FG003|STARTED|Washout (2 Hours)||3
11245588|NCT02125292|12438321|FG004|STARTED|Washout (2 Hours)||3
11245589|NCT02125292|12438322|FG005|STARTED|Washout (2 Hours)||3
11245590|NCT02125292|12438317|FG000|COMPLETED|Washout (2 Hours)||3
11245591|NCT02125292|12438318|FG001|COMPLETED|Washout (2 Hours)||3
11245592|NCT02125292|12438319|FG002|COMPLETED|Washout (2 Hours)||3
11245593|NCT02125292|12438320|FG003|COMPLETED|Washout (2 Hours)||3
11245594|NCT02125292|12438321|FG004|COMPLETED|Washout (2 Hours)||3
11245595|NCT02125292|12438322|FG005|COMPLETED|Washout (2 Hours)||3
11245596|NCT02125292|12438317|FG000|NOT COMPLETED|Washout (2 Hours)||0
11245597|NCT02125292|12438318|FG001|NOT COMPLETED|Washout (2 Hours)||0
11245598|NCT02125292|12438319|FG002|NOT COMPLETED|Washout (2 Hours)||0
11245599|NCT02125292|12438320|FG003|NOT COMPLETED|Washout (2 Hours)||0
11245600|NCT02125292|12438321|FG004|NOT COMPLETED|Washout (2 Hours)||0
11245601|NCT02125292|12438322|FG005|NOT COMPLETED|Washout (2 Hours)||0
11245602|NCT02125292|12438317|FG000|STARTED|Third Intervention (1 Hour)||3
11245603|NCT02125292|12438318|FG001|STARTED|Third Intervention (1 Hour)||3
11245604|NCT02125292|12438319|FG002|STARTED|Third Intervention (1 Hour)||3
11245605|NCT02125292|12438320|FG003|STARTED|Third Intervention (1 Hour)||3
11245606|NCT02125292|12438321|FG004|STARTED|Third Intervention (1 Hour)||3
11245607|NCT02125292|12438322|FG005|STARTED|Third Intervention (1 Hour)||3
11245608|NCT02125292|12438317|FG000|COMPLETED|Third Intervention (1 Hour)||3
11245609|NCT02125292|12438318|FG001|COMPLETED|Third Intervention (1 Hour)||3
11245610|NCT02125292|12438319|FG002|COMPLETED|Third Intervention (1 Hour)||3
11245611|NCT02125292|12438320|FG003|COMPLETED|Third Intervention (1 Hour)||3
11245612|NCT02125292|12438321|FG004|COMPLETED|Third Intervention (1 Hour)||3
11245613|NCT02125292|12438322|FG005|COMPLETED|Third Intervention (1 Hour)||3
11245614|NCT02125292|12438317|FG000|NOT COMPLETED|Third Intervention (1 Hour)||0
11245615|NCT02125292|12438318|FG001|NOT COMPLETED|Third Intervention (1 Hour)||0
11245616|NCT02125292|12438319|FG002|NOT COMPLETED|Third Intervention (1 Hour)||0
11245617|NCT02125292|12438320|FG003|NOT COMPLETED|Third Intervention (1 Hour)||0
11245618|NCT02125292|12438321|FG004|NOT COMPLETED|Third Intervention (1 Hour)||0
11245619|NCT02125292|12438322|FG005|NOT COMPLETED|Third Intervention (1 Hour)||0
11245620|NCT02125331|12438333|FG000|STARTED|Overall Study||58
11245621|NCT02125331|12438334|FG001|STARTED|Overall Study||25
11245622|NCT02125331|12438333|FG000|COMPLETED|Overall Study||53
11245623|NCT02125331|12438334|FG001|COMPLETED|Overall Study||25
11245624|NCT02125331|12438333|FG000|NOT COMPLETED|Overall Study||5
11245625|NCT02125331|12438334|FG001|NOT COMPLETED|Overall Study||0
11245626|NCT02125604|12438340|FG000|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
11245627|NCT02125604|12438340|FG000|COMPLETED|Overall Study||180
11245628|NCT02125604|12438340|FG000|NOT COMPLETED|Overall Study||31
11245629|NCT02125721|12438344|FG000|STARTED|Overall Study||10
11245630|NCT02125721|12438344|FG000|COMPLETED|Overall Study||10
11245631|NCT02125721|12438344|FG000|NOT COMPLETED|Overall Study||0
11245632|NCT02125734|12438350|FG000|STARTED|Period 1||40
11245633|NCT02125734|12438351|FG001|STARTED|Period 1||48
11245634|NCT02125734|12438350|FG000|COMPLETED|Period 1||40
11245635|NCT02125734|12438351|FG001|COMPLETED|Period 1||48
11245636|NCT02125734|12438350|FG000|NOT COMPLETED|Period 1||0
11245637|NCT02125734|12438351|FG001|NOT COMPLETED|Period 1||0
11245638|NCT02125734|12438350|FG000|STARTED|Period 2||40
11245639|NCT02125734|12438351|FG001|STARTED|Period 2||48
11245640|NCT02125734|12438350|FG000|COMPLETED|Period 2||40
11245641|NCT02125734|12438351|FG001|COMPLETED|Period 2||47
11245642|NCT02125734|12438350|FG000|NOT COMPLETED|Period 2||0
11245643|NCT02125734|12438351|FG001|NOT COMPLETED|Period 2||1
11245644|NCT02125838|12438359|FG000|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
11245645|NCT02125838|12438360|FG001|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
11245646|NCT02125838|12438359|FG000|COMPLETED|Overall Study|Analysed (n=50 )|50
11245647|NCT02125838|12438360|FG001|COMPLETED|Overall Study|Analysed (n=50 )|50
11245648|NCT02125838|12438359|FG000|NOT COMPLETED|Overall Study||4
11245649|NCT02125838|12438360|FG001|NOT COMPLETED|Overall Study||4
11245650|NCT02125877|12438368|FG000|STARTED|Overall Study||86
11245651|NCT02125877|12438369|FG001|STARTED|Overall Study||87
11245652|NCT02125877|12438368|FG000|Pharmacokinetic Analysis Set|Overall Study||83
11245653|NCT02125877|12438369|FG001|Pharmacokinetic Analysis Set|Overall Study||83
11245654|NCT02125877|12438368|FG000|Pharmacokinetic Subset A|Overall Study||16
11245655|NCT02125877|12438369|FG001|Pharmacokinetic Subset A|Overall Study||15
11245656|NCT02125877|12438368|FG000|Safety Set|Overall Study||86
11245657|NCT02125877|12438369|FG001|Safety Set|Overall Study||87
11245658|NCT02125877|12438368|FG000|COMPLETED|Overall Study||73
11245659|NCT02125877|12438369|FG001|COMPLETED|Overall Study||77
11245660|NCT02125877|12438368|FG000|NOT COMPLETED|Overall Study||13
11245661|NCT02125877|12438369|FG001|NOT COMPLETED|Overall Study||10
11245662|NCT02126306|12438377|FG000|STARTED|Overall Study||10
11245663|NCT02126306|12438378|FG001|STARTED|Overall Study||13
11245664|NCT02126306|12438377|FG000|COMPLETED|Overall Study||10
11245665|NCT02126306|12438378|FG001|COMPLETED|Overall Study||13
11245666|NCT02126306|12438377|FG000|NOT COMPLETED|Overall Study||0
11245667|NCT02126306|12438378|FG001|NOT COMPLETED|Overall Study||0
11245668|NCT02126319|12438386|FG000|STARTED|Overall Study||61
11245669|NCT02126319|12438387|FG001|STARTED|Overall Study||67
11245670|NCT02126319|12438386|FG000|COMPLETED|Overall Study||40
11245671|NCT02126319|12438387|FG001|COMPLETED|Overall Study||43
11245672|NCT02126319|12438386|FG000|NOT COMPLETED|Overall Study||21
11245673|NCT02126319|12438387|FG001|NOT COMPLETED|Overall Study||24
11245674|NCT02126670|12438399|FG000|STARTED|Overall Study||26
11245675|NCT02126670|12438400|FG001|STARTED|Overall Study||24
11245676|NCT02126670|12438401|FG002|STARTED|Overall Study||25
11245677|NCT02126670|12438402|FG003|STARTED|Overall Study||25
11245678|NCT02126670|12438399|FG000|COMPLETED|Overall Study||25
11245679|NCT02126670|12438400|FG001|COMPLETED|Overall Study||24
11245680|NCT02126670|12438401|FG002|COMPLETED|Overall Study||25
11245681|NCT02126670|12438402|FG003|COMPLETED|Overall Study||24
11245682|NCT02126670|12438399|FG000|NOT COMPLETED|Overall Study||1
11245683|NCT02126670|12438400|FG001|NOT COMPLETED|Overall Study||0
11245684|NCT02126670|12438401|FG002|NOT COMPLETED|Overall Study||0
11245685|NCT02126670|12438402|FG003|NOT COMPLETED|Overall Study||1
11245686|NCT02126748|12438415|FG000|STARTED|Overall Study||33
11245687|NCT02126748|12438416|FG001|STARTED|Overall Study||34
11245688|NCT02126748|12438417|FG002|STARTED|Overall Study||36
11245689|NCT02126748|12438415|FG000|COMPLETED|Overall Study||31
11245690|NCT02126748|12438416|FG001|COMPLETED|Overall Study||31
11245691|NCT02126748|12438417|FG002|COMPLETED|Overall Study||31
11245692|NCT02126748|12438415|FG000|NOT COMPLETED|Overall Study||2
11245693|NCT02126748|12438416|FG001|NOT COMPLETED|Overall Study||3
11245694|NCT02126748|12438417|FG002|NOT COMPLETED|Overall Study||5
11245695|NCT02126826|12438432|FG000|STARTED|Overall Study||9
11245696|NCT02126826|12438433|FG001|STARTED|Overall Study||9
11245697|NCT02126826|12438434|FG002|STARTED|Overall Study||9
11245698|NCT02126826|12438435|FG003|STARTED|Overall Study||9
11245699|NCT02126826|12438436|FG004|STARTED|Overall Study||5
11245700|NCT02126826|12438437|FG005|STARTED|Overall Study||9
11245701|NCT02126826|12438438|FG006|STARTED|Overall Study||8
11245702|NCT02126826|12438432|FG000|COMPLETED|Overall Study||9
11245703|NCT02126826|12438433|FG001|COMPLETED|Overall Study||9
11245704|NCT02126826|12438434|FG002|COMPLETED|Overall Study||9
11245705|NCT02126826|12438435|FG003|COMPLETED|Overall Study||8
11245706|NCT02126826|12438436|FG004|COMPLETED|Overall Study||5
11245707|NCT02126826|12438437|FG005|COMPLETED|Overall Study||9
11245708|NCT02126826|12438438|FG006|COMPLETED|Overall Study||8
11245709|NCT02126826|12438432|FG000|NOT COMPLETED|Overall Study||0
11245710|NCT02126826|12438433|FG001|NOT COMPLETED|Overall Study||0
11245711|NCT02126826|12438434|FG002|NOT COMPLETED|Overall Study||0
11245712|NCT02126826|12438435|FG003|NOT COMPLETED|Overall Study||1
11245713|NCT02126826|12438436|FG004|NOT COMPLETED|Overall Study||0
11245714|NCT02126826|12438437|FG005|NOT COMPLETED|Overall Study||0
11245715|NCT02126826|12438438|FG006|NOT COMPLETED|Overall Study||0
11245716|NCT02126839|12438461|FG000|STARTED|Overall Study||92
11245717|NCT02126839|12438462|FG001|STARTED|Overall Study||94
11245718|NCT02126839|12438461|FG000|Safety Population|Overall Study||92
11245719|NCT02126839|12438462|FG001|Safety Population|Overall Study||93
11245720|NCT02126839|12438461|FG000|Full Analysis Set|Overall Study||92
11245721|NCT02126839|12438462|FG001|Full Analysis Set|Overall Study||92
11245722|NCT02126839|12438461|FG000|COMPLETED|Overall Study||82
11245723|NCT02126839|12438462|FG001|COMPLETED|Overall Study||80
11245724|NCT02126839|12438461|FG000|NOT COMPLETED|Overall Study||10
11245725|NCT02126839|12438462|FG001|NOT COMPLETED|Overall Study||14
11245726|NCT02127125|12438477|FG000|STARTED|Overall Study||6
11245727|NCT02127125|12438478|FG001|STARTED|Overall Study||8
11245728|NCT02127125|12438479|FG002|STARTED|Overall Study||9
11245729|NCT02127125|12438480|FG003|STARTED|Overall Study||11
11245730|NCT02127125|12438481|FG004|STARTED|Overall Study||12
11245731|NCT02127125|12438482|FG005|STARTED|Overall Study||12
11245732|NCT02127125|12438483|FG006|STARTED|Overall Study||2
11245733|NCT02127125|12438484|FG007|STARTED|Overall Study||0
11245734|NCT02127125|12438485|FG008|STARTED|Overall Study||1
11245735|NCT02127125|12438477|FG000|COMPLETED|Overall Study||6
11245736|NCT02127125|12438478|FG001|COMPLETED|Overall Study||8
11245737|NCT02127125|12438479|FG002|COMPLETED|Overall Study||8
11245738|NCT02127125|12438480|FG003|COMPLETED|Overall Study||10
11245739|NCT02127125|12438481|FG004|COMPLETED|Overall Study||9
11245740|NCT02127125|12438482|FG005|COMPLETED|Overall Study||9
11245741|NCT02127125|12438483|FG006|COMPLETED|Overall Study||2
11245742|NCT02127125|12438484|FG007|COMPLETED|Overall Study||0
11245743|NCT02127125|12438485|FG008|COMPLETED|Overall Study||1
11245744|NCT02127125|12438477|FG000|NOT COMPLETED|Overall Study||0
11245745|NCT02127125|12438478|FG001|NOT COMPLETED|Overall Study||0
11245746|NCT02127125|12438479|FG002|NOT COMPLETED|Overall Study||1
11245747|NCT02127125|12438480|FG003|NOT COMPLETED|Overall Study||1
11245748|NCT02127125|12438481|FG004|NOT COMPLETED|Overall Study||3
11245749|NCT02127125|12438482|FG005|NOT COMPLETED|Overall Study||3
11245750|NCT02127125|12438483|FG006|NOT COMPLETED|Overall Study||0
11245751|NCT02127125|12438484|FG007|NOT COMPLETED|Overall Study||0
11245752|NCT02127125|12438485|FG008|NOT COMPLETED|Overall Study||0
11339215|NCT02910713|12536683|FG000|STARTED|Overall Study||185
11339216|NCT02910713|12536683|FG000|Safety Population: Entered CAE|Overall Study||171
11339217|NCT02910713|12536683|FG000|COMPLETED|Overall Study|Completed=Completed both Intranasal and Extranasal applications.|143
11339218|NCT02910713|12536683|FG000|NOT COMPLETED|Overall Study||42
11339219|NCT02910739|12536690|FG000|STARTED|Overall Study||8
11339220|NCT02910739|12536691|FG001|STARTED|Overall Study||8
11339221|NCT02910739|12536692|FG002|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
11339222|NCT02910739|12536693|FG003|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
11339223|NCT02910739|12536690|FG000|COMPLETED|Overall Study||7
11339224|NCT02910739|12536691|FG001|COMPLETED|Overall Study||8
11339225|NCT02910739|12536692|FG002|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
11339226|NCT02910739|12536693|FG003|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
11339227|NCT02910739|12536690|FG000|NOT COMPLETED|Overall Study||1
11339228|NCT02910739|12536691|FG001|NOT COMPLETED|Overall Study||0
11339229|NCT02910739|12536692|FG002|NOT COMPLETED|Overall Study||0
11339230|NCT02910739|12536693|FG003|NOT COMPLETED|Overall Study||0
11339231|NCT02911025|12536699|FG000|STARTED|Overall Study||13
11339232|NCT02911025|12536699|FG000|COMPLETED|Overall Study||10
11245753|NCT02127281|12438507|FG000|STARTED|Overall Study||80
11245754|NCT02127281|12438508|FG001|STARTED|Overall Study||80
11245755|NCT02127281|12438507|FG000|COMPLETED|Overall Study||79
11245756|NCT02127281|12438508|FG001|COMPLETED|Overall Study||80
11245757|NCT02127281|12438507|FG000|NOT COMPLETED|Overall Study||1
11245758|NCT02127281|12438508|FG001|NOT COMPLETED|Overall Study||0
11245759|NCT02127307|12438514|FG000|STARTED|Overall Study||964
11245760|NCT02127307|12438514|FG000|COMPLETED|Overall Study||656
11245761|NCT02127307|12438514|FG000|NOT COMPLETED|Overall Study||308
11245762|NCT02127372|12438520|FG000|STARTED|Overall Study|Signed Consent|15
11245763|NCT02127372|12438521|FG001|STARTED|Overall Study|Signed Consent|28
11245764|NCT02127372|12438520|FG000|Started Study Treatment|Overall Study||15
11245765|NCT02127372|12438521|FG001|Started Study Treatment|Overall Study||28
11245766|NCT02127372|12438520|FG000|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
11245767|NCT02127372|12438521|FG001|COMPLETED|Overall Study||28
11245768|NCT02127372|12438520|FG000|NOT COMPLETED|Overall Study||1
11245769|NCT02127372|12438521|FG001|NOT COMPLETED|Overall Study||0
11245770|NCT02127567|12438528|FG000|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
11245771|NCT02127567|12438528|FG000|COMPLETED|Overall Study||41
11245772|NCT02127567|12438528|FG000|NOT COMPLETED|Overall Study||0
11245773|NCT02127632|12438538|FG000|STARTED|Overall Study||50
11245774|NCT02127632|12438539|FG001|STARTED|Overall Study||50
11245775|NCT02127632|12438538|FG000|COMPLETED|Overall Study||50
11245776|NCT02127632|12438539|FG001|COMPLETED|Overall Study||50
11245777|NCT02127632|12438538|FG000|NOT COMPLETED|Overall Study||0
11245778|NCT02127632|12438539|FG001|NOT COMPLETED|Overall Study||0
11245779|NCT02127710|12438548|FG000|STARTED|Overall Study||46
11245780|NCT02127710|12438549|FG001|STARTED|Overall Study||47
11245781|NCT02127710|12438550|FG002|STARTED|Overall Study||16
11245782|NCT02127710|12438548|FG000|COMPLETED|Overall Study||46
11245783|NCT02127710|12438549|FG001|COMPLETED|Overall Study||47
11245784|NCT02127710|12438550|FG002|COMPLETED|Overall Study||16
11245785|NCT02127710|12438548|FG000|NOT COMPLETED|Overall Study||0
11245786|NCT02127710|12438549|FG001|NOT COMPLETED|Overall Study||0
11245787|NCT02127710|12438550|FG002|NOT COMPLETED|Overall Study||0
11245788|NCT02127892|12438565|FG000|STARTED|Overall Study||7
11245789|NCT02127892|12438566|FG001|STARTED|Overall Study||2
11245790|NCT02127892|12438567|FG002|STARTED|Overall Study||0
11245791|NCT02127892|12438568|FG003|STARTED|Overall Study||0
11245792|NCT02127892|12438565|FG000|COMPLETED|Overall Study||6
11245793|NCT02127892|12438566|FG001|COMPLETED|Overall Study||1
11245794|NCT02127892|12438567|FG002|COMPLETED|Overall Study||0
11245795|NCT02127892|12438568|FG003|COMPLETED|Overall Study||0
11245796|NCT02127892|12438565|FG000|NOT COMPLETED|Overall Study||1
11245797|NCT02127892|12438566|FG001|NOT COMPLETED|Overall Study||1
11245798|NCT02127892|12438567|FG002|NOT COMPLETED|Overall Study||0
11245799|NCT02127892|12438568|FG003|NOT COMPLETED|Overall Study||0
11245800|NCT02127931|12438578|FG000|STARTED|Overall Study||18
11245801|NCT02127931|12438578|FG000|COMPLETED|Overall Study||17
11005375|NCT00722566|12183081|FG001|NOT COMPLETED|Overall Study||35
11005376|NCT00722722|12183092|FG000|STARTED|Overall Study||3
11005377|NCT00722722|12183093|FG001|STARTED|Overall Study||5
11005378|NCT00722722|12183094|FG002|STARTED|Overall Study||10
11005379|NCT00722722|12183092|FG000|COMPLETED|Overall Study||3
11005380|NCT00722722|12183093|FG001|COMPLETED|Overall Study||5
11005381|NCT00722722|12183094|FG002|COMPLETED|Overall Study||10
11005382|NCT00722722|12183092|FG000|NOT COMPLETED|Overall Study||0
11245802|NCT02127931|12438578|FG000|NOT COMPLETED|Overall Study||1
11245803|NCT02127970|12438585|FG000|STARTED|Overall Study||349
11245804|NCT02127970|12438586|FG001|STARTED|Overall Study||349
11245805|NCT02127970|12438585|FG000|COMPLETED|Overall Study||323
11245806|NCT02127970|12438586|FG001|COMPLETED|Overall Study||322
11245807|NCT02127970|12438585|FG000|NOT COMPLETED|Overall Study||26
11245808|NCT02127970|12438586|FG001|NOT COMPLETED|Overall Study||27
11245809|NCT02128074|12438592|FG000|STARTED|Overall Study||32
11245810|NCT02128074|12438592|FG000|COMPLETED|Overall Study||26
11245811|NCT02128074|12438592|FG000|NOT COMPLETED|Overall Study||6
11245812|NCT02128217|12438598|FG000|STARTED|Overall Study||17
11245813|NCT02128217|12438599|FG001|STARTED|Overall Study||27
11245814|NCT02128217|12438598|FG000|COMPLETED|Overall Study||17
11245815|NCT02128217|12438599|FG001|COMPLETED|Overall Study||26
11245816|NCT02128217|12438598|FG000|NOT COMPLETED|Overall Study||0
11245817|NCT02128217|12438599|FG001|NOT COMPLETED|Overall Study||1
11245818|NCT02128230|12438610|FG000|STARTED|Overall Study||20
11245819|NCT02128230|12438610|FG000|COMPLETED|Overall Study||1
11245820|NCT02128230|12438610|FG000|NOT COMPLETED|Overall Study||19
11245821|NCT02128269|12438614|FG000|STARTED|Treatment Period||9
11245822|NCT02128269|12438614|FG000|COMPLETED|Treatment Period||7
11245823|NCT02128269|12438614|FG000|NOT COMPLETED|Treatment Period||2
11005383|NCT00722722|12183093|FG001|NOT COMPLETED|Overall Study||0
11339233|NCT02911025|12536699|FG000|NOT COMPLETED|Overall Study||3
11245824|NCT02128269|12438614|FG000|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
11245825|NCT02128269|12438614|FG000|COMPLETED|Follow-up||9
11245826|NCT02128269|12438614|FG000|NOT COMPLETED|Follow-up||0
11245827|NCT02128490|12438623|FG000|STARTED|Overall Study||38
11245828|NCT02128490|12438624|FG001|STARTED|Overall Study||37
11245829|NCT02128490|12438625|FG002|STARTED|Overall Study||39
11245830|NCT02128490|12438626|FG003|STARTED|Overall Study||37
11245831|NCT02128490|12438627|FG004|STARTED|Overall Study||38
11245832|NCT02128490|12438623|FG000|COMPLETED|Overall Study||33
11245833|NCT02128490|12438624|FG001|COMPLETED|Overall Study||31
11245834|NCT02128490|12438625|FG002|COMPLETED|Overall Study||34
11245835|NCT02128490|12438626|FG003|COMPLETED|Overall Study||31
11245836|NCT02128490|12438627|FG004|COMPLETED|Overall Study||31
11245837|NCT02128490|12438623|FG000|NOT COMPLETED|Overall Study||5
11245838|NCT02128490|12438624|FG001|NOT COMPLETED|Overall Study||6
11245839|NCT02128490|12438625|FG002|NOT COMPLETED|Overall Study||5
11245840|NCT02128490|12438626|FG003|NOT COMPLETED|Overall Study||6
11245841|NCT02128490|12438627|FG004|NOT COMPLETED|Overall Study||7
11245842|NCT02128542|12438641|FG000|STARTED|Overall Study||47
11245843|NCT02128542|12438642|FG001|STARTED|Overall Study||19
11245844|NCT02128542|12438641|FG000|COMPLETED|Overall Study||43
11245845|NCT02128542|12438642|FG001|COMPLETED|Overall Study||19
11245846|NCT02128542|12438641|FG000|NOT COMPLETED|Overall Study||4
11245847|NCT02128542|12438642|FG001|NOT COMPLETED|Overall Study||0
11245848|NCT02128724|12438654|FG000|STARTED|Overall Study||4
11245849|NCT02128724|12438655|FG001|STARTED|Overall Study||4
11245850|NCT02128724|12438656|FG002|STARTED|Overall Study||3
11245851|NCT02128724|12438657|FG003|STARTED|Overall Study||10
11245852|NCT02128724|12438654|FG000|COMPLETED|Overall Study||3
11245853|NCT02128724|12438655|FG001|COMPLETED|Overall Study||3
11245854|NCT02128724|12438656|FG002|COMPLETED|Overall Study||3
11245855|NCT02128724|12438657|FG003|COMPLETED|Overall Study||7
11245856|NCT02128724|12438654|FG000|NOT COMPLETED|Overall Study||1
11245857|NCT02128724|12438655|FG001|NOT COMPLETED|Overall Study||1
11245858|NCT02128724|12438656|FG002|NOT COMPLETED|Overall Study||0
11245859|NCT02128724|12438657|FG003|NOT COMPLETED|Overall Study||3
11245860|NCT02128828|12438666|FG000|STARTED|Overall Study||20
11245861|NCT02128828|12438666|FG000|COMPLETED|Overall Study||17
11245862|NCT02128828|12438666|FG000|NOT COMPLETED|Overall Study||3
11245863|NCT02128867|12438673|FG000|STARTED|Overall Study||53
11245864|NCT02128867|12438674|FG001|STARTED|Overall Study||52
11245865|NCT02128867|12438675|FG002|STARTED|Overall Study||54
11245866|NCT02128867|12438673|FG000|COMPLETED|Overall Study||50
11245867|NCT02128867|12438674|FG001|COMPLETED|Overall Study||50
11245868|NCT02128867|12438675|FG002|COMPLETED|Overall Study||50
11245869|NCT02128867|12438673|FG000|NOT COMPLETED|Overall Study||3
11245870|NCT02128867|12438674|FG001|NOT COMPLETED|Overall Study||2
11245871|NCT02128867|12438675|FG002|NOT COMPLETED|Overall Study||4
11245872|NCT02128919|12438685|FG000|STARTED|Overall Study||17
11245873|NCT02128919|12438686|FG001|STARTED|Overall Study||16
11245874|NCT02128919|12438685|FG000|COMPLETED|Overall Study||14
11245875|NCT02128919|12438686|FG001|COMPLETED|Overall Study||15
11245876|NCT02128919|12438685|FG000|NOT COMPLETED|Overall Study||3
11245877|NCT02128919|12438686|FG001|NOT COMPLETED|Overall Study||1
11245878|NCT02128932|12438696|FG000|STARTED|Overall Study||362
11245879|NCT02128932|12438697|FG001|STARTED|Overall Study||360
11245880|NCT02128932|12438698|FG002|STARTED|Overall Study||360
11245881|NCT02128932|12438696|FG000|COMPLETED|Overall Study||335
11245882|NCT02128932|12438697|FG001|COMPLETED|Overall Study||341
11245883|NCT02128932|12438698|FG002|COMPLETED|Overall Study||342
11245884|NCT02128932|12438696|FG000|NOT COMPLETED|Overall Study||27
11245885|NCT02128932|12438697|FG001|NOT COMPLETED|Overall Study||19
11245886|NCT02128932|12438698|FG002|NOT COMPLETED|Overall Study||18
11245887|NCT02128997|12438708|FG000|STARTED|Overall Study||67
11245888|NCT02128997|12438709|FG001|STARTED|Overall Study||69
11245889|NCT02128997|12438708|FG000|COMPLETED|Overall Study||61
11245890|NCT02128997|12438709|FG001|COMPLETED|Overall Study||58
11245891|NCT02128997|12438708|FG000|NOT COMPLETED|Overall Study||6
11245892|NCT02128997|12438709|FG001|NOT COMPLETED|Overall Study||11
11245893|NCT02129062|12438715|FG000|STARTED|Overall Study||3
11245894|NCT02129062|12438715|FG000|COMPLETED|Overall Study||0
11245895|NCT02129062|12438715|FG000|NOT COMPLETED|Overall Study||3
11245896|NCT02129075|12438721|FG000|STARTED|Overall Study||30
11245897|NCT02129075|12438722|FG001|STARTED|Overall Study||30
11245898|NCT02129075|12438721|FG000|COMPLETED|Overall Study||30
11245899|NCT02129075|12438722|FG001|COMPLETED|Overall Study||30
11245900|NCT02129075|12438721|FG000|NOT COMPLETED|Overall Study||0
11245901|NCT02129075|12438722|FG001|NOT COMPLETED|Overall Study||0
11245902|NCT02129192|12438732|FG000|STARTED|Period 1 Including Washout Period||36
11245903|NCT02129192|12438733|FG001|STARTED|Period 1 Including Washout Period||36
11245904|NCT02129192|12438732|FG000|COMPLETED|Period 1 Including Washout Period||36
11245905|NCT02129192|12438733|FG001|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
11245906|NCT02129192|12438732|FG000|NOT COMPLETED|Period 1 Including Washout Period||0
11245907|NCT02129192|12438733|FG001|NOT COMPLETED|Period 1 Including Washout Period||1
11245908|NCT02129192|12438732|FG000|STARTED|Period 2 Including Washout Period||36
11245909|NCT02129192|12438733|FG001|STARTED|Period 2 Including Washout Period||35
11245910|NCT02129192|12438732|FG000|COMPLETED|Period 2 Including Washout Period||36
11245911|NCT02129192|12438733|FG001|COMPLETED|Period 2 Including Washout Period||35
11245912|NCT02129192|12438732|FG000|NOT COMPLETED|Period 2 Including Washout Period||0
11245913|NCT02129192|12438733|FG001|NOT COMPLETED|Period 2 Including Washout Period||0
11245914|NCT02129192|12438732|FG000|STARTED|Period 3 Including Washout Period||36
11245915|NCT02129192|12438733|FG001|STARTED|Period 3 Including Washout Period||35
11245916|NCT02129192|12438732|FG000|COMPLETED|Period 3 Including Washout Period||36
11245917|NCT02129192|12438733|FG001|COMPLETED|Period 3 Including Washout Period||35
11245918|NCT02129192|12438732|FG000|NOT COMPLETED|Period 3 Including Washout Period||0
11245919|NCT02129192|12438733|FG001|NOT COMPLETED|Period 3 Including Washout Period||0
11245920|NCT02129192|12438732|FG000|STARTED|Period 4 Including Washout Period||36
11245921|NCT02129192|12438733|FG001|STARTED|Period 4 Including Washout Period||35
11245922|NCT02129192|12438732|FG000|COMPLETED|Period 4 Including Washout Period||36
11245923|NCT02129192|12438733|FG001|COMPLETED|Period 4 Including Washout Period||35
11245924|NCT02129192|12438732|FG000|NOT COMPLETED|Period 4 Including Washout Period||0
11245925|NCT02129192|12438733|FG001|NOT COMPLETED|Period 4 Including Washout Period||0
11245926|NCT02129192|12438732|FG000|STARTED|Period 5||36
11245927|NCT02129192|12438733|FG001|STARTED|Period 5|This sequence consists of only 4 periods.|0
11245928|NCT02129192|12438732|FG000|COMPLETED|Period 5||36
11245929|NCT02129192|12438733|FG001|COMPLETED|Period 5||0
11245930|NCT02129192|12438732|FG000|NOT COMPLETED|Period 5||0
11245931|NCT02129192|12438733|FG001|NOT COMPLETED|Period 5||0
11245932|NCT02129205|12438752|FG000|STARTED|Overall Study||2
11245933|NCT02129205|12438753|FG001|STARTED|Overall Study||2
11245934|NCT02129205|12438754|FG002|STARTED|Overall Study||2
11245935|NCT02129205|12438755|FG003|STARTED|Overall Study||2
11245936|NCT02129205|12438756|FG004|STARTED|Overall Study||7
11245937|NCT02129205|12438757|FG005|STARTED|Overall Study||11
11245938|NCT02129205|12438758|FG006|STARTED|Overall Study||6
11245939|NCT02129205|12438759|FG007|STARTED|Overall Study||6
11245940|NCT02129205|12438760|FG008|STARTED|Overall Study||2
11245941|NCT02129205|12438761|FG009|STARTED|Overall Study||0
11245942|NCT02129205|12438752|FG000|COMPLETED|Overall Study||1
11245943|NCT02129205|12438753|FG001|COMPLETED|Overall Study||2
11245944|NCT02129205|12438754|FG002|COMPLETED|Overall Study||2
11245945|NCT02129205|12438755|FG003|COMPLETED|Overall Study||2
11245946|NCT02129205|12438756|FG004|COMPLETED|Overall Study||4
11245947|NCT02129205|12438757|FG005|COMPLETED|Overall Study||7
11245948|NCT02129205|12438758|FG006|COMPLETED|Overall Study||2
11245949|NCT02129205|12438759|FG007|COMPLETED|Overall Study||4
11245950|NCT02129205|12438760|FG008|COMPLETED|Overall Study||0
11245951|NCT02129205|12438761|FG009|COMPLETED|Overall Study||0
11245952|NCT02129205|12438752|FG000|NOT COMPLETED|Overall Study||1
11245953|NCT02129205|12438753|FG001|NOT COMPLETED|Overall Study||0
11245954|NCT02129205|12438754|FG002|NOT COMPLETED|Overall Study||0
11245955|NCT02129205|12438755|FG003|NOT COMPLETED|Overall Study||0
11245956|NCT02129205|12438756|FG004|NOT COMPLETED|Overall Study||3
11245957|NCT02129205|12438757|FG005|NOT COMPLETED|Overall Study||4
11245958|NCT02129205|12438758|FG006|NOT COMPLETED|Overall Study||4
11245959|NCT02129205|12438759|FG007|NOT COMPLETED|Overall Study||2
11245960|NCT02129205|12438760|FG008|NOT COMPLETED|Overall Study||2
11245961|NCT02129205|12438761|FG009|NOT COMPLETED|Overall Study||0
11245962|NCT02129426|12438787|FG000|STARTED|Overall Study||7
11245963|NCT02129426|12438788|FG001|STARTED|Overall Study||13
11245964|NCT02129426|12438787|FG000|COMPLETED|Overall Study||0
11245965|NCT02129426|12438788|FG001|COMPLETED|Overall Study||0
11245966|NCT02129426|12438787|FG000|NOT COMPLETED|Overall Study||7
11245967|NCT02129426|12438788|FG001|NOT COMPLETED|Overall Study||13
11245968|NCT02129478|12438794|FG000|STARTED|Overall Study||15
11245969|NCT02129478|12438794|FG000|COMPLETED|Overall Study||15
11245970|NCT02129478|12438794|FG000|NOT COMPLETED|Overall Study||0
11245971|NCT02129556|12438801|FG000|STARTED|Overall Study||3
11245972|NCT02129556|12438802|FG001|STARTED|Overall Study||3
11245973|NCT02129556|12438803|FG002|STARTED|Overall Study||40
11245974|NCT02129556|12438804|FG003|STARTED|Overall Study||12
11245975|NCT02129556|12438801|FG000|COMPLETED|Overall Study||3
11245976|NCT02129556|12438802|FG001|COMPLETED|Overall Study||3
11245977|NCT02129556|12438803|FG002|COMPLETED|Overall Study||37
11245978|NCT02129556|12438804|FG003|COMPLETED|Overall Study||12
11245979|NCT02129556|12438801|FG000|NOT COMPLETED|Overall Study||0
11245980|NCT02129556|12438802|FG001|NOT COMPLETED|Overall Study||0
11245981|NCT02129556|12438803|FG002|NOT COMPLETED|Overall Study||3
11245982|NCT02129556|12438804|FG003|NOT COMPLETED|Overall Study||0
11245983|NCT02129608|12438816|FG000|STARTED|Overall Study||15
11245984|NCT02129608|12438817|FG001|STARTED|Overall Study||14
11245985|NCT02129608|12438818|FG002|STARTED|Overall Study||15
11245986|NCT02129608|12438816|FG000|End of Treatment|Overall Study||15
11245987|NCT02129608|12438817|FG001|End of Treatment|Overall Study||13
11245988|NCT02129608|12438818|FG002|End of Treatment|Overall Study||12
11245989|NCT02129608|12438816|FG000|COMPLETED|Overall Study||15
11245990|NCT02129608|12438817|FG001|COMPLETED|Overall Study||13
11245991|NCT02129608|12438818|FG002|COMPLETED|Overall Study||12
11245992|NCT02129608|12438816|FG000|NOT COMPLETED|Overall Study||0
11245993|NCT02129608|12438817|FG001|NOT COMPLETED|Overall Study||1
11245994|NCT02129608|12438818|FG002|NOT COMPLETED|Overall Study||3
11245995|NCT02129660|12438831|FG000|STARTED|Overall Study||21
11245996|NCT02129660|12438832|FG001|STARTED|Overall Study||20
11245997|NCT02129660|12438833|FG002|STARTED|Overall Study||22
11245998|NCT02129660|12438834|FG003|STARTED|Overall Study||20
11245999|NCT02129660|12438835|FG004|STARTED|Overall Study||22
11246000|NCT02129660|12438831|FG000|COMPLETED|Overall Study||19
11246001|NCT02129660|12438832|FG001|COMPLETED|Overall Study||20
11246002|NCT02129660|12438833|FG002|COMPLETED|Overall Study||21
11246003|NCT02129660|12438834|FG003|COMPLETED|Overall Study||20
11246004|NCT02129660|12438835|FG004|COMPLETED|Overall Study||20
11246005|NCT02129660|12438831|FG000|NOT COMPLETED|Overall Study||2
11246006|NCT02129660|12438832|FG001|NOT COMPLETED|Overall Study||0
11246007|NCT02129660|12438833|FG002|NOT COMPLETED|Overall Study||1
11246008|NCT02129660|12438834|FG003|NOT COMPLETED|Overall Study||0
11246009|NCT02129660|12438835|FG004|NOT COMPLETED|Overall Study||2
11246010|NCT02129725|12438850|FG000|STARTED|Overall Study||8
11246011|NCT02129725|12438851|FG001|STARTED|Overall Study||7
11246012|NCT02129725|12438850|FG000|COMPLETED|Overall Study||6
11246013|NCT02129725|12438851|FG001|COMPLETED|Overall Study||4
11246014|NCT02129725|12438850|FG000|NOT COMPLETED|Overall Study||2
11246015|NCT02129725|12438851|FG001|NOT COMPLETED|Overall Study||3
11246016|NCT02129777|12438862|FG000|STARTED|Double-Blind Period||24
11246017|NCT02129777|12438863|FG001|STARTED|Double-Blind Period||24
11246018|NCT02129777|12438864|FG002|STARTED|Double-Blind Period||24
11246019|NCT02129777|12438865|FG003|STARTED|Double-Blind Period||25
11246020|NCT02129777|12438866|FG004|STARTED|Double-Blind Period||25
11246021|NCT02129777|12438867|FG005|STARTED|Double-Blind Period||0
11246022|NCT02129777|12438868|FG006|STARTED|Double-Blind Period||0
11246023|NCT02129777|12438862|FG000|COMPLETED|Double-Blind Period||17
11246024|NCT02129777|12438863|FG001|COMPLETED|Double-Blind Period||16
11246025|NCT02129777|12438864|FG002|COMPLETED|Double-Blind Period||20
11246026|NCT02129777|12438865|FG003|COMPLETED|Double-Blind Period||18
11246027|NCT02129777|12438866|FG004|COMPLETED|Double-Blind Period||18
11246028|NCT02129777|12438867|FG005|COMPLETED|Double-Blind Period||0
11246029|NCT02129777|12438868|FG006|COMPLETED|Double-Blind Period||0
11246030|NCT02129777|12438862|FG000|NOT COMPLETED|Double-Blind Period||7
11246031|NCT02129777|12438863|FG001|NOT COMPLETED|Double-Blind Period||8
11246032|NCT02129777|12438864|FG002|NOT COMPLETED|Double-Blind Period||4
11246033|NCT02129777|12438865|FG003|NOT COMPLETED|Double-Blind Period||7
11246034|NCT02129777|12438866|FG004|NOT COMPLETED|Double-Blind Period||7
11246035|NCT02129777|12438867|FG005|NOT COMPLETED|Double-Blind Period||0
11246036|NCT02129777|12438868|FG006|NOT COMPLETED|Double-Blind Period||0
11246037|NCT02129777|12438862|FG000|STARTED|Open-Label Period||0
11246038|NCT02129777|12438863|FG001|STARTED|Open-Label Period||0
11246039|NCT02129777|12438864|FG002|STARTED|Open-Label Period||0
11246040|NCT02129777|12438865|FG003|STARTED|Open-Label Period||0
11246041|NCT02129777|12438866|FG004|STARTED|Open-Label Period||0
11246042|NCT02129777|12438867|FG005|STARTED|Open-Label Period||12
11246043|NCT02129777|12438868|FG006|STARTED|Open-Label Period||48
11246044|NCT02129777|12438862|FG000|COMPLETED|Open-Label Period||0
11246045|NCT02129777|12438863|FG001|COMPLETED|Open-Label Period||0
11246046|NCT02129777|12438864|FG002|COMPLETED|Open-Label Period||0
11246047|NCT02129777|12438865|FG003|COMPLETED|Open-Label Period||0
11246048|NCT02129777|12438866|FG004|COMPLETED|Open-Label Period||0
11246049|NCT02129777|12438867|FG005|COMPLETED|Open-Label Period||0
11246050|NCT02129777|12438868|FG006|COMPLETED|Open-Label Period||0
11246051|NCT02129777|12438862|FG000|NOT COMPLETED|Open-Label Period||0
11246052|NCT02129777|12438863|FG001|NOT COMPLETED|Open-Label Period||0
11246053|NCT02129777|12438864|FG002|NOT COMPLETED|Open-Label Period||0
11246054|NCT02129777|12438865|FG003|NOT COMPLETED|Open-Label Period||0
11246055|NCT02129777|12438866|FG004|NOT COMPLETED|Open-Label Period||0
11246056|NCT02129777|12438867|FG005|NOT COMPLETED|Open-Label Period||12
11246057|NCT02129777|12438868|FG006|NOT COMPLETED|Open-Label Period||48
11246058|NCT02129803|12438889|FG000|STARTED|Overall Study||12
11246059|NCT02129803|12438890|FG001|STARTED|Overall Study||12
11246060|NCT02129803|12438889|FG000|COMPLETED|Overall Study||6
11246061|NCT02129803|12438890|FG001|COMPLETED|Overall Study||9
11246062|NCT02129803|12438889|FG000|NOT COMPLETED|Overall Study||6
11246063|NCT02129803|12438890|FG001|NOT COMPLETED|Overall Study||3
11246064|NCT02130024|12438898|FG000|STARTED|Overall Study||142
11246065|NCT02130024|12438899|FG001|STARTED|Overall Study||139
11246066|NCT02130024|12438898|FG000|Safety Set|Overall Study|One randomized patient did not receive treatment|141
11246067|NCT02130024|12438899|FG001|Safety Set|Overall Study||139
11246068|NCT02130024|12438898|FG000|Full Analysis Set (FAS)|Overall Study||141
11246069|NCT02130024|12438899|FG001|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137
11246070|NCT02130024|12438898|FG000|COMPLETED|Overall Study||117
11246071|NCT02130024|12438899|FG001|COMPLETED|Overall Study||108
11246072|NCT02130024|12438898|FG000|NOT COMPLETED|Overall Study||25
11246073|NCT02130024|12438899|FG001|NOT COMPLETED|Overall Study||31
11246074|NCT02130063|12438907|FG000|STARTED|Overall Study||342
11246075|NCT02130063|12438908|FG001|STARTED|Overall Study||169
11246076|NCT02130063|12438907|FG000|COMPLETED|Overall Study||317
11246077|NCT02130063|12438908|FG001|COMPLETED|Overall Study||152
11246078|NCT02130063|12438907|FG000|NOT COMPLETED|Overall Study||25
11246079|NCT02130063|12438908|FG001|NOT COMPLETED|Overall Study||17
11246080|NCT02130193|12438916|FG000|STARTED|Part A: 4-week Open-label Period||9
11246081|NCT02130193|12438917|FG001|STARTED|Part A: 4-week Open-label Period||0
11246082|NCT02130193|12438918|FG002|STARTED|Part A: 4-week Open-label Period||0
11246083|NCT02130193|12438916|FG000|COMPLETED|Part A: 4-week Open-label Period||9
11246084|NCT02130193|12438917|FG001|COMPLETED|Part A: 4-week Open-label Period||0
11246085|NCT02130193|12438918|FG002|COMPLETED|Part A: 4-week Open-label Period||0
11246086|NCT02130193|12438916|FG000|NOT COMPLETED|Part A: 4-week Open-label Period||0
11246087|NCT02130193|12438917|FG001|NOT COMPLETED|Part A: 4-week Open-label Period||0
11246088|NCT02130193|12438918|FG002|NOT COMPLETED|Part A: 4-week Open-label Period||0
11246089|NCT02130193|12438916|FG000|STARTED|Part B: 52-week Double-blind Period||0
11246090|NCT02130193|12438917|FG001|STARTED|Part B: 52-week Double-blind Period||48
11246091|NCT02130193|12438918|FG002|STARTED|Part B: 52-week Double-blind Period||45
11246092|NCT02130193|12438916|FG000|COMPLETED|Part B: 52-week Double-blind Period||0
11246093|NCT02130193|12438917|FG001|COMPLETED|Part B: 52-week Double-blind Period||38
11246094|NCT02130193|12438918|FG002|COMPLETED|Part B: 52-week Double-blind Period||37
11246095|NCT02130193|12438916|FG000|NOT COMPLETED|Part B: 52-week Double-blind Period||0
11246096|NCT02130193|12438917|FG001|NOT COMPLETED|Part B: 52-week Double-blind Period||10
11246097|NCT02130193|12438918|FG002|NOT COMPLETED|Part B: 52-week Double-blind Period||8
11246098|NCT02130258|12438929|FG000|STARTED|Overall Study||9
11246099|NCT02130258|12438930|FG001|STARTED|Overall Study||11
11246100|NCT02130258|12438929|FG000|COMPLETED|Overall Study||9
11246101|NCT02130258|12438930|FG001|COMPLETED|Overall Study||11
11246102|NCT02130258|12438929|FG000|NOT COMPLETED|Overall Study||0
11246103|NCT02130258|12438930|FG001|NOT COMPLETED|Overall Study||0
11246104|NCT02130284|12438936|FG000|STARTED|Overall Study||80
11246105|NCT02130284|12438936|FG000|COMPLETED|Overall Study||71
11246106|NCT02130284|12438936|FG000|NOT COMPLETED|Overall Study||9
11246107|NCT02130297|12438940|FG000|STARTED|Overall Study||30
11246108|NCT02130297|12438940|FG000|COMPLETED|Overall Study||26
11246109|NCT02130297|12438940|FG000|NOT COMPLETED|Overall Study||4
11246110|NCT02130557|12438946|FG000|STARTED|Overall Study||268
11246111|NCT02130557|12438947|FG001|STARTED|Overall Study||268
11246112|NCT02130557|12438946|FG000|Treated|Overall Study||268
11246113|NCT02130557|12438947|FG001|Treated|Overall Study||265
11246114|NCT02130557|12438946|FG000|mITT Population|Overall Study||246
11246115|NCT02130557|12438947|FG001|mITT Population|Overall Study||241
11246116|NCT02130557|12438946|FG000|COMPLETED|Overall Study||232
11246117|NCT02130557|12438947|FG001|COMPLETED|Overall Study||231
11246118|NCT02130557|12438946|FG000|NOT COMPLETED|Overall Study||36
11246119|NCT02130557|12438947|FG001|NOT COMPLETED|Overall Study||37
11246120|NCT02130570|12438955|FG000|STARTED|Overall Study||987
11246121|NCT02130570|12438956|FG001|STARTED|Overall Study||692
11246122|NCT02130570|12438955|FG000|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978
11246123|NCT02130570|12438956|FG001|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679
11246124|NCT02130570|12438955|FG000|NOT COMPLETED|Overall Study||9
11246125|NCT02130570|12438956|FG001|NOT COMPLETED|Overall Study||13
11246126|NCT02130583|12438965|FG000|STARTED|Overall Study||26
11246127|NCT02130583|12438966|FG001|STARTED|Overall Study||26
11246128|NCT02130583|12438965|FG000|COMPLETED|Overall Study||17
11246129|NCT02130583|12438966|FG001|COMPLETED|Overall Study||19
11246130|NCT02130583|12438965|FG000|NOT COMPLETED|Overall Study||9
11246131|NCT02130583|12438966|FG001|NOT COMPLETED|Overall Study||7
11246132|NCT02130635|12438981|FG000|STARTED|Part A-Safety and Tolerability||7
11246133|NCT02130635|12438982|FG001|STARTED|Part A-Safety and Tolerability||21
11246134|NCT02130635|12438983|FG002|STARTED|Part A-Safety and Tolerability||0
11246135|NCT02130635|12438984|FG003|STARTED|Part A-Safety and Tolerability||0
11246136|NCT02130635|12438985|FG004|STARTED|Part A-Safety and Tolerability||0
11246137|NCT02130635|12438986|FG005|STARTED|Part A-Safety and Tolerability||0
11246138|NCT02130635|12438987|FG006|STARTED|Part A-Safety and Tolerability||0
11246139|NCT02130635|12438988|FG007|STARTED|Part A-Safety and Tolerability||0
11246140|NCT02130635|12438989|FG008|STARTED|Part A-Safety and Tolerability||0
11246141|NCT02130635|12438981|FG000|COMPLETED|Part A-Safety and Tolerability||7
11246142|NCT02130635|12438982|FG001|COMPLETED|Part A-Safety and Tolerability||21
11246143|NCT02130635|12438983|FG002|COMPLETED|Part A-Safety and Tolerability||0
11246144|NCT02130635|12438984|FG003|COMPLETED|Part A-Safety and Tolerability||0
11246145|NCT02130635|12438985|FG004|COMPLETED|Part A-Safety and Tolerability||0
11246146|NCT02130635|12438986|FG005|COMPLETED|Part A-Safety and Tolerability||0
11246147|NCT02130635|12438987|FG006|COMPLETED|Part A-Safety and Tolerability||0
11246148|NCT02130635|12438988|FG007|COMPLETED|Part A-Safety and Tolerability||0
11246149|NCT02130635|12438989|FG008|COMPLETED|Part A-Safety and Tolerability||0
11246150|NCT02130635|12438981|FG000|NOT COMPLETED|Part A-Safety and Tolerability||0
11246151|NCT02130635|12438982|FG001|NOT COMPLETED|Part A-Safety and Tolerability||0
11246152|NCT02130635|12438983|FG002|NOT COMPLETED|Part A-Safety and Tolerability||0
11246153|NCT02130635|12438984|FG003|NOT COMPLETED|Part A-Safety and Tolerability||0
11246154|NCT02130635|12438985|FG004|NOT COMPLETED|Part A-Safety and Tolerability||0
11246155|NCT02130635|12438986|FG005|NOT COMPLETED|Part A-Safety and Tolerability||0
11246156|NCT02130635|12438987|FG006|NOT COMPLETED|Part A-Safety and Tolerability||0
11246157|NCT02130635|12438988|FG007|NOT COMPLETED|Part A-Safety and Tolerability||0
11246158|NCT02130635|12438989|FG008|NOT COMPLETED|Part A-Safety and Tolerability||0
11246159|NCT02130635|12438981|FG000|STARTED|Part B-Dose-Response Relationship||0
11246160|NCT02130635|12438982|FG001|STARTED|Part B-Dose-Response Relationship||0
11246161|NCT02130635|12438983|FG002|STARTED|Part B-Dose-Response Relationship||5
11246162|NCT02130635|12438984|FG003|STARTED|Part B-Dose-Response Relationship||5
11246163|NCT02130635|12438985|FG004|STARTED|Part B-Dose-Response Relationship||5
11246164|NCT02130635|12438986|FG005|STARTED|Part B-Dose-Response Relationship||5
11246165|NCT02130635|12438987|FG006|STARTED|Part B-Dose-Response Relationship||6
11246166|NCT02130635|12438988|FG007|STARTED|Part B-Dose-Response Relationship||5
11246167|NCT02130635|12438989|FG008|STARTED|Part B-Dose-Response Relationship||5
11246168|NCT02130635|12438981|FG000|COMPLETED|Part B-Dose-Response Relationship||0
11246169|NCT02130635|12438982|FG001|COMPLETED|Part B-Dose-Response Relationship||0
11246170|NCT02130635|12438983|FG002|COMPLETED|Part B-Dose-Response Relationship||5
11246171|NCT02130635|12438984|FG003|COMPLETED|Part B-Dose-Response Relationship||5
11246172|NCT02130635|12438985|FG004|COMPLETED|Part B-Dose-Response Relationship||5
11246173|NCT02130635|12438986|FG005|COMPLETED|Part B-Dose-Response Relationship||5
11246174|NCT02130635|12438987|FG006|COMPLETED|Part B-Dose-Response Relationship||6
11246175|NCT02130635|12438988|FG007|COMPLETED|Part B-Dose-Response Relationship||5
11246176|NCT02130635|12438989|FG008|COMPLETED|Part B-Dose-Response Relationship||5
11246177|NCT02130635|12438981|FG000|NOT COMPLETED|Part B-Dose-Response Relationship||0
11246178|NCT02130635|12438982|FG001|NOT COMPLETED|Part B-Dose-Response Relationship||0
11246179|NCT02130635|12438983|FG002|NOT COMPLETED|Part B-Dose-Response Relationship||0
11246180|NCT02130635|12438984|FG003|NOT COMPLETED|Part B-Dose-Response Relationship||0
11246181|NCT02130635|12438985|FG004|NOT COMPLETED|Part B-Dose-Response Relationship||0
11246182|NCT02130635|12438986|FG005|NOT COMPLETED|Part B-Dose-Response Relationship||0
11246183|NCT02130635|12438987|FG006|NOT COMPLETED|Part B-Dose-Response Relationship||0
11246184|NCT02130635|12438988|FG007|NOT COMPLETED|Part B-Dose-Response Relationship||0
11246185|NCT02130635|12438989|FG008|NOT COMPLETED|Part B-Dose-Response Relationship||0
11246186|NCT02130765|12439020|FG000|STARTED|Overall Study||11
11246187|NCT02130765|12439021|FG001|STARTED|Overall Study||8
11246188|NCT02130765|12439022|FG002|STARTED|Overall Study||26
11246189|NCT02130765|12439023|FG003|STARTED|Overall Study||19
11246190|NCT02130765|12439020|FG000|COMPLETED|Overall Study||7
11246191|NCT02130765|12439021|FG001|COMPLETED|Overall Study||8
11246192|NCT02130765|12439022|FG002|COMPLETED|Overall Study||26
11246193|NCT02130765|12439023|FG003|COMPLETED|Overall Study||19
11246194|NCT02130765|12439020|FG000|NOT COMPLETED|Overall Study||4
11246195|NCT02130765|12439021|FG001|NOT COMPLETED|Overall Study||0
11246196|NCT02130765|12439022|FG002|NOT COMPLETED|Overall Study||0
11246197|NCT02130765|12439023|FG003|NOT COMPLETED|Overall Study||0
11246198|NCT02130986|12439037|FG000|STARTED|Overall Study||830
11246199|NCT02130986|12439038|FG001|STARTED|Overall Study||834
11246200|NCT02130986|12439037|FG000|COMPLETED|Overall Study||675
11246201|NCT02130986|12439038|FG001|COMPLETED|Overall Study||670
11246202|NCT02130986|12439037|FG000|NOT COMPLETED|Overall Study||155
11246203|NCT02130986|12439038|FG001|NOT COMPLETED|Overall Study||164
11246204|NCT02130999|12439046|FG000|STARTED|Overall Study||6
11246205|NCT02130999|12439047|FG001|STARTED|Overall Study||8
11246206|NCT02130999|12439046|FG000|COMPLETED|Overall Study||6
11358325|NCT03123471|12555388|FG000|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84
11358326|NCT03123471|12555389|FG001|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163
11358327|NCT03123471|12555388|FG000|COMPLETED|Apremilast Extension Phase||76
11358328|NCT03123471|12555389|FG001|COMPLETED|Apremilast Extension Phase||140
11358329|NCT03123471|12555388|FG000|NOT COMPLETED|Apremilast Extension Phase||8
11358330|NCT03123471|12555389|FG001|NOT COMPLETED|Apremilast Extension Phase||25
11358331|NCT03123588|12555403|FG000|STARTED|Overall Study||6
11358332|NCT03123588|12555404|FG001|STARTED|Overall Study||6
11358333|NCT03123588|12555403|FG000|COMPLETED|Overall Study||0
11358334|NCT03123588|12555404|FG001|COMPLETED|Overall Study||0
11358335|NCT03123588|12555403|FG000|NOT COMPLETED|Overall Study||6
11358336|NCT03123588|12555404|FG001|NOT COMPLETED|Overall Study||6
11358337|NCT03123614|12555413|FG000|STARTED|Overall Study||57
11358338|NCT03123614|12555414|FG001|STARTED|Overall Study||74
11358339|NCT03123614|12555413|FG000|COMPLETED|Overall Study||57
11358340|NCT03123614|12555414|FG001|COMPLETED|Overall Study||74
11358341|NCT03123614|12555413|FG000|NOT COMPLETED|Overall Study||0
11358342|NCT03123614|12555414|FG001|NOT COMPLETED|Overall Study||0
11358343|NCT03123848|12555420|FG000|STARTED|Overall Study||8
11358344|NCT03123848|12555420|FG000|COMPLETED|Overall Study||8
11358345|NCT03123848|12555420|FG000|NOT COMPLETED|Overall Study||0
11358346|NCT03123861|12555428|FG000|STARTED|Overall Study||22
11358347|NCT03123861|12555429|FG001|STARTED|Overall Study||23
11358348|NCT03123861|12555428|FG000|Received Intervention|Overall Study||21
11358349|NCT03123861|12555429|FG001|Received Intervention|Overall Study||22
11246207|NCT02130999|12439047|FG001|COMPLETED|Overall Study||8
11246208|NCT02130999|12439046|FG000|NOT COMPLETED|Overall Study||0
11358350|NCT03123861|12555428|FG000|COMPLETED|Overall Study||19
11358351|NCT03123861|12555429|FG001|COMPLETED|Overall Study||20
11358352|NCT03123861|12555428|FG000|NOT COMPLETED|Overall Study||3
11358353|NCT03123861|12555429|FG001|NOT COMPLETED|Overall Study||3
11358354|NCT03123874|12555437|FG000|STARTED|Overall Study||27
11358355|NCT03123874|12555438|FG001|STARTED|Overall Study||25
11358356|NCT03123874|12555437|FG000|COMPLETED|Overall Study||27
11358357|NCT03123874|12555438|FG001|COMPLETED|Overall Study||25
11358358|NCT03123874|12555437|FG000|NOT COMPLETED|Overall Study||0
11358359|NCT03123874|12555438|FG001|NOT COMPLETED|Overall Study||0
11358360|NCT03123939|12555448|FG000|STARTED|Overall Study||74
11358361|NCT03123939|12555448|FG000|CTL019 Infused|Overall Study||69
11358362|NCT03123939|12555448|FG000|Full Analysis Set (FAS)|Overall Study||69
11358363|NCT03123939|12555448|FG000|Cellular Kinetic Analysis Set (CKAS)|Overall Study||69
11358364|NCT03123939|12555448|FG000|Safety Set (SAF)|Overall Study||69
11358365|NCT03123939|12555448|FG000|COMPLETED|Overall Study||33
11358366|NCT03123939|12555448|FG000|NOT COMPLETED|Overall Study||41
11358367|NCT03124069|12555452|FG000|STARTED|Overall Study||37
11358368|NCT03124069|12555452|FG000|COMPLETED|Overall Study||37
11358369|NCT03124069|12555452|FG000|NOT COMPLETED|Overall Study||0
11358370|NCT03124108|12555461|FG000|STARTED|Overall Study||15
11358371|NCT03124108|12555462|FG001|STARTED|Overall Study||15
11358372|NCT03124108|12555463|FG002|STARTED|Overall Study||15
11358373|NCT03124108|12555461|FG000|COMPLETED|Overall Study||15
11358374|NCT03124108|12555462|FG001|COMPLETED|Overall Study||14
11358375|NCT03124108|12555463|FG002|COMPLETED|Overall Study||15
11358376|NCT03124108|12555461|FG000|NOT COMPLETED|Overall Study||0
11358377|NCT03124108|12555462|FG001|NOT COMPLETED|Overall Study||1
11358378|NCT03124108|12555463|FG002|NOT COMPLETED|Overall Study||0
11358379|NCT03124121|12555475|FG000|STARTED|Overall Study||42
11358380|NCT03124121|12555476|FG001|STARTED|Overall Study||70
11358381|NCT03124121|12555475|FG000|COMPLETED|Overall Study||39
11358382|NCT03124121|12555476|FG001|COMPLETED|Overall Study||67
11358383|NCT03124121|12555475|FG000|NOT COMPLETED|Overall Study||3
11246209|NCT02130999|12439047|FG001|NOT COMPLETED|Overall Study||0
11246210|NCT02131064|12439060|FG000|STARTED|Overall Study||221
11246211|NCT02131064|12439061|FG001|STARTED|Overall Study||223
11246212|NCT02131064|12439060|FG000|COMPLETED|Overall Study||196
11246213|NCT02131064|12439061|FG001|COMPLETED|Overall Study||189
11246214|NCT02131064|12439060|FG000|NOT COMPLETED|Overall Study||25
11246215|NCT02131064|12439061|FG001|NOT COMPLETED|Overall Study||34
11246216|NCT02131129|12439070|FG000|STARTED|Overall Study||10
11246217|NCT02131129|12439071|FG001|STARTED|Overall Study||10
11246218|NCT02131129|12439070|FG000|COMPLETED|Overall Study||9
11246219|NCT02131129|12439071|FG001|COMPLETED|Overall Study||10
11246220|NCT02131129|12439070|FG000|NOT COMPLETED|Overall Study||1
11246221|NCT02131129|12439071|FG001|NOT COMPLETED|Overall Study||0
11246222|NCT02131233|12439079|FG000|STARTED|Overall Study|Enrolled participants|533
11246223|NCT02131233|12439080|FG001|STARTED|Overall Study|Enrolled participants|269
11246224|NCT02131233|12439079|FG000|Treated|Overall Study||531
11246225|NCT02131233|12439080|FG001|Treated|Overall Study||266
11246226|NCT02131233|12439079|FG000|COMPLETED|Overall Study|Completed to Week 96|467
11246227|NCT02131233|12439080|FG001|COMPLETED|Overall Study|Completed to Week 96|227
11246228|NCT02131233|12439079|FG000|NOT COMPLETED|Overall Study||66
11246229|NCT02131233|12439080|FG001|NOT COMPLETED|Overall Study||42
11246230|NCT02131259|12439086|FG000|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
11246231|NCT02131259|12439086|FG000|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
11246232|NCT02131259|12439086|FG000|NOT COMPLETED|Overall Study||1225
11246233|NCT02131272|12439092|FG000|STARTED|Overall Study||20
11246234|NCT02131272|12439093|FG001|STARTED|Overall Study||22
11246235|NCT02131272|12439092|FG000|COMPLETED|Overall Study||19
11246236|NCT02131272|12439093|FG001|COMPLETED|Overall Study||20
11246237|NCT02131272|12439092|FG000|NOT COMPLETED|Overall Study||1
11246238|NCT02131272|12439093|FG001|NOT COMPLETED|Overall Study||2
11246239|NCT02131311|12439099|FG000|STARTED|Overall Study||90
11246240|NCT02131311|12439099|FG000|COMPLETED|Overall Study||86
11246241|NCT02131311|12439099|FG000|NOT COMPLETED|Overall Study||4
11246242|NCT02131324|12439106|FG000|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
11246243|NCT02131324|12439107|FG001|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
11246244|NCT02131324|12439106|FG000|Analyzed|Overall Study||22
11246245|NCT02131324|12439107|FG001|Analyzed|Overall Study||24
11246246|NCT02131324|12439106|FG000|COMPLETED|Overall Study||22
11246247|NCT02131324|12439107|FG001|COMPLETED|Overall Study||23
11246248|NCT02131324|12439106|FG000|NOT COMPLETED|Overall Study||2
11246249|NCT02131324|12439107|FG001|NOT COMPLETED|Overall Study||3
11246250|NCT02131402|12439113|FG000|STARTED|Overall Study||60
11246251|NCT02131402|12439113|FG000|COMPLETED|Overall Study||60
11246252|NCT02131402|12439113|FG000|NOT COMPLETED|Overall Study||0
11246253|NCT02131532|12439176|FG000|STARTED|Overall Study||12
11246254|NCT02131532|12439176|FG000|COMPLETED|Overall Study||8
11246255|NCT02131532|12439176|FG000|NOT COMPLETED|Overall Study||4
11246256|NCT02131636|12439183|FG000|STARTED|Overall Study||222
11246257|NCT02131636|12439184|FG001|STARTED|Overall Study||218
11246258|NCT02131636|12439183|FG000|COMPLETED|Overall Study||210
11246259|NCT02131636|12439184|FG001|COMPLETED|Overall Study||213
11246260|NCT02131636|12439183|FG000|NOT COMPLETED|Overall Study||12
11246261|NCT02131636|12439184|FG001|NOT COMPLETED|Overall Study||5
11246262|NCT02131662|12439195|FG000|STARTED|Overall Study||62
11246263|NCT02131662|12439196|FG001|STARTED|Overall Study||61
11246264|NCT02131662|12439197|FG002|STARTED|Overall Study||63
11246265|NCT02131662|12439198|FG003|STARTED|Overall Study||62
11246266|NCT02131662|12439199|FG004|STARTED|Overall Study||61
11246267|NCT02131662|12439195|FG000|Treated|Overall Study||60
11246268|NCT02131662|12439196|FG001|Treated|Overall Study||61
11246269|NCT02131662|12439197|FG002|Treated|Overall Study||61
11246270|NCT02131662|12439198|FG003|Treated|Overall Study||60
11246271|NCT02131662|12439199|FG004|Treated|Overall Study||58
11246272|NCT02131662|12439195|FG000|Completed Treatment|Overall Study||57
11246273|NCT02131662|12439196|FG001|Completed Treatment|Overall Study||60
11246274|NCT02131662|12439197|FG002|Completed Treatment|Overall Study||61
11246275|NCT02131662|12439198|FG003|Completed Treatment|Overall Study||56
11246276|NCT02131662|12439199|FG004|Completed Treatment|Overall Study||52
11246277|NCT02131662|12439195|FG000|Completed Follow-up|Overall Study||54
11246278|NCT02131662|12439196|FG001|Completed Follow-up|Overall Study||47
11246279|NCT02131662|12439197|FG002|Completed Follow-up|Overall Study||56
11246280|NCT02131662|12439198|FG003|Completed Follow-up|Overall Study||42
11246281|NCT02131662|12439199|FG004|Completed Follow-up|Overall Study||44
11246282|NCT02131662|12439195|FG000|COMPLETED|Overall Study||54
11246283|NCT02131662|12439196|FG001|COMPLETED|Overall Study||47
11246284|NCT02131662|12439197|FG002|COMPLETED|Overall Study||56
11246285|NCT02131662|12439198|FG003|COMPLETED|Overall Study||41
11246286|NCT02131662|12439199|FG004|COMPLETED|Overall Study||43
11246287|NCT02131662|12439195|FG000|NOT COMPLETED|Overall Study||8
11246288|NCT02131662|12439196|FG001|NOT COMPLETED|Overall Study||14
11246289|NCT02131662|12439197|FG002|NOT COMPLETED|Overall Study||7
11246290|NCT02131662|12439198|FG003|NOT COMPLETED|Overall Study||21
11246291|NCT02131662|12439199|FG004|NOT COMPLETED|Overall Study||18
11246292|NCT02131766|12439215|FG000|STARTED|Overall Study||44
11246293|NCT02131766|12439215|FG000|COMPLETED|Overall Study||40
11246294|NCT02131766|12439215|FG000|NOT COMPLETED|Overall Study||4
11246295|NCT02132117|12439224|FG000|STARTED|Overall Study||224
11246296|NCT02132117|12439225|FG001|STARTED|Overall Study||221
11246297|NCT02132117|12439224|FG000|COMPLETED|Overall Study||213
11246298|NCT02132117|12439225|FG001|COMPLETED|Overall Study||216
11246299|NCT02132117|12439224|FG000|NOT COMPLETED|Overall Study||11
11246300|NCT02132117|12439225|FG001|NOT COMPLETED|Overall Study||5
11246301|NCT02132130|12439235|FG000|STARTED|Overall Study||3
11246302|NCT02132130|12439236|FG001|STARTED|Overall Study||12
11246303|NCT02132130|12439237|FG002|STARTED|Overall Study||4
11246304|NCT02132130|12439238|FG003|STARTED|Overall Study||3
11246305|NCT02132130|12439235|FG000|COMPLETED|Overall Study||3
11246306|NCT02132130|12439236|FG001|COMPLETED|Overall Study||10
11246307|NCT02132130|12439237|FG002|COMPLETED|Overall Study||4
11246308|NCT02132130|12439238|FG003|COMPLETED|Overall Study||2
11246309|NCT02132130|12439235|FG000|NOT COMPLETED|Overall Study||0
11246310|NCT02132130|12439236|FG001|NOT COMPLETED|Overall Study||2
11246311|NCT02132130|12439237|FG002|NOT COMPLETED|Overall Study||0
11246312|NCT02132130|12439238|FG003|NOT COMPLETED|Overall Study||1
11246313|NCT02132169|12439254|FG000|STARTED|Overall Study||341
11246314|NCT02132169|12439255|FG001|STARTED|Overall Study||171
11246315|NCT02132169|12439254|FG000|COMPLETED|Overall Study||326
11246316|NCT02132169|12439255|FG001|COMPLETED|Overall Study||162
11246317|NCT02132169|12439254|FG000|NOT COMPLETED|Overall Study||15
11246318|NCT02132169|12439255|FG001|NOT COMPLETED|Overall Study||9
11246319|NCT02132195|12439264|FG000|STARTED|Initial Assignment||15
11246320|NCT02132195|12439265|FG001|STARTED|Initial Assignment||16
11246321|NCT02132195|12439266|FG002|STARTED|Initial Assignment||0
11246322|NCT02132195|12439264|FG000|COMPLETED|Initial Assignment||1
11246323|NCT02132195|12439265|FG001|COMPLETED|Initial Assignment||16
11246324|NCT02132195|12439266|FG002|COMPLETED|Initial Assignment||0
11246325|NCT02132195|12439264|FG000|NOT COMPLETED|Initial Assignment||14
11246326|NCT02132195|12439265|FG001|NOT COMPLETED|Initial Assignment||0
11246327|NCT02132195|12439266|FG002|NOT COMPLETED|Initial Assignment||0
11246328|NCT02132195|12439264|FG000|STARTED|Rescue Therapy||0
11246329|NCT02132195|12439265|FG001|STARTED|Rescue Therapy||0
11246330|NCT02132195|12439266|FG002|STARTED|Rescue Therapy||13
11246331|NCT02132195|12439264|FG000|COMPLETED|Rescue Therapy||0
11246332|NCT02132195|12439265|FG001|COMPLETED|Rescue Therapy||0
11246333|NCT02132195|12439266|FG002|COMPLETED|Rescue Therapy||2
11246334|NCT02132195|12439264|FG000|NOT COMPLETED|Rescue Therapy||0
11246335|NCT02132195|12439265|FG001|NOT COMPLETED|Rescue Therapy||0
11246336|NCT02132195|12439266|FG002|NOT COMPLETED|Rescue Therapy||11
11246337|NCT02132247|12439276|FG000|STARTED|Overall Study||52
11246338|NCT02132247|12439277|FG001|STARTED|Overall Study||52
11246339|NCT02132247|12439276|FG000|COMPLETED|Overall Study||51
11246340|NCT02132247|12439277|FG001|COMPLETED|Overall Study||52
11246341|NCT02132247|12439276|FG000|NOT COMPLETED|Overall Study||1
11246342|NCT02132247|12439277|FG001|NOT COMPLETED|Overall Study||0
11246343|NCT02132312|12439285|FG000|STARTED|Overall Study||37
11246344|NCT02132312|12439286|FG001|STARTED|Overall Study||41
11246345|NCT02132312|12439285|FG000|COMPLETED|Overall Study||31
11246346|NCT02132312|12439286|FG001|COMPLETED|Overall Study||38
11246347|NCT02132312|12439285|FG000|NOT COMPLETED|Overall Study||6
11246348|NCT02132312|12439286|FG001|NOT COMPLETED|Overall Study||3
11246349|NCT02132468|12439292|FG000|STARTED|Overall Study||18
11246350|NCT02132468|12439292|FG000|COMPLETED|Overall Study||11
11246351|NCT02132468|12439292|FG000|NOT COMPLETED|Overall Study||7
11246352|NCT02132520|12439299|FG000|STARTED|Overall Study||0
11246353|NCT02132520|12439300|FG001|STARTED|Overall Study||1
11246354|NCT02132520|12439301|FG002|STARTED|Overall Study||2
11246355|NCT02132520|12439299|FG000|COMPLETED|Overall Study||0
11246356|NCT02132520|12439300|FG001|COMPLETED|Overall Study||1
11246357|NCT02132520|12439301|FG002|COMPLETED|Overall Study||2
11246358|NCT02132520|12439299|FG000|NOT COMPLETED|Overall Study||0
11246359|NCT02132520|12439300|FG001|NOT COMPLETED|Overall Study||0
11246360|NCT02132520|12439301|FG002|NOT COMPLETED|Overall Study||0
11246361|NCT02132533|12439310|FG000|STARTED|Overall Study||46
11246362|NCT02132533|12439311|FG001|STARTED|Overall Study||42
11246363|NCT02132533|12439310|FG000|COMPLETED|Overall Study||46
11246364|NCT02132533|12439311|FG001|COMPLETED|Overall Study||42
11246365|NCT02132533|12439310|FG000|NOT COMPLETED|Overall Study||0
11246366|NCT02132533|12439311|FG001|NOT COMPLETED|Overall Study||0
11246367|NCT02132572|12439317|FG000|STARTED|Overall Study||201
11246368|NCT02132572|12439317|FG000|COMPLETED|Overall Study||201
11246369|NCT02132572|12439317|FG000|NOT COMPLETED|Overall Study||0
11246370|NCT02132598|12439321|FG000|STARTED|Overall Study||5
11246371|NCT02132598|12439321|FG000|COMPLETED|Overall Study||5
11246372|NCT02132598|12439321|FG000|NOT COMPLETED|Overall Study||0
11246373|NCT02132637|12439327|FG000|STARTED|Study Period 1||34
11246374|NCT02132637|12439328|FG001|STARTED|Study Period 1||34
11246375|NCT02132637|12439327|FG000|Received at Least One Dose of Study Drug|Study Period 1||34
11246376|NCT02132637|12439328|FG001|Received at Least One Dose of Study Drug|Study Period 1||34
11246377|NCT02132637|12439327|FG000|COMPLETED|Study Period 1||33
11246378|NCT02132637|12439328|FG001|COMPLETED|Study Period 1||30
11246379|NCT02132637|12439327|FG000|NOT COMPLETED|Study Period 1||1
11246380|NCT02132637|12439328|FG001|NOT COMPLETED|Study Period 1||4
11246381|NCT02132637|12439327|FG000|STARTED|Study Period 2 (Crossover)||33
11246382|NCT02132637|12439328|FG001|STARTED|Study Period 2 (Crossover)||30
11246383|NCT02132637|12439327|FG000|COMPLETED|Study Period 2 (Crossover)||31
11246384|NCT02132637|12439328|FG001|COMPLETED|Study Period 2 (Crossover)||29
11246385|NCT02132637|12439327|FG000|NOT COMPLETED|Study Period 2 (Crossover)||2
11246386|NCT02132637|12439328|FG001|NOT COMPLETED|Study Period 2 (Crossover)||1
11246387|NCT02132676|12439336|FG000|STARTED|Overall Study||727
11246388|NCT02132676|12439337|FG001|STARTED|Overall Study||809
11246389|NCT02132676|12439336|FG000|COMPLETED|Overall Study||727
11246390|NCT02132676|12439337|FG001|COMPLETED|Overall Study||809
11246391|NCT02132676|12439336|FG000|NOT COMPLETED|Overall Study||0
11246392|NCT02132676|12439337|FG001|NOT COMPLETED|Overall Study||0
11246393|NCT02132754|12439378|FG000|STARTED|Overall Study||1
11246394|NCT02132754|12439379|FG001|STARTED|Overall Study||1
11246395|NCT02132754|12439380|FG002|STARTED|Overall Study||1
11246396|NCT02132754|12439381|FG003|STARTED|Overall Study||1
11246397|NCT02132754|12439382|FG004|STARTED|Overall Study||1
11246398|NCT02132754|12439383|FG005|STARTED|Overall Study||1
11246399|NCT02132754|12439384|FG006|STARTED|Overall Study||1
11246400|NCT02132754|12439385|FG007|STARTED|Overall Study||1
11246401|NCT02132754|12439386|FG008|STARTED|Overall Study||1
11246402|NCT02132754|12439387|FG009|STARTED|Overall Study||6
11246403|NCT02132754|12439388|FG010|STARTED|Overall Study||3
11246404|NCT02132754|12439389|FG011|STARTED|Overall Study||3
11246405|NCT02132754|12439390|FG012|STARTED|Overall Study||4
11246406|NCT02132754|12439391|FG013|STARTED|Overall Study||3
11246407|NCT02132754|12439392|FG014|STARTED|Overall Study||3
11246408|NCT02132754|12439393|FG015|STARTED|Overall Study||5
11246409|NCT02132754|12439394|FG016|STARTED|Overall Study||4
11246410|NCT02132754|12439395|FG017|STARTED|Overall Study||3
11246411|NCT02132754|12439396|FG018|STARTED|Overall Study||3
11246412|NCT02132754|12439397|FG019|STARTED|Overall Study||4
11246413|NCT02132754|12439398|FG020|STARTED|Overall Study||3
11246414|NCT02132754|12439399|FG021|STARTED|Overall Study||5
11246415|NCT02132754|12439400|FG022|STARTED|Overall Study||3
11246416|NCT02132754|12439401|FG023|STARTED|Overall Study||3
11246417|NCT02132754|12439402|FG024|STARTED|Overall Study||3
11246418|NCT02132754|12439403|FG025|STARTED|Overall Study||3
11246419|NCT02132754|12439404|FG026|STARTED|Overall Study||4
11246420|NCT02132754|12439405|FG027|STARTED|Overall Study||3
11246421|NCT02132754|12439406|FG028|STARTED|Overall Study||3
11246422|NCT02132754|12439407|FG029|STARTED|Overall Study||3
11246423|NCT02132754|12439408|FG030|STARTED|Overall Study||3
11246424|NCT02132754|12439409|FG031|STARTED|Overall Study||3
11246425|NCT02132754|12439410|FG032|STARTED|Overall Study||4
11246426|NCT02132754|12439411|FG033|STARTED|Overall Study||23
11246427|NCT02132754|12439378|FG000|Treated|Overall Study||1
11246428|NCT02132754|12439379|FG001|Treated|Overall Study||1
11246429|NCT02132754|12439380|FG002|Treated|Overall Study||1
11246430|NCT02132754|12439381|FG003|Treated|Overall Study||1
11246431|NCT02132754|12439382|FG004|Treated|Overall Study||1
11246432|NCT02132754|12439383|FG005|Treated|Overall Study||1
11246433|NCT02132754|12439384|FG006|Treated|Overall Study||1
11246434|NCT02132754|12439385|FG007|Treated|Overall Study||1
11246435|NCT02132754|12439386|FG008|Treated|Overall Study||1
11246436|NCT02132754|12439387|FG009|Treated|Overall Study||6
11246437|NCT02132754|12439388|FG010|Treated|Overall Study||3
11246438|NCT02132754|12439389|FG011|Treated|Overall Study||3
11246439|NCT02132754|12439390|FG012|Treated|Overall Study||3
11246440|NCT02132754|12439391|FG013|Treated|Overall Study||3
11246441|NCT02132754|12439392|FG014|Treated|Overall Study||3
11246442|NCT02132754|12439393|FG015|Treated|Overall Study||5
11246443|NCT02132754|12439394|FG016|Treated|Overall Study||4
11246444|NCT02132754|12439395|FG017|Treated|Overall Study||3
11246445|NCT02132754|12439396|FG018|Treated|Overall Study||3
11246446|NCT02132754|12439397|FG019|Treated|Overall Study||3
11246447|NCT02132754|12439398|FG020|Treated|Overall Study||3
11246448|NCT02132754|12439399|FG021|Treated|Overall Study||4
11246449|NCT02132754|12439400|FG022|Treated|Overall Study||3
11246450|NCT02132754|12439401|FG023|Treated|Overall Study||3
11246451|NCT02132754|12439402|FG024|Treated|Overall Study||3
11246452|NCT02132754|12439403|FG025|Treated|Overall Study||3
11246453|NCT02132754|12439404|FG026|Treated|Overall Study||4
11246454|NCT02132754|12439405|FG027|Treated|Overall Study||3
11246455|NCT02132754|12439406|FG028|Treated|Overall Study||3
11246456|NCT02132754|12439407|FG029|Treated|Overall Study||3
11246457|NCT02132754|12439408|FG030|Treated|Overall Study||3
11246458|NCT02132754|12439409|FG031|Treated|Overall Study||3
11246459|NCT02132754|12439410|FG032|Treated|Overall Study||4
11246460|NCT02132754|12439411|FG033|Treated|Overall Study||23
11246461|NCT02132754|12439378|FG000|COMPLETED|Overall Study||0
11246462|NCT02132754|12439379|FG001|COMPLETED|Overall Study||0
11246463|NCT02132754|12439380|FG002|COMPLETED|Overall Study||0
11246464|NCT02132754|12439381|FG003|COMPLETED|Overall Study||0
11246465|NCT02132754|12439382|FG004|COMPLETED|Overall Study||0
11246466|NCT02132754|12439383|FG005|COMPLETED|Overall Study||0
11246467|NCT02132754|12439384|FG006|COMPLETED|Overall Study||0
11246468|NCT02132754|12439385|FG007|COMPLETED|Overall Study||0
11246469|NCT02132754|12439386|FG008|COMPLETED|Overall Study||0
11246470|NCT02132754|12439387|FG009|COMPLETED|Overall Study||0
11246471|NCT02132754|12439388|FG010|COMPLETED|Overall Study||0
11246472|NCT02132754|12439389|FG011|COMPLETED|Overall Study||0
11246473|NCT02132754|12439390|FG012|COMPLETED|Overall Study||0
11246474|NCT02132754|12439391|FG013|COMPLETED|Overall Study||0
11246475|NCT02132754|12439392|FG014|COMPLETED|Overall Study||0
11246476|NCT02132754|12439393|FG015|COMPLETED|Overall Study||0
11246477|NCT02132754|12439394|FG016|COMPLETED|Overall Study||0
11246478|NCT02132754|12439395|FG017|COMPLETED|Overall Study||0
11246479|NCT02132754|12439396|FG018|COMPLETED|Overall Study||0
11246480|NCT02132754|12439397|FG019|COMPLETED|Overall Study||0
11246481|NCT02132754|12439398|FG020|COMPLETED|Overall Study||0
11246482|NCT02132754|12439399|FG021|COMPLETED|Overall Study||0
11246483|NCT02132754|12439400|FG022|COMPLETED|Overall Study||0
11246484|NCT02132754|12439401|FG023|COMPLETED|Overall Study||0
11246485|NCT02132754|12439402|FG024|COMPLETED|Overall Study||0
11246486|NCT02132754|12439403|FG025|COMPLETED|Overall Study||0
11246487|NCT02132754|12439404|FG026|COMPLETED|Overall Study||0
11246488|NCT02132754|12439405|FG027|COMPLETED|Overall Study||0
11246489|NCT02132754|12439406|FG028|COMPLETED|Overall Study||0
11246490|NCT02132754|12439407|FG029|COMPLETED|Overall Study||0
11246491|NCT02132754|12439408|FG030|COMPLETED|Overall Study||0
11246492|NCT02132754|12439409|FG031|COMPLETED|Overall Study||0
11246493|NCT02132754|12439410|FG032|COMPLETED|Overall Study||0
11246494|NCT02132754|12439411|FG033|COMPLETED|Overall Study||0
11246495|NCT02132754|12439378|FG000|NOT COMPLETED|Overall Study||1
11246496|NCT02132754|12439379|FG001|NOT COMPLETED|Overall Study||1
11246497|NCT02132754|12439380|FG002|NOT COMPLETED|Overall Study||1
11246498|NCT02132754|12439381|FG003|NOT COMPLETED|Overall Study||1
11246499|NCT02132754|12439382|FG004|NOT COMPLETED|Overall Study||1
11246500|NCT02132754|12439383|FG005|NOT COMPLETED|Overall Study||1
11246501|NCT02132754|12439384|FG006|NOT COMPLETED|Overall Study||1
11246502|NCT02132754|12439385|FG007|NOT COMPLETED|Overall Study||1
11246503|NCT02132754|12439386|FG008|NOT COMPLETED|Overall Study||1
11246504|NCT02132754|12439387|FG009|NOT COMPLETED|Overall Study||6
11246505|NCT02132754|12439388|FG010|NOT COMPLETED|Overall Study||3
11246506|NCT02132754|12439389|FG011|NOT COMPLETED|Overall Study||3
11246507|NCT02132754|12439390|FG012|NOT COMPLETED|Overall Study||4
11246508|NCT02132754|12439391|FG013|NOT COMPLETED|Overall Study||3
11246509|NCT02132754|12439392|FG014|NOT COMPLETED|Overall Study||3
11246510|NCT02132754|12439393|FG015|NOT COMPLETED|Overall Study||5
11246511|NCT02132754|12439394|FG016|NOT COMPLETED|Overall Study||4
11246512|NCT02132754|12439395|FG017|NOT COMPLETED|Overall Study||3
11246513|NCT02132754|12439396|FG018|NOT COMPLETED|Overall Study||3
11246514|NCT02132754|12439397|FG019|NOT COMPLETED|Overall Study||4
11246515|NCT02132754|12439398|FG020|NOT COMPLETED|Overall Study||3
11246516|NCT02132754|12439399|FG021|NOT COMPLETED|Overall Study||5
11246517|NCT02132754|12439400|FG022|NOT COMPLETED|Overall Study||3
11246518|NCT02132754|12439401|FG023|NOT COMPLETED|Overall Study||3
11246519|NCT02132754|12439402|FG024|NOT COMPLETED|Overall Study||3
11246520|NCT02132754|12439403|FG025|NOT COMPLETED|Overall Study||3
11246521|NCT02132754|12439404|FG026|NOT COMPLETED|Overall Study||4
11246522|NCT02132754|12439405|FG027|NOT COMPLETED|Overall Study||3
11246523|NCT02132754|12439406|FG028|NOT COMPLETED|Overall Study||3
11246524|NCT02132754|12439407|FG029|NOT COMPLETED|Overall Study||3
11246525|NCT02132754|12439408|FG030|NOT COMPLETED|Overall Study||3
11246526|NCT02132754|12439409|FG031|NOT COMPLETED|Overall Study||3
11246527|NCT02132754|12439410|FG032|NOT COMPLETED|Overall Study||4
11246528|NCT02132754|12439411|FG033|NOT COMPLETED|Overall Study||23
11246529|NCT02132767|12439523|FG000|STARTED|Overall Study||262
11246530|NCT02132767|12439524|FG001|STARTED|Overall Study||261
11246531|NCT02132767|12439523|FG000|COMPLETED|Overall Study||245
11246532|NCT02132767|12439524|FG001|COMPLETED|Overall Study||246
11246533|NCT02132767|12439523|FG000|NOT COMPLETED|Overall Study||17
11246534|NCT02132767|12439524|FG001|NOT COMPLETED|Overall Study||15
11246535|NCT02132832|12439532|FG000|STARTED|Overall Study||19
11246536|NCT02132832|12439533|FG001|STARTED|Overall Study||23
11246537|NCT02132832|12439532|FG000|COMPLETED|Overall Study||16
11246538|NCT02132832|12439533|FG001|COMPLETED|Overall Study||16
11246539|NCT02132832|12439532|FG000|NOT COMPLETED|Overall Study||3
11246540|NCT02132832|12439533|FG001|NOT COMPLETED|Overall Study||7
11246541|NCT02132910|12439541|FG000|STARTED|Overall Study||34
11246542|NCT02132910|12439542|FG001|STARTED|Overall Study||34
11246543|NCT02132910|12439541|FG000|COMPLETED|Overall Study||34
11246544|NCT02132910|12439542|FG001|COMPLETED|Overall Study||34
11246545|NCT02132910|12439541|FG000|NOT COMPLETED|Overall Study||0
11246546|NCT02132910|12439542|FG001|NOT COMPLETED|Overall Study||0
11246547|NCT02132936|12439552|FG000|STARTED|Overall Study||185
11246548|NCT02132936|12439553|FG001|STARTED|Overall Study||47
11246549|NCT02132936|12439554|FG002|STARTED|Overall Study||188
11246550|NCT02132936|12439555|FG003|STARTED|Overall Study||43
11246551|NCT02132936|12439552|FG000|COMPLETED|Overall Study||175
11246552|NCT02132936|12439553|FG001|COMPLETED|Overall Study||38
11246553|NCT02132936|12439554|FG002|COMPLETED|Overall Study||174
11246554|NCT02132936|12439555|FG003|COMPLETED|Overall Study||29
11246555|NCT02132936|12439552|FG000|NOT COMPLETED|Overall Study||10
11246556|NCT02132936|12439553|FG001|NOT COMPLETED|Overall Study||9
11246557|NCT02132936|12439554|FG002|NOT COMPLETED|Overall Study||14
11246558|NCT02132936|12439555|FG003|NOT COMPLETED|Overall Study||14
11246559|NCT02132949|12439568|FG000|STARTED|Overall Study||199
11246560|NCT02132949|12439569|FG001|STARTED|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort B for efficacy).|201
11246561|NCT02132949|12439568|FG000|Received Any Cohort A Study Treatment|Overall Study|1 participant withdrew prior to receiving any study drug.|198
11246562|NCT02132949|12439569|FG001|Received Any Cohort A Study Treatment|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort A for safety).|1
11246563|NCT02132949|12439568|FG000|Received Any Cohort B Study Treatment|Overall Study||0
11246564|NCT02132949|12439569|FG001|Received Any Cohort B Study Treatment|Overall Study|2 participants withdrew prior to receiving any study drug.|198
11246565|NCT02132949|12439568|FG000|Underwent Surgery|Overall Study||187
11246566|NCT02132949|12439569|FG001|Underwent Surgery|Overall Study||194
11246567|NCT02132949|12439568|FG000|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||182
11246568|NCT02132949|12439569|FG001|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||189
11246569|NCT02132949|12439568|FG000|Started Adjuvant Treatment|Overall Study||181
11246570|NCT02132949|12439569|FG001|Started Adjuvant Treatment|Overall Study|1 participant did not complete neoadjuvant treatment but started adjuvant treatment.|190
11246571|NCT02132949|12439568|FG000|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||163
11246572|NCT02132949|12439569|FG001|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||176
11246573|NCT02132949|12439568|FG000|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195
11246574|NCT02132949|12439569|FG001|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195
11246575|NCT02132949|12439568|FG000|COMPLETED|Overall Study||158
11246576|NCT02132949|12439569|FG001|COMPLETED|Overall Study||173
11246577|NCT02132949|12439568|FG000|NOT COMPLETED|Overall Study||41
11246578|NCT02132949|12439569|FG001|NOT COMPLETED|Overall Study||28
11246579|NCT02133001|12439577|FG000|STARTED|Double Blind (Day 1-25)||32
11246580|NCT02133001|12439578|FG001|STARTED|Double Blind (Day 1-25)||36
11246581|NCT02133001|12439577|FG000|Safety|Double Blind (Day 1-25)||31
11246582|NCT02133001|12439578|FG001|Safety|Double Blind (Day 1-25)||35
11246583|NCT02133001|12439577|FG000|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22
11246584|NCT02133001|12439578|FG001|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27
11246585|NCT02133001|12439577|FG000|NOT COMPLETED|Double Blind (Day 1-25)||10
11246586|NCT02133001|12439578|FG001|NOT COMPLETED|Double Blind (Day 1-25)||9
11246587|NCT02133001|12439577|FG000|STARTED|Follow-Up Phase (Day 26-81)||22
11246588|NCT02133001|12439578|FG001|STARTED|Follow-Up Phase (Day 26-81)||27
11246589|NCT02133001|12439577|FG000|COMPLETED|Follow-Up Phase (Day 26-81)||20
11246590|NCT02133001|12439578|FG001|COMPLETED|Follow-Up Phase (Day 26-81)||24
11246591|NCT02133001|12439577|FG000|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2
11246592|NCT02133001|12439578|FG001|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3
11246593|NCT02133066|12439588|FG000|STARTED|Overall Study||64
11246594|NCT02133066|12439589|FG001|STARTED|Overall Study||64
11246595|NCT02133066|12439588|FG000|COMPLETED|Overall Study||64
11246596|NCT02133066|12439589|FG001|COMPLETED|Overall Study||64
11246597|NCT02133066|12439588|FG000|NOT COMPLETED|Overall Study||0
11246598|NCT02133066|12439589|FG001|NOT COMPLETED|Overall Study||0
11246599|NCT02133131|12439602|FG000|STARTED|Overall Study||31
11246600|NCT02133131|12439603|FG001|STARTED|Overall Study||30
11246601|NCT02133131|12439604|FG002|STARTED|Overall Study||20
11246602|NCT02133131|12439605|FG003|STARTED|Overall Study||21
11246603|NCT02133131|12439606|FG004|STARTED|Overall Study||15
11246604|NCT02133131|12439607|FG005|STARTED|Overall Study||14
11246605|NCT02133131|12439608|FG006|STARTED|Overall Study||12
11246606|NCT02133131|12439602|FG000|COMPLETED|Overall Study||26
11246607|NCT02133131|12439603|FG001|COMPLETED|Overall Study||25
11246608|NCT02133131|12439604|FG002|COMPLETED|Overall Study||19
11246609|NCT02133131|12439605|FG003|COMPLETED|Overall Study||15
11246610|NCT02133131|12439606|FG004|COMPLETED|Overall Study||0
11246611|NCT02133131|12439607|FG005|COMPLETED|Overall Study||0
11246612|NCT02133131|12439608|FG006|COMPLETED|Overall Study||0
11246613|NCT02133131|12439602|FG000|NOT COMPLETED|Overall Study||5
11246614|NCT02133131|12439603|FG001|NOT COMPLETED|Overall Study||5
11246615|NCT02133131|12439604|FG002|NOT COMPLETED|Overall Study||1
11246616|NCT02133131|12439605|FG003|NOT COMPLETED|Overall Study||6
11246617|NCT02133131|12439606|FG004|NOT COMPLETED|Overall Study||15
11246618|NCT02133131|12439607|FG005|NOT COMPLETED|Overall Study||14
11246619|NCT02133131|12439608|FG006|NOT COMPLETED|Overall Study||12
11246620|NCT02133235|12439626|FG000|STARTED|Overall Study||55
11246621|NCT02133235|12439627|FG001|STARTED|Overall Study||57
11246622|NCT02133235|12439626|FG000|COMPLETED|Overall Study||55
11246623|NCT02133235|12439627|FG001|COMPLETED|Overall Study||57
11246624|NCT02133235|12439626|FG000|NOT COMPLETED|Overall Study||0
11246625|NCT02133235|12439627|FG001|NOT COMPLETED|Overall Study||0
11246626|NCT02133352|12439639|FG000|STARTED|Main Study (180 Day)||10
11246627|NCT02133352|12439639|FG000|COMPLETED|Main Study (180 Day)||10
11246628|NCT02133352|12439639|FG000|NOT COMPLETED|Main Study (180 Day)||0
11246629|NCT02133352|12439639|FG000|STARTED|Longer Term Extension||10
11246630|NCT02133352|12439639|FG000|COMPLETED|Longer Term Extension||4
11246631|NCT02133352|12439639|FG000|NOT COMPLETED|Longer Term Extension||6
11246632|NCT02133508|12439643|FG000|STARTED|Overall Study||156
11246633|NCT02133508|12439643|FG000|COMPLETED|Overall Study||141
11246634|NCT02133508|12439643|FG000|NOT COMPLETED|Overall Study||15
11246635|NCT02133664|12439649|FG000|STARTED|Overall Study||26
11246636|NCT02133664|12439650|FG001|STARTED|Overall Study||28
11246637|NCT02133664|12439649|FG000|COMPLETED|Overall Study||21
11246638|NCT02133664|12439650|FG001|COMPLETED|Overall Study||21
11246639|NCT02133664|12439649|FG000|NOT COMPLETED|Overall Study||5
11246640|NCT02133664|12439650|FG001|NOT COMPLETED|Overall Study||7
11246641|NCT02133742|12439656|FG000|STARTED|Period 1: Dose Finding Phase (6 Months)||11
11246642|NCT02133742|12439656|FG000|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11
11246643|NCT02133742|12439656|FG000|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0
11246644|NCT02133742|12439656|FG000|STARTED|Period 2:Dose Expansion Phase (1344days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52
11246645|NCT02133742|12439656|FG000|COMPLETED|Period 2:Dose Expansion Phase (1344days)||0
11246646|NCT02133742|12439656|FG000|NOT COMPLETED|Period 2:Dose Expansion Phase (1344days)||52
11246647|NCT02133781|12439665|FG000|STARTED|Overall Study||6
11246648|NCT02133781|12439666|FG001|STARTED|Overall Study||24
11246649|NCT02133781|12439667|FG002|STARTED|Overall Study||21
11246650|NCT02133781|12439665|FG000|COMPLETED|Overall Study||6
11246651|NCT02133781|12439666|FG001|COMPLETED|Overall Study||24
11246652|NCT02133781|12439667|FG002|COMPLETED|Overall Study||21
11246653|NCT02133781|12439665|FG000|NOT COMPLETED|Overall Study||0
11246654|NCT02133781|12439666|FG001|NOT COMPLETED|Overall Study||0
11246655|NCT02133781|12439667|FG002|NOT COMPLETED|Overall Study||0
11246656|NCT02134015|12439677|FG000|STARTED|Overall Study||71
11246657|NCT02134015|12439678|FG001|STARTED|Overall Study||74
11246658|NCT02134015|12439677|FG000|COMPLETED|Overall Study||0
11246659|NCT02134015|12439678|FG001|COMPLETED|Overall Study||0
11246660|NCT02134015|12439677|FG000|NOT COMPLETED|Overall Study||71
11246661|NCT02134015|12439678|FG001|NOT COMPLETED|Overall Study||74
11246662|NCT02134119|12439686|FG000|STARTED|Overall Study||30
11246663|NCT02134119|12439687|FG001|STARTED|Overall Study||15
11246664|NCT02134119|12439686|FG000|COMPLETED|Overall Study||30
11246665|NCT02134119|12439687|FG001|COMPLETED|Overall Study||15
11246666|NCT02134119|12439686|FG000|NOT COMPLETED|Overall Study||0
11246667|NCT02134119|12439687|FG001|NOT COMPLETED|Overall Study||0
11246668|NCT02134184|12439696|FG000|STARTED|Overall Study||33
11246669|NCT02134184|12439697|FG001|STARTED|Overall Study||37
11246670|NCT02134184|12439698|FG002|STARTED|Overall Study||8
11246671|NCT02134184|12439696|FG000|COMPLETED|Overall Study||33
11246672|NCT02134184|12439697|FG001|COMPLETED|Overall Study||37
11246673|NCT02134184|12439698|FG002|COMPLETED|Overall Study||8
11246674|NCT02134184|12439696|FG000|NOT COMPLETED|Overall Study||0
11246675|NCT02134184|12439697|FG001|NOT COMPLETED|Overall Study||0
11246676|NCT02134184|12439698|FG002|NOT COMPLETED|Overall Study||0
11246677|NCT02134210|12439708|FG000|STARTED|Part One: Weeks 0-12||260
11246678|NCT02134210|12439709|FG001|STARTED|Part One: Weeks 0-12||261
11246679|NCT02134210|12439708|FG000|COMPLETED|Part One: Weeks 0-12||241
11246680|NCT02134210|12439709|FG001|COMPLETED|Part One: Weeks 0-12||255
11246681|NCT02134210|12439708|FG000|NOT COMPLETED|Part One: Weeks 0-12||19
11246682|NCT02134210|12439709|FG001|NOT COMPLETED|Part One: Weeks 0-12||6
11246683|NCT02134210|12439708|FG000|STARTED|Part Two: Weeks 13-48||241
11246684|NCT02134210|12439709|FG001|STARTED|Part Two: Weeks 13-48||255
11246685|NCT02134210|12439708|FG000|COMPLETED|Part Two: Weeks 13-48||211
11246686|NCT02134210|12439709|FG001|COMPLETED|Part Two: Weeks 13-48||227
11246687|NCT02134210|12439708|FG000|NOT COMPLETED|Part Two: Weeks 13-48||30
11246688|NCT02134210|12439709|FG001|NOT COMPLETED|Part Two: Weeks 13-48||28
11246689|NCT02134314|12439717|FG000|STARTED|Overall Study||35
11246690|NCT02134314|12439718|FG001|STARTED|Overall Study||35
11246691|NCT02134314|12439717|FG000|COMPLETED|Overall Study||34
11246692|NCT02134314|12439718|FG001|COMPLETED|Overall Study||34
11246693|NCT02134314|12439717|FG000|NOT COMPLETED|Overall Study||1
11246694|NCT02134314|12439718|FG001|NOT COMPLETED|Overall Study||1
11246695|NCT02134353|12439727|FG000|STARTED|Overall Study||209
11246696|NCT02134353|12439728|FG001|STARTED|Overall Study||214
11246697|NCT02134353|12439727|FG000|COMPLETED|Overall Study||183
11246698|NCT02134353|12439728|FG001|COMPLETED|Overall Study||190
11246699|NCT02134353|12439727|FG000|NOT COMPLETED|Overall Study||26
11246700|NCT02134353|12439728|FG001|NOT COMPLETED|Overall Study||24
11246701|NCT02134522|12439734|FG000|STARTED|Overall Study||1
11246702|NCT02134522|12439734|FG000|COMPLETED|Overall Study||1
11246703|NCT02134522|12439734|FG000|NOT COMPLETED|Overall Study||0
11246704|NCT02134587|12439738|FG000|STARTED|Overall Study||203
11246705|NCT02134587|12439738|FG000|COMPLETED|Overall Study||173
11246706|NCT02134587|12439738|FG000|NOT COMPLETED|Overall Study||30
11246707|NCT02134756|12439749|FG000|STARTED|Overall Study||15
11246708|NCT02134756|12439750|FG001|STARTED|Overall Study||15
11246709|NCT02134756|12439749|FG000|COMPLETED|Overall Study||14
11246710|NCT02134756|12439750|FG001|COMPLETED|Overall Study||13
11246711|NCT02134756|12439749|FG000|NOT COMPLETED|Overall Study||1
11246712|NCT02134756|12439750|FG001|NOT COMPLETED|Overall Study||2
11246713|NCT02134951|12439758|FG000|STARTED|Overall Study||39
11246714|NCT02134951|12439759|FG001|STARTED|Overall Study||20
11246715|NCT02134951|12439758|FG000|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
11246716|NCT02134951|12439759|FG001|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
11246717|NCT02134951|12439758|FG000|NOT COMPLETED|Overall Study||0
11246718|NCT02134951|12439759|FG001|NOT COMPLETED|Overall Study||0
11246719|NCT02134977|12439765|FG000|STARTED|Overall Study||2816
11246720|NCT02134977|12439765|FG000|COMPLETED|Overall Study||2714
11246721|NCT02134977|12439765|FG000|NOT COMPLETED|Overall Study||102
11246722|NCT02135016|12439772|FG000|STARTED|Overall Study||15
11246723|NCT02135016|12439773|FG001|STARTED|Overall Study||15
11246724|NCT02135016|12439774|FG002|STARTED|Overall Study||15
11246725|NCT02135016|12439772|FG000|COMPLETED|Overall Study||15
11246726|NCT02135016|12439773|FG001|COMPLETED|Overall Study||15
11246727|NCT02135016|12439774|FG002|COMPLETED|Overall Study||15
11246728|NCT02135016|12439772|FG000|NOT COMPLETED|Overall Study||0
11246729|NCT02135016|12439773|FG001|NOT COMPLETED|Overall Study||0
11246730|NCT02135016|12439774|FG002|NOT COMPLETED|Overall Study||0
11246731|NCT02135094|12439784|FG000|STARTED|Overall Study||25
11246732|NCT02135094|12439785|FG001|STARTED|Overall Study||8
11246733|NCT02135094|12439784|FG000|Week 2|Overall Study||25
11246734|NCT02135094|12439785|FG001|Week 2|Overall Study||8
11246735|NCT02135094|12439784|FG000|Week 3|Overall Study||25
11246736|NCT02135094|12439785|FG001|Week 3|Overall Study||8
11246737|NCT02135094|12439784|FG000|Week 4|Overall Study||25
11246738|NCT02135094|12439785|FG001|Week 4|Overall Study||8
11246739|NCT02135094|12439784|FG000|COMPLETED|Overall Study||25
11246740|NCT02135094|12439785|FG001|COMPLETED|Overall Study||8
11246741|NCT02135094|12439784|FG000|NOT COMPLETED|Overall Study||0
11246742|NCT02135094|12439785|FG001|NOT COMPLETED|Overall Study||0
11246743|NCT02135107|12439793|FG000|STARTED|Treatment Period||437
11246744|NCT02135107|12439794|FG001|STARTED|Treatment Period||80
11246745|NCT02135107|12439795|FG002|STARTED|Treatment Period||0
11246746|NCT02135107|12439796|FG003|STARTED|Treatment Period||0
11246747|NCT02135107|12439793|FG000|COMPLETED|Treatment Period||305
11246748|NCT02135107|12439794|FG001|COMPLETED|Treatment Period||54
11246749|NCT02135107|12439795|FG002|COMPLETED|Treatment Period||0
11246750|NCT02135107|12439796|FG003|COMPLETED|Treatment Period||0
11246751|NCT02135107|12439793|FG000|NOT COMPLETED|Treatment Period||132
11246752|NCT02135107|12439794|FG001|NOT COMPLETED|Treatment Period||26
11246753|NCT02135107|12439795|FG002|NOT COMPLETED|Treatment Period||0
11246754|NCT02135107|12439796|FG003|NOT COMPLETED|Treatment Period||0
11246755|NCT02135107|12439793|FG000|STARTED|Maintenance Therapy Period|Treatment Phase only|0
11246756|NCT02135107|12439794|FG001|STARTED|Maintenance Therapy Period|Treatment Phase only|0
11246757|NCT02135107|12439795|FG002|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
11246758|NCT02135107|12439796|FG003|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
11246759|NCT02135107|12439793|FG000|COMPLETED|Maintenance Therapy Period||0
11246760|NCT02135107|12439794|FG001|COMPLETED|Maintenance Therapy Period||0
11246761|NCT02135107|12439795|FG002|COMPLETED|Maintenance Therapy Period||163
11246762|NCT02135107|12439796|FG003|COMPLETED|Maintenance Therapy Period||161
11246763|NCT02135107|12439793|FG000|NOT COMPLETED|Maintenance Therapy Period||0
11246764|NCT02135107|12439794|FG001|NOT COMPLETED|Maintenance Therapy Period||0
11246765|NCT02135107|12439795|FG002|NOT COMPLETED|Maintenance Therapy Period||15
11246766|NCT02135107|12439796|FG003|NOT COMPLETED|Maintenance Therapy Period||20
11339234|NCT02911116|12536705|FG000|STARTED|Overall Study||5
11339235|NCT02911116|12536706|FG001|STARTED|Overall Study||3
11339236|NCT02911116|12536705|FG000|COMPLETED|Overall Study||4
11339237|NCT02911116|12536706|FG001|COMPLETED|Overall Study||2
11339238|NCT02911116|12536705|FG000|NOT COMPLETED|Overall Study||1
11339239|NCT02911116|12536706|FG001|NOT COMPLETED|Overall Study||1
11339240|NCT02911285|12536714|FG000|STARTED|Overall Study||49
11339241|NCT02911285|12536715|FG001|STARTED|Overall Study||41
11339242|NCT02911285|12536714|FG000|COMPLETED|Overall Study||40
11339243|NCT02911285|12536715|FG001|COMPLETED|Overall Study||36
11339244|NCT02911285|12536714|FG000|NOT COMPLETED|Overall Study||9
11339245|NCT02911285|12536715|FG001|NOT COMPLETED|Overall Study||5
11339246|NCT02911324|12536727|FG000|STARTED|Overall Study||9
11339247|NCT02911324|12536728|FG001|STARTED|Overall Study||7
11339248|NCT02911324|12536727|FG000|COMPLETED|Overall Study||6
11339249|NCT02911324|12536728|FG001|COMPLETED|Overall Study||6
11339250|NCT02911324|12536727|FG000|NOT COMPLETED|Overall Study||3
11339251|NCT02911324|12536728|FG001|NOT COMPLETED|Overall Study||1
11339252|NCT02911519|12536737|FG000|STARTED|Overall Study||90
11339253|NCT02911519|12536738|FG001|STARTED|Overall Study||86
11339254|NCT02911519|12536737|FG000|COMPLETED|Overall Study||88
11339255|NCT02911519|12536738|FG001|COMPLETED|Overall Study||82
11339256|NCT02911519|12536737|FG000|NOT COMPLETED|Overall Study||2
11339257|NCT02911519|12536738|FG001|NOT COMPLETED|Overall Study||4
11339258|NCT02911688|12536746|FG000|STARTED|First Intervention||9
11339259|NCT02911688|12536747|FG001|STARTED|First Intervention||9
11339260|NCT02911688|12536746|FG000|Received Intervention|First Intervention||9
11339261|NCT02911688|12536747|FG001|Received Intervention|First Intervention||9
11339262|NCT02911688|12536746|FG000|COMPLETED|First Intervention||9
11339263|NCT02911688|12536747|FG001|COMPLETED|First Intervention||9
11339264|NCT02911688|12536746|FG000|NOT COMPLETED|First Intervention||0
11339265|NCT02911688|12536747|FG001|NOT COMPLETED|First Intervention||0
11339266|NCT02911688|12536746|FG000|STARTED|Washout||9
11339267|NCT02911688|12536747|FG001|STARTED|Washout||9
11339268|NCT02911688|12536746|FG000|COMPLETED|Washout||8
11339269|NCT02911688|12536747|FG001|COMPLETED|Washout||7
11339270|NCT02911688|12536746|FG000|NOT COMPLETED|Washout||1
11339271|NCT02911688|12536747|FG001|NOT COMPLETED|Washout||2
11339272|NCT02911688|12536746|FG000|STARTED|Second Intervention||8
11339273|NCT02911688|12536747|FG001|STARTED|Second Intervention||7
11339274|NCT02911688|12536746|FG000|COMPLETED|Second Intervention||8
11339275|NCT02911688|12536747|FG001|COMPLETED|Second Intervention||7
11339276|NCT02911688|12536746|FG000|NOT COMPLETED|Second Intervention||0
11339277|NCT02911688|12536747|FG001|NOT COMPLETED|Second Intervention||0
11339278|NCT02911753|12536758|FG000|STARTED|Overall Study||21
11339279|NCT02911753|12536759|FG001|STARTED|Overall Study||19
11339280|NCT02911753|12536760|FG002|STARTED|Overall Study||10
11339281|NCT02911753|12536758|FG000|COMPLETED|Overall Study||18
11339282|NCT02911753|12536759|FG001|COMPLETED|Overall Study||16
11339283|NCT02911753|12536760|FG002|COMPLETED|Overall Study||10
11339284|NCT02911753|12536758|FG000|NOT COMPLETED|Overall Study||3
11339285|NCT02911753|12536759|FG001|NOT COMPLETED|Overall Study||3
11339286|NCT02911753|12536760|FG002|NOT COMPLETED|Overall Study||0
11339287|NCT02911818|12536789|FG000|STARTED|52 Week Study||50
11339288|NCT02911818|12536790|FG001|STARTED|52 Week Study||50
11339289|NCT02911818|12536791|FG002|STARTED|52 Week Study||50
11339290|NCT02911818|12536792|FG003|STARTED|52 Week Study||0
11339291|NCT02911818|12536793|FG004|STARTED|52 Week Study||0
11339292|NCT02911818|12536789|FG000|COMPLETED|52 Week Study||46
11339293|NCT02911818|12536790|FG001|COMPLETED|52 Week Study||45
11339294|NCT02911818|12536791|FG002|COMPLETED|52 Week Study||46
11339295|NCT02911818|12536792|FG003|COMPLETED|52 Week Study||0
11339296|NCT02911818|12536793|FG004|COMPLETED|52 Week Study||0
11339297|NCT02911818|12536789|FG000|NOT COMPLETED|52 Week Study||4
11339298|NCT02911818|12536790|FG001|NOT COMPLETED|52 Week Study||5
11339299|NCT02911818|12536791|FG002|NOT COMPLETED|52 Week Study||4
11246767|NCT02135146|12439810|FG000|STARTED|Overall Study||20
11246768|NCT02135146|12439811|FG001|STARTED|Overall Study||20
11005384|NCT00722722|12183094|FG002|NOT COMPLETED|Overall Study||0
11005385|NCT00722761|12183104|FG000|STARTED|Overall Study||16
11005386|NCT00722761|12183105|FG001|STARTED|Overall Study||14
11005387|NCT00722761|12183104|FG000|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
11005388|NCT00722761|12183105|FG001|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
11005389|NCT00722761|12183104|FG000|COMPLETED|Overall Study||10
11005390|NCT00722761|12183105|FG001|COMPLETED|Overall Study||8
11005391|NCT00722761|12183104|FG000|NOT COMPLETED|Overall Study||6
11005392|NCT00722761|12183105|FG001|NOT COMPLETED|Overall Study||6
11005393|NCT00722800|12183113|FG000|STARTED|Overall Study||2
11005394|NCT00722800|12183114|FG001|STARTED|Overall Study||2
11005395|NCT00722800|12183113|FG000|COMPLETED|Overall Study||0
11246769|NCT02135146|12439810|FG000|COMPLETED|Overall Study||20
11246770|NCT02135146|12439811|FG001|COMPLETED|Overall Study||20
11246771|NCT02135146|12439810|FG000|NOT COMPLETED|Overall Study||0
11246772|NCT02135146|12439811|FG001|NOT COMPLETED|Overall Study||0
11246773|NCT02135432|12439819|FG000|STARTED|Overall Study||8
11246774|NCT02135432|12439820|FG001|STARTED|Overall Study||4
11358384|NCT03124121|12555476|FG001|NOT COMPLETED|Overall Study||3
11246775|NCT02135432|12439819|FG000|COMPLETED|Overall Study||8
11246776|NCT02135432|12439820|FG001|COMPLETED|Overall Study||4
11246777|NCT02135432|12439819|FG000|NOT COMPLETED|Overall Study||0
11246778|NCT02135432|12439820|FG001|NOT COMPLETED|Overall Study||0
11246779|NCT02135445|12439829|FG000|STARTED|Overall Study||65
11246780|NCT02135445|12439830|FG001|STARTED|Overall Study||38
11246781|NCT02135445|12439829|FG000|COMPLETED|Overall Study||63
11246782|NCT02135445|12439830|FG001|COMPLETED|Overall Study||38
11246783|NCT02135445|12439829|FG000|NOT COMPLETED|Overall Study||2
11246784|NCT02135445|12439830|FG001|NOT COMPLETED|Overall Study||0
11246785|NCT02135614|12439838|FG000|STARTED|Overall Study||94
11246786|NCT02135614|12439839|FG001|STARTED|Overall Study||95
11246787|NCT02135614|12439838|FG000|COMPLETED|Overall Study||86
11246788|NCT02135614|12439839|FG001|COMPLETED|Overall Study||90
11246789|NCT02135614|12439838|FG000|NOT COMPLETED|Overall Study||8
11246790|NCT02135614|12439839|FG001|NOT COMPLETED|Overall Study||5
11246791|NCT02135653|12439847|FG000|STARTED|Overall Study||35
11246792|NCT02135653|12439848|FG001|STARTED|Overall Study||33
11246793|NCT02135653|12439847|FG000|COMPLETED|Overall Study||22
11246794|NCT02135653|12439848|FG001|COMPLETED|Overall Study||28
11246795|NCT02135653|12439847|FG000|NOT COMPLETED|Overall Study||13
11246796|NCT02135653|12439848|FG001|NOT COMPLETED|Overall Study||5
11246797|NCT02135692|12439856|FG000|STARTED|Overall Study||339
11246798|NCT02135692|12439856|FG000|COMPLETED|Overall Study||0
11246799|NCT02135692|12439856|FG000|NOT COMPLETED|Overall Study||339
11246800|NCT02135848|12439862|FG000|STARTED|Overall Study||26
11246801|NCT02135848|12439863|FG001|STARTED|Overall Study||20
11246802|NCT02135848|12439862|FG000|COMPLETED|Overall Study||23
11246803|NCT02135848|12439863|FG001|COMPLETED|Overall Study||19
11246804|NCT02135848|12439862|FG000|NOT COMPLETED|Overall Study||3
11246805|NCT02135848|12439863|FG001|NOT COMPLETED|Overall Study||1
11246806|NCT02135861|12439879|FG000|STARTED|Overall Study||21
11246807|NCT02135861|12439880|FG001|STARTED|Overall Study||12
11246808|NCT02135861|12439881|FG002|STARTED|Overall Study||3
11246809|NCT02135861|12439879|FG000|COMPLETED|Overall Study||21
11246810|NCT02135861|12439880|FG001|COMPLETED|Overall Study||12
11246811|NCT02135861|12439881|FG002|COMPLETED|Overall Study||3
11246812|NCT02135861|12439879|FG000|NOT COMPLETED|Overall Study||0
11246813|NCT02135861|12439880|FG001|NOT COMPLETED|Overall Study||0
11246814|NCT02135861|12439881|FG002|NOT COMPLETED|Overall Study||0
11246815|NCT02135900|12439891|FG000|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
11246816|NCT02135900|12439891|FG000|COMPLETED|Overall Study||32
11246817|NCT02135900|12439891|FG000|NOT COMPLETED|Overall Study||0
11246818|NCT02136004|12439897|FG000|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
11246819|NCT02136004|12439897|FG000|COMPLETED|Overall Study||219
11246820|NCT02136004|12439897|FG000|NOT COMPLETED|Overall Study||1
11246821|NCT02136238|12439903|FG000|STARTED|Overall Study||4
11246822|NCT02136238|12439904|FG001|STARTED|Overall Study||4
11246823|NCT02136238|12439905|FG002|STARTED|Overall Study||10
11246824|NCT02136238|12439903|FG000|COMPLETED|Overall Study||4
11246825|NCT02136238|12439904|FG001|COMPLETED|Overall Study||4
11246826|NCT02136238|12439905|FG002|COMPLETED|Overall Study||10
11246827|NCT02136238|12439903|FG000|NOT COMPLETED|Overall Study||0
11246828|NCT02136238|12439904|FG001|NOT COMPLETED|Overall Study||0
11246829|NCT02136238|12439905|FG002|NOT COMPLETED|Overall Study||0
11246830|NCT02136420|12439920|FG000|STARTED|Overall Study||10
11246831|NCT02136420|12439921|FG001|STARTED|Overall Study||0
11246832|NCT02136420|12439922|FG002|STARTED|Overall Study||0
11246833|NCT02136420|12439923|FG003|STARTED|Overall Study||0
11246834|NCT02136420|12439924|FG004|STARTED|Overall Study||10
11246835|NCT02136420|12439925|FG005|STARTED|Overall Study||0
11246836|NCT02136420|12439926|FG006|STARTED|Overall Study||0
11246837|NCT02136420|12439927|FG007|STARTED|Overall Study||0
11246838|NCT02136420|12439928|FG008|STARTED|Overall Study||5
11246839|NCT02136420|12439929|FG009|STARTED|Overall Study||5
11005396|NCT00722800|12183114|FG001|COMPLETED|Overall Study||2
11005397|NCT00722800|12183113|FG000|NOT COMPLETED|Overall Study||2
11246840|NCT02136420|12439920|FG000|COMPLETED|Overall Study||9
11246841|NCT02136420|12439921|FG001|COMPLETED|Overall Study||0
11246842|NCT02136420|12439922|FG002|COMPLETED|Overall Study||0
11246843|NCT02136420|12439923|FG003|COMPLETED|Overall Study||0
11246844|NCT02136420|12439924|FG004|COMPLETED|Overall Study||10
11246845|NCT02136420|12439925|FG005|COMPLETED|Overall Study||0
11246846|NCT02136420|12439926|FG006|COMPLETED|Overall Study||0
11246847|NCT02136420|12439927|FG007|COMPLETED|Overall Study||0
11246848|NCT02136420|12439928|FG008|COMPLETED|Overall Study||5
11246849|NCT02136420|12439929|FG009|COMPLETED|Overall Study||5
11246850|NCT02136420|12439920|FG000|NOT COMPLETED|Overall Study||1
11246851|NCT02136420|12439921|FG001|NOT COMPLETED|Overall Study||0
11246852|NCT02136420|12439922|FG002|NOT COMPLETED|Overall Study||0
11246853|NCT02136420|12439923|FG003|NOT COMPLETED|Overall Study||0
11246854|NCT02136420|12439924|FG004|NOT COMPLETED|Overall Study||0
11246855|NCT02136420|12439925|FG005|NOT COMPLETED|Overall Study||0
11246856|NCT02136420|12439926|FG006|NOT COMPLETED|Overall Study||0
11246857|NCT02136420|12439927|FG007|NOT COMPLETED|Overall Study||0
11246858|NCT02136420|12439928|FG008|NOT COMPLETED|Overall Study||0
11246859|NCT02136420|12439929|FG009|NOT COMPLETED|Overall Study||0
11246860|NCT02136498|12439946|FG000|STARTED|Overall Study||33
11246861|NCT02136498|12439947|FG001|STARTED|Overall Study||33
11246862|NCT02136498|12439946|FG000|COMPLETED|Overall Study||33
11246863|NCT02136498|12439947|FG001|COMPLETED|Overall Study||33
11246864|NCT02136498|12439946|FG000|NOT COMPLETED|Overall Study||0
11246865|NCT02136498|12439947|FG001|NOT COMPLETED|Overall Study||0
11246866|NCT02136576|12439956|FG000|STARTED|Overall Study||13
11246867|NCT02136576|12439957|FG001|STARTED|Overall Study||13
11246868|NCT02136576|12439958|FG002|STARTED|Overall Study||13
11246869|NCT02136576|12439956|FG000|COMPLETED|Overall Study||11
11246870|NCT02136576|12439957|FG001|COMPLETED|Overall Study||13
11246871|NCT02136576|12439958|FG002|COMPLETED|Overall Study||13
11246872|NCT02136576|12439956|FG000|NOT COMPLETED|Overall Study||2
11246873|NCT02136576|12439957|FG001|NOT COMPLETED|Overall Study||0
11246874|NCT02136576|12439958|FG002|NOT COMPLETED|Overall Study||0
11246875|NCT02136680|12439968|FG000|STARTED|Overall Study||112
11246876|NCT02136680|12439969|FG001|STARTED|Overall Study||85
11246877|NCT02136680|12439968|FG000|Interview 1|Overall Study||112
11246878|NCT02136680|12439969|FG001|Interview 1|Overall Study||85
11246879|NCT02136680|12439968|FG000|Interview 2|Overall Study||97
11246880|NCT02136680|12439969|FG001|Interview 2|Overall Study||70
11246881|NCT02136680|12439968|FG000|Interview 3|Overall Study||80
11246882|NCT02136680|12439969|FG001|Interview 3|Overall Study||56
11246883|NCT02136680|12439968|FG000|COMPLETED|Overall Study||80
11246884|NCT02136680|12439969|FG001|COMPLETED|Overall Study||56
11246885|NCT02136680|12439968|FG000|NOT COMPLETED|Overall Study||32
11246886|NCT02136680|12439969|FG001|NOT COMPLETED|Overall Study||29
11246887|NCT02136810|12439975|FG000|STARTED|Overall Study||200
11246888|NCT02136810|12439975|FG000|COMPLETED|Overall Study||200
11246889|NCT02136810|12439975|FG000|NOT COMPLETED|Overall Study||0
11246890|NCT02136914|12439981|FG000|STARTED|Overall Study||63
11246891|NCT02136914|12439982|FG001|STARTED|Overall Study||63
11246892|NCT02136914|12439981|FG000|Received Study Drug|Overall Study||60
11246893|NCT02136914|12439982|FG001|Received Study Drug|Overall Study||63
11246894|NCT02136914|12439981|FG000|COMPLETED|Overall Study||42
11246895|NCT02136914|12439982|FG001|COMPLETED|Overall Study||42
11246896|NCT02136914|12439981|FG000|NOT COMPLETED|Overall Study||21
11246897|NCT02136914|12439982|FG001|NOT COMPLETED|Overall Study||21
11246898|NCT02137226|12439990|FG000|STARTED|Period 1 (Initial Randomization)||324
11246899|NCT02137226|12439991|FG001|STARTED|Period 1 (Initial Randomization)||321
11246900|NCT02137226|12439992|FG002|STARTED|Period 1 (Initial Randomization)||0
11246901|NCT02137226|12439993|FG003|STARTED|Period 1 (Initial Randomization)||0
11246902|NCT02137226|12439994|FG004|STARTED|Period 1 (Initial Randomization)||0
11246903|NCT02137226|12439990|FG000|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
11246904|NCT02137226|12439991|FG001|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
11246905|NCT02137226|12439992|FG002|COMPLETED|Period 1 (Initial Randomization)||0
11246906|NCT02137226|12439993|FG003|COMPLETED|Period 1 (Initial Randomization)||0
11246907|NCT02137226|12439994|FG004|COMPLETED|Period 1 (Initial Randomization)||0
11246908|NCT02137226|12439990|FG000|NOT COMPLETED|Period 1 (Initial Randomization)||20
11246909|NCT02137226|12439991|FG001|NOT COMPLETED|Period 1 (Initial Randomization)||16
11246910|NCT02137226|12439992|FG002|NOT COMPLETED|Period 1 (Initial Randomization)||0
11246911|NCT02137226|12439993|FG003|NOT COMPLETED|Period 1 (Initial Randomization)||0
11246912|NCT02137226|12439994|FG004|NOT COMPLETED|Period 1 (Initial Randomization)||0
11246913|NCT02137226|12439990|FG000|STARTED|Period 2 (Re - Randomization)||0
11246914|NCT02137226|12439991|FG001|STARTED|Period 2 (Re - Randomization)||0
11246915|NCT02137226|12439992|FG002|STARTED|Period 2 (Re - Randomization)||298
11246916|NCT02137226|12439993|FG003|STARTED|Period 2 (Re - Randomization)||148
11246917|NCT02137226|12439994|FG004|STARTED|Period 2 (Re - Randomization)||147
11246918|NCT02137226|12439990|FG000|COMPLETED|Period 2 (Re - Randomization)||0
11246919|NCT02137226|12439991|FG001|COMPLETED|Period 2 (Re - Randomization)||0
11246920|NCT02137226|12439992|FG002|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
11246921|NCT02137226|12439993|FG003|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
11246922|NCT02137226|12439994|FG004|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
11246923|NCT02137226|12439990|FG000|NOT COMPLETED|Period 2 (Re - Randomization)||0
11246924|NCT02137226|12439991|FG001|NOT COMPLETED|Period 2 (Re - Randomization)||0
11246925|NCT02137226|12439992|FG002|NOT COMPLETED|Period 2 (Re - Randomization)||17
11246926|NCT02137226|12439993|FG003|NOT COMPLETED|Period 2 (Re - Randomization)||8
11246927|NCT02137226|12439994|FG004|NOT COMPLETED|Period 2 (Re - Randomization)||9
11246928|NCT02137369|12440004|FG000|STARTED|Overall Study||49
11246929|NCT02137369|12440005|FG001|STARTED|Overall Study||11
11246930|NCT02137369|12440004|FG000|COMPLETED|Overall Study||41
11246931|NCT02137369|12440005|FG001|COMPLETED|Overall Study||9
11246932|NCT02137369|12440004|FG000|NOT COMPLETED|Overall Study||8
11246933|NCT02137369|12440005|FG001|NOT COMPLETED|Overall Study||2
11246934|NCT02137382|12440012|FG000|STARTED|Cross-over Period 1||20
11246935|NCT02137382|12440013|FG001|STARTED|Cross-over Period 1||21
11246936|NCT02137382|12440012|FG000|COMPLETED|Cross-over Period 1||18
11246937|NCT02137382|12440013|FG001|COMPLETED|Cross-over Period 1||21
11246938|NCT02137382|12440012|FG000|NOT COMPLETED|Cross-over Period 1||2
11246939|NCT02137382|12440013|FG001|NOT COMPLETED|Cross-over Period 1||0
11246940|NCT02137382|12440012|FG000|STARTED|Wash Out||18
11246941|NCT02137382|12440013|FG001|STARTED|Wash Out||21
11246942|NCT02137382|12440012|FG000|COMPLETED|Wash Out||18
11246943|NCT02137382|12440013|FG001|COMPLETED|Wash Out||21
11246944|NCT02137382|12440012|FG000|NOT COMPLETED|Wash Out||0
11246945|NCT02137382|12440013|FG001|NOT COMPLETED|Wash Out||0
11246946|NCT02137382|12440012|FG000|STARTED|Cross-over Period 2||18
11246947|NCT02137382|12440013|FG001|STARTED|Cross-over Period 2||21
11246948|NCT02137382|12440012|FG000|COMPLETED|Cross-over Period 2||18
11246949|NCT02137382|12440013|FG001|COMPLETED|Cross-over Period 2||21
11246950|NCT02137382|12440012|FG000|NOT COMPLETED|Cross-over Period 2||0
11246951|NCT02137382|12440013|FG001|NOT COMPLETED|Cross-over Period 2||0
11246952|NCT02137447|12440020|FG000|STARTED|Overall Study||10
11246953|NCT02137447|12440020|FG000|COMPLETED|Overall Study||10
11246954|NCT02137447|12440020|FG000|NOT COMPLETED|Overall Study||0
11246955|NCT02137486|12440026|FG000|STARTED|Overall Study||112
11246956|NCT02137486|12440027|FG001|STARTED|Overall Study||102
11246957|NCT02137486|12440026|FG000|COMPLETED|Overall Study||112
11246958|NCT02137486|12440027|FG001|COMPLETED|Overall Study||102
11246959|NCT02137486|12440026|FG000|NOT COMPLETED|Overall Study||0
11246960|NCT02137486|12440027|FG001|NOT COMPLETED|Overall Study||0
11246961|NCT02137499|12440041|FG000|STARTED|Overall Study||10
11246962|NCT02137499|12440042|FG001|STARTED|Overall Study||10
11246963|NCT02137499|12440043|FG002|STARTED|Overall Study||10
11246964|NCT02137499|12440044|FG003|STARTED|Overall Study||10
11246965|NCT02137499|12440041|FG000|COMPLETED|Overall Study||10
11246966|NCT02137499|12440042|FG001|COMPLETED|Overall Study||10
11246967|NCT02137499|12440043|FG002|COMPLETED|Overall Study||10
11246968|NCT02137499|12440044|FG003|COMPLETED|Overall Study||10
11246969|NCT02137499|12440041|FG000|NOT COMPLETED|Overall Study||0
11246970|NCT02137499|12440042|FG001|NOT COMPLETED|Overall Study||0
11246971|NCT02137499|12440043|FG002|NOT COMPLETED|Overall Study||0
11246972|NCT02137499|12440044|FG003|NOT COMPLETED|Overall Study||0
11246973|NCT02137512|12440054|FG000|STARTED|2-Week Baseline Sensor-Augmented Pump||30
11246974|NCT02137512|12440054|FG000|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
11246975|NCT02137512|12440054|FG000|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
11246976|NCT02137512|12440054|FG000|STARTED|2-Week Overnight-Only Closed-Loop||30
11246977|NCT02137512|12440054|FG000|COMPLETED|2-Week Overnight-Only Closed-Loop||30
11246978|NCT02137512|12440054|FG000|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
11246979|NCT02137512|12440054|FG000|STARTED|2-Week 24/7 Closed-Loop||30
11246980|NCT02137512|12440054|FG000|COMPLETED|2-Week 24/7 Closed-Loop||30
11246981|NCT02137512|12440054|FG000|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
11246982|NCT02137512|12440054|FG000|STARTED|5-Month 24/7 Closed-Loop||14
11246983|NCT02137512|12440054|FG000|COMPLETED|5-Month 24/7 Closed-Loop||14
11246984|NCT02137512|12440054|FG000|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
11246985|NCT02137538|12440064|FG000|STARTED|Overall Study||39
11246986|NCT02137538|12440065|FG001|STARTED|Overall Study||40
11246987|NCT02137538|12440064|FG000|COMPLETED|Overall Study||23
11246988|NCT02137538|12440065|FG001|COMPLETED|Overall Study||26
11246989|NCT02137538|12440064|FG000|NOT COMPLETED|Overall Study||16
11246990|NCT02137538|12440065|FG001|NOT COMPLETED|Overall Study||14
11246991|NCT02137603|12440073|FG000|STARTED|Overall Study||18
11246992|NCT02137603|12440074|FG001|STARTED|Overall Study||18
11246993|NCT02137603|12440073|FG000|COMPLETED|Overall Study||16
11246994|NCT02137603|12440074|FG001|COMPLETED|Overall Study||18
11246995|NCT02137603|12440073|FG000|NOT COMPLETED|Overall Study||2
11246996|NCT02137603|12440074|FG001|NOT COMPLETED|Overall Study||0
11246997|NCT02137772|12440082|FG000|STARTED|Overall Study|Randomized participants|376
11246998|NCT02137772|12440083|FG001|STARTED|Overall Study|Randomized participants|194
11246999|NCT02137772|12440082|FG000|Treated Participants|Overall Study||373
11247000|NCT02137772|12440083|FG001|Treated Participants|Overall Study||192
11247001|NCT02137772|12440082|FG000|COMPLETED|Overall Study||244
11247002|NCT02137772|12440083|FG001|COMPLETED|Overall Study||119
11247003|NCT02137772|12440082|FG000|NOT COMPLETED|Overall Study||132
11247004|NCT02137772|12440083|FG001|NOT COMPLETED|Overall Study||75
11247005|NCT02137785|12440091|FG000|STARTED|Overall Study||135
11247006|NCT02137785|12440092|FG001|STARTED|Overall Study||134
11247007|NCT02137785|12440091|FG000|COMPLETED|Overall Study||132
11247008|NCT02137785|12440092|FG001|COMPLETED|Overall Study||130
11247009|NCT02137785|12440091|FG000|NOT COMPLETED|Overall Study||3
11247010|NCT02137785|12440092|FG001|NOT COMPLETED|Overall Study||4
11247011|NCT02137837|12440101|FG000|STARTED|Overall Study||13
11247012|NCT02137837|12440102|FG001|STARTED|Overall Study||12
11247013|NCT02137837|12440103|FG002|STARTED|Overall Study||12
11247014|NCT02137837|12440101|FG000|Received Protocol Therapy|Overall Study||13
11247015|NCT02137837|12440102|FG001|Received Protocol Therapy|Overall Study||11
11247016|NCT02137837|12440103|FG002|Received Protocol Therapy|Overall Study||12
11247017|NCT02137837|12440101|FG000|COMPLETED|Overall Study||0
11247018|NCT02137837|12440102|FG001|COMPLETED|Overall Study||0
11247019|NCT02137837|12440103|FG002|COMPLETED|Overall Study||0
11247020|NCT02137837|12440101|FG000|NOT COMPLETED|Overall Study||13
11247021|NCT02137837|12440102|FG001|NOT COMPLETED|Overall Study||12
11247022|NCT02137837|12440103|FG002|NOT COMPLETED|Overall Study||12
11247023|NCT02138006|12440118|FG000|STARTED|Overall Study||48
11247024|NCT02138006|12440119|FG001|STARTED|Overall Study||54
11247025|NCT02138006|12440118|FG000|COMPLETED|Overall Study||48
11247026|NCT02138006|12440119|FG001|COMPLETED|Overall Study||54
11247027|NCT02138006|12440118|FG000|NOT COMPLETED|Overall Study||0
11247028|NCT02138006|12440119|FG001|NOT COMPLETED|Overall Study||0
11247029|NCT02138097|12440143|FG000|STARTED|Overall Study||155345
11247030|NCT02138097|12440144|FG001|STARTED|Overall Study||459722
11247031|NCT02138097|12440143|FG000|COMPLETED|Overall Study||155345
11247032|NCT02138097|12440144|FG001|COMPLETED|Overall Study||459722
11247033|NCT02138097|12440143|FG000|NOT COMPLETED|Overall Study||0
11247034|NCT02138097|12440144|FG001|NOT COMPLETED|Overall Study||0
11247035|NCT02138110|12440168|FG000|STARTED|Enrolled in Study||20
11247036|NCT02138110|12440168|FG000|COMPLETED|Enrolled in Study||20
11247037|NCT02138110|12440168|FG000|NOT COMPLETED|Enrolled in Study||0
11247038|NCT02138110|12440168|FG000|STARTED|Enrolled for Scaffold Implantation||20
11247039|NCT02138110|12440168|FG000|COMPLETED|Enrolled for Scaffold Implantation||19
11247040|NCT02138110|12440168|FG000|NOT COMPLETED|Enrolled for Scaffold Implantation||1
11247041|NCT02138110|12440168|FG000|STARTED|Overall Scaffold Implantation||19
11247042|NCT02138110|12440168|FG000|6-month Follow-Up|Overall Scaffold Implantation||16
11247043|NCT02138110|12440168|FG000|COMPLETED|Overall Scaffold Implantation||16
11247044|NCT02138110|12440168|FG000|NOT COMPLETED|Overall Scaffold Implantation||3
11247045|NCT02138136|12440172|FG000|STARTED|Overall Study||419
11247046|NCT02138136|12440172|FG000|Safety Analysis Set|Overall Study||419
11247047|NCT02138136|12440172|FG000|Modified Intent to Treat (mITT)|Overall Study||418
11247048|NCT02138136|12440172|FG000|COMPLETED|Overall Study||280
11247049|NCT02138136|12440172|FG000|NOT COMPLETED|Overall Study||139
11247050|NCT02138214|12440180|FG000|STARTED|Overall Study||30
11247051|NCT02138214|12440181|FG001|STARTED|Overall Study||30
11247052|NCT02138214|12440182|FG002|STARTED|Overall Study||30
11247053|NCT02138214|12440180|FG000|Analyzed for Baseline Measures|Overall Study||30
11247054|NCT02138214|12440181|FG001|Analyzed for Baseline Measures|Overall Study||29
11247055|NCT02138214|12440182|FG002|Analyzed for Baseline Measures|Overall Study||30
11247056|NCT02138214|12440180|FG000|COMPLETED|Overall Study||30
11247057|NCT02138214|12440181|FG001|COMPLETED|Overall Study||26
11247058|NCT02138214|12440182|FG002|COMPLETED|Overall Study||26
11247059|NCT02138214|12440180|FG000|NOT COMPLETED|Overall Study||0
11247060|NCT02138214|12440181|FG001|NOT COMPLETED|Overall Study||4
11247061|NCT02138214|12440182|FG002|NOT COMPLETED|Overall Study||4
11247062|NCT02138227|12440191|FG000|STARTED|Overall Study||55
11247063|NCT02138227|12440192|FG001|STARTED|Overall Study||218
11247064|NCT02138227|12440191|FG000|COMPLETED|Overall Study||55
11247065|NCT02138227|12440192|FG001|COMPLETED|Overall Study||218
11247066|NCT02138227|12440191|FG000|NOT COMPLETED|Overall Study||0
11247067|NCT02138227|12440192|FG001|NOT COMPLETED|Overall Study||0
11247068|NCT02138240|12440223|FG000|STARTED|Overall Study||34
11247069|NCT02138240|12440223|FG000|COMPLETED|Overall Study||34
11247070|NCT02138240|12440223|FG000|NOT COMPLETED|Overall Study||0
11247071|NCT02138253|12440229|FG000|STARTED|Overall Study||41
11247072|NCT02138253|12440230|FG001|STARTED|Overall Study||23
11247073|NCT02138253|12440229|FG000|COMPLETED|Overall Study||32
11247074|NCT02138253|12440230|FG001|COMPLETED|Overall Study||19
11247075|NCT02138253|12440229|FG000|NOT COMPLETED|Overall Study||9
11247076|NCT02138253|12440230|FG001|NOT COMPLETED|Overall Study||4
11247077|NCT02138461|12440238|FG000|STARTED|Overall Study||101
11247078|NCT02138461|12440239|FG001|STARTED|Overall Study||110
11247079|NCT02138461|12440238|FG000|COMPLETED|Overall Study||101
11247080|NCT02138461|12440239|FG001|COMPLETED|Overall Study||110
11247081|NCT02138461|12440238|FG000|NOT COMPLETED|Overall Study||0
11247082|NCT02138461|12440239|FG001|NOT COMPLETED|Overall Study||0
11247083|NCT02138578|12440248|FG000|STARTED|Overall Study||1
11247084|NCT02138578|12440249|FG001|STARTED|Overall Study||0
11247085|NCT02138578|12440250|FG002|STARTED|Overall Study||3
11247086|NCT02138578|12440248|FG000|COMPLETED|Overall Study||1
11247087|NCT02138578|12440249|FG001|COMPLETED|Overall Study||0
11247088|NCT02138578|12440250|FG002|COMPLETED|Overall Study||3
11247089|NCT02138578|12440248|FG000|NOT COMPLETED|Overall Study||0
11247090|NCT02138578|12440249|FG001|NOT COMPLETED|Overall Study||0
11247091|NCT02138578|12440250|FG002|NOT COMPLETED|Overall Study||0
11247092|NCT02138747|12440262|FG000|STARTED|Treatment Period 1||156
11247093|NCT02138747|12440263|FG001|STARTED|Treatment Period 1||157
11247094|NCT02138747|12440264|FG002|STARTED|Treatment Period 1||31
11247095|NCT02138747|12440265|FG003|STARTED|Treatment Period 1||32
11247096|NCT02138747|12440262|FG000|COMPLETED|Treatment Period 1||136
11247097|NCT02138747|12440263|FG001|COMPLETED|Treatment Period 1||132
11247098|NCT02138747|12440264|FG002|COMPLETED|Treatment Period 1||27
11247099|NCT02138747|12440265|FG003|COMPLETED|Treatment Period 1||28
11247100|NCT02138747|12440262|FG000|NOT COMPLETED|Treatment Period 1||20
11247101|NCT02138747|12440263|FG001|NOT COMPLETED|Treatment Period 1||25
11247102|NCT02138747|12440264|FG002|NOT COMPLETED|Treatment Period 1||4
11247103|NCT02138747|12440265|FG003|NOT COMPLETED|Treatment Period 1||4
11247104|NCT02138747|12440262|FG000|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
11247105|NCT02138747|12440263|FG001|STARTED|Treatment Period 2||132
11247106|NCT02138747|12440264|FG002|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
11247107|NCT02138747|12440265|FG003|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
11247108|NCT02138747|12440262|FG000|COMPLETED|Treatment Period 2||121
11247109|NCT02138747|12440263|FG001|COMPLETED|Treatment Period 2||125
11247110|NCT02138747|12440264|FG002|COMPLETED|Treatment Period 2||24
11247111|NCT02138747|12440265|FG003|COMPLETED|Treatment Period 2||24
11247112|NCT02138747|12440262|FG000|NOT COMPLETED|Treatment Period 2||17
11247113|NCT02138747|12440263|FG001|NOT COMPLETED|Treatment Period 2||7
11247114|NCT02138747|12440264|FG002|NOT COMPLETED|Treatment Period 2||2
11247115|NCT02138747|12440265|FG003|NOT COMPLETED|Treatment Period 2||3
11247116|NCT02138786|12440278|FG000|STARTED|Overall Study||3
11247117|NCT02138786|12440279|FG001|STARTED|Overall Study||15
11247118|NCT02138786|12440280|FG002|STARTED|Overall Study||8
11247119|NCT02138786|12440278|FG000|COMPLETED|Overall Study||0
11247120|NCT02138786|12440279|FG001|COMPLETED|Overall Study||0
11247121|NCT02138786|12440280|FG002|COMPLETED|Overall Study||0
11247122|NCT02138786|12440278|FG000|NOT COMPLETED|Overall Study||3
11247123|NCT02138786|12440279|FG001|NOT COMPLETED|Overall Study||15
11247124|NCT02138786|12440280|FG002|NOT COMPLETED|Overall Study||8
11247125|NCT02138825|12440288|FG000|STARTED|Main Study Treatment|safety population|73
11247126|NCT02138825|12440289|FG001|STARTED|Main Study Treatment|safety population|74
11247127|NCT02138825|12440288|FG000|COMPLETED|Main Study Treatment||33
11247128|NCT02138825|12440289|FG001|COMPLETED|Main Study Treatment||39
11247129|NCT02138825|12440288|FG000|NOT COMPLETED|Main Study Treatment||40
11247130|NCT02138825|12440289|FG001|NOT COMPLETED|Main Study Treatment||35
11247131|NCT02138825|12440288|FG000|STARTED|Long-term Extension||32
11247132|NCT02138825|12440289|FG001|STARTED|Long-term Extension||38
11247133|NCT02138825|12440288|FG000|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
11247134|NCT02138825|12440289|FG001|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
11247135|NCT02138825|12440288|FG000|NOT COMPLETED|Long-term Extension||32
11247136|NCT02138825|12440289|FG001|NOT COMPLETED|Long-term Extension||38
11247137|NCT02138825|12440288|FG000|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
11247138|NCT02138825|12440289|FG001|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
11247139|NCT02138825|12440288|FG000|COMPLETED|Safety Follow-up||50
11247140|NCT02138825|12440289|FG001|COMPLETED|Safety Follow-up||47
11247141|NCT02138825|12440288|FG000|NOT COMPLETED|Safety Follow-up||22
11247142|NCT02138825|12440289|FG001|NOT COMPLETED|Safety Follow-up||17
11247143|NCT02138838|12440302|FG000|STARTED|Overall Study||28
11247144|NCT02138838|12440303|FG001|STARTED|Overall Study||27
11247145|NCT02138838|12440302|FG000|Received Study Drug|Overall Study||28
11247146|NCT02138838|12440303|FG001|Received Study Drug|Overall Study||25
11247147|NCT02138838|12440302|FG000|COMPLETED|Overall Study||20
11247148|NCT02138838|12440303|FG001|COMPLETED|Overall Study||16
11247149|NCT02138838|12440302|FG000|NOT COMPLETED|Overall Study||8
11247150|NCT02138838|12440303|FG001|NOT COMPLETED|Overall Study||11
11247151|NCT02138890|12440311|FG000|STARTED|Overall Study||31
11247152|NCT02138890|12440312|FG001|STARTED|Overall Study||15
11247153|NCT02138890|12440311|FG000|COMPLETED|Overall Study||30
11247154|NCT02138890|12440312|FG001|COMPLETED|Overall Study||15
11247155|NCT02138890|12440311|FG000|NOT COMPLETED|Overall Study||1
11247156|NCT02138890|12440312|FG001|NOT COMPLETED|Overall Study||0
11247157|NCT02138916|12440322|FG000|STARTED|Overall Study||554
11247158|NCT02138916|12440323|FG001|STARTED|Overall Study||552
11247159|NCT02138916|12440324|FG002|STARTED|Overall Study||550
11247160|NCT02138916|12440322|FG000|COMPLETED|Overall Study||497
11247161|NCT02138916|12440323|FG001|COMPLETED|Overall Study||492
11247162|NCT02138916|12440324|FG002|COMPLETED|Overall Study||491
11247163|NCT02138916|12440322|FG000|NOT COMPLETED|Overall Study||57
11247164|NCT02138916|12440323|FG001|NOT COMPLETED|Overall Study||60
11247165|NCT02138916|12440324|FG002|NOT COMPLETED|Overall Study||59
11247166|NCT02139007|12440334|FG000|STARTED|Study Site Recruitment||4
11247167|NCT02139007|12440335|FG001|STARTED|Study Site Recruitment||5
11247168|NCT02139007|12440334|FG000|COMPLETED|Study Site Recruitment||1
11247169|NCT02139007|12440335|FG001|COMPLETED|Study Site Recruitment||1
11247170|NCT02139007|12440334|FG000|NOT COMPLETED|Study Site Recruitment||3
11247171|NCT02139007|12440335|FG001|NOT COMPLETED|Study Site Recruitment||4
11247172|NCT02139007|12440334|FG000|STARTED|Patient Participant Recruitment||13
11247173|NCT02139007|12440335|FG001|STARTED|Patient Participant Recruitment||14
11247174|NCT02139007|12440334|FG000|COMPLETED|Patient Participant Recruitment||11
11247175|NCT02139007|12440335|FG001|COMPLETED|Patient Participant Recruitment||13
11247176|NCT02139007|12440334|FG000|NOT COMPLETED|Patient Participant Recruitment||2
11247177|NCT02139007|12440335|FG001|NOT COMPLETED|Patient Participant Recruitment||1
11247178|NCT02139046|12440349|FG000|STARTED|Overall Study||358
11247179|NCT02139046|12440350|FG001|STARTED|Overall Study||359
11247180|NCT02139046|12440351|FG002|STARTED|Overall Study||357
11247181|NCT02139046|12440352|FG003|STARTED|Overall Study||358
11247182|NCT02139046|12440353|FG004|STARTED|Overall Study||358
11247183|NCT02139046|12440349|FG000|Safety Analysis Set|Overall Study||356
11247184|NCT02139046|12440350|FG001|Safety Analysis Set|Overall Study||358
11247185|NCT02139046|12440351|FG002|Safety Analysis Set|Overall Study||355
11247186|NCT02139046|12440352|FG003|Safety Analysis Set|Overall Study||357
11247187|NCT02139046|12440353|FG004|Safety Analysis Set|Overall Study||357
11247188|NCT02139046|12440349|FG000|Full Analysis Set|Overall Study||357
11247189|NCT02139046|12440350|FG001|Full Analysis Set|Overall Study||357
11247190|NCT02139046|12440351|FG002|Full Analysis Set|Overall Study||355
11247191|NCT02139046|12440352|FG003|Full Analysis Set|Overall Study||357
11247192|NCT02139046|12440353|FG004|Full Analysis Set|Overall Study||357
11247193|NCT02139046|12440349|FG000|COMPLETED|Overall Study|Completed=Completed Study Drug|296
11247194|NCT02139046|12440350|FG001|COMPLETED|Overall Study||305
11247195|NCT02139046|12440351|FG002|COMPLETED|Overall Study||298
11247196|NCT02139046|12440352|FG003|COMPLETED|Overall Study||290
11247197|NCT02139046|12440353|FG004|COMPLETED|Overall Study||301
11247198|NCT02139046|12440349|FG000|NOT COMPLETED|Overall Study||62
11247199|NCT02139046|12440350|FG001|NOT COMPLETED|Overall Study||54
11247200|NCT02139046|12440351|FG002|NOT COMPLETED|Overall Study||59
11247201|NCT02139046|12440352|FG003|NOT COMPLETED|Overall Study||68
11247202|NCT02139046|12440353|FG004|NOT COMPLETED|Overall Study||57
11247203|NCT02139124|12440370|FG000|STARTED|Overall Study||78
11247204|NCT02139124|12440371|FG001|STARTED|Overall Study||77
11247205|NCT02139124|12440372|FG002|STARTED|Overall Study||73
11247206|NCT02139124|12440373|FG003|STARTED|Overall Study||73
11247207|NCT02139124|12440374|FG004|STARTED|Overall Study||74
11247208|NCT02139124|12440370|FG000|COMPLETED|Overall Study||69
11247209|NCT02139124|12440371|FG001|COMPLETED|Overall Study||73
11247210|NCT02139124|12440372|FG002|COMPLETED|Overall Study||69
11247211|NCT02139124|12440373|FG003|COMPLETED|Overall Study||61
11247212|NCT02139124|12440374|FG004|COMPLETED|Overall Study||61
11247213|NCT02139124|12440370|FG000|NOT COMPLETED|Overall Study||9
11247214|NCT02139124|12440371|FG001|NOT COMPLETED|Overall Study||4
11247215|NCT02139124|12440372|FG002|NOT COMPLETED|Overall Study||4
11247216|NCT02139124|12440373|FG003|NOT COMPLETED|Overall Study||12
11247217|NCT02139124|12440374|FG004|NOT COMPLETED|Overall Study||13
11247218|NCT02139137|12440388|FG000|STARTED|Overall Study||22
11247219|NCT02139137|12440389|FG001|STARTED|Overall Study||20
11247220|NCT02139137|12440388|FG000|COMPLETED|Overall Study||15
11247221|NCT02139137|12440389|FG001|COMPLETED|Overall Study||10
11247222|NCT02139137|12440388|FG000|NOT COMPLETED|Overall Study||7
11247223|NCT02139137|12440389|FG001|NOT COMPLETED|Overall Study||10
11247224|NCT02139176|12440397|FG000|STARTED|Overall Study||100
11247225|NCT02139176|12440398|FG001|STARTED|Overall Study||100
11247226|NCT02139176|12440397|FG000|COMPLETED|Overall Study||100
11247227|NCT02139176|12440398|FG001|COMPLETED|Overall Study||100
11247228|NCT02139176|12440397|FG000|NOT COMPLETED|Overall Study||0
11247229|NCT02139176|12440398|FG001|NOT COMPLETED|Overall Study||0
11247230|NCT02139228|12440407|FG000|STARTED|Overall Study||215
11247231|NCT02139228|12440408|FG001|STARTED|Overall Study||211
11247232|NCT02139228|12440407|FG000|COMPLETED|Overall Study||215
11247233|NCT02139228|12440408|FG001|COMPLETED|Overall Study||211
11247234|NCT02139228|12440407|FG000|NOT COMPLETED|Overall Study||0
11247235|NCT02139228|12440408|FG001|NOT COMPLETED|Overall Study||0
11247236|NCT02139280|12440416|FG000|STARTED|Overall Study||34
11247237|NCT02139280|12440417|FG001|STARTED|Overall Study||20
11247238|NCT02139280|12440416|FG000|COMPLETED|Overall Study||32
11247239|NCT02139280|12440417|FG001|COMPLETED|Overall Study||20
11247240|NCT02139280|12440416|FG000|NOT COMPLETED|Overall Study||2
11247241|NCT02139280|12440417|FG001|NOT COMPLETED|Overall Study||0
11247242|NCT02139306|12440425|FG000|STARTED|Overall Study||140
11247243|NCT02139306|12440426|FG001|STARTED|Overall Study||139
11247244|NCT02139306|12440425|FG000|COMPLETED|Overall Study||127
11247245|NCT02139306|12440426|FG001|COMPLETED|Overall Study||125
11247246|NCT02139306|12440425|FG000|NOT COMPLETED|Overall Study||13
11247247|NCT02139306|12440426|FG001|NOT COMPLETED|Overall Study||14
11247248|NCT02139358|12440433|FG000|STARTED|Overall Study||15
11247249|NCT02139358|12440433|FG000|COMPLETED|Overall Study||15
11247250|NCT02139358|12440433|FG000|NOT COMPLETED|Overall Study||0
11247251|NCT02139592|12440437|FG000|STARTED|Overall Study||292
11247252|NCT02139592|12440437|FG000|COMPLETED|Overall Study||284
11247253|NCT02139592|12440437|FG000|NOT COMPLETED|Overall Study||8
11247254|NCT02139644|12440446|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
11247255|NCT02139644|12440447|FG001|STARTED|Run-In Period (Pre-assignment)||0
11247256|NCT02139644|12440448|FG002|STARTED|Run-In Period (Pre-assignment)||0
11247257|NCT02139644|12440449|FG003|STARTED|Run-In Period (Pre-assignment)||0
11247258|NCT02139644|12440450|FG004|STARTED|Run-In Period (Pre-assignment)||0
11247259|NCT02139644|12440451|FG005|STARTED|Run-In Period (Pre-assignment)||0
11358385|NCT03124199|12555484|FG000|STARTED|Overall Study||40
11358386|NCT03124199|12555484|FG000|COMPLETED|Overall Study||36
11358387|NCT03124199|12555484|FG000|NOT COMPLETED|Overall Study||4
11358388|NCT03124342|12555490|FG000|STARTED|Overall Study||111
11358389|NCT03124342|12555491|FG001|STARTED|Overall Study||121
11358390|NCT03124342|12555490|FG000|COMPLETED|Overall Study||111
11358391|NCT03124342|12555491|FG001|COMPLETED|Overall Study||121
11358392|NCT03124342|12555490|FG000|NOT COMPLETED|Overall Study||0
11358393|NCT03124342|12555491|FG001|NOT COMPLETED|Overall Study||0
11358394|NCT03124368|12555500|FG000|STARTED|Overall Study||2
11358395|NCT03124368|12555501|FG001|STARTED|Overall Study||4
11358396|NCT03124368|12555500|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
11358397|NCT03124368|12555501|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
11358398|NCT03124368|12555500|FG000|COMPLETED|Overall Study||2
11358399|NCT03124368|12555501|FG001|COMPLETED|Overall Study||4
11358400|NCT03124368|12555500|FG000|NOT COMPLETED|Overall Study||0
11358401|NCT03124368|12555501|FG001|NOT COMPLETED|Overall Study||0
11358402|NCT03124381|12555514|FG000|STARTED|Overall Study||65
11358403|NCT03124381|12555515|FG001|STARTED|Overall Study||61
11358404|NCT03124381|12555514|FG000|COMPLETED|Overall Study||56
11358405|NCT03124381|12555515|FG001|COMPLETED|Overall Study||55
11358406|NCT03124381|12555514|FG000|NOT COMPLETED|Overall Study||9
11358407|NCT03124381|12555515|FG001|NOT COMPLETED|Overall Study||6
11358408|NCT03124407|12555525|FG000|STARTED|Overall Study||40
11358409|NCT03124407|12555526|FG001|STARTED|Overall Study||20
11358410|NCT03124407|12555527|FG002|STARTED|Overall Study||40
11358411|NCT03124407|12555528|FG003|STARTED|Overall Study||20
11358412|NCT03124407|12555525|FG000|COMPLETED|Overall Study||39
11358413|NCT03124407|12555526|FG001|COMPLETED|Overall Study||20
11358414|NCT03124407|12555527|FG002|COMPLETED|Overall Study||39
11358415|NCT03124407|12555528|FG003|COMPLETED|Overall Study||20
11358416|NCT03124407|12555525|FG000|NOT COMPLETED|Overall Study||1
11358417|NCT03124407|12555526|FG001|NOT COMPLETED|Overall Study||0
11358418|NCT03124407|12555527|FG002|NOT COMPLETED|Overall Study||1
11358419|NCT03124407|12555528|FG003|NOT COMPLETED|Overall Study||0
11358420|NCT03124537|12555544|FG000|STARTED|Overall Study||41
11358421|NCT03124537|12555545|FG001|STARTED|Overall Study||45
11358422|NCT03124537|12555544|FG000|COMPLETED|Overall Study||31
11358423|NCT03124537|12555545|FG001|COMPLETED|Overall Study||32
11358424|NCT03124537|12555544|FG000|NOT COMPLETED|Overall Study||10
11358425|NCT03124537|12555545|FG001|NOT COMPLETED|Overall Study||13
11358426|NCT03124550|12555551|FG000|STARTED|Overall Study||18
11358427|NCT03124550|12555551|FG000|COMPLETED|Overall Study||18
11358428|NCT03124550|12555551|FG000|NOT COMPLETED|Overall Study||0
11358429|NCT03124563|12555557|FG000|STARTED|Overall Study||32
11358430|NCT03124563|12555558|FG001|STARTED|Overall Study||31
11358431|NCT03124563|12555557|FG000|Pre-test|Overall Study||30
11358432|NCT03124563|12555558|FG001|Pre-test|Overall Study||30
11358433|NCT03124563|12555557|FG000|COMPLETED|Overall Study||30
11358434|NCT03124563|12555558|FG001|COMPLETED|Overall Study||29
11358435|NCT03124563|12555557|FG000|NOT COMPLETED|Overall Study||2
11358436|NCT03124563|12555558|FG001|NOT COMPLETED|Overall Study||2
11358437|NCT03124602|12555564|FG000|STARTED|Overall Study||35
11358438|NCT03124602|12555564|FG000|COMPLETED|Overall Study||25
11358439|NCT03124602|12555564|FG000|NOT COMPLETED|Overall Study||10
11358440|NCT03124693|12555568|FG000|STARTED|Overall Study||90
11358441|NCT03124693|12555568|FG000|COMPLETED|Overall Study||90
11358442|NCT03124693|12555568|FG000|NOT COMPLETED|Overall Study||0
11358443|NCT03124758|12555572|FG000|STARTED|Overall Study||354
11358444|NCT03124758|12555572|FG000|COMPLETED|Overall Study||354
11358445|NCT03124758|12555572|FG000|NOT COMPLETED|Overall Study||0
11358446|NCT03124771|12555576|FG000|STARTED|Overall Study||132
11358447|NCT03124771|12555576|FG000|COMPLETED|Overall Study||132
11358448|NCT03124771|12555576|FG000|NOT COMPLETED|Overall Study||0
11358449|NCT03124784|12555580|FG000|STARTED|Overall Study||27
11358450|NCT03124784|12555580|FG000|COMPLETED|Overall Study||25
11358451|NCT03124784|12555580|FG000|NOT COMPLETED|Overall Study||2
11358452|NCT03124797|12555584|FG000|STARTED|Overall Study||18
11358453|NCT03124797|12555584|FG000|COMPLETED|Overall Study||18
11358454|NCT03124797|12555584|FG000|NOT COMPLETED|Overall Study||0
11358455|NCT03124823|12555588|FG000|STARTED|Overall Study||11
11358456|NCT03124823|12555588|FG000|COMPLETED|Overall Study||11
11358457|NCT03124823|12555588|FG000|NOT COMPLETED|Overall Study||0
11358458|NCT03124836|12555592|FG000|STARTED|Overall Study||28
11247260|NCT02139644|12440446|FG000|COMPLETED|Run-In Period (Pre-assignment)||647
11247261|NCT02139644|12440447|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
11247262|NCT02139644|12440448|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
11247263|NCT02139644|12440449|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
11247264|NCT02139644|12440450|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
11247265|NCT02139644|12440451|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
11247266|NCT02139644|12440446|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||140
11247267|NCT02139644|12440447|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11247268|NCT02139644|12440448|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11247269|NCT02139644|12440449|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11247270|NCT02139644|12440450|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11247271|NCT02139644|12440451|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11247272|NCT02139644|12440446|FG000|STARTED|Treatment Period||0
11247273|NCT02139644|12440447|FG001|STARTED|Treatment Period|Randomized|129
11247274|NCT02139644|12440448|FG002|STARTED|Treatment Period|Randomized|129
11247275|NCT02139644|12440449|FG003|STARTED|Treatment Period|Randomized|130
11247276|NCT02139644|12440450|FG004|STARTED|Treatment Period|Randomized|129
11247277|NCT02139644|12440451|FG005|STARTED|Treatment Period|Randomized|130
11247278|NCT02139644|12440446|FG000|COMPLETED|Treatment Period||0
11247279|NCT02139644|12440447|FG001|COMPLETED|Treatment Period||126
11247280|NCT02139644|12440448|FG002|COMPLETED|Treatment Period||121
11247281|NCT02139644|12440449|FG003|COMPLETED|Treatment Period||121
11247282|NCT02139644|12440450|FG004|COMPLETED|Treatment Period||121
11247283|NCT02139644|12440451|FG005|COMPLETED|Treatment Period||113
11247284|NCT02139644|12440446|FG000|NOT COMPLETED|Treatment Period||0
11247285|NCT02139644|12440447|FG001|NOT COMPLETED|Treatment Period||3
11247286|NCT02139644|12440448|FG002|NOT COMPLETED|Treatment Period||8
11247287|NCT02139644|12440449|FG003|NOT COMPLETED|Treatment Period||9
11247288|NCT02139644|12440450|FG004|NOT COMPLETED|Treatment Period||8
11247289|NCT02139644|12440451|FG005|NOT COMPLETED|Treatment Period||17
11247290|NCT02139800|12440465|FG000|STARTED|Overall Study||224
11247291|NCT02139800|12440466|FG001|STARTED|Overall Study||236
11247292|NCT02139800|12440465|FG000|COMPLETED|Overall Study||211
11247293|NCT02139800|12440466|FG001|COMPLETED|Overall Study||215
11247294|NCT02139800|12440465|FG000|NOT COMPLETED|Overall Study||13
11247295|NCT02139800|12440466|FG001|NOT COMPLETED|Overall Study||21
11247296|NCT02139826|12440472|FG000|STARTED|Overall Study||12
11247297|NCT02139826|12440472|FG000|COMPLETED|Overall Study||11
11247298|NCT02139826|12440472|FG000|NOT COMPLETED|Overall Study||1
11247299|NCT02139878|12440482|FG000|STARTED|First Intervention (7 Days)||10
11247300|NCT02139878|12440483|FG001|STARTED|First Intervention (7 Days)||10
11247301|NCT02139878|12440482|FG000|COMPLETED|First Intervention (7 Days)||9
11247302|NCT02139878|12440483|FG001|COMPLETED|First Intervention (7 Days)||10
11247303|NCT02139878|12440482|FG000|NOT COMPLETED|First Intervention (7 Days)||1
11247304|NCT02139878|12440483|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11247305|NCT02139878|12440482|FG000|STARTED|Washout Period (8 Days)||9
11247306|NCT02139878|12440483|FG001|STARTED|Washout Period (8 Days)||10
11247307|NCT02139878|12440482|FG000|COMPLETED|Washout Period (8 Days)||9
11247308|NCT02139878|12440483|FG001|COMPLETED|Washout Period (8 Days)||10
11247309|NCT02139878|12440482|FG000|NOT COMPLETED|Washout Period (8 Days)||0
11247310|NCT02139878|12440483|FG001|NOT COMPLETED|Washout Period (8 Days)||0
11247311|NCT02139878|12440482|FG000|STARTED|Second Intervention (7 Days)||9
11247312|NCT02139878|12440483|FG001|STARTED|Second Intervention (7 Days)||10
11247313|NCT02139878|12440482|FG000|COMPLETED|Second Intervention (7 Days)||9
11247314|NCT02139878|12440483|FG001|COMPLETED|Second Intervention (7 Days)||10
11247315|NCT02139878|12440482|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
11247316|NCT02139878|12440483|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11247317|NCT02139943|12440492|FG000|STARTED|Overall Study||117
11247318|NCT02139943|12440493|FG001|STARTED|Overall Study||117
11247319|NCT02139943|12440494|FG002|STARTED|Overall Study||117
11247320|NCT02139943|12440492|FG000|COMPLETED|Overall Study||107
11247321|NCT02139943|12440493|FG001|COMPLETED|Overall Study||111
11247322|NCT02139943|12440494|FG002|COMPLETED|Overall Study||110
11247323|NCT02139943|12440492|FG000|NOT COMPLETED|Overall Study||10
11247324|NCT02139943|12440493|FG001|NOT COMPLETED|Overall Study||6
11247325|NCT02139943|12440494|FG002|NOT COMPLETED|Overall Study||7
11247326|NCT02139969|12440502|FG000|STARTED|Overall Study||956
11247327|NCT02139969|12440502|FG000|COMPLETED|Overall Study||956
11247328|NCT02139969|12440502|FG000|NOT COMPLETED|Overall Study||0
11247329|NCT02139982|12440516|FG000|STARTED|Overall Study||8
11247330|NCT02139982|12440517|FG001|STARTED|Overall Study||8
11247331|NCT02139982|12440518|FG002|STARTED|Overall Study||8
11247332|NCT02139982|12440519|FG003|STARTED|Overall Study||8
11247333|NCT02139982|12440520|FG004|STARTED|Overall Study||13
11247334|NCT02139982|12440521|FG005|STARTED|Overall Study||13
11247335|NCT02139982|12440522|FG006|STARTED|Overall Study||13
11247336|NCT02139982|12440523|FG007|STARTED|Overall Study||13
11247337|NCT02139982|12440524|FG008|STARTED|Overall Study||13
11247338|NCT02139982|12440525|FG009|STARTED|Overall Study||13
11247339|NCT02139982|12440516|FG000|COMPLETED|Overall Study||8
11247340|NCT02139982|12440517|FG001|COMPLETED|Overall Study||7
11247341|NCT02139982|12440518|FG002|COMPLETED|Overall Study||8
11247342|NCT02139982|12440519|FG003|COMPLETED|Overall Study||7
11247343|NCT02139982|12440520|FG004|COMPLETED|Overall Study||13
11247344|NCT02139982|12440521|FG005|COMPLETED|Overall Study||13
11247345|NCT02139982|12440522|FG006|COMPLETED|Overall Study||13
11247346|NCT02139982|12440523|FG007|COMPLETED|Overall Study||13
11247347|NCT02139982|12440524|FG008|COMPLETED|Overall Study||13
11247348|NCT02139982|12440525|FG009|COMPLETED|Overall Study||13
11247349|NCT02139982|12440516|FG000|NOT COMPLETED|Overall Study||0
11247350|NCT02139982|12440517|FG001|NOT COMPLETED|Overall Study||1
11247351|NCT02139982|12440518|FG002|NOT COMPLETED|Overall Study||0
11247352|NCT02139982|12440519|FG003|NOT COMPLETED|Overall Study||1
11247353|NCT02139982|12440520|FG004|NOT COMPLETED|Overall Study||0
11247354|NCT02139982|12440521|FG005|NOT COMPLETED|Overall Study||0
11247355|NCT02139982|12440522|FG006|NOT COMPLETED|Overall Study||0
11247356|NCT02139982|12440523|FG007|NOT COMPLETED|Overall Study||0
11247357|NCT02139982|12440524|FG008|NOT COMPLETED|Overall Study||0
11247358|NCT02139982|12440525|FG009|NOT COMPLETED|Overall Study||0
11247359|NCT02140060|12440553|FG000|STARTED|Overall Study||44
11247360|NCT02140060|12440554|FG001|STARTED|Overall Study||44
11247361|NCT02140060|12440555|FG002|STARTED|Overall Study||44
11247362|NCT02140060|12440556|FG003|STARTED|Overall Study||45
11247363|NCT02140060|12440557|FG004|STARTED|Overall Study||45
11247364|NCT02140060|12440558|FG005|STARTED|Overall Study||44
11247365|NCT02140060|12440553|FG000|COMPLETED|Overall Study||44
11247366|NCT02140060|12440554|FG001|COMPLETED|Overall Study||44
11247367|NCT02140060|12440555|FG002|COMPLETED|Overall Study||44
11247368|NCT02140060|12440556|FG003|COMPLETED|Overall Study||43
11247369|NCT02140060|12440557|FG004|COMPLETED|Overall Study||44
11247370|NCT02140060|12440558|FG005|COMPLETED|Overall Study||43
11247371|NCT02140060|12440553|FG000|NOT COMPLETED|Overall Study||0
11247372|NCT02140060|12440554|FG001|NOT COMPLETED|Overall Study||0
11247373|NCT02140060|12440555|FG002|NOT COMPLETED|Overall Study||0
11247374|NCT02140060|12440556|FG003|NOT COMPLETED|Overall Study||2
11247375|NCT02140060|12440557|FG004|NOT COMPLETED|Overall Study||1
11247376|NCT02140060|12440558|FG005|NOT COMPLETED|Overall Study||1
11247377|NCT02140164|12440573|FG000|STARTED|Overall Study||7
11247378|NCT02140164|12440573|FG000|COMPLETED|Overall Study||5
11247379|NCT02140164|12440573|FG000|NOT COMPLETED|Overall Study||2
11247380|NCT02140372|12440577|FG000|STARTED|Overall Study||10
11247381|NCT02140372|12440577|FG000|COMPLETED|Overall Study||10
11247382|NCT02140372|12440577|FG000|NOT COMPLETED|Overall Study||0
11247383|NCT02140411|12440581|FG000|STARTED|Overall Study||21
11247384|NCT02140411|12440581|FG000|COMPLETED|Overall Study||20
11247385|NCT02140411|12440581|FG000|NOT COMPLETED|Overall Study||1
11247386|NCT02140567|12440585|FG000|STARTED|Overall Study||140
11247387|NCT02140567|12440585|FG000|COMPLETED|Overall Study||134
11247388|NCT02140567|12440585|FG000|NOT COMPLETED|Overall Study||6
11247389|NCT02140593|12440592|FG000|STARTED|Overall Study||63
11247390|NCT02140593|12440593|FG001|STARTED|Overall Study||65
11247391|NCT02140593|12440592|FG000|COMPLETED|Overall Study||63
11247392|NCT02140593|12440593|FG001|COMPLETED|Overall Study||65
11247393|NCT02140593|12440592|FG000|NOT COMPLETED|Overall Study||0
11247394|NCT02140593|12440593|FG001|NOT COMPLETED|Overall Study||0
11247395|NCT02140645|12440605|FG000|STARTED|Overall Study||5732
11247396|NCT02140645|12440606|FG001|STARTED|Overall Study||64695
11247397|NCT02140645|12440607|FG002|STARTED|Overall Study||4441
11247398|NCT02140645|12440608|FG003|STARTED|Overall Study||14363
11247399|NCT02140645|12440609|FG004|STARTED|Overall Study||3436
11247400|NCT02140645|12440610|FG005|STARTED|Overall Study||73946
11247401|NCT02140645|12440605|FG000|COMPLETED|Overall Study||243
11247402|NCT02140645|12440606|FG001|COMPLETED|Overall Study||3041
11247403|NCT02140645|12440607|FG002|COMPLETED|Overall Study||205
11247404|NCT02140645|12440608|FG003|COMPLETED|Overall Study||530
11247405|NCT02140645|12440609|FG004|COMPLETED|Overall Study||150
11247406|NCT02140645|12440610|FG005|COMPLETED|Overall Study||3050
11247407|NCT02140645|12440605|FG000|NOT COMPLETED|Overall Study||5489
11247408|NCT02140645|12440606|FG001|NOT COMPLETED|Overall Study||61654
11247409|NCT02140645|12440607|FG002|NOT COMPLETED|Overall Study||4236
11247410|NCT02140645|12440608|FG003|NOT COMPLETED|Overall Study||13833
11247411|NCT02140645|12440609|FG004|NOT COMPLETED|Overall Study||3286
11247412|NCT02140645|12440610|FG005|NOT COMPLETED|Overall Study||70896
11247413|NCT02140762|12440621|FG000|STARTED|Overall Study||154
11247414|NCT02140762|12440622|FG001|STARTED|Overall Study||151
11247415|NCT02140762|12440621|FG000|COMPLETED|Overall Study||137
11247416|NCT02140762|12440622|FG001|COMPLETED|Overall Study||139
11247417|NCT02140762|12440621|FG000|NOT COMPLETED|Overall Study||17
11247418|NCT02140762|12440622|FG001|NOT COMPLETED|Overall Study||12
11247419|NCT02140775|12440635|FG000|STARTED|Overall Study||87
11247420|NCT02140775|12440636|FG001|STARTED|Overall Study||29
11247421|NCT02140775|12440635|FG000|COMPLETED|Overall Study||57
11247422|NCT02140775|12440636|FG001|COMPLETED|Overall Study||22
11247423|NCT02140775|12440635|FG000|NOT COMPLETED|Overall Study||30
11247424|NCT02140775|12440636|FG001|NOT COMPLETED|Overall Study||7
11247425|NCT02140957|12440646|FG000|STARTED|Overall Study||129
11247426|NCT02140957|12440647|FG001|STARTED|Overall Study||122
11247427|NCT02140957|12440646|FG000|COMPLETED|Overall Study||102
11247428|NCT02140957|12440647|FG001|COMPLETED|Overall Study||99
11247429|NCT02140957|12440646|FG000|NOT COMPLETED|Overall Study||27
11247430|NCT02140957|12440647|FG001|NOT COMPLETED|Overall Study||23
11247431|NCT02140970|12440655|FG000|STARTED|Overall Study||24
11247432|NCT02140970|12440656|FG001|STARTED|Overall Study||25
11247433|NCT02140970|12440655|FG000|Received Intervention|Overall Study||23
11247434|NCT02140970|12440656|FG001|Received Intervention|Overall Study||25
11247435|NCT02140970|12440655|FG000|Analyzed|Overall Study||22
11247436|NCT02140970|12440656|FG001|Analyzed|Overall Study||22
11247437|NCT02140970|12440655|FG000|COMPLETED|Overall Study||22
11247438|NCT02140970|12440656|FG001|COMPLETED|Overall Study||22
11247439|NCT02140970|12440655|FG000|NOT COMPLETED|Overall Study||2
11247440|NCT02140970|12440656|FG001|NOT COMPLETED|Overall Study||3
11247441|NCT02141204|12440664|FG000|STARTED|Overall Study||224
11247442|NCT02141204|12440665|FG001|STARTED|Overall Study||225
11247443|NCT02141204|12440664|FG000|COMPLETED|Overall Study||209
11247444|NCT02141204|12440665|FG001|COMPLETED|Overall Study||210
11247445|NCT02141204|12440664|FG000|NOT COMPLETED|Overall Study||15
11247446|NCT02141204|12440665|FG001|NOT COMPLETED|Overall Study||15
11247447|NCT02141217|12440673|FG000|STARTED|Overall Study||234
11247448|NCT02141217|12440674|FG001|STARTED|Overall Study||237
11247449|NCT02141217|12440673|FG000|ITT Population-Randomized Treatment Arm|Overall Study||234
11247450|NCT02141217|12440674|FG001|ITT Population-Randomized Treatment Arm|Overall Study||237
11247451|NCT02141217|12440673|FG000|ITT Population-Actual Treatment Received|Overall Study||236
11247452|NCT02141217|12440674|FG001|ITT Population-Actual Treatment Received|Overall Study||235
11247453|NCT02141217|12440673|FG000|COMPLETED|Overall Study||223
11247454|NCT02141217|12440674|FG001|COMPLETED|Overall Study||229
11247455|NCT02141217|12440673|FG000|NOT COMPLETED|Overall Study||11
11247456|NCT02141217|12440674|FG001|NOT COMPLETED|Overall Study||8
11247457|NCT02141295|12440686|FG000|STARTED|Overall Study||8
11247458|NCT02141295|12440687|FG001|STARTED|Overall Study||94
11247459|NCT02141295|12440688|FG002|STARTED|Overall Study||95
11247460|NCT02141295|12440686|FG000|COMPLETED|Overall Study||2
11247461|NCT02141295|12440687|FG001|COMPLETED|Overall Study||0
11247462|NCT02141295|12440688|FG002|COMPLETED|Overall Study||0
11247463|NCT02141295|12440686|FG000|NOT COMPLETED|Overall Study||6
11247464|NCT02141295|12440687|FG001|NOT COMPLETED|Overall Study||94
11247465|NCT02141295|12440688|FG002|NOT COMPLETED|Overall Study||95
11247466|NCT02141360|12440700|FG000|STARTED|Overall Study||11
11247467|NCT02141360|12440701|FG001|STARTED|Overall Study||6
11247468|NCT02141360|12440702|FG002|STARTED|Overall Study||6
11247469|NCT02141360|12440700|FG000|COMPLETED|Overall Study||4
11247470|NCT02141360|12440701|FG001|COMPLETED|Overall Study||6
11247471|NCT02141360|12440702|FG002|COMPLETED|Overall Study||6
11247472|NCT02141360|12440700|FG000|NOT COMPLETED|Overall Study||7
11247473|NCT02141360|12440701|FG001|NOT COMPLETED|Overall Study||0
11247474|NCT02141360|12440702|FG002|NOT COMPLETED|Overall Study||0
11247475|NCT02141399|12440710|FG000|STARTED|Overall Study||1485
11247476|NCT02141399|12440710|FG000|COMPLETED|Overall Study||741
11247477|NCT02141399|12440710|FG000|NOT COMPLETED|Overall Study||744
11247478|NCT02141451|12440718|FG000|STARTED|Overall Study||3
11247479|NCT02141451|12440719|FG001|STARTED|Overall Study||4
11247480|NCT02141451|12440720|FG002|STARTED|Overall Study||7
11247481|NCT02141451|12440721|FG003|STARTED|Overall Study||16
11247482|NCT02141451|12440718|FG000|COMPLETED|Overall Study||3
11247483|NCT02141451|12440719|FG001|COMPLETED|Overall Study||2
11247484|NCT02141451|12440720|FG002|COMPLETED|Overall Study||2
11247485|NCT02141451|12440721|FG003|COMPLETED|Overall Study||7
11247486|NCT02141451|12440718|FG000|NOT COMPLETED|Overall Study||0
11247487|NCT02141451|12440719|FG001|NOT COMPLETED|Overall Study||2
11247488|NCT02141451|12440720|FG002|NOT COMPLETED|Overall Study||5
11247489|NCT02141451|12440721|FG003|NOT COMPLETED|Overall Study||9
11247490|NCT02141490|12440737|FG000|STARTED|Overall Study||34
11247491|NCT02141490|12440738|FG001|STARTED|Overall Study||6
11247492|NCT02141490|12440739|FG002|STARTED|Overall Study||3
11247493|NCT02141490|12440737|FG000|COMPLETED|Overall Study||30
11247494|NCT02141490|12440738|FG001|COMPLETED|Overall Study||6
11247495|NCT02141490|12440739|FG002|COMPLETED|Overall Study||3
11247496|NCT02141490|12440737|FG000|NOT COMPLETED|Overall Study||4
11247497|NCT02141490|12440738|FG001|NOT COMPLETED|Overall Study||0
11247498|NCT02141490|12440739|FG002|NOT COMPLETED|Overall Study||0
11247499|NCT02141516|12440752|FG000|STARTED|Overall Study||40
11247500|NCT02141516|12440753|FG001|STARTED|Overall Study||112
11247501|NCT02141516|12440754|FG002|STARTED|Overall Study||87
11247502|NCT02141516|12440752|FG000|COMPLETED|Overall Study||40
11247503|NCT02141516|12440753|FG001|COMPLETED|Overall Study||107
11247504|NCT02141516|12440754|FG002|COMPLETED|Overall Study||87
11247505|NCT02141516|12440752|FG000|NOT COMPLETED|Overall Study||0
11247506|NCT02141516|12440753|FG001|NOT COMPLETED|Overall Study||5
11247507|NCT02141516|12440754|FG002|NOT COMPLETED|Overall Study||0
11247508|NCT02141555|12440768|FG000|STARTED|Overall Study||2
11247509|NCT02141555|12440769|FG001|STARTED|Overall Study||2
11247510|NCT02141555|12440768|FG000|COMPLETED|Overall Study||2
11247511|NCT02141555|12440769|FG001|COMPLETED|Overall Study||2
11247512|NCT02141555|12440768|FG000|NOT COMPLETED|Overall Study||0
11247513|NCT02141555|12440769|FG001|NOT COMPLETED|Overall Study||0
11247514|NCT02141581|12440778|FG000|STARTED|Overall Study||42
11247515|NCT02141581|12440779|FG001|STARTED|Overall Study||19
11247516|NCT02141581|12440780|FG002|STARTED|Overall Study||25
11247517|NCT02141581|12440778|FG000|COMPLETED|Overall Study||42
11247518|NCT02141581|12440779|FG001|COMPLETED|Overall Study||19
11247519|NCT02141581|12440780|FG002|COMPLETED|Overall Study||25
11247520|NCT02141581|12440778|FG000|NOT COMPLETED|Overall Study||0
11247521|NCT02141581|12440779|FG001|NOT COMPLETED|Overall Study||0
11247522|NCT02141581|12440780|FG002|NOT COMPLETED|Overall Study||0
11247523|NCT02141620|12440788|FG000|STARTED|Treatment Condition 1 (7 Days)||8
11247524|NCT02141620|12440789|FG001|STARTED|Treatment Condition 1 (7 Days)||7
11247525|NCT02141620|12440788|FG000|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
11247526|NCT02141620|12440789|FG001|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
11247527|NCT02141620|12440788|FG000|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
11247528|NCT02141620|12440789|FG001|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
11247529|NCT02141620|12440788|FG000|STARTED|Treatment Condition 2 (7 Days)||7
11247530|NCT02141620|12440789|FG001|STARTED|Treatment Condition 2 (7 Days)||7
11247531|NCT02141620|12440788|FG000|COMPLETED|Treatment Condition 2 (7 Days)||7
11247532|NCT02141620|12440789|FG001|COMPLETED|Treatment Condition 2 (7 Days)||7
11247533|NCT02141620|12440788|FG000|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
11247534|NCT02141620|12440789|FG001|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
11247535|NCT02141633|12440797|FG000|STARTED|Overall Study||16
11247536|NCT02141633|12440798|FG001|STARTED|Overall Study||15
11247537|NCT02141633|12440797|FG000|COMPLETED|Overall Study||15
11247538|NCT02141633|12440798|FG001|COMPLETED|Overall Study||15
11247539|NCT02141633|12440797|FG000|NOT COMPLETED|Overall Study||1
11247540|NCT02141633|12440798|FG001|NOT COMPLETED|Overall Study||0
11247541|NCT02141659|12440810|FG000|STARTED|Overall Study||3
11247542|NCT02141659|12440811|FG001|STARTED|Overall Study||4
11247543|NCT02141659|12440812|FG002|STARTED|Overall Study||3
11247544|NCT02141659|12440813|FG003|STARTED|Overall Study||3
11247545|NCT02141659|12440814|FG004|STARTED|Overall Study||15
11247546|NCT02141659|12440815|FG005|STARTED|Overall Study||15
11247547|NCT02141659|12440810|FG000|COMPLETED|Overall Study||3
11247548|NCT02141659|12440811|FG001|COMPLETED|Overall Study||3
11247549|NCT02141659|12440812|FG002|COMPLETED|Overall Study||3
11247550|NCT02141659|12440813|FG003|COMPLETED|Overall Study||3
11247551|NCT02141659|12440814|FG004|COMPLETED|Overall Study||13
11247552|NCT02141659|12440815|FG005|COMPLETED|Overall Study||13
11247553|NCT02141659|12440810|FG000|NOT COMPLETED|Overall Study||0
11247554|NCT02141659|12440811|FG001|NOT COMPLETED|Overall Study||1
11247555|NCT02141659|12440812|FG002|NOT COMPLETED|Overall Study||0
11247556|NCT02141659|12440813|FG003|NOT COMPLETED|Overall Study||0
11247557|NCT02141659|12440814|FG004|NOT COMPLETED|Overall Study||2
11247558|NCT02141659|12440815|FG005|NOT COMPLETED|Overall Study||2
11247559|NCT02141672|12440832|FG000|STARTED|Overall Study||89
11247560|NCT02141672|12440833|FG001|STARTED|Overall Study||88
11247561|NCT02141672|12440834|FG002|STARTED|Overall Study||88
11247562|NCT02141672|12440832|FG000|COMPLETED|Overall Study||73
11247563|NCT02141672|12440833|FG001|COMPLETED|Overall Study||80
11247564|NCT02141672|12440834|FG002|COMPLETED|Overall Study||70
11247565|NCT02141672|12440832|FG000|NOT COMPLETED|Overall Study||16
11247566|NCT02141672|12440833|FG001|NOT COMPLETED|Overall Study||8
11247567|NCT02141672|12440834|FG002|NOT COMPLETED|Overall Study||18
11247568|NCT02141854|12440847|FG000|STARTED|Run-In Period (Pre-assignment)||882
11247569|NCT02141854|12440848|FG001|STARTED|Run-In Period (Pre-assignment)||0
11247570|NCT02141854|12440849|FG002|STARTED|Run-In Period (Pre-assignment)||0
11247571|NCT02141854|12440850|FG003|STARTED|Run-In Period (Pre-assignment)||0
11247572|NCT02141854|12440851|FG004|STARTED|Run-In Period (Pre-assignment)||0
11247573|NCT02141854|12440852|FG005|STARTED|Run-In Period (Pre-assignment)||0
11247574|NCT02141854|12440847|FG000|COMPLETED|Run-In Period (Pre-assignment)||728
11247575|NCT02141854|12440848|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
11247576|NCT02141854|12440849|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
11247577|NCT02141854|12440850|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
11247578|NCT02141854|12440851|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
11247579|NCT02141854|12440852|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
11247580|NCT02141854|12440847|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||154
11247581|NCT02141854|12440848|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11247582|NCT02141854|12440849|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11247583|NCT02141854|12440850|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11247584|NCT02141854|12440851|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11247585|NCT02141854|12440852|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11247586|NCT02141854|12440847|FG000|STARTED|Treatment Period||0
11247587|NCT02141854|12440848|FG001|STARTED|Treatment Period||146
11247588|NCT02141854|12440849|FG002|STARTED|Treatment Period||145
11247589|NCT02141854|12440850|FG003|STARTED|Treatment Period||146
11247590|NCT02141854|12440851|FG004|STARTED|Treatment Period||146
11247591|NCT02141854|12440852|FG005|STARTED|Treatment Period||145
11247592|NCT02141854|12440847|FG000|Intent to Treat Population|Treatment Period||0
11247593|NCT02141854|12440848|FG001|Intent to Treat Population|Treatment Period||146
11247594|NCT02141854|12440849|FG002|Intent to Treat Population|Treatment Period||145
11247595|NCT02141854|12440850|FG003|Intent to Treat Population|Treatment Period||146
11247596|NCT02141854|12440851|FG004|Intent to Treat Population|Treatment Period||146
11247597|NCT02141854|12440852|FG005|Intent to Treat Population|Treatment Period||145
11247598|NCT02141854|12440847|FG000|Safety Population|Treatment Period||0
11247599|NCT02141854|12440848|FG001|Safety Population|Treatment Period||145
11247600|NCT02141854|12440849|FG002|Safety Population|Treatment Period||143
11247601|NCT02141854|12440850|FG003|Safety Population|Treatment Period||146
11247602|NCT02141854|12440851|FG004|Safety Population|Treatment Period||145
11247603|NCT02141854|12440852|FG005|Safety Population|Treatment Period||144
11247604|NCT02141854|12440847|FG000|Full Analysis Set|Treatment Period||0
11247605|NCT02141854|12440848|FG001|Full Analysis Set|Treatment Period||145
11247606|NCT02141854|12440849|FG002|Full Analysis Set|Treatment Period||141
11247607|NCT02141854|12440850|FG003|Full Analysis Set|Treatment Period||146
11247608|NCT02141854|12440851|FG004|Full Analysis Set|Treatment Period||145
11247609|NCT02141854|12440852|FG005|Full Analysis Set|Treatment Period||143
11247610|NCT02141854|12440847|FG000|COMPLETED|Treatment Period||0
11247611|NCT02141854|12440848|FG001|COMPLETED|Treatment Period||136
11247612|NCT02141854|12440849|FG002|COMPLETED|Treatment Period||136
11247613|NCT02141854|12440850|FG003|COMPLETED|Treatment Period||135
11247614|NCT02141854|12440851|FG004|COMPLETED|Treatment Period||136
11247615|NCT02141854|12440852|FG005|COMPLETED|Treatment Period||107
11247616|NCT02141854|12440847|FG000|NOT COMPLETED|Treatment Period||0
11247617|NCT02141854|12440848|FG001|NOT COMPLETED|Treatment Period||10
11247618|NCT02141854|12440849|FG002|NOT COMPLETED|Treatment Period||9
11247619|NCT02141854|12440850|FG003|NOT COMPLETED|Treatment Period||11
11247620|NCT02141854|12440851|FG004|NOT COMPLETED|Treatment Period||10
11247621|NCT02141854|12440852|FG005|NOT COMPLETED|Treatment Period||38
11247622|NCT02141867|12440864|FG000|STARTED|Overall Study||4021
11247623|NCT02141867|12440864|FG000|COMPLETED|Overall Study||3927
11247624|NCT02141867|12440864|FG000|NOT COMPLETED|Overall Study||94
11247625|NCT02141984|12440868|FG000|STARTED|Overall Study||28
11247626|NCT02141984|12440868|FG000|COMPLETED|Overall Study||26
11247627|NCT02141984|12440868|FG000|NOT COMPLETED|Overall Study||2
11247628|NCT02141997|12440876|FG000|STARTED|Overall Study||56
11247629|NCT02141997|12440877|FG001|STARTED|Overall Study||55
11247630|NCT02141997|12440878|FG002|STARTED|Overall Study||56
11247631|NCT02141997|12440879|FG003|STARTED|Overall Study||55
11247632|NCT02141997|12440876|FG000|COMPLETED|Overall Study||53
11247633|NCT02141997|12440877|FG001|COMPLETED|Overall Study||49
11247634|NCT02141997|12440878|FG002|COMPLETED|Overall Study||53
11247635|NCT02141997|12440879|FG003|COMPLETED|Overall Study||54
11247636|NCT02141997|12440876|FG000|NOT COMPLETED|Overall Study||3
11247637|NCT02141997|12440877|FG001|NOT COMPLETED|Overall Study||6
11247638|NCT02141997|12440878|FG002|NOT COMPLETED|Overall Study||3
11247639|NCT02141997|12440879|FG003|NOT COMPLETED|Overall Study||1
11247640|NCT02142049|12440894|FG000|STARTED|Overall Study||3
11247641|NCT02142049|12440895|FG001|STARTED|Overall Study||3
11247642|NCT02142049|12440896|FG002|STARTED|Overall Study||3
11247643|NCT02142049|12440897|FG003|STARTED|Overall Study||6
11247644|NCT02142049|12440898|FG004|STARTED|Overall Study||20
11247645|NCT02142049|12440894|FG000|COMPLETED|Overall Study||3
11247646|NCT02142049|12440895|FG001|COMPLETED|Overall Study||3
11247647|NCT02142049|12440896|FG002|COMPLETED|Overall Study||3
11247648|NCT02142049|12440897|FG003|COMPLETED|Overall Study||6
11247649|NCT02142049|12440898|FG004|COMPLETED|Overall Study||20
11247650|NCT02142049|12440894|FG000|NOT COMPLETED|Overall Study||0
11247651|NCT02142049|12440895|FG001|NOT COMPLETED|Overall Study||0
11247652|NCT02142049|12440896|FG002|NOT COMPLETED|Overall Study||0
11247653|NCT02142049|12440897|FG003|NOT COMPLETED|Overall Study||0
11247654|NCT02142049|12440898|FG004|NOT COMPLETED|Overall Study||0
11247655|NCT02142153|12440925|FG000|STARTED|Overall Study||6
11247656|NCT02142153|12440926|FG001|STARTED|Overall Study||2
11247657|NCT02142153|12440927|FG002|STARTED|Overall Study||6
11247658|NCT02142153|12440928|FG003|STARTED|Overall Study||2
11247659|NCT02142153|12440929|FG004|STARTED|Overall Study||6
11247660|NCT02142153|12440930|FG005|STARTED|Overall Study||2
11247661|NCT02142153|12440931|FG006|STARTED|Overall Study||6
11247662|NCT02142153|12440932|FG007|STARTED|Overall Study||2
11247663|NCT02142153|12440933|FG008|STARTED|Overall Study||6
11247664|NCT02142153|12440934|FG009|STARTED|Overall Study||2
11247665|NCT02142153|12440925|FG000|COMPLETED|Overall Study||6
11247666|NCT02142153|12440926|FG001|COMPLETED|Overall Study||2
11247667|NCT02142153|12440927|FG002|COMPLETED|Overall Study||6
11247668|NCT02142153|12440928|FG003|COMPLETED|Overall Study||2
11247669|NCT02142153|12440929|FG004|COMPLETED|Overall Study||6
11247670|NCT02142153|12440930|FG005|COMPLETED|Overall Study||2
11247671|NCT02142153|12440931|FG006|COMPLETED|Overall Study||6
11247672|NCT02142153|12440932|FG007|COMPLETED|Overall Study||2
11247673|NCT02142153|12440933|FG008|COMPLETED|Overall Study||6
11247674|NCT02142153|12440934|FG009|COMPLETED|Overall Study||2
11247675|NCT02142153|12440925|FG000|NOT COMPLETED|Overall Study||0
11247676|NCT02142153|12440926|FG001|NOT COMPLETED|Overall Study||0
11247677|NCT02142153|12440927|FG002|NOT COMPLETED|Overall Study||0
11247678|NCT02142153|12440928|FG003|NOT COMPLETED|Overall Study||0
11247679|NCT02142153|12440929|FG004|NOT COMPLETED|Overall Study||0
11247680|NCT02142153|12440930|FG005|NOT COMPLETED|Overall Study||0
11247681|NCT02142153|12440931|FG006|NOT COMPLETED|Overall Study||0
11247682|NCT02142153|12440932|FG007|NOT COMPLETED|Overall Study||0
11247683|NCT02142153|12440933|FG008|NOT COMPLETED|Overall Study||0
11247684|NCT02142153|12440934|FG009|NOT COMPLETED|Overall Study||0
11247685|NCT02142283|12440968|FG000|STARTED|Overall Study||107
11247686|NCT02142283|12440969|FG001|STARTED|Overall Study||99
11247687|NCT02142283|12440968|FG000|COMPLETED|Overall Study||86
11247688|NCT02142283|12440969|FG001|COMPLETED|Overall Study||78
11247689|NCT02142283|12440968|FG000|NOT COMPLETED|Overall Study||21
11247690|NCT02142283|12440969|FG001|NOT COMPLETED|Overall Study||21
11247691|NCT02142361|12440975|FG000|STARTED|Overall Study||20
11247692|NCT02142361|12440976|FG001|STARTED|Overall Study||20
11247693|NCT02142361|12440977|FG002|STARTED|Overall Study||20
11247694|NCT02142361|12440975|FG000|COMPLETED|Overall Study||20
11247695|NCT02142361|12440976|FG001|COMPLETED|Overall Study||20
11247696|NCT02142361|12440977|FG002|COMPLETED|Overall Study||20
11247697|NCT02142361|12440975|FG000|NOT COMPLETED|Overall Study||0
11247698|NCT02142361|12440976|FG001|NOT COMPLETED|Overall Study||0
11247699|NCT02142361|12440977|FG002|NOT COMPLETED|Overall Study||0
11247700|NCT02142387|12440990|FG000|STARTED|Overall Study|Out-of-hospital cardiac arrest (OHCA) patients with presumed cardiac etiology.|2551
11247701|NCT02142387|12440991|FG001|STARTED|Overall Study||16271
11247702|NCT02142387|12440990|FG000|COMPLETED|Overall Study|Limited to the case where OHCA occurred in the private place.|1486
11247703|NCT02142387|12440991|FG001|COMPLETED|Overall Study||8641
11247704|NCT02142387|12440990|FG000|NOT COMPLETED|Overall Study||1065
11247705|NCT02142387|12440991|FG001|NOT COMPLETED|Overall Study||7630
11247706|NCT02142504|12441000|FG000|STARTED|Overall Study||153
11247707|NCT02142504|12441001|FG001|STARTED|Overall Study||147
11247708|NCT02142504|12441002|FG002|STARTED|Overall Study||154
11247709|NCT02142504|12441000|FG000|Randomized and Received Treatment|Overall Study||153
11247710|NCT02142504|12441001|FG001|Randomized and Received Treatment|Overall Study||145
11247711|NCT02142504|12441002|FG002|Randomized and Received Treatment|Overall Study||154
11247712|NCT02142504|12441000|FG000|Received Booster (Second Vaccination)|Overall Study||126
11247713|NCT02142504|12441001|FG001|Received Booster (Second Vaccination)|Overall Study||109
11247714|NCT02142504|12441002|FG002|Received Booster (Second Vaccination)|Overall Study||116
11247715|NCT02142504|12441000|FG000|COMPLETED|Overall Study||122
11247716|NCT02142504|12441001|FG001|COMPLETED|Overall Study||105
11247717|NCT02142504|12441002|FG002|COMPLETED|Overall Study||111
11247718|NCT02142504|12441000|FG000|NOT COMPLETED|Overall Study||31
11247719|NCT02142504|12441001|FG001|NOT COMPLETED|Overall Study||42
11247720|NCT02142504|12441002|FG002|NOT COMPLETED|Overall Study||43
11247721|NCT02142608|12441010|FG000|STARTED|Overall Study||18
11247722|NCT02142608|12441010|FG000|COMPLETED|Overall Study||18
11247723|NCT02142608|12441010|FG000|NOT COMPLETED|Overall Study||0
11247724|NCT02142712|12441018|FG000|STARTED|Overall Study||1
11247725|NCT02142712|12441019|FG001|STARTED|Overall Study||1
11247726|NCT02142712|12441020|FG002|STARTED|Overall Study||1
11247727|NCT02142712|12441021|FG003|STARTED|Overall Study||0
11247728|NCT02142712|12441018|FG000|COMPLETED|Overall Study||0
11247729|NCT02142712|12441019|FG001|COMPLETED|Overall Study||0
11247730|NCT02142712|12441020|FG002|COMPLETED|Overall Study||0
11247731|NCT02142712|12441021|FG003|COMPLETED|Overall Study||0
11247732|NCT02142712|12441018|FG000|NOT COMPLETED|Overall Study||1
11247733|NCT02142712|12441019|FG001|NOT COMPLETED|Overall Study||1
11247734|NCT02142712|12441020|FG002|NOT COMPLETED|Overall Study||1
11247735|NCT02142712|12441021|FG003|NOT COMPLETED|Overall Study||0
11247736|NCT02142894|12441030|FG000|STARTED|Overall Study||33
11005398|NCT00722800|12183114|FG001|NOT COMPLETED|Overall Study||0
11005399|NCT00722865|12183120|FG000|STARTED|Overall Study||25
11005400|NCT00722865|12183120|FG000|COMPLETED|Overall Study||23
11247737|NCT02142894|12441030|FG000|COMPLETED|Overall Study||25
11247738|NCT02142894|12441030|FG000|NOT COMPLETED|Overall Study||8
11339300|NCT02911818|12536792|FG003|NOT COMPLETED|52 Week Study||0
11339301|NCT02911818|12536793|FG004|NOT COMPLETED|52 Week Study||0
11339302|NCT02911818|12536789|FG000|STARTED|12 Week Extension Study||0
11339303|NCT02911818|12536790|FG001|STARTED|12 Week Extension Study||0
11339304|NCT02911818|12536791|FG002|STARTED|12 Week Extension Study||0
11339305|NCT02911818|12536792|FG003|STARTED|12 Week Extension Study||22
11339306|NCT02911818|12536793|FG004|STARTED|12 Week Extension Study||23
11339307|NCT02911818|12536789|FG000|COMPLETED|12 Week Extension Study||0
11339308|NCT02911818|12536790|FG001|COMPLETED|12 Week Extension Study||0
11339309|NCT02911818|12536791|FG002|COMPLETED|12 Week Extension Study||0
11339310|NCT02911818|12536792|FG003|COMPLETED|12 Week Extension Study||22
11339311|NCT02911818|12536793|FG004|COMPLETED|12 Week Extension Study||22
11339312|NCT02911818|12536789|FG000|NOT COMPLETED|12 Week Extension Study||0
11339313|NCT02911818|12536790|FG001|NOT COMPLETED|12 Week Extension Study||0
11339314|NCT02911818|12536791|FG002|NOT COMPLETED|12 Week Extension Study||0
11339315|NCT02911818|12536792|FG003|NOT COMPLETED|12 Week Extension Study||0
11339316|NCT02911818|12536793|FG004|NOT COMPLETED|12 Week Extension Study||1
11339317|NCT02911844|12536807|FG000|STARTED|Overall Study||5
11339318|NCT02911844|12536807|FG000|COMPLETED|Overall Study||5
11339319|NCT02911844|12536807|FG000|NOT COMPLETED|Overall Study||0
11339320|NCT02911857|12536814|FG000|STARTED|Overall Study||2
11339321|NCT02911857|12536815|FG001|STARTED|Overall Study||1
11247739|NCT02143024|12441036|FG000|STARTED|Overall Study||15
11247740|NCT02143024|12441037|FG001|STARTED|Overall Study||8
11247741|NCT02143024|12441036|FG000|Received Treatment|Overall Study||13
11247742|NCT02143024|12441037|FG001|Received Treatment|Overall Study||7
11247743|NCT02143024|12441036|FG000|COMPLETED|Overall Study||13
11247744|NCT02143024|12441037|FG001|COMPLETED|Overall Study||7
11247745|NCT02143024|12441036|FG000|NOT COMPLETED|Overall Study||2
11247746|NCT02143024|12441037|FG001|NOT COMPLETED|Overall Study||1
11247747|NCT02143102|12441045|FG000|STARTED|Overall Study||97
11247748|NCT02143102|12441046|FG001|STARTED|Overall Study||28
11247749|NCT02143102|12441045|FG000|COMPLETED|Overall Study||86
11247750|NCT02143102|12441046|FG001|COMPLETED|Overall Study||28
11247751|NCT02143102|12441045|FG000|NOT COMPLETED|Overall Study||11
11247752|NCT02143102|12441046|FG001|NOT COMPLETED|Overall Study||0
11247753|NCT02143141|12441054|FG000|STARTED|Overall Study||7
11247754|NCT02143141|12441055|FG001|STARTED|Overall Study||6
11247755|NCT02143141|12441054|FG000|COMPLETED|Overall Study||6
11247756|NCT02143141|12441055|FG001|COMPLETED|Overall Study||6
11247757|NCT02143141|12441054|FG000|NOT COMPLETED|Overall Study||1
11247758|NCT02143141|12441055|FG001|NOT COMPLETED|Overall Study||0
11247759|NCT02143310|12441061|FG000|STARTED|Overall Study||209
11247760|NCT02143310|12441061|FG000|COMPLETED|Overall Study||102
11247761|NCT02143310|12441061|FG000|NOT COMPLETED|Overall Study||107
11247762|NCT02143583|12441068|FG000|STARTED|Overall Study||62
11247763|NCT02143583|12441069|FG001|STARTED|Overall Study||66
11247764|NCT02143583|12441070|FG002|STARTED|Overall Study||68
11247765|NCT02143583|12441068|FG000|COMPLETED|Overall Study||61
11247766|NCT02143583|12441069|FG001|COMPLETED|Overall Study||66
11247767|NCT02143583|12441070|FG002|COMPLETED|Overall Study||66
11247768|NCT02143583|12441068|FG000|NOT COMPLETED|Overall Study||1
11247769|NCT02143583|12441069|FG001|NOT COMPLETED|Overall Study||0
11247770|NCT02143583|12441070|FG002|NOT COMPLETED|Overall Study||2
11247771|NCT02143648|12441081|FG000|STARTED|Overall Study||128
11247772|NCT02143648|12441082|FG001|STARTED|Overall Study||120
11247773|NCT02143648|12441083|FG002|STARTED|Overall Study||125
11247774|NCT02143648|12441081|FG000|COMPLETED|Overall Study||74
11247775|NCT02143648|12441082|FG001|COMPLETED|Overall Study||78
11247776|NCT02143648|12441083|FG002|COMPLETED|Overall Study||101
11247777|NCT02143648|12441081|FG000|NOT COMPLETED|Overall Study||54
11247778|NCT02143648|12441082|FG001|NOT COMPLETED|Overall Study||42
11247779|NCT02143648|12441083|FG002|NOT COMPLETED|Overall Study||24
11247780|NCT02143713|12441095|FG000|STARTED|Treatment Period (6 Months)||102
11247781|NCT02143713|12441096|FG001|STARTED|Treatment Period (6 Months)||111
11247782|NCT02143713|12441097|FG002|STARTED|Treatment Period (6 Months)||142
11247783|NCT02143713|12441098|FG003|STARTED|Treatment Period (6 Months)||140
11247784|NCT02143713|12441095|FG000|Received Elagolix|Treatment Period (6 Months)||102
11247785|NCT02143713|12441096|FG001|Received Elagolix|Treatment Period (6 Months)||111
11247786|NCT02143713|12441097|FG002|Received Elagolix|Treatment Period (6 Months)||142
11247787|NCT02143713|12441098|FG003|Received Elagolix|Treatment Period (6 Months)||140
11247788|NCT02143713|12441095|FG000|COMPLETED|Treatment Period (6 Months)||82
11247789|NCT02143713|12441096|FG001|COMPLETED|Treatment Period (6 Months)||99
11247790|NCT02143713|12441097|FG002|COMPLETED|Treatment Period (6 Months)||120
11247791|NCT02143713|12441098|FG003|COMPLETED|Treatment Period (6 Months)||112
11247792|NCT02143713|12441095|FG000|NOT COMPLETED|Treatment Period (6 Months)||20
11247793|NCT02143713|12441096|FG001|NOT COMPLETED|Treatment Period (6 Months)||12
11247794|NCT02143713|12441097|FG002|NOT COMPLETED|Treatment Period (6 Months)||22
11247795|NCT02143713|12441098|FG003|NOT COMPLETED|Treatment Period (6 Months)||28
11247796|NCT02143713|12441095|FG000|STARTED|Post-treatment Follow-up (12 Months)||85
11247797|NCT02143713|12441096|FG001|STARTED|Post-treatment Follow-up (12 Months)||105
11247798|NCT02143713|12441097|FG002|STARTED|Post-treatment Follow-up (12 Months)||125
11247799|NCT02143713|12441098|FG003|STARTED|Post-treatment Follow-up (12 Months)||122
11247800|NCT02143713|12441095|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||73
11247801|NCT02143713|12441096|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||81
11247802|NCT02143713|12441097|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||96
11247803|NCT02143713|12441098|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||95
11247804|NCT02143713|12441095|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
11247805|NCT02143713|12441096|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
11247806|NCT02143713|12441097|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
11247807|NCT02143713|12441098|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
11247808|NCT02143778|12441109|FG000|STARTED|Overall Study||246
11247809|NCT02143778|12441109|FG000|COMPLETED|Overall Study||243
11247810|NCT02143778|12441109|FG000|NOT COMPLETED|Overall Study||3
11247811|NCT02143843|12441114|FG000|STARTED|Overall Study||75
11247812|NCT02143843|12441114|FG000|COMPLETED|Overall Study||63
11247813|NCT02143843|12441114|FG000|NOT COMPLETED|Overall Study||12
11247814|NCT02143947|12441120|FG000|STARTED|Overall Study||36
11247815|NCT02143947|12441121|FG001|STARTED|Overall Study||44
11247816|NCT02143947|12441120|FG000|COMPLETED|Overall Study||32
11247817|NCT02143947|12441121|FG001|COMPLETED|Overall Study||42
11247818|NCT02143947|12441120|FG000|NOT COMPLETED|Overall Study||4
11247819|NCT02143947|12441121|FG001|NOT COMPLETED|Overall Study||2
11247820|NCT02143973|12441129|FG000|STARTED|Overall Study||167
11247821|NCT02143973|12441129|FG000|COMPLETED|Overall Study||101
11247822|NCT02143973|12441129|FG000|NOT COMPLETED|Overall Study||66
11247823|NCT02144012|12441135|FG000|STARTED|Overall Study||34
11247824|NCT02144012|12441136|FG001|STARTED|Overall Study||15
11247825|NCT02144012|12441135|FG000|COMPLETED|Overall Study||0
11247826|NCT02144012|12441136|FG001|COMPLETED|Overall Study||0
11247827|NCT02144012|12441135|FG000|NOT COMPLETED|Overall Study||34
11247828|NCT02144012|12441136|FG001|NOT COMPLETED|Overall Study||15
11247829|NCT02144077|12441144|FG000|STARTED|Overall Study||138
11247830|NCT02144077|12441145|FG001|STARTED|Overall Study||143
11247831|NCT02144077|12441144|FG000|COMPLETED|Overall Study||128
11247832|NCT02144077|12441145|FG001|COMPLETED|Overall Study||132
11247833|NCT02144077|12441144|FG000|NOT COMPLETED|Overall Study||10
11247834|NCT02144077|12441145|FG001|NOT COMPLETED|Overall Study||11
11247835|NCT02144220|12441151|FG000|STARTED|Overall Study||277
11247836|NCT02144220|12441151|FG000|COMPLETED|Overall Study||258
11247837|NCT02144220|12441151|FG000|NOT COMPLETED|Overall Study||19
11247838|NCT02144233|12441157|FG000|STARTED|Overall Study||39
11247839|NCT02144233|12441158|FG001|STARTED|Overall Study||38
11247840|NCT02144233|12441157|FG000|COMPLETED|Overall Study|The last participant was assessed at month 3 due to early study stop|39
11247841|NCT02144233|12441158|FG001|COMPLETED|Overall Study||38
11247842|NCT02144233|12441157|FG000|NOT COMPLETED|Overall Study||0
11247843|NCT02144233|12441158|FG001|NOT COMPLETED|Overall Study||0
11247844|NCT02144259|12441167|FG000|STARTED|Overall Study||33
11247845|NCT02144259|12441168|FG001|STARTED|Overall Study||33
11247846|NCT02144259|12441169|FG002|STARTED|Overall Study||34
11247847|NCT02144259|12441167|FG000|COMPLETED|Overall Study||23
11247848|NCT02144259|12441168|FG001|COMPLETED|Overall Study||28
11247849|NCT02144259|12441169|FG002|COMPLETED|Overall Study||16
11247850|NCT02144259|12441167|FG000|NOT COMPLETED|Overall Study||10
11247851|NCT02144259|12441168|FG001|NOT COMPLETED|Overall Study||5
11247852|NCT02144259|12441169|FG002|NOT COMPLETED|Overall Study||18
11247853|NCT02144285|12441187|FG000|STARTED|Overall Study||14
11247854|NCT02144285|12441188|FG001|STARTED|Overall Study||6
11247855|NCT02144285|12441189|FG002|STARTED|Overall Study||6
11247856|NCT02144285|12441190|FG003|STARTED|Overall Study||6
11247857|NCT02144285|12441191|FG004|STARTED|Overall Study||6
11247858|NCT02144285|12441192|FG005|STARTED|Overall Study||6
11247859|NCT02144285|12441193|FG006|STARTED|Overall Study||6
11247860|NCT02144285|12441194|FG007|STARTED|Overall Study||6
11247861|NCT02144285|12441195|FG008|STARTED|Overall Study||2
11247862|NCT02144285|12441196|FG009|STARTED|Overall Study||6
11247863|NCT02144285|12441187|FG000|Received At Least One Dose of Study Drug|Overall Study||14
11247864|NCT02144285|12441188|FG001|Received At Least One Dose of Study Drug|Overall Study||6
11247865|NCT02144285|12441189|FG002|Received At Least One Dose of Study Drug|Overall Study||6
11247866|NCT02144285|12441190|FG003|Received At Least One Dose of Study Drug|Overall Study||6
11247867|NCT02144285|12441191|FG004|Received At Least One Dose of Study Drug|Overall Study||6
11247868|NCT02144285|12441192|FG005|Received At Least One Dose of Study Drug|Overall Study||6
11247869|NCT02144285|12441193|FG006|Received At Least One Dose of Study Drug|Overall Study||6
11247870|NCT02144285|12441194|FG007|Received At Least One Dose of Study Drug|Overall Study||6
11247871|NCT02144285|12441195|FG008|Received At Least One Dose of Study Drug|Overall Study||2
11247872|NCT02144285|12441196|FG009|Received At Least One Dose of Study Drug|Overall Study||6
11247873|NCT02144285|12441187|FG000|COMPLETED|Overall Study||14
11247874|NCT02144285|12441188|FG001|COMPLETED|Overall Study||6
11247875|NCT02144285|12441189|FG002|COMPLETED|Overall Study||6
11247876|NCT02144285|12441190|FG003|COMPLETED|Overall Study||6
11247877|NCT02144285|12441191|FG004|COMPLETED|Overall Study||5
11247878|NCT02144285|12441192|FG005|COMPLETED|Overall Study||6
11247879|NCT02144285|12441193|FG006|COMPLETED|Overall Study||6
11247880|NCT02144285|12441194|FG007|COMPLETED|Overall Study||6
11247881|NCT02144285|12441195|FG008|COMPLETED|Overall Study||2
11247882|NCT02144285|12441196|FG009|COMPLETED|Overall Study||6
11247883|NCT02144285|12441187|FG000|NOT COMPLETED|Overall Study||0
11247884|NCT02144285|12441188|FG001|NOT COMPLETED|Overall Study||0
11247885|NCT02144285|12441189|FG002|NOT COMPLETED|Overall Study||0
11247886|NCT02144285|12441190|FG003|NOT COMPLETED|Overall Study||0
11247887|NCT02144285|12441191|FG004|NOT COMPLETED|Overall Study||1
11247888|NCT02144285|12441192|FG005|NOT COMPLETED|Overall Study||0
11247889|NCT02144285|12441193|FG006|NOT COMPLETED|Overall Study||0
11247890|NCT02144285|12441194|FG007|NOT COMPLETED|Overall Study||0
11247891|NCT02144285|12441195|FG008|NOT COMPLETED|Overall Study||0
11247892|NCT02144285|12441196|FG009|NOT COMPLETED|Overall Study||0
11247893|NCT02144337|12441234|FG000|STARTED|Baseline 0 Months||8
11247894|NCT02144337|12441235|FG001|STARTED|Baseline 0 Months||5
11247895|NCT02144337|12441234|FG000|COMPLETED|Baseline 0 Months||8
11247896|NCT02144337|12441235|FG001|COMPLETED|Baseline 0 Months||5
11247897|NCT02144337|12441234|FG000|NOT COMPLETED|Baseline 0 Months||0
11247898|NCT02144337|12441235|FG001|NOT COMPLETED|Baseline 0 Months||0
11247899|NCT02144337|12441234|FG000|STARTED|T2 Follow-up (Post-intervention)||8
11247900|NCT02144337|12441235|FG001|STARTED|T2 Follow-up (Post-intervention)||5
11247901|NCT02144337|12441234|FG000|COMPLETED|T2 Follow-up (Post-intervention)||4
11247902|NCT02144337|12441235|FG001|COMPLETED|T2 Follow-up (Post-intervention)||4
11247903|NCT02144337|12441234|FG000|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
11247904|NCT02144337|12441235|FG001|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
11339322|NCT02911857|12536816|FG002|STARTED|Overall Study||1
11247905|NCT02144337|12441234|FG000|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
11247906|NCT02144337|12441235|FG001|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
11247907|NCT02144337|12441234|FG000|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
11247908|NCT02144337|12441235|FG001|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
11247909|NCT02144337|12441234|FG000|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
11247910|NCT02144337|12441235|FG001|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
11247911|NCT02139540|12441244|FG000|STARTED|Overall Study||11
11247912|NCT02139540|12441245|FG001|STARTED|Overall Study||10
11247913|NCT02139540|12441244|FG000|COMPLETED|Overall Study||10
11247914|NCT02139540|12441245|FG001|COMPLETED|Overall Study||10
11247915|NCT02139540|12441244|FG000|NOT COMPLETED|Overall Study||1
11247916|NCT02139540|12441245|FG001|NOT COMPLETED|Overall Study||0
11247917|NCT02144519|12441253|FG000|STARTED|Year 1||895
11247918|NCT02144519|12441254|FG001|STARTED|Year 1||870
11247919|NCT02144519|12441253|FG000|COMPLETED|Year 1||895
11247920|NCT02144519|12441254|FG001|COMPLETED|Year 1||870
11247921|NCT02144519|12441253|FG000|NOT COMPLETED|Year 1||0
11247922|NCT02144519|12441254|FG001|NOT COMPLETED|Year 1||0
11247923|NCT02144519|12441253|FG000|STARTED|Year 2||763
11247924|NCT02144519|12441254|FG001|STARTED|Year 2||864
11247925|NCT02144519|12441253|FG000|COMPLETED|Year 2||763
11247926|NCT02144519|12441254|FG001|COMPLETED|Year 2||864
11247927|NCT02144519|12441253|FG000|NOT COMPLETED|Year 2||0
11247928|NCT02144519|12441254|FG001|NOT COMPLETED|Year 2||0
11247929|NCT02144519|12441253|FG000|STARTED|Year 3||894
11247930|NCT02144519|12441254|FG001|STARTED|Year 3||760
11247931|NCT02144519|12441253|FG000|COMPLETED|Year 3||894
11247932|NCT02144519|12441254|FG001|COMPLETED|Year 3||760
11247933|NCT02144519|12441253|FG000|NOT COMPLETED|Year 3||0
11247934|NCT02144519|12441254|FG001|NOT COMPLETED|Year 3||0
11247935|NCT02144597|12441263|FG000|STARTED|Overall Study||10
11247936|NCT02144597|12441264|FG001|STARTED|Overall Study||10
11247937|NCT02144597|12441265|FG002|STARTED|Overall Study||10
11247938|NCT02144597|12441263|FG000|COMPLETED|Overall Study||4
11247939|NCT02144597|12441264|FG001|COMPLETED|Overall Study||6
11247940|NCT02144597|12441265|FG002|COMPLETED|Overall Study||6
11247941|NCT02144597|12441263|FG000|NOT COMPLETED|Overall Study||6
11247942|NCT02144597|12441264|FG001|NOT COMPLETED|Overall Study||4
11247943|NCT02144597|12441265|FG002|NOT COMPLETED|Overall Study||4
11247944|NCT02144610|12441275|FG000|STARTED|Overall Study||23
11247945|NCT02144610|12441276|FG001|STARTED|Overall Study||23
11247946|NCT02144610|12441275|FG000|COMPLETED|Overall Study||0
11247947|NCT02144610|12441276|FG001|COMPLETED|Overall Study||1
11247948|NCT02144610|12441275|FG000|NOT COMPLETED|Overall Study||23
11247949|NCT02144610|12441276|FG001|NOT COMPLETED|Overall Study||22
11247950|NCT02144675|12441284|FG000|STARTED|Overall Study||13
11247951|NCT02144675|12441285|FG001|STARTED|Overall Study||14
11247952|NCT02144675|12441284|FG000|COMPLETED|Overall Study||13
11247953|NCT02144675|12441285|FG001|COMPLETED|Overall Study||14
11247954|NCT02144675|12441284|FG000|NOT COMPLETED|Overall Study||0
11247955|NCT02144675|12441285|FG001|NOT COMPLETED|Overall Study||0
11247956|NCT02144701|12441293|FG000|STARTED|Overall Study||22
11247957|NCT02144701|12441294|FG001|STARTED|Overall Study||11
11247958|NCT02144701|12441293|FG000|COMPLETED|Overall Study||13
11247959|NCT02144701|12441294|FG001|COMPLETED|Overall Study||8
11247960|NCT02144701|12441293|FG000|NOT COMPLETED|Overall Study||9
11247961|NCT02144701|12441294|FG001|NOT COMPLETED|Overall Study||3
11247962|NCT02144714|12441303|FG000|STARTED|Overall Study||63
11247963|NCT02144714|12441304|FG001|STARTED|Overall Study||63
11247964|NCT02144714|12441305|FG002|STARTED|Overall Study||63
11247965|NCT02144714|12441303|FG000|COMPLETED|Overall Study||63
11247966|NCT02144714|12441304|FG001|COMPLETED|Overall Study||63
11247967|NCT02144714|12441305|FG002|COMPLETED|Overall Study||63
11247968|NCT02144714|12441303|FG000|NOT COMPLETED|Overall Study||0
11247969|NCT02144714|12441304|FG001|NOT COMPLETED|Overall Study||0
11247970|NCT02144714|12441305|FG002|NOT COMPLETED|Overall Study||0
11247971|NCT02145026|12441313|FG000|STARTED|Overall Study||100
11247972|NCT02145026|12441313|FG000|COMPLETED|Overall Study||88
11247973|NCT02145026|12441313|FG000|NOT COMPLETED|Overall Study||12
11247974|NCT02145039|12441317|FG000|STARTED|Overall Study||2
11247975|NCT02145039|12441317|FG000|COMPLETED|Overall Study||2
11247976|NCT02145039|12441317|FG000|NOT COMPLETED|Overall Study||0
11247977|NCT02145078|12441321|FG000|STARTED|Overall Study||4
11247978|NCT02145078|12441321|FG000|COMPLETED|Overall Study||0
11247979|NCT02145078|12441321|FG000|NOT COMPLETED|Overall Study||4
11247980|NCT02145156|12441328|FG000|STARTED|Overall Study||430
11247981|NCT02145156|12441329|FG001|STARTED|Overall Study||425
11247982|NCT02145156|12441330|FG002|STARTED|Overall Study||439
11247983|NCT02145156|12441328|FG000|COMPLETED|Overall Study||370
11247984|NCT02145156|12441329|FG001|COMPLETED|Overall Study||373
11247985|NCT02145156|12441330|FG002|COMPLETED|Overall Study||398
11247986|NCT02145156|12441328|FG000|NOT COMPLETED|Overall Study||60
11247987|NCT02145156|12441329|FG001|NOT COMPLETED|Overall Study||52
11247988|NCT02145156|12441330|FG002|NOT COMPLETED|Overall Study||41
11005401|NCT00722865|12183120|FG000|NOT COMPLETED|Overall Study||2
11005402|NCT00723008|12183126|FG000|STARTED|Enrollment||11
11005403|NCT00723008|12183127|FG001|STARTED|Enrollment||9
11005404|NCT00723008|12183126|FG000|COMPLETED|Enrollment||10
11005405|NCT00723008|12183127|FG001|COMPLETED|Enrollment||9
11005406|NCT00723008|12183126|FG000|NOT COMPLETED|Enrollment||1
11005407|NCT00723008|12183127|FG001|NOT COMPLETED|Enrollment||0
11005408|NCT00723008|12183126|FG000|STARTED|4-Week Double Blinded||10
11005409|NCT00723008|12183127|FG001|STARTED|4-Week Double Blinded||9
11005410|NCT00723008|12183126|FG000|COMPLETED|4-Week Double Blinded||5
11005411|NCT00723008|12183127|FG001|COMPLETED|4-Week Double Blinded||4
11005412|NCT00723008|12183126|FG000|NOT COMPLETED|4-Week Double Blinded||5
11005413|NCT00723008|12183127|FG001|NOT COMPLETED|4-Week Double Blinded||5
11005414|NCT00723008|12183126|FG000|STARTED|4-Week Unblinded Treatment||5
11005415|NCT00723008|12183127|FG001|STARTED|4-Week Unblinded Treatment||4
11005416|NCT00723008|12183126|FG000|COMPLETED|4-Week Unblinded Treatment||4
11005417|NCT00723008|12183127|FG001|COMPLETED|4-Week Unblinded Treatment||3
11005418|NCT00723008|12183126|FG000|NOT COMPLETED|4-Week Unblinded Treatment||1
11247989|NCT02145182|12441340|FG000|STARTED|Overall Study||142
11247990|NCT02145182|12441341|FG001|STARTED|Overall Study||146
11247991|NCT02145182|12441340|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142
11247992|NCT02145182|12441341|FG001|Received at Least 1 Dose of Study Drug|Overall Study||146
11247993|NCT02145182|12441340|FG000|COMPLETED|Overall Study||124
11247994|NCT02145182|12441341|FG001|COMPLETED|Overall Study||130
11247995|NCT02145182|12441340|FG000|NOT COMPLETED|Overall Study||18
11247996|NCT02145182|12441341|FG001|NOT COMPLETED|Overall Study||16
11247997|NCT02145247|12441349|FG000|STARTED|Overall Study||20
11247998|NCT02145247|12441350|FG001|STARTED|Overall Study||19
11247999|NCT02145247|12441349|FG000|COMPLETED|Overall Study||20
11248000|NCT02145247|12441350|FG001|COMPLETED|Overall Study||19
11248001|NCT02145247|12441349|FG000|NOT COMPLETED|Overall Study||0
11248002|NCT02145247|12441350|FG001|NOT COMPLETED|Overall Study||0
11248003|NCT02145299|12441358|FG000|STARTED|Overall Study||6
11248004|NCT02145299|12441359|FG001|STARTED|Overall Study||2
11248005|NCT02145299|12441358|FG000|COMPLETED|Overall Study||6
11248006|NCT02145299|12441359|FG001|COMPLETED|Overall Study||2
11248007|NCT02145299|12441358|FG000|NOT COMPLETED|Overall Study||0
11248008|NCT02145299|12441359|FG001|NOT COMPLETED|Overall Study||0
11248009|NCT02145429|12441367|FG000|STARTED|Overall Study||91
11248010|NCT02145429|12441368|FG001|STARTED|Overall Study||90
11248011|NCT02145429|12441367|FG000|COMPLETED|Overall Study||75
11248012|NCT02145429|12441368|FG001|COMPLETED|Overall Study||79
11248013|NCT02145429|12441367|FG000|NOT COMPLETED|Overall Study||16
11248014|NCT02145429|12441368|FG001|NOT COMPLETED|Overall Study||11
11248015|NCT02145468|12441376|FG000|STARTED|Overall Study||1758
11248016|NCT02145468|12441377|FG001|STARTED|Overall Study||1731
11248017|NCT02145468|12441376|FG000|COMPLETED|Overall Study||1753
11248018|NCT02145468|12441377|FG001|COMPLETED|Overall Study||1723
11248019|NCT02145468|12441376|FG000|NOT COMPLETED|Overall Study||5
11248020|NCT02145468|12441377|FG001|NOT COMPLETED|Overall Study||8
11248021|NCT02145676|12441386|FG000|STARTED|Overall Study||17
11248022|NCT02145676|12441387|FG001|STARTED|Overall Study||18
11248023|NCT02145676|12441388|FG002|STARTED|Overall Study||18
11248024|NCT02145676|12441386|FG000|COMPLETED|Overall Study||17
11248025|NCT02145676|12441387|FG001|COMPLETED|Overall Study||18
11248026|NCT02145676|12441388|FG002|COMPLETED|Overall Study||18
11248027|NCT02145676|12441386|FG000|NOT COMPLETED|Overall Study||0
11248028|NCT02145676|12441387|FG001|NOT COMPLETED|Overall Study||0
11248029|NCT02145676|12441388|FG002|NOT COMPLETED|Overall Study||0
11248030|NCT02145754|12441396|FG000|STARTED|Overall Study||235
11248031|NCT02145754|12441396|FG000|COMPLETED|Overall Study||235
11248032|NCT02145754|12441396|FG000|NOT COMPLETED|Overall Study||0
11248033|NCT02146001|12441402|FG000|STARTED|Overall Study||19
11248034|NCT02146001|12441403|FG001|STARTED|Overall Study||19
11248035|NCT02146001|12441402|FG000|COMPLETED|Overall Study||19
11248036|NCT02146001|12441403|FG001|COMPLETED|Overall Study||19
11248037|NCT02146001|12441402|FG000|NOT COMPLETED|Overall Study||0
11248038|NCT02146001|12441403|FG001|NOT COMPLETED|Overall Study||0
11248039|NCT02146105|12441409|FG000|STARTED|Overall Study||45
11248040|NCT02146105|12441409|FG000|COMPLETED|Overall Study||39
11005419|NCT00723008|12183127|FG001|NOT COMPLETED|4-Week Unblinded Treatment||1
11248041|NCT02146105|12441409|FG000|NOT COMPLETED|Overall Study||6
11248042|NCT02146131|12441415|FG000|STARTED|Overall Study||170
11248043|NCT02146131|12441416|FG001|STARTED|Overall Study||169
11248044|NCT02146131|12441415|FG000|COMPLETED|Overall Study||109
11248045|NCT02146131|12441416|FG001|COMPLETED|Overall Study||113
11248046|NCT02146131|12441415|FG000|NOT COMPLETED|Overall Study||61
11005420|NCT00723021|12183141|FG000|STARTED|Intervention Period 1||3
11248047|NCT02146131|12441416|FG001|NOT COMPLETED|Overall Study||56
11248048|NCT02146248|12441422|FG000|STARTED|Overall Study||11
11248049|NCT02146248|12441422|FG000|Enrolled|Overall Study||11
11248050|NCT02146248|12441422|FG000|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
11248051|NCT02146248|12441422|FG000|HSG 1|Overall Study||10
11248052|NCT02146248|12441422|FG000|HSG 2|Overall Study||10
11248053|NCT02146248|12441422|FG000|HSG 3|Overall Study||9
11248054|NCT02146248|12441422|FG000|HSG 4|Overall Study||7
11248055|NCT02146248|12441422|FG000|HSG 5|Overall Study||1
11248056|NCT02146248|12441422|FG000|COMPLETED|Overall Study||9
11248057|NCT02146248|12441422|FG000|NOT COMPLETED|Overall Study||2
11248058|NCT02146274|12441430|FG000|STARTED|Overall Study||1877
11248059|NCT02146274|12441430|FG000|COMPLETED|Overall Study||1804
11005421|NCT00723021|12183142|FG001|STARTED|Intervention Period 1||3
11005422|NCT00723021|12183143|FG002|STARTED|Intervention Period 1||3
11248060|NCT02146274|12441430|FG000|NOT COMPLETED|Overall Study||73
11248061|NCT02146326|12441441|FG000|STARTED|Overall Study||89
11248062|NCT02146326|12441442|FG001|STARTED|Overall Study||103
11248063|NCT02146326|12441443|FG002|STARTED|Overall Study||211
11248064|NCT02146326|12441444|FG003|STARTED|Overall Study||258
11248065|NCT02146326|12441441|FG000|Baseline|Overall Study||89
11248066|NCT02146326|12441442|FG001|Baseline|Overall Study||103
11248067|NCT02146326|12441443|FG002|Baseline|Overall Study||211
11248068|NCT02146326|12441444|FG003|Baseline|Overall Study||258
11248069|NCT02146326|12441441|FG000|3 Months|Overall Study||71
11248070|NCT02146326|12441442|FG001|3 Months|Overall Study||83
11248071|NCT02146326|12441443|FG002|3 Months|Overall Study||0
11248072|NCT02146326|12441444|FG003|3 Months|Overall Study||0
11248073|NCT02146326|12441441|FG000|6 Months|Overall Study||71
11248074|NCT02146326|12441442|FG001|6 Months|Overall Study||71
11248075|NCT02146326|12441443|FG002|6 Months|Overall Study||186
11248076|NCT02146326|12441444|FG003|6 Months|Overall Study||235
11248077|NCT02146326|12441441|FG000|12 Months|Overall Study||61
11248078|NCT02146326|12441442|FG001|12 Months|Overall Study||66
11248079|NCT02146326|12441443|FG002|12 Months|Overall Study||168
11248080|NCT02146326|12441444|FG003|12 Months|Overall Study||210
11248081|NCT02146326|12441441|FG000|COMPLETED|Overall Study||61
11248082|NCT02146326|12441442|FG001|COMPLETED|Overall Study||66
11248083|NCT02146326|12441443|FG002|COMPLETED|Overall Study||168
11248084|NCT02146326|12441444|FG003|COMPLETED|Overall Study||210
11248085|NCT02146326|12441441|FG000|NOT COMPLETED|Overall Study||28
11248086|NCT02146326|12441442|FG001|NOT COMPLETED|Overall Study||37
11248087|NCT02146326|12441443|FG002|NOT COMPLETED|Overall Study||43
11248088|NCT02146326|12441444|FG003|NOT COMPLETED|Overall Study||48
11248089|NCT02146352|12441460|FG000|STARTED|Overall Study||30
11248090|NCT02146352|12441460|FG000|30 or 60 Days Post-procedure|Overall Study||30
11248091|NCT02146352|12441460|FG000|7 Days Post-stent Removal|Overall Study||28
11248092|NCT02146352|12441460|FG000|COMPLETED|Overall Study||28
11248093|NCT02146352|12441460|FG000|NOT COMPLETED|Overall Study||2
11248094|NCT02146365|12441470|FG000|STARTED|Overall Study||49
11248095|NCT02146365|12441471|FG001|STARTED|Overall Study||49
11248096|NCT02146365|12441472|FG002|STARTED|Overall Study||50
11248097|NCT02146365|12441473|FG003|STARTED|Overall Study||50
11248098|NCT02146365|12441474|FG004|STARTED|Overall Study||24
11248099|NCT02146365|12441475|FG005|STARTED|Overall Study||25
11248100|NCT02146365|12441476|FG006|STARTED|Overall Study||25
11248101|NCT02146365|12441477|FG007|STARTED|Overall Study||25
11248102|NCT02146365|12441470|FG000|COMPLETED|Overall Study||45
11248103|NCT02146365|12441471|FG001|COMPLETED|Overall Study||45
11248104|NCT02146365|12441472|FG002|COMPLETED|Overall Study||43
11248105|NCT02146365|12441473|FG003|COMPLETED|Overall Study||41
11248106|NCT02146365|12441474|FG004|COMPLETED|Overall Study||22
11248107|NCT02146365|12441475|FG005|COMPLETED|Overall Study||24
11248108|NCT02146365|12441476|FG006|COMPLETED|Overall Study||25
11248109|NCT02146365|12441477|FG007|COMPLETED|Overall Study||24
11248110|NCT02146365|12441470|FG000|NOT COMPLETED|Overall Study||4
11248111|NCT02146365|12441471|FG001|NOT COMPLETED|Overall Study||4
11248112|NCT02146365|12441472|FG002|NOT COMPLETED|Overall Study||7
11248113|NCT02146365|12441473|FG003|NOT COMPLETED|Overall Study||9
11248114|NCT02146365|12441474|FG004|NOT COMPLETED|Overall Study||2
11248115|NCT02146365|12441475|FG005|NOT COMPLETED|Overall Study||1
11248116|NCT02146365|12441476|FG006|NOT COMPLETED|Overall Study||0
11248117|NCT02146365|12441477|FG007|NOT COMPLETED|Overall Study||1
11248118|NCT02146430|12441499|FG000|STARTED|Overall Study||323
11248119|NCT02146430|12441500|FG001|STARTED|Overall Study||323
11248120|NCT02146430|12441501|FG002|STARTED|Overall Study||324
11248121|NCT02146430|12441502|FG003|STARTED|Overall Study||323
11248122|NCT02146430|12441499|FG000|Safety Analysis Set|Overall Study||318
11248123|NCT02146430|12441500|FG001|Safety Analysis Set|Overall Study||318
11248124|NCT02146430|12441501|FG002|Safety Analysis Set|Overall Study||320
11248125|NCT02146430|12441502|FG003|Safety Analysis Set|Overall Study||320
11248126|NCT02146430|12441499|FG000|Modified Intent to Treat Set (mITT)|Overall Study||318
11248127|NCT02146430|12441500|FG001|Modified Intent to Treat Set (mITT)|Overall Study||317
11248128|NCT02146430|12441501|FG002|Modified Intent to Treat Set (mITT)|Overall Study||319
11248129|NCT02146430|12441502|FG003|Modified Intent to Treat Set (mITT)|Overall Study||319
11248130|NCT02146430|12441499|FG000|COMPLETED|Overall Study||256
11248131|NCT02146430|12441500|FG001|COMPLETED|Overall Study||236
11248132|NCT02146430|12441501|FG002|COMPLETED|Overall Study||242
11248133|NCT02146430|12441502|FG003|COMPLETED|Overall Study||224
11248134|NCT02146430|12441499|FG000|NOT COMPLETED|Overall Study||67
11248135|NCT02146430|12441500|FG001|NOT COMPLETED|Overall Study||87
11248136|NCT02146430|12441501|FG002|NOT COMPLETED|Overall Study||82
11248137|NCT02146430|12441502|FG003|NOT COMPLETED|Overall Study||99
11248138|NCT02146482|12441518|FG000|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
11248139|NCT02146482|12441519|FG001|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
11248140|NCT02146482|12441518|FG000|COMPLETED|Overall Study||21
11248141|NCT02146482|12441519|FG001|COMPLETED|Overall Study||25
11248142|NCT02146482|12441518|FG000|NOT COMPLETED|Overall Study||0
11248143|NCT02146482|12441519|FG001|NOT COMPLETED|Overall Study||0
11248144|NCT02146599|12441525|FG000|STARTED|Overall Study||301
11248145|NCT02146599|12441525|FG000|COMPLETED|Overall Study||296
11358459|NCT03124836|12555592|FG000|COMPLETED|Overall Study||28
11248146|NCT02146599|12441525|FG000|NOT COMPLETED|Overall Study||5
11248147|NCT02146833|12441529|FG000|STARTED|Overall Study||20
11248148|NCT02146833|12441529|FG000|COMPLETED|Overall Study||9
11248149|NCT02146833|12441529|FG000|NOT COMPLETED|Overall Study||11
11248150|NCT02147067|12441535|FG000|STARTED|Overall Study||13
11248151|NCT02147067|12441536|FG001|STARTED|Overall Study||13
11248152|NCT02147067|12441535|FG000|COMPLETED|Overall Study||11
11248153|NCT02147067|12441536|FG001|COMPLETED|Overall Study||11
11248154|NCT02147067|12441535|FG000|NOT COMPLETED|Overall Study||2
11248155|NCT02147067|12441536|FG001|NOT COMPLETED|Overall Study||2
11248156|NCT02147093|12441544|FG000|STARTED|Period 1||20
11248157|NCT02147093|12441545|FG001|STARTED|Period 1||20
11248158|NCT02147093|12441544|FG000|COMPLETED|Period 1||20
11248159|NCT02147093|12441545|FG001|COMPLETED|Period 1||19
11248160|NCT02147093|12441544|FG000|NOT COMPLETED|Period 1||0
11248161|NCT02147093|12441545|FG001|NOT COMPLETED|Period 1||1
11248162|NCT02147093|12441544|FG000|STARTED|Period 2||20
11248163|NCT02147093|12441545|FG001|STARTED|Period 2||19
11248164|NCT02147093|12441544|FG000|COMPLETED|Period 2||18
11248165|NCT02147093|12441545|FG001|COMPLETED|Period 2||19
11248166|NCT02147093|12441544|FG000|NOT COMPLETED|Period 2||2
11248167|NCT02147093|12441545|FG001|NOT COMPLETED|Period 2||0
11248168|NCT02147132|12441551|FG000|STARTED|Overall Study||2
11248169|NCT02147132|12441552|FG001|STARTED|Overall Study||2
11248170|NCT02147132|12441553|FG002|STARTED|Overall Study||1
11248171|NCT02147132|12441554|FG003|STARTED|Overall Study||2
11248172|NCT02147132|12441551|FG000|COMPLETED|Overall Study||1
11248173|NCT02147132|12441552|FG001|COMPLETED|Overall Study||2
11248174|NCT02147132|12441553|FG002|COMPLETED|Overall Study||1
11248175|NCT02147132|12441554|FG003|COMPLETED|Overall Study||2
11248176|NCT02147132|12441551|FG000|NOT COMPLETED|Overall Study||1
11248177|NCT02147132|12441552|FG001|NOT COMPLETED|Overall Study||0
11248178|NCT02147132|12441553|FG002|NOT COMPLETED|Overall Study||0
11248179|NCT02147132|12441554|FG003|NOT COMPLETED|Overall Study||0
11248180|NCT02147158|12441570|FG000|STARTED|Treatment Course 1||55
11248181|NCT02147158|12441571|FG001|STARTED|Treatment Course 1||47
11248182|NCT02147158|12441572|FG002|STARTED|Treatment Course 1||107
11248183|NCT02147158|12441573|FG003|STARTED|Treatment Course 1||110
11248184|NCT02147158|12441574|FG004|STARTED|Treatment Course 1||55
11248185|NCT02147158|12441575|FG005|STARTED|Treatment Course 1||58
11248186|NCT02147158|12441570|FG000|COMPLETED|Treatment Course 1||51
11248187|NCT02147158|12441571|FG001|COMPLETED|Treatment Course 1||38
11248188|NCT02147158|12441572|FG002|COMPLETED|Treatment Course 1||99
11248189|NCT02147158|12441573|FG003|COMPLETED|Treatment Course 1||97
11248190|NCT02147158|12441574|FG004|COMPLETED|Treatment Course 1||49
11248191|NCT02147158|12441575|FG005|COMPLETED|Treatment Course 1||50
11248192|NCT02147158|12441570|FG000|NOT COMPLETED|Treatment Course 1||4
11248193|NCT02147158|12441571|FG001|NOT COMPLETED|Treatment Course 1||9
11248194|NCT02147158|12441572|FG002|NOT COMPLETED|Treatment Course 1||8
11248195|NCT02147158|12441573|FG003|NOT COMPLETED|Treatment Course 1||13
11248196|NCT02147158|12441574|FG004|NOT COMPLETED|Treatment Course 1||6
11248197|NCT02147158|12441575|FG005|NOT COMPLETED|Treatment Course 1||8
11248198|NCT02147158|12441570|FG000|STARTED|Off-Treatment Interval 1||51
11248199|NCT02147158|12441571|FG001|STARTED|Off-Treatment Interval 1||38
11248200|NCT02147158|12441572|FG002|STARTED|Off-Treatment Interval 1||99
11248201|NCT02147158|12441573|FG003|STARTED|Off-Treatment Interval 1||97
11248202|NCT02147158|12441574|FG004|STARTED|Off-Treatment Interval 1||49
11248203|NCT02147158|12441575|FG005|STARTED|Off-Treatment Interval 1||50
11248204|NCT02147158|12441570|FG000|COMPLETED|Off-Treatment Interval 1||41
11248205|NCT02147158|12441571|FG001|COMPLETED|Off-Treatment Interval 1||34
11248206|NCT02147158|12441572|FG002|COMPLETED|Off-Treatment Interval 1||84
11248207|NCT02147158|12441573|FG003|COMPLETED|Off-Treatment Interval 1||82
11248208|NCT02147158|12441574|FG004|COMPLETED|Off-Treatment Interval 1||41
11248209|NCT02147158|12441575|FG005|COMPLETED|Off-Treatment Interval 1||45
11248210|NCT02147158|12441570|FG000|NOT COMPLETED|Off-Treatment Interval 1||10
11248211|NCT02147158|12441571|FG001|NOT COMPLETED|Off-Treatment Interval 1||4
11248212|NCT02147158|12441572|FG002|NOT COMPLETED|Off-Treatment Interval 1||15
11248213|NCT02147158|12441573|FG003|NOT COMPLETED|Off-Treatment Interval 1||15
11248214|NCT02147158|12441574|FG004|NOT COMPLETED|Off-Treatment Interval 1||8
11248215|NCT02147158|12441575|FG005|NOT COMPLETED|Off-Treatment Interval 1||5
11248216|NCT02147158|12441570|FG000|STARTED|Treatment Course 2||41
11248217|NCT02147158|12441571|FG001|STARTED|Treatment Course 2||34
11248218|NCT02147158|12441572|FG002|STARTED|Treatment Course 2||84
11248219|NCT02147158|12441573|FG003|STARTED|Treatment Course 2||82
11248220|NCT02147158|12441574|FG004|STARTED|Treatment Course 2||41
11248221|NCT02147158|12441575|FG005|STARTED|Treatment Course 2||45
11248222|NCT02147158|12441570|FG000|COMPLETED|Treatment Course 2||40
11248223|NCT02147158|12441571|FG001|COMPLETED|Treatment Course 2||29
11248224|NCT02147158|12441572|FG002|COMPLETED|Treatment Course 2||79
11248225|NCT02147158|12441573|FG003|COMPLETED|Treatment Course 2||77
11248226|NCT02147158|12441574|FG004|COMPLETED|Treatment Course 2||41
11248227|NCT02147158|12441575|FG005|COMPLETED|Treatment Course 2||43
11248228|NCT02147158|12441570|FG000|NOT COMPLETED|Treatment Course 2||1
11248229|NCT02147158|12441571|FG001|NOT COMPLETED|Treatment Course 2||5
11248230|NCT02147158|12441572|FG002|NOT COMPLETED|Treatment Course 2||5
11248231|NCT02147158|12441573|FG003|NOT COMPLETED|Treatment Course 2||5
11248232|NCT02147158|12441574|FG004|NOT COMPLETED|Treatment Course 2||0
11248233|NCT02147158|12441575|FG005|NOT COMPLETED|Treatment Course 2||2
11248234|NCT02147158|12441570|FG000|STARTED|Off-Treatment Interval 2||40
11248235|NCT02147158|12441571|FG001|STARTED|Off-Treatment Interval 2||29
11248236|NCT02147158|12441572|FG002|STARTED|Off-Treatment Interval 2||79
11248237|NCT02147158|12441573|FG003|STARTED|Off-Treatment Interval 2||77
11248238|NCT02147158|12441574|FG004|STARTED|Off-Treatment Interval 2||41
11248239|NCT02147158|12441575|FG005|STARTED|Off-Treatment Interval 2||43
11248240|NCT02147158|12441570|FG000|COMPLETED|Off-Treatment Interval 2||36
11248241|NCT02147158|12441571|FG001|COMPLETED|Off-Treatment Interval 2||25
11248242|NCT02147158|12441572|FG002|COMPLETED|Off-Treatment Interval 2||69
11248243|NCT02147158|12441573|FG003|COMPLETED|Off-Treatment Interval 2||66
11248244|NCT02147158|12441574|FG004|COMPLETED|Off-Treatment Interval 2||39
11248245|NCT02147158|12441575|FG005|COMPLETED|Off-Treatment Interval 2||39
11248246|NCT02147158|12441570|FG000|NOT COMPLETED|Off-Treatment Interval 2||4
11248247|NCT02147158|12441571|FG001|NOT COMPLETED|Off-Treatment Interval 2||4
11248248|NCT02147158|12441572|FG002|NOT COMPLETED|Off-Treatment Interval 2||10
11248249|NCT02147158|12441573|FG003|NOT COMPLETED|Off-Treatment Interval 2||11
11248250|NCT02147158|12441574|FG004|NOT COMPLETED|Off-Treatment Interval 2||2
11248251|NCT02147158|12441575|FG005|NOT COMPLETED|Off-Treatment Interval 2||4
11248252|NCT02147197|12441595|FG000|STARTED|Overall Study||56
11248253|NCT02147197|12441596|FG001|STARTED|Overall Study||53
11248254|NCT02147197|12441597|FG002|STARTED|Overall Study||48
11248255|NCT02147197|12441595|FG000|COMPLETED|Overall Study||47
11248256|NCT02147197|12441596|FG001|COMPLETED|Overall Study||47
11248257|NCT02147197|12441597|FG002|COMPLETED|Overall Study||39
11248258|NCT02147197|12441595|FG000|NOT COMPLETED|Overall Study||9
11248259|NCT02147197|12441596|FG001|NOT COMPLETED|Overall Study||6
11248260|NCT02147197|12441597|FG002|NOT COMPLETED|Overall Study||9
11248261|NCT02147288|12441607|FG000|STARTED|Overall Study||22
11248262|NCT02147288|12441608|FG001|STARTED|Overall Study||24
11248263|NCT02147288|12441609|FG002|STARTED|Overall Study||0
11248264|NCT02147288|12441610|FG003|STARTED|Overall Study||0
11248265|NCT02147288|12441611|FG004|STARTED|Overall Study||0
11248266|NCT02147288|12441612|FG005|STARTED|Overall Study||0
11248267|NCT02147288|12441613|FG006|STARTED|Overall Study||0
11248268|NCT02147288|12441614|FG007|STARTED|Overall Study||0
11248269|NCT02147288|12441615|FG008|STARTED|Overall Study||0
11248270|NCT02147288|12441616|FG009|STARTED|Overall Study||0
11248271|NCT02147288|12441607|FG000|COMPLETED|Overall Study||21
11248272|NCT02147288|12441608|FG001|COMPLETED|Overall Study||22
11248273|NCT02147288|12441609|FG002|COMPLETED|Overall Study||0
11248274|NCT02147288|12441610|FG003|COMPLETED|Overall Study||0
11248275|NCT02147288|12441611|FG004|COMPLETED|Overall Study||0
11248276|NCT02147288|12441612|FG005|COMPLETED|Overall Study||0
11248277|NCT02147288|12441613|FG006|COMPLETED|Overall Study||0
11248278|NCT02147288|12441614|FG007|COMPLETED|Overall Study||0
11248279|NCT02147288|12441615|FG008|COMPLETED|Overall Study||0
11248280|NCT02147288|12441616|FG009|COMPLETED|Overall Study||0
11248281|NCT02147288|12441607|FG000|NOT COMPLETED|Overall Study||1
11248282|NCT02147288|12441608|FG001|NOT COMPLETED|Overall Study||2
11248283|NCT02147288|12441609|FG002|NOT COMPLETED|Overall Study||0
11248284|NCT02147288|12441610|FG003|NOT COMPLETED|Overall Study||0
11248285|NCT02147288|12441611|FG004|NOT COMPLETED|Overall Study||0
11248286|NCT02147288|12441612|FG005|NOT COMPLETED|Overall Study||0
11248287|NCT02147288|12441613|FG006|NOT COMPLETED|Overall Study||0
11248288|NCT02147288|12441614|FG007|NOT COMPLETED|Overall Study||0
11248289|NCT02147288|12441615|FG008|NOT COMPLETED|Overall Study||0
11248290|NCT02147288|12441616|FG009|NOT COMPLETED|Overall Study||0
11248291|NCT02147301|12441622|FG000|STARTED|Overall Study||17
11248292|NCT02147301|12441622|FG000|COMPLETED|Overall Study||17
11248293|NCT02147301|12441622|FG000|NOT COMPLETED|Overall Study||0
11248294|NCT02147353|12441628|FG000|STARTED|Overall Study||21
11248295|NCT02147353|12441629|FG001|STARTED|Overall Study||21
11248296|NCT02147353|12441628|FG000|COMPLETED|Overall Study||12
11248297|NCT02147353|12441629|FG001|COMPLETED|Overall Study||21
11248298|NCT02147353|12441628|FG000|NOT COMPLETED|Overall Study||9
11248299|NCT02147353|12441629|FG001|NOT COMPLETED|Overall Study||0
11248300|NCT02147522|12441637|FG000|STARTED|Overall Study||178
11248301|NCT02147522|12441638|FG001|STARTED|Overall Study||170
11248302|NCT02147522|12441637|FG000|COMPLETED|Overall Study||122
11248303|NCT02147522|12441638|FG001|COMPLETED|Overall Study||122
11248304|NCT02147522|12441637|FG000|NOT COMPLETED|Overall Study||56
11248305|NCT02147522|12441638|FG001|NOT COMPLETED|Overall Study||48
11248306|NCT02147561|12441644|FG000|STARTED|Overall Study||280
11248307|NCT02147561|12441644|FG000|COMPLETED|Overall Study||276
11248308|NCT02147561|12441644|FG000|NOT COMPLETED|Overall Study||4
11248309|NCT02147587|12441650|FG000|STARTED|Overall Study||57
11248310|NCT02147587|12441651|FG001|STARTED|Overall Study||55
11248311|NCT02147587|12441650|FG000|COMPLETED|Overall Study||46
11248312|NCT02147587|12441651|FG001|COMPLETED|Overall Study||50
11248313|NCT02147587|12441650|FG000|NOT COMPLETED|Overall Study||11
11248314|NCT02147587|12441651|FG001|NOT COMPLETED|Overall Study||5
11248315|NCT02147613|12441659|FG000|STARTED|Overall Study||10
11248316|NCT02147613|12441660|FG001|STARTED|Overall Study||9
11248317|NCT02147613|12441659|FG000|COMPLETED|Overall Study||9
11248318|NCT02147613|12441660|FG001|COMPLETED|Overall Study||6
11248319|NCT02147613|12441659|FG000|NOT COMPLETED|Overall Study||1
11248320|NCT02147613|12441660|FG001|NOT COMPLETED|Overall Study||3
11248321|NCT02147626|12441668|FG000|STARTED|Overall Study||75
11248322|NCT02147626|12441669|FG001|STARTED|Overall Study||76
11248323|NCT02147626|12441668|FG000|COMPLETED|Overall Study||70
11248324|NCT02147626|12441669|FG001|COMPLETED|Overall Study||69
11248325|NCT02147626|12441668|FG000|NOT COMPLETED|Overall Study||5
11248326|NCT02147626|12441669|FG001|NOT COMPLETED|Overall Study||7
11248327|NCT02147691|12441677|FG000|STARTED|Overall Study||10
11248328|NCT02147691|12441678|FG001|STARTED|Overall Study||12
11248329|NCT02147691|12441677|FG000|COMPLETED|Overall Study||6
11248330|NCT02147691|12441678|FG001|COMPLETED|Overall Study||11
11248331|NCT02147691|12441677|FG000|NOT COMPLETED|Overall Study||4
11248332|NCT02147691|12441678|FG001|NOT COMPLETED|Overall Study||1
11248333|NCT02147769|12441684|FG000|STARTED|Overall Study||111
11248334|NCT02147769|12441684|FG000|COMPLETED|Overall Study||111
11248335|NCT02147769|12441684|FG000|NOT COMPLETED|Overall Study||0
11248336|NCT02147899|12441691|FG000|STARTED|Overall Study||71
11248337|NCT02147899|12441692|FG001|STARTED|Overall Study||72
11248338|NCT02147899|12441693|FG002|STARTED|Overall Study||72
11248339|NCT02147899|12441691|FG000|COMPLETED|Overall Study||71
11248340|NCT02147899|12441692|FG001|COMPLETED|Overall Study||72
11248341|NCT02147899|12441693|FG002|COMPLETED|Overall Study||72
11248342|NCT02147899|12441691|FG000|NOT COMPLETED|Overall Study||0
11248343|NCT02147899|12441692|FG001|NOT COMPLETED|Overall Study||0
11248344|NCT02147899|12441693|FG002|NOT COMPLETED|Overall Study||0
11248345|NCT02147990|12441704|FG000|STARTED|Overall Study||154
11248346|NCT02147990|12441705|FG001|STARTED|Overall Study||100
11248347|NCT02147990|12441706|FG002|STARTED|Overall Study||63
11248348|NCT02147990|12441704|FG000|COMPLETED|Overall Study||154
11248349|NCT02147990|12441705|FG001|COMPLETED|Overall Study||100
11248350|NCT02147990|12441706|FG002|COMPLETED|Overall Study||63
11248351|NCT02147990|12441704|FG000|NOT COMPLETED|Overall Study||0
11248352|NCT02147990|12441705|FG001|NOT COMPLETED|Overall Study||0
11248353|NCT02147990|12441706|FG002|NOT COMPLETED|Overall Study||0
11248354|NCT02148107|12441718|FG000|STARTED|Overall Study||8
11248355|NCT02148107|12441719|FG001|STARTED|Overall Study||7
11248356|NCT02148107|12441720|FG002|STARTED|Overall Study||3
11248357|NCT02148107|12441718|FG000|COMPLETED|Overall Study||8
11248358|NCT02148107|12441719|FG001|COMPLETED|Overall Study||7
11248359|NCT02148107|12441720|FG002|COMPLETED|Overall Study||3
11248360|NCT02148107|12441718|FG000|NOT COMPLETED|Overall Study||0
11248361|NCT02148107|12441719|FG001|NOT COMPLETED|Overall Study||0
11248362|NCT02148107|12441720|FG002|NOT COMPLETED|Overall Study||0
11248363|NCT02148211|12441728|FG000|STARTED|Overall Study||507
11248364|NCT02148211|12441728|FG000|COMPLETED|Overall Study||155
11248365|NCT02148211|12441728|FG000|NOT COMPLETED|Overall Study||352
11248366|NCT02148250|12441732|FG000|STARTED|Screening||17
11248367|NCT02148250|12441733|FG001|STARTED|Screening||0
11248368|NCT02148250|12441732|FG000|COMPLETED|Screening||12
11248369|NCT02148250|12441733|FG001|COMPLETED|Screening||0
11248370|NCT02148250|12441732|FG000|NOT COMPLETED|Screening||5
11248371|NCT02148250|12441733|FG001|NOT COMPLETED|Screening||0
11248372|NCT02148250|12441732|FG000|STARTED|Period 1||6
11248373|NCT02148250|12441733|FG001|STARTED|Period 1||6
11248374|NCT02148250|12441732|FG000|COMPLETED|Period 1||6
11248375|NCT02148250|12441733|FG001|COMPLETED|Period 1||6
11248376|NCT02148250|12441732|FG000|NOT COMPLETED|Period 1||0
11248377|NCT02148250|12441733|FG001|NOT COMPLETED|Period 1||0
11248378|NCT02148250|12441732|FG000|STARTED|Period 2||6
11248379|NCT02148250|12441733|FG001|STARTED|Period 2||6
11248380|NCT02148250|12441732|FG000|COMPLETED|Period 2||6
11248381|NCT02148250|12441733|FG001|COMPLETED|Period 2||6
11248382|NCT02148250|12441732|FG000|NOT COMPLETED|Period 2||0
11248383|NCT02148250|12441733|FG001|NOT COMPLETED|Period 2||0
11248384|NCT02148302|12441742|FG000|STARTED|Overall Study||57
11248385|NCT02148302|12441743|FG001|STARTED|Overall Study||66
11248386|NCT02148302|12441742|FG000|COMPLETED|Overall Study||57
11248387|NCT02148302|12441743|FG001|COMPLETED|Overall Study||66
11248388|NCT02148302|12441742|FG000|NOT COMPLETED|Overall Study||0
11248389|NCT02148302|12441743|FG001|NOT COMPLETED|Overall Study||0
11248390|NCT02148445|12441751|FG000|STARTED|Overall Study||198
11248391|NCT02148445|12441752|FG001|STARTED|Overall Study||200
11248392|NCT02148445|12441751|FG000|COMPLETED|Overall Study||197
11248393|NCT02148445|12441752|FG001|COMPLETED|Overall Study||197
11248394|NCT02148445|12441751|FG000|NOT COMPLETED|Overall Study||1
11248395|NCT02148445|12441752|FG001|NOT COMPLETED|Overall Study||3
11248396|NCT02148523|12441763|FG000|STARTED|Overall Study||67
11248397|NCT02148523|12441764|FG001|STARTED|Overall Study||67
11248398|NCT02148523|12441765|FG002|STARTED|Overall Study||67
11248399|NCT02148523|12441763|FG000|COMPLETED|Overall Study||67
11248400|NCT02148523|12441764|FG001|COMPLETED|Overall Study||67
11248401|NCT02148523|12441765|FG002|COMPLETED|Overall Study||67
11248402|NCT02148523|12441763|FG000|NOT COMPLETED|Overall Study||0
11248403|NCT02148523|12441764|FG001|NOT COMPLETED|Overall Study||0
11248404|NCT02148523|12441765|FG002|NOT COMPLETED|Overall Study||0
11248405|NCT02148588|12441773|FG000|STARTED|Overall Study||8
11248406|NCT02148588|12441773|FG000|COMPLETED|Overall Study||8
11248407|NCT02148588|12441773|FG000|NOT COMPLETED|Overall Study||0
11248408|NCT02148718|12441777|FG000|STARTED|Overall Study||86
11248409|NCT02148718|12441777|FG000|COMPLETED|Overall Study||55
11248410|NCT02148718|12441777|FG000|NOT COMPLETED|Overall Study||31
11248411|NCT02148809|12441781|FG000|STARTED|Overall Study||14
11248412|NCT02148809|12441781|FG000|COMPLETED|Overall Study||14
11248413|NCT02148809|12441781|FG000|NOT COMPLETED|Overall Study||0
11248414|NCT02148835|12441788|FG000|STARTED|Overall Study||22
11248415|NCT02148835|12441789|FG001|STARTED|Overall Study||22
11248416|NCT02148835|12441788|FG000|COMPLETED|Overall Study||22
11248417|NCT02148835|12441789|FG001|COMPLETED|Overall Study||22
11248418|NCT02148835|12441788|FG000|NOT COMPLETED|Overall Study||0
11248419|NCT02148835|12441789|FG001|NOT COMPLETED|Overall Study||0
11248420|NCT02148874|12441797|FG000|STARTED|Overall Study||201
11248421|NCT02148874|12441798|FG001|STARTED|Overall Study||86
11248422|NCT02148874|12441797|FG000|COMPLETED|Overall Study||194
11248423|NCT02148874|12441798|FG001|COMPLETED|Overall Study||84
11248424|NCT02148874|12441797|FG000|NOT COMPLETED|Overall Study||7
11248425|NCT02148874|12441798|FG001|NOT COMPLETED|Overall Study||2
11248426|NCT02148952|12441806|FG000|STARTED|Assessing Eligibility and Consent||83166
11248427|NCT02148952|12441807|FG001|STARTED|Assessing Eligibility and Consent||80773
11248428|NCT02148952|12441806|FG000|COMPLETED|Assessing Eligibility and Consent||80063
11248429|NCT02148952|12441807|FG001|COMPLETED|Assessing Eligibility and Consent||77626
11248430|NCT02148952|12441806|FG000|NOT COMPLETED|Assessing Eligibility and Consent||3103
11248431|NCT02148952|12441807|FG001|NOT COMPLETED|Assessing Eligibility and Consent||3147
11248432|NCT02148952|12441806|FG000|STARTED|Follow-Up||80063
11248433|NCT02148952|12441807|FG001|STARTED|Follow-Up||77626
11248434|NCT02148952|12441806|FG000|COMPLETED|Follow-Up||79798
11248435|NCT02148952|12441807|FG001|COMPLETED|Follow-Up||77347
11248436|NCT02148952|12441806|FG000|NOT COMPLETED|Follow-Up||265
11248437|NCT02148952|12441807|FG001|NOT COMPLETED|Follow-Up||279
11248438|NCT02149108|12441823|FG000|STARTED|Overall Study|Randomised patients.|382
11248439|NCT02149108|12441824|FG001|STARTED|Overall Study|Randomised patients.|386
11248440|NCT02149108|12441823|FG000|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
11248441|NCT02149108|12441824|FG001|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
11248442|NCT02149108|12441823|FG000|NOT COMPLETED|Overall Study||380
11248443|NCT02149108|12441824|FG001|NOT COMPLETED|Overall Study||383
11248444|NCT02149173|12441830|FG000|STARTED|Overall Study||29
11248445|NCT02149173|12441830|FG000|COMPLETED|Overall Study||29
11248446|NCT02149173|12441830|FG000|NOT COMPLETED|Overall Study||0
11248447|NCT02149199|12441843|FG000|STARTED|Overall Study||1277
11248448|NCT02149199|12441844|FG001|STARTED|Overall Study||1277
11248449|NCT02149199|12441845|FG002|STARTED|Overall Study||1282
11248450|NCT02149199|12441843|FG000|COMPLETED|Overall Study||1144
11248451|NCT02149199|12441844|FG001|COMPLETED|Overall Study||1084
11248452|NCT02149199|12441845|FG002|COMPLETED|Overall Study||1135
11248453|NCT02149199|12441843|FG000|NOT COMPLETED|Overall Study||133
11248454|NCT02149199|12441844|FG001|NOT COMPLETED|Overall Study||193
11248455|NCT02149199|12441845|FG002|NOT COMPLETED|Overall Study||147
11248456|NCT02149264|12441853|FG000|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
11248457|NCT02149264|12441853|FG000|COMPLETED|Overall Study||139
11005423|NCT00723021|12183144|FG003|STARTED|Intervention Period 1||3
11005424|NCT00723021|12183145|FG004|STARTED|Intervention Period 1||3
11005425|NCT00723021|12183141|FG000|COMPLETED|Intervention Period 1||3
11005426|NCT00723021|12183142|FG001|COMPLETED|Intervention Period 1||3
11005427|NCT00723021|12183143|FG002|COMPLETED|Intervention Period 1||3
11005428|NCT00723021|12183144|FG003|COMPLETED|Intervention Period 1||3
11248458|NCT02149264|12441853|FG000|NOT COMPLETED|Overall Study||20
11248459|NCT02149290|12441857|FG000|STARTED|Overall Study||198
11248460|NCT02149290|12441857|FG000|COMPLETED|Overall Study||198
11248461|NCT02149290|12441857|FG000|NOT COMPLETED|Overall Study||0
11248462|NCT02149303|12441863|FG000|STARTED|Overall Study||191
11248463|NCT02149303|12441863|FG000|COMPLETED|Overall Study||191
11248464|NCT02149303|12441863|FG000|NOT COMPLETED|Overall Study||0
11248465|NCT02149342|12441867|FG000|STARTED|Overall Study|14 patients|14
11248466|NCT02149342|12441867|FG000|COMPLETED|Overall Study|14 patients|14
11248467|NCT02149342|12441867|FG000|NOT COMPLETED|Overall Study||0
11248468|NCT02149420|12441877|FG000|STARTED|Core Study||9
11248469|NCT02149420|12441878|FG001|STARTED|Core Study||6
11248470|NCT02149420|12441879|FG002|STARTED|Core Study||12
11248471|NCT02149420|12441877|FG000|Safety Analysis Set|Core Study||9
11248472|NCT02149420|12441878|FG001|Safety Analysis Set|Core Study||6
11248473|NCT02149420|12441879|FG002|Safety Analysis Set|Core Study||12
11248474|NCT02149420|12441877|FG000|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5
11248475|NCT02149420|12441878|FG001|PK Analysis Set|Core Study||6
11248476|NCT02149420|12441879|FG002|PK Analysis Set|Core Study||12
11248477|NCT02149420|12441877|FG000|PD (Pharmacodynamics) Analysis Set|Core Study||9
11248478|NCT02149420|12441878|FG001|PD (Pharmacodynamics) Analysis Set|Core Study||6
11248479|NCT02149420|12441879|FG002|PD (Pharmacodynamics) Analysis Set|Core Study||12
11248480|NCT02149420|12441877|FG000|COMPLETED|Core Study||9
11248481|NCT02149420|12441878|FG001|COMPLETED|Core Study||5
11248482|NCT02149420|12441879|FG002|COMPLETED|Core Study||10
11248483|NCT02149420|12441877|FG000|NOT COMPLETED|Core Study||0
11248484|NCT02149420|12441878|FG001|NOT COMPLETED|Core Study||1
11248485|NCT02149420|12441879|FG002|NOT COMPLETED|Core Study||2
11248486|NCT02149420|12441877|FG000|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5
11248487|NCT02149420|12441878|FG001|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
11248488|NCT02149420|12441879|FG002|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
11005429|NCT00723021|12183145|FG004|COMPLETED|Intervention Period 1||3
11248489|NCT02149420|12441877|FG000|COMPLETED|Open Label VAY736 10 mg/kg Extension||4
11358460|NCT03124836|12555592|FG000|NOT COMPLETED|Overall Study||0
11358461|NCT03124901|12555596|FG000|STARTED|Overall Study||147
11358462|NCT03124901|12555596|FG000|COMPLETED|Overall Study||147
11358463|NCT03124901|12555596|FG000|NOT COMPLETED|Overall Study||0
11358464|NCT03124927|12555600|FG000|STARTED|Overall Study||25
11358465|NCT03124927|12555600|FG000|COMPLETED|Overall Study||25
11358466|NCT03124927|12555600|FG000|NOT COMPLETED|Overall Study||0
11358467|NCT03124966|12555604|FG000|STARTED|Overall Study||118
11358468|NCT03124966|12555604|FG000|COMPLETED|Overall Study||118
11358469|NCT03124966|12555604|FG000|NOT COMPLETED|Overall Study||0
11358470|NCT03124979|12555608|FG000|STARTED|Overall Study||13
11358471|NCT03124979|12555608|FG000|COMPLETED|Overall Study||13
11358472|NCT03124979|12555608|FG000|NOT COMPLETED|Overall Study||0
11358473|NCT03125005|12555612|FG000|STARTED|Overall Study||51
11358474|NCT03125005|12555612|FG000|COMPLETED|Overall Study||51
11358475|NCT03125005|12555612|FG000|NOT COMPLETED|Overall Study||0
11358476|NCT03125018|12555616|FG000|STARTED|Overall Study||13
11358477|NCT03125018|12555616|FG000|COMPLETED|Overall Study||13
11358478|NCT03125018|12555616|FG000|NOT COMPLETED|Overall Study||0
11358479|NCT03125031|12555620|FG000|STARTED|Overall Study||44
11358480|NCT03125031|12555621|FG001|STARTED|Overall Study||44
11358481|NCT03125031|12555620|FG000|COMPLETED|Overall Study||44
11358482|NCT03125031|12555621|FG001|COMPLETED|Overall Study||44
11358483|NCT03125031|12555620|FG000|NOT COMPLETED|Overall Study||0
11358484|NCT03125031|12555621|FG001|NOT COMPLETED|Overall Study||0
11358485|NCT03125200|12555633|FG000|STARTED|Overall Study||2
11358486|NCT03125200|12555634|FG001|STARTED|Overall Study||2
11358487|NCT03125200|12555635|FG002|STARTED|Overall Study||2
11358488|NCT03125200|12555636|FG003|STARTED|Overall Study||5
11358489|NCT03125200|12555637|FG004|STARTED|Overall Study||4
11358490|NCT03125200|12555638|FG005|STARTED|Overall Study||3
11358491|NCT03125200|12555639|FG006|STARTED|Overall Study||3
11358492|NCT03125200|12555633|FG000|COMPLETED|Overall Study||0
11358493|NCT03125200|12555634|FG001|COMPLETED|Overall Study||0
11358494|NCT03125200|12555635|FG002|COMPLETED|Overall Study||0
11358495|NCT03125200|12555636|FG003|COMPLETED|Overall Study||0
11358496|NCT03125200|12555637|FG004|COMPLETED|Overall Study||0
11358497|NCT03125200|12555638|FG005|COMPLETED|Overall Study||0
11358498|NCT03125200|12555639|FG006|COMPLETED|Overall Study||0
11358499|NCT03125200|12555633|FG000|NOT COMPLETED|Overall Study||2
11358500|NCT03125200|12555634|FG001|NOT COMPLETED|Overall Study||2
11358501|NCT03125200|12555635|FG002|NOT COMPLETED|Overall Study||2
11358502|NCT03125200|12555636|FG003|NOT COMPLETED|Overall Study||5
11358503|NCT03125200|12555637|FG004|NOT COMPLETED|Overall Study||4
11358504|NCT03125200|12555638|FG005|NOT COMPLETED|Overall Study||3
11358505|NCT03125200|12555639|FG006|NOT COMPLETED|Overall Study||3
11358506|NCT03125226|12555658|FG000|STARTED|Overall Study||12
11358507|NCT03125226|12555658|FG000|COMPLETED|Overall Study||12
11358508|NCT03125226|12555658|FG000|NOT COMPLETED|Overall Study||0
11358509|NCT03125395|12555662|FG000|STARTED|Overall Study||57
11358510|NCT03125395|12555662|FG000|Study 115B FAS|Overall Study||60
11358511|NCT03125395|12555662|FG000|Study 116 FAS|Overall Study||57
11358512|NCT03125395|12555662|FG000|Study 116 LCI Substudy Set|Overall Study||31
11358513|NCT03125395|12555662|FG000|COMPLETED|Overall Study||47
11358514|NCT03125395|12555662|FG000|NOT COMPLETED|Overall Study||10
11358515|NCT03125629|12555666|FG000|STARTED|Overall Study||53
11358516|NCT03125629|12555666|FG000|COMPLETED|Overall Study||50
11358517|NCT03125629|12555666|FG000|NOT COMPLETED|Overall Study||3
11358518|NCT03125915|12555682|FG000|STARTED|Baseline and Intervention||32
11358519|NCT03125915|12555683|FG001|STARTED|Baseline and Intervention||40
11358520|NCT03125915|12555684|FG002|STARTED|Baseline and Intervention||34
11358521|NCT03125915|12555685|FG003|STARTED|Baseline and Intervention||34
11358522|NCT03125915|12555682|FG000|COMPLETED|Baseline and Intervention||32
11358523|NCT03125915|12555683|FG001|COMPLETED|Baseline and Intervention||40
11358524|NCT03125915|12555684|FG002|COMPLETED|Baseline and Intervention||34
11358525|NCT03125915|12555685|FG003|COMPLETED|Baseline and Intervention||34
11358526|NCT03125915|12555682|FG000|NOT COMPLETED|Baseline and Intervention||0
11358527|NCT03125915|12555683|FG001|NOT COMPLETED|Baseline and Intervention||0
11358528|NCT03125915|12555684|FG002|NOT COMPLETED|Baseline and Intervention||0
11358529|NCT03125915|12555685|FG003|NOT COMPLETED|Baseline and Intervention||0
11358530|NCT03125915|12555682|FG000|STARTED|1 Month Follow up||32
11358531|NCT03125915|12555683|FG001|STARTED|1 Month Follow up||40
11248490|NCT02149420|12441878|FG001|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
11248491|NCT02149420|12441879|FG002|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
11248492|NCT02149420|12441877|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1
11248493|NCT02149420|12441878|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
11248494|NCT02149420|12441879|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
11248495|NCT02149524|12441894|FG000|STARTED|Overall Study||438
11248496|NCT02149524|12441895|FG001|STARTED|Overall Study||437
11248497|NCT02149524|12441894|FG000|COMPLETED|Overall Study||384
11248498|NCT02149524|12441895|FG001|COMPLETED|Overall Study||380
11248499|NCT02149524|12441894|FG000|NOT COMPLETED|Overall Study||54
11248500|NCT02149524|12441895|FG001|NOT COMPLETED|Overall Study||57
11248501|NCT02149810|12441903|FG000|STARTED|Overall Study||48
11358532|NCT03125915|12555684|FG002|STARTED|1 Month Follow up||34
11358533|NCT03125915|12555685|FG003|STARTED|1 Month Follow up||34
11358534|NCT03125915|12555682|FG000|COMPLETED|1 Month Follow up||29
11248502|NCT02149810|12441904|FG001|STARTED|Overall Study||47
11248503|NCT02149810|12441903|FG000|Baseline|Overall Study||47
11248504|NCT02149810|12441904|FG001|Baseline|Overall Study||44
11248505|NCT02149810|12441903|FG000|Week 4|Overall Study||43
11248506|NCT02149810|12441904|FG001|Week 4|Overall Study||42
11248507|NCT02149810|12441903|FG000|Week 8|Overall Study||40
11248508|NCT02149810|12441904|FG001|Week 8|Overall Study||43
11248509|NCT02149810|12441903|FG000|Week 12|Overall Study||40
11248510|NCT02149810|12441904|FG001|Week 12|Overall Study||43
11248511|NCT02149810|12441903|FG000|Week 24|Overall Study||31
11248512|NCT02149810|12441904|FG001|Week 24|Overall Study|Not applicable study was amended such that week 24 data was not collected for TAU participants.|0
11248513|NCT02149810|12441903|FG000|COMPLETED|Overall Study||40
11248514|NCT02149810|12441904|FG001|COMPLETED|Overall Study||43
11248515|NCT02149810|12441903|FG000|NOT COMPLETED|Overall Study||8
11248516|NCT02149810|12441904|FG001|NOT COMPLETED|Overall Study||4
11248517|NCT02149836|12441910|FG000|STARTED|Overall Study||18
11248518|NCT02149836|12441910|FG000|COMPLETED|Overall Study||17
11248519|NCT02149836|12441910|FG000|NOT COMPLETED|Overall Study||1
11248520|NCT02149875|12441917|FG000|STARTED|Overall Study||27
11248521|NCT02149875|12441918|FG001|STARTED|Overall Study||28
11248522|NCT02149875|12441919|FG002|STARTED|Overall Study||29
11248523|NCT02149875|12441917|FG000|COMPLETED|Overall Study||20
11248524|NCT02149875|12441918|FG001|COMPLETED|Overall Study||20
11248525|NCT02149875|12441919|FG002|COMPLETED|Overall Study||20
11248526|NCT02149875|12441917|FG000|NOT COMPLETED|Overall Study||7
11248527|NCT02149875|12441918|FG001|NOT COMPLETED|Overall Study||8
11248528|NCT02149875|12441919|FG002|NOT COMPLETED|Overall Study||9
11248529|NCT02150044|12441927|FG000|STARTED|Overall Study||29
11248530|NCT02150044|12441927|FG000|Lead-In Subjects|Overall Study||16
11248531|NCT02150044|12441927|FG000|Study Cohort|Overall Study||13
11248532|NCT02150044|12441927|FG000|COMPLETED|Overall Study||29
11248533|NCT02150044|12441927|FG000|NOT COMPLETED|Overall Study||0
11248534|NCT02150057|12441933|FG000|STARTED|Overall Study||25
11248535|NCT02150057|12441934|FG001|STARTED|Overall Study||26
11248536|NCT02150057|12441933|FG000|COMPLETED|Overall Study||19
11248537|NCT02150057|12441934|FG001|COMPLETED|Overall Study||22
11248538|NCT02150057|12441933|FG000|NOT COMPLETED|Overall Study||6
11248539|NCT02150057|12441934|FG001|NOT COMPLETED|Overall Study||4
11248540|NCT02150109|12441940|FG000|STARTED|Overall Study||372
11248541|NCT02150109|12441940|FG000|COMPLETED|Overall Study||372
11248542|NCT02150109|12441940|FG000|NOT COMPLETED|Overall Study||0
11248543|NCT02150213|12441950|FG000|STARTED|Overall Study||59
11248544|NCT02150213|12441950|FG000|COMPLETED|Overall Study||57
11248545|NCT02150213|12441950|FG000|NOT COMPLETED|Overall Study||2
11248546|NCT02150343|12441958|FG000|STARTED|Overall Study||180
11248547|NCT02150343|12441959|FG001|STARTED|Overall Study||178
11248548|NCT02150343|12441960|FG002|STARTED|Overall Study||178
11248549|NCT02150343|12441961|FG003|STARTED|Overall Study||178
11248550|NCT02150343|12441958|FG000|COMPLETED|Overall Study||159
11248551|NCT02150343|12441959|FG001|COMPLETED|Overall Study||158
11248552|NCT02150343|12441960|FG002|COMPLETED|Overall Study||166
11248553|NCT02150343|12441961|FG003|COMPLETED|Overall Study||168
11248554|NCT02150343|12441958|FG000|NOT COMPLETED|Overall Study||21
11248555|NCT02150343|12441959|FG001|NOT COMPLETED|Overall Study||20
11248556|NCT02150343|12441960|FG002|NOT COMPLETED|Overall Study||12
11248557|NCT02150343|12441961|FG003|NOT COMPLETED|Overall Study||10
11248558|NCT02150460|12441973|FG000|STARTED|Overall Study||50
11248559|NCT02150460|12441974|FG001|STARTED|Overall Study||50
11248560|NCT02150460|12441973|FG000|COMPLETED|Overall Study||50
11248561|NCT02150460|12441974|FG001|COMPLETED|Overall Study||50
11248562|NCT02150460|12441973|FG000|NOT COMPLETED|Overall Study||0
11248563|NCT02150460|12441974|FG001|NOT COMPLETED|Overall Study||0
11248564|NCT02150499|12441982|FG000|STARTED|Overall Study||9
11248565|NCT02150499|12441983|FG001|STARTED|Overall Study||9
11248566|NCT02150499|12441982|FG000|COMPLETED|Overall Study||9
11248567|NCT02150499|12441983|FG001|COMPLETED|Overall Study||9
11248568|NCT02150499|12441982|FG000|NOT COMPLETED|Overall Study||0
11248569|NCT02150499|12441983|FG001|NOT COMPLETED|Overall Study||0
11248570|NCT02150759|12441991|FG000|STARTED|Overall Study||23
11248571|NCT02150759|12441992|FG001|STARTED|Overall Study||23
11248572|NCT02150759|12441991|FG000|COMPLETED|Overall Study||22
11248573|NCT02150759|12441992|FG001|COMPLETED|Overall Study||21
11248574|NCT02150759|12441991|FG000|NOT COMPLETED|Overall Study||1
11248575|NCT02150759|12441992|FG001|NOT COMPLETED|Overall Study||2
11248576|NCT02150837|12442000|FG000|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62
11248577|NCT02150837|12442001|FG001|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310
11248578|NCT02150837|12442000|FG000|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37
11248579|NCT02150837|12442001|FG001|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185
11248580|NCT02150837|12442000|FG000|NOT COMPLETED|Overall Study||25
11248581|NCT02150837|12442001|FG001|NOT COMPLETED|Overall Study||125
11248582|NCT02150954|12442009|FG000|STARTED|Overall Study||58
11248583|NCT02150954|12442010|FG001|STARTED|Overall Study||59
11248584|NCT02150954|12442009|FG000|COMPLETED|Overall Study||57
11248585|NCT02150954|12442010|FG001|COMPLETED|Overall Study||59
11248586|NCT02150954|12442009|FG000|NOT COMPLETED|Overall Study||1
11248587|NCT02150954|12442010|FG001|NOT COMPLETED|Overall Study||0
11248588|NCT02151058|12442019|FG000|STARTED|Overall Study||45
11248589|NCT02151058|12442020|FG001|STARTED|Overall Study||91
11248590|NCT02151058|12442021|FG002|STARTED|Overall Study||91
11248591|NCT02151058|12442019|FG000|COMPLETED|Overall Study||43
11248592|NCT02151058|12442020|FG001|COMPLETED|Overall Study||90
11248593|NCT02151058|12442021|FG002|COMPLETED|Overall Study||86
11248594|NCT02151058|12442019|FG000|NOT COMPLETED|Overall Study||2
11248595|NCT02151058|12442020|FG001|NOT COMPLETED|Overall Study||1
11248596|NCT02151058|12442021|FG002|NOT COMPLETED|Overall Study||5
11339323|NCT02911857|12536814|FG000|COMPLETED|Overall Study||2
11339324|NCT02911857|12536815|FG001|COMPLETED|Overall Study||1
11339325|NCT02911857|12536816|FG002|COMPLETED|Overall Study||1
11339326|NCT02911857|12536814|FG000|NOT COMPLETED|Overall Study||0
11339327|NCT02911857|12536815|FG001|NOT COMPLETED|Overall Study||0
11339328|NCT02911857|12536816|FG002|NOT COMPLETED|Overall Study||0
11339329|NCT02911909|12536826|FG000|STARTED|Overall Study||4
11339330|NCT02911909|12536827|FG001|STARTED|Overall Study||3
11339331|NCT02911909|12536826|FG000|COMPLETED|Overall Study||2
11339332|NCT02911909|12536827|FG001|COMPLETED|Overall Study|No Data was obtained in the study group.|0
11339333|NCT02911909|12536826|FG000|NOT COMPLETED|Overall Study||2
11339334|NCT02911909|12536827|FG001|NOT COMPLETED|Overall Study||3
11339335|NCT02911922|12536835|FG000|STARTED|Overall Study||1
11339336|NCT02911922|12536836|FG001|STARTED|Overall Study||0
11339337|NCT02911922|12536835|FG000|COMPLETED|Overall Study||1
11339338|NCT02911922|12536836|FG001|COMPLETED|Overall Study||0
11339339|NCT02911922|12536835|FG000|NOT COMPLETED|Overall Study||0
11339340|NCT02911922|12536836|FG001|NOT COMPLETED|Overall Study||0
11339341|NCT02911948|12536846|FG000|STARTED|Overall Study||105
11339342|NCT02911948|12536847|FG001|STARTED|Overall Study||105
11339343|NCT02911948|12536846|FG000|COMPLETED|Overall Study||105
11339344|NCT02911948|12536847|FG001|COMPLETED|Overall Study||98
11339345|NCT02911948|12536846|FG000|NOT COMPLETED|Overall Study||0
11339346|NCT02911948|12536847|FG001|NOT COMPLETED|Overall Study||7
11339347|NCT02912195|12536855|FG000|STARTED|Overall Study||16
11339348|NCT02912195|12536856|FG001|STARTED|Overall Study||16
11339349|NCT02912195|12536855|FG000|COMPLETED|Overall Study||16
11339350|NCT02912195|12536856|FG001|COMPLETED|Overall Study||16
11339351|NCT02912195|12536855|FG000|NOT COMPLETED|Overall Study||0
11339352|NCT02912195|12536856|FG001|NOT COMPLETED|Overall Study||0
11339353|NCT02912364|12536862|FG000|STARTED|Treatment 1||23
11339354|NCT02912364|12536863|FG001|STARTED|Treatment 1||23
11339355|NCT02912364|12536862|FG000|Received Intervention|Treatment 1||18
11339356|NCT02912364|12536863|FG001|Received Intervention|Treatment 1||18
11339357|NCT02912364|12536862|FG000|COMPLETED|Treatment 1||13
11339358|NCT02912364|12536863|FG001|COMPLETED|Treatment 1||11
11339359|NCT02912364|12536862|FG000|NOT COMPLETED|Treatment 1||10
11339360|NCT02912364|12536863|FG001|NOT COMPLETED|Treatment 1||12
11339361|NCT02912364|12536862|FG000|STARTED|Washout Period||13
11339362|NCT02912364|12536863|FG001|STARTED|Washout Period||11
11339363|NCT02912364|12536862|FG000|COMPLETED|Washout Period||13
11339364|NCT02912364|12536863|FG001|COMPLETED|Washout Period||11
11339365|NCT02912364|12536862|FG000|NOT COMPLETED|Washout Period||0
11339366|NCT02912364|12536863|FG001|NOT COMPLETED|Washout Period||0
11339367|NCT02912364|12536862|FG000|STARTED|Treatment 2||13
11339368|NCT02912364|12536863|FG001|STARTED|Treatment 2||11
11339369|NCT02912364|12536862|FG000|Received Intervention|Treatment 2||12
11339370|NCT02912364|12536863|FG001|Received Intervention|Treatment 2||11
11339371|NCT02912364|12536862|FG000|COMPLETED|Treatment 2||12
11339372|NCT02912364|12536863|FG001|COMPLETED|Treatment 2||11
11339373|NCT02912364|12536862|FG000|NOT COMPLETED|Treatment 2||1
11339374|NCT02912364|12536863|FG001|NOT COMPLETED|Treatment 2||0
11339375|NCT02912455|12536874|FG000|STARTED|Overall Study||11
11339376|NCT02912455|12536875|FG001|STARTED|Overall Study||5
11339377|NCT02912455|12536874|FG000|COMPLETED|Overall Study||9
11339378|NCT02912455|12536875|FG001|COMPLETED|Overall Study||2
11339379|NCT02912455|12536874|FG000|NOT COMPLETED|Overall Study||2
11339380|NCT02912455|12536875|FG001|NOT COMPLETED|Overall Study||3
11339381|NCT02912468|12536883|FG000|STARTED|Overall Study||133
11339382|NCT02912468|12536884|FG001|STARTED|Overall Study||143
11339383|NCT02912468|12536883|FG000|Treated|Overall Study||133
11339384|NCT02912468|12536884|FG001|Treated|Overall Study||142
11339385|NCT02912468|12536883|FG000|Safety Population|Overall Study||132
11339386|NCT02912468|12536884|FG001|Safety Population|Overall Study||143
11339387|NCT02912468|12536883|FG000|COMPLETED|Overall Study||124
11339388|NCT02912468|12536884|FG001|COMPLETED|Overall Study||138
11339389|NCT02912468|12536883|FG000|NOT COMPLETED|Overall Study||9
11339390|NCT02912468|12536884|FG001|NOT COMPLETED|Overall Study||5
11339391|NCT02912650|12536895|FG000|STARTED|Overall Study||56
11339392|NCT02912650|12536896|FG001|STARTED|Overall Study||172
11339393|NCT02912650|12536897|FG002|STARTED|Overall Study||175
11248597|NCT02151110|12442037|FG000|STARTED|Overall Study||12
11248598|NCT02151110|12442038|FG001|STARTED|Overall Study||2
11248599|NCT02151110|12442039|FG002|STARTED|Overall Study||2
11248600|NCT02151110|12442040|FG003|STARTED|Overall Study||8
11248601|NCT02151110|12442041|FG004|STARTED|Overall Study||8
11248602|NCT02151110|12442042|FG005|STARTED|Overall Study||8
11248603|NCT02151110|12442043|FG006|STARTED|Overall Study||8
11248604|NCT02151110|12442044|FG007|STARTED|Overall Study||8
11248605|NCT02151110|12442037|FG000|COMPLETED|Overall Study||12
11248606|NCT02151110|12442038|FG001|COMPLETED|Overall Study||2
11248607|NCT02151110|12442039|FG002|COMPLETED|Overall Study||2
11248608|NCT02151110|12442040|FG003|COMPLETED|Overall Study||8
11248609|NCT02151110|12442041|FG004|COMPLETED|Overall Study||8
11248610|NCT02151110|12442042|FG005|COMPLETED|Overall Study||8
11248611|NCT02151110|12442043|FG006|COMPLETED|Overall Study||8
11248612|NCT02151110|12442044|FG007|COMPLETED|Overall Study||5
11248613|NCT02151110|12442037|FG000|NOT COMPLETED|Overall Study||0
11248614|NCT02151110|12442038|FG001|NOT COMPLETED|Overall Study||0
11248615|NCT02151110|12442039|FG002|NOT COMPLETED|Overall Study||0
11248616|NCT02151110|12442040|FG003|NOT COMPLETED|Overall Study||0
11248617|NCT02151110|12442041|FG004|NOT COMPLETED|Overall Study||0
11248618|NCT02151110|12442042|FG005|NOT COMPLETED|Overall Study||0
11248619|NCT02151110|12442043|FG006|NOT COMPLETED|Overall Study||0
11248620|NCT02151110|12442044|FG007|NOT COMPLETED|Overall Study||3
11248621|NCT02151149|12442071|FG000|STARTED|Treatment Period|3 participants did not receive treatment|71
11248622|NCT02151149|12442072|FG001|STARTED|Treatment Period|2 participants did not receive treatment|72
11248623|NCT02151149|12442071|FG000|Treated Population|Treatment Period||68
11248624|NCT02151149|12442072|FG001|Treated Population|Treatment Period||70
11248625|NCT02151149|12442071|FG000|COMPLETED|Treatment Period||1
11248626|NCT02151149|12442072|FG001|COMPLETED|Treatment Period||1
11248627|NCT02151149|12442071|FG000|NOT COMPLETED|Treatment Period||70
11248628|NCT02151149|12442072|FG001|NOT COMPLETED|Treatment Period||71
11248629|NCT02151149|12442071|FG000|STARTED|Follow-Up Period||58
11248630|NCT02151149|12442072|FG001|STARTED|Follow-Up Period||55
11248631|NCT02151149|12442071|FG000|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
11248632|NCT02151149|12442072|FG001|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
11248633|NCT02151149|12442071|FG000|NOT COMPLETED|Follow-Up Period||39
11248634|NCT02151149|12442072|FG001|NOT COMPLETED|Follow-Up Period||37
11248635|NCT02151253|12442078|FG000|STARTED|Overall Study||13
11248636|NCT02151253|12442079|FG001|STARTED|Overall Study||15
11248637|NCT02151253|12442078|FG000|COMPLETED|Overall Study||13
11248638|NCT02151253|12442079|FG001|COMPLETED|Overall Study||15
11248639|NCT02151253|12442078|FG000|NOT COMPLETED|Overall Study||0
11248640|NCT02151253|12442079|FG001|NOT COMPLETED|Overall Study||0
11248641|NCT02151266|12442088|FG000|STARTED|Overall Study||19
11248642|NCT02151266|12442089|FG001|STARTED|Overall Study||29
11248643|NCT02151266|12442090|FG002|STARTED|Overall Study||21
11248644|NCT02151266|12442088|FG000|COMPLETED|Overall Study||11
11248645|NCT02151266|12442089|FG001|COMPLETED|Overall Study||14
11248646|NCT02151266|12442090|FG002|COMPLETED|Overall Study||14
11248647|NCT02151266|12442088|FG000|NOT COMPLETED|Overall Study||8
11248648|NCT02151266|12442089|FG001|NOT COMPLETED|Overall Study||15
11248649|NCT02151266|12442090|FG002|NOT COMPLETED|Overall Study||7
11248650|NCT02151331|12442100|FG000|STARTED|Overall Study||77
11248651|NCT02151331|12442101|FG001|STARTED|Overall Study||92
11248652|NCT02151331|12442100|FG000|COMPLETED|Overall Study||45
11248653|NCT02151331|12442101|FG001|COMPLETED|Overall Study||52
11248654|NCT02151331|12442100|FG000|NOT COMPLETED|Overall Study||32
11248655|NCT02151331|12442101|FG001|NOT COMPLETED|Overall Study||40
11248656|NCT02151448|12442107|FG000|STARTED|Phase 1||9
11248657|NCT02151448|12442107|FG000|COMPLETED|Phase 1||9
11248658|NCT02151448|12442107|FG000|NOT COMPLETED|Phase 1||0
11248659|NCT02151448|12442107|FG000|STARTED|Phase 2||55
11248660|NCT02151448|12442107|FG000|COMPLETED|Phase 2||55
11248661|NCT02151448|12442107|FG000|NOT COMPLETED|Phase 2||0
11248662|NCT02151461|12442119|FG000|STARTED|Overall Study||24
11248663|NCT02151461|12442120|FG001|STARTED|Overall Study||25
11248664|NCT02151461|12442121|FG002|STARTED|Overall Study||24
11248665|NCT02151461|12442122|FG003|STARTED|Overall Study||23
11248666|NCT02151461|12442119|FG000|COMPLETED|Overall Study||18
11248667|NCT02151461|12442120|FG001|COMPLETED|Overall Study||24
11248668|NCT02151461|12442121|FG002|COMPLETED|Overall Study||21
11248669|NCT02151461|12442122|FG003|COMPLETED|Overall Study||19
11248670|NCT02151461|12442119|FG000|NOT COMPLETED|Overall Study||6
11248671|NCT02151461|12442120|FG001|NOT COMPLETED|Overall Study||1
11248672|NCT02151461|12442121|FG002|NOT COMPLETED|Overall Study||3
11248673|NCT02151461|12442122|FG003|NOT COMPLETED|Overall Study||4
11248674|NCT02151487|12442136|FG000|STARTED|Overall Study||27
11248675|NCT02151487|12442137|FG001|STARTED|Overall Study||27
11248676|NCT02151487|12442138|FG002|STARTED|Overall Study||20
11248677|NCT02151487|12442139|FG003|STARTED|Overall Study||23
11248678|NCT02151487|12442136|FG000|COMPLETED|Overall Study||25
11248679|NCT02151487|12442137|FG001|COMPLETED|Overall Study||22
11248680|NCT02151487|12442138|FG002|COMPLETED|Overall Study||16
11248681|NCT02151487|12442139|FG003|COMPLETED|Overall Study||20
11248682|NCT02151487|12442136|FG000|NOT COMPLETED|Overall Study||2
11248683|NCT02151487|12442137|FG001|NOT COMPLETED|Overall Study||5
11248684|NCT02151487|12442138|FG002|NOT COMPLETED|Overall Study||4
11248685|NCT02151487|12442139|FG003|NOT COMPLETED|Overall Study||3
11248686|NCT02151591|12442151|FG000|STARTED|Overall Study||13
11248687|NCT02151591|12442152|FG001|STARTED|Overall Study||13
11248688|NCT02151591|12442151|FG000|COMPLETED|Overall Study||7
11248689|NCT02151591|12442152|FG001|COMPLETED|Overall Study||10
11248690|NCT02151591|12442151|FG000|NOT COMPLETED|Overall Study||6
11248691|NCT02151591|12442152|FG001|NOT COMPLETED|Overall Study||3
11248692|NCT02151643|12442163|FG000|STARTED|Overall Study||26
11248693|NCT02151643|12442164|FG001|STARTED|Overall Study||25
11248694|NCT02151643|12442165|FG002|STARTED|Overall Study||25
11248695|NCT02151643|12442166|FG003|STARTED|Overall Study||39
11248696|NCT02151643|12442167|FG004|STARTED|Overall Study||38
11248697|NCT02151643|12442163|FG000|COMPLETED|Overall Study||20
11248698|NCT02151643|12442164|FG001|COMPLETED|Overall Study||21
11248699|NCT02151643|12442165|FG002|COMPLETED|Overall Study||21
11248700|NCT02151643|12442166|FG003|COMPLETED|Overall Study||32
11248701|NCT02151643|12442167|FG004|COMPLETED|Overall Study||35
11248702|NCT02151643|12442163|FG000|NOT COMPLETED|Overall Study||6
11248703|NCT02151643|12442164|FG001|NOT COMPLETED|Overall Study||4
11248704|NCT02151643|12442165|FG002|NOT COMPLETED|Overall Study||4
11248705|NCT02151643|12442166|FG003|NOT COMPLETED|Overall Study||7
11248706|NCT02151643|12442167|FG004|NOT COMPLETED|Overall Study||3
11248707|NCT02151682|12442181|FG000|STARTED|Part 1: 14 Days Morphine or Tapentadol||24
11248708|NCT02151682|12442182|FG001|STARTED|Part 1: 14 Days Morphine or Tapentadol||45
11248709|NCT02151682|12442183|FG002|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
11248710|NCT02151682|12442184|FG003|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
11248711|NCT02151682|12442185|FG004|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
11248712|NCT02151682|12442186|FG005|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
11248713|NCT02151682|12442181|FG000|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22
11248714|NCT02151682|12442182|FG001|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40
11248715|NCT02151682|12442183|FG002|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
11248716|NCT02151682|12442184|FG003|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
11248717|NCT02151682|12442185|FG004|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
11248718|NCT02151682|12442186|FG005|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
11248719|NCT02151682|12442181|FG000|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2
11248720|NCT02151682|12442182|FG001|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5
11248721|NCT02151682|12442183|FG002|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
11248722|NCT02151682|12442184|FG003|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
11248723|NCT02151682|12442185|FG004|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
11248724|NCT02151682|12442186|FG005|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
11248725|NCT02151682|12442181|FG000|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
11248726|NCT02151682|12442182|FG001|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
11248727|NCT02151682|12442183|FG002|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36
11248728|NCT02151682|12442184|FG003|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18
11248729|NCT02151682|12442185|FG004|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14
11248730|NCT02151682|12442186|FG005|STARTED|Part 2: Tapent. Extension or Observation||0
11248731|NCT02151682|12442181|FG000|COMPLETED|Part 2: Tapent. Extension or Observation||0
11248732|NCT02151682|12442182|FG001|COMPLETED|Part 2: Tapent. Extension or Observation||0
11248733|NCT02151682|12442183|FG002|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8
11248734|NCT02151682|12442184|FG003|COMPLETED|Part 2: Tapent. Extension or Observation||14
11248735|NCT02151682|12442185|FG004|COMPLETED|Part 2: Tapent. Extension or Observation||14
11248736|NCT02151682|12442186|FG005|COMPLETED|Part 2: Tapent. Extension or Observation||0
11248737|NCT02151682|12442181|FG000|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
11248738|NCT02151682|12442182|FG001|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
11248739|NCT02151682|12442183|FG002|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28
11248740|NCT02151682|12442184|FG003|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4
11248741|NCT02151682|12442185|FG004|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
11248742|NCT02151682|12442186|FG005|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
11248743|NCT02151682|12442181|FG000|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
11248744|NCT02151682|12442182|FG001|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
11248745|NCT02151682|12442183|FG002|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
11248746|NCT02151682|12442184|FG003|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
11248747|NCT02151682|12442185|FG004|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
11339394|NCT02912650|12536898|FG003|STARTED|Overall Study||165
11248748|NCT02151682|12442186|FG005|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26
11248749|NCT02151682|12442181|FG000|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
11248750|NCT02151682|12442182|FG001|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
11248751|NCT02151682|12442183|FG002|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
11248752|NCT02151682|12442184|FG003|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
11248753|NCT02151682|12442185|FG004|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
11248754|NCT02151682|12442186|FG005|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19
11248755|NCT02151682|12442181|FG000|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
11248756|NCT02151682|12442182|FG001|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
11248757|NCT02151682|12442183|FG002|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
11248758|NCT02151682|12442184|FG003|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
11248759|NCT02151682|12442185|FG004|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
11248760|NCT02151682|12442186|FG005|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7
11248761|NCT02151773|12442204|FG000|STARTED|Overall Study||3493
11248762|NCT02151773|12442204|FG000|COMPLETED|Overall Study||3429
11248763|NCT02151773|12442204|FG000|NOT COMPLETED|Overall Study||64
11248764|NCT02151786|12442208|FG000|STARTED|Overall Study||1120
11248765|NCT02151786|12442208|FG000|COMPLETED|Overall Study||1084
11248766|NCT02151786|12442208|FG000|NOT COMPLETED|Overall Study||36
11248767|NCT02151851|12442214|FG000|STARTED|Overall Study||114
11248768|NCT02151851|12442215|FG001|STARTED|Overall Study||316
11248769|NCT02151851|12442214|FG000|Included in the Safety Set|Overall Study||113
11248770|NCT02151851|12442215|FG001|Included in the Safety Set|Overall Study||316
11248771|NCT02151851|12442214|FG000|COMPLETED|Overall Study||38
11248772|NCT02151851|12442215|FG001|COMPLETED|Overall Study||186
11248773|NCT02151851|12442214|FG000|NOT COMPLETED|Overall Study||76
11248774|NCT02151851|12442215|FG001|NOT COMPLETED|Overall Study||130
11248775|NCT02151877|12442223|FG000|STARTED|Overall Study||12
11248776|NCT02151877|12442224|FG001|STARTED|Overall Study||12
11248777|NCT02151877|12442223|FG000|COMPLETED|Overall Study||12
11248778|NCT02151877|12442224|FG001|COMPLETED|Overall Study||12
11248779|NCT02151877|12442223|FG000|NOT COMPLETED|Overall Study||0
11248780|NCT02151877|12442224|FG001|NOT COMPLETED|Overall Study||0
11248781|NCT02151903|12442234|FG000|STARTED|Overall Study||3
11248782|NCT02151903|12442235|FG001|STARTED|Overall Study||2
11248783|NCT02151903|12442234|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11248784|NCT02151903|12442235|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
11248785|NCT02151903|12442234|FG000|COMPLETED|Overall Study||0
11248786|NCT02151903|12442235|FG001|COMPLETED|Overall Study||1
11248787|NCT02151903|12442234|FG000|NOT COMPLETED|Overall Study||3
11248788|NCT02151903|12442235|FG001|NOT COMPLETED|Overall Study||1
11248789|NCT02151994|12442244|FG000|STARTED|Single Ascending Dose (SAD)||18
11248790|NCT02151994|12442245|FG001|STARTED|Single Ascending Dose (SAD)||6
11248791|NCT02151994|12442246|FG002|STARTED|Single Ascending Dose (SAD)||6
11248792|NCT02151994|12442247|FG003|STARTED|Single Ascending Dose (SAD)||6
11248793|NCT02151994|12442248|FG004|STARTED|Single Ascending Dose (SAD)||6
11248794|NCT02151994|12442249|FG005|STARTED|Single Ascending Dose (SAD)||6
11248795|NCT02151994|12442250|FG006|STARTED|Single Ascending Dose (SAD)||6
11248796|NCT02151994|12442251|FG007|STARTED|Single Ascending Dose (SAD)||6
11248797|NCT02151994|12442252|FG008|STARTED|Single Ascending Dose (SAD)||0
11248798|NCT02151994|12442253|FG009|STARTED|Single Ascending Dose (SAD)||6
11248799|NCT02151994|12442254|FG010|STARTED|Single Ascending Dose (SAD)||6
11248800|NCT02151994|12442255|FG011|STARTED|Single Ascending Dose (SAD)||0
11248801|NCT02151994|12442256|FG012|STARTED|Single Ascending Dose (SAD)||0
11248802|NCT02151994|12442244|FG000|COMPLETED|Single Ascending Dose (SAD)||18
11248803|NCT02151994|12442245|FG001|COMPLETED|Single Ascending Dose (SAD)||6
11248804|NCT02151994|12442246|FG002|COMPLETED|Single Ascending Dose (SAD)||6
11248805|NCT02151994|12442247|FG003|COMPLETED|Single Ascending Dose (SAD)||6
11248806|NCT02151994|12442248|FG004|COMPLETED|Single Ascending Dose (SAD)||6
11248807|NCT02151994|12442249|FG005|COMPLETED|Single Ascending Dose (SAD)||6
11248808|NCT02151994|12442250|FG006|COMPLETED|Single Ascending Dose (SAD)||6
11248809|NCT02151994|12442251|FG007|COMPLETED|Single Ascending Dose (SAD)||6
11248810|NCT02151994|12442252|FG008|COMPLETED|Single Ascending Dose (SAD)||0
11248811|NCT02151994|12442253|FG009|COMPLETED|Single Ascending Dose (SAD)||6
11248812|NCT02151994|12442254|FG010|COMPLETED|Single Ascending Dose (SAD)||6
11248813|NCT02151994|12442255|FG011|COMPLETED|Single Ascending Dose (SAD)||0
11248814|NCT02151994|12442256|FG012|COMPLETED|Single Ascending Dose (SAD)||0
11248815|NCT02151994|12442244|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0
11248816|NCT02151994|12442245|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0
11248817|NCT02151994|12442246|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0
11248818|NCT02151994|12442247|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0
11248819|NCT02151994|12442248|FG004|NOT COMPLETED|Single Ascending Dose (SAD)||0
11248820|NCT02151994|12442249|FG005|NOT COMPLETED|Single Ascending Dose (SAD)||0
11248821|NCT02151994|12442250|FG006|NOT COMPLETED|Single Ascending Dose (SAD)||0
11248822|NCT02151994|12442251|FG007|NOT COMPLETED|Single Ascending Dose (SAD)||0
11248823|NCT02151994|12442252|FG008|NOT COMPLETED|Single Ascending Dose (SAD)||0
11248824|NCT02151994|12442253|FG009|NOT COMPLETED|Single Ascending Dose (SAD)||0
11248825|NCT02151994|12442254|FG010|NOT COMPLETED|Single Ascending Dose (SAD)||0
11248826|NCT02151994|12442255|FG011|NOT COMPLETED|Single Ascending Dose (SAD)||0
11248827|NCT02151994|12442256|FG012|NOT COMPLETED|Single Ascending Dose (SAD)||0
11248828|NCT02151994|12442244|FG000|STARTED|Multiple Ascending Dose (MAD)||10
11248829|NCT02151994|12442245|FG001|STARTED|Multiple Ascending Dose (MAD)||0
11248830|NCT02151994|12442246|FG002|STARTED|Multiple Ascending Dose (MAD)||0
11248831|NCT02151994|12442247|FG003|STARTED|Multiple Ascending Dose (MAD)||6
11248832|NCT02151994|12442248|FG004|STARTED|Multiple Ascending Dose (MAD)||6
11248833|NCT02151994|12442249|FG005|STARTED|Multiple Ascending Dose (MAD)||6
11248834|NCT02151994|12442250|FG006|STARTED|Multiple Ascending Dose (MAD)||6
11248835|NCT02151994|12442251|FG007|STARTED|Multiple Ascending Dose (MAD)||0
11248836|NCT02151994|12442252|FG008|STARTED|Multiple Ascending Dose (MAD)||6
11248837|NCT02151994|12442253|FG009|STARTED|Multiple Ascending Dose (MAD)||0
11248838|NCT02151994|12442254|FG010|STARTED|Multiple Ascending Dose (MAD)||0
11248839|NCT02151994|12442255|FG011|STARTED|Multiple Ascending Dose (MAD)||0
11248840|NCT02151994|12442256|FG012|STARTED|Multiple Ascending Dose (MAD)||0
11248841|NCT02151994|12442244|FG000|COMPLETED|Multiple Ascending Dose (MAD)||10
11248842|NCT02151994|12442245|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0
11248843|NCT02151994|12442246|FG002|COMPLETED|Multiple Ascending Dose (MAD)||0
11248844|NCT02151994|12442247|FG003|COMPLETED|Multiple Ascending Dose (MAD)||6
11248845|NCT02151994|12442248|FG004|COMPLETED|Multiple Ascending Dose (MAD)||6
11248846|NCT02151994|12442249|FG005|COMPLETED|Multiple Ascending Dose (MAD)||6
11248847|NCT02151994|12442250|FG006|COMPLETED|Multiple Ascending Dose (MAD)||6
11248848|NCT02151994|12442251|FG007|COMPLETED|Multiple Ascending Dose (MAD)||0
11248849|NCT02151994|12442252|FG008|COMPLETED|Multiple Ascending Dose (MAD)||6
11248850|NCT02151994|12442253|FG009|COMPLETED|Multiple Ascending Dose (MAD)||0
11248851|NCT02151994|12442254|FG010|COMPLETED|Multiple Ascending Dose (MAD)||0
11248852|NCT02151994|12442255|FG011|COMPLETED|Multiple Ascending Dose (MAD)||0
11248853|NCT02151994|12442256|FG012|COMPLETED|Multiple Ascending Dose (MAD)||0
11248854|NCT02151994|12442244|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11248855|NCT02151994|12442245|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11248856|NCT02151994|12442246|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11248857|NCT02151994|12442247|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11248858|NCT02151994|12442248|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11248859|NCT02151994|12442249|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11248860|NCT02151994|12442250|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11248861|NCT02151994|12442251|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11248862|NCT02151994|12442252|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11248863|NCT02151994|12442253|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11248864|NCT02151994|12442254|FG010|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11248865|NCT02151994|12442255|FG011|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11248866|NCT02151994|12442256|FG012|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11248867|NCT02151994|12442244|FG000|STARTED|Food Effect (FE): Fasted||0
11248868|NCT02151994|12442245|FG001|STARTED|Food Effect (FE): Fasted||0
11248869|NCT02151994|12442246|FG002|STARTED|Food Effect (FE): Fasted||0
11248870|NCT02151994|12442247|FG003|STARTED|Food Effect (FE): Fasted||0
11248871|NCT02151994|12442248|FG004|STARTED|Food Effect (FE): Fasted||0
11248872|NCT02151994|12442249|FG005|STARTED|Food Effect (FE): Fasted||0
11248873|NCT02151994|12442250|FG006|STARTED|Food Effect (FE): Fasted||0
11248874|NCT02151994|12442251|FG007|STARTED|Food Effect (FE): Fasted||0
11248875|NCT02151994|12442252|FG008|STARTED|Food Effect (FE): Fasted||0
11248876|NCT02151994|12442253|FG009|STARTED|Food Effect (FE): Fasted||0
11248877|NCT02151994|12442254|FG010|STARTED|Food Effect (FE): Fasted||0
11248878|NCT02151994|12442255|FG011|STARTED|Food Effect (FE): Fasted||12
11248879|NCT02151994|12442256|FG012|STARTED|Food Effect (FE): Fasted||0
11248880|NCT02151994|12442244|FG000|COMPLETED|Food Effect (FE): Fasted||0
11248881|NCT02151994|12442245|FG001|COMPLETED|Food Effect (FE): Fasted||0
11248882|NCT02151994|12442246|FG002|COMPLETED|Food Effect (FE): Fasted||0
11248883|NCT02151994|12442247|FG003|COMPLETED|Food Effect (FE): Fasted||0
11248884|NCT02151994|12442248|FG004|COMPLETED|Food Effect (FE): Fasted||0
11248885|NCT02151994|12442249|FG005|COMPLETED|Food Effect (FE): Fasted||0
11248886|NCT02151994|12442250|FG006|COMPLETED|Food Effect (FE): Fasted||0
11248887|NCT02151994|12442251|FG007|COMPLETED|Food Effect (FE): Fasted||0
11248888|NCT02151994|12442252|FG008|COMPLETED|Food Effect (FE): Fasted||0
11248889|NCT02151994|12442253|FG009|COMPLETED|Food Effect (FE): Fasted||0
11248890|NCT02151994|12442254|FG010|COMPLETED|Food Effect (FE): Fasted||0
11248891|NCT02151994|12442255|FG011|COMPLETED|Food Effect (FE): Fasted||12
11248892|NCT02151994|12442256|FG012|COMPLETED|Food Effect (FE): Fasted||0
11248893|NCT02151994|12442244|FG000|NOT COMPLETED|Food Effect (FE): Fasted||0
11248894|NCT02151994|12442245|FG001|NOT COMPLETED|Food Effect (FE): Fasted||0
11248895|NCT02151994|12442246|FG002|NOT COMPLETED|Food Effect (FE): Fasted||0
11248896|NCT02151994|12442247|FG003|NOT COMPLETED|Food Effect (FE): Fasted||0
11248897|NCT02151994|12442248|FG004|NOT COMPLETED|Food Effect (FE): Fasted||0
11248898|NCT02151994|12442249|FG005|NOT COMPLETED|Food Effect (FE): Fasted||0
11248899|NCT02151994|12442250|FG006|NOT COMPLETED|Food Effect (FE): Fasted||0
11248900|NCT02151994|12442251|FG007|NOT COMPLETED|Food Effect (FE): Fasted||0
11248901|NCT02151994|12442252|FG008|NOT COMPLETED|Food Effect (FE): Fasted||0
11248902|NCT02151994|12442253|FG009|NOT COMPLETED|Food Effect (FE): Fasted||0
11248903|NCT02151994|12442254|FG010|NOT COMPLETED|Food Effect (FE): Fasted||0
11248904|NCT02151994|12442255|FG011|NOT COMPLETED|Food Effect (FE): Fasted||0
11248905|NCT02151994|12442256|FG012|NOT COMPLETED|Food Effect (FE): Fasted||0
11248906|NCT02151994|12442244|FG000|STARTED|Food Effect (FE): Fed||0
11248907|NCT02151994|12442245|FG001|STARTED|Food Effect (FE): Fed||0
11248908|NCT02151994|12442246|FG002|STARTED|Food Effect (FE): Fed||0
11248909|NCT02151994|12442247|FG003|STARTED|Food Effect (FE): Fed||0
11248910|NCT02151994|12442248|FG004|STARTED|Food Effect (FE): Fed||0
11248911|NCT02151994|12442249|FG005|STARTED|Food Effect (FE): Fed||0
11248912|NCT02151994|12442250|FG006|STARTED|Food Effect (FE): Fed||0
11248913|NCT02151994|12442251|FG007|STARTED|Food Effect (FE): Fed||0
11248914|NCT02151994|12442252|FG008|STARTED|Food Effect (FE): Fed||0
11248915|NCT02151994|12442253|FG009|STARTED|Food Effect (FE): Fed||0
11248916|NCT02151994|12442254|FG010|STARTED|Food Effect (FE): Fed||0
11248917|NCT02151994|12442255|FG011|STARTED|Food Effect (FE): Fed||0
11248918|NCT02151994|12442256|FG012|STARTED|Food Effect (FE): Fed||12
11248919|NCT02151994|12442244|FG000|COMPLETED|Food Effect (FE): Fed||0
11248920|NCT02151994|12442245|FG001|COMPLETED|Food Effect (FE): Fed||0
11248921|NCT02151994|12442246|FG002|COMPLETED|Food Effect (FE): Fed||0
11248922|NCT02151994|12442247|FG003|COMPLETED|Food Effect (FE): Fed||0
11248923|NCT02151994|12442248|FG004|COMPLETED|Food Effect (FE): Fed||0
11248924|NCT02151994|12442249|FG005|COMPLETED|Food Effect (FE): Fed||0
11248925|NCT02151994|12442250|FG006|COMPLETED|Food Effect (FE): Fed||0
11248926|NCT02151994|12442251|FG007|COMPLETED|Food Effect (FE): Fed||0
11248927|NCT02151994|12442252|FG008|COMPLETED|Food Effect (FE): Fed||0
11248928|NCT02151994|12442253|FG009|COMPLETED|Food Effect (FE): Fed||0
11248929|NCT02151994|12442254|FG010|COMPLETED|Food Effect (FE): Fed||0
11248930|NCT02151994|12442255|FG011|COMPLETED|Food Effect (FE): Fed||0
11248931|NCT02151994|12442256|FG012|COMPLETED|Food Effect (FE): Fed||12
11248932|NCT02151994|12442244|FG000|NOT COMPLETED|Food Effect (FE): Fed||0
11248933|NCT02151994|12442245|FG001|NOT COMPLETED|Food Effect (FE): Fed||0
11248934|NCT02151994|12442246|FG002|NOT COMPLETED|Food Effect (FE): Fed||0
11248935|NCT02151994|12442247|FG003|NOT COMPLETED|Food Effect (FE): Fed||0
11248936|NCT02151994|12442248|FG004|NOT COMPLETED|Food Effect (FE): Fed||0
11248937|NCT02151994|12442249|FG005|NOT COMPLETED|Food Effect (FE): Fed||0
11248938|NCT02151994|12442250|FG006|NOT COMPLETED|Food Effect (FE): Fed||0
11248939|NCT02151994|12442251|FG007|NOT COMPLETED|Food Effect (FE): Fed||0
11248940|NCT02151994|12442252|FG008|NOT COMPLETED|Food Effect (FE): Fed||0
11248941|NCT02151994|12442253|FG009|NOT COMPLETED|Food Effect (FE): Fed||0
11248942|NCT02151994|12442254|FG010|NOT COMPLETED|Food Effect (FE): Fed||0
11248943|NCT02151994|12442255|FG011|NOT COMPLETED|Food Effect (FE): Fed||0
11248944|NCT02151994|12442256|FG012|NOT COMPLETED|Food Effect (FE): Fed||0
11248945|NCT02152007|12442293|FG000|STARTED|Overall Study||15
11248946|NCT02152007|12442293|FG000|COMPLETED|Overall Study||14
11248947|NCT02152007|12442293|FG000|NOT COMPLETED|Overall Study||1
11248948|NCT02152085|12442300|FG000|STARTED|Overall Study||14
11248949|NCT02152085|12442301|FG001|STARTED|Overall Study||15
11248950|NCT02152085|12442300|FG000|COMPLETED|Overall Study||13
11248951|NCT02152085|12442301|FG001|COMPLETED|Overall Study||14
11248952|NCT02152085|12442300|FG000|NOT COMPLETED|Overall Study||1
11248953|NCT02152085|12442301|FG001|NOT COMPLETED|Overall Study||1
11248954|NCT02152137|12442307|FG000|STARTED|Overall Study||19
11248955|NCT02152137|12442307|FG000|Originally Assigned to Arm A|Overall Study||16
11248956|NCT02152137|12442307|FG000|Originally Assigned to Arm B|Overall Study|With update #2, Arm B is closed and all patients should receive paclitaxel and efatutazone.|3
11248957|NCT02152137|12442307|FG000|COMPLETED|Overall Study||15
11248958|NCT02152137|12442307|FG000|NOT COMPLETED|Overall Study||4
11248959|NCT02152163|12442313|FG000|STARTED|Overall Study||51
11248960|NCT02152163|12442314|FG001|STARTED|Overall Study||48
11248961|NCT02152163|12442313|FG000|COMPLETED|Overall Study||39
11248962|NCT02152163|12442314|FG001|COMPLETED|Overall Study||35
11248963|NCT02152163|12442313|FG000|NOT COMPLETED|Overall Study||12
11248964|NCT02152163|12442314|FG001|NOT COMPLETED|Overall Study||13
11248965|NCT02152345|12442322|FG000|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28
11248966|NCT02152345|12442323|FG001|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29
11248967|NCT02152345|12442322|FG000|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24
11248968|NCT02152345|12442323|FG001|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24
11248969|NCT02152345|12442322|FG000|NOT COMPLETED|Overall Study||4
11248970|NCT02152345|12442323|FG001|NOT COMPLETED|Overall Study||5
11248971|NCT02152371|12442331|FG000|STARTED|Overall Study||150
11248972|NCT02152371|12442332|FG001|STARTED|Overall Study||150
11248973|NCT02152371|12442331|FG000|Received at Least 1 Dose of Study Drug.|Overall Study||150
11248974|NCT02152371|12442332|FG001|Received at Least 1 Dose of Study Drug.|Overall Study||150
11248975|NCT02152371|12442331|FG000|COMPLETED|Overall Study||138
11248976|NCT02152371|12442332|FG001|COMPLETED|Overall Study||134
11248977|NCT02152371|12442331|FG000|NOT COMPLETED|Overall Study||12
11248978|NCT02152371|12442332|FG001|NOT COMPLETED|Overall Study||16
11248979|NCT02152384|12442338|FG000|STARTED|Run In (1-5 Week Transition)||14
11248980|NCT02152384|12442339|FG001|STARTED|Run In (1-5 Week Transition)||14
11248981|NCT02152384|12442338|FG000|COMPLETED|Run In (1-5 Week Transition)||14
11248982|NCT02152384|12442339|FG001|COMPLETED|Run In (1-5 Week Transition)||14
11248983|NCT02152384|12442338|FG000|NOT COMPLETED|Run In (1-5 Week Transition)||0
11248984|NCT02152384|12442339|FG001|NOT COMPLETED|Run In (1-5 Week Transition)||0
11248985|NCT02152384|12442338|FG000|STARTED|Period 1||14
11248986|NCT02152384|12442339|FG001|STARTED|Period 1||14
11248987|NCT02152384|12442338|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
11248988|NCT02152384|12442339|FG001|Received at Least 1 Dose of Study Drug|Period 1||14
11248989|NCT02152384|12442338|FG000|COMPLETED|Period 1||13
11248990|NCT02152384|12442339|FG001|COMPLETED|Period 1||12
11248991|NCT02152384|12442338|FG000|NOT COMPLETED|Period 1||1
11248992|NCT02152384|12442339|FG001|NOT COMPLETED|Period 1||2
11248993|NCT02152384|12442338|FG000|STARTED|Period 2||13
11248994|NCT02152384|12442339|FG001|STARTED|Period 2||12
11248995|NCT02152384|12442338|FG000|COMPLETED|Period 2||13
11248996|NCT02152384|12442339|FG001|COMPLETED|Period 2||12
11248997|NCT02152384|12442338|FG000|NOT COMPLETED|Period 2||0
11248998|NCT02152384|12442339|FG001|NOT COMPLETED|Period 2||0
11248999|NCT02152540|12442351|FG000|STARTED|Overall Study||17
11249000|NCT02152540|12442352|FG001|STARTED|Overall Study||16
11249001|NCT02152540|12442351|FG000|COMPLETED|Overall Study||17
11249002|NCT02152540|12442352|FG001|COMPLETED|Overall Study||16
11249003|NCT02152540|12442351|FG000|NOT COMPLETED|Overall Study||0
11249004|NCT02152540|12442352|FG001|NOT COMPLETED|Overall Study||0
11249005|NCT02152605|12442367|FG000|STARTED|Overall Study||248
11249006|NCT02152605|12442368|FG001|STARTED|Overall Study||248
11249007|NCT02152605|12442367|FG000|COMPLETED|Overall Study||229
11249008|NCT02152605|12442368|FG001|COMPLETED|Overall Study||230
11249009|NCT02152605|12442367|FG000|NOT COMPLETED|Overall Study||19
11249010|NCT02152605|12442368|FG001|NOT COMPLETED|Overall Study||18
11249011|NCT02152696|12442378|FG000|STARTED|Overall Study||86
11249012|NCT02152696|12442379|FG001|STARTED|Overall Study||87
11249013|NCT02152696|12442380|FG002|STARTED|Overall Study||82
11249014|NCT02152696|12442378|FG000|COMPLETED|Overall Study||86
11249015|NCT02152696|12442379|FG001|COMPLETED|Overall Study||86
11249016|NCT02152696|12442380|FG002|COMPLETED|Overall Study||81
11249017|NCT02152696|12442378|FG000|NOT COMPLETED|Overall Study||0
11249018|NCT02152696|12442379|FG001|NOT COMPLETED|Overall Study||1
11249019|NCT02152696|12442380|FG002|NOT COMPLETED|Overall Study||1
11249020|NCT02152761|12442392|FG000|STARTED|Epoch: Treatment Epoch||75
11249021|NCT02152761|12442393|FG001|STARTED|Epoch: Treatment Epoch||70
11249022|NCT02152761|12442394|FG002|STARTED|Epoch: Treatment Epoch||34
11249023|NCT02152761|12442395|FG003|STARTED|Epoch: Treatment Epoch||72
11249024|NCT02152761|12442392|FG000|COMPLETED|Epoch: Treatment Epoch||64
11249025|NCT02152761|12442393|FG001|COMPLETED|Epoch: Treatment Epoch||50
11249026|NCT02152761|12442394|FG002|COMPLETED|Epoch: Treatment Epoch||29
11249027|NCT02152761|12442395|FG003|COMPLETED|Epoch: Treatment Epoch||64
11249028|NCT02152761|12442392|FG000|NOT COMPLETED|Epoch: Treatment Epoch||11
11249029|NCT02152761|12442393|FG001|NOT COMPLETED|Epoch: Treatment Epoch||20
11249030|NCT02152761|12442394|FG002|NOT COMPLETED|Epoch: Treatment Epoch||5
11249031|NCT02152761|12442395|FG003|NOT COMPLETED|Epoch: Treatment Epoch||8
11249032|NCT02152761|12442392|FG000|STARTED|Epoch: Post-treatment Follow-up Epoch||67
11249033|NCT02152761|12442393|FG001|STARTED|Epoch: Post-treatment Follow-up Epoch||54
11249034|NCT02152761|12442394|FG002|STARTED|Epoch: Post-treatment Follow-up Epoch||30
11249035|NCT02152761|12442395|FG003|STARTED|Epoch: Post-treatment Follow-up Epoch||68
11249036|NCT02152761|12442392|FG000|COMPLETED|Epoch: Post-treatment Follow-up Epoch||63
11249037|NCT02152761|12442393|FG001|COMPLETED|Epoch: Post-treatment Follow-up Epoch||47
11249038|NCT02152761|12442394|FG002|COMPLETED|Epoch: Post-treatment Follow-up Epoch||30
11249039|NCT02152761|12442395|FG003|COMPLETED|Epoch: Post-treatment Follow-up Epoch||66
11249040|NCT02152761|12442392|FG000|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||4
11249041|NCT02152761|12442393|FG001|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||7
11249042|NCT02152761|12442394|FG002|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||0
11249043|NCT02152761|12442395|FG003|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||2
11249044|NCT02152826|12442413|FG000|STARTED|Overall Study||45
11249045|NCT02152826|12442414|FG001|STARTED|Overall Study||35
11249046|NCT02152826|12442413|FG000|COMPLETED|Overall Study||44
11249047|NCT02152826|12442414|FG001|COMPLETED|Overall Study||34
11249048|NCT02152826|12442413|FG000|NOT COMPLETED|Overall Study||1
11249049|NCT02152826|12442414|FG001|NOT COMPLETED|Overall Study||1
11249050|NCT02153073|12442420|FG000|STARTED|Overall Study||3084
11249051|NCT02153073|12442420|FG000|COMPLETED|Overall Study||2786
11249052|NCT02153073|12442420|FG000|NOT COMPLETED|Overall Study||298
11249053|NCT02153086|12442424|FG000|STARTED|Overall Study||236
11249054|NCT02153086|12442424|FG000|COMPLETED|Overall Study||232
11249055|NCT02153086|12442424|FG000|NOT COMPLETED|Overall Study||4
11249056|NCT02153099|12442435|FG000|STARTED|Overall Study||6
11249057|NCT02153099|12442436|FG001|STARTED|Overall Study||6
11249058|NCT02153099|12442437|FG002|STARTED|Overall Study||6
11249059|NCT02153099|12442438|FG003|STARTED|Overall Study||6
11249060|NCT02153099|12442439|FG004|STARTED|Overall Study||6
11249061|NCT02153099|12442440|FG005|STARTED|Overall Study||6
11358535|NCT03125915|12555683|FG001|COMPLETED|1 Month Follow up||37
11249062|NCT02153099|12442441|FG006|STARTED|Overall Study||12
11249063|NCT02153099|12442435|FG000|COMPLETED|Overall Study||6
11249064|NCT02153099|12442436|FG001|COMPLETED|Overall Study||6
11249065|NCT02153099|12442437|FG002|COMPLETED|Overall Study||6
11249066|NCT02153099|12442438|FG003|COMPLETED|Overall Study||6
11249067|NCT02153099|12442439|FG004|COMPLETED|Overall Study||6
11249068|NCT02153099|12442440|FG005|COMPLETED|Overall Study||6
11249069|NCT02153099|12442441|FG006|COMPLETED|Overall Study||12
11249070|NCT02153099|12442435|FG000|NOT COMPLETED|Overall Study||0
11249071|NCT02153099|12442436|FG001|NOT COMPLETED|Overall Study||0
11249072|NCT02153099|12442437|FG002|NOT COMPLETED|Overall Study||0
11249073|NCT02153099|12442438|FG003|NOT COMPLETED|Overall Study||0
11249074|NCT02153099|12442439|FG004|NOT COMPLETED|Overall Study||0
11249075|NCT02153099|12442440|FG005|NOT COMPLETED|Overall Study||0
11249076|NCT02153099|12442441|FG006|NOT COMPLETED|Overall Study||0
11249077|NCT02153112|12442467|FG000|STARTED|Overall Study||61
11249078|NCT02153112|12442468|FG001|STARTED|Overall Study||59
11249079|NCT02153112|12442469|FG002|STARTED|Overall Study||61
11249080|NCT02153112|12442470|FG003|STARTED|Overall Study||59
11249081|NCT02153112|12442471|FG004|STARTED|Overall Study||60
11249082|NCT02153112|12442472|FG005|STARTED|Overall Study||60
11249083|NCT02153112|12442473|FG006|STARTED|Overall Study||60
11249084|NCT02153112|12442474|FG007|STARTED|Overall Study||60
11249085|NCT02153112|12442475|FG008|STARTED|Overall Study||180
11249086|NCT02153112|12442476|FG009|STARTED|Overall Study||180
11249087|NCT02153112|12442467|FG000|COMPLETED|Overall Study||57
11249088|NCT02153112|12442468|FG001|COMPLETED|Overall Study||57
11249089|NCT02153112|12442469|FG002|COMPLETED|Overall Study||58
11249090|NCT02153112|12442470|FG003|COMPLETED|Overall Study||57
11249091|NCT02153112|12442471|FG004|COMPLETED|Overall Study||57
11249092|NCT02153112|12442472|FG005|COMPLETED|Overall Study||58
11249093|NCT02153112|12442473|FG006|COMPLETED|Overall Study||52
11249094|NCT02153112|12442474|FG007|COMPLETED|Overall Study||58
11249095|NCT02153112|12442475|FG008|COMPLETED|Overall Study||165
11249096|NCT02153112|12442476|FG009|COMPLETED|Overall Study||166
11249097|NCT02153112|12442467|FG000|NOT COMPLETED|Overall Study||4
11249098|NCT02153112|12442468|FG001|NOT COMPLETED|Overall Study||2
11249099|NCT02153112|12442469|FG002|NOT COMPLETED|Overall Study||3
11249100|NCT02153112|12442470|FG003|NOT COMPLETED|Overall Study||2
11249101|NCT02153112|12442471|FG004|NOT COMPLETED|Overall Study||3
11249102|NCT02153112|12442472|FG005|NOT COMPLETED|Overall Study||2
11249103|NCT02153112|12442473|FG006|NOT COMPLETED|Overall Study||8
11249104|NCT02153112|12442474|FG007|NOT COMPLETED|Overall Study||2
11249105|NCT02153112|12442475|FG008|NOT COMPLETED|Overall Study||15
11249106|NCT02153112|12442476|FG009|NOT COMPLETED|Overall Study||14
11249107|NCT02153346|12442500|FG000|STARTED|Overall Study||101
11249108|NCT02153346|12442500|FG000|COMPLETED|Overall Study||90
11249109|NCT02153346|12442500|FG000|NOT COMPLETED|Overall Study||11
11249110|NCT02153359|12442505|FG000|STARTED|Intervention 1 (1 Month)||11
11249111|NCT02153359|12442506|FG001|STARTED|Intervention 1 (1 Month)||12
11249112|NCT02153359|12442505|FG000|COMPLETED|Intervention 1 (1 Month)||11
11249113|NCT02153359|12442506|FG001|COMPLETED|Intervention 1 (1 Month)||12
11249114|NCT02153359|12442505|FG000|NOT COMPLETED|Intervention 1 (1 Month)||0
11249115|NCT02153359|12442506|FG001|NOT COMPLETED|Intervention 1 (1 Month)||0
11249116|NCT02153359|12442505|FG000|STARTED|Washout (at Least 1 Month)||11
11249117|NCT02153359|12442506|FG001|STARTED|Washout (at Least 1 Month)||12
11249118|NCT02153359|12442505|FG000|COMPLETED|Washout (at Least 1 Month)||11
11249119|NCT02153359|12442506|FG001|COMPLETED|Washout (at Least 1 Month)||12
11249120|NCT02153359|12442505|FG000|NOT COMPLETED|Washout (at Least 1 Month)||0
11249121|NCT02153359|12442506|FG001|NOT COMPLETED|Washout (at Least 1 Month)||0
11249122|NCT02153359|12442505|FG000|STARTED|Intervention 2 (1 Month)||11
11249123|NCT02153359|12442506|FG001|STARTED|Intervention 2 (1 Month)||12
11249124|NCT02153359|12442505|FG000|COMPLETED|Intervention 2 (1 Month)||11
11249125|NCT02153359|12442506|FG001|COMPLETED|Intervention 2 (1 Month)||10
11249126|NCT02153359|12442505|FG000|NOT COMPLETED|Intervention 2 (1 Month)||0
11249127|NCT02153359|12442506|FG001|NOT COMPLETED|Intervention 2 (1 Month)||2
11249128|NCT02153398|12442520|FG000|STARTED|Overall Study||10
11249129|NCT02153398|12442521|FG001|STARTED|Overall Study||10
11249130|NCT02153398|12442522|FG002|STARTED|Overall Study||10
11249131|NCT02153398|12442523|FG003|STARTED|Overall Study||10
11249132|NCT02153398|12442524|FG004|STARTED|Overall Study||10
11249133|NCT02153398|12442520|FG000|COMPLETED|Overall Study||9
11249134|NCT02153398|12442521|FG001|COMPLETED|Overall Study||10
11249135|NCT02153398|12442522|FG002|COMPLETED|Overall Study||9
11249136|NCT02153398|12442523|FG003|COMPLETED|Overall Study||9
11249137|NCT02153398|12442524|FG004|COMPLETED|Overall Study||10
11249138|NCT02153398|12442520|FG000|NOT COMPLETED|Overall Study||1
11249139|NCT02153398|12442521|FG001|NOT COMPLETED|Overall Study||0
11249140|NCT02153398|12442522|FG002|NOT COMPLETED|Overall Study||1
11249141|NCT02153398|12442523|FG003|NOT COMPLETED|Overall Study||1
11249142|NCT02153398|12442524|FG004|NOT COMPLETED|Overall Study||0
11249143|NCT02153476|12442538|FG000|STARTED|Overall Study||23
11249144|NCT02153476|12442539|FG001|STARTED|Overall Study||22
11249145|NCT02153476|12442538|FG000|COMPLETED|Overall Study||22
11249146|NCT02153476|12442539|FG001|COMPLETED|Overall Study||22
11249147|NCT02153476|12442538|FG000|NOT COMPLETED|Overall Study||1
11249148|NCT02153476|12442539|FG001|NOT COMPLETED|Overall Study||0
11249149|NCT02153489|12442545|FG000|STARTED|Period 1||15
11249150|NCT02153489|12442546|FG001|STARTED|Period 1||15
11249151|NCT02153489|12442545|FG000|COMPLETED|Period 1||15
11249152|NCT02153489|12442546|FG001|COMPLETED|Period 1||15
11249153|NCT02153489|12442545|FG000|NOT COMPLETED|Period 1||0
11249154|NCT02153489|12442546|FG001|NOT COMPLETED|Period 1||0
11249155|NCT02153489|12442545|FG000|STARTED|Period 2||15
11249156|NCT02153489|12442546|FG001|STARTED|Period 2||15
11249157|NCT02153489|12442545|FG000|COMPLETED|Period 2||15
11249158|NCT02153489|12442546|FG001|COMPLETED|Period 2||15
11249159|NCT02153489|12442545|FG000|NOT COMPLETED|Period 2||0
11249160|NCT02153489|12442546|FG001|NOT COMPLETED|Period 2||0
11249161|NCT02153528|12442554|FG000|STARTED|Overall Study||348
11249162|NCT02153528|12442555|FG001|STARTED|Overall Study||353
11249163|NCT02153528|12442554|FG000|COMPLETED|Overall Study||348
11249164|NCT02153528|12442555|FG001|COMPLETED|Overall Study||353
11249165|NCT02153528|12442554|FG000|NOT COMPLETED|Overall Study||0
11249166|NCT02153528|12442555|FG001|NOT COMPLETED|Overall Study||0
11249167|NCT02153671|12442565|FG000|STARTED|Overall Study||19
11249168|NCT02153671|12442566|FG001|STARTED|Overall Study||24
11249169|NCT02153671|12442565|FG000|COMPLETED|Overall Study||19
11249170|NCT02153671|12442566|FG001|COMPLETED|Overall Study||24
11249171|NCT02153671|12442565|FG000|NOT COMPLETED|Overall Study||0
11249172|NCT02153671|12442566|FG001|NOT COMPLETED|Overall Study||0
11249173|NCT02153710|12442574|FG000|STARTED|Overall Study||28
11249174|NCT02153710|12442575|FG001|STARTED|Overall Study||30
11249175|NCT02153710|12442574|FG000|COMPLETED|Overall Study||28
11249176|NCT02153710|12442575|FG001|COMPLETED|Overall Study||30
11249177|NCT02153710|12442574|FG000|NOT COMPLETED|Overall Study||0
11249178|NCT02153710|12442575|FG001|NOT COMPLETED|Overall Study||0
11249179|NCT02153723|12442581|FG000|STARTED|Overall Study||10
11249180|NCT02153723|12442581|FG000|COMPLETED|Overall Study||10
11249181|NCT02153723|12442581|FG000|NOT COMPLETED|Overall Study||0
11249182|NCT02153736|12442587|FG000|STARTED|Overall Study||7
11249183|NCT02153736|12442588|FG001|STARTED|Overall Study||7
11249184|NCT02153736|12442587|FG000|COMPLETED|Overall Study||5
11249185|NCT02153736|12442588|FG001|COMPLETED|Overall Study||5
11249186|NCT02153736|12442587|FG000|NOT COMPLETED|Overall Study||2
11249187|NCT02153736|12442588|FG001|NOT COMPLETED|Overall Study||2
11249188|NCT02153788|12442596|FG000|STARTED|Overall Study||25
11249189|NCT02153788|12442597|FG001|STARTED|Overall Study||19
11249190|NCT02153788|12442596|FG000|COMPLETED|Overall Study||23
11249191|NCT02153788|12442597|FG001|COMPLETED|Overall Study||18
11249192|NCT02153788|12442596|FG000|NOT COMPLETED|Overall Study||2
11249193|NCT02153788|12442597|FG001|NOT COMPLETED|Overall Study||1
11249194|NCT02153827|12442605|FG000|STARTED|Overall Study||25
11249195|NCT02153827|12442606|FG001|STARTED|Overall Study||23
11249196|NCT02153827|12442605|FG000|COMPLETED|Overall Study||22
11249197|NCT02153827|12442606|FG001|COMPLETED|Overall Study||14
11249198|NCT02153827|12442605|FG000|NOT COMPLETED|Overall Study||3
11249199|NCT02153827|12442606|FG001|NOT COMPLETED|Overall Study||9
11249200|NCT02153905|12442614|FG000|STARTED|Overall Study||1
11249201|NCT02153905|12442615|FG001|STARTED|Overall Study||2
11249202|NCT02153905|12442614|FG000|COMPLETED|Overall Study||0
11249203|NCT02153905|12442615|FG001|COMPLETED|Overall Study||2
11249204|NCT02153905|12442614|FG000|NOT COMPLETED|Overall Study||1
11249205|NCT02153905|12442615|FG001|NOT COMPLETED|Overall Study||0
11249206|NCT02153918|12442621|FG000|STARTED|Overall Study||27
11249207|NCT02153918|12442621|FG000|COMPLETED|Overall Study||26
11249208|NCT02153918|12442621|FG000|NOT COMPLETED|Overall Study||1
11249209|NCT02153983|12442631|FG000|STARTED|Overall Study||19
11249210|NCT02153983|12442632|FG001|STARTED|Overall Study||21
11249211|NCT02153983|12442633|FG002|STARTED|Overall Study||4
11249212|NCT02153983|12442634|FG003|STARTED|Overall Study||13
11249213|NCT02153983|12442635|FG004|STARTED|Overall Study||19
11249214|NCT02153983|12442636|FG005|STARTED|Overall Study||1
11249215|NCT02153983|12442631|FG000|COMPLETED|Overall Study||19
11249216|NCT02153983|12442632|FG001|COMPLETED|Overall Study||18
11249217|NCT02153983|12442633|FG002|COMPLETED|Overall Study||2
11249218|NCT02153983|12442634|FG003|COMPLETED|Overall Study||13
11249219|NCT02153983|12442635|FG004|COMPLETED|Overall Study||19
11249220|NCT02153983|12442636|FG005|COMPLETED|Overall Study||1
11249221|NCT02153983|12442631|FG000|NOT COMPLETED|Overall Study||0
11249222|NCT02153983|12442632|FG001|NOT COMPLETED|Overall Study||3
11249223|NCT02153983|12442633|FG002|NOT COMPLETED|Overall Study||2
11249224|NCT02153983|12442634|FG003|NOT COMPLETED|Overall Study||0
11249225|NCT02153983|12442635|FG004|NOT COMPLETED|Overall Study||0
11249226|NCT02153983|12442636|FG005|NOT COMPLETED|Overall Study||0
11249227|NCT02154048|12442653|FG000|STARTED|Overall Study||2
11249228|NCT02154048|12442654|FG001|STARTED|Overall Study||2
11249229|NCT02154048|12442655|FG002|STARTED|Overall Study||1
11249230|NCT02154048|12442653|FG000|COMPLETED|Overall Study||2
11249231|NCT02154048|12442654|FG001|COMPLETED|Overall Study||2
11249232|NCT02154048|12442655|FG002|COMPLETED|Overall Study||1
11249233|NCT02154048|12442653|FG000|NOT COMPLETED|Overall Study||0
11249234|NCT02154048|12442654|FG001|NOT COMPLETED|Overall Study||0
11249235|NCT02154048|12442655|FG002|NOT COMPLETED|Overall Study||0
11249236|NCT02154061|12442665|FG000|STARTED|Overall Study||16
11249237|NCT02154061|12442666|FG001|STARTED|Overall Study||17
11249238|NCT02154061|12442665|FG000|COMPLETED|Overall Study||14
11249239|NCT02154061|12442666|FG001|COMPLETED|Overall Study||17
11249240|NCT02154061|12442665|FG000|NOT COMPLETED|Overall Study||2
11249241|NCT02154061|12442666|FG001|NOT COMPLETED|Overall Study||0
11249242|NCT02154139|12442672|FG000|STARTED|Overall Study||651
11249243|NCT02154139|12442672|FG000|COMPLETED|Overall Study||644
11249244|NCT02154139|12442672|FG000|NOT COMPLETED|Overall Study||7
11249245|NCT02154243|12442679|FG000|STARTED|Overall Study||5
11249246|NCT02154243|12442680|FG001|STARTED|Overall Study||4
11249247|NCT02154243|12442681|FG002|STARTED|Overall Study||4
11249248|NCT02154243|12442679|FG000|COMPLETED|Overall Study||5
11249249|NCT02154243|12442680|FG001|COMPLETED|Overall Study||4
11249250|NCT02154243|12442681|FG002|COMPLETED|Overall Study||4
11249251|NCT02154243|12442679|FG000|NOT COMPLETED|Overall Study||0
11249252|NCT02154243|12442680|FG001|NOT COMPLETED|Overall Study||0
11249253|NCT02154243|12442681|FG002|NOT COMPLETED|Overall Study||0
11249254|NCT02154347|12442691|FG000|STARTED|Double-blind Period||60
11249255|NCT02154347|12442692|FG001|STARTED|Double-blind Period||118
11249256|NCT02154347|12442691|FG000|COMPLETED|Double-blind Period||57
11249257|NCT02154347|12442692|FG001|COMPLETED|Double-blind Period||114
11249258|NCT02154347|12442691|FG000|NOT COMPLETED|Double-blind Period||3
11249259|NCT02154347|12442692|FG001|NOT COMPLETED|Double-blind Period||4
11249260|NCT02154347|12442691|FG000|STARTED|Open-label Period||57
11249261|NCT02154347|12442692|FG001|STARTED|Open-label Period||113
11249262|NCT02154347|12442691|FG000|COMPLETED|Open-label Period||50
11249263|NCT02154347|12442692|FG001|COMPLETED|Open-label Period||88
11249264|NCT02154347|12442691|FG000|NOT COMPLETED|Open-label Period||7
11249265|NCT02154347|12442692|FG001|NOT COMPLETED|Open-label Period||25
11249266|NCT02154386|12442701|FG000|STARTED|Overall Study||23
11249267|NCT02154386|12442702|FG001|STARTED|Overall Study||23
11249268|NCT02154386|12442701|FG000|COMPLETED|Overall Study||22
11249269|NCT02154386|12442702|FG001|COMPLETED|Overall Study||21
11249270|NCT02154386|12442701|FG000|NOT COMPLETED|Overall Study||1
11249271|NCT02154386|12442702|FG001|NOT COMPLETED|Overall Study||2
11249272|NCT02154425|12442708|FG000|STARTED|Screening Period||18
11249273|NCT02154425|12442708|FG000|COMPLETED|Screening Period||17
11249274|NCT02154425|12442708|FG000|NOT COMPLETED|Screening Period||1
11249275|NCT02154425|12442708|FG000|STARTED|Sampling Period||17
11249276|NCT02154425|12442708|FG000|COMPLETED|Sampling Period||17
11249277|NCT02154425|12442708|FG000|NOT COMPLETED|Sampling Period||0
11249278|NCT02154477|12442718|FG000|STARTED|Overall Study||6
11249279|NCT02154477|12442719|FG001|STARTED|Overall Study||8
11249280|NCT02154477|12442718|FG000|COMPLETED|Overall Study||6
11249281|NCT02154477|12442719|FG001|COMPLETED|Overall Study||8
11249282|NCT02154477|12442718|FG000|NOT COMPLETED|Overall Study||0
11249283|NCT02154477|12442719|FG001|NOT COMPLETED|Overall Study||0
11249284|NCT02154581|12442727|FG000|STARTED|Overall Study||21
11249285|NCT02154581|12442728|FG001|STARTED|Overall Study||20
11249286|NCT02154581|12442727|FG000|COMPLETED|Overall Study||14
11249287|NCT02154581|12442728|FG001|COMPLETED|Overall Study||12
11249288|NCT02154581|12442727|FG000|NOT COMPLETED|Overall Study||7
11249289|NCT02154581|12442728|FG001|NOT COMPLETED|Overall Study||8
11249290|NCT02154672|12442736|FG000|STARTED|Overall Study||1
11249291|NCT02154672|12442736|FG000|COMPLETED|Overall Study||1
11249292|NCT02154672|12442736|FG000|NOT COMPLETED|Overall Study||0
11249293|NCT02154763|12442742|FG000|STARTED|Overall Study||60
11249294|NCT02154763|12442743|FG001|STARTED|Overall Study||60
11249295|NCT02154763|12442742|FG000|COMPLETED|Overall Study||46
11249296|NCT02154763|12442743|FG001|COMPLETED|Overall Study||46
11249297|NCT02154763|12442742|FG000|NOT COMPLETED|Overall Study||14
11249298|NCT02154763|12442743|FG001|NOT COMPLETED|Overall Study||14
11249299|NCT02154906|12442753|FG000|STARTED|Overall Study||21
11249300|NCT02154906|12442754|FG001|STARTED|Overall Study||20
11249301|NCT02154906|12442753|FG000|COMPLETED|Overall Study||19
11249302|NCT02154906|12442754|FG001|COMPLETED|Overall Study||17
11249303|NCT02154906|12442753|FG000|NOT COMPLETED|Overall Study||2
11249304|NCT02154906|12442754|FG001|NOT COMPLETED|Overall Study||3
11249305|NCT02155010|12442762|FG000|STARTED|Overall Study||37
11249306|NCT02155010|12442763|FG001|STARTED|Overall Study||37
11249307|NCT02155010|12442762|FG000|COMPLETED|Overall Study||31
11249308|NCT02155010|12442763|FG001|COMPLETED|Overall Study||31
11249309|NCT02155010|12442762|FG000|NOT COMPLETED|Overall Study||6
11249310|NCT02155010|12442763|FG001|NOT COMPLETED|Overall Study||6
11249311|NCT02155101|12442771|FG000|STARTED|Overall Study||39
11249312|NCT02155101|12442772|FG001|STARTED|Overall Study||81
11249313|NCT02155101|12442771|FG000|COMPLETED|Overall Study||39
11249314|NCT02155101|12442772|FG001|COMPLETED|Overall Study||80
11249315|NCT02155101|12442771|FG000|NOT COMPLETED|Overall Study||0
11249316|NCT02155101|12442772|FG001|NOT COMPLETED|Overall Study||1
11249317|NCT02155257|12442781|FG000|STARTED|Overall Study||10
11249318|NCT02155257|12442782|FG001|STARTED|Overall Study||10
11249319|NCT02155257|12442783|FG002|STARTED|Overall Study||10
11249320|NCT02155257|12442781|FG000|COMPLETED|Overall Study||10
11249321|NCT02155257|12442782|FG001|COMPLETED|Overall Study||10
11249322|NCT02155257|12442783|FG002|COMPLETED|Overall Study||10
11249323|NCT02155257|12442781|FG000|NOT COMPLETED|Overall Study||0
11249324|NCT02155257|12442782|FG001|NOT COMPLETED|Overall Study||0
11249325|NCT02155257|12442783|FG002|NOT COMPLETED|Overall Study||0
11249326|NCT02155283|12442791|FG000|STARTED|Overall Study||16
11249327|NCT02155283|12442791|FG000|COMPLETED|Overall Study||9
11249328|NCT02155283|12442791|FG000|NOT COMPLETED|Overall Study||7
11249329|NCT02155309|12442797|FG000|STARTED|Overall Study||13
11249330|NCT02155309|12442798|FG001|STARTED|Overall Study||10
11249331|NCT02155309|12442799|FG002|STARTED|Overall Study||13
11249332|NCT02155309|12442797|FG000|COMPLETED|Overall Study||13
11249333|NCT02155309|12442798|FG001|COMPLETED|Overall Study||10
11249334|NCT02155309|12442799|FG002|COMPLETED|Overall Study||12
11249335|NCT02155309|12442797|FG000|NOT COMPLETED|Overall Study||0
11249336|NCT02155309|12442798|FG001|NOT COMPLETED|Overall Study||0
11249337|NCT02155309|12442799|FG002|NOT COMPLETED|Overall Study||1
11249338|NCT02155322|12442806|FG000|STARTED|Overall Study||33
11249339|NCT02155322|12442806|FG000|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
11249340|NCT02155322|12442806|FG000|COMPLETED|Overall Study||19
11249341|NCT02155322|12442806|FG000|NOT COMPLETED|Overall Study||14
11249342|NCT02155335|12442810|FG000|STARTED|Period 1||50
11249343|NCT02155335|12442811|FG001|STARTED|Period 1||50
11249344|NCT02155335|12442810|FG000|Treated|Period 1||50
11249345|NCT02155335|12442811|FG001|Treated|Period 1||49
11249346|NCT02155335|12442810|FG000|COMPLETED|Period 1||50
11249347|NCT02155335|12442811|FG001|COMPLETED|Period 1||49
11249348|NCT02155335|12442810|FG000|NOT COMPLETED|Period 1||0
11249349|NCT02155335|12442811|FG001|NOT COMPLETED|Period 1||1
11249350|NCT02155335|12442810|FG000|STARTED|Period 2||50
11249351|NCT02155335|12442811|FG001|STARTED|Period 2||49
11249352|NCT02155335|12442810|FG000|COMPLETED|Period 2||50
11249353|NCT02155335|12442811|FG001|COMPLETED|Period 2||49
11249354|NCT02155335|12442810|FG000|NOT COMPLETED|Period 2||0
11249355|NCT02155335|12442811|FG001|NOT COMPLETED|Period 2||0
11249356|NCT02155465|12442822|FG000|STARTED|Overall Study||3
11249357|NCT02155465|12442823|FG001|STARTED|Overall Study||3
11249358|NCT02155465|12442824|FG002|STARTED|Overall Study||6
11249359|NCT02155465|12442825|FG003|STARTED|Overall Study||2
11249360|NCT02155465|12442826|FG004|STARTED|Overall Study||1
11249361|NCT02155465|12442827|FG005|STARTED|Overall Study||2
11249362|NCT02155465|12442828|FG006|STARTED|Overall Study||5
11249363|NCT02155465|12442822|FG000|COMPLETED|Overall Study||3
11249364|NCT02155465|12442823|FG001|COMPLETED|Overall Study||3
11249365|NCT02155465|12442824|FG002|COMPLETED|Overall Study||6
11249366|NCT02155465|12442825|FG003|COMPLETED|Overall Study||2
11249367|NCT02155465|12442826|FG004|COMPLETED|Overall Study||1
11249368|NCT02155465|12442827|FG005|COMPLETED|Overall Study||2
11249369|NCT02155465|12442828|FG006|COMPLETED|Overall Study||5
11249370|NCT02155465|12442822|FG000|NOT COMPLETED|Overall Study||0
11249371|NCT02155465|12442823|FG001|NOT COMPLETED|Overall Study||0
11249372|NCT02155465|12442824|FG002|NOT COMPLETED|Overall Study||0
11249373|NCT02155465|12442825|FG003|NOT COMPLETED|Overall Study||0
11249374|NCT02155465|12442826|FG004|NOT COMPLETED|Overall Study||0
11249375|NCT02155465|12442827|FG005|NOT COMPLETED|Overall Study||0
11249376|NCT02155465|12442828|FG006|NOT COMPLETED|Overall Study||0
11249377|NCT02155543|12442854|FG000|STARTED|Overall Study||9
11249378|NCT02155543|12442855|FG001|STARTED|Overall Study||9
11249379|NCT02155543|12442856|FG002|STARTED|Overall Study||9
11249380|NCT02155543|12442857|FG003|STARTED|Overall Study||9
11249381|NCT02155543|12442858|FG004|STARTED|Overall Study||3
11249382|NCT02155543|12442859|FG005|STARTED|Overall Study||3
11249383|NCT02155543|12442860|FG006|STARTED|Overall Study||9
11249384|NCT02155543|12442854|FG000|COMPLETED|Overall Study||9
11249385|NCT02155543|12442855|FG001|COMPLETED|Overall Study||9
11249386|NCT02155543|12442856|FG002|COMPLETED|Overall Study||9
11249387|NCT02155543|12442857|FG003|COMPLETED|Overall Study||9
11249388|NCT02155543|12442858|FG004|COMPLETED|Overall Study||3
11249389|NCT02155543|12442859|FG005|COMPLETED|Overall Study||3
11249390|NCT02155543|12442860|FG006|COMPLETED|Overall Study||9
11249391|NCT02155543|12442854|FG000|NOT COMPLETED|Overall Study||0
11249392|NCT02155543|12442855|FG001|NOT COMPLETED|Overall Study||0
11249393|NCT02155543|12442856|FG002|NOT COMPLETED|Overall Study||0
11249394|NCT02155543|12442857|FG003|NOT COMPLETED|Overall Study||0
11249395|NCT02155543|12442858|FG004|NOT COMPLETED|Overall Study||0
11249396|NCT02155543|12442859|FG005|NOT COMPLETED|Overall Study||0
11249397|NCT02155543|12442860|FG006|NOT COMPLETED|Overall Study||0
11249398|NCT02155608|12442875|FG000|STARTED|1a: 4 Week Double Blind Sham Controlled||32
11249399|NCT02155608|12442876|FG001|STARTED|1a: 4 Week Double Blind Sham Controlled||30
11249400|NCT02155608|12442875|FG000|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32
11249401|NCT02155608|12442876|FG001|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29
11249402|NCT02155608|12442875|FG000|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0
11249403|NCT02155608|12442876|FG001|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1
11249404|NCT02155608|12442875|FG000|STARTED|1b: 1 Week Blinded Post Treatment||32
11249405|NCT02155608|12442876|FG001|STARTED|1b: 1 Week Blinded Post Treatment||29
11249406|NCT02155608|12442875|FG000|COMPLETED|1b: 1 Week Blinded Post Treatment||31
11249407|NCT02155608|12442876|FG001|COMPLETED|1b: 1 Week Blinded Post Treatment||28
11249408|NCT02155608|12442875|FG000|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
11249409|NCT02155608|12442876|FG001|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
11249410|NCT02155660|12442892|FG000|STARTED|Overall Study||562
11249411|NCT02155660|12442893|FG001|STARTED|Overall Study||562
11249412|NCT02155660|12442894|FG002|STARTED|Overall Study||562
11249413|NCT02155660|12442895|FG003|STARTED|Overall Study||568
11249414|NCT02155660|12442892|FG000|COMPLETED|Overall Study||504
11249415|NCT02155660|12442893|FG001|COMPLETED|Overall Study||489
11249416|NCT02155660|12442894|FG002|COMPLETED|Overall Study||502
11249417|NCT02155660|12442895|FG003|COMPLETED|Overall Study||507
11249418|NCT02155660|12442892|FG000|NOT COMPLETED|Overall Study||58
11249419|NCT02155660|12442893|FG001|NOT COMPLETED|Overall Study||73
11249420|NCT02155660|12442894|FG002|NOT COMPLETED|Overall Study||60
11249421|NCT02155660|12442895|FG003|NOT COMPLETED|Overall Study||61
11249422|NCT02155725|12442907|FG000|STARTED|Treatment Period||224
11249423|NCT02155725|12442908|FG001|STARTED|Treatment Period||213
11249424|NCT02155725|12442907|FG000|COMPLETED|Treatment Period||224
11249425|NCT02155725|12442908|FG001|COMPLETED|Treatment Period||213
11249426|NCT02155725|12442907|FG000|NOT COMPLETED|Treatment Period||0
11249427|NCT02155725|12442908|FG001|NOT COMPLETED|Treatment Period||0
11249428|NCT02155725|12442907|FG000|STARTED|Follow-up Period||224
11249429|NCT02155725|12442908|FG001|STARTED|Follow-up Period||213
11249430|NCT02155725|12442907|FG000|COMPLETED|Follow-up Period||207
11249431|NCT02155725|12442908|FG001|COMPLETED|Follow-up Period||202
11249432|NCT02155725|12442907|FG000|NOT COMPLETED|Follow-up Period||17
11249433|NCT02155725|12442908|FG001|NOT COMPLETED|Follow-up Period||11
11249434|NCT02155738|12442924|FG000|STARTED|Overall Study||50
11249435|NCT02155738|12442925|FG001|STARTED|Overall Study||52
11249436|NCT02155738|12442926|FG002|STARTED|Overall Study||51
11249437|NCT02155738|12442927|FG003|STARTED|Overall Study||51
11249438|NCT02155738|12442924|FG000|COMPLETED|Overall Study||49
11249439|NCT02155738|12442925|FG001|COMPLETED|Overall Study||52
11249440|NCT02155738|12442926|FG002|COMPLETED|Overall Study||51
11249441|NCT02155738|12442927|FG003|COMPLETED|Overall Study||50
11249442|NCT02155738|12442924|FG000|NOT COMPLETED|Overall Study||1
11249443|NCT02155738|12442925|FG001|NOT COMPLETED|Overall Study||0
11249444|NCT02155738|12442926|FG002|NOT COMPLETED|Overall Study||0
11249445|NCT02155738|12442927|FG003|NOT COMPLETED|Overall Study||1
11249446|NCT02155829|12442939|FG000|STARTED|Overall Study||37
11249447|NCT02155829|12442940|FG001|STARTED|Overall Study||38
11249448|NCT02155829|12442939|FG000|COMPLETED|Overall Study||31
11249449|NCT02155829|12442940|FG001|COMPLETED|Overall Study||35
11249450|NCT02155829|12442939|FG000|NOT COMPLETED|Overall Study||6
11249451|NCT02155829|12442940|FG001|NOT COMPLETED|Overall Study||3
11249452|NCT02155881|12442949|FG000|STARTED|Overall Study||40
11249453|NCT02155881|12442950|FG001|STARTED|Overall Study||40
11249454|NCT02155881|12442949|FG000|COMPLETED|Overall Study||38
11249455|NCT02155881|12442950|FG001|COMPLETED|Overall Study||36
11249456|NCT02155881|12442949|FG000|NOT COMPLETED|Overall Study||2
11249457|NCT02155881|12442950|FG001|NOT COMPLETED|Overall Study||4
11249458|NCT02155985|12442959|FG000|STARTED|Overall Study||40
11249459|NCT02155985|12442960|FG001|STARTED|Overall Study||41
11249460|NCT02155985|12442961|FG002|STARTED|Overall Study||40
11249461|NCT02155985|12442959|FG000|COMPLETED|Overall Study||39
11249462|NCT02155985|12442960|FG001|COMPLETED|Overall Study||41
11249463|NCT02155985|12442961|FG002|COMPLETED|Overall Study||39
11249464|NCT02155985|12442959|FG000|NOT COMPLETED|Overall Study||1
11249465|NCT02155985|12442960|FG001|NOT COMPLETED|Overall Study||0
11249466|NCT02155985|12442961|FG002|NOT COMPLETED|Overall Study||1
11249467|NCT02156076|12442973|FG000|STARTED|Treatment Period||7
11249468|NCT02156076|12442974|FG001|STARTED|Treatment Period||7
11249469|NCT02156076|12442975|FG002|STARTED|Treatment Period||6
11249470|NCT02156076|12442976|FG003|STARTED|Treatment Period||6
11249471|NCT02156076|12442973|FG000|COMPLETED|Treatment Period||7
11249472|NCT02156076|12442974|FG001|COMPLETED|Treatment Period||5
11249473|NCT02156076|12442975|FG002|COMPLETED|Treatment Period||4
11249474|NCT02156076|12442976|FG003|COMPLETED|Treatment Period||4
11249475|NCT02156076|12442973|FG000|NOT COMPLETED|Treatment Period||0
11249476|NCT02156076|12442974|FG001|NOT COMPLETED|Treatment Period||2
11249477|NCT02156076|12442975|FG002|NOT COMPLETED|Treatment Period||2
11249478|NCT02156076|12442976|FG003|NOT COMPLETED|Treatment Period||2
11249479|NCT02156076|12442973|FG000|STARTED|Follow-up Period||7
11249480|NCT02156076|12442974|FG001|STARTED|Follow-up Period||5
11249481|NCT02156076|12442975|FG002|STARTED|Follow-up Period||4
11249482|NCT02156076|12442976|FG003|STARTED|Follow-up Period||4
11249483|NCT02156076|12442973|FG000|COMPLETED|Follow-up Period||6
11249484|NCT02156076|12442974|FG001|COMPLETED|Follow-up Period||5
11249485|NCT02156076|12442975|FG002|COMPLETED|Follow-up Period||4
11249486|NCT02156076|12442976|FG003|COMPLETED|Follow-up Period||4
11249487|NCT02156076|12442973|FG000|NOT COMPLETED|Follow-up Period||1
11249488|NCT02156076|12442974|FG001|NOT COMPLETED|Follow-up Period||0
11249489|NCT02156076|12442975|FG002|NOT COMPLETED|Follow-up Period||0
11249490|NCT02156076|12442976|FG003|NOT COMPLETED|Follow-up Period||0
11249491|NCT02156154|12442988|FG000|STARTED|Overall Study||291
11249492|NCT02156154|12442989|FG001|STARTED|Overall Study||289
11249493|NCT02156154|12442988|FG000|COMPLETED|Overall Study||287
11249494|NCT02156154|12442989|FG001|COMPLETED|Overall Study||283
11249495|NCT02156154|12442988|FG000|NOT COMPLETED|Overall Study||4
11249496|NCT02156154|12442989|FG001|NOT COMPLETED|Overall Study||6
11249497|NCT02156167|12442995|FG000|STARTED|Overall Study||15
11249498|NCT02156167|12442995|FG000|COMPLETED|Overall Study||15
11249499|NCT02156167|12442995|FG000|NOT COMPLETED|Overall Study||0
11249500|NCT02156258|12443002|FG000|STARTED|Overall Study||674
11249501|NCT02156258|12443003|FG001|STARTED|Overall Study||203
11249502|NCT02156258|12443004|FG002|STARTED|Overall Study||355
11249503|NCT02156258|12443002|FG000|COMPLETED|Overall Study||642
11249504|NCT02156258|12443003|FG001|COMPLETED|Overall Study||124
11249505|NCT02156258|12443004|FG002|COMPLETED|Overall Study||244
11249506|NCT02156258|12443002|FG000|NOT COMPLETED|Overall Study||32
11249507|NCT02156258|12443003|FG001|NOT COMPLETED|Overall Study||79
11249508|NCT02156258|12443004|FG002|NOT COMPLETED|Overall Study||111
11249509|NCT02156271|12443014|FG000|STARTED|Overall Study||26
11249510|NCT02156271|12443015|FG001|STARTED|Overall Study||13
11249511|NCT02156271|12443014|FG000|COMPLETED|Overall Study||22
11249512|NCT02156271|12443015|FG001|COMPLETED|Overall Study||10
11249513|NCT02156271|12443014|FG000|NOT COMPLETED|Overall Study||4
11249514|NCT02156271|12443015|FG001|NOT COMPLETED|Overall Study||3
11249515|NCT02156466|12443026|FG000|STARTED|Overall Study||8
11249516|NCT02156466|12443027|FG001|STARTED|Overall Study||8
11249517|NCT02156466|12443028|FG002|STARTED|Overall Study||8
11249518|NCT02156466|12443029|FG003|STARTED|Overall Study||9
11249519|NCT02156466|12443030|FG004|STARTED|Overall Study||8
11249520|NCT02156466|12443026|FG000|COMPLETED|Overall Study||8
11249521|NCT02156466|12443027|FG001|COMPLETED|Overall Study||8
11249522|NCT02156466|12443028|FG002|COMPLETED|Overall Study||7
11249523|NCT02156466|12443029|FG003|COMPLETED|Overall Study||7
11249524|NCT02156466|12443030|FG004|COMPLETED|Overall Study||8
11249525|NCT02156466|12443026|FG000|NOT COMPLETED|Overall Study||0
11249526|NCT02156466|12443027|FG001|NOT COMPLETED|Overall Study||0
11249527|NCT02156466|12443028|FG002|NOT COMPLETED|Overall Study||1
11249528|NCT02156466|12443029|FG003|NOT COMPLETED|Overall Study||2
11249529|NCT02156466|12443030|FG004|NOT COMPLETED|Overall Study||0
11249530|NCT02156492|12443054|FG000|STARTED|Period 1||16
11249531|NCT02156492|12443055|FG001|STARTED|Period 1||24
11249532|NCT02156492|12443056|FG002|STARTED|Period 1||22
11249533|NCT02156492|12443054|FG000|Received at Least One Dose of Study Drug|Period 1||16
11249534|NCT02156492|12443055|FG001|Received at Least One Dose of Study Drug|Period 1||24
11249535|NCT02156492|12443056|FG002|Received at Least One Dose of Study Drug|Period 1||22
11249536|NCT02156492|12443054|FG000|COMPLETED|Period 1||16
11249537|NCT02156492|12443055|FG001|COMPLETED|Period 1||23
11249538|NCT02156492|12443056|FG002|COMPLETED|Period 1||22
11249539|NCT02156492|12443054|FG000|NOT COMPLETED|Period 1||0
11249540|NCT02156492|12443055|FG001|NOT COMPLETED|Period 1||1
11249541|NCT02156492|12443056|FG002|NOT COMPLETED|Period 1||0
11249542|NCT02156492|12443054|FG000|STARTED|Period 2||16
11249543|NCT02156492|12443055|FG001|STARTED|Period 2||23
11249544|NCT02156492|12443056|FG002|STARTED|Period 2||22
11249545|NCT02156492|12443054|FG000|COMPLETED|Period 2||16
11249546|NCT02156492|12443055|FG001|COMPLETED|Period 2||23
11249547|NCT02156492|12443056|FG002|COMPLETED|Period 2||22
11249548|NCT02156492|12443054|FG000|NOT COMPLETED|Period 2||0
11249549|NCT02156492|12443055|FG001|NOT COMPLETED|Period 2||0
11249550|NCT02156492|12443056|FG002|NOT COMPLETED|Period 2||0
11249551|NCT02156492|12443054|FG000|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
11249552|NCT02156492|12443055|FG001|STARTED|Period 3||23
11249553|NCT02156492|12443056|FG002|STARTED|Period 3||22
11249554|NCT02156492|12443054|FG000|COMPLETED|Period 3||0
11249555|NCT02156492|12443055|FG001|COMPLETED|Period 3||22
11249556|NCT02156492|12443056|FG002|COMPLETED|Period 3||22
11249557|NCT02156492|12443054|FG000|NOT COMPLETED|Period 3||0
11249558|NCT02156492|12443055|FG001|NOT COMPLETED|Period 3||1
11249559|NCT02156492|12443056|FG002|NOT COMPLETED|Period 3||0
11249560|NCT02156674|12443074|FG000|STARTED|Overall Study||1
11249561|NCT02156674|12443074|FG000|COMPLETED|Overall Study||1
11249562|NCT02156674|12443074|FG000|NOT COMPLETED|Overall Study||0
11249563|NCT02156687|12443080|FG000|STARTED|Overall Study||30
11249564|NCT02156687|12443081|FG001|STARTED|Overall Study||29
11249565|NCT02156687|12443080|FG000|COMPLETED|Overall Study||20
11249566|NCT02156687|12443081|FG001|COMPLETED|Overall Study||24
11249567|NCT02156687|12443080|FG000|NOT COMPLETED|Overall Study||10
11249568|NCT02156687|12443081|FG001|NOT COMPLETED|Overall Study||5
11249569|NCT02156804|12443087|FG000|STARTED|Overall Study||1009
11249570|NCT02156804|12443087|FG000|COMPLETED|Overall Study||1008
11249571|NCT02156804|12443087|FG000|NOT COMPLETED|Overall Study||1
11249572|NCT02156908|12443093|FG000|STARTED|Overall Study||5
11249573|NCT02156908|12443094|FG001|STARTED|Overall Study||3
11249574|NCT02156908|12443093|FG000|COMPLETED|Overall Study||5
11249575|NCT02156908|12443094|FG001|COMPLETED|Overall Study||3
11249576|NCT02156908|12443093|FG000|NOT COMPLETED|Overall Study||0
11249577|NCT02156908|12443094|FG001|NOT COMPLETED|Overall Study||0
11249578|NCT02157103|12443101|FG000|STARTED|Overall Study||3
11249579|NCT02157103|12443101|FG000|COMPLETED|Overall Study||3
11249580|NCT02157103|12443101|FG000|NOT COMPLETED|Overall Study||0
11249581|NCT02157168|12443108|FG000|STARTED|Overall Study||746
11249582|NCT02157168|12443109|FG001|STARTED|Overall Study||159
11249583|NCT02157168|12443110|FG002|STARTED|Overall Study||1362
11249584|NCT02157168|12443108|FG000|COMPLETED|Overall Study||746
11249585|NCT02157168|12443109|FG001|COMPLETED|Overall Study||159
11249586|NCT02157168|12443110|FG002|COMPLETED|Overall Study||1362
11249587|NCT02157168|12443108|FG000|NOT COMPLETED|Overall Study||0
11249588|NCT02157168|12443109|FG001|NOT COMPLETED|Overall Study||0
11249589|NCT02157168|12443110|FG002|NOT COMPLETED|Overall Study||0
11249590|NCT02157298|12443123|FG000|STARTED|Overall Study||123
11249591|NCT02157298|12443124|FG001|STARTED|Overall Study||60
11005430|NCT00723021|12183141|FG000|NOT COMPLETED|Intervention Period 1||0
11005431|NCT00723021|12183142|FG001|NOT COMPLETED|Intervention Period 1||0
11249592|NCT02157298|12443123|FG000|COMPLETED|Overall Study||119
11249593|NCT02157298|12443124|FG001|COMPLETED|Overall Study||58
11249594|NCT02157298|12443123|FG000|NOT COMPLETED|Overall Study||4
11249595|NCT02157298|12443124|FG001|NOT COMPLETED|Overall Study||2
11249596|NCT02157376|12443132|FG000|STARTED|Overall Study||155
11249597|NCT02157376|12443133|FG001|STARTED|Overall Study||156
11249598|NCT02157376|12443132|FG000|COMPLETED|Overall Study||133
11249599|NCT02157376|12443133|FG001|COMPLETED|Overall Study||138
11249600|NCT02157376|12443132|FG000|NOT COMPLETED|Overall Study||22
11249601|NCT02157376|12443133|FG001|NOT COMPLETED|Overall Study||18
11249602|NCT02157506|12443144|FG000|STARTED|Overall Study||12
11249603|NCT02157506|12443145|FG001|STARTED|Overall Study||6
11249604|NCT02157506|12443146|FG002|STARTED|Overall Study||9
11249605|NCT02157506|12443147|FG003|STARTED|Overall Study||12
11249606|NCT02157506|12443148|FG004|STARTED|Overall Study||7
11249607|NCT02157506|12443144|FG000|COMPLETED|Overall Study||12
11358536|NCT03125915|12555684|FG002|COMPLETED|1 Month Follow up||32
11249608|NCT02157506|12443145|FG001|COMPLETED|Overall Study||5
11249609|NCT02157506|12443146|FG002|COMPLETED|Overall Study||8
11249610|NCT02157506|12443147|FG003|COMPLETED|Overall Study||12
11249611|NCT02157506|12443148|FG004|COMPLETED|Overall Study||7
11249612|NCT02157506|12443144|FG000|NOT COMPLETED|Overall Study||0
11249613|NCT02157506|12443145|FG001|NOT COMPLETED|Overall Study||1
11249614|NCT02157506|12443146|FG002|NOT COMPLETED|Overall Study||1
11249615|NCT02157506|12443147|FG003|NOT COMPLETED|Overall Study||0
11249616|NCT02157506|12443148|FG004|NOT COMPLETED|Overall Study||0
11249617|NCT02157519|12443162|FG000|STARTED|Overall Study||91
11249618|NCT02157519|12443163|FG001|STARTED|Overall Study||90
11249619|NCT02157519|12443162|FG000|MEMScap Collected|Overall Study||84
11249620|NCT02157519|12443163|FG001|MEMScap Collected|Overall Study||86
11249621|NCT02157519|12443162|FG000|COMPLETED|Overall Study||80
11249622|NCT02157519|12443163|FG001|COMPLETED|Overall Study||89
11249623|NCT02157519|12443162|FG000|NOT COMPLETED|Overall Study||11
11249624|NCT02157519|12443163|FG001|NOT COMPLETED|Overall Study||1
11249625|NCT02157623|12443169|FG000|STARTED|Overall Study|3 patients, each received red light on half of body and blue light on the contralateral side.|3
11249626|NCT02157623|12443169|FG000|COMPLETED|Overall Study||3
11249627|NCT02157623|12443169|FG000|NOT COMPLETED|Overall Study||0
11249628|NCT02157779|12443181|FG000|STARTED|Overall Study||47
11249629|NCT02157779|12443182|FG001|STARTED|Overall Study||45
11249630|NCT02157779|12443181|FG000|COMPLETED|Overall Study||23
11249631|NCT02157779|12443182|FG001|COMPLETED|Overall Study||34
11249632|NCT02157779|12443181|FG000|NOT COMPLETED|Overall Study||24
11249633|NCT02157779|12443182|FG001|NOT COMPLETED|Overall Study||11
11249634|NCT02157909|12443193|FG000|STARTED|Overall Study||66
11249635|NCT02157909|12443194|FG001|STARTED|Overall Study||66
11249636|NCT02157909|12443193|FG000|COMPLETED|Overall Study||66
11249637|NCT02157909|12443194|FG001|COMPLETED|Overall Study||66
11249638|NCT02157909|12443193|FG000|NOT COMPLETED|Overall Study||0
11249639|NCT02157909|12443194|FG001|NOT COMPLETED|Overall Study||0
11249640|NCT02157935|12443203|FG000|STARTED|Overall Study||606
11249641|NCT02157935|12443204|FG001|STARTED|Overall Study||613
11249642|NCT02157935|12443203|FG000|COMPLETED|Overall Study||567
11249643|NCT02157935|12443204|FG001|COMPLETED|Overall Study||548
11249644|NCT02157935|12443203|FG000|NOT COMPLETED|Overall Study||39
11249645|NCT02157935|12443204|FG001|NOT COMPLETED|Overall Study||65
11249646|NCT02157948|12443212|FG000|STARTED|Overall Study||197
11249647|NCT02157948|12443213|FG001|STARTED|Overall Study||197
11249648|NCT02157948|12443212|FG000|Received Treatment|Overall Study||196
11249649|NCT02157948|12443213|FG001|Received Treatment|Overall Study||196
11249650|NCT02157948|12443212|FG000|COMPLETED|Overall Study||188
11249651|NCT02157948|12443213|FG001|COMPLETED|Overall Study||188
11249652|NCT02157948|12443212|FG000|NOT COMPLETED|Overall Study||9
11249653|NCT02157948|12443213|FG001|NOT COMPLETED|Overall Study||9
11249654|NCT02158039|12443219|FG000|STARTED|Overall Study||33
11249655|NCT02158039|12443219|FG000|COMPLETED|Overall Study||23
11249656|NCT02158039|12443219|FG000|NOT COMPLETED|Overall Study||10
11249657|NCT02158247|12443225|FG000|STARTED|Overall Study||181
11249658|NCT02158247|12443225|FG000|COMPLETED|Overall Study||176
11249659|NCT02158247|12443225|FG000|NOT COMPLETED|Overall Study||5
11339395|NCT02912650|12536895|FG000|COMPLETED|Overall Study||55
11339396|NCT02912650|12536896|FG001|COMPLETED|Overall Study||172
11339397|NCT02912650|12536897|FG002|COMPLETED|Overall Study||173
11339398|NCT02912650|12536898|FG003|COMPLETED|Overall Study||160
11339399|NCT02912650|12536895|FG000|NOT COMPLETED|Overall Study||1
11339400|NCT02912650|12536896|FG001|NOT COMPLETED|Overall Study||0
11339401|NCT02912650|12536897|FG002|NOT COMPLETED|Overall Study||2
11339402|NCT02912650|12536898|FG003|NOT COMPLETED|Overall Study||5
11339403|NCT02913105|12536911|FG000|STARTED|Overall Study||37
11339404|NCT02913105|12536912|FG001|STARTED|Overall Study||44
11339405|NCT02913105|12536913|FG002|STARTED|Overall Study||40
11339406|NCT02913105|12536911|FG000|COMPLETED|Overall Study||22
11339407|NCT02913105|12536912|FG001|COMPLETED|Overall Study||39
11339408|NCT02913105|12536913|FG002|COMPLETED|Overall Study||33
11339409|NCT02913105|12536911|FG000|NOT COMPLETED|Overall Study||15
11339410|NCT02913105|12536912|FG001|NOT COMPLETED|Overall Study||5
11339411|NCT02913105|12536913|FG002|NOT COMPLETED|Overall Study||7
11339412|NCT02913326|12536924|FG000|STARTED|Overall Study||60
11339413|NCT02913326|12536925|FG001|STARTED|Overall Study||60
11339414|NCT02913326|12536924|FG000|COMPLETED|Overall Study||59
11339415|NCT02913326|12536925|FG001|COMPLETED|Overall Study||58
11339416|NCT02913326|12536924|FG000|NOT COMPLETED|Overall Study||1
11339417|NCT02913326|12536925|FG001|NOT COMPLETED|Overall Study||2
11339418|NCT02913521|12536934|FG000|STARTED|Overall Study||316
11339419|NCT02913521|12536935|FG001|STARTED|Overall Study||312
11339420|NCT02913521|12536936|FG002|STARTED|Overall Study||306
11339421|NCT02913521|12536934|FG000|COMPLETED|Overall Study||263
11339422|NCT02913521|12536935|FG001|COMPLETED|Overall Study||262
11339423|NCT02913521|12536936|FG002|COMPLETED|Overall Study||261
11339424|NCT02913521|12536934|FG000|NOT COMPLETED|Overall Study||53
11339425|NCT02913521|12536935|FG001|NOT COMPLETED|Overall Study||50
11339426|NCT02913521|12536936|FG002|NOT COMPLETED|Overall Study||45
11339427|NCT02913924|12536946|FG000|STARTED|Overall Study||34
11339428|NCT02913924|12536947|FG001|STARTED|Overall Study||34
11339429|NCT02913924|12536946|FG000|COMPLETED|Overall Study||21
11339430|NCT02913924|12536947|FG001|COMPLETED|Overall Study||21
11339431|NCT02913924|12536946|FG000|NOT COMPLETED|Overall Study||13
11339432|NCT02913924|12536947|FG001|NOT COMPLETED|Overall Study||13
11339433|NCT02914119|12536953|FG000|STARTED|Overall Study||30430
11339434|NCT02914119|12536953|FG000|COMPLETED|Overall Study||30430
11339435|NCT02914119|12536953|FG000|NOT COMPLETED|Overall Study||0
11339436|NCT02914132|12536957|FG000|STARTED|Overall Study||15
11339437|NCT02914132|12536957|FG000|COMPLETED|Overall Study||15
11339438|NCT02914132|12536957|FG000|NOT COMPLETED|Overall Study||0
11339439|NCT02914184|12536965|FG000|STARTED|Overall Study||400
11339440|NCT02914184|12536966|FG001|STARTED|Overall Study||396
11339441|NCT02914184|12536967|FG002|STARTED|Overall Study||402
11339442|NCT02914184|12536968|FG003|STARTED|Overall Study||402
11339443|NCT02914184|12536965|FG000|COMPLETED|Overall Study||386
11339444|NCT02914184|12536966|FG001|COMPLETED|Overall Study||383
11339445|NCT02914184|12536967|FG002|COMPLETED|Overall Study||385
11339446|NCT02914184|12536968|FG003|COMPLETED|Overall Study||391
11339447|NCT02914184|12536965|FG000|NOT COMPLETED|Overall Study||14
11339448|NCT02914184|12536966|FG001|NOT COMPLETED|Overall Study||13
11339449|NCT02914184|12536967|FG002|NOT COMPLETED|Overall Study||17
11339450|NCT02914184|12536968|FG003|NOT COMPLETED|Overall Study||11
11339451|NCT02914210|12536982|FG000|STARTED|Overall Study||153
11339452|NCT02914210|12536983|FG001|STARTED|Overall Study||153
11339453|NCT02914210|12536982|FG000|COMPLETED|Overall Study||143
11339454|NCT02914210|12536983|FG001|COMPLETED|Overall Study||144
11339455|NCT02914210|12536982|FG000|NOT COMPLETED|Overall Study||10
11339456|NCT02914210|12536983|FG001|NOT COMPLETED|Overall Study||9
11339457|NCT02914236|12536989|FG000|STARTED|Overall Study||50
11339458|NCT02914236|12536989|FG000|4-week Follow-up Visit|Overall Study||50
11339459|NCT02914236|12536989|FG000|12-week Follow-up Visit|Overall Study||50
11339460|NCT02914236|12536989|FG000|26-week Follow-up Visit|Overall Study||49
11339461|NCT02914236|12536989|FG000|COMPLETED|Overall Study||49
11339462|NCT02914236|12536989|FG000|NOT COMPLETED|Overall Study||1
11339463|NCT02914275|12536995|FG000|STARTED|Overall Study||1687
11339464|NCT02914275|12536996|FG001|STARTED|Overall Study||563
11339465|NCT02914275|12536995|FG000|Included in Clinical Database / FAS|Overall Study||1684
11339466|NCT02914275|12536996|FG001|Included in Clinical Database / FAS|Overall Study||563
11339467|NCT02914275|12536995|FG000|COMPLETED|Overall Study||1566
11339468|NCT02914275|12536996|FG001|COMPLETED|Overall Study||521
11339469|NCT02914275|12536995|FG000|NOT COMPLETED|Overall Study||121
11339470|NCT02914275|12536996|FG001|NOT COMPLETED|Overall Study||42
11339471|NCT02914457|12537006|FG000|STARTED|Overall Study||31
11339472|NCT02914457|12537006|FG000|COMPLETED|Overall Study|Subjects who completed electrophysiological study with analyzable data|25
11339473|NCT02914457|12537006|FG000|NOT COMPLETED|Overall Study||6
11339474|NCT02914509|12537012|FG000|STARTED|Overall Study||348
11339475|NCT02914509|12537013|FG001|STARTED|Overall Study||217
11339476|NCT02914509|12537012|FG000|COMPLETED|Overall Study||343
11339477|NCT02914509|12537013|FG001|COMPLETED|Overall Study||211
11249660|NCT02158273|12443243|FG000|STARTED|Overall Study||25
11249661|NCT02158273|12443244|FG001|STARTED|Overall Study||25
11249662|NCT02158273|12443243|FG000|COMPLETED|Overall Study||22
11249663|NCT02158273|12443244|FG001|COMPLETED|Overall Study||22
11249664|NCT02158273|12443243|FG000|NOT COMPLETED|Overall Study||3
11249665|NCT02158273|12443244|FG001|NOT COMPLETED|Overall Study||3
11249666|NCT02158364|12443250|FG000|STARTED|Overall Study||3331
11249667|NCT02158364|12443250|FG000|COMPLETED|Overall Study||3271
11249668|NCT02158364|12443250|FG000|NOT COMPLETED|Overall Study||60
11249669|NCT02158442|12443256|FG000|STARTED|Overall Study||8
11249670|NCT02158442|12443257|FG001|STARTED|Overall Study||7
11249671|NCT02158442|12443256|FG000|COMPLETED|Overall Study||6
11249672|NCT02158442|12443257|FG001|COMPLETED|Overall Study||7
11249673|NCT02158442|12443256|FG000|NOT COMPLETED|Overall Study||2
11249674|NCT02158442|12443257|FG001|NOT COMPLETED|Overall Study||0
11249675|NCT02158494|12443265|FG000|STARTED|Overall Study||22
11249676|NCT02158494|12443266|FG001|STARTED|Overall Study||22
11249677|NCT02158494|12443265|FG000|COMPLETED|Overall Study||22
11249678|NCT02158494|12443266|FG001|COMPLETED|Overall Study||21
11249679|NCT02158494|12443265|FG000|NOT COMPLETED|Overall Study||0
11249680|NCT02158494|12443266|FG001|NOT COMPLETED|Overall Study||1
11249681|NCT02158520|12443279|FG000|STARTED|Overall Study||12
11249682|NCT02158520|12443280|FG001|STARTED|Overall Study||12
11249683|NCT02158520|12443279|FG000|AE Evaluated Prior to Crossover|Overall Study||12
11249684|NCT02158520|12443280|FG001|AE Evaluated Prior to Crossover|Overall Study||12
11249685|NCT02158520|12443279|FG000|Eligible for Crossover|Overall Study||8
11249686|NCT02158520|12443280|FG001|Eligible for Crossover|Overall Study||8
11249687|NCT02158520|12443279|FG000|Eligible for Crossover With AE Evaluated|Overall Study||7
11249688|NCT02158520|12443280|FG001|Eligible for Crossover With AE Evaluated|Overall Study||7
11249689|NCT02158520|12443279|FG000|Crossover Cohort|Overall Study||4
11249690|NCT02158520|12443280|FG001|Crossover Cohort|Overall Study||6
11249691|NCT02158520|12443279|FG000|COMPLETED|Overall Study||12
11249692|NCT02158520|12443280|FG001|COMPLETED|Overall Study||12
11249693|NCT02158520|12443279|FG000|NOT COMPLETED|Overall Study||0
11249694|NCT02158520|12443280|FG001|NOT COMPLETED|Overall Study||0
11249695|NCT02158533|12443291|FG000|STARTED|Stage 1||265
11249696|NCT02158533|12443292|FG001|STARTED|Stage 1||59
11249697|NCT02158533|12443293|FG002|STARTED|Stage 1||60
11249698|NCT02158533|12443294|FG003|STARTED|Stage 1||0
11249699|NCT02158533|12443295|FG004|STARTED|Stage 1||0
11249700|NCT02158533|12443296|FG005|STARTED|Stage 1||0
11249701|NCT02158533|12443291|FG000|COMPLETED|Stage 1||251
11249702|NCT02158533|12443292|FG001|COMPLETED|Stage 1||51
11249703|NCT02158533|12443293|FG002|COMPLETED|Stage 1||52
11249704|NCT02158533|12443294|FG003|COMPLETED|Stage 1||0
11249705|NCT02158533|12443295|FG004|COMPLETED|Stage 1||0
11249706|NCT02158533|12443296|FG005|COMPLETED|Stage 1||0
11249707|NCT02158533|12443291|FG000|NOT COMPLETED|Stage 1||14
11249708|NCT02158533|12443292|FG001|NOT COMPLETED|Stage 1||8
11249709|NCT02158533|12443293|FG002|NOT COMPLETED|Stage 1||8
11249710|NCT02158533|12443294|FG003|NOT COMPLETED|Stage 1||0
11249711|NCT02158533|12443295|FG004|NOT COMPLETED|Stage 1||0
11249712|NCT02158533|12443296|FG005|NOT COMPLETED|Stage 1||0
11249713|NCT02158533|12443291|FG000|STARTED|Stage 2||0
11249714|NCT02158533|12443292|FG001|STARTED|Stage 2||0
11249715|NCT02158533|12443293|FG002|STARTED|Stage 2||0
11249716|NCT02158533|12443294|FG003|STARTED|Stage 2||56
11249717|NCT02158533|12443295|FG004|STARTED|Stage 2||56
11249718|NCT02158533|12443296|FG005|STARTED|Stage 2||56
11249719|NCT02158533|12443291|FG000|COMPLETED|Stage 2||0
11249720|NCT02158533|12443292|FG001|COMPLETED|Stage 2||0
11249721|NCT02158533|12443293|FG002|COMPLETED|Stage 2||0
11249722|NCT02158533|12443294|FG003|COMPLETED|Stage 2||53
11249723|NCT02158533|12443295|FG004|COMPLETED|Stage 2||52
11249724|NCT02158533|12443296|FG005|COMPLETED|Stage 2||50
11249725|NCT02158533|12443291|FG000|NOT COMPLETED|Stage 2||0
11249726|NCT02158533|12443292|FG001|NOT COMPLETED|Stage 2||0
11249727|NCT02158533|12443293|FG002|NOT COMPLETED|Stage 2||0
11249728|NCT02158533|12443294|FG003|NOT COMPLETED|Stage 2||3
11249729|NCT02158533|12443295|FG004|NOT COMPLETED|Stage 2||4
11249730|NCT02158533|12443296|FG005|NOT COMPLETED|Stage 2||6
11249731|NCT02158546|12443314|FG000|STARTED|Overall Study||152
11249732|NCT02158546|12443315|FG001|STARTED|Overall Study||153
11249733|NCT02158546|12443316|FG002|STARTED|Overall Study||18
11249734|NCT02158546|12443317|FG003|STARTED|Overall Study||19
11249735|NCT02158546|12443314|FG000|COMPLETED|Overall Study||133
11249736|NCT02158546|12443315|FG001|COMPLETED|Overall Study||136
11249737|NCT02158546|12443316|FG002|COMPLETED|Overall Study||14
11249738|NCT02158546|12443317|FG003|COMPLETED|Overall Study||13
11249739|NCT02158546|12443314|FG000|NOT COMPLETED|Overall Study||19
11249740|NCT02158546|12443315|FG001|NOT COMPLETED|Overall Study||17
11249741|NCT02158546|12443316|FG002|NOT COMPLETED|Overall Study||4
11249742|NCT02158546|12443317|FG003|NOT COMPLETED|Overall Study||6
11249743|NCT02158572|12443327|FG000|STARTED|Overall Study||2032
11249744|NCT02158572|12443327|FG000|COMPLETED|Overall Study||989
11249745|NCT02158572|12443327|FG000|NOT COMPLETED|Overall Study||1043
11249746|NCT02158663|12443333|FG000|STARTED|Overall Study||22
11249747|NCT02158663|12443334|FG001|STARTED|Overall Study||22
11249748|NCT02158663|12443333|FG000|COMPLETED|Overall Study||17
11249749|NCT02158663|12443334|FG001|COMPLETED|Overall Study||18
11249750|NCT02158663|12443333|FG000|NOT COMPLETED|Overall Study||5
11249751|NCT02158663|12443334|FG001|NOT COMPLETED|Overall Study||4
11249752|NCT02158728|12443342|FG000|STARTED|Overall Study||80
11249753|NCT02158728|12443342|FG000|COMPLETED|Overall Study||53
11249754|NCT02158728|12443342|FG000|NOT COMPLETED|Overall Study||27
11249755|NCT02158806|12443348|FG000|STARTED|Overall Study||125
11249756|NCT02158806|12443349|FG001|STARTED|Overall Study||126
11249757|NCT02158806|12443348|FG000|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
11249758|NCT02158806|12443349|FG001|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
11249759|NCT02158806|12443348|FG000|NOT COMPLETED|Overall Study||4
11249760|NCT02158806|12443349|FG001|NOT COMPLETED|Overall Study||5
11249761|NCT02158884|12443355|FG000|STARTED|Baseline Assessment||91
11249762|NCT02158884|12443355|FG000|COMPLETED|Baseline Assessment||87
11249763|NCT02158884|12443355|FG000|NOT COMPLETED|Baseline Assessment||4
11249764|NCT02158884|12443355|FG000|STARTED|Intervention: IDEO and PT Program||87
11249765|NCT02158884|12443355|FG000|COMPLETED|Intervention: IDEO and PT Program||81
11249766|NCT02158884|12443355|FG000|NOT COMPLETED|Intervention: IDEO and PT Program||6
11249767|NCT02158884|12443355|FG000|STARTED|Post Intervention (~4 Weeks)||81
11249768|NCT02158884|12443355|FG000|COMPLETED|Post Intervention (~4 Weeks)||71
11249769|NCT02158884|12443355|FG000|NOT COMPLETED|Post Intervention (~4 Weeks)||10
11249770|NCT02158884|12443355|FG000|STARTED|6 Month Assessment||81
11249771|NCT02158884|12443355|FG000|COMPLETED|6 Month Assessment||61
11249772|NCT02158884|12443355|FG000|NOT COMPLETED|6 Month Assessment||20
11249773|NCT02158884|12443355|FG000|STARTED|12 Month Assessment||81
11249774|NCT02158884|12443355|FG000|COMPLETED|12 Month Assessment||64
11249775|NCT02158884|12443355|FG000|NOT COMPLETED|12 Month Assessment||17
11249776|NCT02158936|12443362|FG000|STARTED|Overall Study||179
11249777|NCT02158936|12443363|FG001|STARTED|Overall Study||177
11249778|NCT02158936|12443362|FG000|Treated|Overall Study||177
11249779|NCT02158936|12443363|FG001|Treated|Overall Study||177
11249780|NCT02158936|12443362|FG000|Untreated|Overall Study||2
11249781|NCT02158936|12443363|FG001|Untreated|Overall Study||0
11249782|NCT02158936|12443362|FG000|COMPLETED|Overall Study||0
11249783|NCT02158936|12443363|FG001|COMPLETED|Overall Study||0
11249784|NCT02158936|12443362|FG000|NOT COMPLETED|Overall Study||179
11249785|NCT02158936|12443363|FG001|NOT COMPLETED|Overall Study||177
11249786|NCT02158949|12443371|FG000|STARTED|Overall Study||24
11249787|NCT02158949|12443372|FG001|STARTED|Overall Study||24
11249788|NCT02158949|12443371|FG000|COMPLETED|Overall Study||18
11249789|NCT02158949|12443372|FG001|COMPLETED|Overall Study||13
11358537|NCT03125915|12555685|FG003|COMPLETED|1 Month Follow up||31
11358538|NCT03125915|12555682|FG000|NOT COMPLETED|1 Month Follow up||3
11358539|NCT03125915|12555683|FG001|NOT COMPLETED|1 Month Follow up||3
11358540|NCT03125915|12555684|FG002|NOT COMPLETED|1 Month Follow up||2
11358541|NCT03125915|12555685|FG003|NOT COMPLETED|1 Month Follow up||3
11358542|NCT03125915|12555682|FG000|STARTED|3 Month Follow-up||32
11358543|NCT03125915|12555683|FG001|STARTED|3 Month Follow-up||40
11358544|NCT03125915|12555684|FG002|STARTED|3 Month Follow-up||34
11358545|NCT03125915|12555685|FG003|STARTED|3 Month Follow-up||34
11358546|NCT03125915|12555682|FG000|COMPLETED|3 Month Follow-up||26
11358547|NCT03125915|12555683|FG001|COMPLETED|3 Month Follow-up||36
11249790|NCT02158949|12443371|FG000|NOT COMPLETED|Overall Study||6
11249791|NCT02158949|12443372|FG001|NOT COMPLETED|Overall Study||11
11249792|NCT02158975|12443378|FG000|STARTED|Overall Study||13
11358548|NCT03125915|12555684|FG002|COMPLETED|3 Month Follow-up||30
11358549|NCT03125915|12555685|FG003|COMPLETED|3 Month Follow-up||32
11358550|NCT03125915|12555682|FG000|NOT COMPLETED|3 Month Follow-up||6
11358551|NCT03125915|12555683|FG001|NOT COMPLETED|3 Month Follow-up||4
11358552|NCT03125915|12555684|FG002|NOT COMPLETED|3 Month Follow-up||4
11358553|NCT03125915|12555685|FG003|NOT COMPLETED|3 Month Follow-up||2
11358554|NCT03125915|12555682|FG000|STARTED|6 Month Follow-up||32
11358555|NCT03125915|12555683|FG001|STARTED|6 Month Follow-up||40
11358556|NCT03125915|12555684|FG002|STARTED|6 Month Follow-up||34
11358557|NCT03125915|12555685|FG003|STARTED|6 Month Follow-up||34
11358558|NCT03125915|12555682|FG000|COMPLETED|6 Month Follow-up||25
11358559|NCT03125915|12555683|FG001|COMPLETED|6 Month Follow-up||37
11358560|NCT03125915|12555684|FG002|COMPLETED|6 Month Follow-up||28
11358561|NCT03125915|12555685|FG003|COMPLETED|6 Month Follow-up||31
11358562|NCT03125915|12555682|FG000|NOT COMPLETED|6 Month Follow-up||7
11358563|NCT03125915|12555683|FG001|NOT COMPLETED|6 Month Follow-up||3
11358564|NCT03125915|12555684|FG002|NOT COMPLETED|6 Month Follow-up||6
11358565|NCT03125915|12555685|FG003|NOT COMPLETED|6 Month Follow-up||3
11249793|NCT02158975|12443378|FG000|COMPLETED|Overall Study||12
11249794|NCT02158975|12443378|FG000|NOT COMPLETED|Overall Study||1
11249795|NCT02159053|12443386|FG000|STARTED|Overall Study||116
11249796|NCT02159053|12443387|FG001|STARTED|Overall Study||117
11249797|NCT02159053|12443388|FG002|STARTED|Overall Study||117
11249798|NCT02159053|12443386|FG000|Paticipants Week 16 Onwards|Overall Study||116
11249799|NCT02159053|12443387|FG001|Paticipants Week 16 Onwards|Overall Study||117
11249800|NCT02159053|12443388|FG002|Paticipants Week 16 Onwards|Overall Study||113
11249801|NCT02159053|12443386|FG000|COMPLETED|Overall Study||96
11249802|NCT02159053|12443387|FG001|COMPLETED|Overall Study||96
11249803|NCT02159053|12443388|FG002|COMPLETED|Overall Study||97
11249804|NCT02159053|12443386|FG000|NOT COMPLETED|Overall Study||20
11249805|NCT02159053|12443387|FG001|NOT COMPLETED|Overall Study||21
11249806|NCT02159053|12443388|FG002|NOT COMPLETED|Overall Study||20
11249807|NCT02159079|12443400|FG000|STARTED|Overall Study||15
11249808|NCT02159079|12443401|FG001|STARTED|Overall Study||15
11249809|NCT02159079|12443400|FG000|COMPLETED|Overall Study||15
11249810|NCT02159079|12443401|FG001|COMPLETED|Overall Study||15
11249811|NCT02159079|12443400|FG000|NOT COMPLETED|Overall Study||0
11249812|NCT02159079|12443401|FG001|NOT COMPLETED|Overall Study||0
11249813|NCT02159118|12443409|FG000|STARTED|Overall Study||22
11249814|NCT02159118|12443410|FG001|STARTED|Overall Study||22
11249815|NCT02159118|12443409|FG000|COMPLETED|Overall Study||22
11249816|NCT02159118|12443410|FG001|COMPLETED|Overall Study||22
11249817|NCT02159118|12443409|FG000|NOT COMPLETED|Overall Study||0
11249818|NCT02159118|12443410|FG001|NOT COMPLETED|Overall Study||0
11249819|NCT02159183|12443418|FG000|STARTED|Analysis After the 36 Months Follow-up||22
11249820|NCT02159183|12443419|FG001|STARTED|Analysis After the 36 Months Follow-up||21
11249821|NCT02159183|12443418|FG000|COMPLETED|Analysis After the 36 Months Follow-up||19
11249822|NCT02159183|12443419|FG001|COMPLETED|Analysis After the 36 Months Follow-up||19
11249823|NCT02159183|12443418|FG000|NOT COMPLETED|Analysis After the 36 Months Follow-up||3
11249824|NCT02159183|12443419|FG001|NOT COMPLETED|Analysis After the 36 Months Follow-up||2
11249825|NCT02159183|12443418|FG000|STARTED|Analysis of Primary Endpoint (12 Mts)||22
11249826|NCT02159183|12443419|FG001|STARTED|Analysis of Primary Endpoint (12 Mts)||21
11249827|NCT02159183|12443418|FG000|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19
11249828|NCT02159183|12443419|FG001|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20
11249829|NCT02159183|12443418|FG000|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3
11249830|NCT02159183|12443419|FG001|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1
11249831|NCT02159352|12443427|FG000|STARTED|Overall Study||14
11249832|NCT02159352|12443428|FG001|STARTED|Overall Study||14
11249833|NCT02159352|12443427|FG000|Phase 1 (Day 1- 4)|Overall Study||14
11249834|NCT02159352|12443428|FG001|Phase 1 (Day 1- 4)|Overall Study||14
11249835|NCT02159352|12443427|FG000|Phase 2 (Day 5-14)|Overall Study||11
11249836|NCT02159352|12443428|FG001|Phase 2 (Day 5-14)|Overall Study||12
11249837|NCT02159352|12443427|FG000|COMPLETED|Overall Study||11
11249838|NCT02159352|12443428|FG001|COMPLETED|Overall Study||12
11249839|NCT02159352|12443427|FG000|NOT COMPLETED|Overall Study||3
11249840|NCT02159352|12443428|FG001|NOT COMPLETED|Overall Study||2
11249841|NCT02159365|12443453|FG000|STARTED|Overall Study||70
11249842|NCT02159365|12443453|FG000|COMPLETED|Overall Study|Completed = Still on treatment|0
11249843|NCT02159365|12443453|FG000|NOT COMPLETED|Overall Study||70
11249844|NCT02159469|12443457|FG000|STARTED|Overall Study||150
11249845|NCT02159469|12443457|FG000|Completed 12 Week|Overall Study||137
11249846|NCT02159469|12443457|FG000|COMPLETED|Overall Study||97
11249847|NCT02159469|12443457|FG000|NOT COMPLETED|Overall Study||53
11249848|NCT02159482|12443462|FG000|STARTED|Overall Study||11
11249849|NCT02159482|12443462|FG000|COMPLETED|Overall Study||6
11249850|NCT02159482|12443462|FG000|NOT COMPLETED|Overall Study||5
11249851|NCT02159521|12443466|FG000|STARTED|Overall Study|4 participants had both limbs treated.|81
11249852|NCT02159521|12443466|FG000|Received EkoSonic® Treatment|Overall Study||78
11249853|NCT02159521|12443466|FG000|COMPLETED|Overall Study||63
11249854|NCT02159521|12443466|FG000|NOT COMPLETED|Overall Study||18
11249855|NCT02159547|12443472|FG000|STARTED|Overall Study||112
11249856|NCT02159547|12443473|FG001|STARTED|Overall Study||112
11249857|NCT02159547|12443472|FG000|COMPLETED|Overall Study||112
11249858|NCT02159547|12443473|FG001|COMPLETED|Overall Study||112
11249859|NCT02159547|12443472|FG000|NOT COMPLETED|Overall Study||0
11249860|NCT02159547|12443473|FG001|NOT COMPLETED|Overall Study||0
11249861|NCT02159703|12443480|FG000|STARTED|Overall Study||60
11249862|NCT02159703|12443480|FG000|COMPLETED|Overall Study||60
11249863|NCT02159703|12443480|FG000|NOT COMPLETED|Overall Study||0
11249864|NCT02159729|12443486|FG000|STARTED|Overall Study||140
11249865|NCT02159729|12443487|FG001|STARTED|Overall Study||65
11249866|NCT02159729|12443486|FG000|COMPLETED|Overall Study||98
11249867|NCT02159729|12443487|FG001|COMPLETED|Overall Study||44
11249868|NCT02159729|12443486|FG000|NOT COMPLETED|Overall Study||42
11249869|NCT02159729|12443487|FG001|NOT COMPLETED|Overall Study||21
11249870|NCT02159768|12443493|FG000|STARTED|Overall Study|Started 16 July 2014|30
11249871|NCT02159768|12443493|FG000|COMPLETED|Overall Study|Completed 27 July 2015|30
11249872|NCT02159768|12443493|FG000|NOT COMPLETED|Overall Study||0
11249873|NCT02159807|12443500|FG000|STARTED|Overall Study||67
11249874|NCT02159807|12443501|FG001|STARTED|Overall Study||52
11249875|NCT02159807|12443502|FG002|STARTED|Overall Study||51
11249876|NCT02159807|12443500|FG000|COMPLETED|Overall Study||66
11249877|NCT02159807|12443501|FG001|COMPLETED|Overall Study||51
11249878|NCT02159807|12443502|FG002|COMPLETED|Overall Study||48
11249879|NCT02159807|12443500|FG000|NOT COMPLETED|Overall Study||1
11249880|NCT02159807|12443501|FG001|NOT COMPLETED|Overall Study||1
11249881|NCT02159807|12443502|FG002|NOT COMPLETED|Overall Study||3
11249882|NCT02159859|12443510|FG000|STARTED|Overall Study||7
11249883|NCT02159859|12443510|FG000|COMPLETED|Overall Study||7
11249884|NCT02159859|12443510|FG000|NOT COMPLETED|Overall Study||0
11249885|NCT02159872|12443514|FG000|STARTED|Overall Study||48
11249886|NCT02159872|12443514|FG000|COMPLETED|Overall Study||48
11249887|NCT02159872|12443514|FG000|NOT COMPLETED|Overall Study||0
11249888|NCT02159898|12443520|FG000|STARTED|Overall Study||30
11249889|NCT02159898|12443521|FG001|STARTED|Overall Study||30
11249890|NCT02159898|12443520|FG000|COMPLETED|Overall Study||29
11249891|NCT02159898|12443521|FG001|COMPLETED|Overall Study||30
11249892|NCT02159898|12443520|FG000|NOT COMPLETED|Overall Study||1
11249893|NCT02159898|12443521|FG001|NOT COMPLETED|Overall Study||0
11249894|NCT02159950|12443531|FG000|STARTED|Overall Study||0
11249895|NCT02159950|12443532|FG001|STARTED|Overall Study||2
11249896|NCT02159950|12443531|FG000|COMPLETED|Overall Study||0
11249897|NCT02159950|12443532|FG001|COMPLETED|Overall Study||0
11249898|NCT02159950|12443531|FG000|NOT COMPLETED|Overall Study||0
11249899|NCT02159950|12443532|FG001|NOT COMPLETED|Overall Study||2
11249900|NCT02159976|12443540|FG000|STARTED|Overall Study||195
11249901|NCT02159976|12443541|FG001|STARTED|Overall Study||195
11249902|NCT02159976|12443540|FG000|COMPLETED|Overall Study||165
11249903|NCT02159976|12443541|FG001|COMPLETED|Overall Study||170
11249904|NCT02159976|12443540|FG000|NOT COMPLETED|Overall Study||30
11249905|NCT02159976|12443541|FG001|NOT COMPLETED|Overall Study||25
11249906|NCT02160002|12443551|FG000|STARTED|Overall Study||187
11249907|NCT02160002|12443552|FG001|STARTED|Overall Study||179
11249908|NCT02160002|12443551|FG000|Primary Outcome|Overall Study||185
11249909|NCT02160002|12443552|FG001|Primary Outcome|Overall Study||178
11249910|NCT02160002|12443551|FG000|COMPLETED|Overall Study||185
11249911|NCT02160002|12443552|FG001|COMPLETED|Overall Study||178
11249912|NCT02160002|12443551|FG000|NOT COMPLETED|Overall Study||2
11249913|NCT02160002|12443552|FG001|NOT COMPLETED|Overall Study||1
11249914|NCT02160041|12443558|FG000|STARTED|Overall Study||84
11249915|NCT02160041|12443558|FG000|COMPLETED|Overall Study||0
11249916|NCT02160041|12443558|FG000|NOT COMPLETED|Overall Study||84
11249917|NCT02160145|12443564|FG000|STARTED|Prerandomization Single-blind Period||1519
11249918|NCT02160145|12443565|FG001|STARTED|Prerandomization Single-blind Period||0
11249919|NCT02160145|12443566|FG002|STARTED|Prerandomization Single-blind Period||0
11249920|NCT02160145|12443564|FG000|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
11249921|NCT02160145|12443565|FG001|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
11249922|NCT02160145|12443566|FG002|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
11249923|NCT02160145|12443564|FG000|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
11249924|NCT02160145|12443565|FG001|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
11249925|NCT02160145|12443566|FG002|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
11249926|NCT02160145|12443564|FG000|Randomized|Prerandomization Single-blind Period||1370
11249927|NCT02160145|12443565|FG001|Randomized|Prerandomization Single-blind Period||0
11249928|NCT02160145|12443566|FG002|Randomized|Prerandomization Single-blind Period||0
11249929|NCT02160145|12443564|FG000|COMPLETED|Prerandomization Single-blind Period||1370
11249930|NCT02160145|12443565|FG001|COMPLETED|Prerandomization Single-blind Period||0
11249931|NCT02160145|12443566|FG002|COMPLETED|Prerandomization Single-blind Period||0
11249932|NCT02160145|12443564|FG000|NOT COMPLETED|Prerandomization Single-blind Period||149
11249933|NCT02160145|12443565|FG001|NOT COMPLETED|Prerandomization Single-blind Period||0
11249934|NCT02160145|12443566|FG002|NOT COMPLETED|Prerandomization Single-blind Period||0
11249935|NCT02160145|12443564|FG000|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
11249936|NCT02160145|12443565|FG001|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
11249937|NCT02160145|12443566|FG002|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
11249938|NCT02160145|12443564|FG000|On-treatment Completers|Randomized Double-blind Period||0
11249939|NCT02160145|12443565|FG001|On-treatment Completers|Randomized Double-blind Period||578
11249940|NCT02160145|12443566|FG002|On-treatment Completers|Randomized Double-blind Period||637
11249941|NCT02160145|12443564|FG000|Off-treatment Completers|Randomized Double-blind Period||0
11249942|NCT02160145|12443565|FG001|Off-treatment Completers|Randomized Double-blind Period||76
11249943|NCT02160145|12443566|FG002|Off-treatment Completers|Randomized Double-blind Period||22
11249944|NCT02160145|12443564|FG000|COMPLETED|Randomized Double-blind Period||0
11249945|NCT02160145|12443565|FG001|COMPLETED|Randomized Double-blind Period||654
11249946|NCT02160145|12443566|FG002|COMPLETED|Randomized Double-blind Period||659
11249947|NCT02160145|12443564|FG000|NOT COMPLETED|Randomized Double-blind Period||0
11249948|NCT02160145|12443565|FG001|NOT COMPLETED|Randomized Double-blind Period||29
11249949|NCT02160145|12443566|FG002|NOT COMPLETED|Randomized Double-blind Period||28
11249950|NCT02160288|12443575|FG000|STARTED|Overall Study||1
11249951|NCT02160288|12443576|FG001|STARTED|Overall Study||0
11249952|NCT02160288|12443575|FG000|COMPLETED|Overall Study||1
11249953|NCT02160288|12443576|FG001|COMPLETED|Overall Study||0
11249954|NCT02160288|12443575|FG000|NOT COMPLETED|Overall Study||0
11249955|NCT02160288|12443576|FG001|NOT COMPLETED|Overall Study||0
11249956|NCT02160314|12443584|FG000|STARTED|Overall Study||73
11249957|NCT02160314|12443585|FG001|STARTED|Overall Study||72
11249958|NCT02160314|12443584|FG000|COMPLETED|Overall Study||72
11249959|NCT02160314|12443585|FG001|COMPLETED|Overall Study||59
11249960|NCT02160314|12443584|FG000|NOT COMPLETED|Overall Study||1
11249961|NCT02160314|12443585|FG001|NOT COMPLETED|Overall Study||13
11249962|NCT02160535|12443591|FG000|STARTED|Overall Study||13
11249963|NCT02160535|12443591|FG000|COMPLETED|Overall Study||10
11249964|NCT02160535|12443591|FG000|NOT COMPLETED|Overall Study||3
11249965|NCT02160626|12443598|FG000|STARTED|Overall Study||58
11249966|NCT02160626|12443599|FG001|STARTED|Overall Study||57
11249967|NCT02160626|12443600|FG002|STARTED|Overall Study||57
11249968|NCT02160626|12443598|FG000|COMPLETED|Overall Study||57
11249969|NCT02160626|12443599|FG001|COMPLETED|Overall Study||56
11249970|NCT02160626|12443600|FG002|COMPLETED|Overall Study||56
11249971|NCT02160626|12443598|FG000|NOT COMPLETED|Overall Study||1
11249972|NCT02160626|12443599|FG001|NOT COMPLETED|Overall Study||1
11249973|NCT02160626|12443600|FG002|NOT COMPLETED|Overall Study||1
11249974|NCT02160730|12443610|FG000|STARTED|Overall Study||4
11249975|NCT02160730|12443610|FG000|COMPLETED|Overall Study||4
11249976|NCT02160730|12443610|FG000|NOT COMPLETED|Overall Study||0
11249977|NCT02160782|12443615|FG000|STARTED|Open-label Period: Maralixibat||31
11249978|NCT02160782|12443616|FG001|STARTED|Open-label Period: Maralixibat||0
11249979|NCT02160782|12443617|FG002|STARTED|Open-label Period: Maralixibat||0
11249980|NCT02160782|12443618|FG003|STARTED|Open-label Period: Maralixibat||0
11249981|NCT02160782|12443619|FG004|STARTED|Open-label Period: Maralixibat||0
11249982|NCT02160782|12443615|FG000|COMPLETED|Open-label Period: Maralixibat||29
11249983|NCT02160782|12443616|FG001|COMPLETED|Open-label Period: Maralixibat||0
11249984|NCT02160782|12443617|FG002|COMPLETED|Open-label Period: Maralixibat||0
11249985|NCT02160782|12443618|FG003|COMPLETED|Open-label Period: Maralixibat||0
11249986|NCT02160782|12443619|FG004|COMPLETED|Open-label Period: Maralixibat||0
11249987|NCT02160782|12443615|FG000|NOT COMPLETED|Open-label Period: Maralixibat||2
11249988|NCT02160782|12443616|FG001|NOT COMPLETED|Open-label Period: Maralixibat||0
11249989|NCT02160782|12443617|FG002|NOT COMPLETED|Open-label Period: Maralixibat||0
11249990|NCT02160782|12443618|FG003|NOT COMPLETED|Open-label Period: Maralixibat||0
11249991|NCT02160782|12443619|FG004|NOT COMPLETED|Open-label Period: Maralixibat||0
11249992|NCT02160782|12443615|FG000|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
11249993|NCT02160782|12443616|FG001|STARTED|Randomized Withdrawal Period- Pbo vs MRX||13
11249994|NCT02160782|12443617|FG002|STARTED|Randomized Withdrawal Period- Pbo vs MRX||16
11249995|NCT02160782|12443618|FG003|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
11249996|NCT02160782|12443619|FG004|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
11249997|NCT02160782|12443615|FG000|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
11249998|NCT02160782|12443616|FG001|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||13
11249999|NCT02160782|12443617|FG002|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||16
11250000|NCT02160782|12443618|FG003|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
11250001|NCT02160782|12443619|FG004|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
11250002|NCT02160782|12443615|FG000|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
11250003|NCT02160782|12443616|FG001|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
11250004|NCT02160782|12443617|FG002|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
11250005|NCT02160782|12443618|FG003|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
11250006|NCT02160782|12443619|FG004|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
11250007|NCT02160782|12443615|FG000|STARTED|After Randomized Withdrawal: Maralixibat||0
11250008|NCT02160782|12443616|FG001|STARTED|After Randomized Withdrawal: Maralixibat||0
11250009|NCT02160782|12443617|FG002|STARTED|After Randomized Withdrawal: Maralixibat||0
11250010|NCT02160782|12443618|FG003|STARTED|After Randomized Withdrawal: Maralixibat||29
11250011|NCT02160782|12443619|FG004|STARTED|After Randomized Withdrawal: Maralixibat||0
11250012|NCT02160782|12443615|FG000|COMPLETED|After Randomized Withdrawal: Maralixibat||0
11250013|NCT02160782|12443616|FG001|COMPLETED|After Randomized Withdrawal: Maralixibat||0
11250014|NCT02160782|12443617|FG002|COMPLETED|After Randomized Withdrawal: Maralixibat||0
11250015|NCT02160782|12443618|FG003|COMPLETED|After Randomized Withdrawal: Maralixibat||23
11250016|NCT02160782|12443619|FG004|COMPLETED|After Randomized Withdrawal: Maralixibat||0
11250017|NCT02160782|12443615|FG000|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
11250018|NCT02160782|12443616|FG001|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
11250019|NCT02160782|12443617|FG002|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
11250020|NCT02160782|12443618|FG003|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||6
11250021|NCT02160782|12443619|FG004|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
11250022|NCT02160782|12443615|FG000|STARTED|Long-term Extension Period: Maralixibat||0
11250023|NCT02160782|12443616|FG001|STARTED|Long-term Extension Period: Maralixibat||0
11250024|NCT02160782|12443617|FG002|STARTED|Long-term Extension Period: Maralixibat||0
11250025|NCT02160782|12443618|FG003|STARTED|Long-term Extension Period: Maralixibat||0
11250026|NCT02160782|12443619|FG004|STARTED|Long-term Extension Period: Maralixibat||23
11250027|NCT02160782|12443615|FG000|COMPLETED|Long-term Extension Period: Maralixibat||0
11250028|NCT02160782|12443616|FG001|COMPLETED|Long-term Extension Period: Maralixibat||0
11250029|NCT02160782|12443617|FG002|COMPLETED|Long-term Extension Period: Maralixibat||0
11250030|NCT02160782|12443618|FG003|COMPLETED|Long-term Extension Period: Maralixibat||0
11250031|NCT02160782|12443619|FG004|COMPLETED|Long-term Extension Period: Maralixibat||14
11250032|NCT02160782|12443615|FG000|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
11250033|NCT02160782|12443616|FG001|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
11250034|NCT02160782|12443617|FG002|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
11250035|NCT02160782|12443618|FG003|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
11250036|NCT02160782|12443619|FG004|NOT COMPLETED|Long-term Extension Period: Maralixibat||9
11250037|NCT02160808|12443645|FG000|STARTED|Overall Study||87
11250038|NCT02160808|12443646|FG001|STARTED|Overall Study||83
11250039|NCT02160808|12443645|FG000|COMPLETED|Overall Study||87
11250040|NCT02160808|12443646|FG001|COMPLETED|Overall Study||83
11250041|NCT02160808|12443645|FG000|NOT COMPLETED|Overall Study||0
11250042|NCT02160808|12443646|FG001|NOT COMPLETED|Overall Study||0
11250043|NCT02160847|12443654|FG000|STARTED|Overall Study||16
11250044|NCT02160847|12443655|FG001|STARTED|Overall Study||16
11250045|NCT02160847|12443654|FG000|COMPLETED|Overall Study||16
11250046|NCT02160847|12443655|FG001|COMPLETED|Overall Study||16
11250047|NCT02160847|12443654|FG000|NOT COMPLETED|Overall Study||0
11250048|NCT02160847|12443655|FG001|NOT COMPLETED|Overall Study||0
11250049|NCT02160873|12443663|FG000|STARTED|Overall Study||6
11250050|NCT02160873|12443664|FG001|STARTED|Overall Study||6
11250051|NCT02160873|12443663|FG000|COMPLETED|Overall Study||6
11250052|NCT02160873|12443664|FG001|COMPLETED|Overall Study||6
11250053|NCT02160873|12443663|FG000|NOT COMPLETED|Overall Study||0
11250054|NCT02160873|12443664|FG001|NOT COMPLETED|Overall Study||0
11250055|NCT02160899|12443682|FG000|STARTED|Overall Study||26
11250056|NCT02160899|12443683|FG001|STARTED|Overall Study||4
11250057|NCT02160899|12443684|FG002|STARTED|Overall Study||21
11250058|NCT02160899|12443685|FG003|STARTED|Overall Study||3
11250059|NCT02160899|12443686|FG004|STARTED|Overall Study||2
11250060|NCT02160899|12443687|FG005|STARTED|Overall Study||8
11250061|NCT02160899|12443682|FG000|COMPLETED|Overall Study||26
11250062|NCT02160899|12443683|FG001|COMPLETED|Overall Study||3
11250063|NCT02160899|12443684|FG002|COMPLETED|Overall Study||21
11250064|NCT02160899|12443685|FG003|COMPLETED|Overall Study||2
11250065|NCT02160899|12443686|FG004|COMPLETED|Overall Study||0
11250066|NCT02160899|12443687|FG005|COMPLETED|Overall Study||8
11250067|NCT02160899|12443682|FG000|NOT COMPLETED|Overall Study||0
11250068|NCT02160899|12443683|FG001|NOT COMPLETED|Overall Study||1
11250069|NCT02160899|12443684|FG002|NOT COMPLETED|Overall Study||0
11250070|NCT02160899|12443685|FG003|NOT COMPLETED|Overall Study||1
11250071|NCT02160899|12443686|FG004|NOT COMPLETED|Overall Study||2
11250072|NCT02160899|12443687|FG005|NOT COMPLETED|Overall Study||0
11250073|NCT02160977|12443703|FG000|STARTED|One Week After Surgery||45
11250074|NCT02160977|12443704|FG001|STARTED|One Week After Surgery||45
11250075|NCT02160977|12443703|FG000|COMPLETED|One Week After Surgery||45
11250076|NCT02160977|12443704|FG001|COMPLETED|One Week After Surgery||45
11250077|NCT02160977|12443703|FG000|NOT COMPLETED|One Week After Surgery||0
11250078|NCT02160977|12443704|FG001|NOT COMPLETED|One Week After Surgery||0
11250079|NCT02160977|12443703|FG000|STARTED|Six Weeks After Surgery||45
11250080|NCT02160977|12443704|FG001|STARTED|Six Weeks After Surgery||45
11250081|NCT02160977|12443703|FG000|COMPLETED|Six Weeks After Surgery||44
11250082|NCT02160977|12443704|FG001|COMPLETED|Six Weeks After Surgery||45
11250083|NCT02160977|12443703|FG000|NOT COMPLETED|Six Weeks After Surgery||1
11250084|NCT02160977|12443704|FG001|NOT COMPLETED|Six Weeks After Surgery||0
11250085|NCT02160977|12443703|FG000|STARTED|Three Months After Surgery||44
11250086|NCT02160977|12443704|FG001|STARTED|Three Months After Surgery||45
11250087|NCT02160977|12443703|FG000|COMPLETED|Three Months After Surgery||44
11250088|NCT02160977|12443704|FG001|COMPLETED|Three Months After Surgery||43
11250089|NCT02160977|12443703|FG000|NOT COMPLETED|Three Months After Surgery||0
11250090|NCT02160977|12443704|FG001|NOT COMPLETED|Three Months After Surgery||2
11250091|NCT02160977|12443703|FG000|STARTED|Six Months After Surgery||44
11250092|NCT02160977|12443704|FG001|STARTED|Six Months After Surgery||43
11250093|NCT02160977|12443703|FG000|COMPLETED|Six Months After Surgery||42
11250094|NCT02160977|12443704|FG001|COMPLETED|Six Months After Surgery||42
11250095|NCT02160977|12443703|FG000|NOT COMPLETED|Six Months After Surgery||2
11250096|NCT02160977|12443704|FG001|NOT COMPLETED|Six Months After Surgery||1
11250097|NCT02160990|12443712|FG000|STARTED|Overall Study||10
11250098|NCT02160990|12443713|FG001|STARTED|Overall Study||10
11250099|NCT02160990|12443712|FG000|COMPLETED|Overall Study||10
11250100|NCT02160990|12443713|FG001|COMPLETED|Overall Study||10
11250101|NCT02160990|12443712|FG000|NOT COMPLETED|Overall Study||0
11250102|NCT02160990|12443713|FG001|NOT COMPLETED|Overall Study||0
11250103|NCT02161133|12443721|FG000|STARTED|Overall Study||135
11250104|NCT02161133|12443722|FG001|STARTED|Overall Study||133
11250105|NCT02161133|12443721|FG000|COMPLETED|Overall Study||116
11250106|NCT02161133|12443722|FG001|COMPLETED|Overall Study||122
11250107|NCT02161133|12443721|FG000|NOT COMPLETED|Overall Study||19
11250108|NCT02161133|12443722|FG001|NOT COMPLETED|Overall Study||11
11250109|NCT02161146|12443733|FG000|STARTED|Overall Study||47
11250110|NCT02161146|12443734|FG001|STARTED|Overall Study||47
11250111|NCT02161146|12443735|FG002|STARTED|Overall Study||49
11250112|NCT02161146|12443736|FG003|STARTED|Overall Study||48
11250113|NCT02161146|12443737|FG004|STARTED|Overall Study||49
11250114|NCT02161146|12443733|FG000|COMPLETED|Overall Study||46
11250115|NCT02161146|12443734|FG001|COMPLETED|Overall Study||43
11250116|NCT02161146|12443735|FG002|COMPLETED|Overall Study||49
11250117|NCT02161146|12443736|FG003|COMPLETED|Overall Study||45
11250118|NCT02161146|12443737|FG004|COMPLETED|Overall Study||48
11250119|NCT02161146|12443733|FG000|NOT COMPLETED|Overall Study||1
11250120|NCT02161146|12443734|FG001|NOT COMPLETED|Overall Study||4
11250121|NCT02161146|12443735|FG002|NOT COMPLETED|Overall Study||0
11250122|NCT02161146|12443736|FG003|NOT COMPLETED|Overall Study||3
11250123|NCT02161146|12443737|FG004|NOT COMPLETED|Overall Study||1
11250124|NCT02161185|12443747|FG000|STARTED|Test Dose Phase||7
11250125|NCT02161185|12443747|FG000|COMPLETED|Test Dose Phase||7
11250126|NCT02161185|12443747|FG000|NOT COMPLETED|Test Dose Phase||0
11250127|NCT02161185|12443747|FG000|STARTED|Treatment Phase||7
11250128|NCT02161185|12443747|FG000|COMPLETED|Treatment Phase||0
11250129|NCT02161185|12443747|FG000|NOT COMPLETED|Treatment Phase||7
11250130|NCT02161406|12443753|FG000|STARTED|Overall Study||44
11250131|NCT02161406|12443754|FG001|STARTED|Overall Study||44
11250132|NCT02161406|12443753|FG000|COMPLETED|Overall Study||34
11250133|NCT02161406|12443754|FG001|COMPLETED|Overall Study||35
11250134|NCT02161406|12443753|FG000|NOT COMPLETED|Overall Study||10
11250135|NCT02161406|12443754|FG001|NOT COMPLETED|Overall Study||9
11250136|NCT02161458|12443764|FG000|STARTED|Overall Study||22
11250137|NCT02161458|12443765|FG001|STARTED|Overall Study||35
11250138|NCT02161458|12443766|FG002|STARTED|Overall Study||33
11250139|NCT02161458|12443767|FG003|STARTED|Overall Study||8
11250140|NCT02161458|12443764|FG000|COMPLETED|Overall Study||22
11250141|NCT02161458|12443765|FG001|COMPLETED|Overall Study||29
11250142|NCT02161458|12443766|FG002|COMPLETED|Overall Study||28
11250143|NCT02161458|12443767|FG003|COMPLETED|Overall Study||8
11250144|NCT02161458|12443764|FG000|NOT COMPLETED|Overall Study||0
11250145|NCT02161458|12443765|FG001|NOT COMPLETED|Overall Study||6
11250146|NCT02161458|12443766|FG002|NOT COMPLETED|Overall Study||5
11250147|NCT02161458|12443767|FG003|NOT COMPLETED|Overall Study||0
11250148|NCT02161484|12443779|FG000|STARTED|Overall Study||5
11250149|NCT02161484|12443780|FG001|STARTED|Overall Study||5
11250150|NCT02161484|12443779|FG000|COMPLETED|Overall Study||1
11250151|NCT02161484|12443780|FG001|COMPLETED|Overall Study||2
11250152|NCT02161484|12443779|FG000|NOT COMPLETED|Overall Study||4
11250153|NCT02161484|12443780|FG001|NOT COMPLETED|Overall Study||3
11250154|NCT02161536|12443789|FG000|STARTED|Overall Study||6
11250155|NCT02161536|12443790|FG001|STARTED|Overall Study||21
11250156|NCT02161536|12443791|FG002|STARTED|Overall Study||20
11250157|NCT02161536|12443789|FG000|COMPLETED|Overall Study||6
11250158|NCT02161536|12443790|FG001|COMPLETED|Overall Study||21
11250159|NCT02161536|12443791|FG002|COMPLETED|Overall Study||20
11250160|NCT02161536|12443789|FG000|NOT COMPLETED|Overall Study||0
11005432|NCT00723021|12183143|FG002|NOT COMPLETED|Intervention Period 1||0
11005433|NCT00723021|12183144|FG003|NOT COMPLETED|Intervention Period 1||0
11005434|NCT00723021|12183145|FG004|NOT COMPLETED|Intervention Period 1||0
11250161|NCT02161536|12443790|FG001|NOT COMPLETED|Overall Study||0
11250162|NCT02161536|12443791|FG002|NOT COMPLETED|Overall Study||0
11250163|NCT02161549|12443801|FG000|STARTED|Overall Study||40
11250164|NCT02161549|12443802|FG001|STARTED|Overall Study||31
11250165|NCT02161549|12443801|FG000|COMPLETED|Overall Study||34
11250166|NCT02161549|12443802|FG001|COMPLETED|Overall Study||29
11250167|NCT02161549|12443801|FG000|NOT COMPLETED|Overall Study||6
11250168|NCT02161549|12443802|FG001|NOT COMPLETED|Overall Study||2
11250169|NCT02161562|12443810|FG000|STARTED|Overall Study||178
11250170|NCT02161562|12443811|FG001|STARTED|Overall Study||136
11250171|NCT02161562|12443810|FG000|COMPLETED|Overall Study||152
11250172|NCT02161562|12443811|FG001|COMPLETED|Overall Study||119
11250173|NCT02161562|12443810|FG000|NOT COMPLETED|Overall Study||26
11250174|NCT02161562|12443811|FG001|NOT COMPLETED|Overall Study||17
11250175|NCT02161575|12443830|FG000|STARTED|Overall Study||103
11250176|NCT02161575|12443830|FG000|Full Analysis Set (FAS) Population|Overall Study||100
11250177|NCT02161575|12443830|FG000|Safety (SAF) Population|Overall Study||100
11250178|NCT02161575|12443830|FG000|COMPLETED|Overall Study||92
11250179|NCT02161575|12443830|FG000|NOT COMPLETED|Overall Study||11
11250180|NCT02161705|12443836|FG000|STARTED|Overall Study||9
11250181|NCT02161705|12443837|FG001|STARTED|Overall Study||9
11250182|NCT02161705|12443836|FG000|COMPLETED|Overall Study||9
11250183|NCT02161705|12443837|FG001|COMPLETED|Overall Study||9
11250184|NCT02161705|12443836|FG000|NOT COMPLETED|Overall Study||0
11250185|NCT02161705|12443837|FG001|NOT COMPLETED|Overall Study||0
11250186|NCT02161718|12443845|FG000|STARTED|Open-Label ALKS 3831 Period||255
11250187|NCT02161718|12443846|FG001|STARTED|Open-Label ALKS 3831 Period||0
11250188|NCT02161718|12443847|FG002|STARTED|Open-Label ALKS 3831 Period||0
11250189|NCT02161718|12443845|FG000|COMPLETED|Open-Label ALKS 3831 Period||234
11250190|NCT02161718|12443846|FG001|COMPLETED|Open-Label ALKS 3831 Period||0
11250191|NCT02161718|12443847|FG002|COMPLETED|Open-Label ALKS 3831 Period||0
11250192|NCT02161718|12443845|FG000|NOT COMPLETED|Open-Label ALKS 3831 Period||21
11250193|NCT02161718|12443846|FG001|NOT COMPLETED|Open-Label ALKS 3831 Period||0
11250194|NCT02161718|12443847|FG002|NOT COMPLETED|Open-Label ALKS 3831 Period||0
11250195|NCT02161718|12443845|FG000|STARTED|Post- Randomization Period||0
11250196|NCT02161718|12443846|FG001|STARTED|Post- Randomization Period||112
11250197|NCT02161718|12443847|FG002|STARTED|Post- Randomization Period||117
11250198|NCT02161718|12443845|FG000|COMPLETED|Post- Randomization Period||0
11250199|NCT02161718|12443846|FG001|COMPLETED|Post- Randomization Period||53
11250200|NCT02161718|12443847|FG002|COMPLETED|Post- Randomization Period||58
11250201|NCT02161718|12443845|FG000|NOT COMPLETED|Post- Randomization Period||0
11250202|NCT02161718|12443846|FG001|NOT COMPLETED|Post- Randomization Period||59
11250203|NCT02161718|12443847|FG002|NOT COMPLETED|Post- Randomization Period||59
11250204|NCT02161731|12443854|FG000|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
11250205|NCT02161731|12443855|FG001|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
11250206|NCT02161731|12443854|FG000|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
11250207|NCT02161731|12443855|FG001|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
11250208|NCT02161731|12443854|FG000|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
11250209|NCT02161731|12443855|FG001|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
11250210|NCT02161731|12443854|FG000|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
11250211|NCT02161731|12443855|FG001|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
11250212|NCT02161731|12443854|FG000|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
11250213|NCT02161731|12443855|FG001|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
11250214|NCT02161731|12443854|FG000|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
11250215|NCT02161731|12443855|FG001|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
11250216|NCT02161731|12443854|FG000|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
11250217|NCT02161731|12443855|FG001|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
11250218|NCT02161731|12443854|FG000|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
11250219|NCT02161731|12443855|FG001|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
11250220|NCT02161757|12443865|FG000|STARTED|Randomised Through Start Treatment||401
11250221|NCT02161757|12443866|FG001|STARTED|Randomised Through Start Treatment||406
11250222|NCT02161757|12443867|FG002|STARTED|Randomised Through Start Treatment||400
11250223|NCT02161757|12443865|FG000|COMPLETED|Randomised Through Start Treatment||398
11250224|NCT02161757|12443866|FG001|COMPLETED|Randomised Through Start Treatment||404
11250225|NCT02161757|12443867|FG002|COMPLETED|Randomised Through Start Treatment||400
11250226|NCT02161757|12443865|FG000|NOT COMPLETED|Randomised Through Start Treatment||3
11250227|NCT02161757|12443866|FG001|NOT COMPLETED|Randomised Through Start Treatment||2
11250228|NCT02161757|12443867|FG002|NOT COMPLETED|Randomised Through Start Treatment||0
11250229|NCT02161757|12443865|FG000|STARTED|Treatment Through Study Completion||398
11250230|NCT02161757|12443866|FG001|STARTED|Treatment Through Study Completion||404
11250231|NCT02161757|12443867|FG002|STARTED|Treatment Through Study Completion||400
11250232|NCT02161757|12443865|FG000|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
11250233|NCT02161757|12443866|FG001|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
11250234|NCT02161757|12443867|FG002|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
11250235|NCT02161757|12443865|FG000|COMPLETED|Treatment Through Study Completion||341
11250236|NCT02161757|12443866|FG001|COMPLETED|Treatment Through Study Completion||361
11250237|NCT02161757|12443867|FG002|COMPLETED|Treatment Through Study Completion||361
11250238|NCT02161757|12443865|FG000|NOT COMPLETED|Treatment Through Study Completion||57
11250239|NCT02161757|12443866|FG001|NOT COMPLETED|Treatment Through Study Completion||43
11250240|NCT02161757|12443867|FG002|NOT COMPLETED|Treatment Through Study Completion||39
11250241|NCT02162433|12443879|FG000|STARTED|Overall Study||23
11250242|NCT02162433|12443880|FG001|STARTED|Overall Study||23
11250243|NCT02162433|12443881|FG002|STARTED|Overall Study||23
11250244|NCT02162433|12443882|FG003|STARTED|Overall Study||23
11250245|NCT02162433|12443879|FG000|COMPLETED|Overall Study||22
11250246|NCT02162433|12443880|FG001|COMPLETED|Overall Study||21
11250247|NCT02162433|12443881|FG002|COMPLETED|Overall Study||21
11250248|NCT02162433|12443882|FG003|COMPLETED|Overall Study||22
11250249|NCT02162433|12443879|FG000|NOT COMPLETED|Overall Study||1
11250250|NCT02162433|12443880|FG001|NOT COMPLETED|Overall Study||2
11250251|NCT02162433|12443881|FG002|NOT COMPLETED|Overall Study||2
11250252|NCT02162433|12443882|FG003|NOT COMPLETED|Overall Study||1
11250253|NCT02162446|12443892|FG000|STARTED|Overall Study||12
11250254|NCT02162446|12443892|FG000|COMPLETED|Overall Study||12
11250255|NCT02162446|12443892|FG000|NOT COMPLETED|Overall Study||0
11250256|NCT02162576|12443901|FG000|STARTED|Overall Study||95
11250257|NCT02162576|12443901|FG000|COMPLETED|Overall Study||95
11250258|NCT02162576|12443901|FG000|NOT COMPLETED|Overall Study||0
11250259|NCT02162680|12443909|FG000|STARTED|Overall Study||33
11250260|NCT02162680|12443910|FG001|STARTED|Overall Study||33
11250261|NCT02162680|12443911|FG002|STARTED|Overall Study||32
11250262|NCT02162680|12443909|FG000|COMPLETED|Overall Study||33
11250263|NCT02162680|12443910|FG001|COMPLETED|Overall Study||33
11250264|NCT02162680|12443911|FG002|COMPLETED|Overall Study||32
11250265|NCT02162680|12443909|FG000|NOT COMPLETED|Overall Study||0
11250266|NCT02162680|12443910|FG001|NOT COMPLETED|Overall Study||0
11250267|NCT02162680|12443911|FG002|NOT COMPLETED|Overall Study||0
11250268|NCT02162719|12443921|FG000|STARTED|Overall Study||62
11250269|NCT02162719|12443922|FG001|STARTED|Overall Study||62
11250270|NCT02162719|12443921|FG000|COMPLETED|Overall Study||0
11250271|NCT02162719|12443922|FG001|COMPLETED|Overall Study||0
11250272|NCT02162719|12443921|FG000|NOT COMPLETED|Overall Study||62
11250273|NCT02162719|12443922|FG001|NOT COMPLETED|Overall Study||62
11250274|NCT02162758|12443930|FG000|STARTED|Overall Study||3
11250275|NCT02162758|12443931|FG001|STARTED|Overall Study||3
11250276|NCT02162758|12443930|FG000|COMPLETED|Overall Study||3
11250277|NCT02162758|12443931|FG001|COMPLETED|Overall Study||2
11250278|NCT02162758|12443930|FG000|NOT COMPLETED|Overall Study||0
11250279|NCT02162758|12443931|FG001|NOT COMPLETED|Overall Study||1
11250280|NCT02162771|12443939|FG000|STARTED|Core Study Period (Part 2)||70
11250281|NCT02162771|12443940|FG001|STARTED|Core Study Period (Part 2)||70
11250282|NCT02162771|12443939|FG000|COMPLETED|Core Study Period (Part 2)||62
11250283|NCT02162771|12443940|FG001|COMPLETED|Core Study Period (Part 2)||62
11250284|NCT02162771|12443939|FG000|NOT COMPLETED|Core Study Period (Part 2)||8
11250285|NCT02162771|12443940|FG001|NOT COMPLETED|Core Study Period (Part 2)||8
11250286|NCT02162771|12443939|FG000|STARTED|Maintenance Study Period (Part 2)||62
11250287|NCT02162771|12443940|FG001|STARTED|Maintenance Study Period (Part 2)|Two subjects did not enter this period due to Withdrawal by subject and Non-responder, 1 for each.|60
11250288|NCT02162771|12443939|FG000|COMPLETED|Maintenance Study Period (Part 2)||46
11250289|NCT02162771|12443940|FG001|COMPLETED|Maintenance Study Period (Part 2)||38
11250290|NCT02162771|12443939|FG000|NOT COMPLETED|Maintenance Study Period (Part 2)||16
11250291|NCT02162771|12443940|FG001|NOT COMPLETED|Maintenance Study Period (Part 2)||22
11250292|NCT02162862|12443949|FG000|STARTED|Overall Study||31
11250293|NCT02162862|12443950|FG001|STARTED|Overall Study||35
11250294|NCT02162862|12443951|FG002|STARTED|Overall Study||33
11250295|NCT02162862|12443949|FG000|COMPLETED|Overall Study||31
11250296|NCT02162862|12443950|FG001|COMPLETED|Overall Study||24
11250297|NCT02162862|12443951|FG002|COMPLETED|Overall Study||29
11250298|NCT02162862|12443949|FG000|NOT COMPLETED|Overall Study||0
11250299|NCT02162862|12443950|FG001|NOT COMPLETED|Overall Study||11
11250300|NCT02162862|12443951|FG002|NOT COMPLETED|Overall Study||4
11250301|NCT02162992|12443963|FG000|STARTED|Overall Study||51
11250302|NCT02162992|12443964|FG001|STARTED|Overall Study||100
11250303|NCT02162992|12443963|FG000|COMPLETED|Overall Study||46
11250304|NCT02162992|12443964|FG001|COMPLETED|Overall Study||99
11250305|NCT02162992|12443963|FG000|NOT COMPLETED|Overall Study||5
11250306|NCT02162992|12443964|FG001|NOT COMPLETED|Overall Study||1
11250307|NCT02163057|12443972|FG000|STARTED|Overall Study||6
11250308|NCT02163057|12443973|FG001|STARTED|Overall Study||16
11250309|NCT02163057|12443972|FG000|COMPLETED|Overall Study||3
11250310|NCT02163057|12443973|FG001|COMPLETED|Overall Study||11
11250311|NCT02163057|12443972|FG000|NOT COMPLETED|Overall Study||3
11250312|NCT02163057|12443973|FG001|NOT COMPLETED|Overall Study||5
11250313|NCT02163226|12443983|FG000|STARTED|Overall Study||79
11250314|NCT02163226|12443984|FG001|STARTED|Overall Study||81
11250315|NCT02163226|12443983|FG000|COMPLETED|Overall Study||63
11250316|NCT02163226|12443984|FG001|COMPLETED|Overall Study||70
11250317|NCT02163226|12443983|FG000|NOT COMPLETED|Overall Study||16
11250318|NCT02163226|12443984|FG001|NOT COMPLETED|Overall Study||11
11250319|NCT02163421|12443994|FG000|STARTED|Overall Study||12
11250320|NCT02163421|12443995|FG001|STARTED|Overall Study||12
11250321|NCT02163421|12443996|FG002|STARTED|Overall Study||12
11250322|NCT02163421|12443997|FG003|STARTED|Overall Study||12
11250323|NCT02163421|12443994|FG000|COMPLETED|Overall Study||12
11250324|NCT02163421|12443995|FG001|COMPLETED|Overall Study||12
11250325|NCT02163421|12443996|FG002|COMPLETED|Overall Study||12
11250326|NCT02163421|12443997|FG003|COMPLETED|Overall Study||12
11250327|NCT02163421|12443994|FG000|NOT COMPLETED|Overall Study||0
11250328|NCT02163421|12443995|FG001|NOT COMPLETED|Overall Study||0
11250329|NCT02163421|12443996|FG002|NOT COMPLETED|Overall Study||0
11250330|NCT02163421|12443997|FG003|NOT COMPLETED|Overall Study||0
11250331|NCT02163434|12444006|FG000|STARTED|Overall Study||15
11250332|NCT02163434|12444007|FG001|STARTED|Overall Study||16
11250333|NCT02163434|12444006|FG000|COMPLETED|Overall Study||12
11250334|NCT02163434|12444007|FG001|COMPLETED|Overall Study||9
11250335|NCT02163434|12444006|FG000|NOT COMPLETED|Overall Study||3
11250336|NCT02163434|12444007|FG001|NOT COMPLETED|Overall Study||7
11250337|NCT02163447|12444016|FG000|STARTED|Overall Study||106
11250338|NCT02163447|12444017|FG001|STARTED|Overall Study||94
11250339|NCT02163447|12444018|FG002|STARTED|Overall Study||100
11250340|NCT02163447|12444016|FG000|Infants Born|Overall Study||101
11250341|NCT02163447|12444017|FG001|Infants Born|Overall Study||93
11250342|NCT02163447|12444018|FG002|Infants Born|Overall Study||100
11250343|NCT02163447|12444016|FG000|COMPLETED|Overall Study||100
11250344|NCT02163447|12444017|FG001|COMPLETED|Overall Study||88
11250345|NCT02163447|12444018|FG002|COMPLETED|Overall Study||97
11250346|NCT02163447|12444016|FG000|NOT COMPLETED|Overall Study||6
11250347|NCT02163447|12444017|FG001|NOT COMPLETED|Overall Study||6
11250348|NCT02163447|12444018|FG002|NOT COMPLETED|Overall Study||3
11250349|NCT02163486|12444038|FG000|STARTED|Overall Study||51
11250350|NCT02163486|12444039|FG001|STARTED|Overall Study||52
11250351|NCT02163486|12444038|FG000|COMPLETED|Overall Study||50
11250352|NCT02163486|12444039|FG001|COMPLETED|Overall Study||50
11250353|NCT02163486|12444038|FG000|NOT COMPLETED|Overall Study||1
11250354|NCT02163486|12444039|FG001|NOT COMPLETED|Overall Study||2
11250355|NCT02163499|12444045|FG000|STARTED|Acute Phase: ZS 10 g TID||751
11250356|NCT02163499|12444045|FG000|COMPLETED|Acute Phase: ZS 10 g TID||746
11250357|NCT02163499|12444045|FG000|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
11250358|NCT02163499|12444045|FG000|STARTED|Extended Dosing Phase: ZS||746
11250359|NCT02163499|12444045|FG000|COMPLETED|Extended Dosing Phase: ZS||466
11250360|NCT02163499|12444045|FG000|NOT COMPLETED|Extended Dosing Phase: ZS||280
11250361|NCT02163538|12444055|FG000|STARTED|Overall Study||71
11250362|NCT02163538|12444056|FG001|STARTED|Overall Study||71
11250363|NCT02163538|12444055|FG000|COMPLETED|Overall Study||70
11250364|NCT02163538|12444056|FG001|COMPLETED|Overall Study||70
11250365|NCT02163538|12444055|FG000|NOT COMPLETED|Overall Study||1
11250366|NCT02163538|12444056|FG001|NOT COMPLETED|Overall Study||1
11250367|NCT02163577|12444064|FG000|STARTED|Overall Study||26
11250368|NCT02163577|12444065|FG001|STARTED|Overall Study||26
11250369|NCT02163577|12444064|FG000|COMPLETED|Overall Study||26
11250370|NCT02163577|12444065|FG001|COMPLETED|Overall Study||26
11250371|NCT02163577|12444064|FG000|NOT COMPLETED|Overall Study||0
11250372|NCT02163577|12444065|FG001|NOT COMPLETED|Overall Study||0
11250373|NCT02163759|12444074|FG000|STARTED|Overall Study||72
11250374|NCT02163759|12444075|FG001|STARTED|Overall Study||142
11250375|NCT02163759|12444076|FG002|STARTED|Overall Study||144
11250376|NCT02163759|12444074|FG000|Completed Week 10|Overall Study||71
11250377|NCT02163759|12444075|FG001|Completed Week 10|Overall Study||141
11250378|NCT02163759|12444076|FG002|Completed Week 10|Overall Study||143
11250379|NCT02163759|12444074|FG000|COMPLETED|Overall Study||71
11250380|NCT02163759|12444075|FG001|COMPLETED|Overall Study||137
11250381|NCT02163759|12444076|FG002|COMPLETED|Overall Study||141
11250382|NCT02163759|12444074|FG000|NOT COMPLETED|Overall Study||1
11250383|NCT02163759|12444075|FG001|NOT COMPLETED|Overall Study||5
11250384|NCT02163759|12444076|FG002|NOT COMPLETED|Overall Study||3
11250385|NCT02163811|12444089|FG000|STARTED|Overall Study||71
11250386|NCT02163811|12444090|FG001|STARTED|Overall Study||76
11250387|NCT02163811|12444089|FG000|COMPLETED|Overall Study||35
11250388|NCT02163811|12444090|FG001|COMPLETED|Overall Study||60
11250389|NCT02163811|12444089|FG000|NOT COMPLETED|Overall Study||36
11250390|NCT02163811|12444090|FG001|NOT COMPLETED|Overall Study||16
11250391|NCT02163824|12444099|FG000|STARTED|Overall Study||129
11250392|NCT02163824|12444100|FG001|STARTED|Overall Study||125
11250393|NCT02163824|12444101|FG002|STARTED|Overall Study||126
11250394|NCT02163824|12444099|FG000|COMPLETED|Overall Study||127
11250395|NCT02163824|12444100|FG001|COMPLETED|Overall Study||124
11250396|NCT02163824|12444101|FG002|COMPLETED|Overall Study||124
11250397|NCT02163824|12444099|FG000|NOT COMPLETED|Overall Study||2
11250398|NCT02163824|12444100|FG001|NOT COMPLETED|Overall Study||1
11250399|NCT02163824|12444101|FG002|NOT COMPLETED|Overall Study||2
11250400|NCT02163837|12444109|FG000|STARTED|Before Rifaximin||15
11250401|NCT02163837|12444109|FG000|COMPLETED|Before Rifaximin||15
11250402|NCT02163837|12444109|FG000|NOT COMPLETED|Before Rifaximin||0
11250403|NCT02163837|12444109|FG000|STARTED|Day 28 of Rifaximin Treatment||15
11250404|NCT02163837|12444109|FG000|COMPLETED|Day 28 of Rifaximin Treatment||15
11250405|NCT02163837|12444109|FG000|NOT COMPLETED|Day 28 of Rifaximin Treatment||0
11250406|NCT02163902|12444115|FG000|STARTED|Overall Study||113
11250407|NCT02163902|12444116|FG001|STARTED|Overall Study||111
11250408|NCT02163902|12444115|FG000|COMPLETED|Overall Study||102
11250409|NCT02163902|12444116|FG001|COMPLETED|Overall Study||98
11250410|NCT02163902|12444115|FG000|NOT COMPLETED|Overall Study||11
11250411|NCT02163902|12444116|FG001|NOT COMPLETED|Overall Study||13
11250412|NCT02163915|12444127|FG000|STARTED|Overall Study||10
11250413|NCT02163915|12444128|FG001|STARTED|Overall Study||8
11250414|NCT02163915|12444129|FG002|STARTED|Overall Study||10
11250415|NCT02163915|12444130|FG003|STARTED|Overall Study||9
11250416|NCT02163915|12444131|FG004|STARTED|Overall Study||10
11250417|NCT02163915|12444127|FG000|COMPLETED|Overall Study||7
11250418|NCT02163915|12444128|FG001|COMPLETED|Overall Study||8
11250419|NCT02163915|12444129|FG002|COMPLETED|Overall Study||8
11250420|NCT02163915|12444130|FG003|COMPLETED|Overall Study||6
11250421|NCT02163915|12444131|FG004|COMPLETED|Overall Study||6
11250422|NCT02163915|12444127|FG000|NOT COMPLETED|Overall Study||3
11250423|NCT02163915|12444128|FG001|NOT COMPLETED|Overall Study||0
11250424|NCT02163915|12444129|FG002|NOT COMPLETED|Overall Study||2
11250425|NCT02163915|12444130|FG003|NOT COMPLETED|Overall Study||3
11250426|NCT02163915|12444131|FG004|NOT COMPLETED|Overall Study||4
11250427|NCT02163967|12444147|FG000|STARTED|First Intervention/ Day 1||4
11250428|NCT02163967|12444148|FG001|STARTED|First Intervention/ Day 1||4
11250429|NCT02163967|12444149|FG002|STARTED|First Intervention/ Day 1||3
11250430|NCT02163967|12444150|FG003|STARTED|First Intervention/ Day 1||4
11250431|NCT02163967|12444151|FG004|STARTED|First Intervention/ Day 1||3
11250432|NCT02163967|12444152|FG005|STARTED|First Intervention/ Day 1||3
11250433|NCT02163967|12444147|FG000|COMPLETED|First Intervention/ Day 1||4
11250434|NCT02163967|12444148|FG001|COMPLETED|First Intervention/ Day 1||4
11250435|NCT02163967|12444149|FG002|COMPLETED|First Intervention/ Day 1||3
11250436|NCT02163967|12444150|FG003|COMPLETED|First Intervention/ Day 1||4
11250437|NCT02163967|12444151|FG004|COMPLETED|First Intervention/ Day 1||3
11250438|NCT02163967|12444152|FG005|COMPLETED|First Intervention/ Day 1||3
11250439|NCT02163967|12444147|FG000|NOT COMPLETED|First Intervention/ Day 1||0
11250440|NCT02163967|12444148|FG001|NOT COMPLETED|First Intervention/ Day 1||0
11250441|NCT02163967|12444149|FG002|NOT COMPLETED|First Intervention/ Day 1||0
11250442|NCT02163967|12444150|FG003|NOT COMPLETED|First Intervention/ Day 1||0
11250443|NCT02163967|12444151|FG004|NOT COMPLETED|First Intervention/ Day 1||0
11250444|NCT02163967|12444152|FG005|NOT COMPLETED|First Intervention/ Day 1||0
11250445|NCT02163967|12444147|FG000|STARTED|Second Intevention/Day 2||3
11250446|NCT02163967|12444148|FG001|STARTED|Second Intevention/Day 2||4
11250447|NCT02163967|12444149|FG002|STARTED|Second Intevention/Day 2||2
11250448|NCT02163967|12444150|FG003|STARTED|Second Intevention/Day 2||4
11250449|NCT02163967|12444151|FG004|STARTED|Second Intevention/Day 2||3
11250450|NCT02163967|12444152|FG005|STARTED|Second Intevention/Day 2||3
11250451|NCT02163967|12444147|FG000|COMPLETED|Second Intevention/Day 2||3
11250452|NCT02163967|12444148|FG001|COMPLETED|Second Intevention/Day 2||4
11250453|NCT02163967|12444149|FG002|COMPLETED|Second Intevention/Day 2||2
11250454|NCT02163967|12444150|FG003|COMPLETED|Second Intevention/Day 2||4
11250455|NCT02163967|12444151|FG004|COMPLETED|Second Intevention/Day 2||3
11250456|NCT02163967|12444152|FG005|COMPLETED|Second Intevention/Day 2||3
11250457|NCT02163967|12444147|FG000|NOT COMPLETED|Second Intevention/Day 2||0
11250458|NCT02163967|12444148|FG001|NOT COMPLETED|Second Intevention/Day 2||0
11250459|NCT02163967|12444149|FG002|NOT COMPLETED|Second Intevention/Day 2||0
11250460|NCT02163967|12444150|FG003|NOT COMPLETED|Second Intevention/Day 2||0
11250461|NCT02163967|12444151|FG004|NOT COMPLETED|Second Intevention/Day 2||0
11250462|NCT02163967|12444152|FG005|NOT COMPLETED|Second Intevention/Day 2||0
11250463|NCT02163967|12444147|FG000|STARTED|Third Intervention/Day 3||3
11250464|NCT02163967|12444148|FG001|STARTED|Third Intervention/Day 3||3
11250465|NCT02163967|12444149|FG002|STARTED|Third Intervention/Day 3||2
11250466|NCT02163967|12444150|FG003|STARTED|Third Intervention/Day 3||4
11250467|NCT02163967|12444151|FG004|STARTED|Third Intervention/Day 3||3
11250468|NCT02163967|12444152|FG005|STARTED|Third Intervention/Day 3||3
11250469|NCT02163967|12444147|FG000|COMPLETED|Third Intervention/Day 3||3
11250470|NCT02163967|12444148|FG001|COMPLETED|Third Intervention/Day 3||3
11250471|NCT02163967|12444149|FG002|COMPLETED|Third Intervention/Day 3||2
11250472|NCT02163967|12444150|FG003|COMPLETED|Third Intervention/Day 3||4
11250473|NCT02163967|12444151|FG004|COMPLETED|Third Intervention/Day 3||3
11250474|NCT02163967|12444152|FG005|COMPLETED|Third Intervention/Day 3||3
11250475|NCT02163967|12444147|FG000|NOT COMPLETED|Third Intervention/Day 3||0
11250476|NCT02163967|12444148|FG001|NOT COMPLETED|Third Intervention/Day 3||0
11250477|NCT02163967|12444149|FG002|NOT COMPLETED|Third Intervention/Day 3||0
11250478|NCT02163967|12444150|FG003|NOT COMPLETED|Third Intervention/Day 3||0
11250479|NCT02163967|12444151|FG004|NOT COMPLETED|Third Intervention/Day 3||0
11250480|NCT02163967|12444152|FG005|NOT COMPLETED|Third Intervention/Day 3||0
11250481|NCT02163993|12444168|FG000|STARTED|Treatment Period||138
11250482|NCT02163993|12444169|FG001|STARTED|Treatment Period||68
11250483|NCT02163993|12444170|FG002|STARTED|Treatment Period||68
11250484|NCT02163993|12444171|FG003|STARTED|Treatment Period||71
11250485|NCT02163993|12444172|FG004|STARTED|Treatment Period||69
11250486|NCT02163993|12444168|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||137
11250487|NCT02163993|12444169|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||68
11250488|NCT02163993|12444170|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||68
11250489|NCT02163993|12444171|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||70
11250490|NCT02163993|12444172|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||67
11250491|NCT02163993|12444168|FG000|COMPLETED|Treatment Period||126
11250492|NCT02163993|12444169|FG001|COMPLETED|Treatment Period||59
11250493|NCT02163993|12444170|FG002|COMPLETED|Treatment Period||66
11250494|NCT02163993|12444171|FG003|COMPLETED|Treatment Period||62
11250495|NCT02163993|12444172|FG004|COMPLETED|Treatment Period||62
11250496|NCT02163993|12444168|FG000|NOT COMPLETED|Treatment Period||12
11250497|NCT02163993|12444169|FG001|NOT COMPLETED|Treatment Period||9
11250498|NCT02163993|12444170|FG002|NOT COMPLETED|Treatment Period||2
11250499|NCT02163993|12444171|FG003|NOT COMPLETED|Treatment Period||9
11250500|NCT02163993|12444172|FG004|NOT COMPLETED|Treatment Period||7
11250501|NCT02163993|12444168|FG000|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
11250502|NCT02163993|12444169|FG001|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
11250503|NCT02163993|12444170|FG002|STARTED|Post-treatment Period||66
11250504|NCT02163993|12444171|FG003|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
11250505|NCT02163993|12444172|FG004|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
11250506|NCT02163993|12444168|FG000|COMPLETED|Post-treatment Period||121
11250507|NCT02163993|12444169|FG001|COMPLETED|Post-treatment Period||55
11250508|NCT02163993|12444170|FG002|COMPLETED|Post-treatment Period||62
11250509|NCT02163993|12444171|FG003|COMPLETED|Post-treatment Period||61
11250510|NCT02163993|12444172|FG004|COMPLETED|Post-treatment Period||62
11250511|NCT02163993|12444168|FG000|NOT COMPLETED|Post-treatment Period||4
11250512|NCT02163993|12444169|FG001|NOT COMPLETED|Post-treatment Period||6
11250513|NCT02163993|12444170|FG002|NOT COMPLETED|Post-treatment Period||4
11250514|NCT02163993|12444171|FG003|NOT COMPLETED|Post-treatment Period||2
11250515|NCT02163993|12444172|FG004|NOT COMPLETED|Post-treatment Period||3
11250516|NCT02164240|12444193|FG000|STARTED|Overall Study||4
11250517|NCT02164240|12444194|FG001|STARTED|Overall Study||5
11250518|NCT02164240|12444195|FG002|STARTED|Overall Study||4
11250519|NCT02164240|12444193|FG000|COMPLETED|Overall Study||4
11250520|NCT02164240|12444194|FG001|COMPLETED|Overall Study||5
11250521|NCT02164240|12444195|FG002|COMPLETED|Overall Study||4
11250522|NCT02164240|12444193|FG000|NOT COMPLETED|Overall Study||0
11250523|NCT02164240|12444194|FG001|NOT COMPLETED|Overall Study||0
11250524|NCT02164240|12444195|FG002|NOT COMPLETED|Overall Study||0
11250525|NCT02164318|12444208|FG000|STARTED|Overall Study||4
11250526|NCT02164318|12444209|FG001|STARTED|Overall Study||3
11250527|NCT02164318|12444210|FG002|STARTED|Overall Study||1
11250528|NCT02164318|12444211|FG003|STARTED|Overall Study||3
11250529|NCT02164318|12444208|FG000|COMPLETED|Overall Study||4
11250530|NCT02164318|12444209|FG001|COMPLETED|Overall Study||2
11250531|NCT02164318|12444210|FG002|COMPLETED|Overall Study||1
11250532|NCT02164318|12444211|FG003|COMPLETED|Overall Study||2
11250533|NCT02164318|12444208|FG000|NOT COMPLETED|Overall Study||0
11358566|NCT03125941|12555697|FG000|STARTED|Overall Study||65
11250534|NCT02164318|12444209|FG001|NOT COMPLETED|Overall Study||1
11250535|NCT02164318|12444210|FG002|NOT COMPLETED|Overall Study||0
11250536|NCT02164318|12444211|FG003|NOT COMPLETED|Overall Study||1
11250537|NCT02164383|12444223|FG000|STARTED|Overall Study||16
11250538|NCT02164383|12444224|FG001|STARTED|Overall Study||14
11250539|NCT02164383|12444223|FG000|COMPLETED|Overall Study||15
11250540|NCT02164383|12444224|FG001|COMPLETED|Overall Study||14
11250541|NCT02164383|12444223|FG000|NOT COMPLETED|Overall Study||1
11250542|NCT02164383|12444224|FG001|NOT COMPLETED|Overall Study||0
11250543|NCT02164396|12444233|FG000|STARTED|Overall Study||10
11250544|NCT02164396|12444234|FG001|STARTED|Overall Study||10
11250545|NCT02164396|12444235|FG002|STARTED|Overall Study||10
11250546|NCT02164396|12444233|FG000|COMPLETED|Overall Study||10
11250547|NCT02164396|12444234|FG001|COMPLETED|Overall Study||10
11250548|NCT02164396|12444235|FG002|COMPLETED|Overall Study||10
11250549|NCT02164396|12444233|FG000|NOT COMPLETED|Overall Study||0
11250550|NCT02164396|12444234|FG001|NOT COMPLETED|Overall Study||0
11250551|NCT02164396|12444235|FG002|NOT COMPLETED|Overall Study||0
11250552|NCT02164422|12444246|FG000|STARTED|Overall Study||25
11250553|NCT02164422|12444247|FG001|STARTED|Overall Study||22
11250554|NCT02164422|12444248|FG002|STARTED|Overall Study||23
11250555|NCT02164422|12444246|FG000|COMPLETED|Overall Study||24
11250556|NCT02164422|12444247|FG001|COMPLETED|Overall Study||20
11250557|NCT02164422|12444248|FG002|COMPLETED|Overall Study||23
11250558|NCT02164422|12444246|FG000|NOT COMPLETED|Overall Study||1
11250559|NCT02164422|12444247|FG001|NOT COMPLETED|Overall Study||2
11250560|NCT02164422|12444248|FG002|NOT COMPLETED|Overall Study||0
11250561|NCT02164513|12444259|FG000|STARTED|Overall Study||4151
11250562|NCT02164513|12444260|FG001|STARTED|Overall Study||4134
11250563|NCT02164513|12444261|FG002|STARTED|Overall Study||2070
11250564|NCT02164513|12444259|FG000|Completed Investigational Product (IP)|Overall Study||3393
11250565|NCT02164513|12444260|FG001|Completed Investigational Product (IP)|Overall Study||3094
11250566|NCT02164513|12444261|FG002|Completed Investigational Product (IP)|Overall Study||1504
11250567|NCT02164513|12444259|FG000|Not Completed IP|Overall Study||758
11250568|NCT02164513|12444260|FG001|Not Completed IP|Overall Study||1040
11250569|NCT02164513|12444261|FG002|Not Completed IP|Overall Study||566
11250570|NCT02164513|12444259|FG000|Withdrew IP (WIP): Adverse Event|Overall Study||249
11250571|NCT02164513|12444260|FG001|Withdrew IP (WIP): Adverse Event|Overall Study||325
11250572|NCT02164513|12444261|FG002|Withdrew IP (WIP): Adverse Event|Overall Study||186
11250573|NCT02164513|12444259|FG000|WIP: Lack of Efficacy|Overall Study||163
11250574|NCT02164513|12444260|FG001|WIP: Lack of Efficacy|Overall Study||313
11250575|NCT02164513|12444261|FG002|WIP: Lack of Efficacy|Overall Study||172
11250576|NCT02164513|12444259|FG000|Withdrew IP: Protocol Deviation|Overall Study||32
11250577|NCT02164513|12444260|FG001|Withdrew IP: Protocol Deviation|Overall Study||41
11250578|NCT02164513|12444261|FG002|Withdrew IP: Protocol Deviation|Overall Study||19
11250579|NCT02164513|12444259|FG000|WIP (Other): Stopping Criteria Reached|Overall Study||4
11250580|NCT02164513|12444260|FG001|WIP (Other): Stopping Criteria Reached|Overall Study||1
11250581|NCT02164513|12444261|FG002|WIP (Other): Stopping Criteria Reached|Overall Study||2
11250582|NCT02164513|12444259|FG000|WIP: Study Closed/Terminated|Overall Study||5
11250583|NCT02164513|12444260|FG001|WIP: Study Closed/Terminated|Overall Study||2
11250584|NCT02164513|12444261|FG002|WIP: Study Closed/Terminated|Overall Study||5
11250585|NCT02164513|12444259|FG000|WIP: Lost to Follow-up|Overall Study||21
11250586|NCT02164513|12444260|FG001|WIP: Lost to Follow-up|Overall Study||25
11250587|NCT02164513|12444261|FG002|WIP: Lost to Follow-up|Overall Study||14
11250588|NCT02164513|12444259|FG000|WIP: Investigator Discretion|Overall Study||33
11250589|NCT02164513|12444260|FG001|WIP: Investigator Discretion|Overall Study||36
11250590|NCT02164513|12444261|FG002|WIP: Investigator Discretion|Overall Study||15
11250591|NCT02164513|12444259|FG000|WIP: Withdrawal by Participant|Overall Study||250
11250592|NCT02164513|12444260|FG001|WIP: Withdrawal by Participant|Overall Study||296
11250593|NCT02164513|12444261|FG002|WIP: Withdrawal by Participant|Overall Study||153
11250594|NCT02164513|12444259|FG000|WIP :Did Not Complete Study Treatment|Overall Study||1
11250595|NCT02164513|12444260|FG001|WIP :Did Not Complete Study Treatment|Overall Study||1
11250596|NCT02164513|12444261|FG002|WIP :Did Not Complete Study Treatment|Overall Study||0
11250597|NCT02164513|12444259|FG000|COMPLETED|Overall Study||3714
11250598|NCT02164513|12444260|FG001|COMPLETED|Overall Study||3598
11250599|NCT02164513|12444261|FG002|COMPLETED|Overall Study||1775
11250600|NCT02164513|12444259|FG000|NOT COMPLETED|Overall Study||437
11250601|NCT02164513|12444260|FG001|NOT COMPLETED|Overall Study||536
11250602|NCT02164513|12444261|FG002|NOT COMPLETED|Overall Study||295
11250603|NCT02164539|12444276|FG000|STARTED|Treatment Phase A (4 Weeks)||41
11250604|NCT02164539|12444277|FG001|STARTED|Treatment Phase A (4 Weeks)||42
11250605|NCT02164539|12444278|FG002|STARTED|Treatment Phase A (4 Weeks)||40
11250606|NCT02164539|12444279|FG003|STARTED|Treatment Phase A (4 Weeks)||46
11250607|NCT02164539|12444280|FG004|STARTED|Treatment Phase A (4 Weeks)||85
11250608|NCT02164539|12444281|FG005|STARTED|Treatment Phase A (4 Weeks)||84
11250609|NCT02164539|12444282|FG006|STARTED|Treatment Phase A (4 Weeks)||0
11250610|NCT02164539|12444276|FG000|COMPLETED|Treatment Phase A (4 Weeks)||39
11250611|NCT02164539|12444277|FG001|COMPLETED|Treatment Phase A (4 Weeks)||42
11250612|NCT02164539|12444278|FG002|COMPLETED|Treatment Phase A (4 Weeks)||39
11250613|NCT02164539|12444279|FG003|COMPLETED|Treatment Phase A (4 Weeks)||44
11250614|NCT02164539|12444280|FG004|COMPLETED|Treatment Phase A (4 Weeks)||82
11250615|NCT02164539|12444281|FG005|COMPLETED|Treatment Phase A (4 Weeks)||83
11250616|NCT02164539|12444282|FG006|COMPLETED|Treatment Phase A (4 Weeks)||0
11250617|NCT02164539|12444276|FG000|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
11250618|NCT02164539|12444277|FG001|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
11250619|NCT02164539|12444278|FG002|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
11250620|NCT02164539|12444279|FG003|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
11250621|NCT02164539|12444280|FG004|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
11250622|NCT02164539|12444281|FG005|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
11250623|NCT02164539|12444282|FG006|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
11250624|NCT02164539|12444276|FG000|STARTED|Treatment Phase B (1 Week)||0
11250625|NCT02164539|12444277|FG001|STARTED|Treatment Phase B (1 Week)||0
11250626|NCT02164539|12444278|FG002|STARTED|Treatment Phase B (1 Week)||0
11250627|NCT02164539|12444279|FG003|STARTED|Treatment Phase B (1 Week)||0
11250628|NCT02164539|12444280|FG004|STARTED|Treatment Phase B (1 Week)||166
11250629|NCT02164539|12444281|FG005|STARTED|Treatment Phase B (1 Week)||0
11250630|NCT02164539|12444282|FG006|STARTED|Treatment Phase B (1 Week)||163
11250631|NCT02164539|12444276|FG000|COMPLETED|Treatment Phase B (1 Week)||0
11250632|NCT02164539|12444277|FG001|COMPLETED|Treatment Phase B (1 Week)||0
11250633|NCT02164539|12444278|FG002|COMPLETED|Treatment Phase B (1 Week)||0
11250634|NCT02164539|12444279|FG003|COMPLETED|Treatment Phase B (1 Week)||0
11250635|NCT02164539|12444280|FG004|COMPLETED|Treatment Phase B (1 Week)||163
11250636|NCT02164539|12444281|FG005|COMPLETED|Treatment Phase B (1 Week)||0
11250637|NCT02164539|12444282|FG006|COMPLETED|Treatment Phase B (1 Week)||162
11250638|NCT02164539|12444276|FG000|NOT COMPLETED|Treatment Phase B (1 Week)||0
11250639|NCT02164539|12444277|FG001|NOT COMPLETED|Treatment Phase B (1 Week)||0
11250640|NCT02164539|12444278|FG002|NOT COMPLETED|Treatment Phase B (1 Week)||0
11250641|NCT02164539|12444279|FG003|NOT COMPLETED|Treatment Phase B (1 Week)||0
11250642|NCT02164539|12444280|FG004|NOT COMPLETED|Treatment Phase B (1 Week)||3
11250643|NCT02164539|12444281|FG005|NOT COMPLETED|Treatment Phase B (1 Week)||0
11250644|NCT02164539|12444282|FG006|NOT COMPLETED|Treatment Phase B (1 Week)||1
11250645|NCT02164539|12444276|FG000|STARTED|Treatment Phase C (1 Week)||79
11250646|NCT02164539|12444277|FG001|STARTED|Treatment Phase C (1 Week)||0
11250647|NCT02164539|12444278|FG002|STARTED|Treatment Phase C (1 Week)||0
11250648|NCT02164539|12444279|FG003|STARTED|Treatment Phase C (1 Week)||0
11250649|NCT02164539|12444280|FG004|STARTED|Treatment Phase C (1 Week)||84
11250650|NCT02164539|12444281|FG005|STARTED|Treatment Phase C (1 Week)||82
11250651|NCT02164539|12444282|FG006|STARTED|Treatment Phase C (1 Week)||80
11250652|NCT02164539|12444276|FG000|COMPLETED|Treatment Phase C (1 Week)||78
11250653|NCT02164539|12444277|FG001|COMPLETED|Treatment Phase C (1 Week)||0
11250654|NCT02164539|12444278|FG002|COMPLETED|Treatment Phase C (1 Week)||0
11250655|NCT02164539|12444279|FG003|COMPLETED|Treatment Phase C (1 Week)||0
11250656|NCT02164539|12444280|FG004|COMPLETED|Treatment Phase C (1 Week)||84
11250657|NCT02164539|12444281|FG005|COMPLETED|Treatment Phase C (1 Week)||82
11250658|NCT02164539|12444282|FG006|COMPLETED|Treatment Phase C (1 Week)||78
11250659|NCT02164539|12444276|FG000|NOT COMPLETED|Treatment Phase C (1 Week)||1
11250660|NCT02164539|12444277|FG001|NOT COMPLETED|Treatment Phase C (1 Week)||0
11250661|NCT02164539|12444278|FG002|NOT COMPLETED|Treatment Phase C (1 Week)||0
11250662|NCT02164539|12444279|FG003|NOT COMPLETED|Treatment Phase C (1 Week)||0
11250663|NCT02164539|12444280|FG004|NOT COMPLETED|Treatment Phase C (1 Week)||0
11250664|NCT02164539|12444281|FG005|NOT COMPLETED|Treatment Phase C (1 Week)||0
11250665|NCT02164539|12444282|FG006|NOT COMPLETED|Treatment Phase C (1 Week)||2
11250666|NCT02164721|12444297|FG000|STARTED|Overall Study||30
11250667|NCT02164721|12444297|FG000|COMPLETED|Overall Study||30
11250668|NCT02164721|12444297|FG000|NOT COMPLETED|Overall Study||0
11250669|NCT02164864|12444305|FG000|STARTED|Overall Study|Started are the Randomised/entered patients.|981
11250670|NCT02164864|12444306|FG001|STARTED|Overall Study|Started are the Randomised/entered patients.|763
11250671|NCT02164864|12444307|FG002|STARTED|Overall Study|Started are the Randomised/entered patients.|981
11250672|NCT02164864|12444305|FG000|COMPLETED|Overall Study||886
11250673|NCT02164864|12444306|FG001|COMPLETED|Overall Study||703
11250674|NCT02164864|12444307|FG002|COMPLETED|Overall Study||849
11250675|NCT02164864|12444305|FG000|NOT COMPLETED|Overall Study||95
11358567|NCT03125941|12555698|FG001|STARTED|Overall Study||65
11250676|NCT02164864|12444306|FG001|NOT COMPLETED|Overall Study||60
11250677|NCT02164864|12444307|FG002|NOT COMPLETED|Overall Study||132
11250678|NCT02164916|12444320|FG000|STARTED|Overall Study||52
11250679|NCT02164916|12444321|FG001|STARTED|Overall Study||54
11250680|NCT02164916|12444320|FG000|Eligible|Overall Study||50
11250681|NCT02164916|12444321|FG001|Eligible|Overall Study||49
11250682|NCT02164916|12444320|FG000|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
11250683|NCT02164916|12444321|FG001|Cross-over to Arm II|Overall Study||0
11250684|NCT02164916|12444320|FG000|COMPLETED|Overall Study||0
11250685|NCT02164916|12444321|FG001|COMPLETED|Overall Study||0
11250686|NCT02164916|12444320|FG000|NOT COMPLETED|Overall Study||52
11250687|NCT02164916|12444321|FG001|NOT COMPLETED|Overall Study||54
11250688|NCT02164929|12444336|FG000|STARTED|Overall Study||4
11250689|NCT02164929|12444337|FG001|STARTED|Overall Study||3
11250690|NCT02164929|12444338|FG002|STARTED|Overall Study||5
11250691|NCT02164929|12444339|FG003|STARTED|Overall Study||4
11250692|NCT02164929|12444336|FG000|COMPLETED|Overall Study||3
11250693|NCT02164929|12444337|FG001|COMPLETED|Overall Study||3
11250694|NCT02164929|12444338|FG002|COMPLETED|Overall Study||4
11250695|NCT02164929|12444339|FG003|COMPLETED|Overall Study||2
11250696|NCT02164929|12444336|FG000|NOT COMPLETED|Overall Study||1
11250697|NCT02164929|12444337|FG001|NOT COMPLETED|Overall Study||0
11250698|NCT02164929|12444338|FG002|NOT COMPLETED|Overall Study||1
11250699|NCT02164929|12444339|FG003|NOT COMPLETED|Overall Study||2
11339478|NCT02914509|12537012|FG000|NOT COMPLETED|Overall Study||5
11339479|NCT02914509|12537013|FG001|NOT COMPLETED|Overall Study||6
11339480|NCT02914522|12537027|FG000|STARTED|Induction Study: Up to Week 11||245
11339481|NCT02914522|12537028|FG001|STARTED|Induction Study: Up to Week 11||278
11339482|NCT02914522|12537029|FG002|STARTED|Induction Study: Up to Week 11||137
11339483|NCT02914522|12537030|FG003|STARTED|Induction Study: Up to Week 11||262
11339484|NCT02914522|12537031|FG004|STARTED|Induction Study: Up to Week 11||286
11339485|NCT02914522|12537032|FG005|STARTED|Induction Study: Up to Week 11||143
11339486|NCT02914522|12537033|FG006|STARTED|Induction Study: Up to Week 11||0
11339487|NCT02914522|12537034|FG007|STARTED|Induction Study: Up to Week 11||0
11339488|NCT02914522|12537035|FG008|STARTED|Induction Study: Up to Week 11||0
11339489|NCT02914522|12537036|FG009|STARTED|Induction Study: Up to Week 11||0
11339490|NCT02914522|12537037|FG010|STARTED|Induction Study: Up to Week 11||0
11339491|NCT02914522|12537027|FG000|COMPLETED|Induction Study: Up to Week 11||235
11339492|NCT02914522|12537028|FG001|COMPLETED|Induction Study: Up to Week 11||256
11339493|NCT02914522|12537029|FG002|COMPLETED|Induction Study: Up to Week 11||127
11339494|NCT02914522|12537030|FG003|COMPLETED|Induction Study: Up to Week 11||234
11339495|NCT02914522|12537031|FG004|COMPLETED|Induction Study: Up to Week 11||262
11339496|NCT02914522|12537032|FG005|COMPLETED|Induction Study: Up to Week 11||127
11339497|NCT02914522|12537033|FG006|COMPLETED|Induction Study: Up to Week 11||0
11339498|NCT02914522|12537034|FG007|COMPLETED|Induction Study: Up to Week 11||0
11339499|NCT02914522|12537035|FG008|COMPLETED|Induction Study: Up to Week 11||0
11339500|NCT02914522|12537036|FG009|COMPLETED|Induction Study: Up to Week 11||0
11250700|NCT02164981|12444352|FG000|STARTED|Started||23
11250701|NCT02164981|12444353|FG001|STARTED|Started||19
11250702|NCT02164981|12444354|FG002|STARTED|Started||18
11250703|NCT02164981|12444352|FG000|COMPLETED|Started||18
11250704|NCT02164981|12444353|FG001|COMPLETED|Started||16
11250705|NCT02164981|12444354|FG002|COMPLETED|Started||18
11250706|NCT02164981|12444352|FG000|NOT COMPLETED|Started||5
11250707|NCT02164981|12444353|FG001|NOT COMPLETED|Started||3
11250708|NCT02164981|12444354|FG002|NOT COMPLETED|Started||0
11250709|NCT02164981|12444352|FG000|STARTED|Phase 1 (Day 0 - Day 14)||18
11250710|NCT02164981|12444353|FG001|STARTED|Phase 1 (Day 0 - Day 14)||16
11250711|NCT02164981|12444354|FG002|STARTED|Phase 1 (Day 0 - Day 14)||18
11250712|NCT02164981|12444352|FG000|COMPLETED|Phase 1 (Day 0 - Day 14)||18
11250713|NCT02164981|12444353|FG001|COMPLETED|Phase 1 (Day 0 - Day 14)||14
11250714|NCT02164981|12444354|FG002|COMPLETED|Phase 1 (Day 0 - Day 14)||18
11250715|NCT02164981|12444352|FG000|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
11250716|NCT02164981|12444353|FG001|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
11250717|NCT02164981|12444354|FG002|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
11250718|NCT02164981|12444352|FG000|STARTED|Phase 2 (Day 14 - Day 28)||18
11250719|NCT02164981|12444353|FG001|STARTED|Phase 2 (Day 14 - Day 28)||14
11250720|NCT02164981|12444354|FG002|STARTED|Phase 2 (Day 14 - Day 28)||18
11250721|NCT02164981|12444352|FG000|COMPLETED|Phase 2 (Day 14 - Day 28)||16
11250722|NCT02164981|12444353|FG001|COMPLETED|Phase 2 (Day 14 - Day 28)||12
11250723|NCT02164981|12444354|FG002|COMPLETED|Phase 2 (Day 14 - Day 28)||18
11250724|NCT02164981|12444352|FG000|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
11250725|NCT02164981|12444353|FG001|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
11250726|NCT02164981|12444354|FG002|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
11250727|NCT02165072|12444375|FG000|STARTED|Overall Study||30
11250728|NCT02165072|12444375|FG000|COMPLETED|Overall Study||30
11250729|NCT02165072|12444375|FG000|NOT COMPLETED|Overall Study||0
11250730|NCT02165111|12444381|FG000|STARTED|Overall Study||40
11250731|NCT02165111|12444382|FG001|STARTED|Overall Study||40
11250732|NCT02165111|12444381|FG000|COMPLETED|Overall Study||40
11250733|NCT02165111|12444382|FG001|COMPLETED|Overall Study||40
11250734|NCT02165111|12444381|FG000|NOT COMPLETED|Overall Study||0
11250735|NCT02165111|12444382|FG001|NOT COMPLETED|Overall Study||0
11250736|NCT02165124|12444390|FG000|STARTED|Overall Study||20
11250737|NCT02165124|12444390|FG000|COMPLETED|Overall Study||15
11250738|NCT02165124|12444390|FG000|NOT COMPLETED|Overall Study||5
11250739|NCT02165202|12444396|FG000|STARTED|Oral Phase|Participants Enrolled in the study|91
11250740|NCT02165202|12444397|FG001|STARTED|Oral Phase|Participants Enrolled in the study|45
11250741|NCT02165202|12444396|FG000|COMPLETED|Oral Phase||80
11250742|NCT02165202|12444397|FG001|COMPLETED|Oral Phase||42
11250743|NCT02165202|12444396|FG000|NOT COMPLETED|Oral Phase||11
11250744|NCT02165202|12444397|FG001|NOT COMPLETED|Oral Phase||3
11250745|NCT02165202|12444396|FG000|STARTED|Injection Phase|Participants who received at least one injection.|80
11250746|NCT02165202|12444397|FG001|STARTED|Injection Phase|Participants who received at least one injection.|42
11250747|NCT02165202|12444396|FG000|COMPLETED|Injection Phase||70
11250748|NCT02165202|12444397|FG001|COMPLETED|Injection Phase||36
11250749|NCT02165202|12444396|FG000|NOT COMPLETED|Injection Phase||10
11250750|NCT02165202|12444397|FG001|NOT COMPLETED|Injection Phase||6
11250751|NCT02165384|12444403|FG000|STARTED|Overall Study||199
11250752|NCT02165384|12444403|FG000|COMPLETED|Overall Study||199
11250753|NCT02165384|12444403|FG000|NOT COMPLETED|Overall Study||0
11250754|NCT02165397|12444410|FG000|STARTED|Overall Study||75
11250755|NCT02165397|12444411|FG001|STARTED|Overall Study||75
11250756|NCT02165397|12444412|FG002|STARTED|Overall Study||31
11250757|NCT02165397|12444410|FG000|COMPLETED|Overall Study||61
11250758|NCT02165397|12444411|FG001|COMPLETED|Overall Study||56
11250759|NCT02165397|12444412|FG002|COMPLETED|Overall Study||21
11250760|NCT02165397|12444410|FG000|NOT COMPLETED|Overall Study||14
11250761|NCT02165397|12444411|FG001|NOT COMPLETED|Overall Study||19
11250762|NCT02165397|12444412|FG002|NOT COMPLETED|Overall Study||10
11250763|NCT02165462|12444422|FG000|STARTED|Overall Study||17
11250764|NCT02165462|12444422|FG000|COMPLETED|Overall Study||17
11250765|NCT02165462|12444422|FG000|NOT COMPLETED|Overall Study||0
11250766|NCT02165605|12444426|FG000|STARTED|Overall Study||28
11250767|NCT02165605|12444426|FG000|COMPLETED|Overall Study||28
11250768|NCT02165605|12444426|FG000|NOT COMPLETED|Overall Study||0
11250769|NCT02165722|12444435|FG000|STARTED|Overall Study||1971
11250770|NCT02165722|12444436|FG001|STARTED|Overall Study||2202
11250771|NCT02165722|12444435|FG000|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
11250772|NCT02165722|12444436|FG001|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
11250773|NCT02165722|12444435|FG000|NOT COMPLETED|Overall Study||0
11250774|NCT02165722|12444436|FG001|NOT COMPLETED|Overall Study||0
11250775|NCT02165735|12444450|FG000|STARTED|Overall Study||180
11250776|NCT02165735|12444451|FG001|STARTED|Overall Study||180
11250777|NCT02165735|12444450|FG000|COMPLETED|Overall Study||164
11250778|NCT02165735|12444451|FG001|COMPLETED|Overall Study||166
11250779|NCT02165735|12444450|FG000|NOT COMPLETED|Overall Study||16
11250780|NCT02165735|12444451|FG001|NOT COMPLETED|Overall Study||14
11250781|NCT02165761|12444459|FG000|STARTED|Overall Study||23
11250782|NCT02165761|12444460|FG001|STARTED|Overall Study||19
11250783|NCT02165761|12444459|FG000|COMPLETED|Overall Study||4
11250784|NCT02165761|12444460|FG001|COMPLETED|Overall Study||5
11250785|NCT02165761|12444459|FG000|NOT COMPLETED|Overall Study||19
11250786|NCT02165761|12444460|FG001|NOT COMPLETED|Overall Study||14
11250787|NCT02165826|12444469|FG000|STARTED|Main Treatment Period||441
11250788|NCT02165826|12444470|FG001|STARTED|Main Treatment Period||439
11250789|NCT02165826|12444471|FG002|STARTED|Main Treatment Period||443
11250790|NCT02165826|12444469|FG000|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
11250791|NCT02165826|12444470|FG001|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
11250792|NCT02165826|12444471|FG002|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
11250793|NCT02165826|12444469|FG000|COMPLETED|Main Treatment Period||360
11250794|NCT02165826|12444470|FG001|COMPLETED|Main Treatment Period||349
11250795|NCT02165826|12444471|FG002|COMPLETED|Main Treatment Period||334
11250796|NCT02165826|12444469|FG000|NOT COMPLETED|Main Treatment Period||81
11250797|NCT02165826|12444470|FG001|NOT COMPLETED|Main Treatment Period||90
11250798|NCT02165826|12444471|FG002|NOT COMPLETED|Main Treatment Period||109
11250799|NCT02165826|12444469|FG000|STARTED|Down-Titration Period||27
11250800|NCT02165826|12444470|FG001|STARTED|Down-Titration Period||39
11250801|NCT02165826|12444471|FG002|STARTED|Down-Titration Period||38
11250802|NCT02165826|12444469|FG000|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
11250803|NCT02165826|12444470|FG001|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
11250804|NCT02165826|12444471|FG002|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
11250805|NCT02165826|12444469|FG000|COMPLETED|Down-Titration Period||20
11250806|NCT02165826|12444470|FG001|COMPLETED|Down-Titration Period||28
11250807|NCT02165826|12444471|FG002|COMPLETED|Down-Titration Period||31
11250808|NCT02165826|12444469|FG000|NOT COMPLETED|Down-Titration Period||7
11250809|NCT02165826|12444470|FG001|NOT COMPLETED|Down-Titration Period||11
11250810|NCT02165826|12444471|FG002|NOT COMPLETED|Down-Titration Period||7
11250811|NCT02165839|12444498|FG000|STARTED|Overall Study||66
11250812|NCT02165839|12444499|FG001|STARTED|Overall Study||73
11250813|NCT02165839|12444498|FG000|COMPLETED|Overall Study||66
11250814|NCT02165839|12444499|FG001|COMPLETED|Overall Study||73
11250815|NCT02165839|12444498|FG000|NOT COMPLETED|Overall Study||0
11141928|NCT01465659|12328648|FG000|STARTED|Completed 1 Cycle of Treatment||7
11141929|NCT01465659|12328649|FG001|STARTED|Completed 1 Cycle of Treatment||5
11141930|NCT01465659|12328650|FG002|STARTED|Completed 1 Cycle of Treatment||6
11141931|NCT01465659|12328651|FG003|STARTED|Completed 1 Cycle of Treatment||11
11141932|NCT01465659|12328648|FG000|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||7
11250816|NCT02165839|12444499|FG001|NOT COMPLETED|Overall Study||0
11250817|NCT02165904|12444506|FG000|STARTED|Overall Study||10
11250818|NCT02165904|12444506|FG000|COMPLETED|Overall Study||10
11250819|NCT02165904|12444506|FG000|NOT COMPLETED|Overall Study||0
11250820|NCT02166047|12444522|FG000|STARTED|Overall Study||16
11250821|NCT02166047|12444523|FG001|STARTED|Overall Study||15
11250822|NCT02166047|12444524|FG002|STARTED|Overall Study||16
11250823|NCT02166047|12444525|FG003|STARTED|Overall Study||5
11250824|NCT02166047|12444526|FG004|STARTED|Overall Study||18
11250825|NCT02166047|12444527|FG005|STARTED|Overall Study||17
11250826|NCT02166047|12444528|FG006|STARTED|Overall Study||17
11250827|NCT02166047|12444529|FG007|STARTED|Overall Study||5
11250828|NCT02166047|12444530|FG008|STARTED|Overall Study||16
11250829|NCT02166047|12444531|FG009|STARTED|Overall Study||17
11250830|NCT02166047|12444532|FG010|STARTED|Overall Study||14
11250831|NCT02166047|12444533|FG011|STARTED|Overall Study||6
11250832|NCT02166047|12444522|FG000|COMPLETED|Overall Study||16
11250833|NCT02166047|12444523|FG001|COMPLETED|Overall Study||14
11250834|NCT02166047|12444524|FG002|COMPLETED|Overall Study||14
11250835|NCT02166047|12444525|FG003|COMPLETED|Overall Study||5
11250836|NCT02166047|12444526|FG004|COMPLETED|Overall Study||17
11250837|NCT02166047|12444527|FG005|COMPLETED|Overall Study||17
11250838|NCT02166047|12444528|FG006|COMPLETED|Overall Study||15
11250839|NCT02166047|12444529|FG007|COMPLETED|Overall Study||5
11250840|NCT02166047|12444530|FG008|COMPLETED|Overall Study||16
11250841|NCT02166047|12444531|FG009|COMPLETED|Overall Study||17
11250842|NCT02166047|12444532|FG010|COMPLETED|Overall Study||12
11250843|NCT02166047|12444533|FG011|COMPLETED|Overall Study||6
11250844|NCT02166047|12444522|FG000|NOT COMPLETED|Overall Study||0
11250845|NCT02166047|12444523|FG001|NOT COMPLETED|Overall Study||1
11250846|NCT02166047|12444524|FG002|NOT COMPLETED|Overall Study||2
11250847|NCT02166047|12444525|FG003|NOT COMPLETED|Overall Study||0
11250848|NCT02166047|12444526|FG004|NOT COMPLETED|Overall Study||1
11250849|NCT02166047|12444527|FG005|NOT COMPLETED|Overall Study||0
11250850|NCT02166047|12444528|FG006|NOT COMPLETED|Overall Study||2
11250851|NCT02166047|12444529|FG007|NOT COMPLETED|Overall Study||0
11250852|NCT02166047|12444530|FG008|NOT COMPLETED|Overall Study||0
11250853|NCT02166047|12444531|FG009|NOT COMPLETED|Overall Study||0
11250854|NCT02166047|12444532|FG010|NOT COMPLETED|Overall Study||2
11250855|NCT02166047|12444533|FG011|NOT COMPLETED|Overall Study||0
11250856|NCT02166333|12444563|FG000|STARTED|Stage 1||262
11250857|NCT02166333|12444564|FG001|STARTED|Stage 1||0
11250858|NCT02166333|12444565|FG002|STARTED|Stage 1||130
11250859|NCT02166333|12444566|FG003|STARTED|Stage 1||0
11250860|NCT02166333|12444567|FG004|STARTED|Stage 1|Randomization to 2000 IU/d was stopped in February 2018 as part of planned dose-finding|68
11250861|NCT02166333|12444568|FG005|STARTED|Stage 1|Randomization to 4000 IU/d was stopped in March 2018 as part of planned dose-finding|69
11250862|NCT02166333|12444563|FG000|COMPLETED|Stage 1||242
11250863|NCT02166333|12444564|FG001|COMPLETED|Stage 1||0
11250864|NCT02166333|12444565|FG002|COMPLETED|Stage 1||122
11250865|NCT02166333|12444566|FG003|COMPLETED|Stage 1||0
11250866|NCT02166333|12444567|FG004|COMPLETED|Stage 1||59
11250867|NCT02166333|12444568|FG005|COMPLETED|Stage 1||63
11250868|NCT02166333|12444563|FG000|NOT COMPLETED|Stage 1||20
11250869|NCT02166333|12444564|FG001|NOT COMPLETED|Stage 1||0
11141933|NCT01465659|12328649|FG001|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||4
11141934|NCT01465659|12328650|FG002|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||6
11141935|NCT01465659|12328651|FG003|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||11
11141936|NCT01465659|12328648|FG000|COMPLETED|Completed 1 Cycle of Treatment||7
11141937|NCT01465659|12328649|FG001|COMPLETED|Completed 1 Cycle of Treatment||4
11141938|NCT01465659|12328650|FG002|COMPLETED|Completed 1 Cycle of Treatment||6
11141939|NCT01465659|12328651|FG003|COMPLETED|Completed 1 Cycle of Treatment||10
11141940|NCT01465659|12328648|FG000|NOT COMPLETED|Completed 1 Cycle of Treatment||0
11141941|NCT01465659|12328649|FG001|NOT COMPLETED|Completed 1 Cycle of Treatment||1
11141942|NCT01465659|12328650|FG002|NOT COMPLETED|Completed 1 Cycle of Treatment||0
11141943|NCT01465659|12328651|FG003|NOT COMPLETED|Completed 1 Cycle of Treatment||1
11141944|NCT01465659|12328648|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||7
11250870|NCT02166333|12444565|FG002|NOT COMPLETED|Stage 1||8
11250871|NCT02166333|12444566|FG003|NOT COMPLETED|Stage 1||0
11250872|NCT02166333|12444567|FG004|NOT COMPLETED|Stage 1||9
11250873|NCT02166333|12444568|FG005|NOT COMPLETED|Stage 1||6
11250874|NCT02166333|12444563|FG000|STARTED|Stage 2||242
11250875|NCT02166333|12444564|FG001|STARTED|Stage 2||77
11250876|NCT02166333|12444565|FG002|STARTED|Stage 2||122
11250877|NCT02166333|12444566|FG003|STARTED|Stage 2||82
11250878|NCT02166333|12444567|FG004|STARTED|Stage 2||59
11250879|NCT02166333|12444568|FG005|STARTED|Stage 2||63
11250880|NCT02166333|12444563|FG000|COMPLETED|Stage 2||35
11250881|NCT02166333|12444564|FG001|COMPLETED|Stage 2||71
11250882|NCT02166333|12444565|FG002|COMPLETED|Stage 2||47
11250883|NCT02166333|12444566|FG003|COMPLETED|Stage 2||73
11250884|NCT02166333|12444567|FG004|COMPLETED|Stage 2||2
11250885|NCT02166333|12444568|FG005|COMPLETED|Stage 2||4
11250886|NCT02166333|12444563|FG000|NOT COMPLETED|Stage 2||207
11250887|NCT02166333|12444564|FG001|NOT COMPLETED|Stage 2||6
11250888|NCT02166333|12444565|FG002|NOT COMPLETED|Stage 2||75
11250889|NCT02166333|12444566|FG003|NOT COMPLETED|Stage 2||9
11250890|NCT02166333|12444567|FG004|NOT COMPLETED|Stage 2||57
11250891|NCT02166333|12444568|FG005|NOT COMPLETED|Stage 2||59
11250892|NCT02166346|12444580|FG000|STARTED|Screening and Randomization||12
11250893|NCT02166346|12444581|FG001|STARTED|Screening and Randomization||12
11250894|NCT02166346|12444580|FG000|COMPLETED|Screening and Randomization||8
11250895|NCT02166346|12444581|FG001|COMPLETED|Screening and Randomization||8
11250896|NCT02166346|12444580|FG000|NOT COMPLETED|Screening and Randomization||4
11250897|NCT02166346|12444581|FG001|NOT COMPLETED|Screening and Randomization||4
11250898|NCT02166346|12444580|FG000|STARTED|Intervention - Phase 1||8
11250899|NCT02166346|12444581|FG001|STARTED|Intervention - Phase 1||8
11250900|NCT02166346|12444580|FG000|COMPLETED|Intervention - Phase 1||8
11250901|NCT02166346|12444581|FG001|COMPLETED|Intervention - Phase 1||6
11250902|NCT02166346|12444580|FG000|NOT COMPLETED|Intervention - Phase 1||0
11250903|NCT02166346|12444581|FG001|NOT COMPLETED|Intervention - Phase 1||2
11250904|NCT02166346|12444580|FG000|STARTED|Intervention - Phase 2 (After Crossover)||8
11250905|NCT02166346|12444581|FG001|STARTED|Intervention - Phase 2 (After Crossover)||6
11250906|NCT02166346|12444580|FG000|COMPLETED|Intervention - Phase 2 (After Crossover)||7
11250907|NCT02166346|12444581|FG001|COMPLETED|Intervention - Phase 2 (After Crossover)||6
11250908|NCT02166346|12444580|FG000|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
11250909|NCT02166346|12444581|FG001|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
11250910|NCT02166476|12444589|FG000|STARTED|Overall Study||272
11250911|NCT02166476|12444590|FG001|STARTED|Overall Study||273
11250912|NCT02166476|12444589|FG000|Received at Least 1 Dose of Study Drug|Overall Study||272
11250913|NCT02166476|12444590|FG001|Received at Least 1 Dose of Study Drug|Overall Study||273
11250914|NCT02166476|12444589|FG000|COMPLETED|Overall Study||258
11250915|NCT02166476|12444590|FG001|COMPLETED|Overall Study||250
11250916|NCT02166476|12444589|FG000|NOT COMPLETED|Overall Study||14
11250917|NCT02166476|12444590|FG001|NOT COMPLETED|Overall Study||23
11250918|NCT02166606|12444599|FG000|STARTED|Overall Study||1184
11250919|NCT02166606|12444599|FG000|Actively Enrolled|Overall Study||1180
11250920|NCT02166606|12444599|FG000|Consent Eligible|Overall Study||1174
11250921|NCT02166606|12444599|FG000|COMPLETED|Overall Study||1106
11250922|NCT02166606|12444599|FG000|NOT COMPLETED|Overall Study||78
11250923|NCT02166697|12444603|FG000|STARTED|Overall Study||14151
11250924|NCT02166697|12444603|FG000|COMPLETED|Overall Study||13804
11250925|NCT02166697|12444603|FG000|NOT COMPLETED|Overall Study||347
11250926|NCT02167035|12444609|FG000|STARTED|Overall Study||21
11250927|NCT02167035|12444610|FG001|STARTED|Overall Study||22
11250928|NCT02167035|12444609|FG000|COMPLETED|Overall Study||16
11250929|NCT02167035|12444610|FG001|COMPLETED|Overall Study||16
11250930|NCT02167035|12444609|FG000|NOT COMPLETED|Overall Study||5
11250931|NCT02167035|12444610|FG001|NOT COMPLETED|Overall Study||6
11250932|NCT02167074|12444620|FG000|STARTED|Overall Study||306
11250933|NCT02167074|12444621|FG001|STARTED|Overall Study||302
11250934|NCT02167074|12444620|FG000|COMPLETED|Overall Study||306
11250935|NCT02167074|12444621|FG001|COMPLETED|Overall Study||302
11250936|NCT02167074|12444620|FG000|NOT COMPLETED|Overall Study||0
11250937|NCT02167074|12444621|FG001|NOT COMPLETED|Overall Study||0
11250938|NCT02167139|12444629|FG000|STARTED|Randomised, Double-blind||271
11250939|NCT02167139|12444630|FG001|STARTED|Randomised, Double-blind||273
11250940|NCT02167139|12444631|FG002|STARTED|Randomised, Double-blind||0
11250941|NCT02167139|12444632|FG003|STARTED|Randomised, Double-blind||0
11250942|NCT02167139|12444629|FG000|COMPLETED|Randomised, Double-blind||254
11250943|NCT02167139|12444630|FG001|COMPLETED|Randomised, Double-blind||254
11250944|NCT02167139|12444631|FG002|COMPLETED|Randomised, Double-blind||0
11250945|NCT02167139|12444632|FG003|COMPLETED|Randomised, Double-blind||0
11358568|NCT03125941|12555697|FG000|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|1
11250946|NCT02167139|12444629|FG000|NOT COMPLETED|Randomised, Double-blind||17
11250947|NCT02167139|12444630|FG001|NOT COMPLETED|Randomised, Double-blind||19
11250948|NCT02167139|12444631|FG002|NOT COMPLETED|Randomised, Double-blind||0
11250949|NCT02167139|12444632|FG003|NOT COMPLETED|Randomised, Double-blind||0
11250950|NCT02167139|12444629|FG000|STARTED|Transition-extension||254
11250951|NCT02167139|12444630|FG001|STARTED|Transition-extension||0
11250952|NCT02167139|12444631|FG002|STARTED|Transition-extension||125
11250953|NCT02167139|12444632|FG003|STARTED|Transition-extension||129
11250954|NCT02167139|12444629|FG000|COMPLETED|Transition-extension||248
11250955|NCT02167139|12444630|FG001|COMPLETED|Transition-extension||0
11250956|NCT02167139|12444631|FG002|COMPLETED|Transition-extension||117
11250957|NCT02167139|12444632|FG003|COMPLETED|Transition-extension||124
11250958|NCT02167139|12444629|FG000|NOT COMPLETED|Transition-extension||6
11250959|NCT02167139|12444630|FG001|NOT COMPLETED|Transition-extension||0
11250960|NCT02167139|12444631|FG002|NOT COMPLETED|Transition-extension||8
11250961|NCT02167139|12444632|FG003|NOT COMPLETED|Transition-extension||5
11250962|NCT02167204|12444646|FG000|STARTED|Overall Study||9
11250963|NCT02167204|12444646|FG000|COMPLETED|Overall Study||9
11250964|NCT02167204|12444646|FG000|NOT COMPLETED|Overall Study||0
11250965|NCT02167217|12444656|FG000|STARTED|Overall Study||25
11250966|NCT02167217|12444656|FG000|COMPLETED|Overall Study||23
11250967|NCT02167217|12444656|FG000|NOT COMPLETED|Overall Study||2
11250968|NCT02167256|12444662|FG000|STARTED|Overall Study||79
11250969|NCT02167256|12444663|FG001|STARTED|Overall Study||80
11250970|NCT02167256|12444662|FG000|COMPLETED|Overall Study||58
11250971|NCT02167256|12444663|FG001|COMPLETED|Overall Study||70
11250972|NCT02167256|12444662|FG000|NOT COMPLETED|Overall Study||21
11250973|NCT02167256|12444663|FG001|NOT COMPLETED|Overall Study||10
11250974|NCT02167451|12444669|FG000|STARTED|Overall Study||31
11250975|NCT02167451|12444669|FG000|COMPLETED|Overall Study||30
11250976|NCT02167451|12444669|FG000|NOT COMPLETED|Overall Study||1
11250977|NCT02167594|12444676|FG000|STARTED|Overall Study||20
11250978|NCT02167594|12444677|FG001|STARTED|Overall Study||6
11250979|NCT02167594|12444678|FG002|STARTED|Overall Study||3
11250980|NCT02167594|12444676|FG000|COMPLETED|Overall Study||18
11250981|NCT02167594|12444677|FG001|COMPLETED|Overall Study||5
11250982|NCT02167594|12444678|FG002|COMPLETED|Overall Study||3
11250983|NCT02167594|12444676|FG000|NOT COMPLETED|Overall Study||2
11250984|NCT02167594|12444677|FG001|NOT COMPLETED|Overall Study||1
11250985|NCT02167594|12444678|FG002|NOT COMPLETED|Overall Study||0
11005435|NCT00723021|12183141|FG000|STARTED|Intervention Period 2||3
11005436|NCT00723021|12183142|FG001|STARTED|Intervention Period 2||3
11005437|NCT00723021|12183143|FG002|STARTED|Intervention Period 2||3
11005438|NCT00723021|12183144|FG003|STARTED|Intervention Period 2||3
11005439|NCT00723021|12183145|FG004|STARTED|Intervention Period 2||3
11005440|NCT00723021|12183141|FG000|COMPLETED|Intervention Period 2||3
11005441|NCT00723021|12183142|FG001|COMPLETED|Intervention Period 2||3
11005442|NCT00723021|12183143|FG002|COMPLETED|Intervention Period 2||3
11005443|NCT00723021|12183144|FG003|COMPLETED|Intervention Period 2||3
11250986|NCT02167815|12444689|FG000|STARTED|Overall Study||9
11250987|NCT02167815|12444690|FG001|STARTED|Overall Study||21
11250988|NCT02167815|12444689|FG000|COMPLETED|Overall Study||9
11250989|NCT02167815|12444690|FG001|COMPLETED|Overall Study||21
11250990|NCT02167815|12444689|FG000|NOT COMPLETED|Overall Study||0
11250991|NCT02167815|12444690|FG001|NOT COMPLETED|Overall Study||0
11358569|NCT03125941|12555698|FG001|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|2
11358570|NCT03125941|12555697|FG000|COMPLETED|Overall Study||64
11358571|NCT03125941|12555698|FG001|COMPLETED|Overall Study||63
11358572|NCT03125941|12555697|FG000|NOT COMPLETED|Overall Study||1
11358573|NCT03125941|12555698|FG001|NOT COMPLETED|Overall Study||2
11358574|NCT03126227|12555706|FG000|STARTED|Overall Study||338
11358575|NCT03126227|12555707|FG001|STARTED|Overall Study||168
11358576|NCT03126227|12555706|FG000|COMPLETED|Overall Study||260
11358577|NCT03126227|12555707|FG001|COMPLETED|Overall Study||158
11358578|NCT03126227|12555706|FG000|NOT COMPLETED|Overall Study||78
11358579|NCT03126227|12555707|FG001|NOT COMPLETED|Overall Study||10
11358580|NCT03126344|12555716|FG000|STARTED|Overall Study||33
11358581|NCT03126344|12555717|FG001|STARTED|Overall Study||33
11358582|NCT03126344|12555718|FG002|STARTED|Overall Study||33
11358583|NCT03126344|12555716|FG000|COMPLETED|Overall Study||33
11358584|NCT03126344|12555717|FG001|COMPLETED|Overall Study||33
11358585|NCT03126344|12555718|FG002|COMPLETED|Overall Study||28
11358586|NCT03126344|12555716|FG000|NOT COMPLETED|Overall Study||0
11358587|NCT03126344|12555717|FG001|NOT COMPLETED|Overall Study||0
11358588|NCT03126344|12555718|FG002|NOT COMPLETED|Overall Study||5
11358589|NCT03126370|12555726|FG000|STARTED|TDF With a Boosted PI||10
11358590|NCT03126370|12555726|FG000|COMPLETED|TDF With a Boosted PI||10
11358591|NCT03126370|12555726|FG000|NOT COMPLETED|TDF With a Boosted PI||0
11358592|NCT03126370|12555726|FG000|STARTED|TAF With a Boosted PI||10
11358593|NCT03126370|12555726|FG000|COMPLETED|TAF With a Boosted PI||10
11358594|NCT03126370|12555726|FG000|NOT COMPLETED|TAF With a Boosted PI||0
11358595|NCT03126370|12555726|FG000|STARTED|TAF With a Boosted PI and LDV/SOF||10
11358596|NCT03126370|12555726|FG000|COMPLETED|TAF With a Boosted PI and LDV/SOF||10
11358597|NCT03126370|12555726|FG000|NOT COMPLETED|TAF With a Boosted PI and LDV/SOF||0
11358598|NCT03126370|12555726|FG000|STARTED|TAF With a Boosted PI||10
11250992|NCT02167867|12444700|FG000|STARTED|Overall Study||22
11250993|NCT02167867|12444701|FG001|STARTED|Overall Study||22
11250994|NCT02167867|12444700|FG000|COMPLETED|Overall Study||22
11250995|NCT02167867|12444701|FG001|COMPLETED|Overall Study||22
11250996|NCT02167867|12444700|FG000|NOT COMPLETED|Overall Study||0
11250997|NCT02167867|12444701|FG001|NOT COMPLETED|Overall Study||0
11250998|NCT02167893|12444706|FG000|STARTED|Overall Study||11288
11250999|NCT02167893|12444706|FG000|COMPLETED|Overall Study||11125
11251000|NCT02167893|12444706|FG000|NOT COMPLETED|Overall Study||163
11251001|NCT02168062|12444713|FG000|STARTED|Overall Study||23
11251002|NCT02168062|12444714|FG001|STARTED|Overall Study||26
11251003|NCT02168062|12444715|FG002|STARTED|Overall Study||8
11251004|NCT02168062|12444713|FG000|COMPLETED|Overall Study||23
11251005|NCT02168062|12444714|FG001|COMPLETED|Overall Study||26
11251006|NCT02168062|12444715|FG002|COMPLETED|Overall Study||8
11251007|NCT02168062|12444713|FG000|NOT COMPLETED|Overall Study||0
11251008|NCT02168062|12444714|FG001|NOT COMPLETED|Overall Study||0
11251009|NCT02168062|12444715|FG002|NOT COMPLETED|Overall Study||0
11251010|NCT02168101|12444728|FG000|STARTED|Overall Study||3
11251011|NCT02168101|12444729|FG001|STARTED|Overall Study||3
11251012|NCT02168101|12444730|FG002|STARTED|Overall Study||3
11251013|NCT02168101|12444728|FG000|COMPLETED|Overall Study||1
11251014|NCT02168101|12444729|FG001|COMPLETED|Overall Study||1
11251015|NCT02168101|12444730|FG002|COMPLETED|Overall Study||2
11251016|NCT02168101|12444728|FG000|NOT COMPLETED|Overall Study||2
11251017|NCT02168101|12444729|FG001|NOT COMPLETED|Overall Study||2
11251018|NCT02168101|12444730|FG002|NOT COMPLETED|Overall Study||1
11251019|NCT02168153|12444741|FG000|STARTED|Overall Study||60
11251020|NCT02168153|12444742|FG001|STARTED|Overall Study||60
11251021|NCT02168153|12444741|FG000|COMPLETED|Overall Study||57
11251022|NCT02168153|12444742|FG001|COMPLETED|Overall Study||60
11251023|NCT02168153|12444741|FG000|NOT COMPLETED|Overall Study||3
11251024|NCT02168153|12444742|FG001|NOT COMPLETED|Overall Study||0
11251025|NCT02168309|12444750|FG000|STARTED|Overall Study||25
11251026|NCT02168309|12444751|FG001|STARTED|Overall Study||25
11251027|NCT02168309|12444750|FG000|COMPLETED|Overall Study||25
11251028|NCT02168309|12444751|FG001|COMPLETED|Overall Study||25
11251029|NCT02168309|12444750|FG000|NOT COMPLETED|Overall Study||0
11251030|NCT02168309|12444751|FG001|NOT COMPLETED|Overall Study||0
11251031|NCT02168361|12444759|FG000|STARTED|Overall Study||62
11251032|NCT02168361|12444760|FG001|STARTED|Overall Study||31
11251033|NCT02168361|12444759|FG000|COMPLETED|Overall Study||57
11251034|NCT02168361|12444760|FG001|COMPLETED|Overall Study||21
11251035|NCT02168361|12444759|FG000|NOT COMPLETED|Overall Study||5
11251036|NCT02168361|12444760|FG001|NOT COMPLETED|Overall Study||10
11251037|NCT02168387|12444768|FG000|STARTED|Overall Study||20
11251038|NCT02168387|12444769|FG001|STARTED|Overall Study||19
11251039|NCT02168387|12444768|FG000|COMPLETED|Overall Study||13
11251040|NCT02168387|12444769|FG001|COMPLETED|Overall Study||16
11251041|NCT02168387|12444768|FG000|NOT COMPLETED|Overall Study||7
11251042|NCT02168387|12444769|FG001|NOT COMPLETED|Overall Study||3
11251043|NCT02168439|12444777|FG000|STARTED|Overall Study||20
11251044|NCT02168439|12444778|FG001|STARTED|Overall Study||20
11251045|NCT02168439|12444777|FG000|COMPLETED|Overall Study||20
11251046|NCT02168439|12444778|FG001|COMPLETED|Overall Study||18
11251047|NCT02168439|12444777|FG000|NOT COMPLETED|Overall Study||0
11251048|NCT02168439|12444778|FG001|NOT COMPLETED|Overall Study||2
11251049|NCT02168478|12444784|FG000|STARTED|Overall Study||206
11251050|NCT02168478|12444784|FG000|COMPLETED|Overall Study||202
11251051|NCT02168478|12444784|FG000|NOT COMPLETED|Overall Study||4
11251052|NCT02168491|12444788|FG000|STARTED|Overall Study||9
11251053|NCT02168491|12444788|FG000|COMPLETED|Overall Study||8
11251054|NCT02168491|12444788|FG000|NOT COMPLETED|Overall Study||1
11251055|NCT02168660|12444795|FG000|STARTED|Overall Study||38
11251056|NCT02168660|12444796|FG001|STARTED|Overall Study||35
11251057|NCT02168660|12444797|FG002|STARTED|Overall Study||36
11251058|NCT02168660|12444795|FG000|COMPLETED|Overall Study||22
11251059|NCT02168660|12444796|FG001|COMPLETED|Overall Study||18
11251060|NCT02168660|12444797|FG002|COMPLETED|Overall Study||21
11251061|NCT02168660|12444795|FG000|NOT COMPLETED|Overall Study||16
11251062|NCT02168660|12444796|FG001|NOT COMPLETED|Overall Study||17
11251063|NCT02168660|12444797|FG002|NOT COMPLETED|Overall Study||15
11251064|NCT02168777|12444811|FG000|STARTED|Overall Study||2
11251065|NCT02168777|12444812|FG001|STARTED|Overall Study||7
11251066|NCT02168777|12444813|FG002|STARTED|Overall Study||11
11251067|NCT02168777|12444811|FG000|COMPLETED|Overall Study||0
11251068|NCT02168777|12444812|FG001|COMPLETED|Overall Study||0
11251069|NCT02168777|12444813|FG002|COMPLETED|Overall Study||0
11251070|NCT02168777|12444811|FG000|NOT COMPLETED|Overall Study||2
11251071|NCT02168777|12444812|FG001|NOT COMPLETED|Overall Study||7
11251072|NCT02168777|12444813|FG002|NOT COMPLETED|Overall Study||11
11251073|NCT02168803|12444827|FG000|STARTED|Overall Study||30
11251074|NCT02168803|12444828|FG001|STARTED|Overall Study||32
11251075|NCT02168803|12444829|FG002|STARTED|Overall Study||39
11251076|NCT02168803|12444827|FG000|Received at Least 1 Dose of Study Drug|Overall Study||30
11251077|NCT02168803|12444828|FG001|Received at Least 1 Dose of Study Drug|Overall Study||32
11251078|NCT02168803|12444829|FG002|Received at Least 1 Dose of Study Drug|Overall Study||39
11251079|NCT02168803|12444827|FG000|COMPLETED|Overall Study||28
11251080|NCT02168803|12444828|FG001|COMPLETED|Overall Study||29
11251081|NCT02168803|12444829|FG002|COMPLETED|Overall Study||33
11251082|NCT02168803|12444827|FG000|NOT COMPLETED|Overall Study||2
11251083|NCT02168803|12444828|FG001|NOT COMPLETED|Overall Study||3
11251084|NCT02168803|12444829|FG002|NOT COMPLETED|Overall Study||6
11251085|NCT02168816|12444846|FG000|STARTED|Overall Study||5
11251086|NCT02168816|12444847|FG001|STARTED|Overall Study||7
11251087|NCT02168816|12444846|FG000|COMPLETED|Overall Study||3
11251088|NCT02168816|12444847|FG001|COMPLETED|Overall Study||5
11251089|NCT02168816|12444846|FG000|NOT COMPLETED|Overall Study||2
11251090|NCT02168816|12444847|FG001|NOT COMPLETED|Overall Study||2
11251091|NCT02168842|12444855|FG000|STARTED|Overall Study||170
11251092|NCT02168842|12444856|FG001|STARTED|Overall Study||166
11251093|NCT02168842|12444855|FG000|COMPLETED|Overall Study||162
11251094|NCT02168842|12444856|FG001|COMPLETED|Overall Study||158
11251095|NCT02168842|12444855|FG000|NOT COMPLETED|Overall Study||8
11251096|NCT02168842|12444856|FG001|NOT COMPLETED|Overall Study||8
11251097|NCT02168855|12444866|FG000|STARTED|Overall Study||181
11251098|NCT02168855|12444867|FG001|STARTED|Overall Study||188
11251099|NCT02168855|12444866|FG000|COMPLETED|Overall Study||169
11251100|NCT02168855|12444867|FG001|COMPLETED|Overall Study||177
11251101|NCT02168855|12444866|FG000|NOT COMPLETED|Overall Study||12
11251102|NCT02168855|12444867|FG001|NOT COMPLETED|Overall Study||11
11251103|NCT02168933|12444875|FG000|STARTED|Overall Study||8
11251104|NCT02168933|12444875|FG000|COMPLETED|Overall Study||7
11251105|NCT02168933|12444875|FG000|NOT COMPLETED|Overall Study||1
11251106|NCT02168946|12444885|FG000|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
11251107|NCT02168946|12444886|FG001|STARTED|Overall Study||25
11251108|NCT02168946|12444885|FG000|COMPLETED|Overall Study||38
11251109|NCT02168946|12444886|FG001|COMPLETED|Overall Study||20
11251110|NCT02168946|12444885|FG000|NOT COMPLETED|Overall Study||12
11251111|NCT02168946|12444886|FG001|NOT COMPLETED|Overall Study||5
11251112|NCT02169115|12444895|FG000|STARTED|Overall Study||19
11251113|NCT02169115|12444896|FG001|STARTED|Overall Study||21
11251114|NCT02169115|12444897|FG002|STARTED|Overall Study||21
11251115|NCT02169115|12444895|FG000|COMPLETED|Overall Study||19
11251116|NCT02169115|12444896|FG001|COMPLETED|Overall Study||21
11251117|NCT02169115|12444897|FG002|COMPLETED|Overall Study||21
11251118|NCT02169115|12444895|FG000|NOT COMPLETED|Overall Study||0
11251119|NCT02169115|12444896|FG001|NOT COMPLETED|Overall Study||0
11251120|NCT02169115|12444897|FG002|NOT COMPLETED|Overall Study||0
11251121|NCT02169219|12444906|FG000|STARTED|Overall Study||20
11251122|NCT02169219|12444906|FG000|COMPLETED|Overall Study||14
11251123|NCT02169219|12444906|FG000|NOT COMPLETED|Overall Study||6
11251124|NCT02169271|12444917|FG000|STARTED|Overall Study||49
11251125|NCT02169271|12444918|FG001|STARTED|Overall Study||49
11251126|NCT02169271|12444917|FG000|COMPLETED|Overall Study||48
11251127|NCT02169271|12444918|FG001|COMPLETED|Overall Study||47
11251128|NCT02169271|12444917|FG000|NOT COMPLETED|Overall Study||1
11251129|NCT02169271|12444918|FG001|NOT COMPLETED|Overall Study||2
11251130|NCT02169284|12444926|FG000|STARTED|Overall Study||24
11251131|NCT02169284|12444927|FG001|STARTED|Overall Study||13
11251132|NCT02169284|12444926|FG000|COMPLETED|Overall Study||24
11251133|NCT02169284|12444927|FG001|COMPLETED|Overall Study||12
11251134|NCT02169284|12444926|FG000|NOT COMPLETED|Overall Study||0
11251135|NCT02169284|12444927|FG001|NOT COMPLETED|Overall Study||1
11251136|NCT02169336|12444938|FG000|STARTED|Overall Study||31
11251137|NCT02169336|12444939|FG001|STARTED|Overall Study||32
11251138|NCT02169336|12444940|FG002|STARTED|Overall Study||32
11251139|NCT02169336|12444938|FG000|COMPLETED|Overall Study||27
11251140|NCT02169336|12444939|FG001|COMPLETED|Overall Study||28
11251141|NCT02169336|12444940|FG002|COMPLETED|Overall Study||29
11251142|NCT02169336|12444938|FG000|NOT COMPLETED|Overall Study||4
11251143|NCT02169336|12444939|FG001|NOT COMPLETED|Overall Study||4
11251144|NCT02169336|12444940|FG002|NOT COMPLETED|Overall Study||3
11251145|NCT02169414|12444952|FG000|STARTED|Overall Study||19
11251146|NCT02169414|12444953|FG001|STARTED|Overall Study||19
11251147|NCT02169414|12444954|FG002|STARTED|Overall Study||18
11251148|NCT02169414|12444955|FG003|STARTED|Overall Study||18
11251149|NCT02169414|12444952|FG000|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
11251150|NCT02169414|12444953|FG001|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
11251151|NCT02169414|12444954|FG002|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
11251152|NCT02169414|12444955|FG003|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
11251153|NCT02169414|12444952|FG000|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
11251154|NCT02169414|12444953|FG001|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
11251155|NCT02169414|12444954|FG002|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
11251156|NCT02169414|12444955|FG003|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
11251157|NCT02169414|12444952|FG000|COMPLETED|Overall Study||18
11251158|NCT02169414|12444953|FG001|COMPLETED|Overall Study||18
11251159|NCT02169414|12444954|FG002|COMPLETED|Overall Study||18
11251160|NCT02169414|12444955|FG003|COMPLETED|Overall Study||18
11251161|NCT02169414|12444952|FG000|NOT COMPLETED|Overall Study||1
11251162|NCT02169414|12444953|FG001|NOT COMPLETED|Overall Study||1
11251163|NCT02169414|12444954|FG002|NOT COMPLETED|Overall Study||0
11251164|NCT02169414|12444955|FG003|NOT COMPLETED|Overall Study||0
11251165|NCT02169427|12444969|FG000|STARTED|Overall Study||6
11251166|NCT02169427|12444969|FG000|COMPLETED|Overall Study||6
11251167|NCT02169427|12444969|FG000|NOT COMPLETED|Overall Study||0
11251168|NCT02169440|12444975|FG000|STARTED|Overall Study||10
11251169|NCT02169440|12444976|FG001|STARTED|Overall Study||10
11251170|NCT02169440|12444975|FG000|COMPLETED|Overall Study||10
11251171|NCT02169440|12444976|FG001|COMPLETED|Overall Study||10
11251172|NCT02169440|12444975|FG000|NOT COMPLETED|Overall Study||0
11251173|NCT02169440|12444976|FG001|NOT COMPLETED|Overall Study||0
11251174|NCT02169453|12444987|FG000|STARTED|Overall Study||3
11251175|NCT02169453|12444988|FG001|STARTED|Overall Study||3
11251176|NCT02169453|12444989|FG002|STARTED|Overall Study||3
11251177|NCT02169453|12444990|FG003|STARTED|Overall Study||3
11251178|NCT02169453|12444987|FG000|25 mg BIA 9-1067|Overall Study||3
11251179|NCT02169453|12444988|FG001|25 mg BIA 9-1067|Overall Study||3
11251180|NCT02169453|12444989|FG002|25 mg BIA 9-1067|Overall Study||3
11251181|NCT02169453|12444990|FG003|25 mg BIA 9-1067|Overall Study||3
11251182|NCT02169453|12444987|FG000|50 mg BIA 9-1067|Overall Study||3
11251183|NCT02169453|12444988|FG001|50 mg BIA 9-1067|Overall Study||3
11251184|NCT02169453|12444989|FG002|50 mg BIA 9-1067|Overall Study||2
11251185|NCT02169453|12444990|FG003|50 mg BIA 9-1067|Overall Study||3
11251186|NCT02169453|12444987|FG000|100 mg BIA 9-1067|Overall Study||3
11251187|NCT02169453|12444988|FG001|100 mg BIA 9-1067|Overall Study||3
11251188|NCT02169453|12444989|FG002|100 mg BIA 9-1067|Overall Study||3
11251189|NCT02169453|12444990|FG003|100 mg BIA 9-1067|Overall Study||3
11251190|NCT02169453|12444987|FG000|Placebo|Overall Study||3
11251191|NCT02169453|12444988|FG001|Placebo|Overall Study||3
11251192|NCT02169453|12444989|FG002|Placebo|Overall Study||3
11251193|NCT02169453|12444990|FG003|Placebo|Overall Study||3
11251194|NCT02169453|12444987|FG000|COMPLETED|Overall Study||3
11251195|NCT02169453|12444988|FG001|COMPLETED|Overall Study||3
11251196|NCT02169453|12444989|FG002|COMPLETED|Overall Study||2
11251197|NCT02169453|12444990|FG003|COMPLETED|Overall Study||3
11251198|NCT02169453|12444987|FG000|NOT COMPLETED|Overall Study||0
11251199|NCT02169453|12444988|FG001|NOT COMPLETED|Overall Study||0
11251200|NCT02169453|12444989|FG002|NOT COMPLETED|Overall Study||1
11251201|NCT02169453|12444990|FG003|NOT COMPLETED|Overall Study||0
11251202|NCT02169466|12445004|FG000|STARTED|Overall Study||6
11251203|NCT02169466|12445005|FG001|STARTED|Overall Study||6
11251204|NCT02169466|12445006|FG002|STARTED|Overall Study||5
11251205|NCT02169466|12445007|FG003|STARTED|Overall Study||5
11251206|NCT02169466|12445004|FG000|25 mg BIA 9-1067|Overall Study||6
11251207|NCT02169466|12445005|FG001|25 mg BIA 9-1067|Overall Study||5
11251208|NCT02169466|12445006|FG002|25 mg BIA 9-1067|Overall Study||5
11251209|NCT02169466|12445007|FG003|25 mg BIA 9-1067|Overall Study||5
11251210|NCT02169466|12445004|FG000|50 mg BIA 9-1067|Overall Study||6
11251211|NCT02169466|12445005|FG001|50 mg BIA 9-1067|Overall Study||6
11251212|NCT02169466|12445006|FG002|50 mg BIA 9-1067|Overall Study||5
11251213|NCT02169466|12445007|FG003|50 mg BIA 9-1067|Overall Study||5
11251214|NCT02169466|12445004|FG000|100 mg BIA 9-1067|Overall Study||6
11251215|NCT02169466|12445005|FG001|100 mg BIA 9-1067|Overall Study||6
11251216|NCT02169466|12445006|FG002|100 mg BIA 9-1067|Overall Study||5
11251217|NCT02169466|12445007|FG003|100 mg BIA 9-1067|Overall Study||5
11251218|NCT02169466|12445004|FG000|Placebo|Overall Study||5
11251219|NCT02169466|12445005|FG001|Placebo|Overall Study||6
11251220|NCT02169466|12445006|FG002|Placebo|Overall Study||5
11251221|NCT02169466|12445007|FG003|Placebo|Overall Study||5
11251222|NCT02169466|12445004|FG000|COMPLETED|Overall Study||5
11251223|NCT02169466|12445005|FG001|COMPLETED|Overall Study||5
11251224|NCT02169466|12445006|FG002|COMPLETED|Overall Study||5
11251225|NCT02169466|12445007|FG003|COMPLETED|Overall Study||5
11251226|NCT02169466|12445004|FG000|NOT COMPLETED|Overall Study||1
11251227|NCT02169466|12445005|FG001|NOT COMPLETED|Overall Study||1
11251228|NCT02169466|12445006|FG002|NOT COMPLETED|Overall Study||0
11251229|NCT02169466|12445007|FG003|NOT COMPLETED|Overall Study||0
11251230|NCT02169479|12445025|FG000|STARTED|Overall Study||4
11251231|NCT02169479|12445026|FG001|STARTED|Overall Study||4
11251232|NCT02169479|12445027|FG002|STARTED|Overall Study||4
11251233|NCT02169479|12445028|FG003|STARTED|Overall Study||4
11251234|NCT02169479|12445025|FG000|25 mg BIA 9-1067|Overall Study||4
11251235|NCT02169479|12445026|FG001|25 mg BIA 9-1067|Overall Study||3
11251236|NCT02169479|12445027|FG002|25 mg BIA 9-1067|Overall Study||4
11251237|NCT02169479|12445028|FG003|25 mg BIA 9-1067|Overall Study||4
11251238|NCT02169479|12445025|FG000|50 mg BIA 9-1067|Overall Study||4
11251239|NCT02169479|12445026|FG001|50 mg BIA 9-1067|Overall Study||4
11251240|NCT02169479|12445027|FG002|50 mg BIA 9-1067|Overall Study||4
11251241|NCT02169479|12445028|FG003|50 mg BIA 9-1067|Overall Study||4
11251242|NCT02169479|12445025|FG000|100 mg BIA 9-1067|Overall Study||3
11251243|NCT02169479|12445026|FG001|100 mg BIA 9-1067|Overall Study||4
11251244|NCT02169479|12445027|FG002|100 mg BIA 9-1067|Overall Study||4
11251245|NCT02169479|12445028|FG003|100 mg BIA 9-1067|Overall Study||4
11251246|NCT02169479|12445025|FG000|Placebo|Overall Study||3
11251247|NCT02169479|12445026|FG001|Placebo|Overall Study||3
11251248|NCT02169479|12445027|FG002|Placebo|Overall Study||4
11251249|NCT02169479|12445028|FG003|Placebo|Overall Study||4
11251250|NCT02169479|12445025|FG000|COMPLETED|Overall Study||3
11251251|NCT02169479|12445026|FG001|COMPLETED|Overall Study||3
11251252|NCT02169479|12445027|FG002|COMPLETED|Overall Study||4
11251253|NCT02169479|12445028|FG003|COMPLETED|Overall Study||4
11251254|NCT02169479|12445025|FG000|NOT COMPLETED|Overall Study||1
11251255|NCT02169479|12445026|FG001|NOT COMPLETED|Overall Study||1
11251256|NCT02169479|12445027|FG002|NOT COMPLETED|Overall Study||0
11251257|NCT02169479|12445028|FG003|NOT COMPLETED|Overall Study||0
11251258|NCT02169505|12445038|FG000|STARTED|Overall Study||2
11251259|NCT02169505|12445038|FG000|COMPLETED|Overall Study||1
11251260|NCT02169505|12445038|FG000|NOT COMPLETED|Overall Study||1
11251261|NCT02169674|12445044|FG000|STARTED|Overall Study||137
11251262|NCT02169674|12445045|FG001|STARTED|Overall Study||213
11251263|NCT02169674|12445044|FG000|COMPLETED|Overall Study||105
11251264|NCT02169674|12445045|FG001|COMPLETED|Overall Study||135
11251265|NCT02169674|12445044|FG000|NOT COMPLETED|Overall Study||32
11251266|NCT02169674|12445045|FG001|NOT COMPLETED|Overall Study||78
11251267|NCT02169739|12445053|FG000|STARTED|Overall Study||2
11251268|NCT02169739|12445054|FG001|STARTED|Overall Study||4
11251269|NCT02169739|12445053|FG000|COMPLETED|Overall Study||2
11251270|NCT02169739|12445054|FG001|COMPLETED|Overall Study||0
11251271|NCT02169739|12445053|FG000|NOT COMPLETED|Overall Study||0
11251272|NCT02169739|12445054|FG001|NOT COMPLETED|Overall Study||4
11251273|NCT02169791|12445061|FG000|STARTED|Overall Study||25
11251274|NCT02169791|12445061|FG000|COMPLETED|Overall Study||18
11251275|NCT02169791|12445061|FG000|NOT COMPLETED|Overall Study||7
11251276|NCT02169869|12445067|FG000|STARTED|Overall Study||17
11251277|NCT02169869|12445068|FG001|STARTED|Overall Study||16
11251278|NCT02169869|12445067|FG000|COMPLETED|Overall Study||17
11251279|NCT02169869|12445068|FG001|COMPLETED|Overall Study||16
11251280|NCT02169869|12445067|FG000|NOT COMPLETED|Overall Study||0
11251281|NCT02169869|12445068|FG001|NOT COMPLETED|Overall Study||0
11251282|NCT02169895|12445078|FG000|STARTED|Overall Study||4
11251283|NCT02169895|12445079|FG001|STARTED|Overall Study||4
11251284|NCT02169895|12445080|FG002|STARTED|Overall Study||4
11251285|NCT02169895|12445081|FG003|STARTED|Overall Study||4
11251286|NCT02169895|12445078|FG000|25 mg BIA 9-1067|Overall Study||4
11251287|NCT02169895|12445079|FG001|25 mg BIA 9-1067|Overall Study||4
11251288|NCT02169895|12445080|FG002|25 mg BIA 9-1067|Overall Study||4
11251289|NCT02169895|12445081|FG003|25 mg BIA 9-1067|Overall Study||4
11251290|NCT02169895|12445078|FG000|50 mg BIA 9-1067|Overall Study||4
11251291|NCT02169895|12445079|FG001|50 mg BIA 9-1067|Overall Study||4
11251292|NCT02169895|12445080|FG002|50 mg BIA 9-1067|Overall Study||4
11251293|NCT02169895|12445081|FG003|50 mg BIA 9-1067|Overall Study||4
11251294|NCT02169895|12445078|FG000|100 mg BIA 9-1067|Overall Study||4
11251295|NCT02169895|12445079|FG001|100 mg BIA 9-1067|Overall Study||4
11251296|NCT02169895|12445080|FG002|100 mg BIA 9-1067|Overall Study||4
11251297|NCT02169895|12445081|FG003|100 mg BIA 9-1067|Overall Study||2
11251298|NCT02169895|12445078|FG000|Placebo|Overall Study||4
11251299|NCT02169895|12445079|FG001|Placebo|Overall Study||4
11251300|NCT02169895|12445080|FG002|Placebo|Overall Study||4
11251301|NCT02169895|12445081|FG003|Placebo|Overall Study||4
11251302|NCT02169895|12445078|FG000|COMPLETED|Overall Study||4
11251303|NCT02169895|12445079|FG001|COMPLETED|Overall Study||4
11251304|NCT02169895|12445080|FG002|COMPLETED|Overall Study||4
11251305|NCT02169895|12445081|FG003|COMPLETED|Overall Study||2
11251306|NCT02169895|12445078|FG000|NOT COMPLETED|Overall Study||0
11251307|NCT02169895|12445079|FG001|NOT COMPLETED|Overall Study||0
11251308|NCT02169895|12445080|FG002|NOT COMPLETED|Overall Study||0
11251309|NCT02169895|12445081|FG003|NOT COMPLETED|Overall Study||2
11251310|NCT02170025|12445093|FG000|STARTED|Overall Study||14
11251311|NCT02170025|12445094|FG001|STARTED|Overall Study||7
11251312|NCT02170025|12445093|FG000|COMPLETED|Overall Study||12
11251313|NCT02170025|12445094|FG001|COMPLETED|Overall Study||7
11251314|NCT02170025|12445093|FG000|NOT COMPLETED|Overall Study||2
11251315|NCT02170025|12445094|FG001|NOT COMPLETED|Overall Study||0
11251316|NCT02170051|12445102|FG000|STARTED|Overall Study||26
11251317|NCT02170051|12445103|FG001|STARTED|Overall Study||29
11251318|NCT02170051|12445102|FG000|Tested at Mid-point|Overall Study||13
11251319|NCT02170051|12445103|FG001|Tested at Mid-point|Overall Study||18
11251320|NCT02170051|12445102|FG000|Tested at Post-treatment|Overall Study||15
11251321|NCT02170051|12445103|FG001|Tested at Post-treatment|Overall Study||16
11251322|NCT02170051|12445102|FG000|COMPLETED|Overall Study||15
11251323|NCT02170051|12445103|FG001|COMPLETED|Overall Study||16
11251324|NCT02170051|12445102|FG000|NOT COMPLETED|Overall Study||11
11251325|NCT02170051|12445103|FG001|NOT COMPLETED|Overall Study||13
11251326|NCT02170064|12445112|FG000|STARTED|Overall Study||15
11251327|NCT02170064|12445113|FG001|STARTED|Overall Study||9
11251328|NCT02170064|12445114|FG002|STARTED|Overall Study||11
11251329|NCT02170064|12445112|FG000|Safety Population (SP)|Overall Study||12
11251330|NCT02170064|12445113|FG001|Safety Population (SP)|Overall Study||8
11251331|NCT02170064|12445114|FG002|Safety Population (SP)|Overall Study||11
11251332|NCT02170064|12445112|FG000|Pharmacokinetic Population (PKP)|Overall Study||11
11251333|NCT02170064|12445113|FG001|Pharmacokinetic Population (PKP)|Overall Study||8
11251334|NCT02170064|12445114|FG002|Pharmacokinetic Population (PKP)|Overall Study||10
11251335|NCT02170064|12445112|FG000|Efficacy Population (EP)|Overall Study||11
11251336|NCT02170064|12445113|FG001|Efficacy Population (EP)|Overall Study||8
11251337|NCT02170064|12445114|FG002|Efficacy Population (EP)|Overall Study||10
11251338|NCT02170064|12445112|FG000|COMPLETED|Overall Study||9
11251339|NCT02170064|12445113|FG001|COMPLETED|Overall Study||7
11251340|NCT02170064|12445114|FG002|COMPLETED|Overall Study||10
11251341|NCT02170064|12445112|FG000|NOT COMPLETED|Overall Study||6
11251342|NCT02170064|12445113|FG001|NOT COMPLETED|Overall Study||2
11251343|NCT02170064|12445114|FG002|NOT COMPLETED|Overall Study||1
11251344|NCT02170077|12445125|FG000|STARTED|Overall Study||50
11251345|NCT02170077|12445126|FG001|STARTED|Overall Study||47
11251346|NCT02170077|12445127|FG002|STARTED|Overall Study||47
11251347|NCT02170077|12445125|FG000|Intent to Treat (ITT) Population|Overall Study||50
11251348|NCT02170077|12445126|FG001|Intent to Treat (ITT) Population|Overall Study||46
11251349|NCT02170077|12445127|FG002|Intent to Treat (ITT) Population|Overall Study||47
11251350|NCT02170077|12445125|FG000|COMPLETED|Overall Study||41
11251351|NCT02170077|12445126|FG001|COMPLETED|Overall Study||34
11251352|NCT02170077|12445127|FG002|COMPLETED|Overall Study||35
11251353|NCT02170077|12445125|FG000|NOT COMPLETED|Overall Study||9
11251354|NCT02170077|12445126|FG001|NOT COMPLETED|Overall Study||13
11251355|NCT02170077|12445127|FG002|NOT COMPLETED|Overall Study||12
11251356|NCT02170207|12445135|FG000|STARTED|Overall Study||63
11251357|NCT02170207|12445135|FG000|COMPLETED|Overall Study||58
11251358|NCT02170207|12445135|FG000|NOT COMPLETED|Overall Study||5
11251359|NCT02170220|12445141|FG000|STARTED|Overall Study||6
11251360|NCT02170220|12445142|FG001|STARTED|Overall Study||6
11251361|NCT02170220|12445141|FG000|COMPLETED|Overall Study||6
11251362|NCT02170220|12445142|FG001|COMPLETED|Overall Study||6
11251363|NCT02170220|12445141|FG000|NOT COMPLETED|Overall Study||0
11251364|NCT02170220|12445142|FG001|NOT COMPLETED|Overall Study||0
11251365|NCT02170376|12445153|FG000|STARTED|Overall Study||16
11251366|NCT02170376|12445154|FG001|STARTED|Overall Study||16
11251367|NCT02170376|12445155|FG002|STARTED|Overall Study||16
11251368|NCT02170376|12445156|FG003|STARTED|Overall Study||16
11251369|NCT02170376|12445157|FG004|STARTED|Overall Study||16
11251370|NCT02170376|12445153|FG000|Pharmacokinetic Population|Overall Study||16
11251371|NCT02170376|12445154|FG001|Pharmacokinetic Population|Overall Study||15
11251372|NCT02170376|12445155|FG002|Pharmacokinetic Population|Overall Study||16
11005444|NCT00723021|12183145|FG004|COMPLETED|Intervention Period 2||3
11005445|NCT00723021|12183141|FG000|NOT COMPLETED|Intervention Period 2||0
11251373|NCT02170376|12445156|FG003|Pharmacokinetic Population|Overall Study||16
11251374|NCT02170376|12445157|FG004|Pharmacokinetic Population|Overall Study||16
11251375|NCT02170376|12445153|FG000|COMPLETED|Overall Study||16
11251376|NCT02170376|12445154|FG001|COMPLETED|Overall Study||15
11251377|NCT02170376|12445155|FG002|COMPLETED|Overall Study||16
11251378|NCT02170376|12445156|FG003|COMPLETED|Overall Study||16
11251379|NCT02170376|12445157|FG004|COMPLETED|Overall Study||16
11251380|NCT02170376|12445153|FG000|NOT COMPLETED|Overall Study||0
11251381|NCT02170376|12445154|FG001|NOT COMPLETED|Overall Study||1
11251382|NCT02170376|12445155|FG002|NOT COMPLETED|Overall Study||0
11251383|NCT02170376|12445156|FG003|NOT COMPLETED|Overall Study||0
11251384|NCT02170376|12445157|FG004|NOT COMPLETED|Overall Study||0
11251385|NCT02170389|12445169|FG000|STARTED|Overall Study||5
11251386|NCT02170389|12445169|FG000|COMPLETED|Overall Study||4
11251387|NCT02170389|12445169|FG000|NOT COMPLETED|Overall Study||1
11251388|NCT02170519|12445175|FG000|STARTED|Overall Study||22
11251389|NCT02170519|12445176|FG001|STARTED|Overall Study||5
11251390|NCT02170519|12445175|FG000|COMPLETED|Overall Study||22
11251391|NCT02170519|12445176|FG001|COMPLETED|Overall Study||5
11251392|NCT02170519|12445175|FG000|NOT COMPLETED|Overall Study||0
11251393|NCT02170519|12445176|FG001|NOT COMPLETED|Overall Study||0
11251394|NCT02170532|12445183|FG000|STARTED|Overall Study||10
11251395|NCT02170532|12445183|FG000|COMPLETED|Overall Study||10
11251396|NCT02170532|12445183|FG000|NOT COMPLETED|Overall Study||0
11251397|NCT02170649|12445194|FG000|STARTED|Fasting Period||12
11251398|NCT02170649|12445194|FG000|COMPLETED|Fasting Period||12
11251399|NCT02170649|12445194|FG000|NOT COMPLETED|Fasting Period||0
11251400|NCT02170649|12445194|FG000|STARTED|Fed Period||12
11251401|NCT02170649|12445194|FG000|COMPLETED|Fed Period||12
11251402|NCT02170649|12445194|FG000|NOT COMPLETED|Fed Period||0
11251403|NCT02170662|12445200|FG000|STARTED|Overall Study||3
11251404|NCT02170662|12445201|FG001|STARTED|Overall Study||6
11251405|NCT02170662|12445200|FG000|COMPLETED|Overall Study||3
11251406|NCT02170662|12445201|FG001|COMPLETED|Overall Study||6
11251407|NCT02170662|12445200|FG000|NOT COMPLETED|Overall Study||0
11251408|NCT02170662|12445201|FG001|NOT COMPLETED|Overall Study||0
11251409|NCT02170688|12445212|FG000|STARTED|Overall Study||29
11251410|NCT02170688|12445213|FG001|STARTED|Overall Study||29
11251411|NCT02170688|12445214|FG002|STARTED|Overall Study||29
11251412|NCT02170688|12445215|FG003|STARTED|Overall Study||27
11251413|NCT02170688|12445216|FG004|STARTED|Overall Study||25
11251414|NCT02170688|12445212|FG000|COMPLETED|Overall Study||25
11251415|NCT02170688|12445213|FG001|COMPLETED|Overall Study||26
11251416|NCT02170688|12445214|FG002|COMPLETED|Overall Study||25
11251417|NCT02170688|12445215|FG003|COMPLETED|Overall Study||25
11251418|NCT02170688|12445216|FG004|COMPLETED|Overall Study||25
11251419|NCT02170688|12445212|FG000|NOT COMPLETED|Overall Study||4
11251420|NCT02170688|12445213|FG001|NOT COMPLETED|Overall Study||3
11251421|NCT02170688|12445214|FG002|NOT COMPLETED|Overall Study||4
11251422|NCT02170688|12445215|FG003|NOT COMPLETED|Overall Study||2
11251423|NCT02170688|12445216|FG004|NOT COMPLETED|Overall Study||0
11251424|NCT02170727|12445230|FG000|STARTED|Overall Study||138
11251425|NCT02170727|12445231|FG001|STARTED|Overall Study||31
11251426|NCT02170727|12445230|FG000|COMPLETED|Overall Study||135
11251427|NCT02170727|12445231|FG001|COMPLETED|Overall Study||31
11251428|NCT02170727|12445230|FG000|NOT COMPLETED|Overall Study||3
11251429|NCT02170727|12445231|FG001|NOT COMPLETED|Overall Study||0
11251430|NCT02170779|12445242|FG000|STARTED|Overall Study||20
11251431|NCT02170779|12445243|FG001|STARTED|Overall Study||20
11251432|NCT02170779|12445242|FG000|COMPLETED|Overall Study||19
11251433|NCT02170779|12445243|FG001|COMPLETED|Overall Study||19
11251434|NCT02170779|12445242|FG000|NOT COMPLETED|Overall Study||1
11251435|NCT02170779|12445243|FG001|NOT COMPLETED|Overall Study||1
11251436|NCT02170870|12445255|FG000|STARTED|Overall Study||13
11251437|NCT02170870|12445256|FG001|STARTED|Overall Study||11
11251438|NCT02170870|12445257|FG002|STARTED|Overall Study||20
11251439|NCT02170870|12445258|FG003|STARTED|Overall Study||20
11251440|NCT02170870|12445259|FG004|STARTED|Overall Study||20
11251441|NCT02170870|12445260|FG005|STARTED|Overall Study||20
11251442|NCT02170870|12445255|FG000|COMPLETED|Overall Study||13
11251443|NCT02170870|12445256|FG001|COMPLETED|Overall Study||11
11251444|NCT02170870|12445257|FG002|COMPLETED|Overall Study||20
11251445|NCT02170870|12445258|FG003|COMPLETED|Overall Study||20
11251446|NCT02170870|12445259|FG004|COMPLETED|Overall Study||20
11251447|NCT02170870|12445260|FG005|COMPLETED|Overall Study||20
11251448|NCT02170870|12445255|FG000|NOT COMPLETED|Overall Study||0
11251449|NCT02170870|12445256|FG001|NOT COMPLETED|Overall Study||0
11251450|NCT02170870|12445257|FG002|NOT COMPLETED|Overall Study||0
11251451|NCT02170870|12445258|FG003|NOT COMPLETED|Overall Study||0
11251452|NCT02170870|12445259|FG004|NOT COMPLETED|Overall Study||0
11251453|NCT02170870|12445260|FG005|NOT COMPLETED|Overall Study||0
11251454|NCT02171065|12445280|FG000|STARTED|Overall Study||89
11251455|NCT02171065|12445281|FG001|STARTED|Overall Study||93
11251456|NCT02171065|12445282|FG002|STARTED|Overall Study||716
11251457|NCT02171065|12445280|FG000|COMPLETED|Overall Study||88
11251458|NCT02171065|12445281|FG001|COMPLETED|Overall Study||93
11251459|NCT02171065|12445282|FG002|COMPLETED|Overall Study||715
11251460|NCT02171065|12445280|FG000|NOT COMPLETED|Overall Study||1
11251461|NCT02171065|12445281|FG001|NOT COMPLETED|Overall Study||0
11251462|NCT02171065|12445282|FG002|NOT COMPLETED|Overall Study||1
11251463|NCT02171130|12445292|FG000|STARTED|Overall Study||129
11251464|NCT02171130|12445292|FG000|Received at Least One Dose of Study Drug|Overall Study||87
11251465|NCT02171130|12445292|FG000|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87
11251466|NCT02171130|12445292|FG000|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101
11251467|NCT02171130|12445292|FG000|NOT COMPLETED|Overall Study||28
11251468|NCT02171195|12445305|FG000|STARTED|Overall Study||16
11251469|NCT02171195|12445306|FG001|STARTED|Overall Study||6
11251470|NCT02171195|12445307|FG002|STARTED|Overall Study||6
11251471|NCT02171195|12445308|FG003|STARTED|Overall Study||6
11251472|NCT02171195|12445309|FG004|STARTED|Overall Study||6
11251473|NCT02171195|12445310|FG005|STARTED|Overall Study||6
11251474|NCT02171195|12445311|FG006|STARTED|Overall Study||6
11251475|NCT02171195|12445312|FG007|STARTED|Overall Study||6
11251476|NCT02171195|12445313|FG008|STARTED|Overall Study||6
11251477|NCT02171195|12445305|FG000|COMPLETED|Overall Study||16
11251478|NCT02171195|12445306|FG001|COMPLETED|Overall Study||6
11251479|NCT02171195|12445307|FG002|COMPLETED|Overall Study||6
11251480|NCT02171195|12445308|FG003|COMPLETED|Overall Study||6
11251481|NCT02171195|12445309|FG004|COMPLETED|Overall Study||6
11251482|NCT02171195|12445310|FG005|COMPLETED|Overall Study||6
11251483|NCT02171195|12445311|FG006|COMPLETED|Overall Study||6
11251484|NCT02171195|12445312|FG007|COMPLETED|Overall Study||6
11251485|NCT02171195|12445313|FG008|COMPLETED|Overall Study||6
11251486|NCT02171195|12445305|FG000|NOT COMPLETED|Overall Study||0
11251487|NCT02171195|12445306|FG001|NOT COMPLETED|Overall Study||0
11251488|NCT02171195|12445307|FG002|NOT COMPLETED|Overall Study||0
11251489|NCT02171195|12445308|FG003|NOT COMPLETED|Overall Study||0
11251490|NCT02171195|12445309|FG004|NOT COMPLETED|Overall Study||0
11251491|NCT02171195|12445310|FG005|NOT COMPLETED|Overall Study||0
11251492|NCT02171195|12445311|FG006|NOT COMPLETED|Overall Study||0
11251493|NCT02171195|12445312|FG007|NOT COMPLETED|Overall Study||0
11251494|NCT02171195|12445313|FG008|NOT COMPLETED|Overall Study||0
11251495|NCT02171234|12445338|FG000|STARTED|Overall Study||8
11251496|NCT02171234|12445339|FG001|STARTED|Overall Study||6
11251497|NCT02171234|12445340|FG002|STARTED|Overall Study||6
11251498|NCT02171234|12445341|FG003|STARTED|Overall Study||6
11251499|NCT02171234|12445342|FG004|STARTED|Overall Study||6
11251500|NCT02171234|12445338|FG000|COMPLETED|Overall Study||8
11251501|NCT02171234|12445339|FG001|COMPLETED|Overall Study||6
11251502|NCT02171234|12445340|FG002|COMPLETED|Overall Study||6
11251503|NCT02171234|12445341|FG003|COMPLETED|Overall Study||6
11251504|NCT02171234|12445342|FG004|COMPLETED|Overall Study||6
11251505|NCT02171234|12445338|FG000|NOT COMPLETED|Overall Study||0
11251506|NCT02171234|12445339|FG001|NOT COMPLETED|Overall Study||0
11251507|NCT02171234|12445340|FG002|NOT COMPLETED|Overall Study||0
11251508|NCT02171234|12445341|FG003|NOT COMPLETED|Overall Study||0
11251509|NCT02171234|12445342|FG004|NOT COMPLETED|Overall Study||0
11251510|NCT02171247|12445356|FG000|STARTED|Overall Study||16
11251511|NCT02171247|12445357|FG001|STARTED|Overall Study||17
11251512|NCT02171247|12445356|FG000|COMPLETED|Overall Study||16
11251513|NCT02171247|12445357|FG001|COMPLETED|Overall Study||17
11251514|NCT02171247|12445356|FG000|NOT COMPLETED|Overall Study||0
11251515|NCT02171247|12445357|FG001|NOT COMPLETED|Overall Study||0
11251516|NCT02171260|12445367|FG000|STARTED|Overall Study||6
11251517|NCT02171260|12445368|FG001|STARTED|Overall Study||6
11251518|NCT02171260|12445369|FG002|STARTED|Overall Study||5
11251519|NCT02171260|12445370|FG003|STARTED|Overall Study||5
11251520|NCT02171260|12445367|FG000|COMPLETED|Overall Study||0
11251521|NCT02171260|12445368|FG001|COMPLETED|Overall Study||0
11251522|NCT02171260|12445369|FG002|COMPLETED|Overall Study||0
11251523|NCT02171260|12445370|FG003|COMPLETED|Overall Study||0
11251524|NCT02171260|12445367|FG000|NOT COMPLETED|Overall Study||6
11251525|NCT02171260|12445368|FG001|NOT COMPLETED|Overall Study||6
11251526|NCT02171260|12445369|FG002|NOT COMPLETED|Overall Study||5
11251527|NCT02171260|12445370|FG003|NOT COMPLETED|Overall Study||5
11251528|NCT02171429|12445389|FG000|STARTED|Overall Study||72
11251529|NCT02171429|12445390|FG001|STARTED|Overall Study||143
11251530|NCT02171429|12445391|FG002|STARTED|Overall Study||143
11251531|NCT02171429|12445389|FG000|Completed Week 10 Visit|Overall Study||70
11251532|NCT02171429|12445390|FG001|Completed Week 10 Visit|Overall Study||141
11251533|NCT02171429|12445391|FG002|Completed Week 10 Visit|Overall Study||141
11251534|NCT02171429|12445389|FG000|COMPLETED|Overall Study||71
11251535|NCT02171429|12445390|FG001|COMPLETED|Overall Study||140
11251536|NCT02171429|12445391|FG002|COMPLETED|Overall Study||138
11251537|NCT02171429|12445389|FG000|NOT COMPLETED|Overall Study||1
11251538|NCT02171429|12445390|FG001|NOT COMPLETED|Overall Study||3
11251539|NCT02171429|12445391|FG002|NOT COMPLETED|Overall Study||5
11251540|NCT02171611|12445402|FG000|STARTED|Overall Study||5
11251541|NCT02171611|12445403|FG001|STARTED|Overall Study||5
11251542|NCT02171611|12445404|FG002|STARTED|Overall Study||5
11251543|NCT02171611|12445405|FG003|STARTED|Overall Study||5
11251544|NCT02171611|12445406|FG004|STARTED|Overall Study||5
11251545|NCT02171611|12445407|FG005|STARTED|Overall Study||5
11251546|NCT02171611|12445402|FG000|COMPLETED|Overall Study||5
11251547|NCT02171611|12445403|FG001|COMPLETED|Overall Study||5
11251548|NCT02171611|12445404|FG002|COMPLETED|Overall Study||5
11251549|NCT02171611|12445405|FG003|COMPLETED|Overall Study||5
11251550|NCT02171611|12445406|FG004|COMPLETED|Overall Study||5
11251551|NCT02171611|12445407|FG005|COMPLETED|Overall Study||5
11251552|NCT02171611|12445402|FG000|NOT COMPLETED|Overall Study||0
11251553|NCT02171611|12445403|FG001|NOT COMPLETED|Overall Study||0
11251554|NCT02171611|12445404|FG002|NOT COMPLETED|Overall Study||0
11251555|NCT02171611|12445405|FG003|NOT COMPLETED|Overall Study||0
11251556|NCT02171611|12445406|FG004|NOT COMPLETED|Overall Study||0
11251557|NCT02171611|12445407|FG005|NOT COMPLETED|Overall Study||0
11251558|NCT02171819|12445418|FG000|STARTED|Overall Study||31
11251559|NCT02171819|12445419|FG001|STARTED|Overall Study||32
11251560|NCT02171819|12445420|FG002|STARTED|Overall Study||12
11251561|NCT02171819|12445418|FG000|COMPLETED|Overall Study||31
11251562|NCT02171819|12445419|FG001|COMPLETED|Overall Study||32
11251563|NCT02171819|12445420|FG002|COMPLETED|Overall Study||12
11251564|NCT02171819|12445418|FG000|NOT COMPLETED|Overall Study||0
11251565|NCT02171819|12445419|FG001|NOT COMPLETED|Overall Study||0
11251566|NCT02171819|12445420|FG002|NOT COMPLETED|Overall Study||0
11251567|NCT02172040|12445436|FG000|STARTED|Overall Study||49
11251568|NCT02172040|12445437|FG001|STARTED|Overall Study||45
11251569|NCT02172040|12445438|FG002|STARTED|Overall Study||31
11251570|NCT02172040|12445439|FG003|STARTED|Overall Study||27
11251571|NCT02172040|12445436|FG000|COMPLETED|Overall Study||49
11251572|NCT02172040|12445437|FG001|COMPLETED|Overall Study||42
11251573|NCT02172040|12445438|FG002|COMPLETED|Overall Study||29
11251574|NCT02172040|12445439|FG003|COMPLETED|Overall Study||26
11251575|NCT02172040|12445436|FG000|NOT COMPLETED|Overall Study||0
11251576|NCT02172040|12445437|FG001|NOT COMPLETED|Overall Study||3
11251577|NCT02172040|12445438|FG002|NOT COMPLETED|Overall Study||2
11251578|NCT02172040|12445439|FG003|NOT COMPLETED|Overall Study||1
11251579|NCT02172625|12445452|FG000|STARTED|Overall Study||19
11251580|NCT02172625|12445453|FG001|STARTED|Overall Study||19
11251581|NCT02172625|12445452|FG000|COMPLETED|Overall Study||19
11251582|NCT02172625|12445453|FG001|COMPLETED|Overall Study||16
11251583|NCT02172625|12445452|FG000|NOT COMPLETED|Overall Study||0
11251584|NCT02172625|12445453|FG001|NOT COMPLETED|Overall Study||3
11251585|NCT02172664|12445463|FG000|STARTED|Overall Study||33
11251586|NCT02172664|12445464|FG001|STARTED|Overall Study||33
11251587|NCT02172664|12445463|FG000|COMPLETED|Overall Study||27
11251588|NCT02172664|12445464|FG001|COMPLETED|Overall Study||27
11251589|NCT02172664|12445463|FG000|NOT COMPLETED|Overall Study||6
11251590|NCT02172664|12445464|FG001|NOT COMPLETED|Overall Study||6
11251591|NCT02172742|12445471|FG000|STARTED|Overall Study||7
11251592|NCT02172742|12445472|FG001|STARTED|Overall Study||6
11251593|NCT02172742|12445471|FG000|COMPLETED|Overall Study||6
11251594|NCT02172742|12445472|FG001|COMPLETED|Overall Study||6
11251595|NCT02172742|12445471|FG000|NOT COMPLETED|Overall Study||1
11251596|NCT02172742|12445472|FG001|NOT COMPLETED|Overall Study||0
11251597|NCT02172755|12445479|FG000|STARTED|Overall Study||14
11251598|NCT02172755|12445480|FG001|STARTED|Overall Study||16
11251599|NCT02172755|12445479|FG000|COMPLETED|Overall Study||12
11251600|NCT02172755|12445480|FG001|COMPLETED|Overall Study||12
11251601|NCT02172755|12445479|FG000|NOT COMPLETED|Overall Study||2
11251602|NCT02172755|12445480|FG001|NOT COMPLETED|Overall Study||4
11251603|NCT02172820|12445488|FG000|STARTED|Overall Study||65
11251604|NCT02172820|12445489|FG001|STARTED|Overall Study||65
11251605|NCT02172820|12445488|FG000|COMPLETED|Overall Study||65
11251606|NCT02172820|12445489|FG001|COMPLETED|Overall Study||65
11251607|NCT02172820|12445488|FG000|NOT COMPLETED|Overall Study||0
11251608|NCT02172820|12445489|FG001|NOT COMPLETED|Overall Study||0
11251609|NCT02172911|12445497|FG000|STARTED|Overall Study||7
11251610|NCT02172911|12445498|FG001|STARTED|Overall Study||3
11251611|NCT02172911|12445497|FG000|COMPLETED|Overall Study||6
11251612|NCT02172911|12445498|FG001|COMPLETED|Overall Study||1
11251613|NCT02172911|12445497|FG000|NOT COMPLETED|Overall Study||1
11251614|NCT02172911|12445498|FG001|NOT COMPLETED|Overall Study||2
11251615|NCT02172950|12445506|FG000|STARTED|Overall Study||222
11251616|NCT02172950|12445507|FG001|STARTED|Overall Study||24
11251617|NCT02172950|12445506|FG000|COMPLETED|Overall Study||197
11251618|NCT02172950|12445507|FG001|COMPLETED|Overall Study||19
11251619|NCT02172950|12445506|FG000|NOT COMPLETED|Overall Study||25
11251620|NCT02172950|12445507|FG001|NOT COMPLETED|Overall Study||5
11251621|NCT02173054|12445517|FG000|STARTED|Overall Study||40
11251622|NCT02173054|12445518|FG001|STARTED|Overall Study||40
11251623|NCT02173054|12445519|FG002|STARTED|Overall Study||40
11251624|NCT02173054|12445517|FG000|COMPLETED|Overall Study||39
11251625|NCT02173054|12445518|FG001|COMPLETED|Overall Study||40
11251626|NCT02173054|12445519|FG002|COMPLETED|Overall Study||39
11251627|NCT02173054|12445517|FG000|NOT COMPLETED|Overall Study||1
11251628|NCT02173054|12445518|FG001|NOT COMPLETED|Overall Study||0
11251629|NCT02173054|12445519|FG002|NOT COMPLETED|Overall Study||1
11339501|NCT02914522|12537037|FG010|COMPLETED|Induction Study: Up to Week 11||0
11339502|NCT02914522|12537027|FG000|NOT COMPLETED|Induction Study: Up to Week 11||10
11339503|NCT02914522|12537028|FG001|NOT COMPLETED|Induction Study: Up to Week 11||22
11339504|NCT02914522|12537029|FG002|NOT COMPLETED|Induction Study: Up to Week 11||10
11339505|NCT02914522|12537030|FG003|NOT COMPLETED|Induction Study: Up to Week 11||28
11339506|NCT02914522|12537031|FG004|NOT COMPLETED|Induction Study: Up to Week 11||24
11339507|NCT02914522|12537032|FG005|NOT COMPLETED|Induction Study: Up to Week 11||16
11339508|NCT02914522|12537033|FG006|NOT COMPLETED|Induction Study: Up to Week 11||0
11339509|NCT02914522|12537034|FG007|NOT COMPLETED|Induction Study: Up to Week 11||0
11339510|NCT02914522|12537035|FG008|NOT COMPLETED|Induction Study: Up to Week 11||0
11339511|NCT02914522|12537036|FG009|NOT COMPLETED|Induction Study: Up to Week 11||0
11339512|NCT02914522|12537037|FG010|NOT COMPLETED|Induction Study: Up to Week 11||0
11339513|NCT02914522|12537027|FG000|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
11339514|NCT02914522|12537028|FG001|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
11339515|NCT02914522|12537029|FG002|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
11339516|NCT02914522|12537030|FG003|STARTED|Maintenance Study: Week 11 to Week 58||0
11339517|NCT02914522|12537031|FG004|STARTED|Maintenance Study: Week 11 to Week 58||0
11339518|NCT02914522|12537032|FG005|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
11339519|NCT02914522|12537033|FG006|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|202
11339520|NCT02914522|12537034|FG007|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|99
11339521|NCT02914522|12537035|FG008|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|179
11339522|NCT02914522|12537036|FG009|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|91
11339523|NCT02914522|12537037|FG010|STARTED|Maintenance Study: Week 11 to Week 58||93
11339524|NCT02914522|12537027|FG000|COMPLETED|Maintenance Study: Week 11 to Week 58||0
11339525|NCT02914522|12537028|FG001|COMPLETED|Maintenance Study: Week 11 to Week 58||0
11251630|NCT02173158|12445527|FG000|STARTED|Efficacy Phase||9
11251631|NCT02173158|12445527|FG000|COMPLETED|Efficacy Phase||8
11251632|NCT02173158|12445527|FG000|NOT COMPLETED|Efficacy Phase||1
11251633|NCT02173158|12445527|FG000|STARTED|Safety Phase||8
11251634|NCT02173158|12445527|FG000|COMPLETED|Safety Phase||8
11251635|NCT02173158|12445527|FG000|NOT COMPLETED|Safety Phase||0
11251636|NCT02173392|12445534|FG000|STARTED|Overall Study||73
11251637|NCT02173392|12445535|FG001|STARTED|Overall Study||72
11251638|NCT02173392|12445534|FG000|COMPLETED|Overall Study||59
11251639|NCT02173392|12445535|FG001|COMPLETED|Overall Study||68
11251640|NCT02173392|12445534|FG000|NOT COMPLETED|Overall Study||14
11251641|NCT02173392|12445535|FG001|NOT COMPLETED|Overall Study||4
11251642|NCT02173522|12445545|FG000|STARTED|Overall Study||4
11251643|NCT02173522|12445546|FG001|STARTED|Overall Study||0
11251644|NCT02173522|12445545|FG000|COMPLETED|Overall Study||4
11251645|NCT02173522|12445546|FG001|COMPLETED|Overall Study||0
11251646|NCT02173522|12445545|FG000|NOT COMPLETED|Overall Study||0
11251647|NCT02173522|12445546|FG001|NOT COMPLETED|Overall Study||0
11251648|NCT02173535|12445570|FG000|STARTED|Period 1||12
11251649|NCT02173535|12445571|FG001|STARTED|Period 1||12
11251650|NCT02173535|12445572|FG002|STARTED|Period 1||12
11251651|NCT02173535|12445573|FG003|STARTED|Period 1||12
11251652|NCT02173535|12445574|FG004|STARTED|Period 1||12
11251653|NCT02173535|12445575|FG005|STARTED|Period 1||12
11251654|NCT02173535|12445576|FG006|STARTED|Period 1||12
11251655|NCT02173535|12445577|FG007|STARTED|Period 1||12
11251656|NCT02173535|12445578|FG008|STARTED|Period 1||12
11251657|NCT02173535|12445579|FG009|STARTED|Period 1||12
11251658|NCT02173535|12445580|FG010|STARTED|Period 1||12
11251659|NCT02173535|12445581|FG011|STARTED|Period 1||12
11251660|NCT02173535|12445582|FG012|STARTED|Period 1||12
11251661|NCT02173535|12445583|FG013|STARTED|Period 1||12
11251662|NCT02173535|12445584|FG014|STARTED|Period 1||12
11251663|NCT02173535|12445585|FG015|STARTED|Period 1||12
11251664|NCT02173535|12445586|FG016|STARTED|Period 1||12
11251665|NCT02173535|12445587|FG017|STARTED|Period 1||12
11251666|NCT02173535|12445588|FG018|STARTED|Period 1||12
11251667|NCT02173535|12445589|FG019|STARTED|Period 1||12
11251668|NCT02173535|12445570|FG000|COMPLETED|Period 1||12
11251669|NCT02173535|12445571|FG001|COMPLETED|Period 1||12
11251670|NCT02173535|12445572|FG002|COMPLETED|Period 1||12
11251671|NCT02173535|12445573|FG003|COMPLETED|Period 1||12
11251672|NCT02173535|12445574|FG004|COMPLETED|Period 1||12
11251673|NCT02173535|12445575|FG005|COMPLETED|Period 1||12
11251674|NCT02173535|12445576|FG006|COMPLETED|Period 1||12
11251675|NCT02173535|12445577|FG007|COMPLETED|Period 1||12
11251676|NCT02173535|12445578|FG008|COMPLETED|Period 1||12
11251677|NCT02173535|12445579|FG009|COMPLETED|Period 1||12
11251678|NCT02173535|12445580|FG010|COMPLETED|Period 1||12
11251679|NCT02173535|12445581|FG011|COMPLETED|Period 1||12
11251680|NCT02173535|12445582|FG012|COMPLETED|Period 1||12
11251681|NCT02173535|12445583|FG013|COMPLETED|Period 1||12
11251682|NCT02173535|12445584|FG014|COMPLETED|Period 1||12
11251683|NCT02173535|12445585|FG015|COMPLETED|Period 1||12
11251684|NCT02173535|12445586|FG016|COMPLETED|Period 1||12
11251685|NCT02173535|12445587|FG017|COMPLETED|Period 1||12
11251686|NCT02173535|12445588|FG018|COMPLETED|Period 1||12
11251687|NCT02173535|12445589|FG019|COMPLETED|Period 1||12
11251688|NCT02173535|12445570|FG000|NOT COMPLETED|Period 1||0
11251689|NCT02173535|12445571|FG001|NOT COMPLETED|Period 1||0
11251690|NCT02173535|12445572|FG002|NOT COMPLETED|Period 1||0
11251691|NCT02173535|12445573|FG003|NOT COMPLETED|Period 1||0
11251692|NCT02173535|12445574|FG004|NOT COMPLETED|Period 1||0
11251693|NCT02173535|12445575|FG005|NOT COMPLETED|Period 1||0
11251694|NCT02173535|12445576|FG006|NOT COMPLETED|Period 1||0
11251695|NCT02173535|12445577|FG007|NOT COMPLETED|Period 1||0
11251696|NCT02173535|12445578|FG008|NOT COMPLETED|Period 1||0
11251697|NCT02173535|12445579|FG009|NOT COMPLETED|Period 1||0
11251698|NCT02173535|12445580|FG010|NOT COMPLETED|Period 1||0
11251699|NCT02173535|12445581|FG011|NOT COMPLETED|Period 1||0
11251700|NCT02173535|12445582|FG012|NOT COMPLETED|Period 1||0
11251701|NCT02173535|12445583|FG013|NOT COMPLETED|Period 1||0
11251702|NCT02173535|12445584|FG014|NOT COMPLETED|Period 1||0
11251703|NCT02173535|12445585|FG015|NOT COMPLETED|Period 1||0
11251704|NCT02173535|12445586|FG016|NOT COMPLETED|Period 1||0
11251705|NCT02173535|12445587|FG017|NOT COMPLETED|Period 1||0
11251706|NCT02173535|12445588|FG018|NOT COMPLETED|Period 1||0
11251707|NCT02173535|12445589|FG019|NOT COMPLETED|Period 1||0
11251708|NCT02173535|12445570|FG000|STARTED|Period 2||12
11251709|NCT02173535|12445571|FG001|STARTED|Period 2||12
11251710|NCT02173535|12445572|FG002|STARTED|Period 2||12
11251711|NCT02173535|12445573|FG003|STARTED|Period 2||12
11251712|NCT02173535|12445574|FG004|STARTED|Period 2||12
11251713|NCT02173535|12445575|FG005|STARTED|Period 2||12
11251714|NCT02173535|12445576|FG006|STARTED|Period 2||12
11251715|NCT02173535|12445577|FG007|STARTED|Period 2||12
11251716|NCT02173535|12445578|FG008|STARTED|Period 2||12
11251717|NCT02173535|12445579|FG009|STARTED|Period 2||12
11251718|NCT02173535|12445580|FG010|STARTED|Period 2||12
11251719|NCT02173535|12445581|FG011|STARTED|Period 2||12
11251720|NCT02173535|12445582|FG012|STARTED|Period 2||12
11251721|NCT02173535|12445583|FG013|STARTED|Period 2||12
11251722|NCT02173535|12445584|FG014|STARTED|Period 2||12
11251723|NCT02173535|12445585|FG015|STARTED|Period 2||12
11251724|NCT02173535|12445586|FG016|STARTED|Period 2||12
11251725|NCT02173535|12445587|FG017|STARTED|Period 2||12
11251726|NCT02173535|12445588|FG018|STARTED|Period 2||12
11251727|NCT02173535|12445589|FG019|STARTED|Period 2||12
11251728|NCT02173535|12445570|FG000|COMPLETED|Period 2||12
11251729|NCT02173535|12445571|FG001|COMPLETED|Period 2||12
11251730|NCT02173535|12445572|FG002|COMPLETED|Period 2||12
11251731|NCT02173535|12445573|FG003|COMPLETED|Period 2||12
11251732|NCT02173535|12445574|FG004|COMPLETED|Period 2||12
11251733|NCT02173535|12445575|FG005|COMPLETED|Period 2||12
11251734|NCT02173535|12445576|FG006|COMPLETED|Period 2||12
11251735|NCT02173535|12445577|FG007|COMPLETED|Period 2||12
11251736|NCT02173535|12445578|FG008|COMPLETED|Period 2||12
11251737|NCT02173535|12445579|FG009|COMPLETED|Period 2||12
11251738|NCT02173535|12445580|FG010|COMPLETED|Period 2||12
11251739|NCT02173535|12445581|FG011|COMPLETED|Period 2||12
11251740|NCT02173535|12445582|FG012|COMPLETED|Period 2||12
11251741|NCT02173535|12445583|FG013|COMPLETED|Period 2||12
11251742|NCT02173535|12445584|FG014|COMPLETED|Period 2||12
11251743|NCT02173535|12445585|FG015|COMPLETED|Period 2||12
11251744|NCT02173535|12445586|FG016|COMPLETED|Period 2||12
11251745|NCT02173535|12445587|FG017|COMPLETED|Period 2||12
11251746|NCT02173535|12445588|FG018|COMPLETED|Period 2||12
11251747|NCT02173535|12445589|FG019|COMPLETED|Period 2||12
11251748|NCT02173535|12445570|FG000|NOT COMPLETED|Period 2||0
11251749|NCT02173535|12445571|FG001|NOT COMPLETED|Period 2||0
11251750|NCT02173535|12445572|FG002|NOT COMPLETED|Period 2||0
11251751|NCT02173535|12445573|FG003|NOT COMPLETED|Period 2||0
11251752|NCT02173535|12445574|FG004|NOT COMPLETED|Period 2||0
11251753|NCT02173535|12445575|FG005|NOT COMPLETED|Period 2||0
11251754|NCT02173535|12445576|FG006|NOT COMPLETED|Period 2||0
11251755|NCT02173535|12445577|FG007|NOT COMPLETED|Period 2||0
11251756|NCT02173535|12445578|FG008|NOT COMPLETED|Period 2||0
11251757|NCT02173535|12445579|FG009|NOT COMPLETED|Period 2||0
11251758|NCT02173535|12445580|FG010|NOT COMPLETED|Period 2||0
11251759|NCT02173535|12445581|FG011|NOT COMPLETED|Period 2||0
11251760|NCT02173535|12445582|FG012|NOT COMPLETED|Period 2||0
11251761|NCT02173535|12445583|FG013|NOT COMPLETED|Period 2||0
11251762|NCT02173535|12445584|FG014|NOT COMPLETED|Period 2||0
11251763|NCT02173535|12445585|FG015|NOT COMPLETED|Period 2||0
11251764|NCT02173535|12445586|FG016|NOT COMPLETED|Period 2||0
11251765|NCT02173535|12445587|FG017|NOT COMPLETED|Period 2||0
11251766|NCT02173535|12445588|FG018|NOT COMPLETED|Period 2||0
11251767|NCT02173535|12445589|FG019|NOT COMPLETED|Period 2||0
11251768|NCT02173535|12445570|FG000|STARTED|Period 3||12
11251769|NCT02173535|12445571|FG001|STARTED|Period 3||12
11251770|NCT02173535|12445572|FG002|STARTED|Period 3||12
11251771|NCT02173535|12445573|FG003|STARTED|Period 3||12
11251772|NCT02173535|12445574|FG004|STARTED|Period 3||12
11251773|NCT02173535|12445575|FG005|STARTED|Period 3||12
11251774|NCT02173535|12445576|FG006|STARTED|Period 3||12
11251775|NCT02173535|12445577|FG007|STARTED|Period 3||12
11251776|NCT02173535|12445578|FG008|STARTED|Period 3||12
11251777|NCT02173535|12445579|FG009|STARTED|Period 3||12
11251778|NCT02173535|12445580|FG010|STARTED|Period 3||12
11251779|NCT02173535|12445581|FG011|STARTED|Period 3||12
11251780|NCT02173535|12445582|FG012|STARTED|Period 3||12
11251781|NCT02173535|12445583|FG013|STARTED|Period 3||12
11251782|NCT02173535|12445584|FG014|STARTED|Period 3||12
11251783|NCT02173535|12445585|FG015|STARTED|Period 3||12
11251784|NCT02173535|12445586|FG016|STARTED|Period 3||12
11251785|NCT02173535|12445587|FG017|STARTED|Period 3||12
11251786|NCT02173535|12445588|FG018|STARTED|Period 3||12
11251787|NCT02173535|12445589|FG019|STARTED|Period 3||12
11251788|NCT02173535|12445570|FG000|COMPLETED|Period 3||12
11251789|NCT02173535|12445571|FG001|COMPLETED|Period 3||12
11251790|NCT02173535|12445572|FG002|COMPLETED|Period 3||12
11251791|NCT02173535|12445573|FG003|COMPLETED|Period 3||12
11251792|NCT02173535|12445574|FG004|COMPLETED|Period 3||12
11251793|NCT02173535|12445575|FG005|COMPLETED|Period 3||12
11251794|NCT02173535|12445576|FG006|COMPLETED|Period 3||12
11251795|NCT02173535|12445577|FG007|COMPLETED|Period 3||12
11251796|NCT02173535|12445578|FG008|COMPLETED|Period 3||12
11251797|NCT02173535|12445579|FG009|COMPLETED|Period 3||12
11251798|NCT02173535|12445580|FG010|COMPLETED|Period 3||12
11251799|NCT02173535|12445581|FG011|COMPLETED|Period 3||12
11251800|NCT02173535|12445582|FG012|COMPLETED|Period 3||12
11251801|NCT02173535|12445583|FG013|COMPLETED|Period 3||12
11251802|NCT02173535|12445584|FG014|COMPLETED|Period 3||12
11251803|NCT02173535|12445585|FG015|COMPLETED|Period 3||12
11251804|NCT02173535|12445586|FG016|COMPLETED|Period 3||12
11251805|NCT02173535|12445587|FG017|COMPLETED|Period 3||12
11251806|NCT02173535|12445588|FG018|COMPLETED|Period 3||12
11251807|NCT02173535|12445589|FG019|COMPLETED|Period 3||12
11251808|NCT02173535|12445570|FG000|NOT COMPLETED|Period 3||0
11251809|NCT02173535|12445571|FG001|NOT COMPLETED|Period 3||0
11251810|NCT02173535|12445572|FG002|NOT COMPLETED|Period 3||0
11251811|NCT02173535|12445573|FG003|NOT COMPLETED|Period 3||0
11251812|NCT02173535|12445574|FG004|NOT COMPLETED|Period 3||0
11251813|NCT02173535|12445575|FG005|NOT COMPLETED|Period 3||0
11251814|NCT02173535|12445576|FG006|NOT COMPLETED|Period 3||0
11251815|NCT02173535|12445577|FG007|NOT COMPLETED|Period 3||0
11251816|NCT02173535|12445578|FG008|NOT COMPLETED|Period 3||0
11251817|NCT02173535|12445579|FG009|NOT COMPLETED|Period 3||0
11251818|NCT02173535|12445580|FG010|NOT COMPLETED|Period 3||0
11251819|NCT02173535|12445581|FG011|NOT COMPLETED|Period 3||0
11251820|NCT02173535|12445582|FG012|NOT COMPLETED|Period 3||0
11251821|NCT02173535|12445583|FG013|NOT COMPLETED|Period 3||0
11251822|NCT02173535|12445584|FG014|NOT COMPLETED|Period 3||0
11251823|NCT02173535|12445585|FG015|NOT COMPLETED|Period 3||0
11251824|NCT02173535|12445586|FG016|NOT COMPLETED|Period 3||0
11251825|NCT02173535|12445587|FG017|NOT COMPLETED|Period 3||0
11251826|NCT02173535|12445588|FG018|NOT COMPLETED|Period 3||0
11251827|NCT02173535|12445589|FG019|NOT COMPLETED|Period 3||0
11251828|NCT02173535|12445570|FG000|STARTED|Period 4||12
11251829|NCT02173535|12445571|FG001|STARTED|Period 4||12
11251830|NCT02173535|12445572|FG002|STARTED|Period 4||12
11251831|NCT02173535|12445573|FG003|STARTED|Period 4||12
11251832|NCT02173535|12445574|FG004|STARTED|Period 4||12
11251833|NCT02173535|12445575|FG005|STARTED|Period 4||12
11251834|NCT02173535|12445576|FG006|STARTED|Period 4||12
11251835|NCT02173535|12445577|FG007|STARTED|Period 4||12
11251836|NCT02173535|12445578|FG008|STARTED|Period 4||12
11251837|NCT02173535|12445579|FG009|STARTED|Period 4||12
11251838|NCT02173535|12445580|FG010|STARTED|Period 4||12
11251839|NCT02173535|12445581|FG011|STARTED|Period 4||12
11251840|NCT02173535|12445582|FG012|STARTED|Period 4||12
11251841|NCT02173535|12445583|FG013|STARTED|Period 4||12
11251842|NCT02173535|12445584|FG014|STARTED|Period 4||12
11251843|NCT02173535|12445585|FG015|STARTED|Period 4||12
11251844|NCT02173535|12445586|FG016|STARTED|Period 4||12
11251845|NCT02173535|12445587|FG017|STARTED|Period 4||12
11251846|NCT02173535|12445588|FG018|STARTED|Period 4||12
11251847|NCT02173535|12445589|FG019|STARTED|Period 4||12
11251848|NCT02173535|12445570|FG000|COMPLETED|Period 4||12
11251849|NCT02173535|12445571|FG001|COMPLETED|Period 4||12
11251850|NCT02173535|12445572|FG002|COMPLETED|Period 4||12
11251851|NCT02173535|12445573|FG003|COMPLETED|Period 4||12
11251852|NCT02173535|12445574|FG004|COMPLETED|Period 4||12
11251853|NCT02173535|12445575|FG005|COMPLETED|Period 4||12
11251854|NCT02173535|12445576|FG006|COMPLETED|Period 4||12
11251855|NCT02173535|12445577|FG007|COMPLETED|Period 4||12
11251856|NCT02173535|12445578|FG008|COMPLETED|Period 4||12
11251857|NCT02173535|12445579|FG009|COMPLETED|Period 4||12
11251858|NCT02173535|12445580|FG010|COMPLETED|Period 4||12
11251859|NCT02173535|12445581|FG011|COMPLETED|Period 4||12
11251860|NCT02173535|12445582|FG012|COMPLETED|Period 4||12
11251861|NCT02173535|12445583|FG013|COMPLETED|Period 4||12
11251862|NCT02173535|12445584|FG014|COMPLETED|Period 4||12
11358599|NCT03126370|12555726|FG000|COMPLETED|TAF With a Boosted PI||10
11358600|NCT03126370|12555726|FG000|NOT COMPLETED|TAF With a Boosted PI||0
11358601|NCT03126448|12555737|FG000|STARTED|Overall Study||56
11358602|NCT03126448|12555738|FG001|STARTED|Overall Study||49
11358603|NCT03126448|12555739|FG002|STARTED|Overall Study||37
11358604|NCT03126448|12555737|FG000|COMPLETED|Overall Study||43
11358605|NCT03126448|12555738|FG001|COMPLETED|Overall Study||41
11005446|NCT00723021|12183142|FG001|NOT COMPLETED|Intervention Period 2||0
11005447|NCT00723021|12183143|FG002|NOT COMPLETED|Intervention Period 2||0
11005448|NCT00723021|12183144|FG003|NOT COMPLETED|Intervention Period 2||0
11005449|NCT00723021|12183145|FG004|NOT COMPLETED|Intervention Period 2||0
11005450|NCT00723021|12183141|FG000|STARTED|Intervention Period 3||3
11005451|NCT00723021|12183142|FG001|STARTED|Intervention Period 3||3
11358606|NCT03126448|12555739|FG002|COMPLETED|Overall Study||27
11251863|NCT02173535|12445585|FG015|COMPLETED|Period 4||12
11251864|NCT02173535|12445586|FG016|COMPLETED|Period 4||12
11251865|NCT02173535|12445587|FG017|COMPLETED|Period 4||12
11251866|NCT02173535|12445588|FG018|COMPLETED|Period 4||12
11251867|NCT02173535|12445589|FG019|COMPLETED|Period 4||12
11251868|NCT02173535|12445570|FG000|NOT COMPLETED|Period 4||0
11251869|NCT02173535|12445571|FG001|NOT COMPLETED|Period 4||0
11251870|NCT02173535|12445572|FG002|NOT COMPLETED|Period 4||0
11251871|NCT02173535|12445573|FG003|NOT COMPLETED|Period 4||0
11251872|NCT02173535|12445574|FG004|NOT COMPLETED|Period 4||0
11251873|NCT02173535|12445575|FG005|NOT COMPLETED|Period 4||0
11358607|NCT03126448|12555737|FG000|NOT COMPLETED|Overall Study||13
11358608|NCT03126448|12555738|FG001|NOT COMPLETED|Overall Study||8
11358609|NCT03126448|12555739|FG002|NOT COMPLETED|Overall Study||10
11358610|NCT03126682|12555749|FG000|STARTED|Overall Study||5
11358611|NCT03126682|12555750|FG001|STARTED|Overall Study||5
11358612|NCT03126682|12555749|FG000|COMPLETED|Overall Study||5
11358613|NCT03126682|12555750|FG001|COMPLETED|Overall Study||5
11358614|NCT03126682|12555749|FG000|NOT COMPLETED|Overall Study||0
11358615|NCT03126682|12555750|FG001|NOT COMPLETED|Overall Study||0
11358616|NCT03126760|12555758|FG000|STARTED|Overall Study||18
11358617|NCT03126760|12555759|FG001|STARTED|Overall Study||17
11358618|NCT03126760|12555758|FG000|Modified Intent to Treat (mITT)|Overall Study||18
11358619|NCT03126760|12555759|FG001|Modified Intent to Treat (mITT)|Overall Study||17
11358620|NCT03126760|12555758|FG000|Completed Treatment|Overall Study|One participant halted treatment for adverse event, but completed the study|17
11358621|NCT03126760|12555759|FG001|Completed Treatment|Overall Study||17
11358622|NCT03126760|12555758|FG000|COMPLETED|Overall Study||18
11358623|NCT03126760|12555759|FG001|COMPLETED|Overall Study||17
11358624|NCT03126760|12555758|FG000|NOT COMPLETED|Overall Study||0
11358625|NCT03126760|12555759|FG001|NOT COMPLETED|Overall Study||0
11005452|NCT00723021|12183143|FG002|STARTED|Intervention Period 3||3
11358626|NCT03126786|12555767|FG000|STARTED|Overall Study||36
11358627|NCT03126786|12555768|FG001|STARTED|Overall Study||35
11358628|NCT03126786|12555767|FG000|COMPLETED|Overall Study||30
11251874|NCT02173535|12445576|FG006|NOT COMPLETED|Period 4||0
11251875|NCT02173535|12445577|FG007|NOT COMPLETED|Period 4||0
11251876|NCT02173535|12445578|FG008|NOT COMPLETED|Period 4||0
11251877|NCT02173535|12445579|FG009|NOT COMPLETED|Period 4||0
11251878|NCT02173535|12445580|FG010|NOT COMPLETED|Period 4||0
11251879|NCT02173535|12445581|FG011|NOT COMPLETED|Period 4||0
11251880|NCT02173535|12445582|FG012|NOT COMPLETED|Period 4||0
11251881|NCT02173535|12445583|FG013|NOT COMPLETED|Period 4||0
11251882|NCT02173535|12445584|FG014|NOT COMPLETED|Period 4||0
11251883|NCT02173535|12445585|FG015|NOT COMPLETED|Period 4||0
11251884|NCT02173535|12445586|FG016|NOT COMPLETED|Period 4||0
11251885|NCT02173535|12445587|FG017|NOT COMPLETED|Period 4||0
11251886|NCT02173535|12445588|FG018|NOT COMPLETED|Period 4||0
11251887|NCT02173535|12445589|FG019|NOT COMPLETED|Period 4||0
11251888|NCT02173535|12445570|FG000|STARTED|Period 5||12
11251889|NCT02173535|12445571|FG001|STARTED|Period 5||12
11251890|NCT02173535|12445572|FG002|STARTED|Period 5||12
11251891|NCT02173535|12445573|FG003|STARTED|Period 5||12
11251892|NCT02173535|12445574|FG004|STARTED|Period 5||12
11251893|NCT02173535|12445575|FG005|STARTED|Period 5||12
11251894|NCT02173535|12445576|FG006|STARTED|Period 5||12
11251895|NCT02173535|12445577|FG007|STARTED|Period 5||12
11251896|NCT02173535|12445578|FG008|STARTED|Period 5||12
11251897|NCT02173535|12445579|FG009|STARTED|Period 5||12
11251898|NCT02173535|12445580|FG010|STARTED|Period 5||12
11251899|NCT02173535|12445581|FG011|STARTED|Period 5||12
11251900|NCT02173535|12445582|FG012|STARTED|Period 5||12
11251901|NCT02173535|12445583|FG013|STARTED|Period 5||12
11251902|NCT02173535|12445584|FG014|STARTED|Period 5||12
11251903|NCT02173535|12445585|FG015|STARTED|Period 5||12
11251904|NCT02173535|12445586|FG016|STARTED|Period 5||12
11251905|NCT02173535|12445587|FG017|STARTED|Period 5||12
11251906|NCT02173535|12445588|FG018|STARTED|Period 5||12
11251907|NCT02173535|12445589|FG019|STARTED|Period 5||12
11251908|NCT02173535|12445570|FG000|COMPLETED|Period 5||12
11251909|NCT02173535|12445571|FG001|COMPLETED|Period 5||12
11251910|NCT02173535|12445572|FG002|COMPLETED|Period 5||12
11251911|NCT02173535|12445573|FG003|COMPLETED|Period 5||12
11251912|NCT02173535|12445574|FG004|COMPLETED|Period 5||12
11251913|NCT02173535|12445575|FG005|COMPLETED|Period 5||12
11251914|NCT02173535|12445576|FG006|COMPLETED|Period 5||12
11251915|NCT02173535|12445577|FG007|COMPLETED|Period 5||12
11251916|NCT02173535|12445578|FG008|COMPLETED|Period 5||12
11251917|NCT02173535|12445579|FG009|COMPLETED|Period 5||12
11251918|NCT02173535|12445580|FG010|COMPLETED|Period 5||12
11251919|NCT02173535|12445581|FG011|COMPLETED|Period 5||12
11251920|NCT02173535|12445582|FG012|COMPLETED|Period 5||12
11251921|NCT02173535|12445583|FG013|COMPLETED|Period 5||12
11251922|NCT02173535|12445584|FG014|COMPLETED|Period 5||12
11251923|NCT02173535|12445585|FG015|COMPLETED|Period 5||12
11251924|NCT02173535|12445586|FG016|COMPLETED|Period 5||12
11251925|NCT02173535|12445587|FG017|COMPLETED|Period 5||12
11251926|NCT02173535|12445588|FG018|COMPLETED|Period 5||12
11251927|NCT02173535|12445589|FG019|COMPLETED|Period 5||12
11251928|NCT02173535|12445570|FG000|NOT COMPLETED|Period 5||0
11251929|NCT02173535|12445571|FG001|NOT COMPLETED|Period 5||0
11251930|NCT02173535|12445572|FG002|NOT COMPLETED|Period 5||0
11251931|NCT02173535|12445573|FG003|NOT COMPLETED|Period 5||0
11251932|NCT02173535|12445574|FG004|NOT COMPLETED|Period 5||0
11251933|NCT02173535|12445575|FG005|NOT COMPLETED|Period 5||0
11251934|NCT02173535|12445576|FG006|NOT COMPLETED|Period 5||0
11251935|NCT02173535|12445577|FG007|NOT COMPLETED|Period 5||0
11251936|NCT02173535|12445578|FG008|NOT COMPLETED|Period 5||0
11251937|NCT02173535|12445579|FG009|NOT COMPLETED|Period 5||0
11251938|NCT02173535|12445580|FG010|NOT COMPLETED|Period 5||0
11251939|NCT02173535|12445581|FG011|NOT COMPLETED|Period 5||0
11251940|NCT02173535|12445582|FG012|NOT COMPLETED|Period 5||0
11251941|NCT02173535|12445583|FG013|NOT COMPLETED|Period 5||0
11251942|NCT02173535|12445584|FG014|NOT COMPLETED|Period 5||0
11251943|NCT02173535|12445585|FG015|NOT COMPLETED|Period 5||0
11251944|NCT02173535|12445586|FG016|NOT COMPLETED|Period 5||0
11251945|NCT02173535|12445587|FG017|NOT COMPLETED|Period 5||0
11251946|NCT02173535|12445588|FG018|NOT COMPLETED|Period 5||0
11251947|NCT02173535|12445589|FG019|NOT COMPLETED|Period 5||0
11251948|NCT02173548|12445618|FG000|STARTED|Overall Study||21
11251949|NCT02173548|12445619|FG001|STARTED|Overall Study||10
11251950|NCT02173548|12445618|FG000|COMPLETED|Overall Study||20
11251951|NCT02173548|12445619|FG001|COMPLETED|Overall Study||8
11251952|NCT02173548|12445618|FG000|NOT COMPLETED|Overall Study||1
11251953|NCT02173548|12445619|FG001|NOT COMPLETED|Overall Study||2
11251954|NCT02173704|12445627|FG000|STARTED|Overall Study||150
11251955|NCT02173704|12445628|FG001|STARTED|Overall Study||75
11251956|NCT02173704|12445627|FG000|COMPLETED|Overall Study||137
11251957|NCT02173704|12445628|FG001|COMPLETED|Overall Study||71
11251958|NCT02173704|12445627|FG000|NOT COMPLETED|Overall Study||13
11251959|NCT02173704|12445628|FG001|NOT COMPLETED|Overall Study||4
11251960|NCT02173769|12445634|FG000|STARTED|Overall Study||1858
11251961|NCT02173769|12445634|FG000|COMPLETED|Overall Study||1854
11251962|NCT02173769|12445634|FG000|NOT COMPLETED|Overall Study||4
11251963|NCT02174198|12445641|FG000|STARTED|Overall Study||16
11251964|NCT02174198|12445642|FG001|STARTED|Overall Study||16
11251965|NCT02174198|12445641|FG000|COMPLETED|Overall Study||16
11251966|NCT02174198|12445642|FG001|COMPLETED|Overall Study||16
11251967|NCT02174198|12445641|FG000|NOT COMPLETED|Overall Study||0
11251968|NCT02174198|12445642|FG001|NOT COMPLETED|Overall Study||0
11251969|NCT02174276|12445652|FG000|STARTED|Study Treatment Phase (Weeks 1 to 48)||27
11251970|NCT02174276|12445653|FG001|STARTED|Study Treatment Phase (Weeks 1 to 48)||57
11251971|NCT02174276|12445654|FG002|STARTED|Study Treatment Phase (Weeks 1 to 48)||56
11251972|NCT02174276|12445655|FG003|STARTED|Study Treatment Phase (Weeks 1 to 48)||55
11251973|NCT02174276|12445652|FG000|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26
11251974|NCT02174276|12445653|FG001|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56
11251975|NCT02174276|12445654|FG002|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53
11251976|NCT02174276|12445655|FG003|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55
11251977|NCT02174276|12445652|FG000|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
11251978|NCT02174276|12445653|FG001|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
11251979|NCT02174276|12445654|FG002|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3
11251980|NCT02174276|12445655|FG003|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0
11251981|NCT02174276|12445652|FG000|STARTED|OTEP (Weeks 48 to 144)||26
11251982|NCT02174276|12445653|FG001|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54
11251983|NCT02174276|12445654|FG002|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51
11251984|NCT02174276|12445655|FG003|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52
11251985|NCT02174276|12445652|FG000|COMPLETED|OTEP (Weeks 48 to 144)||25
11251986|NCT02174276|12445653|FG001|COMPLETED|OTEP (Weeks 48 to 144)||54
11251987|NCT02174276|12445654|FG002|COMPLETED|OTEP (Weeks 48 to 144)||48
11251988|NCT02174276|12445655|FG003|COMPLETED|OTEP (Weeks 48 to 144)||50
11251989|NCT02174276|12445652|FG000|NOT COMPLETED|OTEP (Weeks 48 to 144)||1
11251990|NCT02174276|12445653|FG001|NOT COMPLETED|OTEP (Weeks 48 to 144)||0
11251991|NCT02174276|12445654|FG002|NOT COMPLETED|OTEP (Weeks 48 to 144)||3
11251992|NCT02174276|12445655|FG003|NOT COMPLETED|OTEP (Weeks 48 to 144)||2
11251993|NCT02174419|12445668|FG000|STARTED|Overall Study||22
11251994|NCT02174419|12445669|FG001|STARTED|Overall Study||18
11251995|NCT02174419|12445670|FG002|STARTED|Overall Study||22
11251996|NCT02174419|12445668|FG000|COMPLETED|Overall Study||18
11251997|NCT02174419|12445669|FG001|COMPLETED|Overall Study||12
11251998|NCT02174419|12445670|FG002|COMPLETED|Overall Study||20
11251999|NCT02174419|12445668|FG000|NOT COMPLETED|Overall Study||4
11252000|NCT02174419|12445669|FG001|NOT COMPLETED|Overall Study||6
11252001|NCT02174419|12445670|FG002|NOT COMPLETED|Overall Study||2
11252002|NCT02174432|12445678|FG000|STARTED|Overall Study||36
11252003|NCT02174432|12445678|FG000|COMPLETED|Overall Study||16
11252004|NCT02174432|12445678|FG000|NOT COMPLETED|Overall Study||20
11252005|NCT02174510|12445686|FG000|STARTED|Overall Study||8
11252006|NCT02174510|12445687|FG001|STARTED|Overall Study||8
11252007|NCT02174510|12445688|FG002|STARTED|Overall Study||12
11252008|NCT02174510|12445689|FG003|STARTED|Overall Study||9
11252009|NCT02174510|12445686|FG000|COMPLETED|Overall Study||8
11252010|NCT02174510|12445687|FG001|COMPLETED|Overall Study||8
11252011|NCT02174510|12445688|FG002|COMPLETED|Overall Study||12
11252012|NCT02174510|12445689|FG003|COMPLETED|Overall Study||9
11252013|NCT02174510|12445686|FG000|NOT COMPLETED|Overall Study||0
11252014|NCT02174510|12445687|FG001|NOT COMPLETED|Overall Study||0
11252015|NCT02174510|12445688|FG002|NOT COMPLETED|Overall Study||0
11252016|NCT02174510|12445689|FG003|NOT COMPLETED|Overall Study||0
11252017|NCT02174523|12445700|FG000|STARTED|Overall Study||10
11252018|NCT02174523|12445701|FG001|STARTED|Overall Study||4
11252019|NCT02174523|12445700|FG000|COMPLETED|Overall Study||9
11252020|NCT02174523|12445701|FG001|COMPLETED|Overall Study||4
11252021|NCT02174523|12445700|FG000|NOT COMPLETED|Overall Study||1
11252022|NCT02174523|12445701|FG001|NOT COMPLETED|Overall Study||0
11252023|NCT02174562|12445708|FG000|STARTED|Overall Study||50
11252024|NCT02174562|12445709|FG001|STARTED|Overall Study||51
11252025|NCT02174562|12445708|FG000|COMPLETED|Overall Study||41
11252026|NCT02174562|12445709|FG001|COMPLETED|Overall Study||46
11252027|NCT02174562|12445708|FG000|NOT COMPLETED|Overall Study||9
11252028|NCT02174562|12445709|FG001|NOT COMPLETED|Overall Study||5
11252029|NCT02174627|12445717|FG000|STARTED|Overall Study||1384
11252030|NCT02174627|12445718|FG001|STARTED|Overall Study||1377
11252031|NCT02174627|12445717|FG000|Received Treatment|Overall Study||1384
11252032|NCT02174627|12445718|FG001|Received Treatment|Overall Study||1376
11252033|NCT02174627|12445717|FG000|Discontinued Treatment|Overall Study||499
11252034|NCT02174627|12445718|FG001|Discontinued Treatment|Overall Study||801
11252035|NCT02174627|12445717|FG000|COMPLETED|Overall Study||1300
11252036|NCT02174627|12445718|FG001|COMPLETED|Overall Study||1247
11252037|NCT02174627|12445717|FG000|NOT COMPLETED|Overall Study||84
11252038|NCT02174627|12445718|FG001|NOT COMPLETED|Overall Study||130
11252039|NCT02174731|12445726|FG000|STARTED|Overall Study||1051
11252040|NCT02174731|12445727|FG001|STARTED|Overall Study||1055
11252041|NCT02174731|12445726|FG000|Received Treatment|Overall Study||1048
11252042|NCT02174731|12445727|FG001|Received Treatment|Overall Study||1053
11252043|NCT02174731|12445726|FG000|COMPLETED|Overall Study||982
11252044|NCT02174731|12445727|FG001|COMPLETED|Overall Study||990
11252045|NCT02174731|12445726|FG000|NOT COMPLETED|Overall Study||69
11252046|NCT02174731|12445727|FG001|NOT COMPLETED|Overall Study||65
11252047|NCT02174848|12445735|FG000|STARTED|Overall Study||24
11252048|NCT02174848|12445736|FG001|STARTED|Overall Study||44
11252049|NCT02174848|12445735|FG000|Provided Post-baseline Efficacy Data|Overall Study||19
11252050|NCT02174848|12445736|FG001|Provided Post-baseline Efficacy Data|Overall Study||43
11252051|NCT02174848|12445735|FG000|COMPLETED|Overall Study||17
11252052|NCT02174848|12445736|FG001|COMPLETED|Overall Study||38
11252053|NCT02174848|12445735|FG000|NOT COMPLETED|Overall Study||7
11252054|NCT02174848|12445736|FG001|NOT COMPLETED|Overall Study||6
11252055|NCT02174913|12445749|FG000|STARTED|Overall Study||17
11252056|NCT02174913|12445750|FG001|STARTED|Overall Study||17
11252057|NCT02174913|12445749|FG000|COMPLETED|Overall Study||17
11252058|NCT02174913|12445750|FG001|COMPLETED|Overall Study||17
11252059|NCT02174913|12445749|FG000|NOT COMPLETED|Overall Study||0
11252060|NCT02174913|12445750|FG001|NOT COMPLETED|Overall Study||0
11252061|NCT02175121|12445761|FG000|STARTED|Overall Study||34
11252062|NCT02175121|12445762|FG001|STARTED|Overall Study||35
11252063|NCT02175121|12445763|FG002|STARTED|Overall Study||34
11252064|NCT02175121|12445764|FG003|STARTED|Overall Study||35
11252065|NCT02175121|12445765|FG004|STARTED|Overall Study||34
11252066|NCT02175121|12445761|FG000|COMPLETED|Overall Study||33
11252067|NCT02175121|12445762|FG001|COMPLETED|Overall Study||34
11252068|NCT02175121|12445763|FG002|COMPLETED|Overall Study||32
11252069|NCT02175121|12445764|FG003|COMPLETED|Overall Study||34
11252070|NCT02175121|12445765|FG004|COMPLETED|Overall Study||33
11252071|NCT02175121|12445761|FG000|NOT COMPLETED|Overall Study||1
11252072|NCT02175121|12445762|FG001|NOT COMPLETED|Overall Study||1
11252073|NCT02175121|12445763|FG002|NOT COMPLETED|Overall Study||2
11252074|NCT02175121|12445764|FG003|NOT COMPLETED|Overall Study||1
11252075|NCT02175121|12445765|FG004|NOT COMPLETED|Overall Study||1
11252076|NCT02175199|12445783|FG000|STARTED|Overall Study||74
11252077|NCT02175199|12445784|FG001|STARTED|Overall Study||76
11252078|NCT02175199|12445783|FG000|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
11252079|NCT02175199|12445784|FG001|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
11252080|NCT02175199|12445783|FG000|COMPLETED|Overall Study||71
11252081|NCT02175199|12445784|FG001|COMPLETED|Overall Study||71
11252082|NCT02175199|12445783|FG000|NOT COMPLETED|Overall Study||3
11252083|NCT02175199|12445784|FG001|NOT COMPLETED|Overall Study||5
11252084|NCT02175212|12445793|FG000|STARTED|Overall Study||177
11252085|NCT02175212|12445794|FG001|STARTED|Overall Study||178
11252086|NCT02175212|12445793|FG000|COMPLETED|Overall Study||14
11252087|NCT02175212|12445794|FG001|COMPLETED|Overall Study||31
11252088|NCT02175212|12445793|FG000|NOT COMPLETED|Overall Study||163
11252089|NCT02175212|12445794|FG001|NOT COMPLETED|Overall Study||147
11252090|NCT02175225|12445802|FG000|STARTED|Overall Study||145
11252091|NCT02175225|12445803|FG001|STARTED|Overall Study||149
11252092|NCT02175225|12445802|FG000|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144
11252093|NCT02175225|12445803|FG001|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147
11252094|NCT02175225|12445802|FG000|90 Day Outcome Obtained|Overall Study||140
11252095|NCT02175225|12445803|FG001|90 Day Outcome Obtained|Overall Study||143
11252096|NCT02175225|12445802|FG000|180 Day Outcome Obtained|Overall Study||135
11252097|NCT02175225|12445803|FG001|180 Day Outcome Obtained|Overall Study||135
11252098|NCT02175225|12445802|FG000|COMPLETED|Overall Study||137
11252099|NCT02175225|12445803|FG001|COMPLETED|Overall Study||138
11252100|NCT02175225|12445802|FG000|NOT COMPLETED|Overall Study||8
11252101|NCT02175225|12445803|FG001|NOT COMPLETED|Overall Study||11
11252102|NCT02175277|12445809|FG000|STARTED|Overall Study||9
11252103|NCT02175277|12445809|FG000|COMPLETED|Overall Study||8
11252104|NCT02175277|12445809|FG000|NOT COMPLETED|Overall Study||1
11252105|NCT02175368|12445813|FG000|STARTED|Overall Study||28
11252106|NCT02175368|12445813|FG000|COMPLETED|Overall Study||27
11252107|NCT02175368|12445813|FG000|NOT COMPLETED|Overall Study||1
11252108|NCT02175472|12445819|FG000|STARTED|Overall Study||45
11252109|NCT02175472|12445820|FG001|STARTED|Overall Study||47
11252110|NCT02175472|12445819|FG000|COMPLETED|Overall Study||38
11252111|NCT02175472|12445820|FG001|COMPLETED|Overall Study||45
11252112|NCT02175472|12445819|FG000|NOT COMPLETED|Overall Study||7
11252113|NCT02175472|12445820|FG001|NOT COMPLETED|Overall Study||2
11252114|NCT02175641|12445828|FG000|STARTED|Overall Study||157
11252115|NCT02175641|12445829|FG001|STARTED|Overall Study||157
11252116|NCT02175641|12445828|FG000|6-month Follow up|Overall Study||144
11252117|NCT02175641|12445829|FG001|6-month Follow up|Overall Study||149
11252118|NCT02175641|12445828|FG000|12-month Follow up|Overall Study||129
11252119|NCT02175641|12445829|FG001|12-month Follow up|Overall Study||136
11252120|NCT02175641|12445828|FG000|18-month Follow up|Overall Study||122
11252121|NCT02175641|12445829|FG001|18-month Follow up|Overall Study||130
11252122|NCT02175641|12445828|FG000|COMPLETED|Overall Study||122
11252123|NCT02175641|12445829|FG001|COMPLETED|Overall Study||130
11252124|NCT02175641|12445828|FG000|NOT COMPLETED|Overall Study||35
11252125|NCT02175641|12445829|FG001|NOT COMPLETED|Overall Study||27
11252126|NCT02175745|12445835|FG000|STARTED|Overall Study||2
11252127|NCT02175745|12445835|FG000|COMPLETED|Overall Study||1
11252128|NCT02175745|12445835|FG000|NOT COMPLETED|Overall Study||1
11252129|NCT02175758|12445845|FG000|STARTED|PK Lead-in Phase||4
11252130|NCT02175758|12445846|FG001|STARTED|PK Lead-in Phase||6
11252131|NCT02175758|12445847|FG002|STARTED|PK Lead-in Phase||2
11252132|NCT02175758|12445848|FG003|STARTED|PK Lead-in Phase||10
11252133|NCT02175758|12445849|FG004|STARTED|PK Lead-in Phase||4
11252134|NCT02175758|12445850|FG005|STARTED|PK Lead-in Phase||8
11252135|NCT02175758|12445845|FG000|COMPLETED|PK Lead-in Phase||4
11252136|NCT02175758|12445846|FG001|COMPLETED|PK Lead-in Phase||6
11252137|NCT02175758|12445847|FG002|COMPLETED|PK Lead-in Phase||2
11252138|NCT02175758|12445848|FG003|COMPLETED|PK Lead-in Phase||10
11252139|NCT02175758|12445849|FG004|COMPLETED|PK Lead-in Phase||4
11252140|NCT02175758|12445850|FG005|COMPLETED|PK Lead-in Phase||8
11252141|NCT02175758|12445845|FG000|NOT COMPLETED|PK Lead-in Phase||0
11252142|NCT02175758|12445846|FG001|NOT COMPLETED|PK Lead-in Phase||0
11252143|NCT02175758|12445847|FG002|NOT COMPLETED|PK Lead-in Phase||0
11252144|NCT02175758|12445848|FG003|NOT COMPLETED|PK Lead-in Phase||0
11252145|NCT02175758|12445849|FG004|NOT COMPLETED|PK Lead-in Phase||0
11252146|NCT02175758|12445850|FG005|NOT COMPLETED|PK Lead-in Phase||0
11252147|NCT02175758|12445845|FG000|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
11252148|NCT02175758|12445846|FG001|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39
11252149|NCT02175758|12445847|FG002|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
11252150|NCT02175758|12445848|FG003|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28
11252151|NCT02175758|12445849|FG004|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5
11252152|NCT02175758|12445850|FG005|STARTED|Treatment Phase||8
11252153|NCT02175758|12445845|FG000|COMPLETED|Treatment Phase||13
11252154|NCT02175758|12445846|FG001|COMPLETED|Treatment Phase||38
11252155|NCT02175758|12445847|FG002|COMPLETED|Treatment Phase||13
11252156|NCT02175758|12445848|FG003|COMPLETED|Treatment Phase||28
11252157|NCT02175758|12445849|FG004|COMPLETED|Treatment Phase||4
11252158|NCT02175758|12445850|FG005|COMPLETED|Treatment Phase||8
11252159|NCT02175758|12445845|FG000|NOT COMPLETED|Treatment Phase||0
11252160|NCT02175758|12445846|FG001|NOT COMPLETED|Treatment Phase||1
11252161|NCT02175758|12445847|FG002|NOT COMPLETED|Treatment Phase||0
11252162|NCT02175758|12445848|FG003|NOT COMPLETED|Treatment Phase||0
11252163|NCT02175758|12445849|FG004|NOT COMPLETED|Treatment Phase||1
11252164|NCT02175758|12445850|FG005|NOT COMPLETED|Treatment Phase||0
11252165|NCT02175771|12445898|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
11252166|NCT02175771|12445899|FG001|STARTED|Run-In Period (Pre-assignment)||0
11252167|NCT02175771|12445900|FG002|STARTED|Run-In Period (Pre-assignment)||0
11252168|NCT02175771|12445901|FG003|STARTED|Run-In Period (Pre-assignment)||0
11252169|NCT02175771|12445902|FG004|STARTED|Run-In Period (Pre-assignment)||0
11252170|NCT02175771|12445903|FG005|STARTED|Run-In Period (Pre-assignment)||0
11252171|NCT02175771|12445904|FG006|STARTED|Run-In Period (Pre-assignment)||0
11252172|NCT02175771|12445905|FG007|STARTED|Run-In Period (Pre-assignment)||0
11252173|NCT02175771|12445906|FG008|STARTED|Run-In Period (Pre-assignment)||0
11252174|NCT02175771|12445898|FG000|COMPLETED|Run-In Period (Pre-assignment)||674
11252175|NCT02175771|12445899|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
11252176|NCT02175771|12445900|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
11252177|NCT02175771|12445901|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
11252178|NCT02175771|12445902|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
11252179|NCT02175771|12445903|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
11252180|NCT02175771|12445904|FG006|COMPLETED|Run-In Period (Pre-assignment)||0
11252181|NCT02175771|12445905|FG007|COMPLETED|Run-In Period (Pre-assignment)||0
11252182|NCT02175771|12445906|FG008|COMPLETED|Run-In Period (Pre-assignment)||0
11252183|NCT02175771|12445898|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||84
11252184|NCT02175771|12445899|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11252185|NCT02175771|12445900|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11252186|NCT02175771|12445901|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11252187|NCT02175771|12445902|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11252188|NCT02175771|12445903|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11252189|NCT02175771|12445904|FG006|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11252190|NCT02175771|12445905|FG007|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11252191|NCT02175771|12445906|FG008|NOT COMPLETED|Run-In Period (Pre-assignment)||0
11252192|NCT02175771|12445898|FG000|STARTED|Treatment Period||0
11252193|NCT02175771|12445899|FG001|STARTED|Treatment Period||127
11252194|NCT02175771|12445900|FG002|STARTED|Treatment Period||42
11252195|NCT02175771|12445901|FG003|STARTED|Treatment Period||126
11252196|NCT02175771|12445902|FG004|STARTED|Treatment Period||41
11252197|NCT02175771|12445903|FG005|STARTED|Treatment Period||120
11252198|NCT02175771|12445904|FG006|STARTED|Treatment Period||41
11252199|NCT02175771|12445905|FG007|STARTED|Treatment Period||133
11252200|NCT02175771|12445906|FG008|STARTED|Treatment Period||44
11252201|NCT02175771|12445898|FG000|COMPLETED|Treatment Period||0
11252202|NCT02175771|12445899|FG001|COMPLETED|Treatment Period||111
11252203|NCT02175771|12445900|FG002|COMPLETED|Treatment Period||35
11252204|NCT02175771|12445901|FG003|COMPLETED|Treatment Period||113
11252205|NCT02175771|12445902|FG004|COMPLETED|Treatment Period||36
11252206|NCT02175771|12445903|FG005|COMPLETED|Treatment Period||110
11252207|NCT02175771|12445904|FG006|COMPLETED|Treatment Period||36
11252208|NCT02175771|12445905|FG007|COMPLETED|Treatment Period||116
11252209|NCT02175771|12445906|FG008|COMPLETED|Treatment Period||38
11252210|NCT02175771|12445898|FG000|NOT COMPLETED|Treatment Period||0
11252211|NCT02175771|12445899|FG001|NOT COMPLETED|Treatment Period||16
11252212|NCT02175771|12445900|FG002|NOT COMPLETED|Treatment Period||7
11252213|NCT02175771|12445901|FG003|NOT COMPLETED|Treatment Period||13
11252214|NCT02175771|12445902|FG004|NOT COMPLETED|Treatment Period||5
11252215|NCT02175771|12445903|FG005|NOT COMPLETED|Treatment Period||10
11252216|NCT02175771|12445904|FG006|NOT COMPLETED|Treatment Period||5
11252217|NCT02175771|12445905|FG007|NOT COMPLETED|Treatment Period||17
11252218|NCT02175771|12445906|FG008|NOT COMPLETED|Treatment Period||6
11252219|NCT02175966|12445926|FG000|STARTED|Treatment Period||14
11252220|NCT02175966|12445927|FG001|STARTED|Treatment Period||14
11252221|NCT02175966|12445926|FG000|COMPLETED|Treatment Period||14
11252222|NCT02175966|12445927|FG001|COMPLETED|Treatment Period||14
11252223|NCT02175966|12445926|FG000|NOT COMPLETED|Treatment Period||0
11252224|NCT02175966|12445927|FG001|NOT COMPLETED|Treatment Period||0
11252225|NCT02175966|12445926|FG000|STARTED|Follow-up Period||14
11252226|NCT02175966|12445927|FG001|STARTED|Follow-up Period||14
11252227|NCT02175966|12445926|FG000|COMPLETED|Follow-up Period||4
11252228|NCT02175966|12445927|FG001|COMPLETED|Follow-up Period||8
11252229|NCT02175966|12445926|FG000|NOT COMPLETED|Follow-up Period||10
11252230|NCT02175966|12445927|FG001|NOT COMPLETED|Follow-up Period||6
11252231|NCT02175979|12445935|FG000|STARTED|Overall Study||140
11252232|NCT02175979|12445936|FG001|STARTED|Overall Study||140
11252233|NCT02175979|12445935|FG000|COMPLETED|Overall Study||133
11252234|NCT02175979|12445936|FG001|COMPLETED|Overall Study||132
11252235|NCT02175979|12445935|FG000|NOT COMPLETED|Overall Study||7
11252236|NCT02175979|12445936|FG001|NOT COMPLETED|Overall Study||8
11252237|NCT02176005|12445946|FG000|STARTED|Overall Study||14
11252238|NCT02176005|12445947|FG001|STARTED|Overall Study||14
11252239|NCT02176005|12445948|FG002|STARTED|Overall Study||8
11252240|NCT02176005|12445949|FG003|STARTED|Overall Study||8
11252241|NCT02176005|12445946|FG000|COMPLETED|Overall Study||14
11252242|NCT02176005|12445947|FG001|COMPLETED|Overall Study||14
11252243|NCT02176005|12445948|FG002|COMPLETED|Overall Study||8
11252244|NCT02176005|12445949|FG003|COMPLETED|Overall Study||8
11252245|NCT02176005|12445946|FG000|NOT COMPLETED|Overall Study||0
11252246|NCT02176005|12445947|FG001|NOT COMPLETED|Overall Study||0
11252247|NCT02176005|12445948|FG002|NOT COMPLETED|Overall Study||0
11252248|NCT02176005|12445949|FG003|NOT COMPLETED|Overall Study||0
11252249|NCT02176018|12445961|FG000|STARTED|Overall Study||22
11252250|NCT02176018|12445962|FG001|STARTED|Overall Study||23
11252251|NCT02176018|12445961|FG000|COMPLETED|Overall Study||17
11252252|NCT02176018|12445962|FG001|COMPLETED|Overall Study||17
11252253|NCT02176018|12445961|FG000|NOT COMPLETED|Overall Study||5
11252254|NCT02176018|12445962|FG001|NOT COMPLETED|Overall Study||6
11252255|NCT02176031|12445968|FG000|STARTED|Overall Study||21
11252256|NCT02176031|12445968|FG000|COMPLETED|Overall Study||9
11252257|NCT02176031|12445968|FG000|NOT COMPLETED|Overall Study||12
11252258|NCT02176083|12445975|FG000|STARTED|Overall Study||11
11252259|NCT02176083|12445976|FG001|STARTED|Overall Study||27
11252260|NCT02176083|12445975|FG000|COMPLETED|Overall Study||11
11252261|NCT02176083|12445976|FG001|COMPLETED|Overall Study||27
11252262|NCT02176083|12445975|FG000|NOT COMPLETED|Overall Study||0
11252263|NCT02176083|12445976|FG001|NOT COMPLETED|Overall Study||0
11252264|NCT02176226|12445982|FG000|STARTED|Overall Study||105
11252265|NCT02176226|12445982|FG000|COMPLETED|Overall Study||96
11252266|NCT02176226|12445982|FG000|NOT COMPLETED|Overall Study||9
11252267|NCT02176291|12445988|FG000|STARTED|Overall Study||20
11252268|NCT02176291|12445989|FG001|STARTED|Overall Study||11
11252269|NCT02176291|12445988|FG000|COMPLETED|Overall Study||15
11252270|NCT02176291|12445989|FG001|COMPLETED|Overall Study||11
11252271|NCT02176291|12445988|FG000|NOT COMPLETED|Overall Study||5
11252272|NCT02176291|12445989|FG001|NOT COMPLETED|Overall Study||0
11252273|NCT02176343|12445995|FG000|STARTED|Overall Study||31
11252274|NCT02176343|12445995|FG000|COMPLETED|Overall Study||31
11252275|NCT02176343|12445995|FG000|NOT COMPLETED|Overall Study||0
11252276|NCT02176356|12445999|FG000|STARTED|Overall Study||116
11252277|NCT02176356|12445999|FG000|Eligible and Received Treatment|Overall Study||100
11252278|NCT02176356|12445999|FG000|COMPLETED|Overall Study||93
11252279|NCT02176356|12445999|FG000|NOT COMPLETED|Overall Study||23
11252280|NCT02176382|12446005|FG000|STARTED|DATA-HD Study||39
11252281|NCT02176382|12446006|FG001|STARTED|DATA-HD Study||37
11252282|NCT02176382|12446005|FG000|COMPLETED|DATA-HD Study||31
11252283|NCT02176382|12446006|FG001|COMPLETED|DATA-HD Study||29
11252284|NCT02176382|12446005|FG000|NOT COMPLETED|DATA-HD Study||8
11252285|NCT02176382|12446006|FG001|NOT COMPLETED|DATA-HD Study||8
11252286|NCT02176382|12446005|FG000|STARTED|DATA-HD Extension||27
11252287|NCT02176382|12446006|FG001|STARTED|DATA-HD Extension||26
11252288|NCT02176382|12446005|FG000|COMPLETED|DATA-HD Extension||26
11252289|NCT02176382|12446006|FG001|COMPLETED|DATA-HD Extension||26
11252290|NCT02176382|12446005|FG000|NOT COMPLETED|DATA-HD Extension||1
11252291|NCT02176382|12446006|FG001|NOT COMPLETED|DATA-HD Extension||0
11252292|NCT02176408|12446014|FG000|STARTED|Overall Study||15
11252293|NCT02176408|12446015|FG001|STARTED|Overall Study||16
11252294|NCT02176408|12446014|FG000|COMPLETED|Overall Study||9
11252295|NCT02176408|12446015|FG001|COMPLETED|Overall Study||12
11252296|NCT02176408|12446014|FG000|NOT COMPLETED|Overall Study||6
11252297|NCT02176408|12446015|FG001|NOT COMPLETED|Overall Study||4
11252298|NCT02176421|12446021|FG000|STARTED|Overall Study||80
11252299|NCT02176421|12446021|FG000|COMPLETED|Overall Study||75
11252300|NCT02176421|12446021|FG000|NOT COMPLETED|Overall Study||5
11252301|NCT02176486|12446028|FG000|STARTED|Overall Study||3
11252302|NCT02176486|12446029|FG001|STARTED|Overall Study||5
11252303|NCT02176486|12446030|FG002|STARTED|Overall Study||4
11252304|NCT02176486|12446028|FG000|COMPLETED|Overall Study||3
11252305|NCT02176486|12446029|FG001|COMPLETED|Overall Study||5
11252306|NCT02176486|12446030|FG002|COMPLETED|Overall Study||4
11252307|NCT02176486|12446028|FG000|NOT COMPLETED|Overall Study||0
11252308|NCT02176486|12446029|FG001|NOT COMPLETED|Overall Study||0
11252309|NCT02176486|12446030|FG002|NOT COMPLETED|Overall Study||0
11252310|NCT02176525|12446048|FG000|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
11252311|NCT02176525|12446049|FG001|STARTED|Overall Study||9
11252312|NCT02176525|12446050|FG002|STARTED|Overall Study||9
11252313|NCT02176525|12446051|FG003|STARTED|Overall Study||9
11252314|NCT02176525|12446052|FG004|STARTED|Overall Study||8
11252315|NCT02176525|12446053|FG005|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
11252316|NCT02176525|12446054|FG006|STARTED|Overall Study||9
11252317|NCT02176525|12446055|FG007|STARTED|Overall Study||10
11252318|NCT02176525|12446048|FG000|COMPLETED|Overall Study||14
11252319|NCT02176525|12446049|FG001|COMPLETED|Overall Study||9
11252320|NCT02176525|12446050|FG002|COMPLETED|Overall Study||9
11252321|NCT02176525|12446051|FG003|COMPLETED|Overall Study||8
11252322|NCT02176525|12446052|FG004|COMPLETED|Overall Study||7
11252323|NCT02176525|12446053|FG005|COMPLETED|Overall Study||5
11252324|NCT02176525|12446054|FG006|COMPLETED|Overall Study||8
11252325|NCT02176525|12446055|FG007|COMPLETED|Overall Study||10
11252326|NCT02176525|12446048|FG000|NOT COMPLETED|Overall Study||1
11252327|NCT02176525|12446049|FG001|NOT COMPLETED|Overall Study||0
11252328|NCT02176525|12446050|FG002|NOT COMPLETED|Overall Study||0
11252329|NCT02176525|12446051|FG003|NOT COMPLETED|Overall Study||1
11252330|NCT02176525|12446052|FG004|NOT COMPLETED|Overall Study||1
11252331|NCT02176525|12446053|FG005|NOT COMPLETED|Overall Study||1
11252332|NCT02176525|12446054|FG006|NOT COMPLETED|Overall Study||1
11252333|NCT02176525|12446055|FG007|NOT COMPLETED|Overall Study||0
11252334|NCT02176642|12446083|FG000|STARTED|Overall Study||18
11252335|NCT02176642|12446084|FG001|STARTED|Overall Study||17
11252336|NCT02176642|12446083|FG000|COMPLETED|Overall Study||18
11252337|NCT02176642|12446084|FG001|COMPLETED|Overall Study||16
11252338|NCT02176642|12446083|FG000|NOT COMPLETED|Overall Study||0
11252339|NCT02176642|12446084|FG001|NOT COMPLETED|Overall Study||1
11252340|NCT02176655|12446090|FG000|STARTED|Overall Study||31
11252341|NCT02176655|12446090|FG000|COMPLETED|Overall Study||25
11252342|NCT02176655|12446090|FG000|NOT COMPLETED|Overall Study||6
11252343|NCT02176837|12446095|FG000|STARTED|Overall Study||6
11252344|NCT02176837|12446095|FG000|COMPLETED|Overall Study||0
11252345|NCT02176837|12446095|FG000|NOT COMPLETED|Overall Study||6
11252346|NCT02176928|12446101|FG000|STARTED|Overall Study||21
11252347|NCT02176928|12446102|FG001|STARTED|Overall Study||21
11252348|NCT02176928|12446101|FG000|COMPLETED|Overall Study||19
11252349|NCT02176928|12446102|FG001|COMPLETED|Overall Study||17
11252350|NCT02176928|12446101|FG000|NOT COMPLETED|Overall Study||2
11252351|NCT02176928|12446102|FG001|NOT COMPLETED|Overall Study||4
11252352|NCT02177032|12446112|FG000|STARTED|Overall Study||355
11252353|NCT02177032|12446113|FG001|STARTED|Overall Study||88
11252354|NCT02177032|12446114|FG002|STARTED|Overall Study||354
11252355|NCT02177032|12446115|FG003|STARTED|Overall Study||88
11252356|NCT02177032|12446112|FG000|COMPLETED|Overall Study||350
11252357|NCT02177032|12446113|FG001|COMPLETED|Overall Study||86
11252358|NCT02177032|12446114|FG002|COMPLETED|Overall Study||351
11252359|NCT02177032|12446115|FG003|COMPLETED|Overall Study||88
11252360|NCT02177032|12446112|FG000|NOT COMPLETED|Overall Study||5
11252361|NCT02177032|12446113|FG001|NOT COMPLETED|Overall Study||2
11252362|NCT02177032|12446114|FG002|NOT COMPLETED|Overall Study||3
11252363|NCT02177032|12446115|FG003|NOT COMPLETED|Overall Study||0
11252364|NCT02177123|12446136|FG000|STARTED|Overall Study||107
11252365|NCT02177123|12446136|FG000|COMPLETED|Overall Study||83
11252366|NCT02177123|12446136|FG000|NOT COMPLETED|Overall Study||24
11252367|NCT02177136|12446146|FG000|STARTED|DB Phase||26
11252368|NCT02177136|12446147|FG001|STARTED|DB Phase||26
11252369|NCT02177136|12446148|FG002|STARTED|DB Phase||25
11252370|NCT02177136|12446149|FG003|STARTED|DB Phase||0
11252371|NCT02177136|12446146|FG000|Received At Least 1 Dose Of Study Drug|DB Phase|One participant randomized to receive 1.5 mg OCA titrating to 3 mg OCA withdrew prior to dosing.|25
11252372|NCT02177136|12446147|FG001|Received At Least 1 Dose Of Study Drug|DB Phase||26
11252373|NCT02177136|12446148|FG002|Received At Least 1 Dose Of Study Drug|DB Phase||25
11252374|NCT02177136|12446149|FG003|Received At Least 1 Dose Of Study Drug|DB Phase||0
11252375|NCT02177136|12446146|FG000|COMPLETED|DB Phase||19
11252376|NCT02177136|12446147|FG001|COMPLETED|DB Phase||21
11252377|NCT02177136|12446148|FG002|COMPLETED|DB Phase||21
11252378|NCT02177136|12446149|FG003|COMPLETED|DB Phase||0
11252379|NCT02177136|12446146|FG000|NOT COMPLETED|DB Phase||7
11252380|NCT02177136|12446147|FG001|NOT COMPLETED|DB Phase||5
11252381|NCT02177136|12446148|FG002|NOT COMPLETED|DB Phase||4
11252382|NCT02177136|12446149|FG003|NOT COMPLETED|DB Phase||0
11252383|NCT02177136|12446146|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
11252384|NCT02177136|12446147|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
11252385|NCT02177136|12446148|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
11252386|NCT02177136|12446149|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|59
11252387|NCT02177136|12446146|FG000|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
11252388|NCT02177136|12446147|FG001|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
11252389|NCT02177136|12446148|FG002|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
11252390|NCT02177136|12446149|FG003|Received At Least 1 Dose Of Study Drug|LTSE Phase||59
11252391|NCT02177136|12446146|FG000|COMPLETED|LTSE Phase||0
11252392|NCT02177136|12446147|FG001|COMPLETED|LTSE Phase||0
11252393|NCT02177136|12446148|FG002|COMPLETED|LTSE Phase||0
11252394|NCT02177136|12446149|FG003|COMPLETED|LTSE Phase||35
11252395|NCT02177136|12446146|FG000|NOT COMPLETED|LTSE Phase||0
11252396|NCT02177136|12446147|FG001|NOT COMPLETED|LTSE Phase||0
11252397|NCT02177136|12446148|FG002|NOT COMPLETED|LTSE Phase||0
11252398|NCT02177136|12446149|FG003|NOT COMPLETED|LTSE Phase||24
11252399|NCT02177201|12446162|FG000|STARTED|Overall Study||80
11252400|NCT02177201|12446163|FG001|STARTED|Overall Study||80
11252401|NCT02177201|12446162|FG000|COMPLETED|Overall Study||77
11252402|NCT02177201|12446163|FG001|COMPLETED|Overall Study||77
11252403|NCT02177201|12446162|FG000|NOT COMPLETED|Overall Study||3
11252404|NCT02177201|12446163|FG001|NOT COMPLETED|Overall Study||3
11252405|NCT02177786|12446173|FG000|STARTED|Overall Study||81
11252406|NCT02177786|12446174|FG001|STARTED|Overall Study||84
11252407|NCT02177786|12446175|FG002|STARTED|Overall Study||84
11252408|NCT02177786|12446176|FG003|STARTED|Overall Study||85
11252409|NCT02177786|12446173|FG000|Randomized and Treated|Overall Study||81
11252410|NCT02177786|12446174|FG001|Randomized and Treated|Overall Study||84
11252411|NCT02177786|12446175|FG002|Randomized and Treated|Overall Study||83
11252412|NCT02177786|12446176|FG003|Randomized and Treated|Overall Study||85
11252413|NCT02177786|12446173|FG000|COMPLETED|Overall Study||75
11252414|NCT02177786|12446174|FG001|COMPLETED|Overall Study||70
11252415|NCT02177786|12446175|FG002|COMPLETED|Overall Study||66
11252416|NCT02177786|12446176|FG003|COMPLETED|Overall Study||72
11252417|NCT02177786|12446173|FG000|NOT COMPLETED|Overall Study||6
11252418|NCT02177786|12446174|FG001|NOT COMPLETED|Overall Study||14
11252419|NCT02177786|12446175|FG002|NOT COMPLETED|Overall Study||18
11252420|NCT02177786|12446176|FG003|NOT COMPLETED|Overall Study||13
11252421|NCT02177812|12446195|FG000|STARTED|Part 1 (Median of 4 Weeks)||1
11252422|NCT02177812|12446196|FG001|STARTED|Part 1 (Median of 4 Weeks)||2
11252423|NCT02177812|12446197|FG002|STARTED|Part 1 (Median of 4 Weeks)||7
11252424|NCT02177812|12446198|FG003|STARTED|Part 1 (Median of 4 Weeks)||5
11252425|NCT02177812|12446199|FG004|STARTED|Part 1 (Median of 4 Weeks)||6
11252426|NCT02177812|12446200|FG005|STARTED|Part 1 (Median of 4 Weeks)||4
11252427|NCT02177812|12446201|FG006|STARTED|Part 1 (Median of 4 Weeks)||10
11252428|NCT02177812|12446202|FG007|STARTED|Part 1 (Median of 4 Weeks)||6
11252429|NCT02177812|12446203|FG008|STARTED|Part 1 (Median of 4 Weeks)||0
11252430|NCT02177812|12446195|FG000|COMPLETED|Part 1 (Median of 4 Weeks)||1
11252431|NCT02177812|12446196|FG001|COMPLETED|Part 1 (Median of 4 Weeks)||2
11252432|NCT02177812|12446197|FG002|COMPLETED|Part 1 (Median of 4 Weeks)||7
11252433|NCT02177812|12446198|FG003|COMPLETED|Part 1 (Median of 4 Weeks)||4
11252434|NCT02177812|12446199|FG004|COMPLETED|Part 1 (Median of 4 Weeks)||5
11252435|NCT02177812|12446200|FG005|COMPLETED|Part 1 (Median of 4 Weeks)||1
11252436|NCT02177812|12446201|FG006|COMPLETED|Part 1 (Median of 4 Weeks)||1
11252437|NCT02177812|12446202|FG007|COMPLETED|Part 1 (Median of 4 Weeks)||4
11252438|NCT02177812|12446203|FG008|COMPLETED|Part 1 (Median of 4 Weeks)||0
11252439|NCT02177812|12446195|FG000|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
11252440|NCT02177812|12446196|FG001|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
11252441|NCT02177812|12446197|FG002|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
11252442|NCT02177812|12446198|FG003|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
11252443|NCT02177812|12446199|FG004|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
11252444|NCT02177812|12446200|FG005|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3
11252445|NCT02177812|12446201|FG006|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9
11252446|NCT02177812|12446202|FG007|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2
11252447|NCT02177812|12446203|FG008|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
11252448|NCT02177812|12446195|FG000|STARTED|Part 2 (Up to 14 Months)||0
11252449|NCT02177812|12446196|FG001|STARTED|Part 2 (Up to 14 Months)||0
11252450|NCT02177812|12446197|FG002|STARTED|Part 2 (Up to 14 Months)||0
11252451|NCT02177812|12446198|FG003|STARTED|Part 2 (Up to 14 Months)||0
11252452|NCT02177812|12446199|FG004|STARTED|Part 2 (Up to 14 Months)||0
11252453|NCT02177812|12446200|FG005|STARTED|Part 2 (Up to 14 Months)||0
11252454|NCT02177812|12446201|FG006|STARTED|Part 2 (Up to 14 Months)||0
11252455|NCT02177812|12446202|FG007|STARTED|Part 2 (Up to 14 Months)||0
11252456|NCT02177812|12446203|FG008|STARTED|Part 2 (Up to 14 Months)||0
11252457|NCT02177812|12446195|FG000|COMPLETED|Part 2 (Up to 14 Months)||0
11252458|NCT02177812|12446196|FG001|COMPLETED|Part 2 (Up to 14 Months)||0
11252459|NCT02177812|12446197|FG002|COMPLETED|Part 2 (Up to 14 Months)||0
11252460|NCT02177812|12446198|FG003|COMPLETED|Part 2 (Up to 14 Months)||0
11252461|NCT02177812|12446199|FG004|COMPLETED|Part 2 (Up to 14 Months)||0
11252462|NCT02177812|12446200|FG005|COMPLETED|Part 2 (Up to 14 Months)||0
11252463|NCT02177812|12446201|FG006|COMPLETED|Part 2 (Up to 14 Months)||0
11252464|NCT02177812|12446202|FG007|COMPLETED|Part 2 (Up to 14 Months)||0
11252465|NCT02177812|12446203|FG008|COMPLETED|Part 2 (Up to 14 Months)||0
11252466|NCT02177812|12446195|FG000|NOT COMPLETED|Part 2 (Up to 14 Months)||0
11252467|NCT02177812|12446196|FG001|NOT COMPLETED|Part 2 (Up to 14 Months)||0
11252468|NCT02177812|12446197|FG002|NOT COMPLETED|Part 2 (Up to 14 Months)||0
11252469|NCT02177812|12446198|FG003|NOT COMPLETED|Part 2 (Up to 14 Months)||0
11252470|NCT02177812|12446199|FG004|NOT COMPLETED|Part 2 (Up to 14 Months)||0
11252471|NCT02177812|12446200|FG005|NOT COMPLETED|Part 2 (Up to 14 Months)||0
11252472|NCT02177812|12446201|FG006|NOT COMPLETED|Part 2 (Up to 14 Months)||0
11252473|NCT02177812|12446202|FG007|NOT COMPLETED|Part 2 (Up to 14 Months)||0
11252474|NCT02177812|12446203|FG008|NOT COMPLETED|Part 2 (Up to 14 Months)||0
11252475|NCT02177838|12446232|FG000|STARTED|Overall Study||8
11252476|NCT02177838|12446232|FG000|COMPLETED|Overall Study||5
11252477|NCT02177838|12446232|FG000|NOT COMPLETED|Overall Study||3
11252478|NCT02177942|12446238|FG000|STARTED|Overall Study||262
11252479|NCT02177942|12446239|FG001|STARTED|Overall Study||266
11252480|NCT02177942|12446238|FG000|COMPLETED|Overall Study||185
11252481|NCT02177942|12446239|FG001|COMPLETED|Overall Study||178
11252482|NCT02177942|12446238|FG000|NOT COMPLETED|Overall Study||77
11252483|NCT02177942|12446239|FG001|NOT COMPLETED|Overall Study||88
11252484|NCT02178059|12446249|FG000|STARTED|First Intervention||17
11252485|NCT02178059|12446250|FG001|STARTED|First Intervention||17
11252486|NCT02178059|12446249|FG000|COMPLETED|First Intervention||17
11252487|NCT02178059|12446250|FG001|COMPLETED|First Intervention||17
11252488|NCT02178059|12446249|FG000|NOT COMPLETED|First Intervention||0
11252489|NCT02178059|12446250|FG001|NOT COMPLETED|First Intervention||0
11252490|NCT02178059|12446249|FG000|STARTED|Washout||17
11252491|NCT02178059|12446250|FG001|STARTED|Washout||17
11252492|NCT02178059|12446249|FG000|COMPLETED|Washout||16
11252493|NCT02178059|12446250|FG001|COMPLETED|Washout||17
11252494|NCT02178059|12446249|FG000|NOT COMPLETED|Washout||1
11252495|NCT02178059|12446250|FG001|NOT COMPLETED|Washout||0
11252496|NCT02178059|12446249|FG000|STARTED|Second Intervention||16
11252497|NCT02178059|12446250|FG001|STARTED|Second Intervention||17
11252498|NCT02178059|12446249|FG000|COMPLETED|Second Intervention||16
11252499|NCT02178059|12446250|FG001|COMPLETED|Second Intervention||17
11252500|NCT02178059|12446249|FG000|NOT COMPLETED|Second Intervention||0
11252501|NCT02178059|12446250|FG001|NOT COMPLETED|Second Intervention||0
11252502|NCT02178241|12446256|FG000|STARTED|Overall Study||24
11252503|NCT02178241|12446256|FG000|COMPLETED|Overall Study||24
11252504|NCT02178241|12446256|FG000|NOT COMPLETED|Overall Study||0
11252505|NCT02178475|12446260|FG000|STARTED|Overall Study||943
11252506|NCT02178475|12446260|FG000|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
11252507|NCT02178475|12446260|FG000|COMPLETED|Overall Study||814
11252508|NCT02178475|12446260|FG000|NOT COMPLETED|Overall Study||129
11252509|NCT02178540|12446264|FG000|STARTED|Overall Study||45
11252510|NCT02178540|12446264|FG000|COMPLETED|Overall Study||45
11252511|NCT02178540|12446264|FG000|NOT COMPLETED|Overall Study||0
11252512|NCT02178553|12446273|FG000|STARTED|Overall Study||53
11252513|NCT02178553|12446274|FG001|STARTED|Overall Study||49
11252514|NCT02178553|12446273|FG000|COMPLETED|Overall Study||45
11252515|NCT02178553|12446274|FG001|COMPLETED|Overall Study||39
11252516|NCT02178553|12446273|FG000|NOT COMPLETED|Overall Study||8
11252517|NCT02178553|12446274|FG001|NOT COMPLETED|Overall Study||10
11252518|NCT02178592|12446282|FG000|STARTED|Randomized Phase (Up to Week 52)||69
11252519|NCT02178592|12446283|FG001|STARTED|Randomized Phase (Up to Week 52)||44
11252520|NCT02178592|12446282|FG000|COMPLETED|Randomized Phase (Up to Week 52)||50
11252521|NCT02178592|12446283|FG001|COMPLETED|Randomized Phase (Up to Week 52)||35
11252522|NCT02178592|12446282|FG000|NOT COMPLETED|Randomized Phase (Up to Week 52)||19
11252523|NCT02178592|12446283|FG001|NOT COMPLETED|Randomized Phase (Up to Week 52)||9
11252524|NCT02178592|12446282|FG000|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 3 participants from DTG arm did not enter OLE from Randomized Phase.|47
11252525|NCT02178592|12446283|FG001|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 16 participants from EFV arm did not enter OLE from Randomized Phase.|19
11252526|NCT02178592|12446282|FG000|COMPLETED|OLE Phase (Week 52 to Week 252)||35
11252527|NCT02178592|12446283|FG001|COMPLETED|OLE Phase (Week 52 to Week 252)||16
11252528|NCT02178592|12446282|FG000|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||12
11252529|NCT02178592|12446283|FG001|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||3
11252530|NCT02178696|12446292|FG000|STARTED|First Assignment and Washout||20
11252531|NCT02178696|12446293|FG001|STARTED|First Assignment and Washout||20
11252532|NCT02178696|12446292|FG000|COMPLETED|First Assignment and Washout||20
11252533|NCT02178696|12446293|FG001|COMPLETED|First Assignment and Washout||20
11252534|NCT02178696|12446292|FG000|NOT COMPLETED|First Assignment and Washout||0
11252535|NCT02178696|12446293|FG001|NOT COMPLETED|First Assignment and Washout||0
11252536|NCT02178696|12446292|FG000|STARTED|Second Assignment After Crossover||20
11252537|NCT02178696|12446293|FG001|STARTED|Second Assignment After Crossover||20
11252538|NCT02178696|12446292|FG000|COMPLETED|Second Assignment After Crossover||20
11252539|NCT02178696|12446293|FG001|COMPLETED|Second Assignment After Crossover||20
11252540|NCT02178696|12446292|FG000|NOT COMPLETED|Second Assignment After Crossover||0
11252541|NCT02178696|12446293|FG001|NOT COMPLETED|Second Assignment After Crossover||0
11252542|NCT02178696|12446292|FG000|STARTED|Open-label Antidepressant||20
11252543|NCT02178696|12446293|FG001|STARTED|Open-label Antidepressant||20
11252544|NCT02178696|12446292|FG000|COMPLETED|Open-label Antidepressant||14
11252545|NCT02178696|12446293|FG001|COMPLETED|Open-label Antidepressant||13
11252546|NCT02178696|12446292|FG000|NOT COMPLETED|Open-label Antidepressant||6
11252547|NCT02178696|12446293|FG001|NOT COMPLETED|Open-label Antidepressant||7
11252548|NCT02178787|12446306|FG000|STARTED|Overall Study||35
11252549|NCT02178787|12446307|FG001|STARTED|Overall Study||39
11252550|NCT02178787|12446306|FG000|COMPLETED|Overall Study||30
11252551|NCT02178787|12446307|FG001|COMPLETED|Overall Study||30
11252552|NCT02178787|12446306|FG000|NOT COMPLETED|Overall Study||5
11252553|NCT02178787|12446307|FG001|NOT COMPLETED|Overall Study||9
11252554|NCT02178800|12446317|FG000|STARTED|Overall Study||151
11252555|NCT02178800|12446318|FG001|STARTED|Overall Study||48
11252556|NCT02178800|12446317|FG000|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
11252557|NCT02178800|12446318|FG001|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
11252558|NCT02178800|12446317|FG000|NOT COMPLETED|Overall Study||20
11252559|NCT02178800|12446318|FG001|NOT COMPLETED|Overall Study||6
11252560|NCT02178995|12446334|FG000|STARTED|Double Blind||0
11252561|NCT02178995|12446335|FG001|STARTED|Double Blind||16
11252562|NCT02178995|12446336|FG002|STARTED|Double Blind||5
11252563|NCT02178995|12446337|FG003|STARTED|Double Blind||6
11252564|NCT02178995|12446338|FG004|STARTED|Double Blind||6
11252565|NCT02178995|12446339|FG005|STARTED|Double Blind||6
11252566|NCT02178995|12446340|FG006|STARTED|Double Blind||5
11252567|NCT02178995|12446341|FG007|STARTED|Double Blind||6
11252568|NCT02178995|12446342|FG008|STARTED|Double Blind||1
11252569|NCT02178995|12446334|FG000|COMPLETED|Double Blind||0
11252570|NCT02178995|12446335|FG001|COMPLETED|Double Blind||15
11252571|NCT02178995|12446336|FG002|COMPLETED|Double Blind||5
11252572|NCT02178995|12446337|FG003|COMPLETED|Double Blind||6
11252573|NCT02178995|12446338|FG004|COMPLETED|Double Blind||6
11252574|NCT02178995|12446339|FG005|COMPLETED|Double Blind||5
11252575|NCT02178995|12446340|FG006|COMPLETED|Double Blind||5
11252576|NCT02178995|12446341|FG007|COMPLETED|Double Blind||4
11252577|NCT02178995|12446342|FG008|COMPLETED|Double Blind||0
11252578|NCT02178995|12446334|FG000|NOT COMPLETED|Double Blind||0
11252579|NCT02178995|12446335|FG001|NOT COMPLETED|Double Blind||1
11252580|NCT02178995|12446336|FG002|NOT COMPLETED|Double Blind||0
11252581|NCT02178995|12446337|FG003|NOT COMPLETED|Double Blind||0
11252582|NCT02178995|12446338|FG004|NOT COMPLETED|Double Blind||0
11252583|NCT02178995|12446339|FG005|NOT COMPLETED|Double Blind||1
11252584|NCT02178995|12446340|FG006|NOT COMPLETED|Double Blind||0
11252585|NCT02178995|12446341|FG007|NOT COMPLETED|Double Blind||2
11252586|NCT02178995|12446342|FG008|NOT COMPLETED|Double Blind||1
11252587|NCT02178995|12446334|FG000|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
11252588|NCT02178995|12446335|FG001|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
11252589|NCT02178995|12446336|FG002|STARTED|Open Label||0
11252590|NCT02178995|12446337|FG003|STARTED|Open Label||0
11252591|NCT02178995|12446338|FG004|STARTED|Open Label||0
11252592|NCT02178995|12446339|FG005|STARTED|Open Label||0
11252593|NCT02178995|12446340|FG006|STARTED|Open Label||0
11252594|NCT02178995|12446341|FG007|STARTED|Open Label||0
11252595|NCT02178995|12446342|FG008|STARTED|Open Label||0
11252596|NCT02178995|12446334|FG000|COMPLETED|Open Label||28
11252597|NCT02178995|12446335|FG001|COMPLETED|Open Label||14
11252598|NCT02178995|12446336|FG002|COMPLETED|Open Label||0
11252599|NCT02178995|12446337|FG003|COMPLETED|Open Label||0
11252600|NCT02178995|12446338|FG004|COMPLETED|Open Label||0
11252601|NCT02178995|12446339|FG005|COMPLETED|Open Label||0
11252602|NCT02178995|12446340|FG006|COMPLETED|Open Label||0
11252603|NCT02178995|12446341|FG007|COMPLETED|Open Label||0
11252604|NCT02178995|12446342|FG008|COMPLETED|Open Label||0
11252605|NCT02178995|12446334|FG000|NOT COMPLETED|Open Label||2
11252606|NCT02178995|12446335|FG001|NOT COMPLETED|Open Label||0
11252607|NCT02178995|12446336|FG002|NOT COMPLETED|Open Label||0
11252608|NCT02178995|12446337|FG003|NOT COMPLETED|Open Label||0
11252609|NCT02178995|12446338|FG004|NOT COMPLETED|Open Label||0
11252610|NCT02178995|12446339|FG005|NOT COMPLETED|Open Label||0
11252611|NCT02178995|12446340|FG006|NOT COMPLETED|Open Label||0
11252612|NCT02178995|12446341|FG007|NOT COMPLETED|Open Label||0
11252613|NCT02178995|12446342|FG008|NOT COMPLETED|Open Label||0
11252614|NCT02179047|12446368|FG000|STARTED|Overall Study||194
11252615|NCT02179047|12446369|FG001|STARTED|Overall Study||20
11252616|NCT02179047|12446368|FG000|COMPLETED|Overall Study||187
11252617|NCT02179047|12446369|FG001|COMPLETED|Overall Study||20
11252618|NCT02179047|12446368|FG000|NOT COMPLETED|Overall Study||7
11252619|NCT02179047|12446369|FG001|NOT COMPLETED|Overall Study||0
11252620|NCT02179177|12446388|FG000|STARTED|Overall Study||8
11252621|NCT02179177|12446389|FG001|STARTED|Overall Study||8
11252622|NCT02179177|12446388|FG000|COMPLETED|Overall Study||6
11252623|NCT02179177|12446389|FG001|COMPLETED|Overall Study||6
11252624|NCT02179177|12446388|FG000|NOT COMPLETED|Overall Study||2
11252625|NCT02179177|12446389|FG001|NOT COMPLETED|Overall Study||2
11252626|NCT02179190|12446395|FG000|STARTED|Enrollment||138
11252627|NCT02179190|12446395|FG000|COMPLETED|Enrollment||127
11252628|NCT02179190|12446395|FG000|NOT COMPLETED|Enrollment||11
11252629|NCT02179190|12446395|FG000|STARTED|Index Procedure With Barrel VRD Attempt||127
11252630|NCT02179190|12446395|FG000|COMPLETED|Index Procedure With Barrel VRD Attempt||120
11252631|NCT02179190|12446395|FG000|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
11252632|NCT02179190|12446395|FG000|STARTED|Follow-Up Post Barrel VRD Implanted||120
11252633|NCT02179190|12446395|FG000|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
11252634|NCT02179190|12446395|FG000|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
11252635|NCT02179398|12446401|FG000|STARTED|Overall Study||134
11252636|NCT02179398|12446402|FG001|STARTED|Overall Study||144
11252637|NCT02179398|12446401|FG000|COMPLETED|Overall Study||131
11252638|NCT02179398|12446402|FG001|COMPLETED|Overall Study||140
11252639|NCT02179398|12446401|FG000|NOT COMPLETED|Overall Study||3
11252640|NCT02179398|12446402|FG001|NOT COMPLETED|Overall Study||4
11252641|NCT02179424|12446416|FG000|STARTED|Overall Study||76
11252642|NCT02179424|12446417|FG001|STARTED|Overall Study||11
11252643|NCT02179424|12446418|FG002|STARTED|Overall Study||516
11252644|NCT02179424|12446419|FG003|STARTED|Overall Study||39
11252645|NCT02179424|12446416|FG000|COMPLETED|Overall Study||76
11252646|NCT02179424|12446417|FG001|COMPLETED|Overall Study||11
11252647|NCT02179424|12446418|FG002|COMPLETED|Overall Study||516
11252648|NCT02179424|12446419|FG003|COMPLETED|Overall Study||39
11252649|NCT02179424|12446416|FG000|NOT COMPLETED|Overall Study||0
11252650|NCT02179424|12446417|FG001|NOT COMPLETED|Overall Study||0
11252651|NCT02179424|12446418|FG002|NOT COMPLETED|Overall Study||0
11252652|NCT02179424|12446419|FG003|NOT COMPLETED|Overall Study||0
11252653|NCT02179515|12446433|FG000|STARTED|Overall Study||3
11252654|NCT02179515|12446434|FG001|STARTED|Overall Study||17
11252655|NCT02179515|12446435|FG002|STARTED|Overall Study||18
11252656|NCT02179515|12446433|FG000|COMPLETED|Overall Study||1
11252657|NCT02179515|12446434|FG001|COMPLETED|Overall Study||1
11252658|NCT02179515|12446435|FG002|COMPLETED|Overall Study||4
11252659|NCT02179515|12446433|FG000|NOT COMPLETED|Overall Study||2
11252660|NCT02179515|12446434|FG001|NOT COMPLETED|Overall Study||16
11252661|NCT02179515|12446435|FG002|NOT COMPLETED|Overall Study||14
11252662|NCT02179671|12446452|FG000|STARTED|Overall Study||1
11252663|NCT02179671|12446453|FG001|STARTED|Overall Study||1
11252664|NCT02179671|12446454|FG002|STARTED|Overall Study||2
11252665|NCT02179671|12446455|FG003|STARTED|Overall Study||14
11252666|NCT02179671|12446456|FG004|STARTED|Overall Study||14
11252667|NCT02179671|12446452|FG000|COMPLETED|Overall Study||0
11252668|NCT02179671|12446453|FG001|COMPLETED|Overall Study||0
11252669|NCT02179671|12446454|FG002|COMPLETED|Overall Study||1
11252670|NCT02179671|12446455|FG003|COMPLETED|Overall Study||1
11252671|NCT02179671|12446456|FG004|COMPLETED|Overall Study||1
11252672|NCT02179671|12446452|FG000|NOT COMPLETED|Overall Study||1
11252673|NCT02179671|12446453|FG001|NOT COMPLETED|Overall Study||1
11252674|NCT02179671|12446454|FG002|NOT COMPLETED|Overall Study||1
11252675|NCT02179671|12446455|FG003|NOT COMPLETED|Overall Study||13
11252676|NCT02179671|12446456|FG004|NOT COMPLETED|Overall Study||13
11252677|NCT02179788|12446470|FG000|STARTED|Overall Study||10
11252678|NCT02179788|12446471|FG001|STARTED|Overall Study||5
11252679|NCT02179788|12446470|FG000|COMPLETED|Overall Study||10
11252680|NCT02179788|12446471|FG001|COMPLETED|Overall Study||5
11252681|NCT02179788|12446470|FG000|NOT COMPLETED|Overall Study||0
11252682|NCT02179788|12446471|FG001|NOT COMPLETED|Overall Study||0
11252683|NCT02179892|12446479|FG000|STARTED|Overall Study||5
11252684|NCT02179892|12446480|FG001|STARTED|Overall Study||4
11252685|NCT02179892|12446479|FG000|COMPLETED|Overall Study||5
11252686|NCT02179892|12446480|FG001|COMPLETED|Overall Study||4
11252687|NCT02179892|12446479|FG000|NOT COMPLETED|Overall Study||0
11252688|NCT02179892|12446480|FG001|NOT COMPLETED|Overall Study||0
11252689|NCT02179918|12446491|FG000|STARTED|Overall Study||5
11252690|NCT02179918|12446492|FG001|STARTED|Overall Study||3
11252691|NCT02179918|12446493|FG002|STARTED|Overall Study||3
11252692|NCT02179918|12446494|FG003|STARTED|Overall Study||3
11252693|NCT02179918|12446495|FG004|STARTED|Overall Study||9
11252694|NCT02179918|12446491|FG000|COMPLETED|Overall Study||1
11252695|NCT02179918|12446492|FG001|COMPLETED|Overall Study||0
11252696|NCT02179918|12446493|FG002|COMPLETED|Overall Study||1
11252697|NCT02179918|12446494|FG003|COMPLETED|Overall Study||0
11252698|NCT02179918|12446495|FG004|COMPLETED|Overall Study||1
11252699|NCT02179918|12446491|FG000|NOT COMPLETED|Overall Study||4
11252700|NCT02179918|12446492|FG001|NOT COMPLETED|Overall Study||3
11252701|NCT02179918|12446493|FG002|NOT COMPLETED|Overall Study||2
11252702|NCT02179918|12446494|FG003|NOT COMPLETED|Overall Study||3
11252703|NCT02179918|12446495|FG004|NOT COMPLETED|Overall Study||8
11252704|NCT02180061|12446510|FG000|STARTED|Overall Study||34
11252705|NCT02180061|12446511|FG001|STARTED|Overall Study||8
11252706|NCT02180061|12446510|FG000|COMPLETED|Overall Study||9
11252707|NCT02180061|12446511|FG001|COMPLETED|Overall Study||0
11252708|NCT02180061|12446510|FG000|NOT COMPLETED|Overall Study||25
11252709|NCT02180061|12446511|FG001|NOT COMPLETED|Overall Study||8
11252710|NCT02180100|12446519|FG000|STARTED|Overall Study||70
11252711|NCT02180100|12446520|FG001|STARTED|Overall Study||70
11252712|NCT02180100|12446519|FG000|COMPLETED|Overall Study||58
11252713|NCT02180100|12446520|FG001|COMPLETED|Overall Study||66
11252714|NCT02180100|12446519|FG000|NOT COMPLETED|Overall Study||12
11252715|NCT02180100|12446520|FG001|NOT COMPLETED|Overall Study||4
11252716|NCT02180165|12446530|FG000|STARTED|Overall Study||15
11252717|NCT02180165|12446531|FG001|STARTED|Overall Study||7
11252718|NCT02180165|12446532|FG002|STARTED|Overall Study||63
11252719|NCT02180165|12446533|FG003|STARTED|Overall Study||31
11252720|NCT02180165|12446530|FG000|Treated Participants|Overall Study||15
11252721|NCT02180165|12446531|FG001|Treated Participants|Overall Study||7
11252722|NCT02180165|12446532|FG002|Treated Participants|Overall Study||62
11252723|NCT02180165|12446533|FG003|Treated Participants|Overall Study||31
11252724|NCT02180165|12446530|FG000|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15
11252725|NCT02180165|12446531|FG001|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7
11252726|NCT02180165|12446532|FG002|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57
11252727|NCT02180165|12446533|FG003|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27
11252728|NCT02180165|12446530|FG000|COMPLETED|Overall Study||4
11252729|NCT02180165|12446531|FG001|COMPLETED|Overall Study||6
11252730|NCT02180165|12446532|FG002|COMPLETED|Overall Study||34
11252731|NCT02180165|12446533|FG003|COMPLETED|Overall Study||25
11252732|NCT02180165|12446530|FG000|NOT COMPLETED|Overall Study||11
11252733|NCT02180165|12446531|FG001|NOT COMPLETED|Overall Study||1
11252734|NCT02180165|12446532|FG002|NOT COMPLETED|Overall Study||29
11252735|NCT02180165|12446533|FG003|NOT COMPLETED|Overall Study||6
11252736|NCT02180230|12446545|FG000|STARTED|Overall Study||38
11252737|NCT02180230|12446545|FG000|COMPLETED|Overall Study||31
11252738|NCT02180230|12446545|FG000|NOT COMPLETED|Overall Study||7
11252739|NCT02180438|12446549|FG000|STARTED|Overall Study||30
11252740|NCT02180438|12446549|FG000|COMPLETED|Overall Study||29
11252741|NCT02180438|12446549|FG000|NOT COMPLETED|Overall Study||1
11252742|NCT02180646|12446555|FG000|STARTED|First Intervention (7 Days)||6
11252743|NCT02180646|12446556|FG001|STARTED|First Intervention (7 Days)||6
11252744|NCT02180646|12446555|FG000|COMPLETED|First Intervention (7 Days)||6
11252745|NCT02180646|12446556|FG001|COMPLETED|First Intervention (7 Days)||6
11252746|NCT02180646|12446555|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11252747|NCT02180646|12446556|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11252748|NCT02180646|12446555|FG000|STARTED|Washout (7 Days)||6
11252749|NCT02180646|12446556|FG001|STARTED|Washout (7 Days)||6
11252750|NCT02180646|12446555|FG000|COMPLETED|Washout (7 Days)||6
11252751|NCT02180646|12446556|FG001|COMPLETED|Washout (7 Days)||6
11252752|NCT02180646|12446555|FG000|NOT COMPLETED|Washout (7 Days)||0
11252753|NCT02180646|12446556|FG001|NOT COMPLETED|Washout (7 Days)||0
11252754|NCT02180646|12446555|FG000|STARTED|Second Intervention (7 Days)||6
11252755|NCT02180646|12446556|FG001|STARTED|Second Intervention (7 Days)||6
11252756|NCT02180646|12446555|FG000|COMPLETED|Second Intervention (7 Days)||6
11252757|NCT02180646|12446556|FG001|COMPLETED|Second Intervention (7 Days)||6
11252758|NCT02180646|12446555|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
11252759|NCT02180646|12446556|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11252760|NCT02180659|12446566|FG000|STARTED|Overall Study||87
11252761|NCT02180659|12446567|FG001|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
11252762|NCT02180659|12446566|FG000|COMPLETED|Overall Study||81
11252763|NCT02180659|12446567|FG001|COMPLETED|Overall Study||84
11252764|NCT02180659|12446566|FG000|NOT COMPLETED|Overall Study||6
11252765|NCT02180659|12446567|FG001|NOT COMPLETED|Overall Study||5
11252766|NCT02180672|12446575|FG000|STARTED|Overall Study||91
11252767|NCT02180672|12446576|FG001|STARTED|Overall Study||43
11252768|NCT02180672|12446575|FG000|COMPLETED|Overall Study||86
11252769|NCT02180672|12446576|FG001|COMPLETED|Overall Study||36
11252770|NCT02180672|12446575|FG000|NOT COMPLETED|Overall Study||5
11252771|NCT02180672|12446576|FG001|NOT COMPLETED|Overall Study||7
11252772|NCT02180828|12446584|FG000|STARTED|Overall Study||120
11252773|NCT02180828|12446585|FG001|STARTED|Overall Study||120
11252774|NCT02180828|12446584|FG000|COMPLETED|Overall Study||115
11252775|NCT02180828|12446585|FG001|COMPLETED|Overall Study||113
11252776|NCT02180828|12446584|FG000|NOT COMPLETED|Overall Study||5
11252777|NCT02180828|12446585|FG001|NOT COMPLETED|Overall Study||7
11252778|NCT02180893|12446593|FG000|STARTED|Overall Study||30
11252779|NCT02180893|12446594|FG001|STARTED|Overall Study||30
11252780|NCT02180893|12446593|FG000|COMPLETED|Overall Study||27
11252781|NCT02180893|12446594|FG001|COMPLETED|Overall Study||23
11252782|NCT02180893|12446593|FG000|NOT COMPLETED|Overall Study||3
11252783|NCT02180893|12446594|FG001|NOT COMPLETED|Overall Study||7
11252784|NCT02181075|12446602|FG000|STARTED|Overall Study||6
11252785|NCT02181075|12446603|FG001|STARTED|Overall Study||4
11252786|NCT02181075|12446602|FG000|COMPLETED|Overall Study||6
11252787|NCT02181075|12446603|FG001|COMPLETED|Overall Study||4
11252788|NCT02181075|12446602|FG000|NOT COMPLETED|Overall Study||0
11252789|NCT02181075|12446603|FG001|NOT COMPLETED|Overall Study||0
11252790|NCT02181127|12446613|FG000|STARTED|Overall Study||22
11252791|NCT02181127|12446613|FG000|COMPLETED|Overall Study||22
11252792|NCT02181127|12446613|FG000|NOT COMPLETED|Overall Study||0
11252793|NCT02181140|12446620|FG000|STARTED|Overall Study||56
11252794|NCT02181140|12446620|FG000|COMPLETED|Overall Study||56
11252795|NCT02181140|12446620|FG000|NOT COMPLETED|Overall Study||0
11252796|NCT02181231|12446628|FG000|STARTED|Overall Study||12
11252797|NCT02181231|12446629|FG001|STARTED|Overall Study||6
11252798|NCT02181231|12446628|FG000|COMPLETED|Overall Study||10
11252799|NCT02181231|12446629|FG001|COMPLETED|Overall Study||6
11252800|NCT02181231|12446628|FG000|NOT COMPLETED|Overall Study||2
11252801|NCT02181231|12446629|FG001|NOT COMPLETED|Overall Study||0
11252802|NCT02181296|12446637|FG000|STARTED|Overall Study||25
11252803|NCT02181296|12446638|FG001|STARTED|Overall Study||25
11252804|NCT02181296|12446637|FG000|COMPLETED|Overall Study||18
11252805|NCT02181296|12446638|FG001|COMPLETED|Overall Study||19
11252806|NCT02181296|12446637|FG000|NOT COMPLETED|Overall Study||7
11252807|NCT02181296|12446638|FG001|NOT COMPLETED|Overall Study||6
11252808|NCT02181387|12446646|FG000|STARTED|Overall Study||14
11252809|NCT02181387|12446647|FG001|STARTED|Overall Study||19
11252810|NCT02181387|12446646|FG000|COMPLETED|Overall Study||12
11252811|NCT02181387|12446647|FG001|COMPLETED|Overall Study||15
11252812|NCT02181387|12446646|FG000|NOT COMPLETED|Overall Study||2
11252813|NCT02181387|12446647|FG001|NOT COMPLETED|Overall Study||4
11252814|NCT02181400|12446656|FG000|STARTED|Overall Study||7
11252815|NCT02181400|12446657|FG001|STARTED|Overall Study||7
11252816|NCT02181400|12446658|FG002|STARTED|Overall Study||7
11252817|NCT02181400|12446656|FG000|COMPLETED|Overall Study||7
11252818|NCT02181400|12446657|FG001|COMPLETED|Overall Study||7
11252819|NCT02181400|12446658|FG002|COMPLETED|Overall Study||7
11252820|NCT02181400|12446656|FG000|NOT COMPLETED|Overall Study||0
11252821|NCT02181400|12446657|FG001|NOT COMPLETED|Overall Study||0
11252822|NCT02181400|12446658|FG002|NOT COMPLETED|Overall Study||0
11252823|NCT02181426|12446670|FG000|STARTED|Overall Study||28
11252824|NCT02181426|12446671|FG001|STARTED|Overall Study||28
11252825|NCT02181426|12446672|FG002|STARTED|Overall Study||28
11252826|NCT02181426|12446673|FG003|STARTED|Overall Study||28
11252827|NCT02181426|12446670|FG000|COMPLETED|Overall Study||28
11252828|NCT02181426|12446671|FG001|COMPLETED|Overall Study||28
11252829|NCT02181426|12446672|FG002|COMPLETED|Overall Study||28
11252830|NCT02181426|12446673|FG003|COMPLETED|Overall Study||28
11252831|NCT02181426|12446670|FG000|NOT COMPLETED|Overall Study||0
11252832|NCT02181426|12446671|FG001|NOT COMPLETED|Overall Study||0
11252833|NCT02181426|12446672|FG002|NOT COMPLETED|Overall Study||0
11252834|NCT02181426|12446673|FG003|NOT COMPLETED|Overall Study||0
11252835|NCT02181504|12446686|FG000|STARTED|Overall Study||10
11252836|NCT02181504|12446687|FG001|STARTED|Overall Study||10
11252837|NCT02181504|12446688|FG002|STARTED|Overall Study||5
11252838|NCT02181504|12446686|FG000|COMPLETED|Overall Study||9
11252839|NCT02181504|12446687|FG001|COMPLETED|Overall Study||9
11252840|NCT02181504|12446688|FG002|COMPLETED|Overall Study||4
11252841|NCT02181504|12446686|FG000|NOT COMPLETED|Overall Study||1
11252842|NCT02181504|12446687|FG001|NOT COMPLETED|Overall Study||1
11252843|NCT02181504|12446688|FG002|NOT COMPLETED|Overall Study||1
11252844|NCT02181517|12446700|FG000|STARTED|Overall Study||10
11252845|NCT02181517|12446701|FG001|STARTED|Overall Study||10
11252846|NCT02181517|12446702|FG002|STARTED|Overall Study||5
11252847|NCT02181517|12446700|FG000|COMPLETED|Overall Study||10
11252848|NCT02181517|12446701|FG001|COMPLETED|Overall Study||10
11252849|NCT02181517|12446702|FG002|COMPLETED|Overall Study||5
11252850|NCT02181517|12446700|FG000|NOT COMPLETED|Overall Study||0
11252851|NCT02181517|12446701|FG001|NOT COMPLETED|Overall Study||0
11252852|NCT02181517|12446702|FG002|NOT COMPLETED|Overall Study||0
11252853|NCT02181530|12446710|FG000|STARTED|Overall Study||43
11252854|NCT02181530|12446710|FG000|COMPLETED|Overall Study||43
11252855|NCT02181530|12446710|FG000|NOT COMPLETED|Overall Study||0
11252856|NCT02181556|12446714|FG000|STARTED|Overall Study||41
11252857|NCT02181556|12446714|FG000|COMPLETED|Overall Study||40
11252858|NCT02181556|12446714|FG000|NOT COMPLETED|Overall Study||1
11252859|NCT02181634|12446718|FG000|STARTED|Overall Study||74
11252860|NCT02181634|12446718|FG000|Eligible and Treated|Overall Study||73
11252861|NCT02181634|12446718|FG000|COMPLETED|Overall Study||2
11252862|NCT02181634|12446718|FG000|NOT COMPLETED|Overall Study||72
11252863|NCT02181673|12446724|FG000|STARTED|Up to Week 24||239
11252864|NCT02181673|12446725|FG001|STARTED|Up to Week 24||0
11252865|NCT02181673|12446726|FG002|STARTED|Up to Week 24||241
11252866|NCT02181673|12446724|FG000|Treated|Up to Week 24||239
11252867|NCT02181673|12446725|FG001|Treated|Up to Week 24||0
11252868|NCT02181673|12446726|FG002|Treated|Up to Week 24||240
11252869|NCT02181673|12446724|FG000|COMPLETED|Up to Week 24||222
11252870|NCT02181673|12446725|FG001|COMPLETED|Up to Week 24||0
11252871|NCT02181673|12446726|FG002|COMPLETED|Up to Week 24||230
11252872|NCT02181673|12446724|FG000|NOT COMPLETED|Up to Week 24||17
11252873|NCT02181673|12446725|FG001|NOT COMPLETED|Up to Week 24||0
11252874|NCT02181673|12446726|FG002|NOT COMPLETED|Up to Week 24||11
11252875|NCT02181673|12446724|FG000|STARTED|Week 24-Week 60||0
11252876|NCT02181673|12446725|FG001|STARTED|Week 24-Week 60||222
11252877|NCT02181673|12446726|FG002|STARTED|Week 24-Week 60||230
11252878|NCT02181673|12446724|FG000|Treated|Week 24-Week 60||0
11252879|NCT02181673|12446725|FG001|Treated|Week 24-Week 60||220
11252880|NCT02181673|12446726|FG002|Treated|Week 24-Week 60||230
11252881|NCT02181673|12446724|FG000|COMPLETED|Week 24-Week 60||0
11252882|NCT02181673|12446725|FG001|COMPLETED|Week 24-Week 60||214
11252883|NCT02181673|12446726|FG002|COMPLETED|Week 24-Week 60||213
11252884|NCT02181673|12446724|FG000|NOT COMPLETED|Week 24-Week 60||0
11252885|NCT02181673|12446725|FG001|NOT COMPLETED|Week 24-Week 60||8
11252886|NCT02181673|12446726|FG002|NOT COMPLETED|Week 24-Week 60||17
11339526|NCT02914522|12537029|FG002|COMPLETED|Maintenance Study: Week 11 to Week 58||0
11339527|NCT02914522|12537030|FG003|COMPLETED|Maintenance Study: Week 11 to Week 58||0
11339528|NCT02914522|12537031|FG004|COMPLETED|Maintenance Study: Week 11 to Week 58||0
11339529|NCT02914522|12537032|FG005|COMPLETED|Maintenance Study: Week 11 to Week 58||0
11339530|NCT02914522|12537033|FG006|COMPLETED|Maintenance Study: Week 11 to Week 58||150
11339531|NCT02914522|12537034|FG007|COMPLETED|Maintenance Study: Week 11 to Week 58||41
11339532|NCT02914522|12537035|FG008|COMPLETED|Maintenance Study: Week 11 to Week 58||104
11339533|NCT02914522|12537036|FG009|COMPLETED|Maintenance Study: Week 11 to Week 58||42
11339534|NCT02914522|12537037|FG010|COMPLETED|Maintenance Study: Week 11 to Week 58||64
11339535|NCT02914522|12537027|FG000|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
11339536|NCT02914522|12537028|FG001|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
11339537|NCT02914522|12537029|FG002|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
11339538|NCT02914522|12537030|FG003|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
11339539|NCT02914522|12537031|FG004|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
11339540|NCT02914522|12537032|FG005|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
11339541|NCT02914522|12537033|FG006|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||52
11339542|NCT02914522|12537034|FG007|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||58
11339543|NCT02914522|12537035|FG008|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||75
11339544|NCT02914522|12537036|FG009|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||49
11339545|NCT02914522|12537037|FG010|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||29
11339546|NCT02914548|12537067|FG000|STARTED|Overall Study||67
11339547|NCT02914548|12537068|FG001|STARTED|Overall Study||67
11339548|NCT02914548|12537069|FG002|STARTED|Overall Study||66
11339549|NCT02914548|12537067|FG000|COMPLETED|Overall Study||46
11339550|NCT02914548|12537068|FG001|COMPLETED|Overall Study||53
11339551|NCT02914548|12537069|FG002|COMPLETED|Overall Study||46
11339552|NCT02914548|12537067|FG000|NOT COMPLETED|Overall Study||21
11339553|NCT02914548|12537068|FG001|NOT COMPLETED|Overall Study||14
11339554|NCT02914548|12537069|FG002|NOT COMPLETED|Overall Study||20
11339555|NCT02914795|12537079|FG000|STARTED|Overall Study||77
11339556|NCT02914795|12537080|FG001|STARTED|Overall Study||22
11339557|NCT02914795|12537079|FG000|COMPLETED|Overall Study||77
11339558|NCT02914795|12537080|FG001|COMPLETED|Overall Study||22
11339559|NCT02914795|12537079|FG000|NOT COMPLETED|Overall Study||0
11339560|NCT02914795|12537080|FG001|NOT COMPLETED|Overall Study||0
11339561|NCT02914834|12537090|FG000|STARTED|Overall Study||12
11339562|NCT02914834|12537091|FG001|STARTED|Overall Study||15
11339563|NCT02914834|12537090|FG000|COMPLETED|Overall Study||11
11339564|NCT02914834|12537091|FG001|COMPLETED|Overall Study||13
11339565|NCT02914834|12537090|FG000|NOT COMPLETED|Overall Study||1
11339566|NCT02914834|12537091|FG001|NOT COMPLETED|Overall Study||2
11339567|NCT02915029|12537099|FG000|STARTED|Overall Study||63
11339568|NCT02915029|12537100|FG001|STARTED|Overall Study||62
11339569|NCT02915029|12537099|FG000|COMPLETED|Overall Study||50
11339570|NCT02915029|12537100|FG001|COMPLETED|Overall Study||48
11339571|NCT02915029|12537099|FG000|NOT COMPLETED|Overall Study||13
11339572|NCT02915029|12537100|FG001|NOT COMPLETED|Overall Study||14
11339573|NCT02915159|12537108|FG000|STARTED|Overall Study||92
11339574|NCT02915159|12537109|FG001|STARTED|Overall Study||95
11339575|NCT02915159|12537108|FG000|COMPLETED|Overall Study||81
11339576|NCT02915159|12537109|FG001|COMPLETED|Overall Study||87
11339577|NCT02915159|12537108|FG000|NOT COMPLETED|Overall Study||11
11339578|NCT02915159|12537109|FG001|NOT COMPLETED|Overall Study||8
11339579|NCT02915705|12537121|FG000|STARTED|Treatment Period||32
11339580|NCT02915705|12537122|FG001|STARTED|Treatment Period||29
11339581|NCT02915705|12537121|FG000|Completed Week 40|Treatment Period||32
11339582|NCT02915705|12537122|FG001|Completed Week 40|Treatment Period||29
11339583|NCT02915705|12537121|FG000|Completed Week 64|Treatment Period||32
11339584|NCT02915705|12537122|FG001|Completed Week 64|Treatment Period||29
11339585|NCT02915705|12537121|FG000|COMPLETED|Treatment Period||32
11339586|NCT02915705|12537122|FG001|COMPLETED|Treatment Period||29
11339587|NCT02915705|12537121|FG000|NOT COMPLETED|Treatment Period||0
11339588|NCT02915705|12537122|FG001|NOT COMPLETED|Treatment Period||0
11339589|NCT02915705|12537121|FG000|STARTED|Long Term Extension Period|6 participants did not enter the extension period|26
11339590|NCT02915705|12537122|FG001|STARTED|Long Term Extension Period|4 participants did not enter the extension period|25
11339591|NCT02915705|12537121|FG000|COMPLETED|Long Term Extension Period||26
11339592|NCT02915705|12537122|FG001|COMPLETED|Long Term Extension Period||25
11339593|NCT02915705|12537121|FG000|NOT COMPLETED|Long Term Extension Period||0
11339594|NCT02915705|12537122|FG001|NOT COMPLETED|Long Term Extension Period||0
11339595|NCT02915744|12537133|FG000|STARTED|Overall Study||92
11339596|NCT02915744|12537134|FG001|STARTED|Overall Study||86
11339597|NCT02915744|12537133|FG000|COMPLETED|Overall Study||13
11339598|NCT02915744|12537134|FG001|COMPLETED|Overall Study||9
11339599|NCT02915744|12537133|FG000|NOT COMPLETED|Overall Study||79
11339600|NCT02915744|12537134|FG001|NOT COMPLETED|Overall Study||77
11339601|NCT02915835|12537144|FG000|STARTED|Overall Study||9
11339602|NCT02915835|12537145|FG001|STARTED|Overall Study||8
11252887|NCT02181738|12446737|FG000|STARTED|Overall Study||63
11252888|NCT02181738|12446738|FG001|STARTED|Overall Study||80
11252889|NCT02181738|12446739|FG002|STARTED|Overall Study||100
11252890|NCT02181738|12446740|FG003|STARTED|Overall Study||51
11252891|NCT02181738|12446737|FG000|COMPLETED|Overall Study||61
11252892|NCT02181738|12446738|FG001|COMPLETED|Overall Study||71
11252893|NCT02181738|12446739|FG002|COMPLETED|Overall Study||90
11252894|NCT02181738|12446740|FG003|COMPLETED|Overall Study||49
11252895|NCT02181738|12446737|FG000|NOT COMPLETED|Overall Study||2
11252896|NCT02181738|12446738|FG001|NOT COMPLETED|Overall Study||9
11252897|NCT02181738|12446739|FG002|NOT COMPLETED|Overall Study||10
11252898|NCT02181738|12446740|FG003|NOT COMPLETED|Overall Study||2
11252899|NCT02181803|12446759|FG000|STARTED|Overall Study||1
11252900|NCT02181803|12446760|FG001|STARTED|Overall Study||13
11252901|NCT02181803|12446761|FG002|STARTED|Overall Study||4
11252902|NCT02181803|12446762|FG003|STARTED|Overall Study||13
11252903|NCT02181803|12446763|FG004|STARTED|Overall Study||6
11252904|NCT02181803|12446764|FG005|STARTED|Overall Study||6
11252905|NCT02181803|12446765|FG006|STARTED|Overall Study||9
11252906|NCT02181803|12446766|FG007|STARTED|Overall Study||1
11252907|NCT02181803|12446767|FG008|STARTED|Overall Study||2
11252908|NCT02181803|12446759|FG000|COMPLETED|Overall Study||1
11252909|NCT02181803|12446760|FG001|COMPLETED|Overall Study||9
11252910|NCT02181803|12446761|FG002|COMPLETED|Overall Study||4
11252911|NCT02181803|12446762|FG003|COMPLETED|Overall Study||11
11252912|NCT02181803|12446763|FG004|COMPLETED|Overall Study||6
11252913|NCT02181803|12446764|FG005|COMPLETED|Overall Study||6
11252914|NCT02181803|12446765|FG006|COMPLETED|Overall Study||8
11252915|NCT02181803|12446766|FG007|COMPLETED|Overall Study||0
11252916|NCT02181803|12446767|FG008|COMPLETED|Overall Study||2
11252917|NCT02181803|12446759|FG000|NOT COMPLETED|Overall Study||0
11252918|NCT02181803|12446760|FG001|NOT COMPLETED|Overall Study||4
11252919|NCT02181803|12446761|FG002|NOT COMPLETED|Overall Study||0
11252920|NCT02181803|12446762|FG003|NOT COMPLETED|Overall Study||2
11252921|NCT02181803|12446763|FG004|NOT COMPLETED|Overall Study||0
11252922|NCT02181803|12446764|FG005|NOT COMPLETED|Overall Study||0
11252923|NCT02181803|12446765|FG006|NOT COMPLETED|Overall Study||1
11252924|NCT02181803|12446766|FG007|NOT COMPLETED|Overall Study||1
11252925|NCT02181803|12446767|FG008|NOT COMPLETED|Overall Study||0
11252926|NCT02181816|12446812|FG000|STARTED|Overall Study||1090
11252927|NCT02181816|12446812|FG000|COMPLETED|Overall Study||1031
11252928|NCT02181816|12446812|FG000|NOT COMPLETED|Overall Study||59
11252929|NCT02181829|12446816|FG000|STARTED|Overall Study||10
11252930|NCT02181829|12446816|FG000|COMPLETED|Overall Study||10
11252931|NCT02181829|12446816|FG000|NOT COMPLETED|Overall Study||0
11252932|NCT02181842|12446820|FG000|STARTED|Overall Study||246
11252933|NCT02181842|12446820|FG000|COMPLETED|Overall Study||244
11252934|NCT02181842|12446820|FG000|NOT COMPLETED|Overall Study||2
11252935|NCT02182115|12446826|FG000|STARTED|Overall Study||53
11252936|NCT02182115|12446827|FG001|STARTED|Overall Study||57
11252937|NCT02182115|12446826|FG000|COMPLETED|Overall Study||53
11252938|NCT02182115|12446827|FG001|COMPLETED|Overall Study||57
11252939|NCT02182115|12446826|FG000|NOT COMPLETED|Overall Study||0
11252940|NCT02182115|12446827|FG001|NOT COMPLETED|Overall Study||0
11252941|NCT02182440|12446837|FG000|STARTED|Overall Study||116
11252942|NCT02182440|12446838|FG001|STARTED|Overall Study||39
11252943|NCT02182440|12446839|FG002|STARTED|Overall Study||35
11252944|NCT02182440|12446840|FG003|STARTED|Overall Study||111
11252945|NCT02182440|12446837|FG000|ITTcombined|Overall Study||116
11252946|NCT02182440|12446838|FG001|ITTcombined|Overall Study||31
11252947|NCT02182440|12446839|FG002|ITTcombined|Overall Study||32
11252948|NCT02182440|12446840|FG003|ITTcombined|Overall Study||111
11252949|NCT02182440|12446837|FG000|ITTinterim|Overall Study||30
11252950|NCT02182440|12446838|FG001|ITTinterim|Overall Study||31
11252951|NCT02182440|12446839|FG002|ITTinterim|Overall Study||32
11252952|NCT02182440|12446840|FG003|ITTinterim|Overall Study||29
11252953|NCT02182440|12446837|FG000|Safety Population|Overall Study||112
11252954|NCT02182440|12446838|FG001|Safety Population|Overall Study||38
11252955|NCT02182440|12446839|FG002|Safety Population|Overall Study||35
11252956|NCT02182440|12446840|FG003|Safety Population|Overall Study||109
11252957|NCT02182440|12446837|FG000|COMPLETED|Overall Study||71
11252958|NCT02182440|12446838|FG001|COMPLETED|Overall Study||25
11252959|NCT02182440|12446839|FG002|COMPLETED|Overall Study||24
11252960|NCT02182440|12446840|FG003|COMPLETED|Overall Study||81
11252961|NCT02182440|12446837|FG000|NOT COMPLETED|Overall Study||45
11252962|NCT02182440|12446838|FG001|NOT COMPLETED|Overall Study||14
11252963|NCT02182440|12446839|FG002|NOT COMPLETED|Overall Study||11
11252964|NCT02182440|12446840|FG003|NOT COMPLETED|Overall Study||30
11252965|NCT02182492|12446854|FG000|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
11252966|NCT02182492|12446855|FG001|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
11252967|NCT02182492|12446854|FG000|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
11252968|NCT02182492|12446855|FG001|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
11252969|NCT02182492|12446854|FG000|NOT COMPLETED|Overall Study||7
11252970|NCT02182492|12446855|FG001|NOT COMPLETED|Overall Study||8
11252971|NCT02182804|12446861|FG000|STARTED|Overall Study||44
11252972|NCT02182804|12446861|FG000|COMPLETED|Overall Study||44
11252973|NCT02182804|12446861|FG000|NOT COMPLETED|Overall Study||0
11252974|NCT02182830|12446867|FG000|STARTED|Overall Study||83
11252975|NCT02182830|12446868|FG001|STARTED|Overall Study||83
11252976|NCT02182830|12446867|FG000|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
11252977|NCT02182830|12446868|FG001|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
11252978|NCT02182830|12446867|FG000|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
11252979|NCT02182830|12446868|FG001|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
11252980|NCT02182830|12446867|FG000|COMPLETED|Overall Study||68
11252981|NCT02182830|12446868|FG001|COMPLETED|Overall Study||68
11252982|NCT02182830|12446867|FG000|NOT COMPLETED|Overall Study||15
11252983|NCT02182830|12446868|FG001|NOT COMPLETED|Overall Study||15
11252984|NCT02182843|12446874|FG000|STARTED|Overall Study||81
11252985|NCT02182843|12446874|FG000|COMPLETED|Overall Study||71
11252986|NCT02182843|12446874|FG000|NOT COMPLETED|Overall Study||10
11252987|NCT02182895|12446880|FG000|STARTED|Overall Study||35
11252988|NCT02182895|12446881|FG001|STARTED|Overall Study||37
11252989|NCT02182895|12446880|FG000|COMPLETED|Overall Study||33
11252990|NCT02182895|12446881|FG001|COMPLETED|Overall Study||33
11252991|NCT02182895|12446880|FG000|NOT COMPLETED|Overall Study||2
11252992|NCT02182895|12446881|FG001|NOT COMPLETED|Overall Study||4
11252993|NCT02182947|12446887|FG000|STARTED|Overall Study||45
11252994|NCT02182947|12446887|FG000|COMPLETED|Overall Study||27
11252995|NCT02182947|12446887|FG000|NOT COMPLETED|Overall Study||18
11252996|NCT02182973|12446893|FG000|STARTED|Overall Study||12
11252997|NCT02182973|12446894|FG001|STARTED|Overall Study||9
11252998|NCT02182973|12446893|FG000|COMPLETED|Overall Study||9
11252999|NCT02182973|12446894|FG001|COMPLETED|Overall Study||9
11253000|NCT02182973|12446893|FG000|NOT COMPLETED|Overall Study||3
11253001|NCT02182973|12446894|FG001|NOT COMPLETED|Overall Study||0
11253002|NCT02182999|12446903|FG000|STARTED|Overall Study||25
11253003|NCT02182999|12446904|FG001|STARTED|Overall Study||25
11253004|NCT02182999|12446903|FG000|COMPLETED|Overall Study||20
11253005|NCT02182999|12446904|FG001|COMPLETED|Overall Study||22
11253006|NCT02182999|12446903|FG000|NOT COMPLETED|Overall Study||5
11253007|NCT02182999|12446904|FG001|NOT COMPLETED|Overall Study||3
11253008|NCT02183519|12446912|FG000|STARTED|Overall Study||28
11253009|NCT02183519|12446913|FG001|STARTED|Overall Study||16
11253010|NCT02183519|12446912|FG000|COMPLETED|Overall Study||25
11253011|NCT02183519|12446913|FG001|COMPLETED|Overall Study||13
11253012|NCT02183519|12446912|FG000|NOT COMPLETED|Overall Study||3
11253013|NCT02183519|12446913|FG001|NOT COMPLETED|Overall Study||3
11253014|NCT02183675|12446925|FG000|STARTED|Treatment Period 1 (10 Days)||6
11253015|NCT02183675|12446926|FG001|STARTED|Treatment Period 1 (10 Days)||6
11253016|NCT02183675|12446927|FG002|STARTED|Treatment Period 1 (10 Days)||6
11253017|NCT02183675|12446928|FG003|STARTED|Treatment Period 1 (10 Days)||6
11253018|NCT02183675|12446929|FG004|STARTED|Treatment Period 1 (10 Days)||6
11253019|NCT02183675|12446930|FG005|STARTED|Treatment Period 1 (10 Days)||6
11253020|NCT02183675|12446925|FG000|COMPLETED|Treatment Period 1 (10 Days)||6
11253021|NCT02183675|12446926|FG001|COMPLETED|Treatment Period 1 (10 Days)||6
11253022|NCT02183675|12446927|FG002|COMPLETED|Treatment Period 1 (10 Days)||6
11253023|NCT02183675|12446928|FG003|COMPLETED|Treatment Period 1 (10 Days)||6
11253024|NCT02183675|12446929|FG004|COMPLETED|Treatment Period 1 (10 Days)||6
11253025|NCT02183675|12446930|FG005|COMPLETED|Treatment Period 1 (10 Days)||6
11253026|NCT02183675|12446925|FG000|NOT COMPLETED|Treatment Period 1 (10 Days)||0
11253027|NCT02183675|12446926|FG001|NOT COMPLETED|Treatment Period 1 (10 Days)||0
11253028|NCT02183675|12446927|FG002|NOT COMPLETED|Treatment Period 1 (10 Days)||0
11253029|NCT02183675|12446928|FG003|NOT COMPLETED|Treatment Period 1 (10 Days)||0
11358629|NCT03126786|12555768|FG001|COMPLETED|Overall Study||33
11358630|NCT03126786|12555767|FG000|NOT COMPLETED|Overall Study||6
11358631|NCT03126786|12555768|FG001|NOT COMPLETED|Overall Study||2
11358632|NCT03127228|12555776|FG000|STARTED|Overall Study||12
11253030|NCT02183675|12446929|FG004|NOT COMPLETED|Treatment Period 1 (10 Days)||0
11253031|NCT02183675|12446930|FG005|NOT COMPLETED|Treatment Period 1 (10 Days)||0
11253032|NCT02183675|12446925|FG000|STARTED|Treatment Period 2 (10 Days)||6
11253033|NCT02183675|12446926|FG001|STARTED|Treatment Period 2 (10 Days)||6
11253034|NCT02183675|12446927|FG002|STARTED|Treatment Period 2 (10 Days)||6
11253035|NCT02183675|12446928|FG003|STARTED|Treatment Period 2 (10 Days)||6
11253036|NCT02183675|12446929|FG004|STARTED|Treatment Period 2 (10 Days)||6
11253037|NCT02183675|12446930|FG005|STARTED|Treatment Period 2 (10 Days)||6
11253038|NCT02183675|12446925|FG000|COMPLETED|Treatment Period 2 (10 Days)||6
11253039|NCT02183675|12446926|FG001|COMPLETED|Treatment Period 2 (10 Days)||6
11253040|NCT02183675|12446927|FG002|COMPLETED|Treatment Period 2 (10 Days)||6
11253041|NCT02183675|12446928|FG003|COMPLETED|Treatment Period 2 (10 Days)||6
11253042|NCT02183675|12446929|FG004|COMPLETED|Treatment Period 2 (10 Days)||6
11253043|NCT02183675|12446930|FG005|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
11253044|NCT02183675|12446925|FG000|NOT COMPLETED|Treatment Period 2 (10 Days)||0
11253045|NCT02183675|12446926|FG001|NOT COMPLETED|Treatment Period 2 (10 Days)||0
11253046|NCT02183675|12446927|FG002|NOT COMPLETED|Treatment Period 2 (10 Days)||0
11253047|NCT02183675|12446928|FG003|NOT COMPLETED|Treatment Period 2 (10 Days)||0
11253048|NCT02183675|12446929|FG004|NOT COMPLETED|Treatment Period 2 (10 Days)||0
11253049|NCT02183675|12446930|FG005|NOT COMPLETED|Treatment Period 2 (10 Days)||2
11253050|NCT02183675|12446925|FG000|STARTED|Treatment Period 3 (10 Days)||6
11253051|NCT02183675|12446926|FG001|STARTED|Treatment Period 3 (10 Days)||6
11253052|NCT02183675|12446927|FG002|STARTED|Treatment Period 3 (10 Days)||6
11253053|NCT02183675|12446928|FG003|STARTED|Treatment Period 3 (10 Days)||6
11253054|NCT02183675|12446929|FG004|STARTED|Treatment Period 3 (10 Days)||6
11253055|NCT02183675|12446930|FG005|STARTED|Treatment Period 3 (10 Days)||4
11253056|NCT02183675|12446925|FG000|COMPLETED|Treatment Period 3 (10 Days)||6
11253057|NCT02183675|12446926|FG001|COMPLETED|Treatment Period 3 (10 Days)||6
11253058|NCT02183675|12446927|FG002|COMPLETED|Treatment Period 3 (10 Days)||6
11253059|NCT02183675|12446928|FG003|COMPLETED|Treatment Period 3 (10 Days)||6
11253060|NCT02183675|12446929|FG004|COMPLETED|Treatment Period 3 (10 Days)||6
11253061|NCT02183675|12446930|FG005|COMPLETED|Treatment Period 3 (10 Days)||4
11253062|NCT02183675|12446925|FG000|NOT COMPLETED|Treatment Period 3 (10 Days)||0
11253063|NCT02183675|12446926|FG001|NOT COMPLETED|Treatment Period 3 (10 Days)||0
11253064|NCT02183675|12446927|FG002|NOT COMPLETED|Treatment Period 3 (10 Days)||0
11253065|NCT02183675|12446928|FG003|NOT COMPLETED|Treatment Period 3 (10 Days)||0
11253066|NCT02183675|12446929|FG004|NOT COMPLETED|Treatment Period 3 (10 Days)||0
11253067|NCT02183675|12446930|FG005|NOT COMPLETED|Treatment Period 3 (10 Days)||0
11253068|NCT02183792|12446942|FG000|STARTED|Overall Study||18
11253069|NCT02183792|12446943|FG001|STARTED|Overall Study||15
11253070|NCT02183792|12446942|FG000|COMPLETED|Overall Study||18
11253071|NCT02183792|12446943|FG001|COMPLETED|Overall Study||15
11253072|NCT02183792|12446942|FG000|NOT COMPLETED|Overall Study||0
11253073|NCT02183792|12446943|FG001|NOT COMPLETED|Overall Study||0
11253074|NCT02184143|12446951|FG000|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124
11253075|NCT02184143|12446952|FG001|STARTED|Overall Study|124 participants randomized; 121 received intervention|124
11253076|NCT02184143|12446951|FG000|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114
11253077|NCT02184143|12446952|FG001|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117
11253078|NCT02184143|12446951|FG000|NOT COMPLETED|Overall Study||10
11253079|NCT02184143|12446952|FG001|NOT COMPLETED|Overall Study||7
11253080|NCT02184169|12446962|FG000|STARTED|Overall Study||21
11253081|NCT02184169|12446963|FG001|STARTED|Overall Study||6
11253082|NCT02184169|12446962|FG000|COMPLETED|Overall Study||21
11253083|NCT02184169|12446963|FG001|COMPLETED|Overall Study||6
11253084|NCT02184169|12446962|FG000|NOT COMPLETED|Overall Study||0
11253085|NCT02184169|12446963|FG001|NOT COMPLETED|Overall Study||0
11253086|NCT02184208|12446971|FG000|STARTED|Overall Study||278
11253087|NCT02184208|12446971|FG000|COMPLETED|Overall Study||222
11253088|NCT02184208|12446971|FG000|NOT COMPLETED|Overall Study||56
11253089|NCT02184442|12446979|FG000|STARTED|Overall Study||284
11253090|NCT02184442|12446980|FG001|STARTED|Overall Study||276
11253091|NCT02184442|12446979|FG000|As-Treated|Overall Study||282
11253092|NCT02184442|12446980|FG001|As-Treated|Overall Study||271
11253093|NCT02184442|12446979|FG000|Valve-Implant|Overall Study||280
11253094|NCT02184442|12446980|FG001|Valve-Implant|Overall Study||263
11253095|NCT02184442|12446979|FG000|COMPLETED|Overall Study||220
11253096|NCT02184442|12446980|FG001|COMPLETED|Overall Study||200
11253097|NCT02184442|12446979|FG000|NOT COMPLETED|Overall Study||64
11253098|NCT02184442|12446980|FG001|NOT COMPLETED|Overall Study||76
11253099|NCT02184455|12446986|FG000|STARTED|Overall Study||11
11253100|NCT02184455|12446986|FG000|COMPLETED|Overall Study||10
11253101|NCT02184455|12446986|FG000|NOT COMPLETED|Overall Study||1
11253102|NCT02184494|12446993|FG000|STARTED|Overall Study||13
11253103|NCT02184494|12446994|FG001|STARTED|Overall Study||13
11253104|NCT02184494|12446995|FG002|STARTED|Overall Study||8
11253105|NCT02184494|12446993|FG000|COMPLETED|Overall Study||12
11253106|NCT02184494|12446994|FG001|COMPLETED|Overall Study||11
11253107|NCT02184494|12446995|FG002|COMPLETED|Overall Study||8
11253108|NCT02184494|12446993|FG000|NOT COMPLETED|Overall Study||1
11253109|NCT02184494|12446994|FG001|NOT COMPLETED|Overall Study||2
11253110|NCT02184494|12446995|FG002|NOT COMPLETED|Overall Study||0
11253111|NCT02184572|12447005|FG000|STARTED|Overall Study||1164
11253112|NCT02184572|12447006|FG001|STARTED|Overall Study||572
11253113|NCT02184572|12447005|FG000|COMPLETED|Overall Study||1117
11253114|NCT02184572|12447006|FG001|COMPLETED|Overall Study||542
11253115|NCT02184572|12447005|FG000|NOT COMPLETED|Overall Study||47
11253116|NCT02184572|12447006|FG001|NOT COMPLETED|Overall Study||30
11253117|NCT02184611|12447016|FG000|STARTED|Overall Study||101
11253118|NCT02184611|12447017|FG001|STARTED|Overall Study||205
11253119|NCT02184611|12447016|FG000|COMPLETED|Overall Study||80
11253120|NCT02184611|12447017|FG001|COMPLETED|Overall Study||177
11253121|NCT02184611|12447016|FG000|NOT COMPLETED|Overall Study||21
11253122|NCT02184611|12447017|FG001|NOT COMPLETED|Overall Study||28
11253123|NCT02184624|12447028|FG000|STARTED|Overall Study||171
11253124|NCT02184624|12447029|FG001|STARTED|Overall Study||80
11253125|NCT02184624|12447030|FG002|STARTED|Overall Study||100
11253126|NCT02184624|12447031|FG003|STARTED|Overall Study||118
11253127|NCT02184624|12447032|FG004|STARTED|Overall Study||98
11253128|NCT02184624|12447028|FG000|COMPLETED|Overall Study||171
11253129|NCT02184624|12447029|FG001|COMPLETED|Overall Study||80
11253130|NCT02184624|12447030|FG002|COMPLETED|Overall Study||100
11253131|NCT02184624|12447031|FG003|COMPLETED|Overall Study||118
11253132|NCT02184624|12447032|FG004|COMPLETED|Overall Study||98
11253133|NCT02184624|12447028|FG000|NOT COMPLETED|Overall Study||0
11253134|NCT02184624|12447029|FG001|NOT COMPLETED|Overall Study||0
11253135|NCT02184624|12447030|FG002|NOT COMPLETED|Overall Study||0
11253136|NCT02184624|12447031|FG003|NOT COMPLETED|Overall Study||0
11253137|NCT02184624|12447032|FG004|NOT COMPLETED|Overall Study||0
11253138|NCT02184988|12447044|FG000|STARTED|Overall Study||352
11253139|NCT02184988|12447044|FG000|COMPLETED|Overall Study||297
11253140|NCT02184988|12447044|FG000|NOT COMPLETED|Overall Study||55
11253141|NCT02185014|12447048|FG000|STARTED|Overall Study||252
11253142|NCT02185014|12447048|FG000|COMPLETED|Overall Study||198
11253143|NCT02185014|12447048|FG000|NOT COMPLETED|Overall Study||54
11253144|NCT02185040|12447057|FG000|STARTED|Part 1 Treatment Phase||8
11253145|NCT02185040|12447058|FG001|STARTED|Part 1 Treatment Phase||8
11253146|NCT02185040|12447059|FG002|STARTED|Part 1 Treatment Phase||8
11253147|NCT02185040|12447060|FG003|STARTED|Part 1 Treatment Phase||9
11253148|NCT02185040|12447061|FG004|STARTED|Part 1 Treatment Phase||9
11253149|NCT02185040|12447062|FG005|STARTED|Part 1 Treatment Phase||0
11253150|NCT02185040|12447063|FG006|STARTED|Part 1 Treatment Phase||0
11253151|NCT02185040|12447057|FG000|COMPLETED|Part 1 Treatment Phase||7
11253152|NCT02185040|12447058|FG001|COMPLETED|Part 1 Treatment Phase||6
11253153|NCT02185040|12447059|FG002|COMPLETED|Part 1 Treatment Phase||7
11253154|NCT02185040|12447060|FG003|COMPLETED|Part 1 Treatment Phase||7
11253155|NCT02185040|12447061|FG004|COMPLETED|Part 1 Treatment Phase||6
11253156|NCT02185040|12447062|FG005|COMPLETED|Part 1 Treatment Phase||0
11253157|NCT02185040|12447063|FG006|COMPLETED|Part 1 Treatment Phase||0
11253158|NCT02185040|12447057|FG000|NOT COMPLETED|Part 1 Treatment Phase||1
11253159|NCT02185040|12447058|FG001|NOT COMPLETED|Part 1 Treatment Phase||2
11253160|NCT02185040|12447059|FG002|NOT COMPLETED|Part 1 Treatment Phase||1
11253161|NCT02185040|12447060|FG003|NOT COMPLETED|Part 1 Treatment Phase||2
11253162|NCT02185040|12447061|FG004|NOT COMPLETED|Part 1 Treatment Phase||3
11253163|NCT02185040|12447062|FG005|NOT COMPLETED|Part 1 Treatment Phase||0
11253164|NCT02185040|12447063|FG006|NOT COMPLETED|Part 1 Treatment Phase||0
11253165|NCT02185040|12447057|FG000|STARTED|Active Treatment Extension Phase||0
11253166|NCT02185040|12447058|FG001|STARTED|Active Treatment Extension Phase||0
11253167|NCT02185040|12447059|FG002|STARTED|Active Treatment Extension Phase||0
11253168|NCT02185040|12447060|FG003|STARTED|Active Treatment Extension Phase||0
11253169|NCT02185040|12447061|FG004|STARTED|Active Treatment Extension Phase||0
11253170|NCT02185040|12447062|FG005|STARTED|Active Treatment Extension Phase||9
11253171|NCT02185040|12447063|FG006|STARTED|Active Treatment Extension Phase||8
11253172|NCT02185040|12447057|FG000|COMPLETED|Active Treatment Extension Phase||0
11253173|NCT02185040|12447058|FG001|COMPLETED|Active Treatment Extension Phase||0
11253174|NCT02185040|12447059|FG002|COMPLETED|Active Treatment Extension Phase||0
11253175|NCT02185040|12447060|FG003|COMPLETED|Active Treatment Extension Phase||0
11253176|NCT02185040|12447061|FG004|COMPLETED|Active Treatment Extension Phase||0
11253177|NCT02185040|12447062|FG005|COMPLETED|Active Treatment Extension Phase||6
11253178|NCT02185040|12447063|FG006|COMPLETED|Active Treatment Extension Phase||1
11253179|NCT02185040|12447057|FG000|NOT COMPLETED|Active Treatment Extension Phase||0
11253180|NCT02185040|12447058|FG001|NOT COMPLETED|Active Treatment Extension Phase||0
11253181|NCT02185040|12447059|FG002|NOT COMPLETED|Active Treatment Extension Phase||0
11253182|NCT02185040|12447060|FG003|NOT COMPLETED|Active Treatment Extension Phase||0
11253183|NCT02185040|12447061|FG004|NOT COMPLETED|Active Treatment Extension Phase||0
11253184|NCT02185040|12447062|FG005|NOT COMPLETED|Active Treatment Extension Phase||3
11253185|NCT02185040|12447063|FG006|NOT COMPLETED|Active Treatment Extension Phase||7
11253186|NCT02185053|12447083|FG000|STARTED|Solifenacin Dose Escalation Phase||41
11253187|NCT02185053|12447084|FG001|STARTED|Solifenacin Dose Escalation Phase||0
11253188|NCT02185053|12447085|FG002|STARTED|Solifenacin Dose Escalation Phase||0
11253189|NCT02185053|12447083|FG000|COMPLETED|Solifenacin Dose Escalation Phase||38
11253190|NCT02185053|12447084|FG001|COMPLETED|Solifenacin Dose Escalation Phase||0
11253191|NCT02185053|12447085|FG002|COMPLETED|Solifenacin Dose Escalation Phase||0
11253192|NCT02185053|12447083|FG000|NOT COMPLETED|Solifenacin Dose Escalation Phase||3
11253193|NCT02185053|12447084|FG001|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
11253194|NCT02185053|12447085|FG002|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
11253195|NCT02185053|12447083|FG000|STARTED|Donepezil Dose Escalation Phase||0
11253196|NCT02185053|12447084|FG001|STARTED|Donepezil Dose Escalation Phase||38
11253197|NCT02185053|12447085|FG002|STARTED|Donepezil Dose Escalation Phase||0
11253198|NCT02185053|12447083|FG000|COMPLETED|Donepezil Dose Escalation Phase||0
11253199|NCT02185053|12447084|FG001|COMPLETED|Donepezil Dose Escalation Phase||33
11253200|NCT02185053|12447085|FG002|COMPLETED|Donepezil Dose Escalation Phase||0
11253201|NCT02185053|12447083|FG000|NOT COMPLETED|Donepezil Dose Escalation Phase||0
11253202|NCT02185053|12447084|FG001|NOT COMPLETED|Donepezil Dose Escalation Phase||5
11253203|NCT02185053|12447085|FG002|NOT COMPLETED|Donepezil Dose Escalation Phase||0
11253204|NCT02185053|12447083|FG000|STARTED|Donepezil Dose Maintenance Phase||0
11253205|NCT02185053|12447084|FG001|STARTED|Donepezil Dose Maintenance Phase||0
11253206|NCT02185053|12447085|FG002|STARTED|Donepezil Dose Maintenance Phase||33
11253207|NCT02185053|12447083|FG000|COMPLETED|Donepezil Dose Maintenance Phase||0
11253208|NCT02185053|12447084|FG001|COMPLETED|Donepezil Dose Maintenance Phase||0
11253209|NCT02185053|12447085|FG002|COMPLETED|Donepezil Dose Maintenance Phase||30
11253210|NCT02185053|12447083|FG000|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
11253211|NCT02185053|12447084|FG001|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
11253212|NCT02185053|12447085|FG002|NOT COMPLETED|Donepezil Dose Maintenance Phase||3
11253213|NCT02185105|12447094|FG000|STARTED|Overall Study||30
11253214|NCT02185105|12447094|FG000|COMPLETED|Overall Study||30
11253215|NCT02185105|12447094|FG000|NOT COMPLETED|Overall Study||0
11253216|NCT02185131|12447107|FG000|STARTED|Overall Study||7
11253217|NCT02185131|12447108|FG001|STARTED|Overall Study||9
11253218|NCT02185131|12447107|FG000|COMPLETED|Overall Study||6
11253219|NCT02185131|12447108|FG001|COMPLETED|Overall Study||8
11253220|NCT02185131|12447107|FG000|NOT COMPLETED|Overall Study||1
11253221|NCT02185131|12447108|FG001|NOT COMPLETED|Overall Study||1
11253222|NCT02185183|12447114|FG000|STARTED|Overall Study||14
11253223|NCT02185183|12447114|FG000|COMPLETED|Overall Study||14
11253224|NCT02185183|12447114|FG000|NOT COMPLETED|Overall Study||0
11253225|NCT02185339|12447120|FG000|STARTED|Overall Study||30
11253226|NCT02185339|12447121|FG001|STARTED|Overall Study||31
11253227|NCT02185339|12447120|FG000|COMPLETED|Overall Study||30
11253228|NCT02185339|12447121|FG001|COMPLETED|Overall Study||30
11253229|NCT02185339|12447120|FG000|NOT COMPLETED|Overall Study||0
11253230|NCT02185339|12447121|FG001|NOT COMPLETED|Overall Study||1
11253231|NCT02185404|12447127|FG000|STARTED|Overall Study||6
11253232|NCT02185404|12447127|FG000|COMPLETED|Overall Study||6
11253233|NCT02185404|12447127|FG000|NOT COMPLETED|Overall Study||0
11253234|NCT02185521|12447131|FG000|STARTED|Overall Study||127
11253235|NCT02185521|12447131|FG000|COMPLETED|Overall Study||125
11253236|NCT02185521|12447131|FG000|NOT COMPLETED|Overall Study||2
11253237|NCT02185534|12447142|FG000|STARTED|First Period||14
11253238|NCT02185534|12447143|FG001|STARTED|First Period||14
11253239|NCT02185534|12447144|FG002|STARTED|First Period||14
11253240|NCT02185534|12447145|FG003|STARTED|First Period||14
11253241|NCT02185534|12447146|FG004|STARTED|First Period||14
11253242|NCT02185534|12447147|FG005|STARTED|First Period||14
11253243|NCT02185534|12447142|FG000|COMPLETED|First Period||14
11253244|NCT02185534|12447143|FG001|COMPLETED|First Period||14
11253245|NCT02185534|12447144|FG002|COMPLETED|First Period||14
11253246|NCT02185534|12447145|FG003|COMPLETED|First Period||13
11253247|NCT02185534|12447146|FG004|COMPLETED|First Period||14
11253248|NCT02185534|12447147|FG005|COMPLETED|First Period||14
11253249|NCT02185534|12447142|FG000|NOT COMPLETED|First Period||0
11253250|NCT02185534|12447143|FG001|NOT COMPLETED|First Period||0
11253251|NCT02185534|12447144|FG002|NOT COMPLETED|First Period||0
11253252|NCT02185534|12447145|FG003|NOT COMPLETED|First Period||1
11253253|NCT02185534|12447146|FG004|NOT COMPLETED|First Period||0
11253254|NCT02185534|12447147|FG005|NOT COMPLETED|First Period||0
11253255|NCT02185534|12447142|FG000|STARTED|First Washout Period||14
11253256|NCT02185534|12447143|FG001|STARTED|First Washout Period||14
11253257|NCT02185534|12447144|FG002|STARTED|First Washout Period||14
11253258|NCT02185534|12447145|FG003|STARTED|First Washout Period||13
11253259|NCT02185534|12447146|FG004|STARTED|First Washout Period||14
11253260|NCT02185534|12447147|FG005|STARTED|First Washout Period||14
11253261|NCT02185534|12447142|FG000|COMPLETED|First Washout Period||13
11253262|NCT02185534|12447143|FG001|COMPLETED|First Washout Period||14
11253263|NCT02185534|12447144|FG002|COMPLETED|First Washout Period||14
11253264|NCT02185534|12447145|FG003|COMPLETED|First Washout Period||13
11253265|NCT02185534|12447146|FG004|COMPLETED|First Washout Period||13
11253266|NCT02185534|12447147|FG005|COMPLETED|First Washout Period||13
11253267|NCT02185534|12447142|FG000|NOT COMPLETED|First Washout Period||1
11253268|NCT02185534|12447143|FG001|NOT COMPLETED|First Washout Period||0
11253269|NCT02185534|12447144|FG002|NOT COMPLETED|First Washout Period||0
11253270|NCT02185534|12447145|FG003|NOT COMPLETED|First Washout Period||0
11253271|NCT02185534|12447146|FG004|NOT COMPLETED|First Washout Period||1
11253272|NCT02185534|12447147|FG005|NOT COMPLETED|First Washout Period||1
11253273|NCT02185534|12447142|FG000|STARTED|Second Period||13
11253274|NCT02185534|12447143|FG001|STARTED|Second Period||14
11253275|NCT02185534|12447144|FG002|STARTED|Second Period||14
11253276|NCT02185534|12447145|FG003|STARTED|Second Period||13
11253277|NCT02185534|12447146|FG004|STARTED|Second Period||13
11253278|NCT02185534|12447147|FG005|STARTED|Second Period||13
11253279|NCT02185534|12447142|FG000|COMPLETED|Second Period||13
11253280|NCT02185534|12447143|FG001|COMPLETED|Second Period||14
11253281|NCT02185534|12447144|FG002|COMPLETED|Second Period||14
11253282|NCT02185534|12447145|FG003|COMPLETED|Second Period||13
11253283|NCT02185534|12447146|FG004|COMPLETED|Second Period||13
11253284|NCT02185534|12447147|FG005|COMPLETED|Second Period||13
11253285|NCT02185534|12447142|FG000|NOT COMPLETED|Second Period||0
11253286|NCT02185534|12447143|FG001|NOT COMPLETED|Second Period||0
11253287|NCT02185534|12447144|FG002|NOT COMPLETED|Second Period||0
11253288|NCT02185534|12447145|FG003|NOT COMPLETED|Second Period||0
11253289|NCT02185534|12447146|FG004|NOT COMPLETED|Second Period||0
11253290|NCT02185534|12447147|FG005|NOT COMPLETED|Second Period||0
11253291|NCT02185534|12447142|FG000|STARTED|Second Washout Period||13
11253292|NCT02185534|12447143|FG001|STARTED|Second Washout Period||14
11253293|NCT02185534|12447144|FG002|STARTED|Second Washout Period||14
11253294|NCT02185534|12447145|FG003|STARTED|Second Washout Period||13
11253295|NCT02185534|12447146|FG004|STARTED|Second Washout Period||13
11253296|NCT02185534|12447147|FG005|STARTED|Second Washout Period||13
11253297|NCT02185534|12447142|FG000|COMPLETED|Second Washout Period||13
11253298|NCT02185534|12447143|FG001|COMPLETED|Second Washout Period||14
11253299|NCT02185534|12447144|FG002|COMPLETED|Second Washout Period||14
11253300|NCT02185534|12447145|FG003|COMPLETED|Second Washout Period||13
11253301|NCT02185534|12447146|FG004|COMPLETED|Second Washout Period||13
11253302|NCT02185534|12447147|FG005|COMPLETED|Second Washout Period||13
11253303|NCT02185534|12447142|FG000|NOT COMPLETED|Second Washout Period||0
11253304|NCT02185534|12447143|FG001|NOT COMPLETED|Second Washout Period||0
11253305|NCT02185534|12447144|FG002|NOT COMPLETED|Second Washout Period||0
11253306|NCT02185534|12447145|FG003|NOT COMPLETED|Second Washout Period||0
11253307|NCT02185534|12447146|FG004|NOT COMPLETED|Second Washout Period||0
11253308|NCT02185534|12447147|FG005|NOT COMPLETED|Second Washout Period||0
11253309|NCT02185534|12447142|FG000|STARTED|Third Period||13
11253310|NCT02185534|12447143|FG001|STARTED|Third Period||14
11253311|NCT02185534|12447144|FG002|STARTED|Third Period||14
11253312|NCT02185534|12447145|FG003|STARTED|Third Period||13
11253313|NCT02185534|12447146|FG004|STARTED|Third Period||13
11253314|NCT02185534|12447147|FG005|STARTED|Third Period||13
11253315|NCT02185534|12447142|FG000|COMPLETED|Third Period||13
11253316|NCT02185534|12447143|FG001|COMPLETED|Third Period||14
11253317|NCT02185534|12447144|FG002|COMPLETED|Third Period||14
11253318|NCT02185534|12447145|FG003|COMPLETED|Third Period||13
11253319|NCT02185534|12447146|FG004|COMPLETED|Third Period||13
11253320|NCT02185534|12447147|FG005|COMPLETED|Third Period||13
11253321|NCT02185534|12447142|FG000|NOT COMPLETED|Third Period||0
11253322|NCT02185534|12447143|FG001|NOT COMPLETED|Third Period||0
11253323|NCT02185534|12447144|FG002|NOT COMPLETED|Third Period||0
11253324|NCT02185534|12447145|FG003|NOT COMPLETED|Third Period||0
11253325|NCT02185534|12447146|FG004|NOT COMPLETED|Third Period||0
11253326|NCT02185534|12447147|FG005|NOT COMPLETED|Third Period||0
11253327|NCT02185729|12447156|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12
11253328|NCT02185729|12447156|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
11253329|NCT02185729|12447156|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
11253330|NCT02185729|12447156|FG000|STARTED|4 Hours Into Saline Infusion||12
11253331|NCT02185729|12447156|FG000|COMPLETED|4 Hours Into Saline Infusion||12
11253332|NCT02185729|12447156|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0
11253333|NCT02185729|12447156|FG000|STARTED|24 Hours Into Saline Infusion||12
11253334|NCT02185729|12447156|FG000|COMPLETED|24 Hours Into Saline Infusion||12
11253335|NCT02185729|12447156|FG000|NOT COMPLETED|24 Hours Into Saline Infusion||0
11253336|NCT02185729|12447156|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
11253337|NCT02185729|12447156|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
11253338|NCT02185729|12447156|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
11253339|NCT02185729|12447156|FG000|STARTED|4 Hours Into Intralipid Infusion||12
11253340|NCT02185729|12447156|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12
11253341|NCT02185729|12447156|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
11253342|NCT02185729|12447156|FG000|STARTED|24 Hours Into Intralipid Infusion||12
11253343|NCT02185729|12447156|FG000|COMPLETED|24 Hours Into Intralipid Infusion||12
11253344|NCT02185729|12447156|FG000|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
11253345|NCT02185729|12447156|FG000|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
11253346|NCT02185729|12447156|FG000|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
11253347|NCT02185729|12447156|FG000|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
11253348|NCT02185729|12447156|FG000|STARTED|4 Hours Into ClinOleic Infusion||12
11253349|NCT02185729|12447156|FG000|COMPLETED|4 Hours Into ClinOleic Infusion||12
11253350|NCT02185729|12447156|FG000|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
11253351|NCT02185729|12447156|FG000|STARTED|24 Hours Into ClinOleic Infusion||12
11253352|NCT02185729|12447156|FG000|COMPLETED|24 Hours Into ClinOleic Infusion||12
11253353|NCT02185729|12447156|FG000|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
11253354|NCT02185729|12447156|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
11253355|NCT02185729|12447156|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
11253356|NCT02185729|12447156|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
11253357|NCT02185729|12447156|FG000|STARTED|4 Hours Into Dextrose Infusion||12
11253358|NCT02185729|12447156|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12
11253359|NCT02185729|12447156|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
11253360|NCT02185729|12447156|FG000|STARTED|24 Hours Into Dextrose Infusion||12
11253361|NCT02185729|12447156|FG000|COMPLETED|24 Hours Into Dextrose Infusion||12
11253362|NCT02185729|12447156|FG000|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
11253363|NCT02185794|12447169|FG000|STARTED|Overall Study||9
11253364|NCT02185794|12447170|FG001|STARTED|Overall Study||20
11253365|NCT02185794|12447171|FG002|STARTED|Overall Study||33
11253366|NCT02185794|12447172|FG003|STARTED|Overall Study||16
11253367|NCT02185794|12447173|FG004|STARTED|Overall Study||7
11253368|NCT02185794|12447174|FG005|STARTED|Overall Study||16
11253369|NCT02185794|12447169|FG000|COMPLETED|Overall Study||4
11253370|NCT02185794|12447170|FG001|COMPLETED|Overall Study||7
11253371|NCT02185794|12447171|FG002|COMPLETED|Overall Study||17
11253372|NCT02185794|12447172|FG003|COMPLETED|Overall Study||8
11253373|NCT02185794|12447173|FG004|COMPLETED|Overall Study||4
11253374|NCT02185794|12447174|FG005|COMPLETED|Overall Study||0
11253375|NCT02185794|12447169|FG000|NOT COMPLETED|Overall Study||5
11253376|NCT02185794|12447170|FG001|NOT COMPLETED|Overall Study||13
11253377|NCT02185794|12447171|FG002|NOT COMPLETED|Overall Study||16
11253378|NCT02185794|12447172|FG003|NOT COMPLETED|Overall Study||8
11253379|NCT02185794|12447173|FG004|NOT COMPLETED|Overall Study||3
11253380|NCT02185794|12447174|FG005|NOT COMPLETED|Overall Study||16
11253381|NCT02186015|12447204|FG000|STARTED|Overall Study||11
11253382|NCT02186015|12447205|FG001|STARTED|Overall Study||31
11253383|NCT02186015|12447204|FG000|COMPLETED|Overall Study||10
11253384|NCT02186015|12447205|FG001|COMPLETED|Overall Study||31
11253385|NCT02186015|12447204|FG000|NOT COMPLETED|Overall Study||1
11253386|NCT02186015|12447205|FG001|NOT COMPLETED|Overall Study||0
11253387|NCT02186171|12447214|FG000|STARTED|Overall Study||82
11253388|NCT02186171|12447215|FG001|STARTED|Overall Study||163
11253389|NCT02186171|12447214|FG000|Received Treatment|Overall Study||81
11253390|NCT02186171|12447215|FG001|Received Treatment|Overall Study||163
11253391|NCT02186171|12447214|FG000|COMPLETED|Overall Study||78
11253392|NCT02186171|12447215|FG001|COMPLETED|Overall Study||148
11253393|NCT02186171|12447214|FG000|NOT COMPLETED|Overall Study||4
11253394|NCT02186171|12447215|FG001|NOT COMPLETED|Overall Study||15
11253395|NCT02186210|12447223|FG000|STARTED|Overall Study||20
11253396|NCT02186210|12447224|FG001|STARTED|Overall Study||20
11253397|NCT02186210|12447223|FG000|COMPLETED|Overall Study||20
11253398|NCT02186210|12447224|FG001|COMPLETED|Overall Study||20
11253399|NCT02186210|12447223|FG000|NOT COMPLETED|Overall Study||0
11253400|NCT02186210|12447224|FG001|NOT COMPLETED|Overall Study||0
11253401|NCT02186223|12447232|FG000|STARTED|Overall Study||172
11253402|NCT02186223|12447232|FG000|Device Placed|Overall Study||163
11253403|NCT02186223|12447232|FG000|COMPLETED|Overall Study||151
11253404|NCT02186223|12447232|FG000|NOT COMPLETED|Overall Study||21
11253405|NCT02186301|12447240|FG000|STARTED|Overall Study||20
11253406|NCT02186301|12447241|FG001|STARTED|Overall Study||30
11253407|NCT02186301|12447242|FG002|STARTED|Overall Study||50
11253408|NCT02186301|12447240|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0
11253409|NCT02186301|12447241|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0
11253410|NCT02186301|12447242|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0
11253411|NCT02186301|12447240|FG000|NOT COMPLETED|Overall Study||20
11253412|NCT02186301|12447241|FG001|NOT COMPLETED|Overall Study||30
11253413|NCT02186301|12447242|FG002|NOT COMPLETED|Overall Study||50
11253414|NCT02186509|12447252|FG000|STARTED|Overall Study||17
11253415|NCT02186509|12447252|FG000|COMPLETED|Overall Study||17
11253416|NCT02186509|12447252|FG000|NOT COMPLETED|Overall Study||0
11253417|NCT02186561|12447256|FG000|STARTED|Enrollment||197
11253418|NCT02186561|12447256|FG000|COMPLETED|Enrollment||141
11253419|NCT02186561|12447256|FG000|NOT COMPLETED|Enrollment||56
11253420|NCT02186561|12447256|FG000|STARTED|Subjects Implanted With Device||141
11253421|NCT02186561|12447256|FG000|COMPLETED|Subjects Implanted With Device||141
11253422|NCT02186561|12447256|FG000|NOT COMPLETED|Subjects Implanted With Device||0
11253423|NCT02186561|12447256|FG000|STARTED|30-Day Post Index Procedure Visit||141
11253424|NCT02186561|12447256|FG000|COMPLETED|30-Day Post Index Procedure Visit||140
11253425|NCT02186561|12447256|FG000|NOT COMPLETED|30-Day Post Index Procedure Visit||1
11253426|NCT02186561|12447256|FG000|STARTED|180- Day Post Index Procedure Visit||141
11253427|NCT02186561|12447256|FG000|COMPLETED|180- Day Post Index Procedure Visit||134
11253428|NCT02186561|12447256|FG000|NOT COMPLETED|180- Day Post Index Procedure Visit||7
11253429|NCT02186561|12447256|FG000|STARTED|1- Year Post Index Procedure Visit||141
11253430|NCT02186561|12447256|FG000|COMPLETED|1- Year Post Index Procedure Visit||139
11253431|NCT02186561|12447256|FG000|NOT COMPLETED|1- Year Post Index Procedure Visit||2
11253432|NCT02186561|12447256|FG000|STARTED|2 - Year Post Index Procedure Visit||141
11253433|NCT02186561|12447256|FG000|COMPLETED|2 - Year Post Index Procedure Visit||134
11253434|NCT02186561|12447256|FG000|NOT COMPLETED|2 - Year Post Index Procedure Visit||7
11253435|NCT02186561|12447256|FG000|STARTED|3 - Year Post Index Procedure Visit||141
11253436|NCT02186561|12447256|FG000|COMPLETED|3 - Year Post Index Procedure Visit||128
11253437|NCT02186561|12447256|FG000|NOT COMPLETED|3 - Year Post Index Procedure Visit||13
11253438|NCT02186587|12447264|FG000|STARTED|Overall Study||28
11253439|NCT02186587|12447265|FG001|STARTED|Overall Study||0
11253440|NCT02186587|12447264|FG000|COMPLETED|Overall Study||23
11253441|NCT02186587|12447265|FG001|COMPLETED|Overall Study||0
11253442|NCT02186587|12447264|FG000|NOT COMPLETED|Overall Study||5
11253443|NCT02186587|12447265|FG001|NOT COMPLETED|Overall Study||0
11253444|NCT02186652|12447272|FG000|STARTED|Overall Study||19
11253445|NCT02186652|12447273|FG001|STARTED|Overall Study||22
11253446|NCT02186652|12447272|FG000|COMPLETED|Overall Study||17
11253447|NCT02186652|12447273|FG001|COMPLETED|Overall Study||22
11253448|NCT02186652|12447272|FG000|NOT COMPLETED|Overall Study||2
11253449|NCT02186652|12447273|FG001|NOT COMPLETED|Overall Study||0
11253450|NCT02186665|12447288|FG000|STARTED|Overall Study||8
11253451|NCT02186665|12447289|FG001|STARTED|Overall Study||11
11253452|NCT02186665|12447288|FG000|COMPLETED|Overall Study||8
11253453|NCT02186665|12447289|FG001|COMPLETED|Overall Study||10
11253454|NCT02186665|12447288|FG000|NOT COMPLETED|Overall Study||0
11253455|NCT02186665|12447289|FG001|NOT COMPLETED|Overall Study||1
11253456|NCT02186795|12447297|FG000|STARTED|Overall Study||24
11253457|NCT02186795|12447298|FG001|STARTED|Overall Study||24
11253458|NCT02186795|12447297|FG000|COMPLETED|Overall Study||24
11253459|NCT02186795|12447298|FG001|COMPLETED|Overall Study||24
11253460|NCT02186795|12447297|FG000|NOT COMPLETED|Overall Study||0
11253461|NCT02186795|12447298|FG001|NOT COMPLETED|Overall Study||0
11253462|NCT02186808|12447304|FG000|STARTED|Overall Study||80
11253463|NCT02186808|12447304|FG000|COMPLETED|Overall Study||67
11253464|NCT02186808|12447304|FG000|NOT COMPLETED|Overall Study||13
11253465|NCT02186821|12447308|FG000|STARTED|Overall Study||47
11253466|NCT02186821|12447308|FG000|COMPLETED|Overall Study||0
11253467|NCT02186821|12447308|FG000|NOT COMPLETED|Overall Study||47
11253468|NCT02186873|12447314|FG000|STARTED|Overall Study||103
11253469|NCT02186873|12447315|FG001|STARTED|Overall Study||105
11253470|NCT02186873|12447314|FG000|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
11253471|NCT02186873|12447315|FG001|End of Control Period|Overall Study|Participants continued to receive golimumab|105
11253472|NCT02186873|12447314|FG000|COMPLETED|Overall Study||94
11253473|NCT02186873|12447315|FG001|COMPLETED|Overall Study||97
11253474|NCT02186873|12447314|FG000|NOT COMPLETED|Overall Study||9
11253475|NCT02186873|12447315|FG001|NOT COMPLETED|Overall Study||8
11253476|NCT02186938|12447324|FG000|STARTED|Overall Study|2012|47
11253477|NCT02186938|12447325|FG001|STARTED|Overall Study||47
11253478|NCT02186938|12447324|FG000|COMPLETED|Overall Study||38
11253479|NCT02186938|12447325|FG001|COMPLETED|Overall Study||44
11253480|NCT02186938|12447324|FG000|NOT COMPLETED|Overall Study||9
11253481|NCT02186938|12447325|FG001|NOT COMPLETED|Overall Study||3
11253482|NCT02187016|12447335|FG000|STARTED|Overall Study||80
11253483|NCT02187016|12447336|FG001|STARTED|Overall Study||80
11253484|NCT02187016|12447337|FG002|STARTED|Overall Study||79
11253485|NCT02187016|12447338|FG003|STARTED|Overall Study||51
11253486|NCT02187016|12447335|FG000|COMPLETED|Overall Study||79
11253487|NCT02187016|12447336|FG001|COMPLETED|Overall Study||78
11253488|NCT02187016|12447337|FG002|COMPLETED|Overall Study||78
11253489|NCT02187016|12447338|FG003|COMPLETED|Overall Study||51
11253490|NCT02187016|12447335|FG000|NOT COMPLETED|Overall Study||1
11253491|NCT02187016|12447336|FG001|NOT COMPLETED|Overall Study||2
11253492|NCT02187016|12447337|FG002|NOT COMPLETED|Overall Study||1
11253493|NCT02187016|12447338|FG003|NOT COMPLETED|Overall Study||0
11253494|NCT02187029|12447352|FG000|STARTED|Overall Study||7
11253495|NCT02187029|12447353|FG001|STARTED|Overall Study||3
11253496|NCT02187029|12447354|FG002|STARTED|Overall Study||11
11253497|NCT02187029|12447355|FG003|STARTED|Overall Study||9
11253498|NCT02187029|12447352|FG000|COMPLETED|Overall Study||6
11253499|NCT02187029|12447353|FG001|COMPLETED|Overall Study||2
11253500|NCT02187029|12447354|FG002|COMPLETED|Overall Study||0
11253501|NCT02187029|12447355|FG003|COMPLETED|Overall Study||6
11253502|NCT02187029|12447352|FG000|NOT COMPLETED|Overall Study||1
11253503|NCT02187029|12447353|FG001|NOT COMPLETED|Overall Study||1
11253504|NCT02187029|12447354|FG002|NOT COMPLETED|Overall Study||11
11253505|NCT02187029|12447355|FG003|NOT COMPLETED|Overall Study||3
11253506|NCT02187042|12447367|FG000|STARTED|Overall Study||42
11253507|NCT02187042|12447368|FG001|STARTED|Overall Study||27
11253508|NCT02187042|12447367|FG000|COMPLETED|Overall Study||29
11253509|NCT02187042|12447368|FG001|COMPLETED|Overall Study||13
11253510|NCT02187042|12447367|FG000|NOT COMPLETED|Overall Study||13
11253511|NCT02187042|12447368|FG001|NOT COMPLETED|Overall Study||14
11253512|NCT02187055|12447378|FG000|STARTED|Overall Study|Treated|384
11253513|NCT02187055|12447379|FG001|STARTED|Overall Study|Treated|376
11253514|NCT02187055|12447380|FG002|STARTED|Overall Study|Treated|386
11253515|NCT02187055|12447378|FG000|COMPLETED|Overall Study||315
11253516|NCT02187055|12447379|FG001|COMPLETED|Overall Study||303
11253517|NCT02187055|12447380|FG002|COMPLETED|Overall Study||312
11358633|NCT03127228|12555777|FG001|STARTED|Overall Study||12
11253518|NCT02187055|12447378|FG000|NOT COMPLETED|Overall Study||69
11253519|NCT02187055|12447379|FG001|NOT COMPLETED|Overall Study||73
11253520|NCT02187055|12447380|FG002|NOT COMPLETED|Overall Study||74
11253521|NCT02187159|12447392|FG000|STARTED|Overall Study||318
11253522|NCT02187159|12447393|FG001|STARTED|Overall Study||317
11253523|NCT02187159|12447394|FG002|STARTED|Overall Study||318
11253524|NCT02187159|12447395|FG003|STARTED|Overall Study||317
11253525|NCT02187159|12447392|FG000|COMPLETED|Overall Study||249
11253526|NCT02187159|12447393|FG001|COMPLETED|Overall Study||238
11253527|NCT02187159|12447394|FG002|COMPLETED|Overall Study||241
11253528|NCT02187159|12447395|FG003|COMPLETED|Overall Study||221
11253529|NCT02187159|12447392|FG000|NOT COMPLETED|Overall Study||69
11253530|NCT02187159|12447393|FG001|NOT COMPLETED|Overall Study||79
11253531|NCT02187159|12447394|FG002|NOT COMPLETED|Overall Study||77
11253532|NCT02187159|12447395|FG003|NOT COMPLETED|Overall Study||96
11253533|NCT02187172|12447407|FG000|STARTED|Overall Study||22
11253534|NCT02187172|12447408|FG001|STARTED|Overall Study||21
11253535|NCT02187172|12447407|FG000|RCT Phase Completed|Overall Study||22
11253536|NCT02187172|12447408|FG001|RCT Phase Completed|Overall Study||19
11253537|NCT02187172|12447407|FG000|COMPLETED|Overall Study||19
11253538|NCT02187172|12447408|FG001|COMPLETED|Overall Study||15
11253539|NCT02187172|12447407|FG000|NOT COMPLETED|Overall Study||3
11253540|NCT02187172|12447408|FG001|NOT COMPLETED|Overall Study||6
11253541|NCT02187471|12447420|FG000|STARTED|Overall Study||325
11253542|NCT02187471|12447421|FG001|STARTED|Overall Study||324
11253543|NCT02187471|12447422|FG002|STARTED|Overall Study||326
11253544|NCT02187471|12447423|FG003|STARTED|Overall Study||326
11253545|NCT02187471|12447420|FG000|COMPLETED|Overall Study||249
11253546|NCT02187471|12447421|FG001|COMPLETED|Overall Study||242
11253547|NCT02187471|12447422|FG002|COMPLETED|Overall Study||240
11253548|NCT02187471|12447423|FG003|COMPLETED|Overall Study||246
11253549|NCT02187471|12447420|FG000|NOT COMPLETED|Overall Study||76
11253550|NCT02187471|12447421|FG001|NOT COMPLETED|Overall Study||82
11253551|NCT02187471|12447422|FG002|NOT COMPLETED|Overall Study||86
11253552|NCT02187471|12447423|FG003|NOT COMPLETED|Overall Study||80
11253553|NCT02187744|12447436|FG000|STARTED|Study|Received treatment|113
11253554|NCT02187744|12447437|FG001|STARTED|Study|Received treatment|112
11253555|NCT02187744|12447436|FG000|COMPLETED|Study||109
11253556|NCT02187744|12447437|FG001|COMPLETED|Study||106
11253557|NCT02187744|12447436|FG000|NOT COMPLETED|Study||4
11253558|NCT02187744|12447437|FG001|NOT COMPLETED|Study||6
11253559|NCT02187744|12447436|FG000|STARTED|Treatment||113
11253560|NCT02187744|12447437|FG001|STARTED|Treatment||112
11253561|NCT02187744|12447436|FG000|COMPLETED|Treatment||109
11253562|NCT02187744|12447437|FG001|COMPLETED|Treatment||107
11253563|NCT02187744|12447436|FG000|NOT COMPLETED|Treatment||4
11253564|NCT02187744|12447437|FG001|NOT COMPLETED|Treatment||5
11253565|NCT02187783|12447443|FG000|STARTED|Overall Study||106
11253566|NCT02187783|12447443|FG000|Patients With Solid Tumors|Overall Study||105
11253567|NCT02187783|12447443|FG000|COMPLETED|Overall Study||0
11253568|NCT02187783|12447443|FG000|NOT COMPLETED|Overall Study||106
11253569|NCT02187809|12447447|FG000|STARTED|Overall Study||3
11253570|NCT02187809|12447447|FG000|Treated|Overall Study||1
11253571|NCT02187809|12447447|FG000|COMPLETED|Overall Study||0
11253572|NCT02187809|12447447|FG000|NOT COMPLETED|Overall Study||3
11253573|NCT02187861|12447455|FG000|STARTED|Overall Study||9
11253574|NCT02187861|12447456|FG001|STARTED|Overall Study||52
11253575|NCT02187861|12447457|FG002|STARTED|Overall Study||51
11253576|NCT02187861|12447458|FG003|STARTED|Overall Study||51
11253577|NCT02187861|12447455|FG000|Treated|Overall Study||9
11253578|NCT02187861|12447456|FG001|Treated|Overall Study||52
11253579|NCT02187861|12447457|FG002|Treated|Overall Study||49
11253580|NCT02187861|12447458|FG003|Treated|Overall Study||50
11253581|NCT02187861|12447455|FG000|COMPLETED|Overall Study||3
11253582|NCT02187861|12447456|FG001|COMPLETED|Overall Study||4
11253583|NCT02187861|12447457|FG002|COMPLETED|Overall Study||19
11253584|NCT02187861|12447458|FG003|COMPLETED|Overall Study||19
11253585|NCT02187861|12447455|FG000|NOT COMPLETED|Overall Study||6
11253586|NCT02187861|12447456|FG001|NOT COMPLETED|Overall Study||48
11253587|NCT02187861|12447457|FG002|NOT COMPLETED|Overall Study||32
11253588|NCT02187861|12447458|FG003|NOT COMPLETED|Overall Study||32
11253589|NCT02187887|12447470|FG000|STARTED|Overall Study||393
11253590|NCT02187887|12447471|FG001|STARTED|Overall Study||400
11253591|NCT02187887|12447470|FG000|COMPLETED|Overall Study||388
11253592|NCT02187887|12447471|FG001|COMPLETED|Overall Study||396
11253593|NCT02187887|12447470|FG000|NOT COMPLETED|Overall Study||5
11253594|NCT02187887|12447471|FG001|NOT COMPLETED|Overall Study||4
11253595|NCT02188160|12447479|FG000|STARTED|Overall Study||73
11253596|NCT02188160|12447480|FG001|STARTED|Overall Study||77
11253597|NCT02188160|12447479|FG000|COMPLETED|Overall Study||72
11253598|NCT02188160|12447480|FG001|COMPLETED|Overall Study||76
11253599|NCT02188160|12447479|FG000|NOT COMPLETED|Overall Study||1
11253600|NCT02188160|12447480|FG001|NOT COMPLETED|Overall Study||1
11253601|NCT02188303|12447494|FG000|STARTED|Overall Study||6
11253602|NCT02188303|12447495|FG001|STARTED|Overall Study||6
11253603|NCT02188303|12447496|FG002|STARTED|Overall Study||6
11253604|NCT02188303|12447497|FG003|STARTED|Overall Study||6
11253605|NCT02188303|12447498|FG004|STARTED|Overall Study||4
11253606|NCT02188303|12447499|FG005|STARTED|Overall Study||12
11253607|NCT02188303|12447500|FG006|STARTED|Overall Study||2
11253608|NCT02188303|12447501|FG007|STARTED|Overall Study||6
11253609|NCT02188303|12447494|FG000|COMPLETED|Overall Study||6
11253610|NCT02188303|12447495|FG001|COMPLETED|Overall Study||6
11253611|NCT02188303|12447496|FG002|COMPLETED|Overall Study||6
11253612|NCT02188303|12447497|FG003|COMPLETED|Overall Study||6
11253613|NCT02188303|12447498|FG004|COMPLETED|Overall Study||4
11253614|NCT02188303|12447499|FG005|COMPLETED|Overall Study||10
11253615|NCT02188303|12447500|FG006|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
11253616|NCT02188303|12447501|FG007|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
11253617|NCT02188303|12447494|FG000|NOT COMPLETED|Overall Study||0
11253618|NCT02188303|12447495|FG001|NOT COMPLETED|Overall Study||0
11253619|NCT02188303|12447496|FG002|NOT COMPLETED|Overall Study||0
11253620|NCT02188303|12447497|FG003|NOT COMPLETED|Overall Study||0
11253621|NCT02188303|12447498|FG004|NOT COMPLETED|Overall Study||0
11253622|NCT02188303|12447499|FG005|NOT COMPLETED|Overall Study||2
11253623|NCT02188303|12447500|FG006|NOT COMPLETED|Overall Study||2
11253624|NCT02188303|12447501|FG007|NOT COMPLETED|Overall Study||6
11253625|NCT02188459|12447527|FG000|STARTED|Overall Study||64
11253626|NCT02188459|12447528|FG001|STARTED|Overall Study||65
11253627|NCT02188459|12447527|FG000|COMPLETED|Overall Study||61
11253628|NCT02188459|12447528|FG001|COMPLETED|Overall Study||58
11253629|NCT02188459|12447527|FG000|NOT COMPLETED|Overall Study||3
11253630|NCT02188459|12447528|FG001|NOT COMPLETED|Overall Study||7
11253631|NCT02188485|12447540|FG000|STARTED|Overall Study||32
11253632|NCT02188485|12447541|FG001|STARTED|Overall Study||30
11253633|NCT02188485|12447540|FG000|COMPLETED|Overall Study||30
11253634|NCT02188485|12447541|FG001|COMPLETED|Overall Study||27
11253635|NCT02188485|12447540|FG000|NOT COMPLETED|Overall Study||2
11253636|NCT02188485|12447541|FG001|NOT COMPLETED|Overall Study||3
11253637|NCT02188576|12447549|FG000|STARTED|Overall Study||32
11253638|NCT02188576|12447550|FG001|STARTED|Overall Study||34
11253639|NCT02188576|12447549|FG000|COMPLETED|Overall Study||32
11253640|NCT02188576|12447550|FG001|COMPLETED|Overall Study||34
11253641|NCT02188576|12447549|FG000|NOT COMPLETED|Overall Study||0
11253642|NCT02188576|12447550|FG001|NOT COMPLETED|Overall Study||0
11253643|NCT02188589|12447556|FG000|STARTED|Overall Study||30
11253644|NCT02188589|12447556|FG000|6 Months|Overall Study||30
11253645|NCT02188589|12447556|FG000|12 Months|Overall Study||30
11253646|NCT02188589|12447556|FG000|24 Months|Overall Study||25
11253647|NCT02188589|12447556|FG000|COMPLETED|Overall Study||25
11253648|NCT02188589|12447556|FG000|NOT COMPLETED|Overall Study||5
11253649|NCT02188719|12447565|FG000|STARTED|Overall Study||6
11253650|NCT02188719|12447566|FG001|STARTED|Overall Study||9
11253651|NCT02188719|12447567|FG002|STARTED|Overall Study||0
11253652|NCT02188719|12447568|FG003|STARTED|Overall Study||0
11253653|NCT02188719|12447565|FG000|COMPLETED|Overall Study||6
11253654|NCT02188719|12447566|FG001|COMPLETED|Overall Study||8
11253655|NCT02188719|12447567|FG002|COMPLETED|Overall Study||0
11253656|NCT02188719|12447568|FG003|COMPLETED|Overall Study||0
11253657|NCT02188719|12447565|FG000|NOT COMPLETED|Overall Study||0
11253658|NCT02188719|12447566|FG001|NOT COMPLETED|Overall Study||1
11253659|NCT02188719|12447567|FG002|NOT COMPLETED|Overall Study||0
11253660|NCT02188719|12447568|FG003|NOT COMPLETED|Overall Study||0
11253661|NCT02188784|12447578|FG000|STARTED|Overall Study||111
11253662|NCT02188784|12447579|FG001|STARTED|Overall Study||114
11253663|NCT02188784|12447578|FG000|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
11253664|NCT02188784|12447579|FG001|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
11253665|NCT02188784|12447578|FG000|NOT COMPLETED|Overall Study||9
11253666|NCT02188784|12447579|FG001|NOT COMPLETED|Overall Study||13
11253667|NCT02188849|12447587|FG000|STARTED|Overall Study||25
11253668|NCT02188849|12447588|FG001|STARTED|Overall Study||25
11253669|NCT02188849|12447587|FG000|COMPLETED|Overall Study||22
11253670|NCT02188849|12447588|FG001|COMPLETED|Overall Study||17
11253671|NCT02188849|12447587|FG000|NOT COMPLETED|Overall Study||3
11253672|NCT02188849|12447588|FG001|NOT COMPLETED|Overall Study||8
11253673|NCT02189122|12447596|FG000|STARTED|Overall Study||18
11253674|NCT02189122|12447597|FG001|STARTED|Overall Study||18
11253675|NCT02189122|12447596|FG000|COMPLETED|Overall Study||18
11253676|NCT02189122|12447597|FG001|COMPLETED|Overall Study||18
11253677|NCT02189122|12447596|FG000|NOT COMPLETED|Overall Study||0
11253678|NCT02189122|12447597|FG001|NOT COMPLETED|Overall Study||0
11253679|NCT02189161|12447605|FG000|STARTED|Overall Study||10
11253680|NCT02189161|12447605|FG000|COMPLETED|Overall Study||10
11253681|NCT02189161|12447605|FG000|NOT COMPLETED|Overall Study||0
11253682|NCT02189213|12447611|FG000|STARTED|Overall Study||13
11253683|NCT02189213|12447612|FG001|STARTED|Overall Study||1
11253684|NCT02189213|12447611|FG000|COMPLETED|Overall Study||7
11253685|NCT02189213|12447612|FG001|COMPLETED|Overall Study||1
11253686|NCT02189213|12447611|FG000|NOT COMPLETED|Overall Study||6
11253687|NCT02189213|12447612|FG001|NOT COMPLETED|Overall Study||0
11253688|NCT02189252|12447622|FG000|STARTED|Period 1 (Visit 4b, Week 4)||4
11253689|NCT02189252|12447623|FG001|STARTED|Period 1 (Visit 4b, Week 4)||4
11253690|NCT02189252|12447624|FG002|STARTED|Period 1 (Visit 4b, Week 4)||3
11253691|NCT02189252|12447625|FG003|STARTED|Period 1 (Visit 4b, Week 4)||4
11253692|NCT02189252|12447622|FG000|COMPLETED|Period 1 (Visit 4b, Week 4)||4
11253693|NCT02189252|12447623|FG001|COMPLETED|Period 1 (Visit 4b, Week 4)||2
11253694|NCT02189252|12447624|FG002|COMPLETED|Period 1 (Visit 4b, Week 4)||3
11253695|NCT02189252|12447625|FG003|COMPLETED|Period 1 (Visit 4b, Week 4)||4
11253696|NCT02189252|12447622|FG000|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
11253697|NCT02189252|12447623|FG001|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
11253698|NCT02189252|12447624|FG002|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
11253699|NCT02189252|12447625|FG003|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
11253700|NCT02189252|12447622|FG000|STARTED|Period 2 (Visit6b, Week 12)||4
11253701|NCT02189252|12447623|FG001|STARTED|Period 2 (Visit6b, Week 12)||2
11253702|NCT02189252|12447624|FG002|STARTED|Period 2 (Visit6b, Week 12)||3
11253703|NCT02189252|12447625|FG003|STARTED|Period 2 (Visit6b, Week 12)||4
11253704|NCT02189252|12447622|FG000|COMPLETED|Period 2 (Visit6b, Week 12)||4
11253705|NCT02189252|12447623|FG001|COMPLETED|Period 2 (Visit6b, Week 12)||2
11253706|NCT02189252|12447624|FG002|COMPLETED|Period 2 (Visit6b, Week 12)||3
11253707|NCT02189252|12447625|FG003|COMPLETED|Period 2 (Visit6b, Week 12)||4
11253708|NCT02189252|12447622|FG000|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
11253709|NCT02189252|12447623|FG001|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
11253710|NCT02189252|12447624|FG002|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
11253711|NCT02189252|12447625|FG003|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
11253712|NCT02189317|12447638|FG000|STARTED|Overall Study||16
11253713|NCT02189317|12447639|FG001|STARTED|Overall Study||16
11253714|NCT02189317|12447638|FG000|COMPLETED|Overall Study||16
11253715|NCT02189317|12447639|FG001|COMPLETED|Overall Study||16
11253716|NCT02189317|12447638|FG000|NOT COMPLETED|Overall Study||0
11253717|NCT02189317|12447639|FG001|NOT COMPLETED|Overall Study||0
11253718|NCT02189382|12447647|FG000|STARTED|Overall Study||35
11253719|NCT02189382|12447648|FG001|STARTED|Overall Study||35
11253720|NCT02189382|12447647|FG000|COMPLETED|Overall Study||35
11253721|NCT02189382|12447648|FG001|COMPLETED|Overall Study||35
11253722|NCT02189382|12447647|FG000|NOT COMPLETED|Overall Study||0
11253723|NCT02189382|12447648|FG001|NOT COMPLETED|Overall Study||0
11253724|NCT02189473|12447656|FG000|STARTED|Overall Study||101
11253725|NCT02189473|12447657|FG001|STARTED|Overall Study||102
11253726|NCT02189473|12447656|FG000|COMPLETED|Overall Study||78
11253727|NCT02189473|12447657|FG001|COMPLETED|Overall Study||77
11253728|NCT02189473|12447656|FG000|NOT COMPLETED|Overall Study||23
11253729|NCT02189473|12447657|FG001|NOT COMPLETED|Overall Study||25
11253730|NCT02189629|12447663|FG000|STARTED|Overall Study||453
11253731|NCT02189629|12447663|FG000|COMPLETED|Overall Study||348
11253732|NCT02189629|12447663|FG000|NOT COMPLETED|Overall Study||105
11253733|NCT02189668|12447669|FG000|STARTED|Overall Study||5
11253734|NCT02189668|12447670|FG001|STARTED|Overall Study||9
11253735|NCT02189668|12447669|FG000|COMPLETED|Overall Study||5
11253736|NCT02189668|12447670|FG001|COMPLETED|Overall Study||9
11253737|NCT02189668|12447669|FG000|NOT COMPLETED|Overall Study||0
11253738|NCT02189668|12447670|FG001|NOT COMPLETED|Overall Study||0
11253739|NCT02189759|12447680|FG000|STARTED|Overall Study||102
11253740|NCT02189759|12447681|FG001|STARTED|Overall Study||101
11253741|NCT02189759|12447682|FG002|STARTED|Overall Study||83
11253742|NCT02189759|12447683|FG003|STARTED|Overall Study||89
11253743|NCT02189759|12447680|FG000|COMPLETED|Overall Study||102
11253744|NCT02189759|12447681|FG001|COMPLETED|Overall Study||101
11253745|NCT02189759|12447682|FG002|COMPLETED|Overall Study||81
11253746|NCT02189759|12447683|FG003|COMPLETED|Overall Study||84
11253747|NCT02189759|12447680|FG000|NOT COMPLETED|Overall Study||0
11253748|NCT02189759|12447681|FG001|NOT COMPLETED|Overall Study||0
11253749|NCT02189759|12447682|FG002|NOT COMPLETED|Overall Study||2
11253750|NCT02189759|12447683|FG003|NOT COMPLETED|Overall Study||5
11253751|NCT02189837|12447699|FG000|STARTED|Overall Study||22
11253752|NCT02189837|12447700|FG001|STARTED|Overall Study||23
11253753|NCT02189837|12447701|FG002|STARTED|Overall Study||23
11253754|NCT02189837|12447702|FG003|STARTED|Overall Study||21
11253755|NCT02189837|12447699|FG000|Received Treatment|Overall Study||21
11253756|NCT02189837|12447700|FG001|Received Treatment|Overall Study||22
11253757|NCT02189837|12447701|FG002|Received Treatment|Overall Study||22
11253758|NCT02189837|12447702|FG003|Received Treatment|Overall Study||20
11253759|NCT02189837|12447699|FG000|COMPLETED|Overall Study||20
11253760|NCT02189837|12447700|FG001|COMPLETED|Overall Study||22
11253761|NCT02189837|12447701|FG002|COMPLETED|Overall Study||20
11253762|NCT02189837|12447702|FG003|COMPLETED|Overall Study||19
11253763|NCT02189837|12447699|FG000|NOT COMPLETED|Overall Study||2
11253764|NCT02189837|12447700|FG001|NOT COMPLETED|Overall Study||1
11253765|NCT02189837|12447701|FG002|NOT COMPLETED|Overall Study||3
11253766|NCT02189837|12447702|FG003|NOT COMPLETED|Overall Study||2
11253767|NCT02189850|12447714|FG000|STARTED|Overall Study||16
11253768|NCT02189850|12447715|FG001|STARTED|Overall Study||13
11253769|NCT02189850|12447714|FG000|COMPLETED|Overall Study||14
11253770|NCT02189850|12447715|FG001|COMPLETED|Overall Study||11
11253771|NCT02189850|12447714|FG000|NOT COMPLETED|Overall Study||2
11253772|NCT02189850|12447715|FG001|NOT COMPLETED|Overall Study||2
11253773|NCT02189863|12447721|FG000|STARTED|First 2 Weeks||12
11253774|NCT02189863|12447722|FG001|STARTED|First 2 Weeks||15
11253775|NCT02189863|12447721|FG000|COMPLETED|First 2 Weeks||8
11253776|NCT02189863|12447722|FG001|COMPLETED|First 2 Weeks||13
11253777|NCT02189863|12447721|FG000|NOT COMPLETED|First 2 Weeks||4
11253778|NCT02189863|12447722|FG001|NOT COMPLETED|First 2 Weeks||2
11253779|NCT02189863|12447721|FG000|STARTED|Second 2 Weeks||8
11253780|NCT02189863|12447722|FG001|STARTED|Second 2 Weeks||13
11253781|NCT02189863|12447721|FG000|COMPLETED|Second 2 Weeks||8
11253782|NCT02189863|12447722|FG001|COMPLETED|Second 2 Weeks||13
11253783|NCT02189863|12447721|FG000|NOT COMPLETED|Second 2 Weeks||0
11253784|NCT02189863|12447722|FG001|NOT COMPLETED|Second 2 Weeks||0
11253785|NCT02189889|12447733|FG000|STARTED|Overall Study||2
11253786|NCT02189889|12447734|FG001|STARTED|Overall Study||3
11253787|NCT02189889|12447733|FG000|COMPLETED|Overall Study||2
11253788|NCT02189889|12447734|FG001|COMPLETED|Overall Study||3
11253789|NCT02189889|12447733|FG000|NOT COMPLETED|Overall Study||0
11253790|NCT02189889|12447734|FG001|NOT COMPLETED|Overall Study||0
11253791|NCT02189915|12447740|FG000|STARTED|Overall Study||14
11253792|NCT02189915|12447740|FG000|COMPLETED|Overall Study||11
11253793|NCT02189915|12447740|FG000|NOT COMPLETED|Overall Study||3
11253794|NCT02189941|12447744|FG000|STARTED|Overall Study||4
11253795|NCT02189941|12447745|FG001|STARTED|Overall Study||4
11253796|NCT02189941|12447746|FG002|STARTED|Overall Study||3
11253797|NCT02189941|12447744|FG000|COMPLETED|Overall Study||4
11253798|NCT02189941|12447745|FG001|COMPLETED|Overall Study||4
11253799|NCT02189941|12447746|FG002|COMPLETED|Overall Study||2
11253800|NCT02189941|12447744|FG000|NOT COMPLETED|Overall Study||0
11253801|NCT02189941|12447745|FG001|NOT COMPLETED|Overall Study||0
11253802|NCT02189941|12447746|FG002|NOT COMPLETED|Overall Study||1
11253803|NCT02189954|12447756|FG000|STARTED|Overall Study||45
11253804|NCT02189954|12447757|FG001|STARTED|Overall Study||45
11253805|NCT02189954|12447756|FG000|COMPLETED|Overall Study||45
11253806|NCT02189954|12447757|FG001|COMPLETED|Overall Study||45
11253807|NCT02189954|12447756|FG000|NOT COMPLETED|Overall Study||0
11253808|NCT02189954|12447757|FG001|NOT COMPLETED|Overall Study||0
11253809|NCT02190045|12447765|FG000|STARTED|Overall Study||15
11253810|NCT02190045|12447766|FG001|STARTED|Overall Study||15
11253811|NCT02190045|12447765|FG000|COMPLETED|Overall Study||12
11253812|NCT02190045|12447766|FG001|COMPLETED|Overall Study||15
11253813|NCT02190045|12447765|FG000|NOT COMPLETED|Overall Study||3
11253814|NCT02190045|12447766|FG001|NOT COMPLETED|Overall Study||0
11253815|NCT02190279|12447775|FG000|STARTED|Overall Study||16
11253816|NCT02190279|12447776|FG001|STARTED|Overall Study||69
11253817|NCT02190279|12447777|FG002|STARTED|Overall Study||31
11253818|NCT02190279|12447775|FG000|COMPLETED|Overall Study||13
11253819|NCT02190279|12447776|FG001|COMPLETED|Overall Study||69
11253820|NCT02190279|12447777|FG002|COMPLETED|Overall Study||28
11253821|NCT02190279|12447775|FG000|NOT COMPLETED|Overall Study||3
11253822|NCT02190279|12447776|FG001|NOT COMPLETED|Overall Study||0
11253823|NCT02190279|12447777|FG002|NOT COMPLETED|Overall Study||3
11253824|NCT02190435|12447789|FG000|STARTED|Overall Study||41
11253825|NCT02190435|12447790|FG001|STARTED|Overall Study||24
11253826|NCT02190435|12447789|FG000|COMPLETED|Overall Study||26
11253827|NCT02190435|12447790|FG001|COMPLETED|Overall Study||24
11253828|NCT02190435|12447789|FG000|NOT COMPLETED|Overall Study||15
11253829|NCT02190435|12447790|FG001|NOT COMPLETED|Overall Study||0
11253830|NCT02190552|12447796|FG000|STARTED|Overall Study||40
11253831|NCT02190552|12447796|FG000|COMPLETED|Overall Study||36
11253832|NCT02190552|12447796|FG000|NOT COMPLETED|Overall Study||4
11253833|NCT02190591|12447803|FG000|STARTED|Overall Study||102
11253834|NCT02190591|12447804|FG001|STARTED|Overall Study||102
11253835|NCT02190591|12447803|FG000|COMPLETED|Overall Study||100
11253836|NCT02190591|12447804|FG001|COMPLETED|Overall Study||91
11253837|NCT02190591|12447803|FG000|NOT COMPLETED|Overall Study||2
11253838|NCT02190591|12447804|FG001|NOT COMPLETED|Overall Study||11
11253839|NCT02190604|12447829|FG000|STARTED|Part 1 and 2 (Healthy Volunteers)||6
11253840|NCT02190604|12447830|FG001|STARTED|Part 1 and 2 (Healthy Volunteers)||6
11253841|NCT02190604|12447831|FG002|STARTED|Part 1 and 2 (Healthy Volunteers)||6
11253842|NCT02190604|12447832|FG003|STARTED|Part 1 and 2 (Healthy Volunteers)||6
11253843|NCT02190604|12447833|FG004|STARTED|Part 1 and 2 (Healthy Volunteers)||6
11253844|NCT02190604|12447834|FG005|STARTED|Part 1 and 2 (Healthy Volunteers)||6
11253845|NCT02190604|12447835|FG006|STARTED|Part 1 and 2 (Healthy Volunteers)||6
11253846|NCT02190604|12447836|FG007|STARTED|Part 1 and 2 (Healthy Volunteers)||6
11253847|NCT02190604|12447837|FG008|STARTED|Part 1 and 2 (Healthy Volunteers)||16
11253848|NCT02190604|12447838|FG009|STARTED|Part 1 and 2 (Healthy Volunteers)||6
11253849|NCT02190604|12447839|FG010|STARTED|Part 1 and 2 (Healthy Volunteers)||6
11253850|NCT02190604|12447840|FG011|STARTED|Part 1 and 2 (Healthy Volunteers)||6
11253851|NCT02190604|12447841|FG012|STARTED|Part 1 and 2 (Healthy Volunteers)||6
11253852|NCT02190604|12447842|FG013|STARTED|Part 1 and 2 (Healthy Volunteers)||6
11253853|NCT02190604|12447843|FG014|STARTED|Part 1 and 2 (Healthy Volunteers)||10
11253854|NCT02190604|12447844|FG015|STARTED|Part 1 and 2 (Healthy Volunteers)||0
11253855|NCT02190604|12447845|FG016|STARTED|Part 1 and 2 (Healthy Volunteers)||0
11253856|NCT02190604|12447846|FG017|STARTED|Part 1 and 2 (Healthy Volunteers)||0
11253857|NCT02190604|12447847|FG018|STARTED|Part 1 and 2 (Healthy Volunteers)||0
11253858|NCT02190604|12447829|FG000|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
11253859|NCT02190604|12447830|FG001|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
11253860|NCT02190604|12447831|FG002|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
11253861|NCT02190604|12447832|FG003|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
11253862|NCT02190604|12447833|FG004|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
11253863|NCT02190604|12447834|FG005|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
11253864|NCT02190604|12447835|FG006|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
11253865|NCT02190604|12447836|FG007|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
11253866|NCT02190604|12447837|FG008|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
11253867|NCT02190604|12447838|FG009|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
11253868|NCT02190604|12447839|FG010|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
11253869|NCT02190604|12447840|FG011|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
11253870|NCT02190604|12447841|FG012|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
11253871|NCT02190604|12447842|FG013|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
11253872|NCT02190604|12447843|FG014|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
11253873|NCT02190604|12447844|FG015|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253874|NCT02190604|12447845|FG016|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253875|NCT02190604|12447846|FG017|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253876|NCT02190604|12447847|FG018|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253877|NCT02190604|12447829|FG000|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253878|NCT02190604|12447830|FG001|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253879|NCT02190604|12447831|FG002|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253880|NCT02190604|12447832|FG003|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253881|NCT02190604|12447833|FG004|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253882|NCT02190604|12447834|FG005|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253883|NCT02190604|12447835|FG006|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253884|NCT02190604|12447836|FG007|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253885|NCT02190604|12447837|FG008|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253886|NCT02190604|12447838|FG009|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253887|NCT02190604|12447839|FG010|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253888|NCT02190604|12447840|FG011|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253889|NCT02190604|12447841|FG012|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253890|NCT02190604|12447842|FG013|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
11253891|NCT02190604|12447843|FG014|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
11253892|NCT02190604|12447844|FG015|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253893|NCT02190604|12447845|FG016|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253894|NCT02190604|12447846|FG017|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253895|NCT02190604|12447847|FG018|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
11253896|NCT02190604|12447829|FG000|STARTED|Part 3 (Patients)||0
11253897|NCT02190604|12447830|FG001|STARTED|Part 3 (Patients)||0
11253898|NCT02190604|12447831|FG002|STARTED|Part 3 (Patients)||0
11358634|NCT03127228|12555776|FG000|COMPLETED|Overall Study||12
11358635|NCT03127228|12555777|FG001|COMPLETED|Overall Study||12
11358636|NCT03127228|12555776|FG000|NOT COMPLETED|Overall Study||0
11358637|NCT03127228|12555777|FG001|NOT COMPLETED|Overall Study||0
11358638|NCT03127358|12555786|FG000|STARTED|Overall Study|3/9/18:Date first participant was randomized to this arm.|3
11358639|NCT03127358|12555787|FG001|STARTED|Overall Study|3/22/18: Date first participant randomized to this arm.|3
11358640|NCT03127358|12555788|FG002|STARTED|Overall Study|3/14/18: Date first participant randomized to this arm..|5
11358641|NCT03127358|12555786|FG000|COMPLETED|Overall Study|12/26/18: Date of SVR for last participant randomized to this arm.|3
11358642|NCT03127358|12555787|FG001|COMPLETED|Overall Study|2/6/19: Date of SVR for last participant randomized to this arm.|3
11358643|NCT03127358|12555788|FG002|COMPLETED|Overall Study|11/20/18: Date of SVR for last participant randomized to this arm.|5
11358644|NCT03127358|12555786|FG000|NOT COMPLETED|Overall Study||0
11358645|NCT03127358|12555787|FG001|NOT COMPLETED|Overall Study||0
11358646|NCT03127358|12555788|FG002|NOT COMPLETED|Overall Study||0
11358647|NCT03127514|12555804|FG000|STARTED|Overall Study||48
11358648|NCT03127514|12555805|FG001|STARTED|Overall Study||89
11358649|NCT03127514|12555804|FG000|COMPLETED|Overall Study||38
11358650|NCT03127514|12555805|FG001|COMPLETED|Overall Study||67
11358651|NCT03127514|12555804|FG000|NOT COMPLETED|Overall Study||10
11358652|NCT03127514|12555805|FG001|NOT COMPLETED|Overall Study||22
11358653|NCT03127644|12555814|FG000|STARTED|Overall Study||34
11358654|NCT03127644|12555815|FG001|STARTED|Overall Study||36
11358655|NCT03127644|12555816|FG002|STARTED|Overall Study||33
11358656|NCT03127644|12555814|FG000|COMPLETED|Overall Study||34
11358657|NCT03127644|12555815|FG001|COMPLETED|Overall Study||36
11358658|NCT03127644|12555816|FG002|COMPLETED|Overall Study||31
11358659|NCT03127644|12555814|FG000|NOT COMPLETED|Overall Study||0
11358660|NCT03127644|12555815|FG001|NOT COMPLETED|Overall Study||0
11358661|NCT03127644|12555816|FG002|NOT COMPLETED|Overall Study||2
11358662|NCT03127943|12555826|FG000|STARTED|First Intervention||12
11358663|NCT03127943|12555827|FG001|STARTED|First Intervention||12
11358664|NCT03127943|12555826|FG000|COMPLETED|First Intervention||12
11358665|NCT03127943|12555827|FG001|COMPLETED|First Intervention||12
11358666|NCT03127943|12555826|FG000|NOT COMPLETED|First Intervention||0
11358667|NCT03127943|12555827|FG001|NOT COMPLETED|First Intervention||0
11358668|NCT03127943|12555826|FG000|STARTED|Washout (1 Week)||12
11358669|NCT03127943|12555827|FG001|STARTED|Washout (1 Week)||12
11358670|NCT03127943|12555826|FG000|COMPLETED|Washout (1 Week)||12
11358671|NCT03127943|12555827|FG001|COMPLETED|Washout (1 Week)||12
11253899|NCT02190604|12447832|FG003|STARTED|Part 3 (Patients)||0
11253900|NCT02190604|12447833|FG004|STARTED|Part 3 (Patients)||0
11253901|NCT02190604|12447834|FG005|STARTED|Part 3 (Patients)||0
11253902|NCT02190604|12447835|FG006|STARTED|Part 3 (Patients)||0
11253903|NCT02190604|12447836|FG007|STARTED|Part 3 (Patients)||0
11253904|NCT02190604|12447837|FG008|STARTED|Part 3 (Patients)||0
11253905|NCT02190604|12447838|FG009|STARTED|Part 3 (Patients)||0
11253906|NCT02190604|12447839|FG010|STARTED|Part 3 (Patients)||0
11253907|NCT02190604|12447840|FG011|STARTED|Part 3 (Patients)||0
11253908|NCT02190604|12447841|FG012|STARTED|Part 3 (Patients)||0
11253909|NCT02190604|12447842|FG013|STARTED|Part 3 (Patients)||0
11253910|NCT02190604|12447843|FG014|STARTED|Part 3 (Patients)||0
11253911|NCT02190604|12447844|FG015|STARTED|Part 3 (Patients)||6
11253912|NCT02190604|12447845|FG016|STARTED|Part 3 (Patients)||12
11253913|NCT02190604|12447846|FG017|STARTED|Part 3 (Patients)||19
11253914|NCT02190604|12447847|FG018|STARTED|Part 3 (Patients)||12
11253915|NCT02190604|12447829|FG000|COMPLETED|Part 3 (Patients)||0
11253916|NCT02190604|12447830|FG001|COMPLETED|Part 3 (Patients)||0
11253917|NCT02190604|12447831|FG002|COMPLETED|Part 3 (Patients)||0
11253918|NCT02190604|12447832|FG003|COMPLETED|Part 3 (Patients)||0
11253919|NCT02190604|12447833|FG004|COMPLETED|Part 3 (Patients)||0
11253920|NCT02190604|12447834|FG005|COMPLETED|Part 3 (Patients)||0
11253921|NCT02190604|12447835|FG006|COMPLETED|Part 3 (Patients)||0
11253922|NCT02190604|12447836|FG007|COMPLETED|Part 3 (Patients)||0
11253923|NCT02190604|12447837|FG008|COMPLETED|Part 3 (Patients)||0
11253924|NCT02190604|12447838|FG009|COMPLETED|Part 3 (Patients)||0
11253925|NCT02190604|12447839|FG010|COMPLETED|Part 3 (Patients)||0
11253926|NCT02190604|12447840|FG011|COMPLETED|Part 3 (Patients)||0
11253927|NCT02190604|12447841|FG012|COMPLETED|Part 3 (Patients)||0
11253928|NCT02190604|12447842|FG013|COMPLETED|Part 3 (Patients)||0
11253929|NCT02190604|12447843|FG014|COMPLETED|Part 3 (Patients)||0
11253930|NCT02190604|12447844|FG015|COMPLETED|Part 3 (Patients)||6
11253931|NCT02190604|12447845|FG016|COMPLETED|Part 3 (Patients)||12
11253932|NCT02190604|12447846|FG017|COMPLETED|Part 3 (Patients)||19
11253933|NCT02190604|12447847|FG018|COMPLETED|Part 3 (Patients)||12
11253934|NCT02190604|12447829|FG000|NOT COMPLETED|Part 3 (Patients)||0
11253935|NCT02190604|12447830|FG001|NOT COMPLETED|Part 3 (Patients)||0
11253936|NCT02190604|12447831|FG002|NOT COMPLETED|Part 3 (Patients)||0
11253937|NCT02190604|12447832|FG003|NOT COMPLETED|Part 3 (Patients)||0
11253938|NCT02190604|12447833|FG004|NOT COMPLETED|Part 3 (Patients)||0
11253939|NCT02190604|12447834|FG005|NOT COMPLETED|Part 3 (Patients)||0
11253940|NCT02190604|12447835|FG006|NOT COMPLETED|Part 3 (Patients)||0
11253941|NCT02190604|12447836|FG007|NOT COMPLETED|Part 3 (Patients)||0
11253942|NCT02190604|12447837|FG008|NOT COMPLETED|Part 3 (Patients)||0
11253943|NCT02190604|12447838|FG009|NOT COMPLETED|Part 3 (Patients)||0
11253944|NCT02190604|12447839|FG010|NOT COMPLETED|Part 3 (Patients)||0
11253945|NCT02190604|12447840|FG011|NOT COMPLETED|Part 3 (Patients)||0
11253946|NCT02190604|12447841|FG012|NOT COMPLETED|Part 3 (Patients)||0
11253947|NCT02190604|12447842|FG013|NOT COMPLETED|Part 3 (Patients)||0
11253948|NCT02190604|12447843|FG014|NOT COMPLETED|Part 3 (Patients)||0
11253949|NCT02190604|12447844|FG015|NOT COMPLETED|Part 3 (Patients)||0
11253950|NCT02190604|12447845|FG016|NOT COMPLETED|Part 3 (Patients)||0
11253951|NCT02190604|12447846|FG017|NOT COMPLETED|Part 3 (Patients)||0
11253952|NCT02190604|12447847|FG018|NOT COMPLETED|Part 3 (Patients)||0
11253953|NCT02190747|12447907|FG000|STARTED|Overall Study||21
11253954|NCT02190747|12447908|FG001|STARTED|Overall Study||9
11253955|NCT02190747|12447909|FG002|STARTED|Overall Study||10
11253956|NCT02190747|12447907|FG000|COMPLETED|Overall Study||21
11253957|NCT02190747|12447908|FG001|COMPLETED|Overall Study||9
11253958|NCT02190747|12447909|FG002|COMPLETED|Overall Study||10
11253959|NCT02190747|12447907|FG000|NOT COMPLETED|Overall Study||0
11253960|NCT02190747|12447908|FG001|NOT COMPLETED|Overall Study||0
11253961|NCT02190747|12447909|FG002|NOT COMPLETED|Overall Study||0
11339603|NCT02915835|12537144|FG000|COMPLETED|Overall Study||8
11339604|NCT02915835|12537145|FG001|COMPLETED|Overall Study||7
11339605|NCT02915835|12537144|FG000|NOT COMPLETED|Overall Study||1
11339606|NCT02915835|12537145|FG001|NOT COMPLETED|Overall Study||1
11339607|NCT02915874|12537153|FG000|STARTED|Overall Study||44
11339608|NCT02915874|12537154|FG001|STARTED|Overall Study||28
11339609|NCT02915874|12537153|FG000|Week 6 Follow Up|Overall Study||41
11339610|NCT02915874|12537154|FG001|Week 6 Follow Up|Overall Study||26
11339611|NCT02915874|12537153|FG000|COMPLETED|Overall Study||38
11339612|NCT02915874|12537154|FG001|COMPLETED|Overall Study||22
11339613|NCT02915874|12537153|FG000|NOT COMPLETED|Overall Study||6
11339614|NCT02915874|12537154|FG001|NOT COMPLETED|Overall Study||6
11339615|NCT02915978|12537163|FG000|STARTED|Overall Study||15
11339616|NCT02915978|12537164|FG001|STARTED|Overall Study||15
11339617|NCT02915978|12537165|FG002|STARTED|Overall Study||15
11339618|NCT02915978|12537163|FG000|COMPLETED|Overall Study||13
11339619|NCT02915978|12537164|FG001|COMPLETED|Overall Study||14
11339620|NCT02915978|12537165|FG002|COMPLETED|Overall Study||15
11339621|NCT02915978|12537163|FG000|NOT COMPLETED|Overall Study||2
11339622|NCT02915978|12537164|FG001|NOT COMPLETED|Overall Study||1
11339623|NCT02915978|12537165|FG002|NOT COMPLETED|Overall Study||0
11339624|NCT02916056|12537173|FG000|STARTED|Overall Study||297
11339625|NCT02916056|12537173|FG000|COMPLETED|Overall Study||0
11339626|NCT02916056|12537173|FG000|NOT COMPLETED|Overall Study||297
11339627|NCT02916407|12537179|FG000|STARTED|Overall Study||28
11339628|NCT02916407|12537180|FG001|STARTED|Overall Study||28
11339629|NCT02916407|12537179|FG000|COMPLETED|Overall Study||28
11339630|NCT02916407|12537180|FG001|COMPLETED|Overall Study||28
11339631|NCT02916407|12537179|FG000|NOT COMPLETED|Overall Study||0
11339632|NCT02916407|12537180|FG001|NOT COMPLETED|Overall Study||0
11339633|NCT02916433|12537188|FG000|STARTED|Overall Study||3
11339634|NCT02916433|12537189|FG001|STARTED|Overall Study||2
11339635|NCT02916433|12537188|FG000|COMPLETED|Overall Study||1
11339636|NCT02916433|12537189|FG001|COMPLETED|Overall Study||2
11339637|NCT02916433|12537188|FG000|NOT COMPLETED|Overall Study||2
11339638|NCT02916433|12537189|FG001|NOT COMPLETED|Overall Study||0
11339639|NCT02916498|12537200|FG000|STARTED|First Intervention, 21 Days||2
11339640|NCT02916498|12537201|FG001|STARTED|First Intervention, 21 Days||4
11339641|NCT02916498|12537200|FG000|COMPLETED|First Intervention, 21 Days||2
11339642|NCT02916498|12537201|FG001|COMPLETED|First Intervention, 21 Days||4
11339643|NCT02916498|12537200|FG000|NOT COMPLETED|First Intervention, 21 Days||0
11339644|NCT02916498|12537201|FG001|NOT COMPLETED|First Intervention, 21 Days||0
11339645|NCT02916498|12537200|FG000|STARTED|Second Intervention, 21 Days||2
11339646|NCT02916498|12537201|FG001|STARTED|Second Intervention, 21 Days||4
11339647|NCT02916498|12537200|FG000|COMPLETED|Second Intervention, 21 Days||2
11339648|NCT02916498|12537201|FG001|COMPLETED|Second Intervention, 21 Days||4
11339649|NCT02916498|12537200|FG000|NOT COMPLETED|Second Intervention, 21 Days||0
11339650|NCT02916498|12537201|FG001|NOT COMPLETED|Second Intervention, 21 Days||0
11339651|NCT02916563|12537207|FG000|STARTED|Overall Study||50
11339652|NCT02916563|12537207|FG000|COMPLETED|Overall Study||50
11339653|NCT02916563|12537207|FG000|NOT COMPLETED|Overall Study||0
11339654|NCT02916693|12537211|FG000|STARTED|Overall Study||20
11339655|NCT02916693|12537211|FG000|COMPLETED|Overall Study||13
11339656|NCT02916693|12537211|FG000|NOT COMPLETED|Overall Study||7
11339657|NCT02916745|12537219|FG000|STARTED|Overall Study||5
11339658|NCT02916745|12537219|FG000|COMPLETED|Overall Study||5
11339659|NCT02916745|12537219|FG000|NOT COMPLETED|Overall Study||0
11339660|NCT02916927|12537225|FG000|STARTED|Overall Study||31
11339661|NCT02916927|12537226|FG001|STARTED|Overall Study||31
11339662|NCT02916927|12537225|FG000|Received Study Drug|Overall Study||31
11339663|NCT02916927|12537226|FG001|Received Study Drug|Overall Study||29
11339664|NCT02916927|12537225|FG000|COMPLETED|Overall Study||30
11339665|NCT02916927|12537226|FG001|COMPLETED|Overall Study|1 participant was in radiology for the 45 and 60 minute time points.|28
11339666|NCT02916927|12537225|FG000|NOT COMPLETED|Overall Study||1
11339667|NCT02916927|12537226|FG001|NOT COMPLETED|Overall Study||3
11339668|NCT02917031|12537235|FG000|STARTED|Overall Study||112
11339669|NCT02917031|12537236|FG001|STARTED|Overall Study||115
11339670|NCT02917031|12537237|FG002|STARTED|Overall Study||120
11339671|NCT02917031|12537235|FG000|COMPLETED|Overall Study||94
11339672|NCT02917031|12537236|FG001|COMPLETED|Overall Study||102
11253962|NCT02190903|12447919|FG000|STARTED|Overall Study||6
11253963|NCT02190903|12447920|FG001|STARTED|Overall Study||6
11253964|NCT02190903|12447919|FG000|COMPLETED|Overall Study||6
11253965|NCT02190903|12447920|FG001|COMPLETED|Overall Study||6
11253966|NCT02190903|12447919|FG000|NOT COMPLETED|Overall Study||0
11253967|NCT02190903|12447920|FG001|NOT COMPLETED|Overall Study||0
11253968|NCT02191033|12447928|FG000|STARTED|Overall Study||20
11253969|NCT02191033|12447929|FG001|STARTED|Overall Study||20
11253970|NCT02191033|12447928|FG000|COMPLETED|Overall Study||18
11253971|NCT02191033|12447929|FG001|COMPLETED|Overall Study||19
11253972|NCT02191033|12447928|FG000|NOT COMPLETED|Overall Study||2
11253973|NCT02191033|12447929|FG001|NOT COMPLETED|Overall Study||1
11253974|NCT02191046|12447937|FG000|STARTED|Overall Study||41
11253975|NCT02191046|12447938|FG001|STARTED|Overall Study||39
11253976|NCT02191046|12447937|FG000|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
11253977|NCT02191046|12447938|FG001|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
11253978|NCT02191046|12447937|FG000|NOT COMPLETED|Overall Study||5
11253979|NCT02191046|12447938|FG001|NOT COMPLETED|Overall Study||1
11253980|NCT02191137|12447944|FG000|STARTED|Treatment||75
11253981|NCT02191137|12447944|FG000|COMPLETED|Treatment||65
11253982|NCT02191137|12447944|FG000|NOT COMPLETED|Treatment||10
11253983|NCT02191137|12447944|FG000|STARTED|Follow-up||65
11253984|NCT02191137|12447944|FG000|COMPLETED|Follow-up||60
11253985|NCT02191137|12447944|FG000|NOT COMPLETED|Follow-up||5
11253986|NCT02191267|12447951|FG000|STARTED|Overall Study||20
11253987|NCT02191267|12447952|FG001|STARTED|Overall Study||6
11253988|NCT02191267|12447953|FG002|STARTED|Overall Study||4
11253989|NCT02191267|12447951|FG000|COMPLETED|Overall Study||19
11253990|NCT02191267|12447952|FG001|COMPLETED|Overall Study||6
11253991|NCT02191267|12447953|FG002|COMPLETED|Overall Study||4
11253992|NCT02191267|12447951|FG000|NOT COMPLETED|Overall Study||1
11253993|NCT02191267|12447952|FG001|NOT COMPLETED|Overall Study||0
11253994|NCT02191267|12447953|FG002|NOT COMPLETED|Overall Study||0
11253995|NCT02191397|12447963|FG000|STARTED|Overall Study||266
11253996|NCT02191397|12447964|FG001|STARTED|Overall Study||268
11253997|NCT02191397|12447963|FG000|COMPLETED|Overall Study||183
11253998|NCT02191397|12447964|FG001|COMPLETED|Overall Study||198
11253999|NCT02191397|12447963|FG000|NOT COMPLETED|Overall Study||83
11254000|NCT02191397|12447964|FG001|NOT COMPLETED|Overall Study||70
11254001|NCT02191579|12447972|FG000|STARTED|Treatment 1||140
11254002|NCT02191579|12447973|FG001|STARTED|Treatment 1||142
11254003|NCT02191579|12447972|FG000|COMPLETED|Treatment 1||113
11254004|NCT02191579|12447973|FG001|COMPLETED|Treatment 1||84
11254005|NCT02191579|12447972|FG000|NOT COMPLETED|Treatment 1||27
11254006|NCT02191579|12447973|FG001|NOT COMPLETED|Treatment 1||58
11254007|NCT02191579|12447972|FG000|STARTED|Treatment 2||0
11254008|NCT02191579|12447973|FG001|STARTED|Treatment 2||80
11254009|NCT02191579|12447972|FG000|COMPLETED|Treatment 2||0
11254010|NCT02191579|12447973|FG001|COMPLETED|Treatment 2||55
11254011|NCT02191579|12447972|FG000|NOT COMPLETED|Treatment 2||0
11254012|NCT02191579|12447973|FG001|NOT COMPLETED|Treatment 2||25
11254013|NCT02191605|12447984|FG000|STARTED|Overall Study||15
11254014|NCT02191605|12447985|FG001|STARTED|Overall Study||15
11254015|NCT02191605|12447986|FG002|STARTED|Overall Study||15
11254016|NCT02191605|12447987|FG003|STARTED|Overall Study||8
11254017|NCT02191605|12447988|FG004|STARTED|Overall Study||7
11254018|NCT02191605|12447984|FG000|Completed Intervention Portion|Overall Study||15
11254019|NCT02191605|12447985|FG001|Completed Intervention Portion|Overall Study||15
11254020|NCT02191605|12447986|FG002|Completed Intervention Portion|Overall Study||15
11254021|NCT02191605|12447987|FG003|Completed Intervention Portion|Overall Study||8
11254022|NCT02191605|12447988|FG004|Completed Intervention Portion|Overall Study||7
11254023|NCT02191605|12447984|FG000|COMPLETED|Overall Study||6
11254024|NCT02191605|12447985|FG001|COMPLETED|Overall Study||11
11254025|NCT02191605|12447986|FG002|COMPLETED|Overall Study||8
11254026|NCT02191605|12447987|FG003|COMPLETED|Overall Study||5
11254027|NCT02191605|12447988|FG004|COMPLETED|Overall Study||3
11254028|NCT02191605|12447984|FG000|NOT COMPLETED|Overall Study||9
11254029|NCT02191605|12447985|FG001|NOT COMPLETED|Overall Study||4
11254030|NCT02191605|12447986|FG002|NOT COMPLETED|Overall Study||7
11254031|NCT02191605|12447987|FG003|NOT COMPLETED|Overall Study||3
11254032|NCT02191605|12447988|FG004|NOT COMPLETED|Overall Study||4
11254033|NCT02191618|12448000|FG000|STARTED|Overall Study||150
11254034|NCT02191618|12448000|FG000|COMPLETED|Overall Study||143
11254035|NCT02191618|12448000|FG000|NOT COMPLETED|Overall Study||7
11254036|NCT02191865|12448007|FG000|STARTED|Overall Study||8
11254037|NCT02191865|12448008|FG001|STARTED|Overall Study||8
11254038|NCT02191865|12448009|FG002|STARTED|Overall Study||17
11254039|NCT02191865|12448007|FG000|COMPLETED|Overall Study||8
11254040|NCT02191865|12448008|FG001|COMPLETED|Overall Study||8
11254041|NCT02191865|12448009|FG002|COMPLETED|Overall Study||17
11254042|NCT02191865|12448007|FG000|NOT COMPLETED|Overall Study||0
11254043|NCT02191865|12448008|FG001|NOT COMPLETED|Overall Study||0
11254044|NCT02191865|12448009|FG002|NOT COMPLETED|Overall Study||0
11254045|NCT02192099|12448020|FG000|STARTED|Overall Study||61
11254046|NCT02192099|12448020|FG000|COMPLETED|Overall Study||0
11254047|NCT02192099|12448020|FG000|NOT COMPLETED|Overall Study||61
11254048|NCT02192164|12448024|FG000|STARTED|Overall Study||126
11254049|NCT02192164|12448024|FG000|Etanercept Treated Population|Overall Study||112
11254050|NCT02192164|12448024|FG000|COMPLETED|Overall Study||112
11254051|NCT02192164|12448024|FG000|NOT COMPLETED|Overall Study||14
11254052|NCT02192190|12448037|FG000|STARTED|Overall Study||76
11254053|NCT02192190|12448038|FG001|STARTED|Overall Study||39
11254054|NCT02192190|12448039|FG002|STARTED|Overall Study||38
11254055|NCT02192190|12448040|FG003|STARTED|Overall Study||38
11254056|NCT02192190|12448041|FG004|STARTED|Overall Study||39
11254057|NCT02192190|12448042|FG005|STARTED|Overall Study||38
11254058|NCT02192190|12448037|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
11254059|NCT02192190|12448038|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
11254060|NCT02192190|12448039|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38
11254061|NCT02192190|12448040|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38
11254062|NCT02192190|12448041|FG004|Received at Least 1 Dose of Study Drug|Overall Study||38
11254063|NCT02192190|12448042|FG005|Received at Least 1 Dose of Study Drug|Overall Study||37
11254064|NCT02192190|12448037|FG000|COMPLETED|Overall Study||22
11254065|NCT02192190|12448038|FG001|COMPLETED|Overall Study||10
11254066|NCT02192190|12448039|FG002|COMPLETED|Overall Study||13
11254067|NCT02192190|12448040|FG003|COMPLETED|Overall Study||12
11254068|NCT02192190|12448041|FG004|COMPLETED|Overall Study||9
11254069|NCT02192190|12448042|FG005|COMPLETED|Overall Study||9
11254070|NCT02192190|12448037|FG000|NOT COMPLETED|Overall Study||54
11254071|NCT02192190|12448038|FG001|NOT COMPLETED|Overall Study||29
11254072|NCT02192190|12448039|FG002|NOT COMPLETED|Overall Study||25
11254073|NCT02192190|12448040|FG003|NOT COMPLETED|Overall Study||26
11254074|NCT02192190|12448041|FG004|NOT COMPLETED|Overall Study||30
11254075|NCT02192190|12448042|FG005|NOT COMPLETED|Overall Study||29
11254076|NCT02192307|12448059|FG000|STARTED|Overall Study||30
11254077|NCT02192307|12448060|FG001|STARTED|Overall Study||30
11254078|NCT02192307|12448059|FG000|COMPLETED|Overall Study||30
11254079|NCT02192307|12448060|FG001|COMPLETED|Overall Study||30
11254080|NCT02192307|12448059|FG000|NOT COMPLETED|Overall Study||0
11254081|NCT02192307|12448060|FG001|NOT COMPLETED|Overall Study||0
11254082|NCT02192541|12448068|FG000|STARTED|Overall Study||2
11254083|NCT02192541|12448069|FG001|STARTED|Overall Study||3
11254084|NCT02192541|12448068|FG000|Treated|Overall Study||2
11254085|NCT02192541|12448069|FG001|Treated|Overall Study||3
11254086|NCT02192541|12448068|FG000|Evaluable for Response|Overall Study||1
11254087|NCT02192541|12448069|FG001|Evaluable for Response|Overall Study||3
11254088|NCT02192541|12448068|FG000|COMPLETED|Overall Study||2
11254089|NCT02192541|12448069|FG001|COMPLETED|Overall Study||3
11254090|NCT02192541|12448068|FG000|NOT COMPLETED|Overall Study||0
11254091|NCT02192541|12448069|FG001|NOT COMPLETED|Overall Study||0
11254092|NCT02192606|12448078|FG000|STARTED|Overall Study||29
11254093|NCT02192606|12448079|FG001|STARTED|Overall Study||28
11254094|NCT02192606|12448078|FG000|COMPLETED|Overall Study||27
11254095|NCT02192606|12448079|FG001|COMPLETED|Overall Study||24
11254096|NCT02192606|12448078|FG000|NOT COMPLETED|Overall Study||2
11254097|NCT02192606|12448079|FG001|NOT COMPLETED|Overall Study||4
11254098|NCT02192684|12448087|FG000|STARTED|Overall Study||30
11254099|NCT02192684|12448088|FG001|STARTED|Overall Study||15
11254100|NCT02192684|12448087|FG000|COMPLETED|Overall Study||30
11254101|NCT02192684|12448088|FG001|COMPLETED|Overall Study||15
11254102|NCT02192684|12448087|FG000|NOT COMPLETED|Overall Study||0
11254103|NCT02192684|12448088|FG001|NOT COMPLETED|Overall Study||0
11254104|NCT02192814|12448094|FG000|STARTED|Overall Study||9
11254105|NCT02192814|12448094|FG000|COMPLETED|Overall Study||9
11254106|NCT02192814|12448094|FG000|NOT COMPLETED|Overall Study||0
11254107|NCT02192879|12448101|FG000|STARTED|Overall Study||3
11254108|NCT02192879|12448102|FG001|STARTED|Overall Study||4
11254109|NCT02192879|12448103|FG002|STARTED|Overall Study||3
11254110|NCT02192879|12448101|FG000|COMPLETED|Overall Study||3
11254111|NCT02192879|12448102|FG001|COMPLETED|Overall Study||4
11254112|NCT02192879|12448103|FG002|COMPLETED|Overall Study||3
11254113|NCT02192879|12448101|FG000|NOT COMPLETED|Overall Study||0
11254114|NCT02192879|12448102|FG001|NOT COMPLETED|Overall Study||0
11254115|NCT02192879|12448103|FG002|NOT COMPLETED|Overall Study||0
11254116|NCT02192905|12448111|FG000|STARTED|Overall Study||43
11254117|NCT02192905|12448111|FG000|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
11254118|NCT02192905|12448111|FG000|NOT COMPLETED|Overall Study||1
11254119|NCT02192970|12448118|FG000|STARTED|Overall Study||101
11254120|NCT02192970|12448119|FG001|STARTED|Overall Study||195
11254121|NCT02192970|12448118|FG000|COMPLETED|Overall Study||95
11254122|NCT02192970|12448119|FG001|COMPLETED|Overall Study||195
11254123|NCT02192970|12448118|FG000|NOT COMPLETED|Overall Study||6
11254124|NCT02192970|12448119|FG001|NOT COMPLETED|Overall Study||0
11254125|NCT02193074|12448127|FG000|STARTED|Overall Study|Randomized and received double-blind treatment.|41
11254126|NCT02193074|12448128|FG001|STARTED|Overall Study|Randomized and received double-blind treatment.|80
11254127|NCT02193074|12448127|FG000|Completed During Follow-Up Period|Overall Study||11
11254128|NCT02193074|12448128|FG001|Completed During Follow-Up Period|Overall Study||26
11254129|NCT02193074|12448127|FG000|Completed Due to Early Study Termination|Overall Study||13
11254130|NCT02193074|12448128|FG001|Completed Due to Early Study Termination|Overall Study||39
11254131|NCT02193074|12448127|FG000|COMPLETED|Overall Study||24
11254132|NCT02193074|12448128|FG001|COMPLETED|Overall Study||65
11254133|NCT02193074|12448127|FG000|NOT COMPLETED|Overall Study||17
11254134|NCT02193074|12448128|FG001|NOT COMPLETED|Overall Study||15
11254135|NCT02193087|12448138|FG000|STARTED|Overall Study||199
11254136|NCT02193087|12448139|FG001|STARTED|Overall Study||100
11254137|NCT02193087|12448140|FG002|STARTED|Overall Study||100
11254138|NCT02193087|12448141|FG003|STARTED|Overall Study||603
11254139|NCT02193087|12448138|FG000|Received Vaccination|Overall Study||197
11254140|NCT02193087|12448139|FG001|Received Vaccination|Overall Study||97
11254141|NCT02193087|12448140|FG002|Received Vaccination|Overall Study||100
11254142|NCT02193087|12448141|FG003|Received Vaccination|Overall Study||602
11254143|NCT02193087|12448138|FG000|COMPLETED|Overall Study||162
11254144|NCT02193087|12448139|FG001|COMPLETED|Overall Study||86
11254145|NCT02193087|12448140|FG002|COMPLETED|Overall Study||93
11254146|NCT02193087|12448141|FG003|COMPLETED|Overall Study||524
11254147|NCT02193087|12448138|FG000|NOT COMPLETED|Overall Study||37
11254148|NCT02193087|12448139|FG001|NOT COMPLETED|Overall Study||14
11254149|NCT02193087|12448140|FG002|NOT COMPLETED|Overall Study||7
11254150|NCT02193087|12448141|FG003|NOT COMPLETED|Overall Study||79
11254151|NCT02193152|12448158|FG000|STARTED|Overall Study||16
11254152|NCT02193152|12448158|FG000|COMPLETED|Overall Study||16
11254153|NCT02193152|12448158|FG000|NOT COMPLETED|Overall Study||0
11254154|NCT02193165|12448165|FG000|STARTED|4 Week Product Use||40
11254155|NCT02193165|12448166|FG001|STARTED|4 Week Product Use||40
11254156|NCT02193165|12448167|FG002|STARTED|4 Week Product Use||40
11254157|NCT02193165|12448165|FG000|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
11254158|NCT02193165|12448166|FG001|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
11254159|NCT02193165|12448167|FG002|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
11254160|NCT02193165|12448165|FG000|NOT COMPLETED|4 Week Product Use||1
11254161|NCT02193165|12448166|FG001|NOT COMPLETED|4 Week Product Use||1
11254162|NCT02193165|12448167|FG002|NOT COMPLETED|4 Week Product Use||1
11254163|NCT02193165|12448165|FG000|STARTED|6 Week Product Use||39
11254164|NCT02193165|12448166|FG001|STARTED|6 Week Product Use||39
11254165|NCT02193165|12448167|FG002|STARTED|6 Week Product Use||39
11254166|NCT02193165|12448165|FG000|COMPLETED|6 Week Product Use||39
11254167|NCT02193165|12448166|FG001|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
11254168|NCT02193165|12448167|FG002|COMPLETED|6 Week Product Use||39
11254169|NCT02193165|12448165|FG000|NOT COMPLETED|6 Week Product Use||0
11254170|NCT02193165|12448166|FG001|NOT COMPLETED|6 Week Product Use||1
11254171|NCT02193165|12448167|FG002|NOT COMPLETED|6 Week Product Use||0
11254172|NCT02193178|12448175|FG000|STARTED|Overall Study||15
11254173|NCT02193178|12448175|FG000|COMPLETED|Overall Study||13
11254174|NCT02193178|12448175|FG000|NOT COMPLETED|Overall Study||2
11254175|NCT02193347|12448193|FG000|STARTED|Overall Study||24
11254176|NCT02193347|12448193|FG000|COMPLETED|Overall Study||24
11254177|NCT02193347|12448193|FG000|NOT COMPLETED|Overall Study||0
11254178|NCT02193490|12448199|FG000|STARTED|Overall Study||25
11254179|NCT02193490|12448200|FG001|STARTED|Overall Study||22
11254180|NCT02193490|12448199|FG000|COMPLETED|Overall Study||21
11254181|NCT02193490|12448200|FG001|COMPLETED|Overall Study||20
11254182|NCT02193490|12448199|FG000|NOT COMPLETED|Overall Study||4
11254183|NCT02193490|12448200|FG001|NOT COMPLETED|Overall Study||2
11254184|NCT02193776|12448210|FG000|STARTED|Overall Study||59
11254185|NCT02193776|12448211|FG001|STARTED|Overall Study||60
11254186|NCT02193776|12448212|FG002|STARTED|Overall Study||61
11254187|NCT02193776|12448213|FG003|STARTED|Overall Study||60
11254188|NCT02193776|12448210|FG000|Completed Day 70 Follow-up|Overall Study||54
11254189|NCT02193776|12448211|FG001|Completed Day 70 Follow-up|Overall Study||56
11254190|NCT02193776|12448212|FG002|Completed Day 70 Follow-up|Overall Study||60
11254191|NCT02193776|12448213|FG003|Completed Day 70 Follow-up|Overall Study||60
11254192|NCT02193776|12448210|FG000|Completed Day 140 Follow-up|Overall Study||52
11254193|NCT02193776|12448211|FG001|Completed Day 140 Follow-up|Overall Study||52
11254194|NCT02193776|12448212|FG002|Completed Day 140 Follow-up|Overall Study||58
11254195|NCT02193776|12448213|FG003|Completed Day 140 Follow-up|Overall Study||58
11254196|NCT02193776|12448210|FG000|COMPLETED|Overall Study||51
11254197|NCT02193776|12448211|FG001|COMPLETED|Overall Study||53
11254198|NCT02193776|12448212|FG002|COMPLETED|Overall Study||59
11254199|NCT02193776|12448213|FG003|COMPLETED|Overall Study||58
11254200|NCT02193776|12448210|FG000|NOT COMPLETED|Overall Study||8
11254201|NCT02193776|12448211|FG001|NOT COMPLETED|Overall Study||7
11254202|NCT02193776|12448212|FG002|NOT COMPLETED|Overall Study||2
11254203|NCT02193776|12448213|FG003|NOT COMPLETED|Overall Study||2
11254204|NCT02193815|12448223|FG000|STARTED|Overall Study||15
11254205|NCT02193815|12448223|FG000|COMPLETED|Overall Study||15
11254206|NCT02193815|12448223|FG000|NOT COMPLETED|Overall Study||0
11254207|NCT02193828|12448241|FG000|STARTED|Overall Study||18
11254208|NCT02193828|12448242|FG001|STARTED|Overall Study||18
11254209|NCT02193828|12448243|FG002|STARTED|Overall Study||23
11254210|NCT02193828|12448244|FG003|STARTED|Overall Study||17
11254211|NCT02193828|12448241|FG000|COMPLETED|Overall Study||18
11254212|NCT02193828|12448242|FG001|COMPLETED|Overall Study||18
11254213|NCT02193828|12448243|FG002|COMPLETED|Overall Study||22
11254214|NCT02193828|12448244|FG003|COMPLETED|Overall Study||16
11254215|NCT02193828|12448241|FG000|NOT COMPLETED|Overall Study||0
11254216|NCT02193828|12448242|FG001|NOT COMPLETED|Overall Study||0
11254217|NCT02193828|12448243|FG002|NOT COMPLETED|Overall Study||1
11254218|NCT02193828|12448244|FG003|NOT COMPLETED|Overall Study||1
11254219|NCT02193880|12448254|FG000|STARTED|Overall Study||7
11254220|NCT02193880|12448254|FG000|COMPLETED|Overall Study||4
11254221|NCT02193880|12448254|FG000|NOT COMPLETED|Overall Study||3
11254222|NCT02194062|12448261|FG000|STARTED|Overall Study||10
11254223|NCT02194062|12448262|FG001|STARTED|Overall Study||10
11254224|NCT02194062|12448263|FG002|STARTED|Overall Study||12
11254225|NCT02194062|12448261|FG000|COMPLETED|Overall Study||8
11254226|NCT02194062|12448262|FG001|COMPLETED|Overall Study||8
11254227|NCT02194062|12448263|FG002|COMPLETED|Overall Study||7
11254228|NCT02194062|12448261|FG000|NOT COMPLETED|Overall Study||2
11254229|NCT02194062|12448262|FG001|NOT COMPLETED|Overall Study||2
11254230|NCT02194062|12448263|FG002|NOT COMPLETED|Overall Study||5
11254231|NCT02194088|12448273|FG000|STARTED|Overall Study||75
11254232|NCT02194088|12448274|FG001|STARTED|Overall Study||25
11254233|NCT02194088|12448273|FG000|COMPLETED|Overall Study||75
11254234|NCT02194088|12448274|FG001|COMPLETED|Overall Study||25
11254235|NCT02194088|12448273|FG000|NOT COMPLETED|Overall Study||0
11254236|NCT02194088|12448274|FG001|NOT COMPLETED|Overall Study||0
11254237|NCT02194439|12448282|FG000|STARTED|Overall Study||415
11254238|NCT02194439|12448282|FG000|COMPLETED|Overall Study||415
11254239|NCT02194439|12448282|FG000|NOT COMPLETED|Overall Study||0
11254240|NCT02194465|12448293|FG000|STARTED|Overall Study||51
11254241|NCT02194465|12448294|FG001|STARTED|Overall Study||50
11254242|NCT02194465|12448295|FG002|STARTED|Overall Study||52
11254243|NCT02194465|12448296|FG003|STARTED|Overall Study||49
11254244|NCT02194465|12448297|FG004|STARTED|Overall Study||51
11254245|NCT02194465|12448298|FG005|STARTED|Overall Study||25
11254246|NCT02194465|12448299|FG006|STARTED|Overall Study||26
11254247|NCT02194465|12448293|FG000|Received at Least 1 Dose of Study Drug|Overall Study||51
11254248|NCT02194465|12448294|FG001|Received at Least 1 Dose of Study Drug|Overall Study||50
11254249|NCT02194465|12448295|FG002|Received at Least 1 Dose of Study Drug|Overall Study||51
11254250|NCT02194465|12448296|FG003|Received at Least 1 Dose of Study Drug|Overall Study||49
11254251|NCT02194465|12448297|FG004|Received at Least 1 Dose of Study Drug|Overall Study||51
11254252|NCT02194465|12448298|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
11254253|NCT02194465|12448299|FG006|Received at Least 1 Dose of Study Drug|Overall Study||26
11254254|NCT02194465|12448293|FG000|COMPLETED|Overall Study||42
11254255|NCT02194465|12448294|FG001|COMPLETED|Overall Study||43
11254256|NCT02194465|12448295|FG002|COMPLETED|Overall Study||44
11254257|NCT02194465|12448296|FG003|COMPLETED|Overall Study||41
11254258|NCT02194465|12448297|FG004|COMPLETED|Overall Study||42
11254259|NCT02194465|12448298|FG005|COMPLETED|Overall Study||21
11254260|NCT02194465|12448299|FG006|COMPLETED|Overall Study||24
11254261|NCT02194465|12448293|FG000|NOT COMPLETED|Overall Study||9
11254262|NCT02194465|12448294|FG001|NOT COMPLETED|Overall Study||7
11254263|NCT02194465|12448295|FG002|NOT COMPLETED|Overall Study||8
11254264|NCT02194465|12448296|FG003|NOT COMPLETED|Overall Study||8
11254265|NCT02194465|12448297|FG004|NOT COMPLETED|Overall Study||9
11254266|NCT02194465|12448298|FG005|NOT COMPLETED|Overall Study||4
11254267|NCT02194465|12448299|FG006|NOT COMPLETED|Overall Study||2
11254268|NCT02194621|12448322|FG000|STARTED|Overall Study||43
11254269|NCT02194621|12448323|FG001|STARTED|Overall Study||42
11254270|NCT02194621|12448324|FG002|STARTED|Overall Study||43
11254271|NCT02194621|12448322|FG000|COMPLETED|Overall Study||37
11254272|NCT02194621|12448323|FG001|COMPLETED|Overall Study||36
11254273|NCT02194621|12448324|FG002|COMPLETED|Overall Study||34
11254274|NCT02194621|12448322|FG000|NOT COMPLETED|Overall Study||6
11254275|NCT02194621|12448323|FG001|NOT COMPLETED|Overall Study||6
11254276|NCT02194621|12448324|FG002|NOT COMPLETED|Overall Study||9
11254277|NCT02194699|12448334|FG000|STARTED|Randomised||428
11254278|NCT02194699|12448335|FG001|STARTED|Randomised||428
11254279|NCT02194699|12448334|FG000|COMPLETED|Randomised||420
11254280|NCT02194699|12448335|FG001|COMPLETED|Randomised||417
11254281|NCT02194699|12448334|FG000|NOT COMPLETED|Randomised||8
11254282|NCT02194699|12448335|FG001|NOT COMPLETED|Randomised||11
11254283|NCT02194699|12448334|FG000|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
11254284|NCT02194699|12448335|FG001|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
11254285|NCT02194699|12448334|FG000|COMPLETED|With Potential to Receive 52 Weeks of IP||370
11254286|NCT02194699|12448335|FG001|COMPLETED|With Potential to Receive 52 Weeks of IP||365
11254287|NCT02194699|12448334|FG000|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
11254288|NCT02194699|12448335|FG001|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
11254289|NCT02194933|12448351|FG000|STARTED|Overall Study||19
11254290|NCT02194933|12448352|FG001|STARTED|Overall Study||19
11254291|NCT02194933|12448351|FG000|COMPLETED|Overall Study||16
11254292|NCT02194933|12448352|FG001|COMPLETED|Overall Study||10
11254293|NCT02194933|12448351|FG000|NOT COMPLETED|Overall Study||3
11254294|NCT02194933|12448352|FG001|NOT COMPLETED|Overall Study||9
11254295|NCT02194985|12448360|FG000|STARTED|Overall Study||84
11254296|NCT02194985|12448360|FG000|Received at Least 1 Dose of Study Drug|Overall Study||84
11254297|NCT02194985|12448360|FG000|COMPLETED|Overall Study||73
11254298|NCT02194985|12448360|FG000|NOT COMPLETED|Overall Study||11
11254299|NCT02194998|12448368|FG000|STARTED|On-HCV Treatment||21
11254300|NCT02194998|12448369|FG001|STARTED|On-HCV Treatment||6
11254301|NCT02194998|12448370|FG002|STARTED|On-HCV Treatment||15
11254302|NCT02194998|12448371|FG003|STARTED|On-HCV Treatment||4
11254303|NCT02194998|12448368|FG000|COMPLETED|On-HCV Treatment||21
11254304|NCT02194998|12448369|FG001|COMPLETED|On-HCV Treatment||5
11254305|NCT02194998|12448370|FG002|COMPLETED|On-HCV Treatment||15
11254306|NCT02194998|12448371|FG003|COMPLETED|On-HCV Treatment||4
11254307|NCT02194998|12448368|FG000|NOT COMPLETED|On-HCV Treatment||0
11254308|NCT02194998|12448369|FG001|NOT COMPLETED|On-HCV Treatment||1
11254309|NCT02194998|12448370|FG002|NOT COMPLETED|On-HCV Treatment||0
11254310|NCT02194998|12448371|FG003|NOT COMPLETED|On-HCV Treatment||0
11254311|NCT02194998|12448368|FG000|STARTED|Post-HCV Treatment Follow-Up||21
11254312|NCT02194998|12448369|FG001|STARTED|Post-HCV Treatment Follow-Up||5
11254313|NCT02194998|12448370|FG002|STARTED|Post-HCV Treatment Follow-Up||15
11254314|NCT02194998|12448371|FG003|STARTED|Post-HCV Treatment Follow-Up||4
11254315|NCT02194998|12448368|FG000|COMPLETED|Post-HCV Treatment Follow-Up||20
11254316|NCT02194998|12448369|FG001|COMPLETED|Post-HCV Treatment Follow-Up||5
11254317|NCT02194998|12448370|FG002|COMPLETED|Post-HCV Treatment Follow-Up||14
11254318|NCT02194998|12448371|FG003|COMPLETED|Post-HCV Treatment Follow-Up||4
11254319|NCT02194998|12448368|FG000|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
11254320|NCT02194998|12448369|FG001|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
11254321|NCT02194998|12448370|FG002|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
11254322|NCT02194998|12448371|FG003|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
11254323|NCT02195011|12448383|FG000|STARTED|Overall Study||25
11254324|NCT02195011|12448384|FG001|STARTED|Overall Study||1
11254325|NCT02195011|12448383|FG000|COMPLETED|Overall Study||0
11254326|NCT02195011|12448384|FG001|COMPLETED|Overall Study||0
11254327|NCT02195011|12448383|FG000|NOT COMPLETED|Overall Study||25
11254328|NCT02195011|12448384|FG001|NOT COMPLETED|Overall Study||1
11254329|NCT02195232|12448392|FG000|STARTED|Overall Study|patients consented|32
11254330|NCT02195232|12448393|FG001|STARTED|Overall Study|patients consented|32
11254331|NCT02195232|12448392|FG000|COMPLETED|Overall Study|Evaluated for VTE and safety|28
11254332|NCT02195232|12448393|FG001|COMPLETED|Overall Study|Evaluated for VTE and safety|29
11254333|NCT02195232|12448392|FG000|NOT COMPLETED|Overall Study||4
11005453|NCT00723021|12183144|FG003|STARTED|Intervention Period 3||3
11005454|NCT00723021|12183145|FG004|STARTED|Intervention Period 3||3
11005455|NCT00723021|12183141|FG000|COMPLETED|Intervention Period 3||3
11005456|NCT00723021|12183142|FG001|COMPLETED|Intervention Period 3||3
11005457|NCT00723021|12183143|FG002|COMPLETED|Intervention Period 3||3
11005458|NCT00723021|12183144|FG003|COMPLETED|Intervention Period 3||3
11005459|NCT00723021|12183145|FG004|COMPLETED|Intervention Period 3||3
11005460|NCT00723021|12183141|FG000|NOT COMPLETED|Intervention Period 3||0
11254334|NCT02195232|12448393|FG001|NOT COMPLETED|Overall Study||3
11254335|NCT02195310|12448405|FG000|STARTED|Overall Study||173
11254336|NCT02195310|12448406|FG001|STARTED|Overall Study||169
11254337|NCT02195310|12448405|FG000|COMPLETED|Overall Study||153
11254338|NCT02195310|12448406|FG001|COMPLETED|Overall Study||153
11254339|NCT02195310|12448405|FG000|NOT COMPLETED|Overall Study||20
11254340|NCT02195310|12448406|FG001|NOT COMPLETED|Overall Study||16
11254341|NCT02195349|12448423|FG000|STARTED|Overall Study||14
11254342|NCT02195349|12448424|FG001|STARTED|Overall Study||1
11254343|NCT02195349|12448425|FG002|STARTED|Overall Study||1
11254344|NCT02195349|12448426|FG003|STARTED|Overall Study||6
11254345|NCT02195349|12448427|FG004|STARTED|Overall Study||6
11254346|NCT02195349|12448428|FG005|STARTED|Overall Study||6
11254347|NCT02195349|12448429|FG006|STARTED|Overall Study||6
11254348|NCT02195349|12448430|FG007|STARTED|Overall Study||9
11254349|NCT02195349|12448431|FG008|STARTED|Overall Study||6
11254350|NCT02195349|12448432|FG009|STARTED|Overall Study||6
11254351|NCT02195349|12448433|FG010|STARTED|Overall Study||6
11254352|NCT02195349|12448423|FG000|COMPLETED|Overall Study||14
11254353|NCT02195349|12448424|FG001|COMPLETED|Overall Study||1
11254354|NCT02195349|12448425|FG002|COMPLETED|Overall Study||1
11254355|NCT02195349|12448426|FG003|COMPLETED|Overall Study||6
11254356|NCT02195349|12448427|FG004|COMPLETED|Overall Study||6
11254357|NCT02195349|12448428|FG005|COMPLETED|Overall Study||6
11254358|NCT02195349|12448429|FG006|COMPLETED|Overall Study||6
11254359|NCT02195349|12448430|FG007|COMPLETED|Overall Study||9
11254360|NCT02195349|12448431|FG008|COMPLETED|Overall Study||6
11254361|NCT02195349|12448432|FG009|COMPLETED|Overall Study||6
11254362|NCT02195349|12448433|FG010|COMPLETED|Overall Study||6
11254363|NCT02195349|12448423|FG000|NOT COMPLETED|Overall Study||0
11254364|NCT02195349|12448424|FG001|NOT COMPLETED|Overall Study||0
11254365|NCT02195349|12448425|FG002|NOT COMPLETED|Overall Study||0
11254366|NCT02195349|12448426|FG003|NOT COMPLETED|Overall Study||0
11254367|NCT02195349|12448427|FG004|NOT COMPLETED|Overall Study||0
11254368|NCT02195349|12448428|FG005|NOT COMPLETED|Overall Study||0
11254369|NCT02195349|12448429|FG006|NOT COMPLETED|Overall Study||0
11254370|NCT02195349|12448430|FG007|NOT COMPLETED|Overall Study||0
11254371|NCT02195349|12448431|FG008|NOT COMPLETED|Overall Study||0
11254372|NCT02195349|12448432|FG009|NOT COMPLETED|Overall Study||0
11254373|NCT02195349|12448433|FG010|NOT COMPLETED|Overall Study||0
11254374|NCT02195414|12448473|FG000|STARTED|Overall Study||31
11254375|NCT02195414|12448473|FG000|Primary Endpoint|Overall Study||31
11254376|NCT02195414|12448473|FG000|COMPLETED|Overall Study||31
11254377|NCT02195414|12448473|FG000|NOT COMPLETED|Overall Study||0
11254378|NCT02195427|12448479|FG000|STARTED|Overall Study||73
11254379|NCT02195427|12448480|FG001|STARTED|Overall Study||74
11254380|NCT02195427|12448479|FG000|N Patients at W24 (Primary Outcome)|Overall Study||67
11254381|NCT02195427|12448480|FG001|N Patients at W24 (Primary Outcome)|Overall Study||62
11254382|NCT02195427|12448479|FG000|N Patients at W36|Overall Study||65
11254383|NCT02195427|12448480|FG001|N Patients at W36|Overall Study||59
11254384|NCT02195427|12448479|FG000|N Patients at W52|Overall Study||63
11254385|NCT02195427|12448480|FG001|N Patients at W52|Overall Study||56
11254386|NCT02195427|12448479|FG000|COMPLETED|Overall Study||47
11254387|NCT02195427|12448480|FG001|COMPLETED|Overall Study||47
11254388|NCT02195427|12448479|FG000|NOT COMPLETED|Overall Study||26
11254389|NCT02195427|12448480|FG001|NOT COMPLETED|Overall Study||27
11254390|NCT02195518|12448490|FG000|STARTED|Overall Study||213
11254391|NCT02195518|12448490|FG000|COMPLETED|Overall Study||204
11254392|NCT02195518|12448490|FG000|NOT COMPLETED|Overall Study||9
11254393|NCT02195531|12448497|FG000|STARTED|Overall Study||64
11254394|NCT02195531|12448498|FG001|STARTED|Overall Study||49
11254395|NCT02195531|12448499|FG002|STARTED|Overall Study||56
11254396|NCT02195531|12448497|FG000|COMPLETED|Overall Study||63
11254397|NCT02195531|12448498|FG001|COMPLETED|Overall Study||48
11254398|NCT02195531|12448499|FG002|COMPLETED|Overall Study||55
11254399|NCT02195531|12448497|FG000|NOT COMPLETED|Overall Study||1
11254400|NCT02195531|12448498|FG001|NOT COMPLETED|Overall Study||1
11254401|NCT02195531|12448499|FG002|NOT COMPLETED|Overall Study||1
11254402|NCT02195583|12448507|FG000|STARTED|Overall Study||62
11254403|NCT02195583|12448507|FG000|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
11254404|NCT02195583|12448507|FG000|Sodium Fluoride (0 Ppm)|Overall Study||59
11254405|NCT02195583|12448507|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
11254406|NCT02195583|12448507|FG000|Sodium Fluoride (250 Ppm)|Overall Study||55
11254407|NCT02195583|12448507|FG000|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
11254408|NCT02195583|12448507|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
11254409|NCT02195583|12448507|FG000|COMPLETED|Overall Study||53
11254410|NCT02195583|12448507|FG000|NOT COMPLETED|Overall Study||9
11254411|NCT02195622|12448524|FG000|STARTED|Overall Study||37
11254412|NCT02195622|12448525|FG001|STARTED|Overall Study||37
11254413|NCT02195622|12448524|FG000|COMPLETED|Overall Study||37
11254414|NCT02195622|12448525|FG001|COMPLETED|Overall Study||37
11254415|NCT02195622|12448524|FG000|NOT COMPLETED|Overall Study||0
11254416|NCT02195622|12448525|FG001|NOT COMPLETED|Overall Study||0
11254417|NCT02195687|12448533|FG000|STARTED|Overall Study||316
11254418|NCT02195687|12448534|FG001|STARTED|Overall Study||101
11254419|NCT02195687|12448533|FG000|COMPLETED|Overall Study||311
11254420|NCT02195687|12448534|FG001|COMPLETED|Overall Study||99
11254421|NCT02195687|12448533|FG000|NOT COMPLETED|Overall Study||5
11254422|NCT02195687|12448534|FG001|NOT COMPLETED|Overall Study||2
11254423|NCT02195700|12448542|FG000|STARTED|Overall Study||58
11254424|NCT02195700|12448543|FG001|STARTED|Overall Study||59
11254425|NCT02195700|12448542|FG000|Safety and ITT Populations|Overall Study||58
11254426|NCT02195700|12448543|FG001|Safety and ITT Populations|Overall Study||59
11254427|NCT02195700|12448542|FG000|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
11254428|NCT02195700|12448543|FG001|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
11254429|NCT02195700|12448542|FG000|Maintenance Period|Overall Study||53
11254430|NCT02195700|12448543|FG001|Maintenance Period|Overall Study||54
11254431|NCT02195700|12448542|FG000|COMPLETED|Overall Study||52
11254432|NCT02195700|12448543|FG001|COMPLETED|Overall Study||52
11254433|NCT02195700|12448542|FG000|NOT COMPLETED|Overall Study||6
11254434|NCT02195700|12448543|FG001|NOT COMPLETED|Overall Study||7
11254435|NCT02195713|12448551|FG000|STARTED|Overall Study||10
11254436|NCT02195713|12448552|FG001|STARTED|Overall Study||10
11254437|NCT02195713|12448551|FG000|COMPLETED|Overall Study||10
11254438|NCT02195713|12448552|FG001|COMPLETED|Overall Study||10
11254439|NCT02195713|12448551|FG000|NOT COMPLETED|Overall Study||0
11254440|NCT02195713|12448552|FG001|NOT COMPLETED|Overall Study||0
11254441|NCT02195869|12448558|FG000|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42
11254442|NCT02195869|12448558|FG000|All-Treated Population|Overall Study||42
11254443|NCT02195869|12448558|FG000|COMPLETED|Overall Study||0
11254444|NCT02195869|12448558|FG000|NOT COMPLETED|Overall Study||42
11254445|NCT02195895|12448565|FG000|STARTED|Overall Study||17
11254446|NCT02195895|12448565|FG000|COMPLETED|Overall Study||17
11254447|NCT02195895|12448565|FG000|NOT COMPLETED|Overall Study||0
11254448|NCT02195921|12448573|FG000|STARTED|Overall Study||40
11254449|NCT02195921|12448574|FG001|STARTED|Overall Study||40
11254450|NCT02195921|12448575|FG002|STARTED|Overall Study||40
11254451|NCT02195921|12448576|FG003|STARTED|Overall Study||40
11254452|NCT02195921|12448573|FG000|COMPLETED|Overall Study||39
11254453|NCT02195921|12448574|FG001|COMPLETED|Overall Study||39
11254454|NCT02195921|12448575|FG002|COMPLETED|Overall Study||39
11254455|NCT02195921|12448576|FG003|COMPLETED|Overall Study||40
11254456|NCT02195921|12448573|FG000|NOT COMPLETED|Overall Study||1
11254457|NCT02195921|12448574|FG001|NOT COMPLETED|Overall Study||1
11254458|NCT02195921|12448575|FG002|NOT COMPLETED|Overall Study||1
11254459|NCT02195921|12448576|FG003|NOT COMPLETED|Overall Study||0
11254460|NCT02196038|12448593|FG000|STARTED|Overall Study||174
11254461|NCT02196038|12448594|FG001|STARTED|Overall Study||175
11254462|NCT02196038|12448593|FG000|COMPLETED|Overall Study||157
11254463|NCT02196038|12448594|FG001|COMPLETED|Overall Study||153
11254464|NCT02196038|12448593|FG000|NOT COMPLETED|Overall Study||17
11254465|NCT02196038|12448594|FG001|NOT COMPLETED|Overall Study||22
11254466|NCT02196077|12448600|FG000|STARTED|Overall Study||180
11254467|NCT02196077|12448600|FG000|BFF MDI 320/9.6 μg|Overall Study||155
11254468|NCT02196077|12448600|FG000|BFF MDI 160/9.6 μg|Overall Study||106
11254469|NCT02196077|12448600|FG000|BFF MDI 80/9.6 μg|Overall Study||103
11254470|NCT02196077|12448600|FG000|BD MDI 320 μg|Overall Study||108
11254471|NCT02196077|12448600|FG000|FF MDI 9.6 μg|Overall Study||157
11254472|NCT02196077|12448600|FG000|COMPLETED|Overall Study||133
11254473|NCT02196077|12448600|FG000|NOT COMPLETED|Overall Study||47
11254474|NCT02196168|12448614|FG000|STARTED|Overall Study||6
11254475|NCT02196168|12448615|FG001|STARTED|Overall Study||0
11254476|NCT02196168|12448614|FG000|COMPLETED|Overall Study||6
11254477|NCT02196168|12448615|FG001|COMPLETED|Overall Study||0
11254478|NCT02196168|12448614|FG000|NOT COMPLETED|Overall Study||0
11254479|NCT02196168|12448615|FG001|NOT COMPLETED|Overall Study||0
11254480|NCT02196259|12448624|FG000|STARTED|Overall Study||3
11254481|NCT02196259|12448625|FG001|STARTED|Overall Study||7
11254482|NCT02196259|12448626|FG002|STARTED|Overall Study||3
11254483|NCT02196259|12448624|FG000|COMPLETED|Overall Study||3
11254484|NCT02196259|12448625|FG001|COMPLETED|Overall Study||4
11254485|NCT02196259|12448626|FG002|COMPLETED|Overall Study||2
11254486|NCT02196259|12448624|FG000|NOT COMPLETED|Overall Study||0
11254487|NCT02196259|12448625|FG001|NOT COMPLETED|Overall Study||3
11254488|NCT02196259|12448626|FG002|NOT COMPLETED|Overall Study||1
11254489|NCT02196324|12448635|FG000|STARTED|Overall Study||63
11254490|NCT02196324|12448636|FG001|STARTED|Overall Study||65
11254491|NCT02196324|12448635|FG000|COMPLETED|Overall Study||48
11254492|NCT02196324|12448636|FG001|COMPLETED|Overall Study||57
11254493|NCT02196324|12448635|FG000|NOT COMPLETED|Overall Study||15
11254494|NCT02196324|12448636|FG001|NOT COMPLETED|Overall Study||8
11254495|NCT02196506|12448644|FG000|STARTED|Phase A||837
11254496|NCT02196506|12448645|FG001|STARTED|Phase A||0
11254497|NCT02196506|12448646|FG002|STARTED|Phase A||0
11254498|NCT02196506|12448647|FG003|STARTED|Phase A||0
11254499|NCT02196506|12448644|FG000|COMPLETED|Phase A||716
11254500|NCT02196506|12448645|FG001|COMPLETED|Phase A||0
11254501|NCT02196506|12448646|FG002|COMPLETED|Phase A||0
11254502|NCT02196506|12448647|FG003|COMPLETED|Phase A||0
11254503|NCT02196506|12448644|FG000|NOT COMPLETED|Phase A||121
11254504|NCT02196506|12448645|FG001|NOT COMPLETED|Phase A||0
11254505|NCT02196506|12448646|FG002|NOT COMPLETED|Phase A||0
11254506|NCT02196506|12448647|FG003|NOT COMPLETED|Phase A||0
11254507|NCT02196506|12448644|FG000|STARTED|Phase B||0
11254508|NCT02196506|12448645|FG001|STARTED|Phase B||192
11254509|NCT02196506|12448646|FG002|STARTED|Phase B||202
11254510|NCT02196506|12448647|FG003|STARTED|Phase B||0
11254511|NCT02196506|12448644|FG000|COMPLETED|Phase B||0
11254512|NCT02196506|12448645|FG001|COMPLETED|Phase B||177
11254513|NCT02196506|12448646|FG002|COMPLETED|Phase B||196
11254514|NCT02196506|12448647|FG003|COMPLETED|Phase B||0
11254515|NCT02196506|12448644|FG000|NOT COMPLETED|Phase B||0
11254516|NCT02196506|12448645|FG001|NOT COMPLETED|Phase B||15
11254517|NCT02196506|12448646|FG002|NOT COMPLETED|Phase B||6
11254518|NCT02196506|12448647|FG003|NOT COMPLETED|Phase B||0
11254519|NCT02196506|12448644|FG000|STARTED|Phase A+||0
11254520|NCT02196506|12448645|FG001|STARTED|Phase A+||0
11254521|NCT02196506|12448646|FG002|STARTED|Phase A+||0
11254522|NCT02196506|12448647|FG003|STARTED|Phase A+||322
11254523|NCT02196506|12448644|FG000|COMPLETED|Phase A+||0
11254524|NCT02196506|12448645|FG001|COMPLETED|Phase A+||0
11254525|NCT02196506|12448646|FG002|COMPLETED|Phase A+||0
11254526|NCT02196506|12448647|FG003|COMPLETED|Phase A+||308
11254527|NCT02196506|12448644|FG000|NOT COMPLETED|Phase A+||0
11254528|NCT02196506|12448645|FG001|NOT COMPLETED|Phase A+||0
11254529|NCT02196506|12448646|FG002|NOT COMPLETED|Phase A+||0
11254530|NCT02196506|12448647|FG003|NOT COMPLETED|Phase A+||14
11254531|NCT02196558|12448656|FG000|STARTED|Treatment Phase (12 Weeks)||12
11254532|NCT02196558|12448657|FG001|STARTED|Treatment Phase (12 Weeks)||15
11254533|NCT02196558|12448658|FG002|STARTED|Treatment Phase (12 Weeks)||10
11254534|NCT02196558|12448656|FG000|COMPLETED|Treatment Phase (12 Weeks)||12
11254535|NCT02196558|12448657|FG001|COMPLETED|Treatment Phase (12 Weeks)||12
11254536|NCT02196558|12448658|FG002|COMPLETED|Treatment Phase (12 Weeks)||8
11254537|NCT02196558|12448656|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||0
11254538|NCT02196558|12448657|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||3
11254539|NCT02196558|12448658|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||2
11254540|NCT02196558|12448656|FG000|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
11254541|NCT02196558|12448657|FG001|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
11254542|NCT02196558|12448658|FG002|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|6
11254543|NCT02196558|12448656|FG000|COMPLETED|Extension Phase (40 Weeks)||9
11254544|NCT02196558|12448657|FG001|COMPLETED|Extension Phase (40 Weeks)||8
11254545|NCT02196558|12448658|FG002|COMPLETED|Extension Phase (40 Weeks)||5
11254546|NCT02196558|12448656|FG000|NOT COMPLETED|Extension Phase (40 Weeks)||2
11254547|NCT02196558|12448657|FG001|NOT COMPLETED|Extension Phase (40 Weeks)||3
11254548|NCT02196558|12448658|FG002|NOT COMPLETED|Extension Phase (40 Weeks)||1
11254549|NCT02196675|12448669|FG000|STARTED|Overall Study||27
11254550|NCT02196675|12448670|FG001|STARTED|Overall Study||70
11254551|NCT02196675|12448671|FG002|STARTED|Overall Study||8
11254552|NCT02196675|12448669|FG000|COMPLETED|Overall Study||25
11254553|NCT02196675|12448670|FG001|COMPLETED|Overall Study||68
11254554|NCT02196675|12448671|FG002|COMPLETED|Overall Study||7
11254555|NCT02196675|12448669|FG000|NOT COMPLETED|Overall Study||2
11254556|NCT02196675|12448670|FG001|NOT COMPLETED|Overall Study||2
11254557|NCT02196675|12448671|FG002|NOT COMPLETED|Overall Study||1
11254558|NCT02196688|12448681|FG000|STARTED|Overall Study||47
11254559|NCT02196688|12448682|FG001|STARTED|Overall Study||24
11254560|NCT02196688|12448681|FG000|COMPLETED|Overall Study||40
11254561|NCT02196688|12448682|FG001|COMPLETED|Overall Study||23
11254562|NCT02196688|12448681|FG000|NOT COMPLETED|Overall Study||7
11254563|NCT02196688|12448682|FG001|NOT COMPLETED|Overall Study||1
11254564|NCT02196701|12448690|FG000|STARTED|Overall Study||46
11254565|NCT02196701|12448690|FG000|COMPLETED|Overall Study||43
11254566|NCT02196701|12448690|FG000|NOT COMPLETED|Overall Study||3
11254567|NCT02196714|12448697|FG000|STARTED|Overall Study||24
11254568|NCT02196714|12448698|FG001|STARTED|Overall Study||23
11254569|NCT02196714|12448699|FG002|STARTED|Overall Study||24
11254570|NCT02196714|12448700|FG003|STARTED|Overall Study||24
11254571|NCT02196714|12448697|FG000|COMPLETED|Overall Study||24
11254572|NCT02196714|12448698|FG001|COMPLETED|Overall Study||23
11254573|NCT02196714|12448699|FG002|COMPLETED|Overall Study||23
11254574|NCT02196714|12448700|FG003|COMPLETED|Overall Study||24
11254575|NCT02196714|12448697|FG000|NOT COMPLETED|Overall Study||0
11254576|NCT02196714|12448698|FG001|NOT COMPLETED|Overall Study||0
11254577|NCT02196714|12448699|FG002|NOT COMPLETED|Overall Study||1
11254578|NCT02196714|12448700|FG003|NOT COMPLETED|Overall Study||0
11254579|NCT02196766|12448712|FG000|STARTED|First Intervention (7 Days)||15
11254580|NCT02196766|12448713|FG001|STARTED|First Intervention (7 Days)||15
11254581|NCT02196766|12448712|FG000|COMPLETED|First Intervention (7 Days)||15
11254582|NCT02196766|12448713|FG001|COMPLETED|First Intervention (7 Days)||15
11254583|NCT02196766|12448712|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11254584|NCT02196766|12448713|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11254585|NCT02196766|12448712|FG000|STARTED|Second Intervention (7 Days)||15
11254586|NCT02196766|12448713|FG001|STARTED|Second Intervention (7 Days)||15
11254587|NCT02196766|12448712|FG000|COMPLETED|Second Intervention (7 Days)||15
11254588|NCT02196766|12448713|FG001|COMPLETED|Second Intervention (7 Days)||15
11254589|NCT02196766|12448712|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
11254590|NCT02196766|12448713|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11254591|NCT02196831|12448721|FG000|STARTED|Overall Study||30
11254592|NCT02196831|12448722|FG001|STARTED|Overall Study||30
11254593|NCT02196831|12448721|FG000|Received Follow-up Imaging|Overall Study||26
11254594|NCT02196831|12448722|FG001|Received Follow-up Imaging|Overall Study||28
11254595|NCT02196831|12448721|FG000|COMPLETED|Overall Study||21
11254596|NCT02196831|12448722|FG001|COMPLETED|Overall Study||26
11254597|NCT02196831|12448721|FG000|NOT COMPLETED|Overall Study||9
11254598|NCT02196831|12448722|FG001|NOT COMPLETED|Overall Study||4
11254599|NCT02196857|12448729|FG000|STARTED|Overall Study||16
11254600|NCT02196857|12448729|FG000|COMPLETED|Overall Study||16
11254601|NCT02196857|12448729|FG000|NOT COMPLETED|Overall Study||0
11254602|NCT02196922|12448735|FG000|STARTED|Overall Study||58
11254603|NCT02196922|12448736|FG001|STARTED|Overall Study||46
11254604|NCT02196922|12448735|FG000|COMPLETED|Overall Study||58
11254605|NCT02196922|12448736|FG001|COMPLETED|Overall Study||46
11254606|NCT02196922|12448735|FG000|NOT COMPLETED|Overall Study||0
11254607|NCT02196922|12448736|FG001|NOT COMPLETED|Overall Study||0
11254608|NCT02197065|12448746|FG000|STARTED|Overall Study||10
11254609|NCT02197065|12448747|FG001|STARTED|Overall Study||10
11254610|NCT02197065|12448746|FG000|COMPLETED|Overall Study||10
11254611|NCT02197065|12448747|FG001|COMPLETED|Overall Study||10
11254612|NCT02197065|12448746|FG000|NOT COMPLETED|Overall Study||0
11254613|NCT02197065|12448747|FG001|NOT COMPLETED|Overall Study||0
11254614|NCT02197078|12448768|FG000|STARTED|Overall Study||14688
11254615|NCT02197078|12448769|FG001|STARTED|Overall Study||14688
11254616|NCT02197078|12448770|FG002|STARTED|Overall Study||10614
11254617|NCT02197078|12448771|FG003|STARTED|Overall Study||10614
11254618|NCT02197078|12448772|FG004|STARTED|Overall Study||9538
11254619|NCT02197078|12448773|FG005|STARTED|Overall Study||9538
11254620|NCT02197078|12448774|FG006|STARTED|Overall Study||25135
11254621|NCT02197078|12448775|FG007|STARTED|Overall Study||25135
11254622|NCT02197078|12448776|FG008|STARTED|Overall Study||18996
11254623|NCT02197078|12448777|FG009|STARTED|Overall Study||18996
11254624|NCT02197078|12448778|FG010|STARTED|Overall Study||15742
11254625|NCT02197078|12448779|FG011|STARTED|Overall Study||15742
11254626|NCT02197078|12448768|FG000|COMPLETED|Overall Study||14688
11254627|NCT02197078|12448769|FG001|COMPLETED|Overall Study||14688
11254628|NCT02197078|12448770|FG002|COMPLETED|Overall Study||10614
11254629|NCT02197078|12448771|FG003|COMPLETED|Overall Study||10614
11254630|NCT02197078|12448772|FG004|COMPLETED|Overall Study||9538
11254631|NCT02197078|12448773|FG005|COMPLETED|Overall Study||9538
11254632|NCT02197078|12448774|FG006|COMPLETED|Overall Study||25135
11254633|NCT02197078|12448775|FG007|COMPLETED|Overall Study||25135
11254634|NCT02197078|12448776|FG008|COMPLETED|Overall Study||18996
11254635|NCT02197078|12448777|FG009|COMPLETED|Overall Study||18996
11254636|NCT02197078|12448778|FG010|COMPLETED|Overall Study||15742
11254637|NCT02197078|12448779|FG011|COMPLETED|Overall Study||15742
11254638|NCT02197078|12448768|FG000|NOT COMPLETED|Overall Study||0
11254639|NCT02197078|12448769|FG001|NOT COMPLETED|Overall Study||0
11254640|NCT02197078|12448770|FG002|NOT COMPLETED|Overall Study||0
11254641|NCT02197078|12448771|FG003|NOT COMPLETED|Overall Study||0
11254642|NCT02197078|12448772|FG004|NOT COMPLETED|Overall Study||0
11254643|NCT02197078|12448773|FG005|NOT COMPLETED|Overall Study||0
11254644|NCT02197078|12448774|FG006|NOT COMPLETED|Overall Study||0
11254645|NCT02197078|12448775|FG007|NOT COMPLETED|Overall Study||0
11254646|NCT02197078|12448776|FG008|NOT COMPLETED|Overall Study||0
11254647|NCT02197078|12448777|FG009|NOT COMPLETED|Overall Study||0
11254648|NCT02197078|12448778|FG010|NOT COMPLETED|Overall Study||0
11254649|NCT02197078|12448779|FG011|NOT COMPLETED|Overall Study||0
11254650|NCT02197130|12448808|FG000|STARTED|Overall Study||95
11254651|NCT02197130|12448809|FG001|STARTED|Overall Study||89
11254652|NCT02197130|12448810|FG002|STARTED|Overall Study||88
11254653|NCT02197130|12448808|FG000|Received Treatment|Overall Study||95
11254654|NCT02197130|12448809|FG001|Received Treatment|Overall Study||88
11254655|NCT02197130|12448810|FG002|Received Treatment|Overall Study||87
11254656|NCT02197130|12448808|FG000|COMPLETED|Overall Study||79
11254657|NCT02197130|12448809|FG001|COMPLETED|Overall Study||81
11254658|NCT02197130|12448810|FG002|COMPLETED|Overall Study||56
11254659|NCT02197130|12448808|FG000|NOT COMPLETED|Overall Study||16
11254660|NCT02197130|12448809|FG001|NOT COMPLETED|Overall Study||8
11254661|NCT02197130|12448810|FG002|NOT COMPLETED|Overall Study||32
11254662|NCT02197247|12448818|FG000|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
11254663|NCT02197247|12448818|FG000|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
11254664|NCT02197247|12448818|FG000|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
11254665|NCT02197247|12448818|FG000|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
11254666|NCT02197247|12448818|FG000|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
11254667|NCT02197247|12448818|FG000|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
11254668|NCT02197247|12448818|FG000|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
11254669|NCT02197247|12448818|FG000|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
11254670|NCT02197247|12448818|FG000|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
11254671|NCT02197247|12448818|FG000|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
11254672|NCT02197247|12448818|FG000|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
11254673|NCT02197247|12448818|FG000|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
11254674|NCT02197273|12448830|FG000|STARTED|Overall Study||107
11254675|NCT02197273|12448831|FG001|STARTED|Overall Study||104
11254676|NCT02197273|12448830|FG000|COMPLETED|Overall Study||107
11254677|NCT02197273|12448831|FG001|COMPLETED|Overall Study||104
11254678|NCT02197273|12448830|FG000|NOT COMPLETED|Overall Study||0
11254679|NCT02197273|12448831|FG001|NOT COMPLETED|Overall Study||0
11254680|NCT02197377|12448839|FG000|STARTED|Overall Study||30
11254681|NCT02197377|12448840|FG001|STARTED|Overall Study||30
11254682|NCT02197377|12448839|FG000|COMPLETED|Overall Study||30
11254683|NCT02197377|12448840|FG001|COMPLETED|Overall Study||27
11254684|NCT02197377|12448839|FG000|NOT COMPLETED|Overall Study||0
11254685|NCT02197377|12448840|FG001|NOT COMPLETED|Overall Study||3
11254686|NCT02197416|12448849|FG000|STARTED|Overall Study||9
11254687|NCT02197416|12448850|FG001|STARTED|Overall Study||43
11254688|NCT02197416|12448851|FG002|STARTED|Overall Study||161
11254689|NCT02197416|12448849|FG000|COMPLETED|Overall Study||8
11254690|NCT02197416|12448850|FG001|COMPLETED|Overall Study||39
11254691|NCT02197416|12448851|FG002|COMPLETED|Overall Study||153
11254692|NCT02197416|12448849|FG000|NOT COMPLETED|Overall Study||1
11254693|NCT02197416|12448850|FG001|NOT COMPLETED|Overall Study||4
11254694|NCT02197416|12448851|FG002|NOT COMPLETED|Overall Study||8
11254695|NCT02197455|12448857|FG000|STARTED|Overall Study||30
11254696|NCT02197455|12448857|FG000|COMPLETED|Overall Study||30
11254697|NCT02197455|12448857|FG000|NOT COMPLETED|Overall Study||0
11254698|NCT02197481|12448863|FG000|STARTED|Overall Study|October 2014|43
11254699|NCT02197481|12448864|FG001|STARTED|Overall Study||43
11254700|NCT02197481|12448863|FG000|COMPLETED|Overall Study|February 2016|43
11254701|NCT02197481|12448864|FG001|COMPLETED|Overall Study||43
11254702|NCT02197481|12448863|FG000|NOT COMPLETED|Overall Study||0
11254703|NCT02197481|12448864|FG001|NOT COMPLETED|Overall Study||0
11254704|NCT02197520|12448870|FG000|STARTED|Period 1||12
11254705|NCT02197520|12448871|FG001|STARTED|Period 1||12
11254706|NCT02197520|12448870|FG000|COMPLETED|Period 1||11
11254707|NCT02197520|12448871|FG001|COMPLETED|Period 1||12
11254708|NCT02197520|12448870|FG000|NOT COMPLETED|Period 1||1
11254709|NCT02197520|12448871|FG001|NOT COMPLETED|Period 1||0
11254710|NCT02197520|12448870|FG000|STARTED|Period 2||11
11254711|NCT02197520|12448871|FG001|STARTED|Period 2||12
11254712|NCT02197520|12448870|FG000|COMPLETED|Period 2||10
11254713|NCT02197520|12448871|FG001|COMPLETED|Period 2||10
11254714|NCT02197520|12448870|FG000|NOT COMPLETED|Period 2||1
11254715|NCT02197520|12448871|FG001|NOT COMPLETED|Period 2||2
11254716|NCT02197572|12448879|FG000|STARTED|Overall Study||44
11254717|NCT02197572|12448879|FG000|COMPLETED|Overall Study||0
11254718|NCT02197572|12448879|FG000|NOT COMPLETED|Overall Study||44
11254719|NCT02197767|12448883|FG000|STARTED|Overall Study||11
11254720|NCT02197767|12448883|FG000|COMPLETED|Overall Study||11
11254721|NCT02197767|12448883|FG000|NOT COMPLETED|Overall Study||0
11254722|NCT02197806|12448891|FG000|STARTED|Overall Study||15
11254723|NCT02197806|12448892|FG001|STARTED|Overall Study||17
11254724|NCT02197806|12448893|FG002|STARTED|Overall Study||16
11254725|NCT02197806|12448894|FG003|STARTED|Overall Study||17
11254726|NCT02197806|12448891|FG000|COMPLETED|Overall Study||15
11254727|NCT02197806|12448892|FG001|COMPLETED|Overall Study||16
11254728|NCT02197806|12448893|FG002|COMPLETED|Overall Study||16
11254729|NCT02197806|12448894|FG003|COMPLETED|Overall Study||16
11254730|NCT02197806|12448891|FG000|NOT COMPLETED|Overall Study||0
11254731|NCT02197806|12448892|FG001|NOT COMPLETED|Overall Study||1
11254732|NCT02197806|12448893|FG002|NOT COMPLETED|Overall Study||0
11254733|NCT02197806|12448894|FG003|NOT COMPLETED|Overall Study||1
11254734|NCT02197897|12448904|FG000|STARTED|Overall Study||15
11254735|NCT02197897|12448904|FG000|COMPLETED|Overall Study||14
11254736|NCT02197897|12448904|FG000|NOT COMPLETED|Overall Study||1
11254737|NCT02198040|12448911|FG000|STARTED|Overall Study||9
11254738|NCT02198040|12448912|FG001|STARTED|Overall Study||9
11254739|NCT02198040|12448913|FG002|STARTED|Overall Study||9
11254740|NCT02198040|12448911|FG000|COMPLETED|Overall Study||9
11254741|NCT02198040|12448912|FG001|COMPLETED|Overall Study||8
11254742|NCT02198040|12448913|FG002|COMPLETED|Overall Study||8
11254743|NCT02198040|12448911|FG000|NOT COMPLETED|Overall Study||0
11254744|NCT02198040|12448912|FG001|NOT COMPLETED|Overall Study||1
11254745|NCT02198040|12448913|FG002|NOT COMPLETED|Overall Study||1
11254746|NCT02198235|12448926|FG000|STARTED|Overall Study||30
11254747|NCT02198235|12448927|FG001|STARTED|Overall Study||30
11254748|NCT02198235|12448928|FG002|STARTED|Overall Study||30
11254749|NCT02198235|12448926|FG000|COMPLETED|Overall Study||27
11254750|NCT02198235|12448927|FG001|COMPLETED|Overall Study||28
11254751|NCT02198235|12448928|FG002|COMPLETED|Overall Study||28
11254752|NCT02198235|12448926|FG000|NOT COMPLETED|Overall Study||3
11254753|NCT02198235|12448927|FG001|NOT COMPLETED|Overall Study||2
11254754|NCT02198235|12448928|FG002|NOT COMPLETED|Overall Study||2
11254755|NCT02198430|12448938|FG000|STARTED|Overall Study||53
11254756|NCT02198430|12448939|FG001|STARTED|Overall Study||51
11254757|NCT02198430|12448938|FG000|COMPLETED|Overall Study||53
11254758|NCT02198430|12448939|FG001|COMPLETED|Overall Study||51
11254759|NCT02198430|12448938|FG000|NOT COMPLETED|Overall Study||0
11254760|NCT02198430|12448939|FG001|NOT COMPLETED|Overall Study||0
11254761|NCT02198651|12448945|FG000|STARTED|Lead-in Period||149
11254762|NCT02198651|12448946|FG001|STARTED|Lead-in Period||0
11254763|NCT02198651|12448947|FG002|STARTED|Lead-in Period||0
11254764|NCT02198651|12448948|FG003|STARTED|Lead-in Period||0
11254765|NCT02198651|12448949|FG004|STARTED|Lead-in Period||0
11254766|NCT02198651|12448945|FG000|Participants Treated in Lead-In Period|Lead-in Period||146
11254767|NCT02198651|12448946|FG001|Participants Treated in Lead-In Period|Lead-in Period||0
11254768|NCT02198651|12448947|FG002|Participants Treated in Lead-In Period|Lead-in Period||0
11254769|NCT02198651|12448948|FG003|Participants Treated in Lead-In Period|Lead-in Period||0
11254770|NCT02198651|12448949|FG004|Participants Treated in Lead-In Period|Lead-in Period||0
11254771|NCT02198651|12448945|FG000|COMPLETED|Lead-in Period||112
11254772|NCT02198651|12448946|FG001|COMPLETED|Lead-in Period||0
11254773|NCT02198651|12448947|FG002|COMPLETED|Lead-in Period||0
11254774|NCT02198651|12448948|FG003|COMPLETED|Lead-in Period||0
11254775|NCT02198651|12448949|FG004|COMPLETED|Lead-in Period||0
11254776|NCT02198651|12448945|FG000|NOT COMPLETED|Lead-in Period||37
11254777|NCT02198651|12448946|FG001|NOT COMPLETED|Lead-in Period||0
11254778|NCT02198651|12448947|FG002|NOT COMPLETED|Lead-in Period||0
11254779|NCT02198651|12448948|FG003|NOT COMPLETED|Lead-in Period||0
11254780|NCT02198651|12448949|FG004|NOT COMPLETED|Lead-in Period||0
11254781|NCT02198651|12448945|FG000|STARTED|Double-blind Period||0
11254782|NCT02198651|12448946|FG001|STARTED|Double-blind Period||102
11254783|NCT02198651|12448947|FG002|STARTED|Double-blind Period||20
11254784|NCT02198651|12448948|FG003|STARTED|Double-blind Period||0
11254785|NCT02198651|12448949|FG004|STARTED|Double-blind Period||0
11254786|NCT02198651|12448945|FG000|COMPLETED|Double-blind Period||0
11254787|NCT02198651|12448946|FG001|COMPLETED|Double-blind Period||93
11254788|NCT02198651|12448947|FG002|COMPLETED|Double-blind Period||19
11254789|NCT02198651|12448948|FG003|COMPLETED|Double-blind Period||0
11254790|NCT02198651|12448949|FG004|COMPLETED|Double-blind Period||0
11254791|NCT02198651|12448945|FG000|NOT COMPLETED|Double-blind Period||0
11254792|NCT02198651|12448946|FG001|NOT COMPLETED|Double-blind Period||9
11254793|NCT02198651|12448947|FG002|NOT COMPLETED|Double-blind Period||1
11254794|NCT02198651|12448948|FG003|NOT COMPLETED|Double-blind Period||0
11254795|NCT02198651|12448949|FG004|NOT COMPLETED|Double-blind Period||0
11254796|NCT02198651|12448945|FG000|STARTED|Open-label Rescue Period||0
11254797|NCT02198651|12448946|FG001|STARTED|Open-label Rescue Period||0
11254798|NCT02198651|12448947|FG002|STARTED|Open-label Rescue Period||0
11254799|NCT02198651|12448948|FG003|STARTED|Open-label Rescue Period||31
11254800|NCT02198651|12448949|FG004|STARTED|Open-label Rescue Period||8
11254801|NCT02198651|12448945|FG000|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
11254802|NCT02198651|12448946|FG001|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
11254803|NCT02198651|12448947|FG002|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
11254804|NCT02198651|12448948|FG003|Correctly Entered Open-label Rescue|Open-label Rescue Period||30
11254805|NCT02198651|12448949|FG004|Correctly Entered Open-label Rescue|Open-label Rescue Period||8
11254806|NCT02198651|12448945|FG000|COMPLETED|Open-label Rescue Period||0
11254807|NCT02198651|12448946|FG001|COMPLETED|Open-label Rescue Period||0
11254808|NCT02198651|12448947|FG002|COMPLETED|Open-label Rescue Period||0
11254809|NCT02198651|12448948|FG003|COMPLETED|Open-label Rescue Period||28
11254810|NCT02198651|12448949|FG004|COMPLETED|Open-label Rescue Period||8
11254811|NCT02198651|12448945|FG000|NOT COMPLETED|Open-label Rescue Period||0
11254812|NCT02198651|12448946|FG001|NOT COMPLETED|Open-label Rescue Period||0
11254813|NCT02198651|12448947|FG002|NOT COMPLETED|Open-label Rescue Period||0
11254814|NCT02198651|12448948|FG003|NOT COMPLETED|Open-label Rescue Period||3
11254815|NCT02198651|12448949|FG004|NOT COMPLETED|Open-label Rescue Period||0
11254816|NCT02198664|12448964|FG000|STARTED|Overall Study||26
11254817|NCT02198664|12448965|FG001|STARTED|Overall Study||21
11254818|NCT02198664|12448964|FG000|COMPLETED|Overall Study||10
11254819|NCT02198664|12448965|FG001|COMPLETED|Overall Study||13
11254820|NCT02198664|12448964|FG000|NOT COMPLETED|Overall Study||16
11254821|NCT02198664|12448965|FG001|NOT COMPLETED|Overall Study||8
11254822|NCT02198963|12448973|FG000|STARTED|Overall Study||43
11254823|NCT02198963|12448973|FG000|COMPLETED|Overall Study||36
11254824|NCT02198963|12448973|FG000|NOT COMPLETED|Overall Study||7
11254825|NCT02199028|12448984|FG000|STARTED|Week 1||15
11254826|NCT02199028|12448985|FG001|STARTED|Week 1||15
11254827|NCT02199028|12448984|FG000|COMPLETED|Week 1||14
11254828|NCT02199028|12448985|FG001|COMPLETED|Week 1||15
11254829|NCT02199028|12448984|FG000|NOT COMPLETED|Week 1||1
11254830|NCT02199028|12448985|FG001|NOT COMPLETED|Week 1||0
11254831|NCT02199028|12448984|FG000|STARTED|Week 2||14
11358672|NCT03127943|12555826|FG000|NOT COMPLETED|Washout (1 Week)||0
11358673|NCT03127943|12555827|FG001|NOT COMPLETED|Washout (1 Week)||0
11358674|NCT03127943|12555826|FG000|STARTED|Second Intervention||12
11358675|NCT03127943|12555827|FG001|STARTED|Second Intervention||12
11358676|NCT03127943|12555826|FG000|COMPLETED|Second Intervention||12
11358677|NCT03127943|12555827|FG001|COMPLETED|Second Intervention||12
11358678|NCT03127943|12555826|FG000|NOT COMPLETED|Second Intervention||0
11358679|NCT03127943|12555827|FG001|NOT COMPLETED|Second Intervention||0
11358680|NCT03127956|12555833|FG000|STARTED|Overall Study||748
11358681|NCT03127956|12555833|FG000|COMPLETED|Overall Study||431
11358682|NCT03127956|12555833|FG000|NOT COMPLETED|Overall Study||317
11358683|NCT03128008|12555837|FG000|STARTED|Overall Study||10
11358684|NCT03128008|12555837|FG000|COMPLETED|Overall Study|9 participants are in follow up|1
11358685|NCT03128008|12555837|FG000|NOT COMPLETED|Overall Study||9
11358686|NCT03128086|12555844|FG000|STARTED|Overall Study||50
11358687|NCT03128086|12555845|FG001|STARTED|Overall Study||44
11358688|NCT03128086|12555844|FG000|COMPLETED|Overall Study||50
11358689|NCT03128086|12555845|FG001|COMPLETED|Overall Study||44
11358690|NCT03128086|12555844|FG000|NOT COMPLETED|Overall Study||0
11358691|NCT03128086|12555845|FG001|NOT COMPLETED|Overall Study||0
11254832|NCT02199028|12448985|FG001|STARTED|Week 2||15
11254833|NCT02199028|12448984|FG000|COMPLETED|Week 2||14
11254834|NCT02199028|12448985|FG001|COMPLETED|Week 2||15
11254835|NCT02199028|12448984|FG000|NOT COMPLETED|Week 2||0
11254836|NCT02199028|12448985|FG001|NOT COMPLETED|Week 2||0
11254837|NCT02199028|12448984|FG000|STARTED|Week 3||14
11254838|NCT02199028|12448985|FG001|STARTED|Week 3||15
11254839|NCT02199028|12448984|FG000|COMPLETED|Week 3||13
11254840|NCT02199028|12448985|FG001|COMPLETED|Week 3||15
11254841|NCT02199028|12448984|FG000|NOT COMPLETED|Week 3||1
11254842|NCT02199028|12448985|FG001|NOT COMPLETED|Week 3||0
11254843|NCT02199028|12448984|FG000|STARTED|Week 4||13
11254844|NCT02199028|12448985|FG001|STARTED|Week 4||15
11254845|NCT02199028|12448984|FG000|COMPLETED|Week 4||13
11254846|NCT02199028|12448985|FG001|COMPLETED|Week 4||15
11254847|NCT02199028|12448984|FG000|NOT COMPLETED|Week 4||0
11254848|NCT02199028|12448985|FG001|NOT COMPLETED|Week 4||0
11254849|NCT02199041|12448992|FG000|STARTED|Overall Study||12
11254850|NCT02199041|12448992|FG000|COMPLETED|Overall Study||12
11254851|NCT02199041|12448992|FG000|NOT COMPLETED|Overall Study||0
11254852|NCT02199080|12448997|FG000|STARTED|Overall Study||2506
11254853|NCT02199080|12448997|FG000|COMPLETED|Overall Study||2494
11254854|NCT02199080|12448997|FG000|NOT COMPLETED|Overall Study||12
11254855|NCT02199197|12449005|FG000|STARTED|Overall Study||35
11254856|NCT02199197|12449006|FG001|STARTED|Overall Study||14
11254857|NCT02199197|12449005|FG000|COMPLETED|Overall Study||35
11254858|NCT02199197|12449006|FG001|COMPLETED|Overall Study||12
11254859|NCT02199197|12449005|FG000|NOT COMPLETED|Overall Study||0
11254860|NCT02199197|12449006|FG001|NOT COMPLETED|Overall Study||2
11254861|NCT02199314|12449013|FG000|STARTED|Overall Study||30
11254862|NCT02199314|12449013|FG000|COMPLETED|Overall Study||14
11254863|NCT02199314|12449013|FG000|NOT COMPLETED|Overall Study||16
11254864|NCT02199496|12449019|FG000|STARTED|Ustekinumab-Single Dose||3
11254865|NCT02199496|12449020|FG001|STARTED|Ustekinumab-Single Dose||0
11254866|NCT02199496|12449019|FG000|COMPLETED|Ustekinumab-Single Dose||3
11254867|NCT02199496|12449020|FG001|COMPLETED|Ustekinumab-Single Dose||0
11254868|NCT02199496|12449019|FG000|NOT COMPLETED|Ustekinumab-Single Dose||0
11254869|NCT02199496|12449020|FG001|NOT COMPLETED|Ustekinumab-Single Dose||0
11254870|NCT02199496|12449019|FG000|STARTED|Ustekinumab-Multi-dose||3
11254871|NCT02199496|12449020|FG001|STARTED|Ustekinumab-Multi-dose|Cohort 2 only participated in multi-dose phase 2|2
11254872|NCT02199496|12449019|FG000|COMPLETED|Ustekinumab-Multi-dose||3
11254873|NCT02199496|12449020|FG001|COMPLETED|Ustekinumab-Multi-dose||2
11254874|NCT02199496|12449019|FG000|NOT COMPLETED|Ustekinumab-Multi-dose||0
11254875|NCT02199496|12449020|FG001|NOT COMPLETED|Ustekinumab-Multi-dose||0
11254876|NCT02199509|12449028|FG000|STARTED|Overall Study||3
11254877|NCT02199509|12449029|FG001|STARTED|Overall Study||4
11254878|NCT02199509|12449028|FG000|COMPLETED|Overall Study||2
11254879|NCT02199509|12449029|FG001|COMPLETED|Overall Study||3
11254880|NCT02199509|12449028|FG000|NOT COMPLETED|Overall Study||1
11254881|NCT02199509|12449029|FG001|NOT COMPLETED|Overall Study||1
11254882|NCT02199574|12449039|FG000|STARTED|Overall Study||12
11254883|NCT02199574|12449039|FG000|COMPLETED|Overall Study||12
11254884|NCT02199574|12449039|FG000|NOT COMPLETED|Overall Study||0
11339673|NCT02917031|12537237|FG002|COMPLETED|Overall Study||105
11339674|NCT02917031|12537235|FG000|NOT COMPLETED|Overall Study||18
11339675|NCT02917031|12537236|FG001|NOT COMPLETED|Overall Study||13
11339676|NCT02917031|12537237|FG002|NOT COMPLETED|Overall Study||15
11339677|NCT02917122|12537248|FG000|STARTED|Overall Study||8
11339678|NCT02917122|12537249|FG001|STARTED|Overall Study||7
11339679|NCT02917122|12537248|FG000|COMPLETED|Overall Study||8
11339680|NCT02917122|12537249|FG001|COMPLETED|Overall Study||7
11339681|NCT02917122|12537248|FG000|NOT COMPLETED|Overall Study||0
11339682|NCT02917122|12537249|FG001|NOT COMPLETED|Overall Study||0
11339683|NCT02917265|12537257|FG000|STARTED|Overall Study||5
11339684|NCT02917265|12537258|FG001|STARTED|Overall Study||2
11339685|NCT02917265|12537257|FG000|COMPLETED|Overall Study||3
11339686|NCT02917265|12537258|FG001|COMPLETED|Overall Study||2
11339687|NCT02917265|12537257|FG000|NOT COMPLETED|Overall Study||2
11339688|NCT02917265|12537258|FG001|NOT COMPLETED|Overall Study||0
11339689|NCT02917278|12537268|FG000|STARTED|Overall Study||10
11339690|NCT02917278|12537269|FG001|STARTED|Overall Study||9
11339691|NCT02917278|12537268|FG000|COMPLETED|Overall Study||9
11339692|NCT02917278|12537269|FG001|COMPLETED|Overall Study||9
11339693|NCT02917278|12537268|FG000|NOT COMPLETED|Overall Study||1
11339694|NCT02917278|12537269|FG001|NOT COMPLETED|Overall Study||0
11339695|NCT02917447|12537277|FG000|STARTED|Overall Study||51
11339696|NCT02917447|12537278|FG001|STARTED|Overall Study||51
11339697|NCT02917447|12537277|FG000|COMPLETED|Overall Study||44
11339698|NCT02917447|12537278|FG001|COMPLETED|Overall Study||48
11339699|NCT02917447|12537277|FG000|NOT COMPLETED|Overall Study||7
11339700|NCT02917447|12537278|FG001|NOT COMPLETED|Overall Study||3
11339701|NCT02917603|12537286|FG000|STARTED|Overall Study||20
11339702|NCT02917603|12537287|FG001|STARTED|Overall Study||20
11339703|NCT02917603|12537286|FG000|COMPLETED|Overall Study||19
11339704|NCT02917603|12537287|FG001|COMPLETED|Overall Study||16
11339705|NCT02917603|12537286|FG000|NOT COMPLETED|Overall Study||1
11339706|NCT02917603|12537287|FG001|NOT COMPLETED|Overall Study||4
11339707|NCT02917642|12537296|FG000|STARTED|Overall Study||25
11339708|NCT02917642|12537297|FG001|STARTED|Overall Study||25
11339709|NCT02917642|12537296|FG000|COMPLETED|Overall Study||25
11339710|NCT02917642|12537297|FG001|COMPLETED|Overall Study||25
11339711|NCT02917642|12537296|FG000|NOT COMPLETED|Overall Study||0
11339712|NCT02917642|12537297|FG001|NOT COMPLETED|Overall Study||0
11339713|NCT02917941|12537303|FG000|STARTED|Treatment Period||34
11339714|NCT02917941|12537303|FG000|COMPLETED|Treatment Period||10
11339715|NCT02917941|12537303|FG000|NOT COMPLETED|Treatment Period||24
11339716|NCT02917941|12537303|FG000|STARTED|Survival Follow-up Period||31
11339717|NCT02917941|12537303|FG000|COMPLETED|Survival Follow-up Period||26
11339718|NCT02917941|12537303|FG000|NOT COMPLETED|Survival Follow-up Period||5
11339719|NCT02918071|12537307|FG000|STARTED|Overall Study||121
11339720|NCT02918071|12537307|FG000|COMPLETED|Overall Study||118
11339721|NCT02918071|12537307|FG000|NOT COMPLETED|Overall Study||3
11339722|NCT02918097|12537311|FG000|STARTED|Overall Study||78
11339723|NCT02918097|12537311|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|58
11339724|NCT02918097|12537311|FG000|NOT COMPLETED|Overall Study||20
11339725|NCT02918266|12537326|FG000|STARTED|Part 1||6
11339726|NCT02918266|12537327|FG001|STARTED|Part 1||0
11339727|NCT02918266|12537328|FG002|STARTED|Part 1||0
11339728|NCT02918266|12537329|FG003|STARTED|Part 1||0
11339729|NCT02918266|12537330|FG004|STARTED|Part 1||0
11339730|NCT02918266|12537331|FG005|STARTED|Part 1||0
11339731|NCT02918266|12537332|FG006|STARTED|Part 1||0
11339732|NCT02918266|12537333|FG007|STARTED|Part 1||0
11339733|NCT02918266|12537334|FG008|STARTED|Part 1||0
11339734|NCT02918266|12537335|FG009|STARTED|Part 1||0
11339735|NCT02918266|12537336|FG010|STARTED|Part 1||0
11339736|NCT02918266|12537326|FG000|COMPLETED|Part 1||6
11339737|NCT02918266|12537327|FG001|COMPLETED|Part 1||0
11339738|NCT02918266|12537328|FG002|COMPLETED|Part 1||0
11339739|NCT02918266|12537329|FG003|COMPLETED|Part 1||0
11339740|NCT02918266|12537330|FG004|COMPLETED|Part 1||0
11339741|NCT02918266|12537331|FG005|COMPLETED|Part 1||0
11339742|NCT02918266|12537332|FG006|COMPLETED|Part 1||0
11339743|NCT02918266|12537333|FG007|COMPLETED|Part 1||0
11339744|NCT02918266|12537334|FG008|COMPLETED|Part 1||0
11339745|NCT02918266|12537335|FG009|COMPLETED|Part 1||0
11339746|NCT02918266|12537336|FG010|COMPLETED|Part 1||0
11339747|NCT02918266|12537326|FG000|NOT COMPLETED|Part 1||0
11339748|NCT02918266|12537327|FG001|NOT COMPLETED|Part 1||0
11339749|NCT02918266|12537328|FG002|NOT COMPLETED|Part 1||0
11339750|NCT02918266|12537329|FG003|NOT COMPLETED|Part 1||0
11339751|NCT02918266|12537330|FG004|NOT COMPLETED|Part 1||0
11339752|NCT02918266|12537331|FG005|NOT COMPLETED|Part 1||0
11339753|NCT02918266|12537332|FG006|NOT COMPLETED|Part 1||0
11339754|NCT02918266|12537333|FG007|NOT COMPLETED|Part 1||0
11339755|NCT02918266|12537334|FG008|NOT COMPLETED|Part 1||0
11339756|NCT02918266|12537335|FG009|NOT COMPLETED|Part 1||0
11339757|NCT02918266|12537336|FG010|NOT COMPLETED|Part 1||0
11339758|NCT02918266|12537326|FG000|STARTED|Part 2: Intervention Period 1 (2 Days)||0
11339759|NCT02918266|12537327|FG001|STARTED|Part 2: Intervention Period 1 (2 Days)||1
11339760|NCT02918266|12537328|FG002|STARTED|Part 2: Intervention Period 1 (2 Days)||1
11339761|NCT02918266|12537329|FG003|STARTED|Part 2: Intervention Period 1 (2 Days)||1
11339762|NCT02918266|12537330|FG004|STARTED|Part 2: Intervention Period 1 (2 Days)||1
11339763|NCT02918266|12537331|FG005|STARTED|Part 2: Intervention Period 1 (2 Days)||1
11339764|NCT02918266|12537332|FG006|STARTED|Part 2: Intervention Period 1 (2 Days)||2
11254885|NCT02199652|12449047|FG000|STARTED|Overall Study||10
11254886|NCT02199652|12449048|FG001|STARTED|Overall Study||10
11254887|NCT02199652|12449047|FG000|COMPLETED|Overall Study||3
11254888|NCT02199652|12449048|FG001|COMPLETED|Overall Study||3
11254889|NCT02199652|12449047|FG000|NOT COMPLETED|Overall Study||7
11254890|NCT02199652|12449048|FG001|NOT COMPLETED|Overall Study||7
11254891|NCT02199717|12449054|FG000|STARTED|Overall Study||66
11254892|NCT02199717|12449054|FG000|COMPLETED|Overall Study||66
11254893|NCT02199717|12449054|FG000|NOT COMPLETED|Overall Study||0
11254894|NCT02199743|12449061|FG000|STARTED|Overall Study||14
11254895|NCT02199743|12449062|FG001|STARTED|Overall Study||10
11254896|NCT02199743|12449061|FG000|COMPLETED|Overall Study||14
11254897|NCT02199743|12449062|FG001|COMPLETED|Overall Study||8
11254898|NCT02199743|12449061|FG000|NOT COMPLETED|Overall Study||0
11254899|NCT02199743|12449062|FG001|NOT COMPLETED|Overall Study||2
11254900|NCT02199795|12449072|FG000|STARTED|Overall Study||4
11254901|NCT02199795|12449073|FG001|STARTED|Overall Study||3
11254902|NCT02199795|12449072|FG000|COMPLETED|Overall Study||2
11254903|NCT02199795|12449073|FG001|COMPLETED|Overall Study||3
11254904|NCT02199795|12449072|FG000|NOT COMPLETED|Overall Study||2
11254905|NCT02199795|12449073|FG001|NOT COMPLETED|Overall Study||0
11254906|NCT02199964|12449081|FG000|STARTED|Overall Study||2
11254907|NCT02199964|12449082|FG001|STARTED|Overall Study||2
11254908|NCT02199964|12449081|FG000|COMPLETED|Overall Study||2
11254909|NCT02199964|12449082|FG001|COMPLETED|Overall Study||2
11254910|NCT02199964|12449081|FG000|NOT COMPLETED|Overall Study||0
11254911|NCT02199964|12449082|FG001|NOT COMPLETED|Overall Study||0
11254912|NCT02200055|12449088|FG000|STARTED|Overall Study||86
11254913|NCT02200055|12449088|FG000|COMPLETED|Overall Study||86
11254914|NCT02200055|12449088|FG000|NOT COMPLETED|Overall Study||0
11254915|NCT02200211|12449098|FG000|STARTED|Overall Study||190
11254916|NCT02200211|12449099|FG001|STARTED|Overall Study||195
11254917|NCT02200211|12449100|FG002|STARTED|Overall Study||40
11254918|NCT02200211|12449101|FG003|STARTED|Overall Study||60
11254919|NCT02200211|12449098|FG000|Included in 16-week Primary Analysis|Overall Study||177
11254920|NCT02200211|12449099|FG001|Included in 16-week Primary Analysis|Overall Study||186
11254921|NCT02200211|12449100|FG002|Included in 16-week Primary Analysis|Overall Study||39
11254922|NCT02200211|12449101|FG003|Included in 16-week Primary Analysis|Overall Study||56
11254923|NCT02200211|12449098|FG000|COMPLETED|Overall Study||182
11254924|NCT02200211|12449099|FG001|COMPLETED|Overall Study||188
11254925|NCT02200211|12449100|FG002|COMPLETED|Overall Study||39
11254926|NCT02200211|12449101|FG003|COMPLETED|Overall Study||58
11254927|NCT02200211|12449098|FG000|NOT COMPLETED|Overall Study||8
11254928|NCT02200211|12449099|FG001|NOT COMPLETED|Overall Study||7
11254929|NCT02200211|12449100|FG002|NOT COMPLETED|Overall Study||1
11254930|NCT02200211|12449101|FG003|NOT COMPLETED|Overall Study||2
11254931|NCT02200458|12449119|FG000|STARTED|Overall Study||62
11254932|NCT02200458|12449119|FG000|COMPLETED|Overall Study||62
11254933|NCT02200458|12449119|FG000|NOT COMPLETED|Overall Study||0
11254934|NCT02200510|12449125|FG000|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
11254935|NCT02200510|12449126|FG001|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
11254936|NCT02200510|12449125|FG000|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
11254937|NCT02200510|12449126|FG001|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
11254938|NCT02200510|12449125|FG000|NOT COMPLETED|Overall Study||9
11254939|NCT02200510|12449126|FG001|NOT COMPLETED|Overall Study||3
11254940|NCT02200523|12449134|FG000|STARTED|Overall Study||20
11254941|NCT02200523|12449135|FG001|STARTED|Overall Study||20
11254942|NCT02200523|12449134|FG000|COMPLETED|Overall Study||20
11254943|NCT02200523|12449135|FG001|COMPLETED|Overall Study||20
11254944|NCT02200523|12449134|FG000|NOT COMPLETED|Overall Study||0
11254945|NCT02200523|12449135|FG001|NOT COMPLETED|Overall Study||0
11254946|NCT02200536|12449144|FG000|STARTED|Overall Study||32
11254947|NCT02200536|12449145|FG001|STARTED|Overall Study||30
11254948|NCT02200536|12449146|FG002|STARTED|Overall Study||30
11254949|NCT02200536|12449144|FG000|COMPLETED|Overall Study||32
11254950|NCT02200536|12449145|FG001|COMPLETED|Overall Study||30
11254951|NCT02200536|12449146|FG002|COMPLETED|Overall Study||30
11254952|NCT02200536|12449144|FG000|NOT COMPLETED|Overall Study||0
11254953|NCT02200536|12449145|FG001|NOT COMPLETED|Overall Study||0
11254954|NCT02200536|12449146|FG002|NOT COMPLETED|Overall Study||0
11254955|NCT02201056|12449161|FG000|STARTED|Overall Study||12
11254956|NCT02201056|12449162|FG001|STARTED|Overall Study||6
11254957|NCT02201056|12449163|FG002|STARTED|Overall Study||6
11254958|NCT02201056|12449164|FG003|STARTED|Overall Study||6
11254959|NCT02201056|12449165|FG004|STARTED|Overall Study||6
11254960|NCT02201056|12449166|FG005|STARTED|Overall Study||6
11254961|NCT02201056|12449167|FG006|STARTED|Overall Study||6
11254962|NCT02201056|12449161|FG000|COMPLETED|Overall Study||12
11254963|NCT02201056|12449162|FG001|COMPLETED|Overall Study||6
11254964|NCT02201056|12449163|FG002|COMPLETED|Overall Study||6
11254965|NCT02201056|12449164|FG003|COMPLETED|Overall Study||6
11254966|NCT02201056|12449165|FG004|COMPLETED|Overall Study||6
11254967|NCT02201056|12449166|FG005|COMPLETED|Overall Study||6
11254968|NCT02201056|12449167|FG006|COMPLETED|Overall Study||6
11254969|NCT02201056|12449161|FG000|NOT COMPLETED|Overall Study||0
11254970|NCT02201056|12449162|FG001|NOT COMPLETED|Overall Study||0
11254971|NCT02201056|12449163|FG002|NOT COMPLETED|Overall Study||0
11254972|NCT02201056|12449164|FG003|NOT COMPLETED|Overall Study||0
11254973|NCT02201056|12449165|FG004|NOT COMPLETED|Overall Study||0
11254974|NCT02201056|12449166|FG005|NOT COMPLETED|Overall Study||0
11254975|NCT02201056|12449167|FG006|NOT COMPLETED|Overall Study||0
11254976|NCT02201212|12449189|FG000|STARTED|Overall Study||30
11254977|NCT02201212|12449189|FG000|COMPLETED|Overall Study||30
11254978|NCT02201212|12449189|FG000|NOT COMPLETED|Overall Study||0
11254979|NCT02201277|12449195|FG000|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24
11254980|NCT02201277|12449196|FG001|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21
11254981|NCT02201277|12449195|FG000|Filter Retrieval|Overall Study||17
11254982|NCT02201277|12449196|FG001|Filter Retrieval|Overall Study||16
11254983|NCT02201277|12449195|FG000|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0
11254984|NCT02201277|12449196|FG001|Signed ICF But Did Not Enroll|Overall Study||1
11254985|NCT02201277|12449195|FG000|Filter Ruled to be Permanent|Overall Study||2
11254986|NCT02201277|12449196|FG001|Filter Ruled to be Permanent|Overall Study||2
11254987|NCT02201277|12449195|FG000|Lost to Follow up|Overall Study||2
11254988|NCT02201277|12449196|FG001|Lost to Follow up|Overall Study||1
11254989|NCT02201277|12449195|FG000|Death (Before Removal)|Overall Study||3
11254990|NCT02201277|12449196|FG001|Death (Before Removal)|Overall Study||4
11254991|NCT02201277|12449195|FG000|Complicated Retrieval|Overall Study||2
11254992|NCT02201277|12449196|FG001|Complicated Retrieval|Overall Study||0
11254993|NCT02201277|12449195|FG000|Failed Retrieval (Referred Elsewhere)|Overall Study||1
11254994|NCT02201277|12449196|FG001|Failed Retrieval (Referred Elsewhere)|Overall Study||0
11254995|NCT02201277|12449195|FG000|COMPLETED|Overall Study||17
11254996|NCT02201277|12449196|FG001|COMPLETED|Overall Study||16
11254997|NCT02201277|12449195|FG000|NOT COMPLETED|Overall Study||7
11254998|NCT02201277|12449196|FG001|NOT COMPLETED|Overall Study||5
11254999|NCT02201290|12449206|FG000|STARTED|Overall Study||9
11255000|NCT02201290|12449206|FG000|COMPLETED|Overall Study||4
11255001|NCT02201290|12449206|FG000|NOT COMPLETED|Overall Study||5
11255002|NCT02201329|12449210|FG000|STARTED|Overall Study||5
11255003|NCT02201329|12449210|FG000|COMPLETED|Overall Study||0
11255004|NCT02201329|12449210|FG000|NOT COMPLETED|Overall Study||5
11255005|NCT02201394|12449214|FG000|STARTED|Loading Dose||20
11255006|NCT02201394|12449214|FG000|COMPLETED|Loading Dose||20
11255007|NCT02201394|12449214|FG000|NOT COMPLETED|Loading Dose||0
11255008|NCT02201394|12449214|FG000|STARTED|Maintenance Dose||20
11255009|NCT02201394|12449214|FG000|COMPLETED|Maintenance Dose||20
11255010|NCT02201394|12449214|FG000|NOT COMPLETED|Maintenance Dose||0
11255011|NCT02201420|12449219|FG000|STARTED|Overall Study||5
11255012|NCT02201420|12449219|FG000|COMPLETED|Overall Study||5
11255013|NCT02201420|12449219|FG000|NOT COMPLETED|Overall Study||0
11255014|NCT02201446|12449225|FG000|STARTED|Overall Study||81
11255015|NCT02201446|12449226|FG001|STARTED|Overall Study||58
11255016|NCT02201446|12449225|FG000|COMPLETED|Overall Study||81
11255017|NCT02201446|12449226|FG001|COMPLETED|Overall Study||58
11255018|NCT02201446|12449225|FG000|NOT COMPLETED|Overall Study||0
11255019|NCT02201446|12449226|FG001|NOT COMPLETED|Overall Study||0
11255020|NCT02201524|12449236|FG000|STARTED|Overall Study||14
11255021|NCT02201524|12449237|FG001|STARTED|Overall Study||15
11255022|NCT02201524|12449238|FG002|STARTED|Overall Study||16
11255023|NCT02201524|12449239|FG003|STARTED|Overall Study||14
11255024|NCT02201524|12449236|FG000|COMPLETED|Overall Study||12
11255025|NCT02201524|12449237|FG001|COMPLETED|Overall Study||12
11255026|NCT02201524|12449238|FG002|COMPLETED|Overall Study||12
11255027|NCT02201524|12449239|FG003|COMPLETED|Overall Study||10
11255028|NCT02201524|12449236|FG000|NOT COMPLETED|Overall Study||2
11255029|NCT02201524|12449237|FG001|NOT COMPLETED|Overall Study||3
11255030|NCT02201524|12449238|FG002|NOT COMPLETED|Overall Study||4
11255031|NCT02201524|12449239|FG003|NOT COMPLETED|Overall Study||4
11255032|NCT02201771|12449252|FG000|STARTED|Overall Study||166
11255033|NCT02201771|12449253|FG001|STARTED|Overall Study||168
11255034|NCT02201771|12449254|FG002|STARTED|Overall Study||166
11255035|NCT02201771|12449252|FG000|COMPLETED|Overall Study||153
11255036|NCT02201771|12449253|FG001|COMPLETED|Overall Study||158
11255037|NCT02201771|12449254|FG002|COMPLETED|Overall Study||156
11255038|NCT02201771|12449252|FG000|NOT COMPLETED|Overall Study||13
11255039|NCT02201771|12449253|FG001|NOT COMPLETED|Overall Study||10
11255040|NCT02201771|12449254|FG002|NOT COMPLETED|Overall Study||10
11255041|NCT02201784|12449264|FG000|STARTED|Overall Study||30
11255042|NCT02201784|12449265|FG001|STARTED|Overall Study||30
11255043|NCT02201784|12449264|FG000|COMPLETED|Overall Study||28
11255044|NCT02201784|12449265|FG001|COMPLETED|Overall Study||30
11255045|NCT02201784|12449264|FG000|NOT COMPLETED|Overall Study||2
11255046|NCT02201784|12449265|FG001|NOT COMPLETED|Overall Study||0
11255047|NCT02201901|12449274|FG000|STARTED|Overall Study||90
11255048|NCT02201901|12449275|FG001|STARTED|Overall Study||88
11255049|NCT02201901|12449276|FG002|STARTED|Overall Study||90
11255050|NCT02201901|12449274|FG000|COMPLETED|Overall Study||75
11255051|NCT02201901|12449275|FG001|COMPLETED|Overall Study||79
11255052|NCT02201901|12449276|FG002|COMPLETED|Overall Study||77
11255053|NCT02201901|12449274|FG000|NOT COMPLETED|Overall Study||15
11255054|NCT02201901|12449275|FG001|NOT COMPLETED|Overall Study||9
11255055|NCT02201901|12449276|FG002|NOT COMPLETED|Overall Study||13
11255056|NCT02201940|12449287|FG000|STARTED|Overall Study||625
11255057|NCT02201940|12449288|FG001|STARTED|Overall Study||116
11255058|NCT02201940|12449287|FG000|COMPLETED|Overall Study||613
11255059|NCT02201940|12449288|FG001|COMPLETED|Overall Study||0
11255060|NCT02201940|12449287|FG000|NOT COMPLETED|Overall Study||12
11255061|NCT02201940|12449288|FG001|NOT COMPLETED|Overall Study||116
11255062|NCT02201953|12449296|FG000|STARTED|Overall Study||278
11255063|NCT02201953|12449297|FG001|STARTED|Overall Study||280
11255064|NCT02201953|12449296|FG000|COMPLETED|Overall Study||258
11255065|NCT02201953|12449297|FG001|COMPLETED|Overall Study||224
11255066|NCT02201953|12449296|FG000|NOT COMPLETED|Overall Study||20
11255067|NCT02201953|12449297|FG001|NOT COMPLETED|Overall Study||56
11255068|NCT02202031|12449305|FG000|STARTED|Overall Study||82
11255069|NCT02202031|12449306|FG001|STARTED|Overall Study||79
11255070|NCT02202031|12449305|FG000|COMPLETED|Overall Study||77
11255071|NCT02202031|12449306|FG001|COMPLETED|Overall Study||74
11255072|NCT02202031|12449305|FG000|NOT COMPLETED|Overall Study||5
11255073|NCT02202031|12449306|FG001|NOT COMPLETED|Overall Study||5
11255074|NCT02202109|12449314|FG000|STARTED|Overall Study||302
11255075|NCT02202109|12449315|FG001|STARTED|Overall Study||300
11255076|NCT02202109|12449314|FG000|COMPLETED|Overall Study||212
11255077|NCT02202109|12449315|FG001|COMPLETED|Overall Study||213
11255078|NCT02202109|12449314|FG000|NOT COMPLETED|Overall Study||90
11255079|NCT02202109|12449315|FG001|NOT COMPLETED|Overall Study||87
11255080|NCT02202135|12449321|FG000|STARTED|Overall Study||4
11255081|NCT02202135|12449321|FG000|COMPLETED|Overall Study||4
11255082|NCT02202135|12449321|FG000|NOT COMPLETED|Overall Study||0
11255083|NCT02202161|12449333|FG000|STARTED|Overall Study||13
11255084|NCT02202161|12449334|FG001|STARTED|Overall Study||5
11255085|NCT02202161|12449335|FG002|STARTED|Overall Study||5
11255086|NCT02202161|12449336|FG003|STARTED|Overall Study||9
11255087|NCT02202161|12449337|FG004|STARTED|Overall Study||9
11255088|NCT02202161|12449338|FG005|STARTED|Overall Study||10
11255089|NCT02202161|12449339|FG006|STARTED|Overall Study||13
11255090|NCT02202161|12449340|FG007|STARTED|Overall Study||6
11255091|NCT02202161|12449333|FG000|COMPLETED|Overall Study||12
11255092|NCT02202161|12449334|FG001|COMPLETED|Overall Study||4
11255093|NCT02202161|12449335|FG002|COMPLETED|Overall Study||5
11255094|NCT02202161|12449336|FG003|COMPLETED|Overall Study||9
11255095|NCT02202161|12449337|FG004|COMPLETED|Overall Study||8
11255096|NCT02202161|12449338|FG005|COMPLETED|Overall Study||9
11255097|NCT02202161|12449339|FG006|COMPLETED|Overall Study||13
11255098|NCT02202161|12449340|FG007|COMPLETED|Overall Study||0
11255099|NCT02202161|12449333|FG000|NOT COMPLETED|Overall Study||1
11255100|NCT02202161|12449334|FG001|NOT COMPLETED|Overall Study||1
11255101|NCT02202161|12449335|FG002|NOT COMPLETED|Overall Study||0
11255102|NCT02202161|12449336|FG003|NOT COMPLETED|Overall Study||0
11255103|NCT02202161|12449337|FG004|NOT COMPLETED|Overall Study||1
11255104|NCT02202161|12449338|FG005|NOT COMPLETED|Overall Study||1
11255105|NCT02202161|12449339|FG006|NOT COMPLETED|Overall Study||0
11255106|NCT02202161|12449340|FG007|NOT COMPLETED|Overall Study||6
11255107|NCT02202252|12449361|FG000|STARTED|Overall Study||30
11255108|NCT02202252|12449362|FG001|STARTED|Overall Study||30
11255109|NCT02202252|12449361|FG000|COMPLETED|Overall Study||30
11255110|NCT02202252|12449362|FG001|COMPLETED|Overall Study||30
11255111|NCT02202252|12449361|FG000|NOT COMPLETED|Overall Study||0
11255112|NCT02202252|12449362|FG001|NOT COMPLETED|Overall Study||0
11255113|NCT02202317|12449368|FG000|STARTED|Overall Study||9
11255114|NCT02202317|12449368|FG000|COMPLETED|Overall Study||8
11255115|NCT02202317|12449368|FG000|NOT COMPLETED|Overall Study||1
11255116|NCT02202499|12449375|FG000|STARTED|Overall Study||21
11255117|NCT02202499|12449376|FG001|STARTED|Overall Study||20
11255118|NCT02202499|12449377|FG002|STARTED|Overall Study||21
11255119|NCT02202499|12449375|FG000|COMPLETED|Overall Study||19
11255120|NCT02202499|12449376|FG001|COMPLETED|Overall Study||20
11255121|NCT02202499|12449377|FG002|COMPLETED|Overall Study||19
11255122|NCT02202499|12449375|FG000|NOT COMPLETED|Overall Study||2
11255123|NCT02202499|12449376|FG001|NOT COMPLETED|Overall Study||0
11255124|NCT02202499|12449377|FG002|NOT COMPLETED|Overall Study||2
11255125|NCT02202538|12449390|FG000|STARTED|Overall Study||53
11255126|NCT02202538|12449390|FG000|Screen Failure|Overall Study||2
11255127|NCT02202538|12449390|FG000|COMPLETED|Overall Study||45
11255128|NCT02202538|12449390|FG000|NOT COMPLETED|Overall Study||8
11255129|NCT02202551|12449398|FG000|STARTED|Overall Study||60
11255130|NCT02202551|12449399|FG001|STARTED|Overall Study||78
11255131|NCT02202551|12449400|FG002|STARTED|Overall Study||24
11255132|NCT02202551|12449401|FG003|STARTED|Overall Study||61
11255133|NCT02202551|12449398|FG000|COMPLETED|Overall Study||35
11255134|NCT02202551|12449399|FG001|COMPLETED|Overall Study||41
11255135|NCT02202551|12449400|FG002|COMPLETED|Overall Study||14
11255136|NCT02202551|12449401|FG003|COMPLETED|Overall Study||39
11255137|NCT02202551|12449398|FG000|NOT COMPLETED|Overall Study||25
11255138|NCT02202551|12449399|FG001|NOT COMPLETED|Overall Study||37
11255139|NCT02202551|12449400|FG002|NOT COMPLETED|Overall Study||10
11255140|NCT02202551|12449401|FG003|NOT COMPLETED|Overall Study||22
11255141|NCT02202616|12449415|FG000|STARTED|Overall Study||401
11255142|NCT02202616|12449415|FG000|Intent to Treat Set (ITT)|Overall Study||338
11255143|NCT02202616|12449415|FG000|COMPLETED|Overall Study||301
11255144|NCT02202616|12449415|FG000|NOT COMPLETED|Overall Study||100
11255145|NCT02202746|12449422|FG000|STARTED|Overall Study||109
11255146|NCT02202746|12449423|FG001|STARTED|Overall Study||69
11255147|NCT02202746|12449422|FG000|COMPLETED|Overall Study||109
11255148|NCT02202746|12449423|FG001|COMPLETED|Overall Study||69
11255149|NCT02202746|12449422|FG000|NOT COMPLETED|Overall Study||0
11255150|NCT02202746|12449423|FG001|NOT COMPLETED|Overall Study||0
11255151|NCT02202759|12449435|FG000|STARTED|Overall Study||9
11255152|NCT02202759|12449436|FG001|STARTED|Overall Study||15
11255153|NCT02202759|12449437|FG002|STARTED|Overall Study||14
11255154|NCT02202759|12449435|FG000|COMPLETED|Overall Study||0
11255155|NCT02202759|12449436|FG001|COMPLETED|Overall Study||0
11255156|NCT02202759|12449437|FG002|COMPLETED|Overall Study||0
11255157|NCT02202759|12449435|FG000|NOT COMPLETED|Overall Study||9
11255158|NCT02202759|12449436|FG001|NOT COMPLETED|Overall Study||15
11255159|NCT02202759|12449437|FG002|NOT COMPLETED|Overall Study||14
11255160|NCT02202785|12449447|FG000|STARTED|Overall Study||11
11255161|NCT02202785|12449448|FG001|STARTED|Overall Study||15
11255162|NCT02202785|12449449|FG002|STARTED|Overall Study||17
11255163|NCT02202785|12449447|FG000|COMPLETED|Overall Study||0
11255164|NCT02202785|12449448|FG001|COMPLETED|Overall Study||0
11255165|NCT02202785|12449449|FG002|COMPLETED|Overall Study||0
11255166|NCT02202785|12449447|FG000|NOT COMPLETED|Overall Study||11
11255167|NCT02202785|12449448|FG001|NOT COMPLETED|Overall Study||15
11255168|NCT02202785|12449449|FG002|NOT COMPLETED|Overall Study||17
11255169|NCT02202837|12449459|FG000|STARTED|Overall Study||140
11255170|NCT02202837|12449460|FG001|STARTED|Overall Study||17
11255171|NCT02202837|12449459|FG000|COMPLETED|Overall Study||87
11255172|NCT02202837|12449460|FG001|COMPLETED|Overall Study||12
11255173|NCT02202837|12449459|FG000|NOT COMPLETED|Overall Study||53
11255174|NCT02202837|12449460|FG001|NOT COMPLETED|Overall Study||5
11255175|NCT02202850|12449468|FG000|STARTED|Overall Study||70
11255176|NCT02202850|12449469|FG001|STARTED|Overall Study||14
11255177|NCT02202850|12449468|FG000|COMPLETED|Overall Study||46
11255178|NCT02202850|12449469|FG001|COMPLETED|Overall Study||8
11255179|NCT02202850|12449468|FG000|NOT COMPLETED|Overall Study||24
11255180|NCT02202850|12449469|FG001|NOT COMPLETED|Overall Study||6
11255181|NCT02202980|12449489|FG000|STARTED|Overall Study||14
11255182|NCT02202980|12449490|FG001|STARTED|Overall Study||26
11255183|NCT02202980|12449491|FG002|STARTED|Overall Study||27
11255184|NCT02202980|12449492|FG003|STARTED|Overall Study||32
11255185|NCT02202980|12449493|FG004|STARTED|Overall Study||13
11255186|NCT02202980|12449494|FG005|STARTED|Overall Study||15
11255187|NCT02202980|12449495|FG006|STARTED|Overall Study||15
11255188|NCT02202980|12449496|FG007|STARTED|Overall Study||15
11255189|NCT02202980|12449497|FG008|STARTED|Overall Study||18
11255190|NCT02202980|12449498|FG009|STARTED|Overall Study||17
11255191|NCT02202980|12449499|FG010|STARTED|Overall Study||19
11255192|NCT02202980|12449500|FG011|STARTED|Overall Study||28
11255193|NCT02202980|12449501|FG012|STARTED|Overall Study||30
11255194|NCT02202980|12449502|FG013|STARTED|Overall Study||4
11255195|NCT02202980|12449489|FG000|COMPLETED|Overall Study||13
11255196|NCT02202980|12449490|FG001|COMPLETED|Overall Study||24
11255197|NCT02202980|12449491|FG002|COMPLETED|Overall Study||17
11255198|NCT02202980|12449492|FG003|COMPLETED|Overall Study||28
11255199|NCT02202980|12449493|FG004|COMPLETED|Overall Study||7
11255200|NCT02202980|12449494|FG005|COMPLETED|Overall Study||14
11255201|NCT02202980|12449495|FG006|COMPLETED|Overall Study||4
11255202|NCT02202980|12449496|FG007|COMPLETED|Overall Study||12
11255203|NCT02202980|12449497|FG008|COMPLETED|Overall Study||14
11255204|NCT02202980|12449498|FG009|COMPLETED|Overall Study||17
11255205|NCT02202980|12449499|FG010|COMPLETED|Overall Study||19
11255206|NCT02202980|12449500|FG011|COMPLETED|Overall Study||25
11255207|NCT02202980|12449501|FG012|COMPLETED|Overall Study||19
11255208|NCT02202980|12449502|FG013|COMPLETED|Overall Study||4
11255209|NCT02202980|12449489|FG000|NOT COMPLETED|Overall Study||1
11255210|NCT02202980|12449490|FG001|NOT COMPLETED|Overall Study||2
11255211|NCT02202980|12449491|FG002|NOT COMPLETED|Overall Study||10
11255212|NCT02202980|12449492|FG003|NOT COMPLETED|Overall Study||4
11255213|NCT02202980|12449493|FG004|NOT COMPLETED|Overall Study||6
11255214|NCT02202980|12449494|FG005|NOT COMPLETED|Overall Study||1
11255215|NCT02202980|12449495|FG006|NOT COMPLETED|Overall Study||11
11255216|NCT02202980|12449496|FG007|NOT COMPLETED|Overall Study||3
11255217|NCT02202980|12449497|FG008|NOT COMPLETED|Overall Study||4
11255218|NCT02202980|12449498|FG009|NOT COMPLETED|Overall Study||0
11255219|NCT02202980|12449499|FG010|NOT COMPLETED|Overall Study||0
11255220|NCT02202980|12449500|FG011|NOT COMPLETED|Overall Study||3
11255221|NCT02202980|12449501|FG012|NOT COMPLETED|Overall Study||11
11255222|NCT02202980|12449502|FG013|NOT COMPLETED|Overall Study||0
11255223|NCT02203019|12449534|FG000|STARTED|Overall Study||19
11255224|NCT02203019|12449535|FG001|STARTED|Overall Study||17
11255225|NCT02203019|12449534|FG000|COMPLETED|Overall Study||19
11255226|NCT02203019|12449535|FG001|COMPLETED|Overall Study||17
11255227|NCT02203019|12449534|FG000|NOT COMPLETED|Overall Study||0
11255228|NCT02203019|12449535|FG001|NOT COMPLETED|Overall Study||0
11255229|NCT02203032|12449541|FG000|STARTED|Open Label Run-in (Week 0 to Week 16)||872
11255230|NCT02203032|12449542|FG001|STARTED|Open Label Run-in (Week 0 to Week 16)||0
11255231|NCT02203032|12449543|FG002|STARTED|Open Label Run-in (Week 0 to Week 16)||0
11255232|NCT02203032|12449544|FG003|STARTED|Open Label Run-in (Week 0 to Week 16)||0
11255233|NCT02203032|12449541|FG000|Treated|Open Label Run-in (Week 0 to Week 16)||871
11255234|NCT02203032|12449542|FG001|Treated|Open Label Run-in (Week 0 to Week 16)||0
11255235|NCT02203032|12449543|FG002|Treated|Open Label Run-in (Week 0 to Week 16)||0
11255236|NCT02203032|12449544|FG003|Treated|Open Label Run-in (Week 0 to Week 16)||0
11255237|NCT02203032|12449541|FG000|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
11255238|NCT02203032|12449542|FG001|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
11255239|NCT02203032|12449543|FG002|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
11255240|NCT02203032|12449544|FG003|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
11255241|NCT02203032|12449541|FG000|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
11255242|NCT02203032|12449542|FG001|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
11255243|NCT02203032|12449543|FG002|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
11255244|NCT02203032|12449544|FG003|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
11255245|NCT02203032|12449541|FG000|STARTED|Blinded Phase (Week 16 to Week 44)||0
11255246|NCT02203032|12449542|FG001|STARTED|Blinded Phase (Week 16 to Week 44)||135
11255247|NCT02203032|12449543|FG002|STARTED|Blinded Phase (Week 16 to Week 44)||133
11255248|NCT02203032|12449544|FG003|STARTED|Blinded Phase (Week 16 to Week 44)||585
11255249|NCT02203032|12449541|FG000|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
11255250|NCT02203032|12449542|FG001|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
11255251|NCT02203032|12449543|FG002|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
11255252|NCT02203032|12449544|FG003|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
11255253|NCT02203032|12449541|FG000|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
11255254|NCT02203032|12449542|FG001|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
11255255|NCT02203032|12449543|FG002|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
11255256|NCT02203032|12449544|FG003|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
11255257|NCT02203071|12449554|FG000|STARTED|Overall Study||13
11255258|NCT02203071|12449555|FG001|STARTED|Overall Study||6
11255259|NCT02203071|12449554|FG000|COMPLETED|Overall Study||10
11255260|NCT02203071|12449555|FG001|COMPLETED|Overall Study||5
11255261|NCT02203071|12449554|FG000|NOT COMPLETED|Overall Study||3
11255262|NCT02203071|12449555|FG001|NOT COMPLETED|Overall Study||1
11255263|NCT02203149|12449566|FG000|STARTED|Part 1||31
11255264|NCT02203149|12449567|FG001|STARTED|Part 1||32
11255265|NCT02203149|12449568|FG002|STARTED|Part 1||0
11255266|NCT02203149|12449569|FG003|STARTED|Part 1||0
11255267|NCT02203149|12449570|FG004|STARTED|Part 1||0
11255268|NCT02203149|12449566|FG000|COMPLETED|Part 1||31
11255269|NCT02203149|12449567|FG001|COMPLETED|Part 1||31
11255270|NCT02203149|12449568|FG002|COMPLETED|Part 1||0
11255271|NCT02203149|12449569|FG003|COMPLETED|Part 1||0
11255272|NCT02203149|12449570|FG004|COMPLETED|Part 1||0
11255273|NCT02203149|12449566|FG000|NOT COMPLETED|Part 1||0
11255274|NCT02203149|12449567|FG001|NOT COMPLETED|Part 1||1
11255275|NCT02203149|12449568|FG002|NOT COMPLETED|Part 1||0
11255276|NCT02203149|12449569|FG003|NOT COMPLETED|Part 1||0
11255277|NCT02203149|12449570|FG004|NOT COMPLETED|Part 1||0
11255278|NCT02203149|12449566|FG000|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
11255279|NCT02203149|12449567|FG001|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
11255280|NCT02203149|12449568|FG002|STARTED|Part 2||227
11255281|NCT02203149|12449569|FG003|STARTED|Part 2||74
11255282|NCT02203149|12449570|FG004|STARTED|Part 2||35
11255283|NCT02203149|12449566|FG000|Started Deferred Active Treatment|Part 2||0
11255284|NCT02203149|12449567|FG001|Started Deferred Active Treatment|Part 2||0
11255285|NCT02203149|12449568|FG002|Started Deferred Active Treatment|Part 2||0
11255286|NCT02203149|12449569|FG003|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
11255287|NCT02203149|12449570|FG004|Started Deferred Active Treatment|Part 2||0
11255288|NCT02203149|12449566|FG000|COMPLETED|Part 2||0
11255289|NCT02203149|12449567|FG001|COMPLETED|Part 2||0
11255290|NCT02203149|12449568|FG002|COMPLETED|Part 2||226
11255291|NCT02203149|12449569|FG003|COMPLETED|Part 2||71
11255292|NCT02203149|12449570|FG004|COMPLETED|Part 2||34
11255293|NCT02203149|12449566|FG000|NOT COMPLETED|Part 2||0
11255294|NCT02203149|12449567|FG001|NOT COMPLETED|Part 2||0
11255295|NCT02203149|12449568|FG002|NOT COMPLETED|Part 2||1
11255296|NCT02203149|12449569|FG003|NOT COMPLETED|Part 2||3
11255297|NCT02203149|12449570|FG004|NOT COMPLETED|Part 2||1
11255298|NCT02203162|12449592|FG000|STARTED|Overall Study||30
11255299|NCT02203162|12449592|FG000|COMPLETED|Overall Study||30
11255300|NCT02203162|12449592|FG000|NOT COMPLETED|Overall Study||0
11255301|NCT02203331|12449602|FG000|STARTED|Overall Study||52
11255302|NCT02203331|12449603|FG001|STARTED|Overall Study||53
11255303|NCT02203331|12449604|FG002|STARTED|Overall Study||55
11255304|NCT02203331|12449605|FG003|STARTED|Overall Study||53
11255305|NCT02203331|12449606|FG004|STARTED|Overall Study||53
11255306|NCT02203331|12449607|FG005|STARTED|Overall Study||53
11255307|NCT02203331|12449602|FG000|Treated|Overall Study||49
11255308|NCT02203331|12449603|FG001|Treated|Overall Study||50
11255309|NCT02203331|12449604|FG002|Treated|Overall Study||54
11255310|NCT02203331|12449605|FG003|Treated|Overall Study||49
11255311|NCT02203331|12449606|FG004|Treated|Overall Study||50
11255312|NCT02203331|12449607|FG005|Treated|Overall Study||53
11255313|NCT02203331|12449602|FG000|COMPLETED|Overall Study||45
11255314|NCT02203331|12449603|FG001|COMPLETED|Overall Study||39
11255315|NCT02203331|12449604|FG002|COMPLETED|Overall Study||50
11255316|NCT02203331|12449605|FG003|COMPLETED|Overall Study||46
11255317|NCT02203331|12449606|FG004|COMPLETED|Overall Study||46
11255318|NCT02203331|12449607|FG005|COMPLETED|Overall Study||46
11255319|NCT02203331|12449602|FG000|NOT COMPLETED|Overall Study||7
11255320|NCT02203331|12449603|FG001|NOT COMPLETED|Overall Study||14
11255321|NCT02203331|12449604|FG002|NOT COMPLETED|Overall Study||5
11255322|NCT02203331|12449605|FG003|NOT COMPLETED|Overall Study||7
11255323|NCT02203331|12449606|FG004|NOT COMPLETED|Overall Study||7
11255324|NCT02203331|12449607|FG005|NOT COMPLETED|Overall Study||7
11255325|NCT02203357|12449624|FG000|STARTED|Overall Study||117
11255326|NCT02203357|12449625|FG001|STARTED|Overall Study||111
11255327|NCT02203357|12449626|FG002|STARTED|Overall Study||125
11255328|NCT02203357|12449624|FG000|mon7/2/3|Overall Study||114
11255329|NCT02203357|12449625|FG001|mon7/2/3|Overall Study||110
11255330|NCT02203357|12449626|FG002|mon7/2/3|Overall Study||124
11255331|NCT02203357|12449624|FG000|mon12|Overall Study||113
11255332|NCT02203357|12449625|FG001|mon12|Overall Study||101
11255333|NCT02203357|12449626|FG002|mon12|Overall Study||122
11255334|NCT02203357|12449624|FG000|mon24|Overall Study||59
11255335|NCT02203357|12449625|FG001|mon24|Overall Study||45
11255336|NCT02203357|12449626|FG002|mon24|Overall Study||55
11255337|NCT02203357|12449624|FG000|COMPLETED|Overall Study||59
11255338|NCT02203357|12449625|FG001|COMPLETED|Overall Study||45
11255339|NCT02203357|12449626|FG002|COMPLETED|Overall Study||55
11255340|NCT02203357|12449624|FG000|NOT COMPLETED|Overall Study||58
11255341|NCT02203357|12449625|FG001|NOT COMPLETED|Overall Study||66
11255342|NCT02203357|12449626|FG002|NOT COMPLETED|Overall Study||70
11255343|NCT02203565|12449637|FG000|STARTED|Overall Study||20
11255344|NCT02203565|12449637|FG000|COMPLETED|Overall Study||19
11255345|NCT02203565|12449637|FG000|NOT COMPLETED|Overall Study||1
11255346|NCT02203578|12449641|FG000|STARTED|Overall Study||1
11255347|NCT02203578|12449641|FG000|COMPLETED|Overall Study||1
11255348|NCT02203578|12449641|FG000|NOT COMPLETED|Overall Study||0
11255349|NCT02203591|12449653|FG000|STARTED|Overall Study||343
11255350|NCT02203591|12449654|FG001|STARTED|Overall Study||344
11255351|NCT02203591|12449655|FG002|STARTED|Overall Study||347
11255352|NCT02203591|12449656|FG003|STARTED|Overall Study||104
11255353|NCT02203591|12449657|FG004|STARTED|Overall Study||242
11255354|NCT02203591|12449658|FG005|STARTED|Overall Study||244
11255355|NCT02203591|12449659|FG006|STARTED|Overall Study||248
11255356|NCT02203591|12449660|FG007|STARTED|Overall Study||74
11255357|NCT02203591|12449653|FG000|COMPLETED|Overall Study||196
11255358|NCT02203591|12449654|FG001|COMPLETED|Overall Study||202
11255359|NCT02203591|12449655|FG002|COMPLETED|Overall Study||196
11255360|NCT02203591|12449656|FG003|COMPLETED|Overall Study||59
11255361|NCT02203591|12449657|FG004|COMPLETED|Overall Study||208
11255362|NCT02203591|12449658|FG005|COMPLETED|Overall Study||209
11255363|NCT02203591|12449659|FG006|COMPLETED|Overall Study||219
11255364|NCT02203591|12449660|FG007|COMPLETED|Overall Study||61
11255365|NCT02203591|12449653|FG000|NOT COMPLETED|Overall Study||147
11255366|NCT02203591|12449654|FG001|NOT COMPLETED|Overall Study||142
11255367|NCT02203591|12449655|FG002|NOT COMPLETED|Overall Study||151
11255368|NCT02203591|12449656|FG003|NOT COMPLETED|Overall Study||45
11255369|NCT02203591|12449657|FG004|NOT COMPLETED|Overall Study||34
11255370|NCT02203591|12449658|FG005|NOT COMPLETED|Overall Study||35
11255371|NCT02203591|12449659|FG006|NOT COMPLETED|Overall Study||29
11255372|NCT02203591|12449660|FG007|NOT COMPLETED|Overall Study||13
11255373|NCT02203630|12449684|FG000|STARTED|Overall Study||8
11255374|NCT02203630|12449685|FG001|STARTED|Overall Study||9
11255375|NCT02203630|12449684|FG000|COMPLETED|Overall Study||8
11255376|NCT02203630|12449685|FG001|COMPLETED|Overall Study||9
11255377|NCT02203630|12449684|FG000|NOT COMPLETED|Overall Study||0
11255378|NCT02203630|12449685|FG001|NOT COMPLETED|Overall Study||0
11255379|NCT02203721|12449693|FG000|STARTED|Overall Study||148
11255380|NCT02203721|12449694|FG001|STARTED|Overall Study||151
11255381|NCT02203721|12449693|FG000|COMPLETED|Overall Study||147
11255382|NCT02203721|12449694|FG001|COMPLETED|Overall Study||148
11255383|NCT02203721|12449693|FG000|NOT COMPLETED|Overall Study||1
11255384|NCT02203721|12449694|FG001|NOT COMPLETED|Overall Study||3
11255385|NCT02203747|12449702|FG000|STARTED|Overall Study||45
11255386|NCT02203747|12449703|FG001|STARTED|Overall Study||34
11255387|NCT02203747|12449702|FG000|COMPLETED|Overall Study||45
11255388|NCT02203747|12449703|FG001|COMPLETED|Overall Study||34
11255389|NCT02203747|12449702|FG000|NOT COMPLETED|Overall Study||0
11255390|NCT02203747|12449703|FG001|NOT COMPLETED|Overall Study||0
11255391|NCT02203786|12449713|FG000|STARTED|Overall Study||15
11255392|NCT02203786|12449714|FG001|STARTED|Overall Study||15
11255393|NCT02203786|12449715|FG002|STARTED|Overall Study||17
11255394|NCT02203786|12449716|FG003|STARTED|Overall Study||15
11255395|NCT02203786|12449713|FG000|COMPLETED|Overall Study||15
11255396|NCT02203786|12449714|FG001|COMPLETED|Overall Study||15
11255397|NCT02203786|12449715|FG002|COMPLETED|Overall Study||15
11255398|NCT02203786|12449716|FG003|COMPLETED|Overall Study||15
11255399|NCT02203786|12449713|FG000|NOT COMPLETED|Overall Study||0
11255400|NCT02203786|12449714|FG001|NOT COMPLETED|Overall Study||0
11255401|NCT02203786|12449715|FG002|NOT COMPLETED|Overall Study||2
11255402|NCT02203786|12449716|FG003|NOT COMPLETED|Overall Study||0
11255403|NCT02203838|12449732|FG000|STARTED|Overall Study||408
11255404|NCT02203838|12449733|FG001|STARTED|Overall Study||28
11255405|NCT02203838|12449734|FG002|STARTED|Overall Study||31
11255406|NCT02203838|12449735|FG003|STARTED|Overall Study||33
11255407|NCT02203838|12449732|FG000|COMPLETED|Overall Study||198
11255408|NCT02203838|12449733|FG001|COMPLETED|Overall Study||6
11255409|NCT02203838|12449734|FG002|COMPLETED|Overall Study||15
11255410|NCT02203838|12449735|FG003|COMPLETED|Overall Study||15
11255411|NCT02203838|12449732|FG000|NOT COMPLETED|Overall Study||210
11255412|NCT02203838|12449733|FG001|NOT COMPLETED|Overall Study||22
11255413|NCT02203838|12449734|FG002|NOT COMPLETED|Overall Study||16
11255414|NCT02203838|12449735|FG003|NOT COMPLETED|Overall Study||18
11255415|NCT02203851|12449745|FG000|STARTED|Overall Study||110
11255416|NCT02203851|12449745|FG000|COMPLETED|Overall Study||99
11255417|NCT02203851|12449745|FG000|NOT COMPLETED|Overall Study||11
11255418|NCT02203916|12449759|FG000|STARTED|Overall Study||65
11255419|NCT02203916|12449760|FG001|STARTED|Overall Study||132
11255420|NCT02203916|12449761|FG002|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
11255421|NCT02203916|12449759|FG000|Full Analysis Set (FAS)|Overall Study||65
11255422|NCT02203916|12449760|FG001|Full Analysis Set (FAS)|Overall Study||132
11255423|NCT02203916|12449761|FG002|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
11255424|NCT02203916|12449759|FG000|Safety Analysis Set (SAS)|Overall Study||65
11255425|NCT02203916|12449760|FG001|Safety Analysis Set (SAS)|Overall Study||132
11255426|NCT02203916|12449761|FG002|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
11255427|NCT02203916|12449759|FG000|COMPLETED|Overall Study||57
11255428|NCT02203916|12449760|FG001|COMPLETED|Overall Study||122
11255429|NCT02203916|12449761|FG002|COMPLETED|Overall Study||120
11255430|NCT02203916|12449759|FG000|NOT COMPLETED|Overall Study||8
11255431|NCT02203916|12449760|FG001|NOT COMPLETED|Overall Study||10
11255432|NCT02203916|12449761|FG002|NOT COMPLETED|Overall Study||11
11255433|NCT02204007|12449771|FG000|STARTED|Overall Study||18
11255434|NCT02204007|12449772|FG001|STARTED|Overall Study||18
11255435|NCT02204007|12449771|FG000|COMPLETED|Overall Study||17
11255436|NCT02204007|12449772|FG001|COMPLETED|Overall Study||17
11255437|NCT02204007|12449771|FG000|NOT COMPLETED|Overall Study||1
11255438|NCT02204007|12449772|FG001|NOT COMPLETED|Overall Study||1
11255439|NCT02204124|12449780|FG000|STARTED|Overall Study||13
11255440|NCT02204124|12449781|FG001|STARTED|Overall Study||19
11255441|NCT02204124|12449780|FG000|COMPLETED|Overall Study||13
11255442|NCT02204124|12449781|FG001|COMPLETED|Overall Study||19
11255443|NCT02204124|12449780|FG000|NOT COMPLETED|Overall Study||0
11255444|NCT02204124|12449781|FG001|NOT COMPLETED|Overall Study||0
11255445|NCT02204150|12449787|FG000|STARTED|Overall Study||56
11255446|NCT02204150|12449787|FG000|COMPLETED|Overall Study||56
11255447|NCT02204150|12449787|FG000|NOT COMPLETED|Overall Study||0
11255448|NCT02204176|12449794|FG000|STARTED|Overall Study||74
11255449|NCT02204176|12449795|FG001|STARTED|Overall Study||73
11255450|NCT02204176|12449796|FG002|STARTED|Overall Study||74
11255451|NCT02204176|12449794|FG000|COMPLETED|Overall Study||64
11255452|NCT02204176|12449795|FG001|COMPLETED|Overall Study||61
11255453|NCT02204176|12449796|FG002|COMPLETED|Overall Study||58
11255454|NCT02204176|12449794|FG000|NOT COMPLETED|Overall Study||10
11255455|NCT02204176|12449795|FG001|NOT COMPLETED|Overall Study||12
11255456|NCT02204176|12449796|FG002|NOT COMPLETED|Overall Study||16
11255457|NCT02204293|12449806|FG000|STARTED|Core Study Part I||19
11255458|NCT02204293|12449807|FG001|STARTED|Core Study Part I||17
11255459|NCT02204293|12449808|FG002|STARTED|Core Study Part I||0
11255460|NCT02204293|12449809|FG003|STARTED|Core Study Part I||0
11255461|NCT02204293|12449810|FG004|STARTED|Core Study Part I||0
11255462|NCT02204293|12449811|FG005|STARTED|Core Study Part I||0
11255463|NCT02204293|12449806|FG000|Intention-to-treat Population|Core Study Part I|One participant left the study before treatment was started.|18
11255464|NCT02204293|12449807|FG001|Intention-to-treat Population|Core Study Part I||17
11255465|NCT02204293|12449808|FG002|Intention-to-treat Population|Core Study Part I||0
11255466|NCT02204293|12449809|FG003|Intention-to-treat Population|Core Study Part I||0
11255467|NCT02204293|12449810|FG004|Intention-to-treat Population|Core Study Part I||0
11255468|NCT02204293|12449811|FG005|Intention-to-treat Population|Core Study Part I||0
11255469|NCT02204293|12449806|FG000|Safety Population|Core Study Part I|2 participants from placebo arm received canakinumab at Week 4, included in Safety population.|20
11255470|NCT02204293|12449807|FG001|Safety Population|Core Study Part I||15
11255471|NCT02204293|12449808|FG002|Safety Population|Core Study Part I||0
11255472|NCT02204293|12449809|FG003|Safety Population|Core Study Part I||0
11255473|NCT02204293|12449810|FG004|Safety Population|Core Study Part I||0
11255474|NCT02204293|12449811|FG005|Safety Population|Core Study Part I||0
11255475|NCT02204293|12449806|FG000|COMPLETED|Core Study Part I||17
11255476|NCT02204293|12449807|FG001|COMPLETED|Core Study Part I||14
11255477|NCT02204293|12449808|FG002|COMPLETED|Core Study Part I||0
11255478|NCT02204293|12449809|FG003|COMPLETED|Core Study Part I||0
11255479|NCT02204293|12449810|FG004|COMPLETED|Core Study Part I||0
11255480|NCT02204293|12449811|FG005|COMPLETED|Core Study Part I||0
11255481|NCT02204293|12449806|FG000|NOT COMPLETED|Core Study Part I||2
11255482|NCT02204293|12449807|FG001|NOT COMPLETED|Core Study Part I||3
11255483|NCT02204293|12449808|FG002|NOT COMPLETED|Core Study Part I||0
11255484|NCT02204293|12449809|FG003|NOT COMPLETED|Core Study Part I||0
11255485|NCT02204293|12449810|FG004|NOT COMPLETED|Core Study Part I||0
11255486|NCT02204293|12449811|FG005|NOT COMPLETED|Core Study Part I||0
11255487|NCT02204293|12449806|FG000|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|0
11255488|NCT02204293|12449807|FG001|STARTED|Core Study Part 2||0
11255489|NCT02204293|12449808|FG002|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|12
11255490|NCT02204293|12449809|FG003|STARTED|Core Study Part 2||4
11255491|NCT02204293|12449810|FG004|STARTED|Core Study Part 2||7
11255492|NCT02204293|12449811|FG005|STARTED|Core Study Part 2||0
11255493|NCT02204293|12449806|FG000|Safety Population|Core Study Part 2||0
11255494|NCT02204293|12449807|FG001|Safety Population|Core Study Part 2||0
11255495|NCT02204293|12449808|FG002|Safety Population|Core Study Part 2|Included 2 participants from placebo arm who received canakinumab at Week 4.|14
11255496|NCT02204293|12449809|FG003|Safety Population|Core Study Part 2||2
11255497|NCT02204293|12449810|FG004|Safety Population|Core Study Part 2||7
11255498|NCT02204293|12449811|FG005|Safety Population|Core Study Part 2||0
11255499|NCT02204293|12449806|FG000|COMPLETED|Core Study Part 2||0
11255500|NCT02204293|12449807|FG001|COMPLETED|Core Study Part 2||0
11255501|NCT02204293|12449808|FG002|COMPLETED|Core Study Part 2||12
11255502|NCT02204293|12449809|FG003|COMPLETED|Core Study Part 2||4
11255503|NCT02204293|12449810|FG004|COMPLETED|Core Study Part 2||7
11255504|NCT02204293|12449811|FG005|COMPLETED|Core Study Part 2||0
11255505|NCT02204293|12449806|FG000|NOT COMPLETED|Core Study Part 2||0
11255506|NCT02204293|12449807|FG001|NOT COMPLETED|Core Study Part 2||0
11255507|NCT02204293|12449808|FG002|NOT COMPLETED|Core Study Part 2||0
11255508|NCT02204293|12449809|FG003|NOT COMPLETED|Core Study Part 2||0
11255509|NCT02204293|12449810|FG004|NOT COMPLETED|Core Study Part 2||0
11255510|NCT02204293|12449811|FG005|NOT COMPLETED|Core Study Part 2||0
11255511|NCT02204293|12449806|FG000|STARTED|LTE Phase||0
11255512|NCT02204293|12449807|FG001|STARTED|LTE Phase||0
11255513|NCT02204293|12449808|FG002|STARTED|LTE Phase||0
11255514|NCT02204293|12449809|FG003|STARTED|LTE Phase||0
11255515|NCT02204293|12449810|FG004|STARTED|LTE Phase||0
11255516|NCT02204293|12449811|FG005|STARTED|LTE Phase||7
11255517|NCT02204293|12449806|FG000|COMPLETED|LTE Phase||0
11255518|NCT02204293|12449807|FG001|COMPLETED|LTE Phase||0
11255519|NCT02204293|12449808|FG002|COMPLETED|LTE Phase||0
11255520|NCT02204293|12449809|FG003|COMPLETED|LTE Phase||0
11255521|NCT02204293|12449810|FG004|COMPLETED|LTE Phase||0
11255522|NCT02204293|12449811|FG005|COMPLETED|LTE Phase||0
11255523|NCT02204293|12449806|FG000|NOT COMPLETED|LTE Phase||0
11255524|NCT02204293|12449807|FG001|NOT COMPLETED|LTE Phase||0
11255525|NCT02204293|12449808|FG002|NOT COMPLETED|LTE Phase||0
11255526|NCT02204293|12449809|FG003|NOT COMPLETED|LTE Phase||0
11255527|NCT02204293|12449810|FG004|NOT COMPLETED|LTE Phase||0
11255528|NCT02204293|12449811|FG005|NOT COMPLETED|LTE Phase||7
11255529|NCT02204319|12449825|FG000|STARTED|Overall Study||10
11255530|NCT02204319|12449825|FG000|COMPLETED|Overall Study|3 did not complete study.|7
11255531|NCT02204319|12449825|FG000|NOT COMPLETED|Overall Study||3
11255532|NCT02204371|12449830|FG000|STARTED|Overall Study||7
11255533|NCT02204371|12449830|FG000|COMPLETED|Overall Study||6
11255534|NCT02204371|12449830|FG000|NOT COMPLETED|Overall Study||1
11255535|NCT02204410|12449834|FG000|STARTED|Overall Study||21
11255536|NCT02204410|12449834|FG000|COMPLETED|Overall Study||10
11255537|NCT02204410|12449834|FG000|NOT COMPLETED|Overall Study||11
11358692|NCT03128099|12555854|FG000|STARTED|Overall Study||21
11358693|NCT03128099|12555855|FG001|STARTED|Overall Study||4
11358694|NCT03128099|12555856|FG002|STARTED|Overall Study||22
11358695|NCT03128099|12555854|FG000|Hour 1 (Low Dose) Started|Overall Study||21
11358696|NCT03128099|12555855|FG001|Hour 1 (Low Dose) Started|Overall Study||4
11358697|NCT03128099|12555856|FG002|Hour 1 (Low Dose) Started|Overall Study||22
11358698|NCT03128099|12555854|FG000|Hour 1 (Low Dose) Completed|Overall Study||19
11358699|NCT03128099|12555855|FG001|Hour 1 (Low Dose) Completed|Overall Study||4
11358700|NCT03128099|12555856|FG002|Hour 1 (Low Dose) Completed|Overall Study||21
11358701|NCT03128099|12555854|FG000|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
11358702|NCT03128099|12555855|FG001|Hour 2 (High Dose)Started|Overall Study||4
11358703|NCT03128099|12555856|FG002|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
11358704|NCT03128099|12555854|FG000|Hour 2 (High Dose) Completed|Overall Study||0
11358705|NCT03128099|12555855|FG001|Hour 2 (High Dose) Completed|Overall Study||0
11358706|NCT03128099|12555856|FG002|Hour 2 (High Dose) Completed|Overall Study||0
11358707|NCT03128099|12555854|FG000|COMPLETED|Overall Study||19
11358708|NCT03128099|12555855|FG001|COMPLETED|Overall Study|hour 2 training was completed by 0 participants|0
11358709|NCT03128099|12555856|FG002|COMPLETED|Overall Study||21
11358710|NCT03128099|12555854|FG000|NOT COMPLETED|Overall Study||2
11358711|NCT03128099|12555855|FG001|NOT COMPLETED|Overall Study||4
11358712|NCT03128099|12555856|FG002|NOT COMPLETED|Overall Study||1
11358713|NCT03128307|12555862|FG000|STARTED|Overall Study||604
11358714|NCT03128307|12555862|FG000|COMPLETED|Overall Study||570
11358715|NCT03128307|12555862|FG000|NOT COMPLETED|Overall Study||34
11358716|NCT03128372|12555866|FG000|STARTED|Overall Study||32
11358717|NCT03128372|12555866|FG000|COMPLETED|Overall Study||32
11358718|NCT03128372|12555866|FG000|NOT COMPLETED|Overall Study||0
11358719|NCT03128723|12555870|FG000|STARTED|Overall Study||45
11358720|NCT03128723|12555870|FG000|COMPLETED|Overall Study||43
11358721|NCT03128723|12555870|FG000|NOT COMPLETED|Overall Study||2
11358722|NCT03128892|12555874|FG000|STARTED|Overall Study||34
11358723|NCT03128892|12555874|FG000|COMPLETED|Overall Study||31
11255538|NCT02204449|12449840|FG000|STARTED|Overall Study||46
11255539|NCT02204449|12449841|FG001|STARTED|Overall Study||48
11255540|NCT02204449|12449840|FG000|COMPLETED|Overall Study||39
11358724|NCT03128892|12555874|FG000|NOT COMPLETED|Overall Study||3
11358725|NCT03129178|12555880|FG000|STARTED|Overall Study||13
11358726|NCT03129178|12555881|FG001|STARTED|Overall Study||13
11358727|NCT03129178|12555880|FG000|COMPLETED|Overall Study||12
11358728|NCT03129178|12555881|FG001|COMPLETED|Overall Study||11
11358729|NCT03129178|12555880|FG000|NOT COMPLETED|Overall Study||1
11358730|NCT03129178|12555881|FG001|NOT COMPLETED|Overall Study||2
11358731|NCT03129568|12555888|FG000|STARTED|Overall Study||5
11358732|NCT03129568|12555888|FG000|COMPLETED|Overall Study||5
11358733|NCT03129568|12555888|FG000|NOT COMPLETED|Overall Study||0
11358734|NCT03129945|12555894|FG000|STARTED|Overall Study||15
11358735|NCT03129945|12555895|FG001|STARTED|Overall Study||21
11358736|NCT03129945|12555894|FG000|COMPLETED|Overall Study||15
11358737|NCT03129945|12555895|FG001|COMPLETED|Overall Study||21
11358738|NCT03129945|12555894|FG000|NOT COMPLETED|Overall Study||0
11358739|NCT03129945|12555895|FG001|NOT COMPLETED|Overall Study||0
11358740|NCT03130257|12555904|FG000|STARTED|Overall Study||172
11358741|NCT03130257|12555905|FG001|STARTED|Overall Study||170
11358742|NCT03130257|12555906|FG002|STARTED|Overall Study||168
11358743|NCT03130257|12555904|FG000|COMPLETED|Overall Study||171
11358744|NCT03130257|12555905|FG001|COMPLETED|Overall Study||170
11358745|NCT03130257|12555906|FG002|COMPLETED|Overall Study||166
11358746|NCT03130257|12555904|FG000|NOT COMPLETED|Overall Study||1
11358747|NCT03130257|12555905|FG001|NOT COMPLETED|Overall Study||0
11358748|NCT03130257|12555906|FG002|NOT COMPLETED|Overall Study||2
11358749|NCT03130738|12555917|FG000|STARTED|Overall Study||23
11358750|NCT03130738|12555918|FG001|STARTED|Overall Study||22
11358751|NCT03130738|12555919|FG002|STARTED|Overall Study||20
11358752|NCT03130738|12555917|FG000|COMPLETED|Overall Study||20
11358753|NCT03130738|12555918|FG001|COMPLETED|Overall Study||20
11358754|NCT03130738|12555919|FG002|COMPLETED|Overall Study||14
11358755|NCT03130738|12555917|FG000|NOT COMPLETED|Overall Study||3
11358756|NCT03130738|12555918|FG001|NOT COMPLETED|Overall Study||2
11358757|NCT03130738|12555919|FG002|NOT COMPLETED|Overall Study||6
11358758|NCT03131167|12555940|FG000|STARTED|Overall Study||6
11358759|NCT03131167|12555941|FG001|STARTED|Overall Study||5
11358760|NCT03131167|12555942|FG002|STARTED|Overall Study||5
11358761|NCT03131167|12555943|FG003|STARTED|Overall Study||5
11358762|NCT03131167|12555944|FG004|STARTED|Overall Study||6
11358763|NCT03131167|12555945|FG005|STARTED|Overall Study||5
11255541|NCT02204449|12449841|FG001|COMPLETED|Overall Study||37
11255542|NCT02204449|12449840|FG000|NOT COMPLETED|Overall Study||7
11255543|NCT02204449|12449841|FG001|NOT COMPLETED|Overall Study||11
11255544|NCT02204566|12449847|FG000|STARTED|Overall Study||5
11255545|NCT02204566|12449847|FG000|COMPLETED|Overall Study||1
11255546|NCT02204566|12449847|FG000|NOT COMPLETED|Overall Study||4
11255547|NCT02204579|12449851|FG000|STARTED|Overall Study||7
11255548|NCT02204579|12449851|FG000|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
11255549|NCT02204579|12449851|FG000|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
11255550|NCT02204579|12449851|FG000|Treated|Overall Study||5
11255551|NCT02204579|12449851|FG000|COMPLETED|Overall Study||5
11255552|NCT02204579|12449851|FG000|NOT COMPLETED|Overall Study||2
11255553|NCT02204657|12449862|FG000|STARTED|Overall Study||32
11255554|NCT02204657|12449863|FG001|STARTED|Overall Study||25
11255555|NCT02204657|12449862|FG000|COMPLETED|Overall Study||25
11255556|NCT02204657|12449863|FG001|COMPLETED|Overall Study||25
11255557|NCT02204657|12449862|FG000|NOT COMPLETED|Overall Study||7
11255558|NCT02204657|12449863|FG001|NOT COMPLETED|Overall Study||0
11255559|NCT02204748|12449869|FG000|STARTED|Overall Study||5
11255560|NCT02204748|12449869|FG000|COMPLETED|Overall Study||5
11255561|NCT02204748|12449869|FG000|NOT COMPLETED|Overall Study||0
11255562|NCT02204761|12449873|FG000|STARTED|Overall Study||6
11255563|NCT02204761|12449873|FG000|COMPLETED|Overall Study||6
11255564|NCT02204761|12449873|FG000|NOT COMPLETED|Overall Study||0
11255565|NCT02204917|12449877|FG000|STARTED|Overall Study||31
11255566|NCT02204917|12449877|FG000|COMPLETED|Overall Study||30
11255567|NCT02204917|12449877|FG000|NOT COMPLETED|Overall Study||1
11255568|NCT02204982|12449886|FG000|STARTED|Overall Study||6
11255569|NCT02204982|12449887|FG001|STARTED|Overall Study||7
11255570|NCT02204982|12449886|FG000|COMPLETED|Overall Study||2
11255571|NCT02204982|12449887|FG001|COMPLETED|Overall Study||0
11255572|NCT02204982|12449886|FG000|NOT COMPLETED|Overall Study||4
11255573|NCT02204982|12449887|FG001|NOT COMPLETED|Overall Study||7
11255574|NCT02205177|12449895|FG000|STARTED|Overall Study||8
11255575|NCT02205177|12449896|FG001|STARTED|Overall Study||2
11255576|NCT02205177|12449895|FG000|COMPLETED|Overall Study||6
11255577|NCT02205177|12449896|FG001|COMPLETED|Overall Study||2
11255578|NCT02205177|12449895|FG000|NOT COMPLETED|Overall Study||2
11255579|NCT02205177|12449896|FG001|NOT COMPLETED|Overall Study||0
11255580|NCT02205307|12449904|FG000|STARTED|Overall Study||178
11255581|NCT02205307|12449905|FG001|STARTED|Overall Study||169
11255582|NCT02205307|12449904|FG000|COMPLETED|Overall Study||161
11255583|NCT02205307|12449905|FG001|COMPLETED|Overall Study||163
11255584|NCT02205307|12449904|FG000|NOT COMPLETED|Overall Study||17
11255585|NCT02205307|12449905|FG001|NOT COMPLETED|Overall Study||6
11255586|NCT02205333|12449921|FG000|STARTED|Overall Study||8
11255587|NCT02205333|12449922|FG001|STARTED|Overall Study||6
11255588|NCT02205333|12449923|FG002|STARTED|Overall Study||3
11255589|NCT02205333|12449924|FG003|STARTED|Overall Study||7
11255590|NCT02205333|12449925|FG004|STARTED|Overall Study||6
11255591|NCT02205333|12449926|FG005|STARTED|Overall Study||7
11255592|NCT02205333|12449927|FG006|STARTED|Overall Study||7
11255593|NCT02205333|12449928|FG007|STARTED|Overall Study||3
11255594|NCT02205333|12449929|FG008|STARTED|Overall Study||1
11255595|NCT02205333|12449921|FG000|COMPLETED|Overall Study||2
11255596|NCT02205333|12449922|FG001|COMPLETED|Overall Study||0
11255597|NCT02205333|12449923|FG002|COMPLETED|Overall Study||1
11255598|NCT02205333|12449924|FG003|COMPLETED|Overall Study||0
11255599|NCT02205333|12449925|FG004|COMPLETED|Overall Study||1
11255600|NCT02205333|12449926|FG005|COMPLETED|Overall Study||4
11255601|NCT02205333|12449927|FG006|COMPLETED|Overall Study||2
11255602|NCT02205333|12449928|FG007|COMPLETED|Overall Study||1
11255603|NCT02205333|12449929|FG008|COMPLETED|Overall Study||1
11255604|NCT02205333|12449921|FG000|NOT COMPLETED|Overall Study||6
11255605|NCT02205333|12449922|FG001|NOT COMPLETED|Overall Study||6
11255606|NCT02205333|12449923|FG002|NOT COMPLETED|Overall Study||2
11255607|NCT02205333|12449924|FG003|NOT COMPLETED|Overall Study||7
11255608|NCT02205333|12449925|FG004|NOT COMPLETED|Overall Study||5
11255609|NCT02205333|12449926|FG005|NOT COMPLETED|Overall Study||3
11255610|NCT02205333|12449927|FG006|NOT COMPLETED|Overall Study||5
11255611|NCT02205333|12449928|FG007|NOT COMPLETED|Overall Study||2
11255612|NCT02205333|12449929|FG008|NOT COMPLETED|Overall Study||0
11255613|NCT02205476|12449951|FG000|STARTED|Overall Study||7
11255614|NCT02205476|12449952|FG001|STARTED|Overall Study||3
11255615|NCT02205476|12449951|FG000|COMPLETED|Overall Study||0
11255616|NCT02205476|12449952|FG001|COMPLETED|Overall Study||0
11255617|NCT02205476|12449951|FG000|NOT COMPLETED|Overall Study||7
11255618|NCT02205476|12449952|FG001|NOT COMPLETED|Overall Study||3
11255619|NCT02205801|12449968|FG000|STARTED|Overall Study||11
11255620|NCT02205801|12449969|FG001|STARTED|Overall Study||8
11255621|NCT02205801|12449970|FG002|STARTED|Overall Study||9
11255622|NCT02205801|12449971|FG003|STARTED|Overall Study||8
11255623|NCT02205801|12449968|FG000|COMPLETED|Overall Study||11
11255624|NCT02205801|12449969|FG001|COMPLETED|Overall Study||8
11255625|NCT02205801|12449970|FG002|COMPLETED|Overall Study||9
11255626|NCT02205801|12449971|FG003|COMPLETED|Overall Study||8
11255627|NCT02205801|12449968|FG000|NOT COMPLETED|Overall Study||0
11255628|NCT02205801|12449969|FG001|NOT COMPLETED|Overall Study||0
11255629|NCT02205801|12449970|FG002|NOT COMPLETED|Overall Study||0
11255630|NCT02205801|12449971|FG003|NOT COMPLETED|Overall Study||0
11255631|NCT02205814|12449985|FG000|STARTED|Overall Study||110
11255632|NCT02205814|12449986|FG001|STARTED|Overall Study||110
11255633|NCT02205814|12449987|FG002|STARTED|Overall Study||108
11255634|NCT02205814|12449988|FG003|STARTED|Overall Study||108
11255635|NCT02205814|12449985|FG000|COMPLETED|Overall Study||108
11255636|NCT02205814|12449986|FG001|COMPLETED|Overall Study||109
11255637|NCT02205814|12449987|FG002|COMPLETED|Overall Study||103
11255638|NCT02205814|12449988|FG003|COMPLETED|Overall Study||104
11255639|NCT02205814|12449985|FG000|NOT COMPLETED|Overall Study||2
11255640|NCT02205814|12449986|FG001|NOT COMPLETED|Overall Study||1
11255641|NCT02205814|12449987|FG002|NOT COMPLETED|Overall Study||5
11255642|NCT02205814|12449988|FG003|NOT COMPLETED|Overall Study||4
11255643|NCT02205983|12450002|FG000|STARTED|Overall Study||12
11255644|NCT02205983|12450003|FG001|STARTED|Overall Study||12
11255645|NCT02205983|12450004|FG002|STARTED|Overall Study||13
11255646|NCT02205983|12450005|FG003|STARTED|Overall Study||13
11255647|NCT02205983|12450002|FG000|COMPLETED|Overall Study||12
11255648|NCT02205983|12450003|FG001|COMPLETED|Overall Study||12
11255649|NCT02205983|12450004|FG002|COMPLETED|Overall Study||13
11255650|NCT02205983|12450005|FG003|COMPLETED|Overall Study||13
11255651|NCT02205983|12450002|FG000|NOT COMPLETED|Overall Study||0
11255652|NCT02205983|12450003|FG001|NOT COMPLETED|Overall Study||0
11255653|NCT02205983|12450004|FG002|NOT COMPLETED|Overall Study||0
11255654|NCT02205983|12450005|FG003|NOT COMPLETED|Overall Study||0
11255655|NCT02206061|12450018|FG000|STARTED|Overall Study||149
11255656|NCT02206061|12450019|FG001|STARTED|Overall Study||142
11255657|NCT02206061|12450020|FG002|STARTED|Overall Study||139
11255658|NCT02206061|12450018|FG000|COMPLETED|Overall Study||131
11255659|NCT02206061|12450019|FG001|COMPLETED|Overall Study||128
11255660|NCT02206061|12450020|FG002|COMPLETED|Overall Study||118
11255661|NCT02206061|12450018|FG000|NOT COMPLETED|Overall Study||18
11255662|NCT02206061|12450019|FG001|NOT COMPLETED|Overall Study||14
11255663|NCT02206061|12450020|FG002|NOT COMPLETED|Overall Study||21
11255664|NCT02206152|12450028|FG000|STARTED|Pre-Randomization||22
11255665|NCT02206152|12450028|FG000|COMPLETED|Pre-Randomization||20
11255666|NCT02206152|12450028|FG000|NOT COMPLETED|Pre-Randomization||2
11255667|NCT02206152|12450028|FG000|STARTED|Placebo, Then NAC||10
11255668|NCT02206152|12450028|FG000|COMPLETED|Placebo, Then NAC||10
11255669|NCT02206152|12450028|FG000|NOT COMPLETED|Placebo, Then NAC||0
11255670|NCT02206152|12450028|FG000|STARTED|NAC, Then Placebo||10
11255671|NCT02206152|12450028|FG000|COMPLETED|NAC, Then Placebo||10
11255672|NCT02206152|12450028|FG000|NOT COMPLETED|NAC, Then Placebo||0
11255673|NCT02206217|12450036|FG000|STARTED|Overall Study||90
11255674|NCT02206217|12450037|FG001|STARTED|Overall Study||93
11255675|NCT02206217|12450036|FG000|COMPLETED|Overall Study||81
11255676|NCT02206217|12450037|FG001|COMPLETED|Overall Study||79
11255677|NCT02206217|12450036|FG000|NOT COMPLETED|Overall Study||9
11255678|NCT02206217|12450037|FG001|NOT COMPLETED|Overall Study||14
11255679|NCT02206607|12450043|FG000|STARTED|Open-Label Run-In||42
11255680|NCT02206607|12450044|FG001|STARTED|Open-Label Run-In||0
11255681|NCT02206607|12450045|FG002|STARTED|Open-Label Run-In||0
11255682|NCT02206607|12450046|FG003|STARTED|Open-Label Run-In||0
11255683|NCT02206607|12450047|FG004|STARTED|Open-Label Run-In||0
11255684|NCT02206607|12450043|FG000|COMPLETED|Open-Label Run-In||39
11255685|NCT02206607|12450044|FG001|COMPLETED|Open-Label Run-In||0
11255686|NCT02206607|12450045|FG002|COMPLETED|Open-Label Run-In||0
11255687|NCT02206607|12450046|FG003|COMPLETED|Open-Label Run-In||0
11255688|NCT02206607|12450047|FG004|COMPLETED|Open-Label Run-In||0
11255689|NCT02206607|12450043|FG000|NOT COMPLETED|Open-Label Run-In||3
11255690|NCT02206607|12450044|FG001|NOT COMPLETED|Open-Label Run-In||0
11255691|NCT02206607|12450045|FG002|NOT COMPLETED|Open-Label Run-In||0
11255692|NCT02206607|12450046|FG003|NOT COMPLETED|Open-Label Run-In||0
11255693|NCT02206607|12450047|FG004|NOT COMPLETED|Open-Label Run-In||0
11255694|NCT02206607|12450043|FG000|STARTED|First Intervention Period||0
11255695|NCT02206607|12450044|FG001|STARTED|First Intervention Period||9
11255696|NCT02206607|12450045|FG002|STARTED|First Intervention Period||9
11255697|NCT02206607|12450046|FG003|STARTED|First Intervention Period||11
11255698|NCT02206607|12450047|FG004|STARTED|First Intervention Period||10
11255699|NCT02206607|12450043|FG000|COMPLETED|First Intervention Period||0
11255700|NCT02206607|12450044|FG001|COMPLETED|First Intervention Period||9
11255701|NCT02206607|12450045|FG002|COMPLETED|First Intervention Period||9
11255702|NCT02206607|12450046|FG003|COMPLETED|First Intervention Period||11
11255703|NCT02206607|12450047|FG004|COMPLETED|First Intervention Period||10
11255704|NCT02206607|12450043|FG000|NOT COMPLETED|First Intervention Period||0
11255705|NCT02206607|12450044|FG001|NOT COMPLETED|First Intervention Period||0
11255706|NCT02206607|12450045|FG002|NOT COMPLETED|First Intervention Period||0
11255707|NCT02206607|12450046|FG003|NOT COMPLETED|First Intervention Period||0
11255708|NCT02206607|12450047|FG004|NOT COMPLETED|First Intervention Period||0
11255709|NCT02206607|12450043|FG000|STARTED|First Washout Period 5 to 10 Days||0
11255710|NCT02206607|12450044|FG001|STARTED|First Washout Period 5 to 10 Days||9
11255711|NCT02206607|12450045|FG002|STARTED|First Washout Period 5 to 10 Days||9
11255712|NCT02206607|12450046|FG003|STARTED|First Washout Period 5 to 10 Days||11
11255713|NCT02206607|12450047|FG004|STARTED|First Washout Period 5 to 10 Days||10
11255714|NCT02206607|12450043|FG000|COMPLETED|First Washout Period 5 to 10 Days||0
11255715|NCT02206607|12450044|FG001|COMPLETED|First Washout Period 5 to 10 Days||9
11255716|NCT02206607|12450045|FG002|COMPLETED|First Washout Period 5 to 10 Days||9
11255717|NCT02206607|12450046|FG003|COMPLETED|First Washout Period 5 to 10 Days||11
11255718|NCT02206607|12450047|FG004|COMPLETED|First Washout Period 5 to 10 Days||10
11255719|NCT02206607|12450043|FG000|NOT COMPLETED|First Washout Period 5 to 10 Days||0
11255720|NCT02206607|12450044|FG001|NOT COMPLETED|First Washout Period 5 to 10 Days||0
11255721|NCT02206607|12450045|FG002|NOT COMPLETED|First Washout Period 5 to 10 Days||0
11255722|NCT02206607|12450046|FG003|NOT COMPLETED|First Washout Period 5 to 10 Days||0
11255723|NCT02206607|12450047|FG004|NOT COMPLETED|First Washout Period 5 to 10 Days||0
11255724|NCT02206607|12450043|FG000|STARTED|Second Intervention Period||0
11255725|NCT02206607|12450044|FG001|STARTED|Second Intervention Period||9
11255726|NCT02206607|12450045|FG002|STARTED|Second Intervention Period||9
11255727|NCT02206607|12450046|FG003|STARTED|Second Intervention Period||11
11255728|NCT02206607|12450047|FG004|STARTED|Second Intervention Period||10
11255729|NCT02206607|12450043|FG000|COMPLETED|Second Intervention Period||0
11255730|NCT02206607|12450044|FG001|COMPLETED|Second Intervention Period||9
11255731|NCT02206607|12450045|FG002|COMPLETED|Second Intervention Period||9
11255732|NCT02206607|12450046|FG003|COMPLETED|Second Intervention Period||10
11255733|NCT02206607|12450047|FG004|COMPLETED|Second Intervention Period||10
11255734|NCT02206607|12450043|FG000|NOT COMPLETED|Second Intervention Period||0
11255735|NCT02206607|12450044|FG001|NOT COMPLETED|Second Intervention Period||0
11255736|NCT02206607|12450045|FG002|NOT COMPLETED|Second Intervention Period||0
11255737|NCT02206607|12450046|FG003|NOT COMPLETED|Second Intervention Period||1
11255738|NCT02206607|12450047|FG004|NOT COMPLETED|Second Intervention Period||0
11255739|NCT02206607|12450043|FG000|STARTED|Second Washout Period 5 to 10 Days||0
11255740|NCT02206607|12450044|FG001|STARTED|Second Washout Period 5 to 10 Days||9
11255741|NCT02206607|12450045|FG002|STARTED|Second Washout Period 5 to 10 Days||9
11255742|NCT02206607|12450046|FG003|STARTED|Second Washout Period 5 to 10 Days||10
11255743|NCT02206607|12450047|FG004|STARTED|Second Washout Period 5 to 10 Days||10
11255744|NCT02206607|12450043|FG000|COMPLETED|Second Washout Period 5 to 10 Days||0
11255745|NCT02206607|12450044|FG001|COMPLETED|Second Washout Period 5 to 10 Days||9
11255746|NCT02206607|12450045|FG002|COMPLETED|Second Washout Period 5 to 10 Days||9
11255747|NCT02206607|12450046|FG003|COMPLETED|Second Washout Period 5 to 10 Days||10
11255748|NCT02206607|12450047|FG004|COMPLETED|Second Washout Period 5 to 10 Days||10
11255749|NCT02206607|12450043|FG000|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
11255750|NCT02206607|12450044|FG001|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
11255751|NCT02206607|12450045|FG002|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
11255752|NCT02206607|12450046|FG003|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
11255753|NCT02206607|12450047|FG004|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
11255754|NCT02206607|12450043|FG000|STARTED|Third Intervention Period||0
11255755|NCT02206607|12450044|FG001|STARTED|Third Intervention Period||9
11255756|NCT02206607|12450045|FG002|STARTED|Third Intervention Period||9
11255757|NCT02206607|12450046|FG003|STARTED|Third Intervention Period||10
11255758|NCT02206607|12450047|FG004|STARTED|Third Intervention Period||10
11255759|NCT02206607|12450043|FG000|COMPLETED|Third Intervention Period||0
11255760|NCT02206607|12450044|FG001|COMPLETED|Third Intervention Period||9
11255761|NCT02206607|12450045|FG002|COMPLETED|Third Intervention Period||9
11255762|NCT02206607|12450046|FG003|COMPLETED|Third Intervention Period||10
11255763|NCT02206607|12450047|FG004|COMPLETED|Third Intervention Period||10
11255764|NCT02206607|12450043|FG000|NOT COMPLETED|Third Intervention Period||0
11255765|NCT02206607|12450044|FG001|NOT COMPLETED|Third Intervention Period||0
11255766|NCT02206607|12450045|FG002|NOT COMPLETED|Third Intervention Period||0
11255767|NCT02206607|12450046|FG003|NOT COMPLETED|Third Intervention Period||0
11255768|NCT02206607|12450047|FG004|NOT COMPLETED|Third Intervention Period||0
11255769|NCT02206607|12450043|FG000|STARTED|Third Washout Period 5 to 10 Days||0
11255770|NCT02206607|12450044|FG001|STARTED|Third Washout Period 5 to 10 Days||9
11255771|NCT02206607|12450045|FG002|STARTED|Third Washout Period 5 to 10 Days||9
11255772|NCT02206607|12450046|FG003|STARTED|Third Washout Period 5 to 10 Days||10
11255773|NCT02206607|12450047|FG004|STARTED|Third Washout Period 5 to 10 Days||10
11255774|NCT02206607|12450043|FG000|COMPLETED|Third Washout Period 5 to 10 Days||0
11255775|NCT02206607|12450044|FG001|COMPLETED|Third Washout Period 5 to 10 Days||9
11255776|NCT02206607|12450045|FG002|COMPLETED|Third Washout Period 5 to 10 Days||9
11255777|NCT02206607|12450046|FG003|COMPLETED|Third Washout Period 5 to 10 Days||10
11255778|NCT02206607|12450047|FG004|COMPLETED|Third Washout Period 5 to 10 Days||10
11255779|NCT02206607|12450043|FG000|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
11255780|NCT02206607|12450044|FG001|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
11255781|NCT02206607|12450045|FG002|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
11255782|NCT02206607|12450046|FG003|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
11255783|NCT02206607|12450047|FG004|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
11255784|NCT02206607|12450043|FG000|STARTED|Fourth Intervention Period||0
11255785|NCT02206607|12450044|FG001|STARTED|Fourth Intervention Period||9
11255786|NCT02206607|12450045|FG002|STARTED|Fourth Intervention Period||9
11255787|NCT02206607|12450046|FG003|STARTED|Fourth Intervention Period||10
11255788|NCT02206607|12450047|FG004|STARTED|Fourth Intervention Period||10
11255789|NCT02206607|12450043|FG000|COMPLETED|Fourth Intervention Period||0
11255790|NCT02206607|12450044|FG001|COMPLETED|Fourth Intervention Period||9
11255791|NCT02206607|12450045|FG002|COMPLETED|Fourth Intervention Period||9
11255792|NCT02206607|12450046|FG003|COMPLETED|Fourth Intervention Period||10
11255793|NCT02206607|12450047|FG004|COMPLETED|Fourth Intervention Period||10
11255794|NCT02206607|12450043|FG000|NOT COMPLETED|Fourth Intervention Period||0
11255795|NCT02206607|12450044|FG001|NOT COMPLETED|Fourth Intervention Period||0
11255796|NCT02206607|12450045|FG002|NOT COMPLETED|Fourth Intervention Period||0
11255797|NCT02206607|12450046|FG003|NOT COMPLETED|Fourth Intervention Period||0
11255798|NCT02206607|12450047|FG004|NOT COMPLETED|Fourth Intervention Period||0
11255799|NCT02206620|12450063|FG000|STARTED|Phase I - First Intervention (6 Weeks)||22
11255800|NCT02206620|12450064|FG001|STARTED|Phase I - First Intervention (6 Weeks)||27
11255801|NCT02206620|12450063|FG000|COMPLETED|Phase I - First Intervention (6 Weeks)||21
11255802|NCT02206620|12450064|FG001|COMPLETED|Phase I - First Intervention (6 Weeks)||26
11255803|NCT02206620|12450063|FG000|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
11255804|NCT02206620|12450064|FG001|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
11255805|NCT02206620|12450063|FG000|STARTED|Washout (6 Weeks)||21
11255806|NCT02206620|12450064|FG001|STARTED|Washout (6 Weeks)||26
11255807|NCT02206620|12450063|FG000|COMPLETED|Washout (6 Weeks)||21
11255808|NCT02206620|12450064|FG001|COMPLETED|Washout (6 Weeks)||26
11255809|NCT02206620|12450063|FG000|NOT COMPLETED|Washout (6 Weeks)||0
11255810|NCT02206620|12450064|FG001|NOT COMPLETED|Washout (6 Weeks)||0
11255811|NCT02206620|12450063|FG000|STARTED|Phase II - Second Intervention (6 Weeks)||21
11255812|NCT02206620|12450064|FG001|STARTED|Phase II - Second Intervention (6 Weeks)||26
11255813|NCT02206620|12450063|FG000|COMPLETED|Phase II - Second Intervention (6 Weeks)||21
11255814|NCT02206620|12450064|FG001|COMPLETED|Phase II - Second Intervention (6 Weeks)||24
11255815|NCT02206620|12450063|FG000|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0
11255816|NCT02206620|12450064|FG001|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2
11255817|NCT02206685|12450078|FG000|STARTED|Overall Study||37
11255818|NCT02206685|12450079|FG001|STARTED|Overall Study||37
11255819|NCT02206685|12450078|FG000|COMPLETED|Overall Study||32
11255820|NCT02206685|12450079|FG001|COMPLETED|Overall Study||30
11255821|NCT02206685|12450078|FG000|NOT COMPLETED|Overall Study||5
11255822|NCT02206685|12450079|FG001|NOT COMPLETED|Overall Study||7
11255823|NCT02206776|12450087|FG000|STARTED|Overall Study||1
11255824|NCT02206776|12450088|FG001|STARTED|Overall Study||1
11255825|NCT02206776|12450087|FG000|COMPLETED|Overall Study||1
11255826|NCT02206776|12450088|FG001|COMPLETED|Overall Study||1
11255827|NCT02206776|12450087|FG000|NOT COMPLETED|Overall Study||0
11255828|NCT02206776|12450088|FG001|NOT COMPLETED|Overall Study||0
11255829|NCT02206828|12450094|FG000|STARTED|Overall Study||100
11255830|NCT02206828|12450094|FG000|COMPLETED|Overall Study||93
11255831|NCT02206828|12450094|FG000|NOT COMPLETED|Overall Study||7
11255832|NCT02207088|12450121|FG000|STARTED|Overall Study||68
11255833|NCT02207088|12450121|FG000|COMPLETED|Overall Study||66
11255834|NCT02207088|12450121|FG000|NOT COMPLETED|Overall Study||2
11255835|NCT02207231|12450128|FG000|STARTED|Placebo Controlled Period: Week 0 - 16||174
11255836|NCT02207231|12450129|FG001|STARTED|Placebo Controlled Period: Week 0 - 16||329
11255837|NCT02207231|12450130|FG002|STARTED|Placebo Controlled Period: Week 0 - 16||334
11255838|NCT02207231|12450131|FG003|STARTED|Placebo Controlled Period: Week 0 - 16||0
11255839|NCT02207231|12450128|FG000|Treated|Placebo Controlled Period: Week 0 - 16||174
11255840|NCT02207231|12450129|FG001|Treated|Placebo Controlled Period: Week 0 - 16||329
11255841|NCT02207231|12450130|FG002|Treated|Placebo Controlled Period: Week 0 - 16||333
11255842|NCT02207231|12450131|FG003|Treated|Placebo Controlled Period: Week 0 - 16||0
11255843|NCT02207231|12450128|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
11255844|NCT02207231|12450129|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
11255845|NCT02207231|12450130|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
11255846|NCT02207231|12450131|FG003|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
11255847|NCT02207231|12450128|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
11255848|NCT02207231|12450129|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
11255849|NCT02207231|12450130|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
11255850|NCT02207231|12450131|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
11255851|NCT02207231|12450128|FG000|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
11255852|NCT02207231|12450129|FG001|STARTED|Active Controlled Period: Week 16 - 48||322
11255853|NCT02207231|12450130|FG002|STARTED|Active Controlled Period: Week 16 - 48||324
11255854|NCT02207231|12450131|FG003|STARTED|Active Controlled Period: Week 16 - 48||0
11255855|NCT02207231|12450128|FG000|COMPLETED|Active Controlled Period: Week 16 - 48||162
11255856|NCT02207231|12450129|FG001|COMPLETED|Active Controlled Period: Week 16 - 48||301
11255857|NCT02207231|12450130|FG002|COMPLETED|Active Controlled Period: Week 16 - 48||281
11255858|NCT02207231|12450131|FG003|COMPLETED|Active Controlled Period: Week 16 - 48||0
11255859|NCT02207231|12450128|FG000|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
11255860|NCT02207231|12450129|FG001|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
11255861|NCT02207231|12450130|FG002|NOT COMPLETED|Active Controlled Period: Week 16 - 48||43
11255862|NCT02207231|12450131|FG003|NOT COMPLETED|Active Controlled Period: Week 16 - 48||0
11255863|NCT02207231|12450128|FG000|STARTED|Open-label Guselkumab: Week 48 - 264||0
11255864|NCT02207231|12450129|FG001|STARTED|Open-label Guselkumab: Week 48 - 264||0
11255865|NCT02207231|12450130|FG002|STARTED|Open-label Guselkumab: Week 48 - 264|One participant did not crossover at Week 52 due to adverse event.|280
11255866|NCT02207231|12450131|FG003|STARTED|Open-label Guselkumab: Week 48 - 264|162 + 301= 463|463
11255867|NCT02207231|12450128|FG000|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
11255868|NCT02207231|12450129|FG001|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
11255869|NCT02207231|12450130|FG002|COMPLETED|Open-label Guselkumab: Week 48 - 264||242
11255870|NCT02207231|12450131|FG003|COMPLETED|Open-label Guselkumab: Week 48 - 264||380
11255871|NCT02207231|12450128|FG000|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
11255872|NCT02207231|12450129|FG001|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
11255873|NCT02207231|12450130|FG002|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||38
11255874|NCT02207231|12450131|FG003|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||83
11255875|NCT02207244|12450152|FG000|STARTED|Placebo Controlled Period: Week 0-16||248
11255876|NCT02207244|12450153|FG001|STARTED|Placebo Controlled Period: Week 0-16||496
11255877|NCT02207244|12450154|FG002|STARTED|Placebo Controlled Period: Week 0-16||248
11255878|NCT02207244|12450155|FG003|STARTED|Placebo Controlled Period: Week 0-16||0
11255879|NCT02207244|12450156|FG004|STARTED|Placebo Controlled Period: Week 0-16||0
11255880|NCT02207244|12450157|FG005|STARTED|Placebo Controlled Period: Week 0-16||0
11255881|NCT02207244|12450158|FG006|STARTED|Placebo Controlled Period: Week 0-16||0
11255882|NCT02207244|12450159|FG007|STARTED|Placebo Controlled Period: Week 0-16||0
11255883|NCT02207244|12450160|FG008|STARTED|Placebo Controlled Period: Week 0-16||0
11255884|NCT02207244|12450161|FG009|STARTED|Placebo Controlled Period: Week 0-16||0
11255885|NCT02207244|12450162|FG010|STARTED|Placebo Controlled Period: Week 0-16||0
11255886|NCT02207244|12450152|FG000|Treated|Placebo Controlled Period: Week 0-16||248
11255887|NCT02207244|12450153|FG001|Treated|Placebo Controlled Period: Week 0-16||494
11255888|NCT02207244|12450154|FG002|Treated|Placebo Controlled Period: Week 0-16||248
11255889|NCT02207244|12450155|FG003|Treated|Placebo Controlled Period: Week 0-16||0
11255890|NCT02207244|12450156|FG004|Treated|Placebo Controlled Period: Week 0-16||0
11255891|NCT02207244|12450157|FG005|Treated|Placebo Controlled Period: Week 0-16||0
11255892|NCT02207244|12450158|FG006|Treated|Placebo Controlled Period: Week 0-16||0
11255893|NCT02207244|12450159|FG007|Treated|Placebo Controlled Period: Week 0-16||0
11255894|NCT02207244|12450160|FG008|Treated|Placebo Controlled Period: Week 0-16||0
11255895|NCT02207244|12450161|FG009|Treated|Placebo Controlled Period: Week 0-16||0
11255896|NCT02207244|12450162|FG010|Treated|Placebo Controlled Period: Week 0-16||0
11255897|NCT02207244|12450152|FG000|COMPLETED|Placebo Controlled Period: Week 0-16||233
11255898|NCT02207244|12450153|FG001|COMPLETED|Placebo Controlled Period: Week 0-16||478
11255899|NCT02207244|12450154|FG002|COMPLETED|Placebo Controlled Period: Week 0-16||237
11255900|NCT02207244|12450155|FG003|COMPLETED|Placebo Controlled Period: Week 0-16||0
11255901|NCT02207244|12450156|FG004|COMPLETED|Placebo Controlled Period: Week 0-16||0
11255902|NCT02207244|12450157|FG005|COMPLETED|Placebo Controlled Period: Week 0-16||0
11255903|NCT02207244|12450158|FG006|COMPLETED|Placebo Controlled Period: Week 0-16||0
11255904|NCT02207244|12450159|FG007|COMPLETED|Placebo Controlled Period: Week 0-16||0
11255905|NCT02207244|12450160|FG008|COMPLETED|Placebo Controlled Period: Week 0-16||0
11255906|NCT02207244|12450161|FG009|COMPLETED|Placebo Controlled Period: Week 0-16||0
11255907|NCT02207244|12450162|FG010|COMPLETED|Placebo Controlled Period: Week 0-16||0
11255908|NCT02207244|12450152|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0-16||15
11255909|NCT02207244|12450153|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0-16||18
11255910|NCT02207244|12450154|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0-16||11
11255911|NCT02207244|12450155|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
11255912|NCT02207244|12450156|FG004|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
11255913|NCT02207244|12450157|FG005|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
11255914|NCT02207244|12450158|FG006|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
11255915|NCT02207244|12450159|FG007|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
11255916|NCT02207244|12450160|FG008|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
11255917|NCT02207244|12450161|FG009|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
11255918|NCT02207244|12450162|FG010|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
11255919|NCT02207244|12450152|FG000|STARTED|Placebo Crossover and ACP: Week 16-28||0
11255920|NCT02207244|12450153|FG001|STARTED|Placebo Crossover and ACP: Week 16-28||0
11255921|NCT02207244|12450154|FG002|STARTED|Placebo Crossover and ACP: Week 16-28||0
11255922|NCT02207244|12450155|FG003|STARTED|Placebo Crossover and ACP: Week 16-28||233
11255923|NCT02207244|12450156|FG004|STARTED|Placebo Crossover and ACP: Week 16-28||478
11255924|NCT02207244|12450157|FG005|STARTED|Placebo Crossover and ACP: Week 16-28||237
11255925|NCT02207244|12450158|FG006|STARTED|Placebo Crossover and ACP: Week 16-28||0
11255926|NCT02207244|12450159|FG007|STARTED|Placebo Crossover and ACP: Week 16-28||0
11255927|NCT02207244|12450160|FG008|STARTED|Placebo Crossover and ACP: Week 16-28||0
11255928|NCT02207244|12450161|FG009|STARTED|Placebo Crossover and ACP: Week 16-28||0
11255929|NCT02207244|12450162|FG010|STARTED|Placebo Crossover and ACP: Week 16-28||0
11255930|NCT02207244|12450152|FG000|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255931|NCT02207244|12450153|FG001|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255932|NCT02207244|12450154|FG002|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255933|NCT02207244|12450155|FG003|COMPLETED|Placebo Crossover and ACP: Week 16-28||227
11255934|NCT02207244|12450156|FG004|COMPLETED|Placebo Crossover and ACP: Week 16-28||470
11255935|NCT02207244|12450157|FG005|COMPLETED|Placebo Crossover and ACP: Week 16-28||228
11255936|NCT02207244|12450158|FG006|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255937|NCT02207244|12450159|FG007|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255938|NCT02207244|12450160|FG008|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255939|NCT02207244|12450161|FG009|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255940|NCT02207244|12450162|FG010|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255941|NCT02207244|12450152|FG000|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255942|NCT02207244|12450153|FG001|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255943|NCT02207244|12450154|FG002|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255944|NCT02207244|12450155|FG003|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||6
11255945|NCT02207244|12450156|FG004|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||8
11255946|NCT02207244|12450157|FG005|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||9
11255947|NCT02207244|12450158|FG006|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255948|NCT02207244|12450159|FG007|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255949|NCT02207244|12450160|FG008|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255950|NCT02207244|12450161|FG009|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255951|NCT02207244|12450162|FG010|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
11255952|NCT02207244|12450152|FG000|STARTED|Withdrawal and Re-treatment: Week 28-72||0
11255953|NCT02207244|12450153|FG001|STARTED|Withdrawal and Re-treatment: Week 28-72||0
11255954|NCT02207244|12450154|FG002|STARTED|Withdrawal and Re-treatment: Week 28-72||0
11255955|NCT02207244|12450155|FG003|STARTED|Withdrawal and Re-treatment: Week 28-72||0
11255956|NCT02207244|12450156|FG004|STARTED|Withdrawal and Re-treatment: Week 28-72||0
11255957|NCT02207244|12450157|FG005|STARTED|Withdrawal and Re-treatment: Week 28-72||0
11255958|NCT02207244|12450158|FG006|STARTED|Withdrawal and Re-treatment: Week 28-72||227
11255959|NCT02207244|12450159|FG007|STARTED|Withdrawal and Re-treatment: Week 28-72||470
11255960|NCT02207244|12450160|FG008|STARTED|Withdrawal and Re-treatment: Week 28-72||220
11255961|NCT02207244|12450161|FG009|STARTED|Withdrawal and Re-treatment: Week 28-72||8
11255962|NCT02207244|12450162|FG010|STARTED|Withdrawal and Re-treatment: Week 28-72||0
11255963|NCT02207244|12450152|FG000|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
11255964|NCT02207244|12450153|FG001|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
11255965|NCT02207244|12450154|FG002|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
11255966|NCT02207244|12450155|FG003|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
11255967|NCT02207244|12450156|FG004|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
11255968|NCT02207244|12450157|FG005|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
11255969|NCT02207244|12450158|FG006|Nonresponders|Withdrawal and Re-treatment: Week 28-72||80
11255970|NCT02207244|12450159|FG007|Nonresponders|Withdrawal and Re-treatment: Week 28-72||95
11255971|NCT02207244|12450160|FG008|Nonresponders|Withdrawal and Re-treatment: Week 28-72||112
11255972|NCT02207244|12450161|FG009|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
11255973|NCT02207244|12450162|FG010|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
11255974|NCT02207244|12450152|FG000|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
11255975|NCT02207244|12450153|FG001|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
11255976|NCT02207244|12450154|FG002|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
11255977|NCT02207244|12450155|FG003|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
11255978|NCT02207244|12450156|FG004|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
11255979|NCT02207244|12450157|FG005|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
11255980|NCT02207244|12450158|FG006|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
11255981|NCT02207244|12450159|FG007|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72|Participants randomized to withdrawal=182 and maintenance= 193|375
11255982|NCT02207244|12450160|FG008|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
11255983|NCT02207244|12450161|FG009|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
11255984|NCT02207244|12450162|FG010|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
11255985|NCT02207244|12450152|FG000|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
11255986|NCT02207244|12450153|FG001|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
11255987|NCT02207244|12450154|FG002|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
11255988|NCT02207244|12450155|FG003|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
11255989|NCT02207244|12450156|FG004|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
11255990|NCT02207244|12450157|FG005|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
11255991|NCT02207244|12450158|FG006|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||147
11255992|NCT02207244|12450159|FG007|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
11255993|NCT02207244|12450160|FG008|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||108
11255994|NCT02207244|12450161|FG009|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
11255995|NCT02207244|12450162|FG010|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
11255996|NCT02207244|12450152|FG000|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11255997|NCT02207244|12450153|FG001|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11255998|NCT02207244|12450154|FG002|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11255999|NCT02207244|12450155|FG003|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11256000|NCT02207244|12450156|FG004|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11256001|NCT02207244|12450157|FG005|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11256002|NCT02207244|12450158|FG006|COMPLETED|Withdrawal and Re-treatment: Week 28-72||213
11256003|NCT02207244|12450159|FG007|COMPLETED|Withdrawal and Re-treatment: Week 28-72||443
11256004|NCT02207244|12450160|FG008|COMPLETED|Withdrawal and Re-treatment: Week 28-72||211
11256005|NCT02207244|12450161|FG009|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11256006|NCT02207244|12450162|FG010|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11256007|NCT02207244|12450152|FG000|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11256008|NCT02207244|12450153|FG001|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11256009|NCT02207244|12450154|FG002|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11256010|NCT02207244|12450155|FG003|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11256011|NCT02207244|12450156|FG004|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11256012|NCT02207244|12450157|FG005|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11256013|NCT02207244|12450158|FG006|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||14
11256014|NCT02207244|12450159|FG007|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||27
11256015|NCT02207244|12450160|FG008|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||9
11256016|NCT02207244|12450161|FG009|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||8
11256017|NCT02207244|12450162|FG010|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
11256018|NCT02207244|12450152|FG000|STARTED|Open-label Guselkumab: Week 72-264||0
11256019|NCT02207244|12450153|FG001|STARTED|Open-label Guselkumab: Week 72-264||0
11256020|NCT02207244|12450154|FG002|STARTED|Open-label Guselkumab: Week 72-264||0
11256021|NCT02207244|12450155|FG003|STARTED|Open-label Guselkumab: Week 72-264||0
11256022|NCT02207244|12450156|FG004|STARTED|Open-label Guselkumab: Week 72-264||0
11256023|NCT02207244|12450157|FG005|STARTED|Open-label Guselkumab: Week 72-264||0
11256024|NCT02207244|12450158|FG006|STARTED|Open-label Guselkumab: Week 72-264||0
11256025|NCT02207244|12450159|FG007|STARTED|Open-label Guselkumab: Week 72-264||0
11256026|NCT02207244|12450160|FG008|STARTED|Open-label Guselkumab: Week 72-264||211
11256027|NCT02207244|12450161|FG009|STARTED|Open-label Guselkumab: Week 72-264||0
11256028|NCT02207244|12450162|FG010|STARTED|Open-label Guselkumab: Week 72-264||656
11256029|NCT02207244|12450152|FG000|COMPLETED|Open-label Guselkumab: Week 72-264||0
11256030|NCT02207244|12450153|FG001|COMPLETED|Open-label Guselkumab: Week 72-264||0
11256031|NCT02207244|12450154|FG002|COMPLETED|Open-label Guselkumab: Week 72-264||0
11256032|NCT02207244|12450155|FG003|COMPLETED|Open-label Guselkumab: Week 72-264||0
11256033|NCT02207244|12450156|FG004|COMPLETED|Open-label Guselkumab: Week 72-264||0
11256034|NCT02207244|12450157|FG005|COMPLETED|Open-label Guselkumab: Week 72-264||0
11256035|NCT02207244|12450158|FG006|COMPLETED|Open-label Guselkumab: Week 72-264||0
11256036|NCT02207244|12450159|FG007|COMPLETED|Open-label Guselkumab: Week 72-264||0
11256037|NCT02207244|12450160|FG008|COMPLETED|Open-label Guselkumab: Week 72-264||173
11256038|NCT02207244|12450161|FG009|COMPLETED|Open-label Guselkumab: Week 72-264||0
11256039|NCT02207244|12450162|FG010|COMPLETED|Open-label Guselkumab: Week 72-264||554
11256040|NCT02207244|12450152|FG000|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
11256041|NCT02207244|12450153|FG001|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
11256042|NCT02207244|12450154|FG002|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
11256043|NCT02207244|12450155|FG003|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
11256044|NCT02207244|12450156|FG004|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
11256045|NCT02207244|12450157|FG005|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
11256046|NCT02207244|12450158|FG006|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
11256047|NCT02207244|12450159|FG007|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
11256048|NCT02207244|12450160|FG008|NOT COMPLETED|Open-label Guselkumab: Week 72-264||38
11256049|NCT02207244|12450161|FG009|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
11256050|NCT02207244|12450162|FG010|NOT COMPLETED|Open-label Guselkumab: Week 72-264||102
11256051|NCT02207322|12450193|FG000|STARTED|Overall Study||79
11256052|NCT02207322|12450194|FG001|STARTED|Overall Study||81
11256053|NCT02207322|12450193|FG000|Week-2|Overall Study||77
11256054|NCT02207322|12450194|FG001|Week-2|Overall Study||80
11256055|NCT02207322|12450193|FG000|3-month|Overall Study||74
11256056|NCT02207322|12450194|FG001|3-month|Overall Study||75
11256057|NCT02207322|12450193|FG000|COMPLETED|Overall Study|6-month|70
11256058|NCT02207322|12450194|FG001|COMPLETED|Overall Study|6-month|71
11256059|NCT02207322|12450193|FG000|NOT COMPLETED|Overall Study||9
11256060|NCT02207322|12450194|FG001|NOT COMPLETED|Overall Study||10
11256061|NCT02207374|12450203|FG000|STARTED|Overall Study||239
11256062|NCT02207374|12450204|FG001|STARTED|Overall Study||241
11256063|NCT02207374|12450205|FG002|STARTED|Overall Study||121
11256064|NCT02207374|12450203|FG000|Exposed|Overall Study||239
11256065|NCT02207374|12450204|FG001|Exposed|Overall Study||241
11256066|NCT02207374|12450205|FG002|Exposed|Overall Study||120
11256067|NCT02207374|12450203|FG000|COMPLETED|Overall Study||233
11256068|NCT02207374|12450204|FG001|COMPLETED|Overall Study||231
11256069|NCT02207374|12450205|FG002|COMPLETED|Overall Study||115
11256070|NCT02207374|12450203|FG000|NOT COMPLETED|Overall Study||6
11256071|NCT02207374|12450204|FG001|NOT COMPLETED|Overall Study||10
11256072|NCT02207374|12450205|FG002|NOT COMPLETED|Overall Study||6
11256073|NCT02207400|12450215|FG000|STARTED|Overall Study||123
11256074|NCT02207400|12450216|FG001|STARTED|Overall Study||123
11256075|NCT02207400|12450215|FG000|COMPLETED|Overall Study||107
11256076|NCT02207400|12450216|FG001|COMPLETED|Overall Study||109
11256077|NCT02207400|12450215|FG000|NOT COMPLETED|Overall Study||16
11256078|NCT02207400|12450216|FG001|NOT COMPLETED|Overall Study||14
11256079|NCT02207413|12450231|FG000|STARTED|Overall Study||60
11256080|NCT02207413|12450232|FG001|STARTED|Overall Study||60
11256081|NCT02207413|12450233|FG002|STARTED|Overall Study||410
11256082|NCT02207413|12450234|FG003|STARTED|Overall Study||411
11256083|NCT02207413|12450235|FG004|STARTED|Overall Study||466
11256084|NCT02207413|12450236|FG005|STARTED|Overall Study||474
11256085|NCT02207413|12450231|FG000|COMPLETED|Overall Study||59
11256086|NCT02207413|12450232|FG001|COMPLETED|Overall Study||60
11256087|NCT02207413|12450233|FG002|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
11256088|NCT02207413|12450234|FG003|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
11343948|NCT02957682|12541259|FG001|Randomized and Treated|Overall Study||1086
11256089|NCT02207413|12450235|FG004|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
11256090|NCT02207413|12450236|FG005|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
11256091|NCT02207413|12450231|FG000|NOT COMPLETED|Overall Study||1
11256092|NCT02207413|12450232|FG001|NOT COMPLETED|Overall Study||0
11256093|NCT02207413|12450233|FG002|NOT COMPLETED|Overall Study||0
11256094|NCT02207413|12450234|FG003|NOT COMPLETED|Overall Study||1
11256095|NCT02207413|12450235|FG004|NOT COMPLETED|Overall Study||7
11256096|NCT02207413|12450236|FG005|NOT COMPLETED|Overall Study||13
11256097|NCT02207478|12450258|FG000|STARTED|Overall Study||40
11256098|NCT02207478|12450259|FG001|STARTED|Overall Study||46
11256099|NCT02207478|12450258|FG000|COMPLETED|Overall Study||40
11256100|NCT02207478|12450259|FG001|COMPLETED|Overall Study||46
11256101|NCT02207478|12450258|FG000|NOT COMPLETED|Overall Study||0
11256102|NCT02207478|12450259|FG001|NOT COMPLETED|Overall Study||0
11256103|NCT02207491|12450267|FG000|STARTED|Overall Study||202
11256104|NCT02207491|12450268|FG001|STARTED|Overall Study||209
11256105|NCT02207491|12450267|FG000|COMPLETED|Overall Study||171
11256106|NCT02207491|12450268|FG001|COMPLETED|Overall Study||196
11256107|NCT02207491|12450267|FG000|NOT COMPLETED|Overall Study||31
11256108|NCT02207491|12450268|FG001|NOT COMPLETED|Overall Study||13
11256109|NCT02207530|12450274|FG000|STARTED|Overall Study||112
11256110|NCT02207530|12450274|FG000|COMPLETED|Overall Study||21
11256111|NCT02207530|12450274|FG000|NOT COMPLETED|Overall Study||91
11256112|NCT02207556|12450280|FG000|STARTED|Overall Study||7
11256113|NCT02207556|12450281|FG001|STARTED|Overall Study||25
11256114|NCT02207556|12450280|FG000|COMPLETED|Overall Study||5
11256115|NCT02207556|12450281|FG001|COMPLETED|Overall Study||20
11256116|NCT02207556|12450280|FG000|NOT COMPLETED|Overall Study||2
11256117|NCT02207556|12450281|FG001|NOT COMPLETED|Overall Study||5
11339765|NCT02918266|12537333|FG007|STARTED|Part 2: Intervention Period 1 (2 Days)||1
11339766|NCT02918266|12537334|FG008|STARTED|Part 2: Intervention Period 1 (2 Days)||2
11339767|NCT02918266|12537335|FG009|STARTED|Part 2: Intervention Period 1 (2 Days)||1
11339768|NCT02918266|12537336|FG010|STARTED|Part 2: Intervention Period 1 (2 Days)||1
11339769|NCT02918266|12537326|FG000|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
11339770|NCT02918266|12537327|FG001|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
11339771|NCT02918266|12537328|FG002|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
11339772|NCT02918266|12537329|FG003|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
11339773|NCT02918266|12537330|FG004|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
11339774|NCT02918266|12537331|FG005|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
11339775|NCT02918266|12537332|FG006|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
11339776|NCT02918266|12537333|FG007|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
11339777|NCT02918266|12537334|FG008|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
11339778|NCT02918266|12537335|FG009|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
11339779|NCT02918266|12537336|FG010|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
11339780|NCT02918266|12537326|FG000|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
11339781|NCT02918266|12537327|FG001|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
11339782|NCT02918266|12537328|FG002|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
11339783|NCT02918266|12537329|FG003|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
11339784|NCT02918266|12537330|FG004|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
11339785|NCT02918266|12537331|FG005|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
11339786|NCT02918266|12537332|FG006|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
11339787|NCT02918266|12537333|FG007|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
11339788|NCT02918266|12537334|FG008|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
11339789|NCT02918266|12537335|FG009|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
11339790|NCT02918266|12537336|FG010|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
11339791|NCT02918266|12537326|FG000|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
11339792|NCT02918266|12537327|FG001|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
11339793|NCT02918266|12537328|FG002|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
11339794|NCT02918266|12537329|FG003|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
11339795|NCT02918266|12537330|FG004|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
11339796|NCT02918266|12537331|FG005|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
11339797|NCT02918266|12537332|FG006|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
11339798|NCT02918266|12537333|FG007|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
11339799|NCT02918266|12537334|FG008|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
11339800|NCT02918266|12537335|FG009|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
11339801|NCT02918266|12537336|FG010|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
11339802|NCT02918266|12537326|FG000|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339803|NCT02918266|12537327|FG001|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339804|NCT02918266|12537328|FG002|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339805|NCT02918266|12537329|FG003|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339806|NCT02918266|12537330|FG004|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339807|NCT02918266|12537331|FG005|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339808|NCT02918266|12537332|FG006|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339809|NCT02918266|12537333|FG007|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339810|NCT02918266|12537334|FG008|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339811|NCT02918266|12537335|FG009|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11256118|NCT02207608|12450292|FG000|STARTED|Overall Study||15
11256119|NCT02207608|12450293|FG001|STARTED|Overall Study||15
11256120|NCT02207608|12450292|FG000|COMPLETED|Overall Study||14
11256121|NCT02207608|12450293|FG001|COMPLETED|Overall Study||15
11256122|NCT02207608|12450292|FG000|NOT COMPLETED|Overall Study||1
11256123|NCT02207608|12450293|FG001|NOT COMPLETED|Overall Study||0
11256124|NCT02207621|12450302|FG000|STARTED|Overall Study||251
11256125|NCT02207621|12450303|FG001|STARTED|Overall Study||251
11256126|NCT02207621|12450304|FG002|STARTED|Overall Study||254
11256127|NCT02207621|12450302|FG000|COMPLETED|Overall Study||146
11256128|NCT02207621|12450303|FG001|COMPLETED|Overall Study||204
11256129|NCT02207621|12450304|FG002|COMPLETED|Overall Study||86
11256130|NCT02207621|12450302|FG000|NOT COMPLETED|Overall Study||105
11256131|NCT02207621|12450303|FG001|NOT COMPLETED|Overall Study||47
11256132|NCT02207621|12450304|FG002|NOT COMPLETED|Overall Study||168
11256133|NCT02207634|12450315|FG000|STARTED|Overall Study||990
11256134|NCT02207634|12450316|FG001|STARTED|Overall Study||984
11256135|NCT02207634|12450315|FG000|Received Treatment|Overall Study||990
11256136|NCT02207634|12450316|FG001|Received Treatment|Overall Study||983
11256137|NCT02207634|12450315|FG000|COMPLETED|Overall Study||968
11005461|NCT00723021|12183142|FG001|NOT COMPLETED|Intervention Period 3||0
11005462|NCT00723021|12183143|FG002|NOT COMPLETED|Intervention Period 3||0
11005463|NCT00723021|12183144|FG003|NOT COMPLETED|Intervention Period 3||0
11256138|NCT02207634|12450316|FG001|COMPLETED|Overall Study||953
11256139|NCT02207634|12450315|FG000|NOT COMPLETED|Overall Study||22
11256140|NCT02207634|12450316|FG001|NOT COMPLETED|Overall Study||31
11256141|NCT02207725|12450326|FG000|STARTED|Overall Study||9
11256142|NCT02207725|12450327|FG001|STARTED|Overall Study||25
11256143|NCT02207725|12450328|FG002|STARTED|Overall Study||9
11256144|NCT02207725|12450329|FG003|STARTED|Overall Study||25
11256145|NCT02207725|12450326|FG000|COMPLETED|Overall Study||9
11256146|NCT02207725|12450327|FG001|COMPLETED|Overall Study||24
11256147|NCT02207725|12450328|FG002|COMPLETED|Overall Study||8
11256148|NCT02207725|12450329|FG003|COMPLETED|Overall Study||24
11256149|NCT02207725|12450326|FG000|NOT COMPLETED|Overall Study||0
11256150|NCT02207725|12450327|FG001|NOT COMPLETED|Overall Study||1
11256151|NCT02207725|12450328|FG002|NOT COMPLETED|Overall Study||1
11256152|NCT02207725|12450329|FG003|NOT COMPLETED|Overall Study||1
11256153|NCT02207803|12450343|FG000|STARTED|Overall Study||125
11256154|NCT02207803|12450344|FG001|STARTED|Overall Study||125
11256155|NCT02207803|12450343|FG000|COMPLETED|Overall Study||110
11256156|NCT02207803|12450344|FG001|COMPLETED|Overall Study||108
11256157|NCT02207803|12450343|FG000|NOT COMPLETED|Overall Study||15
11256158|NCT02207803|12450344|FG001|NOT COMPLETED|Overall Study||17
11256159|NCT02207816|12450353|FG000|STARTED|Overall Study||1046
11256160|NCT02207816|12450354|FG001|STARTED|Overall Study||1010
11256161|NCT02207816|12450355|FG002|STARTED|Overall Study||1028
11256162|NCT02207816|12450353|FG000|COMPLETED|Overall Study||995
11256163|NCT02207816|12450354|FG001|COMPLETED|Overall Study||924
11256164|NCT02207816|12450355|FG002|COMPLETED|Overall Study||961
11256165|NCT02207816|12450353|FG000|NOT COMPLETED|Overall Study||51
11256166|NCT02207816|12450354|FG001|NOT COMPLETED|Overall Study||86
11256167|NCT02207816|12450355|FG002|NOT COMPLETED|Overall Study||67
11256168|NCT02207829|12450368|FG000|STARTED|Overall Study||509
11256169|NCT02207829|12450369|FG001|STARTED|Overall Study||508
11256170|NCT02207829|12450368|FG000|COMPLETED|Overall Study||467
11256171|NCT02207829|12450369|FG001|COMPLETED|Overall Study||474
11256172|NCT02207829|12450368|FG000|NOT COMPLETED|Overall Study||42
11256173|NCT02207829|12450369|FG001|NOT COMPLETED|Overall Study||34
11256174|NCT02207907|12450377|FG000|STARTED|Overall Study||124
11256175|NCT02207907|12450378|FG001|STARTED|Overall Study||123
11256176|NCT02207907|12450377|FG000|COMPLETED|Overall Study||113
11256177|NCT02207907|12450378|FG001|COMPLETED|Overall Study||115
11256178|NCT02207907|12450377|FG000|NOT COMPLETED|Overall Study||11
11256179|NCT02207907|12450378|FG001|NOT COMPLETED|Overall Study||8
11256180|NCT02207946|12450387|FG000|STARTED|Overall Study||19
11256181|NCT02207946|12450388|FG001|STARTED|Overall Study||11
11256182|NCT02207946|12450387|FG000|COMPLETED|Overall Study||18
11256183|NCT02207946|12450388|FG001|COMPLETED|Overall Study||10
11256184|NCT02207946|12450387|FG000|NOT COMPLETED|Overall Study||1
11256185|NCT02207946|12450388|FG001|NOT COMPLETED|Overall Study||1
11256186|NCT02207972|12450397|FG000|STARTED|Overall Study||22
11256187|NCT02207972|12450398|FG001|STARTED|Overall Study||24
11256188|NCT02207972|12450397|FG000|COMPLETED|Overall Study||22
11256189|NCT02207972|12450398|FG001|COMPLETED|Overall Study||24
11256190|NCT02207972|12450397|FG000|NOT COMPLETED|Overall Study||0
11256191|NCT02207972|12450398|FG001|NOT COMPLETED|Overall Study||0
11256192|NCT02208037|12450408|FG000|STARTED|Overall Study||93
11256193|NCT02208037|12450409|FG001|STARTED|Overall Study||93
11256194|NCT02208037|12450410|FG002|STARTED|Overall Study||93
11256195|NCT02208037|12450408|FG000|COMPLETED|Overall Study||89
11256196|NCT02208037|12450409|FG001|COMPLETED|Overall Study||92
11256197|NCT02208037|12450410|FG002|COMPLETED|Overall Study||92
11256198|NCT02208037|12450408|FG000|NOT COMPLETED|Overall Study||4
11256199|NCT02208037|12450409|FG001|NOT COMPLETED|Overall Study||1
11256200|NCT02208037|12450410|FG002|NOT COMPLETED|Overall Study||1
11256201|NCT02208050|12450420|FG000|STARTED|Baseline Assessment Period: 2 Weeks||36
11256202|NCT02208050|12450421|FG001|STARTED|Baseline Assessment Period: 2 Weeks||28
11256203|NCT02208050|12450420|FG000|COMPLETED|Baseline Assessment Period: 2 Weeks||36
11256204|NCT02208050|12450421|FG001|COMPLETED|Baseline Assessment Period: 2 Weeks||28
11256205|NCT02208050|12450420|FG000|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
11256206|NCT02208050|12450421|FG001|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
11256207|NCT02208050|12450420|FG000|STARTED|Treatment Period 1: 8 Weeks Treatment||36
11256208|NCT02208050|12450421|FG001|STARTED|Treatment Period 1: 8 Weeks Treatment||28
11256209|NCT02208050|12450420|FG000|COMPLETED|Treatment Period 1: 8 Weeks Treatment||36
11256210|NCT02208050|12450421|FG001|COMPLETED|Treatment Period 1: 8 Weeks Treatment||28
11256211|NCT02208050|12450420|FG000|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
11256212|NCT02208050|12450421|FG001|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
11256213|NCT02208050|12450420|FG000|STARTED|Washout Period 1: 2 Weeks||36
11256214|NCT02208050|12450421|FG001|STARTED|Washout Period 1: 2 Weeks||28
11256215|NCT02208050|12450420|FG000|COMPLETED|Washout Period 1: 2 Weeks||35
11256216|NCT02208050|12450421|FG001|COMPLETED|Washout Period 1: 2 Weeks||28
11256217|NCT02208050|12450420|FG000|NOT COMPLETED|Washout Period 1: 2 Weeks||1
11256218|NCT02208050|12450421|FG001|NOT COMPLETED|Washout Period 1: 2 Weeks||0
11256219|NCT02208050|12450420|FG000|STARTED|Treatment Period 2: 8 Weeks Treatment||35
11256220|NCT02208050|12450421|FG001|STARTED|Treatment Period 2: 8 Weeks Treatment||28
11256221|NCT02208050|12450420|FG000|COMPLETED|Treatment Period 2: 8 Weeks Treatment||33
11256222|NCT02208050|12450421|FG001|COMPLETED|Treatment Period 2: 8 Weeks Treatment||28
11256223|NCT02208050|12450420|FG000|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||2
11256224|NCT02208050|12450421|FG001|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||0
11256225|NCT02208050|12450420|FG000|STARTED|Washout Period 2: 2 Weeks Washout.||33
11256226|NCT02208050|12450421|FG001|STARTED|Washout Period 2: 2 Weeks Washout.||28
11256227|NCT02208050|12450420|FG000|COMPLETED|Washout Period 2: 2 Weeks Washout.||33
11256228|NCT02208050|12450421|FG001|COMPLETED|Washout Period 2: 2 Weeks Washout.||28
11256229|NCT02208050|12450420|FG000|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
11256230|NCT02208050|12450421|FG001|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
11256231|NCT02208063|12450443|FG000|STARTED|Overall Study||60
11256232|NCT02208063|12450444|FG001|STARTED|Overall Study||61
11256233|NCT02208063|12450443|FG000|Randomized and Treated|Overall Study||58
11256234|NCT02208063|12450444|FG001|Randomized and Treated|Overall Study||60
11256235|NCT02208063|12450443|FG000|Microbiological All Treated|Overall Study||47
11256236|NCT02208063|12450444|FG001|Microbiological All Treated|Overall Study||52
11256237|NCT02208063|12450443|FG000|COMPLETED|Overall Study||48
11256238|NCT02208063|12450444|FG001|COMPLETED|Overall Study||50
11256239|NCT02208063|12450443|FG000|NOT COMPLETED|Overall Study||12
11256240|NCT02208063|12450444|FG001|NOT COMPLETED|Overall Study||11
11256241|NCT02208089|12450452|FG000|STARTED|Overall Study||47
11256242|NCT02208089|12450453|FG001|STARTED|Overall Study||47
11256243|NCT02208089|12450452|FG000|COMPLETED|Overall Study||40
11256244|NCT02208089|12450453|FG001|COMPLETED|Overall Study||47
11256245|NCT02208089|12450452|FG000|NOT COMPLETED|Overall Study||7
11256246|NCT02208089|12450453|FG001|NOT COMPLETED|Overall Study||0
11256247|NCT02208297|12450462|FG000|STARTED|Overall Study||163
11256248|NCT02208297|12450463|FG001|STARTED|Overall Study||163
11256249|NCT02208297|12450462|FG000|COMPLETED|Overall Study||141
11256250|NCT02208297|12450463|FG001|COMPLETED|Overall Study||107
11256251|NCT02208297|12450462|FG000|NOT COMPLETED|Overall Study||22
11256252|NCT02208297|12450463|FG001|NOT COMPLETED|Overall Study||56
11256253|NCT02208310|12450471|FG000|STARTED|Overall Study||6
11256254|NCT02208310|12450472|FG001|STARTED|Overall Study||5
11256255|NCT02208310|12450471|FG000|Day 180|Overall Study||0
11256256|NCT02208310|12450472|FG001|Day 180|Overall Study||1
11256257|NCT02208310|12450471|FG000|COMPLETED|Overall Study||0
11256258|NCT02208310|12450472|FG001|COMPLETED|Overall Study||0
11256259|NCT02208310|12450471|FG000|NOT COMPLETED|Overall Study||6
11256260|NCT02208310|12450472|FG001|NOT COMPLETED|Overall Study||5
11256261|NCT02208349|12450480|FG000|STARTED|Initial 6 Months||16
11256262|NCT02208349|12450481|FG001|STARTED|Initial 6 Months||9
11256263|NCT02208349|12450480|FG000|COMPLETED|Initial 6 Months||16
11256264|NCT02208349|12450481|FG001|COMPLETED|Initial 6 Months||9
11256265|NCT02208349|12450480|FG000|NOT COMPLETED|Initial 6 Months||0
11256266|NCT02208349|12450481|FG001|NOT COMPLETED|Initial 6 Months||0
11256267|NCT02208349|12450480|FG000|STARTED|Second 6 Months||11
11256268|NCT02208349|12450481|FG001|STARTED|Second 6 Months||7
11256269|NCT02208349|12450480|FG000|COMPLETED|Second 6 Months||11
11256270|NCT02208349|12450481|FG001|COMPLETED|Second 6 Months||7
11256271|NCT02208349|12450480|FG000|NOT COMPLETED|Second 6 Months||0
11256272|NCT02208349|12450481|FG001|NOT COMPLETED|Second 6 Months||0
11256273|NCT02208349|12450480|FG000|STARTED|Third 6 Month||6
11256274|NCT02208349|12450481|FG001|STARTED|Third 6 Month||3
11256275|NCT02208349|12450480|FG000|COMPLETED|Third 6 Month||6
11256276|NCT02208349|12450481|FG001|COMPLETED|Third 6 Month||3
11256277|NCT02208349|12450480|FG000|NOT COMPLETED|Third 6 Month||0
11256278|NCT02208349|12450481|FG001|NOT COMPLETED|Third 6 Month||0
11256279|NCT02208349|12450480|FG000|STARTED|Fourth 6 Month||14
11256280|NCT02208349|12450481|FG001|STARTED|Fourth 6 Month||2
11256281|NCT02208349|12450480|FG000|COMPLETED|Fourth 6 Month||14
11256282|NCT02208349|12450481|FG001|COMPLETED|Fourth 6 Month||2
11256283|NCT02208349|12450480|FG000|NOT COMPLETED|Fourth 6 Month||0
11256284|NCT02208349|12450481|FG001|NOT COMPLETED|Fourth 6 Month||0
11256285|NCT02208349|12450480|FG000|STARTED|Fifth 6 Month||7
11256286|NCT02208349|12450481|FG001|STARTED|Fifth 6 Month||2
11256287|NCT02208349|12450480|FG000|COMPLETED|Fifth 6 Month||7
11256288|NCT02208349|12450481|FG001|COMPLETED|Fifth 6 Month||2
11256289|NCT02208349|12450480|FG000|NOT COMPLETED|Fifth 6 Month||0
11256290|NCT02208349|12450481|FG001|NOT COMPLETED|Fifth 6 Month||0
11256291|NCT02208349|12450480|FG000|STARTED|Sixth 6 Month||3
11256292|NCT02208349|12450481|FG001|STARTED|Sixth 6 Month||2
11256293|NCT02208349|12450480|FG000|COMPLETED|Sixth 6 Month||3
11256294|NCT02208349|12450481|FG001|COMPLETED|Sixth 6 Month||2
11256295|NCT02208349|12450480|FG000|NOT COMPLETED|Sixth 6 Month||0
11256296|NCT02208349|12450481|FG001|NOT COMPLETED|Sixth 6 Month||0
11256297|NCT02208466|12450492|FG000|STARTED|Overall Study||9
11256298|NCT02208466|12450493|FG001|STARTED|Overall Study||10
11256299|NCT02208466|12450494|FG002|STARTED|Overall Study||8
11256300|NCT02208466|12450492|FG000|COMPLETED|Overall Study||9
11256301|NCT02208466|12450493|FG001|COMPLETED|Overall Study||10
11256302|NCT02208466|12450494|FG002|COMPLETED|Overall Study||8
11256303|NCT02208466|12450492|FG000|NOT COMPLETED|Overall Study||0
11256304|NCT02208466|12450493|FG001|NOT COMPLETED|Overall Study||0
11256305|NCT02208466|12450494|FG002|NOT COMPLETED|Overall Study||0
11256306|NCT02208843|12450502|FG000|STARTED|Overall Study||60
11256307|NCT02208843|12450502|FG000|COMPLETED|Overall Study||0
11256308|NCT02208843|12450502|FG000|NOT COMPLETED|Overall Study||60
11256309|NCT02208999|12450508|FG000|STARTED|Overall Study||106
11256310|NCT02208999|12450508|FG000|COMPLETED|Overall Study||105
11256311|NCT02208999|12450508|FG000|NOT COMPLETED|Overall Study||1
11256312|NCT02209064|12450527|FG000|STARTED|Overall Study||25
11256313|NCT02209064|12450527|FG000|COMPLETED|Overall Study||25
11256314|NCT02209064|12450527|FG000|NOT COMPLETED|Overall Study||0
11256315|NCT02209181|12450536|FG000|STARTED|Overall Study||67
11256316|NCT02209181|12450537|FG001|STARTED|Overall Study||67
11256317|NCT02209181|12450538|FG002|STARTED|Overall Study||69
11256318|NCT02209181|12450539|FG003|STARTED|Overall Study||66
11256319|NCT02209181|12450536|FG000|COMPLETED|Overall Study||66
11256320|NCT02209181|12450537|FG001|COMPLETED|Overall Study||66
11256321|NCT02209181|12450538|FG002|COMPLETED|Overall Study||68
11256322|NCT02209181|12450539|FG003|COMPLETED|Overall Study||66
11256323|NCT02209181|12450536|FG000|NOT COMPLETED|Overall Study||1
11256324|NCT02209181|12450537|FG001|NOT COMPLETED|Overall Study||1
11256325|NCT02209181|12450538|FG002|NOT COMPLETED|Overall Study||1
11256326|NCT02209181|12450539|FG003|NOT COMPLETED|Overall Study||0
11256327|NCT02209259|12450552|FG000|STARTED|Overall Study||56
11256328|NCT02209259|12450553|FG001|STARTED|Overall Study||56
11256329|NCT02209259|12450554|FG002|STARTED|Overall Study||56
11256330|NCT02209259|12450552|FG000|COMPLETED|Overall Study||56
11256331|NCT02209259|12450553|FG001|COMPLETED|Overall Study||56
11256332|NCT02209259|12450554|FG002|COMPLETED|Overall Study||56
11256333|NCT02209259|12450552|FG000|NOT COMPLETED|Overall Study||0
11256334|NCT02209259|12450553|FG001|NOT COMPLETED|Overall Study||0
11256335|NCT02209259|12450554|FG002|NOT COMPLETED|Overall Study||0
11256336|NCT02209272|12450564|FG000|STARTED|Overall Study||32
11256337|NCT02209272|12450565|FG001|STARTED|Overall Study||36
11256338|NCT02209272|12450564|FG000|COMPLETED|Overall Study||32
11256339|NCT02209272|12450565|FG001|COMPLETED|Overall Study||36
11256340|NCT02209272|12450564|FG000|NOT COMPLETED|Overall Study||0
11256341|NCT02209272|12450565|FG001|NOT COMPLETED|Overall Study||0
11256342|NCT02209454|12450571|FG000|STARTED|First Period||13
11256343|NCT02209454|12450572|FG001|STARTED|First Period||13
11256344|NCT02209454|12450571|FG000|COMPLETED|First Period||13
11256345|NCT02209454|12450572|FG001|COMPLETED|First Period||13
11256346|NCT02209454|12450571|FG000|NOT COMPLETED|First Period||0
11256347|NCT02209454|12450572|FG001|NOT COMPLETED|First Period||0
11256348|NCT02209454|12450571|FG000|STARTED|Washout Period a Minimum of a 7 Day||13
11256349|NCT02209454|12450572|FG001|STARTED|Washout Period a Minimum of a 7 Day||13
11256350|NCT02209454|12450571|FG000|COMPLETED|Washout Period a Minimum of a 7 Day||13
11256351|NCT02209454|12450572|FG001|COMPLETED|Washout Period a Minimum of a 7 Day||13
11256352|NCT02209454|12450571|FG000|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
11256353|NCT02209454|12450572|FG001|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
11256354|NCT02209454|12450571|FG000|STARTED|Second Period||13
11256355|NCT02209454|12450572|FG001|STARTED|Second Period||13
11256356|NCT02209454|12450571|FG000|COMPLETED|Second Period||12
11256357|NCT02209454|12450572|FG001|COMPLETED|Second Period||13
11256358|NCT02209454|12450571|FG000|NOT COMPLETED|Second Period||1
11256359|NCT02209454|12450572|FG001|NOT COMPLETED|Second Period||0
11256360|NCT02209506|12450583|FG000|STARTED|Overall Study||3
11256361|NCT02209506|12450584|FG001|STARTED|Overall Study||6
11256362|NCT02209506|12450585|FG002|STARTED|Overall Study||6
11256363|NCT02209506|12450586|FG003|STARTED|Overall Study||2
11256364|NCT02209506|12450587|FG004|STARTED|Overall Study||6
11256365|NCT02209506|12450583|FG000|COMPLETED|Overall Study||3
11256366|NCT02209506|12450584|FG001|COMPLETED|Overall Study||6
11256367|NCT02209506|12450585|FG002|COMPLETED|Overall Study||6
11256368|NCT02209506|12450586|FG003|COMPLETED|Overall Study||2
11256369|NCT02209506|12450587|FG004|COMPLETED|Overall Study||5
11256370|NCT02209506|12450583|FG000|NOT COMPLETED|Overall Study||0
11256371|NCT02209506|12450584|FG001|NOT COMPLETED|Overall Study||0
11256372|NCT02209506|12450585|FG002|NOT COMPLETED|Overall Study||0
11256373|NCT02209506|12450586|FG003|NOT COMPLETED|Overall Study||0
11256374|NCT02209506|12450587|FG004|NOT COMPLETED|Overall Study||1
11256375|NCT02209519|12450604|FG000|STARTED|Overall Study||107
11256376|NCT02209519|12450605|FG001|STARTED|Overall Study||107
11256377|NCT02209519|12450604|FG000|COMPLETED|Overall Study||107
11256378|NCT02209519|12450605|FG001|COMPLETED|Overall Study||107
11256379|NCT02209519|12450604|FG000|NOT COMPLETED|Overall Study||0
11256380|NCT02209519|12450605|FG001|NOT COMPLETED|Overall Study||0
11256381|NCT02209532|12450614|FG000|STARTED|Overall Study||90
11256382|NCT02209532|12450615|FG001|STARTED|Overall Study||90
11256383|NCT02209532|12450614|FG000|COMPLETED|Overall Study||87
11256384|NCT02209532|12450615|FG001|COMPLETED|Overall Study||89
11256385|NCT02209532|12450614|FG000|NOT COMPLETED|Overall Study||3
11256386|NCT02209532|12450615|FG001|NOT COMPLETED|Overall Study||1
11256387|NCT02209597|12450622|FG000|STARTED|Phase 1 Current Tx (Non-randomized)||74
11256388|NCT02209597|12450622|FG000|COMPLETED|Phase 1 Current Tx (Non-randomized)||71
11256389|NCT02209597|12450622|FG000|NOT COMPLETED|Phase 1 Current Tx (Non-randomized)||3
11256390|NCT02209597|12450622|FG000|STARTED|Phase 2 (Randomized: 1 Brand, 3 Generic)||71
11256391|NCT02209597|12450622|FG000|COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||67
11256392|NCT02209597|12450622|FG000|NOT COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||4
11256393|NCT02209597|12450622|FG000|STARTED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
11256394|NCT02209597|12450622|FG000|COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
11256395|NCT02209597|12450622|FG000|NOT COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||0
11256396|NCT02209597|12450622|FG000|STARTED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
11256397|NCT02209597|12450622|FG000|COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
11256398|NCT02209597|12450622|FG000|NOT COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||0
11256399|NCT02209610|12450634|FG000|STARTED|Overall Study||16
11256400|NCT02209610|12450635|FG001|STARTED|Overall Study||16
11256401|NCT02209610|12450634|FG000|COMPLETED|Overall Study||16
11256402|NCT02209610|12450635|FG001|COMPLETED|Overall Study||16
11256403|NCT02209610|12450634|FG000|NOT COMPLETED|Overall Study||0
11256404|NCT02209610|12450635|FG001|NOT COMPLETED|Overall Study||0
11256405|NCT02209766|12450646|FG000|STARTED|Overall Study||6
11256406|NCT02209766|12450647|FG001|STARTED|Overall Study||3
11256407|NCT02209766|12450648|FG002|STARTED|Overall Study||6
11256408|NCT02209766|12450649|FG003|STARTED|Overall Study||3
11256409|NCT02209766|12450650|FG004|STARTED|Overall Study||6
11256410|NCT02209766|12450646|FG000|COMPLETED|Overall Study||6
11256411|NCT02209766|12450647|FG001|COMPLETED|Overall Study||3
11256412|NCT02209766|12450648|FG002|COMPLETED|Overall Study||6
11256413|NCT02209766|12450649|FG003|COMPLETED|Overall Study||2
11256414|NCT02209766|12450650|FG004|COMPLETED|Overall Study||6
11256415|NCT02209766|12450646|FG000|NOT COMPLETED|Overall Study||0
11256416|NCT02209766|12450647|FG001|NOT COMPLETED|Overall Study||0
11256417|NCT02209766|12450648|FG002|NOT COMPLETED|Overall Study||0
11256418|NCT02209766|12450649|FG003|NOT COMPLETED|Overall Study||1
11256419|NCT02209766|12450650|FG004|NOT COMPLETED|Overall Study||0
11256420|NCT02209948|12450662|FG000|STARTED|Overall Study||80
11256421|NCT02209948|12450663|FG001|STARTED|Overall Study||79
11256422|NCT02209948|12450662|FG000|Recieved Alocated Intervention|Overall Study||80
11256423|NCT02209948|12450663|FG001|Recieved Alocated Intervention|Overall Study||79
11256424|NCT02209948|12450662|FG000|Lost to Follow up|Overall Study||0
11256425|NCT02209948|12450663|FG001|Lost to Follow up|Overall Study||1
11256426|NCT02209948|12450662|FG000|Discontinued Due to Progression|Overall Study||31
11256427|NCT02209948|12450663|FG001|Discontinued Due to Progression|Overall Study||39
11256428|NCT02209948|12450662|FG000|COMPLETED|Overall Study||80
11256429|NCT02209948|12450663|FG001|COMPLETED|Overall Study||79
11256430|NCT02209948|12450662|FG000|NOT COMPLETED|Overall Study||0
11256431|NCT02209948|12450663|FG001|NOT COMPLETED|Overall Study||0
11256432|NCT02210000|12450671|FG000|STARTED|Overall Study||57
11256433|NCT02210000|12450672|FG001|STARTED|Overall Study||57
11256434|NCT02210000|12450671|FG000|COMPLETED|Overall Study||38
11256435|NCT02210000|12450672|FG001|COMPLETED|Overall Study||36
11256436|NCT02210000|12450671|FG000|NOT COMPLETED|Overall Study||19
11256437|NCT02210000|12450672|FG001|NOT COMPLETED|Overall Study||21
11256438|NCT02210039|12450678|FG000|STARTED|Overall Study||6
11256439|NCT02210039|12450678|FG000|COMPLETED|Overall Study||6
11256440|NCT02210039|12450678|FG000|NOT COMPLETED|Overall Study||0
11256441|NCT02210052|12450682|FG000|STARTED|Overall Study||6
11256442|NCT02210052|12450682|FG000|COMPLETED|Overall Study||6
11256443|NCT02210052|12450682|FG000|NOT COMPLETED|Overall Study||0
11256444|NCT02210065|12450686|FG000|STARTED|Overall Study||1
11256445|NCT02210065|12450686|FG000|COMPLETED|Overall Study||1
11256446|NCT02210065|12450686|FG000|NOT COMPLETED|Overall Study||0
11256447|NCT02210091|12450692|FG000|STARTED|Overall Study||32
11256448|NCT02210091|12450693|FG001|STARTED|Overall Study||34
11256449|NCT02210091|12450692|FG000|COMPLETED|Overall Study||32
11256450|NCT02210091|12450693|FG001|COMPLETED|Overall Study||32
11256451|NCT02210091|12450692|FG000|NOT COMPLETED|Overall Study||0
11256452|NCT02210091|12450693|FG001|NOT COMPLETED|Overall Study||2
11256453|NCT02210195|12450717|FG000|STARTED|Overall Study||10
11256454|NCT02210195|12450718|FG001|STARTED|Overall Study||10
11256455|NCT02210195|12450717|FG000|COMPLETED|Overall Study||6
11256456|NCT02210195|12450718|FG001|COMPLETED|Overall Study||10
11256457|NCT02210195|12450717|FG000|NOT COMPLETED|Overall Study||4
11256458|NCT02210195|12450718|FG001|NOT COMPLETED|Overall Study||0
11256459|NCT02210208|12450724|FG000|STARTED|Period A (Graft Site)||25
11256460|NCT02210208|12450724|FG000|COMPLETED|Period A (Graft Site)||23
11256461|NCT02210208|12450724|FG000|NOT COMPLETED|Period A (Graft Site)||2
11256462|NCT02210208|12450724|FG000|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
11256463|NCT02210208|12450724|FG000|COMPLETED|Period B (Donor Site)||12
11256464|NCT02210208|12450724|FG000|NOT COMPLETED|Period B (Donor Site)||7
11256465|NCT02210221|12450730|FG000|STARTED|Overall Study||4559
11256466|NCT02210221|12450730|FG000|COMPLETED|Overall Study||4509
11256467|NCT02210221|12450730|FG000|NOT COMPLETED|Overall Study||50
11256468|NCT02210247|12450744|FG000|STARTED|Overall Study||12
11256469|NCT02210247|12450745|FG001|STARTED|Overall Study||12
11256470|NCT02210247|12450746|FG002|STARTED|Overall Study||12
11256471|NCT02210247|12450747|FG003|STARTED|Overall Study||12
11256472|NCT02210247|12450748|FG004|STARTED|Overall Study||12
11256473|NCT02210247|12450744|FG000|COMPLETED|Overall Study||12
11256474|NCT02210247|12450745|FG001|COMPLETED|Overall Study||12
11256475|NCT02210247|12450746|FG002|COMPLETED|Overall Study||12
11256476|NCT02210247|12450747|FG003|COMPLETED|Overall Study||12
11256477|NCT02210247|12450748|FG004|COMPLETED|Overall Study||12
11256478|NCT02210247|12450744|FG000|NOT COMPLETED|Overall Study||0
11256479|NCT02210247|12450745|FG001|NOT COMPLETED|Overall Study||0
11256480|NCT02210247|12450746|FG002|NOT COMPLETED|Overall Study||0
11256481|NCT02210247|12450747|FG003|NOT COMPLETED|Overall Study||0
11256482|NCT02210247|12450748|FG004|NOT COMPLETED|Overall Study||0
11256483|NCT02210286|12450765|FG000|STARTED|Overall Study||17
11256484|NCT02210286|12450765|FG000|COMPLETED|Overall Study||15
11256485|NCT02210286|12450765|FG000|NOT COMPLETED|Overall Study||2
11256486|NCT02210689|12450776|FG000|STARTED|Overall Study||242
11256487|NCT02210689|12450777|FG001|STARTED|Overall Study||240
11256488|NCT02210689|12450778|FG002|STARTED|Overall Study||122
11256489|NCT02210689|12450776|FG000|Safety Population|Overall Study||233
11256490|NCT02210689|12450777|FG001|Safety Population|Overall Study||236
11256491|NCT02210689|12450778|FG002|Safety Population|Overall Study||122
11256492|NCT02210689|12450776|FG000|mITT Population|Overall Study||199
11256493|NCT02210689|12450777|FG001|mITT Population|Overall Study||207
11256494|NCT02210689|12450778|FG002|mITT Population|Overall Study||107
11256495|NCT02210689|12450776|FG000|PP Population|Overall Study||164
11256496|NCT02210689|12450777|FG001|PP Population|Overall Study||169
11256497|NCT02210689|12450778|FG002|PP Population|Overall Study||84
11256498|NCT02210689|12450776|FG000|COMPLETED|Overall Study||190
11256499|NCT02210689|12450777|FG001|COMPLETED|Overall Study||193
11256500|NCT02210689|12450778|FG002|COMPLETED|Overall Study||99
11256501|NCT02210689|12450776|FG000|NOT COMPLETED|Overall Study||52
11256502|NCT02210689|12450777|FG001|NOT COMPLETED|Overall Study||47
11256503|NCT02210689|12450778|FG002|NOT COMPLETED|Overall Study||23
11256504|NCT02210780|12450788|FG000|STARTED|Overall Study||97
11256505|NCT02210780|12450789|FG001|STARTED|Overall Study||97
11256506|NCT02210780|12450788|FG000|COMPLETED|Overall Study||92
11256507|NCT02210780|12450789|FG001|COMPLETED|Overall Study||89
11256508|NCT02210780|12450788|FG000|NOT COMPLETED|Overall Study||5
11256509|NCT02210780|12450789|FG001|NOT COMPLETED|Overall Study||8
11256510|NCT02211014|12450797|FG000|STARTED|Overall Study||13
11256511|NCT02211014|12450798|FG001|STARTED|Overall Study||14
11256512|NCT02211014|12450797|FG000|COMPLETED|Overall Study||11
11256513|NCT02211014|12450798|FG001|COMPLETED|Overall Study||8
11256514|NCT02211014|12450797|FG000|NOT COMPLETED|Overall Study||2
11256515|NCT02211014|12450798|FG001|NOT COMPLETED|Overall Study||6
11256516|NCT02211261|12450831|FG000|STARTED|Overall Study||9
11256517|NCT02211261|12450832|FG001|STARTED|Overall Study||6
11256518|NCT02211261|12450833|FG002|STARTED|Overall Study||6
11256519|NCT02211261|12450834|FG003|STARTED|Overall Study||6
11256520|NCT02211261|12450835|FG004|STARTED|Overall Study||9
11256521|NCT02211261|12450836|FG005|STARTED|Overall Study||2
11256522|NCT02211261|12450837|FG006|STARTED|Overall Study||6
11256523|NCT02211261|12450838|FG007|STARTED|Overall Study||8
11256524|NCT02211261|12450839|FG008|STARTED|Overall Study||8
11256525|NCT02211261|12450840|FG009|STARTED|Overall Study||16
11256526|NCT02211261|12450841|FG010|STARTED|Overall Study||8
11256527|NCT02211261|12450831|FG000|COMPLETED|Overall Study||9
11256528|NCT02211261|12450832|FG001|COMPLETED|Overall Study||6
11256529|NCT02211261|12450833|FG002|COMPLETED|Overall Study||5
11256530|NCT02211261|12450834|FG003|COMPLETED|Overall Study||6
11256531|NCT02211261|12450835|FG004|COMPLETED|Overall Study||7
11256532|NCT02211261|12450836|FG005|COMPLETED|Overall Study||1
11256533|NCT02211261|12450837|FG006|COMPLETED|Overall Study||6
11256534|NCT02211261|12450838|FG007|COMPLETED|Overall Study||7
11256535|NCT02211261|12450839|FG008|COMPLETED|Overall Study||8
11256536|NCT02211261|12450840|FG009|COMPLETED|Overall Study||14
11256537|NCT02211261|12450841|FG010|COMPLETED|Overall Study||8
11256538|NCT02211261|12450831|FG000|NOT COMPLETED|Overall Study||0
11256539|NCT02211261|12450832|FG001|NOT COMPLETED|Overall Study||0
11256540|NCT02211261|12450833|FG002|NOT COMPLETED|Overall Study||1
11256541|NCT02211261|12450834|FG003|NOT COMPLETED|Overall Study||0
11256542|NCT02211261|12450835|FG004|NOT COMPLETED|Overall Study||2
11256543|NCT02211261|12450836|FG005|NOT COMPLETED|Overall Study||1
11256544|NCT02211261|12450837|FG006|NOT COMPLETED|Overall Study||0
11358764|NCT03131167|12555946|FG006|STARTED|Overall Study||5
11358765|NCT03131167|12555947|FG007|STARTED|Overall Study||5
11358766|NCT03131167|12555948|FG008|STARTED|Overall Study||2
11358767|NCT03131167|12555949|FG009|STARTED|Overall Study||5
11358768|NCT03131167|12555950|FG010|STARTED|Overall Study||4
11358769|NCT03131167|12555951|FG011|STARTED|Overall Study||5
11358770|NCT03131167|12555952|FG012|STARTED|Overall Study||5
11358771|NCT03131167|12555940|FG000|COMPLETED|Overall Study||6
11358772|NCT03131167|12555941|FG001|COMPLETED|Overall Study||5
11358773|NCT03131167|12555942|FG002|COMPLETED|Overall Study||5
11358774|NCT03131167|12555943|FG003|COMPLETED|Overall Study||5
11358775|NCT03131167|12555944|FG004|COMPLETED|Overall Study||6
11358776|NCT03131167|12555945|FG005|COMPLETED|Overall Study||4
11358777|NCT03131167|12555946|FG006|COMPLETED|Overall Study||5
11256545|NCT02211261|12450838|FG007|NOT COMPLETED|Overall Study||1
11256546|NCT02211261|12450839|FG008|NOT COMPLETED|Overall Study||0
11256547|NCT02211261|12450840|FG009|NOT COMPLETED|Overall Study||2
11256548|NCT02211261|12450841|FG010|NOT COMPLETED|Overall Study||0
11256549|NCT02211313|12450876|FG000|STARTED|Overall Study||18
11256550|NCT02211313|12450877|FG001|STARTED|Overall Study||23
11256551|NCT02211313|12450876|FG000|COMPLETED|Overall Study||12
11256552|NCT02211313|12450877|FG001|COMPLETED|Overall Study||20
11256553|NCT02211313|12450876|FG000|NOT COMPLETED|Overall Study||6
11256554|NCT02211313|12450877|FG001|NOT COMPLETED|Overall Study||3
11256555|NCT02211456|12450883|FG000|STARTED|Overall Study||15
11256556|NCT02211456|12450883|FG000|COMPLETED|Overall Study||15
11256557|NCT02211456|12450883|FG000|NOT COMPLETED|Overall Study||0
11256558|NCT02211495|12450889|FG000|STARTED|Overall Study||4
11256559|NCT02211495|12450890|FG001|STARTED|Overall Study||4
11256560|NCT02211495|12450889|FG000|COMPLETED|Overall Study||4
11256561|NCT02211495|12450890|FG001|COMPLETED|Overall Study||4
11256562|NCT02211495|12450889|FG000|NOT COMPLETED|Overall Study||0
11256563|NCT02211495|12450890|FG001|NOT COMPLETED|Overall Study||0
11256564|NCT02211534|12450902|FG000|STARTED|Overall Study||24
11256565|NCT02211534|12450903|FG001|STARTED|Overall Study||11
11256566|NCT02211534|12450902|FG000|COMPLETED|Overall Study||11
11256567|NCT02211534|12450903|FG001|COMPLETED|Overall Study||6
11256568|NCT02211534|12450902|FG000|NOT COMPLETED|Overall Study||13
11256569|NCT02211534|12450903|FG001|NOT COMPLETED|Overall Study||5
11256570|NCT02211638|12450909|FG000|STARTED|Overall Study||18113
11256571|NCT02211638|12450909|FG000|COMPLETED|Overall Study||17130
11256572|NCT02211638|12450909|FG000|NOT COMPLETED|Overall Study||983
11256573|NCT02212028|12450915|FG000|STARTED|Overall Study||26
11256574|NCT02212028|12450916|FG001|STARTED|Overall Study||26
11256575|NCT02212028|12450915|FG000|COMPLETED|Overall Study||26
11256576|NCT02212028|12450916|FG001|COMPLETED|Overall Study||26
11256577|NCT02212028|12450915|FG000|NOT COMPLETED|Overall Study||0
11256578|NCT02212028|12450916|FG001|NOT COMPLETED|Overall Study||0
11256579|NCT02212106|12450924|FG000|STARTED|Overall Study||302
11256580|NCT02212106|12450925|FG001|STARTED|Overall Study||100
11256581|NCT02212106|12450924|FG000|COMPLETED|Overall Study||292
11256582|NCT02212106|12450925|FG001|COMPLETED|Overall Study||96
11256583|NCT02212106|12450924|FG000|NOT COMPLETED|Overall Study||10
11256584|NCT02212106|12450925|FG001|NOT COMPLETED|Overall Study||4
11256585|NCT02212197|12450935|FG000|STARTED|Overall Study||19
11256586|NCT02212197|12450936|FG001|STARTED|Overall Study||15
11256587|NCT02212197|12450937|FG002|STARTED|Overall Study||17
11256588|NCT02212197|12450935|FG000|COMPLETED|Overall Study||18
11256589|NCT02212197|12450936|FG001|COMPLETED|Overall Study||15
11256590|NCT02212197|12450937|FG002|COMPLETED|Overall Study||17
11256591|NCT02212197|12450935|FG000|NOT COMPLETED|Overall Study||1
11256592|NCT02212197|12450936|FG001|NOT COMPLETED|Overall Study||0
11256593|NCT02212197|12450937|FG002|NOT COMPLETED|Overall Study||0
11256594|NCT02212301|12450945|FG000|STARTED|Period 1||21
11256595|NCT02212301|12450946|FG001|STARTED|Period 1||22
11256596|NCT02212301|12450945|FG000|COMPLETED|Period 1||21
11256597|NCT02212301|12450946|FG001|COMPLETED|Period 1||21
11256598|NCT02212301|12450945|FG000|NOT COMPLETED|Period 1||0
11256599|NCT02212301|12450946|FG001|NOT COMPLETED|Period 1||1
11256600|NCT02212301|12450945|FG000|STARTED|Period 2||21
11256601|NCT02212301|12450946|FG001|STARTED|Period 2||21
11256602|NCT02212301|12450945|FG000|COMPLETED|Period 2||21
11256603|NCT02212301|12450946|FG001|COMPLETED|Period 2||21
11256604|NCT02212301|12450945|FG000|NOT COMPLETED|Period 2||0
11256605|NCT02212301|12450946|FG001|NOT COMPLETED|Period 2||0
11256606|NCT02212379|12450953|FG000|STARTED|From Baseline to Week 48||165
11256607|NCT02212379|12450953|FG000|COMPLETED|From Baseline to Week 48||156
11256608|NCT02212379|12450953|FG000|NOT COMPLETED|From Baseline to Week 48||9
11256609|NCT02212379|12450953|FG000|STARTED|From Week 48 to Week 96||156
11256610|NCT02212379|12450953|FG000|COMPLETED|From Week 48 to Week 96||152
11256611|NCT02212379|12450953|FG000|NOT COMPLETED|From Week 48 to Week 96||4
11256612|NCT02212457|12450966|FG000|STARTED|Overall Study||228
11256613|NCT02212457|12450967|FG001|STARTED|Overall Study||232
11256614|NCT02212457|12450968|FG002|STARTED|Overall Study||157
11256615|NCT02212457|12450969|FG003|STARTED|Overall Study||134
11256616|NCT02212457|12450970|FG004|STARTED|Overall Study||152
11256617|NCT02212457|12450971|FG005|STARTED|Overall Study||160
11256618|NCT02212457|12450966|FG000|COMPLETED|Overall Study||209
11256619|NCT02212457|12450967|FG001|COMPLETED|Overall Study||211
11256620|NCT02212457|12450968|FG002|COMPLETED|Overall Study||141
11256621|NCT02212457|12450969|FG003|COMPLETED|Overall Study||123
11256622|NCT02212457|12450970|FG004|COMPLETED|Overall Study||137
11256623|NCT02212457|12450971|FG005|COMPLETED|Overall Study||147
11256624|NCT02212457|12450966|FG000|NOT COMPLETED|Overall Study||19
11256625|NCT02212457|12450967|FG001|NOT COMPLETED|Overall Study||21
11256626|NCT02212457|12450968|FG002|NOT COMPLETED|Overall Study||16
11256627|NCT02212457|12450969|FG003|NOT COMPLETED|Overall Study||11
11256628|NCT02212457|12450970|FG004|NOT COMPLETED|Overall Study||15
11256629|NCT02212457|12450971|FG005|NOT COMPLETED|Overall Study||13
11256630|NCT02212587|12450992|FG000|STARTED|Overall Study||10
11256631|NCT02212587|12450992|FG000|COMPLETED|Overall Study||9
11256632|NCT02212587|12450992|FG000|NOT COMPLETED|Overall Study||1
11256633|NCT02212678|12450996|FG000|STARTED|Overall Study||8
11256634|NCT02212678|12450996|FG000|COMPLETED|Overall Study||7
11256635|NCT02212678|12450996|FG000|NOT COMPLETED|Overall Study||1
11256636|NCT02212730|12451002|FG000|STARTED|Overall Study||6
11256637|NCT02212730|12451003|FG001|STARTED|Overall Study||4
11256638|NCT02212730|12451002|FG000|Received Neoadjuvant Pembrolizumab|Overall Study||4
11256639|NCT02212730|12451003|FG001|Received Neoadjuvant Pembrolizumab|Overall Study||0
11256640|NCT02212730|12451002|FG000|Underwent RCC|Overall Study||4
11256641|NCT02212730|12451003|FG001|Underwent RCC|Overall Study||3
11256642|NCT02212730|12451002|FG000|Received Post-RCC Pembrolizumab|Overall Study||1
11256643|NCT02212730|12451003|FG001|Received Post-RCC Pembrolizumab|Overall Study||1
11256644|NCT02212730|12451002|FG000|COMPLETED|Overall Study||4
11256645|NCT02212730|12451003|FG001|COMPLETED|Overall Study||3
11256646|NCT02212730|12451002|FG000|NOT COMPLETED|Overall Study||2
11256647|NCT02212730|12451003|FG001|NOT COMPLETED|Overall Study||1
11256648|NCT02212834|12451013|FG000|STARTED|Overall Study||33938
11256649|NCT02212834|12451014|FG001|STARTED|Overall Study||2506
11256650|NCT02212834|12451013|FG000|COMPLETED|Overall Study||33938
11256651|NCT02212834|12451014|FG001|COMPLETED|Overall Study||2506
11256652|NCT02212834|12451013|FG000|NOT COMPLETED|Overall Study||0
11256653|NCT02212834|12451014|FG001|NOT COMPLETED|Overall Study||0
11256654|NCT02212977|12451022|FG000|STARTED|Overall Study||55
11256655|NCT02212977|12451023|FG001|STARTED|Overall Study||54
11256656|NCT02212977|12451022|FG000|COMPLETED|Overall Study||50
11256657|NCT02212977|12451023|FG001|COMPLETED|Overall Study||48
11256658|NCT02212977|12451022|FG000|NOT COMPLETED|Overall Study||5
11256659|NCT02212977|12451023|FG001|NOT COMPLETED|Overall Study||6
11256660|NCT02213042|12451032|FG000|STARTED|Overall Study||17
11256661|NCT02213042|12451033|FG001|STARTED|Overall Study||15
11256662|NCT02213042|12451034|FG002|STARTED|Overall Study||10
11256663|NCT02213042|12451032|FG000|Total Deaths|Overall Study||11
11256664|NCT02213042|12451033|FG001|Total Deaths|Overall Study||9
11256665|NCT02213042|12451034|FG002|Total Deaths|Overall Study||6
11256666|NCT02213042|12451032|FG000|COMPLETED|Overall Study||0
11256667|NCT02213042|12451033|FG001|COMPLETED|Overall Study||0
11256668|NCT02213042|12451034|FG002|COMPLETED|Overall Study||0
11256669|NCT02213042|12451032|FG000|NOT COMPLETED|Overall Study||17
11256670|NCT02213042|12451033|FG001|NOT COMPLETED|Overall Study||15
11256671|NCT02213042|12451034|FG002|NOT COMPLETED|Overall Study||10
11256672|NCT02213055|12451046|FG000|STARTED|Overall Study||97
11256673|NCT02213055|12451047|FG001|STARTED|Overall Study||0
11256674|NCT02213055|12451046|FG000|COMPLETED|Overall Study||58
11256675|NCT02213055|12451047|FG001|COMPLETED|Overall Study||0
11256676|NCT02213055|12451046|FG000|NOT COMPLETED|Overall Study||39
11256677|NCT02213055|12451047|FG001|NOT COMPLETED|Overall Study||0
11256678|NCT02213094|12451055|FG000|STARTED|Overall Study||5
11256679|NCT02213094|12451056|FG001|STARTED|Overall Study||5
11256680|NCT02213094|12451055|FG000|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
11256681|NCT02213094|12451056|FG001|COMPLETED|Overall Study||5
11256682|NCT02213094|12451055|FG000|NOT COMPLETED|Overall Study||1
11256683|NCT02213094|12451056|FG001|NOT COMPLETED|Overall Study||0
11256684|NCT02213133|12451065|FG000|STARTED|Overall Study||37
11256685|NCT02213133|12451066|FG001|STARTED|Overall Study||5
11256686|NCT02213133|12451067|FG002|STARTED|Overall Study||3
11256687|NCT02213133|12451065|FG000|Treated|Overall Study||33
11256688|NCT02213133|12451066|FG001|Treated|Overall Study||4
11256689|NCT02213133|12451067|FG002|Treated|Overall Study||1
11256690|NCT02213133|12451065|FG000|COMPLETED|Overall Study||0
11256691|NCT02213133|12451066|FG001|COMPLETED|Overall Study||0
11256692|NCT02213133|12451067|FG002|COMPLETED|Overall Study||0
11256693|NCT02213133|12451065|FG000|NOT COMPLETED|Overall Study||37
11256694|NCT02213133|12451066|FG001|NOT COMPLETED|Overall Study||5
11256695|NCT02213133|12451067|FG002|NOT COMPLETED|Overall Study||3
11256696|NCT02213198|12451078|FG000|STARTED|Baseline||306
11256697|NCT02213198|12451079|FG001|STARTED|Baseline||159
11256698|NCT02213198|12451078|FG000|COMPLETED|Baseline||218
11256699|NCT02213198|12451079|FG001|COMPLETED|Baseline||108
11256700|NCT02213198|12451078|FG000|NOT COMPLETED|Baseline||88
11256701|NCT02213198|12451079|FG001|NOT COMPLETED|Baseline||51
11256702|NCT02213198|12451078|FG000|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
11256703|NCT02213198|12451079|FG001|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
11256704|NCT02213198|12451078|FG000|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
11256705|NCT02213198|12451079|FG001|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
11256706|NCT02213198|12451078|FG000|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
11256707|NCT02213198|12451079|FG001|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
11256708|NCT02213198|12451078|FG000|STARTED|Follow up 2 6 Months Post TCC Treatment||125
11256709|NCT02213198|12451079|FG001|STARTED|Follow up 2 6 Months Post TCC Treatment||67
11256710|NCT02213198|12451078|FG000|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
11256711|NCT02213198|12451079|FG001|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
11256712|NCT02213198|12451078|FG000|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
11256713|NCT02213198|12451079|FG001|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
11256714|NCT02213250|12451085|FG000|STARTED|Overall Study||4
11256715|NCT02213250|12451086|FG001|STARTED|Overall Study||8
11256716|NCT02213250|12451085|FG000|COMPLETED|Overall Study||4
11256717|NCT02213250|12451086|FG001|COMPLETED|Overall Study||8
11256718|NCT02213250|12451085|FG000|NOT COMPLETED|Overall Study||0
11256719|NCT02213250|12451086|FG001|NOT COMPLETED|Overall Study||0
11256720|NCT02213263|12451095|FG000|STARTED|Overall Study||198
11256721|NCT02213263|12451096|FG001|STARTED|Overall Study||196
11256722|NCT02213263|12451095|FG000|Treated|Overall Study||197
11256723|NCT02213263|12451096|FG001|Treated|Overall Study||196
11256724|NCT02213263|12451095|FG000|COMPLETED|Overall Study||170
11256725|NCT02213263|12451096|FG001|COMPLETED|Overall Study||170
11256726|NCT02213263|12451095|FG000|NOT COMPLETED|Overall Study||28
11256727|NCT02213263|12451096|FG001|NOT COMPLETED|Overall Study||26
11256728|NCT02213289|12451104|FG000|STARTED|Overall Study||68
11256729|NCT02213289|12451105|FG001|STARTED|Overall Study||12
11256730|NCT02213289|12451104|FG000|Immuno-oncology|Overall Study||5
11256731|NCT02213289|12451105|FG001|Immuno-oncology|Overall Study||0
11256732|NCT02213289|12451104|FG000|HER2 Amplified|Overall Study||16
11256733|NCT02213289|12451105|FG001|HER2 Amplified|Overall Study||0
11256734|NCT02213289|12451104|FG000|EGFR Amplified|Overall Study||8
11256735|NCT02213289|12451105|FG001|EGFR Amplified|Overall Study||0
11256736|NCT02213289|12451104|FG000|FGFR2 Amplified|Overall Study||1
11256737|NCT02213289|12451105|FG001|FGFR2 Amplified|Overall Study||0
11256738|NCT02213289|12451104|FG000|MAPK/PIK3CA Aberrant|Overall Study||20
11256739|NCT02213289|12451105|FG001|MAPK/PIK3CA Aberrant|Overall Study||0
11256740|NCT02213289|12451104|FG000|EGFR Expressing|Overall Study||9
11256741|NCT02213289|12451105|FG001|EGFR Expressing|Overall Study||0
11256742|NCT02213289|12451104|FG000|All Negative|Overall Study||9
11256743|NCT02213289|12451105|FG001|All Negative|Overall Study||0
11256744|NCT02213289|12451104|FG000|Other (Non-ITT)|Overall Study||0
11256745|NCT02213289|12451105|FG001|Other (Non-ITT)|Overall Study||12
11256746|NCT02213289|12451104|FG000|COMPLETED|Overall Study||68
11256747|NCT02213289|12451105|FG001|COMPLETED|Overall Study||12
11256748|NCT02213289|12451104|FG000|NOT COMPLETED|Overall Study||0
11256749|NCT02213289|12451105|FG001|NOT COMPLETED|Overall Study||0
11256750|NCT02213458|12451117|FG000|STARTED|Overall Study||1024
11256751|NCT02213458|12451118|FG001|STARTED|Overall Study||536
11256752|NCT02213458|12451117|FG000|COMPLETED|Overall Study||970
11256753|NCT02213458|12451118|FG001|COMPLETED|Overall Study||526
11256754|NCT02213458|12451117|FG000|NOT COMPLETED|Overall Study||54
11256755|NCT02213458|12451118|FG001|NOT COMPLETED|Overall Study||10
11256756|NCT02213510|12451126|FG000|STARTED|Overall Study||21
11256757|NCT02213510|12451127|FG001|STARTED|Overall Study||19
11256758|NCT02213510|12451126|FG000|COMPLETED|Overall Study||20
11256759|NCT02213510|12451127|FG001|COMPLETED|Overall Study||18
11256760|NCT02213510|12451126|FG000|NOT COMPLETED|Overall Study||1
11256761|NCT02213510|12451127|FG001|NOT COMPLETED|Overall Study||1
11256762|NCT02213666|12451133|FG000|STARTED|Overall Study||72
11256763|NCT02213666|12451133|FG000|COMPLETED|Overall Study||71
11256764|NCT02213666|12451133|FG000|NOT COMPLETED|Overall Study||1
11256765|NCT02213900|12451139|FG000|STARTED|Overall Study||68
11256766|NCT02213900|12451140|FG001|STARTED|Overall Study||67
11256767|NCT02213900|12451139|FG000|COMPLETED|Overall Study||68
11256768|NCT02213900|12451140|FG001|COMPLETED|Overall Study||67
11256769|NCT02213900|12451139|FG000|NOT COMPLETED|Overall Study||0
11256770|NCT02213900|12451140|FG001|NOT COMPLETED|Overall Study||0
11256771|NCT02214017|12451148|FG000|STARTED|Overall Study||22
11256772|NCT02214017|12451149|FG001|STARTED|Overall Study||18
11256773|NCT02214017|12451148|FG000|COMPLETED|Overall Study||22
11256774|NCT02214017|12451149|FG001|COMPLETED|Overall Study||18
11256775|NCT02214017|12451148|FG000|NOT COMPLETED|Overall Study||0
11256776|NCT02214017|12451149|FG001|NOT COMPLETED|Overall Study||0
11256777|NCT02214121|12451158|FG000|STARTED|Part A||46
11256778|NCT02214121|12451159|FG001|STARTED|Part A||0
11256779|NCT02214121|12451160|FG002|STARTED|Part A||0
11256780|NCT02214121|12451158|FG000|COMPLETED|Part A||39
11256781|NCT02214121|12451159|FG001|COMPLETED|Part A||0
11256782|NCT02214121|12451160|FG002|COMPLETED|Part A||0
11256783|NCT02214121|12451158|FG000|NOT COMPLETED|Part A||7
11256784|NCT02214121|12451159|FG001|NOT COMPLETED|Part A||0
11256785|NCT02214121|12451160|FG002|NOT COMPLETED|Part A||0
11256786|NCT02214121|12451158|FG000|STARTED|Part B||0
11256787|NCT02214121|12451159|FG001|STARTED|Part B||17
11256788|NCT02214121|12451160|FG002|STARTED|Part B||8
11256789|NCT02214121|12451158|FG000|COMPLETED|Part B||0
11256790|NCT02214121|12451159|FG001|COMPLETED|Part B||14
11256791|NCT02214121|12451160|FG002|COMPLETED|Part B||7
11256792|NCT02214121|12451158|FG000|NOT COMPLETED|Part B||0
11256793|NCT02214121|12451159|FG001|NOT COMPLETED|Part B||3
11256794|NCT02214121|12451160|FG002|NOT COMPLETED|Part B||1
11256795|NCT02214147|12451183|FG000|STARTED|Overall Study||16
11256796|NCT02214147|12451184|FG001|STARTED|Overall Study||12
11256797|NCT02214147|12451185|FG002|STARTED|Overall Study||8
11256798|NCT02214147|12451183|FG000|COMPLETED|Overall Study||16
11256799|NCT02214147|12451184|FG001|COMPLETED|Overall Study||12
11256800|NCT02214147|12451185|FG002|COMPLETED|Overall Study||8
11256801|NCT02214147|12451183|FG000|NOT COMPLETED|Overall Study||0
11256802|NCT02214147|12451184|FG001|NOT COMPLETED|Overall Study||0
11256803|NCT02214147|12451185|FG002|NOT COMPLETED|Overall Study||0
11256804|NCT02214186|12451195|FG000|STARTED|Overall Study||23
11256805|NCT02214186|12451196|FG001|STARTED|Overall Study||23
11256806|NCT02214186|12451195|FG000|COMPLETED|Overall Study||21
11256807|NCT02214186|12451196|FG001|COMPLETED|Overall Study||21
11256808|NCT02214186|12451195|FG000|NOT COMPLETED|Overall Study||2
11256809|NCT02214186|12451196|FG001|NOT COMPLETED|Overall Study||2
11256810|NCT02214212|12451204|FG000|STARTED|Overall Study||66
11256811|NCT02214212|12451205|FG001|STARTED|Overall Study||65
11256812|NCT02214212|12451204|FG000|COMPLETED|Overall Study||57
11256813|NCT02214212|12451205|FG001|COMPLETED|Overall Study||59
11256814|NCT02214212|12451204|FG000|NOT COMPLETED|Overall Study||9
11256815|NCT02214212|12451205|FG001|NOT COMPLETED|Overall Study||6
11256816|NCT02214225|12451219|FG000|STARTED|Overall Study||1741
11256817|NCT02214225|12451220|FG001|STARTED|Overall Study||871
11256818|NCT02214225|12451221|FG002|STARTED|Overall Study||872
11256819|NCT02214225|12451219|FG000|COMPLETED|Overall Study||1686
11256820|NCT02214225|12451220|FG001|COMPLETED|Overall Study||852
11256821|NCT02214225|12451221|FG002|COMPLETED|Overall Study||850
11256822|NCT02214225|12451219|FG000|NOT COMPLETED|Overall Study||55
11256823|NCT02214225|12451220|FG001|NOT COMPLETED|Overall Study||19
11256824|NCT02214225|12451221|FG002|NOT COMPLETED|Overall Study||22
11256825|NCT02214238|12451254|FG000|STARTED|Overall Study||26
11256826|NCT02214238|12451255|FG001|STARTED|Overall Study||23
11256827|NCT02214238|12451254|FG000|COMPLETED|Overall Study||20
11256828|NCT02214238|12451255|FG001|COMPLETED|Overall Study||17
11256829|NCT02214238|12451254|FG000|NOT COMPLETED|Overall Study||6
11256830|NCT02214238|12451255|FG001|NOT COMPLETED|Overall Study||6
11256831|NCT02214277|12451264|FG000|STARTED|Overall Study||123
11256832|NCT02214277|12451265|FG001|STARTED|Overall Study||121
11256833|NCT02214277|12451266|FG002|STARTED|Overall Study||119
11256834|NCT02214277|12451264|FG000|COMPLETED|Overall Study||104
11256835|NCT02214277|12451265|FG001|COMPLETED|Overall Study||96
11256836|NCT02214277|12451266|FG002|COMPLETED|Overall Study||85
11256837|NCT02214277|12451264|FG000|NOT COMPLETED|Overall Study||19
11256838|NCT02214277|12451265|FG001|NOT COMPLETED|Overall Study||25
11256839|NCT02214277|12451266|FG002|NOT COMPLETED|Overall Study||34
11256840|NCT02214290|12451273|FG000|STARTED|First Intervention (7 Days)||8
11256841|NCT02214290|12451274|FG001|STARTED|First Intervention (7 Days)||8
11256842|NCT02214290|12451273|FG000|COMPLETED|First Intervention (7 Days)||8
11256843|NCT02214290|12451274|FG001|COMPLETED|First Intervention (7 Days)||8
11256844|NCT02214290|12451273|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11256845|NCT02214290|12451274|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11256846|NCT02214290|12451273|FG000|STARTED|Washout (14 Days)||8
11256847|NCT02214290|12451274|FG001|STARTED|Washout (14 Days)||8
11256848|NCT02214290|12451273|FG000|COMPLETED|Washout (14 Days)||8
11256849|NCT02214290|12451274|FG001|COMPLETED|Washout (14 Days)||8
11256850|NCT02214290|12451273|FG000|NOT COMPLETED|Washout (14 Days)||0
11256851|NCT02214290|12451274|FG001|NOT COMPLETED|Washout (14 Days)||0
11256852|NCT02214290|12451273|FG000|STARTED|Second Intervention (7 Days)||8
11256853|NCT02214290|12451274|FG001|STARTED|Second Intervention (7 Days)||8
11256854|NCT02214290|12451273|FG000|COMPLETED|Second Intervention (7 Days)||8
11256855|NCT02214290|12451274|FG001|COMPLETED|Second Intervention (7 Days)||8
11256856|NCT02214290|12451273|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
11256857|NCT02214290|12451274|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11256858|NCT02214420|12451285|FG000|STARTED|Overall Study||14
11256859|NCT02214420|12451286|FG001|STARTED|Overall Study||10
11256860|NCT02214420|12451285|FG000|COMPLETED|Overall Study||13
11256861|NCT02214420|12451286|FG001|COMPLETED|Overall Study||10
11256862|NCT02214420|12451285|FG000|NOT COMPLETED|Overall Study||1
11256863|NCT02214420|12451286|FG001|NOT COMPLETED|Overall Study||0
11256864|NCT02214615|12451294|FG000|STARTED|First Intervention||1
11256865|NCT02214615|12451295|FG001|STARTED|First Intervention||1
11256866|NCT02214615|12451294|FG000|COMPLETED|First Intervention||1
11256867|NCT02214615|12451295|FG001|COMPLETED|First Intervention||1
11256868|NCT02214615|12451294|FG000|NOT COMPLETED|First Intervention||0
11256869|NCT02214615|12451295|FG001|NOT COMPLETED|First Intervention||0
11256870|NCT02214615|12451294|FG000|STARTED|Washout||1
11256871|NCT02214615|12451295|FG001|STARTED|Washout||1
11256872|NCT02214615|12451294|FG000|COMPLETED|Washout||1
11256873|NCT02214615|12451295|FG001|COMPLETED|Washout||1
11256874|NCT02214615|12451294|FG000|NOT COMPLETED|Washout||0
11256875|NCT02214615|12451295|FG001|NOT COMPLETED|Washout||0
11256876|NCT02214615|12451294|FG000|STARTED|Second Intervention||1
11256877|NCT02214615|12451295|FG001|STARTED|Second Intervention||1
11256878|NCT02214615|12451294|FG000|COMPLETED|Second Intervention||1
11256879|NCT02214615|12451295|FG001|COMPLETED|Second Intervention||1
11256880|NCT02214615|12451294|FG000|NOT COMPLETED|Second Intervention||0
11256881|NCT02214615|12451295|FG001|NOT COMPLETED|Second Intervention||0
11256882|NCT02214628|12451303|FG000|STARTED|Overall Study||63
11256883|NCT02214628|12451304|FG001|STARTED|Overall Study||38
11256884|NCT02214628|12451303|FG000|COMPLETED|Overall Study||36
11256885|NCT02214628|12451304|FG001|COMPLETED|Overall Study||9
11256886|NCT02214628|12451303|FG000|NOT COMPLETED|Overall Study||27
11256887|NCT02214628|12451304|FG001|NOT COMPLETED|Overall Study||29
11256888|NCT02215070|12451314|FG000|STARTED|Overall Study||26
11256889|NCT02215070|12451315|FG001|STARTED|Overall Study||52
11256890|NCT02215070|12451314|FG000|COMPLETED|Overall Study||20
11256891|NCT02215070|12451315|FG001|COMPLETED|Overall Study||52
11256892|NCT02215070|12451314|FG000|NOT COMPLETED|Overall Study||6
11256893|NCT02215070|12451315|FG001|NOT COMPLETED|Overall Study||0
11256894|NCT02215161|12451321|FG000|STARTED|Overall Study||14
11256895|NCT02215161|12451321|FG000|COMPLETED|Overall Study||14
11256896|NCT02215161|12451321|FG000|NOT COMPLETED|Overall Study||0
11256897|NCT02215200|12451336|FG000|STARTED|Overall Study||29
11256898|NCT02215200|12451337|FG001|STARTED|Overall Study||29
11256899|NCT02215200|12451338|FG002|STARTED|Overall Study||31
11256900|NCT02215200|12451336|FG000|COMPLETED|Overall Study||29
11256901|NCT02215200|12451337|FG001|COMPLETED|Overall Study||28
11256902|NCT02215200|12451338|FG002|COMPLETED|Overall Study||30
11256903|NCT02215200|12451336|FG000|NOT COMPLETED|Overall Study||0
11256904|NCT02215200|12451337|FG001|NOT COMPLETED|Overall Study||1
11256905|NCT02215200|12451338|FG002|NOT COMPLETED|Overall Study||1
11256906|NCT02215252|12451349|FG000|STARTED|Overall Study||44
11256907|NCT02215252|12451350|FG001|STARTED|Overall Study||46
11256908|NCT02215252|12451351|FG002|STARTED|Overall Study||45
11256909|NCT02215252|12451349|FG000|COMPLETED|Overall Study||42
11256910|NCT02215252|12451350|FG001|COMPLETED|Overall Study||38
11256911|NCT02215252|12451351|FG002|COMPLETED|Overall Study||41
11256912|NCT02215252|12451349|FG000|NOT COMPLETED|Overall Study||2
11256913|NCT02215252|12451350|FG001|NOT COMPLETED|Overall Study||8
11256914|NCT02215252|12451351|FG002|NOT COMPLETED|Overall Study||4
11256915|NCT02215369|12451359|FG000|STARTED|Overall Study||112
11256916|NCT02215369|12451359|FG000|COMPLETED|Overall Study||70
11256917|NCT02215369|12451359|FG000|NOT COMPLETED|Overall Study||42
11256918|NCT02215616|12451367|FG000|STARTED|Overall Study||108
11256919|NCT02215616|12451368|FG001|STARTED|Overall Study||107
11256920|NCT02215616|12451369|FG002|STARTED|Overall Study||107
11256921|NCT02215616|12451370|FG003|STARTED|Overall Study||30
11256922|NCT02215616|12451367|FG000|Received at Least 1 Dose of Study Drug|Overall Study||108
11256923|NCT02215616|12451368|FG001|Received at Least 1 Dose of Study Drug|Overall Study||107
11256924|NCT02215616|12451369|FG002|Received at Least 1 Dose of Study Drug|Overall Study||106
11256925|NCT02215616|12451370|FG003|Received at Least 1 Dose of Study Drug|Overall Study||29
11256926|NCT02215616|12451367|FG000|COMPLETED|Overall Study||97
11256927|NCT02215616|12451368|FG001|COMPLETED|Overall Study||90
11256928|NCT02215616|12451369|FG002|COMPLETED|Overall Study||93
11256929|NCT02215616|12451370|FG003|COMPLETED|Overall Study||17
11256930|NCT02215616|12451367|FG000|NOT COMPLETED|Overall Study||11
11256931|NCT02215616|12451368|FG001|NOT COMPLETED|Overall Study||17
11256932|NCT02215616|12451369|FG002|NOT COMPLETED|Overall Study||14
11256933|NCT02215616|12451370|FG003|NOT COMPLETED|Overall Study||13
11256934|NCT02215954|12451383|FG000|STARTED|Overall Study||214
11256935|NCT02215954|12451384|FG001|STARTED|Overall Study||212
11256936|NCT02215954|12451385|FG002|STARTED|Overall Study||211
11256937|NCT02215954|12451383|FG000|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
11256938|NCT02215954|12451384|FG001|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
11256939|NCT02215954|12451385|FG002|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
11256940|NCT02215954|12451383|FG000|Per Protocol (PP) Analysis Set|Overall Study||212
11256941|NCT02215954|12451384|FG001|Per Protocol (PP) Analysis Set|Overall Study||208
11256942|NCT02215954|12451385|FG002|Per Protocol (PP) Analysis Set|Overall Study||205
11256943|NCT02215954|12451383|FG000|Safety Analysis Set|Overall Study||213
11256944|NCT02215954|12451384|FG001|Safety Analysis Set|Overall Study||211
11256945|NCT02215954|12451385|FG002|Safety Analysis Set|Overall Study||208
11256946|NCT02215954|12451383|FG000|COMPLETED|Overall Study||213
11256947|NCT02215954|12451384|FG001|COMPLETED|Overall Study||211
11256948|NCT02215954|12451385|FG002|COMPLETED|Overall Study||205
11256949|NCT02215954|12451383|FG000|NOT COMPLETED|Overall Study||1
11256950|NCT02215954|12451384|FG001|NOT COMPLETED|Overall Study||1
11256951|NCT02215954|12451385|FG002|NOT COMPLETED|Overall Study||6
11256952|NCT02215967|12451398|FG000|STARTED|Overall Study||3
11256953|NCT02215967|12451399|FG001|STARTED|Overall Study||3
11256954|NCT02215967|12451400|FG002|STARTED|Overall Study||5
11256955|NCT02215967|12451401|FG003|STARTED|Overall Study||19
11256956|NCT02215967|12451398|FG000|COMPLETED|Overall Study||3
11256957|NCT02215967|12451399|FG001|COMPLETED|Overall Study||3
11256958|NCT02215967|12451400|FG002|COMPLETED|Overall Study||4
11256959|NCT02215967|12451401|FG003|COMPLETED|Overall Study||16
11256960|NCT02215967|12451398|FG000|NOT COMPLETED|Overall Study||0
11256961|NCT02215967|12451399|FG001|NOT COMPLETED|Overall Study||0
11256962|NCT02215967|12451400|FG002|NOT COMPLETED|Overall Study||1
11256963|NCT02215967|12451401|FG003|NOT COMPLETED|Overall Study||3
11256964|NCT02216071|12451413|FG000|STARTED|Overall Study||254
11256965|NCT02216071|12451414|FG001|STARTED|Overall Study||245
11256966|NCT02216071|12451413|FG000|COMPLETED|Overall Study||239
11256967|NCT02216071|12451414|FG001|COMPLETED|Overall Study||233
11256968|NCT02216071|12451413|FG000|NOT COMPLETED|Overall Study||15
11256969|NCT02216071|12451414|FG001|NOT COMPLETED|Overall Study||12
11256970|NCT02216097|12451422|FG000|STARTED|Overall Study||8
11256971|NCT02216097|12451423|FG001|STARTED|Overall Study||6
11256972|NCT02216097|12451422|FG000|COMPLETED|Overall Study||8
11256973|NCT02216097|12451423|FG001|COMPLETED|Overall Study||6
11256974|NCT02216097|12451422|FG000|NOT COMPLETED|Overall Study||0
11256975|NCT02216097|12451423|FG001|NOT COMPLETED|Overall Study||0
11256976|NCT02216123|12451431|FG000|STARTED|Overall Study||166
11256977|NCT02216123|12451432|FG001|STARTED|Overall Study||85
11256978|NCT02216123|12451431|FG000|COMPLETED|Overall Study||160
11256979|NCT02216123|12451432|FG001|COMPLETED|Overall Study||83
11256980|NCT02216123|12451431|FG000|NOT COMPLETED|Overall Study||6
11256981|NCT02216123|12451432|FG001|NOT COMPLETED|Overall Study||2
11256982|NCT02216136|12451445|FG000|STARTED|Overall Study||72
11256983|NCT02216136|12451446|FG001|STARTED|Overall Study||90
11256984|NCT02216136|12451447|FG002|STARTED|Overall Study||0
11256985|NCT02216136|12451445|FG000|COMPLETED|Overall Study||72
11256986|NCT02216136|12451446|FG001|COMPLETED|Overall Study||90
11256987|NCT02216136|12451447|FG002|COMPLETED|Overall Study||0
11256988|NCT02216136|12451445|FG000|NOT COMPLETED|Overall Study||0
11256989|NCT02216136|12451446|FG001|NOT COMPLETED|Overall Study||0
11256990|NCT02216136|12451447|FG002|NOT COMPLETED|Overall Study||0
11256991|NCT02216214|12451457|FG000|STARTED|Overall Study||443
11256992|NCT02216214|12451458|FG001|STARTED|Overall Study||445
11256993|NCT02216214|12451457|FG000|Treated|Overall Study||442
11256994|NCT02216214|12451458|FG001|Treated|Overall Study||445
11256995|NCT02216214|12451457|FG000|COMPLETED|Overall Study||400
11256996|NCT02216214|12451458|FG001|COMPLETED|Overall Study||409
11256997|NCT02216214|12451457|FG000|NOT COMPLETED|Overall Study||43
11256998|NCT02216214|12451458|FG001|NOT COMPLETED|Overall Study||36
11256999|NCT02216357|12451466|FG000|STARTED|Overall Study||14
11257000|NCT02216357|12451467|FG001|STARTED|Overall Study||5
11257001|NCT02216357|12451466|FG000|COMPLETED|Overall Study||12
11257002|NCT02216357|12451467|FG001|COMPLETED|Overall Study||4
11257003|NCT02216357|12451466|FG000|NOT COMPLETED|Overall Study||2
11257004|NCT02216357|12451467|FG001|NOT COMPLETED|Overall Study||1
11339812|NCT02918266|12537336|FG010|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339813|NCT02918266|12537326|FG000|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339814|NCT02918266|12537327|FG001|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339815|NCT02918266|12537328|FG002|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339816|NCT02918266|12537329|FG003|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339817|NCT02918266|12537330|FG004|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339818|NCT02918266|12537331|FG005|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339819|NCT02918266|12537332|FG006|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339820|NCT02918266|12537333|FG007|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339821|NCT02918266|12537334|FG008|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339822|NCT02918266|12537335|FG009|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339823|NCT02918266|12537336|FG010|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
11339824|NCT02918266|12537326|FG000|STARTED|Part 2: Intervention Period 2 (2 Days)||0
11339825|NCT02918266|12537327|FG001|STARTED|Part 2: Intervention Period 2 (2 Days)||0
11339826|NCT02918266|12537328|FG002|STARTED|Part 2: Intervention Period 2 (2 Days)||0
11339827|NCT02918266|12537329|FG003|STARTED|Part 2: Intervention Period 2 (2 Days)||0
11339828|NCT02918266|12537330|FG004|STARTED|Part 2: Intervention Period 2 (2 Days)||0
11339829|NCT02918266|12537331|FG005|STARTED|Part 2: Intervention Period 2 (2 Days)||0
11339830|NCT02918266|12537332|FG006|STARTED|Part 2: Intervention Period 2 (2 Days)||0
11339831|NCT02918266|12537333|FG007|STARTED|Part 2: Intervention Period 2 (2 Days)||0
11339832|NCT02918266|12537334|FG008|STARTED|Part 2: Intervention Period 2 (2 Days)||0
11339833|NCT02918266|12537335|FG009|STARTED|Part 2: Intervention Period 2 (2 Days)||0
11339834|NCT02918266|12537336|FG010|STARTED|Part 2: Intervention Period 2 (2 Days)||0
11339835|NCT02918266|12537326|FG000|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339836|NCT02918266|12537327|FG001|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339837|NCT02918266|12537328|FG002|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339838|NCT02918266|12537329|FG003|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339839|NCT02918266|12537330|FG004|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339840|NCT02918266|12537331|FG005|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339841|NCT02918266|12537332|FG006|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339842|NCT02918266|12537333|FG007|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339843|NCT02918266|12537334|FG008|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339844|NCT02918266|12537335|FG009|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339845|NCT02918266|12537336|FG010|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11257005|NCT02216422|12451473|FG000|STARTED|Overall Study||36
11257006|NCT02216422|12451473|FG000|COMPLETED|Overall Study||36
11257007|NCT02216422|12451473|FG000|NOT COMPLETED|Overall Study||0
11257008|NCT02216526|12451480|FG000|STARTED|Overall Study||45
11257009|NCT02216526|12451481|FG001|STARTED|Overall Study||44
11257010|NCT02216526|12451482|FG002|STARTED|Overall Study||44
11257011|NCT02216526|12451480|FG000|COMPLETED|Overall Study||40
11257012|NCT02216526|12451481|FG001|COMPLETED|Overall Study||41
11257013|NCT02216526|12451482|FG002|COMPLETED|Overall Study||36
11257014|NCT02216526|12451480|FG000|NOT COMPLETED|Overall Study||5
11257015|NCT02216526|12451481|FG001|NOT COMPLETED|Overall Study||3
11257016|NCT02216526|12451482|FG002|NOT COMPLETED|Overall Study||8
11257017|NCT02216591|12451492|FG000|STARTED|Overall Study||11
11257018|NCT02216591|12451493|FG001|STARTED|Overall Study||10
11257019|NCT02216591|12451492|FG000|COMPLETED|Overall Study||11
11257020|NCT02216591|12451493|FG001|COMPLETED|Overall Study||9
11257021|NCT02216591|12451492|FG000|NOT COMPLETED|Overall Study||0
11257022|NCT02216591|12451493|FG001|NOT COMPLETED|Overall Study||1
11257023|NCT02216695|12451499|FG000|STARTED|Overall Study||64882
11257024|NCT02216695|12451499|FG000|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
11257025|NCT02216695|12451499|FG000|NOT COMPLETED|Overall Study||0
11257026|NCT02216773|12451510|FG000|STARTED|Overall Study||28
11257027|NCT02216773|12451511|FG001|STARTED|Overall Study||29
11257028|NCT02216773|12451510|FG000|Underwent Procedure (PVE/RALPPS)|Overall Study||24
11257029|NCT02216773|12451511|FG001|Underwent Procedure (PVE/RALPPS)|Overall Study||26
11257030|NCT02216773|12451510|FG000|COMPLETED|Overall Study||16
11257031|NCT02216773|12451511|FG001|COMPLETED|Overall Study||24
11257032|NCT02216773|12451510|FG000|NOT COMPLETED|Overall Study||12
11257033|NCT02216773|12451511|FG001|NOT COMPLETED|Overall Study||5
11257034|NCT02216812|12451519|FG000|STARTED|Overall Study||67
11257035|NCT02216812|12451520|FG001|STARTED|Overall Study||67
11257036|NCT02216812|12451519|FG000|COMPLETED|Overall Study||57
11257037|NCT02216812|12451520|FG001|COMPLETED|Overall Study||62
11257038|NCT02216812|12451519|FG000|NOT COMPLETED|Overall Study||10
11257039|NCT02216812|12451520|FG001|NOT COMPLETED|Overall Study||5
11257040|NCT02217280|12451526|FG000|STARTED|Overall Study||20
11257041|NCT02217280|12451526|FG000|COMPLETED|Overall Study||16
11257042|NCT02217280|12451526|FG000|NOT COMPLETED|Overall Study||4
11257043|NCT02217332|12451531|FG000|STARTED|Overall Study|Safety Population|20
11257044|NCT02217332|12451531|FG000|COMPLETED|Overall Study|Subjects who continued to optional open-label treatment|13
11257045|NCT02217332|12451531|FG000|NOT COMPLETED|Overall Study||7
11257046|NCT02217410|12451538|FG000|STARTED|Overall Study||7
11257047|NCT02217410|12451539|FG001|STARTED|Overall Study||34
11257048|NCT02217410|12451540|FG002|STARTED|Overall Study||18
11257049|NCT02217410|12451538|FG000|COMPLETED|Overall Study||6
11257050|NCT02217410|12451539|FG001|COMPLETED|Overall Study||30
11257051|NCT02217410|12451540|FG002|COMPLETED|Overall Study||13
11257052|NCT02217410|12451538|FG000|NOT COMPLETED|Overall Study||1
11257053|NCT02217410|12451539|FG001|NOT COMPLETED|Overall Study||4
11257054|NCT02217410|12451540|FG002|NOT COMPLETED|Overall Study||5
11257055|NCT02217436|12451555|FG000|STARTED|Overall Study||40
11257056|NCT02217436|12451556|FG001|STARTED|Overall Study||40
11257057|NCT02217436|12451555|FG000|COMPLETED|Overall Study||39
11257058|NCT02217436|12451556|FG001|COMPLETED|Overall Study||38
11257059|NCT02217436|12451555|FG000|NOT COMPLETED|Overall Study||1
11257060|NCT02217436|12451556|FG001|NOT COMPLETED|Overall Study||2
11257061|NCT02217475|12451565|FG000|STARTED|Treatment Period 1 (Year 1)||72
11257062|NCT02217475|12451566|FG001|STARTED|Treatment Period 1 (Year 1)||72
11257063|NCT02217475|12451567|FG002|STARTED|Treatment Period 1 (Year 1)||145
11257064|NCT02217475|12451565|FG000|Safety Analysis Set|Treatment Period 1 (Year 1)||72
11257065|NCT02217475|12451566|FG001|Safety Analysis Set|Treatment Period 1 (Year 1)||72
11257066|NCT02217475|12451567|FG002|Safety Analysis Set|Treatment Period 1 (Year 1)||144
11257067|NCT02217475|12451565|FG000|COMPLETED|Treatment Period 1 (Year 1)||62
11257068|NCT02217475|12451566|FG001|COMPLETED|Treatment Period 1 (Year 1)||64
11257069|NCT02217475|12451567|FG002|COMPLETED|Treatment Period 1 (Year 1)||124
11257070|NCT02217475|12451565|FG000|NOT COMPLETED|Treatment Period 1 (Year 1)||10
11257071|NCT02217475|12451566|FG001|NOT COMPLETED|Treatment Period 1 (Year 1)||8
11257072|NCT02217475|12451567|FG002|NOT COMPLETED|Treatment Period 1 (Year 1)||21
11257073|NCT02217475|12451565|FG000|STARTED|Discontinued After Period 1||62
11257074|NCT02217475|12451566|FG001|STARTED|Discontinued After Period 1||64
11257075|NCT02217475|12451567|FG002|STARTED|Discontinued After Period 1||124
11257076|NCT02217475|12451565|FG000|COMPLETED|Discontinued After Period 1||60
11257077|NCT02217475|12451566|FG001|COMPLETED|Discontinued After Period 1||61
11257078|NCT02217475|12451567|FG002|COMPLETED|Discontinued After Period 1||121
11257079|NCT02217475|12451565|FG000|NOT COMPLETED|Discontinued After Period 1||2
11257080|NCT02217475|12451566|FG001|NOT COMPLETED|Discontinued After Period 1||3
11257081|NCT02217475|12451567|FG002|NOT COMPLETED|Discontinued After Period 1||3
11257082|NCT02217475|12451565|FG000|STARTED|Treatment Period 2 (Year 2)||60
11257083|NCT02217475|12451566|FG001|STARTED|Treatment Period 2 (Year 2)||61
11257084|NCT02217475|12451567|FG002|STARTED|Treatment Period 2 (Year 2)||121
11257085|NCT02217475|12451565|FG000|COMPLETED|Treatment Period 2 (Year 2)||58
11257086|NCT02217475|12451566|FG001|COMPLETED|Treatment Period 2 (Year 2)||59
11257087|NCT02217475|12451567|FG002|COMPLETED|Treatment Period 2 (Year 2)||109
11257088|NCT02217475|12451565|FG000|NOT COMPLETED|Treatment Period 2 (Year 2)||2
11257089|NCT02217475|12451566|FG001|NOT COMPLETED|Treatment Period 2 (Year 2)||2
11257090|NCT02217475|12451567|FG002|NOT COMPLETED|Treatment Period 2 (Year 2)||12
11257091|NCT02217501|12451586|FG000|STARTED|Overall Study||77
11257092|NCT02217501|12451587|FG001|STARTED|Overall Study||82
11257093|NCT02217501|12451586|FG000|COMPLETED|Overall Study||74
11257094|NCT02217501|12451587|FG001|COMPLETED|Overall Study||78
11257095|NCT02217501|12451586|FG000|NOT COMPLETED|Overall Study||3
11257096|NCT02217501|12451587|FG001|NOT COMPLETED|Overall Study||4
11257097|NCT02217527|12451595|FG000|STARTED|Drug Condition 1: First Study Phase||18
11257098|NCT02217527|12451596|FG001|STARTED|Drug Condition 1: First Study Phase||18
11257099|NCT02217527|12451595|FG000|COMPLETED|Drug Condition 1: First Study Phase||17
11257100|NCT02217527|12451596|FG001|COMPLETED|Drug Condition 1: First Study Phase||15
11257101|NCT02217527|12451595|FG000|NOT COMPLETED|Drug Condition 1: First Study Phase||1
11257102|NCT02217527|12451596|FG001|NOT COMPLETED|Drug Condition 1: First Study Phase||3
11257103|NCT02217527|12451595|FG000|STARTED|Drug Condition 2: Second Study Phase||17
11257104|NCT02217527|12451596|FG001|STARTED|Drug Condition 2: Second Study Phase||15
11257105|NCT02217527|12451595|FG000|COMPLETED|Drug Condition 2: Second Study Phase||17
11257106|NCT02217527|12451596|FG001|COMPLETED|Drug Condition 2: Second Study Phase||14
11257107|NCT02217527|12451595|FG000|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
11257108|NCT02217527|12451596|FG001|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
11257109|NCT02217566|12451602|FG000|STARTED|Overall Study||46
11257110|NCT02217566|12451602|FG000|COMPLETED|Overall Study||35
11257111|NCT02217566|12451602|FG000|NOT COMPLETED|Overall Study||11
11257112|NCT02217618|12451606|FG000|STARTED|Overall Study||16
11257113|NCT02217618|12451606|FG000|Received Study Drug|Overall Study||16
11257114|NCT02217618|12451606|FG000|COMPLETED|Overall Study||16
11257115|NCT02217618|12451606|FG000|NOT COMPLETED|Overall Study||0
11257116|NCT02217800|12451610|FG000|STARTED|Overall Study||8
11257117|NCT02217800|12451610|FG000|COMPLETED|Overall Study||8
11257118|NCT02217800|12451610|FG000|NOT COMPLETED|Overall Study||0
11257119|NCT02217878|12451624|FG000|STARTED|Overall Study||37
11257120|NCT02217878|12451625|FG001|STARTED|Overall Study||37
11257121|NCT02217878|12451624|FG000|COMPLETED|Overall Study||35
11257122|NCT02217878|12451625|FG001|COMPLETED|Overall Study||35
11257123|NCT02217878|12451624|FG000|NOT COMPLETED|Overall Study||2
11257124|NCT02217878|12451625|FG001|NOT COMPLETED|Overall Study||2
11257125|NCT02217904|12451636|FG000|STARTED|Overall Study||6
11257126|NCT02217904|12451637|FG001|STARTED|Overall Study||6
11257127|NCT02217904|12451638|FG002|STARTED|Overall Study||6
11257128|NCT02217904|12451639|FG003|STARTED|Overall Study||6
11257129|NCT02217904|12451640|FG004|STARTED|Overall Study||6
11257130|NCT02217904|12451641|FG005|STARTED|Overall Study||0
11257131|NCT02217904|12451642|FG006|STARTED|Overall Study||0
11257132|NCT02217904|12451636|FG000|COMPLETED|Overall Study||6
11257133|NCT02217904|12451637|FG001|COMPLETED|Overall Study||6
11257134|NCT02217904|12451638|FG002|COMPLETED|Overall Study||6
11257135|NCT02217904|12451639|FG003|COMPLETED|Overall Study||6
11257136|NCT02217904|12451640|FG004|COMPLETED|Overall Study||6
11257137|NCT02217904|12451641|FG005|COMPLETED|Overall Study||0
11257138|NCT02217904|12451642|FG006|COMPLETED|Overall Study||0
11257139|NCT02217904|12451636|FG000|NOT COMPLETED|Overall Study||0
11257140|NCT02217904|12451637|FG001|NOT COMPLETED|Overall Study||0
11257141|NCT02217904|12451638|FG002|NOT COMPLETED|Overall Study||0
11257142|NCT02217904|12451639|FG003|NOT COMPLETED|Overall Study||0
11257143|NCT02217904|12451640|FG004|NOT COMPLETED|Overall Study||0
11257144|NCT02217904|12451641|FG005|NOT COMPLETED|Overall Study||0
11257145|NCT02217904|12451642|FG006|NOT COMPLETED|Overall Study||0
11257146|NCT02217982|12451656|FG000|STARTED|Overall Study||1
11257147|NCT02217982|12451657|FG001|STARTED|Overall Study||4
11257148|NCT02217982|12451656|FG000|COMPLETED|Overall Study|Trial closed before patient finished|0
11257149|NCT02217982|12451657|FG001|COMPLETED|Overall Study||3
11257150|NCT02217982|12451656|FG000|NOT COMPLETED|Overall Study||1
11257151|NCT02217982|12451657|FG001|NOT COMPLETED|Overall Study||1
11257152|NCT02218008|12451666|FG000|STARTED|Stage 1 (S1)||280
11257153|NCT02218008|12451667|FG001|STARTED|Stage 1 (S1)||63
11257154|NCT02218008|12451668|FG002|STARTED|Stage 1 (S1)||63
11257155|NCT02218008|12451669|FG003|STARTED|Stage 1 (S1)||0
11257156|NCT02218008|12451670|FG004|STARTED|Stage 1 (S1)||0
11257157|NCT02218008|12451671|FG005|STARTED|Stage 1 (S1)||0
11257158|NCT02218008|12451666|FG000|COMPLETED|Stage 1 (S1)||258
11257159|NCT02218008|12451667|FG001|COMPLETED|Stage 1 (S1)||56
11257160|NCT02218008|12451668|FG002|COMPLETED|Stage 1 (S1)||48
11257161|NCT02218008|12451669|FG003|COMPLETED|Stage 1 (S1)||0
11257162|NCT02218008|12451670|FG004|COMPLETED|Stage 1 (S1)||0
11257163|NCT02218008|12451671|FG005|COMPLETED|Stage 1 (S1)||0
11257164|NCT02218008|12451666|FG000|NOT COMPLETED|Stage 1 (S1)||22
11257165|NCT02218008|12451667|FG001|NOT COMPLETED|Stage 1 (S1)||7
11257166|NCT02218008|12451668|FG002|NOT COMPLETED|Stage 1 (S1)||15
11257167|NCT02218008|12451669|FG003|NOT COMPLETED|Stage 1 (S1)||0
11257168|NCT02218008|12451670|FG004|NOT COMPLETED|Stage 1 (S1)||0
11257169|NCT02218008|12451671|FG005|NOT COMPLETED|Stage 1 (S1)||0
11257170|NCT02218008|12451666|FG000|STARTED|Stage 2 (S2)||0
11257171|NCT02218008|12451667|FG001|STARTED|Stage 2 (S2)||0
11257172|NCT02218008|12451668|FG002|STARTED|Stage 2 (S2)||0
11257173|NCT02218008|12451669|FG003|STARTED|Stage 2 (S2)||62
11257174|NCT02218008|12451670|FG004|STARTED|Stage 2 (S2)||62
11257175|NCT02218008|12451671|FG005|STARTED|Stage 2 (S2)||63
11257176|NCT02218008|12451666|FG000|COMPLETED|Stage 2 (S2)||0
11257177|NCT02218008|12451667|FG001|COMPLETED|Stage 2 (S2)||0
11257178|NCT02218008|12451668|FG002|COMPLETED|Stage 2 (S2)||0
11257179|NCT02218008|12451669|FG003|COMPLETED|Stage 2 (S2)||58
11257180|NCT02218008|12451670|FG004|COMPLETED|Stage 2 (S2)||58
11257181|NCT02218008|12451671|FG005|COMPLETED|Stage 2 (S2)||57
11257182|NCT02218008|12451666|FG000|NOT COMPLETED|Stage 2 (S2)||0
11257183|NCT02218008|12451667|FG001|NOT COMPLETED|Stage 2 (S2)||0
11257184|NCT02218008|12451668|FG002|NOT COMPLETED|Stage 2 (S2)||0
11257185|NCT02218008|12451669|FG003|NOT COMPLETED|Stage 2 (S2)||4
11257186|NCT02218008|12451670|FG004|NOT COMPLETED|Stage 2 (S2)||4
11257187|NCT02218008|12451671|FG005|NOT COMPLETED|Stage 2 (S2)||6
11257188|NCT02218190|12451687|FG000|STARTED|Overall Study||13
11257189|NCT02218190|12451688|FG001|STARTED|Overall Study||13
11257190|NCT02218190|12451687|FG000|COMPLETED|Overall Study||13
11257191|NCT02218190|12451688|FG001|COMPLETED|Overall Study||13
11257192|NCT02218190|12451687|FG000|NOT COMPLETED|Overall Study||0
11257193|NCT02218190|12451688|FG001|NOT COMPLETED|Overall Study||0
11257194|NCT02218203|12451694|FG000|STARTED|Overall Study||26
11257195|NCT02218203|12451694|FG000|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
11257196|NCT02218203|12451694|FG000|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
11257197|NCT02218203|12451694|FG000|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
11257198|NCT02218203|12451694|FG000|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
11257199|NCT02218203|12451694|FG000|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
11257200|NCT02218203|12451694|FG000|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
11257201|NCT02218203|12451694|FG000|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
11343949|NCT02957682|12541258|FG000|COMPLETED|Overall Study||890
11257202|NCT02218203|12451694|FG000|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
11141945|NCT01465659|12328649|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||4
11141946|NCT01465659|12328650|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||6
11141947|NCT01465659|12328651|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||10
11141948|NCT01465659|12328648|FG000|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||7
11141949|NCT01465659|12328649|FG001|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||4
11141950|NCT01465659|12328650|FG002|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||6
11141951|NCT01465659|12328651|FG003|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||10
11141952|NCT01465659|12328648|FG000|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||7
11141953|NCT01465659|12328649|FG001|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||4
11141954|NCT01465659|12328650|FG002|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||6
11141955|NCT01465659|12328651|FG003|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||10
11141956|NCT01465659|12328648|FG000|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||7
11141957|NCT01465659|12328649|FG001|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
11141958|NCT01465659|12328650|FG002|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
11141959|NCT01465659|12328651|FG003|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||10
11141960|NCT01465659|12328648|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||5
11141961|NCT01465659|12328649|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
11257203|NCT02218203|12451694|FG000|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
11257204|NCT02218203|12451694|FG000|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
11257205|NCT02218203|12451694|FG000|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
11257206|NCT02218203|12451694|FG000|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
11257207|NCT02218203|12451694|FG000|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
11257208|NCT02218203|12451694|FG000|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
11257209|NCT02218203|12451694|FG000|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
11257210|NCT02218203|12451694|FG000|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
11257211|NCT02218203|12451694|FG000|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
11257212|NCT02218203|12451694|FG000|NOT COMPLETED|Overall Study||0
11257213|NCT02218216|12451718|FG000|STARTED|Overall Study||14
11257214|NCT02218216|12451719|FG001|STARTED|Overall Study||2
11257215|NCT02218216|12451720|FG002|STARTED|Overall Study||3
11257216|NCT02218216|12451718|FG000|COMPLETED|Overall Study||8
11257217|NCT02218216|12451719|FG001|COMPLETED|Overall Study||2
11257218|NCT02218216|12451720|FG002|COMPLETED|Overall Study||3
11257219|NCT02218216|12451718|FG000|NOT COMPLETED|Overall Study||6
11257220|NCT02218216|12451719|FG001|NOT COMPLETED|Overall Study||0
11257221|NCT02218216|12451720|FG002|NOT COMPLETED|Overall Study||0
11257222|NCT02218242|12451728|FG000|STARTED|Overall Study||9
11257223|NCT02218242|12451728|FG000|COMPLETED|Overall Study||9
11257224|NCT02218242|12451728|FG000|NOT COMPLETED|Overall Study||0
11257225|NCT02218268|12451732|FG000|STARTED|First Phase (2 Hours)||30
11257226|NCT02218268|12451733|FG001|STARTED|First Phase (2 Hours)||30
11257227|NCT02218268|12451732|FG000|COMPLETED|First Phase (2 Hours)||30
11257228|NCT02218268|12451733|FG001|COMPLETED|First Phase (2 Hours)||30
11257229|NCT02218268|12451732|FG000|NOT COMPLETED|First Phase (2 Hours)||0
11257230|NCT02218268|12451733|FG001|NOT COMPLETED|First Phase (2 Hours)||0
11257231|NCT02218268|12451732|FG000|STARTED|24 Hour Washout||30
11257232|NCT02218268|12451733|FG001|STARTED|24 Hour Washout||30
11257233|NCT02218268|12451732|FG000|COMPLETED|24 Hour Washout||19
11257234|NCT02218268|12451733|FG001|COMPLETED|24 Hour Washout||21
11257235|NCT02218268|12451732|FG000|NOT COMPLETED|24 Hour Washout||11
11257236|NCT02218268|12451733|FG001|NOT COMPLETED|24 Hour Washout||9
11257237|NCT02218268|12451732|FG000|STARTED|Final Phase (2 Hours)||19
11257238|NCT02218268|12451733|FG001|STARTED|Final Phase (2 Hours)||21
11257239|NCT02218268|12451732|FG000|COMPLETED|Final Phase (2 Hours)||19
11257240|NCT02218268|12451733|FG001|COMPLETED|Final Phase (2 Hours)||21
11257241|NCT02218268|12451732|FG000|NOT COMPLETED|Final Phase (2 Hours)||0
11257242|NCT02218268|12451733|FG001|NOT COMPLETED|Final Phase (2 Hours)||0
11257243|NCT02218307|12451741|FG000|STARTED|Overall Study||34
11257244|NCT02218307|12451742|FG001|STARTED|Overall Study||34
11257245|NCT02218307|12451741|FG000|COMPLETED|Overall Study||25
11257246|NCT02218307|12451742|FG001|COMPLETED|Overall Study||33
11257247|NCT02218307|12451741|FG000|NOT COMPLETED|Overall Study||9
11257248|NCT02218307|12451742|FG001|NOT COMPLETED|Overall Study||1
11257249|NCT02218320|12451750|FG000|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
11257250|NCT02218320|12451751|FG001|STARTED|Overall Study|First participant contact on this arm was December 2014|10
11257251|NCT02218320|12451750|FG000|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
11257252|NCT02218320|12451751|FG001|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
11257253|NCT02218320|12451750|FG000|NOT COMPLETED|Overall Study||0
11257254|NCT02218320|12451751|FG001|NOT COMPLETED|Overall Study||0
11257255|NCT02218372|12451759|FG000|STARTED|Overall Study||100
11257256|NCT02218372|12451760|FG001|STARTED|Overall Study||48
11257257|NCT02218372|12451759|FG000|Treated|Overall Study||98
11257258|NCT02218372|12451760|FG001|Treated|Overall Study||44
11257259|NCT02218372|12451759|FG000|COMPLETED|Overall Study||95
11257260|NCT02218372|12451760|FG001|COMPLETED|Overall Study||42
11257261|NCT02218372|12451759|FG000|NOT COMPLETED|Overall Study||5
11257262|NCT02218372|12451760|FG001|NOT COMPLETED|Overall Study||6
11257263|NCT02218424|12451773|FG000|STARTED|Overall Study||30
11257264|NCT02218424|12451774|FG001|STARTED|Overall Study||30
11257265|NCT02218424|12451773|FG000|COMPLETED|Overall Study||30
11257266|NCT02218424|12451774|FG001|COMPLETED|Overall Study||30
11257267|NCT02218424|12451773|FG000|NOT COMPLETED|Overall Study||0
11141962|NCT01465659|12328650|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
11141963|NCT01465659|12328651|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||9
11141964|NCT01465659|12328648|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
11141965|NCT01465659|12328649|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
11141966|NCT01465659|12328650|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
11141967|NCT01465659|12328651|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
11141968|NCT01465659|12328648|FG000|STARTED|Went on to Cycle 3 and Beyond||5
11141969|NCT01465659|12328649|FG001|STARTED|Went on to Cycle 3 and Beyond||4
11141970|NCT01465659|12328650|FG002|STARTED|Went on to Cycle 3 and Beyond||4
11141971|NCT01465659|12328651|FG003|STARTED|Went on to Cycle 3 and Beyond||9
11141972|NCT01465659|12328648|FG000|COMPLETED|Went on to Cycle 3 and Beyond||5
11141973|NCT01465659|12328649|FG001|COMPLETED|Went on to Cycle 3 and Beyond||4
11141974|NCT01465659|12328650|FG002|COMPLETED|Went on to Cycle 3 and Beyond||4
11141975|NCT01465659|12328651|FG003|COMPLETED|Went on to Cycle 3 and Beyond||9
11141976|NCT01465659|12328648|FG000|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
11141977|NCT01465659|12328649|FG001|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
11141978|NCT01465659|12328650|FG002|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
11257268|NCT02218424|12451774|FG001|NOT COMPLETED|Overall Study||0
11257269|NCT02218463|12451782|FG000|STARTED|Overall Study||21
11257270|NCT02218463|12451783|FG001|STARTED|Overall Study||22
11257271|NCT02218463|12451782|FG000|COMPLETED|Overall Study||18
11257272|NCT02218463|12451783|FG001|COMPLETED|Overall Study||19
11257273|NCT02218463|12451782|FG000|NOT COMPLETED|Overall Study||3
11257274|NCT02218463|12451783|FG001|NOT COMPLETED|Overall Study||3
11257275|NCT02218489|12451791|FG000|STARTED|Overall Study||101
11257276|NCT02218489|12451792|FG001|STARTED|Overall Study||104
11257277|NCT02218489|12451791|FG000|COMPLETED|Overall Study||96
11257278|NCT02218489|12451792|FG001|COMPLETED|Overall Study||101
11257279|NCT02218489|12451791|FG000|NOT COMPLETED|Overall Study||5
11257280|NCT02218489|12451792|FG001|NOT COMPLETED|Overall Study||3
11257281|NCT02218541|12451801|FG000|STARTED|Overall Study||11
11257282|NCT02218541|12451802|FG001|STARTED|Overall Study||11
11257283|NCT02218541|12451801|FG000|COMPLETED|Overall Study||5
11257284|NCT02218541|12451802|FG001|COMPLETED|Overall Study||9
11257285|NCT02218541|12451801|FG000|NOT COMPLETED|Overall Study||6
11257286|NCT02218541|12451802|FG001|NOT COMPLETED|Overall Study||2
11257287|NCT02218736|12451811|FG000|STARTED|Overall Study||45
11257288|NCT02218736|12451812|FG001|STARTED|Overall Study||44
11257289|NCT02218736|12451811|FG000|COMPLETED|Overall Study||33
11257290|NCT02218736|12451812|FG001|COMPLETED|Overall Study||35
11257291|NCT02218736|12451811|FG000|NOT COMPLETED|Overall Study||12
11257292|NCT02218736|12451812|FG001|NOT COMPLETED|Overall Study||9
11257293|NCT02219009|12451820|FG000|STARTED|Overall Study||37
11257294|NCT02219009|12451821|FG001|STARTED|Overall Study||30
11257295|NCT02219009|12451820|FG000|COMPLETED|Overall Study||27
11257296|NCT02219009|12451821|FG001|COMPLETED|Overall Study||22
11257297|NCT02219009|12451820|FG000|NOT COMPLETED|Overall Study||10
11257298|NCT02219009|12451821|FG001|NOT COMPLETED|Overall Study||8
11257299|NCT02219048|12451829|FG000|STARTED|Overall Study||26
11257300|NCT02219048|12451830|FG001|STARTED|Overall Study||25
11257301|NCT02219048|12451829|FG000|COMPLETED|Overall Study||5
11257302|NCT02219048|12451830|FG001|COMPLETED|Overall Study||4
11257303|NCT02219048|12451829|FG000|NOT COMPLETED|Overall Study||21
11257304|NCT02219048|12451830|FG001|NOT COMPLETED|Overall Study||21
11257305|NCT02219087|12451838|FG000|STARTED|Overall Study||30
11257306|NCT02219087|12451839|FG001|STARTED|Overall Study||30
11257307|NCT02219087|12451838|FG000|COMPLETED|Overall Study||30
11257308|NCT02219087|12451839|FG001|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
11257309|NCT02219087|12451838|FG000|NOT COMPLETED|Overall Study||0
11257310|NCT02219087|12451839|FG001|NOT COMPLETED|Overall Study||1
11257311|NCT02219256|12451857|FG000|STARTED|Overall Study||12
11257312|NCT02219256|12451858|FG001|STARTED|Overall Study||4
11257313|NCT02219256|12451859|FG002|STARTED|Overall Study||4
11257314|NCT02219256|12451860|FG003|STARTED|Overall Study||4
11257315|NCT02219256|12451861|FG004|STARTED|Overall Study||6
11257316|NCT02219256|12451862|FG005|STARTED|Overall Study||6
11257317|NCT02219256|12451863|FG006|STARTED|Overall Study||6
11257318|NCT02219256|12451864|FG007|STARTED|Overall Study||8
11257319|NCT02219256|12451865|FG008|STARTED|Overall Study||6
11257320|NCT02219256|12451866|FG009|STARTED|Overall Study||6
11257321|NCT02219256|12451867|FG010|STARTED|Overall Study||6
11257322|NCT02219256|12451868|FG011|STARTED|Overall Study||6
11257323|NCT02219256|12451857|FG000|COMPLETED|Overall Study||12
11257324|NCT02219256|12451858|FG001|COMPLETED|Overall Study||4
11257325|NCT02219256|12451859|FG002|COMPLETED|Overall Study||4
11257326|NCT02219256|12451860|FG003|COMPLETED|Overall Study||4
11257327|NCT02219256|12451861|FG004|COMPLETED|Overall Study||6
11257328|NCT02219256|12451862|FG005|COMPLETED|Overall Study||6
11257329|NCT02219256|12451863|FG006|COMPLETED|Overall Study||6
11257330|NCT02219256|12451864|FG007|COMPLETED|Overall Study||8
11257331|NCT02219256|12451865|FG008|COMPLETED|Overall Study||6
11257332|NCT02219256|12451866|FG009|COMPLETED|Overall Study||6
11257333|NCT02219256|12451867|FG010|COMPLETED|Overall Study||6
11257334|NCT02219256|12451868|FG011|COMPLETED|Overall Study||6
11257335|NCT02219256|12451857|FG000|NOT COMPLETED|Overall Study||0
11257336|NCT02219256|12451858|FG001|NOT COMPLETED|Overall Study||0
11257337|NCT02219256|12451859|FG002|NOT COMPLETED|Overall Study||0
11257338|NCT02219256|12451860|FG003|NOT COMPLETED|Overall Study||0
11257339|NCT02219256|12451861|FG004|NOT COMPLETED|Overall Study||0
11257340|NCT02219256|12451862|FG005|NOT COMPLETED|Overall Study||0
11257341|NCT02219256|12451863|FG006|NOT COMPLETED|Overall Study||0
11257342|NCT02219256|12451864|FG007|NOT COMPLETED|Overall Study||0
11257343|NCT02219256|12451865|FG008|NOT COMPLETED|Overall Study||0
11257344|NCT02219256|12451866|FG009|NOT COMPLETED|Overall Study||0
11257345|NCT02219256|12451867|FG010|NOT COMPLETED|Overall Study||0
11257346|NCT02219256|12451868|FG011|NOT COMPLETED|Overall Study||0
11257347|NCT02219282|12451896|FG000|STARTED|Overall Study||33
11257348|NCT02219282|12451897|FG001|STARTED|Overall Study||33
11257349|NCT02219282|12451896|FG000|COMPLETED|Overall Study||32
11257350|NCT02219282|12451897|FG001|COMPLETED|Overall Study||32
11257351|NCT02219282|12451896|FG000|NOT COMPLETED|Overall Study||1
11257352|NCT02219282|12451897|FG001|NOT COMPLETED|Overall Study||1
11257353|NCT02219308|12451909|FG000|STARTED|Overall Study||32
11257354|NCT02219308|12451910|FG001|STARTED|Overall Study||35
11257355|NCT02219308|12451909|FG000|COMPLETED|Overall Study||31
11257356|NCT02219308|12451910|FG001|COMPLETED|Overall Study||33
11257357|NCT02219308|12451909|FG000|NOT COMPLETED|Overall Study||1
11257358|NCT02219308|12451910|FG001|NOT COMPLETED|Overall Study||2
11257359|NCT02219321|12451918|FG000|STARTED|Overall Study||1
11257360|NCT02219321|12451919|FG001|STARTED|Overall Study||2
11257361|NCT02219321|12451918|FG000|COMPLETED|Overall Study||1
11257362|NCT02219321|12451919|FG001|COMPLETED|Overall Study||2
11257363|NCT02219321|12451918|FG000|NOT COMPLETED|Overall Study||0
11257364|NCT02219321|12451919|FG001|NOT COMPLETED|Overall Study||0
11257365|NCT02219334|12451927|FG000|STARTED|Overall Study||32
11257366|NCT02219334|12451928|FG001|STARTED|Overall Study||23
11257367|NCT02219334|12451927|FG000|COMPLETED|Overall Study||24
11257368|NCT02219334|12451928|FG001|COMPLETED|Overall Study||20
11257369|NCT02219334|12451927|FG000|NOT COMPLETED|Overall Study||8
11257370|NCT02219334|12451928|FG001|NOT COMPLETED|Overall Study||3
11257371|NCT02219438|12451936|FG000|STARTED|Overall Study||13
11257372|NCT02219438|12451937|FG001|STARTED|Overall Study||11
11257373|NCT02219438|12451936|FG000|COMPLETED|Overall Study||13
11257374|NCT02219438|12451937|FG001|COMPLETED|Overall Study||11
11257375|NCT02219438|12451936|FG000|NOT COMPLETED|Overall Study||0
11257376|NCT02219438|12451937|FG001|NOT COMPLETED|Overall Study||0
11257377|NCT02219464|12451947|FG000|STARTED|Overall Study||30
11257378|NCT02219464|12451948|FG001|STARTED|Overall Study||30
11257379|NCT02219464|12451947|FG000|COMPLETED|Overall Study||27
11257380|NCT02219464|12451948|FG001|COMPLETED|Overall Study||30
11257381|NCT02219464|12451947|FG000|NOT COMPLETED|Overall Study||3
11257382|NCT02219464|12451948|FG001|NOT COMPLETED|Overall Study||0
11257383|NCT02219477|12451957|FG000|STARTED|Overall Study||9
11257384|NCT02219477|12451958|FG001|STARTED|Overall Study||24
11257385|NCT02219477|12451959|FG002|STARTED|Overall Study||3
11257386|NCT02219477|12451957|FG000|COMPLETED|Overall Study||9
11257387|NCT02219477|12451958|FG001|COMPLETED|Overall Study||22
11257388|NCT02219477|12451959|FG002|COMPLETED|Overall Study||2
11257389|NCT02219477|12451957|FG000|NOT COMPLETED|Overall Study||0
11257390|NCT02219477|12451958|FG001|NOT COMPLETED|Overall Study||2
11257391|NCT02219477|12451959|FG002|NOT COMPLETED|Overall Study||1
11257392|NCT02219503|12451968|FG000|STARTED|Overall Study||60
11257393|NCT02219503|12451968|FG000|COMPLETED|Overall Study||60
11257394|NCT02219503|12451968|FG000|NOT COMPLETED|Overall Study||0
11257395|NCT02219516|12451976|FG000|STARTED|Overall Study||8
11257396|NCT02219516|12451977|FG001|STARTED|Overall Study||8
11257397|NCT02219516|12451978|FG002|STARTED|Overall Study||7
11257398|NCT02219516|12451979|FG003|STARTED|Overall Study||8
11257399|NCT02219516|12451976|FG000|COMPLETED|Overall Study||8
11257400|NCT02219516|12451977|FG001|COMPLETED|Overall Study||8
11257401|NCT02219516|12451978|FG002|COMPLETED|Overall Study||7
11257402|NCT02219516|12451979|FG003|COMPLETED|Overall Study||8
11257403|NCT02219516|12451976|FG000|NOT COMPLETED|Overall Study||0
11257404|NCT02219516|12451977|FG001|NOT COMPLETED|Overall Study||0
11257405|NCT02219516|12451978|FG002|NOT COMPLETED|Overall Study||0
11257406|NCT02219516|12451979|FG003|NOT COMPLETED|Overall Study||0
11257407|NCT02219685|12451991|FG000|STARTED|Blinded Treatment Phase||26
11257408|NCT02219685|12451992|FG001|STARTED|Blinded Treatment Phase||14
11257409|NCT02219685|12451991|FG000|COMPLETED|Blinded Treatment Phase||24
11257410|NCT02219685|12451992|FG001|COMPLETED|Blinded Treatment Phase||14
11257411|NCT02219685|12451991|FG000|NOT COMPLETED|Blinded Treatment Phase||2
11257412|NCT02219685|12451992|FG001|NOT COMPLETED|Blinded Treatment Phase||0
11257413|NCT02219685|12451991|FG000|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
11257414|NCT02219685|12451992|FG001|STARTED|Open-Label (After Posttreatment Week 4)||14
11257415|NCT02219685|12451991|FG000|COMPLETED|Open-Label (After Posttreatment Week 4)||0
11257416|NCT02219685|12451992|FG001|COMPLETED|Open-Label (After Posttreatment Week 4)||14
11257417|NCT02219685|12451991|FG000|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
11257418|NCT02219685|12451992|FG001|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
11257419|NCT02219815|12452002|FG000|STARTED|Overall Study||44
11257420|NCT02219815|12452003|FG001|STARTED|Overall Study||45
11257421|NCT02219815|12452002|FG000|Post Hospital Discharge Analysis|Overall Study||42
11257422|NCT02219815|12452003|FG001|Post Hospital Discharge Analysis|Overall Study||39
11257423|NCT02219815|12452002|FG000|3 Month Post Surgery|Overall Study||34
11257424|NCT02219815|12452003|FG001|3 Month Post Surgery|Overall Study||31
11257425|NCT02219815|12452002|FG000|COMPLETED|Overall Study||22
11257426|NCT02219815|12452003|FG001|COMPLETED|Overall Study||21
11257427|NCT02219815|12452002|FG000|NOT COMPLETED|Overall Study||22
11257428|NCT02219815|12452003|FG001|NOT COMPLETED|Overall Study||24
11257429|NCT02219932|12452011|FG000|STARTED|Overall Study||319
11257430|NCT02219932|12452012|FG001|STARTED|Overall Study||317
11257431|NCT02219932|12452011|FG000|Randomized, Not Treated|Overall Study||0
11257432|NCT02219932|12452012|FG001|Randomized, Not Treated|Overall Study||1
11257433|NCT02219932|12452011|FG000|COMPLETED|Overall Study||254
11257434|NCT02219932|12452012|FG001|COMPLETED|Overall Study||266
11257435|NCT02219932|12452011|FG000|NOT COMPLETED|Overall Study||65
11257436|NCT02219932|12452012|FG001|NOT COMPLETED|Overall Study||51
11257437|NCT02219997|12452020|FG000|STARTED|First Filter||33
11257438|NCT02219997|12452021|FG001|STARTED|First Filter||17
11257439|NCT02219997|12452022|FG002|STARTED|First Filter||18
11257440|NCT02219997|12452020|FG000|COMPLETED|First Filter||33
11257441|NCT02219997|12452021|FG001|COMPLETED|First Filter||17
11257442|NCT02219997|12452022|FG002|COMPLETED|First Filter||18
11257443|NCT02219997|12452020|FG000|NOT COMPLETED|First Filter||0
11257444|NCT02219997|12452021|FG001|NOT COMPLETED|First Filter||0
11257445|NCT02219997|12452022|FG002|NOT COMPLETED|First Filter||0
11257446|NCT02219997|12452020|FG000|STARTED|Second Filter||0
11257447|NCT02219997|12452021|FG001|STARTED|Second Filter||17
11257448|NCT02219997|12452022|FG002|STARTED|Second Filter||18
11257449|NCT02219997|12452020|FG000|COMPLETED|Second Filter||0
11257450|NCT02219997|12452021|FG001|COMPLETED|Second Filter||17
11257451|NCT02219997|12452022|FG002|COMPLETED|Second Filter||18
11257452|NCT02219997|12452020|FG000|NOT COMPLETED|Second Filter||0
11257453|NCT02219997|12452021|FG001|NOT COMPLETED|Second Filter||0
11257454|NCT02219997|12452022|FG002|NOT COMPLETED|Second Filter||0
11257455|NCT02220205|12452035|FG000|STARTED|Overall Study||30
11257456|NCT02220205|12452036|FG001|STARTED|Overall Study||30
11257457|NCT02220205|12452035|FG000|COMPLETED|Overall Study||29
11257458|NCT02220205|12452036|FG001|COMPLETED|Overall Study||30
11257459|NCT02220205|12452035|FG000|NOT COMPLETED|Overall Study||1
11257460|NCT02220205|12452036|FG001|NOT COMPLETED|Overall Study||0
11257461|NCT02220712|12452042|FG000|STARTED|Overall Study||17
11257462|NCT02220712|12452042|FG000|COMPLETED|Overall Study||13
11257463|NCT02220712|12452042|FG000|NOT COMPLETED|Overall Study||4
11257464|NCT02220725|12452054|FG000|STARTED|Overall Study||14
11257465|NCT02220725|12452055|FG001|STARTED|Overall Study||27
11257466|NCT02220725|12452056|FG002|STARTED|Overall Study||13
11257467|NCT02220725|12452057|FG003|STARTED|Overall Study||26
11257468|NCT02220725|12452054|FG000|COMPLETED|Overall Study||14
11257469|NCT02220725|12452055|FG001|COMPLETED|Overall Study||27
11257470|NCT02220725|12452056|FG002|COMPLETED|Overall Study||13
11257471|NCT02220725|12452057|FG003|COMPLETED|Overall Study||24
11257472|NCT02220725|12452054|FG000|NOT COMPLETED|Overall Study||0
11257473|NCT02220725|12452055|FG001|NOT COMPLETED|Overall Study||0
11257474|NCT02220725|12452056|FG002|NOT COMPLETED|Overall Study||0
11257475|NCT02220725|12452057|FG003|NOT COMPLETED|Overall Study||2
11257476|NCT02220764|12452072|FG000|STARTED|Overall Study||24
11257477|NCT02220764|12452073|FG001|STARTED|Overall Study||8
11257478|NCT02220764|12452072|FG000|COMPLETED|Overall Study||20
11257479|NCT02220764|12452073|FG001|COMPLETED|Overall Study||7
11257480|NCT02220764|12452072|FG000|NOT COMPLETED|Overall Study||4
11257481|NCT02220764|12452073|FG001|NOT COMPLETED|Overall Study||1
11257482|NCT02220907|12452079|FG000|STARTED|Overall Study||153
11257483|NCT02220907|12452079|FG000|COMPLETED|Overall Study||142
11257484|NCT02220907|12452079|FG000|NOT COMPLETED|Overall Study||11
11257485|NCT02220920|12452085|FG000|STARTED|Overall Study||76
11257486|NCT02220920|12452086|FG001|STARTED|Overall Study||70
11257487|NCT02220920|12452085|FG000|COMPLETED|Overall Study||73
11257488|NCT02220920|12452086|FG001|COMPLETED|Overall Study||67
11257489|NCT02220920|12452085|FG000|NOT COMPLETED|Overall Study||3
11257490|NCT02220920|12452086|FG001|NOT COMPLETED|Overall Study||3
11257491|NCT02220998|12452094|FG000|STARTED|Overall Study||135
11257492|NCT02220998|12452095|FG001|STARTED|Overall Study||134
11257493|NCT02220998|12452094|FG000|COMPLETED|Overall Study||128
11257494|NCT02220998|12452095|FG001|COMPLETED|Overall Study||123
11257495|NCT02220998|12452094|FG000|NOT COMPLETED|Overall Study||7
11257496|NCT02220998|12452095|FG001|NOT COMPLETED|Overall Study||11
11257497|NCT02221219|12452105|FG000|STARTED|Overall Study||36
11257498|NCT02221219|12452106|FG001|STARTED|Overall Study||87
11257499|NCT02221219|12452107|FG002|STARTED|Overall Study||41
11257500|NCT02221219|12452108|FG003|STARTED|Overall Study||92
11257501|NCT02221219|12452105|FG000|COMPLETED|Overall Study||36
11257502|NCT02221219|12452106|FG001|COMPLETED|Overall Study||87
11257503|NCT02221219|12452107|FG002|COMPLETED|Overall Study||41
11257504|NCT02221219|12452108|FG003|COMPLETED|Overall Study||92
11257505|NCT02221219|12452105|FG000|NOT COMPLETED|Overall Study||0
11257506|NCT02221219|12452106|FG001|NOT COMPLETED|Overall Study||0
11257507|NCT02221219|12452107|FG002|NOT COMPLETED|Overall Study||0
11257508|NCT02221219|12452108|FG003|NOT COMPLETED|Overall Study||0
11257509|NCT02221284|12452122|FG000|STARTED|Overall Study||964
11257510|NCT02221284|12452122|FG000|COMPLETED|Overall Study||903
11257511|NCT02221284|12452122|FG000|NOT COMPLETED|Overall Study||61
11257512|NCT02221349|12452134|FG000|STARTED|Overall Study||15
11257513|NCT02221349|12452135|FG001|STARTED|Overall Study||15
11257514|NCT02221349|12452134|FG000|COMPLETED|Overall Study||14
11257515|NCT02221349|12452135|FG001|COMPLETED|Overall Study||15
11257516|NCT02221349|12452134|FG000|NOT COMPLETED|Overall Study||1
11257517|NCT02221349|12452135|FG001|NOT COMPLETED|Overall Study||0
11257518|NCT02221557|12452141|FG000|STARTED|Overall Study||8
11257519|NCT02221557|12452141|FG000|COMPLETED|Overall Study||5
11257520|NCT02221557|12452141|FG000|NOT COMPLETED|Overall Study||3
11257521|NCT02221648|12452147|FG000|STARTED|Overall Study||22
11257522|NCT02221648|12452148|FG001|STARTED|Overall Study||21
11257523|NCT02221648|12452147|FG000|COMPLETED|Overall Study||19
11257524|NCT02221648|12452148|FG001|COMPLETED|Overall Study||18
11257525|NCT02221648|12452147|FG000|NOT COMPLETED|Overall Study||3
11257526|NCT02221648|12452148|FG001|NOT COMPLETED|Overall Study||3
11257527|NCT02221674|12452161|FG000|STARTED|Overall Study||8
11257528|NCT02221674|12452162|FG001|STARTED|Overall Study||6
11257529|NCT02221674|12452163|FG002|STARTED|Overall Study||5
11257530|NCT02221674|12452161|FG000|COMPLETED|Overall Study||7
11257531|NCT02221674|12452162|FG001|COMPLETED|Overall Study||6
11257532|NCT02221674|12452163|FG002|COMPLETED|Overall Study||5
11257533|NCT02221674|12452161|FG000|NOT COMPLETED|Overall Study||1
11257534|NCT02221674|12452162|FG001|NOT COMPLETED|Overall Study||0
11257535|NCT02221674|12452163|FG002|NOT COMPLETED|Overall Study||0
11257536|NCT02221739|12452174|FG000|STARTED|Overall Study||39
11257537|NCT02221739|12452174|FG000|COMPLETED|Overall Study||21
11257538|NCT02221739|12452174|FG000|NOT COMPLETED|Overall Study||18
11257539|NCT02221869|12452181|FG000|STARTED|Overall Study||31
11257540|NCT02221869|12452182|FG001|STARTED|Overall Study||32
11257541|NCT02221869|12452183|FG002|STARTED|Overall Study||43
11257542|NCT02221869|12452181|FG000|COMPLETED|Overall Study||30
11257543|NCT02221869|12452182|FG001|COMPLETED|Overall Study||32
11257544|NCT02221869|12452183|FG002|COMPLETED|Overall Study||33
11257545|NCT02221869|12452181|FG000|NOT COMPLETED|Overall Study||1
11257546|NCT02221869|12452182|FG001|NOT COMPLETED|Overall Study||0
11257547|NCT02221869|12452183|FG002|NOT COMPLETED|Overall Study||10
11257548|NCT02221882|12452195|FG000|STARTED|Overall Study||3
11257549|NCT02221882|12452196|FG001|STARTED|Overall Study||3
11257550|NCT02221882|12452197|FG002|STARTED|Overall Study||11
11257551|NCT02221882|12452198|FG003|STARTED|Overall Study||3
11257552|NCT02221882|12452199|FG004|STARTED|Overall Study||5
11257553|NCT02221882|12452200|FG005|STARTED|Overall Study||4
11257554|NCT02221882|12452195|FG000|Received at Least One Dose of Study Drug|Overall Study||3
11257555|NCT02221882|12452196|FG001|Received at Least One Dose of Study Drug|Overall Study||3
11257556|NCT02221882|12452197|FG002|Received at Least One Dose of Study Drug|Overall Study||11
11257557|NCT02221882|12452198|FG003|Received at Least One Dose of Study Drug|Overall Study||3
11257558|NCT02221882|12452199|FG004|Received at Least One Dose of Study Drug|Overall Study||5
11257559|NCT02221882|12452200|FG005|Received at Least One Dose of Study Drug|Overall Study||4
11257560|NCT02221882|12452195|FG000|COMPLETED|Overall Study||3
11257561|NCT02221882|12452196|FG001|COMPLETED|Overall Study||2
11257562|NCT02221882|12452197|FG002|COMPLETED|Overall Study||7
11257563|NCT02221882|12452198|FG003|COMPLETED|Overall Study||1
11257564|NCT02221882|12452199|FG004|COMPLETED|Overall Study||3
11257565|NCT02221882|12452200|FG005|COMPLETED|Overall Study||2
11257566|NCT02221882|12452195|FG000|NOT COMPLETED|Overall Study||0
11257567|NCT02221882|12452196|FG001|NOT COMPLETED|Overall Study||1
11257568|NCT02221882|12452197|FG002|NOT COMPLETED|Overall Study||4
11257569|NCT02221882|12452198|FG003|NOT COMPLETED|Overall Study||2
11257570|NCT02221882|12452199|FG004|NOT COMPLETED|Overall Study||2
11257571|NCT02221882|12452200|FG005|NOT COMPLETED|Overall Study||2
11257572|NCT02221947|12452221|FG000|STARTED|Overall Study||6
11257573|NCT02221947|12452222|FG001|STARTED|Overall Study||3
11257574|NCT02221947|12452221|FG000|COMPLETED|Overall Study||6
11257575|NCT02221947|12452222|FG001|COMPLETED|Overall Study||3
11257576|NCT02221947|12452221|FG000|NOT COMPLETED|Overall Study||0
11257577|NCT02221947|12452222|FG001|NOT COMPLETED|Overall Study||0
11257578|NCT02222129|12452233|FG000|STARTED|Overall Study||100
11257579|NCT02222129|12452234|FG001|STARTED|Overall Study||106
11257580|NCT02222129|12452233|FG000|COMPLETED|Overall Study||100
11257581|NCT02222129|12452234|FG001|COMPLETED|Overall Study||106
11257582|NCT02222129|12452233|FG000|NOT COMPLETED|Overall Study||0
11257583|NCT02222129|12452234|FG001|NOT COMPLETED|Overall Study||0
11257584|NCT02222181|12452240|FG000|STARTED|Overall Study||163
11257585|NCT02222181|12452240|FG000|COMPLETED|Overall Study||55
11257586|NCT02222181|12452240|FG000|NOT COMPLETED|Overall Study||108
11257587|NCT02222207|12452244|FG000|STARTED|Overall Study||52
11257588|NCT02222207|12452244|FG000|Treated and Valid for Full Analysis Set|Overall Study||51
11257589|NCT02222207|12452244|FG000|COMPLETED|Overall Study||48
11257590|NCT02222207|12452244|FG000|NOT COMPLETED|Overall Study||4
11257591|NCT02222246|12452250|FG000|STARTED|Overall Study||53
11257592|NCT02222246|12452251|FG001|STARTED|Overall Study||53
11257593|NCT02222246|12452250|FG000|COMPLETED|Overall Study||26
11257594|NCT02222246|12452251|FG001|COMPLETED|Overall Study||26
11257595|NCT02222246|12452250|FG000|NOT COMPLETED|Overall Study||27
11257596|NCT02222246|12452251|FG001|NOT COMPLETED|Overall Study||27
11257597|NCT02222337|12452261|FG000|STARTED|Overall Study||140
11257598|NCT02222337|12452262|FG001|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132
11257599|NCT02222337|12452261|FG000|COMPLETED|Overall Study||114
11257600|NCT02222337|12452262|FG001|COMPLETED|Overall Study||108
11257601|NCT02222337|12452261|FG000|NOT COMPLETED|Overall Study||26
11257602|NCT02222337|12452262|FG001|NOT COMPLETED|Overall Study||24
11257603|NCT02222493|12452274|FG000|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
11257604|NCT02222493|12452275|FG001|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
11257605|NCT02222493|12452274|FG000|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
11257606|NCT02222493|12452275|FG001|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
11257607|NCT02222493|12452274|FG000|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
11257608|NCT02222493|12452275|FG001|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
11257609|NCT02222493|12452274|FG000|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
11257610|NCT02222493|12452275|FG001|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
11257611|NCT02222493|12452274|FG000|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
11257612|NCT02222493|12452275|FG001|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
11257613|NCT02222493|12452274|FG000|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
11257614|NCT02222493|12452275|FG001|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
11257615|NCT02222493|12452274|FG000|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
11257616|NCT02222493|12452275|FG001|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
11257617|NCT02222493|12452274|FG000|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
11257618|NCT02222493|12452275|FG001|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
11257619|NCT02222493|12452274|FG000|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
11257620|NCT02222493|12452275|FG001|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
11257621|NCT02222493|12452274|FG000|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
11257622|NCT02222493|12452275|FG001|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
11257623|NCT02222558|12452294|FG000|STARTED|Period 1: Single Dose||25
11257624|NCT02222558|12452295|FG001|STARTED|Period 1: Single Dose||0
11257625|NCT02222558|12452296|FG002|STARTED|Period 1: Single Dose||0
11257626|NCT02222558|12452297|FG003|STARTED|Period 1: Single Dose||0
11257627|NCT02222558|12452298|FG004|STARTED|Period 1: Single Dose||0
11257628|NCT02222558|12452299|FG005|STARTED|Period 1: Single Dose||0
11257629|NCT02222558|12452294|FG000|COMPLETED|Period 1: Single Dose||21
11257630|NCT02222558|12452295|FG001|COMPLETED|Period 1: Single Dose||0
11257631|NCT02222558|12452296|FG002|COMPLETED|Period 1: Single Dose||0
11257632|NCT02222558|12452297|FG003|COMPLETED|Period 1: Single Dose||0
11257633|NCT02222558|12452298|FG004|COMPLETED|Period 1: Single Dose||0
11257634|NCT02222558|12452299|FG005|COMPLETED|Period 1: Single Dose||0
11257635|NCT02222558|12452294|FG000|NOT COMPLETED|Period 1: Single Dose||4
11257636|NCT02222558|12452295|FG001|NOT COMPLETED|Period 1: Single Dose||0
11257637|NCT02222558|12452296|FG002|NOT COMPLETED|Period 1: Single Dose||0
11257638|NCT02222558|12452297|FG003|NOT COMPLETED|Period 1: Single Dose||0
11257639|NCT02222558|12452298|FG004|NOT COMPLETED|Period 1: Single Dose||0
11257640|NCT02222558|12452299|FG005|NOT COMPLETED|Period 1: Single Dose||0
11257641|NCT02222558|12452294|FG000|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
11257642|NCT02222558|12452295|FG001|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
11257643|NCT02222558|12452296|FG002|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
11257644|NCT02222558|12452297|FG003|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
11257645|NCT02222558|12452298|FG004|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
11257646|NCT02222558|12452299|FG005|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
11257647|NCT02222558|12452294|FG000|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
11257648|NCT02222558|12452295|FG001|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
11257649|NCT02222558|12452296|FG002|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
11257650|NCT02222558|12452297|FG003|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
11257651|NCT02222558|12452298|FG004|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
11257652|NCT02222558|12452299|FG005|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
11257653|NCT02222558|12452294|FG000|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
11257654|NCT02222558|12452295|FG001|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
11257655|NCT02222558|12452296|FG002|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
11257656|NCT02222558|12452297|FG003|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
11257657|NCT02222558|12452298|FG004|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
11257658|NCT02222558|12452299|FG005|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
11257659|NCT02222558|12452294|FG000|STARTED|Period 3||0
11257660|NCT02222558|12452295|FG001|STARTED|Period 3||0
11257661|NCT02222558|12452296|FG002|STARTED|Period 3||4
11257662|NCT02222558|12452297|FG003|STARTED|Period 3||1
11257663|NCT02222558|12452298|FG004|STARTED|Period 3||8
11257664|NCT02222558|12452299|FG005|STARTED|Period 3||8
11257665|NCT02222558|12452294|FG000|COMPLETED|Period 3||0
11257666|NCT02222558|12452295|FG001|COMPLETED|Period 3||0
11257667|NCT02222558|12452296|FG002|COMPLETED|Period 3||4
11257668|NCT02222558|12452297|FG003|COMPLETED|Period 3||1
11257669|NCT02222558|12452298|FG004|COMPLETED|Period 3||8
11257670|NCT02222558|12452299|FG005|COMPLETED|Period 3||7
11257671|NCT02222558|12452294|FG000|NOT COMPLETED|Period 3||0
11257672|NCT02222558|12452295|FG001|NOT COMPLETED|Period 3||0
11257673|NCT02222558|12452296|FG002|NOT COMPLETED|Period 3||0
11257674|NCT02222558|12452297|FG003|NOT COMPLETED|Period 3||0
11257675|NCT02222558|12452298|FG004|NOT COMPLETED|Period 3||0
11257676|NCT02222558|12452299|FG005|NOT COMPLETED|Period 3||1
11257677|NCT02222610|12452316|FG000|STARTED|Baseline to W48||8
11257678|NCT02222610|12452317|FG001|STARTED|Baseline to W48||16
11257679|NCT02222610|12452318|FG002|STARTED|Baseline to W48||16
11257680|NCT02222610|12452316|FG000|COMPLETED|Baseline to W48||8
11257681|NCT02222610|12452317|FG001|COMPLETED|Baseline to W48||14
11257682|NCT02222610|12452318|FG002|COMPLETED|Baseline to W48||15
11257683|NCT02222610|12452316|FG000|NOT COMPLETED|Baseline to W48||0
11257684|NCT02222610|12452317|FG001|NOT COMPLETED|Baseline to W48||2
11257685|NCT02222610|12452318|FG002|NOT COMPLETED|Baseline to W48||1
11257686|NCT02222610|12452316|FG000|STARTED|Baseline to W104||8
11257687|NCT02222610|12452317|FG001|STARTED|Baseline to W104||16
11257688|NCT02222610|12452318|FG002|STARTED|Baseline to W104||16
11257689|NCT02222610|12452316|FG000|COMPLETED|Baseline to W104||8
11257690|NCT02222610|12452317|FG001|COMPLETED|Baseline to W104||11
11257691|NCT02222610|12452318|FG002|COMPLETED|Baseline to W104||10
11257692|NCT02222610|12452316|FG000|NOT COMPLETED|Baseline to W104||0
11257693|NCT02222610|12452317|FG001|NOT COMPLETED|Baseline to W104||5
11257694|NCT02222610|12452318|FG002|NOT COMPLETED|Baseline to W104||6
11257695|NCT02222688|12452333|FG000|STARTED|Overall Study||4
11257696|NCT02222688|12452334|FG001|STARTED|Overall Study||3
11257697|NCT02222688|12452335|FG002|STARTED|Overall Study||3
11257698|NCT02222688|12452336|FG003|STARTED|Overall Study||5
11257699|NCT02222688|12452337|FG004|STARTED|Overall Study||3
11257700|NCT02222688|12452338|FG005|STARTED|Overall Study||3
11257701|NCT02222688|12452339|FG006|STARTED|Overall Study||6
11257702|NCT02222688|12452333|FG000|COMPLETED|Overall Study||3
11257703|NCT02222688|12452334|FG001|COMPLETED|Overall Study||3
11257704|NCT02222688|12452335|FG002|COMPLETED|Overall Study||3
11257705|NCT02222688|12452336|FG003|COMPLETED|Overall Study||3
11257706|NCT02222688|12452337|FG004|COMPLETED|Overall Study||2
11257707|NCT02222688|12452338|FG005|COMPLETED|Overall Study||3
11257708|NCT02222688|12452339|FG006|COMPLETED|Overall Study||5
11257709|NCT02222688|12452333|FG000|NOT COMPLETED|Overall Study||1
11257710|NCT02222688|12452334|FG001|NOT COMPLETED|Overall Study||0
11257711|NCT02222688|12452335|FG002|NOT COMPLETED|Overall Study||0
11257712|NCT02222688|12452336|FG003|NOT COMPLETED|Overall Study||2
11257713|NCT02222688|12452337|FG004|NOT COMPLETED|Overall Study||1
11257714|NCT02222688|12452338|FG005|NOT COMPLETED|Overall Study||0
11257715|NCT02222688|12452339|FG006|NOT COMPLETED|Overall Study||1
11257716|NCT02222714|12452362|FG000|STARTED|Overall Study||15
11257717|NCT02222714|12452363|FG001|STARTED|Overall Study||24
11257718|NCT02222714|12452364|FG002|STARTED|Overall Study||12
11257719|NCT02222714|12452365|FG003|STARTED|Overall Study||15
11257720|NCT02222714|12452366|FG004|STARTED|Overall Study||44
11257721|NCT02222714|12452362|FG000|COMPLETED|Overall Study||15
11257722|NCT02222714|12452363|FG001|COMPLETED|Overall Study||22
11257723|NCT02222714|12452364|FG002|COMPLETED|Overall Study||8
11257724|NCT02222714|12452365|FG003|COMPLETED|Overall Study||11
11257725|NCT02222714|12452366|FG004|COMPLETED|Overall Study||37
11257726|NCT02222714|12452362|FG000|NOT COMPLETED|Overall Study||0
11257727|NCT02222714|12452363|FG001|NOT COMPLETED|Overall Study||2
11257728|NCT02222714|12452364|FG002|NOT COMPLETED|Overall Study||4
11257729|NCT02222714|12452365|FG003|NOT COMPLETED|Overall Study||4
11257730|NCT02222714|12452366|FG004|NOT COMPLETED|Overall Study||7
11257731|NCT02222818|12452383|FG000|STARTED|Period 1|Start of CAFR evaluation period|33
11257732|NCT02222818|12452384|FG001|STARTED|Period 1|Start of CAFRPlus evaluation period|33
11257733|NCT02222818|12452383|FG000|COMPLETED|Period 1|End of CAFR evaluation period|33
11257734|NCT02222818|12452384|FG001|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
11257735|NCT02222818|12452383|FG000|NOT COMPLETED|Period 1||0
11257736|NCT02222818|12452384|FG001|NOT COMPLETED|Period 1||3
11257737|NCT02222818|12452383|FG000|STARTED|Period 2|Start of CAFRPlus evaluation period|33
11257738|NCT02222818|12452384|FG001|STARTED|Period 2|Start of CAFR evaluation period|30
11257739|NCT02222818|12452383|FG000|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
11257740|NCT02222818|12452384|FG001|COMPLETED|Period 2|End of CAFR evaluation period|30
11257741|NCT02222818|12452383|FG000|NOT COMPLETED|Period 2||0
11257742|NCT02222818|12452384|FG001|NOT COMPLETED|Period 2||0
11257743|NCT02222870|12452391|FG000|STARTED|Overall Study||30
11257744|NCT02222870|12452392|FG001|STARTED|Overall Study||30
11257745|NCT02222870|12452391|FG000|COMPLETED|Overall Study||30
11257746|NCT02222870|12452392|FG001|COMPLETED|Overall Study||30
11257747|NCT02222870|12452391|FG000|NOT COMPLETED|Overall Study||0
11257748|NCT02222870|12452392|FG001|NOT COMPLETED|Overall Study||0
11257749|NCT02222896|12452398|FG000|STARTED|Abdomen||253
11257750|NCT02222896|12452399|FG001|STARTED|Abdomen||48
11257751|NCT02222896|12452400|FG002|STARTED|Abdomen||253
11257752|NCT02222896|12452398|FG000|COMPLETED|Abdomen||219
11257753|NCT02222896|12452399|FG001|COMPLETED|Abdomen||38
11257754|NCT02222896|12452400|FG002|COMPLETED|Abdomen||221
11257755|NCT02222896|12452398|FG000|NOT COMPLETED|Abdomen||34
11257756|NCT02222896|12452399|FG001|NOT COMPLETED|Abdomen||10
11257757|NCT02222896|12452400|FG002|NOT COMPLETED|Abdomen||32
11257758|NCT02222896|12452398|FG000|STARTED|Groin||254
11257759|NCT02222896|12452399|FG001|STARTED|Groin||48
11257760|NCT02222896|12452400|FG002|STARTED|Groin||250
11257761|NCT02222896|12452398|FG000|COMPLETED|Groin||211
11257762|NCT02222896|12452399|FG001|COMPLETED|Groin||39
11257763|NCT02222896|12452400|FG002|COMPLETED|Groin||210
11257764|NCT02222896|12452398|FG000|NOT COMPLETED|Groin||43
11257765|NCT02222896|12452399|FG001|NOT COMPLETED|Groin||9
11257766|NCT02222896|12452400|FG002|NOT COMPLETED|Groin||40
11257767|NCT02222922|12452420|FG000|STARTED|Overall Study||2
11257768|NCT02222922|12452421|FG001|STARTED|Overall Study||2
11257769|NCT02222922|12452422|FG002|STARTED|Overall Study||2
11257770|NCT02222922|12452423|FG003|STARTED|Overall Study||5
11257771|NCT02222922|12452424|FG004|STARTED|Overall Study||96
11257772|NCT02222922|12452425|FG005|STARTED|Overall Study||6
11257773|NCT02222922|12452426|FG006|STARTED|Overall Study||3
11257774|NCT02222922|12452427|FG007|STARTED|Overall Study||10
11257775|NCT02222922|12452428|FG008|STARTED|Overall Study||12
11257776|NCT02222922|12452420|FG000|Received Treatment|Overall Study||2
11257777|NCT02222922|12452421|FG001|Received Treatment|Overall Study||2
11257778|NCT02222922|12452422|FG002|Received Treatment|Overall Study||2
11257779|NCT02222922|12452423|FG003|Received Treatment|Overall Study||4
11257780|NCT02222922|12452424|FG004|Received Treatment|Overall Study||96
11257781|NCT02222922|12452425|FG005|Received Treatment|Overall Study||6
11257782|NCT02222922|12452426|FG006|Received Treatment|Overall Study||3
11257783|NCT02222922|12452427|FG007|Received Treatment|Overall Study||10
11257784|NCT02222922|12452428|FG008|Received Treatment|Overall Study||12
11257785|NCT02222922|12452420|FG000|COMPLETED|Overall Study||1
11257786|NCT02222922|12452421|FG001|COMPLETED|Overall Study||2
11257787|NCT02222922|12452422|FG002|COMPLETED|Overall Study||1
11257788|NCT02222922|12452423|FG003|COMPLETED|Overall Study||2
11257789|NCT02222922|12452424|FG004|COMPLETED|Overall Study||58
11257790|NCT02222922|12452425|FG005|COMPLETED|Overall Study||3
11257791|NCT02222922|12452426|FG006|COMPLETED|Overall Study||1
11257792|NCT02222922|12452427|FG007|COMPLETED|Overall Study||6
11257793|NCT02222922|12452428|FG008|COMPLETED|Overall Study||6
11257794|NCT02222922|12452420|FG000|NOT COMPLETED|Overall Study||1
11257795|NCT02222922|12452421|FG001|NOT COMPLETED|Overall Study||0
11257796|NCT02222922|12452422|FG002|NOT COMPLETED|Overall Study||1
11257797|NCT02222922|12452423|FG003|NOT COMPLETED|Overall Study||3
11257798|NCT02222922|12452424|FG004|NOT COMPLETED|Overall Study||38
11257799|NCT02222922|12452425|FG005|NOT COMPLETED|Overall Study||3
11257800|NCT02222922|12452426|FG006|NOT COMPLETED|Overall Study||2
11257801|NCT02222922|12452427|FG007|NOT COMPLETED|Overall Study||4
11257802|NCT02222922|12452428|FG008|NOT COMPLETED|Overall Study||6
11257803|NCT02223065|12452464|FG000|STARTED|Overall Study||18
11257804|NCT02223065|12452465|FG001|STARTED|Overall Study||18
11257805|NCT02223065|12452464|FG000|COMPLETED|Overall Study||18
11257806|NCT02223065|12452465|FG001|COMPLETED|Overall Study||18
11257807|NCT02223065|12452464|FG000|NOT COMPLETED|Overall Study||0
11257808|NCT02223065|12452465|FG001|NOT COMPLETED|Overall Study||0
11257809|NCT02223260|12452471|FG000|STARTED|Overall Study||8
11257810|NCT02223260|12452471|FG000|COMPLETED|Overall Study||8
11257811|NCT02223260|12452471|FG000|NOT COMPLETED|Overall Study||0
11257812|NCT02223338|12452477|FG000|STARTED|Overall Study||60
11257813|NCT02223338|12452478|FG001|STARTED|Overall Study||60
11257814|NCT02223338|12452477|FG000|COMPLETED|Overall Study||60
11257815|NCT02223338|12452478|FG001|COMPLETED|Overall Study||60
11257816|NCT02223338|12452477|FG000|NOT COMPLETED|Overall Study||0
11257817|NCT02223338|12452478|FG001|NOT COMPLETED|Overall Study||0
11257818|NCT02223351|12452486|FG000|STARTED|Overall Study||24
11257819|NCT02223351|12452487|FG001|STARTED|Overall Study||24
11257820|NCT02223351|12452486|FG000|First Intervention (8 Days)|Overall Study||24
11257821|NCT02223351|12452487|FG001|First Intervention (8 Days)|Overall Study||24
11257822|NCT02223351|12452486|FG000|Wasout (2weeks)|Overall Study||24
11257823|NCT02223351|12452487|FG001|Wasout (2weeks)|Overall Study||24
11257824|NCT02223351|12452486|FG000|Second Intervention (8 Days)|Overall Study||24
11257825|NCT02223351|12452487|FG001|Second Intervention (8 Days)|Overall Study||24
11257826|NCT02223351|12452486|FG000|COMPLETED|Overall Study||24
11257827|NCT02223351|12452487|FG001|COMPLETED|Overall Study||24
11257828|NCT02223351|12452486|FG000|NOT COMPLETED|Overall Study||0
11257829|NCT02223351|12452487|FG001|NOT COMPLETED|Overall Study||0
11257830|NCT02223364|12452504|FG000|STARTED|Overall Study||55
11257831|NCT02223364|12452505|FG001|STARTED|Overall Study||55
11257832|NCT02223364|12452506|FG002|STARTED|Overall Study||55
11257833|NCT02223364|12452504|FG000|COMPLETED|Overall Study||50
11257834|NCT02223364|12452505|FG001|COMPLETED|Overall Study||55
11257835|NCT02223364|12452506|FG002|COMPLETED|Overall Study||52
11257836|NCT02223364|12452504|FG000|NOT COMPLETED|Overall Study||5
11257837|NCT02223364|12452505|FG001|NOT COMPLETED|Overall Study||0
11257838|NCT02223364|12452506|FG002|NOT COMPLETED|Overall Study||3
11257839|NCT02223390|12452516|FG000|STARTED|Overall Study||32
11257840|NCT02223390|12452517|FG001|STARTED|Overall Study||32
11257841|NCT02223390|12452516|FG000|COMPLETED|Overall Study||23
11257842|NCT02223390|12452517|FG001|COMPLETED|Overall Study||28
11257843|NCT02223390|12452516|FG000|NOT COMPLETED|Overall Study||9
11257844|NCT02223390|12452517|FG001|NOT COMPLETED|Overall Study||4
11257845|NCT02223429|12452527|FG000|STARTED|Overall Study||8
11257846|NCT02223429|12452528|FG001|STARTED|Overall Study||8
11257847|NCT02223429|12452529|FG002|STARTED|Overall Study||8
11257848|NCT02223429|12452530|FG003|STARTED|Overall Study||8
11257849|NCT02223429|12452527|FG000|COMPLETED|Overall Study||7
11257850|NCT02223429|12452528|FG001|COMPLETED|Overall Study||8
11257851|NCT02223429|12452529|FG002|COMPLETED|Overall Study||8
11257852|NCT02223429|12452530|FG003|COMPLETED|Overall Study||8
11257853|NCT02223429|12452527|FG000|NOT COMPLETED|Overall Study||1
11257854|NCT02223429|12452528|FG001|NOT COMPLETED|Overall Study||0
11257855|NCT02223429|12452529|FG002|NOT COMPLETED|Overall Study||0
11257856|NCT02223429|12452530|FG003|NOT COMPLETED|Overall Study||0
11257857|NCT02223455|12452548|FG000|STARTED|Overall Study|Participant level data not collected.|
11257858|NCT02223455|12452549|FG001|STARTED|Overall Study|Participant level data not collected.|
11257859|NCT02223455|12452550|FG002|STARTED|Overall Study|Participant level data not collected.|
11257860|NCT02223455|12452548|FG000|COMPLETED|Overall Study|Participant level data not collected.|
11257861|NCT02223455|12452549|FG001|COMPLETED|Overall Study|Participant level data not collected.|
11257862|NCT02223455|12452550|FG002|COMPLETED|Overall Study|Participant level data not collected.|
11257863|NCT02223455|12452548|FG000|NOT COMPLETED|Overall Study||
11257864|NCT02223455|12452549|FG001|NOT COMPLETED|Overall Study||
11257865|NCT02223455|12452550|FG002|NOT COMPLETED|Overall Study||
11257866|NCT02223546|12452558|FG000|STARTED|Overall Study||15
11257867|NCT02223546|12452558|FG000|COMPLETED|Overall Study||15
11257868|NCT02223546|12452558|FG000|NOT COMPLETED|Overall Study||0
11257869|NCT02223637|12452562|FG000|STARTED|Overall Study||82
11257870|NCT02223637|12452562|FG000|COMPLETED|Overall Study||82
11257871|NCT02223637|12452562|FG000|NOT COMPLETED|Overall Study||0
11257872|NCT02223650|12452569|FG000|STARTED|Overall Study||27
11257873|NCT02223650|12452570|FG001|STARTED|Overall Study||31
11257874|NCT02223650|12452569|FG000|COMPLETED|Overall Study||27
11257875|NCT02223650|12452570|FG001|COMPLETED|Overall Study||31
11257876|NCT02223650|12452569|FG000|NOT COMPLETED|Overall Study||0
11257877|NCT02223650|12452570|FG001|NOT COMPLETED|Overall Study||0
11257878|NCT02223689|12452578|FG000|STARTED|Overall Study||35
11257879|NCT02223689|12452578|FG000|COMPLETED|Overall Study||35
11257880|NCT02223689|12452578|FG000|NOT COMPLETED|Overall Study||0
11257881|NCT02223702|12452585|FG000|STARTED|Overall Study||20
11257882|NCT02223702|12452586|FG001|STARTED|Overall Study||19
11141979|NCT01465659|12328651|FG003|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
11141980|NCT01465659|12328648|FG000|STARTED|Completed Follow for 1 Year||7
11141981|NCT01465659|12328649|FG001|STARTED|Completed Follow for 1 Year||4
11141982|NCT01465659|12328650|FG002|STARTED|Completed Follow for 1 Year||6
11141983|NCT01465659|12328651|FG003|STARTED|Completed Follow for 1 Year||11
11141984|NCT01465659|12328648|FG000|COMPLETED|Completed Follow for 1 Year||1
11141985|NCT01465659|12328649|FG001|COMPLETED|Completed Follow for 1 Year||1
11141986|NCT01465659|12328650|FG002|COMPLETED|Completed Follow for 1 Year||4
11141987|NCT01465659|12328651|FG003|COMPLETED|Completed Follow for 1 Year||7
11141988|NCT01465659|12328648|FG000|NOT COMPLETED|Completed Follow for 1 Year||6
11141989|NCT01465659|12328649|FG001|NOT COMPLETED|Completed Follow for 1 Year||3
11141990|NCT01465659|12328650|FG002|NOT COMPLETED|Completed Follow for 1 Year||2
11141991|NCT01465659|12328651|FG003|NOT COMPLETED|Completed Follow for 1 Year||4
11141992|NCT01465763|12328667|FG000|STARTED|Overall Study||476
11141993|NCT01465763|12328668|FG001|STARTED|Overall Study||16
11141994|NCT01465763|12328669|FG002|STARTED|Overall Study||122
11141995|NCT01465763|12328667|FG000|COMPLETED|Overall Study||445
11141996|NCT01465763|12328668|FG001|COMPLETED|Overall Study||15
11141997|NCT01465763|12328669|FG002|COMPLETED|Overall Study||118
11141998|NCT01465763|12328667|FG000|NOT COMPLETED|Overall Study||31
11141999|NCT01465763|12328668|FG001|NOT COMPLETED|Overall Study||1
11142000|NCT01465763|12328669|FG002|NOT COMPLETED|Overall Study||4
11142001|NCT01465802|12328681|FG000|STARTED|Overall Study||66
11142002|NCT01465802|12328682|FG001|STARTED|Overall Study||66
11142003|NCT01465802|12328683|FG002|STARTED|Overall Study||7
11142004|NCT01465802|12328684|FG003|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
11142005|NCT01465802|12328685|FG004|STARTED|Overall Study||25
11142006|NCT01465802|12328681|FG000|COMPLETED|Overall Study||33
11142007|NCT01465802|12328682|FG001|COMPLETED|Overall Study||42
11142008|NCT01465802|12328683|FG002|COMPLETED|Overall Study||7
11142009|NCT01465802|12328684|FG003|COMPLETED|Overall Study||38
11142010|NCT01465802|12328685|FG004|COMPLETED|Overall Study||13
11142011|NCT01465802|12328681|FG000|NOT COMPLETED|Overall Study||33
11257883|NCT02223702|12452585|FG000|COMPLETED|Overall Study||19
11257884|NCT02223702|12452586|FG001|COMPLETED|Overall Study||15
11257885|NCT02223702|12452585|FG000|NOT COMPLETED|Overall Study||1
11257886|NCT02223702|12452586|FG001|NOT COMPLETED|Overall Study||4
11257887|NCT02223715|12452592|FG000|STARTED|Overall Study||600
11257888|NCT02223715|12452592|FG000|COMPLETED|Overall Study||496
11257889|NCT02223715|12452592|FG000|NOT COMPLETED|Overall Study||104
11257890|NCT02223754|12452601|FG000|STARTED|Period 1||163
11257891|NCT02223754|12452602|FG001|STARTED|Period 1||159
11257892|NCT02223754|12452601|FG000|COMPLETED|Period 1||159
11257893|NCT02223754|12452602|FG001|COMPLETED|Period 1||144
11257894|NCT02223754|12452601|FG000|NOT COMPLETED|Period 1||4
11257895|NCT02223754|12452602|FG001|NOT COMPLETED|Period 1||15
11257896|NCT02223754|12452601|FG000|STARTED|Period 2||159
11257897|NCT02223754|12452602|FG001|STARTED|Period 2||144
11257898|NCT02223754|12452601|FG000|COMPLETED|Period 2||156
11257899|NCT02223754|12452602|FG001|COMPLETED|Period 2||141
11257900|NCT02223754|12452601|FG000|NOT COMPLETED|Period 2||3
11257901|NCT02223754|12452602|FG001|NOT COMPLETED|Period 2||3
11257902|NCT02223793|12452612|FG000|STARTED|Overall Study||185
11257903|NCT02223793|12452613|FG001|STARTED|Overall Study||199
11257904|NCT02223793|12452614|FG002|STARTED|Overall Study||198
11257905|NCT02223793|12452612|FG000|COMPLETED|Overall Study||168
11257906|NCT02223793|12452613|FG001|COMPLETED|Overall Study||190
11257907|NCT02223793|12452614|FG002|COMPLETED|Overall Study||185
11257908|NCT02223793|12452612|FG000|NOT COMPLETED|Overall Study||17
11257909|NCT02223793|12452613|FG001|NOT COMPLETED|Overall Study||9
11257910|NCT02223793|12452614|FG002|NOT COMPLETED|Overall Study||13
11257911|NCT02223858|12452624|FG000|STARTED|Overall Study||180
11257912|NCT02223858|12452625|FG001|STARTED|Overall Study||180
11257913|NCT02223858|12452624|FG000|1-month Follow-up|Overall Study||156
11257914|NCT02223858|12452625|FG001|1-month Follow-up|Overall Study||150
11257915|NCT02223858|12452624|FG000|3-month Follow-up|Overall Study||155
11257916|NCT02223858|12452625|FG001|3-month Follow-up|Overall Study||154
11257917|NCT02223858|12452624|FG000|6-month Follow-up|Overall Study||156
11257918|NCT02223858|12452625|FG001|6-month Follow-up|Overall Study||154
11257919|NCT02223858|12452624|FG000|COMPLETED|Overall Study||156
11257920|NCT02223858|12452625|FG001|COMPLETED|Overall Study||154
11257921|NCT02223858|12452624|FG000|NOT COMPLETED|Overall Study||24
11257922|NCT02223858|12452625|FG001|NOT COMPLETED|Overall Study||26
11257923|NCT02223871|12452631|FG000|STARTED|Overall Study||8
11257924|NCT02223871|12452631|FG000|COMPLETED|Overall Study||8
11257925|NCT02223871|12452631|FG000|NOT COMPLETED|Overall Study||0
11257926|NCT02224053|12452635|FG000|STARTED|AZD9291 and Omeprazole Co-administration||68
11257927|NCT02224053|12452635|FG000|COMPLETED|AZD9291 and Omeprazole Co-administration||47
11257928|NCT02224053|12452635|FG000|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
11257929|NCT02224053|12452635|FG000|STARTED|AZD9291 Alone||47
11257930|NCT02224053|12452635|FG000|COMPLETED|AZD9291 Alone||47
11257931|NCT02224053|12452635|FG000|NOT COMPLETED|AZD9291 Alone||0
11339846|NCT02918266|12537326|FG000|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339847|NCT02918266|12537327|FG001|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339848|NCT02918266|12537328|FG002|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339849|NCT02918266|12537329|FG003|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339850|NCT02918266|12537330|FG004|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339851|NCT02918266|12537331|FG005|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339852|NCT02918266|12537332|FG006|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339853|NCT02918266|12537333|FG007|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339854|NCT02918266|12537334|FG008|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339855|NCT02918266|12537335|FG009|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11257932|NCT02224157|12452643|FG000|STARTED|Overall Study||2095
11257933|NCT02224157|12452644|FG001|STARTED|Overall Study||2094
11257934|NCT02224157|12452643|FG000|Patients Who Completed Treatment|Overall Study||1924
11257935|NCT02224157|12452644|FG001|Patients Who Completed Treatment|Overall Study||1903
11257936|NCT02224157|12452643|FG000|COMPLETED|Overall Study||1985
11257937|NCT02224157|12452644|FG001|COMPLETED|Overall Study||1983
11257938|NCT02224157|12452643|FG000|NOT COMPLETED|Overall Study||110
11257939|NCT02224157|12452644|FG001|NOT COMPLETED|Overall Study||111
11257940|NCT02224274|12452652|FG000|STARTED|Overall Study||17
11257941|NCT02224274|12452653|FG001|STARTED|Overall Study||20
11257942|NCT02224274|12452652|FG000|COMPLETED|Overall Study||16
11257943|NCT02224274|12452653|FG001|COMPLETED|Overall Study||20
11257944|NCT02224274|12452652|FG000|NOT COMPLETED|Overall Study||1
11257945|NCT02224274|12452653|FG001|NOT COMPLETED|Overall Study||0
11257946|NCT02224313|12452661|FG000|STARTED|Overall Study||10
11257947|NCT02224313|12452662|FG001|STARTED|Overall Study||10
11257948|NCT02224313|12452661|FG000|COMPLETED|Overall Study||7
11257949|NCT02224313|12452662|FG001|COMPLETED|Overall Study||9
11257950|NCT02224313|12452661|FG000|NOT COMPLETED|Overall Study||3
11257951|NCT02224313|12452662|FG001|NOT COMPLETED|Overall Study||1
11257952|NCT02224404|12452668|FG000|STARTED|Overall Study||21
11257953|NCT02224404|12452668|FG000|COMPLETED|Overall Study||21
11257954|NCT02224404|12452668|FG000|NOT COMPLETED|Overall Study||0
11257955|NCT02224482|12452674|FG000|STARTED|Overall Study||214
11257956|NCT02224482|12452675|FG001|STARTED|Overall Study||217
11257957|NCT02224482|12452674|FG000|COMPLETED|Overall Study||63
11257958|NCT02224482|12452675|FG001|COMPLETED|Overall Study||57
11257959|NCT02224482|12452674|FG000|NOT COMPLETED|Overall Study||151
11257960|NCT02224482|12452675|FG001|NOT COMPLETED|Overall Study||160
11257961|NCT02224508|12452683|FG000|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
11257962|NCT02224508|12452684|FG001|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
11257963|NCT02224508|12452683|FG000|COMPLETED|Overall Study||935
11257964|NCT02224508|12452684|FG001|COMPLETED|Overall Study||653
11257965|NCT02224508|12452683|FG000|NOT COMPLETED|Overall Study||0
11257966|NCT02224508|12452684|FG001|NOT COMPLETED|Overall Study||0
11257967|NCT02224612|12452691|FG000|STARTED|Overall Study||48
11257968|NCT02224612|12452692|FG001|STARTED|Overall Study||48
11257969|NCT02224612|12452691|FG000|COMPLETED|Overall Study||48
11257970|NCT02224612|12452692|FG001|COMPLETED|Overall Study||48
11257971|NCT02224612|12452691|FG000|NOT COMPLETED|Overall Study||0
11257972|NCT02224612|12452692|FG001|NOT COMPLETED|Overall Study||0
11257973|NCT02224625|12452700|FG000|STARTED|Irritation||39
11257974|NCT02224625|12452700|FG000|COMPLETED|Irritation||33
11257975|NCT02224625|12452700|FG000|NOT COMPLETED|Irritation||6
11257976|NCT02224625|12452700|FG000|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
11257977|NCT02224625|12452700|FG000|COMPLETED|Sensitization||194
11257978|NCT02224625|12452700|FG000|NOT COMPLETED|Sensitization||55
11257979|NCT02224638|12452714|FG000|STARTED|Overall Study||11
11257980|NCT02224638|12452715|FG001|STARTED|Overall Study||10
11257981|NCT02224638|12452714|FG000|COMPLETED|Overall Study||10
11257982|NCT02224638|12452715|FG001|COMPLETED|Overall Study||9
11257983|NCT02224638|12452714|FG000|NOT COMPLETED|Overall Study||1
11257984|NCT02224638|12452715|FG001|NOT COMPLETED|Overall Study||1
11257985|NCT02224664|12452723|FG000|STARTED|Lead-in Period (3 Days)||50
11257986|NCT02224664|12452724|FG001|STARTED|Lead-in Period (3 Days)||0
11257987|NCT02224664|12452725|FG002|STARTED|Lead-in Period (3 Days)||0
11257988|NCT02224664|12452726|FG003|STARTED|Lead-in Period (3 Days)||0
11257989|NCT02224664|12452727|FG004|STARTED|Lead-in Period (3 Days)||0
11257990|NCT02224664|12452723|FG000|COMPLETED|Lead-in Period (3 Days)||45
11257991|NCT02224664|12452724|FG001|COMPLETED|Lead-in Period (3 Days)||0
11257992|NCT02224664|12452725|FG002|COMPLETED|Lead-in Period (3 Days)||0
11257993|NCT02224664|12452726|FG003|COMPLETED|Lead-in Period (3 Days)||0
11257994|NCT02224664|12452727|FG004|COMPLETED|Lead-in Period (3 Days)||0
11257995|NCT02224664|12452723|FG000|NOT COMPLETED|Lead-in Period (3 Days)||5
11257996|NCT02224664|12452724|FG001|NOT COMPLETED|Lead-in Period (3 Days)||0
11257997|NCT02224664|12452725|FG002|NOT COMPLETED|Lead-in Period (3 Days)||0
11257998|NCT02224664|12452726|FG003|NOT COMPLETED|Lead-in Period (3 Days)||0
11257999|NCT02224664|12452727|FG004|NOT COMPLETED|Lead-in Period (3 Days)||0
11258000|NCT02224664|12452723|FG000|STARTED|Dose Escalation Period (21 Days)||0
11258001|NCT02224664|12452724|FG001|STARTED|Dose Escalation Period (21 Days)||9
11258002|NCT02224664|12452725|FG002|STARTED|Dose Escalation Period (21 Days)||11
11258003|NCT02224664|12452726|FG003|STARTED|Dose Escalation Period (21 Days)||6
11258004|NCT02224664|12452727|FG004|STARTED|Dose Escalation Period (21 Days)||19
11258005|NCT02224664|12452723|FG000|COMPLETED|Dose Escalation Period (21 Days)||0
11258006|NCT02224664|12452724|FG001|COMPLETED|Dose Escalation Period (21 Days)||9
11258007|NCT02224664|12452725|FG002|COMPLETED|Dose Escalation Period (21 Days)||9
11258008|NCT02224664|12452726|FG003|COMPLETED|Dose Escalation Period (21 Days)||3
11258009|NCT02224664|12452727|FG004|COMPLETED|Dose Escalation Period (21 Days)||8
11258010|NCT02224664|12452723|FG000|NOT COMPLETED|Dose Escalation Period (21 Days)||0
11258011|NCT02224664|12452724|FG001|NOT COMPLETED|Dose Escalation Period (21 Days)||0
11258012|NCT02224664|12452725|FG002|NOT COMPLETED|Dose Escalation Period (21 Days)||2
11258013|NCT02224664|12452726|FG003|NOT COMPLETED|Dose Escalation Period (21 Days)||3
11258014|NCT02224664|12452727|FG004|NOT COMPLETED|Dose Escalation Period (21 Days)||11
11258015|NCT02224729|12452743|FG000|STARTED|Overall Study||24
11258016|NCT02224729|12452743|FG000|COMPLETED|Overall Study||24
11258017|NCT02224729|12452743|FG000|NOT COMPLETED|Overall Study||0
11258018|NCT02224820|12452747|FG000|STARTED|Overall Study||8
11258019|NCT02224820|12452747|FG000|COMPLETED|Overall Study|One patient did not receive full dose|8
11258020|NCT02224820|12452747|FG000|NOT COMPLETED|Overall Study||0
11258021|NCT02224846|12452753|FG000|STARTED|Period 1 (Month 3)||211
11258022|NCT02224846|12452754|FG001|STARTED|Period 1 (Month 3)||424
11258023|NCT02224846|12452753|FG000|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
11258024|NCT02224846|12452754|FG001|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
11258025|NCT02224846|12452753|FG000|COMPLETED|Period 1 (Month 3)||192
11258026|NCT02224846|12452754|FG001|COMPLETED|Period 1 (Month 3)||388
11258027|NCT02224846|12452753|FG000|NOT COMPLETED|Period 1 (Month 3)||19
11258028|NCT02224846|12452754|FG001|NOT COMPLETED|Period 1 (Month 3)||36
11258029|NCT02224846|12452753|FG000|STARTED|Period 2 (Month 3 to Month 12)||192
11258030|NCT02224846|12452754|FG001|STARTED|Period 2 (Month 3 to Month 12)||388
11258031|NCT02224846|12452753|FG000|COMPLETED|Period 2 (Month 3 to Month 12)||173
11258032|NCT02224846|12452754|FG001|COMPLETED|Period 2 (Month 3 to Month 12)||357
11258033|NCT02224846|12452753|FG000|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
11258034|NCT02224846|12452754|FG001|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
11358778|NCT03131167|12555947|FG007|COMPLETED|Overall Study||5
11358779|NCT03131167|12555948|FG008|COMPLETED|Overall Study||2
11358780|NCT03131167|12555949|FG009|COMPLETED|Overall Study||5
11358781|NCT03131167|12555950|FG010|COMPLETED|Overall Study||4
11358782|NCT03131167|12555951|FG011|COMPLETED|Overall Study||5
11358783|NCT03131167|12555952|FG012|COMPLETED|Overall Study||5
11358784|NCT03131167|12555940|FG000|NOT COMPLETED|Overall Study||0
11358785|NCT03131167|12555941|FG001|NOT COMPLETED|Overall Study||0
11358786|NCT03131167|12555942|FG002|NOT COMPLETED|Overall Study||0
11358787|NCT03131167|12555943|FG003|NOT COMPLETED|Overall Study||0
11358788|NCT03131167|12555944|FG004|NOT COMPLETED|Overall Study||0
11358789|NCT03131167|12555945|FG005|NOT COMPLETED|Overall Study||1
11358790|NCT03131167|12555946|FG006|NOT COMPLETED|Overall Study||0
11358791|NCT03131167|12555947|FG007|NOT COMPLETED|Overall Study||0
11358792|NCT03131167|12555948|FG008|NOT COMPLETED|Overall Study||0
11358793|NCT03131167|12555949|FG009|NOT COMPLETED|Overall Study||0
11358794|NCT03131167|12555950|FG010|NOT COMPLETED|Overall Study||0
11358795|NCT03131167|12555951|FG011|NOT COMPLETED|Overall Study||0
11358796|NCT03131167|12555952|FG012|NOT COMPLETED|Overall Study||0
11358797|NCT03131206|12555985|FG000|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
11358798|NCT03131206|12555986|FG001|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11358799|NCT03131206|12555987|FG002|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11358800|NCT03131206|12555988|FG003|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11358801|NCT03131206|12555985|FG000|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
11358802|NCT03131206|12555986|FG001|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11358803|NCT03131206|12555987|FG002|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11358804|NCT03131206|12555988|FG003|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11358805|NCT03131206|12555985|FG000|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11358806|NCT03131206|12555986|FG001|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11358807|NCT03131206|12555987|FG002|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11358808|NCT03131206|12555988|FG003|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
11358809|NCT03131206|12555985|FG000|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11358810|NCT03131206|12555986|FG001|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11358811|NCT03131206|12555987|FG002|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11258035|NCT02224846|12452753|FG000|STARTED|Period 2 (Month 12 to Month 24)||173
11258036|NCT02224846|12452754|FG001|STARTED|Period 2 (Month 12 to Month 24)||357
11258037|NCT02224846|12452753|FG000|COMPLETED|Period 2 (Month 12 to Month 24)||131
11258038|NCT02224846|12452754|FG001|COMPLETED|Period 2 (Month 12 to Month 24)||283
11258039|NCT02224846|12452753|FG000|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
11258040|NCT02224846|12452754|FG001|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
11258041|NCT02225080|12452760|FG000|STARTED|Overall Study||100
11258042|NCT02225080|12452760|FG000|COMPLETED|Overall Study||100
11258043|NCT02225080|12452760|FG000|NOT COMPLETED|Overall Study||0
11258044|NCT02225106|12452764|FG000|STARTED|Overall Study||11
11258045|NCT02225106|12452764|FG000|COMPLETED|Overall Study||11
11258046|NCT02225106|12452764|FG000|NOT COMPLETED|Overall Study||0
11258047|NCT02225132|12452768|FG000|STARTED|Overall Study||10
11258048|NCT02225132|12452768|FG000|COMPLETED|Overall Study||10
11258049|NCT02225132|12452768|FG000|NOT COMPLETED|Overall Study||0
11258050|NCT02225223|12452774|FG000|STARTED|Overall Study||27
11258051|NCT02225223|12452775|FG001|STARTED|Overall Study||8
11258052|NCT02225223|12452774|FG000|COMPLETED|Overall Study||8
11258053|NCT02225223|12452775|FG001|COMPLETED|Overall Study||3
11258054|NCT02225223|12452774|FG000|NOT COMPLETED|Overall Study||19
11258055|NCT02225223|12452775|FG001|NOT COMPLETED|Overall Study||5
11258056|NCT02225353|12452784|FG000|STARTED|Overall Study||91
11258057|NCT02225353|12452785|FG001|STARTED|Overall Study||90
11258058|NCT02225353|12452786|FG002|STARTED|Overall Study||90
11258059|NCT02225353|12452784|FG000|COMPLETED|Overall Study||87
11258060|NCT02225353|12452785|FG001|COMPLETED|Overall Study||84
11258061|NCT02225353|12452786|FG002|COMPLETED|Overall Study||75
11258062|NCT02225353|12452784|FG000|NOT COMPLETED|Overall Study||4
11258063|NCT02225353|12452785|FG001|NOT COMPLETED|Overall Study||6
11258064|NCT02225353|12452786|FG002|NOT COMPLETED|Overall Study||15
11258065|NCT02225587|12452799|FG000|STARTED|Overall Study||200
11258066|NCT02225587|12452800|FG001|STARTED|Overall Study||200
11258067|NCT02225587|12452799|FG000|Vaccination 2|Overall Study||188
11258068|NCT02225587|12452800|FG001|Vaccination 2|Overall Study||185
11258069|NCT02225587|12452799|FG000|Vaccination 3|Overall Study||172
11258070|NCT02225587|12452800|FG001|Vaccination 3|Overall Study||164
11258071|NCT02225587|12452799|FG000|COMPLETED|Overall Study||172
11258072|NCT02225587|12452800|FG001|COMPLETED|Overall Study||162
11258073|NCT02225587|12452799|FG000|NOT COMPLETED|Overall Study||28
11258074|NCT02225587|12452800|FG001|NOT COMPLETED|Overall Study||38
11258075|NCT02225665|12452808|FG000|STARTED|Overall Study||3
11258076|NCT02225665|12452809|FG001|STARTED|Overall Study||5
11258077|NCT02225665|12452808|FG000|COMPLETED|Overall Study||2
11258078|NCT02225665|12452809|FG001|COMPLETED|Overall Study||4
11258079|NCT02225665|12452808|FG000|NOT COMPLETED|Overall Study||1
11258080|NCT02225665|12452809|FG001|NOT COMPLETED|Overall Study||1
11258081|NCT02225743|12452815|FG000|STARTED|Overall Study||120
11258082|NCT02225743|12452815|FG000|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102
11258083|NCT02225743|12452815|FG000|NOT COMPLETED|Overall Study||18
11258084|NCT02225860|12452821|FG000|STARTED|Overall Study||17
11258085|NCT02225860|12452822|FG001|STARTED|Overall Study||17
11258086|NCT02225860|12452821|FG000|COMPLETED|Overall Study||16
11258087|NCT02225860|12452822|FG001|COMPLETED|Overall Study||17
11258088|NCT02225860|12452821|FG000|NOT COMPLETED|Overall Study||1
11258089|NCT02225860|12452822|FG001|NOT COMPLETED|Overall Study||0
11258090|NCT02226003|12452832|FG000|STARTED|Overall Study||98
11258091|NCT02226003|12452833|FG001|STARTED|Overall Study||96
11258092|NCT02226003|12452834|FG002|STARTED|Overall Study||97
11258093|NCT02226003|12452832|FG000|COMPLETED|Overall Study||96
11258094|NCT02226003|12452833|FG001|COMPLETED|Overall Study||95
11258095|NCT02226003|12452834|FG002|COMPLETED|Overall Study||91
11258096|NCT02226003|12452832|FG000|NOT COMPLETED|Overall Study||2
11258097|NCT02226003|12452833|FG001|NOT COMPLETED|Overall Study||1
11258098|NCT02226003|12452834|FG002|NOT COMPLETED|Overall Study||6
11258099|NCT02226120|12452842|FG000|STARTED|Overall Study||1980
11258100|NCT02226120|12452842|FG000|COMPLETED|Overall Study||1660
11258101|NCT02226120|12452842|FG000|NOT COMPLETED|Overall Study||320
11258102|NCT02226172|12452846|FG000|STARTED|Overall Study||21
11258103|NCT02226172|12452846|FG000|COMPLETED|Overall Study||4
11258104|NCT02226172|12452846|FG000|NOT COMPLETED|Overall Study||17
11258105|NCT02226198|12452850|FG000|STARTED|Lead-in Phase||11
11258106|NCT02226198|12452851|FG001|STARTED|Lead-in Phase||0
11258107|NCT02226198|12452852|FG002|STARTED|Lead-in Phase||0
11258108|NCT02226198|12452850|FG000|COMPLETED|Lead-in Phase||10
11258109|NCT02226198|12452851|FG001|COMPLETED|Lead-in Phase||0
11258110|NCT02226198|12452852|FG002|COMPLETED|Lead-in Phase||0
11258111|NCT02226198|12452850|FG000|NOT COMPLETED|Lead-in Phase||1
11258112|NCT02226198|12452851|FG001|NOT COMPLETED|Lead-in Phase||0
11258113|NCT02226198|12452852|FG002|NOT COMPLETED|Lead-in Phase||0
11258114|NCT02226198|12452850|FG000|STARTED|Cross-Over: First Intervention (6 Weeks)||0
11258115|NCT02226198|12452851|FG001|STARTED|Cross-Over: First Intervention (6 Weeks)||7
11258116|NCT02226198|12452852|FG002|STARTED|Cross-Over: First Intervention (6 Weeks)||7
11258117|NCT02226198|12452850|FG000|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
11258118|NCT02226198|12452851|FG001|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
11258119|NCT02226198|12452852|FG002|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
11258120|NCT02226198|12452850|FG000|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
11258121|NCT02226198|12452851|FG001|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
11258122|NCT02226198|12452852|FG002|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
11258123|NCT02226198|12452850|FG000|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
11258124|NCT02226198|12452851|FG001|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
11258125|NCT02226198|12452852|FG002|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
11258126|NCT02226198|12452850|FG000|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
11258127|NCT02226198|12452851|FG001|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
11258128|NCT02226198|12452852|FG002|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
11258129|NCT02226198|12452850|FG000|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
11258130|NCT02226198|12452851|FG001|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
11258131|NCT02226198|12452852|FG002|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
11258132|NCT02226198|12452850|FG000|STARTED|Maintenance Phase (12 Weeks)||13
11258133|NCT02226198|12452851|FG001|STARTED|Maintenance Phase (12 Weeks)||0
11258134|NCT02226198|12452852|FG002|STARTED|Maintenance Phase (12 Weeks)||0
11258135|NCT02226198|12452850|FG000|COMPLETED|Maintenance Phase (12 Weeks)||13
11258136|NCT02226198|12452851|FG001|COMPLETED|Maintenance Phase (12 Weeks)||0
11258137|NCT02226198|12452852|FG002|COMPLETED|Maintenance Phase (12 Weeks)||0
11258138|NCT02226198|12452850|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
11258139|NCT02226198|12452851|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
11258140|NCT02226198|12452852|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
11258141|NCT02226549|12452880|FG000|STARTED|Overall Study||23
11258142|NCT02226549|12452881|FG001|STARTED|Overall Study||24
11258143|NCT02226549|12452880|FG000|COMPLETED|Overall Study||22
11258144|NCT02226549|12452881|FG001|COMPLETED|Overall Study||23
11258145|NCT02226549|12452880|FG000|NOT COMPLETED|Overall Study||1
11258146|NCT02226549|12452881|FG001|NOT COMPLETED|Overall Study||1
11258147|NCT02226562|12452889|FG000|STARTED|Overall Study||95
11258148|NCT02226562|12452890|FG001|STARTED|Overall Study||96
11258149|NCT02226562|12452889|FG000|COMPLETED|Overall Study||95
11258150|NCT02226562|12452890|FG001|COMPLETED|Overall Study|Lost to follow up|95
11258151|NCT02226562|12452889|FG000|NOT COMPLETED|Overall Study||0
11258152|NCT02226562|12452890|FG001|NOT COMPLETED|Overall Study||1
11258153|NCT02226653|12452898|FG000|STARTED|Treatment Period 1 Fasted State||24
11258154|NCT02226653|12452899|FG001|STARTED|Treatment Period 1 Fasted State||24
11258155|NCT02226653|12452898|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
11258156|NCT02226653|12452899|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
11258157|NCT02226653|12452898|FG000|COMPLETED|Treatment Period 1 Fasted State||24
11258158|NCT02226653|12452899|FG001|COMPLETED|Treatment Period 1 Fasted State||24
11258159|NCT02226653|12452898|FG000|NOT COMPLETED|Treatment Period 1 Fasted State||0
11258160|NCT02226653|12452899|FG001|NOT COMPLETED|Treatment Period 1 Fasted State||0
11258161|NCT02226653|12452898|FG000|STARTED|Washout Period 1 (at Least 21 Days)||24
11258162|NCT02226653|12452899|FG001|STARTED|Washout Period 1 (at Least 21 Days)||24
11258163|NCT02226653|12452898|FG000|COMPLETED|Washout Period 1 (at Least 21 Days)||24
11258164|NCT02226653|12452899|FG001|COMPLETED|Washout Period 1 (at Least 21 Days)||24
11258165|NCT02226653|12452898|FG000|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
11258166|NCT02226653|12452899|FG001|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
11258167|NCT02226653|12452898|FG000|STARTED|Treatment Period 2 Fasted State||24
11258168|NCT02226653|12452899|FG001|STARTED|Treatment Period 2 Fasted State||24
11258169|NCT02226653|12452898|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
11258170|NCT02226653|12452899|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
11258171|NCT02226653|12452898|FG000|COMPLETED|Treatment Period 2 Fasted State||23
11258172|NCT02226653|12452899|FG001|COMPLETED|Treatment Period 2 Fasted State||24
11258173|NCT02226653|12452898|FG000|NOT COMPLETED|Treatment Period 2 Fasted State||1
11258174|NCT02226653|12452899|FG001|NOT COMPLETED|Treatment Period 2 Fasted State||0
11258175|NCT02226653|12452898|FG000|STARTED|Washout Period 2 (at Least 21 Days)||23
11258176|NCT02226653|12452899|FG001|STARTED|Washout Period 2 (at Least 21 Days)||24
11258177|NCT02226653|12452898|FG000|COMPLETED|Washout Period 2 (at Least 21 Days)||23
11258178|NCT02226653|12452899|FG001|COMPLETED|Washout Period 2 (at Least 21 Days)||24
11258179|NCT02226653|12452898|FG000|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
11258180|NCT02226653|12452899|FG001|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
11258181|NCT02226653|12452898|FG000|STARTED|Treatment Period 3 Fasted State||23
11258182|NCT02226653|12452899|FG001|STARTED|Treatment Period 3 Fasted State||24
11258183|NCT02226653|12452898|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
11258184|NCT02226653|12452899|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
11258185|NCT02226653|12452898|FG000|COMPLETED|Treatment Period 3 Fasted State||23
11258186|NCT02226653|12452899|FG001|COMPLETED|Treatment Period 3 Fasted State||24
11258187|NCT02226653|12452898|FG000|NOT COMPLETED|Treatment Period 3 Fasted State||0
11258188|NCT02226653|12452899|FG001|NOT COMPLETED|Treatment Period 3 Fasted State||0
11258189|NCT02226653|12452898|FG000|STARTED|Washout Period 3 (at Least 21 Days)||23
11258190|NCT02226653|12452899|FG001|STARTED|Washout Period 3 (at Least 21 Days)||24
11258191|NCT02226653|12452898|FG000|COMPLETED|Washout Period 3 (at Least 21 Days)||23
11258192|NCT02226653|12452899|FG001|COMPLETED|Washout Period 3 (at Least 21 Days)||24
11258193|NCT02226653|12452898|FG000|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
11258194|NCT02226653|12452899|FG001|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
11258195|NCT02226653|12452898|FG000|STARTED|Treatment Period 4 Fasted State||23
11258196|NCT02226653|12452899|FG001|STARTED|Treatment Period 4 Fasted State||24
11258197|NCT02226653|12452898|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
11258198|NCT02226653|12452899|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
11258199|NCT02226653|12452898|FG000|COMPLETED|Treatment Period 4 Fasted State||23
11258200|NCT02226653|12452899|FG001|COMPLETED|Treatment Period 4 Fasted State||24
11258201|NCT02226653|12452898|FG000|NOT COMPLETED|Treatment Period 4 Fasted State||0
11258202|NCT02226653|12452899|FG001|NOT COMPLETED|Treatment Period 4 Fasted State||0
11258203|NCT02226653|12452898|FG000|STARTED|Washout Period 4 (at Least 21 Days)||23
11258204|NCT02226653|12452899|FG001|STARTED|Washout Period 4 (at Least 21 Days)||24
11258205|NCT02226653|12452898|FG000|COMPLETED|Washout Period 4 (at Least 21 Days)||23
11258206|NCT02226653|12452899|FG001|COMPLETED|Washout Period 4 (at Least 21 Days)||24
11258207|NCT02226653|12452898|FG000|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
11258208|NCT02226653|12452899|FG001|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
11258209|NCT02226653|12452898|FG000|STARTED|Treatment Period 5 Fed State||23
11258210|NCT02226653|12452899|FG001|STARTED|Treatment Period 5 Fed State||24
11258211|NCT02226653|12452898|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
11258212|NCT02226653|12452899|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
11258213|NCT02226653|12452898|FG000|COMPLETED|Treatment Period 5 Fed State||23
11258214|NCT02226653|12452899|FG001|COMPLETED|Treatment Period 5 Fed State||23
11258215|NCT02226653|12452898|FG000|NOT COMPLETED|Treatment Period 5 Fed State||0
11258216|NCT02226653|12452899|FG001|NOT COMPLETED|Treatment Period 5 Fed State||1
11258217|NCT02226653|12452898|FG000|STARTED|Washout Period 5 (at Least 21 Days)||23
11258218|NCT02226653|12452899|FG001|STARTED|Washout Period 5 (at Least 21 Days)||23
11258219|NCT02226653|12452898|FG000|COMPLETED|Washout Period 5 (at Least 21 Days)||23
11258220|NCT02226653|12452899|FG001|COMPLETED|Washout Period 5 (at Least 21 Days)||23
11258221|NCT02226653|12452898|FG000|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
11258222|NCT02226653|12452899|FG001|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
11258223|NCT02226796|12452912|FG000|STARTED|First Intervention Phase (Week 1)||2
11258224|NCT02226796|12452913|FG001|STARTED|First Intervention Phase (Week 1)||1
11258225|NCT02226796|12452912|FG000|Baseline Assessment|First Intervention Phase (Week 1)||2
11258226|NCT02226796|12452913|FG001|Baseline Assessment|First Intervention Phase (Week 1)||1
11258227|NCT02226796|12452912|FG000|Follow Up Assessment|First Intervention Phase (Week 1)||2
11258228|NCT02226796|12452913|FG001|Follow Up Assessment|First Intervention Phase (Week 1)||1
11258229|NCT02226796|12452912|FG000|COMPLETED|First Intervention Phase (Week 1)||2
11258230|NCT02226796|12452913|FG001|COMPLETED|First Intervention Phase (Week 1)||1
11258231|NCT02226796|12452912|FG000|NOT COMPLETED|First Intervention Phase (Week 1)||0
11258232|NCT02226796|12452913|FG001|NOT COMPLETED|First Intervention Phase (Week 1)||0
11258233|NCT02226796|12452912|FG000|STARTED|Washout (Weeks 2-5)||2
11258234|NCT02226796|12452913|FG001|STARTED|Washout (Weeks 2-5)||1
11258235|NCT02226796|12452912|FG000|COMPLETED|Washout (Weeks 2-5)||2
11258236|NCT02226796|12452913|FG001|COMPLETED|Washout (Weeks 2-5)||1
11258237|NCT02226796|12452912|FG000|NOT COMPLETED|Washout (Weeks 2-5)||0
11258238|NCT02226796|12452913|FG001|NOT COMPLETED|Washout (Weeks 2-5)||0
11258239|NCT02226796|12452912|FG000|STARTED|Second Intervention Phase (Week 6)||2
11258240|NCT02226796|12452913|FG001|STARTED|Second Intervention Phase (Week 6)||1
11258241|NCT02226796|12452912|FG000|Baseline Assessment|Second Intervention Phase (Week 6)||2
11258242|NCT02226796|12452913|FG001|Baseline Assessment|Second Intervention Phase (Week 6)||1
11258243|NCT02226796|12452912|FG000|Follow Up Assessment|Second Intervention Phase (Week 6)||2
11258244|NCT02226796|12452913|FG001|Follow Up Assessment|Second Intervention Phase (Week 6)||1
11258245|NCT02226796|12452912|FG000|COMPLETED|Second Intervention Phase (Week 6)||2
11258246|NCT02226796|12452913|FG001|COMPLETED|Second Intervention Phase (Week 6)||1
11258247|NCT02226796|12452912|FG000|NOT COMPLETED|Second Intervention Phase (Week 6)||0
11358812|NCT03131206|12555988|FG003|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11258248|NCT02226796|12452913|FG001|NOT COMPLETED|Second Intervention Phase (Week 6)||0
11258249|NCT02226965|12452919|FG000|STARTED|Overall Study||45
11258250|NCT02226965|12452919|FG000|COMPLETED|Overall Study||4
11258251|NCT02226965|12452919|FG000|NOT COMPLETED|Overall Study||41
11258252|NCT02227108|12452923|FG000|STARTED|Overall Study||32
11258253|NCT02227108|12452923|FG000|Treated|Overall Study||30
11258254|NCT02227108|12452923|FG000|COMPLETED|Overall Study||1
11258255|NCT02227108|12452923|FG000|NOT COMPLETED|Overall Study||31
11258256|NCT02227121|12452927|FG000|STARTED|Overall Study||16
11258257|NCT02227121|12452927|FG000|COMPLETED|Overall Study||16
11258258|NCT02227121|12452927|FG000|NOT COMPLETED|Overall Study||0
11258259|NCT02227316|12452935|FG000|STARTED|Overall Study||4
11258260|NCT02227316|12452936|FG001|STARTED|Overall Study||4
11258261|NCT02227316|12452937|FG002|STARTED|Overall Study||16
11258262|NCT02227316|12452938|FG003|STARTED|Overall Study||16
11258263|NCT02227316|12452935|FG000|COMPLETED|Overall Study||4
11258264|NCT02227316|12452936|FG001|COMPLETED|Overall Study||4
11258265|NCT02227316|12452937|FG002|COMPLETED|Overall Study||16
11258266|NCT02227316|12452938|FG003|COMPLETED|Overall Study||16
11258267|NCT02227316|12452935|FG000|NOT COMPLETED|Overall Study||0
11258268|NCT02227316|12452936|FG001|NOT COMPLETED|Overall Study||0
11258269|NCT02227316|12452937|FG002|NOT COMPLETED|Overall Study||0
11258270|NCT02227316|12452938|FG003|NOT COMPLETED|Overall Study||0
11258271|NCT02227329|12452950|FG000|STARTED|Overall Study||18
11258272|NCT02227329|12452951|FG001|STARTED|Overall Study||20
11258273|NCT02227329|12452950|FG000|COMPLETED|Overall Study||18
11258274|NCT02227329|12452951|FG001|COMPLETED|Overall Study||20
11258275|NCT02227329|12452950|FG000|NOT COMPLETED|Overall Study||0
11258276|NCT02227329|12452951|FG001|NOT COMPLETED|Overall Study||0
11258277|NCT02227368|12452959|FG000|STARTED|Overall Study||16
11258278|NCT02227368|12452960|FG001|STARTED|Overall Study||24
11258279|NCT02227368|12452959|FG000|Sujects Who Received Treatment|Overall Study||16
11258280|NCT02227368|12452960|FG001|Sujects Who Received Treatment|Overall Study||24
11258281|NCT02227368|12452959|FG000|Sujects Who Completed Treatment|Overall Study||10
11258282|NCT02227368|12452960|FG001|Sujects Who Completed Treatment|Overall Study||17
11258283|NCT02227368|12452959|FG000|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
11258284|NCT02227368|12452960|FG001|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
11258285|NCT02227368|12452959|FG000|NOT COMPLETED|Overall Study||2
11258286|NCT02227368|12452960|FG001|NOT COMPLETED|Overall Study||4
11258287|NCT02227446|12452968|FG000|STARTED|Overall Study||521
11258288|NCT02227446|12452969|FG001|STARTED|Overall Study||515
11258289|NCT02227446|12452968|FG000|COMPLETED|Overall Study||499
11258290|NCT02227446|12452969|FG001|COMPLETED|Overall Study||481
11258291|NCT02227446|12452968|FG000|NOT COMPLETED|Overall Study||22
11258292|NCT02227446|12452969|FG001|NOT COMPLETED|Overall Study||34
11258293|NCT02227485|12452977|FG000|STARTED|First Follow-up||40
11258294|NCT02227485|12452978|FG001|STARTED|First Follow-up||40
11258295|NCT02227485|12452977|FG000|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
11258296|NCT02227485|12452978|FG001|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
11258297|NCT02227485|12452977|FG000|NOT COMPLETED|First Follow-up||4
11258298|NCT02227485|12452978|FG001|NOT COMPLETED|First Follow-up||2
11258299|NCT02227485|12452977|FG000|STARTED|Second Follow-up||36
11258300|NCT02227485|12452978|FG001|STARTED|Second Follow-up||38
11258301|NCT02227485|12452977|FG000|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
11258302|NCT02227485|12452978|FG001|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
11258303|NCT02227485|12452977|FG000|NOT COMPLETED|Second Follow-up||2
11258304|NCT02227485|12452978|FG001|NOT COMPLETED|Second Follow-up||2
11258305|NCT02227667|12452985|FG000|STARTED|Overall Study||16
11258306|NCT02227667|12452985|FG000|COMPLETED|Overall Study||16
11258307|NCT02227667|12452985|FG000|NOT COMPLETED|Overall Study||0
11258308|NCT02227693|12452993|FG000|STARTED|Overall Study||11
11258309|NCT02227693|12452994|FG001|STARTED|Overall Study||7
11258310|NCT02227693|12452995|FG002|STARTED|Overall Study||11
11258311|NCT02227693|12452996|FG003|STARTED|Overall Study||10
11258312|NCT02227693|12452993|FG000|COMPLETED|Overall Study||11
11258313|NCT02227693|12452994|FG001|COMPLETED|Overall Study||7
11258314|NCT02227693|12452995|FG002|COMPLETED|Overall Study||11
11258315|NCT02227693|12452996|FG003|COMPLETED|Overall Study||10
11258316|NCT02227693|12452993|FG000|NOT COMPLETED|Overall Study||0
11258317|NCT02227693|12452994|FG001|NOT COMPLETED|Overall Study||0
11258318|NCT02227693|12452995|FG002|NOT COMPLETED|Overall Study||0
11258319|NCT02227693|12452996|FG003|NOT COMPLETED|Overall Study||0
11258320|NCT02227706|12453012|FG000|STARTED|Overall Study||20
11258321|NCT02227706|12453013|FG001|STARTED|Overall Study||20
11258322|NCT02227706|12453012|FG000|COMPLETED|Overall Study||20
11258323|NCT02227706|12453013|FG001|COMPLETED|Overall Study||20
11258324|NCT02227706|12453012|FG000|NOT COMPLETED|Overall Study||0
11258325|NCT02227706|12453013|FG001|NOT COMPLETED|Overall Study||0
11258326|NCT02227758|12453019|FG000|STARTED|Overall Study||112
11258327|NCT02227758|12453019|FG000|COMPLETED|Overall Study||45
11258328|NCT02227758|12453019|FG000|NOT COMPLETED|Overall Study||67
11258329|NCT02227784|12453029|FG000|STARTED|Double-Blind Phase||123
11258330|NCT02227784|12453030|FG001|STARTED|Double-Blind Phase||54
11258331|NCT02227784|12453031|FG002|STARTED|Double-Blind Phase||62
11258332|NCT02227784|12453032|FG003|STARTED|Double-Blind Phase||127
11258333|NCT02227784|12453033|FG004|STARTED|Double-Blind Phase||0
11258334|NCT02227784|12453029|FG000|COMPLETED|Double-Blind Phase||83
11258335|NCT02227784|12453030|FG001|COMPLETED|Double-Blind Phase||36
11258336|NCT02227784|12453031|FG002|COMPLETED|Double-Blind Phase||41
11258337|NCT02227784|12453032|FG003|COMPLETED|Double-Blind Phase||88
11258338|NCT02227784|12453033|FG004|COMPLETED|Double-Blind Phase||0
11258339|NCT02227784|12453029|FG000|NOT COMPLETED|Double-Blind Phase||40
11258340|NCT02227784|12453030|FG001|NOT COMPLETED|Double-Blind Phase||18
11258341|NCT02227784|12453031|FG002|NOT COMPLETED|Double-Blind Phase||21
11258342|NCT02227784|12453032|FG003|NOT COMPLETED|Double-Blind Phase||39
11258343|NCT02227784|12453033|FG004|NOT COMPLETED|Double-Blind Phase||0
11258344|NCT02227784|12453029|FG000|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
11258345|NCT02227784|12453030|FG001|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
11258346|NCT02227784|12453031|FG002|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
11258347|NCT02227784|12453032|FG003|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
11258348|NCT02227784|12453033|FG004|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
11258349|NCT02227784|12453029|FG000|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
11258350|NCT02227784|12453030|FG001|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
11258351|NCT02227784|12453031|FG002|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
11258352|NCT02227784|12453032|FG003|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
11258353|NCT02227784|12453033|FG004|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
11258354|NCT02227784|12453029|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0
11258355|NCT02227784|12453030|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0
11258356|NCT02227784|12453031|FG002|COMPLETED|Open-Label Extension Phase (OLE)||0
11258357|NCT02227784|12453032|FG003|COMPLETED|Open-Label Extension Phase (OLE)||0
11258358|NCT02227784|12453033|FG004|COMPLETED|Open-Label Extension Phase (OLE)||0
11258359|NCT02227784|12453029|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
11258360|NCT02227784|12453030|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
11258361|NCT02227784|12453031|FG002|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
11258362|NCT02227784|12453032|FG003|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
11258363|NCT02227784|12453033|FG004|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
11258364|NCT02227810|12453048|FG000|STARTED|Overall Study||19
11258365|NCT02227810|12453049|FG001|STARTED|Overall Study||34
11258366|NCT02227810|12453048|FG000|COMPLETED|Overall Study||17
11258367|NCT02227810|12453049|FG001|COMPLETED|Overall Study||29
11258368|NCT02227810|12453048|FG000|NOT COMPLETED|Overall Study||2
11258369|NCT02227810|12453049|FG001|NOT COMPLETED|Overall Study||5
11258370|NCT02227836|12453057|FG000|STARTED|Overall Study||8
11258371|NCT02227836|12453057|FG000|COMPLETED|Overall Study||8
11258372|NCT02227836|12453057|FG000|NOT COMPLETED|Overall Study||0
11258373|NCT02227849|12453061|FG000|STARTED|Overall Study||71
11258374|NCT02227849|12453061|FG000|COMPLETED|Overall Study||63
11258375|NCT02227849|12453061|FG000|NOT COMPLETED|Overall Study||8
11258376|NCT02228096|12453067|FG000|STARTED|Overall Study||75
11258377|NCT02228096|12453067|FG000|Enrolled Into Long-term f/u Protocol|Overall Study||31
11258378|NCT02228096|12453067|FG000|Enrolled But Not Infused|Overall Study||11
11258379|NCT02228096|12453067|FG000|Enrolled and Infused|Overall Study||64
11258380|NCT02228096|12453067|FG000|COMPLETED|Overall Study|Completed = study follow-up completed|4
11258381|NCT02228096|12453067|FG000|NOT COMPLETED|Overall Study||71
11258382|NCT02228174|12453085|FG000|STARTED|Overall Study||147
11258383|NCT02228174|12453085|FG000|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143
11258384|NCT02228174|12453085|FG000|COMPLETED|Overall Study||142
11258385|NCT02228174|12453085|FG000|NOT COMPLETED|Overall Study||5
11258386|NCT02228395|12453089|FG000|STARTED|First Intervention Period||3
11258387|NCT02228395|12453090|FG001|STARTED|First Intervention Period||3
11258388|NCT02228395|12453091|FG002|STARTED|First Intervention Period||3
11258389|NCT02228395|12453089|FG000|COMPLETED|First Intervention Period||2
11258390|NCT02228395|12453090|FG001|COMPLETED|First Intervention Period||2
11258391|NCT02228395|12453091|FG002|COMPLETED|First Intervention Period||2
11258392|NCT02228395|12453089|FG000|NOT COMPLETED|First Intervention Period||1
11258393|NCT02228395|12453090|FG001|NOT COMPLETED|First Intervention Period||1
11258394|NCT02228395|12453091|FG002|NOT COMPLETED|First Intervention Period||1
11258395|NCT02228395|12453089|FG000|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
11258396|NCT02228395|12453090|FG001|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
11258397|NCT02228395|12453091|FG002|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
11258398|NCT02228395|12453089|FG000|COMPLETED|Washout Period (at Least 10 Days)||3
11258399|NCT02228395|12453090|FG001|COMPLETED|Washout Period (at Least 10 Days)||3
11258400|NCT02228395|12453091|FG002|COMPLETED|Washout Period (at Least 10 Days)||3
11258401|NCT02228395|12453089|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0
11258402|NCT02228395|12453090|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0
11258403|NCT02228395|12453091|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0
11258404|NCT02228395|12453089|FG000|STARTED|Second Intervention Period||3
11258405|NCT02228395|12453090|FG001|STARTED|Second Intervention Period||3
11258406|NCT02228395|12453091|FG002|STARTED|Second Intervention Period||3
11258407|NCT02228395|12453089|FG000|COMPLETED|Second Intervention Period||3
11258408|NCT02228395|12453090|FG001|COMPLETED|Second Intervention Period||3
11258409|NCT02228395|12453091|FG002|COMPLETED|Second Intervention Period||3
11258410|NCT02228395|12453089|FG000|NOT COMPLETED|Second Intervention Period||0
11258411|NCT02228395|12453090|FG001|NOT COMPLETED|Second Intervention Period||0
11258412|NCT02228395|12453091|FG002|NOT COMPLETED|Second Intervention Period||0
11258413|NCT02228395|12453089|FG000|STARTED|Washout Period (at Least 10 Days)||3
11258414|NCT02228395|12453090|FG001|STARTED|Washout Period (at Least 10 Days)||3
11258415|NCT02228395|12453091|FG002|STARTED|Washout Period (at Least 10 Days)||3
11005464|NCT00723021|12183145|FG004|NOT COMPLETED|Intervention Period 3||0
11005465|NCT00723021|12183141|FG000|STARTED|Intervention Period 4||3
11005466|NCT00723021|12183142|FG001|STARTED|Intervention Period 4||3
11005467|NCT00723021|12183143|FG002|STARTED|Intervention Period 4||3
11005468|NCT00723021|12183144|FG003|STARTED|Intervention Period 4||3
11005469|NCT00723021|12183145|FG004|STARTED|Intervention Period 4||3
11005470|NCT00723021|12183141|FG000|COMPLETED|Intervention Period 4||3
11258416|NCT02228395|12453089|FG000|COMPLETED|Washout Period (at Least 10 Days)||3
11258417|NCT02228395|12453090|FG001|COMPLETED|Washout Period (at Least 10 Days)||3
11258418|NCT02228395|12453091|FG002|COMPLETED|Washout Period (at Least 10 Days)||3
11258419|NCT02228395|12453089|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0
11258420|NCT02228395|12453090|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0
11258421|NCT02228395|12453091|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0
11258422|NCT02228395|12453089|FG000|STARTED|Third Intervention Period||3
11258423|NCT02228395|12453090|FG001|STARTED|Third Intervention Period||3
11258424|NCT02228395|12453091|FG002|STARTED|Third Intervention Period||3
11258425|NCT02228395|12453089|FG000|COMPLETED|Third Intervention Period||3
11258426|NCT02228395|12453090|FG001|COMPLETED|Third Intervention Period||3
11258427|NCT02228395|12453091|FG002|COMPLETED|Third Intervention Period||3
11258428|NCT02228395|12453089|FG000|NOT COMPLETED|Third Intervention Period||0
11258429|NCT02228395|12453090|FG001|NOT COMPLETED|Third Intervention Period||0
11258430|NCT02228395|12453091|FG002|NOT COMPLETED|Third Intervention Period||0
11258431|NCT02228408|12453103|FG000|STARTED|Overall Study||7
11258432|NCT02228408|12453104|FG001|STARTED|Overall Study||10
11258433|NCT02228408|12453103|FG000|COMPLETED|Overall Study||7
11258434|NCT02228408|12453104|FG001|COMPLETED|Overall Study||10
11258435|NCT02228408|12453103|FG000|NOT COMPLETED|Overall Study||0
11258436|NCT02228408|12453104|FG001|NOT COMPLETED|Overall Study||0
11258437|NCT02228460|12453110|FG000|STARTED|Overall Study||11
11258438|NCT02228460|12453110|FG000|COMPLETED|Overall Study||9
11258439|NCT02228460|12453110|FG000|NOT COMPLETED|Overall Study||2
11258440|NCT02228499|12453117|FG000|STARTED|Overall Study||30
11258441|NCT02228499|12453118|FG001|STARTED|Overall Study||36
11258442|NCT02228499|12453117|FG000|COMPLETED|Overall Study||7
11258443|NCT02228499|12453118|FG001|COMPLETED|Overall Study||10
11258444|NCT02228499|12453117|FG000|NOT COMPLETED|Overall Study||23
11258445|NCT02228499|12453118|FG001|NOT COMPLETED|Overall Study||26
11258446|NCT02228564|12453124|FG000|STARTED|Overall Study||155
11258447|NCT02228564|12453124|FG000|COMPLETED|Overall Study||106
11258448|NCT02228564|12453124|FG000|NOT COMPLETED|Overall Study||49
11258449|NCT02228590|12453128|FG000|STARTED|Overall Study||20
11258450|NCT02228590|12453128|FG000|COMPLETED|Overall Study||19
11258451|NCT02228590|12453128|FG000|NOT COMPLETED|Overall Study||1
11258452|NCT02228681|12453135|FG000|STARTED|Overall Study||37
11258453|NCT02228681|12453136|FG001|STARTED|Overall Study||37
11258454|NCT02228681|12453135|FG000|COMPLETED|Overall Study||37
11258455|NCT02228681|12453136|FG001|COMPLETED|Overall Study||37
11258456|NCT02228681|12453135|FG000|NOT COMPLETED|Overall Study||0
11258457|NCT02228681|12453136|FG001|NOT COMPLETED|Overall Study||0
11258458|NCT02228720|12453142|FG000|STARTED|Open Label - Baseline||15
11258459|NCT02228720|12453142|FG000|COMPLETED|Open Label - Baseline||15
11258460|NCT02228720|12453142|FG000|NOT COMPLETED|Open Label - Baseline||0
11258461|NCT02228720|12453142|FG000|STARTED|Open Label - Day 30||15
11258462|NCT02228720|12453142|FG000|COMPLETED|Open Label - Day 30||14
11258463|NCT02228720|12453142|FG000|NOT COMPLETED|Open Label - Day 30||1
11258464|NCT02228720|12453142|FG000|STARTED|Open Label - Day 90||14
11258465|NCT02228720|12453142|FG000|COMPLETED|Open Label - Day 90||14
11258466|NCT02228720|12453142|FG000|NOT COMPLETED|Open Label - Day 90||0
11005471|NCT00723021|12183142|FG001|COMPLETED|Intervention Period 4||3
11258467|NCT02228824|12453148|FG000|STARTED|Overall Study||118
11005472|NCT00723021|12183143|FG002|COMPLETED|Intervention Period 4||3
11005473|NCT00723021|12183144|FG003|COMPLETED|Intervention Period 4||3
11258468|NCT02228824|12453149|FG001|STARTED|Overall Study||120
11258469|NCT02228824|12453148|FG000|COMPLETED|Overall Study||89
11258470|NCT02228824|12453149|FG001|COMPLETED|Overall Study||98
11258471|NCT02228824|12453148|FG000|NOT COMPLETED|Overall Study||29
11258472|NCT02228824|12453149|FG001|NOT COMPLETED|Overall Study||22
11258473|NCT02228967|12453157|FG000|STARTED|Overall Study||403
11258474|NCT02228967|12453158|FG001|STARTED|Overall Study||388
11258475|NCT02228967|12453157|FG000|COMPLETED|Overall Study||244
11258476|NCT02228967|12453158|FG001|COMPLETED|Overall Study||228
11258477|NCT02228967|12453157|FG000|NOT COMPLETED|Overall Study||159
11258478|NCT02228967|12453158|FG001|NOT COMPLETED|Overall Study||160
11258479|NCT02228980|12453168|FG000|STARTED|Overall Study||150
11258480|NCT02228980|12453169|FG001|STARTED|Overall Study||150
11258481|NCT02228980|12453170|FG002|STARTED|Overall Study||151
11258482|NCT02228980|12453171|FG003|STARTED|Overall Study||151
11258483|NCT02228980|12453168|FG000|COMPLETED|Overall Study||126
11258484|NCT02228980|12453169|FG001|COMPLETED|Overall Study||147
11258485|NCT02228980|12453170|FG002|COMPLETED|Overall Study||149
11258486|NCT02228980|12453171|FG003|COMPLETED|Overall Study||148
11258487|NCT02228980|12453168|FG000|NOT COMPLETED|Overall Study||24
11258488|NCT02228980|12453169|FG001|NOT COMPLETED|Overall Study||3
11258489|NCT02228980|12453170|FG002|NOT COMPLETED|Overall Study||2
11258490|NCT02228980|12453171|FG003|NOT COMPLETED|Overall Study||3
11258491|NCT02229214|12453187|FG000|STARTED|Overall Study||41
11258492|NCT02229214|12453188|FG001|STARTED|Overall Study||10
11258493|NCT02229214|12453187|FG000|COMPLETED|Overall Study||35
11258494|NCT02229214|12453188|FG001|COMPLETED|Overall Study||10
11258495|NCT02229214|12453187|FG000|NOT COMPLETED|Overall Study||6
11258496|NCT02229214|12453188|FG001|NOT COMPLETED|Overall Study||0
11258497|NCT02229227|12453198|FG000|STARTED|Overall Study||402
11258498|NCT02229227|12453199|FG001|STARTED|Overall Study||412
11258499|NCT02229227|12453198|FG000|COMPLETED|Overall Study||351
11258500|NCT02229227|12453199|FG001|COMPLETED|Overall Study||350
11258501|NCT02229227|12453198|FG000|NOT COMPLETED|Overall Study||51
11258502|NCT02229227|12453199|FG001|NOT COMPLETED|Overall Study||62
11258503|NCT02229318|12453205|FG000|STARTED|Overall Study|September 6th 2014 11 enrolled|11
11258504|NCT02229318|12453205|FG000|COMPLETED|Overall Study|September 15th 2014 11 completed|11
11258505|NCT02229318|12453205|FG000|NOT COMPLETED|Overall Study||0
11258506|NCT02229383|12453212|FG000|STARTED|Overall Study||232
11258507|NCT02229383|12453213|FG001|STARTED|Overall Study||229
11258508|NCT02229383|12453212|FG000|Received Treatment|Overall Study||231
11258509|NCT02229383|12453213|FG001|Received Treatment|Overall Study||229
11258510|NCT02229383|12453212|FG000|Safety Analysis Set|Overall Study||231
11258511|NCT02229383|12453213|FG001|Safety Analysis Set|Overall Study||229
11258512|NCT02229383|12453212|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||230
11258513|NCT02229383|12453213|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||228
11258514|NCT02229383|12453212|FG000|COMPLETED|Overall Study||212
11258515|NCT02229383|12453213|FG001|COMPLETED|Overall Study||207
11258516|NCT02229383|12453212|FG000|NOT COMPLETED|Overall Study||20
11258517|NCT02229383|12453213|FG001|NOT COMPLETED|Overall Study||22
11258518|NCT02229396|12453222|FG000|STARTED|Overall Study||233
11258519|NCT02229396|12453223|FG001|STARTED|Overall Study||231
11258520|NCT02229396|12453224|FG002|STARTED|Overall Study||231
11258521|NCT02229396|12453222|FG000|Randomization Code Allocated|Overall Study||233
11258522|NCT02229396|12453223|FG001|Randomization Code Allocated|Overall Study||231
11258523|NCT02229396|12453224|FG002|Randomization Code Allocated|Overall Study||231
11258524|NCT02229396|12453222|FG000|Safety Analysis Set|Overall Study||233
11258525|NCT02229396|12453223|FG001|Safety Analysis Set|Overall Study||231
11258526|NCT02229396|12453224|FG002|Safety Analysis Set|Overall Study||230
11258527|NCT02229396|12453222|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
11258528|NCT02229396|12453223|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
11258529|NCT02229396|12453224|FG002|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
11258530|NCT02229396|12453222|FG000|Completed 28-Week Study Period|Overall Study||208
11258531|NCT02229396|12453223|FG001|Completed 28-Week Study Period|Overall Study||202
11258532|NCT02229396|12453224|FG002|Completed 28-Week Study Period|Overall Study||193
11258533|NCT02229396|12453222|FG000|Completed 52-Week Study Period|Overall Study||194
11258534|NCT02229396|12453223|FG001|Completed 52-Week Study Period|Overall Study||193
11258535|NCT02229396|12453224|FG002|Completed 52-Week Study Period|Overall Study||177
11258536|NCT02229396|12453222|FG000|COMPLETED|Overall Study||155
11258537|NCT02229396|12453223|FG001|COMPLETED|Overall Study||154
11258538|NCT02229396|12453224|FG002|COMPLETED|Overall Study||136
11258539|NCT02229396|12453222|FG000|NOT COMPLETED|Overall Study||78
11258540|NCT02229396|12453223|FG001|NOT COMPLETED|Overall Study||77
11258541|NCT02229396|12453224|FG002|NOT COMPLETED|Overall Study||95
11258542|NCT02229461|12453239|FG000|STARTED|Overall Study|Randomized and received treatment|17
11258543|NCT02229461|12453240|FG001|STARTED|Overall Study|Randomized and received treatment|17
11258544|NCT02229461|12453241|FG002|STARTED|Overall Study|Randomized and received treatment|17
11258545|NCT02229461|12453242|FG003|STARTED|Overall Study|Randomized and received treatment|17
11258546|NCT02229461|12453243|FG004|STARTED|Overall Study|Randomized and received treatment|17
11258547|NCT02229461|12453244|FG005|STARTED|Overall Study|Randomized and received treatment|17
11258548|NCT02229461|12453239|FG000|COMPLETED|Overall Study||17
11258549|NCT02229461|12453240|FG001|COMPLETED|Overall Study||17
11258550|NCT02229461|12453241|FG002|COMPLETED|Overall Study||17
11258551|NCT02229461|12453242|FG003|COMPLETED|Overall Study||17
11258552|NCT02229461|12453243|FG004|COMPLETED|Overall Study||17
11258553|NCT02229461|12453244|FG005|COMPLETED|Overall Study||17
11258554|NCT02229461|12453239|FG000|NOT COMPLETED|Overall Study||0
11005474|NCT00723021|12183145|FG004|COMPLETED|Intervention Period 4||2
11005475|NCT00723021|12183141|FG000|NOT COMPLETED|Intervention Period 4||0
11005476|NCT00723021|12183142|FG001|NOT COMPLETED|Intervention Period 4||0
11005477|NCT00723021|12183143|FG002|NOT COMPLETED|Intervention Period 4||0
11005478|NCT00723021|12183144|FG003|NOT COMPLETED|Intervention Period 4||0
11005479|NCT00723021|12183145|FG004|NOT COMPLETED|Intervention Period 4||1
11005480|NCT00723021|12183141|FG000|STARTED|Intervention Period 5||3
11258555|NCT02229461|12453240|FG001|NOT COMPLETED|Overall Study||0
11258556|NCT02229461|12453241|FG002|NOT COMPLETED|Overall Study||0
11258557|NCT02229461|12453242|FG003|NOT COMPLETED|Overall Study||0
11258558|NCT02229461|12453243|FG004|NOT COMPLETED|Overall Study||0
11258559|NCT02229461|12453244|FG005|NOT COMPLETED|Overall Study||0
11258560|NCT02229474|12453261|FG000|STARTED|Overall Study||16
11258561|NCT02229474|12453262|FG001|STARTED|Overall Study||18
11258562|NCT02229474|12453261|FG000|COMPLETED|Overall Study||16
11258563|NCT02229474|12453262|FG001|COMPLETED|Overall Study||15
11258564|NCT02229474|12453261|FG000|NOT COMPLETED|Overall Study||0
11258565|NCT02229474|12453262|FG001|NOT COMPLETED|Overall Study||3
11258566|NCT02229487|12453271|FG000|STARTED|Overall Study||24
11258567|NCT02229487|12453272|FG001|STARTED|Overall Study||27
11258568|NCT02229487|12453271|FG000|COMPLETED|Overall Study||24
11258569|NCT02229487|12453272|FG001|COMPLETED|Overall Study||27
11258570|NCT02229487|12453271|FG000|NOT COMPLETED|Overall Study||0
11258571|NCT02229487|12453272|FG001|NOT COMPLETED|Overall Study||0
11258572|NCT02229513|12453280|FG000|STARTED|Overall Study||100
11258573|NCT02229513|12453281|FG001|STARTED|Overall Study||100
11258574|NCT02229513|12453280|FG000|COMPLETED|Overall Study||100
11258575|NCT02229513|12453281|FG001|COMPLETED|Overall Study||100
11258576|NCT02229513|12453280|FG000|NOT COMPLETED|Overall Study||0
11258577|NCT02229513|12453281|FG001|NOT COMPLETED|Overall Study||0
11258578|NCT02229539|12453290|FG000|STARTED|Cycle 1 (Treatment Per Protocol)||77
11258579|NCT02229539|12453291|FG001|STARTED|Cycle 1 (Treatment Per Protocol)||76
11258580|NCT02229539|12453292|FG002|STARTED|Cycle 1 (Treatment Per Protocol)||75
11258581|NCT02229539|12453290|FG000|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
11258582|NCT02229539|12453291|FG001|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
11258583|NCT02229539|12453292|FG002|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
11258584|NCT02229539|12453290|FG000|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
11258585|NCT02229539|12453291|FG001|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
11258586|NCT02229539|12453292|FG002|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
11258587|NCT02229539|12453290|FG000|STARTED|Cycle 2 (Optional Continuation Phase)||35
11258588|NCT02229539|12453291|FG001|STARTED|Cycle 2 (Optional Continuation Phase)||36
11258589|NCT02229539|12453292|FG002|STARTED|Cycle 2 (Optional Continuation Phase)||32
11258590|NCT02229539|12453290|FG000|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
11258591|NCT02229539|12453291|FG001|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
11258592|NCT02229539|12453292|FG002|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
11258593|NCT02229539|12453290|FG000|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
11258594|NCT02229539|12453291|FG001|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
11258595|NCT02229539|12453292|FG002|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
11258596|NCT02229552|12453300|FG000|STARTED|Baseline||237
11258597|NCT02229552|12453300|FG000|COMPLETED|Baseline||231
11258598|NCT02229552|12453300|FG000|NOT COMPLETED|Baseline||6
11258599|NCT02229552|12453300|FG000|STARTED|1-year Follow up||231
11258600|NCT02229552|12453300|FG000|COMPLETED|1-year Follow up||206
11258601|NCT02229552|12453300|FG000|NOT COMPLETED|1-year Follow up||25
11258602|NCT02229552|12453300|FG000|STARTED|2-Year Follow up|All baseline participants were eligible for year 2 follow up, regardless of completion of year 1.|231
11258603|NCT02229552|12453300|FG000|COMPLETED|2-Year Follow up||205
11258604|NCT02229552|12453300|FG000|NOT COMPLETED|2-Year Follow up||26
11258605|NCT02229851|12453307|FG000|STARTED|Main Phase (Double-blind Phase)||61
11258606|NCT02229851|12453308|FG001|STARTED|Main Phase (Double-blind Phase)||119
11258607|NCT02229851|12453309|FG002|STARTED|Main Phase (Double-blind Phase)||120
11258608|NCT02229851|12453310|FG003|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
11258609|NCT02229851|12453311|FG004|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
11258610|NCT02229851|12453312|FG005|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
11258611|NCT02229851|12453313|FG006|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
11258612|NCT02229851|12453307|FG000|Full Analysis Set|Main Phase (Double-blind Phase)||61
11258613|NCT02229851|12453308|FG001|Full Analysis Set|Main Phase (Double-blind Phase)||119
11258614|NCT02229851|12453309|FG002|Full Analysis Set|Main Phase (Double-blind Phase)||120
11258615|NCT02229851|12453310|FG003|Full Analysis Set|Main Phase (Double-blind Phase)||0
11258616|NCT02229851|12453311|FG004|Full Analysis Set|Main Phase (Double-blind Phase)||0
11258617|NCT02229851|12453312|FG005|Full Analysis Set|Main Phase (Double-blind Phase)||0
11258618|NCT02229851|12453313|FG006|Full Analysis Set|Main Phase (Double-blind Phase)||0
11258619|NCT02229851|12453307|FG000|Safety Analysis Set|Main Phase (Double-blind Phase)||61
11258620|NCT02229851|12453308|FG001|Safety Analysis Set|Main Phase (Double-blind Phase)||119
11258621|NCT02229851|12453309|FG002|Safety Analysis Set|Main Phase (Double-blind Phase)||120
11258622|NCT02229851|12453310|FG003|Safety Analysis Set|Main Phase (Double-blind Phase)||0
11258623|NCT02229851|12453311|FG004|Safety Analysis Set|Main Phase (Double-blind Phase)||0
11258624|NCT02229851|12453312|FG005|Safety Analysis Set|Main Phase (Double-blind Phase)||0
11258625|NCT02229851|12453313|FG006|Safety Analysis Set|Main Phase (Double-blind Phase)||0
11258626|NCT02229851|12453307|FG000|COMPLETED|Main Phase (Double-blind Phase)||55
11258627|NCT02229851|12453308|FG001|COMPLETED|Main Phase (Double-blind Phase)||103
11258628|NCT02229851|12453309|FG002|COMPLETED|Main Phase (Double-blind Phase)||114
11258629|NCT02229851|12453310|FG003|COMPLETED|Main Phase (Double-blind Phase)||0
11258630|NCT02229851|12453311|FG004|COMPLETED|Main Phase (Double-blind Phase)||0
11258631|NCT02229851|12453312|FG005|COMPLETED|Main Phase (Double-blind Phase)||0
11258632|NCT02229851|12453313|FG006|COMPLETED|Main Phase (Double-blind Phase)||0
11258633|NCT02229851|12453307|FG000|NOT COMPLETED|Main Phase (Double-blind Phase)||6
11258634|NCT02229851|12453308|FG001|NOT COMPLETED|Main Phase (Double-blind Phase)||16
11258635|NCT02229851|12453309|FG002|NOT COMPLETED|Main Phase (Double-blind Phase)||6
11258636|NCT02229851|12453310|FG003|NOT COMPLETED|Main Phase (Double-blind Phase)||0
11258637|NCT02229851|12453311|FG004|NOT COMPLETED|Main Phase (Double-blind Phase)||0
11258638|NCT02229851|12453312|FG005|NOT COMPLETED|Main Phase (Double-blind Phase)||0
11258639|NCT02229851|12453313|FG006|NOT COMPLETED|Main Phase (Double-blind Phase)||0
11258640|NCT02229851|12453307|FG000|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
11258641|NCT02229851|12453308|FG001|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
11258642|NCT02229851|12453309|FG002|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
11258643|NCT02229851|12453310|FG003|STARTED|Extension Phase (Open-label Phase)||55
11258644|NCT02229851|12453311|FG004|STARTED|Extension Phase (Open-label Phase)||114
11258645|NCT02229851|12453312|FG005|STARTED|Extension Phase (Open-label Phase)||52
11258646|NCT02229851|12453313|FG006|STARTED|Extension Phase (Open-label Phase)||51
11258647|NCT02229851|12453307|FG000|COMPLETED|Extension Phase (Open-label Phase)||0
11258648|NCT02229851|12453308|FG001|COMPLETED|Extension Phase (Open-label Phase)||0
11258649|NCT02229851|12453309|FG002|COMPLETED|Extension Phase (Open-label Phase)||0
11258650|NCT02229851|12453310|FG003|COMPLETED|Extension Phase (Open-label Phase)||53
11258651|NCT02229851|12453311|FG004|COMPLETED|Extension Phase (Open-label Phase)||109
11258652|NCT02229851|12453312|FG005|COMPLETED|Extension Phase (Open-label Phase)||47
11258653|NCT02229851|12453313|FG006|COMPLETED|Extension Phase (Open-label Phase)||48
11258654|NCT02229851|12453307|FG000|NOT COMPLETED|Extension Phase (Open-label Phase)||0
11258655|NCT02229851|12453308|FG001|NOT COMPLETED|Extension Phase (Open-label Phase)||0
11258656|NCT02229851|12453309|FG002|NOT COMPLETED|Extension Phase (Open-label Phase)||0
11258657|NCT02229851|12453310|FG003|NOT COMPLETED|Extension Phase (Open-label Phase)||2
11258658|NCT02229851|12453311|FG004|NOT COMPLETED|Extension Phase (Open-label Phase)||5
11258659|NCT02229851|12453312|FG005|NOT COMPLETED|Extension Phase (Open-label Phase)||5
11258660|NCT02229851|12453313|FG006|NOT COMPLETED|Extension Phase (Open-label Phase)||3
11258661|NCT02229864|12453328|FG000|STARTED|Overall Study||12
11258662|NCT02229864|12453328|FG000|COMPLETED|Overall Study||9
11258663|NCT02229864|12453328|FG000|NOT COMPLETED|Overall Study||3
11258664|NCT02230085|12453332|FG000|STARTED|Overall Study||110
11258665|NCT02230085|12453332|FG000|COMPLETED|Overall Study||106
11258666|NCT02230085|12453332|FG000|NOT COMPLETED|Overall Study||4
11258667|NCT02230306|12453336|FG000|STARTED|Overall Study||5
11258668|NCT02230306|12453336|FG000|COMPLETED|Overall Study||4
11258669|NCT02230306|12453336|FG000|NOT COMPLETED|Overall Study||1
11258670|NCT02230332|12453342|FG000|STARTED|Overall Study||38
11258671|NCT02230332|12453343|FG001|STARTED|Overall Study||40
11258672|NCT02230332|12453342|FG000|COMPLETED|Overall Study||34
11258673|NCT02230332|12453343|FG001|COMPLETED|Overall Study||39
11258674|NCT02230332|12453342|FG000|NOT COMPLETED|Overall Study||4
11258675|NCT02230332|12453343|FG001|NOT COMPLETED|Overall Study||1
11258676|NCT02230384|12453351|FG000|STARTED|Phase 1||30
11258677|NCT02230384|12453352|FG001|STARTED|Phase 1||32
11258678|NCT02230384|12453351|FG000|COMPLETED|Phase 1||29
11258679|NCT02230384|12453352|FG001|COMPLETED|Phase 1||31
11258680|NCT02230384|12453351|FG000|NOT COMPLETED|Phase 1||1
11258681|NCT02230384|12453352|FG001|NOT COMPLETED|Phase 1||1
11258682|NCT02230384|12453351|FG000|STARTED|Phase 1 Wash Out||29
11258683|NCT02230384|12453352|FG001|STARTED|Phase 1 Wash Out||31
11258684|NCT02230384|12453351|FG000|COMPLETED|Phase 1 Wash Out||29
11258685|NCT02230384|12453352|FG001|COMPLETED|Phase 1 Wash Out||31
11258686|NCT02230384|12453351|FG000|NOT COMPLETED|Phase 1 Wash Out||0
11258687|NCT02230384|12453352|FG001|NOT COMPLETED|Phase 1 Wash Out||0
11258688|NCT02230384|12453351|FG000|STARTED|Phase 2 - Switch||29
11258689|NCT02230384|12453352|FG001|STARTED|Phase 2 - Switch||31
11258690|NCT02230384|12453351|FG000|COMPLETED|Phase 2 - Switch||26
11258691|NCT02230384|12453352|FG001|COMPLETED|Phase 2 - Switch||30
11258692|NCT02230384|12453351|FG000|NOT COMPLETED|Phase 2 - Switch||3
11258693|NCT02230384|12453352|FG001|NOT COMPLETED|Phase 2 - Switch||1
11258694|NCT02230384|12453351|FG000|STARTED|Phase 2 Wash Out||26
11258695|NCT02230384|12453352|FG001|STARTED|Phase 2 Wash Out||30
11258696|NCT02230384|12453351|FG000|COMPLETED|Phase 2 Wash Out||26
11258697|NCT02230384|12453352|FG001|COMPLETED|Phase 2 Wash Out||30
11258698|NCT02230384|12453351|FG000|NOT COMPLETED|Phase 2 Wash Out||0
11258699|NCT02230384|12453352|FG001|NOT COMPLETED|Phase 2 Wash Out||0
11258700|NCT02230527|12453368|FG000|STARTED|Overall Study||23
11258701|NCT02230527|12453369|FG001|STARTED|Overall Study||23
11258702|NCT02230527|12453368|FG000|COMPLETED|Overall Study||18
11258703|NCT02230527|12453369|FG001|COMPLETED|Overall Study||21
11258704|NCT02230527|12453368|FG000|NOT COMPLETED|Overall Study||5
11258705|NCT02230527|12453369|FG001|NOT COMPLETED|Overall Study||2
11258706|NCT02230540|12453375|FG000|STARTED|Overall Study||8
11258707|NCT02230540|12453376|FG001|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
11258708|NCT02230540|12453375|FG000|COMPLETED|Overall Study||8
11258709|NCT02230540|12453376|FG001|COMPLETED|Overall Study||0
11258710|NCT02230540|12453375|FG000|NOT COMPLETED|Overall Study||0
11258711|NCT02230540|12453376|FG001|NOT COMPLETED|Overall Study||0
11258712|NCT02230566|12453384|FG000|STARTED|Overall Study||3
11258713|NCT02230566|12453385|FG001|STARTED|Overall Study||3
11258714|NCT02230566|12453386|FG002|STARTED|Overall Study||3
11258715|NCT02230566|12453387|FG003|STARTED|Overall Study||3
11258716|NCT02230566|12453384|FG000|COMPLETED|Overall Study||3
11258717|NCT02230566|12453385|FG001|COMPLETED|Overall Study||3
11258718|NCT02230566|12453386|FG002|COMPLETED|Overall Study||3
11258719|NCT02230566|12453387|FG003|COMPLETED|Overall Study||3
11258720|NCT02230566|12453384|FG000|NOT COMPLETED|Overall Study||0
11258721|NCT02230566|12453385|FG001|NOT COMPLETED|Overall Study||0
11258722|NCT02230566|12453386|FG002|NOT COMPLETED|Overall Study||0
11258723|NCT02230566|12453387|FG003|NOT COMPLETED|Overall Study||0
11258724|NCT02230579|12453399|FG000|STARTED|Overall Study||6
11258725|NCT02230579|12453400|FG001|STARTED|Overall Study||6
11258726|NCT02230579|12453401|FG002|STARTED|Overall Study||6
11258727|NCT02230579|12453402|FG003|STARTED|Overall Study||6
11258728|NCT02230579|12453403|FG004|STARTED|Overall Study||6
11258729|NCT02230579|12453404|FG005|STARTED|Overall Study||6
11258730|NCT02230579|12453405|FG006|STARTED|Overall Study||12
11258731|NCT02230579|12453399|FG000|COMPLETED|Overall Study||6
11258732|NCT02230579|12453400|FG001|COMPLETED|Overall Study||6
11258733|NCT02230579|12453401|FG002|COMPLETED|Overall Study||6
11258734|NCT02230579|12453402|FG003|COMPLETED|Overall Study||6
11258735|NCT02230579|12453403|FG004|COMPLETED|Overall Study||6
11258736|NCT02230579|12453404|FG005|COMPLETED|Overall Study||6
11258737|NCT02230579|12453405|FG006|COMPLETED|Overall Study||12
11258738|NCT02230579|12453399|FG000|NOT COMPLETED|Overall Study||0
11258739|NCT02230579|12453400|FG001|NOT COMPLETED|Overall Study||0
11258740|NCT02230579|12453401|FG002|NOT COMPLETED|Overall Study||0
11258741|NCT02230579|12453402|FG003|NOT COMPLETED|Overall Study||0
11258742|NCT02230579|12453403|FG004|NOT COMPLETED|Overall Study||0
11258743|NCT02230579|12453404|FG005|NOT COMPLETED|Overall Study||0
11258744|NCT02230579|12453405|FG006|NOT COMPLETED|Overall Study||0
11258745|NCT02230670|12453423|FG000|STARTED|Overall Study||44
11258746|NCT02230670|12453424|FG001|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
11258747|NCT02230670|12453423|FG000|COMPLETED|Overall Study||40
11258748|NCT02230670|12453424|FG001|COMPLETED|Overall Study||34
11258749|NCT02230670|12453423|FG000|NOT COMPLETED|Overall Study||4
11258750|NCT02230670|12453424|FG001|NOT COMPLETED|Overall Study||8
11258751|NCT02230683|12453430|FG000|STARTED|Overall Study||23
11258752|NCT02230683|12453430|FG000|COMPLETED|Overall Study||22
11258753|NCT02230683|12453430|FG000|NOT COMPLETED|Overall Study||1
11258754|NCT02230696|12453443|FG000|STARTED|Overall Study||381
11258755|NCT02230696|12453444|FG001|STARTED|Overall Study||376
11258756|NCT02230696|12453445|FG002|STARTED|Overall Study||194
11258757|NCT02230696|12453443|FG000|COMPLETED|Overall Study||366
11258758|NCT02230696|12453444|FG001|COMPLETED|Overall Study||365
11258759|NCT02230696|12453445|FG002|COMPLETED|Overall Study||190
11258760|NCT02230696|12453443|FG000|NOT COMPLETED|Overall Study||15
11258761|NCT02230696|12453444|FG001|NOT COMPLETED|Overall Study||11
11258762|NCT02230696|12453445|FG002|NOT COMPLETED|Overall Study||4
11258763|NCT02230761|12453455|FG000|STARTED|Overall Study||60
11258764|NCT02230761|12453456|FG001|STARTED|Overall Study||30
11258765|NCT02230761|12453455|FG000|COMPLETED|Overall Study||60
11258766|NCT02230761|12453456|FG001|COMPLETED|Overall Study||29
11258767|NCT02230761|12453455|FG000|NOT COMPLETED|Overall Study||0
11258768|NCT02230761|12453456|FG001|NOT COMPLETED|Overall Study||1
11258769|NCT02230904|12453464|FG000|STARTED|Overall Study||29
11258770|NCT02230904|12453465|FG001|STARTED|Overall Study||28
11258771|NCT02230904|12453464|FG000|COMPLETED|Overall Study||29
11258772|NCT02230904|12453465|FG001|COMPLETED|Overall Study||27
11258773|NCT02230904|12453464|FG000|NOT COMPLETED|Overall Study||0
11258774|NCT02230904|12453465|FG001|NOT COMPLETED|Overall Study||1
11258775|NCT02230956|12453476|FG000|STARTED|Overall Study||44
11258776|NCT02230956|12453477|FG001|STARTED|Overall Study||43
11258777|NCT02230956|12453478|FG002|STARTED|Overall Study||89
11258778|NCT02230956|12453476|FG000|COMPLETED|Overall Study||39
11258779|NCT02230956|12453477|FG001|COMPLETED|Overall Study||37
11258780|NCT02230956|12453478|FG002|COMPLETED|Overall Study||82
11258781|NCT02230956|12453476|FG000|NOT COMPLETED|Overall Study||5
11258782|NCT02230956|12453477|FG001|NOT COMPLETED|Overall Study||6
11258783|NCT02230956|12453478|FG002|NOT COMPLETED|Overall Study||7
11258784|NCT02230995|12453488|FG000|STARTED|Period 1 + Washout||15
11258785|NCT02230995|12453489|FG001|STARTED|Period 1 + Washout||15
11258786|NCT02230995|12453488|FG000|COMPLETED|Period 1 + Washout||15
11258787|NCT02230995|12453489|FG001|COMPLETED|Period 1 + Washout||15
11258788|NCT02230995|12453488|FG000|NOT COMPLETED|Period 1 + Washout||0
11258789|NCT02230995|12453489|FG001|NOT COMPLETED|Period 1 + Washout||0
11258790|NCT02230995|12453488|FG000|STARTED|Period 2 + Washout||15
11258791|NCT02230995|12453489|FG001|STARTED|Period 2 + Washout||15
11258792|NCT02230995|12453488|FG000|COMPLETED|Period 2 + Washout||15
11258793|NCT02230995|12453489|FG001|COMPLETED|Period 2 + Washout||15
11258794|NCT02230995|12453488|FG000|NOT COMPLETED|Period 2 + Washout||0
11258795|NCT02230995|12453489|FG001|NOT COMPLETED|Period 2 + Washout||0
11258796|NCT02231086|12453497|FG000|STARTED|Overall Study||102
11258797|NCT02231086|12453498|FG001|STARTED|Overall Study||102
11258798|NCT02231086|12453497|FG000|COMPLETED|Overall Study||63
11258799|NCT02231086|12453498|FG001|COMPLETED|Overall Study||65
11258800|NCT02231086|12453497|FG000|NOT COMPLETED|Overall Study||39
11258801|NCT02231086|12453498|FG001|NOT COMPLETED|Overall Study||37
11258802|NCT02231164|12453506|FG000|STARTED|Overall Study||6
11258803|NCT02231164|12453507|FG001|STARTED|Overall Study||6
11258804|NCT02231164|12453506|FG000|COMPLETED|Overall Study||0
11258805|NCT02231164|12453507|FG001|COMPLETED|Overall Study||0
11258806|NCT02231164|12453506|FG000|NOT COMPLETED|Overall Study||6
11258807|NCT02231164|12453507|FG001|NOT COMPLETED|Overall Study||6
11258808|NCT02231177|12453513|FG000|STARTED|Treatment Period 1 (21 Days)||8
11258809|NCT02231177|12453514|FG001|STARTED|Treatment Period 1 (21 Days)||7
11258810|NCT02231177|12453515|FG002|STARTED|Treatment Period 1 (21 Days)||8
11258811|NCT02231177|12453516|FG003|STARTED|Treatment Period 1 (21 Days)||7
11258812|NCT02231177|12453517|FG004|STARTED|Treatment Period 1 (21 Days)||8
11258813|NCT02231177|12453518|FG005|STARTED|Treatment Period 1 (21 Days)||9
11258814|NCT02231177|12453513|FG000|COMPLETED|Treatment Period 1 (21 Days)||8
11258815|NCT02231177|12453514|FG001|COMPLETED|Treatment Period 1 (21 Days)||7
11258816|NCT02231177|12453515|FG002|COMPLETED|Treatment Period 1 (21 Days)||8
11258817|NCT02231177|12453516|FG003|COMPLETED|Treatment Period 1 (21 Days)||7
11258818|NCT02231177|12453517|FG004|COMPLETED|Treatment Period 1 (21 Days)||8
11258819|NCT02231177|12453518|FG005|COMPLETED|Treatment Period 1 (21 Days)||9
11258820|NCT02231177|12453513|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11258821|NCT02231177|12453514|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11258822|NCT02231177|12453515|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11258823|NCT02231177|12453516|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11258824|NCT02231177|12453517|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11258825|NCT02231177|12453518|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0
11258826|NCT02231177|12453513|FG000|STARTED|Treatment Period 2 (21 Days)||8
11258827|NCT02231177|12453514|FG001|STARTED|Treatment Period 2 (21 Days)||7
11258828|NCT02231177|12453515|FG002|STARTED|Treatment Period 2 (21 Days)||8
11258829|NCT02231177|12453516|FG003|STARTED|Treatment Period 2 (21 Days)||7
11258830|NCT02231177|12453517|FG004|STARTED|Treatment Period 2 (21 Days)||8
11258831|NCT02231177|12453518|FG005|STARTED|Treatment Period 2 (21 Days)||9
11258832|NCT02231177|12453513|FG000|COMPLETED|Treatment Period 2 (21 Days)||8
11258833|NCT02231177|12453514|FG001|COMPLETED|Treatment Period 2 (21 Days)||7
11258834|NCT02231177|12453515|FG002|COMPLETED|Treatment Period 2 (21 Days)||8
11258835|NCT02231177|12453516|FG003|COMPLETED|Treatment Period 2 (21 Days)||7
11258836|NCT02231177|12453517|FG004|COMPLETED|Treatment Period 2 (21 Days)||8
11258837|NCT02231177|12453518|FG005|COMPLETED|Treatment Period 2 (21 Days)||9
11258838|NCT02231177|12453513|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11258839|NCT02231177|12453514|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11258840|NCT02231177|12453515|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11258841|NCT02231177|12453516|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11258842|NCT02231177|12453517|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11258843|NCT02231177|12453518|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0
11258844|NCT02231177|12453513|FG000|STARTED|Treatment Period 3 (21 Days)||8
11258845|NCT02231177|12453514|FG001|STARTED|Treatment Period 3 (21 Days)||7
11258846|NCT02231177|12453515|FG002|STARTED|Treatment Period 3 (21 Days)||8
11258847|NCT02231177|12453516|FG003|STARTED|Treatment Period 3 (21 Days)||7
11258848|NCT02231177|12453517|FG004|STARTED|Treatment Period 3 (21 Days)||8
11258849|NCT02231177|12453518|FG005|STARTED|Treatment Period 3 (21 Days)||9
11258850|NCT02231177|12453513|FG000|COMPLETED|Treatment Period 3 (21 Days)||8
11258851|NCT02231177|12453514|FG001|COMPLETED|Treatment Period 3 (21 Days)||7
11258852|NCT02231177|12453515|FG002|COMPLETED|Treatment Period 3 (21 Days)||8
11258853|NCT02231177|12453516|FG003|COMPLETED|Treatment Period 3 (21 Days)||7
11258854|NCT02231177|12453517|FG004|COMPLETED|Treatment Period 3 (21 Days)||8
11258855|NCT02231177|12453518|FG005|COMPLETED|Treatment Period 3 (21 Days)||9
11258856|NCT02231177|12453513|FG000|NOT COMPLETED|Treatment Period 3 (21 Days)||0
11258857|NCT02231177|12453514|FG001|NOT COMPLETED|Treatment Period 3 (21 Days)||0
11258858|NCT02231177|12453515|FG002|NOT COMPLETED|Treatment Period 3 (21 Days)||0
11258859|NCT02231177|12453516|FG003|NOT COMPLETED|Treatment Period 3 (21 Days)||0
11258860|NCT02231177|12453517|FG004|NOT COMPLETED|Treatment Period 3 (21 Days)||0
11258861|NCT02231177|12453518|FG005|NOT COMPLETED|Treatment Period 3 (21 Days)||0
11258862|NCT02231580|12453529|FG000|STARTED|Overall Study||14
11258863|NCT02231580|12453530|FG001|STARTED|Overall Study||3
11258864|NCT02231580|12453529|FG000|Cohort 1|Overall Study||8
11258865|NCT02231580|12453530|FG001|Cohort 1|Overall Study||2
11258866|NCT02231580|12453529|FG000|Cohort 2|Overall Study||6
11258867|NCT02231580|12453530|FG001|Cohort 2|Overall Study||1
11258868|NCT02231580|12453529|FG000|COMPLETED|Overall Study||9
11258869|NCT02231580|12453530|FG001|COMPLETED|Overall Study||3
11258870|NCT02231580|12453529|FG000|NOT COMPLETED|Overall Study||5
11258871|NCT02231580|12453530|FG001|NOT COMPLETED|Overall Study||0
11258872|NCT02231918|12453541|FG000|STARTED|Overall Study||9
11258873|NCT02231918|12453542|FG001|STARTED|Overall Study||15
11258874|NCT02231918|12453543|FG002|STARTED|Overall Study||2
11258875|NCT02231918|12453541|FG000|COMPLETED|Overall Study||9
11258876|NCT02231918|12453542|FG001|COMPLETED|Overall Study||14
11258877|NCT02231918|12453543|FG002|COMPLETED|Overall Study||1
11258878|NCT02231918|12453541|FG000|NOT COMPLETED|Overall Study||0
11258879|NCT02231918|12453542|FG001|NOT COMPLETED|Overall Study||1
11258880|NCT02231918|12453543|FG002|NOT COMPLETED|Overall Study||1
11258881|NCT02232009|12453551|FG000|STARTED|Overall Study||9
11258882|NCT02232009|12453551|FG000|COMPLETED|Overall Study||9
11258883|NCT02232009|12453551|FG000|NOT COMPLETED|Overall Study||0
11258884|NCT02232022|12453555|FG000|STARTED|Overall Study||53
11258885|NCT02232022|12453555|FG000|COMPLETED|Overall Study||51
11258886|NCT02232022|12453555|FG000|NOT COMPLETED|Overall Study||2
11258887|NCT02232061|12453561|FG000|STARTED|Overall Study||6
11258888|NCT02232061|12453561|FG000|COMPLETED|Overall Study||4
11258889|NCT02232061|12453561|FG000|NOT COMPLETED|Overall Study||2
11258890|NCT02232074|12453567|FG000|STARTED|Overall Study||154
11258891|NCT02232074|12453568|FG001|STARTED|Overall Study||152
11258892|NCT02232074|12453567|FG000|COMPLETED|Overall Study||113
11258893|NCT02232074|12453568|FG001|COMPLETED|Overall Study||107
11258894|NCT02232074|12453567|FG000|NOT COMPLETED|Overall Study||41
11258895|NCT02232074|12453568|FG001|NOT COMPLETED|Overall Study||45
11258896|NCT02232126|12453582|FG000|STARTED|Overall Study||91
11258897|NCT02232126|12453583|FG001|STARTED|Overall Study||90
11258898|NCT02232126|12453582|FG000|COMPLETED|Overall Study||91
11258899|NCT02232126|12453583|FG001|COMPLETED|Overall Study||90
11258900|NCT02232126|12453582|FG000|NOT COMPLETED|Overall Study||0
11258901|NCT02232126|12453583|FG001|NOT COMPLETED|Overall Study||0
11258902|NCT02232178|12453594|FG000|STARTED|Overall Study||26
11258903|NCT02232178|12453595|FG001|STARTED|Overall Study||25
11258904|NCT02232178|12453596|FG002|STARTED|Overall Study||13
11258905|NCT02232178|12453594|FG000|Per Protocol PK Population|Overall Study||26
11258906|NCT02232178|12453595|FG001|Per Protocol PK Population|Overall Study||24
11258907|NCT02232178|12453596|FG002|Per Protocol PK Population|Overall Study||11
11258908|NCT02232178|12453594|FG000|Safety Population|Overall Study||26
11258909|NCT02232178|12453595|FG001|Safety Population|Overall Study||24
11258910|NCT02232178|12453596|FG002|Safety Population|Overall Study||12
11258911|NCT02232178|12453594|FG000|COMPLETED|Overall Study||25
11258912|NCT02232178|12453595|FG001|COMPLETED|Overall Study||24
11258913|NCT02232178|12453596|FG002|COMPLETED|Overall Study||12
11258914|NCT02232178|12453594|FG000|NOT COMPLETED|Overall Study||1
11258915|NCT02232178|12453595|FG001|NOT COMPLETED|Overall Study||1
11258916|NCT02232178|12453596|FG002|NOT COMPLETED|Overall Study||1
11258917|NCT02232243|12453607|FG000|STARTED|First Dose (200mg HCQ Twice Daily)||3
11258918|NCT02232243|12453608|FG001|STARTED|First Dose (200mg HCQ Twice Daily)||0
11258919|NCT02232243|12453609|FG002|STARTED|First Dose (200mg HCQ Twice Daily)||0
11258920|NCT02232243|12453607|FG000|COMPLETED|First Dose (200mg HCQ Twice Daily)||3
11258921|NCT02232243|12453608|FG001|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
11258922|NCT02232243|12453609|FG002|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
11258923|NCT02232243|12453607|FG000|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
11258924|NCT02232243|12453608|FG001|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
11258925|NCT02232243|12453609|FG002|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
11258926|NCT02232243|12453607|FG000|STARTED|Second Dose (400mg HCQ Twice Daily)||0
11258927|NCT02232243|12453608|FG001|STARTED|Second Dose (400mg HCQ Twice Daily)||4
11258928|NCT02232243|12453609|FG002|STARTED|Second Dose (400mg HCQ Twice Daily)||0
11258929|NCT02232243|12453607|FG000|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
11258930|NCT02232243|12453608|FG001|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3
11258931|NCT02232243|12453609|FG002|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
11258932|NCT02232243|12453607|FG000|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
11258933|NCT02232243|12453608|FG001|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1
11258934|NCT02232243|12453609|FG002|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
11258935|NCT02232243|12453607|FG000|STARTED|Third Dose(200mg HCQ Twice Daily)||0
11005481|NCT00723021|12183142|FG001|STARTED|Intervention Period 5||3
11005482|NCT00723021|12183143|FG002|STARTED|Intervention Period 5||3
11005483|NCT00723021|12183144|FG003|STARTED|Intervention Period 5||3
11005484|NCT00723021|12183145|FG004|STARTED|Intervention Period 5||2
11005485|NCT00723021|12183141|FG000|COMPLETED|Intervention Period 5||3
11005486|NCT00723021|12183142|FG001|COMPLETED|Intervention Period 5||3
11005487|NCT00723021|12183143|FG002|COMPLETED|Intervention Period 5||3
11005488|NCT00723021|12183144|FG003|COMPLETED|Intervention Period 5||3
11005489|NCT00723021|12183145|FG004|COMPLETED|Intervention Period 5||2
11258936|NCT02232243|12453608|FG001|STARTED|Third Dose(200mg HCQ Twice Daily)||0
11258937|NCT02232243|12453609|FG002|STARTED|Third Dose(200mg HCQ Twice Daily)||3
11258938|NCT02232243|12453607|FG000|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
11258939|NCT02232243|12453608|FG001|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
11258940|NCT02232243|12453609|FG002|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3
11258941|NCT02232243|12453607|FG000|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
11258942|NCT02232243|12453608|FG001|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
11258943|NCT02232243|12453609|FG002|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
11258944|NCT02232425|12453620|FG000|STARTED|Overall Study||58
11258945|NCT02232425|12453621|FG001|STARTED|Overall Study||30
11258946|NCT02232425|12453620|FG000|COMPLETED|Overall Study||44
11258947|NCT02232425|12453621|FG001|COMPLETED|Overall Study||22
11258948|NCT02232425|12453620|FG000|NOT COMPLETED|Overall Study||14
11258949|NCT02232425|12453621|FG001|NOT COMPLETED|Overall Study||8
11339856|NCT02918266|12537336|FG010|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
11339857|NCT02918266|12537326|FG000|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
11339858|NCT02918266|12537327|FG001|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
11339859|NCT02918266|12537328|FG002|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
11339860|NCT02918266|12537329|FG003|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
11339861|NCT02918266|12537330|FG004|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
11339862|NCT02918266|12537331|FG005|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
11339863|NCT02918266|12537332|FG006|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
11258950|NCT02232698|12453629|FG000|STARTED|Overall Study||120
11258951|NCT02232698|12453630|FG001|STARTED|Overall Study||121
11258952|NCT02232698|12453629|FG000|COMPLETED|Overall Study||110
11258953|NCT02232698|12453630|FG001|COMPLETED|Overall Study||101
11258954|NCT02232698|12453629|FG000|NOT COMPLETED|Overall Study||10
11258955|NCT02232698|12453630|FG001|NOT COMPLETED|Overall Study||20
11258956|NCT02232802|12453638|FG000|STARTED|Period 1||24
11258957|NCT02232802|12453639|FG001|STARTED|Period 1||23
11258958|NCT02232802|12453638|FG000|COMPLETED|Period 1||22
11258959|NCT02232802|12453639|FG001|COMPLETED|Period 1||22
11258960|NCT02232802|12453638|FG000|NOT COMPLETED|Period 1||2
11258961|NCT02232802|12453639|FG001|NOT COMPLETED|Period 1||1
11258962|NCT02232802|12453638|FG000|STARTED|Washout||22
11258963|NCT02232802|12453639|FG001|STARTED|Washout||22
11258964|NCT02232802|12453638|FG000|COMPLETED|Washout||22
11258965|NCT02232802|12453639|FG001|COMPLETED|Washout||22
11258966|NCT02232802|12453638|FG000|NOT COMPLETED|Washout||0
11258967|NCT02232802|12453639|FG001|NOT COMPLETED|Washout||0
11258968|NCT02232802|12453638|FG000|STARTED|Period 2||22
11258969|NCT02232802|12453639|FG001|STARTED|Period 2||22
11258970|NCT02232802|12453638|FG000|COMPLETED|Period 2||22
11258971|NCT02232802|12453639|FG001|COMPLETED|Period 2||22
11258972|NCT02232802|12453638|FG000|NOT COMPLETED|Period 2||0
11258973|NCT02232802|12453639|FG001|NOT COMPLETED|Period 2||0
11258974|NCT02232802|12453638|FG000|STARTED|Washout||22
11258975|NCT02232802|12453639|FG001|STARTED|Washout||22
11258976|NCT02232802|12453638|FG000|COMPLETED|Washout||22
11258977|NCT02232802|12453639|FG001|COMPLETED|Washout||22
11258978|NCT02232802|12453638|FG000|NOT COMPLETED|Washout||0
11258979|NCT02232802|12453639|FG001|NOT COMPLETED|Washout||0
11258980|NCT02232893|12453647|FG000|STARTED|Overall Study||35
11258981|NCT02232893|12453648|FG001|STARTED|Overall Study||34
11258982|NCT02232893|12453647|FG000|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|34
11258983|NCT02232893|12453648|FG001|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|32
11258984|NCT02232893|12453647|FG000|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|24
11258985|NCT02232893|12453648|FG001|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|19
11258986|NCT02232893|12453647|FG000|COMPLETED|Overall Study||31
11258987|NCT02232893|12453648|FG001|COMPLETED|Overall Study||27
11258988|NCT02232893|12453647|FG000|NOT COMPLETED|Overall Study||4
11258989|NCT02232893|12453648|FG001|NOT COMPLETED|Overall Study||7
11258990|NCT02232984|12453654|FG000|STARTED|Overall Study|Enrolled subjects|749
11258991|NCT02232984|12453654|FG000|Successfully Implanted|Overall Study|Successfully implanted subjects|675
11258992|NCT02232984|12453654|FG000|COMPLETED|Overall Study|Total number of subjects who completed study|672
11258993|NCT02232984|12453654|FG000|NOT COMPLETED|Overall Study||77
11258994|NCT02233101|12453663|FG000|STARTED|Overall Study||86
11258995|NCT02233101|12453664|FG001|STARTED|Overall Study||81
11258996|NCT02233101|12453663|FG000|COMPLETED|Overall Study||74
11258997|NCT02233101|12453664|FG001|COMPLETED|Overall Study||80
11258998|NCT02233101|12453663|FG000|NOT COMPLETED|Overall Study||12
11258999|NCT02233101|12453664|FG001|NOT COMPLETED|Overall Study||1
11259000|NCT02233296|12453672|FG000|STARTED|Overall Study||16
11259001|NCT02233296|12453673|FG001|STARTED|Overall Study||14
11259002|NCT02233296|12453672|FG000|COMPLETED|Overall Study||16
11259003|NCT02233296|12453673|FG001|COMPLETED|Overall Study||14
11259004|NCT02233296|12453672|FG000|NOT COMPLETED|Overall Study||0
11259005|NCT02233296|12453673|FG001|NOT COMPLETED|Overall Study||0
11259006|NCT02233309|12453683|FG000|STARTED|Overall Study||36
11259007|NCT02233309|12453683|FG000|COMPLETED|Overall Study||31
11259008|NCT02233309|12453683|FG000|NOT COMPLETED|Overall Study||5
11259009|NCT02233413|12453689|FG000|STARTED|Overall Study||35
11259010|NCT02233413|12453690|FG001|STARTED|Overall Study||33
11259011|NCT02233413|12453689|FG000|COMPLETED|Overall Study||24
11259012|NCT02233413|12453690|FG001|COMPLETED|Overall Study||19
11259013|NCT02233413|12453689|FG000|NOT COMPLETED|Overall Study||11
11259014|NCT02233413|12453690|FG001|NOT COMPLETED|Overall Study||14
11259015|NCT02233478|12453696|FG000|STARTED|First Intervention (1 Day)||3
11259016|NCT02233478|12453697|FG001|STARTED|First Intervention (1 Day)||3
11259017|NCT02233478|12453698|FG002|STARTED|First Intervention (1 Day)||3
11259018|NCT02233478|12453699|FG003|STARTED|First Intervention (1 Day)||3
11259019|NCT02233478|12453700|FG004|STARTED|First Intervention (1 Day)||3
11259020|NCT02233478|12453701|FG005|STARTED|First Intervention (1 Day)||3
11259021|NCT02233478|12453696|FG000|COMPLETED|First Intervention (1 Day)||3
11259022|NCT02233478|12453697|FG001|COMPLETED|First Intervention (1 Day)||3
11259023|NCT02233478|12453698|FG002|COMPLETED|First Intervention (1 Day)||3
11259024|NCT02233478|12453699|FG003|COMPLETED|First Intervention (1 Day)||3
11259025|NCT02233478|12453700|FG004|COMPLETED|First Intervention (1 Day)||3
11259026|NCT02233478|12453701|FG005|COMPLETED|First Intervention (1 Day)||3
11259027|NCT02233478|12453696|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11259028|NCT02233478|12453697|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11259029|NCT02233478|12453698|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11259030|NCT02233478|12453699|FG003|NOT COMPLETED|First Intervention (1 Day)||0
11259031|NCT02233478|12453700|FG004|NOT COMPLETED|First Intervention (1 Day)||0
11259032|NCT02233478|12453701|FG005|NOT COMPLETED|First Intervention (1 Day)||0
11259033|NCT02233478|12453696|FG000|STARTED|Washout (7 Days)||3
11259034|NCT02233478|12453697|FG001|STARTED|Washout (7 Days)||3
11259035|NCT02233478|12453698|FG002|STARTED|Washout (7 Days)||3
11259036|NCT02233478|12453699|FG003|STARTED|Washout (7 Days)||3
11259037|NCT02233478|12453700|FG004|STARTED|Washout (7 Days)||3
11259038|NCT02233478|12453701|FG005|STARTED|Washout (7 Days)||3
11259039|NCT02233478|12453696|FG000|COMPLETED|Washout (7 Days)||3
11259040|NCT02233478|12453697|FG001|COMPLETED|Washout (7 Days)||3
11259041|NCT02233478|12453698|FG002|COMPLETED|Washout (7 Days)||3
11259042|NCT02233478|12453699|FG003|COMPLETED|Washout (7 Days)||3
11259043|NCT02233478|12453700|FG004|COMPLETED|Washout (7 Days)||3
11259044|NCT02233478|12453701|FG005|COMPLETED|Washout (7 Days)||3
11259045|NCT02233478|12453696|FG000|NOT COMPLETED|Washout (7 Days)||0
11259046|NCT02233478|12453697|FG001|NOT COMPLETED|Washout (7 Days)||0
11259047|NCT02233478|12453698|FG002|NOT COMPLETED|Washout (7 Days)||0
11259048|NCT02233478|12453699|FG003|NOT COMPLETED|Washout (7 Days)||0
11259049|NCT02233478|12453700|FG004|NOT COMPLETED|Washout (7 Days)||0
11259050|NCT02233478|12453701|FG005|NOT COMPLETED|Washout (7 Days)||0
11259051|NCT02233478|12453696|FG000|STARTED|Second Intervention (1 Day)||3
11259052|NCT02233478|12453697|FG001|STARTED|Second Intervention (1 Day)||3
11259053|NCT02233478|12453698|FG002|STARTED|Second Intervention (1 Day)||3
11259054|NCT02233478|12453699|FG003|STARTED|Second Intervention (1 Day)||3
11259055|NCT02233478|12453700|FG004|STARTED|Second Intervention (1 Day)||3
11259056|NCT02233478|12453701|FG005|STARTED|Second Intervention (1 Day)||3
11259057|NCT02233478|12453696|FG000|COMPLETED|Second Intervention (1 Day)||3
11259058|NCT02233478|12453697|FG001|COMPLETED|Second Intervention (1 Day)||3
11259059|NCT02233478|12453698|FG002|COMPLETED|Second Intervention (1 Day)||3
11259060|NCT02233478|12453699|FG003|COMPLETED|Second Intervention (1 Day)||3
11259061|NCT02233478|12453700|FG004|COMPLETED|Second Intervention (1 Day)||3
11259062|NCT02233478|12453701|FG005|COMPLETED|Second Intervention (1 Day)||3
11259063|NCT02233478|12453696|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11259064|NCT02233478|12453697|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11259065|NCT02233478|12453698|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11259066|NCT02233478|12453699|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
11259067|NCT02233478|12453700|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
11259068|NCT02233478|12453701|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
11259069|NCT02233478|12453696|FG000|STARTED|Washout (7 Days)||3
11259070|NCT02233478|12453697|FG001|STARTED|Washout (7 Days)||3
11259071|NCT02233478|12453698|FG002|STARTED|Washout (7 Days)||3
11259072|NCT02233478|12453699|FG003|STARTED|Washout (7 Days)||3
11259073|NCT02233478|12453700|FG004|STARTED|Washout (7 Days)||3
11259074|NCT02233478|12453701|FG005|STARTED|Washout (7 Days)||3
11259075|NCT02233478|12453696|FG000|COMPLETED|Washout (7 Days)||3
11259076|NCT02233478|12453697|FG001|COMPLETED|Washout (7 Days)||3
11259077|NCT02233478|12453698|FG002|COMPLETED|Washout (7 Days)||3
11259078|NCT02233478|12453699|FG003|COMPLETED|Washout (7 Days)||3
11259079|NCT02233478|12453700|FG004|COMPLETED|Washout (7 Days)||3
11259080|NCT02233478|12453701|FG005|COMPLETED|Washout (7 Days)||3
11259081|NCT02233478|12453696|FG000|NOT COMPLETED|Washout (7 Days)||0
11259082|NCT02233478|12453697|FG001|NOT COMPLETED|Washout (7 Days)||0
11259083|NCT02233478|12453698|FG002|NOT COMPLETED|Washout (7 Days)||0
11259084|NCT02233478|12453699|FG003|NOT COMPLETED|Washout (7 Days)||0
11259085|NCT02233478|12453700|FG004|NOT COMPLETED|Washout (7 Days)||0
11259086|NCT02233478|12453701|FG005|NOT COMPLETED|Washout (7 Days)||0
11259087|NCT02233478|12453696|FG000|STARTED|Third Intervention (1 Day)||3
11259088|NCT02233478|12453697|FG001|STARTED|Third Intervention (1 Day)||3
11259089|NCT02233478|12453698|FG002|STARTED|Third Intervention (1 Day)||3
11259090|NCT02233478|12453699|FG003|STARTED|Third Intervention (1 Day)||3
11259091|NCT02233478|12453700|FG004|STARTED|Third Intervention (1 Day)||3
11259092|NCT02233478|12453701|FG005|STARTED|Third Intervention (1 Day)||3
11259093|NCT02233478|12453696|FG000|COMPLETED|Third Intervention (1 Day)||3
11259094|NCT02233478|12453697|FG001|COMPLETED|Third Intervention (1 Day)||3
11259095|NCT02233478|12453698|FG002|COMPLETED|Third Intervention (1 Day)||3
11259096|NCT02233478|12453699|FG003|COMPLETED|Third Intervention (1 Day)||3
11259097|NCT02233478|12453700|FG004|COMPLETED|Third Intervention (1 Day)||3
11259098|NCT02233478|12453701|FG005|COMPLETED|Third Intervention (1 Day)||3
11259099|NCT02233478|12453696|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11259100|NCT02233478|12453697|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11259101|NCT02233478|12453698|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
11259102|NCT02233478|12453699|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
11259103|NCT02233478|12453700|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
11259104|NCT02233478|12453701|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
11259105|NCT02233517|12453711|FG000|STARTED|Overall Study||19
11259106|NCT02233517|12453712|FG001|STARTED|Overall Study||17
11259107|NCT02233517|12453711|FG000|COMPLETED|Overall Study||12
11259108|NCT02233517|12453712|FG001|COMPLETED|Overall Study||13
11259109|NCT02233517|12453711|FG000|NOT COMPLETED|Overall Study||7
11259110|NCT02233517|12453712|FG001|NOT COMPLETED|Overall Study||4
11259111|NCT02233530|12453718|FG000|STARTED|Overall Study||8
11259112|NCT02233530|12453718|FG000|COMPLETED|Overall Study||8
11259113|NCT02233530|12453718|FG000|NOT COMPLETED|Overall Study||0
11259114|NCT02233543|12453722|FG000|STARTED|Period 1||22
11259115|NCT02233543|12453723|FG001|STARTED|Period 1||16
11259116|NCT02233543|12453722|FG000|COMPLETED|Period 1||19
11259117|NCT02233543|12453723|FG001|COMPLETED|Period 1||13
11259118|NCT02233543|12453722|FG000|NOT COMPLETED|Period 1||3
11259119|NCT02233543|12453723|FG001|NOT COMPLETED|Period 1||3
11259120|NCT02233543|12453722|FG000|STARTED|Period 2||19
11259121|NCT02233543|12453723|FG001|STARTED|Period 2||13
11259122|NCT02233543|12453722|FG000|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
11259123|NCT02233543|12453723|FG001|COMPLETED|Period 2||12
11259124|NCT02233543|12453722|FG000|NOT COMPLETED|Period 2||2
11259125|NCT02233543|12453723|FG001|NOT COMPLETED|Period 2||1
11259126|NCT02233647|12453729|FG000|STARTED|Overall Study||11
11259127|NCT02233647|12453729|FG000|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
11259128|NCT02233647|12453729|FG000|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
11259129|NCT02233647|12453729|FG000|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
11259130|NCT02233647|12453729|FG000|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
11259131|NCT02233647|12453729|FG000|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
11259132|NCT02233647|12453729|FG000|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
11259133|NCT02233647|12453729|FG000|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
11259134|NCT02233647|12453729|FG000|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
11259135|NCT02233647|12453729|FG000|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
11259136|NCT02233647|12453729|FG000|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
11259137|NCT02233647|12453729|FG000|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
11259138|NCT02233647|12453729|FG000|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
11259139|NCT02233647|12453729|FG000|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
11259140|NCT02233647|12453729|FG000|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
11259141|NCT02233647|12453729|FG000|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
11259142|NCT02233647|12453729|FG000|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
11259143|NCT02233647|12453729|FG000|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
11358813|NCT03131206|12555985|FG000|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11358814|NCT03131206|12555986|FG001|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11358815|NCT03131206|12555987|FG002|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11358816|NCT03131206|12555988|FG003|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11358817|NCT03131206|12555985|FG000|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11358818|NCT03131206|12555986|FG001|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11358819|NCT03131206|12555987|FG002|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11358820|NCT03131206|12555988|FG003|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
11358821|NCT03131453|12556005|FG000|STARTED|Overall Study||456
11358822|NCT03131453|12556006|FG001|STARTED|Overall Study||233
11358823|NCT03131453|12556007|FG002|STARTED|Overall Study||456
11358824|NCT03131453|12556005|FG000|Patient Misrandomized|Overall Study||1
11358825|NCT03131453|12556006|FG001|Patient Misrandomized|Overall Study||0
11358826|NCT03131453|12556007|FG002|Patient Misrandomized|Overall Study||0
11358827|NCT03131453|12556005|FG000|COMPLETED|Overall Study||0
11358828|NCT03131453|12556006|FG001|COMPLETED|Overall Study||0
11358829|NCT03131453|12556007|FG002|COMPLETED|Overall Study||0
11358830|NCT03131453|12556005|FG000|NOT COMPLETED|Overall Study||456
11358831|NCT03131453|12556006|FG001|NOT COMPLETED|Overall Study||233
11358832|NCT03131453|12556007|FG002|NOT COMPLETED|Overall Study||456
11358833|NCT03131479|12556020|FG000|STARTED|Overall Study||10
11358834|NCT03131479|12556021|FG001|STARTED|Overall Study||10
11358835|NCT03131479|12556022|FG002|STARTED|Overall Study||11
11358836|NCT03131479|12556023|FG003|STARTED|Overall Study||12
11358837|NCT03131479|12556024|FG004|STARTED|Overall Study||10
11358838|NCT03131479|12556020|FG000|Safety Analysis Set (SS)|Overall Study||10
11358839|NCT03131479|12556021|FG001|Safety Analysis Set (SS)|Overall Study||10
11358840|NCT03131479|12556022|FG002|Safety Analysis Set (SS)|Overall Study||11
11358841|NCT03131479|12556023|FG003|Safety Analysis Set (SS)|Overall Study||12
11358842|NCT03131479|12556024|FG004|Safety Analysis Set (SS)|Overall Study||10
11358843|NCT03131479|12556020|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
11358844|NCT03131479|12556021|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
11358845|NCT03131479|12556022|FG002|Pharmacokinetic Analysis Set (PAS)|Overall Study||11
11358846|NCT03131479|12556023|FG003|Pharmacokinetic Analysis Set (PAS)|Overall Study||12
11358847|NCT03131479|12556024|FG004|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
11358848|NCT03131479|12556020|FG000|Pharcodynamic Analysis Set (PD)|Overall Study||10
11358849|NCT03131479|12556021|FG001|Pharcodynamic Analysis Set (PD)|Overall Study||10
11358850|NCT03131479|12556022|FG002|Pharcodynamic Analysis Set (PD)|Overall Study||11
11358851|NCT03131479|12556023|FG003|Pharcodynamic Analysis Set (PD)|Overall Study||12
11358852|NCT03131479|12556024|FG004|Pharcodynamic Analysis Set (PD)|Overall Study||10
11358853|NCT03131479|12556020|FG000|COMPLETED|Overall Study||10
11358854|NCT03131479|12556021|FG001|COMPLETED|Overall Study||10
11358855|NCT03131479|12556022|FG002|COMPLETED|Overall Study||10
11358856|NCT03131479|12556023|FG003|COMPLETED|Overall Study||10
11358857|NCT03131479|12556024|FG004|COMPLETED|Overall Study||10
11358858|NCT03131479|12556020|FG000|NOT COMPLETED|Overall Study||0
11358859|NCT03131479|12556021|FG001|NOT COMPLETED|Overall Study||0
11358860|NCT03131479|12556022|FG002|NOT COMPLETED|Overall Study||1
11358861|NCT03131479|12556023|FG003|NOT COMPLETED|Overall Study||2
11358862|NCT03131479|12556024|FG004|NOT COMPLETED|Overall Study||0
11358863|NCT03131570|12556038|FG000|STARTED|Overall Study||12
11358864|NCT03131570|12556039|FG001|STARTED|Overall Study||11
11358865|NCT03131570|12556038|FG000|COMPLETED|Overall Study||11
11358866|NCT03131570|12556039|FG001|COMPLETED|Overall Study||11
11358867|NCT03131570|12556038|FG000|NOT COMPLETED|Overall Study||1
11358868|NCT03131570|12556039|FG001|NOT COMPLETED|Overall Study||0
11358869|NCT03131596|12556047|FG000|STARTED|Overall Study||100
11358870|NCT03131596|12556048|FG001|STARTED|Overall Study||100
11358871|NCT03131596|12556047|FG000|COMPLETED|Overall Study||94
11358872|NCT03131596|12556048|FG001|COMPLETED|Overall Study||97
11358873|NCT03131596|12556047|FG000|NOT COMPLETED|Overall Study||6
11358874|NCT03131596|12556048|FG001|NOT COMPLETED|Overall Study||3
11358875|NCT03131648|12556056|FG000|STARTED|Initial Treatment Period||603
11358876|NCT03131648|12556057|FG001|STARTED|Initial Treatment Period||199
11358877|NCT03131648|12556058|FG002|STARTED|Initial Treatment Period||0
11358878|NCT03131648|12556059|FG003|STARTED|Initial Treatment Period||0
11358879|NCT03131648|12556060|FG004|STARTED|Initial Treatment Period||0
11358880|NCT03131648|12556061|FG005|STARTED|Initial Treatment Period||0
11358881|NCT03131648|12556062|FG006|STARTED|Initial Treatment Period||0
11358882|NCT03131648|12556063|FG007|STARTED|Initial Treatment Period||0
11358883|NCT03131648|12556056|FG000|COMPLETED|Initial Treatment Period||550
11358884|NCT03131648|12556057|FG001|COMPLETED|Initial Treatment Period||179
11358885|NCT03131648|12556058|FG002|COMPLETED|Initial Treatment Period||0
11358886|NCT03131648|12556059|FG003|COMPLETED|Initial Treatment Period||0
11358887|NCT03131648|12556060|FG004|COMPLETED|Initial Treatment Period||0
11358888|NCT03131648|12556061|FG005|COMPLETED|Initial Treatment Period||0
11358889|NCT03131648|12556062|FG006|COMPLETED|Initial Treatment Period||0
11259144|NCT02233647|12453729|FG000|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
11259145|NCT02233647|12453729|FG000|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
11259146|NCT02233647|12453729|FG000|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
11259147|NCT02233647|12453729|FG000|COMPLETED|Overall Study||10
11259148|NCT02233647|12453729|FG000|NOT COMPLETED|Overall Study||1
11259149|NCT02233738|12453735|FG000|STARTED|Overall Study||93
11259150|NCT02233738|12453736|FG001|STARTED|Overall Study||91
11259151|NCT02233738|12453735|FG000|1 Month Follow-Up|Overall Study||89
11259152|NCT02233738|12453736|FG001|1 Month Follow-Up|Overall Study||82
11259153|NCT02233738|12453735|FG000|3 Month Follow-Up|Overall Study||87
11259154|NCT02233738|12453736|FG001|3 Month Follow-Up|Overall Study||77
11259155|NCT02233738|12453735|FG000|6 Month Follow-Up|Overall Study||85
11005490|NCT00723021|12183141|FG000|NOT COMPLETED|Intervention Period 5||0
11005491|NCT00723021|12183142|FG001|NOT COMPLETED|Intervention Period 5||0
11005492|NCT00723021|12183143|FG002|NOT COMPLETED|Intervention Period 5||0
11005493|NCT00723021|12183144|FG003|NOT COMPLETED|Intervention Period 5||0
11005494|NCT00723021|12183145|FG004|NOT COMPLETED|Intervention Period 5||0
11259156|NCT02233738|12453736|FG001|6 Month Follow-Up|Overall Study||75
11259157|NCT02233738|12453735|FG000|COMPLETED|Overall Study||85
11259158|NCT02233738|12453736|FG001|COMPLETED|Overall Study||75
11259159|NCT02233738|12453735|FG000|NOT COMPLETED|Overall Study||8
11259160|NCT02233738|12453736|FG001|NOT COMPLETED|Overall Study||16
11259161|NCT02233751|12453906|FG000|STARTED|Overall Study||6
11259162|NCT02233751|12453907|FG001|STARTED|Overall Study||6
11259163|NCT02233751|12453906|FG000|COMPLETED|Overall Study||6
11259164|NCT02233751|12453907|FG001|COMPLETED|Overall Study||6
11259165|NCT02233751|12453906|FG000|NOT COMPLETED|Overall Study||0
11259166|NCT02233751|12453907|FG001|NOT COMPLETED|Overall Study||0
11259167|NCT02233803|12453913|FG000|STARTED|Treatment Period 1 (4-Wks)||100
11259168|NCT02233803|12453914|FG001|STARTED|Treatment Period 1 (4-Wks)||99
11259169|NCT02233803|12453913|FG000|COMPLETED|Treatment Period 1 (4-Wks)||97
11259170|NCT02233803|12453914|FG001|COMPLETED|Treatment Period 1 (4-Wks)||95
11259171|NCT02233803|12453913|FG000|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
11259172|NCT02233803|12453914|FG001|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
11259173|NCT02233803|12453913|FG000|STARTED|Washout Period (4-Wks)||97
11259174|NCT02233803|12453914|FG001|STARTED|Washout Period (4-Wks)||95
11259175|NCT02233803|12453913|FG000|COMPLETED|Washout Period (4-Wks)||95
11259176|NCT02233803|12453914|FG001|COMPLETED|Washout Period (4-Wks)||93
11259177|NCT02233803|12453913|FG000|NOT COMPLETED|Washout Period (4-Wks)||2
11259178|NCT02233803|12453914|FG001|NOT COMPLETED|Washout Period (4-Wks)||2
11259179|NCT02233803|12453913|FG000|STARTED|Treatment Period 2 (4-Wks)||95
11259180|NCT02233803|12453914|FG001|STARTED|Treatment Period 2 (4-Wks)||93
11259181|NCT02233803|12453913|FG000|COMPLETED|Treatment Period 2 (4-Wks)||93
11259182|NCT02233803|12453914|FG001|COMPLETED|Treatment Period 2 (4-Wks)||91
11259183|NCT02233803|12453913|FG000|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
11259184|NCT02233803|12453914|FG001|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
11259185|NCT02233842|12453922|FG000|STARTED|Questionnaire 1 Version 1||5
11259186|NCT02233842|12453922|FG000|COMPLETED|Questionnaire 1 Version 1||5
11259187|NCT02233842|12453922|FG000|NOT COMPLETED|Questionnaire 1 Version 1||0
11259188|NCT02233842|12453922|FG000|STARTED|Questionnaire 1 Version 2||5
11259189|NCT02233842|12453922|FG000|COMPLETED|Questionnaire 1 Version 2||5
11259190|NCT02233842|12453922|FG000|NOT COMPLETED|Questionnaire 1 Version 2||0
11259191|NCT02233842|12453922|FG000|STARTED|Questionnaire 2 Version 1||5
11259192|NCT02233842|12453922|FG000|COMPLETED|Questionnaire 2 Version 1||5
11259193|NCT02233842|12453922|FG000|NOT COMPLETED|Questionnaire 2 Version 1||0
11259194|NCT02233842|12453922|FG000|STARTED|Questionnaire 2 Version 2||5
11259195|NCT02233842|12453922|FG000|COMPLETED|Questionnaire 2 Version 2||5
11259196|NCT02233842|12453922|FG000|NOT COMPLETED|Questionnaire 2 Version 2||0
11259197|NCT02233842|12453922|FG000|STARTED|Questionnaire 3 Version 1||5
11259198|NCT02233842|12453922|FG000|COMPLETED|Questionnaire 3 Version 1||5
11259199|NCT02233842|12453922|FG000|NOT COMPLETED|Questionnaire 3 Version 1||0
11259200|NCT02233842|12453922|FG000|STARTED|Questionnaire 3 Version 2||5
11259201|NCT02233842|12453922|FG000|COMPLETED|Questionnaire 3 Version 2||5
11259202|NCT02233842|12453922|FG000|NOT COMPLETED|Questionnaire 3 Version 2||0
11259203|NCT02233946|12453929|FG000|STARTED|Baseline|Allocated to and received the intervention|628
11259204|NCT02233946|12453930|FG001|STARTED|Baseline|Allocated to and received usual care|243
11259205|NCT02233946|12453929|FG000|COMPLETED|Baseline|Completed baseline assessment|626
11259206|NCT02233946|12453930|FG001|COMPLETED|Baseline|Completed baseline assessment|243
11259207|NCT02233946|12453929|FG000|NOT COMPLETED|Baseline||2
11259208|NCT02233946|12453930|FG001|NOT COMPLETED|Baseline||0
11259209|NCT02233946|12453929|FG000|STARTED|Immediate Post-visit Questionnaire||626
11259210|NCT02233946|12453930|FG001|STARTED|Immediate Post-visit Questionnaire||243
11259211|NCT02233946|12453929|FG000|COMPLETED|Immediate Post-visit Questionnaire||624
11259212|NCT02233946|12453930|FG001|COMPLETED|Immediate Post-visit Questionnaire||243
11259213|NCT02233946|12453929|FG000|NOT COMPLETED|Immediate Post-visit Questionnaire||2
11259214|NCT02233946|12453930|FG001|NOT COMPLETED|Immediate Post-visit Questionnaire||0
11259215|NCT02233946|12453929|FG000|STARTED|3-months Follow-up||624
11259216|NCT02233946|12453930|FG001|STARTED|3-months Follow-up||243
11259217|NCT02233946|12453929|FG000|COMPLETED|3-months Follow-up||571
11259218|NCT02233946|12453930|FG001|COMPLETED|3-months Follow-up||214
11259219|NCT02233946|12453929|FG000|NOT COMPLETED|3-months Follow-up||53
11259220|NCT02233946|12453930|FG001|NOT COMPLETED|3-months Follow-up||29
11259221|NCT02233946|12453929|FG000|STARTED|6-months Follow-up||571
11259222|NCT02233946|12453930|FG001|STARTED|6-months Follow-up||214
11259223|NCT02233946|12453929|FG000|COMPLETED|6-months Follow-up||550
11259224|NCT02233946|12453930|FG001|COMPLETED|6-months Follow-up||212
11259225|NCT02233946|12453929|FG000|NOT COMPLETED|6-months Follow-up||21
11259226|NCT02233946|12453930|FG001|NOT COMPLETED|6-months Follow-up||2
11259227|NCT02233946|12453929|FG000|STARTED|9-month Follow-up||550
11259228|NCT02233946|12453930|FG001|STARTED|9-month Follow-up||212
11259229|NCT02233946|12453929|FG000|COMPLETED|9-month Follow-up||530
11259230|NCT02233946|12453930|FG001|COMPLETED|9-month Follow-up||201
11259231|NCT02233946|12453929|FG000|NOT COMPLETED|9-month Follow-up||20
11005495|NCT00723073|12183166|FG000|STARTED|Overall Study||149
11005496|NCT00723073|12183167|FG001|STARTED|Overall Study||174
11005497|NCT00723073|12183166|FG000|COMPLETED|Overall Study||149
11005498|NCT00723073|12183167|FG001|COMPLETED|Overall Study||174
11005499|NCT00723073|12183166|FG000|NOT COMPLETED|Overall Study||0
11005500|NCT00723073|12183167|FG001|NOT COMPLETED|Overall Study||0
11005501|NCT00723099|12183173|FG000|STARTED|Overall Study||73
11005502|NCT00723099|12183173|FG000|COMPLETED|Overall Study||72
11259232|NCT02233946|12453930|FG001|NOT COMPLETED|9-month Follow-up||11
11259233|NCT02233946|12453929|FG000|STARTED|12-month Follow-up||530
11259234|NCT02233946|12453930|FG001|STARTED|12-month Follow-up||201
11259235|NCT02233946|12453929|FG000|COMPLETED|12-month Follow-up||502
11259236|NCT02233946|12453930|FG001|COMPLETED|12-month Follow-up||190
11259237|NCT02233946|12453929|FG000|NOT COMPLETED|12-month Follow-up||28
11259238|NCT02233946|12453930|FG001|NOT COMPLETED|12-month Follow-up||11
11259239|NCT02233985|12453938|FG000|STARTED|Overall Study||33
11259240|NCT02233985|12453939|FG001|STARTED|Overall Study||31
11259241|NCT02233985|12453938|FG000|COMPLETED|Overall Study||33
11259242|NCT02233985|12453939|FG001|COMPLETED|Overall Study||31
11259243|NCT02233985|12453938|FG000|NOT COMPLETED|Overall Study||0
11259244|NCT02233985|12453939|FG001|NOT COMPLETED|Overall Study||0
11259245|NCT02233998|12453950|FG000|STARTED|Overall Study||53
11259246|NCT02233998|12453951|FG001|STARTED|Overall Study||52
11259247|NCT02233998|12453952|FG002|STARTED|Overall Study||53
11259248|NCT02233998|12453950|FG000|COMPLETED|Overall Study||53
11259249|NCT02233998|12453951|FG001|COMPLETED|Overall Study||52
11259250|NCT02233998|12453952|FG002|COMPLETED|Overall Study||53
11259251|NCT02233998|12453950|FG000|NOT COMPLETED|Overall Study||0
11259252|NCT02233998|12453951|FG001|NOT COMPLETED|Overall Study||0
11259253|NCT02233998|12453952|FG002|NOT COMPLETED|Overall Study||0
11259254|NCT02234063|12453962|FG000|STARTED|Overall Study||1795
11259255|NCT02234063|12453963|FG001|STARTED|Overall Study||255
11259256|NCT02234063|12453962|FG000|COMPLETED|Overall Study||1540
11259257|NCT02234063|12453963|FG001|COMPLETED|Overall Study||212
11259258|NCT02234063|12453962|FG000|NOT COMPLETED|Overall Study||255
11259259|NCT02234063|12453963|FG001|NOT COMPLETED|Overall Study||43
11259260|NCT02234115|12453974|FG000|STARTED|Overall Study||137
11259261|NCT02234115|12453974|FG000|ITT|Overall Study||137
11259262|NCT02234115|12453974|FG000|PP|Overall Study||124
11259263|NCT02234115|12453974|FG000|PK Subgroup|Overall Study||31
11259264|NCT02234115|12453974|FG000|COMPLETED|Overall Study||122
11259265|NCT02234115|12453974|FG000|NOT COMPLETED|Overall Study||15
11259266|NCT02234128|12453981|FG000|STARTED|Overall Study||35
11005503|NCT00723099|12183173|FG000|NOT COMPLETED|Overall Study||1
11259267|NCT02234128|12453982|FG001|STARTED|Overall Study||31
11259268|NCT02234128|12453983|FG002|STARTED|Overall Study||52
11259269|NCT02234128|12453981|FG000|COMPLETED|Overall Study||30
11259270|NCT02234128|12453982|FG001|COMPLETED|Overall Study||29
11259271|NCT02234128|12453983|FG002|COMPLETED|Overall Study||48
11259272|NCT02234128|12453981|FG000|NOT COMPLETED|Overall Study||5
11259273|NCT02234128|12453982|FG001|NOT COMPLETED|Overall Study||2
11259274|NCT02234128|12453983|FG002|NOT COMPLETED|Overall Study||4
11259275|NCT02234141|12453995|FG000|STARTED|Treatment Period (24 Weeks)||39
11259276|NCT02234141|12453996|FG001|STARTED|Treatment Period (24 Weeks)||38
11259277|NCT02234141|12453997|FG002|STARTED|Treatment Period (24 Weeks)||37
11259278|NCT02234141|12453998|FG003|STARTED|Treatment Period (24 Weeks)||37
11259279|NCT02234141|12453999|FG004|STARTED|Treatment Period (24 Weeks)||0
11259280|NCT02234141|12454000|FG005|STARTED|Treatment Period (24 Weeks)||0
11259281|NCT02234141|12454001|FG006|STARTED|Treatment Period (24 Weeks)||0
11259282|NCT02234141|12453995|FG000|COMPLETED|Treatment Period (24 Weeks)||35
11259283|NCT02234141|12453996|FG001|COMPLETED|Treatment Period (24 Weeks)||32
11259284|NCT02234141|12453997|FG002|COMPLETED|Treatment Period (24 Weeks)||35
11259285|NCT02234141|12453998|FG003|COMPLETED|Treatment Period (24 Weeks)||32
11259286|NCT02234141|12453999|FG004|COMPLETED|Treatment Period (24 Weeks)||0
11259287|NCT02234141|12454000|FG005|COMPLETED|Treatment Period (24 Weeks)||0
11259288|NCT02234141|12454001|FG006|COMPLETED|Treatment Period (24 Weeks)||0
11259289|NCT02234141|12453995|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||4
11259290|NCT02234141|12453996|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||6
11259291|NCT02234141|12453997|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||2
11259292|NCT02234141|12453998|FG003|NOT COMPLETED|Treatment Period (24 Weeks)||5
11259293|NCT02234141|12453999|FG004|NOT COMPLETED|Treatment Period (24 Weeks)||0
11259294|NCT02234141|12454000|FG005|NOT COMPLETED|Treatment Period (24 Weeks)||0
11259295|NCT02234141|12454001|FG006|NOT COMPLETED|Treatment Period (24 Weeks)||0
11259296|NCT02234141|12453995|FG000|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
11259297|NCT02234141|12453996|FG001|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31
11259298|NCT02234141|12453997|FG002|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
11259299|NCT02234141|12453998|FG003|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0
11259300|NCT02234141|12453999|FG004|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
11259301|NCT02234141|12454000|FG005|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12
11259302|NCT02234141|12454001|FG006|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
11259303|NCT02234141|12453995|FG000|COMPLETED|Long-Term Treatment Period||0
11259304|NCT02234141|12453996|FG001|COMPLETED|Long-Term Treatment Period||0
11259305|NCT02234141|12453997|FG002|COMPLETED|Long-Term Treatment Period||0
11259306|NCT02234141|12453998|FG003|COMPLETED|Long-Term Treatment Period||0
11259307|NCT02234141|12453999|FG004|COMPLETED|Long-Term Treatment Period||0
11259308|NCT02234141|12454000|FG005|COMPLETED|Long-Term Treatment Period||0
11259309|NCT02234141|12454001|FG006|COMPLETED|Long-Term Treatment Period||0
11259310|NCT02234141|12453995|FG000|NOT COMPLETED|Long-Term Treatment Period||33
11259311|NCT02234141|12453996|FG001|NOT COMPLETED|Long-Term Treatment Period||31
11259312|NCT02234141|12453997|FG002|NOT COMPLETED|Long-Term Treatment Period||33
11259313|NCT02234141|12453998|FG003|NOT COMPLETED|Long-Term Treatment Period||0
11259314|NCT02234141|12453999|FG004|NOT COMPLETED|Long-Term Treatment Period||10
11259315|NCT02234141|12454000|FG005|NOT COMPLETED|Long-Term Treatment Period||12
11259316|NCT02234141|12454001|FG006|NOT COMPLETED|Long-Term Treatment Period||10
11259317|NCT02234180|12454012|FG000|STARTED|Overall Study||2
11259318|NCT02234180|12454013|FG001|STARTED|Overall Study||1
11259319|NCT02234180|12454012|FG000|COMPLETED|Overall Study||2
11259320|NCT02234180|12454013|FG001|COMPLETED|Overall Study||1
11259321|NCT02234180|12454012|FG000|NOT COMPLETED|Overall Study||0
11259322|NCT02234180|12454013|FG001|NOT COMPLETED|Overall Study||0
11259323|NCT02234284|12454019|FG000|STARTED|Overall Study||100
11259324|NCT02234284|12454020|FG001|STARTED|Overall Study||92
11259325|NCT02234284|12454019|FG000|COMPLETED|Overall Study||75
11259326|NCT02234284|12454020|FG001|COMPLETED|Overall Study||83
11259327|NCT02234284|12454019|FG000|NOT COMPLETED|Overall Study||25
11259328|NCT02234284|12454020|FG001|NOT COMPLETED|Overall Study||9
11259329|NCT02234362|12454030|FG000|STARTED|Overall Study||47
11259330|NCT02234362|12454030|FG000|Received at Least One Dose of Medication|Overall Study||27
11259331|NCT02234362|12454030|FG000|COMPLETED|Overall Study||21
11259332|NCT02234362|12454030|FG000|NOT COMPLETED|Overall Study||26
11259333|NCT02234427|12454034|FG000|STARTED|Overall Study||34
11259334|NCT02234427|12454034|FG000|COMPLETED|Overall Study|One individual withdrew after first visit|33
11259335|NCT02234427|12454034|FG000|NOT COMPLETED|Overall Study||1
11259336|NCT02234479|12454040|FG000|STARTED|Overall Study||16
11259337|NCT02234479|12454041|FG001|STARTED|Overall Study||18
11259338|NCT02234479|12454040|FG000|COMPLETED|Overall Study||15
11259339|NCT02234479|12454041|FG001|COMPLETED|Overall Study||15
11259340|NCT02234479|12454040|FG000|NOT COMPLETED|Overall Study||1
11259341|NCT02234479|12454041|FG001|NOT COMPLETED|Overall Study||3
11259342|NCT02234570|12454055|FG000|STARTED|Overall Study||8
11259343|NCT02234570|12454056|FG001|STARTED|Overall Study||8
11259344|NCT02234570|12454057|FG002|STARTED|Overall Study||8
11259345|NCT02234570|12454058|FG003|STARTED|Overall Study||8
11259346|NCT02234570|12454059|FG004|STARTED|Overall Study||8
11259347|NCT02234570|12454060|FG005|STARTED|Overall Study||8
11259348|NCT02234570|12454061|FG006|STARTED|Overall Study||8
11259349|NCT02234570|12454062|FG007|STARTED|Overall Study||14
11259350|NCT02234570|12454055|FG000|COMPLETED|Overall Study||8
11259351|NCT02234570|12454056|FG001|COMPLETED|Overall Study||8
11259352|NCT02234570|12454057|FG002|COMPLETED|Overall Study||8
11259353|NCT02234570|12454058|FG003|COMPLETED|Overall Study||8
11259354|NCT02234570|12454059|FG004|COMPLETED|Overall Study||8
11259355|NCT02234570|12454060|FG005|COMPLETED|Overall Study||8
11259356|NCT02234570|12454061|FG006|COMPLETED|Overall Study||8
11259357|NCT02234570|12454062|FG007|COMPLETED|Overall Study||14
11259358|NCT02234570|12454055|FG000|NOT COMPLETED|Overall Study||0
11259359|NCT02234570|12454056|FG001|NOT COMPLETED|Overall Study||0
11259360|NCT02234570|12454057|FG002|NOT COMPLETED|Overall Study||0
11259361|NCT02234570|12454058|FG003|NOT COMPLETED|Overall Study||0
11259362|NCT02234570|12454059|FG004|NOT COMPLETED|Overall Study||0
11259363|NCT02234570|12454060|FG005|NOT COMPLETED|Overall Study||0
11259364|NCT02234570|12454061|FG006|NOT COMPLETED|Overall Study||0
11259365|NCT02234570|12454062|FG007|NOT COMPLETED|Overall Study||0
11259366|NCT02234583|12454082|FG000|STARTED|Overall Study||847
11259367|NCT02234583|12454083|FG001|STARTED|Overall Study||1241
11259368|NCT02234583|12454082|FG000|COMPLETED|Overall Study||434
11259369|NCT02234583|12454083|FG001|COMPLETED|Overall Study||685
11259370|NCT02234583|12454082|FG000|NOT COMPLETED|Overall Study||413
11259371|NCT02234583|12454083|FG001|NOT COMPLETED|Overall Study||556
11259372|NCT02234596|12454095|FG000|STARTED|Overall Study||34
11259373|NCT02234596|12454095|FG000|COMPLETED|Overall Study||32
11259374|NCT02234596|12454095|FG000|NOT COMPLETED|Overall Study||2
11259375|NCT02234622|12454101|FG000|STARTED|Overall Study||108
11259376|NCT02234622|12454102|FG001|STARTED|Overall Study||104
11259377|NCT02234622|12454101|FG000|COMPLETED|Overall Study||65
11259378|NCT02234622|12454102|FG001|COMPLETED|Overall Study||68
11259379|NCT02234622|12454101|FG000|NOT COMPLETED|Overall Study||43
11259380|NCT02234622|12454102|FG001|NOT COMPLETED|Overall Study||36
11259381|NCT02234713|12454112|FG000|STARTED|Overall Study||31
11259382|NCT02234713|12454113|FG001|STARTED|Overall Study||32
11259383|NCT02234713|12454112|FG000|COMPLETED|Overall Study||25
11259384|NCT02234713|12454113|FG001|COMPLETED|Overall Study||27
11259385|NCT02234713|12454112|FG000|NOT COMPLETED|Overall Study||6
11259386|NCT02234713|12454113|FG001|NOT COMPLETED|Overall Study||5
11259387|NCT02234752|12454120|FG000|STARTED|Overall Study||3
11259388|NCT02234752|12454120|FG000|COMPLETED|Overall Study||2
11259389|NCT02234752|12454120|FG000|NOT COMPLETED|Overall Study||1
11259390|NCT02235064|12454127|FG000|STARTED|Overall Study||1
11259391|NCT02235064|12454128|FG001|STARTED|Overall Study||1
11259392|NCT02235064|12454127|FG000|COMPLETED|Overall Study||1
11259393|NCT02235064|12454128|FG001|COMPLETED|Overall Study||1
11259394|NCT02235064|12454127|FG000|NOT COMPLETED|Overall Study||0
11259395|NCT02235064|12454128|FG001|NOT COMPLETED|Overall Study||0
11259396|NCT02235077|12454138|FG000|STARTED|Overall Study||182
11259397|NCT02235077|12454139|FG001|STARTED|Overall Study||178
11259398|NCT02235077|12454138|FG000|COMPLETED|Overall Study||164
11259399|NCT02235077|12454139|FG001|COMPLETED|Overall Study||159
11259400|NCT02235077|12454138|FG000|NOT COMPLETED|Overall Study||18
11259401|NCT02235077|12454139|FG001|NOT COMPLETED|Overall Study||19
11259402|NCT02235285|12454145|FG000|STARTED|Overall Study||162
11259403|NCT02235285|12454145|FG000|COMPLETED|Overall Study||149
11259404|NCT02235285|12454145|FG000|NOT COMPLETED|Overall Study||13
11259405|NCT02235298|12454151|FG000|STARTED|Overall Study||50
11259406|NCT02235298|12454152|FG001|STARTED|Overall Study||50
11259407|NCT02235298|12454151|FG000|COMPLETED|Overall Study||42
11259408|NCT02235298|12454152|FG001|COMPLETED|Overall Study||42
11259409|NCT02235298|12454151|FG000|NOT COMPLETED|Overall Study||8
11259410|NCT02235298|12454152|FG001|NOT COMPLETED|Overall Study||8
11259411|NCT02235311|12454160|FG000|STARTED|Overall Study||1
11259412|NCT02235311|12454161|FG001|STARTED|Overall Study||2
11259413|NCT02235311|12454160|FG000|COMPLETED|Overall Study||1
11259414|NCT02235311|12454161|FG001|COMPLETED|Overall Study||0
11259415|NCT02235311|12454160|FG000|NOT COMPLETED|Overall Study||0
11259416|NCT02235311|12454161|FG001|NOT COMPLETED|Overall Study||2
11259417|NCT02235454|12454167|FG000|STARTED|Overall Study||57
11259418|NCT02235454|12454167|FG000|COMPLETED|Overall Study||55
11259419|NCT02235454|12454167|FG000|NOT COMPLETED|Overall Study||2
11259420|NCT02235493|12454171|FG000|STARTED|Overall Study||6
11259421|NCT02235493|12454171|FG000|COMPLETED|Overall Study||6
11259422|NCT02235493|12454171|FG000|NOT COMPLETED|Overall Study||0
11259423|NCT02235831|12454175|FG000|STARTED|Period 1, First 5 Days of Wear||4
11259424|NCT02235831|12454176|FG001|STARTED|Period 1, First 5 Days of Wear||4
11259425|NCT02235831|12454177|FG002|STARTED|Period 1, First 5 Days of Wear||4
11259426|NCT02235831|12454178|FG003|STARTED|Period 1, First 5 Days of Wear||4
11259427|NCT02235831|12454179|FG004|STARTED|Period 1, First 5 Days of Wear||4
11259428|NCT02235831|12454180|FG005|STARTED|Period 1, First 5 Days of Wear||4
11259429|NCT02235831|12454175|FG000|COMPLETED|Period 1, First 5 Days of Wear||4
11259430|NCT02235831|12454176|FG001|COMPLETED|Period 1, First 5 Days of Wear||4
11259431|NCT02235831|12454177|FG002|COMPLETED|Period 1, First 5 Days of Wear||4
11259432|NCT02235831|12454178|FG003|COMPLETED|Period 1, First 5 Days of Wear||4
11259433|NCT02235831|12454179|FG004|COMPLETED|Period 1, First 5 Days of Wear||4
11259434|NCT02235831|12454180|FG005|COMPLETED|Period 1, First 5 Days of Wear||4
11259435|NCT02235831|12454175|FG000|NOT COMPLETED|Period 1, First 5 Days of Wear||0
11259436|NCT02235831|12454176|FG001|NOT COMPLETED|Period 1, First 5 Days of Wear||0
11259437|NCT02235831|12454177|FG002|NOT COMPLETED|Period 1, First 5 Days of Wear||0
11259438|NCT02235831|12454178|FG003|NOT COMPLETED|Period 1, First 5 Days of Wear||0
11259439|NCT02235831|12454179|FG004|NOT COMPLETED|Period 1, First 5 Days of Wear||0
11259440|NCT02235831|12454180|FG005|NOT COMPLETED|Period 1, First 5 Days of Wear||0
11259441|NCT02235831|12454175|FG000|STARTED|Period 2, Second 5 Days of Wear||4
11259442|NCT02235831|12454176|FG001|STARTED|Period 2, Second 5 Days of Wear||4
11259443|NCT02235831|12454177|FG002|STARTED|Period 2, Second 5 Days of Wear||4
11259444|NCT02235831|12454178|FG003|STARTED|Period 2, Second 5 Days of Wear||4
11259445|NCT02235831|12454179|FG004|STARTED|Period 2, Second 5 Days of Wear||4
11259446|NCT02235831|12454180|FG005|STARTED|Period 2, Second 5 Days of Wear||4
11259447|NCT02235831|12454175|FG000|COMPLETED|Period 2, Second 5 Days of Wear||4
11259448|NCT02235831|12454176|FG001|COMPLETED|Period 2, Second 5 Days of Wear||4
11259449|NCT02235831|12454177|FG002|COMPLETED|Period 2, Second 5 Days of Wear||4
11259450|NCT02235831|12454178|FG003|COMPLETED|Period 2, Second 5 Days of Wear||4
11259451|NCT02235831|12454179|FG004|COMPLETED|Period 2, Second 5 Days of Wear||4
11259452|NCT02235831|12454180|FG005|COMPLETED|Period 2, Second 5 Days of Wear||4
11259453|NCT02235831|12454175|FG000|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
11259454|NCT02235831|12454176|FG001|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
11259455|NCT02235831|12454177|FG002|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
11259456|NCT02235831|12454178|FG003|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
11259457|NCT02235831|12454179|FG004|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
11259458|NCT02235831|12454180|FG005|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
11259459|NCT02235831|12454175|FG000|STARTED|Period 3, Third 5 Days of Wear||4
11259460|NCT02235831|12454176|FG001|STARTED|Period 3, Third 5 Days of Wear||4
11259461|NCT02235831|12454177|FG002|STARTED|Period 3, Third 5 Days of Wear||4
11259462|NCT02235831|12454178|FG003|STARTED|Period 3, Third 5 Days of Wear||4
11259463|NCT02235831|12454179|FG004|STARTED|Period 3, Third 5 Days of Wear||4
11259464|NCT02235831|12454180|FG005|STARTED|Period 3, Third 5 Days of Wear||4
11259465|NCT02235831|12454175|FG000|COMPLETED|Period 3, Third 5 Days of Wear||4
11259466|NCT02235831|12454176|FG001|COMPLETED|Period 3, Third 5 Days of Wear||4
11259467|NCT02235831|12454177|FG002|COMPLETED|Period 3, Third 5 Days of Wear||4
11259468|NCT02235831|12454178|FG003|COMPLETED|Period 3, Third 5 Days of Wear||4
11259469|NCT02235831|12454179|FG004|COMPLETED|Period 3, Third 5 Days of Wear||4
11259470|NCT02235831|12454180|FG005|COMPLETED|Period 3, Third 5 Days of Wear||4
11259471|NCT02235831|12454175|FG000|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
11259472|NCT02235831|12454176|FG001|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
11259473|NCT02235831|12454177|FG002|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
11259474|NCT02235831|12454178|FG003|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
11259475|NCT02235831|12454179|FG004|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
11259476|NCT02235831|12454180|FG005|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
11259477|NCT02235870|12454189|FG000|STARTED|Overall Study||198
11259478|NCT02235870|12454190|FG001|STARTED|Overall Study||189
11259479|NCT02235870|12454189|FG000|Completed Phase I (Week 24)|Overall Study||182
11259480|NCT02235870|12454190|FG001|Completed Phase I (Week 24)|Overall Study||179
11259481|NCT02235870|12454189|FG000|Crossover (Week 24)|Overall Study||170
11259482|NCT02235870|12454190|FG001|Crossover (Week 24)|Overall Study||138
11259483|NCT02235870|12454189|FG000|COMPLETED|Overall Study||160
11259484|NCT02235870|12454190|FG001|COMPLETED|Overall Study||128
11259485|NCT02235870|12454189|FG000|NOT COMPLETED|Overall Study||38
11259486|NCT02235870|12454190|FG001|NOT COMPLETED|Overall Study||61
11259487|NCT02235987|12454197|FG000|STARTED|Overall Study||20
11259488|NCT02235987|12454197|FG000|Received Octreotide|Overall Study||20
11259489|NCT02235987|12454197|FG000|Received 100 µg DG3173|Overall Study||20
11259490|NCT02235987|12454197|FG000|Received 300 µg DG3173|Overall Study||20
11259491|NCT02235987|12454197|FG000|Received 900 µg DG3173|Overall Study||19
11259492|NCT02235987|12454197|FG000|Received 1800 µg DG3173|Overall Study||19
11259493|NCT02235987|12454197|FG000|COMPLETED|Overall Study||19
11259494|NCT02235987|12454197|FG000|NOT COMPLETED|Overall Study||1
11259495|NCT02236130|12454212|FG000|STARTED|Overall Study||22
11259496|NCT02236130|12454213|FG001|STARTED|Overall Study||27
11259497|NCT02236130|12454212|FG000|COMPLETED|Overall Study||15
11259498|NCT02236130|12454213|FG001|COMPLETED|Overall Study||15
11259499|NCT02236130|12454212|FG000|NOT COMPLETED|Overall Study||7
11259500|NCT02236130|12454213|FG001|NOT COMPLETED|Overall Study||12
11259501|NCT02236338|12454221|FG000|STARTED|Overall Study||100
11259502|NCT02236338|12454222|FG001|STARTED|Overall Study||100
11259503|NCT02236338|12454221|FG000|COMPLETED|Overall Study||100
11259504|NCT02236338|12454222|FG001|COMPLETED|Overall Study||100
11259505|NCT02236338|12454221|FG000|NOT COMPLETED|Overall Study||0
11259506|NCT02236338|12454222|FG001|NOT COMPLETED|Overall Study||0
11259507|NCT02236520|12454232|FG000|STARTED|Overall Study||16
11259508|NCT02236520|12454233|FG001|STARTED|Overall Study||13
11259509|NCT02236520|12454234|FG002|STARTED|Overall Study||15
11259510|NCT02236520|12454235|FG003|STARTED|Overall Study||15
11259511|NCT02236520|12454232|FG000|COMPLETED|Overall Study||14
11259512|NCT02236520|12454233|FG001|COMPLETED|Overall Study||8
11259513|NCT02236520|12454234|FG002|COMPLETED|Overall Study||15
11259514|NCT02236520|12454235|FG003|COMPLETED|Overall Study||14
11259515|NCT02236520|12454232|FG000|NOT COMPLETED|Overall Study||2
11259516|NCT02236520|12454233|FG001|NOT COMPLETED|Overall Study||5
11259517|NCT02236520|12454234|FG002|NOT COMPLETED|Overall Study||0
11259518|NCT02236520|12454235|FG003|NOT COMPLETED|Overall Study||1
11259519|NCT02236559|12454247|FG000|STARTED|Overall Study||112
11259520|NCT02236559|12454248|FG001|STARTED|Overall Study||116
11259521|NCT02236559|12454247|FG000|COMPLETED|Overall Study||100
11259522|NCT02236559|12454248|FG001|COMPLETED|Overall Study||104
11259523|NCT02236559|12454247|FG000|NOT COMPLETED|Overall Study||12
11259524|NCT02236559|12454248|FG001|NOT COMPLETED|Overall Study||12
11259525|NCT02236598|12454256|FG000|STARTED|Overall Study||15
11259526|NCT02236598|12454257|FG001|STARTED|Overall Study||14
11259527|NCT02236598|12454256|FG000|COMPLETED|Overall Study||15
11259528|NCT02236598|12454257|FG001|COMPLETED|Overall Study||12
11259529|NCT02236598|12454256|FG000|NOT COMPLETED|Overall Study||0
11259530|NCT02236598|12454257|FG001|NOT COMPLETED|Overall Study||2
11259531|NCT02236611|12454265|FG000|STARTED|Overall Study||516
11259532|NCT02236611|12454266|FG001|STARTED|Overall Study||518
11259533|NCT02236611|12454265|FG000|COMPLETED|Overall Study||490
11259534|NCT02236611|12454266|FG001|COMPLETED|Overall Study||484
11259535|NCT02236611|12454265|FG000|NOT COMPLETED|Overall Study||26
11259536|NCT02236611|12454266|FG001|NOT COMPLETED|Overall Study||34
11259537|NCT02236767|12454272|FG000|STARTED|Overall Study||1
11259538|NCT02236767|12454272|FG000|COMPLETED|Overall Study||1
11259539|NCT02236767|12454272|FG000|NOT COMPLETED|Overall Study||0
11259540|NCT02236988|12454280|FG000|STARTED|Overall Study||16
11259541|NCT02236988|12454281|FG001|STARTED|Overall Study||16
11259542|NCT02236988|12454282|FG002|STARTED|Overall Study||18
11259543|NCT02236988|12454283|FG003|STARTED|Overall Study||30
11259544|NCT02236988|12454280|FG000|COMPLETED|Overall Study||16
11259545|NCT02236988|12454281|FG001|COMPLETED|Overall Study||16
11259546|NCT02236988|12454282|FG002|COMPLETED|Overall Study||18
11259547|NCT02236988|12454283|FG003|COMPLETED|Overall Study||27
11259548|NCT02236988|12454280|FG000|NOT COMPLETED|Overall Study||0
11259549|NCT02236988|12454281|FG001|NOT COMPLETED|Overall Study||0
11259550|NCT02236988|12454282|FG002|NOT COMPLETED|Overall Study||0
11259551|NCT02236988|12454283|FG003|NOT COMPLETED|Overall Study||3
11259552|NCT02237001|12454334|FG000|STARTED|Overall Study||30
11259553|NCT02237001|12454334|FG000|6 Month Follow-up|Overall Study||27
11259554|NCT02237001|12454334|FG000|12 Month Follow-up|Overall Study||21
11259555|NCT02237001|12454334|FG000|24 Month Follow-up|Overall Study||19
11259556|NCT02237001|12454334|FG000|COMPLETED|Overall Study||19
11259557|NCT02237001|12454334|FG000|NOT COMPLETED|Overall Study||11
11259558|NCT02237092|12454338|FG000|STARTED|Overall Study||196
11259559|NCT02237092|12454338|FG000|COMPLETED|Overall Study||196
11259560|NCT02237092|12454338|FG000|NOT COMPLETED|Overall Study||0
11259561|NCT02237118|12454355|FG000|STARTED|Overall Study||60
11259562|NCT02237118|12454356|FG001|STARTED|Overall Study||63
11259563|NCT02237118|12454355|FG000|COMPLETED|Overall Study||59
11259564|NCT02237118|12454356|FG001|COMPLETED|Overall Study||62
11259565|NCT02237118|12454355|FG000|NOT COMPLETED|Overall Study||1
11259566|NCT02237118|12454356|FG001|NOT COMPLETED|Overall Study||1
11259567|NCT02237157|12454370|FG000|STARTED|Gemcitabine, Local Delivery (Dose 1)||20
11259568|NCT02237157|12454371|FG001|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
11259569|NCT02237157|12454372|FG002|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
11259570|NCT02237157|12454373|FG003|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
11259571|NCT02237157|12454370|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||16
11259572|NCT02237157|12454371|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
11259573|NCT02237157|12454372|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
11259574|NCT02237157|12454373|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
11259575|NCT02237157|12454370|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||4
11259576|NCT02237157|12454371|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
11259577|NCT02237157|12454372|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
11259578|NCT02237157|12454373|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
11259579|NCT02237157|12454370|FG000|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
11259580|NCT02237157|12454371|FG001|STARTED|Gemcitabine, Local Delivery (Dose 2)||15
11259581|NCT02237157|12454372|FG002|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
11259582|NCT02237157|12454373|FG003|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
11259583|NCT02237157|12454370|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
11259584|NCT02237157|12454371|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||15
11259585|NCT02237157|12454372|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
11259586|NCT02237157|12454373|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
11259587|NCT02237157|12454370|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
11259588|NCT02237157|12454371|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
11259589|NCT02237157|12454372|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
11259590|NCT02237157|12454373|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
11259591|NCT02237157|12454370|FG000|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
11259592|NCT02237157|12454371|FG001|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
11259593|NCT02237157|12454372|FG002|STARTED|Gemcitabine, Local Delivery (Dose 3)||11
11259594|NCT02237157|12454373|FG003|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
11259595|NCT02237157|12454370|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
11259596|NCT02237157|12454371|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
11259597|NCT02237157|12454372|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||11
11259598|NCT02237157|12454373|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
11259599|NCT02237157|12454370|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
11259600|NCT02237157|12454371|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
11259601|NCT02237157|12454372|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
11259602|NCT02237157|12454373|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
11259603|NCT02237157|12454370|FG000|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
11259604|NCT02237157|12454371|FG001|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
11259605|NCT02237157|12454372|FG002|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
11259606|NCT02237157|12454373|FG003|STARTED|Gemcitabine, Local Delivery (Dose 4)||8
11259607|NCT02237157|12454370|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
11259608|NCT02237157|12454371|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
11259609|NCT02237157|12454372|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
11259610|NCT02237157|12454373|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||8
11259611|NCT02237157|12454370|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
11259612|NCT02237157|12454371|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
11259613|NCT02237157|12454372|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
11259614|NCT02237157|12454373|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
11259615|NCT02237196|12454384|FG000|STARTED|Overall Study||32
11259616|NCT02237196|12454385|FG001|STARTED|Overall Study||31
11259617|NCT02237196|12454386|FG002|STARTED|Overall Study||30
11259618|NCT02237196|12454387|FG003|STARTED|Overall Study||28
11259619|NCT02237196|12454384|FG000|COMPLETED|Overall Study||24
11259620|NCT02237196|12454385|FG001|COMPLETED|Overall Study||25
11259621|NCT02237196|12454386|FG002|COMPLETED|Overall Study||20
11259622|NCT02237196|12454387|FG003|COMPLETED|Overall Study||17
11259623|NCT02237196|12454384|FG000|NOT COMPLETED|Overall Study||8
11259624|NCT02237196|12454385|FG001|NOT COMPLETED|Overall Study||6
11259625|NCT02237196|12454386|FG002|NOT COMPLETED|Overall Study||10
11259626|NCT02237196|12454387|FG003|NOT COMPLETED|Overall Study||11
11259627|NCT02237417|12454400|FG000|STARTED|Overall Study||16
11259628|NCT02237417|12454401|FG001|STARTED|Overall Study||15
11259629|NCT02237417|12454402|FG002|STARTED|Overall Study||16
11259630|NCT02237417|12454400|FG000|COMPLETED|Overall Study||16
11259631|NCT02237417|12454401|FG001|COMPLETED|Overall Study||9
11259632|NCT02237417|12454402|FG002|COMPLETED|Overall Study||7
11259633|NCT02237417|12454400|FG000|NOT COMPLETED|Overall Study||0
11259634|NCT02237417|12454401|FG001|NOT COMPLETED|Overall Study||6
11259635|NCT02237417|12454402|FG002|NOT COMPLETED|Overall Study||9
11259636|NCT02237898|12454412|FG000|STARTED|Overall Study||12
11259637|NCT02237898|12454413|FG001|STARTED|Overall Study||14
11259638|NCT02237898|12454412|FG000|Completed 12 Weeks of CM|Overall Study||7
11259639|NCT02237898|12454413|FG001|Completed 12 Weeks of CM|Overall Study||2
11259640|NCT02237898|12454412|FG000|Completed 3 Month Follow-up|Overall Study||6
11259641|NCT02237898|12454413|FG001|Completed 3 Month Follow-up|Overall Study||6
11259642|NCT02237898|12454412|FG000|Completed 9 Month Follow-up|Overall Study||6
11259643|NCT02237898|12454413|FG001|Completed 9 Month Follow-up|Overall Study||7
11259644|NCT02237898|12454412|FG000|Completed 15 Month Follow-up|Overall Study||8
11259645|NCT02237898|12454413|FG001|Completed 15 Month Follow-up|Overall Study||8
11259646|NCT02237898|12454412|FG000|COMPLETED|Overall Study||5
11259647|NCT02237898|12454413|FG001|COMPLETED|Overall Study||2
11259648|NCT02237898|12454412|FG000|NOT COMPLETED|Overall Study||7
11259649|NCT02237898|12454413|FG001|NOT COMPLETED|Overall Study||12
11259650|NCT02237911|12454424|FG000|STARTED|Overall Study||96
11259651|NCT02237911|12454425|FG001|STARTED|Overall Study||96
11259652|NCT02237911|12454426|FG002|STARTED|Overall Study||48
11259653|NCT02237911|12454424|FG000|3 Months|Overall Study||90
11259654|NCT02237911|12454425|FG001|3 Months|Overall Study||87
11259655|NCT02237911|12454426|FG002|3 Months|Overall Study||44
11259656|NCT02237911|12454424|FG000|6 Months|Overall Study||89
11259657|NCT02237911|12454425|FG001|6 Months|Overall Study||88
11259658|NCT02237911|12454426|FG002|6 Months|Overall Study||45
11259659|NCT02237911|12454424|FG000|COMPLETED|Overall Study||89
11259660|NCT02237911|12454425|FG001|COMPLETED|Overall Study||88
11259661|NCT02237911|12454426|FG002|COMPLETED|Overall Study||45
11259662|NCT02237911|12454424|FG000|NOT COMPLETED|Overall Study||7
11259663|NCT02237911|12454425|FG001|NOT COMPLETED|Overall Study||8
11259664|NCT02237911|12454426|FG002|NOT COMPLETED|Overall Study||3
11259665|NCT02237950|12454436|FG000|STARTED|Overall Study||295
11259666|NCT02237950|12454437|FG001|STARTED|Overall Study||291
11259667|NCT02237950|12454436|FG000|COMPLETED|Overall Study||247
11259668|NCT02237950|12454437|FG001|COMPLETED|Overall Study||243
11259669|NCT02237950|12454436|FG000|NOT COMPLETED|Overall Study||48
11259670|NCT02237950|12454437|FG001|NOT COMPLETED|Overall Study||48
11259671|NCT02237989|12454445|FG000|STARTED|Overall Study||19
11259672|NCT02237989|12454446|FG001|STARTED|Overall Study||20
11259673|NCT02237989|12454445|FG000|COMPLETED|Overall Study||19
11259674|NCT02237989|12454446|FG001|COMPLETED|Overall Study||20
11259675|NCT02237989|12454445|FG000|NOT COMPLETED|Overall Study||0
11259676|NCT02237989|12454446|FG001|NOT COMPLETED|Overall Study||0
11259677|NCT02238028|12454452|FG000|STARTED|Overall Study||14
11259678|NCT02238028|12454453|FG001|STARTED|Overall Study||14
11259679|NCT02238028|12454452|FG000|COMPLETED|Overall Study||12
11259680|NCT02238028|12454453|FG001|COMPLETED|Overall Study||12
11259681|NCT02238028|12454452|FG000|NOT COMPLETED|Overall Study||2
11259682|NCT02238028|12454453|FG001|NOT COMPLETED|Overall Study||2
11259683|NCT02238067|12454464|FG000|STARTED|Overall Study||196
11259684|NCT02238067|12454464|FG000|COMPLETED|Overall Study||151
11259685|NCT02238067|12454464|FG000|NOT COMPLETED|Overall Study||45
11259686|NCT02238080|12454468|FG000|STARTED|Overall Study||197
11259687|NCT02238080|12454468|FG000|COMPLETED|Overall Study||172
11259688|NCT02238080|12454468|FG000|NOT COMPLETED|Overall Study||25
11259689|NCT02238379|12454474|FG000|STARTED|Overall Study||12
11259690|NCT02238379|12454475|FG001|STARTED|Overall Study||14
11259691|NCT02238379|12454474|FG000|COMPLETED|Overall Study||11
11259692|NCT02238379|12454475|FG001|COMPLETED|Overall Study||14
11259693|NCT02238379|12454474|FG000|NOT COMPLETED|Overall Study||1
11259694|NCT02238379|12454475|FG001|NOT COMPLETED|Overall Study||0
11259695|NCT02238483|12454483|FG000|STARTED|Overall Study||108
11259696|NCT02238483|12454484|FG001|STARTED|Overall Study||105
11259697|NCT02238483|12454483|FG000|COMPLETED|Overall Study||93
11259698|NCT02238483|12454484|FG001|COMPLETED|Overall Study||91
11259699|NCT02238483|12454483|FG000|NOT COMPLETED|Overall Study||15
11259700|NCT02238483|12454484|FG001|NOT COMPLETED|Overall Study||14
11259701|NCT02238626|12454494|FG000|STARTED|Overall Study||17
11259702|NCT02238626|12454495|FG001|STARTED|Overall Study||34
11259703|NCT02238626|12454496|FG002|STARTED|Overall Study||8
11259704|NCT02238626|12454497|FG003|STARTED|Overall Study||11
11259705|NCT02238626|12454494|FG000|COMPLETED|Overall Study||12
11259706|NCT02238626|12454495|FG001|COMPLETED|Overall Study||20
11259707|NCT02238626|12454496|FG002|COMPLETED|Overall Study||5
11259708|NCT02238626|12454497|FG003|COMPLETED|Overall Study||4
11259709|NCT02238626|12454494|FG000|NOT COMPLETED|Overall Study||5
11259710|NCT02238626|12454495|FG001|NOT COMPLETED|Overall Study||14
11259711|NCT02238626|12454496|FG002|NOT COMPLETED|Overall Study||3
11259712|NCT02238626|12454497|FG003|NOT COMPLETED|Overall Study||7
11259713|NCT02238782|12454518|FG000|STARTED|Overall Study||12
11259714|NCT02238782|12454518|FG000|Subjects Treated|Overall Study||12
11259715|NCT02238782|12454518|FG000|COMPLETED|Overall Study||12
11259716|NCT02238782|12454518|FG000|NOT COMPLETED|Overall Study||0
11259717|NCT02238847|12454524|FG000|STARTED|Overall Study||59
11142012|NCT01465802|12328682|FG001|NOT COMPLETED|Overall Study||24
11142013|NCT01465802|12328683|FG002|NOT COMPLETED|Overall Study||0
11142014|NCT01465802|12328684|FG003|NOT COMPLETED|Overall Study||29
11142015|NCT01465802|12328685|FG004|NOT COMPLETED|Overall Study||12
11142016|NCT01465841|12328699|FG000|STARTED|Overall Study||517
11259718|NCT02238847|12454525|FG001|STARTED|Overall Study||60
11259719|NCT02238847|12454524|FG000|COMPLETED|Overall Study||37
11259720|NCT02238847|12454525|FG001|COMPLETED|Overall Study||36
11259721|NCT02238847|12454524|FG000|NOT COMPLETED|Overall Study||22
11259722|NCT02238847|12454525|FG001|NOT COMPLETED|Overall Study||24
11259723|NCT02238925|12454531|FG000|STARTED|Overall Study||26
11259724|NCT02238925|12454531|FG000|COMPLETED|Overall Study||1
11259725|NCT02238925|12454531|FG000|NOT COMPLETED|Overall Study||25
11259726|NCT02238977|12454537|FG000|STARTED|Overall Study||0
11259727|NCT02238977|12454538|FG001|STARTED|Overall Study||1
11259728|NCT02238977|12454537|FG000|COMPLETED|Overall Study||0
11259729|NCT02238977|12454538|FG001|COMPLETED|Overall Study||1
11259730|NCT02238977|12454537|FG000|NOT COMPLETED|Overall Study||0
11259731|NCT02238977|12454538|FG001|NOT COMPLETED|Overall Study||0
11259732|NCT02239094|12454544|FG000|STARTED|Overall Study||20
11259733|NCT02239094|12454544|FG000|COMPLETED|Overall Study||18
11259734|NCT02239094|12454544|FG000|NOT COMPLETED|Overall Study||2
11259735|NCT02239120|12454550|FG000|STARTED|Overall Study||2695
11259736|NCT02239120|12454551|FG001|STARTED|Overall Study||2695
11259737|NCT02239120|12454550|FG000|COMPLETED|Overall Study||2620
11259738|NCT02239120|12454551|FG001|COMPLETED|Overall Study||2623
11259739|NCT02239120|12454550|FG000|NOT COMPLETED|Overall Study||75
11259740|NCT02239120|12454551|FG001|NOT COMPLETED|Overall Study||72
11259741|NCT02239224|12454561|FG000|STARTED|Overall Study||3
11259742|NCT02239224|12454562|FG001|STARTED|Overall Study||6
11259743|NCT02239224|12454563|FG002|STARTED|Overall Study||6
11259744|NCT02239224|12454564|FG003|STARTED|Overall Study||5
11259745|NCT02239224|12454561|FG000|Received at Least One Dose of Study Drug|Overall Study||3
11259746|NCT02239224|12454562|FG001|Received at Least One Dose of Study Drug|Overall Study||6
11259747|NCT02239224|12454563|FG002|Received at Least One Dose of Study Drug|Overall Study||6
11259748|NCT02239224|12454564|FG003|Received at Least One Dose of Study Drug|Overall Study||5
11259749|NCT02239224|12454561|FG000|COMPLETED|Overall Study||3
11259750|NCT02239224|12454562|FG001|COMPLETED|Overall Study||6
11259751|NCT02239224|12454563|FG002|COMPLETED|Overall Study||3
11259752|NCT02239224|12454564|FG003|COMPLETED|Overall Study||4
11259753|NCT02239224|12454561|FG000|NOT COMPLETED|Overall Study||0
11259754|NCT02239224|12454562|FG001|NOT COMPLETED|Overall Study||0
11259755|NCT02239224|12454563|FG002|NOT COMPLETED|Overall Study||3
11259756|NCT02239224|12454564|FG003|NOT COMPLETED|Overall Study||1
11259757|NCT02239263|12454574|FG000|STARTED|Overall Study||40
11259758|NCT02239263|12454574|FG000|COMPLETED|Overall Study||34
11259759|NCT02239263|12454574|FG000|NOT COMPLETED|Overall Study||6
11259760|NCT02239289|12454580|FG000|STARTED|Overall Study||21
11259761|NCT02239289|12454580|FG000|COMPLETED|Overall Study||21
11259762|NCT02239289|12454580|FG000|NOT COMPLETED|Overall Study||0
11259763|NCT02239328|12454584|FG000|STARTED|Overall Study||182
11259764|NCT02239328|12454584|FG000|COMPLETED|Overall Study||174
11259765|NCT02239328|12454584|FG000|NOT COMPLETED|Overall Study||8
11259766|NCT02239380|12454588|FG000|STARTED|Overall Study||26
11259767|NCT02239380|12454588|FG000|COMPLETED|Overall Study||26
11259768|NCT02239380|12454588|FG000|NOT COMPLETED|Overall Study||0
11259769|NCT02239510|12454594|FG000|STARTED|Overall Study||5
11259770|NCT02239510|12454595|FG001|STARTED|Overall Study||4
11259771|NCT02239510|12454594|FG000|COMPLETED|Overall Study||3
11259772|NCT02239510|12454595|FG001|COMPLETED|Overall Study||3
11259773|NCT02239510|12454594|FG000|NOT COMPLETED|Overall Study||2
11259774|NCT02239510|12454595|FG001|NOT COMPLETED|Overall Study||1
11259775|NCT02239536|12454603|FG000|STARTED|Overall Study||190
11259776|NCT02239536|12454604|FG001|STARTED|Overall Study||172
11259777|NCT02239536|12454603|FG000|COMPLETED|Overall Study||167
11259778|NCT02239536|12454604|FG001|COMPLETED|Overall Study||155
11259779|NCT02239536|12454603|FG000|NOT COMPLETED|Overall Study||23
11259780|NCT02239536|12454604|FG001|NOT COMPLETED|Overall Study||17
11259781|NCT02239562|12454616|FG000|STARTED|Overall Study||6
11259782|NCT02239562|12454617|FG001|STARTED|Overall Study||6
11259783|NCT02239562|12454618|FG002|STARTED|Overall Study||6
11259784|NCT02239562|12454619|FG003|STARTED|Overall Study||6
11259785|NCT02239562|12454620|FG004|STARTED|Overall Study||6
11259786|NCT02239562|12454621|FG005|STARTED|Overall Study||6
11142017|NCT01465841|12328699|FG000|COMPLETED|Overall Study||449
11142018|NCT01465841|12328699|FG000|NOT COMPLETED|Overall Study||68
11142019|NCT01465958|12328703|FG000|STARTED|Run-in Phase||11
11142020|NCT01465958|12328704|FG001|STARTED|Run-in Phase||0
11142021|NCT01465958|12328703|FG000|COMPLETED|Run-in Phase||10
11142022|NCT01465958|12328704|FG001|COMPLETED|Run-in Phase||0
11142023|NCT01465958|12328703|FG000|NOT COMPLETED|Run-in Phase||1
11142024|NCT01465958|12328704|FG001|NOT COMPLETED|Run-in Phase||0
11259787|NCT02239562|12454616|FG000|COMPLETED|Overall Study||6
11259788|NCT02239562|12454617|FG001|COMPLETED|Overall Study||6
11259789|NCT02239562|12454618|FG002|COMPLETED|Overall Study||6
11259790|NCT02239562|12454619|FG003|COMPLETED|Overall Study||6
11259791|NCT02239562|12454620|FG004|COMPLETED|Overall Study||6
11259792|NCT02239562|12454621|FG005|COMPLETED|Overall Study||6
11259793|NCT02239562|12454616|FG000|NOT COMPLETED|Overall Study||0
11259794|NCT02239562|12454617|FG001|NOT COMPLETED|Overall Study||0
11259795|NCT02239562|12454618|FG002|NOT COMPLETED|Overall Study||0
11259796|NCT02239562|12454619|FG003|NOT COMPLETED|Overall Study||0
11259797|NCT02239562|12454620|FG004|NOT COMPLETED|Overall Study||0
11259798|NCT02239562|12454621|FG005|NOT COMPLETED|Overall Study||0
11259799|NCT02239601|12454639|FG000|STARTED|Overall Study||29
11259800|NCT02239601|12454640|FG001|STARTED|Overall Study||32
11259801|NCT02239601|12454639|FG000|COMPLETED|Overall Study||22
11259802|NCT02239601|12454640|FG001|COMPLETED|Overall Study||26
11259803|NCT02239601|12454639|FG000|NOT COMPLETED|Overall Study||7
11259804|NCT02239601|12454640|FG001|NOT COMPLETED|Overall Study||6
11259805|NCT02239640|12454651|FG000|STARTED|Overall Study||984
11259806|NCT02239640|12454651|FG000|COMPLETED|Overall Study||767
11259807|NCT02239640|12454651|FG000|NOT COMPLETED|Overall Study||217
11259808|NCT02239679|12454664|FG000|STARTED|Overall Study||53
11259809|NCT02239679|12454665|FG001|STARTED|Overall Study||59
11259810|NCT02239679|12454666|FG002|STARTED|Overall Study||54
11259811|NCT02239679|12454664|FG000|COMPLETED|Overall Study||50
11259812|NCT02239679|12454665|FG001|COMPLETED|Overall Study||56
11259813|NCT02239679|12454666|FG002|COMPLETED|Overall Study||53
11259814|NCT02239679|12454664|FG000|NOT COMPLETED|Overall Study||3
11259815|NCT02239679|12454665|FG001|NOT COMPLETED|Overall Study||3
11259816|NCT02239679|12454666|FG002|NOT COMPLETED|Overall Study||1
11259817|NCT02239692|12454676|FG000|STARTED|Overall Study||73
11259818|NCT02239692|12454677|FG001|STARTED|Overall Study||131
11259819|NCT02239692|12454676|FG000|Intention-to-treat Analysis Set|Overall Study||73
11259820|NCT02239692|12454677|FG001|Intention-to-treat Analysis Set|Overall Study||131
11259821|NCT02239692|12454676|FG000|Per-protocol Analysis Set|Overall Study||66
11259822|NCT02239692|12454677|FG001|Per-protocol Analysis Set|Overall Study||120
11259823|NCT02239692|12454676|FG000|Safety Analysis Set|Overall Study||70
11259824|NCT02239692|12454677|FG001|Safety Analysis Set|Overall Study||125
11259825|NCT02239692|12454676|FG000|COMPLETED|Overall Study||67
11259826|NCT02239692|12454677|FG001|COMPLETED|Overall Study||118
11259827|NCT02239692|12454676|FG000|NOT COMPLETED|Overall Study||6
11259828|NCT02239692|12454677|FG001|NOT COMPLETED|Overall Study||13
11259829|NCT02239744|12454685|FG000|STARTED|Period 1||17
11259830|NCT02239744|12454686|FG001|STARTED|Period 1||18
11259831|NCT02239744|12454685|FG000|COMPLETED|Period 1||17
11259832|NCT02239744|12454686|FG001|COMPLETED|Period 1||18
11259833|NCT02239744|12454685|FG000|NOT COMPLETED|Period 1||0
11259834|NCT02239744|12454686|FG001|NOT COMPLETED|Period 1||0
11259835|NCT02239744|12454685|FG000|STARTED|Period 2||17
11259836|NCT02239744|12454686|FG001|STARTED|Period 2||18
11259837|NCT02239744|12454685|FG000|COMPLETED|Period 2||17
11259838|NCT02239744|12454686|FG001|COMPLETED|Period 2||18
11259839|NCT02239744|12454685|FG000|NOT COMPLETED|Period 2||0
11259840|NCT02239744|12454686|FG001|NOT COMPLETED|Period 2||0
11259841|NCT02239770|12454699|FG000|STARTED|Part 1||4
11259842|NCT02239770|12454700|FG001|STARTED|Part 1||4
11259843|NCT02239770|12454701|FG002|STARTED|Part 1||4
11259844|NCT02239770|12454702|FG003|STARTED|Part 1||0
11259845|NCT02239770|12454703|FG004|STARTED|Part 1||0
11259846|NCT02239770|12454704|FG005|STARTED|Part 1||0
11259847|NCT02239770|12454699|FG000|COMPLETED|Part 1||4
11259848|NCT02239770|12454700|FG001|COMPLETED|Part 1||4
11259849|NCT02239770|12454701|FG002|COMPLETED|Part 1||4
11259850|NCT02239770|12454702|FG003|COMPLETED|Part 1||0
11259851|NCT02239770|12454703|FG004|COMPLETED|Part 1||0
11259852|NCT02239770|12454704|FG005|COMPLETED|Part 1||0
11259853|NCT02239770|12454699|FG000|NOT COMPLETED|Part 1||0
11259854|NCT02239770|12454700|FG001|NOT COMPLETED|Part 1||0
11259855|NCT02239770|12454701|FG002|NOT COMPLETED|Part 1||0
11259856|NCT02239770|12454702|FG003|NOT COMPLETED|Part 1||0
11259857|NCT02239770|12454703|FG004|NOT COMPLETED|Part 1||0
11259858|NCT02239770|12454704|FG005|NOT COMPLETED|Part 1||0
11259859|NCT02239770|12454699|FG000|STARTED|Part 2||0
11259860|NCT02239770|12454700|FG001|STARTED|Part 2||0
11259861|NCT02239770|12454701|FG002|STARTED|Part 2||0
11259862|NCT02239770|12454702|FG003|STARTED|Part 2||4
11259863|NCT02239770|12454703|FG004|STARTED|Part 2||4
11259864|NCT02239770|12454704|FG005|STARTED|Part 2||4
11259865|NCT02239770|12454699|FG000|COMPLETED|Part 2||0
11259866|NCT02239770|12454700|FG001|COMPLETED|Part 2||0
11259867|NCT02239770|12454701|FG002|COMPLETED|Part 2||0
11259868|NCT02239770|12454702|FG003|COMPLETED|Part 2||4
11259869|NCT02239770|12454703|FG004|COMPLETED|Part 2||4
11259870|NCT02239770|12454704|FG005|COMPLETED|Part 2||4
11259871|NCT02239770|12454699|FG000|NOT COMPLETED|Part 2||0
11259872|NCT02239770|12454700|FG001|NOT COMPLETED|Part 2||0
11259873|NCT02239770|12454701|FG002|NOT COMPLETED|Part 2||0
11259874|NCT02239770|12454702|FG003|NOT COMPLETED|Part 2||0
11259875|NCT02239770|12454703|FG004|NOT COMPLETED|Part 2||0
11259876|NCT02239770|12454704|FG005|NOT COMPLETED|Part 2||0
11259877|NCT02239939|12454728|FG000|STARTED|Overall Study||20
11259878|NCT02239939|12454729|FG001|STARTED|Overall Study||17
11259879|NCT02239939|12454728|FG000|COMPLETED|Overall Study||18
11259880|NCT02239939|12454729|FG001|COMPLETED|Overall Study||15
11259881|NCT02239939|12454728|FG000|NOT COMPLETED|Overall Study||2
11259882|NCT02239939|12454729|FG001|NOT COMPLETED|Overall Study||2
11259883|NCT02239978|12454739|FG000|STARTED|Overall Study||30
11259884|NCT02239978|12454740|FG001|STARTED|Overall Study||12
11259885|NCT02239978|12454739|FG000|COMPLETED|Overall Study||28
11259886|NCT02239978|12454740|FG001|COMPLETED|Overall Study||12
11259887|NCT02239978|12454739|FG000|NOT COMPLETED|Overall Study||2
11259888|NCT02239978|12454740|FG001|NOT COMPLETED|Overall Study||0
11259889|NCT02240030|12454751|FG000|STARTED|Overall Study||113
11259890|NCT02240030|12454752|FG001|STARTED|Overall Study||114
11259891|NCT02240030|12454753|FG002|STARTED|Overall Study||112
11259892|NCT02240030|12454751|FG000|COMPLETED|Overall Study||96
11259893|NCT02240030|12454752|FG001|COMPLETED|Overall Study||97
11259894|NCT02240030|12454753|FG002|COMPLETED|Overall Study||97
11259895|NCT02240030|12454751|FG000|NOT COMPLETED|Overall Study||17
11259896|NCT02240030|12454752|FG001|NOT COMPLETED|Overall Study||17
11259897|NCT02240030|12454753|FG002|NOT COMPLETED|Overall Study||15
11259898|NCT02240108|12454765|FG000|STARTED|Overall Study||35
11259899|NCT02240108|12454766|FG001|STARTED|Overall Study||46
11259900|NCT02240108|12454765|FG000|Intent-to-treat (ITT) Population|Overall Study||35
11259901|NCT02240108|12454766|FG001|Intent-to-treat (ITT) Population|Overall Study||45
11259902|NCT02240108|12454765|FG000|COMPLETED|Overall Study||21
11259903|NCT02240108|12454766|FG001|COMPLETED|Overall Study||21
11259904|NCT02240108|12454765|FG000|NOT COMPLETED|Overall Study||14
11259905|NCT02240108|12454766|FG001|NOT COMPLETED|Overall Study||25
11259906|NCT02240121|12454774|FG000|STARTED|Overall Study||40
11259907|NCT02240121|12454775|FG001|STARTED|Overall Study||40
11259908|NCT02240121|12454774|FG000|COMPLETED|Overall Study||22
11259909|NCT02240121|12454775|FG001|COMPLETED|Overall Study||20
11259910|NCT02240121|12454774|FG000|NOT COMPLETED|Overall Study||18
11259911|NCT02240121|12454775|FG001|NOT COMPLETED|Overall Study||20
11259912|NCT02240186|12454781|FG000|STARTED|Overall Study||50
11259913|NCT02240186|12454781|FG000|COMPLETED|Overall Study||23
11259914|NCT02240186|12454781|FG000|NOT COMPLETED|Overall Study||27
11259915|NCT02240329|12454788|FG000|STARTED|Overall Study||4
11259916|NCT02240329|12454788|FG000|Determination of Urge to Cough|Overall Study||4
11259917|NCT02240329|12454788|FG000|COMPLETED|Overall Study||4
11259918|NCT02240329|12454788|FG000|NOT COMPLETED|Overall Study||0
11259919|NCT02240368|12454795|FG000|STARTED|Overall Study||9
11259920|NCT02240368|12454796|FG001|STARTED|Overall Study||22
11259921|NCT02240368|12454797|FG002|STARTED|Overall Study||19
11259922|NCT02240368|12454795|FG000|COMPLETED|Overall Study||8
11259923|NCT02240368|12454796|FG001|COMPLETED|Overall Study||22
11259924|NCT02240368|12454797|FG002|COMPLETED|Overall Study||18
11259925|NCT02240368|12454795|FG000|NOT COMPLETED|Overall Study||1
11259926|NCT02240368|12454796|FG001|NOT COMPLETED|Overall Study||0
11259927|NCT02240368|12454797|FG002|NOT COMPLETED|Overall Study||1
11259928|NCT02240589|12454807|FG000|STARTED|Overall Study||5
11259929|NCT02240589|12454808|FG001|STARTED|Overall Study||6
11259930|NCT02240589|12454807|FG000|COMPLETED|Overall Study||3
11259931|NCT02240589|12454808|FG001|COMPLETED|Overall Study||4
11259932|NCT02240589|12454807|FG000|NOT COMPLETED|Overall Study||2
11259933|NCT02240589|12454808|FG001|NOT COMPLETED|Overall Study||2
11259934|NCT02240628|12454816|FG000|STARTED|Overall Study||38
11259935|NCT02240628|12454817|FG001|STARTED|Overall Study||38
11259936|NCT02240628|12454816|FG000|COMPLETED|Overall Study||32
11259937|NCT02240628|12454817|FG001|COMPLETED|Overall Study||33
11259938|NCT02240628|12454816|FG000|NOT COMPLETED|Overall Study||6
11259939|NCT02240628|12454817|FG001|NOT COMPLETED|Overall Study||5
11259940|NCT02240654|12454828|FG000|STARTED|Overall Study||1706
11259941|NCT02240654|12454829|FG001|STARTED|Overall Study||2813
11259942|NCT02240654|12454830|FG002|STARTED|Overall Study||28619
11259943|NCT02240654|12454831|FG003|STARTED|Overall Study||2150
11259944|NCT02240654|12454832|FG004|STARTED|Overall Study||1285
11259945|NCT02240654|12454828|FG000|COMPLETED|Overall Study||1706
11259946|NCT02240654|12454829|FG001|COMPLETED|Overall Study||2813
11259947|NCT02240654|12454830|FG002|COMPLETED|Overall Study||28619
11259948|NCT02240654|12454831|FG003|COMPLETED|Overall Study||2150
11259949|NCT02240654|12454832|FG004|COMPLETED|Overall Study||1285
11259950|NCT02240654|12454828|FG000|NOT COMPLETED|Overall Study||0
11259951|NCT02240654|12454829|FG001|NOT COMPLETED|Overall Study||0
11259952|NCT02240654|12454830|FG002|NOT COMPLETED|Overall Study||0
11259953|NCT02240654|12454831|FG003|NOT COMPLETED|Overall Study||0
11259954|NCT02240654|12454832|FG004|NOT COMPLETED|Overall Study||0
11339864|NCT02918266|12537333|FG007|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
11339865|NCT02918266|12537334|FG008|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
11339866|NCT02918266|12537335|FG009|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
11339867|NCT02918266|12537336|FG010|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
11339868|NCT02918266|12537326|FG000|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339869|NCT02918266|12537327|FG001|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339870|NCT02918266|12537328|FG002|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339871|NCT02918266|12537329|FG003|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339872|NCT02918266|12537330|FG004|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339873|NCT02918266|12537331|FG005|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339874|NCT02918266|12537332|FG006|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339875|NCT02918266|12537333|FG007|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339876|NCT02918266|12537334|FG008|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339877|NCT02918266|12537335|FG009|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339878|NCT02918266|12537336|FG010|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339879|NCT02918266|12537326|FG000|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339880|NCT02918266|12537327|FG001|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339881|NCT02918266|12537328|FG002|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339882|NCT02918266|12537329|FG003|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339883|NCT02918266|12537330|FG004|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339884|NCT02918266|12537331|FG005|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339885|NCT02918266|12537332|FG006|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339886|NCT02918266|12537333|FG007|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339887|NCT02918266|12537334|FG008|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339888|NCT02918266|12537335|FG009|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339889|NCT02918266|12537336|FG010|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
11339890|NCT02918266|12537326|FG000|STARTED|Part 2: Intervention Period 3 (2 Days)||0
11339891|NCT02918266|12537327|FG001|STARTED|Part 2: Intervention Period 3 (2 Days)||0
11339892|NCT02918266|12537328|FG002|STARTED|Part 2: Intervention Period 3 (2 Days)||0
11339893|NCT02918266|12537329|FG003|STARTED|Part 2: Intervention Period 3 (2 Days)||0
11339894|NCT02918266|12537330|FG004|STARTED|Part 2: Intervention Period 3 (2 Days)||0
11339895|NCT02918266|12537331|FG005|STARTED|Part 2: Intervention Period 3 (2 Days)||0
11339896|NCT02918266|12537332|FG006|STARTED|Part 2: Intervention Period 3 (2 Days)||0
11339897|NCT02918266|12537333|FG007|STARTED|Part 2: Intervention Period 3 (2 Days)||0
11339898|NCT02918266|12537334|FG008|STARTED|Part 2: Intervention Period 3 (2 Days)||0
11339899|NCT02918266|12537335|FG009|STARTED|Part 2: Intervention Period 3 (2 Days)||0
11339900|NCT02918266|12537336|FG010|STARTED|Part 2: Intervention Period 3 (2 Days)||0
11339901|NCT02918266|12537326|FG000|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339902|NCT02918266|12537327|FG001|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339903|NCT02918266|12537328|FG002|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339904|NCT02918266|12537329|FG003|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339905|NCT02918266|12537330|FG004|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339906|NCT02918266|12537331|FG005|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339907|NCT02918266|12537332|FG006|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339908|NCT02918266|12537333|FG007|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339909|NCT02918266|12537334|FG008|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339910|NCT02918266|12537335|FG009|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339911|NCT02918266|12537336|FG010|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339912|NCT02918266|12537326|FG000|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339913|NCT02918266|12537327|FG001|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339914|NCT02918266|12537328|FG002|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339915|NCT02918266|12537329|FG003|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339916|NCT02918266|12537330|FG004|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339917|NCT02918266|12537331|FG005|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339918|NCT02918266|12537332|FG006|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339919|NCT02918266|12537333|FG007|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339920|NCT02918266|12537334|FG008|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339921|NCT02918266|12537335|FG009|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339922|NCT02918266|12537336|FG010|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
11339923|NCT02918266|12537326|FG000|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
11339924|NCT02918266|12537327|FG001|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
11339925|NCT02918266|12537328|FG002|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
11339926|NCT02918266|12537329|FG003|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
11339927|NCT02918266|12537330|FG004|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
11339928|NCT02918266|12537331|FG005|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
11339929|NCT02918266|12537332|FG006|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
11339930|NCT02918266|12537333|FG007|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
11339931|NCT02918266|12537334|FG008|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
11339932|NCT02918266|12537335|FG009|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
11339933|NCT02918266|12537336|FG010|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
11343950|NCT02957682|12541259|FG001|COMPLETED|Overall Study||919
11259955|NCT02240667|12454846|FG000|STARTED|Overall Study||771
11259956|NCT02240667|12454847|FG001|STARTED|Overall Study||650
11259957|NCT02240667|12454846|FG000|COMPLETED|Overall Study||771
11259958|NCT02240667|12454847|FG001|COMPLETED|Overall Study||650
11259959|NCT02240667|12454846|FG000|NOT COMPLETED|Overall Study||0
11259960|NCT02240667|12454847|FG001|NOT COMPLETED|Overall Study||0
11259961|NCT02240680|12454855|FG000|STARTED|Overall Study (Up to 24 Weeks)||151
11259962|NCT02240680|12454856|FG001|STARTED|Overall Study (Up to 24 Weeks)||151
11259963|NCT02240680|12454857|FG002|STARTED|Overall Study (Up to 24 Weeks)||0
11259964|NCT02240680|12454858|FG003|STARTED|Overall Study (Up to 24 Weeks)||0
11259965|NCT02240680|12454855|FG000|COMPLETED|Overall Study (Up to 24 Weeks)||136
11259966|NCT02240680|12454856|FG001|COMPLETED|Overall Study (Up to 24 Weeks)||143
11259967|NCT02240680|12454857|FG002|COMPLETED|Overall Study (Up to 24 Weeks)||0
11259968|NCT02240680|12454858|FG003|COMPLETED|Overall Study (Up to 24 Weeks)||0
11259969|NCT02240680|12454855|FG000|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
11259970|NCT02240680|12454856|FG001|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
11259971|NCT02240680|12454857|FG002|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
11259972|NCT02240680|12454858|FG003|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
11259973|NCT02240680|12454855|FG000|STARTED|Japanese Patients (Up to 52 Weeks)||0
11259974|NCT02240680|12454856|FG001|STARTED|Japanese Patients (Up to 52 Weeks)||0
11259975|NCT02240680|12454857|FG002|STARTED|Japanese Patients (Up to 52 Weeks)||50
11259976|NCT02240680|12454858|FG003|STARTED|Japanese Patients (Up to 52 Weeks)||52
11259977|NCT02240680|12454855|FG000|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
11259978|NCT02240680|12454856|FG001|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
11259979|NCT02240680|12454857|FG002|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
11259980|NCT02240680|12454858|FG003|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
11259981|NCT02240680|12454855|FG000|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
11259982|NCT02240680|12454856|FG001|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
11142025|NCT01465958|12328703|FG000|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
11142026|NCT01465958|12328704|FG001|STARTED|Intravenous (IV) Phase||0
11142027|NCT01465958|12328703|FG000|COMPLETED|Intravenous (IV) Phase||11
11142028|NCT01465958|12328704|FG001|COMPLETED|Intravenous (IV) Phase||0
11142029|NCT01465958|12328703|FG000|NOT COMPLETED|Intravenous (IV) Phase||0
11142030|NCT01465958|12328704|FG001|NOT COMPLETED|Intravenous (IV) Phase||0
11142031|NCT01465958|12328703|FG000|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
11142032|NCT01465958|12328704|FG001|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
11142033|NCT01465958|12328703|FG000|COMPLETED|Subcutaneous (SC) Phase||0
11142034|NCT01465958|12328704|FG001|COMPLETED|Subcutaneous (SC) Phase||10
11142035|NCT01465958|12328703|FG000|NOT COMPLETED|Subcutaneous (SC) Phase||0
11142036|NCT01465958|12328704|FG001|NOT COMPLETED|Subcutaneous (SC) Phase||1
11259983|NCT02240680|12454857|FG002|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
11259984|NCT02240680|12454858|FG003|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
11259985|NCT02240693|12454871|FG000|STARTED|Overall Study||22
11259986|NCT02240693|12454872|FG001|STARTED|Overall Study||21
11259987|NCT02240693|12454873|FG002|STARTED|Overall Study||21
11259988|NCT02240693|12454874|FG003|STARTED|Overall Study||21
11259989|NCT02240693|12454875|FG004|STARTED|Overall Study||43
11259990|NCT02240693|12454871|FG000|COMPLETED|Overall Study||22
11259991|NCT02240693|12454872|FG001|COMPLETED|Overall Study||21
11259992|NCT02240693|12454873|FG002|COMPLETED|Overall Study||17
11259993|NCT02240693|12454874|FG003|COMPLETED|Overall Study||20
11259994|NCT02240693|12454875|FG004|COMPLETED|Overall Study||42
11259995|NCT02240693|12454871|FG000|NOT COMPLETED|Overall Study||0
11259996|NCT02240693|12454872|FG001|NOT COMPLETED|Overall Study||0
11259997|NCT02240693|12454873|FG002|NOT COMPLETED|Overall Study||4
11259998|NCT02240693|12454874|FG003|NOT COMPLETED|Overall Study||1
11259999|NCT02240693|12454875|FG004|NOT COMPLETED|Overall Study||1
11260000|NCT02240706|12454894|FG000|STARTED|Overall Study||3
11260001|NCT02240706|12454895|FG001|STARTED|Overall Study||3
11260002|NCT02240706|12454896|FG002|STARTED|Overall Study||6
11260003|NCT02240706|12454897|FG003|STARTED|Overall Study||4
11260004|NCT02240706|12454898|FG004|STARTED|Overall Study||11
11260005|NCT02240706|12454899|FG005|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
11260006|NCT02240706|12454900|FG006|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
11260007|NCT02240706|12454894|FG000|COMPLETED|Overall Study||0
11260008|NCT02240706|12454895|FG001|COMPLETED|Overall Study||0
11260009|NCT02240706|12454896|FG002|COMPLETED|Overall Study||0
11260010|NCT02240706|12454897|FG003|COMPLETED|Overall Study||0
11260011|NCT02240706|12454898|FG004|COMPLETED|Overall Study||0
11260012|NCT02240706|12454899|FG005|COMPLETED|Overall Study||0
11260013|NCT02240706|12454900|FG006|COMPLETED|Overall Study||0
11260014|NCT02240706|12454894|FG000|NOT COMPLETED|Overall Study||3
11260015|NCT02240706|12454895|FG001|NOT COMPLETED|Overall Study||3
11260016|NCT02240706|12454896|FG002|NOT COMPLETED|Overall Study||6
11260017|NCT02240706|12454897|FG003|NOT COMPLETED|Overall Study||4
11260018|NCT02240706|12454898|FG004|NOT COMPLETED|Overall Study||11
11260019|NCT02240706|12454899|FG005|NOT COMPLETED|Overall Study||0
11260020|NCT02240706|12454900|FG006|NOT COMPLETED|Overall Study||0
11260021|NCT02240810|12454917|FG000|STARTED|Overall Study||1501
11260022|NCT02240810|12454918|FG001|STARTED|Overall Study|correct typo|2681
11260023|NCT02240810|12454917|FG000|COMPLETED|Overall Study||1441
11260024|NCT02240810|12454918|FG001|COMPLETED|Overall Study||2621
11260025|NCT02240810|12454917|FG000|NOT COMPLETED|Overall Study||60
11260026|NCT02240810|12454918|FG001|NOT COMPLETED|Overall Study||60
11260027|NCT02241486|12454925|FG000|STARTED|Overall Study||2
11260028|NCT02241486|12454925|FG000|COMPLETED|Overall Study||2
11260029|NCT02241486|12454925|FG000|NOT COMPLETED|Overall Study||0
11260030|NCT02241512|12454931|FG000|STARTED|Overall Study||30
11260031|NCT02241512|12454932|FG001|STARTED|Overall Study||29
11260032|NCT02241512|12454931|FG000|COMPLETED|Overall Study||29
11260033|NCT02241512|12454932|FG001|COMPLETED|Overall Study||29
11260034|NCT02241512|12454931|FG000|NOT COMPLETED|Overall Study||1
11260035|NCT02241512|12454932|FG001|NOT COMPLETED|Overall Study||0
11260036|NCT02241655|12454940|FG000|STARTED|Overall Study||614
11260037|NCT02241655|12454941|FG001|STARTED|Overall Study||618
11260038|NCT02241655|12454940|FG000|COMPLETED|Overall Study||614
11260039|NCT02241655|12454941|FG001|COMPLETED|Overall Study||618
11260040|NCT02241655|12454940|FG000|NOT COMPLETED|Overall Study||0
11260041|NCT02241655|12454941|FG001|NOT COMPLETED|Overall Study||0
11260042|NCT02241720|12454952|FG000|STARTED|Overall Study||5
11260043|NCT02241720|12454952|FG000|COMPLETED|Overall Study||1
11260044|NCT02241720|12454952|FG000|NOT COMPLETED|Overall Study||4
11260045|NCT02241733|12454958|FG000|STARTED|Overall Study||40
11260046|NCT02241733|12454959|FG001|STARTED|Overall Study||40
11260047|NCT02241733|12454958|FG000|COMPLETED|Overall Study||25
11260048|NCT02241733|12454959|FG001|COMPLETED|Overall Study||30
11260049|NCT02241733|12454958|FG000|NOT COMPLETED|Overall Study||15
11260050|NCT02241733|12454959|FG001|NOT COMPLETED|Overall Study||10
11260051|NCT02241785|12454965|FG000|STARTED|Overall Study||47
11260052|NCT02241785|12454965|FG000|COMPLETED|Overall Study||0
11260053|NCT02241785|12454965|FG000|NOT COMPLETED|Overall Study||47
11260054|NCT02241889|12454969|FG000|STARTED|Overall Study||4
11260055|NCT02241889|12454970|FG001|STARTED|Overall Study||4
11260056|NCT02241889|12454971|FG002|STARTED|Overall Study||3
11260057|NCT02241889|12454972|FG003|STARTED|Overall Study||3
11260058|NCT02241889|12454973|FG004|STARTED|Overall Study||5
11260059|NCT02241889|12454974|FG005|STARTED|Overall Study||4
11260060|NCT02241889|12454969|FG000|COMPLETED|Overall Study||4
11260061|NCT02241889|12454970|FG001|COMPLETED|Overall Study||4
11260062|NCT02241889|12454971|FG002|COMPLETED|Overall Study||2
11260063|NCT02241889|12454972|FG003|COMPLETED|Overall Study||3
11260064|NCT02241889|12454973|FG004|COMPLETED|Overall Study||5
11260065|NCT02241889|12454974|FG005|COMPLETED|Overall Study||3
11260066|NCT02241889|12454969|FG000|NOT COMPLETED|Overall Study||0
11260067|NCT02241889|12454970|FG001|NOT COMPLETED|Overall Study||0
11260068|NCT02241889|12454971|FG002|NOT COMPLETED|Overall Study||1
11260069|NCT02241889|12454972|FG003|NOT COMPLETED|Overall Study||0
11260070|NCT02241889|12454973|FG004|NOT COMPLETED|Overall Study||0
11260071|NCT02241889|12454974|FG005|NOT COMPLETED|Overall Study||1
11260072|NCT02242019|12454982|FG000|STARTED|Overall Study||109
11260073|NCT02242019|12454982|FG000|COMPLETED|Overall Study||109
11260074|NCT02242019|12454982|FG000|NOT COMPLETED|Overall Study||0
11260075|NCT02242045|12454986|FG000|STARTED|Overall Study||6
11260076|NCT02242045|12454986|FG000|COMPLETED|Overall Study||0
11260077|NCT02242045|12454986|FG000|NOT COMPLETED|Overall Study||6
11260078|NCT02242201|12454993|FG000|STARTED|Overall Study||55
11260079|NCT02242201|12454994|FG001|STARTED|Overall Study||55
11260080|NCT02242201|12454995|FG002|STARTED|Overall Study||55
11260081|NCT02242201|12454993|FG000|COMPLETED|Overall Study||51
11260082|NCT02242201|12454994|FG001|COMPLETED|Overall Study||54
11260083|NCT02242201|12454995|FG002|COMPLETED|Overall Study||54
11260084|NCT02242201|12454993|FG000|NOT COMPLETED|Overall Study||4
11260085|NCT02242201|12454994|FG001|NOT COMPLETED|Overall Study||1
11260086|NCT02242201|12454995|FG002|NOT COMPLETED|Overall Study||1
11260087|NCT02242305|12455005|FG000|STARTED|Overall Study||151
11260088|NCT02242305|12455006|FG001|STARTED|Overall Study||151
11260089|NCT02242305|12455005|FG000|COMPLETED|Overall Study||145
11260090|NCT02242305|12455006|FG001|COMPLETED|Overall Study||141
11260091|NCT02242305|12455005|FG000|NOT COMPLETED|Overall Study||6
11260092|NCT02242305|12455006|FG001|NOT COMPLETED|Overall Study||10
11260093|NCT02242487|12455014|FG000|STARTED|Overall Study||161
11260094|NCT02242487|12455015|FG001|STARTED|Overall Study||164
11260095|NCT02242487|12455014|FG000|COMPLETED|Overall Study||99
11260096|NCT02242487|12455015|FG001|COMPLETED|Overall Study||117
11260097|NCT02242487|12455014|FG000|NOT COMPLETED|Overall Study||62
11260098|NCT02242487|12455015|FG001|NOT COMPLETED|Overall Study||47
11260099|NCT02242630|12455027|FG000|STARTED|Overall Study||15
11260100|NCT02242630|12455028|FG001|STARTED|Overall Study||15
11260101|NCT02242630|12455029|FG002|STARTED|Overall Study||15
11260102|NCT02242630|12455030|FG003|STARTED|Overall Study||16
11260103|NCT02242630|12455027|FG000|COMPLETED|Overall Study||15
11260104|NCT02242630|12455028|FG001|COMPLETED|Overall Study||15
11260105|NCT02242630|12455029|FG002|COMPLETED|Overall Study||15
11260106|NCT02242630|12455030|FG003|COMPLETED|Overall Study||16
11260107|NCT02242630|12455027|FG000|NOT COMPLETED|Overall Study||0
11260108|NCT02242630|12455028|FG001|NOT COMPLETED|Overall Study||0
11260109|NCT02242630|12455029|FG002|NOT COMPLETED|Overall Study||0
11260110|NCT02242630|12455030|FG003|NOT COMPLETED|Overall Study||0
11260111|NCT02242643|12455042|FG000|STARTED|Overall Study||1207
11260112|NCT02242643|12455043|FG001|STARTED|Overall Study||1217
11260113|NCT02242643|12455042|FG000|COMPLETED|Overall Study||1132
11260114|NCT02242643|12455043|FG001|COMPLETED|Overall Study||1139
11260115|NCT02242643|12455042|FG000|NOT COMPLETED|Overall Study||75
11260116|NCT02242643|12455043|FG001|NOT COMPLETED|Overall Study||78
11260117|NCT02242903|12455058|FG000|STARTED|Overall Study||12
11260118|NCT02242903|12455059|FG001|STARTED|Overall Study||6
11260119|NCT02242903|12455060|FG002|STARTED|Overall Study||6
11260120|NCT02242903|12455061|FG003|STARTED|Overall Study||6
11260121|NCT02242903|12455062|FG004|STARTED|Overall Study||6
11260122|NCT02242903|12455063|FG005|STARTED|Overall Study||6
11260123|NCT02242903|12455064|FG006|STARTED|Overall Study||6
11260124|NCT02242903|12455058|FG000|Received at Least One Dose of Study Drug|Overall Study||12
11260125|NCT02242903|12455059|FG001|Received at Least One Dose of Study Drug|Overall Study||6
11260126|NCT02242903|12455060|FG002|Received at Least One Dose of Study Drug|Overall Study||6
11260127|NCT02242903|12455061|FG003|Received at Least One Dose of Study Drug|Overall Study||6
11260128|NCT02242903|12455062|FG004|Received at Least One Dose of Study Drug|Overall Study||6
11260129|NCT02242903|12455063|FG005|Received at Least One Dose of Study Drug|Overall Study||6
11260130|NCT02242903|12455064|FG006|Received at Least One Dose of Study Drug|Overall Study||6
11260131|NCT02242903|12455058|FG000|COMPLETED|Overall Study||11
11260132|NCT02242903|12455059|FG001|COMPLETED|Overall Study||6
11260133|NCT02242903|12455060|FG002|COMPLETED|Overall Study||6
11260134|NCT02242903|12455061|FG003|COMPLETED|Overall Study||6
11260135|NCT02242903|12455062|FG004|COMPLETED|Overall Study||6
11260136|NCT02242903|12455063|FG005|COMPLETED|Overall Study||6
11260137|NCT02242903|12455064|FG006|COMPLETED|Overall Study||6
11260138|NCT02242903|12455058|FG000|NOT COMPLETED|Overall Study||1
11260139|NCT02242903|12455059|FG001|NOT COMPLETED|Overall Study||0
11260140|NCT02242903|12455060|FG002|NOT COMPLETED|Overall Study||0
11260141|NCT02242903|12455061|FG003|NOT COMPLETED|Overall Study||0
11260142|NCT02242903|12455062|FG004|NOT COMPLETED|Overall Study||0
11260143|NCT02242903|12455063|FG005|NOT COMPLETED|Overall Study||0
11260144|NCT02242903|12455064|FG006|NOT COMPLETED|Overall Study||0
11260145|NCT02242981|12455086|FG000|STARTED|Overall Study||6
11260146|NCT02242981|12455086|FG000|Received Study Drug|Overall Study||6
11260147|NCT02242981|12455086|FG000|COMPLETED|Overall Study||5
11260148|NCT02242981|12455086|FG000|NOT COMPLETED|Overall Study||1
11260149|NCT02242994|12455090|FG000|STARTED|Overall Study||5
11260150|NCT02242994|12455090|FG000|COMPLETED|Overall Study||5
11260151|NCT02242994|12455090|FG000|NOT COMPLETED|Overall Study||0
11260152|NCT02243007|12455096|FG000|STARTED|Overall Study||4
11260153|NCT02243007|12455097|FG001|STARTED|Overall Study||3
11260154|NCT02243007|12455096|FG000|COMPLETED|Overall Study||4
11260155|NCT02243007|12455097|FG001|COMPLETED|Overall Study||3
11260156|NCT02243007|12455096|FG000|NOT COMPLETED|Overall Study||0
11260157|NCT02243007|12455097|FG001|NOT COMPLETED|Overall Study||0
11260158|NCT02243046|12455106|FG000|STARTED|Overall Study||55
11260159|NCT02243046|12455107|FG001|STARTED|Overall Study||54
11260160|NCT02243046|12455108|FG002|STARTED|Overall Study||53
11260161|NCT02243046|12455106|FG000|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
11260162|NCT02243046|12455107|FG001|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
11260163|NCT02243046|12455108|FG002|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
11260164|NCT02243046|12455106|FG000|6 Month|Overall Study||54
11260165|NCT02243046|12455107|FG001|6 Month|Overall Study||53
11260166|NCT02243046|12455108|FG002|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
11260167|NCT02243046|12455106|FG000|COMPLETED|Overall Study||54
11260168|NCT02243046|12455107|FG001|COMPLETED|Overall Study||53
11260169|NCT02243046|12455108|FG002|COMPLETED|Overall Study||49
11260170|NCT02243046|12455106|FG000|NOT COMPLETED|Overall Study||1
11260171|NCT02243046|12455107|FG001|NOT COMPLETED|Overall Study||1
11260172|NCT02243046|12455108|FG002|NOT COMPLETED|Overall Study||4
11260173|NCT02243176|12455118|FG000|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
11260174|NCT02243176|12455119|FG001|STARTED|Overall Study||244
11260175|NCT02243176|12455118|FG000|COMPLETED|Overall Study||230
11260176|NCT02243176|12455119|FG001|COMPLETED|Overall Study||229
11260177|NCT02243176|12455118|FG000|NOT COMPLETED|Overall Study||14
11260178|NCT02243176|12455119|FG001|NOT COMPLETED|Overall Study||15
11260179|NCT02243202|12455129|FG000|STARTED|Overall Study||82
11260180|NCT02243202|12455130|FG001|STARTED|Overall Study||85
11260181|NCT02243202|12455131|FG002|STARTED|Overall Study||84
11260182|NCT02243202|12455132|FG003|STARTED|Overall Study||84
11260183|NCT02243202|12455129|FG000|Treated|Overall Study||82
11260184|NCT02243202|12455130|FG001|Treated|Overall Study||85
11260185|NCT02243202|12455131|FG002|Treated|Overall Study||84
11260186|NCT02243202|12455132|FG003|Treated|Overall Study||83
11260187|NCT02243202|12455129|FG000|COMPLETED|Overall Study||57
11260188|NCT02243202|12455130|FG001|COMPLETED|Overall Study||60
11260189|NCT02243202|12455131|FG002|COMPLETED|Overall Study||53
11260190|NCT02243202|12455132|FG003|COMPLETED|Overall Study||61
11260191|NCT02243202|12455129|FG000|NOT COMPLETED|Overall Study||25
11260192|NCT02243202|12455130|FG001|NOT COMPLETED|Overall Study||25
11260193|NCT02243202|12455131|FG002|NOT COMPLETED|Overall Study||31
11260194|NCT02243202|12455132|FG003|NOT COMPLETED|Overall Study||23
11260195|NCT02243280|12455153|FG000|STARTED|Enrolled||40
11260196|NCT02243280|12455154|FG001|STARTED|Enrolled||39
11260197|NCT02243280|12455155|FG002|STARTED|Enrolled||0
11260198|NCT02243280|12455156|FG003|STARTED|Enrolled||0
11260199|NCT02243280|12455157|FG004|STARTED|Enrolled||0
11260200|NCT02243280|12455158|FG005|STARTED|Enrolled||27
11260201|NCT02243280|12455159|FG006|STARTED|Enrolled||0
11260202|NCT02243280|12455160|FG007|STARTED|Enrolled||0
11260203|NCT02243280|12455161|FG008|STARTED|Enrolled||34
11260204|NCT02243280|12455162|FG009|STARTED|Enrolled||0
11260205|NCT02243280|12455163|FG010|STARTED|Enrolled||34
11260206|NCT02243280|12455153|FG000|COMPLETED|Enrolled||40
11260207|NCT02243280|12455154|FG001|COMPLETED|Enrolled||39
11260208|NCT02243280|12455155|FG002|COMPLETED|Enrolled||0
11260209|NCT02243280|12455156|FG003|COMPLETED|Enrolled||0
11260210|NCT02243280|12455157|FG004|COMPLETED|Enrolled||0
11260211|NCT02243280|12455158|FG005|COMPLETED|Enrolled||27
11260212|NCT02243280|12455159|FG006|COMPLETED|Enrolled||0
11260213|NCT02243280|12455160|FG007|COMPLETED|Enrolled||0
11260214|NCT02243280|12455161|FG008|COMPLETED|Enrolled||34
11260215|NCT02243280|12455162|FG009|COMPLETED|Enrolled||0
11260216|NCT02243280|12455163|FG010|COMPLETED|Enrolled||34
11260217|NCT02243280|12455153|FG000|NOT COMPLETED|Enrolled||0
11260218|NCT02243280|12455154|FG001|NOT COMPLETED|Enrolled||0
11260219|NCT02243280|12455155|FG002|NOT COMPLETED|Enrolled||0
11260220|NCT02243280|12455156|FG003|NOT COMPLETED|Enrolled||0
11260221|NCT02243280|12455157|FG004|NOT COMPLETED|Enrolled||0
11260222|NCT02243280|12455158|FG005|NOT COMPLETED|Enrolled||0
11260223|NCT02243280|12455159|FG006|NOT COMPLETED|Enrolled||0
11260224|NCT02243280|12455160|FG007|NOT COMPLETED|Enrolled||0
11260225|NCT02243280|12455161|FG008|NOT COMPLETED|Enrolled||0
11260226|NCT02243280|12455162|FG009|NOT COMPLETED|Enrolled||0
11260227|NCT02243280|12455163|FG010|NOT COMPLETED|Enrolled||0
11260228|NCT02243280|12455153|FG000|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
11260229|NCT02243280|12455154|FG001|STARTED|Treated||39
11260230|NCT02243280|12455155|FG002|STARTED|Treated||0
11260231|NCT02243280|12455156|FG003|STARTED|Treated||0
11260232|NCT02243280|12455157|FG004|STARTED|Treated||0
11260233|NCT02243280|12455158|FG005|STARTED|Treated||27
11260234|NCT02243280|12455159|FG006|STARTED|Treated||0
11260235|NCT02243280|12455160|FG007|STARTED|Treated||0
11260236|NCT02243280|12455161|FG008|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
11260237|NCT02243280|12455162|FG009|STARTED|Treated||0
11260238|NCT02243280|12455163|FG010|STARTED|Treated||34
11260239|NCT02243280|12455153|FG000|Completed Treatment|Treated||42
11260240|NCT02243280|12455154|FG001|Completed Treatment|Treated||38
11260241|NCT02243280|12455155|FG002|Completed Treatment|Treated||0
11260242|NCT02243280|12455156|FG003|Completed Treatment|Treated||0
11260243|NCT02243280|12455157|FG004|Completed Treatment|Treated||0
11260244|NCT02243280|12455158|FG005|Completed Treatment|Treated||27
11260245|NCT02243280|12455159|FG006|Completed Treatment|Treated||0
11260246|NCT02243280|12455160|FG007|Completed Treatment|Treated||0
11260247|NCT02243280|12455161|FG008|Completed Treatment|Treated||32
11260248|NCT02243280|12455162|FG009|Completed Treatment|Treated||0
11260249|NCT02243280|12455163|FG010|Completed Treatment|Treated||33
11260250|NCT02243280|12455153|FG000|COMPLETED|Treated||41
11260251|NCT02243280|12455154|FG001|COMPLETED|Treated||39
11260252|NCT02243280|12455155|FG002|COMPLETED|Treated||0
11260253|NCT02243280|12455156|FG003|COMPLETED|Treated||0
11260254|NCT02243280|12455157|FG004|COMPLETED|Treated||0
11260255|NCT02243280|12455158|FG005|COMPLETED|Treated||27
11260256|NCT02243280|12455159|FG006|COMPLETED|Treated||0
11260257|NCT02243280|12455160|FG007|COMPLETED|Treated||0
11260258|NCT02243280|12455161|FG008|COMPLETED|Treated||31
11260259|NCT02243280|12455162|FG009|COMPLETED|Treated||0
11260260|NCT02243280|12455163|FG010|COMPLETED|Treated||31
11260261|NCT02243280|12455153|FG000|NOT COMPLETED|Treated||1
11260262|NCT02243280|12455154|FG001|NOT COMPLETED|Treated||0
11260263|NCT02243280|12455155|FG002|NOT COMPLETED|Treated||0
11260264|NCT02243280|12455156|FG003|NOT COMPLETED|Treated||0
11260265|NCT02243280|12455157|FG004|NOT COMPLETED|Treated||0
11260266|NCT02243280|12455158|FG005|NOT COMPLETED|Treated||0
11260267|NCT02243280|12455159|FG006|NOT COMPLETED|Treated||0
11260268|NCT02243280|12455160|FG007|NOT COMPLETED|Treated||0
11260269|NCT02243280|12455161|FG008|NOT COMPLETED|Treated||1
11260270|NCT02243280|12455162|FG009|NOT COMPLETED|Treated||0
11260271|NCT02243280|12455163|FG010|NOT COMPLETED|Treated||3
11260272|NCT02243293|12455198|FG000|STARTED|Overall Study||25
11260273|NCT02243293|12455199|FG001|STARTED|Overall Study||24
11260274|NCT02243293|12455200|FG002|STARTED|Overall Study||25
11260275|NCT02243293|12455201|FG003|STARTED|Overall Study||30
11260276|NCT02243293|12455202|FG004|STARTED|Overall Study||31
11358890|NCT03131648|12556063|FG007|COMPLETED|Initial Treatment Period||0
11260277|NCT02243293|12455203|FG005|STARTED|Overall Study||31
11260278|NCT02243293|12455204|FG006|STARTED|Overall Study||30
11260279|NCT02243293|12455205|FG007|STARTED|Overall Study||0
11260280|NCT02243293|12455206|FG008|STARTED|Overall Study||0
11260281|NCT02243293|12455207|FG009|STARTED|Overall Study||55
11260282|NCT02243293|12455208|FG010|STARTED|Overall Study||0
11260283|NCT02243293|12455209|FG011|STARTED|Overall Study||53
11260284|NCT02243293|12455210|FG012|STARTED|Overall Study||0
11260285|NCT02243293|12455211|FG013|STARTED|Overall Study||0
11260286|NCT02243293|12455212|FG014|STARTED|Overall Study||28
11260287|NCT02243293|12455213|FG015|STARTED|Overall Study||27
11260288|NCT02243293|12455214|FG016|STARTED|Overall Study||40
11260289|NCT02243293|12455215|FG017|STARTED|Overall Study||22
11260290|NCT02243293|12455216|FG018|STARTED|Overall Study||22
11260291|NCT02243293|12455217|FG019|STARTED|Overall Study||48
11260292|NCT02243293|12455218|FG020|STARTED|Overall Study||145
11260293|NCT02243293|12455219|FG021|STARTED|Overall Study||58
11260294|NCT02243293|12455198|FG000|COMPLETED|Overall Study||23
11260295|NCT02243293|12455199|FG001|COMPLETED|Overall Study||23
11260296|NCT02243293|12455200|FG002|COMPLETED|Overall Study||24
11260297|NCT02243293|12455201|FG003|COMPLETED|Overall Study||29
11260298|NCT02243293|12455202|FG004|COMPLETED|Overall Study||30
11260299|NCT02243293|12455203|FG005|COMPLETED|Overall Study||31
11260300|NCT02243293|12455204|FG006|COMPLETED|Overall Study||27
11260301|NCT02243293|12455205|FG007|COMPLETED|Overall Study||0
11260302|NCT02243293|12455206|FG008|COMPLETED|Overall Study||0
11260303|NCT02243293|12455207|FG009|COMPLETED|Overall Study||53
11260304|NCT02243293|12455208|FG010|COMPLETED|Overall Study||0
11260305|NCT02243293|12455209|FG011|COMPLETED|Overall Study||50
11260306|NCT02243293|12455210|FG012|COMPLETED|Overall Study||0
11260307|NCT02243293|12455211|FG013|COMPLETED|Overall Study||0
11260308|NCT02243293|12455212|FG014|COMPLETED|Overall Study||27
11260309|NCT02243293|12455213|FG015|COMPLETED|Overall Study||26
11260310|NCT02243293|12455214|FG016|COMPLETED|Overall Study||37
11260311|NCT02243293|12455215|FG017|COMPLETED|Overall Study||21
11260312|NCT02243293|12455216|FG018|COMPLETED|Overall Study||22
11260313|NCT02243293|12455217|FG019|COMPLETED|Overall Study||47
11260314|NCT02243293|12455218|FG020|COMPLETED|Overall Study||143
11260315|NCT02243293|12455219|FG021|COMPLETED|Overall Study||55
11260316|NCT02243293|12455198|FG000|NOT COMPLETED|Overall Study||2
11260317|NCT02243293|12455199|FG001|NOT COMPLETED|Overall Study||1
11260318|NCT02243293|12455200|FG002|NOT COMPLETED|Overall Study||1
11260319|NCT02243293|12455201|FG003|NOT COMPLETED|Overall Study||1
11260320|NCT02243293|12455202|FG004|NOT COMPLETED|Overall Study||1
11260321|NCT02243293|12455203|FG005|NOT COMPLETED|Overall Study||0
11260322|NCT02243293|12455204|FG006|NOT COMPLETED|Overall Study||3
11260323|NCT02243293|12455205|FG007|NOT COMPLETED|Overall Study||0
11260324|NCT02243293|12455206|FG008|NOT COMPLETED|Overall Study||0
11260325|NCT02243293|12455207|FG009|NOT COMPLETED|Overall Study||2
11260326|NCT02243293|12455208|FG010|NOT COMPLETED|Overall Study||0
11260327|NCT02243293|12455209|FG011|NOT COMPLETED|Overall Study||3
11260328|NCT02243293|12455210|FG012|NOT COMPLETED|Overall Study||0
11260329|NCT02243293|12455211|FG013|NOT COMPLETED|Overall Study||0
11260330|NCT02243293|12455212|FG014|NOT COMPLETED|Overall Study||1
11260331|NCT02243293|12455213|FG015|NOT COMPLETED|Overall Study||1
11260332|NCT02243293|12455214|FG016|NOT COMPLETED|Overall Study||3
11260333|NCT02243293|12455215|FG017|NOT COMPLETED|Overall Study||1
11260334|NCT02243293|12455216|FG018|NOT COMPLETED|Overall Study||0
11260335|NCT02243293|12455217|FG019|NOT COMPLETED|Overall Study||1
11260336|NCT02243293|12455218|FG020|NOT COMPLETED|Overall Study||2
11260337|NCT02243293|12455219|FG021|NOT COMPLETED|Overall Study||3
11260338|NCT02243371|12455258|FG000|STARTED|Overall Study||51
11260339|NCT02243371|12455259|FG001|STARTED|Overall Study||42
11260340|NCT02243371|12455258|FG000|COMPLETED|Overall Study||14
11260341|NCT02243371|12455259|FG001|COMPLETED|Overall Study||10
11260342|NCT02243371|12455258|FG000|NOT COMPLETED|Overall Study||37
11260343|NCT02243371|12455259|FG001|NOT COMPLETED|Overall Study||32
11260344|NCT02243527|12455267|FG000|STARTED|Overall Study||12
11260345|NCT02243527|12455268|FG001|STARTED|Overall Study||13
11260346|NCT02243527|12455267|FG000|COMPLETED|Overall Study||12
11260347|NCT02243527|12455268|FG001|COMPLETED|Overall Study||13
11260348|NCT02243527|12455267|FG000|NOT COMPLETED|Overall Study||0
11260349|NCT02243527|12455268|FG001|NOT COMPLETED|Overall Study||0
11260350|NCT02243579|12455274|FG000|STARTED|Overall Study||24
11260351|NCT02243579|12455274|FG000|COMPLETED|Overall Study||4
11260352|NCT02243579|12455274|FG000|NOT COMPLETED|Overall Study||20
11260353|NCT02243696|12455278|FG000|STARTED|Overall Study||1694
11260354|NCT02243696|12455278|FG000|COMPLETED|Overall Study||0
11260355|NCT02243696|12455278|FG000|NOT COMPLETED|Overall Study||1694
11260356|NCT02243865|12455284|FG000|STARTED|Overall Study||44
11260357|NCT02243865|12455285|FG001|STARTED|Overall Study||43
11260358|NCT02243865|12455284|FG000|COMPLETED|Overall Study||40
11260359|NCT02243865|12455285|FG001|COMPLETED|Overall Study||38
11260360|NCT02243865|12455284|FG000|NOT COMPLETED|Overall Study||4
11260361|NCT02243865|12455285|FG001|NOT COMPLETED|Overall Study||5
11260362|NCT02243943|12455295|FG000|STARTED|Overall Study||50
11260363|NCT02243943|12455296|FG001|STARTED|Overall Study||50
11260364|NCT02243943|12455295|FG000|COMPLETED|Overall Study||50
11260365|NCT02243943|12455296|FG001|COMPLETED|Overall Study||50
11260366|NCT02243943|12455295|FG000|NOT COMPLETED|Overall Study||0
11260367|NCT02243943|12455296|FG001|NOT COMPLETED|Overall Study||0
11260368|NCT02244424|12455304|FG000|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102
11260369|NCT02244424|12455305|FG001|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62
11260370|NCT02244424|12455304|FG000|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51
11260371|NCT02244424|12455305|FG001|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31
11260372|NCT02244424|12455304|FG000|Mothers|Overall Study||51
11260373|NCT02244424|12455305|FG001|Mothers|Overall Study||31
11260374|NCT02244424|12455304|FG000|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82
11260375|NCT02244424|12455305|FG001|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52
11260376|NCT02244424|12455304|FG000|NOT COMPLETED|Overall Study||20
11260377|NCT02244424|12455305|FG001|NOT COMPLETED|Overall Study||10
11260378|NCT02244580|12455311|FG000|STARTED|Overall Study||1010
11260379|NCT02244580|12455311|FG000|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
11260380|NCT02244580|12455311|FG000|NOT COMPLETED|Overall Study||241
11260381|NCT02244619|12455321|FG000|STARTED|Overall Study||249
11260382|NCT02244619|12455322|FG001|STARTED|Overall Study||266
11260383|NCT02244619|12455321|FG000|COMPLETED|Overall Study||241
11260384|NCT02244619|12455322|FG001|COMPLETED|Overall Study||245
11260385|NCT02244619|12455321|FG000|NOT COMPLETED|Overall Study||8
11260386|NCT02244619|12455322|FG001|NOT COMPLETED|Overall Study||21
11260387|NCT02244840|12455328|FG000|STARTED|Overall Study||40
11260388|NCT02244840|12455328|FG000|COMPLETED|Overall Study||40
11260389|NCT02244840|12455328|FG000|NOT COMPLETED|Overall Study||0
11260390|NCT02244918|12455334|FG000|STARTED|Overall Study||185
11260391|NCT02244918|12455335|FG001|STARTED|Overall Study||93
11260392|NCT02244918|12455334|FG000|Week 12|Overall Study||160
11260393|NCT02244918|12455335|FG001|Week 12|Overall Study||83
11260394|NCT02244918|12455334|FG000|COMPLETED|Overall Study||185
11260395|NCT02244918|12455335|FG001|COMPLETED|Overall Study||93
11260396|NCT02244918|12455334|FG000|NOT COMPLETED|Overall Study||0
11260397|NCT02244918|12455335|FG001|NOT COMPLETED|Overall Study||0
11260398|NCT02244957|12455344|FG000|STARTED|Overall Study||7
11260399|NCT02244957|12455345|FG001|STARTED|Overall Study||16
11260400|NCT02244957|12455344|FG000|COMPLETED|Overall Study||6
11260401|NCT02244957|12455345|FG001|COMPLETED|Overall Study||16
11260402|NCT02244957|12455344|FG000|NOT COMPLETED|Overall Study||1
11260403|NCT02244957|12455345|FG001|NOT COMPLETED|Overall Study||0
11260404|NCT02244996|12455355|FG000|STARTED|Overall Study||25
11260405|NCT02244996|12455356|FG001|STARTED|Overall Study||25
11260406|NCT02244996|12455355|FG000|COMPLETED|Overall Study||23
11260407|NCT02244996|12455356|FG001|COMPLETED|Overall Study||19
11260408|NCT02244996|12455355|FG000|NOT COMPLETED|Overall Study||2
11260409|NCT02244996|12455356|FG001|NOT COMPLETED|Overall Study||6
11260410|NCT02245217|12455362|FG000|STARTED|Overall Study||9
11260411|NCT02245217|12455362|FG000|COMPLETED|Overall Study||7
11260412|NCT02245217|12455362|FG000|NOT COMPLETED|Overall Study||2
11260413|NCT02245360|12455368|FG000|STARTED|Overall Study||53
11260414|NCT02245360|12455369|FG001|STARTED|Overall Study||54
11260415|NCT02245360|12455368|FG000|COMPLETED|Overall Study||48
11260416|NCT02245360|12455369|FG001|COMPLETED|Overall Study||52
11260417|NCT02245360|12455368|FG000|NOT COMPLETED|Overall Study||5
11260418|NCT02245360|12455369|FG001|NOT COMPLETED|Overall Study||2
11260419|NCT02245412|12455378|FG000|STARTED|Treatment Period||17
11260420|NCT02245412|12455379|FG001|STARTED|Treatment Period||6
11260421|NCT02245412|12455380|FG002|STARTED|Treatment Period||2
11260422|NCT02245412|12455378|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||17
11343951|NCT02957682|12541258|FG000|NOT COMPLETED|Overall Study||198
11358891|NCT03131648|12556056|FG000|NOT COMPLETED|Initial Treatment Period||53
11358892|NCT03131648|12556057|FG001|NOT COMPLETED|Initial Treatment Period||20
11358893|NCT03131648|12556058|FG002|NOT COMPLETED|Initial Treatment Period||0
11358894|NCT03131648|12556059|FG003|NOT COMPLETED|Initial Treatment Period||0
11358895|NCT03131648|12556060|FG004|NOT COMPLETED|Initial Treatment Period||0
11358896|NCT03131648|12556061|FG005|NOT COMPLETED|Initial Treatment Period||0
11358897|NCT03131648|12556062|FG006|NOT COMPLETED|Initial Treatment Period||0
11358898|NCT03131648|12556063|FG007|NOT COMPLETED|Initial Treatment Period||0
11358899|NCT03131648|12556056|FG000|STARTED|Open-label Treatment||0
11358900|NCT03131648|12556057|FG001|STARTED|Open-label Treatment||0
11358901|NCT03131648|12556058|FG002|STARTED|Open-label Treatment||0
11358902|NCT03131648|12556059|FG003|STARTED|Open-label Treatment||0
11358903|NCT03131648|12556060|FG004|STARTED|Open-label Treatment||0
11358904|NCT03131648|12556061|FG005|STARTED|Open-label Treatment||0
11358905|NCT03131648|12556062|FG006|STARTED|Open-label Treatment||564
11358906|NCT03131648|12556063|FG007|STARTED|Open-label Treatment||0
11358907|NCT03131648|12556056|FG000|COMPLETED|Open-label Treatment||0
11358908|NCT03131648|12556057|FG001|COMPLETED|Open-label Treatment||0
11358909|NCT03131648|12556058|FG002|COMPLETED|Open-label Treatment||0
11358910|NCT03131648|12556059|FG003|COMPLETED|Open-label Treatment||0
11358911|NCT03131648|12556060|FG004|COMPLETED|Open-label Treatment||0
11358912|NCT03131648|12556061|FG005|COMPLETED|Open-label Treatment||0
11358913|NCT03131648|12556062|FG006|COMPLETED|Open-label Treatment||446
11358914|NCT03131648|12556063|FG007|COMPLETED|Open-label Treatment||0
11358915|NCT03131648|12556056|FG000|NOT COMPLETED|Open-label Treatment||0
11358916|NCT03131648|12556057|FG001|NOT COMPLETED|Open-label Treatment||0
11358917|NCT03131648|12556058|FG002|NOT COMPLETED|Open-label Treatment||0
11358918|NCT03131648|12556059|FG003|NOT COMPLETED|Open-label Treatment||0
11358919|NCT03131648|12556060|FG004|NOT COMPLETED|Open-label Treatment||0
11358920|NCT03131648|12556061|FG005|NOT COMPLETED|Open-label Treatment||0
11358921|NCT03131648|12556062|FG006|NOT COMPLETED|Open-label Treatment||118
11358922|NCT03131648|12556063|FG007|NOT COMPLETED|Open-label Treatment||0
11358923|NCT03131648|12556056|FG000|STARTED|Maintenance Treatment Period||0
11358924|NCT03131648|12556057|FG001|STARTED|Maintenance Treatment Period||0
11358925|NCT03131648|12556058|FG002|STARTED|Maintenance Treatment Period||71
11358926|NCT03131648|12556059|FG003|STARTED|Maintenance Treatment Period||78
11260423|NCT02245412|12455379|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6
11260424|NCT02245412|12455380|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||2
11260425|NCT02245412|12455378|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||16
11260426|NCT02245412|12455379|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||6
11260427|NCT02245412|12455380|FG002|Modified Full Analysis Set (mFAS)|Treatment Period||2
11260428|NCT02245412|12455378|FG000|COMPLETED|Treatment Period||12
11260429|NCT02245412|12455379|FG001|COMPLETED|Treatment Period||3
11260430|NCT02245412|12455380|FG002|COMPLETED|Treatment Period||2
11260431|NCT02245412|12455378|FG000|NOT COMPLETED|Treatment Period||5
11260432|NCT02245412|12455379|FG001|NOT COMPLETED|Treatment Period||3
11260433|NCT02245412|12455380|FG002|NOT COMPLETED|Treatment Period||0
11260434|NCT02245412|12455378|FG000|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13
11260435|NCT02245412|12455379|FG001|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4
11260436|NCT02245412|12455380|FG002|STARTED|Follow-Up Period||2
11260437|NCT02245412|12455378|FG000|COMPLETED|Follow-Up Period||8
11260438|NCT02245412|12455379|FG001|COMPLETED|Follow-Up Period||2
11260439|NCT02245412|12455380|FG002|COMPLETED|Follow-Up Period||0
11260440|NCT02245412|12455378|FG000|NOT COMPLETED|Follow-Up Period||5
11260441|NCT02245412|12455379|FG001|NOT COMPLETED|Follow-Up Period||2
11260442|NCT02245412|12455380|FG002|NOT COMPLETED|Follow-Up Period||2
11260443|NCT02245516|12455390|FG000|STARTED|Overall Study||9
11260444|NCT02245516|12455391|FG001|STARTED|Overall Study||7
11260445|NCT02245516|12455390|FG000|COMPLETED|Overall Study||9
11260446|NCT02245516|12455391|FG001|COMPLETED|Overall Study||4
11260447|NCT02245516|12455390|FG000|NOT COMPLETED|Overall Study||0
11260448|NCT02245516|12455391|FG001|NOT COMPLETED|Overall Study||3
11260449|NCT02245568|12455397|FG000|STARTED|Overall Study||913
11260450|NCT02245568|12455397|FG000|COMPLETED|Overall Study||60
11260451|NCT02245568|12455397|FG000|NOT COMPLETED|Overall Study||853
11260452|NCT02245620|12455403|FG000|STARTED|Overall Study||20
11260453|NCT02245620|12455404|FG001|STARTED|Overall Study||21
11260454|NCT02245620|12455403|FG000|COMPLETED|Overall Study||19
11260455|NCT02245620|12455404|FG001|COMPLETED|Overall Study||20
11260456|NCT02245620|12455403|FG000|NOT COMPLETED|Overall Study||1
11260457|NCT02245620|12455404|FG001|NOT COMPLETED|Overall Study||1
11260458|NCT02245737|12455413|FG000|STARTED|Overall Study||740
11260459|NCT02245737|12455414|FG001|STARTED|Overall Study||739
11260460|NCT02245737|12455415|FG002|STARTED|Overall Study||739
11260461|NCT02245737|12455413|FG000|Received at Least 1 Dose of Study Drug|Overall Study||738
11260462|NCT02245737|12455414|FG001|Received at Least 1 Dose of Study Drug|Overall Study||736
11260463|NCT02245737|12455415|FG002|Received at Least 1 Dose of Study Drug|Overall Study||735
11260464|NCT02245737|12455413|FG000|COMPLETED|Overall Study||187
11260465|NCT02245737|12455414|FG001|COMPLETED|Overall Study||184
11260466|NCT02245737|12455415|FG002|COMPLETED|Overall Study||168
11260467|NCT02245737|12455413|FG000|NOT COMPLETED|Overall Study||553
11260468|NCT02245737|12455414|FG001|NOT COMPLETED|Overall Study||555
11260469|NCT02245737|12455415|FG002|NOT COMPLETED|Overall Study||571
11260470|NCT02245815|12455427|FG000|STARTED|Overall Study||45
11260471|NCT02245815|12455428|FG001|STARTED|Overall Study||45
11260472|NCT02245815|12455427|FG000|COMPLETED|Overall Study||45
11260473|NCT02245815|12455428|FG001|COMPLETED|Overall Study||45
11260474|NCT02245815|12455427|FG000|NOT COMPLETED|Overall Study||0
11260475|NCT02245815|12455428|FG001|NOT COMPLETED|Overall Study||0
11260476|NCT02246010|12455438|FG000|STARTED|Overall Study||4
11260477|NCT02246010|12455439|FG001|STARTED|Overall Study||2
11260478|NCT02246010|12455438|FG000|COMPLETED|Overall Study||4
11260479|NCT02246010|12455439|FG001|COMPLETED|Overall Study||2
11260480|NCT02246010|12455438|FG000|NOT COMPLETED|Overall Study||0
11260481|NCT02246010|12455439|FG001|NOT COMPLETED|Overall Study||0
11260482|NCT02246062|12455449|FG000|STARTED|Overall Study||21
11260483|NCT02246062|12455450|FG001|STARTED|Overall Study||21
11260484|NCT02246062|12455451|FG002|STARTED|Overall Study||21
11260485|NCT02246062|12455452|FG003|STARTED|Overall Study||21
11260486|NCT02246062|12455449|FG000|COMPLETED|Overall Study||21
11260487|NCT02246062|12455450|FG001|COMPLETED|Overall Study||21
11260488|NCT02246062|12455451|FG002|COMPLETED|Overall Study||21
11260489|NCT02246062|12455452|FG003|COMPLETED|Overall Study||21
11260490|NCT02246062|12455449|FG000|NOT COMPLETED|Overall Study||0
11260491|NCT02246062|12455450|FG001|NOT COMPLETED|Overall Study||0
11260492|NCT02246062|12455451|FG002|NOT COMPLETED|Overall Study||0
11260493|NCT02246062|12455452|FG003|NOT COMPLETED|Overall Study||0
11260494|NCT02246166|12455464|FG000|STARTED|Overall Study||26
11260495|NCT02246166|12455465|FG001|STARTED|Overall Study||27
11260496|NCT02246166|12455464|FG000|COMPLETED|Overall Study||25
11260497|NCT02246166|12455465|FG001|COMPLETED|Overall Study||27
11260498|NCT02246166|12455464|FG000|NOT COMPLETED|Overall Study||1
11260499|NCT02246166|12455465|FG001|NOT COMPLETED|Overall Study||0
11260500|NCT02246218|12455473|FG000|STARTED|Overall Study||10
11260501|NCT02246218|12455474|FG001|STARTED|Overall Study||16
11260502|NCT02246218|12455473|FG000|COMPLETED|Overall Study||6
11260503|NCT02246218|12455474|FG001|COMPLETED|Overall Study||10
11260504|NCT02246218|12455473|FG000|NOT COMPLETED|Overall Study||4
11260505|NCT02246218|12455474|FG001|NOT COMPLETED|Overall Study||6
11260506|NCT02246309|12455482|FG000|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
11260507|NCT02246309|12455483|FG001|STARTED|Overall Study||15
11260508|NCT02246309|12455482|FG000|COMPLETED|Overall Study||16
11260509|NCT02246309|12455483|FG001|COMPLETED|Overall Study||15
11260510|NCT02246309|12455482|FG000|NOT COMPLETED|Overall Study||0
11260511|NCT02246309|12455483|FG001|NOT COMPLETED|Overall Study||0
11260512|NCT02246413|12455491|FG000|STARTED|12-months (Primary Outcome)||204
11260513|NCT02246413|12455492|FG001|STARTED|12-months (Primary Outcome)||205
11260514|NCT02246413|12455491|FG000|COMPLETED|12-months (Primary Outcome)||169
11260515|NCT02246413|12455492|FG001|COMPLETED|12-months (Primary Outcome)||175
11260516|NCT02246413|12455491|FG000|NOT COMPLETED|12-months (Primary Outcome)||35
11260517|NCT02246413|12455492|FG001|NOT COMPLETED|12-months (Primary Outcome)||30
11260518|NCT02246413|12455491|FG000|STARTED|24-months (Secondary Outcome)||204
11260519|NCT02246413|12455492|FG001|STARTED|24-months (Secondary Outcome)||205
11260520|NCT02246413|12455491|FG000|COMPLETED|24-months (Secondary Outcome)||153
11260521|NCT02246413|12455492|FG001|COMPLETED|24-months (Secondary Outcome)||173
11260522|NCT02246413|12455491|FG000|NOT COMPLETED|24-months (Secondary Outcome)||51
11260523|NCT02246413|12455492|FG001|NOT COMPLETED|24-months (Secondary Outcome)||32
11260524|NCT02246439|12455500|FG000|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192
11260525|NCT02246439|12455501|FG001|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129
11260526|NCT02246439|12455500|FG000|Randomized|Overall Study||198
11260527|NCT02246439|12455501|FG001|Randomized|Overall Study||132
11260528|NCT02246439|12455500|FG000|COMPLETED|Overall Study||180
11260529|NCT02246439|12455501|FG001|COMPLETED|Overall Study||118
11260530|NCT02246439|12455500|FG000|NOT COMPLETED|Overall Study||12
11260531|NCT02246439|12455501|FG001|NOT COMPLETED|Overall Study||11
11260532|NCT02246478|12455511|FG000|STARTED|Single-dose Phase||6
11260533|NCT02246478|12455512|FG001|STARTED|Single-dose Phase||5
11260534|NCT02246478|12455513|FG002|STARTED|Single-dose Phase||5
11260535|NCT02246478|12455514|FG003|STARTED|Single-dose Phase||5
11260536|NCT02246478|12455511|FG000|COMPLETED|Single-dose Phase||6
11260537|NCT02246478|12455512|FG001|COMPLETED|Single-dose Phase||5
11260538|NCT02246478|12455513|FG002|COMPLETED|Single-dose Phase||5
11260539|NCT02246478|12455514|FG003|COMPLETED|Single-dose Phase||5
11260540|NCT02246478|12455511|FG000|NOT COMPLETED|Single-dose Phase||0
11005504|NCT00723125|12183180|FG000|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
11005505|NCT00723125|12183181|FG001|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
11005506|NCT00723125|12183180|FG000|COMPLETED|Overall Study||15
11005507|NCT00723125|12183181|FG001|COMPLETED|Overall Study||21
11005508|NCT00723125|12183180|FG000|NOT COMPLETED|Overall Study||18
11005509|NCT00723125|12183181|FG001|NOT COMPLETED|Overall Study||6
11005510|NCT00723177|12183196|FG000|STARTED|Overall Study||15
11005511|NCT00723177|12183197|FG001|STARTED|Overall Study||14
11005512|NCT00723177|12183198|FG002|STARTED|Overall Study||15
11005513|NCT00723177|12183196|FG000|COMPLETED|Overall Study||10
11005514|NCT00723177|12183197|FG001|COMPLETED|Overall Study||10
11005515|NCT00723177|12183198|FG002|COMPLETED|Overall Study||10
11005516|NCT00723177|12183196|FG000|NOT COMPLETED|Overall Study||5
11005517|NCT00723177|12183197|FG001|NOT COMPLETED|Overall Study||4
11005518|NCT00723177|12183198|FG002|NOT COMPLETED|Overall Study||5
11005519|NCT00723190|12183206|FG000|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
11260541|NCT02246478|12455512|FG001|NOT COMPLETED|Single-dose Phase||0
11260542|NCT02246478|12455513|FG002|NOT COMPLETED|Single-dose Phase||0
11260543|NCT02246478|12455514|FG003|NOT COMPLETED|Single-dose Phase||0
11260544|NCT02246478|12455511|FG000|STARTED|Multiple-dose Phase||6
11260545|NCT02246478|12455512|FG001|STARTED|Multiple-dose Phase||5
11260546|NCT02246478|12455513|FG002|STARTED|Multiple-dose Phase||5
11260547|NCT02246478|12455514|FG003|STARTED|Multiple-dose Phase||5
11260548|NCT02246478|12455511|FG000|COMPLETED|Multiple-dose Phase||5
11260549|NCT02246478|12455512|FG001|COMPLETED|Multiple-dose Phase||5
11260550|NCT02246478|12455513|FG002|COMPLETED|Multiple-dose Phase||5
11260551|NCT02246478|12455514|FG003|COMPLETED|Multiple-dose Phase||4
11260552|NCT02246478|12455511|FG000|NOT COMPLETED|Multiple-dose Phase||1
11260553|NCT02246478|12455512|FG001|NOT COMPLETED|Multiple-dose Phase||0
11260554|NCT02246478|12455513|FG002|NOT COMPLETED|Multiple-dose Phase||0
11260555|NCT02246478|12455514|FG003|NOT COMPLETED|Multiple-dose Phase||1
11260556|NCT02246582|12455531|FG000|STARTED|Overall Study||44
11260557|NCT02246582|12455532|FG001|STARTED|Overall Study||45
11260558|NCT02246582|12455531|FG000|COMPLETED|Overall Study||41
11260559|NCT02246582|12455532|FG001|COMPLETED|Overall Study||41
11260560|NCT02246582|12455531|FG000|NOT COMPLETED|Overall Study||3
11260561|NCT02246582|12455532|FG001|NOT COMPLETED|Overall Study||4
11260562|NCT02246608|12455538|FG000|STARTED|Overall Study||22
11260563|NCT02246608|12455539|FG001|STARTED|Overall Study||21
11260564|NCT02246608|12455538|FG000|COMPLETED|Overall Study||10
11260565|NCT02246608|12455539|FG001|COMPLETED|Overall Study||11
11260566|NCT02246608|12455538|FG000|NOT COMPLETED|Overall Study||12
11260567|NCT02246608|12455539|FG001|NOT COMPLETED|Overall Study||10
11260568|NCT02246647|12455547|FG000|STARTED|Overall Study||19
11260569|NCT02246647|12455548|FG001|STARTED|Overall Study||20
11260570|NCT02246647|12455547|FG000|COMPLETED|Overall Study||18
11260571|NCT02246647|12455548|FG001|COMPLETED|Overall Study||19
11260572|NCT02246647|12455547|FG000|NOT COMPLETED|Overall Study||1
11260573|NCT02246647|12455548|FG001|NOT COMPLETED|Overall Study||1
11260574|NCT02246660|12455571|FG000|STARTED|Overall Study||23
11260575|NCT02246660|12455572|FG001|STARTED|Overall Study||21
11260576|NCT02246660|12455573|FG002|STARTED|Overall Study||22
11260577|NCT02246660|12455571|FG000|COMPLETED|Overall Study||23
11260578|NCT02246660|12455572|FG001|COMPLETED|Overall Study||20
11260579|NCT02246660|12455573|FG002|COMPLETED|Overall Study||21
11260580|NCT02246660|12455571|FG000|NOT COMPLETED|Overall Study||0
11260581|NCT02246660|12455572|FG001|NOT COMPLETED|Overall Study||1
11260582|NCT02246660|12455573|FG002|NOT COMPLETED|Overall Study||1
11260583|NCT02246673|12455586|FG000|STARTED|Overall Study||14
11260584|NCT02246673|12455587|FG001|STARTED|Overall Study||12
11260585|NCT02246673|12455588|FG002|STARTED|Overall Study||12
11260586|NCT02246673|12455589|FG003|STARTED|Overall Study||14
11260587|NCT02246673|12455590|FG004|STARTED|Overall Study||12
11260588|NCT02246673|12455586|FG000|COMPLETED|Overall Study||13
11260589|NCT02246673|12455587|FG001|COMPLETED|Overall Study||12
11260590|NCT02246673|12455588|FG002|COMPLETED|Overall Study||12
11260591|NCT02246673|12455589|FG003|COMPLETED|Overall Study||12
11260592|NCT02246673|12455590|FG004|COMPLETED|Overall Study||11
11260593|NCT02246673|12455586|FG000|NOT COMPLETED|Overall Study||1
11260594|NCT02246673|12455587|FG001|NOT COMPLETED|Overall Study||0
11260595|NCT02246673|12455588|FG002|NOT COMPLETED|Overall Study||0
11260596|NCT02246673|12455589|FG003|NOT COMPLETED|Overall Study||2
11260597|NCT02246673|12455590|FG004|NOT COMPLETED|Overall Study||1
11260598|NCT02246764|12455635|FG000|STARTED|Overall Study||34
11260599|NCT02246764|12455636|FG001|STARTED|Overall Study||36
11260600|NCT02246764|12455637|FG002|STARTED|Overall Study||23
11260601|NCT02246764|12455635|FG000|COMPLETED|Overall Study||16
11260602|NCT02246764|12455636|FG001|COMPLETED|Overall Study||4
11260603|NCT02246764|12455637|FG002|COMPLETED|Overall Study||19
11260604|NCT02246764|12455635|FG000|NOT COMPLETED|Overall Study||18
11260605|NCT02246764|12455636|FG001|NOT COMPLETED|Overall Study||32
11260606|NCT02246764|12455637|FG002|NOT COMPLETED|Overall Study||4
11260607|NCT02246777|12455645|FG000|STARTED|Overall Study||32
11260608|NCT02246777|12455645|FG000|COMPLETED|Overall Study||29
11260609|NCT02246777|12455645|FG000|NOT COMPLETED|Overall Study||3
11260610|NCT02246998|12455658|FG000|STARTED|Overall Study||18
11260611|NCT02246998|12455659|FG001|STARTED|Overall Study||18
11260612|NCT02246998|12455660|FG002|STARTED|Overall Study||18
11260613|NCT02246998|12455661|FG003|STARTED|Overall Study||18
11260614|NCT02246998|12455658|FG000|COMPLETED|Overall Study||16
11260615|NCT02246998|12455659|FG001|COMPLETED|Overall Study||15
11260616|NCT02246998|12455660|FG002|COMPLETED|Overall Study||15
11260617|NCT02246998|12455661|FG003|COMPLETED|Overall Study||16
11260618|NCT02246998|12455658|FG000|NOT COMPLETED|Overall Study||2
11260619|NCT02246998|12455659|FG001|NOT COMPLETED|Overall Study||3
11260620|NCT02246998|12455660|FG002|NOT COMPLETED|Overall Study||3
11260621|NCT02246998|12455661|FG003|NOT COMPLETED|Overall Study||2
11260622|NCT02247011|12455676|FG000|STARTED|Overall Study||1100
11260623|NCT02247011|12455676|FG000|COMPLETED|Overall Study||975
11260624|NCT02247011|12455676|FG000|NOT COMPLETED|Overall Study||125
11260625|NCT02247063|12455685|FG000|STARTED|Overall Study||12
11260626|NCT02247063|12455686|FG001|STARTED|Overall Study||12
11260627|NCT02247063|12455685|FG000|COMPLETED|Overall Study||12
11260628|NCT02247063|12455686|FG001|COMPLETED|Overall Study||12
11260629|NCT02247063|12455685|FG000|NOT COMPLETED|Overall Study||0
11260630|NCT02247063|12455686|FG001|NOT COMPLETED|Overall Study||0
11260631|NCT02247193|12455694|FG000|STARTED|Overall Study||15
11260632|NCT02247193|12455695|FG001|STARTED|Overall Study||15
11260633|NCT02247193|12455694|FG000|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15
11260634|NCT02247193|12455695|FG001|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15
11260635|NCT02247193|12455694|FG000|Number Who Received Botox or Placebo|Overall Study||15
11260636|NCT02247193|12455695|FG001|Number Who Received Botox or Placebo|Overall Study||15
11260637|NCT02247193|12455694|FG000|Number Who Completed the 6-month Follow up|Overall Study||15
11260638|NCT02247193|12455695|FG001|Number Who Completed the 6-month Follow up|Overall Study||15
11260639|NCT02247193|12455694|FG000|Number Who Completed the 12-month Follow up|Overall Study||15
11260640|NCT02247193|12455695|FG001|Number Who Completed the 12-month Follow up|Overall Study||15
11260641|NCT02247193|12455694|FG000|COMPLETED|Overall Study||15
11260642|NCT02247193|12455695|FG001|COMPLETED|Overall Study||15
11260643|NCT02247193|12455694|FG000|NOT COMPLETED|Overall Study||0
11260644|NCT02247193|12455695|FG001|NOT COMPLETED|Overall Study||0
11260645|NCT02247245|12455705|FG000|STARTED|Overall Study||13
11260646|NCT02247245|12455706|FG001|STARTED|Overall Study||13
11260647|NCT02247245|12455707|FG002|STARTED|Overall Study||7
11260648|NCT02247245|12455708|FG003|STARTED|Overall Study||7
11260649|NCT02247245|12455705|FG000|COMPLETED|Overall Study||13
11260650|NCT02247245|12455706|FG001|COMPLETED|Overall Study||13
11260651|NCT02247245|12455707|FG002|COMPLETED|Overall Study||7
11260652|NCT02247245|12455708|FG003|COMPLETED|Overall Study||7
11260653|NCT02247245|12455705|FG000|NOT COMPLETED|Overall Study||0
11260654|NCT02247245|12455706|FG001|NOT COMPLETED|Overall Study||0
11260655|NCT02247245|12455707|FG002|NOT COMPLETED|Overall Study||0
11260656|NCT02247245|12455708|FG003|NOT COMPLETED|Overall Study||0
11260657|NCT02247336|12455720|FG000|STARTED|Overall Study||252
11260658|NCT02247336|12455721|FG001|STARTED|Overall Study||253
11260659|NCT02247336|12455720|FG000|COMPLETED|Overall Study||252
11260660|NCT02247336|12455721|FG001|COMPLETED|Overall Study||253
11260661|NCT02247336|12455720|FG000|NOT COMPLETED|Overall Study||0
11260662|NCT02247336|12455721|FG001|NOT COMPLETED|Overall Study||0
11260663|NCT02247401|12455730|FG000|STARTED|Overall Study||100
11260664|NCT02247401|12455731|FG001|STARTED|Overall Study||31
11260665|NCT02247401|12455732|FG002|STARTED|Overall Study||29
11260666|NCT02247401|12455730|FG000|COMPLETED|Overall Study||94
11260667|NCT02247401|12455731|FG001|COMPLETED|Overall Study||29
11260668|NCT02247401|12455732|FG002|COMPLETED|Overall Study||27
11260669|NCT02247401|12455730|FG000|NOT COMPLETED|Overall Study||6
11260670|NCT02247401|12455731|FG001|NOT COMPLETED|Overall Study||2
11260671|NCT02247401|12455732|FG002|NOT COMPLETED|Overall Study||2
11260672|NCT02247440|12455741|FG000|STARTED|Overall Study||18
11260673|NCT02247440|12455741|FG000|COMPLETED|Overall Study||14
11260674|NCT02247440|12455741|FG000|NOT COMPLETED|Overall Study||4
11260675|NCT02247466|12455747|FG000|STARTED|Overall Study||19
11260676|NCT02247466|12455748|FG001|STARTED|Overall Study||18
11260677|NCT02247466|12455747|FG000|COMPLETED|Overall Study||19
11260678|NCT02247466|12455748|FG001|COMPLETED|Overall Study||15
11260679|NCT02247466|12455747|FG000|NOT COMPLETED|Overall Study||0
11260680|NCT02247466|12455748|FG001|NOT COMPLETED|Overall Study||3
11260681|NCT02247479|12455757|FG000|STARTED|Overall Study||305
11260682|NCT02247479|12455758|FG001|STARTED|Overall Study||298
11260683|NCT02247479|12455759|FG002|STARTED|Overall Study||303
11260684|NCT02247479|12455757|FG000|COMPLETED|Overall Study||163
11260685|NCT02247479|12455758|FG001|COMPLETED|Overall Study||160
11260686|NCT02247479|12455759|FG002|COMPLETED|Overall Study||165
11260687|NCT02247479|12455757|FG000|NOT COMPLETED|Overall Study||142
11260688|NCT02247479|12455758|FG001|NOT COMPLETED|Overall Study||138
11260689|NCT02247479|12455759|FG002|NOT COMPLETED|Overall Study||138
11260690|NCT02247531|12455770|FG000|STARTED|Overall Study||321
11260691|NCT02247531|12455771|FG001|STARTED|Overall Study||330
11260692|NCT02247531|12455772|FG002|STARTED|Overall Study||324
11260693|NCT02247531|12455770|FG000|COMPLETED|Overall Study||215
11260694|NCT02247531|12455771|FG001|COMPLETED|Overall Study||205
11260695|NCT02247531|12455772|FG002|COMPLETED|Overall Study||214
11260696|NCT02247531|12455770|FG000|NOT COMPLETED|Overall Study||106
11260697|NCT02247531|12455771|FG001|NOT COMPLETED|Overall Study||125
11260698|NCT02247531|12455772|FG002|NOT COMPLETED|Overall Study||110
11260699|NCT02247739|12455780|FG000|STARTED|Overall Study||5
11260700|NCT02247739|12455781|FG001|STARTED|Overall Study||6
11260701|NCT02247739|12455782|FG002|STARTED|Overall Study||5
11260702|NCT02247739|12455783|FG003|STARTED|Overall Study||5
11260703|NCT02247739|12455784|FG004|STARTED|Overall Study||6
11260704|NCT02247739|12455785|FG005|STARTED|Overall Study||5
11260705|NCT02247739|12455780|FG000|COMPLETED|Overall Study||5
11260706|NCT02247739|12455781|FG001|COMPLETED|Overall Study||3
11260707|NCT02247739|12455782|FG002|COMPLETED|Overall Study||4
11260708|NCT02247739|12455783|FG003|COMPLETED|Overall Study||5
11260709|NCT02247739|12455784|FG004|COMPLETED|Overall Study||5
11260710|NCT02247739|12455785|FG005|COMPLETED|Overall Study||4
11260711|NCT02247739|12455780|FG000|NOT COMPLETED|Overall Study||0
11260712|NCT02247739|12455781|FG001|NOT COMPLETED|Overall Study||3
11260713|NCT02247739|12455782|FG002|NOT COMPLETED|Overall Study||1
11260714|NCT02247739|12455783|FG003|NOT COMPLETED|Overall Study||0
11260715|NCT02247739|12455784|FG004|NOT COMPLETED|Overall Study||1
11260716|NCT02247739|12455785|FG005|NOT COMPLETED|Overall Study||1
11260717|NCT02247765|12455795|FG000|STARTED|Overall Study||18
11260718|NCT02247765|12455795|FG000|COMPLETED|Overall Study||18
11260719|NCT02247765|12455795|FG000|NOT COMPLETED|Overall Study||0
11260720|NCT02247804|12455802|FG000|STARTED|Treatment Period 1||198
11260721|NCT02247804|12455803|FG001|STARTED|Treatment Period 1||198
11260722|NCT02247804|12455804|FG002|STARTED|Treatment Period 1||198
11260723|NCT02247804|12455802|FG000|Received (Sham or Bimatoprost SR)|Treatment Period 1||193
11260724|NCT02247804|12455803|FG001|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
11260725|NCT02247804|12455804|FG002|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
11260726|NCT02247804|12455802|FG000|COMPLETED|Treatment Period 1||176
11260727|NCT02247804|12455803|FG001|COMPLETED|Treatment Period 1||194
11260728|NCT02247804|12455804|FG002|COMPLETED|Treatment Period 1||190
11260729|NCT02247804|12455802|FG000|NOT COMPLETED|Treatment Period 1||22
11260730|NCT02247804|12455803|FG001|NOT COMPLETED|Treatment Period 1||4
11260731|NCT02247804|12455804|FG002|NOT COMPLETED|Treatment Period 1||8
11260732|NCT02247804|12455802|FG000|STARTED|Treatment Period 2||172
11260733|NCT02247804|12455803|FG001|STARTED|Treatment Period 2||191
11260734|NCT02247804|12455804|FG002|STARTED|Treatment Period 2||187
11260735|NCT02247804|12455802|FG000|COMPLETED|Treatment Period 2||164
11260736|NCT02247804|12455803|FG001|COMPLETED|Treatment Period 2||186
11260737|NCT02247804|12455804|FG002|COMPLETED|Treatment Period 2||179
11260738|NCT02247804|12455802|FG000|NOT COMPLETED|Treatment Period 2||8
11260739|NCT02247804|12455803|FG001|NOT COMPLETED|Treatment Period 2||5
11260740|NCT02247804|12455804|FG002|NOT COMPLETED|Treatment Period 2||8
11260741|NCT02247804|12455802|FG000|STARTED|Treatment Period 3||158
11260742|NCT02247804|12455803|FG001|STARTED|Treatment Period 3||183
11358927|NCT03131648|12556060|FG004|STARTED|Maintenance Treatment Period||36
11260743|NCT02247804|12455804|FG002|STARTED|Treatment Period 3||177
11260744|NCT02247804|12455802|FG000|COMPLETED|Treatment Period 3||147
11260745|NCT02247804|12455803|FG001|COMPLETED|Treatment Period 3||173
11260746|NCT02247804|12455804|FG002|COMPLETED|Treatment Period 3||167
11260747|NCT02247804|12455802|FG000|NOT COMPLETED|Treatment Period 3||11
11260748|NCT02247804|12455803|FG001|NOT COMPLETED|Treatment Period 3||10
11260749|NCT02247804|12455804|FG002|NOT COMPLETED|Treatment Period 3||10
11260750|NCT02247960|12455814|FG000|STARTED|Patient Consent and Randomization||85
11260751|NCT02247960|12455815|FG001|STARTED|Patient Consent and Randomization||90
11260752|NCT02247960|12455814|FG000|COMPLETED|Patient Consent and Randomization||83
11260753|NCT02247960|12455815|FG001|COMPLETED|Patient Consent and Randomization||84
11260754|NCT02247960|12455814|FG000|NOT COMPLETED|Patient Consent and Randomization||2
11260755|NCT02247960|12455815|FG001|NOT COMPLETED|Patient Consent and Randomization||6
11260756|NCT02247960|12455814|FG000|STARTED|Catheter Removed||83
11260757|NCT02247960|12455815|FG001|STARTED|Catheter Removed||84
11260758|NCT02247960|12455814|FG000|COMPLETED|Catheter Removed||76
11260759|NCT02247960|12455815|FG001|COMPLETED|Catheter Removed||74
11260760|NCT02247960|12455814|FG000|NOT COMPLETED|Catheter Removed||7
11260761|NCT02247960|12455815|FG001|NOT COMPLETED|Catheter Removed||10
11260762|NCT02248103|12455823|FG000|STARTED|Overall Study||10
11260763|NCT02248103|12455824|FG001|STARTED|Overall Study||10
11260764|NCT02248103|12455823|FG000|COMPLETED|Overall Study||10
11260765|NCT02248103|12455824|FG001|COMPLETED|Overall Study||10
11260766|NCT02248103|12455823|FG000|NOT COMPLETED|Overall Study||0
11260767|NCT02248103|12455824|FG001|NOT COMPLETED|Overall Study||0
11260768|NCT02248246|12455830|FG000|STARTED|Overall Study||40
11260769|NCT02248246|12455830|FG000|COMPLETED|Overall Study||40
11260770|NCT02248246|12455830|FG000|NOT COMPLETED|Overall Study||0
11260771|NCT02248285|12455836|FG000|STARTED|Overall Study||687
11260772|NCT02248285|12455837|FG001|STARTED|Overall Study||858
11260773|NCT02248285|12455836|FG000|COMPLETED|Overall Study||586
11260774|NCT02248285|12455837|FG001|COMPLETED|Overall Study||571
11260775|NCT02248285|12455836|FG000|NOT COMPLETED|Overall Study||101
11260776|NCT02248285|12455837|FG001|NOT COMPLETED|Overall Study||287
11260777|NCT02248480|12455845|FG000|STARTED|Overall Study||178
11260778|NCT02248480|12455846|FG001|STARTED|Overall Study||176
11260779|NCT02248480|12455845|FG000|Efficacy Population|Overall Study||177
11260780|NCT02248480|12455846|FG001|Efficacy Population|Overall Study||176
11260781|NCT02248480|12455845|FG000|COMPLETED|Overall Study||161
11260782|NCT02248480|12455846|FG001|COMPLETED|Overall Study||162
11260783|NCT02248480|12455845|FG000|NOT COMPLETED|Overall Study||17
11260784|NCT02248480|12455846|FG001|NOT COMPLETED|Overall Study||14
11260785|NCT02248558|12455855|FG000|STARTED|Overall Study||369
11260786|NCT02248558|12455856|FG001|STARTED|Overall Study||352
11260787|NCT02248558|12455855|FG000|COMPLETED|Overall Study||317
11260788|NCT02248558|12455856|FG001|COMPLETED|Overall Study||307
11260789|NCT02248558|12455855|FG000|NOT COMPLETED|Overall Study||52
11260790|NCT02248558|12455856|FG001|NOT COMPLETED|Overall Study||45
11260791|NCT02248636|12455866|FG000|STARTED|Overall Study||26
11260792|NCT02248636|12455867|FG001|STARTED|Overall Study||35
11260793|NCT02248636|12455866|FG000|COMPLETED|Overall Study||20
11260794|NCT02248636|12455867|FG001|COMPLETED|Overall Study||32
11260795|NCT02248636|12455866|FG000|NOT COMPLETED|Overall Study||6
11260796|NCT02248636|12455867|FG001|NOT COMPLETED|Overall Study||3
11260797|NCT02248649|12455875|FG000|STARTED|Overall Study||80
11260798|NCT02248649|12455876|FG001|STARTED|Overall Study||80
11260799|NCT02248649|12455875|FG000|COMPLETED|Overall Study||59
11260800|NCT02248649|12455876|FG001|COMPLETED|Overall Study||59
11260801|NCT02248649|12455875|FG000|NOT COMPLETED|Overall Study||21
11260802|NCT02248649|12455876|FG001|NOT COMPLETED|Overall Study||21
11260803|NCT02248662|12455884|FG000|STARTED|Overall Study||5320
11260804|NCT02248662|12455885|FG001|STARTED|Overall Study||33194
11260805|NCT02248662|12455884|FG000|COMPLETED|Overall Study||757
11260806|NCT02248662|12455885|FG001|COMPLETED|Overall Study||2679
11260807|NCT02248662|12455884|FG000|NOT COMPLETED|Overall Study||4563
11260808|NCT02248662|12455885|FG001|NOT COMPLETED|Overall Study||30515
11260809|NCT02248675|12455897|FG000|STARTED|Overall Study||26
11260810|NCT02248675|12455898|FG001|STARTED|Overall Study||28
11260811|NCT02248675|12455897|FG000|COMPLETED|Overall Study||23
11260812|NCT02248675|12455898|FG001|COMPLETED|Overall Study||27
11260813|NCT02248675|12455897|FG000|NOT COMPLETED|Overall Study||3
11260814|NCT02248675|12455898|FG001|NOT COMPLETED|Overall Study||1
11260815|NCT02248714|12455906|FG000|STARTED|Overall Study||66
11260816|NCT02248714|12455907|FG001|STARTED|Overall Study||65
11260817|NCT02248714|12455906|FG000|COMPLETED|Overall Study||62
11260818|NCT02248714|12455907|FG001|COMPLETED|Overall Study||61
11260819|NCT02248714|12455906|FG000|NOT COMPLETED|Overall Study||4
11260820|NCT02248714|12455907|FG001|NOT COMPLETED|Overall Study||4
11260821|NCT02248727|12455913|FG000|STARTED|Overall Study||30
11260822|NCT02248727|12455913|FG000|COMPLETED|Overall Study||30
11260823|NCT02248727|12455913|FG000|NOT COMPLETED|Overall Study||0
11260824|NCT02248766|12455920|FG000|STARTED|Overall Study||30
11260825|NCT02248766|12455920|FG000|COMPLETED|Overall Study||30
11260826|NCT02248766|12455920|FG000|NOT COMPLETED|Overall Study||0
11260827|NCT02248818|12455936|FG000|STARTED|Screening||0
11260828|NCT02248818|12455937|FG001|STARTED|Screening||0
11260829|NCT02248818|12455938|FG002|STARTED|Screening||0
11260830|NCT02248818|12455939|FG003|STARTED|Screening||0
11260831|NCT02248818|12455940|FG004|STARTED|Screening||0
11358928|NCT03131648|12556061|FG005|STARTED|Maintenance Treatment Period||29
11260832|NCT02248818|12455941|FG005|STARTED|Screening||0
11260833|NCT02248818|12455942|FG006|STARTED|Screening||0
11260834|NCT02248818|12455943|FG007|STARTED|Screening||0
11260835|NCT02248818|12455944|FG008|STARTED|Screening||155
11260836|NCT02248818|12455936|FG000|COMPLETED|Screening||0
11260837|NCT02248818|12455937|FG001|COMPLETED|Screening||0
11260838|NCT02248818|12455938|FG002|COMPLETED|Screening||0
11260839|NCT02248818|12455939|FG003|COMPLETED|Screening||0
11260840|NCT02248818|12455940|FG004|COMPLETED|Screening||0
11260841|NCT02248818|12455941|FG005|COMPLETED|Screening||0
11260842|NCT02248818|12455942|FG006|COMPLETED|Screening||0
11260843|NCT02248818|12455943|FG007|COMPLETED|Screening||0
11260844|NCT02248818|12455944|FG008|COMPLETED|Screening||48
11260845|NCT02248818|12455936|FG000|NOT COMPLETED|Screening||0
11260846|NCT02248818|12455937|FG001|NOT COMPLETED|Screening||0
11260847|NCT02248818|12455938|FG002|NOT COMPLETED|Screening||0
11260848|NCT02248818|12455939|FG003|NOT COMPLETED|Screening||0
11260849|NCT02248818|12455940|FG004|NOT COMPLETED|Screening||0
11260850|NCT02248818|12455941|FG005|NOT COMPLETED|Screening||0
11260851|NCT02248818|12455942|FG006|NOT COMPLETED|Screening||0
11260852|NCT02248818|12455943|FG007|NOT COMPLETED|Screening||0
11260853|NCT02248818|12455944|FG008|NOT COMPLETED|Screening||107
11260854|NCT02248818|12455936|FG000|STARTED|Randomised Study||6
11260855|NCT02248818|12455937|FG001|STARTED|Randomised Study||6
11260856|NCT02248818|12455938|FG002|STARTED|Randomised Study||6
11260857|NCT02248818|12455939|FG003|STARTED|Randomised Study||6
11260858|NCT02248818|12455940|FG004|STARTED|Randomised Study||6
11260859|NCT02248818|12455941|FG005|STARTED|Randomised Study||8
11260860|NCT02248818|12455942|FG006|STARTED|Randomised Study||6
11260861|NCT02248818|12455943|FG007|STARTED|Randomised Study||4
11260862|NCT02248818|12455944|FG008|STARTED|Randomised Study||0
11260863|NCT02248818|12455936|FG000|COMPLETED|Randomised Study||6
11260864|NCT02248818|12455937|FG001|COMPLETED|Randomised Study||6
11260865|NCT02248818|12455938|FG002|COMPLETED|Randomised Study||6
11260866|NCT02248818|12455939|FG003|COMPLETED|Randomised Study||6
11260867|NCT02248818|12455940|FG004|COMPLETED|Randomised Study||6
11260868|NCT02248818|12455941|FG005|COMPLETED|Randomised Study||0
11260869|NCT02248818|12455942|FG006|COMPLETED|Randomised Study||6
11260870|NCT02248818|12455943|FG007|COMPLETED|Randomised Study||4
11260871|NCT02248818|12455944|FG008|COMPLETED|Randomised Study||0
11260872|NCT02248818|12455936|FG000|NOT COMPLETED|Randomised Study||0
11260873|NCT02248818|12455937|FG001|NOT COMPLETED|Randomised Study||0
11260874|NCT02248818|12455938|FG002|NOT COMPLETED|Randomised Study||0
11260875|NCT02248818|12455939|FG003|NOT COMPLETED|Randomised Study||0
11260876|NCT02248818|12455940|FG004|NOT COMPLETED|Randomised Study||0
11260877|NCT02248818|12455941|FG005|NOT COMPLETED|Randomised Study||8
11260878|NCT02248818|12455942|FG006|NOT COMPLETED|Randomised Study||0
11260879|NCT02248818|12455943|FG007|NOT COMPLETED|Randomised Study||0
11260880|NCT02248818|12455944|FG008|NOT COMPLETED|Randomised Study||0
11260881|NCT02248857|12455965|FG000|STARTED|Baseline||157
11260882|NCT02248857|12455966|FG001|STARTED|Baseline||168
11260883|NCT02248857|12455967|FG002|STARTED|Baseline||127
11260884|NCT02248857|12455965|FG000|COMPLETED|Baseline||157
11260885|NCT02248857|12455966|FG001|COMPLETED|Baseline||168
11260886|NCT02248857|12455967|FG002|COMPLETED|Baseline||127
11260887|NCT02248857|12455965|FG000|NOT COMPLETED|Baseline||0
11260888|NCT02248857|12455966|FG001|NOT COMPLETED|Baseline||0
11260889|NCT02248857|12455967|FG002|NOT COMPLETED|Baseline||0
11260890|NCT02248857|12455965|FG000|STARTED|3 Month||157
11260891|NCT02248857|12455966|FG001|STARTED|3 Month||168
11260892|NCT02248857|12455967|FG002|STARTED|3 Month||127
11260893|NCT02248857|12455965|FG000|COMPLETED|3 Month||111
11260894|NCT02248857|12455966|FG001|COMPLETED|3 Month||134
11260895|NCT02248857|12455967|FG002|COMPLETED|3 Month||96
11260896|NCT02248857|12455965|FG000|NOT COMPLETED|3 Month||46
11260897|NCT02248857|12455966|FG001|NOT COMPLETED|3 Month||34
11260898|NCT02248857|12455967|FG002|NOT COMPLETED|3 Month||31
11260899|NCT02248857|12455965|FG000|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148
11260900|NCT02248857|12455966|FG001|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165
11260901|NCT02248857|12455967|FG002|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123
11260902|NCT02248857|12455965|FG000|COMPLETED|6 Month||120
11260903|NCT02248857|12455966|FG001|COMPLETED|6 Month||136
11260904|NCT02248857|12455967|FG002|COMPLETED|6 Month||106
11260905|NCT02248857|12455965|FG000|NOT COMPLETED|6 Month||28
11260906|NCT02248857|12455966|FG001|NOT COMPLETED|6 Month||29
11260907|NCT02248857|12455967|FG002|NOT COMPLETED|6 Month||17
11260908|NCT02248922|12455977|FG000|STARTED|Overall Study||5
11260909|NCT02248922|12455978|FG001|STARTED|Overall Study||12
11260910|NCT02248922|12455977|FG000|COMPLETED|Overall Study||5
11260911|NCT02248922|12455978|FG001|COMPLETED|Overall Study||12
11260912|NCT02248922|12455977|FG000|NOT COMPLETED|Overall Study||0
11260913|NCT02248922|12455978|FG001|NOT COMPLETED|Overall Study||0
11260914|NCT02248961|12455985|FG000|STARTED|Overall Study||89
11260915|NCT02248961|12455986|FG001|STARTED|Overall Study||90
11260916|NCT02248961|12455985|FG000|COMPLETED|Overall Study||86
11260917|NCT02248961|12455986|FG001|COMPLETED|Overall Study||88
11260918|NCT02248961|12455985|FG000|NOT COMPLETED|Overall Study||3
11260919|NCT02248961|12455986|FG001|NOT COMPLETED|Overall Study||2
11260920|NCT02248974|12455994|FG000|STARTED|Baseline||47
11260921|NCT02248974|12455995|FG001|STARTED|Baseline||51
11260922|NCT02248974|12455994|FG000|COMPLETED|Baseline||47
11260923|NCT02248974|12455995|FG001|COMPLETED|Baseline||51
11260924|NCT02248974|12455994|FG000|NOT COMPLETED|Baseline||0
11260925|NCT02248974|12455995|FG001|NOT COMPLETED|Baseline||0
11260926|NCT02248974|12455994|FG000|STARTED|1-Day Follow-Up||47
11260927|NCT02248974|12455995|FG001|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
11260928|NCT02248974|12455994|FG000|COMPLETED|1-Day Follow-Up||37
11260929|NCT02248974|12455995|FG001|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
11260930|NCT02248974|12455994|FG000|NOT COMPLETED|1-Day Follow-Up||10
11260931|NCT02248974|12455995|FG001|NOT COMPLETED|1-Day Follow-Up||0
11260932|NCT02248974|12455994|FG000|STARTED|1-Week Follow-Up||37
11260933|NCT02248974|12455995|FG001|STARTED|1-Week Follow-Up||51
11260934|NCT02248974|12455994|FG000|COMPLETED|1-Week Follow-Up||29
11260935|NCT02248974|12455995|FG001|COMPLETED|1-Week Follow-Up||34
11260936|NCT02248974|12455994|FG000|NOT COMPLETED|1-Week Follow-Up||8
11260937|NCT02248974|12455995|FG001|NOT COMPLETED|1-Week Follow-Up||17
11260938|NCT02248974|12455994|FG000|STARTED|1-Month Follow-Up||29
11260939|NCT02248974|12455995|FG001|STARTED|1-Month Follow-Up||34
11260940|NCT02248974|12455994|FG000|COMPLETED|1-Month Follow-Up||27
11260941|NCT02248974|12455995|FG001|COMPLETED|1-Month Follow-Up||31
11260942|NCT02248974|12455994|FG000|NOT COMPLETED|1-Month Follow-Up||2
11260943|NCT02248974|12455995|FG001|NOT COMPLETED|1-Month Follow-Up||3
11260944|NCT02249052|12456001|FG000|STARTED|Overall Study||19
11260945|NCT02249052|12456001|FG000|COMPLETED|Overall Study||19
11260946|NCT02249052|12456001|FG000|NOT COMPLETED|Overall Study||0
11260947|NCT02249091|12456011|FG000|STARTED|Overall Study||27
11260948|NCT02249091|12456012|FG001|STARTED|Overall Study||15
11260949|NCT02249091|12456011|FG000|COMPLETED|Overall Study||7
11260950|NCT02249091|12456012|FG001|COMPLETED|Overall Study||2
11260951|NCT02249091|12456011|FG000|NOT COMPLETED|Overall Study||20
11260952|NCT02249091|12456012|FG001|NOT COMPLETED|Overall Study||13
11260953|NCT02249143|12456020|FG000|STARTED|Overall Study||24
11260954|NCT02249143|12456021|FG001|STARTED|Overall Study|randomized|26
11260955|NCT02249143|12456020|FG000|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
11260956|NCT02249143|12456021|FG001|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
11260957|NCT02249143|12456020|FG000|NOT COMPLETED|Overall Study||2
11260958|NCT02249143|12456021|FG001|NOT COMPLETED|Overall Study||4
11260959|NCT02249182|12456032|FG000|STARTED|PK Lead-In Phase||10
11260960|NCT02249182|12456033|FG001|STARTED|PK Lead-In Phase||12
11260961|NCT02249182|12456034|FG002|STARTED|PK Lead-In Phase||0
11260962|NCT02249182|12456035|FG003|STARTED|PK Lead-In Phase||0
11260963|NCT02249182|12456036|FG004|STARTED|PK Lead-In Phase||17
11260964|NCT02249182|12456032|FG000|COMPLETED|PK Lead-In Phase||10
11260965|NCT02249182|12456033|FG001|COMPLETED|PK Lead-In Phase||12
11260966|NCT02249182|12456034|FG002|COMPLETED|PK Lead-In Phase||0
11260967|NCT02249182|12456035|FG003|COMPLETED|PK Lead-In Phase||0
11260968|NCT02249182|12456036|FG004|COMPLETED|PK Lead-In Phase||17
11260969|NCT02249182|12456032|FG000|NOT COMPLETED|PK Lead-In Phase||0
11260970|NCT02249182|12456033|FG001|NOT COMPLETED|PK Lead-In Phase||0
11260971|NCT02249182|12456034|FG002|NOT COMPLETED|PK Lead-In Phase||0
11260972|NCT02249182|12456035|FG003|NOT COMPLETED|PK Lead-In Phase||0
11260973|NCT02249182|12456036|FG004|NOT COMPLETED|PK Lead-In Phase||0
11260974|NCT02249182|12456032|FG000|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100
11260975|NCT02249182|12456033|FG001|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89
11260976|NCT02249182|12456034|FG002|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1
11260977|NCT02249182|12456035|FG003|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2
11260978|NCT02249182|12456036|FG004|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34
11260979|NCT02249182|12456032|FG000|COMPLETED|Treatment Phase||96
11260980|NCT02249182|12456033|FG001|COMPLETED|Treatment Phase||89
11260981|NCT02249182|12456034|FG002|COMPLETED|Treatment Phase||1
11260982|NCT02249182|12456035|FG003|COMPLETED|Treatment Phase||2
11260983|NCT02249182|12456036|FG004|COMPLETED|Treatment Phase||34
11260984|NCT02249182|12456032|FG000|NOT COMPLETED|Treatment Phase||4
11260985|NCT02249182|12456033|FG001|NOT COMPLETED|Treatment Phase||0
11260986|NCT02249182|12456034|FG002|NOT COMPLETED|Treatment Phase||0
11260987|NCT02249182|12456035|FG003|NOT COMPLETED|Treatment Phase||0
11260988|NCT02249182|12456036|FG004|NOT COMPLETED|Treatment Phase||0
11339934|NCT02918266|12537326|FG000|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339935|NCT02918266|12537327|FG001|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339936|NCT02918266|12537328|FG002|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339937|NCT02918266|12537329|FG003|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339938|NCT02918266|12537330|FG004|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339939|NCT02918266|12537331|FG005|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339940|NCT02918266|12537332|FG006|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339941|NCT02918266|12537333|FG007|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339942|NCT02918266|12537334|FG008|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339943|NCT02918266|12537335|FG009|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339944|NCT02918266|12537336|FG010|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339945|NCT02918266|12537326|FG000|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339946|NCT02918266|12537327|FG001|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339947|NCT02918266|12537328|FG002|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339948|NCT02918266|12537329|FG003|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339949|NCT02918266|12537330|FG004|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339950|NCT02918266|12537331|FG005|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339951|NCT02918266|12537332|FG006|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339952|NCT02918266|12537333|FG007|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339953|NCT02918266|12537334|FG008|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339954|NCT02918266|12537335|FG009|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339955|NCT02918266|12537336|FG010|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
11339956|NCT02918266|12537326|FG000|STARTED|Part 2: Intervention Period 4 (2 Days)||0
11339957|NCT02918266|12537327|FG001|STARTED|Part 2: Intervention Period 4 (2 Days)||0
11339958|NCT02918266|12537328|FG002|STARTED|Part 2: Intervention Period 4 (2 Days)||0
11339959|NCT02918266|12537329|FG003|STARTED|Part 2: Intervention Period 4 (2 Days)||0
11339960|NCT02918266|12537330|FG004|STARTED|Part 2: Intervention Period 4 (2 Days)||0
11339961|NCT02918266|12537331|FG005|STARTED|Part 2: Intervention Period 4 (2 Days)||0
11339962|NCT02918266|12537332|FG006|STARTED|Part 2: Intervention Period 4 (2 Days)||0
11339963|NCT02918266|12537333|FG007|STARTED|Part 2: Intervention Period 4 (2 Days)||0
11339964|NCT02918266|12537334|FG008|STARTED|Part 2: Intervention Period 4 (2 Days)||0
11339965|NCT02918266|12537335|FG009|STARTED|Part 2: Intervention Period 4 (2 Days)||0
11339966|NCT02918266|12537336|FG010|STARTED|Part 2: Intervention Period 4 (2 Days)||0
11339967|NCT02918266|12537326|FG000|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339968|NCT02918266|12537327|FG001|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339969|NCT02918266|12537328|FG002|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339970|NCT02918266|12537329|FG003|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339971|NCT02918266|12537330|FG004|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339972|NCT02918266|12537331|FG005|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339973|NCT02918266|12537332|FG006|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339974|NCT02918266|12537333|FG007|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339975|NCT02918266|12537334|FG008|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339976|NCT02918266|12537335|FG009|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339977|NCT02918266|12537336|FG010|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339978|NCT02918266|12537326|FG000|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11260989|NCT02249585|12456064|FG000|STARTED|Overall Study||43
11260990|NCT02249585|12456065|FG001|STARTED|Overall Study||44
11260991|NCT02249585|12456066|FG002|STARTED|Overall Study||44
11260992|NCT02249585|12456064|FG000|COMPLETED|Overall Study||43
11260993|NCT02249585|12456065|FG001|COMPLETED|Overall Study||44
11260994|NCT02249585|12456066|FG002|COMPLETED|Overall Study||44
11260995|NCT02249585|12456064|FG000|NOT COMPLETED|Overall Study||0
11260996|NCT02249585|12456065|FG001|NOT COMPLETED|Overall Study||0
11260997|NCT02249585|12456066|FG002|NOT COMPLETED|Overall Study||0
11260998|NCT02249728|12456074|FG000|STARTED|Part One (4 Days)||6
11260999|NCT02249728|12456074|FG000|COMPLETED|Part One (4 Days)||6
11261000|NCT02249728|12456074|FG000|NOT COMPLETED|Part One (4 Days)||0
11261001|NCT02249728|12456074|FG000|STARTED|Part Two (up to 6 Days)||6
11261002|NCT02249728|12456074|FG000|COMPLETED|Part Two (up to 6 Days)||6
11261003|NCT02249728|12456074|FG000|NOT COMPLETED|Part Two (up to 6 Days)||0
11261004|NCT02249767|12456084|FG000|STARTED|Overall Study||230
11261005|NCT02249767|12456085|FG001|STARTED|Overall Study||229
11261006|NCT02249767|12456086|FG002|STARTED|Overall Study||115
11261007|NCT02249767|12456084|FG000|COMPLETED|Overall Study||222
11261008|NCT02249767|12456085|FG001|COMPLETED|Overall Study||220
11261009|NCT02249767|12456086|FG002|COMPLETED|Overall Study||107
11261010|NCT02249767|12456084|FG000|NOT COMPLETED|Overall Study||8
11261011|NCT02249767|12456085|FG001|NOT COMPLETED|Overall Study||9
11261012|NCT02249767|12456086|FG002|NOT COMPLETED|Overall Study||8
11261013|NCT02249793|12456094|FG000|STARTED|Session 1, 48-hours Healthy Volunteers||6
11261014|NCT02249793|12456094|FG000|COMPLETED|Session 1, 48-hours Healthy Volunteers||6
11261015|NCT02249793|12456094|FG000|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0
11261016|NCT02249793|12456094|FG000|STARTED|Session 2, 48-Hours Healthy Volunteers||6
11261017|NCT02249793|12456094|FG000|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6
11261018|NCT02249793|12456094|FG000|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0
11261019|NCT02249819|12456099|FG000|STARTED|Overall Study||8
11261020|NCT02249819|12456100|FG001|STARTED|Overall Study||7
11261021|NCT02249819|12456099|FG000|COMPLETED|Overall Study||8
11261022|NCT02249819|12456100|FG001|COMPLETED|Overall Study||7
11261023|NCT02249819|12456099|FG000|NOT COMPLETED|Overall Study||0
11261024|NCT02249819|12456100|FG001|NOT COMPLETED|Overall Study||0
11261025|NCT02249832|12456106|FG000|STARTED|Overall Study||55
11261026|NCT02249832|12456106|FG000|COMPLETED|Overall Study||42
11261027|NCT02249832|12456106|FG000|NOT COMPLETED|Overall Study||13
11261028|NCT02249949|12456115|FG000|STARTED|Overall Study||13
11261029|NCT02249949|12456115|FG000|COMPLETED|Overall Study||11
11261030|NCT02249949|12456115|FG000|NOT COMPLETED|Overall Study||2
11261031|NCT02250092|12456121|FG000|STARTED|Overall Study||10
11261032|NCT02250092|12456122|FG001|STARTED|Overall Study||10
11261033|NCT02250092|12456121|FG000|COMPLETED|Overall Study||10
11261034|NCT02250092|12456122|FG001|COMPLETED|Overall Study||10
11261035|NCT02250092|12456121|FG000|NOT COMPLETED|Overall Study||0
11261036|NCT02250092|12456122|FG001|NOT COMPLETED|Overall Study||0
11261037|NCT02250183|12456128|FG000|STARTED|Overall Study||21
11261038|NCT02250183|12456128|FG000|COMPLETED|Overall Study||13
11261039|NCT02250183|12456128|FG000|NOT COMPLETED|Overall Study||8
11261040|NCT02250274|12456137|FG000|STARTED|Overall Study||85
11261041|NCT02250274|12456138|FG001|STARTED|Overall Study||46
11261042|NCT02250274|12456137|FG000|COMPLETED|Overall Study||78
11261043|NCT02250274|12456138|FG001|COMPLETED|Overall Study||40
11261044|NCT02250274|12456137|FG000|NOT COMPLETED|Overall Study||7
11261045|NCT02250274|12456138|FG001|NOT COMPLETED|Overall Study||6
11261046|NCT02250417|12456150|FG000|STARTED|First Intervention (1 Night)||6
11261047|NCT02250417|12456151|FG001|STARTED|First Intervention (1 Night)||6
11261048|NCT02250417|12456150|FG000|COMPLETED|First Intervention (1 Night)||6
11261049|NCT02250417|12456151|FG001|COMPLETED|First Intervention (1 Night)||6
11261050|NCT02250417|12456150|FG000|NOT COMPLETED|First Intervention (1 Night)||0
11261051|NCT02250417|12456151|FG001|NOT COMPLETED|First Intervention (1 Night)||0
11261052|NCT02250417|12456150|FG000|STARTED|Second Intervention (1 Night)||6
11261053|NCT02250417|12456151|FG001|STARTED|Second Intervention (1 Night)||6
11261054|NCT02250417|12456150|FG000|COMPLETED|Second Intervention (1 Night)||6
11261055|NCT02250417|12456151|FG001|COMPLETED|Second Intervention (1 Night)||6
11261056|NCT02250417|12456150|FG000|NOT COMPLETED|Second Intervention (1 Night)||0
11261057|NCT02250417|12456151|FG001|NOT COMPLETED|Second Intervention (1 Night)||0
11261058|NCT02250443|12456160|FG000|STARTED|Overall Study||10
11261059|NCT02250443|12456160|FG000|COMPLETED|Overall Study||0
11261060|NCT02250443|12456160|FG000|NOT COMPLETED|Overall Study||10
11261061|NCT02250521|12456164|FG000|STARTED|Overall Study||100
11261062|NCT02250521|12456164|FG000|COMPLETED|Overall Study||99
11261063|NCT02250521|12456164|FG000|NOT COMPLETED|Overall Study||1
11261064|NCT02250612|12456173|FG000|STARTED|Overall Study||37
11261065|NCT02250612|12456174|FG001|STARTED|Overall Study||40
11261066|NCT02250612|12456175|FG002|STARTED|Overall Study||37
11261067|NCT02250612|12456176|FG003|STARTED|Overall Study||33
11261068|NCT02250612|12456177|FG004|STARTED|Overall Study||37
11261069|NCT02250612|12456173|FG000|COMPLETED|Overall Study||36
11261070|NCT02250612|12456174|FG001|COMPLETED|Overall Study||38
11261071|NCT02250612|12456175|FG002|COMPLETED|Overall Study||35
11261072|NCT02250612|12456176|FG003|COMPLETED|Overall Study||33
11261073|NCT02250612|12456177|FG004|COMPLETED|Overall Study||36
11261074|NCT02250612|12456173|FG000|NOT COMPLETED|Overall Study||1
11261075|NCT02250612|12456174|FG001|NOT COMPLETED|Overall Study||2
11261076|NCT02250612|12456175|FG002|NOT COMPLETED|Overall Study||2
11261077|NCT02250612|12456176|FG003|NOT COMPLETED|Overall Study||0
11261078|NCT02250612|12456177|FG004|NOT COMPLETED|Overall Study||1
11261079|NCT02250651|12456199|FG000|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
11261080|NCT02250651|12456200|FG001|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
11261081|NCT02250651|12456201|FG002|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
11261082|NCT02250651|12456199|FG000|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||176
11261083|NCT02250651|12456200|FG001|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||175
11261084|NCT02250651|12456201|FG002|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||173
11261085|NCT02250651|12456199|FG000|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||172
11261086|NCT02250651|12456200|FG001|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||170
11261087|NCT02250651|12456201|FG002|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||165
11261088|NCT02250651|12456199|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||4
11261089|NCT02250651|12456200|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||6
11261090|NCT02250651|12456201|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||11
11261091|NCT02250651|12456199|FG000|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
11261092|NCT02250651|12456200|FG001|STARTED|Treatment Period 2 (Week 16 to Week 31)||168
11261093|NCT02250651|12456201|FG002|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
11261094|NCT02250651|12456199|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||159
11261095|NCT02250651|12456200|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||162
11261096|NCT02250651|12456201|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||160
11261097|NCT02250651|12456199|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
11261098|NCT02250651|12456200|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
11261099|NCT02250651|12456201|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||5
11261100|NCT02250651|12456199|FG000|STARTED|Treatment Period 3 (Week 32 to Week 52)||147
11261101|NCT02250651|12456200|FG001|STARTED|Treatment Period 3 (Week 32 to Week 52)||156
11261102|NCT02250651|12456201|FG002|STARTED|Treatment Period 3 (Week 32 to Week 52)||159
11261103|NCT02250651|12456199|FG000|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||138
11261104|NCT02250651|12456200|FG001|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||152
11261105|NCT02250651|12456201|FG002|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||154
11261106|NCT02250651|12456199|FG000|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||9
11261107|NCT02250651|12456200|FG001|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||4
11261108|NCT02250651|12456201|FG002|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||5
11261109|NCT02250703|12456211|FG000|STARTED|Overall Study||38
11261110|NCT02250703|12456212|FG001|STARTED|Overall Study||37
11261111|NCT02250703|12456211|FG000|COMPLETED|Overall Study||37
11261112|NCT02250703|12456212|FG001|COMPLETED|Overall Study||36
11261113|NCT02250703|12456211|FG000|NOT COMPLETED|Overall Study||1
11261114|NCT02250703|12456212|FG001|NOT COMPLETED|Overall Study||1
11261115|NCT02250807|12456218|FG000|STARTED|Overall Study||40
11261116|NCT02250807|12456218|FG000|COMPLETED|Overall Study||40
11261117|NCT02250807|12456218|FG000|NOT COMPLETED|Overall Study||0
11261118|NCT02251236|12456225|FG000|STARTED|Overall Study||9
11261119|NCT02251236|12456226|FG001|STARTED|Overall Study||5
11261120|NCT02251236|12456227|FG002|STARTED|Overall Study||0
11261121|NCT02251236|12456225|FG000|COMPLETED|Overall Study||9
11261122|NCT02251236|12456226|FG001|COMPLETED|Overall Study||5
11261123|NCT02251236|12456227|FG002|COMPLETED|Overall Study||0
11261124|NCT02251236|12456225|FG000|NOT COMPLETED|Overall Study||0
11261125|NCT02251236|12456226|FG001|NOT COMPLETED|Overall Study||0
11261126|NCT02251236|12456227|FG002|NOT COMPLETED|Overall Study||0
11261127|NCT02251275|12456240|FG000|STARTED|Overall Study||506
11261128|NCT02251275|12456241|FG001|STARTED|Overall Study||570
11261129|NCT02251275|12456242|FG002|STARTED|Overall Study||718
11261130|NCT02251275|12456243|FG003|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6
11261131|NCT02251275|12456244|FG004|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3
11261132|NCT02251275|12456240|FG000|Received at Least 1 Dose of Study Drug|Overall Study||505
11261133|NCT02251275|12456241|FG001|Received at Least 1 Dose of Study Drug|Overall Study||569
11261134|NCT02251275|12456242|FG002|Received at Least 1 Dose of Study Drug|Overall Study||717
11261135|NCT02251275|12456243|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
11261136|NCT02251275|12456244|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
11261137|NCT02251275|12456240|FG000|COMPLETED|Overall Study||434
11261138|NCT02251275|12456241|FG001|COMPLETED|Overall Study||423
11261139|NCT02251275|12456242|FG002|COMPLETED|Overall Study||624
11261140|NCT02251275|12456243|FG003|COMPLETED|Overall Study||5
11261141|NCT02251275|12456244|FG004|COMPLETED|Overall Study||2
11261142|NCT02251275|12456240|FG000|NOT COMPLETED|Overall Study||72
11261143|NCT02251275|12456241|FG001|NOT COMPLETED|Overall Study||147
11261144|NCT02251275|12456242|FG002|NOT COMPLETED|Overall Study||94
11261145|NCT02251275|12456243|FG003|NOT COMPLETED|Overall Study||1
11261146|NCT02251275|12456244|FG004|NOT COMPLETED|Overall Study||1
11261147|NCT02251379|12456258|FG000|STARTED|Overall Study||77
11261148|NCT02251379|12456259|FG001|STARTED|Overall Study||78
11261149|NCT02251379|12456258|FG000|COMPLETED|Overall Study||57
11261150|NCT02251379|12456259|FG001|COMPLETED|Overall Study||58
11261151|NCT02251379|12456258|FG000|NOT COMPLETED|Overall Study||20
11261152|NCT02251379|12456259|FG001|NOT COMPLETED|Overall Study||20
11261153|NCT02251496|12456267|FG000|STARTED|Overall Study||19
11261154|NCT02251496|12456268|FG001|STARTED|Overall Study||15
11261155|NCT02251496|12456267|FG000|COMPLETED|Overall Study||14
11261156|NCT02251496|12456268|FG001|COMPLETED|Overall Study||11
11261157|NCT02251496|12456267|FG000|NOT COMPLETED|Overall Study||5
11261158|NCT02251496|12456268|FG001|NOT COMPLETED|Overall Study||4
11261159|NCT02251561|12456274|FG000|STARTED|Overall Study||28
11261160|NCT02251561|12456274|FG000|COMPLETED|Overall Study||28
11261161|NCT02251561|12456274|FG000|NOT COMPLETED|Overall Study||0
11261162|NCT02251613|12456280|FG000|STARTED|Overall Study||50
11261163|NCT02251613|12456280|FG000|COMPLETED|Overall Study||50
11261164|NCT02251613|12456280|FG000|NOT COMPLETED|Overall Study||0
11261165|NCT02251652|12456286|FG000|STARTED|Overall Study||17
11261166|NCT02251652|12456286|FG000|COMPLETED|Overall Study||16
11261167|NCT02251652|12456286|FG000|NOT COMPLETED|Overall Study||1
11261168|NCT02251717|12456294|FG000|STARTED|Overall Study||57
11261169|NCT02251717|12456295|FG001|STARTED|Overall Study||57
11261170|NCT02251717|12456294|FG000|COMPLETED|Overall Study||56
11261171|NCT02251717|12456295|FG001|COMPLETED|Overall Study||56
11261172|NCT02251717|12456294|FG000|NOT COMPLETED|Overall Study||1
11261173|NCT02251717|12456295|FG001|NOT COMPLETED|Overall Study||1
11261174|NCT02251743|12456303|FG000|STARTED|Overall Study||85
11261175|NCT02251743|12456304|FG001|STARTED|Overall Study||59
11261176|NCT02251743|12456303|FG000|COMPLETED|Overall Study||84
11261177|NCT02251743|12456304|FG001|COMPLETED|Overall Study||58
11261178|NCT02251743|12456303|FG000|NOT COMPLETED|Overall Study||1
11261179|NCT02251743|12456304|FG001|NOT COMPLETED|Overall Study||1
11261180|NCT02251886|12456314|FG000|STARTED|Overall Study||48
11261181|NCT02251886|12456315|FG001|STARTED|Overall Study||54
11261182|NCT02251886|12456316|FG002|STARTED|Overall Study||44
11261183|NCT02251886|12456317|FG003|STARTED|Overall Study||54
11261184|NCT02251886|12456314|FG000|COMPLETED|Overall Study||48
11261185|NCT02251886|12456315|FG001|COMPLETED|Overall Study||54
11261186|NCT02251886|12456316|FG002|COMPLETED|Overall Study||44
11261187|NCT02251886|12456317|FG003|COMPLETED|Overall Study||54
11261188|NCT02251886|12456314|FG000|NOT COMPLETED|Overall Study||0
11261189|NCT02251886|12456315|FG001|NOT COMPLETED|Overall Study||0
11261190|NCT02251886|12456316|FG002|NOT COMPLETED|Overall Study||0
11261191|NCT02251886|12456317|FG003|NOT COMPLETED|Overall Study||0
11261192|NCT02251912|12456329|FG000|STARTED|Overall Study||12
11261193|NCT02251912|12456330|FG001|STARTED|Overall Study||10
11261194|NCT02251912|12456329|FG000|COMPLETED|Overall Study||10
11261195|NCT02251912|12456330|FG001|COMPLETED|Overall Study||5
11261196|NCT02251912|12456329|FG000|NOT COMPLETED|Overall Study||2
11261197|NCT02251912|12456330|FG001|NOT COMPLETED|Overall Study||5
11261198|NCT02251938|12456336|FG000|STARTED|Overall Study||60
11261199|NCT02251938|12456336|FG000|COMPLETED|Overall Study||43
11261200|NCT02251938|12456336|FG000|NOT COMPLETED|Overall Study||17
11261201|NCT02251990|12456342|FG000|STARTED|Period 1 (Double-blind [DB])||366
11261202|NCT02251990|12456343|FG001|STARTED|Period 1 (Double-blind [DB])||123
11261203|NCT02251990|12456342|FG000|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
11261204|NCT02251990|12456343|FG001|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
11261205|NCT02251990|12456342|FG000|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
11261206|NCT02251990|12456343|FG001|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
11261207|NCT02251990|12456342|FG000|NOT COMPLETED|Period 1 (Double-blind [DB])||8
11261208|NCT02251990|12456343|FG001|NOT COMPLETED|Period 1 (Double-blind [DB])||1
11261209|NCT02251990|12456342|FG000|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
11261210|NCT02251990|12456343|FG001|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
11261211|NCT02251990|12456342|FG000|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
11261212|NCT02251990|12456343|FG001|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
11261213|NCT02251990|12456342|FG000|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
11261214|NCT02251990|12456343|FG001|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
11261215|NCT02251990|12456342|FG000|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
11261216|NCT02251990|12456343|FG001|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
11261217|NCT02251990|12456342|FG000|COMPLETED|Period 3 (DTG Follow-up)||0
11261218|NCT02251990|12456343|FG001|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
11261219|NCT02251990|12456342|FG000|NOT COMPLETED|Period 3 (DTG Follow-up)||0
11261220|NCT02251990|12456343|FG001|NOT COMPLETED|Period 3 (DTG Follow-up)||0
11261221|NCT02252016|12456352|FG000|STARTED|Overall Study||107
11261222|NCT02252016|12456353|FG001|STARTED|Overall Study||52
11261223|NCT02252016|12456352|FG000|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
11261224|NCT02252016|12456353|FG001|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
11261225|NCT02252016|12456352|FG000|NOT COMPLETED|Overall Study||3
11261226|NCT02252016|12456353|FG001|NOT COMPLETED|Overall Study||3
11261227|NCT02252068|12456362|FG000|STARTED|Overall Study||5
11261228|NCT02252068|12456363|FG001|STARTED|Overall Study||13
11261229|NCT02252068|12456364|FG002|STARTED|Overall Study||13
11261230|NCT02252068|12456362|FG000|COMPLETED|Overall Study||3
11261231|NCT02252068|12456363|FG001|COMPLETED|Overall Study||13
11261232|NCT02252068|12456364|FG002|COMPLETED|Overall Study||13
11261233|NCT02252068|12456362|FG000|NOT COMPLETED|Overall Study||2
11261234|NCT02252068|12456363|FG001|NOT COMPLETED|Overall Study||0
11261235|NCT02252068|12456364|FG002|NOT COMPLETED|Overall Study||0
11261236|NCT02252081|12456374|FG000|STARTED|Overall Study||30
11261237|NCT02252081|12456375|FG001|STARTED|Overall Study||30
11261238|NCT02252081|12456374|FG000|COMPLETED|Overall Study||24
11261239|NCT02252081|12456375|FG001|COMPLETED|Overall Study||26
11261240|NCT02252081|12456374|FG000|NOT COMPLETED|Overall Study||6
11261241|NCT02252081|12456375|FG001|NOT COMPLETED|Overall Study||4
11261242|NCT02252133|12456386|FG000|STARTED|Period 1||23
11261243|NCT02252133|12456387|FG001|STARTED|Period 1||24
11261244|NCT02252133|12456386|FG000|COMPLETED|Period 1||23
11261245|NCT02252133|12456387|FG001|COMPLETED|Period 1||24
11261246|NCT02252133|12456386|FG000|NOT COMPLETED|Period 1||0
11261247|NCT02252133|12456387|FG001|NOT COMPLETED|Period 1||0
11261248|NCT02252133|12456386|FG000|STARTED|Period 2||23
11261249|NCT02252133|12456387|FG001|STARTED|Period 2||24
11261250|NCT02252133|12456386|FG000|COMPLETED|Period 2||23
11261251|NCT02252133|12456387|FG001|COMPLETED|Period 2||24
11261252|NCT02252133|12456386|FG000|NOT COMPLETED|Period 2||0
11261253|NCT02252133|12456387|FG001|NOT COMPLETED|Period 2||0
11261254|NCT02252146|12456393|FG000|STARTED|Overall Study||6
11261255|NCT02252146|12456393|FG000|COMPLETED|Overall Study||0
11261256|NCT02252146|12456393|FG000|NOT COMPLETED|Overall Study||6
11261257|NCT02252211|12456399|FG000|STARTED|Overall Study||5
11261258|NCT02252211|12456400|FG001|STARTED|Overall Study||3
11261259|NCT02252211|12456401|FG002|STARTED|Overall Study||1
11261260|NCT02252211|12456399|FG000|Received Dose 1 (Day 1)|Overall Study||4
11261261|NCT02252211|12456400|FG001|Received Dose 1 (Day 1)|Overall Study||3
11261262|NCT02252211|12456401|FG002|Received Dose 1 (Day 1)|Overall Study||0
11261263|NCT02252211|12456399|FG000|Received Dose 2 (Day 8)|Overall Study||4
11261264|NCT02252211|12456400|FG001|Received Dose 2 (Day 8)|Overall Study||3
11261265|NCT02252211|12456401|FG002|Received Dose 2 (Day 8)|Overall Study||0
11261266|NCT02252211|12456399|FG000|Received Dose 3 (Day 22)|Overall Study||3
11261267|NCT02252211|12456400|FG001|Received Dose 3 (Day 22)|Overall Study||3
11261268|NCT02252211|12456401|FG002|Received Dose 3 (Day 22)|Overall Study||0
11261269|NCT02252211|12456399|FG000|Received Dose 4 (Day 36)|Overall Study||1
11261270|NCT02252211|12456400|FG001|Received Dose 4 (Day 36)|Overall Study||1
11261271|NCT02252211|12456401|FG002|Received Dose 4 (Day 36)|Overall Study||0
11261272|NCT02252211|12456399|FG000|Received Further Doses (Through Dose 24)|Overall Study||1
11261273|NCT02252211|12456400|FG001|Received Further Doses (Through Dose 24)|Overall Study||0
11261274|NCT02252211|12456401|FG002|Received Further Doses (Through Dose 24)|Overall Study||0
11261275|NCT02252211|12456399|FG000|COMPLETED|Overall Study||0
11261276|NCT02252211|12456400|FG001|COMPLETED|Overall Study||0
11261277|NCT02252211|12456401|FG002|COMPLETED|Overall Study||0
11261278|NCT02252211|12456399|FG000|NOT COMPLETED|Overall Study||5
11261279|NCT02252211|12456400|FG001|NOT COMPLETED|Overall Study||3
11261280|NCT02252211|12456401|FG002|NOT COMPLETED|Overall Study||1
11261281|NCT02252354|12456410|FG000|STARTED|Overall Study||6
11261282|NCT02252354|12456411|FG001|STARTED|Overall Study||6
11261283|NCT02252354|12456410|FG000|COMPLETED|Overall Study||6
11261284|NCT02252354|12456411|FG001|COMPLETED|Overall Study||6
11261285|NCT02252354|12456410|FG000|NOT COMPLETED|Overall Study||0
11261286|NCT02252354|12456411|FG001|NOT COMPLETED|Overall Study||0
11261287|NCT02252406|12456419|FG000|STARTED|Starting Dose Ranolazine 500 mg BID||16
11261288|NCT02252406|12456420|FG001|STARTED|Starting Dose Ranolazine 500 mg BID||17
11261289|NCT02252406|12456419|FG000|COMPLETED|Starting Dose Ranolazine 500 mg BID||12
11261290|NCT02252406|12456420|FG001|COMPLETED|Starting Dose Ranolazine 500 mg BID||14
11261291|NCT02252406|12456419|FG000|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||4
11261292|NCT02252406|12456420|FG001|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||3
11261293|NCT02252406|12456419|FG000|STARTED|Titrated to Ranolazine 1000mg BID||12
11261294|NCT02252406|12456420|FG001|STARTED|Titrated to Ranolazine 1000mg BID||14
11261295|NCT02252406|12456419|FG000|COMPLETED|Titrated to Ranolazine 1000mg BID||9
11261296|NCT02252406|12456420|FG001|COMPLETED|Titrated to Ranolazine 1000mg BID||13
11261297|NCT02252406|12456419|FG000|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||3
11261298|NCT02252406|12456420|FG001|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||1
11261299|NCT02252445|12456428|FG000|STARTED|Overall Study||41
11261300|NCT02252445|12456429|FG001|STARTED|Overall Study||41
11261301|NCT02252445|12456428|FG000|COMPLETED|Overall Study||41
11261302|NCT02252445|12456429|FG001|COMPLETED|Overall Study||41
11261303|NCT02252445|12456428|FG000|NOT COMPLETED|Overall Study||0
11261304|NCT02252445|12456429|FG001|NOT COMPLETED|Overall Study||0
11261305|NCT02252536|12456437|FG000|STARTED|Overall Study||173
11261306|NCT02252536|12456438|FG001|STARTED|Overall Study||173
11261307|NCT02252536|12456437|FG000|COMPLETED|Overall Study||168
11261308|NCT02252536|12456438|FG001|COMPLETED|Overall Study||170
11261309|NCT02252536|12456437|FG000|NOT COMPLETED|Overall Study||5
11261310|NCT02252536|12456438|FG001|NOT COMPLETED|Overall Study||3
11261311|NCT02252562|12456446|FG000|STARTED|Overall Study||1620
11261312|NCT02252562|12456447|FG001|STARTED|Overall Study||1636
11261313|NCT02252562|12456446|FG000|COMPLETED|Overall Study||1620
11261314|NCT02252562|12456447|FG001|COMPLETED|Overall Study||1636
11261315|NCT02252562|12456446|FG000|NOT COMPLETED|Overall Study||0
11261316|NCT02252562|12456447|FG001|NOT COMPLETED|Overall Study||0
11261317|NCT02252588|12456456|FG000|STARTED|Overall Study||24
11261318|NCT02252588|12456457|FG001|STARTED|Overall Study||20
11261319|NCT02252588|12456456|FG000|COMPLETED|Overall Study||20
11261320|NCT02252588|12456457|FG001|COMPLETED|Overall Study||20
11261321|NCT02252588|12456456|FG000|NOT COMPLETED|Overall Study||4
11261322|NCT02252588|12456457|FG001|NOT COMPLETED|Overall Study||0
11261323|NCT02252666|12456463|FG000|STARTED|Overall Study||6
11261324|NCT02252666|12456463|FG000|COMPLETED|Overall Study||6
11261325|NCT02252666|12456463|FG000|NOT COMPLETED|Overall Study||0
11261326|NCT02252718|12456467|FG000|STARTED|Overall Study||100
11261327|NCT02252718|12456467|FG000|COMPLETED|Overall Study||100
11261328|NCT02252718|12456467|FG000|NOT COMPLETED|Overall Study||0
11261329|NCT02252744|12456471|FG000|STARTED|Overall Study||286
11261330|NCT02252744|12456471|FG000|COMPLETED|Overall Study||286
11261331|NCT02252744|12456471|FG000|NOT COMPLETED|Overall Study||0
11261332|NCT02252939|12456475|FG000|STARTED|Overall Study||62
11261333|NCT02252939|12456475|FG000|COMPLETED|Overall Study||59
11261334|NCT02252939|12456475|FG000|NOT COMPLETED|Overall Study||3
11261335|NCT02252965|12456486|FG000|STARTED|Overall Study||267
11261336|NCT02252965|12456487|FG001|STARTED|Overall Study||265
11261337|NCT02252965|12456486|FG000|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
11261338|NCT02252965|12456487|FG001|Safety Population|Overall Study||264
11261339|NCT02252965|12456486|FG000|COMPLETED|Overall Study||227
11261340|NCT02252965|12456487|FG001|COMPLETED|Overall Study||222
11261341|NCT02252965|12456486|FG000|NOT COMPLETED|Overall Study||40
11261342|NCT02252965|12456487|FG001|NOT COMPLETED|Overall Study||43
11261343|NCT02253147|12456495|FG000|STARTED|Overall Study||118
11261344|NCT02253147|12456495|FG000|N Patients at W24 (Primary Outcome)|Overall Study||88
11261345|NCT02253147|12456495|FG000|N Patients at W36|Overall Study||86
11261346|NCT02253147|12456495|FG000|N Patients at W52|Overall Study||84
11261347|NCT02253147|12456495|FG000|COMPLETED|Overall Study||71
11261348|NCT02253147|12456495|FG000|NOT COMPLETED|Overall Study||47
11261349|NCT02253160|12456504|FG000|STARTED|Overall Study||1
11261350|NCT02253160|12456505|FG001|STARTED|Overall Study||12
11261351|NCT02253160|12456506|FG002|STARTED|Overall Study||10
11261352|NCT02253160|12456504|FG000|COMPLETED|Overall Study||1
11261353|NCT02253160|12456505|FG001|COMPLETED|Overall Study||12
11261354|NCT02253160|12456506|FG002|COMPLETED|Overall Study||10
11261355|NCT02253160|12456504|FG000|NOT COMPLETED|Overall Study||0
11261356|NCT02253160|12456505|FG001|NOT COMPLETED|Overall Study||0
11261357|NCT02253160|12456506|FG002|NOT COMPLETED|Overall Study||0
11261358|NCT02253173|12456520|FG000|STARTED|Overall Study||191
11358929|NCT03131648|12556062|FG006|STARTED|Maintenance Treatment Period||0
11358930|NCT03131648|12556063|FG007|STARTED|Maintenance Treatment Period||0
11358931|NCT03131648|12556056|FG000|COMPLETED|Maintenance Treatment Period||0
11358932|NCT03131648|12556057|FG001|COMPLETED|Maintenance Treatment Period||0
11358933|NCT03131648|12556058|FG002|COMPLETED|Maintenance Treatment Period||44
11358934|NCT03131648|12556059|FG003|COMPLETED|Maintenance Treatment Period||53
11358935|NCT03131648|12556060|FG004|COMPLETED|Maintenance Treatment Period||21
11358936|NCT03131648|12556061|FG005|COMPLETED|Maintenance Treatment Period||15
11358937|NCT03131648|12556062|FG006|COMPLETED|Maintenance Treatment Period||0
11358938|NCT03131648|12556063|FG007|COMPLETED|Maintenance Treatment Period||0
11358939|NCT03131648|12556056|FG000|NOT COMPLETED|Maintenance Treatment Period||0
11358940|NCT03131648|12556057|FG001|NOT COMPLETED|Maintenance Treatment Period||0
11358941|NCT03131648|12556058|FG002|NOT COMPLETED|Maintenance Treatment Period||27
11358942|NCT03131648|12556059|FG003|NOT COMPLETED|Maintenance Treatment Period||25
11358943|NCT03131648|12556060|FG004|NOT COMPLETED|Maintenance Treatment Period||15
11358944|NCT03131648|12556061|FG005|NOT COMPLETED|Maintenance Treatment Period||14
11358945|NCT03131648|12556062|FG006|NOT COMPLETED|Maintenance Treatment Period||0
11358946|NCT03131648|12556063|FG007|NOT COMPLETED|Maintenance Treatment Period||0
11358947|NCT03131648|12556056|FG000|STARTED|Open-label (Short Term Extension)||0
11358948|NCT03131648|12556057|FG001|STARTED|Open-label (Short Term Extension)||0
11358949|NCT03131648|12556058|FG002|STARTED|Open-label (Short Term Extension)||0
11358950|NCT03131648|12556059|FG003|STARTED|Open-label (Short Term Extension)||0
11358951|NCT03131648|12556060|FG004|STARTED|Open-label (Short Term Extension)||0
11358952|NCT03131648|12556061|FG005|STARTED|Open-label (Short Term Extension)||0
11358953|NCT03131648|12556062|FG006|STARTED|Open-label (Short Term Extension)||0
11358954|NCT03131648|12556063|FG007|STARTED|Open-label (Short Term Extension)||65
11358955|NCT03131648|12556056|FG000|COMPLETED|Open-label (Short Term Extension)||0
11358956|NCT03131648|12556057|FG001|COMPLETED|Open-label (Short Term Extension)||0
11358957|NCT03131648|12556058|FG002|COMPLETED|Open-label (Short Term Extension)||0
11358958|NCT03131648|12556059|FG003|COMPLETED|Open-label (Short Term Extension)||0
11358959|NCT03131648|12556060|FG004|COMPLETED|Open-label (Short Term Extension)||0
11358960|NCT03131648|12556061|FG005|COMPLETED|Open-label (Short Term Extension)||0
11358961|NCT03131648|12556062|FG006|COMPLETED|Open-label (Short Term Extension)||0
11358962|NCT03131648|12556063|FG007|COMPLETED|Open-label (Short Term Extension)||62
11358963|NCT03131648|12556056|FG000|NOT COMPLETED|Open-label (Short Term Extension)||0
11358964|NCT03131648|12556057|FG001|NOT COMPLETED|Open-label (Short Term Extension)||0
11358965|NCT03131648|12556058|FG002|NOT COMPLETED|Open-label (Short Term Extension)||0
11358966|NCT03131648|12556059|FG003|NOT COMPLETED|Open-label (Short Term Extension)||0
11358967|NCT03131648|12556060|FG004|NOT COMPLETED|Open-label (Short Term Extension)||0
11358968|NCT03131648|12556061|FG005|NOT COMPLETED|Open-label (Short Term Extension)||0
11261359|NCT02253173|12456521|FG001|STARTED|Overall Study||191
11261360|NCT02253173|12456522|FG002|STARTED|Overall Study||190
11358969|NCT03131648|12556062|FG006|NOT COMPLETED|Open-label (Short Term Extension)||0
11358970|NCT03131648|12556063|FG007|NOT COMPLETED|Open-label (Short Term Extension)||3
11358971|NCT03131687|12556086|FG000|STARTED|Overall Study||51
11358972|NCT03131687|12556087|FG001|STARTED|Overall Study||53
11358973|NCT03131687|12556088|FG002|STARTED|Overall Study||55
11358974|NCT03131687|12556089|FG003|STARTED|Overall Study||52
11358975|NCT03131687|12556090|FG004|STARTED|Overall Study||53
11358976|NCT03131687|12556091|FG005|STARTED|Overall Study||54
11358977|NCT03131687|12556086|FG000|Received at Least One Dose of Study Drug|Overall Study||51
11358978|NCT03131687|12556087|FG001|Received at Least One Dose of Study Drug|Overall Study||52
11358979|NCT03131687|12556088|FG002|Received at Least One Dose of Study Drug|Overall Study||55
11358980|NCT03131687|12556089|FG003|Received at Least One Dose of Study Drug|Overall Study||51
11358981|NCT03131687|12556090|FG004|Received at Least One Dose of Study Drug|Overall Study||53
11261361|NCT02253173|12456523|FG003|STARTED|Overall Study||192
11261362|NCT02253173|12456520|FG000|COMPLETED|Overall Study||175
11261363|NCT02253173|12456521|FG001|COMPLETED|Overall Study||174
11261364|NCT02253173|12456522|FG002|COMPLETED|Overall Study||177
11261365|NCT02253173|12456523|FG003|COMPLETED|Overall Study||178
11261366|NCT02253173|12456520|FG000|NOT COMPLETED|Overall Study||16
11261367|NCT02253173|12456521|FG001|NOT COMPLETED|Overall Study||17
11261368|NCT02253173|12456522|FG002|NOT COMPLETED|Overall Study||13
11261369|NCT02253173|12456523|FG003|NOT COMPLETED|Overall Study||14
11261370|NCT02253433|12456539|FG000|STARTED|Overall Study||130
11261371|NCT02253433|12456540|FG001|STARTED|Overall Study||134
11261372|NCT02253433|12456539|FG000|COMPLETED|Overall Study||114
11261373|NCT02253433|12456540|FG001|COMPLETED|Overall Study||79
11261374|NCT02253433|12456539|FG000|NOT COMPLETED|Overall Study||16
11261375|NCT02253433|12456540|FG001|NOT COMPLETED|Overall Study||55
11261376|NCT02253537|12456547|FG000|STARTED|Overall Study||15
11261377|NCT02253537|12456547|FG000|COMPLETED|Overall Study||15
11261378|NCT02253537|12456547|FG000|NOT COMPLETED|Overall Study||0
11261379|NCT02253654|12456553|FG000|STARTED|Overall Study||108
11261380|NCT02253654|12456554|FG001|STARTED|Overall Study||108
11261381|NCT02253654|12456553|FG000|Received Treatment|Overall Study||104
11261382|NCT02253654|12456554|FG001|Received Treatment|Overall Study||107
11261383|NCT02253654|12456553|FG000|COMPLETED|Overall Study||85
11261384|NCT02253654|12456554|FG001|COMPLETED|Overall Study||90
11261385|NCT02253654|12456553|FG000|NOT COMPLETED|Overall Study||23
11261386|NCT02253654|12456554|FG001|NOT COMPLETED|Overall Study||18
11261387|NCT02253992|12456563|FG000|STARTED|Overall Study||6
11261388|NCT02253992|12456564|FG001|STARTED|Overall Study||4
11261389|NCT02253992|12456565|FG002|STARTED|Overall Study||150
11261390|NCT02253992|12456563|FG000|COMPLETED|Overall Study||0
11261391|NCT02253992|12456564|FG001|COMPLETED|Overall Study||0
11261392|NCT02253992|12456565|FG002|COMPLETED|Overall Study||6
11261393|NCT02253992|12456563|FG000|NOT COMPLETED|Overall Study||6
11261394|NCT02253992|12456564|FG001|NOT COMPLETED|Overall Study||4
11261395|NCT02253992|12456565|FG002|NOT COMPLETED|Overall Study||144
11261396|NCT02254252|12456589|FG000|STARTED|Overall Study||27
11261397|NCT02254252|12456590|FG001|STARTED|Overall Study||27
11261398|NCT02254252|12456589|FG000|COMPLETED|Overall Study||24
11261399|NCT02254252|12456590|FG001|COMPLETED|Overall Study||25
11261400|NCT02254252|12456589|FG000|NOT COMPLETED|Overall Study||3
11261401|NCT02254252|12456590|FG001|NOT COMPLETED|Overall Study||2
11261402|NCT02254291|12456599|FG000|STARTED|Overall Study||103
11261403|NCT02254291|12456600|FG001|STARTED|Overall Study||102
11261404|NCT02254291|12456601|FG002|STARTED|Overall Study||103
11261405|NCT02254291|12456599|FG000|Exposed|Overall Study||103
11261406|NCT02254291|12456600|FG001|Exposed|Overall Study||102
11261407|NCT02254291|12456601|FG002|Exposed|Overall Study||103
11261408|NCT02254291|12456599|FG000|COMPLETED|Overall Study||103
11261409|NCT02254291|12456600|FG001|COMPLETED|Overall Study||99
11261410|NCT02254291|12456601|FG002|COMPLETED|Overall Study||101
11261411|NCT02254291|12456599|FG000|NOT COMPLETED|Overall Study||0
11261412|NCT02254291|12456600|FG001|NOT COMPLETED|Overall Study||3
11261413|NCT02254291|12456601|FG002|NOT COMPLETED|Overall Study||2
11261414|NCT02254304|12456611|FG000|STARTED|Overall Study||89
11261415|NCT02254304|12456612|FG001|STARTED|Overall Study||17
11261416|NCT02254304|12456611|FG000|COMPLETED|Overall Study||75
11261417|NCT02254304|12456612|FG001|COMPLETED|Overall Study||13
11261418|NCT02254304|12456611|FG000|NOT COMPLETED|Overall Study||14
11261419|NCT02254304|12456612|FG001|NOT COMPLETED|Overall Study||4
11261420|NCT02254408|12456622|FG000|STARTED|Overall Study||96
11261421|NCT02254408|12456623|FG001|STARTED|Overall Study||93
11261422|NCT02254408|12456622|FG000|COMPLETED|Overall Study||88
11261423|NCT02254408|12456623|FG001|COMPLETED|Overall Study||83
11261424|NCT02254408|12456622|FG000|NOT COMPLETED|Overall Study||8
11261425|NCT02254408|12456623|FG001|NOT COMPLETED|Overall Study||10
11261426|NCT02254421|12456631|FG000|STARTED|Overall Study||31
11261427|NCT02254421|12456632|FG001|STARTED|Overall Study||29
11261428|NCT02254421|12456631|FG000|COMPLETED|Overall Study||29
11261429|NCT02254421|12456632|FG001|COMPLETED|Overall Study||26
11261430|NCT02254421|12456631|FG000|NOT COMPLETED|Overall Study||2
11261431|NCT02254421|12456632|FG001|NOT COMPLETED|Overall Study||3
11261432|NCT02254460|12456638|FG000|STARTED|Overall Study||13
11261433|NCT02254460|12456639|FG001|STARTED|Overall Study||12
11261434|NCT02254460|12456638|FG000|COMPLETED|Overall Study||12
11261435|NCT02254460|12456639|FG001|COMPLETED|Overall Study||12
11261436|NCT02254460|12456638|FG000|NOT COMPLETED|Overall Study||1
11261437|NCT02254460|12456639|FG001|NOT COMPLETED|Overall Study||0
11261438|NCT02254473|12456647|FG000|STARTED|Overall Study||9
11261439|NCT02254473|12456648|FG001|STARTED|Overall Study||3
11261440|NCT02254473|12456647|FG000|COMPLETED|Overall Study||7
11261441|NCT02254473|12456648|FG001|COMPLETED|Overall Study||2
11261442|NCT02254473|12456647|FG000|NOT COMPLETED|Overall Study||2
11261443|NCT02254473|12456648|FG001|NOT COMPLETED|Overall Study||1
11261444|NCT02254486|12456656|FG000|STARTED|Overall Study||311
11261445|NCT02254486|12456657|FG001|STARTED|Overall Study||310
11261446|NCT02254486|12456656|FG000|COMPLETED|Overall Study||261
11261447|NCT02254486|12456657|FG001|COMPLETED|Overall Study||255
11261448|NCT02254486|12456656|FG000|NOT COMPLETED|Overall Study||50
11261449|NCT02254486|12456657|FG001|NOT COMPLETED|Overall Study||55
11261450|NCT02254551|12456663|FG000|STARTED|Dose Escalation||7
11261451|NCT02254551|12456663|FG000|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
11261452|NCT02254551|12456663|FG000|Cohort 2: LDE225 600mg|Dose Escalation||0
11261453|NCT02254551|12456663|FG000|Cohort 3: LDE225 800mg|Dose Escalation||0
11261454|NCT02254551|12456663|FG000|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
11261455|NCT02254551|12456663|FG000|NOT COMPLETED|Dose Escalation||3
11261456|NCT02254551|12456663|FG000|STARTED|Expansion||0
11261457|NCT02254551|12456663|FG000|COMPLETED|Expansion||0
11261458|NCT02254551|12456663|FG000|NOT COMPLETED|Expansion||0
11261459|NCT02254551|12456663|FG000|STARTED|Maintenance||0
11261460|NCT02254551|12456663|FG000|COMPLETED|Maintenance||0
11261461|NCT02254551|12456663|FG000|NOT COMPLETED|Maintenance||0
11261462|NCT02254681|12456670|FG000|STARTED|Overall Study||6
11261463|NCT02254681|12456670|FG000|COMPLETED|Overall Study||0
11261464|NCT02254681|12456670|FG000|NOT COMPLETED|Overall Study||6
11261465|NCT02254772|12456675|FG000|STARTED|Overall Study||9
11261466|NCT02254772|12456675|FG000|COMPLETED|Overall Study||7
11261467|NCT02254772|12456675|FG000|NOT COMPLETED|Overall Study||2
11261468|NCT02255032|12456681|FG000|STARTED|Overall Study||17
11261469|NCT02255032|12456682|FG001|STARTED|Overall Study||5
11261470|NCT02255032|12456681|FG000|COMPLETED|Overall Study||17
11261471|NCT02255032|12456682|FG001|COMPLETED|Overall Study||5
11261472|NCT02255032|12456681|FG000|NOT COMPLETED|Overall Study||0
11261473|NCT02255032|12456682|FG001|NOT COMPLETED|Overall Study||0
11261474|NCT02255110|12456688|FG000|STARTED|Overall Study||6
11261475|NCT02255110|12456688|FG000|COMPLETED|Overall Study||6
11261476|NCT02255110|12456688|FG000|NOT COMPLETED|Overall Study||0
11261477|NCT02255149|12456692|FG000|STARTED|Overall Study||10
11261478|NCT02255149|12456692|FG000|COMPLETED|Overall Study||5
11261479|NCT02255149|12456692|FG000|NOT COMPLETED|Overall Study||5
11261480|NCT02255175|12456698|FG000|STARTED|Overall Study||33
11261481|NCT02255175|12456699|FG001|STARTED|Overall Study||31
11261482|NCT02255175|12456698|FG000|COMPLETED|Overall Study||16
11261483|NCT02255175|12456699|FG001|COMPLETED|Overall Study||19
11261484|NCT02255175|12456698|FG000|NOT COMPLETED|Overall Study||17
11261485|NCT02255175|12456699|FG001|NOT COMPLETED|Overall Study||12
11261486|NCT02255279|12456711|FG000|STARTED|Overall Study||144
11261487|NCT02255279|12456712|FG001|STARTED|Overall Study||143
11261488|NCT02255279|12456711|FG000|COMPLETED|Overall Study||139
11261489|NCT02255279|12456712|FG001|COMPLETED|Overall Study||134
11261490|NCT02255279|12456711|FG000|NOT COMPLETED|Overall Study||5
11261491|NCT02255279|12456712|FG001|NOT COMPLETED|Overall Study||9
11261492|NCT02255357|12456734|FG000|STARTED|Overall Study||11
11261493|NCT02255357|12456735|FG001|STARTED|Overall Study||15
11261494|NCT02255357|12456734|FG000|COMPLETED|Overall Study||4
11261495|NCT02255357|12456735|FG001|COMPLETED|Overall Study||5
11261496|NCT02255357|12456734|FG000|NOT COMPLETED|Overall Study||7
11261497|NCT02255357|12456735|FG001|NOT COMPLETED|Overall Study||10
11261498|NCT02255422|12456748|FG000|STARTED|Overall Study||13
11261499|NCT02255422|12456749|FG001|STARTED|Overall Study||6
11261500|NCT02255422|12456750|FG002|STARTED|Overall Study||6
11261501|NCT02255422|12456751|FG003|STARTED|Overall Study||6
11261502|NCT02255422|12456752|FG004|STARTED|Overall Study||6
11261503|NCT02255422|12456753|FG005|STARTED|Overall Study||6
11261504|NCT02255422|12456754|FG006|STARTED|Overall Study||10
11261505|NCT02255422|12456748|FG000|COMPLETED|Overall Study||13
11261506|NCT02255422|12456749|FG001|COMPLETED|Overall Study||6
11261507|NCT02255422|12456750|FG002|COMPLETED|Overall Study||5
11261508|NCT02255422|12456751|FG003|COMPLETED|Overall Study||6
11261509|NCT02255422|12456752|FG004|COMPLETED|Overall Study||6
11261510|NCT02255422|12456753|FG005|COMPLETED|Overall Study||6
11261511|NCT02255422|12456754|FG006|COMPLETED|Overall Study||8
11261512|NCT02255422|12456748|FG000|NOT COMPLETED|Overall Study||0
11261513|NCT02255422|12456749|FG001|NOT COMPLETED|Overall Study||0
11261514|NCT02255422|12456750|FG002|NOT COMPLETED|Overall Study||1
11261515|NCT02255422|12456751|FG003|NOT COMPLETED|Overall Study||0
11261516|NCT02255422|12456752|FG004|NOT COMPLETED|Overall Study||0
11261517|NCT02255422|12456753|FG005|NOT COMPLETED|Overall Study||0
11261518|NCT02255422|12456754|FG006|NOT COMPLETED|Overall Study||2
11261519|NCT02255461|12456775|FG000|STARTED|Overall Study||3
11261520|NCT02255461|12456776|FG001|STARTED|Overall Study||12
11261521|NCT02255461|12456777|FG002|STARTED|Overall Study||6
11261522|NCT02255461|12456778|FG003|STARTED|Overall Study||4
11261523|NCT02255461|12456779|FG004|STARTED|Overall Study||10
11261524|NCT02255461|12456775|FG000|COMPLETED|Overall Study||3
11261525|NCT02255461|12456776|FG001|COMPLETED|Overall Study||10
11261526|NCT02255461|12456777|FG002|COMPLETED|Overall Study||5
11261527|NCT02255461|12456778|FG003|COMPLETED|Overall Study||4
11261528|NCT02255461|12456779|FG004|COMPLETED|Overall Study||8
11261529|NCT02255461|12456775|FG000|NOT COMPLETED|Overall Study||0
11261530|NCT02255461|12456776|FG001|NOT COMPLETED|Overall Study||2
11261531|NCT02255461|12456777|FG002|NOT COMPLETED|Overall Study||1
11261532|NCT02255461|12456778|FG003|NOT COMPLETED|Overall Study||0
11261533|NCT02255461|12456779|FG004|NOT COMPLETED|Overall Study||2
11261534|NCT02255474|12456799|FG000|STARTED|Overall Study||98
11261535|NCT02255474|12456800|FG001|STARTED|Overall Study||98
11261536|NCT02255474|12456801|FG002|STARTED|Overall Study||98
11261537|NCT02255474|12456799|FG000|COMPLETED|Overall Study||96
11261538|NCT02255474|12456800|FG001|COMPLETED|Overall Study||96
11261539|NCT02255474|12456801|FG002|COMPLETED|Overall Study||95
11261540|NCT02255474|12456799|FG000|NOT COMPLETED|Overall Study||2
11261541|NCT02255474|12456800|FG001|NOT COMPLETED|Overall Study||2
11261542|NCT02255474|12456801|FG002|NOT COMPLETED|Overall Study||3
11261543|NCT02255500|12456812|FG000|STARTED|Overall Study||16
11261544|NCT02255500|12456813|FG001|STARTED|Overall Study||7
11261545|NCT02255500|12456812|FG000|COMPLETED|Overall Study||15
11261546|NCT02255500|12456813|FG001|COMPLETED|Overall Study||7
11261547|NCT02255500|12456812|FG000|NOT COMPLETED|Overall Study||1
11261548|NCT02255500|12456813|FG001|NOT COMPLETED|Overall Study||0
11261549|NCT02255513|12456821|FG000|STARTED|Open-label, Treatment Optimization||43
11261550|NCT02255513|12456822|FG001|STARTED|Open-label, Treatment Optimization||0
11261551|NCT02255513|12456821|FG000|COMPLETED|Open-label, Treatment Optimization||43
11261552|NCT02255513|12456822|FG001|COMPLETED|Open-label, Treatment Optimization||0
11261553|NCT02255513|12456821|FG000|NOT COMPLETED|Open-label, Treatment Optimization||0
11261554|NCT02255513|12456822|FG001|NOT COMPLETED|Open-label, Treatment Optimization||0
11261555|NCT02255513|12456821|FG000|STARTED|Double Blind, Placebo-controlled||22
11261556|NCT02255513|12456822|FG001|STARTED|Double Blind, Placebo-controlled||21
11261557|NCT02255513|12456821|FG000|COMPLETED|Double Blind, Placebo-controlled||22
11261558|NCT02255513|12456822|FG001|COMPLETED|Double Blind, Placebo-controlled||21
11261559|NCT02255513|12456821|FG000|NOT COMPLETED|Double Blind, Placebo-controlled||0
11261560|NCT02255513|12456822|FG001|NOT COMPLETED|Double Blind, Placebo-controlled||0
11261561|NCT02255552|12456830|FG000|STARTED|Overall Study||79
11261562|NCT02255552|12456831|FG001|STARTED|Overall Study||30
11261563|NCT02255552|12456830|FG000|COMPLETED|Overall Study||78
11261564|NCT02255552|12456831|FG001|COMPLETED|Overall Study||15
11261565|NCT02255552|12456830|FG000|NOT COMPLETED|Overall Study||1
11261566|NCT02255552|12456831|FG001|NOT COMPLETED|Overall Study||15
11261567|NCT02255565|12456840|FG000|STARTED|Overall Study||9
11261568|NCT02255565|12456841|FG001|STARTED|Overall Study||9
11261569|NCT02255565|12456842|FG002|STARTED|Overall Study||9
11261570|NCT02255565|12456840|FG000|COMPLETED|Overall Study||9
11261571|NCT02255565|12456841|FG001|COMPLETED|Overall Study||8
11261572|NCT02255565|12456842|FG002|COMPLETED|Overall Study||9
11261573|NCT02255565|12456840|FG000|NOT COMPLETED|Overall Study||0
11261574|NCT02255565|12456841|FG001|NOT COMPLETED|Overall Study||1
11261575|NCT02255565|12456842|FG002|NOT COMPLETED|Overall Study||0
11261576|NCT02255604|12456886|FG000|STARTED|Overall Study||12
11261577|NCT02255604|12456887|FG001|STARTED|Overall Study||12
11261578|NCT02255604|12456888|FG002|STARTED|Overall Study||12
11261579|NCT02255604|12456886|FG000|COMPLETED|Overall Study||10
11261580|NCT02255604|12456887|FG001|COMPLETED|Overall Study||11
11261581|NCT02255604|12456888|FG002|COMPLETED|Overall Study||9
11261582|NCT02255604|12456886|FG000|NOT COMPLETED|Overall Study||2
11261583|NCT02255604|12456887|FG001|NOT COMPLETED|Overall Study||1
11261584|NCT02255604|12456888|FG002|NOT COMPLETED|Overall Study||3
11261585|NCT02255760|12456901|FG000|STARTED|Overall Study||14
11261586|NCT02255760|12456902|FG001|STARTED|Overall Study||3
11261587|NCT02255760|12456903|FG002|STARTED|Overall Study||15
11261588|NCT02255760|12456904|FG003|STARTED|Overall Study||15
11261589|NCT02255760|12456905|FG004|STARTED|Overall Study||9
11261590|NCT02255760|12456901|FG000|COMPLETED|Overall Study||14
11261591|NCT02255760|12456902|FG001|COMPLETED|Overall Study||2
11261592|NCT02255760|12456903|FG002|COMPLETED|Overall Study||15
11261593|NCT02255760|12456904|FG003|COMPLETED|Overall Study||15
11261594|NCT02255760|12456905|FG004|COMPLETED|Overall Study||9
11261595|NCT02255760|12456901|FG000|NOT COMPLETED|Overall Study||0
11261596|NCT02255760|12456902|FG001|NOT COMPLETED|Overall Study||1
11261597|NCT02255760|12456903|FG002|NOT COMPLETED|Overall Study||0
11261598|NCT02255760|12456904|FG003|NOT COMPLETED|Overall Study||0
11261599|NCT02255760|12456905|FG004|NOT COMPLETED|Overall Study||0
11261600|NCT02255981|12456921|FG000|STARTED|Overall Study|Both eyes of each patient were included except 2 that not were treatable|33
11261601|NCT02255981|12456921|FG000|COMPLETED|Overall Study|2 eyes of the final 29 subjects were excluded.|29
11261602|NCT02255981|12456921|FG000|NOT COMPLETED|Overall Study||4
11261603|NCT02256072|12456933|FG000|STARTED|Overall Study||194
11261604|NCT02256072|12456934|FG001|STARTED|Overall Study||191
11261605|NCT02256072|12456933|FG000|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
11261606|NCT02256072|12456934|FG001|Completed 1 Month Follow-Up|Overall Study||179
11261607|NCT02256072|12456933|FG000|COMPLETED|Overall Study|Completed the 3-month follow-up|152
11261608|NCT02256072|12456934|FG001|COMPLETED|Overall Study||162
11261609|NCT02256072|12456933|FG000|NOT COMPLETED|Overall Study||42
11261610|NCT02256072|12456934|FG001|NOT COMPLETED|Overall Study||29
11261611|NCT02256111|12456943|FG000|STARTED|Overall Study||13
11261612|NCT02256111|12456944|FG001|STARTED|Overall Study||13
11261613|NCT02256111|12456943|FG000|COMPLETED|Overall Study||13
11261614|NCT02256111|12456944|FG001|COMPLETED|Overall Study||13
11261615|NCT02256111|12456943|FG000|NOT COMPLETED|Overall Study||0
11261616|NCT02256111|12456944|FG001|NOT COMPLETED|Overall Study||0
11261617|NCT02256189|12456953|FG000|STARTED|Overall Study||15
11261618|NCT02256189|12456954|FG001|STARTED|Overall Study||13
11261619|NCT02256189|12456953|FG000|COMPLETED|Overall Study||15
11261620|NCT02256189|12456954|FG001|COMPLETED|Overall Study||13
11261621|NCT02256189|12456953|FG000|NOT COMPLETED|Overall Study||0
11261622|NCT02256189|12456954|FG001|NOT COMPLETED|Overall Study||0
11261623|NCT02256267|12456962|FG000|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
11261624|NCT02256267|12456962|FG000|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
11261625|NCT02256267|12456962|FG000|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
11261626|NCT02256267|12456962|FG000|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
11261627|NCT02256267|12456962|FG000|STARTED|Period 2 (Day 1 to Day 6)||23
11261628|NCT02256267|12456962|FG000|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
11261629|NCT02256267|12456962|FG000|COMPLETED|Period 2 (Day 1 to Day 6)||23
11261630|NCT02256267|12456962|FG000|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
11261631|NCT02256267|12456962|FG000|STARTED|Period 2 (Day 7 to Day 14)||23
11261632|NCT02256267|12456962|FG000|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
11261633|NCT02256267|12456962|FG000|COMPLETED|Period 2 (Day 7 to Day 14)||22
11261634|NCT02256267|12456962|FG000|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
11261635|NCT02256345|12456971|FG000|STARTED|Overall Study||9
11261636|NCT02256345|12456972|FG001|STARTED|Overall Study||3
11261637|NCT02256345|12456971|FG000|COMPLETED|Overall Study||9
11261638|NCT02256345|12456972|FG001|COMPLETED|Overall Study||3
11261639|NCT02256345|12456971|FG000|NOT COMPLETED|Overall Study||0
11261640|NCT02256345|12456972|FG001|NOT COMPLETED|Overall Study||0
11261641|NCT02256358|12456980|FG000|STARTED|Overall Study||34
11261642|NCT02256358|12456981|FG001|STARTED|Overall Study||34
11261643|NCT02256358|12456980|FG000|COMPLETED|Overall Study||34
11261644|NCT02256358|12456981|FG001|COMPLETED|Overall Study||33
11261645|NCT02256358|12456980|FG000|NOT COMPLETED|Overall Study||0
11261646|NCT02256358|12456981|FG001|NOT COMPLETED|Overall Study||1
11261647|NCT02256384|12456987|FG000|STARTED|Overall Study||76
11261648|NCT02256384|12456987|FG000|COMPLETED|Overall Study||62
11261649|NCT02256384|12456987|FG000|NOT COMPLETED|Overall Study||14
11261650|NCT02256436|12456997|FG000|STARTED|Overall Study||272
11261651|NCT02256436|12456998|FG001|STARTED|Overall Study||270
11261652|NCT02256436|12456997|FG000|Treated|Overall Study||255
11261653|NCT02256436|12456998|FG001|Treated|Overall Study||266
11261654|NCT02256436|12456997|FG000|Switched Over to Pembrolizumab|Overall Study||13
11261655|NCT02256436|12456998|FG001|Switched Over to Pembrolizumab|Overall Study||0
11261656|NCT02256436|12456997|FG000|COMPLETED|Overall Study||0
11261657|NCT02256436|12456998|FG001|COMPLETED|Overall Study||0
11261658|NCT02256436|12456997|FG000|NOT COMPLETED|Overall Study||272
11261659|NCT02256436|12456998|FG001|NOT COMPLETED|Overall Study||270
11261660|NCT02256488|12457009|FG000|STARTED|Overall Study||387
11261661|NCT02256488|12457010|FG001|STARTED|Overall Study||392
11261662|NCT02256488|12457011|FG002|STARTED|Overall Study||392
11261663|NCT02256488|12457012|FG003|STARTED|Overall Study||390
11261664|NCT02256488|12457009|FG000|COMPLETED|Overall Study||379
11261665|NCT02256488|12457010|FG001|COMPLETED|Overall Study||386
11261666|NCT02256488|12457011|FG002|COMPLETED|Overall Study||382
11261667|NCT02256488|12457012|FG003|COMPLETED|Overall Study||384
11261668|NCT02256488|12457009|FG000|NOT COMPLETED|Overall Study||8
11261669|NCT02256488|12457010|FG001|NOT COMPLETED|Overall Study||6
11261670|NCT02256488|12457011|FG002|NOT COMPLETED|Overall Study||10
11261671|NCT02256488|12457012|FG003|NOT COMPLETED|Overall Study||6
11261672|NCT02256540|12457023|FG000|STARTED|Overall Study||6
11261673|NCT02256540|12457024|FG001|STARTED|Overall Study||6
11261674|NCT02256540|12457025|FG002|STARTED|Overall Study||6
11261675|NCT02256540|12457023|FG000|COMPLETED|Overall Study||6
11261676|NCT02256540|12457024|FG001|COMPLETED|Overall Study||5
11261677|NCT02256540|12457025|FG002|COMPLETED|Overall Study||4
11261678|NCT02256540|12457023|FG000|NOT COMPLETED|Overall Study||0
11261679|NCT02256540|12457024|FG001|NOT COMPLETED|Overall Study||1
11261680|NCT02256540|12457025|FG002|NOT COMPLETED|Overall Study||2
11261681|NCT02256553|12457033|FG000|STARTED|Period I||102
11261682|NCT02256553|12457033|FG000|COMPLETED|Period I||96
11261683|NCT02256553|12457033|FG000|NOT COMPLETED|Period I||6
11261684|NCT02256553|12457033|FG000|STARTED|Period II||96
11261685|NCT02256553|12457033|FG000|COMPLETED|Period II||94
11261686|NCT02256553|12457033|FG000|NOT COMPLETED|Period II||2
11261687|NCT02256553|12457033|FG000|STARTED|Period III||94
11261688|NCT02256553|12457033|FG000|COMPLETED|Period III||91
11261689|NCT02256553|12457033|FG000|NOT COMPLETED|Period III||3
11261690|NCT02256839|12457041|FG000|STARTED|Overall Study||53
11261691|NCT02256839|12457042|FG001|STARTED|Overall Study||215
11261692|NCT02256839|12457041|FG000|COMPLETED|Overall Study||51
11261693|NCT02256839|12457042|FG001|COMPLETED|Overall Study||212
11261694|NCT02256839|12457041|FG000|NOT COMPLETED|Overall Study||2
11261695|NCT02256839|12457042|FG001|NOT COMPLETED|Overall Study||3
11261696|NCT02256891|12457050|FG000|STARTED|Overall Study||55
11261697|NCT02256891|12457051|FG001|STARTED|Overall Study||42
11261698|NCT02256891|12457050|FG000|COMPLETED|Overall Study||43
11261699|NCT02256891|12457051|FG001|COMPLETED|Overall Study||29
11261700|NCT02256891|12457050|FG000|NOT COMPLETED|Overall Study||12
11261701|NCT02256891|12457051|FG001|NOT COMPLETED|Overall Study||13
11261702|NCT02256917|12457059|FG000|STARTED|Pharmacokinetic (PK) Evaluation Phase||58
11261703|NCT02256917|12457059|FG000|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58
11261704|NCT02256917|12457059|FG000|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0
11261705|NCT02256917|12457059|FG000|STARTED|Prophylactic Treatment Phase I||57
11261706|NCT02256917|12457059|FG000|COMPLETED|Prophylactic Treatment Phase I||56
11261707|NCT02256917|12457059|FG000|NOT COMPLETED|Prophylactic Treatment Phase I||1
11261708|NCT02256917|12457059|FG000|STARTED|Prophylactic Treatment Phase II||56
11261709|NCT02256917|12457059|FG000|COMPLETED|Prophylactic Treatment Phase II||52
11261710|NCT02256917|12457059|FG000|NOT COMPLETED|Prophylactic Treatment Phase II||4
11261711|NCT02256969|12457073|FG000|STARTED|Overall Study||15
11261712|NCT02256969|12457074|FG001|STARTED|Overall Study||15
11261713|NCT02256969|12457075|FG002|STARTED|Overall Study||15
11261714|NCT02256969|12457073|FG000|COMPLETED|Overall Study||13
11261715|NCT02256969|12457074|FG001|COMPLETED|Overall Study||14
11261716|NCT02256969|12457075|FG002|COMPLETED|Overall Study||14
11261717|NCT02256969|12457073|FG000|NOT COMPLETED|Overall Study||2
11261718|NCT02256969|12457074|FG001|NOT COMPLETED|Overall Study||1
11261719|NCT02256969|12457075|FG002|NOT COMPLETED|Overall Study||1
11261720|NCT02256982|12457085|FG000|STARTED|Overall Study||1
11261721|NCT02256982|12457086|FG001|STARTED|Overall Study||2
11261722|NCT02256982|12457085|FG000|COMPLETED|Overall Study||1
11261723|NCT02256982|12457086|FG001|COMPLETED|Overall Study||1
11261724|NCT02256982|12457085|FG000|NOT COMPLETED|Overall Study||0
11261725|NCT02256982|12457086|FG001|NOT COMPLETED|Overall Study||1
11261726|NCT02257099|12457092|FG000|STARTED|Overall Study||20
11261727|NCT02257099|12457092|FG000|COMPLETED|Overall Study||20
11261728|NCT02257099|12457092|FG000|NOT COMPLETED|Overall Study||0
11261729|NCT02257177|12457109|FG000|STARTED|Overall Study||4
11261730|NCT02257177|12457110|FG001|STARTED|Overall Study||4
11261731|NCT02257177|12457111|FG002|STARTED|Overall Study||4
11261732|NCT02257177|12457112|FG003|STARTED|Overall Study||4
11261733|NCT02257177|12457113|FG004|STARTED|Overall Study||4
11261734|NCT02257177|12457114|FG005|STARTED|Overall Study||4
11261735|NCT02257177|12457115|FG006|STARTED|Overall Study||12
11261736|NCT02257177|12457116|FG007|STARTED|Overall Study||5
11261737|NCT02257177|12457117|FG008|STARTED|Overall Study||5
11261738|NCT02257177|12457118|FG009|STARTED|Overall Study||5
11261739|NCT02257177|12457119|FG010|STARTED|Overall Study||9
11261740|NCT02257177|12457109|FG000|COMPLETED|Overall Study||4
11261741|NCT02257177|12457110|FG001|COMPLETED|Overall Study||4
11261742|NCT02257177|12457111|FG002|COMPLETED|Overall Study||4
11261743|NCT02257177|12457112|FG003|COMPLETED|Overall Study||4
11261744|NCT02257177|12457113|FG004|COMPLETED|Overall Study||4
11261745|NCT02257177|12457114|FG005|COMPLETED|Overall Study||4
11261746|NCT02257177|12457115|FG006|COMPLETED|Overall Study||12
11261747|NCT02257177|12457116|FG007|COMPLETED|Overall Study||5
11261748|NCT02257177|12457117|FG008|COMPLETED|Overall Study||5
11261749|NCT02257177|12457118|FG009|COMPLETED|Overall Study||4
11261750|NCT02257177|12457119|FG010|COMPLETED|Overall Study||9
11261751|NCT02257177|12457109|FG000|NOT COMPLETED|Overall Study||0
11261752|NCT02257177|12457110|FG001|NOT COMPLETED|Overall Study||0
11261753|NCT02257177|12457111|FG002|NOT COMPLETED|Overall Study||0
11261754|NCT02257177|12457112|FG003|NOT COMPLETED|Overall Study||0
11261755|NCT02257177|12457113|FG004|NOT COMPLETED|Overall Study||0
11261756|NCT02257177|12457114|FG005|NOT COMPLETED|Overall Study||0
11261757|NCT02257177|12457115|FG006|NOT COMPLETED|Overall Study||0
11261758|NCT02257177|12457116|FG007|NOT COMPLETED|Overall Study||0
11261759|NCT02257177|12457117|FG008|NOT COMPLETED|Overall Study||0
11261760|NCT02257177|12457118|FG009|NOT COMPLETED|Overall Study||1
11261761|NCT02257177|12457119|FG010|NOT COMPLETED|Overall Study||0
11261762|NCT02257372|12457145|FG000|STARTED|Overall Study||117
11261763|NCT02257372|12457146|FG001|STARTED|Overall Study||119
11261764|NCT02257372|12457145|FG000|COMPLETED|Overall Study||110
11261765|NCT02257372|12457146|FG001|COMPLETED|Overall Study||109
11261766|NCT02257372|12457145|FG000|NOT COMPLETED|Overall Study||7
11261767|NCT02257372|12457146|FG001|NOT COMPLETED|Overall Study||10
11339979|NCT02918266|12537327|FG001|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339980|NCT02918266|12537328|FG002|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339981|NCT02918266|12537329|FG003|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339982|NCT02918266|12537330|FG004|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339983|NCT02918266|12537331|FG005|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339984|NCT02918266|12537332|FG006|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339985|NCT02918266|12537333|FG007|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339986|NCT02918266|12537334|FG008|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339987|NCT02918266|12537335|FG009|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339988|NCT02918266|12537336|FG010|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
11339989|NCT02918266|12537326|FG000|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
11339990|NCT02918266|12537327|FG001|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
11339991|NCT02918266|12537328|FG002|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
11339992|NCT02918266|12537329|FG003|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
11339993|NCT02918266|12537330|FG004|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
11339994|NCT02918266|12537331|FG005|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
11339995|NCT02918266|12537332|FG006|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
11339996|NCT02918266|12537333|FG007|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
11339997|NCT02918266|12537334|FG008|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
11339998|NCT02918266|12537335|FG009|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
11339999|NCT02918266|12537336|FG010|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
11340000|NCT02918266|12537326|FG000|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340001|NCT02918266|12537327|FG001|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340002|NCT02918266|12537328|FG002|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340003|NCT02918266|12537329|FG003|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340004|NCT02918266|12537330|FG004|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340005|NCT02918266|12537331|FG005|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340006|NCT02918266|12537332|FG006|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340007|NCT02918266|12537333|FG007|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340008|NCT02918266|12537334|FG008|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340009|NCT02918266|12537335|FG009|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340010|NCT02918266|12537336|FG010|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340011|NCT02918266|12537326|FG000|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340012|NCT02918266|12537327|FG001|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340013|NCT02918266|12537328|FG002|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340014|NCT02918266|12537329|FG003|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340015|NCT02918266|12537330|FG004|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340016|NCT02918266|12537331|FG005|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340017|NCT02918266|12537332|FG006|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340018|NCT02918266|12537333|FG007|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340019|NCT02918266|12537334|FG008|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340020|NCT02918266|12537335|FG009|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340021|NCT02918266|12537336|FG010|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
11340022|NCT02918266|12537326|FG000|STARTED|Part 2: Intervention Period 5 (2 Days)||0
11340023|NCT02918266|12537327|FG001|STARTED|Part 2: Intervention Period 5 (2 Days)||0
11340024|NCT02918266|12537328|FG002|STARTED|Part 2: Intervention Period 5 (2 Days)||0
11340025|NCT02918266|12537329|FG003|STARTED|Part 2: Intervention Period 5 (2 Days)||0
11340026|NCT02918266|12537330|FG004|STARTED|Part 2: Intervention Period 5 (2 Days)||0
11340027|NCT02918266|12537331|FG005|STARTED|Part 2: Intervention Period 5 (2 Days)||0
11340028|NCT02918266|12537332|FG006|STARTED|Part 2: Intervention Period 5 (2 Days)||0
11340029|NCT02918266|12537333|FG007|STARTED|Part 2: Intervention Period 5 (2 Days)||0
11340030|NCT02918266|12537334|FG008|STARTED|Part 2: Intervention Period 5 (2 Days)||0
11340031|NCT02918266|12537335|FG009|STARTED|Part 2: Intervention Period 5 (2 Days)||0
11340032|NCT02918266|12537336|FG010|STARTED|Part 2: Intervention Period 5 (2 Days)||0
11340033|NCT02918266|12537326|FG000|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340034|NCT02918266|12537327|FG001|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340035|NCT02918266|12537328|FG002|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11261768|NCT02257385|12457154|FG000|STARTED|Overall Study||482
11261769|NCT02257385|12457155|FG001|STARTED|Overall Study||479
11261770|NCT02257385|12457154|FG000|COMPLETED|Overall Study||460
11261771|NCT02257385|12457155|FG001|COMPLETED|Overall Study||457
11261772|NCT02257385|12457154|FG000|NOT COMPLETED|Overall Study||22
11261773|NCT02257385|12457155|FG001|NOT COMPLETED|Overall Study||22
11261774|NCT02257541|12457166|FG000|STARTED|Overall Study||3
11261775|NCT02257541|12457167|FG001|STARTED|Overall Study||8
11261776|NCT02257541|12457168|FG002|STARTED|Overall Study||1
11261777|NCT02257541|12457169|FG003|STARTED|Overall Study||3
11261778|NCT02257541|12457170|FG004|STARTED|Overall Study||1
11261779|NCT02257541|12457166|FG000|COMPLETED|Overall Study||3
11261780|NCT02257541|12457167|FG001|COMPLETED|Overall Study||8
11261781|NCT02257541|12457168|FG002|COMPLETED|Overall Study||1
11261782|NCT02257541|12457169|FG003|COMPLETED|Overall Study||3
11261783|NCT02257541|12457170|FG004|COMPLETED|Overall Study||1
11261784|NCT02257541|12457166|FG000|NOT COMPLETED|Overall Study||0
11261785|NCT02257541|12457167|FG001|NOT COMPLETED|Overall Study||0
11261786|NCT02257541|12457168|FG002|NOT COMPLETED|Overall Study||0
11261787|NCT02257541|12457169|FG003|NOT COMPLETED|Overall Study||0
11261788|NCT02257541|12457170|FG004|NOT COMPLETED|Overall Study||0
11261789|NCT02257632|12457183|FG000|STARTED|Overall Study||19
11261790|NCT02257632|12457184|FG001|STARTED|Overall Study||22
11261791|NCT02257632|12457183|FG000|Full Analysis Set (FAS)|Overall Study||19
11261792|NCT02257632|12457184|FG001|Full Analysis Set (FAS)|Overall Study||21
11261793|NCT02257632|12457183|FG000|Safety Set (SAF)|Overall Study||19
11261794|NCT02257632|12457184|FG001|Safety Set (SAF)|Overall Study||21
11261795|NCT02257632|12457183|FG000|Per-Protocol Set (PPS)|Overall Study||17
11261796|NCT02257632|12457184|FG001|Per-Protocol Set (PPS)|Overall Study||20
11261797|NCT02257632|12457183|FG000|COMPLETED|Overall Study||18
11261798|NCT02257632|12457184|FG001|COMPLETED|Overall Study||19
11261799|NCT02257632|12457183|FG000|NOT COMPLETED|Overall Study||1
11261800|NCT02257632|12457184|FG001|NOT COMPLETED|Overall Study||3
11261801|NCT02257684|12457192|FG000|STARTED|Overall Study||4
11261802|NCT02257684|12457192|FG000|COMPLETED|Overall Study||0
11261803|NCT02257684|12457192|FG000|NOT COMPLETED|Overall Study||4
11261804|NCT02257957|12457198|FG000|STARTED|Overall Study||15
11261805|NCT02257957|12457199|FG001|STARTED|Overall Study||15
11261806|NCT02257957|12457198|FG000|COMPLETED|Overall Study||15
11261807|NCT02257957|12457199|FG001|COMPLETED|Overall Study||15
11261808|NCT02257957|12457198|FG000|NOT COMPLETED|Overall Study||0
11261809|NCT02257957|12457199|FG001|NOT COMPLETED|Overall Study||0
11261810|NCT02257970|12457209|FG000|STARTED|Part 1||50
11261811|NCT02257970|12457210|FG001|STARTED|Part 1||0
11261812|NCT02257970|12457211|FG002|STARTED|Part 1||0
11261813|NCT02257970|12457212|FG003|STARTED|Part 1||0
11261814|NCT02257970|12457209|FG000|COMPLETED|Part 1||50
11261815|NCT02257970|12457210|FG001|COMPLETED|Part 1||0
11261816|NCT02257970|12457211|FG002|COMPLETED|Part 1||0
11261817|NCT02257970|12457212|FG003|COMPLETED|Part 1||0
11261818|NCT02257970|12457209|FG000|NOT COMPLETED|Part 1||0
11261819|NCT02257970|12457210|FG001|NOT COMPLETED|Part 1||0
11261820|NCT02257970|12457211|FG002|NOT COMPLETED|Part 1||0
11261821|NCT02257970|12457212|FG003|NOT COMPLETED|Part 1||0
11261822|NCT02257970|12457209|FG000|STARTED|Part 2||0
11261823|NCT02257970|12457210|FG001|STARTED|Part 2||23
11261824|NCT02257970|12457211|FG002|STARTED|Part 2||0
11261825|NCT02257970|12457212|FG003|STARTED|Part 2||0
11261826|NCT02257970|12457209|FG000|COMPLETED|Part 2||0
11261827|NCT02257970|12457210|FG001|COMPLETED|Part 2||16
11261828|NCT02257970|12457211|FG002|COMPLETED|Part 2||0
11261829|NCT02257970|12457212|FG003|COMPLETED|Part 2||0
11261830|NCT02257970|12457209|FG000|NOT COMPLETED|Part 2||0
11261831|NCT02257970|12457210|FG001|NOT COMPLETED|Part 2||7
11261832|NCT02257970|12457211|FG002|NOT COMPLETED|Part 2||0
11261833|NCT02257970|12457212|FG003|NOT COMPLETED|Part 2||0
11261834|NCT02257970|12457209|FG000|STARTED|Part 3||0
11261835|NCT02257970|12457210|FG001|STARTED|Part 3||0
11261836|NCT02257970|12457211|FG002|STARTED|Part 3||23
11261837|NCT02257970|12457212|FG003|STARTED|Part 3||21
11261838|NCT02257970|12457209|FG000|COMPLETED|Part 3||0
11261839|NCT02257970|12457210|FG001|COMPLETED|Part 3||0
11261840|NCT02257970|12457211|FG002|COMPLETED|Part 3||16
11261841|NCT02257970|12457212|FG003|COMPLETED|Part 3||14
11261842|NCT02257970|12457209|FG000|NOT COMPLETED|Part 3||0
11261843|NCT02257970|12457210|FG001|NOT COMPLETED|Part 3||0
11261844|NCT02257970|12457211|FG002|NOT COMPLETED|Part 3||7
11261845|NCT02257970|12457212|FG003|NOT COMPLETED|Part 3||7
11261846|NCT02258074|12457235|FG000|STARTED|Overall Study||53
11261847|NCT02258074|12457236|FG001|STARTED|Overall Study||50
11261848|NCT02258074|12457237|FG002|STARTED|Overall Study||51
11261849|NCT02258074|12457238|FG003|STARTED|Overall Study||51
11261850|NCT02258074|12457235|FG000|COMPLETED|Overall Study||52
11261851|NCT02258074|12457236|FG001|COMPLETED|Overall Study||50
11261852|NCT02258074|12457237|FG002|COMPLETED|Overall Study||51
11261853|NCT02258074|12457238|FG003|COMPLETED|Overall Study||51
11261854|NCT02258074|12457235|FG000|NOT COMPLETED|Overall Study||1
11261855|NCT02258074|12457236|FG001|NOT COMPLETED|Overall Study||0
11261856|NCT02258074|12457237|FG002|NOT COMPLETED|Overall Study||0
11261857|NCT02258074|12457238|FG003|NOT COMPLETED|Overall Study||0
11261858|NCT02258139|12457248|FG000|STARTED|Overall Study||38
11261859|NCT02258139|12457248|FG000|COMPLETED|Overall Study||30
11261860|NCT02258139|12457248|FG000|NOT COMPLETED|Overall Study||8
11261861|NCT02258152|12457256|FG000|STARTED|Overall Study||44
11261862|NCT02258152|12457257|FG001|STARTED|Overall Study||38
11261863|NCT02258152|12457256|FG000|COMPLETED|Overall Study||38
11261864|NCT02258152|12457257|FG001|COMPLETED|Overall Study||34
11261865|NCT02258152|12457256|FG000|NOT COMPLETED|Overall Study||6
11261866|NCT02258152|12457257|FG001|NOT COMPLETED|Overall Study||4
11261867|NCT02258217|12457263|FG000|STARTED|Overall Study||30
11261868|NCT02258217|12457263|FG000|COMPLETED|Overall Study||30
11261869|NCT02258217|12457263|FG000|NOT COMPLETED|Overall Study||0
11261870|NCT02258256|12457267|FG000|STARTED|Overall Study||11
11261871|NCT02258256|12457267|FG000|COMPLETED|Overall Study||11
11261872|NCT02258256|12457267|FG000|NOT COMPLETED|Overall Study||0
11261873|NCT02258334|12457275|FG000|STARTED|Overall Study||50
11261874|NCT02258334|12457276|FG001|STARTED|Overall Study||54
11261875|NCT02258334|12457277|FG002|STARTED|Overall Study||52
11261876|NCT02258334|12457278|FG003|STARTED|Overall Study||52
11261877|NCT02258334|12457275|FG000|COMPLETED|Overall Study||49
11261878|NCT02258334|12457276|FG001|COMPLETED|Overall Study||54
11261879|NCT02258334|12457277|FG002|COMPLETED|Overall Study||52
11261880|NCT02258334|12457278|FG003|COMPLETED|Overall Study||52
11261881|NCT02258334|12457275|FG000|NOT COMPLETED|Overall Study||1
11261882|NCT02258334|12457276|FG001|NOT COMPLETED|Overall Study||0
11261883|NCT02258334|12457277|FG002|NOT COMPLETED|Overall Study||0
11261884|NCT02258334|12457278|FG003|NOT COMPLETED|Overall Study||0
11261885|NCT02258373|12457292|FG000|STARTED|Overall Study||149
11261886|NCT02258373|12457293|FG001|STARTED|Overall Study||77
11261887|NCT02258373|12457292|FG000|COMPLETED|Overall Study||142
11261888|NCT02258373|12457293|FG001|COMPLETED|Overall Study||75
11261889|NCT02258373|12457292|FG000|NOT COMPLETED|Overall Study||7
11261890|NCT02258373|12457293|FG001|NOT COMPLETED|Overall Study||2
11261891|NCT02258412|12457302|FG000|STARTED|Overall Study||26
11261892|NCT02258412|12457303|FG001|STARTED|Overall Study||25
11261893|NCT02258412|12457304|FG002|STARTED|Overall Study||61
11261894|NCT02258412|12457302|FG000|COMPLETED|Overall Study||26
11261895|NCT02258412|12457303|FG001|COMPLETED|Overall Study||25
11261896|NCT02258412|12457304|FG002|COMPLETED|Overall Study||61
11261897|NCT02258412|12457302|FG000|NOT COMPLETED|Overall Study||0
11261898|NCT02258412|12457303|FG001|NOT COMPLETED|Overall Study||0
11261899|NCT02258412|12457304|FG002|NOT COMPLETED|Overall Study||0
11261900|NCT02258464|12457313|FG000|STARTED|Overall Study||49
11261901|NCT02258464|12457314|FG001|STARTED|Overall Study||50
11261902|NCT02258464|12457313|FG000|COMPLETED|Overall Study||32
11261903|NCT02258464|12457314|FG001|COMPLETED|Overall Study||25
11261904|NCT02258464|12457313|FG000|NOT COMPLETED|Overall Study||17
11261905|NCT02258464|12457314|FG001|NOT COMPLETED|Overall Study||25
11261906|NCT02258477|12457320|FG000|STARTED|First Intervention (1 Week)||10
11261907|NCT02258477|12457321|FG001|STARTED|First Intervention (1 Week)||9
11261908|NCT02258477|12457322|FG002|STARTED|First Intervention (1 Week)||9
11261909|NCT02258477|12457323|FG003|STARTED|First Intervention (1 Week)||9
11261910|NCT02258477|12457320|FG000|COMPLETED|First Intervention (1 Week)||9
11261911|NCT02258477|12457321|FG001|COMPLETED|First Intervention (1 Week)||8
11261912|NCT02258477|12457322|FG002|COMPLETED|First Intervention (1 Week)||9
11261913|NCT02258477|12457323|FG003|COMPLETED|First Intervention (1 Week)||9
11261914|NCT02258477|12457320|FG000|NOT COMPLETED|First Intervention (1 Week)||1
11261915|NCT02258477|12457321|FG001|NOT COMPLETED|First Intervention (1 Week)||1
11261916|NCT02258477|12457322|FG002|NOT COMPLETED|First Intervention (1 Week)||0
11261917|NCT02258477|12457323|FG003|NOT COMPLETED|First Intervention (1 Week)||0
11261918|NCT02258477|12457320|FG000|STARTED|Second Intervention (1 Week)||9
11261919|NCT02258477|12457321|FG001|STARTED|Second Intervention (1 Week)||8
11261920|NCT02258477|12457322|FG002|STARTED|Second Intervention (1 Week)||9
11261921|NCT02258477|12457323|FG003|STARTED|Second Intervention (1 Week)||9
11261922|NCT02258477|12457320|FG000|COMPLETED|Second Intervention (1 Week)||9
11261923|NCT02258477|12457321|FG001|COMPLETED|Second Intervention (1 Week)||8
11261924|NCT02258477|12457322|FG002|COMPLETED|Second Intervention (1 Week)||8
11261925|NCT02258477|12457323|FG003|COMPLETED|Second Intervention (1 Week)||8
11261926|NCT02258477|12457320|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
11261927|NCT02258477|12457321|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
11261928|NCT02258477|12457322|FG002|NOT COMPLETED|Second Intervention (1 Week)||1
11261929|NCT02258477|12457323|FG003|NOT COMPLETED|Second Intervention (1 Week)||1
11261930|NCT02258477|12457320|FG000|STARTED|Third Intervention (1 Week)||9
11261931|NCT02258477|12457321|FG001|STARTED|Third Intervention (1 Week)||8
11261932|NCT02258477|12457322|FG002|STARTED|Third Intervention (1 Week)||8
11261933|NCT02258477|12457323|FG003|STARTED|Third Intervention (1 Week)||8
11261934|NCT02258477|12457320|FG000|COMPLETED|Third Intervention (1 Week)||9
11261935|NCT02258477|12457321|FG001|COMPLETED|Third Intervention (1 Week)||8
11261936|NCT02258477|12457322|FG002|COMPLETED|Third Intervention (1 Week)||8
11261937|NCT02258477|12457323|FG003|COMPLETED|Third Intervention (1 Week)||8
11261938|NCT02258477|12457320|FG000|NOT COMPLETED|Third Intervention (1 Week)||0
11261939|NCT02258477|12457321|FG001|NOT COMPLETED|Third Intervention (1 Week)||0
11261940|NCT02258477|12457322|FG002|NOT COMPLETED|Third Intervention (1 Week)||0
11261941|NCT02258477|12457323|FG003|NOT COMPLETED|Third Intervention (1 Week)||0
11261942|NCT02258477|12457320|FG000|STARTED|Fourth Intervention (1 Week)||9
11261943|NCT02258477|12457321|FG001|STARTED|Fourth Intervention (1 Week)||8
11261944|NCT02258477|12457322|FG002|STARTED|Fourth Intervention (1 Week)||8
11261945|NCT02258477|12457323|FG003|STARTED|Fourth Intervention (1 Week)||8
11261946|NCT02258477|12457320|FG000|COMPLETED|Fourth Intervention (1 Week)||9
11261947|NCT02258477|12457321|FG001|COMPLETED|Fourth Intervention (1 Week)||8
11261948|NCT02258477|12457322|FG002|COMPLETED|Fourth Intervention (1 Week)||8
11261949|NCT02258477|12457323|FG003|COMPLETED|Fourth Intervention (1 Week)||8
11261950|NCT02258477|12457320|FG000|NOT COMPLETED|Fourth Intervention (1 Week)||0
11261951|NCT02258477|12457321|FG001|NOT COMPLETED|Fourth Intervention (1 Week)||0
11261952|NCT02258477|12457322|FG002|NOT COMPLETED|Fourth Intervention (1 Week)||0
11261953|NCT02258477|12457323|FG003|NOT COMPLETED|Fourth Intervention (1 Week)||0
11261954|NCT02258529|12457332|FG000|STARTED|Overall Study||10
11261955|NCT02258529|12457332|FG000|COMPLETED|Overall Study||0
11261956|NCT02258529|12457332|FG000|NOT COMPLETED|Overall Study||10
11261957|NCT02259010|12457336|FG000|STARTED|Overall Study||24
11261958|NCT02259010|12457336|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19
11261959|NCT02259010|12457336|FG000|NOT COMPLETED|Overall Study||5
11261960|NCT02259088|12457344|FG000|STARTED|Overall Study||307
11261961|NCT02259088|12457345|FG001|STARTED|Overall Study||77
11261962|NCT02259088|12457344|FG000|Full Analysis Set|Overall Study||307
11261963|NCT02259088|12457345|FG001|Full Analysis Set|Overall Study||77
11261964|NCT02259088|12457344|FG000|Treated (Safety Analysis Set)|Overall Study||307
11261965|NCT02259088|12457345|FG001|Treated (Safety Analysis Set)|Overall Study||75
11261966|NCT02259088|12457344|FG000|COMPLETED|Overall Study||279
11261967|NCT02259088|12457345|FG001|COMPLETED|Overall Study||63
11261968|NCT02259088|12457344|FG000|NOT COMPLETED|Overall Study||28
11261969|NCT02259088|12457345|FG001|NOT COMPLETED|Overall Study||14
11261970|NCT02259114|12457356|FG000|STARTED|Overall Study||21
11261971|NCT02259114|12457357|FG001|STARTED|Overall Study||4
11261972|NCT02259114|12457358|FG002|STARTED|Overall Study||13
11261973|NCT02259114|12457359|FG003|STARTED|Overall Study||3
11261974|NCT02259114|12457360|FG004|STARTED|Overall Study||6
11261975|NCT02259114|12457356|FG000|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
11261976|NCT02259114|12457357|FG001|Treated|Overall Study||4
11261977|NCT02259114|12457358|FG002|Treated|Overall Study||13
11261978|NCT02259114|12457359|FG003|Treated|Overall Study||3
11261979|NCT02259114|12457360|FG004|Treated|Overall Study||6
11261980|NCT02259114|12457356|FG000|COMPLETED|Overall Study||0
11261981|NCT02259114|12457357|FG001|COMPLETED|Overall Study||0
11261982|NCT02259114|12457358|FG002|COMPLETED|Overall Study||0
11261983|NCT02259114|12457359|FG003|COMPLETED|Overall Study||0
11261984|NCT02259114|12457360|FG004|COMPLETED|Overall Study||0
11261985|NCT02259114|12457356|FG000|NOT COMPLETED|Overall Study||21
11261986|NCT02259114|12457357|FG001|NOT COMPLETED|Overall Study||4
11261987|NCT02259114|12457358|FG002|NOT COMPLETED|Overall Study||13
11261988|NCT02259114|12457359|FG003|NOT COMPLETED|Overall Study||3
11261989|NCT02259114|12457360|FG004|NOT COMPLETED|Overall Study||6
11261990|NCT02259231|12457379|FG000|STARTED|Overall Study||6
11261991|NCT02259231|12457380|FG001|STARTED|Overall Study||6
11261992|NCT02259231|12457381|FG002|STARTED|Overall Study||6
11261993|NCT02259231|12457382|FG003|STARTED|Overall Study||6
11261994|NCT02259231|12457383|FG004|STARTED|Overall Study||6
11261995|NCT02259231|12457384|FG005|STARTED|Overall Study||6
11261996|NCT02259231|12457385|FG006|STARTED|Overall Study||5
11261997|NCT02259231|12457379|FG000|COMPLETED|Overall Study||0
11261998|NCT02259231|12457380|FG001|COMPLETED|Overall Study||0
11261999|NCT02259231|12457381|FG002|COMPLETED|Overall Study||0
11262000|NCT02259231|12457382|FG003|COMPLETED|Overall Study||0
11262001|NCT02259231|12457383|FG004|COMPLETED|Overall Study||0
11262002|NCT02259231|12457384|FG005|COMPLETED|Overall Study||0
11262003|NCT02259231|12457385|FG006|COMPLETED|Overall Study||0
11262004|NCT02259231|12457379|FG000|NOT COMPLETED|Overall Study||6
11262005|NCT02259231|12457380|FG001|NOT COMPLETED|Overall Study||6
11262006|NCT02259231|12457381|FG002|NOT COMPLETED|Overall Study||6
11262007|NCT02259231|12457382|FG003|NOT COMPLETED|Overall Study||6
11262008|NCT02259231|12457383|FG004|NOT COMPLETED|Overall Study||6
11262009|NCT02259231|12457384|FG005|NOT COMPLETED|Overall Study||6
11262010|NCT02259231|12457385|FG006|NOT COMPLETED|Overall Study||5
11262011|NCT02259348|12457401|FG000|STARTED|Overall Study||12
11262012|NCT02259348|12457401|FG000|One Year Post-transplant|Overall Study||2
11262013|NCT02259348|12457401|FG000|COMPLETED|Overall Study||2
11262014|NCT02259348|12457401|FG000|NOT COMPLETED|Overall Study||10
11262015|NCT02259400|12457407|FG000|STARTED|Overall Study||62
11262016|NCT02259400|12457408|FG001|STARTED|Overall Study||62
11262017|NCT02259400|12457407|FG000|COMPLETED|Overall Study||62
11262018|NCT02259400|12457408|FG001|COMPLETED|Overall Study||60
11262019|NCT02259400|12457407|FG000|NOT COMPLETED|Overall Study||0
11262020|NCT02259400|12457408|FG001|NOT COMPLETED|Overall Study||2
11262021|NCT02259582|12457417|FG000|STARTED|Overall Study||25
11262022|NCT02259582|12457418|FG001|STARTED|Overall Study||28
11262023|NCT02259582|12457419|FG002|STARTED|Overall Study||29
11262024|NCT02259582|12457417|FG000|COMPLETED|Overall Study||9
11262025|NCT02259582|12457418|FG001|COMPLETED|Overall Study||11
11262026|NCT02259582|12457419|FG002|COMPLETED|Overall Study||8
11262027|NCT02259582|12457417|FG000|NOT COMPLETED|Overall Study||16
11262028|NCT02259582|12457418|FG001|NOT COMPLETED|Overall Study||17
11262029|NCT02259582|12457419|FG002|NOT COMPLETED|Overall Study||21
11262030|NCT02259608|12457427|FG000|STARTED|Overall Study||15
11262031|NCT02259608|12457427|FG000|COMPLETED|Overall Study||15
11262032|NCT02259608|12457427|FG000|NOT COMPLETED|Overall Study||0
11262033|NCT02259699|12457433|FG000|STARTED|Overall Study||64
11262034|NCT02259699|12457434|FG001|STARTED|Overall Study||60
11262035|NCT02259699|12457433|FG000|COMPLETED|Overall Study||37
11262036|NCT02259699|12457434|FG001|COMPLETED|Overall Study||40
11262037|NCT02259699|12457433|FG000|NOT COMPLETED|Overall Study||27
11262038|NCT02259699|12457434|FG001|NOT COMPLETED|Overall Study||20
11262039|NCT02260154|12457440|FG000|STARTED|Overall Study||220
11262040|NCT02260154|12457440|FG000|COMPLETED|Overall Study||218
11262041|NCT02260154|12457440|FG000|NOT COMPLETED|Overall Study||2
11262042|NCT02260180|12457448|FG000|STARTED|Overall Study||39
11262043|NCT02260180|12457449|FG001|STARTED|Overall Study||39
11262044|NCT02260180|12457450|FG002|STARTED|Overall Study||41
11262045|NCT02260180|12457448|FG000|COMPLETED|Overall Study||37
11262046|NCT02260180|12457449|FG001|COMPLETED|Overall Study||39
11262047|NCT02260180|12457450|FG002|COMPLETED|Overall Study||40
11262048|NCT02260180|12457448|FG000|NOT COMPLETED|Overall Study||2
11262049|NCT02260180|12457449|FG001|NOT COMPLETED|Overall Study||0
11262050|NCT02260180|12457450|FG002|NOT COMPLETED|Overall Study||1
11262051|NCT02260258|12457460|FG000|STARTED|Overall Study||39
11262052|NCT02260258|12457461|FG001|STARTED|Overall Study||44
11262053|NCT02260258|12457460|FG000|COMPLETED|Overall Study||37
11262054|NCT02260258|12457461|FG001|COMPLETED|Overall Study||43
11262055|NCT02260258|12457460|FG000|NOT COMPLETED|Overall Study||2
11262056|NCT02260258|12457461|FG001|NOT COMPLETED|Overall Study||1
11262057|NCT02260388|12457472|FG000|STARTED|Overall Study||134
11262058|NCT02260388|12457473|FG001|STARTED|Overall Study||126
11262059|NCT02260388|12457474|FG002|STARTED|Overall Study||73
11262060|NCT02260388|12457475|FG003|STARTED|Overall Study||69
11262061|NCT02260388|12457472|FG000|COMPLETED|Overall Study||132
11262062|NCT02260388|12457473|FG001|COMPLETED|Overall Study||118
11262063|NCT02260388|12457474|FG002|COMPLETED|Overall Study||70
11262064|NCT02260388|12457475|FG003|COMPLETED|Overall Study||65
11262065|NCT02260388|12457472|FG000|NOT COMPLETED|Overall Study||2
11262066|NCT02260388|12457473|FG001|NOT COMPLETED|Overall Study||8
11262067|NCT02260388|12457474|FG002|NOT COMPLETED|Overall Study||3
11262068|NCT02260388|12457475|FG003|NOT COMPLETED|Overall Study||4
11262069|NCT02260401|12457487|FG000|STARTED|Overall Study||80
11262070|NCT02260401|12457488|FG001|STARTED|Overall Study||85
11262071|NCT02260401|12457487|FG000|COMPLETED|Overall Study||75
11262072|NCT02260401|12457488|FG001|COMPLETED|Overall Study||73
11262073|NCT02260401|12457487|FG000|NOT COMPLETED|Overall Study||5
11262074|NCT02260401|12457488|FG001|NOT COMPLETED|Overall Study||12
11262075|NCT02260440|12457494|FG000|STARTED|Overall Study||31
11262076|NCT02260440|12457494|FG000|COMPLETED|Overall Study||31
11262077|NCT02260440|12457494|FG000|NOT COMPLETED|Overall Study||0
11262078|NCT02260492|12457501|FG000|STARTED|Overall Study||418
11262079|NCT02260492|12457502|FG001|STARTED|Overall Study||419
11262080|NCT02260492|12457503|FG002|STARTED|Overall Study||42
11262081|NCT02260492|12457501|FG000|Completed Day 1|Overall Study||418
11262082|NCT02260492|12457502|FG001|Completed Day 1|Overall Study||419
11262083|NCT02260492|12457503|FG002|Completed Day 1|Overall Study||42
11262084|NCT02260492|12457501|FG000|COMPLETED|Overall Study||395
11262085|NCT02260492|12457502|FG001|COMPLETED|Overall Study||406
11005520|NCT00723190|12183206|FG000|SAFETY POPULATION|Overall Study||301
11005521|NCT00723190|12183206|FG000|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
11005522|NCT00723190|12183206|FG000|NOT COMPLETED|Overall Study||142
11005523|NCT00723203|12183210|FG000|STARTED|Overall Study||16
11005524|NCT00723203|12183210|FG000|COMPLETED|Overall Study||13
11262086|NCT02260492|12457503|FG002|COMPLETED|Overall Study||37
11262087|NCT02260492|12457501|FG000|NOT COMPLETED|Overall Study||23
11262088|NCT02260492|12457502|FG001|NOT COMPLETED|Overall Study||13
11262089|NCT02260492|12457503|FG002|NOT COMPLETED|Overall Study||5
11262090|NCT02260531|12457514|FG000|STARTED|Overall Study||21
11262091|NCT02260531|12457515|FG001|STARTED|Overall Study||7
11262092|NCT02260531|12457516|FG002|STARTED|Overall Study||8
11262093|NCT02260531|12457514|FG000|COMPLETED|Overall Study||21
11262094|NCT02260531|12457515|FG001|COMPLETED|Overall Study||7
11262095|NCT02260531|12457516|FG002|COMPLETED|Overall Study||8
11262096|NCT02260531|12457514|FG000|NOT COMPLETED|Overall Study||0
11262097|NCT02260531|12457515|FG001|NOT COMPLETED|Overall Study||0
11262098|NCT02260531|12457516|FG002|NOT COMPLETED|Overall Study||0
11262099|NCT02260622|12457533|FG000|STARTED|Overall Study||11
11262100|NCT02260622|12457534|FG001|STARTED|Overall Study||9
11262101|NCT02260622|12457533|FG000|COMPLETED|Overall Study||11
11262102|NCT02260622|12457534|FG001|COMPLETED|Overall Study||9
11262103|NCT02260622|12457533|FG000|NOT COMPLETED|Overall Study||0
11262104|NCT02260622|12457534|FG001|NOT COMPLETED|Overall Study||0
11262105|NCT02260635|12457542|FG000|STARTED|Double-Blind Treatment Period||27
11262106|NCT02260635|12457543|FG001|STARTED|Double-Blind Treatment Period||27
11262107|NCT02260635|12457542|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
11262108|NCT02260635|12457543|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
11262109|NCT02260635|12457542|FG000|COMPLETED|Double-Blind Treatment Period||26
11262110|NCT02260635|12457543|FG001|COMPLETED|Double-Blind Treatment Period||25
11262111|NCT02260635|12457542|FG000|NOT COMPLETED|Double-Blind Treatment Period||1
11262112|NCT02260635|12457543|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
11262113|NCT02260635|12457542|FG000|STARTED|Open-Label Extension||26
11262114|NCT02260635|12457543|FG001|STARTED|Open-Label Extension||25
11262115|NCT02260635|12457542|FG000|Received at Least One Dose of Study Drug|Open-Label Extension||26
11262116|NCT02260635|12457543|FG001|Received at Least One Dose of Study Drug|Open-Label Extension||25
11262117|NCT02260635|12457542|FG000|COMPLETED|Open-Label Extension||0
11262118|NCT02260635|12457543|FG001|COMPLETED|Open-Label Extension||0
11262119|NCT02260635|12457542|FG000|NOT COMPLETED|Open-Label Extension||26
11262120|NCT02260635|12457543|FG001|NOT COMPLETED|Open-Label Extension||25
11262121|NCT02260648|12457554|FG000|STARTED|Overall Study||53
11262122|NCT02260648|12457555|FG001|STARTED|Overall Study||46
11262123|NCT02260648|12457556|FG002|STARTED|Overall Study||50
11262124|NCT02260648|12457554|FG000|Received at Least One Dose of Study Drug|Overall Study||53
11262125|NCT02260648|12457555|FG001|Received at Least One Dose of Study Drug|Overall Study||46
11262126|NCT02260648|12457556|FG002|Received at Least One Dose of Study Drug|Overall Study||50
11262127|NCT02260648|12457554|FG000|COMPLETED|Overall Study||35
11262128|NCT02260648|12457555|FG001|COMPLETED|Overall Study||33
11005525|NCT00723203|12183210|FG000|NOT COMPLETED|Overall Study||3
11262129|NCT02260648|12457556|FG002|COMPLETED|Overall Study||42
11262130|NCT02260648|12457554|FG000|NOT COMPLETED|Overall Study||18
11262131|NCT02260648|12457555|FG001|NOT COMPLETED|Overall Study||13
11262132|NCT02260648|12457556|FG002|NOT COMPLETED|Overall Study||8
11262133|NCT02260791|12457566|FG000|STARTED|Overall Study||366
11262134|NCT02260791|12457567|FG001|STARTED|Overall Study||362
11262135|NCT02260791|12457566|FG000|COMPLETED|Overall Study||333
11262136|NCT02260791|12457567|FG001|COMPLETED|Overall Study||328
11262137|NCT02260791|12457566|FG000|NOT COMPLETED|Overall Study||33
11262138|NCT02260791|12457567|FG001|NOT COMPLETED|Overall Study||34
11262139|NCT02260804|12457575|FG000|STARTED|Induction Study Period||130
11262140|NCT02260804|12457576|FG001|STARTED|Induction Study Period||128
11262141|NCT02260804|12457575|FG000|COMPLETED|Induction Study Period||128
11262142|NCT02260804|12457576|FG001|COMPLETED|Induction Study Period||128
11262143|NCT02260804|12457575|FG000|NOT COMPLETED|Induction Study Period||2
11262144|NCT02260804|12457576|FG001|NOT COMPLETED|Induction Study Period||0
11262145|NCT02260804|12457575|FG000|STARTED|1st Year of the Maintenance Period (MP1)|Five subjects completed the induction period but did not initiate this period in the CT-P10 group.|123
11262146|NCT02260804|12457576|FG001|STARTED|1st Year of the Maintenance Period (MP1)|Eight subjects completed the induction period but did not initiate this period in the Rituxan group.|120
11262147|NCT02260804|12457575|FG000|COMPLETED|1st Year of the Maintenance Period (MP1)||111
11262148|NCT02260804|12457576|FG001|COMPLETED|1st Year of the Maintenance Period (MP1)||105
11262149|NCT02260804|12457575|FG000|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||12
11262150|NCT02260804|12457576|FG001|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||15
11262151|NCT02260804|12457575|FG000|STARTED|2nd Year of the Maintenance Period (MP2)|One subject completed the MP1 but did not initiate this period in the CT-P10 group.|110
11262152|NCT02260804|12457576|FG001|STARTED|2nd Year of the Maintenance Period (MP2)|Two subjects completed the MP1 but did not initiate this period in the Rituxan group.|103
11262153|NCT02260804|12457575|FG000|COMPLETED|2nd Year of the Maintenance Period (MP2)||101
11262154|NCT02260804|12457576|FG001|COMPLETED|2nd Year of the Maintenance Period (MP2)||97
11262155|NCT02260804|12457575|FG000|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||9
11262156|NCT02260804|12457576|FG001|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||6
11262157|NCT02260817|12457584|FG000|STARTED|Overall Study||14
11262158|NCT02260817|12457585|FG001|STARTED|Overall Study||95
11262159|NCT02260817|12457584|FG000|COMPLETED|Overall Study||14
11262160|NCT02260817|12457585|FG001|COMPLETED|Overall Study||58
11262161|NCT02260817|12457584|FG000|NOT COMPLETED|Overall Study||0
11262162|NCT02260817|12457585|FG001|NOT COMPLETED|Overall Study||37
11262163|NCT02260882|12457593|FG000|STARTED|Overall Study||161
11262164|NCT02260882|12457594|FG001|STARTED|Overall Study||82
11262165|NCT02260882|12457593|FG000|COMPLETED|Overall Study||161
11262166|NCT02260882|12457594|FG001|COMPLETED|Overall Study||81
11262167|NCT02260882|12457593|FG000|NOT COMPLETED|Overall Study||0
11262168|NCT02260882|12457594|FG001|NOT COMPLETED|Overall Study||1
11262169|NCT02260921|12457603|FG000|STARTED|Overall Study||121
11262170|NCT02260921|12457604|FG001|STARTED|Overall Study||59
11262171|NCT02260921|12457603|FG000|Per-Protocol Population|Overall Study||112
11262172|NCT02260921|12457604|FG001|Per-Protocol Population|Overall Study||56
11262173|NCT02260921|12457603|FG000|COMPLETED|Overall Study||107
11262174|NCT02260921|12457604|FG001|COMPLETED|Overall Study||55
11262175|NCT02260921|12457603|FG000|NOT COMPLETED|Overall Study||14
11262176|NCT02260921|12457604|FG001|NOT COMPLETED|Overall Study||4
11262177|NCT02260934|12457612|FG000|STARTED|Overall Study||22
11262178|NCT02260934|12457613|FG001|STARTED|Overall Study||21
11262179|NCT02260934|12457612|FG000|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|19
11262180|NCT02260934|12457613|FG001|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|17
11262181|NCT02260934|12457612|FG000|NOT COMPLETED|Overall Study||3
11262182|NCT02260934|12457613|FG001|NOT COMPLETED|Overall Study||4
11262183|NCT02260986|12457629|FG000|STARTED|Overall Study||315
11262184|NCT02260986|12457630|FG001|STARTED|Overall Study||106
11262185|NCT02260986|12457631|FG002|STARTED|Overall Study||319
11262186|NCT02260986|12457629|FG000|Safety Population|Overall Study||315
11262187|NCT02260986|12457630|FG001|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
11262188|NCT02260986|12457631|FG002|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
11262189|NCT02260986|12457629|FG000|COMPLETED|Overall Study||225
11262190|NCT02260986|12457630|FG001|COMPLETED|Overall Study||93
11262191|NCT02260986|12457631|FG002|COMPLETED|Overall Study||278
11262192|NCT02260986|12457629|FG000|NOT COMPLETED|Overall Study||90
11262193|NCT02260986|12457630|FG001|NOT COMPLETED|Overall Study||13
11262194|NCT02260986|12457631|FG002|NOT COMPLETED|Overall Study||41
11262195|NCT02261428|12457646|FG000|STARTED|Overall Study|Washout (30 minutes)|10
11262196|NCT02261428|12457647|FG001|STARTED|Overall Study|Washout (30 minutes)|10
11262197|NCT02261428|12457646|FG000|COMPLETED|Overall Study||10
11262198|NCT02261428|12457647|FG001|COMPLETED|Overall Study||10
11262199|NCT02261428|12457646|FG000|NOT COMPLETED|Overall Study||0
11262200|NCT02261428|12457647|FG001|NOT COMPLETED|Overall Study||0
11262201|NCT02261467|12457667|FG000|STARTED|Overall Study||101
11262202|NCT02261467|12457668|FG001|STARTED|Overall Study||290
11262203|NCT02261467|12457667|FG000|COMPLETED|Overall Study||80
11262204|NCT02261467|12457668|FG001|COMPLETED|Overall Study||253
11262205|NCT02261467|12457667|FG000|NOT COMPLETED|Overall Study||21
11262206|NCT02261467|12457668|FG001|NOT COMPLETED|Overall Study||37
11262207|NCT02261493|12457677|FG000|STARTED|Overall Study||156
11262208|NCT02261493|12457678|FG001|STARTED|Overall Study||318
11262209|NCT02261493|12457679|FG002|STARTED|Overall Study||313
11262210|NCT02261493|12457677|FG000|COMPLETED|Overall Study||126
11262211|NCT02261493|12457678|FG001|COMPLETED|Overall Study||271
11262212|NCT02261493|12457679|FG002|COMPLETED|Overall Study||287
11262213|NCT02261493|12457677|FG000|NOT COMPLETED|Overall Study||30
11262214|NCT02261493|12457678|FG001|NOT COMPLETED|Overall Study||47
11262215|NCT02261493|12457679|FG002|NOT COMPLETED|Overall Study||26
11262216|NCT02261597|12457689|FG000|STARTED|Overall Study||22
11262217|NCT02261597|12457690|FG001|STARTED|Overall Study||22
11262218|NCT02261597|12457689|FG000|COMPLETED|Overall Study||22
11262219|NCT02261597|12457690|FG001|COMPLETED|Overall Study||22
11262220|NCT02261597|12457689|FG000|NOT COMPLETED|Overall Study||0
11262221|NCT02261597|12457690|FG001|NOT COMPLETED|Overall Study||0
11262222|NCT02261714|12457696|FG000|STARTED|Overall Study||32
11262223|NCT02261714|12457696|FG000|COMPLETED|Overall Study||4
11262224|NCT02261714|12457696|FG000|NOT COMPLETED|Overall Study||28
11262225|NCT02261727|12457704|FG000|STARTED|Overall Study||568
11262226|NCT02261727|12457705|FG001|STARTED|Overall Study||554
11262227|NCT02261727|12457706|FG002|STARTED|Overall Study||548
11262228|NCT02261727|12457704|FG000|COMPLETED|Overall Study||411
11262229|NCT02261727|12457705|FG001|COMPLETED|Overall Study||408
11262230|NCT02261727|12457706|FG002|COMPLETED|Overall Study||423
11262231|NCT02261727|12457704|FG000|NOT COMPLETED|Overall Study||157
11262232|NCT02261727|12457705|FG001|NOT COMPLETED|Overall Study||146
11262233|NCT02261727|12457706|FG002|NOT COMPLETED|Overall Study||125
11262234|NCT02261805|12457714|FG000|STARTED|Overall Study||3
11262235|NCT02261805|12457715|FG001|STARTED|Overall Study||6
11262236|NCT02261805|12457716|FG002|STARTED|Overall Study||2
11262237|NCT02261805|12457714|FG000|COMPLETED|Overall Study||3
11262238|NCT02261805|12457715|FG001|COMPLETED|Overall Study||6
11262239|NCT02261805|12457716|FG002|COMPLETED|Overall Study||2
11262240|NCT02261805|12457714|FG000|NOT COMPLETED|Overall Study||0
11262241|NCT02261805|12457715|FG001|NOT COMPLETED|Overall Study||0
11262242|NCT02261805|12457716|FG002|NOT COMPLETED|Overall Study||0
11262243|NCT02261818|12457722|FG000|STARTED|Overall Study||30
11262244|NCT02261818|12457722|FG000|COMPLETED|Overall Study||27
11262245|NCT02261818|12457722|FG000|NOT COMPLETED|Overall Study||3
11262246|NCT02261948|12457728|FG000|STARTED|Overall Study||23
11262247|NCT02261948|12457729|FG001|STARTED|Overall Study||19
11262248|NCT02261948|12457728|FG000|COMPLETED|Overall Study||23
11262249|NCT02261948|12457729|FG001|COMPLETED|Overall Study||19
11262250|NCT02261948|12457728|FG000|NOT COMPLETED|Overall Study||0
11262251|NCT02261948|12457729|FG001|NOT COMPLETED|Overall Study||0
11262252|NCT02261961|12457737|FG000|STARTED|Overall Study||22
11262253|NCT02261961|12457738|FG001|STARTED|Overall Study||22
11262254|NCT02261961|12457737|FG000|COMPLETED|Overall Study||13
11262255|NCT02261961|12457738|FG001|COMPLETED|Overall Study|One subject listed as completed who withdrew but finished training phase and has usable data.|20
11262256|NCT02261961|12457737|FG000|NOT COMPLETED|Overall Study||9
11262257|NCT02261961|12457738|FG001|NOT COMPLETED|Overall Study||2
11262258|NCT02261974|12457757|FG000|STARTED|Overall Study||123
11262259|NCT02261974|12457758|FG001|STARTED|Overall Study||63
11262260|NCT02261974|12457757|FG000|Treated|Overall Study||117
11262261|NCT02261974|12457758|FG001|Treated|Overall Study||57
11262262|NCT02261974|12457757|FG000|COMPLETED|Overall Study||108
11262263|NCT02261974|12457758|FG001|COMPLETED|Overall Study||56
11262264|NCT02261974|12457757|FG000|NOT COMPLETED|Overall Study||15
11262265|NCT02261974|12457758|FG001|NOT COMPLETED|Overall Study||7
11262266|NCT02262039|12457766|FG000|STARTED|Overall Study||14
11262267|NCT02262039|12457767|FG001|STARTED|Overall Study||27
11262268|NCT02262039|12457766|FG000|COMPLETED|Overall Study||14
11262269|NCT02262039|12457767|FG001|COMPLETED|Overall Study||27
11262270|NCT02262039|12457766|FG000|NOT COMPLETED|Overall Study||0
11262271|NCT02262039|12457767|FG001|NOT COMPLETED|Overall Study||0
11262272|NCT02262078|12457775|FG000|STARTED|Overall Study||13
11262273|NCT02262078|12457776|FG001|STARTED|Overall Study||13
11262274|NCT02262078|12457775|FG000|COMPLETED|Overall Study||13
11262275|NCT02262078|12457776|FG001|COMPLETED|Overall Study||13
11262276|NCT02262078|12457775|FG000|NOT COMPLETED|Overall Study||0
11262277|NCT02262078|12457776|FG001|NOT COMPLETED|Overall Study||0
11262278|NCT02262130|12457782|FG000|STARTED|Overall Study||10
11262279|NCT02262130|12457782|FG000|COMPLETED|Overall Study||10
11262280|NCT02262130|12457782|FG000|NOT COMPLETED|Overall Study||0
11262281|NCT02262260|12457788|FG000|STARTED|Overall Study||45
11262282|NCT02262260|12457789|FG001|STARTED|Overall Study||42
11262283|NCT02262260|12457788|FG000|COMPLETED|Overall Study||34
11262284|NCT02262260|12457789|FG001|COMPLETED|Overall Study||32
11262285|NCT02262260|12457788|FG000|NOT COMPLETED|Overall Study||11
11262286|NCT02262260|12457789|FG001|NOT COMPLETED|Overall Study||10
11262287|NCT02262364|12457795|FG000|STARTED|Study Enrollment||11
11262288|NCT02262364|12457795|FG000|COMPLETED|Study Enrollment||11
11262289|NCT02262364|12457795|FG000|NOT COMPLETED|Study Enrollment||0
11262290|NCT02262364|12457795|FG000|STARTED|Blood Draw for Device Processing||11
11262291|NCT02262364|12457795|FG000|COMPLETED|Blood Draw for Device Processing||10
11262292|NCT02262364|12457795|FG000|NOT COMPLETED|Blood Draw for Device Processing||1
11262293|NCT02262364|12457795|FG000|STARTED|Injection With APS||10
11262294|NCT02262364|12457795|FG000|COMPLETED|Injection With APS||10
11262295|NCT02262364|12457795|FG000|NOT COMPLETED|Injection With APS||0
11262296|NCT02262364|12457795|FG000|STARTED|Follow-Up Through 12 Months||10
11262297|NCT02262364|12457795|FG000|COMPLETED|Follow-Up Through 12 Months||10
11262298|NCT02262364|12457795|FG000|NOT COMPLETED|Follow-Up Through 12 Months||0
11262299|NCT02262377|12457801|FG000|STARTED|Overall Study||80
11262300|NCT02262377|12457802|FG001|STARTED|Overall Study||79
11262301|NCT02262377|12457801|FG000|COMPLETED|Overall Study||68
11262302|NCT02262377|12457802|FG001|COMPLETED|Overall Study||73
11262303|NCT02262377|12457801|FG000|NOT COMPLETED|Overall Study||12
11262304|NCT02262377|12457802|FG001|NOT COMPLETED|Overall Study||6
11262305|NCT02262507|12457809|FG000|STARTED|Overall Study||410
11262306|NCT02262507|12457809|FG000|COMPLETED|Overall Study||410
11262307|NCT02262507|12457809|FG000|NOT COMPLETED|Overall Study||0
11262308|NCT02262728|12457816|FG000|STARTED|Treatment Period (12 Weeks)||19
11262309|NCT02262728|12457817|FG001|STARTED|Treatment Period (12 Weeks)||21
11262310|NCT02262728|12457816|FG000|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19
11262311|NCT02262728|12457817|FG001|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21
11262312|NCT02262728|12457816|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||0
11262313|NCT02262728|12457817|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0
11262314|NCT02262728|12457816|FG000|STARTED|Follow-up Phase (3 Years)||19
11262315|NCT02262728|12457817|FG001|STARTED|Follow-up Phase (3 Years)||21
11262316|NCT02262728|12457816|FG000|COMPLETED|Follow-up Phase (3 Years)||15
11262317|NCT02262728|12457817|FG001|COMPLETED|Follow-up Phase (3 Years)||18
11262318|NCT02262728|12457816|FG000|NOT COMPLETED|Follow-up Phase (3 Years)||4
11262319|NCT02262728|12457817|FG001|NOT COMPLETED|Follow-up Phase (3 Years)||3
11262320|NCT02262754|12457826|FG000|STARTED|Overall Study||74
11262321|NCT02262754|12457827|FG001|STARTED|Overall Study||74
11262322|NCT02262754|12457828|FG002|STARTED|Overall Study||74
11262323|NCT02262754|12457826|FG000|COMPLETED|Overall Study||58
11262324|NCT02262754|12457827|FG001|COMPLETED|Overall Study||65
11262325|NCT02262754|12457828|FG002|COMPLETED|Overall Study||65
11262326|NCT02262754|12457826|FG000|NOT COMPLETED|Overall Study||16
11262327|NCT02262754|12457827|FG001|NOT COMPLETED|Overall Study||9
11262328|NCT02262754|12457828|FG002|NOT COMPLETED|Overall Study||9
11262329|NCT02263040|12457840|FG000|STARTED|Overall Study||87
11262330|NCT02263040|12457841|FG001|STARTED|Overall Study||83
11262331|NCT02263040|12457840|FG000|COMPLETED|Overall Study||87
11262332|NCT02263040|12457841|FG001|COMPLETED|Overall Study||83
11262333|NCT02263040|12457840|FG000|NOT COMPLETED|Overall Study||0
11262334|NCT02263040|12457841|FG001|NOT COMPLETED|Overall Study||0
11262335|NCT02263079|12457854|FG000|STARTED|Overall Study||26
11262336|NCT02263079|12457855|FG001|STARTED|Overall Study||33
11262337|NCT02263079|12457856|FG002|STARTED|Overall Study||3
11262338|NCT02263079|12457854|FG000|COMPLETED|Overall Study||23
11262339|NCT02263079|12457855|FG001|COMPLETED|Overall Study||25
11262340|NCT02263079|12457856|FG002|COMPLETED|Overall Study|Completed study but not included in the analysis|3
11262341|NCT02263079|12457854|FG000|NOT COMPLETED|Overall Study||3
11262342|NCT02263079|12457855|FG001|NOT COMPLETED|Overall Study||8
11262343|NCT02263079|12457856|FG002|NOT COMPLETED|Overall Study||0
11262344|NCT02263118|12457868|FG000|STARTED|Overall Study||24
11262345|NCT02263118|12457869|FG001|STARTED|Overall Study||32
11262346|NCT02263118|12457870|FG002|STARTED|Overall Study||30
11262347|NCT02263118|12457871|FG003|STARTED|Overall Study||14
11262348|NCT02263118|12457868|FG000|COMPLETED|Overall Study||20
11262349|NCT02263118|12457869|FG001|COMPLETED|Overall Study||24
11262350|NCT02263118|12457870|FG002|COMPLETED|Overall Study||22
11262351|NCT02263118|12457871|FG003|COMPLETED|Overall Study||12
11262352|NCT02263118|12457868|FG000|NOT COMPLETED|Overall Study||4
11262353|NCT02263118|12457869|FG001|NOT COMPLETED|Overall Study||8
11262354|NCT02263118|12457870|FG002|NOT COMPLETED|Overall Study||8
11262355|NCT02263118|12457871|FG003|NOT COMPLETED|Overall Study||2
11262356|NCT02263131|12457885|FG000|STARTED|Overall Study||347
11262357|NCT02263131|12457886|FG001|STARTED|Overall Study||69
11262358|NCT02263131|12457885|FG000|COMPLETED|Overall Study||337
11262359|NCT02263131|12457886|FG001|COMPLETED|Overall Study||68
11262360|NCT02263131|12457885|FG000|NOT COMPLETED|Overall Study||10
11262361|NCT02263131|12457886|FG001|NOT COMPLETED|Overall Study||1
11262362|NCT02263326|12457894|FG000|STARTED|Overall Study||44
11262363|NCT02263326|12457895|FG001|STARTED|Overall Study||45
11262364|NCT02263326|12457894|FG000|COMPLETED|Overall Study||43
11262365|NCT02263326|12457895|FG001|COMPLETED|Overall Study||44
11262366|NCT02263326|12457894|FG000|NOT COMPLETED|Overall Study||1
11262367|NCT02263326|12457895|FG001|NOT COMPLETED|Overall Study||1
11262368|NCT02263547|12457901|FG000|STARTED|Overall Study||14
11262369|NCT02263547|12457901|FG000|COMPLETED|Overall Study||11
11262370|NCT02263547|12457901|FG000|NOT COMPLETED|Overall Study||3
11262371|NCT02263833|12457905|FG000|STARTED|Overall Study||742
11262372|NCT02263833|12457905|FG000|COMPLETED|Overall Study||742
11262373|NCT02263833|12457905|FG000|NOT COMPLETED|Overall Study||0
11262374|NCT02263911|12457909|FG000|STARTED|Period 1||4
11262375|NCT02263911|12457910|FG001|STARTED|Period 1||4
11262376|NCT02263911|12457911|FG002|STARTED|Period 1||4
11262377|NCT02263911|12457912|FG003|STARTED|Period 1||4
11262378|NCT02263911|12457909|FG000|COMPLETED|Period 1||4
11262379|NCT02263911|12457910|FG001|COMPLETED|Period 1||4
11262380|NCT02263911|12457911|FG002|COMPLETED|Period 1||4
11262381|NCT02263911|12457912|FG003|COMPLETED|Period 1||4
11262382|NCT02263911|12457909|FG000|NOT COMPLETED|Period 1||0
11262383|NCT02263911|12457910|FG001|NOT COMPLETED|Period 1||0
11262384|NCT02263911|12457911|FG002|NOT COMPLETED|Period 1||0
11262385|NCT02263911|12457912|FG003|NOT COMPLETED|Period 1||0
11262386|NCT02263911|12457909|FG000|STARTED|Period 1 Washout||4
11262387|NCT02263911|12457910|FG001|STARTED|Period 1 Washout||4
11262388|NCT02263911|12457911|FG002|STARTED|Period 1 Washout||4
11262389|NCT02263911|12457912|FG003|STARTED|Period 1 Washout||4
11262390|NCT02263911|12457909|FG000|COMPLETED|Period 1 Washout||4
11262391|NCT02263911|12457910|FG001|COMPLETED|Period 1 Washout||4
11262392|NCT02263911|12457911|FG002|COMPLETED|Period 1 Washout||4
11262393|NCT02263911|12457912|FG003|COMPLETED|Period 1 Washout||4
11262394|NCT02263911|12457909|FG000|NOT COMPLETED|Period 1 Washout||0
11262395|NCT02263911|12457910|FG001|NOT COMPLETED|Period 1 Washout||0
11262396|NCT02263911|12457911|FG002|NOT COMPLETED|Period 1 Washout||0
11262397|NCT02263911|12457912|FG003|NOT COMPLETED|Period 1 Washout||0
11262398|NCT02263911|12457909|FG000|STARTED|Period 2||4
11262399|NCT02263911|12457910|FG001|STARTED|Period 2||4
11262400|NCT02263911|12457911|FG002|STARTED|Period 2||4
11262401|NCT02263911|12457912|FG003|STARTED|Period 2||4
11262402|NCT02263911|12457909|FG000|COMPLETED|Period 2||4
11262403|NCT02263911|12457910|FG001|COMPLETED|Period 2||4
11262404|NCT02263911|12457911|FG002|COMPLETED|Period 2||4
11262405|NCT02263911|12457912|FG003|COMPLETED|Period 2||4
11262406|NCT02263911|12457909|FG000|NOT COMPLETED|Period 2||0
11262407|NCT02263911|12457910|FG001|NOT COMPLETED|Period 2||0
11262408|NCT02263911|12457911|FG002|NOT COMPLETED|Period 2||0
11262409|NCT02263911|12457912|FG003|NOT COMPLETED|Period 2||0
11262410|NCT02263911|12457909|FG000|STARTED|Period 2 Washout||4
11262411|NCT02263911|12457910|FG001|STARTED|Period 2 Washout||4
11262412|NCT02263911|12457911|FG002|STARTED|Period 2 Washout||4
11262413|NCT02263911|12457912|FG003|STARTED|Period 2 Washout||4
11262414|NCT02263911|12457909|FG000|COMPLETED|Period 2 Washout||4
11262415|NCT02263911|12457910|FG001|COMPLETED|Period 2 Washout||4
11262416|NCT02263911|12457911|FG002|COMPLETED|Period 2 Washout||4
11262417|NCT02263911|12457912|FG003|COMPLETED|Period 2 Washout||4
11262418|NCT02263911|12457909|FG000|NOT COMPLETED|Period 2 Washout||0
11262419|NCT02263911|12457910|FG001|NOT COMPLETED|Period 2 Washout||0
11262420|NCT02263911|12457911|FG002|NOT COMPLETED|Period 2 Washout||0
11262421|NCT02263911|12457912|FG003|NOT COMPLETED|Period 2 Washout||0
11262422|NCT02263911|12457909|FG000|STARTED|Period 3||4
11262423|NCT02263911|12457910|FG001|STARTED|Period 3||4
11262424|NCT02263911|12457911|FG002|STARTED|Period 3||4
11262425|NCT02263911|12457912|FG003|STARTED|Period 3||4
11262426|NCT02263911|12457909|FG000|COMPLETED|Period 3||4
11262427|NCT02263911|12457910|FG001|COMPLETED|Period 3||4
11262428|NCT02263911|12457911|FG002|COMPLETED|Period 3||4
11262429|NCT02263911|12457912|FG003|COMPLETED|Period 3||4
11262430|NCT02263911|12457909|FG000|NOT COMPLETED|Period 3||0
11262431|NCT02263911|12457910|FG001|NOT COMPLETED|Period 3||0
11262432|NCT02263911|12457911|FG002|NOT COMPLETED|Period 3||0
11262433|NCT02263911|12457912|FG003|NOT COMPLETED|Period 3||0
11262434|NCT02263911|12457909|FG000|STARTED|Period 3 Washout||4
11262435|NCT02263911|12457910|FG001|STARTED|Period 3 Washout||4
11262436|NCT02263911|12457911|FG002|STARTED|Period 3 Washout||4
11262437|NCT02263911|12457912|FG003|STARTED|Period 3 Washout||4
11262438|NCT02263911|12457909|FG000|COMPLETED|Period 3 Washout||4
11262439|NCT02263911|12457910|FG001|COMPLETED|Period 3 Washout||4
11262440|NCT02263911|12457911|FG002|COMPLETED|Period 3 Washout||4
11262441|NCT02263911|12457912|FG003|COMPLETED|Period 3 Washout||4
11262442|NCT02263911|12457909|FG000|NOT COMPLETED|Period 3 Washout||0
11262443|NCT02263911|12457910|FG001|NOT COMPLETED|Period 3 Washout||0
11262444|NCT02263911|12457911|FG002|NOT COMPLETED|Period 3 Washout||0
11262445|NCT02263911|12457912|FG003|NOT COMPLETED|Period 3 Washout||0
11262446|NCT02263911|12457909|FG000|STARTED|Period 4||4
11262447|NCT02263911|12457910|FG001|STARTED|Period 4||4
11262448|NCT02263911|12457911|FG002|STARTED|Period 4||4
11262449|NCT02263911|12457912|FG003|STARTED|Period 4||4
11262450|NCT02263911|12457909|FG000|COMPLETED|Period 4||4
11262451|NCT02263911|12457910|FG001|COMPLETED|Period 4||4
11262452|NCT02263911|12457911|FG002|COMPLETED|Period 4||4
11262453|NCT02263911|12457912|FG003|COMPLETED|Period 4||4
11262454|NCT02263911|12457909|FG000|NOT COMPLETED|Period 4||0
11262455|NCT02263911|12457910|FG001|NOT COMPLETED|Period 4||0
11262456|NCT02263911|12457911|FG002|NOT COMPLETED|Period 4||0
11262457|NCT02263911|12457912|FG003|NOT COMPLETED|Period 4||0
11262458|NCT02263911|12457909|FG000|STARTED|Period 4 Washout||4
11262459|NCT02263911|12457910|FG001|STARTED|Period 4 Washout||4
11262460|NCT02263911|12457911|FG002|STARTED|Period 4 Washout||4
11262461|NCT02263911|12457912|FG003|STARTED|Period 4 Washout||4
11262462|NCT02263911|12457909|FG000|COMPLETED|Period 4 Washout||4
11262463|NCT02263911|12457910|FG001|COMPLETED|Period 4 Washout||4
11262464|NCT02263911|12457911|FG002|COMPLETED|Period 4 Washout||4
11262465|NCT02263911|12457912|FG003|COMPLETED|Period 4 Washout||4
11262466|NCT02263911|12457909|FG000|NOT COMPLETED|Period 4 Washout||0
11262467|NCT02263911|12457910|FG001|NOT COMPLETED|Period 4 Washout||0
11262468|NCT02263911|12457911|FG002|NOT COMPLETED|Period 4 Washout||0
11262469|NCT02263911|12457912|FG003|NOT COMPLETED|Period 4 Washout||0
11262470|NCT02263911|12457909|FG000|STARTED|Period 5||4
11262471|NCT02263911|12457910|FG001|STARTED|Period 5||4
11262472|NCT02263911|12457911|FG002|STARTED|Period 5||4
11262473|NCT02263911|12457912|FG003|STARTED|Period 5||4
11262474|NCT02263911|12457909|FG000|COMPLETED|Period 5||4
11262475|NCT02263911|12457910|FG001|COMPLETED|Period 5||4
11262476|NCT02263911|12457911|FG002|COMPLETED|Period 5||4
11262477|NCT02263911|12457912|FG003|COMPLETED|Period 5||4
11262478|NCT02263911|12457909|FG000|NOT COMPLETED|Period 5||0
11262479|NCT02263911|12457910|FG001|NOT COMPLETED|Period 5||0
11262480|NCT02263911|12457911|FG002|NOT COMPLETED|Period 5||0
11262481|NCT02263911|12457912|FG003|NOT COMPLETED|Period 5||0
11262482|NCT02264249|12457929|FG000|STARTED|Overall Study||21
11262483|NCT02264249|12457930|FG001|STARTED|Overall Study||187
11262484|NCT02264249|12457931|FG002|STARTED|Overall Study||241
11262485|NCT02264249|12457929|FG000|COMPLETED|Overall Study||21
11262486|NCT02264249|12457930|FG001|COMPLETED|Overall Study||187
11262487|NCT02264249|12457931|FG002|COMPLETED|Overall Study||241
11262488|NCT02264249|12457929|FG000|NOT COMPLETED|Overall Study||0
11262489|NCT02264249|12457930|FG001|NOT COMPLETED|Overall Study||0
11262490|NCT02264249|12457931|FG002|NOT COMPLETED|Overall Study||0
11262491|NCT02264353|12457939|FG000|STARTED|Overall Study||20
11262492|NCT02264353|12457940|FG001|STARTED|Overall Study||24
11262493|NCT02264353|12457939|FG000|COMPLETED|Overall Study||17
11262494|NCT02264353|12457940|FG001|COMPLETED|Overall Study||24
11358982|NCT03131687|12556091|FG005|Received at Least One Dose of Study Drug|Overall Study||54
11358983|NCT03131687|12556086|FG000|COMPLETED|Overall Study||45
11358984|NCT03131687|12556087|FG001|COMPLETED|Overall Study||44
11358985|NCT03131687|12556088|FG002|COMPLETED|Overall Study||52
11358986|NCT03131687|12556089|FG003|COMPLETED|Overall Study||48
11358987|NCT03131687|12556090|FG004|COMPLETED|Overall Study||45
11358988|NCT03131687|12556091|FG005|COMPLETED|Overall Study||49
11358989|NCT03131687|12556086|FG000|NOT COMPLETED|Overall Study||6
11358990|NCT03131687|12556087|FG001|NOT COMPLETED|Overall Study||9
11358991|NCT03131687|12556088|FG002|NOT COMPLETED|Overall Study||3
11358992|NCT03131687|12556089|FG003|NOT COMPLETED|Overall Study||4
11262495|NCT02264353|12457939|FG000|NOT COMPLETED|Overall Study||3
11262496|NCT02264353|12457940|FG001|NOT COMPLETED|Overall Study||0
11262497|NCT02264574|12457948|FG000|STARTED|Overall Study||113
11358993|NCT03131687|12556090|FG004|NOT COMPLETED|Overall Study||8
11358994|NCT03131687|12556091|FG005|NOT COMPLETED|Overall Study||5
11358995|NCT03131713|12556120|FG000|STARTED|Overall Study||50
11262498|NCT02264574|12457949|FG001|STARTED|Overall Study||116
11262499|NCT02264574|12457948|FG000|COMPLETED|Overall Study||84
11262500|NCT02264574|12457949|FG001|COMPLETED|Overall Study||86
11262501|NCT02264574|12457948|FG000|NOT COMPLETED|Overall Study||29
11262502|NCT02264574|12457949|FG001|NOT COMPLETED|Overall Study||30
11262503|NCT02264639|12457960|FG000|STARTED|Overall Study|Subjects in this arm participated in Cohort 1 only.|2
11262504|NCT02264639|12457961|FG001|STARTED|Overall Study|Subject in this arm participated in Cohort 2 only.|1
11262505|NCT02264639|12457962|FG002|STARTED|Overall Study|Subject in this arm participated in Cohorts 2, 3 and 4.|1
11262506|NCT02264639|12457963|FG003|STARTED|Overall Study|Subject in this arm participated in Cohorts 3 and 4; single-dose phase was not applicable.|1
11262507|NCT02264639|12457964|FG004|STARTED|Overall Study|Subjects in this arm participated in Cohort 4 only; single-dose phase was not applicable.|4
11262508|NCT02264639|12457960|FG000|COMPLETED|Overall Study||0
11262509|NCT02264639|12457961|FG001|COMPLETED|Overall Study||1
11262510|NCT02264639|12457962|FG002|COMPLETED|Overall Study||0
11262511|NCT02264639|12457963|FG003|COMPLETED|Overall Study||1
11262512|NCT02264639|12457964|FG004|COMPLETED|Overall Study||3
11262513|NCT02264639|12457960|FG000|NOT COMPLETED|Overall Study||2
11262514|NCT02264639|12457961|FG001|NOT COMPLETED|Overall Study||0
11262515|NCT02264639|12457962|FG002|NOT COMPLETED|Overall Study||1
11262516|NCT02264639|12457963|FG003|NOT COMPLETED|Overall Study||0
11262517|NCT02264639|12457964|FG004|NOT COMPLETED|Overall Study||1
11262518|NCT02264821|12457982|FG000|STARTED|Overall Study|Double Blind|64
11262519|NCT02264821|12457983|FG001|STARTED|Overall Study|Double Blind|64
11262520|NCT02264821|12457984|FG002|STARTED|Overall Study|Double Blind|64
11262521|NCT02264821|12457982|FG000|COMPLETED|Overall Study||63
11262522|NCT02264821|12457983|FG001|COMPLETED|Overall Study||61
11262523|NCT02264821|12457984|FG002|COMPLETED|Overall Study||58
11262524|NCT02264821|12457982|FG000|NOT COMPLETED|Overall Study||1
11262525|NCT02264821|12457983|FG001|NOT COMPLETED|Overall Study||3
11262526|NCT02264821|12457984|FG002|NOT COMPLETED|Overall Study||6
11262527|NCT02264990|12457994|FG000|STARTED|Overall Study||297
11262528|NCT02264990|12457995|FG001|STARTED|Overall Study||298
11262529|NCT02264990|12457994|FG000|Received Treatment|Overall Study||288
11262530|NCT02264990|12457995|FG001|Received Treatment|Overall Study||293
11262531|NCT02264990|12457994|FG000|Received Maintenance Therapy|Overall Study||148
11262532|NCT02264990|12457995|FG001|Received Maintenance Therapy|Overall Study||123
11262533|NCT02264990|12457994|FG000|COMPLETED|Overall Study||37
11262534|NCT02264990|12457995|FG001|COMPLETED|Overall Study||39
11262535|NCT02264990|12457994|FG000|NOT COMPLETED|Overall Study||260
11262536|NCT02264990|12457995|FG001|NOT COMPLETED|Overall Study||259
11262537|NCT02265224|12458002|FG000|STARTED|Overall Study||48
11262538|NCT02265224|12458002|FG000|COMPLETED|Overall Study||48
11262539|NCT02265224|12458002|FG000|NOT COMPLETED|Overall Study||0
11262540|NCT02265237|12458013|FG000|STARTED|As Enrolled (Overall Study)||59
11262541|NCT02265237|12458014|FG001|STARTED|As Enrolled (Overall Study)||61
11262542|NCT02265237|12458015|FG002|STARTED|As Enrolled (Overall Study)||61
11262543|NCT02265237|12458016|FG003|STARTED|As Enrolled (Overall Study)||3
11262544|NCT02265237|12458013|FG000|COMPLETED|As Enrolled (Overall Study)||54
11262545|NCT02265237|12458014|FG001|COMPLETED|As Enrolled (Overall Study)||58
11262546|NCT02265237|12458015|FG002|COMPLETED|As Enrolled (Overall Study)||51
11262547|NCT02265237|12458016|FG003|COMPLETED|As Enrolled (Overall Study)||2
11262548|NCT02265237|12458013|FG000|NOT COMPLETED|As Enrolled (Overall Study)||5
11262549|NCT02265237|12458014|FG001|NOT COMPLETED|As Enrolled (Overall Study)||3
11262550|NCT02265237|12458015|FG002|NOT COMPLETED|As Enrolled (Overall Study)||10
11262551|NCT02265237|12458016|FG003|NOT COMPLETED|As Enrolled (Overall Study)||1
11262552|NCT02265237|12458013|FG000|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
11262553|NCT02265237|12458014|FG001|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
11262554|NCT02265237|12458015|FG002|STARTED|As Treated (Overall Study)||61
11262555|NCT02265237|12458016|FG003|STARTED|As Treated (Overall Study)||3
11262556|NCT02265237|12458013|FG000|COMPLETED|As Treated (Overall Study)||55
11262557|NCT02265237|12458014|FG001|COMPLETED|As Treated (Overall Study)||57
11262558|NCT02265237|12458015|FG002|COMPLETED|As Treated (Overall Study)||51
11262559|NCT02265237|12458016|FG003|COMPLETED|As Treated (Overall Study)||2
11262560|NCT02265237|12458013|FG000|NOT COMPLETED|As Treated (Overall Study)||5
11262561|NCT02265237|12458014|FG001|NOT COMPLETED|As Treated (Overall Study)||3
11262562|NCT02265237|12458015|FG002|NOT COMPLETED|As Treated (Overall Study)||10
11262563|NCT02265237|12458016|FG003|NOT COMPLETED|As Treated (Overall Study)||1
11262564|NCT02265341|12458027|FG000|STARTED|Overall Study||12
11262565|NCT02265341|12458027|FG000|COMPLETED|Overall Study||12
11262566|NCT02265341|12458027|FG000|NOT COMPLETED|Overall Study||0
11262567|NCT02265510|12458045|FG000|STARTED|Overall Study||3
11262568|NCT02265510|12458046|FG001|STARTED|Overall Study||3
11262569|NCT02265510|12458047|FG002|STARTED|Overall Study||6
11262570|NCT02265510|12458048|FG003|STARTED|Overall Study||4
11262571|NCT02265510|12458049|FG004|STARTED|Overall Study||3
11262572|NCT02265510|12458050|FG005|STARTED|Overall Study||6
11262573|NCT02265510|12458051|FG006|STARTED|Overall Study||3
11262574|NCT02265510|12458052|FG007|STARTED|Overall Study||4
11262575|NCT02265510|12458053|FG008|STARTED|Overall Study||4
11262576|NCT02265510|12458054|FG009|STARTED|Overall Study||7
11262577|NCT02265510|12458055|FG010|STARTED|Overall Study||5
11262578|NCT02265510|12458056|FG011|STARTED|Overall Study||16
11262579|NCT02265510|12458057|FG012|STARTED|Overall Study||9
11262580|NCT02265510|12458058|FG013|STARTED|Overall Study||10
11262581|NCT02265510|12458045|FG000|COMPLETED|Overall Study||0
11262582|NCT02265510|12458046|FG001|COMPLETED|Overall Study||0
11262583|NCT02265510|12458047|FG002|COMPLETED|Overall Study||0
11262584|NCT02265510|12458048|FG003|COMPLETED|Overall Study||0
11262585|NCT02265510|12458049|FG004|COMPLETED|Overall Study||0
11262586|NCT02265510|12458050|FG005|COMPLETED|Overall Study||0
11262587|NCT02265510|12458051|FG006|COMPLETED|Overall Study||0
11262588|NCT02265510|12458052|FG007|COMPLETED|Overall Study||0
11262589|NCT02265510|12458053|FG008|COMPLETED|Overall Study||0
11262590|NCT02265510|12458054|FG009|COMPLETED|Overall Study||0
11262591|NCT02265510|12458055|FG010|COMPLETED|Overall Study||0
11262592|NCT02265510|12458056|FG011|COMPLETED|Overall Study||0
11262593|NCT02265510|12458057|FG012|COMPLETED|Overall Study||0
11262594|NCT02265510|12458058|FG013|COMPLETED|Overall Study||0
11262595|NCT02265510|12458045|FG000|NOT COMPLETED|Overall Study||3
11262596|NCT02265510|12458046|FG001|NOT COMPLETED|Overall Study||3
11262597|NCT02265510|12458047|FG002|NOT COMPLETED|Overall Study||6
11262598|NCT02265510|12458048|FG003|NOT COMPLETED|Overall Study||4
11262599|NCT02265510|12458049|FG004|NOT COMPLETED|Overall Study||3
11262600|NCT02265510|12458050|FG005|NOT COMPLETED|Overall Study||6
11262601|NCT02265510|12458051|FG006|NOT COMPLETED|Overall Study||3
11262602|NCT02265510|12458052|FG007|NOT COMPLETED|Overall Study||4
11262603|NCT02265510|12458053|FG008|NOT COMPLETED|Overall Study||4
11262604|NCT02265510|12458054|FG009|NOT COMPLETED|Overall Study||7
11262605|NCT02265510|12458055|FG010|NOT COMPLETED|Overall Study||5
11262606|NCT02265510|12458056|FG011|NOT COMPLETED|Overall Study||16
11262607|NCT02265510|12458057|FG012|NOT COMPLETED|Overall Study||9
11262608|NCT02265510|12458058|FG013|NOT COMPLETED|Overall Study||10
11262609|NCT02265705|12458116|FG000|STARTED|Treatment Period Week 0-24||145
11262610|NCT02265705|12458117|FG001|STARTED|Treatment Period Week 0-24||145
11262611|NCT02265705|12458118|FG002|STARTED|Treatment Period Week 0-24||0
11262612|NCT02265705|12458119|FG003|STARTED|Treatment Period Week 0-24||0
11262613|NCT02265705|12458120|FG004|STARTED|Treatment Period Week 0-24||0
11262614|NCT02265705|12458121|FG005|STARTED|Treatment Period Week 0-24||0
11262615|NCT02265705|12458122|FG006|STARTED|Treatment Period Week 0-24||0
11262616|NCT02265705|12458116|FG000|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
11262617|NCT02265705|12458117|FG001|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
11262618|NCT02265705|12458118|FG002|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
11262619|NCT02265705|12458119|FG003|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
11262620|NCT02265705|12458120|FG004|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
11262621|NCT02265705|12458121|FG005|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
11262622|NCT02265705|12458122|FG006|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
11262623|NCT02265705|12458116|FG000|Rescued|Treatment Period Week 0-24||59
11262624|NCT02265705|12458117|FG001|Rescued|Treatment Period Week 0-24||17
11262625|NCT02265705|12458118|FG002|Rescued|Treatment Period Week 0-24||0
11262626|NCT02265705|12458119|FG003|Rescued|Treatment Period Week 0-24||0
11262627|NCT02265705|12458120|FG004|Rescued|Treatment Period Week 0-24||0
11262628|NCT02265705|12458121|FG005|Rescued|Treatment Period Week 0-24||0
11262629|NCT02265705|12458122|FG006|Rescued|Treatment Period Week 0-24||0
11262630|NCT02265705|12458116|FG000|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133
11262631|NCT02265705|12458117|FG001|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136
11262632|NCT02265705|12458118|FG002|COMPLETED|Treatment Period Week 0-24||0
11262633|NCT02265705|12458119|FG003|COMPLETED|Treatment Period Week 0-24||0
11262634|NCT02265705|12458120|FG004|COMPLETED|Treatment Period Week 0-24||0
11262635|NCT02265705|12458121|FG005|COMPLETED|Treatment Period Week 0-24||0
11262636|NCT02265705|12458122|FG006|COMPLETED|Treatment Period Week 0-24||0
11262637|NCT02265705|12458116|FG000|NOT COMPLETED|Treatment Period Week 0-24||12
11262638|NCT02265705|12458117|FG001|NOT COMPLETED|Treatment Period Week 0-24||9
11262639|NCT02265705|12458118|FG002|NOT COMPLETED|Treatment Period Week 0-24||0
11262640|NCT02265705|12458119|FG003|NOT COMPLETED|Treatment Period Week 0-24||0
11262641|NCT02265705|12458120|FG004|NOT COMPLETED|Treatment Period Week 0-24||0
11262642|NCT02265705|12458121|FG005|NOT COMPLETED|Treatment Period Week 0-24||0
11262643|NCT02265705|12458122|FG006|NOT COMPLETED|Treatment Period Week 0-24||0
11262644|NCT02265705|12458116|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
11262645|NCT02265705|12458117|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
11262646|NCT02265705|12458118|FG002|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77
11262647|NCT02265705|12458119|FG003|STARTED|Rescue Period||0
11262648|NCT02265705|12458120|FG004|STARTED|Rescue Period||0
11262649|NCT02265705|12458121|FG005|STARTED|Rescue Period||0
11262650|NCT02265705|12458122|FG006|STARTED|Rescue Period||0
11262651|NCT02265705|12458116|FG000|COMPLETED|Rescue Period||0
11262652|NCT02265705|12458117|FG001|COMPLETED|Rescue Period||0
11262653|NCT02265705|12458118|FG002|COMPLETED|Rescue Period||74
11262654|NCT02265705|12458119|FG003|COMPLETED|Rescue Period||0
11262655|NCT02265705|12458120|FG004|COMPLETED|Rescue Period||0
11262656|NCT02265705|12458121|FG005|COMPLETED|Rescue Period||0
11262657|NCT02265705|12458122|FG006|COMPLETED|Rescue Period||0
11262658|NCT02265705|12458116|FG000|NOT COMPLETED|Rescue Period||0
11262659|NCT02265705|12458117|FG001|NOT COMPLETED|Rescue Period||0
11262660|NCT02265705|12458118|FG002|NOT COMPLETED|Rescue Period||3
11262661|NCT02265705|12458119|FG003|NOT COMPLETED|Rescue Period||0
11262662|NCT02265705|12458120|FG004|NOT COMPLETED|Rescue Period||0
11262663|NCT02265705|12458121|FG005|NOT COMPLETED|Rescue Period||0
11262664|NCT02265705|12458122|FG006|NOT COMPLETED|Rescue Period||0
11262665|NCT02265705|12458116|FG000|STARTED|Open Label Period||0
11262666|NCT02265705|12458117|FG001|STARTED|Open Label Period||0
11262667|NCT02265705|12458118|FG002|STARTED|Open Label Period||0
11262668|NCT02265705|12458119|FG003|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74
11262669|NCT02265705|12458120|FG004|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120
11262670|NCT02265705|12458121|FG005|STARTED|Open Label Period||0
11262671|NCT02265705|12458122|FG006|STARTED|Open Label Period||0
11262672|NCT02265705|12458116|FG000|COMPLETED|Open Label Period||0
11262673|NCT02265705|12458117|FG001|COMPLETED|Open Label Period||0
11262674|NCT02265705|12458118|FG002|COMPLETED|Open Label Period||0
11262675|NCT02265705|12458119|FG003|COMPLETED|Open Label Period||72
11262676|NCT02265705|12458120|FG004|COMPLETED|Open Label Period||115
11262677|NCT02265705|12458121|FG005|COMPLETED|Open Label Period||0
11262678|NCT02265705|12458122|FG006|COMPLETED|Open Label Period||0
11262679|NCT02265705|12458116|FG000|NOT COMPLETED|Open Label Period||0
11262680|NCT02265705|12458117|FG001|NOT COMPLETED|Open Label Period||0
11262681|NCT02265705|12458118|FG002|NOT COMPLETED|Open Label Period||0
11262682|NCT02265705|12458119|FG003|NOT COMPLETED|Open Label Period||2
11262683|NCT02265705|12458120|FG004|NOT COMPLETED|Open Label Period||5
11262684|NCT02265705|12458121|FG005|NOT COMPLETED|Open Label Period||0
11262685|NCT02265705|12458122|FG006|NOT COMPLETED|Open Label Period||0
11262686|NCT02265705|12458116|FG000|STARTED|Follow-up Period||0
11262687|NCT02265705|12458117|FG001|STARTED|Follow-up Period||0
11262688|NCT02265705|12458118|FG002|STARTED|Follow-up Period||0
11262689|NCT02265705|12458119|FG003|STARTED|Follow-up Period||0
11262690|NCT02265705|12458120|FG004|STARTED|Follow-up Period||0
11262691|NCT02265705|12458121|FG005|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2
11262692|NCT02265705|12458122|FG006|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58
11262693|NCT02265705|12458116|FG000|COMPLETED|Follow-up Period||0
11262694|NCT02265705|12458117|FG001|COMPLETED|Follow-up Period||0
11262695|NCT02265705|12458118|FG002|COMPLETED|Follow-up Period||0
11262696|NCT02265705|12458119|FG003|COMPLETED|Follow-up Period||0
11262697|NCT02265705|12458120|FG004|COMPLETED|Follow-up Period||0
11262698|NCT02265705|12458121|FG005|COMPLETED|Follow-up Period||1
11262699|NCT02265705|12458122|FG006|COMPLETED|Follow-up Period||47
11262700|NCT02265705|12458116|FG000|NOT COMPLETED|Follow-up Period||0
11262701|NCT02265705|12458117|FG001|NOT COMPLETED|Follow-up Period||0
11262702|NCT02265705|12458118|FG002|NOT COMPLETED|Follow-up Period||0
11262703|NCT02265705|12458119|FG003|NOT COMPLETED|Follow-up Period||0
11262704|NCT02265705|12458120|FG004|NOT COMPLETED|Follow-up Period||0
11262705|NCT02265705|12458121|FG005|NOT COMPLETED|Follow-up Period||1
11262706|NCT02265705|12458122|FG006|NOT COMPLETED|Follow-up Period||11
11262707|NCT02265744|12458138|FG000|STARTED|Overall Study||69
11262708|NCT02265744|12458139|FG001|STARTED|Overall Study||68
11262709|NCT02265744|12458140|FG002|STARTED|Overall Study||68
11262710|NCT02265744|12458141|FG003|STARTED|Overall Study||70
11262711|NCT02265744|12458142|FG004|STARTED|Overall Study||71
11262712|NCT02265744|12458138|FG000|COMPLETED|Overall Study||49
11262713|NCT02265744|12458139|FG001|COMPLETED|Overall Study||53
11262714|NCT02265744|12458140|FG002|COMPLETED|Overall Study||51
11262715|NCT02265744|12458141|FG003|COMPLETED|Overall Study||47
11262716|NCT02265744|12458142|FG004|COMPLETED|Overall Study||58
11262717|NCT02265744|12458138|FG000|NOT COMPLETED|Overall Study||20
11262718|NCT02265744|12458139|FG001|NOT COMPLETED|Overall Study||15
11262719|NCT02265744|12458140|FG002|NOT COMPLETED|Overall Study||17
11262720|NCT02265744|12458141|FG003|NOT COMPLETED|Overall Study||23
11262721|NCT02265744|12458142|FG004|NOT COMPLETED|Overall Study||13
11262722|NCT02265783|12458154|FG000|STARTED|Overall Study||20
11262723|NCT02265783|12458154|FG000|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
11262724|NCT02265783|12458154|FG000|NOT COMPLETED|Overall Study||0
11262725|NCT02265796|12458160|FG000|STARTED|Overall Study||25
11262726|NCT02265796|12458161|FG001|STARTED|Overall Study||25
11262727|NCT02265796|12458160|FG000|COMPLETED|Overall Study||22
11262728|NCT02265796|12458161|FG001|COMPLETED|Overall Study||24
11262729|NCT02265796|12458160|FG000|NOT COMPLETED|Overall Study||3
11262730|NCT02265796|12458161|FG001|NOT COMPLETED|Overall Study||1
11262731|NCT02265848|12458169|FG000|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
11262732|NCT02265848|12458170|FG001|STARTED|Overall Study||11
11262733|NCT02265848|12458169|FG000|COMPLETED|Overall Study||11
11262734|NCT02265848|12458170|FG001|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
11262735|NCT02265848|12458169|FG000|NOT COMPLETED|Overall Study||0
11262736|NCT02265848|12458170|FG001|NOT COMPLETED|Overall Study||0
11262737|NCT02265913|12458179|FG000|STARTED|Overall Study||1357
11262738|NCT02265913|12458180|FG001|STARTED|Overall Study||1361
11262739|NCT02265913|12458181|FG002|STARTED|Overall Study||1358
11262740|NCT02265913|12458179|FG000|COMPLETED|Overall Study||793
11262741|NCT02265913|12458180|FG001|COMPLETED|Overall Study||810
11262742|NCT02265913|12458181|FG002|COMPLETED|Overall Study||813
11262743|NCT02265913|12458179|FG000|NOT COMPLETED|Overall Study||564
11262744|NCT02265913|12458180|FG001|NOT COMPLETED|Overall Study||551
11262745|NCT02265913|12458181|FG002|NOT COMPLETED|Overall Study||545
11262746|NCT02265952|12458189|FG000|STARTED|Main Study Period||9
11262747|NCT02265952|12458190|FG001|STARTED|Main Study Period||0
11262748|NCT02265952|12458189|FG000|COMPLETED|Main Study Period||9
11262749|NCT02265952|12458190|FG001|COMPLETED|Main Study Period||0
11262750|NCT02265952|12458189|FG000|NOT COMPLETED|Main Study Period||0
11262751|NCT02265952|12458190|FG001|NOT COMPLETED|Main Study Period||0
11262752|NCT02265952|12458189|FG000|STARTED|Open Label Extension (OLE) Period||0
11262753|NCT02265952|12458190|FG001|STARTED|Open Label Extension (OLE) Period||8
11262754|NCT02265952|12458189|FG000|COMPLETED|Open Label Extension (OLE) Period||0
11262755|NCT02265952|12458190|FG001|COMPLETED|Open Label Extension (OLE) Period||0
11262756|NCT02265952|12458189|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0
11262757|NCT02265952|12458190|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||8
11262758|NCT02265965|12458198|FG000|STARTED|Overall Study||7
11262759|NCT02265965|12458199|FG001|STARTED|Overall Study||11
11262760|NCT02265965|12458198|FG000|COMPLETED|Overall Study||7
11262761|NCT02265965|12458199|FG001|COMPLETED|Overall Study||11
11262762|NCT02265965|12458198|FG000|NOT COMPLETED|Overall Study||0
11262763|NCT02265965|12458199|FG001|NOT COMPLETED|Overall Study||0
11262764|NCT02266004|12458205|FG000|STARTED|Overall Study||9
11262765|NCT02266004|12458205|FG000|COMPLETED|Overall Study||7
11262766|NCT02266004|12458205|FG000|NOT COMPLETED|Overall Study||2
11262767|NCT02266108|12458211|FG000|STARTED|Overall Study||80
11262768|NCT02266108|12458212|FG001|STARTED|Overall Study||71
11262769|NCT02266108|12458211|FG000|COMPLETED|Overall Study||80
11262770|NCT02266108|12458212|FG001|COMPLETED|Overall Study||71
11262771|NCT02266108|12458211|FG000|NOT COMPLETED|Overall Study||0
11262772|NCT02266108|12458212|FG001|NOT COMPLETED|Overall Study||0
11262773|NCT02266147|12458222|FG000|STARTED|PART 1: Dose Escalation||3
11262774|NCT02266147|12458223|FG001|STARTED|PART 1: Dose Escalation||3
11262775|NCT02266147|12458224|FG002|STARTED|PART 1: Dose Escalation||3
11262776|NCT02266147|12458225|FG003|STARTED|PART 1: Dose Escalation||4
11262777|NCT02266147|12458222|FG000|COMPLETED|PART 1: Dose Escalation||2
11262778|NCT02266147|12458223|FG001|COMPLETED|PART 1: Dose Escalation||0
11262779|NCT02266147|12458224|FG002|COMPLETED|PART 1: Dose Escalation||0
11262780|NCT02266147|12458225|FG003|COMPLETED|PART 1: Dose Escalation||0
11262781|NCT02266147|12458222|FG000|NOT COMPLETED|PART 1: Dose Escalation||1
11262782|NCT02266147|12458223|FG001|NOT COMPLETED|PART 1: Dose Escalation||3
11262783|NCT02266147|12458224|FG002|NOT COMPLETED|PART 1: Dose Escalation||3
11262784|NCT02266147|12458225|FG003|NOT COMPLETED|PART 1: Dose Escalation||4
11262785|NCT02266147|12458222|FG000|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|7
11262786|NCT02266147|12458223|FG001|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
11262787|NCT02266147|12458224|FG002|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
11262788|NCT02266147|12458225|FG003|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|9
11262789|NCT02266147|12458222|FG000|COMPLETED|PART 2: Dose Expansion||0
11262790|NCT02266147|12458223|FG001|COMPLETED|PART 2: Dose Expansion||0
11262791|NCT02266147|12458224|FG002|COMPLETED|PART 2: Dose Expansion||0
11262792|NCT02266147|12458225|FG003|COMPLETED|PART 2: Dose Expansion||0
11262793|NCT02266147|12458222|FG000|NOT COMPLETED|PART 2: Dose Expansion||7
11262794|NCT02266147|12458223|FG001|NOT COMPLETED|PART 2: Dose Expansion||0
11262795|NCT02266147|12458224|FG002|NOT COMPLETED|PART 2: Dose Expansion||0
11262796|NCT02266147|12458225|FG003|NOT COMPLETED|PART 2: Dose Expansion||9
11262797|NCT02266225|12458237|FG000|STARTED|Overall Study||48
11262798|NCT02266225|12458237|FG000|Enrolled in Intervention|Overall Study||44
11262799|NCT02266225|12458237|FG000|COMPLETED|Overall Study||32
11262800|NCT02266225|12458237|FG000|NOT COMPLETED|Overall Study||16
11262801|NCT02266277|12458248|FG000|STARTED|Overall Study||5000
11262802|NCT02266277|12458249|FG001|STARTED|Overall Study||5000
11262803|NCT02266277|12458250|FG002|STARTED|Overall Study||5000
11262804|NCT02266277|12458251|FG003|STARTED|Overall Study||5000
11262805|NCT02266277|12458252|FG004|STARTED|Overall Study||5000
11262806|NCT02266277|12458253|FG005|STARTED|Overall Study||5000
11262807|NCT02266277|12458248|FG000|COMPLETED|Overall Study||5000
11262808|NCT02266277|12458249|FG001|COMPLETED|Overall Study||5000
11262809|NCT02266277|12458250|FG002|COMPLETED|Overall Study||5000
11262810|NCT02266277|12458251|FG003|COMPLETED|Overall Study||5000
11262811|NCT02266277|12458252|FG004|COMPLETED|Overall Study||5000
11262812|NCT02266277|12458253|FG005|COMPLETED|Overall Study||5000
11262813|NCT02266277|12458248|FG000|NOT COMPLETED|Overall Study||0
11262814|NCT02266277|12458249|FG001|NOT COMPLETED|Overall Study||0
11262815|NCT02266277|12458250|FG002|NOT COMPLETED|Overall Study||0
11262816|NCT02266277|12458251|FG003|NOT COMPLETED|Overall Study||0
11262817|NCT02266277|12458252|FG004|NOT COMPLETED|Overall Study||0
11262818|NCT02266277|12458253|FG005|NOT COMPLETED|Overall Study||0
11262819|NCT02266381|12458272|FG000|STARTED|Overall Study||150
11262820|NCT02266381|12458273|FG001|STARTED|Overall Study||150
11262821|NCT02266381|12458274|FG002|STARTED|Overall Study||150
11262822|NCT02266381|12458272|FG000|COMPLETED|Overall Study||147
11262823|NCT02266381|12458273|FG001|COMPLETED|Overall Study||145
11262824|NCT02266381|12458274|FG002|COMPLETED|Overall Study||146
11262825|NCT02266381|12458272|FG000|NOT COMPLETED|Overall Study||3
11262826|NCT02266381|12458273|FG001|NOT COMPLETED|Overall Study||5
11262827|NCT02266381|12458274|FG002|NOT COMPLETED|Overall Study||4
11262828|NCT02266433|12458286|FG000|STARTED|Overall Study||127
11262829|NCT02266433|12458287|FG001|STARTED|Overall Study||118
11262830|NCT02266433|12458286|FG000|COMPLETED|Overall Study||68
11262831|NCT02266433|12458287|FG001|COMPLETED|Overall Study||65
11262832|NCT02266433|12458286|FG000|NOT COMPLETED|Overall Study||59
11262833|NCT02266433|12458287|FG001|NOT COMPLETED|Overall Study||53
11262834|NCT02266472|12458296|FG000|STARTED|Period 1+ Washout||15
11262835|NCT02266472|12458297|FG001|STARTED|Period 1+ Washout||15
11262836|NCT02266472|12458296|FG000|COMPLETED|Period 1+ Washout||15
11262837|NCT02266472|12458297|FG001|COMPLETED|Period 1+ Washout||15
11262838|NCT02266472|12458296|FG000|NOT COMPLETED|Period 1+ Washout||0
11262839|NCT02266472|12458297|FG001|NOT COMPLETED|Period 1+ Washout||0
11262840|NCT02266472|12458296|FG000|STARTED|Period 2+ Washout||15
11262841|NCT02266472|12458297|FG001|STARTED|Period 2+ Washout||15
11262842|NCT02266472|12458296|FG000|COMPLETED|Period 2+ Washout||15
11262843|NCT02266472|12458297|FG001|COMPLETED|Period 2+ Washout||15
11262844|NCT02266472|12458296|FG000|NOT COMPLETED|Period 2+ Washout||0
11262845|NCT02266472|12458297|FG001|NOT COMPLETED|Period 2+ Washout||0
11262846|NCT02266576|12458305|FG000|STARTED|Overall Study||102
11262847|NCT02266576|12458306|FG001|STARTED|Overall Study||105
11262848|NCT02266576|12458305|FG000|COMPLETED|Overall Study||85
11262849|NCT02266576|12458306|FG001|COMPLETED|Overall Study||90
11262850|NCT02266576|12458305|FG000|NOT COMPLETED|Overall Study||17
11262851|NCT02266576|12458306|FG001|NOT COMPLETED|Overall Study||15
11262852|NCT02266706|12458321|FG000|STARTED|Overall Study||6
11262853|NCT02266706|12458322|FG001|STARTED|Overall Study||7
11262854|NCT02266706|12458323|FG002|STARTED|Overall Study||4
11262855|NCT02266706|12458324|FG003|STARTED|Overall Study||4
11262856|NCT02266706|12458325|FG004|STARTED|Overall Study||1
11262857|NCT02266706|12458326|FG005|STARTED|Overall Study||7
11262858|NCT02266706|12458327|FG006|STARTED|Overall Study||8
11262859|NCT02266706|12458328|FG007|STARTED|Overall Study||2
11262860|NCT02266706|12458329|FG008|STARTED|Overall Study||4
11262861|NCT02266706|12458321|FG000|Treated|Overall Study||6
11262862|NCT02266706|12458322|FG001|Treated|Overall Study||6
11262863|NCT02266706|12458323|FG002|Treated|Overall Study||3
11262864|NCT02266706|12458324|FG003|Treated|Overall Study||3
11262865|NCT02266706|12458325|FG004|Treated|Overall Study||1
11262866|NCT02266706|12458326|FG005|Treated|Overall Study||5
11262867|NCT02266706|12458327|FG006|Treated|Overall Study||7
11262868|NCT02266706|12458328|FG007|Treated|Overall Study||2
11262869|NCT02266706|12458329|FG008|Treated|Overall Study||4
11262870|NCT02266706|12458321|FG000|COMPLETED|Overall Study||6
11262871|NCT02266706|12458322|FG001|COMPLETED|Overall Study||6
11262872|NCT02266706|12458323|FG002|COMPLETED|Overall Study||3
11262873|NCT02266706|12458324|FG003|COMPLETED|Overall Study||3
11262874|NCT02266706|12458325|FG004|COMPLETED|Overall Study||1
11262875|NCT02266706|12458326|FG005|COMPLETED|Overall Study||5
11262876|NCT02266706|12458327|FG006|COMPLETED|Overall Study||7
11262877|NCT02266706|12458328|FG007|COMPLETED|Overall Study||2
11262878|NCT02266706|12458329|FG008|COMPLETED|Overall Study||4
11262879|NCT02266706|12458321|FG000|NOT COMPLETED|Overall Study||0
11262880|NCT02266706|12458322|FG001|NOT COMPLETED|Overall Study||1
11262881|NCT02266706|12458323|FG002|NOT COMPLETED|Overall Study||1
11262882|NCT02266706|12458324|FG003|NOT COMPLETED|Overall Study||1
11262883|NCT02266706|12458325|FG004|NOT COMPLETED|Overall Study||0
11262884|NCT02266706|12458326|FG005|NOT COMPLETED|Overall Study||2
11262885|NCT02266706|12458327|FG006|NOT COMPLETED|Overall Study||1
11262886|NCT02266706|12458328|FG007|NOT COMPLETED|Overall Study||0
11262887|NCT02266706|12458329|FG008|NOT COMPLETED|Overall Study||0
11340036|NCT02918266|12537329|FG003|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340037|NCT02918266|12537330|FG004|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340038|NCT02918266|12537331|FG005|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340039|NCT02918266|12537332|FG006|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340040|NCT02918266|12537333|FG007|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340041|NCT02918266|12537334|FG008|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340042|NCT02918266|12537335|FG009|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340043|NCT02918266|12537336|FG010|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340044|NCT02918266|12537326|FG000|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340045|NCT02918266|12537327|FG001|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340046|NCT02918266|12537328|FG002|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340047|NCT02918266|12537329|FG003|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340048|NCT02918266|12537330|FG004|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340049|NCT02918266|12537331|FG005|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340050|NCT02918266|12537332|FG006|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340051|NCT02918266|12537333|FG007|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340052|NCT02918266|12537334|FG008|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340053|NCT02918266|12537335|FG009|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340054|NCT02918266|12537336|FG010|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
11340055|NCT02918279|12537358|FG000|STARTED|Overall Study||125
11340056|NCT02918279|12537359|FG001|STARTED|Overall Study||126
11340057|NCT02918279|12537358|FG000|Full Analysis Set|Overall Study||125
11340058|NCT02918279|12537359|FG001|Full Analysis Set|Overall Study||126
11340059|NCT02918279|12537358|FG000|Safety Analysis Set|Overall Study||125
11340060|NCT02918279|12537359|FG001|Safety Analysis Set|Overall Study||126
11340061|NCT02918279|12537358|FG000|COMPLETED|Overall Study||112
11340062|NCT02918279|12537359|FG001|COMPLETED|Overall Study||103
11340063|NCT02918279|12537358|FG000|NOT COMPLETED|Overall Study||13
11340064|NCT02918279|12537359|FG001|NOT COMPLETED|Overall Study||23
11340065|NCT02918318|12537369|FG000|STARTED|Double-blind Induction Phase: 4 Weeks||41
11340066|NCT02918318|12537370|FG001|STARTED|Double-blind Induction Phase: 4 Weeks||40
11340067|NCT02918318|12537371|FG002|STARTED|Double-blind Induction Phase: 4 Weeks||41
11340068|NCT02918318|12537372|FG003|STARTED|Double-blind Induction Phase: 4 Weeks||80
11340069|NCT02918318|12537373|FG004|STARTED|Double-blind Induction Phase: 4 Weeks||0
11340070|NCT02918318|12537369|FG000|Responders|Double-blind Induction Phase: 4 Weeks||13
11340071|NCT02918318|12537370|FG001|Responders|Double-blind Induction Phase: 4 Weeks||11
11340072|NCT02918318|12537371|FG002|Responders|Double-blind Induction Phase: 4 Weeks||17
11340073|NCT02918318|12537372|FG003|Responders|Double-blind Induction Phase: 4 Weeks||27
11340074|NCT02918318|12537373|FG004|Responders|Double-blind Induction Phase: 4 Weeks||0
11340075|NCT02918318|12537369|FG000|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
11340076|NCT02918318|12537370|FG001|COMPLETED|Double-blind Induction Phase: 4 Weeks||33
11340077|NCT02918318|12537371|FG002|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
11340078|NCT02918318|12537372|FG003|COMPLETED|Double-blind Induction Phase: 4 Weeks||72
11340079|NCT02918318|12537373|FG004|COMPLETED|Double-blind Induction Phase: 4 Weeks||0
11340080|NCT02918318|12537369|FG000|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
11340081|NCT02918318|12537370|FG001|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||7
11340082|NCT02918318|12537371|FG002|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
11340083|NCT02918318|12537372|FG003|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||8
11340084|NCT02918318|12537373|FG004|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||0
11340085|NCT02918318|12537369|FG000|STARTED|Double-blind Follow-up Phase: 4 Weeks||27
11340086|NCT02918318|12537370|FG001|STARTED|Double-blind Follow-up Phase: 4 Weeks||28
11340087|NCT02918318|12537371|FG002|STARTED|Double-blind Follow-up Phase: 4 Weeks||24
11340088|NCT02918318|12537372|FG003|STARTED|Double-blind Follow-up Phase: 4 Weeks||53
11340089|NCT02918318|12537373|FG004|STARTED|Double-blind Follow-up Phase: 4 Weeks||0
11340090|NCT02918318|12537369|FG000|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||26
11340091|NCT02918318|12537370|FG001|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||28
11340092|NCT02918318|12537371|FG002|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||23
11340093|NCT02918318|12537372|FG003|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||50
11340094|NCT02918318|12537373|FG004|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
11340095|NCT02918318|12537369|FG000|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
11340096|NCT02918318|12537370|FG001|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
11340097|NCT02918318|12537371|FG002|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
11358996|NCT03131713|12556121|FG001|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51
11358997|NCT03131713|12556120|FG000|COMPLETED|Overall Study||45
11358998|NCT03131713|12556121|FG001|COMPLETED|Overall Study||51
11340098|NCT02918318|12537372|FG003|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||3
11340099|NCT02918318|12537373|FG004|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
11262888|NCT02266810|12458351|FG000|STARTED|Overall Study|sinus sides|80
11262889|NCT02266810|12458352|FG001|STARTED|Overall Study|sinus sides|80
11262890|NCT02266810|12458351|FG000|COMPLETED|Overall Study|sinus sides|79
11262891|NCT02266810|12458352|FG001|COMPLETED|Overall Study|sinus sides|79
11262892|NCT02266810|12458351|FG000|NOT COMPLETED|Overall Study||1
11262893|NCT02266810|12458352|FG001|NOT COMPLETED|Overall Study||1
11262894|NCT02266875|12458369|FG000|STARTED|Overall Study||40
11262895|NCT02266875|12458370|FG001|STARTED|Overall Study||30
11262896|NCT02266875|12458369|FG000|COMPLETED|Overall Study||29
11262897|NCT02266875|12458370|FG001|COMPLETED|Overall Study||30
11262898|NCT02266875|12458369|FG000|NOT COMPLETED|Overall Study||11
11262899|NCT02266875|12458370|FG001|NOT COMPLETED|Overall Study||0
11262900|NCT02266888|12458378|FG000|STARTED|Overall Study||15
11262901|NCT02266888|12458379|FG001|STARTED|Overall Study||12
11262902|NCT02266888|12458380|FG002|STARTED|Overall Study||11
11262903|NCT02266888|12458381|FG003|STARTED|Overall Study||7
11262904|NCT02266888|12458378|FG000|COMPLETED|Overall Study||8
11262905|NCT02266888|12458379|FG001|COMPLETED|Overall Study||8
11262906|NCT02266888|12458380|FG002|COMPLETED|Overall Study||0
11262907|NCT02266888|12458381|FG003|COMPLETED|Overall Study||0
11262908|NCT02266888|12458378|FG000|NOT COMPLETED|Overall Study||7
11262909|NCT02266888|12458379|FG001|NOT COMPLETED|Overall Study||4
11262910|NCT02266888|12458380|FG002|NOT COMPLETED|Overall Study||11
11262911|NCT02266888|12458381|FG003|NOT COMPLETED|Overall Study||7
11262912|NCT02267083|12458389|FG000|STARTED|Overall Study||22
11262913|NCT02267083|12458389|FG000|COMPLETED|Overall Study||3
11262914|NCT02267083|12458389|FG000|NOT COMPLETED|Overall Study||19
11262915|NCT02267135|12458395|FG000|STARTED|Period 1 (Randomized Set)||51
11262916|NCT02267135|12458396|FG001|STARTED|Period 1 (Randomized Set)||51
11262917|NCT02267135|12458395|FG000|COMPLETED|Period 1 (Randomized Set)||50
11262918|NCT02267135|12458396|FG001|COMPLETED|Period 1 (Randomized Set)||47
11262919|NCT02267135|12458395|FG000|NOT COMPLETED|Period 1 (Randomized Set)||1
11262920|NCT02267135|12458396|FG001|NOT COMPLETED|Period 1 (Randomized Set)||4
11262921|NCT02267135|12458395|FG000|STARTED|Period 2 (Randomized Set)||50
11262922|NCT02267135|12458396|FG001|STARTED|Period 2 (Randomized Set)||47
11262923|NCT02267135|12458395|FG000|COMPLETED|Period 2 (Randomized Set)||46
11262924|NCT02267135|12458396|FG001|COMPLETED|Period 2 (Randomized Set)||46
11262925|NCT02267135|12458395|FG000|NOT COMPLETED|Period 2 (Randomized Set)||4
11262926|NCT02267135|12458396|FG001|NOT COMPLETED|Period 2 (Randomized Set)||1
11262927|NCT02267187|12458405|FG000|STARTED|Overall Study||15
11262928|NCT02267187|12458405|FG000|COMPLETED|Overall Study||10
11262929|NCT02267187|12458405|FG000|NOT COMPLETED|Overall Study||5
11262930|NCT02267226|12458409|FG000|STARTED|Overall Study||25
11262931|NCT02267226|12458409|FG000|SAFETY Population|Overall Study||25
11262932|NCT02267226|12458409|FG000|FAS-Bleeding Population|Overall Study||24
11262933|NCT02267226|12458409|FG000|Surgical Prophylaxis Population|Overall Study||9
11262934|NCT02267226|12458409|FG000|COMPLETED|Overall Study||18
11262935|NCT02267226|12458409|FG000|NOT COMPLETED|Overall Study||7
11262936|NCT02267278|12458428|FG000|STARTED|Overall Study||25
11262937|NCT02267278|12458428|FG000|COMPLETED|Overall Study||20
11262938|NCT02267278|12458428|FG000|NOT COMPLETED|Overall Study||5
11262939|NCT02267317|12458435|FG000|STARTED|Infusion1||8
11262940|NCT02267317|12458436|FG001|STARTED|Infusion1||3
11262941|NCT02267317|12458437|FG002|STARTED|Infusion1||1
11262942|NCT02267317|12458438|FG003|STARTED|Infusion1||2
11262943|NCT02267317|12458439|FG004|STARTED|Infusion1||0
11262944|NCT02267317|12458440|FG005|STARTED|Infusion1||1
11262945|NCT02267317|12458435|FG000|COMPLETED|Infusion1||8
11262946|NCT02267317|12458436|FG001|COMPLETED|Infusion1||3
11262947|NCT02267317|12458437|FG002|COMPLETED|Infusion1||1
11262948|NCT02267317|12458438|FG003|COMPLETED|Infusion1||2
11262949|NCT02267317|12458439|FG004|COMPLETED|Infusion1||0
11262950|NCT02267317|12458440|FG005|COMPLETED|Infusion1||1
11262951|NCT02267317|12458435|FG000|NOT COMPLETED|Infusion1||0
11262952|NCT02267317|12458436|FG001|NOT COMPLETED|Infusion1||0
11262953|NCT02267317|12458437|FG002|NOT COMPLETED|Infusion1||0
11262954|NCT02267317|12458438|FG003|NOT COMPLETED|Infusion1||0
11262955|NCT02267317|12458439|FG004|NOT COMPLETED|Infusion1||0
11262956|NCT02267317|12458440|FG005|NOT COMPLETED|Infusion1||0
11262957|NCT02267317|12458435|FG000|STARTED|Washout (3-4weeks Between Infusions)||8
11262958|NCT02267317|12458436|FG001|STARTED|Washout (3-4weeks Between Infusions)||3
11262959|NCT02267317|12458437|FG002|STARTED|Washout (3-4weeks Between Infusions)||1
11262960|NCT02267317|12458438|FG003|STARTED|Washout (3-4weeks Between Infusions)||2
11262961|NCT02267317|12458439|FG004|STARTED|Washout (3-4weeks Between Infusions)||0
11262962|NCT02267317|12458440|FG005|STARTED|Washout (3-4weeks Between Infusions)||1
11262963|NCT02267317|12458435|FG000|COMPLETED|Washout (3-4weeks Between Infusions)||6
11262964|NCT02267317|12458436|FG001|COMPLETED|Washout (3-4weeks Between Infusions)||3
11262965|NCT02267317|12458437|FG002|COMPLETED|Washout (3-4weeks Between Infusions)||1
11262966|NCT02267317|12458438|FG003|COMPLETED|Washout (3-4weeks Between Infusions)||2
11262967|NCT02267317|12458439|FG004|COMPLETED|Washout (3-4weeks Between Infusions)||0
11262968|NCT02267317|12458440|FG005|COMPLETED|Washout (3-4weeks Between Infusions)||1
11262969|NCT02267317|12458435|FG000|NOT COMPLETED|Washout (3-4weeks Between Infusions)||2
11262970|NCT02267317|12458436|FG001|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
11262971|NCT02267317|12458437|FG002|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
11262972|NCT02267317|12458438|FG003|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
11262973|NCT02267317|12458439|FG004|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
11262974|NCT02267317|12458440|FG005|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
11262975|NCT02267317|12458435|FG000|STARTED|Infusion2||6
11262976|NCT02267317|12458436|FG001|STARTED|Infusion2||3
11262977|NCT02267317|12458437|FG002|STARTED|Infusion2||1
11262978|NCT02267317|12458438|FG003|STARTED|Infusion2||2
11262979|NCT02267317|12458439|FG004|STARTED|Infusion2||0
11262980|NCT02267317|12458440|FG005|STARTED|Infusion2||1
11262981|NCT02267317|12458435|FG000|COMPLETED|Infusion2||6
11262982|NCT02267317|12458436|FG001|COMPLETED|Infusion2||3
11262983|NCT02267317|12458437|FG002|COMPLETED|Infusion2||1
11262984|NCT02267317|12458438|FG003|COMPLETED|Infusion2||2
11262985|NCT02267317|12458439|FG004|COMPLETED|Infusion2||0
11262986|NCT02267317|12458440|FG005|COMPLETED|Infusion2||1
11262987|NCT02267317|12458435|FG000|NOT COMPLETED|Infusion2||0
11262988|NCT02267317|12458436|FG001|NOT COMPLETED|Infusion2||0
11262989|NCT02267317|12458437|FG002|NOT COMPLETED|Infusion2||0
11262990|NCT02267317|12458438|FG003|NOT COMPLETED|Infusion2||0
11262991|NCT02267317|12458439|FG004|NOT COMPLETED|Infusion2||0
11262992|NCT02267317|12458440|FG005|NOT COMPLETED|Infusion2||0
11262993|NCT02267356|12458459|FG000|STARTED|Initial Study||53
11262994|NCT02267356|12458460|FG001|STARTED|Initial Study||53
11262995|NCT02267356|12458461|FG002|STARTED|Initial Study||52
11262996|NCT02267356|12458462|FG003|STARTED|Initial Study||54
11262997|NCT02267356|12458463|FG004|STARTED|Initial Study||47
11262998|NCT02267356|12458459|FG000|COMPLETED|Initial Study||47
11262999|NCT02267356|12458460|FG001|COMPLETED|Initial Study||48
11263000|NCT02267356|12458461|FG002|COMPLETED|Initial Study||42
11263001|NCT02267356|12458462|FG003|COMPLETED|Initial Study||43
11263002|NCT02267356|12458463|FG004|COMPLETED|Initial Study||42
11263003|NCT02267356|12458459|FG000|NOT COMPLETED|Initial Study||6
11263004|NCT02267356|12458460|FG001|NOT COMPLETED|Initial Study||5
11263005|NCT02267356|12458461|FG002|NOT COMPLETED|Initial Study||10
11263006|NCT02267356|12458462|FG003|NOT COMPLETED|Initial Study||11
11263007|NCT02267356|12458463|FG004|NOT COMPLETED|Initial Study||5
11263008|NCT02267356|12458459|FG000|STARTED|Study Extension||33
11263009|NCT02267356|12458460|FG001|STARTED|Study Extension||37
11263010|NCT02267356|12458461|FG002|STARTED|Study Extension||30
11263011|NCT02267356|12458462|FG003|STARTED|Study Extension||32
11263012|NCT02267356|12458463|FG004|STARTED|Study Extension||26
11263013|NCT02267356|12458459|FG000|COMPLETED|Study Extension||32
11263014|NCT02267356|12458460|FG001|COMPLETED|Study Extension||37
11263015|NCT02267356|12458461|FG002|COMPLETED|Study Extension||29
11263016|NCT02267356|12458462|FG003|COMPLETED|Study Extension||30
11263017|NCT02267356|12458463|FG004|COMPLETED|Study Extension||26
11263018|NCT02267356|12458459|FG000|NOT COMPLETED|Study Extension||1
11263019|NCT02267356|12458460|FG001|NOT COMPLETED|Study Extension||0
11263020|NCT02267356|12458461|FG002|NOT COMPLETED|Study Extension||1
11263021|NCT02267356|12458462|FG003|NOT COMPLETED|Study Extension||2
11263022|NCT02267356|12458463|FG004|NOT COMPLETED|Study Extension||0
11263023|NCT02267382|12458480|FG000|STARTED|Overall Study||42
11263024|NCT02267382|12458481|FG001|STARTED|Overall Study||43
11263025|NCT02267382|12458482|FG002|STARTED|Overall Study||43
11263026|NCT02267382|12458483|FG003|STARTED|Overall Study||41
11263027|NCT02267382|12458484|FG004|STARTED|Overall Study||46
11263028|NCT02267382|12458480|FG000|COMPLETED|Overall Study||35
11263029|NCT02267382|12458481|FG001|COMPLETED|Overall Study||33
11263030|NCT02267382|12458482|FG002|COMPLETED|Overall Study||34
11263031|NCT02267382|12458483|FG003|COMPLETED|Overall Study||35
11263032|NCT02267382|12458484|FG004|COMPLETED|Overall Study||39
11263033|NCT02267382|12458480|FG000|NOT COMPLETED|Overall Study||7
11263034|NCT02267382|12458481|FG001|NOT COMPLETED|Overall Study||10
11263035|NCT02267382|12458482|FG002|NOT COMPLETED|Overall Study||9
11263036|NCT02267382|12458483|FG003|NOT COMPLETED|Overall Study||6
11263037|NCT02267382|12458484|FG004|NOT COMPLETED|Overall Study||7
11263038|NCT02267447|12458498|FG000|STARTED|Overall Study||77251
11263039|NCT02267447|12458499|FG001|STARTED|Overall Study||26968
11263040|NCT02267447|12458498|FG000|COMPLETED|Overall Study||77251
11263041|NCT02267447|12458499|FG001|COMPLETED|Overall Study||26968
11263042|NCT02267447|12458498|FG000|NOT COMPLETED|Overall Study||0
11263043|NCT02267447|12458499|FG001|NOT COMPLETED|Overall Study||0
11263044|NCT02267538|12458508|FG000|STARTED|Overall Study||142
11263045|NCT02267538|12458509|FG001|STARTED|Overall Study||143
11263046|NCT02267538|12458508|FG000|COMPLETED|Overall Study||142
11263047|NCT02267538|12458509|FG001|COMPLETED|Overall Study||143
11263048|NCT02267538|12458508|FG000|NOT COMPLETED|Overall Study||0
11263049|NCT02267538|12458509|FG001|NOT COMPLETED|Overall Study||0
11263050|NCT02267577|12458515|FG000|STARTED|Overall Study||85
11263051|NCT02267577|12458515|FG000|COMPLETED|Overall Study||81
11263052|NCT02267577|12458515|FG000|NOT COMPLETED|Overall Study||4
11263053|NCT02267629|12458520|FG000|STARTED|Overall Study||7
11263054|NCT02267629|12458520|FG000|COMPLETED|Overall Study||7
11263055|NCT02267629|12458520|FG000|NOT COMPLETED|Overall Study||0
11263056|NCT02267746|12458527|FG000|STARTED|Overall Study||298
11263057|NCT02267746|12458528|FG001|STARTED|Overall Study||296
11263058|NCT02267746|12458529|FG002|STARTED|Overall Study||299
11263059|NCT02267746|12458527|FG000|COMPLETED|Overall Study||277
11263060|NCT02267746|12458528|FG001|COMPLETED|Overall Study||274
11263061|NCT02267746|12458529|FG002|COMPLETED|Overall Study||278
11263062|NCT02267746|12458527|FG000|NOT COMPLETED|Overall Study||21
11263063|NCT02267746|12458528|FG001|NOT COMPLETED|Overall Study||22
11263064|NCT02267746|12458529|FG002|NOT COMPLETED|Overall Study||21
11263065|NCT02267772|12458541|FG000|STARTED|Overall Study||50
11263066|NCT02267772|12458542|FG001|STARTED|Overall Study||52
11263067|NCT02267772|12458541|FG000|Randomized|Overall Study||50
11263068|NCT02267772|12458542|FG001|Randomized|Overall Study||52
11263069|NCT02267772|12458541|FG000|Received Study Drug|Overall Study||48
11263070|NCT02267772|12458542|FG001|Received Study Drug|Overall Study||52
11263071|NCT02267772|12458541|FG000|COMPLETED|Overall Study||48
11263072|NCT02267772|12458542|FG001|COMPLETED|Overall Study||52
11263073|NCT02267772|12458541|FG000|NOT COMPLETED|Overall Study||2
11263074|NCT02267772|12458542|FG001|NOT COMPLETED|Overall Study||0
11263075|NCT02267811|12458550|FG000|STARTED|Overall Study||16
11263076|NCT02267811|12458551|FG001|STARTED|Overall Study||17
11263077|NCT02267811|12458550|FG000|COMPLETED|Overall Study||15
11263078|NCT02267811|12458551|FG001|COMPLETED|Overall Study||15
11263079|NCT02267811|12458550|FG000|NOT COMPLETED|Overall Study||1
11263080|NCT02267811|12458551|FG001|NOT COMPLETED|Overall Study||2
11263081|NCT02267824|12458561|FG000|STARTED|Overall Study||83
11263082|NCT02267824|12458562|FG001|STARTED|Overall Study||18
11263083|NCT02267824|12458561|FG000|COMPLETED|Overall Study||73
11263084|NCT02267824|12458562|FG001|COMPLETED|Overall Study||17
11263085|NCT02267824|12458561|FG000|NOT COMPLETED|Overall Study||10
11263086|NCT02267824|12458562|FG001|NOT COMPLETED|Overall Study||1
11263087|NCT02267837|12458570|FG000|STARTED|Overall Study||11
11263088|NCT02267837|12458571|FG001|STARTED|Overall Study||9
11263089|NCT02267837|12458570|FG000|COMPLETED|Overall Study||11
11263090|NCT02267837|12458571|FG001|COMPLETED|Overall Study||9
11263091|NCT02267837|12458570|FG000|NOT COMPLETED|Overall Study||0
11263092|NCT02267837|12458571|FG001|NOT COMPLETED|Overall Study||0
11263093|NCT02267850|12458579|FG000|STARTED|Overall Study||15
11263094|NCT02267850|12458580|FG001|STARTED|Overall Study||14
11263095|NCT02267850|12458579|FG000|COMPLETED|Overall Study||14
11263096|NCT02267850|12458580|FG001|COMPLETED|Overall Study||12
11263097|NCT02267850|12458579|FG000|NOT COMPLETED|Overall Study||1
11263098|NCT02267850|12458580|FG001|NOT COMPLETED|Overall Study||2
11263099|NCT02268045|12458588|FG000|STARTED|Overall Study||136
11263100|NCT02268045|12458589|FG001|STARTED|Overall Study||136
11263101|NCT02268045|12458588|FG000|COMPLETED|Overall Study||120
11263102|NCT02268045|12458589|FG001|COMPLETED|Overall Study||116
11263103|NCT02268045|12458588|FG000|NOT COMPLETED|Overall Study||16
11263104|NCT02268045|12458589|FG001|NOT COMPLETED|Overall Study||20
11263105|NCT02268058|12458601|FG000|STARTED|Overall Study||20
11263106|NCT02268058|12458602|FG001|STARTED|Overall Study||20
11263107|NCT02268058|12458603|FG002|STARTED|Overall Study||20
11263108|NCT02268058|12458604|FG003|STARTED|Overall Study||20
11263109|NCT02268058|12458601|FG000|COMPLETED|Overall Study||19
11263110|NCT02268058|12458602|FG001|COMPLETED|Overall Study||20
11263111|NCT02268058|12458603|FG002|COMPLETED|Overall Study||20
11263112|NCT02268058|12458604|FG003|COMPLETED|Overall Study||20
11263113|NCT02268058|12458601|FG000|NOT COMPLETED|Overall Study||1
11263114|NCT02268058|12458602|FG001|NOT COMPLETED|Overall Study||0
11263115|NCT02268058|12458603|FG002|NOT COMPLETED|Overall Study||0
11263116|NCT02268058|12458604|FG003|NOT COMPLETED|Overall Study||0
11263117|NCT02268084|12458616|FG000|STARTED|Overall Study||49
11263118|NCT02268084|12458617|FG001|STARTED|Overall Study||47
11263119|NCT02268084|12458616|FG000|COMPLETED|Overall Study||40
11263120|NCT02268084|12458617|FG001|COMPLETED|Overall Study||40
11263121|NCT02268084|12458616|FG000|NOT COMPLETED|Overall Study||9
11263122|NCT02268084|12458617|FG001|NOT COMPLETED|Overall Study||7
11263123|NCT02268214|12458632|FG000|STARTED|Overall Study||277
11263124|NCT02268214|12458633|FG001|STARTED|Overall Study||296
11263125|NCT02268214|12458634|FG002|STARTED|Overall Study||260
11263126|NCT02268214|12458632|FG000|COMPLETED 24 WEEK PERIOD|Overall Study||252
11263127|NCT02268214|12458633|FG001|COMPLETED 24 WEEK PERIOD|Overall Study||273
11263128|NCT02268214|12458634|FG002|COMPLETED 24 WEEK PERIOD|Overall Study||232
11263129|NCT02268214|12458632|FG000|COMPLETED|Overall Study||235
11263130|NCT02268214|12458633|FG001|COMPLETED|Overall Study||255
11263131|NCT02268214|12458634|FG002|COMPLETED|Overall Study||218
11263132|NCT02268214|12458632|FG000|NOT COMPLETED|Overall Study||42
11263133|NCT02268214|12458633|FG001|NOT COMPLETED|Overall Study||41
11263134|NCT02268214|12458634|FG002|NOT COMPLETED|Overall Study||42
11263135|NCT02268396|12458642|FG000|STARTED|Overall Study||138
11263136|NCT02268396|12458642|FG000|COMPLETED|Overall Study||126
11263137|NCT02268396|12458642|FG000|NOT COMPLETED|Overall Study||12
11263138|NCT02268500|12458648|FG000|STARTED|Overall Study||24
11263139|NCT02268500|12458649|FG001|STARTED|Overall Study||24
11263140|NCT02268500|12458648|FG000|COMPLETED|Overall Study||24
11263141|NCT02268500|12458649|FG001|COMPLETED|Overall Study||24
11263142|NCT02268500|12458648|FG000|NOT COMPLETED|Overall Study||0
11263143|NCT02268500|12458649|FG001|NOT COMPLETED|Overall Study||0
11263144|NCT02268526|12458658|FG000|STARTED|Overall Study||6
11263145|NCT02268526|12458659|FG001|STARTED|Overall Study||59
11263146|NCT02268526|12458660|FG002|STARTED|Overall Study||21
11263147|NCT02268526|12458658|FG000|PD Analysis Set (Cohort 2)|Overall Study||0
11263148|NCT02268526|12458659|FG001|PD Analysis Set (Cohort 2)|Overall Study||42
11263149|NCT02268526|12458660|FG002|PD Analysis Set (Cohort 2)|Overall Study||17
11263150|NCT02268526|12458658|FG000|COMPLETED|Overall Study||5
11263151|NCT02268526|12458659|FG001|COMPLETED|Overall Study||38
11263152|NCT02268526|12458660|FG002|COMPLETED|Overall Study||16
11263153|NCT02268526|12458658|FG000|NOT COMPLETED|Overall Study||1
11263154|NCT02268526|12458659|FG001|NOT COMPLETED|Overall Study||21
11263155|NCT02268526|12458660|FG002|NOT COMPLETED|Overall Study||5
11263156|NCT02268786|12458672|FG000|STARTED|Overall Study||330
11263157|NCT02268786|12458673|FG001|STARTED|Overall Study||331
11263158|NCT02268786|12458672|FG000|COMPLETED|Overall Study||274
11263159|NCT02268786|12458673|FG001|COMPLETED|Overall Study||313
11263160|NCT02268786|12458672|FG000|NOT COMPLETED|Overall Study||56
11263161|NCT02268786|12458673|FG001|NOT COMPLETED|Overall Study||18
11263162|NCT02268812|12458683|FG000|STARTED|Overall Study||77
11263163|NCT02268812|12458684|FG001|STARTED|Overall Study||72
11263164|NCT02268812|12458685|FG002|STARTED|Overall Study||30
11263165|NCT02268812|12458686|FG003|STARTED|Overall Study||40
11263166|NCT02268812|12458683|FG000|COMPLETED|Overall Study||61
11263167|NCT02268812|12458684|FG001|COMPLETED|Overall Study||40
11263168|NCT02268812|12458685|FG002|COMPLETED|Overall Study||21
11263169|NCT02268812|12458686|FG003|COMPLETED|Overall Study||26
11263170|NCT02268812|12458683|FG000|NOT COMPLETED|Overall Study||16
11263171|NCT02268812|12458684|FG001|NOT COMPLETED|Overall Study||32
11263172|NCT02268812|12458685|FG002|NOT COMPLETED|Overall Study||9
11263173|NCT02268812|12458686|FG003|NOT COMPLETED|Overall Study||14
11263174|NCT02268864|12458699|FG000|STARTED|Overall Study||17
11263175|NCT02268864|12458700|FG001|STARTED|Overall Study||25
11263176|NCT02268864|12458701|FG002|STARTED|Overall Study||64
11263177|NCT02268864|12458699|FG000|COMPLETED|Overall Study||15
11263178|NCT02268864|12458700|FG001|COMPLETED|Overall Study||24
11263179|NCT02268864|12458701|FG002|COMPLETED|Overall Study||64
11263180|NCT02268864|12458699|FG000|NOT COMPLETED|Overall Study||2
11263181|NCT02268864|12458700|FG001|NOT COMPLETED|Overall Study||1
11263182|NCT02268864|12458701|FG002|NOT COMPLETED|Overall Study||0
11263183|NCT02268877|12458713|FG000|STARTED|Overall Study||122
11263184|NCT02268877|12458714|FG001|STARTED|Overall Study|111 patients were randomized to this arm.|111
11263185|NCT02268877|12458713|FG000|COMPLETED|Overall Study||118
11263186|NCT02268877|12458714|FG001|COMPLETED|Overall Study|106 patients received the intervention.|106
11263187|NCT02268877|12458713|FG000|NOT COMPLETED|Overall Study||4
11263188|NCT02268877|12458714|FG001|NOT COMPLETED|Overall Study||5
11263189|NCT02268942|12458720|FG000|STARTED|Overall Study||144
11263190|NCT02268942|12458720|FG000|COMPLETED|Overall Study||144
11263191|NCT02268942|12458720|FG000|NOT COMPLETED|Overall Study||0
11263192|NCT02268955|12458726|FG000|STARTED|Overall Study||11
11263193|NCT02268955|12458727|FG001|STARTED|Overall Study||11
11263194|NCT02268955|12458726|FG000|COMPLETED|Overall Study||9
11263195|NCT02268955|12458727|FG001|COMPLETED|Overall Study||9
11263196|NCT02268955|12458726|FG000|NOT COMPLETED|Overall Study||2
11263197|NCT02268955|12458727|FG001|NOT COMPLETED|Overall Study||2
11263198|NCT02268994|12458735|FG000|STARTED|Overall Study||117
11263199|NCT02268994|12458736|FG001|STARTED|Overall Study||116
11263200|NCT02268994|12458735|FG000|COMPLETED|Overall Study||86
11263201|NCT02268994|12458736|FG001|COMPLETED|Overall Study||81
11263202|NCT02268994|12458735|FG000|NOT COMPLETED|Overall Study||31
11263203|NCT02268994|12458736|FG001|NOT COMPLETED|Overall Study||35
11263204|NCT02269098|12458747|FG000|STARTED|Overall Study||51
11263205|NCT02269098|12458748|FG001|STARTED|Overall Study||50
11263206|NCT02269098|12458747|FG000|COMPLETED|Overall Study||37
11263207|NCT02269098|12458748|FG001|COMPLETED|Overall Study||41
11263208|NCT02269098|12458747|FG000|NOT COMPLETED|Overall Study||14
11263209|NCT02269098|12458748|FG001|NOT COMPLETED|Overall Study||9
11263210|NCT02269124|12458757|FG000|STARTED|Overall Study||21
11263211|NCT02269124|12458758|FG001|STARTED|Overall Study||16
11263212|NCT02269124|12458757|FG000|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||20
11263213|NCT02269124|12458758|FG001|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||14
11263214|NCT02269124|12458757|FG000|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||17
11263215|NCT02269124|12458758|FG001|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||13
11263216|NCT02269124|12458757|FG000|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||17
11263217|NCT02269124|12458758|FG001|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||11
11263218|NCT02269124|12458757|FG000|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||11
11263219|NCT02269124|12458758|FG001|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||8
11263220|NCT02269124|12458757|FG000|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||16
11263221|NCT02269124|12458758|FG001|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||10
11263222|NCT02269124|12458757|FG000|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||14
11263223|NCT02269124|12458758|FG001|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||10
11263224|NCT02269124|12458757|FG000|COMPLETED|Overall Study|One participant from the Conventional Measures Only First arm did not return any surveys, nor did their parent/guardian or teacher, and were deemed lost to follow-up.|20
11263225|NCT02269124|12458758|FG001|COMPLETED|Overall Study|Two participants from the Conventional measures + Hearing Aid First arm withdrew from the study prior to the second arm because they did not wish to stop using the hearing aid.|14
11263226|NCT02269124|12458757|FG000|NOT COMPLETED|Overall Study||1
11263227|NCT02269124|12458758|FG001|NOT COMPLETED|Overall Study||2
11263228|NCT02269163|12458767|FG000|STARTED|Overall Study||50
11263229|NCT02269163|12458768|FG001|STARTED|Overall Study||25
11263230|NCT02269163|12458767|FG000|COMPLETED|Overall Study||47
11263231|NCT02269163|12458768|FG001|COMPLETED|Overall Study||18
11263232|NCT02269163|12458767|FG000|NOT COMPLETED|Overall Study||3
11263233|NCT02269163|12458768|FG001|NOT COMPLETED|Overall Study||7
11263234|NCT02269241|12458776|FG000|STARTED|Overall Study||1552
11263235|NCT02269241|12458776|FG000|COMPLETED|Overall Study||352
11263236|NCT02269241|12458776|FG000|NOT COMPLETED|Overall Study||1200
11263237|NCT02269423|12458785|FG000|STARTED|Overall Study||10
11263238|NCT02269423|12458786|FG001|STARTED|Overall Study||10
11263239|NCT02269423|12458787|FG002|STARTED|Overall Study||10
11263240|NCT02269423|12458788|FG003|STARTED|Overall Study||9
11263241|NCT02269423|12458785|FG000|COMPLETED|Overall Study||10
11263242|NCT02269423|12458786|FG001|COMPLETED|Overall Study||9
11263243|NCT02269423|12458787|FG002|COMPLETED|Overall Study||10
11263244|NCT02269423|12458788|FG003|COMPLETED|Overall Study||8
11263245|NCT02269423|12458785|FG000|NOT COMPLETED|Overall Study||0
11263246|NCT02269423|12458786|FG001|NOT COMPLETED|Overall Study||1
11263247|NCT02269423|12458787|FG002|NOT COMPLETED|Overall Study||0
11263248|NCT02269423|12458788|FG003|NOT COMPLETED|Overall Study||1
11263249|NCT02269475|12458800|FG000|STARTED|Overall Study||868
11263250|NCT02269475|12458801|FG001|STARTED|Overall Study||433
11263251|NCT02269475|12458800|FG000|Received IP (Safety Population)|Overall Study||868
11263252|NCT02269475|12458801|FG001|Received IP (Safety Population)|Overall Study||433
11263253|NCT02269475|12458800|FG000|Per Protocol Population|Overall Study||849
11263254|NCT02269475|12458801|FG001|Per Protocol Population|Overall Study||430
11263255|NCT02269475|12458800|FG000|COMPLETED|Overall Study||865
11263256|NCT02269475|12458801|FG001|COMPLETED|Overall Study||432
11263257|NCT02269475|12458800|FG000|NOT COMPLETED|Overall Study||3
11263258|NCT02269475|12458801|FG001|NOT COMPLETED|Overall Study||1
11263259|NCT02269488|12458808|FG000|STARTED|Overall Study||100
11263260|NCT02269488|12458808|FG000|COMPLETED|Overall Study||100
11263261|NCT02269488|12458808|FG000|NOT COMPLETED|Overall Study||0
11263262|NCT02269631|12458814|FG000|STARTED|Overall Study||7
11263263|NCT02269631|12458815|FG001|STARTED|Overall Study||5
11263264|NCT02269631|12458814|FG000|COMPLETED|Overall Study||7
11263265|NCT02269631|12458815|FG001|COMPLETED|Overall Study||5
11263266|NCT02269631|12458814|FG000|NOT COMPLETED|Overall Study||0
11263267|NCT02269631|12458815|FG001|NOT COMPLETED|Overall Study||0
11263268|NCT02269657|12458821|FG000|STARTED|Overall Study||40
11263269|NCT02269657|12458821|FG000|COMPLETED|Overall Study||37
11263270|NCT02269657|12458821|FG000|NOT COMPLETED|Overall Study||3
11263271|NCT02269709|12458827|FG000|STARTED|Time of Enrollment||21
11263272|NCT02269709|12458827|FG000|COMPLETED|Time of Enrollment||18
11263273|NCT02269709|12458827|FG000|NOT COMPLETED|Time of Enrollment||3
11263274|NCT02269709|12458827|FG000|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
11263275|NCT02269709|12458827|FG000|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
11263276|NCT02269709|12458827|FG000|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
11263277|NCT02269709|12458827|FG000|STARTED|Prior to Hospital Discharge||17
11263278|NCT02269709|12458827|FG000|COMPLETED|Prior to Hospital Discharge||17
11263279|NCT02269709|12458827|FG000|NOT COMPLETED|Prior to Hospital Discharge||0
11263280|NCT02269709|12458827|FG000|STARTED|Six Month Follow-up||17
11263281|NCT02269709|12458827|FG000|COMPLETED|Six Month Follow-up||5
11263282|NCT02269709|12458827|FG000|NOT COMPLETED|Six Month Follow-up||12
11263283|NCT02269787|12458834|FG000|STARTED|Overall Study||148
11263284|NCT02269787|12458835|FG001|STARTED|Overall Study||150
11263285|NCT02269787|12458834|FG000|COMPLETED|Overall Study||126
11263286|NCT02269787|12458835|FG001|COMPLETED|Overall Study||140
11263287|NCT02269787|12458834|FG000|NOT COMPLETED|Overall Study||22
11263288|NCT02269787|12458835|FG001|NOT COMPLETED|Overall Study||10
11263289|NCT02269943|12458843|FG000|STARTED|Treatment Period||6
11263290|NCT02269943|12458844|FG001|STARTED|Treatment Period||30
11263291|NCT02269943|12458843|FG000|Investigational Product (IP) Stopped|Treatment Period||6
11263292|NCT02269943|12458844|FG001|Investigational Product (IP) Stopped|Treatment Period||30
11263293|NCT02269943|12458843|FG000|COMPLETED|Treatment Period|Not applicable according to the study design|0
11263294|NCT02269943|12458844|FG001|COMPLETED|Treatment Period|Not applicable according to the study design|0
11263295|NCT02269943|12458843|FG000|NOT COMPLETED|Treatment Period||6
11263296|NCT02269943|12458844|FG001|NOT COMPLETED|Treatment Period||30
11263297|NCT02269943|12458843|FG000|STARTED|Follow-Up Survival Period||5
11263298|NCT02269943|12458844|FG001|STARTED|Follow-Up Survival Period||26
11263299|NCT02269943|12458843|FG000|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
11263300|NCT02269943|12458844|FG001|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
11263301|NCT02269943|12458843|FG000|NOT COMPLETED|Follow-Up Survival Period||5
11263302|NCT02269943|12458844|FG001|NOT COMPLETED|Follow-Up Survival Period||26
11263303|NCT02270060|12458853|FG000|STARTED|Overall Study||20
11263304|NCT02270060|12458854|FG001|STARTED|Overall Study||20
11263305|NCT02270060|12458855|FG002|STARTED|Overall Study||20
11263306|NCT02270060|12458853|FG000|COMPLETED|Overall Study||20
11263307|NCT02270060|12458854|FG001|COMPLETED|Overall Study||20
11263308|NCT02270060|12458855|FG002|COMPLETED|Overall Study||20
11263309|NCT02270060|12458853|FG000|NOT COMPLETED|Overall Study||0
11263310|NCT02270060|12458854|FG001|NOT COMPLETED|Overall Study||0
11263311|NCT02270060|12458855|FG002|NOT COMPLETED|Overall Study||0
11263312|NCT02270242|12458865|FG000|STARTED|Overall Study||3555
11263313|NCT02270242|12458866|FG001|STARTED|Overall Study||3564
11263314|NCT02270242|12458865|FG000|COMPLETED|Overall Study||3496
11263315|NCT02270242|12458866|FG001|COMPLETED|Overall Study||3511
11263316|NCT02270242|12458865|FG000|NOT COMPLETED|Overall Study||59
11263317|NCT02270242|12458866|FG001|NOT COMPLETED|Overall Study||53
11263318|NCT02270255|12458874|FG000|STARTED|Overall Study||22
11263319|NCT02270255|12458875|FG001|STARTED|Overall Study||22
11263320|NCT02270255|12458874|FG000|Complete Data at Discharge PACU|Overall Study||22
11263321|NCT02270255|12458875|FG001|Complete Data at Discharge PACU|Overall Study||22
11263322|NCT02270255|12458874|FG000|Complete Data From Home Survey|Overall Study||21
11263323|NCT02270255|12458875|FG001|Complete Data From Home Survey|Overall Study||22
11263324|NCT02270255|12458874|FG000|COMPLETED|Overall Study||21
11263325|NCT02270255|12458875|FG001|COMPLETED|Overall Study||22
11263326|NCT02270255|12458874|FG000|NOT COMPLETED|Overall Study||1
11263327|NCT02270255|12458875|FG001|NOT COMPLETED|Overall Study||0
11263328|NCT02270515|12458881|FG000|STARTED|Intervention Period 1: 0-6 Months||175
11263329|NCT02270515|12458881|FG000|COMPLETED|Intervention Period 1: 0-6 Months||159
11263330|NCT02270515|12458881|FG000|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
11263331|NCT02270515|12458881|FG000|STARTED|Intervention Period 2: 6-12 Months||159
11263332|NCT02270515|12458881|FG000|COMPLETED|Intervention Period 2: 6-12 Months||127
11263333|NCT02270515|12458881|FG000|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
11263334|NCT02270515|12458881|FG000|STARTED|Intervention Period 3: 12-18 Months||127
11263335|NCT02270515|12458881|FG000|COMPLETED|Intervention Period 3: 12-18 Months||103
11263336|NCT02270515|12458881|FG000|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
11263337|NCT02270645|12458894|FG000|STARTED|Overall Study||8
11263338|NCT02270645|12458895|FG001|STARTED|Overall Study||4
11263339|NCT02270645|12458894|FG000|COMPLETED|Overall Study||6
11263340|NCT02270645|12458895|FG001|COMPLETED|Overall Study||4
11263341|NCT02270645|12458894|FG000|NOT COMPLETED|Overall Study||2
11263342|NCT02270645|12458895|FG001|NOT COMPLETED|Overall Study||0
11263343|NCT02270671|12458903|FG000|STARTED|Overall Study||64
11263344|NCT02270671|12458904|FG001|STARTED|Overall Study||66
11263345|NCT02270671|12458903|FG000|COMPLETED|Overall Study||59
11263346|NCT02270671|12458904|FG001|COMPLETED|Overall Study||61
11263347|NCT02270671|12458903|FG000|NOT COMPLETED|Overall Study||5
11263348|NCT02270671|12458904|FG001|NOT COMPLETED|Overall Study||5
11263349|NCT02270736|12458913|FG000|STARTED|Main Period (MP) (up to 16 Weeks)||72
11263350|NCT02270736|12458914|FG001|STARTED|Main Period (MP) (up to 16 Weeks)||148
11263351|NCT02270736|12458915|FG002|STARTED|Main Period (MP) (up to 16 Weeks)||36
11358999|NCT03131713|12556120|FG000|NOT COMPLETED|Overall Study||5
11142037|NCT01465997|12328713|FG000|STARTED|Overall Study||279
11142038|NCT01465997|12328714|FG001|STARTED|Overall Study||269
11142039|NCT01465997|12328713|FG000|COMPLETED|Overall Study||211
11142040|NCT01465997|12328714|FG001|COMPLETED|Overall Study||180
11263352|NCT02270736|12458916|FG003|STARTED|Main Period (MP) (up to 16 Weeks)||0
11263353|NCT02270736|12458917|FG004|STARTED|Main Period (MP) (up to 16 Weeks)||0
11263354|NCT02270736|12458913|FG000|Treated|Main Period (MP) (up to 16 Weeks)||72
11263355|NCT02270736|12458914|FG001|Treated|Main Period (MP) (up to 16 Weeks)||148
11263356|NCT02270736|12458915|FG002|Treated|Main Period (MP) (up to 16 Weeks)||35
11263357|NCT02270736|12458916|FG003|Treated|Main Period (MP) (up to 16 Weeks)||0
11263358|NCT02270736|12458917|FG004|Treated|Main Period (MP) (up to 16 Weeks)||0
11263359|NCT02270736|12458913|FG000|COMPLETED|Main Period (MP) (up to 16 Weeks)||70
11142041|NCT01465997|12328713|FG000|NOT COMPLETED|Overall Study||68
11263360|NCT02270736|12458914|FG001|COMPLETED|Main Period (MP) (up to 16 Weeks)||146
11263361|NCT02270736|12458915|FG002|COMPLETED|Main Period (MP) (up to 16 Weeks)||34
11263362|NCT02270736|12458916|FG003|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
11263363|NCT02270736|12458917|FG004|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
11263364|NCT02270736|12458913|FG000|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
11263365|NCT02270736|12458914|FG001|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
11263366|NCT02270736|12458915|FG002|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
11263367|NCT02270736|12458916|FG003|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
11263368|NCT02270736|12458917|FG004|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
11263369|NCT02270736|12458913|FG000|STARTED|OLEX Period (up to 48 Weeks)||0
11263370|NCT02270736|12458914|FG001|STARTED|OLEX Period (up to 48 Weeks)||0
11263371|NCT02270736|12458915|FG002|STARTED|OLEX Period (up to 48 Weeks)||0
11263372|NCT02270736|12458916|FG003|STARTED|OLEX Period (up to 48 Weeks)|2 participants from MP did not enter OLEX due to withdrawal of consent.|214
11263373|NCT02270736|12458917|FG004|STARTED|OLEX Period (up to 48 Weeks)|1 participant from MP did not enter OLEX due to adverse event.|33
11263374|NCT02270736|12458913|FG000|COMPLETED|OLEX Period (up to 48 Weeks)||0
11263375|NCT02270736|12458914|FG001|COMPLETED|OLEX Period (up to 48 Weeks)||0
11263376|NCT02270736|12458915|FG002|COMPLETED|OLEX Period (up to 48 Weeks)||0
11263377|NCT02270736|12458916|FG003|COMPLETED|OLEX Period (up to 48 Weeks)||189
11263378|NCT02270736|12458917|FG004|COMPLETED|OLEX Period (up to 48 Weeks)||33
11263379|NCT02270736|12458913|FG000|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
11263380|NCT02270736|12458914|FG001|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
11263381|NCT02270736|12458915|FG002|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
11263382|NCT02270736|12458916|FG003|NOT COMPLETED|OLEX Period (up to 48 Weeks)||25
11263383|NCT02270736|12458917|FG004|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
11263384|NCT02270944|12458932|FG000|STARTED|Overall Study||529
11263385|NCT02270944|12458933|FG001|STARTED|Overall Study||521
11263386|NCT02270944|12458932|FG000|COMPLETED|Overall Study||518
11263387|NCT02270944|12458933|FG001|COMPLETED|Overall Study||516
11263388|NCT02270944|12458932|FG000|NOT COMPLETED|Overall Study||11
11263389|NCT02270944|12458933|FG001|NOT COMPLETED|Overall Study||5
11263390|NCT02270983|12458943|FG000|STARTED|Overall Study||79
11263391|NCT02270983|12458944|FG001|STARTED|Overall Study||87
11263392|NCT02270983|12458945|FG002|STARTED|Overall Study||88
11263393|NCT02270983|12458943|FG000|COMPLETED|Overall Study||70
11263394|NCT02270983|12458944|FG001|COMPLETED|Overall Study||80
11263395|NCT02270983|12458945|FG002|COMPLETED|Overall Study||76
11263396|NCT02270983|12458943|FG000|NOT COMPLETED|Overall Study||9
11263397|NCT02270983|12458944|FG001|NOT COMPLETED|Overall Study||7
11263398|NCT02270983|12458945|FG002|NOT COMPLETED|Overall Study||12
11263399|NCT02271217|12458956|FG000|STARTED|Overall Study||126
11263400|NCT02271217|12458957|FG001|STARTED|Overall Study||126
11263401|NCT02271217|12458958|FG002|STARTED|Overall Study||125
11263402|NCT02271217|12458956|FG000|COMPLETED|Overall Study||115
11263403|NCT02271217|12458957|FG001|COMPLETED|Overall Study||113
11263404|NCT02271217|12458958|FG002|COMPLETED|Overall Study||113
11263405|NCT02271217|12458956|FG000|NOT COMPLETED|Overall Study||11
11263406|NCT02271217|12458957|FG001|NOT COMPLETED|Overall Study||13
11263407|NCT02271217|12458958|FG002|NOT COMPLETED|Overall Study||12
11263408|NCT02271386|12458970|FG000|STARTED|Baseline Period- 8 Months||53
11263409|NCT02271386|12458971|FG001|STARTED|Baseline Period- 8 Months||52
11263410|NCT02271386|12458972|FG002|STARTED|Baseline Period- 8 Months||200
11263411|NCT02271386|12458973|FG003|STARTED|Baseline Period- 8 Months||191
11263412|NCT02271386|12458970|FG000|COMPLETED|Baseline Period- 8 Months||53
11263413|NCT02271386|12458971|FG001|COMPLETED|Baseline Period- 8 Months||52
11263414|NCT02271386|12458972|FG002|COMPLETED|Baseline Period- 8 Months||200
11263415|NCT02271386|12458973|FG003|COMPLETED|Baseline Period- 8 Months||191
11263416|NCT02271386|12458970|FG000|NOT COMPLETED|Baseline Period- 8 Months||0
11263417|NCT02271386|12458971|FG001|NOT COMPLETED|Baseline Period- 8 Months||0
11263418|NCT02271386|12458972|FG002|NOT COMPLETED|Baseline Period- 8 Months||0
11263419|NCT02271386|12458973|FG003|NOT COMPLETED|Baseline Period- 8 Months||0
11263420|NCT02271386|12458970|FG000|STARTED|Intervention Period- 8 Months||53
11263421|NCT02271386|12458971|FG001|STARTED|Intervention Period- 8 Months||52
11263422|NCT02271386|12458972|FG002|STARTED|Intervention Period- 8 Months||202
11263423|NCT02271386|12458973|FG003|STARTED|Intervention Period- 8 Months||197
11263424|NCT02271386|12458970|FG000|COMPLETED|Intervention Period- 8 Months||53
11263425|NCT02271386|12458971|FG001|COMPLETED|Intervention Period- 8 Months||52
11263426|NCT02271386|12458972|FG002|COMPLETED|Intervention Period- 8 Months||202
11263427|NCT02271386|12458973|FG003|COMPLETED|Intervention Period- 8 Months||197
11359000|NCT03131713|12556121|FG001|NOT COMPLETED|Overall Study||0
11359001|NCT03131895|12556131|FG000|STARTED|Intervention Period 1 (2 Days)||28
11359002|NCT03131895|12556132|FG001|STARTED|Intervention Period 1 (2 Days)||28
11359003|NCT03131895|12556133|FG002|STARTED|Intervention Period 1 (2 Days)||30
11359004|NCT03131895|12556134|FG003|STARTED|Intervention Period 1 (2 Days)||30
11359005|NCT03131895|12556131|FG000|COMPLETED|Intervention Period 1 (2 Days)||28
11359006|NCT03131895|12556132|FG001|COMPLETED|Intervention Period 1 (2 Days)||28
11359007|NCT03131895|12556133|FG002|COMPLETED|Intervention Period 1 (2 Days)||30
11359008|NCT03131895|12556134|FG003|COMPLETED|Intervention Period 1 (2 Days)||30
11359009|NCT03131895|12556131|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11359010|NCT03131895|12556132|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11359011|NCT03131895|12556133|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11359012|NCT03131895|12556134|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11359013|NCT03131895|12556131|FG000|STARTED|Washout Period (at Least 5 Days)||28
11263428|NCT02271386|12458970|FG000|NOT COMPLETED|Intervention Period- 8 Months||0
11005526|NCT00723229|12183216|FG000|STARTED|First Intervention||25
11005527|NCT00723229|12183217|FG001|STARTED|First Intervention||23
11005528|NCT00723229|12183216|FG000|COMPLETED|First Intervention||18
11005529|NCT00723229|12183217|FG001|COMPLETED|First Intervention||20
11005530|NCT00723229|12183216|FG000|NOT COMPLETED|First Intervention||7
11005531|NCT00723229|12183217|FG001|NOT COMPLETED|First Intervention||3
11005532|NCT00723229|12183216|FG000|STARTED|Second Intervention||18
11005533|NCT00723229|12183217|FG001|STARTED|Second Intervention||20
11005534|NCT00723229|12183216|FG000|COMPLETED|Second Intervention||18
11005535|NCT00723229|12183217|FG001|COMPLETED|Second Intervention||20
11005536|NCT00723229|12183216|FG000|NOT COMPLETED|Second Intervention||0
11005537|NCT00723229|12183217|FG001|NOT COMPLETED|Second Intervention||0
11005538|NCT00723255|12183223|FG000|STARTED|Overall Study||53
11005539|NCT00723255|12183223|FG000|COMPLETED|Overall Study|Eligible and treated patients|49
11005540|NCT00723255|12183223|FG000|NOT COMPLETED|Overall Study||4
11263429|NCT02271386|12458971|FG001|NOT COMPLETED|Intervention Period- 8 Months||0
11263430|NCT02271386|12458972|FG002|NOT COMPLETED|Intervention Period- 8 Months||0
11263431|NCT02271386|12458973|FG003|NOT COMPLETED|Intervention Period- 8 Months||0
11263432|NCT02271425|12458987|FG000|STARTED|Overall Study||8
11263433|NCT02271425|12458987|FG000|COMPLETED|Overall Study||8
11263434|NCT02271425|12458987|FG000|NOT COMPLETED|Overall Study||0
11263435|NCT02271451|12458994|FG000|STARTED|Overall Study||7
11263436|NCT02271451|12458995|FG001|STARTED|Overall Study||8
11263437|NCT02271451|12458994|FG000|COMPLETED|Overall Study||7
11263438|NCT02271451|12458995|FG001|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7
11263439|NCT02271451|12458994|FG000|NOT COMPLETED|Overall Study||0
11263440|NCT02271451|12458995|FG001|NOT COMPLETED|Overall Study||1
11263441|NCT02271477|12459003|FG000|STARTED|Overall Study||80
11263442|NCT02271477|12459004|FG001|STARTED|Overall Study||80
11263443|NCT02271477|12459003|FG000|COMPLETED|Overall Study||80
11263444|NCT02271477|12459004|FG001|COMPLETED|Overall Study||80
11005541|NCT00723294|12183239|FG000|STARTED|Overall Study||99
11263445|NCT02271477|12459003|FG000|NOT COMPLETED|Overall Study||0
11263446|NCT02271477|12459004|FG001|NOT COMPLETED|Overall Study||0
11263447|NCT02271529|12459011|FG000|STARTED|Overall Study||40
11263448|NCT02271529|12459011|FG000|COMPLETED|Overall Study||39
11263449|NCT02271529|12459011|FG000|NOT COMPLETED|Overall Study||1
11263450|NCT02271698|12459019|FG000|STARTED|Overall Study||11
11263451|NCT02271698|12459020|FG001|STARTED|Overall Study||10
11263452|NCT02271698|12459021|FG002|STARTED|Overall Study||10
11263453|NCT02271698|12459022|FG003|STARTED|Overall Study||11
11263454|NCT02271698|12459019|FG000|COMPLETED|Overall Study||11
11263455|NCT02271698|12459020|FG001|COMPLETED|Overall Study||10
11263456|NCT02271698|12459021|FG002|COMPLETED|Overall Study||10
11263457|NCT02271698|12459022|FG003|COMPLETED|Overall Study||11
11263458|NCT02271698|12459019|FG000|NOT COMPLETED|Overall Study||0
11263459|NCT02271698|12459020|FG001|NOT COMPLETED|Overall Study||0
11263460|NCT02271698|12459021|FG002|NOT COMPLETED|Overall Study||0
11263461|NCT02271698|12459022|FG003|NOT COMPLETED|Overall Study||0
11263462|NCT02271854|12459032|FG000|STARTED|Overall Study||102
11263463|NCT02271854|12459032|FG000|COMPLETED|Overall Study||98
11263464|NCT02271854|12459032|FG000|NOT COMPLETED|Overall Study||4
11263465|NCT02271880|12459039|FG000|STARTED|Overall Study||3
11263466|NCT02271880|12459040|FG001|STARTED|Overall Study||4
11263467|NCT02271880|12459039|FG000|COMPLETED|Overall Study||0
11263468|NCT02271880|12459040|FG001|COMPLETED|Overall Study||0
11263469|NCT02271880|12459039|FG000|NOT COMPLETED|Overall Study||3
11263470|NCT02271880|12459040|FG001|NOT COMPLETED|Overall Study||4
11263471|NCT02271906|12459048|FG000|STARTED|Overall Study||2
11263472|NCT02271906|12459048|FG000|COMPLETED|Overall Study||2
11263473|NCT02271906|12459048|FG000|NOT COMPLETED|Overall Study||0
11263474|NCT02271945|12459054|FG000|STARTED|Overall Study||5
11263475|NCT02271945|12459055|FG001|STARTED|Overall Study||5
11263476|NCT02271945|12459054|FG000|COMPLETED|Overall Study||0
11263477|NCT02271945|12459055|FG001|COMPLETED|Overall Study||0
11263478|NCT02271945|12459054|FG000|NOT COMPLETED|Overall Study||5
11263479|NCT02271945|12459055|FG001|NOT COMPLETED|Overall Study||5
11263480|NCT02271984|12459061|FG000|STARTED|First Intervention Period (1 Day)||3
11263481|NCT02271984|12459062|FG001|STARTED|First Intervention Period (1 Day)||3
11263482|NCT02271984|12459063|FG002|STARTED|First Intervention Period (1 Day)||3
11263483|NCT02271984|12459064|FG003|STARTED|First Intervention Period (1 Day)||3
11263484|NCT02271984|12459065|FG004|STARTED|First Intervention Period (1 Day)||3
11263485|NCT02271984|12459066|FG005|STARTED|First Intervention Period (1 Day)||3
11263486|NCT02271984|12459067|FG006|STARTED|First Intervention Period (1 Day)||3
11263487|NCT02271984|12459068|FG007|STARTED|First Intervention Period (1 Day)||3
11263488|NCT02271984|12459069|FG008|STARTED|First Intervention Period (1 Day)||3
11263489|NCT02271984|12459070|FG009|STARTED|First Intervention Period (1 Day)||3
11263490|NCT02271984|12459071|FG010|STARTED|First Intervention Period (1 Day)||3
11263491|NCT02271984|12459072|FG011|STARTED|First Intervention Period (1 Day)||3
11263492|NCT02271984|12459061|FG000|COMPLETED|First Intervention Period (1 Day)||3
11263493|NCT02271984|12459062|FG001|COMPLETED|First Intervention Period (1 Day)||3
11263494|NCT02271984|12459063|FG002|COMPLETED|First Intervention Period (1 Day)||3
11263495|NCT02271984|12459064|FG003|COMPLETED|First Intervention Period (1 Day)||3
11263496|NCT02271984|12459065|FG004|COMPLETED|First Intervention Period (1 Day)||3
11263497|NCT02271984|12459066|FG005|COMPLETED|First Intervention Period (1 Day)||3
11263498|NCT02271984|12459067|FG006|COMPLETED|First Intervention Period (1 Day)||3
11263499|NCT02271984|12459068|FG007|COMPLETED|First Intervention Period (1 Day)||3
11263500|NCT02271984|12459069|FG008|COMPLETED|First Intervention Period (1 Day)||3
11263501|NCT02271984|12459070|FG009|COMPLETED|First Intervention Period (1 Day)||3
11263502|NCT02271984|12459071|FG010|COMPLETED|First Intervention Period (1 Day)||3
11263503|NCT02271984|12459072|FG011|COMPLETED|First Intervention Period (1 Day)||3
11263504|NCT02271984|12459061|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
11263505|NCT02271984|12459062|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
11263506|NCT02271984|12459063|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0
11263507|NCT02271984|12459064|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0
11263508|NCT02271984|12459065|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0
11263509|NCT02271984|12459066|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0
11263510|NCT02271984|12459067|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0
11263511|NCT02271984|12459068|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0
11263512|NCT02271984|12459069|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0
11263513|NCT02271984|12459070|FG009|NOT COMPLETED|First Intervention Period (1 Day)||0
11263514|NCT02271984|12459071|FG010|NOT COMPLETED|First Intervention Period (1 Day)||0
11263515|NCT02271984|12459072|FG011|NOT COMPLETED|First Intervention Period (1 Day)||0
11263516|NCT02271984|12459061|FG000|STARTED|Washout Period 1 (7 Days)||3
11263517|NCT02271984|12459062|FG001|STARTED|Washout Period 1 (7 Days)||3
11263518|NCT02271984|12459063|FG002|STARTED|Washout Period 1 (7 Days)||3
11263519|NCT02271984|12459064|FG003|STARTED|Washout Period 1 (7 Days)||3
11263520|NCT02271984|12459065|FG004|STARTED|Washout Period 1 (7 Days)||3
11263521|NCT02271984|12459066|FG005|STARTED|Washout Period 1 (7 Days)||3
11263522|NCT02271984|12459067|FG006|STARTED|Washout Period 1 (7 Days)||3
11263523|NCT02271984|12459068|FG007|STARTED|Washout Period 1 (7 Days)||3
11263524|NCT02271984|12459069|FG008|STARTED|Washout Period 1 (7 Days)||3
11263525|NCT02271984|12459070|FG009|STARTED|Washout Period 1 (7 Days)||3
11263526|NCT02271984|12459071|FG010|STARTED|Washout Period 1 (7 Days)||3
11263527|NCT02271984|12459072|FG011|STARTED|Washout Period 1 (7 Days)||3
11263528|NCT02271984|12459061|FG000|COMPLETED|Washout Period 1 (7 Days)||3
11263529|NCT02271984|12459062|FG001|COMPLETED|Washout Period 1 (7 Days)||3
11263530|NCT02271984|12459063|FG002|COMPLETED|Washout Period 1 (7 Days)||3
11263531|NCT02271984|12459064|FG003|COMPLETED|Washout Period 1 (7 Days)||3
11263532|NCT02271984|12459065|FG004|COMPLETED|Washout Period 1 (7 Days)||3
11263533|NCT02271984|12459066|FG005|COMPLETED|Washout Period 1 (7 Days)||3
11263534|NCT02271984|12459067|FG006|COMPLETED|Washout Period 1 (7 Days)||3
11263535|NCT02271984|12459068|FG007|COMPLETED|Washout Period 1 (7 Days)||3
11263536|NCT02271984|12459069|FG008|COMPLETED|Washout Period 1 (7 Days)||3
11263537|NCT02271984|12459070|FG009|COMPLETED|Washout Period 1 (7 Days)||3
11263538|NCT02271984|12459071|FG010|COMPLETED|Washout Period 1 (7 Days)||3
11263539|NCT02271984|12459072|FG011|COMPLETED|Washout Period 1 (7 Days)||3
11263540|NCT02271984|12459061|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
11263541|NCT02271984|12459062|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
11263542|NCT02271984|12459063|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
11263543|NCT02271984|12459064|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
11263544|NCT02271984|12459065|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
11263545|NCT02271984|12459066|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
11263546|NCT02271984|12459067|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
11263547|NCT02271984|12459068|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
11263548|NCT02271984|12459069|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
11263549|NCT02271984|12459070|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
11263550|NCT02271984|12459071|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0
11263551|NCT02271984|12459072|FG011|NOT COMPLETED|Washout Period 1 (7 Days)||0
11263552|NCT02271984|12459061|FG000|STARTED|Second Intervention Period (1 Day)||3
11263553|NCT02271984|12459062|FG001|STARTED|Second Intervention Period (1 Day)||3
11263554|NCT02271984|12459063|FG002|STARTED|Second Intervention Period (1 Day)||3
11263555|NCT02271984|12459064|FG003|STARTED|Second Intervention Period (1 Day)||3
11263556|NCT02271984|12459065|FG004|STARTED|Second Intervention Period (1 Day)||3
11263557|NCT02271984|12459066|FG005|STARTED|Second Intervention Period (1 Day)||3
11263558|NCT02271984|12459067|FG006|STARTED|Second Intervention Period (1 Day)||3
11263559|NCT02271984|12459068|FG007|STARTED|Second Intervention Period (1 Day)||3
11263560|NCT02271984|12459069|FG008|STARTED|Second Intervention Period (1 Day)||3
11263561|NCT02271984|12459070|FG009|STARTED|Second Intervention Period (1 Day)||3
11263562|NCT02271984|12459071|FG010|STARTED|Second Intervention Period (1 Day)||3
11263563|NCT02271984|12459072|FG011|STARTED|Second Intervention Period (1 Day)||3
11263564|NCT02271984|12459061|FG000|COMPLETED|Second Intervention Period (1 Day)||3
11263565|NCT02271984|12459062|FG001|COMPLETED|Second Intervention Period (1 Day)||3
11263566|NCT02271984|12459063|FG002|COMPLETED|Second Intervention Period (1 Day)||3
11263567|NCT02271984|12459064|FG003|COMPLETED|Second Intervention Period (1 Day)||3
11263568|NCT02271984|12459065|FG004|COMPLETED|Second Intervention Period (1 Day)||3
11263569|NCT02271984|12459066|FG005|COMPLETED|Second Intervention Period (1 Day)||3
11263570|NCT02271984|12459067|FG006|COMPLETED|Second Intervention Period (1 Day)||3
11263571|NCT02271984|12459068|FG007|COMPLETED|Second Intervention Period (1 Day)||3
11263572|NCT02271984|12459069|FG008|COMPLETED|Second Intervention Period (1 Day)||3
11263573|NCT02271984|12459070|FG009|COMPLETED|Second Intervention Period (1 Day)||3
11263574|NCT02271984|12459071|FG010|COMPLETED|Second Intervention Period (1 Day)||3
11263575|NCT02271984|12459072|FG011|COMPLETED|Second Intervention Period (1 Day)||3
11263576|NCT02271984|12459061|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
11263577|NCT02271984|12459062|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
11263578|NCT02271984|12459063|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0
11263579|NCT02271984|12459064|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0
11263580|NCT02271984|12459065|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0
11263581|NCT02271984|12459066|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0
11263582|NCT02271984|12459067|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0
11263583|NCT02271984|12459068|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0
11263584|NCT02271984|12459069|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0
11263585|NCT02271984|12459070|FG009|NOT COMPLETED|Second Intervention Period (1 Day)||0
11263586|NCT02271984|12459071|FG010|NOT COMPLETED|Second Intervention Period (1 Day)||0
11263587|NCT02271984|12459072|FG011|NOT COMPLETED|Second Intervention Period (1 Day)||0
11263588|NCT02271984|12459061|FG000|STARTED|Washout Period 2 (7 Days)||3
11263589|NCT02271984|12459062|FG001|STARTED|Washout Period 2 (7 Days)||3
11263590|NCT02271984|12459063|FG002|STARTED|Washout Period 2 (7 Days)||3
11263591|NCT02271984|12459064|FG003|STARTED|Washout Period 2 (7 Days)||3
11263592|NCT02271984|12459065|FG004|STARTED|Washout Period 2 (7 Days)||3
11263593|NCT02271984|12459066|FG005|STARTED|Washout Period 2 (7 Days)||3
11263594|NCT02271984|12459067|FG006|STARTED|Washout Period 2 (7 Days)||3
11263595|NCT02271984|12459068|FG007|STARTED|Washout Period 2 (7 Days)||3
11263596|NCT02271984|12459069|FG008|STARTED|Washout Period 2 (7 Days)||3
11263597|NCT02271984|12459070|FG009|STARTED|Washout Period 2 (7 Days)||3
11263598|NCT02271984|12459071|FG010|STARTED|Washout Period 2 (7 Days)||3
11263599|NCT02271984|12459072|FG011|STARTED|Washout Period 2 (7 Days)||3
11263600|NCT02271984|12459061|FG000|COMPLETED|Washout Period 2 (7 Days)||3
11263601|NCT02271984|12459062|FG001|COMPLETED|Washout Period 2 (7 Days)||3
11263602|NCT02271984|12459063|FG002|COMPLETED|Washout Period 2 (7 Days)||3
11263603|NCT02271984|12459064|FG003|COMPLETED|Washout Period 2 (7 Days)||3
11359014|NCT03131895|12556132|FG001|STARTED|Washout Period (at Least 5 Days)||28
11359015|NCT03131895|12556133|FG002|STARTED|Washout Period (at Least 5 Days)||30
11359016|NCT03131895|12556134|FG003|STARTED|Washout Period (at Least 5 Days)||30
11359017|NCT03131895|12556131|FG000|COMPLETED|Washout Period (at Least 5 Days)||27
11359018|NCT03131895|12556132|FG001|COMPLETED|Washout Period (at Least 5 Days)||23
11359019|NCT03131895|12556133|FG002|COMPLETED|Washout Period (at Least 5 Days)||26
11359020|NCT03131895|12556134|FG003|COMPLETED|Washout Period (at Least 5 Days)||25
11359021|NCT03131895|12556131|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||1
11359022|NCT03131895|12556132|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||5
11359023|NCT03131895|12556133|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||4
11359024|NCT03131895|12556134|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||5
11359025|NCT03131895|12556131|FG000|STARTED|Intervention Period 2 (2 Days)||27
11359026|NCT03131895|12556132|FG001|STARTED|Intervention Period 2 (2 Days)||23
11359027|NCT03131895|12556133|FG002|STARTED|Intervention Period 2 (2 Days)||26
11359028|NCT03131895|12556134|FG003|STARTED|Intervention Period 2 (2 Days)||25
11359029|NCT03131895|12556131|FG000|COMPLETED|Intervention Period 2 (2 Days)||26
11359030|NCT03131895|12556132|FG001|COMPLETED|Intervention Period 2 (2 Days)||22
11359031|NCT03131895|12556133|FG002|COMPLETED|Intervention Period 2 (2 Days)||26
11359032|NCT03131895|12556134|FG003|COMPLETED|Intervention Period 2 (2 Days)||25
11359033|NCT03131895|12556131|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1
11359034|NCT03131895|12556132|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||1
11359035|NCT03131895|12556133|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11359036|NCT03131895|12556134|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11359037|NCT03131999|12556146|FG000|STARTED|Overall Study||8
11359038|NCT03131999|12556147|FG001|STARTED|Overall Study||8
11359039|NCT03131999|12556146|FG000|COMPLETED|Overall Study||8
11359040|NCT03131999|12556147|FG001|COMPLETED|Overall Study||7
11359041|NCT03131999|12556146|FG000|NOT COMPLETED|Overall Study||0
11359042|NCT03131999|12556147|FG001|NOT COMPLETED|Overall Study||1
11359043|NCT03132220|12556155|FG000|STARTED|Overall Study||65
11359044|NCT03132220|12556156|FG001|STARTED|Overall Study||66
11359045|NCT03132220|12556155|FG000|Began Study Sessions|Overall Study|65 participants randomized to intervention arm;17 lost to f/u prior to study start;48 began sessions|48
11359046|NCT03132220|12556156|FG001|Began Study Sessions|Overall Study|66 participants randomized to control arm;8 were lost to f/u prior to study start; 58 began sessions|58
11359047|NCT03132220|12556155|FG000|COMPLETED|Overall Study||47
11359048|NCT03132220|12556156|FG001|COMPLETED|Overall Study||54
11359049|NCT03132220|12556155|FG000|NOT COMPLETED|Overall Study||18
11359050|NCT03132220|12556156|FG001|NOT COMPLETED|Overall Study||12
11359051|NCT03132246|12556164|FG000|STARTED|Overall Study||260
11359052|NCT03132246|12556164|FG000|COMPLETED|Overall Study||156
11359053|NCT03132246|12556164|FG000|NOT COMPLETED|Overall Study||104
11359054|NCT03132298|12556173|FG000|STARTED|Overall Study||48
11359055|NCT03132298|12556174|FG001|STARTED|Overall Study||48
11359056|NCT03132298|12556173|FG000|COMPLETED|Overall Study||36
11359057|NCT03132298|12556174|FG001|COMPLETED|Overall Study||35
11359058|NCT03132298|12556173|FG000|NOT COMPLETED|Overall Study||12
11359059|NCT03132298|12556174|FG001|NOT COMPLETED|Overall Study||13
11359060|NCT03132571|12556182|FG000|STARTED|Overall Study||3
11359061|NCT03132571|12556183|FG001|STARTED|Overall Study||2
11359062|NCT03132571|12556182|FG000|COMPLETED|Overall Study||3
11359063|NCT03132571|12556183|FG001|COMPLETED|Overall Study||2
11359064|NCT03132571|12556182|FG000|NOT COMPLETED|Overall Study||0
11359065|NCT03132571|12556183|FG001|NOT COMPLETED|Overall Study||0
11359066|NCT03133481|12556191|FG000|STARTED|Overall Study||45
11359067|NCT03133481|12556192|FG001|STARTED|Overall Study||49
11359068|NCT03133481|12556191|FG000|COMPLETED|Overall Study||45
11359069|NCT03133481|12556192|FG001|COMPLETED|Overall Study||45
11359070|NCT03133481|12556191|FG000|NOT COMPLETED|Overall Study||0
11359071|NCT03133481|12556192|FG001|NOT COMPLETED|Overall Study||4
11359072|NCT03133676|12556207|FG000|STARTED|Overall Study||6
11359073|NCT03133676|12556208|FG001|STARTED|Overall Study||3
11359074|NCT03133676|12556209|FG002|STARTED|Overall Study||3
11359075|NCT03133676|12556210|FG003|STARTED|Overall Study||6
11359076|NCT03133676|12556211|FG004|STARTED|Overall Study||6
11359077|NCT03133676|12556212|FG005|STARTED|Overall Study||9
11359078|NCT03133676|12556213|FG006|STARTED|Overall Study||9
11359079|NCT03133676|12556214|FG007|STARTED|Overall Study||9
11359080|NCT03133676|12556215|FG008|STARTED|Overall Study||9
11359081|NCT03133676|12556207|FG000|COMPLETED|Overall Study||6
11359082|NCT03133676|12556208|FG001|COMPLETED|Overall Study||3
11359083|NCT03133676|12556209|FG002|COMPLETED|Overall Study||3
11359084|NCT03133676|12556210|FG003|COMPLETED|Overall Study||6
11359085|NCT03133676|12556211|FG004|COMPLETED|Overall Study||6
11359086|NCT03133676|12556212|FG005|COMPLETED|Overall Study||9
11359087|NCT03133676|12556213|FG006|COMPLETED|Overall Study||9
11359088|NCT03133676|12556214|FG007|COMPLETED|Overall Study||9
11359089|NCT03133676|12556215|FG008|COMPLETED|Overall Study||9
11359090|NCT03133676|12556207|FG000|NOT COMPLETED|Overall Study||0
11359091|NCT03133676|12556208|FG001|NOT COMPLETED|Overall Study||0
11359092|NCT03133676|12556209|FG002|NOT COMPLETED|Overall Study||0
11359093|NCT03133676|12556210|FG003|NOT COMPLETED|Overall Study||0
11359094|NCT03133676|12556211|FG004|NOT COMPLETED|Overall Study||0
11359095|NCT03133676|12556212|FG005|NOT COMPLETED|Overall Study||0
11359096|NCT03133676|12556213|FG006|NOT COMPLETED|Overall Study||0
11359097|NCT03133676|12556214|FG007|NOT COMPLETED|Overall Study||0
11359098|NCT03133676|12556215|FG008|NOT COMPLETED|Overall Study||0
11359099|NCT03133767|12556244|FG000|STARTED|Overall Study||79
11359100|NCT03133767|12556245|FG001|STARTED|Overall Study||78
11359101|NCT03133767|12556244|FG000|COMPLETED|Overall Study||41
11359102|NCT03133767|12556245|FG001|COMPLETED|Overall Study||53
11359103|NCT03133767|12556244|FG000|NOT COMPLETED|Overall Study||38
11359104|NCT03133767|12556245|FG001|NOT COMPLETED|Overall Study||25
11359105|NCT03134092|12556254|FG000|STARTED|Overall Study||434
11359106|NCT03134092|12556255|FG001|STARTED|Overall Study||435
11359107|NCT03134092|12556256|FG002|STARTED|Overall Study||433
11359108|NCT03134092|12556254|FG000|COMPLETED|Overall Study||434
11359109|NCT03134092|12556255|FG001|COMPLETED|Overall Study||435
11359110|NCT03134092|12556256|FG002|COMPLETED|Overall Study||433
11359111|NCT03134092|12556254|FG000|NOT COMPLETED|Overall Study||0
11359112|NCT03134092|12556255|FG001|NOT COMPLETED|Overall Study||0
11359113|NCT03134092|12556256|FG002|NOT COMPLETED|Overall Study||0
11359114|NCT03134144|12556270|FG000|STARTED|Overall Study||15
11359115|NCT03134144|12556271|FG001|STARTED|Overall Study||30
11359116|NCT03134144|12556270|FG000|COMPLETED|Overall Study||15
11359117|NCT03134144|12556271|FG001|COMPLETED|Overall Study||30
11359118|NCT03134144|12556270|FG000|NOT COMPLETED|Overall Study||0
11359119|NCT03134144|12556271|FG001|NOT COMPLETED|Overall Study||0
11359120|NCT03134183|12556284|FG000|STARTED|Overall Study||36
11359121|NCT03134183|12556285|FG001|STARTED|Overall Study||34
11359122|NCT03134183|12556284|FG000|COMPLETED|Overall Study||35
11359123|NCT03134183|12556285|FG001|COMPLETED|Overall Study||33
11359124|NCT03134183|12556284|FG000|NOT COMPLETED|Overall Study||1
11359125|NCT03134183|12556285|FG001|NOT COMPLETED|Overall Study||1
11359126|NCT03134209|12556294|FG000|STARTED|Overall Study||53
11359127|NCT03134209|12556295|FG001|STARTED|Overall Study||54
11359128|NCT03134209|12556296|FG002|STARTED|Overall Study||53
11359129|NCT03134209|12556294|FG000|COMPLETED|Overall Study||53
11359130|NCT03134209|12556295|FG001|COMPLETED|Overall Study||54
11359131|NCT03134209|12556296|FG002|COMPLETED|Overall Study||53
11359132|NCT03134209|12556294|FG000|NOT COMPLETED|Overall Study||0
11359133|NCT03134209|12556295|FG001|NOT COMPLETED|Overall Study||0
11359134|NCT03134209|12556296|FG002|NOT COMPLETED|Overall Study||0
11359135|NCT03134222|12556307|FG000|STARTED|Treatment Period (Up to Week 12)||19
11359136|NCT03134222|12556308|FG001|STARTED|Treatment Period (Up to Week 12)||18
11359137|NCT03134222|12556309|FG002|STARTED|Treatment Period (Up to Week 12)||10
11359138|NCT03134222|12556310|FG003|STARTED|Treatment Period (Up to Week 12)||0
11359139|NCT03134222|12556311|FG004|STARTED|Treatment Period (Up to Week 12)||0
11359140|NCT03134222|12556307|FG000|COMPLETED|Treatment Period (Up to Week 12)||14
11359141|NCT03134222|12556308|FG001|COMPLETED|Treatment Period (Up to Week 12)||14
11359142|NCT03134222|12556309|FG002|COMPLETED|Treatment Period (Up to Week 12)||8
11359143|NCT03134222|12556310|FG003|COMPLETED|Treatment Period (Up to Week 12)||0
11359144|NCT03134222|12556311|FG004|COMPLETED|Treatment Period (Up to Week 12)||0
11359145|NCT03134222|12556307|FG000|NOT COMPLETED|Treatment Period (Up to Week 12)||5
11359146|NCT03134222|12556308|FG001|NOT COMPLETED|Treatment Period (Up to Week 12)||4
11359147|NCT03134222|12556309|FG002|NOT COMPLETED|Treatment Period (Up to Week 12)||2
11359148|NCT03134222|12556310|FG003|NOT COMPLETED|Treatment Period (Up to Week 12)||0
11359149|NCT03134222|12556311|FG004|NOT COMPLETED|Treatment Period (Up to Week 12)||0
11359150|NCT03134222|12556307|FG000|STARTED|Treatment Period (Week 12 to 48)||14
11359151|NCT03134222|12556308|FG001|STARTED|Treatment Period (Week 12 to 48)||14
11359152|NCT03134222|12556309|FG002|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized 1:1 to either Placebo to Lanraplenib or Placebo to Filgotinib arm.|0
11359153|NCT03134222|12556310|FG003|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
11359154|NCT03134222|12556311|FG004|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
11359155|NCT03134222|12556307|FG000|COMPLETED|Treatment Period (Week 12 to 48)||12
11359156|NCT03134222|12556308|FG001|COMPLETED|Treatment Period (Week 12 to 48)||11
11359157|NCT03134222|12556309|FG002|COMPLETED|Treatment Period (Week 12 to 48)||0
11359158|NCT03134222|12556310|FG003|COMPLETED|Treatment Period (Week 12 to 48)||3
11359159|NCT03134222|12556311|FG004|COMPLETED|Treatment Period (Week 12 to 48)||3
11359160|NCT03134222|12556307|FG000|NOT COMPLETED|Treatment Period (Week 12 to 48)||2
11359161|NCT03134222|12556308|FG001|NOT COMPLETED|Treatment Period (Week 12 to 48)||3
11359162|NCT03134222|12556309|FG002|NOT COMPLETED|Treatment Period (Week 12 to 48)||0
11359163|NCT03134222|12556310|FG003|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
11359164|NCT03134222|12556311|FG004|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
11359165|NCT03134248|12556321|FG000|STARTED|Week 1||7
11359166|NCT03134248|12556322|FG001|STARTED|Week 1||8
11359167|NCT03134248|12556323|FG002|STARTED|Week 1||9
11359168|NCT03134248|12556324|FG003|STARTED|Week 1||7
11359169|NCT03134248|12556325|FG004|STARTED|Week 1||9
11359170|NCT03134248|12556326|FG005|STARTED|Week 1||9
11359171|NCT03134248|12556321|FG000|COMPLETED|Week 1||7
11359172|NCT03134248|12556322|FG001|COMPLETED|Week 1||8
11359173|NCT03134248|12556323|FG002|COMPLETED|Week 1||9
11359174|NCT03134248|12556324|FG003|COMPLETED|Week 1||7
11359175|NCT03134248|12556325|FG004|COMPLETED|Week 1||9
11359176|NCT03134248|12556326|FG005|COMPLETED|Week 1||9
11359177|NCT03134248|12556321|FG000|NOT COMPLETED|Week 1||0
11359178|NCT03134248|12556322|FG001|NOT COMPLETED|Week 1||0
11359179|NCT03134248|12556323|FG002|NOT COMPLETED|Week 1||0
11359180|NCT03134248|12556324|FG003|NOT COMPLETED|Week 1||0
11359181|NCT03134248|12556325|FG004|NOT COMPLETED|Week 1||0
11359182|NCT03134248|12556326|FG005|NOT COMPLETED|Week 1||0
11359183|NCT03134248|12556321|FG000|STARTED|Week 2||7
11359184|NCT03134248|12556322|FG001|STARTED|Week 2||8
11359185|NCT03134248|12556323|FG002|STARTED|Week 2||9
11359186|NCT03134248|12556324|FG003|STARTED|Week 2||7
11359187|NCT03134248|12556325|FG004|STARTED|Week 2||9
11359188|NCT03134248|12556326|FG005|STARTED|Week 2||9
11359189|NCT03134248|12556321|FG000|COMPLETED|Week 2||7
11359190|NCT03134248|12556322|FG001|COMPLETED|Week 2||8
11359191|NCT03134248|12556323|FG002|COMPLETED|Week 2||9
11359192|NCT03134248|12556324|FG003|COMPLETED|Week 2||7
11359193|NCT03134248|12556325|FG004|COMPLETED|Week 2||9
11359194|NCT03134248|12556326|FG005|COMPLETED|Week 2||9
11359195|NCT03134248|12556321|FG000|NOT COMPLETED|Week 2||0
11359196|NCT03134248|12556322|FG001|NOT COMPLETED|Week 2||0
11359197|NCT03134248|12556323|FG002|NOT COMPLETED|Week 2||0
11359198|NCT03134248|12556324|FG003|NOT COMPLETED|Week 2||0
11359199|NCT03134248|12556325|FG004|NOT COMPLETED|Week 2||0
11359200|NCT03134248|12556326|FG005|NOT COMPLETED|Week 2||0
11359201|NCT03134248|12556321|FG000|STARTED|Week 3||7
11359202|NCT03134248|12556322|FG001|STARTED|Week 3||8
11359203|NCT03134248|12556323|FG002|STARTED|Week 3||9
11359204|NCT03134248|12556324|FG003|STARTED|Week 3||7
11359205|NCT03134248|12556325|FG004|STARTED|Week 3||9
11359206|NCT03134248|12556326|FG005|STARTED|Week 3||9
11359207|NCT03134248|12556321|FG000|COMPLETED|Week 3||7
11359208|NCT03134248|12556322|FG001|COMPLETED|Week 3||8
11359209|NCT03134248|12556323|FG002|COMPLETED|Week 3||9
11359210|NCT03134248|12556324|FG003|COMPLETED|Week 3||7
11359211|NCT03134248|12556325|FG004|COMPLETED|Week 3||9
11359212|NCT03134248|12556326|FG005|COMPLETED|Week 3||9
11359213|NCT03134248|12556321|FG000|NOT COMPLETED|Week 3||0
11359214|NCT03134248|12556322|FG001|NOT COMPLETED|Week 3||0
11359215|NCT03134248|12556323|FG002|NOT COMPLETED|Week 3||0
11359216|NCT03134248|12556324|FG003|NOT COMPLETED|Week 3||0
11359217|NCT03134248|12556325|FG004|NOT COMPLETED|Week 3||0
11359218|NCT03134248|12556326|FG005|NOT COMPLETED|Week 3||0
11359219|NCT03134313|12556336|FG000|STARTED|Overall Study||25
11359220|NCT03134313|12556336|FG000|COMPLETED|Overall Study||25
11359221|NCT03134313|12556336|FG000|NOT COMPLETED|Overall Study||0
11359222|NCT03134326|12556340|FG000|STARTED|Overall Study||21
11359223|NCT03134326|12556340|FG000|COMPLETED|Overall Study||21
11359224|NCT03134326|12556340|FG000|NOT COMPLETED|Overall Study||0
11359225|NCT03134599|12556344|FG000|STARTED|Week 1||10
11359226|NCT03134599|12556345|FG001|STARTED|Week 1||10
11359227|NCT03134599|12556346|FG002|STARTED|Week 1||10
11359228|NCT03134599|12556347|FG003|STARTED|Week 1||11
11359229|NCT03134599|12556348|FG004|STARTED|Week 1||10
11359230|NCT03134599|12556349|FG005|STARTED|Week 1||9
11359231|NCT03134599|12556344|FG000|COMPLETED|Week 1||10
11359232|NCT03134599|12556345|FG001|COMPLETED|Week 1||10
11359233|NCT03134599|12556346|FG002|COMPLETED|Week 1||10
11359234|NCT03134599|12556347|FG003|COMPLETED|Week 1||11
11359235|NCT03134599|12556348|FG004|COMPLETED|Week 1||9
11359236|NCT03134599|12556349|FG005|COMPLETED|Week 1||9
11359237|NCT03134599|12556344|FG000|NOT COMPLETED|Week 1||0
11359238|NCT03134599|12556345|FG001|NOT COMPLETED|Week 1||0
11359239|NCT03134599|12556346|FG002|NOT COMPLETED|Week 1||0
11359240|NCT03134599|12556347|FG003|NOT COMPLETED|Week 1||0
11359241|NCT03134599|12556348|FG004|NOT COMPLETED|Week 1||1
11359242|NCT03134599|12556349|FG005|NOT COMPLETED|Week 1||0
11359243|NCT03134599|12556344|FG000|STARTED|Week 2||10
11359244|NCT03134599|12556345|FG001|STARTED|Week 2||10
11359245|NCT03134599|12556346|FG002|STARTED|Week 2||10
11359246|NCT03134599|12556347|FG003|STARTED|Week 2||11
11359247|NCT03134599|12556348|FG004|STARTED|Week 2||9
11359248|NCT03134599|12556349|FG005|STARTED|Week 2||9
11359249|NCT03134599|12556344|FG000|COMPLETED|Week 2||9
11359250|NCT03134599|12556345|FG001|COMPLETED|Week 2||10
11359251|NCT03134599|12556346|FG002|COMPLETED|Week 2||10
11359252|NCT03134599|12556347|FG003|COMPLETED|Week 2||10
11359253|NCT03134599|12556348|FG004|COMPLETED|Week 2||8
11359254|NCT03134599|12556349|FG005|COMPLETED|Week 2||9
11359255|NCT03134599|12556344|FG000|NOT COMPLETED|Week 2||1
11359256|NCT03134599|12556345|FG001|NOT COMPLETED|Week 2||0
11359257|NCT03134599|12556346|FG002|NOT COMPLETED|Week 2||0
11359258|NCT03134599|12556347|FG003|NOT COMPLETED|Week 2||1
11359259|NCT03134599|12556348|FG004|NOT COMPLETED|Week 2||1
11359260|NCT03134599|12556349|FG005|NOT COMPLETED|Week 2||0
11359261|NCT03134599|12556344|FG000|STARTED|Week 3||9
11359262|NCT03134599|12556345|FG001|STARTED|Week 3||10
11359263|NCT03134599|12556346|FG002|STARTED|Week 3||10
11359264|NCT03134599|12556347|FG003|STARTED|Week 3||10
11359265|NCT03134599|12556348|FG004|STARTED|Week 3||8
11359266|NCT03134599|12556349|FG005|STARTED|Week 3||9
11359267|NCT03134599|12556344|FG000|COMPLETED|Week 3||9
11359268|NCT03134599|12556345|FG001|COMPLETED|Week 3||10
11359269|NCT03134599|12556346|FG002|COMPLETED|Week 3||10
11359270|NCT03134599|12556347|FG003|COMPLETED|Week 3||9
11359271|NCT03134599|12556348|FG004|COMPLETED|Week 3||8
11359272|NCT03134599|12556349|FG005|COMPLETED|Week 3||8
11359273|NCT03134599|12556344|FG000|NOT COMPLETED|Week 3||0
11359274|NCT03134599|12556345|FG001|NOT COMPLETED|Week 3||0
11359275|NCT03134599|12556346|FG002|NOT COMPLETED|Week 3||0
11359276|NCT03134599|12556347|FG003|NOT COMPLETED|Week 3||1
11359277|NCT03134599|12556348|FG004|NOT COMPLETED|Week 3||0
11359278|NCT03134599|12556349|FG005|NOT COMPLETED|Week 3||1
11359279|NCT03134703|12556359|FG000|STARTED|Overall Study||6
11359280|NCT03134703|12556360|FG001|STARTED|Overall Study||5
11359281|NCT03134703|12556359|FG000|COMPLETED|Overall Study||0
11359282|NCT03134703|12556360|FG001|COMPLETED|Overall Study||3
11359283|NCT03134703|12556359|FG000|NOT COMPLETED|Overall Study||6
11359284|NCT03134703|12556360|FG001|NOT COMPLETED|Overall Study||2
11359285|NCT03134768|12556366|FG000|STARTED|Overall Study||50
11359286|NCT03134768|12556366|FG000|COMPLETED|Overall Study||50
11359287|NCT03134768|12556366|FG000|NOT COMPLETED|Overall Study||0
11359288|NCT03134911|12556372|FG000|STARTED|Overall Study||535
11359289|NCT03134911|12556372|FG000|COMPLETED|Overall Study||501
11359290|NCT03134911|12556372|FG000|NOT COMPLETED|Overall Study||34
11359291|NCT03134963|12556384|FG000|STARTED|Overall Study||12
11359292|NCT03134963|12556385|FG001|STARTED|Overall Study||13
11359293|NCT03134963|12556386|FG002|STARTED|Overall Study||3
11359294|NCT03134963|12556387|FG003|STARTED|Overall Study||14
11359295|NCT03134963|12556384|FG000|COMPLETED|Overall Study||12
11359296|NCT03134963|12556385|FG001|COMPLETED|Overall Study||13
11359297|NCT03134963|12556386|FG002|COMPLETED|Overall Study||3
11359298|NCT03134963|12556387|FG003|COMPLETED|Overall Study||14
11359299|NCT03134963|12556384|FG000|NOT COMPLETED|Overall Study||0
11359300|NCT03134963|12556385|FG001|NOT COMPLETED|Overall Study||0
11359301|NCT03134963|12556386|FG002|NOT COMPLETED|Overall Study||0
11359302|NCT03134963|12556387|FG003|NOT COMPLETED|Overall Study||0
11359303|NCT03134989|12556397|FG000|STARTED|Overall Study||80
11359304|NCT03134989|12556397|FG000|COMPLETED|Overall Study|Clinical investigation termination date: Last Subject, Final Visit 18-Jun-2020|80
11359305|NCT03134989|12556397|FG000|NOT COMPLETED|Overall Study||0
11359306|NCT03135015|12556404|FG000|STARTED|Overall Study||11
11359307|NCT03135015|12556405|FG001|STARTED|Overall Study||11
11359308|NCT03135015|12556404|FG000|Water Control|Overall Study||9
11359309|NCT03135015|12556405|FG001|Water Control|Overall Study||11
11359310|NCT03135015|12556404|FG000|Placebo Capsules|Overall Study||9
11359311|NCT03135015|12556405|FG001|Placebo Capsules|Overall Study||11
11359312|NCT03135015|12556404|FG000|2g Capsules|Overall Study||9
11359313|NCT03135015|12556405|FG001|2g Capsules|Overall Study||11
11359314|NCT03135015|12556404|FG000|4g Capsules|Overall Study||9
11359315|NCT03135015|12556405|FG001|4g Capsules|Overall Study||11
11359316|NCT03135015|12556404|FG000|2g Tablets|Overall Study||9
11359317|NCT03135015|12556405|FG001|2g Tablets|Overall Study||11
11359318|NCT03135015|12556404|FG000|4g Tablets|Overall Study||9
11359319|NCT03135015|12556405|FG001|4g Tablets|Overall Study||11
11359320|NCT03135015|12556404|FG000|COMPLETED|Overall Study||9
11359321|NCT03135015|12556405|FG001|COMPLETED|Overall Study||11
11359322|NCT03135015|12556404|FG000|NOT COMPLETED|Overall Study||2
11359323|NCT03135015|12556405|FG001|NOT COMPLETED|Overall Study||0
11359324|NCT03135028|12556455|FG000|STARTED|Overall Study||9
11359325|NCT03135028|12556455|FG000|COMPLETED|Overall Study||0
11359326|NCT03135028|12556455|FG000|NOT COMPLETED|Overall Study||9
11359327|NCT03135210|12556461|FG000|STARTED|Overall Study||2
11359328|NCT03135210|12556462|FG001|STARTED|Overall Study||2
11359329|NCT03135210|12556461|FG000|COMPLETED|Overall Study||2
11359330|NCT03135210|12556462|FG001|COMPLETED|Overall Study||1
11359331|NCT03135210|12556461|FG000|NOT COMPLETED|Overall Study||0
11359332|NCT03135210|12556462|FG001|NOT COMPLETED|Overall Study||1
11359333|NCT03135379|12556470|FG000|STARTED|Overall Study||62
11359334|NCT03135379|12556471|FG001|STARTED|Overall Study||62
11359335|NCT03135379|12556470|FG000|COMPLETED|Overall Study||61
11359336|NCT03135379|12556471|FG001|COMPLETED|Overall Study||59
11359337|NCT03135379|12556470|FG000|NOT COMPLETED|Overall Study||1
11359338|NCT03135379|12556471|FG001|NOT COMPLETED|Overall Study||3
11359339|NCT03135431|12556479|FG000|STARTED|Overall Study||20
11359340|NCT03135431|12556480|FG001|STARTED|Overall Study||20
11359341|NCT03135431|12556479|FG000|COMPLETED|Overall Study||18
11359342|NCT03135431|12556480|FG001|COMPLETED|Overall Study||20
11359343|NCT03135431|12556479|FG000|NOT COMPLETED|Overall Study||2
11359344|NCT03135431|12556480|FG001|NOT COMPLETED|Overall Study||0
11359345|NCT03135522|12556488|FG000|STARTED|Overall Study||17
11359346|NCT03135522|12556489|FG001|STARTED|Overall Study||17
11359347|NCT03135522|12556488|FG000|COMPLETED|Overall Study||16
11359348|NCT03135522|12556489|FG001|COMPLETED|Overall Study||17
11359349|NCT03135522|12556488|FG000|NOT COMPLETED|Overall Study||1
11359350|NCT03135522|12556489|FG001|NOT COMPLETED|Overall Study||0
11359351|NCT03135535|12556495|FG000|STARTED|Overall Study||30
11359352|NCT03135535|12556495|FG000|COMPLETED|Overall Study||30
11359353|NCT03135535|12556495|FG000|NOT COMPLETED|Overall Study||0
11359354|NCT03135548|12556502|FG000|STARTED|Overall Study||19
11359355|NCT03135548|12556503|FG001|STARTED|Overall Study||19
11359356|NCT03135548|12556504|FG002|STARTED|Overall Study||21
11359357|NCT03135548|12556502|FG000|COMPLETED|Overall Study||14
11359358|NCT03135548|12556503|FG001|COMPLETED|Overall Study||15
11359359|NCT03135548|12556504|FG002|COMPLETED|Overall Study||18
11359360|NCT03135548|12556502|FG000|NOT COMPLETED|Overall Study||5
11359361|NCT03135548|12556503|FG001|NOT COMPLETED|Overall Study||4
11359362|NCT03135548|12556504|FG002|NOT COMPLETED|Overall Study||3
11359363|NCT03135899|12556520|FG000|STARTED|Overall Study||1
11359364|NCT03135899|12556521|FG001|STARTED|Overall Study||1
11359365|NCT03135899|12556522|FG002|STARTED|Overall Study||1
11359366|NCT03135899|12556523|FG003|STARTED|Overall Study||1
11359367|NCT03135899|12556524|FG004|STARTED|Overall Study||8
11359368|NCT03135899|12556525|FG005|STARTED|Overall Study||9
11359369|NCT03135899|12556526|FG006|STARTED|Overall Study||8
11359370|NCT03135899|12556527|FG007|STARTED|Overall Study||8
11359371|NCT03135899|12556520|FG000|COMPLETED|Overall Study||1
11359372|NCT03135899|12556521|FG001|COMPLETED|Overall Study||1
11359373|NCT03135899|12556522|FG002|COMPLETED|Overall Study||1
11359374|NCT03135899|12556523|FG003|COMPLETED|Overall Study||1
11359375|NCT03135899|12556524|FG004|COMPLETED|Overall Study||8
11359376|NCT03135899|12556525|FG005|COMPLETED|Overall Study||7
11359377|NCT03135899|12556526|FG006|COMPLETED|Overall Study||7
11359378|NCT03135899|12556527|FG007|COMPLETED|Overall Study||8
11359379|NCT03135899|12556520|FG000|NOT COMPLETED|Overall Study||0
11359380|NCT03135899|12556521|FG001|NOT COMPLETED|Overall Study||0
11359381|NCT03135899|12556522|FG002|NOT COMPLETED|Overall Study||0
11359382|NCT03135899|12556523|FG003|NOT COMPLETED|Overall Study||0
11359383|NCT03135899|12556524|FG004|NOT COMPLETED|Overall Study||0
11359384|NCT03135899|12556525|FG005|NOT COMPLETED|Overall Study||2
11359385|NCT03135899|12556526|FG006|NOT COMPLETED|Overall Study||1
11359386|NCT03135899|12556527|FG007|NOT COMPLETED|Overall Study||0
11359387|NCT03136068|12556543|FG000|STARTED|Overall Study||88
11359388|NCT03136068|12556544|FG001|STARTED|Overall Study||90
11359389|NCT03136068|12556543|FG000|COMPLETED|Overall Study||86
11359390|NCT03136068|12556544|FG001|COMPLETED|Overall Study||89
11359391|NCT03136068|12556543|FG000|NOT COMPLETED|Overall Study||2
11359392|NCT03136068|12556544|FG001|NOT COMPLETED|Overall Study||1
11359393|NCT03136107|12556550|FG000|STARTED|Overall Study||26
11359394|NCT03136107|12556550|FG000|Test Product|Overall Study||26
11359395|NCT03136107|12556550|FG000|Reference Product|Overall Study||26
11359396|NCT03136107|12556550|FG000|Negative Control|Overall Study||26
11359397|NCT03136107|12556550|FG000|COMPLETED|Overall Study||25
11359398|NCT03136107|12556550|FG000|NOT COMPLETED|Overall Study||1
11359399|NCT03136159|12556560|FG000|STARTED|Overall Study||190
11359400|NCT03136159|12556561|FG001|STARTED|Overall Study||190
11359401|NCT03136159|12556560|FG000|COMPLETED|Overall Study||185
11359402|NCT03136159|12556561|FG001|COMPLETED|Overall Study||190
11359403|NCT03136159|12556560|FG000|NOT COMPLETED|Overall Study||5
11359404|NCT03136159|12556561|FG001|NOT COMPLETED|Overall Study||0
11359405|NCT03136198|12556569|FG000|STARTED|Overall Study||66
11359406|NCT03136198|12556570|FG001|STARTED|Overall Study||64
11359407|NCT03136198|12556569|FG000|COMPLETED|Overall Study||66
11359408|NCT03136198|12556570|FG001|COMPLETED|Overall Study||63
11359409|NCT03136198|12556569|FG000|NOT COMPLETED|Overall Study||0
11359410|NCT03136198|12556570|FG001|NOT COMPLETED|Overall Study||1
11359411|NCT03136328|12556576|FG000|STARTED|Overall Study||11
11359412|NCT03136328|12556576|FG000|COMPLETED|Overall Study||11
11359413|NCT03136328|12556576|FG000|NOT COMPLETED|Overall Study||0
11359414|NCT03136367|12556584|FG000|STARTED|T1 Consultation||66
11359415|NCT03136367|12556585|FG001|STARTED|T1 Consultation||248
11359416|NCT03136367|12556586|FG002|STARTED|T1 Consultation||257
11359417|NCT03136367|12556584|FG000|COMPLETED|T1 Consultation|received the intervention|64
11359418|NCT03136367|12556585|FG001|COMPLETED|T1 Consultation||241
11359419|NCT03136367|12556586|FG002|COMPLETED|T1 Consultation||256
11359420|NCT03136367|12556584|FG000|NOT COMPLETED|T1 Consultation||2
11359421|NCT03136367|12556585|FG001|NOT COMPLETED|T1 Consultation||7
11359422|NCT03136367|12556586|FG002|NOT COMPLETED|T1 Consultation||1
11359423|NCT03136367|12556584|FG000|STARTED|T2 Post-consultation||64
11359424|NCT03136367|12556585|FG001|STARTED|T2 Post-consultation||241
11359425|NCT03136367|12556586|FG002|STARTED|T2 Post-consultation||256
11359426|NCT03136367|12556584|FG000|COMPLETED|T2 Post-consultation||61
11359427|NCT03136367|12556585|FG001|COMPLETED|T2 Post-consultation||235
11359428|NCT03136367|12556586|FG002|COMPLETED|T2 Post-consultation||225
11359429|NCT03136367|12556584|FG000|NOT COMPLETED|T2 Post-consultation||3
11359430|NCT03136367|12556585|FG001|NOT COMPLETED|T2 Post-consultation||6
11359431|NCT03136367|12556586|FG002|NOT COMPLETED|T2 Post-consultation||31
11359432|NCT03136367|12556584|FG000|STARTED|T3 1 Week After Surgery||61
11359433|NCT03136367|12556585|FG001|STARTED|T3 1 Week After Surgery||235
11359434|NCT03136367|12556586|FG002|STARTED|T3 1 Week After Surgery||225
11359435|NCT03136367|12556584|FG000|COMPLETED|T3 1 Week After Surgery||51
11359436|NCT03136367|12556585|FG001|COMPLETED|T3 1 Week After Surgery||203
11359437|NCT03136367|12556586|FG002|COMPLETED|T3 1 Week After Surgery||194
11359438|NCT03136367|12556584|FG000|NOT COMPLETED|T3 1 Week After Surgery||10
11359439|NCT03136367|12556585|FG001|NOT COMPLETED|T3 1 Week After Surgery||32
11359440|NCT03136367|12556586|FG002|NOT COMPLETED|T3 1 Week After Surgery||31
11359441|NCT03136367|12556584|FG000|STARTED|T4 12 Weeks After Surgery||51
11359442|NCT03136367|12556585|FG001|STARTED|T4 12 Weeks After Surgery||203
11359443|NCT03136367|12556586|FG002|STARTED|T4 12 Weeks After Surgery||194
11359444|NCT03136367|12556584|FG000|COMPLETED|T4 12 Weeks After Surgery||49
11359445|NCT03136367|12556585|FG001|COMPLETED|T4 12 Weeks After Surgery||198
11359446|NCT03136367|12556586|FG002|COMPLETED|T4 12 Weeks After Surgery||185
11359447|NCT03136367|12556584|FG000|NOT COMPLETED|T4 12 Weeks After Surgery||2
11359448|NCT03136367|12556585|FG001|NOT COMPLETED|T4 12 Weeks After Surgery||5
11359449|NCT03136367|12556586|FG002|NOT COMPLETED|T4 12 Weeks After Surgery||9
11359450|NCT03136367|12556584|FG000|STARTED|T5 1 Year After Surgery||49
11359451|NCT03136367|12556585|FG001|STARTED|T5 1 Year After Surgery||198
11359452|NCT03136367|12556586|FG002|STARTED|T5 1 Year After Surgery||185
11359453|NCT03136367|12556584|FG000|COMPLETED|T5 1 Year After Surgery||13
11359454|NCT03136367|12556585|FG001|COMPLETED|T5 1 Year After Surgery||62
11359455|NCT03136367|12556586|FG002|COMPLETED|T5 1 Year After Surgery||56
11359456|NCT03136367|12556584|FG000|NOT COMPLETED|T5 1 Year After Surgery||36
11359457|NCT03136367|12556585|FG001|NOT COMPLETED|T5 1 Year After Surgery||136
11359458|NCT03136367|12556586|FG002|NOT COMPLETED|T5 1 Year After Surgery||129
11359459|NCT03136380|12556599|FG000|STARTED|Part 1, Period 1 (3 Days)||6
11359460|NCT03136380|12556600|FG001|STARTED|Part 1, Period 1 (3 Days)||6
11359461|NCT03136380|12556601|FG002|STARTED|Part 1, Period 1 (3 Days)||6
11359462|NCT03136380|12556602|FG003|STARTED|Part 1, Period 1 (3 Days)||0
11359463|NCT03136380|12556603|FG004|STARTED|Part 1, Period 1 (3 Days)||0
11359464|NCT03136380|12556599|FG000|COMPLETED|Part 1, Period 1 (3 Days)||6
11359465|NCT03136380|12556600|FG001|COMPLETED|Part 1, Period 1 (3 Days)||6
11359466|NCT03136380|12556601|FG002|COMPLETED|Part 1, Period 1 (3 Days)||6
11359467|NCT03136380|12556602|FG003|COMPLETED|Part 1, Period 1 (3 Days)||0
11359468|NCT03136380|12556603|FG004|COMPLETED|Part 1, Period 1 (3 Days)||0
11359469|NCT03136380|12556599|FG000|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
11359470|NCT03136380|12556600|FG001|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
11359471|NCT03136380|12556601|FG002|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
11359472|NCT03136380|12556602|FG003|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
11359473|NCT03136380|12556603|FG004|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
11359474|NCT03136380|12556599|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||6
11359475|NCT03136380|12556600|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||6
11359476|NCT03136380|12556601|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||6
11359477|NCT03136380|12556602|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||0
11359478|NCT03136380|12556603|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||0
11359479|NCT03136380|12556599|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
11359480|NCT03136380|12556600|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
11359481|NCT03136380|12556601|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
11359482|NCT03136380|12556602|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11359483|NCT03136380|12556603|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11359484|NCT03136380|12556599|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11359485|NCT03136380|12556600|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11359486|NCT03136380|12556601|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11359487|NCT03136380|12556602|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11359488|NCT03136380|12556603|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11359489|NCT03136380|12556599|FG000|STARTED|Part 1, Period 2 (3 Days)||6
11359490|NCT03136380|12556600|FG001|STARTED|Part 1, Period 2 (3 Days)||6
11359491|NCT03136380|12556601|FG002|STARTED|Part 1, Period 2 (3 Days)||6
11359492|NCT03136380|12556602|FG003|STARTED|Part 1, Period 2 (3 Days)||0
11359493|NCT03136380|12556603|FG004|STARTED|Part 1, Period 2 (3 Days)||0
11359494|NCT03136380|12556599|FG000|COMPLETED|Part 1, Period 2 (3 Days)||6
11359495|NCT03136380|12556600|FG001|COMPLETED|Part 1, Period 2 (3 Days)||6
11359496|NCT03136380|12556601|FG002|COMPLETED|Part 1, Period 2 (3 Days)||6
11359497|NCT03136380|12556602|FG003|COMPLETED|Part 1, Period 2 (3 Days)||0
11359498|NCT03136380|12556603|FG004|COMPLETED|Part 1, Period 2 (3 Days)||0
11359499|NCT03136380|12556599|FG000|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
11359500|NCT03136380|12556600|FG001|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
11359501|NCT03136380|12556601|FG002|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
11359502|NCT03136380|12556602|FG003|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
11359503|NCT03136380|12556603|FG004|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
11359504|NCT03136380|12556599|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||6
11359505|NCT03136380|12556600|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||6
11359506|NCT03136380|12556601|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||6
11359507|NCT03136380|12556602|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||0
11359508|NCT03136380|12556603|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||0
11359509|NCT03136380|12556599|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
11359510|NCT03136380|12556600|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||5
11359511|NCT03136380|12556601|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
11359512|NCT03136380|12556602|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11359513|NCT03136380|12556603|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11359514|NCT03136380|12556599|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11359515|NCT03136380|12556600|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1
11359516|NCT03136380|12556601|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11359517|NCT03136380|12556602|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11359518|NCT03136380|12556603|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11359519|NCT03136380|12556599|FG000|STARTED|Part 1, Period 3 (4 Days)||6
11359520|NCT03136380|12556600|FG001|STARTED|Part 1, Period 3 (4 Days)||5
11359521|NCT03136380|12556601|FG002|STARTED|Part 1, Period 3 (4 Days)||6
11359522|NCT03136380|12556602|FG003|STARTED|Part 1, Period 3 (4 Days)||0
11359523|NCT03136380|12556603|FG004|STARTED|Part 1, Period 3 (4 Days)||0
11359524|NCT03136380|12556599|FG000|COMPLETED|Part 1, Period 3 (4 Days)||6
11359525|NCT03136380|12556600|FG001|COMPLETED|Part 1, Period 3 (4 Days)||5
11359526|NCT03136380|12556601|FG002|COMPLETED|Part 1, Period 3 (4 Days)||6
11359527|NCT03136380|12556602|FG003|COMPLETED|Part 1, Period 3 (4 Days)||0
11359528|NCT03136380|12556603|FG004|COMPLETED|Part 1, Period 3 (4 Days)||0
11359529|NCT03136380|12556599|FG000|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
11359530|NCT03136380|12556600|FG001|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
11359531|NCT03136380|12556601|FG002|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
11359532|NCT03136380|12556602|FG003|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
11359533|NCT03136380|12556603|FG004|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
11359534|NCT03136380|12556599|FG000|STARTED|Part 2, Period 1 (3 Days)||0
11359535|NCT03136380|12556600|FG001|STARTED|Part 2, Period 1 (3 Days)||0
11359536|NCT03136380|12556601|FG002|STARTED|Part 2, Period 1 (3 Days)||0
11359537|NCT03136380|12556602|FG003|STARTED|Part 2, Period 1 (3 Days)||8
11359538|NCT03136380|12556603|FG004|STARTED|Part 2, Period 1 (3 Days)||8
11359539|NCT03136380|12556599|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0
11359540|NCT03136380|12556600|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0
11359541|NCT03136380|12556601|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0
11359542|NCT03136380|12556602|FG003|COMPLETED|Part 2, Period 1 (3 Days)||8
11359543|NCT03136380|12556603|FG004|COMPLETED|Part 2, Period 1 (3 Days)||8
11359544|NCT03136380|12556599|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11359545|NCT03136380|12556600|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11359546|NCT03136380|12556601|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11359547|NCT03136380|12556602|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11359548|NCT03136380|12556603|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11359549|NCT03136380|12556599|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0
11359550|NCT03136380|12556600|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0
11359551|NCT03136380|12556601|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0
11359552|NCT03136380|12556602|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||8
11359553|NCT03136380|12556603|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||8
11359554|NCT03136380|12556599|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11359555|NCT03136380|12556600|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11359556|NCT03136380|12556601|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11359557|NCT03136380|12556602|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
11359558|NCT03136380|12556603|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
11359559|NCT03136380|12556599|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11359560|NCT03136380|12556600|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11359561|NCT03136380|12556601|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11359562|NCT03136380|12556602|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11359563|NCT03136380|12556603|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11359564|NCT03136380|12556599|FG000|STARTED|Part 2, Period 2 (3 Days)||0
11359565|NCT03136380|12556600|FG001|STARTED|Part 2, Period 2 (3 Days)||0
11359566|NCT03136380|12556601|FG002|STARTED|Part 2, Period 2 (3 Days)||0
11359567|NCT03136380|12556602|FG003|STARTED|Part 2, Period 2 (3 Days)||8
11359568|NCT03136380|12556603|FG004|STARTED|Part 2, Period 2 (3 Days)||8
11359569|NCT03136380|12556599|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0
11359570|NCT03136380|12556600|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0
11359571|NCT03136380|12556601|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0
11359572|NCT03136380|12556602|FG003|COMPLETED|Part 2, Period 2 (3 Days)||8
11359573|NCT03136380|12556603|FG004|COMPLETED|Part 2, Period 2 (3 Days)||8
11359574|NCT03136380|12556599|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11359575|NCT03136380|12556600|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11359576|NCT03136380|12556601|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11359577|NCT03136380|12556602|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11359578|NCT03136380|12556603|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11359579|NCT03136484|12556623|FG000|STARTED|Overall Study||394
11359580|NCT03136484|12556624|FG001|STARTED|Overall Study||394
11359581|NCT03136484|12556623|FG000|Exposed|Overall Study||392
11359582|NCT03136484|12556624|FG001|Exposed|Overall Study||394
11359583|NCT03136484|12556623|FG000|COMPLETED|Overall Study||367
11359584|NCT03136484|12556624|FG001|COMPLETED|Overall Study||372
11359585|NCT03136484|12556623|FG000|NOT COMPLETED|Overall Study||27
11359586|NCT03136484|12556624|FG001|NOT COMPLETED|Overall Study||22
11359587|NCT03136861|12556637|FG000|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285
11359588|NCT03136861|12556638|FG001|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95
11359589|NCT03136861|12556639|FG002|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11142042|NCT01465997|12328714|FG001|NOT COMPLETED|Overall Study||89
11359590|NCT03136861|12556640|FG003|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11359591|NCT03136861|12556641|FG004|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11359592|NCT03136861|12556642|FG005|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11359593|NCT03136861|12556643|FG006|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11359594|NCT03136861|12556637|FG000|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278
11359595|NCT03136861|12556638|FG001|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89
11359596|NCT03136861|12556639|FG002|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11359597|NCT03136861|12556640|FG003|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11359598|NCT03136861|12556641|FG004|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11359599|NCT03136861|12556642|FG005|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11359600|NCT03136861|12556643|FG006|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11359601|NCT03136861|12556637|FG000|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7
11359602|NCT03136861|12556638|FG001|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6
11359603|NCT03136861|12556639|FG002|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11005542|NCT00723294|12183239|FG000|COMPLETED|Overall Study||86
11005543|NCT00723294|12183239|FG000|NOT COMPLETED|Overall Study||13
11005544|NCT00723398|12183248|FG000|STARTED|Overall Study||53
11005545|NCT00723398|12183249|FG001|STARTED|Overall Study||53
11005546|NCT00723398|12183250|FG002|STARTED|Overall Study||53
11005547|NCT00723398|12183251|FG003|STARTED|Overall Study||54
11005548|NCT00723398|12183252|FG004|STARTED|Overall Study||53
11005549|NCT00723398|12183248|FG000|COMPLETED|Overall Study||47
11005550|NCT00723398|12183249|FG001|COMPLETED|Overall Study||38
11005551|NCT00723398|12183250|FG002|COMPLETED|Overall Study||36
11005552|NCT00723398|12183251|FG003|COMPLETED|Overall Study||49
11005553|NCT00723398|12183252|FG004|COMPLETED|Overall Study||44
11005554|NCT00723398|12183248|FG000|NOT COMPLETED|Overall Study||6
11005555|NCT00723398|12183249|FG001|NOT COMPLETED|Overall Study||15
11005556|NCT00723398|12183250|FG002|NOT COMPLETED|Overall Study||17
11005557|NCT00723398|12183251|FG003|NOT COMPLETED|Overall Study||5
11005558|NCT00723398|12183252|FG004|NOT COMPLETED|Overall Study||9
11005559|NCT00723450|12183266|FG000|STARTED|Open-Label Phase||298
11005560|NCT00723450|12183267|FG001|STARTED|Open-Label Phase||0
11359604|NCT03136861|12556640|FG003|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11359605|NCT03136861|12556641|FG004|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11359606|NCT03136861|12556642|FG005|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11359607|NCT03136861|12556643|FG006|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
11359608|NCT03136861|12556637|FG000|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
11359609|NCT03136861|12556638|FG001|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
11359610|NCT03136861|12556639|FG002|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90
11359611|NCT03136861|12556640|FG003|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
11359612|NCT03136861|12556641|FG004|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
11359613|NCT03136861|12556642|FG005|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
11359614|NCT03136861|12556643|FG006|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44
11359615|NCT03136861|12556637|FG000|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
11359616|NCT03136861|12556638|FG001|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
11359617|NCT03136861|12556639|FG002|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88
11359618|NCT03136861|12556640|FG003|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93
11359619|NCT03136861|12556641|FG004|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92
11142043|NCT01466062|12328722|FG000|STARTED|Overall Study||28
11142044|NCT01466062|12328722|FG000|COMPLETED|Overall Study||26
11142045|NCT01466062|12328722|FG000|NOT COMPLETED|Overall Study||2
11142046|NCT01466075|12328726|FG000|STARTED|Overall Study||207
11142047|NCT01466075|12328726|FG000|COMPLETED|Overall Study||207
11359620|NCT03136861|12556642|FG005|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
11359621|NCT03136861|12556643|FG006|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43
11359622|NCT03136861|12556637|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
11359623|NCT03136861|12556638|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
11359624|NCT03136861|12556639|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
11359625|NCT03136861|12556640|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
11359626|NCT03136861|12556641|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
11359627|NCT03136861|12556642|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
11359628|NCT03136861|12556643|FG006|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
11359629|NCT03136913|12556654|FG000|STARTED|Overall Study||13
11359630|NCT03136913|12556654|FG000|Subjects Received Both Intervention|Overall Study|10 subjects with 10 OFT and 10 CFT sites received clinical measurement before implant surgery|10
11359631|NCT03136913|12556654|FG000|COMPLETED|Overall Study|8 subjects with 8 OFT and 8 CFT sites received implant surgery|8
11359632|NCT03136913|12556654|FG000|NOT COMPLETED|Overall Study||5
11359633|NCT03137069|12556667|FG000|STARTED|Overall Study||13
11359634|NCT03137069|12556668|FG001|STARTED|Overall Study||28
11359635|NCT03137069|12556669|FG002|STARTED|Overall Study||23
11359636|NCT03137069|12556670|FG003|STARTED|Overall Study||23
11359637|NCT03137069|12556671|FG004|STARTED|Overall Study||24
11359638|NCT03137069|12556672|FG005|STARTED|Overall Study||23
11359639|NCT03137069|12556667|FG000|COMPLETED|Overall Study||12
11359640|NCT03137069|12556668|FG001|COMPLETED|Overall Study||22
11359641|NCT03137069|12556669|FG002|COMPLETED|Overall Study||20
11359642|NCT03137069|12556670|FG003|COMPLETED|Overall Study||17
11359643|NCT03137069|12556671|FG004|COMPLETED|Overall Study||22
11359644|NCT03137069|12556672|FG005|COMPLETED|Overall Study||21
11359645|NCT03137069|12556667|FG000|NOT COMPLETED|Overall Study||1
11359646|NCT03137069|12556668|FG001|NOT COMPLETED|Overall Study||6
11359647|NCT03137069|12556669|FG002|NOT COMPLETED|Overall Study||3
11359648|NCT03137069|12556670|FG003|NOT COMPLETED|Overall Study||6
11359649|NCT03137069|12556671|FG004|NOT COMPLETED|Overall Study||2
11359650|NCT03137069|12556672|FG005|NOT COMPLETED|Overall Study||2
11359651|NCT03137121|12556692|FG000|STARTED|Overall Study||15
11359652|NCT03137121|12556693|FG001|STARTED|Overall Study||15
11359653|NCT03137121|12556692|FG000|COMPLETED|Overall Study||15
11142048|NCT01466075|12328726|FG000|NOT COMPLETED|Overall Study||0
11359654|NCT03137121|12556693|FG001|COMPLETED|Overall Study||14
11359655|NCT03137121|12556692|FG000|NOT COMPLETED|Overall Study||0
11359656|NCT03137121|12556693|FG001|NOT COMPLETED|Overall Study||1
11359657|NCT03137303|12556701|FG000|STARTED|T0: Time of Enrollment - Baseline Visit||231
11359658|NCT03137303|12556702|FG001|STARTED|T0: Time of Enrollment - Baseline Visit||171
11359659|NCT03137303|12556701|FG000|COMPLETED|T0: Time of Enrollment - Baseline Visit||231
11359660|NCT03137303|12556702|FG001|COMPLETED|T0: Time of Enrollment - Baseline Visit||171
11359661|NCT03137303|12556701|FG000|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
11359662|NCT03137303|12556702|FG001|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
11359663|NCT03137303|12556701|FG000|STARTED|T1: 3-month Follow-up||231
11359664|NCT03137303|12556702|FG001|STARTED|T1: 3-month Follow-up||171
11359665|NCT03137303|12556701|FG000|COMPLETED|T1: 3-month Follow-up||225
11359666|NCT03137303|12556702|FG001|COMPLETED|T1: 3-month Follow-up||161
11359667|NCT03137303|12556701|FG000|NOT COMPLETED|T1: 3-month Follow-up||6
11359668|NCT03137303|12556702|FG001|NOT COMPLETED|T1: 3-month Follow-up||10
11359669|NCT03137303|12556701|FG000|STARTED|T2: 6-month Follow-up||230
11359670|NCT03137303|12556702|FG001|STARTED|T2: 6-month Follow-up||167
11359671|NCT03137303|12556701|FG000|COMPLETED|T2: 6-month Follow-up||225
11359672|NCT03137303|12556702|FG001|COMPLETED|T2: 6-month Follow-up||162
11359673|NCT03137303|12556701|FG000|NOT COMPLETED|T2: 6-month Follow-up||5
11359674|NCT03137303|12556702|FG001|NOT COMPLETED|T2: 6-month Follow-up||5
11359675|NCT03137303|12556701|FG000|STARTED|T3: 9-month Follow-up||230
11359676|NCT03137303|12556702|FG001|STARTED|T3: 9-month Follow-up||167
11359677|NCT03137303|12556701|FG000|COMPLETED|T3: 9-month Follow-up||225
11359678|NCT03137303|12556702|FG001|COMPLETED|T3: 9-month Follow-up||163
11359679|NCT03137303|12556701|FG000|NOT COMPLETED|T3: 9-month Follow-up||5
11359680|NCT03137303|12556702|FG001|NOT COMPLETED|T3: 9-month Follow-up||4
11359681|NCT03137303|12556701|FG000|STARTED|T4: 12-month Follow-up||229
11359682|NCT03137303|12556702|FG001|STARTED|T4: 12-month Follow-up||167
11359683|NCT03137303|12556701|FG000|COMPLETED|T4: 12-month Follow-up||222
11359684|NCT03137303|12556702|FG001|COMPLETED|T4: 12-month Follow-up||162
11359685|NCT03137303|12556701|FG000|NOT COMPLETED|T4: 12-month Follow-up||7
11359686|NCT03137303|12556702|FG001|NOT COMPLETED|T4: 12-month Follow-up||5
11359687|NCT03137459|12556710|FG000|STARTED|2-month Assessment||455
11359688|NCT03137459|12556711|FG001|STARTED|2-month Assessment||454
11359689|NCT03137459|12556710|FG000|COMPLETED|2-month Assessment||387
11359690|NCT03137459|12556711|FG001|COMPLETED|2-month Assessment||412
11359691|NCT03137459|12556710|FG000|NOT COMPLETED|2-month Assessment||68
11359692|NCT03137459|12556711|FG001|NOT COMPLETED|2-month Assessment||42
11359693|NCT03137459|12556710|FG000|STARTED|4-month Assessment||442
11359694|NCT03137459|12556711|FG001|STARTED|4-month Assessment||451
11359695|NCT03137459|12556710|FG000|COMPLETED|4-month Assessment||364
11359696|NCT03137459|12556711|FG001|COMPLETED|4-month Assessment||405
11359697|NCT03137459|12556710|FG000|NOT COMPLETED|4-month Assessment||78
11359698|NCT03137459|12556711|FG001|NOT COMPLETED|4-month Assessment||46
11359699|NCT03137459|12556710|FG000|STARTED|6-months||434
11359700|NCT03137459|12556711|FG001|STARTED|6-months||447
11359701|NCT03137459|12556710|FG000|COMPLETED|6-months||413
11359702|NCT03137459|12556711|FG001|COMPLETED|6-months||430
11359703|NCT03137459|12556710|FG000|NOT COMPLETED|6-months||21
11359704|NCT03137459|12556711|FG001|NOT COMPLETED|6-months||17
11359705|NCT03137784|12556718|FG000|STARTED|Overall Study||24
11359706|NCT03137784|12556719|FG001|STARTED|Overall Study||25
11359707|NCT03137784|12556720|FG002|STARTED|Overall Study||25
11359708|NCT03137784|12556721|FG003|STARTED|Overall Study||24
11359709|NCT03137784|12556722|FG004|STARTED|Overall Study||25
11359710|NCT03137784|12556723|FG005|STARTED|Overall Study||25
11359711|NCT03137784|12556718|FG000|COMPLETED|Overall Study||22
11359712|NCT03137784|12556719|FG001|COMPLETED|Overall Study||24
11359713|NCT03137784|12556720|FG002|COMPLETED|Overall Study||25
11359714|NCT03137784|12556721|FG003|COMPLETED|Overall Study||24
11359715|NCT03137784|12556722|FG004|COMPLETED|Overall Study||24
11359716|NCT03137784|12556723|FG005|COMPLETED|Overall Study||25
11359717|NCT03137784|12556718|FG000|NOT COMPLETED|Overall Study||2
11359718|NCT03137784|12556719|FG001|NOT COMPLETED|Overall Study||1
11359719|NCT03137784|12556720|FG002|NOT COMPLETED|Overall Study||0
11359720|NCT03137784|12556721|FG003|NOT COMPLETED|Overall Study||0
11359721|NCT03137784|12556722|FG004|NOT COMPLETED|Overall Study||1
11359722|NCT03137784|12556723|FG005|NOT COMPLETED|Overall Study||0
11359723|NCT03137992|12556731|FG000|STARTED|Period 1 (Visit 2)||62
11359724|NCT03137992|12556732|FG001|STARTED|Period 1 (Visit 2)||63
11359725|NCT03137992|12556733|FG002|STARTED|Period 1 (Visit 2)||63
11359726|NCT03137992|12556734|FG003|STARTED|Period 1 (Visit 2)||63
11359727|NCT03137992|12556735|FG004|STARTED|Period 1 (Visit 2)||62
11359728|NCT03137992|12556736|FG005|STARTED|Period 1 (Visit 2)||61
11359729|NCT03137992|12556731|FG000|COMPLETED|Period 1 (Visit 2)||62
11359730|NCT03137992|12556732|FG001|COMPLETED|Period 1 (Visit 2)||63
11359731|NCT03137992|12556733|FG002|COMPLETED|Period 1 (Visit 2)||63
11359732|NCT03137992|12556734|FG003|COMPLETED|Period 1 (Visit 2)||63
11359733|NCT03137992|12556735|FG004|COMPLETED|Period 1 (Visit 2)||62
11359734|NCT03137992|12556736|FG005|COMPLETED|Period 1 (Visit 2)||61
11359735|NCT03137992|12556731|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
11359736|NCT03137992|12556732|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
11359737|NCT03137992|12556733|FG002|NOT COMPLETED|Period 1 (Visit 2)||0
11359738|NCT03137992|12556734|FG003|NOT COMPLETED|Period 1 (Visit 2)||0
11359739|NCT03137992|12556735|FG004|NOT COMPLETED|Period 1 (Visit 2)||0
11359740|NCT03137992|12556736|FG005|NOT COMPLETED|Period 1 (Visit 2)||0
11359741|NCT03137992|12556731|FG000|STARTED|Washout Period 1||62
11359742|NCT03137992|12556732|FG001|STARTED|Washout Period 1||63
11359743|NCT03137992|12556733|FG002|STARTED|Washout Period 1||63
11359744|NCT03137992|12556734|FG003|STARTED|Washout Period 1||63
11359745|NCT03137992|12556735|FG004|STARTED|Washout Period 1||62
11359746|NCT03137992|12556736|FG005|STARTED|Washout Period 1||61
11359747|NCT03137992|12556731|FG000|COMPLETED|Washout Period 1||59
11359748|NCT03137992|12556732|FG001|COMPLETED|Washout Period 1||59
11359749|NCT03137992|12556733|FG002|COMPLETED|Washout Period 1||61
11359750|NCT03137992|12556734|FG003|COMPLETED|Washout Period 1||63
11359751|NCT03137992|12556735|FG004|COMPLETED|Washout Period 1||60
11359752|NCT03137992|12556736|FG005|COMPLETED|Washout Period 1||59
11359753|NCT03137992|12556731|FG000|NOT COMPLETED|Washout Period 1||3
11359754|NCT03137992|12556732|FG001|NOT COMPLETED|Washout Period 1||4
11359755|NCT03137992|12556733|FG002|NOT COMPLETED|Washout Period 1||2
11359756|NCT03137992|12556734|FG003|NOT COMPLETED|Washout Period 1||0
11359757|NCT03137992|12556735|FG004|NOT COMPLETED|Washout Period 1||2
11359758|NCT03137992|12556736|FG005|NOT COMPLETED|Washout Period 1||2
11359759|NCT03137992|12556731|FG000|STARTED|Period 2 (Visit 3)||59
11359760|NCT03137992|12556732|FG001|STARTED|Period 2 (Visit 3)||59
11359761|NCT03137992|12556733|FG002|STARTED|Period 2 (Visit 3)||61
11359762|NCT03137992|12556734|FG003|STARTED|Period 2 (Visit 3)||63
11359763|NCT03137992|12556735|FG004|STARTED|Period 2 (Visit 3)||60
11359764|NCT03137992|12556736|FG005|STARTED|Period 2 (Visit 3)||59
11359765|NCT03137992|12556731|FG000|COMPLETED|Period 2 (Visit 3)||56
11359766|NCT03137992|12556732|FG001|COMPLETED|Period 2 (Visit 3)||52
11359767|NCT03137992|12556733|FG002|COMPLETED|Period 2 (Visit 3)||58
11359768|NCT03137992|12556734|FG003|COMPLETED|Period 2 (Visit 3)||58
11359769|NCT03137992|12556735|FG004|COMPLETED|Period 2 (Visit 3)||56
11359770|NCT03137992|12556736|FG005|COMPLETED|Period 2 (Visit 3)||51
11359771|NCT03137992|12556731|FG000|NOT COMPLETED|Period 2 (Visit 3)||3
11359772|NCT03137992|12556732|FG001|NOT COMPLETED|Period 2 (Visit 3)||7
11359773|NCT03137992|12556733|FG002|NOT COMPLETED|Period 2 (Visit 3)||3
11359774|NCT03137992|12556734|FG003|NOT COMPLETED|Period 2 (Visit 3)||5
11359775|NCT03137992|12556735|FG004|NOT COMPLETED|Period 2 (Visit 3)||4
11359776|NCT03137992|12556736|FG005|NOT COMPLETED|Period 2 (Visit 3)||8
11359777|NCT03137992|12556731|FG000|STARTED|Washout Period 2||56
11359778|NCT03137992|12556732|FG001|STARTED|Washout Period 2||52
11359779|NCT03137992|12556733|FG002|STARTED|Washout Period 2||58
11359780|NCT03137992|12556734|FG003|STARTED|Washout Period 2||58
11359781|NCT03137992|12556735|FG004|STARTED|Washout Period 2||56
11359782|NCT03137992|12556736|FG005|STARTED|Washout Period 2||51
11359783|NCT03137992|12556731|FG000|COMPLETED|Washout Period 2||54
11359784|NCT03137992|12556732|FG001|COMPLETED|Washout Period 2||50
11359785|NCT03137992|12556733|FG002|COMPLETED|Washout Period 2||58
11359786|NCT03137992|12556734|FG003|COMPLETED|Washout Period 2||57
11359787|NCT03137992|12556735|FG004|COMPLETED|Washout Period 2||53
11359788|NCT03137992|12556736|FG005|COMPLETED|Washout Period 2||50
11359789|NCT03137992|12556731|FG000|NOT COMPLETED|Washout Period 2||2
11359790|NCT03137992|12556732|FG001|NOT COMPLETED|Washout Period 2||2
11359791|NCT03137992|12556733|FG002|NOT COMPLETED|Washout Period 2||0
11359792|NCT03137992|12556734|FG003|NOT COMPLETED|Washout Period 2||1
11359793|NCT03137992|12556735|FG004|NOT COMPLETED|Washout Period 2||3
11359794|NCT03137992|12556736|FG005|NOT COMPLETED|Washout Period 2||1
11359795|NCT03137992|12556731|FG000|STARTED|Period 3 (Visit 04)||54
11359796|NCT03137992|12556732|FG001|STARTED|Period 3 (Visit 04)||50
11359797|NCT03137992|12556733|FG002|STARTED|Period 3 (Visit 04)||58
11359798|NCT03137992|12556734|FG003|STARTED|Period 3 (Visit 04)||57
11359799|NCT03137992|12556735|FG004|STARTED|Period 3 (Visit 04)||53
11359800|NCT03137992|12556736|FG005|STARTED|Period 3 (Visit 04)||50
11359801|NCT03137992|12556731|FG000|COMPLETED|Period 3 (Visit 04)||48
11359802|NCT03137992|12556732|FG001|COMPLETED|Period 3 (Visit 04)||48
11359803|NCT03137992|12556733|FG002|COMPLETED|Period 3 (Visit 04)||55
11359804|NCT03137992|12556734|FG003|COMPLETED|Period 3 (Visit 04)||57
11359805|NCT03137992|12556735|FG004|COMPLETED|Period 3 (Visit 04)||50
11359806|NCT03137992|12556736|FG005|COMPLETED|Period 3 (Visit 04)||47
11359807|NCT03137992|12556731|FG000|NOT COMPLETED|Period 3 (Visit 04)||6
11359808|NCT03137992|12556732|FG001|NOT COMPLETED|Period 3 (Visit 04)||2
11359809|NCT03137992|12556733|FG002|NOT COMPLETED|Period 3 (Visit 04)||3
11359810|NCT03137992|12556734|FG003|NOT COMPLETED|Period 3 (Visit 04)||0
11359811|NCT03137992|12556735|FG004|NOT COMPLETED|Period 3 (Visit 04)||3
11359812|NCT03137992|12556736|FG005|NOT COMPLETED|Period 3 (Visit 04)||3
11359813|NCT03137992|12556731|FG000|STARTED|Part 2 (Open-label Extension)||22
11359814|NCT03137992|12556732|FG001|STARTED|Part 2 (Open-label Extension)||17
11359815|NCT03137992|12556733|FG002|STARTED|Part 2 (Open-label Extension)||21
11359816|NCT03137992|12556734|FG003|STARTED|Part 2 (Open-label Extension)||25
11359817|NCT03137992|12556735|FG004|STARTED|Part 2 (Open-label Extension)||18
11359818|NCT03137992|12556736|FG005|STARTED|Part 2 (Open-label Extension)||22
11359819|NCT03137992|12556731|FG000|COMPLETED|Part 2 (Open-label Extension)||20
11359820|NCT03137992|12556732|FG001|COMPLETED|Part 2 (Open-label Extension)||17
11359821|NCT03137992|12556733|FG002|COMPLETED|Part 2 (Open-label Extension)||20
11359822|NCT03137992|12556734|FG003|COMPLETED|Part 2 (Open-label Extension)||24
11359823|NCT03137992|12556735|FG004|COMPLETED|Part 2 (Open-label Extension)||18
11359824|NCT03137992|12556736|FG005|COMPLETED|Part 2 (Open-label Extension)||21
11359825|NCT03137992|12556731|FG000|NOT COMPLETED|Part 2 (Open-label Extension)||2
11359826|NCT03137992|12556732|FG001|NOT COMPLETED|Part 2 (Open-label Extension)||0
11359827|NCT03137992|12556733|FG002|NOT COMPLETED|Part 2 (Open-label Extension)||1
11359828|NCT03137992|12556734|FG003|NOT COMPLETED|Part 2 (Open-label Extension)||1
11359829|NCT03137992|12556735|FG004|NOT COMPLETED|Part 2 (Open-label Extension)||0
11359830|NCT03137992|12556736|FG005|NOT COMPLETED|Part 2 (Open-label Extension)||1
11359831|NCT03138330|12556744|FG000|STARTED|Overall Study||95
11359832|NCT03138330|12556744|FG000|COMPLETED|Overall Study||91
11359833|NCT03138330|12556744|FG000|NOT COMPLETED|Overall Study||4
11359834|NCT03138382|12556750|FG000|STARTED|Overall Study||10
11359835|NCT03138382|12556751|FG001|STARTED|Overall Study||10
11359836|NCT03138382|12556750|FG000|COMPLETED|Overall Study||10
11359837|NCT03138382|12556751|FG001|COMPLETED|Overall Study||10
11359838|NCT03138382|12556750|FG000|NOT COMPLETED|Overall Study||0
11359839|NCT03138382|12556751|FG001|NOT COMPLETED|Overall Study||0
11359840|NCT03138577|12556764|FG000|STARTED|Overall Study||3
11359841|NCT03138577|12556765|FG001|STARTED|Overall Study||3
11359842|NCT03138577|12556766|FG002|STARTED|Overall Study||3
11359843|NCT03138577|12556767|FG003|STARTED|Overall Study||3
11359844|NCT03138577|12556768|FG004|STARTED|Overall Study||3
11359845|NCT03138577|12556769|FG005|STARTED|Overall Study||3
11359846|NCT03138577|12556770|FG006|STARTED|Overall Study||3
11359847|NCT03138577|12556764|FG000|COMPLETED|Overall Study||3
11359848|NCT03138577|12556765|FG001|COMPLETED|Overall Study||3
11359849|NCT03138577|12556766|FG002|COMPLETED|Overall Study||3
11359850|NCT03138577|12556767|FG003|COMPLETED|Overall Study||3
11359851|NCT03138577|12556768|FG004|COMPLETED|Overall Study||3
11359852|NCT03138577|12556769|FG005|COMPLETED|Overall Study||3
11359853|NCT03138577|12556770|FG006|COMPLETED|Overall Study||3
11359854|NCT03138577|12556764|FG000|NOT COMPLETED|Overall Study||0
11359855|NCT03138577|12556765|FG001|NOT COMPLETED|Overall Study||0
11359856|NCT03138577|12556766|FG002|NOT COMPLETED|Overall Study||0
11359857|NCT03138577|12556767|FG003|NOT COMPLETED|Overall Study||0
11359858|NCT03138577|12556768|FG004|NOT COMPLETED|Overall Study||0
11359859|NCT03138577|12556769|FG005|NOT COMPLETED|Overall Study||0
11359860|NCT03138577|12556770|FG006|NOT COMPLETED|Overall Study||0
11359861|NCT03138655|12556796|FG000|STARTED|Overall Study||10
11359862|NCT03138655|12556797|FG001|STARTED|Overall Study||9
11359863|NCT03138655|12556798|FG002|STARTED|Overall Study||11
11359864|NCT03138655|12556799|FG003|STARTED|Overall Study||10
11359865|NCT03138655|12556800|FG004|STARTED|Overall Study||13
11359866|NCT03138655|12556801|FG005|STARTED|Overall Study||12
11359867|NCT03138655|12556802|FG006|STARTED|Overall Study||12
11359868|NCT03138655|12556803|FG007|STARTED|Overall Study||12
11359869|NCT03138655|12556796|FG000|COMPLETED|Overall Study||7
11359870|NCT03138655|12556797|FG001|COMPLETED|Overall Study||7
11005561|NCT00723450|12183268|FG002|STARTED|Open-Label Phase||0
11005562|NCT00723450|12183266|FG000|COMPLETED|Open-Label Phase||173
11005563|NCT00723450|12183267|FG001|COMPLETED|Open-Label Phase||0
11359871|NCT03138655|12556798|FG002|COMPLETED|Overall Study||9
11359872|NCT03138655|12556799|FG003|COMPLETED|Overall Study||7
11359873|NCT03138655|12556800|FG004|COMPLETED|Overall Study||11
11359874|NCT03138655|12556801|FG005|COMPLETED|Overall Study||7
11359875|NCT03138655|12556802|FG006|COMPLETED|Overall Study||9
11359876|NCT03138655|12556803|FG007|COMPLETED|Overall Study||10
11359877|NCT03138655|12556796|FG000|NOT COMPLETED|Overall Study||3
11359878|NCT03138655|12556797|FG001|NOT COMPLETED|Overall Study||2
11359879|NCT03138655|12556798|FG002|NOT COMPLETED|Overall Study||2
11359880|NCT03138655|12556799|FG003|NOT COMPLETED|Overall Study||3
11359881|NCT03138655|12556800|FG004|NOT COMPLETED|Overall Study||2
11359882|NCT03138655|12556801|FG005|NOT COMPLETED|Overall Study||5
11359883|NCT03138655|12556802|FG006|NOT COMPLETED|Overall Study||3
11359884|NCT03138655|12556803|FG007|NOT COMPLETED|Overall Study||2
11359885|NCT03138798|12556827|FG000|STARTED|Overall Study||173
11005564|NCT00723450|12183268|FG002|COMPLETED|Open-Label Phase||0
11005565|NCT00723450|12183266|FG000|NOT COMPLETED|Open-Label Phase||125
11005566|NCT00723450|12183267|FG001|NOT COMPLETED|Open-Label Phase||0
11005567|NCT00723450|12183268|FG002|NOT COMPLETED|Open-Label Phase||0
11005568|NCT00723450|12183266|FG000|STARTED|Randomized Phase||0
11359886|NCT03138798|12556828|FG001|STARTED|Overall Study||175
11359887|NCT03138798|12556827|FG000|Randomized But Did Not Meet Eligibility|Overall Study||6
11359888|NCT03138798|12556828|FG001|Randomized But Did Not Meet Eligibility|Overall Study||4
11359889|NCT03138798|12556827|FG000|COMPLETED|Overall Study||167
11359890|NCT03138798|12556828|FG001|COMPLETED|Overall Study||171
11359891|NCT03138798|12556827|FG000|NOT COMPLETED|Overall Study||6
11359892|NCT03138798|12556828|FG001|NOT COMPLETED|Overall Study||4
11359893|NCT03138876|12556835|FG000|STARTED|Overall Study||20
11359894|NCT03138876|12556835|FG000|COMPLETED|Overall Study||20
11359895|NCT03138876|12556835|FG000|NOT COMPLETED|Overall Study||0
11359896|NCT03138967|12556841|FG000|STARTED|Overall Study||26
11359897|NCT03138967|12556842|FG001|STARTED|Overall Study||28
11005569|NCT00723450|12183267|FG001|STARTED|Randomized Phase||86
11359898|NCT03138967|12556841|FG000|Post-operative Day(POD) 1 Follow-up|Overall Study||25
11359899|NCT03138967|12556842|FG001|Post-operative Day(POD) 1 Follow-up|Overall Study||25
11359900|NCT03138967|12556841|FG000|Post-operative Day(POD) 7 Follow-up|Overall Study||25
11359901|NCT03138967|12556842|FG001|Post-operative Day(POD) 7 Follow-up|Overall Study||24
11359902|NCT03138967|12556841|FG000|COMPLETED|Overall Study||25
11005570|NCT00723450|12183268|FG002|STARTED|Randomized Phase||87
11005571|NCT00723450|12183266|FG000|COMPLETED|Randomized Phase||0
11359903|NCT03138967|12556842|FG001|COMPLETED|Overall Study||24
11359904|NCT03138967|12556841|FG000|NOT COMPLETED|Overall Study||1
11359905|NCT03138967|12556842|FG001|NOT COMPLETED|Overall Study||4
11359906|NCT03139032|12556848|FG000|STARTED|Overall Study||1
11359907|NCT03139032|12556848|FG000|COMPLETED|Overall Study||1
11359908|NCT03139032|12556848|FG000|NOT COMPLETED|Overall Study||0
11359909|NCT03139240|12556857|FG000|STARTED|Overall Study||48
11359910|NCT03139240|12556858|FG001|STARTED|Overall Study||48
11359911|NCT03139240|12556859|FG002|STARTED|Overall Study||38
11359912|NCT03139240|12556860|FG003|STARTED|Overall Study||38
11359913|NCT03139240|12556857|FG000|COMPLETED|Overall Study||48
11359914|NCT03139240|12556858|FG001|COMPLETED|Overall Study||47
11359915|NCT03139240|12556859|FG002|COMPLETED|Overall Study||37
11359916|NCT03139240|12556860|FG003|COMPLETED|Overall Study||38
11359917|NCT03139240|12556857|FG000|NOT COMPLETED|Overall Study||0
11359918|NCT03139240|12556858|FG001|NOT COMPLETED|Overall Study||1
11359919|NCT03139240|12556859|FG002|NOT COMPLETED|Overall Study||1
11359920|NCT03139240|12556860|FG003|NOT COMPLETED|Overall Study||0
11359921|NCT03139279|12556870|FG000|STARTED|Overall Study||58
11359922|NCT03139279|12556871|FG001|STARTED|Overall Study||56
11359923|NCT03139279|12556870|FG000|COMPLETED|Overall Study||51
11359924|NCT03139279|12556871|FG001|COMPLETED|Overall Study||50
11359925|NCT03139279|12556870|FG000|NOT COMPLETED|Overall Study||7
11359926|NCT03139279|12556871|FG001|NOT COMPLETED|Overall Study||6
11359927|NCT03139448|12556879|FG000|STARTED|Overall Study||85
11359928|NCT03139448|12556880|FG001|STARTED|Overall Study||89
11359929|NCT03139448|12556879|FG000|Intervention Started|Overall Study||79
11359930|NCT03139448|12556880|FG001|Intervention Started|Overall Study||70
11359931|NCT03139448|12556879|FG000|COMPLETED|Overall Study||73
11359932|NCT03139448|12556880|FG001|COMPLETED|Overall Study||63
11359933|NCT03139448|12556879|FG000|NOT COMPLETED|Overall Study||12
11359934|NCT03139448|12556880|FG001|NOT COMPLETED|Overall Study||26
11359935|NCT03139552|12556886|FG000|STARTED|Overall Study||150
11359936|NCT03139552|12556886|FG000|COMPLETED|Overall Study||147
11359937|NCT03139552|12556886|FG000|NOT COMPLETED|Overall Study||3
11359938|NCT03139578|12556897|FG000|STARTED|Period 1||12
11359939|NCT03139578|12556898|FG001|STARTED|Period 1||13
11359940|NCT03139578|12556899|FG002|STARTED|Period 1||12
11359941|NCT03139578|12556900|FG003|STARTED|Period 1||13
11359942|NCT03139578|12556897|FG000|Discontinued|Period 1||0
11359943|NCT03139578|12556898|FG001|Discontinued|Period 1||0
11359944|NCT03139578|12556899|FG002|Discontinued|Period 1||0
11359945|NCT03139578|12556900|FG003|Discontinued|Period 1||0
11359946|NCT03139578|12556897|FG000|COMPLETED|Period 1||12
11359947|NCT03139578|12556898|FG001|COMPLETED|Period 1||13
11359948|NCT03139578|12556899|FG002|COMPLETED|Period 1||12
11359949|NCT03139578|12556900|FG003|COMPLETED|Period 1||13
11359950|NCT03139578|12556897|FG000|NOT COMPLETED|Period 1||0
11359951|NCT03139578|12556898|FG001|NOT COMPLETED|Period 1||0
11359952|NCT03139578|12556899|FG002|NOT COMPLETED|Period 1||0
11359953|NCT03139578|12556900|FG003|NOT COMPLETED|Period 1||0
11359954|NCT03139578|12556897|FG000|STARTED|Period 2||12
11359955|NCT03139578|12556898|FG001|STARTED|Period 2||13
11359956|NCT03139578|12556899|FG002|STARTED|Period 2||12
11359957|NCT03139578|12556900|FG003|STARTED|Period 2||13
11359958|NCT03139578|12556897|FG000|Discontinued|Period 2||0
11359959|NCT03139578|12556898|FG001|Discontinued|Period 2||0
11359960|NCT03139578|12556899|FG002|Discontinued|Period 2||0
11359961|NCT03139578|12556900|FG003|Discontinued|Period 2||0
11359962|NCT03139578|12556897|FG000|COMPLETED|Period 2||12
11359963|NCT03139578|12556898|FG001|COMPLETED|Period 2||13
11359964|NCT03139578|12556899|FG002|COMPLETED|Period 2||12
11359965|NCT03139578|12556900|FG003|COMPLETED|Period 2||13
11359966|NCT03139578|12556897|FG000|NOT COMPLETED|Period 2||0
11359967|NCT03139578|12556898|FG001|NOT COMPLETED|Period 2||0
11359968|NCT03139578|12556899|FG002|NOT COMPLETED|Period 2||0
11359969|NCT03139578|12556900|FG003|NOT COMPLETED|Period 2||0
11359970|NCT03139604|12556912|FG000|STARTED|Overall Study||219
11359971|NCT03139604|12556913|FG001|STARTED|Overall Study||220
11359972|NCT03139604|12556912|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
11359973|NCT03139604|12556913|FG001|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
11359974|NCT03139604|12556912|FG000|NOT COMPLETED|Overall Study||219
11359975|NCT03139604|12556913|FG001|NOT COMPLETED|Overall Study||220
11359976|NCT03140254|12556920|FG000|STARTED|Overall Study||145
11359977|NCT03140254|12556920|FG000|Treatment IP - Groin|Overall Study||51
11359978|NCT03140254|12556920|FG000|Treatment IP - Abdomen|Overall Study||48
11359979|NCT03140254|12556920|FG000|Treatment AC - Groin|Overall Study||51
11359980|NCT03140254|12556920|FG000|Treatment AC - Abdomen|Overall Study||48
11359981|NCT03140254|12556920|FG000|Treatment VC - Groin|Overall Study||18
11359982|NCT03140254|12556920|FG000|Treatment VC - Abdomen|Overall Study||19
11359983|NCT03140254|12556920|FG000|COMPLETED|Overall Study||144
11359984|NCT03140254|12556920|FG000|NOT COMPLETED|Overall Study||1
11359985|NCT03140631|12556928|FG000|STARTED|Overall Study||73
11359986|NCT03140631|12556929|FG001|STARTED|Overall Study||77
11359987|NCT03140631|12556928|FG000|COMPLETED|Overall Study||73
11359988|NCT03140631|12556929|FG001|COMPLETED|Overall Study||77
11359989|NCT03140631|12556928|FG000|NOT COMPLETED|Overall Study||0
11359990|NCT03140631|12556929|FG001|NOT COMPLETED|Overall Study||0
11359991|NCT03140722|12556938|FG000|STARTED|Overall Study||0
11359992|NCT03140722|12556939|FG001|STARTED|Overall Study||2
11359993|NCT03140722|12556938|FG000|COMPLETED|Overall Study||0
11359994|NCT03140722|12556939|FG001|COMPLETED|Overall Study||2
11359995|NCT03140722|12556938|FG000|NOT COMPLETED|Overall Study||0
11359996|NCT03140722|12556939|FG001|NOT COMPLETED|Overall Study||0
11359997|NCT03141086|12556947|FG000|STARTED|Overall Study||7
11359998|NCT03141086|12556948|FG001|STARTED|Overall Study||17
11359999|NCT03141086|12556947|FG000|COMPLETED|Overall Study||6
11360000|NCT03141086|12556948|FG001|COMPLETED|Overall Study||12
11360001|NCT03141086|12556947|FG000|NOT COMPLETED|Overall Study||1
11360002|NCT03141086|12556948|FG001|NOT COMPLETED|Overall Study||5
11360003|NCT03141151|12556956|FG000|STARTED|Overall Study||59
11360004|NCT03141151|12556957|FG001|STARTED|Overall Study||58
11360005|NCT03141151|12556956|FG000|COMPLETED|Overall Study||53
11360006|NCT03141151|12556957|FG001|COMPLETED|Overall Study||54
11360007|NCT03141151|12556956|FG000|NOT COMPLETED|Overall Study||6
11360008|NCT03141151|12556957|FG001|NOT COMPLETED|Overall Study||4
11360009|NCT03141242|12556965|FG000|STARTED|Overall Study||55
11360010|NCT03141242|12556966|FG001|STARTED|Overall Study||55
11360011|NCT03141242|12556965|FG000|Received Allocated Intervenion|Overall Study|11 subjects didn't attend their scheduled group session; all were included in ITT analysis|44
11360012|NCT03141242|12556966|FG001|Received Allocated Intervenion|Overall Study||55
11360013|NCT03141242|12556965|FG000|6 Month Interview|Overall Study||51
11360014|NCT03141242|12556966|FG001|6 Month Interview|Overall Study||49
11360015|NCT03141242|12556965|FG000|COMPLETED|Overall Study||55
11360016|NCT03141242|12556966|FG001|COMPLETED|Overall Study||55
11360017|NCT03141242|12556965|FG000|NOT COMPLETED|Overall Study||0
11360018|NCT03141242|12556966|FG001|NOT COMPLETED|Overall Study||0
11360019|NCT03141281|12556977|FG000|STARTED|Overall Study||57
11360020|NCT03141281|12556978|FG001|STARTED|Overall Study||59
11360021|NCT03141281|12556979|FG002|STARTED|Overall Study||56
11360022|NCT03141281|12556980|FG003|STARTED|Overall Study||58
11360023|NCT03141281|12556977|FG000|Post-Test|Overall Study||50
11360024|NCT03141281|12556978|FG001|Post-Test|Overall Study||47
11360025|NCT03141281|12556979|FG002|Post-Test|Overall Study||50
11360026|NCT03141281|12556980|FG003|Post-Test|Overall Study||56
11360027|NCT03141281|12556977|FG000|COMPLETED|Overall Study||45
11360028|NCT03141281|12556978|FG001|COMPLETED|Overall Study||38
11360029|NCT03141281|12556979|FG002|COMPLETED|Overall Study||42
11360030|NCT03141281|12556980|FG003|COMPLETED|Overall Study||47
11360031|NCT03141281|12556977|FG000|NOT COMPLETED|Overall Study||12
11360032|NCT03141281|12556978|FG001|NOT COMPLETED|Overall Study||21
11360033|NCT03141281|12556979|FG002|NOT COMPLETED|Overall Study||14
11360034|NCT03141281|12556980|FG003|NOT COMPLETED|Overall Study||11
11360035|NCT03141307|12556992|FG000|STARTED|In-Hospital||471
11360036|NCT03141307|12556993|FG001|STARTED|In-Hospital||240
11360037|NCT03141307|12556992|FG000|COMPLETED|In-Hospital||467
11360038|NCT03141307|12556993|FG001|COMPLETED|In-Hospital||238
11360039|NCT03141307|12556992|FG000|NOT COMPLETED|In-Hospital||4
11360040|NCT03141307|12556993|FG001|NOT COMPLETED|In-Hospital||2
11360041|NCT03141307|12556992|FG000|STARTED|Follow-Up||467
11360042|NCT03141307|12556993|FG001|STARTED|Follow-Up||238
11360043|NCT03141307|12556992|FG000|COMPLETED|Follow-Up||370
11360044|NCT03141307|12556993|FG001|COMPLETED|Follow-Up||184
11360045|NCT03141307|12556992|FG000|NOT COMPLETED|Follow-Up||97
11360046|NCT03141307|12556993|FG001|NOT COMPLETED|Follow-Up||54
11360047|NCT03141372|12557001|FG000|STARTED|Overall Study||42
11360048|NCT03141372|12557002|FG001|STARTED|Overall Study||42
11360049|NCT03141372|12557001|FG000|COMPLETED|Overall Study||42
11360050|NCT03141372|12557002|FG001|COMPLETED|Overall Study||40
11360051|NCT03141372|12557001|FG000|NOT COMPLETED|Overall Study||0
11360052|NCT03141372|12557002|FG001|NOT COMPLETED|Overall Study||2
11360053|NCT03141528|12557012|FG000|STARTED|Overall Study||122
11360054|NCT03141528|12557013|FG001|STARTED|Overall Study||118
11360055|NCT03141528|12557012|FG000|COMPLETED|Overall Study||75
11360056|NCT03141528|12557013|FG001|COMPLETED|Overall Study||77
11360057|NCT03141528|12557012|FG000|NOT COMPLETED|Overall Study||47
11360058|NCT03141528|12557013|FG001|NOT COMPLETED|Overall Study||41
11360059|NCT03141788|12557019|FG000|STARTED|Overall Study||52
11360060|NCT03141788|12557019|FG000|COMPLETED|Overall Study||44
11360061|NCT03141788|12557019|FG000|NOT COMPLETED|Overall Study||8
11360062|NCT03141905|12557028|FG000|STARTED|Overall Study||176
11360063|NCT03141905|12557029|FG001|STARTED|Overall Study||166
11360064|NCT03141905|12557028|FG000|COMPLETED|Overall Study||152
11360065|NCT03141905|12557029|FG001|COMPLETED|Overall Study||147
11360066|NCT03141905|12557028|FG000|NOT COMPLETED|Overall Study||24
11360067|NCT03141905|12557029|FG001|NOT COMPLETED|Overall Study||19
11360068|NCT03141931|12557038|FG000|STARTED|Overall Study||61
11360069|NCT03141931|12557039|FG001|STARTED|Overall Study||58
11360070|NCT03141931|12557038|FG000|COMPLETED|Overall Study||49
11360071|NCT03141931|12557039|FG001|COMPLETED|Overall Study||52
11360072|NCT03141931|12557038|FG000|NOT COMPLETED|Overall Study||12
11360073|NCT03141931|12557039|FG001|NOT COMPLETED|Overall Study||6
11360074|NCT03142438|12557045|FG000|STARTED|Overall Study||57
11360075|NCT03142438|12557045|FG000|COMPLETED|Overall Study||57
11360076|NCT03142438|12557045|FG000|NOT COMPLETED|Overall Study||0
11360077|NCT03142451|12557051|FG000|STARTED|Overall Study||495
11360078|NCT03142451|12557052|FG001|STARTED|Overall Study||256
11360079|NCT03142451|12557051|FG000|COMPLETED|Overall Study||437
11360080|NCT03142451|12557052|FG001|COMPLETED|Overall Study||232
11360081|NCT03142451|12557051|FG000|NOT COMPLETED|Overall Study||58
11360082|NCT03142451|12557052|FG001|NOT COMPLETED|Overall Study||24
11360083|NCT03142750|12557060|FG000|STARTED|Overall Study||14
11360084|NCT03142750|12557061|FG001|STARTED|Overall Study||10
11360085|NCT03142750|12557060|FG000|COMPLETED|Overall Study||10
11360086|NCT03142750|12557061|FG001|COMPLETED|Overall Study||9
11360087|NCT03142750|12557060|FG000|NOT COMPLETED|Overall Study||4
11360088|NCT03142750|12557061|FG001|NOT COMPLETED|Overall Study||1
11360089|NCT03142932|12557073|FG000|STARTED|Overall Study||52
11360090|NCT03142932|12557074|FG001|STARTED|Overall Study||50
11360091|NCT03142932|12557073|FG000|COMPLETED|Overall Study||50
11360092|NCT03142932|12557074|FG001|COMPLETED|Overall Study||39
11360093|NCT03142932|12557073|FG000|NOT COMPLETED|Overall Study||2
11360094|NCT03142932|12557074|FG001|NOT COMPLETED|Overall Study||11
11360095|NCT03143101|12557083|FG000|STARTED|Overall Study||67
11360096|NCT03143101|12557084|FG001|STARTED|Overall Study||66
11360097|NCT03143101|12557085|FG002|STARTED|Overall Study||67
11360098|NCT03143101|12557083|FG000|COMPLETED|Overall Study||65
11360099|NCT03143101|12557084|FG001|COMPLETED|Overall Study||63
11360100|NCT03143101|12557085|FG002|COMPLETED|Overall Study||67
11360101|NCT03143101|12557083|FG000|NOT COMPLETED|Overall Study||2
11360102|NCT03143101|12557084|FG001|NOT COMPLETED|Overall Study||3
11360103|NCT03143101|12557085|FG002|NOT COMPLETED|Overall Study||0
11360104|NCT03143166|12557093|FG000|STARTED|Period 1||36
11360105|NCT03143166|12557093|FG000|COMPLETED|Period 1||36
11360106|NCT03143166|12557093|FG000|NOT COMPLETED|Period 1||0
11360107|NCT03143166|12557093|FG000|STARTED|Period 2 (Washout of at Least 4 Days)||36
11360108|NCT03143166|12557093|FG000|COMPLETED|Period 2 (Washout of at Least 4 Days)||35
11360109|NCT03143166|12557093|FG000|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1
11360110|NCT03143569|12557101|FG000|STARTED|Overall Study||10
11360111|NCT03143569|12557102|FG001|STARTED|Overall Study||10
11360112|NCT03143569|12557101|FG000|COMPLETED|Overall Study||10
11360113|NCT03143569|12557102|FG001|COMPLETED|Overall Study||8
11360114|NCT03143569|12557101|FG000|NOT COMPLETED|Overall Study||0
11360115|NCT03143569|12557102|FG001|NOT COMPLETED|Overall Study||2
11360116|NCT03143855|12557112|FG000|STARTED|Overall Study||17
11360117|NCT03143855|12557113|FG001|STARTED|Overall Study||10
11360118|NCT03143855|12557112|FG000|COMPLETED|Overall Study||12
11360119|NCT03143855|12557113|FG001|COMPLETED|Overall Study||6
11360120|NCT03143855|12557112|FG000|NOT COMPLETED|Overall Study||5
11360121|NCT03143855|12557113|FG001|NOT COMPLETED|Overall Study||4
11360122|NCT03143894|12557121|FG000|STARTED|First Intervention (5 Days)||3
11360123|NCT03143894|12557122|FG001|STARTED|First Intervention (5 Days)||4
11360124|NCT03143894|12557121|FG000|COMPLETED|First Intervention (5 Days)||3
11360125|NCT03143894|12557122|FG001|COMPLETED|First Intervention (5 Days)||4
11360126|NCT03143894|12557121|FG000|NOT COMPLETED|First Intervention (5 Days)||0
11360127|NCT03143894|12557122|FG001|NOT COMPLETED|First Intervention (5 Days)||0
11360128|NCT03143894|12557121|FG000|STARTED|Washout (4 Weeks)||3
11360129|NCT03143894|12557122|FG001|STARTED|Washout (4 Weeks)||4
11360130|NCT03143894|12557121|FG000|COMPLETED|Washout (4 Weeks)||3
11360131|NCT03143894|12557122|FG001|COMPLETED|Washout (4 Weeks)||4
11360132|NCT03143894|12557121|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11360133|NCT03143894|12557122|FG001|NOT COMPLETED|Washout (4 Weeks)||0
11360134|NCT03143894|12557121|FG000|STARTED|Second Intervention (5 Days)||3
11360135|NCT03143894|12557122|FG001|STARTED|Second Intervention (5 Days)||4
11360136|NCT03143894|12557121|FG000|COMPLETED|Second Intervention (5 Days)||3
11360137|NCT03143894|12557122|FG001|COMPLETED|Second Intervention (5 Days)||3
11360138|NCT03143894|12557121|FG000|NOT COMPLETED|Second Intervention (5 Days)||0
11360139|NCT03143894|12557122|FG001|NOT COMPLETED|Second Intervention (5 Days)||1
11360140|NCT03144089|12557132|FG000|STARTED|Overall Study||28
11360141|NCT03144089|12557133|FG001|STARTED|Overall Study||28
11360142|NCT03144089|12557132|FG000|COMPLETED|Overall Study||28
11360143|NCT03144089|12557133|FG001|COMPLETED|Overall Study||28
11360144|NCT03144089|12557132|FG000|NOT COMPLETED|Overall Study||0
11360145|NCT03144089|12557133|FG001|NOT COMPLETED|Overall Study||0
11360146|NCT03144180|12557143|FG000|STARTED|Overall Study||16
11360147|NCT03144180|12557144|FG001|STARTED|Overall Study||16
11360148|NCT03144180|12557143|FG000|COMPLETED|Overall Study||14
11360149|NCT03144180|12557144|FG001|COMPLETED|Overall Study||10
11360150|NCT03144180|12557143|FG000|NOT COMPLETED|Overall Study||2
11360151|NCT03144180|12557144|FG001|NOT COMPLETED|Overall Study||6
11360152|NCT03144518|12557154|FG000|STARTED|Primary Outcome (Mood)||52
11360153|NCT03144518|12557155|FG001|STARTED|Primary Outcome (Mood)||51
11360154|NCT03144518|12557154|FG000|COMPLETED|Primary Outcome (Mood)||52
11360155|NCT03144518|12557155|FG001|COMPLETED|Primary Outcome (Mood)||51
11360156|NCT03144518|12557154|FG000|NOT COMPLETED|Primary Outcome (Mood)||0
11360157|NCT03144518|12557155|FG001|NOT COMPLETED|Primary Outcome (Mood)||0
11360158|NCT03144518|12557154|FG000|STARTED|4 Weeks Post-Vaccination||52
11360159|NCT03144518|12557155|FG001|STARTED|4 Weeks Post-Vaccination||51
11360160|NCT03144518|12557154|FG000|COMPLETED|4 Weeks Post-Vaccination||51
11360161|NCT03144518|12557155|FG001|COMPLETED|4 Weeks Post-Vaccination||51
11360162|NCT03144518|12557154|FG000|NOT COMPLETED|4 Weeks Post-Vaccination||1
11360163|NCT03144518|12557155|FG001|NOT COMPLETED|4 Weeks Post-Vaccination||0
11360164|NCT03144518|12557154|FG000|STARTED|16 Week Post-Vaccination||52
11360165|NCT03144518|12557155|FG001|STARTED|16 Week Post-Vaccination||51
11360166|NCT03144518|12557154|FG000|COMPLETED|16 Week Post-Vaccination||49
11360167|NCT03144518|12557155|FG001|COMPLETED|16 Week Post-Vaccination||49
11360168|NCT03144518|12557154|FG000|NOT COMPLETED|16 Week Post-Vaccination||3
11360169|NCT03144518|12557155|FG001|NOT COMPLETED|16 Week Post-Vaccination||2
11360170|NCT03144635|12557162|FG000|STARTED|Overall Study||80
11360171|NCT03144635|12557162|FG000|COMPLETED|Overall Study||0
11360172|NCT03144635|12557162|FG000|NOT COMPLETED|Overall Study||80
11360173|NCT03144804|12557168|FG000|STARTED|Overall Study||36
11360174|NCT03144804|12557168|FG000|COMPLETED|Overall Study||32
11360175|NCT03144804|12557168|FG000|NOT COMPLETED|Overall Study||4
11360176|NCT03145064|12557172|FG000|STARTED|Overall Study||41
11360177|NCT03145064|12557172|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41
11360178|NCT03145064|12557172|FG000|COMPLETED|Overall Study||0
11360179|NCT03145064|12557172|FG000|NOT COMPLETED|Overall Study||41
11360180|NCT03145207|12557177|FG000|STARTED|Overall Study|The same 12 volunteers completed each of the seven study sessions.|14
11360181|NCT03145207|12557177|FG000|COMPLETED|Overall Study||12
11360182|NCT03145207|12557177|FG000|NOT COMPLETED|Overall Study||2
11360183|NCT03145259|12557192|FG000|STARTED|Overall Study||12
11360184|NCT03145259|12557192|FG000|COMPLETED|Overall Study||12
11360185|NCT03145259|12557192|FG000|NOT COMPLETED|Overall Study||0
11360186|NCT03145818|12557203|FG000|STARTED|Overall Study||99
11360187|NCT03145818|12557204|FG001|STARTED|Overall Study||8
11360188|NCT03145818|12557205|FG002|STARTED|Overall Study||10
11360189|NCT03145818|12557206|FG003|STARTED|Overall Study||9
11360190|NCT03145818|12557203|FG000|COMPLETED|Overall Study||8
11360191|NCT03145818|12557204|FG001|COMPLETED|Overall Study||0
11360192|NCT03145818|12557205|FG002|COMPLETED|Overall Study||10
11360193|NCT03145818|12557206|FG003|COMPLETED|Overall Study||9
11360194|NCT03145818|12557203|FG000|NOT COMPLETED|Overall Study||91
11360195|NCT03145818|12557204|FG001|NOT COMPLETED|Overall Study||8
11360196|NCT03145818|12557205|FG002|NOT COMPLETED|Overall Study||0
11360197|NCT03145818|12557206|FG003|NOT COMPLETED|Overall Study||0
11360198|NCT03146403|12557216|FG000|STARTED|Overall Study||16
11360199|NCT03146403|12557217|FG001|STARTED|Overall Study||17
11360200|NCT03146403|12557216|FG000|COMPLETED|Overall Study||14
11360201|NCT03146403|12557217|FG001|COMPLETED|Overall Study||14
11360202|NCT03146403|12557216|FG000|NOT COMPLETED|Overall Study||2
11360203|NCT03146403|12557217|FG001|NOT COMPLETED|Overall Study||3
11360204|NCT03146585|12557226|FG000|STARTED|Overall Study||25
11360205|NCT03146585|12557227|FG001|STARTED|Overall Study||10
11360206|NCT03146585|12557228|FG002|STARTED|Overall Study||5
11360207|NCT03146585|12557226|FG000|COMPLETED|Overall Study||25
11360208|NCT03146585|12557227|FG001|COMPLETED|Overall Study||10
11360209|NCT03146585|12557228|FG002|COMPLETED|Overall Study||5
11360210|NCT03146585|12557226|FG000|NOT COMPLETED|Overall Study||0
11360211|NCT03146585|12557227|FG001|NOT COMPLETED|Overall Study||0
11360212|NCT03146585|12557228|FG002|NOT COMPLETED|Overall Study||0
11360213|NCT03146663|12557238|FG000|STARTED|Overall Study||25
11360214|NCT03146663|12557239|FG001|STARTED|Overall Study||28
11360215|NCT03146663|12557238|FG000|COMPLETED|Overall Study||24
11360216|NCT03146663|12557239|FG001|COMPLETED|Overall Study||27
11360217|NCT03146663|12557238|FG000|NOT COMPLETED|Overall Study||1
11360218|NCT03146663|12557239|FG001|NOT COMPLETED|Overall Study||1
11360219|NCT03146741|12557246|FG000|STARTED|Overall Study||20
11360220|NCT03146741|12557246|FG000|COMPLETED|Overall Study||10
11360221|NCT03146741|12557246|FG000|NOT COMPLETED|Overall Study||10
11360222|NCT03146806|12557250|FG000|STARTED|Overall Study||10
11360223|NCT03146806|12557250|FG000|COMPLETED|Overall Study||10
11360224|NCT03146806|12557250|FG000|NOT COMPLETED|Overall Study||0
11360225|NCT03147248|12557272|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13
11360226|NCT03147248|12557273|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11
11360227|NCT03147248|12557274|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12
11360228|NCT03147248|12557275|FG003|STARTED|Overall Study|This cohort is only for Part 1.|12
11360229|NCT03147248|12557276|FG004|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|167
11360230|NCT03147248|12557277|FG005|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|176
11360231|NCT03147248|12557272|FG000|COMPLETED|Overall Study||12
11360232|NCT03147248|12557273|FG001|COMPLETED|Overall Study||9
11360233|NCT03147248|12557274|FG002|COMPLETED|Overall Study||10
11360234|NCT03147248|12557275|FG003|COMPLETED|Overall Study||10
11360235|NCT03147248|12557276|FG004|COMPLETED|Overall Study||141
11360236|NCT03147248|12557277|FG005|COMPLETED|Overall Study||145
11360237|NCT03147248|12557272|FG000|NOT COMPLETED|Overall Study||1
11360238|NCT03147248|12557273|FG001|NOT COMPLETED|Overall Study||2
11360239|NCT03147248|12557274|FG002|NOT COMPLETED|Overall Study||2
11360240|NCT03147248|12557275|FG003|NOT COMPLETED|Overall Study||2
11360241|NCT03147248|12557276|FG004|NOT COMPLETED|Overall Study||26
11360242|NCT03147248|12557277|FG005|NOT COMPLETED|Overall Study||31
11360243|NCT03147495|12557293|FG000|STARTED|Overall Study||40
11360244|NCT03147495|12557294|FG001|STARTED|Overall Study||46
11360245|NCT03147495|12557293|FG000|COMPLETED|Overall Study||40
11360246|NCT03147495|12557294|FG001|COMPLETED|Overall Study||40
11360247|NCT03147495|12557293|FG000|NOT COMPLETED|Overall Study||0
11360248|NCT03147495|12557294|FG001|NOT COMPLETED|Overall Study||6
11360249|NCT03147690|12557300|FG000|STARTED|Overall Study||74
11360250|NCT03147690|12557300|FG000|COMPLETED|Overall Study||71
11360251|NCT03147690|12557300|FG000|NOT COMPLETED|Overall Study||3
11360252|NCT03148067|12557317|FG000|STARTED|Overall Study||225
11360253|NCT03148067|12557317|FG000|COMPLETED|Overall Study||221
11360254|NCT03148067|12557317|FG000|NOT COMPLETED|Overall Study||4
11360255|NCT03148236|12557324|FG000|STARTED|Overall Study||10
11360256|NCT03148236|12557325|FG001|STARTED|Overall Study||10
11360257|NCT03148236|12557324|FG000|COMPLETED|Overall Study||10
11360258|NCT03148236|12557325|FG001|COMPLETED|Overall Study||10
11360259|NCT03148236|12557324|FG000|NOT COMPLETED|Overall Study||0
11360260|NCT03148236|12557325|FG001|NOT COMPLETED|Overall Study||0
11360261|NCT03148262|12557333|FG000|STARTED|Overall Study||31
11360262|NCT03148262|12557334|FG001|STARTED|Overall Study||32
11360263|NCT03148262|12557333|FG000|COMPLETED|Overall Study||28
11360264|NCT03148262|12557334|FG001|COMPLETED|Overall Study||31
11360265|NCT03148262|12557333|FG000|NOT COMPLETED|Overall Study||3
11360266|NCT03148262|12557334|FG001|NOT COMPLETED|Overall Study||1
11360267|NCT03148470|12557342|FG000|STARTED|Overall Study|21 Participants completed the Tasks following Sham-stimulation|21
11360268|NCT03148470|12557343|FG001|STARTED|Overall Study|20 Participants completed the Tasks following Sham-stimulation|20
11360269|NCT03148470|12557342|FG000|COMPLETED|Overall Study|20 Participants completed the Tasks following iTBS-stimulation|20
11360270|NCT03148470|12557343|FG001|COMPLETED|Overall Study|20 Participants completed the Tasks following cTBS-stimulation|20
11360271|NCT03148470|12557342|FG000|NOT COMPLETED|Overall Study||1
11360272|NCT03148470|12557343|FG001|NOT COMPLETED|Overall Study||0
11360273|NCT03148691|12557360|FG000|STARTED|Overall Study||50
11360274|NCT03148691|12557361|FG001|STARTED|Overall Study||103
11360275|NCT03148691|12557362|FG002|STARTED|Overall Study||100
11360276|NCT03148691|12557360|FG000|COMPLETED|Overall Study||47
11360277|NCT03148691|12557361|FG001|COMPLETED|Overall Study||101
11360278|NCT03148691|12557362|FG002|COMPLETED|Overall Study||92
11360279|NCT03148691|12557360|FG000|NOT COMPLETED|Overall Study||3
11360280|NCT03148691|12557361|FG001|NOT COMPLETED|Overall Study||2
11360281|NCT03148691|12557362|FG002|NOT COMPLETED|Overall Study||8
11360282|NCT03149042|12557370|FG000|STARTED|Overall Study||75
11360283|NCT03149042|12557370|FG000|COMPLETED|Overall Study||52
11360284|NCT03149042|12557370|FG000|NOT COMPLETED|Overall Study||23
11360285|NCT03149055|12557375|FG000|STARTED|Overall Study||99
11360286|NCT03149055|12557375|FG000|COMPLETED|Overall Study||95
11360287|NCT03149055|12557375|FG000|NOT COMPLETED|Overall Study||4
11360288|NCT03149172|12557382|FG000|STARTED|Overall Study||8
11360289|NCT03149172|12557383|FG001|STARTED|Overall Study||6
11360290|NCT03149172|12557384|FG002|STARTED|Overall Study||7
11360291|NCT03149172|12557382|FG000|COMPLETED|Overall Study||6
11360292|NCT03149172|12557383|FG001|COMPLETED|Overall Study||5
11360293|NCT03149172|12557384|FG002|COMPLETED|Overall Study||5
11360294|NCT03149172|12557382|FG000|NOT COMPLETED|Overall Study||2
11360295|NCT03149172|12557383|FG001|NOT COMPLETED|Overall Study||1
11360296|NCT03149172|12557384|FG002|NOT COMPLETED|Overall Study||2
11360297|NCT03149328|12557394|FG000|STARTED|Overall Study||284
11360298|NCT03149328|12557395|FG001|STARTED|Overall Study||259
11360299|NCT03149328|12557394|FG000|COMPLETED|Overall Study||200
11360300|NCT03149328|12557395|FG001|COMPLETED|Overall Study||213
11360301|NCT03149328|12557394|FG000|NOT COMPLETED|Overall Study||84
11360302|NCT03149328|12557395|FG001|NOT COMPLETED|Overall Study||46
11360303|NCT03149848|12557401|FG000|STARTED|Period 1 (Day 1 to Day 14)||15
11360304|NCT03149848|12557401|FG000|COMPLETED|Period 1 (Day 1 to Day 14)||14
11360305|NCT03149848|12557401|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1
11360306|NCT03149848|12557401|FG000|STARTED|Period 2 (Day 15 to Day 28)||14
11360307|NCT03149848|12557401|FG000|COMPLETED|Period 2 (Day 15 to Day 28)||12
11360308|NCT03149848|12557401|FG000|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2
11360309|NCT03149887|12557410|FG000|STARTED|Overall Study||27
11360310|NCT03149887|12557411|FG001|STARTED|Overall Study||27
11360311|NCT03149887|12557410|FG000|COMPLETED|Overall Study||27
11360312|NCT03149887|12557411|FG001|COMPLETED|Overall Study||27
11360313|NCT03149887|12557410|FG000|NOT COMPLETED|Overall Study||0
11360314|NCT03149887|12557411|FG001|NOT COMPLETED|Overall Study||0
11360315|NCT03149991|12557419|FG000|STARTED|Overall Study||25
11360316|NCT03149991|12557420|FG001|STARTED|Overall Study||26
11360317|NCT03149991|12557419|FG000|Completed Primary Endpoint (Day 14)|Overall Study||25
11360318|NCT03149991|12557420|FG001|Completed Primary Endpoint (Day 14)|Overall Study||24
11360319|NCT03149991|12557419|FG000|Exited|Overall Study||4
11360320|NCT03149991|12557420|FG001|Exited|Overall Study||2
11360321|NCT03149991|12557419|FG000|COMPLETED|Overall Study||21
11360322|NCT03149991|12557420|FG001|COMPLETED|Overall Study||24
11360323|NCT03149991|12557419|FG000|NOT COMPLETED|Overall Study||4
11360324|NCT03149991|12557420|FG001|NOT COMPLETED|Overall Study||2
11360325|NCT03150043|12557426|FG000|STARTED|Overall Study||65
11360326|NCT03150043|12557426|FG000|COMPLETED|Overall Study||65
11360327|NCT03150043|12557426|FG000|NOT COMPLETED|Overall Study||0
11360328|NCT03150082|12557431|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
11360329|NCT03150082|12557432|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
11360330|NCT03150082|12557431|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
11360331|NCT03150082|12557432|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
11360332|NCT03150082|12557431|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
11360333|NCT03150082|12557432|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
11360334|NCT03150082|12557431|FG000|STARTED|Washout Period (Up to 4 Weeks)||12
11360335|NCT03150082|12557432|FG001|STARTED|Washout Period (Up to 4 Weeks)||13
11360336|NCT03150082|12557431|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||12
11360337|NCT03150082|12557432|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||13
11360338|NCT03150082|12557431|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
11360339|NCT03150082|12557432|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
11360340|NCT03150082|12557431|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
11360341|NCT03150082|12557432|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
11360342|NCT03150082|12557431|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
11360343|NCT03150082|12557432|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
11360344|NCT03150082|12557431|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
11360345|NCT03150082|12557432|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
11360346|NCT03150108|12557442|FG000|STARTED|Overall Study||12
11360347|NCT03150108|12557443|FG001|STARTED|Overall Study||12
11360348|NCT03150108|12557442|FG000|COMPLETED|Overall Study||12
11360349|NCT03150108|12557443|FG001|COMPLETED|Overall Study||12
11360350|NCT03150108|12557442|FG000|NOT COMPLETED|Overall Study||0
11360351|NCT03150108|12557443|FG001|NOT COMPLETED|Overall Study||0
11360352|NCT03150199|12557460|FG000|STARTED|Overall Study||30
11360353|NCT03150199|12557461|FG001|STARTED|Overall Study||30
11360354|NCT03150199|12557460|FG000|COMPLETED|Overall Study||30
11360355|NCT03150199|12557461|FG001|COMPLETED|Overall Study||30
11360356|NCT03150199|12557460|FG000|NOT COMPLETED|Overall Study||0
11360357|NCT03150199|12557461|FG001|NOT COMPLETED|Overall Study||0
11360358|NCT03150485|12557468|FG000|STARTED|Overall Study||2
11360359|NCT03150485|12557469|FG001|STARTED|Overall Study||9
11360360|NCT03150485|12557470|FG002|STARTED|Overall Study||4
11360361|NCT03150485|12557471|FG003|STARTED|Overall Study||5
11360362|NCT03150485|12557472|FG004|STARTED|Overall Study||2
11360363|NCT03150485|12557473|FG005|STARTED|Overall Study||1
11360364|NCT03150485|12557468|FG000|COMPLETED|Overall Study||2
11360365|NCT03150485|12557469|FG001|COMPLETED|Overall Study||8
11360366|NCT03150485|12557470|FG002|COMPLETED|Overall Study||4
11360367|NCT03150485|12557471|FG003|COMPLETED|Overall Study||5
11360368|NCT03150485|12557472|FG004|COMPLETED|Overall Study||2
11360369|NCT03150485|12557473|FG005|COMPLETED|Overall Study||1
11360370|NCT03150485|12557468|FG000|NOT COMPLETED|Overall Study||0
11360371|NCT03150485|12557469|FG001|NOT COMPLETED|Overall Study||1
11360372|NCT03150485|12557470|FG002|NOT COMPLETED|Overall Study||0
11360373|NCT03150485|12557471|FG003|NOT COMPLETED|Overall Study||0
11360374|NCT03150485|12557472|FG004|NOT COMPLETED|Overall Study||0
11360375|NCT03150485|12557473|FG005|NOT COMPLETED|Overall Study||0
11360376|NCT03150589|12557480|FG000|STARTED|Overall Study||351
11360377|NCT03150589|12557481|FG001|STARTED|Overall Study||354
11360378|NCT03150589|12557480|FG000|COMPLETED|Overall Study||307
11360379|NCT03150589|12557481|FG001|COMPLETED|Overall Study||327
11360380|NCT03150589|12557480|FG000|NOT COMPLETED|Overall Study||44
11360381|NCT03150589|12557481|FG001|NOT COMPLETED|Overall Study||27
11360382|NCT03150719|12557489|FG000|STARTED|Overall Study||47
11360383|NCT03150719|12557490|FG001|STARTED|Overall Study||50
11360384|NCT03150719|12557489|FG000|COMPLETED|Overall Study||46
11360385|NCT03150719|12557490|FG001|COMPLETED|Overall Study||48
11360386|NCT03150719|12557489|FG000|NOT COMPLETED|Overall Study||1
11360387|NCT03150719|12557490|FG001|NOT COMPLETED|Overall Study||2
11360388|NCT03150758|12557496|FG000|STARTED|Overall Study||6
11360389|NCT03150758|12557496|FG000|COMPLETED|Overall Study||6
11360390|NCT03150758|12557496|FG000|NOT COMPLETED|Overall Study||0
11360391|NCT03150875|12557502|FG000|STARTED|Overall Study||145
11360392|NCT03150875|12557503|FG001|STARTED|Overall Study||145
11360393|NCT03150875|12557502|FG000|Treated|Overall Study||144
11360394|NCT03150875|12557503|FG001|Treated|Overall Study||130
11360395|NCT03150875|12557502|FG000|Crossover to Certain Treatment|Overall Study||0
11005572|NCT00723450|12183267|FG001|COMPLETED|Randomized Phase||21
11005573|NCT00723450|12183268|FG002|COMPLETED|Randomized Phase||20
11005574|NCT00723450|12183266|FG000|NOT COMPLETED|Randomized Phase||0
11005575|NCT00723450|12183267|FG001|NOT COMPLETED|Randomized Phase||65
11005576|NCT00723450|12183268|FG002|NOT COMPLETED|Randomized Phase||67
11005577|NCT00723489|12183281|FG000|STARTED|Overall Study||21
11360396|NCT03150875|12557503|FG001|Crossover to Certain Treatment|Overall Study||0
11360397|NCT03150875|12557502|FG000|COMPLETED|Overall Study||0
11360398|NCT03150875|12557503|FG001|COMPLETED|Overall Study||0
11360399|NCT03150875|12557502|FG000|NOT COMPLETED|Overall Study||145
11360400|NCT03150875|12557503|FG001|NOT COMPLETED|Overall Study||145
11360401|NCT03151148|12557511|FG000|STARTED|Overall Study||36
11360402|NCT03151148|12557512|FG001|STARTED|Overall Study||18
11360403|NCT03151148|12557511|FG000|COMPLETED|Overall Study||34
11360404|NCT03151148|12557512|FG001|COMPLETED|Overall Study||18
11360405|NCT03151148|12557511|FG000|NOT COMPLETED|Overall Study||2
11360406|NCT03151148|12557512|FG001|NOT COMPLETED|Overall Study||0
11360407|NCT03151265|12557521|FG000|STARTED|Overall Study||20
11360408|NCT03151265|12557522|FG001|STARTED|Overall Study||20
11360409|NCT03151265|12557521|FG000|COMPLETED|Overall Study||20
11360410|NCT03151265|12557522|FG001|COMPLETED|Overall Study||20
11360411|NCT03151265|12557521|FG000|NOT COMPLETED|Overall Study||0
11360412|NCT03151265|12557522|FG001|NOT COMPLETED|Overall Study||0
11360413|NCT03151395|12557528|FG000|STARTED|Overall Study||197
11360414|NCT03151395|12557528|FG000|COMPLETED|Overall Study||182
11360415|NCT03151395|12557528|FG000|NOT COMPLETED|Overall Study||15
11360416|NCT03151434|12557535|FG000|STARTED|Overall Study||53
11360417|NCT03151434|12557536|FG001|STARTED|Overall Study||47
11360418|NCT03151434|12557537|FG002|STARTED|Overall Study||47
11360419|NCT03151434|12557535|FG000|COMPLETED|Overall Study||40
11360420|NCT03151434|12557536|FG001|COMPLETED|Overall Study||40
11360421|NCT03151434|12557537|FG002|COMPLETED|Overall Study||40
11360422|NCT03151434|12557535|FG000|NOT COMPLETED|Overall Study||13
11360423|NCT03151434|12557536|FG001|NOT COMPLETED|Overall Study||7
11360424|NCT03151434|12557537|FG002|NOT COMPLETED|Overall Study||7
11360425|NCT03151551|12557550|FG000|STARTED|Open-Label Treatment Period||283
11360426|NCT03151551|12557551|FG001|STARTED|Open-Label Treatment Period||283
11360427|NCT03151551|12557550|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
11360428|NCT03151551|12557551|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
11360429|NCT03151551|12557550|FG000|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period||49
11360430|NCT03151551|12557551|FG001|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
11360431|NCT03151551|12557550|FG000|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period||218
11360432|NCT03151551|12557551|FG001|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
11360433|NCT03151551|12557550|FG000|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
11360434|NCT03151551|12557551|FG001|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||51
11360435|NCT03151551|12557550|FG000|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
11360436|NCT03151551|12557551|FG001|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||219
11360437|NCT03151551|12557550|FG000|COMPLETED|Open-Label Treatment Period||265
11360438|NCT03151551|12557551|FG001|COMPLETED|Open-Label Treatment Period||259
11360439|NCT03151551|12557550|FG000|NOT COMPLETED|Open-Label Treatment Period||18
11360440|NCT03151551|12557551|FG001|NOT COMPLETED|Open-Label Treatment Period||24
11360441|NCT03151551|12557550|FG000|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|265
11360442|NCT03151551|12557551|FG001|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|258
11360443|NCT03151551|12557550|FG000|COMPLETED|Post-Treatment Follow-Up Period||240
11360444|NCT03151551|12557551|FG001|COMPLETED|Post-Treatment Follow-Up Period||230
11360445|NCT03151551|12557550|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||25
11360446|NCT03151551|12557551|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||28
11360447|NCT03152019|12557561|FG000|STARTED|Overall Study||25
11360448|NCT03152019|12557562|FG001|STARTED|Overall Study||25
11360449|NCT03152019|12557561|FG000|COMPLETED|Overall Study||25
11360450|NCT03152019|12557562|FG001|COMPLETED|Overall Study||24
11360451|NCT03152019|12557561|FG000|NOT COMPLETED|Overall Study||0
11360452|NCT03152019|12557562|FG001|NOT COMPLETED|Overall Study||1
11360453|NCT03152084|12557570|FG000|STARTED|Overall Study||17
11360454|NCT03152084|12557571|FG001|STARTED|Overall Study||7
11360455|NCT03152084|12557570|FG000|COMPLETED|Overall Study||17
11360456|NCT03152084|12557571|FG001|COMPLETED|Overall Study||7
11360457|NCT03152084|12557570|FG000|NOT COMPLETED|Overall Study||0
11360458|NCT03152084|12557571|FG001|NOT COMPLETED|Overall Study||0
11360459|NCT03152110|12557577|FG000|STARTED|Overall Study||10
11360460|NCT03152110|12557577|FG000|COMPLETED|Overall Study||7
11360461|NCT03152110|12557577|FG000|NOT COMPLETED|Overall Study||3
11360462|NCT03152136|12557585|FG000|STARTED|Overall Study||32
11360463|NCT03152136|12557586|FG001|STARTED|Overall Study||15
11360464|NCT03152136|12557587|FG002|STARTED|Overall Study||15
11360465|NCT03152136|12557585|FG000|COMPLETED|Overall Study||29
11360466|NCT03152136|12557586|FG001|COMPLETED|Overall Study||15
11360467|NCT03152136|12557587|FG002|COMPLETED|Overall Study||14
11360468|NCT03152136|12557585|FG000|NOT COMPLETED|Overall Study||3
11360469|NCT03152136|12557586|FG001|NOT COMPLETED|Overall Study||0
11360470|NCT03152136|12557587|FG002|NOT COMPLETED|Overall Study||1
11360471|NCT03152552|12557599|FG000|STARTED|Treatment Period 1 (12 Weeks)||15
11360472|NCT03152552|12557600|FG001|STARTED|Treatment Period 1 (12 Weeks)||16
11360473|NCT03152552|12557601|FG002|STARTED|Treatment Period 1 (12 Weeks)||31
11360474|NCT03152552|12557602|FG003|STARTED|Treatment Period 1 (12 Weeks)||30
11360475|NCT03152552|12557603|FG004|STARTED|Treatment Period 1 (12 Weeks)||33
11360476|NCT03152552|12557599|FG000|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15
11360477|NCT03152552|12557600|FG001|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16
11360478|NCT03152552|12557601|FG002|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
11360479|NCT03152552|12557602|FG003|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
11360480|NCT03152552|12557603|FG004|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33
11360481|NCT03152552|12557599|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||7
11360482|NCT03152552|12557600|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||5
11360483|NCT03152552|12557601|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||10
11360484|NCT03152552|12557602|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||10
11360485|NCT03152552|12557603|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||12
11360486|NCT03152552|12557599|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
11360487|NCT03152552|12557600|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
11360488|NCT03152552|12557601|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
11360489|NCT03152552|12557602|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20
11360490|NCT03152552|12557603|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
11360491|NCT03152552|12557599|FG000|STARTED|Treatment Period 2 (24 Weeks)||7
11360492|NCT03152552|12557600|FG001|STARTED|Treatment Period 2 (24 Weeks)||5
11360493|NCT03152552|12557601|FG002|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
11360494|NCT03152552|12557602|FG003|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
11360495|NCT03152552|12557603|FG004|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11
11360496|NCT03152552|12557599|FG000|COMPLETED|Treatment Period 2 (24 Weeks)||1
11360497|NCT03152552|12557600|FG001|COMPLETED|Treatment Period 2 (24 Weeks)||0
11360498|NCT03152552|12557601|FG002|COMPLETED|Treatment Period 2 (24 Weeks)||0
11360499|NCT03152552|12557602|FG003|COMPLETED|Treatment Period 2 (24 Weeks)||0
11360500|NCT03152552|12557603|FG004|COMPLETED|Treatment Period 2 (24 Weeks)||0
11360501|NCT03152552|12557599|FG000|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6
11360502|NCT03152552|12557600|FG001|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5
11360503|NCT03152552|12557601|FG002|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
11360504|NCT03152552|12557602|FG003|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
11360505|NCT03152552|12557603|FG004|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11
11360506|NCT03152591|12557618|FG000|STARTED|Overall Study||15
11360507|NCT03152591|12557619|FG001|STARTED|Overall Study||14
11360508|NCT03152591|12557618|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||14
11360509|NCT03152591|12557619|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0
11360510|NCT03152591|12557618|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||15
11360511|NCT03152591|12557619|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||14
11360512|NCT03152591|12557618|FG000|COMPLETED|Overall Study||15
11360513|NCT03152591|12557619|FG001|COMPLETED|Overall Study||14
11360514|NCT03152591|12557618|FG000|NOT COMPLETED|Overall Study||0
11360515|NCT03152591|12557619|FG001|NOT COMPLETED|Overall Study||0
11360516|NCT03153956|12557627|FG000|STARTED|Overall Study||39
11360517|NCT03153956|12557628|FG001|STARTED|Overall Study||38
11360518|NCT03153956|12557627|FG000|COMPLETED|Overall Study||39
11360519|NCT03153956|12557628|FG001|COMPLETED|Overall Study||38
11360520|NCT03153956|12557627|FG000|NOT COMPLETED|Overall Study||0
11360521|NCT03153956|12557628|FG001|NOT COMPLETED|Overall Study||0
11360522|NCT03154047|12557634|FG000|STARTED|Overall Study||80
11360523|NCT03154047|12557634|FG000|Number of Patients Dosed|Overall Study||80
11360524|NCT03154047|12557634|FG000|COMPLETED|Overall Study||0
11360525|NCT03154047|12557634|FG000|NOT COMPLETED|Overall Study||80
11360526|NCT03154086|12557653|FG000|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11360527|NCT03154086|12557654|FG001|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11360528|NCT03154086|12557655|FG002|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11360529|NCT03154086|12557656|FG003|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11360530|NCT03154086|12557657|FG004|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360531|NCT03154086|12557658|FG005|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360532|NCT03154086|12557659|FG006|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360533|NCT03154086|12557660|FG007|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360534|NCT03154086|12557661|FG008|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360535|NCT03154086|12557662|FG009|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360536|NCT03154086|12557663|FG010|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360537|NCT03154086|12557664|FG011|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360538|NCT03154086|12557665|FG012|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360539|NCT03154086|12557666|FG013|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360540|NCT03154086|12557667|FG014|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360541|NCT03154086|12557653|FG000|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11360542|NCT03154086|12557654|FG001|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11360543|NCT03154086|12557655|FG002|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11360544|NCT03154086|12557656|FG003|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
11360545|NCT03154086|12557657|FG004|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360546|NCT03154086|12557658|FG005|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360547|NCT03154086|12557659|FG006|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360548|NCT03154086|12557660|FG007|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360549|NCT03154086|12557661|FG008|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360550|NCT03154086|12557662|FG009|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360551|NCT03154086|12557663|FG010|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360552|NCT03154086|12557664|FG011|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360553|NCT03154086|12557665|FG012|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360554|NCT03154086|12557666|FG013|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360555|NCT03154086|12557667|FG014|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360556|NCT03154086|12557653|FG000|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360557|NCT03154086|12557654|FG001|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360558|NCT03154086|12557655|FG002|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360559|NCT03154086|12557656|FG003|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360560|NCT03154086|12557657|FG004|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360561|NCT03154086|12557658|FG005|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360562|NCT03154086|12557659|FG006|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360563|NCT03154086|12557660|FG007|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360564|NCT03154086|12557661|FG008|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360565|NCT03154086|12557662|FG009|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360566|NCT03154086|12557663|FG010|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360567|NCT03154086|12557664|FG011|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360568|NCT03154086|12557665|FG012|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360569|NCT03154086|12557666|FG013|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360570|NCT03154086|12557667|FG014|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
11360571|NCT03154086|12557653|FG000|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
11360572|NCT03154086|12557654|FG001|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
11360573|NCT03154086|12557655|FG002|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
11360574|NCT03154086|12557656|FG003|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
11360575|NCT03154086|12557657|FG004|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360576|NCT03154086|12557658|FG005|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360577|NCT03154086|12557659|FG006|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360578|NCT03154086|12557660|FG007|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360579|NCT03154086|12557661|FG008|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360580|NCT03154086|12557662|FG009|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360581|NCT03154086|12557663|FG010|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360582|NCT03154086|12557664|FG011|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360583|NCT03154086|12557665|FG012|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360584|NCT03154086|12557666|FG013|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360585|NCT03154086|12557667|FG014|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360586|NCT03154086|12557653|FG000|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
11360587|NCT03154086|12557654|FG001|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
11360588|NCT03154086|12557655|FG002|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
11360589|NCT03154086|12557656|FG003|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
11360590|NCT03154086|12557657|FG004|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360591|NCT03154086|12557658|FG005|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360592|NCT03154086|12557659|FG006|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360593|NCT03154086|12557660|FG007|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360594|NCT03154086|12557661|FG008|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360595|NCT03154086|12557662|FG009|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360596|NCT03154086|12557663|FG010|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360597|NCT03154086|12557664|FG011|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360598|NCT03154086|12557665|FG012|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360599|NCT03154086|12557666|FG013|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360600|NCT03154086|12557667|FG014|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360601|NCT03154086|12557653|FG000|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360602|NCT03154086|12557654|FG001|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360603|NCT03154086|12557655|FG002|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360604|NCT03154086|12557656|FG003|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
11360605|NCT03154086|12557657|FG004|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360606|NCT03154086|12557658|FG005|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360607|NCT03154086|12557659|FG006|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360608|NCT03154086|12557660|FG007|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360609|NCT03154086|12557661|FG008|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360610|NCT03154086|12557662|FG009|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360611|NCT03154086|12557663|FG010|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360612|NCT03154086|12557664|FG011|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360613|NCT03154086|12557665|FG012|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360614|NCT03154086|12557666|FG013|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360615|NCT03154086|12557667|FG014|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
11360616|NCT03154086|12557653|FG000|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
11360617|NCT03154086|12557654|FG001|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
11360618|NCT03154086|12557655|FG002|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
11360619|NCT03154086|12557656|FG003|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2
11360620|NCT03154086|12557657|FG004|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360621|NCT03154086|12557658|FG005|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360622|NCT03154086|12557659|FG006|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360623|NCT03154086|12557660|FG007|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360624|NCT03154086|12557661|FG008|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360625|NCT03154086|12557662|FG009|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360626|NCT03154086|12557663|FG010|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360627|NCT03154086|12557664|FG011|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360628|NCT03154086|12557665|FG012|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360629|NCT03154086|12557666|FG013|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360630|NCT03154086|12557667|FG014|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360631|NCT03154086|12557653|FG000|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
11360632|NCT03154086|12557654|FG001|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
11360633|NCT03154086|12557655|FG002|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
11360634|NCT03154086|12557656|FG003|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
11360635|NCT03154086|12557657|FG004|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360636|NCT03154086|12557658|FG005|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360637|NCT03154086|12557659|FG006|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360638|NCT03154086|12557660|FG007|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360639|NCT03154086|12557661|FG008|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360640|NCT03154086|12557662|FG009|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360641|NCT03154086|12557663|FG010|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360642|NCT03154086|12557664|FG011|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360643|NCT03154086|12557665|FG012|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360644|NCT03154086|12557666|FG013|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360645|NCT03154086|12557667|FG014|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360646|NCT03154086|12557653|FG000|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360647|NCT03154086|12557654|FG001|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360648|NCT03154086|12557655|FG002|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360649|NCT03154086|12557656|FG003|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360650|NCT03154086|12557657|FG004|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360651|NCT03154086|12557658|FG005|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360652|NCT03154086|12557659|FG006|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360653|NCT03154086|12557660|FG007|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360654|NCT03154086|12557661|FG008|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360655|NCT03154086|12557662|FG009|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360656|NCT03154086|12557663|FG010|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360657|NCT03154086|12557664|FG011|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360658|NCT03154086|12557665|FG012|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360659|NCT03154086|12557666|FG013|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360660|NCT03154086|12557667|FG014|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
11360661|NCT03154086|12557653|FG000|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
11360662|NCT03154086|12557654|FG001|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
11360663|NCT03154086|12557655|FG002|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
11360664|NCT03154086|12557656|FG003|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
11360665|NCT03154086|12557657|FG004|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360666|NCT03154086|12557658|FG005|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360667|NCT03154086|12557659|FG006|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360668|NCT03154086|12557660|FG007|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360669|NCT03154086|12557661|FG008|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360670|NCT03154086|12557662|FG009|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360671|NCT03154086|12557663|FG010|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360672|NCT03154086|12557664|FG011|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360673|NCT03154086|12557665|FG012|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360674|NCT03154086|12557666|FG013|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360675|NCT03154086|12557667|FG014|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360676|NCT03154086|12557653|FG000|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
11360677|NCT03154086|12557654|FG001|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
11360678|NCT03154086|12557655|FG002|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
11360679|NCT03154086|12557656|FG003|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
11360680|NCT03154086|12557657|FG004|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360681|NCT03154086|12557658|FG005|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360682|NCT03154086|12557659|FG006|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360683|NCT03154086|12557660|FG007|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360684|NCT03154086|12557661|FG008|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360685|NCT03154086|12557662|FG009|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360686|NCT03154086|12557663|FG010|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360687|NCT03154086|12557664|FG011|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360688|NCT03154086|12557665|FG012|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360689|NCT03154086|12557666|FG013|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360690|NCT03154086|12557667|FG014|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360691|NCT03154086|12557653|FG000|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360692|NCT03154086|12557654|FG001|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
11360693|NCT03154086|12557655|FG002|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360694|NCT03154086|12557656|FG003|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360695|NCT03154086|12557657|FG004|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360696|NCT03154086|12557658|FG005|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360697|NCT03154086|12557659|FG006|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360698|NCT03154086|12557660|FG007|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360699|NCT03154086|12557661|FG008|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360700|NCT03154086|12557662|FG009|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360701|NCT03154086|12557663|FG010|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360702|NCT03154086|12557664|FG011|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360703|NCT03154086|12557665|FG012|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360704|NCT03154086|12557666|FG013|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360705|NCT03154086|12557667|FG014|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
11360706|NCT03154086|12557653|FG000|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
11360707|NCT03154086|12557654|FG001|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2
11360708|NCT03154086|12557655|FG002|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
11360709|NCT03154086|12557656|FG003|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
11360710|NCT03154086|12557657|FG004|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360711|NCT03154086|12557658|FG005|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360712|NCT03154086|12557659|FG006|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360713|NCT03154086|12557660|FG007|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360714|NCT03154086|12557661|FG008|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360715|NCT03154086|12557662|FG009|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360716|NCT03154086|12557663|FG010|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360717|NCT03154086|12557664|FG011|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360718|NCT03154086|12557665|FG012|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360719|NCT03154086|12557666|FG013|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360720|NCT03154086|12557667|FG014|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360721|NCT03154086|12557653|FG000|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
11360722|NCT03154086|12557654|FG001|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
11360723|NCT03154086|12557655|FG002|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
11360724|NCT03154086|12557656|FG003|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
11360725|NCT03154086|12557657|FG004|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360726|NCT03154086|12557658|FG005|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360727|NCT03154086|12557659|FG006|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360728|NCT03154086|12557660|FG007|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360729|NCT03154086|12557661|FG008|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360730|NCT03154086|12557662|FG009|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360731|NCT03154086|12557663|FG010|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360732|NCT03154086|12557664|FG011|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360733|NCT03154086|12557665|FG012|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360734|NCT03154086|12557666|FG013|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360735|NCT03154086|12557667|FG014|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360736|NCT03154086|12557653|FG000|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360737|NCT03154086|12557654|FG001|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360738|NCT03154086|12557655|FG002|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360739|NCT03154086|12557656|FG003|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360740|NCT03154086|12557657|FG004|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360741|NCT03154086|12557658|FG005|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360742|NCT03154086|12557659|FG006|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360743|NCT03154086|12557660|FG007|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360744|NCT03154086|12557661|FG008|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360745|NCT03154086|12557662|FG009|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360746|NCT03154086|12557663|FG010|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360747|NCT03154086|12557664|FG011|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360748|NCT03154086|12557665|FG012|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360749|NCT03154086|12557666|FG013|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360750|NCT03154086|12557667|FG014|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
11360751|NCT03154086|12557653|FG000|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
11360752|NCT03154086|12557654|FG001|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
11360753|NCT03154086|12557655|FG002|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
11360754|NCT03154086|12557656|FG003|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
11360755|NCT03154086|12557657|FG004|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360756|NCT03154086|12557658|FG005|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360757|NCT03154086|12557659|FG006|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360758|NCT03154086|12557660|FG007|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360759|NCT03154086|12557661|FG008|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360760|NCT03154086|12557662|FG009|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360761|NCT03154086|12557663|FG010|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360762|NCT03154086|12557664|FG011|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360763|NCT03154086|12557665|FG012|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360764|NCT03154086|12557666|FG013|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360765|NCT03154086|12557667|FG014|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360766|NCT03154086|12557653|FG000|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
11360767|NCT03154086|12557654|FG001|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
11360768|NCT03154086|12557655|FG002|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
11360769|NCT03154086|12557656|FG003|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
11360770|NCT03154086|12557657|FG004|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360771|NCT03154086|12557658|FG005|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360772|NCT03154086|12557659|FG006|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360773|NCT03154086|12557660|FG007|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360774|NCT03154086|12557661|FG008|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360775|NCT03154086|12557662|FG009|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360776|NCT03154086|12557663|FG010|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360777|NCT03154086|12557664|FG011|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360778|NCT03154086|12557665|FG012|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360779|NCT03154086|12557666|FG013|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360780|NCT03154086|12557667|FG014|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360781|NCT03154086|12557653|FG000|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360782|NCT03154086|12557654|FG001|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360783|NCT03154086|12557655|FG002|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
11360784|NCT03154086|12557656|FG003|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360785|NCT03154086|12557657|FG004|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360786|NCT03154086|12557658|FG005|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360787|NCT03154086|12557659|FG006|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360788|NCT03154086|12557660|FG007|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360789|NCT03154086|12557661|FG008|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360790|NCT03154086|12557662|FG009|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360791|NCT03154086|12557663|FG010|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360792|NCT03154086|12557664|FG011|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360793|NCT03154086|12557665|FG012|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360794|NCT03154086|12557666|FG013|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360795|NCT03154086|12557667|FG014|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
11360796|NCT03154086|12557653|FG000|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3
11360797|NCT03154086|12557654|FG001|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
11360798|NCT03154086|12557655|FG002|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1
11360799|NCT03154086|12557656|FG003|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
11360800|NCT03154086|12557657|FG004|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360801|NCT03154086|12557658|FG005|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360802|NCT03154086|12557659|FG006|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360803|NCT03154086|12557660|FG007|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360804|NCT03154086|12557661|FG008|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360805|NCT03154086|12557662|FG009|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360806|NCT03154086|12557663|FG010|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360807|NCT03154086|12557664|FG011|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360808|NCT03154086|12557665|FG012|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360809|NCT03154086|12557666|FG013|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360810|NCT03154086|12557667|FG014|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360811|NCT03154086|12557653|FG000|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
11360812|NCT03154086|12557654|FG001|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
11360813|NCT03154086|12557655|FG002|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
11360814|NCT03154086|12557656|FG003|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
11360815|NCT03154086|12557657|FG004|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360816|NCT03154086|12557658|FG005|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360817|NCT03154086|12557659|FG006|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360818|NCT03154086|12557660|FG007|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360819|NCT03154086|12557661|FG008|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360820|NCT03154086|12557662|FG009|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360821|NCT03154086|12557663|FG010|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360822|NCT03154086|12557664|FG011|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360823|NCT03154086|12557665|FG012|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360824|NCT03154086|12557666|FG013|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360825|NCT03154086|12557667|FG014|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360826|NCT03154086|12557653|FG000|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
11360827|NCT03154086|12557654|FG001|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360828|NCT03154086|12557655|FG002|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360829|NCT03154086|12557656|FG003|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360830|NCT03154086|12557657|FG004|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360831|NCT03154086|12557658|FG005|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360832|NCT03154086|12557659|FG006|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360833|NCT03154086|12557660|FG007|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360834|NCT03154086|12557661|FG008|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360835|NCT03154086|12557662|FG009|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360836|NCT03154086|12557663|FG010|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360837|NCT03154086|12557664|FG011|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360838|NCT03154086|12557665|FG012|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360839|NCT03154086|12557666|FG013|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360840|NCT03154086|12557667|FG014|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
11360841|NCT03154086|12557653|FG000|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360842|NCT03154086|12557654|FG001|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360843|NCT03154086|12557655|FG002|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360844|NCT03154086|12557656|FG003|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360845|NCT03154086|12557657|FG004|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6
11360846|NCT03154086|12557658|FG005|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2
11360847|NCT03154086|12557659|FG006|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360848|NCT03154086|12557660|FG007|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360849|NCT03154086|12557661|FG008|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360850|NCT03154086|12557662|FG009|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360851|NCT03154086|12557663|FG010|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360852|NCT03154086|12557664|FG011|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360853|NCT03154086|12557665|FG012|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360854|NCT03154086|12557666|FG013|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360855|NCT03154086|12557667|FG014|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360856|NCT03154086|12557653|FG000|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360857|NCT03154086|12557654|FG001|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360858|NCT03154086|12557655|FG002|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360859|NCT03154086|12557656|FG003|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360860|NCT03154086|12557657|FG004|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6
11360861|NCT03154086|12557658|FG005|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2
11360862|NCT03154086|12557659|FG006|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360863|NCT03154086|12557660|FG007|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360864|NCT03154086|12557661|FG008|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360865|NCT03154086|12557662|FG009|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360866|NCT03154086|12557663|FG010|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360867|NCT03154086|12557664|FG011|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360868|NCT03154086|12557665|FG012|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360869|NCT03154086|12557666|FG013|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360870|NCT03154086|12557667|FG014|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360871|NCT03154086|12557653|FG000|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360872|NCT03154086|12557654|FG001|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360873|NCT03154086|12557655|FG002|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360874|NCT03154086|12557656|FG003|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360875|NCT03154086|12557657|FG004|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360876|NCT03154086|12557658|FG005|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360877|NCT03154086|12557659|FG006|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360878|NCT03154086|12557660|FG007|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360879|NCT03154086|12557661|FG008|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360880|NCT03154086|12557662|FG009|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360881|NCT03154086|12557663|FG010|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360882|NCT03154086|12557664|FG011|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360883|NCT03154086|12557665|FG012|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360884|NCT03154086|12557666|FG013|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360885|NCT03154086|12557667|FG014|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
11360886|NCT03154086|12557653|FG000|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360887|NCT03154086|12557654|FG001|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360888|NCT03154086|12557655|FG002|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360889|NCT03154086|12557656|FG003|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360890|NCT03154086|12557657|FG004|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
11360891|NCT03154086|12557658|FG005|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
11360892|NCT03154086|12557659|FG006|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360893|NCT03154086|12557660|FG007|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360894|NCT03154086|12557661|FG008|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360895|NCT03154086|12557662|FG009|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360896|NCT03154086|12557663|FG010|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360897|NCT03154086|12557664|FG011|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360898|NCT03154086|12557665|FG012|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360899|NCT03154086|12557666|FG013|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360900|NCT03154086|12557667|FG014|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360901|NCT03154086|12557653|FG000|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360902|NCT03154086|12557654|FG001|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360903|NCT03154086|12557655|FG002|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360904|NCT03154086|12557656|FG003|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360905|NCT03154086|12557657|FG004|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
11360906|NCT03154086|12557658|FG005|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
11360907|NCT03154086|12557659|FG006|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360908|NCT03154086|12557660|FG007|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360909|NCT03154086|12557661|FG008|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360910|NCT03154086|12557662|FG009|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360911|NCT03154086|12557663|FG010|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360912|NCT03154086|12557664|FG011|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360913|NCT03154086|12557665|FG012|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360914|NCT03154086|12557666|FG013|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360915|NCT03154086|12557667|FG014|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360916|NCT03154086|12557653|FG000|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360917|NCT03154086|12557654|FG001|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360918|NCT03154086|12557655|FG002|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360919|NCT03154086|12557656|FG003|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360920|NCT03154086|12557657|FG004|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360921|NCT03154086|12557658|FG005|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360922|NCT03154086|12557659|FG006|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360923|NCT03154086|12557660|FG007|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360924|NCT03154086|12557661|FG008|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360925|NCT03154086|12557662|FG009|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360926|NCT03154086|12557663|FG010|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360927|NCT03154086|12557664|FG011|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360928|NCT03154086|12557665|FG012|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360929|NCT03154086|12557666|FG013|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360930|NCT03154086|12557667|FG014|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
11360931|NCT03154086|12557653|FG000|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360932|NCT03154086|12557654|FG001|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360933|NCT03154086|12557655|FG002|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360934|NCT03154086|12557656|FG003|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360935|NCT03154086|12557657|FG004|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6
11360936|NCT03154086|12557658|FG005|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2
11360937|NCT03154086|12557659|FG006|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360938|NCT03154086|12557660|FG007|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360939|NCT03154086|12557661|FG008|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360940|NCT03154086|12557662|FG009|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360941|NCT03154086|12557663|FG010|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360942|NCT03154086|12557664|FG011|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360943|NCT03154086|12557665|FG012|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360944|NCT03154086|12557666|FG013|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360945|NCT03154086|12557667|FG014|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360946|NCT03154086|12557653|FG000|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360947|NCT03154086|12557654|FG001|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360948|NCT03154086|12557655|FG002|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360949|NCT03154086|12557656|FG003|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360950|NCT03154086|12557657|FG004|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6
11360951|NCT03154086|12557658|FG005|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2
11360952|NCT03154086|12557659|FG006|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360953|NCT03154086|12557660|FG007|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360954|NCT03154086|12557661|FG008|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360955|NCT03154086|12557662|FG009|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360956|NCT03154086|12557663|FG010|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360957|NCT03154086|12557664|FG011|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360958|NCT03154086|12557665|FG012|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360959|NCT03154086|12557666|FG013|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360960|NCT03154086|12557667|FG014|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360961|NCT03154086|12557653|FG000|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360962|NCT03154086|12557654|FG001|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360963|NCT03154086|12557655|FG002|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360964|NCT03154086|12557656|FG003|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360965|NCT03154086|12557657|FG004|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360966|NCT03154086|12557658|FG005|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360967|NCT03154086|12557659|FG006|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360968|NCT03154086|12557660|FG007|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360969|NCT03154086|12557661|FG008|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360970|NCT03154086|12557662|FG009|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360971|NCT03154086|12557663|FG010|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360972|NCT03154086|12557664|FG011|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360973|NCT03154086|12557665|FG012|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360974|NCT03154086|12557666|FG013|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360975|NCT03154086|12557667|FG014|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
11360976|NCT03154086|12557653|FG000|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360977|NCT03154086|12557654|FG001|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360978|NCT03154086|12557655|FG002|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360979|NCT03154086|12557656|FG003|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360980|NCT03154086|12557657|FG004|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360981|NCT03154086|12557658|FG005|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360982|NCT03154086|12557659|FG006|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
11360983|NCT03154086|12557660|FG007|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
11360984|NCT03154086|12557661|FG008|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4
11360985|NCT03154086|12557662|FG009|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360986|NCT03154086|12557663|FG010|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360987|NCT03154086|12557664|FG011|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360988|NCT03154086|12557665|FG012|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360989|NCT03154086|12557666|FG013|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360990|NCT03154086|12557667|FG014|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360991|NCT03154086|12557653|FG000|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360992|NCT03154086|12557654|FG001|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360993|NCT03154086|12557655|FG002|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360994|NCT03154086|12557656|FG003|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360995|NCT03154086|12557657|FG004|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360996|NCT03154086|12557658|FG005|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11360997|NCT03154086|12557659|FG006|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
11360998|NCT03154086|12557660|FG007|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
11360999|NCT03154086|12557661|FG008|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4
11361000|NCT03154086|12557662|FG009|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361001|NCT03154086|12557663|FG010|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361002|NCT03154086|12557664|FG011|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361003|NCT03154086|12557665|FG012|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361004|NCT03154086|12557666|FG013|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361005|NCT03154086|12557667|FG014|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361006|NCT03154086|12557653|FG000|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361007|NCT03154086|12557654|FG001|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361008|NCT03154086|12557655|FG002|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361009|NCT03154086|12557656|FG003|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361010|NCT03154086|12557657|FG004|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361011|NCT03154086|12557658|FG005|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361012|NCT03154086|12557659|FG006|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361013|NCT03154086|12557660|FG007|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361014|NCT03154086|12557661|FG008|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361015|NCT03154086|12557662|FG009|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361016|NCT03154086|12557663|FG010|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361017|NCT03154086|12557664|FG011|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361018|NCT03154086|12557665|FG012|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361019|NCT03154086|12557666|FG013|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361020|NCT03154086|12557667|FG014|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
11361021|NCT03154086|12557653|FG000|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361022|NCT03154086|12557654|FG001|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361023|NCT03154086|12557655|FG002|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361024|NCT03154086|12557656|FG003|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361025|NCT03154086|12557657|FG004|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361026|NCT03154086|12557658|FG005|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361027|NCT03154086|12557659|FG006|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
11361028|NCT03154086|12557660|FG007|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
11361029|NCT03154086|12557661|FG008|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
11361030|NCT03154086|12557662|FG009|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361031|NCT03154086|12557663|FG010|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361032|NCT03154086|12557664|FG011|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361033|NCT03154086|12557665|FG012|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361034|NCT03154086|12557666|FG013|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361035|NCT03154086|12557667|FG014|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361036|NCT03154086|12557653|FG000|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361037|NCT03154086|12557654|FG001|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361038|NCT03154086|12557655|FG002|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361039|NCT03154086|12557656|FG003|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361040|NCT03154086|12557657|FG004|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361041|NCT03154086|12557658|FG005|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361042|NCT03154086|12557659|FG006|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
11361043|NCT03154086|12557660|FG007|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
11361044|NCT03154086|12557661|FG008|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
11361045|NCT03154086|12557662|FG009|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361046|NCT03154086|12557663|FG010|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361047|NCT03154086|12557664|FG011|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361048|NCT03154086|12557665|FG012|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361049|NCT03154086|12557666|FG013|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361050|NCT03154086|12557667|FG014|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361051|NCT03154086|12557653|FG000|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361052|NCT03154086|12557654|FG001|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361053|NCT03154086|12557655|FG002|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361054|NCT03154086|12557656|FG003|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361055|NCT03154086|12557657|FG004|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361056|NCT03154086|12557658|FG005|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361057|NCT03154086|12557659|FG006|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361058|NCT03154086|12557660|FG007|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361059|NCT03154086|12557661|FG008|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361060|NCT03154086|12557662|FG009|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361061|NCT03154086|12557663|FG010|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361062|NCT03154086|12557664|FG011|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361063|NCT03154086|12557665|FG012|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361064|NCT03154086|12557666|FG013|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361065|NCT03154086|12557667|FG014|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
11361066|NCT03154086|12557653|FG000|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361067|NCT03154086|12557654|FG001|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361068|NCT03154086|12557655|FG002|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361069|NCT03154086|12557656|FG003|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361070|NCT03154086|12557657|FG004|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361071|NCT03154086|12557658|FG005|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361072|NCT03154086|12557659|FG006|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
11361073|NCT03154086|12557660|FG007|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
11361074|NCT03154086|12557661|FG008|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5
11361075|NCT03154086|12557662|FG009|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361076|NCT03154086|12557663|FG010|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361077|NCT03154086|12557664|FG011|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361078|NCT03154086|12557665|FG012|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361079|NCT03154086|12557666|FG013|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361080|NCT03154086|12557667|FG014|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361081|NCT03154086|12557653|FG000|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361082|NCT03154086|12557654|FG001|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361083|NCT03154086|12557655|FG002|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361084|NCT03154086|12557656|FG003|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361085|NCT03154086|12557657|FG004|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361086|NCT03154086|12557658|FG005|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361087|NCT03154086|12557659|FG006|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2
11361088|NCT03154086|12557660|FG007|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
11361089|NCT03154086|12557661|FG008|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4
11361090|NCT03154086|12557662|FG009|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361091|NCT03154086|12557663|FG010|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361092|NCT03154086|12557664|FG011|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361093|NCT03154086|12557665|FG012|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361094|NCT03154086|12557666|FG013|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361095|NCT03154086|12557667|FG014|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361096|NCT03154086|12557653|FG000|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361097|NCT03154086|12557654|FG001|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361098|NCT03154086|12557655|FG002|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361099|NCT03154086|12557656|FG003|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361100|NCT03154086|12557657|FG004|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361101|NCT03154086|12557658|FG005|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361102|NCT03154086|12557659|FG006|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361103|NCT03154086|12557660|FG007|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
11361104|NCT03154086|12557661|FG008|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
11361105|NCT03154086|12557662|FG009|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361106|NCT03154086|12557663|FG010|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361107|NCT03154086|12557664|FG011|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361108|NCT03154086|12557665|FG012|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361109|NCT03154086|12557666|FG013|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361110|NCT03154086|12557667|FG014|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
11361111|NCT03154086|12557653|FG000|STARTED|Part B (Up to 25 Days)||0
11361112|NCT03154086|12557654|FG001|STARTED|Part B (Up to 25 Days)||0
11361113|NCT03154086|12557655|FG002|STARTED|Part B (Up to 25 Days)||0
11361114|NCT03154086|12557656|FG003|STARTED|Part B (Up to 25 Days)||0
11361115|NCT03154086|12557657|FG004|STARTED|Part B (Up to 25 Days)||0
11361116|NCT03154086|12557658|FG005|STARTED|Part B (Up to 25 Days)||0
11361117|NCT03154086|12557659|FG006|STARTED|Part B (Up to 25 Days)||0
11361118|NCT03154086|12557660|FG007|STARTED|Part B (Up to 25 Days)||0
11361119|NCT03154086|12557661|FG008|STARTED|Part B (Up to 25 Days)||0
11361120|NCT03154086|12557662|FG009|STARTED|Part B (Up to 25 Days)||10
11361121|NCT03154086|12557663|FG010|STARTED|Part B (Up to 25 Days)||6
11361122|NCT03154086|12557664|FG011|STARTED|Part B (Up to 25 Days)||6
11361123|NCT03154086|12557665|FG012|STARTED|Part B (Up to 25 Days)||6
11361124|NCT03154086|12557666|FG013|STARTED|Part B (Up to 25 Days)||6
11361125|NCT03154086|12557667|FG014|STARTED|Part B (Up to 25 Days)||6
11361126|NCT03154086|12557653|FG000|COMPLETED|Part B (Up to 25 Days)||0
11361127|NCT03154086|12557654|FG001|COMPLETED|Part B (Up to 25 Days)||0
11361128|NCT03154086|12557655|FG002|COMPLETED|Part B (Up to 25 Days)||0
11361129|NCT03154086|12557656|FG003|COMPLETED|Part B (Up to 25 Days)||0
11361130|NCT03154086|12557657|FG004|COMPLETED|Part B (Up to 25 Days)||0
11361131|NCT03154086|12557658|FG005|COMPLETED|Part B (Up to 25 Days)||0
11361132|NCT03154086|12557659|FG006|COMPLETED|Part B (Up to 25 Days)||0
11361133|NCT03154086|12557660|FG007|COMPLETED|Part B (Up to 25 Days)||0
11361134|NCT03154086|12557661|FG008|COMPLETED|Part B (Up to 25 Days)||0
11361135|NCT03154086|12557662|FG009|COMPLETED|Part B (Up to 25 Days)||10
11361136|NCT03154086|12557663|FG010|COMPLETED|Part B (Up to 25 Days)||5
11361137|NCT03154086|12557664|FG011|COMPLETED|Part B (Up to 25 Days)||6
11361138|NCT03154086|12557665|FG012|COMPLETED|Part B (Up to 25 Days)||6
11361139|NCT03154086|12557666|FG013|COMPLETED|Part B (Up to 25 Days)||6
11361140|NCT03154086|12557667|FG014|COMPLETED|Part B (Up to 25 Days)||6
11361141|NCT03154086|12557653|FG000|NOT COMPLETED|Part B (Up to 25 Days)||0
11361142|NCT03154086|12557654|FG001|NOT COMPLETED|Part B (Up to 25 Days)||0
11361143|NCT03154086|12557655|FG002|NOT COMPLETED|Part B (Up to 25 Days)||0
11361144|NCT03154086|12557656|FG003|NOT COMPLETED|Part B (Up to 25 Days)||0
11361145|NCT03154086|12557657|FG004|NOT COMPLETED|Part B (Up to 25 Days)||0
11361146|NCT03154086|12557658|FG005|NOT COMPLETED|Part B (Up to 25 Days)||0
11361147|NCT03154086|12557659|FG006|NOT COMPLETED|Part B (Up to 25 Days)||0
11361148|NCT03154086|12557660|FG007|NOT COMPLETED|Part B (Up to 25 Days)||0
11361149|NCT03154086|12557661|FG008|NOT COMPLETED|Part B (Up to 25 Days)||0
11361150|NCT03154086|12557662|FG009|NOT COMPLETED|Part B (Up to 25 Days)||0
11361151|NCT03154086|12557663|FG010|NOT COMPLETED|Part B (Up to 25 Days)||1
11361152|NCT03154086|12557664|FG011|NOT COMPLETED|Part B (Up to 25 Days)||0
11361153|NCT03154086|12557665|FG012|NOT COMPLETED|Part B (Up to 25 Days)||0
11361154|NCT03154086|12557666|FG013|NOT COMPLETED|Part B (Up to 25 Days)||0
11361155|NCT03154086|12557667|FG014|NOT COMPLETED|Part B (Up to 25 Days)||0
11361156|NCT03154333|12557725|FG000|STARTED|Overall Study||28
11361157|NCT03154333|12557726|FG001|STARTED|Overall Study||26
11361158|NCT03154333|12557725|FG000|COMPLETED|Overall Study||21
11361159|NCT03154333|12557726|FG001|COMPLETED|Overall Study||21
11361160|NCT03154333|12557725|FG000|NOT COMPLETED|Overall Study||7
11361161|NCT03154333|12557726|FG001|NOT COMPLETED|Overall Study||5
11361162|NCT03154476|12557735|FG000|STARTED|Overall Study||10
11361163|NCT03154476|12557736|FG001|STARTED|Overall Study||10
11361164|NCT03154476|12557735|FG000|COMPLETED|Overall Study||6
11361165|NCT03154476|12557736|FG001|COMPLETED|Overall Study||6
11361166|NCT03154476|12557735|FG000|NOT COMPLETED|Overall Study||4
11361167|NCT03154476|12557736|FG001|NOT COMPLETED|Overall Study||4
11361168|NCT03154658|12557744|FG000|STARTED|Overall Study||33
11361169|NCT03154658|12557745|FG001|STARTED|Overall Study||33
11361170|NCT03154658|12557744|FG000|COMPLETED|Overall Study||32
11361171|NCT03154658|12557745|FG001|COMPLETED|Overall Study||32
11361172|NCT03154658|12557744|FG000|NOT COMPLETED|Overall Study||1
11361173|NCT03154658|12557745|FG001|NOT COMPLETED|Overall Study||1
11361174|NCT03154710|12557753|FG000|STARTED|Overall Study||27
11361175|NCT03154710|12557754|FG001|STARTED|Overall Study||25
11361176|NCT03154710|12557753|FG000|COMPLETED|Overall Study||20
11361177|NCT03154710|12557754|FG001|COMPLETED|Overall Study||20
11361178|NCT03154710|12557753|FG000|NOT COMPLETED|Overall Study||7
11361179|NCT03154710|12557754|FG001|NOT COMPLETED|Overall Study||5
11361180|NCT03155178|12557764|FG000|STARTED|Overall Study||69
11361181|NCT03155178|12557765|FG001|STARTED|Overall Study||69
11361182|NCT03155178|12557766|FG002|STARTED|Overall Study||69
11361183|NCT03155178|12557767|FG003|STARTED|Overall Study||69
11361184|NCT03155178|12557764|FG000|COMPLETED|Overall Study||62
11361185|NCT03155178|12557765|FG001|COMPLETED|Overall Study||62
11361186|NCT03155178|12557766|FG002|COMPLETED|Overall Study||62
11361187|NCT03155178|12557767|FG003|COMPLETED|Overall Study||62
11361188|NCT03155178|12557764|FG000|NOT COMPLETED|Overall Study||7
11361189|NCT03155178|12557765|FG001|NOT COMPLETED|Overall Study||7
11361190|NCT03155178|12557766|FG002|NOT COMPLETED|Overall Study||7
11361191|NCT03155178|12557767|FG003|NOT COMPLETED|Overall Study||7
11361192|NCT03155269|12557783|FG000|STARTED|Overall Study||57
11361193|NCT03155269|12557784|FG001|STARTED|Overall Study||57
11361194|NCT03155269|12557783|FG000|COMPLETED|Overall Study||52
11361195|NCT03155269|12557784|FG001|COMPLETED|Overall Study||50
11361196|NCT03155269|12557783|FG000|NOT COMPLETED|Overall Study||5
11361197|NCT03155269|12557784|FG001|NOT COMPLETED|Overall Study||7
11361198|NCT03155724|12557790|FG000|STARTED|Overall Study||53
11361199|NCT03155724|12557790|FG000|COMPLETED|Overall Study||42
11361200|NCT03155724|12557790|FG000|NOT COMPLETED|Overall Study||11
11361201|NCT03155945|12557796|FG000|STARTED|Overall Study||6
11361202|NCT03155945|12557797|FG001|STARTED|Overall Study||8
11361203|NCT03155945|12557796|FG000|COMPLETED|Overall Study||6
11361204|NCT03155945|12557797|FG001|COMPLETED|Overall Study||5
11361205|NCT03155945|12557796|FG000|NOT COMPLETED|Overall Study||0
11361206|NCT03155945|12557797|FG001|NOT COMPLETED|Overall Study||3
11361207|NCT03156270|12557803|FG000|STARTED|Overall Study||20
11361208|NCT03156270|12557803|FG000|COMPLETED|Overall Study||18
11361209|NCT03156270|12557803|FG000|NOT COMPLETED|Overall Study||2
11361210|NCT03156543|12557811|FG000|STARTED|Overall Study||9
11361211|NCT03156543|12557812|FG001|STARTED|Overall Study||23
11361212|NCT03156543|12557811|FG000|COMPLETED|Overall Study||8
11361213|NCT03156543|12557812|FG001|COMPLETED|Overall Study||23
11361214|NCT03156543|12557811|FG000|NOT COMPLETED|Overall Study||1
11361215|NCT03156543|12557812|FG001|NOT COMPLETED|Overall Study||0
11361216|NCT03156621|12557820|FG000|STARTED|Double-Blind Treatment Period (DBTP)||24
11361217|NCT03156621|12557821|FG001|STARTED|Double-Blind Treatment Period (DBTP)||45
11361218|NCT03156621|12557820|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||24
11361219|NCT03156621|12557821|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||45
11361220|NCT03156621|12557820|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
11361221|NCT03156621|12557821|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
11361222|NCT03156621|12557820|FG000|STARTED|Open-Label Treatment Period (OLTP)||24
11361223|NCT03156621|12557821|FG001|STARTED|Open-Label Treatment Period (OLTP)||45
11361224|NCT03156621|12557820|FG000|COMPLETED|Open-Label Treatment Period (OLTP)||24
11361225|NCT03156621|12557821|FG001|COMPLETED|Open-Label Treatment Period (OLTP)||42
11361226|NCT03156621|12557820|FG000|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0
11361227|NCT03156621|12557821|FG001|NOT COMPLETED|Open-Label Treatment Period (OLTP)||3
11361228|NCT03157089|12557832|FG000|STARTED|Overall Study||12
11361229|NCT03157089|12557833|FG001|STARTED|Overall Study||12
11361230|NCT03157089|12557832|FG000|Treated|Overall Study||12
11361231|NCT03157089|12557833|FG001|Treated|Overall Study||12
11361232|NCT03157089|12557832|FG000|COMPLETED|Overall Study||0
11361233|NCT03157089|12557833|FG001|COMPLETED|Overall Study||0
11361234|NCT03157089|12557832|FG000|NOT COMPLETED|Overall Study||12
11361235|NCT03157089|12557833|FG001|NOT COMPLETED|Overall Study||12
11361236|NCT03157232|12557840|FG000|STARTED|Overall Study||18
11361237|NCT03157232|12557840|FG000|COMPLETED|Overall Study||18
11361238|NCT03157232|12557840|FG000|NOT COMPLETED|Overall Study||0
11361239|NCT03157531|12557844|FG000|STARTED|Overall Study||97
11361240|NCT03157531|12557844|FG000|Analyzed at 30 Days For MAEs|Overall Study||93
11361241|NCT03157531|12557844|FG000|COMPLETED|Overall Study||91
11361242|NCT03157531|12557844|FG000|NOT COMPLETED|Overall Study||6
11361243|NCT03157583|12557848|FG000|STARTED|Overall Study||8
11361244|NCT03157583|12557848|FG000|COMPLETED|Overall Study||7
11361245|NCT03157583|12557848|FG000|NOT COMPLETED|Overall Study||1
11361246|NCT03158012|12557868|FG000|STARTED|Overall Study||8
11361247|NCT03158012|12557869|FG001|STARTED|Overall Study||7
11361248|NCT03158012|12557868|FG000|COMPLETED|Overall Study||8
11361249|NCT03158012|12557869|FG001|COMPLETED|Overall Study||6
11361250|NCT03158012|12557868|FG000|NOT COMPLETED|Overall Study||0
11361251|NCT03158012|12557869|FG001|NOT COMPLETED|Overall Study||1
11361252|NCT03158038|12557877|FG000|STARTED|Overall Study||240
11361253|NCT03158038|12557878|FG001|STARTED|Overall Study||60
11361254|NCT03158038|12557877|FG000|COMPLETED|Overall Study||240
11361255|NCT03158038|12557878|FG001|COMPLETED|Overall Study||60
11361256|NCT03158038|12557877|FG000|NOT COMPLETED|Overall Study||0
11361257|NCT03158038|12557878|FG001|NOT COMPLETED|Overall Study||0
11361258|NCT03158116|12557884|FG000|STARTED|Overall Study||5
11361259|NCT03158116|12557884|FG000|COMPLETED|Overall Study||5
11361260|NCT03158116|12557884|FG000|NOT COMPLETED|Overall Study||0
11361261|NCT03158220|12557890|FG000|STARTED|Overall Study||570
11361262|NCT03158220|12557891|FG001|STARTED|Overall Study||642
11361263|NCT03158220|12557890|FG000|Vaccination 1|Overall Study||570
11361264|NCT03158220|12557891|FG001|Vaccination 1|Overall Study||640
11361265|NCT03158220|12557890|FG000|Vaccination 2|Overall Study||563
11361266|NCT03158220|12557891|FG001|Vaccination 2|Overall Study||635
11361267|NCT03158220|12557890|FG000|Vaccination 3|Overall Study||556
11361268|NCT03158220|12557891|FG001|Vaccination 3|Overall Study||629
11361269|NCT03158220|12557890|FG000|COMPLETED|Overall Study||553
11361270|NCT03158220|12557891|FG001|COMPLETED|Overall Study||626
11361271|NCT03158220|12557890|FG000|NOT COMPLETED|Overall Study||17
11361272|NCT03158220|12557891|FG001|NOT COMPLETED|Overall Study||16
11361273|NCT03158272|12557901|FG000|STARTED|Overall Study||3
11361274|NCT03158272|12557902|FG001|STARTED|Overall Study||4
11361275|NCT03158272|12557903|FG002|STARTED|Overall Study||6
11361276|NCT03158272|12557904|FG003|STARTED|Overall Study||6
11361277|NCT03158272|12557901|FG000|COMPLETED|Overall Study||0
11361278|NCT03158272|12557902|FG001|COMPLETED|Overall Study||0
11361279|NCT03158272|12557903|FG002|COMPLETED|Overall Study||0
11361280|NCT03158272|12557904|FG003|COMPLETED|Overall Study||0
11361281|NCT03158272|12557901|FG000|NOT COMPLETED|Overall Study||3
11361282|NCT03158272|12557902|FG001|NOT COMPLETED|Overall Study||4
11361283|NCT03158272|12557903|FG002|NOT COMPLETED|Overall Study||6
11361284|NCT03158272|12557904|FG003|NOT COMPLETED|Overall Study||6
11361285|NCT03158311|12557919|FG000|STARTED|Overall Study||474
11361286|NCT03158311|12557920|FG001|STARTED|Overall Study||476
11361287|NCT03158311|12557921|FG002|STARTED|Overall Study||476
11361288|NCT03158311|12557919|FG000|Full Analysis Set (FAS)|Overall Study||474
11361289|NCT03158311|12557920|FG001|Full Analysis Set (FAS)|Overall Study||476
11361290|NCT03158311|12557921|FG002|Full Analysis Set (FAS)|Overall Study||475
11361291|NCT03158311|12557919|FG000|Safety Set (SAF)|Overall Study||474
11361292|NCT03158311|12557920|FG001|Safety Set (SAF)|Overall Study||476
11361293|NCT03158311|12557921|FG002|Safety Set (SAF)|Overall Study||475
11361294|NCT03158311|12557919|FG000|COMPLETED|Overall Study||452
11361295|NCT03158311|12557920|FG001|COMPLETED|Overall Study||460
11361296|NCT03158311|12557921|FG002|COMPLETED|Overall Study||448
11361297|NCT03158311|12557919|FG000|NOT COMPLETED|Overall Study||22
11361298|NCT03158311|12557920|FG001|NOT COMPLETED|Overall Study||16
11361299|NCT03158311|12557921|FG002|NOT COMPLETED|Overall Study||28
11361300|NCT03158714|12557932|FG000|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626
11361301|NCT03158714|12557933|FG001|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626
11361302|NCT03158714|12557934|FG002|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|606
11361303|NCT03158714|12557932|FG000|COMPLETED|Overall Study|Participated in half or more of program.|445
11361304|NCT03158714|12557933|FG001|COMPLETED|Overall Study|Participated in half or more of program.|398
11361305|NCT03158714|12557934|FG002|COMPLETED|Overall Study|All control group participants completed the control protocol (no program).|606
11361306|NCT03158714|12557932|FG000|NOT COMPLETED|Overall Study||181
11361307|NCT03158714|12557933|FG001|NOT COMPLETED|Overall Study||228
11361308|NCT03158714|12557934|FG002|NOT COMPLETED|Overall Study||0
11361309|NCT03159091|12557944|FG000|STARTED|Overall Study||121
11361310|NCT03159091|12557945|FG001|STARTED|Overall Study||117
11361311|NCT03159091|12557944|FG000|COMPLETED|Overall Study||116
11361312|NCT03159091|12557945|FG001|COMPLETED|Overall Study||113
11361313|NCT03159091|12557944|FG000|NOT COMPLETED|Overall Study||5
11361314|NCT03159091|12557945|FG001|NOT COMPLETED|Overall Study||4
11361315|NCT03159143|12557951|FG000|STARTED|Overall Study||22
11361316|NCT03159143|12557951|FG000|COMPLETED|Overall Study||22
11361317|NCT03159143|12557951|FG000|NOT COMPLETED|Overall Study||0
11361318|NCT03159260|12557957|FG000|STARTED|Overall Study||28
11361319|NCT03159260|12557958|FG001|STARTED|Overall Study||29
11361320|NCT03159260|12557957|FG000|COMPLETED|Overall Study||25
11361321|NCT03159260|12557958|FG001|COMPLETED|Overall Study||25
11361322|NCT03159260|12557957|FG000|NOT COMPLETED|Overall Study||3
11361323|NCT03159260|12557958|FG001|NOT COMPLETED|Overall Study||4
11361324|NCT03159299|12557966|FG000|STARTED|Overall Study||26
11361325|NCT03159299|12557967|FG001|STARTED|Overall Study||21
11361326|NCT03159299|12557966|FG000|COMPLETED|Overall Study||24
11361327|NCT03159299|12557967|FG001|COMPLETED|Overall Study||20
11361328|NCT03159299|12557966|FG000|NOT COMPLETED|Overall Study||2
11361329|NCT03159299|12557967|FG001|NOT COMPLETED|Overall Study||1
11361330|NCT03159455|12557979|FG000|STARTED|Overall Study||9
11361331|NCT03159455|12557980|FG001|STARTED|Overall Study||9
11361332|NCT03159455|12557981|FG002|STARTED|Overall Study||9
11361333|NCT03159455|12557982|FG003|STARTED|Overall Study||9
11361334|NCT03159455|12557983|FG004|STARTED|Overall Study||3
11361335|NCT03159455|12557984|FG005|STARTED|Overall Study||9
11361336|NCT03159455|12557979|FG000|COMPLETED|Overall Study||9
11361337|NCT03159455|12557980|FG001|COMPLETED|Overall Study||9
11361338|NCT03159455|12557981|FG002|COMPLETED|Overall Study||9
11361339|NCT03159455|12557982|FG003|COMPLETED|Overall Study||9
11361340|NCT03159455|12557983|FG004|COMPLETED|Overall Study||3
11361341|NCT03159455|12557984|FG005|COMPLETED|Overall Study||8
11361342|NCT03159455|12557979|FG000|NOT COMPLETED|Overall Study||0
11361343|NCT03159455|12557980|FG001|NOT COMPLETED|Overall Study||0
11361344|NCT03159455|12557981|FG002|NOT COMPLETED|Overall Study||0
11361345|NCT03159455|12557982|FG003|NOT COMPLETED|Overall Study||0
11361346|NCT03159455|12557983|FG004|NOT COMPLETED|Overall Study||0
11361347|NCT03159455|12557984|FG005|NOT COMPLETED|Overall Study||1
11361348|NCT03159468|12558008|FG000|STARTED|Overall Study||35
11361349|NCT03159468|12558009|FG001|STARTED|Overall Study||35
11361350|NCT03159468|12558010|FG002|STARTED|Overall Study||37
11361351|NCT03159468|12558011|FG003|STARTED|Overall Study||34
11361352|NCT03159468|12558012|FG004|STARTED|Overall Study||34
11361353|NCT03159468|12558013|FG005|STARTED|Overall Study||34
11361354|NCT03159468|12558008|FG000|COMPLETED|Overall Study||35
11361355|NCT03159468|12558009|FG001|COMPLETED|Overall Study||35
11361356|NCT03159468|12558010|FG002|COMPLETED|Overall Study||34
11361357|NCT03159468|12558011|FG003|COMPLETED|Overall Study||34
11361358|NCT03159468|12558012|FG004|COMPLETED|Overall Study||34
11361359|NCT03159468|12558013|FG005|COMPLETED|Overall Study||34
11361360|NCT03159468|12558008|FG000|NOT COMPLETED|Overall Study||0
11361361|NCT03159468|12558009|FG001|NOT COMPLETED|Overall Study||0
11361362|NCT03159468|12558010|FG002|NOT COMPLETED|Overall Study||3
11361363|NCT03159468|12558011|FG003|NOT COMPLETED|Overall Study||0
11361364|NCT03159468|12558012|FG004|NOT COMPLETED|Overall Study||0
11361365|NCT03159468|12558013|FG005|NOT COMPLETED|Overall Study||0
11361366|NCT03159611|12558029|FG000|STARTED|Overall Study||95
11361367|NCT03159611|12558030|FG001|STARTED|Overall Study||87
11361368|NCT03159611|12558029|FG000|COMPLETED|Overall Study||72
11361369|NCT03159611|12558030|FG001|COMPLETED|Overall Study||72
11361370|NCT03159611|12558029|FG000|NOT COMPLETED|Overall Study||23
11361371|NCT03159611|12558030|FG001|NOT COMPLETED|Overall Study||15
11361372|NCT03159624|12558038|FG000|STARTED|Overall Study||21
11361373|NCT03159624|12558039|FG001|STARTED|Overall Study||26
11361374|NCT03159624|12558038|FG000|COMPLETED|Overall Study||21
11361375|NCT03159624|12558039|FG001|COMPLETED|Overall Study||25
11361376|NCT03159624|12558038|FG000|NOT COMPLETED|Overall Study||0
11361377|NCT03159624|12558039|FG001|NOT COMPLETED|Overall Study||1
11361378|NCT03160027|12558049|FG000|STARTED|Overall Study||6
11361379|NCT03160027|12558050|FG001|STARTED|Overall Study||4
11361380|NCT03160027|12558051|FG002|STARTED|Overall Study||6
11361381|NCT03160027|12558052|FG003|STARTED|Overall Study||4
11361382|NCT03160027|12558049|FG000|COMPLETED|Overall Study||6
11361383|NCT03160027|12558050|FG001|COMPLETED|Overall Study||4
11361384|NCT03160027|12558051|FG002|COMPLETED|Overall Study||6
11361385|NCT03160027|12558052|FG003|COMPLETED|Overall Study||4
11361386|NCT03160027|12558049|FG000|NOT COMPLETED|Overall Study||0
11361387|NCT03160027|12558050|FG001|NOT COMPLETED|Overall Study||0
11361388|NCT03160027|12558051|FG002|NOT COMPLETED|Overall Study||0
11361389|NCT03160027|12558052|FG003|NOT COMPLETED|Overall Study||0
11361390|NCT03160170|12558065|FG000|STARTED|Overall Study||10
11361391|NCT03160170|12558066|FG001|STARTED|Overall Study||10
11361392|NCT03160170|12558065|FG000|COMPLETED|Overall Study||10
11361393|NCT03160170|12558066|FG001|COMPLETED|Overall Study||10
11361394|NCT03160170|12558065|FG000|NOT COMPLETED|Overall Study||0
11361395|NCT03160170|12558066|FG001|NOT COMPLETED|Overall Study||0
11361396|NCT03160287|12558072|FG000|STARTED|Overall Study||24
11361397|NCT03160287|12558072|FG000|COMPLETED|Overall Study||22
11361398|NCT03160287|12558072|FG000|NOT COMPLETED|Overall Study||2
11361399|NCT03160560|12558080|FG000|STARTED|First Intervention (3 Weeks)||25
11361400|NCT03160560|12558081|FG001|STARTED|First Intervention (3 Weeks)||25
11361401|NCT03160560|12558082|FG002|STARTED|First Intervention (3 Weeks)||25
11361402|NCT03160560|12558083|FG003|STARTED|First Intervention (3 Weeks)||25
11361403|NCT03160560|12558080|FG000|COMPLETED|First Intervention (3 Weeks)||23
11361404|NCT03160560|12558081|FG001|COMPLETED|First Intervention (3 Weeks)||24
11361405|NCT03160560|12558082|FG002|COMPLETED|First Intervention (3 Weeks)||24
11361406|NCT03160560|12558083|FG003|COMPLETED|First Intervention (3 Weeks)||25
11361407|NCT03160560|12558080|FG000|NOT COMPLETED|First Intervention (3 Weeks)||2
11361408|NCT03160560|12558081|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
11361409|NCT03160560|12558082|FG002|NOT COMPLETED|First Intervention (3 Weeks)||1
11361410|NCT03160560|12558083|FG003|NOT COMPLETED|First Intervention (3 Weeks)||0
11361411|NCT03160560|12558080|FG000|STARTED|Washout (2 Weeks)||23
11361412|NCT03160560|12558081|FG001|STARTED|Washout (2 Weeks)||24
11361413|NCT03160560|12558082|FG002|STARTED|Washout (2 Weeks)||24
11361414|NCT03160560|12558083|FG003|STARTED|Washout (2 Weeks)||25
11361415|NCT03160560|12558080|FG000|COMPLETED|Washout (2 Weeks)||23
11361416|NCT03160560|12558081|FG001|COMPLETED|Washout (2 Weeks)||24
11361417|NCT03160560|12558082|FG002|COMPLETED|Washout (2 Weeks)||24
11361418|NCT03160560|12558083|FG003|COMPLETED|Washout (2 Weeks)||25
11361419|NCT03160560|12558080|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11361420|NCT03160560|12558081|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11361421|NCT03160560|12558082|FG002|NOT COMPLETED|Washout (2 Weeks)||0
11361422|NCT03160560|12558083|FG003|NOT COMPLETED|Washout (2 Weeks)||0
11361423|NCT03160560|12558080|FG000|STARTED|Second Intervention (3 Weeks)||23
11361424|NCT03160560|12558081|FG001|STARTED|Second Intervention (3 Weeks)||24
11361425|NCT03160560|12558082|FG002|STARTED|Second Intervention (3 Weeks)||24
11361426|NCT03160560|12558083|FG003|STARTED|Second Intervention (3 Weeks)||25
11361427|NCT03160560|12558080|FG000|COMPLETED|Second Intervention (3 Weeks)||22
11361428|NCT03160560|12558081|FG001|COMPLETED|Second Intervention (3 Weeks)||24
11361429|NCT03160560|12558082|FG002|COMPLETED|Second Intervention (3 Weeks)||24
11361430|NCT03160560|12558083|FG003|COMPLETED|Second Intervention (3 Weeks)||25
11361431|NCT03160560|12558080|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
11361432|NCT03160560|12558081|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
11361433|NCT03160560|12558082|FG002|NOT COMPLETED|Second Intervention (3 Weeks)||0
11361434|NCT03160560|12558083|FG003|NOT COMPLETED|Second Intervention (3 Weeks)||0
11361435|NCT03160573|12558097|FG000|STARTED|First Sequence (3 Weeks)||23
11361436|NCT03160573|12558098|FG001|STARTED|First Sequence (3 Weeks)||26
11361437|NCT03160573|12558099|FG002|STARTED|First Sequence (3 Weeks)||25
11361438|NCT03160573|12558100|FG003|STARTED|First Sequence (3 Weeks)||25
11361439|NCT03160573|12558097|FG000|COMPLETED|First Sequence (3 Weeks)||22
11361440|NCT03160573|12558098|FG001|COMPLETED|First Sequence (3 Weeks)||23
11361441|NCT03160573|12558099|FG002|COMPLETED|First Sequence (3 Weeks)||23
11361442|NCT03160573|12558100|FG003|COMPLETED|First Sequence (3 Weeks)||23
11361443|NCT03160573|12558097|FG000|NOT COMPLETED|First Sequence (3 Weeks)||1
11361444|NCT03160573|12558098|FG001|NOT COMPLETED|First Sequence (3 Weeks)||3
11361445|NCT03160573|12558099|FG002|NOT COMPLETED|First Sequence (3 Weeks)||2
11361446|NCT03160573|12558100|FG003|NOT COMPLETED|First Sequence (3 Weeks)||2
11361447|NCT03160573|12558097|FG000|STARTED|Washout (2 Weeks)||22
11361448|NCT03160573|12558098|FG001|STARTED|Washout (2 Weeks)||23
11361449|NCT03160573|12558099|FG002|STARTED|Washout (2 Weeks)||23
11361450|NCT03160573|12558100|FG003|STARTED|Washout (2 Weeks)||23
11361451|NCT03160573|12558097|FG000|COMPLETED|Washout (2 Weeks)||22
11361452|NCT03160573|12558098|FG001|COMPLETED|Washout (2 Weeks)||23
11361453|NCT03160573|12558099|FG002|COMPLETED|Washout (2 Weeks)||23
11361454|NCT03160573|12558100|FG003|COMPLETED|Washout (2 Weeks)||23
11361455|NCT03160573|12558097|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11361456|NCT03160573|12558098|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11361457|NCT03160573|12558099|FG002|NOT COMPLETED|Washout (2 Weeks)||0
11361458|NCT03160573|12558100|FG003|NOT COMPLETED|Washout (2 Weeks)||0
11361459|NCT03160573|12558097|FG000|STARTED|Second Sequence (3 Weeks)||22
11361460|NCT03160573|12558098|FG001|STARTED|Second Sequence (3 Weeks)||23
11361461|NCT03160573|12558099|FG002|STARTED|Second Sequence (3 Weeks)||23
11361462|NCT03160573|12558100|FG003|STARTED|Second Sequence (3 Weeks)||23
11361463|NCT03160573|12558097|FG000|COMPLETED|Second Sequence (3 Weeks)||22
11361464|NCT03160573|12558098|FG001|COMPLETED|Second Sequence (3 Weeks)||23
11361465|NCT03160573|12558099|FG002|COMPLETED|Second Sequence (3 Weeks)||23
11361466|NCT03160573|12558100|FG003|COMPLETED|Second Sequence (3 Weeks)||23
11361467|NCT03160573|12558097|FG000|NOT COMPLETED|Second Sequence (3 Weeks)||0
11361468|NCT03160573|12558098|FG001|NOT COMPLETED|Second Sequence (3 Weeks)||0
11361469|NCT03160573|12558099|FG002|NOT COMPLETED|Second Sequence (3 Weeks)||0
11361470|NCT03160573|12558100|FG003|NOT COMPLETED|Second Sequence (3 Weeks)||0
11361471|NCT03160703|12558114|FG000|STARTED|Overall Study||55
11361472|NCT03160703|12558115|FG001|STARTED|Overall Study||55
11361473|NCT03160703|12558116|FG002|STARTED|Overall Study||55
11361474|NCT03160703|12558117|FG003|STARTED|Overall Study||55
11361475|NCT03160703|12558114|FG000|COMPLETED|Overall Study||55
11361476|NCT03160703|12558115|FG001|COMPLETED|Overall Study||55
11361477|NCT03160703|12558116|FG002|COMPLETED|Overall Study||55
11361478|NCT03160703|12558117|FG003|COMPLETED|Overall Study||54
11361479|NCT03160703|12558114|FG000|NOT COMPLETED|Overall Study||0
11361480|NCT03160703|12558115|FG001|NOT COMPLETED|Overall Study||0
11361481|NCT03160703|12558116|FG002|NOT COMPLETED|Overall Study||0
11361482|NCT03160703|12558117|FG003|NOT COMPLETED|Overall Study||1
11361483|NCT03160885|12558129|FG000|STARTED|Initial Treatment Period||593
11361484|NCT03160885|12558130|FG001|STARTED|Initial Treatment Period||201
11361485|NCT03160885|12558131|FG002|STARTED|Initial Treatment Period||0
11361486|NCT03160885|12558132|FG003|STARTED|Initial Treatment Period||0
11361487|NCT03160885|12558133|FG004|STARTED|Initial Treatment Period||0
11361488|NCT03160885|12558134|FG005|STARTED|Initial Treatment Period||0
11361489|NCT03160885|12558135|FG006|STARTED|Initial Treatment Period||0
11361490|NCT03160885|12558129|FG000|COMPLETED|Initial Treatment Period||558
11361491|NCT03160885|12558130|FG001|COMPLETED|Initial Treatment Period||179
11361492|NCT03160885|12558131|FG002|COMPLETED|Initial Treatment Period||0
11361493|NCT03160885|12558132|FG003|COMPLETED|Initial Treatment Period||0
11361494|NCT03160885|12558133|FG004|COMPLETED|Initial Treatment Period||0
11361495|NCT03160885|12558134|FG005|COMPLETED|Initial Treatment Period||0
11361496|NCT03160885|12558135|FG006|COMPLETED|Initial Treatment Period||0
11361497|NCT03160885|12558129|FG000|NOT COMPLETED|Initial Treatment Period||35
11361498|NCT03160885|12558130|FG001|NOT COMPLETED|Initial Treatment Period||22
11361499|NCT03160885|12558131|FG002|NOT COMPLETED|Initial Treatment Period||0
11361500|NCT03160885|12558132|FG003|NOT COMPLETED|Initial Treatment Period||0
11361501|NCT03160885|12558133|FG004|NOT COMPLETED|Initial Treatment Period||0
11361502|NCT03160885|12558134|FG005|NOT COMPLETED|Initial Treatment Period||0
11361503|NCT03160885|12558135|FG006|NOT COMPLETED|Initial Treatment Period||0
11361504|NCT03160885|12558129|FG000|STARTED|Open-label Treatment||0
11361505|NCT03160885|12558130|FG001|STARTED|Open-label Treatment||0
11361506|NCT03160885|12558131|FG002|STARTED|Open-label Treatment||0
11361507|NCT03160885|12558132|FG003|STARTED|Open-label Treatment||0
11361508|NCT03160885|12558133|FG004|STARTED|Open-label Treatment||0
11361509|NCT03160885|12558134|FG005|STARTED|Open-label Treatment||0
11361510|NCT03160885|12558135|FG006|STARTED|Open-label Treatment||560
11361511|NCT03160885|12558129|FG000|COMPLETED|Open-label Treatment||0
11361512|NCT03160885|12558130|FG001|COMPLETED|Open-label Treatment||0
11361513|NCT03160885|12558131|FG002|COMPLETED|Open-label Treatment||0
11361514|NCT03160885|12558132|FG003|COMPLETED|Open-label Treatment||0
11361515|NCT03160885|12558133|FG004|COMPLETED|Open-label Treatment||0
11361516|NCT03160885|12558134|FG005|COMPLETED|Open-label Treatment||0
11361517|NCT03160885|12558135|FG006|COMPLETED|Open-label Treatment||423
11361518|NCT03160885|12558129|FG000|NOT COMPLETED|Open-label Treatment||0
11361519|NCT03160885|12558130|FG001|NOT COMPLETED|Open-label Treatment||0
11361520|NCT03160885|12558131|FG002|NOT COMPLETED|Open-label Treatment||0
11361521|NCT03160885|12558132|FG003|NOT COMPLETED|Open-label Treatment||0
11361522|NCT03160885|12558133|FG004|NOT COMPLETED|Open-label Treatment||0
11361523|NCT03160885|12558134|FG005|NOT COMPLETED|Open-label Treatment||0
11361524|NCT03160885|12558135|FG006|NOT COMPLETED|Open-label Treatment||137
11361525|NCT03160885|12558129|FG000|STARTED|Maintenance Treatment Period||0
11361526|NCT03160885|12558130|FG001|STARTED|Maintenance Treatment Period||0
11361527|NCT03160885|12558131|FG002|STARTED|Maintenance Treatment Period||91
11361528|NCT03160885|12558132|FG003|STARTED|Maintenance Treatment Period||90
11361529|NCT03160885|12558133|FG004|STARTED|Maintenance Treatment Period||46
11361530|NCT03160885|12558134|FG005|STARTED|Maintenance Treatment Period||31
11361531|NCT03160885|12558135|FG006|STARTED|Maintenance Treatment Period||0
11361532|NCT03160885|12558129|FG000|COMPLETED|Maintenance Treatment Period||0
11361533|NCT03160885|12558130|FG001|COMPLETED|Maintenance Treatment Period||0
11361534|NCT03160885|12558131|FG002|COMPLETED|Maintenance Treatment Period||52
11361535|NCT03160885|12558132|FG003|COMPLETED|Maintenance Treatment Period||50
11361536|NCT03160885|12558133|FG004|COMPLETED|Maintenance Treatment Period||15
11361537|NCT03160885|12558134|FG005|COMPLETED|Maintenance Treatment Period||16
11361538|NCT03160885|12558135|FG006|COMPLETED|Maintenance Treatment Period||0
11361539|NCT03160885|12558129|FG000|NOT COMPLETED|Maintenance Treatment Period||0
11361540|NCT03160885|12558130|FG001|NOT COMPLETED|Maintenance Treatment Period||0
11361541|NCT03160885|12558131|FG002|NOT COMPLETED|Maintenance Treatment Period||39
11361542|NCT03160885|12558132|FG003|NOT COMPLETED|Maintenance Treatment Period||40
11361543|NCT03160885|12558133|FG004|NOT COMPLETED|Maintenance Treatment Period||31
11361544|NCT03160885|12558134|FG005|NOT COMPLETED|Maintenance Treatment Period||15
11361545|NCT03160885|12558135|FG006|NOT COMPLETED|Maintenance Treatment Period||0
11361546|NCT03160898|12558156|FG000|STARTED|Overall Study||115
11361547|NCT03160898|12558157|FG001|STARTED|Overall Study|1 patient withdrew consent before study drug dosing and was therefore excluded from safety analysis|113
11361548|NCT03160898|12558158|FG002|STARTED|Overall Study||113
11361549|NCT03160898|12558159|FG003|STARTED|Overall Study||117
11361550|NCT03160898|12558156|FG000|COMPLETED|Overall Study||95
11361551|NCT03160898|12558157|FG001|COMPLETED|Overall Study||100
11361552|NCT03160898|12558158|FG002|COMPLETED|Overall Study||97
11361553|NCT03160898|12558159|FG003|COMPLETED|Overall Study||98
11361554|NCT03160898|12558156|FG000|NOT COMPLETED|Overall Study||20
11361555|NCT03160898|12558157|FG001|NOT COMPLETED|Overall Study||13
11361556|NCT03160898|12558158|FG002|NOT COMPLETED|Overall Study||16
11361557|NCT03160898|12558159|FG003|NOT COMPLETED|Overall Study||19
11361558|NCT03161158|12558172|FG000|STARTED|Overall Study||18
11361559|NCT03161158|12558173|FG001|STARTED|Overall Study||19
11361560|NCT03161158|12558172|FG000|COMPLETED|Overall Study||9
11361561|NCT03161158|12558173|FG001|COMPLETED|Overall Study||13
11361562|NCT03161158|12558172|FG000|NOT COMPLETED|Overall Study||9
11361563|NCT03161158|12558173|FG001|NOT COMPLETED|Overall Study||6
11361564|NCT03161327|12558179|FG000|STARTED|Overall Study||238
11361565|NCT03161327|12558179|FG000|COMPLETED|Overall Study||238
11361566|NCT03161327|12558179|FG000|NOT COMPLETED|Overall Study||0
11361567|NCT03161405|12558184|FG000|STARTED|First Intervention Period (3 Days)||12
11361568|NCT03161405|12558184|FG000|COMPLETED|First Intervention Period (3 Days)||12
11361569|NCT03161405|12558184|FG000|NOT COMPLETED|First Intervention Period (3 Days)||0
11361570|NCT03161405|12558184|FG000|STARTED|Washout Period (at Least 4 Days)||12
11361571|NCT03161405|12558184|FG000|COMPLETED|Washout Period (at Least 4 Days)||12
11361572|NCT03161405|12558184|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0
11361573|NCT03161405|12558184|FG000|STARTED|Second Intervention Period (6 Days)||12
11361574|NCT03161405|12558184|FG000|COMPLETED|Second Intervention Period (6 Days)||11
11361575|NCT03161405|12558184|FG000|NOT COMPLETED|Second Intervention Period (6 Days)||1
11361576|NCT03161483|12558195|FG000|STARTED|Overall Study||83
11361577|NCT03161483|12558196|FG001|STARTED|Overall Study||42
11361578|NCT03161483|12558197|FG002|STARTED|Overall Study||82
11361579|NCT03161483|12558198|FG003|STARTED|Overall Study||81
11361580|NCT03161483|12558195|FG000|COMPLETED|Overall Study||73
11361581|NCT03161483|12558196|FG001|COMPLETED|Overall Study||39
11361582|NCT03161483|12558197|FG002|COMPLETED|Overall Study||62
11361583|NCT03161483|12558198|FG003|COMPLETED|Overall Study||73
11361584|NCT03161483|12558195|FG000|NOT COMPLETED|Overall Study||10
11361585|NCT03161483|12558196|FG001|NOT COMPLETED|Overall Study||3
11361586|NCT03161483|12558197|FG002|NOT COMPLETED|Overall Study||20
11361587|NCT03161483|12558198|FG003|NOT COMPLETED|Overall Study||8
11361588|NCT03161938|12558210|FG000|STARTED|Overall Study||32
11361589|NCT03161938|12558211|FG001|STARTED|Overall Study||32
11361590|NCT03161938|12558210|FG000|COMPLETED|Overall Study||32
11361591|NCT03161938|12558211|FG001|COMPLETED|Overall Study||32
11361592|NCT03161938|12558210|FG000|NOT COMPLETED|Overall Study||0
11361593|NCT03161938|12558211|FG001|NOT COMPLETED|Overall Study||0
11361594|NCT03162055|12558219|FG000|STARTED|Overall Study||559
11361595|NCT03162055|12558220|FG001|STARTED|Overall Study||560
11361596|NCT03162055|12558219|FG000|Received Treatment|Overall Study||557
11361597|NCT03162055|12558220|FG001|Received Treatment|Overall Study||560
11361598|NCT03162055|12558219|FG000|Safety Analysis Set|Overall Study||552
11361599|NCT03162055|12558220|FG001|Safety Analysis Set|Overall Study||552
11361600|NCT03162055|12558219|FG000|Full Analysis Set (FAS)|Overall Study||552
11361601|NCT03162055|12558220|FG001|Full Analysis Set (FAS)|Overall Study||552
11361602|NCT03162055|12558219|FG000|Per Protocol (PP) Analysis Set|Overall Study||506
11361603|NCT03162055|12558220|FG001|Per Protocol (PP) Analysis Set|Overall Study||510
11361604|NCT03162055|12558219|FG000|COMPLETED|Overall Study||497
11361605|NCT03162055|12558220|FG001|COMPLETED|Overall Study||517
11361606|NCT03162055|12558219|FG000|NOT COMPLETED|Overall Study||62
11361607|NCT03162055|12558220|FG001|NOT COMPLETED|Overall Study||43
11361608|NCT03162328|12558226|FG000|STARTED|Screening Period||84
11361609|NCT03162328|12558227|FG001|STARTED|Screening Period||0
11361610|NCT03162328|12558228|FG002|STARTED|Screening Period||0
11361611|NCT03162328|12558226|FG000|COMPLETED|Screening Period||62
11361612|NCT03162328|12558227|FG001|COMPLETED|Screening Period||0
11361613|NCT03162328|12558228|FG002|COMPLETED|Screening Period||0
11361614|NCT03162328|12558226|FG000|NOT COMPLETED|Screening Period||22
11361615|NCT03162328|12558227|FG001|NOT COMPLETED|Screening Period||0
11361616|NCT03162328|12558228|FG002|NOT COMPLETED|Screening Period||0
11361617|NCT03162328|12558226|FG000|STARTED|Study Period||0
11361618|NCT03162328|12558227|FG001|STARTED|Study Period||30
11361619|NCT03162328|12558228|FG002|STARTED|Study Period||32
11361620|NCT03162328|12558226|FG000|COMPLETED|Study Period||0
11361621|NCT03162328|12558227|FG001|COMPLETED|Study Period||30
11361622|NCT03162328|12558228|FG002|COMPLETED|Study Period||31
11361623|NCT03162328|12558226|FG000|NOT COMPLETED|Study Period||0
11361624|NCT03162328|12558227|FG001|NOT COMPLETED|Study Period||0
11361625|NCT03162328|12558228|FG002|NOT COMPLETED|Study Period||1
11361626|NCT03162354|12558241|FG000|STARTED|Overall Study||183
11361627|NCT03162354|12558242|FG001|STARTED|Overall Study||237
11361628|NCT03162354|12558241|FG000|COMPLETED|Overall Study||183
11361629|NCT03162354|12558242|FG001|COMPLETED|Overall Study||237
11361630|NCT03162354|12558241|FG000|NOT COMPLETED|Overall Study||0
11361631|NCT03162354|12558242|FG001|NOT COMPLETED|Overall Study||0
11361632|NCT03162458|12558255|FG000|STARTED|Overall Study||71
11361633|NCT03162458|12558256|FG001|STARTED|Overall Study||71
11361634|NCT03162458|12558255|FG000|COMPLETED|Overall Study||71
11361635|NCT03162458|12558256|FG001|COMPLETED|Overall Study||71
11361636|NCT03162458|12558255|FG000|NOT COMPLETED|Overall Study||0
11361637|NCT03162458|12558256|FG001|NOT COMPLETED|Overall Study||0
11361638|NCT03162614|12558268|FG000|STARTED|Overall Study||26
11361639|NCT03162614|12558269|FG001|STARTED|Overall Study||26
11361640|NCT03162614|12558270|FG002|STARTED|Overall Study||26
11361641|NCT03162614|12558271|FG003|STARTED|Overall Study||26
11361642|NCT03162614|12558272|FG004|STARTED|Overall Study||26
11361643|NCT03162614|12558273|FG005|STARTED|Overall Study||24
11361644|NCT03162614|12558268|FG000|COMPLETED|Overall Study||20
11361645|NCT03162614|12558269|FG001|COMPLETED|Overall Study||21
11361646|NCT03162614|12558270|FG002|COMPLETED|Overall Study||22
11361647|NCT03162614|12558271|FG003|COMPLETED|Overall Study||19
11361648|NCT03162614|12558272|FG004|COMPLETED|Overall Study||21
11361649|NCT03162614|12558273|FG005|COMPLETED|Overall Study||24
11361650|NCT03162614|12558268|FG000|NOT COMPLETED|Overall Study||6
11361651|NCT03162614|12558269|FG001|NOT COMPLETED|Overall Study||5
11361652|NCT03162614|12558270|FG002|NOT COMPLETED|Overall Study||4
11361653|NCT03162614|12558271|FG003|NOT COMPLETED|Overall Study||7
11361654|NCT03162614|12558272|FG004|NOT COMPLETED|Overall Study||5
11361655|NCT03162614|12558273|FG005|NOT COMPLETED|Overall Study||0
11361656|NCT03162796|12558290|FG000|STARTED|Placebo Controlled Period: Week 0 - 24||126
11361657|NCT03162796|12558291|FG001|STARTED|Placebo Controlled Period: Week 0 - 24||127
11361658|NCT03162796|12558292|FG002|STARTED|Placebo Controlled Period: Week 0 - 24||128
11361659|NCT03162796|12558290|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 24||114
11361660|NCT03162796|12558291|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 24||123
11361661|NCT03162796|12558292|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 24||125
11361662|NCT03162796|12558290|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||12
11361663|NCT03162796|12558291|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||4
11361664|NCT03162796|12558292|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||3
11361665|NCT03162796|12558290|FG000|STARTED|Active Treatment Period: Week 24 - 52||114
11361666|NCT03162796|12558291|FG001|STARTED|Active Treatment Period: Week 24 - 52||123
11361667|NCT03162796|12558292|FG002|STARTED|Active Treatment Period: Week 24 - 52||125
11361668|NCT03162796|12558290|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||107
11361669|NCT03162796|12558291|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||116
11361670|NCT03162796|12558292|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||124
11361671|NCT03162796|12558290|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
11361672|NCT03162796|12558291|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
11361673|NCT03162796|12558292|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||1
11361674|NCT03162796|12558290|FG000|STARTED|Safety Follow-up: Week 52 - 60||107
11361675|NCT03162796|12558291|FG001|STARTED|Safety Follow-up: Week 52 - 60||116
11361676|NCT03162796|12558292|FG002|STARTED|Safety Follow-up: Week 52 - 60||124
11361677|NCT03162796|12558290|FG000|COMPLETED|Safety Follow-up: Week 52 - 60||106
11361678|NCT03162796|12558291|FG001|COMPLETED|Safety Follow-up: Week 52 - 60||114
11361679|NCT03162796|12558292|FG002|COMPLETED|Safety Follow-up: Week 52 - 60||123
11361680|NCT03162796|12558290|FG000|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
11361681|NCT03162796|12558291|FG001|NOT COMPLETED|Safety Follow-up: Week 52 - 60||2
11361682|NCT03162796|12558292|FG002|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
11361683|NCT03163017|12558305|FG000|STARTED|Overall Study||30
11361684|NCT03163017|12558305|FG000|COMPLETED|Overall Study||30
11361685|NCT03163017|12558305|FG000|NOT COMPLETED|Overall Study||0
11361686|NCT03163134|12558311|FG000|STARTED|Overall Study||85
11361687|NCT03163134|12558312|FG001|STARTED|Overall Study||85
11361688|NCT03163134|12558311|FG000|COMPLETED|Overall Study||85
11361689|NCT03163134|12558312|FG001|COMPLETED|Overall Study||85
11361690|NCT03163134|12558311|FG000|NOT COMPLETED|Overall Study||0
11361691|NCT03163134|12558312|FG001|NOT COMPLETED|Overall Study||0
11361692|NCT03163303|12558320|FG000|STARTED|Overall Study||85
11361693|NCT03163303|12558321|FG001|STARTED|Overall Study||94
11361694|NCT03163303|12558320|FG000|COMPLETED|Overall Study||85
11361695|NCT03163303|12558321|FG001|COMPLETED|Overall Study||94
11361696|NCT03163303|12558320|FG000|NOT COMPLETED|Overall Study||0
11361697|NCT03163303|12558321|FG001|NOT COMPLETED|Overall Study||0
11361698|NCT03163342|12558327|FG000|STARTED|Overall Study||20
11361699|NCT03163342|12558327|FG000|COMPLETED|Overall Study||20
11361700|NCT03163342|12558327|FG000|NOT COMPLETED|Overall Study||0
11361701|NCT03163446|12558333|FG000|STARTED|Overall Study||73
11361702|NCT03163446|12558334|FG001|STARTED|Overall Study||48
11361703|NCT03163446|12558333|FG000|COMPLETED|Overall Study||45
11361704|NCT03163446|12558334|FG001|COMPLETED|Overall Study||31
11361705|NCT03163446|12558333|FG000|NOT COMPLETED|Overall Study||28
11361706|NCT03163446|12558334|FG001|NOT COMPLETED|Overall Study||17
11361707|NCT03163472|12558348|FG000|STARTED|Overall Study||15
11361708|NCT03163472|12558349|FG001|STARTED|Overall Study||15
11361709|NCT03163472|12558348|FG000|COMPLETED|Overall Study||15
11361710|NCT03163472|12558349|FG001|COMPLETED|Overall Study||15
11361711|NCT03163472|12558348|FG000|NOT COMPLETED|Overall Study||0
11361712|NCT03163472|12558349|FG001|NOT COMPLETED|Overall Study||0
11361713|NCT03163758|12558359|FG000|STARTED|Overall Study||21
11361714|NCT03163758|12558360|FG001|STARTED|Overall Study||21
11361715|NCT03163758|12558359|FG000|COMPLETED|Overall Study||13
11361716|NCT03163758|12558360|FG001|COMPLETED|Overall Study||14
11361717|NCT03163758|12558359|FG000|NOT COMPLETED|Overall Study||8
11361718|NCT03163758|12558360|FG001|NOT COMPLETED|Overall Study||7
11361719|NCT03164538|12558368|FG000|STARTED|Overall Study||35
11361720|NCT03164538|12558369|FG001|STARTED|Overall Study||35
11361721|NCT03164538|12558368|FG000|COMPLETED|Overall Study||28
11361722|NCT03164538|12558369|FG001|COMPLETED|Overall Study||29
11361723|NCT03164538|12558368|FG000|NOT COMPLETED|Overall Study||7
11361724|NCT03164538|12558369|FG001|NOT COMPLETED|Overall Study||6
11361725|NCT03164551|12558377|FG000|STARTED|Overall Study||200
11361726|NCT03164551|12558378|FG001|STARTED|Overall Study||208
11361727|NCT03164551|12558377|FG000|COMPLETED|Overall Study||171
11361728|NCT03164551|12558378|FG001|COMPLETED|Overall Study||192
11361729|NCT03164551|12558377|FG000|NOT COMPLETED|Overall Study||29
11361730|NCT03164551|12558378|FG001|NOT COMPLETED|Overall Study||16
11361731|NCT03164629|12558386|FG000|STARTED|Overall Study||25
11361732|NCT03164629|12558387|FG001|STARTED|Overall Study||25
11361733|NCT03164629|12558386|FG000|COMPLETED|Overall Study||25
11361734|NCT03164629|12558387|FG001|COMPLETED|Overall Study||25
11361735|NCT03164629|12558386|FG000|NOT COMPLETED|Overall Study||0
11361736|NCT03164629|12558387|FG001|NOT COMPLETED|Overall Study||0
11361737|NCT03165045|12558393|FG000|STARTED|Visit 1||1351
11361738|NCT03165045|12558393|FG000|COMPLETED|Visit 1||1322
11361739|NCT03165045|12558393|FG000|NOT COMPLETED|Visit 1||29
11361740|NCT03165045|12558393|FG000|STARTED|Visit 2||1322
11361741|NCT03165045|12558393|FG000|COMPLETED|Visit 2||1140
11361742|NCT03165045|12558393|FG000|NOT COMPLETED|Visit 2||182
11361743|NCT03165058|12558401|FG000|STARTED|Overall Study||21
11361744|NCT03165058|12558402|FG001|STARTED|Overall Study||11
11361745|NCT03165058|12558401|FG000|COMPLETED|Overall Study||21
11361746|NCT03165058|12558402|FG001|COMPLETED|Overall Study||11
11361747|NCT03165058|12558401|FG000|NOT COMPLETED|Overall Study||0
11361748|NCT03165058|12558402|FG001|NOT COMPLETED|Overall Study||0
11361749|NCT03165110|12558408|FG000|STARTED|Overall Study||47
11361750|NCT03165110|12558408|FG000|COMPLETED|Overall Study||46
11361751|NCT03165110|12558408|FG000|NOT COMPLETED|Overall Study||1
11361752|NCT03165175|12558414|FG000|STARTED|1-month to 3-month||41
11361753|NCT03165175|12558415|FG001|STARTED|1-month to 3-month||39
11361754|NCT03165175|12558414|FG000|COMPLETED|1-month to 3-month||35
11361755|NCT03165175|12558415|FG001|COMPLETED|1-month to 3-month||39
11361756|NCT03165175|12558414|FG000|NOT COMPLETED|1-month to 3-month||6
11361757|NCT03165175|12558415|FG001|NOT COMPLETED|1-month to 3-month||0
11361758|NCT03165175|12558414|FG000|STARTED|Baseline to 3-month||35
11361759|NCT03165175|12558415|FG001|STARTED|Baseline to 3-month||39
11361760|NCT03165175|12558414|FG000|COMPLETED|Baseline to 3-month||31
11361761|NCT03165175|12558415|FG001|COMPLETED|Baseline to 3-month||39
11361762|NCT03165175|12558414|FG000|NOT COMPLETED|Baseline to 3-month||4
11361763|NCT03165175|12558415|FG001|NOT COMPLETED|Baseline to 3-month||0
11361764|NCT03165617|12558423|FG000|STARTED|Overall Study||2258
11361765|NCT03165617|12558424|FG001|STARTED|Overall Study||2256
11361766|NCT03165617|12558423|FG000|COMPLETED|Overall Study||2249
11361767|NCT03165617|12558424|FG001|COMPLETED|Overall Study||2247
11361768|NCT03165617|12558423|FG000|NOT COMPLETED|Overall Study||9
11361769|NCT03165617|12558424|FG001|NOT COMPLETED|Overall Study||9
11361770|NCT03165981|12558450|FG000|STARTED|Overall Study||110
11361771|NCT03165981|12558451|FG001|STARTED|Overall Study||111
11361772|NCT03165981|12558450|FG000|Per Protocol Population|Overall Study||99
11361773|NCT03165981|12558451|FG001|Per Protocol Population|Overall Study||107
11361774|NCT03165981|12558450|FG000|COMPLETED|Overall Study||99
11361775|NCT03165981|12558451|FG001|COMPLETED|Overall Study||107
11361776|NCT03165981|12558450|FG000|NOT COMPLETED|Overall Study||11
11361777|NCT03165981|12558451|FG001|NOT COMPLETED|Overall Study||4
11361778|NCT03166124|12558459|FG000|STARTED|Treatment Period 1||20
11361779|NCT03166124|12558460|FG001|STARTED|Treatment Period 1||20
11361780|NCT03166124|12558461|FG002|STARTED|Treatment Period 1||19
11361781|NCT03166124|12558462|FG003|STARTED|Treatment Period 1||21
11361782|NCT03166124|12558459|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||20
11361783|NCT03166124|12558460|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||20
11361784|NCT03166124|12558461|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||18
11361785|NCT03166124|12558462|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||21
11361786|NCT03166124|12558459|FG000|COMPLETED|Treatment Period 1||20
11361787|NCT03166124|12558460|FG001|COMPLETED|Treatment Period 1||20
11361788|NCT03166124|12558461|FG002|COMPLETED|Treatment Period 1||18
11361789|NCT03166124|12558462|FG003|COMPLETED|Treatment Period 1||21
11361790|NCT03166124|12558459|FG000|NOT COMPLETED|Treatment Period 1||0
11361791|NCT03166124|12558460|FG001|NOT COMPLETED|Treatment Period 1||0
11361792|NCT03166124|12558461|FG002|NOT COMPLETED|Treatment Period 1||1
11361793|NCT03166124|12558462|FG003|NOT COMPLETED|Treatment Period 1||0
11361794|NCT03166124|12558459|FG000|STARTED|Wash-out Period||20
11361795|NCT03166124|12558460|FG001|STARTED|Wash-out Period||20
11361796|NCT03166124|12558461|FG002|STARTED|Wash-out Period||18
11361797|NCT03166124|12558462|FG003|STARTED|Wash-out Period||21
11361798|NCT03166124|12558459|FG000|COMPLETED|Wash-out Period||20
11361799|NCT03166124|12558460|FG001|COMPLETED|Wash-out Period||18
11361800|NCT03166124|12558461|FG002|COMPLETED|Wash-out Period||17
11361801|NCT03166124|12558462|FG003|COMPLETED|Wash-out Period||20
11361802|NCT03166124|12558459|FG000|NOT COMPLETED|Wash-out Period||0
11361803|NCT03166124|12558460|FG001|NOT COMPLETED|Wash-out Period||2
11361804|NCT03166124|12558461|FG002|NOT COMPLETED|Wash-out Period||1
11361805|NCT03166124|12558462|FG003|NOT COMPLETED|Wash-out Period||1
11361806|NCT03166124|12558459|FG000|STARTED|Treatment Period 2||20
11361807|NCT03166124|12558460|FG001|STARTED|Treatment Period 2||18
11361808|NCT03166124|12558461|FG002|STARTED|Treatment Period 2||17
11361809|NCT03166124|12558462|FG003|STARTED|Treatment Period 2||20
11361810|NCT03166124|12558459|FG000|COMPLETED|Treatment Period 2||20
11361811|NCT03166124|12558460|FG001|COMPLETED|Treatment Period 2||18
11361812|NCT03166124|12558461|FG002|COMPLETED|Treatment Period 2||17
11361813|NCT03166124|12558462|FG003|COMPLETED|Treatment Period 2||20
11361814|NCT03166124|12558459|FG000|NOT COMPLETED|Treatment Period 2||0
11361815|NCT03166124|12558460|FG001|NOT COMPLETED|Treatment Period 2||0
11361816|NCT03166124|12558461|FG002|NOT COMPLETED|Treatment Period 2||0
11361817|NCT03166124|12558462|FG003|NOT COMPLETED|Treatment Period 2||0
11361818|NCT03166215|12558475|FG000|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4
11361819|NCT03166215|12558476|FG001|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14
11361820|NCT03166215|12558477|FG002|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0
11361821|NCT03166215|12558475|FG000|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4
11361822|NCT03166215|12558476|FG001|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12
11361823|NCT03166215|12558477|FG002|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
11361824|NCT03166215|12558475|FG000|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
11361825|NCT03166215|12558476|FG001|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2
11361826|NCT03166215|12558477|FG002|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
11361827|NCT03166215|12558475|FG000|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
11361828|NCT03166215|12558476|FG001|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
11361829|NCT03166215|12558477|FG002|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16
11361830|NCT03166215|12558475|FG000|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
11361831|NCT03166215|12558476|FG001|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
11361832|NCT03166215|12558477|FG002|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14
11361833|NCT03166215|12558475|FG000|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
11361834|NCT03166215|12558476|FG001|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
11361835|NCT03166215|12558477|FG002|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2
11361836|NCT03166735|12558493|FG000|STARTED|Overall Study||33
11361837|NCT03166735|12558494|FG001|STARTED|Overall Study||16
11361838|NCT03166735|12558495|FG002|STARTED|Overall Study||16
11361839|NCT03166735|12558496|FG003|STARTED|Overall Study||17
11361840|NCT03166735|12558497|FG004|STARTED|Overall Study||32
11361841|NCT03166735|12558493|FG000|Treated|Overall Study||32
11361842|NCT03166735|12558494|FG001|Treated|Overall Study||16
11361843|NCT03166735|12558495|FG002|Treated|Overall Study||16
11361844|NCT03166735|12558496|FG003|Treated|Overall Study||17
11361845|NCT03166735|12558497|FG004|Treated|Overall Study||32
11361846|NCT03166735|12558493|FG000|COMPLETED|Overall Study||32
11361847|NCT03166735|12558494|FG001|COMPLETED|Overall Study||13
11361848|NCT03166735|12558495|FG002|COMPLETED|Overall Study||13
11361849|NCT03166735|12558496|FG003|COMPLETED|Overall Study||16
11361850|NCT03166735|12558497|FG004|COMPLETED|Overall Study||28
11361851|NCT03166735|12558493|FG000|NOT COMPLETED|Overall Study||1
11361852|NCT03166735|12558494|FG001|NOT COMPLETED|Overall Study||3
11361853|NCT03166735|12558495|FG002|NOT COMPLETED|Overall Study||3
11361854|NCT03166735|12558496|FG003|NOT COMPLETED|Overall Study||1
11361855|NCT03166735|12558497|FG004|NOT COMPLETED|Overall Study||4
11361856|NCT03167073|12558512|FG000|STARTED|Overall Study||85
11361857|NCT03167073|12558513|FG001|STARTED|Overall Study||85
11361858|NCT03167073|12558512|FG000|COMPLETED|Overall Study||84
11361859|NCT03167073|12558513|FG001|COMPLETED|Overall Study||85
11361860|NCT03167073|12558512|FG000|NOT COMPLETED|Overall Study||1
11361861|NCT03167073|12558513|FG001|NOT COMPLETED|Overall Study||0
11361862|NCT03167151|12558522|FG000|STARTED|Overall Study||3
11361863|NCT03167151|12558523|FG001|STARTED|Overall Study||3
11361864|NCT03167151|12558524|FG002|STARTED|Overall Study||3
11361865|NCT03167151|12558522|FG000|COMPLETED|Overall Study||2
11361866|NCT03167151|12558523|FG001|COMPLETED|Overall Study||2
11361867|NCT03167151|12558524|FG002|COMPLETED|Overall Study||2
11361868|NCT03167151|12558522|FG000|NOT COMPLETED|Overall Study||1
11361869|NCT03167151|12558523|FG001|NOT COMPLETED|Overall Study||1
11361870|NCT03167151|12558524|FG002|NOT COMPLETED|Overall Study||1
11361871|NCT03167359|12558532|FG000|STARTED|Overall Study||74
11361872|NCT03167359|12558532|FG000|COMPLETED|Overall Study||72
11361873|NCT03167359|12558532|FG000|NOT COMPLETED|Overall Study||2
11361874|NCT03167411|12558538|FG000|STARTED|Overall Study||10
11361875|NCT03167411|12558539|FG001|STARTED|Overall Study||10
11361876|NCT03167411|12558538|FG000|COMPLETED|Overall Study||10
11361877|NCT03167411|12558539|FG001|COMPLETED|Overall Study||9
11361878|NCT03167411|12558538|FG000|NOT COMPLETED|Overall Study||0
11361879|NCT03167411|12558539|FG001|NOT COMPLETED|Overall Study||1
11361880|NCT03167541|12558545|FG000|STARTED|First Intervention||9
11361881|NCT03167541|12558546|FG001|STARTED|First Intervention||9
11361882|NCT03167541|12558545|FG000|COMPLETED|First Intervention||9
11361883|NCT03167541|12558546|FG001|COMPLETED|First Intervention||9
11361884|NCT03167541|12558545|FG000|NOT COMPLETED|First Intervention||0
11361885|NCT03167541|12558546|FG001|NOT COMPLETED|First Intervention||0
11361886|NCT03167541|12558545|FG000|STARTED|Washout: 5-8 Days||9
11361887|NCT03167541|12558546|FG001|STARTED|Washout: 5-8 Days||9
11361888|NCT03167541|12558545|FG000|COMPLETED|Washout: 5-8 Days||9
11361889|NCT03167541|12558546|FG001|COMPLETED|Washout: 5-8 Days||9
11361890|NCT03167541|12558545|FG000|NOT COMPLETED|Washout: 5-8 Days||0
11361891|NCT03167541|12558546|FG001|NOT COMPLETED|Washout: 5-8 Days||0
11361892|NCT03167541|12558545|FG000|STARTED|Second Intervention||9
11361893|NCT03167541|12558546|FG001|STARTED|Second Intervention||9
11361894|NCT03167541|12558545|FG000|COMPLETED|Second Intervention||9
11361895|NCT03167541|12558546|FG001|COMPLETED|Second Intervention||9
11361896|NCT03167541|12558545|FG000|NOT COMPLETED|Second Intervention||0
11361897|NCT03167541|12558546|FG001|NOT COMPLETED|Second Intervention||0
11361898|NCT03168022|12558553|FG000|STARTED|Overall Study||21
11361899|NCT03168022|12558554|FG001|STARTED|Overall Study||22
11361900|NCT03168022|12558553|FG000|COMPLETED|Overall Study||21
11361901|NCT03168022|12558554|FG001|COMPLETED|Overall Study||21
11361902|NCT03168022|12558553|FG000|NOT COMPLETED|Overall Study||0
11361903|NCT03168022|12558554|FG001|NOT COMPLETED|Overall Study||1
11361904|NCT03168295|12558565|FG000|STARTED|Overall Study||3
11361905|NCT03168295|12558566|FG001|STARTED|Overall Study||3
11361906|NCT03168295|12558567|FG002|STARTED|Overall Study||4
11361907|NCT03168295|12558568|FG003|STARTED|Overall Study||4
11361908|NCT03168295|12558569|FG004|STARTED|Overall Study||20
11361909|NCT03168295|12558565|FG000|COMPLETED|Overall Study||3
11361910|NCT03168295|12558566|FG001|COMPLETED|Overall Study||3
11361911|NCT03168295|12558567|FG002|COMPLETED|Overall Study||4
11361912|NCT03168295|12558568|FG003|COMPLETED|Overall Study||4
11361913|NCT03168295|12558569|FG004|COMPLETED|Overall Study||20
11361914|NCT03168295|12558565|FG000|NOT COMPLETED|Overall Study||0
11361915|NCT03168295|12558566|FG001|NOT COMPLETED|Overall Study||0
11361916|NCT03168295|12558567|FG002|NOT COMPLETED|Overall Study||0
11361917|NCT03168295|12558568|FG003|NOT COMPLETED|Overall Study||0
11361918|NCT03168295|12558569|FG004|NOT COMPLETED|Overall Study||0
11361919|NCT03168308|12558582|FG000|STARTED|Overall Study||48
11361920|NCT03168308|12558583|FG001|STARTED|Overall Study||44
11361921|NCT03168308|12558582|FG000|COMPLETED|Overall Study||48
11361922|NCT03168308|12558583|FG001|COMPLETED|Overall Study||44
11361923|NCT03168308|12558582|FG000|NOT COMPLETED|Overall Study||0
11361924|NCT03168308|12558583|FG001|NOT COMPLETED|Overall Study||0
11361925|NCT03168321|12558591|FG000|STARTED|Overall Study||402
11361926|NCT03168321|12558592|FG001|STARTED|Overall Study||411
11361927|NCT03168321|12558591|FG000|COMPLETED|Overall Study||347
11361928|NCT03168321|12558592|FG001|COMPLETED|Overall Study||356
11361929|NCT03168321|12558591|FG000|NOT COMPLETED|Overall Study||55
11361930|NCT03168321|12558592|FG001|NOT COMPLETED|Overall Study||55
11361931|NCT03168334|12558600|FG000|STARTED|Overall Study||397
11361932|NCT03168334|12558601|FG001|STARTED|Overall Study||404
11361933|NCT03168334|12558600|FG000|COMPLETED|Overall Study||345
11361934|NCT03168334|12558601|FG001|COMPLETED|Overall Study||366
11361935|NCT03168334|12558600|FG000|NOT COMPLETED|Overall Study||52
11361936|NCT03168334|12558601|FG001|NOT COMPLETED|Overall Study||38
11361937|NCT03168425|12558609|FG000|STARTED|Overall Study||94
11361938|NCT03168425|12558610|FG001|STARTED|Overall Study||96
11361939|NCT03168425|12558609|FG000|COMPLETED|Overall Study||87
11361940|NCT03168425|12558610|FG001|COMPLETED|Overall Study||85
11361941|NCT03168425|12558609|FG000|NOT COMPLETED|Overall Study||7
11361942|NCT03168425|12558610|FG001|NOT COMPLETED|Overall Study||11
11361943|NCT03168542|12558617|FG000|STARTED|Overall Study||7
11361944|NCT03168542|12558618|FG001|STARTED|Overall Study||5
11361945|NCT03168542|12558619|FG002|STARTED|Overall Study||9
11361946|NCT03168542|12558617|FG000|COMPLETED|Overall Study||7
11361947|NCT03168542|12558618|FG001|COMPLETED|Overall Study||5
11361948|NCT03168542|12558619|FG002|COMPLETED|Overall Study||9
11361949|NCT03168542|12558617|FG000|NOT COMPLETED|Overall Study||0
11361950|NCT03168542|12558618|FG001|NOT COMPLETED|Overall Study||0
11361951|NCT03168542|12558619|FG002|NOT COMPLETED|Overall Study||0
11361952|NCT03168711|12558626|FG000|STARTED|Overall Study||14
11361953|NCT03168711|12558627|FG001|STARTED|Overall Study||9
11361954|NCT03168711|12558626|FG000|COMPLETED|Overall Study||12
11361955|NCT03168711|12558627|FG001|COMPLETED|Overall Study||7
11361956|NCT03168711|12558626|FG000|NOT COMPLETED|Overall Study||2
11361957|NCT03168711|12558627|FG001|NOT COMPLETED|Overall Study||2
11361958|NCT03168841|12558633|FG000|STARTED|Overall Study||40
11361959|NCT03168841|12558633|FG000|COMPLETED|Overall Study||36
11361960|NCT03168841|12558633|FG000|NOT COMPLETED|Overall Study||4
11361961|NCT03168919|12558637|FG000|STARTED|Overall Study||5
11361962|NCT03168919|12558637|FG000|COMPLETED|Overall Study||3
11361963|NCT03168919|12558637|FG000|NOT COMPLETED|Overall Study||2
11361964|NCT03169062|12558645|FG000|STARTED|Overall Study||10
11361965|NCT03169062|12558645|FG000|COMPLETED|Overall Study||10
11361966|NCT03169062|12558645|FG000|NOT COMPLETED|Overall Study||0
11361967|NCT03169153|12558649|FG000|STARTED|Period 1, First 30 Days of Wear||42
11361968|NCT03169153|12558650|FG001|STARTED|Period 1, First 30 Days of Wear||39
11361969|NCT03169153|12558649|FG000|COMPLETED|Period 1, First 30 Days of Wear||39
11361970|NCT03169153|12558650|FG001|COMPLETED|Period 1, First 30 Days of Wear||35
11361971|NCT03169153|12558649|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3
11361972|NCT03169153|12558650|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||4
11361973|NCT03169153|12558649|FG000|STARTED|Period 2, Second 30 Days of Wear||39
11361974|NCT03169153|12558650|FG001|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34
11361975|NCT03169153|12558649|FG000|COMPLETED|Period 2, Second 30 Days of Wear||37
11361976|NCT03169153|12558650|FG001|COMPLETED|Period 2, Second 30 Days of Wear||32
11361977|NCT03169153|12558649|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
11361978|NCT03169153|12558650|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
11361979|NCT03169244|12558658|FG000|STARTED|Overall Study||22
11361980|NCT03169244|12558659|FG001|STARTED|Overall Study||20
11361981|NCT03169244|12558658|FG000|Randomly Assigned|Overall Study||22
11361982|NCT03169244|12558659|FG001|Randomly Assigned|Overall Study||20
11361983|NCT03169244|12558658|FG000|Received Intervention|Overall Study||22
11361984|NCT03169244|12558659|FG001|Received Intervention|Overall Study||18
11361985|NCT03169244|12558658|FG000|COMPLETED|Overall Study||17
11361986|NCT03169244|12558659|FG001|COMPLETED|Overall Study||16
11361987|NCT03169244|12558658|FG000|NOT COMPLETED|Overall Study||5
11361988|NCT03169244|12558659|FG001|NOT COMPLETED|Overall Study||4
11361989|NCT03169816|12558667|FG000|STARTED|Overall Study||33
11361990|NCT03169816|12558668|FG001|STARTED|Overall Study||16
11361991|NCT03169816|12558667|FG000|COMPLETED|Overall Study||6
11361992|NCT03169816|12558668|FG001|COMPLETED|Overall Study||3
11361993|NCT03169816|12558667|FG000|NOT COMPLETED|Overall Study||27
11361994|NCT03169816|12558668|FG001|NOT COMPLETED|Overall Study||13
11361995|NCT03170154|12558674|FG000|STARTED|Overall Study||350
11361996|NCT03170154|12558674|FG000|Rotational Stability Sub-study|Overall Study||141
11361997|NCT03170154|12558674|FG000|COMPLETED|Overall Study||342
11361998|NCT03170154|12558674|FG000|NOT COMPLETED|Overall Study||8
11361999|NCT03170193|12558690|FG000|STARTED|Overall Study||12
11362000|NCT03170193|12558691|FG001|STARTED|Overall Study||6
11362001|NCT03170193|12558692|FG002|STARTED|Overall Study||6
11362002|NCT03170193|12558693|FG003|STARTED|Overall Study||6
11362003|NCT03170193|12558694|FG004|STARTED|Overall Study||6
11362004|NCT03170193|12558695|FG005|STARTED|Overall Study||6
11362005|NCT03170193|12558696|FG006|STARTED|Overall Study||6
11362006|NCT03170193|12558690|FG000|COMPLETED|Overall Study||11
11362007|NCT03170193|12558691|FG001|COMPLETED|Overall Study||5
11362008|NCT03170193|12558692|FG002|COMPLETED|Overall Study||6
11362009|NCT03170193|12558693|FG003|COMPLETED|Overall Study||5
11362010|NCT03170193|12558694|FG004|COMPLETED|Overall Study||6
11362011|NCT03170193|12558695|FG005|COMPLETED|Overall Study||6
11362012|NCT03170193|12558696|FG006|COMPLETED|Overall Study||6
11362013|NCT03170193|12558690|FG000|NOT COMPLETED|Overall Study||1
11362014|NCT03170193|12558691|FG001|NOT COMPLETED|Overall Study||1
11362015|NCT03170193|12558692|FG002|NOT COMPLETED|Overall Study||0
11362016|NCT03170193|12558693|FG003|NOT COMPLETED|Overall Study||1
11362017|NCT03170193|12558694|FG004|NOT COMPLETED|Overall Study||0
11362018|NCT03170193|12558695|FG005|NOT COMPLETED|Overall Study||0
11362019|NCT03170193|12558696|FG006|NOT COMPLETED|Overall Study||0
11362020|NCT03170219|12558720|FG000|STARTED|Overall Study||7
11362021|NCT03170219|12558721|FG001|STARTED|Overall Study||4
11362022|NCT03170219|12558720|FG000|COMPLETED|Overall Study||7
11362023|NCT03170219|12558721|FG001|COMPLETED|Overall Study||4
11362024|NCT03170219|12558720|FG000|NOT COMPLETED|Overall Study||0
11362025|NCT03170219|12558721|FG001|NOT COMPLETED|Overall Study||0
11362026|NCT03170232|12558729|FG000|STARTED|Overall Study||27
11362027|NCT03170232|12558730|FG001|STARTED|Overall Study||27
11362028|NCT03170232|12558729|FG000|COMPLETED|Overall Study||0
11362029|NCT03170232|12558730|FG001|COMPLETED|Overall Study||0
11362030|NCT03170232|12558729|FG000|NOT COMPLETED|Overall Study||27
11362031|NCT03170232|12558730|FG001|NOT COMPLETED|Overall Study||27
11362032|NCT03170271|12558738|FG000|STARTED|Overall Study||431
11362033|NCT03170271|12558739|FG001|STARTED|Overall Study||229
11362034|NCT03170271|12558738|FG000|Received Treatment|Overall Study||427
11362035|NCT03170271|12558739|FG001|Received Treatment|Overall Study||229
11362036|NCT03170271|12558738|FG000|COMPLETED|Overall Study||398
11362037|NCT03170271|12558739|FG001|COMPLETED|Overall Study||218
11362038|NCT03170271|12558738|FG000|NOT COMPLETED|Overall Study||33
11362039|NCT03170271|12558739|FG001|NOT COMPLETED|Overall Study||11
11362040|NCT03170388|12558750|FG000|STARTED|Overall Study||147
11362041|NCT03170388|12558751|FG001|STARTED|Overall Study||150
11362042|NCT03170388|12558752|FG002|STARTED|Overall Study||146
11362043|NCT03170388|12558753|FG003|STARTED|Overall Study||150
11362044|NCT03170388|12558754|FG004|STARTED|Overall Study||148
11362045|NCT03170388|12558750|FG000|COMPLETED|Overall Study||125
11362046|NCT03170388|12558751|FG001|COMPLETED|Overall Study||132
11362047|NCT03170388|12558752|FG002|COMPLETED|Overall Study||133
11362048|NCT03170388|12558753|FG003|COMPLETED|Overall Study||132
11362049|NCT03170388|12558754|FG004|COMPLETED|Overall Study||127
11362050|NCT03170388|12558750|FG000|NOT COMPLETED|Overall Study||22
11362051|NCT03170388|12558751|FG001|NOT COMPLETED|Overall Study||18
11362052|NCT03170388|12558752|FG002|NOT COMPLETED|Overall Study||13
11362053|NCT03170388|12558753|FG003|NOT COMPLETED|Overall Study||18
11362054|NCT03170388|12558754|FG004|NOT COMPLETED|Overall Study||21
11362055|NCT03170544|12558778|FG000|STARTED|Part 1||10
11362056|NCT03170544|12558779|FG001|STARTED|Part 1||6
11362057|NCT03170544|12558780|FG002|STARTED|Part 1||6
11362058|NCT03170544|12558781|FG003|STARTED|Part 1||7
11362059|NCT03170544|12558782|FG004|STARTED|Part 1||6
11362060|NCT03170544|12558783|FG005|STARTED|Part 1||6
11362061|NCT03170544|12558784|FG006|STARTED|Part 1||0
11362062|NCT03170544|12558785|FG007|STARTED|Part 1||0
11362063|NCT03170544|12558786|FG008|STARTED|Part 1||0
11362064|NCT03170544|12558787|FG009|STARTED|Part 1||0
11362065|NCT03170544|12558788|FG010|STARTED|Part 1||0
11362066|NCT03170544|12558789|FG011|STARTED|Part 1||0
11362067|NCT03170544|12558778|FG000|COMPLETED|Part 1||9
11362068|NCT03170544|12558779|FG001|COMPLETED|Part 1||6
11362069|NCT03170544|12558780|FG002|COMPLETED|Part 1||6
11362070|NCT03170544|12558781|FG003|COMPLETED|Part 1||6
11362071|NCT03170544|12558782|FG004|COMPLETED|Part 1||6
11362072|NCT03170544|12558783|FG005|COMPLETED|Part 1||6
11362073|NCT03170544|12558784|FG006|COMPLETED|Part 1||0
11362074|NCT03170544|12558785|FG007|COMPLETED|Part 1||0
11362075|NCT03170544|12558786|FG008|COMPLETED|Part 1||0
11362076|NCT03170544|12558787|FG009|COMPLETED|Part 1||0
11362077|NCT03170544|12558788|FG010|COMPLETED|Part 1||0
11362078|NCT03170544|12558789|FG011|COMPLETED|Part 1||0
11362079|NCT03170544|12558778|FG000|NOT COMPLETED|Part 1||1
11362080|NCT03170544|12558779|FG001|NOT COMPLETED|Part 1||0
11362081|NCT03170544|12558780|FG002|NOT COMPLETED|Part 1||0
11362082|NCT03170544|12558781|FG003|NOT COMPLETED|Part 1||1
11362083|NCT03170544|12558782|FG004|NOT COMPLETED|Part 1||0
11362084|NCT03170544|12558783|FG005|NOT COMPLETED|Part 1||0
11362085|NCT03170544|12558784|FG006|NOT COMPLETED|Part 1||0
11362086|NCT03170544|12558785|FG007|NOT COMPLETED|Part 1||0
11362087|NCT03170544|12558786|FG008|NOT COMPLETED|Part 1||0
11362088|NCT03170544|12558787|FG009|NOT COMPLETED|Part 1||0
11362089|NCT03170544|12558788|FG010|NOT COMPLETED|Part 1||0
11362090|NCT03170544|12558789|FG011|NOT COMPLETED|Part 1||0
11362091|NCT03170544|12558778|FG000|STARTED|Part 2||0
11362092|NCT03170544|12558779|FG001|STARTED|Part 2||0
11362093|NCT03170544|12558780|FG002|STARTED|Part 2||0
11362094|NCT03170544|12558781|FG003|STARTED|Part 2||0
11362095|NCT03170544|12558782|FG004|STARTED|Part 2||0
11362096|NCT03170544|12558783|FG005|STARTED|Part 2||0
11362097|NCT03170544|12558784|FG006|STARTED|Part 2||4
11362098|NCT03170544|12558785|FG007|STARTED|Part 2||0
11362099|NCT03170544|12558786|FG008|STARTED|Part 2||0
11362100|NCT03170544|12558787|FG009|STARTED|Part 2||0
11362101|NCT03170544|12558788|FG010|STARTED|Part 2||0
11362102|NCT03170544|12558789|FG011|STARTED|Part 2||0
11362103|NCT03170544|12558778|FG000|COMPLETED|Part 2||0
11362104|NCT03170544|12558779|FG001|COMPLETED|Part 2||0
11362105|NCT03170544|12558780|FG002|COMPLETED|Part 2||0
11362106|NCT03170544|12558781|FG003|COMPLETED|Part 2||0
11362107|NCT03170544|12558782|FG004|COMPLETED|Part 2||0
11362108|NCT03170544|12558783|FG005|COMPLETED|Part 2||0
11362109|NCT03170544|12558784|FG006|COMPLETED|Part 2||4
11362110|NCT03170544|12558785|FG007|COMPLETED|Part 2||0
11362111|NCT03170544|12558786|FG008|COMPLETED|Part 2||0
11362112|NCT03170544|12558787|FG009|COMPLETED|Part 2||0
11362113|NCT03170544|12558788|FG010|COMPLETED|Part 2||0
11362114|NCT03170544|12558789|FG011|COMPLETED|Part 2||0
11362115|NCT03170544|12558778|FG000|NOT COMPLETED|Part 2||0
11362116|NCT03170544|12558779|FG001|NOT COMPLETED|Part 2||0
11362117|NCT03170544|12558780|FG002|NOT COMPLETED|Part 2||0
11362118|NCT03170544|12558781|FG003|NOT COMPLETED|Part 2||0
11362119|NCT03170544|12558782|FG004|NOT COMPLETED|Part 2||0
11362120|NCT03170544|12558783|FG005|NOT COMPLETED|Part 2||0
11362121|NCT03170544|12558784|FG006|NOT COMPLETED|Part 2||0
11362122|NCT03170544|12558785|FG007|NOT COMPLETED|Part 2||0
11362123|NCT03170544|12558786|FG008|NOT COMPLETED|Part 2||0
11362124|NCT03170544|12558787|FG009|NOT COMPLETED|Part 2||0
11362125|NCT03170544|12558788|FG010|NOT COMPLETED|Part 2||0
11362126|NCT03170544|12558789|FG011|NOT COMPLETED|Part 2||0
11362127|NCT03170544|12558778|FG000|STARTED|Part 3||0
11362128|NCT03170544|12558779|FG001|STARTED|Part 3||0
11362129|NCT03170544|12558780|FG002|STARTED|Part 3||0
11362130|NCT03170544|12558781|FG003|STARTED|Part 3||0
11362131|NCT03170544|12558782|FG004|STARTED|Part 3||0
11362132|NCT03170544|12558783|FG005|STARTED|Part 3||0
11362133|NCT03170544|12558784|FG006|STARTED|Part 3||0
11362134|NCT03170544|12558785|FG007|STARTED|Part 3||4
11362135|NCT03170544|12558786|FG008|STARTED|Part 3||6
11362136|NCT03170544|12558787|FG009|STARTED|Part 3||6
11362137|NCT03170544|12558788|FG010|STARTED|Part 3||0
11362138|NCT03170544|12558789|FG011|STARTED|Part 3||0
11362139|NCT03170544|12558778|FG000|COMPLETED|Part 3||0
11362140|NCT03170544|12558779|FG001|COMPLETED|Part 3||0
11362141|NCT03170544|12558780|FG002|COMPLETED|Part 3||0
11362142|NCT03170544|12558781|FG003|COMPLETED|Part 3||0
11362143|NCT03170544|12558782|FG004|COMPLETED|Part 3||0
11362144|NCT03170544|12558783|FG005|COMPLETED|Part 3||0
11362145|NCT03170544|12558784|FG006|COMPLETED|Part 3||0
11362146|NCT03170544|12558785|FG007|COMPLETED|Part 3||4
11362147|NCT03170544|12558786|FG008|COMPLETED|Part 3||6
11362148|NCT03170544|12558787|FG009|COMPLETED|Part 3||6
11362149|NCT03170544|12558788|FG010|COMPLETED|Part 3||0
11362150|NCT03170544|12558789|FG011|COMPLETED|Part 3||0
11362151|NCT03170544|12558778|FG000|NOT COMPLETED|Part 3||0
11362152|NCT03170544|12558779|FG001|NOT COMPLETED|Part 3||0
11362153|NCT03170544|12558780|FG002|NOT COMPLETED|Part 3||0
11362154|NCT03170544|12558781|FG003|NOT COMPLETED|Part 3||0
11362155|NCT03170544|12558782|FG004|NOT COMPLETED|Part 3||0
11362156|NCT03170544|12558783|FG005|NOT COMPLETED|Part 3||0
11362157|NCT03170544|12558784|FG006|NOT COMPLETED|Part 3||0
11362158|NCT03170544|12558785|FG007|NOT COMPLETED|Part 3||0
11362159|NCT03170544|12558786|FG008|NOT COMPLETED|Part 3||0
11362160|NCT03170544|12558787|FG009|NOT COMPLETED|Part 3||0
11362161|NCT03170544|12558788|FG010|NOT COMPLETED|Part 3||0
11362162|NCT03170544|12558789|FG011|NOT COMPLETED|Part 3||0
11362163|NCT03170544|12558778|FG000|STARTED|Part 4||0
11362164|NCT03170544|12558779|FG001|STARTED|Part 4||0
11362165|NCT03170544|12558780|FG002|STARTED|Part 4||0
11362166|NCT03170544|12558781|FG003|STARTED|Part 4||0
11362167|NCT03170544|12558782|FG004|STARTED|Part 4||0
11362168|NCT03170544|12558783|FG005|STARTED|Part 4||0
11362169|NCT03170544|12558784|FG006|STARTED|Part 4||0
11362170|NCT03170544|12558785|FG007|STARTED|Part 4||0
11362171|NCT03170544|12558786|FG008|STARTED|Part 4||0
11362172|NCT03170544|12558787|FG009|STARTED|Part 4||0
11362173|NCT03170544|12558788|FG010|STARTED|Part 4||3
11362174|NCT03170544|12558789|FG011|STARTED|Part 4||6
11362175|NCT03170544|12558778|FG000|COMPLETED|Part 4||0
11362176|NCT03170544|12558779|FG001|COMPLETED|Part 4||0
11362177|NCT03170544|12558780|FG002|COMPLETED|Part 4||0
11362178|NCT03170544|12558781|FG003|COMPLETED|Part 4||0
11362179|NCT03170544|12558782|FG004|COMPLETED|Part 4||0
11362180|NCT03170544|12558783|FG005|COMPLETED|Part 4||0
11362181|NCT03170544|12558784|FG006|COMPLETED|Part 4||0
11362182|NCT03170544|12558785|FG007|COMPLETED|Part 4||0
11362183|NCT03170544|12558786|FG008|COMPLETED|Part 4||0
11362184|NCT03170544|12558787|FG009|COMPLETED|Part 4||0
11362185|NCT03170544|12558788|FG010|COMPLETED|Part 4||3
11362186|NCT03170544|12558789|FG011|COMPLETED|Part 4||6
11362187|NCT03170544|12558778|FG000|NOT COMPLETED|Part 4||0
11362188|NCT03170544|12558779|FG001|NOT COMPLETED|Part 4||0
11362189|NCT03170544|12558780|FG002|NOT COMPLETED|Part 4||0
11362190|NCT03170544|12558781|FG003|NOT COMPLETED|Part 4||0
11362191|NCT03170544|12558782|FG004|NOT COMPLETED|Part 4||0
11362192|NCT03170544|12558783|FG005|NOT COMPLETED|Part 4||0
11362193|NCT03170544|12558784|FG006|NOT COMPLETED|Part 4||0
11362194|NCT03170544|12558785|FG007|NOT COMPLETED|Part 4||0
11362195|NCT03170544|12558786|FG008|NOT COMPLETED|Part 4||0
11362196|NCT03170544|12558787|FG009|NOT COMPLETED|Part 4||0
11362197|NCT03170544|12558788|FG010|NOT COMPLETED|Part 4||0
11362198|NCT03170544|12558789|FG011|NOT COMPLETED|Part 4||0
11362199|NCT03170609|12558879|FG000|STARTED|Overall Study||53
11362200|NCT03170609|12558880|FG001|STARTED|Overall Study||52
11362201|NCT03170609|12558881|FG002|STARTED|Overall Study||52
11362202|NCT03170609|12558882|FG003|STARTED|Overall Study||52
11362203|NCT03170609|12558883|FG004|STARTED|Overall Study||52
11362204|NCT03170609|12558884|FG005|STARTED|Overall Study||52
11362205|NCT03170609|12558885|FG006|STARTED|Overall Study||52
11362206|NCT03170609|12558879|FG000|Vaccinated|Overall Study||52
11362207|NCT03170609|12558880|FG001|Vaccinated|Overall Study||52
11362208|NCT03170609|12558881|FG002|Vaccinated|Overall Study||52
11362209|NCT03170609|12558882|FG003|Vaccinated|Overall Study||52
11362210|NCT03170609|12558883|FG004|Vaccinated|Overall Study||52
11362211|NCT03170609|12558884|FG005|Vaccinated|Overall Study||52
11362212|NCT03170609|12558885|FG006|Vaccinated|Overall Study||52
11362213|NCT03170609|12558879|FG000|COMPLETED|Overall Study||50
11362214|NCT03170609|12558880|FG001|COMPLETED|Overall Study||50
11362215|NCT03170609|12558881|FG002|COMPLETED|Overall Study||46
11362216|NCT03170609|12558882|FG003|COMPLETED|Overall Study||50
11362217|NCT03170609|12558883|FG004|COMPLETED|Overall Study||51
11362218|NCT03170609|12558884|FG005|COMPLETED|Overall Study||50
11362219|NCT03170609|12558885|FG006|COMPLETED|Overall Study||51
11362220|NCT03170609|12558879|FG000|NOT COMPLETED|Overall Study||3
11362221|NCT03170609|12558880|FG001|NOT COMPLETED|Overall Study||2
11362222|NCT03170609|12558881|FG002|NOT COMPLETED|Overall Study||6
11362223|NCT03170609|12558882|FG003|NOT COMPLETED|Overall Study||2
11362224|NCT03170609|12558883|FG004|NOT COMPLETED|Overall Study||1
11362225|NCT03170609|12558884|FG005|NOT COMPLETED|Overall Study||2
11362226|NCT03170609|12558885|FG006|NOT COMPLETED|Overall Study||1
11362227|NCT03170661|12558903|FG000|STARTED|Overall Study||49
11362228|NCT03170661|12558904|FG001|STARTED|Overall Study||49
11362229|NCT03170661|12558903|FG000|COMPLETED|Overall Study||49
11362230|NCT03170661|12558904|FG001|COMPLETED|Overall Study||49
11362231|NCT03170661|12558903|FG000|NOT COMPLETED|Overall Study||0
11362232|NCT03170661|12558904|FG001|NOT COMPLETED|Overall Study||0
11362233|NCT03171051|12558912|FG000|STARTED|Overall Study||10
11362234|NCT03171051|12558912|FG000|COMPLETED|Overall Study||10
11362235|NCT03171051|12558912|FG000|NOT COMPLETED|Overall Study||0
11362236|NCT03171415|12558922|FG000|STARTED|Overall Study||6
11362237|NCT03171415|12558923|FG001|STARTED|Overall Study||6
11362238|NCT03171415|12558924|FG002|STARTED|Overall Study||6
11362239|NCT03171415|12558925|FG003|STARTED|Overall Study||6
11362240|NCT03171415|12558926|FG004|STARTED|Overall Study||9
11362241|NCT03171415|12558922|FG000|COMPLETED|Overall Study||6
11362242|NCT03171415|12558923|FG001|COMPLETED|Overall Study||6
11362243|NCT03171415|12558924|FG002|COMPLETED|Overall Study||6
11362244|NCT03171415|12558925|FG003|COMPLETED|Overall Study||6
11362245|NCT03171415|12558926|FG004|COMPLETED|Overall Study||7
11362246|NCT03171415|12558922|FG000|NOT COMPLETED|Overall Study||0
11362247|NCT03171415|12558923|FG001|NOT COMPLETED|Overall Study||0
11362248|NCT03171415|12558924|FG002|NOT COMPLETED|Overall Study||0
11362249|NCT03171415|12558925|FG003|NOT COMPLETED|Overall Study||0
11362250|NCT03171415|12558926|FG004|NOT COMPLETED|Overall Study||2
11362251|NCT03172130|12558951|FG000|STARTED|Overall Study||12
11362252|NCT03172130|12558952|FG001|STARTED|Overall Study||10
11362253|NCT03172130|12558951|FG000|COMPLETED|Overall Study||9
11362254|NCT03172130|12558952|FG001|COMPLETED|Overall Study||9
11362255|NCT03172130|12558951|FG000|NOT COMPLETED|Overall Study||3
11362256|NCT03172130|12558952|FG001|NOT COMPLETED|Overall Study||1
11362257|NCT03172325|12558960|FG000|STARTED|Overall Study||68
11362258|NCT03172325|12558961|FG001|STARTED|Overall Study||68
11362259|NCT03172325|12558960|FG000|COMPLETED|Overall Study||64
11362260|NCT03172325|12558961|FG001|COMPLETED|Overall Study||64
11362261|NCT03172325|12558960|FG000|NOT COMPLETED|Overall Study||4
11362262|NCT03172325|12558961|FG001|NOT COMPLETED|Overall Study||4
11362263|NCT03172364|12558969|FG000|STARTED|Overall Study||55
11362264|NCT03172364|12558970|FG001|STARTED|Overall Study||58
11362265|NCT03172364|12558969|FG000|COMPLETED|Overall Study||53
11362266|NCT03172364|12558970|FG001|COMPLETED|Overall Study||57
11362267|NCT03172364|12558969|FG000|NOT COMPLETED|Overall Study||2
11362268|NCT03172364|12558970|FG001|NOT COMPLETED|Overall Study||1
11362269|NCT03172481|12558978|FG000|STARTED|Open-label||156
11362270|NCT03172481|12558979|FG001|STARTED|Open-label||0
11362271|NCT03172481|12558978|FG000|COMPLETED|Open-label||148
11362272|NCT03172481|12558979|FG001|COMPLETED|Open-label||0
11362273|NCT03172481|12558978|FG000|NOT COMPLETED|Open-label||8
11362274|NCT03172481|12558979|FG001|NOT COMPLETED|Open-label||0
11362275|NCT03172481|12558978|FG000|STARTED|Double-blind||75
11362276|NCT03172481|12558979|FG001|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73
11362277|NCT03172481|12558978|FG000|COMPLETED|Double-blind||74
11362278|NCT03172481|12558979|FG001|COMPLETED|Double-blind||73
11362279|NCT03172481|12558978|FG000|NOT COMPLETED|Double-blind||1
11362280|NCT03172481|12558979|FG001|NOT COMPLETED|Double-blind||0
11362281|NCT03172494|12558988|FG000|STARTED|Overall Study||361
11362282|NCT03172494|12558989|FG001|STARTED|Overall Study||179
11362283|NCT03172494|12558990|FG002|STARTED|Overall Study||180
11362284|NCT03172494|12558988|FG000|Full Analysis Set (FAS)|Overall Study||361
11362285|NCT03172494|12558989|FG001|Full Analysis Set (FAS)|Overall Study||179
11362286|NCT03172494|12558990|FG002|Full Analysis Set (FAS)|Overall Study||180
11362287|NCT03172494|12558988|FG000|Safety Analysis Set (SAS)|Overall Study||358
11362288|NCT03172494|12558989|FG001|Safety Analysis Set (SAS)|Overall Study||175
11362289|NCT03172494|12558990|FG002|Safety Analysis Set (SAS)|Overall Study||180
11362290|NCT03172494|12558988|FG000|Exposed|Overall Study||358
11362291|NCT03172494|12558989|FG001|Exposed|Overall Study||175
11362292|NCT03172494|12558990|FG002|Exposed|Overall Study||180
11362293|NCT03172494|12558988|FG000|COMPLETED|Overall Study||341
11362294|NCT03172494|12558989|FG001|COMPLETED|Overall Study||167
11362295|NCT03172494|12558990|FG002|COMPLETED|Overall Study||151
11362296|NCT03172494|12558988|FG000|NOT COMPLETED|Overall Study||20
11362297|NCT03172494|12558989|FG001|NOT COMPLETED|Overall Study||12
11362298|NCT03172494|12558990|FG002|NOT COMPLETED|Overall Study||29
11362299|NCT03172702|12558999|FG000|STARTED|Overall Study||150
11005578|NCT00723489|12183282|FG001|STARTED|Overall Study||19
11005579|NCT00723489|12183283|FG002|STARTED|Overall Study||19
11005580|NCT00723489|12183284|FG003|STARTED|Overall Study||23
11005581|NCT00723489|12183281|FG000|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
11005582|NCT00723489|12183282|FG001|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
11005583|NCT00723489|12183283|FG002|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
11005584|NCT00723489|12183284|FG003|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
11005585|NCT00723489|12183281|FG000|NOT COMPLETED|Overall Study||1
11005586|NCT00723489|12183282|FG001|NOT COMPLETED|Overall Study||4
11005587|NCT00723489|12183283|FG002|NOT COMPLETED|Overall Study||0
11362300|NCT03172702|12558999|FG000|Received Treatment in CP|Overall Study||150
11362301|NCT03172702|12558999|FG000|Received Treatment in MP|Overall Study||150
11362302|NCT03172702|12558999|FG000|COMPLETED|Overall Study||122
11362303|NCT03172702|12558999|FG000|NOT COMPLETED|Overall Study||28
11362304|NCT03172884|12559008|FG000|STARTED|Overall Study||8
11362305|NCT03172884|12559009|FG001|STARTED|Overall Study||6
11362306|NCT03172884|12559010|FG002|STARTED|Overall Study||8
11362307|NCT03172884|12559011|FG003|STARTED|Overall Study||8
11362308|NCT03172884|12559008|FG000|COMPLETED|Overall Study||8
11362309|NCT03172884|12559009|FG001|COMPLETED|Overall Study||6
11362310|NCT03172884|12559010|FG002|COMPLETED|Overall Study||8
11362311|NCT03172884|12559011|FG003|COMPLETED|Overall Study||8
11362312|NCT03172884|12559008|FG000|NOT COMPLETED|Overall Study||0
11362313|NCT03172884|12559009|FG001|NOT COMPLETED|Overall Study||0
11362314|NCT03172884|12559010|FG002|NOT COMPLETED|Overall Study||0
11362315|NCT03172884|12559011|FG003|NOT COMPLETED|Overall Study||0
11362316|NCT03173170|12559021|FG000|STARTED|First Intervention Period (6 Days)||10
11362317|NCT03173170|12559021|FG000|COMPLETED|First Intervention Period (6 Days)||10
11362318|NCT03173170|12559021|FG000|NOT COMPLETED|First Intervention Period (6 Days)||0
11362319|NCT03173170|12559021|FG000|STARTED|Washout Period (at Least 7 Days)||10
11362320|NCT03173170|12559021|FG000|COMPLETED|Washout Period (at Least 7 Days)||10
11362321|NCT03173170|12559021|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11362322|NCT03173170|12559021|FG000|STARTED|Intervention Period 2 (9 Days)||10
11362323|NCT03173170|12559021|FG000|COMPLETED|Intervention Period 2 (9 Days)||10
11362324|NCT03173170|12559021|FG000|NOT COMPLETED|Intervention Period 2 (9 Days)||0
11362325|NCT03173313|12559031|FG000|STARTED|Overall Study||58
11362326|NCT03173313|12559032|FG001|STARTED|Overall Study||53
11362327|NCT03173313|12559031|FG000|Informed Consent Signed|Overall Study||58
11362328|NCT03173313|12559032|FG001|Informed Consent Signed|Overall Study||53
11362329|NCT03173313|12559031|FG000|Randomized|Overall Study||58
11362330|NCT03173313|12559032|FG001|Randomized|Overall Study||53
11362331|NCT03173313|12559031|FG000|Cooled|Overall Study||54
11362332|NCT03173313|12559032|FG001|Cooled|Overall Study||0
11362333|NCT03173313|12559031|FG000|4-6 Day Follow-up|Overall Study||57
11362334|NCT03173313|12559032|FG001|4-6 Day Follow-up|Overall Study||53
11362335|NCT03173313|12559031|FG000|30-day Follow-up|Overall Study||52
11362336|NCT03173313|12559032|FG001|30-day Follow-up|Overall Study||51
11362337|NCT03173313|12559031|FG000|12-month Follow-up|Overall Study||49
11362338|NCT03173313|12559032|FG001|12-month Follow-up|Overall Study||48
11362339|NCT03173313|12559031|FG000|COMPLETED|Overall Study||49
11362340|NCT03173313|12559032|FG001|COMPLETED|Overall Study||48
11362341|NCT03173313|12559031|FG000|NOT COMPLETED|Overall Study||9
11362342|NCT03173313|12559032|FG001|NOT COMPLETED|Overall Study||5
11362343|NCT03173547|12559040|FG000|STARTED|Overall Study||40
11362344|NCT03173547|12559041|FG001|STARTED|Overall Study||40
11362345|NCT03173547|12559040|FG000|COMPLETED|Overall Study||36
11362346|NCT03173547|12559041|FG001|COMPLETED|Overall Study||38
11362347|NCT03173547|12559040|FG000|NOT COMPLETED|Overall Study||4
11362348|NCT03173547|12559041|FG001|NOT COMPLETED|Overall Study||2
11362349|NCT03174158|12559051|FG000|STARTED|Overall Study||39
11362350|NCT03174158|12559052|FG001|STARTED|Overall Study||39
11362351|NCT03174158|12559053|FG002|STARTED|Overall Study||36
11362352|NCT03174158|12559054|FG003|STARTED|Overall Study||39
11362353|NCT03174158|12559051|FG000|COMPLETED|Overall Study||35
11362354|NCT03174158|12559052|FG001|COMPLETED|Overall Study||37
11362355|NCT03174158|12559053|FG002|COMPLETED|Overall Study||34
11362356|NCT03174158|12559054|FG003|COMPLETED|Overall Study||38
11362357|NCT03174158|12559051|FG000|NOT COMPLETED|Overall Study||4
11362358|NCT03174158|12559052|FG001|NOT COMPLETED|Overall Study||2
11362359|NCT03174158|12559053|FG002|NOT COMPLETED|Overall Study||2
11362360|NCT03174158|12559054|FG003|NOT COMPLETED|Overall Study||1
11362361|NCT03174366|12559072|FG000|STARTED|Overall Study||7
11362362|NCT03174366|12559072|FG000|COMPLETED|Overall Study||7
11362363|NCT03174366|12559072|FG000|NOT COMPLETED|Overall Study||0
11362364|NCT03174925|12559076|FG000|STARTED|Overall Study||55
11362365|NCT03174925|12559076|FG000|COMPLETED|Overall Study||52
11362366|NCT03174925|12559076|FG000|NOT COMPLETED|Overall Study||3
11362367|NCT03175120|12559082|FG000|STARTED|Overall Study||302
11362368|NCT03175120|12559083|FG001|STARTED|Overall Study||151
11362369|NCT03175120|12559082|FG000|Treated|Overall Study||301
11362370|NCT03175120|12559083|FG001|Treated|Overall Study||151
11362371|NCT03175120|12559082|FG000|Full Analysis Set (FAS)|Overall Study||302
11362372|NCT03175120|12559083|FG001|Full Analysis Set (FAS)|Overall Study||151
11362373|NCT03175120|12559082|FG000|Safety Analysis Set (SAS)|Overall Study||301
11362374|NCT03175120|12559083|FG001|Safety Analysis Set (SAS)|Overall Study||151
11362375|NCT03175120|12559082|FG000|COMPLETED|Overall Study||290
11362376|NCT03175120|12559083|FG001|COMPLETED|Overall Study||139
11362377|NCT03175120|12559082|FG000|NOT COMPLETED|Overall Study||12
11362378|NCT03175120|12559083|FG001|NOT COMPLETED|Overall Study||12
11362379|NCT03175172|12559089|FG000|STARTED|Overall Study||10
11362380|NCT03175172|12559089|FG000|COMPLETED|Overall Study||0
11362381|NCT03175172|12559089|FG000|NOT COMPLETED|Overall Study||10
11362382|NCT03175562|12559093|FG000|STARTED|Overall Study||240
11362383|NCT03175562|12559093|FG000|Test Product|Overall Study||240
11362384|NCT03175562|12559093|FG000|Negative Control|Overall Study||240
11362385|NCT03175562|12559093|FG000|COMPLETED|Overall Study||224
11362386|NCT03175562|12559093|FG000|NOT COMPLETED|Overall Study||16
11362387|NCT03175731|12559102|FG000|STARTED|Overall Study||53
11362388|NCT03175731|12559103|FG001|STARTED|Overall Study||53
11362389|NCT03175731|12559102|FG000|COMPLETED|Overall Study||46
11362390|NCT03175731|12559103|FG001|COMPLETED|Overall Study||48
11362391|NCT03175731|12559102|FG000|NOT COMPLETED|Overall Study||7
11362392|NCT03175731|12559103|FG001|NOT COMPLETED|Overall Study||5
11362393|NCT03176238|12559111|FG000|STARTED|Overall Study||199
11362394|NCT03176238|12559112|FG001|STARTED|Overall Study||36
11362395|NCT03176238|12559111|FG000|COMPLETED|Overall Study||0
11362396|NCT03176238|12559112|FG001|COMPLETED|Overall Study||0
11362397|NCT03176238|12559111|FG000|NOT COMPLETED|Overall Study||199
11362398|NCT03176238|12559112|FG001|NOT COMPLETED|Overall Study||36
11362399|NCT03176407|12559122|FG000|STARTED|Overall Study||30
11362400|NCT03176407|12559122|FG000|COMPLETED|Overall Study||27
11362401|NCT03176407|12559122|FG000|NOT COMPLETED|Overall Study||3
11362402|NCT03176459|12559130|FG000|STARTED|Overall Study||96
11362403|NCT03176459|12559131|FG001|STARTED|Overall Study||90
11362404|NCT03176459|12559130|FG000|COMPLETED|Overall Study||91
11362405|NCT03176459|12559131|FG001|COMPLETED|Overall Study||83
11362406|NCT03176459|12559130|FG000|NOT COMPLETED|Overall Study||5
11362407|NCT03176459|12559131|FG001|NOT COMPLETED|Overall Study||7
11362408|NCT03176654|12559139|FG000|STARTED|Overall Study||13
11362409|NCT03176654|12559140|FG001|STARTED|Overall Study||15
11362410|NCT03176654|12559139|FG000|COMPLETED|Overall Study||13
11362411|NCT03176654|12559140|FG001|COMPLETED|Overall Study||15
11362412|NCT03176654|12559139|FG000|NOT COMPLETED|Overall Study||0
11362413|NCT03176654|12559140|FG001|NOT COMPLETED|Overall Study||0
11362414|NCT03176784|12559150|FG000|STARTED|Overall Study||314
11362415|NCT03176784|12559151|FG001|STARTED|Overall Study||315
11362416|NCT03176784|12559152|FG002|STARTED|Overall Study||311
11362417|NCT03176784|12559153|FG003|STARTED|Overall Study||311
11362418|NCT03176784|12559150|FG000|COMPLETED|Overall Study||209
11362419|NCT03176784|12559151|FG001|COMPLETED|Overall Study||202
11362420|NCT03176784|12559152|FG002|COMPLETED|Overall Study||198
11362421|NCT03176784|12559153|FG003|COMPLETED|Overall Study||241
11362422|NCT03176784|12559150|FG000|NOT COMPLETED|Overall Study||105
11362423|NCT03176784|12559151|FG001|NOT COMPLETED|Overall Study||113
11362424|NCT03176784|12559152|FG002|NOT COMPLETED|Overall Study||113
11362425|NCT03176784|12559153|FG003|NOT COMPLETED|Overall Study||70
11362426|NCT03177395|12559167|FG000|STARTED|Overall Study||6
11362427|NCT03177395|12559168|FG001|STARTED|Overall Study||6
11362428|NCT03177395|12559169|FG002|STARTED|Overall Study||6
11362429|NCT03177395|12559170|FG003|STARTED|Overall Study||6
11362430|NCT03177395|12559167|FG000|COMPLETED|Overall Study||6
11362431|NCT03177395|12559168|FG001|COMPLETED|Overall Study||6
11362432|NCT03177395|12559169|FG002|COMPLETED|Overall Study||6
11362433|NCT03177395|12559170|FG003|COMPLETED|Overall Study||6
11362434|NCT03177395|12559167|FG000|NOT COMPLETED|Overall Study||0
11362435|NCT03177395|12559168|FG001|NOT COMPLETED|Overall Study||0
11362436|NCT03177395|12559169|FG002|NOT COMPLETED|Overall Study||0
11362437|NCT03177395|12559170|FG003|NOT COMPLETED|Overall Study||0
11362438|NCT03177512|12559184|FG000|STARTED|Overall Study||40
11362439|NCT03177512|12559185|FG001|STARTED|Overall Study||21
11362440|NCT03177512|12559184|FG000|COMPLETED|Overall Study||31
11362441|NCT03177512|12559185|FG001|COMPLETED|Overall Study||18
11362442|NCT03177512|12559184|FG000|NOT COMPLETED|Overall Study||9
11362443|NCT03177512|12559185|FG001|NOT COMPLETED|Overall Study||3
11362444|NCT03177603|12559195|FG000|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
11362445|NCT03177603|12559196|FG001|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
11362446|NCT03177603|12559197|FG002|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
11362447|NCT03177603|12559198|FG003|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
11362448|NCT03177603|12559195|FG000|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
11362449|NCT03177603|12559196|FG001|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
11362450|NCT03177603|12559197|FG002|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
11362451|NCT03177603|12559198|FG003|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
11362452|NCT03177603|12559195|FG000|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
11362453|NCT03177603|12559196|FG001|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
11362454|NCT03177603|12559197|FG002|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
11362455|NCT03177603|12559198|FG003|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
11362456|NCT03177603|12559195|FG000|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
11362457|NCT03177603|12559196|FG001|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
11362458|NCT03177603|12559197|FG002|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
11362459|NCT03177603|12559198|FG003|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
11362460|NCT03177603|12559195|FG000|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
11362461|NCT03177603|12559196|FG001|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
11362462|NCT03177603|12559197|FG002|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
11362463|NCT03177603|12559198|FG003|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
11362464|NCT03177603|12559195|FG000|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
11362465|NCT03177603|12559196|FG001|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
11362466|NCT03177603|12559197|FG002|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
11362467|NCT03177603|12559198|FG003|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
11362468|NCT03177603|12559195|FG000|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
11362469|NCT03177603|12559196|FG001|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
11362470|NCT03177603|12559197|FG002|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
11362471|NCT03177603|12559198|FG003|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
11362472|NCT03177603|12559195|FG000|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
11362473|NCT03177603|12559196|FG001|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
11362474|NCT03177603|12559197|FG002|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
11362475|NCT03177603|12559198|FG003|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
11362476|NCT03177603|12559195|FG000|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
11362477|NCT03177603|12559196|FG001|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
11362478|NCT03177603|12559197|FG002|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
11362479|NCT03177603|12559198|FG003|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
11362480|NCT03177603|12559195|FG000|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
11362481|NCT03177603|12559196|FG001|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
11362482|NCT03177603|12559197|FG002|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
11362483|NCT03177603|12559198|FG003|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
11362484|NCT03177603|12559195|FG000|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
11362485|NCT03177603|12559196|FG001|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
11362486|NCT03177603|12559197|FG002|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
11362487|NCT03177603|12559198|FG003|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
11362488|NCT03177603|12559195|FG000|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
11362489|NCT03177603|12559196|FG001|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
11362490|NCT03177603|12559197|FG002|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
11362491|NCT03177603|12559198|FG003|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
11362492|NCT03177798|12559210|FG000|STARTED|Overall Study||5
11362493|NCT03177798|12559211|FG001|STARTED|Overall Study||6
11362494|NCT03177798|12559210|FG000|Intervention 1|Overall Study||5
11362495|NCT03177798|12559211|FG001|Intervention 1|Overall Study||6
11362496|NCT03177798|12559210|FG000|Washout|Overall Study||5
11362497|NCT03177798|12559211|FG001|Washout|Overall Study||6
11362498|NCT03177798|12559210|FG000|Intervention 2|Overall Study||5
11362499|NCT03177798|12559211|FG001|Intervention 2|Overall Study||6
11362500|NCT03177798|12559210|FG000|COMPLETED|Overall Study||5
11362501|NCT03177798|12559211|FG001|COMPLETED|Overall Study||6
11362502|NCT03177798|12559210|FG000|NOT COMPLETED|Overall Study||0
11362503|NCT03177798|12559211|FG001|NOT COMPLETED|Overall Study||0
11362504|NCT03178266|12559221|FG000|STARTED|Overall Study||21
11362505|NCT03178266|12559222|FG001|STARTED|Overall Study||20
11362506|NCT03178266|12559221|FG000|COMPLETED|Overall Study||21
11362507|NCT03178266|12559222|FG001|COMPLETED|Overall Study||16
11362508|NCT03178266|12559221|FG000|NOT COMPLETED|Overall Study||0
11362509|NCT03178266|12559222|FG001|NOT COMPLETED|Overall Study||4
11362510|NCT03178344|12559228|FG000|STARTED|First Session||10
11362511|NCT03178344|12559229|FG001|STARTED|First Session||10
11362512|NCT03178344|12559228|FG000|COMPLETED|First Session||10
11362513|NCT03178344|12559229|FG001|COMPLETED|First Session||10
11362514|NCT03178344|12559228|FG000|NOT COMPLETED|First Session||0
11362515|NCT03178344|12559229|FG001|NOT COMPLETED|First Session||0
11362516|NCT03178344|12559228|FG000|STARTED|Washout Period (5-9 Days)||10
11362517|NCT03178344|12559229|FG001|STARTED|Washout Period (5-9 Days)||10
11362518|NCT03178344|12559228|FG000|COMPLETED|Washout Period (5-9 Days)||10
11362519|NCT03178344|12559229|FG001|COMPLETED|Washout Period (5-9 Days)||10
11362520|NCT03178344|12559228|FG000|NOT COMPLETED|Washout Period (5-9 Days)||0
11362521|NCT03178344|12559229|FG001|NOT COMPLETED|Washout Period (5-9 Days)||0
11362522|NCT03178344|12559228|FG000|STARTED|Second Session||10
11362523|NCT03178344|12559229|FG001|STARTED|Second Session||10
11362524|NCT03178344|12559228|FG000|COMPLETED|Second Session||10
11362525|NCT03178344|12559229|FG001|COMPLETED|Second Session||10
11362526|NCT03178344|12559228|FG000|NOT COMPLETED|Second Session||0
11362527|NCT03178344|12559229|FG001|NOT COMPLETED|Second Session||0
11362528|NCT03178669|12559240|FG000|STARTED|Overall Study||40
11362529|NCT03178669|12559241|FG001|STARTED|Overall Study||43
11362530|NCT03178669|12559242|FG002|STARTED|Overall Study||42
11362531|NCT03178669|12559243|FG003|STARTED|Overall Study||42
11362532|NCT03178669|12559244|FG004|STARTED|Overall Study||44
11362533|NCT03178669|12559240|FG000|Completed Week 6|Overall Study||35
11362534|NCT03178669|12559241|FG001|Completed Week 6|Overall Study||42
11362535|NCT03178669|12559242|FG002|Completed Week 6|Overall Study||36
11362536|NCT03178669|12559243|FG003|Completed Week 6|Overall Study||38
11362537|NCT03178669|12559244|FG004|Completed Week 6|Overall Study||42
11362538|NCT03178669|12559240|FG000|COMPLETED|Overall Study||35
11362539|NCT03178669|12559241|FG001|COMPLETED|Overall Study||42
11362540|NCT03178669|12559242|FG002|COMPLETED|Overall Study||35
11362541|NCT03178669|12559243|FG003|COMPLETED|Overall Study||38
11362542|NCT03178669|12559244|FG004|COMPLETED|Overall Study||40
11362543|NCT03178669|12559240|FG000|NOT COMPLETED|Overall Study||5
11362544|NCT03178669|12559241|FG001|NOT COMPLETED|Overall Study||1
11362545|NCT03178669|12559242|FG002|NOT COMPLETED|Overall Study||7
11362546|NCT03178669|12559243|FG003|NOT COMPLETED|Overall Study||4
11362547|NCT03178669|12559244|FG004|NOT COMPLETED|Overall Study||4
11362548|NCT03178773|12559258|FG000|STARTED|Overall Study||86
11362549|NCT03178773|12559259|FG001|STARTED|Overall Study||80
11362550|NCT03178773|12559258|FG000|3month Phone Follow up|Overall Study||49
11362551|NCT03178773|12559259|FG001|3month Phone Follow up|Overall Study||51
11362552|NCT03178773|12559258|FG000|6month in Person Follow up|Overall Study||54
11362553|NCT03178773|12559259|FG001|6month in Person Follow up|Overall Study||46
11362554|NCT03178773|12559258|FG000|9month Follow up Phone|Overall Study||36
11362555|NCT03178773|12559259|FG001|9month Follow up Phone|Overall Study||51
11362556|NCT03178773|12559258|FG000|COMPLETED|Overall Study||47
11362557|NCT03178773|12559259|FG001|COMPLETED|Overall Study||40
11362558|NCT03178773|12559258|FG000|NOT COMPLETED|Overall Study||39
11362559|NCT03178773|12559259|FG001|NOT COMPLETED|Overall Study||40
11362560|NCT03178851|12559269|FG000|STARTED|Overall Study||92
11362561|NCT03178851|12559270|FG001|STARTED|Overall Study||11
11362562|NCT03178851|12559271|FG002|STARTED|Overall Study||52
11362563|NCT03178851|12559269|FG000|COMPLETED|Overall Study||0
11362564|NCT03178851|12559270|FG001|COMPLETED|Overall Study||0
11362565|NCT03178851|12559271|FG002|COMPLETED|Overall Study||0
11362566|NCT03178851|12559269|FG000|NOT COMPLETED|Overall Study||92
11362567|NCT03178851|12559270|FG001|NOT COMPLETED|Overall Study||11
11362568|NCT03178851|12559271|FG002|NOT COMPLETED|Overall Study||52
11362569|NCT03178942|12559282|FG000|STARTED|Overall Study||129
11362570|NCT03178942|12559283|FG001|STARTED|Overall Study||125
11362571|NCT03178942|12559282|FG000|COMPLETED|Overall Study||126
11362572|NCT03178942|12559283|FG001|COMPLETED|Overall Study||123
11362573|NCT03178942|12559282|FG000|NOT COMPLETED|Overall Study||3
11362574|NCT03178942|12559283|FG001|NOT COMPLETED|Overall Study||2
11362575|NCT03179319|12559291|FG000|STARTED|Overall Study||40
11362576|NCT03179319|12559292|FG001|STARTED|Overall Study||20
11362577|NCT03179319|12559291|FG000|3 Month Visit|Overall Study||37
11362578|NCT03179319|12559292|FG001|3 Month Visit|Overall Study||20
11362579|NCT03179319|12559291|FG000|COMPLETED|Overall Study||34
11362580|NCT03179319|12559292|FG001|COMPLETED|Overall Study||20
11362581|NCT03179319|12559291|FG000|NOT COMPLETED|Overall Study||6
11362582|NCT03179319|12559292|FG001|NOT COMPLETED|Overall Study||0
11362583|NCT03179345|12559302|FG000|STARTED|Overall Study||8
11362584|NCT03179345|12559303|FG001|STARTED|Overall Study||8
11362585|NCT03179345|12559304|FG002|STARTED|Overall Study||8
11362586|NCT03179345|12559305|FG003|STARTED|Overall Study||8
11362587|NCT03179345|12559302|FG000|Received Gralise®|Overall Study||8
11362588|NCT03179345|12559303|FG001|Received Gralise®|Overall Study||7
11362589|NCT03179345|12559304|FG002|Received Gralise®|Overall Study||7
11362590|NCT03179345|12559305|FG003|Received Gralise®|Overall Study||6
11362591|NCT03179345|12559302|FG000|Received Neurontin®|Overall Study||8
11362592|NCT03179345|12559303|FG001|Received Neurontin®|Overall Study||8
11362593|NCT03179345|12559304|FG002|Received Neurontin®|Overall Study||7
11362594|NCT03179345|12559305|FG003|Received Neurontin®|Overall Study||8
11362595|NCT03179345|12559302|FG000|Received Lyrica®|Overall Study||8
11362596|NCT03179345|12559303|FG001|Received Lyrica®|Overall Study||7
11362597|NCT03179345|12559304|FG002|Received Lyrica®|Overall Study||8
11362598|NCT03179345|12559305|FG003|Received Lyrica®|Overall Study||8
11362599|NCT03179345|12559302|FG000|Received Placebo|Overall Study||8
11362600|NCT03179345|12559303|FG001|Received Placebo|Overall Study||7
11362601|NCT03179345|12559304|FG002|Received Placebo|Overall Study||7
11362602|NCT03179345|12559305|FG003|Received Placebo|Overall Study||8
11362603|NCT03179345|12559302|FG000|COMPLETED|Overall Study||8
11362604|NCT03179345|12559303|FG001|COMPLETED|Overall Study||7
11362605|NCT03179345|12559304|FG002|COMPLETED|Overall Study||7
11362606|NCT03179345|12559305|FG003|COMPLETED|Overall Study||6
11362607|NCT03179345|12559302|FG000|NOT COMPLETED|Overall Study||0
11362608|NCT03179345|12559303|FG001|NOT COMPLETED|Overall Study||1
11362609|NCT03179345|12559304|FG002|NOT COMPLETED|Overall Study||1
11362610|NCT03179345|12559305|FG003|NOT COMPLETED|Overall Study||2
11362611|NCT03179410|12559321|FG000|STARTED|Overall Study||15
11362612|NCT03179410|12559321|FG000|COMPLETED|Overall Study||15
11362613|NCT03179410|12559321|FG000|NOT COMPLETED|Overall Study||0
11362614|NCT03179787|12559325|FG000|STARTED|Overall Study||528
11362615|NCT03179787|12559325|FG000|COMPLETED|Overall Study||510
11362616|NCT03179787|12559325|FG000|NOT COMPLETED|Overall Study||18
11362617|NCT03179891|12559329|FG000|STARTED|First Intervention||13
11362618|NCT03179891|12559330|FG001|STARTED|First Intervention||22
11362619|NCT03179891|12559329|FG000|COMPLETED|First Intervention||11
11362620|NCT03179891|12559330|FG001|COMPLETED|First Intervention||20
11362621|NCT03179891|12559329|FG000|NOT COMPLETED|First Intervention||2
11362622|NCT03179891|12559330|FG001|NOT COMPLETED|First Intervention||2
11362623|NCT03179891|12559329|FG000|STARTED|Second Intervention (After 14 Days)||11
11362624|NCT03179891|12559330|FG001|STARTED|Second Intervention (After 14 Days)||20
11362625|NCT03179891|12559329|FG000|COMPLETED|Second Intervention (After 14 Days)||11
11362626|NCT03179891|12559330|FG001|COMPLETED|Second Intervention (After 14 Days)||20
11362627|NCT03179891|12559329|FG000|NOT COMPLETED|Second Intervention (After 14 Days)||0
11362628|NCT03179891|12559330|FG001|NOT COMPLETED|Second Intervention (After 14 Days)||0
11362629|NCT03180138|12559342|FG000|STARTED|Overall Study||204
11362630|NCT03180138|12559343|FG001|STARTED|Overall Study||201
11362631|NCT03180138|12559344|FG002|STARTED|Overall Study||203
11362632|NCT03180138|12559342|FG000|COMPLETED|Overall Study||182
11362633|NCT03180138|12559343|FG001|COMPLETED|Overall Study||188
11362634|NCT03180138|12559344|FG002|COMPLETED|Overall Study||179
11362635|NCT03180138|12559342|FG000|NOT COMPLETED|Overall Study||22
11362636|NCT03180138|12559343|FG001|NOT COMPLETED|Overall Study||13
11362637|NCT03180138|12559344|FG002|NOT COMPLETED|Overall Study||24
11362638|NCT03180385|12559354|FG000|STARTED|Overall Study||0
11362639|NCT03180385|12559355|FG001|STARTED|Overall Study||2
11362640|NCT03180385|12559354|FG000|COMPLETED|Overall Study||0
11362641|NCT03180385|12559355|FG001|COMPLETED|Overall Study||2
11362642|NCT03180385|12559354|FG000|NOT COMPLETED|Overall Study||0
11362643|NCT03180385|12559355|FG001|NOT COMPLETED|Overall Study||0
11362644|NCT03180489|12559363|FG000|STARTED|Overall Study||33
11362645|NCT03180489|12559364|FG001|STARTED|Overall Study||29
11362646|NCT03180489|12559363|FG000|COMPLETED|Overall Study||25
11362647|NCT03180489|12559364|FG001|COMPLETED|Overall Study||25
11362648|NCT03180489|12559363|FG000|NOT COMPLETED|Overall Study||8
11362649|NCT03180489|12559364|FG001|NOT COMPLETED|Overall Study||4
11362650|NCT03180515|12559370|FG000|STARTED|Aim 1||12
11362651|NCT03180515|12559370|FG000|COMPLETED|Aim 1||12
11362652|NCT03180515|12559370|FG000|NOT COMPLETED|Aim 1||0
11362653|NCT03180515|12559370|FG000|STARTED|Aim 2||12
11362654|NCT03180515|12559370|FG000|COMPLETED|Aim 2||12
11362655|NCT03180515|12559370|FG000|NOT COMPLETED|Aim 2||0
11362656|NCT03180515|12559370|FG000|STARTED|Aim 3||1
11362657|NCT03180515|12559370|FG000|COMPLETED|Aim 3||1
11362658|NCT03180515|12559370|FG000|NOT COMPLETED|Aim 3||0
11362659|NCT03180528|12559386|FG000|STARTED|Overall Study||30
11362660|NCT03180528|12559386|FG000|COMPLETED|Overall Study||27
11362661|NCT03180528|12559386|FG000|NOT COMPLETED|Overall Study||3
11362662|NCT03180619|12559393|FG000|STARTED|Overall Study||78
11362663|NCT03180619|12559394|FG001|STARTED|Overall Study||15
11362664|NCT03180619|12559395|FG002|STARTED|Overall Study||31
11362665|NCT03180619|12559393|FG000|COMPLETED|Overall Study||67
11362666|NCT03180619|12559394|FG001|COMPLETED|Overall Study||14
11362667|NCT03180619|12559395|FG002|COMPLETED|Overall Study||25
11362668|NCT03180619|12559393|FG000|NOT COMPLETED|Overall Study||11
11362669|NCT03180619|12559394|FG001|NOT COMPLETED|Overall Study||1
11362670|NCT03180619|12559395|FG002|NOT COMPLETED|Overall Study||6
11362671|NCT05091047|12559410|FG000|STARTED|Overall Study||8
11362672|NCT05091047|12559410|FG000|COMPLETED|Overall Study||8
11362673|NCT05091047|12559410|FG000|NOT COMPLETED|Overall Study||0
11362674|NCT04957498|12559416|FG000|STARTED|Overall Study||20
11362675|NCT04957498|12559417|FG001|STARTED|Overall Study||20
11362676|NCT04957498|12559416|FG000|COMPLETED|Overall Study||19
11362677|NCT04957498|12559417|FG001|COMPLETED|Overall Study||18
11362678|NCT04957498|12559416|FG000|NOT COMPLETED|Overall Study||1
11362679|NCT04957498|12559417|FG001|NOT COMPLETED|Overall Study||2
11362680|NCT04450108|12559425|FG000|STARTED|Overall Study||122
11362681|NCT04450108|12559425|FG000|COMPLETED|Overall Study||120
11362682|NCT04450108|12559425|FG000|NOT COMPLETED|Overall Study||2
11362683|NCT04448756|12559432|FG000|STARTED|Overall Study||49
11362684|NCT04448756|12559433|FG001|STARTED|Overall Study||54
11362685|NCT04448756|12559434|FG002|STARTED|Overall Study||46
11362686|NCT04448756|12559432|FG000|COMPLETED|Overall Study||46
11362687|NCT04448756|12559433|FG001|COMPLETED|Overall Study||49
11362688|NCT04448756|12559434|FG002|COMPLETED|Overall Study||45
11362689|NCT04448756|12559432|FG000|NOT COMPLETED|Overall Study||3
11362690|NCT04448756|12559433|FG001|NOT COMPLETED|Overall Study||5
11362691|NCT04448756|12559434|FG002|NOT COMPLETED|Overall Study||1
11362692|NCT04397718|12559444|FG000|STARTED|Overall Study||34
11362693|NCT04397718|12559445|FG001|STARTED|Overall Study||62
11362694|NCT04397718|12559444|FG000|COMPLETED|Overall Study||27
11362695|NCT04397718|12559445|FG001|COMPLETED|Overall Study||47
11362696|NCT04397718|12559444|FG000|NOT COMPLETED|Overall Study||7
11362697|NCT04397718|12559445|FG001|NOT COMPLETED|Overall Study||15
11362698|NCT04352127|12559454|FG000|STARTED|Overall Study||29
11362699|NCT04352127|12559455|FG001|STARTED|Overall Study||26
11362700|NCT04352127|12559456|FG002|STARTED|Overall Study||50
11362701|NCT04352127|12559454|FG000|COMPLETED|Overall Study||25
11362702|NCT04352127|12559455|FG001|COMPLETED|Overall Study||25
11362703|NCT04352127|12559456|FG002|COMPLETED|Overall Study||50
11362704|NCT04352127|12559454|FG000|NOT COMPLETED|Overall Study||4
11362705|NCT04352127|12559455|FG001|NOT COMPLETED|Overall Study||1
11362706|NCT04352127|12559456|FG002|NOT COMPLETED|Overall Study||0
11005588|NCT00723489|12183284|FG003|NOT COMPLETED|Overall Study||3
11005589|NCT00723528|12183297|FG000|STARTED|Period 1: Controlled Period (CP)||32
11005590|NCT00723528|12183298|FG001|STARTED|Period 1: Controlled Period (CP)||64
11005591|NCT00723528|12183299|FG002|STARTED|Period 1: Controlled Period (CP)||62
11005592|NCT00723528|12183300|FG003|STARTED|Period 1: Controlled Period (CP)||0
11362707|NCT04253756|12559464|FG000|STARTED|Overall Study||26
11362708|NCT04253756|12559464|FG000|Procedure 1: 18 Guage|Overall Study||12
11362709|NCT04253756|12559464|FG000|Procedure 1: 20 Gauge|Overall Study||14
11362710|NCT04253756|12559464|FG000|Procedure 2: 18 Gauge|Overall Study||9
11362711|NCT04253756|12559464|FG000|Procedure 2: 20 Gauge|Overall Study||7
11362712|NCT04253756|12559464|FG000|Procedure 3: 18 Gauge|Overall Study||6
11362713|NCT04253756|12559464|FG000|Procedure 3: 20 Gauge|Overall Study||5
11362714|NCT04253756|12559464|FG000|Procedure 4: 18 Gauge|Overall Study||5
11362715|NCT04253756|12559464|FG000|Procedure 4: 20 Gauge|Overall Study||3
11362716|NCT04253756|12559464|FG000|Procedure 5: 18 Gauge|Overall Study||2
11362717|NCT04253756|12559464|FG000|Procedure 5: 20 Gauge|Overall Study||3
11362718|NCT04253756|12559464|FG000|Procedure 6: 18 Gauge|Overall Study||1
11362719|NCT04253756|12559464|FG000|Procedure 6: 20 Gauge|Overall Study||2
11362720|NCT04253756|12559464|FG000|Procedure 7: 18 Gauge|Overall Study||1
11362721|NCT04253756|12559464|FG000|Procedure 7: 20 Gauge|Overall Study||1
11362722|NCT04253756|12559464|FG000|Procedure 8: 18 Gauge|Overall Study||0
11362723|NCT04253756|12559464|FG000|Procedure 8: 20 Gauge|Overall Study||2
11362724|NCT04253756|12559464|FG000|COMPLETED|Overall Study||21
11362725|NCT04253756|12559464|FG000|NOT COMPLETED|Overall Study||5
11362726|NCT03975920|12559472|FG000|STARTED|Overall Study|Due to inclusion criteria protocol deviation, data from 1 participant was not used in the analysis.|84
11362727|NCT03975920|12559473|FG001|STARTED|Overall Study|Due to inclusion criteria protocol deviation, data from 1 participant was not used in the analysis.|87
11362728|NCT03975920|12559472|FG000|1-Month Follow-up Survey|Overall Study||80
11362729|NCT03975920|12559473|FG001|1-Month Follow-up Survey|Overall Study||85
11362730|NCT03975920|12559472|FG000|3-Month Follow-up Survey|Overall Study||78
11362731|NCT03975920|12559473|FG001|3-Month Follow-up Survey|Overall Study||84
11362732|NCT03975920|12559472|FG000|6-Month Follow-up Survey|Overall Study||80
11362733|NCT03975920|12559473|FG001|6-Month Follow-up Survey|Overall Study||83
11362734|NCT03975920|12559472|FG000|COMPLETED|Overall Study||80
11362735|NCT03975920|12559473|FG001|COMPLETED|Overall Study||83
11362736|NCT03975920|12559472|FG000|NOT COMPLETED|Overall Study||4
11362737|NCT03975920|12559473|FG001|NOT COMPLETED|Overall Study||4
11362738|NCT03746483|12559481|FG000|STARTED|Overall Study||21
11362739|NCT03746483|12559482|FG001|STARTED|Overall Study||20
11362740|NCT03746483|12559481|FG000|COMPLETED|Overall Study||15
11362741|NCT03746483|12559482|FG001|COMPLETED|Overall Study||17
11362742|NCT03746483|12559481|FG000|NOT COMPLETED|Overall Study||6
11362743|NCT03746483|12559482|FG001|NOT COMPLETED|Overall Study||3
11362744|NCT03717155|12559490|FG000|STARTED|Overall Study||43
11362745|NCT03717155|12559490|FG000|COMPLETED|Overall Study||43
11362746|NCT03717155|12559490|FG000|NOT COMPLETED|Overall Study||0
11362747|NCT03694327|12559496|FG000|STARTED|Overall Study||79
11362748|NCT03694327|12559497|FG001|STARTED|Overall Study||79
11362749|NCT03694327|12559496|FG000|COMPLETED|Overall Study||66
11362750|NCT03694327|12559497|FG001|COMPLETED|Overall Study||56
11362751|NCT03694327|12559496|FG000|NOT COMPLETED|Overall Study||13
11362752|NCT03694327|12559497|FG001|NOT COMPLETED|Overall Study||23
11362753|NCT03624036|12559507|FG000|STARTED|Overall Study||7
11362754|NCT03624036|12559508|FG001|STARTED|Overall Study||3
11362755|NCT03624036|12559509|FG002|STARTED|Overall Study||3
11362756|NCT03624036|12559510|FG003|STARTED|Overall Study||3
11362757|NCT03624036|12559507|FG000|COMPLETED|Overall Study||0
11362758|NCT03624036|12559508|FG001|COMPLETED|Overall Study||0
11362759|NCT03624036|12559509|FG002|COMPLETED|Overall Study||0
11362760|NCT03624036|12559510|FG003|COMPLETED|Overall Study||0
11362761|NCT03624036|12559507|FG000|NOT COMPLETED|Overall Study||7
11362762|NCT03624036|12559508|FG001|NOT COMPLETED|Overall Study||3
11362763|NCT03624036|12559509|FG002|NOT COMPLETED|Overall Study||3
11362764|NCT03624036|12559510|FG003|NOT COMPLETED|Overall Study||3
11362765|NCT03137160|12559520|FG000|STARTED|Overall Study||4
11362766|NCT03137160|12559520|FG000|COMPLETED|Overall Study||2
11362767|NCT03137160|12559520|FG000|NOT COMPLETED|Overall Study||2
11362768|NCT03057951|12559526|FG000|STARTED|Overall Study||2991
11362769|NCT03057951|12559527|FG001|STARTED|Overall Study||2997
11362770|NCT03057951|12559526|FG000|Treated|Overall Study||2989
11362771|NCT03057951|12559527|FG001|Treated|Overall Study||2996
11362772|NCT03057951|12559526|FG000|COMPLETED|Overall Study||2046
11362773|NCT03057951|12559527|FG001|COMPLETED|Overall Study||2051
11362774|NCT03057951|12559526|FG000|NOT COMPLETED|Overall Study||945
11362775|NCT03057951|12559527|FG001|NOT COMPLETED|Overall Study||946
11362776|NCT03007888|12559533|FG000|STARTED|First Intervention (14 Days)||15
11362777|NCT03007888|12559534|FG001|STARTED|First Intervention (14 Days)||13
11362778|NCT03007888|12559533|FG000|COMPLETED|First Intervention (14 Days)||14
11362779|NCT03007888|12559534|FG001|COMPLETED|First Intervention (14 Days)||13
11362780|NCT03007888|12559533|FG000|NOT COMPLETED|First Intervention (14 Days)||1
11362781|NCT03007888|12559534|FG001|NOT COMPLETED|First Intervention (14 Days)||0
11362782|NCT03007888|12559533|FG000|STARTED|Washout (7 Days)||14
11362783|NCT03007888|12559534|FG001|STARTED|Washout (7 Days)||13
11362784|NCT03007888|12559533|FG000|COMPLETED|Washout (7 Days)||14
11362785|NCT03007888|12559534|FG001|COMPLETED|Washout (7 Days)||13
11362786|NCT03007888|12559533|FG000|NOT COMPLETED|Washout (7 Days)||0
11362787|NCT03007888|12559534|FG001|NOT COMPLETED|Washout (7 Days)||0
11362788|NCT03007888|12559533|FG000|STARTED|Second Interventions (14 Days)||14
11362789|NCT03007888|12559534|FG001|STARTED|Second Interventions (14 Days)||13
11362790|NCT03007888|12559533|FG000|COMPLETED|Second Interventions (14 Days)||14
11362791|NCT03007888|12559534|FG001|COMPLETED|Second Interventions (14 Days)||13
11362792|NCT03007888|12559533|FG000|NOT COMPLETED|Second Interventions (14 Days)||0
11362793|NCT03007888|12559534|FG001|NOT COMPLETED|Second Interventions (14 Days)||0
11362794|NCT02971033|12559546|FG000|STARTED|Overall Study||1
11362795|NCT02971033|12559547|FG001|STARTED|Overall Study||1
11362796|NCT02971033|12559548|FG002|STARTED|Overall Study||0
11362797|NCT02971033|12559546|FG000|COMPLETED|Overall Study||1
11362798|NCT02971033|12559547|FG001|COMPLETED|Overall Study||1
11362799|NCT02971033|12559548|FG002|COMPLETED|Overall Study||0
11362800|NCT02971033|12559546|FG000|NOT COMPLETED|Overall Study||0
11362801|NCT02971033|12559547|FG001|NOT COMPLETED|Overall Study||0
11362802|NCT02971033|12559548|FG002|NOT COMPLETED|Overall Study||0
11362803|NCT02949934|12559562|FG000|STARTED|Natural Drinking Period||16
11362804|NCT02949934|12559563|FG001|STARTED|Natural Drinking Period||12
11362805|NCT02949934|12559564|FG002|STARTED|Natural Drinking Period||17
11362806|NCT02949934|12559565|FG003|STARTED|Natural Drinking Period||16
11362807|NCT02949934|12559566|FG004|STARTED|Natural Drinking Period||15
11362808|NCT02949934|12559567|FG005|STARTED|Natural Drinking Period||14
11362809|NCT02949934|12559562|FG000|COMPLETED|Natural Drinking Period||15
11362810|NCT02949934|12559563|FG001|COMPLETED|Natural Drinking Period||12
11362811|NCT02949934|12559564|FG002|COMPLETED|Natural Drinking Period||17
11362812|NCT02949934|12559565|FG003|COMPLETED|Natural Drinking Period||15
11362813|NCT02949934|12559566|FG004|COMPLETED|Natural Drinking Period||14
11362814|NCT02949934|12559567|FG005|COMPLETED|Natural Drinking Period||14
11362815|NCT02949934|12559562|FG000|NOT COMPLETED|Natural Drinking Period||1
11362816|NCT02949934|12559563|FG001|NOT COMPLETED|Natural Drinking Period||0
11362817|NCT02949934|12559564|FG002|NOT COMPLETED|Natural Drinking Period||0
11362818|NCT02949934|12559565|FG003|NOT COMPLETED|Natural Drinking Period||1
11362819|NCT02949934|12559566|FG004|NOT COMPLETED|Natural Drinking Period||1
11362820|NCT02949934|12559567|FG005|NOT COMPLETED|Natural Drinking Period||0
11362821|NCT02949934|12559562|FG000|STARTED|Neuroimaging||15
11362822|NCT02949934|12559563|FG001|STARTED|Neuroimaging||12
11362823|NCT02949934|12559564|FG002|STARTED|Neuroimaging||17
11362824|NCT02949934|12559565|FG003|STARTED|Neuroimaging||15
11362825|NCT02949934|12559566|FG004|STARTED|Neuroimaging||14
11362826|NCT02949934|12559567|FG005|STARTED|Neuroimaging||14
11362827|NCT02949934|12559562|FG000|COMPLETED|Neuroimaging||12
11362828|NCT02949934|12559563|FG001|COMPLETED|Neuroimaging||12
11362829|NCT02949934|12559564|FG002|COMPLETED|Neuroimaging||15
11362830|NCT02949934|12559565|FG003|COMPLETED|Neuroimaging||15
11362831|NCT02949934|12559566|FG004|COMPLETED|Neuroimaging||12
11362832|NCT02949934|12559567|FG005|COMPLETED|Neuroimaging||12
11362833|NCT02949934|12559562|FG000|NOT COMPLETED|Neuroimaging||3
11362834|NCT02949934|12559563|FG001|NOT COMPLETED|Neuroimaging||0
11362835|NCT02949934|12559564|FG002|NOT COMPLETED|Neuroimaging||2
11362836|NCT02949934|12559565|FG003|NOT COMPLETED|Neuroimaging||0
11362837|NCT02949934|12559566|FG004|NOT COMPLETED|Neuroimaging||2
11362838|NCT02949934|12559567|FG005|NOT COMPLETED|Neuroimaging||2
11362839|NCT02949934|12559562|FG000|STARTED|Bar Laboratory||13
11362840|NCT02949934|12559563|FG001|STARTED|Bar Laboratory||12
11362841|NCT02949934|12559564|FG002|STARTED|Bar Laboratory||17
11362842|NCT02949934|12559565|FG003|STARTED|Bar Laboratory||15
11362843|NCT02949934|12559566|FG004|STARTED|Bar Laboratory||13
11362844|NCT02949934|12559567|FG005|STARTED|Bar Laboratory||14
11005593|NCT00723528|12183301|FG004|STARTED|Period 1: Controlled Period (CP)||0
11362845|NCT02949934|12559562|FG000|COMPLETED|Bar Laboratory||12
11362846|NCT02949934|12559563|FG001|COMPLETED|Bar Laboratory||7
11362847|NCT02949934|12559564|FG002|COMPLETED|Bar Laboratory||10
11362848|NCT02949934|12559565|FG003|COMPLETED|Bar Laboratory||11
11362849|NCT02949934|12559566|FG004|COMPLETED|Bar Laboratory||7
11362850|NCT02949934|12559567|FG005|COMPLETED|Bar Laboratory||13
11362851|NCT02949934|12559562|FG000|NOT COMPLETED|Bar Laboratory||1
11362852|NCT02949934|12559563|FG001|NOT COMPLETED|Bar Laboratory||5
11362853|NCT02949934|12559564|FG002|NOT COMPLETED|Bar Laboratory||7
11362854|NCT02949934|12559565|FG003|NOT COMPLETED|Bar Laboratory||4
11362855|NCT02949934|12559566|FG004|NOT COMPLETED|Bar Laboratory||6
11362856|NCT02949934|12559567|FG005|NOT COMPLETED|Bar Laboratory||1
11362857|NCT02796001|12559584|FG000|STARTED|Overall Study||20
11362858|NCT02796001|12559585|FG001|STARTED|Overall Study||22
11362859|NCT02796001|12559586|FG002|STARTED|Overall Study||4
11362860|NCT02796001|12559584|FG000|COMPLETED|Overall Study||20
11362861|NCT02796001|12559585|FG001|COMPLETED|Overall Study||22
11362862|NCT02796001|12559586|FG002|COMPLETED|Overall Study||4
11362863|NCT02796001|12559584|FG000|NOT COMPLETED|Overall Study||0
11362864|NCT02796001|12559585|FG001|NOT COMPLETED|Overall Study||0
11362865|NCT02796001|12559586|FG002|NOT COMPLETED|Overall Study||0
11362866|NCT02658656|12559595|FG000|STARTED|Screening||78
11362867|NCT02658656|12559596|FG001|STARTED|Screening||83
11362868|NCT02658656|12559597|FG002|STARTED|Screening||263
11362869|NCT02658656|12559595|FG000|COMPLETED|Screening||78
11362870|NCT02658656|12559596|FG001|COMPLETED|Screening||83
11362871|NCT02658656|12559597|FG002|COMPLETED|Screening||0
11362872|NCT02658656|12559595|FG000|NOT COMPLETED|Screening||0
11362873|NCT02658656|12559596|FG001|NOT COMPLETED|Screening||0
11362874|NCT02658656|12559597|FG002|NOT COMPLETED|Screening||263
11362875|NCT02658656|12559595|FG000|STARTED|Randomization||78
11362876|NCT02658656|12559596|FG001|STARTED|Randomization||83
11362877|NCT02658656|12559597|FG002|STARTED|Randomization||0
11362878|NCT02658656|12559595|FG000|COMPLETED|Randomization||45
11362879|NCT02658656|12559596|FG001|COMPLETED|Randomization||57
11362880|NCT02658656|12559597|FG002|COMPLETED|Randomization||0
11362881|NCT02658656|12559595|FG000|NOT COMPLETED|Randomization||33
11362882|NCT02658656|12559596|FG001|NOT COMPLETED|Randomization||26
11362883|NCT02658656|12559597|FG002|NOT COMPLETED|Randomization||0
11362884|NCT02536170|12559607|FG000|STARTED|Overall Study||36
11362885|NCT02536170|12559608|FG001|STARTED|Overall Study||36
11362886|NCT02536170|12559609|FG002|STARTED|Overall Study||36
11362887|NCT02536170|12559607|FG000|COMPLETED|Overall Study||36
11362888|NCT02536170|12559608|FG001|COMPLETED|Overall Study||36
11362889|NCT02536170|12559609|FG002|COMPLETED|Overall Study||36
11362890|NCT02536170|12559607|FG000|NOT COMPLETED|Overall Study||0
11362891|NCT02536170|12559608|FG001|NOT COMPLETED|Overall Study||0
11362892|NCT02536170|12559609|FG002|NOT COMPLETED|Overall Study||0
11362893|NCT01801189|12559619|FG000|STARTED|Overall Study||28
11362894|NCT01801189|12559620|FG001|STARTED|Overall Study||33
11362895|NCT01801189|12559619|FG000|COMPLETED|Overall Study||28
11362896|NCT01801189|12559620|FG001|COMPLETED|Overall Study||33
11362897|NCT01801189|12559619|FG000|NOT COMPLETED|Overall Study||0
11362898|NCT01801189|12559620|FG001|NOT COMPLETED|Overall Study||0
11362899|NCT01667081|12559628|FG000|STARTED|Overall Study||1909
11362900|NCT01667081|12559629|FG001|STARTED|Overall Study||526
11362901|NCT01667081|12559628|FG000|COMPLETED|Overall Study||132
11362902|NCT01667081|12559629|FG001|COMPLETED|Overall Study||169
11362903|NCT01667081|12559628|FG000|NOT COMPLETED|Overall Study||1777
11362904|NCT01667081|12559629|FG001|NOT COMPLETED|Overall Study||357
11362905|NCT00634504|12559648|FG000|STARTED|Overall Study||11
11362906|NCT00634504|12559649|FG001|STARTED|Overall Study||9
11362907|NCT00634504|12559648|FG000|COMPLETED|Overall Study||10
11362908|NCT00634504|12559649|FG001|COMPLETED|Overall Study||9
11362909|NCT00634504|12559648|FG000|NOT COMPLETED|Overall Study||1
11362910|NCT00634504|12559649|FG001|NOT COMPLETED|Overall Study||0
11362911|NCT00392821|12559658|FG000|STARTED|Overall Study||3
11362912|NCT00392821|12559659|FG001|STARTED|Overall Study||6
11362913|NCT00392821|12559660|FG002|STARTED|Overall Study||69
11362914|NCT00392821|12559658|FG000|COMPLETED|Overall Study||0
11362915|NCT00392821|12559659|FG001|COMPLETED|Overall Study||0
11362916|NCT00392821|12559660|FG002|COMPLETED|Overall Study||0
11362917|NCT00392821|12559658|FG000|NOT COMPLETED|Overall Study||3
11362918|NCT00392821|12559659|FG001|NOT COMPLETED|Overall Study||6
11362919|NCT00392821|12559660|FG002|NOT COMPLETED|Overall Study||69
11362920|NCT00352027|12559666|FG000|STARTED|Overall Study||80
11362921|NCT00352027|12559666|FG000|COMPLETED|Overall Study||77
11362922|NCT00352027|12559666|FG000|NOT COMPLETED|Overall Study||3
11362923|NCT00104676|12559694|FG000|STARTED|Overall Study||98
11362924|NCT00104676|12559695|FG001|STARTED|Overall Study||105
11362925|NCT00104676|12559694|FG000|COMPLETED|Overall Study||91
11362926|NCT00104676|12559695|FG001|COMPLETED|Overall Study||91
11362927|NCT00104676|12559694|FG000|NOT COMPLETED|Overall Study||7
11362928|NCT00104676|12559695|FG001|NOT COMPLETED|Overall Study||14
11005594|NCT00723528|12183302|FG005|STARTED|Period 1: Controlled Period (CP)||0
11005595|NCT00723528|12183303|FG006|STARTED|Period 1: Controlled Period (CP)||0
11005596|NCT00723528|12183297|FG000|COMPLETED|Period 1: Controlled Period (CP)||28
11005597|NCT00723528|12183298|FG001|COMPLETED|Period 1: Controlled Period (CP)||64
11362929|NCT04426500|12559704|FG000|STARTED|Overall Study||28
11362930|NCT04426500|12559705|FG001|STARTED|Overall Study||64
11362931|NCT04426500|12559706|FG002|STARTED|Overall Study||56
11362932|NCT04426500|12559704|FG000|COMPLETED|Overall Study||28
11362933|NCT04426500|12559705|FG001|COMPLETED|Overall Study||64
11362934|NCT04426500|12559706|FG002|COMPLETED|Overall Study||56
11362935|NCT04426500|12559704|FG000|NOT COMPLETED|Overall Study||0
11362936|NCT04426500|12559705|FG001|NOT COMPLETED|Overall Study||0
11362937|NCT04426500|12559706|FG002|NOT COMPLETED|Overall Study||0
11362938|NCT04042103|12559714|FG000|STARTED|Overall Study||21
11362939|NCT04042103|12559714|FG000|COMPLETED|Overall Study||19
11362940|NCT04042103|12559714|FG000|NOT COMPLETED|Overall Study||2
11362941|NCT04004208|12559720|FG000|STARTED|Overall Study||75
11362942|NCT04004208|12559721|FG001|STARTED|Overall Study||38
11362943|NCT04004208|12559720|FG000|SAF|Overall Study||75
11362944|NCT04004208|12559721|FG001|SAF|Overall Study||38
11362945|NCT04004208|12559720|FG000|PKS|Overall Study||75
11362946|NCT04004208|12559721|FG001|PKS|Overall Study||0
11362947|NCT04004208|12559720|FG000|AAS|Overall Study||75
11362948|NCT04004208|12559721|FG001|AAS|Overall Study||0
11362949|NCT04004208|12559720|FG000|COMPLETED|Overall Study||68
11362950|NCT04004208|12559721|FG001|COMPLETED|Overall Study||36
11362951|NCT04004208|12559720|FG000|NOT COMPLETED|Overall Study||7
11362952|NCT04004208|12559721|FG001|NOT COMPLETED|Overall Study||2
11362953|NCT03817190|12559729|FG000|STARTED|Overall Study||110
11362954|NCT03817190|12559730|FG001|STARTED|Overall Study||109
11362955|NCT03817190|12559729|FG000|COMPLETED|Overall Study||50
11362956|NCT03817190|12559730|FG001|COMPLETED|Overall Study||50
11362957|NCT03817190|12559729|FG000|NOT COMPLETED|Overall Study||60
11362958|NCT03817190|12559730|FG001|NOT COMPLETED|Overall Study||59
11362959|NCT03447782|12559736|FG000|STARTED|Overall Study||45
11362960|NCT03447782|12559736|FG000|COMPLETED|Overall Study||25
11362961|NCT03447782|12559736|FG000|NOT COMPLETED|Overall Study||20
11362962|NCT03041311|12559742|FG000|STARTED|Overall Study||54
11362963|NCT03041311|12559743|FG001|STARTED|Overall Study||53
11362964|NCT03041311|12559742|FG000|COMPLETED|Overall Study||0
11362965|NCT03041311|12559743|FG001|COMPLETED|Overall Study||0
11362966|NCT03041311|12559742|FG000|NOT COMPLETED|Overall Study||54
11362967|NCT03041311|12559743|FG001|NOT COMPLETED|Overall Study||53
11362968|NCT03020914|12559759|FG000|STARTED|Overall Study||10
11362969|NCT03020914|12559760|FG001|STARTED|Overall Study||9
11362970|NCT03020914|12559759|FG000|COMPLETED|Overall Study||9
11362971|NCT03020914|12559760|FG001|COMPLETED|Overall Study||9
11362972|NCT03020914|12559759|FG000|NOT COMPLETED|Overall Study||1
11362973|NCT03020914|12559760|FG001|NOT COMPLETED|Overall Study||0
11362974|NCT02803307|12559768|FG000|STARTED|Overall Study||20
11362975|NCT02803307|12559769|FG001|STARTED|Overall Study||20
11362976|NCT02803307|12559768|FG000|COMPLETED|Overall Study||20
11362977|NCT02803307|12559769|FG001|COMPLETED|Overall Study||20
11362978|NCT02803307|12559768|FG000|NOT COMPLETED|Overall Study||0
11362979|NCT02803307|12559769|FG001|NOT COMPLETED|Overall Study||0
11362980|NCT02698891|12559775|FG000|STARTED|Overall Study||127
11362981|NCT02698891|12559775|FG000|Treated|Overall Study||125
11362982|NCT02698891|12559775|FG000|COMPLETED|Overall Study||115
11362983|NCT02698891|12559775|FG000|NOT COMPLETED|Overall Study||12
11362984|NCT02537678|12559781|FG000|STARTED|Baseline to Post-treatment|91 parents/guardians and 91 children started.|91
11362985|NCT02537678|12559782|FG001|STARTED|Baseline to Post-treatment|92 parents/guardians and 92 children started.|92
11362986|NCT02537678|12559781|FG000|Completed Post-treatment|Baseline to Post-treatment|61 parents/guardians and 61 children completed post-treatment.|61
11362987|NCT02537678|12559782|FG001|Completed Post-treatment|Baseline to Post-treatment|71 parents/guardians and 71 children completed post-treatment.|71
11362988|NCT02537678|12559781|FG000|COMPLETED|Baseline to Post-treatment|61 parent/guardian-child dyads completed.|61
11362989|NCT02537678|12559782|FG001|COMPLETED|Baseline to Post-treatment|71 parent/guardian-child dyads completed.|71
11362990|NCT02537678|12559781|FG000|NOT COMPLETED|Baseline to Post-treatment||30
11362991|NCT02537678|12559782|FG001|NOT COMPLETED|Baseline to Post-treatment||21
11362992|NCT02537678|12559781|FG000|STARTED|Post-treatment to 6 Month Assessment|61 parents/guardians and 61 children started.|61
11362993|NCT02537678|12559782|FG001|STARTED|Post-treatment to 6 Month Assessment|71 parents/guardians and 71 children started.|71
11362994|NCT02537678|12559781|FG000|COMPLETED|Post-treatment to 6 Month Assessment|53 parents/guardians and 53 children completed.|53
11362995|NCT02537678|12559782|FG001|COMPLETED|Post-treatment to 6 Month Assessment|64 parents/guardians and 64 children completed.|64
11362996|NCT02537678|12559781|FG000|NOT COMPLETED|Post-treatment to 6 Month Assessment||8
11362997|NCT02537678|12559782|FG001|NOT COMPLETED|Post-treatment to 6 Month Assessment||7
11362998|NCT02537678|12559781|FG000|STARTED|6 Month to 12 Month Assessment|53 parent/guardians and 53 children started.|53
11362999|NCT02537678|12559782|FG001|STARTED|6 Month to 12 Month Assessment|64 parent/guardians and 64 children started.|64
11363000|NCT02537678|12559781|FG000|COMPLETED|6 Month to 12 Month Assessment|53 parent/guardians and 53 children completed.|53
11363001|NCT02537678|12559782|FG001|COMPLETED|6 Month to 12 Month Assessment|63 parent/guardians and 63 children completed.|63
11363002|NCT02537678|12559781|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||0
11363003|NCT02537678|12559782|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||1
11363004|NCT02400476|12559798|FG000|STARTED|Overall Study||137
11363005|NCT02400476|12559799|FG001|STARTED|Overall Study||64
11363006|NCT02400476|12559800|FG002|STARTED|Overall Study||136
11363007|NCT02400476|12559801|FG003|STARTED|Overall Study||104
11363008|NCT02400476|12559802|FG004|STARTED|Overall Study||60
11363009|NCT02400476|12559803|FG005|STARTED|Overall Study||62
11363010|NCT02400476|12559798|FG000|COMPLETED|Overall Study||76
11363011|NCT02400476|12559799|FG001|COMPLETED|Overall Study||52
11363012|NCT02400476|12559800|FG002|COMPLETED|Overall Study||95
11363013|NCT02400476|12559801|FG003|COMPLETED|Overall Study||74
11363014|NCT02400476|12559802|FG004|COMPLETED|Overall Study||45
11363015|NCT02400476|12559803|FG005|COMPLETED|Overall Study||46
11363016|NCT02400476|12559798|FG000|NOT COMPLETED|Overall Study||61
11363017|NCT02400476|12559799|FG001|NOT COMPLETED|Overall Study||12
11363018|NCT02400476|12559800|FG002|NOT COMPLETED|Overall Study||41
11363019|NCT02400476|12559801|FG003|NOT COMPLETED|Overall Study||30
11363020|NCT02400476|12559802|FG004|NOT COMPLETED|Overall Study||15
11363021|NCT02400476|12559803|FG005|NOT COMPLETED|Overall Study||16
11363022|NCT01818986|12559817|FG000|STARTED|Overall Study||20
11363023|NCT01818986|12559817|FG000|COMPLETED|Overall Study||20
11363024|NCT01818986|12559817|FG000|NOT COMPLETED|Overall Study||0
11363025|NCT01507545|12559823|FG000|STARTED|Overall Study||84
11363026|NCT01507545|12559824|FG001|STARTED|Overall Study||42
11363027|NCT01507545|12559823|FG000|Treated/Safety Set|Overall Study||82
11363028|NCT01507545|12559824|FG001|Treated/Safety Set|Overall Study||40
11363029|NCT01507545|12559823|FG000|COMPLETED|Overall Study||0
11363030|NCT01507545|12559824|FG001|COMPLETED|Overall Study||0
11363031|NCT01507545|12559823|FG000|NOT COMPLETED|Overall Study||84
11363032|NCT01507545|12559824|FG001|NOT COMPLETED|Overall Study||42
11363033|NCT01463670|12559830|FG000|STARTED|Overall Study||11
11363034|NCT01463670|12559830|FG000|COMPLETED|Overall Study||11
11363035|NCT01463670|12559830|FG000|NOT COMPLETED|Overall Study||0
11363036|NCT00920816|12559838|FG000|STARTED|Overall Study||192
11363037|NCT00920816|12559839|FG001|STARTED|Overall Study||96
11363038|NCT00920816|12559840|FG002|STARTED|Overall Study||135
11363039|NCT00920816|12559841|FG003|STARTED|Overall Study||69
11363040|NCT00920816|12559838|FG000|Treated|Overall Study||189
11363041|NCT00920816|12559839|FG001|Treated|Overall Study||96
11363042|NCT00920816|12559840|FG002|Treated|Overall Study||135
11363043|NCT00920816|12559841|FG003|Treated|Overall Study||69
11363044|NCT00920816|12559838|FG000|Participants From China (Excluded From Safety Analysis)|Overall Study||16
11363045|NCT00920816|12559839|FG001|Participants From China (Excluded From Safety Analysis)|Overall Study||8
11363046|NCT00920816|12559840|FG002|Participants From China (Excluded From Safety Analysis)|Overall Study||124
11363047|NCT00920816|12559841|FG003|Participants From China (Excluded From Safety Analysis)|Overall Study||64
11363048|NCT00920816|12559838|FG000|COMPLETED|Overall Study||0
11363049|NCT00920816|12559839|FG001|COMPLETED|Overall Study||0
11363050|NCT00920816|12559840|FG002|COMPLETED|Overall Study||0
11363051|NCT00920816|12559841|FG003|COMPLETED|Overall Study||0
11363052|NCT00920816|12559838|FG000|NOT COMPLETED|Overall Study||192
11363053|NCT00920816|12559839|FG001|NOT COMPLETED|Overall Study||96
11363054|NCT00920816|12559840|FG002|NOT COMPLETED|Overall Study||135
11363055|NCT00920816|12559841|FG003|NOT COMPLETED|Overall Study||69
11363056|NCT03180645|12559854|FG000|STARTED|Overall Study||24
11363057|NCT03180645|12559855|FG001|STARTED|Overall Study||24
11363058|NCT03180645|12559856|FG002|STARTED|Overall Study||24
11363059|NCT03180645|12559854|FG000|COMPLETED|Overall Study||24
11363060|NCT03180645|12559855|FG001|COMPLETED|Overall Study||23
11363061|NCT03180645|12559856|FG002|COMPLETED|Overall Study||22
11363062|NCT03180645|12559854|FG000|NOT COMPLETED|Overall Study||0
11363063|NCT03180645|12559855|FG001|NOT COMPLETED|Overall Study||1
11363064|NCT03180645|12559856|FG002|NOT COMPLETED|Overall Study||2
11363065|NCT03180801|12559871|FG000|STARTED|Overall Study||50
11363066|NCT03180801|12559872|FG001|STARTED|Overall Study||52
11363067|NCT03180801|12559873|FG002|STARTED|Overall Study||51
11363068|NCT03180801|12559871|FG000|Safety Population|Overall Study||50
11363069|NCT03180801|12559872|FG001|Safety Population|Overall Study||52
11363070|NCT03180801|12559873|FG002|Safety Population|Overall Study||51
11363071|NCT03180801|12559871|FG000|Intention to Treat|Overall Study||42
11363072|NCT03180801|12559872|FG001|Intention to Treat|Overall Study||40
11363073|NCT03180801|12559873|FG002|Intention to Treat|Overall Study||41
11363074|NCT03180801|12559871|FG000|COMPLETED|Overall Study||42
11363075|NCT03180801|12559872|FG001|COMPLETED|Overall Study||40
11363076|NCT03180801|12559873|FG002|COMPLETED|Overall Study||41
11363077|NCT03180801|12559871|FG000|NOT COMPLETED|Overall Study||8
11363078|NCT03180801|12559872|FG001|NOT COMPLETED|Overall Study||12
11363079|NCT03180801|12559873|FG002|NOT COMPLETED|Overall Study||10
11363080|NCT03181009|12559886|FG000|STARTED|Overall Study||30
11363081|NCT03181009|12559887|FG001|STARTED|Overall Study||30
11363082|NCT03181009|12559886|FG000|COMPLETED|Overall Study||30
11363083|NCT03181009|12559887|FG001|COMPLETED|Overall Study||28
11363084|NCT03181009|12559886|FG000|NOT COMPLETED|Overall Study||0
11363085|NCT03181009|12559887|FG001|NOT COMPLETED|Overall Study||2
11363086|NCT03181308|12559895|FG000|STARTED|Overall Study||3
11363087|NCT03181308|12559896|FG001|STARTED|Overall Study||8
11363088|NCT03181308|12559895|FG000|COMPLETED|Overall Study||3
11363089|NCT03181308|12559896|FG001|COMPLETED|Overall Study||8
11363090|NCT03181308|12559895|FG000|NOT COMPLETED|Overall Study||0
11363091|NCT03181308|12559896|FG001|NOT COMPLETED|Overall Study||0
11363092|NCT03181451|12559905|FG000|STARTED|Overall Study||12
11363093|NCT03181451|12559906|FG001|STARTED|Overall Study||13
11363094|NCT03181451|12559907|FG002|STARTED|Overall Study||12
11363095|NCT03181451|12559905|FG000|COMPLETED|Overall Study||12
11363096|NCT03181451|12559906|FG001|COMPLETED|Overall Study||11
11363097|NCT03181451|12559907|FG002|COMPLETED|Overall Study||12
11363098|NCT03181451|12559905|FG000|NOT COMPLETED|Overall Study||0
11363099|NCT03181451|12559906|FG001|NOT COMPLETED|Overall Study||2
11363100|NCT03181451|12559907|FG002|NOT COMPLETED|Overall Study||0
11363101|NCT03181503|12559919|FG000|STARTED|Overall Study||36
11363102|NCT03181503|12559920|FG001|STARTED|Overall Study||34
11363103|NCT03181503|12559919|FG000|Treated|Overall Study||36
11363104|NCT03181503|12559920|FG001|Treated|Overall Study||34
11363105|NCT03181503|12559919|FG000|COMPLETED|Overall Study||29
11363106|NCT03181503|12559920|FG001|COMPLETED|Overall Study||31
11363107|NCT03181503|12559919|FG000|NOT COMPLETED|Overall Study||7
11363108|NCT03181503|12559920|FG001|NOT COMPLETED|Overall Study||3
11363109|NCT03181594|12559929|FG000|STARTED|Initial Study Protocol (12-month FU)||100
11363110|NCT03181594|12559929|FG000|30-day Follow-up|Initial Study Protocol (12-month FU)||99
11363111|NCT03181594|12559929|FG000|90-day Follow-up|Initial Study Protocol (12-month FU)||98
11363112|NCT03181594|12559929|FG000|6-month Follow-up|Initial Study Protocol (12-month FU)||98
11363113|NCT03181594|12559929|FG000|9-month Follow-up|Initial Study Protocol (12-month FU)||95
11363114|NCT03181594|12559929|FG000|12-month Follow-up|Initial Study Protocol (12-month FU)||91
11363115|NCT03181594|12559929|FG000|COMPLETED|Initial Study Protocol (12-month FU)||91
11363116|NCT03181594|12559929|FG000|NOT COMPLETED|Initial Study Protocol (12-month FU)||9
11363117|NCT03181594|12559929|FG000|STARTED|Long-term Extension (15-24 Month FU)||62
11363118|NCT03181594|12559929|FG000|15-month Follow-up|Long-term Extension (15-24 Month FU)||56
11363119|NCT03181594|12559929|FG000|18-month Follow-up|Long-term Extension (15-24 Month FU)||57
11363120|NCT03181594|12559929|FG000|21-month Follow-up|Long-term Extension (15-24 Month FU)||55
11363121|NCT03181594|12559929|FG000|24-month Follow-up|Long-term Extension (15-24 Month FU)||57
11363122|NCT03181594|12559929|FG000|COMPLETED|Long-term Extension (15-24 Month FU)||57
11363123|NCT03181594|12559929|FG000|NOT COMPLETED|Long-term Extension (15-24 Month FU)||5
11363124|NCT03181724|12559935|FG000|STARTED|Overall Study||45
11363125|NCT03181724|12559936|FG001|STARTED|Overall Study||45
11363126|NCT03181724|12559935|FG000|COMPLETED|Overall Study||45
11363127|NCT03181724|12559936|FG001|COMPLETED|Overall Study||45
11363128|NCT03181724|12559935|FG000|NOT COMPLETED|Overall Study||0
11363129|NCT03181724|12559936|FG001|NOT COMPLETED|Overall Study||0
11363130|NCT03181932|12559944|FG000|STARTED|Period 1 (Double-blind Period)||90
11363131|NCT03181932|12559945|FG001|STARTED|Period 1 (Double-blind Period)||98
11363132|NCT03181932|12559944|FG000|COMPLETED|Period 1 (Double-blind Period)||79
11363133|NCT03181932|12559945|FG001|COMPLETED|Period 1 (Double-blind Period)||85
11363134|NCT03181932|12559944|FG000|NOT COMPLETED|Period 1 (Double-blind Period)||11
11363135|NCT03181932|12559945|FG001|NOT COMPLETED|Period 1 (Double-blind Period)||13
11363136|NCT03181932|12559944|FG000|STARTED|Period 2 (Open-label Period)||75
11363137|NCT03181932|12559945|FG001|STARTED|Period 2 (Open-label Period)||83
11363138|NCT03181932|12559944|FG000|COMPLETED|Period 2 (Open-label Period)||67
11363139|NCT03181932|12559945|FG001|COMPLETED|Period 2 (Open-label Period)||70
11363140|NCT03181932|12559944|FG000|NOT COMPLETED|Period 2 (Open-label Period)||8
11363141|NCT03181932|12559945|FG001|NOT COMPLETED|Period 2 (Open-label Period)||13
11363142|NCT03181958|12559955|FG000|STARTED|Overall Study||497
11363143|NCT03181958|12559956|FG001|STARTED|Overall Study||501
11363144|NCT03181958|12559957|FG002|STARTED|Overall Study||495
11363145|NCT03181958|12559955|FG000|COMPLETED|Overall Study||480
11363146|NCT03181958|12559956|FG001|COMPLETED|Overall Study||480
11363147|NCT03181958|12559957|FG002|COMPLETED|Overall Study||480
11363148|NCT03181958|12559955|FG000|NOT COMPLETED|Overall Study||17
11363149|NCT03181958|12559956|FG001|NOT COMPLETED|Overall Study||21
11363150|NCT03181958|12559957|FG002|NOT COMPLETED|Overall Study||15
11363151|NCT03182582|12559965|FG000|STARTED|Treatment 1||12
11363152|NCT03182582|12559966|FG001|STARTED|Treatment 1||10
11363153|NCT03182582|12559965|FG000|COMPLETED|Treatment 1||12
11363154|NCT03182582|12559966|FG001|COMPLETED|Treatment 1||10
11363155|NCT03182582|12559965|FG000|NOT COMPLETED|Treatment 1||0
11363156|NCT03182582|12559966|FG001|NOT COMPLETED|Treatment 1||0
11363157|NCT03182582|12559965|FG000|STARTED|Treatment 2||12
11363158|NCT03182582|12559966|FG001|STARTED|Treatment 2||10
11363159|NCT03182582|12559965|FG000|COMPLETED|Treatment 2||12
11363160|NCT03182582|12559966|FG001|COMPLETED|Treatment 2||10
11363161|NCT03182582|12559965|FG000|NOT COMPLETED|Treatment 2||0
11363162|NCT03182582|12559966|FG001|NOT COMPLETED|Treatment 2||0
11363163|NCT03182725|12559979|FG000|STARTED|Treatment Arm 1 (First Half of Study)||16
11363164|NCT03182725|12559980|FG001|STARTED|Treatment Arm 1 (First Half of Study)||10
11363165|NCT03182725|12559979|FG000|COMPLETED|Treatment Arm 1 (First Half of Study)||16
11363166|NCT03182725|12559980|FG001|COMPLETED|Treatment Arm 1 (First Half of Study)||7
11363167|NCT03182725|12559979|FG000|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||0
11363168|NCT03182725|12559980|FG001|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||3
11363169|NCT03182725|12559979|FG000|STARTED|Treatment Arm 2 (Second Half of Study)||16
11363170|NCT03182725|12559980|FG001|STARTED|Treatment Arm 2 (Second Half of Study)|One participant withdrew during crossover and therefore did not start Treatment Arm 2.|6
11363171|NCT03182725|12559979|FG000|COMPLETED|Treatment Arm 2 (Second Half of Study)||16
11363172|NCT03182725|12559980|FG001|COMPLETED|Treatment Arm 2 (Second Half of Study)||6
11363173|NCT03182725|12559979|FG000|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
11363174|NCT03182725|12559980|FG001|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
11363175|NCT03182738|12559988|FG000|STARTED|Overall Study||50
11363176|NCT03182738|12559989|FG001|STARTED|Overall Study||50
11363177|NCT03182738|12559988|FG000|COMPLETED|Overall Study||41
11363178|NCT03182738|12559989|FG001|COMPLETED|Overall Study||45
11363179|NCT03182738|12559988|FG000|NOT COMPLETED|Overall Study||9
11363180|NCT03182738|12559989|FG001|NOT COMPLETED|Overall Study||5
11363181|NCT03182920|12559997|FG000|STARTED|Period 1||9
11363182|NCT03182920|12559998|FG001|STARTED|Period 1||9
11363183|NCT03182920|12559999|FG002|STARTED|Period 1||17
11363184|NCT03182920|12559997|FG000|COMPLETED|Period 1||9
11363185|NCT03182920|12559998|FG001|COMPLETED|Period 1||9
11363186|NCT03182920|12559999|FG002|COMPLETED|Period 1||17
11363187|NCT03182920|12559997|FG000|NOT COMPLETED|Period 1||0
11363188|NCT03182920|12559998|FG001|NOT COMPLETED|Period 1||0
11363189|NCT03182920|12559999|FG002|NOT COMPLETED|Period 1||0
11363190|NCT03182920|12559997|FG000|STARTED|Washout Period||9
11363191|NCT03182920|12559998|FG001|STARTED|Washout Period||9
11363192|NCT03182920|12559999|FG002|STARTED|Washout Period||0
11363193|NCT03182920|12559997|FG000|COMPLETED|Washout Period||9
11363194|NCT03182920|12559998|FG001|COMPLETED|Washout Period||9
11363195|NCT03182920|12559999|FG002|COMPLETED|Washout Period||0
11363196|NCT03182920|12559997|FG000|NOT COMPLETED|Washout Period||0
11363197|NCT03182920|12559998|FG001|NOT COMPLETED|Washout Period||0
11363198|NCT03182920|12559999|FG002|NOT COMPLETED|Washout Period||0
11363199|NCT03182920|12559997|FG000|STARTED|Period 2||9
11363200|NCT03182920|12559998|FG001|STARTED|Period 2||9
11363201|NCT03182920|12559999|FG002|STARTED|Period 2|Young participants on Lasmiditan did not move to study period 2.|0
11363202|NCT03182920|12559997|FG000|COMPLETED|Period 2||9
11363203|NCT03182920|12559998|FG001|COMPLETED|Period 2||9
11363204|NCT03182920|12559999|FG002|COMPLETED|Period 2||0
11363205|NCT03182920|12559997|FG000|NOT COMPLETED|Period 2||0
11363206|NCT03182920|12559998|FG001|NOT COMPLETED|Period 2||0
11363207|NCT03182920|12559999|FG002|NOT COMPLETED|Period 2||0
11363208|NCT03182933|12560008|FG000|STARTED|Overall Study||32
11363209|NCT03182933|12560009|FG001|STARTED|Overall Study||32
11363210|NCT03182933|12560008|FG000|COMPLETED|Overall Study||31
11363211|NCT03182933|12560009|FG001|COMPLETED|Overall Study||32
11363212|NCT03182933|12560008|FG000|NOT COMPLETED|Overall Study||1
11363213|NCT03182933|12560009|FG001|NOT COMPLETED|Overall Study||0
11363214|NCT03183063|12560018|FG000|STARTED|Overall Study||20
11363215|NCT03183063|12560019|FG001|STARTED|Overall Study||4
11363216|NCT03183063|12560020|FG002|STARTED|Overall Study||115
11363217|NCT03183063|12560018|FG000|COMPLETED|Overall Study||15
11363218|NCT03183063|12560019|FG001|COMPLETED|Overall Study||0
11363219|NCT03183063|12560020|FG002|COMPLETED|Overall Study||111
11363220|NCT03183063|12560018|FG000|NOT COMPLETED|Overall Study||5
11363221|NCT03183063|12560019|FG001|NOT COMPLETED|Overall Study||4
11363222|NCT03183063|12560020|FG002|NOT COMPLETED|Overall Study||4
11363223|NCT03183518|12560034|FG000|STARTED|Overall Study||36
11363224|NCT03183518|12560034|FG000|Test Product|Overall Study||36
11363225|NCT03183518|12560034|FG000|Negative Control|Overall Study||36
11363226|NCT03183518|12560034|FG000|COMPLETED|Overall Study||33
11363227|NCT03183518|12560034|FG000|NOT COMPLETED|Overall Study||3
11363228|NCT03183869|12560041|FG000|STARTED|Overall Study||4
11363229|NCT03183869|12560042|FG001|STARTED|Overall Study||7
11363230|NCT03183869|12560041|FG000|COMPLETED|Overall Study||0
11363231|NCT03183869|12560042|FG001|COMPLETED|Overall Study||2
11363232|NCT03183869|12560041|FG000|NOT COMPLETED|Overall Study||4
11363233|NCT03183869|12560042|FG001|NOT COMPLETED|Overall Study||5
11363234|NCT03183908|12560050|FG000|STARTED|Overall Study||378
11363235|NCT03183908|12560051|FG001|STARTED|Overall Study||379
11363236|NCT03183908|12560050|FG000|COMPLETED|Overall Study||378
11363237|NCT03183908|12560051|FG001|COMPLETED|Overall Study||377
11363238|NCT03183908|12560050|FG000|NOT COMPLETED|Overall Study||0
11363239|NCT03183908|12560051|FG001|NOT COMPLETED|Overall Study||2
11363240|NCT03184077|12560063|FG000|STARTED|Overall Study||166
11363241|NCT03184077|12560064|FG001|STARTED|Overall Study||152
11363242|NCT03184077|12560063|FG000|COMPLETED|Overall Study||145
11363243|NCT03184077|12560064|FG001|COMPLETED|Overall Study||131
11363244|NCT03184077|12560063|FG000|NOT COMPLETED|Overall Study||21
11363245|NCT03184077|12560064|FG001|NOT COMPLETED|Overall Study||21
11363246|NCT03184428|12560070|FG000|STARTED|Overall Study||3785
11363247|NCT03184428|12560070|FG000|COMPLETED|Overall Study||2963
11363248|NCT03184428|12560070|FG000|NOT COMPLETED|Overall Study||822
11363249|NCT03184441|12560086|FG000|STARTED|Overall Study||11
11363250|NCT03184441|12560086|FG000|COMPLETED|Overall Study|Last subject completed study|10
11363251|NCT03184441|12560086|FG000|NOT COMPLETED|Overall Study||1
11363252|NCT03184519|12560093|FG000|STARTED|Overall Study||156
11363253|NCT03184519|12560093|FG000|COMPLETED|Overall Study||129
11363254|NCT03184519|12560093|FG000|NOT COMPLETED|Overall Study||27
11363255|NCT03184558|12560097|FG000|STARTED|Overall Study||29
11363256|NCT03184558|12560097|FG000|COMPLETED|Overall Study||0
11363257|NCT03184558|12560097|FG000|NOT COMPLETED|Overall Study||29
11363258|NCT03184701|12560101|FG000|STARTED|Overall Study||45
11363259|NCT03184701|12560101|FG000|COMPLETED|Overall Study||28
11363260|NCT03184701|12560101|FG000|NOT COMPLETED|Overall Study||17
11363261|NCT03184987|12560108|FG000|STARTED|Overall Study||47
11363262|NCT03184987|12560109|FG001|STARTED|Overall Study||9
11363263|NCT03184987|12560110|FG002|STARTED|Overall Study||55
11363264|NCT03184987|12560108|FG000|COMPLETED|Overall Study||46
11363265|NCT03184987|12560109|FG001|COMPLETED|Overall Study||8
11363266|NCT03184987|12560110|FG002|COMPLETED|Overall Study||51
11363267|NCT03184987|12560108|FG000|NOT COMPLETED|Overall Study||1
11363268|NCT03184987|12560109|FG001|NOT COMPLETED|Overall Study||1
11363269|NCT03184987|12560110|FG002|NOT COMPLETED|Overall Study||4
11363270|NCT03185065|12560122|FG000|STARTED|Period 1 (6 Weeks)||35
11363271|NCT03185065|12560123|FG001|STARTED|Period 1 (6 Weeks)||34
11363272|NCT03185065|12560124|FG002|STARTED|Period 1 (6 Weeks)||35
11363273|NCT03185065|12560125|FG003|STARTED|Period 1 (6 Weeks)||37
11363274|NCT03185065|12560122|FG000|COMPLETED|Period 1 (6 Weeks)||32
11363275|NCT03185065|12560123|FG001|COMPLETED|Period 1 (6 Weeks)||33
11363276|NCT03185065|12560124|FG002|COMPLETED|Period 1 (6 Weeks)||32
11363277|NCT03185065|12560125|FG003|COMPLETED|Period 1 (6 Weeks)||36
11363278|NCT03185065|12560122|FG000|NOT COMPLETED|Period 1 (6 Weeks)||3
11363279|NCT03185065|12560123|FG001|NOT COMPLETED|Period 1 (6 Weeks)||1
11363280|NCT03185065|12560124|FG002|NOT COMPLETED|Period 1 (6 Weeks)||3
11363281|NCT03185065|12560125|FG003|NOT COMPLETED|Period 1 (6 Weeks)||1
11363282|NCT03185065|12560122|FG000|STARTED|Washout (2 Weeks)||32
11363283|NCT03185065|12560123|FG001|STARTED|Washout (2 Weeks)||33
11363284|NCT03185065|12560124|FG002|STARTED|Washout (2 Weeks)||32
11363285|NCT03185065|12560125|FG003|STARTED|Washout (2 Weeks)||36
11363286|NCT03185065|12560122|FG000|COMPLETED|Washout (2 Weeks)||32
11363287|NCT03185065|12560123|FG001|COMPLETED|Washout (2 Weeks)||31
11363288|NCT03185065|12560124|FG002|COMPLETED|Washout (2 Weeks)||32
11363289|NCT03185065|12560125|FG003|COMPLETED|Washout (2 Weeks)||35
11363290|NCT03185065|12560122|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11363291|NCT03185065|12560123|FG001|NOT COMPLETED|Washout (2 Weeks)||2
11363292|NCT03185065|12560124|FG002|NOT COMPLETED|Washout (2 Weeks)||0
11363293|NCT03185065|12560125|FG003|NOT COMPLETED|Washout (2 Weeks)||1
11363294|NCT03185065|12560122|FG000|STARTED|Period 2 (6 Weeks)||32
11363295|NCT03185065|12560123|FG001|STARTED|Period 2 (6 Weeks)||31
11363296|NCT03185065|12560124|FG002|STARTED|Period 2 (6 Weeks)||32
11363297|NCT03185065|12560125|FG003|STARTED|Period 2 (6 Weeks)||35
11363298|NCT03185065|12560122|FG000|COMPLETED|Period 2 (6 Weeks)||32
11363299|NCT03185065|12560123|FG001|COMPLETED|Period 2 (6 Weeks)||31
11363300|NCT03185065|12560124|FG002|COMPLETED|Period 2 (6 Weeks)||32
11363301|NCT03185065|12560125|FG003|COMPLETED|Period 2 (6 Weeks)||34
11363302|NCT03185065|12560122|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0
11363303|NCT03185065|12560123|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
11363304|NCT03185065|12560124|FG002|NOT COMPLETED|Period 2 (6 Weeks)||0
11363305|NCT03185065|12560125|FG003|NOT COMPLETED|Period 2 (6 Weeks)||1
11363306|NCT03185065|12560122|FG000|STARTED|Washout (2 Weeks)||32
11363307|NCT03185065|12560123|FG001|STARTED|Washout (2 Weeks)||31
11363308|NCT03185065|12560124|FG002|STARTED|Washout (2 Weeks)||32
11363309|NCT03185065|12560125|FG003|STARTED|Washout (2 Weeks)||34
11363310|NCT03185065|12560122|FG000|COMPLETED|Washout (2 Weeks)||31
11363311|NCT03185065|12560123|FG001|COMPLETED|Washout (2 Weeks)||29
11363312|NCT03185065|12560124|FG002|COMPLETED|Washout (2 Weeks)||31
11363313|NCT03185065|12560125|FG003|COMPLETED|Washout (2 Weeks)||32
11363314|NCT03185065|12560122|FG000|NOT COMPLETED|Washout (2 Weeks)||1
11363315|NCT03185065|12560123|FG001|NOT COMPLETED|Washout (2 Weeks)||2
11363316|NCT03185065|12560124|FG002|NOT COMPLETED|Washout (2 Weeks)||1
11363317|NCT03185065|12560125|FG003|NOT COMPLETED|Washout (2 Weeks)||2
11363318|NCT03185065|12560122|FG000|STARTED|Period 3 (6 Weeks)||31
11363319|NCT03185065|12560123|FG001|STARTED|Period 3 (6 Weeks)||29
11363320|NCT03185065|12560124|FG002|STARTED|Period 3 (6 Weeks)||31
11363321|NCT03185065|12560125|FG003|STARTED|Period 3 (6 Weeks)||32
11363322|NCT03185065|12560122|FG000|COMPLETED|Period 3 (6 Weeks)||31
11363323|NCT03185065|12560123|FG001|COMPLETED|Period 3 (6 Weeks)||29
11363324|NCT03185065|12560124|FG002|COMPLETED|Period 3 (6 Weeks)||29
11363325|NCT03185065|12560125|FG003|COMPLETED|Period 3 (6 Weeks)||32
11363326|NCT03185065|12560122|FG000|NOT COMPLETED|Period 3 (6 Weeks)||0
11363327|NCT03185065|12560123|FG001|NOT COMPLETED|Period 3 (6 Weeks)||0
11363328|NCT03185065|12560124|FG002|NOT COMPLETED|Period 3 (6 Weeks)||2
11363329|NCT03185065|12560125|FG003|NOT COMPLETED|Period 3 (6 Weeks)||0
11363330|NCT03185065|12560122|FG000|STARTED|Washout (2 Weeks)||31
11363331|NCT03185065|12560123|FG001|STARTED|Washout (2 Weeks)||29
11363332|NCT03185065|12560124|FG002|STARTED|Washout (2 Weeks)||29
11363333|NCT03185065|12560125|FG003|STARTED|Washout (2 Weeks)||32
11363334|NCT03185065|12560122|FG000|COMPLETED|Washout (2 Weeks)||31
11363335|NCT03185065|12560123|FG001|COMPLETED|Washout (2 Weeks)||28
11363336|NCT03185065|12560124|FG002|COMPLETED|Washout (2 Weeks)||27
11363337|NCT03185065|12560125|FG003|COMPLETED|Washout (2 Weeks)||32
11363338|NCT03185065|12560122|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11363339|NCT03185065|12560123|FG001|NOT COMPLETED|Washout (2 Weeks)||1
11363340|NCT03185065|12560124|FG002|NOT COMPLETED|Washout (2 Weeks)||2
11363341|NCT03185065|12560125|FG003|NOT COMPLETED|Washout (2 Weeks)||0
11363342|NCT03185065|12560122|FG000|STARTED|Period 4 (6 Weeks)||31
11363343|NCT03185065|12560123|FG001|STARTED|Period 4 (6 Weeks)||28
11363344|NCT03185065|12560124|FG002|STARTED|Period 4 (6 Weeks)||27
11363345|NCT03185065|12560125|FG003|STARTED|Period 4 (6 Weeks)||32
11363346|NCT03185065|12560122|FG000|COMPLETED|Period 4 (6 Weeks)||31
11363347|NCT03185065|12560123|FG001|COMPLETED|Period 4 (6 Weeks)||27
11363348|NCT03185065|12560124|FG002|COMPLETED|Period 4 (6 Weeks)||26
11363349|NCT03185065|12560125|FG003|COMPLETED|Period 4 (6 Weeks)||31
11363350|NCT03185065|12560122|FG000|NOT COMPLETED|Period 4 (6 Weeks)||0
11363351|NCT03185065|12560123|FG001|NOT COMPLETED|Period 4 (6 Weeks)||1
11363352|NCT03185065|12560124|FG002|NOT COMPLETED|Period 4 (6 Weeks)||1
11363353|NCT03185065|12560125|FG003|NOT COMPLETED|Period 4 (6 Weeks)||1
11363354|NCT03185182|12560136|FG000|STARTED|Overall Study||5
11363355|NCT03185182|12560136|FG000|COMPLETED|Overall Study||5
11363356|NCT03185182|12560136|FG000|NOT COMPLETED|Overall Study||0
11363357|NCT03185455|12560143|FG000|STARTED|Overall Study||103
11363358|NCT03185455|12560144|FG001|STARTED|Overall Study||103
11363359|NCT03185455|12560143|FG000|COMPLETED|Overall Study||103
11363360|NCT03185455|12560144|FG001|COMPLETED|Overall Study||103
11363361|NCT03185455|12560143|FG000|NOT COMPLETED|Overall Study||0
11363362|NCT03185455|12560144|FG001|NOT COMPLETED|Overall Study||0
11363363|NCT03185481|12560150|FG000|STARTED|Overall Study||5
11363364|NCT03185481|12560150|FG000|COMPLETED|Overall Study||0
11363365|NCT03185481|12560150|FG000|NOT COMPLETED|Overall Study||5
11363366|NCT03185546|12560162|FG000|STARTED|Baseline Through Week 12||6
11363367|NCT03185546|12560163|FG001|STARTED|Baseline Through Week 12||10
11363368|NCT03185546|12560164|FG002|STARTED|Baseline Through Week 12||5
11363369|NCT03185546|12560165|FG003|STARTED|Baseline Through Week 12||5
11363370|NCT03185546|12560166|FG004|STARTED|Baseline Through Week 12||6
11363371|NCT03185546|12560167|FG005|STARTED|Baseline Through Week 12||6
11363372|NCT03185546|12560168|FG006|STARTED|Baseline Through Week 12||7
11363373|NCT03185546|12560169|FG007|STARTED|Baseline Through Week 12||5
11363374|NCT03185546|12560162|FG000|COMPLETED|Baseline Through Week 12||2
11363375|NCT03185546|12560163|FG001|COMPLETED|Baseline Through Week 12||7
11363376|NCT03185546|12560164|FG002|COMPLETED|Baseline Through Week 12||4
11363377|NCT03185546|12560165|FG003|COMPLETED|Baseline Through Week 12||4
11363378|NCT03185546|12560166|FG004|COMPLETED|Baseline Through Week 12||5
11363379|NCT03185546|12560167|FG005|COMPLETED|Baseline Through Week 12||4
11363380|NCT03185546|12560168|FG006|COMPLETED|Baseline Through Week 12||4
11363381|NCT03185546|12560169|FG007|COMPLETED|Baseline Through Week 12||2
11363382|NCT03185546|12560162|FG000|NOT COMPLETED|Baseline Through Week 12||4
11363383|NCT03185546|12560163|FG001|NOT COMPLETED|Baseline Through Week 12||3
11363384|NCT03185546|12560164|FG002|NOT COMPLETED|Baseline Through Week 12||1
11363385|NCT03185546|12560165|FG003|NOT COMPLETED|Baseline Through Week 12||1
11363386|NCT03185546|12560166|FG004|NOT COMPLETED|Baseline Through Week 12||1
11363387|NCT03185546|12560167|FG005|NOT COMPLETED|Baseline Through Week 12||2
11363388|NCT03185546|12560168|FG006|NOT COMPLETED|Baseline Through Week 12||3
11363389|NCT03185546|12560169|FG007|NOT COMPLETED|Baseline Through Week 12||3
11363390|NCT03185546|12560162|FG000|STARTED|Week 12 Through Day 30 Follow up||2
11363391|NCT03185546|12560163|FG001|STARTED|Week 12 Through Day 30 Follow up||7
11363392|NCT03185546|12560164|FG002|STARTED|Week 12 Through Day 30 Follow up||4
11363393|NCT03185546|12560165|FG003|STARTED|Week 12 Through Day 30 Follow up||4
11363394|NCT03185546|12560166|FG004|STARTED|Week 12 Through Day 30 Follow up||5
11363395|NCT03185546|12560167|FG005|STARTED|Week 12 Through Day 30 Follow up||4
11363396|NCT03185546|12560168|FG006|STARTED|Week 12 Through Day 30 Follow up||4
11363397|NCT03185546|12560169|FG007|STARTED|Week 12 Through Day 30 Follow up||2
11363398|NCT03185546|12560162|FG000|COMPLETED|Week 12 Through Day 30 Follow up||2
11363399|NCT03185546|12560163|FG001|COMPLETED|Week 12 Through Day 30 Follow up||7
11363400|NCT03185546|12560164|FG002|COMPLETED|Week 12 Through Day 30 Follow up||4
11363401|NCT03185546|12560165|FG003|COMPLETED|Week 12 Through Day 30 Follow up||3
11363402|NCT03185546|12560166|FG004|COMPLETED|Week 12 Through Day 30 Follow up||5
11363403|NCT03185546|12560167|FG005|COMPLETED|Week 12 Through Day 30 Follow up||4
11363404|NCT03185546|12560168|FG006|COMPLETED|Week 12 Through Day 30 Follow up||3
11363405|NCT03185546|12560169|FG007|COMPLETED|Week 12 Through Day 30 Follow up||2
11363406|NCT03185546|12560162|FG000|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
11363407|NCT03185546|12560163|FG001|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
11363408|NCT03185546|12560164|FG002|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
11363409|NCT03185546|12560165|FG003|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
11363410|NCT03185546|12560166|FG004|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
11363411|NCT03185546|12560167|FG005|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
11363412|NCT03185546|12560168|FG006|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
11363413|NCT03185546|12560169|FG007|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
11363414|NCT03186261|12560190|FG000|STARTED|Overall Study||22
11363415|NCT03186261|12560191|FG001|STARTED|Overall Study||22
11363416|NCT03186261|12560190|FG000|COMPLETED|Overall Study||22
11363417|NCT03186261|12560191|FG001|COMPLETED|Overall Study||22
11363418|NCT03186261|12560190|FG000|NOT COMPLETED|Overall Study||0
11363419|NCT03186261|12560191|FG001|NOT COMPLETED|Overall Study||0
11363420|NCT03186378|12560199|FG000|STARTED|Overall Study||17
11363421|NCT03186378|12560200|FG001|STARTED|Overall Study||16
11363422|NCT03186378|12560199|FG000|COMPLETED|Overall Study||16
11363423|NCT03186378|12560200|FG001|COMPLETED|Overall Study||16
11363424|NCT03186378|12560199|FG000|NOT COMPLETED|Overall Study||1
11363425|NCT03186378|12560200|FG001|NOT COMPLETED|Overall Study||0
11363426|NCT03186677|12560211|FG000|STARTED|Period 1||3
11363427|NCT03186677|12560212|FG001|STARTED|Period 1||3
11363428|NCT03186677|12560213|FG002|STARTED|Period 1||3
11363429|NCT03186677|12560214|FG003|STARTED|Period 1||0
11363430|NCT03186677|12560215|FG004|STARTED|Period 1||0
11363431|NCT03186677|12560211|FG000|COMPLETED|Period 1||3
11363432|NCT03186677|12560212|FG001|COMPLETED|Period 1||3
11363433|NCT03186677|12560213|FG002|COMPLETED|Period 1||3
11363434|NCT03186677|12560214|FG003|COMPLETED|Period 1||0
11363435|NCT03186677|12560215|FG004|COMPLETED|Period 1||0
11363436|NCT03186677|12560211|FG000|NOT COMPLETED|Period 1||0
11363437|NCT03186677|12560212|FG001|NOT COMPLETED|Period 1||0
11363438|NCT03186677|12560213|FG002|NOT COMPLETED|Period 1||0
11363439|NCT03186677|12560214|FG003|NOT COMPLETED|Period 1||0
11363440|NCT03186677|12560215|FG004|NOT COMPLETED|Period 1||0
11363441|NCT03186677|12560211|FG000|STARTED|Period 2||0
11363442|NCT03186677|12560212|FG001|STARTED|Period 2||0
11363443|NCT03186677|12560213|FG002|STARTED|Period 2||0
11363444|NCT03186677|12560214|FG003|STARTED|Period 2||5
11363445|NCT03186677|12560215|FG004|STARTED|Period 2||2
11363446|NCT03186677|12560211|FG000|COMPLETED|Period 2||0
11363447|NCT03186677|12560212|FG001|COMPLETED|Period 2||0
11363448|NCT03186677|12560213|FG002|COMPLETED|Period 2||0
11363449|NCT03186677|12560214|FG003|COMPLETED|Period 2||5
11363450|NCT03186677|12560215|FG004|COMPLETED|Period 2||2
11363451|NCT03186677|12560211|FG000|NOT COMPLETED|Period 2||0
11363452|NCT03186677|12560212|FG001|NOT COMPLETED|Period 2||0
11363453|NCT03186677|12560213|FG002|NOT COMPLETED|Period 2||0
11363454|NCT03186677|12560214|FG003|NOT COMPLETED|Period 2||0
11363455|NCT03186677|12560215|FG004|NOT COMPLETED|Period 2||0
11363456|NCT03186781|12560233|FG000|STARTED|Overall Study||5
11363457|NCT03186781|12560234|FG001|STARTED|Overall Study||5
11363458|NCT03186781|12560235|FG002|STARTED|Overall Study||10
11363459|NCT03186781|12560236|FG003|STARTED|Overall Study||10
11363460|NCT03186781|12560237|FG004|STARTED|Overall Study||10
11363461|NCT03186781|12560238|FG005|STARTED|Overall Study||10
11363462|NCT03186781|12560233|FG000|Received First Product Administration|Overall Study||5
11363463|NCT03186781|12560234|FG001|Received First Product Administration|Overall Study||5
11363464|NCT03186781|12560235|FG002|Received First Product Administration|Overall Study||10
11363465|NCT03186781|12560236|FG003|Received First Product Administration|Overall Study||10
11363466|NCT03186781|12560237|FG004|Received First Product Administration|Overall Study||10
11363467|NCT03186781|12560238|FG005|Received First Product Administration|Overall Study||10
11363468|NCT03186781|12560233|FG000|Received All Product Administrations|Overall Study||5
11363469|NCT03186781|12560234|FG001|Received All Product Administrations|Overall Study||5
11363470|NCT03186781|12560235|FG002|Received All Product Administrations|Overall Study|2nd dose not given due to unrelated intercurrent illness (n=1) and lost to follow up (n=1)|8
11363471|NCT03186781|12560236|FG003|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
11363472|NCT03186781|12560237|FG004|Received All Product Administrations|Overall Study|2nd dose not given due to subject decision to withdraw (n=2)|8
11363473|NCT03186781|12560238|FG005|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
11363474|NCT03186781|12560233|FG000|COMPLETED|Overall Study||5
11363475|NCT03186781|12560234|FG001|COMPLETED|Overall Study||5
11363476|NCT03186781|12560235|FG002|COMPLETED|Overall Study||9
11363477|NCT03186781|12560236|FG003|COMPLETED|Overall Study||10
11363478|NCT03186781|12560237|FG004|COMPLETED|Overall Study||7
11363479|NCT03186781|12560238|FG005|COMPLETED|Overall Study||10
11363480|NCT03186781|12560233|FG000|NOT COMPLETED|Overall Study||0
11363481|NCT03186781|12560234|FG001|NOT COMPLETED|Overall Study||0
11363482|NCT03186781|12560235|FG002|NOT COMPLETED|Overall Study||1
11363483|NCT03186781|12560236|FG003|NOT COMPLETED|Overall Study||0
11363484|NCT03186781|12560237|FG004|NOT COMPLETED|Overall Study||3
11363485|NCT03186781|12560238|FG005|NOT COMPLETED|Overall Study||0
11363486|NCT03187002|12560258|FG000|STARTED|Overall Study||55
11363487|NCT03187002|12560259|FG001|STARTED|Overall Study||54
11363488|NCT03187002|12560258|FG000|COMPLETED|Overall Study||55
11363489|NCT03187002|12560259|FG001|COMPLETED|Overall Study||54
11363490|NCT03187002|12560258|FG000|NOT COMPLETED|Overall Study||0
11363491|NCT03187002|12560259|FG001|NOT COMPLETED|Overall Study||0
11363492|NCT03187119|12560267|FG000|STARTED|Overall Study||22
11363493|NCT03187119|12560268|FG001|STARTED|Overall Study||23
11363494|NCT03187119|12560267|FG000|COMPLETED|Overall Study||20
11363495|NCT03187119|12560268|FG001|COMPLETED|Overall Study||18
11363496|NCT03187119|12560267|FG000|NOT COMPLETED|Overall Study||2
11363497|NCT03187119|12560268|FG001|NOT COMPLETED|Overall Study||5
11363498|NCT03187132|12560276|FG000|STARTED|Inpatient Trauma Only||12
11363499|NCT03187132|12560277|FG001|STARTED|Inpatient Trauma Only||12
11363500|NCT03187132|12560276|FG000|COMPLETED|Inpatient Trauma Only||8
11363501|NCT03187132|12560277|FG001|COMPLETED|Inpatient Trauma Only||0
11363502|NCT03187132|12560276|FG000|NOT COMPLETED|Inpatient Trauma Only||4
11363503|NCT03187132|12560277|FG001|NOT COMPLETED|Inpatient Trauma Only||12
11363504|NCT03187132|12560276|FG000|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||4
11363505|NCT03187132|12560277|FG001|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||5
11363506|NCT03187132|12560276|FG000|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||3
11363507|NCT03187132|12560277|FG001|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||0
11363508|NCT03187132|12560276|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||1
11363509|NCT03187132|12560277|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||5
11363510|NCT03187132|12560276|FG000|STARTED|Inpatient Trauma+Pain Clinic||11
11363511|NCT03187132|12560277|FG001|STARTED|Inpatient Trauma+Pain Clinic||7
11363512|NCT03187132|12560276|FG000|COMPLETED|Inpatient Trauma+Pain Clinic||8
11363513|NCT03187132|12560277|FG001|COMPLETED|Inpatient Trauma+Pain Clinic||0
11363514|NCT03187132|12560276|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic||3
11363515|NCT03187132|12560277|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic||7
11363516|NCT03187132|12560276|FG000|STARTED|Pain Clinic Only, Fully Remote||76
11363517|NCT03187132|12560277|FG001|STARTED|Pain Clinic Only, Fully Remote||118
11363518|NCT03187132|12560276|FG000|COMPLETED|Pain Clinic Only, Fully Remote||43
11363519|NCT03187132|12560277|FG001|COMPLETED|Pain Clinic Only, Fully Remote||64
11363520|NCT03187132|12560276|FG000|NOT COMPLETED|Pain Clinic Only, Fully Remote||33
11363521|NCT03187132|12560277|FG001|NOT COMPLETED|Pain Clinic Only, Fully Remote||54
11363522|NCT03187197|12560286|FG000|STARTED|Overall Study||153
11363523|NCT03187197|12560287|FG001|STARTED|Overall Study||1097
11363524|NCT03187197|12560288|FG002|STARTED|Overall Study||55
11363525|NCT03187197|12560286|FG000|Started (Eligible Participants as FAS)|Overall Study||139
11363526|NCT03187197|12560287|FG001|Started (Eligible Participants as FAS)|Overall Study||1052
11363527|NCT03187197|12560288|FG002|Started (Eligible Participants as FAS)|Overall Study||54
11363528|NCT03187197|12560286|FG000|COMPLETED|Overall Study||107
11363529|NCT03187197|12560287|FG001|COMPLETED|Overall Study||704
11363530|NCT03187197|12560288|FG002|COMPLETED|Overall Study||32
11363531|NCT03187197|12560286|FG000|NOT COMPLETED|Overall Study||46
11363532|NCT03187197|12560287|FG001|NOT COMPLETED|Overall Study||393
11363533|NCT03187197|12560288|FG002|NOT COMPLETED|Overall Study||23
11363534|NCT03187301|12560296|FG000|STARTED|Titration Period||7
11363535|NCT03187301|12560297|FG001|STARTED|Titration Period||7
11363536|NCT03187301|12560298|FG002|STARTED|Titration Period||7
11363537|NCT03187301|12560299|FG003|STARTED|Titration Period||6
11363538|NCT03187301|12560300|FG004|STARTED|Titration Period||7
11363539|NCT03187301|12560301|FG005|STARTED|Titration Period||7
11363540|NCT03187301|12560302|FG006|STARTED|Titration Period||7
11363541|NCT03187301|12560296|FG000|COMPLETED|Titration Period||7
11363542|NCT03187301|12560297|FG001|COMPLETED|Titration Period||7
11363543|NCT03187301|12560298|FG002|COMPLETED|Titration Period||7
11363544|NCT03187301|12560299|FG003|COMPLETED|Titration Period||6
11363545|NCT03187301|12560300|FG004|COMPLETED|Titration Period||7
11363546|NCT03187301|12560301|FG005|COMPLETED|Titration Period||7
11363547|NCT03187301|12560302|FG006|COMPLETED|Titration Period||0
11363548|NCT03187301|12560296|FG000|NOT COMPLETED|Titration Period||0
11363549|NCT03187301|12560297|FG001|NOT COMPLETED|Titration Period||0
11363550|NCT03187301|12560298|FG002|NOT COMPLETED|Titration Period||0
11363551|NCT03187301|12560299|FG003|NOT COMPLETED|Titration Period||0
11363552|NCT03187301|12560300|FG004|NOT COMPLETED|Titration Period||0
11363553|NCT03187301|12560301|FG005|NOT COMPLETED|Titration Period||0
11363554|NCT03187301|12560302|FG006|NOT COMPLETED|Titration Period||7
11363555|NCT03187301|12560296|FG000|STARTED|Pre-Intervention||7
11363556|NCT03187301|12560297|FG001|STARTED|Pre-Intervention||7
11363557|NCT03187301|12560298|FG002|STARTED|Pre-Intervention||7
11363558|NCT03187301|12560299|FG003|STARTED|Pre-Intervention||6
11363559|NCT03187301|12560300|FG004|STARTED|Pre-Intervention||7
11363560|NCT03187301|12560301|FG005|STARTED|Pre-Intervention||7
11363561|NCT03187301|12560302|FG006|STARTED|Pre-Intervention||0
11363562|NCT03187301|12560296|FG000|COMPLETED|Pre-Intervention||6
11363563|NCT03187301|12560297|FG001|COMPLETED|Pre-Intervention||7
11363564|NCT03187301|12560298|FG002|COMPLETED|Pre-Intervention||7
11363565|NCT03187301|12560299|FG003|COMPLETED|Pre-Intervention||6
11363566|NCT03187301|12560300|FG004|COMPLETED|Pre-Intervention||7
11363567|NCT03187301|12560301|FG005|COMPLETED|Pre-Intervention||7
11363568|NCT03187301|12560302|FG006|COMPLETED|Pre-Intervention||0
11363569|NCT03187301|12560296|FG000|NOT COMPLETED|Pre-Intervention||1
11363570|NCT03187301|12560297|FG001|NOT COMPLETED|Pre-Intervention||0
11363571|NCT03187301|12560298|FG002|NOT COMPLETED|Pre-Intervention||0
11363572|NCT03187301|12560299|FG003|NOT COMPLETED|Pre-Intervention||0
11363573|NCT03187301|12560300|FG004|NOT COMPLETED|Pre-Intervention||0
11363574|NCT03187301|12560301|FG005|NOT COMPLETED|Pre-Intervention||0
11363575|NCT03187301|12560302|FG006|NOT COMPLETED|Pre-Intervention||0
11363576|NCT03187301|12560296|FG000|STARTED|First Intervention||6
11363577|NCT03187301|12560297|FG001|STARTED|First Intervention||7
11363578|NCT03187301|12560298|FG002|STARTED|First Intervention||7
11363579|NCT03187301|12560299|FG003|STARTED|First Intervention||6
11363580|NCT03187301|12560300|FG004|STARTED|First Intervention||7
11363581|NCT03187301|12560301|FG005|STARTED|First Intervention||7
11363582|NCT03187301|12560302|FG006|STARTED|First Intervention||0
11363583|NCT03187301|12560296|FG000|COMPLETED|First Intervention||6
11005598|NCT00723528|12183299|FG002|COMPLETED|Period 1: Controlled Period (CP)||58
11005599|NCT00723528|12183300|FG003|COMPLETED|Period 1: Controlled Period (CP)||0
11005600|NCT00723528|12183301|FG004|COMPLETED|Period 1: Controlled Period (CP)||0
11005601|NCT00723528|12183302|FG005|COMPLETED|Period 1: Controlled Period (CP)||0
11005602|NCT00723528|12183303|FG006|COMPLETED|Period 1: Controlled Period (CP)||0
11005603|NCT00723528|12183297|FG000|NOT COMPLETED|Period 1: Controlled Period (CP)||4
11363584|NCT03187301|12560297|FG001|COMPLETED|First Intervention||7
11363585|NCT03187301|12560298|FG002|COMPLETED|First Intervention||7
11363586|NCT03187301|12560299|FG003|COMPLETED|First Intervention||6
11363587|NCT03187301|12560300|FG004|COMPLETED|First Intervention||7
11363588|NCT03187301|12560301|FG005|COMPLETED|First Intervention||7
11363589|NCT03187301|12560302|FG006|COMPLETED|First Intervention||0
11363590|NCT03187301|12560296|FG000|NOT COMPLETED|First Intervention||0
11363591|NCT03187301|12560297|FG001|NOT COMPLETED|First Intervention||0
11363592|NCT03187301|12560298|FG002|NOT COMPLETED|First Intervention||0
11363593|NCT03187301|12560299|FG003|NOT COMPLETED|First Intervention||0
11363594|NCT03187301|12560300|FG004|NOT COMPLETED|First Intervention||0
11363595|NCT03187301|12560301|FG005|NOT COMPLETED|First Intervention||0
11363596|NCT03187301|12560302|FG006|NOT COMPLETED|First Intervention||0
11363597|NCT03187301|12560296|FG000|STARTED|First Washout||6
11363598|NCT03187301|12560297|FG001|STARTED|First Washout||7
11363599|NCT03187301|12560298|FG002|STARTED|First Washout||7
11363600|NCT03187301|12560299|FG003|STARTED|First Washout||6
11363601|NCT03187301|12560300|FG004|STARTED|First Washout||7
11005604|NCT00723528|12183298|FG001|NOT COMPLETED|Period 1: Controlled Period (CP)||0
11005605|NCT00723528|12183299|FG002|NOT COMPLETED|Period 1: Controlled Period (CP)||4
11363602|NCT03187301|12560301|FG005|STARTED|First Washout||7
11363603|NCT03187301|12560302|FG006|STARTED|First Washout||0
11363604|NCT03187301|12560296|FG000|COMPLETED|First Washout||6
11363605|NCT03187301|12560297|FG001|COMPLETED|First Washout||7
11363606|NCT03187301|12560298|FG002|COMPLETED|First Washout||7
11363607|NCT03187301|12560299|FG003|COMPLETED|First Washout||6
11363608|NCT03187301|12560300|FG004|COMPLETED|First Washout||7
11363609|NCT03187301|12560301|FG005|COMPLETED|First Washout||7
11363610|NCT03187301|12560302|FG006|COMPLETED|First Washout||0
11363611|NCT03187301|12560296|FG000|NOT COMPLETED|First Washout||0
11363612|NCT03187301|12560297|FG001|NOT COMPLETED|First Washout||0
11363613|NCT03187301|12560298|FG002|NOT COMPLETED|First Washout||0
11363614|NCT03187301|12560299|FG003|NOT COMPLETED|First Washout||0
11363615|NCT03187301|12560300|FG004|NOT COMPLETED|First Washout||0
11363616|NCT03187301|12560301|FG005|NOT COMPLETED|First Washout||0
11363617|NCT03187301|12560302|FG006|NOT COMPLETED|First Washout||0
11363618|NCT03187301|12560296|FG000|STARTED|Second Intervention||6
11363619|NCT03187301|12560297|FG001|STARTED|Second Intervention||7
11363620|NCT03187301|12560298|FG002|STARTED|Second Intervention||7
11363621|NCT03187301|12560299|FG003|STARTED|Second Intervention||6
11363622|NCT03187301|12560300|FG004|STARTED|Second Intervention||7
11363623|NCT03187301|12560301|FG005|STARTED|Second Intervention||7
11363624|NCT03187301|12560302|FG006|STARTED|Second Intervention||0
11363625|NCT03187301|12560296|FG000|COMPLETED|Second Intervention||6
11363626|NCT03187301|12560297|FG001|COMPLETED|Second Intervention||7
11363627|NCT03187301|12560298|FG002|COMPLETED|Second Intervention||7
11363628|NCT03187301|12560299|FG003|COMPLETED|Second Intervention||6
11363629|NCT03187301|12560300|FG004|COMPLETED|Second Intervention||7
11363630|NCT03187301|12560301|FG005|COMPLETED|Second Intervention||7
11363631|NCT03187301|12560302|FG006|COMPLETED|Second Intervention||0
11363632|NCT03187301|12560296|FG000|NOT COMPLETED|Second Intervention||0
11363633|NCT03187301|12560297|FG001|NOT COMPLETED|Second Intervention||0
11363634|NCT03187301|12560298|FG002|NOT COMPLETED|Second Intervention||0
11363635|NCT03187301|12560299|FG003|NOT COMPLETED|Second Intervention||0
11363636|NCT03187301|12560300|FG004|NOT COMPLETED|Second Intervention||0
11363637|NCT03187301|12560301|FG005|NOT COMPLETED|Second Intervention||0
11363638|NCT03187301|12560302|FG006|NOT COMPLETED|Second Intervention||0
11363639|NCT03187301|12560296|FG000|STARTED|Second Washout||6
11363640|NCT03187301|12560297|FG001|STARTED|Second Washout||7
11363641|NCT03187301|12560298|FG002|STARTED|Second Washout||7
11363642|NCT03187301|12560299|FG003|STARTED|Second Washout||6
11363643|NCT03187301|12560300|FG004|STARTED|Second Washout||7
11363644|NCT03187301|12560301|FG005|STARTED|Second Washout||7
11363645|NCT03187301|12560302|FG006|STARTED|Second Washout||0
11363646|NCT03187301|12560296|FG000|COMPLETED|Second Washout||6
11363647|NCT03187301|12560297|FG001|COMPLETED|Second Washout||7
11363648|NCT03187301|12560298|FG002|COMPLETED|Second Washout||7
11363649|NCT03187301|12560299|FG003|COMPLETED|Second Washout||6
11363650|NCT03187301|12560300|FG004|COMPLETED|Second Washout||7
11363651|NCT03187301|12560301|FG005|COMPLETED|Second Washout||7
11363652|NCT03187301|12560302|FG006|COMPLETED|Second Washout||0
11363653|NCT03187301|12560296|FG000|NOT COMPLETED|Second Washout||0
11363654|NCT03187301|12560297|FG001|NOT COMPLETED|Second Washout||0
11363655|NCT03187301|12560298|FG002|NOT COMPLETED|Second Washout||0
11363656|NCT03187301|12560299|FG003|NOT COMPLETED|Second Washout||0
11363657|NCT03187301|12560300|FG004|NOT COMPLETED|Second Washout||0
11363658|NCT03187301|12560301|FG005|NOT COMPLETED|Second Washout||0
11363659|NCT03187301|12560302|FG006|NOT COMPLETED|Second Washout||0
11363660|NCT03187301|12560296|FG000|STARTED|Third Intervention||6
11363661|NCT03187301|12560297|FG001|STARTED|Third Intervention||7
11363662|NCT03187301|12560298|FG002|STARTED|Third Intervention||7
11363663|NCT03187301|12560299|FG003|STARTED|Third Intervention||6
11363664|NCT03187301|12560300|FG004|STARTED|Third Intervention||7
11363665|NCT03187301|12560301|FG005|STARTED|Third Intervention||7
11363666|NCT03187301|12560302|FG006|STARTED|Third Intervention||0
11363667|NCT03187301|12560296|FG000|COMPLETED|Third Intervention||6
11005606|NCT00723528|12183300|FG003|NOT COMPLETED|Period 1: Controlled Period (CP)||0
11005607|NCT00723528|12183301|FG004|NOT COMPLETED|Period 1: Controlled Period (CP)||0
11005608|NCT00723528|12183302|FG005|NOT COMPLETED|Period 1: Controlled Period (CP)||0
11005609|NCT00723528|12183303|FG006|NOT COMPLETED|Period 1: Controlled Period (CP)||0
11005610|NCT00723528|12183297|FG000|STARTED|Period 2: After Controlled Period||0
11005611|NCT00723528|12183298|FG001|STARTED|Period 2: After Controlled Period||0
11005612|NCT00723528|12183299|FG002|STARTED|Period 2: After Controlled Period||0
11005613|NCT00723528|12183300|FG003|STARTED|Period 2: After Controlled Period||15
11005614|NCT00723528|12183301|FG004|STARTED|Period 2: After Controlled Period||13
11363668|NCT03187301|12560297|FG001|COMPLETED|Third Intervention||7
11005615|NCT00723528|12183302|FG005|STARTED|Period 2: After Controlled Period||64
11363669|NCT03187301|12560298|FG002|COMPLETED|Third Intervention||7
11363670|NCT03187301|12560299|FG003|COMPLETED|Third Intervention||6
11363671|NCT03187301|12560300|FG004|COMPLETED|Third Intervention||7
11363672|NCT03187301|12560301|FG005|COMPLETED|Third Intervention||7
11363673|NCT03187301|12560302|FG006|COMPLETED|Third Intervention||0
11363674|NCT03187301|12560296|FG000|NOT COMPLETED|Third Intervention||0
11363675|NCT03187301|12560297|FG001|NOT COMPLETED|Third Intervention||0
11363676|NCT03187301|12560298|FG002|NOT COMPLETED|Third Intervention||0
11363677|NCT03187301|12560299|FG003|NOT COMPLETED|Third Intervention||0
11363678|NCT03187301|12560300|FG004|NOT COMPLETED|Third Intervention||0
11363679|NCT03187301|12560301|FG005|NOT COMPLETED|Third Intervention||0
11363680|NCT03187301|12560302|FG006|NOT COMPLETED|Third Intervention||0
11363681|NCT03187418|12560323|FG000|STARTED|Overall Study||52
11363682|NCT03187418|12560323|FG000|COMPLETED|Overall Study||52
11363683|NCT03187418|12560323|FG000|NOT COMPLETED|Overall Study||0
11363684|NCT03187678|12560327|FG000|STARTED|Period 1 (Oral Selexipag)||20
11363685|NCT03187678|12560327|FG000|COMPLETED|Period 1 (Oral Selexipag)||20
11363686|NCT03187678|12560327|FG000|NOT COMPLETED|Period 1 (Oral Selexipag)||0
11363687|NCT03187678|12560327|FG000|STARTED|Period 2 (Intravenous Selexipag)||20
11363688|NCT03187678|12560327|FG000|COMPLETED|Period 2 (Intravenous Selexipag)||20
11363689|NCT03187678|12560327|FG000|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0
11363690|NCT03187678|12560327|FG000|STARTED|Period 3 (Oral Selexipag)||20
11363691|NCT03187678|12560327|FG000|COMPLETED|Period 3 (Oral Selexipag)||20
11363692|NCT03187678|12560327|FG000|NOT COMPLETED|Period 3 (Oral Selexipag)||0
11363693|NCT03187730|12560333|FG000|STARTED|Overall Study||208
11363694|NCT03187730|12560334|FG001|STARTED|Overall Study||202
11363695|NCT03187730|12560333|FG000|COMPLETED|Overall Study||129
11363696|NCT03187730|12560334|FG001|COMPLETED|Overall Study||154
11363697|NCT03187730|12560333|FG000|NOT COMPLETED|Overall Study||79
11363698|NCT03187730|12560334|FG001|NOT COMPLETED|Overall Study||48
11363699|NCT03187756|12560340|FG000|STARTED|Overall Study||6
11363700|NCT03187756|12560340|FG000|COMPLETED|Overall Study||2
11363701|NCT03187756|12560340|FG000|NOT COMPLETED|Overall Study||4
11363702|NCT03188055|12560346|FG000|STARTED|Overall Study||48
11363703|NCT03188055|12560347|FG001|STARTED|Overall Study|Family members consented (24/48 had patient enroll along with them as patient had DMC).|48
11363704|NCT03188055|12560348|FG002|STARTED|Overall Study||62
11363705|NCT03188055|12560349|FG003|STARTED|Overall Study|Family members consented (19/38 had patient enroll along with them as patient had DMC).|38
11363706|NCT03188055|12560350|FG004|STARTED|Overall Study||59
11363707|NCT03188055|12560351|FG005|STARTED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|
11363708|NCT03188055|12560346|FG000|Patients Who Provided Self-Consent|Overall Study||0
11363709|NCT03188055|12560347|FG001|Patients Who Provided Self-Consent|Overall Study||24
11363710|NCT03188055|12560348|FG002|Patients Who Provided Self-Consent|Overall Study||0
11363711|NCT03188055|12560349|FG003|Patients Who Provided Self-Consent|Overall Study||19
11363712|NCT03188055|12560350|FG004|Patients Who Provided Self-Consent|Overall Study||0
11363713|NCT03188055|12560351|FG005|Patients Who Provided Self-Consent|Overall Study||0
11363714|NCT03188055|12560346|FG000|MDS Pre-Intervention Survey Responses|Overall Study||0
11363715|NCT03188055|12560347|FG001|MDS Pre-Intervention Survey Responses|Overall Study||0
11363716|NCT03188055|12560348|FG002|MDS Pre-Intervention Survey Responses|Overall Study||0
11363717|NCT03188055|12560349|FG003|MDS Pre-Intervention Survey Responses|Overall Study||0
11363718|NCT03188055|12560350|FG004|MDS Pre-Intervention Survey Responses|Overall Study||0
11363719|NCT03188055|12560351|FG005|MDS Pre-Intervention Survey Responses|Overall Study||99
11363720|NCT03188055|12560346|FG000|MDS Post-Intervention Survey Responses|Overall Study||0
11363721|NCT03188055|12560347|FG001|MDS Post-Intervention Survey Responses|Overall Study||0
11363722|NCT03188055|12560348|FG002|MDS Post-Intervention Survey Responses|Overall Study||0
11363723|NCT03188055|12560349|FG003|MDS Post-Intervention Survey Responses|Overall Study||0
11363724|NCT03188055|12560350|FG004|MDS Post-Intervention Survey Responses|Overall Study||0
11363725|NCT03188055|12560351|FG005|MDS Post-Intervention Survey Responses|Overall Study||134
11363726|NCT03188055|12560346|FG000|Patient Survey 1|Overall Study||0
11363727|NCT03188055|12560347|FG001|Patient Survey 1|Overall Study||16
11363728|NCT03188055|12560348|FG002|Patient Survey 1|Overall Study||0
11363729|NCT03188055|12560349|FG003|Patient Survey 1|Overall Study||13
11363730|NCT03188055|12560350|FG004|Patient Survey 1|Overall Study||0
11363731|NCT03188055|12560351|FG005|Patient Survey 1|Overall Study||0
11363732|NCT03188055|12560346|FG000|Nurse Survey 1|Overall Study||0
11363733|NCT03188055|12560347|FG001|Nurse Survey 1|Overall Study||32
11363734|NCT03188055|12560348|FG002|Nurse Survey 1|Overall Study||0
11363735|NCT03188055|12560349|FG003|Nurse Survey 1|Overall Study||27
11363736|NCT03188055|12560350|FG004|Nurse Survey 1|Overall Study||0
11363737|NCT03188055|12560351|FG005|Nurse Survey 1|Overall Study||0
11363738|NCT03188055|12560346|FG000|Family Survey 1|Overall Study||0
11363739|NCT03188055|12560347|FG001|Family Survey 1|Overall Study||37
11363740|NCT03188055|12560348|FG002|Family Survey 1|Overall Study||0
11363741|NCT03188055|12560349|FG003|Family Survey 1|Overall Study||38
11363742|NCT03188055|12560350|FG004|Family Survey 1|Overall Study||0
11363743|NCT03188055|12560351|FG005|Family Survey 1|Overall Study||0
11363744|NCT03188055|12560346|FG000|Family Survey 2|Overall Study||0
11363745|NCT03188055|12560347|FG001|Family Survey 2|Overall Study||34
11363746|NCT03188055|12560348|FG002|Family Survey 2|Overall Study||0
11363747|NCT03188055|12560349|FG003|Family Survey 2|Overall Study||35
11363748|NCT03188055|12560350|FG004|Family Survey 2|Overall Study||0
11363749|NCT03188055|12560351|FG005|Family Survey 2|Overall Study||0
11363750|NCT03188055|12560346|FG000|Family Survey 3|Overall Study||0
11363751|NCT03188055|12560347|FG001|Family Survey 3|Overall Study||29
11363752|NCT03188055|12560348|FG002|Family Survey 3|Overall Study||0
11363753|NCT03188055|12560349|FG003|Family Survey 3|Overall Study||26
11363754|NCT03188055|12560350|FG004|Family Survey 3|Overall Study||0
11363755|NCT03188055|12560351|FG005|Family Survey 3|Overall Study||0
11363756|NCT03188055|12560346|FG000|COMPLETED|Overall Study||48
11363757|NCT03188055|12560347|FG001|COMPLETED|Overall Study||29
11363758|NCT03188055|12560348|FG002|COMPLETED|Overall Study||43
11363759|NCT03188055|12560349|FG003|COMPLETED|Overall Study||26
11363760|NCT03188055|12560350|FG004|COMPLETED|Overall Study||59
11363761|NCT03188055|12560351|FG005|COMPLETED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|
11363762|NCT03188055|12560346|FG000|NOT COMPLETED|Overall Study||0
11363763|NCT03188055|12560347|FG001|NOT COMPLETED|Overall Study||19
11363764|NCT03188055|12560348|FG002|NOT COMPLETED|Overall Study||19
11363765|NCT03188055|12560349|FG003|NOT COMPLETED|Overall Study||12
11363766|NCT03188055|12560350|FG004|NOT COMPLETED|Overall Study||0
11363767|NCT03188055|12560351|FG005|NOT COMPLETED|Overall Study||
11363768|NCT03188120|12560362|FG000|STARTED|Overall Study||193
11363769|NCT03188120|12560362|FG000|COMPLETED|Overall Study||146
11363770|NCT03188120|12560362|FG000|NOT COMPLETED|Overall Study||47
11363771|NCT03188185|12560368|FG000|STARTED|Stage 1||198
11363772|NCT03188185|12560369|FG001|STARTED|Stage 1||80
11363773|NCT03188185|12560370|FG002|STARTED|Stage 1||0
11363774|NCT03188185|12560371|FG003|STARTED|Stage 1||0
11363775|NCT03188185|12560368|FG000|COMPLETED|Stage 1||179
11363776|NCT03188185|12560369|FG001|COMPLETED|Stage 1||64
11363777|NCT03188185|12560370|FG002|COMPLETED|Stage 1||0
11363778|NCT03188185|12560371|FG003|COMPLETED|Stage 1||0
11363779|NCT03188185|12560368|FG000|NOT COMPLETED|Stage 1||19
11363780|NCT03188185|12560369|FG001|NOT COMPLETED|Stage 1||16
11363781|NCT03188185|12560370|FG002|NOT COMPLETED|Stage 1||0
11363782|NCT03188185|12560371|FG003|NOT COMPLETED|Stage 1||0
11363783|NCT03188185|12560368|FG000|STARTED|Stage 2||0
11363784|NCT03188185|12560369|FG001|STARTED|Stage 2||0
11363785|NCT03188185|12560370|FG002|STARTED|Stage 2||64
11363786|NCT03188185|12560371|FG003|STARTED|Stage 2||63
11363787|NCT03188185|12560368|FG000|COMPLETED|Stage 2||0
11363788|NCT03188185|12560369|FG001|COMPLETED|Stage 2||0
11363789|NCT03188185|12560370|FG002|COMPLETED|Stage 2||55
11363790|NCT03188185|12560371|FG003|COMPLETED|Stage 2||57
11363791|NCT03188185|12560368|FG000|NOT COMPLETED|Stage 2||0
11363792|NCT03188185|12560369|FG001|NOT COMPLETED|Stage 2||0
11363793|NCT03188185|12560370|FG002|NOT COMPLETED|Stage 2||9
11363794|NCT03188185|12560371|FG003|NOT COMPLETED|Stage 2||6
11363795|NCT03188263|12560383|FG000|STARTED|Overall Study||10
11363796|NCT03188263|12560384|FG001|STARTED|Overall Study||0
11363797|NCT03188263|12560383|FG000|COMPLETED|Overall Study||6
11363798|NCT03188263|12560384|FG001|COMPLETED|Overall Study||0
11363799|NCT03188263|12560383|FG000|NOT COMPLETED|Overall Study||4
11363800|NCT03188263|12560384|FG001|NOT COMPLETED|Overall Study||0
11363801|NCT03188523|12560392|FG000|STARTED|Overall Study||6
11363802|NCT03188523|12560393|FG001|STARTED|Overall Study||6
11363803|NCT03188523|12560394|FG002|STARTED|Overall Study||0
11363804|NCT03188523|12560395|FG003|STARTED|Overall Study||0
11363805|NCT03188523|12560392|FG000|COMPLETED|Overall Study||6
11363806|NCT03188523|12560393|FG001|COMPLETED|Overall Study||6
11363807|NCT03188523|12560394|FG002|COMPLETED|Overall Study||0
11363808|NCT03188523|12560395|FG003|COMPLETED|Overall Study||0
11363809|NCT03188523|12560392|FG000|NOT COMPLETED|Overall Study||0
11363810|NCT03188523|12560393|FG001|NOT COMPLETED|Overall Study||0
11363811|NCT03188523|12560394|FG002|NOT COMPLETED|Overall Study||0
11363812|NCT03188523|12560395|FG003|NOT COMPLETED|Overall Study||0
11363813|NCT03188536|12560401|FG000|STARTED|Overall Study||282
11363814|NCT03188536|12560401|FG000|COMPLETED|Overall Study||276
11363815|NCT03188536|12560401|FG000|NOT COMPLETED|Overall Study||6
11363816|NCT03188718|12560405|FG000|STARTED|Overall Study||45
11363817|NCT03188718|12560405|FG000|COMPLETED|Overall Study||37
11363818|NCT03188718|12560405|FG000|NOT COMPLETED|Overall Study||8
11363819|NCT03188991|12560413|FG000|STARTED|Overall Study||3
11363820|NCT03188991|12560414|FG001|STARTED|Overall Study||3
11363821|NCT03188991|12560415|FG002|STARTED|Overall Study||3
11363822|NCT03188991|12560416|FG003|STARTED|Overall Study||11
11363823|NCT03188991|12560413|FG000|COMPLETED|Overall Study||3
11363824|NCT03188991|12560414|FG001|COMPLETED|Overall Study||3
11363825|NCT03188991|12560415|FG002|COMPLETED|Overall Study||3
11363826|NCT03188991|12560416|FG003|COMPLETED|Overall Study||10
11363827|NCT03188991|12560413|FG000|NOT COMPLETED|Overall Study||0
11363828|NCT03188991|12560414|FG001|NOT COMPLETED|Overall Study||0
11363829|NCT03188991|12560415|FG002|NOT COMPLETED|Overall Study||0
11363830|NCT03188991|12560416|FG003|NOT COMPLETED|Overall Study||1
11363831|NCT03189134|12560426|FG000|STARTED|Overall Study||6
11363832|NCT03189134|12560426|FG000|COMPLETED|Overall Study||6
11363833|NCT03189134|12560426|FG000|NOT COMPLETED|Overall Study||0
11363834|NCT03189446|12560430|FG000|STARTED|Overall Study||32
11363835|NCT03189446|12560430|FG000|COMPLETED|Overall Study||27
11363836|NCT03189446|12560430|FG000|NOT COMPLETED|Overall Study||5
11363837|NCT03189524|12560437|FG000|STARTED|Overall Study||11
11363838|NCT03189524|12560438|FG001|STARTED|Overall Study||10
11363839|NCT03189524|12560439|FG002|STARTED|Overall Study||23
11363840|NCT03189524|12560437|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
11363841|NCT03189524|12560438|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
11363842|NCT03189524|12560439|FG002|Received at Least 1 Dose of Study Drug|Overall Study||23
11363843|NCT03189524|12560437|FG000|COMPLETED|Overall Study||0
11363844|NCT03189524|12560438|FG001|COMPLETED|Overall Study||0
11363845|NCT03189524|12560439|FG002|COMPLETED|Overall Study||0
11363846|NCT03189524|12560437|FG000|NOT COMPLETED|Overall Study||11
11363847|NCT03189524|12560438|FG001|NOT COMPLETED|Overall Study||10
11363848|NCT03189524|12560439|FG002|NOT COMPLETED|Overall Study||23
11363849|NCT03189589|12560453|FG000|STARTED|Overall Study||6
11363850|NCT03189589|12560454|FG001|STARTED|Overall Study||6
11363851|NCT03189589|12560453|FG000|COMPLETED|Overall Study||6
11363852|NCT03189589|12560454|FG001|COMPLETED|Overall Study||6
11363853|NCT03189589|12560453|FG000|NOT COMPLETED|Overall Study||0
11363854|NCT03189589|12560454|FG001|NOT COMPLETED|Overall Study||0
11363855|NCT03189745|12560462|FG000|STARTED|Overall Study||170
11363856|NCT03189745|12560463|FG001|STARTED|Overall Study||59
11363857|NCT03189745|12560462|FG000|COMPLETED|Overall Study||169
11363858|NCT03189745|12560463|FG001|COMPLETED|Overall Study||58
11363859|NCT03189745|12560462|FG000|NOT COMPLETED|Overall Study||1
11363860|NCT03189745|12560463|FG001|NOT COMPLETED|Overall Study||1
11363861|NCT03190005|12560476|FG000|STARTED|Overall Study||5
11363862|NCT03190005|12560477|FG001|STARTED|Overall Study||5
11363863|NCT03190005|12560478|FG002|STARTED|Overall Study||5
11363864|NCT03190005|12560479|FG003|STARTED|Overall Study||5
11363865|NCT03190005|12560480|FG004|STARTED|Overall Study||5
11363866|NCT03190005|12560481|FG005|STARTED|Overall Study||5
11363867|NCT03190005|12560482|FG006|STARTED|Overall Study||5
11363868|NCT03190005|12560476|FG000|COMPLETED|Overall Study||5
11363869|NCT03190005|12560477|FG001|COMPLETED|Overall Study||5
11363870|NCT03190005|12560478|FG002|COMPLETED|Overall Study||5
11363871|NCT03190005|12560479|FG003|COMPLETED|Overall Study||5
11363872|NCT03190005|12560480|FG004|COMPLETED|Overall Study||5
11363873|NCT03190005|12560481|FG005|COMPLETED|Overall Study||5
11363874|NCT03190005|12560482|FG006|COMPLETED|Overall Study||5
11363875|NCT03190005|12560476|FG000|NOT COMPLETED|Overall Study||0
11363876|NCT03190005|12560477|FG001|NOT COMPLETED|Overall Study||0
11363877|NCT03190005|12560478|FG002|NOT COMPLETED|Overall Study||0
11363878|NCT03190005|12560479|FG003|NOT COMPLETED|Overall Study||0
11363879|NCT03190005|12560480|FG004|NOT COMPLETED|Overall Study||0
11363880|NCT03190005|12560481|FG005|NOT COMPLETED|Overall Study||0
11363881|NCT03190005|12560482|FG006|NOT COMPLETED|Overall Study||0
11363882|NCT03190083|12560498|FG000|STARTED|Overall Study||16
11363883|NCT03190083|12560498|FG000|COMPLETED|Overall Study||16
11363884|NCT03190083|12560498|FG000|NOT COMPLETED|Overall Study||0
11363885|NCT03190213|12560502|FG000|STARTED|Overall Study||6
11363886|NCT03190213|12560502|FG000|COMPLETED|Overall Study||6
11363887|NCT03190213|12560502|FG000|NOT COMPLETED|Overall Study||0
11363888|NCT03190993|12560508|FG000|STARTED|Overall Study||10
11363889|NCT03190993|12560509|FG001|STARTED|Overall Study||10
11363890|NCT03190993|12560508|FG000|COMPLETED|Overall Study||10
11363891|NCT03190993|12560509|FG001|COMPLETED|Overall Study||10
11363892|NCT03190993|12560508|FG000|NOT COMPLETED|Overall Study||0
11363893|NCT03190993|12560509|FG001|NOT COMPLETED|Overall Study||0
11363894|NCT03191396|12560517|FG000|STARTED|Overall Study||290
11363895|NCT03191396|12560518|FG001|STARTED|Overall Study||287
11363896|NCT03191396|12560517|FG000|COMPLETED|Overall Study||287
11363897|NCT03191396|12560518|FG001|COMPLETED|Overall Study||282
11363898|NCT03191396|12560517|FG000|NOT COMPLETED|Overall Study||3
11363899|NCT03191396|12560518|FG001|NOT COMPLETED|Overall Study||5
11363900|NCT03191552|12560527|FG000|STARTED|Overall Study||9
11363901|NCT03191552|12560528|FG001|STARTED|Overall Study||9
11363902|NCT03191552|12560529|FG002|STARTED|Overall Study||8
11363903|NCT03191552|12560527|FG000|COMPLETED|Overall Study||8
11363904|NCT03191552|12560528|FG001|COMPLETED|Overall Study||8
11363905|NCT03191552|12560529|FG002|COMPLETED|Overall Study||8
11363906|NCT03191552|12560527|FG000|NOT COMPLETED|Overall Study||1
11363907|NCT03191552|12560528|FG001|NOT COMPLETED|Overall Study||1
11363908|NCT03191552|12560529|FG002|NOT COMPLETED|Overall Study||0
11363909|NCT03191630|12560543|FG000|STARTED|Overall Study||30
11363910|NCT03191630|12560544|FG001|STARTED|Overall Study||30
11363911|NCT03191630|12560543|FG000|COMPLETED|Overall Study||23
11363912|NCT03191630|12560544|FG001|COMPLETED|Overall Study||23
11363913|NCT03191630|12560543|FG000|NOT COMPLETED|Overall Study||7
11363914|NCT03191630|12560544|FG001|NOT COMPLETED|Overall Study||7
11363915|NCT03191799|12560552|FG000|STARTED|Overall Study||195
11363916|NCT03191799|12560552|FG000|Received at Least One Dose of Emicizumab|Overall Study||193
11363917|NCT03191799|12560552|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
11363918|NCT03191799|12560552|FG000|COMPLETED|Overall Study||186
11363919|NCT03191799|12560552|FG000|NOT COMPLETED|Overall Study||9
11363920|NCT03192137|12560558|FG000|STARTED|Overall Study||173
11363921|NCT03192137|12560559|FG001|STARTED|Overall Study||87
11363922|NCT03192137|12560558|FG000|COMPLETED|Overall Study||123
11363923|NCT03192137|12560559|FG001|COMPLETED|Overall Study||29
11005616|NCT00723528|12183303|FG006|STARTED|Period 2: After Controlled Period||58
11005617|NCT00723528|12183297|FG000|COMPLETED|Period 2: After Controlled Period||0
11363924|NCT03192137|12560558|FG000|NOT COMPLETED|Overall Study||50
11363925|NCT03192137|12560559|FG001|NOT COMPLETED|Overall Study||58
11363926|NCT03192150|12560567|FG000|STARTED|Overall Study||163
11363927|NCT03192150|12560568|FG001|STARTED|Overall Study||83
11363928|NCT03192150|12560567|FG000|COMPLETED|Overall Study||108
11363929|NCT03192150|12560568|FG001|COMPLETED|Overall Study||29
11363930|NCT03192150|12560567|FG000|NOT COMPLETED|Overall Study||55
11363931|NCT03192150|12560568|FG001|NOT COMPLETED|Overall Study||54
11363932|NCT03192176|12560582|FG000|STARTED|Overall Study||44
11363933|NCT03192176|12560583|FG001|STARTED|Overall Study||45
11363934|NCT03192176|12560584|FG002|STARTED|Overall Study||44
11363935|NCT03192176|12560585|FG003|STARTED|Overall Study||45
11363936|NCT03192176|12560586|FG004|STARTED|Overall Study||44
11363937|NCT03192176|12560587|FG005|STARTED|Overall Study||45
11363938|NCT03192176|12560588|FG006|STARTED|Overall Study||45
11363939|NCT03192176|12560589|FG007|STARTED|Overall Study||44
11005618|NCT00723528|12183298|FG001|COMPLETED|Period 2: After Controlled Period||0
11005619|NCT00723528|12183299|FG002|COMPLETED|Period 2: After Controlled Period||0
11363940|NCT03192176|12560582|FG000|Treated|Overall Study||43
11363941|NCT03192176|12560583|FG001|Treated|Overall Study||45
11363942|NCT03192176|12560584|FG002|Treated|Overall Study||43
11363943|NCT03192176|12560585|FG003|Treated|Overall Study||45
11363944|NCT03192176|12560586|FG004|Treated|Overall Study||44
11363945|NCT03192176|12560587|FG005|Treated|Overall Study||43
11363946|NCT03192176|12560588|FG006|Treated|Overall Study||45
11363947|NCT03192176|12560589|FG007|Treated|Overall Study||44
11363948|NCT03192176|12560582|FG000|COMPLETED|Overall Study||37
11363949|NCT03192176|12560583|FG001|COMPLETED|Overall Study||40
11363950|NCT03192176|12560584|FG002|COMPLETED|Overall Study||38
11363951|NCT03192176|12560585|FG003|COMPLETED|Overall Study||33
11363952|NCT03192176|12560586|FG004|COMPLETED|Overall Study||32
11363953|NCT03192176|12560587|FG005|COMPLETED|Overall Study||34
11363954|NCT03192176|12560588|FG006|COMPLETED|Overall Study||36
11363955|NCT03192176|12560589|FG007|COMPLETED|Overall Study||37
11363956|NCT03192176|12560582|FG000|NOT COMPLETED|Overall Study||7
11363957|NCT03192176|12560583|FG001|NOT COMPLETED|Overall Study||5
11363958|NCT03192176|12560584|FG002|NOT COMPLETED|Overall Study||6
11363959|NCT03192176|12560585|FG003|NOT COMPLETED|Overall Study||12
11005620|NCT00723528|12183300|FG003|COMPLETED|Period 2: After Controlled Period||14
11363960|NCT03192176|12560586|FG004|NOT COMPLETED|Overall Study||12
11363961|NCT03192176|12560587|FG005|NOT COMPLETED|Overall Study||11
11363962|NCT03192176|12560588|FG006|NOT COMPLETED|Overall Study||9
11363963|NCT03192176|12560589|FG007|NOT COMPLETED|Overall Study||7
11363964|NCT03192306|12560610|FG000|STARTED|Overall Study||227
11363965|NCT03192306|12560611|FG001|STARTED|Overall Study||224
11363966|NCT03192306|12560610|FG000|Modified Intent to Treat (MITT)|Overall Study||76
11363967|NCT03192306|12560611|FG001|Modified Intent to Treat (MITT)|Overall Study||80
11363968|NCT03192306|12560610|FG000|COMPLETED|Overall Study||75
11363969|NCT03192306|12560611|FG001|COMPLETED|Overall Study||79
11363970|NCT03192306|12560610|FG000|NOT COMPLETED|Overall Study||152
11363971|NCT03192306|12560611|FG001|NOT COMPLETED|Overall Study||145
11363972|NCT03192475|12560619|FG000|STARTED|Overall Study||162
11363973|NCT03192475|12560620|FG001|STARTED|Overall Study||160
11363974|NCT03192475|12560619|FG000|COMPLETED|Overall Study||149
11363975|NCT03192475|12560620|FG001|COMPLETED|Overall Study||151
11363976|NCT03192475|12560619|FG000|NOT COMPLETED|Overall Study||13
11363977|NCT03192475|12560620|FG001|NOT COMPLETED|Overall Study||9
11363978|NCT03192488|12560627|FG000|STARTED|First Intervention (d1)||1
11363979|NCT03192488|12560628|FG001|STARTED|First Intervention (d1)||5
11363980|NCT03192488|12560629|FG002|STARTED|First Intervention (d1)||2
11363981|NCT03192488|12560630|FG003|STARTED|First Intervention (d1)||1
11363982|NCT03192488|12560631|FG004|STARTED|First Intervention (d1)||1
11363983|NCT03192488|12560632|FG005|STARTED|First Intervention (d1)||1
11363984|NCT03192488|12560627|FG000|COMPLETED|First Intervention (d1)||1
11363985|NCT03192488|12560628|FG001|COMPLETED|First Intervention (d1)||5
11363986|NCT03192488|12560629|FG002|COMPLETED|First Intervention (d1)||2
11363987|NCT03192488|12560630|FG003|COMPLETED|First Intervention (d1)||1
11363988|NCT03192488|12560631|FG004|COMPLETED|First Intervention (d1)||1
11363989|NCT03192488|12560632|FG005|COMPLETED|First Intervention (d1)||1
11363990|NCT03192488|12560627|FG000|NOT COMPLETED|First Intervention (d1)||0
11363991|NCT03192488|12560628|FG001|NOT COMPLETED|First Intervention (d1)||0
11363992|NCT03192488|12560629|FG002|NOT COMPLETED|First Intervention (d1)||0
11363993|NCT03192488|12560630|FG003|NOT COMPLETED|First Intervention (d1)||0
11363994|NCT03192488|12560631|FG004|NOT COMPLETED|First Intervention (d1)||0
11363995|NCT03192488|12560632|FG005|NOT COMPLETED|First Intervention (d1)||0
11363996|NCT03192488|12560627|FG000|STARTED|First Washout (>6d)||1
11363997|NCT03192488|12560628|FG001|STARTED|First Washout (>6d)||5
11363998|NCT03192488|12560629|FG002|STARTED|First Washout (>6d)||2
11363999|NCT03192488|12560630|FG003|STARTED|First Washout (>6d)||1
11364000|NCT03192488|12560631|FG004|STARTED|First Washout (>6d)||1
11364001|NCT03192488|12560632|FG005|STARTED|First Washout (>6d)||1
11364002|NCT03192488|12560627|FG000|COMPLETED|First Washout (>6d)||1
11364003|NCT03192488|12560628|FG001|COMPLETED|First Washout (>6d)||5
11364004|NCT03192488|12560629|FG002|COMPLETED|First Washout (>6d)||1
11364005|NCT03192488|12560630|FG003|COMPLETED|First Washout (>6d)||1
11364006|NCT03192488|12560631|FG004|COMPLETED|First Washout (>6d)||1
11364007|NCT03192488|12560632|FG005|COMPLETED|First Washout (>6d)||0
11364008|NCT03192488|12560627|FG000|NOT COMPLETED|First Washout (>6d)||0
11364009|NCT03192488|12560628|FG001|NOT COMPLETED|First Washout (>6d)||0
11364010|NCT03192488|12560629|FG002|NOT COMPLETED|First Washout (>6d)||1
11364011|NCT03192488|12560630|FG003|NOT COMPLETED|First Washout (>6d)||0
11364012|NCT03192488|12560631|FG004|NOT COMPLETED|First Washout (>6d)||0
11364013|NCT03192488|12560632|FG005|NOT COMPLETED|First Washout (>6d)||1
11364014|NCT03192488|12560627|FG000|STARTED|Second Intervention (d1)||1
11364015|NCT03192488|12560628|FG001|STARTED|Second Intervention (d1)||5
11364016|NCT03192488|12560629|FG002|STARTED|Second Intervention (d1)||1
11364017|NCT03192488|12560630|FG003|STARTED|Second Intervention (d1)||1
11364018|NCT03192488|12560631|FG004|STARTED|Second Intervention (d1)||1
11364019|NCT03192488|12560632|FG005|STARTED|Second Intervention (d1)||0
11364020|NCT03192488|12560627|FG000|COMPLETED|Second Intervention (d1)||1
11364021|NCT03192488|12560628|FG001|COMPLETED|Second Intervention (d1)||5
11364022|NCT03192488|12560629|FG002|COMPLETED|Second Intervention (d1)||1
11364023|NCT03192488|12560630|FG003|COMPLETED|Second Intervention (d1)||1
11364024|NCT03192488|12560631|FG004|COMPLETED|Second Intervention (d1)||1
11364025|NCT03192488|12560632|FG005|COMPLETED|Second Intervention (d1)||0
11364026|NCT03192488|12560627|FG000|NOT COMPLETED|Second Intervention (d1)||0
11364027|NCT03192488|12560628|FG001|NOT COMPLETED|Second Intervention (d1)||0
11364028|NCT03192488|12560629|FG002|NOT COMPLETED|Second Intervention (d1)||0
11364029|NCT03192488|12560630|FG003|NOT COMPLETED|Second Intervention (d1)||0
11364030|NCT03192488|12560631|FG004|NOT COMPLETED|Second Intervention (d1)||0
11364031|NCT03192488|12560632|FG005|NOT COMPLETED|Second Intervention (d1)||0
11364032|NCT03192488|12560627|FG000|STARTED|Second Washout (>6d)||1
11364033|NCT03192488|12560628|FG001|STARTED|Second Washout (>6d)||5
11364034|NCT03192488|12560629|FG002|STARTED|Second Washout (>6d)||1
11364035|NCT03192488|12560630|FG003|STARTED|Second Washout (>6d)||1
11364036|NCT03192488|12560631|FG004|STARTED|Second Washout (>6d)||1
11364037|NCT03192488|12560632|FG005|STARTED|Second Washout (>6d)||0
11364038|NCT03192488|12560627|FG000|COMPLETED|Second Washout (>6d)||1
11364039|NCT03192488|12560628|FG001|COMPLETED|Second Washout (>6d)||5
11364040|NCT03192488|12560629|FG002|COMPLETED|Second Washout (>6d)||1
11364041|NCT03192488|12560630|FG003|COMPLETED|Second Washout (>6d)||1
11364042|NCT03192488|12560631|FG004|COMPLETED|Second Washout (>6d)||1
11364043|NCT03192488|12560632|FG005|COMPLETED|Second Washout (>6d)||0
11364044|NCT03192488|12560627|FG000|NOT COMPLETED|Second Washout (>6d)||0
11364045|NCT03192488|12560628|FG001|NOT COMPLETED|Second Washout (>6d)||0
11364046|NCT03192488|12560629|FG002|NOT COMPLETED|Second Washout (>6d)||0
11364047|NCT03192488|12560630|FG003|NOT COMPLETED|Second Washout (>6d)||0
11364048|NCT03192488|12560631|FG004|NOT COMPLETED|Second Washout (>6d)||0
11364049|NCT03192488|12560632|FG005|NOT COMPLETED|Second Washout (>6d)||0
11364050|NCT03192488|12560627|FG000|STARTED|Third Intervention (d1)||1
11364051|NCT03192488|12560628|FG001|STARTED|Third Intervention (d1)||5
11364052|NCT03192488|12560629|FG002|STARTED|Third Intervention (d1)||1
11364053|NCT03192488|12560630|FG003|STARTED|Third Intervention (d1)||1
11364054|NCT03192488|12560631|FG004|STARTED|Third Intervention (d1)||1
11364055|NCT03192488|12560632|FG005|STARTED|Third Intervention (d1)||0
11364056|NCT03192488|12560627|FG000|COMPLETED|Third Intervention (d1)||1
11364057|NCT03192488|12560628|FG001|COMPLETED|Third Intervention (d1)||5
11364058|NCT03192488|12560629|FG002|COMPLETED|Third Intervention (d1)||1
11364059|NCT03192488|12560630|FG003|COMPLETED|Third Intervention (d1)||1
11364060|NCT03192488|12560631|FG004|COMPLETED|Third Intervention (d1)||0
11364061|NCT03192488|12560632|FG005|COMPLETED|Third Intervention (d1)||0
11364062|NCT03192488|12560627|FG000|NOT COMPLETED|Third Intervention (d1)||0
11364063|NCT03192488|12560628|FG001|NOT COMPLETED|Third Intervention (d1)||0
11364064|NCT03192488|12560629|FG002|NOT COMPLETED|Third Intervention (d1)||0
11364065|NCT03192488|12560630|FG003|NOT COMPLETED|Third Intervention (d1)||0
11364066|NCT03192488|12560631|FG004|NOT COMPLETED|Third Intervention (d1)||1
11364067|NCT03192488|12560632|FG005|NOT COMPLETED|Third Intervention (d1)||0
11364068|NCT03192826|12560649|FG000|STARTED|Overall Study||27
11364069|NCT03192826|12560650|FG001|STARTED|Overall Study||27
11364070|NCT03192826|12560651|FG002|STARTED|Overall Study||25
11364071|NCT03192826|12560649|FG000|COMPLETED|Overall Study||27
11364072|NCT03192826|12560650|FG001|COMPLETED|Overall Study||27
11364073|NCT03192826|12560651|FG002|COMPLETED|Overall Study||25
11364074|NCT03192826|12560649|FG000|NOT COMPLETED|Overall Study||0
11364075|NCT03192826|12560650|FG001|NOT COMPLETED|Overall Study||0
11364076|NCT03192826|12560651|FG002|NOT COMPLETED|Overall Study||0
11364077|NCT03192904|12560661|FG000|STARTED|Overall Study||35
11364078|NCT03192904|12560662|FG001|STARTED|Overall Study||35
11364079|NCT03192904|12560661|FG000|COMPLETED|Overall Study||32
11364080|NCT03192904|12560662|FG001|COMPLETED|Overall Study||33
11364081|NCT03192904|12560661|FG000|NOT COMPLETED|Overall Study||3
11364082|NCT03192904|12560662|FG001|NOT COMPLETED|Overall Study||2
11364083|NCT03193021|12560670|FG000|STARTED|Overall Study||100
11364084|NCT03193021|12560671|FG001|STARTED|Overall Study||104
11364085|NCT03193021|12560670|FG000|COMPLETED|Overall Study||99
11364086|NCT03193021|12560671|FG001|COMPLETED|Overall Study||103
11364087|NCT03193021|12560670|FG000|NOT COMPLETED|Overall Study||1
11364088|NCT03193021|12560671|FG001|NOT COMPLETED|Overall Study||1
11364089|NCT03193047|12560679|FG000|STARTED|Overall Study||31
11364090|NCT03193047|12560680|FG001|STARTED|Overall Study||28
11364091|NCT03193047|12560679|FG000|COMPLETED|Overall Study||29
11364092|NCT03193047|12560680|FG001|COMPLETED|Overall Study||28
11364093|NCT03193047|12560679|FG000|NOT COMPLETED|Overall Study||2
11364094|NCT03193047|12560680|FG001|NOT COMPLETED|Overall Study||0
11364095|NCT03193398|12560690|FG000|STARTED|Overall Study||53
11364096|NCT03193398|12560691|FG001|STARTED|Overall Study||51
11364097|NCT03193398|12560690|FG000|COMPLETED|Overall Study||38
11364098|NCT03193398|12560691|FG001|COMPLETED|Overall Study||35
11364099|NCT03193398|12560690|FG000|NOT COMPLETED|Overall Study||15
11364100|NCT03193398|12560691|FG001|NOT COMPLETED|Overall Study||16
11364101|NCT03193593|12560704|FG000|STARTED|Overall Study||18
11364102|NCT03193593|12560705|FG001|STARTED|Overall Study||4
11364103|NCT03193593|12560706|FG002|STARTED|Overall Study||4
11364104|NCT03193593|12560707|FG003|STARTED|Overall Study||4
11364105|NCT03193593|12560708|FG004|STARTED|Overall Study||8
11364106|NCT03193593|12560709|FG005|STARTED|Overall Study||16
11364107|NCT03193593|12560710|FG006|STARTED|Overall Study||12
11364108|NCT03193593|12560704|FG000|COMPLETED|Overall Study||14
11005621|NCT00723528|12183301|FG004|COMPLETED|Period 2: After Controlled Period||11
11005622|NCT00723528|12183302|FG005|COMPLETED|Period 2: After Controlled Period||58
11364109|NCT03193593|12560705|FG001|COMPLETED|Overall Study||3
11364110|NCT03193593|12560706|FG002|COMPLETED|Overall Study||3
11364111|NCT03193593|12560707|FG003|COMPLETED|Overall Study||4
11364112|NCT03193593|12560708|FG004|COMPLETED|Overall Study||7
11364113|NCT03193593|12560709|FG005|COMPLETED|Overall Study||13
11364114|NCT03193593|12560710|FG006|COMPLETED|Overall Study||8
11364115|NCT03193593|12560704|FG000|NOT COMPLETED|Overall Study||4
11364116|NCT03193593|12560705|FG001|NOT COMPLETED|Overall Study||1
11364117|NCT03193593|12560706|FG002|NOT COMPLETED|Overall Study||1
11364118|NCT03193593|12560707|FG003|NOT COMPLETED|Overall Study||0
11364119|NCT03193593|12560708|FG004|NOT COMPLETED|Overall Study||1
11364120|NCT03193593|12560709|FG005|NOT COMPLETED|Overall Study||3
11364121|NCT03193593|12560710|FG006|NOT COMPLETED|Overall Study||4
11364122|NCT03193736|12560726|FG000|STARTED|Overall Study||26
11364123|NCT03193736|12560726|FG000|Received Implant|Overall Study||25
11364124|NCT03193736|12560726|FG000|COMPLETED|Overall Study||21
11364125|NCT03193736|12560726|FG000|NOT COMPLETED|Overall Study||5
11364126|NCT03194217|12560734|FG000|STARTED|Overall Study||60
11364127|NCT03194217|12560735|FG001|STARTED|Overall Study||60
11364128|NCT03194217|12560736|FG002|STARTED|Overall Study||60
11364129|NCT03194217|12560737|FG003|STARTED|Overall Study||64
11364130|NCT03194217|12560734|FG000|COMPLETED|Overall Study||60
11364131|NCT03194217|12560735|FG001|COMPLETED|Overall Study||57
11364132|NCT03194217|12560736|FG002|COMPLETED|Overall Study||56
11364133|NCT03194217|12560737|FG003|COMPLETED|Overall Study||60
11364134|NCT03194217|12560734|FG000|NOT COMPLETED|Overall Study||0
11364135|NCT03194217|12560735|FG001|NOT COMPLETED|Overall Study||3
11364136|NCT03194217|12560736|FG002|NOT COMPLETED|Overall Study||4
11364137|NCT03194217|12560737|FG003|NOT COMPLETED|Overall Study||4
11364138|NCT03194334|12560750|FG000|STARTED|0-3 Months||10
11364139|NCT03194334|12560751|FG001|STARTED|0-3 Months||15
11364140|NCT03194334|12560752|FG002|STARTED|0-3 Months||15
11364141|NCT03194334|12560750|FG000|COMPLETED|0-3 Months||10
11364142|NCT03194334|12560751|FG001|COMPLETED|0-3 Months||15
11364143|NCT03194334|12560752|FG002|COMPLETED|0-3 Months||14
11364144|NCT03194334|12560750|FG000|NOT COMPLETED|0-3 Months||0
11364145|NCT03194334|12560751|FG001|NOT COMPLETED|0-3 Months||0
11364146|NCT03194334|12560752|FG002|NOT COMPLETED|0-3 Months||1
11364147|NCT03194334|12560750|FG000|STARTED|3-6 Months||10
11364148|NCT03194334|12560751|FG001|STARTED|3-6 Months||15
11364149|NCT03194334|12560752|FG002|STARTED|3-6 Months||14
11364150|NCT03194334|12560750|FG000|COMPLETED|3-6 Months||10
11364151|NCT03194334|12560751|FG001|COMPLETED|3-6 Months||15
11364152|NCT03194334|12560752|FG002|COMPLETED|3-6 Months||14
11364153|NCT03194334|12560750|FG000|NOT COMPLETED|3-6 Months||0
11364154|NCT03194334|12560751|FG001|NOT COMPLETED|3-6 Months||0
11364155|NCT03194334|12560752|FG002|NOT COMPLETED|3-6 Months||0
11364156|NCT03194373|12560761|FG000|STARTED|Overall Study||20
11364157|NCT03194373|12560761|FG000|Received Palbociclib and Carboplatin|Overall Study||19
11364158|NCT03194373|12560761|FG000|COMPLETED|Overall Study||18
11364159|NCT03194373|12560761|FG000|NOT COMPLETED|Overall Study||2
11364160|NCT03194464|12560765|FG000|STARTED|Overall Study||15
11364161|NCT03194464|12560765|FG000|COMPLETED|Overall Study||13
11364162|NCT03194464|12560765|FG000|NOT COMPLETED|Overall Study||2
11364163|NCT03194490|12560773|FG000|STARTED|Overall Study||20
11364164|NCT03194490|12560774|FG001|STARTED|Overall Study||23
11364165|NCT03194490|12560773|FG000|COMPLETED|Overall Study||18
11364166|NCT03194490|12560774|FG001|COMPLETED|Overall Study||20
11364167|NCT03194490|12560773|FG000|NOT COMPLETED|Overall Study||2
11364168|NCT03194490|12560774|FG001|NOT COMPLETED|Overall Study||3
11364169|NCT03194503|12560783|FG000|STARTED|Overall Study||458
11364170|NCT03194503|12560784|FG001|STARTED|Overall Study||1054
11364171|NCT03194503|12560783|FG000|COMPLETED|Overall Study||458
11364172|NCT03194503|12560784|FG001|COMPLETED|Overall Study||1054
11364173|NCT03194503|12560783|FG000|NOT COMPLETED|Overall Study||0
11364174|NCT03194503|12560784|FG001|NOT COMPLETED|Overall Study||0
11364175|NCT03194698|12560794|FG000|STARTED|Overall Study||10
11364176|NCT03194698|12560795|FG001|STARTED|Overall Study||10
11364177|NCT03194698|12560794|FG000|COMPLETED|Overall Study||10
11364178|NCT03194698|12560795|FG001|COMPLETED|Overall Study||10
11364179|NCT03194698|12560794|FG000|NOT COMPLETED|Overall Study||0
11364180|NCT03194698|12560795|FG001|NOT COMPLETED|Overall Study||0
11364181|NCT03194737|12560803|FG000|STARTED|Overall Study||52
11364182|NCT03194737|12560804|FG001|STARTED|Overall Study||49
11364183|NCT03194737|12560803|FG000|COMPLETED|Overall Study||47
11364184|NCT03194737|12560804|FG001|COMPLETED|Overall Study||49
11364185|NCT03194737|12560803|FG000|NOT COMPLETED|Overall Study||5
11364186|NCT03194737|12560804|FG001|NOT COMPLETED|Overall Study||0
11364187|NCT03194776|12560812|FG000|STARTED|Overall Study||23
11364188|NCT03194776|12560813|FG001|STARTED|Overall Study||23
11364189|NCT03194776|12560812|FG000|COMPLETED|Overall Study||23
11364190|NCT03194776|12560813|FG001|COMPLETED|Overall Study||23
11364191|NCT03194776|12560812|FG000|NOT COMPLETED|Overall Study||0
11364192|NCT03194776|12560813|FG001|NOT COMPLETED|Overall Study||0
11364193|NCT03195010|12560822|FG000|STARTED|Overall Study||2
11364194|NCT03195010|12560823|FG001|STARTED|Overall Study||2
11364195|NCT03195010|12560822|FG000|COMPLETED|Overall Study||2
11364196|NCT03195010|12560823|FG001|COMPLETED|Overall Study||2
11364197|NCT03195010|12560822|FG000|NOT COMPLETED|Overall Study||0
11364198|NCT03195010|12560823|FG001|NOT COMPLETED|Overall Study||0
11364199|NCT03195517|12560831|FG000|STARTED|Overall Study||33
11364200|NCT03195517|12560831|FG000|COMPLETED|Overall Study||33
11364201|NCT03195517|12560831|FG000|NOT COMPLETED|Overall Study||0
11364202|NCT03196076|12560842|FG000|STARTED|Overall Study||5
11364203|NCT03196076|12560843|FG001|STARTED|Overall Study||20
11364204|NCT03196076|12560844|FG002|STARTED|Overall Study||0
11364205|NCT03196076|12560842|FG000|COMPLETED|Overall Study||5
11364206|NCT03196076|12560843|FG001|COMPLETED|Overall Study||20
11364207|NCT03196076|12560844|FG002|COMPLETED|Overall Study||0
11364208|NCT03196076|12560842|FG000|NOT COMPLETED|Overall Study||0
11364209|NCT03196076|12560843|FG001|NOT COMPLETED|Overall Study||0
11364210|NCT03196076|12560844|FG002|NOT COMPLETED|Overall Study||0
11364211|NCT03196193|12560854|FG000|STARTED|Overall Study||121
11364212|NCT03196193|12560855|FG001|STARTED|Overall Study||119
11364213|NCT03196193|12560854|FG000|COMPLETED|Overall Study||118
11364214|NCT03196193|12560855|FG001|COMPLETED|Overall Study||119
11364215|NCT03196193|12560854|FG000|NOT COMPLETED|Overall Study||3
11364216|NCT03196193|12560855|FG001|NOT COMPLETED|Overall Study||0
11364217|NCT03196232|12560861|FG000|STARTED|Overall Study||3
11364218|NCT03196232|12560861|FG000|COMPLETED|Overall Study||3
11364219|NCT03196232|12560861|FG000|NOT COMPLETED|Overall Study||0
11364220|NCT03196284|12560867|FG000|STARTED|Main Part||17
11364221|NCT03196284|12560868|FG001|STARTED|Main Part||9
11364222|NCT03196284|12560869|FG002|STARTED|Main Part||0
11364223|NCT03196284|12560867|FG000|Concizumab 0.15 mg/kg|Main Part||15
11364224|NCT03196284|12560868|FG001|Concizumab 0.15 mg/kg|Main Part||0
11364225|NCT03196284|12560869|FG002|Concizumab 0.15 mg/kg|Main Part||0
11364226|NCT03196284|12560867|FG000|Concizumab 0.20 mg/kg|Main Part||2
11364227|NCT03196284|12560868|FG001|Concizumab 0.20 mg/kg|Main Part||0
11364228|NCT03196284|12560869|FG002|Concizumab 0.20 mg/kg|Main Part||0
11364229|NCT03196284|12560867|FG000|Concizumab 0.25 mg/kg|Main Part||0
11364230|NCT03196284|12560868|FG001|Concizumab 0.25 mg/kg|Main Part||0
11364231|NCT03196284|12560869|FG002|Concizumab 0.25 mg/kg|Main Part||0
11364232|NCT03196284|12560867|FG000|COMPLETED|Main Part||17
11364233|NCT03196284|12560868|FG001|COMPLETED|Main Part||8
11364234|NCT03196284|12560869|FG002|COMPLETED|Main Part||0
11364235|NCT03196284|12560867|FG000|NOT COMPLETED|Main Part||0
11364236|NCT03196284|12560868|FG001|NOT COMPLETED|Main Part||1
11364237|NCT03196284|12560869|FG002|NOT COMPLETED|Main Part||0
11364238|NCT03196284|12560867|FG000|STARTED|Extension Part|Participants who completed main part are presented in separate treatment arm.|0
11364239|NCT03196284|12560868|FG001|STARTED|Extension Part|Participants switched to treatment with concizumab in the extension part of the study.|0
11364240|NCT03196284|12560869|FG002|STARTED|Extension Part|Participants who completed the main part entered the extension part of the study.|25
11364241|NCT03196284|12560867|FG000|Concizumab 0.15 mg/kg|Extension Part||0
11364242|NCT03196284|12560868|FG001|Concizumab 0.15 mg/kg|Extension Part||0
11364243|NCT03196284|12560869|FG002|Concizumab 0.15 mg/kg|Extension Part||12
11364244|NCT03196284|12560867|FG000|Concizumab 0.20 mg/kg|Extension Part||0
11364245|NCT03196284|12560868|FG001|Concizumab 0.20 mg/kg|Extension Part||0
11364246|NCT03196284|12560869|FG002|Concizumab 0.20 mg/kg|Extension Part||9
11364247|NCT03196284|12560867|FG000|Concizumab 0.25 mg/kg|Extension Part||0
11364248|NCT03196284|12560868|FG001|Concizumab 0.25 mg/kg|Extension Part||0
11364249|NCT03196284|12560869|FG002|Concizumab 0.25 mg/kg|Extension Part||4
11364250|NCT03196284|12560867|FG000|COMPLETED|Extension Part||0
11364251|NCT03196284|12560868|FG001|COMPLETED|Extension Part||0
11364252|NCT03196284|12560869|FG002|COMPLETED|Extension Part||22
11364253|NCT03196284|12560867|FG000|NOT COMPLETED|Extension Part||0
11364254|NCT03196284|12560868|FG001|NOT COMPLETED|Extension Part||0
11364255|NCT03196284|12560869|FG002|NOT COMPLETED|Extension Part||3
11364256|NCT03196297|12560889|FG000|STARTED|Main Period||36
11364257|NCT03196297|12560889|FG000|Full Analysis Set (FAS)|Main Period||36
11364258|NCT03196297|12560889|FG000|Subject Analysis Set (SAS)|Main Period||36
11364259|NCT03196297|12560889|FG000|COMPLETED|Main Period||32
11364260|NCT03196297|12560889|FG000|NOT COMPLETED|Main Period||4
11364261|NCT03196297|12560889|FG000|STARTED|Extension Period||32
11364262|NCT03196297|12560889|FG000|FAS|Extension Period||32
11364263|NCT03196297|12560889|FG000|SAS|Extension Period||32
11364264|NCT03196297|12560889|FG000|COMPLETED|Extension Period||29
11364265|NCT03196297|12560889|FG000|NOT COMPLETED|Extension Period||3
11364266|NCT03196349|12560908|FG000|STARTED|Overall Study||17
11364267|NCT03196349|12560909|FG001|STARTED|Overall Study||14
11364268|NCT03196349|12560910|FG002|STARTED|Overall Study||13
11364269|NCT03196349|12560908|FG000|COMPLETED|Overall Study||0
11364270|NCT03196349|12560909|FG001|COMPLETED|Overall Study||0
11364271|NCT03196349|12560910|FG002|COMPLETED|Overall Study||0
11364272|NCT03196349|12560908|FG000|NOT COMPLETED|Overall Study||17
11364273|NCT03196349|12560909|FG001|NOT COMPLETED|Overall Study||14
11364274|NCT03196349|12560910|FG002|NOT COMPLETED|Overall Study||13
11364275|NCT03196505|12560920|FG000|STARTED|Overall Study||115
11364276|NCT03196505|12560921|FG001|STARTED|Overall Study||116
11364277|NCT03196505|12560920|FG000|COMPLETED|Overall Study||89
11364278|NCT03196505|12560921|FG001|COMPLETED|Overall Study||90
11364279|NCT03196505|12560920|FG000|NOT COMPLETED|Overall Study||26
11364280|NCT03196505|12560921|FG001|NOT COMPLETED|Overall Study||26
11364281|NCT03196635|12560927|FG000|STARTED|Overall Study||31
11364282|NCT03196635|12560927|FG000|COMPLETED|Overall Study||30
11364283|NCT03196635|12560927|FG000|NOT COMPLETED|Overall Study||1
11364284|NCT03196791|12560947|FG000|STARTED|Overall Study||98
11364285|NCT03196791|12560948|FG001|STARTED|Overall Study||98
11364286|NCT03196791|12560947|FG000|COMPLETED|Overall Study||88
11364287|NCT03196791|12560948|FG001|COMPLETED|Overall Study||93
11364288|NCT03196791|12560947|FG000|NOT COMPLETED|Overall Study||10
11364289|NCT03196791|12560948|FG001|NOT COMPLETED|Overall Study||5
11364290|NCT03196973|12560957|FG000|STARTED|Overall Study||197
11364291|NCT03196973|12560958|FG001|STARTED|Overall Study||196
11364292|NCT03196973|12560959|FG002|STARTED|Overall Study||100
11364293|NCT03196973|12560957|FG000|COMPLETED|Overall Study||188
11364294|NCT03196973|12560958|FG001|COMPLETED|Overall Study||184
11364295|NCT03196973|12560959|FG002|COMPLETED|Overall Study||95
11364296|NCT03196973|12560957|FG000|NOT COMPLETED|Overall Study||9
11364297|NCT03196973|12560958|FG001|NOT COMPLETED|Overall Study||12
11364298|NCT03196973|12560959|FG002|NOT COMPLETED|Overall Study||5
11364299|NCT03197025|12560967|FG000|STARTED|Overall Study||1
11364300|NCT03197025|12560967|FG000|COMPLETED|Overall Study||1
11364301|NCT03197025|12560967|FG000|NOT COMPLETED|Overall Study||0
11364302|NCT03197038|12560973|FG000|STARTED|Overall Study||22
11364303|NCT03197038|12560974|FG001|STARTED|Overall Study||17
11364304|NCT03197038|12560973|FG000|COMPLETED|Overall Study||18
11364305|NCT03197038|12560974|FG001|COMPLETED|Overall Study||17
11364306|NCT03197038|12560973|FG000|NOT COMPLETED|Overall Study||4
11364307|NCT03197038|12560974|FG001|NOT COMPLETED|Overall Study||0
11364308|NCT03197129|12560982|FG000|STARTED|Overall Study||60
11364309|NCT03197129|12560983|FG001|STARTED|Overall Study||62
11364310|NCT03197129|12560982|FG000|COMPLETED|Overall Study||56
11364311|NCT03197129|12560983|FG001|COMPLETED|Overall Study||57
11364312|NCT03197129|12560982|FG000|NOT COMPLETED|Overall Study||4
11364313|NCT03197129|12560983|FG001|NOT COMPLETED|Overall Study||5
11364314|NCT03197324|12560991|FG000|STARTED|Overall Study||10
11364315|NCT03197324|12560992|FG001|STARTED|Overall Study||10
11364316|NCT03197324|12560991|FG000|COMPLETED|Overall Study||10
11364317|NCT03197324|12560992|FG001|COMPLETED|Overall Study||9
11364318|NCT03197324|12560991|FG000|NOT COMPLETED|Overall Study||0
11364319|NCT03197324|12560992|FG001|NOT COMPLETED|Overall Study||1
11364320|NCT03197376|12561002|FG000|STARTED|Primary and Booster Phase||502
11364321|NCT03197376|12561003|FG001|STARTED|Primary and Booster Phase||501
11364322|NCT03197376|12561004|FG002|STARTED|Primary and Booster Phase||500
11364323|NCT03197376|12561005|FG003|STARTED|Primary and Booster Phase||747
11364324|NCT03197376|12561002|FG000|Vaccinated-Dose 1|Primary and Booster Phase||502
11364325|NCT03197376|12561003|FG001|Vaccinated-Dose 1|Primary and Booster Phase||501
11364326|NCT03197376|12561004|FG002|Vaccinated-Dose 1|Primary and Booster Phase||500
11364327|NCT03197376|12561005|FG003|Vaccinated-Dose 1|Primary and Booster Phase||747
11364328|NCT03197376|12561002|FG000|Vaccinated-Dose 2|Primary and Booster Phase||495
11364329|NCT03197376|12561003|FG001|Vaccinated-Dose 2|Primary and Booster Phase||495
11364330|NCT03197376|12561004|FG002|Vaccinated-Dose 2|Primary and Booster Phase||491
11364331|NCT03197376|12561005|FG003|Vaccinated-Dose 2|Primary and Booster Phase||738
11364332|NCT03197376|12561002|FG000|Vaccinated-Dose 3|Primary and Booster Phase||492
11364333|NCT03197376|12561003|FG001|Vaccinated-Dose 3|Primary and Booster Phase||493
11364334|NCT03197376|12561004|FG002|Vaccinated-Dose 3|Primary and Booster Phase||490
11364335|NCT03197376|12561005|FG003|Vaccinated-Dose 3|Primary and Booster Phase||731
11364336|NCT03197376|12561002|FG000|Primary Reactogenicity Cohort|Primary and Booster Phase||251
11364337|NCT03197376|12561003|FG001|Primary Reactogenicity Cohort|Primary and Booster Phase||243
11364338|NCT03197376|12561004|FG002|Primary Reactogenicity Cohort|Primary and Booster Phase||257
11364339|NCT03197376|12561005|FG003|Primary Reactogenicity Cohort|Primary and Booster Phase||364
11364340|NCT03197376|12561002|FG000|Booster Cohort|Primary and Booster Phase||150
11364341|NCT03197376|12561003|FG001|Booster Cohort|Primary and Booster Phase||151
11364342|NCT03197376|12561004|FG002|Booster Cohort|Primary and Booster Phase||150
11364343|NCT03197376|12561005|FG003|Booster Cohort|Primary and Booster Phase||224
11364344|NCT03197376|12561002|FG000|Received Booster Vaccine|Primary and Booster Phase||145
11364345|NCT03197376|12561003|FG001|Received Booster Vaccine|Primary and Booster Phase||144
11364346|NCT03197376|12561004|FG002|Received Booster Vaccine|Primary and Booster Phase||139
11364347|NCT03197376|12561005|FG003|Received Booster Vaccine|Primary and Booster Phase||213
11364348|NCT03197376|12561002|FG000|COMPLETED|Primary and Booster Phase||487
11364349|NCT03197376|12561003|FG001|COMPLETED|Primary and Booster Phase||488
11364350|NCT03197376|12561004|FG002|COMPLETED|Primary and Booster Phase||480
11364351|NCT03197376|12561005|FG003|COMPLETED|Primary and Booster Phase||722
11364352|NCT03197376|12561002|FG000|NOT COMPLETED|Primary and Booster Phase||15
11364353|NCT03197376|12561003|FG001|NOT COMPLETED|Primary and Booster Phase||13
11364354|NCT03197376|12561004|FG002|NOT COMPLETED|Primary and Booster Phase||20
11364355|NCT03197376|12561005|FG003|NOT COMPLETED|Primary and Booster Phase||25
11364356|NCT03197376|12561002|FG000|STARTED|Immune Persistence Phase||132
11364357|NCT03197376|12561003|FG001|STARTED|Immune Persistence Phase||133
11364358|NCT03197376|12561004|FG002|STARTED|Immune Persistence Phase||128
11364359|NCT03197376|12561005|FG003|STARTED|Immune Persistence Phase||195
11364360|NCT03197376|12561002|FG000|COMPLETED|Immune Persistence Phase||127
11364361|NCT03197376|12561003|FG001|COMPLETED|Immune Persistence Phase||129
11364362|NCT03197376|12561004|FG002|COMPLETED|Immune Persistence Phase||123
11364363|NCT03197376|12561005|FG003|COMPLETED|Immune Persistence Phase||190
11364364|NCT03197376|12561002|FG000|NOT COMPLETED|Immune Persistence Phase||5
11364365|NCT03197376|12561003|FG001|NOT COMPLETED|Immune Persistence Phase||4
11364366|NCT03197376|12561004|FG002|NOT COMPLETED|Immune Persistence Phase||5
11364367|NCT03197376|12561005|FG003|NOT COMPLETED|Immune Persistence Phase||5
11364368|NCT03197389|12561044|FG000|STARTED|Overall Study||16
11364369|NCT03197389|12561045|FG001|STARTED|Overall Study||5
11364370|NCT03197389|12561046|FG002|STARTED|Overall Study||18
11364371|NCT03197389|12561047|FG003|STARTED|Overall Study||9
11364372|NCT03197389|12561048|FG004|STARTED|Overall Study||1
11364373|NCT03197389|12561049|FG005|STARTED|Overall Study||5
11364374|NCT03197389|12561044|FG000|COMPLETED|Overall Study||16
11364375|NCT03197389|12561045|FG001|COMPLETED|Overall Study||5
11364376|NCT03197389|12561046|FG002|COMPLETED|Overall Study||18
11364377|NCT03197389|12561047|FG003|COMPLETED|Overall Study||9
11364378|NCT03197389|12561048|FG004|COMPLETED|Overall Study||1
11364379|NCT03197389|12561049|FG005|COMPLETED|Overall Study||5
11364380|NCT03197389|12561044|FG000|NOT COMPLETED|Overall Study||0
11364381|NCT03197389|12561045|FG001|NOT COMPLETED|Overall Study||0
11364382|NCT03197389|12561046|FG002|NOT COMPLETED|Overall Study||0
11364383|NCT03197389|12561047|FG003|NOT COMPLETED|Overall Study||0
11364384|NCT03197389|12561048|FG004|NOT COMPLETED|Overall Study||0
11364385|NCT03197389|12561049|FG005|NOT COMPLETED|Overall Study||0
11364386|NCT03197558|12561063|FG000|STARTED|Overall Study||30
11364387|NCT03197558|12561063|FG000|COMPLETED|Overall Study||29
11364388|NCT03197558|12561063|FG000|NOT COMPLETED|Overall Study||1
11364389|NCT03197883|12561069|FG000|STARTED|Overall Study||50
11364390|NCT03197883|12561070|FG001|STARTED|Overall Study||50
11364391|NCT03197883|12561069|FG000|COMPLETED|Overall Study||47
11364392|NCT03197883|12561070|FG001|COMPLETED|Overall Study||44
11364393|NCT03197883|12561069|FG000|NOT COMPLETED|Overall Study||3
11364394|NCT03197883|12561070|FG001|NOT COMPLETED|Overall Study||6
11364395|NCT03198000|12561079|FG000|STARTED|Overall Study||41
11364396|NCT03198000|12561080|FG001|STARTED|Overall Study||38
11364397|NCT03198000|12561081|FG002|STARTED|Overall Study||41
11364398|NCT03198000|12561079|FG000|COMPLETED|Overall Study||41
11364399|NCT03198000|12561080|FG001|COMPLETED|Overall Study||38
11364400|NCT03198000|12561081|FG002|COMPLETED|Overall Study||41
11364401|NCT03198000|12561079|FG000|NOT COMPLETED|Overall Study||0
11364402|NCT03198000|12561080|FG001|NOT COMPLETED|Overall Study||0
11364403|NCT03198000|12561081|FG002|NOT COMPLETED|Overall Study||0
11364404|NCT03198221|12561093|FG000|STARTED|Overall Study||3
11364405|NCT03198221|12561094|FG001|STARTED|Overall Study||2
11364406|NCT03198221|12561095|FG002|STARTED|Overall Study||7
11364407|NCT03198221|12561096|FG003|STARTED|Overall Study||2
11364408|NCT03198221|12561093|FG000|COMPLETED|Overall Study||3
11364409|NCT03198221|12561094|FG001|COMPLETED|Overall Study||2
11364410|NCT03198221|12561095|FG002|COMPLETED|Overall Study||7
11364411|NCT03198221|12561096|FG003|COMPLETED|Overall Study||2
11364412|NCT03198221|12561093|FG000|NOT COMPLETED|Overall Study||0
11364413|NCT03198221|12561094|FG001|NOT COMPLETED|Overall Study||0
11364414|NCT03198221|12561095|FG002|NOT COMPLETED|Overall Study||0
11364415|NCT03198221|12561096|FG003|NOT COMPLETED|Overall Study||0
11364416|NCT03198507|12561108|FG000|STARTED|Overall Study||228
11364417|NCT03198507|12561109|FG001|STARTED|Overall Study||227
11364418|NCT03198507|12561108|FG000|COMPLETED|Overall Study||227
11364419|NCT03198507|12561109|FG001|COMPLETED|Overall Study||227
11364420|NCT03198507|12561108|FG000|NOT COMPLETED|Overall Study||1
11364421|NCT03198507|12561109|FG001|NOT COMPLETED|Overall Study||0
11364422|NCT03198520|12561115|FG000|STARTED|Overall Study||46
11364423|NCT03198520|12561115|FG000|COMPLETED|Overall Study||40
11364424|NCT03198520|12561115|FG000|NOT COMPLETED|Overall Study||6
11364425|NCT03198715|12561132|FG000|STARTED|Overall Study||6
11364426|NCT03198715|12561133|FG001|STARTED|Overall Study||12
11364427|NCT03198715|12561134|FG002|STARTED|Overall Study||12
11364428|NCT03198715|12561135|FG003|STARTED|Overall Study||3
11364429|NCT03198715|12561136|FG004|STARTED|Overall Study||9
11364430|NCT03198715|12561132|FG000|COMPLETED|Overall Study||6
11364431|NCT03198715|12561133|FG001|COMPLETED|Overall Study||11
11364432|NCT03198715|12561134|FG002|COMPLETED|Overall Study||10
11364433|NCT03198715|12561135|FG003|COMPLETED|Overall Study||3
11364434|NCT03198715|12561136|FG004|COMPLETED|Overall Study||7
11364435|NCT03198715|12561132|FG000|NOT COMPLETED|Overall Study||0
11364436|NCT03198715|12561133|FG001|NOT COMPLETED|Overall Study||1
11364437|NCT03198715|12561134|FG002|NOT COMPLETED|Overall Study||2
11364438|NCT03198715|12561135|FG003|NOT COMPLETED|Overall Study||0
11364439|NCT03198715|12561136|FG004|NOT COMPLETED|Overall Study||2
11364440|NCT03198754|12561150|FG000|STARTED|Overall Study||38
11364441|NCT03198754|12561151|FG001|STARTED|Overall Study||35
11364442|NCT03198754|12561150|FG000|COMPLETED|Overall Study||27
11364443|NCT03198754|12561151|FG001|COMPLETED|Overall Study||27
11364444|NCT03198754|12561150|FG000|NOT COMPLETED|Overall Study||11
11364445|NCT03198754|12561151|FG001|NOT COMPLETED|Overall Study||8
11364446|NCT03198767|12561164|FG000|STARTED|Overall Study||8
11364447|NCT03198767|12561165|FG001|STARTED|Overall Study||8
11364448|NCT03198767|12561166|FG002|STARTED|Overall Study||8
11364449|NCT03198767|12561167|FG003|STARTED|Overall Study||6
11364450|NCT03198767|12561168|FG004|STARTED|Overall Study||8
11364451|NCT03198767|12561169|FG005|STARTED|Overall Study||8
11364452|NCT03198767|12561170|FG006|STARTED|Overall Study||8
11364453|NCT03198767|12561164|FG000|COMPLETED|Overall Study||8
11364454|NCT03198767|12561165|FG001|COMPLETED|Overall Study||8
11364455|NCT03198767|12561166|FG002|COMPLETED|Overall Study||8
11364456|NCT03198767|12561167|FG003|COMPLETED|Overall Study||0
11364457|NCT03198767|12561168|FG004|COMPLETED|Overall Study||8
11364458|NCT03198767|12561169|FG005|COMPLETED|Overall Study||8
11364459|NCT03198767|12561170|FG006|COMPLETED|Overall Study||8
11364460|NCT03198767|12561164|FG000|NOT COMPLETED|Overall Study||0
11364461|NCT03198767|12561165|FG001|NOT COMPLETED|Overall Study||0
11364462|NCT03198767|12561166|FG002|NOT COMPLETED|Overall Study||0
11364463|NCT03198767|12561167|FG003|NOT COMPLETED|Overall Study||6
11364464|NCT03198767|12561168|FG004|NOT COMPLETED|Overall Study||0
11364465|NCT03198767|12561169|FG005|NOT COMPLETED|Overall Study||0
11364466|NCT03198767|12561170|FG006|NOT COMPLETED|Overall Study||0
11364467|NCT03198871|12561187|FG000|STARTED|Overall Study||90
11364468|NCT03198871|12561188|FG001|STARTED|Overall Study||90
11364469|NCT03198871|12561187|FG000|COMPLETED|Overall Study||76
11364470|NCT03198871|12561188|FG001|COMPLETED|Overall Study||78
11364471|NCT03198871|12561187|FG000|NOT COMPLETED|Overall Study||14
11364472|NCT03198871|12561188|FG001|NOT COMPLETED|Overall Study||12
11364473|NCT03198884|12561194|FG000|STARTED|Overall Study||20
11364474|NCT03198884|12561194|FG000|COMPLETED|Overall Study||20
11364475|NCT03198884|12561194|FG000|NOT COMPLETED|Overall Study||0
11364476|NCT03199079|12561210|FG000|STARTED|Overall Study||10
11364477|NCT03199079|12561211|FG001|STARTED|Overall Study||10
11364478|NCT03199079|12561210|FG000|COMPLETED|Overall Study||10
11364479|NCT03199079|12561211|FG001|COMPLETED|Overall Study||10
11364480|NCT03199079|12561210|FG000|NOT COMPLETED|Overall Study||0
11364481|NCT03199079|12561211|FG001|NOT COMPLETED|Overall Study||0
11364482|NCT03199118|12561219|FG000|STARTED|Overall Study||14
11364483|NCT03199118|12561220|FG001|STARTED|Overall Study||14
11364484|NCT03199118|12561219|FG000|COMPLETED|Overall Study|6 months follow-up|14
11364485|NCT03199118|12561220|FG001|COMPLETED|Overall Study|6 months follow-up|14
11364486|NCT03199118|12561219|FG000|NOT COMPLETED|Overall Study||0
11364487|NCT03199118|12561220|FG001|NOT COMPLETED|Overall Study||0
11364488|NCT03199872|12561231|FG000|STARTED|Overall Study||22
11364489|NCT03199872|12561231|FG000|COMPLETED|Overall Study||22
11364490|NCT03199872|12561231|FG000|NOT COMPLETED|Overall Study||0
11364491|NCT03199911|12561237|FG000|STARTED|Overall Study||208
11364492|NCT03199911|12561238|FG001|STARTED|Overall Study||193
11364493|NCT03199911|12561237|FG000|Did Not Proceed With Surgery|Overall Study||2
11364494|NCT03199911|12561238|FG001|Did Not Proceed With Surgery|Overall Study||1
11364495|NCT03199911|12561237|FG000|Received Allocated Treatment|Overall Study||206
11364496|NCT03199911|12561238|FG001|Received Allocated Treatment|Overall Study||192
11364497|NCT03199911|12561237|FG000|Lost to Follow-up|Overall Study||5
11364498|NCT03199911|12561238|FG001|Lost to Follow-up|Overall Study||5
11364499|NCT03199911|12561237|FG000|Primary Outcome Analyzed|Overall Study||201
11364500|NCT03199911|12561238|FG001|Primary Outcome Analyzed|Overall Study||187
11364501|NCT03199911|12561237|FG000|COMPLETED|Overall Study||201
11005623|NCT00723528|12183303|FG006|COMPLETED|Period 2: After Controlled Period||54
11005624|NCT00723528|12183297|FG000|NOT COMPLETED|Period 2: After Controlled Period||0
11005625|NCT00723528|12183298|FG001|NOT COMPLETED|Period 2: After Controlled Period||0
11005626|NCT00723528|12183299|FG002|NOT COMPLETED|Period 2: After Controlled Period||0
11005627|NCT00723528|12183300|FG003|NOT COMPLETED|Period 2: After Controlled Period||1
11005628|NCT00723528|12183301|FG004|NOT COMPLETED|Period 2: After Controlled Period||2
11005629|NCT00723528|12183302|FG005|NOT COMPLETED|Period 2: After Controlled Period||6
11005630|NCT00723528|12183303|FG006|NOT COMPLETED|Period 2: After Controlled Period||4
11005631|NCT00723554|12183319|FG000|STARTED|Overall Study||63
11005632|NCT00723554|12183319|FG000|COMPLETED|Overall Study||34
11364502|NCT03199911|12561238|FG001|COMPLETED|Overall Study||187
11364503|NCT03199911|12561237|FG000|NOT COMPLETED|Overall Study||7
11364504|NCT03199911|12561238|FG001|NOT COMPLETED|Overall Study||6
11364505|NCT03200366|12561247|FG000|STARTED|Baseline Interview With Randomization||123
11364506|NCT03200366|12561248|FG001|STARTED|Baseline Interview With Randomization||120
11364507|NCT03200366|12561249|FG002|STARTED|Baseline Interview With Randomization||128
11364508|NCT03200366|12561247|FG000|COMPLETED|Baseline Interview With Randomization||123
11364509|NCT03200366|12561248|FG001|COMPLETED|Baseline Interview With Randomization||120
11364510|NCT03200366|12561249|FG002|COMPLETED|Baseline Interview With Randomization||128
11364511|NCT03200366|12561247|FG000|NOT COMPLETED|Baseline Interview With Randomization||0
11364512|NCT03200366|12561248|FG001|NOT COMPLETED|Baseline Interview With Randomization||0
11364513|NCT03200366|12561249|FG002|NOT COMPLETED|Baseline Interview With Randomization||0
11364514|NCT03200366|12561247|FG000|STARTED|Tailored DVD Intervention Given||123
11364515|NCT03200366|12561248|FG001|STARTED|Tailored DVD Intervention Given||120
11364516|NCT03200366|12561249|FG002|STARTED|Tailored DVD Intervention Given||0
11364517|NCT03200366|12561247|FG000|COMPLETED|Tailored DVD Intervention Given||123
11364518|NCT03200366|12561248|FG001|COMPLETED|Tailored DVD Intervention Given||120
11364519|NCT03200366|12561249|FG002|COMPLETED|Tailored DVD Intervention Given||0
11364520|NCT03200366|12561247|FG000|NOT COMPLETED|Tailored DVD Intervention Given||0
11364521|NCT03200366|12561248|FG001|NOT COMPLETED|Tailored DVD Intervention Given||0
11364522|NCT03200366|12561249|FG002|NOT COMPLETED|Tailored DVD Intervention Given||0
11364523|NCT03200366|12561247|FG000|STARTED|Patient Navigation Intervention Given||0
11364524|NCT03200366|12561248|FG001|STARTED|Patient Navigation Intervention Given||120
11364525|NCT03200366|12561249|FG002|STARTED|Patient Navigation Intervention Given||0
11364526|NCT03200366|12561247|FG000|COMPLETED|Patient Navigation Intervention Given||0
11364527|NCT03200366|12561248|FG001|COMPLETED|Patient Navigation Intervention Given||89
11364528|NCT03200366|12561249|FG002|COMPLETED|Patient Navigation Intervention Given||0
11364529|NCT03200366|12561247|FG000|NOT COMPLETED|Patient Navigation Intervention Given||0
11364530|NCT03200366|12561248|FG001|NOT COMPLETED|Patient Navigation Intervention Given||31
11364531|NCT03200366|12561249|FG002|NOT COMPLETED|Patient Navigation Intervention Given||0
11364532|NCT03200366|12561247|FG000|STARTED|6 Month Post-Baseline Interview||123
11364533|NCT03200366|12561248|FG001|STARTED|6 Month Post-Baseline Interview||118
11364534|NCT03200366|12561249|FG002|STARTED|6 Month Post-Baseline Interview||128
11364535|NCT03200366|12561247|FG000|COMPLETED|6 Month Post-Baseline Interview||93
11364536|NCT03200366|12561248|FG001|COMPLETED|6 Month Post-Baseline Interview||95
11364537|NCT03200366|12561249|FG002|COMPLETED|6 Month Post-Baseline Interview||109
11364538|NCT03200366|12561247|FG000|NOT COMPLETED|6 Month Post-Baseline Interview||30
11364539|NCT03200366|12561248|FG001|NOT COMPLETED|6 Month Post-Baseline Interview||23
11364540|NCT03200366|12561249|FG002|NOT COMPLETED|6 Month Post-Baseline Interview||19
11364541|NCT03200366|12561247|FG000|STARTED|9 Month Post-Baseline Interview||121
11364542|NCT03200366|12561248|FG001|STARTED|9 Month Post-Baseline Interview||116
11364543|NCT03200366|12561249|FG002|STARTED|9 Month Post-Baseline Interview||127
11364544|NCT03200366|12561247|FG000|COMPLETED|9 Month Post-Baseline Interview||97
11364545|NCT03200366|12561248|FG001|COMPLETED|9 Month Post-Baseline Interview||95
11364546|NCT03200366|12561249|FG002|COMPLETED|9 Month Post-Baseline Interview||116
11364547|NCT03200366|12561247|FG000|NOT COMPLETED|9 Month Post-Baseline Interview||24
11364548|NCT03200366|12561248|FG001|NOT COMPLETED|9 Month Post-Baseline Interview||21
11364549|NCT03200366|12561249|FG002|NOT COMPLETED|9 Month Post-Baseline Interview||11
11364550|NCT03200535|12561263|FG000|STARTED|Overall Study||1863
11364551|NCT03200535|12561264|FG001|STARTED|Overall Study||1863
11364552|NCT03200535|12561265|FG002|STARTED|Overall Study||1862
11364553|NCT03200535|12561266|FG003|STARTED|Overall Study||1000
11364554|NCT03200535|12561263|FG000|COMPLETED|Overall Study||1863
11364555|NCT03200535|12561264|FG001|COMPLETED|Overall Study||1863
11364556|NCT03200535|12561265|FG002|COMPLETED|Overall Study||1862
11364557|NCT03200535|12561266|FG003|COMPLETED|Overall Study||1000
11364558|NCT03200535|12561263|FG000|NOT COMPLETED|Overall Study||0
11364559|NCT03200535|12561264|FG001|NOT COMPLETED|Overall Study||0
11364560|NCT03200535|12561265|FG002|NOT COMPLETED|Overall Study||0
11364561|NCT03200535|12561266|FG003|NOT COMPLETED|Overall Study||0
11364562|NCT03200860|12561278|FG000|STARTED|Overall Study||41
11364563|NCT03200860|12561279|FG001|STARTED|Overall Study||39
11364564|NCT03200860|12561278|FG000|COMPLETED|Overall Study||40
11364565|NCT03200860|12561279|FG001|COMPLETED|Overall Study||39
11364566|NCT03200860|12561278|FG000|NOT COMPLETED|Overall Study||1
11364567|NCT03200860|12561279|FG001|NOT COMPLETED|Overall Study||0
11364568|NCT03200912|12561288|FG000|STARTED|Overall Study||170
11364569|NCT03200912|12561289|FG001|STARTED|Overall Study||169
11364570|NCT03200912|12561290|FG002|STARTED|Overall Study||168
11364571|NCT03200912|12561288|FG000|COMPLETED|Overall Study||166
11364572|NCT03200912|12561289|FG001|COMPLETED|Overall Study||166
11364573|NCT03200912|12561290|FG002|COMPLETED|Overall Study||164
11364574|NCT03200912|12561288|FG000|NOT COMPLETED|Overall Study||4
11364575|NCT03200912|12561289|FG001|NOT COMPLETED|Overall Study||3
11364576|NCT03200912|12561290|FG002|NOT COMPLETED|Overall Study||4
11364577|NCT03200925|12561300|FG000|STARTED|Overall Study||120
11364578|NCT03200925|12561301|FG001|STARTED|Overall Study||120
11364579|NCT03200925|12561300|FG000|COMPLETED|Overall Study||120
11364580|NCT03200925|12561301|FG001|COMPLETED|Overall Study||120
11364581|NCT03200925|12561300|FG000|NOT COMPLETED|Overall Study||0
11364582|NCT03200925|12561301|FG001|NOT COMPLETED|Overall Study||0
11364583|NCT03201003|12561309|FG000|STARTED|Overall Study||132
11364584|NCT03201003|12561310|FG001|STARTED|Overall Study||43
11364585|NCT03201003|12561309|FG000|COMPLETED|Overall Study||106
11364586|NCT03201003|12561310|FG001|COMPLETED|Overall Study||40
11364587|NCT03201003|12561309|FG000|NOT COMPLETED|Overall Study||26
11364588|NCT03201003|12561310|FG001|NOT COMPLETED|Overall Study||3
11364589|NCT03201211|12561319|FG000|STARTED|Overall Study||27
11364590|NCT03201211|12561320|FG001|STARTED|Overall Study||26
11364591|NCT03201211|12561321|FG002|STARTED|Overall Study||28
11364592|NCT03201211|12561319|FG000|COMPLETED|Overall Study||25
11364593|NCT03201211|12561320|FG001|COMPLETED|Overall Study||25
11364594|NCT03201211|12561321|FG002|COMPLETED|Overall Study||27
11364595|NCT03201211|12561319|FG000|NOT COMPLETED|Overall Study||2
11364596|NCT03201211|12561320|FG001|NOT COMPLETED|Overall Study||1
11364597|NCT03201211|12561321|FG002|NOT COMPLETED|Overall Study||1
11364598|NCT03201809|12561331|FG000|STARTED|Overall Study||6
11364599|NCT03201809|12561332|FG001|STARTED|Overall Study||6
11364600|NCT03201809|12561331|FG000|COMPLETED|Overall Study||4
11364601|NCT03201809|12561332|FG001|COMPLETED|Overall Study||6
11364602|NCT03201809|12561331|FG000|NOT COMPLETED|Overall Study||2
11364603|NCT03201809|12561332|FG001|NOT COMPLETED|Overall Study||0
11364604|NCT03201900|12561338|FG000|STARTED|Treatment Phase (Up to 62 Weeks)||91
11364605|NCT03201900|12561338|FG000|Treated|Treatment Phase (Up to 62 Weeks)||89
11364606|NCT03201900|12561338|FG000|COMPLETED|Treatment Phase (Up to 62 Weeks)||54
11364607|NCT03201900|12561338|FG000|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37
11364608|NCT03201900|12561338|FG000|STARTED|Extension Phase (From Week 63 to 156)|Eligible participants who completed Treatment Phase and agreed to continue in the Extension Phase.|46
11364609|NCT03201900|12561338|FG000|COMPLETED|Extension Phase (From Week 63 to 156)||38
11364610|NCT03201900|12561338|FG000|NOT COMPLETED|Extension Phase (From Week 63 to 156)||8
11364611|NCT03202134|12561344|FG000|STARTED|Overall Study||55
11364612|NCT03202134|12561345|FG001|STARTED|Overall Study||149
11364613|NCT03202134|12561344|FG000|COMPLETED|Overall Study||55
11364614|NCT03202134|12561345|FG001|COMPLETED|Overall Study||149
11364615|NCT03202134|12561344|FG000|NOT COMPLETED|Overall Study||0
11364616|NCT03202134|12561345|FG001|NOT COMPLETED|Overall Study||0
11364617|NCT03202264|12561353|FG000|STARTED|Overall Study||30
11364618|NCT03202264|12561353|FG000|COMPLETED|Overall Study||14
11364619|NCT03202264|12561353|FG000|NOT COMPLETED|Overall Study||16
11364620|NCT03202472|12561357|FG000|STARTED|Overall Study||50
11364621|NCT03202472|12561357|FG000|COMPLETED|Overall Study||50
11364622|NCT03202472|12561357|FG000|NOT COMPLETED|Overall Study||0
11364623|NCT03202511|12561361|FG000|STARTED|Overall Study||8
11364624|NCT03202511|12561362|FG001|STARTED|Overall Study||7
11364625|NCT03202511|12561361|FG000|COMPLETED|Overall Study||7
11364626|NCT03202511|12561362|FG001|COMPLETED|Overall Study||7
11364627|NCT03202511|12561361|FG000|NOT COMPLETED|Overall Study||1
11364628|NCT03202511|12561362|FG001|NOT COMPLETED|Overall Study||0
11364629|NCT03202550|12561370|FG000|STARTED|Overall Study||13
11364630|NCT03202550|12561371|FG001|STARTED|Overall Study||11
11364631|NCT03202550|12561370|FG000|COMPLETED|Overall Study||13
11364632|NCT03202550|12561371|FG001|COMPLETED|Overall Study||11
11364633|NCT03202550|12561370|FG000|NOT COMPLETED|Overall Study||0
11364634|NCT03202550|12561371|FG001|NOT COMPLETED|Overall Study||0
11364635|NCT03203291|12561377|FG000|STARTED|Overall Study||12
11364636|NCT03203291|12561377|FG000|COMPLETED|Overall Study||11
11364637|NCT03203291|12561377|FG000|NOT COMPLETED|Overall Study||1
11364638|NCT03203447|12561383|FG000|STARTED|Overall Study|Two patients were randomized to the Active arm, but did not receive study drug.|162
11364639|NCT03203447|12561384|FG001|STARTED|Overall Study|One patient was randomized to the Control arm, but did not receive study drug.|163
11364640|NCT03203447|12561383|FG000|COMPLETED|Overall Study||0
11364641|NCT03203447|12561384|FG001|COMPLETED|Overall Study||0
11364642|NCT03203447|12561383|FG000|NOT COMPLETED|Overall Study||162
11364643|NCT03203447|12561384|FG001|NOT COMPLETED|Overall Study||163
11364644|NCT03203564|12561394|FG000|STARTED|Overall Study||8
11364645|NCT03203564|12561395|FG001|STARTED|Overall Study||8
11364646|NCT03203564|12561396|FG002|STARTED|Overall Study||8
11364647|NCT03203564|12561397|FG003|STARTED|Overall Study||9
11364648|NCT03203564|12561394|FG000|COMPLETED|Overall Study||8
11364649|NCT03203564|12561395|FG001|COMPLETED|Overall Study||8
11364650|NCT03203564|12561396|FG002|COMPLETED|Overall Study||8
11364651|NCT03203564|12561397|FG003|COMPLETED|Overall Study||9
11364652|NCT03203564|12561394|FG000|NOT COMPLETED|Overall Study||0
11364653|NCT03203564|12561395|FG001|NOT COMPLETED|Overall Study||0
11364654|NCT03203564|12561396|FG002|NOT COMPLETED|Overall Study||0
11364655|NCT03203564|12561397|FG003|NOT COMPLETED|Overall Study||0
11364656|NCT03203681|12561407|FG000|STARTED|Overall Study||60
11364657|NCT03203681|12561407|FG000|3 Month|Overall Study||44
11364658|NCT03203681|12561407|FG000|6 Months|Overall Study||33
11364659|NCT03203681|12561407|FG000|COMPLETED|Overall Study||33
11364660|NCT03203681|12561407|FG000|NOT COMPLETED|Overall Study||27
11364661|NCT03204279|12561413|FG000|STARTED|Overall Study||34
11364662|NCT03204279|12561414|FG001|STARTED|Overall Study||33
11364663|NCT03204279|12561413|FG000|COMPLETED|Overall Study||34
11364664|NCT03204279|12561414|FG001|COMPLETED|Overall Study||32
11364665|NCT03204279|12561413|FG000|NOT COMPLETED|Overall Study||0
11364666|NCT03204279|12561414|FG001|NOT COMPLETED|Overall Study||1
11364667|NCT03204526|12561421|FG000|STARTED|Overall Study||15
11364668|NCT03204526|12561421|FG000|COMPLETED|Overall Study||15
11364669|NCT03204526|12561421|FG000|NOT COMPLETED|Overall Study||0
11364670|NCT03204942|12561428|FG000|STARTED|Overall Study||23
11364671|NCT03204942|12561429|FG001|STARTED|Overall Study||23
11364672|NCT03204942|12561430|FG002|STARTED|Overall Study||23
11364673|NCT03204942|12561428|FG000|COMPLETED|Overall Study||23
11364674|NCT03204942|12561429|FG001|COMPLETED|Overall Study||23
11364675|NCT03204942|12561430|FG002|COMPLETED|Overall Study||23
11364676|NCT03204942|12561428|FG000|NOT COMPLETED|Overall Study||0
11364677|NCT03204942|12561429|FG001|NOT COMPLETED|Overall Study||0
11364678|NCT03204942|12561430|FG002|NOT COMPLETED|Overall Study||0
11364679|NCT03204981|12561443|FG000|STARTED|Overall Study||52
11364680|NCT03204981|12561443|FG000|COMPLETED|Overall Study||46
11364681|NCT03204981|12561443|FG000|NOT COMPLETED|Overall Study||6
11364682|NCT03205046|12561451|FG000|STARTED|Overall Study||13
11364683|NCT03205046|12561452|FG001|STARTED|Overall Study||12
11364684|NCT03205046|12561451|FG000|COMPLETED|Overall Study||0
11364685|NCT03205046|12561452|FG001|COMPLETED|Overall Study||2
11364686|NCT03205046|12561451|FG000|NOT COMPLETED|Overall Study||13
11364687|NCT03205046|12561452|FG001|NOT COMPLETED|Overall Study||10
11364688|NCT03205150|12561461|FG000|STARTED|Overall Study||43
11364689|NCT03205150|12561462|FG001|STARTED|Overall Study||43
11364690|NCT03205150|12561463|FG002|STARTED|Overall Study||21
11364691|NCT03205150|12561461|FG000|Safety Analysis Set|Overall Study||43
11364692|NCT03205150|12561462|FG001|Safety Analysis Set|Overall Study||43
11364693|NCT03205150|12561463|FG002|Safety Analysis Set|Overall Study||21
11364694|NCT03205150|12561461|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|42
11364695|NCT03205150|12561462|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|36
11364696|NCT03205150|12561463|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
11364697|NCT03205150|12561461|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|43
11364698|NCT03205150|12561462|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|41
11364699|NCT03205150|12561463|FG002|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|21
11364700|NCT03205150|12561461|FG000|COMPLETED|Overall Study||41
11364701|NCT03205150|12561462|FG001|COMPLETED|Overall Study||36
11364702|NCT03205150|12561463|FG002|COMPLETED|Overall Study||19
11364703|NCT03205150|12561461|FG000|NOT COMPLETED|Overall Study||2
11364704|NCT03205150|12561462|FG001|NOT COMPLETED|Overall Study||7
11364705|NCT03205150|12561463|FG002|NOT COMPLETED|Overall Study||2
11364706|NCT03205488|12561475|FG000|STARTED|Overall Study||25
11364707|NCT03205488|12561476|FG001|STARTED|Overall Study||25
11364708|NCT03205488|12561477|FG002|STARTED|Overall Study||26
11364709|NCT03205488|12561475|FG000|COMPLETED|Overall Study||24
11364710|NCT03205488|12561476|FG001|COMPLETED|Overall Study||23
11364711|NCT03205488|12561477|FG002|COMPLETED|Overall Study||21
11364712|NCT03205488|12561475|FG000|NOT COMPLETED|Overall Study||1
11364713|NCT03205488|12561476|FG001|NOT COMPLETED|Overall Study||2
11364714|NCT03205488|12561477|FG002|NOT COMPLETED|Overall Study||5
11364715|NCT03205566|12561491|FG000|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
11364716|NCT03205566|12561492|FG001|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
11364717|NCT03205566|12561491|FG000|COMPLETED|Phase 1||18
11364718|NCT03205566|12561492|FG001|COMPLETED|Phase 1||18
11364719|NCT03205566|12561491|FG000|NOT COMPLETED|Phase 1||1
11364720|NCT03205566|12561492|FG001|NOT COMPLETED|Phase 1||1
11364721|NCT03205566|12561491|FG000|STARTED|Phase 2||18
11364722|NCT03205566|12561492|FG001|STARTED|Phase 2||18
11364723|NCT03205566|12561491|FG000|COMPLETED|Phase 2||18
11364724|NCT03205566|12561492|FG001|COMPLETED|Phase 2||18
11364725|NCT03205566|12561491|FG000|NOT COMPLETED|Phase 2||0
11364726|NCT03205566|12561492|FG001|NOT COMPLETED|Phase 2||0
11364727|NCT03206749|12561505|FG000|STARTED|Overall Study||80
11364728|NCT03206749|12561506|FG001|STARTED|Overall Study||81
11364729|NCT03206749|12561507|FG002|STARTED|Overall Study||82
11364730|NCT03206749|12561505|FG000|COMPLETED|Overall Study||75
11364731|NCT03206749|12561506|FG001|COMPLETED|Overall Study||78
11364732|NCT03206749|12561507|FG002|COMPLETED|Overall Study||75
11364733|NCT03206749|12561505|FG000|NOT COMPLETED|Overall Study||5
11364734|NCT03206749|12561506|FG001|NOT COMPLETED|Overall Study||3
11364735|NCT03206749|12561507|FG002|NOT COMPLETED|Overall Study||7
11364736|NCT03206788|12561518|FG000|STARTED|Overall Study||2
11364737|NCT03206788|12561519|FG001|STARTED|Overall Study||5
11364738|NCT03206788|12561518|FG000|COMPLETED|Overall Study||2
11364739|NCT03206788|12561519|FG001|COMPLETED|Overall Study||2
11364740|NCT03206788|12561518|FG000|NOT COMPLETED|Overall Study||0
11364741|NCT03206788|12561519|FG001|NOT COMPLETED|Overall Study||3
11364742|NCT03206918|12561525|FG000|STARTED|Overall Study||91
11364743|NCT03206918|12561525|FG000|COMPLETED|Overall Study||0
11364744|NCT03206918|12561525|FG000|NOT COMPLETED|Overall Study||91
11364745|NCT03206970|12561530|FG000|STARTED|Overall Study||86
11364746|NCT03206970|12561530|FG000|Received at Least 1 Dose of Study Drug|Overall Study||86
11364747|NCT03206970|12561530|FG000|COMPLETED|Overall Study||0
11364748|NCT03206970|12561530|FG000|NOT COMPLETED|Overall Study||86
11364749|NCT03207022|12561536|FG000|STARTED|Overall Study||12
11364750|NCT03207022|12561537|FG001|STARTED|Overall Study||12
11364751|NCT03207022|12561536|FG000|COMPLETED|Overall Study||12
11364752|NCT03207022|12561537|FG001|COMPLETED|Overall Study||12
11364753|NCT03207022|12561536|FG000|NOT COMPLETED|Overall Study||0
11364754|NCT03207022|12561537|FG001|NOT COMPLETED|Overall Study||0
11364755|NCT03207035|12561545|FG000|STARTED|Overall Study||10
11364756|NCT03207035|12561546|FG001|STARTED|Overall Study||10
11364757|NCT03207035|12561545|FG000|COMPLETED|Overall Study||10
11364758|NCT03207035|12561546|FG001|COMPLETED|Overall Study||10
11364759|NCT03207035|12561545|FG000|NOT COMPLETED|Overall Study||0
11364760|NCT03207035|12561546|FG001|NOT COMPLETED|Overall Study||0
11364761|NCT03207074|12561552|FG000|STARTED|Overall Study||150
11364762|NCT03207074|12561552|FG000|COMPLETED|Overall Study||150
11364763|NCT03207074|12561552|FG000|NOT COMPLETED|Overall Study||0
11364764|NCT03207243|12561558|FG000|STARTED|Overall Study||82
11364765|NCT03207243|12561559|FG001|STARTED|Overall Study||83
11364766|NCT03207243|12561558|FG000|COMPLETED|Overall Study||23
11364767|NCT03207243|12561559|FG001|COMPLETED|Overall Study||39
11364768|NCT03207243|12561558|FG000|NOT COMPLETED|Overall Study||59
11364769|NCT03207243|12561559|FG001|NOT COMPLETED|Overall Study||44
11364770|NCT03207386|12561566|FG000|STARTED|Overall Study||2647
11364771|NCT03207386|12561566|FG000|COMPLETED|Overall Study||1487
11364772|NCT03207386|12561566|FG000|NOT COMPLETED|Overall Study||1160
11364773|NCT03207399|12561573|FG000|STARTED|Overall Study||1
11364774|NCT03207399|12561573|FG000|COMPLETED|Overall Study||1
11364775|NCT03207399|12561573|FG000|NOT COMPLETED|Overall Study||0
11364776|NCT03207438|12561581|FG000|STARTED|Overall Study||167
11364777|NCT03207438|12561582|FG001|STARTED|Overall Study||166
11364778|NCT03207438|12561583|FG002|STARTED|Overall Study||875
11364779|NCT03207438|12561584|FG003|STARTED|Overall Study||582
11364780|NCT03207438|12561581|FG000|COMPLETED|Overall Study||148
11364781|NCT03207438|12561582|FG001|COMPLETED|Overall Study||145
11364782|NCT03207438|12561583|FG002|COMPLETED|Overall Study||643
11364783|NCT03207438|12561584|FG003|COMPLETED|Overall Study||470
11364784|NCT03207438|12561581|FG000|NOT COMPLETED|Overall Study||19
11364785|NCT03207438|12561582|FG001|NOT COMPLETED|Overall Study||21
11364786|NCT03207438|12561583|FG002|NOT COMPLETED|Overall Study||232
11364787|NCT03207438|12561584|FG003|NOT COMPLETED|Overall Study||112
11364788|NCT03207750|12561599|FG000|STARTED|Overall Study||632
11364789|NCT03207750|12561600|FG001|STARTED|Overall Study||640
11364790|NCT03207750|12561599|FG000|COMPLETED|Overall Study||574
11364791|NCT03207750|12561600|FG001|COMPLETED|Overall Study||574
11364792|NCT03207750|12561599|FG000|NOT COMPLETED|Overall Study||58
11364793|NCT03207750|12561600|FG001|NOT COMPLETED|Overall Study||66
11364794|NCT03207763|12561608|FG000|STARTED|Overall Study||8
11364795|NCT03207763|12561609|FG001|STARTED|Overall Study||25
11364796|NCT03207763|12561608|FG000|Eligible and Opted for Patches 2 and 3|Overall Study||5
11364797|NCT03207763|12561609|FG001|Eligible and Opted for Patches 2 and 3|Overall Study||23
11364798|NCT03207763|12561608|FG000|Completed Patches 2 and 3 Study|Overall Study||5
11364799|NCT03207763|12561609|FG001|Completed Patches 2 and 3 Study|Overall Study||23
11364800|NCT03207763|12561608|FG000|COMPLETED|Overall Study||7
11364801|NCT03207763|12561609|FG001|COMPLETED|Overall Study||25
11364802|NCT03207763|12561608|FG000|NOT COMPLETED|Overall Study||1
11364803|NCT03207763|12561609|FG001|NOT COMPLETED|Overall Study||0
11364804|NCT03208088|12561624|FG000|STARTED|Period 1||10
11364805|NCT03208088|12561625|FG001|STARTED|Period 1||9
11364806|NCT03208088|12561626|FG002|STARTED|Period 1||10
11364807|NCT03208088|12561627|FG003|STARTED|Period 1||9
11364808|NCT03208088|12561628|FG004|STARTED|Period 1||9
11364809|NCT03208088|12561629|FG005|STARTED|Period 1||9
11364810|NCT03208088|12561630|FG006|STARTED|Period 1||8
11364811|NCT03208088|12561631|FG007|STARTED|Period 1||10
11364812|NCT03208088|12561632|FG008|STARTED|Period 1||8
11364813|NCT03208088|12561633|FG009|STARTED|Period 1||9
11364814|NCT03208088|12561624|FG000|COMPLETED|Period 1||10
11364815|NCT03208088|12561625|FG001|COMPLETED|Period 1||9
11364816|NCT03208088|12561626|FG002|COMPLETED|Period 1||10
11364817|NCT03208088|12561627|FG003|COMPLETED|Period 1||9
11364818|NCT03208088|12561628|FG004|COMPLETED|Period 1||9
11364819|NCT03208088|12561629|FG005|COMPLETED|Period 1||9
11364820|NCT03208088|12561630|FG006|COMPLETED|Period 1||8
11364821|NCT03208088|12561631|FG007|COMPLETED|Period 1||10
11364822|NCT03208088|12561632|FG008|COMPLETED|Period 1||8
11364823|NCT03208088|12561633|FG009|COMPLETED|Period 1||9
11364824|NCT03208088|12561624|FG000|NOT COMPLETED|Period 1||0
11364825|NCT03208088|12561625|FG001|NOT COMPLETED|Period 1||0
11364826|NCT03208088|12561626|FG002|NOT COMPLETED|Period 1||0
11364827|NCT03208088|12561627|FG003|NOT COMPLETED|Period 1||0
11364828|NCT03208088|12561628|FG004|NOT COMPLETED|Period 1||0
11364829|NCT03208088|12561629|FG005|NOT COMPLETED|Period 1||0
11364830|NCT03208088|12561630|FG006|NOT COMPLETED|Period 1||0
11364831|NCT03208088|12561631|FG007|NOT COMPLETED|Period 1||0
11364832|NCT03208088|12561632|FG008|NOT COMPLETED|Period 1||0
11364833|NCT03208088|12561633|FG009|NOT COMPLETED|Period 1||0
11364834|NCT03208088|12561624|FG000|STARTED|Period 2||10
11364835|NCT03208088|12561625|FG001|STARTED|Period 2||9
11364836|NCT03208088|12561626|FG002|STARTED|Period 2||10
11364837|NCT03208088|12561627|FG003|STARTED|Period 2||9
11364838|NCT03208088|12561628|FG004|STARTED|Period 2||9
11364839|NCT03208088|12561629|FG005|STARTED|Period 2||9
11364840|NCT03208088|12561630|FG006|STARTED|Period 2||8
11364841|NCT03208088|12561631|FG007|STARTED|Period 2||10
11364842|NCT03208088|12561632|FG008|STARTED|Period 2||8
11364843|NCT03208088|12561633|FG009|STARTED|Period 2||9
11364844|NCT03208088|12561624|FG000|COMPLETED|Period 2||10
11364845|NCT03208088|12561625|FG001|COMPLETED|Period 2||9
11364846|NCT03208088|12561626|FG002|COMPLETED|Period 2||10
11364847|NCT03208088|12561627|FG003|COMPLETED|Period 2||9
11364848|NCT03208088|12561628|FG004|COMPLETED|Period 2||9
11364849|NCT03208088|12561629|FG005|COMPLETED|Period 2||9
11364850|NCT03208088|12561630|FG006|COMPLETED|Period 2||8
11364851|NCT03208088|12561631|FG007|COMPLETED|Period 2||10
11364852|NCT03208088|12561632|FG008|COMPLETED|Period 2||7
11364853|NCT03208088|12561633|FG009|COMPLETED|Period 2||9
11364854|NCT03208088|12561624|FG000|NOT COMPLETED|Period 2||0
11364855|NCT03208088|12561625|FG001|NOT COMPLETED|Period 2||0
11364856|NCT03208088|12561626|FG002|NOT COMPLETED|Period 2||0
11364857|NCT03208088|12561627|FG003|NOT COMPLETED|Period 2||0
11364858|NCT03208088|12561628|FG004|NOT COMPLETED|Period 2||0
11364859|NCT03208088|12561629|FG005|NOT COMPLETED|Period 2||0
11364860|NCT03208088|12561630|FG006|NOT COMPLETED|Period 2||0
11364861|NCT03208088|12561631|FG007|NOT COMPLETED|Period 2||0
11364862|NCT03208088|12561632|FG008|NOT COMPLETED|Period 2||1
11364863|NCT03208088|12561633|FG009|NOT COMPLETED|Period 2||0
11364864|NCT03208088|12561624|FG000|STARTED|Period 3||10
11364865|NCT03208088|12561625|FG001|STARTED|Period 3||9
11364866|NCT03208088|12561626|FG002|STARTED|Period 3||10
11364867|NCT03208088|12561627|FG003|STARTED|Period 3||9
11364868|NCT03208088|12561628|FG004|STARTED|Period 3||9
11364869|NCT03208088|12561629|FG005|STARTED|Period 3||9
11364870|NCT03208088|12561630|FG006|STARTED|Period 3||8
11364871|NCT03208088|12561631|FG007|STARTED|Period 3||10
11364872|NCT03208088|12561632|FG008|STARTED|Period 3||7
11364873|NCT03208088|12561633|FG009|STARTED|Period 3||9
11364874|NCT03208088|12561624|FG000|COMPLETED|Period 3||10
11364875|NCT03208088|12561625|FG001|COMPLETED|Period 3||9
11364876|NCT03208088|12561626|FG002|COMPLETED|Period 3||10
11364877|NCT03208088|12561627|FG003|COMPLETED|Period 3||8
11364878|NCT03208088|12561628|FG004|COMPLETED|Period 3||9
11364879|NCT03208088|12561629|FG005|COMPLETED|Period 3||9
11364880|NCT03208088|12561630|FG006|COMPLETED|Period 3||8
11364881|NCT03208088|12561631|FG007|COMPLETED|Period 3||10
11364882|NCT03208088|12561632|FG008|COMPLETED|Period 3||7
11364883|NCT03208088|12561633|FG009|COMPLETED|Period 3||9
11364884|NCT03208088|12561624|FG000|NOT COMPLETED|Period 3||0
11364885|NCT03208088|12561625|FG001|NOT COMPLETED|Period 3||0
11364886|NCT03208088|12561626|FG002|NOT COMPLETED|Period 3||0
11364887|NCT03208088|12561627|FG003|NOT COMPLETED|Period 3||1
11364888|NCT03208088|12561628|FG004|NOT COMPLETED|Period 3||0
11364889|NCT03208088|12561629|FG005|NOT COMPLETED|Period 3||0
11364890|NCT03208088|12561630|FG006|NOT COMPLETED|Period 3||0
11364891|NCT03208088|12561631|FG007|NOT COMPLETED|Period 3||0
11364892|NCT03208088|12561632|FG008|NOT COMPLETED|Period 3||0
11364893|NCT03208088|12561633|FG009|NOT COMPLETED|Period 3||0
11364894|NCT03208088|12561624|FG000|STARTED|Period 4||10
11364895|NCT03208088|12561625|FG001|STARTED|Period 4||9
11364896|NCT03208088|12561626|FG002|STARTED|Period 4||10
11364897|NCT03208088|12561627|FG003|STARTED|Period 4||8
11364898|NCT03208088|12561628|FG004|STARTED|Period 4||9
11364899|NCT03208088|12561629|FG005|STARTED|Period 4||9
11364900|NCT03208088|12561630|FG006|STARTED|Period 4||8
11364901|NCT03208088|12561631|FG007|STARTED|Period 4||10
11364902|NCT03208088|12561632|FG008|STARTED|Period 4||7
11364903|NCT03208088|12561633|FG009|STARTED|Period 4||9
11364904|NCT03208088|12561624|FG000|COMPLETED|Period 4||10
11364905|NCT03208088|12561625|FG001|COMPLETED|Period 4||9
11364906|NCT03208088|12561626|FG002|COMPLETED|Period 4||10
11364907|NCT03208088|12561627|FG003|COMPLETED|Period 4||7
11364908|NCT03208088|12561628|FG004|COMPLETED|Period 4||9
11364909|NCT03208088|12561629|FG005|COMPLETED|Period 4||9
11364910|NCT03208088|12561630|FG006|COMPLETED|Period 4||8
11364911|NCT03208088|12561631|FG007|COMPLETED|Period 4||10
11364912|NCT03208088|12561632|FG008|COMPLETED|Period 4||7
11364913|NCT03208088|12561633|FG009|COMPLETED|Period 4||9
11364914|NCT03208088|12561624|FG000|NOT COMPLETED|Period 4||0
11364915|NCT03208088|12561625|FG001|NOT COMPLETED|Period 4||0
11364916|NCT03208088|12561626|FG002|NOT COMPLETED|Period 4||0
11364917|NCT03208088|12561627|FG003|NOT COMPLETED|Period 4||1
11364918|NCT03208088|12561628|FG004|NOT COMPLETED|Period 4||0
11364919|NCT03208088|12561629|FG005|NOT COMPLETED|Period 4||0
11364920|NCT03208088|12561630|FG006|NOT COMPLETED|Period 4||0
11364921|NCT03208088|12561631|FG007|NOT COMPLETED|Period 4||0
11364922|NCT03208088|12561632|FG008|NOT COMPLETED|Period 4||0
11364923|NCT03208088|12561633|FG009|NOT COMPLETED|Period 4||0
11364924|NCT03208088|12561624|FG000|STARTED|Period 5||10
11364925|NCT03208088|12561625|FG001|STARTED|Period 5||9
11364926|NCT03208088|12561626|FG002|STARTED|Period 5||10
11364927|NCT03208088|12561627|FG003|STARTED|Period 5||7
11364928|NCT03208088|12561628|FG004|STARTED|Period 5||9
11364929|NCT03208088|12561629|FG005|STARTED|Period 5||9
11364930|NCT03208088|12561630|FG006|STARTED|Period 5||8
11364931|NCT03208088|12561631|FG007|STARTED|Period 5||10
11364932|NCT03208088|12561632|FG008|STARTED|Period 5||7
11364933|NCT03208088|12561633|FG009|STARTED|Period 5||9
11364934|NCT03208088|12561624|FG000|COMPLETED|Period 5||10
11364935|NCT03208088|12561625|FG001|COMPLETED|Period 5||9
11364936|NCT03208088|12561626|FG002|COMPLETED|Period 5||10
11364937|NCT03208088|12561627|FG003|COMPLETED|Period 5||7
11364938|NCT03208088|12561628|FG004|COMPLETED|Period 5||9
11364939|NCT03208088|12561629|FG005|COMPLETED|Period 5||9
11364940|NCT03208088|12561630|FG006|COMPLETED|Period 5||8
11364941|NCT03208088|12561631|FG007|COMPLETED|Period 5||10
11364942|NCT03208088|12561632|FG008|COMPLETED|Period 5||7
11364943|NCT03208088|12561633|FG009|COMPLETED|Period 5||9
11364944|NCT03208088|12561624|FG000|NOT COMPLETED|Period 5||0
11364945|NCT03208088|12561625|FG001|NOT COMPLETED|Period 5||0
11364946|NCT03208088|12561626|FG002|NOT COMPLETED|Period 5||0
11364947|NCT03208088|12561627|FG003|NOT COMPLETED|Period 5||0
11364948|NCT03208088|12561628|FG004|NOT COMPLETED|Period 5||0
11364949|NCT03208088|12561629|FG005|NOT COMPLETED|Period 5||0
11364950|NCT03208088|12561630|FG006|NOT COMPLETED|Period 5||0
11364951|NCT03208088|12561631|FG007|NOT COMPLETED|Period 5||0
11364952|NCT03208088|12561632|FG008|NOT COMPLETED|Period 5||0
11364953|NCT03208088|12561633|FG009|NOT COMPLETED|Period 5||0
11364954|NCT03208166|12561647|FG000|STARTED|Overall Study||1
11364955|NCT03208166|12561648|FG001|STARTED|Overall Study||1
11364956|NCT03208166|12561647|FG000|COMPLETED|Overall Study||1
11364957|NCT03208166|12561648|FG001|COMPLETED|Overall Study||1
11364958|NCT03208166|12561647|FG000|NOT COMPLETED|Overall Study||0
11364959|NCT03208166|12561648|FG001|NOT COMPLETED|Overall Study||0
11364960|NCT03208192|12561656|FG000|STARTED|Overall Study||32
11364961|NCT03208192|12561657|FG001|STARTED|Overall Study||36
11364962|NCT03208192|12561656|FG000|COMPLETED|Overall Study||32
11364963|NCT03208192|12561657|FG001|COMPLETED|Overall Study||36
11364964|NCT03208192|12561656|FG000|NOT COMPLETED|Overall Study||0
11364965|NCT03208192|12561657|FG001|NOT COMPLETED|Overall Study||0
11364966|NCT03208673|12561665|FG000|STARTED|Overall Study||32
11364967|NCT03208673|12561665|FG000|COMPLETED|Overall Study||32
11364968|NCT03208673|12561665|FG000|NOT COMPLETED|Overall Study||0
11005633|NCT00723554|12183319|FG000|NOT COMPLETED|Overall Study||29
11005634|NCT00723580|12183325|FG000|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
11058427|NCT01004003|12240268|FG000|NOT COMPLETED|Overall Study||6
11364969|NCT03208933|12561669|FG000|STARTED|Overall Study||60
11364970|NCT03208933|12561669|FG000|COMPLETED|Overall Study||47
11364971|NCT03208933|12561669|FG000|NOT COMPLETED|Overall Study||13
11364972|NCT03209050|12561673|FG000|STARTED|Overall Study||30
11364973|NCT03209050|12561673|FG000|COMPLETED|Overall Study||27
11364974|NCT03209050|12561673|FG000|NOT COMPLETED|Overall Study||3
11364975|NCT03209362|12561680|FG000|STARTED|Overall Study||39
11364976|NCT03209362|12561681|FG001|STARTED|Overall Study||41
11364977|NCT03209362|12561680|FG000|COMPLETED|Overall Study||37
11364978|NCT03209362|12561681|FG001|COMPLETED|Overall Study||38
11364979|NCT03209362|12561680|FG000|NOT COMPLETED|Overall Study||2
11364980|NCT03209362|12561681|FG001|NOT COMPLETED|Overall Study||3
11364981|NCT03209492|12561687|FG000|STARTED|Overall Study||333
11364982|NCT03209492|12561687|FG000|COMPLETED|Overall Study||328
11364983|NCT03209492|12561687|FG000|NOT COMPLETED|Overall Study||5
11364984|NCT03209505|12561691|FG000|STARTED|Overall Study||10
11364985|NCT03209505|12561692|FG001|STARTED|Overall Study||10
11364986|NCT03209505|12561691|FG000|COMPLETED|Overall Study||10
11364987|NCT03209505|12561692|FG001|COMPLETED|Overall Study||10
11364988|NCT03209505|12561691|FG000|NOT COMPLETED|Overall Study||0
11364989|NCT03209505|12561692|FG001|NOT COMPLETED|Overall Study||0
11364990|NCT03209518|12561698|FG000|STARTED|Overall Study||312
11364991|NCT03209518|12561698|FG000|COMPLETED|Overall Study||310
11364992|NCT03209518|12561698|FG000|NOT COMPLETED|Overall Study||2
11364993|NCT03209570|12561704|FG000|STARTED|Overall Study||24
11364994|NCT03209570|12561705|FG001|STARTED|Overall Study||25
11364995|NCT03209570|12561704|FG000|COMPLETED|Overall Study||14
11364996|NCT03209570|12561705|FG001|COMPLETED|Overall Study||12
11364997|NCT03209570|12561704|FG000|NOT COMPLETED|Overall Study||10
11364998|NCT03209570|12561705|FG001|NOT COMPLETED|Overall Study||13
11364999|NCT03209882|12561713|FG000|STARTED|Overall Study||6
11365000|NCT03209882|12561714|FG001|STARTED|Overall Study||3
11365001|NCT03209882|12561713|FG000|COMPLETED|Overall Study||6
11365002|NCT03209882|12561714|FG001|COMPLETED|Overall Study||3
11365003|NCT03209882|12561713|FG000|NOT COMPLETED|Overall Study||0
11365004|NCT03209882|12561714|FG001|NOT COMPLETED|Overall Study||0
11365005|NCT03209973|12561722|FG000|STARTED|Overall Study||70
11365006|NCT03209973|12561722|FG000|Completed Primary Outcome Period|Overall Study||66
11365007|NCT03209973|12561722|FG000|COMPLETED|Overall Study||0
11365008|NCT03209973|12561722|FG000|NOT COMPLETED|Overall Study||70
11365009|NCT03210155|12561730|FG000|STARTED|Overall Study||0
11365010|NCT03210155|12561731|FG001|STARTED|Overall Study||1
11365011|NCT03210155|12561730|FG000|COMPLETED|Overall Study||0
11365012|NCT03210155|12561731|FG001|COMPLETED|Overall Study||1
11365013|NCT03210155|12561730|FG000|NOT COMPLETED|Overall Study||0
11365014|NCT03210155|12561731|FG001|NOT COMPLETED|Overall Study||0
11365015|NCT03210220|12561739|FG000|STARTED|Overall Study||20
11365016|NCT03210220|12561740|FG001|STARTED|Overall Study||20
11365017|NCT03210220|12561739|FG000|COMPLETED|Overall Study||19
11365018|NCT03210220|12561740|FG001|COMPLETED|Overall Study||20
11365019|NCT03210220|12561739|FG000|NOT COMPLETED|Overall Study||1
11365020|NCT03210220|12561740|FG001|NOT COMPLETED|Overall Study||0
11365021|NCT03210259|12561748|FG000|STARTED|12-Week Run-in Period||21
11365022|NCT03210259|12561749|FG001|STARTED|12-Week Run-in Period||118
11365023|NCT03210259|12561750|FG002|STARTED|12-Week Run-in Period||120
11365024|NCT03210259|12561748|FG000|COMPLETED|12-Week Run-in Period||0
11365025|NCT03210259|12561749|FG001|COMPLETED|12-Week Run-in Period||118
11365026|NCT03210259|12561750|FG002|COMPLETED|12-Week Run-in Period||120
11365027|NCT03210259|12561748|FG000|NOT COMPLETED|12-Week Run-in Period||21
11365028|NCT03210259|12561749|FG001|NOT COMPLETED|12-Week Run-in Period||0
11365029|NCT03210259|12561750|FG002|NOT COMPLETED|12-Week Run-in Period||0
11365030|NCT03210259|12561748|FG000|STARTED|48-Week Randomized Responder Period||0
11365031|NCT03210259|12561749|FG001|STARTED|48-Week Randomized Responder Period||118
11365032|NCT03210259|12561750|FG002|STARTED|48-Week Randomized Responder Period||120
11365033|NCT03210259|12561748|FG000|COMPLETED|48-Week Randomized Responder Period||0
11365034|NCT03210259|12561749|FG001|COMPLETED|48-Week Randomized Responder Period||107
11365035|NCT03210259|12561750|FG002|COMPLETED|48-Week Randomized Responder Period||91
11365036|NCT03210259|12561748|FG000|NOT COMPLETED|48-Week Randomized Responder Period||0
11365037|NCT03210259|12561749|FG001|NOT COMPLETED|48-Week Randomized Responder Period||11
11365038|NCT03210259|12561750|FG002|NOT COMPLETED|48-Week Randomized Responder Period||29
11365039|NCT03210337|12561759|FG000|STARTED|Overall Study||78
11365040|NCT03210337|12561760|FG001|STARTED|Overall Study||79
11365041|NCT03210337|12561759|FG000|COMPLETED|Overall Study||70
11365042|NCT03210337|12561760|FG001|COMPLETED|Overall Study||74
11365043|NCT03210337|12561759|FG000|NOT COMPLETED|Overall Study||8
11365044|NCT03210337|12561760|FG001|NOT COMPLETED|Overall Study||5
11365045|NCT03210376|12561768|FG000|STARTED|Overall Study||50
11365046|NCT03210376|12561769|FG001|STARTED|Overall Study||50
11365047|NCT03210376|12561768|FG000|COMPLETED|Overall Study||50
11365048|NCT03210376|12561769|FG001|COMPLETED|Overall Study||50
11365049|NCT03210376|12561768|FG000|NOT COMPLETED|Overall Study||0
11365050|NCT03210376|12561769|FG001|NOT COMPLETED|Overall Study||0
11365051|NCT03210519|12561777|FG000|STARTED|Overall Study||11
11365052|NCT03210519|12561778|FG001|STARTED|Overall Study||10
11365053|NCT03210519|12561777|FG000|COMPLETED|Overall Study||9
11365054|NCT03210519|12561778|FG001|COMPLETED|Overall Study||10
11365055|NCT03210519|12561777|FG000|NOT COMPLETED|Overall Study||2
11365056|NCT03210519|12561778|FG001|NOT COMPLETED|Overall Study||0
11365057|NCT03210701|12561784|FG000|STARTED|Overall Study||123
11365058|NCT03210701|12561784|FG000|COMPLETED|Overall Study||123
11365059|NCT03210701|12561784|FG000|NOT COMPLETED|Overall Study||0
11365060|NCT03210961|12561803|FG000|STARTED|Overall Study||4
11365061|NCT03210961|12561804|FG001|STARTED|Overall Study||9
11365062|NCT03210961|12561805|FG002|STARTED|Overall Study||1
11365063|NCT03210961|12561806|FG003|STARTED|Overall Study||2
11365064|NCT03210961|12561807|FG004|STARTED|Overall Study||6
11365065|NCT03210961|12561808|FG005|STARTED|Overall Study||6
11365066|NCT03210961|12561809|FG006|STARTED|Overall Study||8
11365067|NCT03210961|12561810|FG007|STARTED|Overall Study||7
11365068|NCT03210961|12561811|FG008|STARTED|Overall Study||8
11365069|NCT03210961|12561812|FG009|STARTED|Overall Study||6
11365070|NCT03210961|12561813|FG010|STARTED|Overall Study||7
11365071|NCT03210961|12561814|FG011|STARTED|Overall Study||5
11365072|NCT03210961|12561815|FG012|STARTED|Overall Study||14
11365073|NCT03210961|12561816|FG013|STARTED|Overall Study||15
11365074|NCT03210961|12561817|FG014|STARTED|Overall Study||11
11365075|NCT03210961|12561803|FG000|COMPLETED|Overall Study||4
11365076|NCT03210961|12561804|FG001|COMPLETED|Overall Study||9
11365077|NCT03210961|12561805|FG002|COMPLETED|Overall Study||1
11365078|NCT03210961|12561806|FG003|COMPLETED|Overall Study||1
11365079|NCT03210961|12561807|FG004|COMPLETED|Overall Study||6
11365080|NCT03210961|12561808|FG005|COMPLETED|Overall Study||6
11365081|NCT03210961|12561809|FG006|COMPLETED|Overall Study||7
11365082|NCT03210961|12561810|FG007|COMPLETED|Overall Study||7
11365083|NCT03210961|12561811|FG008|COMPLETED|Overall Study||8
11365084|NCT03210961|12561812|FG009|COMPLETED|Overall Study||6
11365085|NCT03210961|12561813|FG010|COMPLETED|Overall Study||6
11365086|NCT03210961|12561814|FG011|COMPLETED|Overall Study||5
11365087|NCT03210961|12561815|FG012|COMPLETED|Overall Study||12
11365088|NCT03210961|12561816|FG013|COMPLETED|Overall Study||11
11365089|NCT03210961|12561817|FG014|COMPLETED|Overall Study||9
11365090|NCT03210961|12561803|FG000|NOT COMPLETED|Overall Study||0
11365091|NCT03210961|12561804|FG001|NOT COMPLETED|Overall Study||0
11365092|NCT03210961|12561805|FG002|NOT COMPLETED|Overall Study||0
11365093|NCT03210961|12561806|FG003|NOT COMPLETED|Overall Study||1
11365094|NCT03210961|12561807|FG004|NOT COMPLETED|Overall Study||0
11365095|NCT03210961|12561808|FG005|NOT COMPLETED|Overall Study||0
11365096|NCT03210961|12561809|FG006|NOT COMPLETED|Overall Study||1
11365097|NCT03210961|12561810|FG007|NOT COMPLETED|Overall Study||0
11365098|NCT03210961|12561811|FG008|NOT COMPLETED|Overall Study||0
11365099|NCT03210961|12561812|FG009|NOT COMPLETED|Overall Study||0
11365100|NCT03210961|12561813|FG010|NOT COMPLETED|Overall Study||1
11365101|NCT03210961|12561814|FG011|NOT COMPLETED|Overall Study||0
11365102|NCT03210961|12561815|FG012|NOT COMPLETED|Overall Study||2
11365103|NCT03210961|12561816|FG013|NOT COMPLETED|Overall Study||4
11365104|NCT03210961|12561817|FG014|NOT COMPLETED|Overall Study||2
11365105|NCT03211117|12561868|FG000|STARTED|Overall Study||0
11365106|NCT03211117|12561869|FG001|STARTED|Overall Study||3
11365107|NCT03211117|12561868|FG000|COMPLETED|Overall Study||0
11365108|NCT03211117|12561869|FG001|COMPLETED|Overall Study||3
11365109|NCT03211117|12561868|FG000|NOT COMPLETED|Overall Study||0
11365110|NCT03211117|12561869|FG001|NOT COMPLETED|Overall Study||0
11365111|NCT03211156|12561877|FG000|STARTED|Overall Study||49
11365112|NCT03211156|12561878|FG001|STARTED|Overall Study||48
11365113|NCT03211156|12561877|FG000|Received Study Drug|Overall Study||47
11365114|NCT03211156|12561878|FG001|Received Study Drug|Overall Study||45
11365115|NCT03211156|12561877|FG000|COMPLETED|Overall Study||47
11365116|NCT03211156|12561878|FG001|COMPLETED|Overall Study||45
11365117|NCT03211156|12561877|FG000|NOT COMPLETED|Overall Study||2
11365118|NCT03211156|12561878|FG001|NOT COMPLETED|Overall Study||3
11365119|NCT03211234|12561887|FG000|STARTED|Overall Study||17
11365120|NCT03211234|12561888|FG001|STARTED|Overall Study||31
11365121|NCT03211234|12561889|FG002|STARTED|Overall Study||28
11365122|NCT03211234|12561887|FG000|COMPLETED|Overall Study||16
11365123|NCT03211234|12561888|FG001|COMPLETED|Overall Study||30
11365124|NCT03211234|12561889|FG002|COMPLETED|Overall Study||25
11365125|NCT03211234|12561887|FG000|NOT COMPLETED|Overall Study||1
11365126|NCT03211234|12561888|FG001|NOT COMPLETED|Overall Study||1
11365127|NCT03211234|12561889|FG002|NOT COMPLETED|Overall Study||3
11365128|NCT03212261|12561897|FG000|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37
11365129|NCT03212261|12561897|FG000|Remained Eligible|Overall Study||35
11365130|NCT03212261|12561897|FG000|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30
11365131|NCT03212261|12561897|FG000|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26
11365132|NCT03212261|12561897|FG000|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22
11365133|NCT03212261|12561897|FG000|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21
11365134|NCT03212261|12561897|FG000|COMPLETED|Overall Study||21
11365135|NCT03212261|12561897|FG000|NOT COMPLETED|Overall Study||16
11365136|NCT03212326|12561902|FG000|STARTED|Overall Study||24
11365137|NCT03212326|12561902|FG000|COMPLETED|Overall Study||20
11365138|NCT03212326|12561902|FG000|NOT COMPLETED|Overall Study||4
11365139|NCT03212365|12561908|FG000|STARTED|Overall Study||151
11365140|NCT03212365|12561909|FG001|STARTED|Overall Study||144
11365141|NCT03212365|12561908|FG000|COMPLETED|Overall Study||128
11365142|NCT03212365|12561909|FG001|COMPLETED|Overall Study||130
11365143|NCT03212365|12561908|FG000|NOT COMPLETED|Overall Study||23
11365144|NCT03212365|12561909|FG001|NOT COMPLETED|Overall Study||14
11365145|NCT03212521|12561915|FG000|STARTED|Overall Study||230
11365146|NCT03212521|12561915|FG000|COMPLETED|Overall Study||223
11365147|NCT03212521|12561915|FG000|NOT COMPLETED|Overall Study||7
11365148|NCT03212638|12561921|FG000|STARTED|Period 1||8
11365149|NCT03212638|12561922|FG001|STARTED|Period 1||8
11365150|NCT03212638|12561923|FG002|STARTED|Period 1||8
11365151|NCT03212638|12561924|FG003|STARTED|Period 1||0
11365152|NCT03212638|12561925|FG004|STARTED|Period 1||0
11365153|NCT03212638|12561921|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
11365154|NCT03212638|12561922|FG001|Received at Least 1 Dose of Study Drug|Period 1||8
11365155|NCT03212638|12561923|FG002|Received at Least 1 Dose of Study Drug|Period 1||8
11365156|NCT03212638|12561924|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
11365157|NCT03212638|12561925|FG004|Received at Least 1 Dose of Study Drug|Period 1||0
11365158|NCT03212638|12561921|FG000|COMPLETED|Period 1||8
11365159|NCT03212638|12561922|FG001|COMPLETED|Period 1||8
11365160|NCT03212638|12561923|FG002|COMPLETED|Period 1||8
11365161|NCT03212638|12561924|FG003|COMPLETED|Period 1||0
11365162|NCT03212638|12561925|FG004|COMPLETED|Period 1||0
11365163|NCT03212638|12561921|FG000|NOT COMPLETED|Period 1||0
11365164|NCT03212638|12561922|FG001|NOT COMPLETED|Period 1||0
11365165|NCT03212638|12561923|FG002|NOT COMPLETED|Period 1||0
11365166|NCT03212638|12561924|FG003|NOT COMPLETED|Period 1||0
11365167|NCT03212638|12561925|FG004|NOT COMPLETED|Period 1||0
11365168|NCT03212638|12561921|FG000|STARTED|Period 2||8
11365169|NCT03212638|12561922|FG001|STARTED|Period 2||8
11365170|NCT03212638|12561923|FG002|STARTED|Period 2||8
11005635|NCT00723580|12183325|FG000|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
11005636|NCT00723580|12183325|FG000|COMPLETED|Overall Study|Completion of repeated Measurements|1
11005637|NCT00723580|12183325|FG000|NOT COMPLETED|Overall Study||0
11005638|NCT00723606|12183331|FG000|STARTED|Overall Study||189
11365171|NCT03212638|12561924|FG003|STARTED|Period 2||0
11365172|NCT03212638|12561925|FG004|STARTED|Period 2||0
11365173|NCT03212638|12561921|FG000|Received at Least 1 Dose of Study Drug|Period 2||8
11365174|NCT03212638|12561922|FG001|Received at Least 1 Dose of Study Drug|Period 2||8
11365175|NCT03212638|12561923|FG002|Received at Least 1 Dose of Study Drug|Period 2||8
11365176|NCT03212638|12561924|FG003|Received at Least 1 Dose of Study Drug|Period 2||0
11365177|NCT03212638|12561925|FG004|Received at Least 1 Dose of Study Drug|Period 2||0
11365178|NCT03212638|12561921|FG000|COMPLETED|Period 2||8
11365179|NCT03212638|12561922|FG001|COMPLETED|Period 2||8
11365180|NCT03212638|12561923|FG002|COMPLETED|Period 2||8
11365181|NCT03212638|12561924|FG003|COMPLETED|Period 2||0
11365182|NCT03212638|12561925|FG004|COMPLETED|Period 2||0
11365183|NCT03212638|12561921|FG000|NOT COMPLETED|Period 2||0
11365184|NCT03212638|12561922|FG001|NOT COMPLETED|Period 2||0
11365185|NCT03212638|12561923|FG002|NOT COMPLETED|Period 2||0
11365186|NCT03212638|12561924|FG003|NOT COMPLETED|Period 2||0
11365187|NCT03212638|12561925|FG004|NOT COMPLETED|Period 2||0
11365188|NCT03212638|12561921|FG000|STARTED|Period 3||8
11365189|NCT03212638|12561922|FG001|STARTED|Period 3||8
11365190|NCT03212638|12561923|FG002|STARTED|Period 3||8
11365191|NCT03212638|12561924|FG003|STARTED|Period 3||0
11365192|NCT03212638|12561925|FG004|STARTED|Period 3||0
11365193|NCT03212638|12561921|FG000|Received at Least 1 Dose of Study Drug|Period 3||8
11365194|NCT03212638|12561922|FG001|Received at Least 1 Dose of Study Drug|Period 3||8
11365195|NCT03212638|12561923|FG002|Received at Least 1 Dose of Study Drug|Period 3||8
11365196|NCT03212638|12561924|FG003|Received at Least 1 Dose of Study Drug|Period 3||0
11365197|NCT03212638|12561925|FG004|Received at Least 1 Dose of Study Drug|Period 3||0
11365198|NCT03212638|12561921|FG000|COMPLETED|Period 3||8
11365199|NCT03212638|12561922|FG001|COMPLETED|Period 3||8
11365200|NCT03212638|12561923|FG002|COMPLETED|Period 3||8
11365201|NCT03212638|12561924|FG003|COMPLETED|Period 3||0
11365202|NCT03212638|12561925|FG004|COMPLETED|Period 3||0
11365203|NCT03212638|12561921|FG000|NOT COMPLETED|Period 3||0
11365204|NCT03212638|12561922|FG001|NOT COMPLETED|Period 3||0
11365205|NCT03212638|12561923|FG002|NOT COMPLETED|Period 3||0
11365206|NCT03212638|12561924|FG003|NOT COMPLETED|Period 3||0
11365207|NCT03212638|12561925|FG004|NOT COMPLETED|Period 3||0
11365208|NCT03212638|12561921|FG000|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
11365209|NCT03212638|12561922|FG001|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
11365210|NCT03212638|12561923|FG002|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
11365211|NCT03212638|12561924|FG003|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
11365212|NCT03212638|12561925|FG004|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
11365213|NCT03212638|12561921|FG000|Received at Least 1 Dose of Study Drug|Period 4||0
11365214|NCT03212638|12561922|FG001|Received at Least 1 Dose of Study Drug|Period 4||0
11365215|NCT03212638|12561923|FG002|Received at Least 1 Dose of Study Drug|Period 4||0
11365216|NCT03212638|12561924|FG003|Received at Least 1 Dose of Study Drug|Period 4||9
11365217|NCT03212638|12561925|FG004|Received at Least 1 Dose of Study Drug|Period 4||9
11365218|NCT03212638|12561921|FG000|COMPLETED|Period 4||0
11365219|NCT03212638|12561922|FG001|COMPLETED|Period 4||0
11365220|NCT03212638|12561923|FG002|COMPLETED|Period 4||0
11365221|NCT03212638|12561924|FG003|COMPLETED|Period 4||9
11365222|NCT03212638|12561925|FG004|COMPLETED|Period 4||9
11365223|NCT03212638|12561921|FG000|NOT COMPLETED|Period 4||0
11365224|NCT03212638|12561922|FG001|NOT COMPLETED|Period 4||0
11365225|NCT03212638|12561923|FG002|NOT COMPLETED|Period 4||0
11365226|NCT03212638|12561924|FG003|NOT COMPLETED|Period 4||0
11365227|NCT03212638|12561925|FG004|NOT COMPLETED|Period 4||0
11365228|NCT03212638|12561921|FG000|STARTED|Period 5||0
11365229|NCT03212638|12561922|FG001|STARTED|Period 5||0
11365230|NCT03212638|12561923|FG002|STARTED|Period 5||0
11365231|NCT03212638|12561924|FG003|STARTED|Period 5||9
11365232|NCT03212638|12561925|FG004|STARTED|Period 5||9
11365233|NCT03212638|12561921|FG000|Received at Least 1 Dose of Study Drug|Period 5||0
11365234|NCT03212638|12561922|FG001|Received at Least 1 Dose of Study Drug|Period 5||0
11365235|NCT03212638|12561923|FG002|Received at Least 1 Dose of Study Drug|Period 5||0
11365236|NCT03212638|12561924|FG003|Received at Least 1 Dose of Study Drug|Period 5||9
11365237|NCT03212638|12561925|FG004|Received at Least 1 Dose of Study Drug|Period 5||9
11365238|NCT03212638|12561921|FG000|COMPLETED|Period 5||0
11365239|NCT03212638|12561922|FG001|COMPLETED|Period 5||0
11365240|NCT03212638|12561923|FG002|COMPLETED|Period 5||0
11365241|NCT03212638|12561924|FG003|COMPLETED|Period 5||9
11365242|NCT03212638|12561925|FG004|COMPLETED|Period 5||9
11365243|NCT03212638|12561921|FG000|NOT COMPLETED|Period 5||0
11365244|NCT03212638|12561922|FG001|NOT COMPLETED|Period 5||0
11365245|NCT03212638|12561923|FG002|NOT COMPLETED|Period 5||0
11365246|NCT03212638|12561924|FG003|NOT COMPLETED|Period 5||0
11365247|NCT03212638|12561925|FG004|NOT COMPLETED|Period 5||0
11365248|NCT03212690|12561937|FG000|STARTED|Overall Study||57
11365249|NCT03212690|12561937|FG000|COMPLETED|Overall Study||56
11365250|NCT03212690|12561937|FG000|NOT COMPLETED|Overall Study||1
11365251|NCT03213210|12561941|FG000|STARTED|Overall Study||5
11365252|NCT03213210|12561941|FG000|6-month Follow-up|Overall Study||3
11365253|NCT03213210|12561941|FG000|COMPLETED|Overall Study||0
11365254|NCT03213210|12561941|FG000|NOT COMPLETED|Overall Study||5
11365255|NCT03213366|12561947|FG000|STARTED|Overall Study||81
11365256|NCT03213366|12561948|FG001|STARTED|Overall Study||71
11365257|NCT03213366|12561947|FG000|COMPLETED|Overall Study||72
11365258|NCT03213366|12561948|FG001|COMPLETED|Overall Study||67
11365259|NCT03213366|12561947|FG000|NOT COMPLETED|Overall Study||9
11365260|NCT03213366|12561948|FG001|NOT COMPLETED|Overall Study||4
11365261|NCT03213405|12561958|FG000|STARTED|Overall Study||6
11365262|NCT03213405|12561959|FG001|STARTED|Overall Study||6
11365263|NCT03213405|12561960|FG002|STARTED|Overall Study||6
11365264|NCT03213405|12561961|FG003|STARTED|Overall Study||6
11365265|NCT03213405|12561958|FG000|COMPLETED|Overall Study||6
11365266|NCT03213405|12561959|FG001|COMPLETED|Overall Study||6
11365267|NCT03213405|12561960|FG002|COMPLETED|Overall Study||6
11365268|NCT03213405|12561961|FG003|COMPLETED|Overall Study||6
11365269|NCT03213405|12561958|FG000|NOT COMPLETED|Overall Study||0
11365270|NCT03213405|12561959|FG001|NOT COMPLETED|Overall Study||0
11365271|NCT03213405|12561960|FG002|NOT COMPLETED|Overall Study||0
11365272|NCT03213405|12561961|FG003|NOT COMPLETED|Overall Study||0
11365273|NCT03213509|12561973|FG000|STARTED|Overall Study||80
11365274|NCT03213509|12561974|FG001|STARTED|Overall Study||90
11365275|NCT03213509|12561973|FG000|COMPLETED|Overall Study||76
11365276|NCT03213509|12561974|FG001|COMPLETED|Overall Study||85
11365277|NCT03213509|12561973|FG000|NOT COMPLETED|Overall Study||4
11365278|NCT03213509|12561974|FG001|NOT COMPLETED|Overall Study||5
11365279|NCT03213626|12561981|FG000|STARTED|Overall Study||7
11365280|NCT03213626|12561981|FG000|COMPLETED|Overall Study||0
11365281|NCT03213626|12561981|FG000|NOT COMPLETED|Overall Study||7
11365282|NCT03214081|12561985|FG000|STARTED|Overall Study||1237
11365283|NCT03214081|12561985|FG000|COMPLETED|Overall Study||1174
11365284|NCT03214081|12561985|FG000|NOT COMPLETED|Overall Study||63
11365285|NCT03214094|12561989|FG000|STARTED|Overall Study||1119
11365286|NCT03214094|12561989|FG000|COMPLETED|Overall Study||1059
11365287|NCT03214094|12561989|FG000|NOT COMPLETED|Overall Study||60
11365288|NCT03214198|12561993|FG000|STARTED|Overall Study||1304
11365289|NCT03214198|12561993|FG000|COMPLETED|Overall Study||1268
11365290|NCT03214198|12561993|FG000|NOT COMPLETED|Overall Study||36
11365291|NCT03214224|12561997|FG000|STARTED|Overall Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49
11365292|NCT03214224|12561997|FG000|COMPLETED|Overall Study|3 therapists enrolled. 3 ctrls enrolled (not incl. in analysis). 3 pts enr. but not completed.|40
11365293|NCT03214224|12561997|FG000|NOT COMPLETED|Overall Study||9
11365294|NCT03214367|12562007|FG000|STARTED|Lead-in Period||1316
11365295|NCT03214367|12562008|FG001|STARTED|Lead-in Period||0
11365296|NCT03214367|12562009|FG002|STARTED|Lead-in Period||0
11365297|NCT03214367|12562010|FG003|STARTED|Lead-in Period||0
11365298|NCT03214367|12562011|FG004|STARTED|Lead-in Period||76
11365299|NCT03214367|12562012|FG005|STARTED|Lead-in Period||0
11365300|NCT03214367|12562013|FG006|STARTED|Lead-in Period||0
11365301|NCT03214367|12562014|FG007|STARTED|Lead-in Period||0
11365302|NCT03214367|12562007|FG000|COMPLETED|Lead-in Period||1222
11365303|NCT03214367|12562008|FG001|COMPLETED|Lead-in Period||0
11365304|NCT03214367|12562009|FG002|COMPLETED|Lead-in Period||0
11365305|NCT03214367|12562010|FG003|COMPLETED|Lead-in Period||0
11365306|NCT03214367|12562011|FG004|COMPLETED|Lead-in Period||74
11365307|NCT03214367|12562012|FG005|COMPLETED|Lead-in Period||0
11365308|NCT03214367|12562013|FG006|COMPLETED|Lead-in Period||0
11365309|NCT03214367|12562014|FG007|COMPLETED|Lead-in Period||0
11365310|NCT03214367|12562007|FG000|NOT COMPLETED|Lead-in Period||94
11365311|NCT03214367|12562008|FG001|NOT COMPLETED|Lead-in Period||0
11365312|NCT03214367|12562009|FG002|NOT COMPLETED|Lead-in Period||0
11365313|NCT03214367|12562010|FG003|NOT COMPLETED|Lead-in Period||0
11365314|NCT03214367|12562011|FG004|NOT COMPLETED|Lead-in Period||2
11365315|NCT03214367|12562012|FG005|NOT COMPLETED|Lead-in Period||0
11365316|NCT03214367|12562013|FG006|NOT COMPLETED|Lead-in Period||0
11365317|NCT03214367|12562014|FG007|NOT COMPLETED|Lead-in Period||0
11365318|NCT03214367|12562007|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
11365319|NCT03214367|12562008|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|442
11365320|NCT03214367|12562009|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|451
11365321|NCT03214367|12562010|FG003|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|329
11365322|NCT03214367|12562011|FG004|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
11365323|NCT03214367|12562012|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|31
11365324|NCT03214367|12562013|FG006|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|21
11365325|NCT03214367|12562014|FG007|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|22
11365326|NCT03214367|12562007|FG000|COMPLETED|Treatment Period||0
11365327|NCT03214367|12562008|FG001|COMPLETED|Treatment Period||408
11365328|NCT03214367|12562009|FG002|COMPLETED|Treatment Period||418
11005639|NCT00723606|12183332|FG001|STARTED|Overall Study||187
11005640|NCT00723606|12183331|FG000|COMPLETED|Overall Study||185
11005641|NCT00723606|12183332|FG001|COMPLETED|Overall Study||180
11005642|NCT00723606|12183331|FG000|NOT COMPLETED|Overall Study||4
11005643|NCT00723606|12183332|FG001|NOT COMPLETED|Overall Study||7
11365329|NCT03214367|12562010|FG003|COMPLETED|Treatment Period||310
11365330|NCT03214367|12562011|FG004|COMPLETED|Treatment Period||0
11365331|NCT03214367|12562012|FG005|COMPLETED|Treatment Period||28
11365332|NCT03214367|12562013|FG006|COMPLETED|Treatment Period||19
11365333|NCT03214367|12562014|FG007|COMPLETED|Treatment Period||21
11365334|NCT03214367|12562007|FG000|NOT COMPLETED|Treatment Period||0
11365335|NCT03214367|12562008|FG001|NOT COMPLETED|Treatment Period||34
11365336|NCT03214367|12562009|FG002|NOT COMPLETED|Treatment Period||33
11005644|NCT00723632|12183338|FG000|STARTED|Overall Study||901
11005645|NCT00723632|12183338|FG000|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
11005646|NCT00723632|12183338|FG000|NOT COMPLETED|Overall Study||203
11005647|NCT00723645|12183342|FG000|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
11005648|NCT00723645|12183342|FG000|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
11365337|NCT03214367|12562010|FG003|NOT COMPLETED|Treatment Period||19
11365338|NCT03214367|12562011|FG004|NOT COMPLETED|Treatment Period||0
11365339|NCT03214367|12562012|FG005|NOT COMPLETED|Treatment Period||3
11365340|NCT03214367|12562013|FG006|NOT COMPLETED|Treatment Period||2
11365341|NCT03214367|12562014|FG007|NOT COMPLETED|Treatment Period||1
11365342|NCT03214380|12562032|FG000|STARTED|Lead-in||750
11365343|NCT03214380|12562033|FG001|STARTED|Lead-in||0
11365344|NCT03214380|12562034|FG002|STARTED|Lead-in||0
11365345|NCT03214380|12562035|FG003|STARTED|Lead-in||183
11365346|NCT03214380|12562036|FG004|STARTED|Lead-in||0
11365347|NCT03214380|12562037|FG005|STARTED|Lead-in||0
11365348|NCT03214380|12562032|FG000|Received at Least 1 Dose Lead-in Insulin|Lead-in||750
11365349|NCT03214380|12562033|FG001|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
11365350|NCT03214380|12562034|FG002|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
11365351|NCT03214380|12562035|FG003|Received at Least 1 Dose Lead-in Insulin|Lead-in||183
11365352|NCT03214380|12562036|FG004|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
11365353|NCT03214380|12562037|FG005|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
11365354|NCT03214380|12562032|FG000|COMPLETED|Lead-in||673
11365355|NCT03214380|12562033|FG001|COMPLETED|Lead-in||0
11365356|NCT03214380|12562034|FG002|COMPLETED|Lead-in||0
11365357|NCT03214380|12562035|FG003|COMPLETED|Lead-in||164
11365358|NCT03214380|12562036|FG004|COMPLETED|Lead-in||0
11365359|NCT03214380|12562037|FG005|COMPLETED|Lead-in||0
11365360|NCT03214380|12562032|FG000|NOT COMPLETED|Lead-in||77
11365361|NCT03214380|12562033|FG001|NOT COMPLETED|Lead-in||0
11365362|NCT03214380|12562034|FG002|NOT COMPLETED|Lead-in||0
11365363|NCT03214380|12562035|FG003|NOT COMPLETED|Lead-in||19
11365364|NCT03214380|12562036|FG004|NOT COMPLETED|Lead-in||0
11365365|NCT03214380|12562037|FG005|NOT COMPLETED|Lead-in||0
11365366|NCT03214380|12562032|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
11365367|NCT03214380|12562033|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|337
11365368|NCT03214380|12562034|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|336
11365369|NCT03214380|12562035|FG003|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
11365370|NCT03214380|12562036|FG004|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
11365371|NCT03214380|12562037|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
11365372|NCT03214380|12562032|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||0
11365373|NCT03214380|12562033|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||337
11365374|NCT03214380|12562034|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||336
11365375|NCT03214380|12562035|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0
11365376|NCT03214380|12562036|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||82
11365377|NCT03214380|12562037|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||82
11365378|NCT03214380|12562032|FG000|COMPLETED|Treatment Period||0
11365379|NCT03214380|12562033|FG001|COMPLETED|Treatment Period||319
11365380|NCT03214380|12562034|FG002|COMPLETED|Treatment Period||320
11365381|NCT03214380|12562035|FG003|COMPLETED|Treatment Period||0
11365382|NCT03214380|12562036|FG004|COMPLETED|Treatment Period||73
11365383|NCT03214380|12562037|FG005|COMPLETED|Treatment Period||71
11365384|NCT03214380|12562032|FG000|NOT COMPLETED|Treatment Period||0
11365385|NCT03214380|12562033|FG001|NOT COMPLETED|Treatment Period||18
11365386|NCT03214380|12562034|FG002|NOT COMPLETED|Treatment Period||16
11365387|NCT03214380|12562035|FG003|NOT COMPLETED|Treatment Period||0
11365388|NCT03214380|12562036|FG004|NOT COMPLETED|Treatment Period||9
11365389|NCT03214380|12562037|FG005|NOT COMPLETED|Treatment Period||11
11365390|NCT03214406|12562051|FG000|STARTED|Overall Study||88
11365391|NCT03214406|12562052|FG001|STARTED|Overall Study||93
11365392|NCT03214406|12562051|FG000|COMPLETED|Overall Study||78
11365393|NCT03214406|12562052|FG001|COMPLETED|Overall Study||78
11365394|NCT03214406|12562051|FG000|NOT COMPLETED|Overall Study||10
11365395|NCT03214406|12562052|FG001|NOT COMPLETED|Overall Study||15
11365396|NCT03214588|12562061|FG000|STARTED|Overall Study||27
11365397|NCT03214588|12562062|FG001|STARTED|Overall Study||14
11365398|NCT03214588|12562063|FG002|STARTED|Overall Study||26
11365399|NCT03214588|12562061|FG000|COMPLETED|Overall Study||26
11365400|NCT03214588|12562062|FG001|COMPLETED|Overall Study||13
11365401|NCT03214588|12562063|FG002|COMPLETED|Overall Study||24
11365402|NCT03214588|12562061|FG000|NOT COMPLETED|Overall Study||1
11365403|NCT03214588|12562062|FG001|NOT COMPLETED|Overall Study||1
11365404|NCT03214588|12562063|FG002|NOT COMPLETED|Overall Study||2
11365405|NCT03214640|12562075|FG000|STARTED|Overall Study||31
11365406|NCT03214640|12562076|FG001|STARTED|Overall Study||32
11365407|NCT03214640|12562077|FG002|STARTED|Overall Study||31
11365408|NCT03214640|12562078|FG003|STARTED|Overall Study||34
11365409|NCT03214640|12562075|FG000|COMPLETED|Overall Study||30
11365410|NCT03214640|12562076|FG001|COMPLETED|Overall Study||30
11365411|NCT03214640|12562077|FG002|COMPLETED|Overall Study||30
11365412|NCT03214640|12562078|FG003|COMPLETED|Overall Study||30
11365413|NCT03214640|12562075|FG000|NOT COMPLETED|Overall Study||1
11365414|NCT03214640|12562076|FG001|NOT COMPLETED|Overall Study||2
11365415|NCT03214640|12562077|FG002|NOT COMPLETED|Overall Study||1
11365416|NCT03214640|12562078|FG003|NOT COMPLETED|Overall Study||4
11365417|NCT03214952|12562088|FG000|STARTED|Overall Study||3183
11365418|NCT03214952|12562088|FG000|COMPLETED|Overall Study||3125
11365419|NCT03214952|12562088|FG000|NOT COMPLETED|Overall Study||58
11365420|NCT03215667|12562092|FG000|STARTED|Overall Study||9
11365421|NCT03215667|12562092|FG000|COMPLETED|Overall Study||5
11365422|NCT03215667|12562092|FG000|NOT COMPLETED|Overall Study||4
11365423|NCT03215758|12562098|FG000|STARTED|Overall Study||339
11365424|NCT03215758|12562099|FG001|STARTED|Overall Study||336
11365425|NCT03215758|12562098|FG000|COMPLETED|Overall Study||334
11365426|NCT03215758|12562099|FG001|COMPLETED|Overall Study||328
11365427|NCT03215758|12562098|FG000|NOT COMPLETED|Overall Study||5
11365428|NCT03215758|12562099|FG001|NOT COMPLETED|Overall Study||8
11365429|NCT03215771|12562105|FG000|STARTED|Overall Study||16
11365430|NCT03215771|12562105|FG000|Stroke Subjects|Overall Study||8
11365431|NCT03215771|12562105|FG000|TBI Subjects|Overall Study||8
11365432|NCT03215771|12562105|FG000|COMPLETED|Overall Study||13
11365433|NCT03215771|12562105|FG000|NOT COMPLETED|Overall Study||3
11365434|NCT03215901|12562113|FG000|STARTED|Overall Study||199
11365435|NCT03215901|12562114|FG001|STARTED|Overall Study||112
11365436|NCT03215901|12562115|FG002|STARTED|Overall Study||116
11365437|NCT03215901|12562113|FG000|COMPLETED|Overall Study||199
11365438|NCT03215901|12562114|FG001|COMPLETED|Overall Study||112
11365439|NCT03215901|12562115|FG002|COMPLETED|Overall Study||116
11365440|NCT03215901|12562113|FG000|NOT COMPLETED|Overall Study||0
11365441|NCT03215901|12562114|FG001|NOT COMPLETED|Overall Study||0
11365442|NCT03215901|12562115|FG002|NOT COMPLETED|Overall Study||0
11365443|NCT03216200|12562123|FG000|STARTED|Overall Study||5
11365444|NCT03216200|12562123|FG000|COMPLETED|Overall Study||5
11365445|NCT03216200|12562123|FG000|NOT COMPLETED|Overall Study||0
11365446|NCT03216226|12562129|FG000|STARTED|Overall Study||57
11365447|NCT03216226|12562130|FG001|STARTED|Overall Study||55
11365448|NCT03216226|12562129|FG000|Randomized and Treated|Overall Study||57
11365449|NCT03216226|12562130|FG001|Randomized and Treated|Overall Study||54
11365450|NCT03216226|12562129|FG000|COMPLETED|Overall Study||52
11365451|NCT03216226|12562130|FG001|COMPLETED|Overall Study||50
11365452|NCT03216226|12562129|FG000|NOT COMPLETED|Overall Study||5
11365453|NCT03216226|12562130|FG001|NOT COMPLETED|Overall Study||5
11365454|NCT03216265|12562139|FG000|STARTED|Overall Study||22
11365455|NCT03216265|12562140|FG001|STARTED|Overall Study||22
11365456|NCT03216265|12562141|FG002|STARTED|Overall Study||22
11365457|NCT03216265|12562139|FG000|COMPLETED|Overall Study||20
11365458|NCT03216265|12562140|FG001|COMPLETED|Overall Study||21
11365459|NCT03216265|12562141|FG002|COMPLETED|Overall Study||19
11365460|NCT03216265|12562139|FG000|NOT COMPLETED|Overall Study||2
11365461|NCT03216265|12562140|FG001|NOT COMPLETED|Overall Study||1
11365462|NCT03216265|12562141|FG002|NOT COMPLETED|Overall Study||3
11365463|NCT03216382|12562158|FG000|STARTED|Overall Study||41
11365464|NCT03216382|12562159|FG001|STARTED|Overall Study||54
11365465|NCT03216382|12562158|FG000|COMPLETED|Overall Study||34
11365466|NCT03216382|12562159|FG001|COMPLETED|Overall Study||44
11365467|NCT03216382|12562158|FG000|NOT COMPLETED|Overall Study||7
11365468|NCT03216382|12562159|FG001|NOT COMPLETED|Overall Study||10
11365469|NCT03216512|12562167|FG000|STARTED|Overall Study||17
11365470|NCT03216512|12562168|FG001|STARTED|Overall Study||14
11365471|NCT03216512|12562167|FG000|COMPLETED|Overall Study||17
11365472|NCT03216512|12562168|FG001|COMPLETED|Overall Study||13
11365473|NCT03216512|12562167|FG000|NOT COMPLETED|Overall Study||0
11365474|NCT03216512|12562168|FG001|NOT COMPLETED|Overall Study||1
11365475|NCT03216746|12562180|FG000|STARTED|Overall Study||72
11365476|NCT03216746|12562181|FG001|STARTED|Overall Study||79
11365477|NCT03216746|12562182|FG002|STARTED|Overall Study||68
11365478|NCT03216746|12562183|FG003|STARTED|Overall Study||69
11365479|NCT03216746|12562180|FG000|COMPLETED|Overall Study||66
11365480|NCT03216746|12562181|FG001|COMPLETED|Overall Study||71
11365481|NCT03216746|12562182|FG002|COMPLETED|Overall Study||63
11365482|NCT03216746|12562183|FG003|COMPLETED|Overall Study||63
11365483|NCT03216746|12562180|FG000|NOT COMPLETED|Overall Study||6
11365484|NCT03216746|12562181|FG001|NOT COMPLETED|Overall Study||8
11365485|NCT03216746|12562182|FG002|NOT COMPLETED|Overall Study||5
11365486|NCT03216746|12562183|FG003|NOT COMPLETED|Overall Study||6
11365487|NCT03216850|12562193|FG000|STARTED|Overall Study||15
11365488|NCT03216850|12562193|FG000|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9
11365489|NCT03216850|12562193|FG000|NOT COMPLETED|Overall Study||6
11365490|NCT03216902|12562203|FG000|STARTED|Overall Study||22
11365491|NCT03216902|12562204|FG001|STARTED|Overall Study||44
11365492|NCT03216902|12562205|FG002|STARTED|Overall Study||43
11365493|NCT03216902|12562206|FG003|STARTED|Overall Study||43
11365494|NCT03216902|12562207|FG004|STARTED|Overall Study||44
11365495|NCT03216902|12562208|FG005|STARTED|Overall Study||45
11365496|NCT03216902|12562203|FG000|COMPLETED|Overall Study||20
11365497|NCT03216902|12562204|FG001|COMPLETED|Overall Study||43
11365498|NCT03216902|12562205|FG002|COMPLETED|Overall Study||42
11365499|NCT03216902|12562206|FG003|COMPLETED|Overall Study||43
11365500|NCT03216902|12562207|FG004|COMPLETED|Overall Study||43
11365501|NCT03216902|12562208|FG005|COMPLETED|Overall Study||42
11365502|NCT03216902|12562203|FG000|NOT COMPLETED|Overall Study||2
11365503|NCT03216902|12562204|FG001|NOT COMPLETED|Overall Study||1
11365504|NCT03216902|12562205|FG002|NOT COMPLETED|Overall Study||1
11365505|NCT03216902|12562206|FG003|NOT COMPLETED|Overall Study||0
11365506|NCT03216902|12562207|FG004|NOT COMPLETED|Overall Study||1
11365507|NCT03216902|12562208|FG005|NOT COMPLETED|Overall Study||3
11365508|NCT03216954|12562230|FG000|STARTED|Overall Study||4
11365509|NCT03216954|12562231|FG001|STARTED|Overall Study||3
11365510|NCT03216954|12562232|FG002|STARTED|Overall Study||3
11365511|NCT03216954|12562233|FG003|STARTED|Overall Study||3
11365512|NCT03216954|12562234|FG004|STARTED|Overall Study||1
11365513|NCT03216954|12562230|FG000|COMPLETED|Overall Study||2
11365514|NCT03216954|12562231|FG001|COMPLETED|Overall Study||2
11365515|NCT03216954|12562232|FG002|COMPLETED|Overall Study||2
11365516|NCT03216954|12562233|FG003|COMPLETED|Overall Study||3
11365517|NCT03216954|12562234|FG004|COMPLETED|Overall Study||0
11365518|NCT03216954|12562230|FG000|NOT COMPLETED|Overall Study||2
11365519|NCT03216954|12562231|FG001|NOT COMPLETED|Overall Study||1
11365520|NCT03216954|12562232|FG002|NOT COMPLETED|Overall Study||1
11365521|NCT03216954|12562233|FG003|NOT COMPLETED|Overall Study||0
11365522|NCT03216954|12562234|FG004|NOT COMPLETED|Overall Study||1
11365523|NCT03217968|12562242|FG000|STARTED|Overall Study||59
11365524|NCT03217968|12562242|FG000|COMPLETED|Overall Study||48
11365525|NCT03217968|12562242|FG000|NOT COMPLETED|Overall Study||11
11365526|NCT03218397|12562248|FG000|STARTED|Overall Study||249
11365527|NCT03218397|12562249|FG001|STARTED|Overall Study||251
11365528|NCT03218397|12562248|FG000|COMPLETED|Overall Study||226
11365529|NCT03218397|12562249|FG001|COMPLETED|Overall Study||222
11365530|NCT03218397|12562248|FG000|NOT COMPLETED|Overall Study||23
11365531|NCT03218397|12562249|FG001|NOT COMPLETED|Overall Study||29
11365532|NCT03218566|12562255|FG000|STARTED|Overall Study||119
11365533|NCT03218566|12562255|FG000|COMPLETED|Overall Study||110
11365534|NCT03218566|12562255|FG000|NOT COMPLETED|Overall Study||9
11365535|NCT03218592|12562262|FG000|STARTED|Phase 1: 1 Dose||12
11365536|NCT03218592|12562263|FG001|STARTED|Phase 1: 1 Dose||12
11365537|NCT03218592|12562264|FG002|STARTED|Phase 1: 1 Dose||12
11365538|NCT03218592|12562262|FG000|COMPLETED|Phase 1: 1 Dose||12
11365539|NCT03218592|12562263|FG001|COMPLETED|Phase 1: 1 Dose||12
11365540|NCT03218592|12562264|FG002|COMPLETED|Phase 1: 1 Dose||12
11365541|NCT03218592|12562262|FG000|NOT COMPLETED|Phase 1: 1 Dose||0
11365542|NCT03218592|12562263|FG001|NOT COMPLETED|Phase 1: 1 Dose||0
11365543|NCT03218592|12562264|FG002|NOT COMPLETED|Phase 1: 1 Dose||0
11365544|NCT03218592|12562262|FG000|STARTED|Phase 2: Daily Doses x 28 Days||12
11365545|NCT03218592|12562263|FG001|STARTED|Phase 2: Daily Doses x 28 Days||12
11365546|NCT03218592|12562264|FG002|STARTED|Phase 2: Daily Doses x 28 Days||12
11365547|NCT03218592|12562262|FG000|COMPLETED|Phase 2: Daily Doses x 28 Days||12
11365548|NCT03218592|12562263|FG001|COMPLETED|Phase 2: Daily Doses x 28 Days||12
11365549|NCT03218592|12562264|FG002|COMPLETED|Phase 2: Daily Doses x 28 Days||12
11365550|NCT03218592|12562262|FG000|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
11365551|NCT03218592|12562263|FG001|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
11365552|NCT03218592|12562264|FG002|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
11365553|NCT03218592|12562262|FG000|STARTED|Phase 3: 0 Doses Per Week||4
11365554|NCT03218592|12562263|FG001|STARTED|Phase 3: 0 Doses Per Week||4
11365555|NCT03218592|12562264|FG002|STARTED|Phase 3: 0 Doses Per Week||4
11365556|NCT03218592|12562262|FG000|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
11365557|NCT03218592|12562263|FG001|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
11365558|NCT03218592|12562264|FG002|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
11365559|NCT03218592|12562262|FG000|COMPLETED|Phase 3: 0 Doses Per Week||4
11365560|NCT03218592|12562263|FG001|COMPLETED|Phase 3: 0 Doses Per Week||4
11365561|NCT03218592|12562264|FG002|COMPLETED|Phase 3: 0 Doses Per Week||4
11365562|NCT03218592|12562262|FG000|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
11365563|NCT03218592|12562263|FG001|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
11365564|NCT03218592|12562264|FG002|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
11365565|NCT03218592|12562262|FG000|STARTED|Phase 3: 1 Dose Per Period||4
11365566|NCT03218592|12562263|FG001|STARTED|Phase 3: 1 Dose Per Period||4
11365567|NCT03218592|12562264|FG002|STARTED|Phase 3: 1 Dose Per Period||4
11365568|NCT03218592|12562262|FG000|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
11365569|NCT03218592|12562263|FG001|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
11365570|NCT03218592|12562264|FG002|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
11365571|NCT03218592|12562262|FG000|COMPLETED|Phase 3: 1 Dose Per Period||4
11365572|NCT03218592|12562263|FG001|COMPLETED|Phase 3: 1 Dose Per Period||4
11365573|NCT03218592|12562264|FG002|COMPLETED|Phase 3: 1 Dose Per Period||4
11365574|NCT03218592|12562262|FG000|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
11365575|NCT03218592|12562263|FG001|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
11365576|NCT03218592|12562264|FG002|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
11365577|NCT03218592|12562262|FG000|STARTED|Phase 3: 3 Doses Per Week||4
11365578|NCT03218592|12562263|FG001|STARTED|Phase 3: 3 Doses Per Week||4
11365579|NCT03218592|12562264|FG002|STARTED|Phase 3: 3 Doses Per Week||4
11365580|NCT03218592|12562262|FG000|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
11365581|NCT03218592|12562263|FG001|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
11365582|NCT03218592|12562264|FG002|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
11365583|NCT03218592|12562262|FG000|COMPLETED|Phase 3: 3 Doses Per Week||4
11365584|NCT03218592|12562263|FG001|COMPLETED|Phase 3: 3 Doses Per Week||4
11365585|NCT03218592|12562264|FG002|COMPLETED|Phase 3: 3 Doses Per Week||4
11365586|NCT03218592|12562262|FG000|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
11365587|NCT03218592|12562263|FG001|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
11365588|NCT03218592|12562264|FG002|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
11365589|NCT03218787|12562277|FG000|STARTED|Overall Study||2047
11365590|NCT03218787|12562277|FG000|COMPLETED|Overall Study||1841
11365591|NCT03218787|12562277|FG000|NOT COMPLETED|Overall Study||206
11365592|NCT03219216|12562283|FG000|STARTED|Overall Study||75
11365593|NCT03219216|12562284|FG001|STARTED|Overall Study||25
11365594|NCT03219216|12562283|FG000|COMPLETED|Overall Study||75
11365595|NCT03219216|12562284|FG001|COMPLETED|Overall Study||24
11365596|NCT03219216|12562283|FG000|NOT COMPLETED|Overall Study||0
11365597|NCT03219216|12562284|FG001|NOT COMPLETED|Overall Study||1
11365598|NCT03219294|12562291|FG000|STARTED|Overall Study||58
11365599|NCT03219294|12562292|FG001|STARTED|Overall Study||58
11365600|NCT03219294|12562291|FG000|COMPLETED|Overall Study||58
11365601|NCT03219294|12562292|FG001|COMPLETED|Overall Study||58
11365602|NCT03219294|12562291|FG000|NOT COMPLETED|Overall Study||0
11365603|NCT03219294|12562292|FG001|NOT COMPLETED|Overall Study||0
11365604|NCT03219320|12562302|FG000|STARTED|Overall Study||75
11365605|NCT03219320|12562303|FG001|STARTED|Overall Study||77
11365606|NCT03219320|12562304|FG002|STARTED|Overall Study||77
11365607|NCT03219320|12562305|FG003|STARTED|Overall Study||72
11365608|NCT03219320|12562302|FG000|COMPLETED|Overall Study||73
11365609|NCT03219320|12562303|FG001|COMPLETED|Overall Study||74
11365610|NCT03219320|12562304|FG002|COMPLETED|Overall Study||72
11365611|NCT03219320|12562305|FG003|COMPLETED|Overall Study||69
11365612|NCT03219320|12562302|FG000|NOT COMPLETED|Overall Study||2
11365613|NCT03219320|12562303|FG001|NOT COMPLETED|Overall Study||3
11365614|NCT03219320|12562304|FG002|NOT COMPLETED|Overall Study||5
11365615|NCT03219320|12562305|FG003|NOT COMPLETED|Overall Study||3
11365616|NCT03219723|12562315|FG000|STARTED|Overall Study||560
11365617|NCT03219723|12562315|FG000|COMPLETED|Overall Study||550
11365618|NCT03219723|12562315|FG000|NOT COMPLETED|Overall Study||10
11365619|NCT03219840|12562319|FG000|STARTED|Overall Study||38
11365620|NCT03219840|12562320|FG001|STARTED|Overall Study||31
11365621|NCT03219840|12562319|FG000|Day 1 Visit for 1st Period|Overall Study||37
11365622|NCT03219840|12562320|FG001|Day 1 Visit for 1st Period|Overall Study||31
11365623|NCT03219840|12562319|FG000|1st Intervention Period of 21 Days|Overall Study||34
11365624|NCT03219840|12562320|FG001|1st Intervention Period of 21 Days|Overall Study||31
11365625|NCT03219840|12562319|FG000|Day 22 Visit for 1st Period|Overall Study||34
11365626|NCT03219840|12562320|FG001|Day 22 Visit for 1st Period|Overall Study||31
11365627|NCT03219840|12562319|FG000|Washout Period of 21 Days|Overall Study||34
11365628|NCT03219840|12562320|FG001|Washout Period of 21 Days|Overall Study||31
11365629|NCT03219840|12562319|FG000|Day 1 Visit for 2nd Period|Overall Study||34
11365630|NCT03219840|12562320|FG001|Day 1 Visit for 2nd Period|Overall Study||31
11365631|NCT03219840|12562319|FG000|2nd Intervention Period of 21 Days|Overall Study||34
11365632|NCT03219840|12562320|FG001|2nd Intervention Period of 21 Days|Overall Study||31
11365633|NCT03219840|12562319|FG000|Day 22 Visit for 2nd Period|Overall Study||34
11365634|NCT03219840|12562320|FG001|Day 22 Visit for 2nd Period|Overall Study||31
11365635|NCT03219840|12562319|FG000|COMPLETED|Overall Study||34
11365636|NCT03219840|12562320|FG001|COMPLETED|Overall Study||31
11365637|NCT03219840|12562319|FG000|NOT COMPLETED|Overall Study||4
11365638|NCT03219840|12562320|FG001|NOT COMPLETED|Overall Study||0
11365639|NCT03219866|12562328|FG000|STARTED|Overall Study||21
11365640|NCT03219866|12562329|FG001|STARTED|Overall Study||19
11365641|NCT03219866|12562328|FG000|COMPLETED|Overall Study||21
11365642|NCT03219866|12562329|FG001|COMPLETED|Overall Study||19
11365643|NCT03219866|12562328|FG000|NOT COMPLETED|Overall Study||0
11365644|NCT03219866|12562329|FG001|NOT COMPLETED|Overall Study||0
11365645|NCT03219892|12562337|FG000|STARTED|Overall Study||20
11365646|NCT03219892|12562338|FG001|STARTED|Overall Study||10
11365647|NCT03219892|12562337|FG000|COMPLETED|Overall Study||20
11365648|NCT03219892|12562338|FG001|COMPLETED|Overall Study||10
11365649|NCT03219892|12562337|FG000|NOT COMPLETED|Overall Study||0
11365650|NCT03219892|12562338|FG001|NOT COMPLETED|Overall Study||0
11365651|NCT03220048|12562347|FG000|STARTED|Overall Study||11
11365652|NCT03220048|12562348|FG001|STARTED|Overall Study||27
11365653|NCT03220048|12562349|FG002|STARTED|Overall Study||28
11365654|NCT03220048|12562347|FG000|COMPLETED|Overall Study||11
11365655|NCT03220048|12562348|FG001|COMPLETED|Overall Study||25
11365656|NCT03220048|12562349|FG002|COMPLETED|Overall Study||27
11365657|NCT03220048|12562347|FG000|NOT COMPLETED|Overall Study||0
11365658|NCT03220048|12562348|FG001|NOT COMPLETED|Overall Study||2
11365659|NCT03220048|12562349|FG002|NOT COMPLETED|Overall Study||1
11365660|NCT03220204|12562365|FG000|STARTED|Overall Study||15
11365661|NCT03220204|12562366|FG001|STARTED|Overall Study||15
11365662|NCT03220204|12562367|FG002|STARTED|Overall Study||15
11365663|NCT03220204|12562365|FG000|COMPLETED|Overall Study||14
11365664|NCT03220204|12562366|FG001|COMPLETED|Overall Study||13
11365665|NCT03220204|12562367|FG002|COMPLETED|Overall Study||12
11365666|NCT03220204|12562365|FG000|NOT COMPLETED|Overall Study||1
11365667|NCT03220204|12562366|FG001|NOT COMPLETED|Overall Study||2
11365668|NCT03220204|12562367|FG002|NOT COMPLETED|Overall Study||3
11365669|NCT03220217|12562381|FG000|STARTED|Overall Study||8
11365670|NCT03220217|12562382|FG001|STARTED|Overall Study||10
11005649|NCT00723645|12183342|FG000|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
11005650|NCT00723645|12183342|FG000|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
11365671|NCT03220217|12562383|FG002|STARTED|Overall Study||11
11365672|NCT03220217|12562381|FG000|COMPLETED|Overall Study||8
11365673|NCT03220217|12562382|FG001|COMPLETED|Overall Study||9
11365674|NCT03220217|12562383|FG002|COMPLETED|Overall Study||10
11365675|NCT03220217|12562381|FG000|NOT COMPLETED|Overall Study||0
11365676|NCT03220217|12562382|FG001|NOT COMPLETED|Overall Study||1
11365677|NCT03220217|12562383|FG002|NOT COMPLETED|Overall Study||1
11365678|NCT03220230|12562412|FG000|STARTED|Overall Study||4240
11365679|NCT03220230|12562412|FG000|COMPLETED|Overall Study||4240
11365680|NCT03220230|12562412|FG000|NOT COMPLETED|Overall Study||0
11365681|NCT03220412|12562418|FG000|STARTED|Overall Study||54
11365682|NCT03220412|12562419|FG001|STARTED|Overall Study||50
11365683|NCT03220412|12562418|FG000|COMPLETED|Overall Study||54
11365684|NCT03220412|12562419|FG001|COMPLETED|Overall Study||50
11365685|NCT03220412|12562418|FG000|NOT COMPLETED|Overall Study||0
11365686|NCT03220412|12562419|FG001|NOT COMPLETED|Overall Study||0
11365687|NCT03220737|12562434|FG000|STARTED|Main Study (Day 1 - 181)||163
11365688|NCT03220737|12562435|FG001|STARTED|Main Study (Day 1 - 181)||26
11365689|NCT03220737|12562436|FG002|STARTED|Main Study (Day 1 - 181)||158
11365690|NCT03220737|12562437|FG003|STARTED|Main Study (Day 1 - 181)||27
11365691|NCT03220737|12562438|FG004|STARTED|Main Study (Day 1 - 181)||150
11365692|NCT03220737|12562439|FG005|STARTED|Main Study (Day 1 - 181)||26
11365693|NCT03220737|12562440|FG006|STARTED|Main Study (Day 1 - 181)||2688
11365694|NCT03220737|12562434|FG000|COMPLETED|Main Study (Day 1 - 181)||157
11365695|NCT03220737|12562435|FG001|COMPLETED|Main Study (Day 1 - 181)||24
11365696|NCT03220737|12562436|FG002|COMPLETED|Main Study (Day 1 - 181)||146
11365697|NCT03220737|12562437|FG003|COMPLETED|Main Study (Day 1 - 181)||24
11365698|NCT03220737|12562438|FG004|COMPLETED|Main Study (Day 1 - 181)||130
11365699|NCT03220737|12562439|FG005|COMPLETED|Main Study (Day 1 - 181)||25
11365700|NCT03220737|12562440|FG006|COMPLETED|Main Study (Day 1 - 181)||2687
11365701|NCT03220737|12562434|FG000|NOT COMPLETED|Main Study (Day 1 - 181)||6
11365702|NCT03220737|12562435|FG001|NOT COMPLETED|Main Study (Day 1 - 181)||2
11365703|NCT03220737|12562436|FG002|NOT COMPLETED|Main Study (Day 1 - 181)||12
11365704|NCT03220737|12562437|FG003|NOT COMPLETED|Main Study (Day 1 - 181)||3
11365705|NCT03220737|12562438|FG004|NOT COMPLETED|Main Study (Day 1 - 181)||20
11365706|NCT03220737|12562439|FG005|NOT COMPLETED|Main Study (Day 1 - 181)||1
11365707|NCT03220737|12562440|FG006|NOT COMPLETED|Main Study (Day 1 - 181)||1
11365708|NCT03220737|12562434|FG000|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|13
11365709|NCT03220737|12562435|FG001|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora.|0
11365710|NCT03220737|12562436|FG002|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|11
11365711|NCT03220737|12562437|FG003|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
11365712|NCT03220737|12562438|FG004|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|7
11365713|NCT03220737|12562439|FG005|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
11365714|NCT03220737|12562440|FG006|STARTED|Placebo Crossover (Day 181-365)||0
11365715|NCT03220737|12562434|FG000|COMPLETED|Placebo Crossover (Day 181-365)||13
11365716|NCT03220737|12562435|FG001|COMPLETED|Placebo Crossover (Day 181-365)||0
11365717|NCT03220737|12562436|FG002|COMPLETED|Placebo Crossover (Day 181-365)||11
11365718|NCT03220737|12562437|FG003|COMPLETED|Placebo Crossover (Day 181-365)||0
11365719|NCT03220737|12562438|FG004|COMPLETED|Placebo Crossover (Day 181-365)||5
11365720|NCT03220737|12562439|FG005|COMPLETED|Placebo Crossover (Day 181-365)||0
11365721|NCT03220737|12562440|FG006|COMPLETED|Placebo Crossover (Day 181-365)||0
11365722|NCT03220737|12562434|FG000|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
11365723|NCT03220737|12562435|FG001|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
11365724|NCT03220737|12562436|FG002|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
11365725|NCT03220737|12562437|FG003|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
11365726|NCT03220737|12562438|FG004|NOT COMPLETED|Placebo Crossover (Day 181-365)||2
11365727|NCT03220737|12562439|FG005|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
11365728|NCT03220737|12562440|FG006|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
11365729|NCT03220737|12562434|FG000|STARTED|Long-term Follow-up (Day 365-730)|Cohort 1 subjects from the main study had to opt to be included in the Long-term follow-up study.|73
11365730|NCT03220737|12562435|FG001|STARTED|Long-term Follow-up (Day 365-730)||0
11365731|NCT03220737|12562436|FG002|STARTED|Long-term Follow-up (Day 365-730)|Cohort 2 subjects were not eligible for the Long-term follow-up study.|0
11365732|NCT03220737|12562437|FG003|STARTED|Long-term Follow-up (Day 365-730)||0
11365733|NCT03220737|12562438|FG004|STARTED|Long-term Follow-up (Day 365-730)|Cohort 3 subjects were not eligible for the Long-term follow-up study.|0
11365734|NCT03220737|12562439|FG005|STARTED|Long-term Follow-up (Day 365-730)||0
11365735|NCT03220737|12562440|FG006|STARTED|Long-term Follow-up (Day 365-730)||0
11365736|NCT03220737|12562434|FG000|COMPLETED|Long-term Follow-up (Day 365-730)||62
11365737|NCT03220737|12562435|FG001|COMPLETED|Long-term Follow-up (Day 365-730)||0
11365738|NCT03220737|12562436|FG002|COMPLETED|Long-term Follow-up (Day 365-730)||0
11365739|NCT03220737|12562437|FG003|COMPLETED|Long-term Follow-up (Day 365-730)||0
11365740|NCT03220737|12562438|FG004|COMPLETED|Long-term Follow-up (Day 365-730)||0
11365741|NCT03220737|12562439|FG005|COMPLETED|Long-term Follow-up (Day 365-730)||0
11365742|NCT03220737|12562440|FG006|COMPLETED|Long-term Follow-up (Day 365-730)||0
11365743|NCT03220737|12562434|FG000|NOT COMPLETED|Long-term Follow-up (Day 365-730)||11
11365744|NCT03220737|12562435|FG001|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
11365745|NCT03220737|12562436|FG002|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
11365746|NCT03220737|12562437|FG003|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
11365747|NCT03220737|12562438|FG004|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
11365748|NCT03220737|12562439|FG005|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
11365749|NCT03220737|12562440|FG006|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
11365750|NCT03220958|12562464|FG000|STARTED|Overall Study||81
11365751|NCT03220958|12562465|FG001|STARTED|Overall Study||79
11365752|NCT03220958|12562464|FG000|COMPLETED|Overall Study||81
11365753|NCT03220958|12562465|FG001|COMPLETED|Overall Study||79
11365754|NCT03220958|12562464|FG000|NOT COMPLETED|Overall Study||0
11365755|NCT03220958|12562465|FG001|NOT COMPLETED|Overall Study||0
11365756|NCT03221192|12562471|FG000|STARTED|Overall Study||27
11365757|NCT03221192|12562471|FG000|COMPLETED|Overall Study||27
11365758|NCT03221192|12562471|FG000|NOT COMPLETED|Overall Study||0
11365759|NCT03221387|12562475|FG000|STARTED|Overall Study||30
11365760|NCT03221387|12562475|FG000|COMPLETED|Overall Study||28
11365761|NCT03221387|12562475|FG000|NOT COMPLETED|Overall Study||2
11365762|NCT03221595|12562481|FG000|STARTED|Overall Study||51
11365763|NCT03221595|12562482|FG001|STARTED|Overall Study||59
11365764|NCT03221595|12562481|FG000|COMPLETED|Overall Study||51
11365765|NCT03221595|12562482|FG001|COMPLETED|Overall Study||59
11365766|NCT03221595|12562481|FG000|NOT COMPLETED|Overall Study||0
11365767|NCT03221595|12562482|FG001|NOT COMPLETED|Overall Study||0
11365768|NCT03221738|12562488|FG000|STARTED|Overall Study||10
11365769|NCT03221738|12562488|FG000|COMPLETED|Overall Study||10
11365770|NCT03221738|12562488|FG000|NOT COMPLETED|Overall Study||0
11365771|NCT03221764|12562492|FG000|STARTED|Overall Study||20
11365772|NCT03221764|12562492|FG000|COMPLETED|Overall Study||20
11365773|NCT03221764|12562492|FG000|NOT COMPLETED|Overall Study||0
11365774|NCT03222037|12562496|FG000|STARTED|Period 1||21
11365775|NCT03222037|12562497|FG001|STARTED|Period 1||22
11365776|NCT03222037|12562496|FG000|COMPLETED|Period 1||21
11365777|NCT03222037|12562497|FG001|COMPLETED|Period 1||22
11365778|NCT03222037|12562496|FG000|NOT COMPLETED|Period 1||0
11365779|NCT03222037|12562497|FG001|NOT COMPLETED|Period 1||0
11365780|NCT03222037|12562496|FG000|STARTED|Period 2||21
11365781|NCT03222037|12562497|FG001|STARTED|Period 2||22
11365782|NCT03222037|12562496|FG000|COMPLETED|Period 2||21
11365783|NCT03222037|12562497|FG001|COMPLETED|Period 2||22
11365784|NCT03222037|12562496|FG000|NOT COMPLETED|Period 2||0
11365785|NCT03222037|12562497|FG001|NOT COMPLETED|Period 2||0
11365786|NCT03222141|12562503|FG000|STARTED|Overall Study||583
11365787|NCT03222141|12562503|FG000|COMPLETED|Overall Study||565
11365788|NCT03222141|12562503|FG000|NOT COMPLETED|Overall Study||18
11365789|NCT03222349|12562508|FG000|STARTED|Overall Study||11
11365790|NCT03222349|12562509|FG001|STARTED|Overall Study||13
11365791|NCT03222349|12562508|FG000|COMPLETED|Overall Study||3
11365792|NCT03222349|12562509|FG001|COMPLETED|Overall Study||6
11365793|NCT03222349|12562508|FG000|NOT COMPLETED|Overall Study||8
11365794|NCT03222349|12562509|FG001|NOT COMPLETED|Overall Study||7
11365795|NCT03222414|12562524|FG000|STARTED|Overall Study||0
11365796|NCT03222414|12562525|FG001|STARTED|Overall Study||1
11142049|NCT01466127|12328732|FG000|STARTED|Overall Study||30
11365797|NCT03222414|12562524|FG000|COMPLETED|Overall Study||0
11365798|NCT03222414|12562525|FG001|COMPLETED|Overall Study||1
11365799|NCT03222414|12562524|FG000|NOT COMPLETED|Overall Study||0
11365800|NCT03222414|12562525|FG001|NOT COMPLETED|Overall Study||0
11365801|NCT03222427|12562531|FG000|STARTED|Overall Study||8
11365802|NCT03222427|12562531|FG000|Received One Dose of Study Drug|Overall Study||8
11365803|NCT03222427|12562531|FG000|COMPLETED|Overall Study||8
11365804|NCT03222427|12562531|FG000|NOT COMPLETED|Overall Study||0
11365805|NCT03222505|12562538|FG000|STARTED|Overall Study||5
11365806|NCT03222505|12562539|FG001|STARTED|Overall Study||7
11365807|NCT03222505|12562538|FG000|COMPLETED|Overall Study||5
11365808|NCT03222505|12562539|FG001|COMPLETED|Overall Study||7
11365809|NCT03222505|12562538|FG000|NOT COMPLETED|Overall Study||0
11365810|NCT03222505|12562539|FG001|NOT COMPLETED|Overall Study||0
11365811|NCT03222583|12562548|FG000|STARTED|Overall Study||363
11365812|NCT03222583|12562549|FG001|STARTED|Overall Study||183
11365813|NCT03222583|12562548|FG000|Received Double-blind Treatment|Overall Study||362
11365814|NCT03222583|12562549|FG001|Received Double-blind Treatment|Overall Study||183
11365815|NCT03222583|12562548|FG000|Completed Double-blind Period|Overall Study||360
11365816|NCT03222583|12562549|FG001|Completed Double-blind Period|Overall Study||183
11365817|NCT03222583|12562548|FG000|Entered Open-label Period|Overall Study||0
11365818|NCT03222583|12562549|FG001|Entered Open-label Period|Overall Study||182
11365819|NCT03222583|12562548|FG000|Completed Open-label Period|Overall Study||0
11365820|NCT03222583|12562549|FG001|Completed Open-label Period|Overall Study||181
11365821|NCT03222583|12562548|FG000|COMPLETED|Overall Study||358
11365822|NCT03222583|12562549|FG001|COMPLETED|Overall Study||177
11365823|NCT03222583|12562548|FG000|NOT COMPLETED|Overall Study||5
11365824|NCT03222583|12562549|FG001|NOT COMPLETED|Overall Study||6
11365825|NCT03223246|12562557|FG000|STARTED|48-72 Hours||83
11365826|NCT03223246|12562558|FG001|STARTED|48-72 Hours||66
11365827|NCT03223246|12562557|FG000|COMPLETED|48-72 Hours||62
11365828|NCT03223246|12562558|FG001|COMPLETED|48-72 Hours||35
11365829|NCT03223246|12562557|FG000|NOT COMPLETED|48-72 Hours||21
11365830|NCT03223246|12562558|FG001|NOT COMPLETED|48-72 Hours||31
11365831|NCT03223246|12562557|FG000|STARTED|5-7 Days||83
11365832|NCT03223246|12562558|FG001|STARTED|5-7 Days||66
11365833|NCT03223246|12562557|FG000|COMPLETED|5-7 Days||41
11365834|NCT03223246|12562558|FG001|COMPLETED|5-7 Days||35
11365835|NCT03223246|12562557|FG000|NOT COMPLETED|5-7 Days||42
11365836|NCT03223246|12562558|FG001|NOT COMPLETED|5-7 Days||31
11365837|NCT03223272|12562564|FG000|STARTED|Overall Study||7
11365838|NCT03223272|12562564|FG000|COMPLETED|Overall Study||6
11365839|NCT03223272|12562564|FG000|NOT COMPLETED|Overall Study||1
11365840|NCT03223337|12562572|FG000|STARTED|Part 1 (Up to 16 Days)||8
11365841|NCT03223337|12562573|FG001|STARTED|Part 1 (Up to 16 Days)||8
11365842|NCT03223337|12562574|FG002|STARTED|Part 1 (Up to 16 Days)||0
11365843|NCT03223337|12562575|FG003|STARTED|Part 1 (Up to 16 Days)||0
11365844|NCT03223337|12562572|FG000|COMPLETED|Part 1 (Up to 16 Days)||8
11365845|NCT03223337|12562573|FG001|COMPLETED|Part 1 (Up to 16 Days)||8
11365846|NCT03223337|12562574|FG002|COMPLETED|Part 1 (Up to 16 Days)||0
11365847|NCT03223337|12562575|FG003|COMPLETED|Part 1 (Up to 16 Days)||0
11365848|NCT03223337|12562572|FG000|NOT COMPLETED|Part 1 (Up to 16 Days)||0
11365849|NCT03223337|12562573|FG001|NOT COMPLETED|Part 1 (Up to 16 Days)||0
11365850|NCT03223337|12562574|FG002|NOT COMPLETED|Part 1 (Up to 16 Days)||0
11365851|NCT03223337|12562575|FG003|NOT COMPLETED|Part 1 (Up to 16 Days)||0
11365852|NCT03223337|12562572|FG000|STARTED|Part 2 (Up to 16 Days)||0
11365853|NCT03223337|12562573|FG001|STARTED|Part 2 (Up to 16 Days)||0
11365854|NCT03223337|12562574|FG002|STARTED|Part 2 (Up to 16 Days)||12
11365855|NCT03223337|12562575|FG003|STARTED|Part 2 (Up to 16 Days)||9
11365856|NCT03223337|12562572|FG000|COMPLETED|Part 2 (Up to 16 Days)||0
11365857|NCT03223337|12562573|FG001|COMPLETED|Part 2 (Up to 16 Days)||0
11365858|NCT03223337|12562574|FG002|COMPLETED|Part 2 (Up to 16 Days)||12
11365859|NCT03223337|12562575|FG003|COMPLETED|Part 2 (Up to 16 Days)||9
11365860|NCT03223337|12562572|FG000|NOT COMPLETED|Part 2 (Up to 16 Days)||0
11365861|NCT03223337|12562573|FG001|NOT COMPLETED|Part 2 (Up to 16 Days)||0
11365862|NCT03223337|12562574|FG002|NOT COMPLETED|Part 2 (Up to 16 Days)||0
11365863|NCT03223337|12562575|FG003|NOT COMPLETED|Part 2 (Up to 16 Days)||0
11365864|NCT03223649|12562587|FG000|STARTED|Overall Study||52
11365865|NCT03223649|12562588|FG001|STARTED|Overall Study||57
11365866|NCT03223649|12562587|FG000|COMPLETED|Overall Study||42
11365867|NCT03223649|12562588|FG001|COMPLETED|Overall Study||51
11365868|NCT03223649|12562587|FG000|NOT COMPLETED|Overall Study||10
11365869|NCT03223649|12562588|FG001|NOT COMPLETED|Overall Study||6
11365870|NCT03223909|12562597|FG000|STARTED|Overall Study||120
11365871|NCT03223909|12562598|FG001|STARTED|Overall Study||109
11365872|NCT03223909|12562599|FG002|STARTED|Overall Study||97
11365873|NCT03223909|12562597|FG000|COMPLETED|Overall Study||72
11365874|NCT03223909|12562598|FG001|COMPLETED|Overall Study||64
11365875|NCT03223909|12562599|FG002|COMPLETED|Overall Study||81
11365876|NCT03223909|12562597|FG000|NOT COMPLETED|Overall Study||48
11365877|NCT03223909|12562598|FG001|NOT COMPLETED|Overall Study||45
11365878|NCT03223909|12562599|FG002|NOT COMPLETED|Overall Study||16
11365879|NCT03224130|12562609|FG000|STARTED|Overall Study||483
11365880|NCT03224130|12562610|FG001|STARTED|Overall Study||483
11365881|NCT03224130|12562609|FG000|COMPLETED|Overall Study||483
11365882|NCT03224130|12562610|FG001|COMPLETED|Overall Study||482
11365883|NCT03224130|12562609|FG000|NOT COMPLETED|Overall Study||0
11365884|NCT03224130|12562610|FG001|NOT COMPLETED|Overall Study||1
11365885|NCT03224182|12562618|FG000|STARTED|Overall Study||81
11365886|NCT03224182|12562619|FG001|STARTED|Overall Study||37
11365887|NCT03224182|12562618|FG000|Safety Population|Overall Study||73
11365888|NCT03224182|12562619|FG001|Safety Population|Overall Study||36
11365889|NCT03224182|12562618|FG000|COMPLETED|Overall Study||0
11365890|NCT03224182|12562619|FG001|COMPLETED|Overall Study||1
11365891|NCT03224182|12562618|FG000|NOT COMPLETED|Overall Study||81
11365892|NCT03224182|12562619|FG001|NOT COMPLETED|Overall Study||36
11365893|NCT03224234|12562629|FG000|STARTED|Main Study||40
11365894|NCT03224234|12562630|FG001|STARTED|Main Study||40
11365895|NCT03224234|12562629|FG000|COMPLETED|Main Study||35
11365896|NCT03224234|12562630|FG001|COMPLETED|Main Study||35
11365897|NCT03224234|12562629|FG000|NOT COMPLETED|Main Study||5
11365898|NCT03224234|12562630|FG001|NOT COMPLETED|Main Study||5
11365899|NCT03224234|12562629|FG000|STARTED|Pilot||11
11365900|NCT03224234|12562630|FG001|STARTED|Pilot||7
11365901|NCT03224234|12562629|FG000|COMPLETED|Pilot||11
11365902|NCT03224234|12562630|FG001|COMPLETED|Pilot||7
11365903|NCT03224234|12562629|FG000|NOT COMPLETED|Pilot||0
11365904|NCT03224234|12562630|FG001|NOT COMPLETED|Pilot||0
11365905|NCT03224299|12562642|FG000|STARTED|Overall Study||131
11365906|NCT03224299|12562643|FG001|STARTED|Overall Study||424
11365907|NCT03224299|12562642|FG000|Treated With IP#1|Overall Study||65
11365908|NCT03224299|12562643|FG001|Treated With IP#1|Overall Study||101
11365909|NCT03224299|12562642|FG000|Treated With IP#2|Overall Study||66
11365910|NCT03224299|12562643|FG001|Treated With IP#2|Overall Study||107
11365911|NCT03224299|12562642|FG000|Treated With AC|Overall Study||66
11365912|NCT03224299|12562643|FG001|Treated With AC|Overall Study||110
11365913|NCT03224299|12562642|FG000|Treated With NC|Overall Study||65
11365914|NCT03224299|12562643|FG001|Treated With NC|Overall Study||106
11365915|NCT03224299|12562642|FG000|COMPLETED|Overall Study||131
11365916|NCT03224299|12562643|FG001|COMPLETED|Overall Study||424
11365917|NCT03224299|12562642|FG000|NOT COMPLETED|Overall Study||0
11365918|NCT03224299|12562643|FG001|NOT COMPLETED|Overall Study||0
11365919|NCT03224325|12562664|FG000|STARTED|Overall Study||13
11365920|NCT03224325|12562665|FG001|STARTED|Overall Study||6
11365921|NCT03224325|12562666|FG002|STARTED|Overall Study||6
11365922|NCT03224325|12562667|FG003|STARTED|Overall Study||6
11365923|NCT03224325|12562668|FG004|STARTED|Overall Study||6
11365924|NCT03224325|12562669|FG005|STARTED|Overall Study||6
11365925|NCT03224325|12562670|FG006|STARTED|Overall Study||7
11365926|NCT03224325|12562664|FG000|COMPLETED|Overall Study||12
11365927|NCT03224325|12562665|FG001|COMPLETED|Overall Study||6
11365928|NCT03224325|12562666|FG002|COMPLETED|Overall Study||6
11365929|NCT03224325|12562667|FG003|COMPLETED|Overall Study||5
11365930|NCT03224325|12562668|FG004|COMPLETED|Overall Study||6
11365931|NCT03224325|12562669|FG005|COMPLETED|Overall Study||6
11365932|NCT03224325|12562670|FG006|COMPLETED|Overall Study||6
11365933|NCT03224325|12562664|FG000|NOT COMPLETED|Overall Study||1
11365934|NCT03224325|12562665|FG001|NOT COMPLETED|Overall Study||0
11365935|NCT03224325|12562666|FG002|NOT COMPLETED|Overall Study||0
11365936|NCT03224325|12562667|FG003|NOT COMPLETED|Overall Study||1
11365937|NCT03224325|12562668|FG004|NOT COMPLETED|Overall Study||0
11365938|NCT03224325|12562669|FG005|NOT COMPLETED|Overall Study||0
11365939|NCT03224325|12562670|FG006|NOT COMPLETED|Overall Study||1
11365940|NCT03224351|12562700|FG000|STARTED|Overall Study||10
11365941|NCT03224351|12562701|FG001|STARTED|Overall Study||11
11365942|NCT03224351|12562702|FG002|STARTED|Overall Study||20
11365943|NCT03224351|12562703|FG003|STARTED|Overall Study||22
11365944|NCT03224351|12562704|FG004|STARTED|Overall Study||11
11365945|NCT03224351|12562705|FG005|STARTED|Overall Study||18
11365946|NCT03224351|12562706|FG006|STARTED|Overall Study||6
11365947|NCT03224351|12562707|FG007|STARTED|Overall Study||19
11365948|NCT03224351|12562700|FG000|COMPLETED|Overall Study||10
11365949|NCT03224351|12562701|FG001|COMPLETED|Overall Study||11
11365950|NCT03224351|12562702|FG002|COMPLETED|Overall Study||20
11365951|NCT03224351|12562703|FG003|COMPLETED|Overall Study||22
11365952|NCT03224351|12562704|FG004|COMPLETED|Overall Study||11
11365953|NCT03224351|12562705|FG005|COMPLETED|Overall Study||18
11365954|NCT03224351|12562706|FG006|COMPLETED|Overall Study||6
11365955|NCT03224351|12562707|FG007|COMPLETED|Overall Study||19
11365956|NCT03224351|12562700|FG000|NOT COMPLETED|Overall Study||0
11365957|NCT03224351|12562701|FG001|NOT COMPLETED|Overall Study||0
11142050|NCT01466127|12328733|FG001|STARTED|Overall Study||30
11142051|NCT01466127|12328732|FG000|COMPLETED|Overall Study||16
11142052|NCT01466127|12328733|FG001|COMPLETED|Overall Study||14
11142053|NCT01466127|12328732|FG000|NOT COMPLETED|Overall Study||14
11142054|NCT01466127|12328733|FG001|NOT COMPLETED|Overall Study||16
11142055|NCT01466153|12328742|FG000|STARTED|Overall Study||62
11142056|NCT01466153|12328743|FG001|STARTED|Overall Study||36
11365958|NCT03224351|12562702|FG002|NOT COMPLETED|Overall Study||0
11365959|NCT03224351|12562703|FG003|NOT COMPLETED|Overall Study||0
11365960|NCT03224351|12562704|FG004|NOT COMPLETED|Overall Study||0
11365961|NCT03224351|12562705|FG005|NOT COMPLETED|Overall Study||0
11365962|NCT03224351|12562706|FG006|NOT COMPLETED|Overall Study||0
11365963|NCT03224351|12562707|FG007|NOT COMPLETED|Overall Study||0
11365964|NCT03224390|12562735|FG000|STARTED|Overall Study||56
11365965|NCT03224390|12562736|FG001|STARTED|Overall Study||56
11365966|NCT03224390|12562735|FG000|COMPLETED|Overall Study||29
11365967|NCT03224390|12562736|FG001|COMPLETED|Overall Study||21
11365968|NCT03224390|12562735|FG000|NOT COMPLETED|Overall Study||27
11365969|NCT03224390|12562736|FG001|NOT COMPLETED|Overall Study||35
11365970|NCT03224403|12562748|FG000|STARTED|Overall Study||59
11365971|NCT03224403|12562749|FG001|STARTED|Overall Study||249
11365972|NCT03224403|12562750|FG002|STARTED|Overall Study||232
11365973|NCT03224403|12562751|FG003|STARTED|Overall Study||124
11365974|NCT03224403|12562748|FG000|COMPLETED|Overall Study||59
11365975|NCT03224403|12562749|FG001|COMPLETED|Overall Study||249
11365976|NCT03224403|12562750|FG002|COMPLETED|Overall Study||232
11365977|NCT03224403|12562751|FG003|COMPLETED|Overall Study||124
11365978|NCT03224403|12562748|FG000|NOT COMPLETED|Overall Study||0
11365979|NCT03224403|12562749|FG001|NOT COMPLETED|Overall Study||0
11365980|NCT03224403|12562750|FG002|NOT COMPLETED|Overall Study||0
11365981|NCT03224403|12562751|FG003|NOT COMPLETED|Overall Study||0
11365982|NCT03224520|12562765|FG000|STARTED|Overall Study||371
11365983|NCT03224520|12562766|FG001|STARTED|Overall Study||370
11365984|NCT03224520|12562767|FG002|STARTED|Overall Study||374
11365985|NCT03224520|12562768|FG003|STARTED|Overall Study||372
11142057|NCT01466153|12328744|FG002|STARTED|Overall Study||61
11142058|NCT01466153|12328742|FG000|COMPLETED|Overall Study||33
11142059|NCT01466153|12328743|FG001|COMPLETED|Overall Study||12
11142060|NCT01466153|12328744|FG002|COMPLETED|Overall Study||36
11365986|NCT03224520|12562765|FG000|COMPLETED|Overall Study||205
11005651|NCT00723645|12183342|FG000|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
11005652|NCT00723645|12183342|FG000|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
11005653|NCT00723645|12183342|FG000|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
11005654|NCT00723645|12183342|FG000|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
11005655|NCT00723645|12183342|FG000|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
11005656|NCT00723697|12183346|FG000|STARTED|Overall Study||1307
11005657|NCT00723697|12183346|FG000|COMPLETED|Overall Study||1289
11005658|NCT00723697|12183346|FG000|NOT COMPLETED|Overall Study||18
11005659|NCT00723710|12183353|FG000|STARTED|Overall Study||294
11365987|NCT03224520|12562766|FG001|COMPLETED|Overall Study||207
11365988|NCT03224520|12562767|FG002|COMPLETED|Overall Study||190
11365989|NCT03224520|12562768|FG003|COMPLETED|Overall Study||199
11365990|NCT03224520|12562765|FG000|NOT COMPLETED|Overall Study||166
11365991|NCT03224520|12562766|FG001|NOT COMPLETED|Overall Study||163
11365992|NCT03224520|12562767|FG002|NOT COMPLETED|Overall Study||184
11365993|NCT03224520|12562768|FG003|NOT COMPLETED|Overall Study||173
11365994|NCT03224585|12562780|FG000|STARTED|Overall Study||2
11365995|NCT03224585|12562781|FG001|STARTED|Overall Study||3
11365996|NCT03224585|12562780|FG000|COMPLETED|Overall Study||2
11005660|NCT00723710|12183353|FG000|COMPLETED|Overall Study||120
11005661|NCT00723710|12183353|FG000|NOT COMPLETED|Overall Study||174
11005662|NCT00723749|12183357|FG000|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
11005663|NCT00723749|12183357|FG000|COMPLETED|Overall Study||182
11005664|NCT00723749|12183357|FG000|NOT COMPLETED|Overall Study||163
11365997|NCT03224585|12562781|FG001|COMPLETED|Overall Study||3
11365998|NCT03224585|12562780|FG000|NOT COMPLETED|Overall Study||0
11365999|NCT03224585|12562781|FG001|NOT COMPLETED|Overall Study||0
11366000|NCT03224598|12562789|FG000|STARTED|Overall Study||9
11366001|NCT03224598|12562790|FG001|STARTED|Overall Study||17
11366002|NCT03224598|12562791|FG002|STARTED|Overall Study||13
11366003|NCT03224598|12562789|FG000|COMPLETED|Overall Study||9
11366004|NCT03224598|12562790|FG001|COMPLETED|Overall Study||14
11366005|NCT03224598|12562791|FG002|COMPLETED|Overall Study||13
11366006|NCT03224598|12562789|FG000|NOT COMPLETED|Overall Study||0
11366007|NCT03224598|12562790|FG001|NOT COMPLETED|Overall Study||3
11366008|NCT03224598|12562791|FG002|NOT COMPLETED|Overall Study||0
11366009|NCT03225001|12562799|FG000|STARTED|Overall Study||197
11366010|NCT03225001|12562799|FG000|Valve-Implanted|Overall Study||195
11366011|NCT03225001|12562799|FG000|COMPLETED|Overall Study||188
11366012|NCT03225001|12562799|FG000|NOT COMPLETED|Overall Study||9
11366013|NCT03225313|12562806|FG000|STARTED|Overall Study|25 Patients|25
11366014|NCT03225313|12562807|FG001|STARTED|Overall Study|25 Patients|25
11366015|NCT03225313|12562808|FG002|STARTED|Overall Study|25 Patients|25
11366016|NCT03225313|12562806|FG000|COMPLETED|Overall Study|25 Patients|25
11366017|NCT03225313|12562807|FG001|COMPLETED|Overall Study|25 Patients|25
11366018|NCT03225313|12562808|FG002|COMPLETED|Overall Study|25 Patients|25
11366019|NCT03225313|12562806|FG000|NOT COMPLETED|Overall Study||0
11366020|NCT03225313|12562807|FG001|NOT COMPLETED|Overall Study||0
11366021|NCT03225313|12562808|FG002|NOT COMPLETED|Overall Study||0
11366022|NCT03225573|12562818|FG000|STARTED|Overall Study||60
11366023|NCT03225573|12562818|FG000|COMPLETED|Overall Study||60
11366024|NCT03225573|12562818|FG000|NOT COMPLETED|Overall Study||0
11366025|NCT03225599|12562822|FG000|STARTED|Overall Study||9
11366026|NCT03225599|12562822|FG000|COMPLETED|Overall Study||7
11366027|NCT03225599|12562822|FG000|NOT COMPLETED|Overall Study||2
11366028|NCT03225859|12562826|FG000|STARTED|Overall Study||12
11366029|NCT03225859|12562826|FG000|COMPLETED|Overall Study||11
11366030|NCT03225859|12562826|FG000|NOT COMPLETED|Overall Study||1
11005665|NCT00723788|12183361|FG000|STARTED|Overall Study||21
11005666|NCT00723788|12183361|FG000|COMPLETED|Overall Study||21
11005667|NCT00723788|12183361|FG000|NOT COMPLETED|Overall Study||0
11366031|NCT03226223|12562832|FG000|STARTED|Overall Study||10
11366032|NCT03226223|12562833|FG001|STARTED|Overall Study||8
11366033|NCT03226223|12562832|FG000|COMPLETED|Overall Study||8
11366034|NCT03226223|12562833|FG001|COMPLETED|Overall Study||6
11366035|NCT03226223|12562832|FG000|NOT COMPLETED|Overall Study||2
11366036|NCT03226223|12562833|FG001|NOT COMPLETED|Overall Study||2
11366037|NCT03226249|12562839|FG000|STARTED|PEM Induction Cycles 1-3, and PET#2||30
11366038|NCT03226249|12562839|FG000|PEM Cycle 1|PEM Induction Cycles 1-3, and PET#2||30
11366039|NCT03226249|12562839|FG000|PEM Cycle 2|PEM Induction Cycles 1-3, and PET#2||30
11366040|NCT03226249|12562839|FG000|PEM Cycle 3|PEM Induction Cycles 1-3, and PET#2||30
11366041|NCT03226249|12562839|FG000|PET#2|PEM Induction Cycles 1-3, and PET#2||30
11366042|NCT03226249|12562839|FG000|COMPLETED|PEM Induction Cycles 1-3, and PET#2||30
11366043|NCT03226249|12562839|FG000|NOT COMPLETED|PEM Induction Cycles 1-3, and PET#2||0
11366044|NCT03226249|12562839|FG000|STARTED|2 Cycles of AVD + PET#3||30
11366045|NCT03226249|12562839|FG000|AVD Cycle 1|2 Cycles of AVD + PET#3||30
11366046|NCT03226249|12562839|FG000|AVD Cycle 2|2 Cycles of AVD + PET#3||30
11366047|NCT03226249|12562839|FG000|PET#3|2 Cycles of AVD + PET#3||30
11366048|NCT03226249|12562839|FG000|COMPLETED|2 Cycles of AVD + PET#3||30
11366049|NCT03226249|12562839|FG000|NOT COMPLETED|2 Cycles of AVD + PET#3||0
11366050|NCT03226249|12562839|FG000|STARTED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||30
11366051|NCT03226249|12562839|FG000|2-4 Cycles of AVD +/- Chemo & RT|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
11366052|NCT03226249|12562839|FG000|PET#4|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
11366053|NCT03226249|12562839|FG000|COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
11366054|NCT03226249|12562839|FG000|NOT COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||1
11366055|NCT03226249|12562839|FG000|STARTED|PEM Consolidation (1-2 Years)||29
11366056|NCT03226249|12562839|FG000|COMPLETED|PEM Consolidation (1-2 Years)||0
11366057|NCT03226249|12562839|FG000|NOT COMPLETED|PEM Consolidation (1-2 Years)||29
11366058|NCT03226249|12562839|FG000|STARTED|Survival Follow-up|All patients that are treated with one dose of study drug go into follow-up.|30
11366059|NCT03226249|12562839|FG000|COMPLETED|Survival Follow-up||0
11366060|NCT03226249|12562839|FG000|NOT COMPLETED|Survival Follow-up||30
11366061|NCT03226275|12562847|FG000|STARTED|Treatment Period 1 (8 Days)||8
11366062|NCT03226275|12562848|FG001|STARTED|Treatment Period 1 (8 Days)||8
11366063|NCT03226275|12562849|FG002|STARTED|Treatment Period 1 (8 Days)||8
11366064|NCT03226275|12562850|FG003|STARTED|Treatment Period 1 (8 Days)||8
11366065|NCT03226275|12562847|FG000|COMPLETED|Treatment Period 1 (8 Days)||8
11366066|NCT03226275|12562848|FG001|COMPLETED|Treatment Period 1 (8 Days)||8
11366067|NCT03226275|12562849|FG002|COMPLETED|Treatment Period 1 (8 Days)||7
11366068|NCT03226275|12562850|FG003|COMPLETED|Treatment Period 1 (8 Days)||7
11366069|NCT03226275|12562847|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11366070|NCT03226275|12562848|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11366071|NCT03226275|12562849|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||1
11366072|NCT03226275|12562850|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||1
11366073|NCT03226275|12562847|FG000|STARTED|Treatment Period 2 (8 Days)||8
11366074|NCT03226275|12562848|FG001|STARTED|Treatment Period 2 (8 Days)||8
11366075|NCT03226275|12562849|FG002|STARTED|Treatment Period 2 (8 Days)||7
11366076|NCT03226275|12562850|FG003|STARTED|Treatment Period 2 (8 Days)||7
11366077|NCT03226275|12562847|FG000|COMPLETED|Treatment Period 2 (8 Days)||8
11366078|NCT03226275|12562848|FG001|COMPLETED|Treatment Period 2 (8 Days)||8
11366079|NCT03226275|12562849|FG002|COMPLETED|Treatment Period 2 (8 Days)||7
11366080|NCT03226275|12562850|FG003|COMPLETED|Treatment Period 2 (8 Days)||7
11366081|NCT03226275|12562847|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11366082|NCT03226275|12562848|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11366083|NCT03226275|12562849|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11366084|NCT03226275|12562850|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11366085|NCT03226353|12562860|FG000|STARTED|Overall Study||77
11366086|NCT03226353|12562860|FG000|Habitual Wearers of Proclear 1 Day|Overall Study||2
11366087|NCT03226353|12562860|FG000|Other Habitual Lens Types|Overall Study||75
11366088|NCT03226353|12562860|FG000|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71
11366089|NCT03226353|12562860|FG000|NOT COMPLETED|Overall Study||6
11366090|NCT03226366|12562871|FG000|STARTED|Overall Study||911
11366091|NCT03226366|12562872|FG001|STARTED|Overall Study||495
11005668|NCT00723801|12183369|FG000|STARTED|Overall Study||20
11005669|NCT00723801|12183370|FG001|STARTED|Overall Study||20
11005670|NCT00723801|12183369|FG000|COMPLETED|Overall Study||17
11366092|NCT03226366|12562873|FG002|STARTED|Overall Study||1183
11366093|NCT03226366|12562874|FG003|STARTED|Overall Study||641
11366094|NCT03226366|12562871|FG000|COMPLETED|Overall Study||911
11366095|NCT03226366|12562872|FG001|COMPLETED|Overall Study||495
11366096|NCT03226366|12562873|FG002|COMPLETED|Overall Study||1183
11366097|NCT03226366|12562874|FG003|COMPLETED|Overall Study||641
11366098|NCT03226366|12562871|FG000|NOT COMPLETED|Overall Study||0
11366099|NCT03226366|12562872|FG001|NOT COMPLETED|Overall Study||0
11366100|NCT03226366|12562873|FG002|NOT COMPLETED|Overall Study||0
11366101|NCT03226366|12562874|FG003|NOT COMPLETED|Overall Study||0
11366102|NCT03226392|12562886|FG000|STARTED|Overall Study||352
11366103|NCT03226392|12562887|FG001|STARTED|Overall Study||352
11366104|NCT03226392|12562886|FG000|FAS|Overall Study||352
11366105|NCT03226392|12562887|FG001|FAS|Overall Study|"2 patients in the placebo were mis-randomized, not treated, not included due to technical problems"|350
11366106|NCT03226392|12562886|FG000|COMPLETED|Overall Study||341
11366107|NCT03226392|12562887|FG001|COMPLETED|Overall Study||344
11366108|NCT03226392|12562886|FG000|NOT COMPLETED|Overall Study||11
11366109|NCT03226392|12562887|FG001|NOT COMPLETED|Overall Study||8
11366110|NCT03226457|12562893|FG000|STARTED|Treatment 1: 6 Weeks||12
11366111|NCT03226457|12562894|FG001|STARTED|Treatment 1: 6 Weeks||11
11366112|NCT03226457|12562893|FG000|COMPLETED|Treatment 1: 6 Weeks||12
11366113|NCT03226457|12562894|FG001|COMPLETED|Treatment 1: 6 Weeks||11
11366114|NCT03226457|12562893|FG000|NOT COMPLETED|Treatment 1: 6 Weeks||0
11366115|NCT03226457|12562894|FG001|NOT COMPLETED|Treatment 1: 6 Weeks||0
11366116|NCT03226457|12562893|FG000|STARTED|Washout Period: Minimum 2 Weeks||12
11366117|NCT03226457|12562894|FG001|STARTED|Washout Period: Minimum 2 Weeks||11
11366118|NCT03226457|12562893|FG000|COMPLETED|Washout Period: Minimum 2 Weeks||12
11366119|NCT03226457|12562894|FG001|COMPLETED|Washout Period: Minimum 2 Weeks||11
11366120|NCT03226457|12562893|FG000|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
11366121|NCT03226457|12562894|FG001|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
11366122|NCT03226457|12562893|FG000|STARTED|Treatment 2: 6 Weeks||12
11366123|NCT03226457|12562894|FG001|STARTED|Treatment 2: 6 Weeks||11
11366124|NCT03226457|12562893|FG000|COMPLETED|Treatment 2: 6 Weeks||12
11366125|NCT03226457|12562894|FG001|COMPLETED|Treatment 2: 6 Weeks||11
11366126|NCT03226457|12562893|FG000|NOT COMPLETED|Treatment 2: 6 Weeks||0
11366127|NCT03226457|12562894|FG001|NOT COMPLETED|Treatment 2: 6 Weeks||0
11366128|NCT03226652|12562900|FG000|STARTED|Overall Study||101
11366129|NCT03226652|12562900|FG000|COMPLETED|Overall Study||101
11366130|NCT03226652|12562900|FG000|NOT COMPLETED|Overall Study||0
11366131|NCT03226691|12562904|FG000|STARTED|Overall Study||15
11366132|NCT03226691|12562904|FG000|COMPLETED|Overall Study||15
11366133|NCT03226691|12562904|FG000|NOT COMPLETED|Overall Study||0
11366134|NCT03226769|12562910|FG000|STARTED|Overall Study||29
11366135|NCT03226769|12562911|FG001|STARTED|Overall Study||28
11366136|NCT03226769|12562910|FG000|COMPLETED|Overall Study||29
11366137|NCT03226769|12562911|FG001|COMPLETED|Overall Study||27
11366138|NCT03226769|12562910|FG000|NOT COMPLETED|Overall Study||0
11366139|NCT03226769|12562911|FG001|NOT COMPLETED|Overall Study||1
11366140|NCT03226899|12562919|FG000|STARTED|Overall Study||118
11366141|NCT03226899|12562920|FG001|STARTED|Overall Study||124
11366142|NCT03226899|12562919|FG000|COMPLETED|Overall Study||0
11366143|NCT03226899|12562920|FG001|COMPLETED|Overall Study||0
11366144|NCT03226899|12562919|FG000|NOT COMPLETED|Overall Study||118
11366145|NCT03226899|12562920|FG001|NOT COMPLETED|Overall Study||124
11366146|NCT03227445|12562926|FG000|STARTED|Period 1 (28 Days)||60
11366147|NCT03227445|12562927|FG001|STARTED|Period 1 (28 Days)||59
11366148|NCT03227445|12562928|FG002|STARTED|Period 1 (28 Days)||60
11366149|NCT03227445|12562929|FG003|STARTED|Period 1 (28 Days)||60
11366150|NCT03227445|12562926|FG000|COMPLETED|Period 1 (28 Days)||58
11366151|NCT03227445|12562927|FG001|COMPLETED|Period 1 (28 Days)||57
11366152|NCT03227445|12562928|FG002|COMPLETED|Period 1 (28 Days)||59
11366153|NCT03227445|12562929|FG003|COMPLETED|Period 1 (28 Days)||58
11366154|NCT03227445|12562926|FG000|NOT COMPLETED|Period 1 (28 Days)||2
11366155|NCT03227445|12562927|FG001|NOT COMPLETED|Period 1 (28 Days)||2
11366156|NCT03227445|12562928|FG002|NOT COMPLETED|Period 1 (28 Days)||1
11366157|NCT03227445|12562929|FG003|NOT COMPLETED|Period 1 (28 Days)||2
11366158|NCT03227445|12562926|FG000|STARTED|Period 2 (28 Days)||58
11366159|NCT03227445|12562927|FG001|STARTED|Period 2 (28 Days)||57
11366160|NCT03227445|12562928|FG002|STARTED|Period 2 (28 Days)||59
11366161|NCT03227445|12562929|FG003|STARTED|Period 2 (28 Days)||58
11366162|NCT03227445|12562926|FG000|COMPLETED|Period 2 (28 Days)||57
11366163|NCT03227445|12562927|FG001|COMPLETED|Period 2 (28 Days)||56
11366164|NCT03227445|12562928|FG002|COMPLETED|Period 2 (28 Days)||57
11366165|NCT03227445|12562929|FG003|COMPLETED|Period 2 (28 Days)||55
11366166|NCT03227445|12562926|FG000|NOT COMPLETED|Period 2 (28 Days)||1
11366167|NCT03227445|12562927|FG001|NOT COMPLETED|Period 2 (28 Days)||1
11366168|NCT03227445|12562928|FG002|NOT COMPLETED|Period 2 (28 Days)||2
11366169|NCT03227445|12562929|FG003|NOT COMPLETED|Period 2 (28 Days)||3
11366170|NCT03227692|12562940|FG000|STARTED|Overall Study||47
11366171|NCT03227692|12562941|FG001|STARTED|Overall Study||46
11366172|NCT03227692|12562940|FG000|COMPLETED|Overall Study||42
11366173|NCT03227692|12562941|FG001|COMPLETED|Overall Study||41
11366174|NCT03227692|12562940|FG000|NOT COMPLETED|Overall Study||5
11366175|NCT03227692|12562941|FG001|NOT COMPLETED|Overall Study||5
11366176|NCT03227861|12562947|FG000|STARTED|Main Study Period (Week 0 to Week 48)||109
11366177|NCT03227861|12562947|FG000|COMPLETED|Main Study Period (Week 0 to Week 48)||97
11366178|NCT03227861|12562947|FG000|NOT COMPLETED|Main Study Period (Week 0 to Week 48)||12
11366179|NCT03227861|12562947|FG000|STARTED|Extension Period (Week 48 to Week 96)|17 participants were not willing to enter extension study and discontinued after main study.|80
11366180|NCT03227861|12562947|FG000|COMPLETED|Extension Period (Week 48 to Week 96)||0
11366181|NCT03227861|12562947|FG000|NOT COMPLETED|Extension Period (Week 48 to Week 96)||80
11366182|NCT03228017|12562955|FG000|STARTED|Overall Study||45
11366183|NCT03228017|12562956|FG001|STARTED|Overall Study||18
11366184|NCT03228017|12562955|FG000|COMPLETED|Overall Study||45
11366185|NCT03228017|12562956|FG001|COMPLETED|Overall Study||18
11366186|NCT03228017|12562955|FG000|NOT COMPLETED|Overall Study||0
11366187|NCT03228017|12562956|FG001|NOT COMPLETED|Overall Study||0
11366188|NCT03228212|12562962|FG000|STARTED|Period 1||65
11366189|NCT03228212|12562963|FG001|STARTED|Period 1||65
11366190|NCT03228212|12562962|FG000|COMPLETED|Period 1||64
11366191|NCT03228212|12562963|FG001|COMPLETED|Period 1||64
11366192|NCT03228212|12562962|FG000|NOT COMPLETED|Period 1||1
11366193|NCT03228212|12562963|FG001|NOT COMPLETED|Period 1||1
11366194|NCT03228212|12562962|FG000|STARTED|Period 2||64
11366195|NCT03228212|12562963|FG001|STARTED|Period 2||64
11366196|NCT03228212|12562962|FG000|COMPLETED|Period 2||63
11366197|NCT03228212|12562963|FG001|COMPLETED|Period 2||64
11366198|NCT03228212|12562962|FG000|NOT COMPLETED|Period 2||1
11366199|NCT03228212|12562963|FG001|NOT COMPLETED|Period 2||0
11366200|NCT03228212|12562962|FG000|STARTED|Period 3||63
11366201|NCT03228212|12562963|FG001|STARTED|Period 3||64
11366202|NCT03228212|12562962|FG000|COMPLETED|Period 3||63
11366203|NCT03228212|12562963|FG001|COMPLETED|Period 3||64
11366204|NCT03228212|12562962|FG000|NOT COMPLETED|Period 3||0
11366205|NCT03228212|12562963|FG001|NOT COMPLETED|Period 3||0
11366206|NCT03228420|12562971|FG000|STARTED|Overall Study||113
11366207|NCT03228420|12562972|FG001|STARTED|Overall Study||103
11366208|NCT03228420|12562971|FG000|Month-1|Overall Study||95
11366209|NCT03228420|12562972|FG001|Month-1|Overall Study||101
11366210|NCT03228420|12562971|FG000|Month-3|Overall Study||93
11366211|NCT03228420|12562972|FG001|Month-3|Overall Study||98
11366212|NCT03228420|12562971|FG000|COMPLETED|Overall Study||93
11366213|NCT03228420|12562972|FG001|COMPLETED|Overall Study||98
11366214|NCT03228420|12562971|FG000|NOT COMPLETED|Overall Study||20
11366215|NCT03228420|12562972|FG001|NOT COMPLETED|Overall Study||5
11366216|NCT03228433|12562984|FG000|STARTED|Overall Study||10
11366217|NCT03228433|12562985|FG001|STARTED|Overall Study||6
11366218|NCT03228433|12562986|FG002|STARTED|Overall Study||6
11366219|NCT03228433|12562987|FG003|STARTED|Overall Study||6
11366220|NCT03228433|12562988|FG004|STARTED|Overall Study||6
11366221|NCT03228433|12562989|FG005|STARTED|Overall Study||6
11366222|NCT03228433|12562984|FG000|COMPLETED|Overall Study||9
11366223|NCT03228433|12562985|FG001|COMPLETED|Overall Study||6
11366224|NCT03228433|12562986|FG002|COMPLETED|Overall Study||6
11366225|NCT03228433|12562987|FG003|COMPLETED|Overall Study||5
11366226|NCT03228433|12562988|FG004|COMPLETED|Overall Study||6
11366227|NCT03228433|12562989|FG005|COMPLETED|Overall Study||6
11366228|NCT03228433|12562984|FG000|NOT COMPLETED|Overall Study||1
11366229|NCT03228433|12562985|FG001|NOT COMPLETED|Overall Study||0
11366230|NCT03228433|12562986|FG002|NOT COMPLETED|Overall Study||0
11366231|NCT03228433|12562987|FG003|NOT COMPLETED|Overall Study||1
11366232|NCT03228433|12562988|FG004|NOT COMPLETED|Overall Study||0
11366233|NCT03228433|12562989|FG005|NOT COMPLETED|Overall Study||0
11366234|NCT03228836|12563011|FG000|STARTED|Overall Study||28
11366235|NCT03228836|12563011|FG000|Treated|Overall Study||28
11366236|NCT03228836|12563011|FG000|COMPLETED|Overall Study||11
11366237|NCT03228836|12563011|FG000|NOT COMPLETED|Overall Study||17
11366238|NCT03228914|12563015|FG000|STARTED|Overall Study||20
11366239|NCT03228914|12563016|FG001|STARTED|Overall Study||20
11366240|NCT03228914|12563015|FG000|COMPLETED|Overall Study||20
11366241|NCT03228914|12563016|FG001|COMPLETED|Overall Study||20
11366242|NCT03228914|12563015|FG000|NOT COMPLETED|Overall Study||0
11366243|NCT03228914|12563016|FG001|NOT COMPLETED|Overall Study||0
11366244|NCT03229109|12563026|FG000|STARTED|Overall Study||50
11366245|NCT03229109|12563027|FG001|STARTED|Overall Study||50
11366246|NCT03229109|12563028|FG002|STARTED|Overall Study||50
11366247|NCT03229109|12563029|FG003|STARTED|Overall Study||51
11366248|NCT03229109|12563026|FG000|COMPLETED|Overall Study||50
11366249|NCT03229109|12563027|FG001|COMPLETED|Overall Study||50
11366250|NCT03229109|12563028|FG002|COMPLETED|Overall Study||50
11366251|NCT03229109|12563029|FG003|COMPLETED|Overall Study||50
11366252|NCT03229109|12563026|FG000|NOT COMPLETED|Overall Study||0
11366253|NCT03229109|12563027|FG001|NOT COMPLETED|Overall Study||0
11366254|NCT03229109|12563028|FG002|NOT COMPLETED|Overall Study||0
11366255|NCT03229109|12563029|FG003|NOT COMPLETED|Overall Study||1
11366256|NCT03229252|12563042|FG000|STARTED|Overall Study||31
11366257|NCT03229252|12563043|FG001|STARTED|Overall Study||15
11366258|NCT03229252|12563044|FG002|STARTED|Overall Study||45
11366259|NCT03229252|12563042|FG000|COMPLETED|Overall Study||29
11366260|NCT03229252|12563043|FG001|COMPLETED|Overall Study||15
11366261|NCT03229252|12563044|FG002|COMPLETED|Overall Study||39
11366262|NCT03229252|12563042|FG000|NOT COMPLETED|Overall Study||2
11366263|NCT03229252|12563043|FG001|NOT COMPLETED|Overall Study||0
11366264|NCT03229252|12563044|FG002|NOT COMPLETED|Overall Study||6
11366265|NCT03229486|12563054|FG000|STARTED|Overall Study||20
11366266|NCT03229486|12563055|FG001|STARTED|Overall Study||20
11366267|NCT03229486|12563054|FG000|COMPLETED|Overall Study||20
11366268|NCT03229486|12563055|FG001|COMPLETED|Overall Study||19
11366269|NCT03229486|12563054|FG000|NOT COMPLETED|Overall Study||0
11366270|NCT03229486|12563055|FG001|NOT COMPLETED|Overall Study||1
11366271|NCT03229759|12563061|FG000|STARTED|Overall Study||99
11366272|NCT03229759|12563061|FG000|Participants Treated|Overall Study||69
11366273|NCT03229759|12563061|FG000|Treated With Investigational Product|Overall Study||45
11366274|NCT03229759|12563061|FG000|Treated With Vehicle Control|Overall Study||47
11366275|NCT03229759|12563061|FG000|Treated With Saline Control|Overall Study||46
11366276|NCT03229759|12563061|FG000|COMPLETED|Overall Study||69
11366277|NCT03229759|12563061|FG000|NOT COMPLETED|Overall Study||30
11366278|NCT03230175|12563067|FG000|STARTED|Overall Study||32
11366279|NCT03230175|12563067|FG000|COMPLETED|Overall Study||30
11366280|NCT03230175|12563067|FG000|NOT COMPLETED|Overall Study||2
11366281|NCT03230864|12563074|FG000|STARTED|Prospective Confirmation (PC) Period||68
11366282|NCT03230864|12563075|FG001|STARTED|Prospective Confirmation (PC) Period||51
11366283|NCT03230864|12563076|FG002|STARTED|Prospective Confirmation (PC) Period||0
11366284|NCT03230864|12563077|FG003|STARTED|Prospective Confirmation (PC) Period||0
11366285|NCT03230864|12563074|FG000|COMPLETED|Prospective Confirmation (PC) Period||36
11366286|NCT03230864|12563075|FG001|COMPLETED|Prospective Confirmation (PC) Period||32
11366287|NCT03230864|12563076|FG002|COMPLETED|Prospective Confirmation (PC) Period||0
11366288|NCT03230864|12563077|FG003|COMPLETED|Prospective Confirmation (PC) Period||0
11366289|NCT03230864|12563074|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||32
11366290|NCT03230864|12563075|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||19
11366291|NCT03230864|12563076|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0
11366292|NCT03230864|12563077|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0
11366293|NCT03230864|12563074|FG000|STARTED|Double Blind Treatment (DBT) Period||0
11366294|NCT03230864|12563075|FG001|STARTED|Double Blind Treatment (DBT) Period||0
11366295|NCT03230864|12563076|FG002|STARTED|Double Blind Treatment (DBT) Period||35
11366296|NCT03230864|12563077|FG003|STARTED|Double Blind Treatment (DBT) Period||33
11366297|NCT03230864|12563074|FG000|COMPLETED|Double Blind Treatment (DBT) Period||0
11366298|NCT03230864|12563075|FG001|COMPLETED|Double Blind Treatment (DBT) Period||0
11366299|NCT03230864|12563076|FG002|COMPLETED|Double Blind Treatment (DBT) Period||27
11366300|NCT03230864|12563077|FG003|COMPLETED|Double Blind Treatment (DBT) Period||31
11366301|NCT03230864|12563074|FG000|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
11366302|NCT03230864|12563075|FG001|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
11366303|NCT03230864|12563076|FG002|NOT COMPLETED|Double Blind Treatment (DBT) Period||8
11366304|NCT03230864|12563077|FG003|NOT COMPLETED|Double Blind Treatment (DBT) Period||2
11366305|NCT03231228|12563089|FG000|STARTED|Overall Study||33
11366306|NCT03231228|12563090|FG001|STARTED|Overall Study||28
11366307|NCT03231228|12563089|FG000|COMPLETED|Overall Study||30
11366308|NCT03231228|12563090|FG001|COMPLETED|Overall Study||28
11366309|NCT03231228|12563089|FG000|NOT COMPLETED|Overall Study||3
11366310|NCT03231228|12563090|FG001|NOT COMPLETED|Overall Study||0
11366311|NCT03231345|12563096|FG000|STARTED|Overall Study||35
11366312|NCT03231345|12563096|FG000|COMPLETED|Overall Study||35
11366313|NCT03231345|12563096|FG000|NOT COMPLETED|Overall Study||0
11366314|NCT03231371|12563100|FG000|STARTED|Overall Study||22
11366315|NCT03231371|12563100|FG000|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
11366316|NCT03231371|12563100|FG000|COMPLETED|Overall Study||9
11366317|NCT03231371|12563100|FG000|NOT COMPLETED|Overall Study||13
11366318|NCT03231709|12563106|FG000|STARTED|Treatment Period 1||30
11366319|NCT03231709|12563107|FG001|STARTED|Treatment Period 1||30
11366320|NCT03231709|12563106|FG000|COMPLETED|Treatment Period 1||30
11366321|NCT03231709|12563107|FG001|COMPLETED|Treatment Period 1||29
11366322|NCT03231709|12563106|FG000|NOT COMPLETED|Treatment Period 1||0
11366323|NCT03231709|12563107|FG001|NOT COMPLETED|Treatment Period 1||1
11366324|NCT03231709|12563106|FG000|STARTED|Treatment Period 2||30
11366325|NCT03231709|12563107|FG001|STARTED|Treatment Period 2||29
11366326|NCT03231709|12563106|FG000|COMPLETED|Treatment Period 2||30
11366327|NCT03231709|12563107|FG001|COMPLETED|Treatment Period 2||28
11366328|NCT03231709|12563106|FG000|NOT COMPLETED|Treatment Period 2||0
11366329|NCT03231709|12563107|FG001|NOT COMPLETED|Treatment Period 2||1
11366330|NCT03231800|12563119|FG000|STARTED|Overall Study||48
11366331|NCT03231800|12563120|FG001|STARTED|Overall Study||47
11366332|NCT03231800|12563119|FG000|Safety Population|Overall Study||47
11366333|NCT03231800|12563120|FG001|Safety Population|Overall Study||47
11366334|NCT03231800|12563119|FG000|COMPLETED|Overall Study||45
11366335|NCT03231800|12563120|FG001|COMPLETED|Overall Study||44
11366336|NCT03231800|12563119|FG000|NOT COMPLETED|Overall Study||3
11366337|NCT03231800|12563120|FG001|NOT COMPLETED|Overall Study||3
11366338|NCT03231917|12563128|FG000|STARTED|Overall Study||60
11366339|NCT03231917|12563129|FG001|STARTED|Overall Study||61
11366340|NCT03231917|12563128|FG000|COMPLETED|Overall Study||60
11366341|NCT03231917|12563129|FG001|COMPLETED|Overall Study||61
11366342|NCT03231917|12563128|FG000|NOT COMPLETED|Overall Study||0
11366343|NCT03231917|12563129|FG001|NOT COMPLETED|Overall Study||0
11366344|NCT03231943|12563142|FG000|STARTED|Part 1, Period 1 (up to Day 15)||2
11366345|NCT03231943|12563143|FG001|STARTED|Part 1, Period 1 (up to Day 15)||2
11366346|NCT03231943|12563144|FG002|STARTED|Part 1, Period 1 (up to Day 15)||2
11366347|NCT03231943|12563145|FG003|STARTED|Part 1, Period 1 (up to Day 15)||2
11366348|NCT03231943|12563146|FG004|STARTED|Part 1, Period 1 (up to Day 15)||2
11366349|NCT03231943|12563147|FG005|STARTED|Part 1, Period 1 (up to Day 15)||2
11366350|NCT03231943|12563148|FG006|STARTED|Part 1, Period 1 (up to Day 15)||2
11366351|NCT03231943|12563149|FG007|STARTED|Part 1, Period 1 (up to Day 15)||2
11366352|NCT03231943|12563150|FG008|STARTED|Part 1, Period 1 (up to Day 15)||0
11366353|NCT03231943|12563151|FG009|STARTED|Part 1, Period 1 (up to Day 15)||0
11366354|NCT03231943|12563152|FG010|STARTED|Part 1, Period 1 (up to Day 15)||0
11366355|NCT03231943|12563153|FG011|STARTED|Part 1, Period 1 (up to Day 15)||0
11366356|NCT03231943|12563154|FG012|STARTED|Part 1, Period 1 (up to Day 15)||0
11366357|NCT03231943|12563142|FG000|COMPLETED|Part 1, Period 1 (up to Day 15)||2
11366358|NCT03231943|12563143|FG001|COMPLETED|Part 1, Period 1 (up to Day 15)||2
11366359|NCT03231943|12563144|FG002|COMPLETED|Part 1, Period 1 (up to Day 15)||2
11366360|NCT03231943|12563145|FG003|COMPLETED|Part 1, Period 1 (up to Day 15)||2
11366361|NCT03231943|12563146|FG004|COMPLETED|Part 1, Period 1 (up to Day 15)||2
11366362|NCT03231943|12563147|FG005|COMPLETED|Part 1, Period 1 (up to Day 15)||2
11366363|NCT03231943|12563148|FG006|COMPLETED|Part 1, Period 1 (up to Day 15)||2
11366364|NCT03231943|12563149|FG007|COMPLETED|Part 1, Period 1 (up to Day 15)||2
11366365|NCT03231943|12563150|FG008|COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366366|NCT03231943|12563151|FG009|COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366367|NCT03231943|12563152|FG010|COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366368|NCT03231943|12563153|FG011|COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366369|NCT03231943|12563154|FG012|COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366370|NCT03231943|12563142|FG000|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366371|NCT03231943|12563143|FG001|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366372|NCT03231943|12563144|FG002|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366373|NCT03231943|12563145|FG003|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366374|NCT03231943|12563146|FG004|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366375|NCT03231943|12563147|FG005|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366376|NCT03231943|12563148|FG006|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366377|NCT03231943|12563149|FG007|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366378|NCT03231943|12563150|FG008|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366379|NCT03231943|12563151|FG009|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366380|NCT03231943|12563152|FG010|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366381|NCT03231943|12563153|FG011|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366382|NCT03231943|12563154|FG012|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
11366383|NCT03231943|12563142|FG000|STARTED|Part 1, Period 2 (up to Day 30)||2
11366384|NCT03231943|12563143|FG001|STARTED|Part 1, Period 2 (up to Day 30)||2
11366385|NCT03231943|12563144|FG002|STARTED|Part 1, Period 2 (up to Day 30)||2
11366386|NCT03231943|12563145|FG003|STARTED|Part 1, Period 2 (up to Day 30)||2
11366387|NCT03231943|12563146|FG004|STARTED|Part 1, Period 2 (up to Day 30)||2
11366388|NCT03231943|12563147|FG005|STARTED|Part 1, Period 2 (up to Day 30)||2
11366389|NCT03231943|12563148|FG006|STARTED|Part 1, Period 2 (up to Day 30)||2
11366390|NCT03231943|12563149|FG007|STARTED|Part 1, Period 2 (up to Day 30)||2
11366391|NCT03231943|12563150|FG008|STARTED|Part 1, Period 2 (up to Day 30)||0
11366392|NCT03231943|12563151|FG009|STARTED|Part 1, Period 2 (up to Day 30)||0
11366393|NCT03231943|12563152|FG010|STARTED|Part 1, Period 2 (up to Day 30)||0
11366394|NCT03231943|12563153|FG011|STARTED|Part 1, Period 2 (up to Day 30)||0
11366395|NCT03231943|12563154|FG012|STARTED|Part 1, Period 2 (up to Day 30)||0
11366396|NCT03231943|12563142|FG000|COMPLETED|Part 1, Period 2 (up to Day 30)||2
11366397|NCT03231943|12563143|FG001|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0
11366398|NCT03231943|12563144|FG002|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1
11366399|NCT03231943|12563145|FG003|COMPLETED|Part 1, Period 2 (up to Day 30)||2
11366400|NCT03231943|12563146|FG004|COMPLETED|Part 1, Period 2 (up to Day 30)||2
11366401|NCT03231943|12563147|FG005|COMPLETED|Part 1, Period 2 (up to Day 30)||2
11366402|NCT03231943|12563148|FG006|COMPLETED|Part 1, Period 2 (up to Day 30)||2
11366403|NCT03231943|12563149|FG007|COMPLETED|Part 1, Period 2 (up to Day 30)||2
11366404|NCT03231943|12563150|FG008|COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366405|NCT03231943|12563151|FG009|COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366406|NCT03231943|12563152|FG010|COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366407|NCT03231943|12563153|FG011|COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366408|NCT03231943|12563154|FG012|COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366409|NCT03231943|12563142|FG000|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366410|NCT03231943|12563143|FG001|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2
11366411|NCT03231943|12563144|FG002|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1
11366412|NCT03231943|12563145|FG003|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366413|NCT03231943|12563146|FG004|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366414|NCT03231943|12563147|FG005|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366415|NCT03231943|12563148|FG006|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366416|NCT03231943|12563149|FG007|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366417|NCT03231943|12563150|FG008|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366418|NCT03231943|12563151|FG009|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366419|NCT03231943|12563152|FG010|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366420|NCT03231943|12563153|FG011|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366421|NCT03231943|12563154|FG012|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
11366422|NCT03231943|12563142|FG000|STARTED|Part 1, Period 3 (up to Day 45)||2
11366423|NCT03231943|12563143|FG001|STARTED|Part 1, Period 3 (up to Day 45)||2
11366424|NCT03231943|12563144|FG002|STARTED|Part 1, Period 3 (up to Day 45)||2
11366425|NCT03231943|12563145|FG003|STARTED|Part 1, Period 3 (up to Day 45)||2
11366426|NCT03231943|12563146|FG004|STARTED|Part 1, Period 3 (up to Day 45)||2
11366427|NCT03231943|12563147|FG005|STARTED|Part 1, Period 3 (up to Day 45)||2
11366428|NCT03231943|12563148|FG006|STARTED|Part 1, Period 3 (up to Day 45)||2
11366429|NCT03231943|12563149|FG007|STARTED|Part 1, Period 3 (up to Day 45)||2
11366430|NCT03231943|12563150|FG008|STARTED|Part 1, Period 3 (up to Day 45)||0
11366431|NCT03231943|12563151|FG009|STARTED|Part 1, Period 3 (up to Day 45)||0
11366432|NCT03231943|12563152|FG010|STARTED|Part 1, Period 3 (up to Day 45)||0
11366433|NCT03231943|12563153|FG011|STARTED|Part 1, Period 3 (up to Day 45)||0
11366434|NCT03231943|12563154|FG012|STARTED|Part 1, Period 3 (up to Day 45)||0
11366435|NCT03231943|12563142|FG000|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1
11366436|NCT03231943|12563143|FG001|COMPLETED|Part 1, Period 3 (up to Day 45)||2
11366437|NCT03231943|12563144|FG002|COMPLETED|Part 1, Period 3 (up to Day 45)||2
11366438|NCT03231943|12563145|FG003|COMPLETED|Part 1, Period 3 (up to Day 45)||2
11366439|NCT03231943|12563146|FG004|COMPLETED|Part 1, Period 3 (up to Day 45)||2
11366440|NCT03231943|12563147|FG005|COMPLETED|Part 1, Period 3 (up to Day 45)||2
11366441|NCT03231943|12563148|FG006|COMPLETED|Part 1, Period 3 (up to Day 45)||2
11366442|NCT03231943|12563149|FG007|COMPLETED|Part 1, Period 3 (up to Day 45)||2
11366443|NCT03231943|12563150|FG008|COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366444|NCT03231943|12563151|FG009|COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366445|NCT03231943|12563152|FG010|COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366446|NCT03231943|12563153|FG011|COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366447|NCT03231943|12563154|FG012|COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366448|NCT03231943|12563142|FG000|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1
11366449|NCT03231943|12563143|FG001|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366450|NCT03231943|12563144|FG002|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366451|NCT03231943|12563145|FG003|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366452|NCT03231943|12563146|FG004|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366453|NCT03231943|12563147|FG005|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366454|NCT03231943|12563148|FG006|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366455|NCT03231943|12563149|FG007|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366456|NCT03231943|12563150|FG008|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366457|NCT03231943|12563151|FG009|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366458|NCT03231943|12563152|FG010|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366459|NCT03231943|12563153|FG011|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366460|NCT03231943|12563154|FG012|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
11366461|NCT03231943|12563142|FG000|STARTED|Part 1 Period 4 (up to Day 60)||2
11366462|NCT03231943|12563143|FG001|STARTED|Part 1 Period 4 (up to Day 60)||2
11366463|NCT03231943|12563144|FG002|STARTED|Part 1 Period 4 (up to Day 60)||2
11366464|NCT03231943|12563145|FG003|STARTED|Part 1 Period 4 (up to Day 60)||2
11366465|NCT03231943|12563146|FG004|STARTED|Part 1 Period 4 (up to Day 60)||2
11366466|NCT03231943|12563147|FG005|STARTED|Part 1 Period 4 (up to Day 60)||2
11366467|NCT03231943|12563148|FG006|STARTED|Part 1 Period 4 (up to Day 60)||2
11366468|NCT03231943|12563149|FG007|STARTED|Part 1 Period 4 (up to Day 60)||2
11366469|NCT03231943|12563150|FG008|STARTED|Part 1 Period 4 (up to Day 60)||0
11366470|NCT03231943|12563151|FG009|STARTED|Part 1 Period 4 (up to Day 60)||0
11366471|NCT03231943|12563152|FG010|STARTED|Part 1 Period 4 (up to Day 60)||0
11366472|NCT03231943|12563153|FG011|STARTED|Part 1 Period 4 (up to Day 60)||0
11366473|NCT03231943|12563154|FG012|STARTED|Part 1 Period 4 (up to Day 60)||0
11366474|NCT03231943|12563142|FG000|COMPLETED|Part 1 Period 4 (up to Day 60)||2
11366475|NCT03231943|12563143|FG001|COMPLETED|Part 1 Period 4 (up to Day 60)||2
11366476|NCT03231943|12563144|FG002|COMPLETED|Part 1 Period 4 (up to Day 60)||2
11366477|NCT03231943|12563145|FG003|COMPLETED|Part 1 Period 4 (up to Day 60)||2
11366478|NCT03231943|12563146|FG004|COMPLETED|Part 1 Period 4 (up to Day 60)||2
11366479|NCT03231943|12563147|FG005|COMPLETED|Part 1 Period 4 (up to Day 60)||2
11366480|NCT03231943|12563148|FG006|COMPLETED|Part 1 Period 4 (up to Day 60)||2
11366481|NCT03231943|12563149|FG007|COMPLETED|Part 1 Period 4 (up to Day 60)||2
11366482|NCT03231943|12563150|FG008|COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366483|NCT03231943|12563151|FG009|COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366484|NCT03231943|12563152|FG010|COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366485|NCT03231943|12563153|FG011|COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366486|NCT03231943|12563154|FG012|COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366487|NCT03231943|12563142|FG000|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366488|NCT03231943|12563143|FG001|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366489|NCT03231943|12563144|FG002|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366490|NCT03231943|12563145|FG003|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366491|NCT03231943|12563146|FG004|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366492|NCT03231943|12563147|FG005|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366493|NCT03231943|12563148|FG006|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366494|NCT03231943|12563149|FG007|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366495|NCT03231943|12563150|FG008|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366496|NCT03231943|12563151|FG009|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366497|NCT03231943|12563152|FG010|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366498|NCT03231943|12563153|FG011|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366499|NCT03231943|12563154|FG012|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
11366500|NCT03231943|12563142|FG000|STARTED|Part 2||0
11366501|NCT03231943|12563143|FG001|STARTED|Part 2||0
11366502|NCT03231943|12563144|FG002|STARTED|Part 2||0
11366503|NCT03231943|12563145|FG003|STARTED|Part 2||0
11366504|NCT03231943|12563146|FG004|STARTED|Part 2||0
11366505|NCT03231943|12563147|FG005|STARTED|Part 2||0
11366506|NCT03231943|12563148|FG006|STARTED|Part 2||0
11366507|NCT03231943|12563149|FG007|STARTED|Part 2||0
11366508|NCT03231943|12563150|FG008|STARTED|Part 2||6
11366509|NCT03231943|12563151|FG009|STARTED|Part 2||6
11366510|NCT03231943|12563152|FG010|STARTED|Part 2||25
11366511|NCT03231943|12563153|FG011|STARTED|Part 2||7
11366512|NCT03231943|12563154|FG012|STARTED|Part 2||14
11366513|NCT03231943|12563142|FG000|COMPLETED|Part 2||0
11366514|NCT03231943|12563143|FG001|COMPLETED|Part 2||0
11366515|NCT03231943|12563144|FG002|COMPLETED|Part 2||0
11366516|NCT03231943|12563145|FG003|COMPLETED|Part 2||0
11366517|NCT03231943|12563146|FG004|COMPLETED|Part 2||0
11366518|NCT03231943|12563147|FG005|COMPLETED|Part 2||0
11366519|NCT03231943|12563148|FG006|COMPLETED|Part 2||0
11366520|NCT03231943|12563149|FG007|COMPLETED|Part 2||0
11366521|NCT03231943|12563150|FG008|COMPLETED|Part 2||6
11366522|NCT03231943|12563151|FG009|COMPLETED|Part 2||6
11366523|NCT03231943|12563152|FG010|COMPLETED|Part 2||24
11366524|NCT03231943|12563153|FG011|COMPLETED|Part 2||6
11366525|NCT03231943|12563154|FG012|COMPLETED|Part 2||14
11366526|NCT03231943|12563142|FG000|NOT COMPLETED|Part 2||0
11366527|NCT03231943|12563143|FG001|NOT COMPLETED|Part 2||0
11366528|NCT03231943|12563144|FG002|NOT COMPLETED|Part 2||0
11366529|NCT03231943|12563145|FG003|NOT COMPLETED|Part 2||0
11366530|NCT03231943|12563146|FG004|NOT COMPLETED|Part 2||0
11366531|NCT03231943|12563147|FG005|NOT COMPLETED|Part 2||0
11366532|NCT03231943|12563148|FG006|NOT COMPLETED|Part 2||0
11366533|NCT03231943|12563149|FG007|NOT COMPLETED|Part 2||0
11366534|NCT03231943|12563150|FG008|NOT COMPLETED|Part 2||0
11366535|NCT03231943|12563151|FG009|NOT COMPLETED|Part 2||0
11366536|NCT03231943|12563152|FG010|NOT COMPLETED|Part 2||1
11366537|NCT03231943|12563153|FG011|NOT COMPLETED|Part 2||1
11366538|NCT03231943|12563154|FG012|NOT COMPLETED|Part 2||0
11366539|NCT03231969|12563188|FG000|STARTED|Overall Study||30
11366540|NCT03231969|12563189|FG001|STARTED|Overall Study||30
11366541|NCT03231969|12563190|FG002|STARTED|Overall Study||31
11366542|NCT03231969|12563191|FG003|STARTED|Overall Study||30
11366543|NCT03231969|12563188|FG000|COMPLETED|Overall Study||28
11366544|NCT03231969|12563189|FG001|COMPLETED|Overall Study||28
11366545|NCT03231969|12563190|FG002|COMPLETED|Overall Study||30
11366546|NCT03231969|12563191|FG003|COMPLETED|Overall Study||30
11366547|NCT03231969|12563188|FG000|NOT COMPLETED|Overall Study||2
11366548|NCT03231969|12563189|FG001|NOT COMPLETED|Overall Study||2
11366549|NCT03231969|12563190|FG002|NOT COMPLETED|Overall Study||1
11366550|NCT03231969|12563191|FG003|NOT COMPLETED|Overall Study||0
11366551|NCT03232281|12563203|FG000|STARTED|Overall Study||150
11366552|NCT03232281|12563204|FG001|STARTED|Overall Study||150
11366553|NCT03232281|12563203|FG000|Received Treatment|Overall Study||149
11366554|NCT03232281|12563204|FG001|Received Treatment|Overall Study||150
11366555|NCT03232281|12563203|FG000|Completed Week 12|Overall Study||143
11366556|NCT03232281|12563204|FG001|Completed Week 12|Overall Study||148
11366557|NCT03232281|12563203|FG000|Completed Week 24|Overall Study||143
11366558|NCT03232281|12563204|FG001|Completed Week 24|Overall Study||144
11366559|NCT03232281|12563203|FG000|COMPLETED|Overall Study||143
11366560|NCT03232281|12563204|FG001|COMPLETED|Overall Study||144
11366561|NCT03232281|12563203|FG000|NOT COMPLETED|Overall Study||7
11366562|NCT03232281|12563204|FG001|NOT COMPLETED|Overall Study||6
11366563|NCT03232333|12563210|FG000|STARTED|Overall Study||53
11366564|NCT03232333|12563210|FG000|COMPLETED|Overall Study||38
11366565|NCT03232333|12563210|FG000|NOT COMPLETED|Overall Study||15
11366566|NCT03232567|12563218|FG000|STARTED|Overall Study||15
11366567|NCT03232567|12563219|FG001|STARTED|Overall Study||15
11366568|NCT03232567|12563220|FG002|STARTED|Overall Study||15
11366569|NCT03232567|12563221|FG003|STARTED|Overall Study||15
11366570|NCT03232567|12563218|FG000|COMPLETED|Overall Study||15
11366571|NCT03232567|12563219|FG001|COMPLETED|Overall Study||14
11366572|NCT03232567|12563220|FG002|COMPLETED|Overall Study||15
11366573|NCT03232567|12563221|FG003|COMPLETED|Overall Study||15
11366574|NCT03232567|12563218|FG000|NOT COMPLETED|Overall Study||0
11366575|NCT03232567|12563219|FG001|NOT COMPLETED|Overall Study||1
11366576|NCT03232567|12563220|FG002|NOT COMPLETED|Overall Study||0
11366577|NCT03232567|12563221|FG003|NOT COMPLETED|Overall Study||0
11366578|NCT03232580|12563231|FG000|STARTED|Overall Study||5
11366579|NCT03232580|12563231|FG000|COMPLETED|Overall Study||5
11366580|NCT03232580|12563231|FG000|NOT COMPLETED|Overall Study||0
11366581|NCT03232645|12563235|FG000|STARTED|Overall Study||62
11366582|NCT03232645|12563235|FG000|COMPLETED|Overall Study||58
11366583|NCT03232645|12563235|FG000|NOT COMPLETED|Overall Study||4
11366584|NCT03232749|12563240|FG000|STARTED|Overall Study||25
11366585|NCT03232749|12563240|FG000|COMPLETED|Overall Study||21
11366586|NCT03232749|12563240|FG000|NOT COMPLETED|Overall Study||4
11366587|NCT03232827|12563244|FG000|STARTED|Flavored-sweetened (FS)||80
11366588|NCT03232827|12563244|FG000|COMPLETED|Flavored-sweetened (FS)||80
11366589|NCT03232827|12563244|FG000|NOT COMPLETED|Flavored-sweetened (FS)||0
11366590|NCT03232827|12563244|FG000|STARTED|Unflavored-sweetened (US)||86
11366591|NCT03232827|12563244|FG000|COMPLETED|Unflavored-sweetened (US)||86
11366592|NCT03232827|12563244|FG000|NOT COMPLETED|Unflavored-sweetened (US)||0
11366593|NCT03232827|12563244|FG000|STARTED|Unflavored-very Low Sweetened (UU)||66
11366594|NCT03232827|12563244|FG000|COMPLETED|Unflavored-very Low Sweetened (UU)||66
11366595|NCT03232827|12563244|FG000|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0
11366596|NCT03232827|12563244|FG000|STARTED|Flavored-very Low Sweetened||66
11366597|NCT03232827|12563244|FG000|COMPLETED|Flavored-very Low Sweetened||66
11366598|NCT03232827|12563244|FG000|NOT COMPLETED|Flavored-very Low Sweetened||0
11366599|NCT03232983|12563254|FG000|STARTED|Period 1||7
11366600|NCT03232983|12563255|FG001|STARTED|Period 1||7
11366601|NCT03232983|12563256|FG002|STARTED|Period 1||7
11366602|NCT03232983|12563257|FG003|STARTED|Period 1||7
11366603|NCT03232983|12563254|FG000|Received at Least One Dose of Study Drug|Period 1||7
11366604|NCT03232983|12563255|FG001|Received at Least One Dose of Study Drug|Period 1||7
11366605|NCT03232983|12563256|FG002|Received at Least One Dose of Study Drug|Period 1||7
11366606|NCT03232983|12563257|FG003|Received at Least One Dose of Study Drug|Period 1||7
11366607|NCT03232983|12563254|FG000|COMPLETED|Period 1||7
11366608|NCT03232983|12563255|FG001|COMPLETED|Period 1||7
11366609|NCT03232983|12563256|FG002|COMPLETED|Period 1||6
11366610|NCT03232983|12563257|FG003|COMPLETED|Period 1||7
11366611|NCT03232983|12563254|FG000|NOT COMPLETED|Period 1||0
11366612|NCT03232983|12563255|FG001|NOT COMPLETED|Period 1||0
11366613|NCT03232983|12563256|FG002|NOT COMPLETED|Period 1||1
11366614|NCT03232983|12563257|FG003|NOT COMPLETED|Period 1||0
11366615|NCT03232983|12563254|FG000|STARTED|Washout Period 1||7
11366616|NCT03232983|12563255|FG001|STARTED|Washout Period 1||7
11366617|NCT03232983|12563256|FG002|STARTED|Washout Period 1||6
11366618|NCT03232983|12563257|FG003|STARTED|Washout Period 1||7
11366619|NCT03232983|12563254|FG000|COMPLETED|Washout Period 1||7
11366620|NCT03232983|12563255|FG001|COMPLETED|Washout Period 1||7
11366621|NCT03232983|12563256|FG002|COMPLETED|Washout Period 1||6
11366622|NCT03232983|12563257|FG003|COMPLETED|Washout Period 1||7
11366623|NCT03232983|12563254|FG000|NOT COMPLETED|Washout Period 1||0
11366624|NCT03232983|12563255|FG001|NOT COMPLETED|Washout Period 1||0
11366625|NCT03232983|12563256|FG002|NOT COMPLETED|Washout Period 1||0
11366626|NCT03232983|12563257|FG003|NOT COMPLETED|Washout Period 1||0
11366627|NCT03232983|12563254|FG000|STARTED|Period 2||7
11366628|NCT03232983|12563255|FG001|STARTED|Period 2||7
11366629|NCT03232983|12563256|FG002|STARTED|Period 2||6
11366630|NCT03232983|12563257|FG003|STARTED|Period 2||7
11366631|NCT03232983|12563254|FG000|COMPLETED|Period 2||7
11366632|NCT03232983|12563255|FG001|COMPLETED|Period 2||7
11366633|NCT03232983|12563256|FG002|COMPLETED|Period 2||6
11366634|NCT03232983|12563257|FG003|COMPLETED|Period 2||7
11366635|NCT03232983|12563254|FG000|NOT COMPLETED|Period 2||0
11366636|NCT03232983|12563255|FG001|NOT COMPLETED|Period 2||0
11366637|NCT03232983|12563256|FG002|NOT COMPLETED|Period 2||0
11366638|NCT03232983|12563257|FG003|NOT COMPLETED|Period 2||0
11366639|NCT03232983|12563254|FG000|STARTED|Washout Period 2||7
11366640|NCT03232983|12563255|FG001|STARTED|Washout Period 2||7
11366641|NCT03232983|12563256|FG002|STARTED|Washout Period 2||6
11366642|NCT03232983|12563257|FG003|STARTED|Washout Period 2||7
11366643|NCT03232983|12563254|FG000|COMPLETED|Washout Period 2||7
11366644|NCT03232983|12563255|FG001|COMPLETED|Washout Period 2||7
11366645|NCT03232983|12563256|FG002|COMPLETED|Washout Period 2||5
11366646|NCT03232983|12563257|FG003|COMPLETED|Washout Period 2||6
11366647|NCT03232983|12563254|FG000|NOT COMPLETED|Washout Period 2||0
11366648|NCT03232983|12563255|FG001|NOT COMPLETED|Washout Period 2||0
11366649|NCT03232983|12563256|FG002|NOT COMPLETED|Washout Period 2||1
11366650|NCT03232983|12563257|FG003|NOT COMPLETED|Washout Period 2||1
11366651|NCT03232983|12563254|FG000|STARTED|Period 3||7
11366652|NCT03232983|12563255|FG001|STARTED|Period 3||7
11366653|NCT03232983|12563256|FG002|STARTED|Period 3||5
11366654|NCT03232983|12563257|FG003|STARTED|Period 3||6
11366655|NCT03232983|12563254|FG000|COMPLETED|Period 3||7
11366656|NCT03232983|12563255|FG001|COMPLETED|Period 3||7
11366657|NCT03232983|12563256|FG002|COMPLETED|Period 3||5
11366658|NCT03232983|12563257|FG003|COMPLETED|Period 3||6
11366659|NCT03232983|12563254|FG000|NOT COMPLETED|Period 3||0
11366660|NCT03232983|12563255|FG001|NOT COMPLETED|Period 3||0
11366661|NCT03232983|12563256|FG002|NOT COMPLETED|Period 3||0
11366662|NCT03232983|12563257|FG003|NOT COMPLETED|Period 3||0
11366663|NCT03232983|12563254|FG000|STARTED|Washout Period 3||7
11366664|NCT03232983|12563255|FG001|STARTED|Washout Period 3||7
11366665|NCT03232983|12563256|FG002|STARTED|Washout Period 3||5
11366666|NCT03232983|12563257|FG003|STARTED|Washout Period 3||6
11366667|NCT03232983|12563254|FG000|COMPLETED|Washout Period 3||7
11366668|NCT03232983|12563255|FG001|COMPLETED|Washout Period 3||7
11366669|NCT03232983|12563256|FG002|COMPLETED|Washout Period 3||5
11366670|NCT03232983|12563257|FG003|COMPLETED|Washout Period 3||6
11366671|NCT03232983|12563254|FG000|NOT COMPLETED|Washout Period 3||0
11366672|NCT03232983|12563255|FG001|NOT COMPLETED|Washout Period 3||0
11366673|NCT03232983|12563256|FG002|NOT COMPLETED|Washout Period 3||0
11366674|NCT03232983|12563257|FG003|NOT COMPLETED|Washout Period 3||0
11366675|NCT03232983|12563254|FG000|STARTED|Period 4||7
11366676|NCT03232983|12563255|FG001|STARTED|Period 4||7
11366677|NCT03232983|12563256|FG002|STARTED|Period 4||5
11366678|NCT03232983|12563257|FG003|STARTED|Period 4||6
11366679|NCT03232983|12563254|FG000|COMPLETED|Period 4||6
11366680|NCT03232983|12563255|FG001|COMPLETED|Period 4||7
11366681|NCT03232983|12563256|FG002|COMPLETED|Period 4||5
11366682|NCT03232983|12563257|FG003|COMPLETED|Period 4||6
11366683|NCT03232983|12563254|FG000|NOT COMPLETED|Period 4||1
11366684|NCT03232983|12563255|FG001|NOT COMPLETED|Period 4||0
11366685|NCT03232983|12563256|FG002|NOT COMPLETED|Period 4||0
11366686|NCT03232983|12563257|FG003|NOT COMPLETED|Period 4||0
11366687|NCT03233009|12563269|FG000|STARTED|Overall Study||40
11366688|NCT03233009|12563269|FG000|Test Product 1|Overall Study||39
11366689|NCT03233009|12563269|FG000|Test Product 2|Overall Study||39
11366690|NCT03233009|12563269|FG000|Test Product 3|Overall Study||39
11366691|NCT03233009|12563269|FG000|Test Product 4|Overall Study||39
11366692|NCT03233009|12563269|FG000|Reference Product|Overall Study||39
11366693|NCT03233009|12563269|FG000|COMPLETED|Overall Study||39
11366694|NCT03233009|12563269|FG000|NOT COMPLETED|Overall Study||1
11366695|NCT03233230|12563286|FG000|STARTED|Overall Study||97
11366696|NCT03233230|12563287|FG001|STARTED|Overall Study||98
11366697|NCT03233230|12563288|FG002|STARTED|Overall Study||96
11366698|NCT03233230|12563289|FG003|STARTED|Overall Study||99
11366699|NCT03233230|12563286|FG000|COMPLETED|Overall Study||82
11366700|NCT03233230|12563287|FG001|COMPLETED|Overall Study||83
11366701|NCT03233230|12563288|FG002|COMPLETED|Overall Study||84
11366702|NCT03233230|12563289|FG003|COMPLETED|Overall Study||91
11366703|NCT03233230|12563286|FG000|NOT COMPLETED|Overall Study||15
11366704|NCT03233230|12563287|FG001|NOT COMPLETED|Overall Study||15
11366705|NCT03233230|12563288|FG002|NOT COMPLETED|Overall Study||12
11366706|NCT03233230|12563289|FG003|NOT COMPLETED|Overall Study||8
11366707|NCT03233308|12563299|FG000|STARTED|Overall Study||20
11366708|NCT03233308|12563299|FG000|COMPLETED|Overall Study||18
11366709|NCT03233308|12563299|FG000|NOT COMPLETED|Overall Study||2
11366710|NCT03233438|12563312|FG000|STARTED|Overall Study||48
11366711|NCT03233438|12563313|FG001|STARTED|Overall Study||43
11366712|NCT03233438|12563312|FG000|COMPLETED|Overall Study||42
11366713|NCT03233438|12563313|FG001|COMPLETED|Overall Study||32
11366714|NCT03233438|12563312|FG000|NOT COMPLETED|Overall Study||6
11366715|NCT03233438|12563313|FG001|NOT COMPLETED|Overall Study||11
11366716|NCT03233529|12563319|FG000|STARTED|Double-Blind Period (Day 1 to Day 15)||40
11366717|NCT03233529|12563319|FG000|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39
11366718|NCT03233529|12563319|FG000|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1
11366719|NCT03233529|12563319|FG000|STARTED|Open-Label Period (Day 15 to Day 71)||39
11366720|NCT03233529|12563319|FG000|COMPLETED|Open-Label Period (Day 15 to Day 71)||38
11366721|NCT03233529|12563319|FG000|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1
11366722|NCT03233737|12563332|FG000|STARTED|Overall Study||10
11366723|NCT03233737|12563333|FG001|STARTED|Overall Study||10
11366724|NCT03233737|12563334|FG002|STARTED|Overall Study||5
11366725|NCT03233737|12563335|FG003|STARTED|Overall Study||24
11366726|NCT03233737|12563336|FG004|STARTED|Overall Study||26
11366727|NCT03233737|12563332|FG000|COMPLETED|Overall Study||10
11366728|NCT03233737|12563333|FG001|COMPLETED|Overall Study||10
11366729|NCT03233737|12563334|FG002|COMPLETED|Overall Study||5
11366730|NCT03233737|12563335|FG003|COMPLETED|Overall Study||24
11366731|NCT03233737|12563336|FG004|COMPLETED|Overall Study||26
11366732|NCT03233737|12563332|FG000|NOT COMPLETED|Overall Study||0
11366733|NCT03233737|12563333|FG001|NOT COMPLETED|Overall Study||0
11366734|NCT03233737|12563334|FG002|NOT COMPLETED|Overall Study||0
11366735|NCT03233737|12563335|FG003|NOT COMPLETED|Overall Study||0
11366736|NCT03233737|12563336|FG004|NOT COMPLETED|Overall Study||0
11366737|NCT03234036|12563352|FG000|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
11366738|NCT03234036|12563353|FG001|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
11366739|NCT03234036|12563354|FG002|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
11366740|NCT03234036|12563355|FG003|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
11366741|NCT03234036|12563352|FG000|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
11366742|NCT03234036|12563353|FG001|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
11366743|NCT03234036|12563354|FG002|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
11366744|NCT03234036|12563355|FG003|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
11366745|NCT03234036|12563352|FG000|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
11366746|NCT03234036|12563353|FG001|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
11366747|NCT03234036|12563354|FG002|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
11366748|NCT03234036|12563355|FG003|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
11366749|NCT03234036|12563352|FG000|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
11366750|NCT03234036|12563353|FG001|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
11366751|NCT03234036|12563354|FG002|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
11366752|NCT03234036|12563355|FG003|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
11366753|NCT03234036|12563352|FG000|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
11366754|NCT03234036|12563353|FG001|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
11366755|NCT03234036|12563354|FG002|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
11366756|NCT03234036|12563355|FG003|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
11366757|NCT03234036|12563352|FG000|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
11366758|NCT03234036|12563353|FG001|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
11366759|NCT03234036|12563354|FG002|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
11366760|NCT03234036|12563355|FG003|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
11366761|NCT03234036|12563352|FG000|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
11366762|NCT03234036|12563353|FG001|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
11366763|NCT03234036|12563354|FG002|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
11366764|NCT03234036|12563355|FG003|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
11366765|NCT03234036|12563352|FG000|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
11366766|NCT03234036|12563353|FG001|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
11366767|NCT03234036|12563354|FG002|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
11366768|NCT03234036|12563355|FG003|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
11366769|NCT03234036|12563352|FG000|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
11366770|NCT03234036|12563353|FG001|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
11366771|NCT03234036|12563354|FG002|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
11366772|NCT03234036|12563355|FG003|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
11366773|NCT03234036|12563352|FG000|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
11366774|NCT03234036|12563353|FG001|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
11366775|NCT03234036|12563354|FG002|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
11366776|NCT03234036|12563355|FG003|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
11366777|NCT03234036|12563352|FG000|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
11366778|NCT03234036|12563353|FG001|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
11366779|NCT03234036|12563354|FG002|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
11366780|NCT03234036|12563355|FG003|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
11366781|NCT03234036|12563352|FG000|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
11366782|NCT03234036|12563353|FG001|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
11366783|NCT03234036|12563354|FG002|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
11366784|NCT03234036|12563355|FG003|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
11366785|NCT03234036|12563352|FG000|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
11366786|NCT03234036|12563353|FG001|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
11366787|NCT03234036|12563354|FG002|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
11366788|NCT03234036|12563355|FG003|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
11366789|NCT03234036|12563352|FG000|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
11366790|NCT03234036|12563353|FG001|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
11366791|NCT03234036|12563354|FG002|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
11366792|NCT03234036|12563355|FG003|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
11366793|NCT03234036|12563352|FG000|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
11366794|NCT03234036|12563353|FG001|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
11366795|NCT03234036|12563354|FG002|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
11366796|NCT03234036|12563355|FG003|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
11366797|NCT03234036|12563352|FG000|STARTED|Part 2 (Up to 25 Days)||0
11366798|NCT03234036|12563353|FG001|STARTED|Part 2 (Up to 25 Days)||0
11366799|NCT03234036|12563354|FG002|STARTED|Part 2 (Up to 25 Days)||3
11366800|NCT03234036|12563355|FG003|STARTED|Part 2 (Up to 25 Days)||7
11366801|NCT03234036|12563352|FG000|COMPLETED|Part 2 (Up to 25 Days)||0
11366802|NCT03234036|12563353|FG001|COMPLETED|Part 2 (Up to 25 Days)||0
11366803|NCT03234036|12563354|FG002|COMPLETED|Part 2 (Up to 25 Days)||3
11366804|NCT03234036|12563355|FG003|COMPLETED|Part 2 (Up to 25 Days)||7
11366805|NCT03234036|12563352|FG000|NOT COMPLETED|Part 2 (Up to 25 Days)||0
11366806|NCT03234036|12563353|FG001|NOT COMPLETED|Part 2 (Up to 25 Days)||0
11366807|NCT03234036|12563354|FG002|NOT COMPLETED|Part 2 (Up to 25 Days)||0
11366808|NCT03234036|12563355|FG003|NOT COMPLETED|Part 2 (Up to 25 Days)||0
11366809|NCT03234374|12563373|FG000|STARTED|Overall Study||35
11366810|NCT03234374|12563374|FG001|STARTED|Overall Study||17
11366811|NCT03234374|12563373|FG000|COMPLETED|Overall Study||34
11366812|NCT03234374|12563374|FG001|COMPLETED|Overall Study||16
11366813|NCT03234374|12563373|FG000|NOT COMPLETED|Overall Study||1
11366814|NCT03234374|12563374|FG001|NOT COMPLETED|Overall Study||1
11366815|NCT03234465|12563382|FG000|STARTED|Overall Study||100
11366816|NCT03234465|12563383|FG001|STARTED|Overall Study||100
11366817|NCT03234465|12563382|FG000|COMPLETED|Overall Study||67
11366818|NCT03234465|12563383|FG001|COMPLETED|Overall Study||60
11366819|NCT03234465|12563382|FG000|NOT COMPLETED|Overall Study||33
11366820|NCT03234465|12563383|FG001|NOT COMPLETED|Overall Study||40
11366821|NCT03234608|12563391|FG000|STARTED|Overall Study||127
11366822|NCT03234608|12563392|FG001|STARTED|Overall Study||117
11366823|NCT03234608|12563391|FG000|COMPLETED|Overall Study||104
11366824|NCT03234608|12563392|FG001|COMPLETED|Overall Study||96
11366825|NCT03234608|12563391|FG000|NOT COMPLETED|Overall Study||23
11366826|NCT03234608|12563392|FG001|NOT COMPLETED|Overall Study||21
11366827|NCT03235050|12563403|FG000|STARTED|Overall Study||112
11366828|NCT03235050|12563404|FG001|STARTED|Overall Study||110
11366829|NCT03235050|12563405|FG002|STARTED|Overall Study||100
11366830|NCT03235050|12563406|FG003|STARTED|Overall Study||256
11366831|NCT03235050|12563407|FG004|STARTED|Overall Study||256
11366832|NCT03235050|12563403|FG000|COMPLETED|Overall Study||108
11366833|NCT03235050|12563404|FG001|COMPLETED|Overall Study||105
11366834|NCT03235050|12563405|FG002|COMPLETED|Overall Study||96
11366835|NCT03235050|12563406|FG003|COMPLETED|Overall Study||242
11366836|NCT03235050|12563407|FG004|COMPLETED|Overall Study||245
11366837|NCT03235050|12563403|FG000|NOT COMPLETED|Overall Study||4
11366838|NCT03235050|12563404|FG001|NOT COMPLETED|Overall Study||5
11366839|NCT03235050|12563405|FG002|NOT COMPLETED|Overall Study||4
11366840|NCT03235050|12563406|FG003|NOT COMPLETED|Overall Study||14
11366841|NCT03235050|12563407|FG004|NOT COMPLETED|Overall Study||11
11366842|NCT03235089|12563419|FG000|STARTED|Overall Study||31
11366843|NCT03235089|12563420|FG001|STARTED|Overall Study||31
11366844|NCT03235089|12563419|FG000|COMPLETED|Overall Study||28
11366845|NCT03235089|12563420|FG001|COMPLETED|Overall Study||28
11366846|NCT03235089|12563419|FG000|NOT COMPLETED|Overall Study||3
11366847|NCT03235089|12563420|FG001|NOT COMPLETED|Overall Study||3
11366848|NCT03235115|12563427|FG000|STARTED|First Intervention (1 Hour, Visit 2)||9
11366849|NCT03235115|12563428|FG001|STARTED|First Intervention (1 Hour, Visit 2)||6
11366850|NCT03235115|12563429|FG002|STARTED|First Intervention (1 Hour, Visit 2)||7
11366851|NCT03235115|12563430|FG003|STARTED|First Intervention (1 Hour, Visit 2)||6
11366852|NCT03235115|12563431|FG004|STARTED|First Intervention (1 Hour, Visit 2)||6
11366853|NCT03235115|12563432|FG005|STARTED|First Intervention (1 Hour, Visit 2)||6
11366854|NCT03235115|12563427|FG000|COMPLETED|First Intervention (1 Hour, Visit 2)||9
11366855|NCT03235115|12563428|FG001|COMPLETED|First Intervention (1 Hour, Visit 2)||6
11366856|NCT03235115|12563429|FG002|COMPLETED|First Intervention (1 Hour, Visit 2)||7
11366857|NCT03235115|12563430|FG003|COMPLETED|First Intervention (1 Hour, Visit 2)||6
11366858|NCT03235115|12563431|FG004|COMPLETED|First Intervention (1 Hour, Visit 2)||6
11366859|NCT03235115|12563432|FG005|COMPLETED|First Intervention (1 Hour, Visit 2)||5
11366860|NCT03235115|12563427|FG000|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
11366861|NCT03235115|12563428|FG001|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
11366862|NCT03235115|12563429|FG002|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
11366863|NCT03235115|12563430|FG003|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
11366864|NCT03235115|12563431|FG004|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
11366865|NCT03235115|12563432|FG005|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
11366866|NCT03235115|12563427|FG000|STARTED|Second Intervention (1 Hour, Visit 4)||9
11366867|NCT03235115|12563428|FG001|STARTED|Second Intervention (1 Hour, Visit 4)||6
11366868|NCT03235115|12563429|FG002|STARTED|Second Intervention (1 Hour, Visit 4)||7
11366869|NCT03235115|12563430|FG003|STARTED|Second Intervention (1 Hour, Visit 4)||6
11366870|NCT03235115|12563431|FG004|STARTED|Second Intervention (1 Hour, Visit 4)||6
11366871|NCT03235115|12563432|FG005|STARTED|Second Intervention (1 Hour, Visit 4)||5
11366872|NCT03235115|12563427|FG000|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
11366873|NCT03235115|12563428|FG001|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
11366874|NCT03235115|12563429|FG002|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
11366875|NCT03235115|12563430|FG003|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
11366876|NCT03235115|12563431|FG004|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
11366877|NCT03235115|12563432|FG005|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
11366878|NCT03235115|12563427|FG000|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
11366879|NCT03235115|12563428|FG001|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
11366880|NCT03235115|12563429|FG002|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
11366881|NCT03235115|12563430|FG003|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
11366882|NCT03235115|12563431|FG004|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
11366883|NCT03235115|12563432|FG005|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
11366884|NCT03235115|12563427|FG000|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
11366885|NCT03235115|12563428|FG001|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
11366886|NCT03235115|12563429|FG002|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
11366887|NCT03235115|12563430|FG003|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
11366888|NCT03235115|12563431|FG004|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
11366889|NCT03235115|12563432|FG005|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
11366890|NCT03235115|12563427|FG000|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
11366891|NCT03235115|12563428|FG001|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
11366892|NCT03235115|12563429|FG002|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
11366893|NCT03235115|12563430|FG003|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
11366894|NCT03235115|12563431|FG004|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
11366895|NCT03235115|12563432|FG005|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
11366896|NCT03235115|12563427|FG000|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
11366897|NCT03235115|12563428|FG001|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
11366898|NCT03235115|12563429|FG002|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
11366899|NCT03235115|12563430|FG003|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
11366900|NCT03235115|12563431|FG004|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
11366901|NCT03235115|12563432|FG005|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
11366902|NCT03235154|12563440|FG000|STARTED|Overall Study||11
11366903|NCT03235154|12563440|FG000|Completed Epclusa. Treatment|Overall Study||8
11366904|NCT03235154|12563440|FG000|12-wk Post-treatment HCV RNA Measured|Overall Study||7
11366905|NCT03235154|12563440|FG000|COMPLETED|Overall Study||7
11366906|NCT03235154|12563440|FG000|NOT COMPLETED|Overall Study||4
11366907|NCT03235180|12563446|FG000|STARTED|Overall Study||9
11366908|NCT03235180|12563446|FG000|COMPLETED|Overall Study||9
11366909|NCT03235180|12563446|FG000|NOT COMPLETED|Overall Study||0
11366910|NCT03235284|12563453|FG000|STARTED|Overall Study||15
11366911|NCT03235284|12563454|FG001|STARTED|Overall Study||15
11366912|NCT03235284|12563455|FG002|STARTED|Overall Study||15
11366913|NCT03235284|12563453|FG000|COMPLETED|Overall Study||14
11366914|NCT03235284|12563454|FG001|COMPLETED|Overall Study||13
11366915|NCT03235284|12563455|FG002|COMPLETED|Overall Study||14
11366916|NCT03235284|12563453|FG000|NOT COMPLETED|Overall Study||1
11366917|NCT03235284|12563454|FG001|NOT COMPLETED|Overall Study||2
11366918|NCT03235284|12563455|FG002|NOT COMPLETED|Overall Study||1
11366919|NCT03235349|12563463|FG000|STARTED|Overall Study||160
11366920|NCT03235349|12563463|FG000|COMPLETED|Overall Study||158
11366921|NCT03235349|12563463|FG000|NOT COMPLETED|Overall Study||2
11366922|NCT03235414|12563467|FG000|STARTED|Overall Study||101
11366923|NCT03235414|12563467|FG000|COMPLETED|Overall Study||101
11366924|NCT03235414|12563467|FG000|NOT COMPLETED|Overall Study||0
11366925|NCT03235479|12563473|FG000|STARTED|Overall Study||582
11366926|NCT03235479|12563474|FG001|STARTED|Overall Study||580
11366927|NCT03235479|12563473|FG000|Treated|Overall Study||546
11366928|NCT03235479|12563474|FG001|Treated|Overall Study||549
11366929|NCT03235479|12563473|FG000|COMPLETED|Overall Study||541
11366930|NCT03235479|12563474|FG001|COMPLETED|Overall Study||540
11366931|NCT03235479|12563473|FG000|NOT COMPLETED|Overall Study||41
11366932|NCT03235479|12563474|FG001|NOT COMPLETED|Overall Study||40
11366933|NCT03235726|12563488|FG000|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6
11366934|NCT03235726|12563489|FG001|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
11366935|NCT03235726|12563490|FG002|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
11366936|NCT03235726|12563491|FG003|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2
11366937|NCT03235726|12563492|FG004|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
11366938|NCT03235726|12563493|FG005|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
11366939|NCT03235726|12563494|FG006|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
11366940|NCT03235726|12563495|FG007|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
11366941|NCT03235726|12563496|FG008|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
11366942|NCT03235726|12563497|FG009|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
11366943|NCT03235726|12563488|FG000|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6
11366944|NCT03235726|12563489|FG001|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366945|NCT03235726|12563490|FG002|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366946|NCT03235726|12563491|FG003|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2
11366947|NCT03235726|12563492|FG004|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366948|NCT03235726|12563493|FG005|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366949|NCT03235726|12563494|FG006|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366950|NCT03235726|12563495|FG007|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366951|NCT03235726|12563496|FG008|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366952|NCT03235726|12563497|FG009|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366953|NCT03235726|12563488|FG000|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366954|NCT03235726|12563489|FG001|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366955|NCT03235726|12563490|FG002|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366956|NCT03235726|12563491|FG003|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366957|NCT03235726|12563492|FG004|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366958|NCT03235726|12563493|FG005|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366959|NCT03235726|12563494|FG006|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366960|NCT03235726|12563495|FG007|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366961|NCT03235726|12563496|FG008|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366962|NCT03235726|12563497|FG009|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
11366963|NCT03235726|12563488|FG000|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
11366964|NCT03235726|12563489|FG001|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6
11366965|NCT03235726|12563490|FG002|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
11366966|NCT03235726|12563491|FG003|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2
11366967|NCT03235726|12563492|FG004|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
11366968|NCT03235726|12563493|FG005|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
11366969|NCT03235726|12563494|FG006|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
11366970|NCT03235726|12563495|FG007|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
11366971|NCT03235726|12563496|FG008|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
11366972|NCT03235726|12563497|FG009|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
11366973|NCT03235726|12563488|FG000|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366974|NCT03235726|12563489|FG001|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6
11366975|NCT03235726|12563490|FG002|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366976|NCT03235726|12563491|FG003|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2
11366977|NCT03235726|12563492|FG004|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366978|NCT03235726|12563493|FG005|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366979|NCT03235726|12563494|FG006|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366980|NCT03235726|12563495|FG007|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366981|NCT03235726|12563496|FG008|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366982|NCT03235726|12563497|FG009|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366983|NCT03235726|12563488|FG000|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366984|NCT03235726|12563489|FG001|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366985|NCT03235726|12563490|FG002|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366986|NCT03235726|12563491|FG003|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366987|NCT03235726|12563492|FG004|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366988|NCT03235726|12563493|FG005|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366989|NCT03235726|12563494|FG006|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366990|NCT03235726|12563495|FG007|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366991|NCT03235726|12563496|FG008|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366992|NCT03235726|12563497|FG009|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
11366993|NCT03235726|12563488|FG000|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11366994|NCT03235726|12563489|FG001|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11366995|NCT03235726|12563490|FG002|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
11366996|NCT03235726|12563491|FG003|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
11366997|NCT03235726|12563492|FG004|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11366998|NCT03235726|12563493|FG005|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11366999|NCT03235726|12563494|FG006|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367000|NCT03235726|12563495|FG007|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367001|NCT03235726|12563496|FG008|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367002|NCT03235726|12563497|FG009|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367003|NCT03235726|12563488|FG000|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367004|NCT03235726|12563489|FG001|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367005|NCT03235726|12563490|FG002|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
11367006|NCT03235726|12563491|FG003|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
11367007|NCT03235726|12563492|FG004|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367008|NCT03235726|12563493|FG005|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367009|NCT03235726|12563494|FG006|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367010|NCT03235726|12563495|FG007|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367011|NCT03235726|12563496|FG008|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367012|NCT03235726|12563497|FG009|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367013|NCT03235726|12563488|FG000|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367014|NCT03235726|12563489|FG001|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367015|NCT03235726|12563490|FG002|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367016|NCT03235726|12563491|FG003|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367017|NCT03235726|12563492|FG004|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367018|NCT03235726|12563493|FG005|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367019|NCT03235726|12563494|FG006|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367020|NCT03235726|12563495|FG007|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367021|NCT03235726|12563496|FG008|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367022|NCT03235726|12563497|FG009|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
11367023|NCT03235726|12563488|FG000|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367024|NCT03235726|12563489|FG001|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367025|NCT03235726|12563490|FG002|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367026|NCT03235726|12563491|FG003|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367027|NCT03235726|12563492|FG004|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12
11367028|NCT03235726|12563493|FG005|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2
11367029|NCT03235726|12563494|FG006|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14
11367030|NCT03235726|12563495|FG007|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367031|NCT03235726|12563496|FG008|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367032|NCT03235726|12563497|FG009|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367033|NCT03235726|12563488|FG000|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367034|NCT03235726|12563489|FG001|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367035|NCT03235726|12563490|FG002|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367036|NCT03235726|12563491|FG003|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367037|NCT03235726|12563492|FG004|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10
11367038|NCT03235726|12563493|FG005|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
11367039|NCT03235726|12563494|FG006|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14
11367040|NCT03235726|12563495|FG007|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367041|NCT03235726|12563496|FG008|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367042|NCT03235726|12563497|FG009|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367043|NCT03235726|12563488|FG000|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367044|NCT03235726|12563489|FG001|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367045|NCT03235726|12563490|FG002|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367046|NCT03235726|12563491|FG003|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367047|NCT03235726|12563492|FG004|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
11367048|NCT03235726|12563493|FG005|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367049|NCT03235726|12563494|FG006|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367050|NCT03235726|12563495|FG007|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367051|NCT03235726|12563496|FG008|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367052|NCT03235726|12563497|FG009|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
11367053|NCT03235726|12563488|FG000|STARTED|Part 2 (Cohort A - Day 1)||0
11367054|NCT03235726|12563489|FG001|STARTED|Part 2 (Cohort A - Day 1)||0
11367055|NCT03235726|12563490|FG002|STARTED|Part 2 (Cohort A - Day 1)||0
11367056|NCT03235726|12563491|FG003|STARTED|Part 2 (Cohort A - Day 1)||0
11367057|NCT03235726|12563492|FG004|STARTED|Part 2 (Cohort A - Day 1)||0
11367058|NCT03235726|12563493|FG005|STARTED|Part 2 (Cohort A - Day 1)||0
11367059|NCT03235726|12563494|FG006|STARTED|Part 2 (Cohort A - Day 1)||0
11367060|NCT03235726|12563495|FG007|STARTED|Part 2 (Cohort A - Day 1)||6
11367061|NCT03235726|12563496|FG008|STARTED|Part 2 (Cohort A - Day 1)||2
11367062|NCT03235726|12563497|FG009|STARTED|Part 2 (Cohort A - Day 1)||0
11367063|NCT03235726|12563488|FG000|COMPLETED|Part 2 (Cohort A - Day 1)||0
11367064|NCT03235726|12563489|FG001|COMPLETED|Part 2 (Cohort A - Day 1)||0
11367065|NCT03235726|12563490|FG002|COMPLETED|Part 2 (Cohort A - Day 1)||0
11367066|NCT03235726|12563491|FG003|COMPLETED|Part 2 (Cohort A - Day 1)||0
11367067|NCT03235726|12563492|FG004|COMPLETED|Part 2 (Cohort A - Day 1)||0
11367068|NCT03235726|12563493|FG005|COMPLETED|Part 2 (Cohort A - Day 1)||0
11367069|NCT03235726|12563494|FG006|COMPLETED|Part 2 (Cohort A - Day 1)||0
11367070|NCT03235726|12563495|FG007|COMPLETED|Part 2 (Cohort A - Day 1)||6
11367071|NCT03235726|12563496|FG008|COMPLETED|Part 2 (Cohort A - Day 1)||2
11367072|NCT03235726|12563497|FG009|COMPLETED|Part 2 (Cohort A - Day 1)||0
11367073|NCT03235726|12563488|FG000|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
11367074|NCT03235726|12563489|FG001|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
11367075|NCT03235726|12563490|FG002|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
11367076|NCT03235726|12563491|FG003|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
11367077|NCT03235726|12563492|FG004|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
11367078|NCT03235726|12563493|FG005|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
11367079|NCT03235726|12563494|FG006|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
11367080|NCT03235726|12563495|FG007|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
11367081|NCT03235726|12563496|FG008|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
11367082|NCT03235726|12563497|FG009|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
11367083|NCT03235726|12563488|FG000|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
11367084|NCT03235726|12563489|FG001|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
11367085|NCT03235726|12563490|FG002|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
11367086|NCT03235726|12563491|FG003|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
11367087|NCT03235726|12563492|FG004|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
11367088|NCT03235726|12563493|FG005|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
11367089|NCT03235726|12563494|FG006|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
11367090|NCT03235726|12563495|FG007|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
11367091|NCT03235726|12563496|FG008|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
11367092|NCT03235726|12563497|FG009|STARTED|Part 2 (Cohort B - Days 1 to 14)||8
11367093|NCT03235726|12563488|FG000|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367094|NCT03235726|12563489|FG001|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367095|NCT03235726|12563490|FG002|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367096|NCT03235726|12563491|FG003|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367097|NCT03235726|12563492|FG004|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367098|NCT03235726|12563493|FG005|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367099|NCT03235726|12563494|FG006|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367100|NCT03235726|12563495|FG007|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367101|NCT03235726|12563496|FG008|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367102|NCT03235726|12563497|FG009|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8
11367103|NCT03235726|12563488|FG000|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367104|NCT03235726|12563489|FG001|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367105|NCT03235726|12563490|FG002|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367106|NCT03235726|12563491|FG003|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367107|NCT03235726|12563492|FG004|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367108|NCT03235726|12563493|FG005|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367109|NCT03235726|12563494|FG006|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367110|NCT03235726|12563495|FG007|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367111|NCT03235726|12563496|FG008|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367112|NCT03235726|12563497|FG009|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
11367113|NCT03236168|12563532|FG000|STARTED|Overall Study||118
11367114|NCT03236168|12563532|FG000|COMPLETED|Overall Study||107
11367115|NCT03236168|12563532|FG000|NOT COMPLETED|Overall Study||11
11367116|NCT03236246|12563538|FG000|STARTED|24-Week Dose Titration Period||104
11367117|NCT03236246|12563539|FG001|STARTED|24-Week Dose Titration Period||102
11367118|NCT03236246|12563538|FG000|COMPLETED|24-Week Dose Titration Period||80
11367119|NCT03236246|12563539|FG001|COMPLETED|24-Week Dose Titration Period||75
11367120|NCT03236246|12563538|FG000|NOT COMPLETED|24-Week Dose Titration Period||24
11367121|NCT03236246|12563539|FG001|NOT COMPLETED|24-Week Dose Titration Period||27
11367122|NCT03236246|12563538|FG000|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|76
11367123|NCT03236246|12563539|FG001|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|72
11367124|NCT03236246|12563538|FG000|COMPLETED|24-Week Dose Maintenance Period||73
11367125|NCT03236246|12563539|FG001|COMPLETED|24-Week Dose Maintenance Period||66
11367126|NCT03236246|12563538|FG000|NOT COMPLETED|24-Week Dose Maintenance Period||3
11367127|NCT03236246|12563539|FG001|NOT COMPLETED|24-Week Dose Maintenance Period||6
11367128|NCT03236506|12563548|FG000|STARTED|Overall Study||39
11367129|NCT03236506|12563549|FG001|STARTED|Overall Study||42
11367130|NCT03236506|12563550|FG002|STARTED|Overall Study||47
11367131|NCT03236506|12563548|FG000|COMPLETED|Overall Study||33
11367132|NCT03236506|12563549|FG001|COMPLETED|Overall Study||37
11367133|NCT03236506|12563550|FG002|COMPLETED|Overall Study||40
11367134|NCT03236506|12563548|FG000|NOT COMPLETED|Overall Study||6
11367135|NCT03236506|12563549|FG001|NOT COMPLETED|Overall Study||5
11367136|NCT03236506|12563550|FG002|NOT COMPLETED|Overall Study||7
11367137|NCT03236779|12563560|FG000|STARTED|Overall Study||51
11367138|NCT03236779|12563561|FG001|STARTED|Overall Study||51
11367139|NCT03236779|12563560|FG000|COMPLETED|Overall Study||38
11367140|NCT03236779|12563561|FG001|COMPLETED|Overall Study||30
11367141|NCT03236779|12563560|FG000|NOT COMPLETED|Overall Study||13
11367142|NCT03236779|12563561|FG001|NOT COMPLETED|Overall Study||21
11367143|NCT03237013|12563572|FG000|STARTED|Baseline to Immediate Post-treatment||73
11367144|NCT03237013|12563573|FG001|STARTED|Baseline to Immediate Post-treatment||73
11367145|NCT03237013|12563574|FG002|STARTED|Baseline to Immediate Post-treatment||73
11367146|NCT03237013|12563572|FG000|COMPLETED|Baseline to Immediate Post-treatment||73
11367147|NCT03237013|12563573|FG001|COMPLETED|Baseline to Immediate Post-treatment||73
11367148|NCT03237013|12563574|FG002|COMPLETED|Baseline to Immediate Post-treatment||73
11367149|NCT03237013|12563572|FG000|NOT COMPLETED|Baseline to Immediate Post-treatment||0
11367150|NCT03237013|12563573|FG001|NOT COMPLETED|Baseline to Immediate Post-treatment||0
11367151|NCT03237013|12563574|FG002|NOT COMPLETED|Baseline to Immediate Post-treatment||0
11367152|NCT03237013|12563572|FG000|STARTED|Immediate Post-treatment to 1-mo F/u||73
11367153|NCT03237013|12563573|FG001|STARTED|Immediate Post-treatment to 1-mo F/u||73
11367154|NCT03237013|12563574|FG002|STARTED|Immediate Post-treatment to 1-mo F/u||73
11367155|NCT03237013|12563572|FG000|COMPLETED|Immediate Post-treatment to 1-mo F/u||30
11367156|NCT03237013|12563573|FG001|COMPLETED|Immediate Post-treatment to 1-mo F/u||43
11367157|NCT03237013|12563574|FG002|COMPLETED|Immediate Post-treatment to 1-mo F/u||36
11367158|NCT03237013|12563572|FG000|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43
11367159|NCT03237013|12563573|FG001|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30
11367160|NCT03237013|12563574|FG002|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37
11367161|NCT03237065|12563584|FG000|STARTED|Overall Study||61
11367162|NCT03237065|12563585|FG001|STARTED|Overall Study||61
11367163|NCT03237065|12563584|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|62
11367164|NCT03237065|12563585|FG001|Safety Analysis Set|Overall Study||57
11367165|NCT03237065|12563584|FG000|COMPLETED|Overall Study||57
11367166|NCT03237065|12563585|FG001|COMPLETED|Overall Study||57
11367167|NCT03237065|12563584|FG000|NOT COMPLETED|Overall Study||4
11367168|NCT03237065|12563585|FG001|NOT COMPLETED|Overall Study||4
11367169|NCT03237156|12563595|FG000|STARTED|Overall Study||6
11367170|NCT03237156|12563596|FG001|STARTED|Overall Study||6
11367171|NCT03237156|12563597|FG002|STARTED|Overall Study||6
11367172|NCT03237156|12563598|FG003|STARTED|Overall Study||6
11367173|NCT03237156|12563595|FG000|COMPLETED|Overall Study||6
11367174|NCT03237156|12563596|FG001|COMPLETED|Overall Study||6
11367175|NCT03237156|12563597|FG002|COMPLETED|Overall Study||6
11367176|NCT03237156|12563598|FG003|COMPLETED|Overall Study||6
11367177|NCT03237156|12563595|FG000|NOT COMPLETED|Overall Study||0
11367178|NCT03237156|12563596|FG001|NOT COMPLETED|Overall Study||0
11367179|NCT03237156|12563597|FG002|NOT COMPLETED|Overall Study||0
11367180|NCT03237156|12563598|FG003|NOT COMPLETED|Overall Study||0
11367181|NCT03237481|12563614|FG000|STARTED|Overall Study||164
11367182|NCT03237481|12563615|FG001|STARTED|Overall Study||172
11367183|NCT03237481|12563616|FG002|STARTED|Overall Study||82
11367184|NCT03237481|12563614|FG000|COMPLETED|Overall Study||159
11367185|NCT03237481|12563615|FG001|COMPLETED|Overall Study||170
11367186|NCT03237481|12563616|FG002|COMPLETED|Overall Study||81
11367187|NCT03237481|12563614|FG000|NOT COMPLETED|Overall Study||5
11367188|NCT03237481|12563615|FG001|NOT COMPLETED|Overall Study||2
11367189|NCT03237481|12563616|FG002|NOT COMPLETED|Overall Study||1
11367190|NCT03237845|12563626|FG000|STARTED|Overall Study||594
11367191|NCT03237845|12563627|FG001|STARTED|Overall Study||592
11367192|NCT03237845|12563626|FG000|Treated|Overall Study||543
11367193|NCT03237845|12563627|FG001|Treated|Overall Study||543
11367194|NCT03237845|12563626|FG000|COMPLETED|Overall Study||538
11367195|NCT03237845|12563627|FG001|COMPLETED|Overall Study||542
11367196|NCT03237845|12563626|FG000|NOT COMPLETED|Overall Study||56
11367197|NCT03237845|12563627|FG001|NOT COMPLETED|Overall Study||50
11367198|NCT03237871|12563633|FG000|STARTED|Overall Study||17
11367199|NCT03237871|12563633|FG000|COMPLETED|Overall Study||11
11367200|NCT03237871|12563633|FG000|NOT COMPLETED|Overall Study||6
11367201|NCT03238001|12563637|FG000|STARTED|Visit 1 (Primary Endpoint Cohort)||436
11367202|NCT03238001|12563637|FG000|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
11367203|NCT03238001|12563637|FG000|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
11367204|NCT03238001|12563637|FG000|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
11367205|NCT03238001|12563637|FG000|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
11367206|NCT03238001|12563637|FG000|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
11367207|NCT03238352|12563652|FG000|STARTED|Overall Study||43
11367208|NCT03238352|12563653|FG001|STARTED|Overall Study||23
11367209|NCT03238352|12563654|FG002|STARTED|Overall Study||23
11367210|NCT03238352|12563652|FG000|COMPLETED|Overall Study||43
11367211|NCT03238352|12563653|FG001|COMPLETED|Overall Study||20
11367212|NCT03238352|12563654|FG002|COMPLETED|Overall Study||22
11367213|NCT03238352|12563652|FG000|NOT COMPLETED|Overall Study||0
11367214|NCT03238352|12563653|FG001|NOT COMPLETED|Overall Study||3
11367215|NCT03238352|12563654|FG002|NOT COMPLETED|Overall Study||1
11367216|NCT03238417|12563664|FG000|STARTED|Overall||1330
11367217|NCT03238417|12563665|FG001|STARTED|Overall||2632
11367218|NCT03238417|12563664|FG000|COMPLETED|Overall||327
11367219|NCT03238417|12563665|FG001|COMPLETED|Overall||644
11367220|NCT03238417|12563664|FG000|NOT COMPLETED|Overall||1003
11367221|NCT03238417|12563665|FG001|NOT COMPLETED|Overall||1988
11367222|NCT03238417|12563664|FG000|STARTED|Baseline||513
11367223|NCT03238417|12563665|FG001|STARTED|Baseline||934
11367224|NCT03238417|12563664|FG000|COMPLETED|Baseline||124
11367225|NCT03238417|12563665|FG001|COMPLETED|Baseline||217
11367226|NCT03238417|12563664|FG000|NOT COMPLETED|Baseline||389
11367227|NCT03238417|12563665|FG001|NOT COMPLETED|Baseline||717
11367228|NCT03238417|12563664|FG000|STARTED|12-month||400
11367229|NCT03238417|12563665|FG001|STARTED|12-month||911
11367230|NCT03238417|12563664|FG000|COMPLETED|12-month||81
11367231|NCT03238417|12563665|FG001|COMPLETED|12-month||205
11367232|NCT03238417|12563664|FG000|NOT COMPLETED|12-month||319
11367233|NCT03238417|12563665|FG001|NOT COMPLETED|12-month||706
11367234|NCT03238417|12563664|FG000|STARTED|24-month||417
11367235|NCT03238417|12563665|FG001|STARTED|24-month||847
11367236|NCT03238417|12563664|FG000|COMPLETED|24-month||122
11367237|NCT03238417|12563665|FG001|COMPLETED|24-month||222
11367238|NCT03238417|12563664|FG000|NOT COMPLETED|24-month||295
11367239|NCT03238417|12563665|FG001|NOT COMPLETED|24-month||625
11367240|NCT03238651|12563676|FG000|STARTED|Overall Study||3
11367241|NCT03238651|12563677|FG001|STARTED|Overall Study||6
11367242|NCT03238651|12563678|FG002|STARTED|Overall Study||4
11367243|NCT03238651|12563679|FG003|STARTED|Overall Study||3
11367244|NCT03238651|12563680|FG004|STARTED|Overall Study||1
11367245|NCT03238651|12563676|FG000|COMPLETED|Overall Study||0
11367246|NCT03238651|12563677|FG001|COMPLETED|Overall Study||0
11367247|NCT03238651|12563678|FG002|COMPLETED|Overall Study||0
11367248|NCT03238651|12563679|FG003|COMPLETED|Overall Study||0
11367249|NCT03238651|12563680|FG004|COMPLETED|Overall Study||0
11367250|NCT03238651|12563676|FG000|NOT COMPLETED|Overall Study||3
11367251|NCT03238651|12563677|FG001|NOT COMPLETED|Overall Study||6
11367252|NCT03238651|12563678|FG002|NOT COMPLETED|Overall Study||4
11367253|NCT03238651|12563679|FG003|NOT COMPLETED|Overall Study||3
11367254|NCT03238651|12563680|FG004|NOT COMPLETED|Overall Study||1
11367255|NCT03238781|12563696|FG000|STARTED|Overall Study||137
11367256|NCT03238781|12563697|FG001|STARTED|Overall Study||104
11367257|NCT03238781|12563698|FG002|STARTED|Overall Study||102
11367258|NCT03238781|12563696|FG000|COMPLETED|Overall Study||111
11367259|NCT03238781|12563697|FG001|COMPLETED|Overall Study||87
11367260|NCT03238781|12563698|FG002|COMPLETED|Overall Study||82
11367261|NCT03238781|12563696|FG000|NOT COMPLETED|Overall Study||26
11367262|NCT03238781|12563697|FG001|NOT COMPLETED|Overall Study||17
11367263|NCT03238781|12563698|FG002|NOT COMPLETED|Overall Study||20
11367264|NCT03238911|12563708|FG000|STARTED|Overall Study||62
11367265|NCT03238911|12563709|FG001|STARTED|Overall Study||61
11367266|NCT03238911|12563708|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|63
11367267|NCT03238911|12563709|FG001|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|60
11367268|NCT03238911|12563708|FG000|COMPLETED|Overall Study||59
11367269|NCT03238911|12563709|FG001|COMPLETED|Overall Study||58
11367270|NCT03238911|12563708|FG000|NOT COMPLETED|Overall Study||3
11367271|NCT03238911|12563709|FG001|NOT COMPLETED|Overall Study||3
11367272|NCT03238924|12563718|FG000|STARTED|Overall Study||8
11367273|NCT03238924|12563719|FG001|STARTED|Overall Study||9
11367274|NCT03238924|12563718|FG000|COMPLETED|Overall Study||6
11367275|NCT03238924|12563719|FG001|COMPLETED|Overall Study||7
11367276|NCT03238924|12563718|FG000|NOT COMPLETED|Overall Study||2
11367277|NCT03238924|12563719|FG001|NOT COMPLETED|Overall Study||2
11367278|NCT03238963|12563727|FG000|STARTED|Overall Study||40
11367279|NCT03238963|12563728|FG001|STARTED|Overall Study||39
11367280|NCT03238963|12563727|FG000|COMPLETED|Overall Study||35
11367281|NCT03238963|12563728|FG001|COMPLETED|Overall Study||37
11367282|NCT03238963|12563727|FG000|NOT COMPLETED|Overall Study||5
11367283|NCT03238963|12563728|FG001|NOT COMPLETED|Overall Study||2
11367284|NCT03239106|12563734|FG000|STARTED|Overall Study||10
11367285|NCT03239106|12563734|FG000|COMPLETED|Overall Study||3
11367286|NCT03239106|12563734|FG000|NOT COMPLETED|Overall Study||7
11367287|NCT03239470|12563739|FG000|STARTED|Blood Donation||5
11367288|NCT03239470|12563740|FG001|STARTED|Blood Donation||0
11367289|NCT03239470|12563739|FG000|COMPLETED|Blood Donation||5
11367290|NCT03239470|12563740|FG001|COMPLETED|Blood Donation||0
11367291|NCT03239470|12563739|FG000|NOT COMPLETED|Blood Donation||0
11367292|NCT03239470|12563740|FG001|NOT COMPLETED|Blood Donation||0
11367293|NCT03239470|12563739|FG000|STARTED|Polyclonal Treg Infusion|Started includes all participants who completed the pre-infusion checklist at the infusion visit.|5
11367294|NCT03239470|12563740|FG001|STARTED|Polyclonal Treg Infusion||0
11367295|NCT03239470|12563739|FG000|COMPLETED|Polyclonal Treg Infusion|Participants who did not meet eligibility, per the pre-infusion checklist, did not complete study infusion.|4
11367296|NCT03239470|12563740|FG001|COMPLETED|Polyclonal Treg Infusion||0
11367297|NCT03239470|12563739|FG000|NOT COMPLETED|Polyclonal Treg Infusion||1
11367298|NCT03239470|12563740|FG001|NOT COMPLETED|Polyclonal Treg Infusion||0
11367299|NCT03239483|12563746|FG000|STARTED|Overall Study||19
11367300|NCT03239483|12563747|FG001|STARTED|Overall Study||9
11367301|NCT03239483|12563746|FG000|COMPLETED|Overall Study||17
11367302|NCT03239483|12563747|FG001|COMPLETED|Overall Study||9
11367303|NCT03239483|12563746|FG000|NOT COMPLETED|Overall Study||2
11367304|NCT03239483|12563747|FG001|NOT COMPLETED|Overall Study||0
11367305|NCT03239496|12563757|FG000|STARTED|Overall Study||200
11367306|NCT03239496|12563758|FG001|STARTED|Overall Study||178
11367307|NCT03239496|12563759|FG002|STARTED|Overall Study||178
11367308|NCT03239496|12563760|FG003|STARTED|Overall Study||217
11367309|NCT03239496|12563757|FG000|COMPLETED|Overall Study||186
11367310|NCT03239496|12563758|FG001|COMPLETED|Overall Study||168
11367311|NCT03239496|12563759|FG002|COMPLETED|Overall Study||166
11367312|NCT03239496|12563760|FG003|COMPLETED|Overall Study||203
11367313|NCT03239496|12563757|FG000|NOT COMPLETED|Overall Study||14
11367314|NCT03239496|12563758|FG001|NOT COMPLETED|Overall Study||10
11367315|NCT03239496|12563759|FG002|NOT COMPLETED|Overall Study||12
11367316|NCT03239496|12563760|FG003|NOT COMPLETED|Overall Study||14
11367317|NCT03239522|12563774|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||6
11367318|NCT03239522|12563774|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||6
11367319|NCT03239522|12563774|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
11367320|NCT03239522|12563774|FG000|STARTED|Washout Period (Up to 7 Days)||6
11367321|NCT03239522|12563774|FG000|COMPLETED|Washout Period (Up to 7 Days)||6
11367322|NCT03239522|12563774|FG000|NOT COMPLETED|Washout Period (Up to 7 Days)||0
11367323|NCT03239522|12563774|FG000|STARTED|Treatment Period 2 (Up to 15 Days)||6
11367324|NCT03239522|12563774|FG000|COMPLETED|Treatment Period 2 (Up to 15 Days)||6
11367325|NCT03239522|12563774|FG000|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0
11367326|NCT03239574|12563785|FG000|STARTED|Overall Study||34
11367327|NCT03239574|12563785|FG000|COMPLETED|Overall Study||34
11367328|NCT03239574|12563785|FG000|NOT COMPLETED|Overall Study||0
11367329|NCT03239665|12563791|FG000|STARTED|Overall Study||175
11367330|NCT03239665|12563792|FG001|STARTED|Overall Study||160
11367331|NCT03239665|12563791|FG000|Met Inclusion Criteria|Overall Study||150
11367332|NCT03239665|12563792|FG001|Met Inclusion Criteria|Overall Study||144
11367333|NCT03239665|12563791|FG000|Submitted Survey Data|Overall Study||147
11367334|NCT03239665|12563792|FG001|Submitted Survey Data|Overall Study||140
11367335|NCT03239665|12563791|FG000|COMPLETED|Overall Study||147
11367336|NCT03239665|12563792|FG001|COMPLETED|Overall Study||140
11367337|NCT03239665|12563791|FG000|NOT COMPLETED|Overall Study||28
11367338|NCT03239665|12563792|FG001|NOT COMPLETED|Overall Study||20
11367339|NCT03239873|12563800|FG000|STARTED|Overall Study||300
11367340|NCT03239873|12563801|FG001|STARTED|Overall Study||300
11367341|NCT03239873|12563800|FG000|Vaccination 1|Overall Study||299
11367342|NCT03239873|12563801|FG001|Vaccination 1|Overall Study||300
11367343|NCT03239873|12563800|FG000|Vaccination 2|Overall Study||276
11367344|NCT03239873|12563801|FG001|Vaccination 2|Overall Study||282
11367345|NCT03239873|12563800|FG000|COMPLETED|Overall Study||268
11367346|NCT03239873|12563801|FG001|COMPLETED|Overall Study||273
11367347|NCT03239873|12563800|FG000|NOT COMPLETED|Overall Study||32
11367348|NCT03239873|12563801|FG001|NOT COMPLETED|Overall Study||27
11367349|NCT03240081|12563809|FG000|STARTED|Overall Study||25
11367350|NCT03240081|12563810|FG001|STARTED|Overall Study||25
11367351|NCT03240081|12563809|FG000|COMPLETED|Overall Study||25
11367352|NCT03240081|12563810|FG001|COMPLETED|Overall Study||22
11367353|NCT03240081|12563809|FG000|NOT COMPLETED|Overall Study||0
11367354|NCT03240081|12563810|FG001|NOT COMPLETED|Overall Study||3
11367355|NCT03240133|12563819|FG000|STARTED|Overall Study||33
11367356|NCT03240133|12563820|FG001|STARTED|Overall Study||14
11367357|NCT03240133|12563821|FG002|STARTED|Overall Study||11
11367358|NCT03240133|12563819|FG000|Completed Period 1|Overall Study||33
11367359|NCT03240133|12563820|FG001|Completed Period 1|Overall Study||14
11367360|NCT03240133|12563821|FG002|Completed Period 1|Overall Study||11
11367361|NCT03240133|12563819|FG000|Completed Period 2|Overall Study||32
11367362|NCT03240133|12563820|FG001|Completed Period 2|Overall Study||11
11367363|NCT03240133|12563821|FG002|Completed Period 2|Overall Study||11
11367364|NCT03240133|12563819|FG000|Completed Period 3|Overall Study||30
11367365|NCT03240133|12563820|FG001|Completed Period 3|Overall Study||11
11367366|NCT03240133|12563821|FG002|Completed Period 3|Overall Study||11
11367367|NCT03240133|12563819|FG000|COMPLETED|Overall Study||30
11367368|NCT03240133|12563820|FG001|COMPLETED|Overall Study||11
11367369|NCT03240133|12563821|FG002|COMPLETED|Overall Study||10
11367370|NCT03240133|12563819|FG000|NOT COMPLETED|Overall Study||3
11367371|NCT03240133|12563820|FG001|NOT COMPLETED|Overall Study||3
11367372|NCT03240133|12563821|FG002|NOT COMPLETED|Overall Study||1
11367373|NCT03240575|12563849|FG000|STARTED|Overall Study||146
11367374|NCT03240575|12563850|FG001|STARTED|Overall Study||145
11367375|NCT03240575|12563851|FG002|STARTED|Overall Study||6
11367376|NCT03240575|12563852|FG003|STARTED|Overall Study||5
11367377|NCT03240575|12563849|FG000|COMPLETED|Overall Study||144
11367378|NCT03240575|12563850|FG001|COMPLETED|Overall Study||131
11367379|NCT03240575|12563851|FG002|COMPLETED|Overall Study||6
11367380|NCT03240575|12563852|FG003|COMPLETED|Overall Study||3
11367381|NCT03240575|12563849|FG000|NOT COMPLETED|Overall Study||2
11367382|NCT03240575|12563850|FG001|NOT COMPLETED|Overall Study||14
11367383|NCT03240575|12563851|FG002|NOT COMPLETED|Overall Study||0
11367384|NCT03240575|12563852|FG003|NOT COMPLETED|Overall Study||2
11367385|NCT03241030|12563862|FG000|STARTED|Overall Study||50
11367386|NCT03241030|12563863|FG001|STARTED|Overall Study||52
11367387|NCT03241030|12563862|FG000|COMPLETED|Overall Study||49
11367388|NCT03241030|12563863|FG001|COMPLETED|Overall Study||51
11367389|NCT03241030|12563862|FG000|NOT COMPLETED|Overall Study||1
11367390|NCT03241030|12563863|FG001|NOT COMPLETED|Overall Study||1
11367391|NCT03241342|12563872|FG000|STARTED|Overall Study||163
11367392|NCT03241342|12563873|FG001|STARTED|Overall Study||163
11367393|NCT03241342|12563874|FG002|STARTED|Overall Study||165
11367394|NCT03241342|12563872|FG000|COMPLETED|Overall Study||141
11367395|NCT03241342|12563873|FG001|COMPLETED|Overall Study||132
11367396|NCT03241342|12563874|FG002|COMPLETED|Overall Study||138
11367397|NCT03241342|12563872|FG000|NOT COMPLETED|Overall Study||22
11367398|NCT03241342|12563873|FG001|NOT COMPLETED|Overall Study||31
11367399|NCT03241342|12563874|FG002|NOT COMPLETED|Overall Study||27
11367400|NCT03241368|12563882|FG000|STARTED|Overall Study||158
11367401|NCT03241368|12563882|FG000|COMPLETED|Overall Study||119
11367402|NCT03241368|12563882|FG000|NOT COMPLETED|Overall Study||39
11367403|NCT03241485|12563889|FG000|STARTED|Overall Study||42
11367404|NCT03241485|12563890|FG001|STARTED|Overall Study||37
11367405|NCT03241485|12563889|FG000|COMPLETED|Overall Study||37
11367406|NCT03241485|12563890|FG001|COMPLETED|Overall Study||33
11367407|NCT03241485|12563889|FG000|NOT COMPLETED|Overall Study||5
11367408|NCT03241485|12563890|FG001|NOT COMPLETED|Overall Study||4
11367409|NCT03241810|12563902|FG000|STARTED|Overall Study||11
11367410|NCT03241810|12563903|FG001|STARTED|Overall Study||11
11367411|NCT03241810|12563902|FG000|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
11367412|NCT03241810|12563903|FG001|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
11367413|NCT03241810|12563902|FG000|NOT COMPLETED|Overall Study||0
11367414|NCT03241810|12563903|FG001|NOT COMPLETED|Overall Study||0
11367415|NCT03241862|12563910|FG000|STARTED|Overall Study||20
11367416|NCT03241862|12563910|FG000|COMPLETED|Overall Study||20
11367417|NCT03241862|12563910|FG000|NOT COMPLETED|Overall Study||0
11367418|NCT03241927|12563914|FG000|STARTED|Overall Study||1
11367419|NCT03241927|12563915|FG001|STARTED|Overall Study||0
11367420|NCT03241927|12563914|FG000|COMPLETED|Overall Study||0
11367421|NCT03241927|12563915|FG001|COMPLETED|Overall Study||0
11367422|NCT03241927|12563914|FG000|NOT COMPLETED|Overall Study||1
11367423|NCT03241927|12563915|FG001|NOT COMPLETED|Overall Study||0
11367424|NCT03242018|12563924|FG000|STARTED|Overall Study||93
11367425|NCT03242018|12563925|FG001|STARTED|Overall Study||92
11367426|NCT03242018|12563926|FG002|STARTED|Overall Study||92
11367427|NCT03242018|12563924|FG000|COMPLETED|Overall Study||75
11367428|NCT03242018|12563925|FG001|COMPLETED|Overall Study||78
11367429|NCT03242018|12563926|FG002|COMPLETED|Overall Study||78
11367430|NCT03242018|12563924|FG000|NOT COMPLETED|Overall Study||18
11367431|NCT03242018|12563925|FG001|NOT COMPLETED|Overall Study||14
11367432|NCT03242018|12563926|FG002|NOT COMPLETED|Overall Study||14
11367433|NCT03242148|12563935|FG000|STARTED|Overall Study||38
11367434|NCT03242148|12563935|FG000|COMPLETED|Overall Study||38
11367435|NCT03242148|12563935|FG000|NOT COMPLETED|Overall Study||0
11367436|NCT03242252|12563942|FG000|STARTED|Overall Study||260
11367437|NCT03242252|12563943|FG001|STARTED|Overall Study||263
11367438|NCT03242252|12563944|FG002|STARTED|Overall Study||264
11367439|NCT03242252|12563942|FG000|COMPLETED|Overall Study||224
11367440|NCT03242252|12563943|FG001|COMPLETED|Overall Study||240
11367441|NCT03242252|12563944|FG002|COMPLETED|Overall Study||232
11367442|NCT03242252|12563942|FG000|NOT COMPLETED|Overall Study||36
11367443|NCT03242252|12563943|FG001|NOT COMPLETED|Overall Study||23
11367444|NCT03242252|12563944|FG002|NOT COMPLETED|Overall Study||32
11367445|NCT03242408|12563958|FG000|STARTED|Overall Study||100
11367446|NCT03242408|12563958|FG000|COMPLETED|Overall Study||98
11367447|NCT03242408|12563958|FG000|NOT COMPLETED|Overall Study||2
11367448|NCT03242434|12563964|FG000|STARTED|Overall Study||15
11367449|NCT03242434|12563965|FG001|STARTED|Overall Study||3
11367450|NCT03242434|12563964|FG000|COMPLETED|Overall Study||15
11367451|NCT03242434|12563965|FG001|COMPLETED|Overall Study||1
11367452|NCT03242434|12563964|FG000|NOT COMPLETED|Overall Study||0
11367453|NCT03242434|12563965|FG001|NOT COMPLETED|Overall Study||2
11367454|NCT03242590|12563972|FG000|STARTED|Overall Study||95
11367455|NCT03242590|12563972|FG000|COMPLETED|Overall Study||95
11367456|NCT03242590|12563972|FG000|NOT COMPLETED|Overall Study||0
11367457|NCT03242759|12563978|FG000|STARTED|Overall Study||88
11367458|NCT03242759|12563979|FG001|STARTED|Overall Study||13
11367459|NCT03242759|12563978|FG000|COMPLETED|Overall Study||53
11367460|NCT03242759|12563979|FG001|COMPLETED|Overall Study||6
11367461|NCT03242759|12563978|FG000|NOT COMPLETED|Overall Study||35
11367462|NCT03242759|12563979|FG001|NOT COMPLETED|Overall Study||7
11367463|NCT03242863|12563985|FG000|STARTED|Study Week 1||13
11367464|NCT03242863|12563986|FG001|STARTED|Study Week 1||16
11367465|NCT03242863|12563987|FG002|STARTED|Study Week 1||4
11367466|NCT03242863|12563988|FG003|STARTED|Study Week 1||4
11367467|NCT03242863|12563989|FG004|STARTED|Study Week 1||15
11367468|NCT03242863|12563990|FG005|STARTED|Study Week 1||5
11367469|NCT03242863|12563985|FG000|COMPLETED|Study Week 1||13
11367470|NCT03242863|12563986|FG001|COMPLETED|Study Week 1||15
11367471|NCT03242863|12563987|FG002|COMPLETED|Study Week 1||4
11367472|NCT03242863|12563988|FG003|COMPLETED|Study Week 1||4
11367473|NCT03242863|12563989|FG004|COMPLETED|Study Week 1||12
11367474|NCT03242863|12563990|FG005|COMPLETED|Study Week 1||5
11367475|NCT03242863|12563985|FG000|NOT COMPLETED|Study Week 1||0
11367476|NCT03242863|12563986|FG001|NOT COMPLETED|Study Week 1||1
11367477|NCT03242863|12563987|FG002|NOT COMPLETED|Study Week 1||0
11367478|NCT03242863|12563988|FG003|NOT COMPLETED|Study Week 1||0
11367479|NCT03242863|12563989|FG004|NOT COMPLETED|Study Week 1||3
11367480|NCT03242863|12563990|FG005|NOT COMPLETED|Study Week 1||0
11367481|NCT03242863|12563985|FG000|STARTED|Study Week 2||13
11367482|NCT03242863|12563986|FG001|STARTED|Study Week 2||15
11367483|NCT03242863|12563987|FG002|STARTED|Study Week 2||4
11367484|NCT03242863|12563988|FG003|STARTED|Study Week 2||4
11367485|NCT03242863|12563989|FG004|STARTED|Study Week 2||12
11367486|NCT03242863|12563990|FG005|STARTED|Study Week 2||5
11367487|NCT03242863|12563985|FG000|COMPLETED|Study Week 2||13
11367488|NCT03242863|12563986|FG001|COMPLETED|Study Week 2||15
11367489|NCT03242863|12563987|FG002|COMPLETED|Study Week 2||4
11367490|NCT03242863|12563988|FG003|COMPLETED|Study Week 2||4
11367491|NCT03242863|12563989|FG004|COMPLETED|Study Week 2||12
11367492|NCT03242863|12563990|FG005|COMPLETED|Study Week 2||5
11367493|NCT03242863|12563985|FG000|NOT COMPLETED|Study Week 2||0
11367494|NCT03242863|12563986|FG001|NOT COMPLETED|Study Week 2||0
11367495|NCT03242863|12563987|FG002|NOT COMPLETED|Study Week 2||0
11367496|NCT03242863|12563988|FG003|NOT COMPLETED|Study Week 2||0
11367497|NCT03242863|12563989|FG004|NOT COMPLETED|Study Week 2||0
11367498|NCT03242863|12563990|FG005|NOT COMPLETED|Study Week 2||0
11367499|NCT03242863|12563985|FG000|STARTED|Study Week 3||13
11367500|NCT03242863|12563986|FG001|STARTED|Study Week 3||15
11367501|NCT03242863|12563987|FG002|STARTED|Study Week 3||4
11367502|NCT03242863|12563988|FG003|STARTED|Study Week 3||4
11367503|NCT03242863|12563989|FG004|STARTED|Study Week 3||12
11367504|NCT03242863|12563990|FG005|STARTED|Study Week 3||5
11367505|NCT03242863|12563985|FG000|COMPLETED|Study Week 3||13
11367506|NCT03242863|12563986|FG001|COMPLETED|Study Week 3||15
11367507|NCT03242863|12563987|FG002|COMPLETED|Study Week 3||4
11367508|NCT03242863|12563988|FG003|COMPLETED|Study Week 3||4
11367509|NCT03242863|12563989|FG004|COMPLETED|Study Week 3||12
11367510|NCT03242863|12563990|FG005|COMPLETED|Study Week 3||5
11367511|NCT03242863|12563985|FG000|NOT COMPLETED|Study Week 3||0
11367512|NCT03242863|12563986|FG001|NOT COMPLETED|Study Week 3||0
11367513|NCT03242863|12563987|FG002|NOT COMPLETED|Study Week 3||0
11367514|NCT03242863|12563988|FG003|NOT COMPLETED|Study Week 3||0
11367515|NCT03242863|12563989|FG004|NOT COMPLETED|Study Week 3||0
11367516|NCT03242863|12563990|FG005|NOT COMPLETED|Study Week 3||0
11367517|NCT03242928|12564000|FG000|STARTED|Overall Study||31
11367518|NCT03242928|12564001|FG001|STARTED|Overall Study||37
11367519|NCT03242928|12564000|FG000|COMPLETED|Overall Study||22
11367520|NCT03242928|12564001|FG001|COMPLETED|Overall Study||32
11367521|NCT03242928|12564000|FG000|NOT COMPLETED|Overall Study||9
11367522|NCT03242928|12564001|FG001|NOT COMPLETED|Overall Study||5
11367523|NCT03242941|12564007|FG000|STARTED|Overall Study||16
11367524|NCT03242941|12564007|FG000|COMPLETED|Overall Study||14
11367525|NCT03242941|12564007|FG000|NOT COMPLETED|Overall Study||2
11367526|NCT03242954|12564016|FG000|STARTED|Overall Study||43
11367527|NCT03242954|12564017|FG001|STARTED|Overall Study||45
11367528|NCT03242954|12564018|FG002|STARTED|Overall Study||41
11367529|NCT03242954|12564019|FG003|STARTED|Overall Study||125
11367530|NCT03242954|12564016|FG000|COMPLETED|Overall Study||43
11367531|NCT03242954|12564017|FG001|COMPLETED|Overall Study||45
11367532|NCT03242954|12564018|FG002|COMPLETED|Overall Study||41
11367533|NCT03242954|12564019|FG003|COMPLETED|Overall Study||125
11367534|NCT03242954|12564016|FG000|NOT COMPLETED|Overall Study||0
11367535|NCT03242954|12564017|FG001|NOT COMPLETED|Overall Study||0
11367536|NCT03242954|12564018|FG002|NOT COMPLETED|Overall Study||0
11367537|NCT03242954|12564019|FG003|NOT COMPLETED|Overall Study||0
11367538|NCT03243084|12564031|FG000|STARTED|Session 1||11
11367539|NCT03243084|12564032|FG001|STARTED|Session 1||10
11367540|NCT03243084|12564031|FG000|COMPLETED|Session 1||11
11367541|NCT03243084|12564032|FG001|COMPLETED|Session 1||10
11367542|NCT03243084|12564031|FG000|NOT COMPLETED|Session 1||0
11367543|NCT03243084|12564032|FG001|NOT COMPLETED|Session 1||0
11367544|NCT03243084|12564031|FG000|STARTED|Washout (1-3 Weeks)||11
11367545|NCT03243084|12564032|FG001|STARTED|Washout (1-3 Weeks)||10
11367546|NCT03243084|12564031|FG000|COMPLETED|Washout (1-3 Weeks)||10
11367547|NCT03243084|12564032|FG001|COMPLETED|Washout (1-3 Weeks)||10
11367548|NCT03243084|12564031|FG000|NOT COMPLETED|Washout (1-3 Weeks)||1
11367549|NCT03243084|12564032|FG001|NOT COMPLETED|Washout (1-3 Weeks)||0
11367550|NCT03243084|12564031|FG000|STARTED|Session 2||10
11367551|NCT03243084|12564032|FG001|STARTED|Session 2||10
11367552|NCT03243084|12564031|FG000|COMPLETED|Session 2||10
11367553|NCT03243084|12564032|FG001|COMPLETED|Session 2||10
11367554|NCT03243084|12564031|FG000|NOT COMPLETED|Session 2||0
11367555|NCT03243084|12564032|FG001|NOT COMPLETED|Session 2||0
11367556|NCT03243305|12564039|FG000|STARTED|Overall Study||1384
11367557|NCT03243305|12564039|FG000|COMPLETED|Overall Study||449
11367558|NCT03243305|12564039|FG000|NOT COMPLETED|Overall Study||935
11367559|NCT03243630|12564043|FG000|STARTED|Overall Study||24
11367560|NCT03243630|12564043|FG000|Menthol E-liquid Saline|Overall Study||22
11367561|NCT03243630|12564043|FG000|Menthol E-liquid Higher|Overall Study||22
11367562|NCT03243630|12564043|FG000|Menthol E-liquid Lower|Overall Study||22
11367563|NCT03243630|12564043|FG000|Green Apple E-liquid Saline|Overall Study||20
11367564|NCT03243630|12564043|FG000|Green Apple E-liquid Higher|Overall Study||20
11367565|NCT03243630|12564043|FG000|Green Apple E-liquid Lower|Overall Study||20
11367566|NCT03243630|12564043|FG000|Green Apple and Menthol E-liquid Saline|Overall Study||21
11367567|NCT03243630|12564043|FG000|Green Apple and Menthol E-liquid Higher|Overall Study||21
11367568|NCT03243630|12564043|FG000|Green Apple and Menthol E-liquid Lower|Overall Study||21
11367569|NCT03243630|12564043|FG000|COMPLETED|Overall Study||22
11367570|NCT03243630|12564043|FG000|NOT COMPLETED|Overall Study||2
11367571|NCT03243981|12564051|FG000|STARTED|Overall Study||5
11367572|NCT03243981|12564051|FG000|COMPLETED|Overall Study||5
11367573|NCT03243981|12564051|FG000|NOT COMPLETED|Overall Study||0
11367574|NCT03244618|12564062|FG000|STARTED|Overall Study||132
11367575|NCT03244618|12564063|FG001|STARTED|Overall Study||131
11367576|NCT03244618|12564062|FG000|Week 2|Overall Study||128
11367577|NCT03244618|12564063|FG001|Week 2|Overall Study||125
11367578|NCT03244618|12564062|FG000|COMPLETED|Overall Study||125
11367579|NCT03244618|12564063|FG001|COMPLETED|Overall Study||122
11367580|NCT03244618|12564062|FG000|NOT COMPLETED|Overall Study||7
11367581|NCT03244618|12564063|FG001|NOT COMPLETED|Overall Study||9
11367582|NCT03244800|12564073|FG000|STARTED|Overall Study||13
11367583|NCT03244800|12564074|FG001|STARTED|Overall Study||26
11367584|NCT03244800|12564075|FG002|STARTED|Overall Study||6
11367585|NCT03244800|12564076|FG003|STARTED|Overall Study||20
11367586|NCT03244800|12564073|FG000|COMPLETED|Overall Study||13
11367587|NCT03244800|12564074|FG001|COMPLETED|Overall Study||25
11367588|NCT03244800|12564075|FG002|COMPLETED|Overall Study||6
11367589|NCT03244800|12564076|FG003|COMPLETED|Overall Study||18
11367590|NCT03244800|12564073|FG000|NOT COMPLETED|Overall Study||0
11367591|NCT03244800|12564074|FG001|NOT COMPLETED|Overall Study||1
11367592|NCT03244800|12564075|FG002|NOT COMPLETED|Overall Study||0
11367593|NCT03244800|12564076|FG003|NOT COMPLETED|Overall Study||2
11367594|NCT03244865|12564089|FG000|STARTED|Overall Study||35
11367595|NCT03244865|12564089|FG000|COMPLETED|Overall Study||35
11367596|NCT03244865|12564089|FG000|NOT COMPLETED|Overall Study||0
11367597|NCT03244917|12564095|FG000|STARTED|Overall Study||201
11367598|NCT03244917|12564096|FG001|STARTED|Overall Study||229
11367599|NCT03244917|12564095|FG000|COMPLETED|Overall Study||199
11367600|NCT03244917|12564096|FG001|COMPLETED|Overall Study||227
11367601|NCT03244917|12564095|FG000|NOT COMPLETED|Overall Study||2
11367602|NCT03244917|12564096|FG001|NOT COMPLETED|Overall Study||2
11367603|NCT03245372|12564104|FG000|STARTED|Overall Study||15
11367604|NCT03245372|12564105|FG001|STARTED|Overall Study||15
11367605|NCT03245372|12564104|FG000|COMPLETED|Overall Study||15
11367606|NCT03245372|12564105|FG001|COMPLETED|Overall Study||15
11367607|NCT03245372|12564104|FG000|NOT COMPLETED|Overall Study||0
11367608|NCT03245372|12564105|FG001|NOT COMPLETED|Overall Study||0
11367609|NCT03245398|12564113|FG000|STARTED|Overall Study||93
11367610|NCT03245398|12564114|FG001|STARTED|Overall Study||93
11367611|NCT03245398|12564113|FG000|COMPLETED|Overall Study||92
11367612|NCT03245398|12564114|FG001|COMPLETED|Overall Study||93
11367613|NCT03245398|12564113|FG000|NOT COMPLETED|Overall Study||1
11367614|NCT03245398|12564114|FG001|NOT COMPLETED|Overall Study||0
11367615|NCT03245463|12564124|FG000|STARTED|Overall Study||12
11367616|NCT03245463|12564125|FG001|STARTED|Overall Study||12
11367617|NCT03245463|12564124|FG000|COMPLETED|Overall Study||12
11367618|NCT03245463|12564125|FG001|COMPLETED|Overall Study||12
11367619|NCT03245463|12564124|FG000|NOT COMPLETED|Overall Study||0
11367620|NCT03245463|12564125|FG001|NOT COMPLETED|Overall Study||0
11367621|NCT03245619|12564148|FG000|STARTED|Part A (Up to Day 22)||5
11367622|NCT03245619|12564149|FG001|STARTED|Part A (Up to Day 22)||6
11367623|NCT03245619|12564150|FG002|STARTED|Part A (Up to Day 22)||6
11367624|NCT03245619|12564151|FG003|STARTED|Part A (Up to Day 22)||1
11367625|NCT03245619|12564152|FG004|STARTED|Part A (Up to Day 22)||0
11367626|NCT03245619|12564153|FG005|STARTED|Part A (Up to Day 22)||0
11367627|NCT03245619|12564154|FG006|STARTED|Part A (Up to Day 22)||0
11367628|NCT03245619|12564155|FG007|STARTED|Part A (Up to Day 22)||0
11367629|NCT03245619|12564156|FG008|STARTED|Part A (Up to Day 22)||0
11367630|NCT03245619|12564157|FG009|STARTED|Part A (Up to Day 22)||0
11367631|NCT03245619|12564158|FG010|STARTED|Part A (Up to Day 22)||0
11367632|NCT03245619|12564159|FG011|STARTED|Part A (Up to Day 22)||0
11367633|NCT03245619|12564160|FG012|STARTED|Part A (Up to Day 22)||0
11367634|NCT03245619|12564161|FG013|STARTED|Part A (Up to Day 22)||0
11367635|NCT03245619|12564162|FG014|STARTED|Part A (Up to Day 22)||0
11367636|NCT03245619|12564163|FG015|STARTED|Part A (Up to Day 22)||0
11367637|NCT03245619|12564164|FG016|STARTED|Part A (Up to Day 22)||0
11367638|NCT03245619|12564148|FG000|COMPLETED|Part A (Up to Day 22)||1
11367639|NCT03245619|12564149|FG001|COMPLETED|Part A (Up to Day 22)||0
11367640|NCT03245619|12564150|FG002|COMPLETED|Part A (Up to Day 22)||0
11367641|NCT03245619|12564151|FG003|COMPLETED|Part A (Up to Day 22)||1
11367642|NCT03245619|12564152|FG004|COMPLETED|Part A (Up to Day 22)||0
11367643|NCT03245619|12564153|FG005|COMPLETED|Part A (Up to Day 22)||0
11367644|NCT03245619|12564154|FG006|COMPLETED|Part A (Up to Day 22)||0
11367645|NCT03245619|12564155|FG007|COMPLETED|Part A (Up to Day 22)||0
11367646|NCT03245619|12564156|FG008|COMPLETED|Part A (Up to Day 22)||0
11367647|NCT03245619|12564157|FG009|COMPLETED|Part A (Up to Day 22)||0
11367648|NCT03245619|12564158|FG010|COMPLETED|Part A (Up to Day 22)||0
11367649|NCT03245619|12564159|FG011|COMPLETED|Part A (Up to Day 22)||0
11367650|NCT03245619|12564160|FG012|COMPLETED|Part A (Up to Day 22)||0
11367651|NCT03245619|12564161|FG013|COMPLETED|Part A (Up to Day 22)||0
11367652|NCT03245619|12564162|FG014|COMPLETED|Part A (Up to Day 22)||0
11367653|NCT03245619|12564163|FG015|COMPLETED|Part A (Up to Day 22)||0
11367654|NCT03245619|12564164|FG016|COMPLETED|Part A (Up to Day 22)||0
11367655|NCT03245619|12564148|FG000|NOT COMPLETED|Part A (Up to Day 22)||4
11367656|NCT03245619|12564149|FG001|NOT COMPLETED|Part A (Up to Day 22)||6
11367657|NCT03245619|12564150|FG002|NOT COMPLETED|Part A (Up to Day 22)||6
11367658|NCT03245619|12564151|FG003|NOT COMPLETED|Part A (Up to Day 22)||0
11367659|NCT03245619|12564152|FG004|NOT COMPLETED|Part A (Up to Day 22)||0
11367660|NCT03245619|12564153|FG005|NOT COMPLETED|Part A (Up to Day 22)||0
11367661|NCT03245619|12564154|FG006|NOT COMPLETED|Part A (Up to Day 22)||0
11367662|NCT03245619|12564155|FG007|NOT COMPLETED|Part A (Up to Day 22)||0
11367663|NCT03245619|12564156|FG008|NOT COMPLETED|Part A (Up to Day 22)||0
11367664|NCT03245619|12564157|FG009|NOT COMPLETED|Part A (Up to Day 22)||0
11367665|NCT03245619|12564158|FG010|NOT COMPLETED|Part A (Up to Day 22)||0
11367666|NCT03245619|12564159|FG011|NOT COMPLETED|Part A (Up to Day 22)||0
11367667|NCT03245619|12564160|FG012|NOT COMPLETED|Part A (Up to Day 22)||0
11367668|NCT03245619|12564161|FG013|NOT COMPLETED|Part A (Up to Day 22)||0
11367669|NCT03245619|12564162|FG014|NOT COMPLETED|Part A (Up to Day 22)||0
11367670|NCT03245619|12564163|FG015|NOT COMPLETED|Part A (Up to Day 22)||0
11367671|NCT03245619|12564164|FG016|NOT COMPLETED|Part A (Up to Day 22)||0
11367672|NCT03245619|12564148|FG000|STARTED|Part B (Up to 34 Days)||0
11367673|NCT03245619|12564149|FG001|STARTED|Part B (Up to 34 Days)||0
11367674|NCT03245619|12564150|FG002|STARTED|Part B (Up to 34 Days)||0
11367675|NCT03245619|12564151|FG003|STARTED|Part B (Up to 34 Days)||0
11367676|NCT03245619|12564152|FG004|STARTED|Part B (Up to 34 Days)||0
11367677|NCT03245619|12564153|FG005|STARTED|Part B (Up to 34 Days)||0
11367678|NCT03245619|12564154|FG006|STARTED|Part B (Up to 34 Days)||0
11367679|NCT03245619|12564155|FG007|STARTED|Part B (Up to 34 Days)||0
11367680|NCT03245619|12564156|FG008|STARTED|Part B (Up to 34 Days)||0
11367681|NCT03245619|12564157|FG009|STARTED|Part B (Up to 34 Days)||0
11367682|NCT03245619|12564158|FG010|STARTED|Part B (Up to 34 Days)||0
11367683|NCT03245619|12564159|FG011|STARTED|Part B (Up to 34 Days)||0
11367684|NCT03245619|12564160|FG012|STARTED|Part B (Up to 34 Days)||0
11367685|NCT03245619|12564161|FG013|STARTED|Part B (Up to 34 Days)||0
11367686|NCT03245619|12564162|FG014|STARTED|Part B (Up to 34 Days)||0
11367687|NCT03245619|12564163|FG015|STARTED|Part B (Up to 34 Days)||0
11367688|NCT03245619|12564164|FG016|STARTED|Part B (Up to 34 Days)||0
11367689|NCT03245619|12564148|FG000|COMPLETED|Part B (Up to 34 Days)||0
11367690|NCT03245619|12564149|FG001|COMPLETED|Part B (Up to 34 Days)||0
11367691|NCT03245619|12564150|FG002|COMPLETED|Part B (Up to 34 Days)||0
11367692|NCT03245619|12564151|FG003|COMPLETED|Part B (Up to 34 Days)||0
11367693|NCT03245619|12564152|FG004|COMPLETED|Part B (Up to 34 Days)||0
11367694|NCT03245619|12564153|FG005|COMPLETED|Part B (Up to 34 Days)||0
11367695|NCT03245619|12564154|FG006|COMPLETED|Part B (Up to 34 Days)||0
11367696|NCT03245619|12564155|FG007|COMPLETED|Part B (Up to 34 Days)||0
11367697|NCT03245619|12564156|FG008|COMPLETED|Part B (Up to 34 Days)||0
11367698|NCT03245619|12564157|FG009|COMPLETED|Part B (Up to 34 Days)||0
11367699|NCT03245619|12564158|FG010|COMPLETED|Part B (Up to 34 Days)||0
11367700|NCT03245619|12564159|FG011|COMPLETED|Part B (Up to 34 Days)||0
11367701|NCT03245619|12564160|FG012|COMPLETED|Part B (Up to 34 Days)||0
11367702|NCT03245619|12564161|FG013|COMPLETED|Part B (Up to 34 Days)||0
11367703|NCT03245619|12564162|FG014|COMPLETED|Part B (Up to 34 Days)||0
11367704|NCT03245619|12564163|FG015|COMPLETED|Part B (Up to 34 Days)||0
11367705|NCT03245619|12564164|FG016|COMPLETED|Part B (Up to 34 Days)||0
11367706|NCT03245619|12564148|FG000|NOT COMPLETED|Part B (Up to 34 Days)||0
11367707|NCT03245619|12564149|FG001|NOT COMPLETED|Part B (Up to 34 Days)||0
11367708|NCT03245619|12564150|FG002|NOT COMPLETED|Part B (Up to 34 Days)||0
11367709|NCT03245619|12564151|FG003|NOT COMPLETED|Part B (Up to 34 Days)||0
11367710|NCT03245619|12564152|FG004|NOT COMPLETED|Part B (Up to 34 Days)||0
11367711|NCT03245619|12564153|FG005|NOT COMPLETED|Part B (Up to 34 Days)||0
11367712|NCT03245619|12564154|FG006|NOT COMPLETED|Part B (Up to 34 Days)||0
11367713|NCT03245619|12564155|FG007|NOT COMPLETED|Part B (Up to 34 Days)||0
11367714|NCT03245619|12564156|FG008|NOT COMPLETED|Part B (Up to 34 Days)||0
11367715|NCT03245619|12564157|FG009|NOT COMPLETED|Part B (Up to 34 Days)||0
11367716|NCT03245619|12564158|FG010|NOT COMPLETED|Part B (Up to 34 Days)||0
11367717|NCT03245619|12564159|FG011|NOT COMPLETED|Part B (Up to 34 Days)||0
11367718|NCT03245619|12564160|FG012|NOT COMPLETED|Part B (Up to 34 Days)||0
11367719|NCT03245619|12564161|FG013|NOT COMPLETED|Part B (Up to 34 Days)||0
11367720|NCT03245619|12564162|FG014|NOT COMPLETED|Part B (Up to 34 Days)||0
11367721|NCT03245619|12564163|FG015|NOT COMPLETED|Part B (Up to 34 Days)||0
11367722|NCT03245619|12564164|FG016|NOT COMPLETED|Part B (Up to 34 Days)||0
11367723|NCT03245619|12564148|FG000|STARTED|Part C (Up to 34 Days)||0
11367724|NCT03245619|12564149|FG001|STARTED|Part C (Up to 34 Days)||0
11367725|NCT03245619|12564150|FG002|STARTED|Part C (Up to 34 Days)||0
11367726|NCT03245619|12564151|FG003|STARTED|Part C (Up to 34 Days)||0
11367727|NCT03245619|12564152|FG004|STARTED|Part C (Up to 34 Days)||0
11367728|NCT03245619|12564153|FG005|STARTED|Part C (Up to 34 Days)||0
11367729|NCT03245619|12564154|FG006|STARTED|Part C (Up to 34 Days)||0
11367730|NCT03245619|12564155|FG007|STARTED|Part C (Up to 34 Days)||0
11367731|NCT03245619|12564156|FG008|STARTED|Part C (Up to 34 Days)||0
11367732|NCT03245619|12564157|FG009|STARTED|Part C (Up to 34 Days)||0
11367733|NCT03245619|12564158|FG010|STARTED|Part C (Up to 34 Days)||0
11367734|NCT03245619|12564159|FG011|STARTED|Part C (Up to 34 Days)||0
11367735|NCT03245619|12564160|FG012|STARTED|Part C (Up to 34 Days)||0
11367736|NCT03245619|12564161|FG013|STARTED|Part C (Up to 34 Days)||0
11367737|NCT03245619|12564162|FG014|STARTED|Part C (Up to 34 Days)||0
11367738|NCT03245619|12564163|FG015|STARTED|Part C (Up to 34 Days)||0
11367739|NCT03245619|12564164|FG016|STARTED|Part C (Up to 34 Days)||0
11367740|NCT03245619|12564148|FG000|COMPLETED|Part C (Up to 34 Days)||0
11367741|NCT03245619|12564149|FG001|COMPLETED|Part C (Up to 34 Days)||0
11367742|NCT03245619|12564150|FG002|COMPLETED|Part C (Up to 34 Days)||0
11367743|NCT03245619|12564151|FG003|COMPLETED|Part C (Up to 34 Days)||0
11367744|NCT03245619|12564152|FG004|COMPLETED|Part C (Up to 34 Days)||0
11367745|NCT03245619|12564153|FG005|COMPLETED|Part C (Up to 34 Days)||0
11367746|NCT03245619|12564154|FG006|COMPLETED|Part C (Up to 34 Days)||0
11367747|NCT03245619|12564155|FG007|COMPLETED|Part C (Up to 34 Days)||0
11367748|NCT03245619|12564156|FG008|COMPLETED|Part C (Up to 34 Days)||0
11367749|NCT03245619|12564157|FG009|COMPLETED|Part C (Up to 34 Days)||0
11367750|NCT03245619|12564158|FG010|COMPLETED|Part C (Up to 34 Days)||0
11367751|NCT03245619|12564159|FG011|COMPLETED|Part C (Up to 34 Days)||0
11367752|NCT03245619|12564160|FG012|COMPLETED|Part C (Up to 34 Days)||0
11367753|NCT03245619|12564161|FG013|COMPLETED|Part C (Up to 34 Days)||0
11367754|NCT03245619|12564162|FG014|COMPLETED|Part C (Up to 34 Days)||0
11367755|NCT03245619|12564163|FG015|COMPLETED|Part C (Up to 34 Days)||0
11367756|NCT03245619|12564164|FG016|COMPLETED|Part C (Up to 34 Days)||0
11367757|NCT03245619|12564148|FG000|NOT COMPLETED|Part C (Up to 34 Days)||0
11367758|NCT03245619|12564149|FG001|NOT COMPLETED|Part C (Up to 34 Days)||0
11367759|NCT03245619|12564150|FG002|NOT COMPLETED|Part C (Up to 34 Days)||0
11367760|NCT03245619|12564151|FG003|NOT COMPLETED|Part C (Up to 34 Days)||0
11367761|NCT03245619|12564152|FG004|NOT COMPLETED|Part C (Up to 34 Days)||0
11367762|NCT03245619|12564153|FG005|NOT COMPLETED|Part C (Up to 34 Days)||0
11367763|NCT03245619|12564154|FG006|NOT COMPLETED|Part C (Up to 34 Days)||0
11367764|NCT03245619|12564155|FG007|NOT COMPLETED|Part C (Up to 34 Days)||0
11367765|NCT03245619|12564156|FG008|NOT COMPLETED|Part C (Up to 34 Days)||0
11367766|NCT03245619|12564157|FG009|NOT COMPLETED|Part C (Up to 34 Days)||0
11367767|NCT03245619|12564158|FG010|NOT COMPLETED|Part C (Up to 34 Days)||0
11367768|NCT03245619|12564159|FG011|NOT COMPLETED|Part C (Up to 34 Days)||0
11367769|NCT03245619|12564160|FG012|NOT COMPLETED|Part C (Up to 34 Days)||0
11367770|NCT03245619|12564161|FG013|NOT COMPLETED|Part C (Up to 34 Days)||0
11367771|NCT03245619|12564162|FG014|NOT COMPLETED|Part C (Up to 34 Days)||0
11367772|NCT03245619|12564163|FG015|NOT COMPLETED|Part C (Up to 34 Days)||0
11367773|NCT03245619|12564164|FG016|NOT COMPLETED|Part C (Up to 34 Days)||0
11367774|NCT03245723|12564225|FG000|STARTED|Overall Study||32
11367775|NCT03245723|12564226|FG001|STARTED|Overall Study||18
11367776|NCT03245723|12564225|FG000|COMPLETED|Overall Study||27
11367777|NCT03245723|12564226|FG001|COMPLETED|Overall Study||17
11367778|NCT03245723|12564225|FG000|NOT COMPLETED|Overall Study||5
11367779|NCT03245723|12564226|FG001|NOT COMPLETED|Overall Study||1
11367780|NCT03245736|12564232|FG000|STARTED|Overall Study||5
11367781|NCT03245736|12564232|FG000|COMPLETED|Overall Study||0
11367782|NCT03245736|12564232|FG000|NOT COMPLETED|Overall Study||5
11367783|NCT03245762|12564238|FG000|STARTED|Overall Study||10
11367784|NCT03245762|12564239|FG001|STARTED|Overall Study||5
11367785|NCT03245762|12564238|FG000|COMPLETED|Overall Study||10
11367786|NCT03245762|12564239|FG001|COMPLETED|Overall Study||5
11367787|NCT03245762|12564238|FG000|NOT COMPLETED|Overall Study||0
11367788|NCT03245762|12564239|FG001|NOT COMPLETED|Overall Study||0
11367789|NCT03246152|12564245|FG000|STARTED|Overall Study||31
11367790|NCT03246152|12564245|FG000|COMPLETED|Overall Study||28
11367791|NCT03246152|12564245|FG000|NOT COMPLETED|Overall Study||3
11367792|NCT03246646|12564251|FG000|STARTED|Overall Study||26
11367793|NCT03246646|12564252|FG001|STARTED|Overall Study||26
11367794|NCT03246646|12564251|FG000|COMPLETED|Overall Study|15 participants completed either 6-month or 12-month follow-up or both.|15
11367795|NCT03246646|12564252|FG001|COMPLETED|Overall Study|Follow-up was limited to chart follow-up in CIC services|26
11367796|NCT03246646|12564251|FG000|NOT COMPLETED|Overall Study||11
11367797|NCT03246646|12564252|FG001|NOT COMPLETED|Overall Study||0
11367798|NCT03246672|12564258|FG000|STARTED|Overall Study||30
11367799|NCT03246672|12564258|FG000|Completed First Phone Call|Overall Study||29
11367800|NCT03246672|12564258|FG000|COMPLETED|Overall Study||28
11367801|NCT03246672|12564258|FG000|NOT COMPLETED|Overall Study||2
11367802|NCT03246724|12564266|FG000|STARTED|Overall Study||99
11367803|NCT03246724|12564267|FG001|STARTED|Overall Study||91
11367804|NCT03246724|12564268|FG002|STARTED|Overall Study||85
11367805|NCT03246724|12564269|FG003|STARTED|Overall Study||52
11367806|NCT03246724|12564266|FG000|COMPLETED|Overall Study||85
11367807|NCT03246724|12564267|FG001|COMPLETED|Overall Study||84
11367808|NCT03246724|12564268|FG002|COMPLETED|Overall Study||70
11367809|NCT03246724|12564269|FG003|COMPLETED|Overall Study||44
11367810|NCT03246724|12564266|FG000|NOT COMPLETED|Overall Study||14
11367811|NCT03246724|12564267|FG001|NOT COMPLETED|Overall Study||7
11367812|NCT03246724|12564268|FG002|NOT COMPLETED|Overall Study||15
11367813|NCT03246724|12564269|FG003|NOT COMPLETED|Overall Study||8
11367814|NCT03247322|12564281|FG000|STARTED|Overall Study||68
11367815|NCT03247322|12564282|FG001|STARTED|Overall Study||68
11367816|NCT03247322|12564281|FG000|COMPLETED|Overall Study||66
11367817|NCT03247322|12564282|FG001|COMPLETED|Overall Study||68
11367818|NCT03247322|12564281|FG000|NOT COMPLETED|Overall Study||2
11367819|NCT03247322|12564282|FG001|NOT COMPLETED|Overall Study||0
11367820|NCT03247517|12564293|FG000|STARTED|Overall Study||104
11367821|NCT03247517|12564294|FG001|STARTED|Overall Study||98
11367822|NCT03247517|12564295|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received 200mg/day SPN-812 during the trial|106
11367823|NCT03247517|12564293|FG000|COMPLETED|Overall Study||96
11367824|NCT03247517|12564294|FG001|COMPLETED|Overall Study||78
11367825|NCT03247517|12564295|FG002|COMPLETED|Overall Study||92
11367826|NCT03247517|12564293|FG000|NOT COMPLETED|Overall Study||8
11367827|NCT03247517|12564294|FG001|NOT COMPLETED|Overall Study||20
11367828|NCT03247517|12564295|FG002|NOT COMPLETED|Overall Study||14
11367829|NCT03247530|12564306|FG000|STARTED|Overall Study||159
11367830|NCT03247530|12564307|FG001|STARTED|Overall Study||154
11367831|NCT03247530|12564308|FG002|STARTED|Overall Study||161
11367832|NCT03247530|12564306|FG000|COMPLETED|Overall Study||132
11367833|NCT03247530|12564307|FG001|COMPLETED|Overall Study||126
11367834|NCT03247530|12564308|FG002|COMPLETED|Overall Study||141
11367835|NCT03247530|12564306|FG000|NOT COMPLETED|Overall Study||27
11367836|NCT03247530|12564307|FG001|NOT COMPLETED|Overall Study||28
11367837|NCT03247530|12564308|FG002|NOT COMPLETED|Overall Study||20
11367838|NCT03247543|12564322|FG000|STARTED|Overall Study||102
11367839|NCT03247543|12564323|FG001|STARTED|Overall Study||107
11367840|NCT03247543|12564324|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received Placebo during the trial.|101
11367841|NCT03247543|12564322|FG000|COMPLETED|Overall Study||85
11367842|NCT03247543|12564323|FG001|COMPLETED|Overall Study||88
11367843|NCT03247543|12564324|FG002|COMPLETED|Overall Study||78
11367844|NCT03247543|12564322|FG000|NOT COMPLETED|Overall Study||17
11367845|NCT03247543|12564323|FG001|NOT COMPLETED|Overall Study||19
11367846|NCT03247543|12564324|FG002|NOT COMPLETED|Overall Study||23
11367847|NCT03247556|12564337|FG000|STARTED|Overall Study||97
11367848|NCT03247556|12564338|FG001|STARTED|Overall Study||100
11367849|NCT03247556|12564339|FG002|STARTED|Overall Study||99
11367850|NCT03247556|12564337|FG000|COMPLETED|Overall Study||85
11367851|NCT03247556|12564338|FG001|COMPLETED|Overall Study||88
11367852|NCT03247556|12564339|FG002|COMPLETED|Overall Study||81
11367853|NCT03247556|12564337|FG000|NOT COMPLETED|Overall Study||12
11367854|NCT03247556|12564338|FG001|NOT COMPLETED|Overall Study||12
11367855|NCT03247556|12564339|FG002|NOT COMPLETED|Overall Study||18
11367856|NCT03247673|12564350|FG000|STARTED|Overall Study||46
11367857|NCT03247673|12564351|FG001|STARTED|Overall Study||47
11367858|NCT03247673|12564352|FG002|STARTED|Overall Study||48
11367859|NCT03247673|12564350|FG000|COMPLETED|Overall Study||45
11367860|NCT03247673|12564351|FG001|COMPLETED|Overall Study||47
11367861|NCT03247673|12564352|FG002|COMPLETED|Overall Study||44
11367862|NCT03247673|12564350|FG000|NOT COMPLETED|Overall Study||1
11367863|NCT03247673|12564351|FG001|NOT COMPLETED|Overall Study||0
11367864|NCT03247673|12564352|FG002|NOT COMPLETED|Overall Study||4
11367865|NCT03247686|12564362|FG000|STARTED|Overall Study||8
11367866|NCT03247686|12564363|FG001|STARTED|Overall Study||20
11367867|NCT03247686|12564362|FG000|COMPLETED|Overall Study||7
11367868|NCT03247686|12564363|FG001|COMPLETED|Overall Study||18
11367869|NCT03247686|12564362|FG000|NOT COMPLETED|Overall Study||1
11367870|NCT03247686|12564363|FG001|NOT COMPLETED|Overall Study||2
11367871|NCT03247738|12564374|FG000|STARTED|Overall Study||25
11367872|NCT03247738|12564375|FG001|STARTED|Overall Study||25
11367873|NCT03247738|12564374|FG000|COMPLETED|Overall Study||25
11367874|NCT03247738|12564375|FG001|COMPLETED|Overall Study||25
11367875|NCT03247738|12564374|FG000|NOT COMPLETED|Overall Study||0
11367876|NCT03247738|12564375|FG001|NOT COMPLETED|Overall Study||0
11367877|NCT03247790|12564381|FG000|STARTED|Period 1: Migraine Attack||16
11367878|NCT03247790|12564381|FG000|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16
11367879|NCT03247790|12564381|FG000|COMPLETED|Period 1: Migraine Attack||16
11367880|NCT03247790|12564381|FG000|NOT COMPLETED|Period 1: Migraine Attack||0
11367881|NCT03247790|12564381|FG000|STARTED|Period 2: Inter-ictal Period||16
11367882|NCT03247790|12564381|FG000|COMPLETED|Period 2: Inter-ictal Period||16
11367883|NCT03247790|12564381|FG000|NOT COMPLETED|Period 2: Inter-ictal Period||0
11367884|NCT03247816|12564387|FG000|STARTED|Overall Study||59
11367885|NCT03247816|12564387|FG000|COMPLETED|Overall Study||30
11367886|NCT03247816|12564387|FG000|NOT COMPLETED|Overall Study||29
11367887|NCT03247985|12564395|FG000|STARTED|Overall Study||19
11367888|NCT03247985|12564396|FG001|STARTED|Overall Study||19
11367889|NCT03247985|12564395|FG000|COMPLETED|Overall Study||19
11367890|NCT03247985|12564396|FG001|COMPLETED|Overall Study||19
11367891|NCT03247985|12564395|FG000|NOT COMPLETED|Overall Study||0
11367892|NCT03247985|12564396|FG001|NOT COMPLETED|Overall Study||0
11367893|NCT03248037|12564404|FG000|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|95
11367894|NCT03248037|12564405|FG001|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|96
11367895|NCT03248037|12564404|FG000|COMPLETED|Overall Study||74
11367896|NCT03248037|12564405|FG001|COMPLETED|Overall Study||87
11367897|NCT03248037|12564404|FG000|NOT COMPLETED|Overall Study||21
11367898|NCT03248037|12564405|FG001|NOT COMPLETED|Overall Study||9
11367899|NCT03248440|12564413|FG000|STARTED|Overall Study||131
11367900|NCT03248440|12564414|FG001|STARTED|Overall Study||132
11367901|NCT03248440|12564413|FG000|COMPLETED|Overall Study||116
11367902|NCT03248440|12564414|FG001|COMPLETED|Overall Study||120
11367903|NCT03248440|12564413|FG000|NOT COMPLETED|Overall Study||15
11367904|NCT03248440|12564414|FG001|NOT COMPLETED|Overall Study||12
11367905|NCT03248492|12564425|FG000|STARTED|Overall Study||50
11367906|NCT03248492|12564426|FG001|STARTED|Overall Study||48
11367907|NCT03248492|12564427|FG002|STARTED|Overall Study||21
11367908|NCT03248492|12564428|FG003|STARTED|Overall Study||130
11367909|NCT03248492|12564429|FG004|STARTED|Overall Study||4
11367910|NCT03248492|12564425|FG000|COMPLETED|Overall Study||0
11367911|NCT03248492|12564426|FG001|COMPLETED|Overall Study||0
11367912|NCT03248492|12564427|FG002|COMPLETED|Overall Study||0
11367913|NCT03248492|12564428|FG003|COMPLETED|Overall Study||0
11367914|NCT03248492|12564429|FG004|COMPLETED|Overall Study||0
11367915|NCT03248492|12564425|FG000|NOT COMPLETED|Overall Study||50
11367916|NCT03248492|12564426|FG001|NOT COMPLETED|Overall Study||48
11367917|NCT03248492|12564427|FG002|NOT COMPLETED|Overall Study||21
11367918|NCT03248492|12564428|FG003|NOT COMPLETED|Overall Study||130
11367919|NCT03248492|12564429|FG004|NOT COMPLETED|Overall Study||4
11367920|NCT03248882|12564454|FG000|STARTED|Overall Study||61
11367921|NCT03248882|12564455|FG001|STARTED|Overall Study||63
11367922|NCT03248882|12564456|FG002|STARTED|Overall Study||62
11367923|NCT03248882|12564457|FG003|STARTED|Overall Study||58
11367924|NCT03248882|12564458|FG004|STARTED|Overall Study||61
11367925|NCT03248882|12564454|FG000|Received Treatment|Overall Study||61
11367926|NCT03248882|12564455|FG001|Received Treatment|Overall Study||63
11367927|NCT03248882|12564456|FG002|Received Treatment|Overall Study||62
11367928|NCT03248882|12564457|FG003|Received Treatment|Overall Study||58
11367929|NCT03248882|12564458|FG004|Received Treatment|Overall Study||61
11367930|NCT03248882|12564454|FG000|COMPLETED|Overall Study||54
11367931|NCT03248882|12564455|FG001|COMPLETED|Overall Study||58
11367932|NCT03248882|12564456|FG002|COMPLETED|Overall Study||55
11367933|NCT03248882|12564457|FG003|COMPLETED|Overall Study||48
11367934|NCT03248882|12564458|FG004|COMPLETED|Overall Study||48
11367935|NCT03248882|12564454|FG000|NOT COMPLETED|Overall Study||7
11367936|NCT03248882|12564455|FG001|NOT COMPLETED|Overall Study||5
11367937|NCT03248882|12564456|FG002|NOT COMPLETED|Overall Study||7
11367938|NCT03248882|12564457|FG003|NOT COMPLETED|Overall Study||10
11367939|NCT03248882|12564458|FG004|NOT COMPLETED|Overall Study||13
11367940|NCT03248947|12564470|FG000|STARTED|Overall Study||71
11367941|NCT03248947|12564470|FG000|COMPLETED|Overall Study||63
11367942|NCT03248947|12564470|FG000|NOT COMPLETED|Overall Study||8
11367943|NCT03249116|12564481|FG000|STARTED|Overall Study||25
11367944|NCT03249116|12564482|FG001|STARTED|Overall Study||25
11367945|NCT03249116|12564483|FG002|STARTED|Overall Study||25
11367946|NCT03249116|12564481|FG000|COMPLETED|Overall Study||25
11367947|NCT03249116|12564482|FG001|COMPLETED|Overall Study||25
11367948|NCT03249116|12564483|FG002|COMPLETED|Overall Study||25
11367949|NCT03249116|12564481|FG000|NOT COMPLETED|Overall Study||0
11367950|NCT03249116|12564482|FG001|NOT COMPLETED|Overall Study||0
11367951|NCT03249116|12564483|FG002|NOT COMPLETED|Overall Study||0
11367952|NCT03249272|12564495|FG000|STARTED|Overall Study||19
11367953|NCT03249272|12564496|FG001|STARTED|Overall Study||6
11367954|NCT03249272|12564497|FG002|STARTED|Overall Study||6
11367955|NCT03249272|12564495|FG000|COMPLETED|Overall Study||19
11367956|NCT03249272|12564496|FG001|COMPLETED|Overall Study||6
11367957|NCT03249272|12564497|FG002|COMPLETED|Overall Study||6
11367958|NCT03249272|12564495|FG000|NOT COMPLETED|Overall Study||0
11367959|NCT03249272|12564496|FG001|NOT COMPLETED|Overall Study||0
11367960|NCT03249272|12564497|FG002|NOT COMPLETED|Overall Study||0
11367961|NCT03249454|12564517|FG000|STARTED|Overall Study||1
11367962|NCT03249454|12564518|FG001|STARTED|Overall Study||1
11367963|NCT03249454|12564519|FG002|STARTED|Overall Study||2
11367964|NCT03249454|12564520|FG003|STARTED|Overall Study||1
11367965|NCT03249454|12564521|FG004|STARTED|Overall Study||1
11367966|NCT03249454|12564522|FG005|STARTED|Overall Study||2
11367967|NCT03249454|12564523|FG006|STARTED|Overall Study||1
11367968|NCT03249454|12564524|FG007|STARTED|Overall Study||1
11367969|NCT03249454|12564525|FG008|STARTED|Overall Study||1
11367970|NCT03249454|12564526|FG009|STARTED|Overall Study||1
11367971|NCT03249454|12564527|FG010|STARTED|Overall Study||1
11367972|NCT03249454|12564517|FG000|First Intervention (1 Day)|Overall Study||1
11367973|NCT03249454|12564518|FG001|First Intervention (1 Day)|Overall Study||1
11367974|NCT03249454|12564519|FG002|First Intervention (1 Day)|Overall Study||2
11367975|NCT03249454|12564520|FG003|First Intervention (1 Day)|Overall Study||1
11367976|NCT03249454|12564521|FG004|First Intervention (1 Day)|Overall Study||1
11367977|NCT03249454|12564522|FG005|First Intervention (1 Day)|Overall Study||2
11367978|NCT03249454|12564523|FG006|First Intervention (1 Day)|Overall Study||1
11367979|NCT03249454|12564524|FG007|First Intervention (1 Day)|Overall Study||1
11367980|NCT03249454|12564525|FG008|First Intervention (1 Day)|Overall Study||1
11367981|NCT03249454|12564526|FG009|First Intervention (1 Day)|Overall Study||0
11367982|NCT03249454|12564527|FG010|First Intervention (1 Day)|Overall Study||0
11367983|NCT03249454|12564517|FG000|Washout (1 Week)|Overall Study||1
11367984|NCT03249454|12564518|FG001|Washout (1 Week)|Overall Study||1
11367985|NCT03249454|12564519|FG002|Washout (1 Week)|Overall Study||2
11367986|NCT03249454|12564520|FG003|Washout (1 Week)|Overall Study||1
11367987|NCT03249454|12564521|FG004|Washout (1 Week)|Overall Study||1
11367988|NCT03249454|12564522|FG005|Washout (1 Week)|Overall Study||2
11367989|NCT03249454|12564523|FG006|Washout (1 Week)|Overall Study||1
11367990|NCT03249454|12564524|FG007|Washout (1 Week)|Overall Study||1
11367991|NCT03249454|12564525|FG008|Washout (1 Week)|Overall Study||1
11367992|NCT03249454|12564526|FG009|Washout (1 Week)|Overall Study||0
11367993|NCT03249454|12564527|FG010|Washout (1 Week)|Overall Study||0
11367994|NCT03249454|12564517|FG000|Second Intervention (1 Day)|Overall Study||1
11367995|NCT03249454|12564518|FG001|Second Intervention (1 Day)|Overall Study||1
11367996|NCT03249454|12564519|FG002|Second Intervention (1 Day)|Overall Study||2
11367997|NCT03249454|12564520|FG003|Second Intervention (1 Day)|Overall Study||1
11367998|NCT03249454|12564521|FG004|Second Intervention (1 Day)|Overall Study||1
11367999|NCT03249454|12564522|FG005|Second Intervention (1 Day)|Overall Study||2
11368000|NCT03249454|12564523|FG006|Second Intervention (1 Day)|Overall Study||1
11368001|NCT03249454|12564524|FG007|Second Intervention (1 Day)|Overall Study||1
11368002|NCT03249454|12564525|FG008|Second Intervention (1 Day)|Overall Study||1
11368003|NCT03249454|12564526|FG009|Second Intervention (1 Day)|Overall Study||0
11368004|NCT03249454|12564527|FG010|Second Intervention (1 Day)|Overall Study||0
11368005|NCT03249454|12564517|FG000|Washout (1 Week)|Overall Study||1
11368006|NCT03249454|12564518|FG001|Washout (1 Week)|Overall Study||1
11368007|NCT03249454|12564519|FG002|Washout (1 Week)|Overall Study||2
11368008|NCT03249454|12564520|FG003|Washout (1 Week)|Overall Study||1
11368009|NCT03249454|12564521|FG004|Washout (1 Week)|Overall Study||1
11368010|NCT03249454|12564522|FG005|Washout (1 Week)|Overall Study||2
11368011|NCT03249454|12564523|FG006|Washout (1 Week)|Overall Study||1
11368012|NCT03249454|12564524|FG007|Washout (1 Week)|Overall Study||1
11368013|NCT03249454|12564525|FG008|Washout (1 Week)|Overall Study||1
11368014|NCT03249454|12564526|FG009|Washout (1 Week)|Overall Study||0
11368015|NCT03249454|12564527|FG010|Washout (1 Week)|Overall Study||0
11368016|NCT03249454|12564517|FG000|Third Intervention (1 Day)|Overall Study||1
11368017|NCT03249454|12564518|FG001|Third Intervention (1 Day)|Overall Study||1
11368018|NCT03249454|12564519|FG002|Third Intervention (1 Day)|Overall Study||2
11368019|NCT03249454|12564520|FG003|Third Intervention (1 Day)|Overall Study||1
11368020|NCT03249454|12564521|FG004|Third Intervention (1 Day)|Overall Study||1
11368021|NCT03249454|12564522|FG005|Third Intervention (1 Day)|Overall Study||2
11368022|NCT03249454|12564523|FG006|Third Intervention (1 Day)|Overall Study||1
11368023|NCT03249454|12564524|FG007|Third Intervention (1 Day)|Overall Study||1
11368024|NCT03249454|12564525|FG008|Third Intervention (1 Day)|Overall Study||1
11368025|NCT03249454|12564526|FG009|Third Intervention (1 Day)|Overall Study||0
11368026|NCT03249454|12564527|FG010|Third Intervention (1 Day)|Overall Study||0
11368027|NCT03249454|12564517|FG000|Washout (1 Week)|Overall Study||1
11368028|NCT03249454|12564518|FG001|Washout (1 Week)|Overall Study||1
11368029|NCT03249454|12564519|FG002|Washout (1 Week)|Overall Study||2
11368030|NCT03249454|12564520|FG003|Washout (1 Week)|Overall Study||1
11368031|NCT03249454|12564521|FG004|Washout (1 Week)|Overall Study||1
11368032|NCT03249454|12564522|FG005|Washout (1 Week)|Overall Study||2
11368033|NCT03249454|12564523|FG006|Washout (1 Week)|Overall Study||1
11368034|NCT03249454|12564524|FG007|Washout (1 Week)|Overall Study||1
11368035|NCT03249454|12564525|FG008|Washout (1 Week)|Overall Study||1
11368036|NCT03249454|12564526|FG009|Washout (1 Week)|Overall Study||0
11368037|NCT03249454|12564527|FG010|Washout (1 Week)|Overall Study||0
11368038|NCT03249454|12564517|FG000|Fourth Intervention (1 Day)|Overall Study||1
11368039|NCT03249454|12564518|FG001|Fourth Intervention (1 Day)|Overall Study||1
11368040|NCT03249454|12564519|FG002|Fourth Intervention (1 Day)|Overall Study||2
11368041|NCT03249454|12564520|FG003|Fourth Intervention (1 Day)|Overall Study||1
11368042|NCT03249454|12564521|FG004|Fourth Intervention (1 Day)|Overall Study||1
11368043|NCT03249454|12564522|FG005|Fourth Intervention (1 Day)|Overall Study||2
11368044|NCT03249454|12564523|FG006|Fourth Intervention (1 Day)|Overall Study||1
11368045|NCT03249454|12564524|FG007|Fourth Intervention (1 Day)|Overall Study||1
11368046|NCT03249454|12564525|FG008|Fourth Intervention (1 Day)|Overall Study||1
11368047|NCT03249454|12564526|FG009|Fourth Intervention (1 Day)|Overall Study||0
11368048|NCT03249454|12564527|FG010|Fourth Intervention (1 Day)|Overall Study||0
11368049|NCT03249454|12564517|FG000|Washout (1 Week)|Overall Study||1
11368050|NCT03249454|12564518|FG001|Washout (1 Week)|Overall Study||1
11368051|NCT03249454|12564519|FG002|Washout (1 Week)|Overall Study||2
11368052|NCT03249454|12564520|FG003|Washout (1 Week)|Overall Study||1
11368053|NCT03249454|12564521|FG004|Washout (1 Week)|Overall Study||1
11368054|NCT03249454|12564522|FG005|Washout (1 Week)|Overall Study||2
11368055|NCT03249454|12564523|FG006|Washout (1 Week)|Overall Study||1
11368056|NCT03249454|12564524|FG007|Washout (1 Week)|Overall Study||1
11368057|NCT03249454|12564525|FG008|Washout (1 Week)|Overall Study||1
11368058|NCT03249454|12564526|FG009|Washout (1 Week)|Overall Study||0
11368059|NCT03249454|12564527|FG010|Washout (1 Week)|Overall Study||0
11368060|NCT03249454|12564517|FG000|Fifth Intervention (1 Day)|Overall Study||1
11368061|NCT03249454|12564518|FG001|Fifth Intervention (1 Day)|Overall Study||1
11368062|NCT03249454|12564519|FG002|Fifth Intervention (1 Day)|Overall Study||2
11368063|NCT03249454|12564520|FG003|Fifth Intervention (1 Day)|Overall Study||1
11368064|NCT03249454|12564521|FG004|Fifth Intervention (1 Day)|Overall Study||1
11368065|NCT03249454|12564522|FG005|Fifth Intervention (1 Day)|Overall Study||2
11368066|NCT03249454|12564523|FG006|Fifth Intervention (1 Day)|Overall Study||1
11368067|NCT03249454|12564524|FG007|Fifth Intervention (1 Day)|Overall Study||1
11368068|NCT03249454|12564525|FG008|Fifth Intervention (1 Day)|Overall Study||1
11368069|NCT03249454|12564526|FG009|Fifth Intervention (1 Day)|Overall Study||0
11368070|NCT03249454|12564527|FG010|Fifth Intervention (1 Day)|Overall Study||0
11368071|NCT03249454|12564517|FG000|COMPLETED|Overall Study||1
11368072|NCT03249454|12564518|FG001|COMPLETED|Overall Study||1
11368073|NCT03249454|12564519|FG002|COMPLETED|Overall Study||2
11368074|NCT03249454|12564520|FG003|COMPLETED|Overall Study||1
11368075|NCT03249454|12564521|FG004|COMPLETED|Overall Study||1
11368076|NCT03249454|12564522|FG005|COMPLETED|Overall Study||2
11368077|NCT03249454|12564523|FG006|COMPLETED|Overall Study||1
11368078|NCT03249454|12564524|FG007|COMPLETED|Overall Study||1
11368079|NCT03249454|12564525|FG008|COMPLETED|Overall Study||1
11368080|NCT03249454|12564526|FG009|COMPLETED|Overall Study||0
11368081|NCT03249454|12564527|FG010|COMPLETED|Overall Study||0
11368082|NCT03249454|12564517|FG000|NOT COMPLETED|Overall Study||0
11368083|NCT03249454|12564518|FG001|NOT COMPLETED|Overall Study||0
11368084|NCT03249454|12564519|FG002|NOT COMPLETED|Overall Study||0
11368085|NCT03249454|12564520|FG003|NOT COMPLETED|Overall Study||0
11368086|NCT03249454|12564521|FG004|NOT COMPLETED|Overall Study||0
11368087|NCT03249454|12564522|FG005|NOT COMPLETED|Overall Study||0
11368088|NCT03249454|12564523|FG006|NOT COMPLETED|Overall Study||0
11368089|NCT03249454|12564524|FG007|NOT COMPLETED|Overall Study||0
11368090|NCT03249454|12564525|FG008|NOT COMPLETED|Overall Study||0
11368091|NCT03249454|12564526|FG009|NOT COMPLETED|Overall Study||1
11368092|NCT03249454|12564527|FG010|NOT COMPLETED|Overall Study||1
11368093|NCT03249584|12564540|FG000|STARTED|Overall Study||184
11368094|NCT03249584|12564541|FG001|STARTED|Overall Study||22
11368095|NCT03249584|12564540|FG000|Month 3|Overall Study||132
11368096|NCT03249584|12564541|FG001|Month 3|Overall Study||15
11368097|NCT03249584|12564540|FG000|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the primary objective included the first 42 Thoracic/Lumbar RF Ablation subjects to complete Month 3.|42
11368098|NCT03249584|12564541|FG001|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the secondary objective included all Periacetabulum/Iliac Crest/Sacrum RF Ablation subjects.|15
11368099|NCT03249584|12564540|FG000|Month 6|Overall Study||101
11368100|NCT03249584|12564541|FG001|Month 6|Overall Study||13
11368101|NCT03249584|12564540|FG000|COMPLETED|Overall Study||51
11368102|NCT03249584|12564541|FG001|COMPLETED|Overall Study||8
11368103|NCT03249584|12564540|FG000|NOT COMPLETED|Overall Study||133
11368104|NCT03249584|12564541|FG001|NOT COMPLETED|Overall Study||14
11368105|NCT03249779|12564546|FG000|STARTED|Overall Study||8
11368106|NCT03249779|12564546|FG000|COMPLETED|Overall Study||8
11368107|NCT03249779|12564546|FG000|NOT COMPLETED|Overall Study||0
11368108|NCT03249909|12564553|FG000|STARTED|Overall Study||78
11368109|NCT03249909|12564554|FG001|STARTED|Overall Study||15
11368110|NCT03249909|12564555|FG002|STARTED|Overall Study||16
11368111|NCT03249909|12564553|FG000|COMPLETED|Overall Study||72
11368112|NCT03249909|12564554|FG001|COMPLETED|Overall Study||14
11368113|NCT03249909|12564555|FG002|COMPLETED|Overall Study||16
11368114|NCT03249909|12564553|FG000|NOT COMPLETED|Overall Study||6
11368115|NCT03249909|12564554|FG001|NOT COMPLETED|Overall Study||1
11368116|NCT03249909|12564555|FG002|NOT COMPLETED|Overall Study||0
11368117|NCT03249935|12564566|FG000|STARTED|Overall Study||100
11368118|NCT03249935|12564566|FG000|COMPLETED|Overall Study||55
11368119|NCT03249935|12564566|FG000|NOT COMPLETED|Overall Study||45
11368120|NCT03250182|12564572|FG000|STARTED|Overall Study||30
11368121|NCT03250182|12564572|FG000|COMPLETED|Overall Study||29
11368122|NCT03250182|12564572|FG000|NOT COMPLETED|Overall Study||1
11368123|NCT03250234|12564578|FG000|STARTED|Overall Study||6
11368124|NCT03250234|12564579|FG001|STARTED|Overall Study||6
11368125|NCT03250234|12564578|FG000|COMPLETED|Overall Study||6
11368126|NCT03250234|12564579|FG001|COMPLETED|Overall Study||6
11368127|NCT03250234|12564578|FG000|NOT COMPLETED|Overall Study||0
11368128|NCT03250234|12564579|FG001|NOT COMPLETED|Overall Study||0
11368129|NCT03250689|12564587|FG000|STARTED|Overall Study||5
11368130|NCT03250689|12564588|FG001|STARTED|Overall Study||14
11368131|NCT03250689|12564587|FG000|COMPLETED|Overall Study||5
11368132|NCT03250689|12564588|FG001|COMPLETED|Overall Study||14
11368133|NCT03250689|12564587|FG000|NOT COMPLETED|Overall Study||0
11368134|NCT03250689|12564588|FG001|NOT COMPLETED|Overall Study||0
11368135|NCT03250845|12564595|FG000|STARTED|Multigam 5% Infusion (Baseline)||30
11368136|NCT03250845|12564595|FG000|COMPLETED|Multigam 5% Infusion (Baseline)||30
11368137|NCT03250845|12564595|FG000|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0
11368138|NCT03250845|12564595|FG000|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30
11368139|NCT03250845|12564595|FG000|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30
11368140|NCT03250845|12564595|FG000|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0
11368141|NCT03251482|12564606|FG000|STARTED|Overall Study||39
11368142|NCT03251482|12564607|FG001|STARTED|Overall Study||41
11368143|NCT03251482|12564608|FG002|STARTED|Overall Study||43
11368144|NCT03251482|12564609|FG003|STARTED|Overall Study||122
11368145|NCT03251482|12564610|FG004|STARTED|Overall Study||63
11368146|NCT03251482|12564606|FG000|Treated|Overall Study||38
11368147|NCT03251482|12564607|FG001|Treated|Overall Study||40
11368148|NCT03251482|12564608|FG002|Treated|Overall Study||42
11368149|NCT03251482|12564609|FG003|Treated|Overall Study||122
11368150|NCT03251482|12564610|FG004|Treated|Overall Study||63
11368151|NCT03251482|12564606|FG000|COMPLETED|Overall Study||39
11368152|NCT03251482|12564607|FG001|COMPLETED|Overall Study||40
11368153|NCT03251482|12564608|FG002|COMPLETED|Overall Study||43
11368154|NCT03251482|12564609|FG003|COMPLETED|Overall Study||122
11368155|NCT03251482|12564610|FG004|COMPLETED|Overall Study||63
11368156|NCT03251482|12564606|FG000|NOT COMPLETED|Overall Study||0
11368157|NCT03251482|12564607|FG001|NOT COMPLETED|Overall Study||1
11368158|NCT03251482|12564608|FG002|NOT COMPLETED|Overall Study||0
11368159|NCT03251482|12564609|FG003|NOT COMPLETED|Overall Study||0
11368160|NCT03251482|12564610|FG004|NOT COMPLETED|Overall Study||0
11368161|NCT03251937|12564622|FG000|STARTED|Overall Study||40
11368162|NCT03251937|12564622|FG000|COMPLETED|Overall Study||37
11368163|NCT03251937|12564622|FG000|NOT COMPLETED|Overall Study||3
11368164|NCT03251963|12564628|FG000|STARTED|Overall Study||65
11368165|NCT03251963|12564629|FG001|STARTED|Overall Study||66
11368166|NCT03251963|12564628|FG000|COMPLETED|Overall Study||56
11368167|NCT03251963|12564629|FG001|COMPLETED|Overall Study||61
11368168|NCT03251963|12564628|FG000|NOT COMPLETED|Overall Study||9
11368169|NCT03251963|12564629|FG001|NOT COMPLETED|Overall Study||5
11368170|NCT03252015|12564639|FG000|STARTED|Overall Study||12
11368171|NCT03252015|12564640|FG001|STARTED|Overall Study||28
11368172|NCT03252015|12564641|FG002|STARTED|Overall Study||15
11368173|NCT03252015|12564642|FG003|STARTED|Overall Study||15
11368174|NCT03252015|12564639|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
11368175|NCT03252015|12564640|FG001|Received at Least 1 Dose of Study Drug|Overall Study||28
11368176|NCT03252015|12564641|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
11368177|NCT03252015|12564642|FG003|Received at Least 1 Dose of Study Drug|Overall Study||15
11368178|NCT03252015|12564639|FG000|COMPLETED|Overall Study||11
11368179|NCT03252015|12564640|FG001|COMPLETED|Overall Study||27
11368180|NCT03252015|12564641|FG002|COMPLETED|Overall Study||14
11368181|NCT03252015|12564642|FG003|COMPLETED|Overall Study||14
11368182|NCT03252015|12564639|FG000|NOT COMPLETED|Overall Study||1
11142061|NCT01466153|12328742|FG000|NOT COMPLETED|Overall Study||29
11142062|NCT01466153|12328743|FG001|NOT COMPLETED|Overall Study||24
11142063|NCT01466153|12328744|FG002|NOT COMPLETED|Overall Study||25
11142064|NCT01466166|12328754|FG000|STARTED|Overall Study||188
11142065|NCT01466166|12328754|FG000|Received Treatment|Overall Study||188
11142066|NCT01466166|12328754|FG000|Completed 24 Weeks of Treatment|Overall Study||55
11142067|NCT01466166|12328754|FG000|COMPLETED|Overall Study||25
11368183|NCT03252015|12564640|FG001|NOT COMPLETED|Overall Study||1
11368184|NCT03252015|12564641|FG002|NOT COMPLETED|Overall Study||1
11368185|NCT03252015|12564642|FG003|NOT COMPLETED|Overall Study||1
11368186|NCT03252145|12564668|FG000|STARTED|Overall Study||13
11368187|NCT03252145|12564669|FG001|STARTED|Overall Study||15
11368188|NCT03252145|12564668|FG000|COMPLETED|Overall Study||11
11368189|NCT03252145|12564669|FG001|COMPLETED|Overall Study||13
11368190|NCT03252145|12564668|FG000|NOT COMPLETED|Overall Study||2
11368191|NCT03252145|12564669|FG001|NOT COMPLETED|Overall Study||2
11368192|NCT03252353|12564677|FG000|STARTED|Overall Study||28
11368193|NCT03252353|12564678|FG001|STARTED|Overall Study||28
11368194|NCT03252353|12564677|FG000|COMPLETED|Overall Study||28
11368195|NCT03252353|12564678|FG001|COMPLETED|Overall Study||28
11368196|NCT03252353|12564677|FG000|NOT COMPLETED|Overall Study||0
11368197|NCT03252353|12564678|FG001|NOT COMPLETED|Overall Study||0
11368198|NCT03252431|12564689|FG000|STARTED|Overall Study||197
11368199|NCT03252431|12564690|FG001|STARTED|Overall Study||196
11368200|NCT03252431|12564689|FG000|COMPLETED|Overall Study||186
11368201|NCT03252431|12564690|FG001|COMPLETED|Overall Study||187
11368202|NCT03252431|12564689|FG000|NOT COMPLETED|Overall Study||11
11368203|NCT03252431|12564690|FG001|NOT COMPLETED|Overall Study||9
11368204|NCT03252964|12564696|FG000|STARTED|Overall Study||52
11368205|NCT03252964|12564696|FG000|COMPLETED|Overall Study||20
11368206|NCT03252964|12564696|FG000|NOT COMPLETED|Overall Study||32
11368207|NCT03253094|12564706|FG000|STARTED|Overall Study||32
11368208|NCT03253094|12564707|FG001|STARTED|Overall Study||30
11368209|NCT03253094|12564708|FG002|STARTED|Overall Study||28
11368210|NCT03253094|12564709|FG003|STARTED|Overall Study||32
11368211|NCT03253094|12564710|FG004|STARTED|Overall Study||32
11368212|NCT03253094|12564711|FG005|STARTED|Overall Study||32
11368213|NCT03253094|12564706|FG000|Subjects Discontinued|Overall Study||4
11368214|NCT03253094|12564707|FG001|Subjects Discontinued|Overall Study||3
11368215|NCT03253094|12564708|FG002|Subjects Discontinued|Overall Study||6
11368216|NCT03253094|12564709|FG003|Subjects Discontinued|Overall Study||4
11368217|NCT03253094|12564710|FG004|Subjects Discontinued|Overall Study||5
11368218|NCT03253094|12564711|FG005|Subjects Discontinued|Overall Study||4
11368219|NCT03253094|12564706|FG000|COMPLETED|Overall Study||28
11368220|NCT03253094|12564707|FG001|COMPLETED|Overall Study||27
11368221|NCT03253094|12564708|FG002|COMPLETED|Overall Study||22
11368222|NCT03253094|12564709|FG003|COMPLETED|Overall Study||28
11368223|NCT03253094|12564710|FG004|COMPLETED|Overall Study||27
11368224|NCT03253094|12564711|FG005|COMPLETED|Overall Study||28
11368225|NCT03253094|12564706|FG000|NOT COMPLETED|Overall Study||4
11368226|NCT03253094|12564707|FG001|NOT COMPLETED|Overall Study||3
11368227|NCT03253094|12564708|FG002|NOT COMPLETED|Overall Study||6
11368228|NCT03253094|12564709|FG003|NOT COMPLETED|Overall Study||4
11368229|NCT03253094|12564710|FG004|NOT COMPLETED|Overall Study||5
11368230|NCT03253094|12564711|FG005|NOT COMPLETED|Overall Study||4
11368231|NCT03254108|12564730|FG000|STARTED|Overall Study||13
11368232|NCT03254108|12564731|FG001|STARTED|Overall Study||12
11368233|NCT03254108|12564732|FG002|STARTED|Overall Study||12
11368234|NCT03254108|12564733|FG003|STARTED|Overall Study||12
11368235|NCT03254108|12564734|FG004|STARTED|Overall Study||12
11368236|NCT03254108|12564730|FG000|Received Treatment|Overall Study||13
11368237|NCT03254108|12564731|FG001|Received Treatment|Overall Study||12
11368238|NCT03254108|12564732|FG002|Received Treatment|Overall Study||12
11368239|NCT03254108|12564733|FG003|Received Treatment|Overall Study||11
11368240|NCT03254108|12564734|FG004|Received Treatment|Overall Study||12
11368241|NCT03254108|12564730|FG000|COMPLETED|Overall Study||13
11368242|NCT03254108|12564731|FG001|COMPLETED|Overall Study||10
11368243|NCT03254108|12564732|FG002|COMPLETED|Overall Study||12
11368244|NCT03254108|12564733|FG003|COMPLETED|Overall Study||11
11368245|NCT03254108|12564734|FG004|COMPLETED|Overall Study||9
11368246|NCT03254108|12564730|FG000|NOT COMPLETED|Overall Study||0
11368247|NCT03254108|12564731|FG001|NOT COMPLETED|Overall Study||2
11368248|NCT03254108|12564732|FG002|NOT COMPLETED|Overall Study||0
11368249|NCT03254108|12564733|FG003|NOT COMPLETED|Overall Study||1
11368250|NCT03254108|12564734|FG004|NOT COMPLETED|Overall Study||3
11368251|NCT03254134|12564748|FG000|STARTED|Overall Study||5745
11368252|NCT03254134|12564749|FG001|STARTED|Overall Study||16745
11368253|NCT03254134|12564748|FG000|COMPLETED|Overall Study||5146
11368254|NCT03254134|12564749|FG001|COMPLETED|Overall Study||13115
11368255|NCT03254134|12564748|FG000|NOT COMPLETED|Overall Study||599
11368256|NCT03254134|12564749|FG001|NOT COMPLETED|Overall Study||3630
11368257|NCT03254147|12564755|FG000|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969
11368258|NCT03254147|12564755|FG000|COMPLETED|Overall Study||53969
11368259|NCT03254147|12564755|FG000|NOT COMPLETED|Overall Study||0
11368260|NCT03254459|12564761|FG000|STARTED|Overall Study||50
11368261|NCT03254459|12564762|FG001|STARTED|Overall Study||50
11368262|NCT03254459|12564761|FG000|COMPLETED|Overall Study||40
11368263|NCT03254459|12564762|FG001|COMPLETED|Overall Study||27
11368264|NCT03254459|12564761|FG000|NOT COMPLETED|Overall Study||10
11368265|NCT03254459|12564762|FG001|NOT COMPLETED|Overall Study||23
11368266|NCT03254602|12564768|FG000|STARTED|Overall Study||33
11368267|NCT03254602|12564768|FG000|COMPLETED|Overall Study||29
11368268|NCT03254602|12564768|FG000|NOT COMPLETED|Overall Study||4
11368269|NCT03254719|12564772|FG000|STARTED|Overall Study||40
11368270|NCT03254719|12564772|FG000|COMPLETED|Overall Study||40
11368271|NCT03254719|12564772|FG000|NOT COMPLETED|Overall Study||0
11368272|NCT03255291|12564782|FG000|STARTED|Overall Study||93
11368273|NCT03255291|12564783|FG001|STARTED|Overall Study||90
11368274|NCT03255291|12564784|FG002|STARTED|Overall Study||91
11368275|NCT03255291|12564785|FG003|STARTED|Overall Study||90
11368276|NCT03255291|12564786|FG004|STARTED|Overall Study||95
11368277|NCT03255291|12564787|FG005|STARTED|Overall Study||95
11368278|NCT03255291|12564782|FG000|COMPLETED|Overall Study||80
11368279|NCT03255291|12564783|FG001|COMPLETED|Overall Study||78
11368280|NCT03255291|12564784|FG002|COMPLETED|Overall Study||85
11368281|NCT03255291|12564785|FG003|COMPLETED|Overall Study||84
11368282|NCT03255291|12564786|FG004|COMPLETED|Overall Study||88
11368283|NCT03255291|12564787|FG005|COMPLETED|Overall Study||85
11368284|NCT03255291|12564782|FG000|NOT COMPLETED|Overall Study||13
11368285|NCT03255291|12564783|FG001|NOT COMPLETED|Overall Study||12
11368286|NCT03255291|12564784|FG002|NOT COMPLETED|Overall Study||6
11368287|NCT03255291|12564785|FG003|NOT COMPLETED|Overall Study||6
11368288|NCT03255291|12564786|FG004|NOT COMPLETED|Overall Study||7
11368289|NCT03255291|12564787|FG005|NOT COMPLETED|Overall Study||10
11368290|NCT03255382|12564807|FG000|STARTED|Overall Study||60
11368291|NCT03255382|12564808|FG001|STARTED|Overall Study||60
11368292|NCT03255382|12564807|FG000|COMPLETED|Overall Study||47
11368293|NCT03255382|12564808|FG001|COMPLETED|Overall Study||60
11368294|NCT03255382|12564807|FG000|NOT COMPLETED|Overall Study||13
11368295|NCT03255382|12564808|FG001|NOT COMPLETED|Overall Study||0
11368296|NCT03255655|12564817|FG000|STARTED|Overall Study||29
11368297|NCT03255655|12564818|FG001|STARTED|Overall Study||12
11368298|NCT03255655|12564817|FG000|COMPLETED|Overall Study||22
11368299|NCT03255655|12564818|FG001|COMPLETED|Overall Study||8
11368300|NCT03255655|12564817|FG000|NOT COMPLETED|Overall Study||7
11368301|NCT03255655|12564818|FG001|NOT COMPLETED|Overall Study||4
11368302|NCT03255733|12564824|FG000|STARTED|Overall Study||29
11368303|NCT03255733|12564824|FG000|COMPLETED|Overall Study||25
11368304|NCT03255733|12564824|FG000|NOT COMPLETED|Overall Study||4
11368305|NCT03255824|12564830|FG000|STARTED|Overall Study||69
11368306|NCT03255824|12564831|FG001|STARTED|Overall Study||75
11368307|NCT03255824|12564830|FG000|COMPLETED|Overall Study||67
11368308|NCT03255824|12564831|FG001|COMPLETED|Overall Study||74
11368309|NCT03255824|12564830|FG000|NOT COMPLETED|Overall Study||2
11368310|NCT03255824|12564831|FG001|NOT COMPLETED|Overall Study||1
11368311|NCT03255902|12564837|FG000|STARTED|Overall Study||7
11368312|NCT03255902|12564837|FG000|COMPLETED|Overall Study||5
11368313|NCT03255902|12564837|FG000|NOT COMPLETED|Overall Study||2
11368314|NCT03255941|12564845|FG000|STARTED|Overall Study||177
11368315|NCT03255941|12564846|FG001|STARTED|Overall Study||178
11368316|NCT03255941|12564847|FG002|STARTED|Overall Study||53
11368317|NCT03255941|12564848|FG003|STARTED|Overall Study||52
11368318|NCT03255941|12564845|FG000|Deemed Eligible to Receive DMPA|Overall Study||140
11368319|NCT03255941|12564846|FG001|Deemed Eligible to Receive DMPA|Overall Study||134
11368320|NCT03255941|12564847|FG002|Deemed Eligible to Receive DMPA|Overall Study||48
11368321|NCT03255941|12564848|FG003|Deemed Eligible to Receive DMPA|Overall Study||46
11368322|NCT03255941|12564845|FG000|COMPLETED|Overall Study||139
11368323|NCT03255941|12564846|FG001|COMPLETED|Overall Study||132
11368324|NCT03255941|12564847|FG002|COMPLETED|Overall Study||48
11368325|NCT03255941|12564848|FG003|COMPLETED|Overall Study||46
11368326|NCT03255941|12564845|FG000|NOT COMPLETED|Overall Study||38
11368327|NCT03255941|12564846|FG001|NOT COMPLETED|Overall Study||46
11368328|NCT03255941|12564847|FG002|NOT COMPLETED|Overall Study||5
11368329|NCT03255941|12564848|FG003|NOT COMPLETED|Overall Study||6
11368330|NCT03255980|12564874|FG000|STARTED|Overall Study||20
11368331|NCT03255980|12564875|FG001|STARTED|Overall Study||20
11368332|NCT03255980|12564876|FG002|STARTED|Overall Study||20
11368333|NCT03255980|12564877|FG003|STARTED|Overall Study||20
11368334|NCT03255980|12564874|FG000|COMPLETED|Overall Study||17
11368335|NCT03255980|12564875|FG001|COMPLETED|Overall Study||12
11368336|NCT03255980|12564876|FG002|COMPLETED|Overall Study||14
11368337|NCT03255980|12564877|FG003|COMPLETED|Overall Study||8
11368338|NCT03255980|12564874|FG000|NOT COMPLETED|Overall Study||3
11368339|NCT03255980|12564875|FG001|NOT COMPLETED|Overall Study||8
11368340|NCT03255980|12564876|FG002|NOT COMPLETED|Overall Study||6
11368341|NCT03255980|12564877|FG003|NOT COMPLETED|Overall Study||12
11368342|NCT03256136|12564891|FG000|STARTED|Overall Study||3
11368343|NCT03256136|12564892|FG001|STARTED|Overall Study||1
11368344|NCT03256136|12564893|FG002|STARTED|Overall Study||4
11368345|NCT03256136|12564894|FG003|STARTED|Overall Study||1
11368346|NCT03256136|12564891|FG000|COMPLETED|Overall Study||3
11368347|NCT03256136|12564892|FG001|COMPLETED|Overall Study||1
11368348|NCT03256136|12564893|FG002|COMPLETED|Overall Study||4
11368349|NCT03256136|12564894|FG003|COMPLETED|Overall Study||1
11368350|NCT03256136|12564891|FG000|NOT COMPLETED|Overall Study||0
11368351|NCT03256136|12564892|FG001|NOT COMPLETED|Overall Study||0
11368352|NCT03256136|12564893|FG002|NOT COMPLETED|Overall Study||0
11368353|NCT03256136|12564894|FG003|NOT COMPLETED|Overall Study||0
11368354|NCT03256162|12564906|FG000|STARTED|Overall Study||13
11368355|NCT03256162|12564907|FG001|STARTED|Overall Study||12
11368356|NCT03256162|12564906|FG000|COMPLETED|Overall Study||8
11368357|NCT03256162|12564907|FG001|COMPLETED|Overall Study||8
11368358|NCT03256162|12564906|FG000|NOT COMPLETED|Overall Study||5
11368359|NCT03256162|12564907|FG001|NOT COMPLETED|Overall Study||4
11368360|NCT03256253|12564913|FG000|STARTED|Overall Study||18
11368361|NCT03256253|12564913|FG000|COMPLETED|Overall Study||6
11368362|NCT03256253|12564913|FG000|NOT COMPLETED|Overall Study||12
11368363|NCT03256526|12564920|FG000|STARTED|Overall Study||19
11368364|NCT03256526|12564921|FG001|STARTED|Overall Study||17
11368365|NCT03256526|12564922|FG002|STARTED|Overall Study||17
11368366|NCT03256526|12564920|FG000|COMPLETED|Overall Study||17
11368367|NCT03256526|12564921|FG001|COMPLETED|Overall Study||17
11368368|NCT03256526|12564922|FG002|COMPLETED|Overall Study||14
11368369|NCT03256526|12564920|FG000|NOT COMPLETED|Overall Study||2
11368370|NCT03256526|12564921|FG001|NOT COMPLETED|Overall Study||0
11368371|NCT03256526|12564922|FG002|NOT COMPLETED|Overall Study||3
11368372|NCT03256552|12564930|FG000|STARTED|Overall Study||66
11368373|NCT03256552|12564930|FG000|GP MDI 28.8 µg|Overall Study||61
11368374|NCT03256552|12564930|FG000|GP MDI 14.4 µg|Overall Study||63
11368375|NCT03256552|12564930|FG000|GP MDI 7.2 µg|Overall Study||62
11368376|NCT03256552|12564930|FG000|Placebo MDI|Overall Study||65
11368377|NCT03256552|12564930|FG000|COMPLETED|Overall Study||61
11368378|NCT03256552|12564930|FG000|NOT COMPLETED|Overall Study||5
11368379|NCT03256578|12564942|FG000|STARTED|Overall Study||204
11368380|NCT03256578|12564943|FG001|STARTED|Overall Study||206
11368381|NCT03256578|12564942|FG000|COMPLETED|Overall Study||138
11368382|NCT03256578|12564943|FG001|COMPLETED|Overall Study||150
11368383|NCT03256578|12564942|FG000|NOT COMPLETED|Overall Study||66
11368384|NCT03256578|12564943|FG001|NOT COMPLETED|Overall Study||56
11368385|NCT03256695|12564949|FG000|STARTED|Overall Study||405
11368386|NCT03256695|12564949|FG000|Used ABS eMDPI at Least Once|Overall Study||390
11368387|NCT03256695|12564949|FG000|COMPLETED|Overall Study||366
11368388|NCT03256695|12564949|FG000|NOT COMPLETED|Overall Study||39
11368389|NCT03256799|12564953|FG000|STARTED|Overall Study||1
11368390|NCT03256799|12564953|FG000|COMPLETED|Overall Study||1
11368391|NCT03256799|12564953|FG000|NOT COMPLETED|Overall Study||0
11005671|NCT00723801|12183370|FG001|COMPLETED|Overall Study||17
11005672|NCT00723801|12183369|FG000|NOT COMPLETED|Overall Study||3
11005673|NCT00723801|12183370|FG001|NOT COMPLETED|Overall Study||3
11005674|NCT00723827|12183376|FG000|STARTED|Overall Study||682
11005675|NCT00723827|12183376|FG000|COMPLETED|Overall Study||682
11005676|NCT00723827|12183376|FG000|NOT COMPLETED|Overall Study||0
11005677|NCT00723840|12183380|FG000|STARTED|Overall Study||245
11005678|NCT00723840|12183380|FG000|COMPLETED|Overall Study||163
11005679|NCT00723840|12183380|FG000|NOT COMPLETED|Overall Study||82
11005680|NCT00723892|12183393|FG000|STARTED|Overall Study||313
11005681|NCT00723892|12183394|FG001|STARTED|Overall Study||255
11005682|NCT00723892|12183393|FG000|COMPLETED|Overall Study||206
11005683|NCT00723892|12183394|FG001|COMPLETED|Overall Study||168
11005684|NCT00723892|12183393|FG000|NOT COMPLETED|Overall Study||107
11005685|NCT00723892|12183394|FG001|NOT COMPLETED|Overall Study||87
11005686|NCT00723931|12183400|FG000|STARTED|Overall Study||1267
11005687|NCT00723931|12183400|FG000|COMPLETED|Overall Study||1267
11005688|NCT00723931|12183400|FG000|NOT COMPLETED|Overall Study||0
11368392|NCT03256851|12564959|FG000|STARTED|Overall Study||10
11368393|NCT03256851|12564960|FG001|STARTED|Overall Study||10
11368394|NCT03256851|12564959|FG000|COMPLETED|Overall Study||9
11368395|NCT03256851|12564960|FG001|COMPLETED|Overall Study||10
11368396|NCT03256851|12564959|FG000|NOT COMPLETED|Overall Study||1
11368397|NCT03256851|12564960|FG001|NOT COMPLETED|Overall Study||0
11368398|NCT03256968|12564966|FG000|STARTED|Overall Study||1
11368399|NCT03256968|12564966|FG000|COMPLETED|Overall Study||1
11368400|NCT03256968|12564966|FG000|NOT COMPLETED|Overall Study||0
11368401|NCT03257189|12564970|FG000|STARTED|Overall Study||30
11368402|NCT03257189|12564970|FG000|COMPLETED|Overall Study||30
11368403|NCT03257189|12564970|FG000|NOT COMPLETED|Overall Study||0
11005689|NCT00723957|12183406|FG000|STARTED|Overall Study|Randomized|98
11005690|NCT00723957|12183407|FG001|STARTED|Overall Study|Randomized|99
11058428|NCT01004003|12240269|FG001|NOT COMPLETED|Overall Study||3
11368404|NCT03257202|12564974|FG000|STARTED|Overall Study||12
11368405|NCT03257202|12564974|FG000|COMPLETED|Overall Study||12
11368406|NCT03257202|12564974|FG000|NOT COMPLETED|Overall Study||0
11368407|NCT03257358|12564986|FG000|STARTED|Overall Study||165
11368408|NCT03257358|12564987|FG001|STARTED|Overall Study||217
11368409|NCT03257358|12564986|FG000|Never Received Treatment|Overall Study||2
11368410|NCT03257358|12564987|FG001|Never Received Treatment|Overall Study||0
11368411|NCT03257358|12564986|FG000|COMPLETED|Overall Study||94
11368412|NCT03257358|12564987|FG001|COMPLETED|Overall Study||183
11368413|NCT03257358|12564986|FG000|NOT COMPLETED|Overall Study||71
11368414|NCT03257358|12564987|FG001|NOT COMPLETED|Overall Study||34
11368415|NCT03257371|12564993|FG000|STARTED|Overall Study||10
11368416|NCT03257371|12564993|FG000|COMPLETED|Overall Study||9
11368417|NCT03257371|12564993|FG000|NOT COMPLETED|Overall Study||1
11368418|NCT03257410|12564999|FG000|STARTED|Overall Study||86
11368419|NCT03257410|12565000|FG001|STARTED|Overall Study||86
11368420|NCT03257410|12564999|FG000|COMPLETED|Overall Study||65
11368421|NCT03257410|12565000|FG001|COMPLETED|Overall Study||65
11368422|NCT03257410|12564999|FG000|NOT COMPLETED|Overall Study||21
11368423|NCT03257410|12565000|FG001|NOT COMPLETED|Overall Study||21
11368424|NCT03257657|12565008|FG000|STARTED|Overall Study||22
11368425|NCT03257657|12565009|FG001|STARTED|Overall Study||20
11368426|NCT03257657|12565008|FG000|COMPLETED|Overall Study||22
11368427|NCT03257657|12565009|FG001|COMPLETED|Overall Study||15
11368428|NCT03257657|12565008|FG000|NOT COMPLETED|Overall Study||0
11368429|NCT03257657|12565009|FG001|NOT COMPLETED|Overall Study||5
11368430|NCT03257813|12565018|FG000|STARTED|Overall Study||30
11368431|NCT03257813|12565019|FG001|STARTED|Overall Study||30
11368432|NCT03257813|12565018|FG000|COMPLETED|Overall Study||24
11368433|NCT03257813|12565019|FG001|COMPLETED|Overall Study||27
11368434|NCT03257813|12565018|FG000|NOT COMPLETED|Overall Study||6
11368435|NCT03257813|12565019|FG001|NOT COMPLETED|Overall Study||3
11368436|NCT03257865|12565030|FG000|STARTED|Overall Study||163
11368437|NCT03257865|12565031|FG001|STARTED|Overall Study||170
11368438|NCT03257865|12565030|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162
11368439|NCT03257865|12565031|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170
11368440|NCT03257865|12565030|FG000|COMPLETED|Overall Study||128
11368441|NCT03257865|12565031|FG001|COMPLETED|Overall Study||135
11368442|NCT03257865|12565030|FG000|NOT COMPLETED|Overall Study||35
11368443|NCT03257865|12565031|FG001|NOT COMPLETED|Overall Study||35
11368444|NCT03257995|12565037|FG000|STARTED|Overall Study||9
11368445|NCT03257995|12565038|FG001|STARTED|Overall Study||9
11368446|NCT03257995|12565039|FG002|STARTED|Overall Study||9
11368447|NCT03257995|12565040|FG003|STARTED|Overall Study||9
11368448|NCT03257995|12565041|FG004|STARTED|Overall Study||9
11368449|NCT03257995|12565042|FG005|STARTED|Overall Study||9
11368450|NCT03257995|12565037|FG000|COMPLETED|Overall Study||9
11368451|NCT03257995|12565038|FG001|COMPLETED|Overall Study||8
11368452|NCT03257995|12565039|FG002|COMPLETED|Overall Study||9
11368453|NCT03257995|12565040|FG003|COMPLETED|Overall Study||9
11368454|NCT03257995|12565041|FG004|COMPLETED|Overall Study||9
11368455|NCT03257995|12565042|FG005|COMPLETED|Overall Study||7
11368456|NCT03257995|12565037|FG000|NOT COMPLETED|Overall Study||0
11368457|NCT03257995|12565038|FG001|NOT COMPLETED|Overall Study||1
11368458|NCT03257995|12565039|FG002|NOT COMPLETED|Overall Study||0
11368459|NCT03257995|12565040|FG003|NOT COMPLETED|Overall Study||0
11368460|NCT03257995|12565041|FG004|NOT COMPLETED|Overall Study||0
11368461|NCT03257995|12565042|FG005|NOT COMPLETED|Overall Study||2
11368462|NCT03258645|12565054|FG000|STARTED|Overall Study||1489
11368463|NCT03258645|12565054|FG000|COMPLETED|Overall Study||1489
11368464|NCT03258645|12565054|FG000|NOT COMPLETED|Overall Study||0
11368465|NCT03258710|12565064|FG000|STARTED|Overall Study||75
11368466|NCT03258710|12565064|FG000|COMPLETED|Overall Study||72
11368467|NCT03258710|12565064|FG000|NOT COMPLETED|Overall Study||3
11368468|NCT03258762|12565070|FG000|STARTED|Overall Study||7
11368469|NCT03258762|12565071|FG001|STARTED|Overall Study||7
11368470|NCT03258762|12565070|FG000|COMPLETED|Overall Study||7
11368471|NCT03258762|12565071|FG001|COMPLETED|Overall Study||6
11368472|NCT03258762|12565070|FG000|NOT COMPLETED|Overall Study||0
11368473|NCT03258762|12565071|FG001|NOT COMPLETED|Overall Study||1
11368474|NCT03258814|12565080|FG000|STARTED|Overall Study||4
11368475|NCT03258814|12565081|FG001|STARTED|Overall Study||3
11368476|NCT03258814|12565082|FG002|STARTED|Overall Study||10
11368477|NCT03258814|12565080|FG000|COMPLETED|Overall Study||0
11368478|NCT03258814|12565081|FG001|COMPLETED|Overall Study||0
11368479|NCT03258814|12565082|FG002|COMPLETED|Overall Study||0
11368480|NCT03258814|12565080|FG000|NOT COMPLETED|Overall Study||4
11368481|NCT03258814|12565081|FG001|NOT COMPLETED|Overall Study||3
11368482|NCT03258814|12565082|FG002|NOT COMPLETED|Overall Study||10
11368483|NCT03259087|12565094|FG000|STARTED|Part 1 and Period 1 of Part 2||8
11368484|NCT03259087|12565095|FG001|STARTED|Part 1 and Period 1 of Part 2||8
11368485|NCT03259087|12565096|FG002|STARTED|Part 1 and Period 1 of Part 2||8
11368486|NCT03259087|12565097|FG003|STARTED|Part 1 and Period 1 of Part 2||10
11368487|NCT03259087|12565098|FG004|STARTED|Part 1 and Period 1 of Part 2||8
11368488|NCT03259087|12565094|FG000|COMPLETED|Part 1 and Period 1 of Part 2||8
11368489|NCT03259087|12565095|FG001|COMPLETED|Part 1 and Period 1 of Part 2||8
11368490|NCT03259087|12565096|FG002|COMPLETED|Part 1 and Period 1 of Part 2||8
11368491|NCT03259087|12565097|FG003|COMPLETED|Part 1 and Period 1 of Part 2||10
11368492|NCT03259087|12565098|FG004|COMPLETED|Part 1 and Period 1 of Part 2||7
11368493|NCT03259087|12565094|FG000|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
11368494|NCT03259087|12565095|FG001|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
11368495|NCT03259087|12565096|FG002|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
11368496|NCT03259087|12565097|FG003|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
11368497|NCT03259087|12565098|FG004|NOT COMPLETED|Part 1 and Period 1 of Part 2||1
11368498|NCT03259087|12565094|FG000|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
11368499|NCT03259087|12565095|FG001|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
11368500|NCT03259087|12565096|FG002|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
11368501|NCT03259087|12565097|FG003|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
11368502|NCT03259087|12565098|FG004|STARTED|Period 2 of Part 2||7
11368503|NCT03259087|12565094|FG000|COMPLETED|Period 2 of Part 2||0
11368504|NCT03259087|12565095|FG001|COMPLETED|Period 2 of Part 2||0
11368505|NCT03259087|12565096|FG002|COMPLETED|Period 2 of Part 2||0
11368506|NCT03259087|12565097|FG003|COMPLETED|Period 2 of Part 2||0
11368507|NCT03259087|12565098|FG004|COMPLETED|Period 2 of Part 2||6
11368508|NCT03259087|12565094|FG000|NOT COMPLETED|Period 2 of Part 2||0
11368509|NCT03259087|12565095|FG001|NOT COMPLETED|Period 2 of Part 2||0
11368510|NCT03259087|12565096|FG002|NOT COMPLETED|Period 2 of Part 2||0
11368511|NCT03259087|12565097|FG003|NOT COMPLETED|Period 2 of Part 2||0
11368512|NCT03259087|12565098|FG004|NOT COMPLETED|Period 2 of Part 2||1
11368513|NCT03259139|12565126|FG000|STARTED|Overall Study||42
11368514|NCT03259139|12565127|FG001|STARTED|Overall Study||42
11368515|NCT03259139|12565128|FG002|STARTED|Overall Study||42
11368516|NCT03259139|12565129|FG003|STARTED|Overall Study||42
11368517|NCT03259139|12565130|FG004|STARTED|Overall Study||41
11368518|NCT03259139|12565131|FG005|STARTED|Overall Study||41
11368519|NCT03259139|12565126|FG000|Eligible|Overall Study||41
11368520|NCT03259139|12565127|FG001|Eligible|Overall Study||41
11368521|NCT03259139|12565128|FG002|Eligible|Overall Study||41
11368522|NCT03259139|12565129|FG003|Eligible|Overall Study||41
11368523|NCT03259139|12565130|FG004|Eligible|Overall Study||41
11368524|NCT03259139|12565131|FG005|Eligible|Overall Study||41
11368525|NCT03259139|12565126|FG000|Outlier Elimination|Overall Study||41
11368526|NCT03259139|12565127|FG001|Outlier Elimination|Overall Study||41
11368527|NCT03259139|12565128|FG002|Outlier Elimination|Overall Study||41
11368528|NCT03259139|12565129|FG003|Outlier Elimination|Overall Study||41
11368529|NCT03259139|12565130|FG004|Outlier Elimination|Overall Study||39
11368530|NCT03259139|12565131|FG005|Outlier Elimination|Overall Study||39
11368531|NCT03259139|12565126|FG000|Found Handgun|Overall Study||38
11368532|NCT03259139|12565127|FG001|Found Handgun|Overall Study||38
11368533|NCT03259139|12565128|FG002|Found Handgun|Overall Study||37
11368534|NCT03259139|12565129|FG003|Found Handgun|Overall Study||37
11368535|NCT03259139|12565130|FG004|Found Handgun|Overall Study||35
11368536|NCT03259139|12565131|FG005|Found Handgun|Overall Study||35
11368537|NCT03259139|12565126|FG000|COMPLETED|Overall Study||38
11368538|NCT03259139|12565127|FG001|COMPLETED|Overall Study||38
11368539|NCT03259139|12565128|FG002|COMPLETED|Overall Study||37
11368540|NCT03259139|12565129|FG003|COMPLETED|Overall Study||37
11368541|NCT03259139|12565130|FG004|COMPLETED|Overall Study||35
11368542|NCT03259139|12565131|FG005|COMPLETED|Overall Study||35
11368543|NCT03259139|12565126|FG000|NOT COMPLETED|Overall Study||4
11368544|NCT03259139|12565127|FG001|NOT COMPLETED|Overall Study||4
11368545|NCT03259139|12565128|FG002|NOT COMPLETED|Overall Study||5
11368546|NCT03259139|12565129|FG003|NOT COMPLETED|Overall Study||5
11368547|NCT03259139|12565130|FG004|NOT COMPLETED|Overall Study||6
11368548|NCT03259139|12565131|FG005|NOT COMPLETED|Overall Study||6
11368549|NCT03259308|12565151|FG000|STARTED|Overall Study||56
11368550|NCT03259308|12565152|FG001|STARTED|Overall Study||111
11368551|NCT03259308|12565153|FG002|STARTED|Overall Study||112
11368552|NCT03259308|12565151|FG000|COMPLETED|Overall Study||49
11368553|NCT03259308|12565152|FG001|COMPLETED|Overall Study||103
11368554|NCT03259308|12565153|FG002|COMPLETED|Overall Study||105
11368555|NCT03259308|12565151|FG000|NOT COMPLETED|Overall Study||7
11368556|NCT03259308|12565152|FG001|NOT COMPLETED|Overall Study||8
11368557|NCT03259308|12565153|FG002|NOT COMPLETED|Overall Study||7
11368558|NCT03259334|12565164|FG000|STARTED|Overall Study||76
11368559|NCT03259334|12565165|FG001|STARTED|Overall Study||153
11368560|NCT03259334|12565166|FG002|STARTED|Overall Study||151
11368561|NCT03259334|12565164|FG000|Treated|Overall Study||76
11368562|NCT03259334|12565165|FG001|Treated|Overall Study||151
11368563|NCT03259334|12565166|FG002|Treated|Overall Study||151
11368564|NCT03259334|12565164|FG000|COMPLETED|Overall Study||66
11368565|NCT03259334|12565165|FG001|COMPLETED|Overall Study||136
11368566|NCT03259334|12565166|FG002|COMPLETED|Overall Study||138
11368567|NCT03259334|12565164|FG000|NOT COMPLETED|Overall Study||10
11368568|NCT03259334|12565165|FG001|NOT COMPLETED|Overall Study||17
11368569|NCT03259334|12565166|FG002|NOT COMPLETED|Overall Study||13
11368570|NCT03259490|12565176|FG000|STARTED|Period 1||15
11368571|NCT03259490|12565177|FG001|STARTED|Period 1||15
11368572|NCT03259490|12565176|FG000|COMPLETED|Period 1||15
11368573|NCT03259490|12565177|FG001|COMPLETED|Period 1||14
11368574|NCT03259490|12565176|FG000|NOT COMPLETED|Period 1||0
11368575|NCT03259490|12565177|FG001|NOT COMPLETED|Period 1||1
11368576|NCT03259490|12565176|FG000|STARTED|Period 2||15
11368577|NCT03259490|12565177|FG001|STARTED|Period 2||14
11368578|NCT03259490|12565176|FG000|COMPLETED|Period 2||14
11368579|NCT03259490|12565177|FG001|COMPLETED|Period 2||14
11368580|NCT03259490|12565176|FG000|NOT COMPLETED|Period 2||1
11368581|NCT03259490|12565177|FG001|NOT COMPLETED|Period 2||0
11368582|NCT03259555|12565185|FG000|STARTED|Overall Study||158
11368583|NCT03259555|12565186|FG001|STARTED|Overall Study||164
11368584|NCT03259555|12565185|FG000|Received At Least 1 Dose of Study Drug|Overall Study||158
11368585|NCT03259555|12565186|FG001|Received At Least 1 Dose of Study Drug|Overall Study||163
11368586|NCT03259555|12565185|FG000|COMPLETED|Overall Study||124
11368587|NCT03259555|12565186|FG001|COMPLETED|Overall Study||134
11368588|NCT03259555|12565185|FG000|NOT COMPLETED|Overall Study||34
11368589|NCT03259555|12565186|FG001|NOT COMPLETED|Overall Study||30
11368590|NCT03259789|12565195|FG000|STARTED|Overall Study||158
11368591|NCT03259789|12565196|FG001|STARTED|Overall Study||159
11368592|NCT03259789|12565197|FG002|STARTED|Overall Study||34
11368593|NCT03259789|12565195|FG000|COMPLETED|Overall Study||141
11368594|NCT03259789|12565196|FG001|COMPLETED|Overall Study||142
11368595|NCT03259789|12565197|FG002|COMPLETED|Overall Study||28
11368596|NCT03259789|12565195|FG000|NOT COMPLETED|Overall Study||17
11368597|NCT03259789|12565196|FG001|NOT COMPLETED|Overall Study||17
11368598|NCT03259789|12565197|FG002|NOT COMPLETED|Overall Study||6
11368599|NCT03260205|12565211|FG000|STARTED|Overall Study||46
11368600|NCT03260205|12565212|FG001|STARTED|Overall Study||40
11368601|NCT03260205|12565213|FG002|STARTED|Overall Study||37
11368602|NCT03260205|12565214|FG003|STARTED|Overall Study||37
11368603|NCT03260205|12565215|FG004|STARTED|Overall Study||39
11368604|NCT03260205|12565211|FG000|Received Treatment|Overall Study||45
11368605|NCT03260205|12565212|FG001|Received Treatment|Overall Study||39
11368606|NCT03260205|12565213|FG002|Received Treatment|Overall Study||35
11368607|NCT03260205|12565214|FG003|Received Treatment|Overall Study||34
11368608|NCT03260205|12565215|FG004|Received Treatment|Overall Study||38
11368609|NCT03260205|12565211|FG000|COMPLETED|Overall Study||37
11368610|NCT03260205|12565212|FG001|COMPLETED|Overall Study||32
11368611|NCT03260205|12565213|FG002|COMPLETED|Overall Study||26
11368612|NCT03260205|12565214|FG003|COMPLETED|Overall Study||30
11368613|NCT03260205|12565215|FG004|COMPLETED|Overall Study||25
11368614|NCT03260205|12565211|FG000|NOT COMPLETED|Overall Study||9
11368615|NCT03260205|12565212|FG001|NOT COMPLETED|Overall Study||8
11368616|NCT03260205|12565213|FG002|NOT COMPLETED|Overall Study||11
11368617|NCT03260205|12565214|FG003|NOT COMPLETED|Overall Study||7
11368618|NCT03260205|12565215|FG004|NOT COMPLETED|Overall Study||14
11368619|NCT03260426|12565234|FG000|STARTED|Overall Study||50
11368620|NCT03260426|12565235|FG001|STARTED|Overall Study||50
11368621|NCT03260426|12565234|FG000|COMPLETED|Overall Study||50
11368622|NCT03260426|12565235|FG001|COMPLETED|Overall Study||50
11368623|NCT03260426|12565234|FG000|NOT COMPLETED|Overall Study||0
11368624|NCT03260426|12565235|FG001|NOT COMPLETED|Overall Study||0
11368625|NCT03260595|12565244|FG000|STARTED|Overall Study||20
11368626|NCT03260595|12565245|FG001|STARTED|Overall Study||10
11368627|NCT03260595|12565246|FG002|STARTED|Overall Study||2
11368628|NCT03260595|12565244|FG000|COMPLETED|Overall Study||20
11368629|NCT03260595|12565245|FG001|COMPLETED|Overall Study||10
11368630|NCT03260595|12565246|FG002|COMPLETED|Overall Study||2
11368631|NCT03260595|12565244|FG000|NOT COMPLETED|Overall Study||0
11368632|NCT03260595|12565245|FG001|NOT COMPLETED|Overall Study||0
11368633|NCT03260595|12565246|FG002|NOT COMPLETED|Overall Study||0
11368634|NCT03260699|12565256|FG000|STARTED|Overall Study||5
11368635|NCT03260699|12565257|FG001|STARTED|Overall Study||4
11368636|NCT03260699|12565256|FG000|COMPLETED|Overall Study||5
11368637|NCT03260699|12565257|FG001|COMPLETED|Overall Study||2
11368638|NCT03260699|12565256|FG000|NOT COMPLETED|Overall Study||0
11368639|NCT03260699|12565257|FG001|NOT COMPLETED|Overall Study||2
11368640|NCT03260790|12565265|FG000|STARTED|Overall Study||8
11368641|NCT03260790|12565266|FG001|STARTED|Overall Study||9
11368642|NCT03260790|12565265|FG000|COMPLETED|Overall Study||8
11368643|NCT03260790|12565266|FG001|COMPLETED|Overall Study||9
11368644|NCT03260790|12565265|FG000|NOT COMPLETED|Overall Study||0
11368645|NCT03260790|12565266|FG001|NOT COMPLETED|Overall Study||0
11368646|NCT03261037|12565276|FG000|STARTED|Overall Study||68
11368647|NCT03261037|12565277|FG001|STARTED|Overall Study||62
11368648|NCT03261037|12565278|FG002|STARTED|Overall Study||9
11368649|NCT03261037|12565279|FG003|STARTED|Overall Study||39
11368650|NCT03261037|12565276|FG000|COMPLETED|Overall Study||64
11368651|NCT03261037|12565277|FG001|COMPLETED|Overall Study||41
11368652|NCT03261037|12565278|FG002|COMPLETED|Overall Study||9
11368653|NCT03261037|12565279|FG003|COMPLETED|Overall Study||11
11368654|NCT03261037|12565276|FG000|NOT COMPLETED|Overall Study||4
11368655|NCT03261037|12565277|FG001|NOT COMPLETED|Overall Study||21
11368656|NCT03261037|12565278|FG002|NOT COMPLETED|Overall Study||0
11368657|NCT03261037|12565279|FG003|NOT COMPLETED|Overall Study||28
11368658|NCT03261167|12565292|FG000|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63
11368659|NCT03261167|12565293|FG001|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61
11368660|NCT03261167|12565292|FG000|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60
11368661|NCT03261167|12565293|FG001|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57
11368662|NCT03261167|12565292|FG000|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3
11368663|NCT03261167|12565293|FG001|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4
11368664|NCT03261167|12565292|FG000|STARTED|Open-label(Treatment cycle2,Upto Week48)||60
11368665|NCT03261167|12565293|FG001|STARTED|Open-label(Treatment cycle2,Upto Week48)||57
11368666|NCT03261167|12565292|FG000|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58
11368667|NCT03261167|12565293|FG001|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57
11368668|NCT03261167|12565292|FG000|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2
11368669|NCT03261167|12565293|FG001|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0
11368670|NCT03261167|12565292|FG000|STARTED|Open-label(Treatment cycle3,Upto Week48)||55
11368671|NCT03261167|12565293|FG001|STARTED|Open-label(Treatment cycle3,Upto Week48)||56
11368672|NCT03261167|12565292|FG000|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54
11368673|NCT03261167|12565293|FG001|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55
11368674|NCT03261167|12565292|FG000|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
11368675|NCT03261167|12565293|FG001|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
11368676|NCT03261167|12565292|FG000|STARTED|Open-label(Treatment cycle4,Upto Week48)||43
11368677|NCT03261167|12565293|FG001|STARTED|Open-label(Treatment cycle4,Upto Week48)||40
11368678|NCT03261167|12565292|FG000|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43
11368679|NCT03261167|12565293|FG001|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40
11368680|NCT03261167|12565292|FG000|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
11368681|NCT03261167|12565293|FG001|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
11368682|NCT03261336|12565305|FG000|STARTED|Overall Study||1
11368683|NCT03261336|12565305|FG000|COMPLETED|Overall Study||0
11368684|NCT03261336|12565305|FG000|NOT COMPLETED|Overall Study||1
11368685|NCT03261947|12565314|FG000|STARTED|Overall Study||12
11368686|NCT03261947|12565315|FG001|STARTED|Overall Study||15
11368687|NCT03261947|12565316|FG002|STARTED|Overall Study||35
11368688|NCT03261947|12565317|FG003|STARTED|Overall Study||21
11368689|NCT03261947|12565318|FG004|STARTED|Overall Study||18
11368690|NCT03261947|12565314|FG000|COMPLETED|Overall Study||0
11368691|NCT03261947|12565315|FG001|COMPLETED|Overall Study||2
11368692|NCT03261947|12565316|FG002|COMPLETED|Overall Study||5
11368693|NCT03261947|12565317|FG003|COMPLETED|Overall Study||0
11368694|NCT03261947|12565318|FG004|COMPLETED|Overall Study||1
11368695|NCT03261947|12565314|FG000|NOT COMPLETED|Overall Study||12
11368696|NCT03261947|12565315|FG001|NOT COMPLETED|Overall Study||13
11368697|NCT03261947|12565316|FG002|NOT COMPLETED|Overall Study||30
11368698|NCT03261947|12565317|FG003|NOT COMPLETED|Overall Study||21
11368699|NCT03261947|12565318|FG004|NOT COMPLETED|Overall Study||17
11368700|NCT03261960|12565336|FG000|STARTED|Overall Study||190
11368701|NCT03261960|12565337|FG001|STARTED|Overall Study||199
11368702|NCT03261960|12565336|FG000|COMPLETED|Overall Study||176
11368703|NCT03261960|12565337|FG001|COMPLETED|Overall Study||185
11368704|NCT03261960|12565336|FG000|NOT COMPLETED|Overall Study||14
11368705|NCT03261960|12565337|FG001|NOT COMPLETED|Overall Study||14
11368706|NCT03261973|12565343|FG000|STARTED|Overall Study||47
11368707|NCT03261973|12565343|FG000|COMPLETED|Overall Study||43
11368708|NCT03261973|12565343|FG000|NOT COMPLETED|Overall Study||4
11368709|NCT03261999|12565347|FG000|STARTED|Overall Study||144
11368710|NCT03261999|12565347|FG000|ITT|Overall Study||144
11368711|NCT03261999|12565347|FG000|PP|Overall Study||132
11368712|NCT03261999|12565347|FG000|COMPLETED|Overall Study||129
11368713|NCT03261999|12565347|FG000|NOT COMPLETED|Overall Study||15
11368714|NCT03262012|12565355|FG000|STARTED|Overall Study||139
11368715|NCT03262012|12565356|FG001|STARTED|Overall Study||138
11368716|NCT03262012|12565357|FG002|STARTED|Overall Study||70
11368717|NCT03262012|12565358|FG003|STARTED|Overall Study||69
11368718|NCT03262012|12565355|FG000|COMPLETED|Overall Study||112
11368719|NCT03262012|12565356|FG001|COMPLETED|Overall Study||102
11368720|NCT03262012|12565357|FG002|COMPLETED|Overall Study||56
11368721|NCT03262012|12565358|FG003|COMPLETED|Overall Study||54
11368722|NCT03262012|12565355|FG000|NOT COMPLETED|Overall Study||27
11368723|NCT03262012|12565356|FG001|NOT COMPLETED|Overall Study||36
11368724|NCT03262012|12565357|FG002|NOT COMPLETED|Overall Study||14
11368725|NCT03262012|12565358|FG003|NOT COMPLETED|Overall Study||15
11368726|NCT03262038|12565370|FG000|STARTED|Overall Study||18
11368727|NCT03262038|12565371|FG001|STARTED|Overall Study||28
11368728|NCT03262038|12565370|FG000|COMPLETED|Overall Study||18
11368729|NCT03262038|12565371|FG001|COMPLETED|Overall Study||27
11368730|NCT03262038|12565370|FG000|NOT COMPLETED|Overall Study||0
11368731|NCT03262038|12565371|FG001|NOT COMPLETED|Overall Study||1
11368732|NCT03262233|12565381|FG000|STARTED|Overall Study||53
11368733|NCT03262233|12565382|FG001|STARTED|Overall Study||53
11368734|NCT03262233|12565383|FG002|STARTED|Overall Study||59
11368735|NCT03262233|12565384|FG003|STARTED|Overall Study||61
11368736|NCT03262233|12565381|FG000|COMPLETED|Overall Study||35
11368737|NCT03262233|12565382|FG001|COMPLETED|Overall Study||32
11368738|NCT03262233|12565383|FG002|COMPLETED|Overall Study||34
11368739|NCT03262233|12565384|FG003|COMPLETED|Overall Study||32
11368740|NCT03262233|12565381|FG000|NOT COMPLETED|Overall Study||18
11368741|NCT03262233|12565382|FG001|NOT COMPLETED|Overall Study||21
11368742|NCT03262233|12565383|FG002|NOT COMPLETED|Overall Study||25
11368743|NCT03262233|12565384|FG003|NOT COMPLETED|Overall Study||29
11368744|NCT03262389|12565395|FG000|STARTED|Overall Study||10
11368745|NCT03262389|12565395|FG000|COMPLETED|Overall Study||7
11368746|NCT03262389|12565395|FG000|NOT COMPLETED|Overall Study||3
11368747|NCT03262441|12565399|FG000|STARTED|Overall Study||5
11368748|NCT03262441|12565399|FG000|COMPLETED|Overall Study||4
11368749|NCT03262441|12565399|FG000|NOT COMPLETED|Overall Study||1
11368750|NCT03263442|12565405|FG000|STARTED|Inpatient Phase||30
11368751|NCT03263442|12565406|FG001|STARTED|Inpatient Phase||34
11368752|NCT03263442|12565405|FG000|COMPLETED|Inpatient Phase||28
11368753|NCT03263442|12565406|FG001|COMPLETED|Inpatient Phase||33
11368754|NCT03263442|12565405|FG000|NOT COMPLETED|Inpatient Phase||2
11368755|NCT03263442|12565406|FG001|NOT COMPLETED|Inpatient Phase||1
11368756|NCT03263442|12565405|FG000|STARTED|1-month Follow-Up||28
11368757|NCT03263442|12565406|FG001|STARTED|1-month Follow-Up||33
11368758|NCT03263442|12565405|FG000|COMPLETED|1-month Follow-Up||27
11368759|NCT03263442|12565406|FG001|COMPLETED|1-month Follow-Up||33
11368760|NCT03263442|12565405|FG000|NOT COMPLETED|1-month Follow-Up||1
11368761|NCT03263442|12565406|FG001|NOT COMPLETED|1-month Follow-Up||0
11368762|NCT03263442|12565405|FG000|STARTED|3-month Follow-Up||27
11368763|NCT03263442|12565406|FG001|STARTED|3-month Follow-Up||33
11368764|NCT03263442|12565405|FG000|COMPLETED|3-month Follow-Up||26
11368765|NCT03263442|12565406|FG001|COMPLETED|3-month Follow-Up||30
11368766|NCT03263442|12565405|FG000|NOT COMPLETED|3-month Follow-Up||1
11368767|NCT03263442|12565406|FG001|NOT COMPLETED|3-month Follow-Up||3
11368768|NCT03263442|12565405|FG000|STARTED|6-month Follow-Up||26
11368769|NCT03263442|12565406|FG001|STARTED|6-month Follow-Up||30
11368770|NCT03263442|12565405|FG000|COMPLETED|6-month Follow-Up||24
11368771|NCT03263442|12565406|FG001|COMPLETED|6-month Follow-Up||28
11368772|NCT03263442|12565405|FG000|NOT COMPLETED|6-month Follow-Up||2
11368773|NCT03263442|12565406|FG001|NOT COMPLETED|6-month Follow-Up||2
11368774|NCT03263702|12565416|FG000|STARTED|Overall Study||38
11368775|NCT03263702|12565417|FG001|STARTED|Overall Study||26
11368776|NCT03263702|12565416|FG000|COMPLETED|Overall Study||35
11368777|NCT03263702|12565417|FG001|COMPLETED|Overall Study||22
11368778|NCT03263702|12565416|FG000|NOT COMPLETED|Overall Study||3
11368779|NCT03263702|12565417|FG001|NOT COMPLETED|Overall Study||4
11368780|NCT03263780|12565423|FG000|STARTED|Overall Study||21
11368781|NCT03263780|12565423|FG000|COMPLETED|Overall Study|13 evaluable for primary outcome, but 11 total completed study.|11
11368782|NCT03263780|12565423|FG000|NOT COMPLETED|Overall Study||10
11368783|NCT03264066|12565433|FG000|STARTED|Overall Study||20
11368784|NCT03264066|12565434|FG001|STARTED|Overall Study||20
11368785|NCT03264066|12565435|FG002|STARTED|Overall Study||17
11368786|NCT03264066|12565436|FG003|STARTED|Overall Study||20
11368787|NCT03264066|12565437|FG004|STARTED|Overall Study||7
11368788|NCT03264066|12565438|FG005|STARTED|Overall Study||3
11368789|NCT03264066|12565433|FG000|COMPLETED|Overall Study||0
11368790|NCT03264066|12565434|FG001|COMPLETED|Overall Study||0
11368791|NCT03264066|12565435|FG002|COMPLETED|Overall Study||0
11368792|NCT03264066|12565436|FG003|COMPLETED|Overall Study||0
11368793|NCT03264066|12565437|FG004|COMPLETED|Overall Study||0
11368794|NCT03264066|12565438|FG005|COMPLETED|Overall Study||0
11368795|NCT03264066|12565433|FG000|NOT COMPLETED|Overall Study||20
11368796|NCT03264066|12565434|FG001|NOT COMPLETED|Overall Study||20
11368797|NCT03264066|12565435|FG002|NOT COMPLETED|Overall Study||17
11368798|NCT03264066|12565436|FG003|NOT COMPLETED|Overall Study||20
11368799|NCT03264066|12565437|FG004|NOT COMPLETED|Overall Study||7
11368800|NCT03264066|12565438|FG005|NOT COMPLETED|Overall Study||3
11368801|NCT03264092|12565456|FG000|STARTED|Overall Study||17
11368802|NCT03264092|12565457|FG001|STARTED|Overall Study||20
11368803|NCT03264092|12565458|FG002|STARTED|Overall Study||18
11368804|NCT03264092|12565456|FG000|COMPLETED|Overall Study||17
11368805|NCT03264092|12565457|FG001|COMPLETED|Overall Study||20
11368806|NCT03264092|12565458|FG002|COMPLETED|Overall Study||18
11368807|NCT03264092|12565456|FG000|NOT COMPLETED|Overall Study||0
11368808|NCT03264092|12565457|FG001|NOT COMPLETED|Overall Study||0
11368809|NCT03264092|12565458|FG002|NOT COMPLETED|Overall Study||0
11368810|NCT03264157|12565474|FG000|STARTED|Overall Study||81
11368811|NCT03264157|12565475|FG001|STARTED|Overall Study||81
11368812|NCT03264157|12565474|FG000|COMPLETED|Overall Study||68
11368813|NCT03264157|12565475|FG001|COMPLETED|Overall Study||74
11368814|NCT03264157|12565474|FG000|NOT COMPLETED|Overall Study||13
11368815|NCT03264157|12565475|FG001|NOT COMPLETED|Overall Study||7
11368816|NCT03264248|12565483|FG000|STARTED|Overall Study||9
11368817|NCT03264248|12565483|FG000|COMPLETED|Overall Study||9
11368818|NCT03264248|12565483|FG000|NOT COMPLETED|Overall Study||0
11368819|NCT03264456|12565487|FG000|STARTED|Overall Study||18
11368820|NCT03264456|12565487|FG000|COMPLETED|Overall Study||14
11368821|NCT03264456|12565487|FG000|NOT COMPLETED|Overall Study||4
11368822|NCT03265119|12565493|FG000|STARTED|Overall Study||34
11368823|NCT03265119|12565494|FG001|STARTED|Overall Study||35
11368824|NCT03265119|12565493|FG000|COMPLETED|Overall Study||24
11368825|NCT03265119|12565494|FG001|COMPLETED|Overall Study||28
11368826|NCT03265119|12565493|FG000|NOT COMPLETED|Overall Study||10
11368827|NCT03265119|12565494|FG001|NOT COMPLETED|Overall Study||7
11368828|NCT03265132|12565502|FG000|STARTED|Overall Study||6
11368829|NCT03265132|12565503|FG001|STARTED|Overall Study|One patient failed disease specific inclusion criteria and was excluded from efficacy analysis|6
11368830|NCT03265132|12565502|FG000|COMPLETED|Overall Study||6
11368831|NCT03265132|12565503|FG001|COMPLETED|Overall Study||0
11368832|NCT03265132|12565502|FG000|NOT COMPLETED|Overall Study||0
11368833|NCT03265132|12565503|FG001|NOT COMPLETED|Overall Study||6
11368834|NCT03265600|12565513|FG000|STARTED|Overall Study||92
11368835|NCT03265600|12565514|FG001|STARTED|Overall Study||44
11368836|NCT03265600|12565513|FG000|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|68
11368837|NCT03265600|12565514|FG001|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|32
11368838|NCT03265600|12565513|FG000|NOT COMPLETED|Overall Study||24
11368839|NCT03265600|12565514|FG001|NOT COMPLETED|Overall Study||12
11368840|NCT03265938|12565520|FG000|STARTED|Overall Study||100
11368841|NCT03265938|12565520|FG000|COMPLETED|Overall Study||92
11368842|NCT03265938|12565520|FG000|NOT COMPLETED|Overall Study||8
11368843|NCT03266094|12565525|FG000|STARTED|Overall Study||60
11368844|NCT03266094|12565525|FG000|COMPLETED|Overall Study||58
11368845|NCT03266094|12565525|FG000|NOT COMPLETED|Overall Study||2
11368846|NCT03266107|12565531|FG000|STARTED|Enrollment to Procedure||50
11368847|NCT03266107|12565531|FG000|COMPLETED|Enrollment to Procedure||47
11368848|NCT03266107|12565531|FG000|NOT COMPLETED|Enrollment to Procedure||3
11368849|NCT03266107|12565531|FG000|STARTED|3-Month Follow-up Visit||47
11368850|NCT03266107|12565531|FG000|COMPLETED|3-Month Follow-up Visit||46
11368851|NCT03266107|12565531|FG000|NOT COMPLETED|3-Month Follow-up Visit||1
11368852|NCT03266107|12565531|FG000|STARTED|12-Month Follow-up Visit||46
11368853|NCT03266107|12565531|FG000|COMPLETED|12-Month Follow-up Visit||45
11368854|NCT03266107|12565531|FG000|NOT COMPLETED|12-Month Follow-up Visit||1
11368855|NCT03266172|12565540|FG000|STARTED|Part A: Period 1(2 Days)||16
11368856|NCT03266172|12565541|FG001|STARTED|Part A: Period 1(2 Days)||0
11368857|NCT03266172|12565542|FG002|STARTED|Part A: Period 1(2 Days)||0
11368858|NCT03266172|12565540|FG000|COMPLETED|Part A: Period 1(2 Days)||15
11368859|NCT03266172|12565541|FG001|COMPLETED|Part A: Period 1(2 Days)||0
11368860|NCT03266172|12565542|FG002|COMPLETED|Part A: Period 1(2 Days)||0
11368861|NCT03266172|12565540|FG000|NOT COMPLETED|Part A: Period 1(2 Days)||1
11368862|NCT03266172|12565541|FG001|NOT COMPLETED|Part A: Period 1(2 Days)||0
11368863|NCT03266172|12565542|FG002|NOT COMPLETED|Part A: Period 1(2 Days)||0
11368864|NCT03266172|12565540|FG000|STARTED|Part A: Washout Period (7 Days)||15
11368865|NCT03266172|12565541|FG001|STARTED|Part A: Washout Period (7 Days)||0
11368866|NCT03266172|12565542|FG002|STARTED|Part A: Washout Period (7 Days)||0
11368867|NCT03266172|12565540|FG000|COMPLETED|Part A: Washout Period (7 Days)||13
11368868|NCT03266172|12565541|FG001|COMPLETED|Part A: Washout Period (7 Days)||0
11368869|NCT03266172|12565542|FG002|COMPLETED|Part A: Washout Period (7 Days)||0
11368870|NCT03266172|12565540|FG000|NOT COMPLETED|Part A: Washout Period (7 Days)||2
11368871|NCT03266172|12565541|FG001|NOT COMPLETED|Part A: Washout Period (7 Days)||0
11368872|NCT03266172|12565542|FG002|NOT COMPLETED|Part A: Washout Period (7 Days)||0
11368873|NCT03266172|12565540|FG000|STARTED|Part A: Period 2 (2 Days)||13
11368874|NCT03266172|12565541|FG001|STARTED|Part A: Period 2 (2 Days)||0
11368875|NCT03266172|12565542|FG002|STARTED|Part A: Period 2 (2 Days)||0
11368876|NCT03266172|12565540|FG000|COMPLETED|Part A: Period 2 (2 Days)||13
11368877|NCT03266172|12565541|FG001|COMPLETED|Part A: Period 2 (2 Days)||0
11368878|NCT03266172|12565542|FG002|COMPLETED|Part A: Period 2 (2 Days)||0
11368879|NCT03266172|12565540|FG000|NOT COMPLETED|Part A: Period 2 (2 Days)||0
11368880|NCT03266172|12565541|FG001|NOT COMPLETED|Part A: Period 2 (2 Days)||0
11368881|NCT03266172|12565542|FG002|NOT COMPLETED|Part A: Period 2 (2 Days)||0
11368882|NCT03266172|12565540|FG000|STARTED|Part A: Washout (7 Days)||13
11368883|NCT03266172|12565541|FG001|STARTED|Part A: Washout (7 Days)||0
11368884|NCT03266172|12565542|FG002|STARTED|Part A: Washout (7 Days)||0
11368885|NCT03266172|12565540|FG000|COMPLETED|Part A: Washout (7 Days)||13
11368886|NCT03266172|12565541|FG001|COMPLETED|Part A: Washout (7 Days)||0
11368887|NCT03266172|12565542|FG002|COMPLETED|Part A: Washout (7 Days)||0
11368888|NCT03266172|12565540|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0
11368889|NCT03266172|12565541|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0
11368890|NCT03266172|12565542|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0
11368891|NCT03266172|12565540|FG000|STARTED|Part A: Period 3 (2 Days)|3 replacement participants were enrolled|16
11368892|NCT03266172|12565541|FG001|STARTED|Part A: Period 3 (2 Days)||0
11368893|NCT03266172|12565542|FG002|STARTED|Part A: Period 3 (2 Days)||0
11368894|NCT03266172|12565540|FG000|COMPLETED|Part A: Period 3 (2 Days)||16
11368895|NCT03266172|12565541|FG001|COMPLETED|Part A: Period 3 (2 Days)||0
11368896|NCT03266172|12565542|FG002|COMPLETED|Part A: Period 3 (2 Days)||0
11368897|NCT03266172|12565540|FG000|NOT COMPLETED|Part A: Period 3 (2 Days)||0
11368898|NCT03266172|12565541|FG001|NOT COMPLETED|Part A: Period 3 (2 Days)||0
11368899|NCT03266172|12565542|FG002|NOT COMPLETED|Part A: Period 3 (2 Days)||0
11368900|NCT03266172|12565540|FG000|STARTED|Part A: Washout (7 Days)||16
11368901|NCT03266172|12565541|FG001|STARTED|Part A: Washout (7 Days)||0
11368902|NCT03266172|12565542|FG002|STARTED|Part A: Washout (7 Days)||0
11368903|NCT03266172|12565540|FG000|COMPLETED|Part A: Washout (7 Days)||16
11368904|NCT03266172|12565541|FG001|COMPLETED|Part A: Washout (7 Days)||0
11368905|NCT03266172|12565542|FG002|COMPLETED|Part A: Washout (7 Days)||0
11368906|NCT03266172|12565540|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0
11368907|NCT03266172|12565541|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0
11368908|NCT03266172|12565542|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0
11368909|NCT03266172|12565540|FG000|STARTED|Part A: Period 4 (2 Days)||16
11368910|NCT03266172|12565541|FG001|STARTED|Part A: Period 4 (2 Days)||0
11368911|NCT03266172|12565542|FG002|STARTED|Part A: Period 4 (2 Days)||0
11368912|NCT03266172|12565540|FG000|COMPLETED|Part A: Period 4 (2 Days)||16
11368913|NCT03266172|12565541|FG001|COMPLETED|Part A: Period 4 (2 Days)||0
11368914|NCT03266172|12565542|FG002|COMPLETED|Part A: Period 4 (2 Days)||0
11368915|NCT03266172|12565540|FG000|NOT COMPLETED|Part A: Period 4 (2 Days)||0
11368916|NCT03266172|12565541|FG001|NOT COMPLETED|Part A: Period 4 (2 Days)||0
11368917|NCT03266172|12565542|FG002|NOT COMPLETED|Part A: Period 4 (2 Days)||0
11368918|NCT03266172|12565540|FG000|STARTED|Part B: Period 1 (4 Days)|Participants from Part A did not enter Part B|0
11368919|NCT03266172|12565541|FG001|STARTED|Part B: Period 1 (4 Days)|New participants were enrolled in Part B of study|10
11368920|NCT03266172|12565542|FG002|STARTED|Part B: Period 1 (4 Days)||0
11368921|NCT03266172|12565540|FG000|COMPLETED|Part B: Period 1 (4 Days)||0
11368922|NCT03266172|12565541|FG001|COMPLETED|Part B: Period 1 (4 Days)||10
11368923|NCT03266172|12565542|FG002|COMPLETED|Part B: Period 1 (4 Days)||0
11368924|NCT03266172|12565540|FG000|NOT COMPLETED|Part B: Period 1 (4 Days)||0
11368925|NCT03266172|12565541|FG001|NOT COMPLETED|Part B: Period 1 (4 Days)||0
11368926|NCT03266172|12565542|FG002|NOT COMPLETED|Part B: Period 1 (4 Days)||0
11368927|NCT03266172|12565540|FG000|STARTED|Part B: Washout (7 Days)||0
11368928|NCT03266172|12565541|FG001|STARTED|Part B: Washout (7 Days)||10
11368929|NCT03266172|12565542|FG002|STARTED|Part B: Washout (7 Days)||0
11368930|NCT03266172|12565540|FG000|COMPLETED|Part B: Washout (7 Days)||0
11368931|NCT03266172|12565541|FG001|COMPLETED|Part B: Washout (7 Days)||10
11368932|NCT03266172|12565542|FG002|COMPLETED|Part B: Washout (7 Days)||0
11368933|NCT03266172|12565540|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0
11368934|NCT03266172|12565541|FG001|NOT COMPLETED|Part B: Washout (7 Days)||0
11368935|NCT03266172|12565542|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0
11368936|NCT03266172|12565540|FG000|STARTED|Part B: Period 2 (4 Days)||0
11368937|NCT03266172|12565541|FG001|STARTED|Part B: Period 2 (4 Days)||10
11368938|NCT03266172|12565542|FG002|STARTED|Part B: Period 2 (4 Days)||0
11368939|NCT03266172|12565540|FG000|COMPLETED|Part B: Period 2 (4 Days)||0
11368940|NCT03266172|12565541|FG001|COMPLETED|Part B: Period 2 (4 Days)||10
11368941|NCT03266172|12565542|FG002|COMPLETED|Part B: Period 2 (4 Days)||0
11368942|NCT03266172|12565540|FG000|NOT COMPLETED|Part B: Period 2 (4 Days)||0
11368943|NCT03266172|12565541|FG001|NOT COMPLETED|Part B: Period 2 (4 Days)||0
11368944|NCT03266172|12565542|FG002|NOT COMPLETED|Part B: Period 2 (4 Days)||0
11368945|NCT03266172|12565540|FG000|STARTED|Part B: Washout (7 Days)||0
11368946|NCT03266172|12565541|FG001|STARTED|Part B: Washout (7 Days)||10
11368947|NCT03266172|12565542|FG002|STARTED|Part B: Washout (7 Days)||0
11368948|NCT03266172|12565540|FG000|COMPLETED|Part B: Washout (7 Days)||0
11368949|NCT03266172|12565541|FG001|COMPLETED|Part B: Washout (7 Days)||8
11368950|NCT03266172|12565542|FG002|COMPLETED|Part B: Washout (7 Days)||0
11368951|NCT03266172|12565540|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0
11368952|NCT03266172|12565541|FG001|NOT COMPLETED|Part B: Washout (7 Days)||2
11368953|NCT03266172|12565542|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0
11368954|NCT03266172|12565540|FG000|STARTED|Part B: Period 3 (4 Days)||0
11368955|NCT03266172|12565541|FG001|STARTED|Part B: Period 3 (4 Days)|Two participants completed Washout Period but withdrew before the start of Period 3.|6
11368956|NCT03266172|12565542|FG002|STARTED|Part B: Period 3 (4 Days)||0
11368957|NCT03266172|12565540|FG000|COMPLETED|Part B: Period 3 (4 Days)||0
11368958|NCT03266172|12565541|FG001|COMPLETED|Part B: Period 3 (4 Days)||6
11368959|NCT03266172|12565542|FG002|COMPLETED|Part B: Period 3 (4 Days)||0
11368960|NCT03266172|12565540|FG000|NOT COMPLETED|Part B: Period 3 (4 Days)||0
11368961|NCT03266172|12565541|FG001|NOT COMPLETED|Part B: Period 3 (4 Days)||0
11368962|NCT03266172|12565542|FG002|NOT COMPLETED|Part B: Period 3 (4 Days)||0
11368963|NCT03266172|12565540|FG000|STARTED|Part C: Period 1(2 Days)||0
11368964|NCT03266172|12565541|FG001|STARTED|Part C: Period 1(2 Days)|Participants from Part B did not enter Part C|0
11368965|NCT03266172|12565542|FG002|STARTED|Part C: Period 1(2 Days)|New participants were enrolled in Part C of study|15
11368966|NCT03266172|12565540|FG000|COMPLETED|Part C: Period 1(2 Days)||0
11368967|NCT03266172|12565541|FG001|COMPLETED|Part C: Period 1(2 Days)||0
11368968|NCT03266172|12565542|FG002|COMPLETED|Part C: Period 1(2 Days)||15
11368969|NCT03266172|12565540|FG000|NOT COMPLETED|Part C: Period 1(2 Days)||0
11368970|NCT03266172|12565541|FG001|NOT COMPLETED|Part C: Period 1(2 Days)||0
11368971|NCT03266172|12565542|FG002|NOT COMPLETED|Part C: Period 1(2 Days)||0
11368972|NCT03266172|12565540|FG000|STARTED|Part C Washout Period (7 Days)||0
11368973|NCT03266172|12565541|FG001|STARTED|Part C Washout Period (7 Days)||0
11368974|NCT03266172|12565542|FG002|STARTED|Part C Washout Period (7 Days)||15
11368975|NCT03266172|12565540|FG000|COMPLETED|Part C Washout Period (7 Days)||0
11368976|NCT03266172|12565541|FG001|COMPLETED|Part C Washout Period (7 Days)||0
11368977|NCT03266172|12565542|FG002|COMPLETED|Part C Washout Period (7 Days)||15
11368978|NCT03266172|12565540|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
11368979|NCT03266172|12565541|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
11368980|NCT03266172|12565542|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
11368981|NCT03266172|12565540|FG000|STARTED|Part C Period 2(2 Days)||0
11368982|NCT03266172|12565541|FG001|STARTED|Part C Period 2(2 Days)||0
11368983|NCT03266172|12565542|FG002|STARTED|Part C Period 2(2 Days)||15
11368984|NCT03266172|12565540|FG000|COMPLETED|Part C Period 2(2 Days)||0
11368985|NCT03266172|12565541|FG001|COMPLETED|Part C Period 2(2 Days)||0
11368986|NCT03266172|12565542|FG002|COMPLETED|Part C Period 2(2 Days)||15
11368987|NCT03266172|12565540|FG000|NOT COMPLETED|Part C Period 2(2 Days)||0
11368988|NCT03266172|12565541|FG001|NOT COMPLETED|Part C Period 2(2 Days)||0
11368989|NCT03266172|12565542|FG002|NOT COMPLETED|Part C Period 2(2 Days)||0
11368990|NCT03266172|12565540|FG000|STARTED|Part C Washout Period (7 Days)||0
11368991|NCT03266172|12565541|FG001|STARTED|Part C Washout Period (7 Days)||0
11368992|NCT03266172|12565542|FG002|STARTED|Part C Washout Period (7 Days)||15
11368993|NCT03266172|12565540|FG000|COMPLETED|Part C Washout Period (7 Days)||0
11368994|NCT03266172|12565541|FG001|COMPLETED|Part C Washout Period (7 Days)||0
11368995|NCT03266172|12565542|FG002|COMPLETED|Part C Washout Period (7 Days)||15
11368996|NCT03266172|12565540|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
11368997|NCT03266172|12565541|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
11368998|NCT03266172|12565542|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
11368999|NCT03266172|12565540|FG000|STARTED|Part C Period 3(2 Days)||0
11369000|NCT03266172|12565541|FG001|STARTED|Part C Period 3(2 Days)||0
11369001|NCT03266172|12565542|FG002|STARTED|Part C Period 3(2 Days)|1 replacement participant enrolled|16
11369002|NCT03266172|12565540|FG000|COMPLETED|Part C Period 3(2 Days)||0
11369003|NCT03266172|12565541|FG001|COMPLETED|Part C Period 3(2 Days)||0
11369004|NCT03266172|12565542|FG002|COMPLETED|Part C Period 3(2 Days)||16
11369005|NCT03266172|12565540|FG000|NOT COMPLETED|Part C Period 3(2 Days)||0
11369006|NCT03266172|12565541|FG001|NOT COMPLETED|Part C Period 3(2 Days)||0
11369007|NCT03266172|12565542|FG002|NOT COMPLETED|Part C Period 3(2 Days)||0
11369008|NCT03266172|12565540|FG000|STARTED|Part C Washout Period (7 Days)||0
11369009|NCT03266172|12565541|FG001|STARTED|Part C Washout Period (7 Days)||0
11369010|NCT03266172|12565542|FG002|STARTED|Part C Washout Period (7 Days)||16
11369011|NCT03266172|12565540|FG000|COMPLETED|Part C Washout Period (7 Days)||0
11369012|NCT03266172|12565541|FG001|COMPLETED|Part C Washout Period (7 Days)||0
11369013|NCT03266172|12565542|FG002|COMPLETED|Part C Washout Period (7 Days)||16
11369014|NCT03266172|12565540|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
11369015|NCT03266172|12565541|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
11369016|NCT03266172|12565542|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
11369017|NCT03266172|12565540|FG000|STARTED|Part C Period 4(2 Days)||0
11369018|NCT03266172|12565541|FG001|STARTED|Part C Period 4(2 Days)||0
11369019|NCT03266172|12565542|FG002|STARTED|Part C Period 4(2 Days)||16
11369020|NCT03266172|12565540|FG000|COMPLETED|Part C Period 4(2 Days)||0
11369021|NCT03266172|12565541|FG001|COMPLETED|Part C Period 4(2 Days)||0
11369022|NCT03266172|12565542|FG002|COMPLETED|Part C Period 4(2 Days)||16
11369023|NCT03266172|12565540|FG000|NOT COMPLETED|Part C Period 4(2 Days)||0
11369024|NCT03266172|12565541|FG001|NOT COMPLETED|Part C Period 4(2 Days)||0
11369025|NCT03266172|12565542|FG002|NOT COMPLETED|Part C Period 4(2 Days)||0
11369026|NCT03266172|12565540|FG000|STARTED|Part C Washout Period (7 Days)||0
11369027|NCT03266172|12565541|FG001|STARTED|Part C Washout Period (7 Days)||0
11369028|NCT03266172|12565542|FG002|STARTED|Part C Washout Period (7 Days)||16
11369029|NCT03266172|12565540|FG000|COMPLETED|Part C Washout Period (7 Days)||0
11369030|NCT03266172|12565541|FG001|COMPLETED|Part C Washout Period (7 Days)||0
11369031|NCT03266172|12565542|FG002|COMPLETED|Part C Washout Period (7 Days)||15
11369032|NCT03266172|12565540|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
11369033|NCT03266172|12565541|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
11369034|NCT03266172|12565542|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1
11369035|NCT03266172|12565540|FG000|STARTED|Part C Period 5(2 Days)||0
11369036|NCT03266172|12565541|FG001|STARTED|Part C Period 5(2 Days)||0
11369037|NCT03266172|12565542|FG002|STARTED|Part C Period 5(2 Days)||15
11369038|NCT03266172|12565540|FG000|COMPLETED|Part C Period 5(2 Days)||0
11369039|NCT03266172|12565541|FG001|COMPLETED|Part C Period 5(2 Days)||0
11369040|NCT03266172|12565542|FG002|COMPLETED|Part C Period 5(2 Days)||15
11369041|NCT03266172|12565540|FG000|NOT COMPLETED|Part C Period 5(2 Days)||0
11369042|NCT03266172|12565541|FG001|NOT COMPLETED|Part C Period 5(2 Days)||0
11369043|NCT03266172|12565542|FG002|NOT COMPLETED|Part C Period 5(2 Days)||0
11369044|NCT03266172|12565540|FG000|STARTED|Part C Washout Period (7 Days)||0
11369045|NCT03266172|12565541|FG001|STARTED|Part C Washout Period (7 Days)||0
11369046|NCT03266172|12565542|FG002|STARTED|Part C Washout Period (7 Days)||15
11369047|NCT03266172|12565540|FG000|COMPLETED|Part C Washout Period (7 Days)||0
11369048|NCT03266172|12565541|FG001|COMPLETED|Part C Washout Period (7 Days)||0
11369049|NCT03266172|12565542|FG002|COMPLETED|Part C Washout Period (7 Days)||14
11369050|NCT03266172|12565540|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
11369051|NCT03266172|12565541|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
11369052|NCT03266172|12565542|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1
11369053|NCT03266172|12565540|FG000|STARTED|Part C Period 6(2 Days)||0
11369054|NCT03266172|12565541|FG001|STARTED|Part C Period 6(2 Days)||0
11369055|NCT03266172|12565542|FG002|STARTED|Part C Period 6(2 Days)||14
11369056|NCT03266172|12565540|FG000|COMPLETED|Part C Period 6(2 Days)||0
11369057|NCT03266172|12565541|FG001|COMPLETED|Part C Period 6(2 Days)||0
11369058|NCT03266172|12565542|FG002|COMPLETED|Part C Period 6(2 Days)||14
11369059|NCT03266172|12565540|FG000|NOT COMPLETED|Part C Period 6(2 Days)||0
11369060|NCT03266172|12565541|FG001|NOT COMPLETED|Part C Period 6(2 Days)||0
11369061|NCT03266172|12565542|FG002|NOT COMPLETED|Part C Period 6(2 Days)||0
11369062|NCT03266419|12565594|FG000|STARTED|Overall Study||51
11369063|NCT03266419|12565595|FG001|STARTED|Overall Study||49
11369064|NCT03266419|12565594|FG000|COMPLETED|Overall Study||51
11369065|NCT03266419|12565595|FG001|COMPLETED|Overall Study||49
11369066|NCT03266419|12565594|FG000|NOT COMPLETED|Overall Study||0
11369067|NCT03266419|12565595|FG001|NOT COMPLETED|Overall Study||0
11369068|NCT03266588|12565604|FG000|STARTED|Observational Period||1605
11369069|NCT03266588|12565605|FG001|STARTED|Observational Period||786
11369070|NCT03266588|12565606|FG002|STARTED|Observational Period||476
11369071|NCT03266588|12565604|FG000|COMPLETED|Observational Period||1089
11369072|NCT03266588|12565605|FG001|COMPLETED|Observational Period||511
11369073|NCT03266588|12565606|FG002|COMPLETED|Observational Period||308
11369074|NCT03266588|12565604|FG000|NOT COMPLETED|Observational Period||516
11369075|NCT03266588|12565605|FG001|NOT COMPLETED|Observational Period||275
11369076|NCT03266588|12565606|FG002|NOT COMPLETED|Observational Period||168
11369077|NCT03266588|12565604|FG000|STARTED|Long-term Treatment Period||1089
11369078|NCT03266588|12565605|FG001|STARTED|Long-term Treatment Period||511
11369079|NCT03266588|12565606|FG002|STARTED|Long-term Treatment Period||308
11369080|NCT03266588|12565604|FG000|Treated|Long-term Treatment Period||1033
11369081|NCT03266588|12565605|FG001|Treated|Long-term Treatment Period||481
11369082|NCT03266588|12565606|FG002|Treated|Long-term Treatment Period||286
11369083|NCT03266588|12565604|FG000|COMPLETED|Long-term Treatment Period||683
11369084|NCT03266588|12565605|FG001|COMPLETED|Long-term Treatment Period||271
11369085|NCT03266588|12565606|FG002|COMPLETED|Long-term Treatment Period||243
11369086|NCT03266588|12565604|FG000|NOT COMPLETED|Long-term Treatment Period||406
11369087|NCT03266588|12565605|FG001|NOT COMPLETED|Long-term Treatment Period||240
11369088|NCT03266588|12565606|FG002|NOT COMPLETED|Long-term Treatment Period||65
11369089|NCT03267212|12565614|FG000|STARTED|First Intervention|Non-invasive ventilation|6
11369090|NCT03267212|12565615|FG001|STARTED|First Intervention|"First Intervention (1 day), Washout (2 days), and Second Intervention (1 day)"|9
11369091|NCT03267212|12565614|FG000|High SCI|First Intervention||2
11369092|NCT03267212|12565615|FG001|High SCI|First Intervention||5
11369093|NCT03267212|12565614|FG000|Low SCI|First Intervention||4
11369094|NCT03267212|12565615|FG001|Low SCI|First Intervention||4
11369095|NCT03267212|12565614|FG000|COMPLETED|First Intervention||5
11369096|NCT03267212|12565615|FG001|COMPLETED|First Intervention||6
11369097|NCT03267212|12565614|FG000|NOT COMPLETED|First Intervention||1
11369098|NCT03267212|12565615|FG001|NOT COMPLETED|First Intervention||3
11369099|NCT03267212|12565614|FG000|STARTED|Washout (Min 2 Days / Max 7 Days)||5
11369100|NCT03267212|12565615|FG001|STARTED|Washout (Min 2 Days / Max 7 Days)||6
11369101|NCT03267212|12565614|FG000|COMPLETED|Washout (Min 2 Days / Max 7 Days)||4
11369102|NCT03267212|12565615|FG001|COMPLETED|Washout (Min 2 Days / Max 7 Days)||6
11369103|NCT03267212|12565614|FG000|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||1
11369104|NCT03267212|12565615|FG001|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||0
11369105|NCT03267212|12565614|FG000|STARTED|Second Intervention||4
11369106|NCT03267212|12565615|FG001|STARTED|Second Intervention||6
11369107|NCT03267212|12565614|FG000|COMPLETED|Second Intervention||4
11369108|NCT03267212|12565615|FG001|COMPLETED|Second Intervention||6
11369109|NCT03267212|12565614|FG000|NOT COMPLETED|Second Intervention||0
11369110|NCT03267212|12565615|FG001|NOT COMPLETED|Second Intervention||0
11369111|NCT03267264|12565625|FG000|STARTED|Overall Study||66
11369112|NCT03267264|12565626|FG001|STARTED|Overall Study||49
11369113|NCT03267264|12565627|FG002|STARTED|Overall Study||68
11369114|NCT03267264|12565628|FG003|STARTED|Overall Study||65
11369115|NCT03267264|12565625|FG000|Sequence A(Nucleus)|Overall Study||34
11369116|NCT03267264|12565626|FG001|Sequence A(Nucleus)|Overall Study||25
11369117|NCT03267264|12565627|FG002|Sequence A(Nucleus)|Overall Study||33
11369118|NCT03267264|12565628|FG003|Sequence A(Nucleus)|Overall Study||33
11369119|NCT03267264|12565625|FG000|Sequence B(Comparator)|Overall Study||32
11369120|NCT03267264|12565626|FG001|Sequence B(Comparator)|Overall Study||24
11369121|NCT03267264|12565627|FG002|Sequence B(Comparator)|Overall Study||33
11369122|NCT03267264|12565628|FG003|Sequence B(Comparator)|Overall Study||32
11369123|NCT03267264|12565625|FG000|COMPLETED|Overall Study||65
11369124|NCT03267264|12565626|FG001|COMPLETED|Overall Study||49
11369125|NCT03267264|12565627|FG002|COMPLETED|Overall Study||66
11369126|NCT03267264|12565628|FG003|COMPLETED|Overall Study||61
11369127|NCT03267264|12565625|FG000|NOT COMPLETED|Overall Study||1
11369128|NCT03267264|12565626|FG001|NOT COMPLETED|Overall Study||0
11369129|NCT03267264|12565627|FG002|NOT COMPLETED|Overall Study||2
11369130|NCT03267264|12565628|FG003|NOT COMPLETED|Overall Study||4
11369131|NCT03267511|12565645|FG000|STARTED|Overall Study||31
11369132|NCT03267511|12565646|FG001|STARTED|Overall Study||31
11369133|NCT03267511|12565647|FG002|STARTED|Overall Study||30
11369134|NCT03267511|12565648|FG003|STARTED|Overall Study||31
11369135|NCT03267511|12565645|FG000|COMPLETED|Overall Study||31
11369136|NCT03267511|12565646|FG001|COMPLETED|Overall Study||31
11369137|NCT03267511|12565647|FG002|COMPLETED|Overall Study||30
11369138|NCT03267511|12565648|FG003|COMPLETED|Overall Study||30
11369139|NCT03267511|12565645|FG000|NOT COMPLETED|Overall Study||0
11369140|NCT03267511|12565646|FG001|NOT COMPLETED|Overall Study||0
11369141|NCT03267511|12565647|FG002|NOT COMPLETED|Overall Study||0
11369142|NCT03267511|12565648|FG003|NOT COMPLETED|Overall Study||1
11369143|NCT03267576|12565662|FG000|STARTED|Period 1: Day 0 to 27||31
11369144|NCT03267576|12565663|FG001|STARTED|Period 1: Day 0 to 27||32
11369145|NCT03267576|12565662|FG000|COMPLETED|Period 1: Day 0 to 27||31
11369146|NCT03267576|12565663|FG001|COMPLETED|Period 1: Day 0 to 27||32
11369147|NCT03267576|12565662|FG000|NOT COMPLETED|Period 1: Day 0 to 27||0
11369148|NCT03267576|12565663|FG001|NOT COMPLETED|Period 1: Day 0 to 27||0
11369149|NCT03267576|12565662|FG000|STARTED|Washout Period: 16 Days||31
11369150|NCT03267576|12565663|FG001|STARTED|Washout Period: 16 Days||32
11369151|NCT03267576|12565662|FG000|COMPLETED|Washout Period: 16 Days||31
11369152|NCT03267576|12565663|FG001|COMPLETED|Washout Period: 16 Days||32
11369153|NCT03267576|12565662|FG000|NOT COMPLETED|Washout Period: 16 Days||0
11369154|NCT03267576|12565663|FG001|NOT COMPLETED|Washout Period: 16 Days||0
11369155|NCT03267576|12565662|FG000|STARTED|Period 2: Day 44 to 71||31
11369156|NCT03267576|12565663|FG001|STARTED|Period 2: Day 44 to 71||32
11369157|NCT03267576|12565662|FG000|COMPLETED|Period 2: Day 44 to 71||30
11369158|NCT03267576|12565663|FG001|COMPLETED|Period 2: Day 44 to 71||30
11369159|NCT03267576|12565662|FG000|NOT COMPLETED|Period 2: Day 44 to 71||1
11369160|NCT03267576|12565663|FG001|NOT COMPLETED|Period 2: Day 44 to 71||2
11369161|NCT03267940|12565675|FG000|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
11369162|NCT03267940|12565676|FG001|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
11369163|NCT03267940|12565677|FG002|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
11369164|NCT03267940|12565678|FG003|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
11369165|NCT03267940|12565679|FG004|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
11369166|NCT03267940|12565680|FG005|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
11369167|NCT03267940|12565675|FG000|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
11369168|NCT03267940|12565676|FG001|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
11369169|NCT03267940|12565677|FG002|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
11369170|NCT03267940|12565678|FG003|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
11369171|NCT03267940|12565679|FG004|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
11369172|NCT03267940|12565680|FG005|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
11369173|NCT03267940|12565675|FG000|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1
11369174|NCT03267940|12565676|FG001|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2
11369175|NCT03267940|12565677|FG002|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
11369176|NCT03267940|12565678|FG003|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
11369177|NCT03267940|12565679|FG004|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
11369178|NCT03267940|12565680|FG005|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
11369179|NCT03267940|12565675|FG000|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8
11369180|NCT03267940|12565676|FG001|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7
11369181|NCT03267940|12565677|FG002|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
11369182|NCT03267940|12565678|FG003|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
11369183|NCT03267940|12565679|FG004|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
11369184|NCT03267940|12565680|FG005|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
11369185|NCT03267940|12565675|FG000|STARTED|Expansion (Maximum Exposure: 421 Days)||0
11369186|NCT03267940|12565676|FG001|STARTED|Expansion (Maximum Exposure: 421 Days)||0
11369187|NCT03267940|12565677|FG002|STARTED|Expansion (Maximum Exposure: 421 Days)||24
11369188|NCT03267940|12565678|FG003|STARTED|Expansion (Maximum Exposure: 421 Days)||22
11369189|NCT03267940|12565679|FG004|STARTED|Expansion (Maximum Exposure: 421 Days)||11
11369190|NCT03267940|12565680|FG005|STARTED|Expansion (Maximum Exposure: 421 Days)||10
11369191|NCT03267940|12565675|FG000|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
11369192|NCT03267940|12565676|FG001|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
11369193|NCT03267940|12565677|FG002|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24
11369194|NCT03267940|12565678|FG003|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22
11369195|NCT03267940|12565679|FG004|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11
11369196|NCT03267940|12565680|FG005|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10
11369197|NCT03267940|12565675|FG000|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
11369198|NCT03267940|12565676|FG001|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
11369199|NCT03267940|12565677|FG002|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3
11369200|NCT03267940|12565678|FG003|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
11369201|NCT03267940|12565679|FG004|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1
11369202|NCT03267940|12565680|FG005|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
11369203|NCT03267940|12565675|FG000|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
11369204|NCT03267940|12565676|FG001|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
11369205|NCT03267940|12565677|FG002|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21
11369206|NCT03267940|12565678|FG003|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22
11369207|NCT03267940|12565679|FG004|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
11369208|NCT03267940|12565680|FG005|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
11369209|NCT03268343|12565698|FG000|STARTED|Overall Study||12
11369210|NCT03268343|12565699|FG001|STARTED|Overall Study||12
11369211|NCT03268343|12565698|FG000|COMPLETED|Overall Study||12
11369212|NCT03268343|12565699|FG001|COMPLETED|Overall Study||12
11369213|NCT03268343|12565698|FG000|NOT COMPLETED|Overall Study||0
11369214|NCT03268343|12565699|FG001|NOT COMPLETED|Overall Study||0
11369215|NCT03268590|12565706|FG000|STARTED|Overall Study||33
11369216|NCT03268590|12565706|FG000|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32
11369217|NCT03268590|12565706|FG000|NOT COMPLETED|Overall Study||1
11369218|NCT03268746|12565713|FG000|STARTED|Overall Study||45
11369219|NCT03268746|12565713|FG000|COMPLETED|Overall Study||44
11369220|NCT03268746|12565713|FG000|NOT COMPLETED|Overall Study||1
11369221|NCT03268941|12565728|FG000|STARTED|Part 1 (Days 1 to 9)||12
11369222|NCT03268941|12565729|FG001|STARTED|Part 1 (Days 1 to 9)||14
11369223|NCT03268941|12565730|FG002|STARTED|Part 1 (Days 1 to 9)||12
11369224|NCT03268941|12565731|FG003|STARTED|Part 1 (Days 1 to 9)||13
11369225|NCT03268941|12565732|FG004|STARTED|Part 1 (Days 1 to 9)||0
11369226|NCT03268941|12565733|FG005|STARTED|Part 1 (Days 1 to 9)||0
11369227|NCT03268941|12565734|FG006|STARTED|Part 1 (Days 1 to 9)||0
11369228|NCT03268941|12565728|FG000|COMPLETED|Part 1 (Days 1 to 9)||11
11369229|NCT03268941|12565729|FG001|COMPLETED|Part 1 (Days 1 to 9)||14
11369230|NCT03268941|12565730|FG002|COMPLETED|Part 1 (Days 1 to 9)||12
11369231|NCT03268941|12565731|FG003|COMPLETED|Part 1 (Days 1 to 9)||11
11369232|NCT03268941|12565732|FG004|COMPLETED|Part 1 (Days 1 to 9)||0
11369233|NCT03268941|12565733|FG005|COMPLETED|Part 1 (Days 1 to 9)||0
11369234|NCT03268941|12565734|FG006|COMPLETED|Part 1 (Days 1 to 9)||0
11369235|NCT03268941|12565728|FG000|NOT COMPLETED|Part 1 (Days 1 to 9)||1
11369236|NCT03268941|12565729|FG001|NOT COMPLETED|Part 1 (Days 1 to 9)||0
11369237|NCT03268941|12565730|FG002|NOT COMPLETED|Part 1 (Days 1 to 9)||0
11369238|NCT03268941|12565731|FG003|NOT COMPLETED|Part 1 (Days 1 to 9)||2
11369239|NCT03268941|12565732|FG004|NOT COMPLETED|Part 1 (Days 1 to 9)||0
11369240|NCT03268941|12565733|FG005|NOT COMPLETED|Part 1 (Days 1 to 9)||0
11369241|NCT03268941|12565734|FG006|NOT COMPLETED|Part 1 (Days 1 to 9)||0
11369242|NCT03268941|12565728|FG000|STARTED|Part 2: Days 17 to 25||0
11369243|NCT03268941|12565729|FG001|STARTED|Part 2: Days 17 to 25||0
11369244|NCT03268941|12565730|FG002|STARTED|Part 2: Days 17 to 25||0
11369245|NCT03268941|12565731|FG003|STARTED|Part 2: Days 17 to 25||0
11369246|NCT03268941|12565732|FG004|STARTED|Part 2: Days 17 to 25||6
11369247|NCT03268941|12565733|FG005|STARTED|Part 2: Days 17 to 25||0
11369248|NCT03268941|12565734|FG006|STARTED|Part 2: Days 17 to 25||15
11369249|NCT03268941|12565728|FG000|Treated|Part 2: Days 17 to 25||0
11369250|NCT03268941|12565729|FG001|Treated|Part 2: Days 17 to 25||0
11369251|NCT03268941|12565730|FG002|Treated|Part 2: Days 17 to 25||0
11369252|NCT03268941|12565731|FG003|Treated|Part 2: Days 17 to 25||0
11369253|NCT03268941|12565732|FG004|Treated|Part 2: Days 17 to 25||6
11369254|NCT03268941|12565733|FG005|Treated|Part 2: Days 17 to 25||0
11369255|NCT03268941|12565734|FG006|Treated|Part 2: Days 17 to 25||13
11369256|NCT03268941|12565728|FG000|COMPLETED|Part 2: Days 17 to 25||0
11369257|NCT03268941|12565729|FG001|COMPLETED|Part 2: Days 17 to 25||0
11369258|NCT03268941|12565730|FG002|COMPLETED|Part 2: Days 17 to 25||0
11369259|NCT03268941|12565731|FG003|COMPLETED|Part 2: Days 17 to 25||0
11369260|NCT03268941|12565732|FG004|COMPLETED|Part 2: Days 17 to 25||6
11369261|NCT03268941|12565733|FG005|COMPLETED|Part 2: Days 17 to 25||0
11369262|NCT03268941|12565734|FG006|COMPLETED|Part 2: Days 17 to 25||13
11369263|NCT03268941|12565728|FG000|NOT COMPLETED|Part 2: Days 17 to 25||0
11369264|NCT03268941|12565729|FG001|NOT COMPLETED|Part 2: Days 17 to 25||0
11369265|NCT03268941|12565730|FG002|NOT COMPLETED|Part 2: Days 17 to 25||0
11369266|NCT03268941|12565731|FG003|NOT COMPLETED|Part 2: Days 17 to 25||0
11369267|NCT03268941|12565732|FG004|NOT COMPLETED|Part 2: Days 17 to 25||0
11369268|NCT03268941|12565733|FG005|NOT COMPLETED|Part 2: Days 17 to 25||0
11369269|NCT03268941|12565734|FG006|NOT COMPLETED|Part 2: Days 17 to 25||2
11369270|NCT03268941|12565728|FG000|STARTED|Part 2: Period 2: Fasted (Day 25)||0
11369271|NCT03268941|12565729|FG001|STARTED|Part 2: Period 2: Fasted (Day 25)||0
11369272|NCT03268941|12565730|FG002|STARTED|Part 2: Period 2: Fasted (Day 25)||0
11369273|NCT03268941|12565731|FG003|STARTED|Part 2: Period 2: Fasted (Day 25)||0
11369274|NCT03268941|12565732|FG004|STARTED|Part 2: Period 2: Fasted (Day 25)||0
11369275|NCT03268941|12565733|FG005|STARTED|Part 2: Period 2: Fasted (Day 25)||6
11369276|NCT03268941|12565734|FG006|STARTED|Part 2: Period 2: Fasted (Day 25)||0
11369277|NCT03268941|12565728|FG000|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
11369278|NCT03268941|12565729|FG001|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
11369279|NCT03268941|12565730|FG002|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
11369280|NCT03268941|12565731|FG003|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
11369281|NCT03268941|12565732|FG004|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
11369282|NCT03268941|12565733|FG005|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6
11369283|NCT03268941|12565734|FG006|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
11369284|NCT03268941|12565728|FG000|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
11369285|NCT03268941|12565729|FG001|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
11369286|NCT03268941|12565730|FG002|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
11369287|NCT03268941|12565731|FG003|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
11369288|NCT03268941|12565732|FG004|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
11369289|NCT03268941|12565733|FG005|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
11369290|NCT03268941|12565734|FG006|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
11369291|NCT03269435|12565755|FG000|STARTED|Overall Study||51
11369292|NCT03269435|12565756|FG001|STARTED|Overall Study||48
11369293|NCT03269435|12565755|FG000|COMPLETED|Overall Study||51
11369294|NCT03269435|12565756|FG001|COMPLETED|Overall Study||48
11369295|NCT03269435|12565755|FG000|NOT COMPLETED|Overall Study||0
11369296|NCT03269435|12565756|FG001|NOT COMPLETED|Overall Study||0
11369297|NCT03269552|12565762|FG000|STARTED|Overall Study||4
11369298|NCT03269552|12565762|FG000|COMPLETED|Overall Study||2
11369299|NCT03269552|12565762|FG000|NOT COMPLETED|Overall Study||2
11369300|NCT03270085|12565769|FG000|STARTED|Overall Study||15
11369301|NCT03270085|12565770|FG001|STARTED|Overall Study||15
11369302|NCT03270085|12565769|FG000|COMPLETED|Overall Study||14
11369303|NCT03270085|12565770|FG001|COMPLETED|Overall Study||15
11369304|NCT03270085|12565769|FG000|NOT COMPLETED|Overall Study||1
11369305|NCT03270085|12565770|FG001|NOT COMPLETED|Overall Study||0
11369306|NCT03270332|12565778|FG000|STARTED|Overall Study||5
11369307|NCT03270332|12565779|FG001|STARTED|Overall Study||5
11369308|NCT03270332|12565778|FG000|COMPLETED|Overall Study||5
11369309|NCT03270332|12565779|FG001|COMPLETED|Overall Study||4
11369310|NCT03270332|12565778|FG000|NOT COMPLETED|Overall Study||0
11369311|NCT03270332|12565779|FG001|NOT COMPLETED|Overall Study||1
11369312|NCT03270436|12565789|FG000|STARTED|Baseline||213
11369313|NCT03270436|12565790|FG001|STARTED|Baseline||167
11369314|NCT03270436|12565789|FG000|COMPLETED|Baseline||212
11369315|NCT03270436|12565790|FG001|COMPLETED|Baseline||166
11369316|NCT03270436|12565789|FG000|NOT COMPLETED|Baseline||1
11369317|NCT03270436|12565790|FG001|NOT COMPLETED|Baseline||1
11369318|NCT03270436|12565789|FG000|STARTED|Immediate Post-Intervention||213
11369319|NCT03270436|12565790|FG001|STARTED|Immediate Post-Intervention||167
11369320|NCT03270436|12565789|FG000|COMPLETED|Immediate Post-Intervention||172
11369321|NCT03270436|12565790|FG001|COMPLETED|Immediate Post-Intervention||111
11369322|NCT03270436|12565789|FG000|NOT COMPLETED|Immediate Post-Intervention||41
11369323|NCT03270436|12565790|FG001|NOT COMPLETED|Immediate Post-Intervention||56
11369324|NCT03270436|12565789|FG000|STARTED|6 Months Post-Intervention||213
11369325|NCT03270436|12565790|FG001|STARTED|6 Months Post-Intervention||167
11369326|NCT03270436|12565789|FG000|COMPLETED|6 Months Post-Intervention||173
11369327|NCT03270436|12565790|FG001|COMPLETED|6 Months Post-Intervention||116
11369328|NCT03270436|12565789|FG000|NOT COMPLETED|6 Months Post-Intervention||40
11369329|NCT03270436|12565790|FG001|NOT COMPLETED|6 Months Post-Intervention||51
11369330|NCT03270514|12565798|FG000|STARTED|Overall Study||29
11369331|NCT03270514|12565799|FG001|STARTED|Overall Study||31
11369332|NCT03270514|12565798|FG000|COMPLETED|Overall Study||29
11369333|NCT03270514|12565799|FG001|COMPLETED|Overall Study||31
11369334|NCT03270514|12565798|FG000|NOT COMPLETED|Overall Study||0
11369335|NCT03270514|12565799|FG001|NOT COMPLETED|Overall Study||0
11369336|NCT03270644|12565805|FG000|STARTED|Day 1 Lasmiditan Reference||44
11369337|NCT03270644|12565805|FG000|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44
11369338|NCT03270644|12565805|FG000|COMPLETED|Day 1 Lasmiditan Reference||43
11369339|NCT03270644|12565805|FG000|NOT COMPLETED|Day 1 Lasmiditan Reference||1
11369340|NCT03270644|12565805|FG000|STARTED|Day 4 - 10 Propranolol Reference||43
11369341|NCT03270644|12565805|FG000|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43
11369342|NCT03270644|12565805|FG000|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42
11369343|NCT03270644|12565805|FG000|COMPLETED|Day 4 - 10 Propranolol Reference||42
11369344|NCT03270644|12565805|FG000|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1
11369345|NCT03270657|12565816|FG000|STARTED|Overall Study||5
11369346|NCT03270657|12565816|FG000|COMPLETED|Overall Study||4
11369347|NCT03270657|12565816|FG000|NOT COMPLETED|Overall Study||1
11369348|NCT03270943|12565822|FG000|STARTED|Intervention Refinement||6
11369349|NCT03270943|12565823|FG001|STARTED|Intervention Refinement||9
11369350|NCT03270943|12565822|FG000|COMPLETED|Intervention Refinement||6
11369351|NCT03270943|12565823|FG001|COMPLETED|Intervention Refinement||6
11369352|NCT03270943|12565822|FG000|NOT COMPLETED|Intervention Refinement||0
11369353|NCT03270943|12565823|FG001|NOT COMPLETED|Intervention Refinement||3
11369354|NCT03270943|12565822|FG000|STARTED|Randomized (Willingness to be)||30
11369355|NCT03270943|12565823|FG001|STARTED|Randomized (Willingness to be)||32
11369356|NCT03270943|12565822|FG000|COMPLETED|Randomized (Willingness to be)||30
11369357|NCT03270943|12565823|FG001|COMPLETED|Randomized (Willingness to be)||31
11369358|NCT03270943|12565822|FG000|NOT COMPLETED|Randomized (Willingness to be)||0
11369359|NCT03270943|12565823|FG001|NOT COMPLETED|Randomized (Willingness to be)||1
11369360|NCT03271307|12565834|FG000|STARTED|Overall Study||1951
11369361|NCT03271307|12565835|FG001|STARTED|Overall Study||1837
11369362|NCT03271307|12565836|FG002|STARTED|Overall Study||2097
11369363|NCT03271307|12565837|FG003|STARTED|Overall Study||135
11369364|NCT03271307|12565838|FG004|STARTED|Overall Study||349
11369365|NCT03271307|12565834|FG000|COMPLETED|Overall Study||1951
11369366|NCT03271307|12565835|FG001|COMPLETED|Overall Study||1837
11369367|NCT03271307|12565836|FG002|COMPLETED|Overall Study||2097
11369368|NCT03271307|12565837|FG003|COMPLETED|Overall Study||107
11369369|NCT03271307|12565838|FG004|COMPLETED|Overall Study||258
11369370|NCT03271307|12565834|FG000|NOT COMPLETED|Overall Study||0
11369371|NCT03271307|12565835|FG001|NOT COMPLETED|Overall Study||0
11369372|NCT03271307|12565836|FG002|NOT COMPLETED|Overall Study||0
11369373|NCT03271307|12565837|FG003|NOT COMPLETED|Overall Study||28
11369374|NCT03271307|12565838|FG004|NOT COMPLETED|Overall Study||91
11369375|NCT03271424|12565856|FG000|STARTED|November 2015||20
11369376|NCT03271424|12565857|FG001|STARTED|November 2015||0
11369377|NCT03271424|12565858|FG002|STARTED|November 2015||0
11369378|NCT03271424|12565856|FG000|COMPLETED|November 2015||20
11369379|NCT03271424|12565857|FG001|COMPLETED|November 2015||0
11369380|NCT03271424|12565858|FG002|COMPLETED|November 2015||0
11369381|NCT03271424|12565856|FG000|NOT COMPLETED|November 2015||0
11369382|NCT03271424|12565857|FG001|NOT COMPLETED|November 2015||0
11369383|NCT03271424|12565858|FG002|NOT COMPLETED|November 2015||0
11369384|NCT03271424|12565856|FG000|STARTED|December 2015||0
11369385|NCT03271424|12565857|FG001|STARTED|December 2015||35
11369386|NCT03271424|12565858|FG002|STARTED|December 2015||0
11369387|NCT03271424|12565856|FG000|COMPLETED|December 2015||0
11369388|NCT03271424|12565857|FG001|COMPLETED|December 2015||35
11369389|NCT03271424|12565858|FG002|COMPLETED|December 2015||0
11369390|NCT03271424|12565856|FG000|NOT COMPLETED|December 2015||0
11369391|NCT03271424|12565857|FG001|NOT COMPLETED|December 2015||0
11369392|NCT03271424|12565858|FG002|NOT COMPLETED|December 2015||0
11369393|NCT03271424|12565856|FG000|STARTED|April-May 2016||0
11369394|NCT03271424|12565857|FG001|STARTED|April-May 2016||0
11369395|NCT03271424|12565858|FG002|STARTED|April-May 2016||40
11369396|NCT03271424|12565856|FG000|COMPLETED|April-May 2016||0
11369397|NCT03271424|12565857|FG001|COMPLETED|April-May 2016||0
11369398|NCT03271424|12565858|FG002|COMPLETED|April-May 2016||40
11369399|NCT03271424|12565856|FG000|NOT COMPLETED|April-May 2016||0
11369400|NCT03271424|12565857|FG001|NOT COMPLETED|April-May 2016||0
11369401|NCT03271424|12565858|FG002|NOT COMPLETED|April-May 2016||0
11369402|NCT03271528|12565870|FG000|STARTED|Medication Dispense/Exposure Period 1||13
11369403|NCT03271528|12565871|FG001|STARTED|Medication Dispense/Exposure Period 1||14
11369404|NCT03271528|12565870|FG000|COMPLETED|Medication Dispense/Exposure Period 1||11
11369405|NCT03271528|12565871|FG001|COMPLETED|Medication Dispense/Exposure Period 1||12
11369406|NCT03271528|12565870|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
11369407|NCT03271528|12565871|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
11369408|NCT03271528|12565870|FG000|STARTED|Alcohol Trial 1, Washout Period 1||11
11369409|NCT03271528|12565871|FG001|STARTED|Alcohol Trial 1, Washout Period 1||12
11369410|NCT03271528|12565870|FG000|COMPLETED|Alcohol Trial 1, Washout Period 1||9
11369411|NCT03271528|12565871|FG001|COMPLETED|Alcohol Trial 1, Washout Period 1||11
11369412|NCT03271528|12565870|FG000|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||2
11369413|NCT03271528|12565871|FG001|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||1
11369414|NCT03271528|12565870|FG000|STARTED|Medication Dispense/Exposure Period 2||9
11369415|NCT03271528|12565871|FG001|STARTED|Medication Dispense/Exposure Period 2||11
11369416|NCT03271528|12565870|FG000|COMPLETED|Medication Dispense/Exposure Period 2||8
11369417|NCT03271528|12565871|FG001|COMPLETED|Medication Dispense/Exposure Period 2||11
11369418|NCT03271528|12565870|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 2||1
11369419|NCT03271528|12565871|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 2||0
11369420|NCT03271528|12565870|FG000|STARTED|Alcohol Self-Administration Trial 2||8
11369421|NCT03271528|12565871|FG001|STARTED|Alcohol Self-Administration Trial 2||11
11369422|NCT03271528|12565870|FG000|COMPLETED|Alcohol Self-Administration Trial 2||8
11369423|NCT03271528|12565871|FG001|COMPLETED|Alcohol Self-Administration Trial 2||11
11369424|NCT03271528|12565870|FG000|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
11369425|NCT03271528|12565871|FG001|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
11369426|NCT03273166|12565877|FG000|STARTED|Overall Study||82
11369427|NCT03273166|12565877|FG000|COMPLETED|Overall Study||51
11369428|NCT03273166|12565877|FG000|NOT COMPLETED|Overall Study||31
11369429|NCT03273257|12565884|FG000|STARTED|Overall Study||7
11369430|NCT03273257|12565885|FG001|STARTED|Overall Study||7
11369431|NCT03273257|12565884|FG000|Started Treatment|Overall Study||7
11369432|NCT03273257|12565885|FG001|Started Treatment|Overall Study|Only 6 patients from the placebo group started treatment because 1 patient died after randomization (= study start), but before initiating treatment|6
11369433|NCT03273257|12565884|FG000|Underwent PEA|Overall Study||6
11369434|NCT03273257|12565885|FG001|Underwent PEA|Overall Study||5
11369435|NCT03273257|12565884|FG000|COMPLETED|Overall Study||3
11369436|NCT03273257|12565885|FG001|COMPLETED|Overall Study||3
11369437|NCT03273257|12565884|FG000|NOT COMPLETED|Overall Study||4
11369438|NCT03273257|12565885|FG001|NOT COMPLETED|Overall Study||4
11369439|NCT03273270|12565893|FG000|STARTED|Overall Study||12
11369440|NCT03273270|12565894|FG001|STARTED|Overall Study||8
11369441|NCT03273270|12565893|FG000|COMPLETED|Overall Study||12
11369442|NCT03273270|12565894|FG001|COMPLETED|Overall Study||8
11369443|NCT03273270|12565893|FG000|NOT COMPLETED|Overall Study||0
11369444|NCT03273270|12565894|FG001|NOT COMPLETED|Overall Study||0
11369445|NCT03273283|12565902|FG000|STARTED|Overall Study||99
11369446|NCT03273283|12565903|FG001|STARTED|Overall Study||101
11369447|NCT03273283|12565902|FG000|COMPLETED|Overall Study||72
11369448|NCT03273283|12565903|FG001|COMPLETED|Overall Study||81
11369449|NCT03273283|12565902|FG000|NOT COMPLETED|Overall Study||27
11369450|NCT03273283|12565903|FG001|NOT COMPLETED|Overall Study||20
11369451|NCT03273387|12565911|FG000|STARTED|Overall Study||13
11369452|NCT03273387|12565912|FG001|STARTED|Overall Study||13
11369453|NCT03273387|12565911|FG000|COMPLETED|Overall Study||10
11369454|NCT03273387|12565912|FG001|COMPLETED|Overall Study||10
11369455|NCT03273387|12565911|FG000|NOT COMPLETED|Overall Study||3
11369456|NCT03273387|12565912|FG001|NOT COMPLETED|Overall Study||3
11369457|NCT03273426|12565920|FG000|STARTED|Overall Study||20
11369458|NCT03273426|12565921|FG001|STARTED|Overall Study||20
11369459|NCT03273426|12565920|FG000|COMPLETED|Overall Study||20
11369460|NCT03273426|12565921|FG001|COMPLETED|Overall Study||20
11369461|NCT03273426|12565920|FG000|NOT COMPLETED|Overall Study||0
11369462|NCT03273426|12565921|FG001|NOT COMPLETED|Overall Study||0
11369463|NCT03273543|12565930|FG000|STARTED|Overall Study||10
11369464|NCT03273543|12565931|FG001|STARTED|Overall Study||10
11369465|NCT03273543|12565930|FG000|COMPLETED|Overall Study||10
11369466|NCT03273543|12565931|FG001|COMPLETED|Overall Study||10
11369467|NCT03273543|12565930|FG000|NOT COMPLETED|Overall Study||0
11369468|NCT03273543|12565931|FG001|NOT COMPLETED|Overall Study||0
11369469|NCT03273673|12565939|FG000|STARTED|Overall Study||18
11369470|NCT03273673|12565940|FG001|STARTED|Overall Study||22
11369471|NCT03273673|12565939|FG000|COMPLETED|Overall Study||14
11369472|NCT03273673|12565940|FG001|COMPLETED|Overall Study||22
11369473|NCT03273673|12565939|FG000|NOT COMPLETED|Overall Study||4
11369474|NCT03273673|12565940|FG001|NOT COMPLETED|Overall Study||0
11369475|NCT03273946|12565946|FG000|STARTED|Overall Study||158
11369476|NCT03273946|12565946|FG000|COMPLETED|Overall Study||149
11369477|NCT03273946|12565946|FG000|NOT COMPLETED|Overall Study||9
11369478|NCT03274076|12565952|FG000|STARTED|24 Weeks Double Blind||10
11369479|NCT03274076|12565953|FG001|STARTED|24 Weeks Double Blind||5
11369480|NCT03274076|12565954|FG002|STARTED|24 Weeks Double Blind||0
11369481|NCT03274076|12565955|FG003|STARTED|24 Weeks Double Blind||0
11369482|NCT03274076|12565952|FG000|COMPLETED|24 Weeks Double Blind||10
11369483|NCT03274076|12565953|FG001|COMPLETED|24 Weeks Double Blind||4
11369484|NCT03274076|12565954|FG002|COMPLETED|24 Weeks Double Blind||0
11369485|NCT03274076|12565955|FG003|COMPLETED|24 Weeks Double Blind||0
11369486|NCT03274076|12565952|FG000|NOT COMPLETED|24 Weeks Double Blind||0
11369487|NCT03274076|12565953|FG001|NOT COMPLETED|24 Weeks Double Blind||1
11369488|NCT03274076|12565954|FG002|NOT COMPLETED|24 Weeks Double Blind||0
11369489|NCT03274076|12565955|FG003|NOT COMPLETED|24 Weeks Double Blind||0
11369490|NCT03274076|12565952|FG000|STARTED|24 Weeks Open Label||0
11369491|NCT03274076|12565953|FG001|STARTED|24 Weeks Open Label||0
11369492|NCT03274076|12565954|FG002|STARTED|24 Weeks Open Label||10
11369493|NCT03274076|12565955|FG003|STARTED|24 Weeks Open Label||4
11369494|NCT03274076|12565952|FG000|COMPLETED|24 Weeks Open Label||0
11369495|NCT03274076|12565953|FG001|COMPLETED|24 Weeks Open Label||0
11369496|NCT03274076|12565954|FG002|COMPLETED|24 Weeks Open Label||8
11369497|NCT03274076|12565955|FG003|COMPLETED|24 Weeks Open Label||3
11369498|NCT03274076|12565952|FG000|NOT COMPLETED|24 Weeks Open Label||0
11369499|NCT03274076|12565953|FG001|NOT COMPLETED|24 Weeks Open Label||0
11369500|NCT03274076|12565954|FG002|NOT COMPLETED|24 Weeks Open Label||2
11369501|NCT03274076|12565955|FG003|NOT COMPLETED|24 Weeks Open Label||1
11369502|NCT03274440|12565974|FG000|STARTED|Overall Study||3
11369503|NCT03274440|12565975|FG001|STARTED|Overall Study||2
11369504|NCT03274440|12565976|FG002|STARTED|Overall Study||4
11369505|NCT03274440|12565977|FG003|STARTED|Overall Study||1
11369506|NCT03274440|12565978|FG004|STARTED|Overall Study||1
11369507|NCT03274440|12565979|FG005|STARTED|Overall Study||3
11369508|NCT03274440|12565974|FG000|COMPLETED|Overall Study||2
11369509|NCT03274440|12565975|FG001|COMPLETED|Overall Study||2
11369510|NCT03274440|12565976|FG002|COMPLETED|Overall Study||4
11369511|NCT03274440|12565977|FG003|COMPLETED|Overall Study||0
11369512|NCT03274440|12565978|FG004|COMPLETED|Overall Study||1
11369513|NCT03274440|12565979|FG005|COMPLETED|Overall Study||3
11369514|NCT03274440|12565974|FG000|NOT COMPLETED|Overall Study||1
11369515|NCT03274440|12565975|FG001|NOT COMPLETED|Overall Study||0
11369516|NCT03274440|12565976|FG002|NOT COMPLETED|Overall Study||0
11369517|NCT03274440|12565977|FG003|NOT COMPLETED|Overall Study||1
11369518|NCT03274440|12565978|FG004|NOT COMPLETED|Overall Study||0
11369519|NCT03274440|12565979|FG005|NOT COMPLETED|Overall Study||0
11369520|NCT03274453|12565991|FG000|STARTED|Overall Study||38
11369521|NCT03274453|12565992|FG001|STARTED|Overall Study||30
11369522|NCT03274453|12565993|FG002|STARTED|Overall Study||32
11369523|NCT03274453|12565994|FG003|STARTED|Overall Study||29
11369524|NCT03274453|12565991|FG000|COMPLETED|Overall Study||34
11369525|NCT03274453|12565992|FG001|COMPLETED|Overall Study||24
11369526|NCT03274453|12565993|FG002|COMPLETED|Overall Study||28
11369527|NCT03274453|12565994|FG003|COMPLETED|Overall Study||25
11369528|NCT03274453|12565991|FG000|NOT COMPLETED|Overall Study||4
11369529|NCT03274453|12565992|FG001|NOT COMPLETED|Overall Study||6
11369530|NCT03274453|12565993|FG002|NOT COMPLETED|Overall Study||4
11369531|NCT03274453|12565994|FG003|NOT COMPLETED|Overall Study||4
11369532|NCT03274518|12566006|FG000|STARTED|First Intervention||8
11369533|NCT03274518|12566007|FG001|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8
11369534|NCT03274518|12566006|FG000|COMPLETED|First Intervention||8
11369535|NCT03274518|12566007|FG001|COMPLETED|First Intervention||8
11369536|NCT03274518|12566006|FG000|NOT COMPLETED|First Intervention||0
11369537|NCT03274518|12566007|FG001|NOT COMPLETED|First Intervention||0
11369538|NCT03274518|12566006|FG000|STARTED|Washout Period||8
11369539|NCT03274518|12566007|FG001|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8
11369540|NCT03274518|12566006|FG000|COMPLETED|Washout Period||8
11369541|NCT03274518|12566007|FG001|COMPLETED|Washout Period||8
11369542|NCT03274518|12566006|FG000|NOT COMPLETED|Washout Period||0
11369543|NCT03274518|12566007|FG001|NOT COMPLETED|Washout Period||0
11369544|NCT03274518|12566006|FG000|STARTED|Second Intervention||8
11369545|NCT03274518|12566007|FG001|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8
11369546|NCT03274518|12566006|FG000|COMPLETED|Second Intervention||8
11369547|NCT03274518|12566007|FG001|COMPLETED|Second Intervention||8
11369548|NCT03274518|12566006|FG000|NOT COMPLETED|Second Intervention||0
11369549|NCT03274518|12566007|FG001|NOT COMPLETED|Second Intervention||0
11369550|NCT03274856|12566015|FG000|STARTED|Overall Study||10
11369551|NCT03274856|12566016|FG001|STARTED|Overall Study||9
11369552|NCT03274856|12566015|FG000|COMPLETED|Overall Study||10
11369553|NCT03274856|12566016|FG001|COMPLETED|Overall Study||9
11369554|NCT03274856|12566015|FG000|NOT COMPLETED|Overall Study||0
11369555|NCT03274856|12566016|FG001|NOT COMPLETED|Overall Study||0
11369556|NCT03274986|12566026|FG000|STARTED|Overall Study||107
11369557|NCT03274986|12566027|FG001|STARTED|Overall Study||113
11369558|NCT03274986|12566026|FG000|Successful Implantation, as Treated|Overall Study||107
11369559|NCT03274986|12566027|FG001|Successful Implantation, as Treated|Overall Study||113
11369560|NCT03274986|12566026|FG000|COMPLETED|Overall Study||107
11369561|NCT03274986|12566027|FG001|COMPLETED|Overall Study||111
11369562|NCT03274986|12566026|FG000|NOT COMPLETED|Overall Study||0
11369563|NCT03274986|12566027|FG001|NOT COMPLETED|Overall Study||2
11369564|NCT03274999|12566040|FG000|STARTED|First Intervention (Day 0)||5
11369565|NCT03274999|12566041|FG001|STARTED|First Intervention (Day 0)||5
11369566|NCT03274999|12566040|FG000|COMPLETED|First Intervention (Day 0)||5
11369567|NCT03274999|12566041|FG001|COMPLETED|First Intervention (Day 0)||5
11369568|NCT03274999|12566040|FG000|NOT COMPLETED|First Intervention (Day 0)||0
11369569|NCT03274999|12566041|FG001|NOT COMPLETED|First Intervention (Day 0)||0
11369570|NCT03274999|12566040|FG000|STARTED|Second Intervention (Day 14)||5
11369571|NCT03274999|12566041|FG001|STARTED|Second Intervention (Day 14)||5
11369572|NCT03274999|12566040|FG000|COMPLETED|Second Intervention (Day 14)||5
11369573|NCT03274999|12566041|FG001|COMPLETED|Second Intervention (Day 14)||5
11369574|NCT03274999|12566040|FG000|NOT COMPLETED|Second Intervention (Day 14)||0
11369575|NCT03274999|12566041|FG001|NOT COMPLETED|Second Intervention (Day 14)||0
11369576|NCT03275246|12566047|FG000|STARTED|Overall Study||8
11369577|NCT03275246|12566047|FG000|COMPLETED|Overall Study||2
11369578|NCT03275246|12566047|FG000|NOT COMPLETED|Overall Study||6
11369579|NCT03275389|12566061|FG000|STARTED|Overall Study||45
11369580|NCT03275389|12566062|FG001|STARTED|Overall Study||46
11369581|NCT03275389|12566063|FG002|STARTED|Overall Study||47
11369582|NCT03275389|12566064|FG003|STARTED|Overall Study||47
11369583|NCT03275389|12566065|FG004|STARTED|Overall Study||48
11369584|NCT03275389|12566066|FG005|STARTED|Overall Study||47
11369585|NCT03275389|12566067|FG006|STARTED|Overall Study||47
11369586|NCT03275389|12566068|FG007|STARTED|Overall Study||48
11369587|NCT03275389|12566069|FG008|STARTED|Overall Study||46
11369588|NCT03275389|12566070|FG009|STARTED|Overall Study||47
11369589|NCT03275389|12566061|FG000|COMPLETED|Overall Study||34
11369590|NCT03275389|12566062|FG001|COMPLETED|Overall Study||30
11369591|NCT03275389|12566063|FG002|COMPLETED|Overall Study||24
11369592|NCT03275389|12566064|FG003|COMPLETED|Overall Study||25
11369593|NCT03275389|12566065|FG004|COMPLETED|Overall Study||32
11369594|NCT03275389|12566066|FG005|COMPLETED|Overall Study||29
11369595|NCT03275389|12566067|FG006|COMPLETED|Overall Study||22
11369596|NCT03275389|12566068|FG007|COMPLETED|Overall Study||30
11369597|NCT03275389|12566069|FG008|COMPLETED|Overall Study||31
11369598|NCT03275389|12566070|FG009|COMPLETED|Overall Study||29
11369599|NCT03275389|12566061|FG000|NOT COMPLETED|Overall Study||11
11369600|NCT03275389|12566062|FG001|NOT COMPLETED|Overall Study||16
11369601|NCT03275389|12566063|FG002|NOT COMPLETED|Overall Study||23
11369602|NCT03275389|12566064|FG003|NOT COMPLETED|Overall Study||22
11369603|NCT03275389|12566065|FG004|NOT COMPLETED|Overall Study||16
11369604|NCT03275389|12566066|FG005|NOT COMPLETED|Overall Study||18
11369605|NCT03275389|12566067|FG006|NOT COMPLETED|Overall Study||25
11369606|NCT03275389|12566068|FG007|NOT COMPLETED|Overall Study||18
11369607|NCT03275389|12566069|FG008|NOT COMPLETED|Overall Study||15
11369608|NCT03275389|12566070|FG009|NOT COMPLETED|Overall Study||18
11369609|NCT03275623|12566094|FG000|STARTED|Overall Study||30
11369610|NCT03275623|12566095|FG001|STARTED|Overall Study||30
11369611|NCT03275623|12566094|FG000|COMPLETED|Overall Study||25
11369612|NCT03275623|12566095|FG001|COMPLETED|Overall Study||28
11369613|NCT03275623|12566094|FG000|NOT COMPLETED|Overall Study||5
11369614|NCT03275623|12566095|FG001|NOT COMPLETED|Overall Study||2
11369615|NCT03275766|12566105|FG000|STARTED|Overall Study||12
11369616|NCT03275766|12566106|FG001|STARTED|Overall Study||12
11369617|NCT03275766|12566107|FG002|STARTED|Overall Study||11
11369618|NCT03275766|12566108|FG003|STARTED|Overall Study||10
11369619|NCT03275766|12566105|FG000|Received Intervention|Overall Study||9
11369620|NCT03275766|12566106|FG001|Received Intervention|Overall Study||11
11369621|NCT03275766|12566107|FG002|Received Intervention|Overall Study||10
11369622|NCT03275766|12566108|FG003|Received Intervention|Overall Study||9
11369623|NCT03275766|12566105|FG000|COMPLETED|Overall Study||7
11369624|NCT03275766|12566106|FG001|COMPLETED|Overall Study||5
11369625|NCT03275766|12566107|FG002|COMPLETED|Overall Study||7
11369626|NCT03275766|12566108|FG003|COMPLETED|Overall Study||4
11369627|NCT03275766|12566105|FG000|NOT COMPLETED|Overall Study||5
11369628|NCT03275766|12566106|FG001|NOT COMPLETED|Overall Study||7
11369629|NCT03275766|12566107|FG002|NOT COMPLETED|Overall Study||4
11369630|NCT03275766|12566108|FG003|NOT COMPLETED|Overall Study||6
11369631|NCT03275870|12566118|FG000|STARTED|Overall Study||17
11369632|NCT03275870|12566118|FG000|COMPLETED|Overall Study||3
11369633|NCT03275870|12566118|FG000|NOT COMPLETED|Overall Study||14
11369634|NCT03276026|12566124|FG000|STARTED|Overall Study||35
11369635|NCT03276026|12566125|FG001|STARTED|Overall Study||33
11369636|NCT03276026|12566124|FG000|COMPLETED|Overall Study||34
11369637|NCT03276026|12566125|FG001|COMPLETED|Overall Study||33
11369638|NCT03276026|12566124|FG000|NOT COMPLETED|Overall Study||1
11369639|NCT03276026|12566125|FG001|NOT COMPLETED|Overall Study||0
11369640|NCT03276078|12566131|FG000|STARTED|Overall Study||20
11369641|NCT03276078|12566131|FG000|COMPLETED|Overall Study||19
11369642|NCT03276078|12566131|FG000|NOT COMPLETED|Overall Study||1
11369643|NCT03276494|12566135|FG000|STARTED|Overall Study||6
11369644|NCT03276494|12566135|FG000|COMPLETED|Overall Study||5
11369645|NCT03276494|12566135|FG000|NOT COMPLETED|Overall Study||1
11369646|NCT03276637|12566139|FG000|STARTED|Overall Study||93
11369647|NCT03276637|12566139|FG000|Completed Pre Survey|Overall Study||93
11369648|NCT03276637|12566139|FG000|Underwent Sequencing|Overall Study||75
11369649|NCT03276637|12566139|FG000|Completed Post Survey|Overall Study||69
11369650|NCT03276637|12566139|FG000|COMPLETED|Overall Study||69
11369651|NCT03276637|12566139|FG000|NOT COMPLETED|Overall Study||24
11369652|NCT03276871|12566146|FG000|STARTED|Overall Study||21
11369653|NCT03276871|12566147|FG001|STARTED|Overall Study||19
11369654|NCT03276871|12566146|FG000|COMPLETED|Overall Study||21
11369655|NCT03276871|12566147|FG001|COMPLETED|Overall Study||19
11369656|NCT03276871|12566146|FG000|NOT COMPLETED|Overall Study||0
11369657|NCT03276871|12566147|FG001|NOT COMPLETED|Overall Study||0
11369658|NCT03276975|12566155|FG000|STARTED|Overall Study||8
11369659|NCT03276975|12566156|FG001|STARTED|Overall Study||7
11369660|NCT03276975|12566155|FG000|Crossover At 2 Months|Overall Study||0
11369661|NCT03276975|12566156|FG001|Crossover At 2 Months|Overall Study||7
11369662|NCT03276975|12566155|FG000|COMPLETED|Overall Study||7
11369663|NCT03276975|12566156|FG001|COMPLETED|Overall Study||7
11369664|NCT03276975|12566155|FG000|NOT COMPLETED|Overall Study||1
11369665|NCT03276975|12566156|FG001|NOT COMPLETED|Overall Study||0
11369666|NCT03277274|12566165|FG000|STARTED|Overall Study||8
11369667|NCT03277274|12566166|FG001|STARTED|Overall Study||10
11369668|NCT03277274|12566167|FG002|STARTED|Overall Study||7
11369669|NCT03277274|12566165|FG000|COMPLETED|Overall Study||8
11369670|NCT03277274|12566166|FG001|COMPLETED|Overall Study||10
11369671|NCT03277274|12566167|FG002|COMPLETED|Overall Study||7
11369672|NCT03277274|12566165|FG000|NOT COMPLETED|Overall Study||0
11369673|NCT03277274|12566166|FG001|NOT COMPLETED|Overall Study||0
11369674|NCT03277274|12566167|FG002|NOT COMPLETED|Overall Study||0
11369675|NCT03277352|12566175|FG000|STARTED|Overall Study||10
11369676|NCT03277352|12566175|FG000|COMPLETED|Overall Study||0
11369677|NCT03277352|12566175|FG000|NOT COMPLETED|Overall Study||10
11369678|NCT03277378|12566182|FG000|STARTED|Overall Study||135
11369679|NCT03277378|12566183|FG001|STARTED|Overall Study||135
11369680|NCT03277378|12566182|FG000|Received Lead Implant|Overall Study||129
11369681|NCT03277378|12566183|FG001|Received Lead Implant|Overall Study||123
11369682|NCT03277378|12566182|FG000|Completed Initial Trial|Overall Study||126
11369683|NCT03277378|12566183|FG001|Completed Initial Trial|Overall Study||122
11369684|NCT03277378|12566182|FG000|Qualified for Permanent Implant|Overall Study||103
11369685|NCT03277378|12566183|FG001|Qualified for Permanent Implant|Overall Study||93
11369686|NCT03277378|12566182|FG000|Not Qualified for Permanent Implant|Overall Study||19
11369687|NCT03277378|12566183|FG001|Not Qualified for Permanent Implant|Overall Study||20
11369688|NCT03277378|12566182|FG000|Completed Extended Trial With Tonic Stim|Overall Study||8
11369689|NCT03277378|12566183|FG001|Completed Extended Trial With Tonic Stim|Overall Study||12
11369690|NCT03277378|12566182|FG000|Exit Study|Overall Study||11
11369691|NCT03277378|12566183|FG001|Exit Study|Overall Study||8
11369692|NCT03277378|12566182|FG000|COMPLETED|Overall Study||111
11369693|NCT03277378|12566183|FG001|COMPLETED|Overall Study||101
11369694|NCT03277378|12566182|FG000|NOT COMPLETED|Overall Study||24
11369695|NCT03277378|12566183|FG001|NOT COMPLETED|Overall Study||34
11369696|NCT03277794|12566195|FG000|STARTED|Overall Study||31
11369697|NCT03277794|12566196|FG001|STARTED|Overall Study||34
11369698|NCT03277794|12566195|FG000|COMPLETED|Overall Study||28
11369699|NCT03277794|12566196|FG001|COMPLETED|Overall Study||30
11369700|NCT03277794|12566195|FG000|NOT COMPLETED|Overall Study||3
11369701|NCT03277794|12566196|FG001|NOT COMPLETED|Overall Study||4
11369702|NCT03277846|12566205|FG000|STARTED|Overall Study||50
11369703|NCT03277846|12566206|FG001|STARTED|Overall Study||51
11369704|NCT03277846|12566205|FG000|COMPLETED|Overall Study||38
11369705|NCT03277846|12566206|FG001|COMPLETED|Overall Study||40
11369706|NCT03277846|12566205|FG000|NOT COMPLETED|Overall Study||12
11369707|NCT03277846|12566206|FG001|NOT COMPLETED|Overall Study||11
11369708|NCT03278028|12566214|FG000|STARTED|Overall Study||81
11369709|NCT03278028|12566215|FG001|STARTED|Overall Study||78
11369710|NCT03278028|12566214|FG000|COMPLETED|Overall Study||77
11369711|NCT03278028|12566215|FG001|COMPLETED|Overall Study||76
11369712|NCT03278028|12566214|FG000|NOT COMPLETED|Overall Study||4
11369713|NCT03278028|12566215|FG001|NOT COMPLETED|Overall Study||2
11369714|NCT03278067|12566224|FG000|STARTED|Overall Study||16433
11369715|NCT03278067|12566225|FG001|STARTED|Overall Study||3310
11369716|NCT03278067|12566226|FG002|STARTED|Overall Study||4196
11369717|NCT03278067|12566224|FG000|COMPLETED|Overall Study||16433
11369718|NCT03278067|12566225|FG001|COMPLETED|Overall Study||3310
11369719|NCT03278067|12566226|FG002|COMPLETED|Overall Study||4196
11369720|NCT03278067|12566224|FG000|NOT COMPLETED|Overall Study||0
11369721|NCT03278067|12566225|FG001|NOT COMPLETED|Overall Study||0
11369722|NCT03278067|12566226|FG002|NOT COMPLETED|Overall Study||0
11369723|NCT03278106|12566239|FG000|STARTED|Overall Study||28
11369724|NCT03278106|12566239|FG000|COMPLETED|Overall Study||27
11369725|NCT03278106|12566239|FG000|NOT COMPLETED|Overall Study||1
11369726|NCT03278223|12566245|FG000|STARTED|Overall Study||125
11369727|NCT03278223|12566246|FG001|STARTED|Overall Study||69
11369728|NCT03278223|12566245|FG000|COMPLETED|Overall Study||122
11369729|NCT03278223|12566246|FG001|COMPLETED|Overall Study||65
11369730|NCT03278223|12566245|FG000|NOT COMPLETED|Overall Study||3
11369731|NCT03278223|12566246|FG001|NOT COMPLETED|Overall Study||4
11369732|NCT03278613|12566254|FG000|STARTED|Overall Study||111
11369733|NCT03278613|12566255|FG001|STARTED|Overall Study||55
11369734|NCT03278613|12566254|FG000|COMPLETED|Overall Study||108
11369735|NCT03278613|12566255|FG001|COMPLETED|Overall Study||54
11369736|NCT03278613|12566254|FG000|NOT COMPLETED|Overall Study||3
11369737|NCT03278613|12566255|FG001|NOT COMPLETED|Overall Study||1
11369738|NCT03278886|12566263|FG000|STARTED|Overall Study||8
11369739|NCT03278886|12566264|FG001|STARTED|Overall Study||3
11369740|NCT03278886|12566263|FG000|COMPLETED|Overall Study||8
11369741|NCT03278886|12566264|FG001|COMPLETED|Overall Study||2
11369742|NCT03278886|12566263|FG000|NOT COMPLETED|Overall Study||0
11369743|NCT03278886|12566264|FG001|NOT COMPLETED|Overall Study||1
11369744|NCT03279237|12566270|FG000|STARTED|Overall Study||25
11369745|NCT03279237|12566270|FG000|Chemo-radiation|Overall Study||23
11369746|NCT03279237|12566270|FG000|Surgical Resection|Overall Study||20
11369747|NCT03279237|12566270|FG000|COMPLETED|Overall Study||20
11369748|NCT03279237|12566270|FG000|NOT COMPLETED|Overall Study||5
11369749|NCT03279458|12566274|FG000|STARTED|Overall Study||40
11369750|NCT03279458|12566274|FG000|COMPLETED|Overall Study||40
11369751|NCT03279458|12566274|FG000|NOT COMPLETED|Overall Study||0
11369752|NCT03279731|12566282|FG000|STARTED|Overall Study||19
11369753|NCT03279731|12566283|FG001|STARTED|Overall Study||17
11369754|NCT03279731|12566282|FG000|COMPLETED|Overall Study||13
11369755|NCT03279731|12566283|FG001|COMPLETED|Overall Study||14
11369756|NCT03279731|12566282|FG000|NOT COMPLETED|Overall Study||6
11369757|NCT03279731|12566283|FG001|NOT COMPLETED|Overall Study||3
11369758|NCT03280108|12566293|FG000|STARTED|Overall Study||129
11369759|NCT03280108|12566294|FG001|STARTED|Overall Study||114
11369760|NCT03280108|12566293|FG000|COMPLETED|Overall Study||127
11369761|NCT03280108|12566294|FG001|COMPLETED|Overall Study||114
11369762|NCT03280108|12566293|FG000|NOT COMPLETED|Overall Study||2
11369763|NCT03280108|12566294|FG001|NOT COMPLETED|Overall Study||0
11369764|NCT03280121|12566305|FG000|STARTED|Overall Study||14
11369765|NCT03280121|12566305|FG000|COMPLETED|Overall Study||8
11369766|NCT03280121|12566305|FG000|NOT COMPLETED|Overall Study||6
11369767|NCT03280264|12566309|FG000|STARTED|Overall Study||18
11369768|NCT03280264|12566309|FG000|COMPLETED|Overall Study||15
11369769|NCT03280264|12566309|FG000|NOT COMPLETED|Overall Study||3
11369770|NCT03280381|12566316|FG000|STARTED|Overall Study||101
11369771|NCT03280381|12566317|FG001|STARTED|Overall Study||99
11369772|NCT03280381|12566316|FG000|COMPLETED|Overall Study||101
11369773|NCT03280381|12566317|FG001|COMPLETED|Overall Study||97
11369774|NCT03280381|12566316|FG000|NOT COMPLETED|Overall Study||0
11369775|NCT03280381|12566317|FG001|NOT COMPLETED|Overall Study||2
11005691|NCT00723957|12183406|FG000|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
11005692|NCT00723957|12183407|FG001|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
11005693|NCT00723957|12183406|FG000|NOT COMPLETED|Overall Study||51
11005694|NCT00723957|12183407|FG001|NOT COMPLETED|Overall Study||53
11005695|NCT00724009|12183413|FG000|STARTED|Overall Study||29
11005696|NCT00724009|12183413|FG000|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
11005697|NCT00724009|12183413|FG000|NOT COMPLETED|Overall Study||0
11369776|NCT03280537|12566326|FG000|STARTED|Overall Study||65
11369777|NCT03280537|12566327|FG001|STARTED|Overall Study||62
11369778|NCT03280537|12566326|FG000|COMPLETED|Overall Study||63
11369779|NCT03280537|12566327|FG001|COMPLETED|Overall Study||58
11369780|NCT03280537|12566326|FG000|NOT COMPLETED|Overall Study||2
11369781|NCT03280537|12566327|FG001|NOT COMPLETED|Overall Study||4
11369782|NCT03280550|12566335|FG000|STARTED|Overall Study||66
11369783|NCT03280550|12566336|FG001|STARTED|Overall Study||72
11369784|NCT03280550|12566335|FG000|COMPLETED|Overall Study||64
11369785|NCT03280550|12566336|FG001|COMPLETED|Overall Study||69
11369786|NCT03280550|12566335|FG000|NOT COMPLETED|Overall Study||2
11369787|NCT03280550|12566336|FG001|NOT COMPLETED|Overall Study||3
11369788|NCT03280615|12566344|FG000|STARTED|Overall Study||50
11369789|NCT03280615|12566345|FG001|STARTED|Overall Study||50
11369790|NCT03280615|12566344|FG000|COMPLETED|Overall Study||46
11369791|NCT03280615|12566345|FG001|COMPLETED|Overall Study||45
11369792|NCT03280615|12566344|FG000|NOT COMPLETED|Overall Study||4
11369793|NCT03280615|12566345|FG001|NOT COMPLETED|Overall Study||5
11369794|NCT03281200|12566351|FG000|STARTED|Overall Study||172
11369795|NCT03281200|12566351|FG000|COMPLETED|Overall Study||172
11369796|NCT03281200|12566351|FG000|NOT COMPLETED|Overall Study||0
11369797|NCT03281538|12566355|FG000|STARTED|Overall Study||288
11369798|NCT03281538|12566355|FG000|COMPLETED|Overall Study||133
11369799|NCT03281538|12566355|FG000|NOT COMPLETED|Overall Study||155
11369800|NCT03281577|12566363|FG000|STARTED|Overall Study||10
11369801|NCT03281577|12566364|FG001|STARTED|Overall Study||10
11369802|NCT03281577|12566365|FG002|STARTED|Overall Study||9
11369803|NCT03281577|12566366|FG003|STARTED|Overall Study||7
11369804|NCT03281577|12566363|FG000|COMPLETED|Overall Study||9
11369805|NCT03281577|12566364|FG001|COMPLETED|Overall Study||10
11369806|NCT03281577|12566365|FG002|COMPLETED|Overall Study||9
11369807|NCT03281577|12566366|FG003|COMPLETED|Overall Study||6
11369808|NCT03281577|12566363|FG000|NOT COMPLETED|Overall Study||1
11369809|NCT03281577|12566364|FG001|NOT COMPLETED|Overall Study||0
11369810|NCT03281577|12566365|FG002|NOT COMPLETED|Overall Study||0
11369811|NCT03281577|12566366|FG003|NOT COMPLETED|Overall Study||1
11369812|NCT03281668|12566379|FG000|STARTED|Overall Study||29
11369813|NCT03281668|12566379|FG000|COMPLETED|Overall Study||21
11369814|NCT03281668|12566379|FG000|NOT COMPLETED|Overall Study||8
11369815|NCT03281876|12566385|FG000|STARTED|Overall Study||304
11369816|NCT03281876|12566386|FG001|STARTED|Overall Study||302
11369817|NCT03281876|12566385|FG000|COMPLETED|Overall Study||281
11369818|NCT03281876|12566386|FG001|COMPLETED|Overall Study||263
11369819|NCT03281876|12566385|FG000|NOT COMPLETED|Overall Study||23
11369820|NCT03281876|12566386|FG001|NOT COMPLETED|Overall Study||39
11369821|NCT03282071|12566394|FG000|STARTED|Overall Study||75
11369822|NCT03282071|12566395|FG001|STARTED|Overall Study||69
11369823|NCT03282071|12566394|FG000|COMPLETED|Overall Study||65
11369824|NCT03282071|12566395|FG001|COMPLETED|Overall Study||60
11369825|NCT03282071|12566394|FG000|NOT COMPLETED|Overall Study||10
11369826|NCT03282071|12566395|FG001|NOT COMPLETED|Overall Study||9
11369827|NCT03282227|12566403|FG000|STARTED|Overall Study||342
11369828|NCT03282227|12566403|FG000|Completed at Least 6 Months|Overall Study||257
11369829|NCT03282227|12566403|FG000|COMPLETED|Overall Study||127
11369830|NCT03282227|12566403|FG000|NOT COMPLETED|Overall Study||215
11369831|NCT03282357|12566407|FG000|STARTED|Overall Study||181
11369832|NCT03282357|12566407|FG000|Safety Evaluation Set|Overall Study||176
11369833|NCT03282357|12566407|FG000|COMPLETED|Overall Study||164
11369834|NCT03282357|12566407|FG000|NOT COMPLETED|Overall Study||17
11369835|NCT03282591|12566414|FG000|STARTED|Overall Study||92
11369836|NCT03282591|12566415|FG001|STARTED|Overall Study||93
11369837|NCT03282591|12566414|FG000|COMPLETED|Overall Study||88
11369838|NCT03282591|12566415|FG001|COMPLETED|Overall Study||89
11369839|NCT03282591|12566414|FG000|NOT COMPLETED|Overall Study||4
11369840|NCT03282591|12566415|FG001|NOT COMPLETED|Overall Study||4
11369841|NCT03282682|12566425|FG000|STARTED|Overall Study||6
11369842|NCT03282682|12566426|FG001|STARTED|Overall Study||8
11369843|NCT03282682|12566427|FG002|STARTED|Overall Study||8
11369844|NCT03282682|12566425|FG000|COMPLETED|Overall Study||6
11369845|NCT03282682|12566426|FG001|COMPLETED|Overall Study||8
11369846|NCT03282682|12566427|FG002|COMPLETED|Overall Study||8
11369847|NCT03282682|12566425|FG000|NOT COMPLETED|Overall Study||0
11369848|NCT03282682|12566426|FG001|NOT COMPLETED|Overall Study||0
11369849|NCT03282682|12566427|FG002|NOT COMPLETED|Overall Study||0
11369850|NCT03283098|12566437|FG000|STARTED|Overall Study||8
11369851|NCT03283098|12566438|FG001|STARTED|Overall Study||25
11369852|NCT03283098|12566437|FG000|COMPLETED|Overall Study||8
11369853|NCT03283098|12566438|FG001|COMPLETED|Overall Study||24
11369854|NCT03283098|12566437|FG000|NOT COMPLETED|Overall Study||0
11369855|NCT03283098|12566438|FG001|NOT COMPLETED|Overall Study||1
11369856|NCT03283319|12566450|FG000|STARTED|Overall Study||62
11369857|NCT03283319|12566451|FG001|STARTED|Overall Study||60
11369858|NCT03283319|12566452|FG002|STARTED|Overall Study||62
11369859|NCT03283319|12566453|FG003|STARTED|Overall Study||61
11369860|NCT03283319|12566454|FG004|STARTED|Overall Study||60
11369861|NCT03283319|12566455|FG005|STARTED|Overall Study||61
11369862|NCT03283319|12566450|FG000|COMPLETED|Overall Study||55
11369863|NCT03283319|12566451|FG001|COMPLETED|Overall Study||54
11369864|NCT03283319|12566452|FG002|COMPLETED|Overall Study||55
11369865|NCT03283319|12566453|FG003|COMPLETED|Overall Study||54
11369866|NCT03283319|12566454|FG004|COMPLETED|Overall Study||56
11369867|NCT03283319|12566455|FG005|COMPLETED|Overall Study||57
11369868|NCT03283319|12566450|FG000|NOT COMPLETED|Overall Study||7
11369869|NCT03283319|12566451|FG001|NOT COMPLETED|Overall Study||6
11369870|NCT03283319|12566452|FG002|NOT COMPLETED|Overall Study||7
11369871|NCT03283319|12566453|FG003|NOT COMPLETED|Overall Study||7
11369872|NCT03283319|12566454|FG004|NOT COMPLETED|Overall Study||4
11369873|NCT03283319|12566455|FG005|NOT COMPLETED|Overall Study||4
11369874|NCT03283436|12566471|FG000|STARTED|Overall Study||50
11369875|NCT03283436|12566472|FG001|STARTED|Overall Study||50
11369876|NCT03283436|12566471|FG000|COMPLETED|Overall Study||44
11369877|NCT03283436|12566472|FG001|COMPLETED|Overall Study||50
11369878|NCT03283436|12566471|FG000|NOT COMPLETED|Overall Study||6
11369879|NCT03283436|12566472|FG001|NOT COMPLETED|Overall Study||0
11369880|NCT03283553|12566480|FG000|STARTED|Patient Participant Flow||69
11369881|NCT03283553|12566481|FG001|STARTED|Patient Participant Flow||63
11369882|NCT03283553|12566480|FG000|Patient Baseline Interview|Patient Participant Flow||69
11369883|NCT03283553|12566481|FG001|Patient Baseline Interview|Patient Participant Flow||62
11369884|NCT03283553|12566480|FG000|Patient 3-Month Interview|Patient Participant Flow||67
11369885|NCT03283553|12566481|FG001|Patient 3-Month Interview|Patient Participant Flow||60
11369886|NCT03283553|12566480|FG000|Patient 9-Month Interview|Patient Participant Flow||63
11369887|NCT03283553|12566481|FG001|Patient 9-Month Interview|Patient Participant Flow||57
11369888|NCT03283553|12566480|FG000|Patient 12-Month Interview|Patient Participant Flow||59
11369889|NCT03283553|12566481|FG001|Patient 12-Month Interview|Patient Participant Flow||50
11369890|NCT03283553|12566480|FG000|COMPLETED|Patient Participant Flow||59
11369891|NCT03283553|12566481|FG001|COMPLETED|Patient Participant Flow||50
11369892|NCT03283553|12566480|FG000|NOT COMPLETED|Patient Participant Flow||10
11369893|NCT03283553|12566481|FG001|NOT COMPLETED|Patient Participant Flow||13
11369894|NCT03283553|12566480|FG000|STARTED|Care Partner Participant Flow||69
11369895|NCT03283553|12566481|FG001|STARTED|Care Partner Participant Flow||63
11369896|NCT03283553|12566480|FG000|Care Partner Baseline Interview|Care Partner Participant Flow||69
11369897|NCT03283553|12566481|FG001|Care Partner Baseline Interview|Care Partner Participant Flow||63
11369898|NCT03283553|12566480|FG000|Care Partner 3-Month Interview|Care Partner Participant Flow||69
11369899|NCT03283553|12566481|FG001|Care Partner 3-Month Interview|Care Partner Participant Flow||60
11369900|NCT03283553|12566480|FG000|Care Partner 9-Month Interview|Care Partner Participant Flow||64
11369901|NCT03283553|12566481|FG001|Care Partner 9-Month Interview|Care Partner Participant Flow||55
11369902|NCT03283553|12566480|FG000|Care Partner 12-Month Interview|Care Partner Participant Flow||59
11369903|NCT03283553|12566481|FG001|Care Partner 12-Month Interview|Care Partner Participant Flow||48
11369904|NCT03283553|12566480|FG000|COMPLETED|Care Partner Participant Flow||59
11369905|NCT03283553|12566481|FG001|COMPLETED|Care Partner Participant Flow||48
11369906|NCT03283553|12566480|FG000|NOT COMPLETED|Care Partner Participant Flow||10
11369907|NCT03283553|12566481|FG001|NOT COMPLETED|Care Partner Participant Flow||15
11369908|NCT03283696|12566491|FG000|STARTED|Overall Study||16
11369909|NCT03283696|12566492|FG001|STARTED|Overall Study||8
11369910|NCT03283696|12566491|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16
11369911|NCT03283696|12566492|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
11369912|NCT03283696|12566491|FG000|COMPLETED|Overall Study||9
11369913|NCT03283696|12566492|FG001|COMPLETED|Overall Study||2
11369914|NCT03283696|12566491|FG000|NOT COMPLETED|Overall Study||7
11369915|NCT03283696|12566492|FG001|NOT COMPLETED|Overall Study||6
11369916|NCT03283787|12566501|FG000|STARTED|Overall Study||20
11369917|NCT03283787|12566502|FG001|STARTED|Overall Study||20
11369918|NCT03283787|12566503|FG002|STARTED|Overall Study||20
11369919|NCT03283787|12566501|FG000|COMPLETED|Overall Study||17
11369920|NCT03283787|12566502|FG001|COMPLETED|Overall Study||13
11369921|NCT03283787|12566503|FG002|COMPLETED|Overall Study||13
11369922|NCT03283787|12566501|FG000|NOT COMPLETED|Overall Study||3
11369923|NCT03283787|12566502|FG001|NOT COMPLETED|Overall Study||7
11369924|NCT03283787|12566503|FG002|NOT COMPLETED|Overall Study||7
11369925|NCT03284229|12566514|FG000|STARTED|Overall Study||28
11369926|NCT03284229|12566514|FG000|COMPLETED|Overall Study||25
11369927|NCT03284229|12566514|FG000|NOT COMPLETED|Overall Study||3
11369928|NCT03284359|12566521|FG000|STARTED|Overall Study||93
11369929|NCT03284359|12566522|FG001|STARTED|Overall Study||89
11369930|NCT03284359|12566521|FG000|COMPLETED|Overall Study||93
11369931|NCT03284359|12566522|FG001|COMPLETED|Overall Study||89
11369932|NCT03284359|12566521|FG000|NOT COMPLETED|Overall Study||0
11369933|NCT03284359|12566522|FG001|NOT COMPLETED|Overall Study||0
11369934|NCT03284398|12566530|FG000|STARTED|Overall Study||2753
11369935|NCT03284398|12566531|FG001|STARTED|Overall Study||970
11369936|NCT03284398|12566530|FG000|COMPLETED|Overall Study||2753
11369937|NCT03284398|12566531|FG001|COMPLETED|Overall Study||970
11369938|NCT03284398|12566530|FG000|NOT COMPLETED|Overall Study||0
11369939|NCT03284398|12566531|FG001|NOT COMPLETED|Overall Study||0
11369940|NCT03284411|12566543|FG000|STARTED|Overall Study||30
11369941|NCT03284411|12566543|FG000|COMPLETED|Overall Study||30
11369942|NCT03284411|12566543|FG000|NOT COMPLETED|Overall Study||0
11369943|NCT03284710|12566552|FG000|STARTED|Overall Study||36
11369944|NCT03284710|12566553|FG001|STARTED|Overall Study||36
11369945|NCT03284710|12566554|FG002|STARTED|Overall Study||36
11369946|NCT03284710|12566555|FG003|STARTED|Overall Study||24
11369947|NCT03284710|12566552|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||31
11369948|NCT03284710|12566553|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||31
11369949|NCT03284710|12566554|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||31
11369950|NCT03284710|12566555|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||18
11369951|NCT03284710|12566552|FG000|Month 12 Immunogenicity Timepoint|Overall Study||30
11369952|NCT03284710|12566553|FG001|Month 12 Immunogenicity Timepoint|Overall Study||31
11369953|NCT03284710|12566554|FG002|Month 12 Immunogenicity Timepoint|Overall Study||31
11369954|NCT03284710|12566555|FG003|Month 12 Immunogenicity Timepoint|Overall Study||17
11369955|NCT03284710|12566552|FG000|Month 12.5 Immunogenicity Timepoint|Overall Study||0
11369956|NCT03284710|12566553|FG001|Month 12.5 Immunogenicity Timepoint|Overall Study||0
11369957|NCT03284710|12566554|FG002|Month 12.5 Immunogenicity Timepoint|Overall Study||0
11369958|NCT03284710|12566555|FG003|Month 12.5 Immunogenicity Timepoint|Overall Study||0
11369959|NCT03284710|12566552|FG000|Month 18 Immunogenicity Timepoint|Overall Study||0
11369960|NCT03284710|12566553|FG001|Month 18 Immunogenicity Timepoint|Overall Study||0
11369961|NCT03284710|12566554|FG002|Month 18 Immunogenicity Timepoint|Overall Study||0
11369962|NCT03284710|12566555|FG003|Month 18 Immunogenicity Timepoint|Overall Study||0
11369963|NCT03284710|12566552|FG000|COMPLETED|Overall Study||30
11369964|NCT03284710|12566553|FG001|COMPLETED|Overall Study||31
11369965|NCT03284710|12566554|FG002|COMPLETED|Overall Study||32
11369966|NCT03284710|12566555|FG003|COMPLETED|Overall Study||16
11369967|NCT03284710|12566552|FG000|NOT COMPLETED|Overall Study||6
11369968|NCT03284710|12566553|FG001|NOT COMPLETED|Overall Study||5
11369969|NCT03284710|12566554|FG002|NOT COMPLETED|Overall Study||4
11369970|NCT03284710|12566555|FG003|NOT COMPLETED|Overall Study||8
11369971|NCT03285061|12566572|FG000|STARTED|Overall Study||37
11369972|NCT03285061|12566573|FG001|STARTED|Overall Study||38
11369973|NCT03285061|12566572|FG000|COMPLETED|Overall Study||36
11369974|NCT03285061|12566573|FG001|COMPLETED|Overall Study||36
11369975|NCT03285061|12566572|FG000|NOT COMPLETED|Overall Study||1
11369976|NCT03285061|12566573|FG001|NOT COMPLETED|Overall Study||2
11369977|NCT03285113|12566579|FG000|STARTED|Overall Study||10
11369978|NCT03285113|12566579|FG000|COMPLETED|Overall Study||8
11369979|NCT03285113|12566579|FG000|NOT COMPLETED|Overall Study||2
11369980|NCT03285295|12566588|FG000|STARTED|Alinity s HBsAg||17095
11369981|NCT03285295|12566589|FG001|STARTED|Alinity s HBsAg||438
11369982|NCT03285295|12566590|FG002|STARTED|Alinity s HBsAg||403
11369983|NCT03285295|12566591|FG003|STARTED|Alinity s HBsAg||0
11369984|NCT03285295|12566592|FG004|STARTED|Alinity s HBsAg||51
11369985|NCT03285295|12566588|FG000|COMPLETED|Alinity s HBsAg||16993
11369986|NCT03285295|12566589|FG001|COMPLETED|Alinity s HBsAg||432
11369987|NCT03285295|12566590|FG002|COMPLETED|Alinity s HBsAg||403
11369988|NCT03285295|12566591|FG003|COMPLETED|Alinity s HBsAg||0
11369989|NCT03285295|12566592|FG004|COMPLETED|Alinity s HBsAg||51
11369990|NCT03285295|12566588|FG000|NOT COMPLETED|Alinity s HBsAg||102
11369991|NCT03285295|12566589|FG001|NOT COMPLETED|Alinity s HBsAg||6
11369992|NCT03285295|12566590|FG002|NOT COMPLETED|Alinity s HBsAg||0
11369993|NCT03285295|12566591|FG003|NOT COMPLETED|Alinity s HBsAg||0
11369994|NCT03285295|12566592|FG004|NOT COMPLETED|Alinity s HBsAg||0
11369995|NCT03285295|12566588|FG000|STARTED|Alinity s HBsAg Confirmatory||8
11369996|NCT03285295|12566589|FG001|STARTED|Alinity s HBsAg Confirmatory||432
11369997|NCT03285295|12566590|FG002|STARTED|Alinity s HBsAg Confirmatory||3
11369998|NCT03285295|12566591|FG003|STARTED|Alinity s HBsAg Confirmatory||0
11369999|NCT03285295|12566592|FG004|STARTED|Alinity s HBsAg Confirmatory||0
11370000|NCT03285295|12566588|FG000|COMPLETED|Alinity s HBsAg Confirmatory||8
11370001|NCT03285295|12566589|FG001|COMPLETED|Alinity s HBsAg Confirmatory||432
11370002|NCT03285295|12566590|FG002|COMPLETED|Alinity s HBsAg Confirmatory||3
11370003|NCT03285295|12566591|FG003|COMPLETED|Alinity s HBsAg Confirmatory||0
11370004|NCT03285295|12566592|FG004|COMPLETED|Alinity s HBsAg Confirmatory||0
11370005|NCT03285295|12566588|FG000|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
11370006|NCT03285295|12566589|FG001|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
11370007|NCT03285295|12566590|FG002|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
11370008|NCT03285295|12566591|FG003|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
11370009|NCT03285295|12566592|FG004|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
11370010|NCT03285295|12566588|FG000|STARTED|Alinity s HBsAg Follow-Up||0
11370011|NCT03285295|12566589|FG001|STARTED|Alinity s HBsAg Follow-Up||0
11370012|NCT03285295|12566590|FG002|STARTED|Alinity s HBsAg Follow-Up||0
11370013|NCT03285295|12566591|FG003|STARTED|Alinity s HBsAg Follow-Up||0
11370014|NCT03285295|12566592|FG004|STARTED|Alinity s HBsAg Follow-Up||0
11370015|NCT03285295|12566588|FG000|COMPLETED|Alinity s HBsAg Follow-Up||0
11370016|NCT03285295|12566589|FG001|COMPLETED|Alinity s HBsAg Follow-Up||0
11370017|NCT03285295|12566590|FG002|COMPLETED|Alinity s HBsAg Follow-Up||0
11370018|NCT03285295|12566591|FG003|COMPLETED|Alinity s HBsAg Follow-Up||0
11370019|NCT03285295|12566592|FG004|COMPLETED|Alinity s HBsAg Follow-Up||0
11370020|NCT03285295|12566588|FG000|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
11370021|NCT03285295|12566589|FG001|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
11370022|NCT03285295|12566590|FG002|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
11370023|NCT03285295|12566591|FG003|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
11370024|NCT03285295|12566592|FG004|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
11370025|NCT03285295|12566588|FG000|STARTED|Alinity s HTLV I/II||15968
11370026|NCT03285295|12566589|FG001|STARTED|Alinity s HTLV I/II||706
11370027|NCT03285295|12566590|FG002|STARTED|Alinity s HTLV I/II||502
11370028|NCT03285295|12566591|FG003|STARTED|Alinity s HTLV I/II||509
11370029|NCT03285295|12566592|FG004|STARTED|Alinity s HTLV I/II||0
11370030|NCT03285295|12566588|FG000|COMPLETED|Alinity s HTLV I/II||15877
11370031|NCT03285295|12566589|FG001|COMPLETED|Alinity s HTLV I/II||706
11370032|NCT03285295|12566590|FG002|COMPLETED|Alinity s HTLV I/II||502
11370033|NCT03285295|12566591|FG003|COMPLETED|Alinity s HTLV I/II||509
11370034|NCT03285295|12566592|FG004|COMPLETED|Alinity s HTLV I/II||0
11370035|NCT03285295|12566588|FG000|NOT COMPLETED|Alinity s HTLV I/II||91
11370036|NCT03285295|12566589|FG001|NOT COMPLETED|Alinity s HTLV I/II||0
11370037|NCT03285295|12566590|FG002|NOT COMPLETED|Alinity s HTLV I/II||0
11370038|NCT03285295|12566591|FG003|NOT COMPLETED|Alinity s HTLV I/II||0
11370039|NCT03285295|12566592|FG004|NOT COMPLETED|Alinity s HTLV I/II||0
11370040|NCT03285295|12566588|FG000|STARTED|Alinity s HTLV I/II Follow-Up||12
11370041|NCT03285295|12566589|FG001|STARTED|Alinity s HTLV I/II Follow-Up||0
11370042|NCT03285295|12566590|FG002|STARTED|Alinity s HTLV I/II Follow-Up||0
11370043|NCT03285295|12566591|FG003|STARTED|Alinity s HTLV I/II Follow-Up||0
11370044|NCT03285295|12566592|FG004|STARTED|Alinity s HTLV I/II Follow-Up||0
11370045|NCT03285295|12566588|FG000|COMPLETED|Alinity s HTLV I/II Follow-Up||8
11370046|NCT03285295|12566589|FG001|COMPLETED|Alinity s HTLV I/II Follow-Up||0
11370047|NCT03285295|12566590|FG002|COMPLETED|Alinity s HTLV I/II Follow-Up||0
11370048|NCT03285295|12566591|FG003|COMPLETED|Alinity s HTLV I/II Follow-Up||0
11370049|NCT03285295|12566592|FG004|COMPLETED|Alinity s HTLV I/II Follow-Up||0
11370050|NCT03285295|12566588|FG000|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4
11370051|NCT03285295|12566589|FG001|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
11370052|NCT03285295|12566590|FG002|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
11370053|NCT03285295|12566591|FG003|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
11370054|NCT03285295|12566592|FG004|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
11370055|NCT03285295|12566588|FG000|STARTED|Alinity s Anti-HCV||17095
11370056|NCT03285295|12566589|FG001|STARTED|Alinity s Anti-HCV||402
11370057|NCT03285295|12566590|FG002|STARTED|Alinity s Anti-HCV||407
11370058|NCT03285295|12566591|FG003|STARTED|Alinity s Anti-HCV||0
11370059|NCT03285295|12566592|FG004|STARTED|Alinity s Anti-HCV||0
11370060|NCT03285295|12566588|FG000|COMPLETED|Alinity s Anti-HCV||16999
11370061|NCT03285295|12566589|FG001|COMPLETED|Alinity s Anti-HCV||402
11370062|NCT03285295|12566590|FG002|COMPLETED|Alinity s Anti-HCV||407
11370063|NCT03285295|12566591|FG003|COMPLETED|Alinity s Anti-HCV||0
11370064|NCT03285295|12566592|FG004|COMPLETED|Alinity s Anti-HCV||0
11370065|NCT03285295|12566588|FG000|NOT COMPLETED|Alinity s Anti-HCV||96
11370066|NCT03285295|12566589|FG001|NOT COMPLETED|Alinity s Anti-HCV||0
11370067|NCT03285295|12566590|FG002|NOT COMPLETED|Alinity s Anti-HCV||0
11370068|NCT03285295|12566591|FG003|NOT COMPLETED|Alinity s Anti-HCV||0
11370069|NCT03285295|12566592|FG004|NOT COMPLETED|Alinity s Anti-HCV||0
11370070|NCT03285295|12566588|FG000|STARTED|Alinity s Anti-HCV Follow-Up||20
11370071|NCT03285295|12566589|FG001|STARTED|Alinity s Anti-HCV Follow-Up||0
11370072|NCT03285295|12566590|FG002|STARTED|Alinity s Anti-HCV Follow-Up||0
11370073|NCT03285295|12566591|FG003|STARTED|Alinity s Anti-HCV Follow-Up||0
11370074|NCT03285295|12566592|FG004|STARTED|Alinity s Anti-HCV Follow-Up||0
11370075|NCT03285295|12566588|FG000|COMPLETED|Alinity s Anti-HCV Follow-Up||2
11370076|NCT03285295|12566589|FG001|COMPLETED|Alinity s Anti-HCV Follow-Up||0
11370077|NCT03285295|12566590|FG002|COMPLETED|Alinity s Anti-HCV Follow-Up||0
11370078|NCT03285295|12566591|FG003|COMPLETED|Alinity s Anti-HCV Follow-Up||0
11370079|NCT03285295|12566592|FG004|COMPLETED|Alinity s Anti-HCV Follow-Up||0
11370080|NCT03285295|12566588|FG000|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18
11370081|NCT03285295|12566589|FG001|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
11370082|NCT03285295|12566590|FG002|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
11370083|NCT03285295|12566591|FG003|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
11370084|NCT03285295|12566592|FG004|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
11370085|NCT03285295|12566588|FG000|STARTED|Alinity s HIV Ag/Ab Combo||17095
11370086|NCT03285295|12566589|FG001|STARTED|Alinity s HIV Ag/Ab Combo||1336
11370087|NCT03285295|12566590|FG002|STARTED|Alinity s HIV Ag/Ab Combo||605
11370088|NCT03285295|12566591|FG003|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
11370089|NCT03285295|12566592|FG004|STARTED|Alinity s HIV Ag/Ab Combo||0
11370090|NCT03285295|12566588|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo||16996
11370091|NCT03285295|12566589|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo||1336
11370092|NCT03285295|12566590|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo||605
11370093|NCT03285295|12566591|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
11370094|NCT03285295|12566592|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo||0
11370095|NCT03285295|12566588|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99
11370096|NCT03285295|12566589|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
11370097|NCT03285295|12566590|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
11370098|NCT03285295|12566591|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
11370099|NCT03285295|12566592|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
11370100|NCT03285295|12566588|FG000|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15
11370101|NCT03285295|12566589|FG001|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
11370102|NCT03285295|12566590|FG002|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
11370103|NCT03285295|12566591|FG003|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
11370104|NCT03285295|12566592|FG004|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
11370105|NCT03285295|12566588|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4
11370106|NCT03285295|12566589|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
11370107|NCT03285295|12566590|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
11370108|NCT03285295|12566591|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
11370109|NCT03285295|12566592|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
11370110|NCT03285295|12566588|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11
11370111|NCT03285295|12566589|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
11370112|NCT03285295|12566590|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
11370113|NCT03285295|12566591|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
11370114|NCT03285295|12566592|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
11370115|NCT03285295|12566588|FG000|STARTED|Alinity s Anti-HBc||15968
11370116|NCT03285295|12566589|FG001|STARTED|Alinity s Anti-HBc||405
11370117|NCT03285295|12566590|FG002|STARTED|Alinity s Anti-HBc||403
11370118|NCT03285295|12566591|FG003|STARTED|Alinity s Anti-HBc||0
11370119|NCT03285295|12566592|FG004|STARTED|Alinity s Anti-HBc||0
11370120|NCT03285295|12566588|FG000|COMPLETED|Alinity s Anti-HBc||15877
11370121|NCT03285295|12566589|FG001|COMPLETED|Alinity s Anti-HBc||404
11370122|NCT03285295|12566590|FG002|COMPLETED|Alinity s Anti-HBc||403
11370123|NCT03285295|12566591|FG003|COMPLETED|Alinity s Anti-HBc||0
11370124|NCT03285295|12566592|FG004|COMPLETED|Alinity s Anti-HBc||0
11370125|NCT03285295|12566588|FG000|NOT COMPLETED|Alinity s Anti-HBc||91
11370126|NCT03285295|12566589|FG001|NOT COMPLETED|Alinity s Anti-HBc||1
11370127|NCT03285295|12566590|FG002|NOT COMPLETED|Alinity s Anti-HBc||0
11370128|NCT03285295|12566591|FG003|NOT COMPLETED|Alinity s Anti-HBc||0
11370129|NCT03285295|12566592|FG004|NOT COMPLETED|Alinity s Anti-HBc||0
11370130|NCT03285295|12566588|FG000|STARTED|Alinity s Anti-HBc Follow-Up||16
11370131|NCT03285295|12566589|FG001|STARTED|Alinity s Anti-HBc Follow-Up||0
11370132|NCT03285295|12566590|FG002|STARTED|Alinity s Anti-HBc Follow-Up||0
11370133|NCT03285295|12566591|FG003|STARTED|Alinity s Anti-HBc Follow-Up||0
11370134|NCT03285295|12566592|FG004|STARTED|Alinity s Anti-HBc Follow-Up||0
11370135|NCT03285295|12566588|FG000|COMPLETED|Alinity s Anti-HBc Follow-Up||2
11370136|NCT03285295|12566589|FG001|COMPLETED|Alinity s Anti-HBc Follow-Up||0
11370137|NCT03285295|12566590|FG002|COMPLETED|Alinity s Anti-HBc Follow-Up||0
11370138|NCT03285295|12566591|FG003|COMPLETED|Alinity s Anti-HBc Follow-Up||0
11370139|NCT03285295|12566592|FG004|COMPLETED|Alinity s Anti-HBc Follow-Up||0
11370140|NCT03285295|12566588|FG000|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14
11370141|NCT03285295|12566589|FG001|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
11370142|NCT03285295|12566590|FG002|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
11370143|NCT03285295|12566591|FG003|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
11370144|NCT03285295|12566592|FG004|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
11370145|NCT03285295|12566588|FG000|STARTED|Alinity s Chagas||16023
11370146|NCT03285295|12566589|FG001|STARTED|Alinity s Chagas||320
11370147|NCT03285295|12566590|FG002|STARTED|Alinity s Chagas||0
11370148|NCT03285295|12566591|FG003|STARTED|Alinity s Chagas||615
11370149|NCT03285295|12566592|FG004|STARTED|Alinity s Chagas||0
11370150|NCT03285295|12566588|FG000|COMPLETED|Alinity s Chagas||15804
11370151|NCT03285295|12566589|FG001|COMPLETED|Alinity s Chagas||320
11370152|NCT03285295|12566590|FG002|COMPLETED|Alinity s Chagas||0
11370153|NCT03285295|12566591|FG003|COMPLETED|Alinity s Chagas||615
11370154|NCT03285295|12566592|FG004|COMPLETED|Alinity s Chagas||0
11370155|NCT03285295|12566588|FG000|NOT COMPLETED|Alinity s Chagas||219
11370156|NCT03285295|12566589|FG001|NOT COMPLETED|Alinity s Chagas||0
11370157|NCT03285295|12566590|FG002|NOT COMPLETED|Alinity s Chagas||0
11370158|NCT03285295|12566591|FG003|NOT COMPLETED|Alinity s Chagas||0
11370159|NCT03285295|12566592|FG004|NOT COMPLETED|Alinity s Chagas||0
11370160|NCT03285295|12566588|FG000|STARTED|Alinity s Chagas Follow-Up||14
11370161|NCT03285295|12566589|FG001|STARTED|Alinity s Chagas Follow-Up||0
11370162|NCT03285295|12566590|FG002|STARTED|Alinity s Chagas Follow-Up||0
11370163|NCT03285295|12566591|FG003|STARTED|Alinity s Chagas Follow-Up||0
11370164|NCT03285295|12566592|FG004|STARTED|Alinity s Chagas Follow-Up||0
11370165|NCT03285295|12566588|FG000|COMPLETED|Alinity s Chagas Follow-Up||1
11370166|NCT03285295|12566589|FG001|COMPLETED|Alinity s Chagas Follow-Up||0
11370167|NCT03285295|12566590|FG002|COMPLETED|Alinity s Chagas Follow-Up||0
11370168|NCT03285295|12566591|FG003|COMPLETED|Alinity s Chagas Follow-Up||0
11370169|NCT03285295|12566592|FG004|COMPLETED|Alinity s Chagas Follow-Up||0
11370170|NCT03285295|12566588|FG000|NOT COMPLETED|Alinity s Chagas Follow-Up||13
11370171|NCT03285295|12566589|FG001|NOT COMPLETED|Alinity s Chagas Follow-Up||0
11370172|NCT03285295|12566590|FG002|NOT COMPLETED|Alinity s Chagas Follow-Up||0
11370173|NCT03285295|12566591|FG003|NOT COMPLETED|Alinity s Chagas Follow-Up||0
11370174|NCT03285295|12566592|FG004|NOT COMPLETED|Alinity s Chagas Follow-Up||0
11370175|NCT03285308|12566623|FG000|STARTED|Overall Study||167
11370176|NCT03285308|12566624|FG001|STARTED|Overall Study||169
11370177|NCT03285308|12566623|FG000|Safety Population|Overall Study||163
11370178|NCT03285308|12566624|FG001|Safety Population|Overall Study||163
11370179|NCT03285308|12566623|FG000|COMPLETED|Overall Study||147
11370180|NCT03285308|12566624|FG001|COMPLETED|Overall Study||146
11370181|NCT03285308|12566623|FG000|NOT COMPLETED|Overall Study||20
11370182|NCT03285308|12566624|FG001|NOT COMPLETED|Overall Study||23
11370183|NCT03285373|12566631|FG000|STARTED|Overall Study||314
11370184|NCT03285373|12566632|FG001|STARTED|Overall Study||253
11370185|NCT03285373|12566633|FG002|STARTED|Overall Study||266
11370186|NCT03285373|12566634|FG003|STARTED|Overall Study||130
11370187|NCT03285373|12566631|FG000|COMPLETED|Overall Study||314
11370188|NCT03285373|12566632|FG001|COMPLETED|Overall Study||253
11370189|NCT03285373|12566633|FG002|COMPLETED|Overall Study||266
11370190|NCT03285373|12566634|FG003|COMPLETED|Overall Study||130
11370191|NCT03285373|12566631|FG000|NOT COMPLETED|Overall Study||0
11370192|NCT03285373|12566632|FG001|NOT COMPLETED|Overall Study||0
11370193|NCT03285373|12566633|FG002|NOT COMPLETED|Overall Study||0
11370194|NCT03285373|12566634|FG003|NOT COMPLETED|Overall Study||0
11370195|NCT03285477|12566645|FG000|STARTED|Treatment and Response Assessment Period||176
11370196|NCT03285477|12566646|FG001|STARTED|Treatment and Response Assessment Period||175
11370197|NCT03285477|12566645|FG000|COMPLETED|Treatment and Response Assessment Period||174
11370198|NCT03285477|12566646|FG001|COMPLETED|Treatment and Response Assessment Period||175
11370199|NCT03285477|12566645|FG000|NOT COMPLETED|Treatment and Response Assessment Period||2
11370200|NCT03285477|12566646|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0
11370201|NCT03285477|12566645|FG000|STARTED|Recurrence Follow-up Period||8
11370202|NCT03285477|12566646|FG001|STARTED|Recurrence Follow-up Period||77
11370203|NCT03285477|12566645|FG000|COMPLETED|Recurrence Follow-up Period||2
11370204|NCT03285477|12566646|FG001|COMPLETED|Recurrence Follow-up Period||22
11370205|NCT03285477|12566645|FG000|NOT COMPLETED|Recurrence Follow-up Period||6
11370206|NCT03285477|12566646|FG001|NOT COMPLETED|Recurrence Follow-up Period||55
11370207|NCT03285490|12566655|FG000|STARTED|Treatment and Response Assessment Period||173
11370208|NCT03285490|12566656|FG001|STARTED|Treatment and Response Assessment Period||178
11370209|NCT03285490|12566655|FG000|COMPLETED|Treatment and Response Assessment Period||173
11370210|NCT03285490|12566656|FG001|COMPLETED|Treatment and Response Assessment Period||178
11370211|NCT03285490|12566655|FG000|NOT COMPLETED|Treatment and Response Assessment Period||0
11370212|NCT03285490|12566656|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0
11370213|NCT03285490|12566655|FG000|STARTED|Recurrence Follow-up Period||22
11370214|NCT03285490|12566656|FG001|STARTED|Recurrence Follow-up Period||97
11370215|NCT03285490|12566655|FG000|COMPLETED|Recurrence Follow-up Period||4
11370216|NCT03285490|12566656|FG001|COMPLETED|Recurrence Follow-up Period||36
11370217|NCT03285490|12566655|FG000|NOT COMPLETED|Recurrence Follow-up Period||18
11370218|NCT03285490|12566656|FG001|NOT COMPLETED|Recurrence Follow-up Period||61
11370219|NCT03285529|12566665|FG000|STARTED|Overall Study||30
11370220|NCT03285529|12566666|FG001|STARTED|Overall Study||30
11370221|NCT03285529|12566665|FG000|COMPLETED|Overall Study||30
11370222|NCT03285529|12566666|FG001|COMPLETED|Overall Study||30
11370223|NCT03285529|12566665|FG000|NOT COMPLETED|Overall Study||0
11370224|NCT03285529|12566666|FG001|NOT COMPLETED|Overall Study||0
11370225|NCT03285542|12566674|FG000|STARTED|Overall Study||30
11370226|NCT03285542|12566675|FG001|STARTED|Overall Study||30
11370227|NCT03285542|12566674|FG000|COMPLETED|Overall Study||30
11370228|NCT03285542|12566675|FG001|COMPLETED|Overall Study||30
11370229|NCT03285542|12566674|FG000|NOT COMPLETED|Overall Study||0
11370230|NCT03285542|12566675|FG001|NOT COMPLETED|Overall Study||0
11370231|NCT03285555|12566683|FG000|STARTED|Overall Study||30
11370232|NCT03285555|12566684|FG001|STARTED|Overall Study||30
11370233|NCT03285555|12566683|FG000|COMPLETED|Overall Study||30
11370234|NCT03285555|12566684|FG001|COMPLETED|Overall Study||30
11370235|NCT03285555|12566683|FG000|NOT COMPLETED|Overall Study||0
11370236|NCT03285555|12566684|FG001|NOT COMPLETED|Overall Study||0
11370237|NCT03285594|12566693|FG000|STARTED|Overall Study||144
11370238|NCT03285594|12566694|FG001|STARTED|Overall Study||141
11370239|NCT03285594|12566695|FG002|STARTED|Overall Study||286
11370240|NCT03285594|12566693|FG000|Treated|Overall Study||144
11370241|NCT03285594|12566694|FG001|Treated|Overall Study||141
11370242|NCT03285594|12566695|FG002|Treated|Overall Study||285
11370243|NCT03285594|12566693|FG000|COMPLETED|Overall Study||129
11370244|NCT03285594|12566694|FG001|COMPLETED|Overall Study||130
11370245|NCT03285594|12566695|FG002|COMPLETED|Overall Study||249
11370246|NCT03285594|12566693|FG000|NOT COMPLETED|Overall Study||15
11370247|NCT03285594|12566694|FG001|NOT COMPLETED|Overall Study||11
11370248|NCT03285594|12566695|FG002|NOT COMPLETED|Overall Study||37
11370249|NCT03285646|12566706|FG000|STARTED|Overall Study||32
11370250|NCT03285646|12566707|FG001|STARTED|Overall Study||31
11370251|NCT03285646|12566706|FG000|COMPLETED|Overall Study||19
11370252|NCT03285646|12566707|FG001|COMPLETED|Overall Study||27
11370253|NCT03285646|12566706|FG000|NOT COMPLETED|Overall Study||13
11370254|NCT03285646|12566707|FG001|NOT COMPLETED|Overall Study||4
11370255|NCT03285711|12566716|FG000|STARTED|Blinded Phase (Up to Week 16)||4
11370256|NCT03285711|12566717|FG001|STARTED|Blinded Phase (Up to Week 16)||5
11370257|NCT03285711|12566718|FG002|STARTED|Blinded Phase (Up to Week 16)||0
11370258|NCT03285711|12566719|FG003|STARTED|Blinded Phase (Up to Week 16)||0
11370259|NCT03285711|12566716|FG000|COMPLETED|Blinded Phase (Up to Week 16)||1
11370260|NCT03285711|12566717|FG001|COMPLETED|Blinded Phase (Up to Week 16)||4
11370261|NCT03285711|12566718|FG002|COMPLETED|Blinded Phase (Up to Week 16)||0
11370262|NCT03285711|12566719|FG003|COMPLETED|Blinded Phase (Up to Week 16)||0
11370263|NCT03285711|12566716|FG000|NOT COMPLETED|Blinded Phase (Up to Week 16)||3
11370264|NCT03285711|12566717|FG001|NOT COMPLETED|Blinded Phase (Up to Week 16)||1
11370265|NCT03285711|12566718|FG002|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
11370266|NCT03285711|12566719|FG003|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
11370267|NCT03285711|12566716|FG000|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to filgotinib.|0
11370268|NCT03285711|12566717|FG001|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to lanraplenib.|3
11370269|NCT03285711|12566718|FG002|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from lanraplenib.|1
11370270|NCT03285711|12566719|FG003|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from filgotinib.|1
11370271|NCT03285711|12566716|FG000|COMPLETED|Blinded Phase (Week 16 to 32)||0
11370272|NCT03285711|12566717|FG001|COMPLETED|Blinded Phase (Week 16 to 32)||3
11370273|NCT03285711|12566718|FG002|COMPLETED|Blinded Phase (Week 16 to 32)||0
11370274|NCT03285711|12566719|FG003|COMPLETED|Blinded Phase (Week 16 to 32)||1
11370275|NCT03285711|12566716|FG000|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
11370276|NCT03285711|12566717|FG001|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
11370277|NCT03285711|12566718|FG002|NOT COMPLETED|Blinded Phase (Week 16 to 32)||1
11370278|NCT03285711|12566719|FG003|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
11370279|NCT03285711|12566716|FG000|STARTED|Extended Blinded Phase (Week 32 to 52)||0
11370280|NCT03285711|12566717|FG001|STARTED|Extended Blinded Phase (Week 32 to 52)||3
11370281|NCT03285711|12566718|FG002|STARTED|Extended Blinded Phase (Week 32 to 52)||0
11370282|NCT03285711|12566719|FG003|STARTED|Extended Blinded Phase (Week 32 to 52)||1
11370283|NCT03285711|12566716|FG000|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
11370284|NCT03285711|12566717|FG001|COMPLETED|Extended Blinded Phase (Week 32 to 52)||2
11370285|NCT03285711|12566718|FG002|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
11370286|NCT03285711|12566719|FG003|COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
11370287|NCT03285711|12566716|FG000|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
11370288|NCT03285711|12566717|FG001|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
11370289|NCT03285711|12566718|FG002|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
11370290|NCT03285711|12566719|FG003|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
11370291|NCT03285724|12566729|FG000|STARTED|Overall Study||1
11370292|NCT03285724|12566729|FG000|COMPLETED|Overall Study||1
11370293|NCT03285724|12566729|FG000|NOT COMPLETED|Overall Study||0
11370294|NCT03285958|12566735|FG000|STARTED|Overall Study||33
11370295|NCT03285958|12566736|FG001|STARTED|Overall Study||24
11370296|NCT03285958|12566735|FG000|COMPLETED|Overall Study||28
11370297|NCT03285958|12566736|FG001|COMPLETED|Overall Study||23
11370298|NCT03285958|12566735|FG000|NOT COMPLETED|Overall Study||5
11370299|NCT03285958|12566736|FG001|NOT COMPLETED|Overall Study||1
11370300|NCT03285984|12566743|FG000|STARTED|Overall Study||56
11370301|NCT03285984|12566743|FG000|Received Test Product 1|Overall Study||56
11370302|NCT03285984|12566743|FG000|Received Test Product 2|Overall Study||56
11370303|NCT03285984|12566743|FG000|Received Test Product 3|Overall Study||56
11370304|NCT03285984|12566743|FG000|Received Test Product 4|Overall Study||56
11370305|NCT03285984|12566743|FG000|COMPLETED|Overall Study||56
11370306|NCT03285984|12566743|FG000|NOT COMPLETED|Overall Study||0
11370307|NCT03286218|12566755|FG000|STARTED|Qualification Phase Period 1||48
11370308|NCT03286218|12566756|FG001|STARTED|Qualification Phase Period 1||48
11370309|NCT03286218|12566757|FG002|STARTED|Qualification Phase Period 1||0
11370310|NCT03286218|12566758|FG003|STARTED|Qualification Phase Period 1||0
11370311|NCT03286218|12566759|FG004|STARTED|Qualification Phase Period 1||0
11370312|NCT03286218|12566760|FG005|STARTED|Qualification Phase Period 1||0
11370313|NCT03286218|12566761|FG006|STARTED|Qualification Phase Period 1||0
11370314|NCT03286218|12566762|FG007|STARTED|Qualification Phase Period 1||0
11370315|NCT03286218|12566763|FG008|STARTED|Qualification Phase Period 1||0
11370316|NCT03286218|12566764|FG009|STARTED|Qualification Phase Period 1||0
11370317|NCT03286218|12566765|FG010|STARTED|Qualification Phase Period 1||0
11370318|NCT03286218|12566766|FG011|STARTED|Qualification Phase Period 1||0
11370319|NCT03286218|12566755|FG000|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
11370320|NCT03286218|12566756|FG001|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
11370321|NCT03286218|12566757|FG002|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
11370322|NCT03286218|12566758|FG003|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
11370323|NCT03286218|12566759|FG004|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
11370324|NCT03286218|12566760|FG005|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
11370325|NCT03286218|12566761|FG006|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
11370326|NCT03286218|12566762|FG007|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
11370327|NCT03286218|12566763|FG008|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
11370328|NCT03286218|12566764|FG009|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
11370329|NCT03286218|12566765|FG010|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
11370330|NCT03286218|12566766|FG011|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
11370331|NCT03286218|12566755|FG000|COMPLETED|Qualification Phase Period 1||47
11370332|NCT03286218|12566756|FG001|COMPLETED|Qualification Phase Period 1||47
11370333|NCT03286218|12566757|FG002|COMPLETED|Qualification Phase Period 1||0
11370334|NCT03286218|12566758|FG003|COMPLETED|Qualification Phase Period 1||0
11370335|NCT03286218|12566759|FG004|COMPLETED|Qualification Phase Period 1||0
11370336|NCT03286218|12566760|FG005|COMPLETED|Qualification Phase Period 1||0
11370337|NCT03286218|12566761|FG006|COMPLETED|Qualification Phase Period 1||0
11370338|NCT03286218|12566762|FG007|COMPLETED|Qualification Phase Period 1||0
11370339|NCT03286218|12566763|FG008|COMPLETED|Qualification Phase Period 1||0
11370340|NCT03286218|12566764|FG009|COMPLETED|Qualification Phase Period 1||0
11370341|NCT03286218|12566765|FG010|COMPLETED|Qualification Phase Period 1||0
11370342|NCT03286218|12566766|FG011|COMPLETED|Qualification Phase Period 1||0
11370343|NCT03286218|12566755|FG000|NOT COMPLETED|Qualification Phase Period 1||1
11370344|NCT03286218|12566756|FG001|NOT COMPLETED|Qualification Phase Period 1||1
11370345|NCT03286218|12566757|FG002|NOT COMPLETED|Qualification Phase Period 1||0
11370346|NCT03286218|12566758|FG003|NOT COMPLETED|Qualification Phase Period 1||0
11370347|NCT03286218|12566759|FG004|NOT COMPLETED|Qualification Phase Period 1||0
11370348|NCT03286218|12566760|FG005|NOT COMPLETED|Qualification Phase Period 1||0
11370349|NCT03286218|12566761|FG006|NOT COMPLETED|Qualification Phase Period 1||0
11370350|NCT03286218|12566762|FG007|NOT COMPLETED|Qualification Phase Period 1||0
11370351|NCT03286218|12566763|FG008|NOT COMPLETED|Qualification Phase Period 1||0
11370352|NCT03286218|12566764|FG009|NOT COMPLETED|Qualification Phase Period 1||0
11370353|NCT03286218|12566765|FG010|NOT COMPLETED|Qualification Phase Period 1||0
11370354|NCT03286218|12566766|FG011|NOT COMPLETED|Qualification Phase Period 1||0
11370355|NCT03286218|12566755|FG000|STARTED|Qualification Phase Period 2||47
11370356|NCT03286218|12566756|FG001|STARTED|Qualification Phase Period 2||47
11370357|NCT03286218|12566757|FG002|STARTED|Qualification Phase Period 2||0
11370358|NCT03286218|12566758|FG003|STARTED|Qualification Phase Period 2||0
11370359|NCT03286218|12566759|FG004|STARTED|Qualification Phase Period 2||0
11370360|NCT03286218|12566760|FG005|STARTED|Qualification Phase Period 2||0
11370361|NCT03286218|12566761|FG006|STARTED|Qualification Phase Period 2||0
11370362|NCT03286218|12566762|FG007|STARTED|Qualification Phase Period 2||0
11370363|NCT03286218|12566763|FG008|STARTED|Qualification Phase Period 2||0
11370364|NCT03286218|12566764|FG009|STARTED|Qualification Phase Period 2||0
11370365|NCT03286218|12566765|FG010|STARTED|Qualification Phase Period 2||0
11370366|NCT03286218|12566766|FG011|STARTED|Qualification Phase Period 2||0
11370367|NCT03286218|12566755|FG000|COMPLETED|Qualification Phase Period 2||30
11370368|NCT03286218|12566756|FG001|COMPLETED|Qualification Phase Period 2||28
11370369|NCT03286218|12566757|FG002|COMPLETED|Qualification Phase Period 2||0
11370370|NCT03286218|12566758|FG003|COMPLETED|Qualification Phase Period 2||0
11370371|NCT03286218|12566759|FG004|COMPLETED|Qualification Phase Period 2||0
11370372|NCT03286218|12566760|FG005|COMPLETED|Qualification Phase Period 2||0
11370373|NCT03286218|12566761|FG006|COMPLETED|Qualification Phase Period 2||0
11370374|NCT03286218|12566762|FG007|COMPLETED|Qualification Phase Period 2||0
11370375|NCT03286218|12566763|FG008|COMPLETED|Qualification Phase Period 2||0
11370376|NCT03286218|12566764|FG009|COMPLETED|Qualification Phase Period 2||0
11370377|NCT03286218|12566765|FG010|COMPLETED|Qualification Phase Period 2||0
11370378|NCT03286218|12566766|FG011|COMPLETED|Qualification Phase Period 2||0
11370379|NCT03286218|12566755|FG000|NOT COMPLETED|Qualification Phase Period 2||17
11370380|NCT03286218|12566756|FG001|NOT COMPLETED|Qualification Phase Period 2||19
11370381|NCT03286218|12566757|FG002|NOT COMPLETED|Qualification Phase Period 2||0
11370382|NCT03286218|12566758|FG003|NOT COMPLETED|Qualification Phase Period 2||0
11370383|NCT03286218|12566759|FG004|NOT COMPLETED|Qualification Phase Period 2||0
11370384|NCT03286218|12566760|FG005|NOT COMPLETED|Qualification Phase Period 2||0
11370385|NCT03286218|12566761|FG006|NOT COMPLETED|Qualification Phase Period 2||0
11370386|NCT03286218|12566762|FG007|NOT COMPLETED|Qualification Phase Period 2||0
11370387|NCT03286218|12566763|FG008|NOT COMPLETED|Qualification Phase Period 2||0
11370388|NCT03286218|12566764|FG009|NOT COMPLETED|Qualification Phase Period 2||0
11370389|NCT03286218|12566765|FG010|NOT COMPLETED|Qualification Phase Period 2||0
11370390|NCT03286218|12566766|FG011|NOT COMPLETED|Qualification Phase Period 2||0
11370391|NCT03286218|12566755|FG000|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
11370392|NCT03286218|12566756|FG001|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
11370393|NCT03286218|12566757|FG002|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
11370394|NCT03286218|12566758|FG003|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
11370395|NCT03286218|12566759|FG004|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
11370396|NCT03286218|12566760|FG005|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
11370397|NCT03286218|12566761|FG006|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
11370398|NCT03286218|12566762|FG007|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
11370399|NCT03286218|12566763|FG008|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
11370400|NCT03286218|12566764|FG009|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
11370401|NCT03286218|12566765|FG010|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
11370402|NCT03286218|12566766|FG011|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
11370403|NCT03286218|12566755|FG000|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
11370404|NCT03286218|12566756|FG001|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
11370405|NCT03286218|12566757|FG002|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
11370406|NCT03286218|12566758|FG003|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
11370407|NCT03286218|12566759|FG004|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
11370408|NCT03286218|12566760|FG005|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
11370409|NCT03286218|12566761|FG006|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
11370410|NCT03286218|12566762|FG007|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
11370411|NCT03286218|12566763|FG008|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
11370412|NCT03286218|12566764|FG009|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
11370413|NCT03286218|12566765|FG010|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
11370414|NCT03286218|12566766|FG011|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
11370415|NCT03286218|12566755|FG000|COMPLETED|Treatment Phase Period 1||0
11370416|NCT03286218|12566756|FG001|COMPLETED|Treatment Phase Period 1||0
11370417|NCT03286218|12566757|FG002|COMPLETED|Treatment Phase Period 1||5
11370418|NCT03286218|12566758|FG003|COMPLETED|Treatment Phase Period 1||5
11370419|NCT03286218|12566759|FG004|COMPLETED|Treatment Phase Period 1||5
11370420|NCT03286218|12566760|FG005|COMPLETED|Treatment Phase Period 1||5
11370421|NCT03286218|12566761|FG006|COMPLETED|Treatment Phase Period 1||6
11370422|NCT03286218|12566762|FG007|COMPLETED|Treatment Phase Period 1||6
11370423|NCT03286218|12566763|FG008|COMPLETED|Treatment Phase Period 1||6
11370424|NCT03286218|12566764|FG009|COMPLETED|Treatment Phase Period 1||6
11370425|NCT03286218|12566765|FG010|COMPLETED|Treatment Phase Period 1||5
11370426|NCT03286218|12566766|FG011|COMPLETED|Treatment Phase Period 1||5
11370427|NCT03286218|12566755|FG000|NOT COMPLETED|Treatment Phase Period 1||0
11370428|NCT03286218|12566756|FG001|NOT COMPLETED|Treatment Phase Period 1||0
11370429|NCT03286218|12566757|FG002|NOT COMPLETED|Treatment Phase Period 1||1
11370430|NCT03286218|12566758|FG003|NOT COMPLETED|Treatment Phase Period 1||1
11370431|NCT03286218|12566759|FG004|NOT COMPLETED|Treatment Phase Period 1||0
11370432|NCT03286218|12566760|FG005|NOT COMPLETED|Treatment Phase Period 1||1
11370433|NCT03286218|12566761|FG006|NOT COMPLETED|Treatment Phase Period 1||0
11370434|NCT03286218|12566762|FG007|NOT COMPLETED|Treatment Phase Period 1||0
11370435|NCT03286218|12566763|FG008|NOT COMPLETED|Treatment Phase Period 1||0
11370436|NCT03286218|12566764|FG009|NOT COMPLETED|Treatment Phase Period 1||0
11370437|NCT03286218|12566765|FG010|NOT COMPLETED|Treatment Phase Period 1||0
11370438|NCT03286218|12566766|FG011|NOT COMPLETED|Treatment Phase Period 1||1
11370439|NCT03286218|12566755|FG000|STARTED|Treatment Phase Period 2||0
11370440|NCT03286218|12566756|FG001|STARTED|Treatment Phase Period 2||0
11370441|NCT03286218|12566757|FG002|STARTED|Treatment Phase Period 2||5
11370442|NCT03286218|12566758|FG003|STARTED|Treatment Phase Period 2||5
11370443|NCT03286218|12566759|FG004|STARTED|Treatment Phase Period 2||5
11370444|NCT03286218|12566760|FG005|STARTED|Treatment Phase Period 2||5
11370445|NCT03286218|12566761|FG006|STARTED|Treatment Phase Period 2||6
11370446|NCT03286218|12566762|FG007|STARTED|Treatment Phase Period 2||6
11370447|NCT03286218|12566763|FG008|STARTED|Treatment Phase Period 2||6
11370448|NCT03286218|12566764|FG009|STARTED|Treatment Phase Period 2||6
11370449|NCT03286218|12566765|FG010|STARTED|Treatment Phase Period 2||5
11370450|NCT03286218|12566766|FG011|STARTED|Treatment Phase Period 2||5
11370451|NCT03286218|12566755|FG000|COMPLETED|Treatment Phase Period 2||0
11370452|NCT03286218|12566756|FG001|COMPLETED|Treatment Phase Period 2||0
11370453|NCT03286218|12566757|FG002|COMPLETED|Treatment Phase Period 2||5
11370454|NCT03286218|12566758|FG003|COMPLETED|Treatment Phase Period 2||5
11370455|NCT03286218|12566759|FG004|COMPLETED|Treatment Phase Period 2||5
11370456|NCT03286218|12566760|FG005|COMPLETED|Treatment Phase Period 2||5
11370457|NCT03286218|12566761|FG006|COMPLETED|Treatment Phase Period 2||6
11370458|NCT03286218|12566762|FG007|COMPLETED|Treatment Phase Period 2||6
11370459|NCT03286218|12566763|FG008|COMPLETED|Treatment Phase Period 2||6
11370460|NCT03286218|12566764|FG009|COMPLETED|Treatment Phase Period 2||6
11370461|NCT03286218|12566765|FG010|COMPLETED|Treatment Phase Period 2||5
11370462|NCT03286218|12566766|FG011|COMPLETED|Treatment Phase Period 2||5
11370463|NCT03286218|12566755|FG000|NOT COMPLETED|Treatment Phase Period 2||0
11370464|NCT03286218|12566756|FG001|NOT COMPLETED|Treatment Phase Period 2||0
11370465|NCT03286218|12566757|FG002|NOT COMPLETED|Treatment Phase Period 2||0
11370466|NCT03286218|12566758|FG003|NOT COMPLETED|Treatment Phase Period 2||0
11370467|NCT03286218|12566759|FG004|NOT COMPLETED|Treatment Phase Period 2||0
11370468|NCT03286218|12566760|FG005|NOT COMPLETED|Treatment Phase Period 2||0
11370469|NCT03286218|12566761|FG006|NOT COMPLETED|Treatment Phase Period 2||0
11370470|NCT03286218|12566762|FG007|NOT COMPLETED|Treatment Phase Period 2||0
11370471|NCT03286218|12566763|FG008|NOT COMPLETED|Treatment Phase Period 2||0
11370472|NCT03286218|12566764|FG009|NOT COMPLETED|Treatment Phase Period 2||0
11370473|NCT03286218|12566765|FG010|NOT COMPLETED|Treatment Phase Period 2||0
11370474|NCT03286218|12566766|FG011|NOT COMPLETED|Treatment Phase Period 2||0
11370475|NCT03286218|12566755|FG000|STARTED|Treatment Phase Period 3||0
11370476|NCT03286218|12566756|FG001|STARTED|Treatment Phase Period 3||0
11370477|NCT03286218|12566757|FG002|STARTED|Treatment Phase Period 3||5
11370478|NCT03286218|12566758|FG003|STARTED|Treatment Phase Period 3||5
11370479|NCT03286218|12566759|FG004|STARTED|Treatment Phase Period 3||5
11370480|NCT03286218|12566760|FG005|STARTED|Treatment Phase Period 3||5
11370481|NCT03286218|12566761|FG006|STARTED|Treatment Phase Period 3||6
11370482|NCT03286218|12566762|FG007|STARTED|Treatment Phase Period 3||6
11370483|NCT03286218|12566763|FG008|STARTED|Treatment Phase Period 3||6
11370484|NCT03286218|12566764|FG009|STARTED|Treatment Phase Period 3||6
11370485|NCT03286218|12566765|FG010|STARTED|Treatment Phase Period 3||5
11370486|NCT03286218|12566766|FG011|STARTED|Treatment Phase Period 3||5
11370487|NCT03286218|12566755|FG000|COMPLETED|Treatment Phase Period 3||0
11370488|NCT03286218|12566756|FG001|COMPLETED|Treatment Phase Period 3||0
11370489|NCT03286218|12566757|FG002|COMPLETED|Treatment Phase Period 3||5
11370490|NCT03286218|12566758|FG003|COMPLETED|Treatment Phase Period 3||5
11370491|NCT03286218|12566759|FG004|COMPLETED|Treatment Phase Period 3||5
11370492|NCT03286218|12566760|FG005|COMPLETED|Treatment Phase Period 3||5
11370493|NCT03286218|12566761|FG006|COMPLETED|Treatment Phase Period 3||6
11370494|NCT03286218|12566762|FG007|COMPLETED|Treatment Phase Period 3||6
11370495|NCT03286218|12566763|FG008|COMPLETED|Treatment Phase Period 3||6
11370496|NCT03286218|12566764|FG009|COMPLETED|Treatment Phase Period 3||6
11370497|NCT03286218|12566765|FG010|COMPLETED|Treatment Phase Period 3||5
11370498|NCT03286218|12566766|FG011|COMPLETED|Treatment Phase Period 3||5
11370499|NCT03286218|12566755|FG000|NOT COMPLETED|Treatment Phase Period 3||0
11370500|NCT03286218|12566756|FG001|NOT COMPLETED|Treatment Phase Period 3||0
11370501|NCT03286218|12566757|FG002|NOT COMPLETED|Treatment Phase Period 3||0
11370502|NCT03286218|12566758|FG003|NOT COMPLETED|Treatment Phase Period 3||0
11370503|NCT03286218|12566759|FG004|NOT COMPLETED|Treatment Phase Period 3||0
11370504|NCT03286218|12566760|FG005|NOT COMPLETED|Treatment Phase Period 3||0
11370505|NCT03286218|12566761|FG006|NOT COMPLETED|Treatment Phase Period 3||0
11370506|NCT03286218|12566762|FG007|NOT COMPLETED|Treatment Phase Period 3||0
11370507|NCT03286218|12566763|FG008|NOT COMPLETED|Treatment Phase Period 3||0
11370508|NCT03286218|12566764|FG009|NOT COMPLETED|Treatment Phase Period 3||0
11370509|NCT03286218|12566765|FG010|NOT COMPLETED|Treatment Phase Period 3||0
11370510|NCT03286218|12566766|FG011|NOT COMPLETED|Treatment Phase Period 3||0
11370511|NCT03286218|12566755|FG000|STARTED|Treatment Phase Period 4||0
11370512|NCT03286218|12566756|FG001|STARTED|Treatment Phase Period 4||0
11370513|NCT03286218|12566757|FG002|STARTED|Treatment Phase Period 4||5
11370514|NCT03286218|12566758|FG003|STARTED|Treatment Phase Period 4||5
11370515|NCT03286218|12566759|FG004|STARTED|Treatment Phase Period 4||5
11370516|NCT03286218|12566760|FG005|STARTED|Treatment Phase Period 4||5
11370517|NCT03286218|12566761|FG006|STARTED|Treatment Phase Period 4||6
11370518|NCT03286218|12566762|FG007|STARTED|Treatment Phase Period 4||6
11370519|NCT03286218|12566763|FG008|STARTED|Treatment Phase Period 4||6
11370520|NCT03286218|12566764|FG009|STARTED|Treatment Phase Period 4||6
11370521|NCT03286218|12566765|FG010|STARTED|Treatment Phase Period 4||5
11370522|NCT03286218|12566766|FG011|STARTED|Treatment Phase Period 4||5
11370523|NCT03286218|12566755|FG000|COMPLETED|Treatment Phase Period 4||0
11370524|NCT03286218|12566756|FG001|COMPLETED|Treatment Phase Period 4||0
11370525|NCT03286218|12566757|FG002|COMPLETED|Treatment Phase Period 4||5
11370526|NCT03286218|12566758|FG003|COMPLETED|Treatment Phase Period 4||5
11370527|NCT03286218|12566759|FG004|COMPLETED|Treatment Phase Period 4||5
11370528|NCT03286218|12566760|FG005|COMPLETED|Treatment Phase Period 4||5
11370529|NCT03286218|12566761|FG006|COMPLETED|Treatment Phase Period 4||6
11370530|NCT03286218|12566762|FG007|COMPLETED|Treatment Phase Period 4||6
11370531|NCT03286218|12566763|FG008|COMPLETED|Treatment Phase Period 4||6
11370532|NCT03286218|12566764|FG009|COMPLETED|Treatment Phase Period 4||6
11370533|NCT03286218|12566765|FG010|COMPLETED|Treatment Phase Period 4||5
11370534|NCT03286218|12566766|FG011|COMPLETED|Treatment Phase Period 4||4
11370535|NCT03286218|12566755|FG000|NOT COMPLETED|Treatment Phase Period 4||0
11370536|NCT03286218|12566756|FG001|NOT COMPLETED|Treatment Phase Period 4||0
11370537|NCT03286218|12566757|FG002|NOT COMPLETED|Treatment Phase Period 4||0
11370538|NCT03286218|12566758|FG003|NOT COMPLETED|Treatment Phase Period 4||0
11370539|NCT03286218|12566759|FG004|NOT COMPLETED|Treatment Phase Period 4||0
11370540|NCT03286218|12566760|FG005|NOT COMPLETED|Treatment Phase Period 4||0
11370541|NCT03286218|12566761|FG006|NOT COMPLETED|Treatment Phase Period 4||0
11370542|NCT03286218|12566762|FG007|NOT COMPLETED|Treatment Phase Period 4||0
11370543|NCT03286218|12566763|FG008|NOT COMPLETED|Treatment Phase Period 4||0
11370544|NCT03286218|12566764|FG009|NOT COMPLETED|Treatment Phase Period 4||0
11370545|NCT03286218|12566765|FG010|NOT COMPLETED|Treatment Phase Period 4||0
11370546|NCT03286218|12566766|FG011|NOT COMPLETED|Treatment Phase Period 4||1
11370547|NCT03286218|12566755|FG000|STARTED|Treatment Phase Period 5||0
11370548|NCT03286218|12566756|FG001|STARTED|Treatment Phase Period 5||0
11370549|NCT03286218|12566757|FG002|STARTED|Treatment Phase Period 5||5
11370550|NCT03286218|12566758|FG003|STARTED|Treatment Phase Period 5||5
11370551|NCT03286218|12566759|FG004|STARTED|Treatment Phase Period 5||5
11370552|NCT03286218|12566760|FG005|STARTED|Treatment Phase Period 5||5
11370553|NCT03286218|12566761|FG006|STARTED|Treatment Phase Period 5||6
11370554|NCT03286218|12566762|FG007|STARTED|Treatment Phase Period 5||6
11370555|NCT03286218|12566763|FG008|STARTED|Treatment Phase Period 5||6
11370556|NCT03286218|12566764|FG009|STARTED|Treatment Phase Period 5||6
11370557|NCT03286218|12566765|FG010|STARTED|Treatment Phase Period 5||5
11370558|NCT03286218|12566766|FG011|STARTED|Treatment Phase Period 5||4
11370559|NCT03286218|12566755|FG000|COMPLETED|Treatment Phase Period 5||0
11370560|NCT03286218|12566756|FG001|COMPLETED|Treatment Phase Period 5||0
11370561|NCT03286218|12566757|FG002|COMPLETED|Treatment Phase Period 5||5
11370562|NCT03286218|12566758|FG003|COMPLETED|Treatment Phase Period 5||5
11370563|NCT03286218|12566759|FG004|COMPLETED|Treatment Phase Period 5||5
11370564|NCT03286218|12566760|FG005|COMPLETED|Treatment Phase Period 5||5
11370565|NCT03286218|12566761|FG006|COMPLETED|Treatment Phase Period 5||6
11370566|NCT03286218|12566762|FG007|COMPLETED|Treatment Phase Period 5||6
11370567|NCT03286218|12566763|FG008|COMPLETED|Treatment Phase Period 5||6
11370568|NCT03286218|12566764|FG009|COMPLETED|Treatment Phase Period 5||6
11370569|NCT03286218|12566765|FG010|COMPLETED|Treatment Phase Period 5||5
11370570|NCT03286218|12566766|FG011|COMPLETED|Treatment Phase Period 5||4
11370571|NCT03286218|12566755|FG000|NOT COMPLETED|Treatment Phase Period 5||0
11370572|NCT03286218|12566756|FG001|NOT COMPLETED|Treatment Phase Period 5||0
11370573|NCT03286218|12566757|FG002|NOT COMPLETED|Treatment Phase Period 5||0
11370574|NCT03286218|12566758|FG003|NOT COMPLETED|Treatment Phase Period 5||0
11370575|NCT03286218|12566759|FG004|NOT COMPLETED|Treatment Phase Period 5||0
11370576|NCT03286218|12566760|FG005|NOT COMPLETED|Treatment Phase Period 5||0
11370577|NCT03286218|12566761|FG006|NOT COMPLETED|Treatment Phase Period 5||0
11370578|NCT03286218|12566762|FG007|NOT COMPLETED|Treatment Phase Period 5||0
11370579|NCT03286218|12566763|FG008|NOT COMPLETED|Treatment Phase Period 5||0
11370580|NCT03286218|12566764|FG009|NOT COMPLETED|Treatment Phase Period 5||0
11370581|NCT03286218|12566765|FG010|NOT COMPLETED|Treatment Phase Period 5||0
11370582|NCT03286218|12566766|FG011|NOT COMPLETED|Treatment Phase Period 5||0
11370583|NCT03286400|12566793|FG000|STARTED|Overall Study||127
11370584|NCT03286400|12566793|FG000|COMPLETED|Overall Study||102
11370585|NCT03286400|12566793|FG000|NOT COMPLETED|Overall Study||25
11370586|NCT03286465|12566799|FG000|STARTED|Overall Study||100
11370587|NCT03286465|12566800|FG001|STARTED|Overall Study||100
11370588|NCT03286465|12566799|FG000|COMPLETED|Overall Study||100
11370589|NCT03286465|12566800|FG001|COMPLETED|Overall Study||100
11370590|NCT03286465|12566799|FG000|NOT COMPLETED|Overall Study||0
11370591|NCT03286465|12566800|FG001|NOT COMPLETED|Overall Study||0
11370592|NCT03286543|12566808|FG000|STARTED|Consented||47
11370593|NCT03286543|12566809|FG001|STARTED|Consented||0
11370594|NCT03286543|12566810|FG002|STARTED|Consented||0
11370595|NCT03286543|12566808|FG000|Randomized|Consented||45
11370596|NCT03286543|12566809|FG001|Randomized|Consented||0
11370597|NCT03286543|12566810|FG002|Randomized|Consented||0
11370598|NCT03286543|12566808|FG000|Enrolled|Consented||41
11370599|NCT03286543|12566809|FG001|Enrolled|Consented||0
11370600|NCT03286543|12566810|FG002|Enrolled|Consented||0
11370601|NCT03286543|12566808|FG000|Intent to Treat Set|Consented||37
11370602|NCT03286543|12566809|FG001|Intent to Treat Set|Consented||0
11370603|NCT03286543|12566810|FG002|Intent to Treat Set|Consented||0
11370604|NCT03286543|12566808|FG000|Per Protocol Set|Consented||23
11370605|NCT03286543|12566809|FG001|Per Protocol Set|Consented||0
11370606|NCT03286543|12566810|FG002|Per Protocol Set|Consented||0
11370607|NCT03286543|12566808|FG000|COMPLETED|Consented||28
11370608|NCT03286543|12566809|FG001|COMPLETED|Consented||0
11370609|NCT03286543|12566810|FG002|COMPLETED|Consented||0
11370610|NCT03286543|12566808|FG000|NOT COMPLETED|Consented||19
11370611|NCT03286543|12566809|FG001|NOT COMPLETED|Consented||0
11370612|NCT03286543|12566810|FG002|NOT COMPLETED|Consented||0
11370613|NCT03286543|12566808|FG000|STARTED|Study Enrollment||0
11370614|NCT03286543|12566809|FG001|STARTED|Study Enrollment||18
11370615|NCT03286543|12566810|FG002|STARTED|Study Enrollment||23
11370616|NCT03286543|12566808|FG000|Intent to Treat Set|Study Enrollment||0
11370617|NCT03286543|12566809|FG001|Intent to Treat Set|Study Enrollment||18
11370618|NCT03286543|12566810|FG002|Intent to Treat Set|Study Enrollment||19
11370619|NCT03286543|12566808|FG000|Per Protocol Set|Study Enrollment||0
11370620|NCT03286543|12566809|FG001|Per Protocol Set|Study Enrollment||7
11370621|NCT03286543|12566810|FG002|Per Protocol Set|Study Enrollment||16
11370622|NCT03286543|12566808|FG000|COMPLETED|Study Enrollment||0
11370623|NCT03286543|12566809|FG001|COMPLETED|Study Enrollment||12
11370624|NCT03286543|12566810|FG002|COMPLETED|Study Enrollment||16
11370625|NCT03286543|12566808|FG000|NOT COMPLETED|Study Enrollment||0
11370626|NCT03286543|12566809|FG001|NOT COMPLETED|Study Enrollment||6
11370627|NCT03286543|12566810|FG002|NOT COMPLETED|Study Enrollment||7
11370628|NCT03286751|12566816|FG000|STARTED|Period 1||7
11370629|NCT03286751|12566817|FG001|STARTED|Period 1||7
11370630|NCT03286751|12566818|FG002|STARTED|Period 1||7
11370631|NCT03286751|12566819|FG003|STARTED|Period 1||7
11370632|NCT03286751|12566820|FG004|STARTED|Period 1||7
11370633|NCT03286751|12566821|FG005|STARTED|Period 1||7
11370634|NCT03286751|12566816|FG000|Received at Least One Dose of Study Drug|Period 1||7
11370635|NCT03286751|12566817|FG001|Received at Least One Dose of Study Drug|Period 1||7
11370636|NCT03286751|12566818|FG002|Received at Least One Dose of Study Drug|Period 1||7
11370637|NCT03286751|12566819|FG003|Received at Least One Dose of Study Drug|Period 1||7
11370638|NCT03286751|12566820|FG004|Received at Least One Dose of Study Drug|Period 1||7
11370639|NCT03286751|12566821|FG005|Received at Least One Dose of Study Drug|Period 1||7
11370640|NCT03286751|12566816|FG000|COMPLETED|Period 1||7
11370641|NCT03286751|12566817|FG001|COMPLETED|Period 1||7
11370642|NCT03286751|12566818|FG002|COMPLETED|Period 1||7
11370643|NCT03286751|12566819|FG003|COMPLETED|Period 1||7
11370644|NCT03286751|12566820|FG004|COMPLETED|Period 1||7
11370645|NCT03286751|12566821|FG005|COMPLETED|Period 1||7
11370646|NCT03286751|12566816|FG000|NOT COMPLETED|Period 1||0
11370647|NCT03286751|12566817|FG001|NOT COMPLETED|Period 1||0
11370648|NCT03286751|12566818|FG002|NOT COMPLETED|Period 1||0
11370649|NCT03286751|12566819|FG003|NOT COMPLETED|Period 1||0
11370650|NCT03286751|12566820|FG004|NOT COMPLETED|Period 1||0
11370651|NCT03286751|12566821|FG005|NOT COMPLETED|Period 1||0
11370652|NCT03286751|12566816|FG000|STARTED|Washout Period 1||7
11370653|NCT03286751|12566817|FG001|STARTED|Washout Period 1||7
11370654|NCT03286751|12566818|FG002|STARTED|Washout Period 1||7
11370655|NCT03286751|12566819|FG003|STARTED|Washout Period 1||7
11370656|NCT03286751|12566820|FG004|STARTED|Washout Period 1||7
11370657|NCT03286751|12566821|FG005|STARTED|Washout Period 1||7
11370658|NCT03286751|12566816|FG000|COMPLETED|Washout Period 1||7
11370659|NCT03286751|12566817|FG001|COMPLETED|Washout Period 1||7
11370660|NCT03286751|12566818|FG002|COMPLETED|Washout Period 1||7
11370661|NCT03286751|12566819|FG003|COMPLETED|Washout Period 1||7
11370662|NCT03286751|12566820|FG004|COMPLETED|Washout Period 1||6
11370663|NCT03286751|12566821|FG005|COMPLETED|Washout Period 1||7
11370664|NCT03286751|12566816|FG000|NOT COMPLETED|Washout Period 1||0
11370665|NCT03286751|12566817|FG001|NOT COMPLETED|Washout Period 1||0
11370666|NCT03286751|12566818|FG002|NOT COMPLETED|Washout Period 1||0
11370667|NCT03286751|12566819|FG003|NOT COMPLETED|Washout Period 1||0
11370668|NCT03286751|12566820|FG004|NOT COMPLETED|Washout Period 1||1
11370669|NCT03286751|12566821|FG005|NOT COMPLETED|Washout Period 1||0
11370670|NCT03286751|12566816|FG000|STARTED|Period 2||7
11370671|NCT03286751|12566817|FG001|STARTED|Period 2||7
11370672|NCT03286751|12566818|FG002|STARTED|Period 2||7
11370673|NCT03286751|12566819|FG003|STARTED|Period 2||7
11370674|NCT03286751|12566820|FG004|STARTED|Period 2||6
11370675|NCT03286751|12566821|FG005|STARTED|Period 2||7
11370676|NCT03286751|12566816|FG000|COMPLETED|Period 2||7
11370677|NCT03286751|12566817|FG001|COMPLETED|Period 2||7
11370678|NCT03286751|12566818|FG002|COMPLETED|Period 2||7
11370679|NCT03286751|12566819|FG003|COMPLETED|Period 2||7
11370680|NCT03286751|12566820|FG004|COMPLETED|Period 2||6
11370681|NCT03286751|12566821|FG005|COMPLETED|Period 2||7
11370682|NCT03286751|12566816|FG000|NOT COMPLETED|Period 2||0
11370683|NCT03286751|12566817|FG001|NOT COMPLETED|Period 2||0
11370684|NCT03286751|12566818|FG002|NOT COMPLETED|Period 2||0
11370685|NCT03286751|12566819|FG003|NOT COMPLETED|Period 2||0
11370686|NCT03286751|12566820|FG004|NOT COMPLETED|Period 2||0
11370687|NCT03286751|12566821|FG005|NOT COMPLETED|Period 2||0
11370688|NCT03286751|12566816|FG000|STARTED|Washout Period 2||7
11370689|NCT03286751|12566817|FG001|STARTED|Washout Period 2||7
11370690|NCT03286751|12566818|FG002|STARTED|Washout Period 2||7
11370691|NCT03286751|12566819|FG003|STARTED|Washout Period 2||7
11370692|NCT03286751|12566820|FG004|STARTED|Washout Period 2||6
11370693|NCT03286751|12566821|FG005|STARTED|Washout Period 2||7
11370694|NCT03286751|12566816|FG000|COMPLETED|Washout Period 2||7
11370695|NCT03286751|12566817|FG001|COMPLETED|Washout Period 2||6
11370696|NCT03286751|12566818|FG002|COMPLETED|Washout Period 2||7
11370697|NCT03286751|12566819|FG003|COMPLETED|Washout Period 2||7
11370698|NCT03286751|12566820|FG004|COMPLETED|Washout Period 2||6
11370699|NCT03286751|12566821|FG005|COMPLETED|Washout Period 2||7
11370700|NCT03286751|12566816|FG000|NOT COMPLETED|Washout Period 2||0
11370701|NCT03286751|12566817|FG001|NOT COMPLETED|Washout Period 2||1
11370702|NCT03286751|12566818|FG002|NOT COMPLETED|Washout Period 2||0
11370703|NCT03286751|12566819|FG003|NOT COMPLETED|Washout Period 2||0
11370704|NCT03286751|12566820|FG004|NOT COMPLETED|Washout Period 2||0
11370705|NCT03286751|12566821|FG005|NOT COMPLETED|Washout Period 2||0
11370706|NCT03286751|12566816|FG000|STARTED|Period 3||7
11370707|NCT03286751|12566817|FG001|STARTED|Period 3||6
11370708|NCT03286751|12566818|FG002|STARTED|Period 3||7
11370709|NCT03286751|12566819|FG003|STARTED|Period 3||7
11370710|NCT03286751|12566820|FG004|STARTED|Period 3||6
11370711|NCT03286751|12566821|FG005|STARTED|Period 3||7
11370712|NCT03286751|12566816|FG000|COMPLETED|Period 3||7
11370713|NCT03286751|12566817|FG001|COMPLETED|Period 3||6
11370714|NCT03286751|12566818|FG002|COMPLETED|Period 3||7
11370715|NCT03286751|12566819|FG003|COMPLETED|Period 3||7
11370716|NCT03286751|12566820|FG004|COMPLETED|Period 3||6
11370717|NCT03286751|12566821|FG005|COMPLETED|Period 3||7
11370718|NCT03286751|12566816|FG000|NOT COMPLETED|Period 3||0
11370719|NCT03286751|12566817|FG001|NOT COMPLETED|Period 3||0
11370720|NCT03286751|12566818|FG002|NOT COMPLETED|Period 3||0
11370721|NCT03286751|12566819|FG003|NOT COMPLETED|Period 3||0
11370722|NCT03286751|12566820|FG004|NOT COMPLETED|Period 3||0
11370723|NCT03286751|12566821|FG005|NOT COMPLETED|Period 3||0
11370724|NCT03286751|12566816|FG000|STARTED|Washout Period 3||7
11370725|NCT03286751|12566817|FG001|STARTED|Washout Period 3||6
11370726|NCT03286751|12566818|FG002|STARTED|Washout Period 3||7
11370727|NCT03286751|12566819|FG003|STARTED|Washout Period 3||7
11370728|NCT03286751|12566820|FG004|STARTED|Washout Period 3||6
11370729|NCT03286751|12566821|FG005|STARTED|Washout Period 3||7
11370730|NCT03286751|12566816|FG000|COMPLETED|Washout Period 3||7
11370731|NCT03286751|12566817|FG001|COMPLETED|Washout Period 3||6
11370732|NCT03286751|12566818|FG002|COMPLETED|Washout Period 3||7
11370733|NCT03286751|12566819|FG003|COMPLETED|Washout Period 3||7
11370734|NCT03286751|12566820|FG004|COMPLETED|Washout Period 3||6
11370735|NCT03286751|12566821|FG005|COMPLETED|Washout Period 3||7
11370736|NCT03286751|12566816|FG000|NOT COMPLETED|Washout Period 3||0
11370737|NCT03286751|12566817|FG001|NOT COMPLETED|Washout Period 3||0
11370738|NCT03286751|12566818|FG002|NOT COMPLETED|Washout Period 3||0
11370739|NCT03286751|12566819|FG003|NOT COMPLETED|Washout Period 3||0
11370740|NCT03286751|12566820|FG004|NOT COMPLETED|Washout Period 3||0
11370741|NCT03286751|12566821|FG005|NOT COMPLETED|Washout Period 3||0
11370742|NCT03286751|12566816|FG000|STARTED|Period 4||7
11370743|NCT03286751|12566817|FG001|STARTED|Period 4||6
11370744|NCT03286751|12566818|FG002|STARTED|Period 4||7
11370745|NCT03286751|12566819|FG003|STARTED|Period 4||7
11370746|NCT03286751|12566820|FG004|STARTED|Period 4||6
11370747|NCT03286751|12566821|FG005|STARTED|Period 4||7
11370748|NCT03286751|12566816|FG000|COMPLETED|Period 4||7
11370749|NCT03286751|12566817|FG001|COMPLETED|Period 4||6
11370750|NCT03286751|12566818|FG002|COMPLETED|Period 4||7
11370751|NCT03286751|12566819|FG003|COMPLETED|Period 4||7
11370752|NCT03286751|12566820|FG004|COMPLETED|Period 4||6
11370753|NCT03286751|12566821|FG005|COMPLETED|Period 4||7
11370754|NCT03286751|12566816|FG000|NOT COMPLETED|Period 4||0
11370755|NCT03286751|12566817|FG001|NOT COMPLETED|Period 4||0
11370756|NCT03286751|12566818|FG002|NOT COMPLETED|Period 4||0
11370757|NCT03286751|12566819|FG003|NOT COMPLETED|Period 4||0
11370758|NCT03286751|12566820|FG004|NOT COMPLETED|Period 4||0
11370759|NCT03286751|12566821|FG005|NOT COMPLETED|Period 4||0
11370760|NCT03286751|12566816|FG000|STARTED|Washout Period 4||7
11370761|NCT03286751|12566817|FG001|STARTED|Washout Period 4||6
11370762|NCT03286751|12566818|FG002|STARTED|Washout Period 4||7
11370763|NCT03286751|12566819|FG003|STARTED|Washout Period 4||7
11370764|NCT03286751|12566820|FG004|STARTED|Washout Period 4||6
11370765|NCT03286751|12566821|FG005|STARTED|Washout Period 4||7
11370766|NCT03286751|12566816|FG000|COMPLETED|Washout Period 4||7
11370767|NCT03286751|12566817|FG001|COMPLETED|Washout Period 4||6
11370768|NCT03286751|12566818|FG002|COMPLETED|Washout Period 4||7
11370769|NCT03286751|12566819|FG003|COMPLETED|Washout Period 4||7
11370770|NCT03286751|12566820|FG004|COMPLETED|Washout Period 4||6
11370771|NCT03286751|12566821|FG005|COMPLETED|Washout Period 4||7
11370772|NCT03286751|12566816|FG000|NOT COMPLETED|Washout Period 4||0
11370773|NCT03286751|12566817|FG001|NOT COMPLETED|Washout Period 4||0
11370774|NCT03286751|12566818|FG002|NOT COMPLETED|Washout Period 4||0
11370775|NCT03286751|12566819|FG003|NOT COMPLETED|Washout Period 4||0
11370776|NCT03286751|12566820|FG004|NOT COMPLETED|Washout Period 4||0
11370777|NCT03286751|12566821|FG005|NOT COMPLETED|Washout Period 4||0
11370778|NCT03286751|12566816|FG000|STARTED|Period 5||7
11370779|NCT03286751|12566817|FG001|STARTED|Period 5||6
11370780|NCT03286751|12566818|FG002|STARTED|Period 5||7
11370781|NCT03286751|12566819|FG003|STARTED|Period 5||7
11005698|NCT00724061|12183417|FG000|STARTED|Dose Escalation Phase||7
11005699|NCT00724061|12183417|FG000|COMPLETED|Dose Escalation Phase||2
11005700|NCT00724061|12183417|FG000|NOT COMPLETED|Dose Escalation Phase||5
11005701|NCT00724061|12183417|FG000|STARTED|Maintenance Therapy||2
11005702|NCT00724061|12183417|FG000|COMPLETED|Maintenance Therapy||2
11005703|NCT00724061|12183417|FG000|NOT COMPLETED|Maintenance Therapy||0
11370782|NCT03286751|12566820|FG004|STARTED|Period 5||6
11370783|NCT03286751|12566821|FG005|STARTED|Period 5||7
11370784|NCT03286751|12566816|FG000|COMPLETED|Period 5||7
11370785|NCT03286751|12566817|FG001|COMPLETED|Period 5||6
11370786|NCT03286751|12566818|FG002|COMPLETED|Period 5||7
11370787|NCT03286751|12566819|FG003|COMPLETED|Period 5||7
11370788|NCT03286751|12566820|FG004|COMPLETED|Period 5||6
11370789|NCT03286751|12566821|FG005|COMPLETED|Period 5||7
11370790|NCT03286751|12566816|FG000|NOT COMPLETED|Period 5||0
11370791|NCT03286751|12566817|FG001|NOT COMPLETED|Period 5||0
11370792|NCT03286751|12566818|FG002|NOT COMPLETED|Period 5||0
11370793|NCT03286751|12566819|FG003|NOT COMPLETED|Period 5||0
11370794|NCT03286751|12566820|FG004|NOT COMPLETED|Period 5||0
11370795|NCT03286751|12566821|FG005|NOT COMPLETED|Period 5||0
11370796|NCT03286751|12566816|FG000|STARTED|Washout Period 5||7
11370797|NCT03286751|12566817|FG001|STARTED|Washout Period 5||6
11370798|NCT03286751|12566818|FG002|STARTED|Washout Period 5||7
11370799|NCT03286751|12566819|FG003|STARTED|Washout Period 5||7
11370800|NCT03286751|12566820|FG004|STARTED|Washout Period 5||6
11370801|NCT03286751|12566821|FG005|STARTED|Washout Period 5||7
11370802|NCT03286751|12566816|FG000|COMPLETED|Washout Period 5||7
11370803|NCT03286751|12566817|FG001|COMPLETED|Washout Period 5||6
11370804|NCT03286751|12566818|FG002|COMPLETED|Washout Period 5||7
11370805|NCT03286751|12566819|FG003|COMPLETED|Washout Period 5||7
11370806|NCT03286751|12566820|FG004|COMPLETED|Washout Period 5||5
11370807|NCT03286751|12566821|FG005|COMPLETED|Washout Period 5||7
11370808|NCT03286751|12566816|FG000|NOT COMPLETED|Washout Period 5||0
11370809|NCT03286751|12566817|FG001|NOT COMPLETED|Washout Period 5||0
11370810|NCT03286751|12566818|FG002|NOT COMPLETED|Washout Period 5||0
11370811|NCT03286751|12566819|FG003|NOT COMPLETED|Washout Period 5||0
11370812|NCT03286751|12566820|FG004|NOT COMPLETED|Washout Period 5||1
11370813|NCT03286751|12566821|FG005|NOT COMPLETED|Washout Period 5||0
11370814|NCT03286751|12566816|FG000|STARTED|Period 6||7
11370815|NCT03286751|12566817|FG001|STARTED|Period 6||6
11370816|NCT03286751|12566818|FG002|STARTED|Period 6||7
11370817|NCT03286751|12566819|FG003|STARTED|Period 6||7
11370818|NCT03286751|12566820|FG004|STARTED|Period 6||5
11370819|NCT03286751|12566821|FG005|STARTED|Period 6||7
11370820|NCT03286751|12566816|FG000|COMPLETED|Period 6||7
11370821|NCT03286751|12566817|FG001|COMPLETED|Period 6||6
11370822|NCT03286751|12566818|FG002|COMPLETED|Period 6||7
11370823|NCT03286751|12566819|FG003|COMPLETED|Period 6||7
11370824|NCT03286751|12566820|FG004|COMPLETED|Period 6||5
11370825|NCT03286751|12566821|FG005|COMPLETED|Period 6||7
11370826|NCT03286751|12566816|FG000|NOT COMPLETED|Period 6||0
11370827|NCT03286751|12566817|FG001|NOT COMPLETED|Period 6||0
11370828|NCT03286751|12566818|FG002|NOT COMPLETED|Period 6||0
11370829|NCT03286751|12566819|FG003|NOT COMPLETED|Period 6||0
11370830|NCT03286751|12566820|FG004|NOT COMPLETED|Period 6||0
11370831|NCT03286751|12566821|FG005|NOT COMPLETED|Period 6||0
11370832|NCT03286829|12566839|FG000|STARTED|Overall Study||15
11370833|NCT03286829|12566840|FG001|STARTED|Overall Study||15
11370834|NCT03286829|12566841|FG002|STARTED|Overall Study||15
11370835|NCT03286829|12566842|FG003|STARTED|Overall Study||15
11370836|NCT03286829|12566839|FG000|COMPLETED|Overall Study||15
11370837|NCT03286829|12566840|FG001|COMPLETED|Overall Study||15
11370838|NCT03286829|12566841|FG002|COMPLETED|Overall Study||15
11370839|NCT03286829|12566842|FG003|COMPLETED|Overall Study||15
11370840|NCT03286829|12566839|FG000|NOT COMPLETED|Overall Study||0
11370841|NCT03286829|12566840|FG001|NOT COMPLETED|Overall Study||0
11370842|NCT03286829|12566841|FG002|NOT COMPLETED|Overall Study||0
11370843|NCT03286829|12566842|FG003|NOT COMPLETED|Overall Study||0
11370844|NCT03287219|12566856|FG000|STARTED|Overall Study||24
11370845|NCT03287219|12566857|FG001|STARTED|Overall Study||90
11370846|NCT03287219|12566856|FG000|COMPLETED|Overall Study||24
11370847|NCT03287219|12566857|FG001|COMPLETED|Overall Study||88
11370848|NCT03287219|12566856|FG000|NOT COMPLETED|Overall Study||0
11370849|NCT03287219|12566857|FG001|NOT COMPLETED|Overall Study||2
11370850|NCT03287310|12566902|FG000|STARTED|Overall Study||12
11370851|NCT03287310|12566903|FG001|STARTED|Overall Study||6
11370852|NCT03287310|12566904|FG002|STARTED|Overall Study||6
11370853|NCT03287310|12566905|FG003|STARTED|Overall Study||9
11370854|NCT03287310|12566906|FG004|STARTED|Overall Study||9
11370855|NCT03287310|12566907|FG005|STARTED|Overall Study||6
11005704|NCT00724126|12183423|FG000|STARTED|Overall Study||321
11370856|NCT03287310|12566902|FG000|COMPLETED|Overall Study||12
11370857|NCT03287310|12566903|FG001|COMPLETED|Overall Study||6
11370858|NCT03287310|12566904|FG002|COMPLETED|Overall Study||6
11370859|NCT03287310|12566905|FG003|COMPLETED|Overall Study||9
11370860|NCT03287310|12566906|FG004|COMPLETED|Overall Study||9
11370861|NCT03287310|12566907|FG005|COMPLETED|Overall Study||6
11370862|NCT03287310|12566902|FG000|NOT COMPLETED|Overall Study||0
11370863|NCT03287310|12566903|FG001|NOT COMPLETED|Overall Study||0
11370864|NCT03287310|12566904|FG002|NOT COMPLETED|Overall Study||0
11370865|NCT03287310|12566905|FG003|NOT COMPLETED|Overall Study||0
11370866|NCT03287310|12566906|FG004|NOT COMPLETED|Overall Study||0
11370867|NCT03287310|12566907|FG005|NOT COMPLETED|Overall Study||0
11370868|NCT03287622|12566931|FG000|STARTED|Overall Study||356
11370869|NCT03287622|12566932|FG001|STARTED|Overall Study||356
11370870|NCT03287622|12566931|FG000|Sub-randomized to Nudge/NoNudge|Overall Study||253
11370871|NCT03287622|12566932|FG001|Sub-randomized to Nudge/NoNudge|Overall Study||266
11370872|NCT03287622|12566931|FG000|COMPLETED|Overall Study||298
11370873|NCT03287622|12566932|FG001|COMPLETED|Overall Study||308
11370874|NCT03287622|12566931|FG000|NOT COMPLETED|Overall Study||58
11370875|NCT03287622|12566932|FG001|NOT COMPLETED|Overall Study||48
11370876|NCT03287635|12566945|FG000|STARTED|Overall Study||19
11370877|NCT03287635|12566945|FG000|COMPLETED|Overall Study||12
11370878|NCT03287635|12566945|FG000|NOT COMPLETED|Overall Study||7
11370879|NCT03287674|12566949|FG000|STARTED|Overall Study||7
11370880|NCT03287674|12566949|FG000|All Treated With TILs|Overall Study||6
11370881|NCT03287674|12566949|FG000|COMPLETED|Overall Study||6
11370882|NCT03287674|12566949|FG000|NOT COMPLETED|Overall Study||1
11370883|NCT03287791|12566957|FG000|STARTED|Overall Study||312
11370884|NCT03287791|12566958|FG001|STARTED|Overall Study||312
11370885|NCT03287791|12566959|FG002|STARTED|Overall Study||300
11370886|NCT03287791|12566957|FG000|Safety Population|Overall Study||306
11370887|NCT03287791|12566958|FG001|Safety Population|Overall Study||297
11370888|NCT03287791|12566959|FG002|Safety Population|Overall Study||291
11370889|NCT03287791|12566957|FG000|mITT Population|Overall Study||291
11370890|NCT03287791|12566958|FG001|mITT Population|Overall Study||291
11370891|NCT03287791|12566959|FG002|mITT Population|Overall Study||283
11370892|NCT03287791|12566957|FG000|PP Population|Overall Study||262
11370893|NCT03287791|12566958|FG001|PP Population|Overall Study||259
11370894|NCT03287791|12566959|FG002|PP Population|Overall Study||245
11370895|NCT03287791|12566957|FG000|COMPLETED|Overall Study||280
11370896|NCT03287791|12566958|FG001|COMPLETED|Overall Study||276
11370897|NCT03287791|12566959|FG002|COMPLETED|Overall Study||264
11370898|NCT03287791|12566957|FG000|NOT COMPLETED|Overall Study||32
11370899|NCT03287791|12566958|FG001|NOT COMPLETED|Overall Study||36
11370900|NCT03287791|12566959|FG002|NOT COMPLETED|Overall Study||36
11370901|NCT03287804|12566967|FG000|STARTED|Overall Study||12
11370902|NCT03287804|12566967|FG000|Leukaperesed|Overall Study||12
11370903|NCT03287804|12566967|FG000|Started Pre-conditioning Therapy|Overall Study||11
11370904|NCT03287804|12566967|FG000|Received Study Treatment|Overall Study||11
11370905|NCT03287804|12566967|FG000|COMPLETED|Overall Study||1
11370906|NCT03287804|12566967|FG000|NOT COMPLETED|Overall Study||11
11370907|NCT03287869|12566974|FG000|STARTED|Overall Study||188
11005705|NCT00724126|12183424|FG001|STARTED|Overall Study||316
11005706|NCT00724126|12183423|FG000|COMPLETED|Overall Study||302
11005707|NCT00724126|12183424|FG001|COMPLETED|Overall Study||301
11005708|NCT00724126|12183423|FG000|NOT COMPLETED|Overall Study||19
11370908|NCT03287869|12566975|FG001|STARTED|Overall Study||193
11370909|NCT03287869|12566974|FG000|Analyzed For Safety (Safety Sample)|Overall Study||184
11370910|NCT03287869|12566975|FG001|Analyzed For Safety (Safety Sample)|Overall Study||184
11370911|NCT03287869|12566974|FG000|COMPLETED|Overall Study||105
11370912|NCT03287869|12566975|FG001|COMPLETED|Overall Study||100
11370913|NCT03287869|12566974|FG000|NOT COMPLETED|Overall Study||83
11370914|NCT03287869|12566975|FG001|NOT COMPLETED|Overall Study||93
11370915|NCT03288714|12566983|FG000|STARTED|Overall Study||59
11370916|NCT03288714|12566984|FG001|STARTED|Overall Study||62
11370917|NCT03288714|12566983|FG000|COMPLETED|Overall Study||49
11370918|NCT03288714|12566984|FG001|COMPLETED|Overall Study||59
11370919|NCT03288714|12566983|FG000|NOT COMPLETED|Overall Study||10
11370920|NCT03288714|12566984|FG001|NOT COMPLETED|Overall Study||3
11370921|NCT03288779|12566992|FG000|STARTED|Overall Study||6
11370922|NCT03288779|12566992|FG000|COMPLETED|Overall Study||3
11370923|NCT03288779|12566992|FG000|NOT COMPLETED|Overall Study||3
11370924|NCT03288987|12566998|FG000|STARTED|Overall Study||82
11370925|NCT03288987|12566999|FG001|STARTED|Overall Study||44
11370926|NCT03288987|12566998|FG000|Patients Receiving Medication|Overall Study||80
11370927|NCT03288987|12566999|FG001|Patients Receiving Medication|Overall Study||44
11370928|NCT03288987|12566998|FG000|COMPLETED|Overall Study|Per protocol population|72
11370929|NCT03288987|12566999|FG001|COMPLETED|Overall Study|Per protocol population|40
11370930|NCT03288987|12566998|FG000|NOT COMPLETED|Overall Study||10
11370931|NCT03288987|12566999|FG001|NOT COMPLETED|Overall Study||4
11370932|NCT03289208|12567008|FG000|STARTED|Overall Study||11
11370933|NCT03289208|12567009|FG001|STARTED|Overall Study||8
11370934|NCT03289208|12567010|FG002|STARTED|Overall Study||11
11370935|NCT03289208|12567008|FG000|COMPLETED|Overall Study||10
11370936|NCT03289208|12567009|FG001|COMPLETED|Overall Study||8
11370937|NCT03289208|12567010|FG002|COMPLETED|Overall Study||11
11370938|NCT03289208|12567008|FG000|NOT COMPLETED|Overall Study||1
11370939|NCT03289208|12567009|FG001|NOT COMPLETED|Overall Study||0
11370940|NCT03289208|12567010|FG002|NOT COMPLETED|Overall Study||0
11370941|NCT03289234|12567021|FG000|STARTED|Overall Study||8
11370942|NCT03289234|12567022|FG001|STARTED|Overall Study||6
11370943|NCT03289234|12567023|FG002|STARTED|Overall Study||8
11370944|NCT03289234|12567021|FG000|COMPLETED|Overall Study||8
11370945|NCT03289234|12567022|FG001|COMPLETED|Overall Study||6
11370946|NCT03289234|12567023|FG002|COMPLETED|Overall Study||8
11370947|NCT03289234|12567021|FG000|NOT COMPLETED|Overall Study||0
11370948|NCT03289234|12567022|FG001|NOT COMPLETED|Overall Study||0
11370949|NCT03289234|12567023|FG002|NOT COMPLETED|Overall Study||0
11370950|NCT03289455|12567034|FG000|STARTED|Overall Study||4
11370951|NCT03289455|12567035|FG001|STARTED|Overall Study||5
11370952|NCT03289455|12567036|FG002|STARTED|Overall Study||6
11370953|NCT03289455|12567034|FG000|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
11370954|NCT03289455|12567035|FG001|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
11370955|NCT03289455|12567036|FG002|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
11370956|NCT03289455|12567034|FG000|NOT COMPLETED|Overall Study||4
11370957|NCT03289455|12567035|FG001|NOT COMPLETED|Overall Study||5
11370958|NCT03289455|12567036|FG002|NOT COMPLETED|Overall Study||6
11370959|NCT03289481|12567047|FG000|STARTED|Overall Study||6
11370960|NCT03289481|12567048|FG001|STARTED|Overall Study||7
11370961|NCT03289481|12567047|FG000|COMPLETED|Overall Study||4
11370962|NCT03289481|12567048|FG001|COMPLETED|Overall Study||5
11370963|NCT03289481|12567047|FG000|NOT COMPLETED|Overall Study||2
11370964|NCT03289481|12567048|FG001|NOT COMPLETED|Overall Study||2
11370965|NCT03289533|12567055|FG000|STARTED|Overall Study||22
11370966|NCT03289533|12567055|FG000|COMPLETED|Overall Study||0
11370967|NCT03289533|12567055|FG000|NOT COMPLETED|Overall Study||22
11370968|NCT03289676|12567061|FG000|STARTED|Overall Study||27
11370969|NCT03289676|12567062|FG001|STARTED|Overall Study||26
11370970|NCT03289676|12567061|FG000|COMPLETED|Overall Study||23
11370971|NCT03289676|12567062|FG001|COMPLETED|Overall Study|Received 80% of the allotted intervention|25
11370972|NCT03289676|12567061|FG000|NOT COMPLETED|Overall Study||4
11370973|NCT03289676|12567062|FG001|NOT COMPLETED|Overall Study||1
11370974|NCT03289858|12567070|FG000|STARTED|Overall Study||27
11370975|NCT03289858|12567071|FG001|STARTED|Overall Study||28
11370976|NCT03289858|12567070|FG000|COMPLETED|Overall Study||25
11370977|NCT03289858|12567071|FG001|COMPLETED|Overall Study||28
11370978|NCT03289858|12567070|FG000|NOT COMPLETED|Overall Study||2
11370979|NCT03289858|12567071|FG001|NOT COMPLETED|Overall Study||0
11370980|NCT03290027|12567079|FG000|STARTED|Overall Study||277
11370981|NCT03290027|12567080|FG001|STARTED|Overall Study||273
11370982|NCT03290027|12567079|FG000|COMPLETED|Overall Study||219
11370983|NCT03290027|12567080|FG001|COMPLETED|Overall Study||228
11370984|NCT03290027|12567079|FG000|NOT COMPLETED|Overall Study||58
11370985|NCT03290027|12567080|FG001|NOT COMPLETED|Overall Study||45
11370986|NCT03290378|12567089|FG000|STARTED|Overall Study||140
11370987|NCT03290378|12567090|FG001|STARTED|Overall Study||133
11370988|NCT03290378|12567091|FG002|STARTED|Overall Study||136
11370989|NCT03290378|12567089|FG000|COMPLETED|Overall Study||137
11370990|NCT03290378|12567090|FG001|COMPLETED|Overall Study||123
11370991|NCT03290378|12567091|FG002|COMPLETED|Overall Study||120
11370992|NCT03290378|12567089|FG000|NOT COMPLETED|Overall Study||3
11370993|NCT03290378|12567090|FG001|NOT COMPLETED|Overall Study||10
11370994|NCT03290378|12567091|FG002|NOT COMPLETED|Overall Study||16
11370995|NCT03290768|12567099|FG000|STARTED|Overall Study||358
11370996|NCT03290768|12567099|FG000|COMPLETED|Overall Study||193
11370997|NCT03290768|12567099|FG000|NOT COMPLETED|Overall Study||165
11370998|NCT03291041|12567105|FG000|STARTED|Overall Study||13
11370999|NCT03291041|12567106|FG001|STARTED|Overall Study||12
11371000|NCT03291041|12567105|FG000|COMPLETED|Overall Study||13
11371001|NCT03291041|12567106|FG001|COMPLETED|Overall Study||12
11371002|NCT03291041|12567105|FG000|NOT COMPLETED|Overall Study||0
11371003|NCT03291041|12567106|FG001|NOT COMPLETED|Overall Study||0
11371004|NCT03291080|12567114|FG000|STARTED|First Cycle (2 Weeks)||11
11371005|NCT03291080|12567115|FG001|STARTED|First Cycle (2 Weeks)||9
11371006|NCT03291080|12567114|FG000|COMPLETED|First Cycle (2 Weeks)||11
11371007|NCT03291080|12567115|FG001|COMPLETED|First Cycle (2 Weeks)||9
11371008|NCT03291080|12567114|FG000|NOT COMPLETED|First Cycle (2 Weeks)||0
11371009|NCT03291080|12567115|FG001|NOT COMPLETED|First Cycle (2 Weeks)||0
11371010|NCT03291080|12567114|FG000|STARTED|Washout (2 Weeks)||11
11371011|NCT03291080|12567115|FG001|STARTED|Washout (2 Weeks)||9
11371012|NCT03291080|12567114|FG000|COMPLETED|Washout (2 Weeks)||11
11371013|NCT03291080|12567115|FG001|COMPLETED|Washout (2 Weeks)||9
11371014|NCT03291080|12567114|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11371015|NCT03291080|12567115|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11371016|NCT03291080|12567114|FG000|STARTED|Second Cylcle (2 Weeks)||9
11371017|NCT03291080|12567115|FG001|STARTED|Second Cylcle (2 Weeks)||11
11371018|NCT03291080|12567114|FG000|COMPLETED|Second Cylcle (2 Weeks)||8
11371019|NCT03291080|12567115|FG001|COMPLETED|Second Cylcle (2 Weeks)||11
11371020|NCT03291080|12567114|FG000|NOT COMPLETED|Second Cylcle (2 Weeks)||1
11371021|NCT03291080|12567115|FG001|NOT COMPLETED|Second Cylcle (2 Weeks)||0
11371022|NCT03291197|12567122|FG000|STARTED|Overall Study||5
11371023|NCT03291197|12567122|FG000|COMPLETED|Overall Study||5
11371024|NCT03291197|12567122|FG000|NOT COMPLETED|Overall Study||0
11371025|NCT03291288|12567130|FG000|STARTED|Drug-drug Interaction Phase||32
11371026|NCT03291288|12567131|FG001|STARTED|Drug-drug Interaction Phase||0
11371027|NCT03291288|12567130|FG000|COMPLETED|Drug-drug Interaction Phase||26
11371028|NCT03291288|12567131|FG001|COMPLETED|Drug-drug Interaction Phase||0
11371029|NCT03291288|12567130|FG000|NOT COMPLETED|Drug-drug Interaction Phase||6
11371030|NCT03291288|12567131|FG001|NOT COMPLETED|Drug-drug Interaction Phase||0
11371031|NCT03291288|12567130|FG000|STARTED|Pexidartinib Only|This is a crossover trial; participants who completed Part 1 continued to Part 2.|0
11371032|NCT03291288|12567131|FG001|STARTED|Pexidartinib Only||26
11371033|NCT03291288|12567130|FG000|COMPLETED|Pexidartinib Only||0
11371034|NCT03291288|12567131|FG001|COMPLETED|Pexidartinib Only||24
11371035|NCT03291288|12567130|FG000|NOT COMPLETED|Pexidartinib Only||0
11371036|NCT03291288|12567131|FG001|NOT COMPLETED|Pexidartinib Only||2
11371037|NCT03291379|12567145|FG000|STARTED|Overall Study||8
11371038|NCT03291379|12567145|FG000|COMPLETED|Overall Study||8
11371039|NCT03291379|12567145|FG000|NOT COMPLETED|Overall Study||0
11371040|NCT03291613|12567150|FG000|STARTED|Overall Study||13
11371041|NCT03291613|12567150|FG000|COMPLETED|Overall Study||12
11371042|NCT03291613|12567150|FG000|NOT COMPLETED|Overall Study||1
11371043|NCT03292016|12567160|FG000|STARTED|First Intervention||1
11371044|NCT03292016|12567161|FG001|STARTED|First Intervention||1
11371045|NCT03292016|12567162|FG002|STARTED|First Intervention||2
11371046|NCT03292016|12567163|FG003|STARTED|First Intervention||1
11371047|NCT03292016|12567164|FG004|STARTED|First Intervention||1
11371048|NCT03292016|12567165|FG005|STARTED|First Intervention||2
11371049|NCT03292016|12567160|FG000|COMPLETED|First Intervention||1
11371050|NCT03292016|12567161|FG001|COMPLETED|First Intervention||1
11371051|NCT03292016|12567162|FG002|COMPLETED|First Intervention||2
11371052|NCT03292016|12567163|FG003|COMPLETED|First Intervention||1
11371053|NCT03292016|12567164|FG004|COMPLETED|First Intervention||1
11371054|NCT03292016|12567165|FG005|COMPLETED|First Intervention||2
11371055|NCT03292016|12567160|FG000|NOT COMPLETED|First Intervention||0
11371056|NCT03292016|12567161|FG001|NOT COMPLETED|First Intervention||0
11371057|NCT03292016|12567162|FG002|NOT COMPLETED|First Intervention||0
11371058|NCT03292016|12567163|FG003|NOT COMPLETED|First Intervention||0
11371059|NCT03292016|12567164|FG004|NOT COMPLETED|First Intervention||0
11371060|NCT03292016|12567165|FG005|NOT COMPLETED|First Intervention||0
11371061|NCT03292016|12567160|FG000|STARTED|First Washout||1
11371062|NCT03292016|12567161|FG001|STARTED|First Washout||1
11371063|NCT03292016|12567162|FG002|STARTED|First Washout||2
11371064|NCT03292016|12567163|FG003|STARTED|First Washout||1
11371065|NCT03292016|12567164|FG004|STARTED|First Washout||1
11371066|NCT03292016|12567165|FG005|STARTED|First Washout||2
11371067|NCT03292016|12567160|FG000|COMPLETED|First Washout||1
11371068|NCT03292016|12567161|FG001|COMPLETED|First Washout||1
11371069|NCT03292016|12567162|FG002|COMPLETED|First Washout||2
11371070|NCT03292016|12567163|FG003|COMPLETED|First Washout||1
11371071|NCT03292016|12567164|FG004|COMPLETED|First Washout||1
11371072|NCT03292016|12567165|FG005|COMPLETED|First Washout||2
11371073|NCT03292016|12567160|FG000|NOT COMPLETED|First Washout||0
11371074|NCT03292016|12567161|FG001|NOT COMPLETED|First Washout||0
11371075|NCT03292016|12567162|FG002|NOT COMPLETED|First Washout||0
11371076|NCT03292016|12567163|FG003|NOT COMPLETED|First Washout||0
11371077|NCT03292016|12567164|FG004|NOT COMPLETED|First Washout||0
11371078|NCT03292016|12567165|FG005|NOT COMPLETED|First Washout||0
11371079|NCT03292016|12567160|FG000|STARTED|Second Intervention||1
11371080|NCT03292016|12567161|FG001|STARTED|Second Intervention||1
11371081|NCT03292016|12567162|FG002|STARTED|Second Intervention||2
11371082|NCT03292016|12567163|FG003|STARTED|Second Intervention||1
11371083|NCT03292016|12567164|FG004|STARTED|Second Intervention||1
11371084|NCT03292016|12567165|FG005|STARTED|Second Intervention||2
11371085|NCT03292016|12567160|FG000|COMPLETED|Second Intervention||1
11371086|NCT03292016|12567161|FG001|COMPLETED|Second Intervention||1
11371087|NCT03292016|12567162|FG002|COMPLETED|Second Intervention||2
11371088|NCT03292016|12567163|FG003|COMPLETED|Second Intervention||1
11371089|NCT03292016|12567164|FG004|COMPLETED|Second Intervention||1
11371090|NCT03292016|12567165|FG005|COMPLETED|Second Intervention||2
11371091|NCT03292016|12567160|FG000|NOT COMPLETED|Second Intervention||0
11371092|NCT03292016|12567161|FG001|NOT COMPLETED|Second Intervention||0
11371093|NCT03292016|12567162|FG002|NOT COMPLETED|Second Intervention||0
11371094|NCT03292016|12567163|FG003|NOT COMPLETED|Second Intervention||0
11371095|NCT03292016|12567164|FG004|NOT COMPLETED|Second Intervention||0
11371096|NCT03292016|12567165|FG005|NOT COMPLETED|Second Intervention||0
11371097|NCT03292016|12567160|FG000|STARTED|Second Washout||1
11371098|NCT03292016|12567161|FG001|STARTED|Second Washout||1
11371099|NCT03292016|12567162|FG002|STARTED|Second Washout||2
11371100|NCT03292016|12567163|FG003|STARTED|Second Washout||1
11371101|NCT03292016|12567164|FG004|STARTED|Second Washout||1
11371102|NCT03292016|12567165|FG005|STARTED|Second Washout||2
11371103|NCT03292016|12567160|FG000|COMPLETED|Second Washout||1
11371104|NCT03292016|12567161|FG001|COMPLETED|Second Washout||0
11371105|NCT03292016|12567162|FG002|COMPLETED|Second Washout||2
11371106|NCT03292016|12567163|FG003|COMPLETED|Second Washout||1
11371107|NCT03292016|12567164|FG004|COMPLETED|Second Washout||1
11371108|NCT03292016|12567165|FG005|COMPLETED|Second Washout||2
11371109|NCT03292016|12567160|FG000|NOT COMPLETED|Second Washout||0
11371110|NCT03292016|12567161|FG001|NOT COMPLETED|Second Washout||1
11371111|NCT03292016|12567162|FG002|NOT COMPLETED|Second Washout||0
11371112|NCT03292016|12567163|FG003|NOT COMPLETED|Second Washout||0
11371113|NCT03292016|12567164|FG004|NOT COMPLETED|Second Washout||0
11371114|NCT03292016|12567165|FG005|NOT COMPLETED|Second Washout||0
11371115|NCT03292016|12567160|FG000|STARTED|Third Intervention||1
11371116|NCT03292016|12567161|FG001|STARTED|Third Intervention||0
11371117|NCT03292016|12567162|FG002|STARTED|Third Intervention||2
11371118|NCT03292016|12567163|FG003|STARTED|Third Intervention||1
11371119|NCT03292016|12567164|FG004|STARTED|Third Intervention||1
11371120|NCT03292016|12567165|FG005|STARTED|Third Intervention||2
11371121|NCT03292016|12567160|FG000|COMPLETED|Third Intervention||1
11371122|NCT03292016|12567161|FG001|COMPLETED|Third Intervention||0
11371123|NCT03292016|12567162|FG002|COMPLETED|Third Intervention||2
11371124|NCT03292016|12567163|FG003|COMPLETED|Third Intervention||1
11371125|NCT03292016|12567164|FG004|COMPLETED|Third Intervention||1
11371126|NCT03292016|12567165|FG005|COMPLETED|Third Intervention||2
11371127|NCT03292016|12567160|FG000|NOT COMPLETED|Third Intervention||0
11371128|NCT03292016|12567161|FG001|NOT COMPLETED|Third Intervention||0
11371129|NCT03292016|12567162|FG002|NOT COMPLETED|Third Intervention||0
11371130|NCT03292016|12567163|FG003|NOT COMPLETED|Third Intervention||0
11371131|NCT03292016|12567164|FG004|NOT COMPLETED|Third Intervention||0
11371132|NCT03292016|12567165|FG005|NOT COMPLETED|Third Intervention||0
11371133|NCT03292406|12567176|FG000|STARTED|Overall Study||30
11371134|NCT03292406|12567177|FG001|STARTED|Overall Study||28
11371135|NCT03292406|12567178|FG002|STARTED|Overall Study||28
11371136|NCT03292406|12567176|FG000|Participants Treated|Overall Study||30
11371137|NCT03292406|12567177|FG001|Participants Treated|Overall Study||28
11371138|NCT03292406|12567178|FG002|Participants Treated|Overall Study||27
11371139|NCT03292406|12567176|FG000|COMPLETED|Overall Study||17
11371140|NCT03292406|12567177|FG001|COMPLETED|Overall Study||15
11371141|NCT03292406|12567178|FG002|COMPLETED|Overall Study||15
11371142|NCT03292406|12567176|FG000|NOT COMPLETED|Overall Study||13
11371143|NCT03292406|12567177|FG001|NOT COMPLETED|Overall Study||13
11371144|NCT03292406|12567178|FG002|NOT COMPLETED|Overall Study||13
11371145|NCT03292432|12567188|FG000|STARTED|Overall Study||46
11371146|NCT03292432|12567189|FG001|STARTED|Overall Study||43
11371147|NCT03292432|12567188|FG000|Started Study Intervention|Overall Study||45
11371148|NCT03292432|12567189|FG001|Started Study Intervention|Overall Study||43
11371149|NCT03292432|12567188|FG000|COMPLETED|Overall Study||31
11371150|NCT03292432|12567189|FG001|COMPLETED|Overall Study||32
11371151|NCT03292432|12567188|FG000|NOT COMPLETED|Overall Study||15
11371152|NCT03292432|12567189|FG001|NOT COMPLETED|Overall Study||11
11371153|NCT03292562|12567197|FG000|STARTED|Overall Study||35
11371154|NCT03292562|12567198|FG001|STARTED|Overall Study||31
11371155|NCT03292562|12567197|FG000|COMPLETED|Overall Study||29
11371156|NCT03292562|12567198|FG001|COMPLETED|Overall Study||30
11371157|NCT03292562|12567197|FG000|NOT COMPLETED|Overall Study||6
11371158|NCT03292562|12567198|FG001|NOT COMPLETED|Overall Study||1
11371159|NCT03292614|12567204|FG000|STARTED|Overall Study||25
11371160|NCT03292614|12567204|FG000|COMPLETED|Overall Study||25
11371161|NCT03292614|12567204|FG000|NOT COMPLETED|Overall Study||0
11371162|NCT03292640|12567210|FG000|STARTED|Overall Study||275
11371163|NCT03292640|12567211|FG001|STARTED|Overall Study||272
11371164|NCT03292640|12567210|FG000|COMPLETED|Overall Study||214
11371165|NCT03292640|12567211|FG001|COMPLETED|Overall Study||230
11371166|NCT03292640|12567210|FG000|NOT COMPLETED|Overall Study||61
11371167|NCT03292640|12567211|FG001|NOT COMPLETED|Overall Study||42
11371168|NCT03292653|12567224|FG000|STARTED|Overall Study||11
11371169|NCT03292653|12567225|FG001|STARTED|Overall Study||10
11371170|NCT03292653|12567226|FG002|STARTED|Overall Study||11
11371171|NCT03292653|12567224|FG000|COMPLETED|Overall Study||10
11371172|NCT03292653|12567225|FG001|COMPLETED|Overall Study||10
11371173|NCT03292653|12567226|FG002|COMPLETED|Overall Study||10
11371174|NCT03292653|12567224|FG000|NOT COMPLETED|Overall Study||1
11371175|NCT03292653|12567225|FG001|NOT COMPLETED|Overall Study||0
11371176|NCT03292653|12567226|FG002|NOT COMPLETED|Overall Study||1
11371177|NCT03292692|12567237|FG000|STARTED|Overall Study||302
11371178|NCT03292692|12567238|FG001|STARTED|Overall Study||298
11371179|NCT03292692|12567237|FG000|COMPLETED|Overall Study||264
11371180|NCT03292692|12567238|FG001|COMPLETED|Overall Study||260
11371181|NCT03292692|12567237|FG000|NOT COMPLETED|Overall Study||38
11371182|NCT03292692|12567238|FG001|NOT COMPLETED|Overall Study||38
11371183|NCT03292809|12567246|FG000|STARTED|Overall Study||162
11371184|NCT03292809|12567247|FG001|STARTED|Overall Study||166
11371185|NCT03292809|12567246|FG000|COMPLETED|Overall Study||155
11371186|NCT03292809|12567247|FG001|COMPLETED|Overall Study||163
11371187|NCT03292809|12567246|FG000|NOT COMPLETED|Overall Study||7
11371188|NCT03292809|12567247|FG001|NOT COMPLETED|Overall Study||3
11371189|NCT03292952|12567255|FG000|STARTED|Open-Label Dose Optimization||155
11371190|NCT03292952|12567256|FG001|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
11371191|NCT03292952|12567257|FG002|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
11371192|NCT03292952|12567255|FG000|COMPLETED|Open-Label Dose Optimization||150
11371193|NCT03292952|12567256|FG001|COMPLETED|Open-Label Dose Optimization||0
11371194|NCT03292952|12567257|FG002|COMPLETED|Open-Label Dose Optimization||0
11371195|NCT03292952|12567255|FG000|NOT COMPLETED|Open-Label Dose Optimization||5
11371196|NCT03292952|12567256|FG001|NOT COMPLETED|Open-Label Dose Optimization||0
11371197|NCT03292952|12567257|FG002|NOT COMPLETED|Open-Label Dose Optimization||0
11371198|NCT03292952|12567255|FG000|STARTED|Double-Blind Treatment Phase|Subjects were randomized to the double-blind Treatment Phase after Open-Label Dose Optimization|0
11371199|NCT03292952|12567256|FG001|STARTED|Double-Blind Treatment Phase||74
11371200|NCT03292952|12567257|FG002|STARTED|Double-Blind Treatment Phase||76
11371201|NCT03292952|12567255|FG000|COMPLETED|Double-Blind Treatment Phase||0
11371202|NCT03292952|12567256|FG001|COMPLETED|Double-Blind Treatment Phase||74
11371203|NCT03292952|12567257|FG002|COMPLETED|Double-Blind Treatment Phase||75
11371204|NCT03292952|12567255|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
11371205|NCT03292952|12567256|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0
11371206|NCT03292952|12567257|FG002|NOT COMPLETED|Double-Blind Treatment Phase||1
11371207|NCT03293394|12567268|FG000|STARTED|First Intervention (2 Weeks)||20
11371208|NCT03293394|12567269|FG001|STARTED|First Intervention (2 Weeks)||10
11371209|NCT03293394|12567268|FG000|COMPLETED|First Intervention (2 Weeks)||20
11371210|NCT03293394|12567269|FG001|COMPLETED|First Intervention (2 Weeks)||10
11371211|NCT03293394|12567268|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
11371212|NCT03293394|12567269|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
11371213|NCT03293394|12567268|FG000|STARTED|Follow-up (6 Months)||20
11371214|NCT03293394|12567269|FG001|STARTED|Follow-up (6 Months)||10
11371215|NCT03293394|12567268|FG000|COMPLETED|Follow-up (6 Months)||16
11371216|NCT03293394|12567269|FG001|COMPLETED|Follow-up (6 Months)||8
11371217|NCT03293394|12567268|FG000|NOT COMPLETED|Follow-up (6 Months)||4
11371218|NCT03293394|12567269|FG001|NOT COMPLETED|Follow-up (6 Months)||2
11371219|NCT03293485|12567275|FG000|STARTED|Overall Study||83
11371220|NCT03293485|12567275|FG000|Treated|Overall Study||81
11371221|NCT03293485|12567275|FG000|COMPLETED|Overall Study||78
11371222|NCT03293485|12567275|FG000|NOT COMPLETED|Overall Study||5
11371223|NCT03293654|12567284|FG000|STARTED|Overall Study||38
11371224|NCT03293654|12567285|FG001|STARTED|Overall Study||38
11371225|NCT03293654|12567286|FG002|STARTED|Overall Study||38
11371226|NCT03293654|12567284|FG000|COMPLETED|Overall Study||38
11371227|NCT03293654|12567285|FG001|COMPLETED|Overall Study||37
11371228|NCT03293654|12567286|FG002|COMPLETED|Overall Study||38
11371229|NCT03293654|12567284|FG000|NOT COMPLETED|Overall Study||0
11371230|NCT03293654|12567285|FG001|NOT COMPLETED|Overall Study||1
11371231|NCT03293654|12567286|FG002|NOT COMPLETED|Overall Study||0
11371232|NCT03294213|12567294|FG000|STARTED|Overall Study||176
11371233|NCT03294213|12567294|FG000|COMPLETED|Overall Study||176
11371234|NCT03294213|12567294|FG000|NOT COMPLETED|Overall Study||0
11371235|NCT03294317|12567298|FG000|STARTED|Overall Study||70
11371236|NCT03294317|12567298|FG000|Implanted With Lead at HIS Bundle|Overall Study||61
11371237|NCT03294317|12567298|FG000|Subjects With Available CT|Overall Study||51
11371238|NCT03294317|12567298|FG000|COMPLETED|Overall Study||50
11371239|NCT03294317|12567298|FG000|NOT COMPLETED|Overall Study||20
11371240|NCT03294538|12567305|FG000|STARTED|Overall Study||268
11371241|NCT03294538|12567306|FG001|STARTED|Overall Study||262
11371242|NCT03294538|12567307|FG002|STARTED|Overall Study||133
11371243|NCT03294538|12567305|FG000|Safety Population|Overall Study||267
11371244|NCT03294538|12567306|FG001|Safety Population|Overall Study||262
11371245|NCT03294538|12567307|FG002|Safety Population|Overall Study||132
11371246|NCT03294538|12567305|FG000|mITT Population|Overall Study||267
11371247|NCT03294538|12567306|FG001|mITT Population|Overall Study||262
11371248|NCT03294538|12567307|FG002|mITT Population|Overall Study||132
11371249|NCT03294538|12567305|FG000|PP Population|Overall Study||244
11371250|NCT03294538|12567306|FG001|PP Population|Overall Study||227
11371251|NCT03294538|12567307|FG002|PP Population|Overall Study||126
11371252|NCT03294538|12567305|FG000|COMPLETED|Overall Study||263
11371253|NCT03294538|12567306|FG001|COMPLETED|Overall Study||257
11371254|NCT03294538|12567307|FG002|COMPLETED|Overall Study||131
11371255|NCT03294538|12567305|FG000|NOT COMPLETED|Overall Study||5
11371256|NCT03294538|12567306|FG001|NOT COMPLETED|Overall Study||5
11371257|NCT03294538|12567307|FG002|NOT COMPLETED|Overall Study||2
11371258|NCT03294629|12567317|FG000|STARTED|First Intervention (2 Weeks)||16
11371259|NCT03294629|12567318|FG001|STARTED|First Intervention (2 Weeks)||19
11371260|NCT03294629|12567317|FG000|COMPLETED|First Intervention (2 Weeks)||14
11371261|NCT03294629|12567318|FG001|COMPLETED|First Intervention (2 Weeks)||15
11371262|NCT03294629|12567317|FG000|NOT COMPLETED|First Intervention (2 Weeks)||2
11371263|NCT03294629|12567318|FG001|NOT COMPLETED|First Intervention (2 Weeks)||4
11371264|NCT03294629|12567317|FG000|STARTED|Second Intervention (2 Weeks)||14
11371265|NCT03294629|12567318|FG001|STARTED|Second Intervention (2 Weeks)||15
11371266|NCT03294629|12567317|FG000|COMPLETED|Second Intervention (2 Weeks)||12
11371267|NCT03294629|12567318|FG001|COMPLETED|Second Intervention (2 Weeks)||13
11371268|NCT03294629|12567317|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||2
11371269|NCT03294629|12567318|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||2
11371270|NCT03294681|12567324|FG000|STARTED|Overall Study||153
11371271|NCT03294681|12567324|FG000|COMPLETED|Overall Study||152
11371272|NCT03294681|12567324|FG000|NOT COMPLETED|Overall Study||1
11371273|NCT03294850|12567330|FG000|STARTED|Overall Study||4
11371274|NCT03294850|12567331|FG001|STARTED|Overall Study||10
11371275|NCT03294850|12567330|FG000|COMPLETED|Overall Study||4
11371276|NCT03294850|12567331|FG001|COMPLETED|Overall Study||10
11371277|NCT03294850|12567330|FG000|NOT COMPLETED|Overall Study||0
11371278|NCT03294850|12567331|FG001|NOT COMPLETED|Overall Study||0
11371279|NCT03294941|12567339|FG000|STARTED|Overall Study||4
11371280|NCT03294941|12567340|FG001|STARTED|Overall Study||13
11371281|NCT03294941|12567339|FG000|COMPLETED|Overall Study||4
11371282|NCT03294941|12567340|FG001|COMPLETED|Overall Study||11
11371283|NCT03294941|12567339|FG000|NOT COMPLETED|Overall Study||0
11371284|NCT03294941|12567340|FG001|NOT COMPLETED|Overall Study||2
11371285|NCT03295201|12567349|FG000|STARTED|Overall Study||11
11371286|NCT03295201|12567350|FG001|STARTED|Overall Study||11
11371287|NCT03295201|12567349|FG000|COMPLETED|Overall Study||10
11371288|NCT03295201|12567350|FG001|COMPLETED|Overall Study||9
11371289|NCT03295201|12567349|FG000|NOT COMPLETED|Overall Study||1
11371290|NCT03295201|12567350|FG001|NOT COMPLETED|Overall Study||2
11371291|NCT03295266|12567358|FG000|STARTED|Overall Study||5
11371292|NCT03295266|12567359|FG001|STARTED|Overall Study||4
11371293|NCT03295266|12567358|FG000|COMPLETED|Overall Study||5
11371294|NCT03295266|12567359|FG001|COMPLETED|Overall Study||4
11371295|NCT03295266|12567358|FG000|NOT COMPLETED|Overall Study||0
11371296|NCT03295266|12567359|FG001|NOT COMPLETED|Overall Study||0
11371297|NCT03295318|12567368|FG000|STARTED|Overall Study||150
11371298|NCT03295318|12567369|FG001|STARTED|Overall Study||150
11371299|NCT03295318|12567370|FG002|STARTED|Overall Study||76
11371300|NCT03295318|12567368|FG000|Received First Vaccination|Overall Study|1 subject withdrew consent after randomization, but prior to vaccination.|149
11371301|NCT03295318|12567369|FG001|Received First Vaccination|Overall Study||150
11371302|NCT03295318|12567370|FG002|Received First Vaccination|Overall Study||76
11371303|NCT03295318|12567368|FG000|Received Second Vaccination|Overall Study||144
11371304|NCT03295318|12567369|FG001|Received Second Vaccination|Overall Study||145
11371305|NCT03295318|12567370|FG002|Received Second Vaccination|Overall Study||73
11371306|NCT03295318|12567368|FG000|COMPLETED|Overall Study||144
11371307|NCT03295318|12567369|FG001|COMPLETED|Overall Study||145
11371308|NCT03295318|12567370|FG002|COMPLETED|Overall Study||71
11371309|NCT03295318|12567368|FG000|NOT COMPLETED|Overall Study||6
11371310|NCT03295318|12567369|FG001|NOT COMPLETED|Overall Study||5
11371311|NCT03295318|12567370|FG002|NOT COMPLETED|Overall Study||5
11371312|NCT03295630|12567396|FG000|STARTED|Overall Study||20
11371313|NCT03295630|12567396|FG000|COMPLETED|Overall Study||20
11371314|NCT03295630|12567396|FG000|NOT COMPLETED|Overall Study||0
11371315|NCT03295721|12567404|FG000|STARTED|Overall Study||157
11371316|NCT03295721|12567405|FG001|STARTED|Overall Study||100
11371317|NCT03295721|12567406|FG002|STARTED|Overall Study||155
11371318|NCT03295721|12567404|FG000|COMPLETED|Overall Study||154
11371319|NCT03295721|12567405|FG001|COMPLETED|Overall Study||99
11371320|NCT03295721|12567406|FG002|COMPLETED|Overall Study||152
11371321|NCT03295721|12567404|FG000|NOT COMPLETED|Overall Study||3
11371322|NCT03295721|12567405|FG001|NOT COMPLETED|Overall Study||1
11371323|NCT03295721|12567406|FG002|NOT COMPLETED|Overall Study||3
11371324|NCT03296072|12567415|FG000|STARTED|Treatment Period 1||10
11371325|NCT03296072|12567416|FG001|STARTED|Treatment Period 1||11
11371326|NCT03296072|12567417|FG002|STARTED|Treatment Period 1||10
11371327|NCT03296072|12567418|FG003|STARTED|Treatment Period 1||10
11371328|NCT03296072|12567419|FG004|STARTED|Treatment Period 1||10
11371329|NCT03296072|12567420|FG005|STARTED|Treatment Period 1||11
11371330|NCT03296072|12567415|FG000|COMPLETED|Treatment Period 1||10
11371331|NCT03296072|12567416|FG001|COMPLETED|Treatment Period 1||11
11371332|NCT03296072|12567417|FG002|COMPLETED|Treatment Period 1||10
11371333|NCT03296072|12567418|FG003|COMPLETED|Treatment Period 1||10
11371334|NCT03296072|12567419|FG004|COMPLETED|Treatment Period 1||10
11371335|NCT03296072|12567420|FG005|COMPLETED|Treatment Period 1||11
11371336|NCT03296072|12567415|FG000|NOT COMPLETED|Treatment Period 1||0
11371337|NCT03296072|12567416|FG001|NOT COMPLETED|Treatment Period 1||0
11371338|NCT03296072|12567417|FG002|NOT COMPLETED|Treatment Period 1||0
11371339|NCT03296072|12567418|FG003|NOT COMPLETED|Treatment Period 1||0
11371340|NCT03296072|12567419|FG004|NOT COMPLETED|Treatment Period 1||0
11371341|NCT03296072|12567420|FG005|NOT COMPLETED|Treatment Period 1||0
11371342|NCT03296072|12567415|FG000|STARTED|Treament Period 1: Wash Out Period||10
11371343|NCT03296072|12567416|FG001|STARTED|Treament Period 1: Wash Out Period||11
11371344|NCT03296072|12567417|FG002|STARTED|Treament Period 1: Wash Out Period||10
11371345|NCT03296072|12567418|FG003|STARTED|Treament Period 1: Wash Out Period||10
11371346|NCT03296072|12567419|FG004|STARTED|Treament Period 1: Wash Out Period||10
11371347|NCT03296072|12567420|FG005|STARTED|Treament Period 1: Wash Out Period||11
11371348|NCT03296072|12567415|FG000|COMPLETED|Treament Period 1: Wash Out Period||10
11371349|NCT03296072|12567416|FG001|COMPLETED|Treament Period 1: Wash Out Period||11
11371350|NCT03296072|12567417|FG002|COMPLETED|Treament Period 1: Wash Out Period||10
11371351|NCT03296072|12567418|FG003|COMPLETED|Treament Period 1: Wash Out Period||10
11371352|NCT03296072|12567419|FG004|COMPLETED|Treament Period 1: Wash Out Period||10
11371353|NCT03296072|12567420|FG005|COMPLETED|Treament Period 1: Wash Out Period||11
11371354|NCT03296072|12567415|FG000|NOT COMPLETED|Treament Period 1: Wash Out Period||0
11371355|NCT03296072|12567416|FG001|NOT COMPLETED|Treament Period 1: Wash Out Period||0
11371356|NCT03296072|12567417|FG002|NOT COMPLETED|Treament Period 1: Wash Out Period||0
11371357|NCT03296072|12567418|FG003|NOT COMPLETED|Treament Period 1: Wash Out Period||0
11371358|NCT03296072|12567419|FG004|NOT COMPLETED|Treament Period 1: Wash Out Period||0
11371359|NCT03296072|12567420|FG005|NOT COMPLETED|Treament Period 1: Wash Out Period||0
11371360|NCT03296072|12567415|FG000|STARTED|Treament Period 2||10
11371361|NCT03296072|12567416|FG001|STARTED|Treament Period 2||11
11371362|NCT03296072|12567417|FG002|STARTED|Treament Period 2||10
11371363|NCT03296072|12567418|FG003|STARTED|Treament Period 2||10
11371364|NCT03296072|12567419|FG004|STARTED|Treament Period 2||10
11371365|NCT03296072|12567420|FG005|STARTED|Treament Period 2||11
11371366|NCT03296072|12567415|FG000|COMPLETED|Treament Period 2||10
11371367|NCT03296072|12567416|FG001|COMPLETED|Treament Period 2||11
11371368|NCT03296072|12567417|FG002|COMPLETED|Treament Period 2||10
11371369|NCT03296072|12567418|FG003|COMPLETED|Treament Period 2||10
11371370|NCT03296072|12567419|FG004|COMPLETED|Treament Period 2||10
11371371|NCT03296072|12567420|FG005|COMPLETED|Treament Period 2||11
11371372|NCT03296072|12567415|FG000|NOT COMPLETED|Treament Period 2||0
11371373|NCT03296072|12567416|FG001|NOT COMPLETED|Treament Period 2||0
11371374|NCT03296072|12567417|FG002|NOT COMPLETED|Treament Period 2||0
11371375|NCT03296072|12567418|FG003|NOT COMPLETED|Treament Period 2||0
11371376|NCT03296072|12567419|FG004|NOT COMPLETED|Treament Period 2||0
11371377|NCT03296072|12567420|FG005|NOT COMPLETED|Treament Period 2||0
11371378|NCT03296072|12567415|FG000|STARTED|Treament Period 2: Wash Out Period||10
11371379|NCT03296072|12567416|FG001|STARTED|Treament Period 2: Wash Out Period||11
11371380|NCT03296072|12567417|FG002|STARTED|Treament Period 2: Wash Out Period||10
11371381|NCT03296072|12567418|FG003|STARTED|Treament Period 2: Wash Out Period||10
11371382|NCT03296072|12567419|FG004|STARTED|Treament Period 2: Wash Out Period||10
11371383|NCT03296072|12567420|FG005|STARTED|Treament Period 2: Wash Out Period||11
11371384|NCT03296072|12567415|FG000|COMPLETED|Treament Period 2: Wash Out Period||10
11371385|NCT03296072|12567416|FG001|COMPLETED|Treament Period 2: Wash Out Period||11
11371386|NCT03296072|12567417|FG002|COMPLETED|Treament Period 2: Wash Out Period||10
11371387|NCT03296072|12567418|FG003|COMPLETED|Treament Period 2: Wash Out Period||10
11371388|NCT03296072|12567419|FG004|COMPLETED|Treament Period 2: Wash Out Period||10
11371389|NCT03296072|12567420|FG005|COMPLETED|Treament Period 2: Wash Out Period||11
11371390|NCT03296072|12567415|FG000|NOT COMPLETED|Treament Period 2: Wash Out Period||0
11371391|NCT03296072|12567416|FG001|NOT COMPLETED|Treament Period 2: Wash Out Period||0
11371392|NCT03296072|12567417|FG002|NOT COMPLETED|Treament Period 2: Wash Out Period||0
11371393|NCT03296072|12567418|FG003|NOT COMPLETED|Treament Period 2: Wash Out Period||0
11371394|NCT03296072|12567419|FG004|NOT COMPLETED|Treament Period 2: Wash Out Period||0
11371395|NCT03296072|12567420|FG005|NOT COMPLETED|Treament Period 2: Wash Out Period||0
11371396|NCT03296072|12567415|FG000|STARTED|Treament Period 3||10
11371397|NCT03296072|12567416|FG001|STARTED|Treament Period 3||11
11371398|NCT03296072|12567417|FG002|STARTED|Treament Period 3||10
11371399|NCT03296072|12567418|FG003|STARTED|Treament Period 3||10
11371400|NCT03296072|12567419|FG004|STARTED|Treament Period 3||10
11371401|NCT03296072|12567420|FG005|STARTED|Treament Period 3||11
11371402|NCT03296072|12567415|FG000|COMPLETED|Treament Period 3||10
11371403|NCT03296072|12567416|FG001|COMPLETED|Treament Period 3||11
11371404|NCT03296072|12567417|FG002|COMPLETED|Treament Period 3||10
11371405|NCT03296072|12567418|FG003|COMPLETED|Treament Period 3||10
11371406|NCT03296072|12567419|FG004|COMPLETED|Treament Period 3||10
11371407|NCT03296072|12567420|FG005|COMPLETED|Treament Period 3||11
11371408|NCT03296072|12567415|FG000|NOT COMPLETED|Treament Period 3||0
11371409|NCT03296072|12567416|FG001|NOT COMPLETED|Treament Period 3||0
11371410|NCT03296072|12567417|FG002|NOT COMPLETED|Treament Period 3||0
11371411|NCT03296072|12567418|FG003|NOT COMPLETED|Treament Period 3||0
11371412|NCT03296072|12567419|FG004|NOT COMPLETED|Treament Period 3||0
11371413|NCT03296072|12567420|FG005|NOT COMPLETED|Treament Period 3||0
11371414|NCT03296163|12567430|FG000|STARTED|Combination Therapy||315
11371415|NCT03296163|12567431|FG001|STARTED|Combination Therapy||312
11371416|NCT03296163|12567430|FG000|COMPLETED|Combination Therapy||207
11371417|NCT03296163|12567431|FG001|COMPLETED|Combination Therapy||220
11371418|NCT03296163|12567430|FG000|NOT COMPLETED|Combination Therapy||108
11371419|NCT03296163|12567431|FG001|NOT COMPLETED|Combination Therapy||92
11371420|NCT03296163|12567430|FG000|STARTED|Monotherapy||207
11371421|NCT03296163|12567431|FG001|STARTED|Monotherapy||220
11371422|NCT03296163|12567430|FG000|COMPLETED|Monotherapy||68
11371423|NCT03296163|12567431|FG001|COMPLETED|Monotherapy||74
11371424|NCT03296163|12567430|FG000|NOT COMPLETED|Monotherapy||139
11371425|NCT03296163|12567431|FG001|NOT COMPLETED|Monotherapy||146
11371426|NCT03296280|12567439|FG000|STARTED|Overall Study||73
11371427|NCT03296280|12567440|FG001|STARTED|Overall Study||43
11371428|NCT03296280|12567439|FG000|COMPLETED|Overall Study||67
11371429|NCT03296280|12567440|FG001|COMPLETED|Overall Study||36
11371430|NCT03296280|12567439|FG000|NOT COMPLETED|Overall Study||6
11371431|NCT03296280|12567440|FG001|NOT COMPLETED|Overall Study||7
11371432|NCT03296345|12567446|FG000|STARTED|Overall Study||62
11371433|NCT03296345|12567446|FG000|COMPLETED|Overall Study||62
11371434|NCT03296345|12567446|FG000|NOT COMPLETED|Overall Study||0
11371435|NCT03296527|12567454|FG000|STARTED|Overall Study||500
11371436|NCT03296527|12567455|FG001|STARTED|Overall Study||511
11371437|NCT03296527|12567454|FG000|Full Analysis Set|Overall Study||499
11371438|NCT03296527|12567455|FG001|Full Analysis Set|Overall Study||510
11371439|NCT03296527|12567454|FG000|COMPLETED|Overall Study||465
11371440|NCT03296527|12567455|FG001|COMPLETED|Overall Study||458
11371441|NCT03296527|12567454|FG000|NOT COMPLETED|Overall Study||35
11371442|NCT03296527|12567455|FG001|NOT COMPLETED|Overall Study||53
11371443|NCT03296566|12567464|FG000|STARTED|Overall Study||145
11371444|NCT03296566|12567465|FG001|STARTED|Overall Study||152
11371445|NCT03296566|12567464|FG000|COMPLETED|Overall Study||126
11371446|NCT03296566|12567465|FG001|COMPLETED|Overall Study||103
11371447|NCT03296566|12567464|FG000|NOT COMPLETED|Overall Study||19
11371448|NCT03296566|12567465|FG001|NOT COMPLETED|Overall Study||49
11371449|NCT03296787|12567475|FG000|STARTED|Overall Study||8
11371450|NCT03296787|12567476|FG001|STARTED|Overall Study||8
11371451|NCT03296787|12567477|FG002|STARTED|Overall Study||9
11371452|NCT03296787|12567478|FG003|STARTED|Overall Study||7
11371453|NCT03296787|12567475|FG000|COMPLETED|Overall Study||8
11371454|NCT03296787|12567476|FG001|COMPLETED|Overall Study||8
11371455|NCT03296787|12567477|FG002|COMPLETED|Overall Study||9
11371456|NCT03296787|12567478|FG003|COMPLETED|Overall Study||7
11371457|NCT03296787|12567475|FG000|NOT COMPLETED|Overall Study||0
11371458|NCT03296787|12567476|FG001|NOT COMPLETED|Overall Study||0
11371459|NCT03296787|12567477|FG002|NOT COMPLETED|Overall Study||0
11371460|NCT03296787|12567478|FG003|NOT COMPLETED|Overall Study||0
11371461|NCT03296800|12567492|FG000|STARTED|Overall Study||16
11371462|NCT03296800|12567493|FG001|STARTED|Overall Study||16
11371463|NCT03296800|12567494|FG002|STARTED|Overall Study||16
11371464|NCT03296800|12567492|FG000|COMPLETED|Overall Study||16
11371465|NCT03296800|12567493|FG001|COMPLETED|Overall Study||16
11371466|NCT03296800|12567494|FG002|COMPLETED|Overall Study||16
11371467|NCT03296800|12567492|FG000|NOT COMPLETED|Overall Study||0
11371468|NCT03296800|12567493|FG001|NOT COMPLETED|Overall Study||0
11371469|NCT03296800|12567494|FG002|NOT COMPLETED|Overall Study||0
11371470|NCT03297021|12567520|FG000|STARTED|Overall Study||48
11371471|NCT03297021|12567521|FG001|STARTED|Overall Study||46
11371472|NCT03297021|12567522|FG002|STARTED|Overall Study||47
11371473|NCT03297021|12567520|FG000|COMPLETED|Overall Study||43
11371474|NCT03297021|12567521|FG001|COMPLETED|Overall Study||42
11371475|NCT03297021|12567522|FG002|COMPLETED|Overall Study||43
11371476|NCT03297021|12567520|FG000|NOT COMPLETED|Overall Study||5
11371477|NCT03297021|12567521|FG001|NOT COMPLETED|Overall Study||4
11371478|NCT03297021|12567522|FG002|NOT COMPLETED|Overall Study||4
11371479|NCT03297112|12567530|FG000|STARTED|Overall Study||12
11371480|NCT03297112|12567530|FG000|COMPLETED|Overall Study||12
11371481|NCT03297112|12567530|FG000|NOT COMPLETED|Overall Study||0
11371482|NCT03297216|12567536|FG000|STARTED|Overall Study||399
11371483|NCT03297216|12567537|FG001|STARTED|Overall Study||401
11371484|NCT03297216|12567536|FG000|Discontinued Intervention|Overall Study||5
11371485|NCT03297216|12567537|FG001|Discontinued Intervention|Overall Study||4
11371486|NCT03297216|12567536|FG000|Infants Born During Study|Overall Study||399
11371487|NCT03297216|12567537|FG001|Infants Born During Study|Overall Study||401
11371488|NCT03297216|12567536|FG000|COMPLETED|Overall Study||396
11371489|NCT03297216|12567537|FG001|COMPLETED|Overall Study||396
11371490|NCT03297216|12567536|FG000|NOT COMPLETED|Overall Study||3
11371491|NCT03297216|12567537|FG001|NOT COMPLETED|Overall Study||5
11371492|NCT03297294|12567552|FG000|STARTED|Double-Blind Treatment Period (DB)||70
11371493|NCT03297294|12567553|FG001|STARTED|Double-Blind Treatment Period (DB)||67
11371494|NCT03297294|12567554|FG002|STARTED|Double-Blind Treatment Period (DB)||0
11371495|NCT03297294|12567555|FG003|STARTED|Double-Blind Treatment Period (DB)||0
11371496|NCT03297294|12567556|FG004|STARTED|Double-Blind Treatment Period (DB)||0
11371497|NCT03297294|12567552|FG000|COMPLETED|Double-Blind Treatment Period (DB)||32
11371498|NCT03297294|12567553|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30
11371499|NCT03297294|12567554|FG002|COMPLETED|Double-Blind Treatment Period (DB)||0
11371500|NCT03297294|12567555|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0
11371501|NCT03297294|12567556|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0
11371502|NCT03297294|12567552|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||38
11371503|NCT03297294|12567553|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||37
11371504|NCT03297294|12567554|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
11371505|NCT03297294|12567555|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
11371506|NCT03297294|12567556|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
11371507|NCT03297294|12567552|FG000|STARTED|Treatment Withdrawal Period (TW)||0
11371508|NCT03297294|12567553|FG001|STARTED|Treatment Withdrawal Period (TW)||0
11371509|NCT03297294|12567554|FG002|STARTED|Treatment Withdrawal Period (TW)||14
11371510|NCT03297294|12567555|FG003|STARTED|Treatment Withdrawal Period (TW)||12
11371511|NCT03297294|12567556|FG004|STARTED|Treatment Withdrawal Period (TW)||27
11371512|NCT03297294|12567552|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0
11371513|NCT03297294|12567553|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0
11371514|NCT03297294|12567554|FG002|COMPLETED|Treatment Withdrawal Period (TW)||14
11371515|NCT03297294|12567555|FG003|COMPLETED|Treatment Withdrawal Period (TW)||11
11371516|NCT03297294|12567556|FG004|COMPLETED|Treatment Withdrawal Period (TW)||27
11371517|NCT03297294|12567552|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
11371518|NCT03297294|12567553|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
11371519|NCT03297294|12567554|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
11371520|NCT03297294|12567555|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||1
11371521|NCT03297294|12567556|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
11371522|NCT03297398|12567571|FG000|STARTED|Overall Study||36
11371523|NCT03297398|12567572|FG001|STARTED|Overall Study||40
11371524|NCT03297398|12567573|FG002|STARTED|Overall Study||38
11371525|NCT03297398|12567571|FG000|COMPLETED|Overall Study||28
11371526|NCT03297398|12567572|FG001|COMPLETED|Overall Study||23
11371527|NCT03297398|12567573|FG002|COMPLETED|Overall Study||23
11371528|NCT03297398|12567571|FG000|NOT COMPLETED|Overall Study||8
11371529|NCT03297398|12567572|FG001|NOT COMPLETED|Overall Study||17
11371530|NCT03297398|12567573|FG002|NOT COMPLETED|Overall Study||15
11371531|NCT03297944|12567581|FG000|STARTED|Overall Study||15
11371532|NCT03297944|12567581|FG000|2ALP/PLC|Overall Study||15
11371533|NCT03297944|12567581|FG000|1ALP/PLC|Overall Study||15
11371534|NCT03297944|12567581|FG000|0.5ALP/PLC|Overall Study||15
11371535|NCT03297944|12567581|FG000|ZOL/PLC|Overall Study||15
11371536|NCT03297944|12567581|FG000|PLC/PLC|Overall Study||15
11371537|NCT03297944|12567581|FG000|PLC/ALP|Overall Study||15
11371538|NCT03297944|12567581|FG000|COMPLETED|Overall Study||15
11371539|NCT03297944|12567581|FG000|NOT COMPLETED|Overall Study||0
11371540|NCT03298035|12567592|FG000|STARTED|Overall Study||10
11371541|NCT03298035|12567593|FG001|STARTED|Overall Study||9
11371542|NCT03298035|12567592|FG000|Received Intervention|Overall Study||9
11371543|NCT03298035|12567593|FG001|Received Intervention|Overall Study||7
11371544|NCT03298035|12567592|FG000|COMPLETED|Overall Study||9
11371545|NCT03298035|12567593|FG001|COMPLETED|Overall Study||7
11371546|NCT03298035|12567592|FG000|NOT COMPLETED|Overall Study||1
11371547|NCT03298035|12567593|FG001|NOT COMPLETED|Overall Study||2
11371548|NCT03298048|12567602|FG000|STARTED|Overall Study||4
11371549|NCT03298048|12567603|FG001|STARTED|Overall Study||3
11371550|NCT03298048|12567604|FG002|STARTED|Overall Study||8
11371551|NCT03298048|12567602|FG000|COMPLETED|Overall Study||4
11371552|NCT03298048|12567603|FG001|COMPLETED|Overall Study||3
11371553|NCT03298048|12567604|FG002|COMPLETED|Overall Study||8
11371554|NCT03298048|12567602|FG000|NOT COMPLETED|Overall Study||0
11371555|NCT03298048|12567603|FG001|NOT COMPLETED|Overall Study||0
11371556|NCT03298048|12567604|FG002|NOT COMPLETED|Overall Study||0
11371557|NCT03298113|12567614|FG000|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10
11371558|NCT03298113|12567615|FG001|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10
11371559|NCT03298113|12567614|FG000|IAD 1A|Overall Study||3
11371560|NCT03298113|12567615|FG001|IAD 1A|Overall Study||4
11371561|NCT03298113|12567614|FG000|IAD 2A|Overall Study||7
11371562|NCT03298113|12567615|FG001|IAD 2A|Overall Study||6
11371563|NCT03298113|12567614|FG000|COMPLETED|Overall Study||10
11371564|NCT03298113|12567615|FG001|COMPLETED|Overall Study||10
11371565|NCT03298113|12567614|FG000|NOT COMPLETED|Overall Study||0
11371566|NCT03298113|12567615|FG001|NOT COMPLETED|Overall Study||0
11371567|NCT03298412|12567621|FG000|STARTED|Run-in Period||10
11371568|NCT03298412|12567621|FG000|COMPLETED|Run-in Period||1
11371569|NCT03298412|12567621|FG000|NOT COMPLETED|Run-in Period||9
11371570|NCT03298412|12567621|FG000|STARTED|Treatment Period||1
11371571|NCT03298412|12567621|FG000|COMPLETED|Treatment Period||1
11371572|NCT03298412|12567621|FG000|NOT COMPLETED|Treatment Period||0
11371573|NCT03298841|12567627|FG000|STARTED|Overall Study||25
11371574|NCT03298841|12567628|FG001|STARTED|Overall Study||25
11371575|NCT03298841|12567627|FG000|COMPLETED|Overall Study||25
11371576|NCT03298841|12567628|FG001|COMPLETED|Overall Study||25
11371577|NCT03298841|12567627|FG000|NOT COMPLETED|Overall Study||0
11371578|NCT03298841|12567628|FG001|NOT COMPLETED|Overall Study||0
11371579|NCT03298880|12567635|FG000|STARTED|Overall Study||75
11371580|NCT03298880|12567635|FG000|COMPLETED|Overall Study||75
11371581|NCT03298880|12567635|FG000|NOT COMPLETED|Overall Study||0
11371582|NCT03299101|12567646|FG000|STARTED|Overall Study||35
11371583|NCT03299101|12567646|FG000|COMPLETED|Overall Study||25
11371584|NCT03299101|12567646|FG000|NOT COMPLETED|Overall Study||10
11371585|NCT03299244|12567652|FG000|STARTED|Overall Study||317
11371586|NCT03299244|12567653|FG001|STARTED|Overall Study||320
11371587|NCT03299244|12567652|FG000|Received Treatment|Overall Study||315
11371588|NCT03299244|12567653|FG001|Received Treatment|Overall Study||318
11371589|NCT03299244|12567652|FG000|COMPLETED|Overall Study||270
11371590|NCT03299244|12567653|FG001|COMPLETED|Overall Study||282
11371591|NCT03299244|12567652|FG000|NOT COMPLETED|Overall Study||47
11371592|NCT03299244|12567653|FG001|NOT COMPLETED|Overall Study||38
11371593|NCT03299686|12567662|FG000|STARTED|Treatment Epoch||70
11371594|NCT03299686|12567663|FG001|STARTED|Treatment Epoch||48
11371595|NCT03299686|12567662|FG000|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||69
11371596|NCT03299686|12567663|FG001|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||48
11371597|NCT03299686|12567662|FG000|COMPLETED|Treatment Epoch||59
11371598|NCT03299686|12567663|FG001|COMPLETED|Treatment Epoch||44
11371599|NCT03299686|12567662|FG000|NOT COMPLETED|Treatment Epoch||11
11371600|NCT03299686|12567663|FG001|NOT COMPLETED|Treatment Epoch||4
11371601|NCT03299686|12567662|FG000|STARTED|Follow-up Epoch||59
11371602|NCT03299686|12567663|FG001|STARTED|Follow-up Epoch||44
11371603|NCT03299686|12567662|FG000|COMPLETED|Follow-up Epoch||59
11371604|NCT03299686|12567663|FG001|COMPLETED|Follow-up Epoch||43
11371605|NCT03299686|12567662|FG000|NOT COMPLETED|Follow-up Epoch||0
11371606|NCT03299686|12567663|FG001|NOT COMPLETED|Follow-up Epoch||1
11371607|NCT03299881|12567671|FG000|STARTED|Overall Study||39
11371608|NCT03299881|12567672|FG001|STARTED|Overall Study||38
11371609|NCT03299881|12567671|FG000|COMPLETED|Overall Study||22
11371610|NCT03299881|12567672|FG001|COMPLETED|Overall Study||25
11371611|NCT03299881|12567671|FG000|NOT COMPLETED|Overall Study||17
11371612|NCT03299881|12567672|FG001|NOT COMPLETED|Overall Study||13
11371613|NCT03300050|12567683|FG000|STARTED|Overall Study||20
11371614|NCT03300050|12567684|FG001|STARTED|Overall Study||15
11371615|NCT03300050|12567685|FG002|STARTED|Overall Study||5
11371616|NCT03300050|12567686|FG003|STARTED|Overall Study||16
11371617|NCT03300050|12567687|FG004|STARTED|Overall Study||10
11371618|NCT03300050|12567683|FG000|Received Treatment|Overall Study||19
11371619|NCT03300050|12567684|FG001|Received Treatment|Overall Study||14
11371620|NCT03300050|12567685|FG002|Received Treatment|Overall Study||3
11371621|NCT03300050|12567686|FG003|Received Treatment|Overall Study||15
11371622|NCT03300050|12567687|FG004|Received Treatment|Overall Study||10
11371623|NCT03300050|12567683|FG000|Received All Scheduled Treatments|Overall Study||16
11371624|NCT03300050|12567684|FG001|Received All Scheduled Treatments|Overall Study||13
11371625|NCT03300050|12567685|FG002|Received All Scheduled Treatments|Overall Study||2
11371626|NCT03300050|12567686|FG003|Received All Scheduled Treatments|Overall Study||15
11371627|NCT03300050|12567687|FG004|Received All Scheduled Treatments|Overall Study||10
11371628|NCT03300050|12567683|FG000|COMPLETED|Overall Study||17
11371629|NCT03300050|12567684|FG001|COMPLETED|Overall Study||13
11371630|NCT03300050|12567685|FG002|COMPLETED|Overall Study||2
11371631|NCT03300050|12567686|FG003|COMPLETED|Overall Study||15
11371632|NCT03300050|12567687|FG004|COMPLETED|Overall Study||9
11371633|NCT03300050|12567683|FG000|NOT COMPLETED|Overall Study||3
11371634|NCT03300050|12567684|FG001|NOT COMPLETED|Overall Study||2
11371635|NCT03300050|12567685|FG002|NOT COMPLETED|Overall Study||3
11371636|NCT03300050|12567686|FG003|NOT COMPLETED|Overall Study||1
11371637|NCT03300050|12567687|FG004|NOT COMPLETED|Overall Study||1
11371638|NCT03300570|12567701|FG000|STARTED|Overall Study||13
11371639|NCT03300570|12567702|FG001|STARTED|Overall Study||14
11371640|NCT03300570|12567701|FG000|COMPLETED|Overall Study||11
11371641|NCT03300570|12567702|FG001|COMPLETED|Overall Study||13
11371642|NCT03300570|12567701|FG000|NOT COMPLETED|Overall Study||2
11371643|NCT03300570|12567702|FG001|NOT COMPLETED|Overall Study||1
11371644|NCT03300674|12567711|FG000|STARTED|Overall Study||77
11371645|NCT03300674|12567712|FG001|STARTED|Overall Study||77
11371646|NCT03300674|12567711|FG000|COMPLETED|Overall Study||77
11371647|NCT03300674|12567712|FG001|COMPLETED|Overall Study||77
11371648|NCT03300674|12567711|FG000|NOT COMPLETED|Overall Study||0
11371649|NCT03300674|12567712|FG001|NOT COMPLETED|Overall Study||0
11371650|NCT03300752|12567720|FG000|STARTED|Overall Study||40
11371651|NCT03300752|12567721|FG001|STARTED|Overall Study||40
11371652|NCT03300752|12567720|FG000|COMPLETED|Overall Study||38
11371653|NCT03300752|12567721|FG001|COMPLETED|Overall Study||38
11371654|NCT03300752|12567720|FG000|NOT COMPLETED|Overall Study||2
11371655|NCT03300752|12567721|FG001|NOT COMPLETED|Overall Study||2
11371656|NCT03300843|12567727|FG000|STARTED|Overall Study||1
11371657|NCT03300843|12567727|FG000|COMPLETED|Overall Study||1
11371658|NCT03300843|12567727|FG000|NOT COMPLETED|Overall Study||0
11371659|NCT03301155|12567733|FG000|STARTED|Overall Study||528
11371660|NCT03301155|12567734|FG001|STARTED|Overall Study||508
11371661|NCT03301155|12567733|FG000|COMPLETED|Overall Study||520
11371662|NCT03301155|12567734|FG001|COMPLETED|Overall Study||501
11371663|NCT03301155|12567733|FG000|NOT COMPLETED|Overall Study||8
11371664|NCT03301155|12567734|FG001|NOT COMPLETED|Overall Study||7
11371665|NCT03301272|12567742|FG000|STARTED|First Intervention (30 Days)||7
11371666|NCT03301272|12567743|FG001|STARTED|First Intervention (30 Days)||9
11371667|NCT03301272|12567742|FG000|COMPLETED|First Intervention (30 Days)||7
11371668|NCT03301272|12567743|FG001|COMPLETED|First Intervention (30 Days)||9
11371669|NCT03301272|12567742|FG000|NOT COMPLETED|First Intervention (30 Days)||0
11371670|NCT03301272|12567743|FG001|NOT COMPLETED|First Intervention (30 Days)||0
11371671|NCT03301272|12567742|FG000|STARTED|Washout (90 Days From 1st Intervention)||7
11371672|NCT03301272|12567743|FG001|STARTED|Washout (90 Days From 1st Intervention)||9
11371673|NCT03301272|12567742|FG000|COMPLETED|Washout (90 Days From 1st Intervention)||7
11371674|NCT03301272|12567743|FG001|COMPLETED|Washout (90 Days From 1st Intervention)||9
11371675|NCT03301272|12567742|FG000|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
11371676|NCT03301272|12567743|FG001|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
11371677|NCT03301272|12567742|FG000|STARTED|Second Intervention (30 Days)||7
11371678|NCT03301272|12567743|FG001|STARTED|Second Intervention (30 Days)||9
11371679|NCT03301272|12567742|FG000|COMPLETED|Second Intervention (30 Days)||7
11371680|NCT03301272|12567743|FG001|COMPLETED|Second Intervention (30 Days)||9
11371681|NCT03301272|12567742|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
11371682|NCT03301272|12567743|FG001|NOT COMPLETED|Second Intervention (30 Days)||0
11371683|NCT03301298|12567756|FG000|STARTED|Unfed Conditions||6
11371684|NCT03301298|12567757|FG001|STARTED|Unfed Conditions||6
11371685|NCT03301298|12567758|FG002|STARTED|Unfed Conditions||6
11371686|NCT03301298|12567759|FG003|STARTED|Unfed Conditions||6
11371687|NCT03301298|12567760|FG004|STARTED|Unfed Conditions||6
11371688|NCT03301298|12567761|FG005|STARTED|Unfed Conditions||6
11371689|NCT03301298|12567762|FG006|STARTED|Unfed Conditions||12
11371690|NCT03301298|12567756|FG000|COMPLETED|Unfed Conditions||6
11371691|NCT03301298|12567757|FG001|COMPLETED|Unfed Conditions||6
11371692|NCT03301298|12567758|FG002|COMPLETED|Unfed Conditions||6
11371693|NCT03301298|12567759|FG003|COMPLETED|Unfed Conditions||6
11371694|NCT03301298|12567760|FG004|COMPLETED|Unfed Conditions||6
11371695|NCT03301298|12567761|FG005|COMPLETED|Unfed Conditions||6
11371696|NCT03301298|12567762|FG006|COMPLETED|Unfed Conditions||12
11371697|NCT03301298|12567756|FG000|NOT COMPLETED|Unfed Conditions||0
11371698|NCT03301298|12567757|FG001|NOT COMPLETED|Unfed Conditions||0
11371699|NCT03301298|12567758|FG002|NOT COMPLETED|Unfed Conditions||0
11371700|NCT03301298|12567759|FG003|NOT COMPLETED|Unfed Conditions||0
11371701|NCT03301298|12567760|FG004|NOT COMPLETED|Unfed Conditions||0
11371702|NCT03301298|12567761|FG005|NOT COMPLETED|Unfed Conditions||0
11371703|NCT03301298|12567762|FG006|NOT COMPLETED|Unfed Conditions||0
11371704|NCT03301298|12567756|FG000|STARTED|Fed Conditions||0
11371705|NCT03301298|12567757|FG001|STARTED|Fed Conditions||0
11371706|NCT03301298|12567758|FG002|STARTED|Fed Conditions||0
11371707|NCT03301298|12567759|FG003|STARTED|Fed Conditions||0
11371708|NCT03301298|12567760|FG004|STARTED|Fed Conditions||5
11371709|NCT03301298|12567761|FG005|STARTED|Fed Conditions||0
11371710|NCT03301298|12567762|FG006|STARTED|Fed Conditions||2
11371711|NCT03301298|12567756|FG000|COMPLETED|Fed Conditions||0
11371712|NCT03301298|12567757|FG001|COMPLETED|Fed Conditions||0
11371713|NCT03301298|12567758|FG002|COMPLETED|Fed Conditions||0
11371714|NCT03301298|12567759|FG003|COMPLETED|Fed Conditions||0
11371715|NCT03301298|12567760|FG004|COMPLETED|Fed Conditions||5
11371716|NCT03301298|12567761|FG005|COMPLETED|Fed Conditions||0
11371717|NCT03301298|12567762|FG006|COMPLETED|Fed Conditions||2
11371718|NCT03301298|12567756|FG000|NOT COMPLETED|Fed Conditions||0
11371719|NCT03301298|12567757|FG001|NOT COMPLETED|Fed Conditions||0
11371720|NCT03301298|12567758|FG002|NOT COMPLETED|Fed Conditions||0
11371721|NCT03301298|12567759|FG003|NOT COMPLETED|Fed Conditions||0
11371722|NCT03301298|12567760|FG004|NOT COMPLETED|Fed Conditions||0
11371723|NCT03301298|12567761|FG005|NOT COMPLETED|Fed Conditions||0
11371724|NCT03301298|12567762|FG006|NOT COMPLETED|Fed Conditions||0
11371725|NCT03301623|12567781|FG000|STARTED|Overall Study||462
11371726|NCT03301623|12567782|FG001|STARTED|Overall Study||521
11371727|NCT03301623|12567781|FG000|COMPLETED|Overall Study||445
11371728|NCT03301623|12567782|FG001|COMPLETED|Overall Study||506
11371729|NCT03301623|12567781|FG000|NOT COMPLETED|Overall Study||17
11371730|NCT03301623|12567782|FG001|NOT COMPLETED|Overall Study||15
11371731|NCT03301649|12567791|FG000|STARTED|Overall Study||399
11371732|NCT03301649|12567792|FG001|STARTED|Overall Study||400
11371733|NCT03301649|12567793|FG002|STARTED|Overall Study||112
11371734|NCT03301649|12567791|FG000|Safety Population|Overall Study||399
11371735|NCT03301649|12567792|FG001|Safety Population|Overall Study||400
11371736|NCT03301649|12567793|FG002|Safety Population|Overall Study||112
11371737|NCT03301649|12567791|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||372
11371738|NCT03301649|12567792|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||380
11371739|NCT03301649|12567793|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||111
11371740|NCT03301649|12567791|FG000|Per-protocol (PP) Population|Overall Study||345
11371741|NCT03301649|12567792|FG001|Per-protocol (PP) Population|Overall Study||354
11371742|NCT03301649|12567793|FG002|Per-protocol (PP) Population|Overall Study||103
11371743|NCT03301649|12567791|FG000|COMPLETED|Overall Study||356
11371744|NCT03301649|12567792|FG001|COMPLETED|Overall Study||356
11371745|NCT03301649|12567793|FG002|COMPLETED|Overall Study||27
11371746|NCT03301649|12567791|FG000|NOT COMPLETED|Overall Study||43
11371747|NCT03301649|12567792|FG001|NOT COMPLETED|Overall Study||44
11371748|NCT03301649|12567793|FG002|NOT COMPLETED|Overall Study||85
11371749|NCT03301714|12567804|FG000|STARTED|Overall Study||60
11371750|NCT03301714|12567805|FG001|STARTED|Overall Study||60
11371751|NCT03301714|12567806|FG002|STARTED|Overall Study||60
11371752|NCT03301714|12567804|FG000|COMPLETED|Overall Study||50
11371753|NCT03301714|12567805|FG001|COMPLETED|Overall Study||54
11371754|NCT03301714|12567806|FG002|COMPLETED|Overall Study||53
11371755|NCT03301714|12567804|FG000|NOT COMPLETED|Overall Study||10
11371756|NCT03301714|12567805|FG001|NOT COMPLETED|Overall Study||6
11371757|NCT03301714|12567806|FG002|NOT COMPLETED|Overall Study||7
11371758|NCT03301740|12567819|FG000|STARTED|Phase 1 Intervention (3 Weeks)||18
11371759|NCT03301740|12567820|FG001|STARTED|Phase 1 Intervention (3 Weeks)||16
11371760|NCT03301740|12567819|FG000|COMPLETED|Phase 1 Intervention (3 Weeks)||18
11371761|NCT03301740|12567820|FG001|COMPLETED|Phase 1 Intervention (3 Weeks)||16
11371762|NCT03301740|12567819|FG000|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
11371763|NCT03301740|12567820|FG001|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
11371764|NCT03301740|12567819|FG000|STARTED|First Washout (1 Week)||18
11371765|NCT03301740|12567820|FG001|STARTED|First Washout (1 Week)||16
11371766|NCT03301740|12567819|FG000|COMPLETED|First Washout (1 Week)||18
11371767|NCT03301740|12567820|FG001|COMPLETED|First Washout (1 Week)||16
11371768|NCT03301740|12567819|FG000|NOT COMPLETED|First Washout (1 Week)||0
11371769|NCT03301740|12567820|FG001|NOT COMPLETED|First Washout (1 Week)||0
11371770|NCT03301740|12567819|FG000|STARTED|Phase 2 Intervention (3 Weeks)||18
11371771|NCT03301740|12567820|FG001|STARTED|Phase 2 Intervention (3 Weeks)||16
11371772|NCT03301740|12567819|FG000|COMPLETED|Phase 2 Intervention (3 Weeks)||17
11371773|NCT03301740|12567820|FG001|COMPLETED|Phase 2 Intervention (3 Weeks)||16
11371774|NCT03301740|12567819|FG000|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||1
11371775|NCT03301740|12567820|FG001|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||0
11371776|NCT03301740|12567819|FG000|STARTED|Second Washout (1 Week)||17
11371777|NCT03301740|12567820|FG001|STARTED|Second Washout (1 Week)||16
11371778|NCT03301740|12567819|FG000|COMPLETED|Second Washout (1 Week)||17
11371779|NCT03301740|12567820|FG001|COMPLETED|Second Washout (1 Week)||16
11371780|NCT03301740|12567819|FG000|NOT COMPLETED|Second Washout (1 Week)||0
11371781|NCT03301740|12567820|FG001|NOT COMPLETED|Second Washout (1 Week)||0
11371782|NCT03301740|12567819|FG000|STARTED|Phase 3 Intervention (3 Weeks)||17
11371783|NCT03301740|12567820|FG001|STARTED|Phase 3 Intervention (3 Weeks)||16
11371784|NCT03301740|12567819|FG000|COMPLETED|Phase 3 Intervention (3 Weeks)||17
11371785|NCT03301740|12567820|FG001|COMPLETED|Phase 3 Intervention (3 Weeks)||16
11371786|NCT03301740|12567819|FG000|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
11371787|NCT03301740|12567820|FG001|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
11371788|NCT03301740|12567819|FG000|STARTED|Third Washout (1 Week)||17
11371789|NCT03301740|12567820|FG001|STARTED|Third Washout (1 Week)||16
11371790|NCT03301740|12567819|FG000|COMPLETED|Third Washout (1 Week)||17
11371791|NCT03301740|12567820|FG001|COMPLETED|Third Washout (1 Week)||16
11371792|NCT03301740|12567819|FG000|NOT COMPLETED|Third Washout (1 Week)||0
11371793|NCT03301740|12567820|FG001|NOT COMPLETED|Third Washout (1 Week)||0
11371794|NCT03301740|12567819|FG000|STARTED|Phase 4 Intervention (3 Weeks)||17
11371795|NCT03301740|12567820|FG001|STARTED|Phase 4 Intervention (3 Weeks)||16
11371796|NCT03301740|12567819|FG000|COMPLETED|Phase 4 Intervention (3 Weeks)||16
11371797|NCT03301740|12567820|FG001|COMPLETED|Phase 4 Intervention (3 Weeks)||16
11371798|NCT03301740|12567819|FG000|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||1
11371799|NCT03301740|12567820|FG001|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||0
11371800|NCT03301779|12567826|FG000|STARTED|Overall Study||48
11371801|NCT03301779|12567827|FG001|STARTED|Overall Study||52
11371802|NCT03301779|12567826|FG000|COMPLETED|Overall Study||40
11371803|NCT03301779|12567827|FG001|COMPLETED|Overall Study||45
11371804|NCT03301779|12567826|FG000|NOT COMPLETED|Overall Study||8
11371805|NCT03301779|12567827|FG001|NOT COMPLETED|Overall Study||7
11371806|NCT03301831|12567835|FG000|STARTED|Overall Study||46
11371807|NCT03301831|12567836|FG001|STARTED|Overall Study||47
11371808|NCT03301831|12567835|FG000|COMPLETED|Overall Study||26
11371809|NCT03301831|12567836|FG001|COMPLETED|Overall Study||44
11371810|NCT03301831|12567835|FG000|NOT COMPLETED|Overall Study||20
11371811|NCT03301831|12567836|FG001|NOT COMPLETED|Overall Study||3
11371812|NCT03301844|12567844|FG000|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
11371813|NCT03301844|12567845|FG001|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
11371814|NCT03301844|12567844|FG000|COMPLETED|Overall Study||18
11371815|NCT03301844|12567845|FG001|COMPLETED|Overall Study||18
11371816|NCT03301844|12567844|FG000|NOT COMPLETED|Overall Study||1
11371817|NCT03301844|12567845|FG001|NOT COMPLETED|Overall Study||1
11371818|NCT03302091|12567853|FG000|STARTED|Overall Study||10
11371819|NCT03302091|12567854|FG001|STARTED|Overall Study||10
11371820|NCT03302091|12567853|FG000|COMPLETED|Overall Study||10
11371821|NCT03302091|12567854|FG001|COMPLETED|Overall Study||10
11371822|NCT03302091|12567853|FG000|NOT COMPLETED|Overall Study||0
11371823|NCT03302091|12567854|FG001|NOT COMPLETED|Overall Study||0
11371824|NCT03302416|12567860|FG000|STARTED|Overall Study||19
11263604|NCT02271984|12459065|FG004|COMPLETED|Washout Period 2 (7 Days)||3
11263605|NCT02271984|12459066|FG005|COMPLETED|Washout Period 2 (7 Days)||3
11263606|NCT02271984|12459067|FG006|COMPLETED|Washout Period 2 (7 Days)||3
11263607|NCT02271984|12459068|FG007|COMPLETED|Washout Period 2 (7 Days)||3
11263608|NCT02271984|12459069|FG008|COMPLETED|Washout Period 2 (7 Days)||3
11263609|NCT02271984|12459070|FG009|COMPLETED|Washout Period 2 (7 Days)||3
11263610|NCT02271984|12459071|FG010|COMPLETED|Washout Period 2 (7 Days)||3
11263611|NCT02271984|12459072|FG011|COMPLETED|Washout Period 2 (7 Days)||3
11263612|NCT02271984|12459061|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
11263613|NCT02271984|12459062|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
11263614|NCT02271984|12459063|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
11263615|NCT02271984|12459064|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
11263616|NCT02271984|12459065|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
11263617|NCT02271984|12459066|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
11263618|NCT02271984|12459067|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
11263619|NCT02271984|12459068|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
11263620|NCT02271984|12459069|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
11263621|NCT02271984|12459070|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0
11263622|NCT02271984|12459071|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0
11263623|NCT02271984|12459072|FG011|NOT COMPLETED|Washout Period 2 (7 Days)||0
11263624|NCT02271984|12459061|FG000|STARTED|Third Intervention Period (1 Day)||3
11263625|NCT02271984|12459062|FG001|STARTED|Third Intervention Period (1 Day)||3
11263626|NCT02271984|12459063|FG002|STARTED|Third Intervention Period (1 Day)||3
11263627|NCT02271984|12459064|FG003|STARTED|Third Intervention Period (1 Day)||3
11263628|NCT02271984|12459065|FG004|STARTED|Third Intervention Period (1 Day)||3
11263629|NCT02271984|12459066|FG005|STARTED|Third Intervention Period (1 Day)||3
11263630|NCT02271984|12459067|FG006|STARTED|Third Intervention Period (1 Day)||3
11263631|NCT02271984|12459068|FG007|STARTED|Third Intervention Period (1 Day)||3
11263632|NCT02271984|12459069|FG008|STARTED|Third Intervention Period (1 Day)||3
11263633|NCT02271984|12459070|FG009|STARTED|Third Intervention Period (1 Day)||3
11263634|NCT02271984|12459071|FG010|STARTED|Third Intervention Period (1 Day)||3
11263635|NCT02271984|12459072|FG011|STARTED|Third Intervention Period (1 Day)||3
11263636|NCT02271984|12459061|FG000|COMPLETED|Third Intervention Period (1 Day)||3
11263637|NCT02271984|12459062|FG001|COMPLETED|Third Intervention Period (1 Day)||3
11263638|NCT02271984|12459063|FG002|COMPLETED|Third Intervention Period (1 Day)||3
11263639|NCT02271984|12459064|FG003|COMPLETED|Third Intervention Period (1 Day)||3
11263640|NCT02271984|12459065|FG004|COMPLETED|Third Intervention Period (1 Day)||3
11263641|NCT02271984|12459066|FG005|COMPLETED|Third Intervention Period (1 Day)||3
11263642|NCT02271984|12459067|FG006|COMPLETED|Third Intervention Period (1 Day)||3
11263643|NCT02271984|12459068|FG007|COMPLETED|Third Intervention Period (1 Day)||3
11263644|NCT02271984|12459069|FG008|COMPLETED|Third Intervention Period (1 Day)||3
11263645|NCT02271984|12459070|FG009|COMPLETED|Third Intervention Period (1 Day)||3
11263646|NCT02271984|12459071|FG010|COMPLETED|Third Intervention Period (1 Day)||3
11263647|NCT02271984|12459072|FG011|COMPLETED|Third Intervention Period (1 Day)||3
11263648|NCT02271984|12459061|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0
11263649|NCT02271984|12459062|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0
11263650|NCT02271984|12459063|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0
11263651|NCT02271984|12459064|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0
11263652|NCT02271984|12459065|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0
11263653|NCT02271984|12459066|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0
11263654|NCT02271984|12459067|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0
11263655|NCT02271984|12459068|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0
11263656|NCT02271984|12459069|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0
11263657|NCT02271984|12459070|FG009|NOT COMPLETED|Third Intervention Period (1 Day)||0
11263658|NCT02271984|12459071|FG010|NOT COMPLETED|Third Intervention Period (1 Day)||0
11263659|NCT02271984|12459072|FG011|NOT COMPLETED|Third Intervention Period (1 Day)||0
11263660|NCT02271984|12459061|FG000|STARTED|Washout Period 3 (7 Days)||3
11263661|NCT02271984|12459062|FG001|STARTED|Washout Period 3 (7 Days)||3
11263662|NCT02271984|12459063|FG002|STARTED|Washout Period 3 (7 Days)||3
11263663|NCT02271984|12459064|FG003|STARTED|Washout Period 3 (7 Days)||3
11263664|NCT02271984|12459065|FG004|STARTED|Washout Period 3 (7 Days)||3
11263665|NCT02271984|12459066|FG005|STARTED|Washout Period 3 (7 Days)||3
11263666|NCT02271984|12459067|FG006|STARTED|Washout Period 3 (7 Days)||3
11263667|NCT02271984|12459068|FG007|STARTED|Washout Period 3 (7 Days)||3
11263668|NCT02271984|12459069|FG008|STARTED|Washout Period 3 (7 Days)||3
11263669|NCT02271984|12459070|FG009|STARTED|Washout Period 3 (7 Days)||3
11263670|NCT02271984|12459071|FG010|STARTED|Washout Period 3 (7 Days)||3
11263671|NCT02271984|12459072|FG011|STARTED|Washout Period 3 (7 Days)||3
11263672|NCT02271984|12459061|FG000|COMPLETED|Washout Period 3 (7 Days)||3
11371825|NCT03302416|12567860|FG000|COMPLETED|Overall Study||19
11371826|NCT03302416|12567860|FG000|NOT COMPLETED|Overall Study||0
11371827|NCT03302559|12567864|FG000|STARTED|Overall Study||29
11371828|NCT03302559|12567864|FG000|COMPLETED|Overall Study||23
11371829|NCT03302559|12567864|FG000|NOT COMPLETED|Overall Study||6
11371830|NCT03302741|12567870|FG000|STARTED|Overall Study||8
11371831|NCT03302741|12567871|FG001|STARTED|Overall Study||9
11371832|NCT03302741|12567870|FG000|COMPLETED|Overall Study||7
11371833|NCT03302741|12567871|FG001|COMPLETED|Overall Study||8
11371834|NCT03302741|12567870|FG000|NOT COMPLETED|Overall Study||1
11371835|NCT03302741|12567871|FG001|NOT COMPLETED|Overall Study||1
11371836|NCT03302767|12567877|FG000|STARTED|Overall Study||29
11371837|NCT03302767|12567877|FG000|COMPLETED|Overall Study||29
11371838|NCT03302767|12567877|FG000|NOT COMPLETED|Overall Study||0
11371839|NCT03302780|12567881|FG000|STARTED|Overall Study||3
11371840|NCT03302780|12567882|FG001|STARTED|Overall Study||3
11371841|NCT03302780|12567881|FG000|COMPLETED|Overall Study||3
11371842|NCT03302780|12567882|FG001|COMPLETED|Overall Study||3
11005709|NCT00724126|12183424|FG001|NOT COMPLETED|Overall Study||15
11005710|NCT00724152|12183435|FG000|STARTED|Two-arm Study Period||14
11005711|NCT00724152|12183436|FG001|STARTED|Two-arm Study Period||11
11005712|NCT00724152|12183437|FG002|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
11005713|NCT00724152|12183435|FG000|COMPLETED|Two-arm Study Period||11
11005714|NCT00724152|12183436|FG001|COMPLETED|Two-arm Study Period||9
11005715|NCT00724152|12183437|FG002|COMPLETED|Two-arm Study Period||0
11005716|NCT00724152|12183435|FG000|NOT COMPLETED|Two-arm Study Period||3
11005717|NCT00724152|12183436|FG001|NOT COMPLETED|Two-arm Study Period||2
11371843|NCT03302780|12567881|FG000|NOT COMPLETED|Overall Study||0
11371844|NCT03302780|12567882|FG001|NOT COMPLETED|Overall Study||0
11371845|NCT03302793|12567888|FG000|STARTED|Overall Study||6
11371846|NCT03302793|12567889|FG001|STARTED|Overall Study||6
11371847|NCT03302793|12567888|FG000|COMPLETED|Overall Study||6
11371848|NCT03302793|12567889|FG001|COMPLETED|Overall Study||4
11371849|NCT03302793|12567888|FG000|NOT COMPLETED|Overall Study||0
11371850|NCT03302793|12567889|FG001|NOT COMPLETED|Overall Study||2
11371851|NCT03302936|12567897|FG000|STARTED|Overall Study||49
11371852|NCT03302936|12567898|FG001|STARTED|Overall Study||49
11371853|NCT03302936|12567897|FG000|COMPLETED|Overall Study||46
11371854|NCT03302936|12567898|FG001|COMPLETED|Overall Study||45
11371855|NCT03302936|12567897|FG000|NOT COMPLETED|Overall Study||3
11371856|NCT03302936|12567898|FG001|NOT COMPLETED|Overall Study||4
11371857|NCT03302975|12567908|FG000|STARTED|Overall Study||16
11371858|NCT03302975|12567908|FG000|COMPLETED|Overall Study||12
11371859|NCT03302975|12567908|FG000|NOT COMPLETED|Overall Study||4
11371860|NCT03303079|12567915|FG000|STARTED|Overall Study||189
11371861|NCT03303079|12567916|FG001|STARTED|Overall Study||191
11371862|NCT03303079|12567917|FG002|STARTED|Overall Study||191
11371863|NCT03303079|12567915|FG000|COMPLETED|Overall Study||182
11371864|NCT03303079|12567916|FG001|COMPLETED|Overall Study||180
11371865|NCT03303079|12567917|FG002|COMPLETED|Overall Study||179
11371866|NCT03303079|12567915|FG000|NOT COMPLETED|Overall Study||7
11371867|NCT03303079|12567916|FG001|NOT COMPLETED|Overall Study||11
11371868|NCT03303079|12567917|FG002|NOT COMPLETED|Overall Study||12
11371869|NCT03303092|12567928|FG000|STARTED|Overall Study||121
11371870|NCT03303092|12567929|FG001|STARTED|Overall Study||119
11371871|NCT03303092|12567930|FG002|STARTED|Overall Study||117
11371872|NCT03303092|12567928|FG000|COMPLETED|Overall Study||118
11371873|NCT03303092|12567929|FG001|COMPLETED|Overall Study||113
11371874|NCT03303092|12567930|FG002|COMPLETED|Overall Study||112
11371875|NCT03303092|12567928|FG000|NOT COMPLETED|Overall Study||3
11371876|NCT03303092|12567929|FG001|NOT COMPLETED|Overall Study||6
11371877|NCT03303092|12567930|FG002|NOT COMPLETED|Overall Study||5
11371878|NCT03303105|12567940|FG000|STARTED|Overall Study||25
11371879|NCT03303105|12567941|FG001|STARTED|Overall Study||25
11371880|NCT03303105|12567940|FG000|COMPLETED|Overall Study||23
11371881|NCT03303105|12567941|FG001|COMPLETED|Overall Study||21
11371882|NCT03303105|12567940|FG000|NOT COMPLETED|Overall Study||2
11371883|NCT03303105|12567941|FG001|NOT COMPLETED|Overall Study||4
11371884|NCT03303144|12567947|FG000|STARTED|Triferic Via Hemodialysate (Day 3)||26
11371885|NCT03303144|12567948|FG001|STARTED|Triferic Via Hemodialysate (Day 3)||0
11371886|NCT03303144|12567949|FG002|STARTED|Triferic Via Hemodialysate (Day 3)||0
11371887|NCT03303144|12567947|FG000|COMPLETED|Triferic Via Hemodialysate (Day 3)||26
11371888|NCT03303144|12567948|FG001|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
11371889|NCT03303144|12567949|FG002|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
11371890|NCT03303144|12567947|FG000|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
11371891|NCT03303144|12567948|FG001|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
11371892|NCT03303144|12567949|FG002|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
11371893|NCT03303144|12567947|FG000|STARTED|Triferic Via IV Infusion (Day 8)||0
11371894|NCT03303144|12567948|FG001|STARTED|Triferic Via IV Infusion (Day 8)||26
11371895|NCT03303144|12567949|FG002|STARTED|Triferic Via IV Infusion (Day 8)||0
11371896|NCT03303144|12567947|FG000|COMPLETED|Triferic Via IV Infusion (Day 8)||0
11371897|NCT03303144|12567948|FG001|COMPLETED|Triferic Via IV Infusion (Day 8)||25
11371898|NCT03303144|12567949|FG002|COMPLETED|Triferic Via IV Infusion (Day 8)||0
11371899|NCT03303144|12567947|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
11371900|NCT03303144|12567948|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||1
11371901|NCT03303144|12567949|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
11371902|NCT03303144|12567947|FG000|STARTED|Triferic Via IV Infusion (Day 10)||0
11371903|NCT03303144|12567948|FG001|STARTED|Triferic Via IV Infusion (Day 10)||0
11371904|NCT03303144|12567949|FG002|STARTED|Triferic Via IV Infusion (Day 10)||26
11371905|NCT03303144|12567947|FG000|COMPLETED|Triferic Via IV Infusion (Day 10)||0
11371906|NCT03303144|12567948|FG001|COMPLETED|Triferic Via IV Infusion (Day 10)||0
11371907|NCT03303144|12567949|FG002|COMPLETED|Triferic Via IV Infusion (Day 10)||25
11371908|NCT03303144|12567947|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
11371909|NCT03303144|12567948|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
11371910|NCT03303144|12567949|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||1
11371911|NCT03303196|12567960|FG000|STARTED|Overall Study|Individuals who were assigned to BHBP admission then SC admission.|5
11371912|NCT03303196|12567961|FG001|STARTED|Overall Study|Individuals who were assigned to SC admission then BHBP admission.|5
11371913|NCT03303196|12567960|FG000|Washout|Overall Study||5
11371914|NCT03303196|12567961|FG001|Washout|Overall Study||5
11371915|NCT03303196|12567960|FG000|COMPLETED|Overall Study||5
11371916|NCT03303196|12567961|FG001|COMPLETED|Overall Study||5
11371917|NCT03303196|12567960|FG000|NOT COMPLETED|Overall Study||0
11371918|NCT03303196|12567961|FG001|NOT COMPLETED|Overall Study||0
11371919|NCT03303404|12567966|FG000|STARTED|Overall Study||22
11371920|NCT03303404|12567966|FG000|COMPLETED|Overall Study||22
11371921|NCT03303404|12567966|FG000|NOT COMPLETED|Overall Study||0
11371922|NCT03303417|12567970|FG000|STARTED|Overall Study||8
11371923|NCT03303417|12567971|FG001|STARTED|Overall Study||8
11371924|NCT03303417|12567970|FG000|COMPLETED|Overall Study||7
11371925|NCT03303417|12567971|FG001|COMPLETED|Overall Study||7
11371926|NCT03303417|12567970|FG000|NOT COMPLETED|Overall Study||1
11371927|NCT03303417|12567971|FG001|NOT COMPLETED|Overall Study||1
11371928|NCT03303521|12567979|FG000|STARTED|Overall Study||97
11371929|NCT03303521|12567980|FG001|STARTED|Overall Study||99
11371930|NCT03303521|12567979|FG000|COMPLETED|Overall Study||92
11371931|NCT03303521|12567980|FG001|COMPLETED|Overall Study||96
11371932|NCT03303521|12567979|FG000|NOT COMPLETED|Overall Study||5
11371933|NCT03303521|12567980|FG001|NOT COMPLETED|Overall Study||3
11371934|NCT03303794|12567988|FG000|STARTED|Overall Study||13
11371935|NCT03303794|12567989|FG001|STARTED|Overall Study||12
11371936|NCT03303794|12567988|FG000|COMPLETED|Overall Study||13
11371937|NCT03303794|12567989|FG001|COMPLETED|Overall Study||12
11371938|NCT03303794|12567988|FG000|NOT COMPLETED|Overall Study||0
11371939|NCT03303794|12567989|FG001|NOT COMPLETED|Overall Study||0
11371940|NCT03303911|12567997|FG000|STARTED|Overall Study||13
11371941|NCT03303911|12567998|FG001|STARTED|Overall Study||13
11371942|NCT03303911|12567997|FG000|COMPLETED|Overall Study||13
11371943|NCT03303911|12567998|FG001|COMPLETED|Overall Study||13
11371944|NCT03303911|12567997|FG000|NOT COMPLETED|Overall Study||0
11371945|NCT03303911|12567998|FG001|NOT COMPLETED|Overall Study||0
11371946|NCT03304054|12568007|FG000|STARTED|Overall Study||27
11371947|NCT03304054|12568008|FG001|STARTED|Overall Study||7
11371948|NCT03304054|12568009|FG002|STARTED|Overall Study||28
11371949|NCT03304054|12568010|FG003|STARTED|Overall Study||8
11371950|NCT03304054|12568011|FG004|STARTED|Overall Study||17
11371951|NCT03304054|12568012|FG005|STARTED|Overall Study||6
11371952|NCT03304054|12568007|FG000|COMPLETED|Overall Study||27
11371953|NCT03304054|12568008|FG001|COMPLETED|Overall Study||7
11371954|NCT03304054|12568009|FG002|COMPLETED|Overall Study||27
11371955|NCT03304054|12568010|FG003|COMPLETED|Overall Study||8
11371956|NCT03304054|12568011|FG004|COMPLETED|Overall Study||0
11371957|NCT03304054|12568012|FG005|COMPLETED|Overall Study||0
11371958|NCT03304054|12568007|FG000|NOT COMPLETED|Overall Study||0
11371959|NCT03304054|12568008|FG001|NOT COMPLETED|Overall Study||0
11371960|NCT03304054|12568009|FG002|NOT COMPLETED|Overall Study||1
11371961|NCT03304054|12568010|FG003|NOT COMPLETED|Overall Study||0
11371962|NCT03304054|12568011|FG004|NOT COMPLETED|Overall Study||17
11371963|NCT03304054|12568012|FG005|NOT COMPLETED|Overall Study||6
11371964|NCT03304106|12568023|FG000|STARTED|Overall Study||44
11371965|NCT03304106|12568024|FG001|STARTED|Overall Study||58
11371966|NCT03304106|12568023|FG000|COMPLETED|Overall Study||31
11371967|NCT03304106|12568024|FG001|COMPLETED|Overall Study||56
11371968|NCT03304106|12568023|FG000|NOT COMPLETED|Overall Study||13
11371969|NCT03304106|12568024|FG001|NOT COMPLETED|Overall Study||2
11371970|NCT03304119|12568032|FG000|STARTED|Overall Study||37
11371971|NCT03304119|12568033|FG001|STARTED|Overall Study||55
11371972|NCT03304119|12568032|FG000|COMPLETED|Overall Study||37
11371973|NCT03304119|12568033|FG001|COMPLETED|Overall Study||55
11371974|NCT03304119|12568032|FG000|NOT COMPLETED|Overall Study||0
11371975|NCT03304119|12568033|FG001|NOT COMPLETED|Overall Study||0
11371976|NCT03304184|12568041|FG000|STARTED|Overall Study||15
11371977|NCT03304184|12568042|FG001|STARTED|Overall Study||9
11371978|NCT03304184|12568041|FG000|COMPLETED|Overall Study||14
11371979|NCT03304184|12568042|FG001|COMPLETED|Overall Study||7
11371980|NCT03304184|12568041|FG000|NOT COMPLETED|Overall Study||1
11371981|NCT03304184|12568042|FG001|NOT COMPLETED|Overall Study||2
11371982|NCT03304522|12568051|FG000|STARTED|Overall Study||46
11371983|NCT03304522|12568052|FG001|STARTED|Overall Study||43
11371984|NCT03304522|12568051|FG000|COMPLETED|Overall Study||45
11371985|NCT03304522|12568052|FG001|COMPLETED|Overall Study||35
11371986|NCT03304522|12568051|FG000|NOT COMPLETED|Overall Study||1
11371987|NCT03304522|12568052|FG001|NOT COMPLETED|Overall Study||8
11371988|NCT03304626|12568060|FG000|STARTED|Overall Study||20
11371989|NCT03304626|12568061|FG001|STARTED|Overall Study||20
11371990|NCT03304626|12568060|FG000|COMPLETED|Overall Study||18
11371991|NCT03304626|12568061|FG001|COMPLETED|Overall Study||19
11371992|NCT03304626|12568060|FG000|NOT COMPLETED|Overall Study||2
11371993|NCT03304626|12568061|FG001|NOT COMPLETED|Overall Study||1
11371994|NCT03304873|12568070|FG000|STARTED|Overall Study||23
11371995|NCT03304873|12568071|FG001|STARTED|Overall Study||24
11371996|NCT03304873|12568070|FG000|COMPLETED|Overall Study||22
11371997|NCT03304873|12568071|FG001|COMPLETED|Overall Study||16
11371998|NCT03304873|12568070|FG000|NOT COMPLETED|Overall Study||1
11371999|NCT03304873|12568071|FG001|NOT COMPLETED|Overall Study||8
11372000|NCT03305081|12568079|FG000|STARTED|Overall Study||25
11372001|NCT03305081|12568080|FG001|STARTED|Overall Study||20
11372002|NCT03305081|12568079|FG000|COMPLETED|Overall Study||15
11372003|NCT03305081|12568080|FG001|COMPLETED|Overall Study||5
11372004|NCT03305081|12568079|FG000|NOT COMPLETED|Overall Study||10
11372005|NCT03305081|12568080|FG001|NOT COMPLETED|Overall Study||15
11372006|NCT03305159|12568088|FG000|STARTED|Overall Study||66
11372007|NCT03305159|12568089|FG001|STARTED|Overall Study||68
11372008|NCT03305159|12568088|FG000|COMPLETED|Overall Study||63
11372009|NCT03305159|12568089|FG001|COMPLETED|Overall Study||60
11372010|NCT03305159|12568088|FG000|NOT COMPLETED|Overall Study||3
11372011|NCT03305159|12568089|FG001|NOT COMPLETED|Overall Study||8
11372012|NCT03305419|12568103|FG000|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
11372013|NCT03305419|12568104|FG001|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
11372014|NCT03305419|12568105|FG002|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
11372015|NCT03305419|12568106|FG003|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
11372016|NCT03305419|12568107|FG004|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
11372017|NCT03305419|12568108|FG005|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
11372018|NCT03305419|12568109|FG006|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
11372019|NCT03305419|12568110|FG007|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
11372020|NCT03305419|12568103|FG000|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
11372021|NCT03305419|12568104|FG001|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2
11372022|NCT03305419|12568105|FG002|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
11372023|NCT03305419|12568106|FG003|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
11372024|NCT03305419|12568107|FG004|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
11372025|NCT03305419|12568108|FG005|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
11372026|NCT03305419|12568109|FG006|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
11372027|NCT03305419|12568110|FG007|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
11372028|NCT03305419|12568103|FG000|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
11372029|NCT03305419|12568104|FG001|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1
11372030|NCT03305419|12568105|FG002|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
11372031|NCT03305419|12568106|FG003|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
11372032|NCT03305419|12568107|FG004|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
11372033|NCT03305419|12568108|FG005|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
11372034|NCT03305419|12568109|FG006|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
11372035|NCT03305419|12568110|FG007|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
11372036|NCT03305419|12568103|FG000|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
11372037|NCT03305419|12568104|FG001|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3
11372038|NCT03305419|12568105|FG002|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
11372039|NCT03305419|12568106|FG003|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
11372040|NCT03305419|12568107|FG004|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
11372041|NCT03305419|12568108|FG005|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
11372042|NCT03305419|12568109|FG006|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
11372043|NCT03305419|12568110|FG007|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
11372044|NCT03305419|12568103|FG000|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1
11372045|NCT03305419|12568104|FG001|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
11372046|NCT03305419|12568105|FG002|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
11372047|NCT03305419|12568106|FG003|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
11372048|NCT03305419|12568107|FG004|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
11372049|NCT03305419|12568108|FG005|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
11372050|NCT03305419|12568109|FG006|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
11372051|NCT03305419|12568110|FG007|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
11372052|NCT03305419|12568103|FG000|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2
11372053|NCT03305419|12568104|FG001|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
11372054|NCT03305419|12568105|FG002|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
11372055|NCT03305419|12568106|FG003|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
11372056|NCT03305419|12568107|FG004|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
11372057|NCT03305419|12568108|FG005|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
11372058|NCT03305419|12568109|FG006|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
11372059|NCT03305419|12568110|FG007|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
11372060|NCT03305419|12568103|FG000|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3
11372061|NCT03305419|12568104|FG001|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
11372062|NCT03305419|12568105|FG002|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
11372063|NCT03305419|12568106|FG003|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
11372064|NCT03305419|12568107|FG004|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
11372065|NCT03305419|12568108|FG005|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
11372066|NCT03305419|12568109|FG006|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
11372067|NCT03305419|12568110|FG007|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
11372068|NCT03305419|12568103|FG000|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
11372069|NCT03305419|12568104|FG001|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
11372070|NCT03305419|12568105|FG002|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
11372071|NCT03305419|12568106|FG003|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
11372072|NCT03305419|12568107|FG004|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
11372073|NCT03305419|12568108|FG005|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
11372074|NCT03305419|12568109|FG006|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
11372075|NCT03305419|12568110|FG007|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
11372076|NCT03305419|12568103|FG000|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
11372077|NCT03305419|12568104|FG001|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
11372078|NCT03305419|12568105|FG002|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
11372079|NCT03305419|12568106|FG003|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
11372080|NCT03305419|12568107|FG004|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
11372081|NCT03305419|12568108|FG005|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
11372082|NCT03305419|12568109|FG006|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
11372083|NCT03305419|12568110|FG007|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
11372084|NCT03305419|12568103|FG000|STARTED|Part B (14 Days)||0
11372085|NCT03305419|12568104|FG001|STARTED|Part B (14 Days)||0
11372086|NCT03305419|12568105|FG002|STARTED|Part B (14 Days)||0
11372087|NCT03305419|12568106|FG003|STARTED|Part B (14 Days)||0
11372088|NCT03305419|12568107|FG004|STARTED|Part B (14 Days)||14
11372089|NCT03305419|12568108|FG005|STARTED|Part B (14 Days)||20
11372090|NCT03305419|12568109|FG006|STARTED|Part B (14 Days)||13
11372091|NCT03305419|12568110|FG007|STARTED|Part B (14 Days)||0
11372092|NCT03305419|12568103|FG000|COMPLETED|Part B (14 Days)||0
11372093|NCT03305419|12568104|FG001|COMPLETED|Part B (14 Days)||0
11372094|NCT03305419|12568105|FG002|COMPLETED|Part B (14 Days)||0
11005718|NCT00724152|12183437|FG002|NOT COMPLETED|Two-arm Study Period||0
11005719|NCT00724152|12183435|FG000|STARTED|Three-arm Study Period (+Standard Care)||4
11372095|NCT03305419|12568106|FG003|COMPLETED|Part B (14 Days)||0
11372096|NCT03305419|12568107|FG004|COMPLETED|Part B (14 Days)||11
11372097|NCT03305419|12568108|FG005|COMPLETED|Part B (14 Days)||10
11372098|NCT03305419|12568109|FG006|COMPLETED|Part B (14 Days)||8
11372099|NCT03305419|12568110|FG007|COMPLETED|Part B (14 Days)||0
11372100|NCT03305419|12568103|FG000|NOT COMPLETED|Part B (14 Days)||0
11005720|NCT00724152|12183436|FG001|STARTED|Three-arm Study Period (+Standard Care)||2
11372101|NCT03305419|12568104|FG001|NOT COMPLETED|Part B (14 Days)||0
11372102|NCT03305419|12568105|FG002|NOT COMPLETED|Part B (14 Days)||0
11372103|NCT03305419|12568106|FG003|NOT COMPLETED|Part B (14 Days)||0
11372104|NCT03305419|12568107|FG004|NOT COMPLETED|Part B (14 Days)||3
11372105|NCT03305419|12568108|FG005|NOT COMPLETED|Part B (14 Days)||10
11372106|NCT03305419|12568109|FG006|NOT COMPLETED|Part B (14 Days)||5
11372107|NCT03305419|12568110|FG007|NOT COMPLETED|Part B (14 Days)||0
11372108|NCT03305575|12568135|FG000|STARTED|Overall Study||5
11372109|NCT03305575|12568136|FG001|STARTED|Overall Study||5
11372110|NCT03305575|12568135|FG000|COMPLETED|Overall Study||4
11372111|NCT03305575|12568136|FG001|COMPLETED|Overall Study||5
11372112|NCT03305575|12568135|FG000|NOT COMPLETED|Overall Study||1
11372113|NCT03305575|12568136|FG001|NOT COMPLETED|Overall Study||0
11372114|NCT03305653|12568142|FG000|STARTED|Overall Study||21
11372115|NCT03305653|12568142|FG000|COMPLETED|Overall Study||21
11372116|NCT03305653|12568142|FG000|NOT COMPLETED|Overall Study||0
11372117|NCT03305666|12568148|FG000|STARTED|Overall Study||18
11372118|NCT03305666|12568149|FG001|STARTED|Overall Study||18
11372119|NCT03305666|12568148|FG000|COMPLETED|Overall Study||16
11372120|NCT03305666|12568149|FG001|COMPLETED|Overall Study||18
11372121|NCT03305666|12568148|FG000|NOT COMPLETED|Overall Study||2
11372122|NCT03305666|12568149|FG001|NOT COMPLETED|Overall Study||0
11372123|NCT03305731|12568155|FG000|STARTED|Overall Study||21
11372124|NCT03305731|12568155|FG000|Week 6|Overall Study||20
11372125|NCT03305731|12568155|FG000|Week 11|Overall Study||20
11372126|NCT03305731|12568155|FG000|COMPLETED|Overall Study||20
11372127|NCT03305731|12568155|FG000|NOT COMPLETED|Overall Study||1
11372128|NCT03305770|12568161|FG000|STARTED|Overall Study||70
11372129|NCT03305770|12568162|FG001|STARTED|Overall Study||37
11372130|NCT03305770|12568161|FG000|Enrolled Dispensed Analysis Set|Overall Study||70
11372131|NCT03305770|12568162|FG001|Enrolled Dispensed Analysis Set|Overall Study||36
11372132|NCT03305770|12568161|FG000|Completed Analysis Set|Overall Study||69
11372133|NCT03305770|12568162|FG001|Completed Analysis Set|Overall Study||36
11372134|NCT03305770|12568161|FG000|COMPLETED|Overall Study||69
11372135|NCT03305770|12568162|FG001|COMPLETED|Overall Study||36
11372136|NCT03305770|12568161|FG000|NOT COMPLETED|Overall Study||1
11372137|NCT03305770|12568162|FG001|NOT COMPLETED|Overall Study||1
11372138|NCT03305809|12568174|FG000|STARTED|Overall Study||86
11372139|NCT03305809|12568175|FG001|STARTED|Overall Study||86
11372140|NCT03305809|12568176|FG002|STARTED|Overall Study||85
11372141|NCT03305809|12568177|FG003|STARTED|Overall Study||87
11372142|NCT03305809|12568174|FG000|Received at Least One Dose of Study Drug|Overall Study||86
11372143|NCT03305809|12568175|FG001|Received at Least One Dose of Study Drug|Overall Study||86
11372144|NCT03305809|12568176|FG002|Received at Least One Dose of Study Drug|Overall Study||85
11372145|NCT03305809|12568177|FG003|Received at Least One Dose of Study Drug|Overall Study||87
11372146|NCT03305809|12568174|FG000|COMPLETED|Overall Study||79
11372147|NCT03305809|12568175|FG001|COMPLETED|Overall Study||78
11372148|NCT03305809|12568176|FG002|COMPLETED|Overall Study||66
11372149|NCT03305809|12568177|FG003|COMPLETED|Overall Study||60
11372150|NCT03305809|12568174|FG000|NOT COMPLETED|Overall Study||7
11372151|NCT03305809|12568175|FG001|NOT COMPLETED|Overall Study||8
11372152|NCT03305809|12568176|FG002|NOT COMPLETED|Overall Study||19
11372153|NCT03305809|12568177|FG003|NOT COMPLETED|Overall Study||27
11372154|NCT03305822|12568190|FG000|STARTED|Period 1||20
11372155|NCT03305822|12568191|FG001|STARTED|Period 1||18
11372156|NCT03305822|12568190|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
11372157|NCT03305822|12568191|FG001|Received at Least 1 Dose of Study Drug|Period 1||18
11372158|NCT03305822|12568190|FG000|COMPLETED|Period 1||20
11372159|NCT03305822|12568191|FG001|COMPLETED|Period 1||18
11372160|NCT03305822|12568190|FG000|NOT COMPLETED|Period 1||0
11372161|NCT03305822|12568191|FG001|NOT COMPLETED|Period 1||0
11372162|NCT03305822|12568190|FG000|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|20
11372163|NCT03305822|12568191|FG001|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|18
11372164|NCT03305822|12568190|FG000|COMPLETED|Washout||20
11372165|NCT03305822|12568191|FG001|COMPLETED|Washout||18
11372166|NCT03305822|12568190|FG000|NOT COMPLETED|Washout||0
11372167|NCT03305822|12568191|FG001|NOT COMPLETED|Washout||0
11372168|NCT03305822|12568190|FG000|STARTED|Period 2||20
11372169|NCT03305822|12568191|FG001|STARTED|Period 2||18
11372170|NCT03305822|12568190|FG000|Received at Least 1 Dose of Study Drug|Period 2||20
11372171|NCT03305822|12568191|FG001|Received at Least 1 Dose of Study Drug|Period 2||18
11372172|NCT03305822|12568190|FG000|COMPLETED|Period 2||20
11372173|NCT03305822|12568191|FG001|COMPLETED|Period 2||18
11372174|NCT03305822|12568190|FG000|NOT COMPLETED|Period 2||0
11372175|NCT03305822|12568191|FG001|NOT COMPLETED|Period 2||0
11372176|NCT03305887|12568199|FG000|STARTED|Overall Study||91
11372177|NCT03305887|12568200|FG001|STARTED|Overall Study||93
11372178|NCT03305887|12568199|FG000|COMPLETED|Overall Study||80
11372179|NCT03305887|12568200|FG001|COMPLETED|Overall Study||83
11372180|NCT03305887|12568199|FG000|NOT COMPLETED|Overall Study||11
11372181|NCT03305887|12568200|FG001|NOT COMPLETED|Overall Study||10
11372182|NCT03306043|12568206|FG000|STARTED|Overall Study||102
11372183|NCT03306043|12568206|FG000|COMPLETED|Overall Study||98
11372184|NCT03306043|12568206|FG000|NOT COMPLETED|Overall Study||4
11372185|NCT03306199|12568210|FG000|STARTED|Overall Study||82
11372186|NCT03306199|12568210|FG000|COMPLETED|Overall Study||67
11372187|NCT03306199|12568210|FG000|NOT COMPLETED|Overall Study||15
11372188|NCT03306420|12568219|FG000|STARTED|Overall Study||3
11372189|NCT03306420|12568220|FG001|STARTED|Overall Study||3
11372190|NCT03306420|12568221|FG002|STARTED|Overall Study||3
11372191|NCT03306420|12568222|FG003|STARTED|Overall Study||3
11372192|NCT03306420|12568223|FG004|STARTED|Overall Study||3
11372193|NCT03306420|12568219|FG000|COMPLETED|Overall Study||3
11372194|NCT03306420|12568220|FG001|COMPLETED|Overall Study||3
11372195|NCT03306420|12568221|FG002|COMPLETED|Overall Study||3
11372196|NCT03306420|12568222|FG003|COMPLETED|Overall Study||3
11372197|NCT03306420|12568223|FG004|COMPLETED|Overall Study||3
11372198|NCT03306420|12568219|FG000|NOT COMPLETED|Overall Study||0
11372199|NCT03306420|12568220|FG001|NOT COMPLETED|Overall Study||0
11372200|NCT03306420|12568221|FG002|NOT COMPLETED|Overall Study||0
11372201|NCT03306420|12568222|FG003|NOT COMPLETED|Overall Study||0
11372202|NCT03306420|12568223|FG004|NOT COMPLETED|Overall Study||0
11372203|NCT03306433|12568235|FG000|STARTED|Overall Study||16
11372204|NCT03306433|12568235|FG000|UDMA-K18|Overall Study||12
11372205|NCT03306433|12568235|FG000|Adhesive Control|Overall Study||12
11372206|NCT03306433|12568235|FG000|UDMA-control|Overall Study||9
11372207|NCT03306433|12568235|FG000|COMPLETED|Overall Study||9
11372208|NCT03306433|12568235|FG000|NOT COMPLETED|Overall Study||7
11372209|NCT03306589|12568249|FG000|STARTED|Part 1 (69 Days)||2
11372210|NCT03306589|12568250|FG001|STARTED|Part 1 (69 Days)||4
11372211|NCT03306589|12568251|FG002|STARTED|Part 1 (69 Days)||2
11372212|NCT03306589|12568252|FG003|STARTED|Part 1 (69 Days)||4
11372213|NCT03306589|12568253|FG004|STARTED|Part 1 (69 Days)||0
11372214|NCT03306589|12568254|FG005|STARTED|Part 1 (69 Days)||0
11372215|NCT03306589|12568249|FG000|COMPLETED|Part 1 (69 Days)||2
11372216|NCT03306589|12568250|FG001|COMPLETED|Part 1 (69 Days)||4
11372217|NCT03306589|12568251|FG002|COMPLETED|Part 1 (69 Days)||2
11372218|NCT03306589|12568252|FG003|COMPLETED|Part 1 (69 Days)||4
11372219|NCT03306589|12568253|FG004|COMPLETED|Part 1 (69 Days)||0
11372220|NCT03306589|12568254|FG005|COMPLETED|Part 1 (69 Days)||0
11372221|NCT03306589|12568249|FG000|NOT COMPLETED|Part 1 (69 Days)||0
11372222|NCT03306589|12568250|FG001|NOT COMPLETED|Part 1 (69 Days)||0
11372223|NCT03306589|12568251|FG002|NOT COMPLETED|Part 1 (69 Days)||0
11372224|NCT03306589|12568252|FG003|NOT COMPLETED|Part 1 (69 Days)||0
11372225|NCT03306589|12568253|FG004|NOT COMPLETED|Part 1 (69 Days)||0
11372226|NCT03306589|12568254|FG005|NOT COMPLETED|Part 1 (69 Days)||0
11372227|NCT03306589|12568249|FG000|STARTED|Part 2 (69 Days)||0
11372228|NCT03306589|12568250|FG001|STARTED|Part 2 (69 Days)||0
11372229|NCT03306589|12568251|FG002|STARTED|Part 2 (69 Days)||0
11372230|NCT03306589|12568252|FG003|STARTED|Part 2 (69 Days)||0
11372231|NCT03306589|12568253|FG004|STARTED|Part 2 (69 Days)||0
11372232|NCT03306589|12568254|FG005|STARTED|Part 2 (69 Days)||0
11372233|NCT03306589|12568249|FG000|COMPLETED|Part 2 (69 Days)||0
11372234|NCT03306589|12568250|FG001|COMPLETED|Part 2 (69 Days)||0
11372235|NCT03306589|12568251|FG002|COMPLETED|Part 2 (69 Days)||0
11372236|NCT03306589|12568252|FG003|COMPLETED|Part 2 (69 Days)||0
11372237|NCT03306589|12568253|FG004|COMPLETED|Part 2 (69 Days)||0
11372238|NCT03306589|12568254|FG005|COMPLETED|Part 2 (69 Days)||0
11372239|NCT03306589|12568249|FG000|NOT COMPLETED|Part 2 (69 Days)||0
11372240|NCT03306589|12568250|FG001|NOT COMPLETED|Part 2 (69 Days)||0
11372241|NCT03306589|12568251|FG002|NOT COMPLETED|Part 2 (69 Days)||0
11372242|NCT03306589|12568252|FG003|NOT COMPLETED|Part 2 (69 Days)||0
11372243|NCT03306589|12568253|FG004|NOT COMPLETED|Part 2 (69 Days)||0
11372244|NCT03306589|12568254|FG005|NOT COMPLETED|Part 2 (69 Days)||0
11372245|NCT03306641|12568270|FG000|STARTED|First Intervention||23
11372246|NCT03306641|12568271|FG001|STARTED|First Intervention||22
11372247|NCT03306641|12568270|FG000|COMPLETED|First Intervention||23
11372248|NCT03306641|12568271|FG001|COMPLETED|First Intervention||22
11372249|NCT03306641|12568270|FG000|NOT COMPLETED|First Intervention||0
11372250|NCT03306641|12568271|FG001|NOT COMPLETED|First Intervention||0
11372251|NCT03306641|12568270|FG000|STARTED|Second Intervention||23
11372252|NCT03306641|12568271|FG001|STARTED|Second Intervention||22
11372253|NCT03306641|12568270|FG000|COMPLETED|Second Intervention||23
11372254|NCT03306641|12568271|FG001|COMPLETED|Second Intervention||22
11372255|NCT03306641|12568270|FG000|NOT COMPLETED|Second Intervention||0
11372256|NCT03306641|12568271|FG001|NOT COMPLETED|Second Intervention||0
11372257|NCT03307005|12568279|FG000|STARTED|Overall Study||3
11372258|NCT03307005|12568280|FG001|STARTED|Overall Study||2
11372259|NCT03307005|12568279|FG000|COMPLETED|Overall Study||3
11372260|NCT03307005|12568280|FG001|COMPLETED|Overall Study||2
11372261|NCT03307005|12568279|FG000|NOT COMPLETED|Overall Study||0
11372262|NCT03307005|12568280|FG001|NOT COMPLETED|Overall Study||0
11372263|NCT03307174|12568290|FG000|STARTED|Overall Study||60
11372264|NCT03307174|12568291|FG001|STARTED|Overall Study||60
11372265|NCT03307174|12568290|FG000|COMPLETED|Overall Study||46
11372266|NCT03307174|12568291|FG001|COMPLETED|Overall Study||53
11372267|NCT03307174|12568290|FG000|NOT COMPLETED|Overall Study||14
11372268|NCT03307174|12568291|FG001|NOT COMPLETED|Overall Study||7
11372269|NCT03307252|12568308|FG000|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
11372270|NCT03307252|12568309|FG001|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
11372271|NCT03307252|12568310|FG002|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
11372272|NCT03307252|12568311|FG003|STARTED|Part 1, Period 1||0
11372273|NCT03307252|12568312|FG004|STARTED|Part 1, Period 1||0
11372274|NCT03307252|12568313|FG005|STARTED|Part 1, Period 1||0
11372275|NCT03307252|12568314|FG006|STARTED|Part 1, Period 1||0
11372276|NCT03307252|12568315|FG007|STARTED|Part 1, Period 1||0
11372277|NCT03307252|12568316|FG008|STARTED|Part 1, Period 1||0
11372278|NCT03307252|12568317|FG009|STARTED|Part 1, Period 1||0
11372279|NCT03307252|12568318|FG010|STARTED|Part 1, Period 1||0
11372280|NCT03307252|12568308|FG000|COMPLETED|Part 1, Period 1||4
11372281|NCT03307252|12568309|FG001|COMPLETED|Part 1, Period 1||4
11372282|NCT03307252|12568310|FG002|COMPLETED|Part 1, Period 1||4
11372283|NCT03307252|12568311|FG003|COMPLETED|Part 1, Period 1||0
11372284|NCT03307252|12568312|FG004|COMPLETED|Part 1, Period 1||0
11372285|NCT03307252|12568313|FG005|COMPLETED|Part 1, Period 1||0
11372286|NCT03307252|12568314|FG006|COMPLETED|Part 1, Period 1||0
11372287|NCT03307252|12568315|FG007|COMPLETED|Part 1, Period 1||0
11372288|NCT03307252|12568316|FG008|COMPLETED|Part 1, Period 1||0
11372289|NCT03307252|12568317|FG009|COMPLETED|Part 1, Period 1||0
11372290|NCT03307252|12568318|FG010|COMPLETED|Part 1, Period 1||0
11372291|NCT03307252|12568308|FG000|NOT COMPLETED|Part 1, Period 1||0
11372292|NCT03307252|12568309|FG001|NOT COMPLETED|Part 1, Period 1||0
11372293|NCT03307252|12568310|FG002|NOT COMPLETED|Part 1, Period 1||0
11372294|NCT03307252|12568311|FG003|NOT COMPLETED|Part 1, Period 1||0
11005721|NCT00724152|12183437|FG002|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
11005722|NCT00724152|12183435|FG000|COMPLETED|Three-arm Study Period (+Standard Care)||3
11005723|NCT00724152|12183436|FG001|COMPLETED|Three-arm Study Period (+Standard Care)||0
11005724|NCT00724152|12183437|FG002|COMPLETED|Three-arm Study Period (+Standard Care)||1
11372295|NCT03307252|12568312|FG004|NOT COMPLETED|Part 1, Period 1||0
11372296|NCT03307252|12568313|FG005|NOT COMPLETED|Part 1, Period 1||0
11372297|NCT03307252|12568314|FG006|NOT COMPLETED|Part 1, Period 1||0
11372298|NCT03307252|12568315|FG007|NOT COMPLETED|Part 1, Period 1||0
11372299|NCT03307252|12568316|FG008|NOT COMPLETED|Part 1, Period 1||0
11372300|NCT03307252|12568317|FG009|NOT COMPLETED|Part 1, Period 1||0
11372301|NCT03307252|12568318|FG010|NOT COMPLETED|Part 1, Period 1||0
11372302|NCT03307252|12568308|FG000|STARTED|Part 1, Washout Period 1 (13 Days)||4
11372303|NCT03307252|12568309|FG001|STARTED|Part 1, Washout Period 1 (13 Days)||4
11372304|NCT03307252|12568310|FG002|STARTED|Part 1, Washout Period 1 (13 Days)||4
11372305|NCT03307252|12568311|FG003|STARTED|Part 1, Washout Period 1 (13 Days)||0
11372306|NCT03307252|12568312|FG004|STARTED|Part 1, Washout Period 1 (13 Days)||0
11372307|NCT03307252|12568313|FG005|STARTED|Part 1, Washout Period 1 (13 Days)||0
11372308|NCT03307252|12568314|FG006|STARTED|Part 1, Washout Period 1 (13 Days)||0
11372309|NCT03307252|12568315|FG007|STARTED|Part 1, Washout Period 1 (13 Days)||0
11372310|NCT03307252|12568316|FG008|STARTED|Part 1, Washout Period 1 (13 Days)||0
11372311|NCT03307252|12568317|FG009|STARTED|Part 1, Washout Period 1 (13 Days)||0
11372312|NCT03307252|12568318|FG010|STARTED|Part 1, Washout Period 1 (13 Days)||0
11372313|NCT03307252|12568308|FG000|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
11372314|NCT03307252|12568309|FG001|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
11372315|NCT03307252|12568310|FG002|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
11372316|NCT03307252|12568311|FG003|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372317|NCT03307252|12568312|FG004|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372318|NCT03307252|12568313|FG005|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372319|NCT03307252|12568314|FG006|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372320|NCT03307252|12568315|FG007|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372321|NCT03307252|12568316|FG008|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372322|NCT03307252|12568317|FG009|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372323|NCT03307252|12568318|FG010|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372324|NCT03307252|12568308|FG000|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372325|NCT03307252|12568309|FG001|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372326|NCT03307252|12568310|FG002|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372327|NCT03307252|12568311|FG003|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372328|NCT03307252|12568312|FG004|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372329|NCT03307252|12568313|FG005|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372330|NCT03307252|12568314|FG006|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372331|NCT03307252|12568315|FG007|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372332|NCT03307252|12568316|FG008|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372333|NCT03307252|12568317|FG009|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372334|NCT03307252|12568318|FG010|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
11372335|NCT03307252|12568308|FG000|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
11372336|NCT03307252|12568309|FG001|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
11372337|NCT03307252|12568310|FG002|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
11372338|NCT03307252|12568311|FG003|STARTED|Part 1, Period 2||0
11372339|NCT03307252|12568312|FG004|STARTED|Part 1, Period 2||0
11372340|NCT03307252|12568313|FG005|STARTED|Part 1, Period 2||0
11372341|NCT03307252|12568314|FG006|STARTED|Part 1, Period 2||0
11372342|NCT03307252|12568315|FG007|STARTED|Part 1, Period 2||0
11372343|NCT03307252|12568316|FG008|STARTED|Part 1, Period 2||0
11372344|NCT03307252|12568317|FG009|STARTED|Part 1, Period 2||0
11372345|NCT03307252|12568318|FG010|STARTED|Part 1, Period 2||0
11372346|NCT03307252|12568308|FG000|COMPLETED|Part 1, Period 2||4
11372347|NCT03307252|12568309|FG001|COMPLETED|Part 1, Period 2||4
11372348|NCT03307252|12568310|FG002|COMPLETED|Part 1, Period 2||4
11372349|NCT03307252|12568311|FG003|COMPLETED|Part 1, Period 2||0
11372350|NCT03307252|12568312|FG004|COMPLETED|Part 1, Period 2||0
11372351|NCT03307252|12568313|FG005|COMPLETED|Part 1, Period 2||0
11372352|NCT03307252|12568314|FG006|COMPLETED|Part 1, Period 2||0
11372353|NCT03307252|12568315|FG007|COMPLETED|Part 1, Period 2||0
11372354|NCT03307252|12568316|FG008|COMPLETED|Part 1, Period 2||0
11372355|NCT03307252|12568317|FG009|COMPLETED|Part 1, Period 2||0
11372356|NCT03307252|12568318|FG010|COMPLETED|Part 1, Period 2||0
11372357|NCT03307252|12568308|FG000|NOT COMPLETED|Part 1, Period 2||0
11372358|NCT03307252|12568309|FG001|NOT COMPLETED|Part 1, Period 2||0
11372359|NCT03307252|12568310|FG002|NOT COMPLETED|Part 1, Period 2||0
11372360|NCT03307252|12568311|FG003|NOT COMPLETED|Part 1, Period 2||0
11372361|NCT03307252|12568312|FG004|NOT COMPLETED|Part 1, Period 2||0
11372362|NCT03307252|12568313|FG005|NOT COMPLETED|Part 1, Period 2||0
11372363|NCT03307252|12568314|FG006|NOT COMPLETED|Part 1, Period 2||0
11372364|NCT03307252|12568315|FG007|NOT COMPLETED|Part 1, Period 2||0
11372365|NCT03307252|12568316|FG008|NOT COMPLETED|Part 1, Period 2||0
11372366|NCT03307252|12568317|FG009|NOT COMPLETED|Part 1, Period 2||0
11372367|NCT03307252|12568318|FG010|NOT COMPLETED|Part 1, Period 2||0
11372368|NCT03307252|12568308|FG000|STARTED|Part 1, Washout Period 2 (13 Days)||4
11372369|NCT03307252|12568309|FG001|STARTED|Part 1, Washout Period 2 (13 Days)||4
11372370|NCT03307252|12568310|FG002|STARTED|Part 1, Washout Period 2 (13 Days)||4
11372371|NCT03307252|12568311|FG003|STARTED|Part 1, Washout Period 2 (13 Days)||0
11372372|NCT03307252|12568312|FG004|STARTED|Part 1, Washout Period 2 (13 Days)||0
11372373|NCT03307252|12568313|FG005|STARTED|Part 1, Washout Period 2 (13 Days)||0
11372374|NCT03307252|12568314|FG006|STARTED|Part 1, Washout Period 2 (13 Days)||0
11372375|NCT03307252|12568315|FG007|STARTED|Part 1, Washout Period 2 (13 Days)||0
11372376|NCT03307252|12568316|FG008|STARTED|Part 1, Washout Period 2 (13 Days)||0
11372377|NCT03307252|12568317|FG009|STARTED|Part 1, Washout Period 2 (13 Days)||0
11372378|NCT03307252|12568318|FG010|STARTED|Part 1, Washout Period 2 (13 Days)||0
11372379|NCT03307252|12568308|FG000|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
11372380|NCT03307252|12568309|FG001|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
11372381|NCT03307252|12568310|FG002|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
11372382|NCT03307252|12568311|FG003|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372383|NCT03307252|12568312|FG004|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372384|NCT03307252|12568313|FG005|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372385|NCT03307252|12568314|FG006|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372386|NCT03307252|12568315|FG007|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372387|NCT03307252|12568316|FG008|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372388|NCT03307252|12568317|FG009|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372389|NCT03307252|12568318|FG010|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372390|NCT03307252|12568308|FG000|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372391|NCT03307252|12568309|FG001|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372392|NCT03307252|12568310|FG002|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372393|NCT03307252|12568311|FG003|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372394|NCT03307252|12568312|FG004|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372395|NCT03307252|12568313|FG005|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372396|NCT03307252|12568314|FG006|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372397|NCT03307252|12568315|FG007|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372398|NCT03307252|12568316|FG008|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372399|NCT03307252|12568317|FG009|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372400|NCT03307252|12568318|FG010|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
11372401|NCT03307252|12568308|FG000|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
11372402|NCT03307252|12568309|FG001|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
11372403|NCT03307252|12568310|FG002|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
11372404|NCT03307252|12568311|FG003|STARTED|Part 1, Period 3||0
11372405|NCT03307252|12568312|FG004|STARTED|Part 1, Period 3||0
11372406|NCT03307252|12568313|FG005|STARTED|Part 1, Period 3||0
11372407|NCT03307252|12568314|FG006|STARTED|Part 1, Period 3||0
11372408|NCT03307252|12568315|FG007|STARTED|Part 1, Period 3||0
11372409|NCT03307252|12568316|FG008|STARTED|Part 1, Period 3||0
11372410|NCT03307252|12568317|FG009|STARTED|Part 1, Period 3||0
11372411|NCT03307252|12568318|FG010|STARTED|Part 1, Period 3||0
11372412|NCT03307252|12568308|FG000|COMPLETED|Part 1, Period 3||4
11372413|NCT03307252|12568309|FG001|COMPLETED|Part 1, Period 3||4
11372414|NCT03307252|12568310|FG002|COMPLETED|Part 1, Period 3||4
11372415|NCT03307252|12568311|FG003|COMPLETED|Part 1, Period 3||0
11372416|NCT03307252|12568312|FG004|COMPLETED|Part 1, Period 3||0
11372417|NCT03307252|12568313|FG005|COMPLETED|Part 1, Period 3||0
11372418|NCT03307252|12568314|FG006|COMPLETED|Part 1, Period 3||0
11372419|NCT03307252|12568315|FG007|COMPLETED|Part 1, Period 3||0
11372420|NCT03307252|12568316|FG008|COMPLETED|Part 1, Period 3||0
11372421|NCT03307252|12568317|FG009|COMPLETED|Part 1, Period 3||0
11372422|NCT03307252|12568318|FG010|COMPLETED|Part 1, Period 3||0
11372423|NCT03307252|12568308|FG000|NOT COMPLETED|Part 1, Period 3||0
11372424|NCT03307252|12568309|FG001|NOT COMPLETED|Part 1, Period 3||0
11372425|NCT03307252|12568310|FG002|NOT COMPLETED|Part 1, Period 3||0
11372426|NCT03307252|12568311|FG003|NOT COMPLETED|Part 1, Period 3||0
11372427|NCT03307252|12568312|FG004|NOT COMPLETED|Part 1, Period 3||0
11372428|NCT03307252|12568313|FG005|NOT COMPLETED|Part 1, Period 3||0
11372429|NCT03307252|12568314|FG006|NOT COMPLETED|Part 1, Period 3||0
11372430|NCT03307252|12568315|FG007|NOT COMPLETED|Part 1, Period 3||0
11372431|NCT03307252|12568316|FG008|NOT COMPLETED|Part 1, Period 3||0
11372432|NCT03307252|12568317|FG009|NOT COMPLETED|Part 1, Period 3||0
11372433|NCT03307252|12568318|FG010|NOT COMPLETED|Part 1, Period 3||0
11372434|NCT03307252|12568308|FG000|STARTED|Part 2, Period 1||0
11372435|NCT03307252|12568309|FG001|STARTED|Part 2, Period 1||0
11372436|NCT03307252|12568310|FG002|STARTED|Part 2, Period 1||0
11372437|NCT03307252|12568311|FG003|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
11372438|NCT03307252|12568312|FG004|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
11372439|NCT03307252|12568313|FG005|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
11372440|NCT03307252|12568314|FG006|STARTED|Part 2, Period 1|Participants randomized in Part 2|5
11372441|NCT03307252|12568315|FG007|STARTED|Part 2, Period 1||0
11372442|NCT03307252|12568316|FG008|STARTED|Part 2, Period 1||0
11372443|NCT03307252|12568317|FG009|STARTED|Part 2, Period 1||0
11372444|NCT03307252|12568318|FG010|STARTED|Part 2, Period 1||0
11372445|NCT03307252|12568308|FG000|COMPLETED|Part 2, Period 1||0
11372446|NCT03307252|12568309|FG001|COMPLETED|Part 2, Period 1||0
11372447|NCT03307252|12568310|FG002|COMPLETED|Part 2, Period 1||0
11372448|NCT03307252|12568311|FG003|COMPLETED|Part 2, Period 1||4
11372449|NCT03307252|12568312|FG004|COMPLETED|Part 2, Period 1||4
11372450|NCT03307252|12568313|FG005|COMPLETED|Part 2, Period 1||3
11372451|NCT03307252|12568314|FG006|COMPLETED|Part 2, Period 1||5
11372452|NCT03307252|12568315|FG007|COMPLETED|Part 2, Period 1||0
11372453|NCT03307252|12568316|FG008|COMPLETED|Part 2, Period 1||0
11372454|NCT03307252|12568317|FG009|COMPLETED|Part 2, Period 1||0
11372455|NCT03307252|12568318|FG010|COMPLETED|Part 2, Period 1||0
11372456|NCT03307252|12568308|FG000|NOT COMPLETED|Part 2, Period 1||0
11372457|NCT03307252|12568309|FG001|NOT COMPLETED|Part 2, Period 1||0
11372458|NCT03307252|12568310|FG002|NOT COMPLETED|Part 2, Period 1||0
11372459|NCT03307252|12568311|FG003|NOT COMPLETED|Part 2, Period 1||0
11372460|NCT03307252|12568312|FG004|NOT COMPLETED|Part 2, Period 1||0
11372461|NCT03307252|12568313|FG005|NOT COMPLETED|Part 2, Period 1||1
11372462|NCT03307252|12568314|FG006|NOT COMPLETED|Part 2, Period 1||0
11372463|NCT03307252|12568315|FG007|NOT COMPLETED|Part 2, Period 1||0
11372464|NCT03307252|12568316|FG008|NOT COMPLETED|Part 2, Period 1||0
11372465|NCT03307252|12568317|FG009|NOT COMPLETED|Part 2, Period 1||0
11372466|NCT03307252|12568318|FG010|NOT COMPLETED|Part 2, Period 1||0
11372467|NCT03307252|12568308|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0
11372468|NCT03307252|12568309|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0
11372469|NCT03307252|12568310|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0
11372470|NCT03307252|12568311|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||4
11372471|NCT03307252|12568312|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||4
11372472|NCT03307252|12568313|FG005|STARTED|Part 2, Washout Period 1 (7 Days)||3
11372473|NCT03307252|12568314|FG006|STARTED|Part 2, Washout Period 1 (7 Days)||5
11372474|NCT03307252|12568315|FG007|STARTED|Part 2, Washout Period 1 (7 Days)||0
11372475|NCT03307252|12568316|FG008|STARTED|Part 2, Washout Period 1 (7 Days)||0
11372476|NCT03307252|12568317|FG009|STARTED|Part 2, Washout Period 1 (7 Days)||0
11372477|NCT03307252|12568318|FG010|STARTED|Part 2, Washout Period 1 (7 Days)||0
11372478|NCT03307252|12568308|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372479|NCT03307252|12568309|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372480|NCT03307252|12568310|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372481|NCT03307252|12568311|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
11372482|NCT03307252|12568312|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
11372483|NCT03307252|12568313|FG005|COMPLETED|Part 2, Washout Period 1 (7 Days)||3
11372484|NCT03307252|12568314|FG006|COMPLETED|Part 2, Washout Period 1 (7 Days)||5
11372485|NCT03307252|12568315|FG007|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372486|NCT03307252|12568316|FG008|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372487|NCT03307252|12568317|FG009|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372488|NCT03307252|12568318|FG010|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372489|NCT03307252|12568308|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372490|NCT03307252|12568309|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372491|NCT03307252|12568310|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372492|NCT03307252|12568311|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372493|NCT03307252|12568312|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372494|NCT03307252|12568313|FG005|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372495|NCT03307252|12568314|FG006|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372496|NCT03307252|12568315|FG007|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372497|NCT03307252|12568316|FG008|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372498|NCT03307252|12568317|FG009|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372499|NCT03307252|12568318|FG010|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
11372500|NCT03307252|12568308|FG000|STARTED|Part 2, Period 2||0
11372501|NCT03307252|12568309|FG001|STARTED|Part 2, Period 2||0
11372502|NCT03307252|12568310|FG002|STARTED|Part 2, Period 2||0
11372503|NCT03307252|12568311|FG003|STARTED|Part 2, Period 2||4
11372504|NCT03307252|12568312|FG004|STARTED|Part 2, Period 2||4
11372505|NCT03307252|12568313|FG005|STARTED|Part 2, Period 2||3
11372506|NCT03307252|12568314|FG006|STARTED|Part 2, Period 2||5
11372507|NCT03307252|12568315|FG007|STARTED|Part 2, Period 2||0
11372508|NCT03307252|12568316|FG008|STARTED|Part 2, Period 2||0
11372509|NCT03307252|12568317|FG009|STARTED|Part 2, Period 2||0
11372510|NCT03307252|12568318|FG010|STARTED|Part 2, Period 2||0
11372511|NCT03307252|12568308|FG000|COMPLETED|Part 2, Period 2||0
11372512|NCT03307252|12568309|FG001|COMPLETED|Part 2, Period 2||0
11005725|NCT00724152|12183435|FG000|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
11005726|NCT00724152|12183436|FG001|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
11372513|NCT03307252|12568310|FG002|COMPLETED|Part 2, Period 2||0
11372514|NCT03307252|12568311|FG003|COMPLETED|Part 2, Period 2||4
11372515|NCT03307252|12568312|FG004|COMPLETED|Part 2, Period 2||4
11372516|NCT03307252|12568313|FG005|COMPLETED|Part 2, Period 2||3
11372517|NCT03307252|12568314|FG006|COMPLETED|Part 2, Period 2||5
11372518|NCT03307252|12568315|FG007|COMPLETED|Part 2, Period 2||0
11372519|NCT03307252|12568316|FG008|COMPLETED|Part 2, Period 2||0
11372520|NCT03307252|12568317|FG009|COMPLETED|Part 2, Period 2||0
11372521|NCT03307252|12568318|FG010|COMPLETED|Part 2, Period 2||0
11372522|NCT03307252|12568308|FG000|NOT COMPLETED|Part 2, Period 2||0
11372523|NCT03307252|12568309|FG001|NOT COMPLETED|Part 2, Period 2||0
11372524|NCT03307252|12568310|FG002|NOT COMPLETED|Part 2, Period 2||0
11372525|NCT03307252|12568311|FG003|NOT COMPLETED|Part 2, Period 2||0
11372526|NCT03307252|12568312|FG004|NOT COMPLETED|Part 2, Period 2||0
11372527|NCT03307252|12568313|FG005|NOT COMPLETED|Part 2, Period 2||0
11372528|NCT03307252|12568314|FG006|NOT COMPLETED|Part 2, Period 2||0
11372529|NCT03307252|12568315|FG007|NOT COMPLETED|Part 2, Period 2||0
11372530|NCT03307252|12568316|FG008|NOT COMPLETED|Part 2, Period 2||0
11372531|NCT03307252|12568317|FG009|NOT COMPLETED|Part 2, Period 2||0
11372532|NCT03307252|12568318|FG010|NOT COMPLETED|Part 2, Period 2||0
11372533|NCT03307252|12568308|FG000|STARTED|Part 2, Washout Period 2 (7 Days)||0
11372534|NCT03307252|12568309|FG001|STARTED|Part 2, Washout Period 2 (7 Days)||0
11372535|NCT03307252|12568310|FG002|STARTED|Part 2, Washout Period 2 (7 Days)||0
11372536|NCT03307252|12568311|FG003|STARTED|Part 2, Washout Period 2 (7 Days)||4
11372537|NCT03307252|12568312|FG004|STARTED|Part 2, Washout Period 2 (7 Days)||4
11372538|NCT03307252|12568313|FG005|STARTED|Part 2, Washout Period 2 (7 Days)||3
11372539|NCT03307252|12568314|FG006|STARTED|Part 2, Washout Period 2 (7 Days)||5
11372540|NCT03307252|12568315|FG007|STARTED|Part 2, Washout Period 2 (7 Days)||0
11372541|NCT03307252|12568316|FG008|STARTED|Part 2, Washout Period 2 (7 Days)||0
11372542|NCT03307252|12568317|FG009|STARTED|Part 2, Washout Period 2 (7 Days)||0
11372543|NCT03307252|12568318|FG010|STARTED|Part 2, Washout Period 2 (7 Days)||0
11372544|NCT03307252|12568308|FG000|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372545|NCT03307252|12568309|FG001|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372546|NCT03307252|12568310|FG002|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372547|NCT03307252|12568311|FG003|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
11372548|NCT03307252|12568312|FG004|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
11372549|NCT03307252|12568313|FG005|COMPLETED|Part 2, Washout Period 2 (7 Days)||3
11372550|NCT03307252|12568314|FG006|COMPLETED|Part 2, Washout Period 2 (7 Days)||5
11372551|NCT03307252|12568315|FG007|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372552|NCT03307252|12568316|FG008|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372553|NCT03307252|12568317|FG009|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372554|NCT03307252|12568318|FG010|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372555|NCT03307252|12568308|FG000|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372556|NCT03307252|12568309|FG001|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372557|NCT03307252|12568310|FG002|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372558|NCT03307252|12568311|FG003|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372559|NCT03307252|12568312|FG004|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372560|NCT03307252|12568313|FG005|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372561|NCT03307252|12568314|FG006|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372562|NCT03307252|12568315|FG007|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372563|NCT03307252|12568316|FG008|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372564|NCT03307252|12568317|FG009|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372565|NCT03307252|12568318|FG010|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
11372566|NCT03307252|12568308|FG000|STARTED|Part 2, Period 3||0
11372567|NCT03307252|12568309|FG001|STARTED|Part 2, Period 3||0
11372568|NCT03307252|12568310|FG002|STARTED|Part 2, Period 3||0
11372569|NCT03307252|12568311|FG003|STARTED|Part 2, Period 3||4
11372570|NCT03307252|12568312|FG004|STARTED|Part 2, Period 3||4
11372571|NCT03307252|12568313|FG005|STARTED|Part 2, Period 3||3
11372572|NCT03307252|12568314|FG006|STARTED|Part 2, Period 3||5
11372573|NCT03307252|12568315|FG007|STARTED|Part 2, Period 3||0
11372574|NCT03307252|12568316|FG008|STARTED|Part 2, Period 3||0
11372575|NCT03307252|12568317|FG009|STARTED|Part 2, Period 3||0
11372576|NCT03307252|12568318|FG010|STARTED|Part 2, Period 3||0
11372577|NCT03307252|12568308|FG000|COMPLETED|Part 2, Period 3||0
11372578|NCT03307252|12568309|FG001|COMPLETED|Part 2, Period 3||0
11372579|NCT03307252|12568310|FG002|COMPLETED|Part 2, Period 3||0
11372580|NCT03307252|12568311|FG003|COMPLETED|Part 2, Period 3||4
11372581|NCT03307252|12568312|FG004|COMPLETED|Part 2, Period 3||3
11372582|NCT03307252|12568313|FG005|COMPLETED|Part 2, Period 3||3
11372583|NCT03307252|12568314|FG006|COMPLETED|Part 2, Period 3||5
11372584|NCT03307252|12568315|FG007|COMPLETED|Part 2, Period 3||0
11372585|NCT03307252|12568316|FG008|COMPLETED|Part 2, Period 3||0
11372586|NCT03307252|12568317|FG009|COMPLETED|Part 2, Period 3||0
11372587|NCT03307252|12568318|FG010|COMPLETED|Part 2, Period 3||0
11372588|NCT03307252|12568308|FG000|NOT COMPLETED|Part 2, Period 3||0
11372589|NCT03307252|12568309|FG001|NOT COMPLETED|Part 2, Period 3||0
11372590|NCT03307252|12568310|FG002|NOT COMPLETED|Part 2, Period 3||0
11372591|NCT03307252|12568311|FG003|NOT COMPLETED|Part 2, Period 3||0
11372592|NCT03307252|12568312|FG004|NOT COMPLETED|Part 2, Period 3||1
11372593|NCT03307252|12568313|FG005|NOT COMPLETED|Part 2, Period 3||0
11372594|NCT03307252|12568314|FG006|NOT COMPLETED|Part 2, Period 3||0
11372595|NCT03307252|12568315|FG007|NOT COMPLETED|Part 2, Period 3||0
11372596|NCT03307252|12568316|FG008|NOT COMPLETED|Part 2, Period 3||0
11372597|NCT03307252|12568317|FG009|NOT COMPLETED|Part 2, Period 3||0
11372598|NCT03307252|12568318|FG010|NOT COMPLETED|Part 2, Period 3||0
11372599|NCT03307252|12568308|FG000|STARTED|Part 2, Washout Period 3 (7 Days)||0
11372600|NCT03307252|12568309|FG001|STARTED|Part 2, Washout Period 3 (7 Days)||0
11005727|NCT00724152|12183437|FG002|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
11005728|NCT00724243|12183447|FG000|STARTED|Overall Study||33
11005729|NCT00724243|12183447|FG000|COMPLETED|Overall Study||18
11005730|NCT00724243|12183447|FG000|NOT COMPLETED|Overall Study||15
11005731|NCT00724308|12183453|FG000|STARTED|Overall Study||270
11005732|NCT00724308|12183454|FG001|STARTED|Overall Study||307
11005733|NCT00724308|12183453|FG000|COMPLETED|Overall Study||190
11005734|NCT00724308|12183454|FG001|COMPLETED|Overall Study||210
11005735|NCT00724308|12183453|FG000|NOT COMPLETED|Overall Study||80
11005736|NCT00724308|12183454|FG001|NOT COMPLETED|Overall Study||97
11005737|NCT00724347|12183460|FG000|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
11372601|NCT03307252|12568310|FG002|STARTED|Part 2, Washout Period 3 (7 Days)||0
11372602|NCT03307252|12568311|FG003|STARTED|Part 2, Washout Period 3 (7 Days)||4
11372603|NCT03307252|12568312|FG004|STARTED|Part 2, Washout Period 3 (7 Days)||3
11372604|NCT03307252|12568313|FG005|STARTED|Part 2, Washout Period 3 (7 Days)||3
11372605|NCT03307252|12568314|FG006|STARTED|Part 2, Washout Period 3 (7 Days)||5
11372606|NCT03307252|12568315|FG007|STARTED|Part 2, Washout Period 3 (7 Days)||0
11372607|NCT03307252|12568316|FG008|STARTED|Part 2, Washout Period 3 (7 Days)||0
11372608|NCT03307252|12568317|FG009|STARTED|Part 2, Washout Period 3 (7 Days)||0
11372609|NCT03307252|12568318|FG010|STARTED|Part 2, Washout Period 3 (7 Days)||0
11372610|NCT03307252|12568308|FG000|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372611|NCT03307252|12568309|FG001|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11005738|NCT00724347|12183460|FG000|Baseline Testing|Overall Study||18
11005739|NCT00724347|12183460|FG000|COMPLETED|Overall Study||16
11005740|NCT00724347|12183460|FG000|NOT COMPLETED|Overall Study||2
11005741|NCT00724373|12183464|FG000|STARTED|Overall Study||442
11005742|NCT00724373|12183464|FG000|COMPLETED|Overall Study||271
11005743|NCT00724373|12183464|FG000|NOT COMPLETED|Overall Study||171
11372612|NCT03307252|12568310|FG002|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372613|NCT03307252|12568311|FG003|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
11372614|NCT03307252|12568312|FG004|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
11372615|NCT03307252|12568313|FG005|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
11372616|NCT03307252|12568314|FG006|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
11372617|NCT03307252|12568315|FG007|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372618|NCT03307252|12568316|FG008|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372619|NCT03307252|12568317|FG009|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372620|NCT03307252|12568318|FG010|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372621|NCT03307252|12568308|FG000|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372622|NCT03307252|12568309|FG001|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372623|NCT03307252|12568310|FG002|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372624|NCT03307252|12568311|FG003|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372625|NCT03307252|12568312|FG004|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372626|NCT03307252|12568313|FG005|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372627|NCT03307252|12568314|FG006|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1
11372628|NCT03307252|12568315|FG007|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372629|NCT03307252|12568316|FG008|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372630|NCT03307252|12568317|FG009|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372631|NCT03307252|12568318|FG010|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
11372632|NCT03307252|12568308|FG000|STARTED|Part 2, Period 4||0
11372633|NCT03307252|12568309|FG001|STARTED|Part 2, Period 4||0
11372634|NCT03307252|12568310|FG002|STARTED|Part 2, Period 4||0
11372635|NCT03307252|12568311|FG003|STARTED|Part 2, Period 4||4
11372636|NCT03307252|12568312|FG004|STARTED|Part 2, Period 4||3
11372637|NCT03307252|12568313|FG005|STARTED|Part 2, Period 4||3
11372638|NCT03307252|12568314|FG006|STARTED|Part 2, Period 4||5
11372639|NCT03307252|12568315|FG007|STARTED|Part 2, Period 4||0
11372640|NCT03307252|12568316|FG008|STARTED|Part 2, Period 4||0
11372641|NCT03307252|12568317|FG009|STARTED|Part 2, Period 4||0
11372642|NCT03307252|12568318|FG010|STARTED|Part 2, Period 4||0
11005744|NCT00724451|12183468|FG000|STARTED|Overall Study||1128
11372643|NCT03307252|12568308|FG000|COMPLETED|Part 2, Period 4||0
11372644|NCT03307252|12568309|FG001|COMPLETED|Part 2, Period 4||0
11372645|NCT03307252|12568310|FG002|COMPLETED|Part 2, Period 4||0
11372646|NCT03307252|12568311|FG003|COMPLETED|Part 2, Period 4||4
11372647|NCT03307252|12568312|FG004|COMPLETED|Part 2, Period 4||3
11372648|NCT03307252|12568313|FG005|COMPLETED|Part 2, Period 4||3
11372649|NCT03307252|12568314|FG006|COMPLETED|Part 2, Period 4||4
11372650|NCT03307252|12568315|FG007|COMPLETED|Part 2, Period 4||0
11372651|NCT03307252|12568316|FG008|COMPLETED|Part 2, Period 4||0
11372652|NCT03307252|12568317|FG009|COMPLETED|Part 2, Period 4||0
11372653|NCT03307252|12568318|FG010|COMPLETED|Part 2, Period 4||0
11372654|NCT03307252|12568308|FG000|NOT COMPLETED|Part 2, Period 4||0
11372655|NCT03307252|12568309|FG001|NOT COMPLETED|Part 2, Period 4||0
11372656|NCT03307252|12568310|FG002|NOT COMPLETED|Part 2, Period 4||0
11372657|NCT03307252|12568311|FG003|NOT COMPLETED|Part 2, Period 4||0
11372658|NCT03307252|12568312|FG004|NOT COMPLETED|Part 2, Period 4||0
11372659|NCT03307252|12568313|FG005|NOT COMPLETED|Part 2, Period 4||0
11372660|NCT03307252|12568314|FG006|NOT COMPLETED|Part 2, Period 4||1
11372661|NCT03307252|12568315|FG007|NOT COMPLETED|Part 2, Period 4||0
11372662|NCT03307252|12568316|FG008|NOT COMPLETED|Part 2, Period 4||0
11372663|NCT03307252|12568317|FG009|NOT COMPLETED|Part 2, Period 4||0
11372664|NCT03307252|12568318|FG010|NOT COMPLETED|Part 2, Period 4||0
11372665|NCT03307252|12568308|FG000|STARTED|Part 3, Period 1||0
11372666|NCT03307252|12568309|FG001|STARTED|Part 3, Period 1||0
11372667|NCT03307252|12568310|FG002|STARTED|Part 3, Period 1||0
11372668|NCT03307252|12568311|FG003|STARTED|Part 3, Period 1||0
11372669|NCT03307252|12568312|FG004|STARTED|Part 3, Period 1||0
11372670|NCT03307252|12568313|FG005|STARTED|Part 3, Period 1||0
11372671|NCT03307252|12568314|FG006|STARTED|Part 3, Period 1||0
11372672|NCT03307252|12568315|FG007|STARTED|Part 3, Period 1||4
11372673|NCT03307252|12568316|FG008|STARTED|Part 3, Period 1||4
11372674|NCT03307252|12568317|FG009|STARTED|Part 3, Period 1||4
11372675|NCT03307252|12568318|FG010|STARTED|Part 3, Period 1||4
11372676|NCT03307252|12568308|FG000|COMPLETED|Part 3, Period 1||0
11372677|NCT03307252|12568309|FG001|COMPLETED|Part 3, Period 1||0
11372678|NCT03307252|12568310|FG002|COMPLETED|Part 3, Period 1||0
11372679|NCT03307252|12568311|FG003|COMPLETED|Part 3, Period 1||0
11372680|NCT03307252|12568312|FG004|COMPLETED|Part 3, Period 1||0
11372681|NCT03307252|12568313|FG005|COMPLETED|Part 3, Period 1||0
11372682|NCT03307252|12568314|FG006|COMPLETED|Part 3, Period 1||0
11372683|NCT03307252|12568315|FG007|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
11372684|NCT03307252|12568316|FG008|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
11372685|NCT03307252|12568317|FG009|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
11372686|NCT03307252|12568318|FG010|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
11372687|NCT03307252|12568308|FG000|NOT COMPLETED|Part 3, Period 1||0
11372688|NCT03307252|12568309|FG001|NOT COMPLETED|Part 3, Period 1||0
11372689|NCT03307252|12568310|FG002|NOT COMPLETED|Part 3, Period 1||0
11372690|NCT03307252|12568311|FG003|NOT COMPLETED|Part 3, Period 1||0
11372691|NCT03307252|12568312|FG004|NOT COMPLETED|Part 3, Period 1||0
11372692|NCT03307252|12568313|FG005|NOT COMPLETED|Part 3, Period 1||0
11372693|NCT03307252|12568314|FG006|NOT COMPLETED|Part 3, Period 1||0
11372694|NCT03307252|12568315|FG007|NOT COMPLETED|Part 3, Period 1||0
11372695|NCT03307252|12568316|FG008|NOT COMPLETED|Part 3, Period 1||0
11372696|NCT03307252|12568317|FG009|NOT COMPLETED|Part 3, Period 1||0
11372697|NCT03307252|12568318|FG010|NOT COMPLETED|Part 3, Period 1||0
11372698|NCT03307252|12568308|FG000|STARTED|Part 3, Washout Period 1 (7 Days)||0
11372699|NCT03307252|12568309|FG001|STARTED|Part 3, Washout Period 1 (7 Days)||0
11372700|NCT03307252|12568310|FG002|STARTED|Part 3, Washout Period 1 (7 Days)||0
11372701|NCT03307252|12568311|FG003|STARTED|Part 3, Washout Period 1 (7 Days)||0
11372702|NCT03307252|12568312|FG004|STARTED|Part 3, Washout Period 1 (7 Days)||0
11372703|NCT03307252|12568313|FG005|STARTED|Part 3, Washout Period 1 (7 Days)||0
11372704|NCT03307252|12568314|FG006|STARTED|Part 3, Washout Period 1 (7 Days)||0
11372705|NCT03307252|12568315|FG007|STARTED|Part 3, Washout Period 1 (7 Days)||4
11372706|NCT03307252|12568316|FG008|STARTED|Part 3, Washout Period 1 (7 Days)||4
11372707|NCT03307252|12568317|FG009|STARTED|Part 3, Washout Period 1 (7 Days)||4
11372708|NCT03307252|12568318|FG010|STARTED|Part 3, Washout Period 1 (7 Days)||4
11372709|NCT03307252|12568308|FG000|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372710|NCT03307252|12568309|FG001|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372711|NCT03307252|12568310|FG002|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372712|NCT03307252|12568311|FG003|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372713|NCT03307252|12568312|FG004|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372714|NCT03307252|12568313|FG005|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372715|NCT03307252|12568314|FG006|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372716|NCT03307252|12568315|FG007|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
11372717|NCT03307252|12568316|FG008|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
11372718|NCT03307252|12568317|FG009|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
11372719|NCT03307252|12568318|FG010|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
11372720|NCT03307252|12568308|FG000|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372721|NCT03307252|12568309|FG001|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372722|NCT03307252|12568310|FG002|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372723|NCT03307252|12568311|FG003|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372724|NCT03307252|12568312|FG004|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372725|NCT03307252|12568313|FG005|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372726|NCT03307252|12568314|FG006|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372727|NCT03307252|12568315|FG007|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372728|NCT03307252|12568316|FG008|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372729|NCT03307252|12568317|FG009|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372730|NCT03307252|12568318|FG010|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
11372731|NCT03307252|12568308|FG000|STARTED|Part 3, Period 2||0
11372732|NCT03307252|12568309|FG001|STARTED|Part 3, Period 2||0
11372733|NCT03307252|12568310|FG002|STARTED|Part 3, Period 2||0
11372734|NCT03307252|12568311|FG003|STARTED|Part 3, Period 2||0
11372735|NCT03307252|12568312|FG004|STARTED|Part 3, Period 2||0
11372736|NCT03307252|12568313|FG005|STARTED|Part 3, Period 2||0
11372737|NCT03307252|12568314|FG006|STARTED|Part 3, Period 2||0
11372738|NCT03307252|12568315|FG007|STARTED|Part 3, Period 2||4
11372739|NCT03307252|12568316|FG008|STARTED|Part 3, Period 2||4
11372740|NCT03307252|12568317|FG009|STARTED|Part 3, Period 2||4
11372741|NCT03307252|12568318|FG010|STARTED|Part 3, Period 2||4
11372742|NCT03307252|12568308|FG000|COMPLETED|Part 3, Period 2||0
11372743|NCT03307252|12568309|FG001|COMPLETED|Part 3, Period 2||0
11372744|NCT03307252|12568310|FG002|COMPLETED|Part 3, Period 2||0
11372745|NCT03307252|12568311|FG003|COMPLETED|Part 3, Period 2||0
11372746|NCT03307252|12568312|FG004|COMPLETED|Part 3, Period 2||0
11372747|NCT03307252|12568313|FG005|COMPLETED|Part 3, Period 2||0
11372748|NCT03307252|12568314|FG006|COMPLETED|Part 3, Period 2||0
11372749|NCT03307252|12568315|FG007|COMPLETED|Part 3, Period 2||4
11372750|NCT03307252|12568316|FG008|COMPLETED|Part 3, Period 2||4
11372751|NCT03307252|12568317|FG009|COMPLETED|Part 3, Period 2||4
11372752|NCT03307252|12568318|FG010|COMPLETED|Part 3, Period 2||4
11372753|NCT03307252|12568308|FG000|NOT COMPLETED|Part 3, Period 2||0
11372754|NCT03307252|12568309|FG001|NOT COMPLETED|Part 3, Period 2||0
11372755|NCT03307252|12568310|FG002|NOT COMPLETED|Part 3, Period 2||0
11372756|NCT03307252|12568311|FG003|NOT COMPLETED|Part 3, Period 2||0
11372757|NCT03307252|12568312|FG004|NOT COMPLETED|Part 3, Period 2||0
11372758|NCT03307252|12568313|FG005|NOT COMPLETED|Part 3, Period 2||0
11372759|NCT03307252|12568314|FG006|NOT COMPLETED|Part 3, Period 2||0
11372760|NCT03307252|12568315|FG007|NOT COMPLETED|Part 3, Period 2||0
11372761|NCT03307252|12568316|FG008|NOT COMPLETED|Part 3, Period 2||0
11372762|NCT03307252|12568317|FG009|NOT COMPLETED|Part 3, Period 2||0
11005745|NCT00724451|12183468|FG000|Received Antiviral Treatment|Overall Study||500
11005746|NCT00724451|12183468|FG000|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
11372763|NCT03307252|12568318|FG010|NOT COMPLETED|Part 3, Period 2||0
11372764|NCT03307252|12568308|FG000|STARTED|Part 3, Washout Period 2 (7 Days)||0
11372765|NCT03307252|12568309|FG001|STARTED|Part 3, Washout Period 2 (7 Days)||0
11372766|NCT03307252|12568310|FG002|STARTED|Part 3, Washout Period 2 (7 Days)||0
11372767|NCT03307252|12568311|FG003|STARTED|Part 3, Washout Period 2 (7 Days)||0
11372768|NCT03307252|12568312|FG004|STARTED|Part 3, Washout Period 2 (7 Days)||0
11372769|NCT03307252|12568313|FG005|STARTED|Part 3, Washout Period 2 (7 Days)||0
11372770|NCT03307252|12568314|FG006|STARTED|Part 3, Washout Period 2 (7 Days)||0
11372771|NCT03307252|12568315|FG007|STARTED|Part 3, Washout Period 2 (7 Days)||4
11372772|NCT03307252|12568316|FG008|STARTED|Part 3, Washout Period 2 (7 Days)||4
11005747|NCT00724451|12183468|FG000|NOT COMPLETED|Overall Study||802
11005748|NCT00724464|12183472|FG000|STARTED|Overall Study||332
11005749|NCT00724464|12183472|FG000|COMPLETED|Overall Study||309
11005750|NCT00724464|12183472|FG000|NOT COMPLETED|Overall Study||23
11372773|NCT03307252|12568317|FG009|STARTED|Part 3, Washout Period 2 (7 Days)||4
11372774|NCT03307252|12568318|FG010|STARTED|Part 3, Washout Period 2 (7 Days)||4
11372775|NCT03307252|12568308|FG000|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372776|NCT03307252|12568309|FG001|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372777|NCT03307252|12568310|FG002|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372778|NCT03307252|12568311|FG003|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372779|NCT03307252|12568312|FG004|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372780|NCT03307252|12568313|FG005|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372781|NCT03307252|12568314|FG006|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372782|NCT03307252|12568315|FG007|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
11372783|NCT03307252|12568316|FG008|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
11372784|NCT03307252|12568317|FG009|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
11372785|NCT03307252|12568318|FG010|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
11372786|NCT03307252|12568308|FG000|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372787|NCT03307252|12568309|FG001|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372788|NCT03307252|12568310|FG002|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372789|NCT03307252|12568311|FG003|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372790|NCT03307252|12568312|FG004|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372791|NCT03307252|12568313|FG005|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372792|NCT03307252|12568314|FG006|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372793|NCT03307252|12568315|FG007|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11005751|NCT00724503|12183479|FG000|STARTED|Overall Study||267
11005752|NCT00724503|12183480|FG001|STARTED|Overall Study||263
11005753|NCT00724503|12183479|FG000|COMPLETED|Overall Study||57
11005754|NCT00724503|12183480|FG001|COMPLETED|Overall Study||43
11005755|NCT00724503|12183479|FG000|NOT COMPLETED|Overall Study||210
11005756|NCT00724503|12183480|FG001|NOT COMPLETED|Overall Study||220
11372794|NCT03307252|12568316|FG008|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372795|NCT03307252|12568317|FG009|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372796|NCT03307252|12568318|FG010|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
11372797|NCT03307252|12568308|FG000|STARTED|Part 3, Period 3||0
11372798|NCT03307252|12568309|FG001|STARTED|Part 3, Period 3||0
11372799|NCT03307252|12568310|FG002|STARTED|Part 3, Period 3||0
11372800|NCT03307252|12568311|FG003|STARTED|Part 3, Period 3||0
11372801|NCT03307252|12568312|FG004|STARTED|Part 3, Period 3||0
11372802|NCT03307252|12568313|FG005|STARTED|Part 3, Period 3||0
11372803|NCT03307252|12568314|FG006|STARTED|Part 3, Period 3||0
11372804|NCT03307252|12568315|FG007|STARTED|Part 3, Period 3||4
11372805|NCT03307252|12568316|FG008|STARTED|Part 3, Period 3||4
11372806|NCT03307252|12568317|FG009|STARTED|Part 3, Period 3||4
11372807|NCT03307252|12568318|FG010|STARTED|Part 3, Period 3||4
11372808|NCT03307252|12568308|FG000|COMPLETED|Part 3, Period 3||0
11372809|NCT03307252|12568309|FG001|COMPLETED|Part 3, Period 3||0
11372810|NCT03307252|12568310|FG002|COMPLETED|Part 3, Period 3||0
11372811|NCT03307252|12568311|FG003|COMPLETED|Part 3, Period 3||0
11372812|NCT03307252|12568312|FG004|COMPLETED|Part 3, Period 3||0
11372813|NCT03307252|12568313|FG005|COMPLETED|Part 3, Period 3||0
11372814|NCT03307252|12568314|FG006|COMPLETED|Part 3, Period 3||0
11372815|NCT03307252|12568315|FG007|COMPLETED|Part 3, Period 3||4
11372816|NCT03307252|12568316|FG008|COMPLETED|Part 3, Period 3||4
11372817|NCT03307252|12568317|FG009|COMPLETED|Part 3, Period 3||4
11372818|NCT03307252|12568318|FG010|COMPLETED|Part 3, Period 3||4
11372819|NCT03307252|12568308|FG000|NOT COMPLETED|Part 3, Period 3||0
11372820|NCT03307252|12568309|FG001|NOT COMPLETED|Part 3, Period 3||0
11372821|NCT03307252|12568310|FG002|NOT COMPLETED|Part 3, Period 3||0
11372822|NCT03307252|12568311|FG003|NOT COMPLETED|Part 3, Period 3||0
11372823|NCT03307252|12568312|FG004|NOT COMPLETED|Part 3, Period 3||0
11372824|NCT03307252|12568313|FG005|NOT COMPLETED|Part 3, Period 3||0
11372825|NCT03307252|12568314|FG006|NOT COMPLETED|Part 3, Period 3||0
11372826|NCT03307252|12568315|FG007|NOT COMPLETED|Part 3, Period 3||0
11372827|NCT03307252|12568316|FG008|NOT COMPLETED|Part 3, Period 3||0
11372828|NCT03307252|12568317|FG009|NOT COMPLETED|Part 3, Period 3||0
11372829|NCT03307252|12568318|FG010|NOT COMPLETED|Part 3, Period 3||0
11372830|NCT03307252|12568308|FG000|STARTED|Part 3, Washout Period 3 (7 Days)||0
11372831|NCT03307252|12568309|FG001|STARTED|Part 3, Washout Period 3 (7 Days)||0
11372832|NCT03307252|12568310|FG002|STARTED|Part 3, Washout Period 3 (7 Days)||0
11372833|NCT03307252|12568311|FG003|STARTED|Part 3, Washout Period 3 (7 Days)||0
11372834|NCT03307252|12568312|FG004|STARTED|Part 3, Washout Period 3 (7 Days)||0
11372835|NCT03307252|12568313|FG005|STARTED|Part 3, Washout Period 3 (7 Days)||0
11372836|NCT03307252|12568314|FG006|STARTED|Part 3, Washout Period 3 (7 Days)||0
11372837|NCT03307252|12568315|FG007|STARTED|Part 3, Washout Period 3 (7 Days)||4
11372838|NCT03307252|12568316|FG008|STARTED|Part 3, Washout Period 3 (7 Days)||4
11372839|NCT03307252|12568317|FG009|STARTED|Part 3, Washout Period 3 (7 Days)||4
11372840|NCT03307252|12568318|FG010|STARTED|Part 3, Washout Period 3 (7 Days)||4
11372841|NCT03307252|12568308|FG000|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372842|NCT03307252|12568309|FG001|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372843|NCT03307252|12568310|FG002|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372844|NCT03307252|12568311|FG003|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372845|NCT03307252|12568312|FG004|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372846|NCT03307252|12568313|FG005|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372847|NCT03307252|12568314|FG006|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372848|NCT03307252|12568315|FG007|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
11372849|NCT03307252|12568316|FG008|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
11372850|NCT03307252|12568317|FG009|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
11372851|NCT03307252|12568318|FG010|COMPLETED|Part 3, Washout Period 3 (7 Days)||3
11372852|NCT03307252|12568308|FG000|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372853|NCT03307252|12568309|FG001|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372854|NCT03307252|12568310|FG002|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372855|NCT03307252|12568311|FG003|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372856|NCT03307252|12568312|FG004|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372857|NCT03307252|12568313|FG005|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372858|NCT03307252|12568314|FG006|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372859|NCT03307252|12568315|FG007|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372860|NCT03307252|12568316|FG008|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372861|NCT03307252|12568317|FG009|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
11372862|NCT03307252|12568318|FG010|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1
11372863|NCT03307252|12568308|FG000|STARTED|Part 3, Period 4||0
11372864|NCT03307252|12568309|FG001|STARTED|Part 3, Period 4||0
11372865|NCT03307252|12568310|FG002|STARTED|Part 3, Period 4||0
11372866|NCT03307252|12568311|FG003|STARTED|Part 3, Period 4||0
11372867|NCT03307252|12568312|FG004|STARTED|Part 3, Period 4||0
11372868|NCT03307252|12568313|FG005|STARTED|Part 3, Period 4||0
11372869|NCT03307252|12568314|FG006|STARTED|Part 3, Period 4||0
11372870|NCT03307252|12568315|FG007|STARTED|Part 3, Period 4||4
11372871|NCT03307252|12568316|FG008|STARTED|Part 3, Period 4||4
11372872|NCT03307252|12568317|FG009|STARTED|Part 3, Period 4||4
11372873|NCT03307252|12568318|FG010|STARTED|Part 3, Period 4||3
11372874|NCT03307252|12568308|FG000|COMPLETED|Part 3, Period 4||0
11372875|NCT03307252|12568309|FG001|COMPLETED|Part 3, Period 4||0
11372876|NCT03307252|12568310|FG002|COMPLETED|Part 3, Period 4||0
11372877|NCT03307252|12568311|FG003|COMPLETED|Part 3, Period 4||0
11372878|NCT03307252|12568312|FG004|COMPLETED|Part 3, Period 4||0
11372879|NCT03307252|12568313|FG005|COMPLETED|Part 3, Period 4||0
11372880|NCT03307252|12568314|FG006|COMPLETED|Part 3, Period 4||0
11372881|NCT03307252|12568315|FG007|COMPLETED|Part 3, Period 4||4
11372882|NCT03307252|12568316|FG008|COMPLETED|Part 3, Period 4||4
11372883|NCT03307252|12568317|FG009|COMPLETED|Part 3, Period 4||4
11372884|NCT03307252|12568318|FG010|COMPLETED|Part 3, Period 4||3
11372885|NCT03307252|12568308|FG000|NOT COMPLETED|Part 3, Period 4||0
11372886|NCT03307252|12568309|FG001|NOT COMPLETED|Part 3, Period 4||0
11372887|NCT03307252|12568310|FG002|NOT COMPLETED|Part 3, Period 4||0
11372888|NCT03307252|12568311|FG003|NOT COMPLETED|Part 3, Period 4||0
11372889|NCT03307252|12568312|FG004|NOT COMPLETED|Part 3, Period 4||0
11372890|NCT03307252|12568313|FG005|NOT COMPLETED|Part 3, Period 4||0
11372891|NCT03307252|12568314|FG006|NOT COMPLETED|Part 3, Period 4||0
11372892|NCT03307252|12568315|FG007|NOT COMPLETED|Part 3, Period 4||0
11372893|NCT03307252|12568316|FG008|NOT COMPLETED|Part 3, Period 4||0
11372894|NCT03307252|12568317|FG009|NOT COMPLETED|Part 3, Period 4||0
11372895|NCT03307252|12568318|FG010|NOT COMPLETED|Part 3, Period 4||0
11372896|NCT03307837|12568340|FG000|STARTED|Overall Study||6
11372897|NCT03307837|12568341|FG001|STARTED|Overall Study||6
11372898|NCT03307837|12568342|FG002|STARTED|Overall Study||6
11372899|NCT03307837|12568343|FG003|STARTED|Overall Study||6
11372900|NCT03307837|12568344|FG004|STARTED|Overall Study||6
11372901|NCT03307837|12568345|FG005|STARTED|Overall Study||10
11372902|NCT03307837|12568340|FG000|COMPLETED|Overall Study||5
11372903|NCT03307837|12568341|FG001|COMPLETED|Overall Study||5
11372904|NCT03307837|12568342|FG002|COMPLETED|Overall Study||5
11372905|NCT03307837|12568343|FG003|COMPLETED|Overall Study||6
11372906|NCT03307837|12568344|FG004|COMPLETED|Overall Study||6
11372907|NCT03307837|12568345|FG005|COMPLETED|Overall Study||8
11372908|NCT03307837|12568340|FG000|NOT COMPLETED|Overall Study||1
11372909|NCT03307837|12568341|FG001|NOT COMPLETED|Overall Study||1
11372910|NCT03307837|12568342|FG002|NOT COMPLETED|Overall Study||1
11372911|NCT03307837|12568343|FG003|NOT COMPLETED|Overall Study||0
11005757|NCT00724568|12183488|FG000|STARTED|Overall Study||42
11005758|NCT00724568|12183489|FG001|STARTED|Overall Study||32
11005759|NCT00724568|12183488|FG000|COMPLETED|Overall Study||42
11005760|NCT00724568|12183489|FG001|COMPLETED|Overall Study||32
11005761|NCT00724568|12183488|FG000|NOT COMPLETED|Overall Study||0
11372912|NCT03307837|12568344|FG004|NOT COMPLETED|Overall Study||0
11372913|NCT03307837|12568345|FG005|NOT COMPLETED|Overall Study||2
11372914|NCT03308058|12568366|FG000|STARTED|Overall Study||23
11005762|NCT00724568|12183489|FG001|NOT COMPLETED|Overall Study||0
11005763|NCT00724594|12183497|FG000|STARTED|Overall Study||12
11372915|NCT03308058|12568367|FG001|STARTED|Overall Study||23
11372916|NCT03308058|12568366|FG000|COMPLETED|Overall Study||23
11372917|NCT03308058|12568367|FG001|COMPLETED|Overall Study||23
11372918|NCT03308058|12568366|FG000|NOT COMPLETED|Overall Study||0
11372919|NCT03308058|12568367|FG001|NOT COMPLETED|Overall Study||0
11372920|NCT03308097|12568375|FG000|STARTED|Overall Study||33
11372921|NCT03308097|12568376|FG001|STARTED|Overall Study||32
11372922|NCT03308097|12568375|FG000|COMPLETED|Overall Study||31
11372923|NCT03308097|12568376|FG001|COMPLETED|Overall Study||31
11372924|NCT03308097|12568375|FG000|NOT COMPLETED|Overall Study||2
11372925|NCT03308097|12568376|FG001|NOT COMPLETED|Overall Study||1
11372926|NCT03308669|12568384|FG000|STARTED|Overall Study||10
11372927|NCT03308669|12568385|FG001|STARTED|Overall Study||20
11372928|NCT03308669|12568384|FG000|Received at Least One Dose of Study Drug|Overall Study||10
11372929|NCT03308669|12568385|FG001|Received at Least One Dose of Study Drug|Overall Study||20
11005764|NCT00724594|12183498|FG001|STARTED|Overall Study||12
11372930|NCT03308669|12568384|FG000|COMPLETED|Overall Study||10
11372931|NCT03308669|12568385|FG001|COMPLETED|Overall Study||20
11372932|NCT03308669|12568384|FG000|NOT COMPLETED|Overall Study||0
11372933|NCT03308669|12568385|FG001|NOT COMPLETED|Overall Study||0
11372934|NCT03308799|12568406|FG000|STARTED|Overall Study||342
11372935|NCT03308799|12568407|FG001|STARTED|Overall Study||337
11372936|NCT03308799|12568408|FG002|STARTED|Overall Study||115
11372937|NCT03308799|12568406|FG000|COMPLETED|Overall Study||320
11372938|NCT03308799|12568407|FG001|COMPLETED|Overall Study||309
11372939|NCT03308799|12568408|FG002|COMPLETED|Overall Study||94
11372940|NCT03308799|12568406|FG000|NOT COMPLETED|Overall Study||22
11372941|NCT03308799|12568407|FG001|NOT COMPLETED|Overall Study||28
11372942|NCT03308799|12568408|FG002|NOT COMPLETED|Overall Study||21
11372943|NCT03308968|12568419|FG000|STARTED|Double-Blind Period (12 Weeks)||279
11372944|NCT03308968|12568420|FG001|STARTED|Double-Blind Period (12 Weeks)||276
11372945|NCT03308968|12568421|FG002|STARTED|Double-Blind Period (12 Weeks)||283
11372946|NCT03308968|12568419|FG000|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277
11372947|NCT03308968|12568420|FG001|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276
11372948|NCT03308968|12568421|FG002|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285
11372949|NCT03308968|12568419|FG000|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278
11372950|NCT03308968|12568420|FG001|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276
11372951|NCT03308968|12568421|FG002|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283
11372952|NCT03308968|12568419|FG000|COMPLETED|Double-Blind Period (12 Weeks)||264
11372953|NCT03308968|12568420|FG001|COMPLETED|Double-Blind Period (12 Weeks)||271
11372954|NCT03308968|12568421|FG002|COMPLETED|Double-Blind Period (12 Weeks)||272
11372955|NCT03308968|12568419|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||15
11372956|NCT03308968|12568420|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||5
11372957|NCT03308968|12568421|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||11
11372958|NCT03308968|12568419|FG000|STARTED|Open-Label Period (12 Weeks)||264
11372959|NCT03308968|12568420|FG001|STARTED|Open-Label Period (12 Weeks)||271
11372960|NCT03308968|12568421|FG002|STARTED|Open-Label Period (12 Weeks)||272
11142068|NCT01466166|12328754|FG000|NOT COMPLETED|Overall Study||163
11142069|NCT01466179|12328758|FG000|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
11205255|NCT01858194|12395997|FG001|NOT COMPLETED|Overall Study||2
11005765|NCT00724594|12183499|FG002|STARTED|Overall Study||11
11005766|NCT00724594|12183500|FG003|STARTED|Overall Study||11
11372961|NCT03308968|12568419|FG000|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263
11372962|NCT03308968|12568420|FG001|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271
11372963|NCT03308968|12568421|FG002|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272
11372964|NCT03308968|12568419|FG000|COMPLETED|Open-Label Period (12 Weeks)||253
11372965|NCT03308968|12568420|FG001|COMPLETED|Open-Label Period (12 Weeks)||259
11372966|NCT03308968|12568421|FG002|COMPLETED|Open-Label Period (12 Weeks)||260
11372967|NCT03308968|12568419|FG000|NOT COMPLETED|Open-Label Period (12 Weeks)||11
11372968|NCT03308968|12568420|FG001|NOT COMPLETED|Open-Label Period (12 Weeks)||12
11372969|NCT03308968|12568421|FG002|NOT COMPLETED|Open-Label Period (12 Weeks)||12
11372970|NCT03309020|12568434|FG000|STARTED|Overall Study||12
11372971|NCT03309020|12568435|FG001|STARTED|Overall Study||25
11372972|NCT03309020|12568434|FG000|Underwent Cataract Surgery|Overall Study||10
11372973|NCT03309020|12568435|FG001|Underwent Cataract Surgery|Overall Study||24
11372974|NCT03309020|12568434|FG000|COMPLETED|Overall Study||9
11372975|NCT03309020|12568435|FG001|COMPLETED|Overall Study||24
11372976|NCT03309020|12568434|FG000|NOT COMPLETED|Overall Study||3
11372977|NCT03309020|12568435|FG001|NOT COMPLETED|Overall Study||1
11372978|NCT03309202|12568447|FG000|STARTED|Overall Study||6
11372979|NCT03309202|12568448|FG001|STARTED|Overall Study||6
11372980|NCT03309202|12568449|FG002|STARTED|Overall Study||6
11372981|NCT03309202|12568450|FG003|STARTED|Overall Study||6
11372982|NCT03309202|12568447|FG000|COMPLETED|Overall Study||5
11372983|NCT03309202|12568448|FG001|COMPLETED|Overall Study||6
11372984|NCT03309202|12568449|FG002|COMPLETED|Overall Study||6
11372985|NCT03309202|12568450|FG003|COMPLETED|Overall Study||6
11372986|NCT03309202|12568447|FG000|NOT COMPLETED|Overall Study||1
11372987|NCT03309202|12568448|FG001|NOT COMPLETED|Overall Study||0
11372988|NCT03309202|12568449|FG002|NOT COMPLETED|Overall Study||0
11372989|NCT03309202|12568450|FG003|NOT COMPLETED|Overall Study||0
11372990|NCT03309449|12568463|FG000|STARTED|Overall Study||46
11372991|NCT03309449|12568464|FG001|STARTED|Overall Study||46
11372992|NCT03309449|12568465|FG002|STARTED|Overall Study||46
11372993|NCT03309449|12568463|FG000|COMPLETED|Overall Study||46
11372994|NCT03309449|12568464|FG001|COMPLETED|Overall Study||46
11372995|NCT03309449|12568465|FG002|COMPLETED|Overall Study||46
11372996|NCT03309449|12568463|FG000|NOT COMPLETED|Overall Study||0
11372997|NCT03309449|12568464|FG001|NOT COMPLETED|Overall Study||0
11372998|NCT03309449|12568465|FG002|NOT COMPLETED|Overall Study||0
11372999|NCT03309605|12568481|FG000|STARTED|Overall Study||6
11373000|NCT03309605|12568482|FG001|STARTED|Overall Study||5
11373001|NCT03309605|12568483|FG002|STARTED|Overall Study||6
11373002|NCT03309605|12568484|FG003|STARTED|Overall Study||6
11373003|NCT03309605|12568485|FG004|STARTED|Overall Study||6
11373004|NCT03309605|12568486|FG005|STARTED|Overall Study||6
11373005|NCT03309605|12568487|FG006|STARTED|Overall Study||6
11373006|NCT03309605|12568488|FG007|STARTED|Overall Study||21
11373007|NCT03309605|12568481|FG000|COMPLETED|Overall Study||6
11373008|NCT03309605|12568482|FG001|COMPLETED|Overall Study||5
11373009|NCT03309605|12568483|FG002|COMPLETED|Overall Study||6
11373010|NCT03309605|12568484|FG003|COMPLETED|Overall Study||5
11373011|NCT03309605|12568485|FG004|COMPLETED|Overall Study||5
11373012|NCT03309605|12568486|FG005|COMPLETED|Overall Study||6
11373013|NCT03309605|12568487|FG006|COMPLETED|Overall Study||3
11373014|NCT03309605|12568488|FG007|COMPLETED|Overall Study||19
11373015|NCT03309605|12568481|FG000|NOT COMPLETED|Overall Study||0
11373016|NCT03309605|12568482|FG001|NOT COMPLETED|Overall Study||0
11373017|NCT03309605|12568483|FG002|NOT COMPLETED|Overall Study||0
11373018|NCT03309605|12568484|FG003|NOT COMPLETED|Overall Study||1
11373019|NCT03309605|12568485|FG004|NOT COMPLETED|Overall Study||1
11373020|NCT03309605|12568486|FG005|NOT COMPLETED|Overall Study||0
11373021|NCT03309605|12568487|FG006|NOT COMPLETED|Overall Study||3
11373022|NCT03309605|12568488|FG007|NOT COMPLETED|Overall Study||2
11373023|NCT03309657|12568502|FG000|STARTED|Overall Study||10
11373024|NCT03309657|12568502|FG000|COMPLETED|Overall Study||10
11373025|NCT03309657|12568502|FG000|NOT COMPLETED|Overall Study||0
11373026|NCT03309696|12568508|FG000|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
11373027|NCT03309696|12568509|FG001|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
11373028|NCT03309696|12568510|FG002|STARTED|Overall Study||0
11373029|NCT03309696|12568511|FG003|STARTED|Overall Study||0
11373030|NCT03309696|12568508|FG000|COMPLETED|Overall Study||5
11373031|NCT03309696|12568509|FG001|COMPLETED|Overall Study||0
11373032|NCT03309696|12568510|FG002|COMPLETED|Overall Study||0
11373033|NCT03309696|12568511|FG003|COMPLETED|Overall Study||0
11373034|NCT03309696|12568508|FG000|NOT COMPLETED|Overall Study||0
11373035|NCT03309696|12568509|FG001|NOT COMPLETED|Overall Study||5
11373036|NCT03309696|12568510|FG002|NOT COMPLETED|Overall Study||0
11373037|NCT03309696|12568511|FG003|NOT COMPLETED|Overall Study||0
11373038|NCT03309787|12568522|FG000|STARTED|Overall Study||8
11373039|NCT03309787|12568523|FG001|STARTED|Overall Study||20
11373040|NCT03309787|12568524|FG002|STARTED|Overall Study||9
11373041|NCT03309787|12568522|FG000|COMPLETED|Overall Study||6
11373042|NCT03309787|12568523|FG001|COMPLETED|Overall Study||14
11373043|NCT03309787|12568524|FG002|COMPLETED|Overall Study||7
11373044|NCT03309787|12568522|FG000|NOT COMPLETED|Overall Study||2
11373045|NCT03309787|12568523|FG001|NOT COMPLETED|Overall Study||6
11373046|NCT03309787|12568524|FG002|NOT COMPLETED|Overall Study||2
11373047|NCT03309943|12568540|FG000|STARTED|Overall Study||22
11373048|NCT03309943|12568541|FG001|STARTED|Overall Study||22
11373049|NCT03309943|12568540|FG000|COMPLETED|Overall Study||22
11373050|NCT03309943|12568541|FG001|COMPLETED|Overall Study||20
11373051|NCT03309943|12568540|FG000|NOT COMPLETED|Overall Study||0
11373052|NCT03309943|12568541|FG001|NOT COMPLETED|Overall Study||2
11373053|NCT03310021|12568567|FG000|STARTED|Overall Study||6
11373054|NCT03310021|12568568|FG001|STARTED|Overall Study||3
11373055|NCT03310021|12568569|FG002|STARTED|Overall Study||6
11373056|NCT03310021|12568570|FG003|STARTED|Overall Study||3
11373057|NCT03310021|12568571|FG004|STARTED|Overall Study||8
11373058|NCT03310021|12568572|FG005|STARTED|Overall Study||4
11373059|NCT03310021|12568573|FG006|STARTED|Overall Study||8
11373060|NCT03310021|12568574|FG007|STARTED|Overall Study||4
11373061|NCT03310021|12568575|FG008|STARTED|Overall Study||6
11373062|NCT03310021|12568576|FG009|STARTED|Overall Study||3
11373063|NCT03310021|12568577|FG010|STARTED|Overall Study||6
11373064|NCT03310021|12568578|FG011|STARTED|Overall Study||3
11373065|NCT03310021|12568579|FG012|STARTED|Overall Study||8
11373066|NCT03310021|12568580|FG013|STARTED|Overall Study||4
11373067|NCT03310021|12568581|FG014|STARTED|Overall Study||6
11373068|NCT03310021|12568582|FG015|STARTED|Overall Study||3
11373069|NCT03310021|12568583|FG016|STARTED|Overall Study||10
11373070|NCT03310021|12568584|FG017|STARTED|Overall Study||5
11373071|NCT03310021|12568585|FG018|STARTED|Overall Study||8
11373072|NCT03310021|12568586|FG019|STARTED|Overall Study||3
11373073|NCT03310021|12568567|FG000|COMPLETED|Overall Study||6
11373074|NCT03310021|12568568|FG001|COMPLETED|Overall Study||3
11373075|NCT03310021|12568569|FG002|COMPLETED|Overall Study||6
11373076|NCT03310021|12568570|FG003|COMPLETED|Overall Study||3
11005767|NCT00724594|12183497|FG000|COMPLETED|Overall Study||12
11005768|NCT00724594|12183498|FG001|COMPLETED|Overall Study||12
11005769|NCT00724594|12183499|FG002|COMPLETED|Overall Study||11
11005770|NCT00724594|12183500|FG003|COMPLETED|Overall Study||10
11005771|NCT00724594|12183497|FG000|NOT COMPLETED|Overall Study||0
11005772|NCT00724594|12183498|FG001|NOT COMPLETED|Overall Study||0
11005773|NCT00724594|12183499|FG002|NOT COMPLETED|Overall Study||0
11005774|NCT00724594|12183500|FG003|NOT COMPLETED|Overall Study||1
11005775|NCT00724711|12183527|FG000|STARTED|Overall Study||155
11005776|NCT00724711|12183528|FG001|STARTED|Overall Study||156
11005777|NCT00724711|12183527|FG000|COMPLETED|Overall Study||138
11373077|NCT03310021|12568571|FG004|COMPLETED|Overall Study||8
11005778|NCT00724711|12183528|FG001|COMPLETED|Overall Study||139
11005779|NCT00724711|12183527|FG000|NOT COMPLETED|Overall Study||17
11005780|NCT00724711|12183528|FG001|NOT COMPLETED|Overall Study||17
11005781|NCT00724750|12183536|FG000|STARTED|Overall Study||45
11005782|NCT00724750|12183537|FG001|STARTED|Overall Study||42
11005783|NCT00724750|12183536|FG000|COMPLETED|Overall Study||45
11005784|NCT00724750|12183537|FG001|COMPLETED|Overall Study||42
11005785|NCT00724750|12183536|FG000|NOT COMPLETED|Overall Study||0
11005786|NCT00724750|12183537|FG001|NOT COMPLETED|Overall Study||0
11005787|NCT00724815|12183545|FG000|STARTED|Overall Study|subjects randomized|265
11005788|NCT00724815|12183546|FG001|STARTED|Overall Study|subjects randomized|265
11005789|NCT00724815|12183545|FG000|COMPLETED|Overall Study||222
11005790|NCT00724815|12183546|FG001|COMPLETED|Overall Study||226
11373078|NCT03310021|12568572|FG005|COMPLETED|Overall Study||4
11373079|NCT03310021|12568573|FG006|COMPLETED|Overall Study||7
11373080|NCT03310021|12568574|FG007|COMPLETED|Overall Study||4
11373081|NCT03310021|12568575|FG008|COMPLETED|Overall Study||6
11373082|NCT03310021|12568576|FG009|COMPLETED|Overall Study||3
11373083|NCT03310021|12568577|FG010|COMPLETED|Overall Study||5
11373084|NCT03310021|12568578|FG011|COMPLETED|Overall Study||3
11373085|NCT03310021|12568579|FG012|COMPLETED|Overall Study||8
11373086|NCT03310021|12568580|FG013|COMPLETED|Overall Study||4
11373087|NCT03310021|12568581|FG014|COMPLETED|Overall Study||6
11373088|NCT03310021|12568582|FG015|COMPLETED|Overall Study||3
11373089|NCT03310021|12568583|FG016|COMPLETED|Overall Study||10
11373090|NCT03310021|12568584|FG017|COMPLETED|Overall Study||5
11373091|NCT03310021|12568585|FG018|COMPLETED|Overall Study||8
11373092|NCT03310021|12568586|FG019|COMPLETED|Overall Study||3
11373093|NCT03310021|12568567|FG000|NOT COMPLETED|Overall Study||0
11373094|NCT03310021|12568568|FG001|NOT COMPLETED|Overall Study||0
11373095|NCT03310021|12568569|FG002|NOT COMPLETED|Overall Study||0
11373096|NCT03310021|12568570|FG003|NOT COMPLETED|Overall Study||0
11373097|NCT03310021|12568571|FG004|NOT COMPLETED|Overall Study||0
11373098|NCT03310021|12568572|FG005|NOT COMPLETED|Overall Study||0
11373099|NCT03310021|12568573|FG006|NOT COMPLETED|Overall Study||1
11373100|NCT03310021|12568574|FG007|NOT COMPLETED|Overall Study||0
11373101|NCT03310021|12568575|FG008|NOT COMPLETED|Overall Study||0
11373102|NCT03310021|12568576|FG009|NOT COMPLETED|Overall Study||0
11373103|NCT03310021|12568577|FG010|NOT COMPLETED|Overall Study||1
11005791|NCT00724815|12183545|FG000|NOT COMPLETED|Overall Study||43
11005792|NCT00724815|12183546|FG001|NOT COMPLETED|Overall Study||39
11005793|NCT00724854|12183554|FG000|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
11005794|NCT00724854|12183555|FG001|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
11005795|NCT00724854|12183554|FG000|COMPLETED|Overall Study||607
11005796|NCT00724854|12183555|FG001|COMPLETED|Overall Study||41
11005797|NCT00724854|12183554|FG000|NOT COMPLETED|Overall Study||403
11005798|NCT00724854|12183555|FG001|NOT COMPLETED|Overall Study||31
11005799|NCT00724867|12183562|FG000|STARTED|Overall Study||268
11373104|NCT03310021|12568578|FG011|NOT COMPLETED|Overall Study||0
11373105|NCT03310021|12568579|FG012|NOT COMPLETED|Overall Study||0
11373106|NCT03310021|12568580|FG013|NOT COMPLETED|Overall Study||0
11373107|NCT03310021|12568581|FG014|NOT COMPLETED|Overall Study||0
11373108|NCT03310021|12568582|FG015|NOT COMPLETED|Overall Study||0
11373109|NCT03310021|12568583|FG016|NOT COMPLETED|Overall Study||0
11373110|NCT03310021|12568584|FG017|NOT COMPLETED|Overall Study||0
11373111|NCT03310021|12568585|FG018|NOT COMPLETED|Overall Study||0
11373112|NCT03310021|12568586|FG019|NOT COMPLETED|Overall Study||0
11373113|NCT03310268|12568631|FG000|STARTED|Overall Study||62
11373114|NCT03310268|12568632|FG001|STARTED|Overall Study||62
11373115|NCT03310268|12568633|FG002|STARTED|Overall Study||61
11373116|NCT03310268|12568631|FG000|COMPLETED|Overall Study||61
11373117|NCT03310268|12568632|FG001|COMPLETED|Overall Study||57
11373118|NCT03310268|12568633|FG002|COMPLETED|Overall Study||61
11373119|NCT03310268|12568631|FG000|NOT COMPLETED|Overall Study||1
11373120|NCT03310268|12568632|FG001|NOT COMPLETED|Overall Study||5
11373121|NCT03310268|12568633|FG002|NOT COMPLETED|Overall Study||0
11373122|NCT03310411|12568641|FG000|STARTED|Period 1||10
11373123|NCT03310411|12568642|FG001|STARTED|Period 1||10
11373124|NCT03310411|12568643|FG002|STARTED|Period 1||10
11373125|NCT03310411|12568644|FG003|STARTED|Period 1||10
11373126|NCT03310411|12568641|FG000|Received at Least 1 Dose of Study Drug|Period 1||10
11373127|NCT03310411|12568642|FG001|Received at Least 1 Dose of Study Drug|Period 1||10
11373128|NCT03310411|12568643|FG002|Received at Least 1 Dose of Study Drug|Period 1||10
11373129|NCT03310411|12568644|FG003|Received at Least 1 Dose of Study Drug|Period 1||10
11373130|NCT03310411|12568641|FG000|COMPLETED|Period 1||10
11373131|NCT03310411|12568642|FG001|COMPLETED|Period 1||10
11373132|NCT03310411|12568643|FG002|COMPLETED|Period 1||10
11373133|NCT03310411|12568644|FG003|COMPLETED|Period 1||9
11373134|NCT03310411|12568641|FG000|NOT COMPLETED|Period 1||0
11373135|NCT03310411|12568642|FG001|NOT COMPLETED|Period 1||0
11373136|NCT03310411|12568643|FG002|NOT COMPLETED|Period 1||0
11373137|NCT03310411|12568644|FG003|NOT COMPLETED|Period 1||1
11373138|NCT03310411|12568641|FG000|STARTED|Period 2||10
11373139|NCT03310411|12568642|FG001|STARTED|Period 2||10
11373140|NCT03310411|12568643|FG002|STARTED|Period 2||10
11373141|NCT03310411|12568644|FG003|STARTED|Period 2||9
11373142|NCT03310411|12568641|FG000|COMPLETED|Period 2||10
11373143|NCT03310411|12568642|FG001|COMPLETED|Period 2||10
11373144|NCT03310411|12568643|FG002|COMPLETED|Period 2||10
11373145|NCT03310411|12568644|FG003|COMPLETED|Period 2||9
11373146|NCT03310411|12568641|FG000|NOT COMPLETED|Period 2||0
11005800|NCT00724867|12183562|FG000|COMPLETED|Overall Study||140
11005801|NCT00724867|12183562|FG000|NOT COMPLETED|Overall Study||128
11005802|NCT00724893|12183571|FG000|STARTED|Overall Study||1302
11005803|NCT00724893|12183572|FG001|STARTED|Overall Study||1128
11005804|NCT00724893|12183571|FG000|COMPLETED|Overall Study||938
11005805|NCT00724893|12183572|FG001|COMPLETED|Overall Study||670
11373147|NCT03310411|12568642|FG001|NOT COMPLETED|Period 2||0
11373148|NCT03310411|12568643|FG002|NOT COMPLETED|Period 2||0
11373149|NCT03310411|12568644|FG003|NOT COMPLETED|Period 2||0
11373150|NCT03310411|12568641|FG000|STARTED|Period 3||10
11373151|NCT03310411|12568642|FG001|STARTED|Period 3||10
11373152|NCT03310411|12568643|FG002|STARTED|Period 3||10
11373153|NCT03310411|12568644|FG003|STARTED|Period 3||9
11373154|NCT03310411|12568641|FG000|COMPLETED|Period 3||10
11373155|NCT03310411|12568642|FG001|COMPLETED|Period 3||10
11373156|NCT03310411|12568643|FG002|COMPLETED|Period 3||10
11373157|NCT03310411|12568644|FG003|COMPLETED|Period 3||9
11373158|NCT03310411|12568641|FG000|NOT COMPLETED|Period 3||0
11373159|NCT03310411|12568642|FG001|NOT COMPLETED|Period 3||0
11373160|NCT03310411|12568643|FG002|NOT COMPLETED|Period 3||0
11373161|NCT03310411|12568644|FG003|NOT COMPLETED|Period 3||0
11005806|NCT00724893|12183571|FG000|NOT COMPLETED|Overall Study||364
11373162|NCT03310411|12568641|FG000|STARTED|Period Title: Period 4||10
11373163|NCT03310411|12568642|FG001|STARTED|Period Title: Period 4||10
11373164|NCT03310411|12568643|FG002|STARTED|Period Title: Period 4||10
11373165|NCT03310411|12568644|FG003|STARTED|Period Title: Period 4||9
11373166|NCT03310411|12568641|FG000|COMPLETED|Period Title: Period 4||10
11373167|NCT03310411|12568642|FG001|COMPLETED|Period Title: Period 4||10
11373168|NCT03310411|12568643|FG002|COMPLETED|Period Title: Period 4||10
11373169|NCT03310411|12568644|FG003|COMPLETED|Period Title: Period 4||9
11373170|NCT03310411|12568641|FG000|NOT COMPLETED|Period Title: Period 4||0
11373171|NCT03310411|12568642|FG001|NOT COMPLETED|Period Title: Period 4||0
11373172|NCT03310411|12568643|FG002|NOT COMPLETED|Period Title: Period 4||0
11373173|NCT03310411|12568644|FG003|NOT COMPLETED|Period Title: Period 4||0
11373174|NCT03310450|12568663|FG000|STARTED|Overall Study||32
11373175|NCT03310450|12568664|FG001|STARTED|Overall Study||34
11373176|NCT03310450|12568665|FG002|STARTED|Overall Study||28
11373177|NCT03310450|12568663|FG000|COMPLETED|Overall Study||30
11373178|NCT03310450|12568664|FG001|COMPLETED|Overall Study||30
11373179|NCT03310450|12568665|FG002|COMPLETED|Overall Study||28
11373180|NCT03310450|12568663|FG000|NOT COMPLETED|Overall Study||2
11373181|NCT03310450|12568664|FG001|NOT COMPLETED|Overall Study||4
11373182|NCT03310450|12568665|FG002|NOT COMPLETED|Overall Study||0
11373183|NCT03310580|12568679|FG000|STARTED|Overall Study||15
11373184|NCT03310580|12568680|FG001|STARTED|Overall Study||15
11373185|NCT03310580|12568681|FG002|STARTED|Overall Study||12
11373186|NCT03310580|12568679|FG000|COMPLETED|Overall Study||15
11373187|NCT03310580|12568680|FG001|COMPLETED|Overall Study||14
11373188|NCT03310580|12568681|FG002|COMPLETED|Overall Study||12
11373189|NCT03310580|12568679|FG000|NOT COMPLETED|Overall Study||0
11373190|NCT03310580|12568680|FG001|NOT COMPLETED|Overall Study||1
11373191|NCT03310580|12568681|FG002|NOT COMPLETED|Overall Study||0
11373192|NCT03310723|12568692|FG000|STARTED|Overall Study||20
11373193|NCT03310723|12568693|FG001|STARTED|Overall Study||20
11373194|NCT03310723|12568692|FG000|COMPLETED|Overall Study||20
11373195|NCT03310723|12568693|FG001|COMPLETED|Overall Study||17
11373196|NCT03310723|12568692|FG000|NOT COMPLETED|Overall Study||0
11373197|NCT03310723|12568693|FG001|NOT COMPLETED|Overall Study||3
11373198|NCT03310775|12568701|FG000|STARTED|Overall Study||19
11373199|NCT03310775|12568702|FG001|STARTED|Overall Study||18
11373200|NCT03310775|12568701|FG000|COMPLETED|Overall Study||17
11373201|NCT03310775|12568702|FG001|COMPLETED|Overall Study||14
11373202|NCT03310775|12568701|FG000|NOT COMPLETED|Overall Study||2
11373203|NCT03310775|12568702|FG001|NOT COMPLETED|Overall Study||4
11373204|NCT03310970|12568708|FG000|STARTED|Overall Study||11
11373205|NCT03310970|12568709|FG001|STARTED|Overall Study||12
11373206|NCT03310970|12568708|FG000|COMPLETED|Overall Study||11
11373207|NCT03310970|12568709|FG001|COMPLETED|Overall Study||11
11373208|NCT03310970|12568708|FG000|NOT COMPLETED|Overall Study||0
11373209|NCT03310970|12568709|FG001|NOT COMPLETED|Overall Study||1
11373210|NCT03311230|12568720|FG000|STARTED|Overall Study||151
11373211|NCT03311230|12568721|FG001|STARTED|Overall Study||151
11373212|NCT03311230|12568722|FG002|STARTED|Overall Study||150
11373213|NCT03311230|12568723|FG003|STARTED|Overall Study||150
11373214|NCT03311230|12568720|FG000|COMPLETED|Overall Study||150
11373215|NCT03311230|12568721|FG001|COMPLETED|Overall Study||146
11373216|NCT03311230|12568722|FG002|COMPLETED|Overall Study||148
11373217|NCT03311230|12568723|FG003|COMPLETED|Overall Study||143
11373218|NCT03311230|12568720|FG000|NOT COMPLETED|Overall Study||1
11373219|NCT03311230|12568721|FG001|NOT COMPLETED|Overall Study||5
11373220|NCT03311230|12568722|FG002|NOT COMPLETED|Overall Study||2
11373221|NCT03311230|12568723|FG003|NOT COMPLETED|Overall Study||7
11373222|NCT03311373|12568733|FG000|STARTED|Overall Study||56
11373223|NCT03311373|12568733|FG000|COMPLETED|Overall Study||47
11373224|NCT03311373|12568733|FG000|NOT COMPLETED|Overall Study||9
11373225|NCT03311646|12568743|FG000|STARTED|Overall Study|Number who were eligible and consented.|31
11373226|NCT03311646|12568743|FG000|COMPLETED|Overall Study|Completed VLNC Condition|16
11373227|NCT03311646|12568743|FG000|NOT COMPLETED|Overall Study||15
11373228|NCT03311659|12568748|FG000|STARTED|Overall Study||447
11373229|NCT03311659|12568748|FG000|COMPLETED|Overall Study||446
11373230|NCT03311659|12568748|FG000|NOT COMPLETED|Overall Study||1
11373231|NCT03311724|12568756|FG000|STARTED|Overall Study||26
11373232|NCT03311724|12568757|FG001|STARTED|Overall Study||29
11373233|NCT03311724|12568758|FG002|STARTED|Overall Study||28
11373234|NCT03311724|12568759|FG003|STARTED|Overall Study||28
11373235|NCT03311724|12568756|FG000|Received At Least One Dose of Study Drug|Overall Study||26
11373236|NCT03311724|12568757|FG001|Received At Least One Dose of Study Drug|Overall Study||29
11373237|NCT03311724|12568758|FG002|Received At Least One Dose of Study Drug|Overall Study||28
11373238|NCT03311724|12568759|FG003|Received At Least One Dose of Study Drug|Overall Study||28
11373239|NCT03311724|12568756|FG000|Completed Treatment|Overall Study||20
11373240|NCT03311724|12568757|FG001|Completed Treatment|Overall Study||27
11373241|NCT03311724|12568758|FG002|Completed Treatment|Overall Study||22
11373242|NCT03311724|12568759|FG003|Completed Treatment|Overall Study||26
11373243|NCT03311724|12568756|FG000|COMPLETED|Overall Study||23
11373244|NCT03311724|12568757|FG001|COMPLETED|Overall Study||28
11373245|NCT03311724|12568758|FG002|COMPLETED|Overall Study||26
11373246|NCT03311724|12568759|FG003|COMPLETED|Overall Study||27
11373247|NCT03311724|12568756|FG000|NOT COMPLETED|Overall Study||3
11373248|NCT03311724|12568757|FG001|NOT COMPLETED|Overall Study||1
11373249|NCT03311724|12568758|FG002|NOT COMPLETED|Overall Study||2
11373250|NCT03311724|12568759|FG003|NOT COMPLETED|Overall Study||1
11373251|NCT03311841|12568777|FG000|STARTED|Period 1||6
11373252|NCT03311841|12568778|FG001|STARTED|Period 1||7
11373253|NCT03311841|12568779|FG002|STARTED|Period 1||6
11373254|NCT03311841|12568780|FG003|STARTED|Period 1||7
11373255|NCT03311841|12568781|FG004|STARTED|Period 1||6
11373256|NCT03311841|12568777|FG000|COMPLETED|Period 1||6
11373257|NCT03311841|12568778|FG001|COMPLETED|Period 1||7
11373258|NCT03311841|12568779|FG002|COMPLETED|Period 1||6
11373259|NCT03311841|12568780|FG003|COMPLETED|Period 1||7
11373260|NCT03311841|12568781|FG004|COMPLETED|Period 1||6
11373261|NCT03311841|12568777|FG000|NOT COMPLETED|Period 1||0
11373262|NCT03311841|12568778|FG001|NOT COMPLETED|Period 1||0
11373263|NCT03311841|12568779|FG002|NOT COMPLETED|Period 1||0
11373264|NCT03311841|12568780|FG003|NOT COMPLETED|Period 1||0
11373265|NCT03311841|12568781|FG004|NOT COMPLETED|Period 1||0
11373266|NCT03311841|12568777|FG000|STARTED|14-day Wash-out||6
11373267|NCT03311841|12568778|FG001|STARTED|14-day Wash-out||7
11373268|NCT03311841|12568779|FG002|STARTED|14-day Wash-out||6
11373269|NCT03311841|12568780|FG003|STARTED|14-day Wash-out||7
11373270|NCT03311841|12568781|FG004|STARTED|14-day Wash-out||6
11373271|NCT03311841|12568777|FG000|COMPLETED|14-day Wash-out||6
11373272|NCT03311841|12568778|FG001|COMPLETED|14-day Wash-out||6
11373273|NCT03311841|12568779|FG002|COMPLETED|14-day Wash-out||6
11373274|NCT03311841|12568780|FG003|COMPLETED|14-day Wash-out||6
11373275|NCT03311841|12568781|FG004|COMPLETED|14-day Wash-out||6
11373276|NCT03311841|12568777|FG000|NOT COMPLETED|14-day Wash-out||0
11373277|NCT03311841|12568778|FG001|NOT COMPLETED|14-day Wash-out||1
11373278|NCT03311841|12568779|FG002|NOT COMPLETED|14-day Wash-out||0
11373279|NCT03311841|12568780|FG003|NOT COMPLETED|14-day Wash-out||1
11373280|NCT03311841|12568781|FG004|NOT COMPLETED|14-day Wash-out||0
11373281|NCT03311841|12568777|FG000|STARTED|Period 2||6
11373282|NCT03311841|12568778|FG001|STARTED|Period 2||6
11373283|NCT03311841|12568779|FG002|STARTED|Period 2||6
11373284|NCT03311841|12568780|FG003|STARTED|Period 2||6
11373285|NCT03311841|12568781|FG004|STARTED|Period 2||6
11373286|NCT03311841|12568777|FG000|COMPLETED|Period 2||6
11373287|NCT03311841|12568778|FG001|COMPLETED|Period 2||6
11373288|NCT03311841|12568779|FG002|COMPLETED|Period 2||6
11373289|NCT03311841|12568780|FG003|COMPLETED|Period 2||6
11373290|NCT03311841|12568781|FG004|COMPLETED|Period 2||6
11373291|NCT03311841|12568777|FG000|NOT COMPLETED|Period 2||0
11373292|NCT03311841|12568778|FG001|NOT COMPLETED|Period 2||0
11373293|NCT03311841|12568779|FG002|NOT COMPLETED|Period 2||0
11373294|NCT03311841|12568780|FG003|NOT COMPLETED|Period 2||0
11373295|NCT03311841|12568781|FG004|NOT COMPLETED|Period 2||0
11373296|NCT03312023|12568806|FG000|STARTED|Overall Study||8
11373297|NCT03312023|12568807|FG001|STARTED|Overall Study||5
11373298|NCT03312023|12568808|FG002|STARTED|Overall Study||4
11373299|NCT03312023|12568809|FG003|STARTED|Overall Study||4
11373300|NCT03312023|12568806|FG000|Completed Week 12|Overall Study||8
11373301|NCT03312023|12568807|FG001|Completed Week 12|Overall Study||5
11373302|NCT03312023|12568808|FG002|Completed Week 12|Overall Study||4
11373303|NCT03312023|12568809|FG003|Completed Week 12|Overall Study||4
11373304|NCT03312023|12568806|FG000|COMPLETED|Overall Study||8
11373305|NCT03312023|12568807|FG001|COMPLETED|Overall Study||5
11373306|NCT03312023|12568808|FG002|COMPLETED|Overall Study||4
11373307|NCT03312023|12568809|FG003|COMPLETED|Overall Study||4
11373308|NCT03312023|12568806|FG000|NOT COMPLETED|Overall Study||0
11373309|NCT03312023|12568807|FG001|NOT COMPLETED|Overall Study||0
11373310|NCT03312023|12568808|FG002|NOT COMPLETED|Overall Study||0
11373311|NCT03312023|12568809|FG003|NOT COMPLETED|Overall Study||0
11373312|NCT03312114|12568820|FG000|STARTED|Overall Study||5
11373313|NCT03312114|12568820|FG000|COMPLETED|Overall Study||0
11373314|NCT03312114|12568820|FG000|NOT COMPLETED|Overall Study||5
11373315|NCT03312218|12568827|FG000|STARTED|Overall Study||335
11373316|NCT03312218|12568828|FG001|STARTED|Overall Study||299
11373317|NCT03312218|12568827|FG000|COMPLETED|Overall Study||281
11373318|NCT03312218|12568828|FG001|COMPLETED|Overall Study||241
11373319|NCT03312218|12568827|FG000|NOT COMPLETED|Overall Study||54
11373320|NCT03312218|12568828|FG001|NOT COMPLETED|Overall Study||58
11373321|NCT03312231|12568839|FG000|STARTED|Overall Study||184
11373322|NCT03312231|12568840|FG001|STARTED|Overall Study||176
11373323|NCT03312231|12568841|FG002|STARTED|Overall Study||181
11373324|NCT03312231|12568842|FG003|STARTED|Overall Study||89
11373325|NCT03312231|12568843|FG004|STARTED|Overall Study||90
11373326|NCT03312231|12568839|FG000|COMPLETED|Overall Study||181
11373327|NCT03312231|12568840|FG001|COMPLETED|Overall Study||165
11373328|NCT03312231|12568841|FG002|COMPLETED|Overall Study||177
11373329|NCT03312231|12568842|FG003|COMPLETED|Overall Study||86
11373330|NCT03312231|12568843|FG004|COMPLETED|Overall Study||89
11373331|NCT03312231|12568839|FG000|NOT COMPLETED|Overall Study||3
11005807|NCT00724893|12183572|FG001|NOT COMPLETED|Overall Study||458
11005808|NCT00724932|12183595|FG000|STARTED|Overall Study||70
11005809|NCT00724932|12183596|FG001|STARTED|Overall Study||70
11005810|NCT00724932|12183595|FG000|COMPLETED|Overall Study||65
11005811|NCT00724932|12183596|FG001|COMPLETED|Overall Study||67
11005812|NCT00724932|12183595|FG000|NOT COMPLETED|Overall Study||5
11005813|NCT00724932|12183596|FG001|NOT COMPLETED|Overall Study||3
11005814|NCT00724945|12183604|FG000|STARTED|Period 1||58
11005815|NCT00724945|12183605|FG001|STARTED|Period 1||55
11005816|NCT00724945|12183604|FG000|COMPLETED|Period 1||55
11005817|NCT00724945|12183605|FG001|COMPLETED|Period 1||54
11005818|NCT00724945|12183604|FG000|NOT COMPLETED|Period 1||3
11373332|NCT03312231|12568840|FG001|NOT COMPLETED|Overall Study||11
11373333|NCT03312231|12568841|FG002|NOT COMPLETED|Overall Study||4
11373334|NCT03312231|12568842|FG003|NOT COMPLETED|Overall Study||3
11373335|NCT03312231|12568843|FG004|NOT COMPLETED|Overall Study||1
11373336|NCT03312348|12568855|FG000|STARTED|Overall Study||30
11373337|NCT03312348|12568855|FG000|COMPLETED|Overall Study||30
11373338|NCT03312348|12568855|FG000|NOT COMPLETED|Overall Study||0
11373339|NCT03312517|12568859|FG000|STARTED|Overall Study||2
11373340|NCT03312517|12568860|FG001|STARTED|Overall Study||2
11373341|NCT03312517|12568861|FG002|STARTED|Overall Study||2
11373342|NCT03312517|12568862|FG003|STARTED|Overall Study||2
11373343|NCT03312517|12568863|FG004|STARTED|Overall Study||2
11373344|NCT03312517|12568864|FG005|STARTED|Overall Study||2
11373345|NCT03312517|12568859|FG000|COMPLETED|Overall Study||2
11373346|NCT03312517|12568860|FG001|COMPLETED|Overall Study||2
11373347|NCT03312517|12568861|FG002|COMPLETED|Overall Study||2
11373348|NCT03312517|12568862|FG003|COMPLETED|Overall Study||2
11373349|NCT03312517|12568863|FG004|COMPLETED|Overall Study||2
11373350|NCT03312517|12568864|FG005|COMPLETED|Overall Study||2
11373351|NCT03312517|12568859|FG000|NOT COMPLETED|Overall Study||0
11373352|NCT03312517|12568860|FG001|NOT COMPLETED|Overall Study||0
11373353|NCT03312517|12568861|FG002|NOT COMPLETED|Overall Study||0
11373354|NCT03312517|12568862|FG003|NOT COMPLETED|Overall Study||0
11373355|NCT03312517|12568863|FG004|NOT COMPLETED|Overall Study||0
11373356|NCT03312517|12568864|FG005|NOT COMPLETED|Overall Study||0
11373357|NCT03312543|12568874|FG000|STARTED|Before Treatment (Screening to Baseline)||61
11373358|NCT03312543|12568875|FG001|STARTED|Before Treatment (Screening to Baseline)||63
11373359|NCT03312543|12568874|FG000|COMPLETED|Before Treatment (Screening to Baseline)||60
11373360|NCT03312543|12568875|FG001|COMPLETED|Before Treatment (Screening to Baseline)||59
11373361|NCT03312543|12568874|FG000|NOT COMPLETED|Before Treatment (Screening to Baseline)||1
11373362|NCT03312543|12568875|FG001|NOT COMPLETED|Before Treatment (Screening to Baseline)||4
11373363|NCT03312543|12568874|FG000|STARTED|Treatment (Baseline to Week 12)||60
11373364|NCT03312543|12568875|FG001|STARTED|Treatment (Baseline to Week 12)||59
11373365|NCT03312543|12568874|FG000|COMPLETED|Treatment (Baseline to Week 12)||56
11373366|NCT03312543|12568875|FG001|COMPLETED|Treatment (Baseline to Week 12)||54
11373367|NCT03312543|12568874|FG000|NOT COMPLETED|Treatment (Baseline to Week 12)||4
11373368|NCT03312543|12568875|FG001|NOT COMPLETED|Treatment (Baseline to Week 12)||5
11373369|NCT03312543|12568874|FG000|STARTED|Regression (Week 12 to Week 24)||56
11373370|NCT03312543|12568875|FG001|STARTED|Regression (Week 12 to Week 24)||54
11373371|NCT03312543|12568874|FG000|COMPLETED|Regression (Week 12 to Week 24)||55
11373372|NCT03312543|12568875|FG001|COMPLETED|Regression (Week 12 to Week 24)||52
11373373|NCT03312543|12568874|FG000|NOT COMPLETED|Regression (Week 12 to Week 24)||1
11373374|NCT03312543|12568875|FG001|NOT COMPLETED|Regression (Week 12 to Week 24)||2
11373375|NCT03312595|12568881|FG000|STARTED|Overall Study||30
11373376|NCT03312595|12568881|FG000|COMPLETED|Overall Study||24
11373377|NCT03312595|12568881|FG000|NOT COMPLETED|Overall Study||6
11373378|NCT03312933|12568885|FG000|STARTED|Overall Study||100
11373379|NCT03312933|12568885|FG000|COMPLETED|Overall Study||46
11373380|NCT03312933|12568885|FG000|NOT COMPLETED|Overall Study||54
11373381|NCT03313037|12568891|FG000|STARTED|Overall Study||222
11373382|NCT03313037|12568892|FG001|STARTED|Overall Study||222
11373383|NCT03313037|12568891|FG000|Safety Population|Overall Study||221
11373384|NCT03313037|12568892|FG001|Safety Population|Overall Study||222
11373385|NCT03313037|12568891|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||210
11373386|NCT03313037|12568892|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||208
11373387|NCT03313037|12568891|FG000|COMPLETED|Overall Study||202
11373388|NCT03313037|12568892|FG001|COMPLETED|Overall Study||202
11373389|NCT03313037|12568891|FG000|NOT COMPLETED|Overall Study||20
11373390|NCT03313037|12568892|FG001|NOT COMPLETED|Overall Study||20
11373391|NCT03313050|12568902|FG000|STARTED|Stage 1: 6 Months||34
11373392|NCT03313050|12568903|FG001|STARTED|Stage 1: 6 Months||32
11373393|NCT03313050|12568904|FG002|STARTED|Stage 1: 6 Months||0
11373394|NCT03313050|12568905|FG003|STARTED|Stage 1: 6 Months||0
11373395|NCT03313050|12568902|FG000|Vaccinated|Stage 1: 6 Months||34
11373396|NCT03313050|12568903|FG001|Vaccinated|Stage 1: 6 Months||32
11373397|NCT03313050|12568904|FG002|Vaccinated|Stage 1: 6 Months||0
11373398|NCT03313050|12568905|FG003|Vaccinated|Stage 1: 6 Months||0
11373399|NCT03313050|12568902|FG000|COMPLETED|Stage 1: 6 Months||34
11373400|NCT03313050|12568903|FG001|COMPLETED|Stage 1: 6 Months||32
11373401|NCT03313050|12568904|FG002|COMPLETED|Stage 1: 6 Months||0
11373402|NCT03313050|12568905|FG003|COMPLETED|Stage 1: 6 Months||0
11373403|NCT03313050|12568902|FG000|NOT COMPLETED|Stage 1: 6 Months||0
11373404|NCT03313050|12568903|FG001|NOT COMPLETED|Stage 1: 6 Months||0
11373405|NCT03313050|12568904|FG002|NOT COMPLETED|Stage 1: 6 Months||0
11373406|NCT03313050|12568905|FG003|NOT COMPLETED|Stage 1: 6 Months||0
11373407|NCT03313050|12568902|FG000|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
11373408|NCT03313050|12568903|FG001|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
11373409|NCT03313050|12568904|FG002|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|221
11373410|NCT03313050|12568905|FG003|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|224
11373411|NCT03313050|12568902|FG000|Vaccinated|Stage 2: 12 Months||0
11373412|NCT03313050|12568903|FG001|Vaccinated|Stage 2: 12 Months||0
11373413|NCT03313050|12568904|FG002|Vaccinated|Stage 2: 12 Months||221
11373414|NCT03313050|12568905|FG003|Vaccinated|Stage 2: 12 Months||223
11373415|NCT03313050|12568902|FG000|COMPLETED|Stage 2: 12 Months||0
11373416|NCT03313050|12568903|FG001|COMPLETED|Stage 2: 12 Months||0
11373417|NCT03313050|12568904|FG002|COMPLETED|Stage 2: 12 Months||210
11373418|NCT03313050|12568905|FG003|COMPLETED|Stage 2: 12 Months||204
11373419|NCT03313050|12568902|FG000|NOT COMPLETED|Stage 2: 12 Months||0
11373420|NCT03313050|12568903|FG001|NOT COMPLETED|Stage 2: 12 Months||0
11373421|NCT03313050|12568904|FG002|NOT COMPLETED|Stage 2: 12 Months||11
11373422|NCT03313050|12568905|FG003|NOT COMPLETED|Stage 2: 12 Months||20
11373423|NCT03313076|12568919|FG000|STARTED|Overall Study||7
11373424|NCT03313076|12568920|FG001|STARTED|Overall Study||6
11373425|NCT03313076|12568921|FG002|STARTED|Overall Study||6
11373426|NCT03313076|12568922|FG003|STARTED|Overall Study||5
11373427|NCT03313076|12568919|FG000|COMPLETED|Overall Study||5
11373428|NCT03313076|12568920|FG001|COMPLETED|Overall Study||4
11373429|NCT03313076|12568921|FG002|COMPLETED|Overall Study||4
11373430|NCT03313076|12568922|FG003|COMPLETED|Overall Study||3
11373431|NCT03313076|12568919|FG000|NOT COMPLETED|Overall Study||2
11373432|NCT03313076|12568920|FG001|NOT COMPLETED|Overall Study||2
11373433|NCT03313076|12568921|FG002|NOT COMPLETED|Overall Study||2
11373434|NCT03313076|12568922|FG003|NOT COMPLETED|Overall Study||2
11373435|NCT03313310|12568940|FG000|STARTED|Phase 2||51
11373436|NCT03313310|12568941|FG001|STARTED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
11373437|NCT03313310|12568940|FG000|COMPLETED|Phase 2||47
11373438|NCT03313310|12568941|FG001|COMPLETED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
11373439|NCT03313310|12568940|FG000|NOT COMPLETED|Phase 2||4
11373440|NCT03313310|12568941|FG001|NOT COMPLETED|Phase 2||0
11373441|NCT03313310|12568940|FG000|STARTED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
11373442|NCT03313310|12568941|FG001|STARTED|Phase 3||41
11373443|NCT03313310|12568940|FG000|COMPLETED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
11373444|NCT03313310|12568941|FG001|COMPLETED|Phase 3||40
11373445|NCT03313310|12568940|FG000|NOT COMPLETED|Phase 3||0
11373446|NCT03313310|12568941|FG001|NOT COMPLETED|Phase 3||1
11373447|NCT03314233|12568947|FG000|STARTED|Overall Study|21 mothers provided informed consent for participation in the trial.|21
11373448|NCT03314233|12568947|FG000|COMPLETED|Overall Study|20 mothers who had provided informed consent met eligibility criteria at time of delivery.|20
11373449|NCT03314233|12568947|FG000|NOT COMPLETED|Overall Study||1
11373450|NCT03314519|12568953|FG000|STARTED|Overall Study||100
11373451|NCT03314519|12568954|FG001|STARTED|Overall Study||100
11373452|NCT03314519|12568953|FG000|COMPLETED|Overall Study||97
11373453|NCT03314519|12568954|FG001|COMPLETED|Overall Study||98
11373454|NCT03314519|12568953|FG000|NOT COMPLETED|Overall Study||3
11373455|NCT03314519|12568954|FG001|NOT COMPLETED|Overall Study||2
11373456|NCT03314662|12568963|FG000|STARTED|Overall Study||889
11373457|NCT03314662|12568964|FG001|STARTED|Overall Study||445
11373458|NCT03314662|12568965|FG002|STARTED|Overall Study||444
11373459|NCT03314662|12568963|FG000|Treated|Overall Study||888
11373460|NCT03314662|12568964|FG001|Treated|Overall Study||444
11373461|NCT03314662|12568965|FG002|Treated|Overall Study||444
11373462|NCT03314662|12568963|FG000|COMPLETED|Overall Study||881
11373463|NCT03314662|12568964|FG001|COMPLETED|Overall Study||440
11373464|NCT03314662|12568965|FG002|COMPLETED|Overall Study||439
11373465|NCT03314662|12568963|FG000|NOT COMPLETED|Overall Study||8
11373466|NCT03314662|12568964|FG001|NOT COMPLETED|Overall Study||5
11373467|NCT03314662|12568965|FG002|NOT COMPLETED|Overall Study||5
11373468|NCT03314753|12568983|FG000|STARTED|Overall Study||53
11373469|NCT03314753|12568984|FG001|STARTED|Overall Study||36
11373470|NCT03314753|12568983|FG000|COMPLETED|Overall Study||53
11373471|NCT03314753|12568984|FG001|COMPLETED|Overall Study||36
11373472|NCT03314753|12568983|FG000|NOT COMPLETED|Overall Study||0
11373473|NCT03314753|12568984|FG001|NOT COMPLETED|Overall Study||0
11373474|NCT03315104|12568993|FG000|STARTED|Overall Study||21
11373475|NCT03315104|12568994|FG001|STARTED|Overall Study||20
11373476|NCT03315104|12568995|FG002|STARTED|Overall Study||24
11373477|NCT03315104|12568993|FG000|Dosed (Safety Population)|Overall Study||19
11373478|NCT03315104|12568994|FG001|Dosed (Safety Population)|Overall Study||19
11373479|NCT03315104|12568995|FG002|Dosed (Safety Population)|Overall Study||22
11373480|NCT03315104|12568993|FG000|COMPLETED|Overall Study||18
11373481|NCT03315104|12568994|FG001|COMPLETED|Overall Study||16
11373482|NCT03315104|12568995|FG002|COMPLETED|Overall Study||19
11373483|NCT03315104|12568993|FG000|NOT COMPLETED|Overall Study||3
11373484|NCT03315104|12568994|FG001|NOT COMPLETED|Overall Study||4
11373485|NCT03315104|12568995|FG002|NOT COMPLETED|Overall Study||5
11373486|NCT03315208|12569005|FG000|STARTED|Overall Study||29
11373487|NCT03315208|12569006|FG001|STARTED|Overall Study||18
11373488|NCT03315208|12569005|FG000|COMPLETED|Overall Study||16
11373489|NCT03315208|12569006|FG001|COMPLETED|Overall Study||12
11373490|NCT03315208|12569005|FG000|NOT COMPLETED|Overall Study||13
11373491|NCT03315208|12569006|FG001|NOT COMPLETED|Overall Study||6
11373492|NCT03315286|12569015|FG000|STARTED|Overall Study||50
11373493|NCT03315286|12569016|FG001|STARTED|Overall Study||47
11373494|NCT03315286|12569015|FG000|COMPLETED|Overall Study||49
11373495|NCT03315286|12569016|FG001|COMPLETED|Overall Study||43
11373496|NCT03315286|12569015|FG000|NOT COMPLETED|Overall Study||1
11373497|NCT03315286|12569016|FG001|NOT COMPLETED|Overall Study||4
11373498|NCT03315559|12569022|FG000|STARTED|Treatment Period 1 (8 Days)||6
11373499|NCT03315559|12569022|FG000|COMPLETED|Treatment Period 1 (8 Days)||6
11373500|NCT03315559|12569022|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11373501|NCT03315559|12569022|FG000|STARTED|Washout Period (14 Days)||6
11373502|NCT03315559|12569022|FG000|COMPLETED|Washout Period (14 Days)||6
11373503|NCT03315559|12569022|FG000|NOT COMPLETED|Washout Period (14 Days)||0
11373504|NCT03315559|12569022|FG000|STARTED|Treatment Period 2 (15 Days)||6
11373505|NCT03315559|12569022|FG000|COMPLETED|Treatment Period 2 (15 Days)||6
11373506|NCT03315559|12569022|FG000|NOT COMPLETED|Treatment Period 2 (15 Days)||0
11373507|NCT03315572|12569031|FG000|STARTED|Overall Study||14
11373508|NCT03315572|12569032|FG001|STARTED|Overall Study||14
11373509|NCT03315572|12569031|FG000|COMPLETED|Overall Study||14
11373510|NCT03315572|12569032|FG001|COMPLETED|Overall Study||14
11373511|NCT03315572|12569031|FG000|NOT COMPLETED|Overall Study||0
11373512|NCT03315572|12569032|FG001|NOT COMPLETED|Overall Study||0
11373513|NCT03315689|12569041|FG000|STARTED|Double-blind Period = 28 Days||4
11373514|NCT03315689|12569042|FG001|STARTED|Double-blind Period = 28 Days||7
11373515|NCT03315689|12569041|FG000|COMPLETED|Double-blind Period = 28 Days||3
11373516|NCT03315689|12569042|FG001|COMPLETED|Double-blind Period = 28 Days||7
11373517|NCT03315689|12569041|FG000|NOT COMPLETED|Double-blind Period = 28 Days||1
11373518|NCT03315689|12569042|FG001|NOT COMPLETED|Double-blind Period = 28 Days||0
11373519|NCT03315689|12569041|FG000|STARTED|Open Label Extension = 52 Weeks||0
11373520|NCT03315689|12569042|FG001|STARTED|Open Label Extension = 52 Weeks||10
11373521|NCT03315689|12569041|FG000|COMPLETED|Open Label Extension = 52 Weeks||0
11373522|NCT03315689|12569042|FG001|COMPLETED|Open Label Extension = 52 Weeks||7
11373523|NCT03315689|12569041|FG000|NOT COMPLETED|Open Label Extension = 52 Weeks||0
11373524|NCT03315689|12569042|FG001|NOT COMPLETED|Open Label Extension = 52 Weeks||3
11373525|NCT03315702|12569050|FG000|STARTED|Overall Study||52
11373526|NCT03315702|12569050|FG000|COMPLETED|Overall Study||52
11373527|NCT03315702|12569050|FG000|NOT COMPLETED|Overall Study||0
11373528|NCT03315780|12569055|FG000|STARTED|Period 1||6
11373529|NCT03315780|12569056|FG001|STARTED|Period 1||6
11373530|NCT03315780|12569055|FG000|Received One Dose of Study Drug|Period 1||6
11373531|NCT03315780|12569056|FG001|Received One Dose of Study Drug|Period 1||6
11373532|NCT03315780|12569055|FG000|COMPLETED|Period 1||6
11373533|NCT03315780|12569056|FG001|COMPLETED|Period 1||6
11373534|NCT03315780|12569055|FG000|NOT COMPLETED|Period 1||0
11373535|NCT03315780|12569056|FG001|NOT COMPLETED|Period 1||0
11373536|NCT03315780|12569055|FG000|STARTED|Period 2||6
11373537|NCT03315780|12569056|FG001|STARTED|Period 2||6
11373538|NCT03315780|12569055|FG000|COMPLETED|Period 2||6
11373539|NCT03315780|12569056|FG001|COMPLETED|Period 2||6
11373540|NCT03315780|12569055|FG000|NOT COMPLETED|Period 2||0
11373541|NCT03315780|12569056|FG001|NOT COMPLETED|Period 2||0
11373542|NCT03315793|12569064|FG000|STARTED|Overall Study||75
11373543|NCT03315793|12569065|FG001|STARTED|Overall Study||74
11373544|NCT03315793|12569064|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75
11373545|NCT03315793|12569065|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
11373546|NCT03315793|12569064|FG000|COMPLETED|Overall Study||70
11373547|NCT03315793|12569065|FG001|COMPLETED|Overall Study||71
11373548|NCT03315793|12569064|FG000|NOT COMPLETED|Overall Study||5
11373549|NCT03315793|12569065|FG001|NOT COMPLETED|Overall Study||3
11373550|NCT03315949|12569075|FG000|STARTED|Overall Study||176
11373551|NCT03315949|12569076|FG001|STARTED|Overall Study||176
11373552|NCT03315949|12569075|FG000|COMPLETED|Overall Study||171
11373553|NCT03315949|12569076|FG001|COMPLETED|Overall Study||166
11373554|NCT03315949|12569075|FG000|NOT COMPLETED|Overall Study||5
11373555|NCT03315949|12569076|FG001|NOT COMPLETED|Overall Study||10
11373556|NCT03316131|12569082|FG000|STARTED|Treatment Period 1||18
11373557|NCT03316131|12569083|FG001|STARTED|Treatment Period 1||18
11373558|NCT03316131|12569082|FG000|COMPLETED|Treatment Period 1||18
11373559|NCT03316131|12569083|FG001|COMPLETED|Treatment Period 1||18
11373560|NCT03316131|12569082|FG000|NOT COMPLETED|Treatment Period 1||0
11373561|NCT03316131|12569083|FG001|NOT COMPLETED|Treatment Period 1||0
11373562|NCT03316131|12569082|FG000|STARTED|Treatment Period 2||18
11373563|NCT03316131|12569083|FG001|STARTED|Treatment Period 2||18
11373564|NCT03316131|12569082|FG000|COMPLETED|Treatment Period 2||17
11373565|NCT03316131|12569083|FG001|COMPLETED|Treatment Period 2||18
11373566|NCT03316131|12569082|FG000|NOT COMPLETED|Treatment Period 2||1
11373567|NCT03316131|12569083|FG001|NOT COMPLETED|Treatment Period 2||0
11373568|NCT03316170|12569091|FG000|STARTED|Overall Study||24
11373569|NCT03316170|12569092|FG001|STARTED|Overall Study||25
11373570|NCT03316170|12569091|FG000|COMPLETED|Overall Study||17
11373571|NCT03316170|12569092|FG001|COMPLETED|Overall Study||18
11373572|NCT03316170|12569091|FG000|NOT COMPLETED|Overall Study||7
11373573|NCT03316170|12569092|FG001|NOT COMPLETED|Overall Study||7
11373574|NCT03316378|12569101|FG000|STARTED|Overall Study||23
11373575|NCT03316378|12569102|FG001|STARTED|Overall Study||23
11373576|NCT03316378|12569101|FG000|COMPLETED|Overall Study||23
11373577|NCT03316378|12569102|FG001|COMPLETED|Overall Study||23
11373578|NCT03316378|12569101|FG000|NOT COMPLETED|Overall Study||0
11373579|NCT03316378|12569102|FG001|NOT COMPLETED|Overall Study||0
11373580|NCT03316547|12569111|FG000|STARTED|Overall Study||39
11373581|NCT03316547|12569112|FG001|STARTED|Overall Study||31
11373582|NCT03316547|12569111|FG000|COMPLETED|Overall Study||21
11373583|NCT03316547|12569112|FG001|COMPLETED|Overall Study||18
11373584|NCT03316547|12569111|FG000|NOT COMPLETED|Overall Study||18
11373585|NCT03316547|12569112|FG001|NOT COMPLETED|Overall Study||13
11373586|NCT03316911|12569122|FG000|STARTED|Overall Study|2 did not complete baseline survey|122
11373587|NCT03316911|12569123|FG001|STARTED|Overall Study|3 did not complete baseline survey|139
11373588|NCT03316911|12569122|FG000|3-Month Follow-up Survey|Overall Study||93
11373589|NCT03316911|12569123|FG001|3-Month Follow-up Survey|Overall Study||112
11373590|NCT03316911|12569122|FG000|5-Month Follow-up Survey|Overall Study||89
11373591|NCT03316911|12569123|FG001|5-Month Follow-up Survey|Overall Study||110
11373592|NCT03316911|12569122|FG000|COMPLETED|Overall Study||89
11373593|NCT03316911|12569123|FG001|COMPLETED|Overall Study||110
11373594|NCT03316911|12569122|FG000|NOT COMPLETED|Overall Study||33
11373595|NCT03316911|12569123|FG001|NOT COMPLETED|Overall Study||29
11373596|NCT03316976|12569131|FG000|STARTED|Overall Study||20
11373597|NCT03316976|12569132|FG001|STARTED|Overall Study||20
11373598|NCT03316976|12569131|FG000|COMPLETED|Overall Study||20
11373599|NCT03316976|12569132|FG001|COMPLETED|Overall Study||20
11373600|NCT03316976|12569131|FG000|NOT COMPLETED|Overall Study||0
11373601|NCT03316976|12569132|FG001|NOT COMPLETED|Overall Study||0
11373602|NCT03317002|12569141|FG000|STARTED|Overall Study||52
11373603|NCT03317002|12569142|FG001|STARTED|Overall Study||25
11373604|NCT03317002|12569143|FG002|STARTED|Overall Study||52
11373605|NCT03317002|12569141|FG000|COMPLETED|Overall Study||50
11373606|NCT03317002|12569142|FG001|COMPLETED|Overall Study||24
11373607|NCT03317002|12569143|FG002|COMPLETED|Overall Study||51
11373608|NCT03317002|12569141|FG000|NOT COMPLETED|Overall Study||2
11373609|NCT03317002|12569142|FG001|NOT COMPLETED|Overall Study||1
11373610|NCT03317002|12569143|FG002|NOT COMPLETED|Overall Study||1
11373611|NCT03317288|12569151|FG000|STARTED|Overall Study||15
11373612|NCT03317288|12569151|FG000|COMPLETED|Overall Study||15
11373613|NCT03317288|12569151|FG000|NOT COMPLETED|Overall Study||0
11373614|NCT03317379|12569172|FG000|STARTED|Overall Study||20
11373615|NCT03317379|12569173|FG001|STARTED|Overall Study||18
11373616|NCT03317379|12569174|FG002|STARTED|Overall Study||22
11373617|NCT03317379|12569172|FG000|Completed Intervention|Overall Study||16
11373618|NCT03317379|12569173|FG001|Completed Intervention|Overall Study||6
11373619|NCT03317379|12569174|FG002|Completed Intervention|Overall Study||0
11373620|NCT03317379|12569172|FG000|COMPLETED|Overall Study||20
11373621|NCT03317379|12569173|FG001|COMPLETED|Overall Study||15
11373622|NCT03317379|12569174|FG002|COMPLETED|Overall Study||20
11373623|NCT03317379|12569172|FG000|NOT COMPLETED|Overall Study||0
11373624|NCT03317379|12569173|FG001|NOT COMPLETED|Overall Study||3
11373625|NCT03317379|12569174|FG002|NOT COMPLETED|Overall Study||2
11373626|NCT03317431|12569182|FG000|STARTED|Overall Study||46
11373627|NCT03317431|12569182|FG000|COMPLETED|Overall Study||46
11373628|NCT03317431|12569182|FG000|NOT COMPLETED|Overall Study||0
11373629|NCT03317444|12569188|FG000|STARTED|Overall Study||124
11373630|NCT03317444|12569189|FG001|STARTED|Overall Study||93
11373631|NCT03317444|12569188|FG000|COMPLETED|Overall Study||119
11373632|NCT03317444|12569189|FG001|COMPLETED|Overall Study||89
11373633|NCT03317444|12569188|FG000|NOT COMPLETED|Overall Study||5
11373634|NCT03317444|12569189|FG001|NOT COMPLETED|Overall Study||4
11373635|NCT03318315|12569198|FG000|STARTED|Overall Study||62
11373636|NCT03318315|12569199|FG001|STARTED|Overall Study||53
11373637|NCT03318315|12569200|FG002|STARTED|Overall Study||34
11373638|NCT03318315|12569198|FG000|Received First Vaccination|Overall Study||62
11373639|NCT03318315|12569199|FG001|Received First Vaccination|Overall Study||53
11373640|NCT03318315|12569200|FG002|Received First Vaccination|Overall Study||34
11373641|NCT03318315|12569198|FG000|Received Second Vaccination|Overall Study||59
11373642|NCT03318315|12569199|FG001|Received Second Vaccination|Overall Study||48
11373643|NCT03318315|12569200|FG002|Received Second Vaccination|Overall Study||0
11373644|NCT03318315|12569198|FG000|Received Third Vaccination|Overall Study||0
11373645|NCT03318315|12569199|FG001|Received Third Vaccination|Overall Study||46
11373646|NCT03318315|12569200|FG002|Received Third Vaccination|Overall Study||0
11373647|NCT03318315|12569198|FG000|COMPLETED|Overall Study||58
11373648|NCT03318315|12569199|FG001|COMPLETED|Overall Study||50
11373649|NCT03318315|12569200|FG002|COMPLETED|Overall Study||30
11373650|NCT03318315|12569198|FG000|NOT COMPLETED|Overall Study||4
11373651|NCT03318315|12569199|FG001|NOT COMPLETED|Overall Study||3
11373652|NCT03318315|12569200|FG002|NOT COMPLETED|Overall Study||4
11373653|NCT03318341|12569211|FG000|STARTED|Month 1||13
11373654|NCT03318341|12569212|FG001|STARTED|Month 1||13
11373655|NCT03318341|12569211|FG000|COMPLETED|Month 1||13
11373656|NCT03318341|12569212|FG001|COMPLETED|Month 1||12
11373657|NCT03318341|12569211|FG000|NOT COMPLETED|Month 1||0
11373658|NCT03318341|12569212|FG001|NOT COMPLETED|Month 1||1
11373659|NCT03318341|12569211|FG000|STARTED|Month 2||13
11373660|NCT03318341|12569212|FG001|STARTED|Month 2||12
11373661|NCT03318341|12569211|FG000|COMPLETED|Month 2||13
11373662|NCT03318341|12569212|FG001|COMPLETED|Month 2||12
11373663|NCT03318341|12569211|FG000|NOT COMPLETED|Month 2||0
11373664|NCT03318341|12569212|FG001|NOT COMPLETED|Month 2||0
11373665|NCT03318783|12569222|FG000|STARTED|Overall Study||10
11373666|NCT03318783|12569223|FG001|STARTED|Overall Study||10
11373667|NCT03318783|12569222|FG000|COMPLETED|Overall Study||10
11373668|NCT03318783|12569223|FG001|COMPLETED|Overall Study||8
11373669|NCT03318783|12569222|FG000|NOT COMPLETED|Overall Study||0
11373670|NCT03318783|12569223|FG001|NOT COMPLETED|Overall Study||2
11373671|NCT03319134|12569232|FG000|STARTED|Overall Study||15
11373672|NCT03319134|12569233|FG001|STARTED|Overall Study||15
11373673|NCT03319134|12569234|FG002|STARTED|Overall Study||15
11373674|NCT03319134|12569232|FG000|COMPLETED|Overall Study||15
11373675|NCT03319134|12569233|FG001|COMPLETED|Overall Study||15
11373676|NCT03319134|12569234|FG002|COMPLETED|Overall Study||15
11373677|NCT03319134|12569232|FG000|NOT COMPLETED|Overall Study||0
11373678|NCT03319134|12569233|FG001|NOT COMPLETED|Overall Study||0
11373679|NCT03319134|12569234|FG002|NOT COMPLETED|Overall Study||0
11373680|NCT03319173|12569244|FG000|STARTED|Overall Study||48
11373681|NCT03319173|12569245|FG001|STARTED|Overall Study||50
11373682|NCT03319173|12569244|FG000|COMPLETED|Overall Study||48
11373683|NCT03319173|12569245|FG001|COMPLETED|Overall Study||50
11373684|NCT03319173|12569244|FG000|NOT COMPLETED|Overall Study||0
11373685|NCT03319173|12569245|FG001|NOT COMPLETED|Overall Study||0
11373686|NCT03319212|12569257|FG000|STARTED|Overall Study||29
11373687|NCT03319212|12569258|FG001|STARTED|Overall Study||52
11373688|NCT03319212|12569257|FG000|COMPLETED|Overall Study||26
11373689|NCT03319212|12569258|FG001|COMPLETED|Overall Study||47
11373690|NCT03319212|12569257|FG000|NOT COMPLETED|Overall Study||3
11373691|NCT03319212|12569258|FG001|NOT COMPLETED|Overall Study||5
11373692|NCT03319277|12569265|FG000|STARTED|Overall Study||59
11373693|NCT03319277|12569266|FG001|STARTED|Overall Study||59
11373694|NCT03319277|12569265|FG000|COMPLETED|Overall Study||59
11373695|NCT03319277|12569266|FG001|COMPLETED|Overall Study||59
11373696|NCT03319277|12569265|FG000|NOT COMPLETED|Overall Study||0
11373697|NCT03319277|12569266|FG001|NOT COMPLETED|Overall Study||0
11373698|NCT03319719|12569272|FG000|STARTED|Overall Study||52
11373699|NCT03319719|12569272|FG000|COMPLETED|Overall Study||51
11373700|NCT03319719|12569272|FG000|NOT COMPLETED|Overall Study||1
11373701|NCT03319810|12569278|FG000|STARTED|Overall Study||5
11373702|NCT03319810|12569278|FG000|COMPLETED|Overall Study||5
11373703|NCT03319810|12569278|FG000|NOT COMPLETED|Overall Study||0
11373704|NCT03319953|12569286|FG000|STARTED|Period 1 (Day 1 to 14)||3
11373705|NCT03319953|12569287|FG001|STARTED|Period 1 (Day 1 to 14)||4
11373706|NCT03319953|12569288|FG002|STARTED|Period 1 (Day 1 to 14)||9
11373707|NCT03319953|12569289|FG003|STARTED|Period 1 (Day 1 to 14)||7
11373708|NCT03319953|12569286|FG000|COMPLETED|Period 1 (Day 1 to 14)||3
11373709|NCT03319953|12569287|FG001|COMPLETED|Period 1 (Day 1 to 14)||4
11373710|NCT03319953|12569288|FG002|COMPLETED|Period 1 (Day 1 to 14)||9
11373711|NCT03319953|12569289|FG003|COMPLETED|Period 1 (Day 1 to 14)||7
11373712|NCT03319953|12569286|FG000|NOT COMPLETED|Period 1 (Day 1 to 14)||0
11373713|NCT03319953|12569287|FG001|NOT COMPLETED|Period 1 (Day 1 to 14)||0
11373714|NCT03319953|12569288|FG002|NOT COMPLETED|Period 1 (Day 1 to 14)||0
11373715|NCT03319953|12569289|FG003|NOT COMPLETED|Period 1 (Day 1 to 14)||0
11373716|NCT03319953|12569286|FG000|STARTED|Washout Period (Day 15 to 49)||3
11373717|NCT03319953|12569287|FG001|STARTED|Washout Period (Day 15 to 49)||4
11373718|NCT03319953|12569288|FG002|STARTED|Washout Period (Day 15 to 49)||9
11373719|NCT03319953|12569289|FG003|STARTED|Washout Period (Day 15 to 49)||7
11373720|NCT03319953|12569286|FG000|COMPLETED|Washout Period (Day 15 to 49)||3
11373721|NCT03319953|12569287|FG001|COMPLETED|Washout Period (Day 15 to 49)||4
11373722|NCT03319953|12569288|FG002|COMPLETED|Washout Period (Day 15 to 49)||9
11373723|NCT03319953|12569289|FG003|COMPLETED|Washout Period (Day 15 to 49)||7
11373724|NCT03319953|12569286|FG000|NOT COMPLETED|Washout Period (Day 15 to 49)||0
11373725|NCT03319953|12569287|FG001|NOT COMPLETED|Washout Period (Day 15 to 49)||0
11373726|NCT03319953|12569288|FG002|NOT COMPLETED|Washout Period (Day 15 to 49)||0
11373727|NCT03319953|12569289|FG003|NOT COMPLETED|Washout Period (Day 15 to 49)||0
11373728|NCT03319953|12569286|FG000|STARTED|Period 2 (Day 49 to 154)||3
11373729|NCT03319953|12569287|FG001|STARTED|Period 2 (Day 49 to 154)||4
11373730|NCT03319953|12569288|FG002|STARTED|Period 2 (Day 49 to 154)||9
11373731|NCT03319953|12569289|FG003|STARTED|Period 2 (Day 49 to 154)||7
11373732|NCT03319953|12569286|FG000|Treated|Period 2 (Day 49 to 154)||2
11373733|NCT03319953|12569287|FG001|Treated|Period 2 (Day 49 to 154)||4
11373734|NCT03319953|12569288|FG002|Treated|Period 2 (Day 49 to 154)||8
11373735|NCT03319953|12569289|FG003|Treated|Period 2 (Day 49 to 154)||6
11373736|NCT03319953|12569286|FG000|COMPLETED|Period 2 (Day 49 to 154)||2
11373737|NCT03319953|12569287|FG001|COMPLETED|Period 2 (Day 49 to 154)||4
11373738|NCT03319953|12569288|FG002|COMPLETED|Period 2 (Day 49 to 154)||8
11373739|NCT03319953|12569289|FG003|COMPLETED|Period 2 (Day 49 to 154)||6
11373740|NCT03319953|12569286|FG000|NOT COMPLETED|Period 2 (Day 49 to 154)||1
11373741|NCT03319953|12569287|FG001|NOT COMPLETED|Period 2 (Day 49 to 154)||0
11373742|NCT03319953|12569288|FG002|NOT COMPLETED|Period 2 (Day 49 to 154)||1
11373743|NCT03319953|12569289|FG003|NOT COMPLETED|Period 2 (Day 49 to 154)||1
11373744|NCT03320057|12569297|FG000|STARTED|Overall Study||266
11373745|NCT03320057|12569298|FG001|STARTED|Overall Study|Includes pharmacists at study pharmacies that consented to training on mifepristone dispensing.|60
11373746|NCT03320057|12569297|FG000|Patient's Clinical Outcome Information Obtained|Overall Study||262
11373747|NCT03320057|12569298|FG001|Patient's Clinical Outcome Information Obtained|Overall Study|Clinical outcome data were not collected for pharmacists - this milestone does not apply|0
11373748|NCT03320057|12569297|FG000|Received Pharmacist Training|Overall Study||0
11373749|NCT03320057|12569298|FG001|Received Pharmacist Training|Overall Study||56
11373750|NCT03320057|12569297|FG000|Pharmacists Completed Baseline Survey|Overall Study||0
11373751|NCT03320057|12569298|FG001|Pharmacists Completed Baseline Survey|Overall Study||47
11373752|NCT03320057|12569297|FG000|COMPLETED|Overall Study||260
11373753|NCT03320057|12569298|FG001|COMPLETED|Overall Study|This includes pharmacists who completed the endline survey. Only trained pharmacists (n=56) were eligible.|43
11373754|NCT03320057|12569297|FG000|NOT COMPLETED|Overall Study||6
11373755|NCT03320057|12569298|FG001|NOT COMPLETED|Overall Study||17
11373756|NCT03320096|12569304|FG000|STARTED|Overall Study||20
11373757|NCT03320096|12569304|FG000|COMPLETED|Overall Study||20
11373758|NCT03320096|12569304|FG000|NOT COMPLETED|Overall Study||0
11373759|NCT03320369|12569308|FG000|STARTED|Overall Study||18
11373760|NCT03320369|12569308|FG000|COMPLETED|Overall Study||15
11373761|NCT03320369|12569308|FG000|NOT COMPLETED|Overall Study||3
11373762|NCT03320850|12569322|FG000|STARTED|Overall Study||18
11373763|NCT03320850|12569323|FG001|STARTED|Overall Study||12
11373764|NCT03320850|12569324|FG002|STARTED|Overall Study||18
11373765|NCT03320850|12569325|FG003|STARTED|Overall Study||22
11373766|NCT03320850|12569326|FG004|STARTED|Overall Study||19
11373767|NCT03320850|12569327|FG005|STARTED|Overall Study||58
11373768|NCT03320850|12569328|FG006|STARTED|Overall Study||57
11373769|NCT03320850|12569329|FG007|STARTED|Overall Study||60
11373770|NCT03320850|12569330|FG008|STARTED|Overall Study||60
11373771|NCT03320850|12569331|FG009|STARTED|Overall Study||59
11373772|NCT03320850|12569322|FG000|Safety Population|Overall Study||18
11373773|NCT03320850|12569323|FG001|Safety Population|Overall Study||12
11373774|NCT03320850|12569324|FG002|Safety Population|Overall Study||18
11373775|NCT03320850|12569325|FG003|Safety Population|Overall Study||22
11373776|NCT03320850|12569326|FG004|Safety Population|Overall Study||19
11373777|NCT03320850|12569327|FG005|Safety Population|Overall Study||57
11373778|NCT03320850|12569328|FG006|Safety Population|Overall Study||57
11373779|NCT03320850|12569329|FG007|Safety Population|Overall Study||60
11373780|NCT03320850|12569330|FG008|Safety Population|Overall Study||60
11373781|NCT03320850|12569331|FG009|Safety Population|Overall Study||58
11373782|NCT03320850|12569322|FG000|COMPLETED|Overall Study||18
11373783|NCT03320850|12569323|FG001|COMPLETED|Overall Study||12
11373784|NCT03320850|12569324|FG002|COMPLETED|Overall Study||18
11373785|NCT03320850|12569325|FG003|COMPLETED|Overall Study||21
11373786|NCT03320850|12569326|FG004|COMPLETED|Overall Study||17
11373787|NCT03320850|12569327|FG005|COMPLETED|Overall Study||49
11373788|NCT03320850|12569328|FG006|COMPLETED|Overall Study||50
11373789|NCT03320850|12569329|FG007|COMPLETED|Overall Study||53
11373790|NCT03320850|12569330|FG008|COMPLETED|Overall Study||50
11373791|NCT03320850|12569331|FG009|COMPLETED|Overall Study||50
11373792|NCT03320850|12569322|FG000|NOT COMPLETED|Overall Study||0
11373793|NCT03320850|12569323|FG001|NOT COMPLETED|Overall Study||0
11373794|NCT03320850|12569324|FG002|NOT COMPLETED|Overall Study||0
11373795|NCT03320850|12569325|FG003|NOT COMPLETED|Overall Study||1
11373796|NCT03320850|12569326|FG004|NOT COMPLETED|Overall Study||2
11373797|NCT03320850|12569327|FG005|NOT COMPLETED|Overall Study||9
11373798|NCT03320850|12569328|FG006|NOT COMPLETED|Overall Study||7
11373799|NCT03320850|12569329|FG007|NOT COMPLETED|Overall Study||7
11373800|NCT03320850|12569330|FG008|NOT COMPLETED|Overall Study||10
11373801|NCT03320850|12569331|FG009|NOT COMPLETED|Overall Study||9
11373802|NCT03320941|12569363|FG000|STARTED|Overall Study||19
11373803|NCT03320941|12569364|FG001|STARTED|Overall Study||19
11373804|NCT03320941|12569365|FG002|STARTED|Overall Study||28
11373805|NCT03320941|12569366|FG003|STARTED|Overall Study||31
11373806|NCT03320941|12569367|FG004|STARTED|Overall Study||29
11373807|NCT03320941|12569363|FG000|COMPLETED|Overall Study||19
11373808|NCT03320941|12569364|FG001|COMPLETED|Overall Study||19
11373809|NCT03320941|12569365|FG002|COMPLETED|Overall Study||28
11373810|NCT03320941|12569366|FG003|COMPLETED|Overall Study||30
11373811|NCT03320941|12569367|FG004|COMPLETED|Overall Study||29
11373812|NCT03320941|12569363|FG000|NOT COMPLETED|Overall Study||0
11373813|NCT03320941|12569364|FG001|NOT COMPLETED|Overall Study||0
11373814|NCT03320941|12569365|FG002|NOT COMPLETED|Overall Study||0
11373815|NCT03320941|12569366|FG003|NOT COMPLETED|Overall Study||1
11373816|NCT03320941|12569367|FG004|NOT COMPLETED|Overall Study||0
11373817|NCT03321006|12569381|FG000|STARTED|Overall Study||14
11373818|NCT03321006|12569382|FG001|STARTED|Overall Study||11
11373819|NCT03321006|12569381|FG000|COMPLETED|Overall Study||12
11373820|NCT03321006|12569382|FG001|COMPLETED|Overall Study||11
11373821|NCT03321006|12569381|FG000|NOT COMPLETED|Overall Study||2
11373822|NCT03321006|12569382|FG001|NOT COMPLETED|Overall Study||0
11373823|NCT03321097|12569390|FG000|STARTED|Overall Study||18
11373824|NCT03321097|12569391|FG001|STARTED|Overall Study||18
11373825|NCT03321097|12569390|FG000|COMPLETED|Overall Study||18
11373826|NCT03321097|12569391|FG001|COMPLETED|Overall Study||18
11373827|NCT03321097|12569390|FG000|NOT COMPLETED|Overall Study||0
11373828|NCT03321097|12569391|FG001|NOT COMPLETED|Overall Study||0
11373829|NCT03321253|12569397|FG000|STARTED|Overall Study||38
11373830|NCT03321253|12569397|FG000|COMPLETED|Overall Study||38
11373831|NCT03321253|12569397|FG000|NOT COMPLETED|Overall Study||0
11373832|NCT03321396|12569401|FG000|STARTED|Overall Study||13
11373833|NCT03321396|12569401|FG000|COMPLETED|Overall Study||12
11373834|NCT03321396|12569401|FG000|NOT COMPLETED|Overall Study||1
11373835|NCT03321721|12569408|FG000|STARTED|Overall Study||4
11373836|NCT03321721|12569409|FG001|STARTED|Overall Study||10
11373837|NCT03321721|12569410|FG002|STARTED|Overall Study||12
11373838|NCT03321721|12569408|FG000|COMPLETED|Overall Study||0
11373839|NCT03321721|12569409|FG001|COMPLETED|Overall Study||2
11373840|NCT03321721|12569410|FG002|COMPLETED|Overall Study||1
11373841|NCT03321721|12569408|FG000|NOT COMPLETED|Overall Study||4
11373842|NCT03321721|12569409|FG001|NOT COMPLETED|Overall Study||8
11373843|NCT03321721|12569410|FG002|NOT COMPLETED|Overall Study||11
11373844|NCT03322423|12569419|FG000|STARTED|Period 1||38
11373845|NCT03322423|12569420|FG001|STARTED|Period 1||40
11373846|NCT03322423|12569419|FG000|COMPLETED|Period 1||36
11373847|NCT03322423|12569420|FG001|COMPLETED|Period 1||38
11373848|NCT03322423|12569419|FG000|NOT COMPLETED|Period 1||2
11373849|NCT03322423|12569420|FG001|NOT COMPLETED|Period 1||2
11373850|NCT03322423|12569419|FG000|STARTED|Period 2||36
11373851|NCT03322423|12569420|FG001|STARTED|Period 2||38
11373852|NCT03322423|12569419|FG000|COMPLETED|Period 2||35
11373853|NCT03322423|12569420|FG001|COMPLETED|Period 2||36
11373854|NCT03322423|12569419|FG000|NOT COMPLETED|Period 2||1
11373855|NCT03322423|12569420|FG001|NOT COMPLETED|Period 2||2
11373856|NCT03322462|12569426|FG000|STARTED|Overall Study||155
11373857|NCT03322462|12569426|FG000|Flortaucipir PET Scan|Overall Study||155
11373858|NCT03322462|12569426|FG000|COMPLETED|Overall Study||152
11373859|NCT03322462|12569426|FG000|NOT COMPLETED|Overall Study||3
11373860|NCT03322514|12569434|FG000|STARTED|Overall Study||6
11373861|NCT03322514|12569435|FG001|STARTED|Overall Study||6
11373862|NCT03322514|12569434|FG000|COMPLETED|Overall Study||5
11373863|NCT03322514|12569435|FG001|COMPLETED|Overall Study||5
11373864|NCT03322514|12569434|FG000|NOT COMPLETED|Overall Study||1
11373865|NCT03322514|12569435|FG001|NOT COMPLETED|Overall Study||1
11373866|NCT03322657|12569443|FG000|STARTED|Overall Study||34
11373867|NCT03322657|12569444|FG001|STARTED|Overall Study||35
11373868|NCT03322657|12569443|FG000|COMPLETED|Overall Study||33
11373869|NCT03322657|12569444|FG001|COMPLETED|Overall Study||35
11373870|NCT03322657|12569443|FG000|NOT COMPLETED|Overall Study||1
11373871|NCT03322657|12569444|FG001|NOT COMPLETED|Overall Study||0
11373872|NCT03322930|12569452|FG000|STARTED|Overall Study|recruitment of 20 patients with retinitis pigmentosa|20
11373873|NCT03322930|12569453|FG001|STARTED|Overall Study|recruitment of 20 patients with macular degeneration|20
11373874|NCT03322930|12569452|FG000|COMPLETED|Overall Study||20
11373875|NCT03322930|12569453|FG001|COMPLETED|Overall Study||20
11373876|NCT03322930|12569452|FG000|NOT COMPLETED|Overall Study||0
11373877|NCT03322930|12569453|FG001|NOT COMPLETED|Overall Study||0
11373878|NCT03323086|12569461|FG000|STARTED|Overall Study||26
11373879|NCT03323086|12569462|FG001|STARTED|Overall Study||22
11373880|NCT03323086|12569461|FG000|COMPLETED|Overall Study||23
11373881|NCT03323086|12569462|FG001|COMPLETED|Overall Study||20
11373882|NCT03323086|12569461|FG000|NOT COMPLETED|Overall Study||3
11373883|NCT03323086|12569462|FG001|NOT COMPLETED|Overall Study||2
11373884|NCT03323164|12569470|FG000|STARTED|Overall Study||18
11373885|NCT03323164|12569471|FG001|STARTED|Overall Study||17
11373886|NCT03323164|12569470|FG000|COMPLETED|Overall Study||16
11373887|NCT03323164|12569471|FG001|COMPLETED|Overall Study||15
11373888|NCT03323164|12569470|FG000|NOT COMPLETED|Overall Study||2
11373889|NCT03323164|12569471|FG001|NOT COMPLETED|Overall Study||2
11373890|NCT03323307|12569481|FG000|STARTED|Overall Study||70
11373891|NCT03323307|12569481|FG000|COMPLETED|Overall Study||70
11373892|NCT03323307|12569481|FG000|NOT COMPLETED|Overall Study||0
11373893|NCT03323723|12569485|FG000|STARTED|Screening||73
11373894|NCT03323723|12569485|FG000|COMPLETED|Screening||64
11373895|NCT03323723|12569485|FG000|NOT COMPLETED|Screening||9
11373896|NCT03323723|12569485|FG000|STARTED|Baseline Phase||64
11373897|NCT03323723|12569485|FG000|COMPLETED|Baseline Phase||60
11373898|NCT03323723|12569485|FG000|NOT COMPLETED|Baseline Phase||4
11373899|NCT03323723|12569485|FG000|STARTED|Treatment Phase||60
11373900|NCT03323723|12569485|FG000|COMPLETED|Treatment Phase||51
11373901|NCT03323723|12569485|FG000|NOT COMPLETED|Treatment Phase||9
11373902|NCT03323801|12569490|FG000|STARTED|Overall Study||10
11373903|NCT03323801|12569490|FG000|COMPLETED|Overall Study||10
11373904|NCT03323801|12569490|FG000|NOT COMPLETED|Overall Study||0
11373905|NCT03323853|12569497|FG000|STARTED|Overall Study||213
11373906|NCT03323853|12569498|FG001|STARTED|Overall Study||238
11373907|NCT03323853|12569497|FG000|COMPLETED|Overall Study||213
11373908|NCT03323853|12569498|FG001|COMPLETED|Overall Study||238
11373909|NCT03323853|12569497|FG000|NOT COMPLETED|Overall Study||0
11373910|NCT03323853|12569498|FG001|NOT COMPLETED|Overall Study||0
11373911|NCT03324451|12569506|FG000|STARTED|Overall Study||97
11373912|NCT03324451|12569507|FG001|STARTED|Overall Study||54
11373913|NCT03324451|12569506|FG000|COMPLETED|Overall Study||65
11373914|NCT03324451|12569507|FG001|COMPLETED|Overall Study||41
11373915|NCT03324451|12569506|FG000|NOT COMPLETED|Overall Study||32
11373916|NCT03324451|12569507|FG001|NOT COMPLETED|Overall Study||13
11373917|NCT03324581|12569516|FG000|STARTED|Overall Study||77
11373918|NCT03324581|12569517|FG001|STARTED|Overall Study||80
11373919|NCT03324581|12569518|FG002|STARTED|Overall Study||82
11373920|NCT03324581|12569516|FG000|COMPLETED|Overall Study||38
11373921|NCT03324581|12569517|FG001|COMPLETED|Overall Study||44
11373922|NCT03324581|12569518|FG002|COMPLETED|Overall Study||57
11373923|NCT03324581|12569516|FG000|NOT COMPLETED|Overall Study||39
11373924|NCT03324581|12569517|FG001|NOT COMPLETED|Overall Study||36
11373925|NCT03324581|12569518|FG002|NOT COMPLETED|Overall Study||25
11373926|NCT03324607|12569526|FG000|STARTED|Overall Study||20
11373927|NCT03324607|12569526|FG000|COMPLETED|Overall Study||20
11373928|NCT03324607|12569526|FG000|NOT COMPLETED|Overall Study||0
11373929|NCT03325010|12569535|FG000|STARTED|Overall Study||64
11373930|NCT03325010|12569536|FG001|STARTED|Overall Study||63
11373931|NCT03325010|12569535|FG000|Safety Analysis Set|Overall Study||62
11373932|NCT03325010|12569536|FG001|Safety Analysis Set|Overall Study||59
11373933|NCT03325010|12569535|FG000|Full Analysis Set|Overall Study||61
11373934|NCT03325010|12569536|FG001|Full Analysis Set|Overall Study||58
11373935|NCT03325010|12569535|FG000|COMPLETED|Overall Study||55
11373936|NCT03325010|12569536|FG001|COMPLETED|Overall Study||43
11373937|NCT03325010|12569535|FG000|NOT COMPLETED|Overall Study||9
11373938|NCT03325010|12569536|FG001|NOT COMPLETED|Overall Study||20
11373939|NCT03325556|12569542|FG000|STARTED|Open-label Period||392
11373940|NCT03325556|12569543|FG001|STARTED|Open-label Period||0
11373941|NCT03325556|12569544|FG002|STARTED|Open-label Period||0
11373942|NCT03325556|12569542|FG000|COMPLETED|Open-label Period||217
11373943|NCT03325556|12569543|FG001|COMPLETED|Open-label Period||0
11373944|NCT03325556|12569544|FG002|COMPLETED|Open-label Period||0
11373945|NCT03325556|12569542|FG000|NOT COMPLETED|Open-label Period||175
11373946|NCT03325556|12569543|FG001|NOT COMPLETED|Open-label Period||0
11373947|NCT03325556|12569544|FG002|NOT COMPLETED|Open-label Period||0
11373948|NCT03325556|12569542|FG000|STARTED|Double-blind Period||0
11373949|NCT03325556|12569543|FG001|STARTED|Double-blind Period||105
11373950|NCT03325556|12569544|FG002|STARTED|Double-blind Period||112
11373951|NCT03325556|12569542|FG000|COMPLETED|Double-blind Period||0
11373952|NCT03325556|12569543|FG001|COMPLETED|Double-blind Period||44
11373953|NCT03325556|12569544|FG002|COMPLETED|Double-blind Period||35
11373954|NCT03325556|12569542|FG000|NOT COMPLETED|Double-blind Period||0
11373955|NCT03325556|12569543|FG001|NOT COMPLETED|Double-blind Period||61
11373956|NCT03325556|12569544|FG002|NOT COMPLETED|Double-blind Period||77
11373957|NCT03325673|12569553|FG000|STARTED|Overall Study||42
11373958|NCT03325673|12569554|FG001|STARTED|Overall Study||42
11373959|NCT03325673|12569553|FG000|COMPLETED|Overall Study||38
11373960|NCT03325673|12569554|FG001|COMPLETED|Overall Study||42
11373961|NCT03325673|12569553|FG000|NOT COMPLETED|Overall Study||4
11373962|NCT03325673|12569554|FG001|NOT COMPLETED|Overall Study||0
11373963|NCT03325816|12569562|FG000|STARTED|Overall Study||3
11373964|NCT03325816|12569563|FG001|STARTED|Overall Study||6
11373965|NCT03325816|12569562|FG000|COMPLETED|Overall Study||3
11373966|NCT03325816|12569563|FG001|COMPLETED|Overall Study||6
11373967|NCT03325816|12569562|FG000|NOT COMPLETED|Overall Study||0
11373968|NCT03325816|12569563|FG001|NOT COMPLETED|Overall Study||0
11373969|NCT03325881|12569573|FG000|STARTED|Overall Study||44
11373970|NCT03325881|12569574|FG001|STARTED|Overall Study||45
11373971|NCT03325881|12569573|FG000|Treated|Overall Study||43
11373972|NCT03325881|12569574|FG001|Treated|Overall Study||45
11373973|NCT03325881|12569573|FG000|COMPLETED|Overall Study||41
11373974|NCT03325881|12569574|FG001|COMPLETED|Overall Study||42
11373975|NCT03325881|12569573|FG000|NOT COMPLETED|Overall Study||3
11373976|NCT03325881|12569574|FG001|NOT COMPLETED|Overall Study||3
11373977|NCT03325894|12569584|FG000|STARTED|Overall Study||64
11373978|NCT03325894|12569585|FG001|STARTED|Overall Study||77
11373979|NCT03325894|12569584|FG000|COMPLETED|Overall Study||0
11373980|NCT03325894|12569585|FG001|COMPLETED|Overall Study||0
11373981|NCT03325894|12569584|FG000|NOT COMPLETED|Overall Study||64
11373982|NCT03325894|12569585|FG001|NOT COMPLETED|Overall Study||77
11373983|NCT03326323|12569594|FG000|STARTED|Overall Study||43
11005819|NCT00724945|12183605|FG001|NOT COMPLETED|Period 1||1
11005820|NCT00724945|12183604|FG000|STARTED|Period 2||55
11005821|NCT00724945|12183605|FG001|STARTED|Period 2||54
11373984|NCT03326323|12569594|FG000|COMPLETED|Overall Study||40
11373985|NCT03326323|12569594|FG000|NOT COMPLETED|Overall Study||3
11373986|NCT03326518|12569601|FG000|STARTED|Overall Study||19
11373987|NCT03326518|12569602|FG001|STARTED|Overall Study||12
11373988|NCT03326518|12569603|FG002|STARTED|Overall Study||14
11373989|NCT03326518|12569601|FG000|COMPLETED|Overall Study||16
11373990|NCT03326518|12569602|FG001|COMPLETED|Overall Study||12
11373991|NCT03326518|12569603|FG002|COMPLETED|Overall Study||13
11373992|NCT03326518|12569601|FG000|NOT COMPLETED|Overall Study||3
11373993|NCT03326518|12569602|FG001|NOT COMPLETED|Overall Study||0
11373994|NCT03326518|12569603|FG002|NOT COMPLETED|Overall Study||1
11373995|NCT03326843|12569611|FG000|STARTED|Overall Study||4
11373996|NCT03326843|12569611|FG000|COMPLETED|Overall Study||4
11373997|NCT03326843|12569611|FG000|NOT COMPLETED|Overall Study||0
11373998|NCT03326895|12569615|FG000|STARTED|Overall Study||168
11373999|NCT03326895|12569615|FG000|COMPLETED|Overall Study||168
11005822|NCT00724945|12183604|FG000|COMPLETED|Period 2||51
11374000|NCT03326895|12569615|FG000|NOT COMPLETED|Overall Study||0
11374001|NCT03326986|12569622|FG000|STARTED|Overall Study||8
11374002|NCT03326986|12569623|FG001|STARTED|Overall Study||8
11374003|NCT03326986|12569624|FG002|STARTED|Overall Study||8
11374004|NCT03326986|12569622|FG000|COMPLETED|Overall Study||8
11374005|NCT03326986|12569623|FG001|COMPLETED|Overall Study||8
11374006|NCT03326986|12569624|FG002|COMPLETED|Overall Study||8
11374007|NCT03326986|12569622|FG000|NOT COMPLETED|Overall Study||0
11374008|NCT03326986|12569623|FG001|NOT COMPLETED|Overall Study||0
11374009|NCT03326986|12569624|FG002|NOT COMPLETED|Overall Study||0
11374010|NCT03326999|12569667|FG000|STARTED|Overall Study||30
11374011|NCT03326999|12569668|FG001|STARTED|Overall Study||30
11374012|NCT03326999|12569667|FG000|COMPLETED|Overall Study||30
11374013|NCT03326999|12569668|FG001|COMPLETED|Overall Study||30
11374014|NCT03326999|12569667|FG000|NOT COMPLETED|Overall Study||0
11374015|NCT03326999|12569668|FG001|NOT COMPLETED|Overall Study||0
11374016|NCT03327051|12569676|FG000|STARTED|Overall Study||19
11374017|NCT03327051|12569677|FG001|STARTED|Overall Study||20
11374018|NCT03327051|12569676|FG000|Received Treatment|Overall Study||16
11374019|NCT03327051|12569677|FG001|Received Treatment|Overall Study||16
11005823|NCT00724945|12183605|FG001|COMPLETED|Period 2||54
11374020|NCT03327051|12569676|FG000|Attended Visit 2 (Week 0)|Overall Study||15
11374021|NCT03327051|12569677|FG001|Attended Visit 2 (Week 0)|Overall Study||15
11374022|NCT03327051|12569676|FG000|COMPLETED|Overall Study||14
11374023|NCT03327051|12569677|FG001|COMPLETED|Overall Study||15
11374024|NCT03327051|12569676|FG000|NOT COMPLETED|Overall Study||5
11374025|NCT03327051|12569677|FG001|NOT COMPLETED|Overall Study||5
11374026|NCT03327220|12569686|FG000|STARTED|Overall Study||62
11374027|NCT03327220|12569687|FG001|STARTED|Overall Study||62
11374028|NCT03327220|12569686|FG000|Safety Population: Received Study Treatment|Overall Study||59
11374029|NCT03327220|12569687|FG001|Safety Population: Received Study Treatment|Overall Study||60
11374030|NCT03327220|12569686|FG000|COMPLETED|Overall Study||57
11374031|NCT03327220|12569687|FG001|COMPLETED|Overall Study||58
11374032|NCT03327220|12569686|FG000|NOT COMPLETED|Overall Study||5
11374033|NCT03327220|12569687|FG001|NOT COMPLETED|Overall Study||4
11374034|NCT03327402|12569693|FG000|STARTED|Overall Study||24
11374035|NCT03327402|12569693|FG000|Rich PK Sampling Group|Overall Study||12
11374036|NCT03327402|12569693|FG000|Sparse PK Sampling Group|Overall Study||12
11374037|NCT03327402|12569693|FG000|COMPLETED|Overall Study||22
11374038|NCT03327402|12569693|FG000|NOT COMPLETED|Overall Study||2
11374039|NCT03327571|12569699|FG000|STARTED|Group 1: cHL||1598
11374040|NCT03327571|12569700|FG001|STARTED|Group 1: cHL||0
11374041|NCT03327571|12569699|FG000|COMPLETED|Group 1: cHL||1598
11374042|NCT03327571|12569700|FG001|COMPLETED|Group 1: cHL||0
11374043|NCT03327571|12569699|FG000|NOT COMPLETED|Group 1: cHL||0
11374044|NCT03327571|12569700|FG001|NOT COMPLETED|Group 1: cHL||0
11374045|NCT03327571|12569699|FG000|STARTED|Group 2: RRHL||0
11374046|NCT03327571|12569700|FG001|STARTED|Group 2: RRHL|105 RRHL only participants and 321 common participants who had CHL, and subsequently RRHL between 2010-2013.|426
11374047|NCT03327571|12569699|FG000|Participants Were Counted in Both Groups|Group 2: RRHL||0
11374048|NCT03327571|12569700|FG001|Participants Were Counted in Both Groups|Group 2: RRHL|Participants who were diagnosed with CHL, and subsequently RRHL between 2010 and 2013.|321
11374049|NCT03327571|12569699|FG000|COMPLETED|Group 2: RRHL||0
11374050|NCT03327571|12569700|FG001|COMPLETED|Group 2: RRHL||426
11374051|NCT03327571|12569699|FG000|NOT COMPLETED|Group 2: RRHL||0
11374052|NCT03327571|12569700|FG001|NOT COMPLETED|Group 2: RRHL||0
11374053|NCT03328182|12569707|FG000|STARTED|Overall Study||34
11374054|NCT03328182|12569707|FG000|COMPLETED|Overall Study||30
11374055|NCT03328182|12569707|FG000|NOT COMPLETED|Overall Study||4
11374056|NCT03328208|12569713|FG000|STARTED|Overall Study||37
11374057|NCT03328208|12569714|FG001|STARTED|Overall Study||35
11374058|NCT03328208|12569713|FG000|COMPLETED|Overall Study||37
11374059|NCT03328208|12569714|FG001|COMPLETED|Overall Study||35
11374060|NCT03328208|12569713|FG000|NOT COMPLETED|Overall Study||0
11374061|NCT03328208|12569714|FG001|NOT COMPLETED|Overall Study||0
11374062|NCT03328325|12569720|FG000|STARTED|Overall Study||152
11374063|NCT03328325|12569720|FG000|COMPLETED|Overall Study||141
11374064|NCT03328325|12569720|FG000|NOT COMPLETED|Overall Study||11
11374065|NCT03328624|12569724|FG000|STARTED|Overall Study||36
11374066|NCT03328624|12569724|FG000|COMPLETED|Overall Study||36
11374067|NCT03328624|12569724|FG000|NOT COMPLETED|Overall Study||0
11374068|NCT03328832|12569730|FG000|STARTED|Overall Study||35
11374069|NCT03328832|12569731|FG001|STARTED|Overall Study||35
11374070|NCT03328832|12569730|FG000|COMPLETED|Overall Study||35
11374071|NCT03328832|12569731|FG001|COMPLETED|Overall Study||34
11374072|NCT03328832|12569730|FG000|NOT COMPLETED|Overall Study||0
11374073|NCT03328832|12569731|FG001|NOT COMPLETED|Overall Study||1
11374074|NCT03328897|12569740|FG000|STARTED|Randomized-treatment Epoch||168
11374075|NCT03328897|12569741|FG001|STARTED|Randomized-treatment Epoch||167
11374076|NCT03328897|12569742|FG002|STARTED|Randomized-treatment Epoch||83
11374077|NCT03328897|12569740|FG000|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
11374078|NCT03328897|12569741|FG001|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
11374079|NCT03328897|12569742|FG002|Full Analysis Set (FAS)|Randomized-treatment Epoch||83
11374080|NCT03328897|12569740|FG000|COMPLETED|Randomized-treatment Epoch||152
11374081|NCT03328897|12569741|FG001|COMPLETED|Randomized-treatment Epoch||162
11374082|NCT03328897|12569742|FG002|COMPLETED|Randomized-treatment Epoch||81
11374083|NCT03328897|12569740|FG000|NOT COMPLETED|Randomized-treatment Epoch||16
11374084|NCT03328897|12569741|FG001|NOT COMPLETED|Randomized-treatment Epoch||5
11374085|NCT03328897|12569742|FG002|NOT COMPLETED|Randomized-treatment Epoch||2
11374086|NCT03328897|12569740|FG000|STARTED|Follow-up Epoch||161
11374087|NCT03328897|12569741|FG001|STARTED|Follow-up Epoch||163
11374088|NCT03328897|12569742|FG002|STARTED|Follow-up Epoch||81
11374089|NCT03328897|12569740|FG000|COMPLETED|Follow-up Epoch||153
11374090|NCT03328897|12569741|FG001|COMPLETED|Follow-up Epoch||160
11374091|NCT03328897|12569742|FG002|COMPLETED|Follow-up Epoch||79
11374092|NCT03328897|12569740|FG000|NOT COMPLETED|Follow-up Epoch||8
11374093|NCT03328897|12569741|FG001|NOT COMPLETED|Follow-up Epoch||3
11374094|NCT03328897|12569742|FG002|NOT COMPLETED|Follow-up Epoch||2
11374095|NCT03328949|12569750|FG000|STARTED|Overall Study||120
11374096|NCT03328949|12569750|FG000|COMPLETED|Overall Study||120
11374097|NCT03328949|12569750|FG000|NOT COMPLETED|Overall Study||0
11374098|NCT03329196|12569757|FG000|STARTED|Overall Study||151
11374099|NCT03329196|12569758|FG001|STARTED|Overall Study||153
11374100|NCT03329196|12569757|FG000|COMPLETED|Overall Study||111
11374101|NCT03329196|12569758|FG001|COMPLETED|Overall Study||123
11374102|NCT03329196|12569757|FG000|NOT COMPLETED|Overall Study||40
11374103|NCT03329196|12569758|FG001|NOT COMPLETED|Overall Study||30
11374104|NCT03329209|12569764|FG000|STARTED|Overall Study||16
11374105|NCT03329209|12569764|FG000|COMPLETED|Overall Study||16
11374106|NCT03329209|12569764|FG000|NOT COMPLETED|Overall Study||0
11374107|NCT03329352|12569768|FG000|STARTED|F&P Toffee Full Face Mask Validation||44
11374108|NCT03329352|12569768|FG000|COMPLETED|F&P Toffee Full Face Mask Validation||42
11374109|NCT03329352|12569768|FG000|NOT COMPLETED|F&P Toffee Full Face Mask Validation||2
11374110|NCT03329352|12569768|FG000|STARTED|Extension||29
11374111|NCT03329352|12569768|FG000|COMPLETED|Extension||22
11374112|NCT03329352|12569768|FG000|NOT COMPLETED|Extension||7
11374113|NCT03329573|12569778|FG000|STARTED|Treatment Period 1 (Up to 5 Days)||23
11374114|NCT03329573|12569779|FG001|STARTED|Treatment Period 1 (Up to 5 Days)||24
11374115|NCT03329573|12569780|FG002|STARTED|Treatment Period 1 (Up to 5 Days)||19
11374116|NCT03329573|12569781|FG003|STARTED|Treatment Period 1 (Up to 5 Days)||19
11374117|NCT03329573|12569778|FG000|COMPLETED|Treatment Period 1 (Up to 5 Days)||22
11374118|NCT03329573|12569779|FG001|COMPLETED|Treatment Period 1 (Up to 5 Days)||21
11374119|NCT03329573|12569780|FG002|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
11374120|NCT03329573|12569781|FG003|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
11374121|NCT03329573|12569778|FG000|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1
11374122|NCT03329573|12569779|FG001|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3
11374123|NCT03329573|12569780|FG002|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
11374124|NCT03329573|12569781|FG003|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
11374125|NCT03329573|12569778|FG000|STARTED|Washout Period (Day 6 to Day 11)||22
11374126|NCT03329573|12569779|FG001|STARTED|Washout Period (Day 6 to Day 11)||21
11374127|NCT03329573|12569780|FG002|STARTED|Washout Period (Day 6 to Day 11)||19
11374128|NCT03329573|12569781|FG003|STARTED|Washout Period (Day 6 to Day 11)||19
11374129|NCT03329573|12569778|FG000|COMPLETED|Washout Period (Day 6 to Day 11)||22
11374130|NCT03329573|12569779|FG001|COMPLETED|Washout Period (Day 6 to Day 11)||21
11374131|NCT03329573|12569780|FG002|COMPLETED|Washout Period (Day 6 to Day 11)||19
11374132|NCT03329573|12569781|FG003|COMPLETED|Washout Period (Day 6 to Day 11)||19
11374133|NCT03329573|12569778|FG000|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
11374134|NCT03329573|12569779|FG001|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
11374135|NCT03329573|12569780|FG002|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
11374136|NCT03329573|12569781|FG003|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
11374137|NCT03329573|12569778|FG000|STARTED|Treatment Period 2 (Day 12 to Day 26)||22
11374138|NCT03329573|12569779|FG001|STARTED|Treatment Period 2 (Day 12 to Day 26)||21
11374139|NCT03329573|12569780|FG002|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
11374140|NCT03329573|12569781|FG003|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
11374141|NCT03329573|12569778|FG000|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21
11374142|NCT03329573|12569779|FG001|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20
11374143|NCT03329573|12569780|FG002|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
11374144|NCT03329573|12569781|FG003|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
11374145|NCT03329573|12569778|FG000|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
11374146|NCT03329573|12569779|FG001|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
11374147|NCT03329573|12569780|FG002|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
11374148|NCT03329573|12569781|FG003|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
11374149|NCT03329846|12569793|FG000|STARTED|Overall Study||10
11374150|NCT03329846|12569794|FG001|STARTED|Overall Study||10
11374151|NCT03329846|12569793|FG000|COMPLETED|Overall Study||2
11374152|NCT03329846|12569794|FG001|COMPLETED|Overall Study||1
11374153|NCT03329846|12569793|FG000|NOT COMPLETED|Overall Study||8
11374154|NCT03329846|12569794|FG001|NOT COMPLETED|Overall Study||9
11374155|NCT03329885|12569806|FG000|STARTED|Overall Study||9
11374156|NCT03329885|12569807|FG001|STARTED|Overall Study||6
11374157|NCT03329885|12569808|FG002|STARTED|Overall Study||6
11374158|NCT03329885|12569809|FG003|STARTED|Overall Study||6
11374159|NCT03329885|12569810|FG004|STARTED|Overall Study||6
11374160|NCT03329885|12569811|FG005|STARTED|Overall Study||3
11374161|NCT03329885|12569812|FG006|STARTED|Overall Study||1
11374162|NCT03329885|12569813|FG007|STARTED|Overall Study||1
11374163|NCT03329885|12569814|FG008|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0
11374164|NCT03329885|12569806|FG000|COMPLETED|Overall Study||9
11374165|NCT03329885|12569807|FG001|COMPLETED|Overall Study||6
11374166|NCT03329885|12569808|FG002|COMPLETED|Overall Study||6
11374167|NCT03329885|12569809|FG003|COMPLETED|Overall Study||6
11374168|NCT03329885|12569810|FG004|COMPLETED|Overall Study||6
11374169|NCT03329885|12569811|FG005|COMPLETED|Overall Study||3
11374170|NCT03329885|12569812|FG006|COMPLETED|Overall Study||0
11374171|NCT03329885|12569813|FG007|COMPLETED|Overall Study||0
11374172|NCT03329885|12569814|FG008|COMPLETED|Overall Study||0
11374173|NCT03329885|12569806|FG000|NOT COMPLETED|Overall Study||0
11374174|NCT03329885|12569807|FG001|NOT COMPLETED|Overall Study||0
11374175|NCT03329885|12569808|FG002|NOT COMPLETED|Overall Study||0
11374176|NCT03329885|12569809|FG003|NOT COMPLETED|Overall Study||0
11374177|NCT03329885|12569810|FG004|NOT COMPLETED|Overall Study||0
11374178|NCT03329885|12569811|FG005|NOT COMPLETED|Overall Study||0
11374179|NCT03329885|12569812|FG006|NOT COMPLETED|Overall Study||1
11374180|NCT03329885|12569813|FG007|NOT COMPLETED|Overall Study||1
11374181|NCT03329885|12569814|FG008|NOT COMPLETED|Overall Study||0
11374182|NCT03329911|12569836|FG000|STARTED|Overall Study||326
11374183|NCT03329911|12569837|FG001|STARTED|Overall Study||325
11374184|NCT03329911|12569836|FG000|COMPLETED|Overall Study||209
11374185|NCT03329911|12569837|FG001|COMPLETED|Overall Study||222
11374186|NCT03329911|12569836|FG000|NOT COMPLETED|Overall Study||117
11374187|NCT03329911|12569837|FG001|NOT COMPLETED|Overall Study||103
11374188|NCT03329937|12569843|FG000|STARTED|Overall Study||21
11374189|NCT03329937|12569843|FG000|COMPLETED|Overall Study||21
11374190|NCT03329937|12569843|FG000|NOT COMPLETED|Overall Study||0
11374191|NCT03329989|12569847|FG000|STARTED|Overall Study||158
11374192|NCT03329989|12569847|FG000|COMPLETED|Overall Study||135
11374193|NCT03329989|12569847|FG000|NOT COMPLETED|Overall Study||23
11374194|NCT03330002|12569851|FG000|STARTED|Overall Study|Subjects that received the MANTA VCD|500
11374195|NCT03330002|12569851|FG000|COMPLETED|Overall Study|Subjects that received the MANTA VCD and completed 30 day follow-up visit|478
11374196|NCT03330002|12569851|FG000|NOT COMPLETED|Overall Study||22
11374197|NCT03330041|12569855|FG000|STARTED|Overall Study||50
11374198|NCT03330041|12569855|FG000|COMPLETED|Overall Study||48
11374199|NCT03330041|12569855|FG000|NOT COMPLETED|Overall Study||2
11374200|NCT03330119|12569863|FG000|STARTED|Overall Study||641
11374201|NCT03330119|12569864|FG001|STARTED|Overall Study||853
11374202|NCT03330119|12569863|FG000|COMPLETED|Overall Study||475
11374203|NCT03330119|12569864|FG001|COMPLETED|Overall Study||571
11374204|NCT03330119|12569863|FG000|NOT COMPLETED|Overall Study||166
11374205|NCT03330119|12569864|FG001|NOT COMPLETED|Overall Study||282
11374206|NCT03330236|12569872|FG000|STARTED|Overall Study||779
11374207|NCT03330236|12569873|FG001|STARTED|Overall Study||781
11374208|NCT03330236|12569872|FG000|Received Surgery|Overall Study||779
11374209|NCT03330236|12569873|FG001|Received Surgery|Overall Study||781
11374210|NCT03330236|12569872|FG000|Modified ITT|Overall Study||773
11374211|NCT03330236|12569873|FG001|Modified ITT|Overall Study||774
11374212|NCT03330236|12569872|FG000|COMPLETED|Overall Study||679
11374213|NCT03330236|12569873|FG001|COMPLETED|Overall Study||697
11374214|NCT03330236|12569872|FG000|NOT COMPLETED|Overall Study||100
11374215|NCT03330236|12569873|FG001|NOT COMPLETED|Overall Study||84
11374216|NCT03330262|12569881|FG000|STARTED|First Six Weeks||7
11374217|NCT03330262|12569882|FG001|STARTED|First Six Weeks||6
11374218|NCT03330262|12569881|FG000|COMPLETED|First Six Weeks||7
11374219|NCT03330262|12569882|FG001|COMPLETED|First Six Weeks||6
11374220|NCT03330262|12569881|FG000|NOT COMPLETED|First Six Weeks||0
11374221|NCT03330262|12569882|FG001|NOT COMPLETED|First Six Weeks||0
11374222|NCT03330262|12569881|FG000|STARTED|Second Six Weeks||7
11374223|NCT03330262|12569882|FG001|STARTED|Second Six Weeks||6
11374224|NCT03330262|12569881|FG000|COMPLETED|Second Six Weeks||5
11374225|NCT03330262|12569882|FG001|COMPLETED|Second Six Weeks||5
11374226|NCT03330262|12569881|FG000|NOT COMPLETED|Second Six Weeks||2
11374227|NCT03330262|12569882|FG001|NOT COMPLETED|Second Six Weeks||1
11374228|NCT03330275|12569891|FG000|STARTED|Visit 1 - Period 1||6
11374229|NCT03330275|12569892|FG001|STARTED|Visit 1 - Period 1||6
11374230|NCT03330275|12569893|FG002|STARTED|Visit 1 - Period 1||6
11374231|NCT03330275|12569894|FG003|STARTED|Visit 1 - Period 1||6
11374232|NCT03330275|12569895|FG004|STARTED|Visit 1 - Period 1||0
11374233|NCT03330275|12569896|FG005|STARTED|Visit 1 - Period 1||0
11374234|NCT03330275|12569897|FG006|STARTED|Visit 1 - Period 1||0
11374235|NCT03330275|12569898|FG007|STARTED|Visit 1 - Period 1||0
11374236|NCT03330275|12569899|FG008|STARTED|Visit 1 - Period 1||0
11374237|NCT03330275|12569900|FG009|STARTED|Visit 1 - Period 1||0
11374238|NCT03330275|12569891|FG000|COMPLETED|Visit 1 - Period 1||6
11374239|NCT03330275|12569892|FG001|COMPLETED|Visit 1 - Period 1||6
11374240|NCT03330275|12569893|FG002|COMPLETED|Visit 1 - Period 1||6
11374241|NCT03330275|12569894|FG003|COMPLETED|Visit 1 - Period 1||6
11374242|NCT03330275|12569895|FG004|COMPLETED|Visit 1 - Period 1||0
11374243|NCT03330275|12569896|FG005|COMPLETED|Visit 1 - Period 1||0
11374244|NCT03330275|12569897|FG006|COMPLETED|Visit 1 - Period 1||0
11374245|NCT03330275|12569898|FG007|COMPLETED|Visit 1 - Period 1||0
11374246|NCT03330275|12569899|FG008|COMPLETED|Visit 1 - Period 1||0
11374247|NCT03330275|12569900|FG009|COMPLETED|Visit 1 - Period 1||0
11374248|NCT03330275|12569891|FG000|NOT COMPLETED|Visit 1 - Period 1||0
11374249|NCT03330275|12569892|FG001|NOT COMPLETED|Visit 1 - Period 1||0
11374250|NCT03330275|12569893|FG002|NOT COMPLETED|Visit 1 - Period 1||0
11374251|NCT03330275|12569894|FG003|NOT COMPLETED|Visit 1 - Period 1||0
11374252|NCT03330275|12569895|FG004|NOT COMPLETED|Visit 1 - Period 1||0
11374253|NCT03330275|12569896|FG005|NOT COMPLETED|Visit 1 - Period 1||0
11374254|NCT03330275|12569897|FG006|NOT COMPLETED|Visit 1 - Period 1||0
11374255|NCT03330275|12569898|FG007|NOT COMPLETED|Visit 1 - Period 1||0
11374256|NCT03330275|12569899|FG008|NOT COMPLETED|Visit 1 - Period 1||0
11374257|NCT03330275|12569900|FG009|NOT COMPLETED|Visit 1 - Period 1||0
11374258|NCT03330275|12569891|FG000|STARTED|Visit 1 - Period 2||6
11374259|NCT03330275|12569892|FG001|STARTED|Visit 1 - Period 2||6
11374260|NCT03330275|12569893|FG002|STARTED|Visit 1 - Period 2||6
11374261|NCT03330275|12569894|FG003|STARTED|Visit 1 - Period 2||6
11374262|NCT03330275|12569895|FG004|STARTED|Visit 1 - Period 2||0
11374263|NCT03330275|12569896|FG005|STARTED|Visit 1 - Period 2||0
11374264|NCT03330275|12569897|FG006|STARTED|Visit 1 - Period 2||0
11374265|NCT03330275|12569898|FG007|STARTED|Visit 1 - Period 2||0
11374266|NCT03330275|12569899|FG008|STARTED|Visit 1 - Period 2||0
11374267|NCT03330275|12569900|FG009|STARTED|Visit 1 - Period 2||0
11374268|NCT03330275|12569891|FG000|COMPLETED|Visit 1 - Period 2||6
11374269|NCT03330275|12569892|FG001|COMPLETED|Visit 1 - Period 2||6
11374270|NCT03330275|12569893|FG002|COMPLETED|Visit 1 - Period 2||6
11374271|NCT03330275|12569894|FG003|COMPLETED|Visit 1 - Period 2||6
11374272|NCT03330275|12569895|FG004|COMPLETED|Visit 1 - Period 2||0
11374273|NCT03330275|12569896|FG005|COMPLETED|Visit 1 - Period 2||0
11374274|NCT03330275|12569897|FG006|COMPLETED|Visit 1 - Period 2||0
11374275|NCT03330275|12569898|FG007|COMPLETED|Visit 1 - Period 2||0
11374276|NCT03330275|12569899|FG008|COMPLETED|Visit 1 - Period 2||0
11374277|NCT03330275|12569900|FG009|COMPLETED|Visit 1 - Period 2||0
11374278|NCT03330275|12569891|FG000|NOT COMPLETED|Visit 1 - Period 2||0
11374279|NCT03330275|12569892|FG001|NOT COMPLETED|Visit 1 - Period 2||0
11374280|NCT03330275|12569893|FG002|NOT COMPLETED|Visit 1 - Period 2||0
11374281|NCT03330275|12569894|FG003|NOT COMPLETED|Visit 1 - Period 2||0
11374282|NCT03330275|12569895|FG004|NOT COMPLETED|Visit 1 - Period 2||0
11374283|NCT03330275|12569896|FG005|NOT COMPLETED|Visit 1 - Period 2||0
11374284|NCT03330275|12569897|FG006|NOT COMPLETED|Visit 1 - Period 2||0
11374285|NCT03330275|12569898|FG007|NOT COMPLETED|Visit 1 - Period 2||0
11374286|NCT03330275|12569899|FG008|NOT COMPLETED|Visit 1 - Period 2||0
11374287|NCT03330275|12569900|FG009|NOT COMPLETED|Visit 1 - Period 2||0
11374288|NCT03330275|12569891|FG000|STARTED|Visits 2, 3 and 4 - Period 1||0
11374289|NCT03330275|12569892|FG001|STARTED|Visits 2, 3 and 4 - Period 1||0
11374290|NCT03330275|12569893|FG002|STARTED|Visits 2, 3 and 4 - Period 1||0
11374291|NCT03330275|12569894|FG003|STARTED|Visits 2, 3 and 4 - Period 1||0
11374292|NCT03330275|12569895|FG004|STARTED|Visits 2, 3 and 4 - Period 1||4
11374293|NCT03330275|12569896|FG005|STARTED|Visits 2, 3 and 4 - Period 1||4
11374294|NCT03330275|12569897|FG006|STARTED|Visits 2, 3 and 4 - Period 1||4
11374295|NCT03330275|12569898|FG007|STARTED|Visits 2, 3 and 4 - Period 1||4
11374296|NCT03330275|12569899|FG008|STARTED|Visits 2, 3 and 4 - Period 1||4
11374297|NCT03330275|12569900|FG009|STARTED|Visits 2, 3 and 4 - Period 1||4
11374298|NCT03330275|12569891|FG000|COMPLETED|Visits 2, 3 and 4 - Period 1||0
11374299|NCT03330275|12569892|FG001|COMPLETED|Visits 2, 3 and 4 - Period 1||0
11374300|NCT03330275|12569893|FG002|COMPLETED|Visits 2, 3 and 4 - Period 1||0
11374301|NCT03330275|12569894|FG003|COMPLETED|Visits 2, 3 and 4 - Period 1||0
11374302|NCT03330275|12569895|FG004|COMPLETED|Visits 2, 3 and 4 - Period 1||4
11374303|NCT03330275|12569896|FG005|COMPLETED|Visits 2, 3 and 4 - Period 1||4
11374304|NCT03330275|12569897|FG006|COMPLETED|Visits 2, 3 and 4 - Period 1||4
11374305|NCT03330275|12569898|FG007|COMPLETED|Visits 2, 3 and 4 - Period 1||4
11374306|NCT03330275|12569899|FG008|COMPLETED|Visits 2, 3 and 4 - Period 1||4
11374307|NCT03330275|12569900|FG009|COMPLETED|Visits 2, 3 and 4 - Period 1||4
11374308|NCT03330275|12569891|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
11374309|NCT03330275|12569892|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
11374310|NCT03330275|12569893|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
11374311|NCT03330275|12569894|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
11374312|NCT03330275|12569895|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
11374313|NCT03330275|12569896|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
11374314|NCT03330275|12569897|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
11374315|NCT03330275|12569898|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
11374316|NCT03330275|12569899|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
11374317|NCT03330275|12569900|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
11374318|NCT03330275|12569891|FG000|STARTED|Visits 2, 3 and 4 - Period 2||0
11374319|NCT03330275|12569892|FG001|STARTED|Visits 2, 3 and 4 - Period 2||0
11374320|NCT03330275|12569893|FG002|STARTED|Visits 2, 3 and 4 - Period 2||0
11374321|NCT03330275|12569894|FG003|STARTED|Visits 2, 3 and 4 - Period 2||0
11374322|NCT03330275|12569895|FG004|STARTED|Visits 2, 3 and 4 - Period 2||4
11374323|NCT03330275|12569896|FG005|STARTED|Visits 2, 3 and 4 - Period 2||4
11374324|NCT03330275|12569897|FG006|STARTED|Visits 2, 3 and 4 - Period 2||4
11374325|NCT03330275|12569898|FG007|STARTED|Visits 2, 3 and 4 - Period 2||4
11374326|NCT03330275|12569899|FG008|STARTED|Visits 2, 3 and 4 - Period 2||4
11374327|NCT03330275|12569900|FG009|STARTED|Visits 2, 3 and 4 - Period 2||4
11374328|NCT03330275|12569891|FG000|COMPLETED|Visits 2, 3 and 4 - Period 2||0
11374329|NCT03330275|12569892|FG001|COMPLETED|Visits 2, 3 and 4 - Period 2||0
11374330|NCT03330275|12569893|FG002|COMPLETED|Visits 2, 3 and 4 - Period 2||0
11374331|NCT03330275|12569894|FG003|COMPLETED|Visits 2, 3 and 4 - Period 2||0
11374332|NCT03330275|12569895|FG004|COMPLETED|Visits 2, 3 and 4 - Period 2||4
11374333|NCT03330275|12569896|FG005|COMPLETED|Visits 2, 3 and 4 - Period 2||4
11374334|NCT03330275|12569897|FG006|COMPLETED|Visits 2, 3 and 4 - Period 2||4
11374335|NCT03330275|12569898|FG007|COMPLETED|Visits 2, 3 and 4 - Period 2||4
11374336|NCT03330275|12569899|FG008|COMPLETED|Visits 2, 3 and 4 - Period 2||4
11374337|NCT03330275|12569900|FG009|COMPLETED|Visits 2, 3 and 4 - Period 2||4
11374338|NCT03330275|12569891|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
11374339|NCT03330275|12569892|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
11374340|NCT03330275|12569893|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
11374341|NCT03330275|12569894|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
11374342|NCT03330275|12569895|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
11374343|NCT03330275|12569896|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
11374344|NCT03330275|12569897|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
11374345|NCT03330275|12569898|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
11374346|NCT03330275|12569899|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
11374347|NCT03330275|12569900|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
11374348|NCT03330275|12569891|FG000|STARTED|Visits 2, 3 and 4 - Period 3||0
11374349|NCT03330275|12569892|FG001|STARTED|Visits 2, 3 and 4 - Period 3||0
11374350|NCT03330275|12569893|FG002|STARTED|Visits 2, 3 and 4 - Period 3||0
11374351|NCT03330275|12569894|FG003|STARTED|Visits 2, 3 and 4 - Period 3||0
11374352|NCT03330275|12569895|FG004|STARTED|Visits 2, 3 and 4 - Period 3||4
11374353|NCT03330275|12569896|FG005|STARTED|Visits 2, 3 and 4 - Period 3||4
11374354|NCT03330275|12569897|FG006|STARTED|Visits 2, 3 and 4 - Period 3||4
11374355|NCT03330275|12569898|FG007|STARTED|Visits 2, 3 and 4 - Period 3||4
11374356|NCT03330275|12569899|FG008|STARTED|Visits 2, 3 and 4 - Period 3||4
11374357|NCT03330275|12569900|FG009|STARTED|Visits 2, 3 and 4 - Period 3||4
11374358|NCT03330275|12569891|FG000|COMPLETED|Visits 2, 3 and 4 - Period 3||0
11374359|NCT03330275|12569892|FG001|COMPLETED|Visits 2, 3 and 4 - Period 3||0
11374360|NCT03330275|12569893|FG002|COMPLETED|Visits 2, 3 and 4 - Period 3||0
11374361|NCT03330275|12569894|FG003|COMPLETED|Visits 2, 3 and 4 - Period 3||0
11374362|NCT03330275|12569895|FG004|COMPLETED|Visits 2, 3 and 4 - Period 3||4
11374363|NCT03330275|12569896|FG005|COMPLETED|Visits 2, 3 and 4 - Period 3||4
11374364|NCT03330275|12569897|FG006|COMPLETED|Visits 2, 3 and 4 - Period 3||4
11374365|NCT03330275|12569898|FG007|COMPLETED|Visits 2, 3 and 4 - Period 3||4
11374366|NCT03330275|12569899|FG008|COMPLETED|Visits 2, 3 and 4 - Period 3||4
11374367|NCT03330275|12569900|FG009|COMPLETED|Visits 2, 3 and 4 - Period 3||4
11374368|NCT03330275|12569891|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
11374369|NCT03330275|12569892|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
11374370|NCT03330275|12569893|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
11374371|NCT03330275|12569894|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
11374372|NCT03330275|12569895|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
11374373|NCT03330275|12569896|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
11374374|NCT03330275|12569897|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
11374375|NCT03330275|12569898|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
11374376|NCT03330275|12569899|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
11374377|NCT03330275|12569900|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
11374378|NCT03330288|12569910|FG000|STARTED|Overall Study|Enrolled|824
11374379|NCT03330288|12569911|FG001|STARTED|Overall Study|Enrolled|278
11374380|NCT03330288|12569910|FG000|COMPLETED|Overall Study||794
11374381|NCT03330288|12569911|FG001|COMPLETED|Overall Study||270
11374382|NCT03330288|12569910|FG000|NOT COMPLETED|Overall Study||30
11374383|NCT03330288|12569911|FG001|NOT COMPLETED|Overall Study||8
11374384|NCT03330457|12569921|FG000|STARTED|Overall Study||6
11374385|NCT03330457|12569922|FG001|STARTED|Overall Study||3
11374386|NCT03330457|12569923|FG002|STARTED|Overall Study||6
11374387|NCT03330457|12569924|FG003|STARTED|Overall Study||3
11374388|NCT03330457|12569921|FG000|COMPLETED|Overall Study||6
11374389|NCT03330457|12569922|FG001|COMPLETED|Overall Study||3
11374390|NCT03330457|12569923|FG002|COMPLETED|Overall Study||6
11374391|NCT03330457|12569924|FG003|COMPLETED|Overall Study||3
11374392|NCT03330457|12569921|FG000|NOT COMPLETED|Overall Study||0
11374393|NCT03330457|12569922|FG001|NOT COMPLETED|Overall Study||0
11374394|NCT03330457|12569923|FG002|NOT COMPLETED|Overall Study||0
11374395|NCT03330457|12569924|FG003|NOT COMPLETED|Overall Study||0
11374396|NCT03330834|12569934|FG000|STARTED|Overall Study||1
11374397|NCT03330834|12569934|FG000|COMPLETED|Overall Study||1
11374398|NCT03330834|12569934|FG000|NOT COMPLETED|Overall Study||0
11374399|NCT03331042|12569942|FG000|STARTED|Overall Study||22
11374400|NCT03331042|12569943|FG001|STARTED|Overall Study||21
11374401|NCT03331042|12569944|FG002|STARTED|Overall Study||21
11374402|NCT03331042|12569945|FG003|STARTED|Overall Study||21
11374403|NCT03331042|12569942|FG000|COMPLETED|Overall Study||21
11374404|NCT03331042|12569943|FG001|COMPLETED|Overall Study||21
11374405|NCT03331042|12569944|FG002|COMPLETED|Overall Study||20
11374406|NCT03331042|12569945|FG003|COMPLETED|Overall Study||20
11374407|NCT03331042|12569942|FG000|NOT COMPLETED|Overall Study||1
11374408|NCT03331042|12569943|FG001|NOT COMPLETED|Overall Study||0
11374409|NCT03331042|12569944|FG002|NOT COMPLETED|Overall Study||1
11374410|NCT03331042|12569945|FG003|NOT COMPLETED|Overall Study||1
11374411|NCT03331185|12569963|FG000|STARTED|Overall Study||14
11374412|NCT03331185|12569964|FG001|STARTED|Overall Study||12
11374413|NCT03331185|12569963|FG000|COMPLETED|Overall Study||14
11374414|NCT03331185|12569964|FG001|COMPLETED|Overall Study||12
11374415|NCT03331185|12569963|FG000|NOT COMPLETED|Overall Study||0
11374416|NCT03331185|12569964|FG001|NOT COMPLETED|Overall Study||0
11374417|NCT03331315|12569972|FG000|STARTED|Overall Study||88
11374418|NCT03331315|12569973|FG001|STARTED|Overall Study||82
11374419|NCT03331315|12569972|FG000|COMPLETED|Overall Study||70
11374420|NCT03331315|12569973|FG001|COMPLETED|Overall Study||68
11374421|NCT03331315|12569972|FG000|NOT COMPLETED|Overall Study||18
11374422|NCT03331315|12569973|FG001|NOT COMPLETED|Overall Study||14
11374423|NCT03331666|12569983|FG000|STARTED|Overall Study||2
11374424|NCT03331666|12569984|FG001|STARTED|Overall Study||2
11374425|NCT03331666|12569983|FG000|COMPLETED|Overall Study||0
11374426|NCT03331666|12569984|FG001|COMPLETED|Overall Study||0
11374427|NCT03331666|12569983|FG000|NOT COMPLETED|Overall Study||2
11374428|NCT03331666|12569984|FG001|NOT COMPLETED|Overall Study||2
11374429|NCT03331835|12569992|FG000|STARTED|Overall Study||105
11374430|NCT03331835|12569993|FG001|STARTED|Overall Study||105
11374431|NCT03331835|12569992|FG000|COMPLETED|Overall Study||91
11374432|NCT03331835|12569993|FG001|COMPLETED|Overall Study||58
11374433|NCT03331835|12569992|FG000|NOT COMPLETED|Overall Study||14
11374434|NCT03331835|12569993|FG001|NOT COMPLETED|Overall Study||47
11374435|NCT03331965|12570001|FG000|STARTED|Overall Study||55
11374436|NCT03331965|12570002|FG001|STARTED|Overall Study||55
11374437|NCT03331965|12570001|FG000|COMPLETED|Overall Study||45
11374438|NCT03331965|12570002|FG001|COMPLETED|Overall Study||51
11374439|NCT03331965|12570001|FG000|NOT COMPLETED|Overall Study||10
11374440|NCT03331965|12570002|FG001|NOT COMPLETED|Overall Study||4
11374441|NCT03332160|12570010|FG000|STARTED|Overall Study||25
11374442|NCT03332160|12570011|FG001|STARTED|Overall Study||24
11374443|NCT03332160|12570010|FG000|COMPLETED|Overall Study||24
11374444|NCT03332160|12570011|FG001|COMPLETED|Overall Study||19
11374445|NCT03332160|12570010|FG000|NOT COMPLETED|Overall Study||1
11374446|NCT03332160|12570011|FG001|NOT COMPLETED|Overall Study||5
11374447|NCT03332212|12570022|FG000|STARTED|Overall Study||19
11374448|NCT03332212|12570023|FG001|STARTED|Overall Study||18
11374449|NCT03332212|12570024|FG002|STARTED|Overall Study||17
11374450|NCT03332212|12570025|FG003|STARTED|Overall Study||18
11374451|NCT03332212|12570022|FG000|Treated|Overall Study||19
11374452|NCT03332212|12570023|FG001|Treated|Overall Study||17
11374453|NCT03332212|12570024|FG002|Treated|Overall Study||17
11374454|NCT03332212|12570025|FG003|Treated|Overall Study||18
11374455|NCT03332212|12570022|FG000|COMPLETED|Overall Study||18
11374456|NCT03332212|12570023|FG001|COMPLETED|Overall Study||16
11374457|NCT03332212|12570024|FG002|COMPLETED|Overall Study||17
11374458|NCT03332212|12570025|FG003|COMPLETED|Overall Study||17
11374459|NCT03332212|12570022|FG000|NOT COMPLETED|Overall Study||1
11374460|NCT03332212|12570023|FG001|NOT COMPLETED|Overall Study||2
11374461|NCT03332212|12570024|FG002|NOT COMPLETED|Overall Study||0
11374462|NCT03332212|12570025|FG003|NOT COMPLETED|Overall Study||1
11374463|NCT03332459|12570036|FG000|STARTED|Overall Study||3
11374464|NCT03332459|12570037|FG001|STARTED|Overall Study||1
11374465|NCT03332459|12570038|FG002|STARTED|Overall Study||3
11374466|NCT03332459|12570036|FG000|COMPLETED|Overall Study||3
11374467|NCT03332459|12570037|FG001|COMPLETED|Overall Study||1
11374468|NCT03332459|12570038|FG002|COMPLETED|Overall Study||3
11374469|NCT03332459|12570036|FG000|NOT COMPLETED|Overall Study||0
11374470|NCT03332459|12570037|FG001|NOT COMPLETED|Overall Study||0
11374471|NCT03332459|12570038|FG002|NOT COMPLETED|Overall Study||0
11374472|NCT03332628|12570046|FG000|STARTED|Overall Study||113
11374473|NCT03332628|12570046|FG000|COMPLETED|Overall Study||111
11374474|NCT03332628|12570046|FG000|NOT COMPLETED|Overall Study||2
11374475|NCT03332771|12570055|FG000|STARTED|Overall Study||159
11374476|NCT03332771|12570056|FG001|STARTED|Overall Study||317
11374477|NCT03332771|12570057|FG002|STARTED|Overall Study||160
11374478|NCT03332771|12570058|FG003|STARTED|Overall Study||318
11374479|NCT03332771|12570055|FG000|COMPLETED|Overall Study||125
11374480|NCT03332771|12570056|FG001|COMPLETED|Overall Study||266
11374481|NCT03332771|12570057|FG002|COMPLETED|Overall Study||128
11374482|NCT03332771|12570058|FG003|COMPLETED|Overall Study||270
11374483|NCT03332771|12570055|FG000|NOT COMPLETED|Overall Study||34
11374484|NCT03332771|12570056|FG001|NOT COMPLETED|Overall Study||51
11374485|NCT03332771|12570057|FG002|NOT COMPLETED|Overall Study||32
11374486|NCT03332771|12570058|FG003|NOT COMPLETED|Overall Study||48
11374487|NCT03332784|12570088|FG000|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
11374488|NCT03332784|12570089|FG001|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
11374489|NCT03332784|12570090|FG002|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
11374490|NCT03332784|12570091|FG003|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
11374491|NCT03332784|12570092|FG004|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
11374492|NCT03332784|12570093|FG005|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
11374493|NCT03332784|12570094|FG006|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
11374494|NCT03332784|12570095|FG007|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
11374495|NCT03332784|12570096|FG008|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
11374496|NCT03332784|12570097|FG009|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
11374497|NCT03332784|12570098|FG010|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
11374498|NCT03332784|12570099|FG011|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
11374499|NCT03332784|12570100|FG012|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
11374500|NCT03332784|12570101|FG013|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
11374501|NCT03332784|12570102|FG014|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
11374502|NCT03332784|12570103|FG015|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
11374503|NCT03332784|12570104|FG016|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
11374504|NCT03332784|12570105|FG017|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
11374505|NCT03332784|12570106|FG018|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
11374506|NCT03332784|12570107|FG019|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
11374507|NCT03332784|12570088|FG000|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
11374508|NCT03332784|12570089|FG001|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
11374509|NCT03332784|12570090|FG002|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
11374510|NCT03332784|12570091|FG003|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
11374511|NCT03332784|12570092|FG004|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
11374512|NCT03332784|12570093|FG005|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
11374513|NCT03332784|12570094|FG006|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
11374514|NCT03332784|12570095|FG007|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
11374515|NCT03332784|12570096|FG008|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
11374516|NCT03332784|12570097|FG009|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
11374517|NCT03332784|12570098|FG010|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
11374518|NCT03332784|12570099|FG011|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
11374519|NCT03332784|12570100|FG012|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
11374520|NCT03332784|12570101|FG013|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
11374521|NCT03332784|12570102|FG014|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
11374522|NCT03332784|12570103|FG015|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
11374523|NCT03332784|12570104|FG016|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
11374524|NCT03332784|12570105|FG017|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
11374525|NCT03332784|12570106|FG018|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
11374526|NCT03332784|12570107|FG019|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
11374527|NCT03332784|12570088|FG000|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374528|NCT03332784|12570089|FG001|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
11374529|NCT03332784|12570090|FG002|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374530|NCT03332784|12570091|FG003|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374531|NCT03332784|12570092|FG004|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374532|NCT03332784|12570093|FG005|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374533|NCT03332784|12570094|FG006|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374534|NCT03332784|12570095|FG007|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374535|NCT03332784|12570096|FG008|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374536|NCT03332784|12570097|FG009|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374537|NCT03332784|12570098|FG010|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374538|NCT03332784|12570099|FG011|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374539|NCT03332784|12570100|FG012|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374540|NCT03332784|12570101|FG013|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374541|NCT03332784|12570102|FG014|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
11374542|NCT03332784|12570103|FG015|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374543|NCT03332784|12570104|FG016|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374544|NCT03332784|12570105|FG017|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374545|NCT03332784|12570106|FG018|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374546|NCT03332784|12570107|FG019|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
11374547|NCT03332784|12570088|FG000|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
11374548|NCT03332784|12570089|FG001|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
11374549|NCT03332784|12570090|FG002|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
11374550|NCT03332784|12570091|FG003|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
11374551|NCT03332784|12570092|FG004|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
11374552|NCT03332784|12570093|FG005|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
11374553|NCT03332784|12570094|FG006|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
11374554|NCT03332784|12570095|FG007|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
11374555|NCT03332784|12570096|FG008|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
11374556|NCT03332784|12570097|FG009|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
11374557|NCT03332784|12570098|FG010|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
11374558|NCT03332784|12570099|FG011|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
11374559|NCT03332784|12570100|FG012|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
11374560|NCT03332784|12570101|FG013|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
11374561|NCT03332784|12570102|FG014|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
11374562|NCT03332784|12570103|FG015|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
11374563|NCT03332784|12570104|FG016|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
11374564|NCT03332784|12570105|FG017|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
11374565|NCT03332784|12570106|FG018|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
11374566|NCT03332784|12570107|FG019|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
11374567|NCT03332784|12570088|FG000|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
11374568|NCT03332784|12570089|FG001|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
11374569|NCT03332784|12570090|FG002|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
11374570|NCT03332784|12570091|FG003|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
11374571|NCT03332784|12570092|FG004|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
11374572|NCT03332784|12570093|FG005|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
11374573|NCT03332784|12570094|FG006|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
11374574|NCT03332784|12570095|FG007|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
11374575|NCT03332784|12570096|FG008|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374576|NCT03332784|12570097|FG009|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374577|NCT03332784|12570098|FG010|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374578|NCT03332784|12570099|FG011|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374579|NCT03332784|12570100|FG012|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374580|NCT03332784|12570101|FG013|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374581|NCT03332784|12570102|FG014|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
11374582|NCT03332784|12570103|FG015|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
11374583|NCT03332784|12570104|FG016|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
11374584|NCT03332784|12570105|FG017|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
11374585|NCT03332784|12570106|FG018|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
11374586|NCT03332784|12570107|FG019|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
11374587|NCT03332784|12570088|FG000|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374588|NCT03332784|12570089|FG001|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374589|NCT03332784|12570090|FG002|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374590|NCT03332784|12570091|FG003|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374591|NCT03332784|12570092|FG004|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374592|NCT03332784|12570093|FG005|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374593|NCT03332784|12570094|FG006|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374594|NCT03332784|12570095|FG007|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374595|NCT03332784|12570096|FG008|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374596|NCT03332784|12570097|FG009|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374597|NCT03332784|12570098|FG010|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374598|NCT03332784|12570099|FG011|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374599|NCT03332784|12570100|FG012|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374600|NCT03332784|12570101|FG013|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374601|NCT03332784|12570102|FG014|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374602|NCT03332784|12570103|FG015|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374603|NCT03332784|12570104|FG016|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374604|NCT03332784|12570105|FG017|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374605|NCT03332784|12570106|FG018|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374606|NCT03332784|12570107|FG019|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
11374607|NCT03332784|12570088|FG000|STARTED|Part 1- Period 3 (1 Day)||2
11374608|NCT03332784|12570089|FG001|STARTED|Part 1- Period 3 (1 Day)||1
11374609|NCT03332784|12570090|FG002|STARTED|Part 1- Period 3 (1 Day)||2
11374610|NCT03332784|12570091|FG003|STARTED|Part 1- Period 3 (1 Day)||2
11374611|NCT03332784|12570092|FG004|STARTED|Part 1- Period 3 (1 Day)||2
11374612|NCT03332784|12570093|FG005|STARTED|Part 1- Period 3 (1 Day)||2
11374613|NCT03332784|12570094|FG006|STARTED|Part 1- Period 3 (1 Day)||2
11374614|NCT03332784|12570095|FG007|STARTED|Part 1- Period 3 (1 Day)||2
11374615|NCT03332784|12570096|FG008|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
11374616|NCT03332784|12570097|FG009|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
11374617|NCT03332784|12570098|FG010|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
11374618|NCT03332784|12570099|FG011|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
11374619|NCT03332784|12570100|FG012|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
11374620|NCT03332784|12570101|FG013|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
11374621|NCT03332784|12570102|FG014|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
11374622|NCT03332784|12570103|FG015|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
11374623|NCT03332784|12570104|FG016|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
11374624|NCT03332784|12570105|FG017|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
11374625|NCT03332784|12570106|FG018|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
11374626|NCT03332784|12570107|FG019|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
11374627|NCT03332784|12570088|FG000|COMPLETED|Part 1- Period 3 (1 Day)||2
11374628|NCT03332784|12570089|FG001|COMPLETED|Part 1- Period 3 (1 Day)||1
11374629|NCT03332784|12570090|FG002|COMPLETED|Part 1- Period 3 (1 Day)||2
11374630|NCT03332784|12570091|FG003|COMPLETED|Part 1- Period 3 (1 Day)||2
11374631|NCT03332784|12570092|FG004|COMPLETED|Part 1- Period 3 (1 Day)||2
11374632|NCT03332784|12570093|FG005|COMPLETED|Part 1- Period 3 (1 Day)||2
11374633|NCT03332784|12570094|FG006|COMPLETED|Part 1- Period 3 (1 Day)||2
11374634|NCT03332784|12570095|FG007|COMPLETED|Part 1- Period 3 (1 Day)||2
11374635|NCT03332784|12570096|FG008|COMPLETED|Part 1- Period 3 (1 Day)||0
11374636|NCT03332784|12570097|FG009|COMPLETED|Part 1- Period 3 (1 Day)||0
11374637|NCT03332784|12570098|FG010|COMPLETED|Part 1- Period 3 (1 Day)||0
11374638|NCT03332784|12570099|FG011|COMPLETED|Part 1- Period 3 (1 Day)||0
11374639|NCT03332784|12570100|FG012|COMPLETED|Part 1- Period 3 (1 Day)||0
11374640|NCT03332784|12570101|FG013|COMPLETED|Part 1- Period 3 (1 Day)||0
11374641|NCT03332784|12570102|FG014|COMPLETED|Part 1- Period 3 (1 Day)||0
11374642|NCT03332784|12570103|FG015|COMPLETED|Part 1- Period 3 (1 Day)||0
11374643|NCT03332784|12570104|FG016|COMPLETED|Part 1- Period 3 (1 Day)||0
11374644|NCT03332784|12570105|FG017|COMPLETED|Part 1- Period 3 (1 Day)||0
11374645|NCT03332784|12570106|FG018|COMPLETED|Part 1- Period 3 (1 Day)||0
11374646|NCT03332784|12570107|FG019|COMPLETED|Part 1- Period 3 (1 Day)||0
11374647|NCT03332784|12570088|FG000|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374648|NCT03332784|12570089|FG001|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374649|NCT03332784|12570090|FG002|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374650|NCT03332784|12570091|FG003|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374651|NCT03332784|12570092|FG004|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374652|NCT03332784|12570093|FG005|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374653|NCT03332784|12570094|FG006|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374654|NCT03332784|12570095|FG007|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374655|NCT03332784|12570096|FG008|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374656|NCT03332784|12570097|FG009|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374657|NCT03332784|12570098|FG010|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374658|NCT03332784|12570099|FG011|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374659|NCT03332784|12570100|FG012|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374660|NCT03332784|12570101|FG013|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374661|NCT03332784|12570102|FG014|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374662|NCT03332784|12570103|FG015|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374663|NCT03332784|12570104|FG016|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374664|NCT03332784|12570105|FG017|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374665|NCT03332784|12570106|FG018|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374666|NCT03332784|12570107|FG019|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
11374667|NCT03332979|12570161|FG000|STARTED|Overall Study||150
11374668|NCT03332979|12570161|FG000|COMPLETED|Overall Study||150
11374669|NCT03332979|12570161|FG000|NOT COMPLETED|Overall Study||0
11374670|NCT03333109|12570168|FG000|STARTED|Double-blind Treatment Period (DBTP)||338
11374671|NCT03333109|12570169|FG001|STARTED|Double-blind Treatment Period (DBTP)||224
11374672|NCT03333109|12570170|FG002|STARTED|Double-blind Treatment Period (DBTP)||338
11374673|NCT03333109|12570168|FG000|Full Analysis Set|Double-blind Treatment Period (DBTP)||329
11374674|NCT03333109|12570169|FG001|Full Analysis Set|Double-blind Treatment Period (DBTP)||219
11374675|NCT03333109|12570170|FG002|Full Analysis Set|Double-blind Treatment Period (DBTP)||330
11374676|NCT03333109|12570168|FG000|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
11374677|NCT03333109|12570169|FG001|Safety Analysis Set|Double-blind Treatment Period (DBTP)||224
11374678|NCT03333109|12570170|FG002|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
11374679|NCT03333109|12570168|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||321
11374680|NCT03333109|12570169|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||218
11374681|NCT03333109|12570170|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||326
11374682|NCT03333109|12570168|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||17
11374683|NCT03333109|12570169|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||6
11374684|NCT03333109|12570170|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||12
11374685|NCT03333109|12570168|FG000|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|324
11374686|NCT03333109|12570169|FG001|STARTED|Safety Follow-up Period||218
11374687|NCT03333109|12570170|FG002|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|328
11374688|NCT03333109|12570168|FG000|COMPLETED|Safety Follow-up Period||311
11374689|NCT03333109|12570169|FG001|COMPLETED|Safety Follow-up Period||214
11374690|NCT03333109|12570170|FG002|COMPLETED|Safety Follow-up Period||315
11374691|NCT03333109|12570168|FG000|NOT COMPLETED|Safety Follow-up Period||13
11374692|NCT03333109|12570169|FG001|NOT COMPLETED|Safety Follow-up Period||4
11374693|NCT03333109|12570170|FG002|NOT COMPLETED|Safety Follow-up Period||13
11374694|NCT03333317|12570181|FG000|STARTED|Overall Study||3
11374695|NCT03333317|12570182|FG001|STARTED|Overall Study||1
11374696|NCT03333317|12570183|FG002|STARTED|Overall Study||3
11374697|NCT03333317|12570181|FG000|COMPLETED|Overall Study||3
11374698|NCT03333317|12570182|FG001|COMPLETED|Overall Study||1
11374699|NCT03333317|12570183|FG002|COMPLETED|Overall Study||3
11374700|NCT03333317|12570181|FG000|NOT COMPLETED|Overall Study||0
11374701|NCT03333317|12570182|FG001|NOT COMPLETED|Overall Study||0
11374702|NCT03333317|12570183|FG002|NOT COMPLETED|Overall Study||0
11374703|NCT03333577|12570193|FG000|STARTED|Overall Study||32
11374704|NCT03333577|12570193|FG000|COMPLETED|Overall Study||25
11374705|NCT03333577|12570193|FG000|NOT COMPLETED|Overall Study||7
11374706|NCT03333876|12570199|FG000|STARTED|Screening Period||58
11374707|NCT03333876|12570199|FG000|COMPLETED|Screening Period||54
11374708|NCT03333876|12570199|FG000|NOT COMPLETED|Screening Period||4
11374709|NCT03333876|12570199|FG000|STARTED|Nasal Dilator||54
11374710|NCT03333876|12570199|FG000|COMPLETED|Nasal Dilator||48
11374711|NCT03333876|12570199|FG000|NOT COMPLETED|Nasal Dilator||6
11374712|NCT03333876|12570199|FG000|STARTED|Mandibular Advancement||54
11374713|NCT03333876|12570199|FG000|COMPLETED|Mandibular Advancement||50
11374714|NCT03333876|12570199|FG000|NOT COMPLETED|Mandibular Advancement||4
11374715|NCT03333876|12570199|FG000|STARTED|Positional Therapy||54
11374716|NCT03333876|12570199|FG000|COMPLETED|Positional Therapy||54
11374717|NCT03333876|12570199|FG000|NOT COMPLETED|Positional Therapy||0
11374718|NCT03333941|12570212|FG000|STARTED|Overall Study||76
11374719|NCT03333941|12570212|FG000|COMPLETED|Overall Study||63
11374720|NCT03333941|12570212|FG000|NOT COMPLETED|Overall Study||13
11374721|NCT03334175|12570218|FG000|STARTED|Overall Study||8
11374722|NCT03334175|12570219|FG001|STARTED|Overall Study||10
11374723|NCT03334175|12570218|FG000|COMPLETED|Overall Study||8
11374724|NCT03334175|12570219|FG001|COMPLETED|Overall Study||9
11374725|NCT03334175|12570218|FG000|NOT COMPLETED|Overall Study||0
11374726|NCT03334175|12570219|FG001|NOT COMPLETED|Overall Study||1
11374727|NCT03334188|12570227|FG000|STARTED|Overall Study||153
11374728|NCT03334188|12570228|FG001|STARTED|Overall Study||153
11374729|NCT03334188|12570227|FG000|COMPLETED|Overall Study||145
11374730|NCT03334188|12570228|FG001|COMPLETED|Overall Study||145
11374731|NCT03334188|12570227|FG000|NOT COMPLETED|Overall Study||8
11374732|NCT03334188|12570228|FG001|NOT COMPLETED|Overall Study||8
11374733|NCT03334214|12570237|FG000|STARTED|Overall Study||15
11374734|NCT03334214|12570238|FG001|STARTED|Overall Study||29
11374735|NCT03334214|12570237|FG000|COMPLETED|Overall Study||14
11374736|NCT03334214|12570238|FG001|COMPLETED|Overall Study||27
11374737|NCT03334214|12570237|FG000|NOT COMPLETED|Overall Study||1
11374738|NCT03334214|12570238|FG001|NOT COMPLETED|Overall Study||2
11374739|NCT03334396|12570253|FG000|STARTED|Overall Study||249
11374740|NCT03334396|12570254|FG001|STARTED|Overall Study||127
11374741|NCT03334396|12570255|FG002|STARTED|Overall Study||123
11374742|NCT03334396|12570256|FG003|STARTED|Overall Study||125
11374743|NCT03334396|12570257|FG004|STARTED|Overall Study||15
11374744|NCT03334396|12570258|FG005|STARTED|Overall Study||5
11374745|NCT03334396|12570259|FG006|STARTED|Overall Study||8
11374746|NCT03334396|12570260|FG007|STARTED|Overall Study||8
11374747|NCT03334396|12570253|FG000|Received at Least One Dose of Study Drug|Overall Study||249
11374748|NCT03334396|12570254|FG001|Received at Least One Dose of Study Drug|Overall Study||127
11374749|NCT03334396|12570255|FG002|Received at Least One Dose of Study Drug|Overall Study||123
11374750|NCT03334396|12570256|FG003|Received at Least One Dose of Study Drug|Overall Study||125
11374751|NCT03334396|12570257|FG004|Received at Least One Dose of Study Drug|Overall Study||15
11374752|NCT03334396|12570258|FG005|Received at Least One Dose of Study Drug|Overall Study||5
11374753|NCT03334396|12570259|FG006|Received at Least One Dose of Study Drug|Overall Study||8
11374754|NCT03334396|12570260|FG007|Received at Least One Dose of Study Drug|Overall Study||8
11374755|NCT03334396|12570253|FG000|COMPLETED|Overall Study||226
11374756|NCT03334396|12570254|FG001|COMPLETED|Overall Study||116
11374757|NCT03334396|12570255|FG002|COMPLETED|Overall Study||113
11374758|NCT03334396|12570256|FG003|COMPLETED|Overall Study||120
11374759|NCT03334396|12570257|FG004|COMPLETED|Overall Study||12
11374760|NCT03334396|12570258|FG005|COMPLETED|Overall Study||4
11374761|NCT03334396|12570259|FG006|COMPLETED|Overall Study||5
11374762|NCT03334396|12570260|FG007|COMPLETED|Overall Study||7
11374763|NCT03334396|12570253|FG000|NOT COMPLETED|Overall Study||23
11374764|NCT03334396|12570254|FG001|NOT COMPLETED|Overall Study||11
11374765|NCT03334396|12570255|FG002|NOT COMPLETED|Overall Study||10
11374766|NCT03334396|12570256|FG003|NOT COMPLETED|Overall Study||5
11374767|NCT03334396|12570257|FG004|NOT COMPLETED|Overall Study||3
11374768|NCT03334396|12570258|FG005|NOT COMPLETED|Overall Study||1
11374769|NCT03334396|12570259|FG006|NOT COMPLETED|Overall Study||3
11374770|NCT03334396|12570260|FG007|NOT COMPLETED|Overall Study||1
11374771|NCT03334422|12570281|FG000|STARTED|Overall Study||244
11374772|NCT03334422|12570282|FG001|STARTED|Overall Study||125
11374773|NCT03334422|12570283|FG002|STARTED|Overall Study||123
11374774|NCT03334422|12570284|FG003|STARTED|Overall Study||123
11374775|NCT03334422|12570281|FG000|Received at Least One Dose of Study Drug|Overall Study||244
11374776|NCT03334422|12570282|FG001|Received at Least One Dose of Study Drug|Overall Study||124
11374777|NCT03334422|12570283|FG002|Received at Least One Dose of Study Drug|Overall Study||123
11374778|NCT03334422|12570284|FG003|Received at Least One Dose of Study Drug|Overall Study||123
11374779|NCT03334422|12570281|FG000|COMPLETED|Overall Study||225
11374780|NCT03334422|12570282|FG001|COMPLETED|Overall Study||115
11374781|NCT03334422|12570283|FG002|COMPLETED|Overall Study||113
11374782|NCT03334422|12570284|FG003|COMPLETED|Overall Study||117
11374783|NCT03334422|12570281|FG000|NOT COMPLETED|Overall Study||19
11374784|NCT03334422|12570282|FG001|NOT COMPLETED|Overall Study||10
11374785|NCT03334422|12570283|FG002|NOT COMPLETED|Overall Study||10
11374786|NCT03334422|12570284|FG003|NOT COMPLETED|Overall Study||6
11374787|NCT03334448|12570299|FG000|STARTED|Period 1||12
11374788|NCT03334448|12570300|FG001|STARTED|Period 1||12
11374789|NCT03334448|12570301|FG002|STARTED|Period 1||13
11374790|NCT03334448|12570302|FG003|STARTED|Period 1||12
11374791|NCT03334448|12570299|FG000|Received at Least 1 Dose of Study Drug|Period 1||12
11374792|NCT03334448|12570300|FG001|Received at Least 1 Dose of Study Drug|Period 1||12
11374793|NCT03334448|12570301|FG002|Received at Least 1 Dose of Study Drug|Period 1||13
11374794|NCT03334448|12570302|FG003|Received at Least 1 Dose of Study Drug|Period 1||12
11374795|NCT03334448|12570299|FG000|COMPLETED|Period 1||12
11374796|NCT03334448|12570300|FG001|COMPLETED|Period 1||12
11374797|NCT03334448|12570301|FG002|COMPLETED|Period 1||13
11374798|NCT03334448|12570302|FG003|COMPLETED|Period 1||12
11374799|NCT03334448|12570299|FG000|NOT COMPLETED|Period 1||0
11374800|NCT03334448|12570300|FG001|NOT COMPLETED|Period 1||0
11374801|NCT03334448|12570301|FG002|NOT COMPLETED|Period 1||0
11374802|NCT03334448|12570302|FG003|NOT COMPLETED|Period 1||0
11374803|NCT03334448|12570299|FG000|STARTED|Washout||12
11374804|NCT03334448|12570300|FG001|STARTED|Washout||12
11374805|NCT03334448|12570301|FG002|STARTED|Washout||13
11374806|NCT03334448|12570302|FG003|STARTED|Washout||12
11374807|NCT03334448|12570299|FG000|COMPLETED|Washout||12
11374808|NCT03334448|12570300|FG001|COMPLETED|Washout||12
11374809|NCT03334448|12570301|FG002|COMPLETED|Washout||13
11374810|NCT03334448|12570302|FG003|COMPLETED|Washout||12
11374811|NCT03334448|12570299|FG000|NOT COMPLETED|Washout||0
11374812|NCT03334448|12570300|FG001|NOT COMPLETED|Washout||0
11374813|NCT03334448|12570301|FG002|NOT COMPLETED|Washout||0
11374814|NCT03334448|12570302|FG003|NOT COMPLETED|Washout||0
11374815|NCT03334448|12570299|FG000|STARTED|Period 2||12
11374816|NCT03334448|12570300|FG001|STARTED|Period 2||12
11374817|NCT03334448|12570301|FG002|STARTED|Period 2||13
11374818|NCT03334448|12570302|FG003|STARTED|Period 2||12
11374819|NCT03334448|12570299|FG000|Received at Least 1 Dose of Study Drug|Period 2||12
11374820|NCT03334448|12570300|FG001|Received at Least 1 Dose of Study Drug|Period 2||12
11374821|NCT03334448|12570301|FG002|Received at Least 1 Dose of Study Drug|Period 2||13
11374822|NCT03334448|12570302|FG003|Received at Least 1 Dose of Study Drug|Period 2||12
11374823|NCT03334448|12570299|FG000|COMPLETED|Period 2||12
11374824|NCT03334448|12570300|FG001|COMPLETED|Period 2||12
11374825|NCT03334448|12570301|FG002|COMPLETED|Period 2||13
11374826|NCT03334448|12570302|FG003|COMPLETED|Period 2||12
11374827|NCT03334448|12570299|FG000|NOT COMPLETED|Period 2||0
11374828|NCT03334448|12570300|FG001|NOT COMPLETED|Period 2||0
11374829|NCT03334448|12570301|FG002|NOT COMPLETED|Period 2||0
11374830|NCT03334448|12570302|FG003|NOT COMPLETED|Period 2||0
11374831|NCT03334448|12570299|FG000|STARTED|Washout||12
11374832|NCT03334448|12570300|FG001|STARTED|Washout||12
11374833|NCT03334448|12570301|FG002|STARTED|Washout||13
11374834|NCT03334448|12570302|FG003|STARTED|Washout||12
11374835|NCT03334448|12570299|FG000|COMPLETED|Washout||12
11374836|NCT03334448|12570300|FG001|COMPLETED|Washout||11
11374837|NCT03334448|12570301|FG002|COMPLETED|Washout||13
11374838|NCT03334448|12570302|FG003|COMPLETED|Washout||12
11374839|NCT03334448|12570299|FG000|NOT COMPLETED|Washout||0
11374840|NCT03334448|12570300|FG001|NOT COMPLETED|Washout||1
11374841|NCT03334448|12570301|FG002|NOT COMPLETED|Washout||0
11374842|NCT03334448|12570302|FG003|NOT COMPLETED|Washout||0
11374843|NCT03334448|12570299|FG000|STARTED|Period 3||12
11374844|NCT03334448|12570300|FG001|STARTED|Period 3||11
11374845|NCT03334448|12570301|FG002|STARTED|Period 3||13
11374846|NCT03334448|12570302|FG003|STARTED|Period 3||12
11374847|NCT03334448|12570299|FG000|Received at Least 1 Dose of Study Drug|Period 3||12
11374848|NCT03334448|12570300|FG001|Received at Least 1 Dose of Study Drug|Period 3||11
11374849|NCT03334448|12570301|FG002|Received at Least 1 Dose of Study Drug|Period 3||13
11374850|NCT03334448|12570302|FG003|Received at Least 1 Dose of Study Drug|Period 3||12
11374851|NCT03334448|12570299|FG000|COMPLETED|Period 3||12
11374852|NCT03334448|12570300|FG001|COMPLETED|Period 3||11
11374853|NCT03334448|12570301|FG002|COMPLETED|Period 3||13
11374854|NCT03334448|12570302|FG003|COMPLETED|Period 3||12
11374855|NCT03334448|12570299|FG000|NOT COMPLETED|Period 3||0
11374856|NCT03334448|12570300|FG001|NOT COMPLETED|Period 3||0
11374857|NCT03334448|12570301|FG002|NOT COMPLETED|Period 3||0
11374858|NCT03334448|12570302|FG003|NOT COMPLETED|Period 3||0
11374859|NCT03334448|12570299|FG000|STARTED|Washout||12
11374860|NCT03334448|12570300|FG001|STARTED|Washout||11
11374861|NCT03334448|12570301|FG002|STARTED|Washout||13
11374862|NCT03334448|12570302|FG003|STARTED|Washout||12
11374863|NCT03334448|12570299|FG000|COMPLETED|Washout||12
11374864|NCT03334448|12570300|FG001|COMPLETED|Washout||11
11374865|NCT03334448|12570301|FG002|COMPLETED|Washout||13
11374866|NCT03334448|12570302|FG003|COMPLETED|Washout||11
11374867|NCT03334448|12570299|FG000|NOT COMPLETED|Washout||0
11374868|NCT03334448|12570300|FG001|NOT COMPLETED|Washout||0
11374869|NCT03334448|12570301|FG002|NOT COMPLETED|Washout||0
11374870|NCT03334448|12570302|FG003|NOT COMPLETED|Washout||1
11374871|NCT03334448|12570299|FG000|STARTED|Period 4||12
11374872|NCT03334448|12570300|FG001|STARTED|Period 4||11
11374873|NCT03334448|12570301|FG002|STARTED|Period 4||13
11374874|NCT03334448|12570302|FG003|STARTED|Period 4||11
11374875|NCT03334448|12570299|FG000|Received at Least 1 Dose of Study Drug|Period 4||12
11374876|NCT03334448|12570300|FG001|Received at Least 1 Dose of Study Drug|Period 4||11
11374877|NCT03334448|12570301|FG002|Received at Least 1 Dose of Study Drug|Period 4||13
11374878|NCT03334448|12570302|FG003|Received at Least 1 Dose of Study Drug|Period 4||11
11374879|NCT03334448|12570299|FG000|COMPLETED|Period 4||12
11374880|NCT03334448|12570300|FG001|COMPLETED|Period 4||11
11374881|NCT03334448|12570301|FG002|COMPLETED|Period 4||13
11374882|NCT03334448|12570302|FG003|COMPLETED|Period 4||11
11374883|NCT03334448|12570299|FG000|NOT COMPLETED|Period 4||0
11374884|NCT03334448|12570300|FG001|NOT COMPLETED|Period 4||0
11374885|NCT03334448|12570301|FG002|NOT COMPLETED|Period 4||0
11374886|NCT03334448|12570302|FG003|NOT COMPLETED|Period 4||0
11374887|NCT03334630|12570310|FG000|STARTED|Overall Study||239
11374888|NCT03334630|12570311|FG001|STARTED|Overall Study||243
11374889|NCT03334630|12570310|FG000|COMPLETED|Overall Study||225
11374890|NCT03334630|12570311|FG001|COMPLETED|Overall Study||230
11374891|NCT03334630|12570310|FG000|NOT COMPLETED|Overall Study||14
11374892|NCT03334630|12570311|FG001|NOT COMPLETED|Overall Study||13
11374893|NCT03334695|12570319|FG000|STARTED|Overall Study||31
11374894|NCT03334695|12570320|FG001|STARTED|Overall Study||32
11374895|NCT03334695|12570319|FG000|COMPLETED|Overall Study||27
11374896|NCT03334695|12570320|FG001|COMPLETED|Overall Study||26
11374897|NCT03334695|12570319|FG000|NOT COMPLETED|Overall Study||4
11374898|NCT03334695|12570320|FG001|NOT COMPLETED|Overall Study||6
11374899|NCT03334721|12570330|FG000|STARTED|Overall Study||12
11374900|NCT03334721|12570331|FG001|STARTED|Overall Study||11
11374901|NCT03334721|12570330|FG000|COMPLETED|Overall Study||10
11374902|NCT03334721|12570331|FG001|COMPLETED|Overall Study||11
11374903|NCT03334721|12570330|FG000|NOT COMPLETED|Overall Study||2
11374904|NCT03334721|12570331|FG001|NOT COMPLETED|Overall Study||0
11374905|NCT03334734|12570341|FG000|STARTED|Overall Study||4
11374906|NCT03334734|12570342|FG001|STARTED|Overall Study||4
11374907|NCT03334734|12570343|FG002|STARTED|Overall Study||7
11374908|NCT03334734|12570344|FG003|STARTED|Overall Study||1
11374909|NCT03334734|12570341|FG000|COMPLETED|Overall Study||4
11374910|NCT03334734|12570342|FG001|COMPLETED|Overall Study||4
11374911|NCT03334734|12570343|FG002|COMPLETED|Overall Study||5
11374912|NCT03334734|12570344|FG003|COMPLETED|Overall Study||1
11374913|NCT03334734|12570341|FG000|NOT COMPLETED|Overall Study||0
11374914|NCT03334734|12570342|FG001|NOT COMPLETED|Overall Study||0
11374915|NCT03334734|12570343|FG002|NOT COMPLETED|Overall Study||2
11374916|NCT03334734|12570344|FG003|NOT COMPLETED|Overall Study||0
11374917|NCT03334747|12570363|FG000|STARTED|Treatment Phase||10
11374918|NCT03334747|12570364|FG001|STARTED|Treatment Phase||10
11374919|NCT03334747|12570365|FG002|STARTED|Treatment Phase||12
11374920|NCT03334747|12570366|FG003|STARTED|Treatment Phase||20
11374921|NCT03334747|12570367|FG004|STARTED|Treatment Phase||22
11374922|NCT03334747|12570368|FG005|STARTED|Treatment Phase||20
11374923|NCT03334747|12570369|FG006|STARTED|Treatment Phase||21
11374924|NCT03334747|12570370|FG007|STARTED|Treatment Phase||22
11374925|NCT03334747|12570371|FG008|STARTED|Treatment Phase||51
11374926|NCT03334747|12570363|FG000|COMPLETED|Treatment Phase||9
11374927|NCT03334747|12570364|FG001|COMPLETED|Treatment Phase||10
11374928|NCT03334747|12570365|FG002|COMPLETED|Treatment Phase||12
11374929|NCT03334747|12570366|FG003|COMPLETED|Treatment Phase||20
11374930|NCT03334747|12570367|FG004|COMPLETED|Treatment Phase||21
11374931|NCT03334747|12570368|FG005|COMPLETED|Treatment Phase||19
11374932|NCT03334747|12570369|FG006|COMPLETED|Treatment Phase||21
11374933|NCT03334747|12570370|FG007|COMPLETED|Treatment Phase||22
11374934|NCT03334747|12570371|FG008|COMPLETED|Treatment Phase||51
11374935|NCT03334747|12570363|FG000|NOT COMPLETED|Treatment Phase||1
11374936|NCT03334747|12570364|FG001|NOT COMPLETED|Treatment Phase||0
11374937|NCT03334747|12570365|FG002|NOT COMPLETED|Treatment Phase||0
11374938|NCT03334747|12570366|FG003|NOT COMPLETED|Treatment Phase||0
11374939|NCT03334747|12570367|FG004|NOT COMPLETED|Treatment Phase||1
11374940|NCT03334747|12570368|FG005|NOT COMPLETED|Treatment Phase||1
11374941|NCT03334747|12570369|FG006|NOT COMPLETED|Treatment Phase||0
11374942|NCT03334747|12570370|FG007|NOT COMPLETED|Treatment Phase||0
11374943|NCT03334747|12570371|FG008|NOT COMPLETED|Treatment Phase||0
11374944|NCT03334747|12570363|FG000|STARTED|Follow-Up Phase||9
11374945|NCT03334747|12570364|FG001|STARTED|Follow-Up Phase||10
11374946|NCT03334747|12570365|FG002|STARTED|Follow-Up Phase||12
11374947|NCT03334747|12570366|FG003|STARTED|Follow-Up Phase||20
11374948|NCT03334747|12570367|FG004|STARTED|Follow-Up Phase||21
11374949|NCT03334747|12570368|FG005|STARTED|Follow-Up Phase||19
11374950|NCT03334747|12570369|FG006|STARTED|Follow-Up Phase||21
11374951|NCT03334747|12570370|FG007|STARTED|Follow-Up Phase||22
11374952|NCT03334747|12570371|FG008|STARTED|Follow-Up Phase||51
11374953|NCT03334747|12570363|FG000|COMPLETED|Follow-Up Phase||9
11374954|NCT03334747|12570364|FG001|COMPLETED|Follow-Up Phase||10
11374955|NCT03334747|12570365|FG002|COMPLETED|Follow-Up Phase||12
11374956|NCT03334747|12570366|FG003|COMPLETED|Follow-Up Phase||20
11374957|NCT03334747|12570367|FG004|COMPLETED|Follow-Up Phase||21
11374958|NCT03334747|12570368|FG005|COMPLETED|Follow-Up Phase||19
11374959|NCT03334747|12570369|FG006|COMPLETED|Follow-Up Phase||20
11374960|NCT03334747|12570370|FG007|COMPLETED|Follow-Up Phase||22
11374961|NCT03334747|12570371|FG008|COMPLETED|Follow-Up Phase||50
11374962|NCT03334747|12570363|FG000|NOT COMPLETED|Follow-Up Phase||0
11374963|NCT03334747|12570364|FG001|NOT COMPLETED|Follow-Up Phase||0
11374964|NCT03334747|12570365|FG002|NOT COMPLETED|Follow-Up Phase||0
11374965|NCT03334747|12570366|FG003|NOT COMPLETED|Follow-Up Phase||0
11374966|NCT03334747|12570367|FG004|NOT COMPLETED|Follow-Up Phase||0
11374967|NCT03334747|12570368|FG005|NOT COMPLETED|Follow-Up Phase||0
11374968|NCT03334747|12570369|FG006|NOT COMPLETED|Follow-Up Phase||1
11374969|NCT03334747|12570370|FG007|NOT COMPLETED|Follow-Up Phase||0
11374970|NCT03334747|12570371|FG008|NOT COMPLETED|Follow-Up Phase||1
11374971|NCT03334812|12570393|FG000|STARTED|Overall Study||9
11374972|NCT03334812|12570394|FG001|STARTED|Overall Study||5
11374973|NCT03334812|12570395|FG002|STARTED|Overall Study||0
11374974|NCT03334812|12570396|FG003|STARTED|Overall Study||0
11374975|NCT03334812|12570393|FG000|COMPLETED|Overall Study||9
11374976|NCT03334812|12570394|FG001|COMPLETED|Overall Study||5
11374977|NCT03334812|12570395|FG002|COMPLETED|Overall Study||0
11374978|NCT03334812|12570396|FG003|COMPLETED|Overall Study||0
11374979|NCT03334812|12570393|FG000|NOT COMPLETED|Overall Study||0
11374980|NCT03334812|12570394|FG001|NOT COMPLETED|Overall Study||0
11374981|NCT03334812|12570395|FG002|NOT COMPLETED|Overall Study||0
11374982|NCT03334812|12570396|FG003|NOT COMPLETED|Overall Study||0
11374983|NCT03334825|12570404|FG000|STARTED|Overall Study||119
11374984|NCT03334825|12570405|FG001|STARTED|Overall Study||117
11374985|NCT03334825|12570404|FG000|COMPLETED|Overall Study||112
11374986|NCT03334825|12570405|FG001|COMPLETED|Overall Study||113
11374987|NCT03334825|12570404|FG000|NOT COMPLETED|Overall Study||7
11374988|NCT03334825|12570405|FG001|NOT COMPLETED|Overall Study||4
11374989|NCT03334903|12570413|FG000|STARTED|Overall Study||39
11374990|NCT03334903|12570414|FG001|STARTED|Overall Study||38
11374991|NCT03334903|12570413|FG000|COMPLETED|Overall Study||35
11374992|NCT03334903|12570414|FG001|COMPLETED|Overall Study||33
11374993|NCT03334903|12570413|FG000|NOT COMPLETED|Overall Study||4
11374994|NCT03334903|12570414|FG001|NOT COMPLETED|Overall Study||5
11374995|NCT03335150|12570422|FG000|STARTED|Overall Study||55
11374996|NCT03335150|12570423|FG001|STARTED|Overall Study||55
11374997|NCT03335150|12570422|FG000|Enrolled + Assigned Group|Overall Study||54
11374998|NCT03335150|12570423|FG001|Enrolled + Assigned Group|Overall Study||55
11374999|NCT03335150|12570422|FG000|PRE Testing Session|Overall Study||53
11375000|NCT03335150|12570423|FG001|PRE Testing Session|Overall Study||55
11375001|NCT03335150|12570422|FG000|Commenced Group|Overall Study||47
11375002|NCT03335150|12570423|FG001|Commenced Group|Overall Study||52
11375003|NCT03335150|12570422|FG000|POST Testing Session|Overall Study||45
11375004|NCT03335150|12570423|FG001|POST Testing Session|Overall Study||50
11375005|NCT03335150|12570422|FG000|COMPLETED|Overall Study||45
11375006|NCT03335150|12570423|FG001|COMPLETED|Overall Study||50
11375007|NCT03335150|12570422|FG000|NOT COMPLETED|Overall Study||10
11375008|NCT03335150|12570423|FG001|NOT COMPLETED|Overall Study||5
11375009|NCT03335254|12570449|FG000|STARTED|Period 1||9
11375010|NCT03335254|12570450|FG001|STARTED|Period 1||0
11375011|NCT03335254|12570451|FG002|STARTED|Period 1||0
11375012|NCT03335254|12570452|FG003|STARTED|Period 1||0
11375013|NCT03335254|12570453|FG004|STARTED|Period 1||0
11375014|NCT03335254|12570454|FG005|STARTED|Period 1||0
11375015|NCT03335254|12570455|FG006|STARTED|Period 1||0
11375016|NCT03335254|12570456|FG007|STARTED|Period 1||0
11375017|NCT03335254|12570457|FG008|STARTED|Period 1||0
11375018|NCT03335254|12570458|FG009|STARTED|Period 1||0
11375019|NCT03335254|12570459|FG010|STARTED|Period 1||0
11375020|NCT03335254|12570460|FG011|STARTED|Period 1||0
11375021|NCT03335254|12570461|FG012|STARTED|Period 1||0
11375022|NCT03335254|12570462|FG013|STARTED|Period 1||0
11375023|NCT03335254|12570463|FG014|STARTED|Period 1||0
11375024|NCT03335254|12570464|FG015|STARTED|Period 1||0
11375025|NCT03335254|12570465|FG016|STARTED|Period 1||0
11375026|NCT03335254|12570466|FG017|STARTED|Period 1||0
11375027|NCT03335254|12570467|FG018|STARTED|Period 1||0
11375028|NCT03335254|12570468|FG019|STARTED|Period 1||0
11375029|NCT03335254|12570449|FG000|COMPLETED|Period 1||9
11375030|NCT03335254|12570450|FG001|COMPLETED|Period 1||0
11375031|NCT03335254|12570451|FG002|COMPLETED|Period 1||0
11375032|NCT03335254|12570452|FG003|COMPLETED|Period 1||0
11375033|NCT03335254|12570453|FG004|COMPLETED|Period 1||0
11375034|NCT03335254|12570454|FG005|COMPLETED|Period 1||0
11375035|NCT03335254|12570455|FG006|COMPLETED|Period 1||0
11375036|NCT03335254|12570456|FG007|COMPLETED|Period 1||0
11375037|NCT03335254|12570457|FG008|COMPLETED|Period 1||0
11375038|NCT03335254|12570458|FG009|COMPLETED|Period 1||0
11375039|NCT03335254|12570459|FG010|COMPLETED|Period 1||0
11375040|NCT03335254|12570460|FG011|COMPLETED|Period 1||0
11375041|NCT03335254|12570461|FG012|COMPLETED|Period 1||0
11375042|NCT03335254|12570462|FG013|COMPLETED|Period 1||0
11375043|NCT03335254|12570463|FG014|COMPLETED|Period 1||0
11375044|NCT03335254|12570464|FG015|COMPLETED|Period 1||0
11375045|NCT03335254|12570465|FG016|COMPLETED|Period 1||0
11375046|NCT03335254|12570466|FG017|COMPLETED|Period 1||0
11375047|NCT03335254|12570467|FG018|COMPLETED|Period 1||0
11375048|NCT03335254|12570468|FG019|COMPLETED|Period 1||0
11375049|NCT03335254|12570449|FG000|NOT COMPLETED|Period 1||0
11375050|NCT03335254|12570450|FG001|NOT COMPLETED|Period 1||0
11375051|NCT03335254|12570451|FG002|NOT COMPLETED|Period 1||0
11375052|NCT03335254|12570452|FG003|NOT COMPLETED|Period 1||0
11375053|NCT03335254|12570453|FG004|NOT COMPLETED|Period 1||0
11375054|NCT03335254|12570454|FG005|NOT COMPLETED|Period 1||0
11375055|NCT03335254|12570455|FG006|NOT COMPLETED|Period 1||0
11375056|NCT03335254|12570456|FG007|NOT COMPLETED|Period 1||0
11375057|NCT03335254|12570457|FG008|NOT COMPLETED|Period 1||0
11375058|NCT03335254|12570458|FG009|NOT COMPLETED|Period 1||0
11375059|NCT03335254|12570459|FG010|NOT COMPLETED|Period 1||0
11375060|NCT03335254|12570460|FG011|NOT COMPLETED|Period 1||0
11375061|NCT03335254|12570461|FG012|NOT COMPLETED|Period 1||0
11375062|NCT03335254|12570462|FG013|NOT COMPLETED|Period 1||0
11375063|NCT03335254|12570463|FG014|NOT COMPLETED|Period 1||0
11375064|NCT03335254|12570464|FG015|NOT COMPLETED|Period 1||0
11375065|NCT03335254|12570465|FG016|NOT COMPLETED|Period 1||0
11375066|NCT03335254|12570466|FG017|NOT COMPLETED|Period 1||0
11375067|NCT03335254|12570467|FG018|NOT COMPLETED|Period 1||0
11375068|NCT03335254|12570468|FG019|NOT COMPLETED|Period 1||0
11375069|NCT03335254|12570449|FG000|STARTED|Period 2, Day 1-15||9
11375070|NCT03335254|12570450|FG001|STARTED|Period 2, Day 1-15||0
11375071|NCT03335254|12570451|FG002|STARTED|Period 2, Day 1-15||0
11375072|NCT03335254|12570452|FG003|STARTED|Period 2, Day 1-15||0
11375073|NCT03335254|12570453|FG004|STARTED|Period 2, Day 1-15||0
11375074|NCT03335254|12570454|FG005|STARTED|Period 2, Day 1-15||0
11375075|NCT03335254|12570455|FG006|STARTED|Period 2, Day 1-15||0
11375076|NCT03335254|12570456|FG007|STARTED|Period 2, Day 1-15||0
11375077|NCT03335254|12570457|FG008|STARTED|Period 2, Day 1-15||0
11375078|NCT03335254|12570458|FG009|STARTED|Period 2, Day 1-15||0
11375079|NCT03335254|12570459|FG010|STARTED|Period 2, Day 1-15||0
11375080|NCT03335254|12570460|FG011|STARTED|Period 2, Day 1-15||0
11375081|NCT03335254|12570461|FG012|STARTED|Period 2, Day 1-15||0
11375082|NCT03335254|12570462|FG013|STARTED|Period 2, Day 1-15||0
11375083|NCT03335254|12570463|FG014|STARTED|Period 2, Day 1-15||0
11375084|NCT03335254|12570464|FG015|STARTED|Period 2, Day 1-15||0
11375085|NCT03335254|12570465|FG016|STARTED|Period 2, Day 1-15||0
11375086|NCT03335254|12570466|FG017|STARTED|Period 2, Day 1-15||0
11375087|NCT03335254|12570467|FG018|STARTED|Period 2, Day 1-15||0
11375088|NCT03335254|12570468|FG019|STARTED|Period 2, Day 1-15||0
11375089|NCT03335254|12570449|FG000|COMPLETED|Period 2, Day 1-15||9
11375090|NCT03335254|12570450|FG001|COMPLETED|Period 2, Day 1-15||0
11375091|NCT03335254|12570451|FG002|COMPLETED|Period 2, Day 1-15||0
11375092|NCT03335254|12570452|FG003|COMPLETED|Period 2, Day 1-15||0
11375093|NCT03335254|12570453|FG004|COMPLETED|Period 2, Day 1-15||0
11375094|NCT03335254|12570454|FG005|COMPLETED|Period 2, Day 1-15||0
11375095|NCT03335254|12570455|FG006|COMPLETED|Period 2, Day 1-15||0
11375096|NCT03335254|12570456|FG007|COMPLETED|Period 2, Day 1-15||0
11375097|NCT03335254|12570457|FG008|COMPLETED|Period 2, Day 1-15||0
11375098|NCT03335254|12570458|FG009|COMPLETED|Period 2, Day 1-15||0
11375099|NCT03335254|12570459|FG010|COMPLETED|Period 2, Day 1-15||0
11375100|NCT03335254|12570460|FG011|COMPLETED|Period 2, Day 1-15||0
11375101|NCT03335254|12570461|FG012|COMPLETED|Period 2, Day 1-15||0
11375102|NCT03335254|12570462|FG013|COMPLETED|Period 2, Day 1-15||0
11375103|NCT03335254|12570463|FG014|COMPLETED|Period 2, Day 1-15||0
11375104|NCT03335254|12570464|FG015|COMPLETED|Period 2, Day 1-15||0
11375105|NCT03335254|12570465|FG016|COMPLETED|Period 2, Day 1-15||0
11375106|NCT03335254|12570466|FG017|COMPLETED|Period 2, Day 1-15||0
11375107|NCT03335254|12570467|FG018|COMPLETED|Period 2, Day 1-15||0
11375108|NCT03335254|12570468|FG019|COMPLETED|Period 2, Day 1-15||0
11375109|NCT03335254|12570449|FG000|NOT COMPLETED|Period 2, Day 1-15||0
11375110|NCT03335254|12570450|FG001|NOT COMPLETED|Period 2, Day 1-15||0
11375111|NCT03335254|12570451|FG002|NOT COMPLETED|Period 2, Day 1-15||0
11375112|NCT03335254|12570452|FG003|NOT COMPLETED|Period 2, Day 1-15||0
11375113|NCT03335254|12570453|FG004|NOT COMPLETED|Period 2, Day 1-15||0
11375114|NCT03335254|12570454|FG005|NOT COMPLETED|Period 2, Day 1-15||0
11375115|NCT03335254|12570455|FG006|NOT COMPLETED|Period 2, Day 1-15||0
11375116|NCT03335254|12570456|FG007|NOT COMPLETED|Period 2, Day 1-15||0
11375117|NCT03335254|12570457|FG008|NOT COMPLETED|Period 2, Day 1-15||0
11375118|NCT03335254|12570458|FG009|NOT COMPLETED|Period 2, Day 1-15||0
11375119|NCT03335254|12570459|FG010|NOT COMPLETED|Period 2, Day 1-15||0
11375120|NCT03335254|12570460|FG011|NOT COMPLETED|Period 2, Day 1-15||0
11375121|NCT03335254|12570461|FG012|NOT COMPLETED|Period 2, Day 1-15||0
11375122|NCT03335254|12570462|FG013|NOT COMPLETED|Period 2, Day 1-15||0
11375123|NCT03335254|12570463|FG014|NOT COMPLETED|Period 2, Day 1-15||0
11375124|NCT03335254|12570464|FG015|NOT COMPLETED|Period 2, Day 1-15||0
11375125|NCT03335254|12570465|FG016|NOT COMPLETED|Period 2, Day 1-15||0
11375126|NCT03335254|12570466|FG017|NOT COMPLETED|Period 2, Day 1-15||0
11375127|NCT03335254|12570467|FG018|NOT COMPLETED|Period 2, Day 1-15||0
11375128|NCT03335254|12570468|FG019|NOT COMPLETED|Period 2, Day 1-15||0
11375129|NCT03335254|12570449|FG000|STARTED|Period 3, Day 16-25||9
11375130|NCT03335254|12570450|FG001|STARTED|Period 3, Day 16-25||0
11375131|NCT03335254|12570451|FG002|STARTED|Period 3, Day 16-25||0
11375132|NCT03335254|12570452|FG003|STARTED|Period 3, Day 16-25||0
11375133|NCT03335254|12570453|FG004|STARTED|Period 3, Day 16-25||0
11375134|NCT03335254|12570454|FG005|STARTED|Period 3, Day 16-25||0
11375135|NCT03335254|12570455|FG006|STARTED|Period 3, Day 16-25||0
11375136|NCT03335254|12570456|FG007|STARTED|Period 3, Day 16-25||0
11375137|NCT03335254|12570457|FG008|STARTED|Period 3, Day 16-25||0
11375138|NCT03335254|12570458|FG009|STARTED|Period 3, Day 16-25||0
11375139|NCT03335254|12570459|FG010|STARTED|Period 3, Day 16-25||0
11375140|NCT03335254|12570460|FG011|STARTED|Period 3, Day 16-25||0
11375141|NCT03335254|12570461|FG012|STARTED|Period 3, Day 16-25||0
11375142|NCT03335254|12570462|FG013|STARTED|Period 3, Day 16-25||0
11375143|NCT03335254|12570463|FG014|STARTED|Period 3, Day 16-25||0
11375144|NCT03335254|12570464|FG015|STARTED|Period 3, Day 16-25||0
11375145|NCT03335254|12570465|FG016|STARTED|Period 3, Day 16-25||0
11375146|NCT03335254|12570466|FG017|STARTED|Period 3, Day 16-25||0
11375147|NCT03335254|12570467|FG018|STARTED|Period 3, Day 16-25||0
11375148|NCT03335254|12570468|FG019|STARTED|Period 3, Day 16-25||0
11375149|NCT03335254|12570449|FG000|COMPLETED|Period 3, Day 16-25||9
11375150|NCT03335254|12570450|FG001|COMPLETED|Period 3, Day 16-25||0
11375151|NCT03335254|12570451|FG002|COMPLETED|Period 3, Day 16-25||0
11375152|NCT03335254|12570452|FG003|COMPLETED|Period 3, Day 16-25||0
11375153|NCT03335254|12570453|FG004|COMPLETED|Period 3, Day 16-25||0
11375154|NCT03335254|12570454|FG005|COMPLETED|Period 3, Day 16-25||0
11375155|NCT03335254|12570455|FG006|COMPLETED|Period 3, Day 16-25||0
11375156|NCT03335254|12570456|FG007|COMPLETED|Period 3, Day 16-25||0
11375157|NCT03335254|12570457|FG008|COMPLETED|Period 3, Day 16-25||0
11375158|NCT03335254|12570458|FG009|COMPLETED|Period 3, Day 16-25||0
11375159|NCT03335254|12570459|FG010|COMPLETED|Period 3, Day 16-25||0
11375160|NCT03335254|12570460|FG011|COMPLETED|Period 3, Day 16-25||0
11375161|NCT03335254|12570461|FG012|COMPLETED|Period 3, Day 16-25||0
11375162|NCT03335254|12570462|FG013|COMPLETED|Period 3, Day 16-25||0
11375163|NCT03335254|12570463|FG014|COMPLETED|Period 3, Day 16-25||0
11375164|NCT03335254|12570464|FG015|COMPLETED|Period 3, Day 16-25||0
11375165|NCT03335254|12570465|FG016|COMPLETED|Period 3, Day 16-25||0
11375166|NCT03335254|12570466|FG017|COMPLETED|Period 3, Day 16-25||0
11375167|NCT03335254|12570467|FG018|COMPLETED|Period 3, Day 16-25||0
11375168|NCT03335254|12570468|FG019|COMPLETED|Period 3, Day 16-25||0
11375169|NCT03335254|12570449|FG000|NOT COMPLETED|Period 3, Day 16-25||0
11375170|NCT03335254|12570450|FG001|NOT COMPLETED|Period 3, Day 16-25||0
11375171|NCT03335254|12570451|FG002|NOT COMPLETED|Period 3, Day 16-25||0
11375172|NCT03335254|12570452|FG003|NOT COMPLETED|Period 3, Day 16-25||0
11375173|NCT03335254|12570453|FG004|NOT COMPLETED|Period 3, Day 16-25||0
11375174|NCT03335254|12570454|FG005|NOT COMPLETED|Period 3, Day 16-25||0
11375175|NCT03335254|12570455|FG006|NOT COMPLETED|Period 3, Day 16-25||0
11375176|NCT03335254|12570456|FG007|NOT COMPLETED|Period 3, Day 16-25||0
11375177|NCT03335254|12570457|FG008|NOT COMPLETED|Period 3, Day 16-25||0
11375178|NCT03335254|12570458|FG009|NOT COMPLETED|Period 3, Day 16-25||0
11375179|NCT03335254|12570459|FG010|NOT COMPLETED|Period 3, Day 16-25||0
11375180|NCT03335254|12570460|FG011|NOT COMPLETED|Period 3, Day 16-25||0
11375181|NCT03335254|12570461|FG012|NOT COMPLETED|Period 3, Day 16-25||0
11375182|NCT03335254|12570462|FG013|NOT COMPLETED|Period 3, Day 16-25||0
11375183|NCT03335254|12570463|FG014|NOT COMPLETED|Period 3, Day 16-25||0
11375184|NCT03335254|12570464|FG015|NOT COMPLETED|Period 3, Day 16-25||0
11375185|NCT03335254|12570465|FG016|NOT COMPLETED|Period 3, Day 16-25||0
11375186|NCT03335254|12570466|FG017|NOT COMPLETED|Period 3, Day 16-25||0
11375187|NCT03335254|12570467|FG018|NOT COMPLETED|Period 3, Day 16-25||0
11375188|NCT03335254|12570468|FG019|NOT COMPLETED|Period 3, Day 16-25||0
11375189|NCT03335254|12570449|FG000|STARTED|Period 3, Day 26-30||9
11375190|NCT03335254|12570450|FG001|STARTED|Period 3, Day 26-30||0
11375191|NCT03335254|12570451|FG002|STARTED|Period 3, Day 26-30||0
11375192|NCT03335254|12570452|FG003|STARTED|Period 3, Day 26-30||0
11375193|NCT03335254|12570453|FG004|STARTED|Period 3, Day 26-30||0
11375194|NCT03335254|12570454|FG005|STARTED|Period 3, Day 26-30||0
11375195|NCT03335254|12570455|FG006|STARTED|Period 3, Day 26-30||0
11375196|NCT03335254|12570456|FG007|STARTED|Period 3, Day 26-30||0
11375197|NCT03335254|12570457|FG008|STARTED|Period 3, Day 26-30||0
11375198|NCT03335254|12570458|FG009|STARTED|Period 3, Day 26-30||0
11375199|NCT03335254|12570459|FG010|STARTED|Period 3, Day 26-30||0
11375200|NCT03335254|12570460|FG011|STARTED|Period 3, Day 26-30||0
11375201|NCT03335254|12570461|FG012|STARTED|Period 3, Day 26-30||0
11375202|NCT03335254|12570462|FG013|STARTED|Period 3, Day 26-30||0
11375203|NCT03335254|12570463|FG014|STARTED|Period 3, Day 26-30||0
11375204|NCT03335254|12570464|FG015|STARTED|Period 3, Day 26-30||0
11375205|NCT03335254|12570465|FG016|STARTED|Period 3, Day 26-30||0
11375206|NCT03335254|12570466|FG017|STARTED|Period 3, Day 26-30||0
11375207|NCT03335254|12570467|FG018|STARTED|Period 3, Day 26-30||0
11375208|NCT03335254|12570468|FG019|STARTED|Period 3, Day 26-30||0
11375209|NCT03335254|12570449|FG000|COMPLETED|Period 3, Day 26-30||9
11375210|NCT03335254|12570450|FG001|COMPLETED|Period 3, Day 26-30||0
11375211|NCT03335254|12570451|FG002|COMPLETED|Period 3, Day 26-30||0
11375212|NCT03335254|12570452|FG003|COMPLETED|Period 3, Day 26-30||0
11375213|NCT03335254|12570453|FG004|COMPLETED|Period 3, Day 26-30||0
11375214|NCT03335254|12570454|FG005|COMPLETED|Period 3, Day 26-30||0
11375215|NCT03335254|12570455|FG006|COMPLETED|Period 3, Day 26-30||0
11375216|NCT03335254|12570456|FG007|COMPLETED|Period 3, Day 26-30||0
11375217|NCT03335254|12570457|FG008|COMPLETED|Period 3, Day 26-30||0
11375218|NCT03335254|12570458|FG009|COMPLETED|Period 3, Day 26-30||0
11375219|NCT03335254|12570459|FG010|COMPLETED|Period 3, Day 26-30||0
11375220|NCT03335254|12570460|FG011|COMPLETED|Period 3, Day 26-30||0
11375221|NCT03335254|12570461|FG012|COMPLETED|Period 3, Day 26-30||0
11375222|NCT03335254|12570462|FG013|COMPLETED|Period 3, Day 26-30||0
11375223|NCT03335254|12570463|FG014|COMPLETED|Period 3, Day 26-30||0
11375224|NCT03335254|12570464|FG015|COMPLETED|Period 3, Day 26-30||0
11375225|NCT03335254|12570465|FG016|COMPLETED|Period 3, Day 26-30||0
11375226|NCT03335254|12570466|FG017|COMPLETED|Period 3, Day 26-30||0
11375227|NCT03335254|12570467|FG018|COMPLETED|Period 3, Day 26-30||0
11375228|NCT03335254|12570468|FG019|COMPLETED|Period 3, Day 26-30||0
11375229|NCT03335254|12570449|FG000|NOT COMPLETED|Period 3, Day 26-30||0
11375230|NCT03335254|12570450|FG001|NOT COMPLETED|Period 3, Day 26-30||0
11375231|NCT03335254|12570451|FG002|NOT COMPLETED|Period 3, Day 26-30||0
11375232|NCT03335254|12570452|FG003|NOT COMPLETED|Period 3, Day 26-30||0
11375233|NCT03335254|12570453|FG004|NOT COMPLETED|Period 3, Day 26-30||0
11375234|NCT03335254|12570454|FG005|NOT COMPLETED|Period 3, Day 26-30||0
11375235|NCT03335254|12570455|FG006|NOT COMPLETED|Period 3, Day 26-30||0
11375236|NCT03335254|12570456|FG007|NOT COMPLETED|Period 3, Day 26-30||0
11375237|NCT03335254|12570457|FG008|NOT COMPLETED|Period 3, Day 26-30||0
11375238|NCT03335254|12570458|FG009|NOT COMPLETED|Period 3, Day 26-30||0
11375239|NCT03335254|12570459|FG010|NOT COMPLETED|Period 3, Day 26-30||0
11375240|NCT03335254|12570460|FG011|NOT COMPLETED|Period 3, Day 26-30||0
11375241|NCT03335254|12570461|FG012|NOT COMPLETED|Period 3, Day 26-30||0
11375242|NCT03335254|12570462|FG013|NOT COMPLETED|Period 3, Day 26-30||0
11375243|NCT03335254|12570463|FG014|NOT COMPLETED|Period 3, Day 26-30||0
11375244|NCT03335254|12570464|FG015|NOT COMPLETED|Period 3, Day 26-30||0
11375245|NCT03335254|12570465|FG016|NOT COMPLETED|Period 3, Day 26-30||0
11375246|NCT03335254|12570466|FG017|NOT COMPLETED|Period 3, Day 26-30||0
11375247|NCT03335254|12570467|FG018|NOT COMPLETED|Period 3, Day 26-30||0
11375248|NCT03335254|12570468|FG019|NOT COMPLETED|Period 3, Day 26-30||0
11375249|NCT03335566|12570499|FG000|STARTED|Overall Study||218
11375250|NCT03335566|12570500|FG001|STARTED|Overall Study||206
11375251|NCT03335566|12570499|FG000|COMPLETED|Overall Study||214
11375252|NCT03335566|12570500|FG001|COMPLETED|Overall Study||203
11375253|NCT03335566|12570499|FG000|NOT COMPLETED|Overall Study||4
11375254|NCT03335566|12570500|FG001|NOT COMPLETED|Overall Study||3
11375255|NCT03335761|12570509|FG000|STARTED|Overall Study||19
11375256|NCT03335761|12570510|FG001|STARTED|Overall Study||14
11375257|NCT03335761|12570511|FG002|STARTED|Overall Study||15
11375258|NCT03335761|12570509|FG000|Implanted With a Neurostimulator Device|Overall Study||18
11375259|NCT03335761|12570510|FG001|Implanted With a Neurostimulator Device|Overall Study||14
11375260|NCT03335761|12570511|FG002|Implanted With a Neurostimulator Device|Overall Study||14
11375261|NCT03335761|12570509|FG000|COMPLETED|Overall Study||17
11375262|NCT03335761|12570510|FG001|COMPLETED|Overall Study||13
11375263|NCT03335761|12570511|FG002|COMPLETED|Overall Study||13
11375264|NCT03335761|12570509|FG000|NOT COMPLETED|Overall Study||2
11375265|NCT03335761|12570510|FG001|NOT COMPLETED|Overall Study||1
11375266|NCT03335761|12570511|FG002|NOT COMPLETED|Overall Study||2
11375267|NCT03335800|12570519|FG000|STARTED|Overall Study||419927
11375268|NCT03335800|12570519|FG000|Received Irregular Pulse Notification|Overall Study||2161
11375269|NCT03335800|12570519|FG000|Attended First Study Visit|Overall Study||945
11375270|NCT03335800|12570519|FG000|ECG Patch Shipped|Overall Study||658
11375271|NCT03335800|12570519|FG000|ECG Patch Returned for Analysis|Overall Study||450
11375272|NCT03335800|12570519|FG000|Attended Second Study Visit|Overall Study||396
11375273|NCT03335800|12570519|FG000|COMPLETED|Overall Study||396
11375274|NCT03335800|12570519|FG000|NOT COMPLETED|Overall Study||419531
11375275|NCT03336450|12570523|FG000|STARTED|Overall Study||3
11375276|NCT03336450|12570523|FG000|COMPLETED|Overall Study||3
11375277|NCT03336450|12570523|FG000|NOT COMPLETED|Overall Study||0
11375278|NCT03336502|12570529|FG000|STARTED|Overall Study||30
11375279|NCT03336502|12570530|FG001|STARTED|Overall Study||40
11375280|NCT03336502|12570529|FG000|COMPLETED|Overall Study||26
11375281|NCT03336502|12570530|FG001|COMPLETED|Overall Study||31
11375282|NCT03336502|12570529|FG000|NOT COMPLETED|Overall Study||4
11375283|NCT03336502|12570530|FG001|NOT COMPLETED|Overall Study||9
11375284|NCT03336645|12570536|FG000|STARTED|Overall Study||25
11375285|NCT03336645|12570536|FG000|COMPLETED|Overall Study||25
11375286|NCT03336645|12570536|FG000|NOT COMPLETED|Overall Study||0
11375287|NCT03336853|12570542|FG000|STARTED|Overall Study||30
11375288|NCT03336853|12570543|FG001|STARTED|Overall Study||30
11375289|NCT03336853|12570542|FG000|COMPLETED|Overall Study||30
11375290|NCT03336853|12570543|FG001|COMPLETED|Overall Study||30
11375291|NCT03336853|12570542|FG000|NOT COMPLETED|Overall Study||0
11375292|NCT03336853|12570543|FG001|NOT COMPLETED|Overall Study||0
11375293|NCT03337139|12570551|FG000|STARTED|Phase I||87
11375294|NCT03337139|12570552|FG001|STARTED|Phase I|There were not two conditions in Phase I: all participants received standard group LM treatment.|0
11375295|NCT03337139|12570551|FG000|COMPLETED|Phase I||77
11375296|NCT03337139|12570552|FG001|COMPLETED|Phase I||0
11375297|NCT03337139|12570551|FG000|NOT COMPLETED|Phase I||10
11375298|NCT03337139|12570552|FG001|NOT COMPLETED|Phase I||0
11375299|NCT03337139|12570551|FG000|STARTED|Phase II||38
11375300|NCT03337139|12570552|FG001|STARTED|Phase II||39
11375301|NCT03337139|12570551|FG000|26 Week Assessment|Phase II||34
11375302|NCT03337139|12570552|FG001|26 Week Assessment|Phase II||37
11375303|NCT03337139|12570551|FG000|COMPLETED|Phase II||33
11375304|NCT03337139|12570552|FG001|COMPLETED|Phase II||36
11375305|NCT03337139|12570551|FG000|NOT COMPLETED|Phase II||5
11375306|NCT03337139|12570552|FG001|NOT COMPLETED|Phase II||3
11375307|NCT03337152|12570560|FG000|STARTED|Overall Study||24
11375308|NCT03337152|12570561|FG001|STARTED|Overall Study||24
11375309|NCT03337152|12570560|FG000|COMPLETED|Overall Study||13
11375310|NCT03337152|12570561|FG001|COMPLETED|Overall Study||13
11375311|NCT03337152|12570560|FG000|NOT COMPLETED|Overall Study||11
11375312|NCT03337152|12570561|FG001|NOT COMPLETED|Overall Study||11
11375313|NCT03337308|12570573|FG000|STARTED|Overall Study||108
11375314|NCT03337308|12570574|FG001|STARTED|Overall Study||110
11375315|NCT03337308|12570575|FG002|STARTED|Overall Study||109
11375316|NCT03337308|12570576|FG003|STARTED|Overall Study||55
11375317|NCT03337308|12570573|FG000|COMPLETED|Overall Study||103
11375318|NCT03337308|12570574|FG001|COMPLETED|Overall Study||103
11375319|NCT03337308|12570575|FG002|COMPLETED|Overall Study||104
11375320|NCT03337308|12570576|FG003|COMPLETED|Overall Study||53
11375321|NCT03337308|12570573|FG000|NOT COMPLETED|Overall Study||5
11375322|NCT03337308|12570574|FG001|NOT COMPLETED|Overall Study||7
11375323|NCT03337308|12570575|FG002|NOT COMPLETED|Overall Study||5
11375324|NCT03337308|12570576|FG003|NOT COMPLETED|Overall Study||2
11375325|NCT03337477|12570588|FG000|STARTED|Overall Study||33
11375326|NCT03337477|12570589|FG001|STARTED|Overall Study||37
11375327|NCT03337477|12570588|FG000|COMPLETED|Overall Study||22
11375328|NCT03337477|12570589|FG001|COMPLETED|Overall Study||24
11375329|NCT03337477|12570588|FG000|NOT COMPLETED|Overall Study||11
11375330|NCT03337477|12570589|FG001|NOT COMPLETED|Overall Study||13
11375331|NCT03337490|12570600|FG000|STARTED|Overall Study||128
11375332|NCT03337490|12570601|FG001|STARTED|Overall Study||126
11375333|NCT03337490|12570602|FG002|STARTED|Overall Study||42
11375334|NCT03337490|12570600|FG000|COMPLETED|Overall Study||117
11375335|NCT03337490|12570601|FG001|COMPLETED|Overall Study||112
11375336|NCT03337490|12570602|FG002|COMPLETED|Overall Study||7
11375337|NCT03337490|12570600|FG000|NOT COMPLETED|Overall Study||11
11375338|NCT03337490|12570601|FG001|NOT COMPLETED|Overall Study||14
11375339|NCT03337490|12570602|FG002|NOT COMPLETED|Overall Study||35
11375340|NCT03337542|12570610|FG000|STARTED|Overall Study||243
11375341|NCT03337542|12570610|FG000|Safety Population|Overall Study||242
11375342|NCT03337542|12570610|FG000|COMPLETED|Overall Study||222
11375343|NCT03337542|12570610|FG000|NOT COMPLETED|Overall Study||21
11375344|NCT03338010|12570617|FG000|STARTED|Overall Study||359
11375345|NCT03338010|12570618|FG001|STARTED|Overall Study||177
11375346|NCT03338010|12570617|FG000|Received at Least One Dose of Study Drug|Overall Study||359
11375347|NCT03338010|12570618|FG001|Received at Least One Dose of Study Drug|Overall Study||177
11375348|NCT03338010|12570617|FG000|COMPLETED|Overall Study||336
11375349|NCT03338010|12570618|FG001|COMPLETED|Overall Study||159
11375350|NCT03338010|12570617|FG000|NOT COMPLETED|Overall Study||23
11375351|NCT03338010|12570618|FG001|NOT COMPLETED|Overall Study||18
11375352|NCT03338023|12570626|FG000|STARTED|Overall Study||137
11375353|NCT03338023|12570627|FG001|STARTED|Overall Study||135
11375354|NCT03338023|12570626|FG000|Received at Least One Dose of Study Drug|Overall Study||137
11375355|NCT03338023|12570627|FG001|Received at Least One Dose of Study Drug|Overall Study||135
11375356|NCT03338023|12570626|FG000|COMPLETED|Overall Study||128
11375357|NCT03338023|12570627|FG001|COMPLETED|Overall Study||125
11375358|NCT03338023|12570626|FG000|NOT COMPLETED|Overall Study||9
11375359|NCT03338023|12570627|FG001|NOT COMPLETED|Overall Study||10
11375360|NCT03338062|12570635|FG000|STARTED|Overall Study||10
11375361|NCT03338062|12570636|FG001|STARTED|Overall Study||5
11375362|NCT03338062|12570635|FG000|COMPLETED|Overall Study||9
11375363|NCT03338062|12570636|FG001|COMPLETED|Overall Study||5
11375364|NCT03338062|12570635|FG000|NOT COMPLETED|Overall Study||1
11375365|NCT03338062|12570636|FG001|NOT COMPLETED|Overall Study||0
11375366|NCT03338296|12570645|FG000|STARTED|Overall Study||139
11375367|NCT03338296|12570646|FG001|STARTED|Overall Study||139
11375368|NCT03338296|12570645|FG000|Safety Analysis Set|Overall Study||139
11375369|NCT03338296|12570646|FG001|Safety Analysis Set|Overall Study||136
11375370|NCT03338296|12570645|FG000|COMPLETED|Overall Study||36
11375371|NCT03338296|12570646|FG001|COMPLETED|Overall Study||31
11375372|NCT03338296|12570645|FG000|NOT COMPLETED|Overall Study||103
11375373|NCT03338296|12570646|FG001|NOT COMPLETED|Overall Study||108
11375374|NCT03338400|12570654|FG000|STARTED|Overall Study||25
11375375|NCT03338400|12570655|FG001|STARTED|Overall Study||26
11375376|NCT03338400|12570654|FG000|COMPLETED|Overall Study||24
11375377|NCT03338400|12570655|FG001|COMPLETED|Overall Study||24
11375378|NCT03338400|12570654|FG000|NOT COMPLETED|Overall Study||1
11375379|NCT03338400|12570655|FG001|NOT COMPLETED|Overall Study||2
11375380|NCT03338556|12570673|FG000|STARTED|Overall Study||25
11375381|NCT03338556|12570674|FG001|STARTED|Overall Study||27
11375382|NCT03338556|12570675|FG002|STARTED|Overall Study||24
11375383|NCT03338556|12570676|FG003|STARTED|Overall Study||26
11375384|NCT03338556|12570673|FG000|COMPLETED|Overall Study||23
11375385|NCT03338556|12570674|FG001|COMPLETED|Overall Study||23
11375386|NCT03338556|12570675|FG002|COMPLETED|Overall Study||22
11375387|NCT03338556|12570676|FG003|COMPLETED|Overall Study||24
11375388|NCT03338556|12570673|FG000|NOT COMPLETED|Overall Study||2
11375389|NCT03338556|12570674|FG001|NOT COMPLETED|Overall Study||4
11375390|NCT03338556|12570675|FG002|NOT COMPLETED|Overall Study||2
11375391|NCT03338556|12570676|FG003|NOT COMPLETED|Overall Study||2
11375392|NCT03338569|12570688|FG000|STARTED|Overall Study||64
11375393|NCT03338569|12570689|FG001|STARTED|Overall Study||61
11375394|NCT03338569|12570688|FG000|COMPLETED|Overall Study||56
11375395|NCT03338569|12570689|FG001|COMPLETED|Overall Study||56
11375396|NCT03338569|12570688|FG000|NOT COMPLETED|Overall Study||8
11375397|NCT03338569|12570689|FG001|NOT COMPLETED|Overall Study||5
11375398|NCT03338673|12570697|FG000|STARTED|Overall Study||6
11375399|NCT03338673|12570698|FG001|STARTED|Overall Study||6
11375400|NCT03338673|12570697|FG000|COMPLETED|Overall Study||5
11375401|NCT03338673|12570698|FG001|COMPLETED|Overall Study||5
11375402|NCT03338673|12570697|FG000|NOT COMPLETED|Overall Study||1
11375403|NCT03338673|12570698|FG001|NOT COMPLETED|Overall Study||1
11375404|NCT03338686|12570707|FG000|STARTED|Overall Study||2
11375405|NCT03338686|12570708|FG001|STARTED|Overall Study||5
11375406|NCT03338686|12570709|FG002|STARTED|Overall Study|12 FGG implant sites and 7 CTG implant sites for this Arm/Group|7
11375407|NCT03338686|12570707|FG000|COMPLETED|Overall Study||2
11375408|NCT03338686|12570708|FG001|COMPLETED|Overall Study||5
11375409|NCT03338686|12570709|FG002|COMPLETED|Overall Study||7
11375410|NCT03338686|12570707|FG000|NOT COMPLETED|Overall Study||0
11375411|NCT03338686|12570708|FG001|NOT COMPLETED|Overall Study||0
11375412|NCT03338686|12570709|FG002|NOT COMPLETED|Overall Study||0
11375413|NCT03338803|12570716|FG000|STARTED|Overall Study||11001
11375414|NCT03338803|12570716|FG000|COMPLETED|Overall Study||11001
11375415|NCT03338803|12570716|FG000|NOT COMPLETED|Overall Study||0
11375416|NCT03338855|12570722|FG000|STARTED|Overall Study||12
11375417|NCT03338855|12570723|FG001|STARTED|Overall Study||14
11375418|NCT03338855|12570722|FG000|Received Treatment in Period 1|Overall Study||12
11375419|NCT03338855|12570723|FG001|Received Treatment in Period 1|Overall Study||14
11375420|NCT03338855|12570722|FG000|Received Treatment in Period 2|Overall Study||11
11375421|NCT03338855|12570723|FG001|Received Treatment in Period 2|Overall Study||14
11375422|NCT03338855|12570722|FG000|COMPLETED|Overall Study||11
11375423|NCT03338855|12570723|FG001|COMPLETED|Overall Study||14
11375424|NCT03338855|12570722|FG000|NOT COMPLETED|Overall Study||1
11375425|NCT03338855|12570723|FG001|NOT COMPLETED|Overall Study||0
11375426|NCT03339206|12570732|FG000|STARTED|Overall Study||262
11375427|NCT03339206|12570733|FG001|STARTED|Overall Study||263
11375428|NCT03339206|12570734|FG002|STARTED|Overall Study||264
11375429|NCT03339206|12570732|FG000|COMPLETED|Overall Study||262
11375430|NCT03339206|12570733|FG001|COMPLETED|Overall Study||263
11375431|NCT03339206|12570734|FG002|COMPLETED|Overall Study||264
11375432|NCT03339206|12570732|FG000|NOT COMPLETED|Overall Study||0
11375433|NCT03339206|12570733|FG001|NOT COMPLETED|Overall Study||0
11375434|NCT03339206|12570734|FG002|NOT COMPLETED|Overall Study||0
11375435|NCT03339219|12570742|FG000|STARTED|Overall Study||35
11375436|NCT03339219|12570742|FG000|COMPLETED|Overall Study||0
11375437|NCT03339219|12570742|FG000|NOT COMPLETED|Overall Study||35
11375438|NCT03339297|12570748|FG000|STARTED|Overall Study||79
11375439|NCT03339297|12570749|FG001|STARTED|Overall Study||73
11375440|NCT03339297|12570748|FG000|COMPLETED|Overall Study||56
11375441|NCT03339297|12570749|FG001|COMPLETED|Overall Study||59
11375442|NCT03339297|12570748|FG000|NOT COMPLETED|Overall Study||23
11375443|NCT03339297|12570749|FG001|NOT COMPLETED|Overall Study||14
11375444|NCT03339453|12570757|FG000|STARTED|First Visit of Glucagon Treatment||35
11375445|NCT03339453|12570758|FG001|STARTED|First Visit of Glucagon Treatment||35
11375446|NCT03339453|12570757|FG000|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
11375447|NCT03339453|12570758|FG001|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
11375448|NCT03339453|12570757|FG000|COMPLETED|First Visit of Glucagon Treatment||35
11375449|NCT03339453|12570758|FG001|COMPLETED|First Visit of Glucagon Treatment||34
11375450|NCT03339453|12570757|FG000|NOT COMPLETED|First Visit of Glucagon Treatment||0
11375451|NCT03339453|12570758|FG001|NOT COMPLETED|First Visit of Glucagon Treatment||1
11375452|NCT03339453|12570757|FG000|STARTED|Second Visit for Alternate Glucagon||35
11375453|NCT03339453|12570758|FG001|STARTED|Second Visit for Alternate Glucagon||34
11375454|NCT03339453|12570757|FG000|COMPLETED|Second Visit for Alternate Glucagon||35
11375455|NCT03339453|12570758|FG001|COMPLETED|Second Visit for Alternate Glucagon||34
11375456|NCT03339453|12570757|FG000|NOT COMPLETED|Second Visit for Alternate Glucagon||0
11375457|NCT03339453|12570758|FG001|NOT COMPLETED|Second Visit for Alternate Glucagon||0
11375458|NCT03339570|12570764|FG000|STARTED|Overall Study||20
11375459|NCT03339570|12570764|FG000|COMPLETED|Overall Study||16
11375460|NCT03339570|12570764|FG000|NOT COMPLETED|Overall Study||4
11375461|NCT03339583|12570779|FG000|STARTED|First Intervention (14 Days)||19
11375462|NCT03339583|12570780|FG001|STARTED|First Intervention (14 Days)||23
11375463|NCT03339583|12570779|FG000|COMPLETED|First Intervention (14 Days)||18
11375464|NCT03339583|12570780|FG001|COMPLETED|First Intervention (14 Days)||23
11375465|NCT03339583|12570779|FG000|NOT COMPLETED|First Intervention (14 Days)||1
11375466|NCT03339583|12570780|FG001|NOT COMPLETED|First Intervention (14 Days)||0
11375467|NCT03339583|12570779|FG000|STARTED|Washout (14 Days)||18
11375468|NCT03339583|12570780|FG001|STARTED|Washout (14 Days)||23
11375469|NCT03339583|12570779|FG000|COMPLETED|Washout (14 Days)||18
11375470|NCT03339583|12570780|FG001|COMPLETED|Washout (14 Days)||23
11375471|NCT03339583|12570779|FG000|NOT COMPLETED|Washout (14 Days)||0
11375472|NCT03339583|12570780|FG001|NOT COMPLETED|Washout (14 Days)||0
11375473|NCT03339583|12570779|FG000|STARTED|Second Intervention (14 Days)||18
11375474|NCT03339583|12570780|FG001|STARTED|Second Intervention (14 Days)||23
11375475|NCT03339583|12570779|FG000|COMPLETED|Second Intervention (14 Days)||18
11375476|NCT03339583|12570780|FG001|COMPLETED|Second Intervention (14 Days)||21
11375477|NCT03339583|12570779|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
11375478|NCT03339583|12570780|FG001|NOT COMPLETED|Second Intervention (14 Days)||2
11375479|NCT03339583|12570779|FG000|STARTED|Follow-up (14 Days)||18
11375480|NCT03339583|12570780|FG001|STARTED|Follow-up (14 Days)||21
11375481|NCT03339583|12570779|FG000|COMPLETED|Follow-up (14 Days)||12
11375482|NCT03339583|12570780|FG001|COMPLETED|Follow-up (14 Days)||18
11375483|NCT03339583|12570779|FG000|NOT COMPLETED|Follow-up (14 Days)||6
11375484|NCT03339583|12570780|FG001|NOT COMPLETED|Follow-up (14 Days)||3
11375485|NCT03339713|12570790|FG000|STARTED|Overall Study||90
11375486|NCT03339713|12570791|FG001|STARTED|Overall Study||90
11375487|NCT03339713|12570790|FG000|COMPLETED|Overall Study||86
11375488|NCT03339713|12570791|FG001|COMPLETED|Overall Study||88
11375489|NCT03339713|12570790|FG000|NOT COMPLETED|Overall Study||4
11375490|NCT03339713|12570791|FG001|NOT COMPLETED|Overall Study||2
11375491|NCT03339726|12570802|FG000|STARTED|Overall Study||64
11375492|NCT03339726|12570803|FG001|STARTED|Overall Study||66
11375493|NCT03339726|12570804|FG002|STARTED|Overall Study||63
11375494|NCT03339726|12570802|FG000|COMPLETED|Overall Study||63
11375495|NCT03339726|12570803|FG001|COMPLETED|Overall Study||65
11375496|NCT03339726|12570804|FG002|COMPLETED|Overall Study||63
11375497|NCT03339726|12570802|FG000|NOT COMPLETED|Overall Study||1
11375498|NCT03339726|12570803|FG001|NOT COMPLETED|Overall Study||1
11375499|NCT03339726|12570804|FG002|NOT COMPLETED|Overall Study||0
11375500|NCT03339999|12570816|FG000|STARTED|Overall Study||7
11375501|NCT03339999|12570817|FG001|STARTED|Overall Study||6
11375502|NCT03339999|12570818|FG002|STARTED|Overall Study||6
11375503|NCT03339999|12570819|FG003|STARTED|Overall Study||5
11375504|NCT03339999|12570816|FG000|Modified Intent-to-Treat Population|Overall Study||7
11375505|NCT03339999|12570817|FG001|Modified Intent-to-Treat Population|Overall Study||6
11375506|NCT03339999|12570818|FG002|Modified Intent-to-Treat Population|Overall Study||5
11375507|NCT03339999|12570819|FG003|Modified Intent-to-Treat Population|Overall Study||4
11375508|NCT03339999|12570816|FG000|Safety Population: Received Treatment|Overall Study||7
11375509|NCT03339999|12570817|FG001|Safety Population: Received Treatment|Overall Study||6
11375510|NCT03339999|12570818|FG002|Safety Population: Received Treatment|Overall Study||6
11375511|NCT03339999|12570819|FG003|Safety Population: Received Treatment|Overall Study||4
11375512|NCT03339999|12570816|FG000|COMPLETED|Overall Study||0
11375513|NCT03339999|12570817|FG001|COMPLETED|Overall Study||0
11375514|NCT03339999|12570818|FG002|COMPLETED|Overall Study||0
11375515|NCT03339999|12570819|FG003|COMPLETED|Overall Study||0
11375516|NCT03339999|12570816|FG000|NOT COMPLETED|Overall Study||7
11375517|NCT03339999|12570817|FG001|NOT COMPLETED|Overall Study||6
11375518|NCT03339999|12570818|FG002|NOT COMPLETED|Overall Study||6
11375519|NCT03339999|12570819|FG003|NOT COMPLETED|Overall Study||5
11375520|NCT03340025|12570834|FG000|STARTED|Overall Study||11
11375521|NCT03340025|12570835|FG001|STARTED|Overall Study||9
11375522|NCT03340025|12570834|FG000|COMPLETED|Overall Study||9
11375523|NCT03340025|12570835|FG001|COMPLETED|Overall Study||7
11375524|NCT03340025|12570834|FG000|NOT COMPLETED|Overall Study||2
11375525|NCT03340025|12570835|FG001|NOT COMPLETED|Overall Study||2
11375526|NCT03340337|12570841|FG000|STARTED|Overall Study||30
11375527|NCT03340337|12570841|FG000|Received Neo-Russian|Overall Study||30
11375528|NCT03340337|12570841|FG000|Received Aussie|Overall Study||30
11375529|NCT03340337|12570841|FG000|Received RBS|Overall Study||30
11375530|NCT03340337|12570841|FG000|COMPLETED|Overall Study||30
11375531|NCT03340337|12570841|FG000|NOT COMPLETED|Overall Study||0
11375532|NCT03340350|12570856|FG000|STARTED|Overall Study||10
11375533|NCT03340350|12570856|FG000|COMPLETED|Overall Study||4
11375534|NCT03340350|12570856|FG000|NOT COMPLETED|Overall Study||6
11375535|NCT03340415|12570863|FG000|STARTED|Overall Study||29
11375536|NCT03340415|12570864|FG001|STARTED|Overall Study||24
11375537|NCT03340415|12570863|FG000|COMPLETED|Overall Study||29
11375538|NCT03340415|12570864|FG001|COMPLETED|Overall Study||21
11375539|NCT03340415|12570863|FG000|NOT COMPLETED|Overall Study||0
11375540|NCT03340415|12570864|FG001|NOT COMPLETED|Overall Study||3
11375541|NCT03340428|12570874|FG000|STARTED|Overall Study||117
11375542|NCT03340428|12570875|FG001|STARTED|Overall Study||59
11375543|NCT03340428|12570874|FG000|COMPLETED|Overall Study||116
11375544|NCT03340428|12570875|FG001|COMPLETED|Overall Study||59
11375545|NCT03340428|12570874|FG000|NOT COMPLETED|Overall Study||1
11375546|NCT03340428|12570875|FG001|NOT COMPLETED|Overall Study||0
11375547|NCT03340610|12570881|FG000|STARTED|Overall Study||30
11375548|NCT03340610|12570881|FG000|COMPLETED|Overall Study||27
11375549|NCT03340610|12570881|FG000|NOT COMPLETED|Overall Study||3
11375550|NCT03340805|12570887|FG000|STARTED|Overall Study||24
11375551|NCT03340805|12570888|FG001|STARTED|Overall Study||26
11375552|NCT03340805|12570887|FG000|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24
11375553|NCT03340805|12570888|FG001|COMPLETED|Overall Study||26
11375554|NCT03340805|12570887|FG000|NOT COMPLETED|Overall Study||0
11375555|NCT03340805|12570888|FG001|NOT COMPLETED|Overall Study||0
11375556|NCT03340883|12570896|FG000|STARTED|Overall Study||4
11375557|NCT03340883|12570897|FG001|STARTED|Overall Study||3
11375558|NCT03340883|12570898|FG002|STARTED|Overall Study||4
11375559|NCT03340883|12570899|FG003|STARTED|Overall Study||4
11375560|NCT03340883|12570900|FG004|STARTED|Overall Study||3
11375561|NCT03340883|12570901|FG005|STARTED|Overall Study||3
11375562|NCT03340883|12570896|FG000|COMPLETED|Overall Study||4
11375563|NCT03340883|12570897|FG001|COMPLETED|Overall Study||3
11375564|NCT03340883|12570898|FG002|COMPLETED|Overall Study||4
11375565|NCT03340883|12570899|FG003|COMPLETED|Overall Study||4
11375566|NCT03340883|12570900|FG004|COMPLETED|Overall Study||3
11375567|NCT03340883|12570901|FG005|COMPLETED|Overall Study||3
11375568|NCT03340883|12570896|FG000|NOT COMPLETED|Overall Study||0
11375569|NCT03340883|12570897|FG001|NOT COMPLETED|Overall Study||0
11375570|NCT03340883|12570898|FG002|NOT COMPLETED|Overall Study||0
11375571|NCT03340883|12570899|FG003|NOT COMPLETED|Overall Study||0
11375572|NCT03340883|12570900|FG004|NOT COMPLETED|Overall Study||0
11375573|NCT03340883|12570901|FG005|NOT COMPLETED|Overall Study||0
11375574|NCT03340961|12570919|FG000|STARTED|Overall Study||53
11375575|NCT03340961|12570920|FG001|STARTED|Overall Study||50
11375576|NCT03340961|12570921|FG002|STARTED|Overall Study||49
11375577|NCT03340961|12570922|FG003|STARTED|Overall Study||53
11375578|NCT03340961|12570919|FG000|COMPLETED|Overall Study||47
11375579|NCT03340961|12570920|FG001|COMPLETED|Overall Study||38
11375580|NCT03340961|12570921|FG002|COMPLETED|Overall Study||40
11375581|NCT03340961|12570922|FG003|COMPLETED|Overall Study||35
11375582|NCT03340961|12570919|FG000|NOT COMPLETED|Overall Study||6
11375583|NCT03340961|12570920|FG001|NOT COMPLETED|Overall Study||12
11375584|NCT03340961|12570921|FG002|NOT COMPLETED|Overall Study||9
11375585|NCT03340961|12570922|FG003|NOT COMPLETED|Overall Study||18
11375586|NCT03341273|12570934|FG000|STARTED|Overall Study||249
11005824|NCT00724945|12183604|FG000|NOT COMPLETED|Period 2||4
11005825|NCT00724945|12183605|FG001|NOT COMPLETED|Period 2||0
11005826|NCT00724958|12183611|FG000|STARTED|Overall Study||348
11005827|NCT00724958|12183611|FG000|COMPLETED|Overall Study||166
11005828|NCT00724958|12183611|FG000|NOT COMPLETED|Overall Study||182
11005829|NCT00724971|12183615|FG000|STARTED|Overall Study||10
11005830|NCT00724971|12183615|FG000|COMPLETED|Overall Study||4
11005831|NCT00724971|12183615|FG000|NOT COMPLETED|Overall Study||6
11005832|NCT00724984|12183625|FG000|STARTED|Overall Study||5
11375587|NCT03341273|12570935|FG001|STARTED|Overall Study||250
11375588|NCT03341273|12570934|FG000|COMPLETED|Overall Study||229
11375589|NCT03341273|12570935|FG001|COMPLETED|Overall Study||238
11375590|NCT03341273|12570934|FG000|NOT COMPLETED|Overall Study||20
11375591|NCT03341273|12570935|FG001|NOT COMPLETED|Overall Study||12
11375592|NCT03341299|12570941|FG000|STARTED|Period 1||9
11375593|NCT03341299|12570942|FG001|STARTED|Period 1||9
11375594|NCT03341299|12570943|FG002|STARTED|Period 1||9
11375595|NCT03341299|12570944|FG003|STARTED|Period 1||9
11375596|NCT03341299|12570941|FG000|COMPLETED|Period 1||9
11375597|NCT03341299|12570942|FG001|COMPLETED|Period 1||9
11375598|NCT03341299|12570943|FG002|COMPLETED|Period 1||9
11375599|NCT03341299|12570944|FG003|COMPLETED|Period 1||9
11375600|NCT03341299|12570941|FG000|NOT COMPLETED|Period 1||0
11375601|NCT03341299|12570942|FG001|NOT COMPLETED|Period 1||0
11375602|NCT03341299|12570943|FG002|NOT COMPLETED|Period 1||0
11375603|NCT03341299|12570944|FG003|NOT COMPLETED|Period 1||0
11375604|NCT03341299|12570941|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
11375605|NCT03341299|12570942|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
11375606|NCT03341299|12570943|FG002|STARTED|Washout (A Minimum of 21 Hours)||9
11375607|NCT03341299|12570944|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
11375608|NCT03341299|12570941|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
11375609|NCT03341299|12570942|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
11375610|NCT03341299|12570943|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
11375611|NCT03341299|12570944|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
11375612|NCT03341299|12570941|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
11375613|NCT03341299|12570942|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
11375614|NCT03341299|12570943|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||1
11375615|NCT03341299|12570944|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
11375616|NCT03341299|12570941|FG000|STARTED|Period 2||9
11375617|NCT03341299|12570942|FG001|STARTED|Period 2||9
11375618|NCT03341299|12570943|FG002|STARTED|Period 2||8
11375619|NCT03341299|12570944|FG003|STARTED|Period 2||9
11375620|NCT03341299|12570941|FG000|COMPLETED|Period 2||9
11375621|NCT03341299|12570942|FG001|COMPLETED|Period 2||9
11375622|NCT03341299|12570943|FG002|COMPLETED|Period 2||8
11375623|NCT03341299|12570944|FG003|COMPLETED|Period 2||9
11375624|NCT03341299|12570941|FG000|NOT COMPLETED|Period 2||0
11375625|NCT03341299|12570942|FG001|NOT COMPLETED|Period 2||0
11375626|NCT03341299|12570943|FG002|NOT COMPLETED|Period 2||0
11375627|NCT03341299|12570944|FG003|NOT COMPLETED|Period 2||0
11375628|NCT03341299|12570941|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
11375629|NCT03341299|12570942|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
11375630|NCT03341299|12570943|FG002|STARTED|Washout (A Minimum of 21 Hours)||8
11375631|NCT03341299|12570944|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
11375632|NCT03341299|12570941|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
11375633|NCT03341299|12570942|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
11375634|NCT03341299|12570943|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
11375635|NCT03341299|12570944|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
11375636|NCT03341299|12570941|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
11375637|NCT03341299|12570942|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
11375638|NCT03341299|12570943|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
11375639|NCT03341299|12570944|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
11375640|NCT03341299|12570941|FG000|STARTED|Period 3||9
11375641|NCT03341299|12570942|FG001|STARTED|Period 3||9
11375642|NCT03341299|12570943|FG002|STARTED|Period 3||8
11375643|NCT03341299|12570944|FG003|STARTED|Period 3||9
11375644|NCT03341299|12570941|FG000|COMPLETED|Period 3||9
11375645|NCT03341299|12570942|FG001|COMPLETED|Period 3||9
11375646|NCT03341299|12570943|FG002|COMPLETED|Period 3||8
11375647|NCT03341299|12570944|FG003|COMPLETED|Period 3||9
11375648|NCT03341299|12570941|FG000|NOT COMPLETED|Period 3||0
11375649|NCT03341299|12570942|FG001|NOT COMPLETED|Period 3||0
11375650|NCT03341299|12570943|FG002|NOT COMPLETED|Period 3||0
11375651|NCT03341299|12570944|FG003|NOT COMPLETED|Period 3||0
11375652|NCT03341299|12570941|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
11375653|NCT03341299|12570942|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
11375654|NCT03341299|12570943|FG002|STARTED|Washout (A Minimum of 21 Hours)||8
11375655|NCT03341299|12570944|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
11375656|NCT03341299|12570941|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
11375657|NCT03341299|12570942|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
11375658|NCT03341299|12570943|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
11375659|NCT03341299|12570944|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
11375660|NCT03341299|12570941|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
11375661|NCT03341299|12570942|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
11375662|NCT03341299|12570943|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
11375663|NCT03341299|12570944|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
11375664|NCT03341299|12570941|FG000|STARTED|Period 4||9
11375665|NCT03341299|12570942|FG001|STARTED|Period 4||9
11375666|NCT03341299|12570943|FG002|STARTED|Period 4||8
11375667|NCT03341299|12570944|FG003|STARTED|Period 4||9
11375668|NCT03341299|12570941|FG000|COMPLETED|Period 4||9
11375669|NCT03341299|12570942|FG001|COMPLETED|Period 4||9
11375670|NCT03341299|12570943|FG002|COMPLETED|Period 4||8
11375671|NCT03341299|12570944|FG003|COMPLETED|Period 4||9
11375672|NCT03341299|12570941|FG000|NOT COMPLETED|Period 4||0
11375673|NCT03341299|12570942|FG001|NOT COMPLETED|Period 4||0
11375674|NCT03341299|12570943|FG002|NOT COMPLETED|Period 4||0
11375675|NCT03341299|12570944|FG003|NOT COMPLETED|Period 4||0
11375676|NCT03341312|12570956|FG000|STARTED|Period 1||9
11375677|NCT03341312|12570957|FG001|STARTED|Period 1||10
11375678|NCT03341312|12570958|FG002|STARTED|Period 1||9
11375679|NCT03341312|12570959|FG003|STARTED|Period 1||8
11375680|NCT03341312|12570956|FG000|Received at Least One Dose of Study Drug|Period 1||9
11375681|NCT03341312|12570957|FG001|Received at Least One Dose of Study Drug|Period 1||10
11375682|NCT03341312|12570958|FG002|Received at Least One Dose of Study Drug|Period 1||9
11375683|NCT03341312|12570959|FG003|Received at Least One Dose of Study Drug|Period 1||8
11375684|NCT03341312|12570956|FG000|COMPLETED|Period 1||9
11375685|NCT03341312|12570957|FG001|COMPLETED|Period 1||9
11375686|NCT03341312|12570958|FG002|COMPLETED|Period 1||9
11375687|NCT03341312|12570959|FG003|COMPLETED|Period 1||8
11375688|NCT03341312|12570956|FG000|NOT COMPLETED|Period 1||0
11375689|NCT03341312|12570957|FG001|NOT COMPLETED|Period 1||1
11375690|NCT03341312|12570958|FG002|NOT COMPLETED|Period 1||0
11375691|NCT03341312|12570959|FG003|NOT COMPLETED|Period 1||0
11375692|NCT03341312|12570956|FG000|STARTED|Period 2||9
11375693|NCT03341312|12570957|FG001|STARTED|Period 2||9
11375694|NCT03341312|12570958|FG002|STARTED|Period 2||9
11375695|NCT03341312|12570959|FG003|STARTED|Period 2||8
11375696|NCT03341312|12570956|FG000|COMPLETED|Period 2||9
11375697|NCT03341312|12570957|FG001|COMPLETED|Period 2||9
11375698|NCT03341312|12570958|FG002|COMPLETED|Period 2||9
11375699|NCT03341312|12570959|FG003|COMPLETED|Period 2||8
11375700|NCT03341312|12570956|FG000|NOT COMPLETED|Period 2||0
11375701|NCT03341312|12570957|FG001|NOT COMPLETED|Period 2||0
11375702|NCT03341312|12570958|FG002|NOT COMPLETED|Period 2||0
11375703|NCT03341312|12570959|FG003|NOT COMPLETED|Period 2||0
11375704|NCT03341312|12570956|FG000|STARTED|Period 3||9
11375705|NCT03341312|12570957|FG001|STARTED|Period 3||9
11375706|NCT03341312|12570958|FG002|STARTED|Period 3||9
11375707|NCT03341312|12570959|FG003|STARTED|Period 3||8
11375708|NCT03341312|12570956|FG000|COMPLETED|Period 3||9
11375709|NCT03341312|12570957|FG001|COMPLETED|Period 3||9
11375710|NCT03341312|12570958|FG002|COMPLETED|Period 3||9
11375711|NCT03341312|12570959|FG003|COMPLETED|Period 3||8
11375712|NCT03341312|12570956|FG000|NOT COMPLETED|Period 3||0
11375713|NCT03341312|12570957|FG001|NOT COMPLETED|Period 3||0
11375714|NCT03341312|12570958|FG002|NOT COMPLETED|Period 3||0
11375715|NCT03341312|12570959|FG003|NOT COMPLETED|Period 3||0
11375716|NCT03341312|12570956|FG000|STARTED|Period 4||9
11375717|NCT03341312|12570957|FG001|STARTED|Period 4||9
11375718|NCT03341312|12570958|FG002|STARTED|Period 4||9
11375719|NCT03341312|12570959|FG003|STARTED|Period 4||8
11375720|NCT03341312|12570956|FG000|COMPLETED|Period 4||9
11375721|NCT03341312|12570957|FG001|COMPLETED|Period 4||9
11375722|NCT03341312|12570958|FG002|COMPLETED|Period 4||9
11375723|NCT03341312|12570959|FG003|COMPLETED|Period 4||8
11375724|NCT03341312|12570956|FG000|NOT COMPLETED|Period 4||0
11375725|NCT03341312|12570957|FG001|NOT COMPLETED|Period 4||0
11375726|NCT03341312|12570958|FG002|NOT COMPLETED|Period 4||0
11375727|NCT03341312|12570959|FG003|NOT COMPLETED|Period 4||0
11375728|NCT03341507|12570971|FG000|STARTED|Overall Study||64
11375729|NCT03341507|12570971|FG000|COMPLETED|Overall Study||30
11375730|NCT03341507|12570971|FG000|NOT COMPLETED|Overall Study||34
11375731|NCT03341533|12570977|FG000|STARTED|Overall Study||72
11375732|NCT03341533|12570978|FG001|STARTED|Overall Study||70
11375733|NCT03341533|12570977|FG000|COMPLETED|Overall Study||69
11375734|NCT03341533|12570978|FG001|COMPLETED|Overall Study||68
11375735|NCT03341533|12570977|FG000|NOT COMPLETED|Overall Study||3
11375736|NCT03341533|12570978|FG001|NOT COMPLETED|Overall Study||2
11375737|NCT03341546|12570984|FG000|STARTED|Overall Study||20
11375738|NCT03341546|12570984|FG000|COMPLETED|Overall Study||20
11375739|NCT03341546|12570984|FG000|NOT COMPLETED|Overall Study||0
11375740|NCT03341637|12570990|FG000|STARTED|Overall Study||100
11375741|NCT03341637|12570991|FG001|STARTED|Overall Study||300
11375742|NCT03341637|12570990|FG000|COMPLETED|Overall Study||95
11375743|NCT03341637|12570991|FG001|COMPLETED|Overall Study||296
11375744|NCT03341637|12570990|FG000|NOT COMPLETED|Overall Study||5
11375745|NCT03341637|12570991|FG001|NOT COMPLETED|Overall Study||4
11375746|NCT03341728|12570997|FG000|STARTED|Session 1||7
11375747|NCT03341728|12570998|FG001|STARTED|Session 1||7
11375748|NCT03341728|12570997|FG000|COMPLETED|Session 1||7
11375749|NCT03341728|12570998|FG001|COMPLETED|Session 1||7
11375750|NCT03341728|12570997|FG000|NOT COMPLETED|Session 1||0
11375751|NCT03341728|12570998|FG001|NOT COMPLETED|Session 1||0
11375752|NCT03341728|12570997|FG000|STARTED|Washout (1 Week)||7
11375753|NCT03341728|12570998|FG001|STARTED|Washout (1 Week)||7
11375754|NCT03341728|12570997|FG000|COMPLETED|Washout (1 Week)||7
11375755|NCT03341728|12570998|FG001|COMPLETED|Washout (1 Week)||7
11375756|NCT03341728|12570997|FG000|NOT COMPLETED|Washout (1 Week)||0
11375757|NCT03341728|12570998|FG001|NOT COMPLETED|Washout (1 Week)||0
11375758|NCT03341728|12570997|FG000|STARTED|Session 2||7
11375759|NCT03341728|12570998|FG001|STARTED|Session 2||7
11375760|NCT03341728|12570997|FG000|COMPLETED|Session 2||7
11375761|NCT03341728|12570998|FG001|COMPLETED|Session 2||7
11375762|NCT03341728|12570997|FG000|NOT COMPLETED|Session 2||0
11375763|NCT03341728|12570998|FG001|NOT COMPLETED|Session 2||0
11375764|NCT03341910|12571008|FG000|STARTED|Overall Study||54
11375765|NCT03341910|12571009|FG001|STARTED|Overall Study||49
11375766|NCT03341910|12571010|FG002|STARTED|Overall Study||26
11375767|NCT03341910|12571011|FG003|STARTED|Overall Study||26
11375768|NCT03341910|12571008|FG000|COMPLETED|Overall Study||54
11375769|NCT03341910|12571009|FG001|COMPLETED|Overall Study||49
11375770|NCT03341910|12571010|FG002|COMPLETED|Overall Study||26
11375771|NCT03341910|12571011|FG003|COMPLETED|Overall Study||26
11375772|NCT03341910|12571008|FG000|NOT COMPLETED|Overall Study||0
11375773|NCT03341910|12571009|FG001|NOT COMPLETED|Overall Study||0
11375774|NCT03341910|12571010|FG002|NOT COMPLETED|Overall Study||0
11375775|NCT03341910|12571011|FG003|NOT COMPLETED|Overall Study||0
11375776|NCT03341923|12571021|FG000|STARTED|Period 1, First 14 Days of Wear||67
11375777|NCT03341923|12571022|FG001|STARTED|Period 1, First 14 Days of Wear||67
11375778|NCT03341923|12571021|FG000|COMPLETED|Period 1, First 14 Days of Wear||67
11375779|NCT03341923|12571022|FG001|COMPLETED|Period 1, First 14 Days of Wear||67
11005833|NCT00724984|12183626|FG001|STARTED|Overall Study||8
11005834|NCT00724984|12183627|FG002|STARTED|Overall Study||3
11005835|NCT00724984|12183628|FG003|STARTED|Overall Study||9
11005836|NCT00724984|12183629|FG004|STARTED|Overall Study||16
11005837|NCT00724984|12183630|FG005|STARTED|Overall Study||14
11005838|NCT00724984|12183625|FG000|COMPLETED|Overall Study||4
11375780|NCT03341923|12571021|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0
11375781|NCT03341923|12571022|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||0
11375782|NCT03341923|12571021|FG000|STARTED|Period 2, Second 14 Days of Wear||67
11375783|NCT03341923|12571022|FG001|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66
11375784|NCT03341923|12571021|FG000|COMPLETED|Period 2, Second 14 Days of Wear||67
11375785|NCT03341923|12571022|FG001|COMPLETED|Period 2, Second 14 Days of Wear||65
11375786|NCT03341923|12571021|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
11375787|NCT03341923|12571022|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||1
11375788|NCT03341975|12571032|FG000|STARTED|Overall Study||44
11375789|NCT03341975|12571033|FG001|STARTED|Overall Study||47
11375790|NCT03341975|12571032|FG000|COMPLETED|Overall Study||44
11375791|NCT03341975|12571033|FG001|COMPLETED|Overall Study||47
11375792|NCT03341975|12571032|FG000|NOT COMPLETED|Overall Study||0
11375793|NCT03341975|12571033|FG001|NOT COMPLETED|Overall Study||0
11375794|NCT03342469|12571041|FG000|STARTED|Overall Study||9
11375795|NCT03342469|12571042|FG001|STARTED|Overall Study||9
11375796|NCT03342469|12571043|FG002|STARTED|Overall Study||3
11375797|NCT03342469|12571044|FG003|STARTED|Overall Study||8
11375798|NCT03342469|12571041|FG000|COMPLETED|Overall Study||9
11375799|NCT03342469|12571042|FG001|COMPLETED|Overall Study||8
11375800|NCT03342469|12571043|FG002|COMPLETED|Overall Study||3
11375801|NCT03342469|12571044|FG003|COMPLETED|Overall Study||8
11375802|NCT03342469|12571041|FG000|NOT COMPLETED|Overall Study||0
11375803|NCT03342469|12571042|FG001|NOT COMPLETED|Overall Study||1
11375804|NCT03342469|12571043|FG002|NOT COMPLETED|Overall Study||0
11375805|NCT03342469|12571044|FG003|NOT COMPLETED|Overall Study||0
11375806|NCT03342560|12571055|FG000|STARTED|Overall Study||30
11375807|NCT03342560|12571055|FG000|COMPLETED|Overall Study||28
11375808|NCT03342560|12571055|FG000|NOT COMPLETED|Overall Study||2
11375809|NCT03342690|12571063|FG000|STARTED|Overall Study||1164
11375810|NCT03342690|12571063|FG000|COMPLETED|Overall Study||1139
11375811|NCT03342690|12571063|FG000|NOT COMPLETED|Overall Study||25
11375812|NCT03342898|12571070|FG000|STARTED|Overall Study||300
11375813|NCT03342898|12571071|FG001|STARTED|Overall Study||300
11375814|NCT03342898|12571072|FG002|STARTED|Overall Study||300
11375815|NCT03342898|12571070|FG000|COMPLETED|Overall Study||246
11375816|NCT03342898|12571071|FG001|COMPLETED|Overall Study||247
11375817|NCT03342898|12571072|FG002|COMPLETED|Overall Study||246
11375818|NCT03342898|12571070|FG000|NOT COMPLETED|Overall Study||54
11375819|NCT03342898|12571071|FG001|NOT COMPLETED|Overall Study||53
11375820|NCT03342898|12571072|FG002|NOT COMPLETED|Overall Study||54
11375821|NCT03342963|12571084|FG000|STARTED|Overall Study||27
11375822|NCT03342963|12571085|FG001|STARTED|Overall Study||27
11375823|NCT03342963|12571086|FG002|STARTED|Overall Study||10
11375824|NCT03342963|12571087|FG003|STARTED|Overall Study||10
11375825|NCT03342963|12571084|FG000|COMPLETED|Overall Study||25
11375826|NCT03342963|12571085|FG001|COMPLETED|Overall Study||25
11375827|NCT03342963|12571086|FG002|COMPLETED|Overall Study||10
11375828|NCT03342963|12571087|FG003|COMPLETED|Overall Study||10
11375829|NCT03342963|12571084|FG000|NOT COMPLETED|Overall Study||2
11375830|NCT03342963|12571085|FG001|NOT COMPLETED|Overall Study||2
11375831|NCT03342963|12571086|FG002|NOT COMPLETED|Overall Study||0
11375832|NCT03342963|12571087|FG003|NOT COMPLETED|Overall Study||0
11375833|NCT03343067|12571100|FG000|STARTED|Open Label Period: Day 1 to Month 3||7
11375834|NCT03343067|12571101|FG001|STARTED|Open Label Period: Day 1 to Month 3||3
11375835|NCT03343067|12571102|FG002|STARTED|Open Label Period: Day 1 to Month 3||1
11375836|NCT03343067|12571100|FG000|COMPLETED|Open Label Period: Day 1 to Month 3||0
11375837|NCT03343067|12571101|FG001|COMPLETED|Open Label Period: Day 1 to Month 3||3
11375838|NCT03343067|12571102|FG002|COMPLETED|Open Label Period: Day 1 to Month 3||1
11375839|NCT03343067|12571100|FG000|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7
11375840|NCT03343067|12571101|FG001|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
11005839|NCT00724984|12183626|FG001|COMPLETED|Overall Study||7
11375841|NCT03343067|12571102|FG002|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
11375842|NCT03343067|12571100|FG000|STARTED|Double Blind Period: Month 3 to Month 6||0
11375843|NCT03343067|12571101|FG001|STARTED|Double Blind Period: Month 3 to Month 6||3
11375844|NCT03343067|12571102|FG002|STARTED|Double Blind Period: Month 3 to Month 6||1
11375845|NCT03343067|12571100|FG000|COMPLETED|Double Blind Period: Month 3 to Month 6||0
11375846|NCT03343067|12571101|FG001|COMPLETED|Double Blind Period: Month 3 to Month 6||0
11375847|NCT03343067|12571102|FG002|COMPLETED|Double Blind Period: Month 3 to Month 6||0
11375848|NCT03343067|12571100|FG000|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0
11375849|NCT03343067|12571101|FG001|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3
11375850|NCT03343067|12571102|FG002|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1
11375851|NCT03343080|12571112|FG000|STARTED|Overall Study||14
11375852|NCT03343080|12571113|FG001|STARTED|Overall Study||18
11375853|NCT03343080|12571112|FG000|COMPLETED|Overall Study||14
11375854|NCT03343080|12571113|FG001|COMPLETED|Overall Study||18
11375855|NCT03343080|12571112|FG000|NOT COMPLETED|Overall Study||0
11375856|NCT03343080|12571113|FG001|NOT COMPLETED|Overall Study||0
11375857|NCT03343639|12571121|FG000|STARTED|Overall Study||102
11375858|NCT03343639|12571122|FG001|STARTED|Overall Study||102
11375859|NCT03343639|12571121|FG000|COMPLETED|Overall Study||88
11375860|NCT03343639|12571122|FG001|COMPLETED|Overall Study||90
11375861|NCT03343639|12571121|FG000|NOT COMPLETED|Overall Study||14
11375862|NCT03343639|12571122|FG001|NOT COMPLETED|Overall Study||12
11375863|NCT03344172|12571130|FG000|STARTED|Overall Study||16
11375864|NCT03344172|12571131|FG001|STARTED|Overall Study||16
11375865|NCT03344172|12571130|FG000|COMPLETED|Overall Study||15
11375866|NCT03344172|12571131|FG001|COMPLETED|Overall Study||16
11375867|NCT03344172|12571130|FG000|NOT COMPLETED|Overall Study||1
11375868|NCT03344172|12571131|FG001|NOT COMPLETED|Overall Study||0
11375869|NCT03344510|12571137|FG000|STARTED|First Injection (5 Minutes)||21
11375870|NCT03344510|12571138|FG001|STARTED|First Injection (5 Minutes)||26
11375871|NCT03344510|12571137|FG000|Received Injection|First Injection (5 Minutes)||21
11375872|NCT03344510|12571138|FG001|Received Injection|First Injection (5 Minutes)||26
11375873|NCT03344510|12571137|FG000|COMPLETED|First Injection (5 Minutes)||21
11375874|NCT03344510|12571138|FG001|COMPLETED|First Injection (5 Minutes)||26
11375875|NCT03344510|12571137|FG000|NOT COMPLETED|First Injection (5 Minutes)||0
11375876|NCT03344510|12571138|FG001|NOT COMPLETED|First Injection (5 Minutes)||0
11375877|NCT03344510|12571137|FG000|STARTED|Wash Out (10 Minutes||21
11375878|NCT03344510|12571138|FG001|STARTED|Wash Out (10 Minutes||26
11375879|NCT03344510|12571137|FG000|COMPLETED|Wash Out (10 Minutes||21
11375880|NCT03344510|12571138|FG001|COMPLETED|Wash Out (10 Minutes||26
11375881|NCT03344510|12571137|FG000|NOT COMPLETED|Wash Out (10 Minutes||0
11375882|NCT03344510|12571138|FG001|NOT COMPLETED|Wash Out (10 Minutes||0
11375883|NCT03344510|12571137|FG000|STARTED|Second Injection (5 Minutes)||21
11375884|NCT03344510|12571138|FG001|STARTED|Second Injection (5 Minutes)||26
11375885|NCT03344510|12571137|FG000|Received Injection|Second Injection (5 Minutes)||21
11375886|NCT03344510|12571138|FG001|Received Injection|Second Injection (5 Minutes)||26
11375887|NCT03344510|12571137|FG000|COMPLETED|Second Injection (5 Minutes)||21
11375888|NCT03344510|12571138|FG001|COMPLETED|Second Injection (5 Minutes)||26
11375889|NCT03344510|12571137|FG000|NOT COMPLETED|Second Injection (5 Minutes)||0
11375890|NCT03344510|12571138|FG001|NOT COMPLETED|Second Injection (5 Minutes)||0
11375891|NCT03344640|12571147|FG000|STARTED|Overall Study||49
11375892|NCT03344640|12571148|FG001|STARTED|Overall Study||47
11375893|NCT03344640|12571147|FG000|COMPLETED|Overall Study||46
11375894|NCT03344640|12571148|FG001|COMPLETED|Overall Study||44
11375895|NCT03344640|12571147|FG000|NOT COMPLETED|Overall Study||3
11375896|NCT03344640|12571148|FG001|NOT COMPLETED|Overall Study||3
11375897|NCT03344640|12571147|FG000|STARTED|Follow-up Epoch||46
11375898|NCT03344640|12571148|FG001|STARTED|Follow-up Epoch||44
11375899|NCT03344640|12571147|FG000|COMPLETED|Follow-up Epoch||46
11375900|NCT03344640|12571148|FG001|COMPLETED|Follow-up Epoch||42
11375901|NCT03344640|12571147|FG000|NOT COMPLETED|Follow-up Epoch||0
11375902|NCT03344640|12571148|FG001|NOT COMPLETED|Follow-up Epoch||2
11375903|NCT03344861|12571154|FG000|STARTED|Overall Study||10
11375904|NCT03344861|12571154|FG000|COMPLETED|Overall Study||10
11375905|NCT03344861|12571154|FG000|NOT COMPLETED|Overall Study||0
11375906|NCT03345108|12571158|FG000|STARTED|Period-1||8
11375907|NCT03345108|12571159|FG001|STARTED|Period-1||8
11375908|NCT03345108|12571160|FG002|STARTED|Period-1||8
11005840|NCT00724984|12183627|FG002|COMPLETED|Overall Study||3
11005841|NCT00724984|12183628|FG003|COMPLETED|Overall Study||7
11005842|NCT00724984|12183629|FG004|COMPLETED|Overall Study||12
11005843|NCT00724984|12183630|FG005|COMPLETED|Overall Study||9
11005844|NCT00724984|12183625|FG000|NOT COMPLETED|Overall Study||1
11005845|NCT00724984|12183626|FG001|NOT COMPLETED|Overall Study||1
11005846|NCT00724984|12183627|FG002|NOT COMPLETED|Overall Study||0
11005847|NCT00724984|12183628|FG003|NOT COMPLETED|Overall Study||2
11005848|NCT00724984|12183629|FG004|NOT COMPLETED|Overall Study||4
11005849|NCT00724984|12183630|FG005|NOT COMPLETED|Overall Study||5
11005850|NCT00725010|12183644|FG000|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
11005851|NCT00725010|12183644|FG000|COMPLETED|Overall Study||25
11005852|NCT00725010|12183644|FG000|NOT COMPLETED|Overall Study||25
11005853|NCT00725075|12183653|FG000|STARTED|Overall Study||72
11005854|NCT00725075|12183654|FG001|STARTED|Overall Study||73
11005855|NCT00725075|12183655|FG002|STARTED|Overall Study||70
11005856|NCT00725075|12183653|FG000|Treated|Overall Study||71
11005857|NCT00725075|12183654|FG001|Treated|Overall Study||73
11005858|NCT00725075|12183655|FG002|Treated|Overall Study||70
11005859|NCT00725075|12183653|FG000|COMPLETED|Overall Study||61
11375909|NCT03345108|12571161|FG003|STARTED|Period-1||8
11375910|NCT03345108|12571162|FG004|STARTED|Period-1||8
11375911|NCT03345108|12571163|FG005|STARTED|Period-1||8
11375912|NCT03345108|12571158|FG000|COMPLETED|Period-1||8
11375913|NCT03345108|12571159|FG001|COMPLETED|Period-1||8
11375914|NCT03345108|12571160|FG002|COMPLETED|Period-1||8
11375915|NCT03345108|12571161|FG003|COMPLETED|Period-1||8
11375916|NCT03345108|12571162|FG004|COMPLETED|Period-1||8
11375917|NCT03345108|12571163|FG005|COMPLETED|Period-1||8
11375918|NCT03345108|12571158|FG000|NOT COMPLETED|Period-1||0
11375919|NCT03345108|12571159|FG001|NOT COMPLETED|Period-1||0
11375920|NCT03345108|12571160|FG002|NOT COMPLETED|Period-1||0
11375921|NCT03345108|12571161|FG003|NOT COMPLETED|Period-1||0
11375922|NCT03345108|12571162|FG004|NOT COMPLETED|Period-1||0
11375923|NCT03345108|12571163|FG005|NOT COMPLETED|Period-1||0
11375924|NCT03345108|12571158|FG000|STARTED|Period-2||8
11375925|NCT03345108|12571159|FG001|STARTED|Period-2||8
11375926|NCT03345108|12571160|FG002|STARTED|Period-2||8
11375927|NCT03345108|12571161|FG003|STARTED|Period-2||8
11375928|NCT03345108|12571162|FG004|STARTED|Period-2||8
11375929|NCT03345108|12571163|FG005|STARTED|Period-2||8
11375930|NCT03345108|12571158|FG000|COMPLETED|Period-2||8
11375931|NCT03345108|12571159|FG001|COMPLETED|Period-2||8
11375932|NCT03345108|12571160|FG002|COMPLETED|Period-2||8
11375933|NCT03345108|12571161|FG003|COMPLETED|Period-2||8
11375934|NCT03345108|12571162|FG004|COMPLETED|Period-2||8
11375935|NCT03345108|12571163|FG005|COMPLETED|Period-2||8
11375936|NCT03345108|12571158|FG000|NOT COMPLETED|Period-2||0
11375937|NCT03345108|12571159|FG001|NOT COMPLETED|Period-2||0
11375938|NCT03345108|12571160|FG002|NOT COMPLETED|Period-2||0
11375939|NCT03345108|12571161|FG003|NOT COMPLETED|Period-2||0
11375940|NCT03345108|12571162|FG004|NOT COMPLETED|Period-2||0
11375941|NCT03345108|12571163|FG005|NOT COMPLETED|Period-2||0
11375942|NCT03345108|12571158|FG000|STARTED|Period-3||7
11375943|NCT03345108|12571159|FG001|STARTED|Period-3||8
11375944|NCT03345108|12571160|FG002|STARTED|Period-3||8
11375945|NCT03345108|12571161|FG003|STARTED|Period-3||8
11375946|NCT03345108|12571162|FG004|STARTED|Period-3||8
11375947|NCT03345108|12571163|FG005|STARTED|Period-3||8
11375948|NCT03345108|12571158|FG000|COMPLETED|Period-3||7
11375949|NCT03345108|12571159|FG001|COMPLETED|Period-3||8
11375950|NCT03345108|12571160|FG002|COMPLETED|Period-3||8
11375951|NCT03345108|12571161|FG003|COMPLETED|Period-3||8
11375952|NCT03345108|12571162|FG004|COMPLETED|Period-3||8
11375953|NCT03345108|12571163|FG005|COMPLETED|Period-3||8
11375954|NCT03345108|12571158|FG000|NOT COMPLETED|Period-3||0
11375955|NCT03345108|12571159|FG001|NOT COMPLETED|Period-3||0
11375956|NCT03345108|12571160|FG002|NOT COMPLETED|Period-3||0
11375957|NCT03345108|12571161|FG003|NOT COMPLETED|Period-3||0
11375958|NCT03345108|12571162|FG004|NOT COMPLETED|Period-3||0
11375959|NCT03345108|12571163|FG005|NOT COMPLETED|Period-3||0
11375960|NCT03345160|12571171|FG000|STARTED|Overall Study||7
11375961|NCT03345160|12571171|FG000|COMPLETED|Overall Study||7
11375962|NCT03345160|12571171|FG000|NOT COMPLETED|Overall Study||0
11375963|NCT03345394|12571177|FG000|STARTED|Overall Study||48
11375964|NCT03345394|12571178|FG001|STARTED|Overall Study||50
11375965|NCT03345394|12571177|FG000|COMPLETED|Overall Study||48
11375966|NCT03345394|12571178|FG001|COMPLETED|Overall Study||50
11375967|NCT03345394|12571177|FG000|NOT COMPLETED|Overall Study||0
11375968|NCT03345394|12571178|FG001|NOT COMPLETED|Overall Study||0
11375969|NCT03345407|12571191|FG000|STARTED|Overall Study||276
11375970|NCT03345407|12571192|FG001|STARTED|Overall Study||22
11375971|NCT03345407|12571193|FG002|STARTED|Overall Study||91
11375972|NCT03345407|12571194|FG003|STARTED|Overall Study||92
11375973|NCT03345407|12571195|FG004|STARTED|Overall Study||90
11375974|NCT03345407|12571196|FG005|STARTED|Overall Study||89
11375975|NCT03345407|12571197|FG006|STARTED|Overall Study||278
11375976|NCT03345407|12571191|FG000|COMPLETED|Overall Study||244
11375977|NCT03345407|12571192|FG001|COMPLETED|Overall Study||19
11375978|NCT03345407|12571193|FG002|COMPLETED|Overall Study||79
11375979|NCT03345407|12571194|FG003|COMPLETED|Overall Study||81
11375980|NCT03345407|12571195|FG004|COMPLETED|Overall Study||75
11375981|NCT03345407|12571196|FG005|COMPLETED|Overall Study||73
11375982|NCT03345407|12571197|FG006|COMPLETED|Overall Study||233
11375983|NCT03345407|12571191|FG000|NOT COMPLETED|Overall Study||32
11375984|NCT03345407|12571192|FG001|NOT COMPLETED|Overall Study||3
11375985|NCT03345407|12571193|FG002|NOT COMPLETED|Overall Study||12
11375986|NCT03345407|12571194|FG003|NOT COMPLETED|Overall Study||11
11375987|NCT03345407|12571195|FG004|NOT COMPLETED|Overall Study||15
11375988|NCT03345407|12571196|FG005|NOT COMPLETED|Overall Study||16
11375989|NCT03345407|12571197|FG006|NOT COMPLETED|Overall Study||45
11375990|NCT03345472|12571219|FG000|STARTED|Implant to 3 Months||103
11375991|NCT03345472|12571219|FG000|COMPLETED|Implant to 3 Months||99
11375992|NCT03345472|12571219|FG000|NOT COMPLETED|Implant to 3 Months||4
11375993|NCT03345472|12571219|FG000|STARTED|3 Months to 12 Months||99
11375994|NCT03345472|12571219|FG000|COMPLETED|3 Months to 12 Months||91
11375995|NCT03345472|12571219|FG000|NOT COMPLETED|3 Months to 12 Months||8
11375996|NCT03345914|12571226|FG000|STARTED|Overall Study||123
11375997|NCT03345914|12571227|FG001|STARTED|Overall Study||122
11375998|NCT03345914|12571228|FG002|STARTED|Overall Study||122
11375999|NCT03345914|12571226|FG000|Completed Week 16 Study Treatment|Overall Study||114
11376000|NCT03345914|12571227|FG001|Completed Week 16 Study Treatment|Overall Study||118
11376001|NCT03345914|12571228|FG002|Completed Week 16 Study Treatment|Overall Study||119
11376002|NCT03345914|12571226|FG000|Completed Week 28 End of Study|Overall Study||0
11376003|NCT03345914|12571227|FG001|Completed Week 28 End of Study|Overall Study||0
11376004|NCT03345914|12571228|FG002|Completed Week 28 End of Study|Overall Study||0
11376005|NCT03345914|12571226|FG000|COMPLETED|Overall Study||0
11376006|NCT03345914|12571227|FG001|COMPLETED|Overall Study||0
11376007|NCT03345914|12571228|FG002|COMPLETED|Overall Study||0
11376008|NCT03345914|12571226|FG000|NOT COMPLETED|Overall Study||123
11376009|NCT03345914|12571227|FG001|NOT COMPLETED|Overall Study||122
11376010|NCT03345914|12571228|FG002|NOT COMPLETED|Overall Study||122
11376011|NCT03345979|12571238|FG000|STARTED|Overall Study||99
11376012|NCT03345979|12571239|FG001|STARTED|Overall Study||101
11376013|NCT03345979|12571238|FG000|COMPLETED|Overall Study||56
11376014|NCT03345979|12571239|FG001|COMPLETED|Overall Study||43
11376015|NCT03345979|12571238|FG000|NOT COMPLETED|Overall Study||43
11376016|NCT03345979|12571239|FG001|NOT COMPLETED|Overall Study||58
11376017|NCT03346057|12571249|FG000|STARTED|Overall Study||111
11376018|NCT03346057|12571250|FG001|STARTED|Overall Study||112
11376019|NCT03346057|12571251|FG002|STARTED|Overall Study||68
11376020|NCT03346057|12571252|FG003|STARTED|Overall Study||53
11376021|NCT03346057|12571249|FG000|Treated|Overall Study||105
11376022|NCT03346057|12571250|FG001|Treated|Overall Study||107
11376023|NCT03346057|12571251|FG002|Treated|Overall Study||68
11376024|NCT03346057|12571252|FG003|Treated|Overall Study||51
11376025|NCT03346057|12571249|FG000|COMPLETED|Overall Study||104
11376026|NCT03346057|12571250|FG001|COMPLETED|Overall Study||104
11376027|NCT03346057|12571251|FG002|COMPLETED|Overall Study||67
11376028|NCT03346057|12571252|FG003|COMPLETED|Overall Study||51
11376029|NCT03346057|12571249|FG000|NOT COMPLETED|Overall Study||7
11376030|NCT03346057|12571250|FG001|NOT COMPLETED|Overall Study||8
11376031|NCT03346057|12571251|FG002|NOT COMPLETED|Overall Study||1
11376032|NCT03346057|12571252|FG003|NOT COMPLETED|Overall Study||2
11376033|NCT03346070|12571267|FG000|STARTED|Overall Study||41
11376034|NCT03346070|12571268|FG001|STARTED|Overall Study||41
11376035|NCT03346070|12571269|FG002|STARTED|Overall Study||41
11376036|NCT03346070|12571270|FG003|STARTED|Overall Study||42
11376037|NCT03346070|12571271|FG004|STARTED|Overall Study||42
11376038|NCT03346070|12571267|FG000|Treated|Overall Study||38
11376039|NCT03346070|12571268|FG001|Treated|Overall Study||38
11376040|NCT03346070|12571269|FG002|Treated|Overall Study||38
11376041|NCT03346070|12571270|FG003|Treated|Overall Study||36
11376042|NCT03346070|12571271|FG004|Treated|Overall Study||38
11376043|NCT03346070|12571267|FG000|COMPLETED|Overall Study||38
11376044|NCT03346070|12571268|FG001|COMPLETED|Overall Study||37
11376045|NCT03346070|12571269|FG002|COMPLETED|Overall Study||37
11376046|NCT03346070|12571270|FG003|COMPLETED|Overall Study||36
11376047|NCT03346070|12571271|FG004|COMPLETED|Overall Study||37
11376048|NCT03346070|12571267|FG000|NOT COMPLETED|Overall Study||3
11376049|NCT03346070|12571268|FG001|NOT COMPLETED|Overall Study||4
11376050|NCT03346070|12571269|FG002|NOT COMPLETED|Overall Study||4
11376051|NCT03346070|12571270|FG003|NOT COMPLETED|Overall Study||6
11376052|NCT03346070|12571271|FG004|NOT COMPLETED|Overall Study||5
11376053|NCT03346161|12571287|FG000|STARTED|Overall Study||60
11376054|NCT03346161|12571288|FG001|STARTED|Overall Study||60
11376055|NCT03346161|12571287|FG000|COMPLETED|Overall Study||60
11376056|NCT03346161|12571288|FG001|COMPLETED|Overall Study||60
11376057|NCT03346161|12571287|FG000|NOT COMPLETED|Overall Study||0
11376058|NCT03346161|12571288|FG001|NOT COMPLETED|Overall Study||0
11376059|NCT03346759|12571296|FG000|STARTED|Enrollment to Baseline Data Collected||15
11376060|NCT03346759|12571297|FG001|STARTED|Enrollment to Baseline Data Collected||13
11376061|NCT03346759|12571296|FG000|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
11376062|NCT03346759|12571297|FG001|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
11376063|NCT03346759|12571296|FG000|NOT COMPLETED|Enrollment to Baseline Data Collected||2
11376064|NCT03346759|12571297|FG001|NOT COMPLETED|Enrollment to Baseline Data Collected||3
11376065|NCT03346759|12571296|FG000|STARTED|First Menstrual Cycle||13
11376066|NCT03346759|12571297|FG001|STARTED|First Menstrual Cycle||10
11376067|NCT03346759|12571296|FG000|COMPLETED|First Menstrual Cycle||12
11376068|NCT03346759|12571297|FG001|COMPLETED|First Menstrual Cycle||10
11376069|NCT03346759|12571296|FG000|NOT COMPLETED|First Menstrual Cycle||1
11376070|NCT03346759|12571297|FG001|NOT COMPLETED|First Menstrual Cycle||0
11376071|NCT03346759|12571296|FG000|STARTED|Second Menstrual Cycle||12
11376072|NCT03346759|12571297|FG001|STARTED|Second Menstrual Cycle||10
11376073|NCT03346759|12571296|FG000|COMPLETED|Second Menstrual Cycle||11
11376074|NCT03346759|12571297|FG001|COMPLETED|Second Menstrual Cycle||10
11376075|NCT03346759|12571296|FG000|NOT COMPLETED|Second Menstrual Cycle||1
11376076|NCT03346759|12571297|FG001|NOT COMPLETED|Second Menstrual Cycle||0
11376077|NCT03346759|12571296|FG000|STARTED|Third Menstrual Cycle||11
11376078|NCT03346759|12571297|FG001|STARTED|Third Menstrual Cycle||10
11376079|NCT03346759|12571296|FG000|COMPLETED|Third Menstrual Cycle||11
11376080|NCT03346759|12571297|FG001|COMPLETED|Third Menstrual Cycle||10
11376081|NCT03346759|12571296|FG000|NOT COMPLETED|Third Menstrual Cycle||0
11376082|NCT03346759|12571297|FG001|NOT COMPLETED|Third Menstrual Cycle||0
11376083|NCT03346850|12571306|FG000|STARTED|Overall Study||20
11376084|NCT03346850|12571307|FG001|STARTED|Overall Study||20
11376085|NCT03346850|12571306|FG000|COMPLETED|Overall Study||18
11376086|NCT03346850|12571307|FG001|COMPLETED|Overall Study||17
11376087|NCT03346850|12571306|FG000|NOT COMPLETED|Overall Study||2
11376088|NCT03346850|12571307|FG001|NOT COMPLETED|Overall Study||3
11376089|NCT03346902|12571315|FG000|STARTED|Overall Study||4
11376090|NCT03346902|12571316|FG001|STARTED|Overall Study||8
11376091|NCT03346902|12571315|FG000|COMPLETED|Overall Study||4
11376092|NCT03346902|12571316|FG001|COMPLETED|Overall Study||8
11376093|NCT03346902|12571315|FG000|NOT COMPLETED|Overall Study||0
11376094|NCT03346902|12571316|FG001|NOT COMPLETED|Overall Study||0
11376095|NCT03347188|12571324|FG000|STARTED|Double-blind (DB) Period (12 Weeks)||44
11376096|NCT03347188|12571325|FG001|STARTED|Double-blind (DB) Period (12 Weeks)||43
11376097|NCT03347188|12571324|FG000|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
11376098|NCT03347188|12571325|FG001|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
11376099|NCT03347188|12571324|FG000|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||42
11376100|NCT03347188|12571325|FG001|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||43
11376101|NCT03347188|12571324|FG000|COMPLETED|Double-blind (DB) Period (12 Weeks)||29
11376102|NCT03347188|12571325|FG001|COMPLETED|Double-blind (DB) Period (12 Weeks)||26
11376103|NCT03347188|12571324|FG000|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||15
11376104|NCT03347188|12571325|FG001|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||17
11376105|NCT03347188|12571324|FG000|STARTED|Open-label (OL) Period (12 Weeks)||35
11376106|NCT03347188|12571325|FG001|STARTED|Open-label (OL) Period (12 Weeks)||35
11376107|NCT03347188|12571324|FG000|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||26
11376108|NCT03347188|12571325|FG001|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||28
11376109|NCT03347188|12571324|FG000|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||9
11376110|NCT03347188|12571325|FG001|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||7
11376111|NCT03347188|12571324|FG000|COMPLETED|Open-label (OL) Period (12 Weeks)||8
11376112|NCT03347188|12571325|FG001|COMPLETED|Open-label (OL) Period (12 Weeks)||6
11376113|NCT03347188|12571324|FG000|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||27
11376114|NCT03347188|12571325|FG001|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||29
11376115|NCT03347279|12571333|FG000|STARTED|Overall Study||529
11376116|NCT03347279|12571334|FG001|STARTED|Overall Study||532
11376117|NCT03347279|12571333|FG000|Received Treatment|Overall Study||528
11376118|NCT03347279|12571334|FG001|Received Treatment|Overall Study||531
11376119|NCT03347279|12571333|FG000|COMPLETED|Overall Study||513
11376120|NCT03347279|12571334|FG001|COMPLETED|Overall Study||509
11376121|NCT03347279|12571333|FG000|NOT COMPLETED|Overall Study||16
11376122|NCT03347279|12571334|FG001|NOT COMPLETED|Overall Study||23
11376123|NCT03347695|12571342|FG000|STARTED|Overall Study||20
11376124|NCT03347695|12571343|FG001|STARTED|Overall Study||120
11376125|NCT03347695|12571342|FG000|COMPLETED|Overall Study||20
11376126|NCT03347695|12571343|FG001|COMPLETED|Overall Study||115
11376127|NCT03347695|12571342|FG000|NOT COMPLETED|Overall Study||0
11376128|NCT03347695|12571343|FG001|NOT COMPLETED|Overall Study||5
11376129|NCT03348683|12571353|FG000|STARTED|Overall Study||121
11376130|NCT03348683|12571354|FG001|STARTED|Overall Study||119
11376131|NCT03348683|12571353|FG000|COMPLETED|Overall Study||121
11376132|NCT03348683|12571354|FG001|COMPLETED|Overall Study||119
11376133|NCT03348683|12571353|FG000|NOT COMPLETED|Overall Study||0
11376134|NCT03348683|12571354|FG001|NOT COMPLETED|Overall Study||0
11376135|NCT03349034|12571362|FG000|STARTED|Overall Study||12
11376136|NCT03349034|12571363|FG001|STARTED|Overall Study||12
11376137|NCT03349034|12571362|FG000|COMPLETED|Overall Study||8
11376138|NCT03349034|12571363|FG001|COMPLETED|Overall Study||10
11376139|NCT03349034|12571362|FG000|NOT COMPLETED|Overall Study||4
11376140|NCT03349034|12571363|FG001|NOT COMPLETED|Overall Study||2
11376141|NCT03349060|12571374|FG000|STARTED|Overall Study||156
11376142|NCT03349060|12571375|FG001|STARTED|Overall Study||154
11376143|NCT03349060|12571376|FG002|STARTED|Overall Study||77
11376144|NCT03349060|12571374|FG000|COMPLETED|Overall Study||135
11376145|NCT03349060|12571375|FG001|COMPLETED|Overall Study||137
11376146|NCT03349060|12571376|FG002|COMPLETED|Overall Study||61
11376147|NCT03349060|12571374|FG000|NOT COMPLETED|Overall Study||21
11376148|NCT03349060|12571375|FG001|NOT COMPLETED|Overall Study||17
11376149|NCT03349060|12571376|FG002|NOT COMPLETED|Overall Study||16
11376150|NCT03349099|12571386|FG000|STARTED|Overall Study||48
11376151|NCT03349099|12571387|FG001|STARTED|Overall Study||47
11376152|NCT03349099|12571386|FG000|COMPLETED|Overall Study||44
11376153|NCT03349099|12571387|FG001|COMPLETED|Overall Study||43
11376154|NCT03349099|12571386|FG000|NOT COMPLETED|Overall Study||4
11376155|NCT03349099|12571387|FG001|NOT COMPLETED|Overall Study||4
11376156|NCT03349333|12571393|FG000|STARTED|Overall Study||71
11376157|NCT03349333|12571393|FG000|COMPLETED|Overall Study||0
11376158|NCT03349333|12571393|FG000|NOT COMPLETED|Overall Study||71
11376159|NCT03349437|12571397|FG000|STARTED|Screening||25
11376160|NCT03349437|12571398|FG001|STARTED|Screening||0
11376161|NCT03349437|12571399|FG002|STARTED|Screening||0
11376162|NCT03349437|12571397|FG000|COMPLETED|Screening||20
11376163|NCT03349437|12571398|FG001|COMPLETED|Screening||0
11376164|NCT03349437|12571399|FG002|COMPLETED|Screening||0
11376165|NCT03349437|12571397|FG000|NOT COMPLETED|Screening||5
11376166|NCT03349437|12571398|FG001|NOT COMPLETED|Screening||0
11376167|NCT03349437|12571399|FG002|NOT COMPLETED|Screening||0
11376168|NCT03349437|12571397|FG000|STARTED|Intervention||0
11376169|NCT03349437|12571398|FG001|STARTED|Intervention||10
11376170|NCT03349437|12571399|FG002|STARTED|Intervention||10
11376171|NCT03349437|12571397|FG000|COMPLETED|Intervention||0
11376172|NCT03349437|12571398|FG001|COMPLETED|Intervention||10
11376173|NCT03349437|12571399|FG002|COMPLETED|Intervention||10
11376174|NCT03349437|12571397|FG000|NOT COMPLETED|Intervention||0
11376175|NCT03349437|12571398|FG001|NOT COMPLETED|Intervention||0
11376176|NCT03349437|12571399|FG002|NOT COMPLETED|Intervention||0
11376177|NCT03349515|12571408|FG000|STARTED|Overall Study||55
11376178|NCT03349515|12571409|FG001|STARTED|Overall Study||51
11376179|NCT03349515|12571408|FG000|COMPLETED|Overall Study||50
11376180|NCT03349515|12571409|FG001|COMPLETED|Overall Study||50
11376181|NCT03349515|12571408|FG000|NOT COMPLETED|Overall Study||5
11376182|NCT03349515|12571409|FG001|NOT COMPLETED|Overall Study||1
11376183|NCT03349567|12571419|FG000|STARTED|Overall Study||2
11376184|NCT03349567|12571420|FG001|STARTED|Overall Study||2
11376185|NCT03349567|12571419|FG000|COMPLETED|Overall Study||2
11376186|NCT03349567|12571420|FG001|COMPLETED|Overall Study||2
11376187|NCT03349567|12571419|FG000|NOT COMPLETED|Overall Study||0
11376188|NCT03349567|12571420|FG001|NOT COMPLETED|Overall Study||0
11376189|NCT03349632|12571428|FG000|STARTED|Period 1, First Week of Wear||11
11376190|NCT03349632|12571429|FG001|STARTED|Period 1, First Week of Wear||11
11376191|NCT03349632|12571430|FG002|STARTED|Period 1, First Week of Wear||11
11376192|NCT03349632|12571431|FG003|STARTED|Period 1, First Week of Wear||11
11376193|NCT03349632|12571432|FG004|STARTED|Period 1, First Week of Wear||11
11376194|NCT03349632|12571433|FG005|STARTED|Period 1, First Week of Wear||11
11376195|NCT03349632|12571428|FG000|COMPLETED|Period 1, First Week of Wear||11
11376196|NCT03349632|12571429|FG001|COMPLETED|Period 1, First Week of Wear||11
11376197|NCT03349632|12571430|FG002|COMPLETED|Period 1, First Week of Wear||11
11376198|NCT03349632|12571431|FG003|COMPLETED|Period 1, First Week of Wear||11
11376199|NCT03349632|12571432|FG004|COMPLETED|Period 1, First Week of Wear||11
11376200|NCT03349632|12571433|FG005|COMPLETED|Period 1, First Week of Wear||11
11376201|NCT03349632|12571428|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
11376202|NCT03349632|12571429|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
11376203|NCT03349632|12571430|FG002|NOT COMPLETED|Period 1, First Week of Wear||0
11376204|NCT03349632|12571431|FG003|NOT COMPLETED|Period 1, First Week of Wear||0
11376205|NCT03349632|12571432|FG004|NOT COMPLETED|Period 1, First Week of Wear||0
11376206|NCT03349632|12571433|FG005|NOT COMPLETED|Period 1, First Week of Wear||0
11376207|NCT03349632|12571428|FG000|STARTED|Period 2, Second Week of Wear||11
11376208|NCT03349632|12571429|FG001|STARTED|Period 2, Second Week of Wear||11
11376209|NCT03349632|12571430|FG002|STARTED|Period 2, Second Week of Wear||11
11376210|NCT03349632|12571431|FG003|STARTED|Period 2, Second Week of Wear||11
11376211|NCT03349632|12571432|FG004|STARTED|Period 2, Second Week of Wear||11
11376212|NCT03349632|12571433|FG005|STARTED|Period 2, Second Week of Wear||11
11376213|NCT03349632|12571428|FG000|COMPLETED|Period 2, Second Week of Wear||11
11376214|NCT03349632|12571429|FG001|COMPLETED|Period 2, Second Week of Wear||11
11376215|NCT03349632|12571430|FG002|COMPLETED|Period 2, Second Week of Wear||11
11376216|NCT03349632|12571431|FG003|COMPLETED|Period 2, Second Week of Wear||11
11376217|NCT03349632|12571432|FG004|COMPLETED|Period 2, Second Week of Wear||11
11376218|NCT03349632|12571433|FG005|COMPLETED|Period 2, Second Week of Wear||11
11376219|NCT03349632|12571428|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
11376220|NCT03349632|12571429|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
11376221|NCT03349632|12571430|FG002|NOT COMPLETED|Period 2, Second Week of Wear||0
11376222|NCT03349632|12571431|FG003|NOT COMPLETED|Period 2, Second Week of Wear||0
11376223|NCT03349632|12571432|FG004|NOT COMPLETED|Period 2, Second Week of Wear||0
11376224|NCT03349632|12571433|FG005|NOT COMPLETED|Period 2, Second Week of Wear||0
11376225|NCT03349710|12571451|FG000|STARTED|Randomized||12
11376226|NCT03349710|12571452|FG001|STARTED|Randomized||10
11376227|NCT03349710|12571453|FG002|STARTED|Randomized||27
11376228|NCT03349710|12571454|FG003|STARTED|Randomized||25
11376229|NCT03349710|12571451|FG000|COMPLETED|Randomized||12
11376230|NCT03349710|12571452|FG001|COMPLETED|Randomized||10
11376231|NCT03349710|12571453|FG002|COMPLETED|Randomized||27
11376232|NCT03349710|12571454|FG003|COMPLETED|Randomized||24
11376233|NCT03349710|12571451|FG000|NOT COMPLETED|Randomized||0
11376234|NCT03349710|12571452|FG001|NOT COMPLETED|Randomized||0
11376235|NCT03349710|12571453|FG002|NOT COMPLETED|Randomized||0
11376236|NCT03349710|12571454|FG003|NOT COMPLETED|Randomized||1
11376237|NCT03349710|12571451|FG000|STARTED|Treatment Period||12
11376238|NCT03349710|12571452|FG001|STARTED|Treatment Period||10
11376239|NCT03349710|12571453|FG002|STARTED|Treatment Period||27
11376240|NCT03349710|12571454|FG003|STARTED|Treatment Period||24
11376241|NCT03349710|12571451|FG000|COMPLETED|Treatment Period||0
11376242|NCT03349710|12571452|FG001|COMPLETED|Treatment Period||0
11376243|NCT03349710|12571453|FG002|COMPLETED|Treatment Period||0
11376244|NCT03349710|12571454|FG003|COMPLETED|Treatment Period||0
11376245|NCT03349710|12571451|FG000|NOT COMPLETED|Treatment Period||12
11376246|NCT03349710|12571452|FG001|NOT COMPLETED|Treatment Period||10
11376247|NCT03349710|12571453|FG002|NOT COMPLETED|Treatment Period||27
11376248|NCT03349710|12571454|FG003|NOT COMPLETED|Treatment Period||24
11376249|NCT03349892|12571464|FG000|STARTED|Overall Study||1
11376250|NCT03349892|12571464|FG000|COMPLETED|Overall Study||1
11376251|NCT03349892|12571464|FG000|NOT COMPLETED|Overall Study||0
11376252|NCT03350217|12571470|FG000|STARTED|Overall Study||79
11376253|NCT03350217|12571471|FG001|STARTED|Overall Study||81
11376254|NCT03350217|12571470|FG000|COMPLETED|Overall Study||77
11376255|NCT03350217|12571471|FG001|COMPLETED|Overall Study||81
11376256|NCT03350217|12571470|FG000|NOT COMPLETED|Overall Study||2
11376257|NCT03350217|12571471|FG001|NOT COMPLETED|Overall Study||0
11376258|NCT03350256|12571477|FG000|STARTED|Overall Study||60
11376259|NCT03350256|12571477|FG000|Spinal Cord Stimulation Trial|Overall Study|Subject that underwent SCS trial|50
11376260|NCT03350256|12571477|FG000|Permanent Implant|Overall Study|subjects that underwent permanent SCS implant|35
11376261|NCT03350256|12571477|FG000|1 Month Follow up|Overall Study||30
11376262|NCT03350256|12571477|FG000|3 Month Follow up|Overall Study||27
11376263|NCT03350256|12571477|FG000|6 Month Follow up|Overall Study||24
11376264|NCT03350256|12571477|FG000|COMPLETED|Overall Study||24
11376265|NCT03350256|12571477|FG000|NOT COMPLETED|Overall Study||36
11376266|NCT03350542|12571481|FG000|STARTED|Overall Study||100
11376267|NCT03350542|12571481|FG000|Completed 12-Month Clinical F/U|Overall Study||96
11376268|NCT03350542|12571481|FG000|Death With no 12-month F/U|Overall Study||4
11376269|NCT03350542|12571481|FG000|COMPLETED|Overall Study||96
11376270|NCT03350542|12571481|FG000|NOT COMPLETED|Overall Study||4
11376271|NCT03350672|12571488|FG000|STARTED|Overall Study||17
11376272|NCT03350672|12571489|FG001|STARTED|Overall Study||10
11376273|NCT03350672|12571490|FG002|STARTED|Overall Study||10
11376274|NCT03350672|12571488|FG000|COMPLETED|Overall Study||10
11376275|NCT03350672|12571489|FG001|COMPLETED|Overall Study||10
11376276|NCT03350672|12571490|FG002|COMPLETED|Overall Study||10
11376277|NCT03350672|12571488|FG000|NOT COMPLETED|Overall Study||7
11376278|NCT03350672|12571489|FG001|NOT COMPLETED|Overall Study||0
11376279|NCT03350672|12571490|FG002|NOT COMPLETED|Overall Study||0
11376280|NCT03350724|12571500|FG000|STARTED|Overall Study||17
11376281|NCT03350724|12571501|FG001|STARTED|Overall Study||17
11376282|NCT03350724|12571500|FG000|COMPLETED|Overall Study||17
11376283|NCT03350724|12571501|FG001|COMPLETED|Overall Study||17
11376284|NCT03350724|12571500|FG000|NOT COMPLETED|Overall Study||0
11376285|NCT03350724|12571501|FG001|NOT COMPLETED|Overall Study||0
11376286|NCT03350919|12571509|FG000|STARTED|Overall Study||25
11376287|NCT03350919|12571510|FG001|STARTED|Overall Study||23
11376288|NCT03350919|12571509|FG000|COMPLETED|Overall Study||23
11376289|NCT03350919|12571510|FG001|COMPLETED|Overall Study||23
11376290|NCT03350919|12571509|FG000|NOT COMPLETED|Overall Study||2
11376291|NCT03350919|12571510|FG001|NOT COMPLETED|Overall Study||0
11376292|NCT03351101|12571520|FG000|STARTED|Overall Study||136
11376293|NCT03351101|12571521|FG001|STARTED|Overall Study||132
11376294|NCT03351101|12571520|FG000|COMPLETED|Overall Study||135
11376295|NCT03351101|12571521|FG001|COMPLETED|Overall Study||129
11376296|NCT03351101|12571520|FG000|NOT COMPLETED|Overall Study||1
11376297|NCT03351101|12571521|FG001|NOT COMPLETED|Overall Study||3
11376298|NCT03351114|12571527|FG000|STARTED|Overall Study||8
11376299|NCT03351114|12571527|FG000|COMPLETED|Overall Study||7
11376300|NCT03351114|12571527|FG000|NOT COMPLETED|Overall Study||1
11376301|NCT03351231|12571531|FG000|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5
11376302|NCT03351231|12571531|FG000|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0
11376303|NCT03351231|12571531|FG000|NOT COMPLETED|Combination Therapy Period||5
11376304|NCT03351231|12571531|FG000|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3
11376305|NCT03351231|12571531|FG000|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0
11376306|NCT03351231|12571531|FG000|NOT COMPLETED|Safety Follow-Up Period||3
11376307|NCT03351335|12571538|FG000|STARTED|Overall Study||21
11376308|NCT03351335|12571539|FG001|STARTED|Overall Study||19
11376309|NCT03351335|12571540|FG002|STARTED|Overall Study||20
11376310|NCT03351335|12571538|FG000|COMPLETED|Overall Study||21
11376311|NCT03351335|12571539|FG001|COMPLETED|Overall Study||19
11376312|NCT03351335|12571540|FG002|COMPLETED|Overall Study||16
11376313|NCT03351335|12571538|FG000|NOT COMPLETED|Overall Study||0
11376314|NCT03351335|12571539|FG001|NOT COMPLETED|Overall Study||0
11376315|NCT03351335|12571540|FG002|NOT COMPLETED|Overall Study||4
11376316|NCT03351478|12571551|FG000|STARTED|Overall Study||307
11376317|NCT03351478|12571552|FG001|STARTED|Overall Study||309
11376318|NCT03351478|12571553|FG002|STARTED|Overall Study||154
11376319|NCT03351478|12571551|FG000|COMPLETED|Overall Study||293
11376320|NCT03351478|12571552|FG001|COMPLETED|Overall Study||292
11376321|NCT03351478|12571553|FG002|COMPLETED|Overall Study||147
11376322|NCT03351478|12571551|FG000|NOT COMPLETED|Overall Study||14
11376323|NCT03351478|12571552|FG001|NOT COMPLETED|Overall Study||17
11376324|NCT03351478|12571553|FG002|NOT COMPLETED|Overall Study||7
11376325|NCT03351608|12571566|FG000|STARTED|Overall Study||19
11376326|NCT03351608|12571567|FG001|STARTED|Overall Study||23
11376327|NCT03351608|12571568|FG002|STARTED|Overall Study||35
11376328|NCT03351608|12571569|FG003|STARTED|Overall Study||176
11376329|NCT03351608|12571570|FG004|STARTED|Overall Study||35
11376330|NCT03351608|12571566|FG000|Treated|Overall Study||18
11376331|NCT03351608|12571567|FG001|Treated|Overall Study||22
11376332|NCT03351608|12571568|FG002|Treated|Overall Study||33
11376333|NCT03351608|12571569|FG003|Treated|Overall Study||169
11376334|NCT03351608|12571570|FG004|Treated|Overall Study||34
11376335|NCT03351608|12571566|FG000|COMPLETED|Overall Study||18
11376336|NCT03351608|12571567|FG001|COMPLETED|Overall Study||21
11376337|NCT03351608|12571568|FG002|COMPLETED|Overall Study||32
11376338|NCT03351608|12571569|FG003|COMPLETED|Overall Study||168
11376339|NCT03351608|12571570|FG004|COMPLETED|Overall Study||33
11376340|NCT03351608|12571566|FG000|NOT COMPLETED|Overall Study||1
11376341|NCT03351608|12571567|FG001|NOT COMPLETED|Overall Study||2
11376342|NCT03351608|12571568|FG002|NOT COMPLETED|Overall Study||3
11376343|NCT03351608|12571569|FG003|NOT COMPLETED|Overall Study||8
11376344|NCT03351608|12571570|FG004|NOT COMPLETED|Overall Study||2
11376345|NCT03351699|12571598|FG000|STARTED|Overall Study||6
11376346|NCT03351699|12571599|FG001|STARTED|Overall Study||6
11376347|NCT03351699|12571600|FG002|STARTED|Overall Study||6
11376348|NCT03351699|12571601|FG003|STARTED|Overall Study||6
11376349|NCT03351699|12571602|FG004|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
11376350|NCT03351699|12571598|FG000|COMPLETED|Overall Study||6
11376351|NCT03351699|12571599|FG001|COMPLETED|Overall Study||6
11376352|NCT03351699|12571600|FG002|COMPLETED|Overall Study||6
11376353|NCT03351699|12571601|FG003|COMPLETED|Overall Study||6
11376354|NCT03351699|12571602|FG004|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
11005860|NCT00725075|12183654|FG001|COMPLETED|Overall Study||65
11005861|NCT00725075|12183655|FG002|COMPLETED|Overall Study||61
11005862|NCT00725075|12183653|FG000|NOT COMPLETED|Overall Study||11
11005863|NCT00725075|12183654|FG001|NOT COMPLETED|Overall Study||8
11005864|NCT00725075|12183655|FG002|NOT COMPLETED|Overall Study||9
11005865|NCT00725101|12183663|FG000|STARTED|Overall Study||1700
11005866|NCT00725101|12183663|FG000|COMPLETED|Overall Study||1205
11005867|NCT00725101|12183663|FG000|NOT COMPLETED|Overall Study||495
11005868|NCT00725153|12183667|FG000|STARTED|Period One, 10 Hours of Wear||27
11005869|NCT00725153|12183668|FG001|STARTED|Period One, 10 Hours of Wear||28
11005870|NCT00725153|12183667|FG000|COMPLETED|Period One, 10 Hours of Wear||27
11376355|NCT03351699|12571598|FG000|NOT COMPLETED|Overall Study||0
11376356|NCT03351699|12571599|FG001|NOT COMPLETED|Overall Study||0
11376357|NCT03351699|12571600|FG002|NOT COMPLETED|Overall Study||0
11005871|NCT00725153|12183668|FG001|COMPLETED|Period One, 10 Hours of Wear||28
11005872|NCT00725153|12183667|FG000|NOT COMPLETED|Period One, 10 Hours of Wear||0
11005873|NCT00725153|12183668|FG001|NOT COMPLETED|Period One, 10 Hours of Wear||0
11005874|NCT00725153|12183667|FG000|STARTED|Period Two, 10 Hours of Wear||27
11005875|NCT00725153|12183668|FG001|STARTED|Period Two, 10 Hours of Wear||28
11005876|NCT00725153|12183667|FG000|COMPLETED|Period Two, 10 Hours of Wear||27
11005877|NCT00725153|12183668|FG001|COMPLETED|Period Two, 10 Hours of Wear||28
11005878|NCT00725153|12183667|FG000|NOT COMPLETED|Period Two, 10 Hours of Wear||0
11005879|NCT00725153|12183668|FG001|NOT COMPLETED|Period Two, 10 Hours of Wear||0
11005880|NCT00725205|12183674|FG000|STARTED|Overall Study||294
11005881|NCT00725205|12183674|FG000|COMPLETED|Overall Study||207
11005882|NCT00725205|12183674|FG000|NOT COMPLETED|Overall Study||87
11005883|NCT00725270|12183680|FG000|STARTED|Overall Study||5
11376358|NCT03351699|12571601|FG003|NOT COMPLETED|Overall Study||0
11376359|NCT03351699|12571602|FG004|NOT COMPLETED|Overall Study||0
11376360|NCT03351738|12571626|FG000|STARTED|Overall Study||23
11376361|NCT03351738|12571627|FG001|STARTED|Overall Study||20
11376362|NCT03351738|12571628|FG002|STARTED|Overall Study||24
11376363|NCT03351738|12571629|FG003|STARTED|Overall Study||22
11376364|NCT03351738|12571630|FG004|STARTED|Overall Study||21
11376365|NCT03351738|12571631|FG005|STARTED|Overall Study||22
11376366|NCT03351738|12571626|FG000|COMPLETED|Overall Study||23
11376367|NCT03351738|12571627|FG001|COMPLETED|Overall Study||19
11376368|NCT03351738|12571628|FG002|COMPLETED|Overall Study||24
11376369|NCT03351738|12571629|FG003|COMPLETED|Overall Study||21
11376370|NCT03351738|12571630|FG004|COMPLETED|Overall Study||21
11376371|NCT03351738|12571631|FG005|COMPLETED|Overall Study||22
11376372|NCT03351738|12571626|FG000|NOT COMPLETED|Overall Study||0
11376373|NCT03351738|12571627|FG001|NOT COMPLETED|Overall Study||1
11376374|NCT03351738|12571628|FG002|NOT COMPLETED|Overall Study||0
11376375|NCT03351738|12571629|FG003|NOT COMPLETED|Overall Study||1
11376376|NCT03351738|12571630|FG004|NOT COMPLETED|Overall Study||0
11005884|NCT00725270|12183681|FG001|STARTED|Overall Study||7
11005885|NCT00725270|12183680|FG000|COMPLETED|Overall Study||5
11376377|NCT03351738|12571631|FG005|NOT COMPLETED|Overall Study||0
11376378|NCT03351933|12571650|FG000|STARTED|Overall Study||28
11376379|NCT03351933|12571650|FG000|COMPLETED|Overall Study||26
11376380|NCT03351933|12571650|FG000|NOT COMPLETED|Overall Study||2
11376381|NCT03352245|12571656|FG000|STARTED|Overall Study||20
11376382|NCT03352245|12571657|FG001|STARTED|Overall Study||20
11376383|NCT03352245|12571656|FG000|COMPLETED|Overall Study||20
11376384|NCT03352245|12571657|FG001|COMPLETED|Overall Study||19
11376385|NCT03352245|12571656|FG000|NOT COMPLETED|Overall Study||0
11376386|NCT03352245|12571657|FG001|NOT COMPLETED|Overall Study||1
11376387|NCT03352323|12571663|FG000|STARTED|Overall Study||50
11376388|NCT03352323|12571663|FG000|COMPLETED|Overall Study||49
11376389|NCT03352323|12571663|FG000|NOT COMPLETED|Overall Study||1
11376390|NCT03352414|12571669|FG000|STARTED|Overall Study||42
11376391|NCT03352414|12571670|FG001|STARTED|Overall Study||42
11376392|NCT03352414|12571669|FG000|Allocated|Overall Study||30
11376393|NCT03352414|12571670|FG001|Allocated|Overall Study||32
11376394|NCT03352414|12571669|FG000|COMPLETED|Overall Study||30
11376395|NCT03352414|12571670|FG001|COMPLETED|Overall Study||32
11376396|NCT03352414|12571669|FG000|NOT COMPLETED|Overall Study||12
11376397|NCT03352414|12571670|FG001|NOT COMPLETED|Overall Study||10
11376398|NCT03352453|12571680|FG000|STARTED|Overall Study||66
11376399|NCT03352453|12571681|FG001|STARTED|Overall Study||72
11376400|NCT03352453|12571680|FG000|COMPLETED|Overall Study||44
11376401|NCT03352453|12571681|FG001|COMPLETED|Overall Study||40
11376402|NCT03352453|12571680|FG000|NOT COMPLETED|Overall Study||22
11376403|NCT03352453|12571681|FG001|NOT COMPLETED|Overall Study||32
11376404|NCT03352609|12571689|FG000|STARTED|Overall Study||2
11376405|NCT03352609|12571690|FG001|STARTED|Overall Study||3
11376406|NCT03352609|12571689|FG000|COMPLETED|Overall Study||2
11376407|NCT03352609|12571690|FG001|COMPLETED|Overall Study||3
11376408|NCT03352609|12571689|FG000|NOT COMPLETED|Overall Study||0
11376409|NCT03352609|12571690|FG001|NOT COMPLETED|Overall Study||0
11376410|NCT03352713|12571696|FG000|STARTED|Overall Study||185
11376411|NCT03352713|12571696|FG000|COMPLETED|Overall Study|Participants who completed at least 1 EMA for inclusion in data analysis|159
11376412|NCT03352713|12571696|FG000|NOT COMPLETED|Overall Study||26
11376413|NCT03353220|12571700|FG000|STARTED|First Intervention (7 Days) - Phase 1||14
11376414|NCT03353220|12571701|FG001|STARTED|First Intervention (7 Days) - Phase 1||16
11376415|NCT03353220|12571700|FG000|COMPLETED|First Intervention (7 Days) - Phase 1||14
11376416|NCT03353220|12571701|FG001|COMPLETED|First Intervention (7 Days) - Phase 1||16
11376417|NCT03353220|12571700|FG000|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0
11376418|NCT03353220|12571701|FG001|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0
11376419|NCT03353220|12571700|FG000|STARTED|Washout (3 Weeks) - Phase 1||14
11376420|NCT03353220|12571701|FG001|STARTED|Washout (3 Weeks) - Phase 1||16
11376421|NCT03353220|12571700|FG000|COMPLETED|Washout (3 Weeks) - Phase 1||14
11376422|NCT03353220|12571701|FG001|COMPLETED|Washout (3 Weeks) - Phase 1||16
11376423|NCT03353220|12571700|FG000|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0
11376424|NCT03353220|12571701|FG001|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0
11005886|NCT00725270|12183681|FG001|COMPLETED|Overall Study||7
11376425|NCT03353220|12571700|FG000|STARTED|Second Intervention (7 Days) - Phase 1||14
11376426|NCT03353220|12571701|FG001|STARTED|Second Intervention (7 Days) - Phase 1||16
11376427|NCT03353220|12571700|FG000|COMPLETED|Second Intervention (7 Days) - Phase 1||14
11376428|NCT03353220|12571701|FG001|COMPLETED|Second Intervention (7 Days) - Phase 1||16
11376429|NCT03353220|12571700|FG000|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0
11376430|NCT03353220|12571701|FG001|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0
11376431|NCT03353220|12571700|FG000|STARTED|Third Intervention (6 Months) - Phase 2||14
11376432|NCT03353220|12571701|FG001|STARTED|Third Intervention (6 Months) - Phase 2||16
11376433|NCT03353220|12571700|FG000|COMPLETED|Third Intervention (6 Months) - Phase 2||10
11376434|NCT03353220|12571701|FG001|COMPLETED|Third Intervention (6 Months) - Phase 2||9
11376435|NCT03353220|12571700|FG000|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||4
11376436|NCT03353220|12571701|FG001|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||7
11376437|NCT03353246|12571707|FG000|STARTED|Overall Study||500
11376438|NCT03353246|12571707|FG000|COMPLETED|Overall Study||500
11376439|NCT03353246|12571707|FG000|NOT COMPLETED|Overall Study||0
11376440|NCT03353740|12571711|FG000|STARTED|Overall Study||346
11376441|NCT03353740|12571711|FG000|COMPLETED|Overall Study||294
11376442|NCT03353740|12571711|FG000|NOT COMPLETED|Overall Study||52
11376443|NCT03353753|12571717|FG000|STARTED|Overall Study||85
11376444|NCT03353753|12571718|FG001|STARTED|Overall Study|1 patient was randomized but not dosed|44
11376445|NCT03353753|12571717|FG000|COMPLETED|Overall Study||46
11376446|NCT03353753|12571718|FG001|COMPLETED|Overall Study||35
11376447|NCT03353753|12571717|FG000|NOT COMPLETED|Overall Study||39
11376448|NCT03353753|12571718|FG001|NOT COMPLETED|Overall Study||9
11376449|NCT03354325|12571726|FG000|STARTED|Overall Study||151
11376450|NCT03354325|12571727|FG001|STARTED|Overall Study||153
11376451|NCT03354325|12571726|FG000|COMPLETED|Overall Study||131
11376452|NCT03354325|12571727|FG001|COMPLETED|Overall Study||138
11376453|NCT03354325|12571726|FG000|NOT COMPLETED|Overall Study||20
11376454|NCT03354325|12571727|FG001|NOT COMPLETED|Overall Study||15
11376455|NCT03354429|12571735|FG000|STARTED|Overall Study||5523
11376456|NCT03354429|12571736|FG001|STARTED|Overall Study||5493
11376457|NCT03354429|12571735|FG000|COMPLETED|Overall Study||5514
11376458|NCT03354429|12571736|FG001|COMPLETED|Overall Study||5486
11376459|NCT03354429|12571735|FG000|NOT COMPLETED|Overall Study||9
11376460|NCT03354429|12571736|FG001|NOT COMPLETED|Overall Study||7
11376461|NCT03354598|12571744|FG000|STARTED|Overall Study||835
11376462|NCT03354598|12571745|FG001|STARTED|Overall Study||836
11376463|NCT03354598|12571744|FG000|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||147
11376464|NCT03354598|12571745|FG001|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||139
11376465|NCT03354598|12571744|FG000|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||370
11376466|NCT03354598|12571745|FG001|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||415
11376467|NCT03354598|12571744|FG000|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||517
11376468|NCT03354598|12571745|FG001|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||554
11376469|NCT03354598|12571744|FG000|Modified Intent to Treat (MITT) Participants|Overall Study||785
11376470|NCT03354598|12571745|FG001|Modified Intent to Treat (MITT) Participants|Overall Study||794
11376471|NCT03354598|12571744|FG000|Intent to Treat (ITT) Participants|Overall Study||787
11376472|NCT03354598|12571745|FG001|Intent to Treat (ITT) Participants|Overall Study||803
11376473|NCT03354598|12571744|FG000|Safety Participants|Overall Study||833
11376474|NCT03354598|12571745|FG001|Safety Participants|Overall Study||827
11376475|NCT03354598|12571744|FG000|COMPLETED|Overall Study||755
11376476|NCT03354598|12571745|FG001|COMPLETED|Overall Study||761
11376477|NCT03354598|12571744|FG000|NOT COMPLETED|Overall Study||80
11376478|NCT03354598|12571745|FG001|NOT COMPLETED|Overall Study||75
11376479|NCT03354637|12571754|FG000|STARTED|Double-blind Period||43
11376480|NCT03354637|12571755|FG001|STARTED|Double-blind Period||44
11376481|NCT03354637|12571756|FG002|STARTED|Double-blind Period||42
11376482|NCT03354637|12571754|FG000|COMPLETED|Double-blind Period||26
11376483|NCT03354637|12571755|FG001|COMPLETED|Double-blind Period||31
11376484|NCT03354637|12571756|FG002|COMPLETED|Double-blind Period||35
11376485|NCT03354637|12571754|FG000|NOT COMPLETED|Double-blind Period||17
11376486|NCT03354637|12571755|FG001|NOT COMPLETED|Double-blind Period||13
11376487|NCT03354637|12571756|FG002|NOT COMPLETED|Double-blind Period||7
11376488|NCT03354637|12571754|FG000|STARTED|Open Label Extension||0
11376489|NCT03354637|12571755|FG001|STARTED|Open Label Extension||0
11376490|NCT03354637|12571756|FG002|STARTED|Open Label Extension||61
11376491|NCT03354637|12571754|FG000|COMPLETED|Open Label Extension||0
11376492|NCT03354637|12571755|FG001|COMPLETED|Open Label Extension||0
11376493|NCT03354637|12571756|FG002|COMPLETED|Open Label Extension||33
11376494|NCT03354637|12571754|FG000|NOT COMPLETED|Open Label Extension||0
11376495|NCT03354637|12571755|FG001|NOT COMPLETED|Open Label Extension||0
11376496|NCT03354637|12571756|FG002|NOT COMPLETED|Open Label Extension||28
11376497|NCT03354663|12571765|FG000|STARTED|Enrollment to Catheter Insertion||156
11376498|NCT03354663|12571765|FG000|COMPLETED|Enrollment to Catheter Insertion||151
11376499|NCT03354663|12571765|FG000|NOT COMPLETED|Enrollment to Catheter Insertion||5
11376500|NCT03354663|12571765|FG000|STARTED|Completed 30-day Visit||151
11376501|NCT03354663|12571765|FG000|COMPLETED|Completed 30-day Visit||149
11376502|NCT03354663|12571765|FG000|NOT COMPLETED|Completed 30-day Visit||2
11376503|NCT03354754|12571775|FG000|STARTED|Overall Study||2
11376504|NCT03354754|12571776|FG001|STARTED|Overall Study||1
11376505|NCT03354754|12571775|FG000|COMPLETED|Overall Study||2
11376506|NCT03354754|12571776|FG001|COMPLETED|Overall Study||1
11376507|NCT03354754|12571775|FG000|NOT COMPLETED|Overall Study||0
11376508|NCT03354754|12571776|FG001|NOT COMPLETED|Overall Study||0
11376509|NCT03355326|12571784|FG000|STARTED|Overall Study||9
11376510|NCT03355326|12571785|FG001|STARTED|Overall Study||7
11376511|NCT03355326|12571784|FG000|COMPLETED|Overall Study||6
11376512|NCT03355326|12571785|FG001|COMPLETED|Overall Study||4
11376513|NCT03355326|12571784|FG000|NOT COMPLETED|Overall Study||3
11376514|NCT03355326|12571785|FG001|NOT COMPLETED|Overall Study||3
11376515|NCT03355742|12571791|FG000|STARTED|Overall Study||963
11376516|NCT03355742|12571791|FG000|COMPLETED|Overall Study||864
11376517|NCT03355742|12571791|FG000|NOT COMPLETED|Overall Study||99
11376518|NCT03355820|12571795|FG000|STARTED|Overall Study||227
11376519|NCT03355820|12571795|FG000|COMPLETED|Overall Study||227
11376520|NCT03355820|12571795|FG000|NOT COMPLETED|Overall Study||0
11376521|NCT03356145|12571801|FG000|STARTED|Overall Study||48
11376522|NCT03356145|12571802|FG001|STARTED|Overall Study||48
11376523|NCT03356145|12571801|FG000|Received Allocated Intervention|Overall Study||45
11376524|NCT03356145|12571802|FG001|Received Allocated Intervention|Overall Study||47
11376525|NCT03356145|12571801|FG000|COMPLETED|Overall Study||45
11376526|NCT03356145|12571802|FG001|COMPLETED|Overall Study||47
11376527|NCT03356145|12571801|FG000|NOT COMPLETED|Overall Study||3
11376528|NCT03356145|12571802|FG001|NOT COMPLETED|Overall Study||1
11376529|NCT03356977|12571808|FG000|STARTED|Overall Study||137
11376530|NCT03356977|12571808|FG000|COMPLETED|Overall Study||132
11376531|NCT03356977|12571808|FG000|NOT COMPLETED|Overall Study||5
11376532|NCT03357341|12571814|FG000|STARTED|Overall Study||96
11376533|NCT03357341|12571815|FG001|STARTED|Overall Study||98
11376534|NCT03357341|12571814|FG000|COMPLETED|Overall Study||89
11376535|NCT03357341|12571815|FG001|COMPLETED|Overall Study||86
11376536|NCT03357341|12571814|FG000|NOT COMPLETED|Overall Study||7
11376537|NCT03357341|12571815|FG001|NOT COMPLETED|Overall Study||12
11376538|NCT03357393|12571825|FG000|STARTED|Overall Study||50
11376539|NCT03357393|12571826|FG001|STARTED|Overall Study||50
11376540|NCT03357393|12571827|FG002|STARTED|Overall Study||50
11376541|NCT03357393|12571825|FG000|COMPLETED|Overall Study||50
11376542|NCT03357393|12571826|FG001|COMPLETED|Overall Study||50
11376543|NCT03357393|12571827|FG002|COMPLETED|Overall Study||50
11376544|NCT03357393|12571825|FG000|NOT COMPLETED|Overall Study||0
11376545|NCT03357393|12571826|FG001|NOT COMPLETED|Overall Study||0
11376546|NCT03357393|12571827|FG002|NOT COMPLETED|Overall Study||0
11376547|NCT03357471|12571837|FG000|STARTED|Overall Study||35
11376548|NCT03357471|12571838|FG001|STARTED|Overall Study||32
11376549|NCT03357471|12571837|FG000|COMPLETED|Overall Study||33
11376550|NCT03357471|12571838|FG001|COMPLETED|Overall Study||32
11376551|NCT03357471|12571837|FG000|NOT COMPLETED|Overall Study||2
11376552|NCT03357471|12571838|FG001|NOT COMPLETED|Overall Study||0
11376553|NCT03357614|12571846|FG000|STARTED|Overall Study||697
11376554|NCT03357614|12571847|FG001|STARTED|Overall Study||698
11376555|NCT03357614|12571846|FG000|COMPLETED|Overall Study||672
11376556|NCT03357614|12571847|FG001|COMPLETED|Overall Study||670
11376557|NCT03357614|12571846|FG000|NOT COMPLETED|Overall Study||25
11376558|NCT03357614|12571847|FG001|NOT COMPLETED|Overall Study||28
11376559|NCT03357731|12571853|FG000|STARTED|Overall Study||8
11376560|NCT03357731|12571854|FG001|STARTED|Overall Study||7
11376561|NCT03357731|12571855|FG002|STARTED|Overall Study||7
11376562|NCT03357731|12571856|FG003|STARTED|Overall Study||7
11376563|NCT03357731|12571857|FG004|STARTED|Overall Study||8
11376564|NCT03357731|12571858|FG005|STARTED|Overall Study||8
11005887|NCT00725270|12183680|FG000|NOT COMPLETED|Overall Study||0
11005888|NCT00725270|12183681|FG001|NOT COMPLETED|Overall Study||0
11005889|NCT00725283|12183687|FG000|STARTED|Overall Study||34
11005890|NCT00725283|12183687|FG000|COMPLETED|Overall Study||10
11005891|NCT00725283|12183687|FG000|NOT COMPLETED|Overall Study||24
11005892|NCT00725296|12183691|FG000|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
11005893|NCT00725296|12183691|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
11005894|NCT00725296|12183691|FG000|NOT COMPLETED|Overall Study||62
11005895|NCT00725322|12183698|FG000|STARTED|First Injection Visit||15
11005896|NCT00725322|12183699|FG001|STARTED|First Injection Visit||15
11005897|NCT00725322|12183698|FG000|COMPLETED|First Injection Visit||15
11005898|NCT00725322|12183699|FG001|COMPLETED|First Injection Visit||15
11376565|NCT03357731|12571853|FG000|Completed Period 1 (P1)|Overall Study|1 withdrew post-P1 completion/prior to P2 therapy due to acute cholecystitis, but returned for P2/P3|8
11376566|NCT03357731|12571854|FG001|Completed Period 1 (P1)|Overall Study||7
11376567|NCT03357731|12571855|FG002|Completed Period 1 (P1)|Overall Study||7
11376568|NCT03357731|12571856|FG003|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to acute bradycardia and hypotension|6
11376569|NCT03357731|12571857|FG004|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to hypotension but resumed P2/P3|7
11376570|NCT03357731|12571858|FG005|Completed Period 1 (P1)|Overall Study||8
11376571|NCT03357731|12571853|FG000|Completed Period 2 (P2)|Overall Study||8
11376572|NCT03357731|12571854|FG001|Completed Period 2 (P2)|Overall Study||7
11376573|NCT03357731|12571855|FG002|Completed Period 2 (P2)|Overall Study||7
11376574|NCT03357731|12571856|FG003|Completed Period 2 (P2)|Overall Study|"1 completed P1, did not proceed to P2/P3 (lost to follow-up);~1 discontinued P2 due to hypotension"|4
11376575|NCT03357731|12571857|FG004|Completed Period 2 (P2)|Overall Study|1 only completed P1, did not continue to P2/P3 (withdrew consent due to personal reasons)|7
11376576|NCT03357731|12571858|FG005|Completed Period 2 (P2)|Overall Study|1 discontinued P2 due to an Adverse Event (AE)|7
11376577|NCT03357731|12571853|FG000|COMPLETED|Overall Study||8
11376578|NCT03357731|12571854|FG001|COMPLETED|Overall Study||7
11376579|NCT03357731|12571855|FG002|COMPLETED|Overall Study|1 discontinuation due to hypotension|6
11005899|NCT00725322|12183698|FG000|NOT COMPLETED|First Injection Visit||0
11005900|NCT00725322|12183699|FG001|NOT COMPLETED|First Injection Visit||0
11005901|NCT00725322|12183698|FG000|STARTED|Washout (28 Days)||15
11005902|NCT00725322|12183699|FG001|STARTED|Washout (28 Days)||15
11005903|NCT00725322|12183698|FG000|COMPLETED|Washout (28 Days)||13
11005904|NCT00725322|12183699|FG001|COMPLETED|Washout (28 Days)||14
11376580|NCT03357731|12571856|FG003|COMPLETED|Overall Study||4
11376581|NCT03357731|12571857|FG004|COMPLETED|Overall Study||7
11376582|NCT03357731|12571858|FG005|COMPLETED|Overall Study||7
11376583|NCT03357731|12571853|FG000|NOT COMPLETED|Overall Study||0
11376584|NCT03357731|12571854|FG001|NOT COMPLETED|Overall Study||0
11376585|NCT03357731|12571855|FG002|NOT COMPLETED|Overall Study||1
11376586|NCT03357731|12571856|FG003|NOT COMPLETED|Overall Study||3
11376587|NCT03357731|12571857|FG004|NOT COMPLETED|Overall Study||1
11376588|NCT03357731|12571858|FG005|NOT COMPLETED|Overall Study||1
11376589|NCT03358147|12571871|FG000|STARTED|Overall Study||235
11376590|NCT03358147|12571872|FG001|STARTED|Overall Study||240
11376591|NCT03358147|12571873|FG002|STARTED|Overall Study||240
11376592|NCT03358147|12571874|FG003|STARTED|Overall Study||237
11376593|NCT03358147|12571875|FG004|STARTED|Overall Study||119
11376594|NCT03358147|12571871|FG000|COMPLETED|Overall Study||201
11376595|NCT03358147|12571872|FG001|COMPLETED|Overall Study||201
11376596|NCT03358147|12571873|FG002|COMPLETED|Overall Study||206
11376597|NCT03358147|12571874|FG003|COMPLETED|Overall Study||201
11376598|NCT03358147|12571875|FG004|COMPLETED|Overall Study||105
11376599|NCT03358147|12571871|FG000|NOT COMPLETED|Overall Study||34
11376600|NCT03358147|12571872|FG001|NOT COMPLETED|Overall Study||39
11376601|NCT03358147|12571873|FG002|NOT COMPLETED|Overall Study||34
11376602|NCT03358147|12571874|FG003|NOT COMPLETED|Overall Study||36
11376603|NCT03358147|12571875|FG004|NOT COMPLETED|Overall Study||14
11376604|NCT03358238|12571889|FG000|STARTED|Overall Study||23
11376605|NCT03358238|12571890|FG001|STARTED|Overall Study||25
11376606|NCT03358238|12571889|FG000|COMPLETED|Overall Study||23
11376607|NCT03358238|12571890|FG001|COMPLETED|Overall Study||24
11376608|NCT03358238|12571889|FG000|NOT COMPLETED|Overall Study||0
11376609|NCT03358238|12571890|FG001|NOT COMPLETED|Overall Study||1
11376610|NCT03358251|12571900|FG000|STARTED|Overall Study||34
11376611|NCT03358251|12571900|FG000|COMPLETED|Overall Study||34
11376612|NCT03358251|12571900|FG000|NOT COMPLETED|Overall Study||0
11376613|NCT03358290|12571912|FG000|STARTED|Overall Study||2
11376614|NCT03358290|12571913|FG001|STARTED|Overall Study||3
11376615|NCT03358290|12571914|FG002|STARTED|Overall Study||3
11376616|NCT03358290|12571915|FG003|STARTED|Overall Study||3
11376617|NCT03358290|12571916|FG004|STARTED|Overall Study||2
11376618|NCT03358290|12571912|FG000|COMPLETED|Overall Study||2
11376619|NCT03358290|12571913|FG001|COMPLETED|Overall Study||2
11376620|NCT03358290|12571914|FG002|COMPLETED|Overall Study||1
11376621|NCT03358290|12571915|FG003|COMPLETED|Overall Study||1
11376622|NCT03358290|12571916|FG004|COMPLETED|Overall Study||1
11376623|NCT03358290|12571912|FG000|NOT COMPLETED|Overall Study||0
11376624|NCT03358290|12571913|FG001|NOT COMPLETED|Overall Study||1
11376625|NCT03358290|12571914|FG002|NOT COMPLETED|Overall Study||2
11376626|NCT03358290|12571915|FG003|NOT COMPLETED|Overall Study||2
11376627|NCT03358290|12571916|FG004|NOT COMPLETED|Overall Study||1
11376628|NCT03358329|12571928|FG000|STARTED|Overall Study||50
11376629|NCT03358329|12571928|FG000|COMPLETED|Overall Study||46
11376630|NCT03358329|12571928|FG000|NOT COMPLETED|Overall Study||4
11376631|NCT03358355|12571934|FG000|STARTED|Overall Study||9
11376632|NCT03358355|12571934|FG000|COMPLETED|Overall Study||9
11376633|NCT03358355|12571934|FG000|NOT COMPLETED|Overall Study||0
11376634|NCT03358407|12571953|FG000|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
11376635|NCT03358407|12571954|FG001|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
11376636|NCT03358407|12571955|FG002|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
11376637|NCT03358407|12571956|FG003|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
11376638|NCT03358407|12571957|FG004|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
11376639|NCT03358407|12571958|FG005|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376640|NCT03358407|12571959|FG006|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376641|NCT03358407|12571960|FG007|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376642|NCT03358407|12571961|FG008|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376643|NCT03358407|12571962|FG009|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376644|NCT03358407|12571953|FG000|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
11376645|NCT03358407|12571954|FG001|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
11376646|NCT03358407|12571955|FG002|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
11376647|NCT03358407|12571956|FG003|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
11376648|NCT03358407|12571957|FG004|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
11376649|NCT03358407|12571958|FG005|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376650|NCT03358407|12571959|FG006|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376651|NCT03358407|12571960|FG007|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376652|NCT03358407|12571961|FG008|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376653|NCT03358407|12571962|FG009|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376654|NCT03358407|12571953|FG000|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376655|NCT03358407|12571954|FG001|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376656|NCT03358407|12571955|FG002|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376657|NCT03358407|12571956|FG003|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376658|NCT03358407|12571957|FG004|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376659|NCT03358407|12571958|FG005|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376660|NCT03358407|12571959|FG006|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376661|NCT03358407|12571960|FG007|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376662|NCT03358407|12571961|FG008|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376663|NCT03358407|12571962|FG009|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
11376664|NCT03358407|12571953|FG000|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
11376665|NCT03358407|12571954|FG001|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
11376666|NCT03358407|12571955|FG002|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
11376667|NCT03358407|12571956|FG003|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
11376668|NCT03358407|12571957|FG004|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
11376669|NCT03358407|12571958|FG005|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376670|NCT03358407|12571959|FG006|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376671|NCT03358407|12571960|FG007|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376672|NCT03358407|12571961|FG008|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376673|NCT03358407|12571962|FG009|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376674|NCT03358407|12571953|FG000|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
11376675|NCT03358407|12571954|FG001|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
11376676|NCT03358407|12571955|FG002|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
11376677|NCT03358407|12571956|FG003|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
11376678|NCT03358407|12571957|FG004|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
11376679|NCT03358407|12571958|FG005|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376680|NCT03358407|12571959|FG006|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376681|NCT03358407|12571960|FG007|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376682|NCT03358407|12571961|FG008|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376683|NCT03358407|12571962|FG009|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376684|NCT03358407|12571953|FG000|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376685|NCT03358407|12571954|FG001|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11005905|NCT00725322|12183698|FG000|NOT COMPLETED|Washout (28 Days)||2
11005906|NCT00725322|12183699|FG001|NOT COMPLETED|Washout (28 Days)||1
11005907|NCT00725322|12183698|FG000|STARTED|Second Injection Visit||13
11005908|NCT00725322|12183699|FG001|STARTED|Second Injection Visit||14
11142070|NCT01466179|12328758|FG000|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
11142071|NCT01466179|12328758|FG000|NOT COMPLETED|Overall Study||179
11142072|NCT01466192|12328765|FG000|STARTED|Overall Study||108
11005909|NCT00725322|12183698|FG000|COMPLETED|Second Injection Visit||13
11005910|NCT00725322|12183699|FG001|COMPLETED|Second Injection Visit||14
11005911|NCT00725322|12183698|FG000|NOT COMPLETED|Second Injection Visit||0
11005912|NCT00725322|12183699|FG001|NOT COMPLETED|Second Injection Visit||0
11005913|NCT00725361|12183705|FG000|STARTED|Overall Study||20
11005914|NCT00725361|12183705|FG000|COMPLETED|Overall Study||16
11005915|NCT00725361|12183705|FG000|NOT COMPLETED|Overall Study||4
11056438|NCT00994214|12238018|FG002|COMPLETED|ITT (Intention-to-Treat) - Part A||5
11056439|NCT00994214|12238019|FG003|COMPLETED|ITT (Intention-to-Treat) - Part A||5
11056440|NCT00994214|12238016|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
11056441|NCT00994214|12238017|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
11056442|NCT00994214|12238018|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
11056443|NCT00994214|12238019|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
11056444|NCT00994214|12238016|FG000|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
11056445|NCT00994214|12238017|FG001|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
11056446|NCT00994214|12238018|FG002|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
11056447|NCT00994214|12238019|FG003|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
11056448|NCT00994214|12238016|FG000|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
11056449|NCT00994214|12238017|FG001|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
11056450|NCT00994214|12238018|FG002|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
11056451|NCT00994214|12238019|FG003|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
11056452|NCT00994214|12238016|FG000|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
11056453|NCT00994214|12238017|FG001|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
11056454|NCT00994214|12238018|FG002|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
11056455|NCT00994214|12238019|FG003|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
11056456|NCT00994214|12238016|FG000|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
11056457|NCT00994214|12238017|FG001|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
11056458|NCT00994214|12238018|FG002|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
11056459|NCT00994214|12238019|FG003|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
11056460|NCT00994214|12238016|FG000|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
11056461|NCT00994214|12238017|FG001|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
11056462|NCT00994214|12238018|FG002|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
11056463|NCT00994214|12238019|FG003|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
11056464|NCT00994214|12238016|FG000|COMPLETED|ITT (Intention-to-Treat) - Part B||0
11005916|NCT00725452|12183709|FG000|STARTED|Overall Study||26
11005917|NCT00725452|12183709|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
11005918|NCT00725452|12183709|FG000|NOT COMPLETED|Overall Study||11
11005919|NCT00725504|12183713|FG000|STARTED|Overall Study||71
11005920|NCT00725504|12183713|FG000|COMPLETED|Overall Study||71
11005921|NCT00725504|12183713|FG000|NOT COMPLETED|Overall Study||0
11005922|NCT00725530|12183720|FG000|STARTED|First Intervention, 7 Days (+0/-1)||27
11005923|NCT00725530|12183721|FG001|STARTED|First Intervention, 7 Days (+0/-1)||27
11005924|NCT00725530|12183720|FG000|COMPLETED|First Intervention, 7 Days (+0/-1)||27
11005925|NCT00725530|12183721|FG001|COMPLETED|First Intervention, 7 Days (+0/-1)||27
11005926|NCT00725530|12183720|FG000|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
11005927|NCT00725530|12183721|FG001|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
11005928|NCT00725530|12183720|FG000|STARTED|Second Intervention, 7 Days (+0/-1)||27
11005929|NCT00725530|12183721|FG001|STARTED|Second Intervention, 7 Days (+0/-1)||27
11005930|NCT00725530|12183720|FG000|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
11005931|NCT00725530|12183721|FG001|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
11005932|NCT00725530|12183720|FG000|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
11005933|NCT00725530|12183721|FG001|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
11005934|NCT00725543|12183727|FG000|STARTED|Overall Study||358
11005935|NCT00725543|12183727|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
11005936|NCT00725543|12183727|FG000|NOT COMPLETED|Overall Study||153
11005937|NCT00725608|12183731|FG000|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
11005938|NCT00725608|12183731|FG000|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
11005939|NCT00725608|12183731|FG000|NOT COMPLETED|Overall Study||167
11005940|NCT00725621|12183735|FG000|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
11005941|NCT00725621|12183735|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
11142073|NCT01466192|12328765|FG000|COMPLETED|Overall Study||104
11142074|NCT01466192|12328765|FG000|NOT COMPLETED|Overall Study||4
11005942|NCT00725621|12183735|FG000|NOT COMPLETED|Overall Study||271
11005943|NCT00725712|12183745|FG000|STARTED|Overall Study||48
11005944|NCT00725712|12183746|FG001|STARTED|Overall Study||26
11005945|NCT00725712|12183745|FG000|COMPLETED|Overall Study||0
11005946|NCT00725712|12183746|FG001|COMPLETED|Overall Study||0
11005947|NCT00725712|12183745|FG000|NOT COMPLETED|Overall Study||48
11005948|NCT00725712|12183746|FG001|NOT COMPLETED|Overall Study||26
11005949|NCT00725725|12183759|FG000|STARTED|Overall Study||14
11005950|NCT00725725|12183760|FG001|STARTED|Overall Study||15
11005951|NCT00725725|12183761|FG002|STARTED|Overall Study||17
11005952|NCT00725725|12183759|FG000|Treated|Overall Study||11
11005953|NCT00725725|12183760|FG001|Treated|Overall Study||15
11005954|NCT00725725|12183761|FG002|Treated|Overall Study||14
11005955|NCT00725725|12183759|FG000|COMPLETED|Overall Study||10
11005956|NCT00725725|12183760|FG001|COMPLETED|Overall Study||11
11142075|NCT01466270|12328771|FG000|STARTED|Overall Study||31
11376686|NCT03358407|12571955|FG002|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
11376687|NCT03358407|12571956|FG003|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376688|NCT03358407|12571957|FG004|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376689|NCT03358407|12571958|FG005|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376690|NCT03358407|12571959|FG006|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376691|NCT03358407|12571960|FG007|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376692|NCT03358407|12571961|FG008|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376693|NCT03358407|12571962|FG009|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
11376694|NCT03358407|12571953|FG000|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
11376695|NCT03358407|12571954|FG001|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
11376696|NCT03358407|12571955|FG002|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/Placebo/GSK 30mg/GSK 100mg arm|2
11376697|NCT03358407|12571956|FG003|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
11376698|NCT03358407|12571957|FG004|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
11376699|NCT03358407|12571958|FG005|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376700|NCT03358407|12571959|FG006|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376701|NCT03358407|12571960|FG007|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376702|NCT03358407|12571961|FG008|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376703|NCT03358407|12571962|FG009|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376704|NCT03358407|12571953|FG000|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
11376705|NCT03358407|12571954|FG001|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
11376706|NCT03358407|12571955|FG002|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
11376707|NCT03358407|12571956|FG003|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
11376708|NCT03358407|12571957|FG004|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
11376709|NCT03358407|12571958|FG005|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376710|NCT03358407|12571959|FG006|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376711|NCT03358407|12571960|FG007|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376712|NCT03358407|12571961|FG008|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376713|NCT03358407|12571962|FG009|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376714|NCT03358407|12571953|FG000|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376715|NCT03358407|12571954|FG001|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376716|NCT03358407|12571955|FG002|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376717|NCT03358407|12571956|FG003|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376718|NCT03358407|12571957|FG004|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376719|NCT03358407|12571958|FG005|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376720|NCT03358407|12571959|FG006|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376721|NCT03358407|12571960|FG007|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376722|NCT03358407|12571961|FG008|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376723|NCT03358407|12571962|FG009|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
11376724|NCT03358407|12571953|FG000|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
11376725|NCT03358407|12571954|FG001|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
11376726|NCT03358407|12571955|FG002|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
11376727|NCT03358407|12571956|FG003|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
11376728|NCT03358407|12571957|FG004|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
11376729|NCT03358407|12571958|FG005|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376730|NCT03358407|12571959|FG006|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376731|NCT03358407|12571960|FG007|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376732|NCT03358407|12571961|FG008|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376733|NCT03358407|12571962|FG009|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376734|NCT03358407|12571953|FG000|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
11376735|NCT03358407|12571954|FG001|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
11376736|NCT03358407|12571955|FG002|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
11376737|NCT03358407|12571956|FG003|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
11376738|NCT03358407|12571957|FG004|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
11376739|NCT03358407|12571958|FG005|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376740|NCT03358407|12571959|FG006|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376741|NCT03358407|12571960|FG007|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376742|NCT03358407|12571961|FG008|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376743|NCT03358407|12571962|FG009|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376744|NCT03358407|12571953|FG000|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376745|NCT03358407|12571954|FG001|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376746|NCT03358407|12571955|FG002|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376747|NCT03358407|12571956|FG003|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376748|NCT03358407|12571957|FG004|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
11376749|NCT03358407|12571958|FG005|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376750|NCT03358407|12571959|FG006|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376751|NCT03358407|12571960|FG007|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376752|NCT03358407|12571961|FG008|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376753|NCT03358407|12571962|FG009|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
11376754|NCT03358407|12571953|FG000|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
11376755|NCT03358407|12571954|FG001|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
11376756|NCT03358407|12571955|FG002|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
11376757|NCT03358407|12571956|FG003|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
11376758|NCT03358407|12571957|FG004|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/GSK 10mg/GSK 30mg/Placebo arm|2
11376759|NCT03358407|12571958|FG005|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376760|NCT03358407|12571959|FG006|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376761|NCT03358407|12571960|FG007|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376762|NCT03358407|12571961|FG008|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376763|NCT03358407|12571962|FG009|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376764|NCT03358407|12571953|FG000|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
11376765|NCT03358407|12571954|FG001|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
11376766|NCT03358407|12571955|FG002|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
11376767|NCT03358407|12571956|FG003|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
11376768|NCT03358407|12571957|FG004|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
11376769|NCT03358407|12571958|FG005|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376770|NCT03358407|12571959|FG006|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376771|NCT03358407|12571960|FG007|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376772|NCT03358407|12571961|FG008|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376773|NCT03358407|12571962|FG009|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376774|NCT03358407|12571953|FG000|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376775|NCT03358407|12571954|FG001|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376776|NCT03358407|12571955|FG002|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376777|NCT03358407|12571956|FG003|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376778|NCT03358407|12571957|FG004|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376779|NCT03358407|12571958|FG005|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376780|NCT03358407|12571959|FG006|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376781|NCT03358407|12571960|FG007|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376782|NCT03358407|12571961|FG008|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376783|NCT03358407|12571962|FG009|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
11376784|NCT03358407|12571953|FG000|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376785|NCT03358407|12571954|FG001|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376786|NCT03358407|12571955|FG002|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376787|NCT03358407|12571956|FG003|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376788|NCT03358407|12571957|FG004|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376789|NCT03358407|12571958|FG005|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
11376790|NCT03358407|12571959|FG006|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
11376791|NCT03358407|12571960|FG007|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||6
11376792|NCT03358407|12571961|FG008|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376793|NCT03358407|12571962|FG009|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376794|NCT03358407|12571953|FG000|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376795|NCT03358407|12571954|FG001|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376796|NCT03358407|12571955|FG002|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376797|NCT03358407|12571956|FG003|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376798|NCT03358407|12571957|FG004|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376799|NCT03358407|12571958|FG005|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376800|NCT03358407|12571959|FG006|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||2
11376801|NCT03358407|12571960|FG007|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
11376802|NCT03358407|12571961|FG008|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376803|NCT03358407|12571962|FG009|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376804|NCT03358407|12571953|FG000|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376805|NCT03358407|12571954|FG001|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376806|NCT03358407|12571955|FG002|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376807|NCT03358407|12571956|FG003|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376808|NCT03358407|12571957|FG004|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376809|NCT03358407|12571958|FG005|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
11376810|NCT03358407|12571959|FG006|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||1
11376811|NCT03358407|12571960|FG007|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
11376812|NCT03358407|12571961|FG008|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376813|NCT03358407|12571962|FG009|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
11376814|NCT03358407|12571953|FG000|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376815|NCT03358407|12571954|FG001|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376816|NCT03358407|12571955|FG002|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376817|NCT03358407|12571956|FG003|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376818|NCT03358407|12571957|FG004|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376819|NCT03358407|12571958|FG005|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: Placebo/GSK 400mg arm|3
11376820|NCT03358407|12571959|FG006|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|1 participant was added to Part A-Cohort 2: GSK 200mg/ Placebo arm|3
11376821|NCT03358407|12571960|FG007|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: GSK 200mg/GSK 400mg arm|6
11376822|NCT03358407|12571961|FG008|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376823|NCT03358407|12571962|FG009|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376824|NCT03358407|12571953|FG000|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376825|NCT03358407|12571954|FG001|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376826|NCT03358407|12571955|FG002|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376827|NCT03358407|12571956|FG003|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376828|NCT03358407|12571957|FG004|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376829|NCT03358407|12571958|FG005|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376830|NCT03358407|12571959|FG006|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376831|NCT03358407|12571960|FG007|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376832|NCT03358407|12571961|FG008|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376833|NCT03358407|12571962|FG009|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376834|NCT03358407|12571953|FG000|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376835|NCT03358407|12571954|FG001|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376836|NCT03358407|12571955|FG002|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376837|NCT03358407|12571956|FG003|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376838|NCT03358407|12571957|FG004|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376839|NCT03358407|12571958|FG005|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
11376840|NCT03358407|12571959|FG006|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
11376841|NCT03358407|12571960|FG007|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||6
11376842|NCT03358407|12571961|FG008|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376843|NCT03358407|12571962|FG009|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
11376844|NCT03358407|12571953|FG000|STARTED|Part B: Overall Period (11 Weeks)||0
11376845|NCT03358407|12571954|FG001|STARTED|Part B: Overall Period (11 Weeks)||0
11376846|NCT03358407|12571955|FG002|STARTED|Part B: Overall Period (11 Weeks)||0
11376847|NCT03358407|12571956|FG003|STARTED|Part B: Overall Period (11 Weeks)||0
11376848|NCT03358407|12571957|FG004|STARTED|Part B: Overall Period (11 Weeks)||0
11376849|NCT03358407|12571958|FG005|STARTED|Part B: Overall Period (11 Weeks)||0
11376850|NCT03358407|12571959|FG006|STARTED|Part B: Overall Period (11 Weeks)||0
11376851|NCT03358407|12571960|FG007|STARTED|Part B: Overall Period (11 Weeks)||0
11376852|NCT03358407|12571961|FG008|STARTED|Part B: Overall Period (11 Weeks)||0
11376853|NCT03358407|12571962|FG009|STARTED|Part B: Overall Period (11 Weeks)||0
11376854|NCT03358407|12571953|FG000|COMPLETED|Part B: Overall Period (11 Weeks)||0
11376855|NCT03358407|12571954|FG001|COMPLETED|Part B: Overall Period (11 Weeks)||0
11376856|NCT03358407|12571955|FG002|COMPLETED|Part B: Overall Period (11 Weeks)||0
11376857|NCT03358407|12571956|FG003|COMPLETED|Part B: Overall Period (11 Weeks)||0
11376858|NCT03358407|12571957|FG004|COMPLETED|Part B: Overall Period (11 Weeks)||0
11376859|NCT03358407|12571958|FG005|COMPLETED|Part B: Overall Period (11 Weeks)||0
11376860|NCT03358407|12571959|FG006|COMPLETED|Part B: Overall Period (11 Weeks)||0
11376861|NCT03358407|12571960|FG007|COMPLETED|Part B: Overall Period (11 Weeks)||0
11376862|NCT03358407|12571961|FG008|COMPLETED|Part B: Overall Period (11 Weeks)||0
11376863|NCT03358407|12571962|FG009|COMPLETED|Part B: Overall Period (11 Weeks)||0
11376864|NCT03358407|12571953|FG000|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
11376865|NCT03358407|12571954|FG001|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
11376866|NCT03358407|12571955|FG002|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
11376867|NCT03358407|12571956|FG003|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
11376868|NCT03358407|12571957|FG004|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
11376869|NCT03358407|12571958|FG005|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
11376870|NCT03358407|12571959|FG006|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
11142076|NCT01466270|12328772|FG001|STARTED|Overall Study||31
11142077|NCT01466270|12328771|FG000|COMPLETED|Overall Study||19
11142078|NCT01466270|12328772|FG001|COMPLETED|Overall Study||25
11142079|NCT01466270|12328771|FG000|NOT COMPLETED|Overall Study||12
11142080|NCT01466270|12328772|FG001|NOT COMPLETED|Overall Study||6
11376871|NCT03358407|12571960|FG007|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
11376872|NCT03358407|12571961|FG008|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
11376873|NCT03358407|12571962|FG009|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
11376874|NCT03358576|12571992|FG000|STARTED|Overall Study||338
11376875|NCT03358576|12571993|FG001|STARTED|Overall Study||336
11376876|NCT03358576|12571992|FG000|COMPLETED|Overall Study||312
11376877|NCT03358576|12571993|FG001|COMPLETED|Overall Study||311
11376878|NCT03358576|12571992|FG000|NOT COMPLETED|Overall Study||26
11376879|NCT03358576|12571993|FG001|NOT COMPLETED|Overall Study||25
11376880|NCT03359395|12572001|FG000|STARTED|First Intervention A / B||49
11376881|NCT03359395|12572002|FG001|STARTED|First Intervention A / B||50
11376882|NCT03359395|12572001|FG000|COMPLETED|First Intervention A / B||46
11376883|NCT03359395|12572002|FG001|COMPLETED|First Intervention A / B||47
11376884|NCT03359395|12572001|FG000|NOT COMPLETED|First Intervention A / B||3
11142081|NCT01466348|12328780|FG000|STARTED|Period I - First Intervention||36
11142082|NCT01466348|12328781|FG001|STARTED|Period I - First Intervention||36
11376885|NCT03359395|12572002|FG001|NOT COMPLETED|First Intervention A / B||3
11376886|NCT03359395|12572001|FG000|STARTED|Second Intervention B/A||46
11376887|NCT03359395|12572002|FG001|STARTED|Second Intervention B/A||47
11376888|NCT03359395|12572001|FG000|COMPLETED|Second Intervention B/A||43
11376889|NCT03359395|12572002|FG001|COMPLETED|Second Intervention B/A||44
11376890|NCT03359395|12572001|FG000|NOT COMPLETED|Second Intervention B/A||3
11376891|NCT03359395|12572002|FG001|NOT COMPLETED|Second Intervention B/A||3
11376892|NCT03359473|12572012|FG000|STARTED|Overall Study||23
11376893|NCT03359473|12572013|FG001|STARTED|Overall Study||24
11376894|NCT03359473|12572014|FG002|STARTED|Overall Study||24
11376895|NCT03359473|12572015|FG003|STARTED|Overall Study||25
11376896|NCT03359473|12572012|FG000|COMPLETED|Overall Study||21
11376897|NCT03359473|12572013|FG001|COMPLETED|Overall Study||18
11376898|NCT03359473|12572014|FG002|COMPLETED|Overall Study||18
11376899|NCT03359473|12572015|FG003|COMPLETED|Overall Study||20
11376900|NCT03359473|12572012|FG000|NOT COMPLETED|Overall Study||2
11376901|NCT03359473|12572013|FG001|NOT COMPLETED|Overall Study||6
11376902|NCT03359473|12572014|FG002|NOT COMPLETED|Overall Study||6
11376903|NCT03359473|12572015|FG003|NOT COMPLETED|Overall Study||5
11376904|NCT03359590|12572028|FG000|STARTED|First Intervention||10
11376905|NCT03359590|12572029|FG001|STARTED|First Intervention||10
11376906|NCT03359590|12572028|FG000|Exposed|First Intervention||9
11376907|NCT03359590|12572029|FG001|Exposed|First Intervention||10
11376908|NCT03359590|12572028|FG000|Discontinued|First Intervention||1
11376909|NCT03359590|12572029|FG001|Discontinued|First Intervention||2
11376910|NCT03359590|12572028|FG000|COMPLETED|First Intervention||9
11376911|NCT03359590|12572029|FG001|COMPLETED|First Intervention||8
11376912|NCT03359590|12572028|FG000|NOT COMPLETED|First Intervention||1
11376913|NCT03359590|12572029|FG001|NOT COMPLETED|First Intervention||2
11376914|NCT03359590|12572028|FG000|STARTED|Second Intervention||9
11376915|NCT03359590|12572029|FG001|STARTED|Second Intervention||8
11376916|NCT03359590|12572028|FG000|Exposed|Second Intervention||9
11376917|NCT03359590|12572029|FG001|Exposed|Second Intervention||8
11376918|NCT03359590|12572028|FG000|Discontinued|Second Intervention||0
11376919|NCT03359590|12572029|FG001|Discontinued|Second Intervention||0
11376920|NCT03359590|12572028|FG000|COMPLETED|Second Intervention||9
11376921|NCT03359590|12572029|FG001|COMPLETED|Second Intervention||8
11376922|NCT03359590|12572028|FG000|NOT COMPLETED|Second Intervention||0
11376923|NCT03359590|12572029|FG001|NOT COMPLETED|Second Intervention||0
11376924|NCT03359629|12572037|FG000|STARTED|Overall Study||200
11376925|NCT03359629|12572038|FG001|STARTED|Overall Study||10
11376926|NCT03359629|12572037|FG000|COMPLETED|Overall Study||200
11376927|NCT03359629|12572038|FG001|COMPLETED|Overall Study||10
11376928|NCT03359629|12572037|FG000|NOT COMPLETED|Overall Study||0
11376929|NCT03359629|12572038|FG001|NOT COMPLETED|Overall Study||0
11376930|NCT03359850|12572046|FG000|STARTED|PK Phase (Up to Day 8)||9
11376931|NCT03359850|12572047|FG001|STARTED|PK Phase (Up to Day 8)||8
11376932|NCT03359850|12572046|FG000|COMPLETED|PK Phase (Up to Day 8)||8
11376933|NCT03359850|12572047|FG001|COMPLETED|PK Phase (Up to Day 8)||7
11376934|NCT03359850|12572046|FG000|NOT COMPLETED|PK Phase (Up to Day 8)||1
11376935|NCT03359850|12572047|FG001|NOT COMPLETED|PK Phase (Up to Day 8)||1
11376936|NCT03359850|12572046|FG000|STARTED|Extension Phase (Up to 28 Months)||8
11376937|NCT03359850|12572047|FG001|STARTED|Extension Phase (Up to 28 Months)||7
11376938|NCT03359850|12572046|FG000|COMPLETED|Extension Phase (Up to 28 Months)||0
11376939|NCT03359850|12572047|FG001|COMPLETED|Extension Phase (Up to 28 Months)||1
11376940|NCT03359850|12572046|FG000|NOT COMPLETED|Extension Phase (Up to 28 Months)||8
11376941|NCT03359850|12572047|FG001|NOT COMPLETED|Extension Phase (Up to 28 Months)||6
11376942|NCT03359889|12572055|FG000|STARTED|Overall Study||5
11376943|NCT03359889|12572055|FG000|COMPLETED|Overall Study||5
11376944|NCT03359889|12572055|FG000|NOT COMPLETED|Overall Study||0
11376945|NCT03360071|12572061|FG000|STARTED|Overall Study||17
11376946|NCT03360071|12572062|FG001|STARTED|Overall Study||14
11376947|NCT03360071|12572061|FG000|COMPLETED|Overall Study||16
11376948|NCT03360071|12572062|FG001|COMPLETED|Overall Study||14
11376949|NCT03360071|12572061|FG000|NOT COMPLETED|Overall Study||1
11376950|NCT03360071|12572062|FG001|NOT COMPLETED|Overall Study||0
11376951|NCT03360110|12572068|FG000|STARTED|First Intervention||27
11376952|NCT03360110|12572069|FG001|STARTED|First Intervention||26
11376953|NCT03360110|12572068|FG000|COMPLETED|First Intervention||27
11376954|NCT03360110|12572069|FG001|COMPLETED|First Intervention||26
11376955|NCT03360110|12572068|FG000|NOT COMPLETED|First Intervention||0
11376956|NCT03360110|12572069|FG001|NOT COMPLETED|First Intervention||0
11376957|NCT03360110|12572068|FG000|STARTED|Second Intervention||27
11376958|NCT03360110|12572069|FG001|STARTED|Second Intervention||26
11376959|NCT03360110|12572068|FG000|COMPLETED|Second Intervention||27
11376960|NCT03360110|12572069|FG001|COMPLETED|Second Intervention||26
11376961|NCT03360110|12572068|FG000|NOT COMPLETED|Second Intervention||0
11376962|NCT03360110|12572069|FG001|NOT COMPLETED|Second Intervention||0
11376963|NCT03360344|12572090|FG000|STARTED|Overall Study||15
11376964|NCT03360344|12572091|FG001|STARTED|Overall Study||16
11376965|NCT03360344|12572092|FG002|STARTED|Overall Study||13
11376966|NCT03360344|12572090|FG000|COMPLETED|Overall Study||15
11376967|NCT03360344|12572091|FG001|COMPLETED|Overall Study||15
11376968|NCT03360344|12572092|FG002|COMPLETED|Overall Study||12
11376969|NCT03360344|12572090|FG000|NOT COMPLETED|Overall Study||0
11376970|NCT03360344|12572091|FG001|NOT COMPLETED|Overall Study||1
11376971|NCT03360344|12572092|FG002|NOT COMPLETED|Overall Study||1
11376972|NCT03360747|12572100|FG000|STARTED|Overall Study||3
11376973|NCT03360747|12572100|FG000|COMPLETED|Overall Study||2
11376974|NCT03360747|12572100|FG000|NOT COMPLETED|Overall Study||1
11376975|NCT03361137|12572109|FG000|STARTED|Overall Study||1
11376976|NCT03361137|12572110|FG001|STARTED|Overall Study||9
11376977|NCT03361137|12572111|FG002|STARTED|Overall Study||1
11376978|NCT03361137|12572112|FG003|STARTED|Overall Study||2
11376979|NCT03361137|12572113|FG004|STARTED|Overall Study||1
11376980|NCT03361137|12572109|FG000|COMPLETED|Overall Study||0
11376981|NCT03361137|12572110|FG001|COMPLETED|Overall Study||9
11376982|NCT03361137|12572111|FG002|COMPLETED|Overall Study||1
11376983|NCT03361137|12572112|FG003|COMPLETED|Overall Study||2
11376984|NCT03361137|12572113|FG004|COMPLETED|Overall Study||1
11376985|NCT03361137|12572109|FG000|NOT COMPLETED|Overall Study||1
11376986|NCT03361137|12572110|FG001|NOT COMPLETED|Overall Study||0
11376987|NCT03361137|12572111|FG002|NOT COMPLETED|Overall Study||0
11376988|NCT03361137|12572112|FG003|NOT COMPLETED|Overall Study||0
11376989|NCT03361137|12572113|FG004|NOT COMPLETED|Overall Study||0
11376990|NCT03361176|12572129|FG000|STARTED|Overall Study||10
11376991|NCT03361176|12572130|FG001|STARTED|Overall Study||20
11376992|NCT03361176|12572129|FG000|COMPLETED|Overall Study||9
11376993|NCT03361176|12572130|FG001|COMPLETED|Overall Study||15
11376994|NCT03361176|12572129|FG000|NOT COMPLETED|Overall Study||1
11376995|NCT03361176|12572130|FG001|NOT COMPLETED|Overall Study||5
11376996|NCT03361293|12572138|FG000|STARTED|Overall Study||20
11376997|NCT03361293|12572139|FG001|STARTED|Overall Study||24
11376998|NCT03361293|12572138|FG000|COMPLETED|Overall Study||19
11376999|NCT03361293|12572139|FG001|COMPLETED|Overall Study||19
11377000|NCT03361293|12572138|FG000|NOT COMPLETED|Overall Study||1
11377001|NCT03361293|12572139|FG001|NOT COMPLETED|Overall Study||5
11377002|NCT03361423|12572147|FG000|STARTED|Overall Study||126
11377003|NCT03361423|12572148|FG001|STARTED|Overall Study||126
11377004|NCT03361423|12572147|FG000|COMPLETED|Overall Study||99
11377005|NCT03361423|12572148|FG001|COMPLETED|Overall Study||103
11377006|NCT03361423|12572147|FG000|NOT COMPLETED|Overall Study||27
11377007|NCT03361423|12572148|FG001|NOT COMPLETED|Overall Study||23
11377008|NCT03361605|12572154|FG000|STARTED|Overall Study||29
11377009|NCT03361605|12572154|FG000|COMPLETED|Overall Study||26
11377010|NCT03361605|12572154|FG000|NOT COMPLETED|Overall Study||3
11377011|NCT03361917|12572160|FG000|STARTED|Overall Study||99
11377012|NCT03361917|12572161|FG001|STARTED|Overall Study||101
11377013|NCT03361917|12572160|FG000|COMPLETED|Overall Study||99
11377014|NCT03361917|12572161|FG001|COMPLETED|Overall Study||101
11377015|NCT03361917|12572160|FG000|NOT COMPLETED|Overall Study||0
11377016|NCT03361917|12572161|FG001|NOT COMPLETED|Overall Study||0
11377017|NCT03362879|12572167|FG000|STARTED|Overall Study||409
11377018|NCT03362879|12572167|FG000|COMPLETED|Overall Study||409
11377019|NCT03362879|12572167|FG000|NOT COMPLETED|Overall Study||0
11377020|NCT03362944|12572172|FG000|STARTED|First Intervention||8
11377021|NCT03362944|12572173|FG001|STARTED|First Intervention||8
11377022|NCT03362944|12572172|FG000|COMPLETED|First Intervention||8
11377023|NCT03362944|12572173|FG001|COMPLETED|First Intervention||8
11377024|NCT03362944|12572172|FG000|NOT COMPLETED|First Intervention||0
11377025|NCT03362944|12572173|FG001|NOT COMPLETED|First Intervention||0
11377026|NCT03362944|12572172|FG000|STARTED|Single Week Washout Period||8
11377027|NCT03362944|12572173|FG001|STARTED|Single Week Washout Period||8
11377028|NCT03362944|12572172|FG000|COMPLETED|Single Week Washout Period||8
11377029|NCT03362944|12572173|FG001|COMPLETED|Single Week Washout Period||8
11377030|NCT03362944|12572172|FG000|NOT COMPLETED|Single Week Washout Period||0
11377031|NCT03362944|12572173|FG001|NOT COMPLETED|Single Week Washout Period||0
11377032|NCT03362944|12572172|FG000|STARTED|Second Intervention||8
11377033|NCT03362944|12572173|FG001|STARTED|Second Intervention||8
11377034|NCT03362944|12572172|FG000|COMPLETED|Second Intervention||8
11377035|NCT03362944|12572173|FG001|COMPLETED|Second Intervention||8
11377036|NCT03362944|12572172|FG000|NOT COMPLETED|Second Intervention||0
11377037|NCT03362944|12572173|FG001|NOT COMPLETED|Second Intervention||0
11377038|NCT03362957|12572181|FG000|STARTED|Overall Study||14
11377039|NCT03362957|12572182|FG001|STARTED|Overall Study||7
11377040|NCT03362957|12572181|FG000|Crossover to Receive GAE Procedure|Overall Study||0
11377041|NCT03362957|12572182|FG001|Crossover to Receive GAE Procedure|Overall Study||7
11377042|NCT03362957|12572181|FG000|COMPLETED|Overall Study||14
11377043|NCT03362957|12572182|FG001|COMPLETED|Overall Study||7
11377044|NCT03362957|12572181|FG000|NOT COMPLETED|Overall Study||0
11377045|NCT03362957|12572182|FG001|NOT COMPLETED|Overall Study||0
11377046|NCT03363321|12572195|FG000|STARTED|Overall Study||5
11377047|NCT03363321|12572196|FG001|STARTED|Overall Study||4
11377048|NCT03363321|12572197|FG002|STARTED|Overall Study||4
11377049|NCT03363321|12572198|FG003|STARTED|Overall Study||5
11377050|NCT03363321|12572199|FG004|STARTED|Overall Study||2
11377051|NCT03363321|12572195|FG000|COMPLETED|Overall Study||5
11377052|NCT03363321|12572196|FG001|COMPLETED|Overall Study||3
11377053|NCT03363321|12572197|FG002|COMPLETED|Overall Study||4
11377054|NCT03363321|12572198|FG003|COMPLETED|Overall Study||4
11377055|NCT03363321|12572199|FG004|COMPLETED|Overall Study||2
11377056|NCT03363321|12572195|FG000|NOT COMPLETED|Overall Study||0
11377057|NCT03363321|12572196|FG001|NOT COMPLETED|Overall Study||1
11377058|NCT03363321|12572197|FG002|NOT COMPLETED|Overall Study||0
11377059|NCT03363321|12572198|FG003|NOT COMPLETED|Overall Study||1
11377060|NCT03363321|12572199|FG004|NOT COMPLETED|Overall Study||0
11377061|NCT03363776|12572215|FG000|STARTED|Overall Study||4
11377062|NCT03363776|12572216|FG001|STARTED|Overall Study||3
11377063|NCT03363776|12572217|FG002|STARTED|Overall Study||3
11377064|NCT03363776|12572215|FG000|COMPLETED|Overall Study||1
11377065|NCT03363776|12572216|FG001|COMPLETED|Overall Study||0
11377066|NCT03363776|12572217|FG002|COMPLETED|Overall Study||1
11377067|NCT03363776|12572215|FG000|NOT COMPLETED|Overall Study||3
11377068|NCT03363776|12572216|FG001|NOT COMPLETED|Overall Study||3
11377069|NCT03363776|12572217|FG002|NOT COMPLETED|Overall Study||2
11377070|NCT03363854|12572227|FG000|STARTED|Initial Treatment Period||253
11377071|NCT03363854|12572228|FG001|STARTED|Initial Treatment Period||127
11377072|NCT03363854|12572229|FG002|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
11377073|NCT03363854|12572230|FG003|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
11377074|NCT03363854|12572231|FG004|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
11377075|NCT03363854|12572232|FG005|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
11377076|NCT03363854|12572233|FG006|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
11377077|NCT03363854|12572234|FG007|STARTED|Initial Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
11377078|NCT03363854|12572227|FG000|COMPLETED|Initial Treatment Period||235
11377079|NCT03363854|12572228|FG001|COMPLETED|Initial Treatment Period||120
11377080|NCT03363854|12572229|FG002|COMPLETED|Initial Treatment Period||0
11377081|NCT03363854|12572230|FG003|COMPLETED|Initial Treatment Period||0
11377082|NCT03363854|12572231|FG004|COMPLETED|Initial Treatment Period||0
11377083|NCT03363854|12572232|FG005|COMPLETED|Initial Treatment Period||0
11377084|NCT03363854|12572233|FG006|COMPLETED|Initial Treatment Period||0
11377085|NCT03363854|12572234|FG007|COMPLETED|Initial Treatment Period||0
11377086|NCT03363854|12572227|FG000|NOT COMPLETED|Initial Treatment Period||18
11377087|NCT03363854|12572228|FG001|NOT COMPLETED|Initial Treatment Period||7
11377088|NCT03363854|12572229|FG002|NOT COMPLETED|Initial Treatment Period||0
11377089|NCT03363854|12572230|FG003|NOT COMPLETED|Initial Treatment Period||0
11377090|NCT03363854|12572231|FG004|NOT COMPLETED|Initial Treatment Period||0
11377091|NCT03363854|12572232|FG005|NOT COMPLETED|Initial Treatment Period||0
11377092|NCT03363854|12572233|FG006|NOT COMPLETED|Initial Treatment Period||0
11377093|NCT03363854|12572234|FG007|NOT COMPLETED|Initial Treatment Period||0
11377094|NCT03363854|12572227|FG000|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
11377095|NCT03363854|12572228|FG001|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
11377096|NCT03363854|12572229|FG002|STARTED|Continuation Treatment Period||69
11377097|NCT03363854|12572230|FG003|STARTED|Continuation Treatment Period||69
11377098|NCT03363854|12572231|FG004|STARTED|Continuation Treatment Period||95
11377099|NCT03363854|12572232|FG005|STARTED|Continuation Treatment Period||79
11377100|NCT03363854|12572233|FG006|STARTED|Continuation Treatment Period||41
11377101|NCT03363854|12572234|FG007|STARTED|Continuation Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
11377102|NCT03363854|12572227|FG000|COMPLETED|Continuation Treatment Period||0
11377103|NCT03363854|12572228|FG001|COMPLETED|Continuation Treatment Period||0
11377104|NCT03363854|12572229|FG002|COMPLETED|Continuation Treatment Period||68
11377105|NCT03363854|12572230|FG003|COMPLETED|Continuation Treatment Period||65
11377106|NCT03363854|12572231|FG004|COMPLETED|Continuation Treatment Period||87
11377107|NCT03363854|12572232|FG005|COMPLETED|Continuation Treatment Period||72
11377108|NCT03363854|12572233|FG006|COMPLETED|Continuation Treatment Period||38
11377109|NCT03363854|12572234|FG007|COMPLETED|Continuation Treatment Period||0
11377110|NCT03363854|12572227|FG000|NOT COMPLETED|Continuation Treatment Period||0
11377111|NCT03363854|12572228|FG001|NOT COMPLETED|Continuation Treatment Period||0
11377112|NCT03363854|12572229|FG002|NOT COMPLETED|Continuation Treatment Period||1
11377113|NCT03363854|12572230|FG003|NOT COMPLETED|Continuation Treatment Period||4
11377114|NCT03363854|12572231|FG004|NOT COMPLETED|Continuation Treatment Period||8
11377115|NCT03363854|12572232|FG005|NOT COMPLETED|Continuation Treatment Period||7
11377116|NCT03363854|12572233|FG006|NOT COMPLETED|Continuation Treatment Period||3
11377117|NCT03363854|12572234|FG007|NOT COMPLETED|Continuation Treatment Period||0
11377118|NCT03363854|12572227|FG000|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
11377119|NCT03363854|12572228|FG001|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
11377120|NCT03363854|12572229|FG002|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
11377121|NCT03363854|12572230|FG003|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
11377122|NCT03363854|12572231|FG004|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
11377123|NCT03363854|12572232|FG005|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
11377124|NCT03363854|12572233|FG006|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
11377125|NCT03363854|12572234|FG007|STARTED|Safety Follow-up Period||278
11377126|NCT03363854|12572227|FG000|COMPLETED|Safety Follow-up Period||0
11377127|NCT03363854|12572228|FG001|COMPLETED|Safety Follow-up Period||0
11377128|NCT03363854|12572229|FG002|COMPLETED|Safety Follow-up Period||0
11377129|NCT03363854|12572230|FG003|COMPLETED|Safety Follow-up Period||0
11377130|NCT03363854|12572231|FG004|COMPLETED|Safety Follow-up Period||0
11377131|NCT03363854|12572232|FG005|COMPLETED|Safety Follow-up Period||0
11377132|NCT03363854|12572233|FG006|COMPLETED|Safety Follow-up Period||0
11377133|NCT03363854|12572234|FG007|COMPLETED|Safety Follow-up Period||62
11377134|NCT03363854|12572227|FG000|NOT COMPLETED|Safety Follow-up Period||0
11377135|NCT03363854|12572228|FG001|NOT COMPLETED|Safety Follow-up Period||0
11377136|NCT03363854|12572229|FG002|NOT COMPLETED|Safety Follow-up Period||0
11377137|NCT03363854|12572230|FG003|NOT COMPLETED|Safety Follow-up Period||0
11377138|NCT03363854|12572231|FG004|NOT COMPLETED|Safety Follow-up Period||0
11377139|NCT03363854|12572232|FG005|NOT COMPLETED|Safety Follow-up Period||0
11377140|NCT03363854|12572233|FG006|NOT COMPLETED|Safety Follow-up Period||0
11377141|NCT03363854|12572234|FG007|NOT COMPLETED|Safety Follow-up Period||216
11377142|NCT03363906|12572257|FG000|STARTED|Period 1 (Reference or Test)||15
11377143|NCT03363906|12572258|FG001|STARTED|Period 1 (Reference or Test)||12
11377144|NCT03363906|12572257|FG000|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15
11377145|NCT03363906|12572258|FG001|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11
11377146|NCT03363906|12572257|FG000|COMPLETED|Period 1 (Reference or Test)||14
11377147|NCT03363906|12572258|FG001|COMPLETED|Period 1 (Reference or Test)||10
11377148|NCT03363906|12572257|FG000|NOT COMPLETED|Period 1 (Reference or Test)||1
11377149|NCT03363906|12572258|FG001|NOT COMPLETED|Period 1 (Reference or Test)||2
11377150|NCT03363906|12572257|FG000|STARTED|Period 2 (Test or Reference)||14
11377151|NCT03363906|12572258|FG001|STARTED|Period 2 (Test or Reference)||10
11377152|NCT03363906|12572257|FG000|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12
11377153|NCT03363906|12572258|FG001|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9
11377154|NCT03363906|12572257|FG000|COMPLETED|Period 2 (Test or Reference)||10
11377155|NCT03363906|12572258|FG001|COMPLETED|Period 2 (Test or Reference)||9
11377156|NCT03363906|12572257|FG000|NOT COMPLETED|Period 2 (Test or Reference)||4
11377157|NCT03363906|12572258|FG001|NOT COMPLETED|Period 2 (Test or Reference)||1
11377158|NCT03364023|12572264|FG000|STARTED|Overall Study||183
11377159|NCT03364023|12572264|FG000|COMPLETED|Overall Study||166
11377160|NCT03364023|12572264|FG000|NOT COMPLETED|Overall Study||17
11377161|NCT03364049|12572272|FG000|STARTED|Overall Study||6
11377162|NCT03364049|12572273|FG001|STARTED|Overall Study||6
11377163|NCT03364049|12572274|FG002|STARTED|Overall Study||6
11377164|NCT03364049|12572275|FG003|STARTED|Overall Study||15
11377165|NCT03364049|12572272|FG000|COMPLETED|Overall Study||0
11377166|NCT03364049|12572273|FG001|COMPLETED|Overall Study||0
11377167|NCT03364049|12572274|FG002|COMPLETED|Overall Study||0
11377168|NCT03364049|12572275|FG003|COMPLETED|Overall Study||0
11377169|NCT03364049|12572272|FG000|NOT COMPLETED|Overall Study||6
11377170|NCT03364049|12572273|FG001|NOT COMPLETED|Overall Study||6
11377171|NCT03364049|12572274|FG002|NOT COMPLETED|Overall Study||6
11377172|NCT03364049|12572275|FG003|NOT COMPLETED|Overall Study||15
11377173|NCT03364192|12572285|FG000|STARTED|Overall Study||28
11377174|NCT03364192|12572285|FG000|COMPLETED|Overall Study||12
11377175|NCT03364192|12572285|FG000|NOT COMPLETED|Overall Study||16
11377176|NCT03364309|12572293|FG000|STARTED|Induction Period||88
11377177|NCT03364309|12572294|FG001|STARTED|Induction Period||174
11377178|NCT03364309|12572295|FG002|STARTED|Induction Period||176
11377179|NCT03364309|12572296|FG003|STARTED|Induction Period||0
11377180|NCT03364309|12572297|FG004|STARTED|Induction Period||0
11377181|NCT03364309|12572298|FG005|STARTED|Induction Period||0
11377182|NCT03364309|12572299|FG006|STARTED|Induction Period||0
11377183|NCT03364309|12572300|FG007|STARTED|Induction Period||0
11377184|NCT03364309|12572301|FG008|STARTED|Induction Period||0
11377185|NCT03364309|12572302|FG009|STARTED|Induction Period||0
11377186|NCT03364309|12572303|FG010|STARTED|Induction Period||0
11377187|NCT03364309|12572304|FG011|STARTED|Induction Period||0
11377188|NCT03364309|12572305|FG012|STARTED|Induction Period||0
11377189|NCT03364309|12572306|FG013|STARTED|Induction Period||0
11377190|NCT03364309|12572307|FG014|STARTED|Induction Period||0
11377191|NCT03364309|12572308|FG015|STARTED|Induction Period||0
11377192|NCT03364309|12572309|FG016|STARTED|Induction Period||0
11377193|NCT03364309|12572310|FG017|STARTED|Induction Period||0
11377194|NCT03364309|12572311|FG018|STARTED|Induction Period||0
11377195|NCT03364309|12572293|FG000|Received at Least One Dose of Study Drug|Induction Period||88
11377196|NCT03364309|12572294|FG001|Received at Least One Dose of Study Drug|Induction Period||174
11377197|NCT03364309|12572295|FG002|Received at Least One Dose of Study Drug|Induction Period||176
11377198|NCT03364309|12572296|FG003|Received at Least One Dose of Study Drug|Induction Period||0
11377199|NCT03364309|12572297|FG004|Received at Least One Dose of Study Drug|Induction Period||0
11377200|NCT03364309|12572298|FG005|Received at Least One Dose of Study Drug|Induction Period||0
11377201|NCT03364309|12572299|FG006|Received at Least One Dose of Study Drug|Induction Period||0
11377202|NCT03364309|12572300|FG007|Received at Least One Dose of Study Drug|Induction Period||0
11377203|NCT03364309|12572301|FG008|Received at Least One Dose of Study Drug|Induction Period||0
11377204|NCT03364309|12572302|FG009|Received at Least One Dose of Study Drug|Induction Period||0
11377205|NCT03364309|12572303|FG010|Received at Least One Dose of Study Drug|Induction Period||0
11377206|NCT03364309|12572304|FG011|Received at Least One Dose of Study Drug|Induction Period||0
11377207|NCT03364309|12572305|FG012|Received at Least One Dose of Study Drug|Induction Period||0
11377208|NCT03364309|12572306|FG013|Received at Least One Dose of Study Drug|Induction Period||0
11377209|NCT03364309|12572307|FG014|Received at Least One Dose of Study Drug|Induction Period||0
11377210|NCT03364309|12572308|FG015|Received at Least One Dose of Study Drug|Induction Period||0
11377211|NCT03364309|12572309|FG016|Received at Least One Dose of Study Drug|Induction Period||0
11377212|NCT03364309|12572310|FG017|Received at Least One Dose of Study Drug|Induction Period||0
11377213|NCT03364309|12572311|FG018|Received at Least One Dose of Study Drug|Induction Period||0
11377214|NCT03364309|12572293|FG000|COMPLETED|Induction Period||82
11377215|NCT03364309|12572294|FG001|COMPLETED|Induction Period||170
11377216|NCT03364309|12572295|FG002|COMPLETED|Induction Period||175
11377217|NCT03364309|12572296|FG003|COMPLETED|Induction Period||0
11377218|NCT03364309|12572297|FG004|COMPLETED|Induction Period||0
11377219|NCT03364309|12572298|FG005|COMPLETED|Induction Period||0
11377220|NCT03364309|12572299|FG006|COMPLETED|Induction Period||0
11377221|NCT03364309|12572300|FG007|COMPLETED|Induction Period||0
11377222|NCT03364309|12572301|FG008|COMPLETED|Induction Period||0
11377223|NCT03364309|12572302|FG009|COMPLETED|Induction Period||0
11377224|NCT03364309|12572303|FG010|COMPLETED|Induction Period||0
11377225|NCT03364309|12572304|FG011|COMPLETED|Induction Period||0
11377226|NCT03364309|12572305|FG012|COMPLETED|Induction Period||0
11377227|NCT03364309|12572306|FG013|COMPLETED|Induction Period||0
11377228|NCT03364309|12572307|FG014|COMPLETED|Induction Period||0
11377229|NCT03364309|12572308|FG015|COMPLETED|Induction Period||0
11377230|NCT03364309|12572309|FG016|COMPLETED|Induction Period||0
11377231|NCT03364309|12572310|FG017|COMPLETED|Induction Period||0
11377232|NCT03364309|12572311|FG018|COMPLETED|Induction Period||0
11377233|NCT03364309|12572293|FG000|NOT COMPLETED|Induction Period||6
11377234|NCT03364309|12572294|FG001|NOT COMPLETED|Induction Period||4
11377235|NCT03364309|12572295|FG002|NOT COMPLETED|Induction Period||1
11377236|NCT03364309|12572296|FG003|NOT COMPLETED|Induction Period||0
11377237|NCT03364309|12572297|FG004|NOT COMPLETED|Induction Period||0
11377238|NCT03364309|12572298|FG005|NOT COMPLETED|Induction Period||0
11377239|NCT03364309|12572299|FG006|NOT COMPLETED|Induction Period||0
11377240|NCT03364309|12572300|FG007|NOT COMPLETED|Induction Period||0
11377241|NCT03364309|12572301|FG008|NOT COMPLETED|Induction Period||0
11377242|NCT03364309|12572302|FG009|NOT COMPLETED|Induction Period||0
11377243|NCT03364309|12572303|FG010|NOT COMPLETED|Induction Period||0
11377244|NCT03364309|12572304|FG011|NOT COMPLETED|Induction Period||0
11377245|NCT03364309|12572305|FG012|NOT COMPLETED|Induction Period||0
11377246|NCT03364309|12572306|FG013|NOT COMPLETED|Induction Period||0
11377247|NCT03364309|12572307|FG014|NOT COMPLETED|Induction Period||0
11377248|NCT03364309|12572308|FG015|NOT COMPLETED|Induction Period||0
11377249|NCT03364309|12572309|FG016|NOT COMPLETED|Induction Period||0
11377250|NCT03364309|12572310|FG017|NOT COMPLETED|Induction Period||0
11377251|NCT03364309|12572311|FG018|NOT COMPLETED|Induction Period||0
11377252|NCT03364309|12572293|FG000|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
11377253|NCT03364309|12572294|FG001|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
11377254|NCT03364309|12572295|FG002|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
11377255|NCT03364309|12572296|FG003|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|47
11377256|NCT03364309|12572297|FG004|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|92
11377257|NCT03364309|12572298|FG005|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|50
11005957|NCT00725725|12183761|FG002|COMPLETED|Overall Study||12
11005958|NCT00725725|12183759|FG000|NOT COMPLETED|Overall Study||4
11005959|NCT00725725|12183760|FG001|NOT COMPLETED|Overall Study||4
11005960|NCT00725725|12183761|FG002|NOT COMPLETED|Overall Study||5
11005961|NCT00725751|12183771|FG000|STARTED|Overall Study||90
11005962|NCT00725751|12183772|FG001|STARTED|Overall Study||258
11377258|NCT03364309|12572299|FG006|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|100
11377259|NCT03364309|12572300|FG007|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|3
11377260|NCT03364309|12572301|FG008|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|79
11377261|NCT03364309|12572302|FG009|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|31
11377262|NCT03364309|12572303|FG010|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|23
11377263|NCT03364309|12572304|FG011|STARTED|Maintenance Period||0
11377264|NCT03364309|12572305|FG012|STARTED|Maintenance Period||0
11377265|NCT03364309|12572306|FG013|STARTED|Maintenance Period||0
11377266|NCT03364309|12572307|FG014|STARTED|Maintenance Period||0
11377267|NCT03364309|12572308|FG015|STARTED|Maintenance Period||0
11377268|NCT03364309|12572309|FG016|STARTED|Maintenance Period||0
11377269|NCT03364309|12572310|FG017|STARTED|Maintenance Period||0
11377270|NCT03364309|12572311|FG018|STARTED|Maintenance Period||0
11377271|NCT03364309|12572293|FG000|Received at Least One Dose of Study Drug|Maintenance Period||0
11377272|NCT03364309|12572294|FG001|Received at Least One Dose of Study Drug|Maintenance Period||0
11377273|NCT03364309|12572295|FG002|Received at Least One Dose of Study Drug|Maintenance Period||0
11377274|NCT03364309|12572296|FG003|Received at Least One Dose of Study Drug|Maintenance Period||47
11377275|NCT03364309|12572297|FG004|Received at Least One Dose of Study Drug|Maintenance Period||92
11377276|NCT03364309|12572298|FG005|Received at Least One Dose of Study Drug|Maintenance Period||50
11377277|NCT03364309|12572299|FG006|Received at Least One Dose of Study Drug|Maintenance Period||100
11377278|NCT03364309|12572300|FG007|Received at Least One Dose of Study Drug|Maintenance Period||3
11377279|NCT03364309|12572301|FG008|Received at Least One Dose of Study Drug|Maintenance Period||79
11377280|NCT03364309|12572302|FG009|Received at Least One Dose of Study Drug|Maintenance Period||31
11377281|NCT03364309|12572303|FG010|Received at Least One Dose of Study Drug|Maintenance Period||23
11377282|NCT03364309|12572304|FG011|Received at Least One Dose of Study Drug|Maintenance Period||0
11377283|NCT03364309|12572305|FG012|Received at Least One Dose of Study Drug|Maintenance Period||0
11377284|NCT03364309|12572306|FG013|Received at Least One Dose of Study Drug|Maintenance Period||0
11377285|NCT03364309|12572307|FG014|Received at Least One Dose of Study Drug|Maintenance Period||0
11377286|NCT03364309|12572308|FG015|Received at Least One Dose of Study Drug|Maintenance Period||0
11377287|NCT03364309|12572309|FG016|Received at Least One Dose of Study Drug|Maintenance Period||0
11377288|NCT03364309|12572310|FG017|Received at Least One Dose of Study Drug|Maintenance Period||0
11377289|NCT03364309|12572311|FG018|Received at Least One Dose of Study Drug|Maintenance Period||0
11377290|NCT03364309|12572293|FG000|COMPLETED|Maintenance Period||0
11377291|NCT03364309|12572294|FG001|COMPLETED|Maintenance Period||0
11377292|NCT03364309|12572295|FG002|COMPLETED|Maintenance Period||0
11377293|NCT03364309|12572296|FG003|COMPLETED|Maintenance Period||3
11377294|NCT03364309|12572297|FG004|COMPLETED|Maintenance Period||80
11377295|NCT03364309|12572298|FG005|COMPLETED|Maintenance Period||4
11377296|NCT03364309|12572299|FG006|COMPLETED|Maintenance Period||84
11377297|NCT03364309|12572300|FG007|COMPLETED|Maintenance Period||1
11377298|NCT03364309|12572301|FG008|COMPLETED|Maintenance Period||73
11377299|NCT03364309|12572302|FG009|COMPLETED|Maintenance Period||27
11377300|NCT03364309|12572303|FG010|COMPLETED|Maintenance Period||17
11377301|NCT03364309|12572304|FG011|COMPLETED|Maintenance Period||0
11377302|NCT03364309|12572305|FG012|COMPLETED|Maintenance Period||0
11377303|NCT03364309|12572306|FG013|COMPLETED|Maintenance Period||0
11377304|NCT03364309|12572307|FG014|COMPLETED|Maintenance Period||0
11377305|NCT03364309|12572308|FG015|COMPLETED|Maintenance Period||0
11377306|NCT03364309|12572309|FG016|COMPLETED|Maintenance Period||0
11377307|NCT03364309|12572310|FG017|COMPLETED|Maintenance Period||0
11377308|NCT03364309|12572311|FG018|COMPLETED|Maintenance Period||0
11377309|NCT03364309|12572293|FG000|NOT COMPLETED|Maintenance Period||0
11377310|NCT03364309|12572294|FG001|NOT COMPLETED|Maintenance Period||0
11377311|NCT03364309|12572295|FG002|NOT COMPLETED|Maintenance Period||0
11377312|NCT03364309|12572296|FG003|NOT COMPLETED|Maintenance Period||44
11377313|NCT03364309|12572297|FG004|NOT COMPLETED|Maintenance Period||12
11377314|NCT03364309|12572298|FG005|NOT COMPLETED|Maintenance Period||46
11377315|NCT03364309|12572299|FG006|NOT COMPLETED|Maintenance Period||16
11377316|NCT03364309|12572300|FG007|NOT COMPLETED|Maintenance Period||2
11377317|NCT03364309|12572301|FG008|NOT COMPLETED|Maintenance Period||6
11377318|NCT03364309|12572302|FG009|NOT COMPLETED|Maintenance Period||4
11377319|NCT03364309|12572303|FG010|NOT COMPLETED|Maintenance Period||6
11377320|NCT03364309|12572304|FG011|NOT COMPLETED|Maintenance Period||0
11377321|NCT03364309|12572305|FG012|NOT COMPLETED|Maintenance Period||0
11377322|NCT03364309|12572306|FG013|NOT COMPLETED|Maintenance Period||0
11377323|NCT03364309|12572307|FG014|NOT COMPLETED|Maintenance Period||0
11377324|NCT03364309|12572308|FG015|NOT COMPLETED|Maintenance Period||0
11377325|NCT03364309|12572309|FG016|NOT COMPLETED|Maintenance Period||0
11377326|NCT03364309|12572310|FG017|NOT COMPLETED|Maintenance Period||0
11377327|NCT03364309|12572311|FG018|NOT COMPLETED|Maintenance Period||0
11377328|NCT03364309|12572293|FG000|STARTED|Re-treatment (Maintenance) Period||0
11377329|NCT03364309|12572294|FG001|STARTED|Re-treatment (Maintenance) Period||0
11377330|NCT03364309|12572295|FG002|STARTED|Re-treatment (Maintenance) Period||0
11377331|NCT03364309|12572296|FG003|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
11377332|NCT03364309|12572297|FG004|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
11377333|NCT03364309|12572298|FG005|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
11377334|NCT03364309|12572299|FG006|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
11377335|NCT03364309|12572300|FG007|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
11377336|NCT03364309|12572301|FG008|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
11377337|NCT03364309|12572302|FG009|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
11377338|NCT03364309|12572303|FG010|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
11377339|NCT03364309|12572304|FG011|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|2
11377340|NCT03364309|12572305|FG012|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|43
11377341|NCT03364309|12572306|FG013|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|7
11377342|NCT03364309|12572307|FG014|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|45
11377343|NCT03364309|12572308|FG015|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|10
11377344|NCT03364309|12572309|FG016|STARTED|Re-treatment (Maintenance) Period||0
11377345|NCT03364309|12572310|FG017|STARTED|Re-treatment (Maintenance) Period||0
11377346|NCT03364309|12572311|FG018|STARTED|Re-treatment (Maintenance) Period||0
11377347|NCT03364309|12572293|FG000|COMPLETED|Re-treatment (Maintenance) Period||0
11377348|NCT03364309|12572294|FG001|COMPLETED|Re-treatment (Maintenance) Period||0
11377349|NCT03364309|12572295|FG002|COMPLETED|Re-treatment (Maintenance) Period||0
11377350|NCT03364309|12572296|FG003|COMPLETED|Re-treatment (Maintenance) Period||0
11377351|NCT03364309|12572297|FG004|COMPLETED|Re-treatment (Maintenance) Period||0
11377352|NCT03364309|12572298|FG005|COMPLETED|Re-treatment (Maintenance) Period||0
11377353|NCT03364309|12572299|FG006|COMPLETED|Re-treatment (Maintenance) Period||0
11377354|NCT03364309|12572300|FG007|COMPLETED|Re-treatment (Maintenance) Period||0
11377355|NCT03364309|12572301|FG008|COMPLETED|Re-treatment (Maintenance) Period||0
11377356|NCT03364309|12572302|FG009|COMPLETED|Re-treatment (Maintenance) Period||0
11377357|NCT03364309|12572303|FG010|COMPLETED|Re-treatment (Maintenance) Period||0
11377358|NCT03364309|12572304|FG011|COMPLETED|Re-treatment (Maintenance) Period||2
11377359|NCT03364309|12572305|FG012|COMPLETED|Re-treatment (Maintenance) Period||42
11377360|NCT03364309|12572306|FG013|COMPLETED|Re-treatment (Maintenance) Period||6
11377361|NCT03364309|12572307|FG014|COMPLETED|Re-treatment (Maintenance) Period||43
11377362|NCT03364309|12572308|FG015|COMPLETED|Re-treatment (Maintenance) Period||8
11377363|NCT03364309|12572309|FG016|COMPLETED|Re-treatment (Maintenance) Period||0
11377364|NCT03364309|12572310|FG017|COMPLETED|Re-treatment (Maintenance) Period||0
11377365|NCT03364309|12572311|FG018|COMPLETED|Re-treatment (Maintenance) Period||0
11377366|NCT03364309|12572293|FG000|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377367|NCT03364309|12572294|FG001|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377368|NCT03364309|12572295|FG002|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377369|NCT03364309|12572296|FG003|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377370|NCT03364309|12572297|FG004|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377371|NCT03364309|12572298|FG005|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377372|NCT03364309|12572299|FG006|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377373|NCT03364309|12572300|FG007|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377374|NCT03364309|12572301|FG008|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377375|NCT03364309|12572302|FG009|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377376|NCT03364309|12572303|FG010|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377377|NCT03364309|12572304|FG011|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377378|NCT03364309|12572305|FG012|NOT COMPLETED|Re-treatment (Maintenance) Period||1
11377379|NCT03364309|12572306|FG013|NOT COMPLETED|Re-treatment (Maintenance) Period||1
11377380|NCT03364309|12572307|FG014|NOT COMPLETED|Re-treatment (Maintenance) Period||2
11377381|NCT03364309|12572308|FG015|NOT COMPLETED|Re-treatment (Maintenance) Period||2
11377382|NCT03364309|12572309|FG016|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377383|NCT03364309|12572310|FG017|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377384|NCT03364309|12572311|FG018|NOT COMPLETED|Re-treatment (Maintenance) Period||0
11377385|NCT03364309|12572293|FG000|STARTED|Post-Treatment Followup Period||0
11377386|NCT03364309|12572294|FG001|STARTED|Post-Treatment Followup Period||0
11377387|NCT03364309|12572295|FG002|STARTED|Post-Treatment Followup Period||0
11377388|NCT03364309|12572296|FG003|STARTED|Post-Treatment Followup Period||0
11377389|NCT03364309|12572297|FG004|STARTED|Post-Treatment Followup Period||0
11377390|NCT03364309|12572298|FG005|STARTED|Post-Treatment Followup Period||0
11377391|NCT03364309|12572299|FG006|STARTED|Post-Treatment Followup Period||0
11377392|NCT03364309|12572300|FG007|STARTED|Post-Treatment Followup Period||0
11377393|NCT03364309|12572301|FG008|STARTED|Post-Treatment Followup Period||0
11377394|NCT03364309|12572302|FG009|STARTED|Post-Treatment Followup Period||0
11377395|NCT03364309|12572303|FG010|STARTED|Post-Treatment Followup Period||0
11377396|NCT03364309|12572304|FG011|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
11377397|NCT03364309|12572305|FG012|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
11377398|NCT03364309|12572306|FG013|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
11377399|NCT03364309|12572307|FG014|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
11377400|NCT03364309|12572308|FG015|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
11377401|NCT03364309|12572309|FG016|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|11
11377402|NCT03364309|12572310|FG017|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|375
11377403|NCT03364309|12572311|FG018|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|2
11377404|NCT03364309|12572293|FG000|COMPLETED|Post-Treatment Followup Period||0
11377405|NCT03364309|12572294|FG001|COMPLETED|Post-Treatment Followup Period||0
11377406|NCT03364309|12572295|FG002|COMPLETED|Post-Treatment Followup Period||0
11377407|NCT03364309|12572296|FG003|COMPLETED|Post-Treatment Followup Period||0
11377408|NCT03364309|12572297|FG004|COMPLETED|Post-Treatment Followup Period||0
11377409|NCT03364309|12572298|FG005|COMPLETED|Post-Treatment Followup Period||0
11377410|NCT03364309|12572299|FG006|COMPLETED|Post-Treatment Followup Period||0
11377411|NCT03364309|12572300|FG007|COMPLETED|Post-Treatment Followup Period||0
11377412|NCT03364309|12572301|FG008|COMPLETED|Post-Treatment Followup Period||0
11377413|NCT03364309|12572302|FG009|COMPLETED|Post-Treatment Followup Period||0
11377414|NCT03364309|12572303|FG010|COMPLETED|Post-Treatment Followup Period||0
11377415|NCT03364309|12572304|FG011|COMPLETED|Post-Treatment Followup Period||0
11377416|NCT03364309|12572305|FG012|COMPLETED|Post-Treatment Followup Period||0
11377417|NCT03364309|12572306|FG013|COMPLETED|Post-Treatment Followup Period||0
11377418|NCT03364309|12572307|FG014|COMPLETED|Post-Treatment Followup Period||0
11377419|NCT03364309|12572308|FG015|COMPLETED|Post-Treatment Followup Period||0
11377420|NCT03364309|12572309|FG016|COMPLETED|Post-Treatment Followup Period||6
11377421|NCT03364309|12572310|FG017|COMPLETED|Post-Treatment Followup Period||344
11377422|NCT03364309|12572311|FG018|COMPLETED|Post-Treatment Followup Period||0
11377423|NCT03364309|12572293|FG000|NOT COMPLETED|Post-Treatment Followup Period||0
11377424|NCT03364309|12572294|FG001|NOT COMPLETED|Post-Treatment Followup Period||0
11377425|NCT03364309|12572295|FG002|NOT COMPLETED|Post-Treatment Followup Period||0
11377426|NCT03364309|12572296|FG003|NOT COMPLETED|Post-Treatment Followup Period||0
11377427|NCT03364309|12572297|FG004|NOT COMPLETED|Post-Treatment Followup Period||0
11377428|NCT03364309|12572298|FG005|NOT COMPLETED|Post-Treatment Followup Period||0
11377429|NCT03364309|12572299|FG006|NOT COMPLETED|Post-Treatment Followup Period||0
11377430|NCT03364309|12572300|FG007|NOT COMPLETED|Post-Treatment Followup Period||0
11377431|NCT03364309|12572301|FG008|NOT COMPLETED|Post-Treatment Followup Period||0
11377432|NCT03364309|12572302|FG009|NOT COMPLETED|Post-Treatment Followup Period||0
11377433|NCT03364309|12572303|FG010|NOT COMPLETED|Post-Treatment Followup Period||0
11377434|NCT03364309|12572304|FG011|NOT COMPLETED|Post-Treatment Followup Period||0
11377435|NCT03364309|12572305|FG012|NOT COMPLETED|Post-Treatment Followup Period||0
11377436|NCT03364309|12572306|FG013|NOT COMPLETED|Post-Treatment Followup Period||0
11377437|NCT03364309|12572307|FG014|NOT COMPLETED|Post-Treatment Followup Period||0
11377438|NCT03364309|12572308|FG015|NOT COMPLETED|Post-Treatment Followup Period||0
11377439|NCT03364309|12572309|FG016|NOT COMPLETED|Post-Treatment Followup Period||5
11377440|NCT03364309|12572310|FG017|NOT COMPLETED|Post-Treatment Followup Period||31
11377441|NCT03364309|12572311|FG018|NOT COMPLETED|Post-Treatment Followup Period||2
11377442|NCT03364335|12572340|FG000|STARTED|Overall Study||52
11377443|NCT03364335|12572341|FG001|STARTED|Overall Study||51
11377444|NCT03364335|12572342|FG002|STARTED|Overall Study||53
11377445|NCT03364335|12572343|FG003|STARTED|Overall Study||50
11377446|NCT03364335|12572344|FG004|STARTED|Overall Study||52
11377447|NCT03364335|12572340|FG000|COMPLETED|Overall Study||42
11377448|NCT03364335|12572341|FG001|COMPLETED|Overall Study||40
11377449|NCT03364335|12572342|FG002|COMPLETED|Overall Study||42
11377450|NCT03364335|12572343|FG003|COMPLETED|Overall Study||37
11377451|NCT03364335|12572344|FG004|COMPLETED|Overall Study||41
11377452|NCT03364335|12572340|FG000|NOT COMPLETED|Overall Study||10
11377453|NCT03364335|12572341|FG001|NOT COMPLETED|Overall Study||11
11377454|NCT03364335|12572342|FG002|NOT COMPLETED|Overall Study||11
11377455|NCT03364335|12572343|FG003|NOT COMPLETED|Overall Study||13
11377456|NCT03364335|12572344|FG004|NOT COMPLETED|Overall Study||11
11377457|NCT03364608|12572356|FG000|STARTED|Overall Study||86
11377458|NCT03364608|12572356|FG000|Placebo MDI|Overall Study||82
11377459|NCT03364608|12572356|FG000|AS MDI 90 µg|Overall Study||81
11377460|NCT03364608|12572356|FG000|AS MDI 180 µg|Overall Study||81
11377461|NCT03364608|12572356|FG000|Proventil 90 µg|Overall Study||82
11377462|NCT03364608|12572356|FG000|Proventil 180 µg|Overall Study||79
11377463|NCT03364608|12572356|FG000|COMPLETED|Overall Study||78
11377464|NCT03364608|12572356|FG000|NOT COMPLETED|Overall Study||8
11377465|NCT03364738|12572368|FG000|STARTED|Overall Study||22
11005963|NCT00725751|12183771|FG000|COMPLETED|Overall Study||56
11005964|NCT00725751|12183772|FG001|COMPLETED|Overall Study||150
11005965|NCT00725751|12183771|FG000|NOT COMPLETED|Overall Study||34
11005966|NCT00725751|12183772|FG001|NOT COMPLETED|Overall Study||108
11005967|NCT00725764|12183779|FG000|STARTED|Overall Study||14
11005968|NCT00725764|12183779|FG000|COMPLETED|Overall Study||0
11005969|NCT00725764|12183779|FG000|NOT COMPLETED|Overall Study||14
11005970|NCT00725842|12183784|FG000|STARTED|Overall Study||97
11005971|NCT00725842|12183784|FG000|Participants Eligible for Analysis|Overall Study||90
11005972|NCT00725842|12183784|FG000|COMPLETED|Overall Study||57
11005973|NCT00725842|12183784|FG000|NOT COMPLETED|Overall Study||40
11005974|NCT00725920|12183790|FG000|STARTED|Overall Study||17
11005975|NCT00725920|12183791|FG001|STARTED|Overall Study||18
11005976|NCT00725920|12183790|FG000|COMPLETED|Overall Study||14
11005977|NCT00725920|12183791|FG001|COMPLETED|Overall Study||12
11005978|NCT00725920|12183790|FG000|NOT COMPLETED|Overall Study||3
11005979|NCT00725920|12183791|FG001|NOT COMPLETED|Overall Study||6
11377466|NCT03364738|12572368|FG000|COMPLETED|Overall Study||14
11377467|NCT03364738|12572368|FG000|NOT COMPLETED|Overall Study||8
11377468|NCT03364751|12572377|FG000|STARTED|Overall Study||70
11377469|NCT03364751|12572378|FG001|STARTED|Overall Study||84
11377470|NCT03364751|12572379|FG002|STARTED|Overall Study||17
11377471|NCT03364751|12572380|FG003|STARTED|Overall Study||1
11377472|NCT03364751|12572377|FG000|COMPLETED|Overall Study||69
11377473|NCT03364751|12572378|FG001|COMPLETED|Overall Study||83
11377474|NCT03364751|12572379|FG002|COMPLETED|Overall Study||17
11377475|NCT03364751|12572380|FG003|COMPLETED|Overall Study||1
11377476|NCT03364751|12572377|FG000|NOT COMPLETED|Overall Study||1
11377477|NCT03364751|12572378|FG001|NOT COMPLETED|Overall Study||1
11377478|NCT03364751|12572379|FG002|NOT COMPLETED|Overall Study||0
11377479|NCT03364751|12572380|FG003|NOT COMPLETED|Overall Study||0
11377480|NCT03365011|12572396|FG000|STARTED|Overall Study||20
11377481|NCT03365011|12572397|FG001|STARTED|Overall Study||20
11377482|NCT03365011|12572396|FG000|COMPLETED|Overall Study||19
11377483|NCT03365011|12572397|FG001|COMPLETED|Overall Study||18
11377484|NCT03365011|12572396|FG000|NOT COMPLETED|Overall Study||1
11377485|NCT03365011|12572397|FG001|NOT COMPLETED|Overall Study||2
11377486|NCT03365154|12572403|FG000|STARTED|Overall Study||10
11377487|NCT03365154|12572403|FG000|COMPLETED|Overall Study||10
11377488|NCT03365154|12572403|FG000|NOT COMPLETED|Overall Study||0
11377489|NCT03365778|12572410|FG000|STARTED|Overall Study||16
11377490|NCT03365778|12572411|FG001|STARTED|Overall Study||17
11377491|NCT03365778|12572412|FG002|STARTED|Overall Study||53
11377492|NCT03365778|12572410|FG000|COMPLETED|Overall Study||16
11377493|NCT03365778|12572411|FG001|COMPLETED|Overall Study||17
11377494|NCT03365778|12572412|FG002|COMPLETED|Overall Study||53
11377495|NCT03365778|12572410|FG000|NOT COMPLETED|Overall Study||0
11377496|NCT03365778|12572411|FG001|NOT COMPLETED|Overall Study||0
11377497|NCT03365778|12572412|FG002|NOT COMPLETED|Overall Study||0
11377498|NCT03365934|12572420|FG000|STARTED|Overall Study||35
11377499|NCT03365934|12572420|FG000|COMPLETED|Overall Study||33
11377500|NCT03365934|12572420|FG000|NOT COMPLETED|Overall Study||2
11377501|NCT03366207|12572429|FG000|STARTED|Overall Study||250
11377502|NCT03366207|12572429|FG000|COMPLETED|Overall Study||242
11377503|NCT03366207|12572429|FG000|NOT COMPLETED|Overall Study||8
11377504|NCT03367793|12572439|FG000|STARTED|Initial Acuity at Dispense Visit (10min)||5
11377505|NCT03367793|12572440|FG001|STARTED|Initial Acuity at Dispense Visit (10min)||5
11377506|NCT03367793|12572441|FG002|STARTED|Initial Acuity at Dispense Visit (10min)||5
11377507|NCT03367793|12572442|FG003|STARTED|Initial Acuity at Dispense Visit (10min)||5
11377508|NCT03367793|12572443|FG004|STARTED|Initial Acuity at Dispense Visit (10min)||5
11377509|NCT03367793|12572444|FG005|STARTED|Initial Acuity at Dispense Visit (10min)||5
11377510|NCT03367793|12572439|FG000|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
11377511|NCT03367793|12572440|FG001|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
11377512|NCT03367793|12572441|FG002|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
11377513|NCT03367793|12572442|FG003|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
11377514|NCT03367793|12572443|FG004|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
11377515|NCT03367793|12572444|FG005|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
11377516|NCT03367793|12572439|FG000|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
11377517|NCT03367793|12572440|FG001|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
11377518|NCT03367793|12572441|FG002|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
11377519|NCT03367793|12572442|FG003|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
11377520|NCT03367793|12572443|FG004|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
11377521|NCT03367793|12572444|FG005|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
11377522|NCT03367793|12572439|FG000|STARTED|Treatment 1 Dispense to 2 Months Wear||5
11377523|NCT03367793|12572440|FG001|STARTED|Treatment 1 Dispense to 2 Months Wear||5
11377524|NCT03367793|12572441|FG002|STARTED|Treatment 1 Dispense to 2 Months Wear||5
11377525|NCT03367793|12572442|FG003|STARTED|Treatment 1 Dispense to 2 Months Wear||5
11377526|NCT03367793|12572443|FG004|STARTED|Treatment 1 Dispense to 2 Months Wear||5
11377527|NCT03367793|12572444|FG005|STARTED|Treatment 1 Dispense to 2 Months Wear||5
11377528|NCT03367793|12572439|FG000|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
11377529|NCT03367793|12572440|FG001|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
11377530|NCT03367793|12572441|FG002|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
11377531|NCT03367793|12572442|FG003|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
11377532|NCT03367793|12572443|FG004|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
11377533|NCT03367793|12572444|FG005|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
11377534|NCT03367793|12572439|FG000|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
11377535|NCT03367793|12572440|FG001|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
11377536|NCT03367793|12572441|FG002|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
11377537|NCT03367793|12572442|FG003|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
11377538|NCT03367793|12572443|FG004|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
11377539|NCT03367793|12572444|FG005|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
11377540|NCT03367793|12572439|FG000|STARTED|Treatment 2 Dispense to 2 Months Wear||5
11377541|NCT03367793|12572440|FG001|STARTED|Treatment 2 Dispense to 2 Months Wear||5
11377542|NCT03367793|12572441|FG002|STARTED|Treatment 2 Dispense to 2 Months Wear||5
11377543|NCT03367793|12572442|FG003|STARTED|Treatment 2 Dispense to 2 Months Wear||5
11377544|NCT03367793|12572443|FG004|STARTED|Treatment 2 Dispense to 2 Months Wear||5
11377545|NCT03367793|12572444|FG005|STARTED|Treatment 2 Dispense to 2 Months Wear||5
11377546|NCT03367793|12572439|FG000|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
11377547|NCT03367793|12572440|FG001|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
11377548|NCT03367793|12572441|FG002|COMPLETED|Treatment 2 Dispense to 2 Months Wear||4
11377549|NCT03367793|12572442|FG003|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
11377550|NCT03367793|12572443|FG004|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
11377551|NCT03367793|12572444|FG005|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
11377552|NCT03367793|12572439|FG000|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
11377553|NCT03367793|12572440|FG001|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
11377554|NCT03367793|12572441|FG002|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||1
11377555|NCT03367793|12572442|FG003|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
11377556|NCT03367793|12572443|FG004|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
11377557|NCT03367793|12572444|FG005|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
11377558|NCT03367793|12572439|FG000|STARTED|Treatment 3 Dispense to 2 Months Wear||5
11377559|NCT03367793|12572440|FG001|STARTED|Treatment 3 Dispense to 2 Months Wear||5
11377560|NCT03367793|12572441|FG002|STARTED|Treatment 3 Dispense to 2 Months Wear||5
11377561|NCT03367793|12572442|FG003|STARTED|Treatment 3 Dispense to 2 Months Wear||5
11377562|NCT03367793|12572443|FG004|STARTED|Treatment 3 Dispense to 2 Months Wear||5
11377563|NCT03367793|12572444|FG005|STARTED|Treatment 3 Dispense to 2 Months Wear||5
11377564|NCT03367793|12572439|FG000|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
11377565|NCT03367793|12572440|FG001|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
11377566|NCT03367793|12572441|FG002|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
11377567|NCT03367793|12572442|FG003|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
11377568|NCT03367793|12572443|FG004|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
11377569|NCT03367793|12572444|FG005|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
11377570|NCT03367793|12572439|FG000|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
11377571|NCT03367793|12572440|FG001|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
11377572|NCT03367793|12572441|FG002|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
11377573|NCT03367793|12572442|FG003|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
11377574|NCT03367793|12572443|FG004|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
11377575|NCT03367793|12572444|FG005|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
11377576|NCT03368053|12572455|FG000|STARTED|Overall Study||36
11377577|NCT03368053|12572455|FG000|COMPLETED|Overall Study||36
11377578|NCT03368053|12572455|FG000|NOT COMPLETED|Overall Study||0
11377579|NCT03368235|12572461|FG000|STARTED|Overall Study||11
11377580|NCT03368235|12572462|FG001|STARTED|Overall Study||10
11377581|NCT03368235|12572461|FG000|COMPLETED|Overall Study||11
11377582|NCT03368235|12572462|FG001|COMPLETED|Overall Study||10
11377583|NCT03368235|12572461|FG000|NOT COMPLETED|Overall Study||0
11377584|NCT03368235|12572462|FG001|NOT COMPLETED|Overall Study||0
11377585|NCT03368807|12572468|FG000|STARTED|Period 1 (Blinded CGM)||79
11377586|NCT03368807|12572468|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78
11377587|NCT03368807|12572468|FG000|COMPLETED|Period 1 (Blinded CGM)||73
11377588|NCT03368807|12572468|FG000|NOT COMPLETED|Period 1 (Blinded CGM)||6
11377589|NCT03368807|12572468|FG000|STARTED|Period 2 (Unblinded CGM)||73
11377590|NCT03368807|12572468|FG000|COMPLETED|Period 2 (Unblinded CGM)||73
11377591|NCT03368807|12572468|FG000|NOT COMPLETED|Period 2 (Unblinded CGM)||0
11377592|NCT03368859|12572476|FG000|STARTED|Overall Study||36
11377593|NCT03368859|12572477|FG001|STARTED|Overall Study||34
11377594|NCT03368859|12572476|FG000|COMPLETED|Overall Study||0
11005980|NCT00725959|12183799|FG000|STARTED|Overall Study||942
11005981|NCT00725959|12183800|FG001|STARTED|Overall Study||636
11005982|NCT00725959|12183799|FG000|COMPLETED|Overall Study||653
11005983|NCT00725959|12183800|FG001|COMPLETED|Overall Study||439
11005984|NCT00725959|12183799|FG000|NOT COMPLETED|Overall Study||289
11005985|NCT00725959|12183800|FG001|NOT COMPLETED|Overall Study||197
11005986|NCT00726232|12183812|FG000|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
11377595|NCT03368859|12572477|FG001|COMPLETED|Overall Study||0
11377596|NCT03368859|12572476|FG000|NOT COMPLETED|Overall Study||36
11377597|NCT03368859|12572477|FG001|NOT COMPLETED|Overall Study||34
11377598|NCT03368898|12572486|FG000|STARTED|Overall Study||37
11377599|NCT03368898|12572487|FG001|STARTED|Overall Study||33
11377600|NCT03368898|12572488|FG002|STARTED|Overall Study||34
11377601|NCT03368898|12572486|FG000|COMPLETED|Overall Study||37
11377602|NCT03368898|12572487|FG001|COMPLETED|Overall Study||33
11377603|NCT03368898|12572488|FG002|COMPLETED|Overall Study||34
11377604|NCT03368898|12572486|FG000|NOT COMPLETED|Overall Study||0
11377605|NCT03368898|12572487|FG001|NOT COMPLETED|Overall Study||0
11377606|NCT03368898|12572488|FG002|NOT COMPLETED|Overall Study||0
11377607|NCT03369158|12572498|FG000|STARTED|Overall Study||14
11377608|NCT03369158|12572499|FG001|STARTED|Overall Study||15
11377609|NCT03369158|12572498|FG000|COMPLETED|Overall Study||14
11377610|NCT03369158|12572499|FG001|COMPLETED|Overall Study||15
11377611|NCT03369158|12572498|FG000|NOT COMPLETED|Overall Study||0
11377612|NCT03369158|12572499|FG001|NOT COMPLETED|Overall Study||0
11377613|NCT03369236|12572507|FG000|STARTED|Double-blind Treatment Period||6
11377614|NCT03369236|12572508|FG001|STARTED|Double-blind Treatment Period||7
11377615|NCT03369236|12572507|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||6
11377616|NCT03369236|12572508|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||7
11377617|NCT03369236|12572507|FG000|COMPLETED|Double-blind Treatment Period||6
11377618|NCT03369236|12572508|FG001|COMPLETED|Double-blind Treatment Period||6
11377619|NCT03369236|12572507|FG000|NOT COMPLETED|Double-blind Treatment Period||0
11377620|NCT03369236|12572508|FG001|NOT COMPLETED|Double-blind Treatment Period||1
11377621|NCT03369236|12572507|FG000|STARTED|Open-label Extension Period||6
11377622|NCT03369236|12572508|FG001|STARTED|Open-label Extension Period||6
11377623|NCT03369236|12572507|FG000|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6
11377624|NCT03369236|12572508|FG001|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6
11377625|NCT03369236|12572507|FG000|COMPLETED|Open-label Extension Period||1
11377626|NCT03369236|12572508|FG001|COMPLETED|Open-label Extension Period||0
11377627|NCT03369236|12572507|FG000|NOT COMPLETED|Open-label Extension Period||5
11377628|NCT03369236|12572508|FG001|NOT COMPLETED|Open-label Extension Period||6
11377629|NCT03369340|12572520|FG000|STARTED|Day 2||3
11377630|NCT03369340|12572521|FG001|STARTED|Day 2||3
11377631|NCT03369340|12572522|FG002|STARTED|Day 2||3
11377632|NCT03369340|12572523|FG003|STARTED|Day 2||3
11377633|NCT03369340|12572524|FG004|STARTED|Day 2||3
11377634|NCT03369340|12572525|FG005|STARTED|Day 2||3
11377635|NCT03369340|12572520|FG000|COMPLETED|Day 2||3
11377636|NCT03369340|12572521|FG001|COMPLETED|Day 2||3
11377637|NCT03369340|12572522|FG002|COMPLETED|Day 2||3
11377638|NCT03369340|12572523|FG003|COMPLETED|Day 2||3
11377639|NCT03369340|12572524|FG004|COMPLETED|Day 2||3
11377640|NCT03369340|12572525|FG005|COMPLETED|Day 2||3
11377641|NCT03369340|12572520|FG000|NOT COMPLETED|Day 2||0
11377642|NCT03369340|12572521|FG001|NOT COMPLETED|Day 2||0
11377643|NCT03369340|12572522|FG002|NOT COMPLETED|Day 2||0
11377644|NCT03369340|12572523|FG003|NOT COMPLETED|Day 2||0
11377645|NCT03369340|12572524|FG004|NOT COMPLETED|Day 2||0
11377646|NCT03369340|12572525|FG005|NOT COMPLETED|Day 2||0
11377647|NCT03369340|12572520|FG000|STARTED|Day 3||3
11377648|NCT03369340|12572521|FG001|STARTED|Day 3||3
11377649|NCT03369340|12572522|FG002|STARTED|Day 3||3
11377650|NCT03369340|12572523|FG003|STARTED|Day 3||3
11377651|NCT03369340|12572524|FG004|STARTED|Day 3||3
11377652|NCT03369340|12572525|FG005|STARTED|Day 3||3
11377653|NCT03369340|12572520|FG000|COMPLETED|Day 3||3
11377654|NCT03369340|12572521|FG001|COMPLETED|Day 3||3
11377655|NCT03369340|12572522|FG002|COMPLETED|Day 3||3
11377656|NCT03369340|12572523|FG003|COMPLETED|Day 3||3
11377657|NCT03369340|12572524|FG004|COMPLETED|Day 3||3
11377658|NCT03369340|12572525|FG005|COMPLETED|Day 3||3
11377659|NCT03369340|12572520|FG000|NOT COMPLETED|Day 3||0
11377660|NCT03369340|12572521|FG001|NOT COMPLETED|Day 3||0
11377661|NCT03369340|12572522|FG002|NOT COMPLETED|Day 3||0
11377662|NCT03369340|12572523|FG003|NOT COMPLETED|Day 3||0
11377663|NCT03369340|12572524|FG004|NOT COMPLETED|Day 3||0
11377664|NCT03369340|12572525|FG005|NOT COMPLETED|Day 3||0
11377665|NCT03369340|12572520|FG000|STARTED|Day 4||3
11377666|NCT03369340|12572521|FG001|STARTED|Day 4||3
11377667|NCT03369340|12572522|FG002|STARTED|Day 4||3
11377668|NCT03369340|12572523|FG003|STARTED|Day 4||3
11377669|NCT03369340|12572524|FG004|STARTED|Day 4||3
11377670|NCT03369340|12572525|FG005|STARTED|Day 4||3
11377671|NCT03369340|12572520|FG000|COMPLETED|Day 4||3
11377672|NCT03369340|12572521|FG001|COMPLETED|Day 4||3
11377673|NCT03369340|12572522|FG002|COMPLETED|Day 4||3
11377674|NCT03369340|12572523|FG003|COMPLETED|Day 4||3
11377675|NCT03369340|12572524|FG004|COMPLETED|Day 4||3
11377676|NCT03369340|12572525|FG005|COMPLETED|Day 4||3
11377677|NCT03369340|12572520|FG000|NOT COMPLETED|Day 4||0
11377678|NCT03369340|12572521|FG001|NOT COMPLETED|Day 4||0
11377679|NCT03369340|12572522|FG002|NOT COMPLETED|Day 4||0
11377680|NCT03369340|12572523|FG003|NOT COMPLETED|Day 4||0
11377681|NCT03369340|12572524|FG004|NOT COMPLETED|Day 4||0
11377682|NCT03369340|12572525|FG005|NOT COMPLETED|Day 4||0
11377683|NCT03369418|12572537|FG000|STARTED|Overall Study||16
11377684|NCT03369418|12572538|FG001|STARTED|Overall Study||14
11377685|NCT03369418|12572537|FG000|COMPLETED|Overall Study||13
11377686|NCT03369418|12572538|FG001|COMPLETED|Overall Study||11
11377687|NCT03369418|12572537|FG000|NOT COMPLETED|Overall Study||3
11377688|NCT03369418|12572538|FG001|NOT COMPLETED|Overall Study||3
11377689|NCT03369704|12572546|FG000|STARTED|Treatment Epoch||162
11377690|NCT03369704|12572547|FG001|STARTED|Treatment Epoch||175
11377691|NCT03369704|12572546|FG000|COMPLETED|Treatment Epoch||158
11377692|NCT03369704|12572547|FG001|COMPLETED|Treatment Epoch||172
11377693|NCT03369704|12572546|FG000|NOT COMPLETED|Treatment Epoch||4
11377694|NCT03369704|12572547|FG001|NOT COMPLETED|Treatment Epoch||3
11377695|NCT03369704|12572546|FG000|STARTED|Follow-up Epoch||161
11377696|NCT03369704|12572547|FG001|STARTED|Follow-up Epoch||174
11377697|NCT03369704|12572546|FG000|COMPLETED|Follow-up Epoch||160
11377698|NCT03369704|12572547|FG001|COMPLETED|Follow-up Epoch||174
11377699|NCT03369704|12572546|FG000|NOT COMPLETED|Follow-up Epoch||1
11377700|NCT03369704|12572547|FG001|NOT COMPLETED|Follow-up Epoch||0
11377701|NCT03369756|12572553|FG000|STARTED|Overall Study||43
11377702|NCT03369756|12572553|FG000|COMPLETED|Overall Study|36 completed 4 weeks of treatment; 40 were considered statistical completers|36
11377703|NCT03369756|12572553|FG000|NOT COMPLETED|Overall Study||7
11377704|NCT03369951|12572557|FG000|STARTED|Overall Study||58
11377705|NCT03369951|12572557|FG000|Received Study Drug|Overall Study||57
11377706|NCT03369951|12572557|FG000|COMPLETED|Overall Study||52
11377707|NCT03369951|12572557|FG000|NOT COMPLETED|Overall Study||6
11377708|NCT03370042|12572563|FG000|STARTED|Overall Study||10
11377709|NCT03370042|12572564|FG001|STARTED|Overall Study||10
11377710|NCT03370042|12572563|FG000|COMPLETED|Overall Study||10
11377711|NCT03370042|12572564|FG001|COMPLETED|Overall Study||10
11377712|NCT03370042|12572563|FG000|NOT COMPLETED|Overall Study||0
11377713|NCT03370042|12572564|FG001|NOT COMPLETED|Overall Study||0
11377714|NCT03370289|12572574|FG000|STARTED|Overall Study||55
11377715|NCT03370289|12572574|FG000|COMPLETED|Overall Study||50
11377716|NCT03370289|12572574|FG000|NOT COMPLETED|Overall Study||5
11377717|NCT03370302|12572584|FG000|STARTED|Dose Escalation Phase||3
11377718|NCT03370302|12572585|FG001|STARTED|Dose Escalation Phase||6
11377719|NCT03370302|12572586|FG002|STARTED|Dose Escalation Phase||7
11377720|NCT03370302|12572587|FG003|STARTED|Dose Escalation Phase||0
11377721|NCT03370302|12572588|FG004|STARTED|Dose Escalation Phase||3
11377722|NCT03370302|12572589|FG005|STARTED|Dose Escalation Phase||3
11377723|NCT03370302|12572584|FG000|COMPLETED|Dose Escalation Phase||0
11377724|NCT03370302|12572585|FG001|COMPLETED|Dose Escalation Phase||0
11377725|NCT03370302|12572586|FG002|COMPLETED|Dose Escalation Phase||0
11377726|NCT03370302|12572587|FG003|COMPLETED|Dose Escalation Phase||0
11377727|NCT03370302|12572588|FG004|COMPLETED|Dose Escalation Phase||0
11377728|NCT03370302|12572589|FG005|COMPLETED|Dose Escalation Phase||0
11377729|NCT03370302|12572584|FG000|NOT COMPLETED|Dose Escalation Phase||3
11377730|NCT03370302|12572585|FG001|NOT COMPLETED|Dose Escalation Phase||6
11377731|NCT03370302|12572586|FG002|NOT COMPLETED|Dose Escalation Phase||7
11377732|NCT03370302|12572587|FG003|NOT COMPLETED|Dose Escalation Phase||0
11377733|NCT03370302|12572588|FG004|NOT COMPLETED|Dose Escalation Phase||3
11377734|NCT03370302|12572589|FG005|NOT COMPLETED|Dose Escalation Phase||3
11377735|NCT03370302|12572584|FG000|STARTED|Dose Expansion Phase||0
11377736|NCT03370302|12572585|FG001|STARTED|Dose Expansion Phase||0
11377737|NCT03370302|12572586|FG002|STARTED|Dose Expansion Phase||0
11377738|NCT03370302|12572587|FG003|STARTED|Dose Expansion Phase||6
11377739|NCT03370302|12572588|FG004|STARTED|Dose Expansion Phase||0
11377740|NCT03370302|12572589|FG005|STARTED|Dose Expansion Phase||0
11377741|NCT03370302|12572584|FG000|COMPLETED|Dose Expansion Phase||0
11377742|NCT03370302|12572585|FG001|COMPLETED|Dose Expansion Phase||0
11377743|NCT03370302|12572586|FG002|COMPLETED|Dose Expansion Phase||0
11377744|NCT03370302|12572587|FG003|COMPLETED|Dose Expansion Phase||0
11377745|NCT03370302|12572588|FG004|COMPLETED|Dose Expansion Phase||0
11377746|NCT03370302|12572589|FG005|COMPLETED|Dose Expansion Phase||0
11377747|NCT03370302|12572584|FG000|NOT COMPLETED|Dose Expansion Phase||0
11377748|NCT03370302|12572585|FG001|NOT COMPLETED|Dose Expansion Phase||0
11377749|NCT03370302|12572586|FG002|NOT COMPLETED|Dose Expansion Phase||0
11377750|NCT03370302|12572587|FG003|NOT COMPLETED|Dose Expansion Phase||6
11377751|NCT03370302|12572588|FG004|NOT COMPLETED|Dose Expansion Phase||0
11377752|NCT03370302|12572589|FG005|NOT COMPLETED|Dose Expansion Phase||0
11377753|NCT03370419|12572607|FG000|STARTED|Overall Study||40
11377754|NCT03370419|12572607|FG000|COMPLETED|Overall Study||24
11377755|NCT03370419|12572607|FG000|NOT COMPLETED|Overall Study||16
11377756|NCT03370471|12572613|FG000|STARTED|Overall Study||23
11377757|NCT03370471|12572614|FG001|STARTED|Overall Study||5
11377758|NCT03370471|12572613|FG000|COMPLETED|Overall Study||16
11377759|NCT03370471|12572614|FG001|COMPLETED|Overall Study||3
11377760|NCT03370471|12572613|FG000|NOT COMPLETED|Overall Study||7
11377761|NCT03370471|12572614|FG001|NOT COMPLETED|Overall Study||2
11377762|NCT03370770|12572622|FG000|STARTED|Overall Study||204
11377763|NCT03370770|12572622|FG000|COMPLETED|Overall Study||98
11377764|NCT03370770|12572622|FG000|NOT COMPLETED|Overall Study||106
11377765|NCT03371355|12572630|FG000|STARTED|Overall Study||27
11377766|NCT03371355|12572631|FG001|STARTED|Overall Study||26
11377767|NCT03371355|12572632|FG002|STARTED|Overall Study||26
11377768|NCT03371355|12572633|FG003|STARTED|Overall Study||26
11377769|NCT03371355|12572630|FG000|COMPLETED|Overall Study||26
11377770|NCT03371355|12572631|FG001|COMPLETED|Overall Study||24
11377771|NCT03371355|12572632|FG002|COMPLETED|Overall Study||22
11377772|NCT03371355|12572633|FG003|COMPLETED|Overall Study||19
11377773|NCT03371355|12572630|FG000|NOT COMPLETED|Overall Study||1
11377774|NCT03371355|12572631|FG001|NOT COMPLETED|Overall Study||2
11377775|NCT03371355|12572632|FG002|NOT COMPLETED|Overall Study||4
11377776|NCT03371355|12572633|FG003|NOT COMPLETED|Overall Study||7
11377777|NCT03371381|12572647|FG000|STARTED|Overall Study||12
11377778|NCT03371381|12572647|FG000|COMPLETED|Overall Study||0
11377779|NCT03371381|12572647|FG000|NOT COMPLETED|Overall Study||12
11377780|NCT03371459|12572651|FG000|STARTED|Period 1||23
11377781|NCT03371459|12572652|FG001|STARTED|Period 1||23
11377782|NCT03371459|12572651|FG000|COMPLETED|Period 1||23
11377783|NCT03371459|12572652|FG001|COMPLETED|Period 1||23
11377784|NCT03371459|12572651|FG000|NOT COMPLETED|Period 1||0
11377785|NCT03371459|12572652|FG001|NOT COMPLETED|Period 1||0
11377786|NCT03371459|12572651|FG000|STARTED|Washout||23
11377787|NCT03371459|12572652|FG001|STARTED|Washout||23
11377788|NCT03371459|12572651|FG000|COMPLETED|Washout||23
11377789|NCT03371459|12572652|FG001|COMPLETED|Washout||22
11377790|NCT03371459|12572651|FG000|NOT COMPLETED|Washout||0
11377791|NCT03371459|12572652|FG001|NOT COMPLETED|Washout||1
11377792|NCT03371459|12572651|FG000|STARTED|Period 2||23
11377793|NCT03371459|12572652|FG001|STARTED|Period 2||22
11377794|NCT03371459|12572651|FG000|COMPLETED|Period 2||23
11377795|NCT03371459|12572652|FG001|COMPLETED|Period 2||22
11377796|NCT03371459|12572651|FG000|NOT COMPLETED|Period 2||0
11377797|NCT03371459|12572652|FG001|NOT COMPLETED|Period 2||0
11377798|NCT03371732|12572660|FG000|STARTED|Overall Study||51
11377799|NCT03371732|12572661|FG001|STARTED|Overall Study||53
11377800|NCT03371732|12572660|FG000|COMPLETED|Overall Study||39
11377801|NCT03371732|12572661|FG001|COMPLETED|Overall Study||46
11377802|NCT03371732|12572660|FG000|NOT COMPLETED|Overall Study||12
11377803|NCT03371732|12572661|FG001|NOT COMPLETED|Overall Study||7
11377804|NCT03371836|12572669|FG000|STARTED|Overall Study||20
11377805|NCT03371836|12572669|FG000|COMPLETED|Overall Study||18
11377806|NCT03371836|12572669|FG000|NOT COMPLETED|Overall Study||2
11377807|NCT03372083|12572673|FG000|STARTED|Overall Study||44
11377808|NCT03372083|12572673|FG000|COMPLETED|Overall Study||39
11377809|NCT03372083|12572673|FG000|NOT COMPLETED|Overall Study||5
11377810|NCT03372096|12572677|FG000|STARTED|Overall Study||18
11377811|NCT03372096|12572677|FG000|Received Intervention|Overall Study||10
11377812|NCT03372096|12572677|FG000|COMPLETED|Overall Study||10
11377813|NCT03372096|12572677|FG000|NOT COMPLETED|Overall Study||8
11377814|NCT03372369|12572686|FG000|STARTED|Qualification Period||495
11377815|NCT03372369|12572687|FG001|STARTED|Qualification Period||495
11377816|NCT03372369|12572686|FG000|COMPLETED|Qualification Period||469
11377817|NCT03372369|12572687|FG001|COMPLETED|Qualification Period||473
11377818|NCT03372369|12572686|FG000|NOT COMPLETED|Qualification Period||26
11377819|NCT03372369|12572687|FG001|NOT COMPLETED|Qualification Period||22
11377820|NCT03372369|12572686|FG000|STARTED|Intervention and Follow-Up Period||469
11377821|NCT03372369|12572687|FG001|STARTED|Intervention and Follow-Up Period||473
11377822|NCT03372369|12572686|FG000|COMPLETED|Intervention and Follow-Up Period||466
11377823|NCT03372369|12572687|FG001|COMPLETED|Intervention and Follow-Up Period||470
11377824|NCT03372369|12572686|FG000|NOT COMPLETED|Intervention and Follow-Up Period||3
11377825|NCT03372369|12572687|FG001|NOT COMPLETED|Intervention and Follow-Up Period||3
11377826|NCT03372382|12572695|FG000|STARTED|Overall Study||85
11377827|NCT03372382|12572696|FG001|STARTED|Overall Study||85
11377828|NCT03372382|12572695|FG000|COMPLETED|Overall Study||76
11377829|NCT03372382|12572696|FG001|COMPLETED|Overall Study||81
11377830|NCT03372382|12572695|FG000|NOT COMPLETED|Overall Study||9
11377831|NCT03372382|12572696|FG001|NOT COMPLETED|Overall Study||4
11377832|NCT03372434|12572707|FG000|STARTED|Overall Study||78
11377833|NCT03372434|12572708|FG001|STARTED|Overall Study||73
11377834|NCT03372434|12572709|FG002|STARTED|Overall Study||74
11377835|NCT03372434|12572707|FG000|1 Month Follow-up|Overall Study||76
11377836|NCT03372434|12572708|FG001|1 Month Follow-up|Overall Study||72
11377837|NCT03372434|12572709|FG002|1 Month Follow-up|Overall Study||73
11377838|NCT03372434|12572707|FG000|COMPLETED|Overall Study||76
11377839|NCT03372434|12572708|FG001|COMPLETED|Overall Study||70
11377840|NCT03372434|12572709|FG002|COMPLETED|Overall Study||72
11377841|NCT03372434|12572707|FG000|NOT COMPLETED|Overall Study||2
11377842|NCT03372434|12572708|FG001|NOT COMPLETED|Overall Study||3
11377843|NCT03372434|12572709|FG002|NOT COMPLETED|Overall Study||2
11377844|NCT03372551|12572717|FG000|STARTED|First Intervention (1 Week)||17
11377845|NCT03372551|12572718|FG001|STARTED|First Intervention (1 Week)||16
11377846|NCT03372551|12572717|FG000|COMPLETED|First Intervention (1 Week)||16
11377847|NCT03372551|12572718|FG001|COMPLETED|First Intervention (1 Week)||16
11377848|NCT03372551|12572717|FG000|NOT COMPLETED|First Intervention (1 Week)||1
11377849|NCT03372551|12572718|FG001|NOT COMPLETED|First Intervention (1 Week)||0
11377850|NCT03372551|12572717|FG000|STARTED|Second Intervention (1 Week)||16
11377851|NCT03372551|12572718|FG001|STARTED|Second Intervention (1 Week)||16
11377852|NCT03372551|12572717|FG000|COMPLETED|Second Intervention (1 Week)||16
11377853|NCT03372551|12572718|FG001|COMPLETED|Second Intervention (1 Week)||16
11377854|NCT03372551|12572717|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
11377855|NCT03372551|12572718|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
11377856|NCT03372603|12572731|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||9
11377857|NCT03372603|12572732|FG001|STARTED|Treatment Period 1 (Up to 7 Days)||8
11377858|NCT03372603|12572731|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||9
11377859|NCT03372603|12572732|FG001|COMPLETED|Treatment Period 1 (Up to 7 Days)||8
11377860|NCT03372603|12572731|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
11377861|NCT03372603|12572732|FG001|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
11377862|NCT03372603|12572731|FG000|STARTED|Wash-out Period (14-21 Days)||9
11377863|NCT03372603|12572732|FG001|STARTED|Wash-out Period (14-21 Days)||8
11377864|NCT03372603|12572731|FG000|COMPLETED|Wash-out Period (14-21 Days)||8
11377865|NCT03372603|12572732|FG001|COMPLETED|Wash-out Period (14-21 Days)||8
11377866|NCT03372603|12572731|FG000|NOT COMPLETED|Wash-out Period (14-21 Days)||1
11377867|NCT03372603|12572732|FG001|NOT COMPLETED|Wash-out Period (14-21 Days)||0
11377868|NCT03372603|12572731|FG000|STARTED|Treatment Period 2 (Up to 7 Days)||8
11377869|NCT03372603|12572732|FG001|STARTED|Treatment Period 2 (Up to 7 Days)||8
11377870|NCT03372603|12572731|FG000|COMPLETED|Treatment Period 2 (Up to 7 Days)||7
11377871|NCT03372603|12572732|FG001|COMPLETED|Treatment Period 2 (Up to 7 Days)||8
11377872|NCT03372603|12572731|FG000|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1
11377873|NCT03372603|12572732|FG001|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0
11377874|NCT03372928|12572738|FG000|STARTED|First Intervention (5 d Energy Deficit)||10
11377875|NCT03372928|12572739|FG001|STARTED|First Intervention (5 d Energy Deficit)||10
11377876|NCT03372928|12572738|FG000|COMPLETED|First Intervention (5 d Energy Deficit)||10
11377877|NCT03372928|12572739|FG001|COMPLETED|First Intervention (5 d Energy Deficit)||10
11377878|NCT03372928|12572738|FG000|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
11377879|NCT03372928|12572739|FG001|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
11377880|NCT03372928|12572738|FG000|STARTED|Washout (14 d)||10
11377881|NCT03372928|12572739|FG001|STARTED|Washout (14 d)||10
11377882|NCT03372928|12572738|FG000|COMPLETED|Washout (14 d)||10
11377883|NCT03372928|12572739|FG001|COMPLETED|Washout (14 d)||9
11377884|NCT03372928|12572738|FG000|NOT COMPLETED|Washout (14 d)||0
11377885|NCT03372928|12572739|FG001|NOT COMPLETED|Washout (14 d)||1
11377886|NCT03372928|12572738|FG000|STARTED|Second Intervention (5 d Energy Deficit)||10
11377887|NCT03372928|12572739|FG001|STARTED|Second Intervention (5 d Energy Deficit)||9
11377888|NCT03372928|12572738|FG000|COMPLETED|Second Intervention (5 d Energy Deficit)||10
11377889|NCT03372928|12572739|FG001|COMPLETED|Second Intervention (5 d Energy Deficit)||9
11377890|NCT03372928|12572738|FG000|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
11377891|NCT03372928|12572739|FG001|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
11377892|NCT03373162|12572750|FG000|STARTED|Overall Study||10
11377893|NCT03373162|12572750|FG000|COMPLETED|Overall Study||10
11377894|NCT03373162|12572750|FG000|NOT COMPLETED|Overall Study||0
11377895|NCT03373240|12572757|FG000|STARTED|Overall Study||22
11377896|NCT03373240|12572758|FG001|STARTED|Overall Study||24
11377897|NCT03373240|12572757|FG000|4-week Post Treatment|Overall Study||14
11377898|NCT03373240|12572758|FG001|4-week Post Treatment|Overall Study||23
11377899|NCT03373240|12572757|FG000|COMPLETED|Overall Study|This is the 1-month post follow-up|11
11377900|NCT03373240|12572758|FG001|COMPLETED|Overall Study|This is the 1-month post follow-up|20
11377901|NCT03373240|12572757|FG000|NOT COMPLETED|Overall Study||11
11377902|NCT03373240|12572758|FG001|NOT COMPLETED|Overall Study||4
11377903|NCT03373383|12572769|FG000|STARTED|Treatment Period: Wk0-16||83
11377904|NCT03373383|12572770|FG001|STARTED|Treatment Period: Wk0-16||81
11377905|NCT03373383|12572771|FG002|STARTED|Treatment Period: Wk0-16||83
11377906|NCT03373383|12572772|FG003|STARTED|Treatment Period: Wk0-16||82
11377907|NCT03373383|12572773|FG004|STARTED|Treatment Period: Wk0-16||82
11377908|NCT03373383|12572769|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||78
11377909|NCT03373383|12572770|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||72
11377910|NCT03373383|12572771|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||71
11377911|NCT03373383|12572772|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||68
11377912|NCT03373383|12572773|FG004|Completed Titration and Stabilization|Treatment Period: Wk0-16||65
11377913|NCT03373383|12572769|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||70
11377914|NCT03373383|12572770|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||66
11377915|NCT03373383|12572771|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||68
11377916|NCT03373383|12572772|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||61
11377917|NCT03373383|12572773|FG004|Completed Maintenance Period|Treatment Period: Wk0-16||58
11377918|NCT03373383|12572769|FG000|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||6
11377919|NCT03373383|12572770|FG001|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||11
11377920|NCT03373383|12572771|FG002|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||8
11377921|NCT03373383|12572772|FG003|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||18
11377922|NCT03373383|12572773|FG004|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||21
11377923|NCT03373383|12572769|FG000|COMPLETED|Treatment Period: Wk0-16||70
11377924|NCT03373383|12572770|FG001|COMPLETED|Treatment Period: Wk0-16||66
11377925|NCT03373383|12572771|FG002|COMPLETED|Treatment Period: Wk0-16||68
11377926|NCT03373383|12572772|FG003|COMPLETED|Treatment Period: Wk0-16||61
11377927|NCT03373383|12572773|FG004|COMPLETED|Treatment Period: Wk0-16||58
11377928|NCT03373383|12572769|FG000|NOT COMPLETED|Treatment Period: Wk0-16||13
11377929|NCT03373383|12572770|FG001|NOT COMPLETED|Treatment Period: Wk0-16||15
11377930|NCT03373383|12572771|FG002|NOT COMPLETED|Treatment Period: Wk0-16||15
11377931|NCT03373383|12572772|FG003|NOT COMPLETED|Treatment Period: Wk0-16||21
11377932|NCT03373383|12572773|FG004|NOT COMPLETED|Treatment Period: Wk0-16||24
11377933|NCT03373383|12572769|FG000|STARTED|Post-Treatment Period: Wk16-23||70
11377934|NCT03373383|12572770|FG001|STARTED|Post-Treatment Period: Wk16-23||66
11377935|NCT03373383|12572771|FG002|STARTED|Post-Treatment Period: Wk16-23||68
11377936|NCT03373383|12572772|FG003|STARTED|Post-Treatment Period: Wk16-23||61
11377937|NCT03373383|12572773|FG004|STARTED|Post-Treatment Period: Wk16-23||58
11377938|NCT03373383|12572769|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||69
11377939|NCT03373383|12572770|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||64
11377940|NCT03373383|12572771|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||66
11377941|NCT03373383|12572772|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||55
11377942|NCT03373383|12572773|FG004|Started Conversion Period|Post-Treatment Period: Wk16-23||57
11377943|NCT03373383|12572769|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||68
11377944|NCT03373383|12572770|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||64
11377945|NCT03373383|12572771|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||66
11377946|NCT03373383|12572772|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||55
11377947|NCT03373383|12572773|FG004|Completed Conversion Period|Post-Treatment Period: Wk16-23||57
11377948|NCT03373383|12572769|FG000|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
11377949|NCT03373383|12572770|FG001|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
11377950|NCT03373383|12572771|FG002|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
11377951|NCT03373383|12572772|FG003|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||6
11005987|NCT00726232|12183813|FG001|STARTED|Initial Phase (Dose-finding)||8
11005988|NCT00726232|12183814|FG002|STARTED|Initial Phase (Dose-finding)||7
11005989|NCT00726232|12183815|FG003|STARTED|Initial Phase (Dose-finding)||8
11005990|NCT00726232|12183816|FG004|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
11005991|NCT00726232|12183817|FG005|STARTED|Initial Phase (Dose-finding)||9
11377952|NCT03373383|12572773|FG004|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||1
11377953|NCT03373383|12572769|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||67
11377954|NCT03373383|12572770|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||63
11377955|NCT03373383|12572771|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||65
11377956|NCT03373383|12572772|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||55
11377957|NCT03373383|12572773|FG004|Enrolled in EP0093|Post-Treatment Period: Wk16-23||57
11377958|NCT03373383|12572769|FG000|COMPLETED|Post-Treatment Period: Wk16-23||69
11377959|NCT03373383|12572770|FG001|COMPLETED|Post-Treatment Period: Wk16-23||66
11377960|NCT03373383|12572771|FG002|COMPLETED|Post-Treatment Period: Wk16-23||68
11377961|NCT03373383|12572772|FG003|COMPLETED|Post-Treatment Period: Wk16-23||61
11377962|NCT03373383|12572773|FG004|COMPLETED|Post-Treatment Period: Wk16-23||58
11005992|NCT00726232|12183818|FG006|STARTED|Initial Phase (Dose-finding)||0
11005993|NCT00726232|12183819|FG007|STARTED|Initial Phase (Dose-finding)||0
11005994|NCT00726232|12183812|FG000|Safety Evaluable Participants|Initial Phase (Dose-finding)||19
11005995|NCT00726232|12183813|FG001|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
11005996|NCT00726232|12183814|FG002|Safety Evaluable Participants|Initial Phase (Dose-finding)||7
11005997|NCT00726232|12183815|FG003|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
11005998|NCT00726232|12183816|FG004|Safety Evaluable Participants|Initial Phase (Dose-finding)||22
11005999|NCT00726232|12183817|FG005|Safety Evaluable Participants|Initial Phase (Dose-finding)||9
11006000|NCT00726232|12183818|FG006|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
11006001|NCT00726232|12183819|FG007|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
11006002|NCT00726232|12183812|FG000|ITT Participants|Initial Phase (Dose-finding)||19
11006003|NCT00726232|12183813|FG001|ITT Participants|Initial Phase (Dose-finding)||8
11006004|NCT00726232|12183814|FG002|ITT Participants|Initial Phase (Dose-finding)||7
11006005|NCT00726232|12183815|FG003|ITT Participants|Initial Phase (Dose-finding)||8
11006006|NCT00726232|12183816|FG004|ITT Participants|Initial Phase (Dose-finding)||22
11006007|NCT00726232|12183817|FG005|ITT Participants|Initial Phase (Dose-finding)||9
11006008|NCT00726232|12183818|FG006|ITT Participants|Initial Phase (Dose-finding)||0
11006009|NCT00726232|12183819|FG007|ITT Participants|Initial Phase (Dose-finding)||0
11006010|NCT00726232|12183812|FG000|COMPLETED|Initial Phase (Dose-finding)||6
11006011|NCT00726232|12183813|FG001|COMPLETED|Initial Phase (Dose-finding)||2
11006012|NCT00726232|12183814|FG002|COMPLETED|Initial Phase (Dose-finding)||2
11006013|NCT00726232|12183815|FG003|COMPLETED|Initial Phase (Dose-finding)||0
11006014|NCT00726232|12183816|FG004|COMPLETED|Initial Phase (Dose-finding)||1
11006015|NCT00726232|12183817|FG005|COMPLETED|Initial Phase (Dose-finding)||0
11006016|NCT00726232|12183818|FG006|COMPLETED|Initial Phase (Dose-finding)||0
11006017|NCT00726232|12183819|FG007|COMPLETED|Initial Phase (Dose-finding)||0
11006018|NCT00726232|12183812|FG000|NOT COMPLETED|Initial Phase (Dose-finding)||13
11006019|NCT00726232|12183813|FG001|NOT COMPLETED|Initial Phase (Dose-finding)||6
11006020|NCT00726232|12183814|FG002|NOT COMPLETED|Initial Phase (Dose-finding)||5
11377963|NCT03373383|12572769|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
11377964|NCT03373383|12572770|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
11377965|NCT03373383|12572771|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
11377966|NCT03373383|12572772|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
11377967|NCT03373383|12572773|FG004|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
11377968|NCT03373591|12572803|FG000|STARTED|Overall Study||75
11377969|NCT03373591|12572804|FG001|STARTED|Overall Study||71
11006021|NCT00726232|12183815|FG003|NOT COMPLETED|Initial Phase (Dose-finding)||8
11006022|NCT00726232|12183816|FG004|NOT COMPLETED|Initial Phase (Dose-finding)||21
11006023|NCT00726232|12183817|FG005|NOT COMPLETED|Initial Phase (Dose-finding)||9
11006024|NCT00726232|12183818|FG006|NOT COMPLETED|Initial Phase (Dose-finding)||0
11006025|NCT00726232|12183819|FG007|NOT COMPLETED|Initial Phase (Dose-finding)||0
11006026|NCT00726232|12183812|FG000|STARTED|Expansion Phase||0
11006027|NCT00726232|12183813|FG001|STARTED|Expansion Phase||0
11377970|NCT03373591|12572805|FG002|STARTED|Overall Study||73
11377971|NCT03373591|12572803|FG000|COMPLETED|Overall Study||75
11377972|NCT03373591|12572804|FG001|COMPLETED|Overall Study||71
11377973|NCT03373591|12572805|FG002|COMPLETED|Overall Study||73
11377974|NCT03373591|12572803|FG000|NOT COMPLETED|Overall Study||0
11377975|NCT03373591|12572804|FG001|NOT COMPLETED|Overall Study||0
11377976|NCT03373591|12572805|FG002|NOT COMPLETED|Overall Study||0
11377977|NCT03373890|12572815|FG000|STARTED|Overall Study||6
11377978|NCT03373890|12572816|FG001|STARTED|Overall Study||6
11377979|NCT03373890|12572815|FG000|COMPLETED|Overall Study||6
11377980|NCT03373890|12572816|FG001|COMPLETED|Overall Study||6
11377981|NCT03373890|12572815|FG000|NOT COMPLETED|Overall Study||0
11377982|NCT03373890|12572816|FG001|NOT COMPLETED|Overall Study||0
11377983|NCT03374176|12572826|FG000|STARTED|Overall Study||21
11377984|NCT03374176|12572827|FG001|STARTED|Overall Study||21
11377985|NCT03374176|12572826|FG000|COMPLETED|Overall Study||21
11377986|NCT03374176|12572827|FG001|COMPLETED|Overall Study||21
11377987|NCT03374176|12572826|FG000|NOT COMPLETED|Overall Study||0
11377988|NCT03374176|12572827|FG001|NOT COMPLETED|Overall Study||0
11377989|NCT03374189|12572835|FG000|STARTED|Overall Study||40
11377990|NCT03374189|12572836|FG001|STARTED|Overall Study||39
11377991|NCT03374189|12572835|FG000|COMPLETED|Overall Study||39
11377992|NCT03374189|12572836|FG001|COMPLETED|Overall Study||39
11377993|NCT03374189|12572835|FG000|NOT COMPLETED|Overall Study||1
11377994|NCT03374189|12572836|FG001|NOT COMPLETED|Overall Study||0
11377995|NCT03374358|12572844|FG000|STARTED|Overall Study||24
11377996|NCT03374358|12572845|FG001|STARTED|Overall Study||21
11377997|NCT03374358|12572844|FG000|COMPLETED|Overall Study||24
11377998|NCT03374358|12572845|FG001|COMPLETED|Overall Study||19
11377999|NCT03374358|12572844|FG000|NOT COMPLETED|Overall Study||0
11378000|NCT03374358|12572845|FG001|NOT COMPLETED|Overall Study||2
11378001|NCT03374488|12572853|FG000|STARTED|Overall Study||42
11378002|NCT03374488|12572854|FG001|STARTED|Overall Study||42
11378003|NCT03374488|12572853|FG000|Intention-to-Treat (ITT)|Overall Study||42
11378004|NCT03374488|12572854|FG001|Intention-to-Treat (ITT)|Overall Study||42
11378005|NCT03374488|12572853|FG000|All Participants as Treated (APaT)|Overall Study||42
11378006|NCT03374488|12572854|FG001|All Participants as Treated (APaT)|Overall Study||41
11378007|NCT03374488|12572853|FG000|COMPLETED|Overall Study||23
11378008|NCT03374488|12572854|FG001|COMPLETED|Overall Study||28
11378009|NCT03374488|12572853|FG000|NOT COMPLETED|Overall Study||19
11378010|NCT03374488|12572854|FG001|NOT COMPLETED|Overall Study||14
11378011|NCT03374683|12572864|FG000|STARTED|Overall Study||148
11378012|NCT03374683|12572865|FG001|STARTED|Overall Study||150
11378013|NCT03374683|12572866|FG002|STARTED|Overall Study||153
11378014|NCT03374683|12572864|FG000|1-week Post-intervention|Overall Study||135
11378015|NCT03374683|12572865|FG001|1-week Post-intervention|Overall Study||113
11378016|NCT03374683|12572866|FG002|1-week Post-intervention|Overall Study||85
11378017|NCT03374683|12572864|FG000|COMPLETED|Overall Study||123
11378018|NCT03374683|12572865|FG001|COMPLETED|Overall Study||105
11378019|NCT03374683|12572866|FG002|COMPLETED|Overall Study||84
11378020|NCT03374683|12572864|FG000|NOT COMPLETED|Overall Study||25
11378021|NCT03374683|12572865|FG001|NOT COMPLETED|Overall Study||45
11378022|NCT03374683|12572866|FG002|NOT COMPLETED|Overall Study||69
11378023|NCT03374995|12572876|FG000|STARTED|Overall Study||13
11378024|NCT03374995|12572877|FG001|STARTED|Overall Study||12
11378025|NCT03374995|12572876|FG000|COMPLETED|Overall Study||13
11378026|NCT03374995|12572877|FG001|COMPLETED|Overall Study||11
11378027|NCT03374995|12572876|FG000|NOT COMPLETED|Overall Study||0
11378028|NCT03374995|12572877|FG001|NOT COMPLETED|Overall Study||1
11378029|NCT03375294|12572883|FG000|STARTED|Overall Study||3
11378030|NCT03375294|12572883|FG000|COMPLETED|Overall Study||3
11378031|NCT03375294|12572883|FG000|NOT COMPLETED|Overall Study||0
11378032|NCT03376061|12572889|FG000|STARTED|Overall Study||49
11378033|NCT03376061|12572890|FG001|STARTED|Overall Study||48
11378034|NCT03376061|12572889|FG000|COMPLETED|Overall Study||49
11378035|NCT03376061|12572890|FG001|COMPLETED|Overall Study||48
11378036|NCT03376061|12572889|FG000|NOT COMPLETED|Overall Study||0
11378037|NCT03376061|12572890|FG001|NOT COMPLETED|Overall Study||0
11378038|NCT03376256|12572899|FG000|STARTED|Overall Study||2
11378039|NCT03376256|12572900|FG001|STARTED|Overall Study||0
11378040|NCT03376256|12572899|FG000|COMPLETED|Overall Study||2
11378041|NCT03376256|12572900|FG001|COMPLETED|Overall Study||0
11378042|NCT03376256|12572899|FG000|NOT COMPLETED|Overall Study||0
11378043|NCT03376256|12572900|FG001|NOT COMPLETED|Overall Study||0
11378044|NCT03376295|12572908|FG000|STARTED|Overall Study||1977
11378045|NCT03376295|12572909|FG001|STARTED|Overall Study||1977
11378046|NCT03376295|12572908|FG000|COMPLETED|Overall Study||1977
11378047|NCT03376295|12572909|FG001|COMPLETED|Overall Study||1977
11378048|NCT03376295|12572908|FG000|NOT COMPLETED|Overall Study||0
11378049|NCT03376295|12572909|FG001|NOT COMPLETED|Overall Study||0
11378050|NCT03376321|12572917|FG000|STARTED|Overall Study||168
11378051|NCT03376321|12572918|FG001|STARTED|Overall Study||166
11378052|NCT03376321|12572917|FG000|Treated|Overall Study||163
11378053|NCT03376321|12572918|FG001|Treated|Overall Study||163
11378054|NCT03376321|12572917|FG000|COMPLETED|Overall Study||145
11378055|NCT03376321|12572918|FG001|COMPLETED|Overall Study||141
11378056|NCT03376321|12572917|FG000|NOT COMPLETED|Overall Study||23
11378057|NCT03376321|12572918|FG001|NOT COMPLETED|Overall Study||25
11378058|NCT03376516|12572924|FG000|STARTED|Overall Study||11
11378059|NCT03376516|12572924|FG000|Received Treatment|Overall Study||10
11378060|NCT03376516|12572924|FG000|SAF Population|Overall Study||10
11378061|NCT03376516|12572924|FG000|FAS Population|Overall Study||10
11378062|NCT03376516|12572924|FG000|PK Population|Overall Study||10
11378063|NCT03376516|12572924|FG000|PP Population|Overall Study||9
11378064|NCT03376516|12572924|FG000|SURG Population|Overall Study||2
11378065|NCT03376516|12572924|FG000|COMPLETED|Overall Study||9
11378066|NCT03376516|12572924|FG000|NOT COMPLETED|Overall Study||2
11378067|NCT03377127|12572941|FG000|STARTED|Overall Study||42
11378068|NCT03377127|12572942|FG001|STARTED|Overall Study||44
11378069|NCT03377127|12572941|FG000|COMPLETED|Overall Study||42
11378070|NCT03377127|12572942|FG001|COMPLETED|Overall Study||44
11378071|NCT03377127|12572941|FG000|NOT COMPLETED|Overall Study||0
11378072|NCT03377127|12572942|FG001|NOT COMPLETED|Overall Study||0
11378073|NCT03377244|12572951|FG000|STARTED|Baseline||19
11378074|NCT03377244|12572952|FG001|STARTED|Baseline||14
11378075|NCT03377244|12572953|FG002|STARTED|Baseline||69
11378076|NCT03377244|12572951|FG000|COMPLETED|Baseline||19
11378077|NCT03377244|12572952|FG001|COMPLETED|Baseline||14
11378078|NCT03377244|12572953|FG002|COMPLETED|Baseline||69
11378079|NCT03377244|12572951|FG000|NOT COMPLETED|Baseline||0
11378080|NCT03377244|12572952|FG001|NOT COMPLETED|Baseline||0
11378081|NCT03377244|12572953|FG002|NOT COMPLETED|Baseline||0
11378082|NCT03377244|12572951|FG000|STARTED|6 Months Post-intervention||19
11378083|NCT03377244|12572952|FG001|STARTED|6 Months Post-intervention||14
11378084|NCT03377244|12572953|FG002|STARTED|6 Months Post-intervention||69
11378085|NCT03377244|12572951|FG000|COMPLETED|6 Months Post-intervention||13
11378086|NCT03377244|12572952|FG001|COMPLETED|6 Months Post-intervention||7
11378087|NCT03377244|12572953|FG002|COMPLETED|6 Months Post-intervention||55
11378088|NCT03377244|12572951|FG000|NOT COMPLETED|6 Months Post-intervention||6
11378089|NCT03377244|12572952|FG001|NOT COMPLETED|6 Months Post-intervention||7
11378090|NCT03377244|12572953|FG002|NOT COMPLETED|6 Months Post-intervention||14
11378091|NCT03377556|12572961|FG000|STARTED|Overall Study||47
11378092|NCT03377556|12572961|FG000|Primary Analysis Population (HRRD-positive Per MDVN Criteria)|Overall Study||24
11378093|NCT03377556|12572961|FG000|COMPLETED|Overall Study||0
11378094|NCT03377556|12572961|FG000|NOT COMPLETED|Overall Study||47
11378095|NCT03377634|12572967|FG000|STARTED|Intervention Usability Testing Period||5
11378096|NCT03377634|12572968|FG001|STARTED|Intervention Usability Testing Period||0
11378097|NCT03377634|12572967|FG000|COMPLETED|Intervention Usability Testing Period||5
11378098|NCT03377634|12572968|FG001|COMPLETED|Intervention Usability Testing Period||0
11378099|NCT03377634|12572967|FG000|NOT COMPLETED|Intervention Usability Testing Period||0
11378100|NCT03377634|12572968|FG001|NOT COMPLETED|Intervention Usability Testing Period||0
11378101|NCT03377634|12572967|FG000|STARTED|Study Period||15
11378102|NCT03377634|12572968|FG001|STARTED|Study Period||13
11378103|NCT03377634|12572967|FG000|COMPLETED|Study Period||13
11378104|NCT03377634|12572968|FG001|COMPLETED|Study Period||13
11378105|NCT03377634|12572967|FG000|NOT COMPLETED|Study Period||2
11378106|NCT03377634|12572968|FG001|NOT COMPLETED|Study Period||0
11378107|NCT03378076|12572976|FG000|STARTED|Overall Study||12
11378108|NCT03378076|12572977|FG001|STARTED|Overall Study||12
11378109|NCT03378076|12572976|FG000|COMPLETED|Overall Study||12
11378110|NCT03378076|12572977|FG001|COMPLETED|Overall Study||12
11378111|NCT03378076|12572976|FG000|NOT COMPLETED|Overall Study||0
11378112|NCT03378076|12572977|FG001|NOT COMPLETED|Overall Study||0
11378113|NCT03378635|12572986|FG000|STARTED|Overall Study||84
11378114|NCT03378635|12572987|FG001|STARTED|Overall Study||43
11378115|NCT03378635|12572988|FG002|STARTED|Overall Study||43
11378116|NCT03378635|12572986|FG000|Randomized and Exposed to Treatment|Overall Study||82
11378117|NCT03378635|12572987|FG001|Randomized and Exposed to Treatment|Overall Study||43
11378118|NCT03378635|12572988|FG002|Randomized and Exposed to Treatment|Overall Study||43
11378119|NCT03378635|12572986|FG000|COMPLETED|Overall Study||82
11378120|NCT03378635|12572987|FG001|COMPLETED|Overall Study||43
11378121|NCT03378635|12572988|FG002|COMPLETED|Overall Study||43
11378122|NCT03378635|12572986|FG000|NOT COMPLETED|Overall Study||2
11378123|NCT03378635|12572987|FG001|NOT COMPLETED|Overall Study||0
11378124|NCT03378635|12572988|FG002|NOT COMPLETED|Overall Study||0
11378125|NCT03378921|12572999|FG000|STARTED|Overall Study||13
11378126|NCT03378921|12573000|FG001|STARTED|Overall Study||13
11378127|NCT03378921|12572999|FG000|COMPLETED|Overall Study||13
11378128|NCT03378921|12573000|FG001|COMPLETED|Overall Study||13
11378129|NCT03378921|12572999|FG000|NOT COMPLETED|Overall Study||0
11378130|NCT03378921|12573000|FG001|NOT COMPLETED|Overall Study||0
11378131|NCT03378973|12573008|FG000|STARTED|Overall Study||4
11378132|NCT03378973|12573009|FG001|STARTED|Overall Study||3
11378133|NCT03378973|12573008|FG000|COMPLETED|Overall Study||4
11378134|NCT03378973|12573009|FG001|COMPLETED|Overall Study||3
11378135|NCT03378973|12573008|FG000|NOT COMPLETED|Overall Study||0
11378136|NCT03378973|12573009|FG001|NOT COMPLETED|Overall Study||0
11378137|NCT03379259|12573021|FG000|STARTED|Overall Study||3
11378138|NCT03379259|12573022|FG001|STARTED|Overall Study||3
11378139|NCT03379259|12573023|FG002|STARTED|Overall Study||6
11378140|NCT03379259|12573024|FG003|STARTED|Overall Study||3
11378141|NCT03379259|12573025|FG004|STARTED|Overall Study||12
11378142|NCT03379259|12573026|FG005|STARTED|Overall Study||12
11378143|NCT03379259|12573021|FG000|COMPLETED|Overall Study||2
11378144|NCT03379259|12573022|FG001|COMPLETED|Overall Study||2
11378145|NCT03379259|12573023|FG002|COMPLETED|Overall Study||3
11378146|NCT03379259|12573024|FG003|COMPLETED|Overall Study||0
11378147|NCT03379259|12573025|FG004|COMPLETED|Overall Study||3
11378148|NCT03379259|12573026|FG005|COMPLETED|Overall Study||5
11378149|NCT03379259|12573021|FG000|NOT COMPLETED|Overall Study||1
11378150|NCT03379259|12573022|FG001|NOT COMPLETED|Overall Study||1
11378151|NCT03379259|12573023|FG002|NOT COMPLETED|Overall Study||3
11378152|NCT03379259|12573024|FG003|NOT COMPLETED|Overall Study||3
11378153|NCT03379259|12573025|FG004|NOT COMPLETED|Overall Study||9
11378154|NCT03379259|12573026|FG005|NOT COMPLETED|Overall Study||7
11378155|NCT03379376|12573043|FG000|STARTED|Overall Study||10
11378156|NCT03379376|12573043|FG000|COMPLETED|Overall Study||5
11378157|NCT03379376|12573043|FG000|NOT COMPLETED|Overall Study||5
11378158|NCT03379506|12573051|FG000|STARTED|Overall Study||22
11378159|NCT03379506|12573052|FG001|STARTED|Overall Study||17
11378160|NCT03379506|12573053|FG002|STARTED|Overall Study||7
11378161|NCT03379506|12573054|FG003|STARTED|Overall Study||11
11378162|NCT03379506|12573051|FG000|COMPLETED|Overall Study||22
11378163|NCT03379506|12573052|FG001|COMPLETED|Overall Study||17
11378164|NCT03379506|12573053|FG002|COMPLETED|Overall Study||7
11378165|NCT03379506|12573054|FG003|COMPLETED|Overall Study||11
11378166|NCT03379506|12573051|FG000|NOT COMPLETED|Overall Study||0
11378167|NCT03379506|12573052|FG001|NOT COMPLETED|Overall Study||0
11378168|NCT03379506|12573053|FG002|NOT COMPLETED|Overall Study||0
11378169|NCT03379506|12573054|FG003|NOT COMPLETED|Overall Study||0
11378170|NCT03379545|12573064|FG000|STARTED|Overall Study||29
11378171|NCT03379545|12573064|FG000|COMPLETED|Overall Study||29
11378172|NCT03379545|12573064|FG000|NOT COMPLETED|Overall Study||0
11378173|NCT03379662|12573071|FG000|STARTED|Overall Study||21
11378174|NCT03379662|12573072|FG001|STARTED|Overall Study||19
11378175|NCT03379662|12573071|FG000|COMPLETED|Overall Study||21
11378176|NCT03379662|12573072|FG001|COMPLETED|Overall Study||19
11378177|NCT03379662|12573071|FG000|NOT COMPLETED|Overall Study||0
11378178|NCT03379662|12573072|FG001|NOT COMPLETED|Overall Study||0
11378179|NCT03379740|12573080|FG000|STARTED|Overall Study||8
11378180|NCT03379740|12573081|FG001|STARTED|Overall Study||7
11378181|NCT03379740|12573080|FG000|COMPLETED|Overall Study||8
11378182|NCT03379740|12573081|FG001|COMPLETED|Overall Study||7
11378183|NCT03379740|12573080|FG000|NOT COMPLETED|Overall Study||0
11378184|NCT03379740|12573081|FG001|NOT COMPLETED|Overall Study||0
11378185|NCT03379753|12573096|FG000|STARTED|Overall Study||61
11378186|NCT03379753|12573097|FG001|STARTED|Overall Study||71
11378187|NCT03379753|12573096|FG000|COMPLETED|Overall Study||46
11378188|NCT03379753|12573097|FG001|COMPLETED|Overall Study||46
11378189|NCT03379753|12573096|FG000|NOT COMPLETED|Overall Study||15
11378190|NCT03379753|12573097|FG001|NOT COMPLETED|Overall Study||25
11378191|NCT03380026|12573103|FG000|STARTED|Overall Study||28
11378192|NCT03380026|12573103|FG000|Half of Body Assigned to Treatment With Valchlor Only|Overall Study||28
11378193|NCT03380026|12573103|FG000|Half of Body Assigned to Treatment With Valchlor and Triamcinolone Acetonide|Overall Study||28
11378194|NCT03380026|12573103|FG000|COMPLETED|Overall Study||25
11378195|NCT03380026|12573103|FG000|NOT COMPLETED|Overall Study||3
11378196|NCT03380091|12573112|FG000|STARTED|Overall Study||3
11378197|NCT03380091|12573113|FG001|STARTED|Overall Study||2
11378198|NCT03380091|12573112|FG000|Began Arm Treatment|Overall Study|1 participant withdrew after completing baseline measures and another withdrew just after enrolling.|1
11378199|NCT03380091|12573113|FG001|Began Arm Treatment|Overall Study|1 of the 2 participant assigned to Metformin withdrew from the study just after enrolling.|1
11378200|NCT03380091|12573112|FG000|COMPLETED|Overall Study||1
11378201|NCT03380091|12573113|FG001|COMPLETED|Overall Study||1
11378202|NCT03380091|12573112|FG000|NOT COMPLETED|Overall Study||2
11378203|NCT03380091|12573113|FG001|NOT COMPLETED|Overall Study||1
11378204|NCT03380390|12573121|FG000|STARTED|Overall Study||46
11378205|NCT03380390|12573121|FG000|COMPLETED|Overall Study||43
11378206|NCT03380390|12573121|FG000|NOT COMPLETED|Overall Study||3
11378207|NCT03380429|12573130|FG000|STARTED|Overall Study||87
11378208|NCT03380429|12573131|FG001|STARTED|Overall Study||88
11378209|NCT03380429|12573132|FG002|STARTED|Overall Study||88
11378210|NCT03380429|12573133|FG003|STARTED|Overall Study||88
11378211|NCT03380429|12573134|FG004|STARTED|Overall Study||86
11378212|NCT03380429|12573130|FG000|COMPLETED|Overall Study||82
11378213|NCT03380429|12573131|FG001|COMPLETED|Overall Study||81
11378214|NCT03380429|12573132|FG002|COMPLETED|Overall Study||77
11378215|NCT03380429|12573133|FG003|COMPLETED|Overall Study||78
11378216|NCT03380429|12573134|FG004|COMPLETED|Overall Study||81
11378217|NCT03380429|12573130|FG000|NOT COMPLETED|Overall Study||5
11378218|NCT03380429|12573131|FG001|NOT COMPLETED|Overall Study||7
11378219|NCT03380429|12573132|FG002|NOT COMPLETED|Overall Study||11
11378220|NCT03380429|12573133|FG003|NOT COMPLETED|Overall Study||10
11378221|NCT03380429|12573134|FG004|NOT COMPLETED|Overall Study||5
11378222|NCT03380572|12573153|FG000|STARTED|Overall Study||20
11378223|NCT03380572|12573154|FG001|STARTED|Overall Study||20
11378224|NCT03380572|12573153|FG000|COMPLETED|Overall Study||20
11378225|NCT03380572|12573154|FG001|COMPLETED|Overall Study||20
11378226|NCT03380572|12573153|FG000|NOT COMPLETED|Overall Study||0
11378227|NCT03380572|12573154|FG001|NOT COMPLETED|Overall Study||0
11378228|NCT03380624|12573160|FG000|STARTED|Overall Study||10
11378229|NCT03380624|12573161|FG001|STARTED|Overall Study||9
11378230|NCT03380624|12573160|FG000|COMPLETED|Overall Study||10
11378231|NCT03380624|12573161|FG001|COMPLETED|Overall Study||9
11378232|NCT03380624|12573160|FG000|NOT COMPLETED|Overall Study||0
11378233|NCT03380624|12573161|FG001|NOT COMPLETED|Overall Study||0
11378234|NCT03380780|12573167|FG000|STARTED|Overall Study||16
11378235|NCT03380780|12573167|FG000|COMPLETED|Overall Study||16
11378236|NCT03380780|12573167|FG000|NOT COMPLETED|Overall Study||0
11378237|NCT03380845|12573171|FG000|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4
11378238|NCT03380845|12573171|FG000|COMPLETED|Overall Study||4
11378239|NCT03380845|12573171|FG000|NOT COMPLETED|Overall Study||0
11378240|NCT03381196|12573179|FG000|STARTED|Overall Study||276
11378241|NCT03381196|12573180|FG001|STARTED|Overall Study||277
11378242|NCT03381196|12573179|FG000|Treated|Overall Study||273
11378243|NCT03381196|12573180|FG001|Treated|Overall Study||271
11378244|NCT03381196|12573179|FG000|COMPLETED|Overall Study||260
11378245|NCT03381196|12573180|FG001|COMPLETED|Overall Study||258
11378246|NCT03381196|12573179|FG000|NOT COMPLETED|Overall Study||16
11378247|NCT03381196|12573180|FG001|NOT COMPLETED|Overall Study||19
11378248|NCT03381248|12573188|FG000|STARTED|Overall Study||89
11378249|NCT03381248|12573189|FG001|STARTED|Overall Study||88
11378250|NCT03381248|12573188|FG000|COMPLETED|Overall Study||76
11378251|NCT03381248|12573189|FG001|COMPLETED|Overall Study||82
11378252|NCT03381248|12573188|FG000|NOT COMPLETED|Overall Study||13
11378253|NCT03381248|12573189|FG001|NOT COMPLETED|Overall Study||6
11378254|NCT03381339|12573197|FG000|STARTED|Overall Study||27
11378255|NCT03381339|12573198|FG001|STARTED|Overall Study||28
11378256|NCT03381339|12573197|FG000|COMPLETED|Overall Study||23
11378257|NCT03381339|12573198|FG001|COMPLETED|Overall Study||24
11378258|NCT03381339|12573197|FG000|NOT COMPLETED|Overall Study||4
11378259|NCT03381339|12573198|FG001|NOT COMPLETED|Overall Study||4
11378260|NCT03381742|12573208|FG000|STARTED|Overall Study||525
11378261|NCT03381742|12573209|FG001|STARTED|Overall Study||501
11378262|NCT03381742|12573210|FG002|STARTED|Overall Study||1511
11378263|NCT03381742|12573211|FG003|STARTED|Overall Study||506
11378264|NCT03381742|12573208|FG000|COMPLETED|Overall Study||525
11378265|NCT03381742|12573209|FG001|COMPLETED|Overall Study||501
11378266|NCT03381742|12573210|FG002|COMPLETED|Overall Study||1511
11378267|NCT03381742|12573211|FG003|COMPLETED|Overall Study||506
11378268|NCT03381742|12573208|FG000|NOT COMPLETED|Overall Study||0
11378269|NCT03381742|12573209|FG001|NOT COMPLETED|Overall Study||0
11378270|NCT03381742|12573210|FG002|NOT COMPLETED|Overall Study||0
11378271|NCT03381742|12573211|FG003|NOT COMPLETED|Overall Study||0
11378272|NCT03381989|12573221|FG000|STARTED|Overall Study||30
11378273|NCT03381989|12573221|FG000|COMPLETED|Overall Study||22
11378274|NCT03381989|12573221|FG000|NOT COMPLETED|Overall Study||8
11378275|NCT03382262|12573230|FG000|STARTED|Overall Study||12
11378276|NCT03382262|12573231|FG001|STARTED|Overall Study||13
11378277|NCT03382262|12573232|FG002|STARTED|Overall Study||15
11378278|NCT03382262|12573233|FG003|STARTED|Overall Study||15
11378279|NCT03382262|12573230|FG000|COMPLETED|Overall Study||12
11378280|NCT03382262|12573231|FG001|COMPLETED|Overall Study||13
11378281|NCT03382262|12573232|FG002|COMPLETED|Overall Study||14
11378282|NCT03382262|12573233|FG003|COMPLETED|Overall Study||14
11378283|NCT03382262|12573230|FG000|NOT COMPLETED|Overall Study||0
11378284|NCT03382262|12573231|FG001|NOT COMPLETED|Overall Study||0
11378285|NCT03382262|12573232|FG002|NOT COMPLETED|Overall Study||1
11378286|NCT03382262|12573233|FG003|NOT COMPLETED|Overall Study||1
11378287|NCT03382418|12573246|FG000|STARTED|Overall Study||25
11378288|NCT03382418|12573247|FG001|STARTED|Overall Study||15
11378289|NCT03382418|12573248|FG002|STARTED|Overall Study||5
11378290|NCT03382418|12573246|FG000|Month .5 Immunogenicity Cohort|Overall Study||25
11378291|NCT03382418|12573247|FG001|Month .5 Immunogenicity Cohort|Overall Study||14
11378292|NCT03382418|12573248|FG002|Month .5 Immunogenicity Cohort|Overall Study||5
11378293|NCT03382418|12573246|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||21
11378294|NCT03382418|12573247|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||13
11378295|NCT03382418|12573248|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||5
11378296|NCT03382418|12573246|FG000|COMPLETED|Overall Study||22
11378297|NCT03382418|12573247|FG001|COMPLETED|Overall Study||12
11378298|NCT03382418|12573248|FG002|COMPLETED|Overall Study||5
11378299|NCT03382418|12573246|FG000|NOT COMPLETED|Overall Study||3
11142083|NCT01466348|12328780|FG000|Intent To Treat (ITT) Population|Period I - First Intervention||36
11142084|NCT01466348|12328781|FG001|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
11142085|NCT01466348|12328780|FG000|COMPLETED|Period I - First Intervention||36
11142086|NCT01466348|12328781|FG001|COMPLETED|Period I - First Intervention||35
11378300|NCT03382418|12573247|FG001|NOT COMPLETED|Overall Study||3
11378301|NCT03382418|12573248|FG002|NOT COMPLETED|Overall Study||0
11378302|NCT03382509|12573259|FG000|STARTED|Overall Study||8
11378303|NCT03382509|12573260|FG001|STARTED|Overall Study||8
11378304|NCT03382509|12573259|FG000|COMPLETED|Overall Study||8
11378305|NCT03382509|12573260|FG001|COMPLETED|Overall Study||8
11378306|NCT03382509|12573259|FG000|NOT COMPLETED|Overall Study||0
11378307|NCT03382509|12573260|FG001|NOT COMPLETED|Overall Study||0
11378308|NCT03382665|12573267|FG000|STARTED|Overall Study||70
11378309|NCT03382665|12573267|FG000|Actual Enrollment|Overall Study||59
11378310|NCT03382665|12573267|FG000|5 Year Follow up|Overall Study||25
11378311|NCT03382665|12573267|FG000|COMPLETED|Overall Study||25
11378312|NCT03382665|12573267|FG000|NOT COMPLETED|Overall Study||45
11378313|NCT03382821|12573277|FG000|STARTED|Overall Study||60
11378314|NCT03382821|12573278|FG001|STARTED|Overall Study||60
11378315|NCT03382821|12573277|FG000|COMPLETED|Overall Study||60
11378316|NCT03382821|12573278|FG001|COMPLETED|Overall Study||57
11378317|NCT03382821|12573277|FG000|NOT COMPLETED|Overall Study||0
11378318|NCT03382821|12573278|FG001|NOT COMPLETED|Overall Study||3
11378319|NCT03382847|12573285|FG000|STARTED|Overall Study||25
11378320|NCT03382847|12573285|FG000|COMPLETED|Overall Study||25
11378321|NCT03382847|12573285|FG000|NOT COMPLETED|Overall Study||0
11378322|NCT03382899|12573291|FG000|STARTED|Overall Study||51
11378323|NCT03382899|12573292|FG001|STARTED|Overall Study||50
11378324|NCT03382899|12573291|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
11378325|NCT03382899|12573292|FG001|Received at Least 1 Dose of Study Drug|Overall Study||48
11378326|NCT03382899|12573291|FG000|COMPLETED|Overall Study||20
11378327|NCT03382899|12573292|FG001|COMPLETED|Overall Study||15
11378328|NCT03382899|12573291|FG000|NOT COMPLETED|Overall Study||31
11378329|NCT03382899|12573292|FG001|NOT COMPLETED|Overall Study||35
11378330|NCT03382912|12573300|FG000|STARTED|Overall Study||27
11378331|NCT03382912|12573301|FG001|STARTED|Overall Study||25
11378332|NCT03382912|12573300|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27
11378333|NCT03382912|12573301|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24
11378334|NCT03382912|12573300|FG000|COMPLETED|Overall Study||21
11378335|NCT03382912|12573301|FG001|COMPLETED|Overall Study||13
11378336|NCT03382912|12573300|FG000|NOT COMPLETED|Overall Study||6
11378337|NCT03382912|12573301|FG001|NOT COMPLETED|Overall Study||12
11378338|NCT03383146|12573309|FG000|STARTED|Overall Study||148
11378339|NCT03383146|12573310|FG001|STARTED|Overall Study||302
11378340|NCT03383146|12573309|FG000|Safety Population|Overall Study||145
11378341|NCT03383146|12573310|FG001|Safety Population|Overall Study||299
11378342|NCT03383146|12573309|FG000|Run-in Period|Overall Study||91
11378343|NCT03383146|12573310|FG001|Run-in Period|Overall Study||207
11378344|NCT03383146|12573309|FG000|COMPLETED|Overall Study||63
11378345|NCT03383146|12573310|FG001|COMPLETED|Overall Study||118
11378346|NCT03383146|12573309|FG000|NOT COMPLETED|Overall Study||85
11378347|NCT03383146|12573310|FG001|NOT COMPLETED|Overall Study||184
11378348|NCT03383198|12573319|FG000|STARTED|Overall Study||4
11378349|NCT03383198|12573320|FG001|STARTED|Overall Study||1
11378350|NCT03383198|12573319|FG000|COMPLETED|Overall Study||4
11378351|NCT03383198|12573320|FG001|COMPLETED|Overall Study||1
11378352|NCT03383198|12573319|FG000|NOT COMPLETED|Overall Study||0
11378353|NCT03383198|12573320|FG001|NOT COMPLETED|Overall Study||0
11378354|NCT03383523|12573333|FG000|STARTED|Overall Study||11
11378355|NCT03383523|12573334|FG001|STARTED|Overall Study||11
11378356|NCT03383523|12573335|FG002|STARTED|Overall Study||10
11378357|NCT03383523|12573336|FG003|STARTED|Overall Study||12
11378358|NCT03383523|12573337|FG004|STARTED|Overall Study||11
11378359|NCT03383523|12573338|FG005|STARTED|Overall Study||12
11378360|NCT03383523|12573339|FG006|STARTED|Overall Study||10
11378361|NCT03383523|12573333|FG000|COMPLETED|Overall Study||10
11378362|NCT03383523|12573334|FG001|COMPLETED|Overall Study||11
11378363|NCT03383523|12573335|FG002|COMPLETED|Overall Study||9
11378364|NCT03383523|12573336|FG003|COMPLETED|Overall Study||12
11378365|NCT03383523|12573337|FG004|COMPLETED|Overall Study||11
11378366|NCT03383523|12573338|FG005|COMPLETED|Overall Study||12
11378367|NCT03383523|12573339|FG006|COMPLETED|Overall Study||10
11378368|NCT03383523|12573333|FG000|NOT COMPLETED|Overall Study||1
11378369|NCT03383523|12573334|FG001|NOT COMPLETED|Overall Study||0
11378370|NCT03383523|12573335|FG002|NOT COMPLETED|Overall Study||1
11378371|NCT03383523|12573336|FG003|NOT COMPLETED|Overall Study||0
11378372|NCT03383523|12573337|FG004|NOT COMPLETED|Overall Study||0
11378373|NCT03383523|12573338|FG005|NOT COMPLETED|Overall Study||0
11378374|NCT03383523|12573339|FG006|NOT COMPLETED|Overall Study||0
11378375|NCT03383588|12573358|FG000|STARTED|Overall Study||8
11378376|NCT03383588|12573359|FG001|STARTED|Overall Study||9
11378377|NCT03383588|12573360|FG002|STARTED|Overall Study||9
11378378|NCT03383588|12573358|FG000|COMPLETED|Overall Study||8
11378379|NCT03383588|12573359|FG001|COMPLETED|Overall Study||9
11378380|NCT03383588|12573360|FG002|COMPLETED|Overall Study||9
11378381|NCT03383588|12573358|FG000|NOT COMPLETED|Overall Study||0
11378382|NCT03383588|12573359|FG001|NOT COMPLETED|Overall Study||0
11378383|NCT03383588|12573360|FG002|NOT COMPLETED|Overall Study||0
11378384|NCT03383614|12573372|FG000|STARTED|Overall Study||6
11378385|NCT03383614|12573373|FG001|STARTED|Overall Study||6
11378386|NCT03383614|12573374|FG002|STARTED|Overall Study||6
11378387|NCT03383614|12573375|FG003|STARTED|Overall Study||6
11378388|NCT03383614|12573372|FG000|COMPLETED|Overall Study||6
11378389|NCT03383614|12573373|FG001|COMPLETED|Overall Study||5
11378390|NCT03383614|12573374|FG002|COMPLETED|Overall Study||6
11378391|NCT03383614|12573375|FG003|COMPLETED|Overall Study||6
11378392|NCT03383614|12573372|FG000|NOT COMPLETED|Overall Study||0
11378393|NCT03383614|12573373|FG001|NOT COMPLETED|Overall Study||1
11378394|NCT03383614|12573374|FG002|NOT COMPLETED|Overall Study||0
11378395|NCT03383614|12573375|FG003|NOT COMPLETED|Overall Study||0
11378396|NCT03383627|12573390|FG000|STARTED|Overall Study||80
11378397|NCT03383627|12573390|FG000|COMPLETED|Overall Study||80
11378398|NCT03383627|12573390|FG000|NOT COMPLETED|Overall Study||0
11378399|NCT03383757|12573394|FG000|STARTED|Overall Study||117
11378400|NCT03383757|12573394|FG000|TruSignal AllFit Sensor Subjects|Overall Study||56
11378401|NCT03383757|12573394|FG000|TruSignal Sensitive Sensor Subjects|Overall Study||59
11378402|NCT03383757|12573394|FG000|TruSignal AllFit Sensor Data Pairs|Overall Study||52
11378403|NCT03383757|12573394|FG000|TruSignal Sensitive Sensor Data Pairs|Overall Study||51
11378404|NCT03383757|12573394|FG000|COMPLETED|Overall Study||78
11378405|NCT03383757|12573394|FG000|NOT COMPLETED|Overall Study||39
11378406|NCT03383783|12573398|FG000|STARTED|Overall Study||27
11378407|NCT03383783|12573398|FG000|COMPLETED|Overall Study||25
11378408|NCT03383783|12573398|FG000|NOT COMPLETED|Overall Study||2
11378409|NCT03383887|12573414|FG000|STARTED|Overall Study||5
11378410|NCT03383887|12573415|FG001|STARTED|Overall Study||6
11378411|NCT03383887|12573414|FG000|COMPLETED|Overall Study||5
11378412|NCT03383887|12573415|FG001|COMPLETED|Overall Study||5
11378413|NCT03383887|12573414|FG000|NOT COMPLETED|Overall Study||0
11378414|NCT03383887|12573415|FG001|NOT COMPLETED|Overall Study||1
11378415|NCT03384173|12573423|FG000|STARTED|Overall Study||35
11378416|NCT03384173|12573423|FG000|COMPLETED|Overall Study||35
11378417|NCT03384173|12573423|FG000|NOT COMPLETED|Overall Study||0
11378418|NCT03384316|12573435|FG000|STARTED|Overall Study||6
11378419|NCT03384316|12573436|FG001|STARTED|Overall Study||5
11378420|NCT03384316|12573435|FG000|COMPLETED|Overall Study||6
11378421|NCT03384316|12573436|FG001|COMPLETED|Overall Study||4
11378422|NCT03384316|12573435|FG000|NOT COMPLETED|Overall Study||0
11378423|NCT03384316|12573436|FG001|NOT COMPLETED|Overall Study||1
11378424|NCT03384329|12573446|FG000|STARTED|Overall Study||11
11378425|NCT03384329|12573447|FG001|STARTED|Overall Study||11
11378426|NCT03384329|12573446|FG000|COMPLETED|Overall Study||11
11378427|NCT03384329|12573447|FG001|COMPLETED|Overall Study||11
11378428|NCT03384329|12573446|FG000|NOT COMPLETED|Overall Study||0
11378429|NCT03384329|12573447|FG001|NOT COMPLETED|Overall Study||0
11378430|NCT03384693|12573453|FG000|STARTED|Overall Study||25
11378431|NCT03384693|12573453|FG000|COMPLETED|Overall Study||22
11378432|NCT03384693|12573453|FG000|NOT COMPLETED|Overall Study||3
11378433|NCT03384745|12573463|FG000|STARTED|Placebo Controlled Induction (W0 - W12)||52
11378434|NCT03384745|12573464|FG001|STARTED|Placebo Controlled Induction (W0 - W12)||52
11378435|NCT03384745|12573465|FG002|STARTED|Placebo Controlled Induction (W0 - W12)||53
11378436|NCT03384745|12573466|FG003|STARTED|Placebo Controlled Induction (W0 - W12)||51
11378437|NCT03384745|12573467|FG004|STARTED|Placebo Controlled Induction (W0 - W12)||52
11378438|NCT03384745|12573468|FG005|STARTED|Placebo Controlled Induction (W0 - W12)||53
11378439|NCT03384745|12573463|FG000|COMPLETED|Placebo Controlled Induction (W0 - W12)||52
11378440|NCT03384745|12573464|FG001|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
11378441|NCT03384745|12573465|FG002|COMPLETED|Placebo Controlled Induction (W0 - W12)||50
11378442|NCT03384745|12573466|FG003|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
11378443|NCT03384745|12573467|FG004|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
11378444|NCT03384745|12573468|FG005|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
11378445|NCT03384745|12573463|FG000|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||0
11378446|NCT03384745|12573464|FG001|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||1
11378447|NCT03384745|12573465|FG002|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
11378448|NCT03384745|12573466|FG003|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
11378449|NCT03384745|12573467|FG004|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
11378450|NCT03384745|12573468|FG005|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
11378451|NCT03384745|12573463|FG000|STARTED|Maintenance/Escalation (W12-W24)||52
11378452|NCT03384745|12573464|FG001|STARTED|Maintenance/Escalation (W12-W24)||51
11378453|NCT03384745|12573465|FG002|STARTED|Maintenance/Escalation (W12-W24)||50
11378454|NCT03384745|12573466|FG003|STARTED|Maintenance/Escalation (W12-W24)||49
11378455|NCT03384745|12573467|FG004|STARTED|Maintenance/Escalation (W12-W24)||49
11378456|NCT03384745|12573468|FG005|STARTED|Maintenance/Escalation (W12-W24)||51
11378457|NCT03384745|12573463|FG000|COMPLETED|Maintenance/Escalation (W12-W24)||52
11378458|NCT03384745|12573464|FG001|COMPLETED|Maintenance/Escalation (W12-W24)||51
11378459|NCT03384745|12573465|FG002|COMPLETED|Maintenance/Escalation (W12-W24)||49
11378460|NCT03384745|12573466|FG003|COMPLETED|Maintenance/Escalation (W12-W24)||47
11378461|NCT03384745|12573467|FG004|COMPLETED|Maintenance/Escalation (W12-W24)||47
11378462|NCT03384745|12573468|FG005|COMPLETED|Maintenance/Escalation (W12-W24)||51
11378463|NCT03384745|12573463|FG000|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
11378464|NCT03384745|12573464|FG001|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
11378465|NCT03384745|12573465|FG002|NOT COMPLETED|Maintenance/Escalation (W12-W24)||1
11378466|NCT03384745|12573466|FG003|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
11378467|NCT03384745|12573467|FG004|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
11378468|NCT03384745|12573468|FG005|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
11378469|NCT03384745|12573463|FG000|STARTED|Response Assess/Dose Hold (W24-W48)||52
11378470|NCT03384745|12573464|FG001|STARTED|Response Assess/Dose Hold (W24-W48)||51
11378471|NCT03384745|12573465|FG002|STARTED|Response Assess/Dose Hold (W24-W48)||49
11378472|NCT03384745|12573466|FG003|STARTED|Response Assess/Dose Hold (W24-W48)||47
11378473|NCT03384745|12573467|FG004|STARTED|Response Assess/Dose Hold (W24-W48)||47
11378474|NCT03384745|12573468|FG005|STARTED|Response Assess/Dose Hold (W24-W48)||51
11378475|NCT03384745|12573463|FG000|COMPLETED|Response Assess/Dose Hold (W24-W48)||51
11378476|NCT03384745|12573464|FG001|COMPLETED|Response Assess/Dose Hold (W24-W48)||48
11378477|NCT03384745|12573465|FG002|COMPLETED|Response Assess/Dose Hold (W24-W48)||45
11378478|NCT03384745|12573466|FG003|COMPLETED|Response Assess/Dose Hold (W24-W48)||43
11378479|NCT03384745|12573467|FG004|COMPLETED|Response Assess/Dose Hold (W24-W48)||46
11378480|NCT03384745|12573468|FG005|COMPLETED|Response Assess/Dose Hold (W24-W48)||49
11378481|NCT03384745|12573463|FG000|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
11378482|NCT03384745|12573464|FG001|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||3
11378483|NCT03384745|12573465|FG002|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
11378484|NCT03384745|12573466|FG003|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
11378485|NCT03384745|12573467|FG004|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
11378486|NCT03384745|12573468|FG005|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||2
11378487|NCT03384940|12573491|FG000|STARTED|Overall Study||53
11378488|NCT03384940|12573492|FG001|STARTED|Overall Study||15
11378489|NCT03384940|12573493|FG002|STARTED|Overall Study||18
11378490|NCT03384940|12573491|FG000|COMPLETED|Overall Study||0
11378491|NCT03384940|12573492|FG001|COMPLETED|Overall Study||0
11378492|NCT03384940|12573493|FG002|COMPLETED|Overall Study||0
11378493|NCT03384940|12573491|FG000|NOT COMPLETED|Overall Study||53
11378494|NCT03384940|12573492|FG001|NOT COMPLETED|Overall Study||15
11378495|NCT03384940|12573493|FG002|NOT COMPLETED|Overall Study||18
11378496|NCT03384953|12573503|FG000|STARTED|Overall Study||91
11378497|NCT03384953|12573504|FG001|STARTED|Overall Study||12
11378498|NCT03384953|12573503|FG000|Completed Treatment|Overall Study||68
11378499|NCT03384953|12573504|FG001|Completed Treatment|Overall Study||6
11378500|NCT03384953|12573503|FG000|COMPLETED|Overall Study||51
11378501|NCT03384953|12573504|FG001|COMPLETED|Overall Study||4
11378502|NCT03384953|12573503|FG000|NOT COMPLETED|Overall Study||40
11378503|NCT03384953|12573504|FG001|NOT COMPLETED|Overall Study||8
11378504|NCT03384966|12573513|FG000|STARTED|Randomized at End of Screening Period||115
11378505|NCT03384966|12573514|FG001|STARTED|Randomized at End of Screening Period||115
11378506|NCT03384966|12573515|FG002|STARTED|Randomized at End of Screening Period||116
11378507|NCT03384966|12573513|FG000|COMPLETED|Randomized at End of Screening Period||114
11378508|NCT03384966|12573514|FG001|COMPLETED|Randomized at End of Screening Period||115
11378509|NCT03384966|12573515|FG002|COMPLETED|Randomized at End of Screening Period||116
11378510|NCT03384966|12573513|FG000|NOT COMPLETED|Randomized at End of Screening Period||1
11378511|NCT03384966|12573514|FG001|NOT COMPLETED|Randomized at End of Screening Period||0
11378512|NCT03384966|12573515|FG002|NOT COMPLETED|Randomized at End of Screening Period||0
11378513|NCT03384966|12573513|FG000|STARTED|Treatment Period||114
11378514|NCT03384966|12573514|FG001|STARTED|Treatment Period||115
11378515|NCT03384966|12573515|FG002|STARTED|Treatment Period||116
11378516|NCT03384966|12573513|FG000|Thigh Administration|Treatment Period||57
11378517|NCT03384966|12573514|FG001|Thigh Administration|Treatment Period||57
11378518|NCT03384966|12573515|FG002|Thigh Administration|Treatment Period||58
11378519|NCT03384966|12573513|FG000|Abdomen Administration|Treatment Period||57
11378520|NCT03384966|12573514|FG001|Abdomen Administration|Treatment Period||58
11378521|NCT03384966|12573515|FG002|Abdomen Administration|Treatment Period||58
11378522|NCT03384966|12573513|FG000|Per-protocol Analysis Set|Treatment Period||96
11378523|NCT03384966|12573514|FG001|Per-protocol Analysis Set|Treatment Period||90
11378524|NCT03384966|12573515|FG002|Per-protocol Analysis Set|Treatment Period||93
11378525|NCT03384966|12573513|FG000|Safety Analysis Set|Treatment Period||114
11378526|NCT03384966|12573514|FG001|Safety Analysis Set|Treatment Period||115
11378527|NCT03384966|12573515|FG002|Safety Analysis Set|Treatment Period||116
11378528|NCT03384966|12573513|FG000|Pharmacokinetic Analysis Set|Treatment Period||111
11378529|NCT03384966|12573514|FG001|Pharmacokinetic Analysis Set|Treatment Period||115
11378530|NCT03384966|12573515|FG002|Pharmacokinetic Analysis Set|Treatment Period||0
11378531|NCT03384966|12573513|FG000|COMPLETED|Treatment Period||114
11378532|NCT03384966|12573514|FG001|COMPLETED|Treatment Period||115
11378533|NCT03384966|12573515|FG002|COMPLETED|Treatment Period||116
11378534|NCT03384966|12573513|FG000|NOT COMPLETED|Treatment Period||0
11378535|NCT03384966|12573514|FG001|NOT COMPLETED|Treatment Period||0
11378536|NCT03384966|12573515|FG002|NOT COMPLETED|Treatment Period||0
11378537|NCT03384966|12573513|FG000|STARTED|Follow-up Period||114
11378538|NCT03384966|12573514|FG001|STARTED|Follow-up Period||115
11378539|NCT03384966|12573515|FG002|STARTED|Follow-up Period||116
11378540|NCT03384966|12573513|FG000|COMPLETED|Follow-up Period||113
11378541|NCT03384966|12573514|FG001|COMPLETED|Follow-up Period||115
11378542|NCT03384966|12573515|FG002|COMPLETED|Follow-up Period||116
11378543|NCT03384966|12573513|FG000|NOT COMPLETED|Follow-up Period||1
11378544|NCT03384966|12573514|FG001|NOT COMPLETED|Follow-up Period||0
11378545|NCT03384966|12573515|FG002|NOT COMPLETED|Follow-up Period||0
11378546|NCT03386032|12573535|FG000|STARTED|Overall Study||36
11378547|NCT03386032|12573536|FG001|STARTED|Overall Study||18
11378548|NCT03386032|12573537|FG002|STARTED|Overall Study||11
11378549|NCT03386032|12573535|FG000|COMPLETED|Overall Study||18
11378550|NCT03386032|12573536|FG001|COMPLETED|Overall Study||11
11378551|NCT03386032|12573537|FG002|COMPLETED|Overall Study||11
11378552|NCT03386032|12573535|FG000|NOT COMPLETED|Overall Study||18
11378553|NCT03386032|12573536|FG001|NOT COMPLETED|Overall Study||7
11378554|NCT03386032|12573537|FG002|NOT COMPLETED|Overall Study||0
11378555|NCT03386110|12573547|FG000|STARTED|Overall Study||56
11378556|NCT03386110|12573548|FG001|STARTED|Overall Study||44
11378557|NCT03386110|12573547|FG000|COMPLETED|Overall Study||41
11378558|NCT03386110|12573548|FG001|COMPLETED|Overall Study||38
11378559|NCT03386110|12573547|FG000|NOT COMPLETED|Overall Study||15
11378560|NCT03386110|12573548|FG001|NOT COMPLETED|Overall Study||6
11378561|NCT03386344|12573557|FG000|STARTED|Overall Study||126
11378562|NCT03386344|12573558|FG001|STARTED|Overall Study||125
11378563|NCT03386344|12573559|FG002|STARTED|Overall Study||125
11378564|NCT03386344|12573557|FG000|COMPLETED|Overall Study||9
11378565|NCT03386344|12573558|FG001|COMPLETED|Overall Study||9
11378566|NCT03386344|12573559|FG002|COMPLETED|Overall Study||9
11378567|NCT03386344|12573557|FG000|NOT COMPLETED|Overall Study||117
11378568|NCT03386344|12573558|FG001|NOT COMPLETED|Overall Study||116
11378569|NCT03386344|12573559|FG002|NOT COMPLETED|Overall Study||116
11378570|NCT03386435|12573569|FG000|STARTED|Overall Study||80
11378571|NCT03386435|12573570|FG001|STARTED|Overall Study||80
11378572|NCT03386435|12573569|FG000|COMPLETED|Overall Study||75
11378573|NCT03386435|12573570|FG001|COMPLETED|Overall Study||73
11378574|NCT03386435|12573569|FG000|NOT COMPLETED|Overall Study||5
11378575|NCT03386435|12573570|FG001|NOT COMPLETED|Overall Study||7
11378576|NCT03386448|12573578|FG000|STARTED|Overall Study||6
11378577|NCT03386448|12573579|FG001|STARTED|Overall Study||8
11378578|NCT03386448|12573578|FG000|COMPLETED|Overall Study||6
11378579|NCT03386448|12573579|FG001|COMPLETED|Overall Study||6
11378580|NCT03386448|12573578|FG000|NOT COMPLETED|Overall Study||0
11378581|NCT03386448|12573579|FG001|NOT COMPLETED|Overall Study||2
11378582|NCT03386474|12573587|FG000|STARTED|Overall Study||107
11378583|NCT03386474|12573588|FG001|STARTED|Overall Study||43
11378584|NCT03386474|12573587|FG000|COMPLETED|Overall Study||106
11378585|NCT03386474|12573588|FG001|COMPLETED|Overall Study||42
11378586|NCT03386474|12573587|FG000|NOT COMPLETED|Overall Study||1
11378587|NCT03386474|12573588|FG001|NOT COMPLETED|Overall Study||1
11378588|NCT03386994|12573602|FG000|STARTED|Overall Study||204
11378589|NCT03386994|12573602|FG000|COMPLETED|Overall Study||166
11378590|NCT03386994|12573602|FG000|NOT COMPLETED|Overall Study||38
11378591|NCT03387020|12573620|FG000|STARTED|Overall Study||13
11378592|NCT03387020|12573621|FG001|STARTED|Overall Study||3
11378593|NCT03387020|12573622|FG002|STARTED|Overall Study||5
11378594|NCT03387020|12573620|FG000|Received Treatment|Overall Study||12
11378595|NCT03387020|12573621|FG001|Received Treatment|Overall Study||3
11378596|NCT03387020|12573622|FG002|Received Treatment|Overall Study||5
11378597|NCT03387020|12573620|FG000|COMPLETED|Overall Study||11
11378598|NCT03387020|12573621|FG001|COMPLETED|Overall Study||1
11378599|NCT03387020|12573622|FG002|COMPLETED|Overall Study||5
11378600|NCT03387020|12573620|FG000|NOT COMPLETED|Overall Study||2
11378601|NCT03387020|12573621|FG001|NOT COMPLETED|Overall Study||2
11378602|NCT03387020|12573622|FG002|NOT COMPLETED|Overall Study||0
11378603|NCT03387033|12573640|FG000|STARTED|Overall Study||20
11378604|NCT03387033|12573640|FG000|COMPLETED|Overall Study||20
11378605|NCT03387033|12573640|FG000|NOT COMPLETED|Overall Study||0
11378606|NCT03387046|12573646|FG000|STARTED|Overall Study||5
11378607|NCT03387046|12573647|FG001|STARTED|Overall Study||2
11378608|NCT03387046|12573646|FG000|COMPLETED|Overall Study||4
11378609|NCT03387046|12573647|FG001|COMPLETED|Overall Study||1
11378610|NCT03387046|12573646|FG000|NOT COMPLETED|Overall Study||1
11378611|NCT03387046|12573647|FG001|NOT COMPLETED|Overall Study||1
11378612|NCT03387267|12573653|FG000|STARTED|Overall Study||452
11378613|NCT03387267|12573653|FG000|COMPLETED|Overall Study||438
11378614|NCT03387267|12573653|FG000|NOT COMPLETED|Overall Study||14
11378615|NCT03387319|12573660|FG000|STARTED|Overall Study||25
11378616|NCT03387319|12573661|FG001|STARTED|Overall Study||25
11378617|NCT03387319|12573660|FG000|COMPLETED|Overall Study||25
11378618|NCT03387319|12573661|FG001|COMPLETED|Overall Study||25
11378619|NCT03387319|12573660|FG000|NOT COMPLETED|Overall Study||0
11378620|NCT03387319|12573661|FG001|NOT COMPLETED|Overall Study||0
11378621|NCT03387462|12573667|FG000|STARTED|Overall Study||20
11378622|NCT03387462|12573667|FG000|4 Weeks|Overall Study||20
11378623|NCT03387462|12573667|FG000|8 Weeks|Overall Study||19
11378624|NCT03387462|12573667|FG000|COMPLETED|Overall Study||19
11378625|NCT03387462|12573667|FG000|NOT COMPLETED|Overall Study||1
11378626|NCT03387683|12573673|FG000|STARTED|Overall Study||27
11378627|NCT03387683|12573674|FG001|STARTED|Overall Study||26
11378628|NCT03387683|12573673|FG000|COMPLETED|Overall Study||25
11378629|NCT03387683|12573674|FG001|COMPLETED|Overall Study||26
11378630|NCT03387683|12573673|FG000|NOT COMPLETED|Overall Study||2
11378631|NCT03387683|12573674|FG001|NOT COMPLETED|Overall Study||0
11378632|NCT03388164|12573682|FG000|STARTED|Overall Study||10
11378633|NCT03388164|12573683|FG001|STARTED|Overall Study||10
11378634|NCT03388164|12573682|FG000|COMPLETED|Overall Study||7
11378635|NCT03388164|12573683|FG001|COMPLETED|Overall Study||9
11378636|NCT03388164|12573682|FG000|NOT COMPLETED|Overall Study||3
11378637|NCT03388164|12573683|FG001|NOT COMPLETED|Overall Study||1
11378638|NCT03388268|12573691|FG000|STARTED|Overall Study||8
11378639|NCT03388268|12573692|FG001|STARTED|Overall Study||7
11378640|NCT03388268|12573691|FG000|COMPLETED|Overall Study||7
11378641|NCT03388268|12573692|FG001|COMPLETED|Overall Study||4
11378642|NCT03388268|12573691|FG000|NOT COMPLETED|Overall Study||1
11378643|NCT03388268|12573692|FG001|NOT COMPLETED|Overall Study||3
11378644|NCT03388294|12573700|FG000|STARTED|Overall Study||42
11378645|NCT03388294|12573701|FG001|STARTED|Overall Study||30
11378646|NCT03388294|12573700|FG000|Posttest 1|Overall Study||38
11378647|NCT03388294|12573701|FG001|Posttest 1|Overall Study||30
11378648|NCT03388294|12573700|FG000|Posttest 2|Overall Study||38
11378649|NCT03388294|12573701|FG001|Posttest 2|Overall Study||30
11378650|NCT03388294|12573700|FG000|COMPLETED|Overall Study||38
11378651|NCT03388294|12573701|FG001|COMPLETED|Overall Study||30
11378652|NCT03388294|12573700|FG000|NOT COMPLETED|Overall Study||4
11378653|NCT03388294|12573701|FG001|NOT COMPLETED|Overall Study||0
11378654|NCT03388645|12573709|FG000|STARTED|Low Dose RSV A2||4
11378655|NCT03388645|12573710|FG001|STARTED|Low Dose RSV A2||0
11378656|NCT03388645|12573709|FG000|COMPLETED|Low Dose RSV A2||4
11378657|NCT03388645|12573710|FG001|COMPLETED|Low Dose RSV A2||0
11378658|NCT03388645|12573709|FG000|NOT COMPLETED|Low Dose RSV A2||0
11378659|NCT03388645|12573710|FG001|NOT COMPLETED|Low Dose RSV A2||0
11378660|NCT03388645|12573709|FG000|STARTED|High Dose RSV A2||0
11378661|NCT03388645|12573710|FG001|STARTED|High Dose RSV A2||8
11378662|NCT03388645|12573709|FG000|COMPLETED|High Dose RSV A2||0
11378663|NCT03388645|12573710|FG001|COMPLETED|High Dose RSV A2||7
11378664|NCT03388645|12573709|FG000|NOT COMPLETED|High Dose RSV A2||0
11378665|NCT03388645|12573710|FG001|NOT COMPLETED|High Dose RSV A2||1
11378666|NCT03389308|12573716|FG000|STARTED|Overall Study||51
11378667|NCT03389308|12573716|FG000|COMPLETED|Overall Study||39
11378668|NCT03389308|12573716|FG000|NOT COMPLETED|Overall Study||12
11378669|NCT03389555|12573722|FG000|STARTED|Overall Study||103
11378670|NCT03389555|12573723|FG001|STARTED|Overall Study||102
11378671|NCT03389555|12573722|FG000|COMPLETED|Overall Study||101
11378672|NCT03389555|12573723|FG001|COMPLETED|Overall Study||99
11378673|NCT03389555|12573722|FG000|NOT COMPLETED|Overall Study||2
11378674|NCT03389555|12573723|FG001|NOT COMPLETED|Overall Study||3
11378675|NCT03389854|12573733|FG000|STARTED|Overall Study||28
11378676|NCT03389854|12573734|FG001|STARTED|Overall Study||27
11378677|NCT03389854|12573735|FG002|STARTED|Overall Study||28
11378678|NCT03389854|12573736|FG003|STARTED|Overall Study||27
11378679|NCT03389854|12573733|FG000|COMPLETED|Overall Study||27
11378680|NCT03389854|12573734|FG001|COMPLETED|Overall Study||21
11378681|NCT03389854|12573735|FG002|COMPLETED|Overall Study||23
11378682|NCT03389854|12573736|FG003|COMPLETED|Overall Study||19
11378683|NCT03389854|12573733|FG000|NOT COMPLETED|Overall Study||1
11378684|NCT03389854|12573734|FG001|NOT COMPLETED|Overall Study||6
11378685|NCT03389854|12573735|FG002|NOT COMPLETED|Overall Study||5
11378686|NCT03389854|12573736|FG003|NOT COMPLETED|Overall Study||8
11378687|NCT03389893|12573752|FG000|STARTED|Randomized Double Blind Period||46
11378688|NCT03389893|12573753|FG001|STARTED|Randomized Double Blind Period||26
11378689|NCT03389893|12573754|FG002|STARTED|Randomized Double Blind Period||0
11378690|NCT03389893|12573755|FG003|STARTED|Randomized Double Blind Period||0
11378691|NCT03389893|12573752|FG000|COMPLETED|Randomized Double Blind Period||45
11378692|NCT03389893|12573753|FG001|COMPLETED|Randomized Double Blind Period||26
11378693|NCT03389893|12573754|FG002|COMPLETED|Randomized Double Blind Period||0
11378694|NCT03389893|12573755|FG003|COMPLETED|Randomized Double Blind Period||0
11378695|NCT03389893|12573752|FG000|NOT COMPLETED|Randomized Double Blind Period||1
11378696|NCT03389893|12573753|FG001|NOT COMPLETED|Randomized Double Blind Period||0
11378697|NCT03389893|12573754|FG002|NOT COMPLETED|Randomized Double Blind Period||0
11378698|NCT03389893|12573755|FG003|NOT COMPLETED|Randomized Double Blind Period||0
11378699|NCT03389893|12573752|FG000|STARTED|Open Label Extension and Follow-Up||0
11378700|NCT03389893|12573753|FG001|STARTED|Open Label Extension and Follow-Up||0
11378701|NCT03389893|12573754|FG002|STARTED|Open Label Extension and Follow-Up||45
11378702|NCT03389893|12573755|FG003|STARTED|Open Label Extension and Follow-Up||26
11378703|NCT03389893|12573752|FG000|COMPLETED|Open Label Extension and Follow-Up||0
11378704|NCT03389893|12573753|FG001|COMPLETED|Open Label Extension and Follow-Up||0
11378705|NCT03389893|12573754|FG002|COMPLETED|Open Label Extension and Follow-Up||41
11378706|NCT03389893|12573755|FG003|COMPLETED|Open Label Extension and Follow-Up||25
11378707|NCT03389893|12573752|FG000|NOT COMPLETED|Open Label Extension and Follow-Up||0
11378708|NCT03389893|12573753|FG001|NOT COMPLETED|Open Label Extension and Follow-Up||0
11378709|NCT03389893|12573754|FG002|NOT COMPLETED|Open Label Extension and Follow-Up||4
11378710|NCT03389893|12573755|FG003|NOT COMPLETED|Open Label Extension and Follow-Up||1
11378711|NCT03390114|12573763|FG000|STARTED|Overall Study||10
11378712|NCT03390114|12573764|FG001|STARTED|Overall Study||10
11378713|NCT03390114|12573763|FG000|COMPLETED|Overall Study||6
11378714|NCT03390114|12573764|FG001|COMPLETED|Overall Study||8
11378715|NCT03390114|12573763|FG000|NOT COMPLETED|Overall Study||4
11378716|NCT03390114|12573764|FG001|NOT COMPLETED|Overall Study||2
11378717|NCT03390166|12573772|FG000|STARTED|Overall Study||630
11378718|NCT03390166|12573773|FG001|STARTED|Overall Study||315
11378719|NCT03390166|12573772|FG000|COMPLETED|Overall Study||618
11378720|NCT03390166|12573773|FG001|COMPLETED|Overall Study||305
11378721|NCT03390166|12573772|FG000|NOT COMPLETED|Overall Study||12
11378722|NCT03390166|12573773|FG001|NOT COMPLETED|Overall Study||10
11378723|NCT03390257|12573779|FG000|STARTED|Overall Study||14
11378724|NCT03390257|12573779|FG000|COMPLETED|Overall Study||14
11378725|NCT03390257|12573779|FG000|NOT COMPLETED|Overall Study||0
11378726|NCT03390426|12573787|FG000|STARTED|Overall Study||15
11378727|NCT03390426|12573788|FG001|STARTED|Overall Study||16
11378728|NCT03390426|12573787|FG000|COMPLETED|Overall Study||15
11378729|NCT03390426|12573788|FG001|COMPLETED|Overall Study||15
11378730|NCT03390426|12573787|FG000|NOT COMPLETED|Overall Study||0
11378731|NCT03390426|12573788|FG001|NOT COMPLETED|Overall Study||1
11378732|NCT03390842|12573796|FG000|STARTED|Overall Study||114
11378733|NCT03390842|12573797|FG001|STARTED|Overall Study||82
11378734|NCT03390842|12573796|FG000|COMPLETED|Overall Study||111
11378735|NCT03390842|12573797|FG001|COMPLETED|Overall Study||74
11378736|NCT03390842|12573796|FG000|NOT COMPLETED|Overall Study||3
11378737|NCT03390842|12573797|FG001|NOT COMPLETED|Overall Study||8
11378738|NCT03390907|12573803|FG000|STARTED|Overall Study||40
11378739|NCT03390907|12573803|FG000|COMPLETED|Overall Study||40
11378740|NCT03390907|12573803|FG000|NOT COMPLETED|Overall Study||0
11378741|NCT03391115|12573810|FG000|STARTED|Overall Study||20
11378742|NCT03391115|12573811|FG001|STARTED|Overall Study||18
11378743|NCT03391115|12573810|FG000|COMPLETED|Overall Study||20
11378744|NCT03391115|12573811|FG001|COMPLETED|Overall Study|Two Nurse participants in the dyadic patient-nurse enrollment were not successfully recruited.|18
11378745|NCT03391115|12573810|FG000|NOT COMPLETED|Overall Study||0
11378746|NCT03391115|12573811|FG001|NOT COMPLETED|Overall Study||0
11378747|NCT03391765|12573821|FG000|STARTED|Overall Study||51
11378748|NCT03391765|12573822|FG001|STARTED|Overall Study||45
11378749|NCT03391765|12573823|FG002|STARTED|Overall Study||23
11378750|NCT03391765|12573824|FG003|STARTED|Overall Study||23
11378751|NCT03391765|12573821|FG000|COMPLETED|Overall Study||0
11378752|NCT03391765|12573822|FG001|COMPLETED|Overall Study||0
11378753|NCT03391765|12573823|FG002|COMPLETED|Overall Study||0
11378754|NCT03391765|12573824|FG003|COMPLETED|Overall Study||0
11378755|NCT03391765|12573821|FG000|NOT COMPLETED|Overall Study||51
11378756|NCT03391765|12573822|FG001|NOT COMPLETED|Overall Study||45
11378757|NCT03391765|12573823|FG002|NOT COMPLETED|Overall Study||23
11378758|NCT03391765|12573824|FG003|NOT COMPLETED|Overall Study||23
11378759|NCT03391986|12573837|FG000|STARTED|Overall Study||53
11378760|NCT03391986|12573838|FG001|STARTED|Overall Study||50
11378761|NCT03391986|12573839|FG002|STARTED|Overall Study||50
11378762|NCT03391986|12573837|FG000|COMPLETED|Overall Study||53
11378763|NCT03391986|12573838|FG001|COMPLETED|Overall Study||50
11378764|NCT03391986|12573839|FG002|COMPLETED|Overall Study||50
11378765|NCT03391986|12573837|FG000|NOT COMPLETED|Overall Study||0
11378766|NCT03391986|12573838|FG001|NOT COMPLETED|Overall Study||0
11378767|NCT03391986|12573839|FG002|NOT COMPLETED|Overall Study||0
11378768|NCT03392194|12573849|FG000|STARTED|Overall Study||16
11378769|NCT03392194|12573850|FG001|STARTED|Overall Study||17
11378770|NCT03392194|12573849|FG000|COMPLETED|Overall Study||14
11378771|NCT03392194|12573850|FG001|COMPLETED|Overall Study||15
11378772|NCT03392194|12573849|FG000|NOT COMPLETED|Overall Study||2
11378773|NCT03392194|12573850|FG001|NOT COMPLETED|Overall Study||2
11378774|NCT03392532|12573856|FG000|STARTED|Period 1, FIrst 30 Minutes of Wear||18
11378775|NCT03392532|12573857|FG001|STARTED|Period 1, FIrst 30 Minutes of Wear||18
11378776|NCT03392532|12573856|FG000|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
11378777|NCT03392532|12573857|FG001|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
11378778|NCT03392532|12573856|FG000|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
11378779|NCT03392532|12573857|FG001|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
11378780|NCT03392532|12573856|FG000|STARTED|Period 2, Second 30 Minutes of Wear||18
11378781|NCT03392532|12573857|FG001|STARTED|Period 2, Second 30 Minutes of Wear||18
11378782|NCT03392532|12573856|FG000|COMPLETED|Period 2, Second 30 Minutes of Wear||18
11378783|NCT03392532|12573857|FG001|COMPLETED|Period 2, Second 30 Minutes of Wear||18
11378784|NCT03392532|12573856|FG000|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
11378785|NCT03392532|12573857|FG001|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
11378786|NCT03392935|12573863|FG000|STARTED|Overall Study||37
11378787|NCT03392935|12573863|FG000|COMPLETED|Overall Study||35
11378788|NCT03392935|12573863|FG000|NOT COMPLETED|Overall Study||2
11378789|NCT03393000|12573867|FG000|STARTED|Overall Study|23 subjects screened|19
11378790|NCT03393000|12573867|FG000|COMPLETED|Overall Study|19 subjects treated|5
11378791|NCT03393000|12573867|FG000|NOT COMPLETED|Overall Study||14
11378792|NCT03393208|12573875|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||13
11378793|NCT03393208|12573876|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||13
11378794|NCT03393208|12573877|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||9
11378795|NCT03393208|12573878|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||9
11378796|NCT03393208|12573875|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
11378797|NCT03393208|12573876|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
11378798|NCT03393208|12573877|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
11378799|NCT03393208|12573878|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
11378800|NCT03393208|12573875|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
11378801|NCT03393208|12573876|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
11378802|NCT03393208|12573877|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
11378803|NCT03393208|12573878|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
11378804|NCT03393208|12573875|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||13
11378805|NCT03393208|12573876|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||13
11378806|NCT03393208|12573877|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||9
11378807|NCT03393208|12573878|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||9
11378808|NCT03393208|12573875|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
11378809|NCT03393208|12573876|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
11378810|NCT03393208|12573877|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
11378811|NCT03393208|12573878|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
11378812|NCT03393208|12573875|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
11378813|NCT03393208|12573876|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
11378814|NCT03393208|12573877|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
11378815|NCT03393208|12573878|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
11378816|NCT03393494|12573893|FG000|STARTED|Overall Study||329
11378817|NCT03393494|12573894|FG001|STARTED|Overall Study||331
11378818|NCT03393494|12573895|FG002|STARTED|Overall Study||165
11378819|NCT03393494|12573893|FG000|COMPLETED|Overall Study||261
11378820|NCT03393494|12573894|FG001|COMPLETED|Overall Study||256
11378821|NCT03393494|12573895|FG002|COMPLETED|Overall Study||140
11378822|NCT03393494|12573893|FG000|NOT COMPLETED|Overall Study||68
11378823|NCT03393494|12573894|FG001|NOT COMPLETED|Overall Study||75
11378824|NCT03393494|12573895|FG002|NOT COMPLETED|Overall Study||25
11378825|NCT03393754|12573905|FG000|STARTED|Overall Study||811
11378826|NCT03393754|12573906|FG001|STARTED|Overall Study||796
11378827|NCT03393754|12573905|FG000|COMPLETED|Overall Study||785
11378828|NCT03393754|12573906|FG001|COMPLETED|Overall Study||758
11378829|NCT03393754|12573905|FG000|NOT COMPLETED|Overall Study||26
11378830|NCT03393754|12573906|FG001|NOT COMPLETED|Overall Study||38
11378831|NCT03393806|12573914|FG000|STARTED|Overall Study||9
11378832|NCT03393806|12573915|FG001|STARTED|Overall Study||8
11378833|NCT03393806|12573914|FG000|COMPLETED|Overall Study||8
11378834|NCT03393806|12573915|FG001|COMPLETED|Overall Study||8
11378835|NCT03393806|12573914|FG000|NOT COMPLETED|Overall Study||1
11378836|NCT03393806|12573915|FG001|NOT COMPLETED|Overall Study||0
11378837|NCT03394391|12573924|FG000|STARTED|Overall Study||106
11378838|NCT03394391|12573925|FG001|STARTED|Overall Study||106
11378839|NCT03394391|12573924|FG000|COMPLETED|Overall Study||105
11378840|NCT03394391|12573925|FG001|COMPLETED|Overall Study||104
11378841|NCT03394391|12573924|FG000|NOT COMPLETED|Overall Study||1
11378842|NCT03394391|12573925|FG001|NOT COMPLETED|Overall Study||2
11378843|NCT03394508|12573933|FG000|STARTED|Overall Study||13
11378844|NCT03394508|12573934|FG001|STARTED|Overall Study||17
11378845|NCT03394508|12573933|FG000|COMPLETED|Overall Study||12
11378846|NCT03394508|12573934|FG001|COMPLETED|Overall Study||14
11378847|NCT03394508|12573933|FG000|NOT COMPLETED|Overall Study||1
11378848|NCT03394508|12573934|FG001|NOT COMPLETED|Overall Study||3
11378849|NCT03394768|12573944|FG000|STARTED|Overall Study||26
11378850|NCT03394768|12573944|FG000|COMPLETED|Overall Study||26
11378851|NCT03394768|12573944|FG000|NOT COMPLETED|Overall Study||0
11378852|NCT03394885|12573948|FG000|STARTED|Overall Study||18
11378853|NCT03394885|12573948|FG000|COMPLETED|Overall Study||3
11378854|NCT03394885|12573948|FG000|NOT COMPLETED|Overall Study||15
11378855|NCT03394924|12573955|FG000|STARTED|Overall Study||31
11378856|NCT03394924|12573956|FG001|STARTED|Overall Study||28
11378857|NCT03394924|12573957|FG002|STARTED|Overall Study||9
11378858|NCT03394924|12573955|FG000|COMPLETED|Overall Study||28
11378859|NCT03394924|12573956|FG001|COMPLETED|Overall Study||22
11378860|NCT03394924|12573957|FG002|COMPLETED|Overall Study||9
11378861|NCT03394924|12573955|FG000|NOT COMPLETED|Overall Study||3
11378862|NCT03394924|12573956|FG001|NOT COMPLETED|Overall Study||6
11378863|NCT03394924|12573957|FG002|NOT COMPLETED|Overall Study||0
11378864|NCT03395353|12573967|FG000|STARTED|Overall Study||151
11378865|NCT03395353|12573967|FG000|Received At Least 1 Dose of Study Drug|Overall Study||150
11378866|NCT03395353|12573967|FG000|COMPLETED|Overall Study||64
11378867|NCT03395353|12573967|FG000|NOT COMPLETED|Overall Study||87
11378868|NCT03395808|12573975|FG000|STARTED|Overall Study||251
11378869|NCT03395808|12573975|FG000|COMPLETED|Overall Study||251
11378870|NCT03395808|12573975|FG000|NOT COMPLETED|Overall Study||0
11378871|NCT03395886|12573981|FG000|STARTED|Overall Study||52
11378872|NCT03395886|12573982|FG001|STARTED|Overall Study||38
11378873|NCT03395886|12573981|FG000|COMPLETED|Overall Study||0
11378874|NCT03395886|12573982|FG001|COMPLETED|Overall Study||0
11378875|NCT03395886|12573981|FG000|NOT COMPLETED|Overall Study||52
11378876|NCT03395886|12573982|FG001|NOT COMPLETED|Overall Study||38
11378877|NCT03395990|12573990|FG000|STARTED|Overall Study||8
11378878|NCT03395990|12573991|FG001|STARTED|Overall Study||8
11378879|NCT03395990|12573990|FG000|COMPLETED|Overall Study||8
11378880|NCT03395990|12573991|FG001|COMPLETED|Overall Study||8
11378881|NCT03395990|12573990|FG000|NOT COMPLETED|Overall Study||0
11378882|NCT03395990|12573991|FG001|NOT COMPLETED|Overall Study||0
11378883|NCT03396432|12573999|FG000|STARTED|Overall Study||283
11378884|NCT03396432|12574000|FG001|STARTED|Overall Study||283
11378885|NCT03396432|12573999|FG000|COMPLETED|Overall Study||274
11378886|NCT03396432|12574000|FG001|COMPLETED|Overall Study||277
11378887|NCT03396432|12573999|FG000|NOT COMPLETED|Overall Study||9
11378888|NCT03396432|12574000|FG001|NOT COMPLETED|Overall Study||6
11378889|NCT03396835|12574008|FG000|STARTED|Overall Study||16
11378890|NCT03396835|12574008|FG000|COMPLETED|Overall Study||14
11378891|NCT03396835|12574008|FG000|NOT COMPLETED|Overall Study||2
11378892|NCT03396913|12574014|FG000|STARTED|Overall Study||43
11378893|NCT03396913|12574015|FG001|STARTED|Overall Study||45
11378894|NCT03396913|12574014|FG000|COMPLETED|Overall Study||43
11378895|NCT03396913|12574015|FG001|COMPLETED|Overall Study||39
11378896|NCT03396913|12574014|FG000|NOT COMPLETED|Overall Study||0
11378897|NCT03396913|12574015|FG001|NOT COMPLETED|Overall Study||6
11378898|NCT03397121|12574023|FG000|STARTED|Overall Study||242
11378899|NCT03397121|12574024|FG001|STARTED|Overall Study||240
11378900|NCT03397121|12574023|FG000|COMPLETED|Overall Study||235
11378901|NCT03397121|12574024|FG001|COMPLETED|Overall Study||231
11378902|NCT03397121|12574023|FG000|NOT COMPLETED|Overall Study||7
11378903|NCT03397121|12574024|FG001|NOT COMPLETED|Overall Study||9
11378904|NCT03397394|12574034|FG000|STARTED|Overall Study||47
11378905|NCT03397394|12574035|FG001|STARTED|Overall Study||30
11378906|NCT03397394|12574036|FG002|STARTED|Overall Study||20
11378907|NCT03397394|12574034|FG000|COMPLETED|Overall Study||47
11378908|NCT03397394|12574035|FG001|COMPLETED|Overall Study||30
11378909|NCT03397394|12574036|FG002|COMPLETED|Overall Study||20
11378910|NCT03397394|12574034|FG000|NOT COMPLETED|Overall Study||0
11378911|NCT03397394|12574035|FG001|NOT COMPLETED|Overall Study||0
11378912|NCT03397394|12574036|FG002|NOT COMPLETED|Overall Study||0
11378913|NCT03397771|12574048|FG000|STARTED|Overall Study||53
11378914|NCT03397771|12574049|FG001|STARTED|Overall Study||29
11378915|NCT03397771|12574048|FG000|COMPLETED|Overall Study||45
11378916|NCT03397771|12574049|FG001|COMPLETED|Overall Study||22
11378917|NCT03397771|12574048|FG000|NOT COMPLETED|Overall Study||8
11378918|NCT03397771|12574049|FG001|NOT COMPLETED|Overall Study||7
11378919|NCT03398213|12574058|FG000|STARTED|Overall Study||26
11378920|NCT03398213|12574059|FG001|STARTED|Overall Study||24
11378921|NCT03398213|12574060|FG002|STARTED|Overall Study||22
11378922|NCT03398213|12574058|FG000|COMPLETED|Overall Study||26
11378923|NCT03398213|12574059|FG001|COMPLETED|Overall Study||24
11378924|NCT03398213|12574060|FG002|COMPLETED|Overall Study||22
11378925|NCT03398213|12574058|FG000|NOT COMPLETED|Overall Study||0
11378926|NCT03398213|12574059|FG001|NOT COMPLETED|Overall Study||0
11378927|NCT03398213|12574060|FG002|NOT COMPLETED|Overall Study||0
11378928|NCT03398265|12574070|FG000|STARTED|Overall Study||7
11378929|NCT03398265|12574071|FG001|STARTED|Overall Study||8
11378930|NCT03398265|12574070|FG000|COMPLETED|Overall Study||7
11378931|NCT03398265|12574071|FG001|COMPLETED|Overall Study||8
11378932|NCT03398265|12574070|FG000|NOT COMPLETED|Overall Study||0
11378933|NCT03398265|12574071|FG001|NOT COMPLETED|Overall Study||0
11378934|NCT03398278|12574080|FG000|STARTED|Period 1||19
11378935|NCT03398278|12574081|FG001|STARTED|Period 1||19
11378936|NCT03398278|12574080|FG000|COMPLETED|Period 1||18
11378937|NCT03398278|12574081|FG001|COMPLETED|Period 1||19
11378938|NCT03398278|12574080|FG000|NOT COMPLETED|Period 1||1
11378939|NCT03398278|12574081|FG001|NOT COMPLETED|Period 1||0
11378940|NCT03398278|12574080|FG000|STARTED|Period 2||18
11378941|NCT03398278|12574081|FG001|STARTED|Period 2||19
11378942|NCT03398278|12574080|FG000|COMPLETED|Period 2||16
11378943|NCT03398278|12574081|FG001|COMPLETED|Period 2||17
11378944|NCT03398278|12574080|FG000|NOT COMPLETED|Period 2||2
11378945|NCT03398278|12574081|FG001|NOT COMPLETED|Period 2||2
11378946|NCT03398330|12574103|FG000|STARTED|Period 1||21
11378947|NCT03398330|12574104|FG001|STARTED|Period 1||21
11378948|NCT03398330|12574103|FG000|COMPLETED|Period 1||20
11378949|NCT03398330|12574104|FG001|COMPLETED|Period 1||17
11378950|NCT03398330|12574103|FG000|NOT COMPLETED|Period 1||1
11378951|NCT03398330|12574104|FG001|NOT COMPLETED|Period 1||4
11378952|NCT03398330|12574103|FG000|STARTED|Period 2||20
11378953|NCT03398330|12574104|FG001|STARTED|Period 2||17
11378954|NCT03398330|12574103|FG000|COMPLETED|Period 2||19
11378955|NCT03398330|12574104|FG001|COMPLETED|Period 2||17
11378956|NCT03398330|12574103|FG000|NOT COMPLETED|Period 2||1
11378957|NCT03398330|12574104|FG001|NOT COMPLETED|Period 2||0
11378958|NCT03398421|12574124|FG000|STARTED|Treatment Period 1 (Up to 6 Days)||20
11378959|NCT03398421|12574125|FG001|STARTED|Treatment Period 1 (Up to 6 Days)||0
11378960|NCT03398421|12574124|FG000|COMPLETED|Treatment Period 1 (Up to 6 Days)||20
11378961|NCT03398421|12574125|FG001|COMPLETED|Treatment Period 1 (Up to 6 Days)||0
11378962|NCT03398421|12574124|FG000|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
11378963|NCT03398421|12574125|FG001|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
11378964|NCT03398421|12574124|FG000|STARTED|Washout Period (Up to 14 Days)||20
11378965|NCT03398421|12574125|FG001|STARTED|Washout Period (Up to 14 Days)||0
11378966|NCT03398421|12574124|FG000|COMPLETED|Washout Period (Up to 14 Days)||20
11378967|NCT03398421|12574125|FG001|COMPLETED|Washout Period (Up to 14 Days)||0
11378968|NCT03398421|12574124|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0
11378969|NCT03398421|12574125|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0
11378970|NCT03398421|12574124|FG000|STARTED|Treatment Period 2 (Up to 11 Days)||0
11378971|NCT03398421|12574125|FG001|STARTED|Treatment Period 2 (Up to 11 Days)||20
11378972|NCT03398421|12574124|FG000|COMPLETED|Treatment Period 2 (Up to 11 Days)||0
11378973|NCT03398421|12574125|FG001|COMPLETED|Treatment Period 2 (Up to 11 Days)||20
11378974|NCT03398421|12574124|FG000|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
11378975|NCT03398421|12574125|FG001|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
11378976|NCT03398798|12574137|FG000|STARTED|Overall Study||9
11378977|NCT03398798|12574138|FG001|STARTED|Overall Study||9
11378978|NCT03398798|12574139|FG002|STARTED|Overall Study||9
11378979|NCT03398798|12574140|FG003|STARTED|Overall Study||9
11378980|NCT03398798|12574137|FG000|COMPLETED|Overall Study||9
11378981|NCT03398798|12574138|FG001|COMPLETED|Overall Study||9
11378982|NCT03398798|12574139|FG002|COMPLETED|Overall Study||9
11378983|NCT03398798|12574140|FG003|COMPLETED|Overall Study||9
11378984|NCT03398798|12574137|FG000|NOT COMPLETED|Overall Study||0
11378985|NCT03398798|12574138|FG001|NOT COMPLETED|Overall Study||0
11378986|NCT03398798|12574139|FG002|NOT COMPLETED|Overall Study||0
11378987|NCT03398798|12574140|FG003|NOT COMPLETED|Overall Study||0
11378988|NCT03398928|12574152|FG000|STARTED|Overall Study||50
11378989|NCT03398928|12574153|FG001|STARTED|Overall Study||31
11378990|NCT03398928|12574152|FG000|COMPLETED|Overall Study||50
11378991|NCT03398928|12574153|FG001|COMPLETED|Overall Study||31
11378992|NCT03398928|12574152|FG000|NOT COMPLETED|Overall Study||0
11378993|NCT03398928|12574153|FG001|NOT COMPLETED|Overall Study||0
11378994|NCT03399370|12574161|FG000|STARTED|Overall Study||781
11378995|NCT03399370|12574162|FG001|STARTED|Overall Study||780
11378996|NCT03399370|12574161|FG000|COMPLETED|Overall Study||721
11378997|NCT03399370|12574162|FG001|COMPLETED|Overall Study||694
11378998|NCT03399370|12574161|FG000|NOT COMPLETED|Overall Study||60
11378999|NCT03399370|12574162|FG001|NOT COMPLETED|Overall Study||86
11379000|NCT03399786|12574171|FG000|STARTED|Double-blind Treatment Period (DBTP)||22
11379001|NCT03399786|12574172|FG001|STARTED|Double-blind Treatment Period (DBTP)||43
11379002|NCT03399786|12574173|FG002|STARTED|Double-blind Treatment Period (DBTP)||0
11379003|NCT03399786|12574174|FG003|STARTED|Double-blind Treatment Period (DBTP)||0
11379004|NCT03399786|12574171|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||21
11379005|NCT03399786|12574172|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||43
11379006|NCT03399786|12574173|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||0
11379007|NCT03399786|12574174|FG003|COMPLETED|Double-blind Treatment Period (DBTP)||0
11379008|NCT03399786|12574171|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||1
11379009|NCT03399786|12574172|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
11379010|NCT03399786|12574173|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
11379011|NCT03399786|12574174|FG003|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
11379012|NCT03399786|12574171|FG000|STARTED|Open-label Treatment Period (OLTP)||0
11379013|NCT03399786|12574172|FG001|STARTED|Open-label Treatment Period (OLTP)||0
11379014|NCT03399786|12574173|FG002|STARTED|Open-label Treatment Period (OLTP)|One participant from the placebo group received evinacumab during the DBTP|20
11379015|NCT03399786|12574174|FG003|STARTED|Open-label Treatment Period (OLTP)||44
11379016|NCT03399786|12574171|FG000|COMPLETED|Open-label Treatment Period (OLTP)||0
11379017|NCT03399786|12574172|FG001|COMPLETED|Open-label Treatment Period (OLTP)||0
11379018|NCT03399786|12574173|FG002|COMPLETED|Open-label Treatment Period (OLTP)||19
11379019|NCT03399786|12574174|FG003|COMPLETED|Open-label Treatment Period (OLTP)||43
11379020|NCT03399786|12574171|FG000|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
11379021|NCT03399786|12574172|FG001|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
11379022|NCT03399786|12574173|FG002|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
11379023|NCT03399786|12574174|FG003|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
11379024|NCT03400033|12574184|FG000|STARTED|Overall Study||270
11379025|NCT03400033|12574185|FG001|STARTED|Overall Study||137
11379026|NCT03400033|12574184|FG000|COMPLETED|Overall Study||269
11379027|NCT03400033|12574185|FG001|COMPLETED|Overall Study||135
11379028|NCT03400033|12574184|FG000|NOT COMPLETED|Overall Study||1
11379029|NCT03400033|12574185|FG001|NOT COMPLETED|Overall Study||2
11379030|NCT03400163|12574202|FG000|STARTED|Treatment Period||1
11379031|NCT03400163|12574203|FG001|STARTED|Treatment Period||2
11379032|NCT03400163|12574202|FG000|COMPLETED|Treatment Period||1
11379033|NCT03400163|12574203|FG001|COMPLETED|Treatment Period||2
11379034|NCT03400163|12574202|FG000|NOT COMPLETED|Treatment Period||0
11379035|NCT03400163|12574203|FG001|NOT COMPLETED|Treatment Period||0
11379036|NCT03400163|12574202|FG000|STARTED|Follow-up Period||1
11379037|NCT03400163|12574203|FG001|STARTED|Follow-up Period||2
11379038|NCT03400163|12574202|FG000|COMPLETED|Follow-up Period||1
11379039|NCT03400163|12574203|FG001|COMPLETED|Follow-up Period||2
11379040|NCT03400163|12574202|FG000|NOT COMPLETED|Follow-up Period||0
11379041|NCT03400163|12574203|FG001|NOT COMPLETED|Follow-up Period||0
11379042|NCT03400449|12574211|FG000|STARTED|Overall Study||121
11379043|NCT03400449|12574212|FG001|STARTED|Overall Study||119
11379044|NCT03400449|12574211|FG000|COMPLETED|Overall Study||120
11379045|NCT03400449|12574212|FG001|COMPLETED|Overall Study||119
11379046|NCT03400449|12574211|FG000|NOT COMPLETED|Overall Study||1
11379047|NCT03400449|12574212|FG001|NOT COMPLETED|Overall Study||0
11379048|NCT03400475|12574222|FG000|STARTED|Overall Study||24
11379049|NCT03400475|12574223|FG001|STARTED|Overall Study||22
11379050|NCT03400475|12574222|FG000|COMPLETED|Overall Study||24
11379051|NCT03400475|12574223|FG001|COMPLETED|Overall Study||22
11379052|NCT03400475|12574222|FG000|NOT COMPLETED|Overall Study||0
11379053|NCT03400475|12574223|FG001|NOT COMPLETED|Overall Study||0
11379054|NCT03400579|12574230|FG000|STARTED|Overall Study||10
11379055|NCT03400579|12574230|FG000|COMPLETED|Overall Study||10
11379056|NCT03400579|12574230|FG000|NOT COMPLETED|Overall Study||0
11379057|NCT03400748|12574234|FG000|STARTED|Overall Study||6
11379058|NCT03400748|12574234|FG000|COMPLETED|Overall Study||6
11379059|NCT03400748|12574234|FG000|NOT COMPLETED|Overall Study||0
11379060|NCT03400787|12574240|FG000|STARTED|Overall Study||66
11379061|NCT03400787|12574241|FG001|STARTED|Overall Study||71
11379062|NCT03400787|12574240|FG000|3-Month Follow-up|Overall Study||64
11379063|NCT03400787|12574241|FG001|3-Month Follow-up|Overall Study||63
11379064|NCT03400787|12574240|FG000|COMPLETED|Overall Study||64
11379065|NCT03400787|12574241|FG001|COMPLETED|Overall Study||63
11379066|NCT03400787|12574240|FG000|NOT COMPLETED|Overall Study||2
11379067|NCT03400787|12574241|FG001|NOT COMPLETED|Overall Study||8
11379068|NCT03400800|12574249|FG000|STARTED|Overall Study||810
11379069|NCT03400800|12574250|FG001|STARTED|Overall Study||807
11379070|NCT03400800|12574249|FG000|COMPLETED|Overall Study||772
11379071|NCT03400800|12574250|FG001|COMPLETED|Overall Study||770
11379072|NCT03400800|12574249|FG000|NOT COMPLETED|Overall Study||38
11379073|NCT03400800|12574250|FG001|NOT COMPLETED|Overall Study||37
11379074|NCT03400852|12574258|FG000|STARTED|Blinded Treatment Period||29
11379075|NCT03400852|12574259|FG001|STARTED|Blinded Treatment Period||15
11379076|NCT03400852|12574260|FG002|STARTED|Blinded Treatment Period||0
11379077|NCT03400852|12574258|FG000|COMPLETED|Blinded Treatment Period||20
11379078|NCT03400852|12574259|FG001|COMPLETED|Blinded Treatment Period||9
11379079|NCT03400852|12574260|FG002|COMPLETED|Blinded Treatment Period||0
11379080|NCT03400852|12574258|FG000|NOT COMPLETED|Blinded Treatment Period||9
11379081|NCT03400852|12574259|FG001|NOT COMPLETED|Blinded Treatment Period||6
11379082|NCT03400852|12574260|FG002|NOT COMPLETED|Blinded Treatment Period||0
11379083|NCT03400852|12574258|FG000|STARTED|Open Label Period||0
11379084|NCT03400852|12574259|FG001|STARTED|Open Label Period||0
11379085|NCT03400852|12574260|FG002|STARTED|Open Label Period||24
11379086|NCT03400852|12574258|FG000|COMPLETED|Open Label Period||0
11379087|NCT03400852|12574259|FG001|COMPLETED|Open Label Period||0
11379088|NCT03400852|12574260|FG002|COMPLETED|Open Label Period||2
11379089|NCT03400852|12574258|FG000|NOT COMPLETED|Open Label Period||0
11379090|NCT03400852|12574259|FG001|NOT COMPLETED|Open Label Period||0
11379091|NCT03400852|12574260|FG002|NOT COMPLETED|Open Label Period||22
11379092|NCT03401229|12574270|FG000|STARTED|Overall Study||207
11379093|NCT03401229|12574271|FG001|STARTED|Overall Study||203
11379094|NCT03401229|12574270|FG000|COMPLETED|Overall Study||167
11379095|NCT03401229|12574271|FG001|COMPLETED|Overall Study||166
11379096|NCT03401229|12574270|FG000|NOT COMPLETED|Overall Study||40
11379097|NCT03401229|12574271|FG001|NOT COMPLETED|Overall Study||37
11379098|NCT03401450|12574279|FG000|STARTED|Overall Study||33
11379099|NCT03401450|12574280|FG001|STARTED|Overall Study||36
11379100|NCT03401450|12574279|FG000|COMPLETED|Overall Study||21
11379101|NCT03401450|12574280|FG001|COMPLETED|Overall Study||23
11379102|NCT03401450|12574279|FG000|NOT COMPLETED|Overall Study||12
11379103|NCT03401450|12574280|FG001|NOT COMPLETED|Overall Study||13
11379104|NCT03401671|12574288|FG000|STARTED|Overall Study||16
11379105|NCT03401671|12574289|FG001|STARTED|Overall Study||16
11379106|NCT03401671|12574288|FG000|COMPLETED|Overall Study||16
11379107|NCT03401671|12574289|FG001|COMPLETED|Overall Study||16
11379108|NCT03401671|12574288|FG000|NOT COMPLETED|Overall Study||0
11379109|NCT03401671|12574289|FG001|NOT COMPLETED|Overall Study||0
11379110|NCT03402126|12574295|FG000|STARTED|Overall Study||138
11379111|NCT03402126|12574295|FG000|COMPLETED|Overall Study||76
11379112|NCT03402126|12574295|FG000|NOT COMPLETED|Overall Study||62
11379113|NCT03402243|12574302|FG000|STARTED|Overall Study||16
11379114|NCT03402243|12574303|FG001|STARTED|Overall Study||15
11379115|NCT03402243|12574304|FG002|STARTED|Overall Study||16
11379116|NCT03402243|12574302|FG000|COMPLETED|Overall Study||13
11379117|NCT03402243|12574303|FG001|COMPLETED|Overall Study||12
11379118|NCT03402243|12574304|FG002|COMPLETED|Overall Study||14
11379119|NCT03402243|12574302|FG000|NOT COMPLETED|Overall Study||3
11379120|NCT03402243|12574303|FG001|NOT COMPLETED|Overall Study||3
11379121|NCT03402243|12574304|FG002|NOT COMPLETED|Overall Study||2
11379122|NCT03402386|12574312|FG000|STARTED|Overall Study||42
11379123|NCT03402386|12574312|FG000|Correction Group|Overall Study||2
11379124|NCT03402386|12574312|FG000|Conversion Group|Overall Study||40
11379125|NCT03402386|12574312|FG000|COMPLETED|Overall Study||36
11379126|NCT03402386|12574312|FG000|NOT COMPLETED|Overall Study||6
11379127|NCT03402555|12574316|FG000|STARTED|Overall Study||96
11379128|NCT03402555|12574316|FG000|COMPLETED|Overall Study||91
11379129|NCT03402555|12574316|FG000|NOT COMPLETED|Overall Study||5
11379130|NCT03402659|12574322|FG000|STARTED|Overall Study||83
11379131|NCT03402659|12574323|FG001|STARTED|Overall Study||78
11379132|NCT03402659|12574322|FG000|COMPLETED|Overall Study||78
11379133|NCT03402659|12574323|FG001|COMPLETED|Overall Study||73
11379134|NCT03402659|12574322|FG000|NOT COMPLETED|Overall Study||5
11379135|NCT03402659|12574323|FG001|NOT COMPLETED|Overall Study||5
11379136|NCT03402750|12574331|FG000|STARTED|Overall Study||20
11379137|NCT03402750|12574332|FG001|STARTED|Overall Study||20
11379138|NCT03402750|12574331|FG000|COMPLETED|Overall Study||18
11379139|NCT03402750|12574332|FG001|COMPLETED|Overall Study||19
11379140|NCT03402750|12574331|FG000|NOT COMPLETED|Overall Study||2
11379141|NCT03402750|12574332|FG001|NOT COMPLETED|Overall Study||1
11379142|NCT03402893|12574338|FG000|STARTED|Overall Study||21
11379143|NCT03402893|12574338|FG000|COMPLETED|Overall Study||20
11379144|NCT03402893|12574338|FG000|NOT COMPLETED|Overall Study||1
11379145|NCT03402932|12574347|FG000|STARTED|Overall Study||13
11379146|NCT03402932|12574348|FG001|STARTED|Overall Study||8
11379147|NCT03402932|12574349|FG002|STARTED|Overall Study||8
11379148|NCT03402932|12574350|FG003|STARTED|Overall Study||8
11379149|NCT03402932|12574347|FG000|COMPLETED|Overall Study||13
11379150|NCT03402932|12574348|FG001|COMPLETED|Overall Study||8
11379151|NCT03402932|12574349|FG002|COMPLETED|Overall Study||8
11379152|NCT03402932|12574350|FG003|COMPLETED|Overall Study||8
11379153|NCT03402932|12574347|FG000|NOT COMPLETED|Overall Study||0
11379154|NCT03402932|12574348|FG001|NOT COMPLETED|Overall Study||0
11379155|NCT03402932|12574349|FG002|NOT COMPLETED|Overall Study||0
11379156|NCT03402932|12574350|FG003|NOT COMPLETED|Overall Study||0
11379157|NCT03403036|12574364|FG000|STARTED|Overall Study||39
11379158|NCT03403036|12574364|FG000|COMPLETED|Overall Study||34
11379159|NCT03403036|12574364|FG000|NOT COMPLETED|Overall Study||5
11379160|NCT03403192|12574372|FG000|STARTED|Overall Study||41
11379161|NCT03403192|12574373|FG001|STARTED|Overall Study||40
11379162|NCT03403192|12574374|FG002|STARTED|Overall Study||40
11379163|NCT03403192|12574375|FG003|STARTED|Overall Study||42
11379164|NCT03403192|12574372|FG000|COMPLETED|Overall Study||37
11379165|NCT03403192|12574373|FG001|COMPLETED|Overall Study||36
11379166|NCT03403192|12574374|FG002|COMPLETED|Overall Study||37
11379167|NCT03403192|12574375|FG003|COMPLETED|Overall Study||36
11379168|NCT03403192|12574372|FG000|NOT COMPLETED|Overall Study||4
11379169|NCT03403192|12574373|FG001|NOT COMPLETED|Overall Study||4
11379170|NCT03403192|12574374|FG002|NOT COMPLETED|Overall Study||3
11379171|NCT03403192|12574375|FG003|NOT COMPLETED|Overall Study||6
11379172|NCT03403231|12574401|FG000|STARTED|Overall Study||9
11379173|NCT03403231|12574402|FG001|STARTED|Overall Study||9
11379174|NCT03403231|12574403|FG002|STARTED|Overall Study||9
11379175|NCT03403231|12574404|FG003|STARTED|Overall Study||9
11379176|NCT03403231|12574405|FG004|STARTED|Overall Study||9
11379177|NCT03403231|12574406|FG005|STARTED|Overall Study||9
11379178|NCT03403231|12574407|FG006|STARTED|Overall Study||9
11379179|NCT03403231|12574408|FG007|STARTED|Overall Study||9
11379180|NCT03403231|12574409|FG008|STARTED|Overall Study||9
11379181|NCT03403231|12574410|FG009|STARTED|Overall Study||9
11379182|NCT03403231|12574411|FG010|STARTED|Overall Study||9
11379183|NCT03403231|12574412|FG011|STARTED|Overall Study||9
11379184|NCT03403231|12574413|FG012|STARTED|Overall Study||9
11379185|NCT03403231|12574414|FG013|STARTED|Overall Study||9
11379186|NCT03403231|12574415|FG014|STARTED|Overall Study||9
11379187|NCT03403231|12574416|FG015|STARTED|Overall Study||9
11379188|NCT03403231|12574401|FG000|COMPLETED|Overall Study||9
11379189|NCT03403231|12574402|FG001|COMPLETED|Overall Study||9
11379190|NCT03403231|12574403|FG002|COMPLETED|Overall Study||9
11379191|NCT03403231|12574404|FG003|COMPLETED|Overall Study||9
11379192|NCT03403231|12574405|FG004|COMPLETED|Overall Study||9
11379193|NCT03403231|12574406|FG005|COMPLETED|Overall Study||9
11379194|NCT03403231|12574407|FG006|COMPLETED|Overall Study||9
11379195|NCT03403231|12574408|FG007|COMPLETED|Overall Study||9
11379196|NCT03403231|12574409|FG008|COMPLETED|Overall Study||9
11379197|NCT03403231|12574410|FG009|COMPLETED|Overall Study||9
11379198|NCT03403231|12574411|FG010|COMPLETED|Overall Study||9
11379199|NCT03403231|12574412|FG011|COMPLETED|Overall Study||9
11379200|NCT03403231|12574413|FG012|COMPLETED|Overall Study||9
11379201|NCT03403231|12574414|FG013|COMPLETED|Overall Study||9
11379202|NCT03403231|12574415|FG014|COMPLETED|Overall Study||9
11379203|NCT03403231|12574416|FG015|COMPLETED|Overall Study||9
11379204|NCT03403231|12574401|FG000|NOT COMPLETED|Overall Study||0
11379205|NCT03403231|12574402|FG001|NOT COMPLETED|Overall Study||0
11379206|NCT03403231|12574403|FG002|NOT COMPLETED|Overall Study||0
11379207|NCT03403231|12574404|FG003|NOT COMPLETED|Overall Study||0
11379208|NCT03403231|12574405|FG004|NOT COMPLETED|Overall Study||0
11379209|NCT03403231|12574406|FG005|NOT COMPLETED|Overall Study||0
11379210|NCT03403231|12574407|FG006|NOT COMPLETED|Overall Study||0
11379211|NCT03403231|12574408|FG007|NOT COMPLETED|Overall Study||0
11379212|NCT03403231|12574409|FG008|NOT COMPLETED|Overall Study||0
11379213|NCT03403231|12574410|FG009|NOT COMPLETED|Overall Study||0
11379214|NCT03403231|12574411|FG010|NOT COMPLETED|Overall Study||0
11379215|NCT03403231|12574412|FG011|NOT COMPLETED|Overall Study||0
11379216|NCT03403231|12574413|FG012|NOT COMPLETED|Overall Study||0
11379217|NCT03403231|12574414|FG013|NOT COMPLETED|Overall Study||0
11379218|NCT03403231|12574415|FG014|NOT COMPLETED|Overall Study||0
11379219|NCT03403231|12574416|FG015|NOT COMPLETED|Overall Study||0
11379220|NCT03403374|12574450|FG000|STARTED|Overall Study||30
11379221|NCT03403374|12574450|FG000|COMPLETED|Overall Study||29
11379222|NCT03403374|12574450|FG000|NOT COMPLETED|Overall Study||1
11379223|NCT03403400|12574457|FG000|STARTED|Overall Study||5
11379224|NCT03403400|12574458|FG001|STARTED|Overall Study||6
11379225|NCT03403400|12574459|FG002|STARTED|Overall Study||6
11379226|NCT03403400|12574457|FG000|COMPLETED|Overall Study||3
11379227|NCT03403400|12574458|FG001|COMPLETED|Overall Study||6
11379228|NCT03403400|12574459|FG002|COMPLETED|Overall Study||4
11379229|NCT03403400|12574457|FG000|NOT COMPLETED|Overall Study||2
11379230|NCT03403400|12574458|FG001|NOT COMPLETED|Overall Study||0
11379231|NCT03403400|12574459|FG002|NOT COMPLETED|Overall Study||2
11379232|NCT03403413|12574482|FG000|STARTED|Overall Study||5
11379233|NCT03403413|12574482|FG000|COMPLETED|Overall Study||3
11379234|NCT03403413|12574482|FG000|NOT COMPLETED|Overall Study||2
11379235|NCT03403426|12574488|FG000|STARTED|Overall Study||85
11379236|NCT03403426|12574488|FG000|COMPLETED|Overall Study||82
11379237|NCT03403426|12574488|FG000|NOT COMPLETED|Overall Study||3
11379238|NCT03403491|12574492|FG000|STARTED|Overall Study||20
11379239|NCT03403491|12574493|FG001|STARTED|Overall Study||23
11379240|NCT03403491|12574492|FG000|COMPLETED|Overall Study||17
11379241|NCT03403491|12574493|FG001|COMPLETED|Overall Study||18
11379242|NCT03403491|12574492|FG000|NOT COMPLETED|Overall Study||3
11379243|NCT03403491|12574493|FG001|NOT COMPLETED|Overall Study||5
11379244|NCT03403504|12574502|FG000|STARTED|Period 1||12
11379245|NCT03403504|12574503|FG001|STARTED|Period 1||12
11379246|NCT03403504|12574502|FG000|COMPLETED|Period 1||12
11379247|NCT03403504|12574503|FG001|COMPLETED|Period 1||11
11379248|NCT03403504|12574502|FG000|NOT COMPLETED|Period 1||0
11379249|NCT03403504|12574503|FG001|NOT COMPLETED|Period 1||1
11379250|NCT03403504|12574502|FG000|STARTED|Period 2||12
11379251|NCT03403504|12574503|FG001|STARTED|Period 2||11
11379252|NCT03403504|12574502|FG000|COMPLETED|Period 2||12
11379253|NCT03403504|12574503|FG001|COMPLETED|Period 2||11
11379254|NCT03403504|12574502|FG000|NOT COMPLETED|Period 2||0
11379255|NCT03403504|12574503|FG001|NOT COMPLETED|Period 2||0
11379256|NCT03403517|12574525|FG000|STARTED|Overall Study||88
11379257|NCT03403517|12574526|FG001|STARTED|Overall Study||86
11379258|NCT03403517|12574525|FG000|COMPLETED|Overall Study||88
11379259|NCT03403517|12574526|FG001|COMPLETED|Overall Study||86
11379260|NCT03403517|12574525|FG000|NOT COMPLETED|Overall Study||0
11379261|NCT03403517|12574526|FG001|NOT COMPLETED|Overall Study||0
11379262|NCT03403712|12574534|FG000|STARTED|Overall Study||200
11379263|NCT03403712|12574535|FG001|STARTED|Overall Study||202
11379264|NCT03403712|12574534|FG000|COMPLETED|Overall Study||95
11379265|NCT03403712|12574535|FG001|COMPLETED|Overall Study||102
11379266|NCT03403712|12574534|FG000|NOT COMPLETED|Overall Study||105
11379267|NCT03403712|12574535|FG001|NOT COMPLETED|Overall Study||100
11379268|NCT03403725|12574552|FG000|STARTED|Overall Study||1
11379269|NCT03403725|12574553|FG001|STARTED|Overall Study||1
11379270|NCT03403725|12574554|FG002|STARTED|Overall Study||1
11379271|NCT03403725|12574555|FG003|STARTED|Overall Study||1
11379272|NCT03403725|12574556|FG004|STARTED|Overall Study||1
11379273|NCT03403725|12574557|FG005|STARTED|Overall Study||6
11379274|NCT03403725|12574558|FG006|STARTED|Overall Study||6
11379275|NCT03403725|12574559|FG007|STARTED|Overall Study||3
11379276|NCT03403725|12574560|FG008|STARTED|Overall Study||3
11379277|NCT03403725|12574561|FG009|STARTED|Overall Study||4
11379278|NCT03403725|12574562|FG010|STARTED|Overall Study||1
11379279|NCT03403725|12574552|FG000|COMPLETED|Overall Study||1
11379280|NCT03403725|12574553|FG001|COMPLETED|Overall Study||1
11379281|NCT03403725|12574554|FG002|COMPLETED|Overall Study||1
11379282|NCT03403725|12574555|FG003|COMPLETED|Overall Study||1
11379283|NCT03403725|12574556|FG004|COMPLETED|Overall Study||1
11379284|NCT03403725|12574557|FG005|COMPLETED|Overall Study||6
11379285|NCT03403725|12574558|FG006|COMPLETED|Overall Study||6
11379286|NCT03403725|12574559|FG007|COMPLETED|Overall Study||3
11379287|NCT03403725|12574560|FG008|COMPLETED|Overall Study||3
11379288|NCT03403725|12574561|FG009|COMPLETED|Overall Study||4
11379289|NCT03403725|12574562|FG010|COMPLETED|Overall Study||1
11379290|NCT03403725|12574552|FG000|NOT COMPLETED|Overall Study||0
11379291|NCT03403725|12574553|FG001|NOT COMPLETED|Overall Study||0
11379292|NCT03403725|12574554|FG002|NOT COMPLETED|Overall Study||0
11379293|NCT03403725|12574555|FG003|NOT COMPLETED|Overall Study||0
11379294|NCT03403725|12574556|FG004|NOT COMPLETED|Overall Study||0
11379295|NCT03403725|12574557|FG005|NOT COMPLETED|Overall Study||0
11379296|NCT03403725|12574558|FG006|NOT COMPLETED|Overall Study||0
11379297|NCT03403725|12574559|FG007|NOT COMPLETED|Overall Study||0
11379298|NCT03403725|12574560|FG008|NOT COMPLETED|Overall Study||0
11379299|NCT03403725|12574561|FG009|NOT COMPLETED|Overall Study||0
11379300|NCT03403725|12574562|FG010|NOT COMPLETED|Overall Study||0
11379301|NCT03403751|12574590|FG000|STARTED|Overall Study||28
11379302|NCT03403751|12574591|FG001|STARTED|Overall Study||30
11379303|NCT03403751|12574590|FG000|COMPLETED|Overall Study||21
11379304|NCT03403751|12574591|FG001|COMPLETED|Overall Study||22
11379305|NCT03403751|12574590|FG000|NOT COMPLETED|Overall Study||7
11379306|NCT03403751|12574591|FG001|NOT COMPLETED|Overall Study||8
11379307|NCT03404167|12574599|FG000|STARTED|Overall Study||8
11379308|NCT03404167|12574599|FG000|COMPLETED|Overall Study||8
11379309|NCT03404167|12574599|FG000|NOT COMPLETED|Overall Study||0
11379310|NCT03404206|12574608|FG000|STARTED|Overall Study||166
11379311|NCT03404206|12574609|FG001|STARTED|Overall Study||166
11379312|NCT03404206|12574610|FG002|STARTED|Overall Study||55
11379313|NCT03404206|12574608|FG000|COMPLETED|Overall Study||162
11379314|NCT03404206|12574609|FG001|COMPLETED|Overall Study||164
11379315|NCT03404206|12574610|FG002|COMPLETED|Overall Study||55
11379316|NCT03404206|12574608|FG000|NOT COMPLETED|Overall Study||4
11379317|NCT03404206|12574609|FG001|NOT COMPLETED|Overall Study||2
11379318|NCT03404206|12574610|FG002|NOT COMPLETED|Overall Study||0
11379319|NCT03404219|12574618|FG000|STARTED|Overall Study||31
11379320|NCT03404219|12574618|FG000|COMPLETED|Overall Study||31
11379321|NCT03404219|12574618|FG000|NOT COMPLETED|Overall Study||0
11379322|NCT03404375|12574625|FG000|STARTED|Overall Study||70
11379323|NCT03404375|12574626|FG001|STARTED|Overall Study||172
11379324|NCT03404375|12574625|FG000|COMPLETED|Overall Study||70
11379325|NCT03404375|12574626|FG001|COMPLETED|Overall Study||172
11379326|NCT03404375|12574625|FG000|NOT COMPLETED|Overall Study||0
11379327|NCT03404375|12574626|FG001|NOT COMPLETED|Overall Study||0
11379328|NCT03404401|12574634|FG000|STARTED|Overall Study||281
11379329|NCT03404401|12574635|FG001|STARTED|Overall Study||271
11379330|NCT03404401|12574634|FG000|COMPLETED|Overall Study||263
11379331|NCT03404401|12574635|FG001|COMPLETED|Overall Study||252
11379332|NCT03404401|12574634|FG000|NOT COMPLETED|Overall Study||18
11379333|NCT03404401|12574635|FG001|NOT COMPLETED|Overall Study||19
11379334|NCT03404609|12574641|FG000|STARTED|Overall Study||7
11379335|NCT03404609|12574641|FG000|COMPLETED|Overall Study||7
11379336|NCT03404609|12574641|FG000|NOT COMPLETED|Overall Study||0
11379337|NCT03404648|12574645|FG000|STARTED|Overall Study||19
11379338|NCT03404648|12574645|FG000|COMPLETED|Overall Study||19
11379339|NCT03404648|12574645|FG000|NOT COMPLETED|Overall Study||0
11379340|NCT03404674|12574655|FG000|STARTED|Overall Study||5
11379341|NCT03404674|12574656|FG001|STARTED|Overall Study||5
11379342|NCT03404674|12574657|FG002|STARTED|Overall Study||10
11379343|NCT03404674|12574658|FG003|STARTED|Overall Study||10
11379344|NCT03404674|12574659|FG004|STARTED|Overall Study||10
11379345|NCT03404674|12574660|FG005|STARTED|Overall Study||10
11379346|NCT03404674|12574655|FG000|Received Dose 2|Overall Study||5
11379347|NCT03404674|12574656|FG001|Received Dose 2|Overall Study||4
11379348|NCT03404674|12574657|FG002|Received Dose 2|Overall Study||10
11379349|NCT03404674|12574658|FG003|Received Dose 2|Overall Study||9
11379350|NCT03404674|12574659|FG004|Received Dose 2|Overall Study||10
11379351|NCT03404674|12574660|FG005|Received Dose 2|Overall Study||10
11379352|NCT03404674|12574655|FG000|Received Dose 3|Overall Study||5
11379353|NCT03404674|12574656|FG001|Received Dose 3|Overall Study||4
11379354|NCT03404674|12574657|FG002|Received Dose 3|Overall Study||9
11379355|NCT03404674|12574658|FG003|Received Dose 3|Overall Study||9
11379356|NCT03404674|12574659|FG004|Received Dose 3|Overall Study||10
11379357|NCT03404674|12574660|FG005|Received Dose 3|Overall Study||9
11379358|NCT03404674|12574655|FG000|COMPLETED|Overall Study||5
11379359|NCT03404674|12574656|FG001|COMPLETED|Overall Study||4
11379360|NCT03404674|12574657|FG002|COMPLETED|Overall Study||8
11379361|NCT03404674|12574658|FG003|COMPLETED|Overall Study||9
11379362|NCT03404674|12574659|FG004|COMPLETED|Overall Study||10
11379363|NCT03404674|12574660|FG005|COMPLETED|Overall Study||9
11379364|NCT03404674|12574655|FG000|NOT COMPLETED|Overall Study||0
11379365|NCT03404674|12574656|FG001|NOT COMPLETED|Overall Study||1
11379366|NCT03404674|12574657|FG002|NOT COMPLETED|Overall Study||2
11379367|NCT03404674|12574658|FG003|NOT COMPLETED|Overall Study||1
11379368|NCT03404674|12574659|FG004|NOT COMPLETED|Overall Study||0
11379369|NCT03404674|12574660|FG005|NOT COMPLETED|Overall Study||1
11379370|NCT03404843|12574677|FG000|STARTED|Overall Study||17
11379371|NCT03404843|12574678|FG001|STARTED|Overall Study||14
11379372|NCT03404843|12574677|FG000|COMPLETED|Overall Study||13
11379373|NCT03404843|12574678|FG001|COMPLETED|Overall Study||13
11379374|NCT03404843|12574677|FG000|NOT COMPLETED|Overall Study||4
11379375|NCT03404843|12574678|FG001|NOT COMPLETED|Overall Study||1
11379376|NCT03405259|12574690|FG000|STARTED|Overall Study||11
11379377|NCT03405259|12574691|FG001|STARTED|Overall Study||11
11379378|NCT03405259|12574690|FG000|COMPLETED|Overall Study||11
11379379|NCT03405259|12574691|FG001|COMPLETED|Overall Study||11
11379380|NCT03405259|12574690|FG000|NOT COMPLETED|Overall Study||0
11379381|NCT03405259|12574691|FG001|NOT COMPLETED|Overall Study||0
11379382|NCT03405363|12574699|FG000|STARTED|Overall Study||14239
11379383|NCT03405363|12574700|FG001|STARTED|Overall Study||51167
11379384|NCT03405363|12574699|FG000|COMPLETED|Overall Study||14239
11379385|NCT03405363|12574700|FG001|COMPLETED|Overall Study||51167
11379386|NCT03405363|12574699|FG000|NOT COMPLETED|Overall Study||0
11379387|NCT03405363|12574700|FG001|NOT COMPLETED|Overall Study||0
11379388|NCT03405818|12574706|FG000|STARTED|Overall Study||55
11379389|NCT03405818|12574706|FG000|COMPLETED|Overall Study||47
11379390|NCT03405818|12574706|FG000|NOT COMPLETED|Overall Study||8
11379391|NCT03405935|12574710|FG000|STARTED|Overall Study||86
11379392|NCT03405935|12574710|FG000|COMPLETED|Overall Study||78
11379393|NCT03405935|12574710|FG000|NOT COMPLETED|Overall Study||8
11379394|NCT03406260|12574720|FG000|STARTED|Period 1||6
11379395|NCT03406260|12574721|FG001|STARTED|Period 1||6
11379396|NCT03406260|12574722|FG002|STARTED|Period 1||6
11379397|NCT03406260|12574723|FG003|STARTED|Period 1||6
11379398|NCT03406260|12574724|FG004|STARTED|Period 1||6
11379399|NCT03406260|12574725|FG005|STARTED|Period 1||6
11379400|NCT03406260|12574720|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
11379401|NCT03406260|12574721|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
11379402|NCT03406260|12574722|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
11379403|NCT03406260|12574723|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
11379404|NCT03406260|12574724|FG004|Received at Least 1 Dose of Study Drug|Period 1||6
11379405|NCT03406260|12574725|FG005|Received at Least 1 Dose of Study Drug|Period 1||6
11379406|NCT03406260|12574720|FG000|COMPLETED|Period 1||6
11379407|NCT03406260|12574721|FG001|COMPLETED|Period 1||6
11379408|NCT03406260|12574722|FG002|COMPLETED|Period 1||6
11379409|NCT03406260|12574723|FG003|COMPLETED|Period 1||6
11379410|NCT03406260|12574724|FG004|COMPLETED|Period 1||5
11379411|NCT03406260|12574725|FG005|COMPLETED|Period 1||6
11379412|NCT03406260|12574720|FG000|NOT COMPLETED|Period 1||0
11379413|NCT03406260|12574721|FG001|NOT COMPLETED|Period 1||0
11379414|NCT03406260|12574722|FG002|NOT COMPLETED|Period 1||0
11379415|NCT03406260|12574723|FG003|NOT COMPLETED|Period 1||0
11379416|NCT03406260|12574724|FG004|NOT COMPLETED|Period 1||1
11379417|NCT03406260|12574725|FG005|NOT COMPLETED|Period 1||0
11379418|NCT03406260|12574720|FG000|STARTED|Period 2||6
11379419|NCT03406260|12574721|FG001|STARTED|Period 2||6
11379420|NCT03406260|12574722|FG002|STARTED|Period 2||6
11379421|NCT03406260|12574723|FG003|STARTED|Period 2||6
11379422|NCT03406260|12574724|FG004|STARTED|Period 2||5
11379423|NCT03406260|12574725|FG005|STARTED|Period 2||6
11379424|NCT03406260|12574720|FG000|COMPLETED|Period 2||6
11379425|NCT03406260|12574721|FG001|COMPLETED|Period 2||6
11379426|NCT03406260|12574722|FG002|COMPLETED|Period 2||6
11379427|NCT03406260|12574723|FG003|COMPLETED|Period 2||6
11379428|NCT03406260|12574724|FG004|COMPLETED|Period 2||5
11379429|NCT03406260|12574725|FG005|COMPLETED|Period 2||6
11379430|NCT03406260|12574720|FG000|NOT COMPLETED|Period 2||0
11379431|NCT03406260|12574721|FG001|NOT COMPLETED|Period 2||0
11379432|NCT03406260|12574722|FG002|NOT COMPLETED|Period 2||0
11379433|NCT03406260|12574723|FG003|NOT COMPLETED|Period 2||0
11379434|NCT03406260|12574724|FG004|NOT COMPLETED|Period 2||0
11379435|NCT03406260|12574725|FG005|NOT COMPLETED|Period 2||0
11379436|NCT03406260|12574720|FG000|STARTED|Period 3||6
11379437|NCT03406260|12574721|FG001|STARTED|Period 3||6
11379438|NCT03406260|12574722|FG002|STARTED|Period 3||6
11379439|NCT03406260|12574723|FG003|STARTED|Period 3||6
11379440|NCT03406260|12574724|FG004|STARTED|Period 3||5
11379441|NCT03406260|12574725|FG005|STARTED|Period 3||6
11379442|NCT03406260|12574720|FG000|COMPLETED|Period 3||6
11379443|NCT03406260|12574721|FG001|COMPLETED|Period 3||6
11379444|NCT03406260|12574722|FG002|COMPLETED|Period 3||6
11379445|NCT03406260|12574723|FG003|COMPLETED|Period 3||6
11379446|NCT03406260|12574724|FG004|COMPLETED|Period 3||5
11379447|NCT03406260|12574725|FG005|COMPLETED|Period 3||6
11379448|NCT03406260|12574720|FG000|NOT COMPLETED|Period 3||0
11379449|NCT03406260|12574721|FG001|NOT COMPLETED|Period 3||0
11379450|NCT03406260|12574722|FG002|NOT COMPLETED|Period 3||0
11379451|NCT03406260|12574723|FG003|NOT COMPLETED|Period 3||0
11379452|NCT03406260|12574724|FG004|NOT COMPLETED|Period 3||0
11379453|NCT03406260|12574725|FG005|NOT COMPLETED|Period 3||0
11379454|NCT03406325|12574743|FG000|STARTED|Overall Study||12
11379455|NCT03406325|12574744|FG001|STARTED|Overall Study||1
11379456|NCT03406325|12574745|FG002|STARTED|Overall Study||1
11379457|NCT03406325|12574746|FG003|STARTED|Overall Study||1
11379458|NCT03406325|12574747|FG004|STARTED|Overall Study||1
11379459|NCT03406325|12574748|FG005|STARTED|Overall Study||1
11379460|NCT03406325|12574749|FG006|STARTED|Overall Study||1
11379461|NCT03406325|12574750|FG007|STARTED|Overall Study||1
11379462|NCT03406325|12574743|FG000|COMPLETED|Overall Study||12
11379463|NCT03406325|12574744|FG001|COMPLETED|Overall Study||1
11379464|NCT03406325|12574745|FG002|COMPLETED|Overall Study||1
11379465|NCT03406325|12574746|FG003|COMPLETED|Overall Study||1
11379466|NCT03406325|12574747|FG004|COMPLETED|Overall Study||1
11379467|NCT03406325|12574748|FG005|COMPLETED|Overall Study||1
11379468|NCT03406325|12574749|FG006|COMPLETED|Overall Study||1
11379469|NCT03406325|12574750|FG007|COMPLETED|Overall Study||1
11379470|NCT03406325|12574743|FG000|NOT COMPLETED|Overall Study||0
11379471|NCT03406325|12574744|FG001|NOT COMPLETED|Overall Study||0
11379472|NCT03406325|12574745|FG002|NOT COMPLETED|Overall Study||0
11379473|NCT03406325|12574746|FG003|NOT COMPLETED|Overall Study||0
11379474|NCT03406325|12574747|FG004|NOT COMPLETED|Overall Study||0
11379475|NCT03406325|12574748|FG005|NOT COMPLETED|Overall Study||0
11379476|NCT03406325|12574749|FG006|NOT COMPLETED|Overall Study||0
11379477|NCT03406325|12574750|FG007|NOT COMPLETED|Overall Study||0
11379478|NCT03406377|12574784|FG000|STARTED|Overall Study||41
11379479|NCT03406377|12574785|FG001|STARTED|Overall Study||72
11379480|NCT03406377|12574784|FG000|COMPLETED|Overall Study||25
11379481|NCT03406377|12574785|FG001|COMPLETED|Overall Study||51
11379482|NCT03406377|12574784|FG000|NOT COMPLETED|Overall Study||16
11379483|NCT03406377|12574785|FG001|NOT COMPLETED|Overall Study||21
11379484|NCT03406962|12574791|FG000|STARTED|Overall Study||8
11379485|NCT03406962|12574791|FG000|COMPLETED|Overall Study||5
11379486|NCT03406962|12574791|FG000|NOT COMPLETED|Overall Study||3
11379487|NCT03407053|12574798|FG000|STARTED|Overall Study||10
11379488|NCT03407053|12574799|FG001|STARTED|Overall Study||10
11379489|NCT03407053|12574798|FG000|COMPLETED|Overall Study||10
11379490|NCT03407053|12574799|FG001|COMPLETED|Overall Study||10
11379491|NCT03407053|12574798|FG000|NOT COMPLETED|Overall Study||0
11379492|NCT03407053|12574799|FG001|NOT COMPLETED|Overall Study||0
11379493|NCT03407118|12574805|FG000|STARTED|Period 1||14
11379494|NCT03407118|12574806|FG001|STARTED|Period 1||17
11379495|NCT03407118|12574805|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
11379496|NCT03407118|12574806|FG001|Received at Least 1 Dose of Study Drug|Period 1||17
11379497|NCT03407118|12574805|FG000|COMPLETED|Period 1||14
11379498|NCT03407118|12574806|FG001|COMPLETED|Period 1||17
11379499|NCT03407118|12574805|FG000|NOT COMPLETED|Period 1||0
11379500|NCT03407118|12574806|FG001|NOT COMPLETED|Period 1||0
11379501|NCT03407118|12574805|FG000|STARTED|Period 2||14
11379502|NCT03407118|12574806|FG001|STARTED|Period 2||17
11379503|NCT03407118|12574805|FG000|Received at Least 1 Dose of Study Drug|Period 2||13
11379504|NCT03407118|12574806|FG001|Received at Least 1 Dose of Study Drug|Period 2||17
11379505|NCT03407118|12574805|FG000|COMPLETED|Period 2||13
11379506|NCT03407118|12574806|FG001|COMPLETED|Period 2||17
11379507|NCT03407118|12574805|FG000|NOT COMPLETED|Period 2||1
11379508|NCT03407118|12574806|FG001|NOT COMPLETED|Period 2||0
11379509|NCT03407170|12574812|FG000|STARTED|Overall Study||1
11379510|NCT03407170|12574812|FG000|COMPLETED|Overall Study||0
11379511|NCT03407170|12574812|FG000|NOT COMPLETED|Overall Study||1
11379512|NCT03407313|12574816|FG000|STARTED|Overall Study||68
11379513|NCT03407313|12574816|FG000|COMPLETED|Overall Study||66
11379514|NCT03407313|12574816|FG000|NOT COMPLETED|Overall Study||2
11379515|NCT03407430|12574822|FG000|STARTED|First Intervention||5
11379516|NCT03407430|12574823|FG001|STARTED|First Intervention||3
11379517|NCT03407430|12574822|FG000|COMPLETED|First Intervention||5
11379518|NCT03407430|12574823|FG001|COMPLETED|First Intervention||3
11379519|NCT03407430|12574822|FG000|NOT COMPLETED|First Intervention||0
11379520|NCT03407430|12574823|FG001|NOT COMPLETED|First Intervention||0
11379521|NCT03407430|12574822|FG000|STARTED|Washout||5
11379522|NCT03407430|12574823|FG001|STARTED|Washout||3
11379523|NCT03407430|12574822|FG000|COMPLETED|Washout||4
11379524|NCT03407430|12574823|FG001|COMPLETED|Washout||3
11379525|NCT03407430|12574822|FG000|NOT COMPLETED|Washout||1
11379526|NCT03407430|12574823|FG001|NOT COMPLETED|Washout||0
11379527|NCT03407430|12574822|FG000|STARTED|Second Intervention||4
11379528|NCT03407430|12574823|FG001|STARTED|Second Intervention||3
11379529|NCT03407430|12574822|FG000|COMPLETED|Second Intervention||4
11379530|NCT03407430|12574823|FG001|COMPLETED|Second Intervention||3
11379531|NCT03407430|12574822|FG000|NOT COMPLETED|Second Intervention||0
11379532|NCT03407430|12574823|FG001|NOT COMPLETED|Second Intervention||0
11379533|NCT03407482|12574836|FG000|STARTED|Overall Study||160
11379534|NCT03407482|12574836|FG000|COMPLETED|Overall Study||29
11379535|NCT03407482|12574836|FG000|NOT COMPLETED|Overall Study||131
11379536|NCT03407612|12574842|FG000|STARTED|Overall Study||19
11379537|NCT03407612|12574843|FG001|STARTED|Overall Study||23
11379538|NCT03407612|12574842|FG000|COMPLETED|Overall Study||19
11379539|NCT03407612|12574843|FG001|COMPLETED|Overall Study||23
11379540|NCT03407612|12574842|FG000|NOT COMPLETED|Overall Study||0
11379541|NCT03407612|12574843|FG001|NOT COMPLETED|Overall Study||0
11379542|NCT03407625|12574851|FG000|STARTED|Overall Study||1117
11379543|NCT03407625|12574852|FG001|STARTED|Overall Study||1110
11379544|NCT03407625|12574851|FG000|COMPLETED|Overall Study||1117
11379545|NCT03407625|12574852|FG001|COMPLETED|Overall Study||1110
11379546|NCT03407625|12574851|FG000|NOT COMPLETED|Overall Study||0
11379547|NCT03407625|12574852|FG001|NOT COMPLETED|Overall Study||0
11379548|NCT03407651|12574858|FG000|STARTED|Period 1: Part 1a||11
11379549|NCT03407651|12574858|FG000|COMPLETED|Period 1: Part 1a||10
11379550|NCT03407651|12574858|FG000|NOT COMPLETED|Period 1: Part 1a||1
11379551|NCT03407651|12574858|FG000|STARTED|Period 2: Part 1b||9
11379552|NCT03407651|12574858|FG000|COMPLETED|Period 2: Part 1b||9
11379553|NCT03407651|12574858|FG000|NOT COMPLETED|Period 2: Part 1b||0
11379554|NCT03407651|12574858|FG000|STARTED|Period 3: Part 2|The subject who discontinued after 44 daily SC doses in Part 2 elected to participate in Period 3.|11
11379555|NCT03407651|12574858|FG000|COMPLETED|Period 3: Part 2||8
11379556|NCT03407651|12574858|FG000|NOT COMPLETED|Period 3: Part 2||3
11379557|NCT03408171|12574880|FG000|STARTED|Overall Study||20
11379558|NCT03408171|12574881|FG001|STARTED|Overall Study||20
11379559|NCT03408171|12574880|FG000|COMPLETED|Overall Study||20
11379560|NCT03408171|12574881|FG001|COMPLETED|Overall Study||20
11379561|NCT03408171|12574880|FG000|NOT COMPLETED|Overall Study||0
11379562|NCT03408171|12574881|FG001|NOT COMPLETED|Overall Study||0
11379563|NCT03408392|12574887|FG000|STARTED|Treatment Period 1 (16 Days)||14
11379564|NCT03408392|12574888|FG001|STARTED|Treatment Period 1 (16 Days)||14
11379565|NCT03408392|12574887|FG000|COMPLETED|Treatment Period 1 (16 Days)||14
11379566|NCT03408392|12574888|FG001|COMPLETED|Treatment Period 1 (16 Days)||14
11379567|NCT03408392|12574887|FG000|NOT COMPLETED|Treatment Period 1 (16 Days)||0
11379568|NCT03408392|12574888|FG001|NOT COMPLETED|Treatment Period 1 (16 Days)||0
11379569|NCT03408392|12574887|FG000|STARTED|Wash-out Period (14 Days)||14
11379570|NCT03408392|12574888|FG001|STARTED|Wash-out Period (14 Days)||14
11379571|NCT03408392|12574887|FG000|COMPLETED|Wash-out Period (14 Days)||14
11379572|NCT03408392|12574888|FG001|COMPLETED|Wash-out Period (14 Days)||14
11379573|NCT03408392|12574887|FG000|NOT COMPLETED|Wash-out Period (14 Days)||0
11379574|NCT03408392|12574888|FG001|NOT COMPLETED|Wash-out Period (14 Days)||0
11379575|NCT03408392|12574887|FG000|STARTED|Treatment Period 2 (16 Days)||14
11379576|NCT03408392|12574888|FG001|STARTED|Treatment Period 2 (16 Days)||14
11379577|NCT03408392|12574887|FG000|COMPLETED|Treatment Period 2 (16 Days)||14
11379578|NCT03408392|12574888|FG001|COMPLETED|Treatment Period 2 (16 Days)||14
11379579|NCT03408392|12574887|FG000|NOT COMPLETED|Treatment Period 2 (16 Days)||0
11379580|NCT03408392|12574888|FG001|NOT COMPLETED|Treatment Period 2 (16 Days)||0
11379581|NCT03408483|12574896|FG000|STARTED|Overall Study||42
11379582|NCT03408483|12574897|FG001|STARTED|Overall Study||38
11379583|NCT03408483|12574896|FG000|COMPLETED|Overall Study||36
11379584|NCT03408483|12574897|FG001|COMPLETED|Overall Study||35
11379585|NCT03408483|12574896|FG000|NOT COMPLETED|Overall Study||6
11379586|NCT03408483|12574897|FG001|NOT COMPLETED|Overall Study||3
11379587|NCT03408639|12574905|FG000|STARTED|Overall Study||78
11379588|NCT03408639|12574906|FG001|STARTED|Overall Study||78
11379589|NCT03408639|12574905|FG000|COMPLETED|Overall Study||67
11379590|NCT03408639|12574906|FG001|COMPLETED|Overall Study||56
11379591|NCT03408639|12574905|FG000|NOT COMPLETED|Overall Study||11
11379592|NCT03408639|12574906|FG001|NOT COMPLETED|Overall Study||22
11379593|NCT03408730|12574916|FG000|STARTED|Overall Study||712
11379594|NCT03408730|12574917|FG001|STARTED|Overall Study||711
11379595|NCT03408730|12574918|FG002|STARTED|Overall Study||709
11379596|NCT03408730|12574919|FG003|STARTED|Overall Study||706
11379597|NCT03408730|12574916|FG000|COMPLETED|Overall Study||643
11379598|NCT03408730|12574917|FG001|COMPLETED|Overall Study||636
11379599|NCT03408730|12574918|FG002|COMPLETED|Overall Study||637
11379600|NCT03408730|12574919|FG003|COMPLETED|Overall Study||625
11379601|NCT03408730|12574916|FG000|NOT COMPLETED|Overall Study||69
11379602|NCT03408730|12574917|FG001|NOT COMPLETED|Overall Study||75
11379603|NCT03408730|12574918|FG002|NOT COMPLETED|Overall Study||72
11379604|NCT03408730|12574919|FG003|NOT COMPLETED|Overall Study||81
11379605|NCT03408808|12574935|FG000|STARTED|Overall Study||8
11379606|NCT03408808|12574936|FG001|STARTED|Overall Study||9
11379607|NCT03408808|12574935|FG000|COMPLETED|Overall Study||8
11379608|NCT03408808|12574936|FG001|COMPLETED|Overall Study||8
11379609|NCT03408808|12574935|FG000|NOT COMPLETED|Overall Study||0
11379610|NCT03408808|12574936|FG001|NOT COMPLETED|Overall Study||1
11379611|NCT03409107|12574944|FG000|STARTED|Overall Study||307
11379612|NCT03409107|12574945|FG001|STARTED|Overall Study||307
11379613|NCT03409107|12574944|FG000|COMPLETED|Overall Study||290
11379614|NCT03409107|12574945|FG001|COMPLETED|Overall Study||300
11379615|NCT03409107|12574944|FG000|NOT COMPLETED|Overall Study||17
11379616|NCT03409107|12574945|FG001|NOT COMPLETED|Overall Study||7
11379617|NCT03410056|12574955|FG000|STARTED|Overall Study||8
11379618|NCT03410056|12574956|FG001|STARTED|Overall Study||6
11379619|NCT03410056|12574957|FG002|STARTED|Overall Study||11
11379620|NCT03410056|12574958|FG003|STARTED|Overall Study||11
11379621|NCT03410056|12574959|FG004|STARTED|Overall Study||0
11379622|NCT03410056|12574960|FG005|STARTED|Overall Study||0
11379623|NCT03410056|12574961|FG006|STARTED|Overall Study||0
11379624|NCT03410056|12574955|FG000|Received Treatment|Overall Study||8
11379625|NCT03410056|12574956|FG001|Received Treatment|Overall Study||6
11379626|NCT03410056|12574957|FG002|Received Treatment|Overall Study||11
11379627|NCT03410056|12574958|FG003|Received Treatment|Overall Study||11
11379628|NCT03410056|12574959|FG004|Received Treatment|Overall Study||0
11379629|NCT03410056|12574960|FG005|Received Treatment|Overall Study||0
11379630|NCT03410056|12574961|FG006|Received Treatment|Overall Study||0
11379631|NCT03410056|12574955|FG000|COMPLETED|Overall Study||8
11379632|NCT03410056|12574956|FG001|COMPLETED|Overall Study||4
11379633|NCT03410056|12574957|FG002|COMPLETED|Overall Study||3
11379634|NCT03410056|12574958|FG003|COMPLETED|Overall Study||6
11379635|NCT03410056|12574959|FG004|COMPLETED|Overall Study||0
11379636|NCT03410056|12574960|FG005|COMPLETED|Overall Study||0
11379637|NCT03410056|12574961|FG006|COMPLETED|Overall Study||0
11379638|NCT03410056|12574955|FG000|NOT COMPLETED|Overall Study||0
11379639|NCT03410056|12574956|FG001|NOT COMPLETED|Overall Study||2
11379640|NCT03410056|12574957|FG002|NOT COMPLETED|Overall Study||8
11379641|NCT03410056|12574958|FG003|NOT COMPLETED|Overall Study||5
11379642|NCT03410056|12574959|FG004|NOT COMPLETED|Overall Study||0
11379643|NCT03410056|12574960|FG005|NOT COMPLETED|Overall Study||0
11379644|NCT03410056|12574961|FG006|NOT COMPLETED|Overall Study||0
11379645|NCT03410628|12574977|FG000|STARTED|Overall Study||21
11379646|NCT03410628|12574977|FG000|COMPLETED|Overall Study||15
11379647|NCT03410628|12574977|FG000|NOT COMPLETED|Overall Study||6
11379648|NCT03410797|12574981|FG000|STARTED|Overall Study||11
11379649|NCT03410797|12574981|FG000|COMPLETED|Overall Study||11
11379650|NCT03410797|12574981|FG000|NOT COMPLETED|Overall Study||0
11379651|NCT03410862|12574988|FG000|STARTED|Overall Study||43
11379652|NCT03410862|12574989|FG001|STARTED|Overall Study||44
11379653|NCT03410862|12574988|FG000|COMPLETED|Overall Study||41
11379654|NCT03410862|12574989|FG001|COMPLETED|Overall Study||42
11379655|NCT03410862|12574988|FG000|NOT COMPLETED|Overall Study||2
11379656|NCT03410862|12574989|FG001|NOT COMPLETED|Overall Study||2
11379657|NCT03410914|12574995|FG000|STARTED|Overall Study||52
11379658|NCT03410914|12574995|FG000|COMPLETED|Overall Study||52
11379659|NCT03410914|12574995|FG000|NOT COMPLETED|Overall Study||0
11379660|NCT03410953|12574999|FG000|STARTED|Overall Study|First patient recruited|67
11379661|NCT03410953|12574999|FG000|COMPLETED|Overall Study|67 participants were enrolled in the Clinical Trial and included the analyses|67
11379662|NCT03410953|12574999|FG000|NOT COMPLETED|Overall Study||0
11379663|NCT03411902|12575005|FG000|STARTED|Overall Study||11
11379664|NCT03411902|12575006|FG001|STARTED|Overall Study||13
11379665|NCT03411902|12575005|FG000|COMPLETED|Overall Study||8
11379666|NCT03411902|12575006|FG001|COMPLETED|Overall Study||13
11379667|NCT03411902|12575005|FG000|NOT COMPLETED|Overall Study||3
11379668|NCT03411902|12575006|FG001|NOT COMPLETED|Overall Study||0
11379669|NCT03412019|12575014|FG000|STARTED|Overall Study||11
11379670|NCT03412019|12575015|FG001|STARTED|Overall Study||11
11379671|NCT03412019|12575014|FG000|COMPLETED|Overall Study||10
11379672|NCT03412019|12575015|FG001|COMPLETED|Overall Study||10
11379673|NCT03412019|12575014|FG000|NOT COMPLETED|Overall Study||1
11379674|NCT03412019|12575015|FG001|NOT COMPLETED|Overall Study||1
11379675|NCT03412084|12575023|FG000|STARTED|Overall Study||48
11379676|NCT03412084|12575024|FG001|STARTED|Overall Study||36
11379677|NCT03412084|12575023|FG000|COMPLETED|Overall Study||44
11379678|NCT03412084|12575024|FG001|COMPLETED|Overall Study||35
11379679|NCT03412084|12575023|FG000|NOT COMPLETED|Overall Study||4
11379680|NCT03412084|12575024|FG001|NOT COMPLETED|Overall Study||1
11379681|NCT03412734|12575032|FG000|STARTED|Overall Study||47
11379682|NCT03412734|12575033|FG001|STARTED|Overall Study||41
11379683|NCT03412734|12575032|FG000|COMPLETED|Overall Study||44
11379684|NCT03412734|12575033|FG001|COMPLETED|Overall Study||41
11379685|NCT03412734|12575032|FG000|NOT COMPLETED|Overall Study||3
11379686|NCT03412734|12575033|FG001|NOT COMPLETED|Overall Study||0
11379687|NCT03412929|12575039|FG000|STARTED|Overall Study||8
11379688|NCT03412929|12575039|FG000|COMPLETED|Overall Study||5
11379689|NCT03412929|12575039|FG000|NOT COMPLETED|Overall Study||3
11379690|NCT03413618|12575045|FG000|STARTED|Overall Study||45
11379691|NCT03413618|12575046|FG001|STARTED|Overall Study||45
11379692|NCT03413618|12575045|FG000|COMPLETED|Overall Study||45
11379693|NCT03413618|12575046|FG001|COMPLETED|Overall Study||45
11379694|NCT03413618|12575045|FG000|NOT COMPLETED|Overall Study||0
11379695|NCT03413618|12575046|FG001|NOT COMPLETED|Overall Study||0
11379696|NCT03414359|12575054|FG000|STARTED|Overall Study||35
11379697|NCT03414359|12575055|FG001|STARTED|Overall Study||35
11379698|NCT03414359|12575054|FG000|COMPLETED|Overall Study||34
11379699|NCT03414359|12575055|FG001|COMPLETED|Overall Study||33
11379700|NCT03414359|12575054|FG000|NOT COMPLETED|Overall Study||1
11379701|NCT03414359|12575055|FG001|NOT COMPLETED|Overall Study||2
11379702|NCT03415152|12575061|FG000|STARTED|Overall Study||3000
11379703|NCT03415152|12575061|FG000|COMPLETED|Overall Study||1975
11379704|NCT03415152|12575061|FG000|NOT COMPLETED|Overall Study||1025
11379705|NCT03415178|12575070|FG000|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34
11379706|NCT03415178|12575071|FG001|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35
11379707|NCT03415178|12575070|FG000|Treated|Parallel-Arm Period (up to Week 4)||34
11379708|NCT03415178|12575071|FG001|Treated|Parallel-Arm Period (up to Week 4)||33
11379709|NCT03415178|12575070|FG000|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34
11379710|NCT03415178|12575071|FG001|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33
11379711|NCT03415178|12575070|FG000|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0
11379712|NCT03415178|12575071|FG001|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2
11379713|NCT03415178|12575070|FG000|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0
11379714|NCT03415178|12575071|FG001|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66
11379715|NCT03415178|12575070|FG000|COMPLETED|Single Arm Period (up to Week 16)||0
11379716|NCT03415178|12575071|FG001|COMPLETED|Single Arm Period (up to Week 16)||65
11379717|NCT03415178|12575070|FG000|NOT COMPLETED|Single Arm Period (up to Week 16)||0
11379718|NCT03415178|12575071|FG001|NOT COMPLETED|Single Arm Period (up to Week 16)||1
11006028|NCT00726232|12183814|FG002|STARTED|Expansion Phase||0
11006029|NCT00726232|12183815|FG003|STARTED|Expansion Phase||0
11006030|NCT00726232|12183816|FG004|STARTED|Expansion Phase||0
11006031|NCT00726232|12183817|FG005|STARTED|Expansion Phase||0
11006032|NCT00726232|12183818|FG006|STARTED|Expansion Phase||34
11379719|NCT03415243|12575083|FG000|STARTED|Overall Study||14
11379720|NCT03415243|12575084|FG001|STARTED|Overall Study||14
11379721|NCT03415243|12575083|FG000|COMPLETED|Overall Study||14
11379722|NCT03415243|12575084|FG001|COMPLETED|Overall Study||14
11379723|NCT03415243|12575083|FG000|NOT COMPLETED|Overall Study||0
11379724|NCT03415243|12575084|FG001|NOT COMPLETED|Overall Study||0
11142087|NCT01466348|12328780|FG000|NOT COMPLETED|Period I - First Intervention||0
11142088|NCT01466348|12328781|FG001|NOT COMPLETED|Period I - First Intervention||1
11142089|NCT01466348|12328780|FG000|STARTED|Period II - Second Intervention||35
11142090|NCT01466348|12328781|FG001|STARTED|Period II - Second Intervention||36
11142091|NCT01466348|12328780|FG000|COMPLETED|Period II - Second Intervention||35
11142092|NCT01466348|12328781|FG001|COMPLETED|Period II - Second Intervention||36
11379725|NCT03415581|12575092|FG000|STARTED|Overall Study||7
11379726|NCT03415581|12575093|FG001|STARTED|Overall Study||6
11379727|NCT03415581|12575092|FG000|COMPLETED|Overall Study||1
11379728|NCT03415581|12575093|FG001|COMPLETED|Overall Study||1
11379729|NCT03415581|12575092|FG000|NOT COMPLETED|Overall Study||6
11379730|NCT03415581|12575093|FG001|NOT COMPLETED|Overall Study||5
11379731|NCT03416127|12575104|FG000|STARTED|Overall Study||12
11379732|NCT03416127|12575105|FG001|STARTED|Overall Study||12
11379733|NCT03416127|12575106|FG002|STARTED|Overall Study||12
11379734|NCT03416127|12575104|FG000|COMPLETED|Overall Study||12
11379735|NCT03416127|12575105|FG001|COMPLETED|Overall Study||11
11379736|NCT03416127|12575106|FG002|COMPLETED|Overall Study||11
11379737|NCT03416127|12575104|FG000|NOT COMPLETED|Overall Study||0
11379738|NCT03416127|12575105|FG001|NOT COMPLETED|Overall Study||1
11379739|NCT03416127|12575106|FG002|NOT COMPLETED|Overall Study||1
11379740|NCT03416621|12575118|FG000|STARTED|Overall Study||13
11379741|NCT03416621|12575119|FG001|STARTED|Overall Study||12
11379742|NCT03416621|12575120|FG002|STARTED|Overall Study||6
11379743|NCT03416621|12575118|FG000|COMPLETED|Overall Study||13
11379744|NCT03416621|12575119|FG001|COMPLETED|Overall Study||11
11379745|NCT03416621|12575120|FG002|COMPLETED|Overall Study||1
11379746|NCT03416621|12575118|FG000|NOT COMPLETED|Overall Study||0
11379747|NCT03416621|12575119|FG001|NOT COMPLETED|Overall Study||1
11379748|NCT03416621|12575120|FG002|NOT COMPLETED|Overall Study||5
11379749|NCT03416946|12575132|FG000|STARTED|Overall Study||25
11379750|NCT03416946|12575133|FG001|STARTED|Overall Study||29
11379751|NCT03416946|12575132|FG000|COMPLETED|Overall Study||25
11379752|NCT03416946|12575133|FG001|COMPLETED|Overall Study||29
11379753|NCT03416946|12575132|FG000|NOT COMPLETED|Overall Study||0
11379754|NCT03416946|12575133|FG001|NOT COMPLETED|Overall Study||0
11379755|NCT03416985|12575142|FG000|STARTED|Overall Study||30
11379756|NCT03416985|12575143|FG001|STARTED|Overall Study||30
11379757|NCT03416985|12575144|FG002|STARTED|Overall Study||30
11379758|NCT03416985|12575142|FG000|COMPLETED|Overall Study||28
11379759|NCT03416985|12575143|FG001|COMPLETED|Overall Study||30
11379760|NCT03416985|12575144|FG002|COMPLETED|Overall Study||24
11379761|NCT03416985|12575142|FG000|NOT COMPLETED|Overall Study||2
11379762|NCT03416985|12575143|FG001|NOT COMPLETED|Overall Study||0
11379763|NCT03416985|12575144|FG002|NOT COMPLETED|Overall Study||6
11379764|NCT03417024|12575155|FG000|STARTED|Overall Study||13
11379765|NCT03417024|12575155|FG000|COMPLETED|Overall Study||0
11379766|NCT03417024|12575155|FG000|NOT COMPLETED|Overall Study||13
11379767|NCT03417141|12575159|FG000|STARTED|Overall Study||12
11379768|NCT03417141|12575159|FG000|COMPLETED|Overall Study||8
11379769|NCT03417141|12575159|FG000|NOT COMPLETED|Overall Study||4
11379770|NCT03417219|12575165|FG000|STARTED|Overall Study||8
11379771|NCT03417219|12575166|FG001|STARTED|Overall Study||8
11379772|NCT03417219|12575165|FG000|COMPLETED|Overall Study||8
11379773|NCT03417219|12575166|FG001|COMPLETED|Overall Study||5
11379774|NCT03417219|12575165|FG000|NOT COMPLETED|Overall Study||0
11379775|NCT03417219|12575166|FG001|NOT COMPLETED|Overall Study||3
11379776|NCT03417466|12575172|FG000|STARTED|Overall Study||66
11379777|NCT03417466|12575172|FG000|COMPLETED|Overall Study||66
11379778|NCT03417466|12575172|FG000|NOT COMPLETED|Overall Study||0
11379779|NCT03417505|12575176|FG000|STARTED|First Lens Type (30 Days)||9
11379780|NCT03417505|12575177|FG001|STARTED|First Lens Type (30 Days)||12
11379781|NCT03417505|12575176|FG000|COMPLETED|First Lens Type (30 Days)||8
11379782|NCT03417505|12575177|FG001|COMPLETED|First Lens Type (30 Days)||11
11379783|NCT03417505|12575176|FG000|NOT COMPLETED|First Lens Type (30 Days)||1
11379784|NCT03417505|12575177|FG001|NOT COMPLETED|First Lens Type (30 Days)||1
11379785|NCT03417505|12575176|FG000|STARTED|Washout Period (7 Days)||8
11379786|NCT03417505|12575177|FG001|STARTED|Washout Period (7 Days)||11
11379787|NCT03417505|12575176|FG000|COMPLETED|Washout Period (7 Days)||8
11379788|NCT03417505|12575177|FG001|COMPLETED|Washout Period (7 Days)||11
11379789|NCT03417505|12575176|FG000|NOT COMPLETED|Washout Period (7 Days)||0
11379790|NCT03417505|12575177|FG001|NOT COMPLETED|Washout Period (7 Days)||0
11379791|NCT03417505|12575176|FG000|STARTED|Second Lens Type (30 Days)||8
11379792|NCT03417505|12575177|FG001|STARTED|Second Lens Type (30 Days)||11
11379793|NCT03417505|12575176|FG000|COMPLETED|Second Lens Type (30 Days)||8
11379794|NCT03417505|12575177|FG001|COMPLETED|Second Lens Type (30 Days)||11
11379795|NCT03417505|12575176|FG000|NOT COMPLETED|Second Lens Type (30 Days)||0
11379796|NCT03417505|12575177|FG001|NOT COMPLETED|Second Lens Type (30 Days)||0
11379797|NCT03417557|12575183|FG000|STARTED|1st Intervention (3 Hours)||8
11006033|NCT00726232|12183819|FG007|STARTED|Expansion Phase||39
11006034|NCT00726232|12183812|FG000|Safety Evaluable Participants|Expansion Phase||0
11006035|NCT00726232|12183813|FG001|Safety Evaluable Participants|Expansion Phase||0
11379798|NCT03417557|12575184|FG001|STARTED|1st Intervention (3 Hours)||9
11379799|NCT03417557|12575183|FG000|COMPLETED|1st Intervention (3 Hours)||8
11379800|NCT03417557|12575184|FG001|COMPLETED|1st Intervention (3 Hours)||9
11379801|NCT03417557|12575183|FG000|NOT COMPLETED|1st Intervention (3 Hours)||0
11379802|NCT03417557|12575184|FG001|NOT COMPLETED|1st Intervention (3 Hours)||0
11379803|NCT03417557|12575183|FG000|STARTED|2nd Intervention (3 Hours)||9
11379804|NCT03417557|12575184|FG001|STARTED|2nd Intervention (3 Hours)||8
11379805|NCT03417557|12575183|FG000|COMPLETED|2nd Intervention (3 Hours)||9
11379806|NCT03417557|12575184|FG001|COMPLETED|2nd Intervention (3 Hours)||8
11379807|NCT03417557|12575183|FG000|NOT COMPLETED|2nd Intervention (3 Hours)||0
11379808|NCT03417557|12575184|FG001|NOT COMPLETED|2nd Intervention (3 Hours)||0
11379809|NCT03417713|12575190|FG000|STARTED|Overall Study||33
11379810|NCT03417713|12575190|FG000|COMPLETED|Overall Study||30
11379811|NCT03417713|12575190|FG000|NOT COMPLETED|Overall Study||3
11379812|NCT03417739|12575194|FG000|STARTED|Overall Study||13
11379813|NCT03417739|12575194|FG000|COMPLETED|Overall Study||13
11379814|NCT03417739|12575194|FG000|NOT COMPLETED|Overall Study||0
11379815|NCT03417752|12575201|FG000|STARTED|Overall Study||149
11379816|NCT03417752|12575202|FG001|STARTED|Overall Study||175
11379817|NCT03417752|12575203|FG002|STARTED|Overall Study||150
11379818|NCT03417752|12575201|FG000|COMPLETED|Overall Study||115
11379819|NCT03417752|12575202|FG001|COMPLETED|Overall Study||133
11379820|NCT03417752|12575203|FG002|COMPLETED|Overall Study||110
11379821|NCT03417752|12575201|FG000|NOT COMPLETED|Overall Study||34
11379822|NCT03417752|12575202|FG001|NOT COMPLETED|Overall Study||42
11379823|NCT03417752|12575203|FG002|NOT COMPLETED|Overall Study||40
11006036|NCT00726232|12183814|FG002|Safety Evaluable Participants|Expansion Phase||0
11006037|NCT00726232|12183815|FG003|Safety Evaluable Participants|Expansion Phase||0
11379824|NCT03417778|12575213|FG000|STARTED|Overall Study||10
11379825|NCT03417778|12575214|FG001|STARTED|Overall Study||10
11379826|NCT03417778|12575213|FG000|COMPLETED|Overall Study||10
11379827|NCT03417778|12575214|FG001|COMPLETED|Overall Study||10
11379828|NCT03417778|12575213|FG000|NOT COMPLETED|Overall Study||0
11379829|NCT03417778|12575214|FG001|NOT COMPLETED|Overall Study||0
11379830|NCT03417804|12575220|FG000|STARTED|Overall Study|at least 360 patients|366
11379831|NCT03417804|12575220|FG000|COMPLETED|Overall Study||366
11379832|NCT03417804|12575220|FG000|NOT COMPLETED|Overall Study||0
11379833|NCT03417830|12575227|FG000|STARTED|Part A (up to 26 Days)||2
11379834|NCT03417830|12575228|FG001|STARTED|Part A (up to 26 Days)||0
11379835|NCT03417830|12575227|FG000|COMPLETED|Part A (up to 26 Days)||1
11379836|NCT03417830|12575228|FG001|COMPLETED|Part A (up to 26 Days)||0
11379837|NCT03417830|12575227|FG000|NOT COMPLETED|Part A (up to 26 Days)||1
11379838|NCT03417830|12575228|FG001|NOT COMPLETED|Part A (up to 26 Days)||0
11379839|NCT03417830|12575227|FG000|STARTED|Part B (up to 26 Days)||0
11379840|NCT03417830|12575228|FG001|STARTED|Part B (up to 26 Days)||0
11379841|NCT03417830|12575227|FG000|COMPLETED|Part B (up to 26 Days)||0
11379842|NCT03417830|12575228|FG001|COMPLETED|Part B (up to 26 Days)||0
11379843|NCT03417830|12575227|FG000|NOT COMPLETED|Part B (up to 26 Days)||0
11379844|NCT03417830|12575228|FG001|NOT COMPLETED|Part B (up to 26 Days)||0
11379845|NCT03418051|12575238|FG000|STARTED|Overall Study||20
11379846|NCT03418051|12575239|FG001|STARTED|Overall Study||20
11379847|NCT03418051|12575240|FG002|STARTED|Overall Study||20
11379848|NCT03418051|12575238|FG000|COMPLETED|Overall Study||14
11379849|NCT03418051|12575239|FG001|COMPLETED|Overall Study||18
11379850|NCT03418051|12575240|FG002|COMPLETED|Overall Study||17
11379851|NCT03418051|12575238|FG000|NOT COMPLETED|Overall Study||6
11379852|NCT03418051|12575239|FG001|NOT COMPLETED|Overall Study||2
11379853|NCT03418051|12575240|FG002|NOT COMPLETED|Overall Study||3
11379854|NCT03418064|12575248|FG000|STARTED|First Intervention (1 Month)||21
11379855|NCT03418064|12575249|FG001|STARTED|First Intervention (1 Month)||21
11379856|NCT03418064|12575248|FG000|COMPLETED|First Intervention (1 Month)||21
11379857|NCT03418064|12575249|FG001|COMPLETED|First Intervention (1 Month)||21
11379858|NCT03418064|12575248|FG000|NOT COMPLETED|First Intervention (1 Month)||0
11379859|NCT03418064|12575249|FG001|NOT COMPLETED|First Intervention (1 Month)||0
11379860|NCT03418064|12575248|FG000|STARTED|Second Intervention (1 Month)||21
11379861|NCT03418064|12575249|FG001|STARTED|Second Intervention (1 Month)||21
11379862|NCT03418064|12575248|FG000|COMPLETED|Second Intervention (1 Month)||21
11379863|NCT03418064|12575249|FG001|COMPLETED|Second Intervention (1 Month)||21
11379864|NCT03418064|12575248|FG000|NOT COMPLETED|Second Intervention (1 Month)||0
11379865|NCT03418064|12575249|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
11379866|NCT03418324|12575265|FG000|STARTED|Overall Study||3
11379867|NCT03418324|12575266|FG001|STARTED|Overall Study||8
11379868|NCT03418324|12575265|FG000|COMPLETED|Overall Study||2
11379869|NCT03418324|12575266|FG001|COMPLETED|Overall Study||6
11379870|NCT03418324|12575265|FG000|NOT COMPLETED|Overall Study||1
11379871|NCT03418324|12575266|FG001|NOT COMPLETED|Overall Study||2
11379872|NCT03418376|12575276|FG000|STARTED|Overall Study||12
11379873|NCT03418376|12575277|FG001|STARTED|Overall Study||11
11379874|NCT03418376|12575278|FG002|STARTED|Overall Study||11
11379875|NCT03418376|12575279|FG003|STARTED|Overall Study||11
11379876|NCT03418376|12575276|FG000|COMPLETED|Overall Study||11
11379877|NCT03418376|12575277|FG001|COMPLETED|Overall Study||6
11379878|NCT03418376|12575278|FG002|COMPLETED|Overall Study||8
11379879|NCT03418376|12575279|FG003|COMPLETED|Overall Study||10
11379880|NCT03418376|12575276|FG000|NOT COMPLETED|Overall Study||1
11379881|NCT03418376|12575277|FG001|NOT COMPLETED|Overall Study||5
11379882|NCT03418376|12575278|FG002|NOT COMPLETED|Overall Study||3
11379883|NCT03418376|12575279|FG003|NOT COMPLETED|Overall Study||1
11379884|NCT03418545|12575291|FG000|STARTED|Overall Study||35
11379885|NCT03418545|12575292|FG001|STARTED|Overall Study||105
11379886|NCT03418545|12575291|FG000|Safety Population|Overall Study||34
11379887|NCT03418545|12575292|FG001|Safety Population|Overall Study||105
11379888|NCT03418545|12575291|FG000|Received Optional or Repeat Treatment|Overall Study||29
11379889|NCT03418545|12575292|FG001|Received Optional or Repeat Treatment|Overall Study||37
11379890|NCT03418545|12575291|FG000|COMPLETED|Overall Study||30
11379891|NCT03418545|12575292|FG001|COMPLETED|Overall Study||94
11379892|NCT03418545|12575291|FG000|NOT COMPLETED|Overall Study||5
11379893|NCT03418545|12575292|FG001|NOT COMPLETED|Overall Study||11
11379894|NCT03418571|12575303|FG000|STARTED|Overall Study||12
11379895|NCT03418571|12575304|FG001|STARTED|Overall Study||3
11379896|NCT03418571|12575303|FG000|COMPLETED|Overall Study||11
11379897|NCT03418571|12575304|FG001|COMPLETED|Overall Study||3
11379898|NCT03418571|12575303|FG000|NOT COMPLETED|Overall Study||1
11379899|NCT03418571|12575304|FG001|NOT COMPLETED|Overall Study||0
11379900|NCT03418662|12575312|FG000|STARTED|Overall Study||287
11379901|NCT03418662|12575313|FG001|STARTED|Overall Study||282
11379902|NCT03418662|12575312|FG000|COMPLETED|Overall Study||284
11379903|NCT03418662|12575313|FG001|COMPLETED|Overall Study||278
11379904|NCT03418662|12575312|FG000|NOT COMPLETED|Overall Study||3
11379905|NCT03418662|12575313|FG001|NOT COMPLETED|Overall Study||4
11379906|NCT03418714|12575319|FG000|STARTED|Overall Study||13
11379907|NCT03418714|12575319|FG000|COMPLETED|Overall Study|One participant moved too much during the practice session and was therefore excluded from the scan.|12
11379908|NCT03418714|12575319|FG000|NOT COMPLETED|Overall Study||1
11379909|NCT03419078|12575326|FG000|STARTED|Overall Study||245
11379910|NCT03419078|12575327|FG001|STARTED|Overall Study||148
11379911|NCT03419078|12575328|FG002|STARTED|Overall Study||91
11379912|NCT03419078|12575326|FG000|COMPLETED|Overall Study||245
11379913|NCT03419078|12575327|FG001|COMPLETED|Overall Study||148
11379914|NCT03419078|12575328|FG002|COMPLETED|Overall Study||91
11379915|NCT03419078|12575326|FG000|NOT COMPLETED|Overall Study||0
11379916|NCT03419078|12575327|FG001|NOT COMPLETED|Overall Study||0
11379917|NCT03419078|12575328|FG002|NOT COMPLETED|Overall Study||0
11379918|NCT03419403|12575339|FG000|STARTED|Overall Study||14
11379919|NCT03419403|12575340|FG001|STARTED|Overall Study||12
11379920|NCT03419403|12575341|FG002|STARTED|Overall Study||12
11379921|NCT03419403|12575342|FG003|STARTED|Overall Study||2
11379922|NCT03419403|12575339|FG000|COMPLETED|Overall Study||2
11379923|NCT03419403|12575340|FG001|COMPLETED|Overall Study||3
11379924|NCT03419403|12575341|FG002|COMPLETED|Overall Study||0
11379925|NCT03419403|12575342|FG003|COMPLETED|Overall Study||0
11379926|NCT03419403|12575339|FG000|NOT COMPLETED|Overall Study||12
11379927|NCT03419403|12575340|FG001|NOT COMPLETED|Overall Study||9
11379928|NCT03419403|12575341|FG002|NOT COMPLETED|Overall Study||12
11379929|NCT03419403|12575342|FG003|NOT COMPLETED|Overall Study||2
11379930|NCT03419533|12575352|FG000|STARTED|Overall Study||4107
11379931|NCT03419533|12575353|FG001|STARTED|Overall Study||2695
11379932|NCT03419533|12575352|FG000|COMPLETED|Overall Study||4107
11379933|NCT03419533|12575353|FG001|COMPLETED|Overall Study||2695
11379934|NCT03419533|12575352|FG000|NOT COMPLETED|Overall Study||0
11379935|NCT03419533|12575353|FG001|NOT COMPLETED|Overall Study||0
11379936|NCT03419598|12575367|FG000|STARTED|Overall Study||30
11379937|NCT03419598|12575367|FG000|Subject Specific Tibia Models Created and Virtual Osteotomy Performed|Overall Study||28
11379938|NCT03419598|12575367|FG000|Virtual Cohort Duplicated Into A. Personalised and B. Generic Copies|Overall Study||28
11379939|NCT03419598|12575367|FG000|Finite Element (FE) Model Created for Cohort Copy Stabilised by Personalised HTO Plate|Overall Study||28
11379940|NCT03419598|12575367|FG000|FE Models Created for Cohort Copy Stabilised by Generic HTO Plate|Overall Study||28
11379941|NCT03419598|12575367|FG000|FE Models Solved for Personalised HTO Plate Stabilised Cohort Copy|Overall Study||28
11379942|NCT03419598|12575367|FG000|FE Models Solved for Generic HTO Plate Stabilised Cohort Copy|Overall Study||28
11379943|NCT03419598|12575367|FG000|COMPLETED|Overall Study||28
11379944|NCT03419598|12575367|FG000|NOT COMPLETED|Overall Study||2
11379945|NCT03419780|12575375|FG000|STARTED|Overall Study||33
11379946|NCT03419780|12575376|FG001|STARTED|Overall Study||33
11379947|NCT03419780|12575375|FG000|COMPLETED|Overall Study||33
11379948|NCT03419780|12575376|FG001|COMPLETED|Overall Study||33
11379949|NCT03419780|12575375|FG000|NOT COMPLETED|Overall Study||0
11379950|NCT03419780|12575376|FG001|NOT COMPLETED|Overall Study||0
11379951|NCT03419962|12575382|FG000|STARTED|Overall Study||1359
11379952|NCT03419962|12575382|FG000|COMPLETED|Overall Study||1322
11379953|NCT03419962|12575382|FG000|NOT COMPLETED|Overall Study||37
11379954|NCT03420300|12575386|FG000|STARTED|Overall Study||40
11379955|NCT03420300|12575386|FG000|COMPLETED|Overall Study||38
11379956|NCT03420300|12575386|FG000|NOT COMPLETED|Overall Study||2
11379957|NCT03420625|12575390|FG000|STARTED|Overall Study||10
11379958|NCT03420625|12575390|FG000|Baseline|Overall Study||10
11379959|NCT03420625|12575390|FG000|Foot IPC|Overall Study||10
11379960|NCT03420625|12575390|FG000|Rapid Calf IPC|Overall Study||10
11379961|NCT03420625|12575390|FG000|Slow Calf IPC|Overall Study||10
11379962|NCT03420625|12575390|FG000|Calf NMES|Overall Study||10
11379963|NCT03420625|12575390|FG000|COMPLETED|Overall Study||10
11379964|NCT03420625|12575390|FG000|NOT COMPLETED|Overall Study||0
11379965|NCT03421210|12575406|FG000|STARTED|Overall Study||88
11379966|NCT03421210|12575406|FG000|Received Functional Magnetic Resonance Imaging (fMRI)|Overall Study||42
11379967|NCT03421210|12575406|FG000|COMPLETED|Overall Study||35
11379968|NCT03421210|12575406|FG000|NOT COMPLETED|Overall Study||53
11379969|NCT03421379|12575412|FG000|STARTED|Period 1||34
11379970|NCT03421379|12575413|FG001|STARTED|Period 1||41
11379971|NCT03421379|12575412|FG000|Received at Least One Dose of Study Drug|Period 1||33
11379972|NCT03421379|12575413|FG001|Received at Least One Dose of Study Drug|Period 1||39
11379973|NCT03421379|12575412|FG000|COMPLETED|Period 1||32
11379974|NCT03421379|12575413|FG001|COMPLETED|Period 1||37
11379975|NCT03421379|12575412|FG000|NOT COMPLETED|Period 1||2
11379976|NCT03421379|12575413|FG001|NOT COMPLETED|Period 1||4
11379977|NCT03421379|12575412|FG000|STARTED|Washout Period (3 to 14 Days)||32
11379978|NCT03421379|12575413|FG001|STARTED|Washout Period (3 to 14 Days)||37
11379979|NCT03421379|12575412|FG000|COMPLETED|Washout Period (3 to 14 Days)||32
11379980|NCT03421379|12575413|FG001|COMPLETED|Washout Period (3 to 14 Days)||37
11379981|NCT03421379|12575412|FG000|NOT COMPLETED|Washout Period (3 to 14 Days)||0
11379982|NCT03421379|12575413|FG001|NOT COMPLETED|Washout Period (3 to 14 Days)||0
11379983|NCT03421379|12575412|FG000|STARTED|Period 2||32
11379984|NCT03421379|12575413|FG001|STARTED|Period 2||37
11379985|NCT03421379|12575412|FG000|COMPLETED|Period 2||32
11379986|NCT03421379|12575413|FG001|COMPLETED|Period 2||37
11379987|NCT03421379|12575412|FG000|NOT COMPLETED|Period 2||0
11379988|NCT03421379|12575413|FG001|NOT COMPLETED|Period 2||0
11379989|NCT03421431|12575422|FG000|STARTED|Overall Study||24
11379990|NCT03421431|12575423|FG001|STARTED|Overall Study||55
11379991|NCT03421431|12575424|FG002|STARTED|Overall Study||53
11379992|NCT03421431|12575422|FG000|COMPLETED|Overall Study||18
11379993|NCT03421431|12575423|FG001|COMPLETED|Overall Study||49
11379994|NCT03421431|12575424|FG002|COMPLETED|Overall Study||39
11379995|NCT03421431|12575422|FG000|NOT COMPLETED|Overall Study||6
11379996|NCT03421431|12575423|FG001|NOT COMPLETED|Overall Study||6
11379997|NCT03421431|12575424|FG002|NOT COMPLETED|Overall Study||14
11379998|NCT03421730|12575434|FG000|STARTED|First Intervention (Day 1, Visit 2)||1
11379999|NCT03421730|12575435|FG001|STARTED|First Intervention (Day 1, Visit 2)||3
11380000|NCT03421730|12575436|FG002|STARTED|First Intervention (Day 1, Visit 2)||1
11380001|NCT03421730|12575437|FG003|STARTED|First Intervention (Day 1, Visit 2)||1
11380002|NCT03421730|12575438|FG004|STARTED|First Intervention (Day 1, Visit 2)||3
11380003|NCT03421730|12575439|FG005|STARTED|First Intervention (Day 1, Visit 2)||1
11380004|NCT03421730|12575440|FG006|STARTED|First Intervention (Day 1, Visit 2)||1
11380005|NCT03421730|12575441|FG007|STARTED|First Intervention (Day 1, Visit 2)||1
11380006|NCT03421730|12575442|FG008|STARTED|First Intervention (Day 1, Visit 2)||1
11380007|NCT03421730|12575443|FG009|STARTED|First Intervention (Day 1, Visit 2)||2
11380008|NCT03421730|12575444|FG010|STARTED|First Intervention (Day 1, Visit 2)||1
11380009|NCT03421730|12575445|FG011|STARTED|First Intervention (Day 1, Visit 2)||1
11380010|NCT03421730|12575434|FG000|COMPLETED|First Intervention (Day 1, Visit 2)||1
11380011|NCT03421730|12575435|FG001|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1
11380012|NCT03421730|12575436|FG002|COMPLETED|First Intervention (Day 1, Visit 2)||1
11380013|NCT03421730|12575437|FG003|COMPLETED|First Intervention (Day 1, Visit 2)||1
11380014|NCT03421730|12575438|FG004|COMPLETED|First Intervention (Day 1, Visit 2)||3
11380015|NCT03421730|12575439|FG005|COMPLETED|First Intervention (Day 1, Visit 2)||1
11380016|NCT03421730|12575440|FG006|COMPLETED|First Intervention (Day 1, Visit 2)||1
11380017|NCT03421730|12575441|FG007|COMPLETED|First Intervention (Day 1, Visit 2)||1
11380018|NCT03421730|12575442|FG008|COMPLETED|First Intervention (Day 1, Visit 2)||1
11380019|NCT03421730|12575443|FG009|COMPLETED|First Intervention (Day 1, Visit 2)||2
11380020|NCT03421730|12575444|FG010|COMPLETED|First Intervention (Day 1, Visit 2)||1
11380021|NCT03421730|12575445|FG011|COMPLETED|First Intervention (Day 1, Visit 2)||1
11380022|NCT03421730|12575434|FG000|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
11380023|NCT03421730|12575435|FG001|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2
11380024|NCT03421730|12575436|FG002|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
11380025|NCT03421730|12575437|FG003|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
11380026|NCT03421730|12575438|FG004|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
11380027|NCT03421730|12575439|FG005|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
11380028|NCT03421730|12575440|FG006|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
11380029|NCT03421730|12575441|FG007|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
11380030|NCT03421730|12575442|FG008|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
11380031|NCT03421730|12575443|FG009|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
11380032|NCT03421730|12575444|FG010|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
11380033|NCT03421730|12575445|FG011|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
11380034|NCT03421730|12575434|FG000|STARTED|Washout (Days 4 to 10)||1
11380035|NCT03421730|12575435|FG001|STARTED|Washout (Days 4 to 10)||1
11380036|NCT03421730|12575436|FG002|STARTED|Washout (Days 4 to 10)||1
11380037|NCT03421730|12575437|FG003|STARTED|Washout (Days 4 to 10)||1
11380038|NCT03421730|12575438|FG004|STARTED|Washout (Days 4 to 10)||3
11380039|NCT03421730|12575439|FG005|STARTED|Washout (Days 4 to 10)||1
11380040|NCT03421730|12575440|FG006|STARTED|Washout (Days 4 to 10)||1
11380041|NCT03421730|12575441|FG007|STARTED|Washout (Days 4 to 10)||1
11380042|NCT03421730|12575442|FG008|STARTED|Washout (Days 4 to 10)||1
11380043|NCT03421730|12575443|FG009|STARTED|Washout (Days 4 to 10)||2
11380044|NCT03421730|12575444|FG010|STARTED|Washout (Days 4 to 10)||1
11380045|NCT03421730|12575445|FG011|STARTED|Washout (Days 4 to 10)||1
11380046|NCT03421730|12575434|FG000|COMPLETED|Washout (Days 4 to 10)||1
11380047|NCT03421730|12575435|FG001|COMPLETED|Washout (Days 4 to 10)||1
11380048|NCT03421730|12575436|FG002|COMPLETED|Washout (Days 4 to 10)||1
11380049|NCT03421730|12575437|FG003|COMPLETED|Washout (Days 4 to 10)||1
11380050|NCT03421730|12575438|FG004|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1
11380051|NCT03421730|12575439|FG005|COMPLETED|Washout (Days 4 to 10)||1
11380052|NCT03421730|12575440|FG006|COMPLETED|Washout (Days 4 to 10)||1
11380053|NCT03421730|12575441|FG007|COMPLETED|Washout (Days 4 to 10)||1
11380054|NCT03421730|12575442|FG008|COMPLETED|Washout (Days 4 to 10)||1
11380055|NCT03421730|12575443|FG009|COMPLETED|Washout (Days 4 to 10)||2
11380056|NCT03421730|12575444|FG010|COMPLETED|Washout (Days 4 to 10)||1
11380057|NCT03421730|12575445|FG011|COMPLETED|Washout (Days 4 to 10)||1
11380058|NCT03421730|12575434|FG000|NOT COMPLETED|Washout (Days 4 to 10)||0
11380059|NCT03421730|12575435|FG001|NOT COMPLETED|Washout (Days 4 to 10)||0
11380060|NCT03421730|12575436|FG002|NOT COMPLETED|Washout (Days 4 to 10)||0
11380061|NCT03421730|12575437|FG003|NOT COMPLETED|Washout (Days 4 to 10)||0
11380062|NCT03421730|12575438|FG004|NOT COMPLETED|Washout (Days 4 to 10)||2
11380063|NCT03421730|12575439|FG005|NOT COMPLETED|Washout (Days 4 to 10)||0
11380064|NCT03421730|12575440|FG006|NOT COMPLETED|Washout (Days 4 to 10)||0
11380065|NCT03421730|12575441|FG007|NOT COMPLETED|Washout (Days 4 to 10)||0
11380066|NCT03421730|12575442|FG008|NOT COMPLETED|Washout (Days 4 to 10)||0
11380067|NCT03421730|12575443|FG009|NOT COMPLETED|Washout (Days 4 to 10)||0
11380068|NCT03421730|12575444|FG010|NOT COMPLETED|Washout (Days 4 to 10)||0
11380069|NCT03421730|12575445|FG011|NOT COMPLETED|Washout (Days 4 to 10)||0
11380070|NCT03421730|12575434|FG000|STARTED|Second Intervention (Day 8±3, Visit 3)||1
11380071|NCT03421730|12575435|FG001|STARTED|Second Intervention (Day 8±3, Visit 3)||1
11380072|NCT03421730|12575436|FG002|STARTED|Second Intervention (Day 8±3, Visit 3)||1
11380073|NCT03421730|12575437|FG003|STARTED|Second Intervention (Day 8±3, Visit 3)||1
11380074|NCT03421730|12575438|FG004|STARTED|Second Intervention (Day 8±3, Visit 3)||1
11380075|NCT03421730|12575439|FG005|STARTED|Second Intervention (Day 8±3, Visit 3)||1
11380076|NCT03421730|12575440|FG006|STARTED|Second Intervention (Day 8±3, Visit 3)||1
11380077|NCT03421730|12575441|FG007|STARTED|Second Intervention (Day 8±3, Visit 3)||1
11380078|NCT03421730|12575442|FG008|STARTED|Second Intervention (Day 8±3, Visit 3)||1
11380079|NCT03421730|12575443|FG009|STARTED|Second Intervention (Day 8±3, Visit 3)||2
11380080|NCT03421730|12575444|FG010|STARTED|Second Intervention (Day 8±3, Visit 3)||1
11380081|NCT03421730|12575445|FG011|STARTED|Second Intervention (Day 8±3, Visit 3)||1
11380082|NCT03421730|12575434|FG000|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
11380083|NCT03421730|12575435|FG001|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
11380084|NCT03421730|12575436|FG002|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
11380085|NCT03421730|12575437|FG003|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
11380086|NCT03421730|12575438|FG004|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
11380087|NCT03421730|12575439|FG005|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
11380088|NCT03421730|12575440|FG006|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
11380089|NCT03421730|12575441|FG007|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
11380090|NCT03421730|12575442|FG008|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
11380091|NCT03421730|12575443|FG009|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2
11380092|NCT03421730|12575444|FG010|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
11380093|NCT03421730|12575445|FG011|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
11380094|NCT03421730|12575434|FG000|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
11380095|NCT03421730|12575435|FG001|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
11380096|NCT03421730|12575436|FG002|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
11380097|NCT03421730|12575437|FG003|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
11380098|NCT03421730|12575438|FG004|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
11380099|NCT03421730|12575439|FG005|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
11380100|NCT03421730|12575440|FG006|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
11380101|NCT03421730|12575441|FG007|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
11380102|NCT03421730|12575442|FG008|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
11380103|NCT03421730|12575443|FG009|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
11380104|NCT03421730|12575444|FG010|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
11380105|NCT03421730|12575445|FG011|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
11380106|NCT03421886|12575461|FG000|STARTED|Overall Study||30
11380107|NCT03421886|12575462|FG001|STARTED|Overall Study||15
11380108|NCT03421886|12575461|FG000|COMPLETED|Overall Study||23
11380109|NCT03421886|12575462|FG001|COMPLETED|Overall Study||13
11380110|NCT03421886|12575461|FG000|NOT COMPLETED|Overall Study||7
11380111|NCT03421886|12575462|FG001|NOT COMPLETED|Overall Study||2
11380112|NCT03422159|12575470|FG000|STARTED|Overall Study||70
11380113|NCT03422159|12575471|FG001|STARTED|Overall Study||70
11380114|NCT03422159|12575470|FG000|COMPLETED|Overall Study||68
11380115|NCT03422159|12575471|FG001|COMPLETED|Overall Study||69
11380116|NCT03422159|12575470|FG000|NOT COMPLETED|Overall Study||2
11380117|NCT03422159|12575471|FG001|NOT COMPLETED|Overall Study||1
11380118|NCT03422172|12575479|FG000|STARTED|Oral lead-in Phase (4 Weeks)||48
11380119|NCT03422172|12575479|FG000|COMPLETED|Oral lead-in Phase (4 Weeks)||47
11380120|NCT03422172|12575479|FG000|NOT COMPLETED|Oral lead-in Phase (4 Weeks)||1
11380121|NCT03422172|12575479|FG000|STARTED|Washout (7 Days)||47
11380122|NCT03422172|12575479|FG000|COMPLETED|Washout (7 Days)||47
11380123|NCT03422172|12575479|FG000|NOT COMPLETED|Washout (7 Days)||0
11380124|NCT03422172|12575479|FG000|STARTED|Injection Phase (Week 5 to Week 41)||47
11380125|NCT03422172|12575479|FG000|COMPLETED|Injection Phase (Week 5 to Week 41)||43
11380126|NCT03422172|12575479|FG000|NOT COMPLETED|Injection Phase (Week 5 to Week 41)||4
11380127|NCT03422172|12575479|FG000|STARTED|Long Term Follow-up Phase(Upto Week 89)||43
11380128|NCT03422172|12575479|FG000|COMPLETED|Long Term Follow-up Phase(Upto Week 89)||43
11380129|NCT03422172|12575479|FG000|NOT COMPLETED|Long Term Follow-up Phase(Upto Week 89)||0
11380130|NCT03422250|12575492|FG000|STARTED|Intervention||11
11380131|NCT03422250|12575493|FG001|STARTED|Intervention||11
11380132|NCT03422250|12575494|FG002|STARTED|Intervention||12
11380133|NCT03422250|12575495|FG003|STARTED|Intervention||11
11380134|NCT03422250|12575492|FG000|COMPLETED|Intervention||10
11380135|NCT03422250|12575493|FG001|COMPLETED|Intervention||10
11380136|NCT03422250|12575494|FG002|COMPLETED|Intervention||10
11380137|NCT03422250|12575495|FG003|COMPLETED|Intervention||10
11380138|NCT03422250|12575492|FG000|NOT COMPLETED|Intervention||1
11380139|NCT03422250|12575493|FG001|NOT COMPLETED|Intervention||1
11380140|NCT03422250|12575494|FG002|NOT COMPLETED|Intervention||2
11380141|NCT03422250|12575495|FG003|NOT COMPLETED|Intervention||1
11380142|NCT03422250|12575492|FG000|STARTED|Follow-up||10
11380143|NCT03422250|12575493|FG001|STARTED|Follow-up||10
11380144|NCT03422250|12575494|FG002|STARTED|Follow-up||10
11380145|NCT03422250|12575495|FG003|STARTED|Follow-up||10
11380146|NCT03422250|12575492|FG000|COMPLETED|Follow-up||10
11380147|NCT03422250|12575493|FG001|COMPLETED|Follow-up||10
11380148|NCT03422250|12575494|FG002|COMPLETED|Follow-up||10
11380149|NCT03422250|12575495|FG003|COMPLETED|Follow-up||8
11380150|NCT03422250|12575492|FG000|NOT COMPLETED|Follow-up||0
11380151|NCT03422250|12575493|FG001|NOT COMPLETED|Follow-up||0
11380152|NCT03422250|12575494|FG002|NOT COMPLETED|Follow-up||0
11380153|NCT03422250|12575495|FG003|NOT COMPLETED|Follow-up||2
11380154|NCT03423082|12575507|FG000|STARTED|Overall Study||1
11380155|NCT03423082|12575507|FG000|COMPLETED|Overall Study||1
11380156|NCT03423082|12575507|FG000|NOT COMPLETED|Overall Study||0
11380157|NCT03423173|12575515|FG000|STARTED|Overall Study||132
11380158|NCT03423173|12575516|FG001|STARTED|Overall Study||263
11380159|NCT03423173|12575517|FG002|STARTED|Overall Study||264
11380160|NCT03423173|12575518|FG003|STARTED|Overall Study||264
11380161|NCT03423173|12575515|FG000|Received at Least 1 Dose of the IP|Overall Study||131
11380162|NCT03423173|12575516|FG001|Received at Least 1 Dose of the IP|Overall Study||263
11380163|NCT03423173|12575517|FG002|Received at Least 1 Dose of the IP|Overall Study|1 participant of TDV Lot 2 received vaccine of Lot 1 and was included in TDV Lot 1 in Safety Set.|262
11380164|NCT03423173|12575518|FG003|Received at Least 1 Dose of the IP|Overall Study||263
11380165|NCT03423173|12575515|FG000|COMPLETED|Overall Study||113
11380166|NCT03423173|12575516|FG001|COMPLETED|Overall Study||228
11380167|NCT03423173|12575517|FG002|COMPLETED|Overall Study||237
11380168|NCT03423173|12575518|FG003|COMPLETED|Overall Study||234
11380169|NCT03423173|12575515|FG000|NOT COMPLETED|Overall Study||19
11380170|NCT03423173|12575516|FG001|NOT COMPLETED|Overall Study||35
11380171|NCT03423173|12575517|FG002|NOT COMPLETED|Overall Study||27
11380172|NCT03423173|12575518|FG003|NOT COMPLETED|Overall Study||30
11380173|NCT03423186|12575530|FG000|STARTED|Overall Study||3
11380174|NCT03423186|12575531|FG001|STARTED|Overall Study||3
11380175|NCT03423186|12575530|FG000|COMPLETED|Overall Study||3
11380176|NCT03423186|12575531|FG001|COMPLETED|Overall Study||3
11380177|NCT03423186|12575530|FG000|NOT COMPLETED|Overall Study||0
11380178|NCT03423186|12575531|FG001|NOT COMPLETED|Overall Study||0
11380179|NCT03423238|12575539|FG000|STARTED|Overall Study||19
11380180|NCT03423238|12575540|FG001|STARTED|Overall Study||19
11380181|NCT03423238|12575539|FG000|COMPLETED|Overall Study||17
11380182|NCT03423238|12575540|FG001|COMPLETED|Overall Study||19
11380183|NCT03423238|12575539|FG000|NOT COMPLETED|Overall Study||2
11380184|NCT03423238|12575540|FG001|NOT COMPLETED|Overall Study||0
11380185|NCT03423641|12575549|FG000|STARTED|Overall Study||15524
11380186|NCT03423641|12575550|FG001|STARTED|Overall Study||18284
11380187|NCT03423641|12575549|FG000|COMPLETED|Overall Study||15193
11380188|NCT03423641|12575550|FG001|COMPLETED|Overall Study||10210
11380189|NCT03423641|12575549|FG000|NOT COMPLETED|Overall Study||331
11380190|NCT03423641|12575550|FG001|NOT COMPLETED|Overall Study||8074
11380191|NCT03424044|12575556|FG000|STARTED|Dexcom Training Visit (1 Week)||4
11380192|NCT03424044|12575557|FG001|STARTED|Dexcom Training Visit (1 Week)||3
11380193|NCT03424044|12575558|FG002|STARTED|Dexcom Training Visit (1 Week)||3
11380194|NCT03424044|12575559|FG003|STARTED|Dexcom Training Visit (1 Week)||3
11380195|NCT03424044|12575560|FG004|STARTED|Dexcom Training Visit (1 Week)||3
11380196|NCT03424044|12575561|FG005|STARTED|Dexcom Training Visit (1 Week)||4
11380197|NCT03424044|12575562|FG006|STARTED|Dexcom Training Visit (1 Week)||1
11380198|NCT03424044|12575563|FG007|STARTED|Dexcom Training Visit (1 Week)||1
11380199|NCT03424044|12575564|FG008|STARTED|Dexcom Training Visit (1 Week)||1
11380200|NCT03424044|12575556|FG000|COMPLETED|Dexcom Training Visit (1 Week)||4
11380201|NCT03424044|12575557|FG001|COMPLETED|Dexcom Training Visit (1 Week)||3
11380202|NCT03424044|12575558|FG002|COMPLETED|Dexcom Training Visit (1 Week)||3
11380203|NCT03424044|12575559|FG003|COMPLETED|Dexcom Training Visit (1 Week)||3
11380204|NCT03424044|12575560|FG004|COMPLETED|Dexcom Training Visit (1 Week)||3
11380205|NCT03424044|12575561|FG005|COMPLETED|Dexcom Training Visit (1 Week)||4
11380206|NCT03424044|12575562|FG006|COMPLETED|Dexcom Training Visit (1 Week)||1
11380207|NCT03424044|12575563|FG007|COMPLETED|Dexcom Training Visit (1 Week)||1
11380208|NCT03424044|12575564|FG008|COMPLETED|Dexcom Training Visit (1 Week)||1
11380209|NCT03424044|12575556|FG000|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
11380210|NCT03424044|12575557|FG001|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
11380211|NCT03424044|12575558|FG002|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
11380212|NCT03424044|12575559|FG003|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
11380213|NCT03424044|12575560|FG004|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
11380214|NCT03424044|12575561|FG005|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
11380215|NCT03424044|12575562|FG006|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
11380216|NCT03424044|12575563|FG007|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
11380217|NCT03424044|12575564|FG008|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
11006038|NCT00726232|12183816|FG004|Safety Evaluable Participants|Expansion Phase||0
11006039|NCT00726232|12183817|FG005|Safety Evaluable Participants|Expansion Phase||0
11006040|NCT00726232|12183818|FG006|Safety Evaluable Participants|Expansion Phase||34
11006041|NCT00726232|12183819|FG007|Safety Evaluable Participants|Expansion Phase||39
11006042|NCT00726232|12183812|FG000|ITT Participants|Expansion Phase||0
11006043|NCT00726232|12183813|FG001|ITT Participants|Expansion Phase||0
11380218|NCT03424044|12575556|FG000|STARTED|First Rest Period (1-12 Weeks)||4
11380219|NCT03424044|12575557|FG001|STARTED|First Rest Period (1-12 Weeks)||3
11380220|NCT03424044|12575558|FG002|STARTED|First Rest Period (1-12 Weeks)||3
11380221|NCT03424044|12575559|FG003|STARTED|First Rest Period (1-12 Weeks)||3
11380222|NCT03424044|12575560|FG004|STARTED|First Rest Period (1-12 Weeks)||3
11380223|NCT03424044|12575561|FG005|STARTED|First Rest Period (1-12 Weeks)||4
11380224|NCT03424044|12575562|FG006|STARTED|First Rest Period (1-12 Weeks)||1
11380225|NCT03424044|12575563|FG007|STARTED|First Rest Period (1-12 Weeks)||1
11380226|NCT03424044|12575564|FG008|STARTED|First Rest Period (1-12 Weeks)||1
11380227|NCT03424044|12575556|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4
11380228|NCT03424044|12575557|FG001|COMPLETED|First Rest Period (1-12 Weeks)||3
11380229|NCT03424044|12575558|FG002|COMPLETED|First Rest Period (1-12 Weeks)||2
11380230|NCT03424044|12575559|FG003|COMPLETED|First Rest Period (1-12 Weeks)||3
11380231|NCT03424044|12575560|FG004|COMPLETED|First Rest Period (1-12 Weeks)||3
11380232|NCT03424044|12575561|FG005|COMPLETED|First Rest Period (1-12 Weeks)||4
11380233|NCT03424044|12575562|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1
11006044|NCT00726232|12183814|FG002|ITT Participants|Expansion Phase||0
11006045|NCT00726232|12183815|FG003|ITT Participants|Expansion Phase||0
11380234|NCT03424044|12575563|FG007|COMPLETED|First Rest Period (1-12 Weeks)||1
11380235|NCT03424044|12575564|FG008|COMPLETED|First Rest Period (1-12 Weeks)||1
11380236|NCT03424044|12575556|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11380237|NCT03424044|12575557|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11380238|NCT03424044|12575558|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||1
11380239|NCT03424044|12575559|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11380240|NCT03424044|12575560|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11380241|NCT03424044|12575561|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11380242|NCT03424044|12575562|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11380243|NCT03424044|12575563|FG007|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11380244|NCT03424044|12575564|FG008|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11380245|NCT03424044|12575556|FG000|STARTED|First Intervention (76 Hours)||4
11380246|NCT03424044|12575557|FG001|STARTED|First Intervention (76 Hours)||3
11380247|NCT03424044|12575558|FG002|STARTED|First Intervention (76 Hours)||2
11380248|NCT03424044|12575559|FG003|STARTED|First Intervention (76 Hours)||3
11380249|NCT03424044|12575560|FG004|STARTED|First Intervention (76 Hours)||3
11380250|NCT03424044|12575561|FG005|STARTED|First Intervention (76 Hours)||4
11380251|NCT03424044|12575562|FG006|STARTED|First Intervention (76 Hours)||1
11380252|NCT03424044|12575563|FG007|STARTED|First Intervention (76 Hours)||1
11380253|NCT03424044|12575564|FG008|STARTED|First Intervention (76 Hours)||1
11380254|NCT03424044|12575556|FG000|COMPLETED|First Intervention (76 Hours)||4
11380255|NCT03424044|12575557|FG001|COMPLETED|First Intervention (76 Hours)||3
11380256|NCT03424044|12575558|FG002|COMPLETED|First Intervention (76 Hours)||2
11380257|NCT03424044|12575559|FG003|COMPLETED|First Intervention (76 Hours)||3
11380258|NCT03424044|12575560|FG004|COMPLETED|First Intervention (76 Hours)||2
11380259|NCT03424044|12575561|FG005|COMPLETED|First Intervention (76 Hours)||4
11380260|NCT03424044|12575562|FG006|COMPLETED|First Intervention (76 Hours)||0
11380261|NCT03424044|12575563|FG007|COMPLETED|First Intervention (76 Hours)||0
11380262|NCT03424044|12575564|FG008|COMPLETED|First Intervention (76 Hours)||0
11380263|NCT03424044|12575556|FG000|NOT COMPLETED|First Intervention (76 Hours)||0
11380264|NCT03424044|12575557|FG001|NOT COMPLETED|First Intervention (76 Hours)||0
11380265|NCT03424044|12575558|FG002|NOT COMPLETED|First Intervention (76 Hours)||0
11380266|NCT03424044|12575559|FG003|NOT COMPLETED|First Intervention (76 Hours)||0
11380267|NCT03424044|12575560|FG004|NOT COMPLETED|First Intervention (76 Hours)||1
11006046|NCT00726232|12183816|FG004|ITT Participants|Expansion Phase||0
11006047|NCT00726232|12183817|FG005|ITT Participants|Expansion Phase||0
11006048|NCT00726232|12183818|FG006|ITT Participants|Expansion Phase||34
11006049|NCT00726232|12183819|FG007|ITT Participants|Expansion Phase||39
11006050|NCT00726232|12183812|FG000|COMPLETED|Expansion Phase||0
11006051|NCT00726232|12183813|FG001|COMPLETED|Expansion Phase||0
11380268|NCT03424044|12575561|FG005|NOT COMPLETED|First Intervention (76 Hours)||0
11380269|NCT03424044|12575562|FG006|NOT COMPLETED|First Intervention (76 Hours)||1
11380270|NCT03424044|12575563|FG007|NOT COMPLETED|First Intervention (76 Hours)||1
11380271|NCT03424044|12575564|FG008|NOT COMPLETED|First Intervention (76 Hours)||1
11380272|NCT03424044|12575556|FG000|STARTED|Second Rest Period (7-45 Days)||4
11380273|NCT03424044|12575557|FG001|STARTED|Second Rest Period (7-45 Days)||3
11380274|NCT03424044|12575558|FG002|STARTED|Second Rest Period (7-45 Days)||2
11380275|NCT03424044|12575559|FG003|STARTED|Second Rest Period (7-45 Days)||3
11380276|NCT03424044|12575560|FG004|STARTED|Second Rest Period (7-45 Days)||2
11380277|NCT03424044|12575561|FG005|STARTED|Second Rest Period (7-45 Days)||4
11380278|NCT03424044|12575562|FG006|STARTED|Second Rest Period (7-45 Days)||1
11380279|NCT03424044|12575563|FG007|STARTED|Second Rest Period (7-45 Days)||1
11380280|NCT03424044|12575564|FG008|STARTED|Second Rest Period (7-45 Days)||1
11380281|NCT03424044|12575556|FG000|COMPLETED|Second Rest Period (7-45 Days)||4
11380282|NCT03424044|12575557|FG001|COMPLETED|Second Rest Period (7-45 Days)||3
11380283|NCT03424044|12575558|FG002|COMPLETED|Second Rest Period (7-45 Days)||2
11380284|NCT03424044|12575559|FG003|COMPLETED|Second Rest Period (7-45 Days)||3
11380285|NCT03424044|12575560|FG004|COMPLETED|Second Rest Period (7-45 Days)||2
11380286|NCT03424044|12575561|FG005|COMPLETED|Second Rest Period (7-45 Days)||4
11380287|NCT03424044|12575562|FG006|COMPLETED|Second Rest Period (7-45 Days)||1
11380288|NCT03424044|12575563|FG007|COMPLETED|Second Rest Period (7-45 Days)||1
11380289|NCT03424044|12575564|FG008|COMPLETED|Second Rest Period (7-45 Days)||1
11380290|NCT03424044|12575556|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11380291|NCT03424044|12575557|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11380292|NCT03424044|12575558|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11380293|NCT03424044|12575559|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11380294|NCT03424044|12575560|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11380295|NCT03424044|12575561|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11380296|NCT03424044|12575562|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11380297|NCT03424044|12575563|FG007|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11380298|NCT03424044|12575564|FG008|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11380299|NCT03424044|12575556|FG000|STARTED|Second Intervention (76 Hours)||4
11380300|NCT03424044|12575557|FG001|STARTED|Second Intervention (76 Hours)||3
11380301|NCT03424044|12575558|FG002|STARTED|Second Intervention (76 Hours)||2
11380302|NCT03424044|12575559|FG003|STARTED|Second Intervention (76 Hours)||3
11380303|NCT03424044|12575560|FG004|STARTED|Second Intervention (76 Hours)||2
11380304|NCT03424044|12575561|FG005|STARTED|Second Intervention (76 Hours)||4
11380305|NCT03424044|12575562|FG006|STARTED|Second Intervention (76 Hours)||1
11380306|NCT03424044|12575563|FG007|STARTED|Second Intervention (76 Hours)||1
11380307|NCT03424044|12575564|FG008|STARTED|Second Intervention (76 Hours)||1
11380308|NCT03424044|12575556|FG000|COMPLETED|Second Intervention (76 Hours)||4
11380309|NCT03424044|12575557|FG001|COMPLETED|Second Intervention (76 Hours)||3
11380310|NCT03424044|12575558|FG002|COMPLETED|Second Intervention (76 Hours)||2
11380311|NCT03424044|12575559|FG003|COMPLETED|Second Intervention (76 Hours)||3
11380312|NCT03424044|12575560|FG004|COMPLETED|Second Intervention (76 Hours)||2
11380313|NCT03424044|12575561|FG005|COMPLETED|Second Intervention (76 Hours)||4
11380314|NCT03424044|12575562|FG006|COMPLETED|Second Intervention (76 Hours)||1
11380315|NCT03424044|12575563|FG007|COMPLETED|Second Intervention (76 Hours)||1
11380316|NCT03424044|12575564|FG008|COMPLETED|Second Intervention (76 Hours)||1
11380317|NCT03424044|12575556|FG000|NOT COMPLETED|Second Intervention (76 Hours)||0
11380318|NCT03424044|12575557|FG001|NOT COMPLETED|Second Intervention (76 Hours)||0
11380319|NCT03424044|12575558|FG002|NOT COMPLETED|Second Intervention (76 Hours)||0
11380320|NCT03424044|12575559|FG003|NOT COMPLETED|Second Intervention (76 Hours)||0
11380321|NCT03424044|12575560|FG004|NOT COMPLETED|Second Intervention (76 Hours)||0
11380322|NCT03424044|12575561|FG005|NOT COMPLETED|Second Intervention (76 Hours)||0
11380323|NCT03424044|12575562|FG006|NOT COMPLETED|Second Intervention (76 Hours)||0
11380324|NCT03424044|12575563|FG007|NOT COMPLETED|Second Intervention (76 Hours)||0
11380325|NCT03424044|12575564|FG008|NOT COMPLETED|Second Intervention (76 Hours)||0
11380326|NCT03424044|12575556|FG000|STARTED|Third Rest Period (7-45 Days)||4
11380327|NCT03424044|12575557|FG001|STARTED|Third Rest Period (7-45 Days)||3
11380328|NCT03424044|12575558|FG002|STARTED|Third Rest Period (7-45 Days)||2
11380329|NCT03424044|12575559|FG003|STARTED|Third Rest Period (7-45 Days)||3
11380330|NCT03424044|12575560|FG004|STARTED|Third Rest Period (7-45 Days)||2
11380331|NCT03424044|12575561|FG005|STARTED|Third Rest Period (7-45 Days)||4
11380332|NCT03424044|12575562|FG006|STARTED|Third Rest Period (7-45 Days)||1
11380333|NCT03424044|12575563|FG007|STARTED|Third Rest Period (7-45 Days)||1
11380334|NCT03424044|12575564|FG008|STARTED|Third Rest Period (7-45 Days)||1
11380335|NCT03424044|12575556|FG000|COMPLETED|Third Rest Period (7-45 Days)||4
11380336|NCT03424044|12575557|FG001|COMPLETED|Third Rest Period (7-45 Days)||3
11380337|NCT03424044|12575558|FG002|COMPLETED|Third Rest Period (7-45 Days)||2
11380338|NCT03424044|12575559|FG003|COMPLETED|Third Rest Period (7-45 Days)||3
11380339|NCT03424044|12575560|FG004|COMPLETED|Third Rest Period (7-45 Days)||2
11380340|NCT03424044|12575561|FG005|COMPLETED|Third Rest Period (7-45 Days)||4
11380341|NCT03424044|12575562|FG006|COMPLETED|Third Rest Period (7-45 Days)||1
11380342|NCT03424044|12575563|FG007|COMPLETED|Third Rest Period (7-45 Days)||1
11380343|NCT03424044|12575564|FG008|COMPLETED|Third Rest Period (7-45 Days)||1
11380344|NCT03424044|12575556|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0
11380345|NCT03424044|12575557|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0
11380346|NCT03424044|12575558|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||0
11380347|NCT03424044|12575559|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0
11380348|NCT03424044|12575560|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||0
11380349|NCT03424044|12575561|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0
11380350|NCT03424044|12575562|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0
11380351|NCT03424044|12575563|FG007|NOT COMPLETED|Third Rest Period (7-45 Days)||0
11380352|NCT03424044|12575564|FG008|NOT COMPLETED|Third Rest Period (7-45 Days)||0
11380353|NCT03424044|12575556|FG000|STARTED|Third Intervention (76 Hours)||4
11380354|NCT03424044|12575557|FG001|STARTED|Third Intervention (76 Hours)||3
11380355|NCT03424044|12575558|FG002|STARTED|Third Intervention (76 Hours)||2
11380356|NCT03424044|12575559|FG003|STARTED|Third Intervention (76 Hours)||3
11380357|NCT03424044|12575560|FG004|STARTED|Third Intervention (76 Hours)||2
11380358|NCT03424044|12575561|FG005|STARTED|Third Intervention (76 Hours)||4
11380359|NCT03424044|12575562|FG006|STARTED|Third Intervention (76 Hours)||1
11380360|NCT03424044|12575563|FG007|STARTED|Third Intervention (76 Hours)||1
11380361|NCT03424044|12575564|FG008|STARTED|Third Intervention (76 Hours)||1
11380362|NCT03424044|12575556|FG000|COMPLETED|Third Intervention (76 Hours)||3
11380363|NCT03424044|12575557|FG001|COMPLETED|Third Intervention (76 Hours)||3
11380364|NCT03424044|12575558|FG002|COMPLETED|Third Intervention (76 Hours)||2
11380365|NCT03424044|12575559|FG003|COMPLETED|Third Intervention (76 Hours)||2
11380366|NCT03424044|12575560|FG004|COMPLETED|Third Intervention (76 Hours)||2
11380367|NCT03424044|12575561|FG005|COMPLETED|Third Intervention (76 Hours)||4
11380368|NCT03424044|12575562|FG006|COMPLETED|Third Intervention (76 Hours)||0
11380369|NCT03424044|12575563|FG007|COMPLETED|Third Intervention (76 Hours)||1
11380370|NCT03424044|12575564|FG008|COMPLETED|Third Intervention (76 Hours)||1
11380371|NCT03424044|12575556|FG000|NOT COMPLETED|Third Intervention (76 Hours)||1
11380372|NCT03424044|12575557|FG001|NOT COMPLETED|Third Intervention (76 Hours)||0
11380373|NCT03424044|12575558|FG002|NOT COMPLETED|Third Intervention (76 Hours)||0
11380374|NCT03424044|12575559|FG003|NOT COMPLETED|Third Intervention (76 Hours)||1
11380375|NCT03424044|12575560|FG004|NOT COMPLETED|Third Intervention (76 Hours)||0
11380376|NCT03424044|12575561|FG005|NOT COMPLETED|Third Intervention (76 Hours)||0
11380377|NCT03424044|12575562|FG006|NOT COMPLETED|Third Intervention (76 Hours)||1
11380378|NCT03424044|12575563|FG007|NOT COMPLETED|Third Intervention (76 Hours)||0
11380379|NCT03424044|12575564|FG008|NOT COMPLETED|Third Intervention (76 Hours)||0
11380380|NCT03424044|12575556|FG000|STARTED|Optional Fourth Rest Period (7-45 Days)||0
11380381|NCT03424044|12575557|FG001|STARTED|Optional Fourth Rest Period (7-45 Days)||0
11380382|NCT03424044|12575558|FG002|STARTED|Optional Fourth Rest Period (7-45 Days)||0
11380383|NCT03424044|12575559|FG003|STARTED|Optional Fourth Rest Period (7-45 Days)||0
11380384|NCT03424044|12575560|FG004|STARTED|Optional Fourth Rest Period (7-45 Days)||0
11380385|NCT03424044|12575561|FG005|STARTED|Optional Fourth Rest Period (7-45 Days)||0
11380386|NCT03424044|12575562|FG006|STARTED|Optional Fourth Rest Period (7-45 Days)||0
11380387|NCT03424044|12575563|FG007|STARTED|Optional Fourth Rest Period (7-45 Days)||1
11380388|NCT03424044|12575564|FG008|STARTED|Optional Fourth Rest Period (7-45 Days)||1
11380389|NCT03424044|12575556|FG000|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380390|NCT03424044|12575557|FG001|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380391|NCT03424044|12575558|FG002|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380392|NCT03424044|12575559|FG003|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380393|NCT03424044|12575560|FG004|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380394|NCT03424044|12575561|FG005|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380395|NCT03424044|12575562|FG006|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380396|NCT03424044|12575563|FG007|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
11380397|NCT03424044|12575564|FG008|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
11380398|NCT03424044|12575556|FG000|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380399|NCT03424044|12575557|FG001|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380400|NCT03424044|12575558|FG002|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380401|NCT03424044|12575559|FG003|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380402|NCT03424044|12575560|FG004|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380403|NCT03424044|12575561|FG005|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380404|NCT03424044|12575562|FG006|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380405|NCT03424044|12575563|FG007|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380406|NCT03424044|12575564|FG008|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
11380407|NCT03424044|12575556|FG000|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
11380408|NCT03424044|12575557|FG001|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
11380409|NCT03424044|12575558|FG002|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
11380410|NCT03424044|12575559|FG003|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
11380411|NCT03424044|12575560|FG004|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
11380412|NCT03424044|12575561|FG005|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
11380413|NCT03424044|12575562|FG006|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
11380414|NCT03424044|12575563|FG007|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
11380415|NCT03424044|12575564|FG008|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
11380416|NCT03424044|12575556|FG000|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380417|NCT03424044|12575557|FG001|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380418|NCT03424044|12575558|FG002|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380419|NCT03424044|12575559|FG003|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380420|NCT03424044|12575560|FG004|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380421|NCT03424044|12575561|FG005|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380422|NCT03424044|12575562|FG006|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380423|NCT03424044|12575563|FG007|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
11380424|NCT03424044|12575564|FG008|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
11380425|NCT03424044|12575556|FG000|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380426|NCT03424044|12575557|FG001|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380427|NCT03424044|12575558|FG002|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380428|NCT03424044|12575559|FG003|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380429|NCT03424044|12575560|FG004|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380430|NCT03424044|12575561|FG005|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380431|NCT03424044|12575562|FG006|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380432|NCT03424044|12575563|FG007|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380433|NCT03424044|12575564|FG008|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
11380434|NCT03424187|12575580|FG000|STARTED|Overall Study||2
11380435|NCT03424187|12575581|FG001|STARTED|Overall Study||3
11380436|NCT03424187|12575582|FG002|STARTED|Overall Study||2
11380437|NCT03424187|12575583|FG003|STARTED|Overall Study||3
11380438|NCT03424187|12575584|FG004|STARTED|Overall Study||2
11380439|NCT03424187|12575585|FG005|STARTED|Overall Study||3
11380440|NCT03424187|12575580|FG000|COMPLETED|Overall Study||2
11380441|NCT03424187|12575581|FG001|COMPLETED|Overall Study||3
11380442|NCT03424187|12575582|FG002|COMPLETED|Overall Study||2
11380443|NCT03424187|12575583|FG003|COMPLETED|Overall Study||3
11380444|NCT03424187|12575584|FG004|COMPLETED|Overall Study||2
11380445|NCT03424187|12575585|FG005|COMPLETED|Overall Study||3
11380446|NCT03424187|12575580|FG000|NOT COMPLETED|Overall Study||0
11380447|NCT03424187|12575581|FG001|NOT COMPLETED|Overall Study||0
11380448|NCT03424187|12575582|FG002|NOT COMPLETED|Overall Study||0
11380449|NCT03424187|12575583|FG003|NOT COMPLETED|Overall Study||0
11380450|NCT03424187|12575584|FG004|NOT COMPLETED|Overall Study||0
11380451|NCT03424187|12575585|FG005|NOT COMPLETED|Overall Study||0
11380452|NCT03424239|12575598|FG000|STARTED|Overall Study||6
11380453|NCT03424239|12575598|FG000|Baseline/Zoledronic Acid Administration|Overall Study||4
11380454|NCT03424239|12575598|FG000|2 Week Post-op|Overall Study||4
11380455|NCT03424239|12575598|FG000|12 Week Post-op|Overall Study||4
11380456|NCT03424239|12575598|FG000|24 Week Post-op|Overall Study||4
11380457|NCT03424239|12575598|FG000|COMPLETED|Overall Study||4
11380458|NCT03424239|12575598|FG000|NOT COMPLETED|Overall Study||2
11380459|NCT03424265|12575604|FG000|STARTED|Overall Study||29
11380460|NCT03424265|12575605|FG001|STARTED|Overall Study||34
11380461|NCT03424265|12575604|FG000|COMPLETED|Overall Study||28
11380462|NCT03424265|12575605|FG001|COMPLETED|Overall Study||32
11380463|NCT03424265|12575604|FG000|NOT COMPLETED|Overall Study||1
11380464|NCT03424265|12575605|FG001|NOT COMPLETED|Overall Study||2
11380465|NCT03424681|12575613|FG000|STARTED|Overall Study||6
11380466|NCT03424681|12575614|FG001|STARTED|Overall Study||6
11380467|NCT03424681|12575613|FG000|COMPLETED|Overall Study||6
11380468|NCT03424681|12575614|FG001|COMPLETED|Overall Study||5
11380469|NCT03424681|12575613|FG000|NOT COMPLETED|Overall Study||0
11380470|NCT03424681|12575614|FG001|NOT COMPLETED|Overall Study||1
11380471|NCT03425019|12575620|FG000|STARTED|Overall Study||20
11380472|NCT03425019|12575620|FG000|COMPLETED|Overall Study||20
11380473|NCT03425019|12575620|FG000|NOT COMPLETED|Overall Study||0
11380474|NCT03425097|12575625|FG000|STARTED|Treatment Period 1 (2 Weeks)||6
11380475|NCT03425097|12575626|FG001|STARTED|Treatment Period 1 (2 Weeks)||5
11380476|NCT03425097|12575625|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||6
11380477|NCT03425097|12575626|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||5
11380478|NCT03425097|12575625|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
11380479|NCT03425097|12575626|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
11380480|NCT03425097|12575625|FG000|STARTED|Washout Period (1 Week)||6
11380481|NCT03425097|12575626|FG001|STARTED|Washout Period (1 Week)||5
11380482|NCT03425097|12575625|FG000|COMPLETED|Washout Period (1 Week)||6
11380483|NCT03425097|12575626|FG001|COMPLETED|Washout Period (1 Week)||5
11380484|NCT03425097|12575625|FG000|NOT COMPLETED|Washout Period (1 Week)||0
11380485|NCT03425097|12575626|FG001|NOT COMPLETED|Washout Period (1 Week)||0
11380486|NCT03425097|12575625|FG000|STARTED|Second Treatment Period (2 Weeks)||6
11380487|NCT03425097|12575626|FG001|STARTED|Second Treatment Period (2 Weeks)||5
11380488|NCT03425097|12575625|FG000|COMPLETED|Second Treatment Period (2 Weeks)||6
11380489|NCT03425097|12575626|FG001|COMPLETED|Second Treatment Period (2 Weeks)||5
11380490|NCT03425097|12575625|FG000|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
11380491|NCT03425097|12575626|FG001|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
11380492|NCT03425188|12575635|FG000|STARTED|Overall Study||53
11380493|NCT03425188|12575635|FG000|COMPLETED|Overall Study||52
11380494|NCT03425188|12575635|FG000|NOT COMPLETED|Overall Study||1
11380495|NCT03425253|12575640|FG000|STARTED|Overall Study||58
11380496|NCT03425253|12575640|FG000|Safety Analysis Set|Overall Study||53
11380497|NCT03425253|12575640|FG000|FAS|Overall Study||53
11380498|NCT03425253|12575640|FG000|Evaluable Set (ES)|Overall Study||42
11380499|NCT03425253|12575640|FG000|COMPLETED|Overall Study||42
11380500|NCT03425253|12575640|FG000|NOT COMPLETED|Overall Study||16
11380501|NCT03425396|12575650|FG000|STARTED|Overall Study||55
11380502|NCT03425396|12575651|FG001|STARTED|Overall Study||54
11380503|NCT03425396|12575652|FG002|STARTED|Overall Study||54
11380504|NCT03425396|12575653|FG003|STARTED|Overall Study||8
11380505|NCT03425396|12575654|FG004|STARTED|Overall Study||54
11380506|NCT03425396|12575650|FG000|Completed End of Treatment Visit|Overall Study||53
11380507|NCT03425396|12575651|FG001|Completed End of Treatment Visit|Overall Study||52
11380508|NCT03425396|12575652|FG002|Completed End of Treatment Visit|Overall Study||51
11380509|NCT03425396|12575653|FG003|Completed End of Treatment Visit|Overall Study||7
11380510|NCT03425396|12575654|FG004|Completed End of Treatment Visit|Overall Study||53
11380511|NCT03425396|12575650|FG000|Completed Post-therapy Evaluation Visit|Overall Study||53
11380512|NCT03425396|12575651|FG001|Completed Post-therapy Evaluation Visit|Overall Study||49
11380513|NCT03425396|12575652|FG002|Completed Post-therapy Evaluation Visit|Overall Study||51
11380514|NCT03425396|12575653|FG003|Completed Post-therapy Evaluation Visit|Overall Study||7
11380515|NCT03425396|12575654|FG004|Completed Post-therapy Evaluation Visit|Overall Study||54
11380516|NCT03425396|12575650|FG000|Completed Final Follow-up Visit|Overall Study||53
11380517|NCT03425396|12575651|FG001|Completed Final Follow-up Visit|Overall Study||47
11380518|NCT03425396|12575652|FG002|Completed Final Follow-up Visit|Overall Study||51
11380519|NCT03425396|12575653|FG003|Completed Final Follow-up Visit|Overall Study||7
11380520|NCT03425396|12575654|FG004|Completed Final Follow-up Visit|Overall Study||53
11380521|NCT03425396|12575650|FG000|COMPLETED|Overall Study||53
11380522|NCT03425396|12575651|FG001|COMPLETED|Overall Study||47
11380523|NCT03425396|12575652|FG002|COMPLETED|Overall Study||51
11380524|NCT03425396|12575653|FG003|COMPLETED|Overall Study||7
11380525|NCT03425396|12575654|FG004|COMPLETED|Overall Study||53
11380526|NCT03425396|12575650|FG000|NOT COMPLETED|Overall Study||2
11380527|NCT03425396|12575651|FG001|NOT COMPLETED|Overall Study||7
11380528|NCT03425396|12575652|FG002|NOT COMPLETED|Overall Study||3
11380529|NCT03425396|12575653|FG003|NOT COMPLETED|Overall Study||1
11380530|NCT03425396|12575654|FG004|NOT COMPLETED|Overall Study||1
11380531|NCT03426228|12575668|FG000|STARTED|Overall Study||158
11380532|NCT03426228|12575669|FG001|STARTED|Overall Study||191
11380533|NCT03426228|12575668|FG000|COMPLETED|Overall Study||117
11380534|NCT03426228|12575669|FG001|COMPLETED|Overall Study||158
11380535|NCT03426228|12575668|FG000|NOT COMPLETED|Overall Study||41
11380536|NCT03426228|12575669|FG001|NOT COMPLETED|Overall Study||33
11380537|NCT03426267|12575679|FG000|STARTED|Overall Study||163
11380538|NCT03426267|12575680|FG001|STARTED|Overall Study||162
11380539|NCT03426267|12575679|FG000|Modified Intent-to-Treat Population|Overall Study||154
11380540|NCT03426267|12575680|FG001|Modified Intent-to-Treat Population|Overall Study||144
11380541|NCT03426267|12575679|FG000|COMPLETED|Overall Study||142
11380542|NCT03426267|12575680|FG001|COMPLETED|Overall Study||90
11380543|NCT03426267|12575679|FG000|NOT COMPLETED|Overall Study||21
11380544|NCT03426267|12575680|FG001|NOT COMPLETED|Overall Study||72
11380545|NCT03426345|12575688|FG000|STARTED|Overall Study||155
11380546|NCT03426345|12575689|FG001|STARTED|Overall Study||156
11380547|NCT03426345|12575688|FG000|Safety Population|Overall Study||152
11380548|NCT03426345|12575689|FG001|Safety Population|Overall Study||155
11380549|NCT03426345|12575688|FG000|COMPLETED|Overall Study||137
11380550|NCT03426345|12575689|FG001|COMPLETED|Overall Study||139
11380551|NCT03426345|12575688|FG000|NOT COMPLETED|Overall Study||18
11380552|NCT03426345|12575689|FG001|NOT COMPLETED|Overall Study||17
11380553|NCT03426436|12575696|FG000|STARTED|Overall Study||314
11380554|NCT03426436|12575696|FG000|COMPLETED|Overall Study||295
11380555|NCT03426436|12575696|FG000|NOT COMPLETED|Overall Study||19
11380556|NCT03426631|12575700|FG000|STARTED|Overall Study||7
11380557|NCT03426631|12575701|FG001|STARTED|Overall Study||6
11380558|NCT03426631|12575700|FG000|COMPLETED|Overall Study||7
11380559|NCT03426631|12575701|FG001|COMPLETED|Overall Study||5
11380560|NCT03426631|12575700|FG000|NOT COMPLETED|Overall Study||0
11380561|NCT03426631|12575701|FG001|NOT COMPLETED|Overall Study||1
11380562|NCT03426787|12575707|FG000|STARTED|Overall Study||70
11380563|NCT03426787|12575707|FG000|COMPLETED|Overall Study||56
11380564|NCT03426787|12575707|FG000|NOT COMPLETED|Overall Study||14
11380565|NCT03426995|12575736|FG000|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
11380566|NCT03426995|12575737|FG001|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
11380567|NCT03426995|12575738|FG002|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
11380568|NCT03426995|12575739|FG003|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
11380569|NCT03426995|12575740|FG004|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
11380570|NCT03426995|12575741|FG005|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
11380571|NCT03426995|12575742|FG006|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
11380572|NCT03426995|12575743|FG007|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
11380573|NCT03426995|12575744|FG008|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
11380574|NCT03426995|12575745|FG009|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
11380575|NCT03426995|12575746|FG010|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
11380576|NCT03426995|12575747|FG011|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
11380577|NCT03426995|12575748|FG012|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
11380578|NCT03426995|12575749|FG013|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
11380579|NCT03426995|12575750|FG014|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
11380580|NCT03426995|12575751|FG015|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
11380581|NCT03426995|12575752|FG016|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
11380582|NCT03426995|12575753|FG017|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
11380583|NCT03426995|12575754|FG018|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
11380584|NCT03426995|12575736|FG000|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380585|NCT03426995|12575737|FG001|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
11380586|NCT03426995|12575738|FG002|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380587|NCT03426995|12575739|FG003|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
11380588|NCT03426995|12575740|FG004|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
11380589|NCT03426995|12575741|FG005|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
11380590|NCT03426995|12575742|FG006|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380591|NCT03426995|12575743|FG007|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380592|NCT03426995|12575744|FG008|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380593|NCT03426995|12575745|FG009|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380594|NCT03426995|12575746|FG010|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380595|NCT03426995|12575747|FG011|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380596|NCT03426995|12575748|FG012|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380597|NCT03426995|12575749|FG013|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380598|NCT03426995|12575750|FG014|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380599|NCT03426995|12575751|FG015|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380600|NCT03426995|12575752|FG016|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380601|NCT03426995|12575753|FG017|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380602|NCT03426995|12575754|FG018|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380603|NCT03426995|12575736|FG000|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380604|NCT03426995|12575737|FG001|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380605|NCT03426995|12575738|FG002|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
11380606|NCT03426995|12575739|FG003|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380607|NCT03426995|12575740|FG004|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380608|NCT03426995|12575741|FG005|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380609|NCT03426995|12575742|FG006|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380610|NCT03426995|12575743|FG007|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380611|NCT03426995|12575744|FG008|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380612|NCT03426995|12575745|FG009|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380613|NCT03426995|12575746|FG010|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380614|NCT03426995|12575747|FG011|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380615|NCT03426995|12575748|FG012|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380616|NCT03426995|12575749|FG013|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380617|NCT03426995|12575750|FG014|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380618|NCT03426995|12575751|FG015|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380619|NCT03426995|12575752|FG016|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380620|NCT03426995|12575753|FG017|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380621|NCT03426995|12575754|FG018|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
11380622|NCT03426995|12575736|FG000|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380623|NCT03426995|12575737|FG001|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
11380624|NCT03426995|12575738|FG002|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380625|NCT03426995|12575739|FG003|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
11380626|NCT03426995|12575740|FG004|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
11380627|NCT03426995|12575741|FG005|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
11380628|NCT03426995|12575742|FG006|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380629|NCT03426995|12575743|FG007|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380630|NCT03426995|12575744|FG008|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380631|NCT03426995|12575745|FG009|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380632|NCT03426995|12575746|FG010|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380633|NCT03426995|12575747|FG011|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380634|NCT03426995|12575748|FG012|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380635|NCT03426995|12575749|FG013|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380636|NCT03426995|12575750|FG014|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380637|NCT03426995|12575751|FG015|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380638|NCT03426995|12575752|FG016|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380639|NCT03426995|12575753|FG017|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380640|NCT03426995|12575754|FG018|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380641|NCT03426995|12575736|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380642|NCT03426995|12575737|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
11380643|NCT03426995|12575738|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380644|NCT03426995|12575739|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
11380645|NCT03426995|12575740|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
11380646|NCT03426995|12575741|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
11380647|NCT03426995|12575742|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380648|NCT03426995|12575743|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380649|NCT03426995|12575744|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380650|NCT03426995|12575745|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380651|NCT03426995|12575746|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380652|NCT03426995|12575747|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380653|NCT03426995|12575748|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380654|NCT03426995|12575749|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380655|NCT03426995|12575750|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380656|NCT03426995|12575751|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380657|NCT03426995|12575752|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380658|NCT03426995|12575753|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380659|NCT03426995|12575754|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380660|NCT03426995|12575736|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380661|NCT03426995|12575737|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380662|NCT03426995|12575738|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380663|NCT03426995|12575739|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380664|NCT03426995|12575740|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380665|NCT03426995|12575741|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380666|NCT03426995|12575742|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380667|NCT03426995|12575743|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380668|NCT03426995|12575744|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380669|NCT03426995|12575745|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380670|NCT03426995|12575746|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380671|NCT03426995|12575747|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380672|NCT03426995|12575748|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380673|NCT03426995|12575749|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380674|NCT03426995|12575750|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380675|NCT03426995|12575751|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380676|NCT03426995|12575752|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380677|NCT03426995|12575753|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380678|NCT03426995|12575754|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
11380679|NCT03426995|12575736|FG000|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
11380680|NCT03426995|12575737|FG001|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
11380681|NCT03426995|12575738|FG002|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
11380682|NCT03426995|12575739|FG003|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
11380683|NCT03426995|12575740|FG004|STARTED|Part A: Cohort 1-Period 2 (Day1)||1
11380684|NCT03426995|12575741|FG005|STARTED|Part A: Cohort 1-Period 2 (Day1)|Two additional participants were enrolled and dosed.|3
11380685|NCT03426995|12575742|FG006|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
11380686|NCT03426995|12575743|FG007|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
11380687|NCT03426995|12575744|FG008|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
11380688|NCT03426995|12575745|FG009|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
11380689|NCT03426995|12575746|FG010|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
11380690|NCT03426995|12575747|FG011|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
11380691|NCT03426995|12575748|FG012|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
11380692|NCT03426995|12575749|FG013|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
11380693|NCT03426995|12575750|FG014|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
11380694|NCT03426995|12575751|FG015|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
11380695|NCT03426995|12575752|FG016|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
11380696|NCT03426995|12575753|FG017|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
11380697|NCT03426995|12575754|FG018|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
11380698|NCT03426995|12575736|FG000|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
11380699|NCT03426995|12575737|FG001|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
11380700|NCT03426995|12575738|FG002|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
11380701|NCT03426995|12575739|FG003|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
11380702|NCT03426995|12575740|FG004|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380703|NCT03426995|12575741|FG005|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
11380704|NCT03426995|12575742|FG006|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380705|NCT03426995|12575743|FG007|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380706|NCT03426995|12575744|FG008|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380707|NCT03426995|12575745|FG009|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380708|NCT03426995|12575746|FG010|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380709|NCT03426995|12575747|FG011|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380710|NCT03426995|12575748|FG012|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380711|NCT03426995|12575749|FG013|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380712|NCT03426995|12575750|FG014|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380713|NCT03426995|12575751|FG015|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380714|NCT03426995|12575752|FG016|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380715|NCT03426995|12575753|FG017|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380716|NCT03426995|12575754|FG018|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380717|NCT03426995|12575736|FG000|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380718|NCT03426995|12575737|FG001|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380719|NCT03426995|12575738|FG002|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380720|NCT03426995|12575739|FG003|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380721|NCT03426995|12575740|FG004|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
11380722|NCT03426995|12575741|FG005|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
11380723|NCT03426995|12575742|FG006|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380724|NCT03426995|12575743|FG007|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380725|NCT03426995|12575744|FG008|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380726|NCT03426995|12575745|FG009|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380727|NCT03426995|12575746|FG010|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380728|NCT03426995|12575747|FG011|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380729|NCT03426995|12575748|FG012|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380730|NCT03426995|12575749|FG013|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380731|NCT03426995|12575750|FG014|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380732|NCT03426995|12575751|FG015|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380733|NCT03426995|12575752|FG016|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380734|NCT03426995|12575753|FG017|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380735|NCT03426995|12575754|FG018|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
11380736|NCT03426995|12575736|FG000|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
11380737|NCT03426995|12575737|FG001|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
11380738|NCT03426995|12575738|FG002|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
11380739|NCT03426995|12575739|FG003|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
11380740|NCT03426995|12575740|FG004|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380741|NCT03426995|12575741|FG005|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
11380742|NCT03426995|12575742|FG006|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380743|NCT03426995|12575743|FG007|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380744|NCT03426995|12575744|FG008|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380745|NCT03426995|12575745|FG009|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380746|NCT03426995|12575746|FG010|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380747|NCT03426995|12575747|FG011|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380748|NCT03426995|12575748|FG012|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380749|NCT03426995|12575749|FG013|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380750|NCT03426995|12575750|FG014|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380751|NCT03426995|12575751|FG015|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380752|NCT03426995|12575752|FG016|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380753|NCT03426995|12575753|FG017|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380754|NCT03426995|12575754|FG018|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380755|NCT03426995|12575736|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
11380756|NCT03426995|12575737|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
11380757|NCT03426995|12575738|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
11380758|NCT03426995|12575739|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
11380759|NCT03426995|12575740|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380760|NCT03426995|12575741|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
11380761|NCT03426995|12575742|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380762|NCT03426995|12575743|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380763|NCT03426995|12575744|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380764|NCT03426995|12575745|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380765|NCT03426995|12575746|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380766|NCT03426995|12575747|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380767|NCT03426995|12575748|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380768|NCT03426995|12575749|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380769|NCT03426995|12575750|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380770|NCT03426995|12575751|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380771|NCT03426995|12575752|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380772|NCT03426995|12575753|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380773|NCT03426995|12575754|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380774|NCT03426995|12575736|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380775|NCT03426995|12575737|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380776|NCT03426995|12575738|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380777|NCT03426995|12575739|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380778|NCT03426995|12575740|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380779|NCT03426995|12575741|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380780|NCT03426995|12575742|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380781|NCT03426995|12575743|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380782|NCT03426995|12575744|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380783|NCT03426995|12575745|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380784|NCT03426995|12575746|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380785|NCT03426995|12575747|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380786|NCT03426995|12575748|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380787|NCT03426995|12575749|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380788|NCT03426995|12575750|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380789|NCT03426995|12575751|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380790|NCT03426995|12575752|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380791|NCT03426995|12575753|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380792|NCT03426995|12575754|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
11380793|NCT03426995|12575736|FG000|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
11380794|NCT03426995|12575737|FG001|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
11380795|NCT03426995|12575738|FG002|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
11380796|NCT03426995|12575739|FG003|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
11380797|NCT03426995|12575740|FG004|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|1
11380798|NCT03426995|12575741|FG005|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|2
11380799|NCT03426995|12575742|FG006|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
11380800|NCT03426995|12575743|FG007|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
11380801|NCT03426995|12575744|FG008|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
11380802|NCT03426995|12575745|FG009|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
11380803|NCT03426995|12575746|FG010|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
11380804|NCT03426995|12575747|FG011|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
11380805|NCT03426995|12575748|FG012|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
11380806|NCT03426995|12575749|FG013|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
11380807|NCT03426995|12575750|FG014|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
11380808|NCT03426995|12575751|FG015|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
11380809|NCT03426995|12575752|FG016|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
11380810|NCT03426995|12575753|FG017|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
11380811|NCT03426995|12575754|FG018|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
11380812|NCT03426995|12575736|FG000|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
11380813|NCT03426995|12575737|FG001|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
11380814|NCT03426995|12575738|FG002|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
11380815|NCT03426995|12575739|FG003|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
11380816|NCT03426995|12575740|FG004|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
11380817|NCT03426995|12575741|FG005|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
11380818|NCT03426995|12575742|FG006|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380819|NCT03426995|12575743|FG007|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380820|NCT03426995|12575744|FG008|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380821|NCT03426995|12575745|FG009|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380822|NCT03426995|12575746|FG010|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380823|NCT03426995|12575747|FG011|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380824|NCT03426995|12575748|FG012|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380825|NCT03426995|12575749|FG013|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380826|NCT03426995|12575750|FG014|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380827|NCT03426995|12575751|FG015|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380828|NCT03426995|12575752|FG016|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380829|NCT03426995|12575753|FG017|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380830|NCT03426995|12575754|FG018|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380831|NCT03426995|12575736|FG000|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380832|NCT03426995|12575737|FG001|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380833|NCT03426995|12575738|FG002|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380834|NCT03426995|12575739|FG003|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380835|NCT03426995|12575740|FG004|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380836|NCT03426995|12575741|FG005|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380837|NCT03426995|12575742|FG006|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380838|NCT03426995|12575743|FG007|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380839|NCT03426995|12575744|FG008|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380840|NCT03426995|12575745|FG009|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380841|NCT03426995|12575746|FG010|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380842|NCT03426995|12575747|FG011|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380843|NCT03426995|12575748|FG012|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380844|NCT03426995|12575749|FG013|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380845|NCT03426995|12575750|FG014|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380846|NCT03426995|12575751|FG015|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380847|NCT03426995|12575752|FG016|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380848|NCT03426995|12575753|FG017|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380849|NCT03426995|12575754|FG018|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
11380850|NCT03426995|12575736|FG000|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
11380851|NCT03426995|12575737|FG001|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
11380852|NCT03426995|12575738|FG002|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
11380853|NCT03426995|12575739|FG003|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
11380854|NCT03426995|12575740|FG004|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
11380855|NCT03426995|12575741|FG005|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
11380856|NCT03426995|12575742|FG006|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380857|NCT03426995|12575743|FG007|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380858|NCT03426995|12575744|FG008|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380859|NCT03426995|12575745|FG009|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380860|NCT03426995|12575746|FG010|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380861|NCT03426995|12575747|FG011|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380862|NCT03426995|12575748|FG012|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380863|NCT03426995|12575749|FG013|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380864|NCT03426995|12575750|FG014|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380865|NCT03426995|12575751|FG015|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380866|NCT03426995|12575752|FG016|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380867|NCT03426995|12575753|FG017|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380868|NCT03426995|12575754|FG018|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380869|NCT03426995|12575736|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
11380870|NCT03426995|12575737|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
11380871|NCT03426995|12575738|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
11380872|NCT03426995|12575739|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
11380873|NCT03426995|12575740|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
11380874|NCT03426995|12575741|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
11380875|NCT03426995|12575742|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380876|NCT03426995|12575743|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380877|NCT03426995|12575744|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380878|NCT03426995|12575745|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380879|NCT03426995|12575746|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380880|NCT03426995|12575747|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380881|NCT03426995|12575748|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380882|NCT03426995|12575749|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380883|NCT03426995|12575750|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380884|NCT03426995|12575751|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380885|NCT03426995|12575752|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380886|NCT03426995|12575753|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380887|NCT03426995|12575754|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380888|NCT03426995|12575736|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380889|NCT03426995|12575737|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380890|NCT03426995|12575738|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380891|NCT03426995|12575739|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380892|NCT03426995|12575740|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380893|NCT03426995|12575741|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380894|NCT03426995|12575742|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380895|NCT03426995|12575743|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380896|NCT03426995|12575744|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380897|NCT03426995|12575745|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380898|NCT03426995|12575746|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380899|NCT03426995|12575747|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380900|NCT03426995|12575748|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380901|NCT03426995|12575749|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380902|NCT03426995|12575750|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380903|NCT03426995|12575751|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380904|NCT03426995|12575752|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380905|NCT03426995|12575753|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380906|NCT03426995|12575754|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
11380907|NCT03426995|12575736|FG000|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
11380908|NCT03426995|12575737|FG001|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
11380909|NCT03426995|12575738|FG002|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
11380910|NCT03426995|12575739|FG003|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
11380911|NCT03426995|12575740|FG004|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
11380912|NCT03426995|12575741|FG005|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
11380913|NCT03426995|12575742|FG006|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
11380914|NCT03426995|12575743|FG007|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
11380915|NCT03426995|12575744|FG008|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
11380916|NCT03426995|12575745|FG009|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
11380917|NCT03426995|12575746|FG010|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
11380918|NCT03426995|12575747|FG011|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
11380919|NCT03426995|12575748|FG012|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
11380920|NCT03426995|12575749|FG013|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
11380921|NCT03426995|12575750|FG014|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
11380922|NCT03426995|12575751|FG015|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
11380923|NCT03426995|12575752|FG016|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
11380924|NCT03426995|12575753|FG017|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
11380925|NCT03426995|12575754|FG018|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
11380926|NCT03426995|12575736|FG000|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
11380927|NCT03426995|12575737|FG001|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
11380928|NCT03426995|12575738|FG002|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
11380929|NCT03426995|12575739|FG003|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
11380930|NCT03426995|12575740|FG004|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
11380931|NCT03426995|12575741|FG005|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
11380932|NCT03426995|12575742|FG006|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380933|NCT03426995|12575743|FG007|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380934|NCT03426995|12575744|FG008|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380935|NCT03426995|12575745|FG009|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380936|NCT03426995|12575746|FG010|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380937|NCT03426995|12575747|FG011|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380938|NCT03426995|12575748|FG012|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380939|NCT03426995|12575749|FG013|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380940|NCT03426995|12575750|FG014|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380941|NCT03426995|12575751|FG015|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380942|NCT03426995|12575752|FG016|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380943|NCT03426995|12575753|FG017|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380944|NCT03426995|12575754|FG018|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380945|NCT03426995|12575736|FG000|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380946|NCT03426995|12575737|FG001|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380947|NCT03426995|12575738|FG002|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380948|NCT03426995|12575739|FG003|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380949|NCT03426995|12575740|FG004|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380950|NCT03426995|12575741|FG005|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380951|NCT03426995|12575742|FG006|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380952|NCT03426995|12575743|FG007|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380953|NCT03426995|12575744|FG008|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380954|NCT03426995|12575745|FG009|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380955|NCT03426995|12575746|FG010|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380956|NCT03426995|12575747|FG011|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380957|NCT03426995|12575748|FG012|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380958|NCT03426995|12575749|FG013|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380959|NCT03426995|12575750|FG014|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380960|NCT03426995|12575751|FG015|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380961|NCT03426995|12575752|FG016|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380962|NCT03426995|12575753|FG017|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380963|NCT03426995|12575754|FG018|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
11380964|NCT03426995|12575736|FG000|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
11380965|NCT03426995|12575737|FG001|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
11380966|NCT03426995|12575738|FG002|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
11380967|NCT03426995|12575739|FG003|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
11380968|NCT03426995|12575740|FG004|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
11380969|NCT03426995|12575741|FG005|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
11380970|NCT03426995|12575742|FG006|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
11380971|NCT03426995|12575743|FG007|STARTED|Part A: Cohort 2-Period 1 (Day1)||2
11380972|NCT03426995|12575744|FG008|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
11380973|NCT03426995|12575745|FG009|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
11380974|NCT03426995|12575746|FG010|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
11380975|NCT03426995|12575747|FG011|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
11380976|NCT03426995|12575748|FG012|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
11380977|NCT03426995|12575749|FG013|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
11380978|NCT03426995|12575750|FG014|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
11380979|NCT03426995|12575751|FG015|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
11380980|NCT03426995|12575752|FG016|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
11380981|NCT03426995|12575753|FG017|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
11380982|NCT03426995|12575754|FG018|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
11380983|NCT03426995|12575736|FG000|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11380984|NCT03426995|12575737|FG001|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11380985|NCT03426995|12575738|FG002|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11380986|NCT03426995|12575739|FG003|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11380987|NCT03426995|12575740|FG004|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11380988|NCT03426995|12575741|FG005|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11380989|NCT03426995|12575742|FG006|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
11380990|NCT03426995|12575743|FG007|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2
11380991|NCT03426995|12575744|FG008|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
11380992|NCT03426995|12575745|FG009|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11380993|NCT03426995|12575746|FG010|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
11380994|NCT03426995|12575747|FG011|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
11380995|NCT03426995|12575748|FG012|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11380996|NCT03426995|12575749|FG013|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11380997|NCT03426995|12575750|FG014|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11380998|NCT03426995|12575751|FG015|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11380999|NCT03426995|12575752|FG016|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381000|NCT03426995|12575753|FG017|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381001|NCT03426995|12575754|FG018|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381002|NCT03426995|12575736|FG000|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381003|NCT03426995|12575737|FG001|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381004|NCT03426995|12575738|FG002|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381005|NCT03426995|12575739|FG003|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381006|NCT03426995|12575740|FG004|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381007|NCT03426995|12575741|FG005|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381008|NCT03426995|12575742|FG006|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381009|NCT03426995|12575743|FG007|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381010|NCT03426995|12575744|FG008|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381011|NCT03426995|12575745|FG009|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381012|NCT03426995|12575746|FG010|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381013|NCT03426995|12575747|FG011|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381014|NCT03426995|12575748|FG012|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381015|NCT03426995|12575749|FG013|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381016|NCT03426995|12575750|FG014|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381017|NCT03426995|12575751|FG015|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381018|NCT03426995|12575752|FG016|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381019|NCT03426995|12575753|FG017|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381020|NCT03426995|12575754|FG018|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
11381021|NCT03426995|12575736|FG000|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381022|NCT03426995|12575737|FG001|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381023|NCT03426995|12575738|FG002|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381024|NCT03426995|12575739|FG003|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381025|NCT03426995|12575740|FG004|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381026|NCT03426995|12575741|FG005|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381027|NCT03426995|12575742|FG006|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
11381028|NCT03426995|12575743|FG007|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
11381029|NCT03426995|12575744|FG008|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
11381030|NCT03426995|12575745|FG009|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381031|NCT03426995|12575746|FG010|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
11381032|NCT03426995|12575747|FG011|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
11381033|NCT03426995|12575748|FG012|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381034|NCT03426995|12575749|FG013|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381035|NCT03426995|12575750|FG014|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381036|NCT03426995|12575751|FG015|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381037|NCT03426995|12575752|FG016|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381038|NCT03426995|12575753|FG017|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381039|NCT03426995|12575754|FG018|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381040|NCT03426995|12575736|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381041|NCT03426995|12575737|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381042|NCT03426995|12575738|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381043|NCT03426995|12575739|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381044|NCT03426995|12575740|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381045|NCT03426995|12575741|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381046|NCT03426995|12575742|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
11381047|NCT03426995|12575743|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
11381048|NCT03426995|12575744|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
11381049|NCT03426995|12575745|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381050|NCT03426995|12575746|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
11381051|NCT03426995|12575747|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
11381052|NCT03426995|12575748|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381053|NCT03426995|12575749|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381054|NCT03426995|12575750|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381055|NCT03426995|12575751|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381056|NCT03426995|12575752|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381057|NCT03426995|12575753|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381058|NCT03426995|12575754|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381059|NCT03426995|12575736|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381060|NCT03426995|12575737|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381061|NCT03426995|12575738|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381062|NCT03426995|12575739|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381063|NCT03426995|12575740|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381064|NCT03426995|12575741|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381065|NCT03426995|12575742|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381066|NCT03426995|12575743|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381067|NCT03426995|12575744|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381068|NCT03426995|12575745|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381069|NCT03426995|12575746|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381070|NCT03426995|12575747|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381071|NCT03426995|12575748|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381072|NCT03426995|12575749|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381073|NCT03426995|12575750|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381074|NCT03426995|12575751|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381075|NCT03426995|12575752|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381076|NCT03426995|12575753|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381077|NCT03426995|12575754|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
11381078|NCT03426995|12575736|FG000|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
11381079|NCT03426995|12575737|FG001|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
11381080|NCT03426995|12575738|FG002|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
11381081|NCT03426995|12575739|FG003|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
11381082|NCT03426995|12575740|FG004|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
11381083|NCT03426995|12575741|FG005|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
11381084|NCT03426995|12575742|FG006|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
11381085|NCT03426995|12575743|FG007|STARTED|Part A: Cohort 2-Period 2 (Day1)||2
11381086|NCT03426995|12575744|FG008|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
11381087|NCT03426995|12575745|FG009|STARTED|Part A: Cohort 2-Period 2 (Day1)|Two additional participants were enrolled and dosed.|2
11381088|NCT03426995|12575746|FG010|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
11381089|NCT03426995|12575747|FG011|STARTED|Part A: Cohort 2-Period 2 (Day1)|New participant enrolled and dosed.|2
11381090|NCT03426995|12575748|FG012|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
11381091|NCT03426995|12575749|FG013|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
11381092|NCT03426995|12575750|FG014|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
11381093|NCT03426995|12575751|FG015|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
11381094|NCT03426995|12575752|FG016|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
11381095|NCT03426995|12575753|FG017|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
11381096|NCT03426995|12575754|FG018|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
11381097|NCT03426995|12575736|FG000|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381098|NCT03426995|12575737|FG001|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381099|NCT03426995|12575738|FG002|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381100|NCT03426995|12575739|FG003|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381101|NCT03426995|12575740|FG004|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381102|NCT03426995|12575741|FG005|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381103|NCT03426995|12575742|FG006|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
11381104|NCT03426995|12575743|FG007|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
11381105|NCT03426995|12575744|FG008|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
11381106|NCT03426995|12575745|FG009|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
11381107|NCT03426995|12575746|FG010|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
11381108|NCT03426995|12575747|FG011|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
11381109|NCT03426995|12575748|FG012|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381110|NCT03426995|12575749|FG013|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381111|NCT03426995|12575750|FG014|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381112|NCT03426995|12575751|FG015|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381113|NCT03426995|12575752|FG016|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381114|NCT03426995|12575753|FG017|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381115|NCT03426995|12575754|FG018|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381116|NCT03426995|12575736|FG000|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381117|NCT03426995|12575737|FG001|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381118|NCT03426995|12575738|FG002|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381119|NCT03426995|12575739|FG003|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381120|NCT03426995|12575740|FG004|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381121|NCT03426995|12575741|FG005|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381122|NCT03426995|12575742|FG006|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381123|NCT03426995|12575743|FG007|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381124|NCT03426995|12575744|FG008|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381125|NCT03426995|12575745|FG009|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381126|NCT03426995|12575746|FG010|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381127|NCT03426995|12575747|FG011|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381128|NCT03426995|12575748|FG012|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381129|NCT03426995|12575749|FG013|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381130|NCT03426995|12575750|FG014|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381131|NCT03426995|12575751|FG015|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381132|NCT03426995|12575752|FG016|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381133|NCT03426995|12575753|FG017|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381134|NCT03426995|12575754|FG018|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
11381135|NCT03426995|12575736|FG000|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381136|NCT03426995|12575737|FG001|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381137|NCT03426995|12575738|FG002|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381138|NCT03426995|12575739|FG003|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381139|NCT03426995|12575740|FG004|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381140|NCT03426995|12575741|FG005|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381141|NCT03426995|12575742|FG006|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
11381142|NCT03426995|12575743|FG007|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
11381143|NCT03426995|12575744|FG008|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
11381144|NCT03426995|12575745|FG009|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
11381145|NCT03426995|12575746|FG010|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
11381146|NCT03426995|12575747|FG011|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
11381147|NCT03426995|12575748|FG012|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381148|NCT03426995|12575749|FG013|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381149|NCT03426995|12575750|FG014|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381150|NCT03426995|12575751|FG015|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381151|NCT03426995|12575752|FG016|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381152|NCT03426995|12575753|FG017|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381153|NCT03426995|12575754|FG018|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381154|NCT03426995|12575736|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381155|NCT03426995|12575737|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381156|NCT03426995|12575738|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381157|NCT03426995|12575739|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381158|NCT03426995|12575740|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381159|NCT03426995|12575741|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381160|NCT03426995|12575742|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
11381161|NCT03426995|12575743|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
11381162|NCT03426995|12575744|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
11381163|NCT03426995|12575745|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
11381164|NCT03426995|12575746|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
11381165|NCT03426995|12575747|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
11381166|NCT03426995|12575748|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381167|NCT03426995|12575749|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381168|NCT03426995|12575750|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381169|NCT03426995|12575751|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381170|NCT03426995|12575752|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381171|NCT03426995|12575753|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381172|NCT03426995|12575754|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381173|NCT03426995|12575736|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381174|NCT03426995|12575737|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381175|NCT03426995|12575738|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381176|NCT03426995|12575739|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381177|NCT03426995|12575740|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381178|NCT03426995|12575741|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381179|NCT03426995|12575742|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381180|NCT03426995|12575743|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381181|NCT03426995|12575744|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381182|NCT03426995|12575745|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381183|NCT03426995|12575746|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381184|NCT03426995|12575747|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381185|NCT03426995|12575748|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381186|NCT03426995|12575749|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381187|NCT03426995|12575750|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381188|NCT03426995|12575751|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381189|NCT03426995|12575752|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381190|NCT03426995|12575753|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381191|NCT03426995|12575754|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
11381192|NCT03426995|12575736|FG000|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
11381193|NCT03426995|12575737|FG001|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
11381194|NCT03426995|12575738|FG002|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
11381195|NCT03426995|12575739|FG003|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
11381196|NCT03426995|12575740|FG004|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
11381197|NCT03426995|12575741|FG005|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
11381198|NCT03426995|12575742|FG006|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
11381199|NCT03426995|12575743|FG007|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
11381200|NCT03426995|12575744|FG008|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
11381201|NCT03426995|12575745|FG009|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
11381202|NCT03426995|12575746|FG010|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
11381203|NCT03426995|12575747|FG011|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
11381204|NCT03426995|12575748|FG012|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
11381205|NCT03426995|12575749|FG013|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
11381206|NCT03426995|12575750|FG014|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
11381207|NCT03426995|12575751|FG015|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
11381208|NCT03426995|12575752|FG016|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
11381209|NCT03426995|12575753|FG017|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
11381210|NCT03426995|12575754|FG018|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
11381211|NCT03426995|12575736|FG000|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381212|NCT03426995|12575737|FG001|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381213|NCT03426995|12575738|FG002|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381214|NCT03426995|12575739|FG003|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381215|NCT03426995|12575740|FG004|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381216|NCT03426995|12575741|FG005|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381217|NCT03426995|12575742|FG006|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
11381218|NCT03426995|12575743|FG007|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
11381219|NCT03426995|12575744|FG008|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
11381220|NCT03426995|12575745|FG009|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
11381221|NCT03426995|12575746|FG010|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
11381222|NCT03426995|12575747|FG011|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
11381223|NCT03426995|12575748|FG012|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381224|NCT03426995|12575749|FG013|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381225|NCT03426995|12575750|FG014|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381226|NCT03426995|12575751|FG015|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381227|NCT03426995|12575752|FG016|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381228|NCT03426995|12575753|FG017|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381229|NCT03426995|12575754|FG018|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381230|NCT03426995|12575736|FG000|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381231|NCT03426995|12575737|FG001|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381232|NCT03426995|12575738|FG002|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381233|NCT03426995|12575739|FG003|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381234|NCT03426995|12575740|FG004|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381235|NCT03426995|12575741|FG005|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381236|NCT03426995|12575742|FG006|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381237|NCT03426995|12575743|FG007|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381238|NCT03426995|12575744|FG008|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381239|NCT03426995|12575745|FG009|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381240|NCT03426995|12575746|FG010|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381241|NCT03426995|12575747|FG011|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381242|NCT03426995|12575748|FG012|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381243|NCT03426995|12575749|FG013|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381244|NCT03426995|12575750|FG014|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381245|NCT03426995|12575751|FG015|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381246|NCT03426995|12575752|FG016|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381247|NCT03426995|12575753|FG017|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381248|NCT03426995|12575754|FG018|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
11381249|NCT03426995|12575736|FG000|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381250|NCT03426995|12575737|FG001|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381251|NCT03426995|12575738|FG002|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381252|NCT03426995|12575739|FG003|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381253|NCT03426995|12575740|FG004|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381254|NCT03426995|12575741|FG005|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381255|NCT03426995|12575742|FG006|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
11381256|NCT03426995|12575743|FG007|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
11381257|NCT03426995|12575744|FG008|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
11381258|NCT03426995|12575745|FG009|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
11381259|NCT03426995|12575746|FG010|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
11381260|NCT03426995|12575747|FG011|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
11381261|NCT03426995|12575748|FG012|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381262|NCT03426995|12575749|FG013|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381263|NCT03426995|12575750|FG014|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381264|NCT03426995|12575751|FG015|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381265|NCT03426995|12575752|FG016|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381266|NCT03426995|12575753|FG017|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381267|NCT03426995|12575754|FG018|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381268|NCT03426995|12575736|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381269|NCT03426995|12575737|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381270|NCT03426995|12575738|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381271|NCT03426995|12575739|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381272|NCT03426995|12575740|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381273|NCT03426995|12575741|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381274|NCT03426995|12575742|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
11381275|NCT03426995|12575743|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
11381276|NCT03426995|12575744|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
11381277|NCT03426995|12575745|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
11381278|NCT03426995|12575746|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
11381279|NCT03426995|12575747|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
11381280|NCT03426995|12575748|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381281|NCT03426995|12575749|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381282|NCT03426995|12575750|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381283|NCT03426995|12575751|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381284|NCT03426995|12575752|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381285|NCT03426995|12575753|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381286|NCT03426995|12575754|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381287|NCT03426995|12575736|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381288|NCT03426995|12575737|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381289|NCT03426995|12575738|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381290|NCT03426995|12575739|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381291|NCT03426995|12575740|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381292|NCT03426995|12575741|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381293|NCT03426995|12575742|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381294|NCT03426995|12575743|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381295|NCT03426995|12575744|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381296|NCT03426995|12575745|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381297|NCT03426995|12575746|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381298|NCT03426995|12575747|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381299|NCT03426995|12575748|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381300|NCT03426995|12575749|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381301|NCT03426995|12575750|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381302|NCT03426995|12575751|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381303|NCT03426995|12575752|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381304|NCT03426995|12575753|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381305|NCT03426995|12575754|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
11381306|NCT03426995|12575736|FG000|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
11381307|NCT03426995|12575737|FG001|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
11381308|NCT03426995|12575738|FG002|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
11381309|NCT03426995|12575739|FG003|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
11381310|NCT03426995|12575740|FG004|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
11381311|NCT03426995|12575741|FG005|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
11381312|NCT03426995|12575742|FG006|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
11381313|NCT03426995|12575743|FG007|STARTED|Part A: Cohort 2-Period 4 (Day1)|New participant enrolled and dosed.|3
11381314|NCT03426995|12575744|FG008|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
11381315|NCT03426995|12575745|FG009|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
11381316|NCT03426995|12575746|FG010|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
11381317|NCT03426995|12575747|FG011|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
11381318|NCT03426995|12575748|FG012|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
11381319|NCT03426995|12575749|FG013|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
11381320|NCT03426995|12575750|FG014|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
11381321|NCT03426995|12575751|FG015|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
11381322|NCT03426995|12575752|FG016|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
11381323|NCT03426995|12575753|FG017|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
11381324|NCT03426995|12575754|FG018|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
11381325|NCT03426995|12575736|FG000|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381326|NCT03426995|12575737|FG001|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381327|NCT03426995|12575738|FG002|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381328|NCT03426995|12575739|FG003|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381329|NCT03426995|12575740|FG004|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381330|NCT03426995|12575741|FG005|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381331|NCT03426995|12575742|FG006|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
11381332|NCT03426995|12575743|FG007|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
11381333|NCT03426995|12575744|FG008|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
11381334|NCT03426995|12575745|FG009|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
11381335|NCT03426995|12575746|FG010|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381336|NCT03426995|12575747|FG011|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
11381337|NCT03426995|12575748|FG012|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381338|NCT03426995|12575749|FG013|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381339|NCT03426995|12575750|FG014|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381340|NCT03426995|12575751|FG015|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381341|NCT03426995|12575752|FG016|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381342|NCT03426995|12575753|FG017|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381343|NCT03426995|12575754|FG018|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381344|NCT03426995|12575736|FG000|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381345|NCT03426995|12575737|FG001|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381346|NCT03426995|12575738|FG002|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381347|NCT03426995|12575739|FG003|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381348|NCT03426995|12575740|FG004|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381349|NCT03426995|12575741|FG005|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381350|NCT03426995|12575742|FG006|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381351|NCT03426995|12575743|FG007|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
11381352|NCT03426995|12575744|FG008|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381353|NCT03426995|12575745|FG009|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381354|NCT03426995|12575746|FG010|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
11381355|NCT03426995|12575747|FG011|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381356|NCT03426995|12575748|FG012|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11263673|NCT02271984|12459062|FG001|COMPLETED|Washout Period 3 (7 Days)||3
11263674|NCT02271984|12459063|FG002|COMPLETED|Washout Period 3 (7 Days)||3
11263675|NCT02271984|12459064|FG003|COMPLETED|Washout Period 3 (7 Days)||3
11381357|NCT03426995|12575749|FG013|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381358|NCT03426995|12575750|FG014|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381359|NCT03426995|12575751|FG015|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381360|NCT03426995|12575752|FG016|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381361|NCT03426995|12575753|FG017|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381362|NCT03426995|12575754|FG018|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
11381363|NCT03426995|12575736|FG000|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381364|NCT03426995|12575737|FG001|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381365|NCT03426995|12575738|FG002|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381366|NCT03426995|12575739|FG003|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381367|NCT03426995|12575740|FG004|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381368|NCT03426995|12575741|FG005|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381369|NCT03426995|12575742|FG006|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381370|NCT03426995|12575743|FG007|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381371|NCT03426995|12575744|FG008|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381372|NCT03426995|12575745|FG009|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381373|NCT03426995|12575746|FG010|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381374|NCT03426995|12575747|FG011|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381375|NCT03426995|12575748|FG012|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381376|NCT03426995|12575749|FG013|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381377|NCT03426995|12575750|FG014|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381378|NCT03426995|12575751|FG015|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381379|NCT03426995|12575752|FG016|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381380|NCT03426995|12575753|FG017|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381381|NCT03426995|12575754|FG018|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
11381382|NCT03426995|12575736|FG000|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381383|NCT03426995|12575737|FG001|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381384|NCT03426995|12575738|FG002|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381385|NCT03426995|12575739|FG003|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381386|NCT03426995|12575740|FG004|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381387|NCT03426995|12575741|FG005|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381388|NCT03426995|12575742|FG006|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381389|NCT03426995|12575743|FG007|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381390|NCT03426995|12575744|FG008|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381391|NCT03426995|12575745|FG009|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381392|NCT03426995|12575746|FG010|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381393|NCT03426995|12575747|FG011|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381394|NCT03426995|12575748|FG012|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381395|NCT03426995|12575749|FG013|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381396|NCT03426995|12575750|FG014|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381397|NCT03426995|12575751|FG015|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381398|NCT03426995|12575752|FG016|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381399|NCT03426995|12575753|FG017|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381400|NCT03426995|12575754|FG018|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11263676|NCT02271984|12459065|FG004|COMPLETED|Washout Period 3 (7 Days)||3
11263677|NCT02271984|12459066|FG005|COMPLETED|Washout Period 3 (7 Days)||3
11263678|NCT02271984|12459067|FG006|COMPLETED|Washout Period 3 (7 Days)||3
11263679|NCT02271984|12459068|FG007|COMPLETED|Washout Period 3 (7 Days)||3
11263680|NCT02271984|12459069|FG008|COMPLETED|Washout Period 3 (7 Days)||3
11263681|NCT02271984|12459070|FG009|COMPLETED|Washout Period 3 (7 Days)||3
11263682|NCT02271984|12459071|FG010|COMPLETED|Washout Period 3 (7 Days)||3
11381401|NCT03426995|12575736|FG000|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381402|NCT03426995|12575737|FG001|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381403|NCT03426995|12575738|FG002|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381404|NCT03426995|12575739|FG003|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381405|NCT03426995|12575740|FG004|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381406|NCT03426995|12575741|FG005|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381407|NCT03426995|12575742|FG006|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381408|NCT03426995|12575743|FG007|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381409|NCT03426995|12575744|FG008|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381410|NCT03426995|12575745|FG009|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381411|NCT03426995|12575746|FG010|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381412|NCT03426995|12575747|FG011|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381413|NCT03426995|12575748|FG012|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381414|NCT03426995|12575749|FG013|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381415|NCT03426995|12575750|FG014|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381416|NCT03426995|12575751|FG015|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381417|NCT03426995|12575752|FG016|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381418|NCT03426995|12575753|FG017|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381419|NCT03426995|12575754|FG018|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
11381420|NCT03426995|12575736|FG000|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381421|NCT03426995|12575737|FG001|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381422|NCT03426995|12575738|FG002|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381423|NCT03426995|12575739|FG003|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381424|NCT03426995|12575740|FG004|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381425|NCT03426995|12575741|FG005|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381426|NCT03426995|12575742|FG006|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381427|NCT03426995|12575743|FG007|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381428|NCT03426995|12575744|FG008|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381429|NCT03426995|12575745|FG009|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381430|NCT03426995|12575746|FG010|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381431|NCT03426995|12575747|FG011|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381432|NCT03426995|12575748|FG012|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381433|NCT03426995|12575749|FG013|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381434|NCT03426995|12575750|FG014|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381435|NCT03426995|12575751|FG015|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381436|NCT03426995|12575752|FG016|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381437|NCT03426995|12575753|FG017|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381438|NCT03426995|12575754|FG018|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381439|NCT03426995|12575736|FG000|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381440|NCT03426995|12575737|FG001|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381441|NCT03426995|12575738|FG002|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381442|NCT03426995|12575739|FG003|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381443|NCT03426995|12575740|FG004|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381444|NCT03426995|12575741|FG005|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381445|NCT03426995|12575742|FG006|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381446|NCT03426995|12575743|FG007|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381447|NCT03426995|12575744|FG008|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381448|NCT03426995|12575745|FG009|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381449|NCT03426995|12575746|FG010|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381450|NCT03426995|12575747|FG011|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381451|NCT03426995|12575748|FG012|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381452|NCT03426995|12575749|FG013|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381453|NCT03426995|12575750|FG014|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381454|NCT03426995|12575751|FG015|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381455|NCT03426995|12575752|FG016|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381456|NCT03426995|12575753|FG017|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381457|NCT03426995|12575754|FG018|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381458|NCT03426995|12575736|FG000|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381459|NCT03426995|12575737|FG001|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381460|NCT03426995|12575738|FG002|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381461|NCT03426995|12575739|FG003|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381462|NCT03426995|12575740|FG004|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381463|NCT03426995|12575741|FG005|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381464|NCT03426995|12575742|FG006|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381465|NCT03426995|12575743|FG007|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381466|NCT03426995|12575744|FG008|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381467|NCT03426995|12575745|FG009|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381468|NCT03426995|12575746|FG010|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381469|NCT03426995|12575747|FG011|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381470|NCT03426995|12575748|FG012|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381471|NCT03426995|12575749|FG013|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381472|NCT03426995|12575750|FG014|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381473|NCT03426995|12575751|FG015|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381474|NCT03426995|12575752|FG016|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381475|NCT03426995|12575753|FG017|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381476|NCT03426995|12575754|FG018|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
11381477|NCT03426995|12575736|FG000|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381478|NCT03426995|12575737|FG001|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381479|NCT03426995|12575738|FG002|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381480|NCT03426995|12575739|FG003|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381481|NCT03426995|12575740|FG004|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381482|NCT03426995|12575741|FG005|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381483|NCT03426995|12575742|FG006|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381484|NCT03426995|12575743|FG007|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381485|NCT03426995|12575744|FG008|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381486|NCT03426995|12575745|FG009|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381487|NCT03426995|12575746|FG010|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381488|NCT03426995|12575747|FG011|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381489|NCT03426995|12575748|FG012|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381490|NCT03426995|12575749|FG013|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381491|NCT03426995|12575750|FG014|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381492|NCT03426995|12575751|FG015|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381493|NCT03426995|12575752|FG016|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381494|NCT03426995|12575753|FG017|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381495|NCT03426995|12575754|FG018|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
11381496|NCT03426995|12575736|FG000|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381497|NCT03426995|12575737|FG001|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381498|NCT03426995|12575738|FG002|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381499|NCT03426995|12575739|FG003|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381500|NCT03426995|12575740|FG004|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381501|NCT03426995|12575741|FG005|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381502|NCT03426995|12575742|FG006|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381503|NCT03426995|12575743|FG007|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381504|NCT03426995|12575744|FG008|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381505|NCT03426995|12575745|FG009|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381506|NCT03426995|12575746|FG010|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381507|NCT03426995|12575747|FG011|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381508|NCT03426995|12575748|FG012|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381509|NCT03426995|12575749|FG013|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381510|NCT03426995|12575750|FG014|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381511|NCT03426995|12575751|FG015|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381512|NCT03426995|12575752|FG016|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381513|NCT03426995|12575753|FG017|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381514|NCT03426995|12575754|FG018|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381515|NCT03426995|12575736|FG000|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381516|NCT03426995|12575737|FG001|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381517|NCT03426995|12575738|FG002|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381518|NCT03426995|12575739|FG003|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381519|NCT03426995|12575740|FG004|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381520|NCT03426995|12575741|FG005|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381521|NCT03426995|12575742|FG006|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381522|NCT03426995|12575743|FG007|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381523|NCT03426995|12575744|FG008|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381524|NCT03426995|12575745|FG009|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381525|NCT03426995|12575746|FG010|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381526|NCT03426995|12575747|FG011|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381527|NCT03426995|12575748|FG012|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381528|NCT03426995|12575749|FG013|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381529|NCT03426995|12575750|FG014|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381530|NCT03426995|12575751|FG015|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381531|NCT03426995|12575752|FG016|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381532|NCT03426995|12575753|FG017|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381533|NCT03426995|12575754|FG018|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
11381534|NCT03426995|12575736|FG000|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381535|NCT03426995|12575737|FG001|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381536|NCT03426995|12575738|FG002|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381537|NCT03426995|12575739|FG003|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381538|NCT03426995|12575740|FG004|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381539|NCT03426995|12575741|FG005|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381540|NCT03426995|12575742|FG006|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381541|NCT03426995|12575743|FG007|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381542|NCT03426995|12575744|FG008|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381543|NCT03426995|12575745|FG009|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381544|NCT03426995|12575746|FG010|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381545|NCT03426995|12575747|FG011|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381546|NCT03426995|12575748|FG012|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381547|NCT03426995|12575749|FG013|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381548|NCT03426995|12575750|FG014|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||11
11381549|NCT03426995|12575751|FG015|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||14
11381550|NCT03426995|12575752|FG016|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381551|NCT03426995|12575753|FG017|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381552|NCT03426995|12575754|FG018|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381553|NCT03426995|12575736|FG000|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381554|NCT03426995|12575737|FG001|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381555|NCT03426995|12575738|FG002|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381556|NCT03426995|12575739|FG003|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381557|NCT03426995|12575740|FG004|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381558|NCT03426995|12575741|FG005|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381559|NCT03426995|12575742|FG006|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381560|NCT03426995|12575743|FG007|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381561|NCT03426995|12575744|FG008|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381562|NCT03426995|12575745|FG009|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381563|NCT03426995|12575746|FG010|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381564|NCT03426995|12575747|FG011|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381565|NCT03426995|12575748|FG012|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381566|NCT03426995|12575749|FG013|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381567|NCT03426995|12575750|FG014|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
11381568|NCT03426995|12575751|FG015|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
11381569|NCT03426995|12575752|FG016|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381570|NCT03426995|12575753|FG017|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381571|NCT03426995|12575754|FG018|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381572|NCT03426995|12575736|FG000|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381573|NCT03426995|12575737|FG001|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381574|NCT03426995|12575738|FG002|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381575|NCT03426995|12575739|FG003|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381576|NCT03426995|12575740|FG004|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381577|NCT03426995|12575741|FG005|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381578|NCT03426995|12575742|FG006|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381579|NCT03426995|12575743|FG007|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381580|NCT03426995|12575744|FG008|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381581|NCT03426995|12575745|FG009|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381582|NCT03426995|12575746|FG010|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381583|NCT03426995|12575747|FG011|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381584|NCT03426995|12575748|FG012|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381585|NCT03426995|12575749|FG013|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381586|NCT03426995|12575750|FG014|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||9
11381587|NCT03426995|12575751|FG015|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||12
11381588|NCT03426995|12575752|FG016|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381589|NCT03426995|12575753|FG017|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381590|NCT03426995|12575754|FG018|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
11381591|NCT03427073|12575809|FG000|STARTED|Overall Study||1
11381592|NCT03427073|12575810|FG001|STARTED|Overall Study||1
11381593|NCT03427073|12575811|FG002|STARTED|Overall Study||1
11381594|NCT03427073|12575812|FG003|STARTED|Overall Study||3
11381595|NCT03427073|12575813|FG004|STARTED|Overall Study||3
11381596|NCT03427073|12575814|FG005|STARTED|Overall Study||4
11381597|NCT03427073|12575815|FG006|STARTED|Overall Study||3
11381598|NCT03427073|12575816|FG007|STARTED|Overall Study||4
11381599|NCT03427073|12575809|FG000|COMPLETED|Overall Study||0
11381600|NCT03427073|12575810|FG001|COMPLETED|Overall Study||0
11381601|NCT03427073|12575811|FG002|COMPLETED|Overall Study||0
11381602|NCT03427073|12575812|FG003|COMPLETED|Overall Study||0
11381603|NCT03427073|12575813|FG004|COMPLETED|Overall Study||0
11381604|NCT03427073|12575814|FG005|COMPLETED|Overall Study||0
11381605|NCT03427073|12575815|FG006|COMPLETED|Overall Study||0
11381606|NCT03427073|12575816|FG007|COMPLETED|Overall Study||0
11381607|NCT03427073|12575809|FG000|NOT COMPLETED|Overall Study||1
11381608|NCT03427073|12575810|FG001|NOT COMPLETED|Overall Study||1
11381609|NCT03427073|12575811|FG002|NOT COMPLETED|Overall Study||1
11381610|NCT03427073|12575812|FG003|NOT COMPLETED|Overall Study||3
11381611|NCT03427073|12575813|FG004|NOT COMPLETED|Overall Study||3
11381612|NCT03427073|12575814|FG005|NOT COMPLETED|Overall Study||4
11381613|NCT03427073|12575815|FG006|NOT COMPLETED|Overall Study||3
11381614|NCT03427073|12575816|FG007|NOT COMPLETED|Overall Study||4
11381615|NCT03427177|12575836|FG000|STARTED|Overall Study||125
11381616|NCT03427177|12575837|FG001|STARTED|Overall Study||132
11381617|NCT03427177|12575836|FG000|COMPLETED|Overall Study||92
11381618|NCT03427177|12575837|FG001|COMPLETED|Overall Study||105
11381619|NCT03427177|12575836|FG000|NOT COMPLETED|Overall Study||33
11381620|NCT03427177|12575837|FG001|NOT COMPLETED|Overall Study||27
11381621|NCT03427268|12575843|FG000|STARTED|Overall Study||32
11381622|NCT03427268|12575843|FG000|COMPLETED|Overall Study||0
11381623|NCT03427268|12575843|FG000|NOT COMPLETED|Overall Study||32
11381624|NCT03427619|12575847|FG000|STARTED|Overall Study||275
11381625|NCT03427619|12575847|FG000|Safety Population|Overall Study||275
11381626|NCT03427619|12575847|FG000|Modified Intention to Treat Population|Overall Study||143
11381627|NCT03427619|12575847|FG000|COMPLETED|Overall Study||209
11381628|NCT03427619|12575847|FG000|NOT COMPLETED|Overall Study||66
11381629|NCT03427892|12575851|FG000|STARTED|Overall Study||21
11381630|NCT03427892|12575851|FG000|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19
11381631|NCT03427892|12575851|FG000|NOT COMPLETED|Overall Study||2
11381632|NCT03427931|12575855|FG000|STARTED|Overall Study||7
11381633|NCT03427931|12575855|FG000|COMPLETED|Overall Study||5
11381634|NCT03427931|12575855|FG000|NOT COMPLETED|Overall Study||2
11381635|NCT03428152|12575861|FG000|STARTED|Overall Study||37
11381636|NCT03428152|12575862|FG001|STARTED|Overall Study||41
11381637|NCT03428152|12575861|FG000|COMPLETED|Overall Study||30
11381638|NCT03428152|12575862|FG001|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30
11381639|NCT03428152|12575861|FG000|NOT COMPLETED|Overall Study||7
11381640|NCT03428152|12575862|FG001|NOT COMPLETED|Overall Study||11
11381641|NCT03428230|12575872|FG000|STARTED|Overall Study||15
11381642|NCT03428230|12575873|FG001|STARTED|Overall Study||15
11381643|NCT03428230|12575874|FG002|STARTED|Overall Study||15
11381644|NCT03428230|12575875|FG003|STARTED|Overall Study||15
11381645|NCT03428230|12575872|FG000|COMPLETED|Overall Study||15
11381646|NCT03428230|12575873|FG001|COMPLETED|Overall Study||15
11381647|NCT03428230|12575874|FG002|COMPLETED|Overall Study||15
11381648|NCT03428230|12575875|FG003|COMPLETED|Overall Study||15
11381649|NCT03428230|12575872|FG000|NOT COMPLETED|Overall Study||0
11381650|NCT03428230|12575873|FG001|NOT COMPLETED|Overall Study||0
11381651|NCT03428230|12575874|FG002|NOT COMPLETED|Overall Study||0
11381652|NCT03428230|12575875|FG003|NOT COMPLETED|Overall Study||0
11381653|NCT03428360|12575885|FG000|STARTED|Overall Study||130
11381654|NCT03428360|12575885|FG000|COMPLETED|Overall Study||90
11381655|NCT03428360|12575885|FG000|NOT COMPLETED|Overall Study||40
11381656|NCT03428750|12575895|FG000|STARTED|Overall Study||210
11381657|NCT03428750|12575896|FG001|STARTED|Overall Study||213
11381658|NCT03428750|12575895|FG000|COMPLETED|Overall Study||186
11381659|NCT03428750|12575896|FG001|COMPLETED|Overall Study||192
11381660|NCT03428750|12575895|FG000|NOT COMPLETED|Overall Study||24
11381661|NCT03428750|12575896|FG001|NOT COMPLETED|Overall Study||21
11381662|NCT03428815|12575927|FG000|STARTED|Overall Study||17
11381663|NCT03428815|12575928|FG001|STARTED|Overall Study||19
11381664|NCT03428815|12575927|FG000|COMPLETED|Overall Study||7
11381665|NCT03428815|12575928|FG001|COMPLETED|Overall Study||14
11381666|NCT03428815|12575927|FG000|NOT COMPLETED|Overall Study||10
11381667|NCT03428815|12575928|FG001|NOT COMPLETED|Overall Study||5
11381668|NCT03429270|12575934|FG000|STARTED|Overall Study||28
11381669|NCT03429270|12575934|FG000|COMPLETED|Overall Study||28
11381670|NCT03429270|12575934|FG000|NOT COMPLETED|Overall Study||0
11381671|NCT03429348|12575940|FG000|STARTED|Overall Study|4 participants had no additional rehab & had no corresponding sauna rehab participant to compare to.|12
11381672|NCT03429348|12575941|FG001|STARTED|Overall Study||12
11381673|NCT03429348|12575940|FG000|COMPLETED|Overall Study||12
11381674|NCT03429348|12575941|FG001|COMPLETED|Overall Study||12
11381675|NCT03429348|12575940|FG000|NOT COMPLETED|Overall Study||0
11381676|NCT03429348|12575941|FG001|NOT COMPLETED|Overall Study||0
11381677|NCT03429556|12575953|FG000|STARTED|Overall Study||12
11381678|NCT03429556|12575954|FG001|STARTED|Overall Study||4
11381679|NCT03429556|12575955|FG002|STARTED|Overall Study||4
11381680|NCT03429556|12575956|FG003|STARTED|Overall Study||3
11381681|NCT03429556|12575953|FG000|COMPLETED|Overall Study||12
11381682|NCT03429556|12575954|FG001|COMPLETED|Overall Study||3
11381683|NCT03429556|12575955|FG002|COMPLETED|Overall Study||4
11381684|NCT03429556|12575956|FG003|COMPLETED|Overall Study||3
11381685|NCT03429556|12575953|FG000|NOT COMPLETED|Overall Study||0
11381686|NCT03429556|12575954|FG001|NOT COMPLETED|Overall Study||1
11381687|NCT03429556|12575955|FG002|NOT COMPLETED|Overall Study||0
11381688|NCT03429556|12575956|FG003|NOT COMPLETED|Overall Study||0
11381689|NCT03430050|12575968|FG000|STARTED|Overall Study||3
11381690|NCT03430050|12575969|FG001|STARTED|Overall Study||5
11381691|NCT03430050|12575968|FG000|COMPLETED|Overall Study||3
11381692|NCT03430050|12575969|FG001|COMPLETED|Overall Study||5
11381693|NCT03430050|12575968|FG000|NOT COMPLETED|Overall Study||0
11381694|NCT03430050|12575969|FG001|NOT COMPLETED|Overall Study||0
11381695|NCT03430206|12575977|FG000|STARTED|Overall Study||40
11381696|NCT03430206|12575978|FG001|STARTED|Overall Study||38
11381697|NCT03430206|12575977|FG000|COMPLETED|Overall Study||18
11381698|NCT03430206|12575978|FG001|COMPLETED|Overall Study||21
11381699|NCT03430206|12575977|FG000|NOT COMPLETED|Overall Study||22
11381700|NCT03430206|12575978|FG001|NOT COMPLETED|Overall Study||17
11381701|NCT03430245|12575984|FG000|STARTED|Overall Study||16
11381702|NCT03430245|12575984|FG000|COMPLETED|Overall Study|6 subjects withdrew from study due to lengthy treatment. Treatment protocol amended.|9
11381703|NCT03430245|12575984|FG000|NOT COMPLETED|Overall Study||7
11381704|NCT03430349|12575990|FG000|STARTED|Overall Study||15
11381705|NCT03430349|12575991|FG001|STARTED|Overall Study||15
11381706|NCT03430349|12575990|FG000|Received nOPV Vaccination|Overall Study||15
11381707|NCT03430349|12575991|FG001|Received nOPV Vaccination|Overall Study||15
11381708|NCT03430349|12575990|FG000|COMPLETED|Overall Study||15
11381709|NCT03430349|12575991|FG001|COMPLETED|Overall Study||15
11381710|NCT03430349|12575990|FG000|NOT COMPLETED|Overall Study||0
11381711|NCT03430349|12575991|FG001|NOT COMPLETED|Overall Study||0
11381712|NCT03430856|12576001|FG000|STARTED|Overall Study||31
11381713|NCT03430856|12576002|FG001|STARTED|Overall Study||30
11381714|NCT03430856|12576003|FG002|STARTED|Overall Study||30
11381715|NCT03430856|12576001|FG000|Exposed|Overall Study||31
11381716|NCT03430856|12576002|FG001|Exposed|Overall Study||30
11381717|NCT03430856|12576003|FG002|Exposed|Overall Study||30
11381718|NCT03430856|12576001|FG000|COMPLETED|Overall Study||29
11381719|NCT03430856|12576002|FG001|COMPLETED|Overall Study||27
11381720|NCT03430856|12576003|FG002|COMPLETED|Overall Study||29
11381721|NCT03430856|12576001|FG000|NOT COMPLETED|Overall Study||2
11381722|NCT03430856|12576002|FG001|NOT COMPLETED|Overall Study||3
11381723|NCT03430856|12576003|FG002|NOT COMPLETED|Overall Study||1
11381724|NCT03430986|12576016|FG000|STARTED|24-week Control Period||42
11381725|NCT03430986|12576017|FG001|STARTED|24-week Control Period||122
11381726|NCT03430986|12576016|FG000|Treated as Randomized|24-week Control Period||42
11381727|NCT03430986|12576017|FG001|Treated as Randomized|24-week Control Period||120
11381728|NCT03430986|12576016|FG000|COMPLETED|24-week Control Period||34
11381729|NCT03430986|12576017|FG001|COMPLETED|24-week Control Period||118
11381730|NCT03430986|12576016|FG000|NOT COMPLETED|24-week Control Period||8
11381731|NCT03430986|12576017|FG001|NOT COMPLETED|24-week Control Period||4
11381732|NCT03430986|12576016|FG000|STARTED|24-week Post-Control Period|Not all participants received the Optional Treatment.|31
11381733|NCT03430986|12576017|FG001|STARTED|24-week Post-Control Period||118
11381734|NCT03430986|12576016|FG000|COMPLETED|24-week Post-Control Period||30
11381735|NCT03430986|12576017|FG001|COMPLETED|24-week Post-Control Period||116
11381736|NCT03430986|12576016|FG000|NOT COMPLETED|24-week Post-Control Period||1
11381737|NCT03430986|12576017|FG001|NOT COMPLETED|24-week Post-Control Period||2
11381738|NCT03431012|12576030|FG000|STARTED|Overall Study||47
11381739|NCT03431012|12576031|FG001|STARTED|Overall Study||60
11381740|NCT03431012|12576032|FG002|STARTED|Overall Study||56
11381741|NCT03431012|12576033|FG003|STARTED|Overall Study||53
11381742|NCT03431012|12576030|FG000|COMPLETED|Overall Study||47
11381743|NCT03431012|12576031|FG001|COMPLETED|Overall Study||60
11381744|NCT03431012|12576032|FG002|COMPLETED|Overall Study||56
11381745|NCT03431012|12576033|FG003|COMPLETED|Overall Study||53
11381746|NCT03431012|12576030|FG000|NOT COMPLETED|Overall Study||0
11381747|NCT03431012|12576031|FG001|NOT COMPLETED|Overall Study||0
11381748|NCT03431012|12576032|FG002|NOT COMPLETED|Overall Study||0
11381749|NCT03431012|12576033|FG003|NOT COMPLETED|Overall Study||0
11381750|NCT03431337|12576049|FG000|STARTED|Overall Study||78
11381751|NCT03431337|12576050|FG001|STARTED|Overall Study||79
11381752|NCT03431337|12576049|FG000|COMPLETED|Overall Study||49
11381753|NCT03431337|12576050|FG001|COMPLETED|Overall Study||57
11381754|NCT03431337|12576049|FG000|NOT COMPLETED|Overall Study||29
11381755|NCT03431337|12576050|FG001|NOT COMPLETED|Overall Study||22
11381756|NCT03431441|12576060|FG000|STARTED|Overall Study||24
11381757|NCT03431441|12576060|FG000|COMPLETED|Overall Study||19
11381758|NCT03431441|12576060|FG000|NOT COMPLETED|Overall Study||5
11381759|NCT03431857|12576064|FG000|STARTED|Overall Study||106
11381760|NCT03431857|12576064|FG000|COMPLETED|Overall Study|52 subjects have completed the study, and 50 had complete data (all pages of CRF visit are complete)|52
11381761|NCT03431857|12576064|FG000|NOT COMPLETED|Overall Study||54
11381762|NCT03432390|12576070|FG000|STARTED|Apnea Period||36
11381763|NCT03432390|12576071|FG001|STARTED|Apnea Period||36
11381764|NCT03432390|12576070|FG000|COMPLETED|Apnea Period||34
11381765|NCT03432390|12576071|FG001|COMPLETED|Apnea Period||34
11381766|NCT03432390|12576070|FG000|NOT COMPLETED|Apnea Period||2
11381767|NCT03432390|12576071|FG001|NOT COMPLETED|Apnea Period||2
11381768|NCT03432390|12576070|FG000|STARTED|Recovery Period||34
11381769|NCT03432390|12576071|FG001|STARTED|Recovery Period||34
11381770|NCT03432390|12576070|FG000|COMPLETED|Recovery Period||34
11381771|NCT03432390|12576071|FG001|COMPLETED|Recovery Period||34
11381772|NCT03432390|12576070|FG000|NOT COMPLETED|Recovery Period||0
11381773|NCT03432390|12576071|FG001|NOT COMPLETED|Recovery Period||0
11381774|NCT03432533|12576079|FG000|STARTED|Overall Study||141
11381775|NCT03432533|12576080|FG001|STARTED|Overall Study||142
11381776|NCT03432533|12576079|FG000|Completed 6-Month Treatment Period|Overall Study||136
11381777|NCT03432533|12576080|FG001|Completed 6-Month Treatment Period|Overall Study||137
11381778|NCT03432533|12576079|FG000|COMPLETED|Overall Study||126
11381779|NCT03432533|12576080|FG001|COMPLETED|Overall Study||131
11381780|NCT03432533|12576079|FG000|NOT COMPLETED|Overall Study||15
11381781|NCT03432533|12576080|FG001|NOT COMPLETED|Overall Study||11
11381782|NCT03432858|12576089|FG000|STARTED|Overall Study||12
11381783|NCT03432858|12576090|FG001|STARTED|Overall Study||83
11381784|NCT03432858|12576091|FG002|STARTED|Overall Study||89
11381785|NCT03432858|12576089|FG000|COMPLETED|Overall Study||10
11381786|NCT03432858|12576090|FG001|COMPLETED|Overall Study||72
11381787|NCT03432858|12576091|FG002|COMPLETED|Overall Study||72
11381788|NCT03432858|12576089|FG000|NOT COMPLETED|Overall Study||2
11381789|NCT03432858|12576090|FG001|NOT COMPLETED|Overall Study||11
11381790|NCT03432858|12576091|FG002|NOT COMPLETED|Overall Study||17
11381791|NCT03433482|12576103|FG000|STARTED|Overall Study||420
11381792|NCT03433482|12576104|FG001|STARTED|Overall Study||424
11381793|NCT03433482|12576105|FG002|STARTED|Overall Study||427
11381794|NCT03433482|12576106|FG003|STARTED|Overall Study||419
11381795|NCT03433482|12576103|FG000|COMPLETED|Overall Study||419
11381796|NCT03433482|12576104|FG001|COMPLETED|Overall Study||424
11381797|NCT03433482|12576105|FG002|COMPLETED|Overall Study||423
11381798|NCT03433482|12576106|FG003|COMPLETED|Overall Study||418
11381799|NCT03433482|12576103|FG000|NOT COMPLETED|Overall Study||1
11381800|NCT03433482|12576104|FG001|NOT COMPLETED|Overall Study||0
11381801|NCT03433482|12576105|FG002|NOT COMPLETED|Overall Study||4
11381802|NCT03433482|12576106|FG003|NOT COMPLETED|Overall Study||1
11381803|NCT03433677|12576118|FG000|STARTED|Period 1||24
11381804|NCT03433677|12576119|FG001|STARTED|Period 1||25
11381805|NCT03433677|12576118|FG000|Received at Least 1 Dose of Study Drug|Period 1||24
11381806|NCT03433677|12576119|FG001|Received at Least 1 Dose of Study Drug|Period 1||25
11381807|NCT03433677|12576118|FG000|COMPLETED|Period 1||23
11381808|NCT03433677|12576119|FG001|COMPLETED|Period 1||25
11381809|NCT03433677|12576118|FG000|NOT COMPLETED|Period 1||1
11381810|NCT03433677|12576119|FG001|NOT COMPLETED|Period 1||0
11381811|NCT03433677|12576118|FG000|STARTED|Period 2||23
11381812|NCT03433677|12576119|FG001|STARTED|Period 2||25
11381813|NCT03433677|12576118|FG000|Received at Least 1 Dose of Study Drug|Period 2||23
11381814|NCT03433677|12576119|FG001|Received at Least 1 Dose of Study Drug|Period 2||25
11381815|NCT03433677|12576118|FG000|COMPLETED|Period 2||22
11381816|NCT03433677|12576119|FG001|COMPLETED|Period 2||24
11381817|NCT03433677|12576118|FG000|NOT COMPLETED|Period 2||1
11381818|NCT03433677|12576119|FG001|NOT COMPLETED|Period 2||1
11381819|NCT03433703|12576126|FG000|STARTED|Overall Study||2
11381820|NCT03433703|12576126|FG000|COMPLETED|Overall Study||0
11381821|NCT03433703|12576126|FG000|NOT COMPLETED|Overall Study||2
11381822|NCT03433755|12576134|FG000|STARTED|Overall Study||42
11381823|NCT03433755|12576135|FG001|STARTED|Overall Study||41
11381824|NCT03433755|12576136|FG002|STARTED|Overall Study||79
11381825|NCT03433755|12576137|FG003|STARTED|Overall Study||80
11381826|NCT03433755|12576134|FG000|Randomized and Treated|Overall Study||41
11381827|NCT03433755|12576135|FG001|Randomized and Treated|Overall Study||41
11381828|NCT03433755|12576136|FG002|Randomized and Treated|Overall Study||79
11381829|NCT03433755|12576137|FG003|Randomized and Treated|Overall Study||80
11381830|NCT03433755|12576134|FG000|COMPLETED|Overall Study||40
11381831|NCT03433755|12576135|FG001|COMPLETED|Overall Study||41
11381832|NCT03433755|12576136|FG002|COMPLETED|Overall Study||79
11381833|NCT03433755|12576137|FG003|COMPLETED|Overall Study||80
11381834|NCT03433755|12576134|FG000|NOT COMPLETED|Overall Study||2
11381835|NCT03433755|12576135|FG001|NOT COMPLETED|Overall Study||0
11381836|NCT03433755|12576136|FG002|NOT COMPLETED|Overall Study||0
11381837|NCT03433755|12576137|FG003|NOT COMPLETED|Overall Study||0
11381838|NCT03433794|12576152|FG000|STARTED|Baseline||183
11381839|NCT03433794|12576153|FG001|STARTED|Baseline||173
11381840|NCT03433794|12576154|FG002|STARTED|Baseline||181
11381841|NCT03433794|12576152|FG000|COMPLETED|Baseline||183
11381842|NCT03433794|12576153|FG001|COMPLETED|Baseline||173
11381843|NCT03433794|12576154|FG002|COMPLETED|Baseline||181
11381844|NCT03433794|12576152|FG000|NOT COMPLETED|Baseline||0
11381845|NCT03433794|12576153|FG001|NOT COMPLETED|Baseline||0
11381846|NCT03433794|12576154|FG002|NOT COMPLETED|Baseline||0
11381847|NCT03433794|12576152|FG000|STARTED|2-Week Assessment||183
11381848|NCT03433794|12576153|FG001|STARTED|2-Week Assessment||173
11381849|NCT03433794|12576154|FG002|STARTED|2-Week Assessment||181
11381850|NCT03433794|12576152|FG000|COMPLETED|2-Week Assessment||117
11381851|NCT03433794|12576153|FG001|COMPLETED|2-Week Assessment||112
11381852|NCT03433794|12576154|FG002|COMPLETED|2-Week Assessment||109
11381853|NCT03433794|12576152|FG000|NOT COMPLETED|2-Week Assessment||66
11381854|NCT03433794|12576153|FG001|NOT COMPLETED|2-Week Assessment||61
11381855|NCT03433794|12576154|FG002|NOT COMPLETED|2-Week Assessment||72
11381856|NCT03433794|12576152|FG000|STARTED|4-Week Assessment||183
11381857|NCT03433794|12576153|FG001|STARTED|4-Week Assessment||173
11381858|NCT03433794|12576154|FG002|STARTED|4-Week Assessment||181
11381859|NCT03433794|12576152|FG000|COMPLETED|4-Week Assessment||98
11381860|NCT03433794|12576153|FG001|COMPLETED|4-Week Assessment||95
11381861|NCT03433794|12576154|FG002|COMPLETED|4-Week Assessment||91
11381862|NCT03433794|12576152|FG000|NOT COMPLETED|4-Week Assessment||85
11381863|NCT03433794|12576153|FG001|NOT COMPLETED|4-Week Assessment||78
11381864|NCT03433794|12576154|FG002|NOT COMPLETED|4-Week Assessment||90
11381865|NCT03433794|12576152|FG000|STARTED|6-Week Assessment||183
11381866|NCT03433794|12576153|FG001|STARTED|6-Week Assessment||173
11381867|NCT03433794|12576154|FG002|STARTED|6-Week Assessment||181
11381868|NCT03433794|12576152|FG000|COMPLETED|6-Week Assessment||94
11381869|NCT03433794|12576153|FG001|COMPLETED|6-Week Assessment||85
11381870|NCT03433794|12576154|FG002|COMPLETED|6-Week Assessment||80
11381871|NCT03433794|12576152|FG000|NOT COMPLETED|6-Week Assessment||89
11381872|NCT03433794|12576153|FG001|NOT COMPLETED|6-Week Assessment||88
11381873|NCT03433794|12576154|FG002|NOT COMPLETED|6-Week Assessment||101
11381874|NCT03433794|12576152|FG000|STARTED|3-Month Assessment||183
11381875|NCT03433794|12576153|FG001|STARTED|3-Month Assessment||173
11381876|NCT03433794|12576154|FG002|STARTED|3-Month Assessment||181
11381877|NCT03433794|12576152|FG000|COMPLETED|3-Month Assessment||69
11381878|NCT03433794|12576153|FG001|COMPLETED|3-Month Assessment||73
11381879|NCT03433794|12576154|FG002|COMPLETED|3-Month Assessment||71
11381880|NCT03433794|12576152|FG000|NOT COMPLETED|3-Month Assessment||114
11381881|NCT03433794|12576153|FG001|NOT COMPLETED|3-Month Assessment||100
11381882|NCT03433794|12576154|FG002|NOT COMPLETED|3-Month Assessment||110
11381883|NCT03433794|12576152|FG000|STARTED|6-Month Assessment||183
11381884|NCT03433794|12576153|FG001|STARTED|6-Month Assessment||173
11381885|NCT03433794|12576154|FG002|STARTED|6-Month Assessment||181
11381886|NCT03433794|12576152|FG000|COMPLETED|6-Month Assessment||65
11381887|NCT03433794|12576153|FG001|COMPLETED|6-Month Assessment||58
11381888|NCT03433794|12576154|FG002|COMPLETED|6-Month Assessment||50
11381889|NCT03433794|12576152|FG000|NOT COMPLETED|6-Month Assessment||118
11381890|NCT03433794|12576153|FG001|NOT COMPLETED|6-Month Assessment||115
11381891|NCT03433794|12576154|FG002|NOT COMPLETED|6-Month Assessment||131
11381892|NCT03433794|12576152|FG000|STARTED|9-Month Assessment||183
11381893|NCT03433794|12576153|FG001|STARTED|9-Month Assessment||173
11381894|NCT03433794|12576154|FG002|STARTED|9-Month Assessment||181
11381895|NCT03433794|12576152|FG000|COMPLETED|9-Month Assessment||49
11381896|NCT03433794|12576153|FG001|COMPLETED|9-Month Assessment||52
11381897|NCT03433794|12576154|FG002|COMPLETED|9-Month Assessment||39
11381898|NCT03433794|12576152|FG000|NOT COMPLETED|9-Month Assessment||134
11381899|NCT03433794|12576153|FG001|NOT COMPLETED|9-Month Assessment||121
11381900|NCT03433794|12576154|FG002|NOT COMPLETED|9-Month Assessment||142
11381901|NCT03434249|12576164|FG000|STARTED|Overall Study||40
11381902|NCT03434249|12576165|FG001|STARTED|Overall Study||40
11381903|NCT03434249|12576164|FG000|COMPLETED|Overall Study||35
11381904|NCT03434249|12576165|FG001|COMPLETED|Overall Study||37
11381905|NCT03434249|12576164|FG000|NOT COMPLETED|Overall Study||5
11381906|NCT03434249|12576165|FG001|NOT COMPLETED|Overall Study||3
11381907|NCT03434457|12576171|FG000|STARTED|Overall Study||630
11381908|NCT03434457|12576171|FG000|COMPLETED|Overall Study||630
11381909|NCT03434457|12576171|FG000|NOT COMPLETED|Overall Study||0
11381910|NCT03434834|12576175|FG000|STARTED|Overall Study||53
11381911|NCT03434834|12576175|FG000|COMPLETED|Overall Study||37
11381912|NCT03434834|12576175|FG000|NOT COMPLETED|Overall Study||16
11381913|NCT03434977|12576181|FG000|STARTED|Intervention Period 1 (6 Days)||6
11381914|NCT03434977|12576182|FG001|STARTED|Intervention Period 1 (6 Days)||6
11381915|NCT03434977|12576181|FG000|COMPLETED|Intervention Period 1 (6 Days)||6
11381916|NCT03434977|12576182|FG001|COMPLETED|Intervention Period 1 (6 Days)||6
11381917|NCT03434977|12576181|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
11381918|NCT03434977|12576182|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
11381919|NCT03434977|12576181|FG000|STARTED|Washout Period (at Least 6 Days)||6
11381920|NCT03434977|12576182|FG001|STARTED|Washout Period (at Least 6 Days)||6
11381921|NCT03434977|12576181|FG000|COMPLETED|Washout Period (at Least 6 Days)||6
11381922|NCT03434977|12576182|FG001|COMPLETED|Washout Period (at Least 6 Days)||5
11381923|NCT03434977|12576181|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0
11381924|NCT03434977|12576182|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1
11381925|NCT03434977|12576181|FG000|STARTED|Intervention Period 2 (6 Days)||6
11381926|NCT03434977|12576182|FG001|STARTED|Intervention Period 2 (6 Days)||5
11381927|NCT03434977|12576181|FG000|COMPLETED|Intervention Period 2 (6 Days)||6
11381928|NCT03434977|12576182|FG001|COMPLETED|Intervention Period 2 (6 Days)||5
11381929|NCT03434977|12576181|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
11381930|NCT03434977|12576182|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
11381931|NCT03435055|12576188|FG000|STARTED|Screening||21
11381932|NCT03435055|12576188|FG000|COMPLETED|Screening||19
11381933|NCT03435055|12576188|FG000|NOT COMPLETED|Screening||2
11381934|NCT03435055|12576188|FG000|STARTED|Received Intervention||19
11381935|NCT03435055|12576188|FG000|COMPLETED|Received Intervention||16
11381936|NCT03435055|12576188|FG000|NOT COMPLETED|Received Intervention||3
11381937|NCT03435211|12576199|FG000|STARTED|Overall Study||26
11381938|NCT03435211|12576199|FG000|COMPLETED|Overall Study||25
11381939|NCT03435211|12576199|FG000|NOT COMPLETED|Overall Study||1
11381940|NCT03435224|12576203|FG000|STARTED|Overall Study||29
11381941|NCT03435224|12576203|FG000|COMPLETED|Overall Study||25
11381942|NCT03435224|12576203|FG000|NOT COMPLETED|Overall Study||4
11381943|NCT03435497|12576209|FG000|STARTED|Overall Study||51
11381944|NCT03435497|12576210|FG001|STARTED|Overall Study||47
11381945|NCT03435497|12576209|FG000|COMPLETED|Overall Study||49
11381946|NCT03435497|12576210|FG001|COMPLETED|Overall Study||41
11381947|NCT03435497|12576209|FG000|NOT COMPLETED|Overall Study||2
11381948|NCT03435497|12576210|FG001|NOT COMPLETED|Overall Study||6
11381949|NCT03435562|12576216|FG000|STARTED|Overall Study||22
11381950|NCT03435562|12576216|FG000|COMPLETED|Overall Study||18
11381951|NCT03435562|12576216|FG000|NOT COMPLETED|Overall Study||4
11381952|NCT03435614|12576229|FG000|STARTED|Overall Study||6
11381953|NCT03435614|12576230|FG001|STARTED|Overall Study||23
11381954|NCT03435614|12576229|FG000|COMPLETED|Overall Study||6
11381955|NCT03435614|12576230|FG001|COMPLETED|Overall Study||23
11381956|NCT03435614|12576229|FG000|NOT COMPLETED|Overall Study||0
11381957|NCT03435614|12576230|FG001|NOT COMPLETED|Overall Study||0
11006052|NCT00726232|12183814|FG002|COMPLETED|Expansion Phase||0
11006053|NCT00726232|12183815|FG003|COMPLETED|Expansion Phase||0
11006054|NCT00726232|12183816|FG004|COMPLETED|Expansion Phase||0
11006055|NCT00726232|12183817|FG005|COMPLETED|Expansion Phase||0
11006056|NCT00726232|12183818|FG006|COMPLETED|Expansion Phase||10
11006057|NCT00726232|12183819|FG007|COMPLETED|Expansion Phase||1
11006058|NCT00726232|12183812|FG000|NOT COMPLETED|Expansion Phase||0
11006059|NCT00726232|12183813|FG001|NOT COMPLETED|Expansion Phase||0
11006060|NCT00726232|12183814|FG002|NOT COMPLETED|Expansion Phase||0
11006061|NCT00726232|12183815|FG003|NOT COMPLETED|Expansion Phase||0
11006062|NCT00726232|12183816|FG004|NOT COMPLETED|Expansion Phase||0
11006063|NCT00726232|12183817|FG005|NOT COMPLETED|Expansion Phase||0
11381958|NCT03435692|12576240|FG000|STARTED|Overall Study||17
11381959|NCT03435692|12576241|FG001|STARTED|Overall Study||18
11381960|NCT03435692|12576242|FG002|STARTED|Overall Study||7
11381961|NCT03435692|12576240|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 0, Lumbar Epidural Catheter (LEC) removed and morphine infusion started - patient 1 year old. 2) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 1, Lumbar Epidural Catheter (LEC) removed and Patient Controlled Analgesia (PCA) started.|15
11381962|NCT03435692|12576241|FG001|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Successful lumbar plexus injection, but unable to thread catheter, morphine infusion started (patient 1 year old). 2) Lumbar Plexus Catheter (LPC) catheter (10 cm) not long enough to reach lumbar plexus in patient weighing 136kg, Lumbar Epidural Catheter (LEC) placed instead.|16
11381963|NCT03435692|12576242|FG002|COMPLETED|Overall Study||7
11381964|NCT03435692|12576240|FG000|NOT COMPLETED|Overall Study||2
11381965|NCT03435692|12576241|FG001|NOT COMPLETED|Overall Study||2
11381966|NCT03435692|12576242|FG002|NOT COMPLETED|Overall Study||0
11381967|NCT03435783|12576256|FG000|STARTED|Overall Study||20
11381968|NCT03435783|12576257|FG001|STARTED|Overall Study||20
11381969|NCT03435783|12576256|FG000|COMPLETED|Overall Study||20
11381970|NCT03435783|12576257|FG001|COMPLETED|Overall Study||19
11381971|NCT03435783|12576256|FG000|NOT COMPLETED|Overall Study||0
11381972|NCT03435783|12576257|FG001|NOT COMPLETED|Overall Study||1
11381973|NCT03436082|12576265|FG000|STARTED|Overall Study||30
11381974|NCT03436082|12576266|FG001|STARTED|Overall Study||30
11381975|NCT03436082|12576265|FG000|COMPLETED|Overall Study|Had procedure|29
11381976|NCT03436082|12576266|FG001|COMPLETED|Overall Study|Had procedure|30
11381977|NCT03436082|12576265|FG000|NOT COMPLETED|Overall Study||1
11381978|NCT03436082|12576266|FG001|NOT COMPLETED|Overall Study||0
11381979|NCT03436147|12576274|FG000|STARTED|Overall Study||19
11381980|NCT03436147|12576275|FG001|STARTED|Overall Study||30
11381981|NCT03436147|12576274|FG000|COMPLETED|Overall Study||15
11381982|NCT03436147|12576275|FG001|COMPLETED|Overall Study||19
11381983|NCT03436147|12576274|FG000|NOT COMPLETED|Overall Study||4
11381984|NCT03436147|12576275|FG001|NOT COMPLETED|Overall Study||11
11381985|NCT03436420|12576283|FG000|STARTED|Overall Study||6
11381986|NCT03436420|12576283|FG000|COMPLETED|Overall Study||3
11381987|NCT03436420|12576283|FG000|NOT COMPLETED|Overall Study||3
11381988|NCT03436732|12576289|FG000|STARTED|Overall Study||4
11381989|NCT03436732|12576290|FG001|STARTED|Overall Study||1
11381990|NCT03436732|12576289|FG000|COMPLETED|Overall Study||0
11381991|NCT03436732|12576290|FG001|COMPLETED|Overall Study||0
11381992|NCT03436732|12576289|FG000|NOT COMPLETED|Overall Study||4
11381993|NCT03436732|12576290|FG001|NOT COMPLETED|Overall Study||1
11381994|NCT03436810|12576299|FG000|STARTED|Overall Study||20
11381995|NCT03436810|12576300|FG001|STARTED|Overall Study||20
11381996|NCT03436810|12576299|FG000|COMPLETED|Overall Study||20
11381997|NCT03436810|12576300|FG001|COMPLETED|Overall Study||20
11381998|NCT03436810|12576299|FG000|NOT COMPLETED|Overall Study||0
11381999|NCT03436810|12576300|FG001|NOT COMPLETED|Overall Study||0
11382000|NCT03437031|12576308|FG000|STARTED|Overall Study||19
11382001|NCT03437031|12576309|FG001|STARTED|Overall Study||21
11382002|NCT03437031|12576308|FG000|COMPLETED|Overall Study||19
11382003|NCT03437031|12576309|FG001|COMPLETED|Overall Study||21
11382004|NCT03437031|12576308|FG000|NOT COMPLETED|Overall Study||0
11382005|NCT03437031|12576309|FG001|NOT COMPLETED|Overall Study||0
11382006|NCT03437044|12576319|FG000|STARTED|Overall Study||20
11382007|NCT03437044|12576320|FG001|STARTED|Overall Study||20
11382008|NCT03437044|12576319|FG000|COMPLETED|Overall Study||17
11382009|NCT03437044|12576320|FG001|COMPLETED|Overall Study||18
11382010|NCT03437044|12576319|FG000|NOT COMPLETED|Overall Study||3
11382011|NCT03437044|12576320|FG001|NOT COMPLETED|Overall Study||2
11382012|NCT03437265|12576326|FG000|STARTED|Overall Study||19
11382013|NCT03437265|12576326|FG000|COMPLETED|Overall Study||13
11382014|NCT03437265|12576326|FG000|NOT COMPLETED|Overall Study||6
11382015|NCT03437447|12576333|FG000|STARTED|Treatment Period 1||20
11382016|NCT03437447|12576334|FG001|STARTED|Treatment Period 1||20
11382017|NCT03437447|12576335|FG002|STARTED|Treatment Period 1||20
11382018|NCT03437447|12576333|FG000|COMPLETED|Treatment Period 1||20
11382019|NCT03437447|12576334|FG001|COMPLETED|Treatment Period 1||20
11382020|NCT03437447|12576335|FG002|COMPLETED|Treatment Period 1||19
11382021|NCT03437447|12576333|FG000|NOT COMPLETED|Treatment Period 1||0
11382022|NCT03437447|12576334|FG001|NOT COMPLETED|Treatment Period 1||0
11382023|NCT03437447|12576335|FG002|NOT COMPLETED|Treatment Period 1||1
11382024|NCT03437447|12576333|FG000|STARTED|Treatment Period 2||20
11382025|NCT03437447|12576334|FG001|STARTED|Treatment Period 2||20
11382026|NCT03437447|12576335|FG002|STARTED|Treatment Period 2||19
11382027|NCT03437447|12576333|FG000|COMPLETED|Treatment Period 2||20
11382028|NCT03437447|12576334|FG001|COMPLETED|Treatment Period 2||20
11382029|NCT03437447|12576335|FG002|COMPLETED|Treatment Period 2||19
11382030|NCT03437447|12576333|FG000|NOT COMPLETED|Treatment Period 2||0
11382031|NCT03437447|12576334|FG001|NOT COMPLETED|Treatment Period 2||0
11382032|NCT03437447|12576335|FG002|NOT COMPLETED|Treatment Period 2||0
11382033|NCT03437447|12576333|FG000|STARTED|Treatment Period 3||20
11382034|NCT03437447|12576334|FG001|STARTED|Treatment Period 3||20
11382035|NCT03437447|12576335|FG002|STARTED|Treatment Period 3||19
11382036|NCT03437447|12576333|FG000|COMPLETED|Treatment Period 3||20
11382037|NCT03437447|12576334|FG001|COMPLETED|Treatment Period 3||20
11382038|NCT03437447|12576335|FG002|COMPLETED|Treatment Period 3||19
11382039|NCT03437447|12576333|FG000|NOT COMPLETED|Treatment Period 3||0
11382040|NCT03437447|12576334|FG001|NOT COMPLETED|Treatment Period 3||0
11382041|NCT03437447|12576335|FG002|NOT COMPLETED|Treatment Period 3||0
11382042|NCT03437512|12576345|FG000|STARTED|Randomized||12
11382043|NCT03437512|12576346|FG001|STARTED|Randomized||13
11382044|NCT03437512|12576345|FG000|COMPLETED|Randomized||12
11382045|NCT03437512|12576346|FG001|COMPLETED|Randomized||11
11382046|NCT03437512|12576345|FG000|NOT COMPLETED|Randomized||0
11382047|NCT03437512|12576346|FG001|NOT COMPLETED|Randomized||2
11382048|NCT03437512|12576345|FG000|STARTED|Received First tDCS Session||12
11382049|NCT03437512|12576346|FG001|STARTED|Received First tDCS Session||11
11382050|NCT03437512|12576345|FG000|COMPLETED|Received First tDCS Session||12
11382051|NCT03437512|12576346|FG001|COMPLETED|Received First tDCS Session||11
11382052|NCT03437512|12576345|FG000|NOT COMPLETED|Received First tDCS Session||0
11382053|NCT03437512|12576346|FG001|NOT COMPLETED|Received First tDCS Session||0
11382054|NCT03437512|12576345|FG000|STARTED|Received Final tDCS Session||12
11382055|NCT03437512|12576346|FG001|STARTED|Received Final tDCS Session||11
11382056|NCT03437512|12576345|FG000|COMPLETED|Received Final tDCS Session||12
11382057|NCT03437512|12576346|FG001|COMPLETED|Received Final tDCS Session||11
11382058|NCT03437512|12576345|FG000|NOT COMPLETED|Received Final tDCS Session||0
11382059|NCT03437512|12576346|FG001|NOT COMPLETED|Received Final tDCS Session||0
11382060|NCT03437512|12576345|FG000|STARTED|Completed Study Follow up||12
11382061|NCT03437512|12576346|FG001|STARTED|Completed Study Follow up||11
11382062|NCT03437512|12576345|FG000|COMPLETED|Completed Study Follow up||10
11382063|NCT03437512|12576346|FG001|COMPLETED|Completed Study Follow up||10
11382064|NCT03437512|12576345|FG000|NOT COMPLETED|Completed Study Follow up||2
11382065|NCT03437512|12576346|FG001|NOT COMPLETED|Completed Study Follow up||1
11382066|NCT03437564|12576354|FG000|STARTED|Overall Study||14
11382067|NCT03437564|12576355|FG001|STARTED|Overall Study||14
11382068|NCT03437564|12576354|FG000|COMPLETED|Overall Study||14
11382069|NCT03437564|12576355|FG001|COMPLETED|Overall Study||14
11382070|NCT03437564|12576354|FG000|NOT COMPLETED|Overall Study||0
11382071|NCT03437564|12576355|FG001|NOT COMPLETED|Overall Study||0
11382072|NCT03437577|12576364|FG000|STARTED|Pre-Randomization||0
11382073|NCT03437577|12576365|FG001|STARTED|Pre-Randomization||0
11382074|NCT03437577|12576366|FG002|STARTED|Pre-Randomization||10
11382075|NCT03437577|12576364|FG000|COMPLETED|Pre-Randomization||0
11382076|NCT03437577|12576365|FG001|COMPLETED|Pre-Randomization||0
11382077|NCT03437577|12576366|FG002|COMPLETED|Pre-Randomization||0
11382078|NCT03437577|12576364|FG000|NOT COMPLETED|Pre-Randomization||0
11382079|NCT03437577|12576365|FG001|NOT COMPLETED|Pre-Randomization||0
11382080|NCT03437577|12576366|FG002|NOT COMPLETED|Pre-Randomization||10
11382081|NCT03437577|12576364|FG000|STARTED|Post-Randomization||3
11382082|NCT03437577|12576365|FG001|STARTED|Post-Randomization||5
11382083|NCT03437577|12576366|FG002|STARTED|Post-Randomization||0
11382084|NCT03437577|12576364|FG000|COMPLETED|Post-Randomization||3
11382085|NCT03437577|12576365|FG001|COMPLETED|Post-Randomization||3
11382086|NCT03437577|12576366|FG002|COMPLETED|Post-Randomization||0
11382087|NCT03437577|12576364|FG000|NOT COMPLETED|Post-Randomization||0
11382088|NCT03437577|12576365|FG001|NOT COMPLETED|Post-Randomization||2
11382089|NCT03437577|12576366|FG002|NOT COMPLETED|Post-Randomization||0
11382090|NCT03437733|12576374|FG000|STARTED|Overall Study||8
11382091|NCT03437733|12576375|FG001|STARTED|Overall Study||90
11382092|NCT03437733|12576374|FG000|Safety|Overall Study||8
11382093|NCT03437733|12576375|FG001|Safety|Overall Study||87
11382094|NCT03437733|12576374|FG000|COMPLETED|Overall Study||8
11382095|NCT03437733|12576375|FG001|COMPLETED|Overall Study||87
11382096|NCT03437733|12576374|FG000|NOT COMPLETED|Overall Study||0
11382097|NCT03437733|12576375|FG001|NOT COMPLETED|Overall Study||3
11382098|NCT03437863|12576380|FG000|STARTED|Overall Study||12
11382099|NCT03437863|12576380|FG000|COMPLETED|Overall Study||12
11382100|NCT03437863|12576380|FG000|NOT COMPLETED|Overall Study||0
11382101|NCT03438006|12576384|FG000|STARTED|Overall Study||3013
11382102|NCT03438006|12576384|FG000|COMPLETED|Overall Study||2895
11382103|NCT03438006|12576384|FG000|NOT COMPLETED|Overall Study||118
11382104|NCT03438045|12576388|FG000|STARTED|Overall Study||75
11382105|NCT03438045|12576388|FG000|COMPLETED|Overall Study||75
11382106|NCT03438045|12576388|FG000|NOT COMPLETED|Overall Study||0
11382107|NCT03438266|12576392|FG000|STARTED|Overall Study||60
11382108|NCT03438266|12576392|FG000|COMPLETED|Overall Study||60
11382109|NCT03438266|12576392|FG000|NOT COMPLETED|Overall Study||0
11382110|NCT03438383|12576400|FG000|STARTED|Overall Study||23
11382111|NCT03438383|12576401|FG001|STARTED|Overall Study||24
11382112|NCT03438383|12576400|FG000|COMPLETED|Overall Study||14
11382113|NCT03438383|12576401|FG001|COMPLETED|Overall Study||21
11382114|NCT03438383|12576400|FG000|NOT COMPLETED|Overall Study||9
11382115|NCT03438383|12576401|FG001|NOT COMPLETED|Overall Study||3
11382116|NCT03438539|12576413|FG000|STARTED|Overall Study||76
11382117|NCT03438539|12576414|FG001|STARTED|Overall Study||72
11382118|NCT03438539|12576415|FG002|STARTED|Overall Study||76
11382119|NCT03438539|12576416|FG003|STARTED|Overall Study||73
11382120|NCT03438539|12576417|FG004|STARTED|Overall Study||73
11382121|NCT03438539|12576418|FG005|STARTED|Overall Study||74
11382122|NCT03438539|12576413|FG000|COMPLETED|Overall Study||68
11382123|NCT03438539|12576414|FG001|COMPLETED|Overall Study||68
11382124|NCT03438539|12576415|FG002|COMPLETED|Overall Study||66
11382125|NCT03438539|12576416|FG003|COMPLETED|Overall Study||64
11382126|NCT03438539|12576417|FG004|COMPLETED|Overall Study||70
11382127|NCT03438539|12576418|FG005|COMPLETED|Overall Study||66
11382128|NCT03438539|12576413|FG000|NOT COMPLETED|Overall Study||8
11382129|NCT03438539|12576414|FG001|NOT COMPLETED|Overall Study||4
11382130|NCT03438539|12576415|FG002|NOT COMPLETED|Overall Study||10
11382131|NCT03438539|12576416|FG003|NOT COMPLETED|Overall Study||9
11382132|NCT03438539|12576417|FG004|NOT COMPLETED|Overall Study||3
11382133|NCT03438539|12576418|FG005|NOT COMPLETED|Overall Study||8
11382134|NCT03438578|12576434|FG000|STARTED|Overall Study||100
11382135|NCT03438578|12576435|FG001|STARTED|Overall Study||100
11382136|NCT03438578|12576434|FG000|COMPLETED|Overall Study||99
11382137|NCT03438578|12576435|FG001|COMPLETED|Overall Study||96
11382138|NCT03438578|12576434|FG000|NOT COMPLETED|Overall Study||1
11382139|NCT03438578|12576435|FG001|NOT COMPLETED|Overall Study||4
11382140|NCT03439072|12576441|FG000|STARTED|Overall Study||41
11382141|NCT03439072|12576442|FG001|STARTED|Overall Study||40
11382142|NCT03439072|12576441|FG000|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39
11382143|NCT03439072|12576442|FG001|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36
11382144|NCT03439072|12576441|FG000|NOT COMPLETED|Overall Study||2
11382145|NCT03439072|12576442|FG001|NOT COMPLETED|Overall Study||4
11382146|NCT03439137|12576450|FG000|STARTED|Overall Study||162
11382147|NCT03439137|12576451|FG001|STARTED|Overall Study||161
11382148|NCT03439137|12576450|FG000|COMPLETED|Overall Study||120
11382149|NCT03439137|12576451|FG001|COMPLETED|Overall Study||135
11382150|NCT03439137|12576450|FG000|NOT COMPLETED|Overall Study||42
11382151|NCT03439137|12576451|FG001|NOT COMPLETED|Overall Study||26
11382152|NCT03439189|12576457|FG000|STARTED|Overall Study|Subjects performed at least one Methacetin Breath Test (MBT)|343
11382153|NCT03439189|12576457|FG000|COMPLETED|Overall Study||261
11382154|NCT03439189|12576457|FG000|NOT COMPLETED|Overall Study||82
11382155|NCT03440229|12576464|FG000|STARTED|Overall Study||9
11382156|NCT03440229|12576465|FG001|STARTED|Overall Study||7
11382157|NCT03440229|12576464|FG000|COMPLETED|Overall Study||9
11382158|NCT03440229|12576465|FG001|COMPLETED|Overall Study||7
11382159|NCT03440229|12576464|FG000|NOT COMPLETED|Overall Study||0
11382160|NCT03440229|12576465|FG001|NOT COMPLETED|Overall Study||0
11382161|NCT03440320|12576475|FG000|STARTED|Overall Study||18
11382162|NCT03440320|12576476|FG001|STARTED|Overall Study||14
11382163|NCT03440320|12576475|FG000|COMPLETED|Overall Study||18
11382164|NCT03440320|12576476|FG001|COMPLETED|Overall Study||13
11382165|NCT03440320|12576475|FG000|NOT COMPLETED|Overall Study||0
11382166|NCT03440320|12576476|FG001|NOT COMPLETED|Overall Study||1
11382167|NCT03440411|12576488|FG000|STARTED|Overall Study||3
11382168|NCT03440411|12576489|FG001|STARTED|Overall Study||1
11382169|NCT03440411|12576490|FG002|STARTED|Overall Study||2
11382170|NCT03440411|12576491|FG003|STARTED|Overall Study||2
11382171|NCT03440411|12576488|FG000|COMPLETED|Overall Study||0
11382172|NCT03440411|12576489|FG001|COMPLETED|Overall Study||0
11382173|NCT03440411|12576490|FG002|COMPLETED|Overall Study||0
11382174|NCT03440411|12576491|FG003|COMPLETED|Overall Study||0
11382175|NCT03440411|12576488|FG000|NOT COMPLETED|Overall Study||3
11382176|NCT03440411|12576489|FG001|NOT COMPLETED|Overall Study||1
11382177|NCT03440411|12576490|FG002|NOT COMPLETED|Overall Study||2
11382178|NCT03440411|12576491|FG003|NOT COMPLETED|Overall Study||2
11382179|NCT03440424|12576509|FG000|STARTED|Overall Study||8
11382180|NCT03440424|12576510|FG001|STARTED|Overall Study||8
11382181|NCT03440424|12576511|FG002|STARTED|Overall Study||8
11382182|NCT03440424|12576509|FG000|COMPLETED|Overall Study||8
11382183|NCT03440424|12576510|FG001|COMPLETED|Overall Study||8
11382184|NCT03440424|12576511|FG002|COMPLETED|Overall Study||8
11382185|NCT03440424|12576509|FG000|NOT COMPLETED|Overall Study||0
11382186|NCT03440424|12576510|FG001|NOT COMPLETED|Overall Study||0
11382187|NCT03440424|12576511|FG002|NOT COMPLETED|Overall Study||0
11382188|NCT03440619|12576519|FG000|STARTED|Overall Study||28
11382189|NCT03440619|12576519|FG000|COMPLETED|Overall Study||28
11382190|NCT03440619|12576519|FG000|NOT COMPLETED|Overall Study||0
11382191|NCT03440723|12576525|FG000|STARTED|Overall Study||21
11382192|NCT03440723|12576526|FG001|STARTED|Overall Study||21
11382193|NCT03440723|12576525|FG000|COMPLETED|Overall Study||21
11382194|NCT03440723|12576526|FG001|COMPLETED|Overall Study||21
11382195|NCT03440723|12576525|FG000|NOT COMPLETED|Overall Study||0
11382196|NCT03440723|12576526|FG001|NOT COMPLETED|Overall Study||0
11382197|NCT03440918|12576535|FG000|STARTED|Overall Study||133
11382198|NCT03440918|12576536|FG001|STARTED|Overall Study||138
11382199|NCT03440918|12576535|FG000|COMPLETED|Overall Study||133
11382200|NCT03440918|12576536|FG001|COMPLETED|Overall Study||122
11382201|NCT03440918|12576535|FG000|NOT COMPLETED|Overall Study||0
11382202|NCT03440918|12576536|FG001|NOT COMPLETED|Overall Study||16
11382203|NCT03440944|12576544|FG000|STARTED|Overall Study||9
11382204|NCT03440944|12576545|FG001|STARTED|Overall Study||9
11382205|NCT03440944|12576544|FG000|COMPLETED|Overall Study||8
11382206|NCT03440944|12576545|FG001|COMPLETED|Overall Study||8
11382207|NCT03440944|12576544|FG000|NOT COMPLETED|Overall Study||1
11382208|NCT03440944|12576545|FG001|NOT COMPLETED|Overall Study||1
11382209|NCT03441178|12576552|FG000|STARTED|Overall Study||36
11382210|NCT03441178|12576553|FG001|STARTED|Overall Study||44
11382211|NCT03441178|12576554|FG002|STARTED|Overall Study||21
11382212|NCT03441178|12576552|FG000|COMPLETED|Overall Study||36
11382213|NCT03441178|12576553|FG001|COMPLETED|Overall Study||43
11382214|NCT03441178|12576554|FG002|COMPLETED|Overall Study||20
11382215|NCT03441178|12576552|FG000|NOT COMPLETED|Overall Study||0
11382216|NCT03441178|12576553|FG001|NOT COMPLETED|Overall Study||1
11382217|NCT03441178|12576554|FG002|NOT COMPLETED|Overall Study||1
11382218|NCT03441269|12576567|FG000|STARTED|Overall Study||75
11382219|NCT03441269|12576568|FG001|STARTED|Overall Study||75
11382220|NCT03441269|12576569|FG002|STARTED|Overall Study||75
11382221|NCT03441269|12576567|FG000|COMPLETED|Overall Study||75
11382222|NCT03441269|12576568|FG001|COMPLETED|Overall Study||74
11382223|NCT03441269|12576569|FG002|COMPLETED|Overall Study||74
11382224|NCT03441269|12576567|FG000|NOT COMPLETED|Overall Study||0
11382225|NCT03441269|12576568|FG001|NOT COMPLETED|Overall Study||1
11382226|NCT03441269|12576569|FG002|NOT COMPLETED|Overall Study||1
11382227|NCT03441581|12576579|FG000|STARTED|Overall Study||12
11382228|NCT03441581|12576580|FG001|STARTED|Overall Study||12
11382229|NCT03441581|12576579|FG000|COMPLETED|Overall Study||12
11382230|NCT03441581|12576580|FG001|COMPLETED|Overall Study||12
11382231|NCT03441581|12576579|FG000|NOT COMPLETED|Overall Study||0
11382232|NCT03441581|12576580|FG001|NOT COMPLETED|Overall Study||0
11382233|NCT03441594|12576586|FG000|STARTED|Overall Study||56
11382234|NCT03441594|12576586|FG000|COMPLETED|Overall Study||56
11382235|NCT03441594|12576586|FG000|NOT COMPLETED|Overall Study||0
11382236|NCT03441633|12576600|FG000|STARTED|Overall Study||4712
11382237|NCT03441633|12576601|FG001|STARTED|Overall Study||1423
11382238|NCT03441633|12576602|FG002|STARTED|Overall Study||32212
11382239|NCT03441633|12576603|FG003|STARTED|Overall Study||192
11382240|NCT03441633|12576604|FG004|STARTED|Overall Study||2286
11382241|NCT03441633|12576605|FG005|STARTED|Overall Study||363
11382242|NCT03441633|12576606|FG006|STARTED|Overall Study||2855
11382243|NCT03441633|12576607|FG007|STARTED|Overall Study||953
11382244|NCT03441633|12576608|FG008|STARTED|Overall Study||5132
11382245|NCT03441633|12576609|FG009|STARTED|Overall Study||1562
11382246|NCT03441633|12576600|FG000|COMPLETED|Overall Study||4712
11382247|NCT03441633|12576601|FG001|COMPLETED|Overall Study||1423
11382248|NCT03441633|12576602|FG002|COMPLETED|Overall Study||32212
11382249|NCT03441633|12576603|FG003|COMPLETED|Overall Study||192
11382250|NCT03441633|12576604|FG004|COMPLETED|Overall Study||2286
11382251|NCT03441633|12576605|FG005|COMPLETED|Overall Study||363
11382252|NCT03441633|12576606|FG006|COMPLETED|Overall Study||2855
11382253|NCT03441633|12576607|FG007|COMPLETED|Overall Study||953
11382254|NCT03441633|12576608|FG008|COMPLETED|Overall Study||5132
11382255|NCT03441633|12576609|FG009|COMPLETED|Overall Study||1562
11382256|NCT03441633|12576600|FG000|NOT COMPLETED|Overall Study||0
11382257|NCT03441633|12576601|FG001|NOT COMPLETED|Overall Study||0
11382258|NCT03441633|12576602|FG002|NOT COMPLETED|Overall Study||0
11382259|NCT03441633|12576603|FG003|NOT COMPLETED|Overall Study||0
11382260|NCT03441633|12576604|FG004|NOT COMPLETED|Overall Study||0
11382261|NCT03441633|12576605|FG005|NOT COMPLETED|Overall Study||0
11382262|NCT03441633|12576606|FG006|NOT COMPLETED|Overall Study||0
11382263|NCT03441633|12576607|FG007|NOT COMPLETED|Overall Study||0
11382264|NCT03441633|12576608|FG008|NOT COMPLETED|Overall Study||0
11382265|NCT03441633|12576609|FG009|NOT COMPLETED|Overall Study||0
11382266|NCT03441789|12576637|FG000|STARTED|Overall Study||14
11382267|NCT03441789|12576638|FG001|STARTED|Overall Study||14
11382268|NCT03441789|12576637|FG000|COMPLETED|Overall Study||13
11382269|NCT03441789|12576638|FG001|COMPLETED|Overall Study||10
11382270|NCT03441789|12576637|FG000|NOT COMPLETED|Overall Study||1
11382271|NCT03441789|12576638|FG001|NOT COMPLETED|Overall Study||4
11382272|NCT03441984|12576646|FG000|STARTED|Part 1: Period 1 (Up to Day 4)||3
11382273|NCT03441984|12576647|FG001|STARTED|Part 1: Period 1 (Up to Day 4)||3
11382274|NCT03441984|12576648|FG002|STARTED|Part 1: Period 1 (Up to Day 4)||3
11382275|NCT03441984|12576649|FG003|STARTED|Part 1: Period 1 (Up to Day 4)||3
11382276|NCT03441984|12576650|FG004|STARTED|Part 1: Period 1 (Up to Day 4)||3
11382277|NCT03441984|12576651|FG005|STARTED|Part 1: Period 1 (Up to Day 4)||3
11382278|NCT03441984|12576652|FG006|STARTED|Part 1: Period 1 (Up to Day 4)||0
11382279|NCT03441984|12576653|FG007|STARTED|Part 1: Period 1 (Up to Day 4)||0
11382280|NCT03441984|12576654|FG008|STARTED|Part 1: Period 1 (Up to Day 4)||0
11382281|NCT03441984|12576655|FG009|STARTED|Part 1: Period 1 (Up to Day 4)||0
11382282|NCT03441984|12576656|FG010|STARTED|Part 1: Period 1 (Up to Day 4)||0
11382283|NCT03441984|12576657|FG011|STARTED|Part 1: Period 1 (Up to Day 4)||0
11382284|NCT03441984|12576646|FG000|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
11382285|NCT03441984|12576647|FG001|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
11382286|NCT03441984|12576648|FG002|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
11382287|NCT03441984|12576649|FG003|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
11382288|NCT03441984|12576650|FG004|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
11382289|NCT03441984|12576651|FG005|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
11382290|NCT03441984|12576652|FG006|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382291|NCT03441984|12576653|FG007|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382292|NCT03441984|12576654|FG008|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382293|NCT03441984|12576655|FG009|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382294|NCT03441984|12576656|FG010|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382295|NCT03441984|12576657|FG011|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382296|NCT03441984|12576646|FG000|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382297|NCT03441984|12576647|FG001|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382298|NCT03441984|12576648|FG002|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382299|NCT03441984|12576649|FG003|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382300|NCT03441984|12576650|FG004|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382301|NCT03441984|12576651|FG005|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382302|NCT03441984|12576652|FG006|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382303|NCT03441984|12576653|FG007|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382304|NCT03441984|12576654|FG008|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382305|NCT03441984|12576655|FG009|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382306|NCT03441984|12576656|FG010|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382307|NCT03441984|12576657|FG011|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
11382308|NCT03441984|12576646|FG000|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
11382309|NCT03441984|12576647|FG001|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
11382310|NCT03441984|12576648|FG002|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
11382311|NCT03441984|12576649|FG003|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
11382312|NCT03441984|12576650|FG004|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
11382313|NCT03441984|12576651|FG005|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
11382314|NCT03441984|12576652|FG006|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382315|NCT03441984|12576653|FG007|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382316|NCT03441984|12576654|FG008|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382317|NCT03441984|12576655|FG009|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382318|NCT03441984|12576656|FG010|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382319|NCT03441984|12576657|FG011|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382320|NCT03441984|12576646|FG000|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
11382321|NCT03441984|12576647|FG001|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
11382322|NCT03441984|12576648|FG002|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
11382323|NCT03441984|12576649|FG003|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
11382324|NCT03441984|12576650|FG004|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
11382325|NCT03441984|12576651|FG005|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
11382326|NCT03441984|12576652|FG006|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382327|NCT03441984|12576653|FG007|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382328|NCT03441984|12576654|FG008|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382329|NCT03441984|12576655|FG009|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382330|NCT03441984|12576656|FG010|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382331|NCT03441984|12576657|FG011|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382332|NCT03441984|12576646|FG000|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382333|NCT03441984|12576647|FG001|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382334|NCT03441984|12576648|FG002|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382335|NCT03441984|12576649|FG003|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382336|NCT03441984|12576650|FG004|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382337|NCT03441984|12576651|FG005|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382338|NCT03441984|12576652|FG006|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382339|NCT03441984|12576653|FG007|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382340|NCT03441984|12576654|FG008|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382341|NCT03441984|12576655|FG009|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382342|NCT03441984|12576656|FG010|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382343|NCT03441984|12576657|FG011|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
11382344|NCT03441984|12576646|FG000|STARTED|Part 1: Period 2 (Up to Day 4 )||3
11382345|NCT03441984|12576647|FG001|STARTED|Part 1: Period 2 (Up to Day 4 )||3
11382346|NCT03441984|12576648|FG002|STARTED|Part 1: Period 2 (Up to Day 4 )||3
11382347|NCT03441984|12576649|FG003|STARTED|Part 1: Period 2 (Up to Day 4 )||3
11382348|NCT03441984|12576650|FG004|STARTED|Part 1: Period 2 (Up to Day 4 )||3
11382349|NCT03441984|12576651|FG005|STARTED|Part 1: Period 2 (Up to Day 4 )||3
11382350|NCT03441984|12576652|FG006|STARTED|Part 1: Period 2 (Up to Day 4 )||0
11382351|NCT03441984|12576653|FG007|STARTED|Part 1: Period 2 (Up to Day 4 )||0
11382352|NCT03441984|12576654|FG008|STARTED|Part 1: Period 2 (Up to Day 4 )||0
11382353|NCT03441984|12576655|FG009|STARTED|Part 1: Period 2 (Up to Day 4 )||0
11382354|NCT03441984|12576656|FG010|STARTED|Part 1: Period 2 (Up to Day 4 )||0
11382355|NCT03441984|12576657|FG011|STARTED|Part 1: Period 2 (Up to Day 4 )||0
11382356|NCT03441984|12576646|FG000|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
11382357|NCT03441984|12576647|FG001|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
11382358|NCT03441984|12576648|FG002|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2
11382359|NCT03441984|12576649|FG003|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
11382360|NCT03441984|12576650|FG004|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
11382361|NCT03441984|12576651|FG005|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
11382362|NCT03441984|12576652|FG006|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382363|NCT03441984|12576653|FG007|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382364|NCT03441984|12576654|FG008|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382365|NCT03441984|12576655|FG009|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382366|NCT03441984|12576656|FG010|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382367|NCT03441984|12576657|FG011|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382368|NCT03441984|12576646|FG000|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382369|NCT03441984|12576647|FG001|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382370|NCT03441984|12576648|FG002|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1
11382371|NCT03441984|12576649|FG003|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382372|NCT03441984|12576650|FG004|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382373|NCT03441984|12576651|FG005|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382374|NCT03441984|12576652|FG006|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382375|NCT03441984|12576653|FG007|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382376|NCT03441984|12576654|FG008|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382377|NCT03441984|12576655|FG009|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382378|NCT03441984|12576656|FG010|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382379|NCT03441984|12576657|FG011|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
11382380|NCT03441984|12576646|FG000|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
11382381|NCT03441984|12576647|FG001|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
11382382|NCT03441984|12576648|FG002|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2
11382383|NCT03441984|12576649|FG003|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
11382384|NCT03441984|12576650|FG004|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
11382385|NCT03441984|12576651|FG005|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
11382386|NCT03441984|12576652|FG006|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382387|NCT03441984|12576653|FG007|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382388|NCT03441984|12576654|FG008|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382389|NCT03441984|12576655|FG009|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382390|NCT03441984|12576656|FG010|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382391|NCT03441984|12576657|FG011|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382392|NCT03441984|12576646|FG000|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
11382393|NCT03441984|12576647|FG001|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
11382394|NCT03441984|12576648|FG002|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2
11382395|NCT03441984|12576649|FG003|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
11382396|NCT03441984|12576650|FG004|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
11382397|NCT03441984|12576651|FG005|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
11382398|NCT03441984|12576652|FG006|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382399|NCT03441984|12576653|FG007|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382400|NCT03441984|12576654|FG008|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382401|NCT03441984|12576655|FG009|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382402|NCT03441984|12576656|FG010|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382403|NCT03441984|12576657|FG011|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382404|NCT03441984|12576646|FG000|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382405|NCT03441984|12576647|FG001|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382406|NCT03441984|12576648|FG002|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382407|NCT03441984|12576649|FG003|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382408|NCT03441984|12576650|FG004|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382409|NCT03441984|12576651|FG005|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382410|NCT03441984|12576652|FG006|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382411|NCT03441984|12576653|FG007|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382412|NCT03441984|12576654|FG008|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382413|NCT03441984|12576655|FG009|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382414|NCT03441984|12576656|FG010|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382415|NCT03441984|12576657|FG011|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
11382416|NCT03441984|12576646|FG000|STARTED|Part 1: Period 3 (Up to Day 4 )||3
11382417|NCT03441984|12576647|FG001|STARTED|Part 1: Period 3 (Up to Day 4 )||3
11382418|NCT03441984|12576648|FG002|STARTED|Part 1: Period 3 (Up to Day 4 )||2
11382419|NCT03441984|12576649|FG003|STARTED|Part 1: Period 3 (Up to Day 4 )||3
11382420|NCT03441984|12576650|FG004|STARTED|Part 1: Period 3 (Up to Day 4 )||3
11382421|NCT03441984|12576651|FG005|STARTED|Part 1: Period 3 (Up to Day 4 )||3
11382422|NCT03441984|12576652|FG006|STARTED|Part 1: Period 3 (Up to Day 4 )||0
11382423|NCT03441984|12576653|FG007|STARTED|Part 1: Period 3 (Up to Day 4 )||0
11382424|NCT03441984|12576654|FG008|STARTED|Part 1: Period 3 (Up to Day 4 )||0
11382425|NCT03441984|12576655|FG009|STARTED|Part 1: Period 3 (Up to Day 4 )||0
11382426|NCT03441984|12576656|FG010|STARTED|Part 1: Period 3 (Up to Day 4 )||0
11382427|NCT03441984|12576657|FG011|STARTED|Part 1: Period 3 (Up to Day 4 )||0
11382428|NCT03441984|12576646|FG000|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
11382429|NCT03441984|12576647|FG001|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
11382430|NCT03441984|12576648|FG002|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2
11382431|NCT03441984|12576649|FG003|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
11382432|NCT03441984|12576650|FG004|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
11382433|NCT03441984|12576651|FG005|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
11382434|NCT03441984|12576652|FG006|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382435|NCT03441984|12576653|FG007|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382436|NCT03441984|12576654|FG008|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382437|NCT03441984|12576655|FG009|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382438|NCT03441984|12576656|FG010|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382439|NCT03441984|12576657|FG011|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382440|NCT03441984|12576646|FG000|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382441|NCT03441984|12576647|FG001|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382442|NCT03441984|12576648|FG002|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382443|NCT03441984|12576649|FG003|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382444|NCT03441984|12576650|FG004|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382445|NCT03441984|12576651|FG005|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382446|NCT03441984|12576652|FG006|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382447|NCT03441984|12576653|FG007|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382448|NCT03441984|12576654|FG008|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382449|NCT03441984|12576655|FG009|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382450|NCT03441984|12576656|FG010|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382451|NCT03441984|12576657|FG011|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
11382452|NCT03441984|12576646|FG000|STARTED|Part 2: Period 1(Up to Day 4)||0
11382453|NCT03441984|12576647|FG001|STARTED|Part 2: Period 1(Up to Day 4)||0
11382454|NCT03441984|12576648|FG002|STARTED|Part 2: Period 1(Up to Day 4)||0
11382455|NCT03441984|12576649|FG003|STARTED|Part 2: Period 1(Up to Day 4)||0
11382456|NCT03441984|12576650|FG004|STARTED|Part 2: Period 1(Up to Day 4)||0
11382457|NCT03441984|12576651|FG005|STARTED|Part 2: Period 1(Up to Day 4)||0
11382458|NCT03441984|12576652|FG006|STARTED|Part 2: Period 1(Up to Day 4)||3
11382459|NCT03441984|12576653|FG007|STARTED|Part 2: Period 1(Up to Day 4)||3
11382460|NCT03441984|12576654|FG008|STARTED|Part 2: Period 1(Up to Day 4)||3
11382461|NCT03441984|12576655|FG009|STARTED|Part 2: Period 1(Up to Day 4)||3
11382462|NCT03441984|12576656|FG010|STARTED|Part 2: Period 1(Up to Day 4)||3
11382463|NCT03441984|12576657|FG011|STARTED|Part 2: Period 1(Up to Day 4)||3
11382464|NCT03441984|12576646|FG000|COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382465|NCT03441984|12576647|FG001|COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382466|NCT03441984|12576648|FG002|COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382467|NCT03441984|12576649|FG003|COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382468|NCT03441984|12576650|FG004|COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382469|NCT03441984|12576651|FG005|COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382470|NCT03441984|12576652|FG006|COMPLETED|Part 2: Period 1(Up to Day 4)||3
11382471|NCT03441984|12576653|FG007|COMPLETED|Part 2: Period 1(Up to Day 4)||3
11382472|NCT03441984|12576654|FG008|COMPLETED|Part 2: Period 1(Up to Day 4)||3
11382473|NCT03441984|12576655|FG009|COMPLETED|Part 2: Period 1(Up to Day 4)||3
11382474|NCT03441984|12576656|FG010|COMPLETED|Part 2: Period 1(Up to Day 4)||3
11382475|NCT03441984|12576657|FG011|COMPLETED|Part 2: Period 1(Up to Day 4)||3
11382476|NCT03441984|12576646|FG000|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382477|NCT03441984|12576647|FG001|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382478|NCT03441984|12576648|FG002|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382479|NCT03441984|12576649|FG003|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382480|NCT03441984|12576650|FG004|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382481|NCT03441984|12576651|FG005|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382482|NCT03441984|12576652|FG006|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382483|NCT03441984|12576653|FG007|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382484|NCT03441984|12576654|FG008|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382485|NCT03441984|12576655|FG009|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382486|NCT03441984|12576656|FG010|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382487|NCT03441984|12576657|FG011|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
11382488|NCT03441984|12576646|FG000|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382489|NCT03441984|12576647|FG001|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382490|NCT03441984|12576648|FG002|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382491|NCT03441984|12576649|FG003|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382492|NCT03441984|12576650|FG004|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382493|NCT03441984|12576651|FG005|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382494|NCT03441984|12576652|FG006|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
11382495|NCT03441984|12576653|FG007|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
11382496|NCT03441984|12576654|FG008|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
11382497|NCT03441984|12576655|FG009|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
11382498|NCT03441984|12576656|FG010|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
11382499|NCT03441984|12576657|FG011|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
11382500|NCT03441984|12576646|FG000|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382501|NCT03441984|12576647|FG001|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382502|NCT03441984|12576648|FG002|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382503|NCT03441984|12576649|FG003|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382504|NCT03441984|12576650|FG004|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382505|NCT03441984|12576651|FG005|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382506|NCT03441984|12576652|FG006|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
11382507|NCT03441984|12576653|FG007|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
11382508|NCT03441984|12576654|FG008|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
11382509|NCT03441984|12576655|FG009|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
11382510|NCT03441984|12576656|FG010|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
11382511|NCT03441984|12576657|FG011|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
11382512|NCT03441984|12576646|FG000|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382513|NCT03441984|12576647|FG001|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382514|NCT03441984|12576648|FG002|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382515|NCT03441984|12576649|FG003|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382516|NCT03441984|12576650|FG004|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382517|NCT03441984|12576651|FG005|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382518|NCT03441984|12576652|FG006|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382519|NCT03441984|12576653|FG007|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382520|NCT03441984|12576654|FG008|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382521|NCT03441984|12576655|FG009|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382522|NCT03441984|12576656|FG010|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382523|NCT03441984|12576657|FG011|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
11382524|NCT03441984|12576646|FG000|STARTED|Part 2: Period 2 (Up to Day 4)||0
11382525|NCT03441984|12576647|FG001|STARTED|Part 2: Period 2 (Up to Day 4)||0
11382526|NCT03441984|12576648|FG002|STARTED|Part 2: Period 2 (Up to Day 4)||0
11382527|NCT03441984|12576649|FG003|STARTED|Part 2: Period 2 (Up to Day 4)||0
11382528|NCT03441984|12576650|FG004|STARTED|Part 2: Period 2 (Up to Day 4)||0
11382529|NCT03441984|12576651|FG005|STARTED|Part 2: Period 2 (Up to Day 4)||0
11382530|NCT03441984|12576652|FG006|STARTED|Part 2: Period 2 (Up to Day 4)||3
11382531|NCT03441984|12576653|FG007|STARTED|Part 2: Period 2 (Up to Day 4)||3
11382532|NCT03441984|12576654|FG008|STARTED|Part 2: Period 2 (Up to Day 4)||3
11382533|NCT03441984|12576655|FG009|STARTED|Part 2: Period 2 (Up to Day 4)||3
11382534|NCT03441984|12576656|FG010|STARTED|Part 2: Period 2 (Up to Day 4)||3
11382535|NCT03441984|12576657|FG011|STARTED|Part 2: Period 2 (Up to Day 4)||3
11382536|NCT03441984|12576646|FG000|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382537|NCT03441984|12576647|FG001|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382538|NCT03441984|12576648|FG002|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382539|NCT03441984|12576649|FG003|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382540|NCT03441984|12576650|FG004|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382541|NCT03441984|12576651|FG005|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382542|NCT03441984|12576652|FG006|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
11382543|NCT03441984|12576653|FG007|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
11382544|NCT03441984|12576654|FG008|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
11382545|NCT03441984|12576655|FG009|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
11382546|NCT03441984|12576656|FG010|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
11382547|NCT03441984|12576657|FG011|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
11382548|NCT03441984|12576646|FG000|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382549|NCT03441984|12576647|FG001|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382550|NCT03441984|12576648|FG002|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382551|NCT03441984|12576649|FG003|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382552|NCT03441984|12576650|FG004|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382553|NCT03441984|12576651|FG005|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382554|NCT03441984|12576652|FG006|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382555|NCT03441984|12576653|FG007|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382556|NCT03441984|12576654|FG008|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382557|NCT03441984|12576655|FG009|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382558|NCT03441984|12576656|FG010|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382559|NCT03441984|12576657|FG011|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
11382560|NCT03441984|12576646|FG000|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382561|NCT03441984|12576647|FG001|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382562|NCT03441984|12576648|FG002|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382563|NCT03441984|12576649|FG003|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382564|NCT03441984|12576650|FG004|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382565|NCT03441984|12576651|FG005|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382566|NCT03441984|12576652|FG006|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
11382567|NCT03441984|12576653|FG007|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
11382568|NCT03441984|12576654|FG008|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
11382569|NCT03441984|12576655|FG009|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
11382570|NCT03441984|12576656|FG010|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
11382571|NCT03441984|12576657|FG011|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
11382572|NCT03441984|12576646|FG000|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382573|NCT03441984|12576647|FG001|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382574|NCT03441984|12576648|FG002|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382575|NCT03441984|12576649|FG003|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382576|NCT03441984|12576650|FG004|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382577|NCT03441984|12576651|FG005|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382578|NCT03441984|12576652|FG006|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
11382579|NCT03441984|12576653|FG007|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
11382580|NCT03441984|12576654|FG008|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
11382581|NCT03441984|12576655|FG009|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
11382582|NCT03441984|12576656|FG010|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
11382583|NCT03441984|12576657|FG011|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
11382584|NCT03441984|12576646|FG000|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382585|NCT03441984|12576647|FG001|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382586|NCT03441984|12576648|FG002|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382587|NCT03441984|12576649|FG003|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382588|NCT03441984|12576650|FG004|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382589|NCT03441984|12576651|FG005|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382590|NCT03441984|12576652|FG006|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382591|NCT03441984|12576653|FG007|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382592|NCT03441984|12576654|FG008|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382593|NCT03441984|12576655|FG009|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382594|NCT03441984|12576656|FG010|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382595|NCT03441984|12576657|FG011|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
11382596|NCT03441984|12576646|FG000|STARTED|Part 2: Period 3 (Up to Day 4)||0
11382597|NCT03441984|12576647|FG001|STARTED|Part 2: Period 3 (Up to Day 4)||0
11382598|NCT03441984|12576648|FG002|STARTED|Part 2: Period 3 (Up to Day 4)||0
11382599|NCT03441984|12576649|FG003|STARTED|Part 2: Period 3 (Up to Day 4)||0
11382600|NCT03441984|12576650|FG004|STARTED|Part 2: Period 3 (Up to Day 4)||0
11382601|NCT03441984|12576651|FG005|STARTED|Part 2: Period 3 (Up to Day 4)||0
11382602|NCT03441984|12576652|FG006|STARTED|Part 2: Period 3 (Up to Day 4)||3
11382603|NCT03441984|12576653|FG007|STARTED|Part 2: Period 3 (Up to Day 4)||3
11382604|NCT03441984|12576654|FG008|STARTED|Part 2: Period 3 (Up to Day 4)||3
11382605|NCT03441984|12576655|FG009|STARTED|Part 2: Period 3 (Up to Day 4)||3
11382606|NCT03441984|12576656|FG010|STARTED|Part 2: Period 3 (Up to Day 4)||3
11382607|NCT03441984|12576657|FG011|STARTED|Part 2: Period 3 (Up to Day 4)||3
11382608|NCT03441984|12576646|FG000|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382609|NCT03441984|12576647|FG001|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382610|NCT03441984|12576648|FG002|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382611|NCT03441984|12576649|FG003|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382612|NCT03441984|12576650|FG004|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382613|NCT03441984|12576651|FG005|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382614|NCT03441984|12576652|FG006|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
11382615|NCT03441984|12576653|FG007|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
11382616|NCT03441984|12576654|FG008|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
11382617|NCT03441984|12576655|FG009|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
11382618|NCT03441984|12576656|FG010|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
11382619|NCT03441984|12576657|FG011|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
11382620|NCT03441984|12576646|FG000|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382621|NCT03441984|12576647|FG001|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382622|NCT03441984|12576648|FG002|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382623|NCT03441984|12576649|FG003|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382624|NCT03441984|12576650|FG004|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382625|NCT03441984|12576651|FG005|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382626|NCT03441984|12576652|FG006|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382627|NCT03441984|12576653|FG007|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382628|NCT03441984|12576654|FG008|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382629|NCT03441984|12576655|FG009|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382630|NCT03441984|12576656|FG010|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382631|NCT03441984|12576657|FG011|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
11382632|NCT03442036|12576674|FG000|STARTED|Overall Study||35
11382633|NCT03442036|12576675|FG001|STARTED|Overall Study||35
11382634|NCT03442036|12576674|FG000|COMPLETED|Overall Study||35
11382635|NCT03442036|12576675|FG001|COMPLETED|Overall Study||35
11382636|NCT03442036|12576674|FG000|NOT COMPLETED|Overall Study||0
11382637|NCT03442036|12576675|FG001|NOT COMPLETED|Overall Study||0
11382638|NCT03442296|12576685|FG000|STARTED|3 Month Follow-up||78
11382639|NCT03442296|12576686|FG001|STARTED|3 Month Follow-up||73
11382640|NCT03442296|12576685|FG000|COMPLETED|3 Month Follow-up||73
11382641|NCT03442296|12576686|FG001|COMPLETED|3 Month Follow-up||70
11382642|NCT03442296|12576685|FG000|NOT COMPLETED|3 Month Follow-up||5
11382643|NCT03442296|12576686|FG001|NOT COMPLETED|3 Month Follow-up||3
11382644|NCT03442296|12576685|FG000|STARTED|12 Month Follow-up|15 participants in the immediate group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (6), or withdrew consent (6)|58
11382645|NCT03442296|12576686|FG001|STARTED|12 Month Follow-up|18 participants in the delayed group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (5), or withdrew consent (10)|52
11382646|NCT03442296|12576685|FG000|COMPLETED|12 Month Follow-up||57
11382647|NCT03442296|12576686|FG001|COMPLETED|12 Month Follow-up||51
11382648|NCT03442296|12576685|FG000|NOT COMPLETED|12 Month Follow-up||1
11382649|NCT03442296|12576686|FG001|NOT COMPLETED|12 Month Follow-up||1
11382650|NCT03442569|12576692|FG000|STARTED|Overall Study||56
11382651|NCT03442569|12576692|FG000|Started Treatment|Overall Study||55
11382652|NCT03442569|12576692|FG000|COMPLETED|Overall Study||55
11382653|NCT03442569|12576692|FG000|NOT COMPLETED|Overall Study||1
11382654|NCT03442595|12576698|FG000|STARTED|Overall Study||460
11382655|NCT03442595|12576699|FG001|STARTED|Overall Study||366
11382656|NCT03442595|12576698|FG000|COMPLETED|Overall Study||366
11382657|NCT03442595|12576699|FG001|COMPLETED|Overall Study||366
11382658|NCT03442595|12576698|FG000|NOT COMPLETED|Overall Study||94
11382659|NCT03442595|12576699|FG001|NOT COMPLETED|Overall Study||0
11382660|NCT03442699|12576704|FG000|STARTED|Overall Study||6
11382661|NCT03442699|12576704|FG000|COMPLETED|Overall Study||6
11382662|NCT03442699|12576704|FG000|NOT COMPLETED|Overall Study||0
11382663|NCT03442725|12576712|FG000|STARTED|Overall Study||8
11382664|NCT03442725|12576713|FG001|STARTED|Overall Study||8
11382665|NCT03442725|12576712|FG000|COMPLETED|Overall Study||8
11382666|NCT03442725|12576713|FG001|COMPLETED|Overall Study||8
11382667|NCT03442725|12576712|FG000|NOT COMPLETED|Overall Study||0
11382668|NCT03442725|12576713|FG001|NOT COMPLETED|Overall Study||0
11382669|NCT03442777|12576722|FG000|STARTED|Overall Study|All participants received at least 1 dressing|542
11382670|NCT03442777|12576723|FG001|STARTED|Overall Study|One participant received one Allevyn® Life dressing (wrong brand by mistake), besides 13 Mepilex® Border on sacrum, (0.2%) All participants received at least 1 dressing|545
11382671|NCT03442777|12576724|FG002|STARTED|Overall Study|No participants received dressings|546
11382672|NCT03442777|12576722|FG000|COMPLETED|Overall Study||534
11382673|NCT03442777|12576723|FG001|COMPLETED|Overall Study||532
11382674|NCT03442777|12576724|FG002|COMPLETED|Overall Study||539
11382675|NCT03442777|12576722|FG000|NOT COMPLETED|Overall Study||8
11382676|NCT03442777|12576723|FG001|NOT COMPLETED|Overall Study||13
11382677|NCT03442777|12576724|FG002|NOT COMPLETED|Overall Study||7
11382678|NCT03442829|12576732|FG000|STARTED|Overall Study||27
11382679|NCT03442829|12576733|FG001|STARTED|Overall Study||27
11382680|NCT03442829|12576732|FG000|COMPLETED|Overall Study||23
11382681|NCT03442829|12576733|FG001|COMPLETED|Overall Study||25
11382682|NCT03442829|12576732|FG000|NOT COMPLETED|Overall Study||4
11382683|NCT03442829|12576733|FG001|NOT COMPLETED|Overall Study||2
11382684|NCT03442868|12576739|FG000|STARTED|Overall Study||15
11382685|NCT03442868|12576739|FG000|COMPLETED|Overall Study||15
11382686|NCT03442868|12576739|FG000|NOT COMPLETED|Overall Study||0
11382687|NCT03442933|12576743|FG000|STARTED|Overall Study||20
11382688|NCT03442933|12576744|FG001|STARTED|Overall Study||20
11382689|NCT03442933|12576743|FG000|COMPLETED|Overall Study||20
11382690|NCT03442933|12576744|FG001|COMPLETED|Overall Study||20
11382691|NCT03442933|12576743|FG000|NOT COMPLETED|Overall Study||0
11382692|NCT03442933|12576744|FG001|NOT COMPLETED|Overall Study||0
11382693|NCT03443024|12576757|FG000|STARTED|Overall Study||73
11382694|NCT03443024|12576758|FG001|STARTED|Overall Study||80
11382695|NCT03443024|12576759|FG002|STARTED|Overall Study||75
11382696|NCT03443024|12576760|FG003|STARTED|Overall Study||52
11382697|NCT03443024|12576757|FG000|Received at Least One Dose of Study Drug|Overall Study||73
11382698|NCT03443024|12576758|FG001|Received at Least One Dose of Study Drug|Overall Study||80
11382699|NCT03443024|12576759|FG002|Received at Least One Dose of Study Drug|Overall Study||75
11382700|NCT03443024|12576760|FG003|Received at Least One Dose of Study Drug|Overall Study||52
11382701|NCT03443024|12576757|FG000|COMPLETED|Overall Study||52
11382702|NCT03443024|12576758|FG001|COMPLETED|Overall Study||49
11382703|NCT03443024|12576759|FG002|COMPLETED|Overall Study||56
11382704|NCT03443024|12576760|FG003|COMPLETED|Overall Study||20
11382705|NCT03443024|12576757|FG000|NOT COMPLETED|Overall Study||21
11382706|NCT03443024|12576758|FG001|NOT COMPLETED|Overall Study||31
11382707|NCT03443024|12576759|FG002|NOT COMPLETED|Overall Study||19
11382708|NCT03443024|12576760|FG003|NOT COMPLETED|Overall Study||32
11382709|NCT03443063|12576772|FG000|STARTED|Overall Study||8
11382710|NCT03443063|12576773|FG001|STARTED|Overall Study||8
11382711|NCT03443063|12576772|FG000|COMPLETED|Overall Study||8
11382712|NCT03443063|12576773|FG001|COMPLETED|Overall Study||8
11382713|NCT03443063|12576772|FG000|NOT COMPLETED|Overall Study||0
11382714|NCT03443063|12576773|FG001|NOT COMPLETED|Overall Study||0
11382715|NCT03443414|12576786|FG000|STARTED|Overall Study||82
11382716|NCT03443414|12576787|FG001|STARTED|Overall Study||81
11382717|NCT03443414|12576788|FG002|STARTED|Overall Study||82
11382718|NCT03443414|12576789|FG003|STARTED|Overall Study||80
11382719|NCT03443414|12576790|FG004|STARTED|Overall Study||80
11382720|NCT03443414|12576786|FG000|Received Treatment|Overall Study||81
11382721|NCT03443414|12576787|FG001|Received Treatment|Overall Study||81
11382722|NCT03443414|12576788|FG002|Received Treatment|Overall Study||82
11382723|NCT03443414|12576789|FG003|Received Treatment|Overall Study||80
11382724|NCT03443414|12576790|FG004|Received Treatment|Overall Study||79
11382725|NCT03443414|12576786|FG000|COMPLETED|Overall Study||71
11382726|NCT03443414|12576787|FG001|COMPLETED|Overall Study||78
11382727|NCT03443414|12576788|FG002|COMPLETED|Overall Study||76
11382728|NCT03443414|12576789|FG003|COMPLETED|Overall Study||75
11382729|NCT03443414|12576790|FG004|COMPLETED|Overall Study||75
11382730|NCT03443414|12576786|FG000|NOT COMPLETED|Overall Study||11
11382731|NCT03443414|12576787|FG001|NOT COMPLETED|Overall Study||3
11382732|NCT03443414|12576788|FG002|NOT COMPLETED|Overall Study||6
11382733|NCT03443414|12576789|FG003|NOT COMPLETED|Overall Study||5
11382734|NCT03443414|12576790|FG004|NOT COMPLETED|Overall Study||5
11382735|NCT03443427|12576804|FG000|STARTED|Overall Study||100
11382736|NCT03443427|12576805|FG001|STARTED|Overall Study||100
11382737|NCT03443427|12576804|FG000|COMPLETED|Overall Study||88
11382738|NCT03443427|12576805|FG001|COMPLETED|Overall Study||89
11382739|NCT03443427|12576804|FG000|NOT COMPLETED|Overall Study||12
11382740|NCT03443427|12576805|FG001|NOT COMPLETED|Overall Study||11
11382741|NCT03443713|12576814|FG000|STARTED|Start up Visit (2 Hours)||8
11382742|NCT03443713|12576815|FG001|STARTED|Start up Visit (2 Hours)||8
11382743|NCT03443713|12576816|FG002|STARTED|Start up Visit (2 Hours)||9
11382744|NCT03443713|12576814|FG000|COMPLETED|Start up Visit (2 Hours)||8
11382745|NCT03443713|12576815|FG001|COMPLETED|Start up Visit (2 Hours)||8
11382746|NCT03443713|12576816|FG002|COMPLETED|Start up Visit (2 Hours)||9
11382747|NCT03443713|12576814|FG000|NOT COMPLETED|Start up Visit (2 Hours)||0
11382748|NCT03443713|12576815|FG001|NOT COMPLETED|Start up Visit (2 Hours)||0
11382749|NCT03443713|12576816|FG002|NOT COMPLETED|Start up Visit (2 Hours)||0
11382750|NCT03443713|12576814|FG000|STARTED|First at Home Period (9-14 Days)||8
11382751|NCT03443713|12576815|FG001|STARTED|First at Home Period (9-14 Days)||8
11382752|NCT03443713|12576816|FG002|STARTED|First at Home Period (9-14 Days)||9
11382753|NCT03443713|12576814|FG000|COMPLETED|First at Home Period (9-14 Days)||8
11382754|NCT03443713|12576815|FG001|COMPLETED|First at Home Period (9-14 Days)||8
11382755|NCT03443713|12576816|FG002|COMPLETED|First at Home Period (9-14 Days)||8
11382756|NCT03443713|12576814|FG000|NOT COMPLETED|First at Home Period (9-14 Days)||0
11382757|NCT03443713|12576815|FG001|NOT COMPLETED|First at Home Period (9-14 Days)||0
11382758|NCT03443713|12576816|FG002|NOT COMPLETED|First at Home Period (9-14 Days)||1
11382759|NCT03443713|12576814|FG000|STARTED|First Exercise Visit (1 Hour)||8
11382760|NCT03443713|12576815|FG001|STARTED|First Exercise Visit (1 Hour)||8
11382761|NCT03443713|12576816|FG002|STARTED|First Exercise Visit (1 Hour)||8
11382762|NCT03443713|12576814|FG000|COMPLETED|First Exercise Visit (1 Hour)||8
11382763|NCT03443713|12576815|FG001|COMPLETED|First Exercise Visit (1 Hour)||8
11382764|NCT03443713|12576816|FG002|COMPLETED|First Exercise Visit (1 Hour)||8
11382765|NCT03443713|12576814|FG000|NOT COMPLETED|First Exercise Visit (1 Hour)||0
11382766|NCT03443713|12576815|FG001|NOT COMPLETED|First Exercise Visit (1 Hour)||0
11382767|NCT03443713|12576816|FG002|NOT COMPLETED|First Exercise Visit (1 Hour)||0
11382768|NCT03443713|12576814|FG000|STARTED|Dexcom Insertion Visit (30 Minutes)||8
11382769|NCT03443713|12576815|FG001|STARTED|Dexcom Insertion Visit (30 Minutes)||8
11382770|NCT03443713|12576816|FG002|STARTED|Dexcom Insertion Visit (30 Minutes)||8
11382771|NCT03443713|12576814|FG000|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
11382772|NCT03443713|12576815|FG001|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
11382773|NCT03443713|12576816|FG002|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
11382774|NCT03443713|12576814|FG000|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
11382775|NCT03443713|12576815|FG001|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
11382776|NCT03443713|12576816|FG002|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
11382777|NCT03443713|12576814|FG000|STARTED|Second at Home Period (2-11 Days)||8
11382778|NCT03443713|12576815|FG001|STARTED|Second at Home Period (2-11 Days)||8
11382779|NCT03443713|12576816|FG002|STARTED|Second at Home Period (2-11 Days)||8
11382780|NCT03443713|12576814|FG000|COMPLETED|Second at Home Period (2-11 Days)||8
11382781|NCT03443713|12576815|FG001|COMPLETED|Second at Home Period (2-11 Days)||8
11382782|NCT03443713|12576816|FG002|COMPLETED|Second at Home Period (2-11 Days)||8
11382783|NCT03443713|12576814|FG000|NOT COMPLETED|Second at Home Period (2-11 Days)||0
11382784|NCT03443713|12576815|FG001|NOT COMPLETED|Second at Home Period (2-11 Days)||0
11382785|NCT03443713|12576816|FG002|NOT COMPLETED|Second at Home Period (2-11 Days)||0
11382786|NCT03443713|12576814|FG000|STARTED|Second Exercise Visit (1 Hour)||8
11382787|NCT03443713|12576815|FG001|STARTED|Second Exercise Visit (1 Hour)||8
11382788|NCT03443713|12576816|FG002|STARTED|Second Exercise Visit (1 Hour)||8
11382789|NCT03443713|12576814|FG000|COMPLETED|Second Exercise Visit (1 Hour)||8
11382790|NCT03443713|12576815|FG001|COMPLETED|Second Exercise Visit (1 Hour)||8
11382791|NCT03443713|12576816|FG002|COMPLETED|Second Exercise Visit (1 Hour)||8
11382792|NCT03443713|12576814|FG000|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
11382793|NCT03443713|12576815|FG001|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
11382794|NCT03443713|12576816|FG002|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
11382795|NCT03443713|12576814|FG000|STARTED|Third at Home Period (8-12 Days)||8
11382796|NCT03443713|12576815|FG001|STARTED|Third at Home Period (8-12 Days)||8
11382797|NCT03443713|12576816|FG002|STARTED|Third at Home Period (8-12 Days)||8
11382798|NCT03443713|12576814|FG000|COMPLETED|Third at Home Period (8-12 Days)||8
11382799|NCT03443713|12576815|FG001|COMPLETED|Third at Home Period (8-12 Days)||8
11382800|NCT03443713|12576816|FG002|COMPLETED|Third at Home Period (8-12 Days)||8
11382801|NCT03443713|12576814|FG000|NOT COMPLETED|Third at Home Period (8-12 Days)||0
11382802|NCT03443713|12576815|FG001|NOT COMPLETED|Third at Home Period (8-12 Days)||0
11382803|NCT03443713|12576816|FG002|NOT COMPLETED|Third at Home Period (8-12 Days)||0
11382804|NCT03443713|12576814|FG000|STARTED|Close-out Visit (30 Minutes)||8
11382805|NCT03443713|12576815|FG001|STARTED|Close-out Visit (30 Minutes)||8
11382806|NCT03443713|12576816|FG002|STARTED|Close-out Visit (30 Minutes)||8
11382807|NCT03443713|12576814|FG000|COMPLETED|Close-out Visit (30 Minutes)||8
11382808|NCT03443713|12576815|FG001|COMPLETED|Close-out Visit (30 Minutes)||8
11382809|NCT03443713|12576816|FG002|COMPLETED|Close-out Visit (30 Minutes)||8
11382810|NCT03443713|12576814|FG000|NOT COMPLETED|Close-out Visit (30 Minutes)||0
11382811|NCT03443713|12576815|FG001|NOT COMPLETED|Close-out Visit (30 Minutes)||0
11382812|NCT03443713|12576816|FG002|NOT COMPLETED|Close-out Visit (30 Minutes)||0
11382813|NCT03444090|12576830|FG000|STARTED|Overall Study||214
11382814|NCT03444090|12576831|FG001|STARTED|Overall Study||214
11382815|NCT03444090|12576830|FG000|COMPLETED|Overall Study||211
11382816|NCT03444090|12576831|FG001|COMPLETED|Overall Study||210
11382817|NCT03444090|12576830|FG000|NOT COMPLETED|Overall Study||3
11382818|NCT03444090|12576831|FG001|NOT COMPLETED|Overall Study||4
11382819|NCT03444155|12576839|FG000|STARTED|First Intervention (6 Weeks)||15
11382820|NCT03444155|12576840|FG001|STARTED|First Intervention (6 Weeks)||15
11382821|NCT03444155|12576839|FG000|COMPLETED|First Intervention (6 Weeks)||14
11382822|NCT03444155|12576840|FG001|COMPLETED|First Intervention (6 Weeks)||15
11382823|NCT03444155|12576839|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
11382824|NCT03444155|12576840|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
11382825|NCT03444155|12576839|FG000|STARTED|Washout (2 Weeks)||14
11382826|NCT03444155|12576840|FG001|STARTED|Washout (2 Weeks)||15
11382827|NCT03444155|12576839|FG000|COMPLETED|Washout (2 Weeks)||14
11382828|NCT03444155|12576840|FG001|COMPLETED|Washout (2 Weeks)||15
11382829|NCT03444155|12576839|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11382830|NCT03444155|12576840|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11382831|NCT03444155|12576839|FG000|STARTED|Second Intervention (6 Weeks)||14
11382832|NCT03444155|12576840|FG001|STARTED|Second Intervention (6 Weeks)||15
11382833|NCT03444155|12576839|FG000|COMPLETED|Second Intervention (6 Weeks)||14
11382834|NCT03444155|12576840|FG001|COMPLETED|Second Intervention (6 Weeks)||15
11382835|NCT03444155|12576839|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
11382836|NCT03444155|12576840|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
11382837|NCT03444584|12576848|FG000|STARTED|Overall Study||24
11382838|NCT03444584|12576849|FG001|STARTED|Overall Study||25
11382839|NCT03444584|12576848|FG000|COMPLETED|Overall Study||24
11382840|NCT03444584|12576849|FG001|COMPLETED|Overall Study||23
11382841|NCT03444584|12576848|FG000|NOT COMPLETED|Overall Study||0
11382842|NCT03444584|12576849|FG001|NOT COMPLETED|Overall Study||2
11382843|NCT03444766|12576856|FG000|STARTED|Overall Study||100
11382844|NCT03444766|12576856|FG000|COMPLETED|Overall Study||34
11382845|NCT03444766|12576856|FG000|NOT COMPLETED|Overall Study||66
11382846|NCT03444961|12576860|FG000|STARTED|Overall Study||4
11382847|NCT03444961|12576860|FG000|COMPLETED|Overall Study||4
11382848|NCT03444961|12576860|FG000|NOT COMPLETED|Overall Study||0
11382849|NCT03445065|12576872|FG000|STARTED|Overall Study||97
11382850|NCT03445065|12576873|FG001|STARTED|Overall Study||52
11382851|NCT03445065|12576874|FG002|STARTED|Overall Study||62
11382852|NCT03445065|12576875|FG003|STARTED|Overall Study||28
11382853|NCT03445065|12576872|FG000|COMPLETED|Overall Study||90
11382854|NCT03445065|12576873|FG001|COMPLETED|Overall Study||43
11382855|NCT03445065|12576874|FG002|COMPLETED|Overall Study||57
11382856|NCT03445065|12576875|FG003|COMPLETED|Overall Study||25
11382857|NCT03445065|12576872|FG000|NOT COMPLETED|Overall Study||7
11382858|NCT03445065|12576873|FG001|NOT COMPLETED|Overall Study||9
11382859|NCT03445065|12576874|FG002|NOT COMPLETED|Overall Study||5
11382860|NCT03445065|12576875|FG003|NOT COMPLETED|Overall Study||3
11382861|NCT03445156|12576900|FG000|STARTED|Pilot Study||20
11382862|NCT03445156|12576901|FG001|STARTED|Pilot Study||20
11382863|NCT03445156|12576902|FG002|STARTED|Pilot Study||0
11382864|NCT03445156|12576900|FG000|COMPLETED|Pilot Study||20
11382865|NCT03445156|12576901|FG001|COMPLETED|Pilot Study||20
11382866|NCT03445156|12576902|FG002|COMPLETED|Pilot Study||0
11382867|NCT03445156|12576900|FG000|NOT COMPLETED|Pilot Study||0
11382868|NCT03445156|12576901|FG001|NOT COMPLETED|Pilot Study||0
11382869|NCT03445156|12576902|FG002|NOT COMPLETED|Pilot Study||0
11382870|NCT03445156|12576900|FG000|STARTED|Experiment Proper||113
11382871|NCT03445156|12576901|FG001|STARTED|Experiment Proper||115
11382872|NCT03445156|12576902|FG002|STARTED|Experiment Proper||59
11382873|NCT03445156|12576900|FG000|COMPLETED|Experiment Proper||113
11382874|NCT03445156|12576901|FG001|COMPLETED|Experiment Proper||115
11382875|NCT03445156|12576902|FG002|COMPLETED|Experiment Proper||59
11382876|NCT03445156|12576900|FG000|NOT COMPLETED|Experiment Proper||0
11382877|NCT03445156|12576901|FG001|NOT COMPLETED|Experiment Proper||0
11382878|NCT03445156|12576902|FG002|NOT COMPLETED|Experiment Proper||0
11382879|NCT03445195|12576916|FG000|STARTED|Overall Study||53
11382880|NCT03445195|12576917|FG001|STARTED|Overall Study||27
11382881|NCT03445195|12576916|FG000|COMPLETED|Overall Study||51
11382882|NCT03445195|12576917|FG001|COMPLETED|Overall Study||27
11382883|NCT03445195|12576916|FG000|NOT COMPLETED|Overall Study||2
11382884|NCT03445195|12576917|FG001|NOT COMPLETED|Overall Study||0
11382885|NCT03445390|12576923|FG000|STARTED|First Intervention||14
11382886|NCT03445390|12576924|FG001|STARTED|First Intervention||13
11382887|NCT03445390|12576923|FG000|COMPLETED|First Intervention||12
11382888|NCT03445390|12576924|FG001|COMPLETED|First Intervention||11
11382889|NCT03445390|12576923|FG000|NOT COMPLETED|First Intervention||2
11382890|NCT03445390|12576924|FG001|NOT COMPLETED|First Intervention||2
11382891|NCT03445390|12576923|FG000|STARTED|Second Intervention||12
11382892|NCT03445390|12576924|FG001|STARTED|Second Intervention||11
11382893|NCT03445390|12576923|FG000|COMPLETED|Second Intervention||10
11382894|NCT03445390|12576924|FG001|COMPLETED|Second Intervention||10
11382895|NCT03445390|12576923|FG000|NOT COMPLETED|Second Intervention||2
11382896|NCT03445390|12576924|FG001|NOT COMPLETED|Second Intervention||1
11382897|NCT03445793|12576930|FG000|STARTED|Overall Study||5
11382898|NCT03445793|12576930|FG000|COMPLETED|Overall Study||5
11382899|NCT03445793|12576930|FG000|NOT COMPLETED|Overall Study||0
11382900|NCT03446053|12576939|FG000|STARTED|Overall Study||2
11382901|NCT03446053|12576940|FG001|STARTED|Overall Study||6
11382902|NCT03446053|12576941|FG002|STARTED|Overall Study||6
11382903|NCT03446053|12576942|FG003|STARTED|Overall Study||7
11382904|NCT03446053|12576943|FG004|STARTED|Overall Study||6
11382905|NCT03446053|12576944|FG005|STARTED|Overall Study||6
11382906|NCT03446053|12576939|FG000|Randomized Set|Overall Study||2
11382907|NCT03446053|12576940|FG001|Randomized Set|Overall Study||6
11382908|NCT03446053|12576941|FG002|Randomized Set|Overall Study||6
11382909|NCT03446053|12576942|FG003|Randomized Set|Overall Study||7
11382910|NCT03446053|12576943|FG004|Randomized Set|Overall Study||6
11382911|NCT03446053|12576944|FG005|Randomized Set|Overall Study||6
11382912|NCT03446053|12576939|FG000|Safety Analysis Set|Overall Study||2
11382913|NCT03446053|12576940|FG001|Safety Analysis Set|Overall Study||6
11382914|NCT03446053|12576941|FG002|Safety Analysis Set|Overall Study||6
11382915|NCT03446053|12576942|FG003|Safety Analysis Set|Overall Study||6
11382916|NCT03446053|12576943|FG004|Safety Analysis Set|Overall Study||6
11382917|NCT03446053|12576944|FG005|Safety Analysis Set|Overall Study||6
11382918|NCT03446053|12576939|FG000|PK/PD Analysis Set|Overall Study||2
11382919|NCT03446053|12576940|FG001|PK/PD Analysis Set|Overall Study||6
11382920|NCT03446053|12576941|FG002|PK/PD Analysis Set|Overall Study||6
11382921|NCT03446053|12576942|FG003|PK/PD Analysis Set|Overall Study||6
11382922|NCT03446053|12576943|FG004|PK/PD Analysis Set|Overall Study||6
11382923|NCT03446053|12576944|FG005|PK/PD Analysis Set|Overall Study||5
11382924|NCT03446053|12576939|FG000|COMPLETED|Overall Study||2
11382925|NCT03446053|12576940|FG001|COMPLETED|Overall Study||5
11382926|NCT03446053|12576941|FG002|COMPLETED|Overall Study||6
11382927|NCT03446053|12576942|FG003|COMPLETED|Overall Study||6
11382928|NCT03446053|12576943|FG004|COMPLETED|Overall Study||6
11382929|NCT03446053|12576944|FG005|COMPLETED|Overall Study||5
11382930|NCT03446053|12576939|FG000|NOT COMPLETED|Overall Study||0
11382931|NCT03446053|12576940|FG001|NOT COMPLETED|Overall Study||1
11382932|NCT03446053|12576941|FG002|NOT COMPLETED|Overall Study||0
11382933|NCT03446053|12576942|FG003|NOT COMPLETED|Overall Study||1
11382934|NCT03446053|12576943|FG004|NOT COMPLETED|Overall Study||0
11382935|NCT03446053|12576944|FG005|NOT COMPLETED|Overall Study||1
11382936|NCT03446690|12576973|FG000|STARTED|Overall Study||33
11382937|NCT03446690|12576974|FG001|STARTED|Overall Study||29
11382938|NCT03446690|12576973|FG000|COMPLETED|Overall Study||26
11382939|NCT03446690|12576974|FG001|COMPLETED|Overall Study||29
11382940|NCT03446690|12576973|FG000|NOT COMPLETED|Overall Study||7
11382941|NCT03446690|12576974|FG001|NOT COMPLETED|Overall Study||0
11382942|NCT03446781|12576982|FG000|STARTED|Overall Study||214
11382943|NCT03446781|12576983|FG001|STARTED|Overall Study||208
11382944|NCT03446781|12576982|FG000|COMPLETED|Overall Study||186
11382945|NCT03446781|12576983|FG001|COMPLETED|Overall Study||191
11382946|NCT03446781|12576982|FG000|NOT COMPLETED|Overall Study||28
11382947|NCT03446781|12576983|FG001|NOT COMPLETED|Overall Study||17
11382948|NCT03446846|12577014|FG000|STARTED|Overall Study||90
11382949|NCT03446846|12577015|FG001|STARTED|Overall Study||92
11382950|NCT03446846|12577016|FG002|STARTED|Overall Study||178
11382951|NCT03446846|12577014|FG000|COMPLETED|Overall Study||83
11382952|NCT03446846|12577015|FG001|COMPLETED|Overall Study||87
11382953|NCT03446846|12577016|FG002|COMPLETED|Overall Study||162
11382954|NCT03446846|12577014|FG000|NOT COMPLETED|Overall Study||7
11382955|NCT03446846|12577015|FG001|NOT COMPLETED|Overall Study||5
11382956|NCT03446846|12577016|FG002|NOT COMPLETED|Overall Study||16
11382957|NCT03446885|12577024|FG000|STARTED|Overall Study||12
11382958|NCT03446885|12577025|FG001|STARTED|Overall Study||10
11382959|NCT03446885|12577024|FG000|COMPLETED|Overall Study||10
11382960|NCT03446885|12577025|FG001|COMPLETED|Overall Study||10
11382961|NCT03446885|12577024|FG000|NOT COMPLETED|Overall Study||2
11382962|NCT03446885|12577025|FG001|NOT COMPLETED|Overall Study||0
11382963|NCT03447015|12577035|FG000|STARTED|Overall Study||140
11382964|NCT03447015|12577036|FG001|STARTED|Overall Study||150
11382965|NCT03447015|12577035|FG000|COMPLETED|Overall Study||95
11382966|NCT03447015|12577036|FG001|COMPLETED|Overall Study||106
11382967|NCT03447015|12577035|FG000|NOT COMPLETED|Overall Study||45
11382968|NCT03447015|12577036|FG001|NOT COMPLETED|Overall Study||44
11382969|NCT03447249|12577044|FG000|STARTED|Overall Study||190
11382970|NCT03447249|12577045|FG001|STARTED|Overall Study||192
11382971|NCT03447249|12577044|FG000|Safety Set|Overall Study||189
11382972|NCT03447249|12577045|FG001|Safety Set|Overall Study||193
11382973|NCT03447249|12577044|FG000|COMPLETED|Overall Study||185
11382974|NCT03447249|12577045|FG001|COMPLETED|Overall Study||192
11382975|NCT03447249|12577044|FG000|NOT COMPLETED|Overall Study||5
11382976|NCT03447249|12577045|FG001|NOT COMPLETED|Overall Study||0
11382977|NCT03447353|12577053|FG000|STARTED|Overall Study||18
11382978|NCT03447353|12577053|FG000|COMPLETED|Overall Study||8
11382979|NCT03447353|12577053|FG000|NOT COMPLETED|Overall Study||10
11382980|NCT03447730|12577066|FG000|STARTED|Overall Study||6
11382981|NCT03447730|12577067|FG001|STARTED|Overall Study||9
11382982|NCT03447730|12577068|FG002|STARTED|Overall Study||8
11382983|NCT03447730|12577066|FG000|COMPLETED|Overall Study||6
11382984|NCT03447730|12577067|FG001|COMPLETED|Overall Study||7
11382985|NCT03447730|12577068|FG002|COMPLETED|Overall Study||8
11382986|NCT03447730|12577066|FG000|NOT COMPLETED|Overall Study||0
11382987|NCT03447730|12577067|FG001|NOT COMPLETED|Overall Study||2
11382988|NCT03447730|12577068|FG002|NOT COMPLETED|Overall Study||0
11382989|NCT03447821|12577079|FG000|STARTED|Overall Study||14
11382990|NCT03447821|12577080|FG001|STARTED|Overall Study||13
11382991|NCT03447821|12577081|FG002|STARTED|Overall Study||13
11382992|NCT03447821|12577079|FG000|COMPLETED|Overall Study||13
11382993|NCT03447821|12577080|FG001|COMPLETED|Overall Study||12
11382994|NCT03447821|12577081|FG002|COMPLETED|Overall Study||12
11382995|NCT03447821|12577079|FG000|NOT COMPLETED|Overall Study||1
11382996|NCT03447821|12577080|FG001|NOT COMPLETED|Overall Study||1
11382997|NCT03447821|12577081|FG002|NOT COMPLETED|Overall Study||1
11382998|NCT03448068|12577091|FG000|STARTED|Overall Study||17
11382999|NCT03448068|12577092|FG001|STARTED|Overall Study||17
11383000|NCT03448068|12577091|FG000|COMPLETED|Overall Study||17
11383001|NCT03448068|12577092|FG001|COMPLETED|Overall Study||17
11383002|NCT03448068|12577091|FG000|NOT COMPLETED|Overall Study||0
11383003|NCT03448068|12577092|FG001|NOT COMPLETED|Overall Study||0
11383004|NCT03448224|12577100|FG000|STARTED|Overall Study||28
11383005|NCT03448224|12577101|FG001|STARTED|Overall Study||26
11383006|NCT03448224|12577100|FG000|COMPLETED|Overall Study||27
11383007|NCT03448224|12577101|FG001|COMPLETED|Overall Study||26
11383008|NCT03448224|12577100|FG000|NOT COMPLETED|Overall Study||1
11383009|NCT03448224|12577101|FG001|NOT COMPLETED|Overall Study||0
11383010|NCT03448406|12577109|FG000|STARTED|Overall Study||158
11383011|NCT03448406|12577110|FG001|STARTED|Overall Study||157
11383012|NCT03448406|12577109|FG000|COMPLETED|Overall Study||147
11383013|NCT03448406|12577110|FG001|COMPLETED|Overall Study||144
11383014|NCT03448406|12577109|FG000|NOT COMPLETED|Overall Study||11
11383015|NCT03448406|12577110|FG001|NOT COMPLETED|Overall Study||13
11383016|NCT03448419|12577118|FG000|STARTED|Overall Study||156
11383017|NCT03448419|12577119|FG001|STARTED|Overall Study||156
11383018|NCT03448419|12577118|FG000|Treated|Overall Study||156
11383019|NCT03448419|12577119|FG001|Treated|Overall Study||155
11383020|NCT03448419|12577118|FG000|COMPLETED|Overall Study||143
11383021|NCT03448419|12577119|FG001|COMPLETED|Overall Study||140
11383022|NCT03448419|12577118|FG000|NOT COMPLETED|Overall Study||13
11383023|NCT03448419|12577119|FG001|NOT COMPLETED|Overall Study||16
11383024|NCT03448536|12577129|FG000|STARTED|Overall Study||100
11383025|NCT03448536|12577130|FG001|STARTED|Overall Study||101
11383026|NCT03448536|12577129|FG000|Completed First Intervention|Overall Study||83
11383027|NCT03448536|12577130|FG001|Completed First Intervention|Overall Study||78
11383028|NCT03448536|12577129|FG000|Completed First Intervention|Overall Study||95
11383029|NCT03448536|12577130|FG001|Completed First Intervention|Overall Study||97
11383030|NCT03448536|12577129|FG000|Completed Second Intervention|Overall Study||82
11383031|NCT03448536|12577130|FG001|Completed Second Intervention|Overall Study||87
11383032|NCT03448536|12577129|FG000|COMPLETED|Overall Study||88
11383033|NCT03448536|12577130|FG001|COMPLETED|Overall Study||97
11383034|NCT03448536|12577129|FG000|NOT COMPLETED|Overall Study||12
11383035|NCT03448536|12577130|FG001|NOT COMPLETED|Overall Study||4
11383036|NCT03449030|12577146|FG000|STARTED|Overall Study||1
11383037|NCT03449030|12577147|FG001|STARTED|Overall Study||1
11383038|NCT03449030|12577148|FG002|STARTED|Overall Study||1
11383039|NCT03449030|12577149|FG003|STARTED|Overall Study||5
11383040|NCT03449030|12577150|FG004|STARTED|Overall Study||7
11383041|NCT03449030|12577151|FG005|STARTED|Overall Study||7
11383042|NCT03449030|12577152|FG006|STARTED|Overall Study||2
11383043|NCT03449030|12577153|FG007|STARTED|Overall Study||3
11383044|NCT03449030|12577154|FG008|STARTED|Overall Study||3
11383045|NCT03449030|12577155|FG009|STARTED|Overall Study||1
11383046|NCT03449030|12577146|FG000|COMPLETED|Overall Study||0
11383047|NCT03449030|12577147|FG001|COMPLETED|Overall Study||0
11383048|NCT03449030|12577148|FG002|COMPLETED|Overall Study||0
11383049|NCT03449030|12577149|FG003|COMPLETED|Overall Study||0
11383050|NCT03449030|12577150|FG004|COMPLETED|Overall Study||0
11383051|NCT03449030|12577151|FG005|COMPLETED|Overall Study||0
11383052|NCT03449030|12577152|FG006|COMPLETED|Overall Study||0
11383053|NCT03449030|12577153|FG007|COMPLETED|Overall Study||0
11383054|NCT03449030|12577154|FG008|COMPLETED|Overall Study||0
11383055|NCT03449030|12577155|FG009|COMPLETED|Overall Study||0
11383056|NCT03449030|12577146|FG000|NOT COMPLETED|Overall Study||1
11383057|NCT03449030|12577147|FG001|NOT COMPLETED|Overall Study||1
11383058|NCT03449030|12577148|FG002|NOT COMPLETED|Overall Study||1
11383059|NCT03449030|12577149|FG003|NOT COMPLETED|Overall Study||5
11383060|NCT03449030|12577150|FG004|NOT COMPLETED|Overall Study||7
11383061|NCT03449030|12577151|FG005|NOT COMPLETED|Overall Study||7
11383062|NCT03449030|12577152|FG006|NOT COMPLETED|Overall Study||2
11383063|NCT03449030|12577153|FG007|NOT COMPLETED|Overall Study||3
11383064|NCT03449030|12577154|FG008|NOT COMPLETED|Overall Study||3
11383065|NCT03449030|12577155|FG009|NOT COMPLETED|Overall Study||1
11383066|NCT03449134|12577181|FG000|STARTED|52-Week Treatment Period||244
11383067|NCT03449134|12577182|FG001|STARTED|52-Week Treatment Period||244
11383068|NCT03449134|12577183|FG002|STARTED|52-Week Treatment Period||244
11383069|NCT03449134|12577181|FG000|Treated|52-Week Treatment Period||243
11383070|NCT03449134|12577182|FG001|Treated|52-Week Treatment Period||244
11383071|NCT03449134|12577183|FG002|Treated|52-Week Treatment Period||243
11383072|NCT03449134|12577181|FG000|COMPLETED|52-Week Treatment Period||199
11383073|NCT03449134|12577182|FG001|COMPLETED|52-Week Treatment Period||200
11383074|NCT03449134|12577183|FG002|COMPLETED|52-Week Treatment Period||184
11383075|NCT03449134|12577181|FG000|NOT COMPLETED|52-Week Treatment Period||45
11383076|NCT03449134|12577182|FG001|NOT COMPLETED|52-Week Treatment Period||44
11383077|NCT03449134|12577183|FG002|NOT COMPLETED|52-Week Treatment Period||60
11383078|NCT03449134|12577181|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|10
11383079|NCT03449134|12577182|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|18
11383080|NCT03449134|12577183|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|13
11383081|NCT03449134|12577181|FG000|COMPLETED|12-Week Off-Treatment Durability Period||10
11383082|NCT03449134|12577182|FG001|COMPLETED|12-Week Off-Treatment Durability Period||18
11383083|NCT03449134|12577183|FG002|COMPLETED|12-Week Off-Treatment Durability Period||13
11383084|NCT03449134|12577181|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
11383085|NCT03449134|12577182|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
11383086|NCT03449134|12577183|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
11383087|NCT03449147|12577197|FG000|STARTED|52-week Treatment Period||436
11383088|NCT03449147|12577198|FG001|STARTED|52-week Treatment Period||442
11383089|NCT03449147|12577199|FG002|STARTED|52-week Treatment Period||439
11383090|NCT03449147|12577197|FG000|COMPLETED|52-week Treatment Period||382
11383091|NCT03449147|12577198|FG001|COMPLETED|52-week Treatment Period||368
11383092|NCT03449147|12577199|FG002|COMPLETED|52-week Treatment Period||355
11383093|NCT03449147|12577197|FG000|NOT COMPLETED|52-week Treatment Period||54
11383094|NCT03449147|12577198|FG001|NOT COMPLETED|52-week Treatment Period||74
11383095|NCT03449147|12577199|FG002|NOT COMPLETED|52-week Treatment Period||84
11383096|NCT03449147|12577197|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|48
11383097|NCT03449147|12577198|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37
11383098|NCT03449147|12577199|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37
11383099|NCT03449147|12577197|FG000|COMPLETED|12-Week Off-Treatment Durability Period||47
11383100|NCT03449147|12577198|FG001|COMPLETED|12-Week Off-Treatment Durability Period||36
11383101|NCT03449147|12577199|FG002|COMPLETED|12-Week Off-Treatment Durability Period||37
11383102|NCT03449147|12577197|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||1
11383103|NCT03449147|12577198|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||1
11383104|NCT03449147|12577199|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
11383105|NCT03449342|12577213|FG000|STARTED|Overall Study||10
11383106|NCT03449342|12577214|FG001|STARTED|Overall Study||50
11383107|NCT03449342|12577213|FG000|COMPLETED|Overall Study||10
11383108|NCT03449342|12577214|FG001|COMPLETED|Overall Study||50
11383109|NCT03449342|12577213|FG000|NOT COMPLETED|Overall Study||0
11383110|NCT03449342|12577214|FG001|NOT COMPLETED|Overall Study||0
11383111|NCT03449433|12577222|FG000|STARTED|Period 1||17
11383112|NCT03449433|12577223|FG001|STARTED|Period 1||16
11383113|NCT03449433|12577224|FG002|STARTED|Period 1||18
11383114|NCT03449433|12577225|FG003|STARTED|Period 1||17
11383115|NCT03449433|12577226|FG004|STARTED|Period 1||12
11383116|NCT03449433|12577222|FG000|Received at Least 1 Dose of Study Drug|Period 1||17
11383117|NCT03449433|12577223|FG001|Received at Least 1 Dose of Study Drug|Period 1||16
11383118|NCT03449433|12577224|FG002|Received at Least 1 Dose of Study Drug|Period 1||18
11383119|NCT03449433|12577225|FG003|Received at Least 1 Dose of Study Drug|Period 1||17
11383120|NCT03449433|12577226|FG004|Received at Least 1 Dose of Study Drug|Period 1||0
11383121|NCT03449433|12577222|FG000|COMPLETED|Period 1||17
11383122|NCT03449433|12577223|FG001|COMPLETED|Period 1||16
11383123|NCT03449433|12577224|FG002|COMPLETED|Period 1||18
11383124|NCT03449433|12577225|FG003|COMPLETED|Period 1||17
11383125|NCT03449433|12577226|FG004|COMPLETED|Period 1||12
11383126|NCT03449433|12577222|FG000|NOT COMPLETED|Period 1||0
11383127|NCT03449433|12577223|FG001|NOT COMPLETED|Period 1||0
11383128|NCT03449433|12577224|FG002|NOT COMPLETED|Period 1||0
11383129|NCT03449433|12577225|FG003|NOT COMPLETED|Period 1||0
11383130|NCT03449433|12577226|FG004|NOT COMPLETED|Period 1||0
11383131|NCT03449433|12577222|FG000|STARTED|Period 2||17
11383132|NCT03449433|12577223|FG001|STARTED|Period 2||16
11383133|NCT03449433|12577224|FG002|STARTED|Period 2||18
11383134|NCT03449433|12577225|FG003|STARTED|Period 2||17
11383135|NCT03449433|12577226|FG004|STARTED|Period 2||12
11383136|NCT03449433|12577222|FG000|Received at Least 1 Dose of Study Drug|Period 2||17
11383137|NCT03449433|12577223|FG001|Received at Least 1 Dose of Study Drug|Period 2||16
11383138|NCT03449433|12577224|FG002|Received at Least 1 Dose of Study Drug|Period 2||18
11383139|NCT03449433|12577225|FG003|Received at Least 1 Dose of Study Drug|Period 2||17
11383140|NCT03449433|12577226|FG004|Received at Least 1 Dose of Study Drug|Period 2||0
11383141|NCT03449433|12577222|FG000|COMPLETED|Period 2||17
11383142|NCT03449433|12577223|FG001|COMPLETED|Period 2||16
11383143|NCT03449433|12577224|FG002|COMPLETED|Period 2||18
11383144|NCT03449433|12577225|FG003|COMPLETED|Period 2||17
11383145|NCT03449433|12577226|FG004|COMPLETED|Period 2||12
11383146|NCT03449433|12577222|FG000|NOT COMPLETED|Period 2||0
11383147|NCT03449433|12577223|FG001|NOT COMPLETED|Period 2||0
11383148|NCT03449433|12577224|FG002|NOT COMPLETED|Period 2||0
11383149|NCT03449433|12577225|FG003|NOT COMPLETED|Period 2||0
11383150|NCT03449433|12577226|FG004|NOT COMPLETED|Period 2||0
11383151|NCT03449433|12577222|FG000|STARTED|Period 3||17
11383152|NCT03449433|12577223|FG001|STARTED|Period 3||16
11383153|NCT03449433|12577224|FG002|STARTED|Period 3||18
11383154|NCT03449433|12577225|FG003|STARTED|Period 3||17
11383155|NCT03449433|12577226|FG004|STARTED|Period 3||12
11383156|NCT03449433|12577222|FG000|Received at Least 1 Dose of Study Drug|Period 3||17
11383157|NCT03449433|12577223|FG001|Received at Least 1 Dose of Study Drug|Period 3||15
11383158|NCT03449433|12577224|FG002|Received at Least 1 Dose of Study Drug|Period 3||18
11383159|NCT03449433|12577225|FG003|Received at Least 1 Dose of Study Drug|Period 3||17
11383160|NCT03449433|12577226|FG004|Received at Least 1 Dose of Study Drug|Period 3||0
11383161|NCT03449433|12577222|FG000|COMPLETED|Period 3||17
11383162|NCT03449433|12577223|FG001|COMPLETED|Period 3||15
11383163|NCT03449433|12577224|FG002|COMPLETED|Period 3||18
11383164|NCT03449433|12577225|FG003|COMPLETED|Period 3||17
11383165|NCT03449433|12577226|FG004|COMPLETED|Period 3||12
11383166|NCT03449433|12577222|FG000|NOT COMPLETED|Period 3||0
11383167|NCT03449433|12577223|FG001|NOT COMPLETED|Period 3||1
11383168|NCT03449433|12577224|FG002|NOT COMPLETED|Period 3||0
11383169|NCT03449433|12577225|FG003|NOT COMPLETED|Period 3||0
11383170|NCT03449433|12577226|FG004|NOT COMPLETED|Period 3||0
11383171|NCT03449433|12577222|FG000|STARTED|Period 4||17
11383172|NCT03449433|12577223|FG001|STARTED|Period 4||15
11383173|NCT03449433|12577224|FG002|STARTED|Period 4||18
11383174|NCT03449433|12577225|FG003|STARTED|Period 4||17
11383175|NCT03449433|12577226|FG004|STARTED|Period 4||12
11383176|NCT03449433|12577222|FG000|Received at Least 1 Dose of Study Drug|Period 4||17
11383177|NCT03449433|12577223|FG001|Received at Least 1 Dose of Study Drug|Period 4||15
11383178|NCT03449433|12577224|FG002|Received at Least 1 Dose of Study Drug|Period 4||18
11383179|NCT03449433|12577225|FG003|Received at Least 1 Dose of Study Drug|Period 4||17
11383180|NCT03449433|12577226|FG004|Received at Least 1 Dose of Study Drug|Period 4||0
11383181|NCT03449433|12577222|FG000|COMPLETED|Period 4||17
11383182|NCT03449433|12577223|FG001|COMPLETED|Period 4||15
11383183|NCT03449433|12577224|FG002|COMPLETED|Period 4||18
11383184|NCT03449433|12577225|FG003|COMPLETED|Period 4||17
11383185|NCT03449433|12577226|FG004|COMPLETED|Period 4||12
11383186|NCT03449433|12577222|FG000|NOT COMPLETED|Period 4||0
11383187|NCT03449433|12577223|FG001|NOT COMPLETED|Period 4||0
11383188|NCT03449433|12577224|FG002|NOT COMPLETED|Period 4||0
11383189|NCT03449433|12577225|FG003|NOT COMPLETED|Period 4||0
11383190|NCT03449433|12577226|FG004|NOT COMPLETED|Period 4||0
11383191|NCT03449446|12577247|FG000|STARTED|Overall Study||39
11383192|NCT03449446|12577248|FG001|STARTED|Overall Study||40
11383193|NCT03449446|12577249|FG002|STARTED|Overall Study||41
11383194|NCT03449446|12577250|FG003|STARTED|Overall Study||80
11383195|NCT03449446|12577251|FG004|STARTED|Overall Study||78
11383196|NCT03449446|12577252|FG005|STARTED|Overall Study||78
11383197|NCT03449446|12577253|FG006|STARTED|Overall Study||39
11383198|NCT03449446|12577247|FG000|COMPLETED|Overall Study||3
11383199|NCT03449446|12577248|FG001|COMPLETED|Overall Study||33
11383200|NCT03449446|12577249|FG002|COMPLETED|Overall Study||34
11383201|NCT03449446|12577250|FG003|COMPLETED|Overall Study||71
11383202|NCT03449446|12577251|FG004|COMPLETED|Overall Study||66
11383203|NCT03449446|12577252|FG005|COMPLETED|Overall Study||69
11383204|NCT03449446|12577253|FG006|COMPLETED|Overall Study||38
11383205|NCT03449446|12577247|FG000|NOT COMPLETED|Overall Study||36
11383206|NCT03449446|12577248|FG001|NOT COMPLETED|Overall Study||7
11383207|NCT03449446|12577249|FG002|NOT COMPLETED|Overall Study||7
11383208|NCT03449446|12577250|FG003|NOT COMPLETED|Overall Study||9
11383209|NCT03449446|12577251|FG004|NOT COMPLETED|Overall Study||12
11383210|NCT03449446|12577252|FG005|NOT COMPLETED|Overall Study||9
11383211|NCT03449446|12577253|FG006|NOT COMPLETED|Overall Study||1
11383212|NCT03449979|12577273|FG000|STARTED|Overall Study||21
11383213|NCT03449979|12577274|FG001|STARTED|Overall Study||20
11383214|NCT03449979|12577275|FG002|STARTED|Overall Study||21
11383215|NCT03449979|12577276|FG003|STARTED|Overall Study||22
11383216|NCT03449979|12577273|FG000|COMPLETED|Overall Study||21
11383217|NCT03449979|12577274|FG001|COMPLETED|Overall Study||20
11383218|NCT03449979|12577275|FG002|COMPLETED|Overall Study||21
11383219|NCT03449979|12577276|FG003|COMPLETED|Overall Study||21
11383220|NCT03449979|12577273|FG000|NOT COMPLETED|Overall Study||0
11383221|NCT03449979|12577274|FG001|NOT COMPLETED|Overall Study||0
11383222|NCT03449979|12577275|FG002|NOT COMPLETED|Overall Study||0
11383223|NCT03449979|12577276|FG003|NOT COMPLETED|Overall Study||1
11383224|NCT03450070|12577286|FG000|STARTED|Overall Study||118
11383225|NCT03450070|12577286|FG000|COMPLETED|Overall Study||110
11383226|NCT03450070|12577286|FG000|NOT COMPLETED|Overall Study||8
11383227|NCT03450083|12577292|FG000|STARTED|Overall Study||12
11383228|NCT03450083|12577293|FG001|STARTED|Overall Study||12
11383229|NCT03450083|12577292|FG000|COMPLETED|Overall Study||12
11383230|NCT03450083|12577293|FG001|COMPLETED|Overall Study||12
11383231|NCT03450083|12577292|FG000|NOT COMPLETED|Overall Study||0
11383232|NCT03450083|12577293|FG001|NOT COMPLETED|Overall Study||0
11383233|NCT03450369|12577301|FG000|STARTED|Overall Study||5
11383234|NCT03450369|12577302|FG001|STARTED|Overall Study||5
11383235|NCT03450369|12577301|FG000|COMPLETED|Overall Study||5
11383236|NCT03450369|12577302|FG001|COMPLETED|Overall Study||5
11383237|NCT03450369|12577301|FG000|NOT COMPLETED|Overall Study||0
11383238|NCT03450369|12577302|FG001|NOT COMPLETED|Overall Study||0
11383239|NCT03450915|12577310|FG000|STARTED|Overall Study||6230
11383240|NCT03450915|12577311|FG001|STARTED|Overall Study||6230
11383241|NCT03450915|12577310|FG000|COMPLETED|Overall Study||5827
11383242|NCT03450915|12577311|FG001|COMPLETED|Overall Study||5855
11383243|NCT03450915|12577310|FG000|NOT COMPLETED|Overall Study||403
11383244|NCT03450915|12577311|FG001|NOT COMPLETED|Overall Study||375
11383245|NCT03451071|12577317|FG000|STARTED|First Vaccine||56
11383246|NCT03451071|12577317|FG000|COMPLETED|First Vaccine||55
11383247|NCT03451071|12577317|FG000|NOT COMPLETED|First Vaccine||1
11383248|NCT03451071|12577317|FG000|STARTED|Second Vaccine||55
11383249|NCT03451071|12577317|FG000|COMPLETED|Second Vaccine||36
11383250|NCT03451071|12577317|FG000|NOT COMPLETED|Second Vaccine||19
11383251|NCT03451071|12577317|FG000|STARTED|Third Vaccine||36
11383252|NCT03451071|12577317|FG000|COMPLETED|Third Vaccine||14
11383253|NCT03451071|12577317|FG000|NOT COMPLETED|Third Vaccine||22
11383254|NCT03451071|12577317|FG000|STARTED|Final Questionnaire and Blood Draw||14
11383255|NCT03451071|12577317|FG000|COMPLETED|Final Questionnaire and Blood Draw||10
11383256|NCT03451071|12577317|FG000|NOT COMPLETED|Final Questionnaire and Blood Draw||4
11383257|NCT03451084|12577325|FG000|STARTED|Overall Study||6
11383258|NCT03451084|12577326|FG001|STARTED|Overall Study||6
11383259|NCT03451084|12577327|FG002|STARTED|Overall Study||6
11383260|NCT03451084|12577328|FG003|STARTED|Overall Study||6
11383261|NCT03451084|12577325|FG000|COMPLETED|Overall Study||0
11383262|NCT03451084|12577326|FG001|COMPLETED|Overall Study||0
11383263|NCT03451084|12577327|FG002|COMPLETED|Overall Study||0
11383264|NCT03451084|12577328|FG003|COMPLETED|Overall Study||0
11383265|NCT03451084|12577325|FG000|NOT COMPLETED|Overall Study||6
11383266|NCT03451084|12577326|FG001|NOT COMPLETED|Overall Study||6
11383267|NCT03451084|12577327|FG002|NOT COMPLETED|Overall Study||6
11383268|NCT03451084|12577328|FG003|NOT COMPLETED|Overall Study||6
11383269|NCT03451721|12577338|FG000|STARTED|Overall Study||20
11383270|NCT03451721|12577338|FG000|COMPLETED|Overall Study||19
11383271|NCT03451721|12577338|FG000|NOT COMPLETED|Overall Study||1
11383272|NCT03451773|12577344|FG000|STARTED|Overall Study||1
11383273|NCT03451773|12577345|FG001|STARTED|Overall Study||6
11383274|NCT03451773|12577344|FG000|COMPLETED|Overall Study||0
11383275|NCT03451773|12577345|FG001|COMPLETED|Overall Study||0
11383276|NCT03451773|12577344|FG000|NOT COMPLETED|Overall Study||1
11383277|NCT03451773|12577345|FG001|NOT COMPLETED|Overall Study||6
11383278|NCT03452176|12577354|FG000|STARTED|Overall Study||11
11383279|NCT03452176|12577355|FG001|STARTED|Overall Study||11
11383280|NCT03452176|12577354|FG000|COMPLETED|Overall Study||11
11383281|NCT03452176|12577355|FG001|COMPLETED|Overall Study||11
11383282|NCT03452176|12577354|FG000|NOT COMPLETED|Overall Study||0
11383283|NCT03452176|12577355|FG001|NOT COMPLETED|Overall Study||0
11383284|NCT03452189|12577369|FG000|STARTED|First Intervention (3 Months)||10
11383285|NCT03452189|12577370|FG001|STARTED|First Intervention (3 Months)||5
11383286|NCT03452189|12577369|FG000|COMPLETED|First Intervention (3 Months)||5
11383287|NCT03452189|12577370|FG001|COMPLETED|First Intervention (3 Months)||5
11383288|NCT03452189|12577369|FG000|NOT COMPLETED|First Intervention (3 Months)||5
11383289|NCT03452189|12577370|FG001|NOT COMPLETED|First Intervention (3 Months)||0
11383290|NCT03452189|12577369|FG000|STARTED|Intervention 2 (3 Months)||5
11383291|NCT03452189|12577370|FG001|STARTED|Intervention 2 (3 Months)||5
11383292|NCT03452189|12577369|FG000|COMPLETED|Intervention 2 (3 Months)||5
11383293|NCT03452189|12577370|FG001|COMPLETED|Intervention 2 (3 Months)||5
11383294|NCT03452189|12577369|FG000|NOT COMPLETED|Intervention 2 (3 Months)||0
11383295|NCT03452189|12577370|FG001|NOT COMPLETED|Intervention 2 (3 Months)||0
11383296|NCT03452371|12577378|FG000|STARTED|Overall Study||21
11383297|NCT03452371|12577379|FG001|STARTED|Overall Study||23
11383298|NCT03452371|12577378|FG000|COMPLETED|Overall Study||21
11383299|NCT03452371|12577379|FG001|COMPLETED|Overall Study||23
11383300|NCT03452371|12577378|FG000|NOT COMPLETED|Overall Study||0
11383301|NCT03452371|12577379|FG001|NOT COMPLETED|Overall Study||0
11383302|NCT03452527|12577387|FG000|STARTED|Overall Study||7
11383303|NCT03452527|12577388|FG001|STARTED|Overall Study||8
11383304|NCT03452527|12577387|FG000|COMPLETED|Overall Study||4
11383305|NCT03452527|12577388|FG001|COMPLETED|Overall Study||4
11383306|NCT03452527|12577387|FG000|NOT COMPLETED|Overall Study||3
11383307|NCT03452527|12577388|FG001|NOT COMPLETED|Overall Study||4
11383308|NCT03452943|12577396|FG000|STARTED|Titration Period (7 Weeks)||59
11383309|NCT03452943|12577397|FG001|STARTED|Titration Period (7 Weeks)||60
11383310|NCT03452943|12577396|FG000|Safety Analysis Set|Titration Period (7 Weeks)||58
11383311|NCT03452943|12577397|FG001|Safety Analysis Set|Titration Period (7 Weeks)||59
11383312|NCT03452943|12577396|FG000|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||58
11383313|NCT03452943|12577397|FG001|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||59
11383314|NCT03452943|12577396|FG000|COMPLETED|Titration Period (7 Weeks)||54
11383315|NCT03452943|12577397|FG001|COMPLETED|Titration Period (7 Weeks)||56
11383316|NCT03452943|12577396|FG000|NOT COMPLETED|Titration Period (7 Weeks)||5
11383317|NCT03452943|12577397|FG001|NOT COMPLETED|Titration Period (7 Weeks)||4
11383318|NCT03452943|12577396|FG000|STARTED|Maintenance Period (5 Weeks)||54
11383319|NCT03452943|12577397|FG001|STARTED|Maintenance Period (5 Weeks)||56
11383320|NCT03452943|12577396|FG000|COMPLETED|Maintenance Period (5 Weeks)||51
11383321|NCT03452943|12577397|FG001|COMPLETED|Maintenance Period (5 Weeks)||56
11383322|NCT03452943|12577396|FG000|NOT COMPLETED|Maintenance Period (5 Weeks)||3
11383323|NCT03452943|12577397|FG001|NOT COMPLETED|Maintenance Period (5 Weeks)||0
11383324|NCT03453060|12577408|FG000|STARTED|Overall Study||4
11383325|NCT03453060|12577409|FG001|STARTED|Overall Study||4
11383326|NCT03453060|12577410|FG002|STARTED|Overall Study||4
11383327|NCT03453060|12577411|FG003|STARTED|Overall Study||4
11383328|NCT03453060|12577412|FG004|STARTED|Overall Study||5
11383329|NCT03453060|12577408|FG000|COMPLETED|Overall Study||4
11383330|NCT03453060|12577409|FG001|COMPLETED|Overall Study||4
11383331|NCT03453060|12577410|FG002|COMPLETED|Overall Study||4
11383332|NCT03453060|12577411|FG003|COMPLETED|Overall Study||4
11383333|NCT03453060|12577412|FG004|COMPLETED|Overall Study||5
11383334|NCT03453060|12577408|FG000|NOT COMPLETED|Overall Study||0
11383335|NCT03453060|12577409|FG001|NOT COMPLETED|Overall Study||0
11383336|NCT03453060|12577410|FG002|NOT COMPLETED|Overall Study||0
11383337|NCT03453060|12577411|FG003|NOT COMPLETED|Overall Study||0
11383338|NCT03453060|12577412|FG004|NOT COMPLETED|Overall Study||0
11383339|NCT03453151|12577424|FG000|STARTED|Overall Study||19
11383340|NCT03453151|12577424|FG000|COMPLETED|Overall Study||15
11383341|NCT03453151|12577424|FG000|NOT COMPLETED|Overall Study||4
11383342|NCT03453515|12577430|FG000|STARTED|Overall Study||113
11383343|NCT03453515|12577431|FG001|STARTED|Overall Study||113
11383344|NCT03453515|12577430|FG000|COMPLETED|Overall Study||107
11383345|NCT03453515|12577431|FG001|COMPLETED|Overall Study||100
11383346|NCT03453515|12577430|FG000|NOT COMPLETED|Overall Study||6
11383347|NCT03453515|12577431|FG001|NOT COMPLETED|Overall Study||13
11383348|NCT03454048|12577441|FG000|STARTED|Overall Study||6
11383349|NCT03454048|12577442|FG001|STARTED|Overall Study||6
11383350|NCT03454048|12577443|FG002|STARTED|Overall Study||6
11383351|NCT03454048|12577444|FG003|STARTED|Overall Study||6
11383352|NCT03454048|12577441|FG000|COMPLETED|Overall Study||6
11383353|NCT03454048|12577442|FG001|COMPLETED|Overall Study||6
11383354|NCT03454048|12577443|FG002|COMPLETED|Overall Study||6
11383355|NCT03454048|12577444|FG003|COMPLETED|Overall Study||6
11383356|NCT03454048|12577441|FG000|NOT COMPLETED|Overall Study||0
11383357|NCT03454048|12577442|FG001|NOT COMPLETED|Overall Study||0
11383358|NCT03454048|12577443|FG002|NOT COMPLETED|Overall Study||0
11383359|NCT03454048|12577444|FG003|NOT COMPLETED|Overall Study||0
11383360|NCT03454412|12577456|FG000|STARTED|Baseline Assesment||44
11383361|NCT03454412|12577456|FG000|COMPLETED|Baseline Assesment||32
11383362|NCT03454412|12577456|FG000|NOT COMPLETED|Baseline Assesment||12
11383363|NCT03454412|12577456|FG000|STARTED|Treatment Course||32
11383364|NCT03454412|12577456|FG000|COMPLETED|Treatment Course||32
11383365|NCT03454412|12577456|FG000|NOT COMPLETED|Treatment Course||0
11383366|NCT03454412|12577456|FG000|STARTED|Final Assesment||32
11383367|NCT03454412|12577456|FG000|COMPLETED|Final Assesment||32
11383368|NCT03454412|12577456|FG000|NOT COMPLETED|Final Assesment||0
11383369|NCT03454581|12577463|FG000|STARTED|Overall Study||18
11383370|NCT03454581|12577464|FG001|STARTED|Overall Study||16
11383371|NCT03454581|12577465|FG002|STARTED|Overall Study||17
11383372|NCT03454581|12577463|FG000|COMPLETED|Overall Study||14
11383373|NCT03454581|12577464|FG001|COMPLETED|Overall Study||13
11383374|NCT03454581|12577465|FG002|COMPLETED|Overall Study||14
11383375|NCT03454581|12577463|FG000|NOT COMPLETED|Overall Study||4
11383376|NCT03454581|12577464|FG001|NOT COMPLETED|Overall Study||3
11383377|NCT03454581|12577465|FG002|NOT COMPLETED|Overall Study||3
11383378|NCT03455218|12577476|FG000|STARTED|Overall Study||18
11383379|NCT03455218|12577477|FG001|STARTED|Overall Study||22
11383380|NCT03455218|12577476|FG000|COMPLETED|Overall Study||18
11383381|NCT03455218|12577477|FG001|COMPLETED|Overall Study||22
11383382|NCT03455218|12577476|FG000|NOT COMPLETED|Overall Study||0
11383383|NCT03455218|12577477|FG001|NOT COMPLETED|Overall Study||0
11383384|NCT03455491|12577486|FG000|STARTED|Overall Study||40
11383385|NCT03455491|12577487|FG001|STARTED|Overall Study||40
11383386|NCT03455491|12577488|FG002|STARTED|Overall Study||40
11383387|NCT03455491|12577486|FG000|COMPLETED|Overall Study||40
11383388|NCT03455491|12577487|FG001|COMPLETED|Overall Study||40
11383389|NCT03455491|12577488|FG002|COMPLETED|Overall Study||40
11383390|NCT03455491|12577486|FG000|NOT COMPLETED|Overall Study||0
11383391|NCT03455491|12577487|FG001|NOT COMPLETED|Overall Study||0
11383392|NCT03455491|12577488|FG002|NOT COMPLETED|Overall Study||0
11383393|NCT03455543|12577498|FG000|STARTED|Part A: Randomized Treatment (17 Weeks)||92
11383394|NCT03455543|12577499|FG001|STARTED|Part A: Randomized Treatment (17 Weeks)||90
11383395|NCT03455543|12577500|FG002|STARTED|Part A: Randomized Treatment (17 Weeks)||0
11383396|NCT03455543|12577498|FG000|COMPLETED|Part A: Randomized Treatment (17 Weeks)||81
11383397|NCT03455543|12577499|FG001|COMPLETED|Part A: Randomized Treatment (17 Weeks)||83
11383398|NCT03455543|12577500|FG002|COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
11383399|NCT03455543|12577498|FG000|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||11
11383400|NCT03455543|12577499|FG001|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||7
11383401|NCT03455543|12577500|FG002|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
11383402|NCT03455543|12577498|FG000|STARTED|Part B: Open-label Extension (24 Weeks)||0
11383403|NCT03455543|12577499|FG001|STARTED|Part B: Open-label Extension (24 Weeks)||0
11383404|NCT03455543|12577500|FG002|STARTED|Part B: Open-label Extension (24 Weeks)||152
11383405|NCT03455543|12577498|FG000|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
11383406|NCT03455543|12577499|FG001|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
11383407|NCT03455543|12577500|FG002|COMPLETED|Part B: Open-label Extension (24 Weeks)||115
11383408|NCT03455543|12577498|FG000|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
11383409|NCT03455543|12577499|FG001|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
11383410|NCT03455543|12577500|FG002|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||37
11383411|NCT03456245|12577508|FG000|STARTED|Overall Study||205
11383412|NCT03456245|12577508|FG000|COMPLETED|Overall Study||190
11383413|NCT03456245|12577508|FG000|NOT COMPLETED|Overall Study||15
11383414|NCT03456427|12577512|FG000|STARTED|Overall Study||36
11383415|NCT03456427|12577512|FG000|COMPLETED|Overall Study||33
11383416|NCT03456427|12577512|FG000|NOT COMPLETED|Overall Study||3
11383417|NCT03456856|12577517|FG000|STARTED|Overall Study||30
11383418|NCT03456856|12577517|FG000|COMPLETED|Overall Study||27
11383419|NCT03456856|12577517|FG000|NOT COMPLETED|Overall Study||3
11383420|NCT03456960|12577527|FG000|STARTED|Period 1 (1 Day)||12
11383421|NCT03456960|12577528|FG001|STARTED|Period 1 (1 Day)||12
11383422|NCT03456960|12577529|FG002|STARTED|Period 1 (1 Day)||120
11383423|NCT03456960|12577530|FG003|STARTED|Period 1 (1 Day)||120
11383424|NCT03456960|12577531|FG004|STARTED|Period 1 (1 Day)||6
11383425|NCT03456960|12577532|FG005|STARTED|Period 1 (1 Day)||6
11383426|NCT03456960|12577527|FG000|COMPLETED|Period 1 (1 Day)||12
11383427|NCT03456960|12577528|FG001|COMPLETED|Period 1 (1 Day)||12
11383428|NCT03456960|12577529|FG002|COMPLETED|Period 1 (1 Day)||120
11383429|NCT03456960|12577530|FG003|COMPLETED|Period 1 (1 Day)||120
11383430|NCT03456960|12577531|FG004|COMPLETED|Period 1 (1 Day)||6
11383431|NCT03456960|12577532|FG005|COMPLETED|Period 1 (1 Day)||6
11383432|NCT03456960|12577527|FG000|NOT COMPLETED|Period 1 (1 Day)||0
11383433|NCT03456960|12577528|FG001|NOT COMPLETED|Period 1 (1 Day)||0
11383434|NCT03456960|12577529|FG002|NOT COMPLETED|Period 1 (1 Day)||0
11383435|NCT03456960|12577530|FG003|NOT COMPLETED|Period 1 (1 Day)||0
11383436|NCT03456960|12577531|FG004|NOT COMPLETED|Period 1 (1 Day)||0
11383437|NCT03456960|12577532|FG005|NOT COMPLETED|Period 1 (1 Day)||0
11383438|NCT03456960|12577527|FG000|STARTED|Washout Period (at Least 14 Days)||12
11383439|NCT03456960|12577528|FG001|STARTED|Washout Period (at Least 14 Days)||12
11383440|NCT03456960|12577529|FG002|STARTED|Washout Period (at Least 14 Days)||120
11383441|NCT03456960|12577530|FG003|STARTED|Washout Period (at Least 14 Days)||120
11383442|NCT03456960|12577531|FG004|STARTED|Washout Period (at Least 14 Days)||6
11383443|NCT03456960|12577532|FG005|STARTED|Washout Period (at Least 14 Days)||6
11383444|NCT03456960|12577527|FG000|COMPLETED|Washout Period (at Least 14 Days)||12
11383445|NCT03456960|12577528|FG001|COMPLETED|Washout Period (at Least 14 Days)||12
11383446|NCT03456960|12577529|FG002|COMPLETED|Washout Period (at Least 14 Days)||119
11383447|NCT03456960|12577530|FG003|COMPLETED|Washout Period (at Least 14 Days)||118
11383448|NCT03456960|12577531|FG004|COMPLETED|Washout Period (at Least 14 Days)||6
11383449|NCT03456960|12577532|FG005|COMPLETED|Washout Period (at Least 14 Days)||6
11383450|NCT03456960|12577527|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11383451|NCT03456960|12577528|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11383452|NCT03456960|12577529|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||1
11383453|NCT03456960|12577530|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||2
11383454|NCT03456960|12577531|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11383455|NCT03456960|12577532|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11383456|NCT03456960|12577527|FG000|STARTED|Period 2 (1 Day)||12
11383457|NCT03456960|12577528|FG001|STARTED|Period 2 (1 Day)||12
11383458|NCT03456960|12577529|FG002|STARTED|Period 2 (1 Day)||119
11383459|NCT03456960|12577530|FG003|STARTED|Period 2 (1 Day)||118
11383460|NCT03456960|12577531|FG004|STARTED|Period 2 (1 Day)||6
11383461|NCT03456960|12577532|FG005|STARTED|Period 2 (1 Day)||6
11383462|NCT03456960|12577527|FG000|COMPLETED|Period 2 (1 Day)||11
11383463|NCT03456960|12577528|FG001|COMPLETED|Period 2 (1 Day)||12
11383464|NCT03456960|12577529|FG002|COMPLETED|Period 2 (1 Day)||119
11383465|NCT03456960|12577530|FG003|COMPLETED|Period 2 (1 Day)||117
11006064|NCT00726232|12183818|FG006|NOT COMPLETED|Expansion Phase||24
11006065|NCT00726232|12183819|FG007|NOT COMPLETED|Expansion Phase||38
11006066|NCT00726323|12183840|FG000|STARTED|Overall Study||37
11383466|NCT03456960|12577531|FG004|COMPLETED|Period 2 (1 Day)||6
11383467|NCT03456960|12577532|FG005|COMPLETED|Period 2 (1 Day)||6
11383468|NCT03456960|12577527|FG000|NOT COMPLETED|Period 2 (1 Day)||1
11383469|NCT03456960|12577528|FG001|NOT COMPLETED|Period 2 (1 Day)||0
11383470|NCT03456960|12577529|FG002|NOT COMPLETED|Period 2 (1 Day)||0
11383471|NCT03456960|12577530|FG003|NOT COMPLETED|Period 2 (1 Day)||1
11383472|NCT03456960|12577531|FG004|NOT COMPLETED|Period 2 (1 Day)||0
11383473|NCT03456960|12577532|FG005|NOT COMPLETED|Period 2 (1 Day)||0
11383474|NCT03457103|12577550|FG000|STARTED|Overall Study||22
11383475|NCT03457103|12577551|FG001|STARTED|Overall Study||9
11383476|NCT03457103|12577550|FG000|COMPLETED|Overall Study||14
11383477|NCT03457103|12577551|FG001|COMPLETED|Overall Study||3
11383478|NCT03457103|12577550|FG000|NOT COMPLETED|Overall Study||8
11383479|NCT03457103|12577551|FG001|NOT COMPLETED|Overall Study||6
11383480|NCT03457116|12577559|FG000|STARTED|Overall Study||41
11383481|NCT03457116|12577560|FG001|STARTED|Overall Study||29
11383482|NCT03457116|12577559|FG000|COMPLETED|Overall Study||41
11383483|NCT03457116|12577560|FG001|COMPLETED|Overall Study||29
11383484|NCT03457116|12577559|FG000|NOT COMPLETED|Overall Study||0
11383485|NCT03457116|12577560|FG001|NOT COMPLETED|Overall Study||0
11383486|NCT03457636|12577566|FG000|STARTED|Overall Study||22
11383487|NCT03457636|12577566|FG000|COMPLETED|Overall Study||20
11383488|NCT03457636|12577566|FG000|NOT COMPLETED|Overall Study||2
11383489|NCT03457727|12577574|FG000|STARTED|Part 1, Period 1 (1 Day)||8
11383490|NCT03457727|12577575|FG001|STARTED|Part 1, Period 1 (1 Day)||8
11383491|NCT03457727|12577576|FG002|STARTED|Part 1, Period 1 (1 Day)||0
11383492|NCT03457727|12577577|FG003|STARTED|Part 1, Period 1 (1 Day)||0
11383493|NCT03457727|12577574|FG000|COMPLETED|Part 1, Period 1 (1 Day)||8
11383494|NCT03457727|12577575|FG001|COMPLETED|Part 1, Period 1 (1 Day)||8
11383495|NCT03457727|12577576|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0
11383496|NCT03457727|12577577|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0
11383497|NCT03457727|12577574|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
11383498|NCT03457727|12577575|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
11383499|NCT03457727|12577576|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
11383500|NCT03457727|12577577|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
11383501|NCT03457727|12577574|FG000|STARTED|Part 1, Washout Period 1 (5 Days)||8
11383502|NCT03457727|12577575|FG001|STARTED|Part 1, Washout Period 1 (5 Days)||8
11383503|NCT03457727|12577576|FG002|STARTED|Part 1, Washout Period 1 (5 Days)||0
11383504|NCT03457727|12577577|FG003|STARTED|Part 1, Washout Period 1 (5 Days)||0
11383505|NCT03457727|12577574|FG000|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
11383506|NCT03457727|12577575|FG001|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
11383507|NCT03457727|12577576|FG002|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
11383508|NCT03457727|12577577|FG003|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
11383509|NCT03457727|12577574|FG000|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
11383510|NCT03457727|12577575|FG001|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
11383511|NCT03457727|12577576|FG002|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
11383512|NCT03457727|12577577|FG003|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
11383513|NCT03457727|12577574|FG000|STARTED|Part 1, Period 2 (1 Day)||8
11383514|NCT03457727|12577575|FG001|STARTED|Part 1, Period 2 (1 Day)||8
11383515|NCT03457727|12577576|FG002|STARTED|Part 1, Period 2 (1 Day)||0
11383516|NCT03457727|12577577|FG003|STARTED|Part 1, Period 2 (1 Day)||0
11383517|NCT03457727|12577574|FG000|COMPLETED|Part 1, Period 2 (1 Day)||8
11383518|NCT03457727|12577575|FG001|COMPLETED|Part 1, Period 2 (1 Day)||8
11383519|NCT03457727|12577576|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0
11383520|NCT03457727|12577577|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0
11383521|NCT03457727|12577574|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
11383522|NCT03457727|12577575|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
11383523|NCT03457727|12577576|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
11383524|NCT03457727|12577577|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
11383525|NCT03457727|12577574|FG000|STARTED|Part 1, Washout Period 2 (5 Days)||8
11383526|NCT03457727|12577575|FG001|STARTED|Part 1, Washout Period 2 (5 Days)||8
11383527|NCT03457727|12577576|FG002|STARTED|Part 1, Washout Period 2 (5 Days)||0
11383528|NCT03457727|12577577|FG003|STARTED|Part 1, Washout Period 2 (5 Days)||0
11383529|NCT03457727|12577574|FG000|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
11383530|NCT03457727|12577575|FG001|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
11383531|NCT03457727|12577576|FG002|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
11383532|NCT03457727|12577577|FG003|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
11383533|NCT03457727|12577574|FG000|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
11383534|NCT03457727|12577575|FG001|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
11383535|NCT03457727|12577576|FG002|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
11383536|NCT03457727|12577577|FG003|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
11383537|NCT03457727|12577574|FG000|STARTED|Part 1, Period 3 (1 Day)||8
11383538|NCT03457727|12577575|FG001|STARTED|Part 1, Period 3 (1 Day)||8
11383539|NCT03457727|12577576|FG002|STARTED|Part 1, Period 3 (1 Day)||0
11383540|NCT03457727|12577577|FG003|STARTED|Part 1, Period 3 (1 Day)||0
11383541|NCT03457727|12577574|FG000|COMPLETED|Part 1, Period 3 (1 Day)||8
11383542|NCT03457727|12577575|FG001|COMPLETED|Part 1, Period 3 (1 Day)||8
11383543|NCT03457727|12577576|FG002|COMPLETED|Part 1, Period 3 (1 Day)||0
11383544|NCT03457727|12577577|FG003|COMPLETED|Part 1, Period 3 (1 Day)||0
11383545|NCT03457727|12577574|FG000|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
11383546|NCT03457727|12577575|FG001|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
11383547|NCT03457727|12577576|FG002|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
11383548|NCT03457727|12577577|FG003|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
11383549|NCT03457727|12577574|FG000|STARTED|Part 1, Washout Period 3 (5 Days)||8
11383550|NCT03457727|12577575|FG001|STARTED|Part 1, Washout Period 3 (5 Days)||8
11383551|NCT03457727|12577576|FG002|STARTED|Part 1, Washout Period 3 (5 Days)||0
11383552|NCT03457727|12577577|FG003|STARTED|Part 1, Washout Period 3 (5 Days)||0
11383553|NCT03457727|12577574|FG000|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
11383554|NCT03457727|12577575|FG001|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
11383555|NCT03457727|12577576|FG002|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
11383556|NCT03457727|12577577|FG003|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
11383557|NCT03457727|12577574|FG000|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
11383558|NCT03457727|12577575|FG001|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
11383559|NCT03457727|12577576|FG002|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
11383560|NCT03457727|12577577|FG003|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
11383561|NCT03457727|12577574|FG000|STARTED|Part 1, Period 4 (1 Day)||8
11383562|NCT03457727|12577575|FG001|STARTED|Part 1, Period 4 (1 Day)||8
11383563|NCT03457727|12577576|FG002|STARTED|Part 1, Period 4 (1 Day)||0
11383564|NCT03457727|12577577|FG003|STARTED|Part 1, Period 4 (1 Day)||0
11383565|NCT03457727|12577574|FG000|COMPLETED|Part 1, Period 4 (1 Day)||8
11383566|NCT03457727|12577575|FG001|COMPLETED|Part 1, Period 4 (1 Day)||8
11383567|NCT03457727|12577576|FG002|COMPLETED|Part 1, Period 4 (1 Day)||0
11383568|NCT03457727|12577577|FG003|COMPLETED|Part 1, Period 4 (1 Day)||0
11383569|NCT03457727|12577574|FG000|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
11383570|NCT03457727|12577575|FG001|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
11383571|NCT03457727|12577576|FG002|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
11383572|NCT03457727|12577577|FG003|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
11383573|NCT03457727|12577574|FG000|STARTED|Part 2, Period 1 (1 Day)||0
11383574|NCT03457727|12577575|FG001|STARTED|Part 2, Period 1 (1 Day)||0
11383575|NCT03457727|12577576|FG002|STARTED|Part 2, Period 1 (1 Day)||12
11383576|NCT03457727|12577577|FG003|STARTED|Part 2, Period 1 (1 Day)||12
11383577|NCT03457727|12577574|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0
11383578|NCT03457727|12577575|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0
11383579|NCT03457727|12577576|FG002|COMPLETED|Part 2, Period 1 (1 Day)||12
11383580|NCT03457727|12577577|FG003|COMPLETED|Part 2, Period 1 (1 Day)||12
11383581|NCT03457727|12577574|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
11383582|NCT03457727|12577575|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
11383583|NCT03457727|12577576|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
11383584|NCT03457727|12577577|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
11383585|NCT03457727|12577574|FG000|STARTED|Part 2, Washout Period 1 (5 Days)||0
11383586|NCT03457727|12577575|FG001|STARTED|Part 2, Washout Period 1 (5 Days)||0
11383587|NCT03457727|12577576|FG002|STARTED|Part 2, Washout Period 1 (5 Days)||12
11383588|NCT03457727|12577577|FG003|STARTED|Part 2, Washout Period 1 (5 Days)||12
11383589|NCT03457727|12577574|FG000|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
11383590|NCT03457727|12577575|FG001|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
11383591|NCT03457727|12577576|FG002|COMPLETED|Part 2, Washout Period 1 (5 Days)||12
11383592|NCT03457727|12577577|FG003|COMPLETED|Part 2, Washout Period 1 (5 Days)||11
11383593|NCT03457727|12577574|FG000|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
11383594|NCT03457727|12577575|FG001|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
11383595|NCT03457727|12577576|FG002|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
11383596|NCT03457727|12577577|FG003|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1
11383597|NCT03457727|12577574|FG000|STARTED|Part 2, Period 2 (1 Day)||0
11383598|NCT03457727|12577575|FG001|STARTED|Part 2, Period 2 (1 Day)||0
11383599|NCT03457727|12577576|FG002|STARTED|Part 2, Period 2 (1 Day)||12
11383600|NCT03457727|12577577|FG003|STARTED|Part 2, Period 2 (1 Day)||11
11383601|NCT03457727|12577574|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0
11383602|NCT03457727|12577575|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0
11383603|NCT03457727|12577576|FG002|COMPLETED|Part 2, Period 2 (1 Day)||12
11383604|NCT03457727|12577577|FG003|COMPLETED|Part 2, Period 2 (1 Day)||11
11383605|NCT03457727|12577574|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
11383606|NCT03457727|12577575|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
11383607|NCT03457727|12577576|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
11383608|NCT03457727|12577577|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
11383609|NCT03457727|12577574|FG000|STARTED|Part 2, Washout Period 2 (5 Days)||0
11383610|NCT03457727|12577575|FG001|STARTED|Part 2, Washout Period 2 (5 Days)||0
11383611|NCT03457727|12577576|FG002|STARTED|Part 2, Washout Period 2 (5 Days)||12
11383612|NCT03457727|12577577|FG003|STARTED|Part 2, Washout Period 2 (5 Days)||11
11383613|NCT03457727|12577574|FG000|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
11383614|NCT03457727|12577575|FG001|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
11383615|NCT03457727|12577576|FG002|COMPLETED|Part 2, Washout Period 2 (5 Days)||12
11383616|NCT03457727|12577577|FG003|COMPLETED|Part 2, Washout Period 2 (5 Days)||11
11383617|NCT03457727|12577574|FG000|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
11383618|NCT03457727|12577575|FG001|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
11383619|NCT03457727|12577576|FG002|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
11383620|NCT03457727|12577577|FG003|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
11383621|NCT03457727|12577574|FG000|STARTED|Part 2, Period 3 (1 Day)||0
11383622|NCT03457727|12577575|FG001|STARTED|Part 2, Period 3 (1 Day)||0
11383623|NCT03457727|12577576|FG002|STARTED|Part 2, Period 3 (1 Day)||12
11383624|NCT03457727|12577577|FG003|STARTED|Part 2, Period 3 (1 Day)||11
11383625|NCT03457727|12577574|FG000|COMPLETED|Part 2, Period 3 (1 Day)||0
11383626|NCT03457727|12577575|FG001|COMPLETED|Part 2, Period 3 (1 Day)||0
11383627|NCT03457727|12577576|FG002|COMPLETED|Part 2, Period 3 (1 Day)||12
11383628|NCT03457727|12577577|FG003|COMPLETED|Part 2, Period 3 (1 Day)||11
11383629|NCT03457727|12577574|FG000|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
11383630|NCT03457727|12577575|FG001|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
11383631|NCT03457727|12577576|FG002|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
11383632|NCT03457727|12577577|FG003|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
11383633|NCT03457727|12577574|FG000|STARTED|Part 2, Washout Period 3 (5 Days)||0
11383634|NCT03457727|12577575|FG001|STARTED|Part 2, Washout Period 3 (5 Days)||0
11383635|NCT03457727|12577576|FG002|STARTED|Part 2, Washout Period 3 (5 Days)||12
11383636|NCT03457727|12577577|FG003|STARTED|Part 2, Washout Period 3 (5 Days)||11
11383637|NCT03457727|12577574|FG000|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
11383638|NCT03457727|12577575|FG001|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
11383639|NCT03457727|12577576|FG002|COMPLETED|Part 2, Washout Period 3 (5 Days)||12
11383640|NCT03457727|12577577|FG003|COMPLETED|Part 2, Washout Period 3 (5 Days)||11
11383641|NCT03457727|12577574|FG000|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
11383642|NCT03457727|12577575|FG001|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
11383643|NCT03457727|12577576|FG002|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
11383644|NCT03457727|12577577|FG003|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
11383645|NCT03457727|12577574|FG000|STARTED|Part 2, Period 4 (1 Day)||0
11383646|NCT03457727|12577575|FG001|STARTED|Part 2, Period 4 (1 Day)||0
11383647|NCT03457727|12577576|FG002|STARTED|Part 2, Period 4 (1 Day)||12
11383648|NCT03457727|12577577|FG003|STARTED|Part 2, Period 4 (1 Day)||0
11383649|NCT03457727|12577574|FG000|COMPLETED|Part 2, Period 4 (1 Day)||0
11383650|NCT03457727|12577575|FG001|COMPLETED|Part 2, Period 4 (1 Day)||0
11383651|NCT03457727|12577576|FG002|COMPLETED|Part 2, Period 4 (1 Day)||12
11383652|NCT03457727|12577577|FG003|COMPLETED|Part 2, Period 4 (1 Day)||0
11383653|NCT03457727|12577574|FG000|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
11383654|NCT03457727|12577575|FG001|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
11383655|NCT03457727|12577576|FG002|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
11383656|NCT03457727|12577577|FG003|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
11383657|NCT03457909|12577609|FG000|STARTED|Overall Study||25
11383658|NCT03457909|12577609|FG000|COMPLETED|Overall Study||25
11383659|NCT03457909|12577609|FG000|NOT COMPLETED|Overall Study||0
11383660|NCT03458702|12577613|FG000|STARTED|Study Condition A (Yoga or Rest)||28
11383661|NCT03458702|12577614|FG001|STARTED|Study Condition A (Yoga or Rest)||28
11383662|NCT03458702|12577613|FG000|COMPLETED|Study Condition A (Yoga or Rest)||24
11383663|NCT03458702|12577614|FG001|COMPLETED|Study Condition A (Yoga or Rest)||22
11383664|NCT03458702|12577613|FG000|NOT COMPLETED|Study Condition A (Yoga or Rest)||4
11383665|NCT03458702|12577614|FG001|NOT COMPLETED|Study Condition A (Yoga or Rest)||6
11383666|NCT03458702|12577613|FG000|STARTED|Study Condition B (Yoga or Rest)||24
11383667|NCT03458702|12577614|FG001|STARTED|Study Condition B (Yoga or Rest)||22
11383668|NCT03458702|12577613|FG000|COMPLETED|Study Condition B (Yoga or Rest)||20
11383669|NCT03458702|12577614|FG001|COMPLETED|Study Condition B (Yoga or Rest)||20
11383670|NCT03458702|12577613|FG000|NOT COMPLETED|Study Condition B (Yoga or Rest)||4
11383671|NCT03458702|12577614|FG001|NOT COMPLETED|Study Condition B (Yoga or Rest)||2
11383672|NCT03458702|12577613|FG000|STARTED|Picture Rating/Body Composition||20
11383673|NCT03458702|12577614|FG001|STARTED|Picture Rating/Body Composition||20
11383674|NCT03458702|12577613|FG000|COMPLETED|Picture Rating/Body Composition||20
11383675|NCT03458702|12577614|FG001|COMPLETED|Picture Rating/Body Composition||20
11383676|NCT03458702|12577613|FG000|NOT COMPLETED|Picture Rating/Body Composition||0
11383677|NCT03458702|12577614|FG001|NOT COMPLETED|Picture Rating/Body Composition||0
11383678|NCT03458871|12577620|FG000|STARTED|Overall Study||16
11383679|NCT03458871|12577620|FG000|COMPLETED|Overall Study||16
11383680|NCT03458871|12577620|FG000|NOT COMPLETED|Overall Study||0
11383681|NCT03459040|12577624|FG000|STARTED|Overall Study||30
11383682|NCT03459040|12577624|FG000|COMPLETED|Overall Study||21
11383683|NCT03459040|12577624|FG000|NOT COMPLETED|Overall Study||9
11383684|NCT03459131|12577629|FG000|STARTED|Period 1, First 7 Days of Wear||7
11383685|NCT03459131|12577630|FG001|STARTED|Period 1, First 7 Days of Wear||8
11383686|NCT03459131|12577629|FG000|COMPLETED|Period 1, First 7 Days of Wear||7
11383687|NCT03459131|12577630|FG001|COMPLETED|Period 1, First 7 Days of Wear||8
11383688|NCT03459131|12577629|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0
11383689|NCT03459131|12577630|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0
11383690|NCT03459131|12577629|FG000|STARTED|Period 2, Second 7 Days of Wear||7
11383691|NCT03459131|12577630|FG001|STARTED|Period 2, Second 7 Days of Wear||8
11383692|NCT03459131|12577629|FG000|COMPLETED|Period 2, Second 7 Days of Wear||7
11383693|NCT03459131|12577630|FG001|COMPLETED|Period 2, Second 7 Days of Wear||8
11383694|NCT03459131|12577629|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
11383695|NCT03459131|12577630|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
11383696|NCT03459196|12577636|FG000|STARTED|Overall Study||54
11383697|NCT03459196|12577636|FG000|COMPLETED|Overall Study||52
11383698|NCT03459196|12577636|FG000|NOT COMPLETED|Overall Study||2
11383699|NCT03459612|12577644|FG000|STARTED|Period 1||17
11383700|NCT03459612|12577645|FG001|STARTED|Period 1||17
11383701|NCT03459612|12577646|FG002|STARTED|Period 1||17
11383702|NCT03459612|12577647|FG003|STARTED|Period 1||17
11383703|NCT03459612|12577644|FG000|Received at Least 1 Dose of Study Drug|Period 1||17
11383704|NCT03459612|12577645|FG001|Received at Least 1 Dose of Study Drug|Period 1||17
11383705|NCT03459612|12577646|FG002|Received at Least 1 Dose of Study Drug|Period 1||17
11383706|NCT03459612|12577647|FG003|Received at Least 1 Dose of Study Drug|Period 1||17
11383707|NCT03459612|12577644|FG000|COMPLETED|Period 1||17
11383708|NCT03459612|12577645|FG001|COMPLETED|Period 1||17
11383709|NCT03459612|12577646|FG002|COMPLETED|Period 1||17
11383710|NCT03459612|12577647|FG003|COMPLETED|Period 1||17
11383711|NCT03459612|12577644|FG000|NOT COMPLETED|Period 1||0
11383712|NCT03459612|12577645|FG001|NOT COMPLETED|Period 1||0
11383713|NCT03459612|12577646|FG002|NOT COMPLETED|Period 1||0
11383714|NCT03459612|12577647|FG003|NOT COMPLETED|Period 1||0
11383715|NCT03459612|12577644|FG000|STARTED|Period 2||17
11383716|NCT03459612|12577645|FG001|STARTED|Period 2||17
11383717|NCT03459612|12577646|FG002|STARTED|Period 2||17
11383718|NCT03459612|12577647|FG003|STARTED|Period 2||17
11383719|NCT03459612|12577644|FG000|Received at Least 1 Dose of Study Drug|Period 2||17
11383720|NCT03459612|12577645|FG001|Received at Least 1 Dose of Study Drug|Period 2||17
11383721|NCT03459612|12577646|FG002|Received at Least 1 Dose of Study Drug|Period 2||17
11383722|NCT03459612|12577647|FG003|Received at Least 1 Dose of Study Drug|Period 2||17
11383723|NCT03459612|12577644|FG000|COMPLETED|Period 2||17
11383724|NCT03459612|12577645|FG001|COMPLETED|Period 2||17
11383725|NCT03459612|12577646|FG002|COMPLETED|Period 2||17
11383726|NCT03459612|12577647|FG003|COMPLETED|Period 2||17
11383727|NCT03459612|12577644|FG000|NOT COMPLETED|Period 2||0
11383728|NCT03459612|12577645|FG001|NOT COMPLETED|Period 2||0
11383729|NCT03459612|12577646|FG002|NOT COMPLETED|Period 2||0
11383730|NCT03459612|12577647|FG003|NOT COMPLETED|Period 2||0
11383731|NCT03459612|12577644|FG000|STARTED|Period 3||17
11383732|NCT03459612|12577645|FG001|STARTED|Period 3||17
11383733|NCT03459612|12577646|FG002|STARTED|Period 3||17
11383734|NCT03459612|12577647|FG003|STARTED|Period 3||17
11383735|NCT03459612|12577644|FG000|Received at Least 1 Dose of Study Drug|Period 3||17
11383736|NCT03459612|12577645|FG001|Received at Least 1 Dose of Study Drug|Period 3||17
11383737|NCT03459612|12577646|FG002|Received at Least 1 Dose of Study Drug|Period 3||17
11383738|NCT03459612|12577647|FG003|Received at Least 1 Dose of Study Drug|Period 3||17
11383739|NCT03459612|12577644|FG000|COMPLETED|Period 3||17
11383740|NCT03459612|12577645|FG001|COMPLETED|Period 3||17
11383741|NCT03459612|12577646|FG002|COMPLETED|Period 3||17
11383742|NCT03459612|12577647|FG003|COMPLETED|Period 3||17
11383743|NCT03459612|12577644|FG000|NOT COMPLETED|Period 3||0
11383744|NCT03459612|12577645|FG001|NOT COMPLETED|Period 3||0
11383745|NCT03459612|12577646|FG002|NOT COMPLETED|Period 3||0
11383746|NCT03459612|12577647|FG003|NOT COMPLETED|Period 3||0
11383747|NCT03459612|12577644|FG000|STARTED|Period 4||17
11383748|NCT03459612|12577645|FG001|STARTED|Period 4||17
11383749|NCT03459612|12577646|FG002|STARTED|Period 4|One participant completed period 3 and withdrew for personal reasons prior to Period 4.|16
11383750|NCT03459612|12577647|FG003|STARTED|Period 4||17
11383751|NCT03459612|12577644|FG000|Received at Least 1 Dose of Study Drug|Period 4||17
11383752|NCT03459612|12577645|FG001|Received at Least 1 Dose of Study Drug|Period 4||17
11383753|NCT03459612|12577646|FG002|Received at Least 1 Dose of Study Drug|Period 4||16
11383754|NCT03459612|12577647|FG003|Received at Least 1 Dose of Study Drug|Period 4||17
11383755|NCT03459612|12577644|FG000|COMPLETED|Period 4||17
11383756|NCT03459612|12577645|FG001|COMPLETED|Period 4||17
11383757|NCT03459612|12577646|FG002|COMPLETED|Period 4||16
11383758|NCT03459612|12577647|FG003|COMPLETED|Period 4||17
11383759|NCT03459612|12577644|FG000|NOT COMPLETED|Period 4||0
11383760|NCT03459612|12577645|FG001|NOT COMPLETED|Period 4||0
11383761|NCT03459612|12577646|FG002|NOT COMPLETED|Period 4||0
11383762|NCT03459612|12577647|FG003|NOT COMPLETED|Period 4||0
11383763|NCT03459794|12577662|FG000|STARTED|Overall Study||8
11383764|NCT03459794|12577663|FG001|STARTED|Overall Study||4
11383765|NCT03459794|12577662|FG000|COMPLETED|Overall Study||8
11383766|NCT03459794|12577663|FG001|COMPLETED|Overall Study||4
11383767|NCT03459794|12577662|FG000|NOT COMPLETED|Overall Study||0
11383768|NCT03459794|12577663|FG001|NOT COMPLETED|Overall Study||0
11383769|NCT03460587|12577675|FG000|STARTED|Overall Study||13
11383770|NCT03460587|12577675|FG000|COMPLETED|Overall Study||13
11383771|NCT03460587|12577675|FG000|NOT COMPLETED|Overall Study||0
11383772|NCT03460652|12577679|FG000|STARTED|Overall Study||282
11383773|NCT03460652|12577679|FG000|Entered Treatment Phase|Overall Study||238
11383774|NCT03460652|12577679|FG000|COMPLETED|Overall Study||155
11383775|NCT03460652|12577679|FG000|NOT COMPLETED|Overall Study||127
11383776|NCT03460899|12577684|FG000|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14
11383777|NCT03460899|12577684|FG000|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14
11383778|NCT03460899|12577684|FG000|NOT COMPLETED|Euglycaemic Clamp||0
11383779|NCT03460899|12577684|FG000|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14
11383780|NCT03460899|12577684|FG000|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14
11383781|NCT03460899|12577684|FG000|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0
11383782|NCT03460990|12577690|FG000|STARTED|Overall Study||57
11383783|NCT03460990|12577691|FG001|STARTED|Overall Study||54
11383784|NCT03460990|12577690|FG000|COMPLETED|Overall Study||57
11383785|NCT03460990|12577691|FG001|COMPLETED|Overall Study||54
11383786|NCT03460990|12577690|FG000|NOT COMPLETED|Overall Study||0
11383787|NCT03460990|12577691|FG001|NOT COMPLETED|Overall Study||0
11383788|NCT03461146|12577697|FG000|STARTED|Overall Study||24
11383789|NCT03461146|12577697|FG000|COMPLETED|Overall Study||21
11383790|NCT03461146|12577697|FG000|NOT COMPLETED|Overall Study||3
11383791|NCT03461757|12577703|FG000|STARTED|Overall Study||732
11383792|NCT03461757|12577704|FG001|STARTED|Overall Study||734
11383793|NCT03461757|12577703|FG000|Treated|Overall Study||682
11383794|NCT03461757|12577704|FG001|Treated|Overall Study||693
11383795|NCT03461757|12577703|FG000|COMPLETED|Overall Study||679
11383796|NCT03461757|12577704|FG001|COMPLETED|Overall Study||689
11383797|NCT03461757|12577703|FG000|NOT COMPLETED|Overall Study||53
11383798|NCT03461757|12577704|FG001|NOT COMPLETED|Overall Study||45
11383799|NCT03461965|12577712|FG000|STARTED|Overall Study||42
11383800|NCT03461965|12577713|FG001|STARTED|Overall Study||40
11383801|NCT03461965|12577712|FG000|COMPLETED|Overall Study||42
11383802|NCT03461965|12577713|FG001|COMPLETED|Overall Study||40
11383803|NCT03461965|12577712|FG000|NOT COMPLETED|Overall Study||0
11383804|NCT03461965|12577713|FG001|NOT COMPLETED|Overall Study||0
11383805|NCT03462082|12577719|FG000|STARTED|Study Phase (Randomized, Blinded Period)||3
11383806|NCT03462082|12577720|FG001|STARTED|Study Phase (Randomized, Blinded Period)||4
11383807|NCT03462082|12577721|FG002|STARTED|Study Phase (Randomized, Blinded Period)||4
11383808|NCT03462082|12577722|FG003|STARTED|Study Phase (Randomized, Blinded Period)||3
11383809|NCT03462082|12577723|FG004|STARTED|Study Phase (Randomized, Blinded Period)||3
11383810|NCT03462082|12577724|FG005|STARTED|Study Phase (Randomized, Blinded Period)||5
11383811|NCT03462082|12577725|FG006|STARTED|Study Phase (Randomized, Blinded Period)||0
11383812|NCT03462082|12577726|FG007|STARTED|Study Phase (Randomized, Blinded Period)||0
11383813|NCT03462082|12577719|FG000|COMPLETED|Study Phase (Randomized, Blinded Period)||3
11383814|NCT03462082|12577720|FG001|COMPLETED|Study Phase (Randomized, Blinded Period)||4
11383815|NCT03462082|12577721|FG002|COMPLETED|Study Phase (Randomized, Blinded Period)||4
11383816|NCT03462082|12577722|FG003|COMPLETED|Study Phase (Randomized, Blinded Period)||3
11383817|NCT03462082|12577723|FG004|COMPLETED|Study Phase (Randomized, Blinded Period)||3
11383818|NCT03462082|12577724|FG005|COMPLETED|Study Phase (Randomized, Blinded Period)||5
11383819|NCT03462082|12577725|FG006|COMPLETED|Study Phase (Randomized, Blinded Period)||0
11383820|NCT03462082|12577726|FG007|COMPLETED|Study Phase (Randomized, Blinded Period)||0
11383821|NCT03462082|12577719|FG000|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
11383822|NCT03462082|12577720|FG001|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
11383823|NCT03462082|12577721|FG002|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
11383824|NCT03462082|12577722|FG003|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
11383825|NCT03462082|12577723|FG004|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
11383826|NCT03462082|12577724|FG005|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
11383827|NCT03462082|12577725|FG006|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
11383828|NCT03462082|12577726|FG007|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
11383829|NCT03462082|12577719|FG000|STARTED|Open Label Phase||0
11383830|NCT03462082|12577720|FG001|STARTED|Open Label Phase||0
11383831|NCT03462082|12577721|FG002|STARTED|Open Label Phase||0
11383832|NCT03462082|12577722|FG003|STARTED|Open Label Phase||0
11383833|NCT03462082|12577723|FG004|STARTED|Open Label Phase||0
11383834|NCT03462082|12577724|FG005|STARTED|Open Label Phase||0
11383835|NCT03462082|12577725|FG006|STARTED|Open Label Phase||7
11383836|NCT03462082|12577726|FG007|STARTED|Open Label Phase||10
11383837|NCT03462082|12577719|FG000|COMPLETED|Open Label Phase||0
11383838|NCT03462082|12577720|FG001|COMPLETED|Open Label Phase||0
11383839|NCT03462082|12577721|FG002|COMPLETED|Open Label Phase||0
11383840|NCT03462082|12577722|FG003|COMPLETED|Open Label Phase||0
11383841|NCT03462082|12577723|FG004|COMPLETED|Open Label Phase||0
11383842|NCT03462082|12577724|FG005|COMPLETED|Open Label Phase||0
11383843|NCT03462082|12577725|FG006|COMPLETED|Open Label Phase||6
11383844|NCT03462082|12577726|FG007|COMPLETED|Open Label Phase||8
11383845|NCT03462082|12577719|FG000|NOT COMPLETED|Open Label Phase||0
11383846|NCT03462082|12577720|FG001|NOT COMPLETED|Open Label Phase||0
11383847|NCT03462082|12577721|FG002|NOT COMPLETED|Open Label Phase||0
11383848|NCT03462082|12577722|FG003|NOT COMPLETED|Open Label Phase||0
11383849|NCT03462082|12577723|FG004|NOT COMPLETED|Open Label Phase||0
11383850|NCT03462082|12577724|FG005|NOT COMPLETED|Open Label Phase||0
11383851|NCT03462082|12577725|FG006|NOT COMPLETED|Open Label Phase||1
11383852|NCT03462082|12577726|FG007|NOT COMPLETED|Open Label Phase||2
11383853|NCT03462576|12577739|FG000|STARTED|Overall Study||46
11383854|NCT03462576|12577740|FG001|STARTED|Overall Study||48
11383855|NCT03462576|12577741|FG002|STARTED|Overall Study||45
11383856|NCT03462576|12577739|FG000|COMPLETED|Overall Study||41
11383857|NCT03462576|12577740|FG001|COMPLETED|Overall Study||37
11383858|NCT03462576|12577741|FG002|COMPLETED|Overall Study||37
11383859|NCT03462576|12577739|FG000|NOT COMPLETED|Overall Study||5
11383860|NCT03462576|12577740|FG001|NOT COMPLETED|Overall Study||11
11383861|NCT03462576|12577741|FG002|NOT COMPLETED|Overall Study||8
11383862|NCT03462680|12577751|FG000|STARTED|Overall Study||21
11383863|NCT03462680|12577752|FG001|STARTED|Overall Study||26
11383864|NCT03462680|12577751|FG000|COMPLETED|Overall Study||18
11383865|NCT03462680|12577752|FG001|COMPLETED|Overall Study||21
11383866|NCT03462680|12577751|FG000|NOT COMPLETED|Overall Study||3
11383867|NCT03462680|12577752|FG001|NOT COMPLETED|Overall Study||5
11383868|NCT03462745|12577760|FG000|STARTED|Overall Study||92
11383869|NCT03462745|12577761|FG001|STARTED|Overall Study||92
11383870|NCT03462745|12577760|FG000|COMPLETED|Overall Study||92
11383871|NCT03462745|12577761|FG001|COMPLETED|Overall Study||92
11383872|NCT03462745|12577760|FG000|NOT COMPLETED|Overall Study||0
11383873|NCT03462745|12577761|FG001|NOT COMPLETED|Overall Study||0
11383874|NCT03462927|12577769|FG000|STARTED|Overall Study||32
11383875|NCT03462927|12577770|FG001|STARTED|Overall Study||31
11383876|NCT03462927|12577769|FG000|COMPLETED|Overall Study||26
11383877|NCT03462927|12577770|FG001|COMPLETED|Overall Study||29
11383878|NCT03462927|12577769|FG000|NOT COMPLETED|Overall Study||6
11383879|NCT03462927|12577770|FG001|NOT COMPLETED|Overall Study||2
11383880|NCT03463031|12577780|FG000|STARTED|Overall Study||225
11383881|NCT03463031|12577781|FG001|STARTED|Overall Study||221
11383882|NCT03463031|12577780|FG000|COMPLETED|Overall Study||215
11383883|NCT03463031|12577781|FG001|COMPLETED|Overall Study||216
11383884|NCT03463031|12577780|FG000|NOT COMPLETED|Overall Study||10
11383885|NCT03463031|12577781|FG001|NOT COMPLETED|Overall Study||5
11383886|NCT03463161|12577787|FG000|STARTED|Overall Study||2
11383887|NCT03463161|12577787|FG000|COMPLETED|Overall Study||2
11383888|NCT03463161|12577787|FG000|NOT COMPLETED|Overall Study||0
11383889|NCT03463512|12577793|FG000|STARTED|Overall Study||62
11383890|NCT03463512|12577794|FG001|STARTED|Overall Study||62
11383891|NCT03463512|12577793|FG000|COMPLETED|Overall Study||62
11383892|NCT03463512|12577794|FG001|COMPLETED|Overall Study||62
11383893|NCT03463512|12577793|FG000|NOT COMPLETED|Overall Study||0
11383894|NCT03463512|12577794|FG001|NOT COMPLETED|Overall Study||0
11383895|NCT03463889|12577800|FG000|STARTED|Overall Study||12
11383896|NCT03463889|12577800|FG000|COMPLETED|Overall Study||12
11383897|NCT03463889|12577800|FG000|NOT COMPLETED|Overall Study||0
11383898|NCT03463915|12577806|FG000|STARTED|Overall Study||45
11383899|NCT03463915|12577807|FG001|STARTED|Overall Study||45
11383900|NCT03463915|12577806|FG000|COMPLETED|Overall Study||35
11383901|NCT03463915|12577807|FG001|COMPLETED|Overall Study||36
11383902|NCT03463915|12577806|FG000|NOT COMPLETED|Overall Study||10
11383903|NCT03463915|12577807|FG001|NOT COMPLETED|Overall Study||9
11383904|NCT03463941|12577815|FG000|STARTED|Overall Study||80
11383905|NCT03463941|12577815|FG000|COMPLETED|Overall Study||62
11383906|NCT03463941|12577815|FG000|NOT COMPLETED|Overall Study||18
11383907|NCT03464383|12577823|FG000|STARTED|Overall Study||3
11383908|NCT03464383|12577824|FG001|STARTED|Overall Study||3
11383909|NCT03464383|12577825|FG002|STARTED|Overall Study||63
11383910|NCT03464383|12577823|FG000|COMPLETED|Overall Study||2
11383911|NCT03464383|12577824|FG001|COMPLETED|Overall Study||2
11383912|NCT03464383|12577825|FG002|COMPLETED|Overall Study||63
11383913|NCT03464383|12577823|FG000|NOT COMPLETED|Overall Study||1
11383914|NCT03464383|12577824|FG001|NOT COMPLETED|Overall Study||1
11383915|NCT03464383|12577825|FG002|NOT COMPLETED|Overall Study||0
11383916|NCT03464422|12577834|FG000|STARTED|Overall Study||21
11383917|NCT03464422|12577834|FG000|COMPLETED|Overall Study||17
11383918|NCT03464422|12577834|FG000|NOT COMPLETED|Overall Study||4
11383919|NCT03465436|12577844|FG000|STARTED|Period 1||14
11383920|NCT03465436|12577845|FG001|STARTED|Period 1||14
11383921|NCT03465436|12577846|FG002|STARTED|Period 1||14
11383922|NCT03465436|12577847|FG003|STARTED|Period 1||14
11383923|NCT03465436|12577844|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
11383924|NCT03465436|12577845|FG001|Received at Least 1 Dose of Study Drug|Period 1||14
11383925|NCT03465436|12577846|FG002|Received at Least 1 Dose of Study Drug|Period 1||14
11383926|NCT03465436|12577847|FG003|Received at Least 1 Dose of Study Drug|Period 1||14
11383927|NCT03465436|12577844|FG000|COMPLETED|Period 1||14
11383928|NCT03465436|12577845|FG001|COMPLETED|Period 1||14
11383929|NCT03465436|12577846|FG002|COMPLETED|Period 1||13
11383930|NCT03465436|12577847|FG003|COMPLETED|Period 1||14
11383931|NCT03465436|12577844|FG000|NOT COMPLETED|Period 1||0
11383932|NCT03465436|12577845|FG001|NOT COMPLETED|Period 1||0
11383933|NCT03465436|12577846|FG002|NOT COMPLETED|Period 1||1
11383934|NCT03465436|12577847|FG003|NOT COMPLETED|Period 1||0
11383935|NCT03465436|12577844|FG000|STARTED|Period 2||14
11383936|NCT03465436|12577845|FG001|STARTED|Period 2||14
11383937|NCT03465436|12577846|FG002|STARTED|Period 2||13
11383938|NCT03465436|12577847|FG003|STARTED|Period 2||14
11383939|NCT03465436|12577844|FG000|Received at Least 1 Dose of Study Drug|Period 2||14
11383940|NCT03465436|12577845|FG001|Received at Least 1 Dose of Study Drug|Period 2||13
11383941|NCT03465436|12577846|FG002|Received at Least 1 Dose of Study Drug|Period 2||13
11383942|NCT03465436|12577847|FG003|Received at Least 1 Dose of Study Drug|Period 2||14
11383943|NCT03465436|12577844|FG000|COMPLETED|Period 2||14
11383944|NCT03465436|12577845|FG001|COMPLETED|Period 2||13
11383945|NCT03465436|12577846|FG002|COMPLETED|Period 2||13
11383946|NCT03465436|12577847|FG003|COMPLETED|Period 2||14
11383947|NCT03465436|12577844|FG000|NOT COMPLETED|Period 2||0
11383948|NCT03465436|12577845|FG001|NOT COMPLETED|Period 2||1
11383949|NCT03465436|12577846|FG002|NOT COMPLETED|Period 2||0
11383950|NCT03465436|12577847|FG003|NOT COMPLETED|Period 2||0
11383951|NCT03465436|12577844|FG000|STARTED|Period 3||14
11383952|NCT03465436|12577845|FG001|STARTED|Period 3||13
11383953|NCT03465436|12577846|FG002|STARTED|Period 3||13
11383954|NCT03465436|12577847|FG003|STARTED|Period 3||14
11383955|NCT03465436|12577844|FG000|Received at Least One Dose of Study Drug|Period 3||13
11383956|NCT03465436|12577845|FG001|Received at Least One Dose of Study Drug|Period 3||12
11383957|NCT03465436|12577846|FG002|Received at Least One Dose of Study Drug|Period 3||13
11383958|NCT03465436|12577847|FG003|Received at Least One Dose of Study Drug|Period 3||14
11383959|NCT03465436|12577844|FG000|COMPLETED|Period 3||13
11383960|NCT03465436|12577845|FG001|COMPLETED|Period 3||12
11383961|NCT03465436|12577846|FG002|COMPLETED|Period 3||13
11383962|NCT03465436|12577847|FG003|COMPLETED|Period 3||14
11383963|NCT03465436|12577844|FG000|NOT COMPLETED|Period 3||1
11383964|NCT03465436|12577845|FG001|NOT COMPLETED|Period 3||1
11383965|NCT03465436|12577846|FG002|NOT COMPLETED|Period 3||0
11383966|NCT03465436|12577847|FG003|NOT COMPLETED|Period 3||0
11383967|NCT03465436|12577844|FG000|STARTED|Period 4||13
11383968|NCT03465436|12577845|FG001|STARTED|Period 4||12
11383969|NCT03465436|12577846|FG002|STARTED|Period 4||13
11383970|NCT03465436|12577847|FG003|STARTED|Period 4||14
11383971|NCT03465436|12577844|FG000|Received at Least 1 Dose of Study Drug|Period 4||13
11383972|NCT03465436|12577845|FG001|Received at Least 1 Dose of Study Drug|Period 4||12
11383973|NCT03465436|12577846|FG002|Received at Least 1 Dose of Study Drug|Period 4||13
11383974|NCT03465436|12577847|FG003|Received at Least 1 Dose of Study Drug|Period 4||14
11383975|NCT03465436|12577844|FG000|COMPLETED|Period 4||13
11383976|NCT03465436|12577845|FG001|COMPLETED|Period 4||12
11383977|NCT03465436|12577846|FG002|COMPLETED|Period 4||12
11383978|NCT03465436|12577847|FG003|COMPLETED|Period 4||14
11383979|NCT03465436|12577844|FG000|NOT COMPLETED|Period 4||0
11383980|NCT03465436|12577845|FG001|NOT COMPLETED|Period 4||0
11383981|NCT03465436|12577846|FG002|NOT COMPLETED|Period 4||1
11383982|NCT03465436|12577847|FG003|NOT COMPLETED|Period 4||0
11383983|NCT03465709|12577859|FG000|STARTED|Overall Study||17
11383984|NCT03465709|12577859|FG000|COMPLETED|Overall Study||0
11383985|NCT03465709|12577859|FG000|NOT COMPLETED|Overall Study||17
11383986|NCT03465722|12577867|FG000|STARTED|End of Treatment||240
11383987|NCT03465722|12577868|FG001|STARTED|End of Treatment||236
11383988|NCT03465722|12577867|FG000|COMPLETED|End of Treatment||0
11383989|NCT03465722|12577868|FG001|COMPLETED|End of Treatment||0
11383990|NCT03465722|12577867|FG000|NOT COMPLETED|End of Treatment||240
11383991|NCT03465722|12577868|FG001|NOT COMPLETED|End of Treatment||236
11383992|NCT03465722|12577867|FG000|STARTED|End of Study||240
11383993|NCT03465722|12577868|FG001|STARTED|End of Study||236
11383994|NCT03465722|12577867|FG000|COMPLETED|End of Study||0
11383995|NCT03465722|12577868|FG001|COMPLETED|End of Study||0
11383996|NCT03465722|12577867|FG000|NOT COMPLETED|End of Study||240
11383997|NCT03465722|12577868|FG001|NOT COMPLETED|End of Study||236
11383998|NCT03465878|12577876|FG000|STARTED|Period 1-Part A First Intervention Day 1||21
11383999|NCT03465878|12577877|FG001|STARTED|Period 1-Part A First Intervention Day 1||21
11384000|NCT03465878|12577878|FG002|STARTED|Period 1-Part A First Intervention Day 1||0
11384001|NCT03465878|12577879|FG003|STARTED|Period 1-Part A First Intervention Day 1||0
11384002|NCT03465878|12577876|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
11384003|NCT03465878|12577877|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
11384004|NCT03465878|12577878|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
11384005|NCT03465878|12577879|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
11384006|NCT03465878|12577876|FG000|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||7
11384007|NCT03465878|12577877|FG001|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||6
11384008|NCT03465878|12577878|FG002|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
11384009|NCT03465878|12577879|FG003|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
11384010|NCT03465878|12577876|FG000|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
11384011|NCT03465878|12577877|FG001|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
11384012|NCT03465878|12577878|FG002|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
11384013|NCT03465878|12577879|FG003|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
11384014|NCT03465878|12577876|FG000|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||7
11384015|NCT03465878|12577877|FG001|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||8
11384016|NCT03465878|12577878|FG002|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
11384017|NCT03465878|12577879|FG003|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
11384018|NCT03465878|12577876|FG000|COMPLETED|Period 1-Part A First Intervention Day 1||21
11384019|NCT03465878|12577877|FG001|COMPLETED|Period 1-Part A First Intervention Day 1||20
11384020|NCT03465878|12577878|FG002|COMPLETED|Period 1-Part A First Intervention Day 1||0
11384021|NCT03465878|12577879|FG003|COMPLETED|Period 1-Part A First Intervention Day 1||0
11384022|NCT03465878|12577876|FG000|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
11384023|NCT03465878|12577877|FG001|NOT COMPLETED|Period 1-Part A First Intervention Day 1||1
11384024|NCT03465878|12577878|FG002|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
11384025|NCT03465878|12577879|FG003|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
11384026|NCT03465878|12577876|FG000|STARTED|Period2-Part A Second Intervention Day 1||21
11384027|NCT03465878|12577877|FG001|STARTED|Period2-Part A Second Intervention Day 1||20
11384028|NCT03465878|12577878|FG002|STARTED|Period2-Part A Second Intervention Day 1||0
11384029|NCT03465878|12577879|FG003|STARTED|Period2-Part A Second Intervention Day 1||0
11384030|NCT03465878|12577876|FG000|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||7
11384031|NCT03465878|12577877|FG001|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||6
11384032|NCT03465878|12577878|FG002|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
11384033|NCT03465878|12577879|FG003|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
11384034|NCT03465878|12577876|FG000|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
11384035|NCT03465878|12577877|FG001|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
11384036|NCT03465878|12577878|FG002|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
11384037|NCT03465878|12577879|FG003|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
11384038|NCT03465878|12577876|FG000|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
11384039|NCT03465878|12577877|FG001|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
11384040|NCT03465878|12577878|FG002|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
11384041|NCT03465878|12577879|FG003|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
11384042|NCT03465878|12577876|FG000|COMPLETED|Period2-Part A Second Intervention Day 1||21
11384043|NCT03465878|12577877|FG001|COMPLETED|Period2-Part A Second Intervention Day 1||20
11384044|NCT03465878|12577878|FG002|COMPLETED|Period2-Part A Second Intervention Day 1||0
11384045|NCT03465878|12577879|FG003|COMPLETED|Period2-Part A Second Intervention Day 1||0
11384046|NCT03465878|12577876|FG000|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
11384047|NCT03465878|12577877|FG001|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
11384048|NCT03465878|12577878|FG002|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
11384049|NCT03465878|12577879|FG003|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
11384050|NCT03465878|12577876|FG000|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
11384051|NCT03465878|12577877|FG001|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
11384052|NCT03465878|12577878|FG002|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|20
11384053|NCT03465878|12577879|FG003|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|19
11384054|NCT03465878|12577876|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
11384055|NCT03465878|12577877|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
11384056|NCT03465878|12577878|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||20
11384057|NCT03465878|12577879|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||17
11384058|NCT03465878|12577876|FG000|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
11384059|NCT03465878|12577877|FG001|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
11384060|NCT03465878|12577878|FG002|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
11384061|NCT03465878|12577879|FG003|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
11384062|NCT03465878|12577876|FG000|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
11384063|NCT03465878|12577877|FG001|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
11384064|NCT03465878|12577878|FG002|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||7
11384065|NCT03465878|12577879|FG003|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||6
11384066|NCT03465878|12577876|FG000|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
11384067|NCT03465878|12577877|FG001|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
11384068|NCT03465878|12577878|FG002|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||7
11384069|NCT03465878|12577879|FG003|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||5
11384070|NCT03465878|12577876|FG000|COMPLETED|Period 1-Part B First Intervention Day 1||0
11384071|NCT03465878|12577877|FG001|COMPLETED|Period 1-Part B First Intervention Day 1||0
11384072|NCT03465878|12577878|FG002|COMPLETED|Period 1-Part B First Intervention Day 1||20
11384073|NCT03465878|12577879|FG003|COMPLETED|Period 1-Part B First Intervention Day 1||17
11384074|NCT03465878|12577876|FG000|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
11384075|NCT03465878|12577877|FG001|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
11384076|NCT03465878|12577878|FG002|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
11384077|NCT03465878|12577879|FG003|NOT COMPLETED|Period 1-Part B First Intervention Day 1||2
11384078|NCT03465878|12577876|FG000|STARTED|Period2-Part B Second Intervention Day 1||0
11384079|NCT03465878|12577877|FG001|STARTED|Period2-Part B Second Intervention Day 1||0
11384080|NCT03465878|12577878|FG002|STARTED|Period2-Part B Second Intervention Day 1||20
11384081|NCT03465878|12577879|FG003|STARTED|Period2-Part B Second Intervention Day 1||17
11384082|NCT03465878|12577876|FG000|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
11384083|NCT03465878|12577877|FG001|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
11384084|NCT03465878|12577878|FG002|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
11384085|NCT03465878|12577879|FG003|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
11384086|NCT03465878|12577876|FG000|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
11384087|NCT03465878|12577877|FG001|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
11384088|NCT03465878|12577878|FG002|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||7
11384089|NCT03465878|12577879|FG003|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||6
11384090|NCT03465878|12577876|FG000|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
11384091|NCT03465878|12577877|FG001|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
11384092|NCT03465878|12577878|FG002|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||7
11384093|NCT03465878|12577879|FG003|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||5
11384094|NCT03465878|12577876|FG000|COMPLETED|Period2-Part B Second Intervention Day 1||0
11384095|NCT03465878|12577877|FG001|COMPLETED|Period2-Part B Second Intervention Day 1||0
11384096|NCT03465878|12577878|FG002|COMPLETED|Period2-Part B Second Intervention Day 1||20
11384097|NCT03465878|12577879|FG003|COMPLETED|Period2-Part B Second Intervention Day 1||17
11384098|NCT03465878|12577876|FG000|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
11384099|NCT03465878|12577877|FG001|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
11384100|NCT03465878|12577878|FG002|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
11384101|NCT03465878|12577879|FG003|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
11384102|NCT03465904|12577907|FG000|STARTED|Overall Study||298
11384103|NCT03465904|12577908|FG001|STARTED|Overall Study||303
11384104|NCT03465904|12577907|FG000|COMPLETED|Overall Study||209
11384105|NCT03465904|12577908|FG001|COMPLETED|Overall Study||237
11384106|NCT03465904|12577907|FG000|NOT COMPLETED|Overall Study||89
11384107|NCT03465904|12577908|FG001|NOT COMPLETED|Overall Study||66
11384108|NCT03466047|12577914|FG000|STARTED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
11384109|NCT03466047|12577914|FG000|COMPLETED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
11384110|NCT03466047|12577914|FG000|NOT COMPLETED|Protein Stomach (1day)||0
11384111|NCT03466047|12577914|FG000|STARTED|Protein Small Intestine (1 Day)||8
11384112|NCT03466047|12577914|FG000|COMPLETED|Protein Small Intestine (1 Day)||8
11384113|NCT03466047|12577914|FG000|NOT COMPLETED|Protein Small Intestine (1 Day)||0
11384114|NCT03466047|12577914|FG000|STARTED|CHO Stomach (1 Day)||8
11384115|NCT03466047|12577914|FG000|COMPLETED|CHO Stomach (1 Day)||8
11384116|NCT03466047|12577914|FG000|NOT COMPLETED|CHO Stomach (1 Day)||0
11384117|NCT03466047|12577914|FG000|STARTED|CHO Small Intestine (1 Day)||8
11384118|NCT03466047|12577914|FG000|COMPLETED|CHO Small Intestine (1 Day)||8
11384119|NCT03466047|12577914|FG000|NOT COMPLETED|CHO Small Intestine (1 Day)||0
11384120|NCT03466047|12577914|FG000|STARTED|Fat Stomach (1 Day)||8
11384121|NCT03466047|12577914|FG000|COMPLETED|Fat Stomach (1 Day)||8
11384122|NCT03466047|12577914|FG000|NOT COMPLETED|Fat Stomach (1 Day)||0
11384123|NCT03466047|12577914|FG000|STARTED|Fat Small Intestine (1 Day)||8
11384124|NCT03466047|12577914|FG000|COMPLETED|Fat Small Intestine (1 Day)||8
11384125|NCT03466047|12577914|FG000|NOT COMPLETED|Fat Small Intestine (1 Day)||0
11384126|NCT03466060|12577943|FG000|STARTED|Period 1||19
11384127|NCT03466060|12577944|FG001|STARTED|Period 1||18
11384128|NCT03466060|12577945|FG002|STARTED|Period 1||20
11384129|NCT03466060|12577946|FG003|STARTED|Period 1||18
11384130|NCT03466060|12577947|FG004|STARTED|Period 1||20
11384131|NCT03466060|12577948|FG005|STARTED|Period 1||18
11384132|NCT03466060|12577943|FG000|COMPLETED|Period 1||19
11384133|NCT03466060|12577944|FG001|COMPLETED|Period 1||16
11384134|NCT03466060|12577945|FG002|COMPLETED|Period 1||17
11384135|NCT03466060|12577946|FG003|COMPLETED|Period 1||17
11384136|NCT03466060|12577947|FG004|COMPLETED|Period 1||20
11384137|NCT03466060|12577948|FG005|COMPLETED|Period 1||18
11384138|NCT03466060|12577943|FG000|NOT COMPLETED|Period 1||0
11384139|NCT03466060|12577944|FG001|NOT COMPLETED|Period 1||2
11384140|NCT03466060|12577945|FG002|NOT COMPLETED|Period 1||3
11384141|NCT03466060|12577946|FG003|NOT COMPLETED|Period 1||1
11384142|NCT03466060|12577947|FG004|NOT COMPLETED|Period 1||0
11384143|NCT03466060|12577948|FG005|NOT COMPLETED|Period 1||0
11384144|NCT03466060|12577943|FG000|STARTED|Period 2||19
11384145|NCT03466060|12577944|FG001|STARTED|Period 2||16
11384146|NCT03466060|12577945|FG002|STARTED|Period 2||17
11384147|NCT03466060|12577946|FG003|STARTED|Period 2||17
11384148|NCT03466060|12577947|FG004|STARTED|Period 2||20
11384149|NCT03466060|12577948|FG005|STARTED|Period 2||18
11384150|NCT03466060|12577943|FG000|COMPLETED|Period 2||19
11384151|NCT03466060|12577944|FG001|COMPLETED|Period 2||16
11384152|NCT03466060|12577945|FG002|COMPLETED|Period 2||16
11384153|NCT03466060|12577946|FG003|COMPLETED|Period 2||17
11384154|NCT03466060|12577947|FG004|COMPLETED|Period 2||20
11384155|NCT03466060|12577948|FG005|COMPLETED|Period 2||18
11384156|NCT03466060|12577943|FG000|NOT COMPLETED|Period 2||0
11384157|NCT03466060|12577944|FG001|NOT COMPLETED|Period 2||0
11384158|NCT03466060|12577945|FG002|NOT COMPLETED|Period 2||1
11384159|NCT03466060|12577946|FG003|NOT COMPLETED|Period 2||0
11384160|NCT03466060|12577947|FG004|NOT COMPLETED|Period 2||0
11384161|NCT03466060|12577948|FG005|NOT COMPLETED|Period 2||0
11384162|NCT03466073|12577968|FG000|STARTED|Overall Study||6
11384163|NCT03466073|12577969|FG001|STARTED|Overall Study||2
11384164|NCT03466073|12577970|FG002|STARTED|Overall Study||6
11384165|NCT03466073|12577971|FG003|STARTED|Overall Study||6
11384166|NCT03466073|12577972|FG004|STARTED|Overall Study||6
11384167|NCT03466073|12577973|FG005|STARTED|Overall Study||7
11384168|NCT03466073|12577968|FG000|COMPLETED|Overall Study||5
11384169|NCT03466073|12577969|FG001|COMPLETED|Overall Study||2
11384170|NCT03466073|12577970|FG002|COMPLETED|Overall Study||6
11384171|NCT03466073|12577971|FG003|COMPLETED|Overall Study||6
11384172|NCT03466073|12577972|FG004|COMPLETED|Overall Study||6
11384173|NCT03466073|12577973|FG005|COMPLETED|Overall Study||6
11384174|NCT03466073|12577968|FG000|NOT COMPLETED|Overall Study||1
11384175|NCT03466073|12577969|FG001|NOT COMPLETED|Overall Study||0
11384176|NCT03466073|12577970|FG002|NOT COMPLETED|Overall Study||0
11384177|NCT03466073|12577971|FG003|NOT COMPLETED|Overall Study||0
11384178|NCT03466073|12577972|FG004|NOT COMPLETED|Overall Study||0
11384179|NCT03466073|12577973|FG005|NOT COMPLETED|Overall Study||1
11384180|NCT03466086|12577994|FG000|STARTED|Period 1||28
11384181|NCT03466086|12577995|FG001|STARTED|Period 1||27
11384182|NCT03466086|12577994|FG000|COMPLETED|Period 1||26
11384183|NCT03466086|12577995|FG001|COMPLETED|Period 1||27
11384184|NCT03466086|12577994|FG000|NOT COMPLETED|Period 1||2
11384185|NCT03466086|12577995|FG001|NOT COMPLETED|Period 1||0
11384186|NCT03466086|12577994|FG000|STARTED|Period 2||26
11384187|NCT03466086|12577995|FG001|STARTED|Period 2||27
11384188|NCT03466086|12577994|FG000|COMPLETED|Period 2||26
11384189|NCT03466086|12577995|FG001|COMPLETED|Period 2||27
11384190|NCT03466086|12577994|FG000|NOT COMPLETED|Period 2||0
11384191|NCT03466086|12577995|FG001|NOT COMPLETED|Period 2||0
11384192|NCT03466099|12578004|FG000|STARTED|Overall Study||41
11384193|NCT03466099|12578005|FG001|STARTED|Overall Study||44
11384194|NCT03466099|12578006|FG002|STARTED|Overall Study|One study subject consented and was randomized, but withdrew prior to receiving any study treatments|45
11384195|NCT03466099|12578004|FG000|Treated|Overall Study||41
11384196|NCT03466099|12578005|FG001|Treated|Overall Study||44
11384197|NCT03466099|12578006|FG002|Treated|Overall Study||44
11384198|NCT03466099|12578004|FG000|COMPLETED|Overall Study||24
11384199|NCT03466099|12578005|FG001|COMPLETED|Overall Study||30
11384200|NCT03466099|12578006|FG002|COMPLETED|Overall Study||28
11384201|NCT03466099|12578004|FG000|NOT COMPLETED|Overall Study||17
11384202|NCT03466099|12578005|FG001|NOT COMPLETED|Overall Study||14
11384203|NCT03466099|12578006|FG002|NOT COMPLETED|Overall Study||17
11384204|NCT03467048|12578016|FG000|STARTED|Overall Study||66
11384205|NCT03467048|12578017|FG001|STARTED|Overall Study||64
11384206|NCT03467048|12578016|FG000|COMPLETED|Overall Study||66
11384207|NCT03467048|12578017|FG001|COMPLETED|Overall Study||63
11384208|NCT03467048|12578016|FG000|NOT COMPLETED|Overall Study||0
11384209|NCT03467048|12578017|FG001|NOT COMPLETED|Overall Study||1
11384210|NCT03467217|12578025|FG000|STARTED|Overall Study||43
11384211|NCT03467217|12578026|FG001|STARTED|Overall Study||40
11384212|NCT03467217|12578025|FG000|COMPLETED|Overall Study||33
11384213|NCT03467217|12578026|FG001|COMPLETED|Overall Study||34
11384214|NCT03467217|12578025|FG000|NOT COMPLETED|Overall Study||10
11384215|NCT03467217|12578026|FG001|NOT COMPLETED|Overall Study||6
11384216|NCT03467412|12578032|FG000|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
11384217|NCT03467412|12578033|FG001|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
11384218|NCT03467412|12578034|FG002|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
11384219|NCT03467412|12578035|FG003|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
11384220|NCT03467412|12578036|FG004|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|20
11384221|NCT03467412|12578032|FG000|COMPLETED|Overall Study||22
11384222|NCT03467412|12578033|FG001|COMPLETED|Overall Study||24
11384223|NCT03467412|12578034|FG002|COMPLETED|Overall Study||20
11384224|NCT03467412|12578035|FG003|COMPLETED|Overall Study||23
11384225|NCT03467412|12578036|FG004|COMPLETED|Overall Study||17
11384226|NCT03467412|12578032|FG000|NOT COMPLETED|Overall Study||3
11384227|NCT03467412|12578033|FG001|NOT COMPLETED|Overall Study||1
11384228|NCT03467412|12578034|FG002|NOT COMPLETED|Overall Study||5
11384229|NCT03467412|12578035|FG003|NOT COMPLETED|Overall Study||2
11384230|NCT03467412|12578036|FG004|NOT COMPLETED|Overall Study||3
11384231|NCT03467425|12578057|FG000|STARTED|Overall Study||1545
11384232|NCT03467425|12578058|FG001|STARTED|Overall Study||1547
11384233|NCT03467425|12578057|FG000|Randomized But Did Not Start IP|Overall Study||1
11384234|NCT03467425|12578058|FG001|Randomized But Did Not Start IP|Overall Study||0
11384235|NCT03467425|12578057|FG000|Completed IP|Overall Study||1256
11384236|NCT03467425|12578058|FG001|Completed IP|Overall Study||1359
11384237|NCT03467425|12578057|FG000|Not Completed IP|Overall Study||288
11384238|NCT03467425|12578058|FG001|Not Completed IP|Overall Study||188
11384239|NCT03467425|12578057|FG000|Withdrew IP (WIP): Lost to Follow-up|Overall Study||15
11384240|NCT03467425|12578058|FG001|Withdrew IP (WIP): Lost to Follow-up|Overall Study||24
11384241|NCT03467425|12578057|FG000|WIP: Protocol Deviation|Overall Study||0
11384242|NCT03467425|12578058|FG001|WIP: Protocol Deviation|Overall Study||2
11384243|NCT03467425|12578057|FG000|WIP: Adverse Event|Overall Study||112
11384244|NCT03467425|12578058|FG001|WIP: Adverse Event|Overall Study||29
11384245|NCT03467425|12578057|FG000|WIP: Lack of Efficacy|Overall Study||56
11384246|NCT03467425|12578058|FG001|WIP: Lack of Efficacy|Overall Study||28
11384247|NCT03467425|12578057|FG000|WIP: Physician Decision|Overall Study||14
11384248|NCT03467425|12578058|FG001|WIP: Physician Decision|Overall Study||27
11384249|NCT03467425|12578057|FG000|WIP: Withdrawal by Participant|Overall Study||91
11384250|NCT03467425|12578058|FG001|WIP: Withdrawal by Participant|Overall Study||78
11384251|NCT03467425|12578057|FG000|COMPLETED|Overall Study||1498
11384252|NCT03467425|12578058|FG001|COMPLETED|Overall Study||1493
11384253|NCT03467425|12578057|FG000|NOT COMPLETED|Overall Study||47
11384254|NCT03467425|12578058|FG001|NOT COMPLETED|Overall Study||54
11384255|NCT03467477|12578064|FG000|STARTED|Overall Study||161
11384256|NCT03467477|12578064|FG000|COMPLETED|Overall Study||161
11384257|NCT03467477|12578064|FG000|NOT COMPLETED|Overall Study||0
11384258|NCT03467685|12578073|FG000|STARTED|Overall Study||52
11384259|NCT03467685|12578074|FG001|STARTED|Overall Study||49
11384260|NCT03467685|12578073|FG000|COMPLETED|Overall Study||52
11384261|NCT03467685|12578074|FG001|COMPLETED|Overall Study||49
11384262|NCT03467685|12578073|FG000|NOT COMPLETED|Overall Study||0
11384263|NCT03467685|12578074|FG001|NOT COMPLETED|Overall Study||0
11384264|NCT03467763|12578080|FG000|STARTED|Overall Study||13
11384265|NCT03467763|12578080|FG000|Weeks 1-2|Overall Study||13
11384266|NCT03467763|12578080|FG000|Weeks 3-4|Overall Study||10
11384267|NCT03467763|12578080|FG000|Weeks 5-6|Overall Study||8
11384268|NCT03467763|12578080|FG000|Weeks 7-8|Overall Study||7
11384269|NCT03467763|12578080|FG000|Weeks 9 - 10|Overall Study||6
11384270|NCT03467763|12578080|FG000|Week 11-12|Overall Study||6
11384271|NCT03467763|12578080|FG000|Weeks 13-14|Overall Study||2
11384272|NCT03467763|12578080|FG000|Weeks 15-16|Overall Study||2
11384273|NCT03467763|12578080|FG000|COMPLETED|Overall Study||10
11384274|NCT03467763|12578080|FG000|NOT COMPLETED|Overall Study||3
11384275|NCT03467945|12578090|FG000|STARTED|Treatment Period 1||10
11384276|NCT03467945|12578091|FG001|STARTED|Treatment Period 1||10
11384277|NCT03467945|12578092|FG002|STARTED|Treatment Period 1||10
11384278|NCT03467945|12578093|FG003|STARTED|Treatment Period 1||10
11384279|NCT03467945|12578090|FG000|COMPLETED|Treatment Period 1||10
11384280|NCT03467945|12578091|FG001|COMPLETED|Treatment Period 1||10
11384281|NCT03467945|12578092|FG002|COMPLETED|Treatment Period 1||10
11384282|NCT03467945|12578093|FG003|COMPLETED|Treatment Period 1||10
11384283|NCT03467945|12578090|FG000|NOT COMPLETED|Treatment Period 1||0
11384284|NCT03467945|12578091|FG001|NOT COMPLETED|Treatment Period 1||0
11384285|NCT03467945|12578092|FG002|NOT COMPLETED|Treatment Period 1||0
11384286|NCT03467945|12578093|FG003|NOT COMPLETED|Treatment Period 1||0
11384287|NCT03467945|12578090|FG000|STARTED|Treatment Period 2||10
11384288|NCT03467945|12578091|FG001|STARTED|Treatment Period 2||10
11384289|NCT03467945|12578092|FG002|STARTED|Treatment Period 2||10
11384290|NCT03467945|12578093|FG003|STARTED|Treatment Period 2||10
11384291|NCT03467945|12578090|FG000|COMPLETED|Treatment Period 2||10
11384292|NCT03467945|12578091|FG001|COMPLETED|Treatment Period 2||9
11384293|NCT03467945|12578092|FG002|COMPLETED|Treatment Period 2||10
11384294|NCT03467945|12578093|FG003|COMPLETED|Treatment Period 2||10
11384295|NCT03467945|12578090|FG000|NOT COMPLETED|Treatment Period 2||0
11384296|NCT03467945|12578091|FG001|NOT COMPLETED|Treatment Period 2||1
11384297|NCT03467945|12578092|FG002|NOT COMPLETED|Treatment Period 2||0
11384298|NCT03467945|12578093|FG003|NOT COMPLETED|Treatment Period 2||0
11384299|NCT03467945|12578090|FG000|STARTED|Treatment Period 3||10
11384300|NCT03467945|12578091|FG001|STARTED|Treatment Period 3||9
11384301|NCT03467945|12578092|FG002|STARTED|Treatment Period 3||10
11384302|NCT03467945|12578093|FG003|STARTED|Treatment Period 3||10
11384303|NCT03467945|12578090|FG000|COMPLETED|Treatment Period 3||9
11384304|NCT03467945|12578091|FG001|COMPLETED|Treatment Period 3||9
11384305|NCT03467945|12578092|FG002|COMPLETED|Treatment Period 3||8
11384306|NCT03467945|12578093|FG003|COMPLETED|Treatment Period 3||9
11384307|NCT03467945|12578090|FG000|NOT COMPLETED|Treatment Period 3||1
11384308|NCT03467945|12578091|FG001|NOT COMPLETED|Treatment Period 3||0
11384309|NCT03467945|12578092|FG002|NOT COMPLETED|Treatment Period 3||2
11384310|NCT03467945|12578093|FG003|NOT COMPLETED|Treatment Period 3||1
11384311|NCT03467945|12578090|FG000|STARTED|Treatment Period 4||9
11384312|NCT03467945|12578091|FG001|STARTED|Treatment Period 4||9
11384313|NCT03467945|12578092|FG002|STARTED|Treatment Period 4||8
11384314|NCT03467945|12578093|FG003|STARTED|Treatment Period 4||9
11384315|NCT03467945|12578090|FG000|COMPLETED|Treatment Period 4||9
11384316|NCT03467945|12578091|FG001|COMPLETED|Treatment Period 4||9
11384317|NCT03467945|12578092|FG002|COMPLETED|Treatment Period 4||8
11384318|NCT03467945|12578093|FG003|COMPLETED|Treatment Period 4||9
11384319|NCT03467945|12578090|FG000|NOT COMPLETED|Treatment Period 4||0
11384320|NCT03467945|12578091|FG001|NOT COMPLETED|Treatment Period 4||0
11384321|NCT03467945|12578092|FG002|NOT COMPLETED|Treatment Period 4||0
11384322|NCT03467945|12578093|FG003|NOT COMPLETED|Treatment Period 4||0
11384323|NCT03467971|12578106|FG000|STARTED|Treatment Period 1||10
11384324|NCT03467971|12578107|FG001|STARTED|Treatment Period 1||11
11384325|NCT03467971|12578106|FG000|COMPLETED|Treatment Period 1||10
11384326|NCT03467971|12578107|FG001|COMPLETED|Treatment Period 1||11
11384327|NCT03467971|12578106|FG000|NOT COMPLETED|Treatment Period 1||0
11384328|NCT03467971|12578107|FG001|NOT COMPLETED|Treatment Period 1||0
11384329|NCT03467971|12578106|FG000|STARTED|Treatment Period 2||10
11384330|NCT03467971|12578107|FG001|STARTED|Treatment Period 2||11
11384331|NCT03467971|12578106|FG000|COMPLETED|Treatment Period 2||10
11384332|NCT03467971|12578107|FG001|COMPLETED|Treatment Period 2||10
11384333|NCT03467971|12578106|FG000|NOT COMPLETED|Treatment Period 2||0
11384334|NCT03467971|12578107|FG001|NOT COMPLETED|Treatment Period 2||1
11384335|NCT03468075|12578114|FG000|STARTED|Overall Study||10
11384336|NCT03468075|12578114|FG000|COMPLETED|Overall Study||10
11384337|NCT03468075|12578114|FG000|NOT COMPLETED|Overall Study||0
11384338|NCT03468179|12578118|FG000|STARTED|Overall Study||10
11384339|NCT03468179|12578118|FG000|COMPLETED|Overall Study||10
11384340|NCT03468179|12578118|FG000|NOT COMPLETED|Overall Study||0
11384341|NCT03468543|12578125|FG000|STARTED|Overall Study||3
11384342|NCT03468543|12578125|FG000|COMPLETED|Overall Study||0
11384343|NCT03468543|12578125|FG000|NOT COMPLETED|Overall Study||3
11384344|NCT03468816|12578131|FG000|STARTED|Overall Study||2
11384345|NCT03468816|12578132|FG001|STARTED|Overall Study||3
11384346|NCT03468816|12578131|FG000|COMPLETED|Overall Study||2
11384347|NCT03468816|12578132|FG001|COMPLETED|Overall Study||3
11384348|NCT03468816|12578131|FG000|NOT COMPLETED|Overall Study||0
11384349|NCT03468816|12578132|FG001|NOT COMPLETED|Overall Study||0
11384350|NCT03468855|12578140|FG000|STARTED|Overall Study||34
11384351|NCT03468855|12578140|FG000|COMPLETED|Overall Study||23
11384352|NCT03468855|12578140|FG000|NOT COMPLETED|Overall Study||11
11384353|NCT03468920|12578146|FG000|STARTED|Overall Study||60
11384354|NCT03468920|12578147|FG001|STARTED|Overall Study||60
11384355|NCT03468920|12578146|FG000|COMPLETED|Overall Study||60
11384356|NCT03468920|12578147|FG001|COMPLETED|Overall Study||60
11384357|NCT03468920|12578146|FG000|NOT COMPLETED|Overall Study||0
11384358|NCT03468920|12578147|FG001|NOT COMPLETED|Overall Study||0
11384359|NCT03468933|12578155|FG000|STARTED|Overall Study||16
11384360|NCT03468933|12578156|FG001|STARTED|Overall Study||16
11384361|NCT03468933|12578155|FG000|COMPLETED|Overall Study||16
11384362|NCT03468933|12578156|FG001|COMPLETED|Overall Study||16
11384363|NCT03468933|12578155|FG000|NOT COMPLETED|Overall Study||0
11384364|NCT03468933|12578156|FG001|NOT COMPLETED|Overall Study||0
11384365|NCT03469336|12578162|FG000|STARTED|Overall Study||18
11384366|NCT03469336|12578162|FG000|COMPLETED|Overall Study||17
11384367|NCT03469336|12578162|FG000|NOT COMPLETED|Overall Study||1
11384368|NCT03469349|12578174|FG000|STARTED|Overall Study||182
11384369|NCT03469349|12578175|FG001|STARTED|Overall Study||184
11384370|NCT03469349|12578174|FG000|COMPLETED|Overall Study||177
11384371|NCT03469349|12578175|FG001|COMPLETED|Overall Study||174
11384372|NCT03469349|12578174|FG000|NOT COMPLETED|Overall Study||5
11384373|NCT03469349|12578175|FG001|NOT COMPLETED|Overall Study||10
11384374|NCT03470012|12578181|FG000|STARTED|Overall Study||24
11384375|NCT03470012|12578181|FG000|COMPLETED|Overall Study||24
11384376|NCT03470012|12578181|FG000|NOT COMPLETED|Overall Study||0
11384377|NCT03470194|12578187|FG000|STARTED|Overall Study||49
11384378|NCT03470194|12578188|FG001|STARTED|Overall Study||57
11384379|NCT03470194|12578187|FG000|COMPLETED|Overall Study||38
11384380|NCT03470194|12578188|FG001|COMPLETED|Overall Study||40
11384381|NCT03470194|12578187|FG000|NOT COMPLETED|Overall Study||11
11384382|NCT03470194|12578188|FG001|NOT COMPLETED|Overall Study||17
11384383|NCT03470493|12578194|FG000|STARTED|Overall Study||130
11384384|NCT03470493|12578194|FG000|Met Primary Endpoint|Overall Study||80
11384385|NCT03470493|12578194|FG000|COMPLETED|Overall Study||130
11384386|NCT03470493|12578194|FG000|NOT COMPLETED|Overall Study||0
11384387|NCT03470545|12578200|FG000|STARTED|Overall Study||123
11384388|NCT03470545|12578201|FG001|STARTED|Overall Study||128
11384389|NCT03470545|12578200|FG000|COMPLETED|Overall Study||119
11384390|NCT03470545|12578201|FG001|COMPLETED|Overall Study||125
11384391|NCT03470545|12578200|FG000|NOT COMPLETED|Overall Study||4
11384392|NCT03470545|12578201|FG001|NOT COMPLETED|Overall Study||3
11384393|NCT03470740|12578210|FG000|STARTED|Overall Study||112
11384394|NCT03470740|12578211|FG001|STARTED|Overall Study||112
11384395|NCT03470740|12578210|FG000|COMPLETED|Overall Study||108
11384396|NCT03470740|12578211|FG001|COMPLETED|Overall Study||106
11384397|NCT03470740|12578210|FG000|NOT COMPLETED|Overall Study||4
11384398|NCT03470740|12578211|FG001|NOT COMPLETED|Overall Study||6
11384399|NCT03471065|12578218|FG000|STARTED|Overall Study||100
11384400|NCT03471065|12578218|FG000|COMPLETED|Overall Study||100
11384401|NCT03471065|12578218|FG000|NOT COMPLETED|Overall Study||0
11384402|NCT03471078|12578224|FG000|STARTED|Overall Study||82
11384403|NCT03471078|12578225|FG001|STARTED|Overall Study||40
11384404|NCT03471078|12578224|FG000|COMPLETED|Overall Study||61
11384405|NCT03471078|12578225|FG001|COMPLETED|Overall Study||34
11384406|NCT03471078|12578224|FG000|NOT COMPLETED|Overall Study||21
11384407|NCT03471078|12578225|FG001|NOT COMPLETED|Overall Study||6
11384408|NCT03471832|12578231|FG000|STARTED|Overall Study||40
11384409|NCT03471832|12578232|FG001|STARTED|Overall Study||40
11384410|NCT03471832|12578231|FG000|COMPLETED|Overall Study||40
11384411|NCT03471832|12578232|FG001|COMPLETED|Overall Study||40
11384412|NCT03471832|12578231|FG000|NOT COMPLETED|Overall Study||0
11384413|NCT03471832|12578232|FG001|NOT COMPLETED|Overall Study||0
11384414|NCT03471871|12578242|FG000|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
11384415|NCT03471871|12578243|FG001|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
11384416|NCT03471871|12578244|FG002|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
11384417|NCT03471871|12578245|FG003|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
11384418|NCT03471871|12578246|FG004|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
11384419|NCT03471871|12578242|FG000|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
11384420|NCT03471871|12578243|FG001|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
11384421|NCT03471871|12578244|FG002|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
11384422|NCT03471871|12578245|FG003|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
11384423|NCT03471871|12578246|FG004|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
11384424|NCT03471871|12578242|FG000|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
11384425|NCT03471871|12578243|FG001|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
11384426|NCT03471871|12578244|FG002|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
11384427|NCT03471871|12578245|FG003|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
11384428|NCT03471871|12578246|FG004|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
11384429|NCT03471871|12578242|FG000|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
11384430|NCT03471871|12578243|FG001|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
11384431|NCT03471871|12578244|FG002|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
11384432|NCT03471871|12578245|FG003|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
11384433|NCT03471871|12578246|FG004|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
11384434|NCT03471871|12578242|FG000|STARTED|Washout Period 1 (14 Days)||6
11384435|NCT03471871|12578243|FG001|STARTED|Washout Period 1 (14 Days)||5
11384436|NCT03471871|12578244|FG002|STARTED|Washout Period 1 (14 Days)||5
11384437|NCT03471871|12578245|FG003|STARTED|Washout Period 1 (14 Days)||18
11384438|NCT03471871|12578246|FG004|STARTED|Washout Period 1 (14 Days)||19
11384439|NCT03471871|12578242|FG000|COMPLETED|Washout Period 1 (14 Days)||6
11384440|NCT03471871|12578243|FG001|COMPLETED|Washout Period 1 (14 Days)||5
11384441|NCT03471871|12578244|FG002|COMPLETED|Washout Period 1 (14 Days)||5
11384442|NCT03471871|12578245|FG003|COMPLETED|Washout Period 1 (14 Days)||18
11384443|NCT03471871|12578246|FG004|COMPLETED|Washout Period 1 (14 Days)||19
11384444|NCT03471871|12578242|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
11384445|NCT03471871|12578243|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
11384446|NCT03471871|12578244|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0
11384447|NCT03471871|12578245|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
11384448|NCT03471871|12578246|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
11384449|NCT03471871|12578242|FG000|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
11384450|NCT03471871|12578243|FG001|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
11384451|NCT03471871|12578244|FG002|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
11384452|NCT03471871|12578245|FG003|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
11384453|NCT03471871|12578246|FG004|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19
11384454|NCT03471871|12578242|FG000|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
11384455|NCT03471871|12578243|FG001|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
11384456|NCT03471871|12578244|FG002|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
11384457|NCT03471871|12578245|FG003|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
11384458|NCT03471871|12578246|FG004|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
11384459|NCT03471871|12578242|FG000|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
11384460|NCT03471871|12578243|FG001|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
11384461|NCT03471871|12578244|FG002|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
11384462|NCT03471871|12578245|FG003|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
11384463|NCT03471871|12578246|FG004|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1
11384464|NCT03471871|12578242|FG000|STARTED|Washout Period 2 (14 Days)||6
11384465|NCT03471871|12578243|FG001|STARTED|Washout Period 2 (14 Days)||5
11384466|NCT03471871|12578244|FG002|STARTED|Washout Period 2 (14 Days)||5
11384467|NCT03471871|12578245|FG003|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
11384468|NCT03471871|12578246|FG004|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
11384469|NCT03471871|12578242|FG000|COMPLETED|Washout Period 2 (14 Days)||6
11384470|NCT03471871|12578243|FG001|COMPLETED|Washout Period 2 (14 Days)||5
11384471|NCT03471871|12578244|FG002|COMPLETED|Washout Period 2 (14 Days)||5
11384472|NCT03471871|12578245|FG003|COMPLETED|Washout Period 2 (14 Days)||0
11384473|NCT03471871|12578246|FG004|COMPLETED|Washout Period 2 (14 Days)||0
11384474|NCT03471871|12578242|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0
11384475|NCT03471871|12578243|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
11384476|NCT03471871|12578244|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0
11384477|NCT03471871|12578245|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
11384478|NCT03471871|12578246|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
11384479|NCT03471871|12578242|FG000|STARTED|Treatment Period 3: ( HV:1 Day)||6
11384480|NCT03471871|12578243|FG001|STARTED|Treatment Period 3: ( HV:1 Day)||5
11384481|NCT03471871|12578244|FG002|STARTED|Treatment Period 3: ( HV:1 Day)||5
11384482|NCT03471871|12578245|FG003|STARTED|Treatment Period 3: ( HV:1 Day)||0
11384483|NCT03471871|12578246|FG004|STARTED|Treatment Period 3: ( HV:1 Day)||0
11384484|NCT03471871|12578242|FG000|COMPLETED|Treatment Period 3: ( HV:1 Day)||6
11384485|NCT03471871|12578243|FG001|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
11384486|NCT03471871|12578244|FG002|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
11384487|NCT03471871|12578245|FG003|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
11384488|NCT03471871|12578246|FG004|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
11384489|NCT03471871|12578242|FG000|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
11384490|NCT03471871|12578243|FG001|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
11384491|NCT03471871|12578244|FG002|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
11384492|NCT03471871|12578245|FG003|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
11384493|NCT03471871|12578246|FG004|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
11384494|NCT03471871|12578242|FG000|STARTED|Follow Up (14 Days for Both HV and OSA)||6
11384495|NCT03471871|12578243|FG001|STARTED|Follow Up (14 Days for Both HV and OSA)||5
11384496|NCT03471871|12578244|FG002|STARTED|Follow Up (14 Days for Both HV and OSA)||5
11384497|NCT03471871|12578245|FG003|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
11384498|NCT03471871|12578246|FG004|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
11384499|NCT03471871|12578242|FG000|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6
11384500|NCT03471871|12578243|FG001|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
11384501|NCT03471871|12578244|FG002|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
11384502|NCT03471871|12578245|FG003|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
11384503|NCT03471871|12578246|FG004|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
11384504|NCT03471871|12578242|FG000|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
11384505|NCT03471871|12578243|FG001|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
11384506|NCT03471871|12578244|FG002|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
11384507|NCT03471871|12578245|FG003|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
11384508|NCT03471871|12578246|FG004|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
11384509|NCT03471975|12578260|FG000|STARTED|Overall Study||17
11384510|NCT03471975|12578261|FG001|STARTED|Overall Study||20
11384511|NCT03471975|12578260|FG000|COMPLETED|Overall Study||17
11384512|NCT03471975|12578261|FG001|COMPLETED|Overall Study||20
11384513|NCT03471975|12578260|FG000|NOT COMPLETED|Overall Study||0
11384514|NCT03471975|12578261|FG001|NOT COMPLETED|Overall Study||0
11384515|NCT03472014|12578267|FG000|STARTED|Overall Study||22
11384516|NCT03472014|12578267|FG000|COMPLETED|Overall Study||18
11384517|NCT03472014|12578267|FG000|NOT COMPLETED|Overall Study||4
11384518|NCT03472287|12578273|FG000|STARTED|Overall Study||8
11384519|NCT03472287|12578274|FG001|STARTED|Overall Study||3
11384520|NCT03472287|12578273|FG000|COMPLETED|Overall Study||8
11384521|NCT03472287|12578274|FG001|COMPLETED|Overall Study||3
11384522|NCT03472287|12578273|FG000|NOT COMPLETED|Overall Study||0
11384523|NCT03472287|12578274|FG001|NOT COMPLETED|Overall Study||0
11384524|NCT03472326|12578282|FG000|STARTED|Part 1: GS-9131 Functional Monotherapy||11
11384525|NCT03472326|12578283|FG001|STARTED|Part 1: GS-9131 Functional Monotherapy||10
11384526|NCT03472326|12578284|FG002|STARTED|Part 1: GS-9131 Functional Monotherapy||0
11384527|NCT03472326|12578285|FG003|STARTED|Part 1: GS-9131 Functional Monotherapy||0
11384528|NCT03472326|12578282|FG000|COMPLETED|Part 1: GS-9131 Functional Monotherapy||11
11384529|NCT03472326|12578283|FG001|COMPLETED|Part 1: GS-9131 Functional Monotherapy||10
11384530|NCT03472326|12578284|FG002|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
11384531|NCT03472326|12578285|FG003|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
11384532|NCT03472326|12578282|FG000|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
11384533|NCT03472326|12578283|FG001|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
11384534|NCT03472326|12578284|FG002|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
11384535|NCT03472326|12578285|FG003|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
11384536|NCT03472326|12578282|FG000|STARTED|Part 2: Combination Therapy||0
11384537|NCT03472326|12578283|FG001|STARTED|Part 2: Combination Therapy||0
11384538|NCT03472326|12578284|FG002|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 1 participant entered in Part 2.|1
11384539|NCT03472326|12578285|FG003|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 3 participants entered in Part 2.|3
11384540|NCT03472326|12578282|FG000|COMPLETED|Part 2: Combination Therapy||0
11384541|NCT03472326|12578283|FG001|COMPLETED|Part 2: Combination Therapy||0
11384542|NCT03472326|12578284|FG002|COMPLETED|Part 2: Combination Therapy||0
11384543|NCT03472326|12578285|FG003|COMPLETED|Part 2: Combination Therapy||0
11384544|NCT03472326|12578282|FG000|NOT COMPLETED|Part 2: Combination Therapy||0
11384545|NCT03472326|12578283|FG001|NOT COMPLETED|Part 2: Combination Therapy||0
11384546|NCT03472326|12578284|FG002|NOT COMPLETED|Part 2: Combination Therapy||1
11384547|NCT03472326|12578285|FG003|NOT COMPLETED|Part 2: Combination Therapy||3
11384548|NCT03472469|12578296|FG000|STARTED|Overall Study||787
11384549|NCT03472469|12578297|FG001|STARTED|Overall Study||774
11384550|NCT03472469|12578296|FG000|COMPLETED|Overall Study||787
11384551|NCT03472469|12578297|FG001|COMPLETED|Overall Study||774
11384552|NCT03472469|12578296|FG000|NOT COMPLETED|Overall Study||0
11384553|NCT03472469|12578297|FG001|NOT COMPLETED|Overall Study||0
11384554|NCT03472534|12578303|FG000|STARTED|Overall Study|Each participant receives all 4 unit interventions.|46
11384555|NCT03472534|12578303|FG000|Diacerein 1% Ointment|Overall Study||46
11384556|NCT03472534|12578303|FG000|Vehicle Ointment|Overall Study||46
11384557|NCT03472534|12578303|FG000|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46
11384558|NCT03472534|12578303|FG000|0.9% Saline|Overall Study||46
11384559|NCT03472534|12578303|FG000|COMPLETED|Overall Study||35
11384560|NCT03472534|12578303|FG000|NOT COMPLETED|Overall Study||11
11384561|NCT03472547|12578307|FG000|STARTED|Overall Study||234
11384562|NCT03472547|12578307|FG000|COMPLETED|Overall Study||204
11384563|NCT03472547|12578307|FG000|NOT COMPLETED|Overall Study||30
11384564|NCT03473171|12578311|FG000|STARTED|Overall Study||5
11384565|NCT03473171|12578311|FG000|COMPLETED|Overall Study||5
11384566|NCT03473171|12578311|FG000|NOT COMPLETED|Overall Study||0
11384567|NCT03473184|12578315|FG000|STARTED|Overall Study||34
11384568|NCT03473184|12578315|FG000|Diacerein 1% Ointment Irradiated|Overall Study||34
11384569|NCT03473184|12578315|FG000|Vehicle Ointment Irradiated|Overall Study||34
11384570|NCT03473184|12578315|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||34
11384571|NCT03473184|12578315|FG000|Vehicle Ointment Non-irradiated|Overall Study||34
11384572|NCT03473184|12578315|FG000|Untreated Irradiated|Overall Study||34
11384573|NCT03473184|12578315|FG000|COMPLETED|Overall Study||34
11384574|NCT03473184|12578315|FG000|NOT COMPLETED|Overall Study||0
11384575|NCT03473197|12578319|FG000|STARTED|Overall Study||61
11384576|NCT03473197|12578319|FG000|Diacerein 1% Ointment Irradiated|Overall Study||51
11384577|NCT03473197|12578319|FG000|Vehicle Ointment Irradiated|Overall Study||51
11384578|NCT03473197|12578319|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||51
11384579|NCT03473197|12578319|FG000|Vehicle Ointment Non-irradiated|Overall Study||51
11384580|NCT03473197|12578319|FG000|Untreated Irradiated|Overall Study||51
11384581|NCT03473197|12578319|FG000|COMPLETED|Overall Study||51
11384582|NCT03473197|12578319|FG000|NOT COMPLETED|Overall Study||10
11384583|NCT03473236|12578333|FG000|STARTED|Overall Study||10
11384584|NCT03473236|12578334|FG001|STARTED|Overall Study||6
11384585|NCT03473236|12578335|FG002|STARTED|Overall Study||6
11384586|NCT03473236|12578336|FG003|STARTED|Overall Study||6
11384587|NCT03473236|12578337|FG004|STARTED|Overall Study||6
11384588|NCT03473236|12578338|FG005|STARTED|Overall Study||7
11384589|NCT03473236|12578339|FG006|STARTED|Overall Study||6
11384590|NCT03473236|12578340|FG007|STARTED|Overall Study||6
11384591|NCT03473236|12578341|FG008|STARTED|Overall Study||7
11384592|NCT03473236|12578342|FG009|STARTED|Overall Study||6
11384593|NCT03473236|12578333|FG000|COMPLETED|Overall Study||10
11384594|NCT03473236|12578334|FG001|COMPLETED|Overall Study||6
11384595|NCT03473236|12578335|FG002|COMPLETED|Overall Study||6
11384596|NCT03473236|12578336|FG003|COMPLETED|Overall Study||6
11384597|NCT03473236|12578337|FG004|COMPLETED|Overall Study||6
11384598|NCT03473236|12578338|FG005|COMPLETED|Overall Study||6
11384599|NCT03473236|12578339|FG006|COMPLETED|Overall Study||6
11384600|NCT03473236|12578340|FG007|COMPLETED|Overall Study||6
11384601|NCT03473236|12578341|FG008|COMPLETED|Overall Study||6
11384602|NCT03473236|12578342|FG009|COMPLETED|Overall Study||6
11384603|NCT03473236|12578333|FG000|NOT COMPLETED|Overall Study||0
11384604|NCT03473236|12578334|FG001|NOT COMPLETED|Overall Study||0
11384605|NCT03473236|12578335|FG002|NOT COMPLETED|Overall Study||0
11384606|NCT03473236|12578336|FG003|NOT COMPLETED|Overall Study||0
11384607|NCT03473236|12578337|FG004|NOT COMPLETED|Overall Study||0
11384608|NCT03473236|12578338|FG005|NOT COMPLETED|Overall Study||1
11384609|NCT03473236|12578339|FG006|NOT COMPLETED|Overall Study||0
11384610|NCT03473236|12578340|FG007|NOT COMPLETED|Overall Study||0
11384611|NCT03473236|12578341|FG008|NOT COMPLETED|Overall Study||1
11384612|NCT03473236|12578342|FG009|NOT COMPLETED|Overall Study||0
11384613|NCT03473301|12578375|FG000|STARTED|Overall Study||31
11384614|NCT03473301|12578376|FG001|STARTED|Overall Study||29
11384615|NCT03473301|12578377|FG002|STARTED|Overall Study||31
11384616|NCT03473301|12578375|FG000|COMPLETED|Overall Study||20
11384617|NCT03473301|12578376|FG001|COMPLETED|Overall Study||23
11384618|NCT03473301|12578377|FG002|COMPLETED|Overall Study||25
11384619|NCT03473301|12578375|FG000|NOT COMPLETED|Overall Study||11
11384620|NCT03473301|12578376|FG001|NOT COMPLETED|Overall Study||6
11384621|NCT03473301|12578377|FG002|NOT COMPLETED|Overall Study||6
11384622|NCT03473665|12578387|FG000|STARTED|Overall Study||9
11384623|NCT03473665|12578387|FG000|COMPLETED|Overall Study||9
11384624|NCT03473665|12578387|FG000|NOT COMPLETED|Overall Study||0
11384625|NCT03473808|12578396|FG000|STARTED|Overall Study||5
11384626|NCT03473808|12578396|FG000|COMPLETED|Overall Study||4
11384627|NCT03473808|12578396|FG000|NOT COMPLETED|Overall Study||1
11384628|NCT03473886|12578400|FG000|STARTED|Overall Study||8
11384629|NCT03473886|12578400|FG000|COMPLETED|Overall Study||7
11384630|NCT03473886|12578400|FG000|NOT COMPLETED|Overall Study||1
11384631|NCT03474081|12578406|FG000|STARTED|Overall Study||400
11384632|NCT03474081|12578407|FG001|STARTED|Overall Study||400
11384633|NCT03474081|12578406|FG000|Received Study Treatment|Overall Study||400
11384634|NCT03474081|12578407|FG001|Received Study Treatment|Overall Study|One randomized participant withdrew consent and never received study treatment.|399
11384635|NCT03474081|12578406|FG000|COMPLETED|Overall Study||383
11384636|NCT03474081|12578407|FG001|COMPLETED|Overall Study||387
11384637|NCT03474081|12578406|FG000|NOT COMPLETED|Overall Study||17
11384638|NCT03474081|12578407|FG001|NOT COMPLETED|Overall Study||13
11384639|NCT03474172|12578415|FG000|STARTED|Overall Study||30
11384640|NCT03474172|12578416|FG001|STARTED|Overall Study||30
11384641|NCT03474172|12578415|FG000|COMPLETED|Overall Study||30
11384642|NCT03474172|12578416|FG001|COMPLETED|Overall Study||30
11384643|NCT03474172|12578415|FG000|NOT COMPLETED|Overall Study||0
11384644|NCT03474172|12578416|FG001|NOT COMPLETED|Overall Study||0
11384645|NCT03474406|12578425|FG000|STARTED|Overall Study||150
11384646|NCT03474406|12578425|FG000|COMPLETED|Overall Study||72
11384647|NCT03474406|12578425|FG000|NOT COMPLETED|Overall Study||78
11384648|NCT03474874|12578429|FG000|STARTED|Overall Study||68
11384649|NCT03474874|12578429|FG000|COMPLETED|Overall Study||54
11384650|NCT03474874|12578429|FG000|NOT COMPLETED|Overall Study||14
11384651|NCT03475316|12578437|FG000|STARTED|6 Month Intervention||13
11384652|NCT03475316|12578438|FG001|STARTED|6 Month Intervention||12
11384653|NCT03475316|12578437|FG000|COMPLETED|6 Month Intervention||8
11384654|NCT03475316|12578438|FG001|COMPLETED|6 Month Intervention||8
11384655|NCT03475316|12578437|FG000|NOT COMPLETED|6 Month Intervention||5
11384656|NCT03475316|12578438|FG001|NOT COMPLETED|6 Month Intervention||4
11384657|NCT03475316|12578437|FG000|STARTED|9 Months||8
11384658|NCT03475316|12578438|FG001|STARTED|9 Months||8
11384659|NCT03475316|12578437|FG000|COMPLETED|9 Months||5
11384660|NCT03475316|12578438|FG001|COMPLETED|9 Months||4
11384661|NCT03475316|12578437|FG000|NOT COMPLETED|9 Months||3
11384662|NCT03475316|12578438|FG001|NOT COMPLETED|9 Months||4
11384663|NCT03475875|12578444|FG000|STARTED|Period 1||46
11384664|NCT03475875|12578445|FG001|STARTED|Period 1||45
11384665|NCT03475875|12578444|FG000|COMPLETED|Period 1||43
11384666|NCT03475875|12578445|FG001|COMPLETED|Period 1||44
11384667|NCT03475875|12578444|FG000|NOT COMPLETED|Period 1||3
11384668|NCT03475875|12578445|FG001|NOT COMPLETED|Period 1||1
11384669|NCT03475875|12578444|FG000|STARTED|Period 2||43
11384670|NCT03475875|12578445|FG001|STARTED|Period 2||44
11384671|NCT03475875|12578444|FG000|COMPLETED|Period 2||40
11384672|NCT03475875|12578445|FG001|COMPLETED|Period 2||43
11384673|NCT03475875|12578444|FG000|NOT COMPLETED|Period 2||3
11384674|NCT03475875|12578445|FG001|NOT COMPLETED|Period 2||1
11384675|NCT03475875|12578444|FG000|STARTED|Period 3||40
11384676|NCT03475875|12578445|FG001|STARTED|Period 3||43
11384677|NCT03475875|12578444|FG000|COMPLETED|Period 3||40
11384678|NCT03475875|12578445|FG001|COMPLETED|Period 3||43
11384679|NCT03475875|12578444|FG000|NOT COMPLETED|Period 3||0
11384680|NCT03475875|12578445|FG001|NOT COMPLETED|Period 3||0
11384681|NCT03475992|12578454|FG000|STARTED|Overall Study||11
11384682|NCT03475992|12578455|FG001|STARTED|Overall Study||9
11384683|NCT03475992|12578456|FG002|STARTED|Overall Study||5
11384684|NCT03475992|12578454|FG000|COMPLETED|Overall Study||11
11384685|NCT03475992|12578455|FG001|COMPLETED|Overall Study||9
11384686|NCT03475992|12578456|FG002|COMPLETED|Overall Study||5
11384687|NCT03475992|12578454|FG000|NOT COMPLETED|Overall Study||0
11384688|NCT03475992|12578455|FG001|NOT COMPLETED|Overall Study||0
11384689|NCT03475992|12578456|FG002|NOT COMPLETED|Overall Study||0
11384690|NCT03476278|12578464|FG000|STARTED|Overall Study||300
11384691|NCT03476278|12578464|FG000|COMPLETED|Overall Study||300
11384692|NCT03476278|12578464|FG000|NOT COMPLETED|Overall Study||0
11384693|NCT03476850|12578480|FG000|STARTED|Overall Study||24
11384694|NCT03476850|12578481|FG001|STARTED|Overall Study||24
11384695|NCT03476850|12578480|FG000|COMPLETED|Overall Study||24
11384696|NCT03476850|12578481|FG001|COMPLETED|Overall Study||24
11384697|NCT03476850|12578480|FG000|NOT COMPLETED|Overall Study||0
11384698|NCT03476850|12578481|FG001|NOT COMPLETED|Overall Study||0
11384699|NCT03477006|12578489|FG000|STARTED|Overall Study||40
11384700|NCT03477006|12578490|FG001|STARTED|Overall Study||46
11384701|NCT03477006|12578489|FG000|COMPLETED|Overall Study||40
11384702|NCT03477006|12578490|FG001|COMPLETED|Overall Study||46
11384703|NCT03477006|12578489|FG000|NOT COMPLETED|Overall Study||0
11384704|NCT03477006|12578490|FG001|NOT COMPLETED|Overall Study||0
11384705|NCT03477279|12578501|FG000|STARTED|Overall Study||250
11384706|NCT03477279|12578502|FG001|STARTED|Overall Study||250
11384707|NCT03477279|12578503|FG002|STARTED|Overall Study||98
11384708|NCT03477279|12578504|FG003|STARTED|Overall Study||168
11384709|NCT03477279|12578505|FG004|STARTED|Overall Study||350
11384710|NCT03477279|12578501|FG000|COMPLETED|Overall Study||203
11384711|NCT03477279|12578502|FG001|COMPLETED|Overall Study||202
11384712|NCT03477279|12578503|FG002|COMPLETED|Overall Study||98
11384713|NCT03477279|12578504|FG003|COMPLETED|Overall Study||136
11384714|NCT03477279|12578505|FG004|COMPLETED|Overall Study||349
11384715|NCT03477279|12578501|FG000|NOT COMPLETED|Overall Study||47
11384716|NCT03477279|12578502|FG001|NOT COMPLETED|Overall Study||48
11384717|NCT03477279|12578503|FG002|NOT COMPLETED|Overall Study||0
11384718|NCT03477279|12578504|FG003|NOT COMPLETED|Overall Study||32
11384719|NCT03477279|12578505|FG004|NOT COMPLETED|Overall Study||1
11384720|NCT03477838|12578518|FG000|STARTED|Overall Study||28
11384721|NCT03477838|12578518|FG000|COMPLETED|Overall Study||14
11384722|NCT03477838|12578518|FG000|NOT COMPLETED|Overall Study||14
11384723|NCT03478163|12578524|FG000|STARTED|Overall Study||5
11384724|NCT03478163|12578525|FG001|STARTED|Overall Study||6
11384725|NCT03478163|12578524|FG000|COMPLETED|Overall Study||5
11384726|NCT03478163|12578525|FG001|COMPLETED|Overall Study||6
11384727|NCT03478163|12578524|FG000|NOT COMPLETED|Overall Study||0
11384728|NCT03478163|12578525|FG001|NOT COMPLETED|Overall Study||0
11384729|NCT03478254|12578531|FG000|STARTED|Overall Study||300
11384730|NCT03478254|12578531|FG000|COMPLETED|Overall Study||300
11384731|NCT03478254|12578531|FG000|NOT COMPLETED|Overall Study||0
11384732|NCT03478371|12578536|FG000|STARTED|Overall Study||94
11384733|NCT03478371|12578536|FG000|Received Tampon D|Overall Study||91
11384734|NCT03478371|12578536|FG000|Received Tampon M|Overall Study||92
11384735|NCT03478371|12578536|FG000|Recived Tampon T|Overall Study||90
11384736|NCT03478371|12578536|FG000|Received Tampon V|Overall Study||91
11384737|NCT03478371|12578536|FG000|COMPLETED|Overall Study||89
11384738|NCT03478371|12578536|FG000|NOT COMPLETED|Overall Study||5
11384739|NCT03478644|12578548|FG000|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
11384740|NCT03478644|12578549|FG001|STARTED|Phase 1||0
11384741|NCT03478644|12578548|FG000|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
11384742|NCT03478644|12578549|FG001|COMPLETED|Phase 1||0
11384743|NCT03478644|12578548|FG000|NOT COMPLETED|Phase 1||0
11384744|NCT03478644|12578549|FG001|NOT COMPLETED|Phase 1||0
11384745|NCT03478644|12578548|FG000|STARTED|Phase 2||76
11384746|NCT03478644|12578549|FG001|STARTED|Phase 2||76
11384747|NCT03478644|12578548|FG000|COMPLETED|Phase 2||73
11384748|NCT03478644|12578549|FG001|COMPLETED|Phase 2||75
11384749|NCT03478644|12578548|FG000|NOT COMPLETED|Phase 2||3
11384750|NCT03478644|12578549|FG001|NOT COMPLETED|Phase 2||1
11384751|NCT03478657|12578557|FG000|STARTED|Overall Study||88
11384752|NCT03478657|12578558|FG001|STARTED|Overall Study||134
11384753|NCT03478657|12578557|FG000|COMPLETED|Overall Study||88
11384754|NCT03478657|12578558|FG001|COMPLETED|Overall Study||133
11384755|NCT03478657|12578557|FG000|NOT COMPLETED|Overall Study||0
11384756|NCT03478657|12578558|FG001|NOT COMPLETED|Overall Study||1
11384757|NCT03478683|12578566|FG000|STARTED|Overall Study||363
11384758|NCT03478683|12578567|FG001|STARTED|Overall Study||365
11384759|NCT03478683|12578566|FG000|COMPLETED|Overall Study||350
11384760|NCT03478683|12578567|FG001|COMPLETED|Overall Study||347
11384761|NCT03478683|12578566|FG000|NOT COMPLETED|Overall Study||13
11384762|NCT03478683|12578567|FG001|NOT COMPLETED|Overall Study||18
11384763|NCT03478696|12578575|FG000|STARTED|Overall Study||366
11384764|NCT03478696|12578576|FG001|STARTED|Overall Study||366
11384765|NCT03478696|12578575|FG000|COMPLETED|Overall Study||349
11384766|NCT03478696|12578576|FG001|COMPLETED|Overall Study||354
11384767|NCT03478696|12578575|FG000|NOT COMPLETED|Overall Study||17
11384768|NCT03478696|12578576|FG001|NOT COMPLETED|Overall Study||12
11384769|NCT03478787|12578584|FG000|STARTED|Overall Study||163
11384770|NCT03478787|12578585|FG001|STARTED|Overall Study||164
11384771|NCT03478787|12578584|FG000|COMPLETED|Overall Study||134
11384772|NCT03478787|12578585|FG001|COMPLETED|Overall Study||151
11384773|NCT03478787|12578584|FG000|NOT COMPLETED|Overall Study||29
11384774|NCT03478787|12578585|FG001|NOT COMPLETED|Overall Study||13
11384775|NCT03478891|12578594|FG000|STARTED|Overall Study||3
11384776|NCT03478891|12578595|FG001|STARTED|Overall Study||5
11384777|NCT03478891|12578596|FG002|STARTED|Overall Study||11
11384778|NCT03478891|12578594|FG000|Received MAb114|Overall Study||3
11384779|NCT03478891|12578595|FG001|Received MAb114|Overall Study||5
11384780|NCT03478891|12578596|FG002|Received MAb114|Overall Study|One Group 3 subject discontinued prior to MAb114 infusion due to inadequate venous access|10
11384781|NCT03478891|12578594|FG000|COMPLETED|Overall Study||2
11384782|NCT03478891|12578595|FG001|COMPLETED|Overall Study||5
11384783|NCT03478891|12578596|FG002|COMPLETED|Overall Study||8
11384784|NCT03478891|12578594|FG000|NOT COMPLETED|Overall Study||1
11384785|NCT03478891|12578595|FG001|NOT COMPLETED|Overall Study||0
11384786|NCT03478891|12578596|FG002|NOT COMPLETED|Overall Study||3
11384787|NCT03478904|12578608|FG000|STARTED|Overall Study||1
11384788|NCT03478904|12578608|FG000|COMPLETED|Overall Study||1
11384789|NCT03478904|12578608|FG000|NOT COMPLETED|Overall Study||0
11384790|NCT03478969|12578622|FG000|STARTED|Overall Study||62
11384791|NCT03478969|12578623|FG001|STARTED|Overall Study||61
11384792|NCT03478969|12578624|FG002|STARTED|Overall Study||58
11384793|NCT03478969|12578622|FG000|Participants at End of Parallel Phase|Overall Study||55
11384794|NCT03478969|12578623|FG001|Participants at End of Parallel Phase|Overall Study||58
11384795|NCT03478969|12578624|FG002|Participants at End of Parallel Phase|Overall Study||52
11384796|NCT03478969|12578622|FG000|COMPLETED|Overall Study||53
11384797|NCT03478969|12578623|FG001|COMPLETED|Overall Study||49
11384798|NCT03478969|12578624|FG002|COMPLETED|Overall Study||40
11384799|NCT03478969|12578622|FG000|NOT COMPLETED|Overall Study||9
11384800|NCT03478969|12578623|FG001|NOT COMPLETED|Overall Study||12
11384801|NCT03478969|12578624|FG002|NOT COMPLETED|Overall Study||18
11384802|NCT03478982|12578638|FG000|STARTED|Overall Study||11
11384803|NCT03478982|12578639|FG001|STARTED|Overall Study||50
11384804|NCT03478982|12578640|FG002|STARTED|Overall Study||47
11384805|NCT03478982|12578641|FG003|STARTED|Overall Study||48
11384806|NCT03478982|12578638|FG000|Enrolled Participants But Not Treated|Overall Study||3
11384807|NCT03478982|12578639|FG001|Enrolled Participants But Not Treated|Overall Study||10
11384808|NCT03478982|12578640|FG002|Enrolled Participants But Not Treated|Overall Study||9
11384809|NCT03478982|12578641|FG003|Enrolled Participants But Not Treated|Overall Study||10
11384810|NCT03478982|12578638|FG000|Intent-to-treat (ITT) Population|Overall Study||8
11384811|NCT03478982|12578639|FG001|Intent-to-treat (ITT) Population|Overall Study||40
11384812|NCT03478982|12578640|FG002|Intent-to-treat (ITT) Population|Overall Study||38
11384813|NCT03478982|12578641|FG003|Intent-to-treat (ITT) Population|Overall Study||38
11384814|NCT03478982|12578638|FG000|COMPLETED|Overall Study||11
11384815|NCT03478982|12578639|FG001|COMPLETED|Overall Study||50
11384816|NCT03478982|12578640|FG002|COMPLETED|Overall Study||47
11384817|NCT03478982|12578641|FG003|COMPLETED|Overall Study||48
11384818|NCT03478982|12578638|FG000|NOT COMPLETED|Overall Study||0
11384819|NCT03478982|12578639|FG001|NOT COMPLETED|Overall Study||0
11384820|NCT03478982|12578640|FG002|NOT COMPLETED|Overall Study||0
11384821|NCT03478982|12578641|FG003|NOT COMPLETED|Overall Study||0
11384822|NCT03479216|12578653|FG000|STARTED|Overall Study||31
11384823|NCT03479216|12578654|FG001|STARTED|Overall Study||31
11384824|NCT03479216|12578653|FG000|COMPLETED|Overall Study||26
11384825|NCT03479216|12578654|FG001|COMPLETED|Overall Study||26
11384826|NCT03479216|12578653|FG000|NOT COMPLETED|Overall Study||5
11384827|NCT03479216|12578654|FG001|NOT COMPLETED|Overall Study||5
11384828|NCT03479944|12578660|FG000|STARTED|Overall Study||55
11384829|NCT03479944|12578660|FG000|FLACS|Overall Study||55
11384830|NCT03479944|12578660|FG000|Conventional|Overall Study||55
11384831|NCT03479944|12578660|FG000|Full Analysis Set|Overall Study||53
11384832|NCT03479944|12578660|FG000|COMPLETED|Overall Study||55
11384833|NCT03479944|12578660|FG000|NOT COMPLETED|Overall Study||0
11384834|NCT03480009|12578672|FG000|STARTED|Overall Study||62
11384835|NCT03480009|12578673|FG001|STARTED|Overall Study||62
11384836|NCT03480009|12578674|FG002|STARTED|Overall Study||16
11384837|NCT03480009|12578675|FG003|STARTED|Overall Study||16
11384838|NCT03480009|12578672|FG000|COMPLETED|Overall Study||58
11384839|NCT03480009|12578673|FG001|COMPLETED|Overall Study||57
11384840|NCT03480009|12578674|FG002|COMPLETED|Overall Study||12
11384841|NCT03480009|12578675|FG003|COMPLETED|Overall Study||16
11384842|NCT03480009|12578672|FG000|NOT COMPLETED|Overall Study||4
11384843|NCT03480009|12578673|FG001|NOT COMPLETED|Overall Study||5
11384844|NCT03480009|12578674|FG002|NOT COMPLETED|Overall Study||4
11384845|NCT03480009|12578675|FG003|NOT COMPLETED|Overall Study||0
11384846|NCT03480022|12578690|FG000|STARTED|Overall Study||55
11384847|NCT03480022|12578691|FG001|STARTED|Overall Study||27
11384848|NCT03480022|12578690|FG000|COMPLETED|Overall Study||44
11384849|NCT03480022|12578691|FG001|COMPLETED|Overall Study||23
11384850|NCT03480022|12578690|FG000|NOT COMPLETED|Overall Study||11
11384851|NCT03480022|12578691|FG001|NOT COMPLETED|Overall Study||4
11384852|NCT03480048|12578699|FG000|STARTED|Overall Study||28
11384853|NCT03480048|12578700|FG001|STARTED|Overall Study||25
11384854|NCT03480048|12578699|FG000|COMPLETED|Overall Study||18
11384855|NCT03480048|12578700|FG001|COMPLETED|Overall Study||17
11384856|NCT03480048|12578699|FG000|NOT COMPLETED|Overall Study||10
11384857|NCT03480048|12578700|FG001|NOT COMPLETED|Overall Study||8
11384858|NCT03480152|12578708|FG000|STARTED|Phase I||3
11384859|NCT03480152|12578709|FG001|STARTED|Phase I||2
11384860|NCT03480152|12578710|FG002|STARTED|Phase I||0
11384861|NCT03480152|12578708|FG000|Received Intervention|Phase I||2
11384862|NCT03480152|12578709|FG001|Received Intervention|Phase I||2
11384863|NCT03480152|12578710|FG002|Received Intervention|Phase I||0
11384864|NCT03480152|12578708|FG000|COMPLETED|Phase I||2
11384865|NCT03480152|12578709|FG001|COMPLETED|Phase I||2
11384866|NCT03480152|12578710|FG002|COMPLETED|Phase I||0
11384867|NCT03480152|12578708|FG000|NOT COMPLETED|Phase I||1
11384868|NCT03480152|12578709|FG001|NOT COMPLETED|Phase I||0
11384869|NCT03480152|12578710|FG002|NOT COMPLETED|Phase I||0
11384870|NCT03480152|12578708|FG000|STARTED|Phase II||0
11384871|NCT03480152|12578709|FG001|STARTED|Phase II||0
11384872|NCT03480152|12578710|FG002|STARTED|Phase II||0
11384873|NCT03480152|12578708|FG000|COMPLETED|Phase II||0
11384874|NCT03480152|12578709|FG001|COMPLETED|Phase II||0
11384875|NCT03480152|12578710|FG002|COMPLETED|Phase II||0
11384876|NCT03480152|12578708|FG000|NOT COMPLETED|Phase II||0
11384877|NCT03480152|12578709|FG001|NOT COMPLETED|Phase II||0
11384878|NCT03480152|12578710|FG002|NOT COMPLETED|Phase II||0
11384879|NCT03480243|12578718|FG000|STARTED|Padsevonil (Period 1)||28
11384880|NCT03480243|12578718|FG000|COMPLETED|Padsevonil (Period 1)||28
11384881|NCT03480243|12578718|FG000|NOT COMPLETED|Padsevonil (Period 1)||0
11384882|NCT03480243|12578718|FG000|STARTED|Padsevonil (Period 2)||28
11384883|NCT03480243|12578718|FG000|COMPLETED|Padsevonil (Period 2)||27
11384884|NCT03480243|12578718|FG000|NOT COMPLETED|Padsevonil (Period 2)||1
11384885|NCT03480243|12578718|FG000|STARTED|Erythromycin (Period 3a)||27
11384886|NCT03480243|12578718|FG000|COMPLETED|Erythromycin (Period 3a)||27
11384887|NCT03480243|12578718|FG000|NOT COMPLETED|Erythromycin (Period 3a)||0
11384888|NCT03480243|12578718|FG000|STARTED|Padsevonil and Erythromycin (Period 3b)||27
11384889|NCT03480243|12578718|FG000|COMPLETED|Padsevonil and Erythromycin (Period 3b)||26
11384890|NCT03480243|12578718|FG000|NOT COMPLETED|Padsevonil and Erythromycin (Period 3b)||1
11384891|NCT03480243|12578718|FG000|STARTED|Erythromycin (Period 3c)||26
11384892|NCT03480243|12578718|FG000|COMPLETED|Erythromycin (Period 3c)||26
11384893|NCT03480243|12578718|FG000|NOT COMPLETED|Erythromycin (Period 3c)||0
11384894|NCT03480425|12578731|FG000|STARTED|Overall Study||11
11384895|NCT03480425|12578731|FG000|COMPLETED|Overall Study||10
11384896|NCT03480425|12578731|FG000|NOT COMPLETED|Overall Study||1
11384897|NCT03480685|12578735|FG000|STARTED|Overall Study||12
11384898|NCT03480685|12578735|FG000|COMPLETED|Overall Study||12
11384899|NCT03480685|12578735|FG000|NOT COMPLETED|Overall Study||0
11384900|NCT03480750|12578747|FG000|STARTED|Overall Study||3
11384901|NCT03480750|12578748|FG001|STARTED|Overall Study||4
11384902|NCT03480750|12578749|FG002|STARTED|Overall Study||3
11384903|NCT03480750|12578750|FG003|STARTED|Overall Study||3
11384904|NCT03480750|12578751|FG004|STARTED|Overall Study||3
11384905|NCT03480750|12578752|FG005|STARTED|Overall Study||2
11384906|NCT03480750|12578747|FG000|COMPLETED|Overall Study||3
11384907|NCT03480750|12578748|FG001|COMPLETED|Overall Study||3
11384908|NCT03480750|12578749|FG002|COMPLETED|Overall Study||3
11384909|NCT03480750|12578750|FG003|COMPLETED|Overall Study||3
11384910|NCT03480750|12578751|FG004|COMPLETED|Overall Study||3
11384911|NCT03480750|12578752|FG005|COMPLETED|Overall Study||1
11384912|NCT03480750|12578747|FG000|NOT COMPLETED|Overall Study||0
11384913|NCT03480750|12578748|FG001|NOT COMPLETED|Overall Study||1
11384914|NCT03480750|12578749|FG002|NOT COMPLETED|Overall Study||0
11384915|NCT03480750|12578750|FG003|NOT COMPLETED|Overall Study||0
11384916|NCT03480750|12578751|FG004|NOT COMPLETED|Overall Study||0
11384917|NCT03480750|12578752|FG005|NOT COMPLETED|Overall Study||1
11384918|NCT03480763|12578777|FG000|STARTED|Overall Study||327
11384919|NCT03480763|12578778|FG001|STARTED|Overall Study||325
11384920|NCT03480763|12578777|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||326
11384921|NCT03480763|12578778|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||325
11384922|NCT03480763|12578777|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||298
11384923|NCT03480763|12578778|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||302
11384924|NCT03480763|12578777|FG000|COMPLETED|Overall Study||303
11384925|NCT03480763|12578778|FG001|COMPLETED|Overall Study||306
11384926|NCT03480763|12578777|FG000|NOT COMPLETED|Overall Study||24
11384927|NCT03480763|12578778|FG001|NOT COMPLETED|Overall Study||19
11384928|NCT03480841|12578790|FG000|STARTED|Overall Study||10
11384929|NCT03480841|12578790|FG000|Time 1 Data Collection (T1)|Overall Study||10
11384930|NCT03480841|12578790|FG000|LENA Baseline|Overall Study||10
11384931|NCT03480841|12578790|FG000|LENA Time 1|Overall Study||10
11384932|NCT03480841|12578790|FG000|LENA Time 2|Overall Study||10
11384933|NCT03480841|12578790|FG000|LENA Time 3|Overall Study||10
11384934|NCT03480841|12578790|FG000|LENA Time 4|Overall Study||9
11384935|NCT03480841|12578790|FG000|LENA Time 5|Overall Study||8
11384936|NCT03480841|12578790|FG000|Time 2 Data Collection (T2)|Overall Study||8
11384937|NCT03480841|12578790|FG000|COMPLETED|Overall Study||8
11384938|NCT03480841|12578790|FG000|NOT COMPLETED|Overall Study||2
11384939|NCT03480919|12578797|FG000|STARTED|Overall Study||1
11384940|NCT03480919|12578798|FG001|STARTED|Overall Study||2
11384941|NCT03480919|12578799|FG002|STARTED|Overall Study||1
11384942|NCT03480919|12578797|FG000|COMPLETED|Overall Study||1
11384943|NCT03480919|12578798|FG001|COMPLETED|Overall Study||2
11384944|NCT03480919|12578799|FG002|COMPLETED|Overall Study||1
11384945|NCT03480919|12578797|FG000|NOT COMPLETED|Overall Study||0
11384946|NCT03480919|12578798|FG001|NOT COMPLETED|Overall Study||0
11384947|NCT03480919|12578799|FG002|NOT COMPLETED|Overall Study||0
11384948|NCT03480932|12578810|FG000|STARTED|Overall Study||50
11384949|NCT03480932|12578811|FG001|STARTED|Overall Study||50
11384950|NCT03480932|12578812|FG002|STARTED|Overall Study||50
11384951|NCT03480932|12578810|FG000|COMPLETED|Overall Study||47
11384952|NCT03480932|12578811|FG001|COMPLETED|Overall Study||45
11384953|NCT03480932|12578812|FG002|COMPLETED|Overall Study||45
11384954|NCT03480932|12578810|FG000|NOT COMPLETED|Overall Study||3
11384955|NCT03480932|12578811|FG001|NOT COMPLETED|Overall Study||5
11384956|NCT03480932|12578812|FG002|NOT COMPLETED|Overall Study||5
11384957|NCT03481270|12578822|FG000|STARTED|Overall Study||324
11384958|NCT03481270|12578823|FG001|STARTED|Overall Study||313
11384959|NCT03481270|12578822|FG000|COMPLETED|Overall Study||324
11384960|NCT03481270|12578823|FG001|COMPLETED|Overall Study||313
11384961|NCT03481270|12578822|FG000|NOT COMPLETED|Overall Study||0
11384962|NCT03481270|12578823|FG001|NOT COMPLETED|Overall Study||0
11384963|NCT03481309|12578835|FG000|STARTED|First Intervention (1 Day)||4
11384964|NCT03481309|12578836|FG001|STARTED|First Intervention (1 Day)||3
11384965|NCT03481309|12578837|FG002|STARTED|First Intervention (1 Day)||3
11384966|NCT03481309|12578838|FG003|STARTED|First Intervention (1 Day)||3
11384967|NCT03481309|12578839|FG004|STARTED|First Intervention (1 Day)||3
11384968|NCT03481309|12578840|FG005|STARTED|First Intervention (1 Day)||3
11384969|NCT03481309|12578835|FG000|COMPLETED|First Intervention (1 Day)||4
11384970|NCT03481309|12578836|FG001|COMPLETED|First Intervention (1 Day)||3
11384971|NCT03481309|12578837|FG002|COMPLETED|First Intervention (1 Day)||3
11384972|NCT03481309|12578838|FG003|COMPLETED|First Intervention (1 Day)||3
11384973|NCT03481309|12578839|FG004|COMPLETED|First Intervention (1 Day)||3
11384974|NCT03481309|12578840|FG005|COMPLETED|First Intervention (1 Day)||3
11384975|NCT03481309|12578835|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11384976|NCT03481309|12578836|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11384977|NCT03481309|12578837|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11384978|NCT03481309|12578838|FG003|NOT COMPLETED|First Intervention (1 Day)||0
11384979|NCT03481309|12578839|FG004|NOT COMPLETED|First Intervention (1 Day)||0
11384980|NCT03481309|12578840|FG005|NOT COMPLETED|First Intervention (1 Day)||0
11384981|NCT03481309|12578835|FG000|STARTED|Washout (at Least 3 Days)||4
11384982|NCT03481309|12578836|FG001|STARTED|Washout (at Least 3 Days)||3
11384983|NCT03481309|12578837|FG002|STARTED|Washout (at Least 3 Days)||3
11384984|NCT03481309|12578838|FG003|STARTED|Washout (at Least 3 Days)||3
11384985|NCT03481309|12578839|FG004|STARTED|Washout (at Least 3 Days)||3
11384986|NCT03481309|12578840|FG005|STARTED|Washout (at Least 3 Days)||3
11384987|NCT03481309|12578835|FG000|COMPLETED|Washout (at Least 3 Days)||3
11384988|NCT03481309|12578836|FG001|COMPLETED|Washout (at Least 3 Days)||3
11384989|NCT03481309|12578837|FG002|COMPLETED|Washout (at Least 3 Days)||3
11384990|NCT03481309|12578838|FG003|COMPLETED|Washout (at Least 3 Days)||3
11384991|NCT03481309|12578839|FG004|COMPLETED|Washout (at Least 3 Days)||3
11384992|NCT03481309|12578840|FG005|COMPLETED|Washout (at Least 3 Days)||3
11384993|NCT03481309|12578835|FG000|NOT COMPLETED|Washout (at Least 3 Days)||1
11384994|NCT03481309|12578836|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0
11384995|NCT03481309|12578837|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0
11384996|NCT03481309|12578838|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0
11384997|NCT03481309|12578839|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0
11384998|NCT03481309|12578840|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0
11384999|NCT03481309|12578835|FG000|STARTED|Second Intervention (1 Day)||3
11385000|NCT03481309|12578836|FG001|STARTED|Second Intervention (1 Day)||3
11385001|NCT03481309|12578837|FG002|STARTED|Second Intervention (1 Day)||3
11385002|NCT03481309|12578838|FG003|STARTED|Second Intervention (1 Day)||3
11385003|NCT03481309|12578839|FG004|STARTED|Second Intervention (1 Day)||3
11385004|NCT03481309|12578840|FG005|STARTED|Second Intervention (1 Day)||3
11385005|NCT03481309|12578835|FG000|COMPLETED|Second Intervention (1 Day)||3
11385006|NCT03481309|12578836|FG001|COMPLETED|Second Intervention (1 Day)||3
11385007|NCT03481309|12578837|FG002|COMPLETED|Second Intervention (1 Day)||3
11385008|NCT03481309|12578838|FG003|COMPLETED|Second Intervention (1 Day)||3
11385009|NCT03481309|12578839|FG004|COMPLETED|Second Intervention (1 Day)||3
11385010|NCT03481309|12578840|FG005|COMPLETED|Second Intervention (1 Day)||3
11385011|NCT03481309|12578835|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11385012|NCT03481309|12578836|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11385013|NCT03481309|12578837|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11385014|NCT03481309|12578838|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
11385015|NCT03481309|12578839|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
11385016|NCT03481309|12578840|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
11385017|NCT03481309|12578835|FG000|STARTED|Washout (at Least 3 Days)||3
11385018|NCT03481309|12578836|FG001|STARTED|Washout (at Least 3 Days)||3
11385019|NCT03481309|12578837|FG002|STARTED|Washout (at Least 3 Days)||3
11385020|NCT03481309|12578838|FG003|STARTED|Washout (at Least 3 Days)||3
11385021|NCT03481309|12578839|FG004|STARTED|Washout (at Least 3 Days)||3
11385022|NCT03481309|12578840|FG005|STARTED|Washout (at Least 3 Days)||3
11385023|NCT03481309|12578835|FG000|COMPLETED|Washout (at Least 3 Days)||3
11385024|NCT03481309|12578836|FG001|COMPLETED|Washout (at Least 3 Days)||3
11385025|NCT03481309|12578837|FG002|COMPLETED|Washout (at Least 3 Days)||3
11385026|NCT03481309|12578838|FG003|COMPLETED|Washout (at Least 3 Days)||3
11385027|NCT03481309|12578839|FG004|COMPLETED|Washout (at Least 3 Days)||3
11385028|NCT03481309|12578840|FG005|COMPLETED|Washout (at Least 3 Days)||3
11385029|NCT03481309|12578835|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
11385030|NCT03481309|12578836|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0
11385031|NCT03481309|12578837|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0
11385032|NCT03481309|12578838|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0
11385033|NCT03481309|12578839|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0
11385034|NCT03481309|12578840|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0
11385035|NCT03481309|12578835|FG000|STARTED|Third Intervention (1 Day)||3
11385036|NCT03481309|12578836|FG001|STARTED|Third Intervention (1 Day)||3
11385037|NCT03481309|12578837|FG002|STARTED|Third Intervention (1 Day)||3
11385038|NCT03481309|12578838|FG003|STARTED|Third Intervention (1 Day)||3
11385039|NCT03481309|12578839|FG004|STARTED|Third Intervention (1 Day)||3
11385040|NCT03481309|12578840|FG005|STARTED|Third Intervention (1 Day)||3
11385041|NCT03481309|12578835|FG000|COMPLETED|Third Intervention (1 Day)||3
11385042|NCT03481309|12578836|FG001|COMPLETED|Third Intervention (1 Day)||3
11385043|NCT03481309|12578837|FG002|COMPLETED|Third Intervention (1 Day)||3
11385044|NCT03481309|12578838|FG003|COMPLETED|Third Intervention (1 Day)||3
11385045|NCT03481309|12578839|FG004|COMPLETED|Third Intervention (1 Day)||3
11385046|NCT03481309|12578840|FG005|COMPLETED|Third Intervention (1 Day)||3
11385047|NCT03481309|12578835|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11385048|NCT03481309|12578836|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11385049|NCT03481309|12578837|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
11385050|NCT03481309|12578838|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
11385051|NCT03481309|12578839|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
11385052|NCT03481309|12578840|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
11385053|NCT03481595|12578850|FG000|STARTED|Overall Study||146
11385054|NCT03481595|12578851|FG001|STARTED|Overall Study||148
11385055|NCT03481595|12578850|FG000|COMPLETED|Overall Study||143
11385056|NCT03481595|12578851|FG001|COMPLETED|Overall Study||127
11385057|NCT03481595|12578850|FG000|NOT COMPLETED|Overall Study||3
11385058|NCT03481595|12578851|FG001|NOT COMPLETED|Overall Study||21
11385059|NCT03481725|12578859|FG000|STARTED|Overall Study||31
11385060|NCT03481725|12578860|FG001|STARTED|Overall Study||34
11385061|NCT03481725|12578859|FG000|COMPLETED|Overall Study||30
11385062|NCT03481725|12578860|FG001|COMPLETED|Overall Study||34
11385063|NCT03481725|12578859|FG000|NOT COMPLETED|Overall Study||1
11385064|NCT03481725|12578860|FG001|NOT COMPLETED|Overall Study||0
11385065|NCT03481816|12578870|FG000|STARTED|Starting Dose||6
11385066|NCT03481816|12578871|FG001|STARTED|Starting Dose||0
11385067|NCT03481816|12578870|FG000|COMPLETED|Starting Dose||5
11385068|NCT03481816|12578871|FG001|COMPLETED|Starting Dose||0
11385069|NCT03481816|12578870|FG000|NOT COMPLETED|Starting Dose||1
11385070|NCT03481816|12578871|FG001|NOT COMPLETED|Starting Dose||0
11385071|NCT03481816|12578870|FG000|STARTED|Dose Expansion||0
11385072|NCT03481816|12578871|FG001|STARTED|Dose Expansion||12
11385073|NCT03481816|12578870|FG000|COMPLETED|Dose Expansion||0
11385074|NCT03481816|12578871|FG001|COMPLETED|Dose Expansion||0
11385075|NCT03481816|12578870|FG000|NOT COMPLETED|Dose Expansion||0
11385076|NCT03481816|12578871|FG001|NOT COMPLETED|Dose Expansion||12
11385077|NCT03482011|12578881|FG000|STARTED|Induction Period (16 Weeks)||107
11385078|NCT03482011|12578882|FG001|STARTED|Induction Period (16 Weeks)||423
11385079|NCT03482011|12578883|FG002|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
11385080|NCT03482011|12578884|FG003|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
11385081|NCT03482011|12578885|FG004|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
11385082|NCT03482011|12578886|FG005|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
11385083|NCT03482011|12578887|FG006|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
11385084|NCT03482011|12578888|FG007|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
11385085|NCT03482011|12578881|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||107
11385086|NCT03482011|12578882|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||422
11385087|NCT03482011|12578883|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11385088|NCT03482011|12578884|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11385089|NCT03482011|12578885|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11385090|NCT03482011|12578886|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11385091|NCT03482011|12578887|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11385092|NCT03482011|12578888|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11385093|NCT03482011|12578881|FG000|COMPLETED|Induction Period (16 Weeks)||101
11385094|NCT03482011|12578882|FG001|COMPLETED|Induction Period (16 Weeks)||412
11385095|NCT03482011|12578883|FG002|COMPLETED|Induction Period (16 Weeks)||0
11385096|NCT03482011|12578884|FG003|COMPLETED|Induction Period (16 Weeks)||0
11385097|NCT03482011|12578885|FG004|COMPLETED|Induction Period (16 Weeks)||0
11385098|NCT03482011|12578886|FG005|COMPLETED|Induction Period (16 Weeks)||0
11385099|NCT03482011|12578887|FG006|COMPLETED|Induction Period (16 Weeks)||0
11385100|NCT03482011|12578888|FG007|COMPLETED|Induction Period (16 Weeks)||0
11385101|NCT03482011|12578881|FG000|NOT COMPLETED|Induction Period (16 Weeks)||6
11385102|NCT03482011|12578882|FG001|NOT COMPLETED|Induction Period (16 Weeks)||11
11385103|NCT03482011|12578883|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
11385104|NCT03482011|12578884|FG003|NOT COMPLETED|Induction Period (16 Weeks)||0
11385105|NCT03482011|12578885|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
11385106|NCT03482011|12578886|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
11385107|NCT03482011|12578887|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
11385108|NCT03482011|12578888|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
11385109|NCT03482011|12578881|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
11385110|NCT03482011|12578882|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
11385111|NCT03482011|12578883|FG002|STARTED|Maintenance Period (36 Weeks)||7
11385112|NCT03482011|12578884|FG003|STARTED|Maintenance Period (36 Weeks)||94
11385113|NCT03482011|12578885|FG004|STARTED|Maintenance Period (36 Weeks)||91
11385114|NCT03482011|12578886|FG005|STARTED|Maintenance Period (36 Weeks)||90
11385115|NCT03482011|12578887|FG006|STARTED|Maintenance Period (36 Weeks)||91
11385116|NCT03482011|12578888|FG007|STARTED|Maintenance Period (36 Weeks)||140
11385117|NCT03482011|12578881|FG000|Relapse|Maintenance Period (36 Weeks)||0
11385118|NCT03482011|12578882|FG001|Relapse|Maintenance Period (36 Weeks)||0
11385119|NCT03482011|12578883|FG002|Relapse|Maintenance Period (36 Weeks)||1
11385120|NCT03482011|12578884|FG003|Relapse|Maintenance Period (36 Weeks)||0
11385121|NCT03482011|12578885|FG004|Relapse|Maintenance Period (36 Weeks)||41
11385122|NCT03482011|12578886|FG005|Relapse|Maintenance Period (36 Weeks)||3
11385123|NCT03482011|12578887|FG006|Relapse|Maintenance Period (36 Weeks)||2
11385124|NCT03482011|12578888|FG007|Relapse|Maintenance Period (36 Weeks)||0
11385125|NCT03482011|12578881|FG000|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
11385126|NCT03482011|12578882|FG001|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
11385127|NCT03482011|12578883|FG002|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||6
11385128|NCT03482011|12578884|FG003|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||88
11385129|NCT03482011|12578885|FG004|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||86
11385130|NCT03482011|12578886|FG005|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||85
11385131|NCT03482011|12578887|FG006|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||87
11385132|NCT03482011|12578888|FG007|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||121
11385133|NCT03482011|12578881|FG000|COMPLETED|Maintenance Period (36 Weeks)||0
11385134|NCT03482011|12578882|FG001|COMPLETED|Maintenance Period (36 Weeks)||0
11385135|NCT03482011|12578883|FG002|COMPLETED|Maintenance Period (36 Weeks)||6
11385136|NCT03482011|12578884|FG003|COMPLETED|Maintenance Period (36 Weeks)||90
11385137|NCT03482011|12578885|FG004|COMPLETED|Maintenance Period (36 Weeks)||86
11385138|NCT03482011|12578886|FG005|COMPLETED|Maintenance Period (36 Weeks)||86
11385139|NCT03482011|12578887|FG006|COMPLETED|Maintenance Period (36 Weeks)||87
11385140|NCT03482011|12578888|FG007|COMPLETED|Maintenance Period (36 Weeks)||123
11385141|NCT03482011|12578881|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0
11385142|NCT03482011|12578882|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0
11385143|NCT03482011|12578883|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||1
11385144|NCT03482011|12578884|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||4
11385145|NCT03482011|12578885|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||5
11385146|NCT03482011|12578886|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||4
11385147|NCT03482011|12578887|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||4
11385148|NCT03482011|12578888|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||17
11385149|NCT03482011|12578881|FG000|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
11385150|NCT03482011|12578882|FG001|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
11385151|NCT03482011|12578883|FG002|STARTED|Follow-up Period (12 Weeks)||1
11385152|NCT03482011|12578884|FG003|STARTED|Follow-up Period (12 Weeks)||10
11385153|NCT03482011|12578885|FG004|STARTED|Follow-up Period (12 Weeks)||2
11385154|NCT03482011|12578886|FG005|STARTED|Follow-up Period (12 Weeks)||4
11385155|NCT03482011|12578887|FG006|STARTED|Follow-up Period (12 Weeks)||4
11385156|NCT03482011|12578888|FG007|STARTED|Follow-up Period (12 Weeks)||21
11385157|NCT03482011|12578881|FG000|COMPLETED|Follow-up Period (12 Weeks)||0
11385158|NCT03482011|12578882|FG001|COMPLETED|Follow-up Period (12 Weeks)||0
11385159|NCT03482011|12578883|FG002|COMPLETED|Follow-up Period (12 Weeks)||0
11385160|NCT03482011|12578884|FG003|COMPLETED|Follow-up Period (12 Weeks)||5
11385161|NCT03482011|12578885|FG004|COMPLETED|Follow-up Period (12 Weeks)||2
11385162|NCT03482011|12578886|FG005|COMPLETED|Follow-up Period (12 Weeks)||3
11385163|NCT03482011|12578887|FG006|COMPLETED|Follow-up Period (12 Weeks)||2
11385164|NCT03482011|12578888|FG007|COMPLETED|Follow-up Period (12 Weeks)||4
11385165|NCT03482011|12578881|FG000|NOT COMPLETED|Follow-up Period (12 Weeks)||0
11385166|NCT03482011|12578882|FG001|NOT COMPLETED|Follow-up Period (12 Weeks)||0
11385167|NCT03482011|12578883|FG002|NOT COMPLETED|Follow-up Period (12 Weeks)||1
11385168|NCT03482011|12578884|FG003|NOT COMPLETED|Follow-up Period (12 Weeks)||5
11385169|NCT03482011|12578885|FG004|NOT COMPLETED|Follow-up Period (12 Weeks)||0
11385170|NCT03482011|12578886|FG005|NOT COMPLETED|Follow-up Period (12 Weeks)||1
11385171|NCT03482011|12578887|FG006|NOT COMPLETED|Follow-up Period (12 Weeks)||2
11385172|NCT03482011|12578888|FG007|NOT COMPLETED|Follow-up Period (12 Weeks)||17
11385173|NCT03482453|12578925|FG000|STARTED|Part 1 (1 Day)||10
11385174|NCT03482453|12578926|FG001|STARTED|Part 1 (1 Day)||6
11385175|NCT03482453|12578927|FG002|STARTED|Part 1 (1 Day)||6
11385176|NCT03482453|12578928|FG003|STARTED|Part 1 (1 Day)||6
11385177|NCT03482453|12578929|FG004|STARTED|Part 1 (1 Day)||6
11385178|NCT03482453|12578930|FG005|STARTED|Part 1 (1 Day)||6
11385179|NCT03482453|12578931|FG006|STARTED|Part 1 (1 Day)||0
11385180|NCT03482453|12578932|FG007|STARTED|Part 1 (1 Day)||0
11385181|NCT03482453|12578933|FG008|STARTED|Part 1 (1 Day)||0
11385182|NCT03482453|12578934|FG009|STARTED|Part 1 (1 Day)||0
11385183|NCT03482453|12578935|FG010|STARTED|Part 1 (1 Day)||0
11385184|NCT03482453|12578936|FG011|STARTED|Part 1 (1 Day)||0
11385185|NCT03482453|12578925|FG000|COMPLETED|Part 1 (1 Day)||10
11385186|NCT03482453|12578926|FG001|COMPLETED|Part 1 (1 Day)||6
11385187|NCT03482453|12578927|FG002|COMPLETED|Part 1 (1 Day)||6
11385188|NCT03482453|12578928|FG003|COMPLETED|Part 1 (1 Day)||6
11385189|NCT03482453|12578929|FG004|COMPLETED|Part 1 (1 Day)||6
11385190|NCT03482453|12578930|FG005|COMPLETED|Part 1 (1 Day)||6
11385191|NCT03482453|12578931|FG006|COMPLETED|Part 1 (1 Day)||0
11385192|NCT03482453|12578932|FG007|COMPLETED|Part 1 (1 Day)||0
11385193|NCT03482453|12578933|FG008|COMPLETED|Part 1 (1 Day)||0
11385194|NCT03482453|12578934|FG009|COMPLETED|Part 1 (1 Day)||0
11385195|NCT03482453|12578935|FG010|COMPLETED|Part 1 (1 Day)||0
11385196|NCT03482453|12578936|FG011|COMPLETED|Part 1 (1 Day)||0
11385197|NCT03482453|12578925|FG000|NOT COMPLETED|Part 1 (1 Day)||0
11385198|NCT03482453|12578926|FG001|NOT COMPLETED|Part 1 (1 Day)||0
11385199|NCT03482453|12578927|FG002|NOT COMPLETED|Part 1 (1 Day)||0
11385200|NCT03482453|12578928|FG003|NOT COMPLETED|Part 1 (1 Day)||0
11385201|NCT03482453|12578929|FG004|NOT COMPLETED|Part 1 (1 Day)||0
11385202|NCT03482453|12578930|FG005|NOT COMPLETED|Part 1 (1 Day)||0
11385203|NCT03482453|12578931|FG006|NOT COMPLETED|Part 1 (1 Day)||0
11385204|NCT03482453|12578932|FG007|NOT COMPLETED|Part 1 (1 Day)||0
11385205|NCT03482453|12578933|FG008|NOT COMPLETED|Part 1 (1 Day)||0
11385206|NCT03482453|12578934|FG009|NOT COMPLETED|Part 1 (1 Day)||0
11385207|NCT03482453|12578935|FG010|NOT COMPLETED|Part 1 (1 Day)||0
11385208|NCT03482453|12578936|FG011|NOT COMPLETED|Part 1 (1 Day)||0
11385209|NCT03482453|12578925|FG000|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385210|NCT03482453|12578926|FG001|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385211|NCT03482453|12578927|FG002|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385212|NCT03482453|12578928|FG003|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385213|NCT03482453|12578929|FG004|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385214|NCT03482453|12578930|FG005|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385215|NCT03482453|12578931|FG006|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
11385216|NCT03482453|12578932|FG007|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
11385217|NCT03482453|12578933|FG008|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
11385218|NCT03482453|12578934|FG009|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
11385219|NCT03482453|12578935|FG010|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7
11385220|NCT03482453|12578936|FG011|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6
11385221|NCT03482453|12578925|FG000|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385222|NCT03482453|12578926|FG001|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385223|NCT03482453|12578927|FG002|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385224|NCT03482453|12578928|FG003|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385225|NCT03482453|12578929|FG004|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385226|NCT03482453|12578930|FG005|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385227|NCT03482453|12578931|FG006|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
11385228|NCT03482453|12578932|FG007|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
11385229|NCT03482453|12578933|FG008|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
11385230|NCT03482453|12578934|FG009|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
11385231|NCT03482453|12578935|FG010|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
11385232|NCT03482453|12578936|FG011|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
11385233|NCT03482453|12578925|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385234|NCT03482453|12578926|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385235|NCT03482453|12578927|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385236|NCT03482453|12578928|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385237|NCT03482453|12578929|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385238|NCT03482453|12578930|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385239|NCT03482453|12578931|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385240|NCT03482453|12578932|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385241|NCT03482453|12578933|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385242|NCT03482453|12578934|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385243|NCT03482453|12578935|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1
11385244|NCT03482453|12578936|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
11385245|NCT03482453|12578925|FG000|STARTED|Parts 2, 3 Washout Period (7 Days)||0
11385246|NCT03482453|12578926|FG001|STARTED|Parts 2, 3 Washout Period (7 Days)||0
11385247|NCT03482453|12578927|FG002|STARTED|Parts 2, 3 Washout Period (7 Days)||0
11385248|NCT03482453|12578928|FG003|STARTED|Parts 2, 3 Washout Period (7 Days)||0
11385249|NCT03482453|12578929|FG004|STARTED|Parts 2, 3 Washout Period (7 Days)||0
11385250|NCT03482453|12578930|FG005|STARTED|Parts 2, 3 Washout Period (7 Days)||0
11385251|NCT03482453|12578931|FG006|STARTED|Parts 2, 3 Washout Period (7 Days)||3
11385252|NCT03482453|12578932|FG007|STARTED|Parts 2, 3 Washout Period (7 Days)||3
11385253|NCT03482453|12578933|FG008|STARTED|Parts 2, 3 Washout Period (7 Days)||5
11385254|NCT03482453|12578934|FG009|STARTED|Parts 2, 3 Washout Period (7 Days)||5
11385255|NCT03482453|12578935|FG010|STARTED|Parts 2, 3 Washout Period (7 Days)||6
11385256|NCT03482453|12578936|FG011|STARTED|Parts 2, 3 Washout Period (7 Days)||6
11385257|NCT03482453|12578925|FG000|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385258|NCT03482453|12578926|FG001|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385259|NCT03482453|12578927|FG002|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385260|NCT03482453|12578928|FG003|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385261|NCT03482453|12578929|FG004|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385262|NCT03482453|12578930|FG005|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385263|NCT03482453|12578931|FG006|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
11385264|NCT03482453|12578932|FG007|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
11385265|NCT03482453|12578933|FG008|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
11385266|NCT03482453|12578934|FG009|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
11385267|NCT03482453|12578935|FG010|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
11385268|NCT03482453|12578936|FG011|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
11385269|NCT03482453|12578925|FG000|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385270|NCT03482453|12578926|FG001|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385271|NCT03482453|12578927|FG002|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385272|NCT03482453|12578928|FG003|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385273|NCT03482453|12578929|FG004|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385274|NCT03482453|12578930|FG005|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385275|NCT03482453|12578931|FG006|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385276|NCT03482453|12578932|FG007|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385277|NCT03482453|12578933|FG008|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385278|NCT03482453|12578934|FG009|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385279|NCT03482453|12578935|FG010|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385280|NCT03482453|12578936|FG011|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
11385281|NCT03482453|12578925|FG000|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385282|NCT03482453|12578926|FG001|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385283|NCT03482453|12578927|FG002|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385284|NCT03482453|12578928|FG003|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385285|NCT03482453|12578929|FG004|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385286|NCT03482453|12578930|FG005|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385287|NCT03482453|12578931|FG006|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
11385288|NCT03482453|12578932|FG007|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
11385289|NCT03482453|12578933|FG008|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
11385290|NCT03482453|12578934|FG009|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
11385291|NCT03482453|12578935|FG010|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
11385292|NCT03482453|12578936|FG011|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
11385293|NCT03482453|12578925|FG000|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385294|NCT03482453|12578926|FG001|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385295|NCT03482453|12578927|FG002|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385296|NCT03482453|12578928|FG003|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385297|NCT03482453|12578929|FG004|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385298|NCT03482453|12578930|FG005|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385299|NCT03482453|12578931|FG006|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
11385300|NCT03482453|12578932|FG007|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
11385301|NCT03482453|12578933|FG008|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
11385302|NCT03482453|12578934|FG009|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
11385303|NCT03482453|12578935|FG010|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
11385304|NCT03482453|12578936|FG011|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
11385305|NCT03482453|12578925|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385306|NCT03482453|12578926|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385307|NCT03482453|12578927|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385308|NCT03482453|12578928|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385309|NCT03482453|12578929|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385310|NCT03482453|12578930|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385311|NCT03482453|12578931|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385312|NCT03482453|12578932|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385313|NCT03482453|12578933|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385314|NCT03482453|12578934|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385315|NCT03482453|12578935|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385316|NCT03482453|12578936|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
11385317|NCT03482583|12578975|FG000|STARTED|Overall Study||37
11385318|NCT03482583|12578976|FG001|STARTED|Overall Study||14
11385319|NCT03482583|12578977|FG002|STARTED|Overall Study||39
11385320|NCT03482583|12578975|FG000|COMPLETED|Overall Study||12
11385321|NCT03482583|12578976|FG001|COMPLETED|Overall Study||5
11385322|NCT03482583|12578977|FG002|COMPLETED|Overall Study||18
11385323|NCT03482583|12578975|FG000|NOT COMPLETED|Overall Study||25
11385324|NCT03482583|12578976|FG001|NOT COMPLETED|Overall Study||9
11385325|NCT03482583|12578977|FG002|NOT COMPLETED|Overall Study||21
11385326|NCT03482635|12578990|FG000|STARTED|Overall Study||23
11385327|NCT03482635|12578991|FG001|STARTED|Overall Study||24
11385328|NCT03482635|12578992|FG002|STARTED|Overall Study||23
11385329|NCT03482635|12578993|FG003|STARTED|Overall Study||28
11385330|NCT03482635|12578990|FG000|Treated|Overall Study||23
11385331|NCT03482635|12578991|FG001|Treated|Overall Study||24
11385332|NCT03482635|12578992|FG002|Treated|Overall Study||23
11385333|NCT03482635|12578993|FG003|Treated|Overall Study||27
11385334|NCT03482635|12578990|FG000|COMPLETED|Overall Study||18
11385335|NCT03482635|12578991|FG001|COMPLETED|Overall Study||21
11385336|NCT03482635|12578992|FG002|COMPLETED|Overall Study||22
11385337|NCT03482635|12578993|FG003|COMPLETED|Overall Study||20
11385338|NCT03482635|12578990|FG000|NOT COMPLETED|Overall Study||5
11385339|NCT03482635|12578991|FG001|NOT COMPLETED|Overall Study||3
11385340|NCT03482635|12578992|FG002|NOT COMPLETED|Overall Study||1
11385341|NCT03482635|12578993|FG003|NOT COMPLETED|Overall Study||8
11385342|NCT03482713|12579005|FG000|STARTED|Overall Study||11
11385343|NCT03482713|12579006|FG001|STARTED|Overall Study||12
11385344|NCT03482713|12579005|FG000|COMPLETED|Overall Study||11
11385345|NCT03482713|12579006|FG001|COMPLETED|Overall Study||12
11385346|NCT03482713|12579005|FG000|NOT COMPLETED|Overall Study||0
11385347|NCT03482713|12579006|FG001|NOT COMPLETED|Overall Study||0
11385348|NCT03482882|12579012|FG000|STARTED|Overall Study||47
11385349|NCT03482882|12579012|FG000|COMPLETED|Overall Study||40
11385350|NCT03482882|12579012|FG000|NOT COMPLETED|Overall Study||7
11385351|NCT03482973|12579018|FG000|STARTED|Overall Study||40
11385352|NCT03482973|12579019|FG001|STARTED|Overall Study||40
11385353|NCT03482973|12579018|FG000|COMPLETED|Overall Study||40
11385354|NCT03482973|12579019|FG001|COMPLETED|Overall Study||40
11385355|NCT03482973|12579018|FG000|NOT COMPLETED|Overall Study||0
11385356|NCT03482973|12579019|FG001|NOT COMPLETED|Overall Study||0
11385357|NCT03483506|12579025|FG000|STARTED|Overall Study||12
11385358|NCT03483506|12579025|FG000|COMPLETED|Overall Study||12
11385359|NCT03483506|12579025|FG000|NOT COMPLETED|Overall Study||0
11385360|NCT03483623|12579031|FG000|STARTED|Overall Study||44
11385361|NCT03483623|12579031|FG000|Started NATO WELP|Overall Study||44
11385362|NCT03483623|12579031|FG000|Completeded NATO WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
11385363|NCT03483623|12579031|FG000|Started NATO FIS|Overall Study||44
11385364|NCT03483623|12579031|FG000|Completed NATO FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
11385365|NCT03483623|12579031|FG000|Started RAVEN WELP|Overall Study||44
11385366|NCT03483623|12579031|FG000|Completed RAVEN WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
11385367|NCT03483623|12579031|FG000|Started RAVEN FIS|Overall Study||44
11385368|NCT03483623|12579031|FG000|Completed RAVEN FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
11385369|NCT03483623|12579031|FG000|COMPLETED|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
11385370|NCT03483623|12579031|FG000|NOT COMPLETED|Overall Study||1
11385371|NCT03483675|12579037|FG000|STARTED|Overall Study||9
11385372|NCT03483675|12579038|FG001|STARTED|Overall Study||8
11385373|NCT03483675|12579037|FG000|COMPLETED|Overall Study||9
11385374|NCT03483675|12579038|FG001|COMPLETED|Overall Study||8
11385375|NCT03483675|12579037|FG000|NOT COMPLETED|Overall Study||0
11385376|NCT03483675|12579038|FG001|NOT COMPLETED|Overall Study||0
11385377|NCT03483896|12579047|FG000|STARTED|Overall Study||33
11385378|NCT03483896|12579048|FG001|STARTED|Overall Study||50
11385379|NCT03483896|12579047|FG000|COMPLETED|Overall Study||31
11385380|NCT03483896|12579048|FG001|COMPLETED|Overall Study||46
11385381|NCT03483896|12579047|FG000|NOT COMPLETED|Overall Study||2
11385382|NCT03483896|12579048|FG001|NOT COMPLETED|Overall Study||4
11385383|NCT03483935|12579056|FG000|STARTED|Stage 1: Dose Setting Study||7
11385384|NCT03483935|12579056|FG000|COMPLETED|Stage 1: Dose Setting Study||7
11385385|NCT03483935|12579056|FG000|NOT COMPLETED|Stage 1: Dose Setting Study||0
11385386|NCT03483935|12579056|FG000|STARTED|Stage 2: Randomised Controlled Trial|Participants were randomised to receiving treatment on the left or right side.|11
11385387|NCT03483935|12579056|FG000|AKs Treated|Stage 2: Randomised Controlled Trial||11
11385388|NCT03483935|12579056|FG000|AKs Not Treated|Stage 2: Randomised Controlled Trial||11
11385389|NCT03483935|12579056|FG000|COMPLETED|Stage 2: Randomised Controlled Trial||11
11385390|NCT03483935|12579056|FG000|NOT COMPLETED|Stage 2: Randomised Controlled Trial||0
11385391|NCT03483961|12579074|FG000|STARTED|Overall Study||53
11385392|NCT03483961|12579075|FG001|STARTED|Overall Study||52
11385393|NCT03483961|12579076|FG002|STARTED|Overall Study||51
11385394|NCT03483961|12579077|FG003|STARTED|Overall Study||50
11385395|NCT03483961|12579078|FG004|STARTED|Overall Study||53
11385396|NCT03483961|12579079|FG005|STARTED|Overall Study||53
11385397|NCT03483961|12579080|FG006|STARTED|Overall Study||51
11385398|NCT03483961|12579081|FG007|STARTED|Overall Study||52
11385399|NCT03483961|12579082|FG008|STARTED|Overall Study||20
11385400|NCT03483961|12579083|FG009|STARTED|Overall Study||10
11385401|NCT03483961|12579074|FG000|Exposed / Safety|Overall Study||53
11385402|NCT03483961|12579075|FG001|Exposed / Safety|Overall Study||52
11385403|NCT03483961|12579076|FG002|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|50
11385404|NCT03483961|12579077|FG003|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|51
11385405|NCT03483961|12579078|FG004|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|53
11385406|NCT03483961|12579079|FG005|Exposed / Safety|Overall Study||53
11385407|NCT03483961|12579080|FG006|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|51
11385408|NCT03483961|12579081|FG007|Exposed / Safety|Overall Study|Two subjects did not receive PXVX0317 but are in the Exposed / Safety population because of receipt of placebo.|52
11385409|NCT03483961|12579082|FG008|Exposed / Safety|Overall Study||20
11142093|NCT01466348|12328780|FG000|NOT COMPLETED|Period II - Second Intervention||0
11142094|NCT01466348|12328781|FG001|NOT COMPLETED|Period II - Second Intervention||0
11142095|NCT01466361|12328793|FG000|STARTED|Overall Study||52
11142096|NCT01466361|12328794|FG001|STARTED|Overall Study||34
11142097|NCT01466361|12328795|FG002|STARTED|Overall Study||60
11142098|NCT01466361|12328796|FG003|STARTED|Overall Study||41
11142099|NCT01466361|12328793|FG000|COMPLETED|Overall Study||52
11142100|NCT01466361|12328794|FG001|COMPLETED|Overall Study||34
11142101|NCT01466361|12328795|FG002|COMPLETED|Overall Study||60
11385410|NCT03483961|12579083|FG009|Exposed / Safety|Overall Study||10
11385411|NCT03483961|12579074|FG000|Immunogenicity-evaluable|Overall Study||47
11385412|NCT03483961|12579075|FG001|Immunogenicity-evaluable|Overall Study||44
11385413|NCT03483961|12579076|FG002|Immunogenicity-evaluable|Overall Study||44
11385414|NCT03483961|12579077|FG003|Immunogenicity-evaluable|Overall Study||45
11385415|NCT03483961|12579078|FG004|Immunogenicity-evaluable|Overall Study||48
11385416|NCT03483961|12579079|FG005|Immunogenicity-evaluable|Overall Study||48
11385417|NCT03483961|12579080|FG006|Immunogenicity-evaluable|Overall Study||47
11385418|NCT03483961|12579081|FG007|Immunogenicity-evaluable|Overall Study||50
11385419|NCT03483961|12579082|FG008|Immunogenicity-evaluable|Overall Study||20
11385420|NCT03483961|12579083|FG009|Immunogenicity-evaluable|Overall Study||10
11385421|NCT03483961|12579074|FG000|COMPLETED|Overall Study||42
11385422|NCT03483961|12579075|FG001|COMPLETED|Overall Study||42
11385423|NCT03483961|12579076|FG002|COMPLETED|Overall Study||39
11385424|NCT03483961|12579077|FG003|COMPLETED|Overall Study||41
11385425|NCT03483961|12579078|FG004|COMPLETED|Overall Study||43
11385426|NCT03483961|12579079|FG005|COMPLETED|Overall Study||47
11385427|NCT03483961|12579080|FG006|COMPLETED|Overall Study||46
11385428|NCT03483961|12579081|FG007|COMPLETED|Overall Study||39
11385429|NCT03483961|12579082|FG008|COMPLETED|Overall Study||18
11385430|NCT03483961|12579083|FG009|COMPLETED|Overall Study||10
11385431|NCT03483961|12579074|FG000|NOT COMPLETED|Overall Study||11
11385432|NCT03483961|12579075|FG001|NOT COMPLETED|Overall Study||10
11385433|NCT03483961|12579076|FG002|NOT COMPLETED|Overall Study||12
11385434|NCT03483961|12579077|FG003|NOT COMPLETED|Overall Study||9
11385435|NCT03483961|12579078|FG004|NOT COMPLETED|Overall Study||10
11385436|NCT03483961|12579079|FG005|NOT COMPLETED|Overall Study||6
11385437|NCT03483961|12579080|FG006|NOT COMPLETED|Overall Study||5
11385438|NCT03483961|12579081|FG007|NOT COMPLETED|Overall Study||13
11385439|NCT03483961|12579082|FG008|NOT COMPLETED|Overall Study||2
11385440|NCT03483961|12579083|FG009|NOT COMPLETED|Overall Study||0
11385441|NCT03484273|12579104|FG000|STARTED|Overall Study|This was a crossover trial. A total of 32 participants were enrolled in this study.|32
11385442|NCT03484273|12579104|FG000|COMPLETED|Overall Study|This was a crossover trial. A total of 30 participants completed all 4 arms.|30
11385443|NCT03484273|12579104|FG000|NOT COMPLETED|Overall Study||2
11385444|NCT03484429|12579118|FG000|STARTED|Overall Study||8
11385445|NCT03484429|12579119|FG001|STARTED|Overall Study||8
11385446|NCT03484429|12579118|FG000|Postamputation Week 1-4|Overall Study||8
11385447|NCT03484429|12579119|FG001|Postamputation Week 1-4|Overall Study||8
11385448|NCT03484429|12579118|FG000|Postamputation Week 5-8|Overall Study||5
11385449|NCT03484429|12579119|FG001|Postamputation Week 5-8|Overall Study||8
11385450|NCT03484429|12579118|FG000|Postamputation Month 3|Overall Study||5
11142102|NCT01466361|12328796|FG003|COMPLETED|Overall Study||41
11385451|NCT03484429|12579119|FG001|Postamputation Month 3|Overall Study||7
11385452|NCT03484429|12579118|FG000|COMPLETED|Overall Study||5
11385453|NCT03484429|12579119|FG001|COMPLETED|Overall Study||8
11385454|NCT03484429|12579118|FG000|NOT COMPLETED|Overall Study||3
11385455|NCT03484429|12579119|FG001|NOT COMPLETED|Overall Study||0
11385456|NCT03485222|12579127|FG000|STARTED|Overall Study||42
11385457|NCT03485222|12579128|FG001|STARTED|Overall Study||42
11385458|NCT03485222|12579127|FG000|COMPLETED|Overall Study||40
11385459|NCT03485222|12579128|FG001|COMPLETED|Overall Study||40
11385460|NCT03485222|12579127|FG000|NOT COMPLETED|Overall Study||2
11385461|NCT03485222|12579128|FG001|NOT COMPLETED|Overall Study||2
11385462|NCT03485495|12579136|FG000|STARTED|Overall Study||65
11385463|NCT03485495|12579137|FG001|STARTED|Overall Study||59
11385464|NCT03485495|12579136|FG000|COMPLETED|Overall Study||64
11142103|NCT01466361|12328793|FG000|NOT COMPLETED|Overall Study||0
11142104|NCT01466361|12328794|FG001|NOT COMPLETED|Overall Study||0
11142105|NCT01466361|12328795|FG002|NOT COMPLETED|Overall Study||0
11385465|NCT03485495|12579137|FG001|COMPLETED|Overall Study||59
11385466|NCT03485495|12579136|FG000|NOT COMPLETED|Overall Study||1
11385467|NCT03485495|12579137|FG001|NOT COMPLETED|Overall Study||0
11385468|NCT03485976|12579143|FG000|STARTED|Overall Study||12
11385469|NCT03485976|12579143|FG000|COMPLETED|Overall Study||11
11385470|NCT03485976|12579143|FG000|NOT COMPLETED|Overall Study||1
11385471|NCT03486392|12579152|FG000|STARTED|Overall Study||60
11385472|NCT03486392|12579153|FG001|STARTED|Overall Study||59
11385473|NCT03486392|12579154|FG002|STARTED|Overall Study||118
11385474|NCT03486392|12579155|FG003|STARTED|Overall Study||118
11385475|NCT03486392|12579156|FG004|STARTED|Overall Study||119
11385476|NCT03486392|12579152|FG000|COMPLETED|Overall Study||57
11385477|NCT03486392|12579153|FG001|COMPLETED|Overall Study||59
11385478|NCT03486392|12579154|FG002|COMPLETED|Overall Study||104
11385479|NCT03486392|12579155|FG003|COMPLETED|Overall Study||109
11385480|NCT03486392|12579156|FG004|COMPLETED|Overall Study||115
11385481|NCT03486392|12579152|FG000|NOT COMPLETED|Overall Study||3
11385482|NCT03486392|12579153|FG001|NOT COMPLETED|Overall Study||0
11385483|NCT03486392|12579154|FG002|NOT COMPLETED|Overall Study||14
11385484|NCT03486392|12579155|FG003|NOT COMPLETED|Overall Study||9
11385485|NCT03486392|12579156|FG004|NOT COMPLETED|Overall Study||4
11385486|NCT03486834|12579171|FG000|STARTED|Overall Study||733
11385487|NCT03486834|12579172|FG001|STARTED|Overall Study||733
11385488|NCT03486834|12579173|FG002|STARTED|Overall Study||734
11385489|NCT03486834|12579171|FG000|Treatment 1|Overall Study||729
11385490|NCT03486834|12579172|FG001|Treatment 1|Overall Study||729
11385491|NCT03486834|12579173|FG002|Treatment 1|Overall Study||733
11385492|NCT03486834|12579171|FG000|Treatment 2|Overall Study||680
11385493|NCT03486834|12579172|FG001|Treatment 2|Overall Study||680
11385494|NCT03486834|12579173|FG002|Treatment 2|Overall Study||679
11385495|NCT03486834|12579171|FG000|Treatment 3|Overall Study||614
11385496|NCT03486834|12579172|FG001|Treatment 3|Overall Study||631
11385497|NCT03486834|12579173|FG002|Treatment 3|Overall Study||622
11385498|NCT03486834|12579171|FG000|COMPLETED|Overall Study||614
11385499|NCT03486834|12579172|FG001|COMPLETED|Overall Study||631
11385500|NCT03486834|12579173|FG002|COMPLETED|Overall Study||622
11385501|NCT03486834|12579171|FG000|NOT COMPLETED|Overall Study||119
11385502|NCT03486834|12579172|FG001|NOT COMPLETED|Overall Study||102
11385503|NCT03486834|12579173|FG002|NOT COMPLETED|Overall Study||112
11385504|NCT03486990|12579192|FG000|STARTED|Overall Study||2
11385505|NCT03486990|12579193|FG001|STARTED|Overall Study||2
11385506|NCT03486990|12579194|FG002|STARTED|Overall Study||3
11385507|NCT03486990|12579195|FG003|STARTED|Overall Study||3
11385508|NCT03486990|12579196|FG004|STARTED|Overall Study||3
11385509|NCT03486990|12579197|FG005|STARTED|Overall Study||4
11385510|NCT03486990|12579198|FG006|STARTED|Overall Study||2
11385511|NCT03486990|12579199|FG007|STARTED|Overall Study||2
11385512|NCT03486990|12579200|FG008|STARTED|Overall Study||2
11385513|NCT03486990|12579192|FG000|COMPLETED|Overall Study||2
11385514|NCT03486990|12579193|FG001|COMPLETED|Overall Study||2
11385515|NCT03486990|12579194|FG002|COMPLETED|Overall Study||3
11385516|NCT03486990|12579195|FG003|COMPLETED|Overall Study||3
11385517|NCT03486990|12579196|FG004|COMPLETED|Overall Study||3
11385518|NCT03486990|12579197|FG005|COMPLETED|Overall Study||4
11385519|NCT03486990|12579198|FG006|COMPLETED|Overall Study||2
11385520|NCT03486990|12579199|FG007|COMPLETED|Overall Study||2
11385521|NCT03486990|12579200|FG008|COMPLETED|Overall Study||2
11385522|NCT03486990|12579192|FG000|NOT COMPLETED|Overall Study||0
11385523|NCT03486990|12579193|FG001|NOT COMPLETED|Overall Study||0
11385524|NCT03486990|12579194|FG002|NOT COMPLETED|Overall Study||0
11385525|NCT03486990|12579195|FG003|NOT COMPLETED|Overall Study||0
11385526|NCT03486990|12579196|FG004|NOT COMPLETED|Overall Study||0
11385527|NCT03486990|12579197|FG005|NOT COMPLETED|Overall Study||0
11385528|NCT03486990|12579198|FG006|NOT COMPLETED|Overall Study||0
11385529|NCT03486990|12579199|FG007|NOT COMPLETED|Overall Study||0
11385530|NCT03486990|12579200|FG008|NOT COMPLETED|Overall Study||0
11385531|NCT03487276|12579241|FG000|STARTED|Main Period (16 Weeks)||37
11385532|NCT03487276|12579242|FG001|STARTED|Main Period (16 Weeks)||34
11385533|NCT03487276|12579243|FG002|STARTED|Main Period (16 Weeks)||36
11385534|NCT03487276|12579244|FG003|STARTED|Main Period (16 Weeks)||36
11385535|NCT03487276|12579245|FG004|STARTED|Main Period (16 Weeks)||36
11385536|NCT03487276|12579241|FG000|COMPLETED|Main Period (16 Weeks)||34
11385537|NCT03487276|12579242|FG001|COMPLETED|Main Period (16 Weeks)||30
11385538|NCT03487276|12579243|FG002|COMPLETED|Main Period (16 Weeks)||32
11385539|NCT03487276|12579244|FG003|COMPLETED|Main Period (16 Weeks)||30
11385540|NCT03487276|12579245|FG004|COMPLETED|Main Period (16 Weeks)|One patient completed the Main Period but was lost to follow-up afterwards and not treated in the Extension Period|31
11385541|NCT03487276|12579241|FG000|NOT COMPLETED|Main Period (16 Weeks)||3
11385542|NCT03487276|12579242|FG001|NOT COMPLETED|Main Period (16 Weeks)||4
11385543|NCT03487276|12579243|FG002|NOT COMPLETED|Main Period (16 Weeks)||4
11385544|NCT03487276|12579244|FG003|NOT COMPLETED|Main Period (16 Weeks)||6
11385545|NCT03487276|12579245|FG004|NOT COMPLETED|Main Period (16 Weeks)||5
11385546|NCT03487276|12579241|FG000|STARTED|Extension Period (28 Weeks)||0
11385547|NCT03487276|12579242|FG001|STARTED|Extension Period (28 Weeks)||0
11385548|NCT03487276|12579243|FG002|STARTED|Extension Period (28 Weeks)||72
11385549|NCT03487276|12579244|FG003|STARTED|Extension Period (28 Weeks)||84
11385550|NCT03487276|12579245|FG004|STARTED|Extension Period (28 Weeks)||0
11385551|NCT03487276|12579241|FG000|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11385552|NCT03487276|12579242|FG001|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11142106|NCT01466361|12328796|FG003|NOT COMPLETED|Overall Study||0
11142107|NCT01466387|12328817|FG000|STARTED|Overall Study||101
11142108|NCT01466387|12328818|FG001|STARTED|Overall Study||100
11142109|NCT01466387|12328819|FG002|STARTED|Overall Study||99
11142110|NCT01466387|12328820|FG003|STARTED|Overall Study||101
11142111|NCT01466387|12328821|FG004|STARTED|Overall Study||51
11142112|NCT01466387|12328822|FG005|STARTED|Overall Study||100
11142113|NCT01466387|12328817|FG000|COMPLETED|Overall Study||100
11142114|NCT01466387|12328818|FG001|COMPLETED|Overall Study||100
11142115|NCT01466387|12328819|FG002|COMPLETED|Overall Study||98
11142116|NCT01466387|12328820|FG003|COMPLETED|Overall Study||99
11142117|NCT01466387|12328821|FG004|COMPLETED|Overall Study||51
11142118|NCT01466387|12328822|FG005|COMPLETED|Overall Study||99
11142119|NCT01466387|12328817|FG000|NOT COMPLETED|Overall Study||1
11142120|NCT01466387|12328818|FG001|NOT COMPLETED|Overall Study||0
11385553|NCT03487276|12579243|FG002|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
11385554|NCT03487276|12579244|FG003|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
11385555|NCT03487276|12579245|FG004|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11385556|NCT03487276|12579241|FG000|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11385557|NCT03487276|12579242|FG001|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11385558|NCT03487276|12579243|FG002|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
11385559|NCT03487276|12579244|FG003|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
11385560|NCT03487276|12579245|FG004|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11385561|NCT03487276|12579241|FG000|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11385562|NCT03487276|12579242|FG001|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11385563|NCT03487276|12579243|FG002|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||17
11385564|NCT03487276|12579244|FG003|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
11385565|NCT03487276|12579245|FG004|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11385566|NCT03487276|12579241|FG000|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11385567|NCT03487276|12579242|FG001|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11385568|NCT03487276|12579243|FG002|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
11385569|NCT03487276|12579244|FG003|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
11385570|NCT03487276|12579245|FG004|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11385571|NCT03487276|12579241|FG000|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11385572|NCT03487276|12579242|FG001|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11385573|NCT03487276|12579243|FG002|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
11385574|NCT03487276|12579244|FG003|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
11385575|NCT03487276|12579245|FG004|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
11385576|NCT03487276|12579241|FG000|COMPLETED|Extension Period (28 Weeks)||0
11006067|NCT00726323|12183841|FG001|STARTED|Overall Study||37
11006068|NCT00726323|12183840|FG000|COMPLETED|Overall Study||0
11006069|NCT00726323|12183841|FG001|COMPLETED|Overall Study||6
11006070|NCT00726323|12183840|FG000|NOT COMPLETED|Overall Study||37
11006071|NCT00726323|12183841|FG001|NOT COMPLETED|Overall Study||31
11006072|NCT00726375|12183847|FG000|STARTED|Overall Study||34
11006073|NCT00726375|12183847|FG000|COMPLETED|Overall Study||34
11006074|NCT00726375|12183847|FG000|NOT COMPLETED|Overall Study||0
11006075|NCT00726388|12183851|FG000|STARTED|Overall Study||1050
11006076|NCT00726388|12183851|FG000|Treated|Overall Study||971
11006077|NCT00726388|12183851|FG000|COMPLETED|Overall Study||943
11006078|NCT00726388|12183851|FG000|NOT COMPLETED|Overall Study||107
11385577|NCT03487276|12579242|FG001|COMPLETED|Extension Period (28 Weeks)||0
11385578|NCT03487276|12579243|FG002|COMPLETED|Extension Period (28 Weeks)||67
11385579|NCT03487276|12579244|FG003|COMPLETED|Extension Period (28 Weeks)||54
11385580|NCT03487276|12579245|FG004|COMPLETED|Extension Period (28 Weeks)||0
11385581|NCT03487276|12579241|FG000|NOT COMPLETED|Extension Period (28 Weeks)||0
11142121|NCT01466387|12328819|FG002|NOT COMPLETED|Overall Study||1
11142122|NCT01466387|12328820|FG003|NOT COMPLETED|Overall Study||2
11142123|NCT01466387|12328821|FG004|NOT COMPLETED|Overall Study||0
11142124|NCT01466387|12328822|FG005|NOT COMPLETED|Overall Study||1
11385582|NCT03487276|12579242|FG001|NOT COMPLETED|Extension Period (28 Weeks)||0
11385583|NCT03487276|12579243|FG002|NOT COMPLETED|Extension Period (28 Weeks)||5
11385584|NCT03487276|12579244|FG003|NOT COMPLETED|Extension Period (28 Weeks)||30
11385585|NCT03487276|12579245|FG004|NOT COMPLETED|Extension Period (28 Weeks)||0
11385586|NCT03487445|12579268|FG000|STARTED|Randomization||25
11385587|NCT03487445|12579269|FG001|STARTED|Randomization||23
11385588|NCT03487445|12579268|FG000|COMPLETED|Randomization||24
11385589|NCT03487445|12579269|FG001|COMPLETED|Randomization||23
11385590|NCT03487445|12579268|FG000|NOT COMPLETED|Randomization||1
11385591|NCT03487445|12579269|FG001|NOT COMPLETED|Randomization||0
11385592|NCT03487445|12579268|FG000|STARTED|Treatment Period||24
11385593|NCT03487445|12579269|FG001|STARTED|Treatment Period||23
11385594|NCT03487445|12579268|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||23
11385595|NCT03487445|12579269|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||22
11385596|NCT03487445|12579268|FG000|Per Protocol Set|Treatment Period||20
11385597|NCT03487445|12579269|FG001|Per Protocol Set|Treatment Period||20
11385598|NCT03487445|12579268|FG000|COMPLETED|Treatment Period||24
11385599|NCT03487445|12579269|FG001|COMPLETED|Treatment Period||23
11385600|NCT03487445|12579268|FG000|NOT COMPLETED|Treatment Period||0
11385601|NCT03487445|12579269|FG001|NOT COMPLETED|Treatment Period||0
11385602|NCT03487549|12579277|FG000|STARTED|Overall Study||21
11385603|NCT03487549|12579278|FG001|STARTED|Overall Study||35
11385604|NCT03487549|12579277|FG000|COMPLETED|Overall Study||17
11385605|NCT03487549|12579278|FG001|COMPLETED|Overall Study||33
11385606|NCT03487549|12579277|FG000|NOT COMPLETED|Overall Study||4
11385607|NCT03487549|12579278|FG001|NOT COMPLETED|Overall Study||2
11385608|NCT03487588|12579284|FG000|STARTED|Overall Study||41
11385609|NCT03487588|12579284|FG000|COMPLETED|Overall Study||41
11385610|NCT03487588|12579284|FG000|NOT COMPLETED|Overall Study||0
11385611|NCT03487718|12579290|FG000|STARTED|Overall Study||12
11385612|NCT03487718|12579291|FG001|STARTED|Overall Study||15
11385613|NCT03487718|12579290|FG000|COMPLETED|Overall Study||11
11385614|NCT03487718|12579291|FG001|COMPLETED|Overall Study||11
11385615|NCT03487718|12579290|FG000|NOT COMPLETED|Overall Study||1
11385616|NCT03487718|12579291|FG001|NOT COMPLETED|Overall Study||4
11385617|NCT03487848|12579297|FG000|STARTED|Overall Study||5
11385618|NCT03487848|12579297|FG000|COMPLETED|Overall Study||4
11385619|NCT03487848|12579297|FG000|NOT COMPLETED|Overall Study||1
11385620|NCT03488108|12579303|FG000|STARTED|First Intervention (12 Weeks)||10
11385621|NCT03488108|12579304|FG001|STARTED|First Intervention (12 Weeks)||10
11385622|NCT03488108|12579303|FG000|COMPLETED|First Intervention (12 Weeks)||10
11385623|NCT03488108|12579304|FG001|COMPLETED|First Intervention (12 Weeks)||9
11385624|NCT03488108|12579303|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
11385625|NCT03488108|12579304|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
11385626|NCT03488108|12579303|FG000|STARTED|Washout (2 Months)||10
11385627|NCT03488108|12579304|FG001|STARTED|Washout (2 Months)||9
11385628|NCT03488108|12579303|FG000|COMPLETED|Washout (2 Months)||10
11385629|NCT03488108|12579304|FG001|COMPLETED|Washout (2 Months)||9
11385630|NCT03488108|12579303|FG000|NOT COMPLETED|Washout (2 Months)||0
11385631|NCT03488108|12579304|FG001|NOT COMPLETED|Washout (2 Months)||0
11385632|NCT03488108|12579303|FG000|STARTED|Second Intervention (12 Weeks)||10
11385633|NCT03488108|12579304|FG001|STARTED|Second Intervention (12 Weeks)||9
11385634|NCT03488108|12579303|FG000|COMPLETED|Second Intervention (12 Weeks)||9
11385635|NCT03488108|12579304|FG001|COMPLETED|Second Intervention (12 Weeks)||9
11385636|NCT03488108|12579303|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1
11385637|NCT03488108|12579304|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
11385638|NCT03488225|12579312|FG000|STARTED|Overall Study||4
11385639|NCT03488225|12579312|FG000|COMPLETED|Overall Study||0
11385640|NCT03488225|12579312|FG000|NOT COMPLETED|Overall Study||4
11385641|NCT03488238|12579316|FG000|STARTED|Overall Study||31
11385642|NCT03488238|12579316|FG000|COMPLETED|Overall Study||29
11385643|NCT03488238|12579316|FG000|NOT COMPLETED|Overall Study||2
11385644|NCT03488849|12579323|FG000|STARTED|Overall Study||10
11385645|NCT03488849|12579324|FG001|STARTED|Overall Study||8
11385646|NCT03488849|12579325|FG002|STARTED|Overall Study||6
11385647|NCT03488849|12579323|FG000|COMPLETED|Overall Study||10
11385648|NCT03488849|12579324|FG001|COMPLETED|Overall Study||8
11385649|NCT03488849|12579325|FG002|COMPLETED|Overall Study||6
11385650|NCT03488849|12579323|FG000|NOT COMPLETED|Overall Study||0
11385651|NCT03488849|12579324|FG001|NOT COMPLETED|Overall Study||0
11385652|NCT03488849|12579325|FG002|NOT COMPLETED|Overall Study||0
11385653|NCT03488927|12579336|FG000|STARTED|Overall Study||305
11385654|NCT03488927|12579337|FG001|STARTED|Overall Study||432
11385655|NCT03488927|12579338|FG002|STARTED|Overall Study||531
11385656|NCT03488927|12579336|FG000|COMPLETED|Overall Study||261
11385657|NCT03488927|12579337|FG001|COMPLETED|Overall Study||314
11385658|NCT03488927|12579338|FG002|COMPLETED|Overall Study||314
11385659|NCT03488927|12579336|FG000|NOT COMPLETED|Overall Study||44
11385660|NCT03488927|12579337|FG001|NOT COMPLETED|Overall Study||118
11385661|NCT03488927|12579338|FG002|NOT COMPLETED|Overall Study||217
11385662|NCT03489304|12579346|FG000|STARTED|Overall Study||20
11385663|NCT03489304|12579346|FG000|COMPLETED|Overall Study||16
11385664|NCT03489304|12579346|FG000|NOT COMPLETED|Overall Study||4
11385665|NCT03489343|12579357|FG000|STARTED|Overall Study||1
11385666|NCT03489343|12579358|FG001|STARTED|Overall Study||1
11385667|NCT03489343|12579359|FG002|STARTED|Overall Study||3
11385668|NCT03489343|12579360|FG003|STARTED|Overall Study||3
11385669|NCT03489343|12579361|FG004|STARTED|Overall Study||3
11385670|NCT03489343|12579362|FG005|STARTED|Overall Study||7
11385671|NCT03489343|12579363|FG006|STARTED|Overall Study||6
11385672|NCT03489343|12579357|FG000|COMPLETED|Overall Study||0
11385673|NCT03489343|12579358|FG001|COMPLETED|Overall Study||0
11385674|NCT03489343|12579359|FG002|COMPLETED|Overall Study||0
11385675|NCT03489343|12579360|FG003|COMPLETED|Overall Study||0
11385676|NCT03489343|12579361|FG004|COMPLETED|Overall Study||0
11385677|NCT03489343|12579362|FG005|COMPLETED|Overall Study||0
11385678|NCT03489343|12579363|FG006|COMPLETED|Overall Study||0
11385679|NCT03489343|12579357|FG000|NOT COMPLETED|Overall Study||1
11385680|NCT03489343|12579358|FG001|NOT COMPLETED|Overall Study||1
11385681|NCT03489343|12579359|FG002|NOT COMPLETED|Overall Study||3
11385682|NCT03489343|12579360|FG003|NOT COMPLETED|Overall Study||3
11385683|NCT03489343|12579361|FG004|NOT COMPLETED|Overall Study||3
11385684|NCT03489343|12579362|FG005|NOT COMPLETED|Overall Study||7
11385685|NCT03489343|12579363|FG006|NOT COMPLETED|Overall Study||6
11385686|NCT03489369|12579383|FG000|STARTED|Overall Study||3
11385687|NCT03489369|12579384|FG001|STARTED|Overall Study||3
11385688|NCT03489369|12579385|FG002|STARTED|Overall Study||3
11385689|NCT03489369|12579386|FG003|STARTED|Overall Study||6
11385690|NCT03489369|12579383|FG000|COMPLETED|Overall Study||0
11385691|NCT03489369|12579384|FG001|COMPLETED|Overall Study||0
11385692|NCT03489369|12579385|FG002|COMPLETED|Overall Study||0
11385693|NCT03489369|12579386|FG003|COMPLETED|Overall Study||0
11385694|NCT03489369|12579383|FG000|NOT COMPLETED|Overall Study||3
11385695|NCT03489369|12579384|FG001|NOT COMPLETED|Overall Study||3
11385696|NCT03489369|12579385|FG002|NOT COMPLETED|Overall Study||3
11385697|NCT03489369|12579386|FG003|NOT COMPLETED|Overall Study||6
11385698|NCT03489551|12579396|FG000|STARTED|Overall Study||17
11385699|NCT03489551|12579396|FG000|COMPLETED|Overall Study||15
11385700|NCT03489551|12579396|FG000|NOT COMPLETED|Overall Study||2
11385701|NCT03489720|12579402|FG000|STARTED|Overall Study||24
11385702|NCT03489720|12579403|FG001|STARTED|Overall Study||22
11385703|NCT03489720|12579402|FG000|COMPLETED|Overall Study||22
11385704|NCT03489720|12579403|FG001|COMPLETED|Overall Study||22
11385705|NCT03489720|12579402|FG000|NOT COMPLETED|Overall Study||2
11385706|NCT03489720|12579403|FG001|NOT COMPLETED|Overall Study||0
11385707|NCT03489850|12579415|FG000|STARTED|Overall Study||24
11385708|NCT03489850|12579416|FG001|STARTED|Overall Study||28
11385709|NCT03489850|12579415|FG000|COMPLETED|Overall Study||23
11385710|NCT03489850|12579416|FG001|COMPLETED|Overall Study||27
11385711|NCT03489850|12579415|FG000|NOT COMPLETED|Overall Study||1
11385712|NCT03489850|12579416|FG001|NOT COMPLETED|Overall Study||1
11385713|NCT03489863|12579424|FG000|STARTED|Overall Study||7
11385714|NCT03489863|12579425|FG001|STARTED|Overall Study||7
11385715|NCT03489863|12579424|FG000|COMPLETED|Overall Study||7
11385716|NCT03489863|12579425|FG001|COMPLETED|Overall Study||6
11385717|NCT03489863|12579424|FG000|NOT COMPLETED|Overall Study||0
11385718|NCT03489863|12579425|FG001|NOT COMPLETED|Overall Study||1
11385719|NCT03489941|12579431|FG000|STARTED|Overall Study||51
11385720|NCT03489941|12579432|FG001|STARTED|Overall Study||52
11385721|NCT03489941|12579433|FG002|STARTED|Overall Study||27
11385722|NCT03489941|12579431|FG000|COMPLETED|Overall Study||51
11385723|NCT03489941|12579432|FG001|COMPLETED|Overall Study||52
11385724|NCT03489941|12579433|FG002|COMPLETED|Overall Study||27
11385725|NCT03489941|12579431|FG000|NOT COMPLETED|Overall Study||0
11385726|NCT03489941|12579432|FG001|NOT COMPLETED|Overall Study||0
11385727|NCT03489941|12579433|FG002|NOT COMPLETED|Overall Study||0
11385728|NCT03490032|12579442|FG000|STARTED|Overall Study||6
11385729|NCT03490032|12579443|FG001|STARTED|Overall Study||12
11385730|NCT03490032|12579444|FG002|STARTED|Overall Study||12
11385731|NCT03490032|12579442|FG000|COMPLETED|Overall Study||5
11385732|NCT03490032|12579443|FG001|COMPLETED|Overall Study||12
11385733|NCT03490032|12579444|FG002|COMPLETED|Overall Study||12
11385734|NCT03490032|12579442|FG000|NOT COMPLETED|Overall Study||1
11385735|NCT03490032|12579443|FG001|NOT COMPLETED|Overall Study||0
11385736|NCT03490032|12579444|FG002|NOT COMPLETED|Overall Study||0
11385737|NCT03490110|12579455|FG000|STARTED|Overall Study||9
11385738|NCT03490110|12579456|FG001|STARTED|Overall Study||9
11385739|NCT03490110|12579455|FG000|COMPLETED|Overall Study||6
11385740|NCT03490110|12579456|FG001|COMPLETED|Overall Study||6
11385741|NCT03490110|12579455|FG000|NOT COMPLETED|Overall Study||3
11385742|NCT03490110|12579456|FG001|NOT COMPLETED|Overall Study||3
11385743|NCT03490942|12579465|FG000|STARTED|Overall Study||15
11385744|NCT03490942|12579466|FG001|STARTED|Overall Study||18
11385745|NCT03490942|12579467|FG002|STARTED|Overall Study||16
11385746|NCT03490942|12579465|FG000|COMPLETED|Overall Study||5
11385747|NCT03490942|12579466|FG001|COMPLETED|Overall Study||8
11385748|NCT03490942|12579467|FG002|COMPLETED|Overall Study||9
11385749|NCT03490942|12579465|FG000|NOT COMPLETED|Overall Study||10
11385750|NCT03490942|12579466|FG001|NOT COMPLETED|Overall Study||10
11385751|NCT03490942|12579467|FG002|NOT COMPLETED|Overall Study||7
11385752|NCT03490981|12579477|FG000|STARTED|Overall Study||15
11385753|NCT03490981|12579478|FG001|STARTED|Overall Study||15
11385754|NCT03490981|12579477|FG000|COMPLETED|Overall Study||14
11385755|NCT03490981|12579478|FG001|COMPLETED|Overall Study||13
11385756|NCT03490981|12579477|FG000|NOT COMPLETED|Overall Study||1
11385757|NCT03490981|12579478|FG001|NOT COMPLETED|Overall Study||2
11385758|NCT03491150|12579486|FG000|STARTED|Overall Study||76
11385759|NCT03491150|12579487|FG001|STARTED|Overall Study||73
11385760|NCT03491150|12579486|FG000|COMPLETED|Overall Study||0
11385761|NCT03491150|12579487|FG001|COMPLETED|Overall Study||0
11385762|NCT03491150|12579486|FG000|NOT COMPLETED|Overall Study||76
11385763|NCT03491150|12579487|FG001|NOT COMPLETED|Overall Study||73
11385764|NCT03491228|12579493|FG000|STARTED|Overall Study||107
11385765|NCT03491228|12579493|FG000|COMPLETED|Overall Study||107
11385766|NCT03491228|12579493|FG000|NOT COMPLETED|Overall Study||0
11385767|NCT03491553|12579503|FG000|STARTED|Main Study (Up to Week 48)||9
11385768|NCT03491553|12579504|FG001|STARTED|Main Study (Up to Week 48)||10
11385769|NCT03491553|12579505|FG002|STARTED|Main Study (Up to Week 48)||10
11385770|NCT03491553|12579506|FG003|STARTED|Main Study (Up to Week 48)||10
11385771|NCT03491553|12579507|FG004|STARTED|Main Study (Up to Week 48)||5
11385772|NCT03491553|12579508|FG005|STARTED|Main Study (Up to Week 48)||4
11385773|NCT03491553|12579503|FG000|COMPLETED|Main Study (Up to Week 48)||8
11385774|NCT03491553|12579504|FG001|COMPLETED|Main Study (Up to Week 48)||9
11385775|NCT03491553|12579505|FG002|COMPLETED|Main Study (Up to Week 48)||10
11385776|NCT03491553|12579506|FG003|COMPLETED|Main Study (Up to Week 48)||9
11385777|NCT03491553|12579507|FG004|COMPLETED|Main Study (Up to Week 48)||5
11385778|NCT03491553|12579508|FG005|COMPLETED|Main Study (Up to Week 48)||4
11385779|NCT03491553|12579503|FG000|NOT COMPLETED|Main Study (Up to Week 48)||1
11385780|NCT03491553|12579504|FG001|NOT COMPLETED|Main Study (Up to Week 48)||1
11385781|NCT03491553|12579505|FG002|NOT COMPLETED|Main Study (Up to Week 48)||0
11385782|NCT03491553|12579506|FG003|NOT COMPLETED|Main Study (Up to Week 48)||1
11385783|NCT03491553|12579507|FG004|NOT COMPLETED|Main Study (Up to Week 48)||0
11385784|NCT03491553|12579508|FG005|NOT COMPLETED|Main Study (Up to Week 48)||0
11385785|NCT03491553|12579503|FG000|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|8 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
11385786|NCT03491553|12579504|FG001|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but only 1 participant continued in the TFFU phase.|1
11385787|NCT03491553|12579505|FG002|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|10 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
11385788|NCT03491553|12579506|FG003|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
11385789|NCT03491553|12579507|FG004|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|5 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
11385790|NCT03491553|12579508|FG005|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|4 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
11385791|NCT03491553|12579503|FG000|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
11385792|NCT03491553|12579504|FG001|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||1
11385793|NCT03491553|12579505|FG002|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
11385794|NCT03491553|12579506|FG003|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
11385795|NCT03491553|12579507|FG004|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
11385796|NCT03491553|12579508|FG005|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
11385797|NCT03491553|12579503|FG000|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
11385798|NCT03491553|12579504|FG001|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
11385799|NCT03491553|12579505|FG002|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
11385800|NCT03491553|12579506|FG003|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
11385801|NCT03491553|12579507|FG004|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
11385802|NCT03491553|12579508|FG005|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
11385803|NCT03491800|12579527|FG000|STARTED|Overall Study||23
11385804|NCT03491800|12579528|FG001|STARTED|Overall Study||23
11385805|NCT03491800|12579529|FG002|STARTED|Overall Study||7
11385806|NCT03491800|12579527|FG000|COMPLETED|Overall Study||23
11385807|NCT03491800|12579528|FG001|COMPLETED|Overall Study||23
11385808|NCT03491800|12579529|FG002|COMPLETED|Overall Study||7
11385809|NCT03491800|12579527|FG000|NOT COMPLETED|Overall Study||0
11385810|NCT03491800|12579528|FG001|NOT COMPLETED|Overall Study||0
11385811|NCT03491800|12579529|FG002|NOT COMPLETED|Overall Study||0
11385812|NCT03491891|12579540|FG000|STARTED|Overall Study||6038
11385813|NCT03491891|12579541|FG001|STARTED|Overall Study||2438
11385814|NCT03491891|12579540|FG000|COMPLETED|Overall Study||5185
11385815|NCT03491891|12579541|FG001|COMPLETED|Overall Study||2058
11385816|NCT03491891|12579540|FG000|NOT COMPLETED|Overall Study||853
11385817|NCT03491891|12579541|FG001|NOT COMPLETED|Overall Study||380
11385818|NCT03491917|12579547|FG000|STARTED|First Reading Session||50
11385819|NCT03491917|12579548|FG001|STARTED|First Reading Session||50
11385820|NCT03491917|12579547|FG000|COMPLETED|First Reading Session||50
11385821|NCT03491917|12579548|FG001|COMPLETED|First Reading Session||50
11385822|NCT03491917|12579547|FG000|NOT COMPLETED|First Reading Session||0
11385823|NCT03491917|12579548|FG001|NOT COMPLETED|First Reading Session||0
11385824|NCT03491917|12579547|FG000|STARTED|4 Week Memory Washout Period||50
11385825|NCT03491917|12579548|FG001|STARTED|4 Week Memory Washout Period||50
11385826|NCT03491917|12579547|FG000|COMPLETED|4 Week Memory Washout Period||50
11385827|NCT03491917|12579548|FG001|COMPLETED|4 Week Memory Washout Period||50
11385828|NCT03491917|12579547|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
11385829|NCT03491917|12579548|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
11385830|NCT03491917|12579547|FG000|STARTED|Second Reading Session||50
11385831|NCT03491917|12579548|FG001|STARTED|Second Reading Session||50
11385832|NCT03491917|12579547|FG000|COMPLETED|Second Reading Session||50
11385833|NCT03491917|12579548|FG001|COMPLETED|Second Reading Session||50
11385834|NCT03491917|12579547|FG000|NOT COMPLETED|Second Reading Session||0
11385835|NCT03491917|12579548|FG001|NOT COMPLETED|Second Reading Session||0
11385836|NCT03492281|12579557|FG000|STARTED|Overall Study||540
11385837|NCT03492281|12579558|FG001|STARTED|Overall Study||547
11385838|NCT03492281|12579559|FG002|STARTED|Overall Study||431
11385839|NCT03492281|12579557|FG000|COMPLETED|Overall Study||486
11385840|NCT03492281|12579558|FG001|COMPLETED|Overall Study||502
11385841|NCT03492281|12579559|FG002|COMPLETED|Overall Study||385
11385842|NCT03492281|12579557|FG000|NOT COMPLETED|Overall Study||54
11385843|NCT03492281|12579558|FG001|NOT COMPLETED|Overall Study||45
11385844|NCT03492281|12579559|FG002|NOT COMPLETED|Overall Study||46
11385845|NCT03492398|12579579|FG000|STARTED|Overall Study||8
11385846|NCT03492398|12579580|FG001|STARTED|Overall Study||6
11385847|NCT03492398|12579581|FG002|STARTED|Overall Study||6
11385848|NCT03492398|12579582|FG003|STARTED|Overall Study||6
11385849|NCT03492398|12579583|FG004|STARTED|Overall Study||6
11385850|NCT03492398|12579584|FG005|STARTED|Overall Study||6
11385851|NCT03492398|12579585|FG006|STARTED|Overall Study||6
11385852|NCT03492398|12579586|FG007|STARTED|Overall Study||6
11385853|NCT03492398|12579587|FG008|STARTED|Overall Study||6
11385854|NCT03492398|12579579|FG000|COMPLETED|Overall Study||8
11385855|NCT03492398|12579580|FG001|COMPLETED|Overall Study||6
11385856|NCT03492398|12579581|FG002|COMPLETED|Overall Study||6
11385857|NCT03492398|12579582|FG003|COMPLETED|Overall Study||6
11385858|NCT03492398|12579583|FG004|COMPLETED|Overall Study||6
11385859|NCT03492398|12579584|FG005|COMPLETED|Overall Study||6
11385860|NCT03492398|12579585|FG006|COMPLETED|Overall Study||5
11385861|NCT03492398|12579586|FG007|COMPLETED|Overall Study||5
11385862|NCT03492398|12579587|FG008|COMPLETED|Overall Study||6
11385863|NCT03492398|12579579|FG000|NOT COMPLETED|Overall Study||0
11385864|NCT03492398|12579580|FG001|NOT COMPLETED|Overall Study||0
11385865|NCT03492398|12579581|FG002|NOT COMPLETED|Overall Study||0
11385866|NCT03492398|12579582|FG003|NOT COMPLETED|Overall Study||0
11385867|NCT03492398|12579583|FG004|NOT COMPLETED|Overall Study||0
11385868|NCT03492398|12579584|FG005|NOT COMPLETED|Overall Study||0
11385869|NCT03492398|12579585|FG006|NOT COMPLETED|Overall Study||1
11385870|NCT03492398|12579586|FG007|NOT COMPLETED|Overall Study||1
11385871|NCT03492398|12579587|FG008|NOT COMPLETED|Overall Study||0
11385872|NCT03492554|12579609|FG000|STARTED|Overall Study||301
11385873|NCT03492554|12579610|FG001|STARTED|Overall Study||301
11385874|NCT03492554|12579609|FG000|COMPLETED|Overall Study||301
11385875|NCT03492554|12579610|FG001|COMPLETED|Overall Study||287
11385876|NCT03492554|12579609|FG000|NOT COMPLETED|Overall Study||0
11385877|NCT03492554|12579610|FG001|NOT COMPLETED|Overall Study||14
11385878|NCT03493386|12579619|FG000|STARTED|Part 1, Intervention Period 1 (2 Days)||26
11385879|NCT03493386|12579620|FG001|STARTED|Part 1, Intervention Period 1 (2 Days)||26
11385880|NCT03493386|12579621|FG002|STARTED|Part 1, Intervention Period 1 (2 Days)||0
11385881|NCT03493386|12579622|FG003|STARTED|Part 1, Intervention Period 1 (2 Days)||0
11385882|NCT03493386|12579619|FG000|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
11385883|NCT03493386|12579620|FG001|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
11385884|NCT03493386|12579621|FG002|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
11385885|NCT03493386|12579622|FG003|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
11385886|NCT03493386|12579619|FG000|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
11385887|NCT03493386|12579620|FG001|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
11385888|NCT03493386|12579621|FG002|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
11385889|NCT03493386|12579622|FG003|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
11385890|NCT03493386|12579619|FG000|STARTED|Part 1, Washout Period (at Least 5 Days)||26
11385891|NCT03493386|12579620|FG001|STARTED|Part 1, Washout Period (at Least 5 Days)||26
11385892|NCT03493386|12579621|FG002|STARTED|Part 1, Washout Period (at Least 5 Days)||0
11385893|NCT03493386|12579622|FG003|STARTED|Part 1, Washout Period (at Least 5 Days)||0
11385894|NCT03493386|12579619|FG000|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26
11385895|NCT03493386|12579620|FG001|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25
11385896|NCT03493386|12579621|FG002|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
11385897|NCT03493386|12579622|FG003|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
11385898|NCT03493386|12579619|FG000|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
11385899|NCT03493386|12579620|FG001|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1
11385900|NCT03493386|12579621|FG002|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
11385901|NCT03493386|12579622|FG003|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
11385902|NCT03493386|12579619|FG000|STARTED|Part 1, Intervention Period 2 (2 Days)||26
11385903|NCT03493386|12579620|FG001|STARTED|Part 1, Intervention Period 2 (2 Days)||25
11385904|NCT03493386|12579621|FG002|STARTED|Part 1, Intervention Period 2 (2 Days)||0
11385905|NCT03493386|12579622|FG003|STARTED|Part 1, Intervention Period 2 (2 Days)||0
11385906|NCT03493386|12579619|FG000|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26
11385907|NCT03493386|12579620|FG001|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25
11385908|NCT03493386|12579621|FG002|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
11385909|NCT03493386|12579622|FG003|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
11385910|NCT03493386|12579619|FG000|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
11385911|NCT03493386|12579620|FG001|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
11385912|NCT03493386|12579621|FG002|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
11385913|NCT03493386|12579622|FG003|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
11385914|NCT03493386|12579619|FG000|STARTED|Part 2, Intervention Period 1 (2 Days)||0
11385915|NCT03493386|12579620|FG001|STARTED|Part 2, Intervention Period 1 (2 Days)||0
11385916|NCT03493386|12579621|FG002|STARTED|Part 2, Intervention Period 1 (2 Days)||6
11385917|NCT03493386|12579622|FG003|STARTED|Part 2, Intervention Period 1 (2 Days)||6
11385918|NCT03493386|12579619|FG000|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
11385919|NCT03493386|12579620|FG001|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
11385920|NCT03493386|12579621|FG002|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
11385921|NCT03493386|12579622|FG003|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
11385922|NCT03493386|12579619|FG000|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
11385923|NCT03493386|12579620|FG001|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
11385924|NCT03493386|12579621|FG002|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
11385925|NCT03493386|12579622|FG003|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
11385926|NCT03493386|12579619|FG000|STARTED|Part 2, Washout Period (at Least 5 Days)||0
11385927|NCT03493386|12579620|FG001|STARTED|Part 2, Washout Period (at Least 5 Days)||0
11385928|NCT03493386|12579621|FG002|STARTED|Part 2, Washout Period (at Least 5 Days)||6
11385929|NCT03493386|12579622|FG003|STARTED|Part 2, Washout Period (at Least 5 Days)||6
11385930|NCT03493386|12579619|FG000|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
11385931|NCT03493386|12579620|FG001|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
11385932|NCT03493386|12579621|FG002|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
11385933|NCT03493386|12579622|FG003|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
11385934|NCT03493386|12579619|FG000|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
11385935|NCT03493386|12579620|FG001|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
11385936|NCT03493386|12579621|FG002|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
11385937|NCT03493386|12579622|FG003|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
11385938|NCT03493386|12579619|FG000|STARTED|Part 2, Intervention Period 2 (2 Days)||0
11385939|NCT03493386|12579620|FG001|STARTED|Part 2, Intervention Period 2 (2 Days)||0
11385940|NCT03493386|12579621|FG002|STARTED|Part 2, Intervention Period 2 (2 Days)||6
11385941|NCT03493386|12579622|FG003|STARTED|Part 2, Intervention Period 2 (2 Days)||6
11385942|NCT03493386|12579619|FG000|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
11385943|NCT03493386|12579620|FG001|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
11385944|NCT03493386|12579621|FG002|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
11385945|NCT03493386|12579622|FG003|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
11385946|NCT03493386|12579619|FG000|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
11385947|NCT03493386|12579620|FG001|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
11385948|NCT03493386|12579621|FG002|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
11385949|NCT03493386|12579622|FG003|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
11385950|NCT03493542|12579641|FG000|STARTED|Overall Study||383
11385951|NCT03493542|12579642|FG001|STARTED|Overall Study||383
11385952|NCT03493542|12579641|FG000|Vaccination 1|Overall Study||383
11385953|NCT03493542|12579642|FG001|Vaccination 1|Overall Study||383
11385954|NCT03493542|12579641|FG000|Vaccination 2|Overall Study||379
11385955|NCT03493542|12579642|FG001|Vaccination 2|Overall Study||378
11385956|NCT03493542|12579641|FG000|Vaccination 3|Overall Study||376
11385957|NCT03493542|12579642|FG001|Vaccination 3|Overall Study||374
11385958|NCT03493542|12579641|FG000|COMPLETED|Overall Study||376
11385959|NCT03493542|12579642|FG001|COMPLETED|Overall Study||374
11385960|NCT03493542|12579641|FG000|NOT COMPLETED|Overall Study||7
11385961|NCT03493542|12579642|FG001|NOT COMPLETED|Overall Study||9
11385962|NCT03493607|12579648|FG000|STARTED|Overall Study||6
11385963|NCT03493607|12579648|FG000|COMPLETED|Overall Study||6
11385964|NCT03493607|12579648|FG000|NOT COMPLETED|Overall Study||0
11385965|NCT03493698|12579652|FG000|STARTED|Treatment Period A||17
11385966|NCT03493698|12579652|FG000|COMPLETED|Treatment Period A||17
11385967|NCT03493698|12579652|FG000|NOT COMPLETED|Treatment Period A||0
11385968|NCT03493698|12579652|FG000|STARTED|Treatment Period B||17
11385969|NCT03493698|12579652|FG000|COMPLETED|Treatment Period B||17
11385970|NCT03493698|12579652|FG000|NOT COMPLETED|Treatment Period B||0
11385971|NCT03493698|12579652|FG000|STARTED|Treatment Period C||17
11385972|NCT03493698|12579652|FG000|COMPLETED|Treatment Period C||15
11385973|NCT03493698|12579652|FG000|NOT COMPLETED|Treatment Period C||2
11385974|NCT03493698|12579652|FG000|STARTED|Treatment Period D||15
11385975|NCT03493698|12579652|FG000|COMPLETED|Treatment Period D||15
11385976|NCT03493698|12579652|FG000|NOT COMPLETED|Treatment Period D||0
11385977|NCT03493815|12579668|FG000|STARTED|Overall Study||42
11385978|NCT03493815|12579669|FG001|STARTED|Overall Study||43
11385979|NCT03493815|12579668|FG000|COMPLETED|Overall Study||33
11385980|NCT03493815|12579669|FG001|COMPLETED|Overall Study||32
11385981|NCT03493815|12579668|FG000|NOT COMPLETED|Overall Study||9
11385982|NCT03493815|12579669|FG001|NOT COMPLETED|Overall Study||11
11385983|NCT03493828|12579678|FG000|STARTED|Overall Study||20
11385984|NCT03493828|12579679|FG001|STARTED|Overall Study||20
11385985|NCT03493828|12579680|FG002|STARTED|Overall Study||20
11385986|NCT03493828|12579678|FG000|COMPLETED|Overall Study||20
11385987|NCT03493828|12579679|FG001|COMPLETED|Overall Study||20
11385988|NCT03493828|12579680|FG002|COMPLETED|Overall Study||20
11385989|NCT03493828|12579678|FG000|NOT COMPLETED|Overall Study||0
11385990|NCT03493828|12579679|FG001|NOT COMPLETED|Overall Study||0
11385991|NCT03493828|12579680|FG002|NOT COMPLETED|Overall Study||0
11385992|NCT03494725|12579690|FG000|STARTED|Overall Study||60
11385993|NCT03494725|12579691|FG001|STARTED|Overall Study||60
11385994|NCT03494725|12579690|FG000|Intervention (Post 2 Weeks run-in)|Overall Study||59
11385995|NCT03494725|12579691|FG001|Intervention (Post 2 Weeks run-in)|Overall Study||59
11385996|NCT03494725|12579690|FG000|COMPLETED|Overall Study||59
11385997|NCT03494725|12579691|FG001|COMPLETED|Overall Study||58
11385998|NCT03494725|12579690|FG000|NOT COMPLETED|Overall Study||1
11385999|NCT03494725|12579691|FG001|NOT COMPLETED|Overall Study||2
11386000|NCT03494816|12579703|FG000|STARTED|Overall Study||24
11386001|NCT03494816|12579703|FG000|COMPLETED|Overall Study||18
11386002|NCT03494816|12579703|FG000|NOT COMPLETED|Overall Study||6
11386003|NCT03494985|12579715|FG000|STARTED|Overall Study||101
11386004|NCT03494985|12579716|FG001|STARTED|Overall Study||98
11386005|NCT03494985|12579717|FG002|STARTED|Overall Study||98
11386006|NCT03494985|12579718|FG003|STARTED|Overall Study||99
11386007|NCT03494985|12579715|FG000|COMPLETED|Overall Study||96
11386008|NCT03494985|12579716|FG001|COMPLETED|Overall Study||92
11386009|NCT03494985|12579717|FG002|COMPLETED|Overall Study||92
11006079|NCT00726414|12183855|FG000|STARTED|First Intervention||11
11006080|NCT00726414|12183856|FG001|STARTED|First Intervention||11
11006081|NCT00726414|12183855|FG000|COMPLETED|First Intervention||11
11006082|NCT00726414|12183856|FG001|COMPLETED|First Intervention||11
11006083|NCT00726414|12183855|FG000|NOT COMPLETED|First Intervention||0
11006084|NCT00726414|12183856|FG001|NOT COMPLETED|First Intervention||0
11006085|NCT00726414|12183855|FG000|STARTED|Washout Period of 7 Days||11
11006086|NCT00726414|12183856|FG001|STARTED|Washout Period of 7 Days||11
11006087|NCT00726414|12183855|FG000|COMPLETED|Washout Period of 7 Days||11
11006088|NCT00726414|12183856|FG001|COMPLETED|Washout Period of 7 Days||11
11006089|NCT00726414|12183855|FG000|NOT COMPLETED|Washout Period of 7 Days||0
11006090|NCT00726414|12183856|FG001|NOT COMPLETED|Washout Period of 7 Days||0
11006091|NCT00726414|12183855|FG000|STARTED|Second Intervention||11
11006092|NCT00726414|12183856|FG001|STARTED|Second Intervention||11
11006093|NCT00726414|12183855|FG000|COMPLETED|Second Intervention||11
11006094|NCT00726414|12183856|FG001|COMPLETED|Second Intervention||11
11006095|NCT00726414|12183855|FG000|NOT COMPLETED|Second Intervention||0
11006096|NCT00726414|12183856|FG001|NOT COMPLETED|Second Intervention||0
11006097|NCT00726453|12183864|FG000|STARTED|Primary Enrollment Group||1402
11386010|NCT03494985|12579718|FG003|COMPLETED|Overall Study||94
11386011|NCT03494985|12579715|FG000|NOT COMPLETED|Overall Study||5
11386012|NCT03494985|12579716|FG001|NOT COMPLETED|Overall Study||6
11386013|NCT03494985|12579717|FG002|NOT COMPLETED|Overall Study||6
11386014|NCT03494985|12579718|FG003|NOT COMPLETED|Overall Study||5
11386015|NCT03495102|12579731|FG000|STARTED|Overall Study||612
11386016|NCT03495102|12579732|FG001|STARTED|Overall Study||616
11386017|NCT03495102|12579733|FG002|STARTED|Overall Study||614
11386018|NCT03495102|12579731|FG000|Received at Least One Dose of Study Drug|Overall Study||612
11386019|NCT03495102|12579732|FG001|Received at Least One Dose of Study Drug|Overall Study||616
11386020|NCT03495102|12579733|FG002|Received at Least One Dose of Study Drug|Overall Study||614
11386021|NCT03495102|12579731|FG000|COMPLETED|Overall Study||556
11386022|NCT03495102|12579732|FG001|COMPLETED|Overall Study||549
11386023|NCT03495102|12579733|FG002|COMPLETED|Overall Study||560
11386024|NCT03495102|12579731|FG000|NOT COMPLETED|Overall Study||56
11386025|NCT03495102|12579732|FG001|NOT COMPLETED|Overall Study||67
11386026|NCT03495102|12579733|FG002|NOT COMPLETED|Overall Study||54
11386027|NCT03495648|12579743|FG000|STARTED|Overall Study||60
11386028|NCT03495648|12579744|FG001|STARTED|Overall Study||61
11386029|NCT03495648|12579743|FG000|COMPLETED|Overall Study||60
11386030|NCT03495648|12579744|FG001|COMPLETED|Overall Study||61
11386031|NCT03495648|12579743|FG000|NOT COMPLETED|Overall Study||0
11386032|NCT03495648|12579744|FG001|NOT COMPLETED|Overall Study||0
11386033|NCT03495817|12579750|FG000|STARTED|26 Week Open Label||31
11386034|NCT03495817|12579750|FG000|COMPLETED|26 Week Open Label||23
11386035|NCT03495817|12579750|FG000|NOT COMPLETED|26 Week Open Label||8
11386036|NCT03495817|12579750|FG000|STARTED|26 Week Extension||19
11386037|NCT03495817|12579750|FG000|COMPLETED|26 Week Extension||17
11386038|NCT03495817|12579750|FG000|NOT COMPLETED|26 Week Extension||2
11386039|NCT03495856|12579754|FG000|STARTED|Overall Study||23
11386040|NCT03495856|12579754|FG000|COMPLETED|Overall Study||22
11386041|NCT03495856|12579754|FG000|NOT COMPLETED|Overall Study||1
11386042|NCT03495869|12579762|FG000|STARTED|Overall Study||54
11386043|NCT03495869|12579763|FG001|STARTED|Overall Study||124
11386044|NCT03495869|12579764|FG002|STARTED|Overall Study||61
11386045|NCT03495869|12579765|FG003|STARTED|Overall Study||129
11386046|NCT03495869|12579762|FG000|COMPLETED|Overall Study||50
11386047|NCT03495869|12579763|FG001|COMPLETED|Overall Study||97
11386048|NCT03495869|12579764|FG002|COMPLETED|Overall Study||51
11386049|NCT03495869|12579765|FG003|COMPLETED|Overall Study||108
11386050|NCT03495869|12579762|FG000|NOT COMPLETED|Overall Study||4
11386051|NCT03495869|12579763|FG001|NOT COMPLETED|Overall Study||27
11386052|NCT03495869|12579764|FG002|NOT COMPLETED|Overall Study||10
11386053|NCT03495869|12579765|FG003|NOT COMPLETED|Overall Study||21
11386054|NCT03495908|12579777|FG000|STARTED|Overall Study||69
11386055|NCT03495908|12579778|FG001|STARTED|Overall Study||67
11386056|NCT03495908|12579777|FG000|COMPLETED|Overall Study||59
11386057|NCT03495908|12579778|FG001|COMPLETED|Overall Study||54
11386058|NCT03495908|12579777|FG000|NOT COMPLETED|Overall Study||10
11386059|NCT03495908|12579778|FG001|NOT COMPLETED|Overall Study||13
11386060|NCT03496220|12579786|FG000|STARTED|First Intervention||15
11386061|NCT03496220|12579787|FG001|STARTED|First Intervention||4
11386062|NCT03496220|12579788|FG002|STARTED|First Intervention||10
11386063|NCT03496220|12579786|FG000|COMPLETED|First Intervention||15
11386064|NCT03496220|12579787|FG001|COMPLETED|First Intervention||4
11386065|NCT03496220|12579788|FG002|COMPLETED|First Intervention||10
11386066|NCT03496220|12579786|FG000|NOT COMPLETED|First Intervention||0
11386067|NCT03496220|12579787|FG001|NOT COMPLETED|First Intervention||0
11386068|NCT03496220|12579788|FG002|NOT COMPLETED|First Intervention||0
11386069|NCT03496220|12579786|FG000|STARTED|Second Intervention||17
11386070|NCT03496220|12579787|FG001|STARTED|Second Intervention||9
11386071|NCT03496220|12579788|FG002|STARTED|Second Intervention||11
11386072|NCT03496220|12579786|FG000|COMPLETED|Second Intervention||17
11386073|NCT03496220|12579787|FG001|COMPLETED|Second Intervention||9
11386074|NCT03496220|12579788|FG002|COMPLETED|Second Intervention||11
11386075|NCT03496220|12579786|FG000|NOT COMPLETED|Second Intervention||0
11386076|NCT03496220|12579787|FG001|NOT COMPLETED|Second Intervention||0
11386077|NCT03496220|12579788|FG002|NOT COMPLETED|Second Intervention||0
11386078|NCT03496220|12579786|FG000|STARTED|Third Intervention||11
11386079|NCT03496220|12579787|FG001|STARTED|Third Intervention||8
11386080|NCT03496220|12579788|FG002|STARTED|Third Intervention||5
11386081|NCT03496220|12579786|FG000|COMPLETED|Third Intervention||11
11386082|NCT03496220|12579787|FG001|COMPLETED|Third Intervention||8
11386083|NCT03496220|12579788|FG002|COMPLETED|Third Intervention||5
11386084|NCT03496220|12579786|FG000|NOT COMPLETED|Third Intervention||0
11386085|NCT03496220|12579787|FG001|NOT COMPLETED|Third Intervention||0
11386086|NCT03496220|12579788|FG002|NOT COMPLETED|Third Intervention||0
11386087|NCT03496298|12579797|FG000|STARTED|Overall Study||1359
11386088|NCT03496298|12579798|FG001|STARTED|Overall Study||1359
11386089|NCT03496298|12579799|FG002|STARTED|Overall Study||1358
11386090|NCT03496298|12579797|FG000|Randomized and Treated|Overall Study||1358
11386091|NCT03496298|12579798|FG001|Randomized and Treated|Overall Study||1358
11386092|NCT03496298|12579799|FG002|Randomized and Treated|Overall Study||1357
11386093|NCT03496298|12579797|FG000|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and 1 participant received Efpeglenatide 6 mg treatment. Hence, they were counted in the respective arm for safety analysis.|1355
11386094|NCT03496298|12579798|FG001|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and thus counted in the 4 mg treatment arm for safety analysis.|1360
11386095|NCT03496298|12579799|FG002|Safety Population|Overall Study|1 participant of Placebo arm received Efpeglenatide 6 mg treatment and thus counted in the 6 mg treatment arm for safety analysis.|1358
11386096|NCT03496298|12579797|FG000|COMPLETED|Overall Study||42
11386097|NCT03496298|12579798|FG001|COMPLETED|Overall Study||36
11386098|NCT03496298|12579799|FG002|COMPLETED|Overall Study||23
11386099|NCT03496298|12579797|FG000|NOT COMPLETED|Overall Study||1317
11386100|NCT03496298|12579798|FG001|NOT COMPLETED|Overall Study||1323
11386101|NCT03496298|12579799|FG002|NOT COMPLETED|Overall Study||1335
11386102|NCT03496324|12579806|FG000|STARTED|Period 1||6
11386103|NCT03496324|12579807|FG001|STARTED|Period 1||6
11386104|NCT03496324|12579808|FG002|STARTED|Period 1||6
11386105|NCT03496324|12579809|FG003|STARTED|Period 1||6
11386106|NCT03496324|12579806|FG000|COMPLETED|Period 1||6
11386107|NCT03496324|12579807|FG001|COMPLETED|Period 1||6
11386108|NCT03496324|12579808|FG002|COMPLETED|Period 1||6
11386109|NCT03496324|12579809|FG003|COMPLETED|Period 1||6
11386110|NCT03496324|12579806|FG000|NOT COMPLETED|Period 1||0
11386111|NCT03496324|12579807|FG001|NOT COMPLETED|Period 1||0
11386112|NCT03496324|12579808|FG002|NOT COMPLETED|Period 1||0
11386113|NCT03496324|12579809|FG003|NOT COMPLETED|Period 1||0
11386114|NCT03496324|12579806|FG000|STARTED|Period 1: Washout (3 to 7 Days)||6
11386115|NCT03496324|12579807|FG001|STARTED|Period 1: Washout (3 to 7 Days)||6
11386116|NCT03496324|12579808|FG002|STARTED|Period 1: Washout (3 to 7 Days)||6
11386117|NCT03496324|12579809|FG003|STARTED|Period 1: Washout (3 to 7 Days)||6
11386118|NCT03496324|12579806|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||6
11386119|NCT03496324|12579807|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||6
11386120|NCT03496324|12579808|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||6
11386121|NCT03496324|12579809|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||6
11386122|NCT03496324|12579806|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
11386123|NCT03496324|12579807|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
11386124|NCT03496324|12579808|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
11386125|NCT03496324|12579809|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
11386126|NCT03496324|12579806|FG000|STARTED|Period 2||6
11386127|NCT03496324|12579807|FG001|STARTED|Period 2||6
11386128|NCT03496324|12579808|FG002|STARTED|Period 2||6
11386129|NCT03496324|12579809|FG003|STARTED|Period 2||6
11386130|NCT03496324|12579806|FG000|COMPLETED|Period 2||6
11386131|NCT03496324|12579807|FG001|COMPLETED|Period 2||6
11386132|NCT03496324|12579808|FG002|COMPLETED|Period 2||6
11386133|NCT03496324|12579809|FG003|COMPLETED|Period 2||6
11386134|NCT03496324|12579806|FG000|NOT COMPLETED|Period 2||0
11386135|NCT03496324|12579807|FG001|NOT COMPLETED|Period 2||0
11386136|NCT03496324|12579808|FG002|NOT COMPLETED|Period 2||0
11386137|NCT03496324|12579809|FG003|NOT COMPLETED|Period 2||0
11386138|NCT03496324|12579806|FG000|STARTED|Period 2: Washout (3 to 7 Days)||6
11386139|NCT03496324|12579807|FG001|STARTED|Period 2: Washout (3 to 7 Days)||6
11386140|NCT03496324|12579808|FG002|STARTED|Period 2: Washout (3 to 7 Days)||6
11386141|NCT03496324|12579809|FG003|STARTED|Period 2: Washout (3 to 7 Days)||6
11386142|NCT03496324|12579806|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6
11386143|NCT03496324|12579807|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||6
11386144|NCT03496324|12579808|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6
11386145|NCT03496324|12579809|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||6
11386146|NCT03496324|12579806|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
11386147|NCT03496324|12579807|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
11386148|NCT03496324|12579808|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
11386149|NCT03496324|12579809|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
11386150|NCT03496324|12579806|FG000|STARTED|Period 3||6
11386151|NCT03496324|12579807|FG001|STARTED|Period 3||6
11386152|NCT03496324|12579808|FG002|STARTED|Period 3||6
11386153|NCT03496324|12579809|FG003|STARTED|Period 3||6
11386154|NCT03496324|12579806|FG000|COMPLETED|Period 3||6
11386155|NCT03496324|12579807|FG001|COMPLETED|Period 3||6
11386156|NCT03496324|12579808|FG002|COMPLETED|Period 3||6
11386157|NCT03496324|12579809|FG003|COMPLETED|Period 3||6
11386158|NCT03496324|12579806|FG000|NOT COMPLETED|Period 3||0
11386159|NCT03496324|12579807|FG001|NOT COMPLETED|Period 3||0
11386160|NCT03496324|12579808|FG002|NOT COMPLETED|Period 3||0
11386161|NCT03496324|12579809|FG003|NOT COMPLETED|Period 3||0
11386162|NCT03496324|12579806|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6
11386163|NCT03496324|12579807|FG001|STARTED|Period 3: Washout (3 to 7 Days)||6
11386164|NCT03496324|12579808|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6
11386165|NCT03496324|12579809|FG003|STARTED|Period 3: Washout (3 to 7 Days)||6
11386166|NCT03496324|12579806|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6
11386167|NCT03496324|12579807|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||6
11386168|NCT03496324|12579808|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6
11386169|NCT03496324|12579809|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||6
11386170|NCT03496324|12579806|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
11386171|NCT03496324|12579807|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
11386172|NCT03496324|12579808|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
11386173|NCT03496324|12579809|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
11386174|NCT03496324|12579806|FG000|STARTED|Period 7: Period 4||6
11386175|NCT03496324|12579807|FG001|STARTED|Period 7: Period 4||6
11386176|NCT03496324|12579808|FG002|STARTED|Period 7: Period 4||6
11386177|NCT03496324|12579809|FG003|STARTED|Period 7: Period 4||6
11386178|NCT03496324|12579806|FG000|COMPLETED|Period 7: Period 4||6
11386179|NCT03496324|12579807|FG001|COMPLETED|Period 7: Period 4||6
11386180|NCT03496324|12579808|FG002|COMPLETED|Period 7: Period 4||6
11386181|NCT03496324|12579809|FG003|COMPLETED|Period 7: Period 4||6
11386182|NCT03496324|12579806|FG000|NOT COMPLETED|Period 7: Period 4||0
11386183|NCT03496324|12579807|FG001|NOT COMPLETED|Period 7: Period 4||0
11386184|NCT03496324|12579808|FG002|NOT COMPLETED|Period 7: Period 4||0
11386185|NCT03496324|12579809|FG003|NOT COMPLETED|Period 7: Period 4||0
11386186|NCT03496428|12579819|FG000|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
11386187|NCT03496428|12579819|FG000|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
11386188|NCT03496428|12579819|FG000|NOT COMPLETED|Overall Study||0
11386189|NCT03496467|12579825|FG000|STARTED|Overall Study||38
11386190|NCT03496467|12579826|FG001|STARTED|Overall Study||18
11386191|NCT03496467|12579825|FG000|COMPLETED|Overall Study||34
11386192|NCT03496467|12579826|FG001|COMPLETED|Overall Study||14
11386193|NCT03496467|12579825|FG000|NOT COMPLETED|Overall Study||4
11386194|NCT03496467|12579826|FG001|NOT COMPLETED|Overall Study||4
11386195|NCT03496545|12579834|FG000|STARTED|Overall Study||21
11386196|NCT03496545|12579835|FG001|STARTED|Overall Study||26
11386197|NCT03496545|12579834|FG000|COMPLETED|Overall Study||20
11386198|NCT03496545|12579835|FG001|COMPLETED|Overall Study||24
11386199|NCT03496545|12579834|FG000|NOT COMPLETED|Overall Study||1
11386200|NCT03496545|12579835|FG001|NOT COMPLETED|Overall Study||2
11386201|NCT03496701|12579841|FG000|STARTED|Overall Study||77
11386202|NCT03496701|12579841|FG000|COMPLETED|Overall Study||77
11386203|NCT03496701|12579841|FG000|NOT COMPLETED|Overall Study||0
11386204|NCT03496974|12579849|FG000|STARTED|Overall Study||10
11386205|NCT03496974|12579850|FG001|STARTED|Overall Study||28
11386206|NCT03496974|12579849|FG000|COMPLETED|Overall Study||9
11386207|NCT03496974|12579850|FG001|COMPLETED|Overall Study||20
11386208|NCT03496974|12579849|FG000|NOT COMPLETED|Overall Study||1
11386209|NCT03496974|12579850|FG001|NOT COMPLETED|Overall Study||8
11386210|NCT03496987|12579858|FG000|STARTED|Overall Study||49
11386211|NCT03496987|12579859|FG001|STARTED|Overall Study||51
11386212|NCT03496987|12579858|FG000|COMPLETED|Overall Study||49
11386213|NCT03496987|12579859|FG001|COMPLETED|Overall Study||51
11386214|NCT03496987|12579858|FG000|NOT COMPLETED|Overall Study||0
11386215|NCT03496987|12579859|FG001|NOT COMPLETED|Overall Study||0
11386216|NCT03497026|12579865|FG000|STARTED|Overall Study||4
11386217|NCT03497026|12579865|FG000|COMPLETED|Overall Study||4
11386218|NCT03497026|12579865|FG000|NOT COMPLETED|Overall Study||0
11386219|NCT03497039|12579871|FG000|STARTED|Overall Study||30
11386220|NCT03497039|12579872|FG001|STARTED|Overall Study||17
11386221|NCT03497039|12579871|FG000|Treated|Overall Study||29
11386222|NCT03497039|12579872|FG001|Treated|Overall Study||17
11386223|NCT03497039|12579871|FG000|COMPLETED|Overall Study||29
11386224|NCT03497039|12579872|FG001|COMPLETED|Overall Study||16
11386225|NCT03497039|12579871|FG000|NOT COMPLETED|Overall Study||1
11386226|NCT03497039|12579872|FG001|NOT COMPLETED|Overall Study||1
11386227|NCT03497130|12579880|FG000|STARTED|Overall Study||40
11386228|NCT03497130|12579881|FG001|STARTED|Overall Study||14
11386229|NCT03497130|12579880|FG000|COMPLETED|Overall Study||39
11386230|NCT03497130|12579881|FG001|COMPLETED|Overall Study||13
11386231|NCT03497130|12579880|FG000|NOT COMPLETED|Overall Study||1
11386232|NCT03497130|12579881|FG001|NOT COMPLETED|Overall Study||1
11386233|NCT03497429|12579889|FG000|STARTED|Overall Study||3
11386234|NCT03497429|12579890|FG001|STARTED|Overall Study||6
11386235|NCT03497429|12579889|FG000|Started|Overall Study||3
11386236|NCT03497429|12579890|FG001|Started|Overall Study||6
11386237|NCT03497429|12579889|FG000|Completed|Overall Study||0
11386238|NCT03497429|12579890|FG001|Completed|Overall Study||0
11386239|NCT03497429|12579889|FG000|COMPLETED|Overall Study||0
11386240|NCT03497429|12579890|FG001|COMPLETED|Overall Study||0
11386241|NCT03497429|12579889|FG000|NOT COMPLETED|Overall Study||3
11386242|NCT03497429|12579890|FG001|NOT COMPLETED|Overall Study||6
11386243|NCT03497585|12579896|FG000|STARTED|Overall Study|112 participants were recruited: 107 patients, plus 5 HCPs for the acceptability interviews.|112
11386244|NCT03497585|12579896|FG000|COMPLETED|Overall Study||57
11386245|NCT03497585|12579896|FG000|NOT COMPLETED|Overall Study||55
11386246|NCT03497845|12579912|FG000|STARTED|Overall Study||60
11386247|NCT03497845|12579913|FG001|STARTED|Overall Study||58
11386248|NCT03497845|12579914|FG002|STARTED|Overall Study||61
11386249|NCT03497845|12579915|FG003|STARTED|Overall Study||60
11386250|NCT03497845|12579916|FG004|STARTED|Overall Study||59
11386251|NCT03497845|12579917|FG005|STARTED|Overall Study||62
11386252|NCT03497845|12579918|FG006|STARTED|Overall Study||59
11386253|NCT03497845|12579919|FG007|STARTED|Overall Study||60
11386254|NCT03497845|12579920|FG008|STARTED|Overall Study||61
11386255|NCT03497845|12579921|FG009|STARTED|Overall Study||59
11386256|NCT03497845|12579922|FG010|STARTED|Overall Study||61
11386257|NCT03497845|12579923|FG011|STARTED|Overall Study||60
11386258|NCT03497845|12579912|FG000|COMPLETED|Overall Study|Day 142|55
11386259|NCT03497845|12579913|FG001|COMPLETED|Overall Study|Day 142|45
11386260|NCT03497845|12579914|FG002|COMPLETED|Overall Study|Day 142|50
11386261|NCT03497845|12579915|FG003|COMPLETED|Overall Study|Day 142|50
11386262|NCT03497845|12579916|FG004|COMPLETED|Overall Study|Day 262|38
11386263|NCT03497845|12579917|FG005|COMPLETED|Overall Study|Day 262|44
11386264|NCT03497845|12579918|FG006|COMPLETED|Overall Study|Day 142|51
11386265|NCT03497845|12579919|FG007|COMPLETED|Overall Study|Day 142|50
11386266|NCT03497845|12579920|FG008|COMPLETED|Overall Study|Day 142|47
11386267|NCT03497845|12579921|FG009|COMPLETED|Overall Study|Day 142|53
11386268|NCT03497845|12579922|FG010|COMPLETED|Overall Study|Day 262|46
11386269|NCT03497845|12579923|FG011|COMPLETED|Overall Study|Day 262|38
11386270|NCT03497845|12579912|FG000|NOT COMPLETED|Overall Study||5
11386271|NCT03497845|12579913|FG001|NOT COMPLETED|Overall Study||13
11386272|NCT03497845|12579914|FG002|NOT COMPLETED|Overall Study||11
11386273|NCT03497845|12579915|FG003|NOT COMPLETED|Overall Study||10
11386274|NCT03497845|12579916|FG004|NOT COMPLETED|Overall Study||21
11386275|NCT03497845|12579917|FG005|NOT COMPLETED|Overall Study||18
11386276|NCT03497845|12579918|FG006|NOT COMPLETED|Overall Study||8
11386277|NCT03497845|12579919|FG007|NOT COMPLETED|Overall Study||10
11386278|NCT03497845|12579920|FG008|NOT COMPLETED|Overall Study||14
11386279|NCT03497845|12579921|FG009|NOT COMPLETED|Overall Study||6
11386280|NCT03497845|12579922|FG010|NOT COMPLETED|Overall Study||15
11386281|NCT03497845|12579923|FG011|NOT COMPLETED|Overall Study||22
11386282|NCT03498196|12579955|FG000|STARTED|Overall Study||1
11386283|NCT03498196|12579955|FG000|COMPLETED|Overall Study||1
11386284|NCT03498196|12579955|FG000|NOT COMPLETED|Overall Study||0
11386285|NCT03498287|12579961|FG000|STARTED|Overall Study||45
11386286|NCT03498287|12579962|FG001|STARTED|Overall Study||43
11386287|NCT03498287|12579961|FG000|COMPLETED|Overall Study||42
11386288|NCT03498287|12579962|FG001|COMPLETED|Overall Study||38
11386289|NCT03498287|12579961|FG000|NOT COMPLETED|Overall Study||3
11386290|NCT03498287|12579962|FG001|NOT COMPLETED|Overall Study||5
11386291|NCT03498300|12579970|FG000|STARTED|Overall Study||21
11386292|NCT03498300|12579971|FG001|STARTED|Overall Study||21
11386293|NCT03498300|12579970|FG000|COMPLETED|Overall Study||18
11386294|NCT03498300|12579971|FG001|COMPLETED|Overall Study||13
11386295|NCT03498300|12579970|FG000|NOT COMPLETED|Overall Study||3
11386296|NCT03498300|12579971|FG001|NOT COMPLETED|Overall Study||8
11386297|NCT03499028|12579980|FG000|STARTED|Overall Study||226
11386298|NCT03499028|12579981|FG001|STARTED|Overall Study||220
11386299|NCT03499028|12579980|FG000|COMPLETED|Overall Study||204
11386300|NCT03499028|12579981|FG001|COMPLETED|Overall Study||195
11386301|NCT03499028|12579980|FG000|NOT COMPLETED|Overall Study||22
11386302|NCT03499028|12579981|FG001|NOT COMPLETED|Overall Study||25
11386303|NCT03499067|12579989|FG000|STARTED|First Intervention||27
11386304|NCT03499067|12579990|FG001|STARTED|First Intervention||31
11386305|NCT03499067|12579989|FG000|COMPLETED|First Intervention||22
11386306|NCT03499067|12579990|FG001|COMPLETED|First Intervention||24
11386307|NCT03499067|12579989|FG000|NOT COMPLETED|First Intervention||5
11386308|NCT03499067|12579990|FG001|NOT COMPLETED|First Intervention||7
11386309|NCT03499067|12579989|FG000|STARTED|Second Intervention||22
11386310|NCT03499067|12579990|FG001|STARTED|Second Intervention||24
11386311|NCT03499067|12579989|FG000|COMPLETED|Second Intervention||22
11386312|NCT03499067|12579990|FG001|COMPLETED|Second Intervention||24
11386313|NCT03499067|12579989|FG000|NOT COMPLETED|Second Intervention||0
11386314|NCT03499067|12579990|FG001|NOT COMPLETED|Second Intervention||0
11386315|NCT03499353|12579996|FG000|STARTED|Treatment||61
11386316|NCT03499353|12579996|FG000|COMPLETED|Treatment||45
11386317|NCT03499353|12579996|FG000|NOT COMPLETED|Treatment||16
11386318|NCT03499353|12579996|FG000|STARTED|Safety Follow-up||49
11386319|NCT03499353|12579996|FG000|Received Treatment|Safety Follow-up||0
11386320|NCT03499353|12579996|FG000|COMPLETED|Safety Follow-up||49
11386321|NCT03499353|12579996|FG000|NOT COMPLETED|Safety Follow-up||0
11386322|NCT03499353|12579996|FG000|STARTED|Long-Term Follow-up||58
11386323|NCT03499353|12579996|FG000|Received Treatment|Long-Term Follow-up||0
11386324|NCT03499353|12579996|FG000|COMPLETED|Long-Term Follow-up||0
11386325|NCT03499353|12579996|FG000|NOT COMPLETED|Long-Term Follow-up||58
11386326|NCT03499873|12580003|FG000|STARTED|Overall Study||183
11386327|NCT03499873|12580004|FG001|STARTED|Overall Study||182
11386328|NCT03499873|12580005|FG002|STARTED|Overall Study||83
11386329|NCT03499873|12580003|FG000|Safety Population|Overall Study||175
11386330|NCT03499873|12580004|FG001|Safety Population|Overall Study||174
11386331|NCT03499873|12580005|FG002|Safety Population|Overall Study||80
11386332|NCT03499873|12580003|FG000|Per-Protocol Population|Overall Study||144
11386333|NCT03499873|12580004|FG001|Per-Protocol Population|Overall Study||143
11386334|NCT03499873|12580005|FG002|Per-Protocol Population|Overall Study||58
11386335|NCT03499873|12580003|FG000|Modified-Intent-to-Treat|Overall Study||170
11386336|NCT03499873|12580004|FG001|Modified-Intent-to-Treat|Overall Study||168
11386337|NCT03499873|12580005|FG002|Modified-Intent-to-Treat|Overall Study||77
11386338|NCT03499873|12580003|FG000|COMPLETED|Overall Study||163
11386339|NCT03499873|12580004|FG001|COMPLETED|Overall Study||162
11386340|NCT03499873|12580005|FG002|COMPLETED|Overall Study||56
11386341|NCT03499873|12580003|FG000|NOT COMPLETED|Overall Study||20
11386342|NCT03499873|12580004|FG001|NOT COMPLETED|Overall Study||20
11386343|NCT03499873|12580005|FG002|NOT COMPLETED|Overall Study||27
11386344|NCT03500094|12580013|FG000|STARTED|Overall Study||22
11386345|NCT03500094|12580013|FG000|Received At Least 1 Dose of Study Drug|Overall Study||21
11386346|NCT03500094|12580013|FG000|COMPLETED|Overall Study||19
11386347|NCT03500094|12580013|FG000|NOT COMPLETED|Overall Study||3
11386348|NCT03500198|12580021|FG000|STARTED|Overall Study||110
11386349|NCT03500198|12580022|FG001|STARTED|Overall Study||108
11386350|NCT03500198|12580021|FG000|First Eye|Overall Study||110
11386351|NCT03500198|12580022|FG001|First Eye|Overall Study||108
11386352|NCT03500198|12580021|FG000|Second Eye|Overall Study||109
11386353|NCT03500198|12580022|FG001|Second Eye|Overall Study||108
11386354|NCT03500198|12580021|FG000|COMPLETED|Overall Study||110
11386355|NCT03500198|12580022|FG001|COMPLETED|Overall Study||107
11386356|NCT03500198|12580021|FG000|NOT COMPLETED|Overall Study||0
11386357|NCT03500198|12580022|FG001|NOT COMPLETED|Overall Study||1
11386358|NCT03500211|12580032|FG000|STARTED|Overall Study||25
11386359|NCT03500211|12580033|FG001|STARTED|Overall Study||25
11386360|NCT03500211|12580032|FG000|COMPLETED|Overall Study||24
11386361|NCT03500211|12580033|FG001|COMPLETED|Overall Study||24
11386362|NCT03500211|12580032|FG000|NOT COMPLETED|Overall Study||1
11386363|NCT03500211|12580033|FG001|NOT COMPLETED|Overall Study||1
11386364|NCT03500224|12580039|FG000|STARTED|Overall Study||6
11386365|NCT03500224|12580039|FG000|COMPLETED|Overall Study||4
11386366|NCT03500224|12580039|FG000|NOT COMPLETED|Overall Study||2
11386367|NCT03500289|12580045|FG000|STARTED|Overall Study||12
11386368|NCT03500289|12580046|FG001|STARTED|Overall Study||6
11386369|NCT03500289|12580045|FG000|COMPLETED|Overall Study||12
11386370|NCT03500289|12580046|FG001|COMPLETED|Overall Study||6
11386371|NCT03500289|12580045|FG000|NOT COMPLETED|Overall Study||0
11386372|NCT03500289|12580046|FG001|NOT COMPLETED|Overall Study||0
11386373|NCT03500302|12580052|FG000|STARTED|Overall Study||19
11386374|NCT03500302|12580052|FG000|COMPLETED|Overall Study||19
11386375|NCT03500302|12580052|FG000|NOT COMPLETED|Overall Study||0
11386376|NCT03500419|12580058|FG000|STARTED|Overall Study||27
11386377|NCT03500419|12580059|FG001|STARTED|Overall Study||55
11386378|NCT03500419|12580058|FG000|COMPLETED|Overall Study||25
11386379|NCT03500419|12580059|FG001|COMPLETED|Overall Study||30
11386380|NCT03500419|12580058|FG000|NOT COMPLETED|Overall Study||2
11386381|NCT03500419|12580059|FG001|NOT COMPLETED|Overall Study||25
11386382|NCT03500679|12580067|FG000|STARTED|Overall Study||75
11386383|NCT03500679|12580068|FG001|STARTED|Overall Study||25
11386384|NCT03500679|12580067|FG000|COMPLETED|Overall Study||66
11386385|NCT03500679|12580068|FG001|COMPLETED|Overall Study||22
11386386|NCT03500679|12580067|FG000|NOT COMPLETED|Overall Study||9
11386387|NCT03500679|12580068|FG001|NOT COMPLETED|Overall Study||3
11386388|NCT03501043|12580074|FG000|STARTED|Overall Study||11
11386389|NCT03501043|12580074|FG000|COMPLETED|Overall Study||10
11386390|NCT03501043|12580074|FG000|NOT COMPLETED|Overall Study||1
11386391|NCT03501069|12580098|FG000|STARTED|Period A||2
11386392|NCT03501069|12580099|FG001|STARTED|Period A||4
11386393|NCT03501069|12580100|FG002|STARTED|Period A||2
11386394|NCT03501069|12580101|FG003|STARTED|Period A||5
11386395|NCT03501069|12580102|FG004|STARTED|Period A||1
11386396|NCT03501069|12580103|FG005|STARTED|Period A||6
11386397|NCT03501069|12580104|FG006|STARTED|Period A||6
11386398|NCT03501069|12580105|FG007|STARTED|Period A||3
11386399|NCT03501069|12580106|FG008|STARTED|Period A||3
11386400|NCT03501069|12580098|FG000|COMPLETED|Period A||2
11386401|NCT03501069|12580099|FG001|COMPLETED|Period A||4
11386402|NCT03501069|12580100|FG002|COMPLETED|Period A||2
11386403|NCT03501069|12580101|FG003|COMPLETED|Period A||5
11386404|NCT03501069|12580102|FG004|COMPLETED|Period A||1
11386405|NCT03501069|12580103|FG005|COMPLETED|Period A||6
11386406|NCT03501069|12580104|FG006|COMPLETED|Period A||6
11386407|NCT03501069|12580105|FG007|COMPLETED|Period A||3
11386408|NCT03501069|12580106|FG008|COMPLETED|Period A||3
11386409|NCT03501069|12580098|FG000|NOT COMPLETED|Period A||0
11386410|NCT03501069|12580099|FG001|NOT COMPLETED|Period A||0
11386411|NCT03501069|12580100|FG002|NOT COMPLETED|Period A||0
11386412|NCT03501069|12580101|FG003|NOT COMPLETED|Period A||0
11386413|NCT03501069|12580102|FG004|NOT COMPLETED|Period A||0
11386414|NCT03501069|12580103|FG005|NOT COMPLETED|Period A||0
11386415|NCT03501069|12580104|FG006|NOT COMPLETED|Period A||0
11386416|NCT03501069|12580105|FG007|NOT COMPLETED|Period A||0
11386417|NCT03501069|12580106|FG008|NOT COMPLETED|Period A||0
11386418|NCT03501069|12580098|FG000|STARTED|Washout Period (at Least 14 Days)||2
11386419|NCT03501069|12580099|FG001|STARTED|Washout Period (at Least 14 Days)||4
11386420|NCT03501069|12580100|FG002|STARTED|Washout Period (at Least 14 Days)||2
11386421|NCT03501069|12580101|FG003|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
11386422|NCT03501069|12580102|FG004|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
11386423|NCT03501069|12580103|FG005|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
11386424|NCT03501069|12580104|FG006|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
11386425|NCT03501069|12580105|FG007|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
11386426|NCT03501069|12580106|FG008|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
11386427|NCT03501069|12580098|FG000|COMPLETED|Washout Period (at Least 14 Days)||2
11386428|NCT03501069|12580099|FG001|COMPLETED|Washout Period (at Least 14 Days)||4
11386429|NCT03501069|12580100|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
11386430|NCT03501069|12580101|FG003|COMPLETED|Washout Period (at Least 14 Days)||0
11386431|NCT03501069|12580102|FG004|COMPLETED|Washout Period (at Least 14 Days)||0
11386432|NCT03501069|12580103|FG005|COMPLETED|Washout Period (at Least 14 Days)||0
11386433|NCT03501069|12580104|FG006|COMPLETED|Washout Period (at Least 14 Days)||0
11386434|NCT03501069|12580105|FG007|COMPLETED|Washout Period (at Least 14 Days)||0
11386435|NCT03501069|12580106|FG008|COMPLETED|Washout Period (at Least 14 Days)||0
11386436|NCT03501069|12580098|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11386437|NCT03501069|12580099|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11386438|NCT03501069|12580100|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11386439|NCT03501069|12580101|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11386440|NCT03501069|12580102|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11386441|NCT03501069|12580103|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11386442|NCT03501069|12580104|FG006|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11386443|NCT03501069|12580105|FG007|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11386444|NCT03501069|12580106|FG008|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11386445|NCT03501069|12580098|FG000|STARTED|Period B||2
11386446|NCT03501069|12580099|FG001|STARTED|Period B||4
11386447|NCT03501069|12580100|FG002|STARTED|Period B||2
11386448|NCT03501069|12580101|FG003|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
11386449|NCT03501069|12580102|FG004|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
11386450|NCT03501069|12580103|FG005|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
11386451|NCT03501069|12580104|FG006|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
11386452|NCT03501069|12580105|FG007|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
11386453|NCT03501069|12580106|FG008|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
11386454|NCT03501069|12580098|FG000|COMPLETED|Period B||2
11386455|NCT03501069|12580099|FG001|COMPLETED|Period B||4
11386456|NCT03501069|12580100|FG002|COMPLETED|Period B||2
11386457|NCT03501069|12580101|FG003|COMPLETED|Period B||0
11386458|NCT03501069|12580102|FG004|COMPLETED|Period B||0
11386459|NCT03501069|12580103|FG005|COMPLETED|Period B||0
11386460|NCT03501069|12580104|FG006|COMPLETED|Period B||0
11386461|NCT03501069|12580105|FG007|COMPLETED|Period B||0
11386462|NCT03501069|12580106|FG008|COMPLETED|Period B||0
11386463|NCT03501069|12580098|FG000|NOT COMPLETED|Period B||0
11386464|NCT03501069|12580099|FG001|NOT COMPLETED|Period B||0
11386465|NCT03501069|12580100|FG002|NOT COMPLETED|Period B||0
11386466|NCT03501069|12580101|FG003|NOT COMPLETED|Period B||0
11386467|NCT03501069|12580102|FG004|NOT COMPLETED|Period B||0
11386468|NCT03501069|12580103|FG005|NOT COMPLETED|Period B||0
11386469|NCT03501069|12580104|FG006|NOT COMPLETED|Period B||0
11386470|NCT03501069|12580105|FG007|NOT COMPLETED|Period B||0
11386471|NCT03501069|12580106|FG008|NOT COMPLETED|Period B||0
11386472|NCT03501264|12580136|FG000|STARTED|Overall Study||120
11386473|NCT03501264|12580137|FG001|STARTED|Overall Study||120
11386474|NCT03501264|12580136|FG000|COMPLETED|Overall Study||120
11386475|NCT03501264|12580137|FG001|COMPLETED|Overall Study||120
11386476|NCT03501264|12580136|FG000|NOT COMPLETED|Overall Study||0
11386477|NCT03501264|12580137|FG001|NOT COMPLETED|Overall Study||0
11386478|NCT03501277|12580147|FG000|STARTED|Intervention Period 1 (4 Days)||18
11386479|NCT03501277|12580148|FG001|STARTED|Intervention Period 1 (4 Days)||18
11386480|NCT03501277|12580149|FG002|STARTED|Intervention Period 1 (4 Days)||18
11386481|NCT03501277|12580150|FG003|STARTED|Intervention Period 1 (4 Days)||18
11386482|NCT03501277|12580147|FG000|Safety Analysis Set|Intervention Period 1 (4 Days)||18
11386483|NCT03501277|12580148|FG001|Safety Analysis Set|Intervention Period 1 (4 Days)||18
11386484|NCT03501277|12580149|FG002|Safety Analysis Set|Intervention Period 1 (4 Days)||17
11386485|NCT03501277|12580150|FG003|Safety Analysis Set|Intervention Period 1 (4 Days)||17
11386486|NCT03501277|12580147|FG000|COMPLETED|Intervention Period 1 (4 Days)||18
11386487|NCT03501277|12580148|FG001|COMPLETED|Intervention Period 1 (4 Days)||18
11386488|NCT03501277|12580149|FG002|COMPLETED|Intervention Period 1 (4 Days)||17
11386489|NCT03501277|12580150|FG003|COMPLETED|Intervention Period 1 (4 Days)||17
11386490|NCT03501277|12580147|FG000|NOT COMPLETED|Intervention Period 1 (4 Days)||0
11386491|NCT03501277|12580148|FG001|NOT COMPLETED|Intervention Period 1 (4 Days)||0
11386492|NCT03501277|12580149|FG002|NOT COMPLETED|Intervention Period 1 (4 Days)||1
11386493|NCT03501277|12580150|FG003|NOT COMPLETED|Intervention Period 1 (4 Days)||1
11386494|NCT03501277|12580147|FG000|STARTED|Washout Period 1 (7 Days)||18
11386495|NCT03501277|12580148|FG001|STARTED|Washout Period 1 (7 Days)||18
11386496|NCT03501277|12580149|FG002|STARTED|Washout Period 1 (7 Days)||17
11386497|NCT03501277|12580150|FG003|STARTED|Washout Period 1 (7 Days)||17
11386498|NCT03501277|12580147|FG000|COMPLETED|Washout Period 1 (7 Days)||18
11386499|NCT03501277|12580148|FG001|COMPLETED|Washout Period 1 (7 Days)||18
11386500|NCT03501277|12580149|FG002|COMPLETED|Washout Period 1 (7 Days)||17
11386501|NCT03501277|12580150|FG003|COMPLETED|Washout Period 1 (7 Days)||17
11386502|NCT03501277|12580147|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
11386503|NCT03501277|12580148|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
11386504|NCT03501277|12580149|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
11386505|NCT03501277|12580150|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
11386506|NCT03501277|12580147|FG000|STARTED|Intervention Period 2 (4 Days)||18
11386507|NCT03501277|12580148|FG001|STARTED|Intervention Period 2 (4 Days)||18
11386508|NCT03501277|12580149|FG002|STARTED|Intervention Period 2 (4 Days)||17
11386509|NCT03501277|12580150|FG003|STARTED|Intervention Period 2 (4 Days)||17
11386510|NCT03501277|12580147|FG000|COMPLETED|Intervention Period 2 (4 Days)||18
11386511|NCT03501277|12580148|FG001|COMPLETED|Intervention Period 2 (4 Days)||18
11386512|NCT03501277|12580149|FG002|COMPLETED|Intervention Period 2 (4 Days)||17
11386513|NCT03501277|12580150|FG003|COMPLETED|Intervention Period 2 (4 Days)||16
11386514|NCT03501277|12580147|FG000|NOT COMPLETED|Intervention Period 2 (4 Days)||0
11386515|NCT03501277|12580148|FG001|NOT COMPLETED|Intervention Period 2 (4 Days)||0
11386516|NCT03501277|12580149|FG002|NOT COMPLETED|Intervention Period 2 (4 Days)||0
11386517|NCT03501277|12580150|FG003|NOT COMPLETED|Intervention Period 2 (4 Days)||1
11386518|NCT03501277|12580147|FG000|STARTED|Washout Period 2 (7 Days)||18
11386519|NCT03501277|12580148|FG001|STARTED|Washout Period 2 (7 Days)||18
11386520|NCT03501277|12580149|FG002|STARTED|Washout Period 2 (7 Days)||17
11386521|NCT03501277|12580150|FG003|STARTED|Washout Period 2 (7 Days)||16
11386522|NCT03501277|12580147|FG000|COMPLETED|Washout Period 2 (7 Days)||18
11386523|NCT03501277|12580148|FG001|COMPLETED|Washout Period 2 (7 Days)||18
11386524|NCT03501277|12580149|FG002|COMPLETED|Washout Period 2 (7 Days)||17
11386525|NCT03501277|12580150|FG003|COMPLETED|Washout Period 2 (7 Days)||16
11386526|NCT03501277|12580147|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
11386527|NCT03501277|12580148|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
11386528|NCT03501277|12580149|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
11386529|NCT03501277|12580150|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
11386530|NCT03501277|12580147|FG000|STARTED|Intervention Period 3 (4 Days)||18
11386531|NCT03501277|12580148|FG001|STARTED|Intervention Period 3 (4 Days)||18
11386532|NCT03501277|12580149|FG002|STARTED|Intervention Period 3 (4 Days)||17
11386533|NCT03501277|12580150|FG003|STARTED|Intervention Period 3 (4 Days)||16
11386534|NCT03501277|12580147|FG000|COMPLETED|Intervention Period 3 (4 Days)||18
11386535|NCT03501277|12580148|FG001|COMPLETED|Intervention Period 3 (4 Days)||18
11386536|NCT03501277|12580149|FG002|COMPLETED|Intervention Period 3 (4 Days)||17
11386537|NCT03501277|12580150|FG003|COMPLETED|Intervention Period 3 (4 Days)||15
11386538|NCT03501277|12580147|FG000|NOT COMPLETED|Intervention Period 3 (4 Days)||0
11386539|NCT03501277|12580148|FG001|NOT COMPLETED|Intervention Period 3 (4 Days)||0
11386540|NCT03501277|12580149|FG002|NOT COMPLETED|Intervention Period 3 (4 Days)||0
11006098|NCT00726453|12183865|FG001|STARTED|Primary Enrollment Group||0
11006099|NCT00726453|12183864|FG000|COMPLETED|Primary Enrollment Group||1371
11006100|NCT00726453|12183865|FG001|COMPLETED|Primary Enrollment Group||0
11006101|NCT00726453|12183864|FG000|NOT COMPLETED|Primary Enrollment Group||31
11386541|NCT03501277|12580150|FG003|NOT COMPLETED|Intervention Period 3 (4 Days)||1
11386542|NCT03501277|12580147|FG000|STARTED|Washout Period 3 (7 Days)||18
11386543|NCT03501277|12580148|FG001|STARTED|Washout Period 3 (7 Days)||18
11386544|NCT03501277|12580149|FG002|STARTED|Washout Period 3 (7 Days)||17
11386545|NCT03501277|12580150|FG003|STARTED|Washout Period 3 (7 Days)||15
11386546|NCT03501277|12580147|FG000|COMPLETED|Washout Period 3 (7 Days)||18
11386547|NCT03501277|12580148|FG001|COMPLETED|Washout Period 3 (7 Days)||18
11386548|NCT03501277|12580149|FG002|COMPLETED|Washout Period 3 (7 Days)||17
11386549|NCT03501277|12580150|FG003|COMPLETED|Washout Period 3 (7 Days)||15
11386550|NCT03501277|12580147|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
11386551|NCT03501277|12580148|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
11386552|NCT03501277|12580149|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
11386553|NCT03501277|12580150|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
11386554|NCT03501277|12580147|FG000|STARTED|Intervention Period 4 (4 Days)||18
11386555|NCT03501277|12580148|FG001|STARTED|Intervention Period 4 (4 Days)||18
11386556|NCT03501277|12580149|FG002|STARTED|Intervention Period 4 (4 Days)||17
11386557|NCT03501277|12580150|FG003|STARTED|Intervention Period 4 (4 Days)||15
11386558|NCT03501277|12580147|FG000|COMPLETED|Intervention Period 4 (4 Days)||18
11386559|NCT03501277|12580148|FG001|COMPLETED|Intervention Period 4 (4 Days)||18
11386560|NCT03501277|12580149|FG002|COMPLETED|Intervention Period 4 (4 Days)||17
11386561|NCT03501277|12580150|FG003|COMPLETED|Intervention Period 4 (4 Days)||15
11386562|NCT03501277|12580147|FG000|NOT COMPLETED|Intervention Period 4 (4 Days)||0
11386563|NCT03501277|12580148|FG001|NOT COMPLETED|Intervention Period 4 (4 Days)||0
11386564|NCT03501277|12580149|FG002|NOT COMPLETED|Intervention Period 4 (4 Days)||0
11386565|NCT03501277|12580150|FG003|NOT COMPLETED|Intervention Period 4 (4 Days)||0
11386566|NCT03501550|12580160|FG000|STARTED|Overall Study||12
11386567|NCT03501550|12580160|FG000|COMPLETED|Overall Study||12
11386568|NCT03501550|12580160|FG000|NOT COMPLETED|Overall Study||0
11386569|NCT03501693|12580164|FG000|STARTED|First Reading Session||75
11386570|NCT03501693|12580165|FG001|STARTED|First Reading Session||75
11386571|NCT03501693|12580164|FG000|COMPLETED|First Reading Session||75
11386572|NCT03501693|12580165|FG001|COMPLETED|First Reading Session||75
11386573|NCT03501693|12580164|FG000|NOT COMPLETED|First Reading Session||0
11386574|NCT03501693|12580165|FG001|NOT COMPLETED|First Reading Session||0
11386575|NCT03501693|12580164|FG000|STARTED|4 Week Memory Washout Period||75
11386576|NCT03501693|12580165|FG001|STARTED|4 Week Memory Washout Period||75
11386577|NCT03501693|12580164|FG000|COMPLETED|4 Week Memory Washout Period||75
11386578|NCT03501693|12580165|FG001|COMPLETED|4 Week Memory Washout Period||75
11386579|NCT03501693|12580164|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
11386580|NCT03501693|12580165|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
11386581|NCT03501693|12580164|FG000|STARTED|Second Reading Session||75
11386582|NCT03501693|12580165|FG001|STARTED|Second Reading Session||75
11386583|NCT03501693|12580164|FG000|COMPLETED|Second Reading Session||75
11386584|NCT03501693|12580165|FG001|COMPLETED|Second Reading Session||75
11386585|NCT03501693|12580164|FG000|NOT COMPLETED|Second Reading Session||0
11386586|NCT03501693|12580165|FG001|NOT COMPLETED|Second Reading Session||0
11386587|NCT03502265|12580171|FG000|STARTED|Overall Study||4
11386588|NCT03502265|12580171|FG000|COMPLETED|Overall Study||4
11386589|NCT03502265|12580171|FG000|NOT COMPLETED|Overall Study||0
11386590|NCT03502616|12580177|FG000|STARTED|Up to Week 16||134
11386591|NCT03502616|12580178|FG001|STARTED|Up to Week 16||136
11386592|NCT03502616|12580177|FG000|Treated|Up to Week 16||133
11386593|NCT03502616|12580178|FG001|Treated|Up to Week 16||136
11386594|NCT03502616|12580177|FG000|COMPLETED|Up to Week 16||132
11386595|NCT03502616|12580178|FG001|COMPLETED|Up to Week 16||133
11386596|NCT03502616|12580177|FG000|NOT COMPLETED|Up to Week 16||2
11386597|NCT03502616|12580178|FG001|NOT COMPLETED|Up to Week 16||3
11386598|NCT03502616|12580177|FG000|STARTED|Week 16 to Week 48||132
11386599|NCT03502616|12580178|FG001|STARTED|Week 16 to Week 48||133
11386600|NCT03502616|12580177|FG000|Treated|Week 16 to Week 48||132
11386601|NCT03502616|12580178|FG001|Treated|Week 16 to Week 48||133
11386602|NCT03502616|12580177|FG000|COMPLETED|Week 16 to Week 48||125
11386603|NCT03502616|12580178|FG001|COMPLETED|Week 16 to Week 48||127
11386604|NCT03502616|12580177|FG000|NOT COMPLETED|Week 16 to Week 48||7
11386605|NCT03502616|12580178|FG001|NOT COMPLETED|Week 16 to Week 48||6
11386606|NCT03502798|12580188|FG000|STARTED|Overall Study||5
11386607|NCT03502798|12580189|FG001|STARTED|Overall Study||40
11386608|NCT03502798|12580188|FG000|COMPLETED|Overall Study||5
11386609|NCT03502798|12580189|FG001|COMPLETED|Overall Study||33
11386610|NCT03502798|12580188|FG000|NOT COMPLETED|Overall Study||0
11386611|NCT03502798|12580189|FG001|NOT COMPLETED|Overall Study||7
11386612|NCT03502915|12580197|FG000|STARTED|Overall Study||24
11386613|NCT03502915|12580198|FG001|STARTED|Overall Study||24
11386614|NCT03502915|12580197|FG000|COMPLETED|Overall Study||24
11386615|NCT03502915|12580198|FG001|COMPLETED|Overall Study||24
11386616|NCT03502915|12580197|FG000|NOT COMPLETED|Overall Study||0
11386617|NCT03502915|12580198|FG001|NOT COMPLETED|Overall Study||0
11386618|NCT03502941|12580207|FG000|STARTED|Overall Study||3
11386619|NCT03502941|12580208|FG001|STARTED|Overall Study||5
11386620|NCT03502941|12580209|FG002|STARTED|Overall Study||8
11386621|NCT03502941|12580207|FG000|COMPLETED|Overall Study||3
11386622|NCT03502941|12580208|FG001|COMPLETED|Overall Study||5
11386623|NCT03502941|12580209|FG002|COMPLETED|Overall Study||8
11386624|NCT03502941|12580207|FG000|NOT COMPLETED|Overall Study||0
11386625|NCT03502941|12580208|FG001|NOT COMPLETED|Overall Study||0
11386626|NCT03502941|12580209|FG002|NOT COMPLETED|Overall Study||0
11386627|NCT03503162|12580217|FG000|STARTED|Overall Study||95
11386628|NCT03503162|12580217|FG000|COMPLETED|Overall Study||94
11386629|NCT03503162|12580217|FG000|NOT COMPLETED|Overall Study||1
11386630|NCT03503188|12580223|FG000|STARTED|Overall Study||128
11386631|NCT03503188|12580224|FG001|STARTED|Overall Study||146
11386632|NCT03503188|12580223|FG000|Entered in the Entire Study|Overall Study||128
11386633|NCT03503188|12580224|FG001|Entered in the Entire Study|Overall Study||145
11386634|NCT03503188|12580223|FG000|Main Study|Overall Study||99
11386635|NCT03503188|12580224|FG001|Main Study|Overall Study||101
11386636|NCT03503188|12580223|FG000|Sub-study|Overall Study||29
11386637|NCT03503188|12580224|FG001|Sub-study|Overall Study||44
11386638|NCT03503188|12580223|FG000|COMPLETED|Overall Study||128
11386639|NCT03503188|12580224|FG001|COMPLETED|Overall Study||145
11386640|NCT03503188|12580223|FG000|NOT COMPLETED|Overall Study||0
11386641|NCT03503188|12580224|FG001|NOT COMPLETED|Overall Study||1
11386642|NCT03503292|12580232|FG000|STARTED|Overall Study||2
11386643|NCT03503292|12580233|FG001|STARTED|Overall Study||90
11386644|NCT03503292|12580232|FG000|COMPLETED|Overall Study||2
11386645|NCT03503292|12580233|FG001|COMPLETED|Overall Study||90
11386646|NCT03503292|12580232|FG000|NOT COMPLETED|Overall Study||0
11386647|NCT03503292|12580233|FG001|NOT COMPLETED|Overall Study||0
11386648|NCT03503565|12580241|FG000|STARTED|Overall Study||59
11386649|NCT03503565|12580242|FG001|STARTED|Overall Study||58
11386650|NCT03503565|12580241|FG000|COMPLETED|Overall Study||59
11386651|NCT03503565|12580242|FG001|COMPLETED|Overall Study||58
11386652|NCT03503565|12580241|FG000|NOT COMPLETED|Overall Study||0
11386653|NCT03503565|12580242|FG001|NOT COMPLETED|Overall Study||0
11386654|NCT03503578|12580248|FG000|STARTED|Overall Study||12
11386655|NCT03503578|12580248|FG000|COMPLETED|Overall Study||12
11386656|NCT03503578|12580248|FG000|NOT COMPLETED|Overall Study||0
11386657|NCT03504189|12580252|FG000|STARTED|Overall Study||151
11386658|NCT03504189|12580252|FG000|COMPLETED|Overall Study||147
11386659|NCT03504189|12580252|FG000|NOT COMPLETED|Overall Study||4
11386660|NCT03504839|12580261|FG000|STARTED|Overall Study||53
11386661|NCT03504839|12580261|FG000|COMPLETED|Overall Study||49
11386662|NCT03504839|12580261|FG000|NOT COMPLETED|Overall Study||4
11386663|NCT03504852|12580268|FG000|STARTED|Overall Study||165
11386664|NCT03504852|12580269|FG001|STARTED|Overall Study||135
11386665|NCT03504852|12580270|FG002|STARTED|Overall Study||31
11386666|NCT03504852|12580268|FG000|COMPLETED|Overall Study||148
11386667|NCT03504852|12580269|FG001|COMPLETED|Overall Study||117
11386668|NCT03504852|12580270|FG002|COMPLETED|Overall Study||28
11386669|NCT03504852|12580268|FG000|NOT COMPLETED|Overall Study||17
11386670|NCT03504852|12580269|FG001|NOT COMPLETED|Overall Study||18
11386671|NCT03504852|12580270|FG002|NOT COMPLETED|Overall Study||3
11386672|NCT03504917|12580282|FG000|STARTED|Blinded Treatment Period||163
11386673|NCT03504917|12580283|FG001|STARTED|Blinded Treatment Period||158
11386674|NCT03504917|12580282|FG000|COMPLETED|Blinded Treatment Period||103
11386675|NCT03504917|12580283|FG001|COMPLETED|Blinded Treatment Period||102
11386676|NCT03504917|12580282|FG000|NOT COMPLETED|Blinded Treatment Period||60
11386677|NCT03504917|12580283|FG001|NOT COMPLETED|Blinded Treatment Period||56
11386678|NCT03504917|12580282|FG000|STARTED|Open Label Extension Treatment Period||100
11386679|NCT03504917|12580283|FG001|STARTED|Open Label Extension Treatment Period||97
11386680|NCT03504917|12580282|FG000|COMPLETED|Open Label Extension Treatment Period||0
11386681|NCT03504917|12580283|FG001|COMPLETED|Open Label Extension Treatment Period||0
11386682|NCT03504917|12580282|FG000|NOT COMPLETED|Open Label Extension Treatment Period||100
11386683|NCT03504917|12580283|FG001|NOT COMPLETED|Open Label Extension Treatment Period||97
11386684|NCT03505190|12580300|FG000|STARTED|Overall Study||9
11386685|NCT03505190|12580301|FG001|STARTED|Overall Study||8
11386686|NCT03505190|12580302|FG002|STARTED|Overall Study||8
11386687|NCT03505190|12580303|FG003|STARTED|Overall Study||8
11386688|NCT03505190|12580304|FG004|STARTED|Overall Study||8
11386689|NCT03505190|12580300|FG000|COMPLETED|Overall Study||9
11386690|NCT03505190|12580301|FG001|COMPLETED|Overall Study||8
11386691|NCT03505190|12580302|FG002|COMPLETED|Overall Study||8
11386692|NCT03505190|12580303|FG003|COMPLETED|Overall Study||8
11386693|NCT03505190|12580304|FG004|COMPLETED|Overall Study||8
11386694|NCT03505190|12580300|FG000|NOT COMPLETED|Overall Study||0
11386695|NCT03505190|12580301|FG001|NOT COMPLETED|Overall Study||0
11386696|NCT03505190|12580302|FG002|NOT COMPLETED|Overall Study||0
11386697|NCT03505190|12580303|FG003|NOT COMPLETED|Overall Study||0
11386698|NCT03505190|12580304|FG004|NOT COMPLETED|Overall Study||0
11386699|NCT03505593|12580316|FG000|STARTED|Overall Study||48
11386700|NCT03505593|12580316|FG000|COMPLETED|Overall Study||43
11386701|NCT03505593|12580316|FG000|NOT COMPLETED|Overall Study||5
11386702|NCT03506295|12580320|FG000|STARTED|Overall Study||10
11386703|NCT03506295|12580320|FG000|COMPLETED|Overall Study||10
11386704|NCT03506295|12580320|FG000|NOT COMPLETED|Overall Study||0
11386705|NCT03506347|12580328|FG000|STARTED|Overall Study||12
11386706|NCT03506347|12580329|FG001|STARTED|Overall Study||12
11386707|NCT03506347|12580328|FG000|COMPLETED|Overall Study||12
11386708|NCT03506347|12580329|FG001|COMPLETED|Overall Study||12
11386709|NCT03506347|12580328|FG000|NOT COMPLETED|Overall Study||0
11386710|NCT03506347|12580329|FG001|NOT COMPLETED|Overall Study||0
11386711|NCT03506386|12580335|FG000|STARTED|Overall Study||943
11386712|NCT03506386|12580335|FG000|COMPLETED|Overall Study||943
11386713|NCT03506386|12580335|FG000|NOT COMPLETED|Overall Study||0
11386714|NCT03506425|12580342|FG000|STARTED|Overall Study||5
11386715|NCT03506425|12580343|FG001|STARTED|Overall Study||5
11386716|NCT03506425|12580344|FG002|STARTED|Overall Study||5
11386717|NCT03506425|12580342|FG000|COMPLETED|Overall Study||3
11386718|NCT03506425|12580343|FG001|COMPLETED|Overall Study||2
11386719|NCT03506425|12580344|FG002|COMPLETED|Overall Study||4
11386720|NCT03506425|12580342|FG000|NOT COMPLETED|Overall Study||2
11386721|NCT03506425|12580343|FG001|NOT COMPLETED|Overall Study||3
11386722|NCT03506425|12580344|FG002|NOT COMPLETED|Overall Study||1
11386723|NCT03506477|12580355|FG000|STARTED|Overall Study||20
11386724|NCT03506477|12580356|FG001|STARTED|Overall Study||5
11386725|NCT03506477|12580355|FG000|COMPLETED|Overall Study||19
11386726|NCT03506477|12580356|FG001|COMPLETED|Overall Study||5
11386727|NCT03506477|12580355|FG000|NOT COMPLETED|Overall Study||1
11386728|NCT03506477|12580356|FG001|NOT COMPLETED|Overall Study||0
11386729|NCT03506724|12580364|FG000|STARTED|Overall Study||54
11386730|NCT03506724|12580365|FG001|STARTED|Overall Study||55
11386731|NCT03506724|12580364|FG000|COMPLETED|Overall Study||54
11386732|NCT03506724|12580365|FG001|COMPLETED|Overall Study||55
11386733|NCT03506724|12580364|FG000|NOT COMPLETED|Overall Study||0
11386734|NCT03506724|12580365|FG001|NOT COMPLETED|Overall Study||0
11386735|NCT03507036|12580371|FG000|STARTED|Overall Study||20
11386736|NCT03507036|12580371|FG000|COMPLETED|Overall Study||15
11386737|NCT03507036|12580371|FG000|NOT COMPLETED|Overall Study||5
11386738|NCT03507569|12580382|FG000|STARTED|Overall Study||2
11386739|NCT03507569|12580383|FG001|STARTED|Overall Study||1
11386740|NCT03507569|12580384|FG002|STARTED|Overall Study||2
11386741|NCT03507569|12580385|FG003|STARTED|Overall Study||1
11386742|NCT03507569|12580382|FG000|COMPLETED|Overall Study||2
11386743|NCT03507569|12580383|FG001|COMPLETED|Overall Study||1
11386744|NCT03507569|12580384|FG002|COMPLETED|Overall Study||2
11386745|NCT03507569|12580385|FG003|COMPLETED|Overall Study||1
11386746|NCT03507569|12580382|FG000|NOT COMPLETED|Overall Study||0
11386747|NCT03507569|12580383|FG001|NOT COMPLETED|Overall Study||0
11386748|NCT03507569|12580384|FG002|NOT COMPLETED|Overall Study||0
11386749|NCT03507569|12580385|FG003|NOT COMPLETED|Overall Study||0
11386750|NCT03508050|12580397|FG000|STARTED|Overall Study||20
11386751|NCT03508050|12580398|FG001|STARTED|Overall Study||17
11386752|NCT03508050|12580397|FG000|COMPLETED|Overall Study||15
11386753|NCT03508050|12580398|FG001|COMPLETED|Overall Study||15
11386754|NCT03508050|12580397|FG000|NOT COMPLETED|Overall Study||5
11386755|NCT03508050|12580398|FG001|NOT COMPLETED|Overall Study||2
11386756|NCT03508609|12580405|FG000|STARTED|Overall Study||20
11386757|NCT03508609|12580405|FG000|COMPLETED|Overall Study||19
11386758|NCT03508609|12580405|FG000|NOT COMPLETED|Overall Study||1
11386759|NCT03508661|12580409|FG000|STARTED|Overall Study||10
11386760|NCT03508661|12580409|FG000|COMPLETED|Overall Study||10
11386761|NCT03508661|12580409|FG000|NOT COMPLETED|Overall Study||0
11386762|NCT03508687|12580415|FG000|STARTED|Overall Study||2
11386763|NCT03508687|12580416|FG001|STARTED|Overall Study||3
11386764|NCT03508687|12580415|FG000|COMPLETED|Overall Study||2
11386765|NCT03508687|12580416|FG001|COMPLETED|Overall Study||3
11386766|NCT03508687|12580415|FG000|NOT COMPLETED|Overall Study||0
11386767|NCT03508687|12580416|FG001|NOT COMPLETED|Overall Study||0
11386768|NCT03508830|12580426|FG000|STARTED|Overall Study||46
11386769|NCT03508830|12580427|FG001|STARTED|Overall Study||45
11386770|NCT03508830|12580426|FG000|COMPLETED|Overall Study||41
11386771|NCT03508830|12580427|FG001|COMPLETED|Overall Study||39
11386772|NCT03508830|12580426|FG000|NOT COMPLETED|Overall Study||5
11386773|NCT03508830|12580427|FG001|NOT COMPLETED|Overall Study||6
11386774|NCT03508843|12580433|FG000|STARTED|Overall Study||150
11386775|NCT03508843|12580433|FG000|COMPLETED|Overall Study||147
11386776|NCT03508843|12580433|FG000|NOT COMPLETED|Overall Study||3
11386777|NCT03509350|12580439|FG000|STARTED|Overall Study||252
11386778|NCT03509350|12580440|FG001|STARTED|Overall Study||249
11386779|NCT03509350|12580439|FG000|COMPLETED|Overall Study||252
11386780|NCT03509350|12580440|FG001|COMPLETED|Overall Study||247
11386781|NCT03509350|12580439|FG000|NOT COMPLETED|Overall Study||0
11386782|NCT03509350|12580440|FG001|NOT COMPLETED|Overall Study||2
11386783|NCT03509675|12580448|FG000|STARTED|First Intervention (7 Days)||11
11386784|NCT03509675|12580449|FG001|STARTED|First Intervention (7 Days)||12
11386785|NCT03509675|12580448|FG000|COMPLETED|First Intervention (7 Days)||6
11386786|NCT03509675|12580449|FG001|COMPLETED|First Intervention (7 Days)||8
11386787|NCT03509675|12580448|FG000|NOT COMPLETED|First Intervention (7 Days)||5
11386788|NCT03509675|12580449|FG001|NOT COMPLETED|First Intervention (7 Days)||4
11386789|NCT03509675|12580448|FG000|STARTED|Washout Period (7 Days)||6
11386790|NCT03509675|12580449|FG001|STARTED|Washout Period (7 Days)||8
11386791|NCT03509675|12580448|FG000|COMPLETED|Washout Period (7 Days)||6
11386792|NCT03509675|12580449|FG001|COMPLETED|Washout Period (7 Days)||8
11386793|NCT03509675|12580448|FG000|NOT COMPLETED|Washout Period (7 Days)||0
11386794|NCT03509675|12580449|FG001|NOT COMPLETED|Washout Period (7 Days)||0
11386795|NCT03509675|12580448|FG000|STARTED|Second Intervention )7 Days)||6
11386796|NCT03509675|12580449|FG001|STARTED|Second Intervention )7 Days)||8
11386797|NCT03509675|12580448|FG000|COMPLETED|Second Intervention )7 Days)||4
11386798|NCT03509675|12580449|FG001|COMPLETED|Second Intervention )7 Days)||8
11386799|NCT03509675|12580448|FG000|NOT COMPLETED|Second Intervention )7 Days)||2
11386800|NCT03509675|12580449|FG001|NOT COMPLETED|Second Intervention )7 Days)||0
11386801|NCT03509766|12580455|FG000|STARTED|Overall Study||24
11386802|NCT03509766|12580455|FG000|COMPLETED|Overall Study||24
11386803|NCT03509766|12580455|FG000|NOT COMPLETED|Overall Study||0
11386804|NCT03509883|12580462|FG000|STARTED|Initial Treatment||15
11386805|NCT03509883|12580463|FG001|STARTED|Initial Treatment||15
11386806|NCT03509883|12580462|FG000|COMPLETED|Initial Treatment||15
11386807|NCT03509883|12580463|FG001|COMPLETED|Initial Treatment||15
11386808|NCT03509883|12580462|FG000|NOT COMPLETED|Initial Treatment||0
11386809|NCT03509883|12580463|FG001|NOT COMPLETED|Initial Treatment||0
11386810|NCT03509883|12580462|FG000|STARTED|Initial Treatment Washout||15
11386811|NCT03509883|12580463|FG001|STARTED|Initial Treatment Washout||15
11386812|NCT03509883|12580462|FG000|COMPLETED|Initial Treatment Washout||15
11386813|NCT03509883|12580463|FG001|COMPLETED|Initial Treatment Washout||15
11386814|NCT03509883|12580462|FG000|NOT COMPLETED|Initial Treatment Washout||0
11386815|NCT03509883|12580463|FG001|NOT COMPLETED|Initial Treatment Washout||0
11386816|NCT03509883|12580462|FG000|STARTED|Cross-over and Treatment||15
11386817|NCT03509883|12580463|FG001|STARTED|Cross-over and Treatment||15
11386818|NCT03509883|12580462|FG000|COMPLETED|Cross-over and Treatment||15
11386819|NCT03509883|12580463|FG001|COMPLETED|Cross-over and Treatment||15
11386820|NCT03509883|12580462|FG000|NOT COMPLETED|Cross-over and Treatment||0
11386821|NCT03509883|12580463|FG001|NOT COMPLETED|Cross-over and Treatment||0
11386822|NCT03509948|12580470|FG000|STARTED|Overall Study||6
11386823|NCT03509948|12580471|FG001|STARTED|Overall Study||7
11386824|NCT03509948|12580470|FG000|COMPLETED|Overall Study||6
11386825|NCT03509948|12580471|FG001|COMPLETED|Overall Study||6
11386826|NCT03509948|12580470|FG000|NOT COMPLETED|Overall Study||0
11386827|NCT03509948|12580471|FG001|NOT COMPLETED|Overall Study||1
11386828|NCT03509974|12580477|FG000|STARTED|Overall Study||14
11386829|NCT03509974|12580477|FG000|COMPLETED|Overall Study||14
11386830|NCT03509974|12580477|FG000|NOT COMPLETED|Overall Study||0
11386831|NCT03510182|12580481|FG000|STARTED|Overall Study||25
11386832|NCT03510182|12580481|FG000|COMPLETED|Overall Study||23
11386833|NCT03510182|12580481|FG000|NOT COMPLETED|Overall Study||2
11386834|NCT03510195|12580485|FG000|STARTED|Overall Study||267
11386835|NCT03510195|12580485|FG000|COMPLETED|Overall Study||101
11386836|NCT03510195|12580485|FG000|NOT COMPLETED|Overall Study||166
11386837|NCT03510273|12580499|FG000|STARTED|Overall Study||319
11386838|NCT03510273|12580499|FG000|Treated With Thermal Coagulation|Overall Study||319
11386839|NCT03510273|12580499|FG000|Completed 1-mth Follow-up Visit & Exited|Overall Study||192
11386840|NCT03510273|12580499|FG000|Completed 1-mth Follow-up Visit & Cont'd|Overall Study||126
11386841|NCT03510273|12580499|FG000|Completed All One-year Follow up Visits|Overall Study||118
11386842|NCT03510273|12580499|FG000|COMPLETED|Overall Study||310
11386843|NCT03510273|12580499|FG000|NOT COMPLETED|Overall Study||9
11386844|NCT03510455|12580507|FG000|STARTED|Overall Study||4
11386845|NCT03510455|12580507|FG000|Treated|Overall Study||4
11386846|NCT03510455|12580507|FG000|Extension Phase|Overall Study||1
11386847|NCT03510455|12580507|FG000|Screening Failures|Overall Study||0
11386848|NCT03510455|12580507|FG000|COMPLETED|Overall Study|3 of 4 patients completed the 24 week treatment phase of the study|3
11386849|NCT03510455|12580507|FG000|NOT COMPLETED|Overall Study||1
11386850|NCT03510481|12580517|FG000|STARTED|Year 1||69
11386851|NCT03510481|12580518|FG001|STARTED|Year 1||70
11386852|NCT03510481|12580519|FG002|STARTED|Year 1||36
11386853|NCT03510481|12580520|FG003|STARTED|Year 1||35
11386854|NCT03510481|12580517|FG000|COMPLETED|Year 1||56
11386855|NCT03510481|12580518|FG001|COMPLETED|Year 1||61
11386856|NCT03510481|12580519|FG002|COMPLETED|Year 1||34
11386857|NCT03510481|12580520|FG003|COMPLETED|Year 1||31
11386858|NCT03510481|12580517|FG000|NOT COMPLETED|Year 1||13
11386859|NCT03510481|12580518|FG001|NOT COMPLETED|Year 1||9
11386860|NCT03510481|12580519|FG002|NOT COMPLETED|Year 1||2
11386861|NCT03510481|12580520|FG003|NOT COMPLETED|Year 1||4
11386862|NCT03510481|12580517|FG000|STARTED|Year 2 - Booster Dose|10 participants who completed Period 1 did not re-consent for Period 2.|46
11386863|NCT03510481|12580518|FG001|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|52
11386864|NCT03510481|12580519|FG002|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|25
11386865|NCT03510481|12580520|FG003|STARTED|Year 2 - Booster Dose|12 participants who completed Period 1 did not re-consent for Period 2.|19
11386866|NCT03510481|12580517|FG000|COMPLETED|Year 2 - Booster Dose||42
11386867|NCT03510481|12580518|FG001|COMPLETED|Year 2 - Booster Dose||49
11386868|NCT03510481|12580519|FG002|COMPLETED|Year 2 - Booster Dose||23
11386869|NCT03510481|12580520|FG003|COMPLETED|Year 2 - Booster Dose||18
11386870|NCT03510481|12580517|FG000|NOT COMPLETED|Year 2 - Booster Dose||4
11386871|NCT03510481|12580518|FG001|NOT COMPLETED|Year 2 - Booster Dose||3
11386872|NCT03510481|12580519|FG002|NOT COMPLETED|Year 2 - Booster Dose||2
11386873|NCT03510481|12580520|FG003|NOT COMPLETED|Year 2 - Booster Dose||1
11386874|NCT03510663|12580540|FG000|STARTED|Overall Study||6
11386875|NCT03510663|12580541|FG001|STARTED|Overall Study||6
11386876|NCT03510663|12580542|FG002|STARTED|Overall Study||6
11386877|NCT03510663|12580543|FG003|STARTED|Overall Study||6
11386878|NCT03510663|12580544|FG004|STARTED|Overall Study||6
11386879|NCT03510663|12580545|FG005|STARTED|Overall Study||6
11386880|NCT03510663|12580546|FG006|STARTED|Overall Study||6
11386881|NCT03510663|12580547|FG007|STARTED|Overall Study||6
11386882|NCT03510663|12580540|FG000|COMPLETED|Overall Study||6
11386883|NCT03510663|12580541|FG001|COMPLETED|Overall Study||5
11386884|NCT03510663|12580542|FG002|COMPLETED|Overall Study||6
11386885|NCT03510663|12580543|FG003|COMPLETED|Overall Study||6
11386886|NCT03510663|12580544|FG004|COMPLETED|Overall Study||6
11386887|NCT03510663|12580545|FG005|COMPLETED|Overall Study||6
11386888|NCT03510663|12580546|FG006|COMPLETED|Overall Study||6
11386889|NCT03510663|12580547|FG007|COMPLETED|Overall Study||6
11386890|NCT03510663|12580540|FG000|NOT COMPLETED|Overall Study||0
11386891|NCT03510663|12580541|FG001|NOT COMPLETED|Overall Study||1
11386892|NCT03510663|12580542|FG002|NOT COMPLETED|Overall Study||0
11386893|NCT03510663|12580543|FG003|NOT COMPLETED|Overall Study||0
11386894|NCT03510663|12580544|FG004|NOT COMPLETED|Overall Study||0
11386895|NCT03510663|12580545|FG005|NOT COMPLETED|Overall Study||0
11386896|NCT03510663|12580546|FG006|NOT COMPLETED|Overall Study||0
11386897|NCT03510663|12580547|FG007|NOT COMPLETED|Overall Study||0
11386898|NCT03510715|12580559|FG000|STARTED|Overall Study||9
11386899|NCT03510715|12580560|FG001|STARTED|Overall Study||9
11386900|NCT03510715|12580559|FG000|COMPLETED|Overall Study||8
11386901|NCT03510715|12580560|FG001|COMPLETED|Overall Study||9
11386902|NCT03510715|12580559|FG000|NOT COMPLETED|Overall Study||1
11386903|NCT03510715|12580560|FG001|NOT COMPLETED|Overall Study||0
11386904|NCT03510910|12580569|FG000|STARTED|Overall Study||42
11386905|NCT03510910|12580570|FG001|STARTED|Overall Study||43
11386906|NCT03510910|12580569|FG000|COMPLETED|Overall Study||40
11386907|NCT03510910|12580570|FG001|COMPLETED|Overall Study||40
11386908|NCT03510910|12580569|FG000|NOT COMPLETED|Overall Study||2
11386909|NCT03510910|12580570|FG001|NOT COMPLETED|Overall Study||3
11386910|NCT03511001|12580578|FG000|STARTED|Overall Study||126
11386911|NCT03511001|12580579|FG001|STARTED|Overall Study||61
11386912|NCT03511001|12580578|FG000|Completers Analyzed|Overall Study|1 participant was excluded post-randomization due to not meeting race/ethnicity inclusion criteria.|114
11386913|NCT03511001|12580579|FG001|Completers Analyzed|Overall Study||61
11386914|NCT03511001|12580578|FG000|COMPLETED|Overall Study||115
11386915|NCT03511001|12580579|FG001|COMPLETED|Overall Study||54
11386916|NCT03511001|12580578|FG000|NOT COMPLETED|Overall Study||11
11386917|NCT03511001|12580579|FG001|NOT COMPLETED|Overall Study||7
11386918|NCT03511053|12580585|FG000|STARTED|Overall Study||11
11386919|NCT03511053|12580585|FG000|COMPLETED|Overall Study||10
11386920|NCT03511053|12580585|FG000|NOT COMPLETED|Overall Study||1
11386921|NCT03511105|12580591|FG000|STARTED|Overall Study||25
11386922|NCT03511105|12580592|FG001|STARTED|Overall Study||22
11386923|NCT03511105|12580591|FG000|COMPLETED|Overall Study||23
11386924|NCT03511105|12580592|FG001|COMPLETED|Overall Study||22
11386925|NCT03511105|12580591|FG000|NOT COMPLETED|Overall Study||2
11386926|NCT03511105|12580592|FG001|NOT COMPLETED|Overall Study||0
11386927|NCT03511326|12580599|FG000|STARTED|Overall Study||50
11386928|NCT03511326|12580599|FG000|COMPLETED|Overall Study||49
11386929|NCT03511326|12580599|FG000|NOT COMPLETED|Overall Study||1
11386930|NCT03511378|12580605|FG000|STARTED|Overall Study||70
11386931|NCT03511378|12580606|FG001|STARTED|Overall Study||68
11386932|NCT03511378|12580605|FG000|COMPLETED|Overall Study||67
11386933|NCT03511378|12580606|FG001|COMPLETED|Overall Study||66
11386934|NCT03511378|12580605|FG000|NOT COMPLETED|Overall Study||3
11386935|NCT03511378|12580606|FG001|NOT COMPLETED|Overall Study||2
11386936|NCT03511521|12580614|FG000|STARTED|Overall Study||2
11386937|NCT03511521|12580615|FG001|STARTED|Overall Study||1
11386938|NCT03511521|12580614|FG000|COMPLETED|Overall Study||2
11386939|NCT03511521|12580615|FG001|COMPLETED|Overall Study||1
11386940|NCT03511521|12580614|FG000|NOT COMPLETED|Overall Study||0
11386941|NCT03511521|12580615|FG001|NOT COMPLETED|Overall Study||0
11386942|NCT03511638|12580623|FG000|STARTED|Overall Study||184
11386943|NCT03511638|12580624|FG001|STARTED|Overall Study||188
11386944|NCT03511638|12580623|FG000|COMPLETED|Overall Study||182
11386945|NCT03511638|12580624|FG001|COMPLETED|Overall Study||187
11386946|NCT03511638|12580623|FG000|NOT COMPLETED|Overall Study||2
11386947|NCT03511638|12580624|FG001|NOT COMPLETED|Overall Study||1
11386948|NCT03511937|12580632|FG000|STARTED|Overall Study||200
11386949|NCT03511937|12580633|FG001|STARTED|Overall Study||200
11386950|NCT03511937|12580632|FG000|COMPLETED|Overall Study||200
11386951|NCT03511937|12580633|FG001|COMPLETED|Overall Study||200
11386952|NCT03511937|12580632|FG000|NOT COMPLETED|Overall Study||0
11386953|NCT03511937|12580633|FG001|NOT COMPLETED|Overall Study||0
11386954|NCT03512028|12580643|FG000|STARTED|Overall Study||19
11386955|NCT03512028|12580644|FG001|STARTED|Overall Study||15
11386956|NCT03512028|12580643|FG000|COMPLETED|Overall Study||15
11386957|NCT03512028|12580644|FG001|COMPLETED|Overall Study||15
11386958|NCT03512028|12580643|FG000|NOT COMPLETED|Overall Study||4
11386959|NCT03512028|12580644|FG001|NOT COMPLETED|Overall Study||0
11386960|NCT03512041|12580654|FG000|STARTED|Overall Study||10
11386961|NCT03512041|12580655|FG001|STARTED|Overall Study||10
11386962|NCT03512041|12580656|FG002|STARTED|Overall Study||11
11386963|NCT03512041|12580657|FG003|STARTED|Overall Study||9
11386964|NCT03512041|12580654|FG000|COMPLETED|Overall Study||10
11386965|NCT03512041|12580655|FG001|COMPLETED|Overall Study||10
11386966|NCT03512041|12580656|FG002|COMPLETED|Overall Study||11
11386967|NCT03512041|12580657|FG003|COMPLETED|Overall Study||9
11386968|NCT03512041|12580654|FG000|NOT COMPLETED|Overall Study||0
11386969|NCT03512041|12580655|FG001|NOT COMPLETED|Overall Study||0
11386970|NCT03512041|12580656|FG002|NOT COMPLETED|Overall Study||0
11386971|NCT03512041|12580657|FG003|NOT COMPLETED|Overall Study||0
11386972|NCT03512067|12580667|FG000|STARTED|Overall Study||1
11386973|NCT03512067|12580667|FG000|COMPLETED|Overall Study||1
11386974|NCT03512067|12580667|FG000|NOT COMPLETED|Overall Study||0
11386975|NCT03512288|12580673|FG000|STARTED|Overall Study||232
11386976|NCT03512288|12580674|FG001|STARTED|Overall Study||228
11386977|NCT03512288|12580673|FG000|Vaccination 1|Overall Study||231
11386978|NCT03512288|12580674|FG001|Vaccination 1|Overall Study||227
11386979|NCT03512288|12580673|FG000|Vaccination 2|Overall Study||222
11386980|NCT03512288|12580674|FG001|Vaccination 2|Overall Study||213
11386981|NCT03512288|12580673|FG000|Vaccination 3|Overall Study||210
11386982|NCT03512288|12580674|FG001|Vaccination 3|Overall Study||206
11386983|NCT03512288|12580673|FG000|Vaccination 4|Overall Study||197
11386984|NCT03512288|12580674|FG001|Vaccination 4|Overall Study||194
11386985|NCT03512288|12580673|FG000|COMPLETED|Overall Study||191
11386986|NCT03512288|12580674|FG001|COMPLETED|Overall Study||185
11386987|NCT03512288|12580673|FG000|NOT COMPLETED|Overall Study||41
11386988|NCT03512288|12580674|FG001|NOT COMPLETED|Overall Study||43
11386989|NCT03512353|12580680|FG000|STARTED|Overall Study||7
11386990|NCT03512353|12580680|FG000|Received Treatment|Overall Study||6
11386991|NCT03512353|12580680|FG000|COMPLETED|Overall Study||3
11386992|NCT03512353|12580680|FG000|NOT COMPLETED|Overall Study||4
11386993|NCT03512457|12580688|FG000|STARTED|Overall Study||195
11386994|NCT03512457|12580689|FG001|STARTED|Overall Study||225
11386995|NCT03512457|12580688|FG000|COMPLETED|Overall Study||161
11386996|NCT03512457|12580689|FG001|COMPLETED|Overall Study||185
11386997|NCT03512457|12580688|FG000|NOT COMPLETED|Overall Study||34
11386998|NCT03512457|12580689|FG001|NOT COMPLETED|Overall Study||40
11386999|NCT03513588|12580700|FG000|STARTED|Overall Study||16
11387000|NCT03513588|12580701|FG001|STARTED|Overall Study||17
11387001|NCT03513588|12580702|FG002|STARTED|Overall Study||15
11387002|NCT03513588|12580700|FG000|COMPLETED|Overall Study||15
11387003|NCT03513588|12580701|FG001|COMPLETED|Overall Study||15
11387004|NCT03513588|12580702|FG002|COMPLETED|Overall Study||13
11387005|NCT03513588|12580700|FG000|NOT COMPLETED|Overall Study||1
11387006|NCT03513588|12580701|FG001|NOT COMPLETED|Overall Study||2
11387007|NCT03513588|12580702|FG002|NOT COMPLETED|Overall Study||2
11387008|NCT03513757|12580714|FG000|STARTED|Overall Study||22
11387009|NCT03513757|12580715|FG001|STARTED|Overall Study||18
11387010|NCT03513757|12580714|FG000|COMPLETED|Overall Study||22
11387011|NCT03513757|12580715|FG001|COMPLETED|Overall Study||18
11387012|NCT03513757|12580714|FG000|NOT COMPLETED|Overall Study||0
11387013|NCT03513757|12580715|FG001|NOT COMPLETED|Overall Study||0
11387014|NCT03513848|12580726|FG000|STARTED|Overall Study||9
11387015|NCT03513848|12580727|FG001|STARTED|Overall Study||6
11387016|NCT03513848|12580726|FG000|COMPLETED|Overall Study||9
11387017|NCT03513848|12580727|FG001|COMPLETED|Overall Study||6
11387018|NCT03513848|12580726|FG000|NOT COMPLETED|Overall Study||0
11387019|NCT03513848|12580727|FG001|NOT COMPLETED|Overall Study||0
11387020|NCT03514277|12580736|FG000|STARTED|Overall Study||11
11387021|NCT03514277|12580737|FG001|STARTED|Overall Study||4
11387022|NCT03514277|12580738|FG002|STARTED|Overall Study||4
11387023|NCT03514277|12580736|FG000|COMPLETED|Overall Study||11
11387024|NCT03514277|12580737|FG001|COMPLETED|Overall Study||4
11387025|NCT03514277|12580738|FG002|COMPLETED|Overall Study||4
11387026|NCT03514277|12580736|FG000|NOT COMPLETED|Overall Study||0
11387027|NCT03514277|12580737|FG001|NOT COMPLETED|Overall Study||0
11387028|NCT03514277|12580738|FG002|NOT COMPLETED|Overall Study||0
11387029|NCT03514420|12580746|FG000|STARTED|Overall Study||4
11387030|NCT03514420|12580746|FG000|COMPLETED|Overall Study||4
11387031|NCT03514420|12580746|FG000|NOT COMPLETED|Overall Study||0
11387032|NCT03514641|12580754|FG000|STARTED|603A: 0-12 Week Study Period||334
11387033|NCT03514641|12580755|FG001|STARTED|603A: 0-12 Week Study Period||339
11387034|NCT03514641|12580756|FG002|STARTED|603A: 0-12 Week Study Period||0
11387035|NCT03514641|12580757|FG003|STARTED|603A: 0-12 Week Study Period||0
11387036|NCT03514641|12580754|FG000|COMPLETED|603A: 0-12 Week Study Period||307
11387037|NCT03514641|12580755|FG001|COMPLETED|603A: 0-12 Week Study Period||319
11387038|NCT03514641|12580756|FG002|COMPLETED|603A: 0-12 Week Study Period||0
11387039|NCT03514641|12580757|FG003|COMPLETED|603A: 0-12 Week Study Period||0
11387040|NCT03514641|12580754|FG000|NOT COMPLETED|603A: 0-12 Week Study Period||27
11387041|NCT03514641|12580755|FG001|NOT COMPLETED|603A: 0-12 Week Study Period||20
11387042|NCT03514641|12580756|FG002|NOT COMPLETED|603A: 0-12 Week Study Period||0
11387043|NCT03514641|12580757|FG003|NOT COMPLETED|603A: 0-12 Week Study Period||0
11387044|NCT03514641|12580754|FG000|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0
11387045|NCT03514641|12580755|FG001|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0
11387046|NCT03514641|12580756|FG002|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281
11387047|NCT03514641|12580757|FG003|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281
11387048|NCT03514641|12580754|FG000|COMPLETED|603B: 24-36 Week Study Period||0
11387049|NCT03514641|12580755|FG001|COMPLETED|603B: 24-36 Week Study Period||0
11387050|NCT03514641|12580756|FG002|COMPLETED|603B: 24-36 Week Study Period||267
11387051|NCT03514641|12580757|FG003|COMPLETED|603B: 24-36 Week Study Period||266
11387052|NCT03514641|12580754|FG000|NOT COMPLETED|603B: 24-36 Week Study Period||0
11387053|NCT03514641|12580755|FG001|NOT COMPLETED|603B: 24-36 Week Study Period||0
11387054|NCT03514641|12580756|FG002|NOT COMPLETED|603B: 24-36 Week Study Period||14
11387055|NCT03514641|12580757|FG003|NOT COMPLETED|603B: 24-36 Week Study Period||15
11387056|NCT03514966|12580771|FG000|STARTED|Overall Study||40
11387057|NCT03514966|12580772|FG001|STARTED|Overall Study||43
11387058|NCT03514966|12580771|FG000|COMPLETED|Overall Study||40
11387059|NCT03514966|12580772|FG001|COMPLETED|Overall Study||43
11387060|NCT03514966|12580771|FG000|NOT COMPLETED|Overall Study||0
11387061|NCT03514966|12580772|FG001|NOT COMPLETED|Overall Study||0
11387062|NCT03515681|12580780|FG000|STARTED|Overall Study||70
11387063|NCT03515681|12580781|FG001|STARTED|Overall Study||70
11387064|NCT03515681|12580780|FG000|Randomized|Overall Study||70
11387065|NCT03515681|12580781|FG001|Randomized|Overall Study||70
11387066|NCT03515681|12580780|FG000|Completed at 6 Months|Overall Study||61
11387067|NCT03515681|12580781|FG001|Completed at 6 Months|Overall Study||62
11387068|NCT03515681|12580780|FG000|COMPLETED|Overall Study||37
11387069|NCT03515681|12580781|FG001|COMPLETED|Overall Study||25
11387070|NCT03515681|12580780|FG000|NOT COMPLETED|Overall Study||33
11387071|NCT03515681|12580781|FG001|NOT COMPLETED|Overall Study||45
11387072|NCT03515824|12580790|FG000|STARTED|Overall Study||3
11387073|NCT03515824|12580791|FG001|STARTED|Overall Study||4
11387074|NCT03515824|12580792|FG002|STARTED|Overall Study||15
11387075|NCT03515824|12580793|FG003|STARTED|Overall Study||0
11387076|NCT03515824|12580790|FG000|COMPLETED|Overall Study||0
11387077|NCT03515824|12580791|FG001|COMPLETED|Overall Study||0
11387078|NCT03515824|12580792|FG002|COMPLETED|Overall Study||0
11387079|NCT03515824|12580793|FG003|COMPLETED|Overall Study||0
11387080|NCT03515824|12580790|FG000|NOT COMPLETED|Overall Study||3
11387081|NCT03515824|12580791|FG001|NOT COMPLETED|Overall Study||4
11387082|NCT03515824|12580792|FG002|NOT COMPLETED|Overall Study||15
11387083|NCT03515824|12580793|FG003|NOT COMPLETED|Overall Study||0
11387084|NCT03515941|12580803|FG000|STARTED|Overall Study||4
11387085|NCT03515941|12580804|FG001|STARTED|Overall Study||2
11387086|NCT03515941|12580803|FG000|COMPLETED|Overall Study||3
11387087|NCT03515941|12580804|FG001|COMPLETED|Overall Study||2
11387088|NCT03515941|12580803|FG000|NOT COMPLETED|Overall Study||1
11387089|NCT03515941|12580804|FG001|NOT COMPLETED|Overall Study||0
11387090|NCT03516227|12580812|FG000|STARTED|Overall Study||20
11387091|NCT03516227|12580813|FG001|STARTED|Overall Study||20
11387092|NCT03516227|12580812|FG000|COMPLETED|Overall Study||19
11387093|NCT03516227|12580813|FG001|COMPLETED|Overall Study||16
11387094|NCT03516227|12580812|FG000|NOT COMPLETED|Overall Study||1
11387095|NCT03516227|12580813|FG001|NOT COMPLETED|Overall Study||4
11387096|NCT03517436|12580820|FG000|STARTED|Overall Study||101
11387097|NCT03517436|12580820|FG000|COMPLETED|Overall Study||93
11387098|NCT03517436|12580820|FG000|NOT COMPLETED|Overall Study||8
11387099|NCT03517566|12580829|FG000|STARTED|Overall Study||74
11387100|NCT03517566|12580830|FG001|STARTED|Overall Study||37
11387101|NCT03517566|12580831|FG002|STARTED|Overall Study||36
11387102|NCT03517566|12580832|FG003|STARTED|Overall Study||73
11387103|NCT03517566|12580833|FG004|STARTED|Overall Study||73
11387104|NCT03517566|12580829|FG000|COMPLETED|Overall Study||42
11387105|NCT03517566|12580830|FG001|COMPLETED|Overall Study||16
11387106|NCT03517566|12580831|FG002|COMPLETED|Overall Study||21
11387107|NCT03517566|12580832|FG003|COMPLETED|Overall Study||39
11387108|NCT03517566|12580833|FG004|COMPLETED|Overall Study||41
11387109|NCT03517566|12580829|FG000|NOT COMPLETED|Overall Study||32
11387110|NCT03517566|12580830|FG001|NOT COMPLETED|Overall Study||21
11387111|NCT03517566|12580831|FG002|NOT COMPLETED|Overall Study||15
11387112|NCT03517566|12580832|FG003|NOT COMPLETED|Overall Study||34
11387113|NCT03517566|12580833|FG004|NOT COMPLETED|Overall Study||32
11387114|NCT03518008|12580846|FG000|STARTED|Period 1, First Week of Wear||11
11387115|NCT03518008|12580847|FG001|STARTED|Period 1, First Week of Wear||11
11387116|NCT03518008|12580846|FG000|COMPLETED|Period 1, First Week of Wear||11
11387117|NCT03518008|12580847|FG001|COMPLETED|Period 1, First Week of Wear||11
11387118|NCT03518008|12580846|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
11387119|NCT03518008|12580847|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
11387120|NCT03518008|12580846|FG000|STARTED|Period 2, Second Week of Wear||11
11387121|NCT03518008|12580847|FG001|STARTED|Period 2, Second Week of Wear||11
11387122|NCT03518008|12580846|FG000|COMPLETED|Period 2, Second Week of Wear||11
11387123|NCT03518008|12580847|FG001|COMPLETED|Period 2, Second Week of Wear||10
11387124|NCT03518008|12580846|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
11387125|NCT03518008|12580847|FG001|NOT COMPLETED|Period 2, Second Week of Wear||1
11387126|NCT03518125|12580859|FG000|STARTED|Overall Study||50
11387127|NCT03518125|12580860|FG001|STARTED|Overall Study||50
11387128|NCT03518125|12580861|FG002|STARTED|Overall Study||49
11387129|NCT03518125|12580862|FG003|STARTED|Overall Study||52
11387130|NCT03518125|12580863|FG004|STARTED|Overall Study||52
11387131|NCT03518125|12580864|FG005|STARTED|Overall Study||52
11387132|NCT03518125|12580859|FG000|COMPLETED|Overall Study||48
11387133|NCT03518125|12580860|FG001|COMPLETED|Overall Study||46
11387134|NCT03518125|12580861|FG002|COMPLETED|Overall Study||49
11387135|NCT03518125|12580862|FG003|COMPLETED|Overall Study||51
11387136|NCT03518125|12580863|FG004|COMPLETED|Overall Study||48
11387137|NCT03518125|12580864|FG005|COMPLETED|Overall Study||44
11387138|NCT03518125|12580859|FG000|NOT COMPLETED|Overall Study||2
11387139|NCT03518125|12580860|FG001|NOT COMPLETED|Overall Study||4
11387140|NCT03518125|12580861|FG002|NOT COMPLETED|Overall Study||0
11387141|NCT03518125|12580862|FG003|NOT COMPLETED|Overall Study||1
11387142|NCT03518125|12580863|FG004|NOT COMPLETED|Overall Study||4
11387143|NCT03518125|12580864|FG005|NOT COMPLETED|Overall Study||8
11387144|NCT03518658|12580881|FG000|STARTED|Overall Study|Number of patients completing device pairing survey|257
11387145|NCT03518658|12580882|FG001|STARTED|Overall Study||128607
11387146|NCT03518658|12580881|FG000|COMPLETED|Overall Study|Number of patients completing annual survey|206
11387147|NCT03518658|12580882|FG001|COMPLETED|Overall Study||128607
11387148|NCT03518658|12580881|FG000|NOT COMPLETED|Overall Study||51
11387149|NCT03518658|12580882|FG001|NOT COMPLETED|Overall Study||0
11387150|NCT03518840|12580890|FG000|STARTED|Overall Study||63
11387151|NCT03518840|12580890|FG000|COMPLETED|Overall Study||57
11387152|NCT03518840|12580890|FG000|NOT COMPLETED|Overall Study||6
11387153|NCT03519087|12580899|FG000|STARTED|Clinic Evaluation||55
11387154|NCT03519087|12580900|FG001|STARTED|Clinic Evaluation||57
11387155|NCT03519087|12580901|FG002|STARTED|Clinic Evaluation||0
11387156|NCT03519087|12580902|FG003|STARTED|Clinic Evaluation||0
11387157|NCT03519087|12580903|FG004|STARTED|Clinic Evaluation||0
11387158|NCT03519087|12580899|FG000|Received Assigned Intervention|Clinic Evaluation||54
11387159|NCT03519087|12580900|FG001|Received Assigned Intervention|Clinic Evaluation||57
11387160|NCT03519087|12580901|FG002|Received Assigned Intervention|Clinic Evaluation||0
11387161|NCT03519087|12580902|FG003|Received Assigned Intervention|Clinic Evaluation||0
11387162|NCT03519087|12580903|FG004|Received Assigned Intervention|Clinic Evaluation||0
11387163|NCT03519087|12580899|FG000|Confirmed Diagnosis by Physician|Clinic Evaluation||39
11387164|NCT03519087|12580900|FG001|Confirmed Diagnosis by Physician|Clinic Evaluation||39
11387165|NCT03519087|12580901|FG002|Confirmed Diagnosis by Physician|Clinic Evaluation||0
11387166|NCT03519087|12580902|FG003|Confirmed Diagnosis by Physician|Clinic Evaluation||0
11387167|NCT03519087|12580903|FG004|Confirmed Diagnosis by Physician|Clinic Evaluation||0
11387168|NCT03519087|12580899|FG000|COMPLETED|Clinic Evaluation||39
11387169|NCT03519087|12580900|FG001|COMPLETED|Clinic Evaluation||39
11387170|NCT03519087|12580901|FG002|COMPLETED|Clinic Evaluation||0
11387171|NCT03519087|12580902|FG003|COMPLETED|Clinic Evaluation||0
11387172|NCT03519087|12580903|FG004|COMPLETED|Clinic Evaluation||0
11387173|NCT03519087|12580899|FG000|NOT COMPLETED|Clinic Evaluation||16
11387174|NCT03519087|12580900|FG001|NOT COMPLETED|Clinic Evaluation||18
11387175|NCT03519087|12580901|FG002|NOT COMPLETED|Clinic Evaluation||0
11387176|NCT03519087|12580902|FG003|NOT COMPLETED|Clinic Evaluation||0
11387177|NCT03519087|12580903|FG004|NOT COMPLETED|Clinic Evaluation||0
11387178|NCT03519087|12580899|FG000|STARTED|Re-randomization for Treatment||39
11387179|NCT03519087|12580900|FG001|STARTED|Re-randomization for Treatment||39
11387180|NCT03519087|12580901|FG002|STARTED|Re-randomization for Treatment||0
11387181|NCT03519087|12580902|FG003|STARTED|Re-randomization for Treatment||0
11387182|NCT03519087|12580903|FG004|STARTED|Re-randomization for Treatment||0
11387183|NCT03519087|12580899|FG000|COMPLETED|Re-randomization for Treatment||12
11387184|NCT03519087|12580900|FG001|COMPLETED|Re-randomization for Treatment||7
11387185|NCT03519087|12580901|FG002|COMPLETED|Re-randomization for Treatment||0
11387186|NCT03519087|12580902|FG003|COMPLETED|Re-randomization for Treatment||0
11387187|NCT03519087|12580903|FG004|COMPLETED|Re-randomization for Treatment||0
11387188|NCT03519087|12580899|FG000|NOT COMPLETED|Re-randomization for Treatment||27
11387189|NCT03519087|12580900|FG001|NOT COMPLETED|Re-randomization for Treatment||32
11387190|NCT03519087|12580901|FG002|NOT COMPLETED|Re-randomization for Treatment||0
11387191|NCT03519087|12580902|FG003|NOT COMPLETED|Re-randomization for Treatment||0
11387192|NCT03519087|12580903|FG004|NOT COMPLETED|Re-randomization for Treatment||0
11387193|NCT03519087|12580899|FG000|STARTED|Laboratory Testing||0
11387194|NCT03519087|12580900|FG001|STARTED|Laboratory Testing||0
11387195|NCT03519087|12580901|FG002|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
11387196|NCT03519087|12580902|FG003|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
11387197|NCT03519087|12580903|FG004|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (3) evaluation from Period 1|7
11387198|NCT03519087|12580899|FG000|Baseline Lab Testing|Laboratory Testing||0
11387199|NCT03519087|12580900|FG001|Baseline Lab Testing|Laboratory Testing||0
11387200|NCT03519087|12580901|FG002|Baseline Lab Testing|Laboratory Testing||5
11387201|NCT03519087|12580902|FG003|Baseline Lab Testing|Laboratory Testing||4
11387202|NCT03519087|12580903|FG004|Baseline Lab Testing|Laboratory Testing||3
11387203|NCT03519087|12580899|FG000|COMPLETED|Laboratory Testing||0
11387204|NCT03519087|12580900|FG001|COMPLETED|Laboratory Testing||0
11387205|NCT03519087|12580901|FG002|COMPLETED|Laboratory Testing||4
11387206|NCT03519087|12580902|FG003|COMPLETED|Laboratory Testing||2
11387207|NCT03519087|12580903|FG004|COMPLETED|Laboratory Testing||1
11387208|NCT03519087|12580899|FG000|NOT COMPLETED|Laboratory Testing||0
11387209|NCT03519087|12580900|FG001|NOT COMPLETED|Laboratory Testing||0
11387210|NCT03519087|12580901|FG002|NOT COMPLETED|Laboratory Testing||2
11387211|NCT03519087|12580902|FG003|NOT COMPLETED|Laboratory Testing||4
11387212|NCT03519087|12580903|FG004|NOT COMPLETED|Laboratory Testing||6
11387213|NCT03519204|12580921|FG000|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43
11387214|NCT03519204|12580922|FG001|STARTED|Overall Study||133
11387215|NCT03519204|12580921|FG000|mITT Population|Overall Study||33
11387216|NCT03519204|12580922|FG001|mITT Population|Overall Study||130
11387217|NCT03519204|12580921|FG000|Safety Population|Overall Study||40
11387218|NCT03519204|12580922|FG001|Safety Population|Overall Study||136
11387219|NCT03519204|12580921|FG000|COMPLETED|Overall Study||30
11387220|NCT03519204|12580922|FG001|COMPLETED|Overall Study||118
11387221|NCT03519204|12580921|FG000|NOT COMPLETED|Overall Study||13
11387222|NCT03519204|12580922|FG001|NOT COMPLETED|Overall Study||15
11387223|NCT03519243|12580935|FG000|STARTED|Overall Study||25
11387224|NCT03519243|12580936|FG001|STARTED|Overall Study||25
11387225|NCT03519243|12580937|FG002|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0
11387226|NCT03519243|12580938|FG003|STARTED|Overall Study||25
11387227|NCT03519243|12580935|FG000|COMPLETED|Overall Study||20
11387228|NCT03519243|12580936|FG001|COMPLETED|Overall Study||21
11387229|NCT03519243|12580937|FG002|COMPLETED|Overall Study||0
11387230|NCT03519243|12580938|FG003|COMPLETED|Overall Study||24
11387231|NCT03519243|12580935|FG000|NOT COMPLETED|Overall Study||5
11387232|NCT03519243|12580936|FG001|NOT COMPLETED|Overall Study||4
11387233|NCT03519243|12580937|FG002|NOT COMPLETED|Overall Study||0
11387234|NCT03519243|12580938|FG003|NOT COMPLETED|Overall Study||1
11387235|NCT03519282|12580946|FG000|STARTED|First Intervention||5
11387236|NCT03519282|12580947|FG001|STARTED|First Intervention||5
11387237|NCT03519282|12580946|FG000|COMPLETED|First Intervention||5
11387238|NCT03519282|12580947|FG001|COMPLETED|First Intervention||5
11387239|NCT03519282|12580946|FG000|NOT COMPLETED|First Intervention||0
11387240|NCT03519282|12580947|FG001|NOT COMPLETED|First Intervention||0
11387241|NCT03519282|12580946|FG000|STARTED|Second Intervention||5
11387242|NCT03519282|12580947|FG001|STARTED|Second Intervention||5
11387243|NCT03519282|12580946|FG000|COMPLETED|Second Intervention||5
11387244|NCT03519282|12580947|FG001|COMPLETED|Second Intervention||5
11387245|NCT03519282|12580946|FG000|NOT COMPLETED|Second Intervention||0
11387246|NCT03519282|12580947|FG001|NOT COMPLETED|Second Intervention||0
11387247|NCT03519516|12580955|FG000|STARTED|Overall Study||15
11387248|NCT03519516|12580956|FG001|STARTED|Overall Study||15
11387249|NCT03519516|12580955|FG000|COMPLETED|Overall Study||15
11387250|NCT03519516|12580956|FG001|COMPLETED|Overall Study||14
11387251|NCT03519516|12580955|FG000|NOT COMPLETED|Overall Study||0
11387252|NCT03519516|12580956|FG001|NOT COMPLETED|Overall Study||1
11387253|NCT03519854|12580980|FG000|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4
11387254|NCT03519854|12580981|FG001|STARTED|Overall Study||6
11387255|NCT03519854|12580982|FG002|STARTED|Overall Study||5
11387256|NCT03519854|12580983|FG003|STARTED|Overall Study||6
11387257|NCT03519854|12580984|FG004|STARTED|Overall Study||6
11387258|NCT03519854|12580985|FG005|STARTED|Overall Study||6
11387259|NCT03519854|12580986|FG006|STARTED|Overall Study||3
11387260|NCT03519854|12580987|FG007|STARTED|Overall Study||6
11387261|NCT03519854|12580988|FG008|STARTED|Overall Study||6
11387262|NCT03519854|12580989|FG009|STARTED|Overall Study||6
11387263|NCT03519854|12580990|FG010|STARTED|Overall Study||6
11387264|NCT03519854|12580991|FG011|STARTED|Overall Study||6
11387265|NCT03519854|12580992|FG012|STARTED|Overall Study||3
11387266|NCT03519854|12580993|FG013|STARTED|Overall Study||6
11387267|NCT03519854|12580994|FG014|STARTED|Overall Study||6
11387268|NCT03519854|12580995|FG015|STARTED|Overall Study||6
11387269|NCT03519854|12580996|FG016|STARTED|Overall Study||6
11387270|NCT03519854|12580997|FG017|STARTED|Overall Study||6
11387271|NCT03519854|12580980|FG000|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4
11387272|NCT03519854|12580981|FG001|Treated|Overall Study||6
11387273|NCT03519854|12580982|FG002|Treated|Overall Study||4
11387274|NCT03519854|12580983|FG003|Treated|Overall Study||6
11387275|NCT03519854|12580984|FG004|Treated|Overall Study||6
11387276|NCT03519854|12580985|FG005|Treated|Overall Study||6
11387277|NCT03519854|12580986|FG006|Treated|Overall Study||3
11387278|NCT03519854|12580987|FG007|Treated|Overall Study||6
11387279|NCT03519854|12580988|FG008|Treated|Overall Study||6
11387280|NCT03519854|12580989|FG009|Treated|Overall Study||6
11387281|NCT03519854|12580990|FG010|Treated|Overall Study||6
11006102|NCT00726453|12183865|FG001|NOT COMPLETED|Primary Enrollment Group||0
11006103|NCT00726453|12183864|FG000|STARTED|38 mm Length Group||0
11006104|NCT00726453|12183865|FG001|STARTED|38 mm Length Group||114
11006105|NCT00726453|12183864|FG000|COMPLETED|38 mm Length Group||0
11006106|NCT00726453|12183865|FG001|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
11006107|NCT00726453|12183864|FG000|NOT COMPLETED|38 mm Length Group||0
11006108|NCT00726453|12183865|FG001|NOT COMPLETED|38 mm Length Group||3
11006109|NCT00726557|12183870|FG000|STARTED|Overall Study||246
11006110|NCT00726557|12183870|FG000|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
11006111|NCT00726557|12183870|FG000|NOT COMPLETED|Overall Study||128
11006112|NCT00726609|12183875|FG000|STARTED|Overall Study||214
11387282|NCT03519854|12580991|FG011|Treated|Overall Study||6
11387283|NCT03519854|12580992|FG012|Treated|Overall Study||3
11006113|NCT00726609|12183875|FG000|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
11006114|NCT00726609|12183875|FG000|NOT COMPLETED|Overall Study||98
11006115|NCT00726622|12183881|FG000|STARTED|Overall Study||243
11387284|NCT03519854|12580993|FG013|Treated|Overall Study||6
11387285|NCT03519854|12580994|FG014|Treated|Overall Study||6
11387286|NCT03519854|12580995|FG015|Treated|Overall Study||6
11387287|NCT03519854|12580996|FG016|Treated|Overall Study||6
11387288|NCT03519854|12580997|FG017|Treated|Overall Study||6
11387289|NCT03519854|12580980|FG000|COMPLETED|Overall Study||4
11387290|NCT03519854|12580981|FG001|COMPLETED|Overall Study||6
11387291|NCT03519854|12580982|FG002|COMPLETED|Overall Study||4
11387292|NCT03519854|12580983|FG003|COMPLETED|Overall Study||6
11387293|NCT03519854|12580984|FG004|COMPLETED|Overall Study||6
11387294|NCT03519854|12580985|FG005|COMPLETED|Overall Study||6
11387295|NCT03519854|12580986|FG006|COMPLETED|Overall Study||3
11387296|NCT03519854|12580987|FG007|COMPLETED|Overall Study||6
11387297|NCT03519854|12580988|FG008|COMPLETED|Overall Study||6
11387298|NCT03519854|12580989|FG009|COMPLETED|Overall Study||6
11387299|NCT03519854|12580990|FG010|COMPLETED|Overall Study||6
11387300|NCT03519854|12580991|FG011|COMPLETED|Overall Study||6
11387301|NCT03519854|12580992|FG012|COMPLETED|Overall Study||3
11387302|NCT03519854|12580993|FG013|COMPLETED|Overall Study||6
11387303|NCT03519854|12580994|FG014|COMPLETED|Overall Study||6
11387304|NCT03519854|12580995|FG015|COMPLETED|Overall Study||6
11387305|NCT03519854|12580996|FG016|COMPLETED|Overall Study||6
11387306|NCT03519854|12580997|FG017|COMPLETED|Overall Study||6
11387307|NCT03519854|12580980|FG000|NOT COMPLETED|Overall Study||0
11387308|NCT03519854|12580981|FG001|NOT COMPLETED|Overall Study||0
11387309|NCT03519854|12580982|FG002|NOT COMPLETED|Overall Study||1
11387310|NCT03519854|12580983|FG003|NOT COMPLETED|Overall Study||0
11387311|NCT03519854|12580984|FG004|NOT COMPLETED|Overall Study||0
11387312|NCT03519854|12580985|FG005|NOT COMPLETED|Overall Study||0
11387313|NCT03519854|12580986|FG006|NOT COMPLETED|Overall Study||0
11387314|NCT03519854|12580987|FG007|NOT COMPLETED|Overall Study||0
11387315|NCT03519854|12580988|FG008|NOT COMPLETED|Overall Study||0
11387316|NCT03519854|12580989|FG009|NOT COMPLETED|Overall Study||0
11387317|NCT03519854|12580990|FG010|NOT COMPLETED|Overall Study||0
11387318|NCT03519854|12580991|FG011|NOT COMPLETED|Overall Study||0
11387319|NCT03519854|12580992|FG012|NOT COMPLETED|Overall Study||0
11387320|NCT03519854|12580993|FG013|NOT COMPLETED|Overall Study||0
11387321|NCT03519854|12580994|FG014|NOT COMPLETED|Overall Study||0
11387322|NCT03519854|12580995|FG015|NOT COMPLETED|Overall Study||0
11387323|NCT03519854|12580996|FG016|NOT COMPLETED|Overall Study||0
11387324|NCT03519854|12580997|FG017|NOT COMPLETED|Overall Study||0
11387325|NCT03519867|12581045|FG000|STARTED|Overall Study||6
11387326|NCT03519867|12581046|FG001|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7
11387327|NCT03519867|12581047|FG002|STARTED|Overall Study||6
11387328|NCT03519867|12581048|FG003|STARTED|Overall Study||4
11387329|NCT03519867|12581049|FG004|STARTED|Overall Study||5
11387330|NCT03519867|12581050|FG005|STARTED|Overall Study||5
11387331|NCT03519867|12581051|FG006|STARTED|Overall Study||4
11387332|NCT03519867|12581052|FG007|STARTED|Overall Study||5
11387333|NCT03519867|12581053|FG008|STARTED|Overall Study||4
11387334|NCT03519867|12581054|FG009|STARTED|Overall Study||4
11387335|NCT03519867|12581045|FG000|Treated|Overall Study||5
11387336|NCT03519867|12581046|FG001|Treated|Overall Study||6
11387337|NCT03519867|12581047|FG002|Treated|Overall Study||5
11387338|NCT03519867|12581048|FG003|Treated|Overall Study||3
11387339|NCT03519867|12581049|FG004|Treated|Overall Study||5
11387340|NCT03519867|12581050|FG005|Treated|Overall Study||4
11387341|NCT03519867|12581051|FG006|Treated|Overall Study||4
11387342|NCT03519867|12581052|FG007|Treated|Overall Study||4
11387343|NCT03519867|12581053|FG008|Treated|Overall Study||3
11387344|NCT03519867|12581054|FG009|Treated|Overall Study||4
11387345|NCT03519867|12581045|FG000|COMPLETED|Overall Study||3
11387346|NCT03519867|12581046|FG001|COMPLETED|Overall Study||4
11387347|NCT03519867|12581047|FG002|COMPLETED|Overall Study||5
11387348|NCT03519867|12581048|FG003|COMPLETED|Overall Study||3
11387349|NCT03519867|12581049|FG004|COMPLETED|Overall Study||5
11387350|NCT03519867|12581050|FG005|COMPLETED|Overall Study||2
11387351|NCT03519867|12581051|FG006|COMPLETED|Overall Study||3
11006116|NCT00726622|12183882|FG001|STARTED|Overall Study||243
11006117|NCT00726622|12183881|FG000|COMPLETED|Overall Study||225
11006118|NCT00726622|12183882|FG001|COMPLETED|Overall Study||240
11387352|NCT03519867|12581052|FG007|COMPLETED|Overall Study||4
11387353|NCT03519867|12581053|FG008|COMPLETED|Overall Study||3
11387354|NCT03519867|12581054|FG009|COMPLETED|Overall Study||4
11387355|NCT03519867|12581045|FG000|NOT COMPLETED|Overall Study||3
11387356|NCT03519867|12581046|FG001|NOT COMPLETED|Overall Study||3
11387357|NCT03519867|12581047|FG002|NOT COMPLETED|Overall Study||1
11387358|NCT03519867|12581048|FG003|NOT COMPLETED|Overall Study||1
11387359|NCT03519867|12581049|FG004|NOT COMPLETED|Overall Study||0
11387360|NCT03519867|12581050|FG005|NOT COMPLETED|Overall Study||3
11387361|NCT03519867|12581051|FG006|NOT COMPLETED|Overall Study||1
11387362|NCT03519867|12581052|FG007|NOT COMPLETED|Overall Study||1
11387363|NCT03519867|12581053|FG008|NOT COMPLETED|Overall Study||1
11387364|NCT03519867|12581054|FG009|NOT COMPLETED|Overall Study||0
11387365|NCT03519919|12581076|FG000|STARTED|Overall Study||51
11387366|NCT03519919|12581076|FG000|COMPLETED|Overall Study||48
11387367|NCT03519919|12581076|FG000|NOT COMPLETED|Overall Study||3
11387368|NCT03519932|12581106|FG000|STARTED|First Intervention||24
11387369|NCT03519932|12581107|FG001|STARTED|First Intervention||25
11387370|NCT03519932|12581106|FG000|COMPLETED|First Intervention|One subject had non-significant adverse event and data not included in the analysis|23
11387371|NCT03519932|12581107|FG001|COMPLETED|First Intervention|3 subjects had non-significant adverse events and data not included in analysis.|22
11387372|NCT03519932|12581106|FG000|NOT COMPLETED|First Intervention||1
11387373|NCT03519932|12581107|FG001|NOT COMPLETED|First Intervention||3
11387374|NCT03519932|12581106|FG000|STARTED|Second Intervention|Subjects who wore samfilcon A toric at 1st intervention wear comfilcon A toric at 2nd intervention|22
11387375|NCT03519932|12581107|FG001|STARTED|Second Intervention|Subjects who wore comfilcon A toric at 1st intervention wear Samfilcon A toric at 2nd intervention|23
11387376|NCT03519932|12581106|FG000|COMPLETED|Second Intervention||22
11387377|NCT03519932|12581107|FG001|COMPLETED|Second Intervention||23
11387378|NCT03519932|12581106|FG000|NOT COMPLETED|Second Intervention||0
11387379|NCT03519932|12581107|FG001|NOT COMPLETED|Second Intervention||0
11387380|NCT03520283|12581120|FG000|STARTED|Overall Study||24
11387381|NCT03520283|12581121|FG001|STARTED|Overall Study||42
11387382|NCT03520283|12581120|FG000|COMPLETED|Overall Study||24
11387383|NCT03520283|12581121|FG001|COMPLETED|Overall Study||42
11387384|NCT03520283|12581120|FG000|NOT COMPLETED|Overall Study||0
11387385|NCT03520283|12581121|FG001|NOT COMPLETED|Overall Study||0
11387386|NCT03520348|12581138|FG000|STARTED|Overall Study||12
11387387|NCT03520348|12581139|FG001|STARTED|Overall Study||12
11387388|NCT03520348|12581138|FG000|COMPLETED|Overall Study||12
11387389|NCT03520348|12581139|FG001|COMPLETED|Overall Study||12
11387390|NCT03520348|12581138|FG000|NOT COMPLETED|Overall Study||0
11387391|NCT03520348|12581139|FG001|NOT COMPLETED|Overall Study||0
11387392|NCT03520387|12581150|FG000|STARTED|Pre-Randomization||16
11387393|NCT03520387|12581151|FG001|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
11387394|NCT03520387|12581152|FG002|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
11387395|NCT03520387|12581153|FG003|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
11387396|NCT03520387|12581154|FG004|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
11387397|NCT03520387|12581150|FG000|COMPLETED|Pre-Randomization||13
11387398|NCT03520387|12581151|FG001|COMPLETED|Pre-Randomization||0
11387399|NCT03520387|12581152|FG002|COMPLETED|Pre-Randomization||0
11387400|NCT03520387|12581153|FG003|COMPLETED|Pre-Randomization||0
11387401|NCT03520387|12581154|FG004|COMPLETED|Pre-Randomization||0
11387402|NCT03520387|12581150|FG000|NOT COMPLETED|Pre-Randomization||3
11387403|NCT03520387|12581151|FG001|NOT COMPLETED|Pre-Randomization||0
11387404|NCT03520387|12581152|FG002|NOT COMPLETED|Pre-Randomization||0
11387405|NCT03520387|12581153|FG003|NOT COMPLETED|Pre-Randomization||0
11387406|NCT03520387|12581154|FG004|NOT COMPLETED|Pre-Randomization||0
11387407|NCT03520387|12581150|FG000|STARTED|Randomized|There are no participants in this group during this period, because the pre-randomization run-in period has ended.|0
11387408|NCT03520387|12581151|FG001|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|4
11387409|NCT03520387|12581152|FG002|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
11387410|NCT03520387|12581153|FG003|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
11387411|NCT03520387|12581154|FG004|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
11387412|NCT03520387|12581150|FG000|COMPLETED|Randomized||0
11387413|NCT03520387|12581151|FG001|COMPLETED|Randomized||4
11387414|NCT03520387|12581152|FG002|COMPLETED|Randomized||3
11387415|NCT03520387|12581153|FG003|COMPLETED|Randomized||3
11387416|NCT03520387|12581154|FG004|COMPLETED|Randomized||3
11387417|NCT03520387|12581150|FG000|NOT COMPLETED|Randomized||0
11387418|NCT03520387|12581151|FG001|NOT COMPLETED|Randomized||0
11387419|NCT03520387|12581152|FG002|NOT COMPLETED|Randomized||0
11387420|NCT03520387|12581153|FG003|NOT COMPLETED|Randomized||0
11387421|NCT03520387|12581154|FG004|NOT COMPLETED|Randomized||0
11387422|NCT03520400|12581167|FG000|STARTED|Overall Study||37
11387423|NCT03520400|12581168|FG001|STARTED|Overall Study||14
11387424|NCT03520400|12581167|FG000|COMPLETED|Overall Study||22
11387425|NCT03520400|12581168|FG001|COMPLETED|Overall Study||7
11387426|NCT03520400|12581167|FG000|NOT COMPLETED|Overall Study||15
11387427|NCT03520400|12581168|FG001|NOT COMPLETED|Overall Study||7
11387428|NCT03520920|12581177|FG000|STARTED|Overall Study||20
11387429|NCT03520920|12581178|FG001|STARTED|Overall Study||16
11387430|NCT03520920|12581179|FG002|STARTED|Overall Study||5
11387431|NCT03520920|12581177|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
11387432|NCT03520920|12581178|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
11387433|NCT03520920|12581179|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5
11387434|NCT03520920|12581177|FG000|COMPLETED|Overall Study||0
11387435|NCT03520920|12581178|FG001|COMPLETED|Overall Study||0
11387436|NCT03520920|12581179|FG002|COMPLETED|Overall Study||0
11387437|NCT03520920|12581177|FG000|NOT COMPLETED|Overall Study||20
11387438|NCT03520920|12581178|FG001|NOT COMPLETED|Overall Study||16
11387439|NCT03520920|12581179|FG002|NOT COMPLETED|Overall Study||5
11387440|NCT03520959|12581195|FG000|STARTED|Overall Study||0
11387441|NCT03520959|12581196|FG001|STARTED|Overall Study||1
11387442|NCT03520959|12581195|FG000|COMPLETED|Overall Study||0
11387443|NCT03520959|12581196|FG001|COMPLETED|Overall Study||0
11387444|NCT03520959|12581195|FG000|NOT COMPLETED|Overall Study||0
11387445|NCT03520959|12581196|FG001|NOT COMPLETED|Overall Study||1
11387446|NCT03520998|12581204|FG000|STARTED|Overall Study||24
11387447|NCT03520998|12581205|FG001|STARTED|Overall Study||23
11387448|NCT03520998|12581204|FG000|COMPLETED|Overall Study||18
11387449|NCT03520998|12581205|FG001|COMPLETED|Overall Study||21
11387450|NCT03520998|12581204|FG000|NOT COMPLETED|Overall Study||6
11387451|NCT03520998|12581205|FG001|NOT COMPLETED|Overall Study||2
11387452|NCT03521089|12581213|FG000|STARTED|Overall Study||8
11387453|NCT03521089|12581214|FG001|STARTED|Overall Study||8
11387454|NCT03521089|12581213|FG000|COMPLETED|Overall Study||8
11387455|NCT03521089|12581214|FG001|COMPLETED|Overall Study||8
11387456|NCT03521089|12581213|FG000|NOT COMPLETED|Overall Study||0
11387457|NCT03521089|12581214|FG001|NOT COMPLETED|Overall Study||0
11387458|NCT03521115|12581222|FG000|STARTED|Time 0 Baseline Surveys||206
11387459|NCT03521115|12581223|FG001|STARTED|Time 0 Baseline Surveys||205
11387460|NCT03521115|12581222|FG000|COMPLETED|Time 0 Baseline Surveys||206
11387461|NCT03521115|12581223|FG001|COMPLETED|Time 0 Baseline Surveys||205
11387462|NCT03521115|12581222|FG000|NOT COMPLETED|Time 0 Baseline Surveys||0
11387463|NCT03521115|12581223|FG001|NOT COMPLETED|Time 0 Baseline Surveys||0
11387464|NCT03521115|12581222|FG000|STARTED|Time 1 Survey (6 Months Post Baseline)||206
11387465|NCT03521115|12581223|FG001|STARTED|Time 1 Survey (6 Months Post Baseline)||205
11387466|NCT03521115|12581222|FG000|COMPLETED|Time 1 Survey (6 Months Post Baseline)||150
11387467|NCT03521115|12581223|FG001|COMPLETED|Time 1 Survey (6 Months Post Baseline)||165
11387468|NCT03521115|12581222|FG000|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||56
11387469|NCT03521115|12581223|FG001|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||40
11387470|NCT03521115|12581222|FG000|STARTED|Time 2 Survey (12 Months Post Baseline)||150
11387471|NCT03521115|12581223|FG001|STARTED|Time 2 Survey (12 Months Post Baseline)||165
11387472|NCT03521115|12581222|FG000|COMPLETED|Time 2 Survey (12 Months Post Baseline)||147
11387473|NCT03521115|12581223|FG001|COMPLETED|Time 2 Survey (12 Months Post Baseline)||164
11387474|NCT03521115|12581222|FG000|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||3
11387475|NCT03521115|12581223|FG001|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||1
11387476|NCT03521115|12581222|FG000|STARTED|Time 3 Survey (18 Months Post Baseline)||147
11387477|NCT03521115|12581223|FG001|STARTED|Time 3 Survey (18 Months Post Baseline)||164
11387478|NCT03521115|12581222|FG000|COMPLETED|Time 3 Survey (18 Months Post Baseline)||145
11387479|NCT03521115|12581223|FG001|COMPLETED|Time 3 Survey (18 Months Post Baseline)||164
11387480|NCT03521115|12581222|FG000|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||2
11387481|NCT03521115|12581223|FG001|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||0
11387482|NCT03521141|12581238|FG000|STARTED|Overall Study||19
11387483|NCT03521141|12581239|FG001|STARTED|Overall Study||19
11387484|NCT03521141|12581240|FG002|STARTED|Overall Study||20
11387485|NCT03521141|12581238|FG000|COMPLETED|Overall Study||18
11387486|NCT03521141|12581239|FG001|COMPLETED|Overall Study||19
11387487|NCT03521141|12581240|FG002|COMPLETED|Overall Study||19
11387488|NCT03521141|12581238|FG000|NOT COMPLETED|Overall Study||1
11387489|NCT03521141|12581239|FG001|NOT COMPLETED|Overall Study||0
11387490|NCT03521141|12581240|FG002|NOT COMPLETED|Overall Study||1
11387491|NCT03521479|12581252|FG000|STARTED|Overall Study||10
11387492|NCT03521479|12581253|FG001|STARTED|Overall Study||10
11387493|NCT03521479|12581254|FG002|STARTED|Overall Study||10
11387494|NCT03521479|12581255|FG003|STARTED|Overall Study||10
11387495|NCT03521479|12581252|FG000|COMPLETED|Overall Study||10
11387496|NCT03521479|12581253|FG001|COMPLETED|Overall Study||10
11387497|NCT03521479|12581254|FG002|COMPLETED|Overall Study||10
11387498|NCT03521479|12581255|FG003|COMPLETED|Overall Study||10
11387499|NCT03521479|12581252|FG000|NOT COMPLETED|Overall Study||0
11387500|NCT03521479|12581253|FG001|NOT COMPLETED|Overall Study||0
11387501|NCT03521479|12581254|FG002|NOT COMPLETED|Overall Study||0
11387502|NCT03521479|12581255|FG003|NOT COMPLETED|Overall Study||0
11387503|NCT03521505|12581267|FG000|STARTED|Overall Study||25
11387504|NCT03521505|12581268|FG001|STARTED|Overall Study||25
11387505|NCT03521505|12581267|FG000|COMPLETED|Overall Study||25
11387506|NCT03521505|12581268|FG001|COMPLETED|Overall Study||25
11387507|NCT03521505|12581267|FG000|NOT COMPLETED|Overall Study||0
11387508|NCT03521505|12581268|FG001|NOT COMPLETED|Overall Study||0
11387509|NCT03521635|12581276|FG000|STARTED|Overall Study||49
11387510|NCT03521635|12581277|FG001|STARTED|Overall Study||49
11387511|NCT03521635|12581276|FG000|COMPLETED|Overall Study||45
11387512|NCT03521635|12581277|FG001|COMPLETED|Overall Study||43
11387513|NCT03521635|12581276|FG000|NOT COMPLETED|Overall Study||4
11387514|NCT03521635|12581277|FG001|NOT COMPLETED|Overall Study||6
11387515|NCT03521791|12581285|FG000|STARTED|Overall Study||76
11387516|NCT03521791|12581286|FG001|STARTED|Overall Study||90
11387517|NCT03521791|12581285|FG000|COMPLETED|Overall Study||69
11387518|NCT03521791|12581286|FG001|COMPLETED|Overall Study||73
11387519|NCT03521791|12581285|FG000|NOT COMPLETED|Overall Study||7
11387520|NCT03521791|12581286|FG001|NOT COMPLETED|Overall Study||17
11387521|NCT03521817|12581294|FG000|STARTED|Overall Study||7
11387522|NCT03521817|12581295|FG001|STARTED|Overall Study||5
11387523|NCT03521817|12581294|FG000|COMPLETED|Overall Study||7
11387524|NCT03521817|12581295|FG001|COMPLETED|Overall Study|1 completer was non adherent based on weekly intervention body weight|4
11387525|NCT03521817|12581294|FG000|NOT COMPLETED|Overall Study||0
11387526|NCT03521817|12581295|FG001|NOT COMPLETED|Overall Study||1
11387527|NCT03522350|12581301|FG000|STARTED|Overall Study||18
11387528|NCT03522350|12581302|FG001|STARTED|Overall Study||18
11387529|NCT03522350|12581301|FG000|COMPLETED|Overall Study||18
11387530|NCT03522350|12581302|FG001|COMPLETED|Overall Study||18
11387531|NCT03522350|12581301|FG000|NOT COMPLETED|Overall Study||0
11387532|NCT03522350|12581302|FG001|NOT COMPLETED|Overall Study||0
11387533|NCT03522441|12581310|FG000|STARTED|Overall Study||450
11387534|NCT03522441|12581311|FG001|STARTED|Overall Study||450
11387535|NCT03522441|12581312|FG002|STARTED|Overall Study||225
11387536|NCT03522441|12581310|FG000|COMPLETED|Overall Study||424
11387537|NCT03522441|12581311|FG001|COMPLETED|Overall Study||431
11387538|NCT03522441|12581312|FG002|COMPLETED|Overall Study||214
11387539|NCT03522441|12581310|FG000|NOT COMPLETED|Overall Study||26
11387540|NCT03522441|12581311|FG001|NOT COMPLETED|Overall Study||19
11387541|NCT03522441|12581312|FG002|NOT COMPLETED|Overall Study||11
11387542|NCT03522506|12581324|FG000|STARTED|Treatment Period 1 (2 Days)||5
11387543|NCT03522506|12581325|FG001|STARTED|Treatment Period 1 (2 Days)||5
11387544|NCT03522506|12581326|FG002|STARTED|Treatment Period 1 (2 Days)||5
11387545|NCT03522506|12581327|FG003|STARTED|Treatment Period 1 (2 Days)||5
11387546|NCT03522506|12581324|FG000|COMPLETED|Treatment Period 1 (2 Days)||5
11387547|NCT03522506|12581325|FG001|COMPLETED|Treatment Period 1 (2 Days)||5
11387548|NCT03522506|12581326|FG002|COMPLETED|Treatment Period 1 (2 Days)||5
11387549|NCT03522506|12581327|FG003|COMPLETED|Treatment Period 1 (2 Days)||5
11387550|NCT03522506|12581324|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
11387551|NCT03522506|12581325|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
11387552|NCT03522506|12581326|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0
11387553|NCT03522506|12581327|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
11387554|NCT03522506|12581324|FG000|STARTED|Washout Period 1 (7 Days)||5
11387555|NCT03522506|12581325|FG001|STARTED|Washout Period 1 (7 Days)||5
11387556|NCT03522506|12581326|FG002|STARTED|Washout Period 1 (7 Days)||5
11387557|NCT03522506|12581327|FG003|STARTED|Washout Period 1 (7 Days)||5
11387558|NCT03522506|12581324|FG000|COMPLETED|Washout Period 1 (7 Days)||5
11387559|NCT03522506|12581325|FG001|COMPLETED|Washout Period 1 (7 Days)||5
11387560|NCT03522506|12581326|FG002|COMPLETED|Washout Period 1 (7 Days)||5
11387561|NCT03522506|12581327|FG003|COMPLETED|Washout Period 1 (7 Days)||4
11387562|NCT03522506|12581324|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
11387563|NCT03522506|12581325|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
11387564|NCT03522506|12581326|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
11387565|NCT03522506|12581327|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
11387566|NCT03522506|12581324|FG000|STARTED|Treatment Period 2 (2 Days)||5
11387567|NCT03522506|12581325|FG001|STARTED|Treatment Period 2 (2 Days)||5
11387568|NCT03522506|12581326|FG002|STARTED|Treatment Period 2 (2 Days)||5
11387569|NCT03522506|12581327|FG003|STARTED|Treatment Period 2 (2 Days)||4
11387570|NCT03522506|12581324|FG000|COMPLETED|Treatment Period 2 (2 Days)||5
11387571|NCT03522506|12581325|FG001|COMPLETED|Treatment Period 2 (2 Days)||5
11387572|NCT03522506|12581326|FG002|COMPLETED|Treatment Period 2 (2 Days)||5
11387573|NCT03522506|12581327|FG003|COMPLETED|Treatment Period 2 (2 Days)||4
11387574|NCT03522506|12581324|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
11387575|NCT03522506|12581325|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
11387576|NCT03522506|12581326|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
11387577|NCT03522506|12581327|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
11387578|NCT03522506|12581324|FG000|STARTED|Washout Period 2 (7 Days)||5
11387579|NCT03522506|12581325|FG001|STARTED|Washout Period 2 (7 Days)||5
11387580|NCT03522506|12581326|FG002|STARTED|Washout Period 2 (7 Days)||5
11387581|NCT03522506|12581327|FG003|STARTED|Washout Period 2 (7 Days)||4
11387582|NCT03522506|12581324|FG000|COMPLETED|Washout Period 2 (7 Days)||5
11387583|NCT03522506|12581325|FG001|COMPLETED|Washout Period 2 (7 Days)||5
11387584|NCT03522506|12581326|FG002|COMPLETED|Washout Period 2 (7 Days)||5
11387585|NCT03522506|12581327|FG003|COMPLETED|Washout Period 2 (7 Days)||3
11387586|NCT03522506|12581324|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
11387587|NCT03522506|12581325|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
11387588|NCT03522506|12581326|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
11387589|NCT03522506|12581327|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1
11387590|NCT03522506|12581324|FG000|STARTED|Treatment Period 3 (2 Days)||5
11387591|NCT03522506|12581325|FG001|STARTED|Treatment Period 3 (2 Days)||5
11387592|NCT03522506|12581326|FG002|STARTED|Treatment Period 3 (2 Days)||5
11387593|NCT03522506|12581327|FG003|STARTED|Treatment Period 3 (2 Days)||3
11387594|NCT03522506|12581324|FG000|COMPLETED|Treatment Period 3 (2 Days)||5
11387595|NCT03522506|12581325|FG001|COMPLETED|Treatment Period 3 (2 Days)||5
11387596|NCT03522506|12581326|FG002|COMPLETED|Treatment Period 3 (2 Days)||5
11387597|NCT03522506|12581327|FG003|COMPLETED|Treatment Period 3 (2 Days)||3
11387598|NCT03522506|12581324|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
11387599|NCT03522506|12581325|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
11387600|NCT03522506|12581326|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
11387601|NCT03522506|12581327|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
11387602|NCT03522506|12581324|FG000|STARTED|Washout Period 3 (7 Days)||5
11387603|NCT03522506|12581325|FG001|STARTED|Washout Period 3 (7 Days)||5
11387604|NCT03522506|12581326|FG002|STARTED|Washout Period 3 (7 Days)||5
11387605|NCT03522506|12581327|FG003|STARTED|Washout Period 3 (7 Days)||3
11387606|NCT03522506|12581324|FG000|COMPLETED|Washout Period 3 (7 Days)||5
11387607|NCT03522506|12581325|FG001|COMPLETED|Washout Period 3 (7 Days)||5
11387608|NCT03522506|12581326|FG002|COMPLETED|Washout Period 3 (7 Days)||5
11387609|NCT03522506|12581327|FG003|COMPLETED|Washout Period 3 (7 Days)||3
11387610|NCT03522506|12581324|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
11387611|NCT03522506|12581325|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
11387612|NCT03522506|12581326|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
11387613|NCT03522506|12581327|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
11387614|NCT03522506|12581324|FG000|STARTED|Treatment Period 4 (2 Days)||5
11387615|NCT03522506|12581325|FG001|STARTED|Treatment Period 4 (2 Days)||5
11387616|NCT03522506|12581326|FG002|STARTED|Treatment Period 4 (2 Days)||5
11387617|NCT03522506|12581327|FG003|STARTED|Treatment Period 4 (2 Days)||3
11387618|NCT03522506|12581324|FG000|COMPLETED|Treatment Period 4 (2 Days)||5
11387619|NCT03522506|12581325|FG001|COMPLETED|Treatment Period 4 (2 Days)||5
11387620|NCT03522506|12581326|FG002|COMPLETED|Treatment Period 4 (2 Days)||5
11387621|NCT03522506|12581327|FG003|COMPLETED|Treatment Period 4 (2 Days)||3
11387622|NCT03522506|12581324|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0
11387623|NCT03522506|12581325|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
11387624|NCT03522506|12581326|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
11387625|NCT03522506|12581327|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
11387626|NCT03522675|12581341|FG000|STARTED|Overall Study||22
11387627|NCT03522675|12581341|FG000|COMPLETED|Overall Study||20
11387628|NCT03522675|12581341|FG000|NOT COMPLETED|Overall Study||2
11387629|NCT03522948|12581349|FG000|STARTED|Overall Study||8
11387630|NCT03522948|12581349|FG000|COMPLETED|Overall Study||7
11387631|NCT03522948|12581349|FG000|NOT COMPLETED|Overall Study||1
11387632|NCT03523715|12581355|FG000|STARTED|Overall Study||38
11387633|NCT03523715|12581356|FG001|STARTED|Overall Study||39
11387634|NCT03523715|12581355|FG000|COMPLETED|Overall Study||26
11387635|NCT03523715|12581356|FG001|COMPLETED|Overall Study||23
11387636|NCT03523715|12581355|FG000|NOT COMPLETED|Overall Study||12
11387637|NCT03523715|12581356|FG001|NOT COMPLETED|Overall Study||16
11387638|NCT03523871|12581362|FG000|STARTED|Overall Study||20
11387639|NCT03523871|12581362|FG000|COMPLETED|Overall Study||19
11387640|NCT03523871|12581362|FG000|NOT COMPLETED|Overall Study||1
11387641|NCT03523988|12581369|FG000|STARTED|Overall Study||24
11387642|NCT03523988|12581370|FG001|STARTED|Overall Study||24
11387643|NCT03523988|12581371|FG002|STARTED|Overall Study||25
11387644|NCT03523988|12581369|FG000|COMPLETED|Overall Study||7
11387645|NCT03523988|12581370|FG001|COMPLETED|Overall Study||8
11387646|NCT03523988|12581371|FG002|COMPLETED|Overall Study||7
11387647|NCT03523988|12581369|FG000|NOT COMPLETED|Overall Study||17
11387648|NCT03523988|12581370|FG001|NOT COMPLETED|Overall Study||16
11387649|NCT03523988|12581371|FG002|NOT COMPLETED|Overall Study||18
11387650|NCT03524157|12581382|FG000|STARTED|Overall Study||10
11387651|NCT03524157|12581383|FG001|STARTED|Overall Study||10
11387652|NCT03524157|12581384|FG002|STARTED|Overall Study||10
11387653|NCT03524157|12581382|FG000|COMPLETED|Overall Study||10
11387654|NCT03524157|12581383|FG001|COMPLETED|Overall Study||10
11387655|NCT03524157|12581384|FG002|COMPLETED|Overall Study||9
11387656|NCT03524157|12581382|FG000|NOT COMPLETED|Overall Study||0
11387657|NCT03524157|12581383|FG001|NOT COMPLETED|Overall Study||0
11387658|NCT03524157|12581384|FG002|NOT COMPLETED|Overall Study||1
11387659|NCT03524339|12581394|FG000|STARTED|Overall Study||66
11387660|NCT03524339|12581395|FG001|STARTED|Overall Study||66
11387661|NCT03524339|12581394|FG000|COMPLETED|Overall Study||57
11387662|NCT03524339|12581395|FG001|COMPLETED|Overall Study||62
11387663|NCT03524339|12581394|FG000|NOT COMPLETED|Overall Study||9
11387664|NCT03524339|12581395|FG001|NOT COMPLETED|Overall Study||4
11387665|NCT03525210|12581403|FG000|STARTED|Overall Study||100
11387666|NCT03525210|12581404|FG001|STARTED|Overall Study||171
11387667|NCT03525210|12581403|FG000|COMPLETED|Overall Study||96
11387668|NCT03525210|12581404|FG001|COMPLETED|Overall Study||169
11387669|NCT03525210|12581403|FG000|NOT COMPLETED|Overall Study||4
11387670|NCT03525210|12581404|FG001|NOT COMPLETED|Overall Study||2
11387671|NCT03525444|12581414|FG000|STARTED|Overall Study||203
11387672|NCT03525444|12581415|FG001|STARTED|Overall Study||200
11387673|NCT03525444|12581414|FG000|Safety Set|Overall Study||201
11387674|NCT03525444|12581415|FG001|Safety Set|Overall Study||202
11387675|NCT03525444|12581414|FG000|COMPLETED|Overall Study||203
11387676|NCT03525444|12581415|FG001|COMPLETED|Overall Study||197
11387677|NCT03525444|12581414|FG000|NOT COMPLETED|Overall Study||0
11387678|NCT03525444|12581415|FG001|NOT COMPLETED|Overall Study||3
11387679|NCT03525548|12581424|FG000|STARTED|Overall Study||52
11387680|NCT03525548|12581425|FG001|STARTED|Overall Study||55
11387681|NCT03525548|12581424|FG000|COMPLETED|Overall Study||52
11387682|NCT03525548|12581425|FG001|COMPLETED|Overall Study||55
11387683|NCT03525548|12581424|FG000|NOT COMPLETED|Overall Study||0
11387684|NCT03525548|12581425|FG001|NOT COMPLETED|Overall Study||0
11387685|NCT03525834|12581431|FG000|STARTED|Overall Study||40
11387686|NCT03525834|12581431|FG000|COMPLETED|Overall Study||39
11387687|NCT03525834|12581431|FG000|NOT COMPLETED|Overall Study||1
11387688|NCT03526055|12581435|FG000|STARTED|Initial Program||5
11387689|NCT03526055|12581436|FG001|STARTED|Initial Program||5
11387690|NCT03526055|12581435|FG000|COMPLETED|Initial Program||5
11387691|NCT03526055|12581436|FG001|COMPLETED|Initial Program||5
11387692|NCT03526055|12581435|FG000|NOT COMPLETED|Initial Program||0
11387693|NCT03526055|12581436|FG001|NOT COMPLETED|Initial Program||0
11387694|NCT03526055|12581435|FG000|STARTED|Second Program||5
11387695|NCT03526055|12581436|FG001|STARTED|Second Program||5
11387696|NCT03526055|12581435|FG000|COMPLETED|Second Program||5
11387697|NCT03526055|12581436|FG001|COMPLETED|Second Program||5
11387698|NCT03526055|12581435|FG000|NOT COMPLETED|Second Program||0
11387699|NCT03526055|12581436|FG001|NOT COMPLETED|Second Program||0
11387700|NCT03526458|12581445|FG000|STARTED|Overall Study||20
11387701|NCT03526458|12581446|FG001|STARTED|Overall Study||20
11387702|NCT03526458|12581445|FG000|COMPLETED|Overall Study||12
11387703|NCT03526458|12581446|FG001|COMPLETED|Overall Study||15
11387704|NCT03526458|12581445|FG000|NOT COMPLETED|Overall Study||8
11387705|NCT03526458|12581446|FG001|NOT COMPLETED|Overall Study||5
11387706|NCT03527160|12581454|FG000|STARTED|Overall Study||134
11387707|NCT03527160|12581454|FG000|COMPLETED|Overall Study||113
11387708|NCT03527160|12581454|FG000|NOT COMPLETED|Overall Study||21
11387709|NCT03527173|12581463|FG000|STARTED|Overall Study||36
11387710|NCT03527173|12581464|FG001|STARTED|Overall Study||35
11387711|NCT03527173|12581463|FG000|COMPLETED|Overall Study||29
11387712|NCT03527173|12581464|FG001|COMPLETED|Overall Study||28
11387713|NCT03527173|12581463|FG000|NOT COMPLETED|Overall Study||7
11387714|NCT03527173|12581464|FG001|NOT COMPLETED|Overall Study||7
11387715|NCT03527550|12581472|FG000|STARTED|Overall Study||24
11387716|NCT03527550|12581473|FG001|STARTED|Overall Study||22
11387717|NCT03527550|12581472|FG000|COMPLETED|Overall Study||15
11387718|NCT03527550|12581473|FG001|COMPLETED|Overall Study||19
11387719|NCT03527550|12581472|FG000|NOT COMPLETED|Overall Study||9
11387720|NCT03527550|12581473|FG001|NOT COMPLETED|Overall Study||3
11387721|NCT03527745|12581507|FG000|STARTED|Overall Study||27
11387722|NCT03527745|12581508|FG001|STARTED|Overall Study||27
11387723|NCT03527745|12581509|FG002|STARTED|Overall Study||30
11387724|NCT03527745|12581510|FG003|STARTED|Overall Study||27
11387725|NCT03527745|12581511|FG004|STARTED|Overall Study||46
11387726|NCT03527745|12581512|FG005|STARTED|Overall Study||45
11387727|NCT03527745|12581513|FG006|STARTED|Overall Study||46
11387728|NCT03527745|12581514|FG007|STARTED|Overall Study||43
11387729|NCT03527745|12581515|FG008|STARTED|Overall Study||10
11387730|NCT03527745|12581516|FG009|STARTED|Overall Study||11
11387731|NCT03527745|12581517|FG010|STARTED|Overall Study||9
11387732|NCT03527745|12581518|FG011|STARTED|Overall Study||12
11387733|NCT03527745|12581519|FG012|STARTED|Overall Study|During screening, the principal investigator decided to remove the this arm due to recruitment.|0
11387734|NCT03527745|12581520|FG013|STARTED|Overall Study||13
11387735|NCT03527745|12581521|FG014|STARTED|Overall Study||13
11387736|NCT03527745|12581522|FG015|STARTED|Overall Study||12
11387737|NCT03527745|12581523|FG016|STARTED|Overall Study||24
11387738|NCT03527745|12581524|FG017|STARTED|Overall Study||27
11387739|NCT03527745|12581525|FG018|STARTED|Overall Study||27
11387740|NCT03527745|12581526|FG019|STARTED|Overall Study||29
11387741|NCT03527745|12581527|FG020|STARTED|Overall Study||26
11387742|NCT03527745|12581528|FG021|STARTED|Overall Study||40
11387743|NCT03527745|12581529|FG022|STARTED|Overall Study||41
11387744|NCT03527745|12581530|FG023|STARTED|Overall Study||38
11387745|NCT03527745|12581531|FG024|STARTED|Overall Study||40
11387746|NCT03527745|12581532|FG025|STARTED|Overall Study||37
11387747|NCT03527745|12581507|FG000|COMPLETED|Overall Study||24
11387748|NCT03527745|12581508|FG001|COMPLETED|Overall Study||21
11387749|NCT03527745|12581509|FG002|COMPLETED|Overall Study||23
11387750|NCT03527745|12581510|FG003|COMPLETED|Overall Study||18
11387751|NCT03527745|12581511|FG004|COMPLETED|Overall Study||46
11387752|NCT03527745|12581512|FG005|COMPLETED|Overall Study||43
11387753|NCT03527745|12581513|FG006|COMPLETED|Overall Study||43
11387754|NCT03527745|12581514|FG007|COMPLETED|Overall Study||41
11387755|NCT03527745|12581515|FG008|COMPLETED|Overall Study||7
11387756|NCT03527745|12581516|FG009|COMPLETED|Overall Study||9
11387757|NCT03527745|12581517|FG010|COMPLETED|Overall Study||8
11387758|NCT03527745|12581518|FG011|COMPLETED|Overall Study||11
11387759|NCT03527745|12581519|FG012|COMPLETED|Overall Study||0
11387760|NCT03527745|12581520|FG013|COMPLETED|Overall Study||13
11387761|NCT03527745|12581521|FG014|COMPLETED|Overall Study||13
11387762|NCT03527745|12581522|FG015|COMPLETED|Overall Study||12
11387763|NCT03527745|12581523|FG016|COMPLETED|Overall Study||23
11387764|NCT03527745|12581524|FG017|COMPLETED|Overall Study||27
11387765|NCT03527745|12581525|FG018|COMPLETED|Overall Study||27
11387766|NCT03527745|12581526|FG019|COMPLETED|Overall Study||28
11387767|NCT03527745|12581527|FG020|COMPLETED|Overall Study||25
11387768|NCT03527745|12581528|FG021|COMPLETED|Overall Study||35
11387769|NCT03527745|12581529|FG022|COMPLETED|Overall Study||35
11387770|NCT03527745|12581530|FG023|COMPLETED|Overall Study||30
11387771|NCT03527745|12581531|FG024|COMPLETED|Overall Study||39
11387772|NCT03527745|12581532|FG025|COMPLETED|Overall Study||34
11387773|NCT03527745|12581507|FG000|NOT COMPLETED|Overall Study||3
11387774|NCT03527745|12581508|FG001|NOT COMPLETED|Overall Study||6
11387775|NCT03527745|12581509|FG002|NOT COMPLETED|Overall Study||7
11387776|NCT03527745|12581510|FG003|NOT COMPLETED|Overall Study||9
11387777|NCT03527745|12581511|FG004|NOT COMPLETED|Overall Study||0
11387778|NCT03527745|12581512|FG005|NOT COMPLETED|Overall Study||2
11387779|NCT03527745|12581513|FG006|NOT COMPLETED|Overall Study||3
11387780|NCT03527745|12581514|FG007|NOT COMPLETED|Overall Study||2
11387781|NCT03527745|12581515|FG008|NOT COMPLETED|Overall Study||3
11387782|NCT03527745|12581516|FG009|NOT COMPLETED|Overall Study||2
11387783|NCT03527745|12581517|FG010|NOT COMPLETED|Overall Study||1
11387784|NCT03527745|12581518|FG011|NOT COMPLETED|Overall Study||1
11387785|NCT03527745|12581519|FG012|NOT COMPLETED|Overall Study||0
11387786|NCT03527745|12581520|FG013|NOT COMPLETED|Overall Study||0
11387787|NCT03527745|12581521|FG014|NOT COMPLETED|Overall Study||0
11387788|NCT03527745|12581522|FG015|NOT COMPLETED|Overall Study||0
11387789|NCT03527745|12581523|FG016|NOT COMPLETED|Overall Study||1
11387790|NCT03527745|12581524|FG017|NOT COMPLETED|Overall Study||0
11387791|NCT03527745|12581525|FG018|NOT COMPLETED|Overall Study||0
11387792|NCT03527745|12581526|FG019|NOT COMPLETED|Overall Study||1
11387793|NCT03527745|12581527|FG020|NOT COMPLETED|Overall Study||1
11387794|NCT03527745|12581528|FG021|NOT COMPLETED|Overall Study||5
11387795|NCT03527745|12581529|FG022|NOT COMPLETED|Overall Study||6
11387796|NCT03527745|12581530|FG023|NOT COMPLETED|Overall Study||8
11387797|NCT03527745|12581531|FG024|NOT COMPLETED|Overall Study||1
11387798|NCT03527745|12581532|FG025|NOT COMPLETED|Overall Study||3
11387799|NCT03527966|12581590|FG000|STARTED|Overall Study||3
11387800|NCT03527966|12581591|FG001|STARTED|Overall Study||0
11387801|NCT03527966|12581590|FG000|COMPLETED|Overall Study||0
11387802|NCT03527966|12581591|FG001|COMPLETED|Overall Study||0
11387803|NCT03527966|12581590|FG000|NOT COMPLETED|Overall Study||3
11387804|NCT03527966|12581591|FG001|NOT COMPLETED|Overall Study||0
11387805|NCT03528174|12581597|FG000|STARTED|Overall Study||10
11387806|NCT03528174|12581597|FG000|COMPLETED|Overall Study||8
11387807|NCT03528174|12581597|FG000|NOT COMPLETED|Overall Study||2
11387808|NCT03528369|12581604|FG000|STARTED|Overall Study||40
11387809|NCT03528369|12581605|FG001|STARTED|Overall Study||42
11387810|NCT03528369|12581606|FG002|STARTED|Overall Study||40
11387811|NCT03528369|12581604|FG000|COMPLETED|Overall Study||37
11387812|NCT03528369|12581605|FG001|COMPLETED|Overall Study||41
11387813|NCT03528369|12581606|FG002|COMPLETED|Overall Study||40
11387814|NCT03528369|12581604|FG000|NOT COMPLETED|Overall Study||3
11387815|NCT03528369|12581605|FG001|NOT COMPLETED|Overall Study||1
11387816|NCT03528369|12581606|FG002|NOT COMPLETED|Overall Study||0
11387817|NCT03528512|12581616|FG000|STARTED|Overall Study||3
11387818|NCT03528512|12581617|FG001|STARTED|Overall Study||2
11387819|NCT03528512|12581616|FG000|COMPLETED|Overall Study||3
11387820|NCT03528512|12581617|FG001|COMPLETED|Overall Study||2
11387821|NCT03528512|12581616|FG000|NOT COMPLETED|Overall Study||0
11387822|NCT03528512|12581617|FG001|NOT COMPLETED|Overall Study||0
11387823|NCT03528551|12581626|FG000|STARTED|Overall Study||25
11387824|NCT03528551|12581627|FG001|STARTED|Overall Study||133
11387825|NCT03528551|12581628|FG002|STARTED|Overall Study||2
11387826|NCT03528551|12581626|FG000|COMPLETED|Overall Study||23
11387827|NCT03528551|12581627|FG001|COMPLETED|Overall Study||114
11387828|NCT03528551|12581628|FG002|COMPLETED|Overall Study||2
11387829|NCT03528551|12581626|FG000|NOT COMPLETED|Overall Study||2
11387830|NCT03528551|12581627|FG001|NOT COMPLETED|Overall Study||19
11387831|NCT03528551|12581628|FG002|NOT COMPLETED|Overall Study||0
11387832|NCT03528577|12581637|FG000|STARTED|Sequence 1||128
11387833|NCT03528577|12581637|FG000|COMPLETED|Sequence 1|Per report, 119 completed the trial, and all 119 received Treatment A, B, C and D.|126
11387834|NCT03528577|12581637|FG000|NOT COMPLETED|Sequence 1||2
11387835|NCT03528577|12581637|FG000|STARTED|Sequence 2||128
11387836|NCT03528577|12581637|FG000|COMPLETED|Sequence 2||125
11387837|NCT03528577|12581637|FG000|NOT COMPLETED|Sequence 2||3
11387838|NCT03528577|12581637|FG000|STARTED|Sequence 3||128
11387839|NCT03528577|12581637|FG000|COMPLETED|Sequence 3||127
11387840|NCT03528577|12581637|FG000|NOT COMPLETED|Sequence 3||1
11387841|NCT03528577|12581637|FG000|STARTED|Sequence 4||128
11387842|NCT03528577|12581637|FG000|COMPLETED|Sequence 4||125
11387843|NCT03528577|12581637|FG000|NOT COMPLETED|Sequence 4||3
11387844|NCT03529162|12581646|FG000|STARTED|Overall Study||2
11387845|NCT03529162|12581647|FG001|STARTED|Overall Study||2
11387846|NCT03529162|12581646|FG000|COMPLETED|Overall Study||0
11387847|NCT03529162|12581647|FG001|COMPLETED|Overall Study||0
11387848|NCT03529162|12581646|FG000|NOT COMPLETED|Overall Study||2
11387849|NCT03529162|12581647|FG001|NOT COMPLETED|Overall Study||2
11387850|NCT03529461|12581657|FG000|STARTED|Overall Study||28
11387851|NCT03529461|12581658|FG001|STARTED|Overall Study||28
11387852|NCT03529461|12581657|FG000|COMPLETED|Overall Study||28
11387853|NCT03529461|12581658|FG001|COMPLETED|Overall Study||28
11387854|NCT03529461|12581657|FG000|NOT COMPLETED|Overall Study||0
11387855|NCT03529461|12581658|FG001|NOT COMPLETED|Overall Study||0
11387856|NCT03530098|12581667|FG000|STARTED|Overall Study||939
11387857|NCT03530098|12581668|FG001|STARTED|Overall Study||964
11387858|NCT03530098|12581667|FG000|Ground-truth Labeled|Overall Study||741
11387859|NCT03530098|12581668|FG001|Ground-truth Labeled|Overall Study||794
11387860|NCT03530098|12581667|FG000|Primary Analysis Set|Overall Study||739
11387861|NCT03530098|12581668|FG001|Primary Analysis Set|Overall Study||792
11387862|NCT03530098|12581667|FG000|COMPLETED|Overall Study||939
11387863|NCT03530098|12581668|FG001|COMPLETED|Overall Study||964
11387864|NCT03530098|12581667|FG000|NOT COMPLETED|Overall Study||0
11387865|NCT03530098|12581668|FG001|NOT COMPLETED|Overall Study||0
11387866|NCT03530345|12581677|FG000|STARTED|Treatment Period A/Follow-up Period 1||28
11387867|NCT03530345|12581678|FG001|STARTED|Treatment Period A/Follow-up Period 1||29
11387868|NCT03530345|12581677|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||26
11387869|NCT03530345|12581678|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||27
11387870|NCT03530345|12581677|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||7
11387871|NCT03530345|12581678|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||7
11387872|NCT03530345|12581677|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||21
11387873|NCT03530345|12581678|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||22
11387874|NCT03530345|12581677|FG000|STARTED|Treatment Period B/Follow-up Period 2|2 participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|5
11387875|NCT03530345|12581678|FG001|STARTED|Treatment Period B/Follow-up Period 2||7
11387876|NCT03530345|12581677|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||4
11387877|NCT03530345|12581678|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||6
11387878|NCT03530345|12581677|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||0
11387879|NCT03530345|12581678|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0
11387880|NCT03530345|12581677|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||5
11387881|NCT03530345|12581678|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||7
11387882|NCT03530631|12581690|FG000|STARTED|Adderall/Truth||4
11387883|NCT03530631|12581690|FG000|COMPLETED|Adderall/Truth||4
11387884|NCT03530631|12581690|FG000|NOT COMPLETED|Adderall/Truth||0
11387885|NCT03530631|12581690|FG000|STARTED|Placebo/Truth||4
11387886|NCT03530631|12581690|FG000|COMPLETED|Placebo/Truth||4
11387887|NCT03530631|12581690|FG000|NOT COMPLETED|Placebo/Truth||0
11387888|NCT03530631|12581690|FG000|STARTED|Adderall/Deception||4
11387889|NCT03530631|12581690|FG000|COMPLETED|Adderall/Deception||4
11387890|NCT03530631|12581690|FG000|NOT COMPLETED|Adderall/Deception||0
11387891|NCT03530631|12581690|FG000|STARTED|Placebo/Deception||4
11387892|NCT03530631|12581690|FG000|COMPLETED|Placebo/Deception||4
11387893|NCT03530631|12581690|FG000|NOT COMPLETED|Placebo/Deception||0
11387894|NCT03530917|12581708|FG000|STARTED|Overall Study||8
11387895|NCT03530917|12581709|FG001|STARTED|Overall Study||8
11387896|NCT03530917|12581710|FG002|STARTED|Overall Study||8
11387897|NCT03530917|12581711|FG003|STARTED|Overall Study||8
11387898|NCT03530917|12581712|FG004|STARTED|Overall Study||8
11387899|NCT03530917|12581713|FG005|STARTED|Overall Study||6
11387900|NCT03530917|12581714|FG006|STARTED|Overall Study||8
11387901|NCT03530917|12581715|FG007|STARTED|Overall Study||16
11387902|NCT03530917|12581708|FG000|COMPLETED|Overall Study||8
11387903|NCT03530917|12581709|FG001|COMPLETED|Overall Study||8
11387904|NCT03530917|12581710|FG002|COMPLETED|Overall Study||8
11387905|NCT03530917|12581711|FG003|COMPLETED|Overall Study||8
11387906|NCT03530917|12581712|FG004|COMPLETED|Overall Study||8
11387907|NCT03530917|12581713|FG005|COMPLETED|Overall Study||6
11387908|NCT03530917|12581714|FG006|COMPLETED|Overall Study||8
11387909|NCT03530917|12581715|FG007|COMPLETED|Overall Study||16
11387910|NCT03530917|12581708|FG000|NOT COMPLETED|Overall Study||0
11387911|NCT03530917|12581709|FG001|NOT COMPLETED|Overall Study||0
11387912|NCT03530917|12581710|FG002|NOT COMPLETED|Overall Study||0
11387913|NCT03530917|12581711|FG003|NOT COMPLETED|Overall Study||0
11387914|NCT03530917|12581712|FG004|NOT COMPLETED|Overall Study||0
11387915|NCT03530917|12581713|FG005|NOT COMPLETED|Overall Study||0
11387916|NCT03530917|12581714|FG006|NOT COMPLETED|Overall Study||0
11387917|NCT03530917|12581715|FG007|NOT COMPLETED|Overall Study||0
11387918|NCT03531710|12581745|FG000|STARTED|Overall Study||10
11387919|NCT03531710|12581746|FG001|STARTED|Overall Study||2
11387920|NCT03531710|12581747|FG002|STARTED|Overall Study||7
11387921|NCT03531710|12581748|FG003|STARTED|Overall Study||5
11387922|NCT03531710|12581749|FG004|STARTED|Overall Study||8
11387923|NCT03531710|12581750|FG005|STARTED|Overall Study||2
11387924|NCT03531710|12581745|FG000|COMPLETED|Overall Study||8
11387925|NCT03531710|12581746|FG001|COMPLETED|Overall Study||2
11387926|NCT03531710|12581747|FG002|COMPLETED|Overall Study||7
11387927|NCT03531710|12581748|FG003|COMPLETED|Overall Study||5
11387928|NCT03531710|12581749|FG004|COMPLETED|Overall Study||8
11387929|NCT03531710|12581750|FG005|COMPLETED|Overall Study||2
11387930|NCT03531710|12581745|FG000|NOT COMPLETED|Overall Study||2
11387931|NCT03531710|12581746|FG001|NOT COMPLETED|Overall Study||0
11387932|NCT03531710|12581747|FG002|NOT COMPLETED|Overall Study||0
11387933|NCT03531710|12581748|FG003|NOT COMPLETED|Overall Study||0
11387934|NCT03531710|12581749|FG004|NOT COMPLETED|Overall Study||0
11387935|NCT03531710|12581750|FG005|NOT COMPLETED|Overall Study||0
11387936|NCT03531840|12581768|FG000|STARTED|Overall Study||5
11387937|NCT03531840|12581769|FG001|STARTED|Overall Study||6
11387938|NCT03531840|12581770|FG002|STARTED|Overall Study||8
11387939|NCT03531840|12581771|FG003|STARTED|Overall Study||4
11387940|NCT03531840|12581768|FG000|COMPLETED|Overall Study||0
11387941|NCT03531840|12581769|FG001|COMPLETED|Overall Study||1
11387942|NCT03531840|12581770|FG002|COMPLETED|Overall Study||3
11387943|NCT03531840|12581771|FG003|COMPLETED|Overall Study||1
11387944|NCT03531840|12581768|FG000|NOT COMPLETED|Overall Study||5
11387945|NCT03531840|12581769|FG001|NOT COMPLETED|Overall Study||5
11387946|NCT03531840|12581770|FG002|NOT COMPLETED|Overall Study||5
11387947|NCT03531840|12581771|FG003|NOT COMPLETED|Overall Study||3
11387948|NCT03531905|12581789|FG000|STARTED|Overall Study||81
11387949|NCT03531905|12581790|FG001|STARTED|Overall Study||81
11387950|NCT03531905|12581791|FG002|STARTED|Overall Study||80
11387951|NCT03531905|12581789|FG000|COMPLETED|Overall Study||74
11387952|NCT03531905|12581790|FG001|COMPLETED|Overall Study||76
11387953|NCT03531905|12581791|FG002|COMPLETED|Overall Study||77
11387954|NCT03531905|12581789|FG000|NOT COMPLETED|Overall Study||7
11387955|NCT03531905|12581790|FG001|NOT COMPLETED|Overall Study||5
11387956|NCT03531905|12581791|FG002|NOT COMPLETED|Overall Study||3
11387957|NCT03532009|12581803|FG000|STARTED|Overall Study||92
11387958|NCT03532009|12581804|FG001|STARTED|Overall Study||90
11387959|NCT03532009|12581803|FG000|Received Treatment|Overall Study||91
11387960|NCT03532009|12581804|FG001|Received Treatment|Overall Study||90
11387961|NCT03532009|12581803|FG000|COMPLETED|Overall Study||90
11387962|NCT03532009|12581804|FG001|COMPLETED|Overall Study||86
11387963|NCT03532009|12581803|FG000|NOT COMPLETED|Overall Study||2
11387964|NCT03532009|12581804|FG001|NOT COMPLETED|Overall Study||4
11387965|NCT03532048|12581812|FG000|STARTED|Overall Study|68 individuals (19 fathers, 31 children & 18 mothers)|68
11387966|NCT03532048|12581813|FG001|STARTED|Overall Study|67 individuals (17 fathers, 33 children & 17 mothers)|67
11387967|NCT03532048|12581812|FG000|COMPLETED|Overall Study|49 individuals (14 fathers, 22 children, 13 mothers). 1 father only took part in interview|49
11387968|NCT03532048|12581813|FG001|COMPLETED|Overall Study|50 individuals (13 fathers, 24 children & 13 mothers)|50
11387969|NCT03532048|12581812|FG000|NOT COMPLETED|Overall Study||19
11387970|NCT03532048|12581813|FG001|NOT COMPLETED|Overall Study||17
11387971|NCT03532308|12581821|FG000|STARTED|Overall Study||10
11387972|NCT03532308|12581822|FG001|STARTED|Overall Study||9
11387973|NCT03532308|12581821|FG000|Completed Assessments|Overall Study||9
11387974|NCT03532308|12581822|FG001|Completed Assessments|Overall Study||7
11387975|NCT03532308|12581821|FG000|COMPLETED|Overall Study||10
11387976|NCT03532308|12581822|FG001|COMPLETED|Overall Study||8
11387977|NCT03532308|12581821|FG000|NOT COMPLETED|Overall Study||0
11387978|NCT03532308|12581822|FG001|NOT COMPLETED|Overall Study||1
11387979|NCT03532776|12581831|FG000|STARTED|Overall Study||201
11387980|NCT03532776|12581832|FG001|STARTED|Overall Study||198
11387981|NCT03532776|12581833|FG002|STARTED|Overall Study||67
11387982|NCT03532776|12581831|FG000|COMPLETED|Overall Study||196
11387983|NCT03532776|12581832|FG001|COMPLETED|Overall Study||194
11387984|NCT03532776|12581833|FG002|COMPLETED|Overall Study||63
11387985|NCT03532776|12581831|FG000|NOT COMPLETED|Overall Study||5
11387986|NCT03532776|12581832|FG001|NOT COMPLETED|Overall Study||4
11387987|NCT03532776|12581833|FG002|NOT COMPLETED|Overall Study||4
11387988|NCT03533036|12581844|FG000|STARTED|Overall Study||15
11387989|NCT03533036|12581845|FG001|STARTED|Overall Study||15
11387990|NCT03533036|12581844|FG000|COMPLETED|Overall Study||15
11387991|NCT03533036|12581845|FG001|COMPLETED|Overall Study||15
11387992|NCT03533036|12581844|FG000|NOT COMPLETED|Overall Study||0
11387993|NCT03533036|12581845|FG001|NOT COMPLETED|Overall Study||0
11387994|NCT03533114|12581853|FG000|STARTED|Overall||88
11387995|NCT03533114|12581854|FG001|STARTED|Overall||66
11387996|NCT03533114|12581853|FG000|COMPLETED|Overall||57
11387997|NCT03533114|12581854|FG001|COMPLETED|Overall||38
11387998|NCT03533114|12581853|FG000|NOT COMPLETED|Overall||31
11387999|NCT03533114|12581854|FG001|NOT COMPLETED|Overall||28
11388000|NCT03533114|12581853|FG000|STARTED|Open Label Titration and Optimization||88
11388001|NCT03533114|12581854|FG001|STARTED|Open Label Titration and Optimization||66
11388002|NCT03533114|12581853|FG000|COMPLETED|Open Label Titration and Optimization||72
11388003|NCT03533114|12581854|FG001|COMPLETED|Open Label Titration and Optimization||53
11388004|NCT03533114|12581853|FG000|NOT COMPLETED|Open Label Titration and Optimization||16
11388005|NCT03533114|12581854|FG001|NOT COMPLETED|Open Label Titration and Optimization||13
11388006|NCT03533114|12581853|FG000|STARTED|Stable Dose||71
11388007|NCT03533114|12581854|FG001|STARTED|Stable Dose||52
11388008|NCT03533114|12581853|FG000|COMPLETED|Stable Dose||69
11388009|NCT03533114|12581854|FG001|COMPLETED|Stable Dose||50
11388010|NCT03533114|12581853|FG000|NOT COMPLETED|Stable Dose||2
11388011|NCT03533114|12581854|FG001|NOT COMPLETED|Stable Dose||2
11388012|NCT03533114|12581853|FG000|STARTED|Double Blind Randomized-Withdrawal||69
11388013|NCT03533114|12581854|FG001|STARTED|Double Blind Randomized-Withdrawal||47
11388014|NCT03533114|12581853|FG000|JZP-258|Double Blind Randomized-Withdrawal||57
11388015|NCT03533114|12581854|FG001|JZP-258|Double Blind Randomized-Withdrawal||0
11388016|NCT03533114|12581853|FG000|Placebo|Double Blind Randomized-Withdrawal||0
11388017|NCT03533114|12581854|FG001|Placebo|Double Blind Randomized-Withdrawal||59
11388018|NCT03533114|12581853|FG000|COMPLETED|Double Blind Randomized-Withdrawal||67
11388019|NCT03533114|12581854|FG001|COMPLETED|Double Blind Randomized-Withdrawal||46
11388020|NCT03533114|12581853|FG000|NOT COMPLETED|Double Blind Randomized-Withdrawal||2
11388021|NCT03533114|12581854|FG001|NOT COMPLETED|Double Blind Randomized-Withdrawal||1
11388022|NCT03533114|12581853|FG000|STARTED|Open-Label Safety Extension||65
11388023|NCT03533114|12581854|FG001|STARTED|Open-Label Safety Extension||41
11388024|NCT03533114|12581853|FG000|COMPLETED|Open-Label Safety Extension||57
11388025|NCT03533114|12581854|FG001|COMPLETED|Open-Label Safety Extension||38
11388026|NCT03533114|12581853|FG000|NOT COMPLETED|Open-Label Safety Extension||8
11388027|NCT03533114|12581854|FG001|NOT COMPLETED|Open-Label Safety Extension||3
11388028|NCT03533244|12581865|FG000|STARTED|Overall Study||20
11388029|NCT03533244|12581866|FG001|STARTED|Overall Study||22
11388030|NCT03533244|12581867|FG002|STARTED|Overall Study||22
11006119|NCT00726622|12183881|FG000|NOT COMPLETED|Overall Study||18
11006120|NCT00726622|12183882|FG001|NOT COMPLETED|Overall Study||3
11006121|NCT00726661|12183890|FG000|STARTED|Overall Study||832
11006122|NCT00726661|12183891|FG001|STARTED|Overall Study||435
11006123|NCT00726661|12183890|FG000|COMPLETED|Overall Study||18
11006124|NCT00726661|12183891|FG001|COMPLETED|Overall Study||17
11388031|NCT03533244|12581865|FG000|COMPLETED|Overall Study||18
11388032|NCT03533244|12581866|FG001|COMPLETED|Overall Study||21
11388033|NCT03533244|12581867|FG002|COMPLETED|Overall Study||22
11388034|NCT03533244|12581865|FG000|NOT COMPLETED|Overall Study||2
11388035|NCT03533244|12581866|FG001|NOT COMPLETED|Overall Study||1
11388036|NCT03533244|12581867|FG002|NOT COMPLETED|Overall Study||0
11388037|NCT03533374|12581877|FG000|STARTED|Overall Study||54
11388038|NCT03533374|12581878|FG001|STARTED|Overall Study||46
11006125|NCT00726661|12183890|FG000|NOT COMPLETED|Overall Study||814
11006126|NCT00726661|12183891|FG001|NOT COMPLETED|Overall Study||418
11006127|NCT00726713|12183900|FG000|STARTED|Overall Study||106
11006128|NCT00726713|12183901|FG001|STARTED|Overall Study||108
11388039|NCT03533374|12581877|FG000|COMPLETED|Overall Study||54
11388040|NCT03533374|12581878|FG001|COMPLETED|Overall Study||46
11388041|NCT03533374|12581877|FG000|NOT COMPLETED|Overall Study||0
11388042|NCT03533374|12581878|FG001|NOT COMPLETED|Overall Study||0
11388043|NCT03533608|12581884|FG000|STARTED|Overall Study||39
11388044|NCT03533608|12581884|FG000|COMPLETED|Overall Study||34
11388045|NCT03533608|12581884|FG000|NOT COMPLETED|Overall Study||5
11388046|NCT03533829|12581892|FG000|STARTED|Overall Study||10
11388047|NCT03533829|12581893|FG001|STARTED|Overall Study||10
11388048|NCT03533829|12581894|FG002|STARTED|Overall Study||10
11388049|NCT03533829|12581892|FG000|COMPLETED|Overall Study||10
11388050|NCT03533829|12581893|FG001|COMPLETED|Overall Study||10
11388051|NCT03533829|12581894|FG002|COMPLETED|Overall Study||10
11388052|NCT03533829|12581892|FG000|NOT COMPLETED|Overall Study||0
11388053|NCT03533829|12581893|FG001|NOT COMPLETED|Overall Study||0
11388054|NCT03533829|12581894|FG002|NOT COMPLETED|Overall Study||0
11388055|NCT03534427|12581904|FG000|STARTED|Overall Study||20
11388056|NCT03534427|12581905|FG001|STARTED|Overall Study||20
11388057|NCT03534427|12581904|FG000|COMPLETED|Overall Study||20
11388058|NCT03534427|12581905|FG001|COMPLETED|Overall Study||20
11388059|NCT03534427|12581904|FG000|NOT COMPLETED|Overall Study||0
11388060|NCT03534427|12581905|FG001|NOT COMPLETED|Overall Study||0
11388061|NCT03534986|12581914|FG000|STARTED|Overall Study||10
11388062|NCT03534986|12581915|FG001|STARTED|Overall Study||10
11388063|NCT03534986|12581916|FG002|STARTED|Overall Study||12
11388064|NCT03534986|12581914|FG000|COMPLETED|Overall Study||10
11388065|NCT03534986|12581915|FG001|COMPLETED|Overall Study||10
11388066|NCT03534986|12581916|FG002|COMPLETED|Overall Study||10
11388067|NCT03534986|12581914|FG000|NOT COMPLETED|Overall Study||0
11388068|NCT03534986|12581915|FG001|NOT COMPLETED|Overall Study||0
11388069|NCT03534986|12581916|FG002|NOT COMPLETED|Overall Study||2
11388070|NCT03535194|12581929|FG000|STARTED|Induction Period||454
11388071|NCT03535194|12581930|FG001|STARTED|Induction Period||451
11388072|NCT03535194|12581931|FG002|STARTED|Induction Period||112
11388073|NCT03535194|12581932|FG003|STARTED|Induction Period||448
11388074|NCT03535194|12581933|FG004|STARTED|Induction Period|A plaque psoriasis participant was misrandomized by the site.|19
11388075|NCT03535194|12581929|FG000|Received at Least One Dose of Study Drug|Induction Period||454
11388076|NCT03535194|12581930|FG001|Received at Least One Dose of Study Drug|Induction Period||450
11388077|NCT03535194|12581931|FG002|Received at Least One Dose of Study Drug|Induction Period||112
11388078|NCT03535194|12581932|FG003|Received at Least One Dose of Study Drug|Induction Period||448
11388079|NCT03535194|12581933|FG004|Received at Least One Dose of Study Drug|Induction Period||19
11388080|NCT03535194|12581929|FG000|COMPLETED|Induction Period||443
11388081|NCT03535194|12581930|FG001|COMPLETED|Induction Period||434
11388082|NCT03535194|12581931|FG002|COMPLETED|Induction Period||104
11388083|NCT03535194|12581932|FG003|COMPLETED|Induction Period||437
11388084|NCT03535194|12581933|FG004|COMPLETED|Induction Period||19
11388085|NCT03535194|12581929|FG000|NOT COMPLETED|Induction Period||11
11388086|NCT03535194|12581930|FG001|NOT COMPLETED|Induction Period||17
11388087|NCT03535194|12581931|FG002|NOT COMPLETED|Induction Period||8
11388088|NCT03535194|12581932|FG003|NOT COMPLETED|Induction Period||11
11388089|NCT03535194|12581933|FG004|NOT COMPLETED|Induction Period||0
11388090|NCT03535194|12581929|FG000|STARTED|Maintenance Period||443
11388091|NCT03535194|12581930|FG001|STARTED|Maintenance Period||434
11388092|NCT03535194|12581931|FG002|STARTED|Maintenance Period||104
11388093|NCT03535194|12581932|FG003|STARTED|Maintenance Period||437
11388094|NCT03535194|12581933|FG004|STARTED|Maintenance Period||19
11388095|NCT03535194|12581929|FG000|COMPLETED|Maintenance Period||421
11388096|NCT03535194|12581930|FG001|COMPLETED|Maintenance Period||418
11388097|NCT03535194|12581931|FG002|COMPLETED|Maintenance Period||96
11388098|NCT03535194|12581932|FG003|COMPLETED|Maintenance Period||400
11006129|NCT00726713|12183900|FG000|COMPLETED|Overall Study||99
11006130|NCT00726713|12183901|FG001|COMPLETED|Overall Study||101
11006131|NCT00726713|12183900|FG000|NOT COMPLETED|Overall Study||7
11006132|NCT00726713|12183901|FG001|NOT COMPLETED|Overall Study||7
11006133|NCT00726739|12183910|FG000|STARTED|Overall Study||11
11006134|NCT00726739|12183911|FG001|STARTED|Overall Study||10
11006135|NCT00726739|12183910|FG000|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
11006136|NCT00726739|12183911|FG001|COMPLETED|Overall Study||10
11006137|NCT00726739|12183910|FG000|NOT COMPLETED|Overall Study||1
11006138|NCT00726739|12183911|FG001|NOT COMPLETED|Overall Study||0
11006139|NCT00726752|12183918|FG000|STARTED|Overall Study||6
11388099|NCT03535194|12581933|FG004|COMPLETED|Maintenance Period||13
11388100|NCT03535194|12581929|FG000|NOT COMPLETED|Maintenance Period||22
11388101|NCT03535194|12581930|FG001|NOT COMPLETED|Maintenance Period||16
11388102|NCT03535194|12581931|FG002|NOT COMPLETED|Maintenance Period||8
11388103|NCT03535194|12581932|FG003|NOT COMPLETED|Maintenance Period||37
11388104|NCT03535194|12581933|FG004|NOT COMPLETED|Maintenance Period||6
11388105|NCT03535194|12581929|FG000|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|38
11388106|NCT03535194|12581930|FG001|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|35
11388107|NCT03535194|12581931|FG002|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|18
11388108|NCT03535194|12581932|FG003|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|47
11388109|NCT03535194|12581933|FG004|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|8
11388110|NCT03535194|12581929|FG000|COMPLETED|Post-Treatment Followup Period||27
11388111|NCT03535194|12581930|FG001|COMPLETED|Post-Treatment Followup Period||21
11388112|NCT03535194|12581931|FG002|COMPLETED|Post-Treatment Followup Period||7
11388113|NCT03535194|12581932|FG003|COMPLETED|Post-Treatment Followup Period||23
11388114|NCT03535194|12581933|FG004|COMPLETED|Post-Treatment Followup Period||8
11388115|NCT03535194|12581929|FG000|NOT COMPLETED|Post-Treatment Followup Period||11
11388116|NCT03535194|12581930|FG001|NOT COMPLETED|Post-Treatment Followup Period||14
11388117|NCT03535194|12581931|FG002|NOT COMPLETED|Post-Treatment Followup Period||11
11388118|NCT03535194|12581932|FG003|NOT COMPLETED|Post-Treatment Followup Period||24
11388119|NCT03535194|12581933|FG004|NOT COMPLETED|Post-Treatment Followup Period||0
11388120|NCT03535571|12581957|FG000|STARTED|Overall Study||20
11006140|NCT00726752|12183918|FG000|COMPLETED|Overall Study||0
11006141|NCT00726752|12183918|FG000|NOT COMPLETED|Overall Study||6
11006142|NCT00726882|12183922|FG000|STARTED|Overall Study||35
11006143|NCT00726882|12183922|FG000|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
11056465|NCT00994214|12238017|FG001|COMPLETED|ITT (Intention-to-Treat) - Part B||0
11388121|NCT03535571|12581957|FG000|COMPLETED|Overall Study||19
11388122|NCT03535571|12581957|FG000|NOT COMPLETED|Overall Study||1
11388123|NCT03535649|12581963|FG000|STARTED|Overall Study||105
11388124|NCT03535649|12581963|FG000|COMPLETED|Overall Study||105
11388125|NCT03535649|12581963|FG000|NOT COMPLETED|Overall Study||0
11388126|NCT03535844|12581969|FG000|STARTED|Overall Study||22
11388127|NCT03535844|12581970|FG001|STARTED|Overall Study||19
11388128|NCT03535844|12581969|FG000|COMPLETED|Overall Study||22
11388129|NCT03535844|12581970|FG001|COMPLETED|Overall Study||18
11388130|NCT03535844|12581969|FG000|NOT COMPLETED|Overall Study||0
11388131|NCT03535844|12581970|FG001|NOT COMPLETED|Overall Study||1
11388132|NCT03535974|12581979|FG000|STARTED|First Intervention Weeks 0-6 (V1-V2)||14
11388133|NCT03535974|12581980|FG001|STARTED|First Intervention Weeks 0-6 (V1-V2)||19
11388134|NCT03535974|12581981|FG002|STARTED|First Intervention Weeks 0-6 (V1-V2)||5
11388135|NCT03535974|12581979|FG000|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||12
11388136|NCT03535974|12581980|FG001|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||17
11388137|NCT03535974|12581981|FG002|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||5
11388138|NCT03535974|12581979|FG000|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
11388139|NCT03535974|12581980|FG001|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
11388140|NCT03535974|12581981|FG002|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||0
11388141|NCT03535974|12581979|FG000|STARTED|Second Intervention Weeks 6-12 (V2-V3)||12
11388142|NCT03535974|12581980|FG001|STARTED|Second Intervention Weeks 6-12 (V2-V3)||17
11388143|NCT03535974|12581981|FG002|STARTED|Second Intervention Weeks 6-12 (V2-V3)||5
11388144|NCT03535974|12581979|FG000|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||12
11388145|NCT03535974|12581980|FG001|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||17
11388146|NCT03535974|12581981|FG002|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||5
11388147|NCT03535974|12581979|FG000|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
11388148|NCT03535974|12581980|FG001|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
11388149|NCT03535974|12581981|FG002|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
11388150|NCT03536663|12581989|FG000|STARTED|Optiflux||23
11388151|NCT03536663|12581989|FG000|COMPLETED|Optiflux||19
11388152|NCT03536663|12581989|FG000|NOT COMPLETED|Optiflux||4
11388153|NCT03536663|12581989|FG000|STARTED|Endexo|One subject completed the Optiflux period but missed Visit 13 and was withdrawn per protocol.|18
11388154|NCT03536663|12581989|FG000|COMPLETED|Endexo||17
11388155|NCT03536663|12581989|FG000|NOT COMPLETED|Endexo||1
11388156|NCT03536702|12582000|FG000|STARTED|Overall Study||40
11388157|NCT03536702|12582001|FG001|STARTED|Overall Study||20
11388158|NCT03536702|12582000|FG000|COMPLETED|Overall Study||26
11388159|NCT03536702|12582001|FG001|COMPLETED|Overall Study||8
11388160|NCT03536702|12582000|FG000|NOT COMPLETED|Overall Study||14
11388161|NCT03536702|12582001|FG001|NOT COMPLETED|Overall Study||12
11388162|NCT03536819|12582007|FG000|STARTED|Overall Study||20
11388163|NCT03536819|12582007|FG000|COMPLETED|Overall Study||15
11388164|NCT03536819|12582007|FG000|NOT COMPLETED|Overall Study||5
11388165|NCT03536923|12582011|FG000|STARTED|Overall Study||23
11388166|NCT03536923|12582011|FG000|COMPLETED|Overall Study||23
11388167|NCT03536923|12582011|FG000|NOT COMPLETED|Overall Study||0
11388168|NCT03536949|12582017|FG000|STARTED|Overall Study||157
11388169|NCT03536949|12582018|FG001|STARTED|Overall Study||77
11388170|NCT03536949|12582017|FG000|COMPLETED|Overall Study||143
11388171|NCT03536949|12582018|FG001|COMPLETED|Overall Study||75
11388172|NCT03536949|12582017|FG000|NOT COMPLETED|Overall Study||14
11388173|NCT03536949|12582018|FG001|NOT COMPLETED|Overall Study||2
11388174|NCT03537092|12582024|FG000|STARTED|Overall Study||64
11388175|NCT03537092|12582024|FG000|COMPLETED|Overall Study||64
11388176|NCT03537092|12582024|FG000|NOT COMPLETED|Overall Study||0
11388177|NCT03537261|12582030|FG000|STARTED|Overall Study||41
11388178|NCT03537261|12582031|FG001|STARTED|Overall Study||39
11388179|NCT03537261|12582030|FG000|Completed Baseline Assessment|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|35
11388180|NCT03537261|12582031|FG001|Completed Baseline Assessment|Overall Study||28
11388181|NCT03537261|12582030|FG000|COMPLETED|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|33
11388182|NCT03537261|12582031|FG001|COMPLETED|Overall Study||27
11388183|NCT03537261|12582030|FG000|NOT COMPLETED|Overall Study||8
11388184|NCT03537261|12582031|FG001|NOT COMPLETED|Overall Study||12
11388185|NCT03537274|12582041|FG000|STARTED|Overall Study||315
11388186|NCT03537274|12582042|FG001|STARTED|Overall Study||298
11388187|NCT03537274|12582043|FG002|STARTED|Overall Study||304
11388188|NCT03537274|12582044|FG003|STARTED|Overall Study||307
11388189|NCT03537274|12582041|FG000|Treated|Overall Study||315
11388190|NCT03537274|12582042|FG001|Treated|Overall Study||297
11388191|NCT03537274|12582043|FG002|Treated|Overall Study||304
11388192|NCT03537274|12582044|FG003|Treated|Overall Study||303
11388193|NCT03537274|12582041|FG000|COMPLETED|Overall Study||255
11388194|NCT03537274|12582042|FG001|COMPLETED|Overall Study||229
11388195|NCT03537274|12582043|FG002|COMPLETED|Overall Study||228
11388196|NCT03537274|12582044|FG003|COMPLETED|Overall Study||231
11388197|NCT03537274|12582041|FG000|NOT COMPLETED|Overall Study||60
11388198|NCT03537274|12582042|FG001|NOT COMPLETED|Overall Study||69
11388199|NCT03537274|12582043|FG002|NOT COMPLETED|Overall Study||76
11388200|NCT03537274|12582044|FG003|NOT COMPLETED|Overall Study||76
11388201|NCT03537404|12582057|FG000|STARTED|First Intervention (A or B or C)||18
11388202|NCT03537404|12582058|FG001|STARTED|First Intervention (A or B or C)||18
11388203|NCT03537404|12582057|FG000|COMPLETED|First Intervention (A or B or C)||18
11388204|NCT03537404|12582058|FG001|COMPLETED|First Intervention (A or B or C)||18
11388205|NCT03537404|12582057|FG000|NOT COMPLETED|First Intervention (A or B or C)||0
11388206|NCT03537404|12582058|FG001|NOT COMPLETED|First Intervention (A or B or C)||0
11388207|NCT03537404|12582057|FG000|STARTED|First Washout Period (8 Days)||18
11388208|NCT03537404|12582058|FG001|STARTED|First Washout Period (8 Days)||18
11388209|NCT03537404|12582057|FG000|COMPLETED|First Washout Period (8 Days)||18
11388210|NCT03537404|12582058|FG001|COMPLETED|First Washout Period (8 Days)||18
11388211|NCT03537404|12582057|FG000|NOT COMPLETED|First Washout Period (8 Days)||0
11388212|NCT03537404|12582058|FG001|NOT COMPLETED|First Washout Period (8 Days)||0
11388213|NCT03537404|12582057|FG000|STARTED|Second Intervention (A or B or C)||18
11388214|NCT03537404|12582058|FG001|STARTED|Second Intervention (A or B or C)||18
11388215|NCT03537404|12582057|FG000|COMPLETED|Second Intervention (A or B or C)||18
11388216|NCT03537404|12582058|FG001|COMPLETED|Second Intervention (A or B or C)||18
11388217|NCT03537404|12582057|FG000|NOT COMPLETED|Second Intervention (A or B or C)||0
11388218|NCT03537404|12582058|FG001|NOT COMPLETED|Second Intervention (A or B or C)||0
11388219|NCT03537404|12582057|FG000|STARTED|Second Washout Period (8 Days)||18
11388220|NCT03537404|12582058|FG001|STARTED|Second Washout Period (8 Days)||18
11388221|NCT03537404|12582057|FG000|COMPLETED|Second Washout Period (8 Days)||18
11388222|NCT03537404|12582058|FG001|COMPLETED|Second Washout Period (8 Days)||18
11388223|NCT03537404|12582057|FG000|NOT COMPLETED|Second Washout Period (8 Days)||0
11388224|NCT03537404|12582058|FG001|NOT COMPLETED|Second Washout Period (8 Days)||0
11388225|NCT03537404|12582057|FG000|STARTED|Third Intervention (A or B or C)||18
11388226|NCT03537404|12582058|FG001|STARTED|Third Intervention (A or B or C)||18
11388227|NCT03537404|12582057|FG000|COMPLETED|Third Intervention (A or B or C)||18
11388228|NCT03537404|12582058|FG001|COMPLETED|Third Intervention (A or B or C)||18
11388229|NCT03537404|12582057|FG000|NOT COMPLETED|Third Intervention (A or B or C)||0
11388230|NCT03537404|12582058|FG001|NOT COMPLETED|Third Intervention (A or B or C)||0
11388231|NCT03537651|12582082|FG000|STARTED|Overall Study||130
11388232|NCT03537651|12582082|FG000|113B/116 FAS|Overall Study||64
11388233|NCT03537651|12582082|FG000|113B/116 LCI FAS|Overall Study||30
11388234|NCT03537651|12582082|FG000|115/116 FAS|Overall Study||66
11388235|NCT03537651|12582082|FG000|115/116 FAS (TEZ/IVA Group)|Overall Study||53
11388236|NCT03537651|12582082|FG000|COMPLETED|Overall Study||69
11388237|NCT03537651|12582082|FG000|NOT COMPLETED|Overall Study||61
11388238|NCT03537664|12582089|FG000|STARTED|Overall Study||20
11388239|NCT03537664|12582090|FG001|STARTED|Overall Study||25
11388240|NCT03537664|12582089|FG000|Metabolic Activity of Bacteria|Overall Study|5 patients were excluded from metabolic activity analysis (lost of RNA)|15
11388241|NCT03537664|12582090|FG001|Metabolic Activity of Bacteria|Overall Study||25
11388242|NCT03537664|12582089|FG000|Bacterial Levels|Overall Study||20
11388243|NCT03537664|12582090|FG001|Bacterial Levels|Overall Study||25
11388244|NCT03537664|12582089|FG000|Bacterial Community Diversity|Overall Study||10
11388245|NCT03537664|12582090|FG001|Bacterial Community Diversity|Overall Study||0
11388246|NCT03537664|12582089|FG000|Endodontic Success|Overall Study||20
11388247|NCT03537664|12582090|FG001|Endodontic Success|Overall Study||10
11388248|NCT03537664|12582089|FG000|COMPLETED|Overall Study||20
11388249|NCT03537664|12582090|FG001|COMPLETED|Overall Study||25
11388250|NCT03537664|12582089|FG000|NOT COMPLETED|Overall Study||0
11388251|NCT03537664|12582090|FG001|NOT COMPLETED|Overall Study||0
11388252|NCT03538431|12582101|FG000|STARTED|Overall Study||13
11388253|NCT03538431|12582102|FG001|STARTED|Overall Study||13
11388254|NCT03538431|12582101|FG000|COMPLETED|Overall Study||12
11388255|NCT03538431|12582102|FG001|COMPLETED|Overall Study||12
11388256|NCT03538431|12582101|FG000|NOT COMPLETED|Overall Study||1
11388257|NCT03538431|12582102|FG001|NOT COMPLETED|Overall Study||1
11388258|NCT03538678|12582112|FG000|STARTED|Overall Study||20
11388259|NCT03538678|12582113|FG001|STARTED|Overall Study||20
11388260|NCT03538678|12582112|FG000|COMPLETED|Overall Study||5
11388261|NCT03538678|12582113|FG001|COMPLETED|Overall Study||9
11388262|NCT03538678|12582112|FG000|NOT COMPLETED|Overall Study||15
11388263|NCT03538678|12582113|FG001|NOT COMPLETED|Overall Study||11
11388264|NCT03538743|12582128|FG000|STARTED|Overall Study||25
11388265|NCT03538743|12582129|FG001|STARTED|Overall Study||9
11388266|NCT03538743|12582130|FG002|STARTED|Overall Study||9
11388267|NCT03538743|12582131|FG003|STARTED|Overall Study||10
11388268|NCT03538743|12582132|FG004|STARTED|Overall Study||9
11388269|NCT03538743|12582133|FG005|STARTED|Overall Study||9
11388270|NCT03538743|12582134|FG006|STARTED|Overall Study||9
11388271|NCT03538743|12582135|FG007|STARTED|Overall Study||8
11388272|NCT03538743|12582136|FG008|STARTED|Overall Study||10
11388273|NCT03538743|12582128|FG000|Received Treatment|Overall Study||25
11388274|NCT03538743|12582129|FG001|Received Treatment|Overall Study||9
11388275|NCT03538743|12582130|FG002|Received Treatment|Overall Study||9
11388276|NCT03538743|12582131|FG003|Received Treatment|Overall Study||10
11388277|NCT03538743|12582132|FG004|Received Treatment|Overall Study||9
11388278|NCT03538743|12582133|FG005|Received Treatment|Overall Study||9
11388279|NCT03538743|12582134|FG006|Received Treatment|Overall Study||9
11388280|NCT03538743|12582135|FG007|Received Treatment|Overall Study||8
11388281|NCT03538743|12582136|FG008|Received Treatment|Overall Study||10
11388282|NCT03538743|12582128|FG000|COMPLETED|Overall Study||25
11388283|NCT03538743|12582129|FG001|COMPLETED|Overall Study||9
11388284|NCT03538743|12582130|FG002|COMPLETED|Overall Study||8
11388285|NCT03538743|12582131|FG003|COMPLETED|Overall Study||8
11388286|NCT03538743|12582132|FG004|COMPLETED|Overall Study||9
11388287|NCT03538743|12582133|FG005|COMPLETED|Overall Study||9
11388288|NCT03538743|12582134|FG006|COMPLETED|Overall Study||9
11388289|NCT03538743|12582135|FG007|COMPLETED|Overall Study||8
11388290|NCT03538743|12582136|FG008|COMPLETED|Overall Study||7
11388291|NCT03538743|12582128|FG000|NOT COMPLETED|Overall Study||0
11388292|NCT03538743|12582129|FG001|NOT COMPLETED|Overall Study||0
11388293|NCT03538743|12582130|FG002|NOT COMPLETED|Overall Study||1
11388294|NCT03538743|12582131|FG003|NOT COMPLETED|Overall Study||2
11388295|NCT03538743|12582132|FG004|NOT COMPLETED|Overall Study||0
11388296|NCT03538743|12582133|FG005|NOT COMPLETED|Overall Study||0
11388297|NCT03538743|12582134|FG006|NOT COMPLETED|Overall Study||0
11388298|NCT03538743|12582135|FG007|NOT COMPLETED|Overall Study||0
11388299|NCT03538743|12582136|FG008|NOT COMPLETED|Overall Study||3
11388300|NCT03538795|12582164|FG000|STARTED|Overall Study||3
11388301|NCT03538795|12582164|FG000|COMPLETED|Overall Study||3
11388302|NCT03538795|12582164|FG000|NOT COMPLETED|Overall Study||0
11388303|NCT03538808|12582172|FG000|STARTED|Overall Study||20
11388304|NCT03538808|12582173|FG001|STARTED|Overall Study||20
11388305|NCT03538808|12582174|FG002|STARTED|Overall Study||20
11388306|NCT03538808|12582175|FG003|STARTED|Overall Study||20
11388307|NCT03538808|12582172|FG000|COMPLETED|Overall Study||18
11388308|NCT03538808|12582173|FG001|COMPLETED|Overall Study||20
11388309|NCT03538808|12582174|FG002|COMPLETED|Overall Study||16
11388310|NCT03538808|12582175|FG003|COMPLETED|Overall Study||18
11388311|NCT03538808|12582172|FG000|NOT COMPLETED|Overall Study||2
11388312|NCT03538808|12582173|FG001|NOT COMPLETED|Overall Study||0
11388313|NCT03538808|12582174|FG002|NOT COMPLETED|Overall Study||4
11388314|NCT03538808|12582175|FG003|NOT COMPLETED|Overall Study||2
11388315|NCT03539211|12582187|FG000|STARTED|Overall Study||16
11388316|NCT03539211|12582188|FG001|STARTED|Overall Study||15
11388317|NCT03539211|12582187|FG000|COMPLETED|Overall Study||16
11388318|NCT03539211|12582188|FG001|COMPLETED|Overall Study||15
11388319|NCT03539211|12582187|FG000|NOT COMPLETED|Overall Study||0
11388320|NCT03539211|12582188|FG001|NOT COMPLETED|Overall Study||0
11388321|NCT03539432|12582196|FG000|STARTED|Overall Study||2
11388322|NCT03539432|12582197|FG001|STARTED|Overall Study||1
11388323|NCT03539432|12582196|FG000|COMPLETED|Overall Study||2
11388324|NCT03539432|12582197|FG001|COMPLETED|Overall Study||0
11388325|NCT03539432|12582196|FG000|NOT COMPLETED|Overall Study||0
11388326|NCT03539432|12582197|FG001|NOT COMPLETED|Overall Study||1
11388327|NCT03539484|12582210|FG000|STARTED|Overall Study||1
11388328|NCT03539484|12582211|FG001|STARTED|Overall Study||1
11388329|NCT03539484|12582212|FG002|STARTED|Overall Study||1
11388330|NCT03539484|12582213|FG003|STARTED|Overall Study||3
11388331|NCT03539484|12582214|FG004|STARTED|Overall Study||13
11388332|NCT03539484|12582215|FG005|STARTED|Overall Study||5
11388333|NCT03539484|12582216|FG006|STARTED|Overall Study||2
11388334|NCT03539484|12582210|FG000|COMPLETED|Overall Study||0
11388335|NCT03539484|12582211|FG001|COMPLETED|Overall Study||0
11388336|NCT03539484|12582212|FG002|COMPLETED|Overall Study||0
11388337|NCT03539484|12582213|FG003|COMPLETED|Overall Study||0
11388338|NCT03539484|12582214|FG004|COMPLETED|Overall Study||0
11388339|NCT03539484|12582215|FG005|COMPLETED|Overall Study||0
11388340|NCT03539484|12582216|FG006|COMPLETED|Overall Study||0
11388341|NCT03539484|12582210|FG000|NOT COMPLETED|Overall Study||1
11388342|NCT03539484|12582211|FG001|NOT COMPLETED|Overall Study||1
11388343|NCT03539484|12582212|FG002|NOT COMPLETED|Overall Study||1
11388344|NCT03539484|12582213|FG003|NOT COMPLETED|Overall Study||3
11388345|NCT03539484|12582214|FG004|NOT COMPLETED|Overall Study||13
11388346|NCT03539484|12582215|FG005|NOT COMPLETED|Overall Study||5
11388347|NCT03539484|12582216|FG006|NOT COMPLETED|Overall Study||2
11388348|NCT03539549|12582237|FG000|STARTED|Overall Study||123
11388349|NCT03539549|12582237|FG000|COMPLETED|Overall Study||106
11388350|NCT03539549|12582237|FG000|NOT COMPLETED|Overall Study||17
11388351|NCT03540030|12582243|FG000|STARTED|Overall Study||48
11388352|NCT03540030|12582244|FG001|STARTED|Overall Study||38
11388353|NCT03540030|12582243|FG000|COMPLETED|Overall Study||30
11388354|NCT03540030|12582244|FG001|COMPLETED|Overall Study||35
11388355|NCT03540030|12582243|FG000|NOT COMPLETED|Overall Study||18
11388356|NCT03540030|12582244|FG001|NOT COMPLETED|Overall Study||3
11388357|NCT03540134|12582250|FG000|STARTED|Overall Study||4
11388358|NCT03540134|12582250|FG000|COMPLETED|Overall Study||4
11388359|NCT03540134|12582250|FG000|NOT COMPLETED|Overall Study||0
11388360|NCT03540147|12582254|FG000|STARTED|Overall Study||20
11388361|NCT03540147|12582254|FG000|COMPLETED|Overall Study||20
11388362|NCT03540147|12582254|FG000|NOT COMPLETED|Overall Study||0
11388363|NCT03540160|12582266|FG000|STARTED|Overall Study||558
11388364|NCT03540160|12582266|FG000|COMPLETED|Overall Study||179
11388365|NCT03540160|12582266|FG000|NOT COMPLETED|Overall Study||379
11388366|NCT03541044|12582270|FG000|STARTED|Study Period 1: Up to Day 1||23
11388367|NCT03541044|12582271|FG001|STARTED|Study Period 1: Up to Day 1||23
11388368|NCT03541044|12582270|FG000|COMPLETED|Study Period 1: Up to Day 1||23
11388369|NCT03541044|12582271|FG001|COMPLETED|Study Period 1: Up to Day 1||23
11388370|NCT03541044|12582270|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0
11388371|NCT03541044|12582271|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0
11388372|NCT03541044|12582270|FG000|STARTED|Washout Period: 5 to 7 Days||23
11388373|NCT03541044|12582271|FG001|STARTED|Washout Period: 5 to 7 Days||23
11388374|NCT03541044|12582270|FG000|COMPLETED|Washout Period: 5 to 7 Days||23
11388375|NCT03541044|12582271|FG001|COMPLETED|Washout Period: 5 to 7 Days||23
11388376|NCT03541044|12582270|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0
11388377|NCT03541044|12582271|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0
11388378|NCT03541044|12582270|FG000|STARTED|Study Period 2: Up to Day 8||23
11388379|NCT03541044|12582271|FG001|STARTED|Study Period 2: Up to Day 8||23
11388380|NCT03541044|12582270|FG000|COMPLETED|Study Period 2: Up to Day 8||21
11388381|NCT03541044|12582271|FG001|COMPLETED|Study Period 2: Up to Day 8||23
11388382|NCT03541044|12582270|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2
11388383|NCT03541044|12582271|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||0
11388384|NCT03541356|12582284|FG000|STARTED|Overall Study||8
11388385|NCT03541356|12582285|FG001|STARTED|Overall Study||6
11388386|NCT03541356|12582286|FG002|STARTED|Overall Study||6
11388387|NCT03541356|12582287|FG003|STARTED|Overall Study||6
11388388|NCT03541356|12582288|FG004|STARTED|Overall Study||6
11388389|NCT03541356|12582284|FG000|COMPLETED|Overall Study||8
11388390|NCT03541356|12582285|FG001|COMPLETED|Overall Study||6
11388391|NCT03541356|12582286|FG002|COMPLETED|Overall Study||6
11388392|NCT03541356|12582287|FG003|COMPLETED|Overall Study||6
11388393|NCT03541356|12582288|FG004|COMPLETED|Overall Study||6
11388394|NCT03541356|12582284|FG000|NOT COMPLETED|Overall Study||0
11388395|NCT03541356|12582285|FG001|NOT COMPLETED|Overall Study||0
11388396|NCT03541356|12582286|FG002|NOT COMPLETED|Overall Study||0
11388397|NCT03541356|12582287|FG003|NOT COMPLETED|Overall Study||0
11388398|NCT03541356|12582288|FG004|NOT COMPLETED|Overall Study||0
11388399|NCT03541941|12582308|FG000|STARTED|Overall Study||57
11388400|NCT03541941|12582309|FG001|STARTED|Overall Study||55
11388401|NCT03541941|12582310|FG002|STARTED|Overall Study||52
11388402|NCT03541941|12582308|FG000|COMPLETED|Overall Study||57
11388403|NCT03541941|12582309|FG001|COMPLETED|Overall Study||55
11388404|NCT03541941|12582310|FG002|COMPLETED|Overall Study||52
11388405|NCT03541941|12582308|FG000|NOT COMPLETED|Overall Study||0
11388406|NCT03541941|12582309|FG001|NOT COMPLETED|Overall Study||0
11388407|NCT03541941|12582310|FG002|NOT COMPLETED|Overall Study||0
11388408|NCT03541980|12582320|FG000|STARTED|Overall Study||35
11388409|NCT03541980|12582321|FG001|STARTED|Overall Study||36
11388410|NCT03541980|12582320|FG000|COMPLETED|Overall Study||35
11388411|NCT03541980|12582321|FG001|COMPLETED|Overall Study||36
11388412|NCT03541980|12582320|FG000|NOT COMPLETED|Overall Study||0
11388413|NCT03541980|12582321|FG001|NOT COMPLETED|Overall Study||0
11388414|NCT03542019|12582336|FG000|STARTED|Overall Study||20
11388415|NCT03542019|12582337|FG001|STARTED|Overall Study||20
11388416|NCT03542019|12582338|FG002|STARTED|Overall Study||20
11388417|NCT03542019|12582336|FG000|COMPLETED|Overall Study||19
11388418|NCT03542019|12582337|FG001|COMPLETED|Overall Study||17
11388419|NCT03542019|12582338|FG002|COMPLETED|Overall Study||19
11388420|NCT03542019|12582336|FG000|NOT COMPLETED|Overall Study||1
11388421|NCT03542019|12582337|FG001|NOT COMPLETED|Overall Study||3
11388422|NCT03542019|12582338|FG002|NOT COMPLETED|Overall Study||1
11388423|NCT03542305|12582350|FG000|STARTED|Overall Study||8
11388424|NCT03542305|12582351|FG001|STARTED|Overall Study||8
11388425|NCT03542305|12582352|FG002|STARTED|Overall Study||8
11388426|NCT03542305|12582353|FG003|STARTED|Overall Study||5
11388427|NCT03542305|12582350|FG000|COMPLETED|Overall Study||8
11388428|NCT03542305|12582351|FG001|COMPLETED|Overall Study||8
11388429|NCT03542305|12582352|FG002|COMPLETED|Overall Study||8
11388430|NCT03542305|12582353|FG003|COMPLETED|Overall Study||5
11388431|NCT03542305|12582350|FG000|NOT COMPLETED|Overall Study||0
11388432|NCT03542305|12582351|FG001|NOT COMPLETED|Overall Study||0
11388433|NCT03542305|12582352|FG002|NOT COMPLETED|Overall Study||0
11388434|NCT03542305|12582353|FG003|NOT COMPLETED|Overall Study||0
11388435|NCT03542474|12582363|FG000|STARTED|Overall Study||8
11388436|NCT03542474|12582363|FG000|COMPLETED|Overall Study||8
11388437|NCT03542474|12582363|FG000|NOT COMPLETED|Overall Study||0
11388438|NCT03543085|12582367|FG000|STARTED|Overall Study||10
11388439|NCT03543085|12582367|FG000|COMPLETED|Overall Study||10
11388440|NCT03543085|12582367|FG000|NOT COMPLETED|Overall Study||0
11388441|NCT03543137|12582371|FG000|STARTED|Study Period 1: Up to Day 1||18
11388442|NCT03543137|12582372|FG001|STARTED|Study Period 1: Up to Day 1||19
11388443|NCT03543137|12582371|FG000|COMPLETED|Study Period 1: Up to Day 1||18
11388444|NCT03543137|12582372|FG001|COMPLETED|Study Period 1: Up to Day 1||19
11388445|NCT03543137|12582371|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0
11388446|NCT03543137|12582372|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0
11388447|NCT03543137|12582371|FG000|STARTED|Washout Period: 5 to 7 Days||18
11388448|NCT03543137|12582372|FG001|STARTED|Washout Period: 5 to 7 Days||19
11388449|NCT03543137|12582371|FG000|COMPLETED|Washout Period: 5 to 7 Days||18
11388450|NCT03543137|12582372|FG001|COMPLETED|Washout Period: 5 to 7 Days||19
11388451|NCT03543137|12582371|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0
11388452|NCT03543137|12582372|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0
11388453|NCT03543137|12582371|FG000|STARTED|Study Period 2: Up to Day 8||18
11388454|NCT03543137|12582372|FG001|STARTED|Study Period 2: Up to Day 8||19
11388455|NCT03543137|12582371|FG000|Treated|Study Period 2: Up to Day 8||16
11388456|NCT03543137|12582372|FG001|Treated|Study Period 2: Up to Day 8||18
11388457|NCT03543137|12582371|FG000|COMPLETED|Study Period 2: Up to Day 8||16
11388458|NCT03543137|12582372|FG001|COMPLETED|Study Period 2: Up to Day 8||18
11388459|NCT03543137|12582371|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2
11388460|NCT03543137|12582372|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||1
11388461|NCT03543176|12582382|FG000|STARTED|Overall Study||392
11388462|NCT03543176|12582383|FG001|STARTED|Overall Study||397
11388463|NCT03543176|12582382|FG000|COMPLETED|Overall Study||392
11388464|NCT03543176|12582383|FG001|COMPLETED|Overall Study||397
11388465|NCT03543176|12582382|FG000|NOT COMPLETED|Overall Study||0
11388466|NCT03543176|12582383|FG001|NOT COMPLETED|Overall Study||0
11388467|NCT03543878|12582391|FG000|STARTED|Overall Study||5
11388468|NCT03543878|12582392|FG001|STARTED|Overall Study||5
11388469|NCT03543878|12582391|FG000|COMPLETED|Overall Study||5
11388470|NCT03543878|12582392|FG001|COMPLETED|Overall Study||5
11388471|NCT03543878|12582391|FG000|NOT COMPLETED|Overall Study||0
11388472|NCT03543878|12582392|FG001|NOT COMPLETED|Overall Study||0
11388473|NCT03544216|12582401|FG000|STARTED|Overall Study||42
11388474|NCT03544216|12582402|FG001|STARTED|Overall Study||42
11388475|NCT03544216|12582401|FG000|COMPLETED|Overall Study||42
11388476|NCT03544216|12582402|FG001|COMPLETED|Overall Study||42
11388477|NCT03544216|12582401|FG000|NOT COMPLETED|Overall Study||0
11388478|NCT03544216|12582402|FG001|NOT COMPLETED|Overall Study||0
11388479|NCT03544307|12582411|FG000|STARTED|Overall Study||10
11388480|NCT03544307|12582412|FG001|STARTED|Overall Study||10
11388481|NCT03544307|12582411|FG000|COMPLETED|Overall Study||10
11388482|NCT03544307|12582412|FG001|COMPLETED|Overall Study||10
11388483|NCT03544307|12582411|FG000|NOT COMPLETED|Overall Study||0
11388484|NCT03544307|12582412|FG001|NOT COMPLETED|Overall Study||0
11388485|NCT03544333|12582420|FG000|STARTED|Overall Study||3
11388486|NCT03544333|12582421|FG001|STARTED|Overall Study||2
11388487|NCT03544333|12582420|FG000|COMPLETED|Overall Study||2
11388488|NCT03544333|12582421|FG001|COMPLETED|Overall Study||2
11388489|NCT03544333|12582420|FG000|NOT COMPLETED|Overall Study||1
11388490|NCT03544333|12582421|FG001|NOT COMPLETED|Overall Study||0
11388491|NCT03544879|12582429|FG000|STARTED|Overall Study||22
11388492|NCT03544879|12582430|FG001|STARTED|Overall Study||24
11388493|NCT03544879|12582429|FG000|Completed Follow-up Physical Assessment|Overall Study||20
11388494|NCT03544879|12582430|FG001|Completed Follow-up Physical Assessment|Overall Study||21
11388495|NCT03544879|12582429|FG000|COMPLETED|Overall Study||22
11388496|NCT03544879|12582430|FG001|COMPLETED|Overall Study||23
11388497|NCT03544879|12582429|FG000|NOT COMPLETED|Overall Study||0
11388498|NCT03544879|12582430|FG001|NOT COMPLETED|Overall Study||1
11388499|NCT03545165|12582438|FG000|STARTED|Overall Study||6
11388500|NCT03545165|12582438|FG000|COMPLETED|Overall Study||6
11388501|NCT03545165|12582438|FG000|NOT COMPLETED|Overall Study||0
11388502|NCT03545412|12582442|FG000|STARTED|Overall Study||25
11388503|NCT03545412|12582442|FG000|COMPLETED|Overall Study||25
11388504|NCT03545412|12582442|FG000|NOT COMPLETED|Overall Study||0
11388505|NCT03545503|12582448|FG000|STARTED|Overall Study||208
11388506|NCT03545503|12582449|FG001|STARTED|Overall Study||220
11388507|NCT03545503|12582448|FG000|COMPLETED|Overall Study||194
11388508|NCT03545503|12582449|FG001|COMPLETED|Overall Study||204
11388509|NCT03545503|12582448|FG000|NOT COMPLETED|Overall Study||14
11388510|NCT03545503|12582449|FG001|NOT COMPLETED|Overall Study||16
11388511|NCT03545893|12582457|FG000|STARTED|Overall Study||35
11388512|NCT03545893|12582458|FG001|STARTED|Overall Study||35
11388513|NCT03545893|12582457|FG000|COMPLETED|Overall Study||35
11388514|NCT03545893|12582458|FG001|COMPLETED|Overall Study||35
11388515|NCT03545893|12582457|FG000|NOT COMPLETED|Overall Study||0
11388516|NCT03545893|12582458|FG001|NOT COMPLETED|Overall Study||0
11388517|NCT03545984|12582466|FG000|STARTED|Overall Study||24
11388518|NCT03545984|12582467|FG001|STARTED|Overall Study||24
11388519|NCT03545984|12582466|FG000|COMPLETED|Overall Study||13
11388520|NCT03545984|12582467|FG001|COMPLETED|Overall Study||15
11388521|NCT03545984|12582466|FG000|NOT COMPLETED|Overall Study||11
11388522|NCT03545984|12582467|FG001|NOT COMPLETED|Overall Study||9
11388523|NCT03546270|12582475|FG000|STARTED|Overall Study||52
11388524|NCT03546270|12582476|FG001|STARTED|Overall Study||48
11388525|NCT03546270|12582475|FG000|COMPLETED|Overall Study||52
11388526|NCT03546270|12582476|FG001|COMPLETED|Overall Study||48
11388527|NCT03546270|12582475|FG000|NOT COMPLETED|Overall Study||0
11388528|NCT03546270|12582476|FG001|NOT COMPLETED|Overall Study||0
11388529|NCT03546491|12582482|FG000|STARTED|Overall Study||32
11388530|NCT03546491|12582482|FG000|Recieved Test Product 1|Overall Study||32
11388531|NCT03546491|12582482|FG000|Received Test Product 2|Overall Study||32
11388532|NCT03546491|12582482|FG000|COMPLETED|Overall Study||30
11388533|NCT03546491|12582482|FG000|NOT COMPLETED|Overall Study||2
11388534|NCT03546621|12582496|FG000|STARTED|Overall Study||28
11388535|NCT03546621|12582497|FG001|STARTED|Overall Study||32
11388536|NCT03546621|12582498|FG002|STARTED|Overall Study||30
11388537|NCT03546621|12582499|FG003|STARTED|Overall Study|2 patients from Tenofovir only group withdrew from the study before treatment.|28
11388538|NCT03546621|12582496|FG000|COMPLETED|Overall Study||28
11388539|NCT03546621|12582497|FG001|COMPLETED|Overall Study||29
11388540|NCT03546621|12582498|FG002|COMPLETED|Overall Study||28
11388541|NCT03546621|12582499|FG003|COMPLETED|Overall Study||25
11388542|NCT03546621|12582496|FG000|NOT COMPLETED|Overall Study||0
11388543|NCT03546621|12582497|FG001|NOT COMPLETED|Overall Study||3
11388544|NCT03546621|12582498|FG002|NOT COMPLETED|Overall Study||2
11388545|NCT03546621|12582499|FG003|NOT COMPLETED|Overall Study||3
11388546|NCT03546647|12582509|FG000|STARTED|Overall Study||18
11388547|NCT03546647|12582510|FG001|STARTED|Overall Study|34|17
11388548|NCT03546647|12582509|FG000|COMPLETED|Overall Study||17
11388549|NCT03546647|12582510|FG001|COMPLETED|Overall Study||17
11388550|NCT03546647|12582509|FG000|NOT COMPLETED|Overall Study||1
11388551|NCT03546647|12582510|FG001|NOT COMPLETED|Overall Study||0
11388552|NCT03546816|12582518|FG000|STARTED|Overall Study||142
11388553|NCT03546816|12582519|FG001|STARTED|Overall Study||143
11388554|NCT03546816|12582518|FG000|COMPLETED|Overall Study||121
11388555|NCT03546816|12582519|FG001|COMPLETED|Overall Study||124
11388556|NCT03546816|12582518|FG000|NOT COMPLETED|Overall Study||21
11388557|NCT03546816|12582519|FG001|NOT COMPLETED|Overall Study||19
11388558|NCT03546842|12582527|FG000|STARTED|Overall Study||201
11388559|NCT03546842|12582527|FG000|Vaccination 1|Overall Study||200
11388560|NCT03546842|12582527|FG000|Vaccination 2|Overall Study||200
11388561|NCT03546842|12582527|FG000|Vaccination 3|Overall Study||198
11388562|NCT03546842|12582527|FG000|COMPLETED|Overall Study||198
11388563|NCT03546842|12582527|FG000|NOT COMPLETED|Overall Study||3
11388564|NCT03547154|12582533|FG000|STARTED|Overall Study||173
11388565|NCT03547154|12582534|FG001|STARTED|Overall Study||171
11388566|NCT03547154|12582533|FG000|COMPLETED|Overall Study||50
11388567|NCT03547154|12582534|FG001|COMPLETED|Overall Study||55
11388568|NCT03547154|12582533|FG000|NOT COMPLETED|Overall Study||123
11388569|NCT03547154|12582534|FG001|NOT COMPLETED|Overall Study||116
11388570|NCT03547167|12582542|FG000|STARTED|Overall Study||1135
11388571|NCT03547167|12582543|FG001|STARTED|Overall Study||380
11388572|NCT03547167|12582542|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||1133
11388573|NCT03547167|12582543|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||379
11388574|NCT03547167|12582542|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||1035
11388575|NCT03547167|12582543|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||346
11388576|NCT03547167|12582542|FG000|COMPLETED|Overall Study||1038
11388577|NCT03547167|12582543|FG001|COMPLETED|Overall Study||350
11388578|NCT03547167|12582542|FG000|NOT COMPLETED|Overall Study||97
11388579|NCT03547167|12582543|FG001|NOT COMPLETED|Overall Study||30
11388580|NCT03547531|12582555|FG000|STARTED|Overall Study||62
11388581|NCT03547531|12582556|FG001|STARTED|Overall Study||62
11388582|NCT03547531|12582555|FG000|COMPLETED|Overall Study||60
11388583|NCT03547531|12582556|FG001|COMPLETED|Overall Study||58
11388584|NCT03547531|12582555|FG000|NOT COMPLETED|Overall Study||2
11388585|NCT03547531|12582556|FG001|NOT COMPLETED|Overall Study||4
11388586|NCT03547583|12582565|FG000|STARTED|Overall Study||263
11388587|NCT03547583|12582566|FG001|STARTED|Overall Study||264
11388588|NCT03547583|12582567|FG002|STARTED|Overall Study||262
11388589|NCT03547583|12582565|FG000|Treated|Overall Study||262
11388590|NCT03547583|12582566|FG001|Treated|Overall Study||264
11388591|NCT03547583|12582567|FG002|Treated|Overall Study||262
11388592|NCT03547583|12582565|FG000|COMPLETED|Overall Study||218
11388593|NCT03547583|12582566|FG001|COMPLETED|Overall Study||224
11388594|NCT03547583|12582567|FG002|COMPLETED|Overall Study||230
11388595|NCT03547583|12582565|FG000|NOT COMPLETED|Overall Study||45
11388596|NCT03547583|12582566|FG001|NOT COMPLETED|Overall Study||40
11388597|NCT03547583|12582567|FG002|NOT COMPLETED|Overall Study||32
11388598|NCT03547635|12582581|FG000|STARTED|Overall Study||41
11388599|NCT03547635|12582582|FG001|STARTED|Overall Study||38
11388600|NCT03547635|12582583|FG002|STARTED|Overall Study||37
11388601|NCT03547635|12582581|FG000|COMPLETED|Overall Study||33
11388602|NCT03547635|12582582|FG001|COMPLETED|Overall Study||31
11388603|NCT03547635|12582583|FG002|COMPLETED|Overall Study||29
11388604|NCT03547635|12582581|FG000|NOT COMPLETED|Overall Study||8
11388605|NCT03547635|12582582|FG001|NOT COMPLETED|Overall Study||7
11388606|NCT03547635|12582583|FG002|NOT COMPLETED|Overall Study||8
11388607|NCT03547687|12582591|FG000|STARTED|Overall Study||9
11388608|NCT03547687|12582591|FG000|COMPLETED|Overall Study||7
11388609|NCT03547687|12582591|FG000|NOT COMPLETED|Overall Study||2
11388610|NCT03548337|12582597|FG000|STARTED|Infant Series||151
11388611|NCT03548337|12582598|FG001|STARTED|Infant Series||150
11388612|NCT03548337|12582597|FG000|Vaccination 1|Infant Series||150
11388613|NCT03548337|12582598|FG001|Vaccination 1|Infant Series||150
11388614|NCT03548337|12582597|FG000|Vaccination 2|Infant Series||144
11388615|NCT03548337|12582598|FG001|Vaccination 2|Infant Series||144
11388616|NCT03548337|12582597|FG000|Vaccination 3|Infant Series||144
11388617|NCT03548337|12582598|FG001|Vaccination 3|Infant Series||141
11388618|NCT03548337|12582597|FG000|COMPLETED|Infant Series||139
11388619|NCT03548337|12582598|FG001|COMPLETED|Infant Series||139
11388620|NCT03548337|12582597|FG000|NOT COMPLETED|Infant Series||12
11388621|NCT03548337|12582598|FG001|NOT COMPLETED|Infant Series||11
11388622|NCT03548337|12582597|FG000|STARTED|Toddler Dose||139
11388623|NCT03548337|12582598|FG001|STARTED|Toddler Dose||139
11388624|NCT03548337|12582597|FG000|Vaccination 4|Toddler Dose||139
11388625|NCT03548337|12582598|FG001|Vaccination 4|Toddler Dose||139
11388626|NCT03548337|12582597|FG000|COMPLETED|Toddler Dose||138
11388627|NCT03548337|12582598|FG001|COMPLETED|Toddler Dose||138
11388628|NCT03548337|12582597|FG000|NOT COMPLETED|Toddler Dose||1
11388629|NCT03548337|12582598|FG001|NOT COMPLETED|Toddler Dose||1
11388630|NCT03548935|12582612|FG000|STARTED|Overall Study||1306
11388631|NCT03548935|12582613|FG001|STARTED|Overall Study||655
11388632|NCT03548935|12582612|FG000|Full Analysis Set (FAS)|Overall Study||1306
11388633|NCT03548935|12582613|FG001|Full Analysis Set (FAS)|Overall Study||655
11388634|NCT03548935|12582612|FG000|Safety Analysis Set (SAS)|Overall Study||1306
11388635|NCT03548935|12582613|FG001|Safety Analysis Set (SAS)|Overall Study||655
11388636|NCT03548935|12582612|FG000|COMPLETED|Overall Study||1240
11388637|NCT03548935|12582613|FG001|COMPLETED|Overall Study||609
11388638|NCT03548935|12582612|FG000|NOT COMPLETED|Overall Study||66
11388639|NCT03548935|12582613|FG001|NOT COMPLETED|Overall Study||46
11388640|NCT03549117|12582621|FG000|STARTED|Overall Study||70
11388641|NCT03549117|12582622|FG001|STARTED|Overall Study||70
11388642|NCT03549117|12582621|FG000|COMPLETED|Overall Study||69
11388643|NCT03549117|12582622|FG001|COMPLETED|Overall Study||70
11388644|NCT03549117|12582621|FG000|NOT COMPLETED|Overall Study||1
11388645|NCT03549117|12582622|FG001|NOT COMPLETED|Overall Study||0
11388646|NCT03549130|12582630|FG000|STARTED|Overall Study||64
11388647|NCT03549130|12582631|FG001|STARTED|Overall Study||66
11388648|NCT03549130|12582630|FG000|COMPLETED|Overall Study||64
11388649|NCT03549130|12582631|FG001|COMPLETED|Overall Study||64
11388650|NCT03549130|12582630|FG000|NOT COMPLETED|Overall Study||0
11388651|NCT03549130|12582631|FG001|NOT COMPLETED|Overall Study||2
11388652|NCT03549234|12582641|FG000|STARTED|Overall Study||50
11388653|NCT03549234|12582642|FG001|STARTED|Overall Study||50
11388654|NCT03549234|12582641|FG000|COMPLETED|Overall Study||50
11388655|NCT03549234|12582642|FG001|COMPLETED|Overall Study||50
11388656|NCT03549234|12582641|FG000|NOT COMPLETED|Overall Study||0
11388657|NCT03549234|12582642|FG001|NOT COMPLETED|Overall Study||0
11388658|NCT03549338|12582651|FG000|STARTED|Overall Study||1
11388659|NCT03549338|12582652|FG001|STARTED|Overall Study||1
11388660|NCT03549338|12582653|FG002|STARTED|Overall Study||0
11388661|NCT03549338|12582651|FG000|COMPLETED|Overall Study||0
11388662|NCT03549338|12582652|FG001|COMPLETED|Overall Study|Patient crossed-over to Sym004 at the EOC1 per Sponsor decision following trial termination.|0
11388663|NCT03549338|12582653|FG002|COMPLETED|Overall Study||0
11388664|NCT03549338|12582651|FG000|NOT COMPLETED|Overall Study||1
11388665|NCT03549338|12582652|FG001|NOT COMPLETED|Overall Study||1
11388666|NCT03549338|12582653|FG002|NOT COMPLETED|Overall Study||0
11388667|NCT03549429|12582661|FG000|STARTED|Overall Study||81
11388668|NCT03549429|12582662|FG001|STARTED|Overall Study||78
11388669|NCT03549429|12582661|FG000|COMPLETED|Overall Study||76
11388670|NCT03549429|12582662|FG001|COMPLETED|Overall Study||75
11388671|NCT03549429|12582661|FG000|NOT COMPLETED|Overall Study||5
11388672|NCT03549429|12582662|FG001|NOT COMPLETED|Overall Study||3
11388673|NCT03549598|12582670|FG000|STARTED|Overall Study||15
11388674|NCT03549598|12582670|FG000|COMPLETED|Overall Study||15
11388675|NCT03549598|12582670|FG000|NOT COMPLETED|Overall Study||0
11388676|NCT03550066|12582678|FG000|STARTED|Overall Study||49
11388677|NCT03550066|12582679|FG001|STARTED|Overall Study||41
11388678|NCT03550066|12582678|FG000|COMPLETED|Overall Study||49
11388679|NCT03550066|12582679|FG001|COMPLETED|Overall Study||41
11388680|NCT03550066|12582678|FG000|NOT COMPLETED|Overall Study||0
11388681|NCT03550066|12582679|FG001|NOT COMPLETED|Overall Study||0
11388682|NCT03550209|12582689|FG000|STARTED|Overall Study||12
11388683|NCT03550209|12582690|FG001|STARTED|Overall Study||12
11388684|NCT03550209|12582691|FG002|STARTED|Overall Study||13
11388685|NCT03550209|12582692|FG003|STARTED|Overall Study||35
11388686|NCT03550209|12582689|FG000|COMPLETED|Overall Study||11
11388687|NCT03550209|12582690|FG001|COMPLETED|Overall Study||9
11388688|NCT03550209|12582691|FG002|COMPLETED|Overall Study||11
11388689|NCT03550209|12582692|FG003|COMPLETED|Overall Study||31
11388690|NCT03550209|12582689|FG000|NOT COMPLETED|Overall Study||1
11388691|NCT03550209|12582690|FG001|NOT COMPLETED|Overall Study||3
11388692|NCT03550209|12582691|FG002|NOT COMPLETED|Overall Study||2
11388693|NCT03550209|12582692|FG003|NOT COMPLETED|Overall Study||4
11388694|NCT03550313|12582705|FG000|STARTED|Overall Study||192
11388695|NCT03550313|12582706|FG001|STARTED|Overall Study||187
11388696|NCT03550313|12582707|FG002|STARTED|Overall Study||186
11388697|NCT03550313|12582705|FG000|Vaccinated for Dose 1|Overall Study||171
11388698|NCT03550313|12582706|FG001|Vaccinated for Dose 1|Overall Study||147
11388699|NCT03550313|12582707|FG002|Vaccinated for Dose 1|Overall Study||166
11388700|NCT03550313|12582705|FG000|Vaccinated for Dose 2|Overall Study||159
11388701|NCT03550313|12582706|FG001|Vaccinated for Dose 2|Overall Study||135
11388702|NCT03550313|12582707|FG002|Vaccinated for Dose 2|Overall Study||153
11388703|NCT03550313|12582705|FG000|Vaccinated for Dose 3|Overall Study||151
11388704|NCT03550313|12582706|FG001|Vaccinated for Dose 3|Overall Study||127
11388705|NCT03550313|12582707|FG002|Vaccinated for Dose 3|Overall Study||146
11388706|NCT03550313|12582705|FG000|COMPLETED|Overall Study||95
11388707|NCT03550313|12582706|FG001|COMPLETED|Overall Study||77
11388708|NCT03550313|12582707|FG002|COMPLETED|Overall Study||72
11388709|NCT03550313|12582705|FG000|NOT COMPLETED|Overall Study||97
11388710|NCT03550313|12582706|FG001|NOT COMPLETED|Overall Study||110
11388711|NCT03550313|12582707|FG002|NOT COMPLETED|Overall Study||114
11388712|NCT03550378|12582718|FG000|STARTED|Overall Study||20
11388713|NCT03550378|12582719|FG001|STARTED|Overall Study||21
11388714|NCT03550378|12582718|FG000|COMPLETED|Overall Study||20
11388715|NCT03550378|12582719|FG001|COMPLETED|Overall Study||20
11388716|NCT03550378|12582718|FG000|NOT COMPLETED|Overall Study||0
11388717|NCT03550378|12582719|FG001|NOT COMPLETED|Overall Study||1
11388718|NCT03550989|12582730|FG000|STARTED|Overall Study||190
11388719|NCT03550989|12582731|FG001|STARTED|Overall Study||74
11388720|NCT03550989|12582732|FG002|STARTED|Overall Study||77
11388721|NCT03550989|12582733|FG003|STARTED|Overall Study||60
11388722|NCT03550989|12582730|FG000|COMPLETED|Overall Study||188
11388723|NCT03550989|12582731|FG001|COMPLETED|Overall Study||73
11388724|NCT03550989|12582732|FG002|COMPLETED|Overall Study||76
11388725|NCT03550989|12582733|FG003|COMPLETED|Overall Study||60
11388726|NCT03550989|12582730|FG000|NOT COMPLETED|Overall Study||2
11388727|NCT03550989|12582731|FG001|NOT COMPLETED|Overall Study||1
11388728|NCT03550989|12582732|FG002|NOT COMPLETED|Overall Study||1
11388729|NCT03550989|12582733|FG003|NOT COMPLETED|Overall Study||0
11388730|NCT03551730|12582751|FG000|STARTED|Overall Study||9
11388731|NCT03551730|12582752|FG001|STARTED|Overall Study||6
11388732|NCT03551730|12582753|FG002|STARTED|Overall Study||6
11388733|NCT03551730|12582754|FG003|STARTED|Overall Study||6
11388734|NCT03551730|12582751|FG000|COMPLETED|Overall Study||8
11388735|NCT03551730|12582752|FG001|COMPLETED|Overall Study||6
11388736|NCT03551730|12582753|FG002|COMPLETED|Overall Study||6
11388737|NCT03551730|12582754|FG003|COMPLETED|Overall Study||6
11388738|NCT03551730|12582751|FG000|NOT COMPLETED|Overall Study||1
11388739|NCT03551730|12582752|FG001|NOT COMPLETED|Overall Study||0
11388740|NCT03551730|12582753|FG002|NOT COMPLETED|Overall Study||0
11388741|NCT03551730|12582754|FG003|NOT COMPLETED|Overall Study||0
11388742|NCT03551743|12582768|FG000|STARTED|Overall Study||10
11388743|NCT03551743|12582769|FG001|STARTED|Overall Study||6
11388744|NCT03551743|12582770|FG002|STARTED|Overall Study||6
11388745|NCT03551743|12582771|FG003|STARTED|Overall Study||6
11388746|NCT03551743|12582768|FG000|COMPLETED|Overall Study||8
11388747|NCT03551743|12582769|FG001|COMPLETED|Overall Study||6
11388748|NCT03551743|12582770|FG002|COMPLETED|Overall Study||6
11388749|NCT03551743|12582771|FG003|COMPLETED|Overall Study||6
11388750|NCT03551743|12582768|FG000|NOT COMPLETED|Overall Study||2
11388751|NCT03551743|12582769|FG001|NOT COMPLETED|Overall Study||0
11388752|NCT03551743|12582770|FG002|NOT COMPLETED|Overall Study||0
11388753|NCT03551743|12582771|FG003|NOT COMPLETED|Overall Study||0
11388754|NCT03551821|12582781|FG000|STARTED|Overall Study||1
11388755|NCT03551821|12582781|FG000|COMPLETED|Overall Study||1
11388756|NCT03551821|12582781|FG000|NOT COMPLETED|Overall Study||0
11388757|NCT03552198|12582789|FG000|STARTED|Overall Study||83
11388758|NCT03552198|12582790|FG001|STARTED|Overall Study||84
11388759|NCT03552198|12582791|FG002|STARTED|Overall Study||24
11388760|NCT03552198|12582792|FG003|STARTED|Overall Study||34
11388761|NCT03552198|12582789|FG000|Final Questionnaire 4 Weeks Follow-up|Overall Study||34
11388762|NCT03552198|12582790|FG001|Final Questionnaire 4 Weeks Follow-up|Overall Study||29
11388763|NCT03552198|12582791|FG002|Final Questionnaire 4 Weeks Follow-up|Overall Study||7
11388764|NCT03552198|12582792|FG003|Final Questionnaire 4 Weeks Follow-up|Overall Study||12
11388765|NCT03552198|12582789|FG000|COMPLETED|Overall Study||34
11388766|NCT03552198|12582790|FG001|COMPLETED|Overall Study||29
11388767|NCT03552198|12582791|FG002|COMPLETED|Overall Study||7
11388768|NCT03552198|12582792|FG003|COMPLETED|Overall Study||12
11388769|NCT03552198|12582789|FG000|NOT COMPLETED|Overall Study||49
11388770|NCT03552198|12582790|FG001|NOT COMPLETED|Overall Study||55
11388771|NCT03552198|12582791|FG002|NOT COMPLETED|Overall Study||17
11388772|NCT03552198|12582792|FG003|NOT COMPLETED|Overall Study||22
11388773|NCT03552289|12582804|FG000|STARTED|Overall Study||102
11388774|NCT03552289|12582805|FG001|STARTED|Overall Study||109
11388775|NCT03552289|12582804|FG000|COMPLETED|Overall Study||101
11388776|NCT03552289|12582805|FG001|COMPLETED|Overall Study||106
11388777|NCT03552289|12582804|FG000|NOT COMPLETED|Overall Study||1
11388778|NCT03552289|12582805|FG001|NOT COMPLETED|Overall Study||3
11388779|NCT03552523|12582811|FG000|STARTED|Overall Study||5
11388780|NCT03552523|12582812|FG001|STARTED|Overall Study||2
11388781|NCT03552523|12582811|FG000|COMPLETED|Overall Study||4
11388782|NCT03552523|12582812|FG001|COMPLETED|Overall Study||1
11388783|NCT03552523|12582811|FG000|NOT COMPLETED|Overall Study||1
11388784|NCT03552523|12582812|FG001|NOT COMPLETED|Overall Study||1
11388785|NCT03552536|12582821|FG000|STARTED|Overall Study||5
11388786|NCT03552536|12582822|FG001|STARTED|Overall Study||0
11388787|NCT03552536|12582823|FG002|STARTED|Overall Study||0
11388788|NCT03552536|12582821|FG000|COMPLETED|Overall Study||5
11388789|NCT03552536|12582822|FG001|COMPLETED|Overall Study||0
11388790|NCT03552536|12582823|FG002|COMPLETED|Overall Study||0
11388791|NCT03552536|12582821|FG000|NOT COMPLETED|Overall Study||0
11388792|NCT03552536|12582822|FG001|NOT COMPLETED|Overall Study||0
11388793|NCT03552536|12582823|FG002|NOT COMPLETED|Overall Study||0
11388794|NCT03552549|12582831|FG000|STARTED|Overall Study||63
11388795|NCT03552549|12582832|FG001|STARTED|Overall Study||63
11388796|NCT03552549|12582831|FG000|Treated|Overall Study||62
11388797|NCT03552549|12582832|FG001|Treated|Overall Study||62
11388798|NCT03552549|12582831|FG000|COMPLETED|Overall Study||10
11388799|NCT03552549|12582832|FG001|COMPLETED|Overall Study||11
11388800|NCT03552549|12582831|FG000|NOT COMPLETED|Overall Study||53
11388801|NCT03552549|12582832|FG001|NOT COMPLETED|Overall Study||52
11388802|NCT03552757|12582841|FG000|STARTED|Overall Study||403
11388803|NCT03552757|12582842|FG001|STARTED|Overall Study||404
11388804|NCT03552757|12582843|FG002|STARTED|Overall Study||403
11388805|NCT03552757|12582841|FG000|Exposed|Overall Study||402
11388806|NCT03552757|12582842|FG001|Exposed|Overall Study||403
11388807|NCT03552757|12582843|FG002|Exposed|Overall Study||402
11388808|NCT03552757|12582841|FG000|Full Analysis Set (FAS)|Overall Study||403
11388809|NCT03552757|12582842|FG001|Full Analysis Set (FAS)|Overall Study||404
11388810|NCT03552757|12582843|FG002|Full Analysis Set (FAS)|Overall Study||403
11388811|NCT03552757|12582841|FG000|Safety Analysis Set (SAS)|Overall Study||402
11388812|NCT03552757|12582842|FG001|Safety Analysis Set (SAS)|Overall Study||403
11388813|NCT03552757|12582843|FG002|Safety Analysis Set (SAS)|Overall Study||402
11388814|NCT03552757|12582841|FG000|COMPLETED|Overall Study||390
11388815|NCT03552757|12582842|FG001|COMPLETED|Overall Study||391
11388816|NCT03552757|12582843|FG002|COMPLETED|Overall Study||383
11388817|NCT03552757|12582841|FG000|NOT COMPLETED|Overall Study||13
11388818|NCT03552757|12582842|FG001|NOT COMPLETED|Overall Study||13
11388819|NCT03552757|12582843|FG002|NOT COMPLETED|Overall Study||20
11388820|NCT03553758|12582854|FG000|STARTED|Overall Study||16
11388821|NCT03553758|12582854|FG000|Completed Screening Visit|Overall Study||16
11388822|NCT03553758|12582854|FG000|COMPLETED|Overall Study||15
11388823|NCT03553758|12582854|FG000|NOT COMPLETED|Overall Study||1
11388824|NCT03553823|12582862|FG000|STARTED|Overall Study||20
11388825|NCT03553823|12582863|FG001|STARTED|Overall Study||20
11388826|NCT03553823|12582862|FG000|COMPLETED|Overall Study||20
11388827|NCT03553823|12582863|FG001|COMPLETED|Overall Study||19
11388828|NCT03553823|12582862|FG000|NOT COMPLETED|Overall Study||0
11388829|NCT03553823|12582863|FG001|NOT COMPLETED|Overall Study||1
11388830|NCT03553940|12582871|FG000|STARTED|Overall Study||22
11388831|NCT03553940|12582872|FG001|STARTED|Overall Study||21
11388832|NCT03553940|12582871|FG000|COMPLETED|Overall Study||22
11388833|NCT03553940|12582872|FG001|COMPLETED|Overall Study||21
11388834|NCT03553940|12582871|FG000|NOT COMPLETED|Overall Study||0
11388835|NCT03553940|12582872|FG001|NOT COMPLETED|Overall Study||0
11388836|NCT03554005|12582884|FG000|STARTED|Overall Study||1
11388837|NCT03554005|12582885|FG001|STARTED|Overall Study||2
11388838|NCT03554005|12582886|FG002|STARTED|Overall Study||2
11388839|NCT03554005|12582887|FG003|STARTED|Overall Study||2
11388840|NCT03554005|12582888|FG004|STARTED|Overall Study||11
11388841|NCT03554005|12582889|FG005|STARTED|Overall Study||11
11388842|NCT03554005|12582884|FG000|COMPLETED|Overall Study||0
11388843|NCT03554005|12582885|FG001|COMPLETED|Overall Study||1
11388844|NCT03554005|12582886|FG002|COMPLETED|Overall Study||1
11388845|NCT03554005|12582887|FG003|COMPLETED|Overall Study||1
11388846|NCT03554005|12582888|FG004|COMPLETED|Overall Study||5
11388847|NCT03554005|12582889|FG005|COMPLETED|Overall Study||0
11388848|NCT03554005|12582884|FG000|NOT COMPLETED|Overall Study||1
11388849|NCT03554005|12582885|FG001|NOT COMPLETED|Overall Study||1
11388850|NCT03554005|12582886|FG002|NOT COMPLETED|Overall Study||1
11388851|NCT03554005|12582887|FG003|NOT COMPLETED|Overall Study||1
11388852|NCT03554005|12582888|FG004|NOT COMPLETED|Overall Study||6
11388853|NCT03554005|12582889|FG005|NOT COMPLETED|Overall Study||11
11388854|NCT03554018|12582905|FG000|STARTED|Overall Study||60
11388855|NCT03554018|12582906|FG001|STARTED|Overall Study||60
11388856|NCT03554018|12582905|FG000|COMPLETED|Overall Study||57
11388857|NCT03554018|12582906|FG001|COMPLETED|Overall Study||53
11388858|NCT03554018|12582905|FG000|NOT COMPLETED|Overall Study||3
11388859|NCT03554018|12582906|FG001|NOT COMPLETED|Overall Study||7
11388860|NCT03554486|12582914|FG000|STARTED|Run-in Period (2 Weeks)||24
11388861|NCT03554486|12582915|FG001|STARTED|Run-in Period (2 Weeks)||0
11388862|NCT03554486|12582916|FG002|STARTED|Run-in Period (2 Weeks)||0
11388863|NCT03554486|12582914|FG000|COMPLETED|Run-in Period (2 Weeks)||21
11388864|NCT03554486|12582915|FG001|COMPLETED|Run-in Period (2 Weeks)||0
11388865|NCT03554486|12582916|FG002|COMPLETED|Run-in Period (2 Weeks)||0
11388866|NCT03554486|12582914|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||3
11388867|NCT03554486|12582915|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0
11388868|NCT03554486|12582916|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0
11388869|NCT03554486|12582914|FG000|STARTED|Treatment Period 1 (2 Weeks)||0
11388870|NCT03554486|12582915|FG001|STARTED|Treatment Period 1 (2 Weeks)||11
11388871|NCT03554486|12582916|FG002|STARTED|Treatment Period 1 (2 Weeks)||10
11388872|NCT03554486|12582914|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||0
11388873|NCT03554486|12582915|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||10
11388874|NCT03554486|12582916|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||9
11388875|NCT03554486|12582914|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
11388876|NCT03554486|12582915|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
11388877|NCT03554486|12582916|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
11388878|NCT03554486|12582914|FG000|STARTED|Treatment Period 2 (2 Weeks)||0
11388879|NCT03554486|12582915|FG001|STARTED|Treatment Period 2 (2 Weeks)||10
11388880|NCT03554486|12582916|FG002|STARTED|Treatment Period 2 (2 Weeks)||9
11388881|NCT03554486|12582914|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||0
11388882|NCT03554486|12582915|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||10
11388883|NCT03554486|12582916|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||9
11388884|NCT03554486|12582914|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
11388885|NCT03554486|12582915|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
11388886|NCT03554486|12582916|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
11388887|NCT03554629|12582923|FG000|STARTED|Overall Study|8 filterlines per participant for four scripted activities with supplemental oxygen|29
11388888|NCT03554629|12582923|FG000|COMPLETED|Overall Study|8 filterlines (CCSF) per participate for four scripted activities with supplemental oxygen.|23
11388889|NCT03554629|12582923|FG000|NOT COMPLETED|Overall Study||6
11388890|NCT03554746|12582953|FG000|STARTED|Overall Study||24
11388891|NCT03554746|12582954|FG001|STARTED|Overall Study||24
11388892|NCT03554746|12582953|FG000|COMPLETED|Overall Study||24
11388893|NCT03554746|12582954|FG001|COMPLETED|Overall Study||24
11388894|NCT03554746|12582953|FG000|NOT COMPLETED|Overall Study||0
11388895|NCT03554746|12582954|FG001|NOT COMPLETED|Overall Study||0
11388896|NCT03554772|12582964|FG000|STARTED|Overall Study||30
11388897|NCT03554772|12582965|FG001|STARTED|Overall Study||30
11388898|NCT03554772|12582966|FG002|STARTED|Overall Study||29
11388899|NCT03554772|12582967|FG003|STARTED|Overall Study||31
11388900|NCT03554772|12582964|FG000|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
11388901|NCT03554772|12582965|FG001|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
11388902|NCT03554772|12582966|FG002|Completed Treatment Period (8 Hours Post Dose)|Overall Study||29
11388903|NCT03554772|12582967|FG003|Completed Treatment Period (8 Hours Post Dose)|Overall Study||31
11388904|NCT03554772|12582964|FG000|COMPLETED|Overall Study||30
11388905|NCT03554772|12582965|FG001|COMPLETED|Overall Study||30
11388906|NCT03554772|12582966|FG002|COMPLETED|Overall Study||29
11388907|NCT03554772|12582967|FG003|COMPLETED|Overall Study||29
11388908|NCT03554772|12582964|FG000|NOT COMPLETED|Overall Study||0
11388909|NCT03554772|12582965|FG001|NOT COMPLETED|Overall Study||0
11388910|NCT03554772|12582966|FG002|NOT COMPLETED|Overall Study||0
11388911|NCT03554772|12582967|FG003|NOT COMPLETED|Overall Study||2
11388912|NCT03554954|12582977|FG000|STARTED|Overall Study||108
11388913|NCT03554954|12582977|FG000|COMPLETED|Overall Study||108
11388914|NCT03554954|12582977|FG000|NOT COMPLETED|Overall Study||0
11388915|NCT03555266|12582987|FG000|STARTED|Overall Study||32
11388916|NCT03555266|12582988|FG001|STARTED|Overall Study||31
11388917|NCT03555266|12582987|FG000|COMPLETED|Overall Study||26
11388918|NCT03555266|12582988|FG001|COMPLETED|Overall Study||27
11388919|NCT03555266|12582987|FG000|NOT COMPLETED|Overall Study||6
11388920|NCT03555266|12582988|FG001|NOT COMPLETED|Overall Study||4
11388921|NCT03555305|12582994|FG000|STARTED|Period 1||29
11388922|NCT03555305|12582995|FG001|STARTED|Period 1||29
11388923|NCT03555305|12582994|FG000|Received at Least 1 Dose of Study Drug|Period 1||29
11388924|NCT03555305|12582995|FG001|Received at Least 1 Dose of Study Drug|Period 1||29
11388925|NCT03555305|12582994|FG000|COMPLETED|Period 1||29
11388926|NCT03555305|12582995|FG001|COMPLETED|Period 1||27
11388927|NCT03555305|12582994|FG000|NOT COMPLETED|Period 1||0
11388928|NCT03555305|12582995|FG001|NOT COMPLETED|Period 1||2
11388929|NCT03555305|12582994|FG000|STARTED|Period 2||29
11388930|NCT03555305|12582995|FG001|STARTED|Period 2||27
11388931|NCT03555305|12582994|FG000|COMPLETED|Period 2||29
11388932|NCT03555305|12582995|FG001|COMPLETED|Period 2||27
11388933|NCT03555305|12582994|FG000|NOT COMPLETED|Period 2||0
11388934|NCT03555305|12582995|FG001|NOT COMPLETED|Period 2||0
11388935|NCT03555435|12583004|FG000|STARTED|Overall Study||28
11388936|NCT03555435|12583005|FG001|STARTED|Overall Study||27
11388937|NCT03555435|12583006|FG002|STARTED|Overall Study||26
11388938|NCT03555435|12583004|FG000|COMPLETED|Overall Study||11
11388939|NCT03555435|12583005|FG001|COMPLETED|Overall Study||8
11388940|NCT03555435|12583006|FG002|COMPLETED|Overall Study||18
11388941|NCT03555435|12583004|FG000|NOT COMPLETED|Overall Study||17
11388942|NCT03555435|12583005|FG001|NOT COMPLETED|Overall Study||19
11388943|NCT03555435|12583006|FG002|NOT COMPLETED|Overall Study||8
11388944|NCT03555565|12583014|FG000|STARTED|Overall Study||1026
11388945|NCT03555565|12583014|FG000|COMPLETED|Overall Study||1011
11388946|NCT03555565|12583014|FG000|NOT COMPLETED|Overall Study||15
11388947|NCT03555890|12583022|FG000|STARTED|Part 1:Treatment Period 1 (3 Days)||12
11388948|NCT03555890|12583023|FG001|STARTED|Part 1:Treatment Period 1 (3 Days)||12
11388949|NCT03555890|12583024|FG002|STARTED|Part 1:Treatment Period 1 (3 Days)||0
11388950|NCT03555890|12583025|FG003|STARTED|Part 1:Treatment Period 1 (3 Days)||0
11388951|NCT03555890|12583022|FG000|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
11388952|NCT03555890|12583023|FG001|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
11388953|NCT03555890|12583024|FG002|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
11388954|NCT03555890|12583025|FG003|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
11388955|NCT03555890|12583022|FG000|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
11388956|NCT03555890|12583023|FG001|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
11388957|NCT03555890|12583024|FG002|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
11388958|NCT03555890|12583025|FG003|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
11388959|NCT03555890|12583022|FG000|STARTED|Part 1:Washout Period (at Least 5 Days)||12
11388960|NCT03555890|12583023|FG001|STARTED|Part 1:Washout Period (at Least 5 Days)||12
11388961|NCT03555890|12583024|FG002|STARTED|Part 1:Washout Period (at Least 5 Days)||0
11388962|NCT03555890|12583025|FG003|STARTED|Part 1:Washout Period (at Least 5 Days)||0
11388963|NCT03555890|12583022|FG000|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
11388964|NCT03555890|12583023|FG001|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
11388965|NCT03555890|12583024|FG002|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
11388966|NCT03555890|12583025|FG003|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
11388967|NCT03555890|12583022|FG000|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
11388968|NCT03555890|12583023|FG001|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
11388969|NCT03555890|12583024|FG002|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
11388970|NCT03555890|12583025|FG003|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
11388971|NCT03555890|12583022|FG000|STARTED|Part 1:Treatment Period 2 (10 Days)||12
11388972|NCT03555890|12583023|FG001|STARTED|Part 1:Treatment Period 2 (10 Days)||12
11388973|NCT03555890|12583024|FG002|STARTED|Part 1:Treatment Period 2 (10 Days)||0
11388974|NCT03555890|12583025|FG003|STARTED|Part 1:Treatment Period 2 (10 Days)||0
11388975|NCT03555890|12583022|FG000|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
11388976|NCT03555890|12583023|FG001|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
11388977|NCT03555890|12583024|FG002|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
11388978|NCT03555890|12583025|FG003|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
11388979|NCT03555890|12583022|FG000|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
11388980|NCT03555890|12583023|FG001|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
11388981|NCT03555890|12583024|FG002|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
11388982|NCT03555890|12583025|FG003|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
11388983|NCT03555890|12583022|FG000|STARTED|Part 2:Treatment Period 1 (3 Days)||0
11388984|NCT03555890|12583023|FG001|STARTED|Part 2:Treatment Period 1 (3 Days)||0
11388985|NCT03555890|12583024|FG002|STARTED|Part 2:Treatment Period 1 (3 Days)||24
11388986|NCT03555890|12583025|FG003|STARTED|Part 2:Treatment Period 1 (3 Days)||24
11388987|NCT03555890|12583022|FG000|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
11388988|NCT03555890|12583023|FG001|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
11388989|NCT03555890|12583024|FG002|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
11388990|NCT03555890|12583025|FG003|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
11388991|NCT03555890|12583022|FG000|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
11388992|NCT03555890|12583023|FG001|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
11388993|NCT03555890|12583024|FG002|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
11388994|NCT03555890|12583025|FG003|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
11388995|NCT03555890|12583022|FG000|STARTED|Part 2:Washout Period (at Least 5 Days)||0
11388996|NCT03555890|12583023|FG001|STARTED|Part 2:Washout Period (at Least 5 Days)||0
11388997|NCT03555890|12583024|FG002|STARTED|Part 2:Washout Period (at Least 5 Days)||24
11388998|NCT03555890|12583025|FG003|STARTED|Part 2:Washout Period (at Least 5 Days)||24
11388999|NCT03555890|12583022|FG000|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
11389000|NCT03555890|12583023|FG001|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
11389001|NCT03555890|12583024|FG002|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24
11389002|NCT03555890|12583025|FG003|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23
11389003|NCT03555890|12583022|FG000|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
11389004|NCT03555890|12583023|FG001|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
11389005|NCT03555890|12583024|FG002|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
11389006|NCT03555890|12583025|FG003|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1
11389007|NCT03555890|12583022|FG000|STARTED|Part 2:Treatment Period 2 (10 Days)||0
11389008|NCT03555890|12583023|FG001|STARTED|Part 2:Treatment Period 2 (10 Days)||0
11389009|NCT03555890|12583024|FG002|STARTED|Part 2:Treatment Period 2 (10 Days)||24
11389010|NCT03555890|12583025|FG003|STARTED|Part 2:Treatment Period 2 (10 Days)||23
11389011|NCT03555890|12583022|FG000|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
11389012|NCT03555890|12583023|FG001|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
11389013|NCT03555890|12583024|FG002|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24
11389014|NCT03555890|12583025|FG003|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23
11389015|NCT03555890|12583022|FG000|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
11389016|NCT03555890|12583023|FG001|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
11389017|NCT03555890|12583024|FG002|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
11389018|NCT03555890|12583025|FG003|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
11389019|NCT03556579|12583035|FG000|STARTED|Visit 1||16
11389020|NCT03556579|12583036|FG001|STARTED|Visit 1||14
11389021|NCT03556579|12583037|FG002|STARTED|Visit 1||14
11389022|NCT03556579|12583038|FG003|STARTED|Visit 1||16
11389023|NCT03556579|12583035|FG000|COMPLETED|Visit 1||16
11389024|NCT03556579|12583036|FG001|COMPLETED|Visit 1||14
11389025|NCT03556579|12583037|FG002|COMPLETED|Visit 1||14
11389026|NCT03556579|12583038|FG003|COMPLETED|Visit 1||16
11389027|NCT03556579|12583035|FG000|NOT COMPLETED|Visit 1||0
11389028|NCT03556579|12583036|FG001|NOT COMPLETED|Visit 1||0
11389029|NCT03556579|12583037|FG002|NOT COMPLETED|Visit 1||0
11389030|NCT03556579|12583038|FG003|NOT COMPLETED|Visit 1||0
11389031|NCT03556579|12583035|FG000|STARTED|Visit 2||16
11389032|NCT03556579|12583036|FG001|STARTED|Visit 2||14
11389033|NCT03556579|12583037|FG002|STARTED|Visit 2||14
11389034|NCT03556579|12583038|FG003|STARTED|Visit 2||16
11389035|NCT03556579|12583035|FG000|COMPLETED|Visit 2||16
11389036|NCT03556579|12583036|FG001|COMPLETED|Visit 2||14
11389037|NCT03556579|12583037|FG002|COMPLETED|Visit 2||14
11389038|NCT03556579|12583038|FG003|COMPLETED|Visit 2||16
11389039|NCT03556579|12583035|FG000|NOT COMPLETED|Visit 2||0
11389040|NCT03556579|12583036|FG001|NOT COMPLETED|Visit 2||0
11389041|NCT03556579|12583037|FG002|NOT COMPLETED|Visit 2||0
11389042|NCT03556579|12583038|FG003|NOT COMPLETED|Visit 2||0
11389043|NCT03556761|12583050|FG000|STARTED|Overall Study||192
11389044|NCT03556761|12583051|FG001|STARTED|Overall Study||192
11389045|NCT03556761|12583050|FG000|COMPLETED|Overall Study||168
11389046|NCT03556761|12583051|FG001|COMPLETED|Overall Study||163
11389047|NCT03556761|12583050|FG000|NOT COMPLETED|Overall Study||24
11389048|NCT03556761|12583051|FG001|NOT COMPLETED|Overall Study||29
11389049|NCT03556891|12583057|FG000|STARTED|Overall Study||133
11389050|NCT03556891|12583057|FG000|COMPLETED|Overall Study||120
11389051|NCT03556891|12583057|FG000|NOT COMPLETED|Overall Study||13
11389052|NCT03557034|12583063|FG000|STARTED|Overall Study||49
11389053|NCT03557034|12583064|FG001|STARTED|Overall Study||51
11389054|NCT03557034|12583063|FG000|Randomization|Overall Study||49
11389055|NCT03557034|12583064|FG001|Randomization|Overall Study||51
11389056|NCT03557034|12583063|FG000|COMPLETED|Overall Study||48
11389057|NCT03557034|12583064|FG001|COMPLETED|Overall Study||51
11389058|NCT03557034|12583063|FG000|NOT COMPLETED|Overall Study||1
11389059|NCT03557034|12583064|FG001|NOT COMPLETED|Overall Study||0
11389060|NCT03557086|12583072|FG000|STARTED|Overall Study||26
11389061|NCT03557086|12583073|FG001|STARTED|Overall Study||24
11389062|NCT03557086|12583072|FG000|COMPLETED|Overall Study||26
11389063|NCT03557086|12583073|FG001|COMPLETED|Overall Study||24
11389064|NCT03557086|12583072|FG000|NOT COMPLETED|Overall Study||0
11389065|NCT03557086|12583073|FG001|NOT COMPLETED|Overall Study||0
11389066|NCT03557125|12583083|FG000|STARTED|Overall Study||22
11389067|NCT03557125|12583084|FG001|STARTED|Overall Study||24
11058429|NCT01004003|12240270|FG002|NOT COMPLETED|Overall Study||4
11389068|NCT03557125|12583083|FG000|COMPLETED|Overall Study||22
11389069|NCT03557125|12583084|FG001|COMPLETED|Overall Study||24
11389070|NCT03557125|12583083|FG000|NOT COMPLETED|Overall Study||0
11389071|NCT03557125|12583084|FG001|NOT COMPLETED|Overall Study||0
11389072|NCT03557333|12583090|FG000|STARTED|Overall Study||354
11389073|NCT03557333|12583090|FG000|COMPLETED|Overall Study||262
11389074|NCT03557333|12583090|FG000|NOT COMPLETED|Overall Study||92
11389075|NCT03557372|12583096|FG000|STARTED|Overall Study||14
11389076|NCT03557372|12583096|FG000|COMPLETED|Overall Study||14
11389077|NCT03557372|12583096|FG000|NOT COMPLETED|Overall Study||0
11389078|NCT03557476|12583102|FG000|STARTED|Overall Study||13
11389079|NCT03557476|12583103|FG001|STARTED|Overall Study||13
11389080|NCT03557476|12583102|FG000|COMPLETED|Overall Study||13
11389081|NCT03557476|12583103|FG001|COMPLETED|Overall Study||13
11389082|NCT03557476|12583102|FG000|NOT COMPLETED|Overall Study||0
11389083|NCT03557476|12583103|FG001|NOT COMPLETED|Overall Study||0
11389084|NCT03557658|12583111|FG000|STARTED|Overall Study||8
11389085|NCT03557658|12583112|FG001|STARTED|Overall Study||8
11389086|NCT03557658|12583111|FG000|COMPLETED|Overall Study||8
11389087|NCT03557658|12583112|FG001|COMPLETED|Overall Study||8
11389088|NCT03557658|12583111|FG000|NOT COMPLETED|Overall Study||0
11389089|NCT03557658|12583112|FG001|NOT COMPLETED|Overall Study||0
11389090|NCT03557775|12583121|FG000|STARTED|Overall Study||5
11389091|NCT03557775|12583122|FG001|STARTED|Overall Study||7
11389092|NCT03557775|12583123|FG002|STARTED|Overall Study||8
11389093|NCT03557775|12583121|FG000|COMPLETED|Overall Study||4
11389094|NCT03557775|12583122|FG001|COMPLETED|Overall Study||4
11389095|NCT03557775|12583123|FG002|COMPLETED|Overall Study||4
11389096|NCT03557775|12583121|FG000|NOT COMPLETED|Overall Study||1
11389097|NCT03557775|12583122|FG001|NOT COMPLETED|Overall Study||3
11389098|NCT03557775|12583123|FG002|NOT COMPLETED|Overall Study||4
11389099|NCT03557801|12583134|FG000|STARTED|Overall Study||34
11389100|NCT03557801|12583135|FG001|STARTED|Overall Study||33
11389101|NCT03557801|12583136|FG002|STARTED|Overall Study||33
11389102|NCT03557801|12583134|FG000|COMPLETED|Overall Study||32
11389103|NCT03557801|12583135|FG001|COMPLETED|Overall Study||32
11389104|NCT03557801|12583136|FG002|COMPLETED|Overall Study||30
11058430|NCT01004003|12240271|FG003|NOT COMPLETED|Overall Study||3
11389105|NCT03557801|12583134|FG000|NOT COMPLETED|Overall Study||2
11389106|NCT03557801|12583135|FG001|NOT COMPLETED|Overall Study||1
11389107|NCT03557801|12583136|FG002|NOT COMPLETED|Overall Study||3
11389108|NCT03558061|12583144|FG000|STARTED|Overall Study||30
11389109|NCT03558061|12583144|FG000|COMPLETED|Overall Study||29
11389110|NCT03558061|12583144|FG000|NOT COMPLETED|Overall Study||1
11389111|NCT03558074|12583148|FG000|STARTED|Overall Study||26
11389112|NCT03558074|12583148|FG000|COMPLETED|Overall Study||24
11389113|NCT03558074|12583148|FG000|NOT COMPLETED|Overall Study||2
11389114|NCT03558230|12583155|FG000|STARTED|Overall Study||7
11389115|NCT03558230|12583156|FG001|STARTED|Overall Study||6
11389116|NCT03558230|12583155|FG000|COMPLETED|Overall Study||7
11389117|NCT03558230|12583156|FG001|COMPLETED|Overall Study||6
11389118|NCT03558230|12583155|FG000|NOT COMPLETED|Overall Study||0
11389119|NCT03558230|12583156|FG001|NOT COMPLETED|Overall Study||0
11389120|NCT03558516|12583164|FG000|STARTED|Overall Study||40
11389121|NCT03558516|12583165|FG001|STARTED|Overall Study||40
11389122|NCT03558516|12583164|FG000|COMPLETED|Overall Study||38
11389123|NCT03558516|12583165|FG001|COMPLETED|Overall Study||38
11389124|NCT03558516|12583164|FG000|NOT COMPLETED|Overall Study||2
11389125|NCT03558516|12583165|FG001|NOT COMPLETED|Overall Study||2
11389126|NCT03558555|12583173|FG000|STARTED|Overall Study||58
11389127|NCT03558555|12583174|FG001|STARTED|Overall Study||45
11389128|NCT03558555|12583173|FG000|COMPLETED|Overall Study||56
11389129|NCT03558555|12583174|FG001|COMPLETED|Overall Study||44
11389130|NCT03558555|12583173|FG000|NOT COMPLETED|Overall Study||2
11389131|NCT03558555|12583174|FG001|NOT COMPLETED|Overall Study||1
11389132|NCT03558672|12583180|FG000|STARTED|Overall Study||18
11389133|NCT03558672|12583180|FG000|COMPLETED|Overall Study||8
11389134|NCT03558672|12583180|FG000|NOT COMPLETED|Overall Study||10
11389135|NCT03558997|12583188|FG000|STARTED|Overall Study||25
11389136|NCT03558997|12583189|FG001|STARTED|Overall Study||26
11389137|NCT03558997|12583190|FG002|STARTED|Overall Study||26
11389138|NCT03558997|12583191|FG003|STARTED|Overall Study||26
11389139|NCT03558997|12583188|FG000|COMPLETED|Overall Study||24
11389140|NCT03558997|12583189|FG001|COMPLETED|Overall Study||24
11389141|NCT03558997|12583190|FG002|COMPLETED|Overall Study||18
11389142|NCT03558997|12583191|FG003|COMPLETED|Overall Study||24
11389143|NCT03558997|12583188|FG000|NOT COMPLETED|Overall Study||1
11389144|NCT03558997|12583189|FG001|NOT COMPLETED|Overall Study||2
11389145|NCT03558997|12583190|FG002|NOT COMPLETED|Overall Study||8
11389146|NCT03558997|12583191|FG003|NOT COMPLETED|Overall Study||2
11389147|NCT03559062|12583207|FG000|STARTED|Overall Study||10
11389148|NCT03559062|12583208|FG001|STARTED|Overall Study||54
11389149|NCT03559062|12583209|FG002|STARTED|Overall Study||3
11389150|NCT03559062|12583207|FG000|COMPLETED|Overall Study||10
11389151|NCT03559062|12583208|FG001|COMPLETED|Overall Study||53
11389152|NCT03559062|12583209|FG002|COMPLETED|Overall Study||3
11389153|NCT03559062|12583207|FG000|NOT COMPLETED|Overall Study||0
11389154|NCT03559062|12583208|FG001|NOT COMPLETED|Overall Study||1
11389155|NCT03559062|12583209|FG002|NOT COMPLETED|Overall Study||0
11389156|NCT03559179|12583221|FG000|STARTED|Overall Study||8
11389157|NCT03559179|12583222|FG001|STARTED|Overall Study||24
11389158|NCT03559179|12583223|FG002|STARTED|Overall Study||23
11389159|NCT03559179|12583221|FG000|COMPLETED|Overall Study||8
11389160|NCT03559179|12583222|FG001|COMPLETED|Overall Study||23
11389161|NCT03559179|12583223|FG002|COMPLETED|Overall Study||23
11389162|NCT03559179|12583221|FG000|NOT COMPLETED|Overall Study||0
11389163|NCT03559179|12583222|FG001|NOT COMPLETED|Overall Study||1
11389164|NCT03559179|12583223|FG002|NOT COMPLETED|Overall Study||0
11389165|NCT03559205|12583242|FG000|STARTED|Overall Study||177
11389166|NCT03559205|12583243|FG001|STARTED|Overall Study||144
11389167|NCT03559205|12583242|FG000|Baseline Data|Overall Study||141
11389168|NCT03559205|12583243|FG001|Baseline Data|Overall Study||132
11389169|NCT03559205|12583242|FG000|COMPLETED|Overall Study||65
11389170|NCT03559205|12583243|FG001|COMPLETED|Overall Study||57
11389171|NCT03559205|12583242|FG000|NOT COMPLETED|Overall Study||112
11389172|NCT03559205|12583243|FG001|NOT COMPLETED|Overall Study||87
11389173|NCT03559218|12583251|FG000|STARTED|Overall Study||12
11389174|NCT03559218|12583252|FG001|STARTED|Overall Study||13
11389175|NCT03559218|12583251|FG000|COMPLETED|Overall Study||11
11389176|NCT03559218|12583252|FG001|COMPLETED|Overall Study||13
11389177|NCT03559218|12583251|FG000|NOT COMPLETED|Overall Study||1
11389178|NCT03559218|12583252|FG001|NOT COMPLETED|Overall Study||0
11389179|NCT03559257|12583260|FG000|STARTED|Double Blind Treatment Period||230
11389180|NCT03559257|12583261|FG001|STARTED|Double Blind Treatment Period||233
11389181|NCT03559257|12583260|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||230
11389182|NCT03559257|12583261|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||232
11389183|NCT03559257|12583260|FG000|COMPLETED|Double Blind Treatment Period||226
11389184|NCT03559257|12583261|FG001|COMPLETED|Double Blind Treatment Period||225
11389185|NCT03559257|12583260|FG000|NOT COMPLETED|Double Blind Treatment Period||4
11389186|NCT03559257|12583261|FG001|NOT COMPLETED|Double Blind Treatment Period||8
11389187|NCT03559257|12583260|FG000|STARTED|Open-label Treatment Period|One participant who completed double blind period has withdrawn from the study.|225
11389188|NCT03559257|12583261|FG001|STARTED|Open-label Treatment Period|One participant who completed double blind period had discontinued due to adverse event.|224
11389189|NCT03559257|12583260|FG000|COMPLETED|Open-label Treatment Period||215
11389190|NCT03559257|12583261|FG001|COMPLETED|Open-label Treatment Period||217
11389191|NCT03559257|12583260|FG000|NOT COMPLETED|Open-label Treatment Period||10
11389192|NCT03559257|12583261|FG001|NOT COMPLETED|Open-label Treatment Period||7
11389193|NCT03559517|12583273|FG000|STARTED|Overall Study||8
11389194|NCT03559517|12583274|FG001|STARTED|Overall Study||9
11389195|NCT03559517|12583275|FG002|STARTED|Overall Study||12
11389196|NCT03559517|12583273|FG000|COMPLETED|Overall Study||7
11389197|NCT03559517|12583274|FG001|COMPLETED|Overall Study||9
11389198|NCT03559517|12583275|FG002|COMPLETED|Overall Study||12
11389199|NCT03559517|12583273|FG000|NOT COMPLETED|Overall Study||1
11389200|NCT03559517|12583274|FG001|NOT COMPLETED|Overall Study||0
11389201|NCT03559517|12583275|FG002|NOT COMPLETED|Overall Study||0
11389202|NCT03559530|12583283|FG000|STARTED|Overall Study||197
11389203|NCT03559530|12583284|FG001|STARTED|Overall Study||65
11389204|NCT03559530|12583283|FG000|COMPLETED|Overall Study||106
11389205|NCT03559530|12583284|FG001|COMPLETED|Overall Study||65
11389206|NCT03559530|12583283|FG000|NOT COMPLETED|Overall Study||91
11389207|NCT03559530|12583284|FG001|NOT COMPLETED|Overall Study||0
11389208|NCT03559829|12583289|FG000|STARTED|Overall Study||20
11389209|NCT03559829|12583289|FG000|COMPLETED|Overall Study||20
11389210|NCT03559829|12583289|FG000|NOT COMPLETED|Overall Study||0
11389211|NCT03559933|12583293|FG000|STARTED|Overall Study||12
11389212|NCT03559933|12583293|FG000|COMPLETED|Overall Study||12
11389213|NCT03559933|12583293|FG000|NOT COMPLETED|Overall Study||0
11389214|NCT03560102|12583298|FG000|STARTED|Overall Study||1
11389215|NCT03560102|12583298|FG000|COMPLETED|Overall Study||1
11389216|NCT03560102|12583298|FG000|NOT COMPLETED|Overall Study||0
11389217|NCT03560128|12583304|FG000|STARTED|Overall Study||306
11389218|NCT03560128|12583305|FG001|STARTED|Overall Study||306
11389219|NCT03560128|12583304|FG000|COMPLETED|Overall Study||294
11389220|NCT03560128|12583305|FG001|COMPLETED|Overall Study||298
11389221|NCT03560128|12583304|FG000|NOT COMPLETED|Overall Study||12
11389222|NCT03560128|12583305|FG001|NOT COMPLETED|Overall Study||8
11389223|NCT03560141|12583313|FG000|STARTED|Overall Study||6
11389224|NCT03560141|12583314|FG001|STARTED|Overall Study||5
11389225|NCT03560141|12583313|FG000|COMPLETED|Overall Study||6
11389226|NCT03560141|12583314|FG001|COMPLETED|Overall Study||5
11389227|NCT03560141|12583313|FG000|NOT COMPLETED|Overall Study||0
11389228|NCT03560141|12583314|FG001|NOT COMPLETED|Overall Study||0
11389229|NCT03560245|12583324|FG000|STARTED|Overall Study||53
11389230|NCT03560245|12583325|FG001|STARTED|Overall Study||55
11389231|NCT03560245|12583324|FG000|COMPLETED|Overall Study||48
11389232|NCT03560245|12583325|FG001|COMPLETED|Overall Study||48
11389233|NCT03560245|12583324|FG000|NOT COMPLETED|Overall Study||5
11389234|NCT03560245|12583325|FG001|NOT COMPLETED|Overall Study||7
11389235|NCT03560518|12583336|FG000|STARTED|Double Blind Treatment Period||147
11389236|NCT03560518|12583337|FG001|STARTED|Double Blind Treatment Period||145
11389237|NCT03560518|12583338|FG002|STARTED|Double Blind Treatment Period||147
11389238|NCT03560518|12583336|FG000|COMPLETED|Double Blind Treatment Period||122
11389239|NCT03560518|12583337|FG001|COMPLETED|Double Blind Treatment Period||116
11389240|NCT03560518|12583338|FG002|COMPLETED|Double Blind Treatment Period||124
11389241|NCT03560518|12583336|FG000|NOT COMPLETED|Double Blind Treatment Period||25
11389242|NCT03560518|12583337|FG001|NOT COMPLETED|Double Blind Treatment Period||29
11389243|NCT03560518|12583338|FG002|NOT COMPLETED|Double Blind Treatment Period||23
11389244|NCT03560518|12583336|FG000|STARTED|Safety Follow-Up Period||10
11389245|NCT03560518|12583337|FG001|STARTED|Safety Follow-Up Period||17
11389246|NCT03560518|12583338|FG002|STARTED|Safety Follow-Up Period||22
11389247|NCT03560518|12583336|FG000|COMPLETED|Safety Follow-Up Period||10
11389248|NCT03560518|12583337|FG001|COMPLETED|Safety Follow-Up Period||17
11389249|NCT03560518|12583338|FG002|COMPLETED|Safety Follow-Up Period||22
11389250|NCT03560518|12583336|FG000|NOT COMPLETED|Safety Follow-Up Period||0
11389251|NCT03560518|12583337|FG001|NOT COMPLETED|Safety Follow-Up Period||0
11389252|NCT03560518|12583338|FG002|NOT COMPLETED|Safety Follow-Up Period||0
11389253|NCT03560739|12583350|FG000|STARTED|Overall Study||128
11389254|NCT03560739|12583351|FG001|STARTED|Overall Study||130
11389255|NCT03560739|12583352|FG002|STARTED|Overall Study||13
11389256|NCT03560739|12583353|FG003|STARTED|Overall Study||13
11389257|NCT03560739|12583350|FG000|COMPLETED|Overall Study||128
11389258|NCT03560739|12583351|FG001|COMPLETED|Overall Study||129
11389259|NCT03560739|12583352|FG002|COMPLETED|Overall Study||13
11389260|NCT03560739|12583353|FG003|COMPLETED|Overall Study||13
11389261|NCT03560739|12583350|FG000|NOT COMPLETED|Overall Study||0
11389262|NCT03560739|12583351|FG001|NOT COMPLETED|Overall Study||1
11389263|NCT03560739|12583352|FG002|NOT COMPLETED|Overall Study||0
11389264|NCT03560739|12583353|FG003|NOT COMPLETED|Overall Study||0
11389265|NCT03560869|12583363|FG000|STARTED|Overall Study||14
11389266|NCT03560869|12583364|FG001|STARTED|Overall Study||21
11389267|NCT03560869|12583363|FG000|COMPLETED|Overall Study||7
11389268|NCT03560869|12583364|FG001|COMPLETED|Overall Study||12
11389269|NCT03560869|12583363|FG000|NOT COMPLETED|Overall Study||7
11389270|NCT03560869|12583364|FG001|NOT COMPLETED|Overall Study||9
11389271|NCT03560986|12583372|FG000|STARTED|Treatment Period A/Follow-up Period 1||48
11389272|NCT03560986|12583373|FG001|STARTED|Treatment Period A/Follow-up Period 1|One additional participant was allocated to placebo but not treated.|51
11389273|NCT03560986|12583372|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
11389274|NCT03560986|12583373|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
11389275|NCT03560986|12583372|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||12
11389276|NCT03560986|12583373|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||13
11389277|NCT03560986|12583372|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||36
11389278|NCT03560986|12583373|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||38
11389279|NCT03560986|12583372|FG000|STARTED|Treatment Period B/Follow-up Period 2|3 Participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|9
11389280|NCT03560986|12583373|FG001|STARTED|Treatment Period B/Follow-up Period 2|5 Part. completed Placebo Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|8
11389281|NCT03560986|12583372|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
11389282|NCT03560986|12583373|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
11389283|NCT03560986|12583372|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||1
11389284|NCT03560986|12583373|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0
11389285|NCT03560986|12583372|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
11389286|NCT03560986|12583373|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
11389287|NCT03561090|12583387|FG000|STARTED|Overall Study||247
11389288|NCT03561090|12583388|FG001|STARTED|Overall Study||248
11389289|NCT03561090|12583387|FG000|Randomized and Treated|Overall Study||246
11389290|NCT03561090|12583388|FG001|Randomized and Treated|Overall Study||247
11389291|NCT03561090|12583387|FG000|COMPLETED|Overall Study||207
11389292|NCT03561090|12583388|FG001|COMPLETED|Overall Study||212
11389293|NCT03561090|12583387|FG000|NOT COMPLETED|Overall Study||40
11389294|NCT03561090|12583388|FG001|NOT COMPLETED|Overall Study||36
11389295|NCT03561883|12583398|FG000|STARTED|Overall Study||305
11389296|NCT03561883|12583399|FG001|STARTED|Overall Study||304
11389297|NCT03561883|12583398|FG000|COMPLETED|Overall Study||259
11389298|NCT03561883|12583399|FG001|COMPLETED|Overall Study||261
11389299|NCT03561883|12583398|FG000|NOT COMPLETED|Overall Study||46
11389300|NCT03561883|12583399|FG001|NOT COMPLETED|Overall Study||43
11389301|NCT03562117|12583408|FG000|STARTED|Part 1, Up to 3 Days||8
11389302|NCT03562117|12583409|FG001|STARTED|Part 1, Up to 3 Days||8
11389303|NCT03562117|12583410|FG002|STARTED|Part 1, Up to 3 Days||0
11389304|NCT03562117|12583408|FG000|COMPLETED|Part 1, Up to 3 Days||7
11389305|NCT03562117|12583409|FG001|COMPLETED|Part 1, Up to 3 Days||8
11389306|NCT03562117|12583410|FG002|COMPLETED|Part 1, Up to 3 Days||0
11389307|NCT03562117|12583408|FG000|NOT COMPLETED|Part 1, Up to 3 Days||1
11389308|NCT03562117|12583409|FG001|NOT COMPLETED|Part 1, Up to 3 Days||0
11389309|NCT03562117|12583410|FG002|NOT COMPLETED|Part 1, Up to 3 Days||0
11389310|NCT03562117|12583408|FG000|STARTED|Part 2, Up to 3 Days|Only 1 additional participant with normal hepatic function enrolled in Part 2 received dosing|8
11389311|NCT03562117|12583409|FG001|STARTED|Part 2, Up to 3 Days||0
11389312|NCT03562117|12583410|FG002|STARTED|Part 2, Up to 3 Days||8
11389313|NCT03562117|12583408|FG000|COMPLETED|Part 2, Up to 3 Days||8
11389314|NCT03562117|12583409|FG001|COMPLETED|Part 2, Up to 3 Days||0
11389315|NCT03562117|12583410|FG002|COMPLETED|Part 2, Up to 3 Days||8
11389316|NCT03562117|12583408|FG000|NOT COMPLETED|Part 2, Up to 3 Days||0
11389317|NCT03562117|12583409|FG001|NOT COMPLETED|Part 2, Up to 3 Days||0
11389318|NCT03562117|12583410|FG002|NOT COMPLETED|Part 2, Up to 3 Days||0
11389319|NCT03562377|12583420|FG000|STARTED|Treatment Period|Number of participants assigned to treatment|107
11389320|NCT03562377|12583421|FG001|STARTED|Treatment Period|Number of participants assigned to treatment|108
11389321|NCT03562377|12583420|FG000|Safety Analysis Set|Treatment Period||107
11389322|NCT03562377|12583421|FG001|Safety Analysis Set|Treatment Period||107
11389323|NCT03562377|12583420|FG000|Per Protocol Anaysis Set|Treatment Period||88
11389324|NCT03562377|12583421|FG001|Per Protocol Anaysis Set|Treatment Period||78
11389325|NCT03562377|12583420|FG000|Full Analysis Set|Treatment Period||106
11389326|NCT03562377|12583421|FG001|Full Analysis Set|Treatment Period||108
11389327|NCT03562377|12583420|FG000|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|100
11389328|NCT03562377|12583421|FG001|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|89
11389329|NCT03562377|12583420|FG000|NOT COMPLETED|Treatment Period||7
11389330|NCT03562377|12583421|FG001|NOT COMPLETED|Treatment Period||19
11389331|NCT03562377|12583420|FG000|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
11389332|NCT03562377|12583421|FG001|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
11389333|NCT03562377|12583420|FG000|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|16
11389334|NCT03562377|12583421|FG001|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|18
11389335|NCT03562377|12583420|FG000|NOT COMPLETED|Safety Follow-up Period||59
11389336|NCT03562377|12583421|FG001|NOT COMPLETED|Safety Follow-up Period||57
11389337|NCT03562481|12583429|FG000|STARTED|First Intervention||12
11389338|NCT03562481|12583430|FG001|STARTED|First Intervention||14
11389339|NCT03562481|12583429|FG000|COMPLETED|First Intervention||11
11389340|NCT03562481|12583430|FG001|COMPLETED|First Intervention||14
11389341|NCT03562481|12583429|FG000|NOT COMPLETED|First Intervention||1
11389342|NCT03562481|12583430|FG001|NOT COMPLETED|First Intervention||0
11389343|NCT03562481|12583429|FG000|STARTED|Washout||11
11389344|NCT03562481|12583430|FG001|STARTED|Washout||14
11389345|NCT03562481|12583429|FG000|COMPLETED|Washout||11
11389346|NCT03562481|12583430|FG001|COMPLETED|Washout||14
11389347|NCT03562481|12583429|FG000|NOT COMPLETED|Washout||0
11389348|NCT03562481|12583430|FG001|NOT COMPLETED|Washout||0
11389349|NCT03562481|12583429|FG000|STARTED|Second Intervention||11
11389350|NCT03562481|12583430|FG001|STARTED|Second Intervention||14
11389351|NCT03562481|12583429|FG000|COMPLETED|Second Intervention||11
11389352|NCT03562481|12583430|FG001|COMPLETED|Second Intervention||14
11389353|NCT03562481|12583429|FG000|NOT COMPLETED|Second Intervention||0
11389354|NCT03562481|12583430|FG001|NOT COMPLETED|Second Intervention||0
11389355|NCT03562559|12583440|FG000|STARTED|Overall Study||40
11389356|NCT03562559|12583440|FG000|COMPLETED|Overall Study||40
11389357|NCT03562559|12583440|FG000|NOT COMPLETED|Overall Study||0
11389358|NCT03562663|12583446|FG000|STARTED|Overall Study||41
11389359|NCT03562663|12583447|FG001|STARTED|Overall Study||41
11389360|NCT03562663|12583446|FG000|COMPLETED|Overall Study||34
11389361|NCT03562663|12583447|FG001|COMPLETED|Overall Study||35
11389362|NCT03562663|12583446|FG000|NOT COMPLETED|Overall Study||7
11389363|NCT03562663|12583447|FG001|NOT COMPLETED|Overall Study||6
11389364|NCT03562988|12583453|FG000|STARTED|Overall Study||17
11389365|NCT03562988|12583454|FG001|STARTED|Overall Study||18
11389366|NCT03562988|12583453|FG000|COMPLETED|Overall Study||15
11389367|NCT03562988|12583454|FG001|COMPLETED|Overall Study||15
11389368|NCT03562988|12583453|FG000|NOT COMPLETED|Overall Study||2
11389369|NCT03562988|12583454|FG001|NOT COMPLETED|Overall Study||3
11389370|NCT03563027|12583467|FG000|STARTED|Overall Study||60
11389371|NCT03563027|12583468|FG001|STARTED|Overall Study||60
11389372|NCT03563027|12583469|FG002|STARTED|Overall Study||60
11389373|NCT03563027|12583467|FG000|COMPLETED|Overall Study||60
11389374|NCT03563027|12583468|FG001|COMPLETED|Overall Study||60
11389375|NCT03563027|12583469|FG002|COMPLETED|Overall Study||58
11389376|NCT03563027|12583467|FG000|NOT COMPLETED|Overall Study||0
11389377|NCT03563027|12583468|FG001|NOT COMPLETED|Overall Study||0
11389378|NCT03563027|12583469|FG002|NOT COMPLETED|Overall Study||2
11389379|NCT03563183|12583477|FG000|STARTED|Overall Study||26976
11389380|NCT03563183|12583477|FG000|COMPLETED|Overall Study||26976
11389381|NCT03563183|12583477|FG000|NOT COMPLETED|Overall Study||0
11389382|NCT03563209|12583496|FG000|STARTED|Overall Study||60
11389383|NCT03563209|12583496|FG000|COMPLETED|Overall Study||60
11389384|NCT03563209|12583496|FG000|NOT COMPLETED|Overall Study||0
11389385|NCT03563313|12583504|FG000|STARTED|Overall Study||112
11389386|NCT03563313|12583505|FG001|STARTED|Overall Study||56
11389387|NCT03563313|12583504|FG000|COMPLETED|Overall Study||112
11389388|NCT03563313|12583505|FG001|COMPLETED|Overall Study||56
11389389|NCT03563313|12583504|FG000|NOT COMPLETED|Overall Study||0
11389390|NCT03563313|12583505|FG001|NOT COMPLETED|Overall Study||0
11389391|NCT03564444|12583519|FG000|STARTED|Overall Study||60
11389392|NCT03564444|12583520|FG001|STARTED|Overall Study||240
11389393|NCT03564444|12583519|FG000|COMPLETED|Overall Study||60
11389394|NCT03564444|12583520|FG001|COMPLETED|Overall Study||240
11389395|NCT03564444|12583519|FG000|NOT COMPLETED|Overall Study||0
11389396|NCT03564444|12583520|FG001|NOT COMPLETED|Overall Study||0
11389397|NCT03564886|12583528|FG000|STARTED|Overall Study||24
11389398|NCT03564886|12583529|FG001|STARTED|Overall Study||24
11389399|NCT03564886|12583528|FG000|COMPLETED|Overall Study||23
11389400|NCT03564886|12583529|FG001|COMPLETED|Overall Study||23
11389401|NCT03564886|12583528|FG000|NOT COMPLETED|Overall Study||1
11389402|NCT03564886|12583529|FG001|NOT COMPLETED|Overall Study||1
11389403|NCT03565068|12583544|FG000|STARTED|Overall Study||12
11389404|NCT03565068|12583545|FG001|STARTED|Overall Study||4
11389405|NCT03565068|12583546|FG002|STARTED|Overall Study||12
11389406|NCT03565068|12583547|FG003|STARTED|Overall Study||4
11389407|NCT03565068|12583548|FG004|STARTED|Overall Study||12
11389408|NCT03565068|12583549|FG005|STARTED|Overall Study||1
11389409|NCT03565068|12583550|FG006|STARTED|Overall Study||4
11389410|NCT03565068|12583551|FG007|STARTED|Overall Study||17
11389411|NCT03565068|12583552|FG008|STARTED|Overall Study||9
11389412|NCT03565068|12583544|FG000|COMPLETED|Overall Study||12
11389413|NCT03565068|12583545|FG001|COMPLETED|Overall Study||4
11389414|NCT03565068|12583546|FG002|COMPLETED|Overall Study||11
11389415|NCT03565068|12583547|FG003|COMPLETED|Overall Study||4
11389416|NCT03565068|12583548|FG004|COMPLETED|Overall Study||8
11389417|NCT03565068|12583549|FG005|COMPLETED|Overall Study||0
11389418|NCT03565068|12583550|FG006|COMPLETED|Overall Study||3
11389419|NCT03565068|12583551|FG007|COMPLETED|Overall Study||9
11389420|NCT03565068|12583552|FG008|COMPLETED|Overall Study||8
11389421|NCT03565068|12583544|FG000|NOT COMPLETED|Overall Study||0
11389422|NCT03565068|12583545|FG001|NOT COMPLETED|Overall Study||0
11389423|NCT03565068|12583546|FG002|NOT COMPLETED|Overall Study||1
11389424|NCT03565068|12583547|FG003|NOT COMPLETED|Overall Study||0
11389425|NCT03565068|12583548|FG004|NOT COMPLETED|Overall Study||4
11389426|NCT03565068|12583549|FG005|NOT COMPLETED|Overall Study||1
11389427|NCT03565068|12583550|FG006|NOT COMPLETED|Overall Study||1
11389428|NCT03565068|12583551|FG007|NOT COMPLETED|Overall Study||8
11389429|NCT03565068|12583552|FG008|NOT COMPLETED|Overall Study||1
11389430|NCT03565211|12583609|FG000|STARTED|Overall Study||254
11389431|NCT03565211|12583609|FG000|Modified Intention-to-treat (mITT)|Overall Study|Had successful oocyte retrieval, received >=1 dose of IMP, and completed fresh embryo transfer|243
11389432|NCT03565211|12583609|FG000|COMPLETED|Overall Study||206
11389433|NCT03565211|12583609|FG000|NOT COMPLETED|Overall Study||48
11389434|NCT03565315|12583617|FG000|STARTED|Overall Study||3
11389435|NCT03565315|12583618|FG001|STARTED|Overall Study||3
11389436|NCT03565315|12583619|FG002|STARTED|Overall Study||1
11389437|NCT03565315|12583620|FG003|STARTED|Overall Study||2
11389438|NCT03565315|12583617|FG000|Product Administration Completed|Overall Study||3
11389439|NCT03565315|12583618|FG001|Product Administration Completed|Overall Study||0
11389440|NCT03565315|12583619|FG002|Product Administration Completed|Overall Study||1
11389441|NCT03565315|12583620|FG003|Product Administration Completed|Overall Study||0
11389442|NCT03565315|12583617|FG000|Discontinued Product Administrations|Overall Study||0
11389443|NCT03565315|12583618|FG001|Discontinued Product Administrations|Overall Study||3
11389444|NCT03565315|12583619|FG002|Discontinued Product Administrations|Overall Study||0
11389445|NCT03565315|12583620|FG003|Discontinued Product Administrations|Overall Study|One Group 4 participant enrolled but did not receive product due to IND/PI voluntary study pause.|2
11389446|NCT03565315|12583617|FG000|COMPLETED|Overall Study||3
11389447|NCT03565315|12583618|FG001|COMPLETED|Overall Study||3
11389448|NCT03565315|12583619|FG002|COMPLETED|Overall Study||1
11389449|NCT03565315|12583620|FG003|COMPLETED|Overall Study||1
11389450|NCT03565315|12583617|FG000|NOT COMPLETED|Overall Study||0
11389451|NCT03565315|12583618|FG001|NOT COMPLETED|Overall Study||0
11389452|NCT03565315|12583619|FG002|NOT COMPLETED|Overall Study||0
11389453|NCT03565315|12583620|FG003|NOT COMPLETED|Overall Study||1
11389454|NCT03565666|12583643|FG000|STARTED|Overall Study||12
11389455|NCT03565666|12583644|FG001|STARTED|Overall Study||12
11389456|NCT03565666|12583645|FG002|STARTED|Overall Study||12
11389457|NCT03565666|12583643|FG000|COMPLETED|Overall Study||12
11389458|NCT03565666|12583644|FG001|COMPLETED|Overall Study||12
11389459|NCT03565666|12583645|FG002|COMPLETED|Overall Study||11
11389460|NCT03565666|12583643|FG000|NOT COMPLETED|Overall Study||0
11389461|NCT03565666|12583644|FG001|NOT COMPLETED|Overall Study||0
11389462|NCT03565666|12583645|FG002|NOT COMPLETED|Overall Study||1
11389463|NCT03565679|12583656|FG000|STARTED|Overall Study||10
11389464|NCT03565679|12583656|FG000|COMPLETED|Overall Study||10
11389465|NCT03565679|12583656|FG000|NOT COMPLETED|Overall Study||0
11389466|NCT03565874|12583663|FG000|STARTED|Overall Study||6
11389467|NCT03565874|12583663|FG000|COMPLETED|Overall Study||4
11389468|NCT03565874|12583663|FG000|NOT COMPLETED|Overall Study||2
11389469|NCT03565887|12583669|FG000|STARTED|Overall Study||109
11389470|NCT03565887|12583670|FG001|STARTED|Overall Study||55
11389471|NCT03565887|12583669|FG000|COMPLETED|Overall Study||108
11389472|NCT03565887|12583670|FG001|COMPLETED|Overall Study||53
11389473|NCT03565887|12583669|FG000|NOT COMPLETED|Overall Study||1
11389474|NCT03565887|12583670|FG001|NOT COMPLETED|Overall Study||2
11389475|NCT03566238|12583679|FG000|STARTED|Overall Study||23
11389476|NCT03566238|12583680|FG001|STARTED|Overall Study||19
11389477|NCT03566238|12583681|FG002|STARTED|Overall Study||20
11389478|NCT03566238|12583679|FG000|Received Treatment|Overall Study||23
11389479|NCT03566238|12583680|FG001|Received Treatment|Overall Study||19
11389480|NCT03566238|12583681|FG002|Received Treatment|Overall Study||20
11389481|NCT03566238|12583679|FG000|COMPLETED|Overall Study||18
11389482|NCT03566238|12583680|FG001|COMPLETED|Overall Study||16
11389483|NCT03566238|12583681|FG002|COMPLETED|Overall Study||15
11389484|NCT03566238|12583679|FG000|NOT COMPLETED|Overall Study||5
11389485|NCT03566238|12583680|FG001|NOT COMPLETED|Overall Study||3
11389486|NCT03566238|12583681|FG002|NOT COMPLETED|Overall Study||5
11389487|NCT03566485|12583691|FG000|STARTED|Overall Study||5
11389488|NCT03566485|12583692|FG001|STARTED|Overall Study|Dose level 1 (Idasanutlin 100mg PO)|7
11389489|NCT03566485|12583691|FG000|COMPLETED|Overall Study||0
11389490|NCT03566485|12583692|FG001|COMPLETED|Overall Study||0
11389491|NCT03566485|12583691|FG000|NOT COMPLETED|Overall Study||5
11389492|NCT03566485|12583692|FG001|NOT COMPLETED|Overall Study||7
11389493|NCT03566550|12583700|FG000|STARTED|Overall Study||12
11389494|NCT03566550|12583701|FG001|STARTED|Overall Study||13
11389495|NCT03566550|12583700|FG000|COMPLETED|Overall Study||12
11389496|NCT03566550|12583701|FG001|COMPLETED|Overall Study||12
11389497|NCT03566550|12583700|FG000|NOT COMPLETED|Overall Study||0
11389498|NCT03566550|12583701|FG001|NOT COMPLETED|Overall Study||1
11389499|NCT03566680|12583707|FG000|STARTED|Overall Study||46
11389500|NCT03566680|12583707|FG000|COMPLETED|Overall Study||29
11389501|NCT03566680|12583707|FG000|NOT COMPLETED|Overall Study||17
11389502|NCT03566810|12583715|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||19
11389503|NCT03566810|12583716|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||19
11389504|NCT03566810|12583717|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||8
11389505|NCT03566810|12583718|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||8
11389506|NCT03566810|12583715|FG000|Treated|Treatment Period 1 (Day 1-Day 3)||19
11389507|NCT03566810|12583716|FG001|Treated|Treatment Period 1 (Day 1-Day 3)||18
11389508|NCT03566810|12583717|FG002|Treated|Treatment Period 1 (Day 1-Day 3)||8
11389509|NCT03566810|12583718|FG003|Treated|Treatment Period 1 (Day 1-Day 3)||8
11389510|NCT03566810|12583715|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19
11389511|NCT03566810|12583716|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18
11389512|NCT03566810|12583717|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
11389513|NCT03566810|12583718|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
11389514|NCT03566810|12583715|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
11389515|NCT03566810|12583716|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1
11389516|NCT03566810|12583717|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
11389517|NCT03566810|12583718|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
11389518|NCT03566810|12583715|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||19
11389519|NCT03566810|12583716|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||18
11389520|NCT03566810|12583717|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||8
11389521|NCT03566810|12583718|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||8
11389522|NCT03566810|12583715|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19
11389523|NCT03566810|12583716|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18
11389524|NCT03566810|12583717|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
11389525|NCT03566810|12583718|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
11389526|NCT03566810|12583715|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
11389527|NCT03566810|12583716|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
11389528|NCT03566810|12583717|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
11389529|NCT03566810|12583718|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
11389530|NCT03566823|12583731|FG000|STARTED|Overall Study||6
11389531|NCT03566823|12583732|FG001|STARTED|Overall Study||15
11389532|NCT03566823|12583733|FG002|STARTED|Overall Study||13
11389533|NCT03566823|12583731|FG000|COMPLETED|Overall Study||4
11389534|NCT03566823|12583732|FG001|COMPLETED|Overall Study||12
11389535|NCT03566823|12583733|FG002|COMPLETED|Overall Study||11
11389536|NCT03566823|12583731|FG000|NOT COMPLETED|Overall Study||2
11389537|NCT03566823|12583732|FG001|NOT COMPLETED|Overall Study||3
11389538|NCT03566823|12583733|FG002|NOT COMPLETED|Overall Study||2
11389539|NCT03566979|12583745|FG000|STARTED|Overall Study||58
11389540|NCT03566979|12583746|FG001|STARTED|Overall Study||152
11389541|NCT03566979|12583747|FG002|STARTED|Overall Study||142
11389542|NCT03566979|12583748|FG003|STARTED|Overall Study||149
11389543|NCT03566979|12583745|FG000|COMPLETED|Overall Study||53
11389544|NCT03566979|12583746|FG001|COMPLETED|Overall Study||145
11389545|NCT03566979|12583747|FG002|COMPLETED|Overall Study||132
11389546|NCT03566979|12583748|FG003|COMPLETED|Overall Study||143
11389547|NCT03566979|12583745|FG000|NOT COMPLETED|Overall Study||5
11389548|NCT03566979|12583746|FG001|NOT COMPLETED|Overall Study||7
11389549|NCT03566979|12583747|FG002|NOT COMPLETED|Overall Study||10
11389550|NCT03566979|12583748|FG003|NOT COMPLETED|Overall Study||6
11389551|NCT03567005|12583758|FG000|STARTED|Period 1, First 7 Days of Wear||29
11389552|NCT03567005|12583759|FG001|STARTED|Period 1, First 7 Days of Wear||31
11389553|NCT03567005|12583758|FG000|COMPLETED|Period 1, First 7 Days of Wear||29
11389554|NCT03567005|12583759|FG001|COMPLETED|Period 1, First 7 Days of Wear||31
11389555|NCT03567005|12583758|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0
11389556|NCT03567005|12583759|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0
11389557|NCT03567005|12583758|FG000|STARTED|Period 2, Second 7 Days of Wear||29
11389558|NCT03567005|12583759|FG001|STARTED|Period 2, Second 7 Days of Wear||31
11389559|NCT03567005|12583758|FG000|COMPLETED|Period 2, Second 7 Days of Wear||29
11389560|NCT03567005|12583759|FG001|COMPLETED|Period 2, Second 7 Days of Wear||31
11389561|NCT03567005|12583758|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
11389562|NCT03567005|12583759|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
11389563|NCT03567252|12583767|FG000|STARTED|Overall Study||48
11389564|NCT03567252|12583768|FG001|STARTED|Overall Study||19
11389565|NCT03567252|12583767|FG000|COMPLETED|Overall Study||48
11389566|NCT03567252|12583768|FG001|COMPLETED|Overall Study||19
11389567|NCT03567252|12583767|FG000|NOT COMPLETED|Overall Study||0
11389568|NCT03567252|12583768|FG001|NOT COMPLETED|Overall Study||0
11389569|NCT03567291|12583774|FG000|STARTED|Period I||228
11389570|NCT03567291|12583775|FG001|STARTED|Period I||0
11389571|NCT03567291|12583776|FG002|STARTED|Period I||0
11389572|NCT03567291|12583777|FG003|STARTED|Period I||0
11389573|NCT03567291|12583774|FG000|Safety Set|Period I||227
11389574|NCT03567291|12583775|FG001|Safety Set|Period I||0
11389575|NCT03567291|12583776|FG002|Safety Set|Period I||0
11389576|NCT03567291|12583777|FG003|Safety Set|Period I||0
11389577|NCT03567291|12583774|FG000|Intent to Treat Set|Period I||228
11389578|NCT03567291|12583775|FG001|Intent to Treat Set|Period I||0
11389579|NCT03567291|12583776|FG002|Intent to Treat Set|Period I||0
11389580|NCT03567291|12583777|FG003|Intent to Treat Set|Period I||0
11389581|NCT03567291|12583774|FG000|COMPLETED|Period I||137
11389582|NCT03567291|12583775|FG001|COMPLETED|Period I||0
11389583|NCT03567291|12583776|FG002|COMPLETED|Period I||0
11389584|NCT03567291|12583777|FG003|COMPLETED|Period I||0
11389585|NCT03567291|12583774|FG000|NOT COMPLETED|Period I||91
11389586|NCT03567291|12583775|FG001|NOT COMPLETED|Period I||0
11389587|NCT03567291|12583776|FG002|NOT COMPLETED|Period I||0
11389588|NCT03567291|12583777|FG003|NOT COMPLETED|Period I||0
11389589|NCT03567291|12583774|FG000|STARTED|Period II||0
11389590|NCT03567291|12583775|FG001|STARTED|Period II||91
11389591|NCT03567291|12583776|FG002|STARTED|Period II||46
11389592|NCT03567291|12583777|FG003|STARTED|Period II||0
11389593|NCT03567291|12583774|FG000|COMPLETED|Period II||0
11389594|NCT03567291|12583775|FG001|COMPLETED|Period II||88
11389595|NCT03567291|12583776|FG002|COMPLETED|Period II||45
11389596|NCT03567291|12583777|FG003|COMPLETED|Period II||0
11389597|NCT03567291|12583774|FG000|NOT COMPLETED|Period II||0
11389598|NCT03567291|12583775|FG001|NOT COMPLETED|Period II||3
11389599|NCT03567291|12583776|FG002|NOT COMPLETED|Period II||1
11389600|NCT03567291|12583777|FG003|NOT COMPLETED|Period II||0
11389601|NCT03567291|12583774|FG000|STARTED|Period III||0
11389602|NCT03567291|12583775|FG001|STARTED|Period III||0
11389603|NCT03567291|12583776|FG002|STARTED|Period III||0
11389604|NCT03567291|12583777|FG003|STARTED|Period III||133
11389605|NCT03567291|12583774|FG000|COMPLETED|Period III||0
11389606|NCT03567291|12583775|FG001|COMPLETED|Period III||0
11389607|NCT03567291|12583776|FG002|COMPLETED|Period III||0
11389608|NCT03567291|12583777|FG003|COMPLETED|Period III||48
11389609|NCT03567291|12583774|FG000|NOT COMPLETED|Period III||0
11389610|NCT03567291|12583775|FG001|NOT COMPLETED|Period III||0
11389611|NCT03567291|12583776|FG002|NOT COMPLETED|Period III||0
11389612|NCT03567291|12583777|FG003|NOT COMPLETED|Period III||85
11389613|NCT03567382|12583785|FG000|STARTED|Overall Study||10
11389614|NCT03567382|12583786|FG001|STARTED|Overall Study||81
11389615|NCT03567382|12583787|FG002|STARTED|Overall Study||9
11389616|NCT03567382|12583788|FG003|STARTED|Overall Study||79
11389617|NCT03567382|12583785|FG000|Received Tenofovir|Overall Study||9
11389618|NCT03567382|12583786|FG001|Received Tenofovir|Overall Study||0
11389619|NCT03567382|12583787|FG002|Received Tenofovir|Overall Study||0
11389620|NCT03567382|12583788|FG003|Received Tenofovir|Overall Study||0
11389621|NCT03567382|12583785|FG000|COMPLETED|Overall Study||7
11389622|NCT03567382|12583786|FG001|COMPLETED|Overall Study||46
11389623|NCT03567382|12583787|FG002|COMPLETED|Overall Study||7
11389624|NCT03567382|12583788|FG003|COMPLETED|Overall Study||46
11389625|NCT03567382|12583785|FG000|NOT COMPLETED|Overall Study||3
11389626|NCT03567382|12583786|FG001|NOT COMPLETED|Overall Study||35
11389627|NCT03567382|12583787|FG002|NOT COMPLETED|Overall Study||2
11389628|NCT03567382|12583788|FG003|NOT COMPLETED|Overall Study||33
11389629|NCT03567616|12583801|FG000|STARTED|Overall Study||8
11389630|NCT03567616|12583801|FG000|COMPLETED|Overall Study||0
11389631|NCT03567616|12583801|FG000|NOT COMPLETED|Overall Study||8
11389632|NCT03567980|12583808|FG000|STARTED|Overall Study||30
11389633|NCT03567980|12583808|FG000|COMPLETED|Overall Study||29
11389634|NCT03567980|12583808|FG000|NOT COMPLETED|Overall Study||1
11389635|NCT03568500|12583815|FG000|STARTED|Overall Study||18
11389636|NCT03568500|12583816|FG001|STARTED|Overall Study||20
11389637|NCT03568500|12583817|FG002|STARTED|Overall Study||6
11389638|NCT03568500|12583815|FG000|Received At Least 1 Dose of Study Drug|Overall Study||18
11389639|NCT03568500|12583816|FG001|Received At Least 1 Dose of Study Drug|Overall Study||19
11389640|NCT03568500|12583817|FG002|Received At Least 1 Dose of Study Drug|Overall Study||6
11389641|NCT03568500|12583815|FG000|COMPLETED|Overall Study||8
11389642|NCT03568500|12583816|FG001|COMPLETED|Overall Study||14
11389643|NCT03568500|12583817|FG002|COMPLETED|Overall Study||2
11389644|NCT03568500|12583815|FG000|NOT COMPLETED|Overall Study||10
11389645|NCT03568500|12583816|FG001|NOT COMPLETED|Overall Study||6
11389646|NCT03568500|12583817|FG002|NOT COMPLETED|Overall Study||4
11389647|NCT03568539|12583832|FG000|STARTED|Overall Study||3
11389648|NCT03568539|12583833|FG001|STARTED|Overall Study||36
11389649|NCT03568539|12583832|FG000|COMPLETED|Overall Study||3
11389650|NCT03568539|12583833|FG001|COMPLETED|Overall Study||36
11389651|NCT03568539|12583832|FG000|NOT COMPLETED|Overall Study||0
11389652|NCT03568539|12583833|FG001|NOT COMPLETED|Overall Study||0
11389653|NCT03568942|12583840|FG000|STARTED|Overall Study||22
11389654|NCT03568942|12583840|FG000|COMPLETED|Overall Study||20
11389655|NCT03568942|12583840|FG000|NOT COMPLETED|Overall Study||2
11389656|NCT03569020|12583846|FG000|STARTED|Period 1||22
11006144|NCT00726882|12183922|FG000|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
11006145|NCT00726882|12183922|FG000|COMPLETED|Overall Study||13
11006146|NCT00726882|12183922|FG000|NOT COMPLETED|Overall Study||22
11006147|NCT00726895|12183928|FG000|STARTED|First Intervention||12
11006148|NCT00726895|12183929|FG001|STARTED|First Intervention||12
11006149|NCT00726895|12183928|FG000|COMPLETED|First Intervention||12
11006150|NCT00726895|12183929|FG001|COMPLETED|First Intervention||12
11006151|NCT00726895|12183928|FG000|NOT COMPLETED|First Intervention||0
11389657|NCT03569020|12583847|FG001|STARTED|Period 1||21
11389658|NCT03569020|12583846|FG000|COMPLETED|Period 1||22
11389659|NCT03569020|12583847|FG001|COMPLETED|Period 1||21
11389660|NCT03569020|12583846|FG000|NOT COMPLETED|Period 1||0
11389661|NCT03569020|12583847|FG001|NOT COMPLETED|Period 1||0
11389662|NCT03569020|12583846|FG000|STARTED|Period 2||22
11389663|NCT03569020|12583847|FG001|STARTED|Period 2||21
11389664|NCT03569020|12583846|FG000|COMPLETED|Period 2||22
11389665|NCT03569020|12583847|FG001|COMPLETED|Period 2||21
11389666|NCT03569020|12583846|FG000|NOT COMPLETED|Period 2||0
11389667|NCT03569020|12583847|FG001|NOT COMPLETED|Period 2||0
11389668|NCT03569033|12583859|FG000|STARTED|Overall Study||23
11389669|NCT03569033|12583860|FG001|STARTED|Overall Study||23
11389670|NCT03569033|12583859|FG000|COMPLETED|Overall Study||23
11006152|NCT00726895|12183929|FG001|NOT COMPLETED|First Intervention||0
11006153|NCT00726895|12183928|FG000|STARTED|Washout Period of 7 Days||12
11389671|NCT03569033|12583860|FG001|COMPLETED|Overall Study||23
11389672|NCT03569033|12583859|FG000|NOT COMPLETED|Overall Study||0
11389673|NCT03569033|12583860|FG001|NOT COMPLETED|Overall Study||0
11389674|NCT03569098|12583869|FG000|STARTED|Double-Blind Treatment Cycle 1||63
11389675|NCT03569098|12583870|FG001|STARTED|Double-Blind Treatment Cycle 1||63
11389676|NCT03569098|12583871|FG002|STARTED|Double-Blind Treatment Cycle 1||60
11389677|NCT03569098|12583869|FG000|Received Study Medication|Double-Blind Treatment Cycle 1||61
11389678|NCT03569098|12583870|FG001|Received Study Medication|Double-Blind Treatment Cycle 1||63
11389679|NCT03569098|12583871|FG002|Received Study Medication|Double-Blind Treatment Cycle 1||56
11389680|NCT03569098|12583869|FG000|COMPLETED|Double-Blind Treatment Cycle 1||55
11389681|NCT03569098|12583870|FG001|COMPLETED|Double-Blind Treatment Cycle 1||53
11389682|NCT03569098|12583871|FG002|COMPLETED|Double-Blind Treatment Cycle 1||49
11389683|NCT03569098|12583869|FG000|NOT COMPLETED|Double-Blind Treatment Cycle 1||8
11389684|NCT03569098|12583870|FG001|NOT COMPLETED|Double-Blind Treatment Cycle 1||10
11389685|NCT03569098|12583871|FG002|NOT COMPLETED|Double-Blind Treatment Cycle 1||11
11389686|NCT03569098|12583869|FG000|STARTED|Open-Label Treatment Cycle 2|No participants were treated with placebo during the open-label treatment cycle 2.|0
11389687|NCT03569098|12583870|FG001|STARTED|Open-Label Treatment Cycle 2|All participants who met retreatment criteria were treated with Dysport 300 U during the open-label treatment cycle 2.|146
11389688|NCT03569098|12583871|FG002|STARTED|Open-Label Treatment Cycle 2|No participants were treated with Dysport 500 U during the open-label treatment cycle 2.|0
11389689|NCT03569098|12583869|FG000|COMPLETED|Open-Label Treatment Cycle 2||0
11389690|NCT03569098|12583870|FG001|COMPLETED|Open-Label Treatment Cycle 2||111
11389691|NCT03569098|12583871|FG002|COMPLETED|Open-Label Treatment Cycle 2||0
11389692|NCT03569098|12583869|FG000|NOT COMPLETED|Open-Label Treatment Cycle 2||0
11389693|NCT03569098|12583870|FG001|NOT COMPLETED|Open-Label Treatment Cycle 2||35
11389694|NCT03569098|12583871|FG002|NOT COMPLETED|Open-Label Treatment Cycle 2||0
11389695|NCT03569098|12583869|FG000|STARTED|Open-Label Treatment Cycle 3||0
11389696|NCT03569098|12583870|FG001|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 300 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|8
11389697|NCT03569098|12583871|FG002|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 500 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|56
11389698|NCT03569098|12583869|FG000|COMPLETED|Open-Label Treatment Cycle 3||0
11389699|NCT03569098|12583870|FG001|COMPLETED|Open-Label Treatment Cycle 3||7
11389700|NCT03569098|12583871|FG002|COMPLETED|Open-Label Treatment Cycle 3||50
11389701|NCT03569098|12583869|FG000|NOT COMPLETED|Open-Label Treatment Cycle 3||0
11389702|NCT03569098|12583870|FG001|NOT COMPLETED|Open-Label Treatment Cycle 3||1
11389703|NCT03569098|12583871|FG002|NOT COMPLETED|Open-Label Treatment Cycle 3||6
11389704|NCT03569202|12583884|FG000|STARTED|Part 1|Emulsion Eye Drops were used on one eye only.|3
11389705|NCT03569202|12583885|FG001|STARTED|Part 1|Control Eye Drops were not used for Part 1.|0
11389706|NCT03569202|12583884|FG000|COMPLETED|Part 1|No participant completing Part 1 was allowed to continue to Parts 2 or 3.|3
11389707|NCT03569202|12583885|FG001|COMPLETED|Part 1||0
11389708|NCT03569202|12583884|FG000|NOT COMPLETED|Part 1||0
11389709|NCT03569202|12583885|FG001|NOT COMPLETED|Part 1||0
11389710|NCT03569202|12583884|FG000|STARTED|Part 2|Emulsion Eye Drops were used on one randomized eye. Participants were different from Part 1.|9
11389711|NCT03569202|12583885|FG001|STARTED|Part 2|Control Eye Drops were used on contralateral eye. Participants were different from Part 1.|9
11389712|NCT03569202|12583884|FG000|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
11389713|NCT03569202|12583885|FG001|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
11389714|NCT03569202|12583884|FG000|NOT COMPLETED|Part 2||0
11389715|NCT03569202|12583885|FG001|NOT COMPLETED|Part 2||0
11389716|NCT03569202|12583884|FG000|STARTED|Part 3|Emulsion Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
11389717|NCT03569202|12583885|FG001|STARTED|Part 3|Control Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
11389718|NCT03569202|12583884|FG000|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|24
11389719|NCT03569202|12583885|FG001|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|25
11389720|NCT03569202|12583884|FG000|NOT COMPLETED|Part 3||2
11389721|NCT03569202|12583885|FG001|NOT COMPLETED|Part 3||1
11389722|NCT03569397|12583893|FG000|STARTED|Overall Study||29
11389723|NCT03569397|12583894|FG001|STARTED|Overall Study||28
11389724|NCT03569397|12583893|FG000|COMPLETED|Overall Study||29
11389725|NCT03569397|12583894|FG001|COMPLETED|Overall Study||28
11389726|NCT03569397|12583893|FG000|NOT COMPLETED|Overall Study||0
11389727|NCT03569397|12583894|FG001|NOT COMPLETED|Overall Study||0
11389728|NCT03569618|12583901|FG000|STARTED|Overall Study||23
11389729|NCT03569618|12583902|FG001|STARTED|Overall Study||21
11389730|NCT03569618|12583901|FG000|COMPLETED|Overall Study||20
11389731|NCT03569618|12583902|FG001|COMPLETED|Overall Study||20
11389732|NCT03569618|12583901|FG000|NOT COMPLETED|Overall Study||3
11389733|NCT03569618|12583902|FG001|NOT COMPLETED|Overall Study||1
11389734|NCT03569748|12583911|FG000|STARTED|Overall Study||110
11389735|NCT03569748|12583912|FG001|STARTED|Overall Study||110
11389736|NCT03569748|12583911|FG000|COMPLETED|Overall Study||110
11389737|NCT03569748|12583912|FG001|COMPLETED|Overall Study||101
11389738|NCT03569748|12583911|FG000|NOT COMPLETED|Overall Study||0
11389739|NCT03569748|12583912|FG001|NOT COMPLETED|Overall Study||9
11389740|NCT03570047|12583929|FG000|STARTED|Overall Study||15902
11389741|NCT03570047|12583930|FG001|STARTED|Overall Study||22336
11389742|NCT03570047|12583931|FG002|STARTED|Overall Study||6925
11389743|NCT03570047|12583932|FG003|STARTED|Overall Study||16564
11389744|NCT03570047|12583933|FG004|STARTED|Overall Study||12262
11389745|NCT03570047|12583929|FG000|COMPLETED|Overall Study||15902
11389746|NCT03570047|12583930|FG001|COMPLETED|Overall Study||22336
11389747|NCT03570047|12583931|FG002|COMPLETED|Overall Study||6925
11389748|NCT03570047|12583932|FG003|COMPLETED|Overall Study||16564
11389749|NCT03570047|12583933|FG004|COMPLETED|Overall Study||12262
11389750|NCT03570047|12583929|FG000|NOT COMPLETED|Overall Study||0
11389751|NCT03570047|12583930|FG001|NOT COMPLETED|Overall Study||0
11389752|NCT03570047|12583931|FG002|NOT COMPLETED|Overall Study||0
11389753|NCT03570047|12583932|FG003|NOT COMPLETED|Overall Study||0
11389754|NCT03570047|12583933|FG004|NOT COMPLETED|Overall Study||0
11389755|NCT03570255|12583945|FG000|STARTED|Overall Study||28
11389756|NCT03570255|12583945|FG000|COMPLETED|Overall Study||28
11389757|NCT03570255|12583945|FG000|NOT COMPLETED|Overall Study||0
11389758|NCT03570476|12583949|FG000|STARTED|Overall Study||2
11389759|NCT03570476|12583949|FG000|COMPLETED|Overall Study||2
11389760|NCT03570476|12583949|FG000|NOT COMPLETED|Overall Study||0
11389761|NCT03570554|12583958|FG000|STARTED|Overall Study||10
11389762|NCT03570554|12583959|FG001|STARTED|Overall Study||10
11389763|NCT03570554|12583960|FG002|STARTED|Overall Study||11
11389764|NCT03570554|12583961|FG003|STARTED|Overall Study||10
11389765|NCT03570554|12583958|FG000|COMPLETED|Overall Study||10
11389766|NCT03570554|12583959|FG001|COMPLETED|Overall Study||10
11389767|NCT03570554|12583960|FG002|COMPLETED|Overall Study||10
11389768|NCT03570554|12583961|FG003|COMPLETED|Overall Study||9
11389769|NCT03570554|12583958|FG000|NOT COMPLETED|Overall Study||0
11389770|NCT03570554|12583959|FG001|NOT COMPLETED|Overall Study||0
11389771|NCT03570554|12583960|FG002|NOT COMPLETED|Overall Study||1
11389772|NCT03570554|12583961|FG003|NOT COMPLETED|Overall Study||1
11389773|NCT03570658|12583975|FG000|STARTED|Single Ascending Dose (SAD)||6
11389774|NCT03570658|12583976|FG001|STARTED|Single Ascending Dose (SAD)||2
11389775|NCT03570658|12583977|FG002|STARTED|Single Ascending Dose (SAD)||10
11389776|NCT03570658|12583978|FG003|STARTED|Single Ascending Dose (SAD)||10
11389777|NCT03570658|12583975|FG000|COMPLETED|Single Ascending Dose (SAD)||6
11389778|NCT03570658|12583976|FG001|COMPLETED|Single Ascending Dose (SAD)||2
11389779|NCT03570658|12583977|FG002|COMPLETED|Single Ascending Dose (SAD)||10
11389780|NCT03570658|12583978|FG003|COMPLETED|Single Ascending Dose (SAD)||10
11389781|NCT03570658|12583975|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0
11389782|NCT03570658|12583976|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0
11389783|NCT03570658|12583977|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0
11389784|NCT03570658|12583978|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0
11389785|NCT03570658|12583975|FG000|STARTED|Multiple Ascending Dose (MAD)||4
11389786|NCT03570658|12583976|FG001|STARTED|Multiple Ascending Dose (MAD)||0
11389787|NCT03570658|12583977|FG002|STARTED|Multiple Ascending Dose (MAD)||10
11389788|NCT03570658|12583978|FG003|STARTED|Multiple Ascending Dose (MAD)||10
11389789|NCT03570658|12583975|FG000|COMPLETED|Multiple Ascending Dose (MAD)||4
11389790|NCT03570658|12583976|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0
11389791|NCT03570658|12583977|FG002|COMPLETED|Multiple Ascending Dose (MAD)||10
11389792|NCT03570658|12583978|FG003|COMPLETED|Multiple Ascending Dose (MAD)||10
11389793|NCT03570658|12583975|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11389794|NCT03570658|12583976|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11389795|NCT03570658|12583977|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11389796|NCT03570658|12583978|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
11389797|NCT03571256|12584005|FG000|STARTED|Overall Study||52
11389798|NCT03571256|12584006|FG001|STARTED|Overall Study||54
11389799|NCT03571256|12584007|FG002|STARTED|Overall Study||52
11389800|NCT03571256|12584005|FG000|Safety Analysis Set|Overall Study||52
11389801|NCT03571256|12584006|FG001|Safety Analysis Set|Overall Study||54
11389802|NCT03571256|12584007|FG002|Safety Analysis Set|Overall Study||51
11389803|NCT03571256|12584005|FG000|Modified ITT (mITT) Analysis Set|Overall Study||49
11389804|NCT03571256|12584006|FG001|Modified ITT (mITT) Analysis Set|Overall Study||53
11389805|NCT03571256|12584007|FG002|Modified ITT (mITT) Analysis Set|Overall Study||51
11389806|NCT03571256|12584005|FG000|COMPLETED|Overall Study||46
11389807|NCT03571256|12584006|FG001|COMPLETED|Overall Study||51
11389808|NCT03571256|12584007|FG002|COMPLETED|Overall Study||48
11389809|NCT03571256|12584005|FG000|NOT COMPLETED|Overall Study||6
11389810|NCT03571256|12584006|FG001|NOT COMPLETED|Overall Study||3
11389811|NCT03571256|12584007|FG002|NOT COMPLETED|Overall Study||4
11389812|NCT03571516|12584019|FG000|STARTED|Overall Study||5
11389813|NCT03571516|12584020|FG001|STARTED|Overall Study||5
11389814|NCT03571516|12584019|FG000|COMPLETED|Overall Study||4
11389815|NCT03571516|12584020|FG001|COMPLETED|Overall Study||4
11389816|NCT03571516|12584019|FG000|NOT COMPLETED|Overall Study||1
11389817|NCT03571516|12584020|FG001|NOT COMPLETED|Overall Study||1
11389818|NCT03571555|12584028|FG000|STARTED|Overall Study||252
11389819|NCT03571555|12584029|FG001|STARTED|Overall Study||263
11389820|NCT03571555|12584028|FG000|COMPLETED|Overall Study||177
11389821|NCT03571555|12584029|FG001|COMPLETED|Overall Study||195
11389822|NCT03571555|12584028|FG000|NOT COMPLETED|Overall Study||75
11389823|NCT03571555|12584029|FG001|NOT COMPLETED|Overall Study||68
11389824|NCT03571607|12584037|FG000|STARTED|Overall Study||53
11389825|NCT03571607|12584038|FG001|STARTED|Overall Study||153
11389826|NCT03571607|12584037|FG000|Vaccinated|Overall Study||53
11389827|NCT03571607|12584038|FG001|Vaccinated|Overall Study||153
11389828|NCT03571607|12584037|FG000|COMPLETED|Overall Study||53
11389829|NCT03571607|12584038|FG001|COMPLETED|Overall Study||153
11389830|NCT03571607|12584037|FG000|NOT COMPLETED|Overall Study||0
11389831|NCT03571607|12584038|FG001|NOT COMPLETED|Overall Study||0
11389832|NCT03571672|12584046|FG000|STARTED|Overall Study||153
11389833|NCT03571672|12584046|FG000|COMPLETED|Overall Study||148
11389834|NCT03571672|12584046|FG000|NOT COMPLETED|Overall Study||5
11389835|NCT03571724|12584056|FG000|STARTED|Week -1 (Prior to Switching)||0
11389836|NCT03571724|12584057|FG001|STARTED|Week -1 (Prior to Switching)||0
11389837|NCT03571724|12584058|FG002|STARTED|Week -1 (Prior to Switching)||72
11389838|NCT03571724|12584059|FG003|STARTED|Week -1 (Prior to Switching)||70
11389839|NCT03571724|12584056|FG000|Topography|Week -1 (Prior to Switching)||0
11389840|NCT03571724|12584057|FG001|Topography|Week -1 (Prior to Switching)||0
11389841|NCT03571724|12584058|FG002|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
11389842|NCT03571724|12584059|FG003|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
11389843|NCT03571724|12584056|FG000|PK Nicotine|Week -1 (Prior to Switching)||0
11389844|NCT03571724|12584057|FG001|PK Nicotine|Week -1 (Prior to Switching)||0
11389845|NCT03571724|12584058|FG002|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
11389846|NCT03571724|12584059|FG003|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
11389847|NCT03571724|12584056|FG000|COMPLETED|Week -1 (Prior to Switching)||0
11389848|NCT03571724|12584057|FG001|COMPLETED|Week -1 (Prior to Switching)||0
11389849|NCT03571724|12584058|FG002|COMPLETED|Week -1 (Prior to Switching)||72
11389850|NCT03571724|12584059|FG003|COMPLETED|Week -1 (Prior to Switching)||70
11389851|NCT03571724|12584056|FG000|NOT COMPLETED|Week -1 (Prior to Switching)||0
11389852|NCT03571724|12584057|FG001|NOT COMPLETED|Week -1 (Prior to Switching)||0
11389853|NCT03571724|12584058|FG002|NOT COMPLETED|Week -1 (Prior to Switching)||0
11389854|NCT03571724|12584059|FG003|NOT COMPLETED|Week -1 (Prior to Switching)||0
11389855|NCT03571724|12584056|FG000|STARTED|Week 1-6|Non-menthol VLN subjects were assigned to this arm after randomization at week 1|50
11389856|NCT03571724|12584057|FG001|STARTED|Week 1-6|Menthol VLN subjects were assigned to this arm after randomization at week 1|50
11389857|NCT03571724|12584058|FG002|STARTED|Week 1-6||22
11389858|NCT03571724|12584059|FG003|STARTED|Week 1-6||20
11006154|NCT00726895|12183929|FG001|STARTED|Washout Period of 7 Days||12
11006155|NCT00726895|12183928|FG000|COMPLETED|Washout Period of 7 Days||12
11006156|NCT00726895|12183929|FG001|COMPLETED|Washout Period of 7 Days||11
11006157|NCT00726895|12183928|FG000|NOT COMPLETED|Washout Period of 7 Days||0
11006158|NCT00726895|12183929|FG001|NOT COMPLETED|Washout Period of 7 Days||1
11006159|NCT00726895|12183928|FG000|STARTED|Second Intervention||12
11006160|NCT00726895|12183929|FG001|STARTED|Second Intervention||11
11006161|NCT00726895|12183928|FG000|COMPLETED|Second Intervention||12
11006162|NCT00726895|12183929|FG001|COMPLETED|Second Intervention||11
11006163|NCT00726895|12183928|FG000|NOT COMPLETED|Second Intervention||0
11389859|NCT03571724|12584056|FG000|COMPLETED|Week 1-6||43
11389860|NCT03571724|12584057|FG001|COMPLETED|Week 1-6||42
11389861|NCT03571724|12584058|FG002|COMPLETED|Week 1-6||19
11389862|NCT03571724|12584059|FG003|COMPLETED|Week 1-6||20
11389863|NCT03571724|12584056|FG000|NOT COMPLETED|Week 1-6||7
11389864|NCT03571724|12584057|FG001|NOT COMPLETED|Week 1-6||8
11389865|NCT03571724|12584058|FG002|NOT COMPLETED|Week 1-6||3
11389866|NCT03571724|12584059|FG003|NOT COMPLETED|Week 1-6||0
11389867|NCT03572062|12584090|FG000|STARTED|Overall Study||32
11389868|NCT03572062|12584091|FG001|STARTED|Overall Study||32
11389869|NCT03572062|12584092|FG002|STARTED|Overall Study||32
11389870|NCT03572062|12584093|FG003|STARTED|Overall Study||31
11389871|NCT03572062|12584094|FG004|STARTED|Overall Study||32
11389872|NCT03572062|12584095|FG005|STARTED|Overall Study||32
11389873|NCT03572062|12584096|FG006|STARTED|Overall Study||32
11389874|NCT03572062|12584097|FG007|STARTED|Overall Study||31
11389875|NCT03572062|12584098|FG008|STARTED|Overall Study||32
11389876|NCT03572062|12584099|FG009|STARTED|Overall Study||31
11389877|NCT03572062|12584090|FG000|Treated|Overall Study||32
11389878|NCT03572062|12584091|FG001|Treated|Overall Study||32
11389879|NCT03572062|12584092|FG002|Treated|Overall Study||32
11389880|NCT03572062|12584093|FG003|Treated|Overall Study||31
11389881|NCT03572062|12584094|FG004|Treated|Overall Study||31
11389882|NCT03572062|12584095|FG005|Treated|Overall Study||30
11389883|NCT03572062|12584096|FG006|Treated|Overall Study||32
11389884|NCT03572062|12584097|FG007|Treated|Overall Study||30
11389885|NCT03572062|12584098|FG008|Treated|Overall Study||32
11389886|NCT03572062|12584099|FG009|Treated|Overall Study||31
11389887|NCT03572062|12584090|FG000|COMPLETED|Overall Study||32
11389888|NCT03572062|12584091|FG001|COMPLETED|Overall Study||32
11389889|NCT03572062|12584092|FG002|COMPLETED|Overall Study||32
11389890|NCT03572062|12584093|FG003|COMPLETED|Overall Study||31
11006164|NCT00726895|12183929|FG001|NOT COMPLETED|Second Intervention||0
11006165|NCT00726986|12183936|FG000|STARTED|Induction Phase||18
11006166|NCT00726986|12183936|FG000|Maintance|Induction Phase||3
11006167|NCT00726986|12183936|FG000|COMPLETED|Induction Phase||3
11006168|NCT00726986|12183936|FG000|NOT COMPLETED|Induction Phase||15
11389891|NCT03572062|12584094|FG004|COMPLETED|Overall Study||31
11389892|NCT03572062|12584095|FG005|COMPLETED|Overall Study||28
11389893|NCT03572062|12584096|FG006|COMPLETED|Overall Study||31
11389894|NCT03572062|12584097|FG007|COMPLETED|Overall Study||30
11389895|NCT03572062|12584098|FG008|COMPLETED|Overall Study||0
11389896|NCT03572062|12584099|FG009|COMPLETED|Overall Study||0
11389897|NCT03572062|12584090|FG000|NOT COMPLETED|Overall Study||0
11389898|NCT03572062|12584091|FG001|NOT COMPLETED|Overall Study||0
11389899|NCT03572062|12584092|FG002|NOT COMPLETED|Overall Study||0
11389900|NCT03572062|12584093|FG003|NOT COMPLETED|Overall Study||0
11389901|NCT03572062|12584094|FG004|NOT COMPLETED|Overall Study||1
11389902|NCT03572062|12584095|FG005|NOT COMPLETED|Overall Study||4
11389903|NCT03572062|12584096|FG006|NOT COMPLETED|Overall Study||1
11389904|NCT03572062|12584097|FG007|NOT COMPLETED|Overall Study||1
11389905|NCT03572062|12584098|FG008|NOT COMPLETED|Overall Study||32
11389906|NCT03572062|12584099|FG009|NOT COMPLETED|Overall Study||31
11389907|NCT03572218|12584121|FG000|STARTED|Overall Study||36
11389908|NCT03572218|12584122|FG001|STARTED|Overall Study||36
11389909|NCT03572218|12584121|FG000|Week 12|Overall Study||30
11389910|NCT03572218|12584122|FG001|Week 12|Overall Study||31
11389911|NCT03572218|12584121|FG000|Week 26|Overall Study||30
11389912|NCT03572218|12584122|FG001|Week 26|Overall Study||31
11389913|NCT03572218|12584121|FG000|COMPLETED|Overall Study||30
11389914|NCT03572218|12584122|FG001|COMPLETED|Overall Study||31
11389915|NCT03572218|12584121|FG000|NOT COMPLETED|Overall Study||6
11389916|NCT03572218|12584122|FG001|NOT COMPLETED|Overall Study||5
11389917|NCT03572478|12584128|FG000|STARTED|Overall Study||12
11389918|NCT03572478|12584128|FG000|COMPLETED|Overall Study||12
11389919|NCT03572478|12584128|FG000|NOT COMPLETED|Overall Study||0
11389920|NCT03572972|12584137|FG000|STARTED|Overall Study||10548
11389921|NCT03572972|12584138|FG001|STARTED|Overall Study||11414
11389922|NCT03572972|12584139|FG002|STARTED|Overall Study||17779
11389923|NCT03572972|12584140|FG003|STARTED|Overall Study||8648
11389924|NCT03572972|12584141|FG004|STARTED|Overall Study||16295
11389925|NCT03572972|12584137|FG000|COMPLETED|Overall Study||10548
11389926|NCT03572972|12584138|FG001|COMPLETED|Overall Study||11414
11389927|NCT03572972|12584139|FG002|COMPLETED|Overall Study||17779
11389928|NCT03572972|12584140|FG003|COMPLETED|Overall Study||8648
11389929|NCT03572972|12584141|FG004|COMPLETED|Overall Study||16295
11389930|NCT03572972|12584137|FG000|NOT COMPLETED|Overall Study||0
11389931|NCT03572972|12584138|FG001|NOT COMPLETED|Overall Study||0
11389932|NCT03572972|12584139|FG002|NOT COMPLETED|Overall Study||0
11389933|NCT03572972|12584140|FG003|NOT COMPLETED|Overall Study||0
11389934|NCT03572972|12584141|FG004|NOT COMPLETED|Overall Study||0
11389935|NCT03573206|12584161|FG000|STARTED|Overall Study||168
11389936|NCT03573206|12584161|FG000|COMPLETED|Overall Study||168
11389937|NCT03573206|12584161|FG000|NOT COMPLETED|Overall Study||0
11389938|NCT03573323|12584167|FG000|STARTED|Blinded Treatment Period (Weeks 0-24)||520
11389939|NCT03573323|12584168|FG001|STARTED|Blinded Treatment Period (Weeks 0-24)||507
11389940|NCT03573323|12584167|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||519
11389941|NCT03573323|12584168|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||506
11389942|NCT03573323|12584167|FG000|COMPLETED|Blinded Treatment Period (Weeks 0-24)||465
11389943|NCT03573323|12584168|FG001|COMPLETED|Blinded Treatment Period (Weeks 0-24)||459
11389944|NCT03573323|12584167|FG000|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||55
11389945|NCT03573323|12584168|FG001|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||48
11389946|NCT03573323|12584167|FG000|STARTED|Post-Treatment Follow Up (Weeks 25-36)||465
11389947|NCT03573323|12584168|FG001|STARTED|Post-Treatment Follow Up (Weeks 25-36)|Excludes participants who completed treatment and did not enter the PTFU.|456
11389948|NCT03573323|12584167|FG000|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||406
11389949|NCT03573323|12584168|FG001|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||399
11389950|NCT03573323|12584167|FG000|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||59
11389951|NCT03573323|12584168|FG001|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||57
11389952|NCT03573505|12584180|FG000|STARTED|Overall Study||52
11389953|NCT03573505|12584181|FG001|STARTED|Overall Study||54
11389954|NCT03573505|12584180|FG000|COMPLETED|Overall Study||0
11389955|NCT03573505|12584181|FG001|COMPLETED|Overall Study||0
11389956|NCT03573505|12584180|FG000|NOT COMPLETED|Overall Study||52
11389957|NCT03573505|12584181|FG001|NOT COMPLETED|Overall Study||54
11389958|NCT03573804|12584188|FG000|STARTED|Overall Study||72
11389959|NCT03573804|12584188|FG000|COMPLETED|Overall Study||62
11389960|NCT03573804|12584188|FG000|NOT COMPLETED|Overall Study||10
11389961|NCT03573830|12584200|FG000|STARTED|Overall Study||364
11389962|NCT03573830|12584201|FG001|STARTED|Overall Study||367
11389963|NCT03573830|12584200|FG000|Reviewed Assigned Material|Overall Study|All participants assigned to this arm reviewed their assigned material.|364
11389964|NCT03573830|12584201|FG001|Reviewed Assigned Material|Overall Study|360 reviewed their assigned material:Transport Canada information plus the enhanced material.|360
11389965|NCT03573830|12584200|FG000|COMPLETED|Overall Study||360
11389966|NCT03573830|12584201|FG001|COMPLETED|Overall Study||360
11389967|NCT03573830|12584200|FG000|NOT COMPLETED|Overall Study||4
11389968|NCT03573830|12584201|FG001|NOT COMPLETED|Overall Study||7
11389969|NCT03573908|12584208|FG000|STARTED|Treatment Period||308
11389970|NCT03573908|12584209|FG001|STARTED|Treatment Period||306
11389971|NCT03573908|12584210|FG002|STARTED|Treatment Period||0
11389972|NCT03573908|12584211|FG003|STARTED|Treatment Period||0
11389973|NCT03573908|12584212|FG004|STARTED|Treatment Period||0
11389974|NCT03573908|12584208|FG000|COMPLETED|Treatment Period||284
11389975|NCT03573908|12584209|FG001|COMPLETED|Treatment Period||280
11389976|NCT03573908|12584210|FG002|COMPLETED|Treatment Period||0
11389977|NCT03573908|12584211|FG003|COMPLETED|Treatment Period||0
11389978|NCT03573908|12584212|FG004|COMPLETED|Treatment Period||0
11389979|NCT03573908|12584208|FG000|NOT COMPLETED|Treatment Period||24
11389980|NCT03573908|12584209|FG001|NOT COMPLETED|Treatment Period||26
11389981|NCT03573908|12584210|FG002|NOT COMPLETED|Treatment Period||0
11389982|NCT03573908|12584211|FG003|NOT COMPLETED|Treatment Period||0
11389983|NCT03573908|12584212|FG004|NOT COMPLETED|Treatment Period||0
11389984|NCT03573908|12584208|FG000|STARTED|Randomized Withdrawal Period||0
11389985|NCT03573908|12584209|FG001|STARTED|Randomized Withdrawal Period||0
11389986|NCT03573908|12584210|FG002|STARTED|Randomized Withdrawal Period||280
11389987|NCT03573908|12584211|FG003|STARTED|Randomized Withdrawal Period||138
11389988|NCT03573908|12584212|FG004|STARTED|Randomized Withdrawal Period||139
11389989|NCT03573908|12584208|FG000|COMPLETED|Randomized Withdrawal Period||0
11389990|NCT03573908|12584209|FG001|COMPLETED|Randomized Withdrawal Period||0
11389991|NCT03573908|12584210|FG002|COMPLETED|Randomized Withdrawal Period||272
11389992|NCT03573908|12584211|FG003|COMPLETED|Randomized Withdrawal Period||136
11389993|NCT03573908|12584212|FG004|COMPLETED|Randomized Withdrawal Period||137
11389994|NCT03573908|12584208|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
11389995|NCT03573908|12584209|FG001|NOT COMPLETED|Randomized Withdrawal Period||0
11389996|NCT03573908|12584210|FG002|NOT COMPLETED|Randomized Withdrawal Period||8
11389997|NCT03573908|12584211|FG003|NOT COMPLETED|Randomized Withdrawal Period||2
11389998|NCT03573908|12584212|FG004|NOT COMPLETED|Randomized Withdrawal Period||2
11389999|NCT03574181|12584221|FG000|STARTED|Overall Study||9
11390000|NCT03574181|12584221|FG000|COMPLETED|Overall Study||0
11390001|NCT03574181|12584221|FG000|NOT COMPLETED|Overall Study||9
11390002|NCT03574441|12584228|FG000|STARTED|Overall Study||31
11390003|NCT03574441|12584229|FG001|STARTED|Overall Study||30
11390004|NCT03574441|12584230|FG002|STARTED|Overall Study||30
11390005|NCT03574441|12584228|FG000|COMPLETED|Overall Study||31
11390006|NCT03574441|12584229|FG001|COMPLETED|Overall Study||30
11390007|NCT03574441|12584230|FG002|COMPLETED|Overall Study||30
11390008|NCT03574441|12584228|FG000|NOT COMPLETED|Overall Study||0
11390009|NCT03574441|12584229|FG001|NOT COMPLETED|Overall Study||0
11390010|NCT03574441|12584230|FG002|NOT COMPLETED|Overall Study||0
11390011|NCT03574753|12584238|FG000|STARTED|Overall Study||23
11390012|NCT03574753|12584238|FG000|COMPLETED|Overall Study||0
11390013|NCT03574753|12584238|FG000|NOT COMPLETED|Overall Study||23
11390014|NCT03574818|12584243|FG000|STARTED|Overall Study||1
11390015|NCT03574818|12584243|FG000|COMPLETED|Overall Study||1
11390016|NCT03574818|12584243|FG000|NOT COMPLETED|Overall Study||0
11390017|NCT03575702|12584249|FG000|STARTED|Overall Study||149
11390018|NCT03575702|12584250|FG001|STARTED|Overall Study||150
11390019|NCT03575702|12584249|FG000|COMPLETED|Overall Study||143
11390020|NCT03575702|12584250|FG001|COMPLETED|Overall Study||146
11390021|NCT03575702|12584249|FG000|NOT COMPLETED|Overall Study||6
11390022|NCT03575702|12584250|FG001|NOT COMPLETED|Overall Study||4
11390023|NCT03575754|12584258|FG000|STARTED|Overall Study||25
11390024|NCT03575754|12584259|FG001|STARTED|Overall Study||25
11390025|NCT03575754|12584258|FG000|COMPLETED|Overall Study||25
11390026|NCT03575754|12584259|FG001|COMPLETED|Overall Study||25
11390027|NCT03575754|12584258|FG000|NOT COMPLETED|Overall Study||0
11390028|NCT03575754|12584259|FG001|NOT COMPLETED|Overall Study||0
11390029|NCT03575806|12584267|FG000|STARTED|Overall Study||25
11390030|NCT03575806|12584268|FG001|STARTED|Overall Study||27
11390031|NCT03575806|12584267|FG000|COMPLETED|Overall Study||25
11390032|NCT03575806|12584268|FG001|COMPLETED|Overall Study||23
11390033|NCT03575806|12584267|FG000|NOT COMPLETED|Overall Study||0
11390034|NCT03575806|12584268|FG001|NOT COMPLETED|Overall Study||4
11390035|NCT03575871|12584277|FG000|STARTED|Overall Study||158
11390036|NCT03575871|12584278|FG001|STARTED|Overall Study||155
11390037|NCT03575871|12584279|FG002|STARTED|Overall Study||78
11390038|NCT03575871|12584277|FG000|COMPLETED|Overall Study||137
11390039|NCT03575871|12584278|FG001|COMPLETED|Overall Study||141
11390040|NCT03575871|12584279|FG002|COMPLETED|Overall Study||52
11390041|NCT03575871|12584277|FG000|NOT COMPLETED|Overall Study||21
11390042|NCT03575871|12584278|FG001|NOT COMPLETED|Overall Study||14
11390043|NCT03575871|12584279|FG002|NOT COMPLETED|Overall Study||26
11390044|NCT03575962|12584287|FG000|STARTED|Treatment Period 1 (4 Days)||7
11390045|NCT03575962|12584288|FG001|STARTED|Treatment Period 1 (4 Days)||7
11390046|NCT03575962|12584287|FG000|COMPLETED|Treatment Period 1 (4 Days)||7
11390047|NCT03575962|12584288|FG001|COMPLETED|Treatment Period 1 (4 Days)||7
11390048|NCT03575962|12584287|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11390049|NCT03575962|12584288|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11390050|NCT03575962|12584287|FG000|STARTED|Washout Period (7 Days)||7
11390051|NCT03575962|12584288|FG001|STARTED|Washout Period (7 Days)||7
11390052|NCT03575962|12584287|FG000|COMPLETED|Washout Period (7 Days)||7
11390053|NCT03575962|12584288|FG001|COMPLETED|Washout Period (7 Days)||7
11390054|NCT03575962|12584287|FG000|NOT COMPLETED|Washout Period (7 Days)||0
11390055|NCT03575962|12584288|FG001|NOT COMPLETED|Washout Period (7 Days)||0
11390056|NCT03575962|12584287|FG000|STARTED|Treatment Period 2 (4 Days)||7
11390057|NCT03575962|12584288|FG001|STARTED|Treatment Period 2 (4 Days)||7
11390058|NCT03575962|12584287|FG000|COMPLETED|Treatment Period 2 (4 Days)||7
11390059|NCT03575962|12584288|FG001|COMPLETED|Treatment Period 2 (4 Days)||7
11390060|NCT03575962|12584287|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11390061|NCT03575962|12584288|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11390062|NCT03575975|12584297|FG000|STARTED|Overall Study||4
11390063|NCT03575975|12584298|FG001|STARTED|Overall Study||5
11390064|NCT03575975|12584299|FG002|STARTED|Overall Study||0
11390065|NCT03575975|12584297|FG000|COMPLETED|Overall Study||3
11390066|NCT03575975|12584298|FG001|COMPLETED|Overall Study||5
11390067|NCT03575975|12584299|FG002|COMPLETED|Overall Study||0
11390068|NCT03575975|12584297|FG000|NOT COMPLETED|Overall Study||1
11390069|NCT03575975|12584298|FG001|NOT COMPLETED|Overall Study||0
11390070|NCT03575975|12584299|FG002|NOT COMPLETED|Overall Study||0
11390071|NCT03576066|12584307|FG000|STARTED|Overall Study||45
11390072|NCT03576066|12584308|FG001|STARTED|Overall Study||28
11390073|NCT03576066|12584307|FG000|COMPLETED|Overall Study||45
11390074|NCT03576066|12584308|FG001|COMPLETED|Overall Study||27
11390075|NCT03576066|12584307|FG000|NOT COMPLETED|Overall Study||0
11390076|NCT03576066|12584308|FG001|NOT COMPLETED|Overall Study||1
11390077|NCT03576118|12584320|FG000|STARTED|Overall Study||37
11390078|NCT03576118|12584321|FG001|STARTED|Overall Study||37
11390079|NCT03576118|12584320|FG000|COMPLETED|Overall Study||34
11390080|NCT03576118|12584321|FG001|COMPLETED|Overall Study||33
11390081|NCT03576118|12584320|FG000|NOT COMPLETED|Overall Study||3
11390082|NCT03576118|12584321|FG001|NOT COMPLETED|Overall Study||4
11390083|NCT03576183|12584329|FG000|STARTED|Overall Study||17
11390084|NCT03576183|12584330|FG001|STARTED|Overall Study||17
11390085|NCT03576183|12584329|FG000|COMPLETED|Overall Study||15
11390086|NCT03576183|12584330|FG001|COMPLETED|Overall Study||16
11390087|NCT03576183|12584329|FG000|NOT COMPLETED|Overall Study||2
11390088|NCT03576183|12584330|FG001|NOT COMPLETED|Overall Study||1
11390089|NCT03576768|12584340|FG000|STARTED|Overall Study||13
11390090|NCT03576768|12584341|FG001|STARTED|Overall Study||12
11390091|NCT03576768|12584342|FG002|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
11390092|NCT03576768|12584343|FG003|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
11390093|NCT03576768|12584340|FG000|COMPLETED|Overall Study||10
11390094|NCT03576768|12584341|FG001|COMPLETED|Overall Study||9
11390095|NCT03576768|12584342|FG002|COMPLETED|Overall Study||0
11390096|NCT03576768|12584343|FG003|COMPLETED|Overall Study||0
11390097|NCT03576768|12584340|FG000|NOT COMPLETED|Overall Study||3
11390098|NCT03576768|12584341|FG001|NOT COMPLETED|Overall Study||3
11390099|NCT03576768|12584342|FG002|NOT COMPLETED|Overall Study||0
11390100|NCT03576768|12584343|FG003|NOT COMPLETED|Overall Study||0
11390101|NCT03577171|12584355|FG000|STARTED|Overall Study||13
11390102|NCT03577171|12584356|FG001|STARTED|Overall Study||12
11390103|NCT03577171|12584355|FG000|COMPLETED|Overall Study||13
11390104|NCT03577171|12584356|FG001|COMPLETED|Overall Study||12
11390105|NCT03577171|12584355|FG000|NOT COMPLETED|Overall Study||0
11390106|NCT03577171|12584356|FG001|NOT COMPLETED|Overall Study||0
11390107|NCT03577275|12584362|FG000|STARTED|Overall Study|All participants received all of the 4 interventions|32
11390108|NCT03577275|12584362|FG000|Placebo|Overall Study||32
11390109|NCT03577275|12584362|FG000|Moxifloxacin 400mg|Overall Study||32
11390110|NCT03577275|12584362|FG000|NST-4016 600mg|Overall Study||32
11390111|NCT03577275|12584362|FG000|NST-4016 2000mg|Overall Study||32
11390112|NCT03577275|12584362|FG000|COMPLETED|Overall Study||32
11390113|NCT03577275|12584362|FG000|NOT COMPLETED|Overall Study||0
11390114|NCT03577730|12584378|FG000|STARTED|Overall Study||34
11390115|NCT03577730|12584379|FG001|STARTED|Overall Study||31
11390116|NCT03577730|12584378|FG000|Received Treatment|Overall Study||33
11390117|NCT03577730|12584379|FG001|Received Treatment|Overall Study||31
11390118|NCT03577730|12584378|FG000|COMPLETED|Overall Study||30
11390119|NCT03577730|12584379|FG001|COMPLETED|Overall Study||30
11390120|NCT03577730|12584378|FG000|NOT COMPLETED|Overall Study||4
11390121|NCT03577730|12584379|FG001|NOT COMPLETED|Overall Study||1
11390122|NCT03578146|12584391|FG000|STARTED|Overall Study||16
11390123|NCT03578146|12584392|FG001|STARTED|Overall Study||6
11390124|NCT03578146|12584393|FG002|STARTED|Overall Study||6
11390125|NCT03578146|12584394|FG003|STARTED|Overall Study||6
11390126|NCT03578146|12584395|FG004|STARTED|Overall Study||6
11390127|NCT03578146|12584396|FG005|STARTED|Overall Study||8
11390128|NCT03578146|12584391|FG000|COMPLETED|Overall Study||15
11390129|NCT03578146|12584392|FG001|COMPLETED|Overall Study||5
11390130|NCT03578146|12584393|FG002|COMPLETED|Overall Study||5
11390131|NCT03578146|12584394|FG003|COMPLETED|Overall Study||6
11390132|NCT03578146|12584395|FG004|COMPLETED|Overall Study||6
11390133|NCT03578146|12584396|FG005|COMPLETED|Overall Study||5
11390134|NCT03578146|12584391|FG000|NOT COMPLETED|Overall Study||1
11390135|NCT03578146|12584392|FG001|NOT COMPLETED|Overall Study||1
11390136|NCT03578146|12584393|FG002|NOT COMPLETED|Overall Study||1
11390137|NCT03578146|12584394|FG003|NOT COMPLETED|Overall Study||0
11390138|NCT03578146|12584395|FG004|NOT COMPLETED|Overall Study||0
11390139|NCT03578146|12584396|FG005|NOT COMPLETED|Overall Study||3
11390140|NCT03578549|12584410|FG000|STARTED|Overall Study||30
11390141|NCT03578549|12584410|FG000|COMPLETED|Overall Study||29
11390142|NCT03578549|12584410|FG000|NOT COMPLETED|Overall Study||1
11390143|NCT03578926|12584414|FG000|STARTED|First Intervention||21
11390144|NCT03578926|12584415|FG001|STARTED|First Intervention||23
11390145|NCT03578926|12584414|FG000|COMPLETED|First Intervention||21
11390146|NCT03578926|12584415|FG001|COMPLETED|First Intervention||23
11390147|NCT03578926|12584414|FG000|NOT COMPLETED|First Intervention||0
11390148|NCT03578926|12584415|FG001|NOT COMPLETED|First Intervention||0
11390149|NCT03578926|12584414|FG000|STARTED|Second Intervention||23
11390150|NCT03578926|12584415|FG001|STARTED|Second Intervention||21
11390151|NCT03578926|12584414|FG000|COMPLETED|Second Intervention||23
11390152|NCT03578926|12584415|FG001|COMPLETED|Second Intervention||21
11390153|NCT03578926|12584414|FG000|NOT COMPLETED|Second Intervention||0
11390154|NCT03578926|12584415|FG001|NOT COMPLETED|Second Intervention||0
11390155|NCT03579290|12584423|FG000|STARTED|Overall Study||40
11390156|NCT03579290|12584423|FG000|COMPLETED|Overall Study||31
11390157|NCT03579290|12584423|FG000|NOT COMPLETED|Overall Study||9
11390158|NCT03579433|12584427|FG000|STARTED|Overall Study||104
11390159|NCT03579433|12584427|FG000|ORA With VerifEye+|Overall Study||96
11390160|NCT03579433|12584427|FG000|Barrett Calculator|Overall Study||102
11390161|NCT03579433|12584427|FG000|COMPLETED|Overall Study||98
11390162|NCT03579433|12584427|FG000|NOT COMPLETED|Overall Study||6
11390163|NCT03579719|12584435|FG000|STARTED|Overall Study||15
11390164|NCT03579719|12584435|FG000|COMPLETED|Overall Study||14
11390165|NCT03579719|12584435|FG000|NOT COMPLETED|Overall Study||1
11390166|NCT03579940|12584450|FG000|STARTED|Period 1||3
11390167|NCT03579940|12584451|FG001|STARTED|Period 1||2
11390168|NCT03579940|12584452|FG002|STARTED|Period 1||2
11390169|NCT03579940|12584453|FG003|STARTED|Period 1||2
11390170|NCT03579940|12584454|FG004|STARTED|Period 1||2
11390171|NCT03579940|12584455|FG005|STARTED|Period 1||2
11390172|NCT03579940|12584456|FG006|STARTED|Period 1||3
11390173|NCT03579940|12584457|FG007|STARTED|Period 1||3
11390174|NCT03579940|12584458|FG008|STARTED|Period 1||3
11390175|NCT03579940|12584459|FG009|STARTED|Period 1||2
11390176|NCT03579940|12584460|FG010|STARTED|Period 1||3
11390177|NCT03579940|12584450|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
11390178|NCT03579940|12584451|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
11390179|NCT03579940|12584452|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
11390180|NCT03579940|12584453|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
11390181|NCT03579940|12584454|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
11390182|NCT03579940|12584455|FG005|Received at Least 1 Dose of Study Drug|Period 1||2
11390183|NCT03579940|12584456|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
11390184|NCT03579940|12584457|FG007|Received at Least 1 Dose of Study Drug|Period 1||3
11390185|NCT03579940|12584458|FG008|Received at Least 1 Dose of Study Drug|Period 1||3
11390186|NCT03579940|12584459|FG009|Received at Least 1 Dose of Study Drug|Period 1||2
11390187|NCT03579940|12584460|FG010|Received at Least 1 Dose of Study Drug|Period 1||3
11390188|NCT03579940|12584450|FG000|COMPLETED|Period 1||3
11390189|NCT03579940|12584451|FG001|COMPLETED|Period 1||2
11390190|NCT03579940|12584452|FG002|COMPLETED|Period 1||2
11390191|NCT03579940|12584453|FG003|COMPLETED|Period 1||2
11390192|NCT03579940|12584454|FG004|COMPLETED|Period 1||2
11390193|NCT03579940|12584455|FG005|COMPLETED|Period 1||2
11390194|NCT03579940|12584456|FG006|COMPLETED|Period 1||3
11390195|NCT03579940|12584457|FG007|COMPLETED|Period 1||3
11390196|NCT03579940|12584458|FG008|COMPLETED|Period 1||3
11390197|NCT03579940|12584459|FG009|COMPLETED|Period 1||2
11390198|NCT03579940|12584460|FG010|COMPLETED|Period 1||3
11390199|NCT03579940|12584450|FG000|NOT COMPLETED|Period 1||0
11390200|NCT03579940|12584451|FG001|NOT COMPLETED|Period 1||0
11390201|NCT03579940|12584452|FG002|NOT COMPLETED|Period 1||0
11390202|NCT03579940|12584453|FG003|NOT COMPLETED|Period 1||0
11390203|NCT03579940|12584454|FG004|NOT COMPLETED|Period 1||0
11390204|NCT03579940|12584455|FG005|NOT COMPLETED|Period 1||0
11390205|NCT03579940|12584456|FG006|NOT COMPLETED|Period 1||0
11390206|NCT03579940|12584457|FG007|NOT COMPLETED|Period 1||0
11390207|NCT03579940|12584458|FG008|NOT COMPLETED|Period 1||0
11390208|NCT03579940|12584459|FG009|NOT COMPLETED|Period 1||0
11390209|NCT03579940|12584460|FG010|NOT COMPLETED|Period 1||0
11390210|NCT03579940|12584450|FG000|STARTED|Period 2||3
11390211|NCT03579940|12584451|FG001|STARTED|Period 2||2
11390212|NCT03579940|12584452|FG002|STARTED|Period 2||2
11390213|NCT03579940|12584453|FG003|STARTED|Period 2||2
11390214|NCT03579940|12584454|FG004|STARTED|Period 2||2
11390215|NCT03579940|12584455|FG005|STARTED|Period 2||2
11390216|NCT03579940|12584456|FG006|STARTED|Period 2||3
11390217|NCT03579940|12584457|FG007|STARTED|Period 2||3
11390218|NCT03579940|12584458|FG008|STARTED|Period 2||3
11390219|NCT03579940|12584459|FG009|STARTED|Period 2||2
11390220|NCT03579940|12584460|FG010|STARTED|Period 2||3
11390221|NCT03579940|12584450|FG000|COMPLETED|Period 2||3
11390222|NCT03579940|12584451|FG001|COMPLETED|Period 2||2
11390223|NCT03579940|12584452|FG002|COMPLETED|Period 2||1
11390224|NCT03579940|12584453|FG003|COMPLETED|Period 2||2
11390225|NCT03579940|12584454|FG004|COMPLETED|Period 2||2
11390226|NCT03579940|12584455|FG005|COMPLETED|Period 2||2
11390227|NCT03579940|12584456|FG006|COMPLETED|Period 2||3
11390228|NCT03579940|12584457|FG007|COMPLETED|Period 2||3
11390229|NCT03579940|12584458|FG008|COMPLETED|Period 2||3
11390230|NCT03579940|12584459|FG009|COMPLETED|Period 2||2
11390231|NCT03579940|12584460|FG010|COMPLETED|Period 2||3
11390232|NCT03579940|12584450|FG000|NOT COMPLETED|Period 2||0
11390233|NCT03579940|12584451|FG001|NOT COMPLETED|Period 2||0
11390234|NCT03579940|12584452|FG002|NOT COMPLETED|Period 2||1
11390235|NCT03579940|12584453|FG003|NOT COMPLETED|Period 2||0
11390236|NCT03579940|12584454|FG004|NOT COMPLETED|Period 2||0
11390237|NCT03579940|12584455|FG005|NOT COMPLETED|Period 2||0
11390238|NCT03579940|12584456|FG006|NOT COMPLETED|Period 2||0
11390239|NCT03579940|12584457|FG007|NOT COMPLETED|Period 2||0
11390240|NCT03579940|12584458|FG008|NOT COMPLETED|Period 2||0
11390241|NCT03579940|12584459|FG009|NOT COMPLETED|Period 2||0
11390242|NCT03579940|12584460|FG010|NOT COMPLETED|Period 2||0
11390243|NCT03579940|12584450|FG000|STARTED|Period 3||3
11390244|NCT03579940|12584451|FG001|STARTED|Period 3||2
11390245|NCT03579940|12584452|FG002|STARTED|Period 3||1
11390246|NCT03579940|12584453|FG003|STARTED|Period 3||2
11390247|NCT03579940|12584454|FG004|STARTED|Period 3||2
11390248|NCT03579940|12584455|FG005|STARTED|Period 3||2
11390249|NCT03579940|12584456|FG006|STARTED|Period 3||3
11390250|NCT03579940|12584457|FG007|STARTED|Period 3||3
11390251|NCT03579940|12584458|FG008|STARTED|Period 3||3
11390252|NCT03579940|12584459|FG009|STARTED|Period 3||2
11390253|NCT03579940|12584460|FG010|STARTED|Period 3||3
11390254|NCT03579940|12584450|FG000|COMPLETED|Period 3||3
11390255|NCT03579940|12584451|FG001|COMPLETED|Period 3||2
11390256|NCT03579940|12584452|FG002|COMPLETED|Period 3||1
11390257|NCT03579940|12584453|FG003|COMPLETED|Period 3||2
11390258|NCT03579940|12584454|FG004|COMPLETED|Period 3||2
11390259|NCT03579940|12584455|FG005|COMPLETED|Period 3||2
11390260|NCT03579940|12584456|FG006|COMPLETED|Period 3||3
11390261|NCT03579940|12584457|FG007|COMPLETED|Period 3||3
11390262|NCT03579940|12584458|FG008|COMPLETED|Period 3||3
11390263|NCT03579940|12584459|FG009|COMPLETED|Period 3||2
11390264|NCT03579940|12584460|FG010|COMPLETED|Period 3||3
11390265|NCT03579940|12584450|FG000|NOT COMPLETED|Period 3||0
11390266|NCT03579940|12584451|FG001|NOT COMPLETED|Period 3||0
11390267|NCT03579940|12584452|FG002|NOT COMPLETED|Period 3||0
11390268|NCT03579940|12584453|FG003|NOT COMPLETED|Period 3||0
11390269|NCT03579940|12584454|FG004|NOT COMPLETED|Period 3||0
11390270|NCT03579940|12584455|FG005|NOT COMPLETED|Period 3||0
11390271|NCT03579940|12584456|FG006|NOT COMPLETED|Period 3||0
11390272|NCT03579940|12584457|FG007|NOT COMPLETED|Period 3||0
11390273|NCT03579940|12584458|FG008|NOT COMPLETED|Period 3||0
11390274|NCT03579940|12584459|FG009|NOT COMPLETED|Period 3||0
11390275|NCT03579940|12584460|FG010|NOT COMPLETED|Period 3||0
11390276|NCT03580343|12584492|FG000|STARTED|Overall Study||5
11390277|NCT03580343|12584492|FG000|COMPLETED|Overall Study||4
11390278|NCT03580343|12584492|FG000|NOT COMPLETED|Overall Study||1
11390279|NCT03581084|12584496|FG000|STARTED|Overall Study||1
11390280|NCT03581084|12584496|FG000|COMPLETED|Overall Study||1
11390281|NCT03581084|12584496|FG000|NOT COMPLETED|Overall Study||0
11390282|NCT03581097|12584502|FG000|STARTED|Overall Study||46
11390283|NCT03581097|12584503|FG001|STARTED|Overall Study||47
11390284|NCT03581097|12584502|FG000|COMPLETED|Overall Study||46
11390285|NCT03581097|12584503|FG001|COMPLETED|Overall Study||47
11390286|NCT03581097|12584502|FG000|NOT COMPLETED|Overall Study||0
11390287|NCT03581097|12584503|FG001|NOT COMPLETED|Overall Study||0
11390288|NCT03581474|12584511|FG000|STARTED|Overall Study||12
11390289|NCT03581474|12584511|FG000|COMPLETED|Overall Study||12
11390290|NCT03581474|12584511|FG000|NOT COMPLETED|Overall Study||0
11390291|NCT03581825|12584515|FG000|STARTED|Period 1||31
11390292|NCT03581825|12584516|FG001|STARTED|Period 1||31
11390293|NCT03581825|12584515|FG000|COMPLETED|Period 1||30
11390294|NCT03581825|12584516|FG001|COMPLETED|Period 1||31
11390295|NCT03581825|12584515|FG000|NOT COMPLETED|Period 1||1
11390296|NCT03581825|12584516|FG001|NOT COMPLETED|Period 1||0
11390297|NCT03581825|12584515|FG000|STARTED|Period 2||30
11390298|NCT03581825|12584516|FG001|STARTED|Period 2||31
11390299|NCT03581825|12584515|FG000|COMPLETED|Period 2||30
11390300|NCT03581825|12584516|FG001|COMPLETED|Period 2||30
11390301|NCT03581825|12584515|FG000|NOT COMPLETED|Period 2||0
11390302|NCT03581825|12584516|FG001|NOT COMPLETED|Period 2||1
11390303|NCT03582215|12584530|FG000|STARTED|Overall Study||6
11390304|NCT03582215|12584531|FG001|STARTED|Overall Study||6
11390305|NCT03582215|12584532|FG002|STARTED|Overall Study||6
11390306|NCT03582215|12584533|FG003|STARTED|Overall Study||6
11390307|NCT03582215|12584534|FG004|STARTED|Overall Study||12
11390308|NCT03582215|12584535|FG005|STARTED|Overall Study||12
11390309|NCT03582215|12584536|FG006|STARTED|Overall Study||12
11390310|NCT03582215|12584537|FG007|STARTED|Overall Study||12
11390311|NCT03582215|12584530|FG000|COMPLETED|Overall Study||5
11390312|NCT03582215|12584531|FG001|COMPLETED|Overall Study||6
11390313|NCT03582215|12584532|FG002|COMPLETED|Overall Study||6
11390314|NCT03582215|12584533|FG003|COMPLETED|Overall Study||6
11390315|NCT03582215|12584534|FG004|COMPLETED|Overall Study||12
11390316|NCT03582215|12584535|FG005|COMPLETED|Overall Study||12
11390317|NCT03582215|12584536|FG006|COMPLETED|Overall Study||10
11390318|NCT03582215|12584537|FG007|COMPLETED|Overall Study||10
11390319|NCT03582215|12584530|FG000|NOT COMPLETED|Overall Study||1
11390320|NCT03582215|12584531|FG001|NOT COMPLETED|Overall Study||0
11390321|NCT03582215|12584532|FG002|NOT COMPLETED|Overall Study||0
11390322|NCT03582215|12584533|FG003|NOT COMPLETED|Overall Study||0
11390323|NCT03582215|12584534|FG004|NOT COMPLETED|Overall Study||0
11390324|NCT03582215|12584535|FG005|NOT COMPLETED|Overall Study||0
11390325|NCT03582215|12584536|FG006|NOT COMPLETED|Overall Study||2
11390326|NCT03582215|12584537|FG007|NOT COMPLETED|Overall Study||2
11390327|NCT03582553|12584572|FG000|STARTED|Intervention 1/Visit 1||3
11390328|NCT03582553|12584573|FG001|STARTED|Intervention 1/Visit 1||3
11390329|NCT03582553|12584574|FG002|STARTED|Intervention 1/Visit 1||3
11390330|NCT03582553|12584575|FG003|STARTED|Intervention 1/Visit 1||3
11390331|NCT03582553|12584576|FG004|STARTED|Intervention 1/Visit 1||3
11390332|NCT03582553|12584577|FG005|STARTED|Intervention 1/Visit 1||3
11390333|NCT03582553|12584572|FG000|COMPLETED|Intervention 1/Visit 1||3
11390334|NCT03582553|12584573|FG001|COMPLETED|Intervention 1/Visit 1||3
11390335|NCT03582553|12584574|FG002|COMPLETED|Intervention 1/Visit 1||3
11390336|NCT03582553|12584575|FG003|COMPLETED|Intervention 1/Visit 1||3
11390337|NCT03582553|12584576|FG004|COMPLETED|Intervention 1/Visit 1||3
11390338|NCT03582553|12584577|FG005|COMPLETED|Intervention 1/Visit 1||3
11390339|NCT03582553|12584572|FG000|NOT COMPLETED|Intervention 1/Visit 1||0
11390340|NCT03582553|12584573|FG001|NOT COMPLETED|Intervention 1/Visit 1||0
11390341|NCT03582553|12584574|FG002|NOT COMPLETED|Intervention 1/Visit 1||0
11390342|NCT03582553|12584575|FG003|NOT COMPLETED|Intervention 1/Visit 1||0
11390343|NCT03582553|12584576|FG004|NOT COMPLETED|Intervention 1/Visit 1||0
11390344|NCT03582553|12584577|FG005|NOT COMPLETED|Intervention 1/Visit 1||0
11390345|NCT03582553|12584572|FG000|STARTED|Washout Period ( At Least 1 Week)||3
11390346|NCT03582553|12584573|FG001|STARTED|Washout Period ( At Least 1 Week)||3
11390347|NCT03582553|12584574|FG002|STARTED|Washout Period ( At Least 1 Week)||3
11390348|NCT03582553|12584575|FG003|STARTED|Washout Period ( At Least 1 Week)||3
11390349|NCT03582553|12584576|FG004|STARTED|Washout Period ( At Least 1 Week)||3
11390350|NCT03582553|12584577|FG005|STARTED|Washout Period ( At Least 1 Week)||3
11390351|NCT03582553|12584572|FG000|COMPLETED|Washout Period ( At Least 1 Week)||3
11390352|NCT03582553|12584573|FG001|COMPLETED|Washout Period ( At Least 1 Week)||3
11390353|NCT03582553|12584574|FG002|COMPLETED|Washout Period ( At Least 1 Week)||3
11390354|NCT03582553|12584575|FG003|COMPLETED|Washout Period ( At Least 1 Week)||3
11390355|NCT03582553|12584576|FG004|COMPLETED|Washout Period ( At Least 1 Week)||3
11390356|NCT03582553|12584577|FG005|COMPLETED|Washout Period ( At Least 1 Week)||3
11390357|NCT03582553|12584572|FG000|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
11390358|NCT03582553|12584573|FG001|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
11390359|NCT03582553|12584574|FG002|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
11390360|NCT03582553|12584575|FG003|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
11390361|NCT03582553|12584576|FG004|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
11390362|NCT03582553|12584577|FG005|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
11390363|NCT03582553|12584572|FG000|STARTED|Intervention 2/Visit 2||3
11390364|NCT03582553|12584573|FG001|STARTED|Intervention 2/Visit 2||3
11390365|NCT03582553|12584574|FG002|STARTED|Intervention 2/Visit 2||3
11390366|NCT03582553|12584575|FG003|STARTED|Intervention 2/Visit 2||3
11390367|NCT03582553|12584576|FG004|STARTED|Intervention 2/Visit 2||3
11390368|NCT03582553|12584577|FG005|STARTED|Intervention 2/Visit 2||3
11390369|NCT03582553|12584572|FG000|COMPLETED|Intervention 2/Visit 2||3
11390370|NCT03582553|12584573|FG001|COMPLETED|Intervention 2/Visit 2||3
11390371|NCT03582553|12584574|FG002|COMPLETED|Intervention 2/Visit 2||3
11390372|NCT03582553|12584575|FG003|COMPLETED|Intervention 2/Visit 2||3
11390373|NCT03582553|12584576|FG004|COMPLETED|Intervention 2/Visit 2||3
11390374|NCT03582553|12584577|FG005|COMPLETED|Intervention 2/Visit 2||3
11390375|NCT03582553|12584572|FG000|NOT COMPLETED|Intervention 2/Visit 2||0
11390376|NCT03582553|12584573|FG001|NOT COMPLETED|Intervention 2/Visit 2||0
11390377|NCT03582553|12584574|FG002|NOT COMPLETED|Intervention 2/Visit 2||0
11390378|NCT03582553|12584575|FG003|NOT COMPLETED|Intervention 2/Visit 2||0
11390379|NCT03582553|12584576|FG004|NOT COMPLETED|Intervention 2/Visit 2||0
11390380|NCT03582553|12584577|FG005|NOT COMPLETED|Intervention 2/Visit 2||0
11390381|NCT03582553|12584572|FG000|STARTED|Washout Period (At Least 1 Week)||3
11390382|NCT03582553|12584573|FG001|STARTED|Washout Period (At Least 1 Week)||3
11390383|NCT03582553|12584574|FG002|STARTED|Washout Period (At Least 1 Week)||3
11390384|NCT03582553|12584575|FG003|STARTED|Washout Period (At Least 1 Week)||3
11390385|NCT03582553|12584576|FG004|STARTED|Washout Period (At Least 1 Week)||3
11390386|NCT03582553|12584577|FG005|STARTED|Washout Period (At Least 1 Week)||3
11390387|NCT03582553|12584572|FG000|COMPLETED|Washout Period (At Least 1 Week)||3
11390388|NCT03582553|12584573|FG001|COMPLETED|Washout Period (At Least 1 Week)||3
11390389|NCT03582553|12584574|FG002|COMPLETED|Washout Period (At Least 1 Week)||3
11390390|NCT03582553|12584575|FG003|COMPLETED|Washout Period (At Least 1 Week)||3
11390391|NCT03582553|12584576|FG004|COMPLETED|Washout Period (At Least 1 Week)||3
11390392|NCT03582553|12584577|FG005|COMPLETED|Washout Period (At Least 1 Week)||3
11390393|NCT03582553|12584572|FG000|NOT COMPLETED|Washout Period (At Least 1 Week)||0
11390394|NCT03582553|12584573|FG001|NOT COMPLETED|Washout Period (At Least 1 Week)||0
11390395|NCT03582553|12584574|FG002|NOT COMPLETED|Washout Period (At Least 1 Week)||0
11390396|NCT03582553|12584575|FG003|NOT COMPLETED|Washout Period (At Least 1 Week)||0
11390397|NCT03582553|12584576|FG004|NOT COMPLETED|Washout Period (At Least 1 Week)||0
11390398|NCT03582553|12584577|FG005|NOT COMPLETED|Washout Period (At Least 1 Week)||0
11390399|NCT03582553|12584572|FG000|STARTED|Intervention 3/Visit 3||3
11390400|NCT03582553|12584573|FG001|STARTED|Intervention 3/Visit 3||3
11390401|NCT03582553|12584574|FG002|STARTED|Intervention 3/Visit 3||3
11390402|NCT03582553|12584575|FG003|STARTED|Intervention 3/Visit 3||3
11390403|NCT03582553|12584576|FG004|STARTED|Intervention 3/Visit 3||3
11390404|NCT03582553|12584577|FG005|STARTED|Intervention 3/Visit 3||3
11390405|NCT03582553|12584572|FG000|COMPLETED|Intervention 3/Visit 3||3
11390406|NCT03582553|12584573|FG001|COMPLETED|Intervention 3/Visit 3||3
11390407|NCT03582553|12584574|FG002|COMPLETED|Intervention 3/Visit 3||3
11390408|NCT03582553|12584575|FG003|COMPLETED|Intervention 3/Visit 3||3
11390409|NCT03582553|12584576|FG004|COMPLETED|Intervention 3/Visit 3||3
11390410|NCT03582553|12584577|FG005|COMPLETED|Intervention 3/Visit 3||3
11390411|NCT03582553|12584572|FG000|NOT COMPLETED|Intervention 3/Visit 3||0
11390412|NCT03582553|12584573|FG001|NOT COMPLETED|Intervention 3/Visit 3||0
11390413|NCT03582553|12584574|FG002|NOT COMPLETED|Intervention 3/Visit 3||0
11390414|NCT03582553|12584575|FG003|NOT COMPLETED|Intervention 3/Visit 3||0
11390415|NCT03582553|12584576|FG004|NOT COMPLETED|Intervention 3/Visit 3||0
11390416|NCT03582553|12584577|FG005|NOT COMPLETED|Intervention 3/Visit 3||0
11390417|NCT03582813|12584597|FG000|STARTED|Overall Study||114
11390418|NCT03582813|12584598|FG001|STARTED|Overall Study||102
11390419|NCT03582813|12584597|FG000|COMPLETED|Overall Study||95
11390420|NCT03582813|12584598|FG001|COMPLETED|Overall Study||81
11390421|NCT03582813|12584597|FG000|NOT COMPLETED|Overall Study||19
11390422|NCT03582813|12584598|FG001|NOT COMPLETED|Overall Study||21
11390423|NCT03582826|12584606|FG000|STARTED|Overall Study||119
11390424|NCT03582826|12584607|FG001|STARTED|Overall Study||6
11390425|NCT03582826|12584606|FG000|COMPLETED|Overall Study||78
11390426|NCT03582826|12584607|FG001|COMPLETED|Overall Study||6
11390427|NCT03582826|12584606|FG000|NOT COMPLETED|Overall Study||41
11390428|NCT03582826|12584607|FG001|NOT COMPLETED|Overall Study||0
11390429|NCT03582943|12584624|FG000|STARTED|Allocated to Groups||42
11390430|NCT03582943|12584625|FG001|STARTED|Allocated to Groups||40
11390431|NCT03582943|12584624|FG000|COMPLETED|Allocated to Groups||41
11390432|NCT03582943|12584625|FG001|COMPLETED|Allocated to Groups||39
11390433|NCT03582943|12584624|FG000|NOT COMPLETED|Allocated to Groups||1
11390434|NCT03582943|12584625|FG001|NOT COMPLETED|Allocated to Groups||1
11390435|NCT03582943|12584624|FG000|STARTED|Intervention and Follow up||41
11390436|NCT03582943|12584625|FG001|STARTED|Intervention and Follow up||39
11390437|NCT03582943|12584624|FG000|COMPLETED|Intervention and Follow up||37
11390438|NCT03582943|12584625|FG001|COMPLETED|Intervention and Follow up||37
11390439|NCT03582943|12584624|FG000|NOT COMPLETED|Intervention and Follow up||4
11390440|NCT03582943|12584625|FG001|NOT COMPLETED|Intervention and Follow up||2
11390441|NCT03582943|12584624|FG000|STARTED|Analyzed||37
11390442|NCT03582943|12584625|FG001|STARTED|Analyzed||37
11390443|NCT03582943|12584624|FG000|COMPLETED|Analyzed||33
11390444|NCT03582943|12584625|FG001|COMPLETED|Analyzed||36
11390445|NCT03582943|12584624|FG000|NOT COMPLETED|Analyzed||4
11390446|NCT03582943|12584625|FG001|NOT COMPLETED|Analyzed||1
11390447|NCT03583372|12584635|FG000|STARTED|Overall Study||92
11390448|NCT03583372|12584636|FG001|STARTED|Overall Study||182
11390449|NCT03583372|12584637|FG002|STARTED|Overall Study||91
11390450|NCT03583372|12584638|FG003|STARTED|Overall Study||141
11390451|NCT03583372|12584635|FG000|COMPLETED|Overall Study||79
11390452|NCT03583372|12584636|FG001|COMPLETED|Overall Study||156
11390453|NCT03583372|12584637|FG002|COMPLETED|Overall Study||72
11390454|NCT03583372|12584638|FG003|COMPLETED|Overall Study||123
11390455|NCT03583372|12584635|FG000|NOT COMPLETED|Overall Study||13
11390456|NCT03583372|12584636|FG001|NOT COMPLETED|Overall Study||26
11390457|NCT03583372|12584637|FG002|NOT COMPLETED|Overall Study||19
11390458|NCT03583372|12584638|FG003|NOT COMPLETED|Overall Study||18
11390459|NCT03583385|12584648|FG000|STARTED|Treatment Period 1||24
11390460|NCT03583385|12584649|FG001|STARTED|Treatment Period 1||24
11390461|NCT03583385|12584648|FG000|COMPLETED|Treatment Period 1||23
11390462|NCT03583385|12584649|FG001|COMPLETED|Treatment Period 1||23
11390463|NCT03583385|12584648|FG000|NOT COMPLETED|Treatment Period 1||1
11390464|NCT03583385|12584649|FG001|NOT COMPLETED|Treatment Period 1||1
11390465|NCT03583385|12584648|FG000|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn't attend period2.|22
11390466|NCT03583385|12584649|FG001|STARTED|Treatment Period 2||23
11390467|NCT03583385|12584648|FG000|COMPLETED|Treatment Period 2||21
11390468|NCT03583385|12584649|FG001|COMPLETED|Treatment Period 2||23
11390469|NCT03583385|12584648|FG000|NOT COMPLETED|Treatment Period 2||1
11390470|NCT03583385|12584649|FG001|NOT COMPLETED|Treatment Period 2||0
11390471|NCT03583450|12584657|FG000|STARTED|Overall Study||34
11390472|NCT03583450|12584658|FG001|STARTED|Overall Study||37
11390473|NCT03583450|12584657|FG000|COMPLETED|Overall Study||33
11390474|NCT03583450|12584658|FG001|COMPLETED|Overall Study||37
11390475|NCT03583450|12584657|FG000|NOT COMPLETED|Overall Study||1
11390476|NCT03583450|12584658|FG001|NOT COMPLETED|Overall Study||0
11390477|NCT03583606|12584669|FG000|STARTED|Overall Study||22
11390478|NCT03583606|12584670|FG001|STARTED|Overall Study||20
11390479|NCT03583606|12584671|FG002|STARTED|Overall Study||19
11390480|NCT03583606|12584669|FG000|COMPLETED|Overall Study||21
11390481|NCT03583606|12584670|FG001|COMPLETED|Overall Study||19
11390482|NCT03583606|12584671|FG002|COMPLETED|Overall Study||19
11390483|NCT03583606|12584669|FG000|NOT COMPLETED|Overall Study||1
11390484|NCT03583606|12584670|FG001|NOT COMPLETED|Overall Study||1
11390485|NCT03583606|12584671|FG002|NOT COMPLETED|Overall Study||0
11390486|NCT03584100|12584680|FG000|STARTED|Overall Study||12
11390487|NCT03584100|12584680|FG000|COMPLETED|Overall Study||12
11390488|NCT03584100|12584680|FG000|NOT COMPLETED|Overall Study||0
11390489|NCT03585244|12584687|FG000|STARTED|Overall Study||180
11390490|NCT03585244|12584687|FG000|COMPLETED|Overall Study||165
11390491|NCT03585244|12584687|FG000|NOT COMPLETED|Overall Study||15
11390492|NCT03585296|12584691|FG000|STARTED|Overall Study||22
11390493|NCT03585296|12584691|FG000|COMPLETED|Overall Study||17
11390494|NCT03585296|12584691|FG000|NOT COMPLETED|Overall Study||5
11390495|NCT03585504|12584697|FG000|STARTED|Overall Study||41
11390496|NCT03585504|12584698|FG001|STARTED|Overall Study||40
11390497|NCT03585504|12584697|FG000|COMPLETED|Overall Study||15
11390498|NCT03585504|12584698|FG001|COMPLETED|Overall Study||11
11390499|NCT03585504|12584697|FG000|NOT COMPLETED|Overall Study||26
11390500|NCT03585504|12584698|FG001|NOT COMPLETED|Overall Study||29
11390501|NCT03585543|12584704|FG000|STARTED|Overall Study||30
11390502|NCT03585543|12584704|FG000|Mid-intervention Assessment (6-weeks)|Overall Study||25
11390503|NCT03585543|12584704|FG000|End-of-intervention Assessment (12 Weeks|Overall Study||22
11390504|NCT03585543|12584704|FG000|3-month Post-intervention Follow-up (6 m|Overall Study||15
11390505|NCT03585543|12584704|FG000|COMPLETED|Overall Study||15
11390506|NCT03585543|12584704|FG000|NOT COMPLETED|Overall Study||15
11390507|NCT03585712|12584709|FG000|STARTED|Treatment Period 1||52
11390508|NCT03585712|12584710|FG001|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
11390509|NCT03585712|12584711|FG002|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
11390510|NCT03585712|12584709|FG000|COMPLETED|Treatment Period 1||51
11390511|NCT03585712|12584710|FG001|COMPLETED|Treatment Period 1||0
11390512|NCT03585712|12584711|FG002|COMPLETED|Treatment Period 1||0
11390513|NCT03585712|12584709|FG000|NOT COMPLETED|Treatment Period 1||1
11390514|NCT03585712|12584710|FG001|NOT COMPLETED|Treatment Period 1||0
11390515|NCT03585712|12584711|FG002|NOT COMPLETED|Treatment Period 1||0
11390516|NCT03585712|12584709|FG000|STARTED|Treatment Periods 2 and 3|Subjects having completed Treatment Period 1 randomized in Arm A or Arm B|0
11390517|NCT03585712|12584710|FG001|STARTED|Treatment Periods 2 and 3||26
11390518|NCT03585712|12584711|FG002|STARTED|Treatment Periods 2 and 3||25
11390519|NCT03585712|12584709|FG000|COMPLETED|Treatment Periods 2 and 3||0
11390520|NCT03585712|12584710|FG001|COMPLETED|Treatment Periods 2 and 3||23
11390521|NCT03585712|12584711|FG002|COMPLETED|Treatment Periods 2 and 3||22
11390522|NCT03585712|12584709|FG000|NOT COMPLETED|Treatment Periods 2 and 3||0
11390523|NCT03585712|12584710|FG001|NOT COMPLETED|Treatment Periods 2 and 3||3
11390524|NCT03585712|12584711|FG002|NOT COMPLETED|Treatment Periods 2 and 3||3
11390525|NCT03585790|12584730|FG000|STARTED|First Intervention (1 Week)||23
11390526|NCT03585790|12584731|FG001|STARTED|First Intervention (1 Week)||22
11390527|NCT03585790|12584730|FG000|COMPLETED|First Intervention (1 Week)||23
11390528|NCT03585790|12584731|FG001|COMPLETED|First Intervention (1 Week)||22
11390529|NCT03585790|12584730|FG000|NOT COMPLETED|First Intervention (1 Week)||0
11390530|NCT03585790|12584731|FG001|NOT COMPLETED|First Intervention (1 Week)||0
11390531|NCT03585790|12584730|FG000|STARTED|Second Intervention (1 Week)||23
11390532|NCT03585790|12584731|FG001|STARTED|Second Intervention (1 Week)||22
11390533|NCT03585790|12584730|FG000|COMPLETED|Second Intervention (1 Week)||23
11390534|NCT03585790|12584731|FG001|COMPLETED|Second Intervention (1 Week)||22
11390535|NCT03585790|12584730|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
11390536|NCT03585790|12584731|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
11390537|NCT03585959|12584738|FG000|STARTED|Overall Study||50
11390538|NCT03585959|12584738|FG000|COMPLETED|Overall Study||47
11390539|NCT03585959|12584738|FG000|NOT COMPLETED|Overall Study||3
11390540|NCT03586167|12584746|FG000|STARTED|Overall Study||58
11390541|NCT03586167|12584747|FG001|STARTED|Overall Study||28
11390542|NCT03586167|12584746|FG000|COMPLETED|Overall Study||57
11390543|NCT03586167|12584747|FG001|COMPLETED|Overall Study||28
11390544|NCT03586167|12584746|FG000|NOT COMPLETED|Overall Study||1
11390545|NCT03586167|12584747|FG001|NOT COMPLETED|Overall Study||0
11390546|NCT03586544|12584755|FG000|STARTED|First Intervention||6
11390547|NCT03586544|12584756|FG001|STARTED|First Intervention||12
11390548|NCT03586544|12584755|FG000|COMPLETED|First Intervention||6
11390549|NCT03586544|12584756|FG001|COMPLETED|First Intervention||11
11390550|NCT03586544|12584755|FG000|NOT COMPLETED|First Intervention||0
11390551|NCT03586544|12584756|FG001|NOT COMPLETED|First Intervention||1
11390552|NCT03586544|12584755|FG000|STARTED|Second Intervention||6
11390553|NCT03586544|12584756|FG001|STARTED|Second Intervention||11
11390554|NCT03586544|12584755|FG000|COMPLETED|Second Intervention||6
11390555|NCT03586544|12584756|FG001|COMPLETED|Second Intervention||10
11390556|NCT03586544|12584755|FG000|NOT COMPLETED|Second Intervention||0
11390557|NCT03586544|12584756|FG001|NOT COMPLETED|Second Intervention||1
11390558|NCT03586583|12584762|FG000|STARTED|Overall Study||600
11390559|NCT03586583|12584762|FG000|COMPLETED|Overall Study||600
11390560|NCT03586583|12584762|FG000|NOT COMPLETED|Overall Study||0
11390561|NCT03586648|12584767|FG000|STARTED|Period 1||36
11390562|NCT03586648|12584768|FG001|STARTED|Period 1||34
11390563|NCT03586648|12584767|FG000|COMPLETED|Period 1||32
11390564|NCT03586648|12584768|FG001|COMPLETED|Period 1||30
11390565|NCT03586648|12584767|FG000|NOT COMPLETED|Period 1||4
11390566|NCT03586648|12584768|FG001|NOT COMPLETED|Period 1||4
11390567|NCT03586648|12584767|FG000|STARTED|Period 2||32
11390568|NCT03586648|12584768|FG001|STARTED|Period 2||30
11390569|NCT03586648|12584767|FG000|COMPLETED|Period 2||31
11390570|NCT03586648|12584768|FG001|COMPLETED|Period 2||30
11390571|NCT03586648|12584767|FG000|NOT COMPLETED|Period 2||1
11390572|NCT03586648|12584768|FG001|NOT COMPLETED|Period 2||0
11390573|NCT03586726|12584774|FG000|STARTED|Overall Study||16
11390574|NCT03586726|12584774|FG000|COMPLETED|Overall Study||15
11390575|NCT03586726|12584774|FG000|NOT COMPLETED|Overall Study||1
11390576|NCT03586830|12584782|FG000|STARTED|Overall Study||50
11390577|NCT03586830|12584783|FG001|STARTED|Overall Study||48
11390578|NCT03586830|12584784|FG002|STARTED|Overall Study||49
11390579|NCT03586830|12584785|FG003|STARTED|Overall Study||49
11390580|NCT03586830|12584782|FG000|Treated|Overall Study||49
11390581|NCT03586830|12584783|FG001|Treated|Overall Study||48
11390582|NCT03586830|12584784|FG002|Treated|Overall Study||49
11390583|NCT03586830|12584785|FG003|Treated|Overall Study||49
11390584|NCT03586830|12584782|FG000|COMPLETED|Overall Study||48
11390585|NCT03586830|12584783|FG001|COMPLETED|Overall Study||42
11390586|NCT03586830|12584784|FG002|COMPLETED|Overall Study||41
11390587|NCT03586830|12584785|FG003|COMPLETED|Overall Study||44
11390588|NCT03586830|12584782|FG000|NOT COMPLETED|Overall Study||2
11390589|NCT03586830|12584783|FG001|NOT COMPLETED|Overall Study||6
11390590|NCT03586830|12584784|FG002|NOT COMPLETED|Overall Study||8
11390591|NCT03586830|12584785|FG003|NOT COMPLETED|Overall Study||5
11390592|NCT03587207|12584800|FG000|STARTED|Overall Study||100
11390593|NCT03587207|12584801|FG001|STARTED|Overall Study||104
11390594|NCT03587207|12584802|FG002|STARTED|Overall Study||100
11390595|NCT03587207|12584803|FG003|STARTED|Overall Study||94
11390596|NCT03587207|12584804|FG004|STARTED|Overall Study||102
11390597|NCT03587207|12584800|FG000|COMPLETED|Overall Study||100
11390598|NCT03587207|12584801|FG001|COMPLETED|Overall Study||104
11390599|NCT03587207|12584802|FG002|COMPLETED|Overall Study||100
11390600|NCT03587207|12584803|FG003|COMPLETED|Overall Study||94
11390601|NCT03587207|12584804|FG004|COMPLETED|Overall Study||102
11390602|NCT03587207|12584800|FG000|NOT COMPLETED|Overall Study||0
11390603|NCT03587207|12584801|FG001|NOT COMPLETED|Overall Study||0
11390604|NCT03587207|12584802|FG002|NOT COMPLETED|Overall Study||0
11390605|NCT03587207|12584803|FG003|NOT COMPLETED|Overall Study||0
11390606|NCT03587207|12584804|FG004|NOT COMPLETED|Overall Study||0
11390607|NCT03587428|12584816|FG000|STARTED|Period 1||3
11390608|NCT03587428|12584817|FG001|STARTED|Period 1||2
11390609|NCT03587428|12584818|FG002|STARTED|Period 1||3
11390610|NCT03587428|12584819|FG003|STARTED|Period 1||3
11390611|NCT03587428|12584820|FG004|STARTED|Period 1||2
11390612|NCT03587428|12584821|FG005|STARTED|Period 1||2
11390613|NCT03587428|12584816|FG000|COMPLETED|Period 1||3
11390614|NCT03587428|12584817|FG001|COMPLETED|Period 1||2
11390615|NCT03587428|12584818|FG002|COMPLETED|Period 1||3
11390616|NCT03587428|12584819|FG003|COMPLETED|Period 1||3
11390617|NCT03587428|12584820|FG004|COMPLETED|Period 1||2
11390618|NCT03587428|12584821|FG005|COMPLETED|Period 1||2
11390619|NCT03587428|12584816|FG000|NOT COMPLETED|Period 1||0
11390620|NCT03587428|12584817|FG001|NOT COMPLETED|Period 1||0
11390621|NCT03587428|12584818|FG002|NOT COMPLETED|Period 1||0
11390622|NCT03587428|12584819|FG003|NOT COMPLETED|Period 1||0
11390623|NCT03587428|12584820|FG004|NOT COMPLETED|Period 1||0
11390624|NCT03587428|12584821|FG005|NOT COMPLETED|Period 1||0
11390625|NCT03587428|12584816|FG000|STARTED|Period 2||3
11390626|NCT03587428|12584817|FG001|STARTED|Period 2||2
11390627|NCT03587428|12584818|FG002|STARTED|Period 2||3
11390628|NCT03587428|12584819|FG003|STARTED|Period 2||3
11390629|NCT03587428|12584820|FG004|STARTED|Period 2||2
11390630|NCT03587428|12584821|FG005|STARTED|Period 2||2
11390631|NCT03587428|12584816|FG000|COMPLETED|Period 2||3
11390632|NCT03587428|12584817|FG001|COMPLETED|Period 2||2
11390633|NCT03587428|12584818|FG002|COMPLETED|Period 2||3
11390634|NCT03587428|12584819|FG003|COMPLETED|Period 2||3
11390635|NCT03587428|12584820|FG004|COMPLETED|Period 2||2
11390636|NCT03587428|12584821|FG005|COMPLETED|Period 2||2
11390637|NCT03587428|12584816|FG000|NOT COMPLETED|Period 2||0
11390638|NCT03587428|12584817|FG001|NOT COMPLETED|Period 2||0
11390639|NCT03587428|12584818|FG002|NOT COMPLETED|Period 2||0
11390640|NCT03587428|12584819|FG003|NOT COMPLETED|Period 2||0
11390641|NCT03587428|12584820|FG004|NOT COMPLETED|Period 2||0
11390642|NCT03587428|12584821|FG005|NOT COMPLETED|Period 2||0
11390643|NCT03587428|12584816|FG000|STARTED|Period 3||3
11390644|NCT03587428|12584817|FG001|STARTED|Period 3||2
11390645|NCT03587428|12584818|FG002|STARTED|Period 3||3
11390646|NCT03587428|12584819|FG003|STARTED|Period 3||3
11390647|NCT03587428|12584820|FG004|STARTED|Period 3||2
11390648|NCT03587428|12584821|FG005|STARTED|Period 3||2
11390649|NCT03587428|12584816|FG000|COMPLETED|Period 3||3
11390650|NCT03587428|12584817|FG001|COMPLETED|Period 3||2
11390651|NCT03587428|12584818|FG002|COMPLETED|Period 3||3
11390652|NCT03587428|12584819|FG003|COMPLETED|Period 3||3
11390653|NCT03587428|12584820|FG004|COMPLETED|Period 3||2
11390654|NCT03587428|12584821|FG005|COMPLETED|Period 3||2
11390655|NCT03587428|12584816|FG000|NOT COMPLETED|Period 3||0
11390656|NCT03587428|12584817|FG001|NOT COMPLETED|Period 3||0
11390657|NCT03587428|12584818|FG002|NOT COMPLETED|Period 3||0
11390658|NCT03587428|12584819|FG003|NOT COMPLETED|Period 3||0
11390659|NCT03587428|12584820|FG004|NOT COMPLETED|Period 3||0
11390660|NCT03587428|12584821|FG005|NOT COMPLETED|Period 3||0
11390661|NCT03587974|12584831|FG000|STARTED|Overall Study||30
11390662|NCT03587974|12584832|FG001|STARTED|Overall Study||30
11390663|NCT03587974|12584831|FG000|COMPLETED|Overall Study||25
11390664|NCT03587974|12584832|FG001|COMPLETED|Overall Study||26
11390665|NCT03587974|12584831|FG000|NOT COMPLETED|Overall Study||5
11390666|NCT03587974|12584832|FG001|NOT COMPLETED|Overall Study||4
11390667|NCT03588572|12584840|FG000|STARTED|Visitation 1||22
11390668|NCT03588572|12584841|FG001|STARTED|Visitation 1||21
11390669|NCT03588572|12584840|FG000|COMPLETED|Visitation 1||21
11390670|NCT03588572|12584841|FG001|COMPLETED|Visitation 1||20
11390671|NCT03588572|12584840|FG000|NOT COMPLETED|Visitation 1||1
11390672|NCT03588572|12584841|FG001|NOT COMPLETED|Visitation 1||1
11390673|NCT03588572|12584840|FG000|STARTED|Visitation 2||21
11390674|NCT03588572|12584841|FG001|STARTED|Visitation 2||20
11390675|NCT03588572|12584840|FG000|COMPLETED|Visitation 2||19
11390676|NCT03588572|12584841|FG001|COMPLETED|Visitation 2||18
11390677|NCT03588572|12584840|FG000|NOT COMPLETED|Visitation 2||2
11390678|NCT03588572|12584841|FG001|NOT COMPLETED|Visitation 2||2
11390679|NCT03588572|12584840|FG000|STARTED|Visitation 3||19
11390680|NCT03588572|12584841|FG001|STARTED|Visitation 3||18
11390681|NCT03588572|12584840|FG000|COMPLETED|Visitation 3||16
11390682|NCT03588572|12584841|FG001|COMPLETED|Visitation 3||16
11390683|NCT03588572|12584840|FG000|NOT COMPLETED|Visitation 3||3
11390684|NCT03588572|12584841|FG001|NOT COMPLETED|Visitation 3||2
11390685|NCT03588741|12584847|FG000|STARTED|Overall Study||1
11390686|NCT03588741|12584847|FG000|COMPLETED|Overall Study||0
11390687|NCT03588741|12584847|FG000|NOT COMPLETED|Overall Study||1
11390688|NCT03588806|12584851|FG000|STARTED|Overall Study||11
11390689|NCT03588806|12584851|FG000|COMPLETED|Overall Study||11
11390690|NCT03588806|12584851|FG000|NOT COMPLETED|Overall Study||0
11390691|NCT03588910|12584857|FG000|STARTED|Overall Study||60
11390692|NCT03588910|12584858|FG001|STARTED|Overall Study||60
11390693|NCT03588910|12584857|FG000|Post Op Day 1 Survey|Overall Study||52
11390694|NCT03588910|12584858|FG001|Post Op Day 1 Survey|Overall Study||47
11390695|NCT03588910|12584857|FG000|COMPLETED|Overall Study||47
11390696|NCT03588910|12584858|FG001|COMPLETED|Overall Study||45
11390697|NCT03588910|12584857|FG000|NOT COMPLETED|Overall Study||13
11390698|NCT03588910|12584858|FG001|NOT COMPLETED|Overall Study||15
11390699|NCT03589807|12584870|FG000|STARTED|Overall Study||27
11390700|NCT03589807|12584871|FG001|STARTED|Overall Study||30
11390701|NCT03589807|12584872|FG002|STARTED|Overall Study||33
11390702|NCT03589807|12584873|FG003|STARTED|Overall Study||32
11390703|NCT03589807|12584874|FG004|STARTED|Overall Study||28
11390704|NCT03589807|12584875|FG005|STARTED|Overall Study||30
11390705|NCT03589807|12584870|FG000|COMPLETED|Overall Study||27
11390706|NCT03589807|12584871|FG001|COMPLETED|Overall Study||23
11390707|NCT03589807|12584872|FG002|COMPLETED|Overall Study||31
11390708|NCT03589807|12584873|FG003|COMPLETED|Overall Study||28
11390709|NCT03589807|12584874|FG004|COMPLETED|Overall Study||26
11390710|NCT03589807|12584875|FG005|COMPLETED|Overall Study||29
11390711|NCT03589807|12584870|FG000|NOT COMPLETED|Overall Study||0
11390712|NCT03589807|12584871|FG001|NOT COMPLETED|Overall Study||7
11390713|NCT03589807|12584872|FG002|NOT COMPLETED|Overall Study||2
11390714|NCT03589807|12584873|FG003|NOT COMPLETED|Overall Study||4
11390715|NCT03589807|12584874|FG004|NOT COMPLETED|Overall Study||2
11390716|NCT03589807|12584875|FG005|NOT COMPLETED|Overall Study||1
11390717|NCT03589885|12584895|FG000|STARTED|Treatment Period 1-Randomized Set||41
11390718|NCT03589885|12584896|FG001|STARTED|Treatment Period 1-Randomized Set||41
11390719|NCT03589885|12584897|FG002|STARTED|Treatment Period 1-Randomized Set||40
11390720|NCT03589885|12584898|FG003|STARTED|Treatment Period 1-Randomized Set||0
11390721|NCT03589885|12584899|FG004|STARTED|Treatment Period 1-Randomized Set||0
11390722|NCT03589885|12584895|FG000|COMPLETED|Treatment Period 1-Randomized Set||41
11390723|NCT03589885|12584896|FG001|COMPLETED|Treatment Period 1-Randomized Set||39
11390724|NCT03589885|12584897|FG002|COMPLETED|Treatment Period 1-Randomized Set||37
11390725|NCT03589885|12584898|FG003|COMPLETED|Treatment Period 1-Randomized Set||0
11390726|NCT03589885|12584899|FG004|COMPLETED|Treatment Period 1-Randomized Set||0
11390727|NCT03589885|12584895|FG000|NOT COMPLETED|Treatment Period 1-Randomized Set||0
11390728|NCT03589885|12584896|FG001|NOT COMPLETED|Treatment Period 1-Randomized Set||2
11390729|NCT03589885|12584897|FG002|NOT COMPLETED|Treatment Period 1-Randomized Set||3
11390730|NCT03589885|12584898|FG003|NOT COMPLETED|Treatment Period 1-Randomized Set||0
11390731|NCT03589885|12584899|FG004|NOT COMPLETED|Treatment Period 1-Randomized Set||0
11390732|NCT03589885|12584895|FG000|STARTED|Treatment Period 2-Randomized Set||41
11390733|NCT03589885|12584896|FG001|STARTED|Treatment Period 2-Randomized Set||39
11390734|NCT03589885|12584897|FG002|STARTED|Treatment Period 2-Randomized Set||4
11390735|NCT03589885|12584898|FG003|STARTED|Treatment Period 2-Randomized Set||16
11390736|NCT03589885|12584899|FG004|STARTED|Treatment Period 2-Randomized Set||17
11390737|NCT03589885|12584895|FG000|COMPLETED|Treatment Period 2-Randomized Set||40
11390738|NCT03589885|12584896|FG001|COMPLETED|Treatment Period 2-Randomized Set||34
11390739|NCT03589885|12584897|FG002|COMPLETED|Treatment Period 2-Randomized Set||3
11390740|NCT03589885|12584898|FG003|COMPLETED|Treatment Period 2-Randomized Set||16
11390741|NCT03589885|12584899|FG004|COMPLETED|Treatment Period 2-Randomized Set||16
11390742|NCT03589885|12584895|FG000|NOT COMPLETED|Treatment Period 2-Randomized Set||1
11390743|NCT03589885|12584896|FG001|NOT COMPLETED|Treatment Period 2-Randomized Set||5
11390744|NCT03589885|12584897|FG002|NOT COMPLETED|Treatment Period 2-Randomized Set||1
11390745|NCT03589885|12584898|FG003|NOT COMPLETED|Treatment Period 2-Randomized Set||0
11390746|NCT03589885|12584899|FG004|NOT COMPLETED|Treatment Period 2-Randomized Set||1
11390747|NCT03590613|12584917|FG000|STARTED|Period 1, 4 Days||3
11390748|NCT03590613|12584918|FG001|STARTED|Period 1, 4 Days||3
11390749|NCT03590613|12584919|FG002|STARTED|Period 1, 4 Days||3
11390750|NCT03590613|12584920|FG003|STARTED|Period 1, 4 Days||3
11390751|NCT03590613|12584917|FG000|COMPLETED|Period 1, 4 Days||3
11390752|NCT03590613|12584918|FG001|COMPLETED|Period 1, 4 Days||3
11390753|NCT03590613|12584919|FG002|COMPLETED|Period 1, 4 Days||3
11390754|NCT03590613|12584920|FG003|COMPLETED|Period 1, 4 Days||3
11390755|NCT03590613|12584917|FG000|NOT COMPLETED|Period 1, 4 Days||0
11390756|NCT03590613|12584918|FG001|NOT COMPLETED|Period 1, 4 Days||0
11390757|NCT03590613|12584919|FG002|NOT COMPLETED|Period 1, 4 Days||0
11390758|NCT03590613|12584920|FG003|NOT COMPLETED|Period 1, 4 Days||0
11390759|NCT03590613|12584917|FG000|STARTED|Period 1, Wash-out, at Least 3 Days||3
11390760|NCT03590613|12584918|FG001|STARTED|Period 1, Wash-out, at Least 3 Days||3
11390761|NCT03590613|12584919|FG002|STARTED|Period 1, Wash-out, at Least 3 Days||3
11390762|NCT03590613|12584920|FG003|STARTED|Period 1, Wash-out, at Least 3 Days||3
11390763|NCT03590613|12584917|FG000|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
11390764|NCT03590613|12584918|FG001|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
11390765|NCT03590613|12584919|FG002|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
11390766|NCT03590613|12584920|FG003|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
11390767|NCT03590613|12584917|FG000|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
11390768|NCT03590613|12584918|FG001|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
11390769|NCT03590613|12584919|FG002|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
11390770|NCT03590613|12584920|FG003|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
11390771|NCT03590613|12584917|FG000|STARTED|Period 2, 4 Days||3
11390772|NCT03590613|12584918|FG001|STARTED|Period 2, 4 Days||3
11390773|NCT03590613|12584919|FG002|STARTED|Period 2, 4 Days||3
11390774|NCT03590613|12584920|FG003|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4
11390775|NCT03590613|12584917|FG000|COMPLETED|Period 2, 4 Days||3
11390776|NCT03590613|12584918|FG001|COMPLETED|Period 2, 4 Days||3
11390777|NCT03590613|12584919|FG002|COMPLETED|Period 2, 4 Days||3
11390778|NCT03590613|12584920|FG003|COMPLETED|Period 2, 4 Days||3
11390779|NCT03590613|12584917|FG000|NOT COMPLETED|Period 2, 4 Days||0
11390780|NCT03590613|12584918|FG001|NOT COMPLETED|Period 2, 4 Days||0
11390781|NCT03590613|12584919|FG002|NOT COMPLETED|Period 2, 4 Days||0
11390782|NCT03590613|12584920|FG003|NOT COMPLETED|Period 2, 4 Days||1
11390783|NCT03590613|12584917|FG000|STARTED|Period 2, Wash-out, at Least 3 Days||3
11390784|NCT03590613|12584918|FG001|STARTED|Period 2, Wash-out, at Least 3 Days||3
11390785|NCT03590613|12584919|FG002|STARTED|Period 2, Wash-out, at Least 3 Days||3
11390786|NCT03590613|12584920|FG003|STARTED|Period 2, Wash-out, at Least 3 Days||3
11390787|NCT03590613|12584917|FG000|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
11390788|NCT03590613|12584918|FG001|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
11390789|NCT03590613|12584919|FG002|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
11390790|NCT03590613|12584920|FG003|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
11390791|NCT03590613|12584917|FG000|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
11390792|NCT03590613|12584918|FG001|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
11390793|NCT03590613|12584919|FG002|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
11390794|NCT03590613|12584920|FG003|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
11390795|NCT03590613|12584917|FG000|STARTED|Period 3, 4 Days||3
11390796|NCT03590613|12584918|FG001|STARTED|Period 3, 4 Days||3
11390797|NCT03590613|12584919|FG002|STARTED|Period 3, 4 Days||3
11390798|NCT03590613|12584920|FG003|STARTED|Period 3, 4 Days||3
11390799|NCT03590613|12584917|FG000|COMPLETED|Period 3, 4 Days||3
11390800|NCT03590613|12584918|FG001|COMPLETED|Period 3, 4 Days||3
11390801|NCT03590613|12584919|FG002|COMPLETED|Period 3, 4 Days||3
11390802|NCT03590613|12584920|FG003|COMPLETED|Period 3, 4 Days||3
11390803|NCT03590613|12584917|FG000|NOT COMPLETED|Period 3, 4 Days||0
11390804|NCT03590613|12584918|FG001|NOT COMPLETED|Period 3, 4 Days||0
11390805|NCT03590613|12584919|FG002|NOT COMPLETED|Period 3, 4 Days||0
11390806|NCT03590613|12584920|FG003|NOT COMPLETED|Period 3, 4 Days||0
11390807|NCT03590613|12584917|FG000|STARTED|Period 3,Wash-out, at Least 3 Days||3
11390808|NCT03590613|12584918|FG001|STARTED|Period 3,Wash-out, at Least 3 Days||3
11390809|NCT03590613|12584919|FG002|STARTED|Period 3,Wash-out, at Least 3 Days||3
11390810|NCT03590613|12584920|FG003|STARTED|Period 3,Wash-out, at Least 3 Days||3
11390811|NCT03590613|12584917|FG000|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
11390812|NCT03590613|12584918|FG001|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
11390813|NCT03590613|12584919|FG002|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
11390814|NCT03590613|12584920|FG003|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
11390815|NCT03590613|12584917|FG000|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
11390816|NCT03590613|12584918|FG001|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
11390817|NCT03590613|12584919|FG002|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
11390818|NCT03590613|12584920|FG003|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
11390819|NCT03590613|12584917|FG000|STARTED|Period 4, 4 Days||3
11390820|NCT03590613|12584918|FG001|STARTED|Period 4, 4 Days||3
11390821|NCT03590613|12584919|FG002|STARTED|Period 4, 4 Days||3
11390822|NCT03590613|12584920|FG003|STARTED|Period 4, 4 Days||3
11390823|NCT03590613|12584917|FG000|COMPLETED|Period 4, 4 Days||3
11390824|NCT03590613|12584918|FG001|COMPLETED|Period 4, 4 Days||3
11390825|NCT03590613|12584919|FG002|COMPLETED|Period 4, 4 Days||3
11390826|NCT03590613|12584920|FG003|COMPLETED|Period 4, 4 Days||3
11390827|NCT03590613|12584917|FG000|NOT COMPLETED|Period 4, 4 Days||0
11390828|NCT03590613|12584918|FG001|NOT COMPLETED|Period 4, 4 Days||0
11390829|NCT03590613|12584919|FG002|NOT COMPLETED|Period 4, 4 Days||0
11390830|NCT03590613|12584920|FG003|NOT COMPLETED|Period 4, 4 Days||0
11390831|NCT03591068|12584933|FG000|STARTED|Overall Study||11
11390832|NCT03591068|12584933|FG000|COMPLETED|Overall Study||9
11390833|NCT03591068|12584933|FG000|NOT COMPLETED|Overall Study||2
11390834|NCT03591146|12584944|FG000|STARTED|TLC590 190mg and Naropin 150mg||12
11390835|NCT03591146|12584945|FG001|STARTED|TLC590 190mg and Naropin 150mg||0
11390836|NCT03591146|12584946|FG002|STARTED|TLC590 190mg and Naropin 150mg||0
11390837|NCT03591146|12584947|FG003|STARTED|TLC590 190mg and Naropin 150mg||0
11390838|NCT03591146|12584948|FG004|STARTED|TLC590 190mg and Naropin 150mg||4
11390839|NCT03591146|12584944|FG000|COMPLETED|TLC590 190mg and Naropin 150mg||12
11390840|NCT03591146|12584945|FG001|COMPLETED|TLC590 190mg and Naropin 150mg||0
11390841|NCT03591146|12584946|FG002|COMPLETED|TLC590 190mg and Naropin 150mg||0
11390842|NCT03591146|12584947|FG003|COMPLETED|TLC590 190mg and Naropin 150mg||0
11390843|NCT03591146|12584948|FG004|COMPLETED|TLC590 190mg and Naropin 150mg||3
11390844|NCT03591146|12584944|FG000|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
11390845|NCT03591146|12584945|FG001|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
11390846|NCT03591146|12584946|FG002|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
11390847|NCT03591146|12584947|FG003|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
11390848|NCT03591146|12584948|FG004|NOT COMPLETED|TLC590 190mg and Naropin 150mg||1
11390849|NCT03591146|12584944|FG000|STARTED|TLC590 380mg and Naropin 150mg||0
11390850|NCT03591146|12584945|FG001|STARTED|TLC590 380mg and Naropin 150mg||12
11390851|NCT03591146|12584946|FG002|STARTED|TLC590 380mg and Naropin 150mg||0
11390852|NCT03591146|12584947|FG003|STARTED|TLC590 380mg and Naropin 150mg||0
11390853|NCT03591146|12584948|FG004|STARTED|TLC590 380mg and Naropin 150mg||5
11390854|NCT03591146|12584944|FG000|COMPLETED|TLC590 380mg and Naropin 150mg||0
11390855|NCT03591146|12584945|FG001|COMPLETED|TLC590 380mg and Naropin 150mg||11
11390856|NCT03591146|12584946|FG002|COMPLETED|TLC590 380mg and Naropin 150mg||0
11390857|NCT03591146|12584947|FG003|COMPLETED|TLC590 380mg and Naropin 150mg||0
11390858|NCT03591146|12584948|FG004|COMPLETED|TLC590 380mg and Naropin 150mg||4
11390859|NCT03591146|12584944|FG000|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
11390860|NCT03591146|12584945|FG001|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
11390861|NCT03591146|12584946|FG002|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
11390862|NCT03591146|12584947|FG003|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
11390863|NCT03591146|12584948|FG004|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
11390864|NCT03591146|12584944|FG000|STARTED|TLC590 570mg and Naropin 150mg||0
11390865|NCT03591146|12584945|FG001|STARTED|TLC590 570mg and Naropin 150mg||0
11390866|NCT03591146|12584946|FG002|STARTED|TLC590 570mg and Naropin 150mg||12
11390867|NCT03591146|12584947|FG003|STARTED|TLC590 570mg and Naropin 150mg||0
11390868|NCT03591146|12584948|FG004|STARTED|TLC590 570mg and Naropin 150mg||4
11390869|NCT03591146|12584944|FG000|COMPLETED|TLC590 570mg and Naropin 150mg||0
11390870|NCT03591146|12584945|FG001|COMPLETED|TLC590 570mg and Naropin 150mg||0
11390871|NCT03591146|12584946|FG002|COMPLETED|TLC590 570mg and Naropin 150mg||11
11390872|NCT03591146|12584947|FG003|COMPLETED|TLC590 570mg and Naropin 150mg||0
11390873|NCT03591146|12584948|FG004|COMPLETED|TLC590 570mg and Naropin 150mg||3
11390874|NCT03591146|12584944|FG000|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
11390875|NCT03591146|12584945|FG001|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
11390876|NCT03591146|12584946|FG002|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
11390877|NCT03591146|12584947|FG003|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
11390878|NCT03591146|12584948|FG004|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
11390879|NCT03591146|12584944|FG000|STARTED|TLC590 475mg and Naropin 150mg||0
11390880|NCT03591146|12584945|FG001|STARTED|TLC590 475mg and Naropin 150mg||0
11390881|NCT03591146|12584946|FG002|STARTED|TLC590 475mg and Naropin 150mg||0
11390882|NCT03591146|12584947|FG003|STARTED|TLC590 475mg and Naropin 150mg||12
11390883|NCT03591146|12584948|FG004|STARTED|TLC590 475mg and Naropin 150mg||4
11390884|NCT03591146|12584944|FG000|COMPLETED|TLC590 475mg and Naropin 150mg||0
11390885|NCT03591146|12584945|FG001|COMPLETED|TLC590 475mg and Naropin 150mg||0
11390886|NCT03591146|12584946|FG002|COMPLETED|TLC590 475mg and Naropin 150mg||0
11390887|NCT03591146|12584947|FG003|COMPLETED|TLC590 475mg and Naropin 150mg||12
11390888|NCT03591146|12584948|FG004|COMPLETED|TLC590 475mg and Naropin 150mg||4
11390889|NCT03591146|12584944|FG000|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
11390890|NCT03591146|12584945|FG001|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
11390891|NCT03591146|12584946|FG002|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
11390892|NCT03591146|12584947|FG003|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
11390893|NCT03591146|12584948|FG004|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
11390894|NCT03591406|12584962|FG000|STARTED|Overall Study||188
11390895|NCT03591406|12584963|FG001|STARTED|Overall Study||183
11390896|NCT03591406|12584962|FG000|COMPLETED|Overall Study||181
11390897|NCT03591406|12584963|FG001|COMPLETED|Overall Study||174
11390898|NCT03591406|12584962|FG000|NOT COMPLETED|Overall Study||7
11390899|NCT03591406|12584963|FG001|NOT COMPLETED|Overall Study||9
11390900|NCT03592121|12584971|FG000|STARTED|Overall Study||3
11390901|NCT03592121|12584972|FG001|STARTED|Overall Study||0
11390902|NCT03592121|12584971|FG000|COMPLETED|Overall Study||3
11390903|NCT03592121|12584972|FG001|COMPLETED|Overall Study||0
11390904|NCT03592121|12584971|FG000|NOT COMPLETED|Overall Study||0
11390905|NCT03592121|12584972|FG001|NOT COMPLETED|Overall Study||0
11390906|NCT03592745|12584980|FG000|STARTED|Overall Study||18
11390907|NCT03592745|12584981|FG001|STARTED|Overall Study||18
11390908|NCT03592745|12584980|FG000|COMPLETED|Overall Study||15
11390909|NCT03592745|12584981|FG001|COMPLETED|Overall Study||15
11390910|NCT03592745|12584980|FG000|NOT COMPLETED|Overall Study||3
11390911|NCT03592745|12584981|FG001|NOT COMPLETED|Overall Study||3
11390912|NCT03593200|12584987|FG000|STARTED|Overall Study||4
11390913|NCT03593200|12584987|FG000|COMPLETED|Overall Study||4
11390914|NCT03593200|12584987|FG000|NOT COMPLETED|Overall Study||0
11390915|NCT03593538|12584994|FG000|STARTED|Overall Study||26
11390916|NCT03593538|12584995|FG001|STARTED|Overall Study||21
11390917|NCT03593538|12584996|FG002|STARTED|Overall Study||22
11390918|NCT03593538|12584994|FG000|COMPLETED|Overall Study||15
11390919|NCT03593538|12584995|FG001|COMPLETED|Overall Study||15
11390920|NCT03593538|12584996|FG002|COMPLETED|Overall Study||11
11390921|NCT03593538|12584994|FG000|NOT COMPLETED|Overall Study||11
11390922|NCT03593538|12584995|FG001|NOT COMPLETED|Overall Study||6
11390923|NCT03593538|12584996|FG002|NOT COMPLETED|Overall Study||11
11390924|NCT03593681|12585004|FG000|STARTED|Overall Study||150
11390925|NCT03593681|12585004|FG000|COMPLETED|Overall Study||115
11390926|NCT03593681|12585004|FG000|NOT COMPLETED|Overall Study||35
11390927|NCT03593876|12585025|FG000|STARTED|Overall Study||16
11390928|NCT03593876|12585025|FG000|COMPLETED|Overall Study||13
11390929|NCT03593876|12585025|FG000|NOT COMPLETED|Overall Study||3
11390930|NCT03593902|12585029|FG000|STARTED|Overall Study||9
11390931|NCT03593902|12585029|FG000|COMPLETED|Overall Study||9
11390932|NCT03593902|12585029|FG000|NOT COMPLETED|Overall Study||0
11390933|NCT03594045|12585035|FG000|STARTED|Overall Study||0
11390934|NCT03594045|12585036|FG001|STARTED|Overall Study||5
11390935|NCT03594045|12585035|FG000|COMPLETED|Overall Study||0
11390936|NCT03594045|12585036|FG001|COMPLETED|Overall Study||5
11390937|NCT03594045|12585035|FG000|NOT COMPLETED|Overall Study||0
11390938|NCT03594045|12585036|FG001|NOT COMPLETED|Overall Study||0
11390939|NCT03594071|12585042|FG000|STARTED|Overall Study||294
11390940|NCT03594071|12585042|FG000|COMPLETED|Overall Study||289
11390941|NCT03594071|12585042|FG000|NOT COMPLETED|Overall Study||5
11390942|NCT03594227|12585050|FG000|STARTED|Overall Study||23
11390943|NCT03594227|12585051|FG001|STARTED|Overall Study||23
11390944|NCT03594227|12585052|FG002|STARTED|Overall Study||22
11390945|NCT03594227|12585053|FG003|STARTED|Overall Study||19
11390946|NCT03594227|12585050|FG000|COMPLETED|Overall Study||18
11390947|NCT03594227|12585051|FG001|COMPLETED|Overall Study||19
11390948|NCT03594227|12585052|FG002|COMPLETED|Overall Study||19
11390949|NCT03594227|12585053|FG003|COMPLETED|Overall Study||14
11390950|NCT03594227|12585050|FG000|NOT COMPLETED|Overall Study||5
11390951|NCT03594227|12585051|FG001|NOT COMPLETED|Overall Study||4
11390952|NCT03594227|12585052|FG002|NOT COMPLETED|Overall Study||3
11390953|NCT03594227|12585053|FG003|NOT COMPLETED|Overall Study||5
11390954|NCT03594500|12585076|FG000|STARTED|Overall Study||66
11390955|NCT03594500|12585077|FG001|STARTED|Overall Study||67
11390956|NCT03594500|12585076|FG000|COMPLETED|Overall Study||60
11390957|NCT03594500|12585077|FG001|COMPLETED|Overall Study||63
11390958|NCT03594500|12585076|FG000|NOT COMPLETED|Overall Study||6
11390959|NCT03594500|12585077|FG001|NOT COMPLETED|Overall Study||4
11390960|NCT03595215|12585086|FG000|STARTED|Overall Study||18
11390961|NCT03595215|12585086|FG000|COMPLETED|Overall Study||10
11390962|NCT03595215|12585086|FG000|NOT COMPLETED|Overall Study||8
11390963|NCT03595280|12585093|FG000|STARTED|Overall Study||119
11390964|NCT03595280|12585094|FG001|STARTED|Overall Study||117
11390965|NCT03595280|12585095|FG002|STARTED|Overall Study||113
11390966|NCT03595280|12585093|FG000|COMPLETED|Overall Study||113
11390967|NCT03595280|12585094|FG001|COMPLETED|Overall Study||108
11390968|NCT03595280|12585095|FG002|COMPLETED|Overall Study||98
11390969|NCT03595280|12585093|FG000|NOT COMPLETED|Overall Study||6
11390970|NCT03595280|12585094|FG001|NOT COMPLETED|Overall Study||9
11390971|NCT03595280|12585095|FG002|NOT COMPLETED|Overall Study||15
11390972|NCT03595449|12585105|FG000|STARTED|Overall Study||118
11390973|NCT03595449|12585106|FG001|STARTED|Overall Study||115
11390974|NCT03595449|12585105|FG000|COMPLETED|Overall Study||118
11390975|NCT03595449|12585106|FG001|COMPLETED|Overall Study||115
11390976|NCT03595449|12585105|FG000|NOT COMPLETED|Overall Study||0
11390977|NCT03595449|12585106|FG001|NOT COMPLETED|Overall Study||0
11390978|NCT03595579|12585114|FG000|STARTED|Overall Study||48
11390979|NCT03595579|12585115|FG001|STARTED|Overall Study||49
11390980|NCT03595579|12585114|FG000|mITT Population|Overall Study||43
11390981|NCT03595579|12585115|FG001|mITT Population|Overall Study||37
11390982|NCT03595579|12585114|FG000|Safety Population|Overall Study||48
11390983|NCT03595579|12585115|FG001|Safety Population|Overall Study||48
11390984|NCT03595579|12585114|FG000|COMPLETED|Overall Study||38
11390985|NCT03595579|12585115|FG001|COMPLETED|Overall Study||35
11390986|NCT03595579|12585114|FG000|NOT COMPLETED|Overall Study||10
11390987|NCT03595579|12585115|FG001|NOT COMPLETED|Overall Study||14
11390988|NCT03595618|12585125|FG000|STARTED|Overall Study||234
11390989|NCT03595618|12585126|FG001|STARTED|Overall Study||231
11390990|NCT03595618|12585127|FG002|STARTED|Overall Study||233
11390991|NCT03595618|12585128|FG003|STARTED|Overall Study||234
11390992|NCT03595618|12585125|FG000|Treated|Overall Study||234
11390993|NCT03595618|12585126|FG001|Treated|Overall Study||231
11390994|NCT03595618|12585127|FG002|Treated|Overall Study||232
11390995|NCT03595618|12585128|FG003|Treated|Overall Study||234
11390996|NCT03595618|12585125|FG000|COMPLETED|Overall Study||191
11390997|NCT03595618|12585126|FG001|COMPLETED|Overall Study||191
11390998|NCT03595618|12585127|FG002|COMPLETED|Overall Study||177
11390999|NCT03595618|12585128|FG003|COMPLETED|Overall Study||200
11391000|NCT03595618|12585125|FG000|NOT COMPLETED|Overall Study||43
11391001|NCT03595618|12585126|FG001|NOT COMPLETED|Overall Study||40
11391002|NCT03595618|12585127|FG002|NOT COMPLETED|Overall Study||56
11391003|NCT03595618|12585128|FG003|NOT COMPLETED|Overall Study||34
11391004|NCT03595904|12585140|FG000|STARTED|Overall Study||39
11391005|NCT03595904|12585141|FG001|STARTED|Overall Study||39
11391006|NCT03595904|12585140|FG000|COMPLETED|Overall Study||29
11391007|NCT03595904|12585141|FG001|COMPLETED|Overall Study||34
11391008|NCT03595904|12585140|FG000|NOT COMPLETED|Overall Study||10
11391009|NCT03595904|12585141|FG001|NOT COMPLETED|Overall Study||5
11391010|NCT03596151|12585147|FG000|STARTED|Overall Study||295
11391011|NCT03596151|12585147|FG000|COMPLETED|Overall Study||294
11391012|NCT03596151|12585147|FG000|NOT COMPLETED|Overall Study||1
11391013|NCT03596177|12585153|FG000|STARTED|Single Blind Period||9
11391014|NCT03596177|12585154|FG001|STARTED|Single Blind Period||19
11391015|NCT03596177|12585153|FG000|COMPLETED|Single Blind Period||7
11391016|NCT03596177|12585154|FG001|COMPLETED|Single Blind Period||18
11391017|NCT03596177|12585153|FG000|NOT COMPLETED|Single Blind Period||2
11391018|NCT03596177|12585154|FG001|NOT COMPLETED|Single Blind Period||1
11391019|NCT03596177|12585153|FG000|STARTED|Double Blind Period||7
11391020|NCT03596177|12585154|FG001|STARTED|Double Blind Period||18
11391021|NCT03596177|12585153|FG000|COMPLETED|Double Blind Period||7
11391022|NCT03596177|12585154|FG001|COMPLETED|Double Blind Period||12
11391023|NCT03596177|12585153|FG000|NOT COMPLETED|Double Blind Period||0
11391024|NCT03596177|12585154|FG001|NOT COMPLETED|Double Blind Period||6
11391025|NCT03596723|12585162|FG000|STARTED|Overall Study||1
11391026|NCT03596723|12585163|FG001|STARTED|Overall Study||1
11391027|NCT03596723|12585162|FG000|COMPLETED|Overall Study||1
11391028|NCT03596723|12585163|FG001|COMPLETED|Overall Study||1
11391029|NCT03596723|12585162|FG000|NOT COMPLETED|Overall Study||0
11391030|NCT03596723|12585163|FG001|NOT COMPLETED|Overall Study||0
11391031|NCT03597009|12585169|FG000|STARTED|Overall Study||1
11391032|NCT03597009|12585169|FG000|COMPLETED|Overall Study||1
11391033|NCT03597009|12585169|FG000|NOT COMPLETED|Overall Study||0
11391034|NCT03597022|12585176|FG000|STARTED|Overall Study||8
11391035|NCT03597022|12585177|FG001|STARTED|Overall Study||8
11391036|NCT03597022|12585178|FG002|STARTED|Overall Study||8
11391037|NCT03597022|12585176|FG000|COMPLETED|Overall Study||0
11391038|NCT03597022|12585177|FG001|COMPLETED|Overall Study||0
11391039|NCT03597022|12585178|FG002|COMPLETED|Overall Study||0
11391040|NCT03597022|12585176|FG000|NOT COMPLETED|Overall Study||8
11391041|NCT03597022|12585177|FG001|NOT COMPLETED|Overall Study||8
11391042|NCT03597022|12585178|FG002|NOT COMPLETED|Overall Study||8
11391043|NCT03597061|12585188|FG000|STARTED|Overall Study||17
11391044|NCT03597061|12585189|FG001|STARTED|Overall Study||17
11391045|NCT03597061|12585188|FG000|COMPLETED|Overall Study||16
11391046|NCT03597061|12585189|FG001|COMPLETED|Overall Study||16
11391047|NCT03597061|12585188|FG000|NOT COMPLETED|Overall Study||1
11391048|NCT03597061|12585189|FG001|NOT COMPLETED|Overall Study||1
11391049|NCT03597139|12585197|FG000|STARTED|Overall Study||51
11391050|NCT03597139|12585198|FG001|STARTED|Overall Study||49
11391051|NCT03597139|12585197|FG000|COMPLETED|Overall Study||47
11391052|NCT03597139|12585198|FG001|COMPLETED|Overall Study||49
11391053|NCT03597139|12585197|FG000|NOT COMPLETED|Overall Study||4
11391054|NCT03597139|12585198|FG001|NOT COMPLETED|Overall Study||0
11391055|NCT03597178|12585204|FG000|STARTED|Overall Study||14
11391056|NCT03597178|12585204|FG000|COMPLETED|Overall Study||14
11391057|NCT03597178|12585204|FG000|NOT COMPLETED|Overall Study||0
11391058|NCT03597347|12585211|FG000|STARTED|Overall Study||7
11391059|NCT03597347|12585212|FG001|STARTED|Overall Study||3
11391060|NCT03597347|12585213|FG002|STARTED|Overall Study||4
11391061|NCT03597347|12585211|FG000|COMPLETED|Overall Study||0
11391062|NCT03597347|12585212|FG001|COMPLETED|Overall Study||0
11391063|NCT03597347|12585213|FG002|COMPLETED|Overall Study||0
11391064|NCT03597347|12585211|FG000|NOT COMPLETED|Overall Study||7
11391065|NCT03597347|12585212|FG001|NOT COMPLETED|Overall Study||3
11391066|NCT03597347|12585213|FG002|NOT COMPLETED|Overall Study||4
11391067|NCT03597529|12585223|FG000|STARTED|Overall Study||42
11391068|NCT03597529|12585224|FG001|STARTED|Overall Study||42
11391069|NCT03597529|12585223|FG000|Follow-up|Overall Study||22
11391070|NCT03597529|12585224|FG001|Follow-up|Overall Study||24
11391071|NCT03597529|12585223|FG000|COMPLETED|Overall Study||22
11391072|NCT03597529|12585224|FG001|COMPLETED|Overall Study||24
11391073|NCT03597529|12585223|FG000|NOT COMPLETED|Overall Study||20
11391074|NCT03597529|12585224|FG001|NOT COMPLETED|Overall Study||18
11391075|NCT03597789|12585230|FG000|STARTED|Overall Study||45
11391076|NCT03597789|12585230|FG000|COMPLETED|Overall Study||10
11391077|NCT03597789|12585230|FG000|NOT COMPLETED|Overall Study||35
11391078|NCT03598647|12585236|FG000|STARTED|Exercisers vs. Non-exercisers||30
11391079|NCT03598647|12585237|FG001|STARTED|Exercisers vs. Non-exercisers||30
11391080|NCT03598647|12585238|FG002|STARTED|Exercisers vs. Non-exercisers||0
11391081|NCT03598647|12585239|FG003|STARTED|Exercisers vs. Non-exercisers||0
11391082|NCT03598647|12585236|FG000|COMPLETED|Exercisers vs. Non-exercisers||29
11391083|NCT03598647|12585237|FG001|COMPLETED|Exercisers vs. Non-exercisers||30
11391084|NCT03598647|12585238|FG002|COMPLETED|Exercisers vs. Non-exercisers||0
11391085|NCT03598647|12585239|FG003|COMPLETED|Exercisers vs. Non-exercisers||0
11391086|NCT03598647|12585236|FG000|NOT COMPLETED|Exercisers vs. Non-exercisers||1
11391087|NCT03598647|12585237|FG001|NOT COMPLETED|Exercisers vs. Non-exercisers||0
11391088|NCT03598647|12585238|FG002|NOT COMPLETED|Exercisers vs. Non-exercisers||0
11391089|NCT03598647|12585239|FG003|NOT COMPLETED|Exercisers vs. Non-exercisers||0
11391090|NCT03598647|12585236|FG000|STARTED|Interventions for Non-exercisers||0
11391091|NCT03598647|12585237|FG001|STARTED|Interventions for Non-exercisers||0
11391092|NCT03598647|12585238|FG002|STARTED|Interventions for Non-exercisers||14
11391093|NCT03598647|12585239|FG003|STARTED|Interventions for Non-exercisers||16
11391094|NCT03598647|12585236|FG000|COMPLETED|Interventions for Non-exercisers||0
11391095|NCT03598647|12585237|FG001|COMPLETED|Interventions for Non-exercisers||0
11391096|NCT03598647|12585238|FG002|COMPLETED|Interventions for Non-exercisers||14
11391097|NCT03598647|12585239|FG003|COMPLETED|Interventions for Non-exercisers||16
11391098|NCT03598647|12585236|FG000|NOT COMPLETED|Interventions for Non-exercisers||0
11391099|NCT03598647|12585237|FG001|NOT COMPLETED|Interventions for Non-exercisers||0
11391100|NCT03598647|12585238|FG002|NOT COMPLETED|Interventions for Non-exercisers||0
11391101|NCT03598647|12585239|FG003|NOT COMPLETED|Interventions for Non-exercisers||0
11391102|NCT03599089|12585253|FG000|STARTED|Overall Study||36
11391103|NCT03599089|12585254|FG001|STARTED|Overall Study||36
11391104|NCT03599089|12585255|FG002|STARTED|Overall Study||38
11391105|NCT03599089|12585256|FG003|STARTED|Overall Study||37
11391106|NCT03599089|12585253|FG000|COMPLETED|Overall Study||33
11391107|NCT03599089|12585254|FG001|COMPLETED|Overall Study||35
11391108|NCT03599089|12585255|FG002|COMPLETED|Overall Study||37
11391109|NCT03599089|12585256|FG003|COMPLETED|Overall Study||35
11391110|NCT03599089|12585253|FG000|NOT COMPLETED|Overall Study||3
11391111|NCT03599089|12585254|FG001|NOT COMPLETED|Overall Study||1
11142125|NCT01466491|12328849|FG000|STARTED|Overall Study||83
11142126|NCT01466491|12328850|FG001|STARTED|Overall Study||83
11142127|NCT01466491|12328851|FG002|STARTED|Overall Study||83
11142128|NCT01466491|12328852|FG003|STARTED|Overall Study||83
11142129|NCT01466491|12328849|FG000|COMPLETED|Overall Study||83
11142130|NCT01466491|12328850|FG001|COMPLETED|Overall Study||80
11142131|NCT01466491|12328851|FG002|COMPLETED|Overall Study||80
11142132|NCT01466491|12328852|FG003|COMPLETED|Overall Study||83
11391112|NCT03599089|12585255|FG002|NOT COMPLETED|Overall Study||1
11391113|NCT03599089|12585256|FG003|NOT COMPLETED|Overall Study||2
11391114|NCT03599193|12585268|FG000|STARTED|Overall Study||34
11391115|NCT03599193|12585269|FG001|STARTED|Overall Study||24
11391116|NCT03599193|12585268|FG000|COMPLETED|Overall Study||32
11391117|NCT03599193|12585269|FG001|COMPLETED|Overall Study||21
11391118|NCT03599193|12585268|FG000|NOT COMPLETED|Overall Study||2
11391119|NCT03599193|12585269|FG001|NOT COMPLETED|Overall Study||3
11391120|NCT03599271|12585278|FG000|STARTED|Overall Study||70
11391121|NCT03599271|12585279|FG001|STARTED|Overall Study||5
11391122|NCT03599271|12585278|FG000|Drug-Coated Device|Overall Study||70
11391123|NCT03599271|12585279|FG001|Drug-Coated Device|Overall Study||5
11391124|NCT03599271|12585278|FG000|Control Device|Overall Study||70
11391125|NCT03599271|12585279|FG001|Control Device|Overall Study||0
11391126|NCT03599271|12585278|FG000|COMPLETED|Overall Study||70
11391127|NCT03599271|12585279|FG001|COMPLETED|Overall Study||5
11391128|NCT03599271|12585278|FG000|NOT COMPLETED|Overall Study||0
11391129|NCT03599271|12585279|FG001|NOT COMPLETED|Overall Study||0
11391130|NCT03599349|12585287|FG000|STARTED|Overall Study||20
11391131|NCT03599349|12585287|FG000|Treated|Overall Study||20
11391132|NCT03599349|12585287|FG000|COMPLETED|Overall Study||19
11391133|NCT03599349|12585287|FG000|NOT COMPLETED|Overall Study||1
11391134|NCT03599362|12585291|FG000|STARTED|Overall Study||7
11391135|NCT03599362|12585291|FG000|COMPLETED|Overall Study||4
11391136|NCT03599362|12585291|FG000|NOT COMPLETED|Overall Study||3
11391137|NCT03599687|12585297|FG000|STARTED|Overall Study||82
11391138|NCT03599687|12585298|FG001|STARTED|Overall Study||82
11391139|NCT03599687|12585297|FG000|COMPLETED|Overall Study||82
11391140|NCT03599687|12585298|FG001|COMPLETED|Overall Study||82
11391141|NCT03599687|12585297|FG000|NOT COMPLETED|Overall Study||0
11391142|NCT03599687|12585298|FG001|NOT COMPLETED|Overall Study||0
11391143|NCT03599986|12585304|FG000|STARTED|Overall Study||398
11391144|NCT03599986|12585304|FG000|COMPLETED|Overall Study||366
11391145|NCT03599986|12585304|FG000|NOT COMPLETED|Overall Study||32
11391146|NCT03600194|12585309|FG000|STARTED|Screening||38
11391147|NCT03600194|12585310|FG001|STARTED|Screening||0
11391148|NCT03600194|12585311|FG002|STARTED|Screening||0
11391149|NCT03600194|12585309|FG000|COMPLETED|Screening||11
11391150|NCT03600194|12585310|FG001|COMPLETED|Screening||0
11391151|NCT03600194|12585311|FG002|COMPLETED|Screening||0
11391152|NCT03600194|12585309|FG000|NOT COMPLETED|Screening||27
11391153|NCT03600194|12585310|FG001|NOT COMPLETED|Screening||0
11391154|NCT03600194|12585311|FG002|NOT COMPLETED|Screening||0
11391155|NCT03600194|12585309|FG000|STARTED|In Lab Phase||0
11391156|NCT03600194|12585310|FG001|STARTED|In Lab Phase||5
11391157|NCT03600194|12585311|FG002|STARTED|In Lab Phase||6
11391158|NCT03600194|12585309|FG000|COMPLETED|In Lab Phase||0
11391159|NCT03600194|12585310|FG001|COMPLETED|In Lab Phase||5
11391160|NCT03600194|12585311|FG002|COMPLETED|In Lab Phase||6
11391161|NCT03600194|12585309|FG000|NOT COMPLETED|In Lab Phase||0
11391162|NCT03600194|12585310|FG001|NOT COMPLETED|In Lab Phase||0
11391163|NCT03600194|12585311|FG002|NOT COMPLETED|In Lab Phase||0
11391164|NCT03600376|12585324|FG000|STARTED|Overall Study||9
11391165|NCT03600376|12585325|FG001|STARTED|Overall Study||8
11391166|NCT03600376|12585324|FG000|COMPLETED|Overall Study||7
11391167|NCT03600376|12585325|FG001|COMPLETED|Overall Study||2
11391168|NCT03600376|12585324|FG000|NOT COMPLETED|Overall Study||2
11391169|NCT03600376|12585325|FG001|NOT COMPLETED|Overall Study||6
11391170|NCT03600428|12585333|FG000|STARTED|Overall Study||79
11391171|NCT03600428|12585334|FG001|STARTED|Overall Study||73
11391172|NCT03600428|12585333|FG000|15-day Follow-up|Overall Study||76
11142133|NCT01466491|12328849|FG000|NOT COMPLETED|Overall Study||0
11391173|NCT03600428|12585334|FG001|15-day Follow-up|Overall Study||70
11391174|NCT03600428|12585333|FG000|43-day Follow-up|Overall Study||74
11391175|NCT03600428|12585334|FG001|43-day Follow-up|Overall Study||68
11391176|NCT03600428|12585333|FG000|COMPLETED|Overall Study||74
11391177|NCT03600428|12585334|FG001|COMPLETED|Overall Study||68
11142134|NCT01466491|12328850|FG001|NOT COMPLETED|Overall Study||3
11142135|NCT01466491|12328851|FG002|NOT COMPLETED|Overall Study||3
11142136|NCT01466491|12328852|FG003|NOT COMPLETED|Overall Study||0
11391178|NCT03600428|12585333|FG000|NOT COMPLETED|Overall Study||5
11391179|NCT03600428|12585334|FG001|NOT COMPLETED|Overall Study||5
11391180|NCT03601052|12585340|FG000|STARTED|Overall Study||14
11391181|NCT03601052|12585340|FG000|COMPLETED|Overall Study||12
11391182|NCT03601052|12585340|FG000|NOT COMPLETED|Overall Study||2
11391183|NCT03601715|12585352|FG000|STARTED|First Intervention||7
11391184|NCT03601715|12585353|FG001|STARTED|First Intervention||7
11391185|NCT03601715|12585354|FG002|STARTED|First Intervention||6
11391186|NCT03601715|12585352|FG000|COMPLETED|First Intervention||7
11391187|NCT03601715|12585353|FG001|COMPLETED|First Intervention||7
11391188|NCT03601715|12585354|FG002|COMPLETED|First Intervention||6
11391189|NCT03601715|12585352|FG000|NOT COMPLETED|First Intervention||0
11391190|NCT03601715|12585353|FG001|NOT COMPLETED|First Intervention||0
11391191|NCT03601715|12585354|FG002|NOT COMPLETED|First Intervention||0
11391192|NCT03601715|12585352|FG000|STARTED|Washout 1 (at Least 24 Hours)||7
11391193|NCT03601715|12585353|FG001|STARTED|Washout 1 (at Least 24 Hours)||7
11391194|NCT03601715|12585354|FG002|STARTED|Washout 1 (at Least 24 Hours)||6
11391195|NCT03601715|12585352|FG000|COMPLETED|Washout 1 (at Least 24 Hours)||7
11391196|NCT03601715|12585353|FG001|COMPLETED|Washout 1 (at Least 24 Hours)||7
11391197|NCT03601715|12585354|FG002|COMPLETED|Washout 1 (at Least 24 Hours)||6
11391198|NCT03601715|12585352|FG000|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
11391199|NCT03601715|12585353|FG001|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
11391200|NCT03601715|12585354|FG002|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
11391201|NCT03601715|12585352|FG000|STARTED|Second Intervention||7
11391202|NCT03601715|12585353|FG001|STARTED|Second Intervention||7
11391203|NCT03601715|12585354|FG002|STARTED|Second Intervention||6
11391204|NCT03601715|12585352|FG000|COMPLETED|Second Intervention||6
11391205|NCT03601715|12585353|FG001|COMPLETED|Second Intervention||6
11391206|NCT03601715|12585354|FG002|COMPLETED|Second Intervention||6
11391207|NCT03601715|12585352|FG000|NOT COMPLETED|Second Intervention||1
11391208|NCT03601715|12585353|FG001|NOT COMPLETED|Second Intervention||1
11391209|NCT03601715|12585354|FG002|NOT COMPLETED|Second Intervention||0
11391210|NCT03601715|12585352|FG000|STARTED|Wash Out 2 (at Least 24 Hours)||6
11391211|NCT03601715|12585353|FG001|STARTED|Wash Out 2 (at Least 24 Hours)||6
11391212|NCT03601715|12585354|FG002|STARTED|Wash Out 2 (at Least 24 Hours)||6
11391213|NCT03601715|12585352|FG000|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
11391214|NCT03601715|12585353|FG001|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
11391215|NCT03601715|12585354|FG002|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
11391216|NCT03601715|12585352|FG000|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
11391217|NCT03601715|12585353|FG001|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
11391218|NCT03601715|12585354|FG002|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
11391219|NCT03601715|12585352|FG000|STARTED|Third Intervention||6
11391220|NCT03601715|12585353|FG001|STARTED|Third Intervention||6
11391221|NCT03601715|12585354|FG002|STARTED|Third Intervention||6
11391222|NCT03601715|12585352|FG000|COMPLETED|Third Intervention||6
11391223|NCT03601715|12585353|FG001|COMPLETED|Third Intervention||6
11391224|NCT03601715|12585354|FG002|COMPLETED|Third Intervention||6
11391225|NCT03601715|12585352|FG000|NOT COMPLETED|Third Intervention||0
11391226|NCT03601715|12585353|FG001|NOT COMPLETED|Third Intervention||0
11391227|NCT03601715|12585354|FG002|NOT COMPLETED|Third Intervention||0
11391228|NCT03602053|12585365|FG000|STARTED|Overall Study||150
11391229|NCT03602053|12585366|FG001|STARTED|Overall Study||150
11391230|NCT03602053|12585367|FG002|STARTED|Overall Study||150
11391231|NCT03602053|12585365|FG000|COMPLETED|Overall Study||131
11391232|NCT03602053|12585366|FG001|COMPLETED|Overall Study||132
11391233|NCT03602053|12585367|FG002|COMPLETED|Overall Study||139
11391234|NCT03602053|12585365|FG000|NOT COMPLETED|Overall Study||19
11391235|NCT03602053|12585366|FG001|NOT COMPLETED|Overall Study||18
11391236|NCT03602053|12585367|FG002|NOT COMPLETED|Overall Study||11
11391237|NCT03602339|12585379|FG000|STARTED|Overall Study||157
11391238|NCT03602339|12585379|FG000|Completed Period 1 (Gadoterate)|Overall Study||155
11391239|NCT03602339|12585379|FG000|Started Period 2 (Gadobutrol)|Overall Study||142
11391240|NCT03602339|12585379|FG000|COMPLETED|Overall Study||142
11391241|NCT03602339|12585379|FG000|NOT COMPLETED|Overall Study||15
11391242|NCT03602482|12585388|FG000|STARTED|Overall Study||50
11391243|NCT03602482|12585389|FG001|STARTED|Overall Study||50
11391244|NCT03602482|12585390|FG002|STARTED|Overall Study||20
11391245|NCT03602482|12585391|FG003|STARTED|Overall Study||19
11391246|NCT03602482|12585388|FG000|COMPLETED|Overall Study||44
11391247|NCT03602482|12585389|FG001|COMPLETED|Overall Study||43
11391248|NCT03602482|12585390|FG002|COMPLETED|Overall Study||20
11391249|NCT03602482|12585391|FG003|COMPLETED|Overall Study||19
11391250|NCT03602482|12585388|FG000|NOT COMPLETED|Overall Study||6
11391251|NCT03602482|12585389|FG001|NOT COMPLETED|Overall Study||7
11391252|NCT03602482|12585390|FG002|NOT COMPLETED|Overall Study||0
11391253|NCT03602482|12585391|FG003|NOT COMPLETED|Overall Study||0
11391254|NCT03603028|12585404|FG000|STARTED|Overall Study||13
11391255|NCT03603028|12585404|FG000|COMPLETED|Overall Study||12
11391256|NCT03603028|12585404|FG000|NOT COMPLETED|Overall Study||1
11391257|NCT03603106|12585419|FG000|STARTED|Overall Study||6
11391258|NCT03603106|12585420|FG001|STARTED|Overall Study||6
11391259|NCT03603106|12585421|FG002|STARTED|Overall Study||6
11391260|NCT03603106|12585422|FG003|STARTED|Overall Study||6
11391261|NCT03603106|12585423|FG004|STARTED|Overall Study||6
11391262|NCT03603106|12585424|FG005|STARTED|Overall Study||6
11391263|NCT03603106|12585425|FG006|STARTED|Overall Study||18
11391264|NCT03603106|12585426|FG007|STARTED|Overall Study||3
11391265|NCT03603106|12585427|FG008|STARTED|Overall Study||3
11391266|NCT03603106|12585428|FG009|STARTED|Overall Study||3
11391267|NCT03603106|12585429|FG010|STARTED|Overall Study||3
11391268|NCT03603106|12585419|FG000|COMPLETED|Overall Study||6
11391269|NCT03603106|12585420|FG001|COMPLETED|Overall Study||6
11391270|NCT03603106|12585421|FG002|COMPLETED|Overall Study||6
11391271|NCT03603106|12585422|FG003|COMPLETED|Overall Study||6
11391272|NCT03603106|12585423|FG004|COMPLETED|Overall Study||6
11391273|NCT03603106|12585424|FG005|COMPLETED|Overall Study||6
11391274|NCT03603106|12585425|FG006|COMPLETED|Overall Study||18
11391275|NCT03603106|12585426|FG007|COMPLETED|Overall Study||3
11391276|NCT03603106|12585427|FG008|COMPLETED|Overall Study||3
11391277|NCT03603106|12585428|FG009|COMPLETED|Overall Study||3
11391278|NCT03603106|12585429|FG010|COMPLETED|Overall Study||3
11391279|NCT03603106|12585419|FG000|NOT COMPLETED|Overall Study||0
11391280|NCT03603106|12585420|FG001|NOT COMPLETED|Overall Study||0
11391281|NCT03603106|12585421|FG002|NOT COMPLETED|Overall Study||0
11391282|NCT03603106|12585422|FG003|NOT COMPLETED|Overall Study||0
11391283|NCT03603106|12585423|FG004|NOT COMPLETED|Overall Study||0
11391284|NCT03603106|12585424|FG005|NOT COMPLETED|Overall Study||0
11391285|NCT03603106|12585425|FG006|NOT COMPLETED|Overall Study||0
11391286|NCT03603106|12585426|FG007|NOT COMPLETED|Overall Study||0
11391287|NCT03603106|12585427|FG008|NOT COMPLETED|Overall Study||0
11391288|NCT03603106|12585428|FG009|NOT COMPLETED|Overall Study||0
11391289|NCT03603106|12585429|FG010|NOT COMPLETED|Overall Study||0
11391290|NCT03603652|12585462|FG000|STARTED|Overall Study||10
11391291|NCT03603652|12585462|FG000|COMPLETED|Overall Study||8
11391292|NCT03603652|12585462|FG000|NOT COMPLETED|Overall Study||2
11391293|NCT03604263|12585466|FG000|STARTED|Overall Study||17
11391294|NCT03604263|12585466|FG000|COMPLETED|Overall Study||15
11391295|NCT03604263|12585466|FG000|NOT COMPLETED|Overall Study||2
11391296|NCT03604341|12585472|FG000|STARTED|Overall Study||35
11391297|NCT03604341|12585473|FG001|STARTED|Overall Study||35
11391298|NCT03604341|12585472|FG000|COMPLETED|Overall Study||33
11391299|NCT03604341|12585473|FG001|COMPLETED|Overall Study||33
11391300|NCT03604341|12585472|FG000|NOT COMPLETED|Overall Study||2
11391301|NCT03604341|12585473|FG001|NOT COMPLETED|Overall Study||2
11391302|NCT03604497|12585479|FG000|STARTED|Overall Study||437
11391303|NCT03604497|12585479|FG000|COMPLETED|Overall Study||385
11391304|NCT03604497|12585479|FG000|NOT COMPLETED|Overall Study||52
11391305|NCT03604523|12585489|FG000|STARTED|Overall Study||5
11391306|NCT03604523|12585490|FG001|STARTED|Overall Study||5
11391307|NCT03604523|12585489|FG000|COMPLETED|Overall Study||4
11391308|NCT03604523|12585490|FG001|COMPLETED|Overall Study||5
11391309|NCT03604523|12585489|FG000|NOT COMPLETED|Overall Study||1
11391310|NCT03604523|12585490|FG001|NOT COMPLETED|Overall Study||0
11391311|NCT03604705|12585496|FG000|STARTED|Overall Study||21
11391312|NCT03604705|12585496|FG000|COMPLETED|Overall Study||20
11391313|NCT03604705|12585496|FG000|NOT COMPLETED|Overall Study||1
11391314|NCT03605212|12585513|FG000|STARTED|Baseline Period||3
11391315|NCT03605212|12585514|FG001|STARTED|Baseline Period||0
11391316|NCT03605212|12585515|FG002|STARTED|Baseline Period||3
11391317|NCT03605212|12585516|FG003|STARTED|Baseline Period||0
11391318|NCT03605212|12585517|FG004|STARTED|Baseline Period||24
11391319|NCT03605212|12585513|FG000|COMPLETED|Baseline Period||3
11391320|NCT03605212|12585514|FG001|COMPLETED|Baseline Period||0
11391321|NCT03605212|12585515|FG002|COMPLETED|Baseline Period||3
11391322|NCT03605212|12585516|FG003|COMPLETED|Baseline Period||0
11391323|NCT03605212|12585517|FG004|COMPLETED|Baseline Period||24
11391324|NCT03605212|12585513|FG000|NOT COMPLETED|Baseline Period||0
11391325|NCT03605212|12585514|FG001|NOT COMPLETED|Baseline Period||0
11391326|NCT03605212|12585515|FG002|NOT COMPLETED|Baseline Period||0
11391327|NCT03605212|12585516|FG003|NOT COMPLETED|Baseline Period||0
11391328|NCT03605212|12585517|FG004|NOT COMPLETED|Baseline Period||0
11391329|NCT03605212|12585513|FG000|STARTED|Treatment Period||3
11391330|NCT03605212|12585514|FG001|STARTED|Treatment Period||0
11391331|NCT03605212|12585515|FG002|STARTED|Treatment Period||3
11391332|NCT03605212|12585516|FG003|STARTED|Treatment Period||0
11391333|NCT03605212|12585517|FG004|STARTED|Treatment Period||24
11391334|NCT03605212|12585513|FG000|COMPLETED|Treatment Period||2
11391335|NCT03605212|12585514|FG001|COMPLETED|Treatment Period||0
11391336|NCT03605212|12585515|FG002|COMPLETED|Treatment Period||3
11391337|NCT03605212|12585516|FG003|COMPLETED|Treatment Period||0
11391338|NCT03605212|12585517|FG004|COMPLETED|Treatment Period||23
11391339|NCT03605212|12585513|FG000|NOT COMPLETED|Treatment Period||1
11391340|NCT03605212|12585514|FG001|NOT COMPLETED|Treatment Period||0
11391341|NCT03605212|12585515|FG002|NOT COMPLETED|Treatment Period||0
11391342|NCT03605212|12585516|FG003|NOT COMPLETED|Treatment Period||0
11391343|NCT03605212|12585517|FG004|NOT COMPLETED|Treatment Period||1
11391344|NCT03605693|12585532|FG000|STARTED|Overall Study||5
11391345|NCT03605693|12585533|FG001|STARTED|Overall Study||5
11391346|NCT03605693|12585532|FG000|COMPLETED|Overall Study||0
11391347|NCT03605693|12585533|FG001|COMPLETED|Overall Study||5
11391348|NCT03605693|12585532|FG000|NOT COMPLETED|Overall Study||5
11391349|NCT03605693|12585533|FG001|NOT COMPLETED|Overall Study||0
11391350|NCT03605745|12585539|FG000|STARTED|Overall Study||47
11391351|NCT03605745|12585539|FG000|2 Weeks|Overall Study||47
11391352|NCT03605745|12585539|FG000|6 Weeks|Overall Study||47
11391353|NCT03605745|12585539|FG000|3 Months|Overall Study||47
11391354|NCT03605745|12585539|FG000|6 Months|Overall Study||47
11391355|NCT03605745|12585539|FG000|12 Months|Overall Study||40
11391356|NCT03605745|12585539|FG000|24 Months|Overall Study||1
11391357|NCT03605745|12585539|FG000|COMPLETED|Overall Study||0
11391358|NCT03605745|12585539|FG000|NOT COMPLETED|Overall Study||47
11391359|NCT03605836|12585547|FG000|STARTED|OL Placebo Run-in Period [1 Week]||590
11391360|NCT03605836|12585548|FG001|STARTED|OL Placebo Run-in Period [1 Week]||0
11391361|NCT03605836|12585549|FG002|STARTED|OL Placebo Run-in Period [1 Week]||0
11391362|NCT03605836|12585550|FG003|STARTED|OL Placebo Run-in Period [1 Week]||0
11391363|NCT03605836|12585547|FG000|Treated|OL Placebo Run-in Period [1 Week]||579
11391364|NCT03605836|12585548|FG001|Treated|OL Placebo Run-in Period [1 Week]||0
11391365|NCT03605836|12585549|FG002|Treated|OL Placebo Run-in Period [1 Week]||0
11391366|NCT03605836|12585550|FG003|Treated|OL Placebo Run-in Period [1 Week]||0
11391367|NCT03605836|12585547|FG000|COMPLETED|OL Placebo Run-in Period [1 Week]||440
11391368|NCT03605836|12585548|FG001|COMPLETED|OL Placebo Run-in Period [1 Week]||0
11391369|NCT03605836|12585549|FG002|COMPLETED|OL Placebo Run-in Period [1 Week]||0
11391370|NCT03605836|12585550|FG003|COMPLETED|OL Placebo Run-in Period [1 Week]||0
11391371|NCT03605836|12585547|FG000|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||150
11391372|NCT03605836|12585548|FG001|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
11391373|NCT03605836|12585549|FG002|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
11391374|NCT03605836|12585550|FG003|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
11391375|NCT03605836|12585547|FG000|STARTED|Double-blind Treatment Period [6 Weeks]||0
11391376|NCT03605836|12585548|FG001|STARTED|Double-blind Treatment Period [6 Weeks]||147
11391377|NCT03605836|12585549|FG002|STARTED|Double-blind Treatment Period [6 Weeks]||147
11391378|NCT03605836|12585550|FG003|STARTED|Double-blind Treatment Period [6 Weeks]||146
11391379|NCT03605836|12585547|FG000|Treated|Double-blind Treatment Period [6 Weeks]||0
11391380|NCT03605836|12585548|FG001|Treated|Double-blind Treatment Period [6 Weeks]||145
11391381|NCT03605836|12585549|FG002|Treated|Double-blind Treatment Period [6 Weeks]||143
11391382|NCT03605836|12585550|FG003|Treated|Double-blind Treatment Period [6 Weeks]||142
11391383|NCT03605836|12585547|FG000|COMPLETED|Double-blind Treatment Period [6 Weeks]||0
11391384|NCT03605836|12585548|FG001|COMPLETED|Double-blind Treatment Period [6 Weeks]||111
11391385|NCT03605836|12585549|FG002|COMPLETED|Double-blind Treatment Period [6 Weeks]||102
11391386|NCT03605836|12585550|FG003|COMPLETED|Double-blind Treatment Period [6 Weeks]||123
11391387|NCT03605836|12585547|FG000|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||0
11391388|NCT03605836|12585548|FG001|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||36
11391389|NCT03605836|12585549|FG002|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||45
11391390|NCT03605836|12585550|FG003|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||23
11391391|NCT03605914|12585561|FG000|STARTED|Overall Study||57
11391392|NCT03605914|12585562|FG001|STARTED|Overall Study||43
11391393|NCT03605914|12585561|FG000|Completed Day 1 Assessment|Overall Study||31
11391394|NCT03605914|12585562|FG001|Completed Day 1 Assessment|Overall Study||26
11391395|NCT03605914|12585561|FG000|Completed Day 2 Assessment|Overall Study||32
11391396|NCT03605914|12585562|FG001|Completed Day 2 Assessment|Overall Study||27
11391397|NCT03605914|12585561|FG000|Completed Day 3 Assessment|Overall Study||31
11391398|NCT03605914|12585562|FG001|Completed Day 3 Assessment|Overall Study||28
11391399|NCT03605914|12585561|FG000|Completed Day 5 Assessment|Overall Study||30
11391400|NCT03605914|12585562|FG001|Completed Day 5 Assessment|Overall Study||24
11391401|NCT03605914|12585561|FG000|COMPLETED|Overall Study||30
11391402|NCT03605914|12585562|FG001|COMPLETED|Overall Study||24
11391403|NCT03605914|12585561|FG000|NOT COMPLETED|Overall Study||27
11391404|NCT03605914|12585562|FG001|NOT COMPLETED|Overall Study||19
11391405|NCT03606187|12585570|FG000|STARTED|Overall Study||67
11391406|NCT03606187|12585571|FG001|STARTED|Overall Study||61
11391407|NCT03606187|12585570|FG000|COMPLETED|Overall Study||67
11391408|NCT03606187|12585571|FG001|COMPLETED|Overall Study||61
11391409|NCT03606187|12585570|FG000|NOT COMPLETED|Overall Study||0
11391410|NCT03606187|12585571|FG001|NOT COMPLETED|Overall Study||0
11391411|NCT03606343|12585577|FG000|STARTED|Overall Study||21
11391412|NCT03606343|12585577|FG000|COMPLETED|Overall Study||21
11391413|NCT03606343|12585577|FG000|NOT COMPLETED|Overall Study||0
11391414|NCT03606460|12585583|FG000|STARTED|Overall Study||95
11391415|NCT03606460|12585584|FG001|STARTED|Overall Study||46
11391416|NCT03606460|12585583|FG000|COMPLETED|Overall Study||94
11391417|NCT03606460|12585584|FG001|COMPLETED|Overall Study||38
11391418|NCT03606460|12585583|FG000|NOT COMPLETED|Overall Study||1
11391419|NCT03606460|12585584|FG001|NOT COMPLETED|Overall Study||8
11391420|NCT03607539|12585593|FG000|STARTED|Overall Study||266
11391421|NCT03607539|12585594|FG001|STARTED|Overall Study||131
11391422|NCT03607539|12585593|FG000|COMPLETED|Overall Study||0
11391423|NCT03607539|12585594|FG001|COMPLETED|Overall Study||0
11391424|NCT03607539|12585593|FG000|NOT COMPLETED|Overall Study||266
11391425|NCT03607539|12585594|FG001|NOT COMPLETED|Overall Study||131
11391426|NCT03607682|12585600|FG000|STARTED|Overall Study||2
11391427|NCT03607682|12585600|FG000|COMPLETED|Overall Study||0
11391428|NCT03607682|12585600|FG000|NOT COMPLETED|Overall Study||2
11391429|NCT03607695|12585604|FG000|STARTED|2 Week||19
11391430|NCT03607695|12585604|FG000|COMPLETED|2 Week||19
11391431|NCT03607695|12585604|FG000|NOT COMPLETED|2 Week||0
11391432|NCT03607695|12585604|FG000|STARTED|10 Week||19
11391433|NCT03607695|12585604|FG000|COMPLETED|10 Week||18
11006169|NCT00726986|12183936|FG000|STARTED|Maintenance Phase||3
11006170|NCT00726986|12183936|FG000|COMPLETED|Maintenance Phase||0
11006171|NCT00726986|12183936|FG000|NOT COMPLETED|Maintenance Phase||3
11006172|NCT00726999|12183942|FG000|STARTED|Overall Study||32
11006173|NCT00726999|12183943|FG001|STARTED|Overall Study||31
11006174|NCT00726999|12183942|FG000|COMPLETED|Overall Study||29
11391434|NCT03607695|12585604|FG000|NOT COMPLETED|10 Week||1
11391435|NCT03607695|12585604|FG000|STARTED|16 Week||18
11391436|NCT03607695|12585604|FG000|COMPLETED|16 Week||16
11391437|NCT03607695|12585604|FG000|NOT COMPLETED|16 Week||2
11391438|NCT03608488|12585612|FG000|STARTED|Overall Study||22
11391439|NCT03608488|12585613|FG001|STARTED|Overall Study||21
11391440|NCT03608488|12585614|FG002|STARTED|Overall Study||22
11391441|NCT03608488|12585615|FG003|STARTED|Overall Study||45
11391442|NCT03608488|12585612|FG000|COMPLETED|Overall Study||21
11391443|NCT03608488|12585613|FG001|COMPLETED|Overall Study||18
11391444|NCT03608488|12585614|FG002|COMPLETED|Overall Study||20
11391445|NCT03608488|12585615|FG003|COMPLETED|Overall Study||40
11391446|NCT03608488|12585612|FG000|NOT COMPLETED|Overall Study||1
11391447|NCT03608488|12585613|FG001|NOT COMPLETED|Overall Study||3
11391448|NCT03608488|12585614|FG002|NOT COMPLETED|Overall Study||2
11391449|NCT03608488|12585615|FG003|NOT COMPLETED|Overall Study||5
11391450|NCT03608774|12585627|FG000|STARTED|Overall Study||89
11391451|NCT03608774|12585628|FG001|STARTED|Overall Study||88
11391452|NCT03608774|12585627|FG000|COMPLETED|Overall Study||82
11391453|NCT03608774|12585628|FG001|COMPLETED|Overall Study||81
11391454|NCT03608774|12585627|FG000|NOT COMPLETED|Overall Study||7
11391455|NCT03608774|12585628|FG001|NOT COMPLETED|Overall Study||7
11391456|NCT03608839|12585637|FG000|STARTED|Overall Study||9
11391457|NCT03608839|12585638|FG001|STARTED|Overall Study||9
11391458|NCT03608839|12585639|FG002|STARTED|Overall Study||9
11391459|NCT03608839|12585637|FG000|COMPLETED|Overall Study||9
11391460|NCT03608839|12585638|FG001|COMPLETED|Overall Study||9
11391461|NCT03608839|12585639|FG002|COMPLETED|Overall Study||9
11391462|NCT03608839|12585637|FG000|NOT COMPLETED|Overall Study||0
11391463|NCT03608839|12585638|FG001|NOT COMPLETED|Overall Study||0
11391464|NCT03608839|12585639|FG002|NOT COMPLETED|Overall Study||0
11391465|NCT03609619|12585649|FG000|STARTED|Overall Study||54
11391466|NCT03609619|12585650|FG001|STARTED|Overall Study||55
11391467|NCT03609619|12585649|FG000|COMPLETED|Overall Study||44
11391468|NCT03609619|12585650|FG001|COMPLETED|Overall Study||49
11391469|NCT03609619|12585649|FG000|NOT COMPLETED|Overall Study||10
11391470|NCT03609619|12585650|FG001|NOT COMPLETED|Overall Study||6
11391471|NCT03609658|12585658|FG000|STARTED|Overall Study||379
11391472|NCT03609658|12585659|FG001|STARTED|Overall Study||380
11391473|NCT03609658|12585658|FG000|COMPLETED|Overall Study||379
11391474|NCT03609658|12585659|FG001|COMPLETED|Overall Study||380
11391475|NCT03609658|12585658|FG000|NOT COMPLETED|Overall Study||0
11391476|NCT03609658|12585659|FG001|NOT COMPLETED|Overall Study||0
11391477|NCT03610048|12585665|FG000|STARTED|Overall Study||175
11391478|NCT03610048|12585665|FG000|Completed Treatment|Overall Study||15
11391479|NCT03610048|12585665|FG000|COMPLETED|Overall Study||14
11391480|NCT03610048|12585665|FG000|NOT COMPLETED|Overall Study||161
11391481|NCT03610165|12585671|FG000|STARTED|Overall Study||108
11391482|NCT03610165|12585672|FG001|STARTED|Overall Study||106
11391483|NCT03610165|12585671|FG000|COMPLETED|Overall Study||108
11391484|NCT03610165|12585672|FG001|COMPLETED|Overall Study||105
11391485|NCT03610165|12585671|FG000|NOT COMPLETED|Overall Study||0
11391486|NCT03610165|12585672|FG001|NOT COMPLETED|Overall Study||1
11391487|NCT03610269|12585678|FG000|STARTED|Overall Study||143
11391488|NCT03610269|12585678|FG000|COMPLETED|Overall Study||127
11391489|NCT03610269|12585678|FG000|NOT COMPLETED|Overall Study||16
11391490|NCT03610399|12585685|FG000|STARTED|Overall Study||63
11391491|NCT03610399|12585686|FG001|STARTED|Overall Study||96
11391492|NCT03610399|12585687|FG002|STARTED|Overall Study||95
11391493|NCT03610399|12585685|FG000|COMPLETED|Overall Study||53
11391494|NCT03610399|12585686|FG001|COMPLETED|Overall Study||78
11391495|NCT03610399|12585687|FG002|COMPLETED|Overall Study||79
11391496|NCT03610399|12585685|FG000|NOT COMPLETED|Overall Study||10
11391497|NCT03610399|12585686|FG001|NOT COMPLETED|Overall Study||18
11391498|NCT03610399|12585687|FG002|NOT COMPLETED|Overall Study||16
11391499|NCT03610464|12585695|FG000|STARTED|Overall Study||5
11391500|NCT03610464|12585695|FG000|COMPLETED|Overall Study||5
11391501|NCT03610464|12585695|FG000|NOT COMPLETED|Overall Study||0
11391502|NCT03610581|12585702|FG000|STARTED|Overall Study||5
11391503|NCT03610581|12585703|FG001|STARTED|Overall Study||4
11391504|NCT03610581|12585702|FG000|Vaccinated|Overall Study||4
11391505|NCT03610581|12585703|FG001|Vaccinated|Overall Study||4
11391506|NCT03610581|12585702|FG000|COMPLETED|Overall Study||2
11391507|NCT03610581|12585703|FG001|COMPLETED|Overall Study||3
11391508|NCT03610581|12585702|FG000|NOT COMPLETED|Overall Study||3
11391509|NCT03610581|12585703|FG001|NOT COMPLETED|Overall Study||1
11391510|NCT03610633|12585711|FG000|STARTED|Overall Study||5
11391511|NCT03610633|12585712|FG001|STARTED|Overall Study||6
11391512|NCT03610633|12585711|FG000|COMPLETED|Overall Study||5
11391513|NCT03610633|12585712|FG001|COMPLETED|Overall Study||5
11391514|NCT03610633|12585711|FG000|NOT COMPLETED|Overall Study||0
11391515|NCT03610633|12585712|FG001|NOT COMPLETED|Overall Study||1
11391516|NCT03611062|12585720|FG000|STARTED|Overall Study||14
11391517|NCT03611062|12585721|FG001|STARTED|Overall Study||13
11391518|NCT03611062|12585720|FG000|COMPLETED|Overall Study||13
11391519|NCT03611062|12585721|FG001|COMPLETED|Overall Study||12
11391520|NCT03611062|12585720|FG000|NOT COMPLETED|Overall Study||1
11391521|NCT03611062|12585721|FG001|NOT COMPLETED|Overall Study||1
11391522|NCT03611582|12585729|FG000|STARTED|Overall Study||407
11391523|NCT03611582|12585730|FG001|STARTED|Overall Study||204
11391524|NCT03611582|12585729|FG000|Full Analysis Set (FAS)|Overall Study||407
11391525|NCT03611582|12585730|FG001|Full Analysis Set (FAS)|Overall Study||204
11391526|NCT03611582|12585729|FG000|Safety Analysis Set (SAS)|Overall Study||407
11391527|NCT03611582|12585730|FG001|Safety Analysis Set (SAS)|Overall Study||204
11391528|NCT03611582|12585729|FG000|COMPLETED|Overall Study||339
11391529|NCT03611582|12585730|FG001|COMPLETED|Overall Study||166
11391530|NCT03611582|12585729|FG000|NOT COMPLETED|Overall Study||68
11391531|NCT03611582|12585730|FG001|NOT COMPLETED|Overall Study||38
11391532|NCT03611777|12585738|FG000|STARTED|Overall Study||432
11391533|NCT03611777|12585739|FG001|STARTED|Overall Study||469
11391534|NCT03611777|12585738|FG000|COMPLETED|Overall Study||432
11391535|NCT03611777|12585739|FG001|COMPLETED|Overall Study||469
11391536|NCT03611777|12585738|FG000|NOT COMPLETED|Overall Study||0
11391537|NCT03611777|12585739|FG001|NOT COMPLETED|Overall Study||0
11391538|NCT03611829|12585750|FG000|STARTED|Overall Study||43
11391539|NCT03611829|12585751|FG001|STARTED|Overall Study||44
11391540|NCT03611829|12585750|FG000|COMPLETED|Overall Study||21
11391541|NCT03611829|12585751|FG001|COMPLETED|Overall Study||19
11391542|NCT03611829|12585750|FG000|NOT COMPLETED|Overall Study||22
11391543|NCT03611829|12585751|FG001|NOT COMPLETED|Overall Study||25
11391544|NCT03613129|12585762|FG000|STARTED|Pre-treatment Assessment||3
11391545|NCT03613129|12585763|FG001|STARTED|Pre-treatment Assessment||3
11391546|NCT03613129|12585764|FG002|STARTED|Pre-treatment Assessment||7
11391547|NCT03613129|12585765|FG003|STARTED|Pre-treatment Assessment||2
11391548|NCT03613129|12585766|FG004|STARTED|Pre-treatment Assessment||2
11391549|NCT03613129|12585762|FG000|COMPLETED|Pre-treatment Assessment||0
11391550|NCT03613129|12585763|FG001|COMPLETED|Pre-treatment Assessment||3
11391551|NCT03613129|12585764|FG002|COMPLETED|Pre-treatment Assessment||7
11391552|NCT03613129|12585765|FG003|COMPLETED|Pre-treatment Assessment||2
11391553|NCT03613129|12585766|FG004|COMPLETED|Pre-treatment Assessment||2
11391554|NCT03613129|12585762|FG000|NOT COMPLETED|Pre-treatment Assessment||3
11391555|NCT03613129|12585763|FG001|NOT COMPLETED|Pre-treatment Assessment||0
11391556|NCT03613129|12585764|FG002|NOT COMPLETED|Pre-treatment Assessment||0
11391557|NCT03613129|12585765|FG003|NOT COMPLETED|Pre-treatment Assessment||0
11391558|NCT03613129|12585766|FG004|NOT COMPLETED|Pre-treatment Assessment||0
11391559|NCT03613129|12585762|FG000|STARTED|Treatment||0
11391560|NCT03613129|12585763|FG001|STARTED|Treatment||3
11391561|NCT03613129|12585764|FG002|STARTED|Treatment||7
11391562|NCT03613129|12585765|FG003|STARTED|Treatment||2
11391563|NCT03613129|12585766|FG004|STARTED|Treatment||2
11391564|NCT03613129|12585762|FG000|COMPLETED|Treatment||0
11391565|NCT03613129|12585763|FG001|COMPLETED|Treatment|ID35 received only 1 infusion (due to symptom worsening)|3
11391566|NCT03613129|12585764|FG002|COMPLETED|Treatment||7
11391567|NCT03613129|12585765|FG003|COMPLETED|Treatment|ID34 did not receive 3rd infusion (for lack of venous access)|2
11391568|NCT03613129|12585766|FG004|COMPLETED|Treatment||2
11391569|NCT03613129|12585762|FG000|NOT COMPLETED|Treatment||0
11391570|NCT03613129|12585763|FG001|NOT COMPLETED|Treatment||0
11391571|NCT03613129|12585764|FG002|NOT COMPLETED|Treatment||0
11391572|NCT03613129|12585765|FG003|NOT COMPLETED|Treatment||0
11391573|NCT03613129|12585766|FG004|NOT COMPLETED|Treatment||0
11391574|NCT03613129|12585762|FG000|STARTED|Post-treatment Assessment||0
11391575|NCT03613129|12585763|FG001|STARTED|Post-treatment Assessment||3
11391576|NCT03613129|12585764|FG002|STARTED|Post-treatment Assessment||7
11391577|NCT03613129|12585765|FG003|STARTED|Post-treatment Assessment||2
11391578|NCT03613129|12585766|FG004|STARTED|Post-treatment Assessment||2
11391579|NCT03613129|12585762|FG000|COMPLETED|Post-treatment Assessment||0
11391580|NCT03613129|12585763|FG001|COMPLETED|Post-treatment Assessment||3
11391581|NCT03613129|12585764|FG002|COMPLETED|Post-treatment Assessment||7
11391582|NCT03613129|12585765|FG003|COMPLETED|Post-treatment Assessment||2
11391583|NCT03613129|12585766|FG004|COMPLETED|Post-treatment Assessment||2
11391584|NCT03613129|12585762|FG000|NOT COMPLETED|Post-treatment Assessment||0
11391585|NCT03613129|12585763|FG001|NOT COMPLETED|Post-treatment Assessment||0
11391586|NCT03613129|12585764|FG002|NOT COMPLETED|Post-treatment Assessment||0
11391587|NCT03613129|12585765|FG003|NOT COMPLETED|Post-treatment Assessment||0
11391588|NCT03613129|12585766|FG004|NOT COMPLETED|Post-treatment Assessment||0
11391589|NCT03613454|12585780|FG000|STARTED|Overall Study||24
11391590|NCT03613454|12585781|FG001|STARTED|Overall Study||24
11391591|NCT03613454|12585780|FG000|COMPLETED|Overall Study||23
11391592|NCT03613454|12585781|FG001|COMPLETED|Overall Study||23
11391593|NCT03613454|12585780|FG000|NOT COMPLETED|Overall Study||1
11391594|NCT03613454|12585781|FG001|NOT COMPLETED|Overall Study||1
11391595|NCT03613493|12585791|FG000|STARTED|Overall Study||10
11391596|NCT03613493|12585792|FG001|STARTED|Overall Study||75
11391597|NCT03613493|12585793|FG002|STARTED|Overall Study||0
11391598|NCT03613493|12585794|FG003|STARTED|Overall Study||90
11391599|NCT03613493|12585791|FG000|Enrollment Criteria Met|Overall Study||10
11391600|NCT03613493|12585792|FG001|Enrollment Criteria Met|Overall Study||74
11391601|NCT03613493|12585793|FG002|Enrollment Criteria Met|Overall Study||0
11391602|NCT03613493|12585794|FG003|Enrollment Criteria Met|Overall Study||89
11391603|NCT03613493|12585791|FG000|COMPLETED|Overall Study||10
11391604|NCT03613493|12585792|FG001|COMPLETED|Overall Study||73
11391605|NCT03613493|12585793|FG002|COMPLETED|Overall Study||0
11391606|NCT03613493|12585794|FG003|COMPLETED|Overall Study||83
11391607|NCT03613493|12585791|FG000|NOT COMPLETED|Overall Study||0
11391608|NCT03613493|12585792|FG001|NOT COMPLETED|Overall Study||2
11391609|NCT03613493|12585793|FG002|NOT COMPLETED|Overall Study||0
11391610|NCT03613493|12585794|FG003|NOT COMPLETED|Overall Study||7
11391611|NCT03613649|12585815|FG000|STARTED|First Treatment||6
11391612|NCT03613649|12585816|FG001|STARTED|First Treatment||6
11391613|NCT03613649|12585817|FG002|STARTED|First Treatment||6
11391614|NCT03613649|12585818|FG003|STARTED|First Treatment||6
11391615|NCT03613649|12585819|FG004|STARTED|First Treatment||6
11391616|NCT03613649|12585820|FG005|STARTED|First Treatment||6
11391617|NCT03613649|12585821|FG006|STARTED|First Treatment||6
11391618|NCT03613649|12585822|FG007|STARTED|First Treatment||6
11391619|NCT03613649|12585823|FG008|STARTED|First Treatment||6
11391620|NCT03613649|12585824|FG009|STARTED|First Treatment||6
11391621|NCT03613649|12585825|FG010|STARTED|First Treatment||6
11391622|NCT03613649|12585826|FG011|STARTED|First Treatment||6
11391623|NCT03613649|12585815|FG000|Received Treatment|First Treatment||6
11391624|NCT03613649|12585816|FG001|Received Treatment|First Treatment||6
11391625|NCT03613649|12585817|FG002|Received Treatment|First Treatment||6
11391626|NCT03613649|12585818|FG003|Received Treatment|First Treatment||6
11391627|NCT03613649|12585819|FG004|Received Treatment|First Treatment||6
11391628|NCT03613649|12585820|FG005|Received Treatment|First Treatment||6
11391629|NCT03613649|12585821|FG006|Received Treatment|First Treatment||6
11391630|NCT03613649|12585822|FG007|Received Treatment|First Treatment||6
11391631|NCT03613649|12585823|FG008|Received Treatment|First Treatment||6
11391632|NCT03613649|12585824|FG009|Received Treatment|First Treatment||6
11391633|NCT03613649|12585825|FG010|Received Treatment|First Treatment||6
11391634|NCT03613649|12585826|FG011|Received Treatment|First Treatment||6
11391635|NCT03613649|12585815|FG000|COMPLETED|First Treatment||6
11391636|NCT03613649|12585816|FG001|COMPLETED|First Treatment||6
11391637|NCT03613649|12585817|FG002|COMPLETED|First Treatment||6
11391638|NCT03613649|12585818|FG003|COMPLETED|First Treatment||6
11391639|NCT03613649|12585819|FG004|COMPLETED|First Treatment||6
11391640|NCT03613649|12585820|FG005|COMPLETED|First Treatment||6
11391641|NCT03613649|12585821|FG006|COMPLETED|First Treatment||6
11391642|NCT03613649|12585822|FG007|COMPLETED|First Treatment||6
11391643|NCT03613649|12585823|FG008|COMPLETED|First Treatment||6
11391644|NCT03613649|12585824|FG009|COMPLETED|First Treatment||6
11391645|NCT03613649|12585825|FG010|COMPLETED|First Treatment||6
11391646|NCT03613649|12585826|FG011|COMPLETED|First Treatment||6
11391647|NCT03613649|12585815|FG000|NOT COMPLETED|First Treatment||0
11391648|NCT03613649|12585816|FG001|NOT COMPLETED|First Treatment||0
11391649|NCT03613649|12585817|FG002|NOT COMPLETED|First Treatment||0
11391650|NCT03613649|12585818|FG003|NOT COMPLETED|First Treatment||0
11391651|NCT03613649|12585819|FG004|NOT COMPLETED|First Treatment||0
11391652|NCT03613649|12585820|FG005|NOT COMPLETED|First Treatment||0
11391653|NCT03613649|12585821|FG006|NOT COMPLETED|First Treatment||0
11391654|NCT03613649|12585822|FG007|NOT COMPLETED|First Treatment||0
11391655|NCT03613649|12585823|FG008|NOT COMPLETED|First Treatment||0
11391656|NCT03613649|12585824|FG009|NOT COMPLETED|First Treatment||0
11391657|NCT03613649|12585825|FG010|NOT COMPLETED|First Treatment||0
11391658|NCT03613649|12585826|FG011|NOT COMPLETED|First Treatment||0
11391659|NCT03613649|12585815|FG000|STARTED|Second Treatment||6
11391660|NCT03613649|12585816|FG001|STARTED|Second Treatment||6
11391661|NCT03613649|12585817|FG002|STARTED|Second Treatment||6
11391662|NCT03613649|12585818|FG003|STARTED|Second Treatment||6
11391663|NCT03613649|12585819|FG004|STARTED|Second Treatment||6
11391664|NCT03613649|12585820|FG005|STARTED|Second Treatment||6
11391665|NCT03613649|12585821|FG006|STARTED|Second Treatment||6
11391666|NCT03613649|12585822|FG007|STARTED|Second Treatment||6
11391667|NCT03613649|12585823|FG008|STARTED|Second Treatment||6
11391668|NCT03613649|12585824|FG009|STARTED|Second Treatment||6
11391669|NCT03613649|12585825|FG010|STARTED|Second Treatment||6
11391670|NCT03613649|12585826|FG011|STARTED|Second Treatment||6
11391671|NCT03613649|12585815|FG000|Received Treatment|Second Treatment||6
11391672|NCT03613649|12585816|FG001|Received Treatment|Second Treatment||6
11391673|NCT03613649|12585817|FG002|Received Treatment|Second Treatment||6
11391674|NCT03613649|12585818|FG003|Received Treatment|Second Treatment||6
11391675|NCT03613649|12585819|FG004|Received Treatment|Second Treatment||6
11391676|NCT03613649|12585820|FG005|Received Treatment|Second Treatment||6
11391677|NCT03613649|12585821|FG006|Received Treatment|Second Treatment||6
11391678|NCT03613649|12585822|FG007|Received Treatment|Second Treatment||6
11391679|NCT03613649|12585823|FG008|Received Treatment|Second Treatment||6
11391680|NCT03613649|12585824|FG009|Received Treatment|Second Treatment||6
11391681|NCT03613649|12585825|FG010|Received Treatment|Second Treatment||6
11391682|NCT03613649|12585826|FG011|Received Treatment|Second Treatment||6
11391683|NCT03613649|12585815|FG000|COMPLETED|Second Treatment||6
11391684|NCT03613649|12585816|FG001|COMPLETED|Second Treatment||6
11391685|NCT03613649|12585817|FG002|COMPLETED|Second Treatment||5
11391686|NCT03613649|12585818|FG003|COMPLETED|Second Treatment||6
11391687|NCT03613649|12585819|FG004|COMPLETED|Second Treatment||5
11391688|NCT03613649|12585820|FG005|COMPLETED|Second Treatment||6
11391689|NCT03613649|12585821|FG006|COMPLETED|Second Treatment||6
11391690|NCT03613649|12585822|FG007|COMPLETED|Second Treatment||6
11391691|NCT03613649|12585823|FG008|COMPLETED|Second Treatment||6
11391692|NCT03613649|12585824|FG009|COMPLETED|Second Treatment||6
11391693|NCT03613649|12585825|FG010|COMPLETED|Second Treatment||6
11391694|NCT03613649|12585826|FG011|COMPLETED|Second Treatment||6
11391695|NCT03613649|12585815|FG000|NOT COMPLETED|Second Treatment||0
11391696|NCT03613649|12585816|FG001|NOT COMPLETED|Second Treatment||0
11391697|NCT03613649|12585817|FG002|NOT COMPLETED|Second Treatment||1
11391698|NCT03613649|12585818|FG003|NOT COMPLETED|Second Treatment||0
11391699|NCT03613649|12585819|FG004|NOT COMPLETED|Second Treatment||1
11391700|NCT03613649|12585820|FG005|NOT COMPLETED|Second Treatment||0
11391701|NCT03613649|12585821|FG006|NOT COMPLETED|Second Treatment||0
11391702|NCT03613649|12585822|FG007|NOT COMPLETED|Second Treatment||0
11391703|NCT03613649|12585823|FG008|NOT COMPLETED|Second Treatment||0
11391704|NCT03613649|12585824|FG009|NOT COMPLETED|Second Treatment||0
11391705|NCT03613649|12585825|FG010|NOT COMPLETED|Second Treatment||0
11391706|NCT03613649|12585826|FG011|NOT COMPLETED|Second Treatment||0
11391707|NCT03613649|12585815|FG000|STARTED|Third Treatment||6
11391708|NCT03613649|12585816|FG001|STARTED|Third Treatment||6
11391709|NCT03613649|12585817|FG002|STARTED|Third Treatment||5
11391710|NCT03613649|12585818|FG003|STARTED|Third Treatment||6
11391711|NCT03613649|12585819|FG004|STARTED|Third Treatment||5
11391712|NCT03613649|12585820|FG005|STARTED|Third Treatment||6
11391713|NCT03613649|12585821|FG006|STARTED|Third Treatment||6
11391714|NCT03613649|12585822|FG007|STARTED|Third Treatment||6
11391715|NCT03613649|12585823|FG008|STARTED|Third Treatment||6
11391716|NCT03613649|12585824|FG009|STARTED|Third Treatment||6
11391717|NCT03613649|12585825|FG010|STARTED|Third Treatment||6
11391718|NCT03613649|12585826|FG011|STARTED|Third Treatment||6
11391719|NCT03613649|12585815|FG000|Received Treatment|Third Treatment||6
11391720|NCT03613649|12585816|FG001|Received Treatment|Third Treatment||6
11391721|NCT03613649|12585817|FG002|Received Treatment|Third Treatment||5
11391722|NCT03613649|12585818|FG003|Received Treatment|Third Treatment||6
11391723|NCT03613649|12585819|FG004|Received Treatment|Third Treatment||5
11391724|NCT03613649|12585820|FG005|Received Treatment|Third Treatment||6
11391725|NCT03613649|12585821|FG006|Received Treatment|Third Treatment||5
11391726|NCT03613649|12585822|FG007|Received Treatment|Third Treatment||6
11391727|NCT03613649|12585823|FG008|Received Treatment|Third Treatment||6
11391728|NCT03613649|12585824|FG009|Received Treatment|Third Treatment||6
11391729|NCT03613649|12585825|FG010|Received Treatment|Third Treatment||6
11391730|NCT03613649|12585826|FG011|Received Treatment|Third Treatment||6
11391731|NCT03613649|12585815|FG000|COMPLETED|Third Treatment||6
11391732|NCT03613649|12585816|FG001|COMPLETED|Third Treatment||6
11391733|NCT03613649|12585817|FG002|COMPLETED|Third Treatment||5
11391734|NCT03613649|12585818|FG003|COMPLETED|Third Treatment||6
11391735|NCT03613649|12585819|FG004|COMPLETED|Third Treatment||4
11391736|NCT03613649|12585820|FG005|COMPLETED|Third Treatment||6
11391737|NCT03613649|12585821|FG006|COMPLETED|Third Treatment||5
11391738|NCT03613649|12585822|FG007|COMPLETED|Third Treatment||6
11391739|NCT03613649|12585823|FG008|COMPLETED|Third Treatment||6
11391740|NCT03613649|12585824|FG009|COMPLETED|Third Treatment||6
11391741|NCT03613649|12585825|FG010|COMPLETED|Third Treatment||6
11391742|NCT03613649|12585826|FG011|COMPLETED|Third Treatment||4
11391743|NCT03613649|12585815|FG000|NOT COMPLETED|Third Treatment||0
11391744|NCT03613649|12585816|FG001|NOT COMPLETED|Third Treatment||0
11391745|NCT03613649|12585817|FG002|NOT COMPLETED|Third Treatment||0
11391746|NCT03613649|12585818|FG003|NOT COMPLETED|Third Treatment||0
11391747|NCT03613649|12585819|FG004|NOT COMPLETED|Third Treatment||1
11391748|NCT03613649|12585820|FG005|NOT COMPLETED|Third Treatment||0
11391749|NCT03613649|12585821|FG006|NOT COMPLETED|Third Treatment||1
11391750|NCT03613649|12585822|FG007|NOT COMPLETED|Third Treatment||0
11391751|NCT03613649|12585823|FG008|NOT COMPLETED|Third Treatment||0
11391752|NCT03613649|12585824|FG009|NOT COMPLETED|Third Treatment||0
11391753|NCT03613649|12585825|FG010|NOT COMPLETED|Third Treatment||0
11391754|NCT03613649|12585826|FG011|NOT COMPLETED|Third Treatment||2
11391755|NCT03613649|12585815|FG000|STARTED|Fourth Treatment||6
11391756|NCT03613649|12585816|FG001|STARTED|Fourth Treatment||6
11391757|NCT03613649|12585817|FG002|STARTED|Fourth Treatment||5
11391758|NCT03613649|12585818|FG003|STARTED|Fourth Treatment||6
11391759|NCT03613649|12585819|FG004|STARTED|Fourth Treatment||4
11391760|NCT03613649|12585820|FG005|STARTED|Fourth Treatment||6
11391761|NCT03613649|12585821|FG006|STARTED|Fourth Treatment||5
11391762|NCT03613649|12585822|FG007|STARTED|Fourth Treatment||6
11391763|NCT03613649|12585823|FG008|STARTED|Fourth Treatment||6
11391764|NCT03613649|12585824|FG009|STARTED|Fourth Treatment||6
11391765|NCT03613649|12585825|FG010|STARTED|Fourth Treatment||6
11391766|NCT03613649|12585826|FG011|STARTED|Fourth Treatment||4
11391767|NCT03613649|12585815|FG000|Received Treatment|Fourth Treatment||5
11391768|NCT03613649|12585816|FG001|Received Treatment|Fourth Treatment||6
11391769|NCT03613649|12585817|FG002|Received Treatment|Fourth Treatment||5
11391770|NCT03613649|12585818|FG003|Received Treatment|Fourth Treatment||6
11391771|NCT03613649|12585819|FG004|Received Treatment|Fourth Treatment||4
11391772|NCT03613649|12585820|FG005|Received Treatment|Fourth Treatment||6
11391773|NCT03613649|12585821|FG006|Received Treatment|Fourth Treatment||4
11391774|NCT03613649|12585822|FG007|Received Treatment|Fourth Treatment||6
11391775|NCT03613649|12585823|FG008|Received Treatment|Fourth Treatment||6
11391776|NCT03613649|12585824|FG009|Received Treatment|Fourth Treatment||6
11391777|NCT03613649|12585825|FG010|Received Treatment|Fourth Treatment||6
11391778|NCT03613649|12585826|FG011|Received Treatment|Fourth Treatment||4
11391779|NCT03613649|12585815|FG000|COMPLETED|Fourth Treatment||5
11391780|NCT03613649|12585816|FG001|COMPLETED|Fourth Treatment||6
11391781|NCT03613649|12585817|FG002|COMPLETED|Fourth Treatment||5
11391782|NCT03613649|12585818|FG003|COMPLETED|Fourth Treatment||6
11391783|NCT03613649|12585819|FG004|COMPLETED|Fourth Treatment||3
11391784|NCT03613649|12585820|FG005|COMPLETED|Fourth Treatment||6
11391785|NCT03613649|12585821|FG006|COMPLETED|Fourth Treatment||4
11391786|NCT03613649|12585822|FG007|COMPLETED|Fourth Treatment||6
11391787|NCT03613649|12585823|FG008|COMPLETED|Fourth Treatment||6
11391788|NCT03613649|12585824|FG009|COMPLETED|Fourth Treatment||6
11391789|NCT03613649|12585825|FG010|COMPLETED|Fourth Treatment||6
11391790|NCT03613649|12585826|FG011|COMPLETED|Fourth Treatment||4
11391791|NCT03613649|12585815|FG000|NOT COMPLETED|Fourth Treatment||1
11391792|NCT03613649|12585816|FG001|NOT COMPLETED|Fourth Treatment||0
11391793|NCT03613649|12585817|FG002|NOT COMPLETED|Fourth Treatment||0
11391794|NCT03613649|12585818|FG003|NOT COMPLETED|Fourth Treatment||0
11391795|NCT03613649|12585819|FG004|NOT COMPLETED|Fourth Treatment||1
11391796|NCT03613649|12585820|FG005|NOT COMPLETED|Fourth Treatment||0
11391797|NCT03613649|12585821|FG006|NOT COMPLETED|Fourth Treatment||1
11391798|NCT03613649|12585822|FG007|NOT COMPLETED|Fourth Treatment||0
11391799|NCT03613649|12585823|FG008|NOT COMPLETED|Fourth Treatment||0
11391800|NCT03613649|12585824|FG009|NOT COMPLETED|Fourth Treatment||0
11391801|NCT03613649|12585825|FG010|NOT COMPLETED|Fourth Treatment||0
11391802|NCT03613649|12585826|FG011|NOT COMPLETED|Fourth Treatment||0
11391803|NCT03613818|12585846|FG000|STARTED|Overall Study||174
11391804|NCT03613818|12585847|FG001|STARTED|Overall Study||137
11391805|NCT03613818|12585846|FG000|COMPLETED|Overall Study||137
11391806|NCT03613818|12585847|FG001|COMPLETED|Overall Study||110
11391807|NCT03613818|12585846|FG000|NOT COMPLETED|Overall Study||37
11391808|NCT03613818|12585847|FG001|NOT COMPLETED|Overall Study||27
11391809|NCT03614078|12585856|FG000|STARTED|Overall Study||31
11391810|NCT03614078|12585857|FG001|STARTED|Overall Study||30
11391811|NCT03614078|12585858|FG002|STARTED|Overall Study||31
11391812|NCT03614078|12585856|FG000|COMPLETED|Overall Study||28
11391813|NCT03614078|12585857|FG001|COMPLETED|Overall Study||23
11391814|NCT03614078|12585858|FG002|COMPLETED|Overall Study||26
11391815|NCT03614078|12585856|FG000|NOT COMPLETED|Overall Study||3
11391816|NCT03614078|12585857|FG001|NOT COMPLETED|Overall Study||7
11391817|NCT03614078|12585858|FG002|NOT COMPLETED|Overall Study||5
11391818|NCT03614130|12585868|FG000|STARTED|Overall Study||10
11391819|NCT03614130|12585869|FG001|STARTED|Overall Study||12
11391820|NCT03614130|12585868|FG000|COMPLETED|Overall Study||10
11391821|NCT03614130|12585869|FG001|COMPLETED|Overall Study||12
11391822|NCT03614130|12585868|FG000|NOT COMPLETED|Overall Study||0
11391823|NCT03614130|12585869|FG001|NOT COMPLETED|Overall Study||0
11391824|NCT03614156|12585880|FG000|STARTED|Open-Label Treatment Period||363
11391825|NCT03614156|12585881|FG001|STARTED|Open-Label Treatment Period||0
11391826|NCT03614156|12585882|FG002|STARTED|Open-Label Treatment Period||0
11391827|NCT03614156|12585883|FG003|STARTED|Open-Label Treatment Period||0
11391828|NCT03614156|12585880|FG000|COMPLETED|Open-Label Treatment Period||209
11391829|NCT03614156|12585881|FG001|COMPLETED|Open-Label Treatment Period||0
11391830|NCT03614156|12585882|FG002|COMPLETED|Open-Label Treatment Period||0
11391831|NCT03614156|12585883|FG003|COMPLETED|Open-Label Treatment Period||0
11391832|NCT03614156|12585880|FG000|NOT COMPLETED|Open-Label Treatment Period||154
11391833|NCT03614156|12585881|FG001|NOT COMPLETED|Open-Label Treatment Period||0
11391834|NCT03614156|12585882|FG002|NOT COMPLETED|Open-Label Treatment Period||0
11391835|NCT03614156|12585883|FG003|NOT COMPLETED|Open-Label Treatment Period||0
11391836|NCT03614156|12585880|FG000|STARTED|Double-Blind Treatment Period (DBTP)||0
11391837|NCT03614156|12585881|FG001|STARTED|Double-Blind Treatment Period (DBTP)||40
11391838|NCT03614156|12585882|FG002|STARTED|Double-Blind Treatment Period (DBTP)||42
11391839|NCT03614156|12585883|FG003|STARTED|Double-Blind Treatment Period (DBTP)||55
11391840|NCT03614156|12585880|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||0
11391841|NCT03614156|12585881|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||10
11391842|NCT03614156|12585882|FG002|COMPLETED|Double-Blind Treatment Period (DBTP)||11
11391843|NCT03614156|12585883|FG003|COMPLETED|Double-Blind Treatment Period (DBTP)||10
11391844|NCT03614156|12585880|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
11391845|NCT03614156|12585881|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||30
11391846|NCT03614156|12585882|FG002|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||31
11391847|NCT03614156|12585883|FG003|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||45
11391848|NCT03614156|12585880|FG000|STARTED|Safety Follow-Up Period||165
11391849|NCT03614156|12585881|FG001|STARTED|Safety Follow-Up Period||26
11391850|NCT03614156|12585882|FG002|STARTED|Safety Follow-Up Period||30
11391851|NCT03614156|12585883|FG003|STARTED|Safety Follow-Up Period||35
11391852|NCT03614156|12585880|FG000|COMPLETED|Safety Follow-Up Period||162
11391853|NCT03614156|12585881|FG001|COMPLETED|Safety Follow-Up Period||26
11391854|NCT03614156|12585882|FG002|COMPLETED|Safety Follow-Up Period||29
11391855|NCT03614156|12585883|FG003|COMPLETED|Safety Follow-Up Period||34
11391856|NCT03614156|12585880|FG000|NOT COMPLETED|Safety Follow-Up Period||3
11391857|NCT03614156|12585881|FG001|NOT COMPLETED|Safety Follow-Up Period||0
11391858|NCT03614156|12585882|FG002|NOT COMPLETED|Safety Follow-Up Period||1
11391859|NCT03614156|12585883|FG003|NOT COMPLETED|Safety Follow-Up Period||1
11391860|NCT03614416|12585892|FG000|STARTED|Overall Study||13
11391861|NCT03614416|12585892|FG000|COMPLETED|Overall Study||13
11391862|NCT03614416|12585892|FG000|NOT COMPLETED|Overall Study||0
11391863|NCT03614975|12585900|FG000|STARTED|Overall Study||85
11391864|NCT03614975|12585901|FG001|STARTED|Overall Study||81
11391865|NCT03614975|12585900|FG000|COMPLETED|Overall Study||75
11391866|NCT03614975|12585901|FG001|COMPLETED|Overall Study||73
11391867|NCT03614975|12585900|FG000|NOT COMPLETED|Overall Study||10
11391868|NCT03614975|12585901|FG001|NOT COMPLETED|Overall Study||8
11391869|NCT03615001|12585907|FG000|STARTED|Overall Study||20
11391870|NCT03615001|12585907|FG000|COMPLETED|Overall Study||20
11391871|NCT03615001|12585907|FG000|NOT COMPLETED|Overall Study||0
11391872|NCT03615079|12585911|FG000|STARTED|Overall Study||28
11391873|NCT03615079|12585911|FG000|COMPLETED|Overall Study||11
11391874|NCT03615079|12585911|FG000|NOT COMPLETED|Overall Study||17
11391875|NCT03615183|12585920|FG000|STARTED|Overall Study||6
11391876|NCT03615183|12585921|FG001|STARTED|Overall Study||6
11391877|NCT03615183|12585922|FG002|STARTED|Overall Study||5
11391878|NCT03615183|12585923|FG003|STARTED|Overall Study|Panel D was not conducted as the scientific study objectives were met in the conducted panels.|0
11391879|NCT03615183|12585924|FG004|STARTED|Overall Study|Panel E was not conducted as the scientific study objectives were met in the conducted panels.|0
11391880|NCT03615183|12585920|FG000|COMPLETED|Overall Study||6
11391881|NCT03615183|12585921|FG001|COMPLETED|Overall Study||6
11391882|NCT03615183|12585922|FG002|COMPLETED|Overall Study||5
11391883|NCT03615183|12585923|FG003|COMPLETED|Overall Study||0
11391884|NCT03615183|12585924|FG004|COMPLETED|Overall Study||0
11391885|NCT03615183|12585920|FG000|NOT COMPLETED|Overall Study||0
11391886|NCT03615183|12585921|FG001|NOT COMPLETED|Overall Study||0
11391887|NCT03615183|12585922|FG002|NOT COMPLETED|Overall Study||0
11391888|NCT03615183|12585923|FG003|NOT COMPLETED|Overall Study||0
11391889|NCT03615183|12585924|FG004|NOT COMPLETED|Overall Study||0
11391890|NCT03615404|12585932|FG000|STARTED|Overall Study||11
11391891|NCT03615404|12585932|FG000|COMPLETED|Overall Study||9
11391892|NCT03615404|12585932|FG000|NOT COMPLETED|Overall Study||2
11391893|NCT03615534|12585940|FG000|STARTED|Overall Study||14
11391894|NCT03615534|12585941|FG001|STARTED|Overall Study||15
11391895|NCT03615534|12585942|FG002|STARTED|Overall Study||14
11391896|NCT03615534|12585943|FG003|STARTED|Overall Study||14
11391897|NCT03615534|12585940|FG000|COMPLETED|Overall Study||12
11391898|NCT03615534|12585941|FG001|COMPLETED|Overall Study||15
11391899|NCT03615534|12585942|FG002|COMPLETED|Overall Study||14
11391900|NCT03615534|12585943|FG003|COMPLETED|Overall Study||13
11391901|NCT03615534|12585940|FG000|NOT COMPLETED|Overall Study||2
11391902|NCT03615534|12585941|FG001|NOT COMPLETED|Overall Study||0
11391903|NCT03615534|12585942|FG002|NOT COMPLETED|Overall Study||0
11391904|NCT03615534|12585943|FG003|NOT COMPLETED|Overall Study||1
11391905|NCT03615807|12585955|FG000|STARTED|Overall Study||91
11391906|NCT03615807|12585956|FG001|STARTED|Overall Study||91
11391907|NCT03615807|12585955|FG000|COMPLETED|Overall Study||79
11391908|NCT03615807|12585956|FG001|COMPLETED|Overall Study||80
11391909|NCT03615807|12585955|FG000|NOT COMPLETED|Overall Study||12
11391910|NCT03615807|12585956|FG001|NOT COMPLETED|Overall Study||11
11391911|NCT03615911|12585964|FG000|STARTED|Overall Study||14
11391912|NCT03615911|12585965|FG001|STARTED|Overall Study||12
11391913|NCT03615911|12585964|FG000|Received Late Booster Immunization|Overall Study||3
11391914|NCT03615911|12585965|FG001|Received Late Booster Immunization|Overall Study||7
11391915|NCT03615911|12585964|FG000|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|12
11391916|NCT03615911|12585965|FG001|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|11
11391917|NCT03615911|12585964|FG000|NOT COMPLETED|Overall Study||2
11391918|NCT03615911|12585965|FG001|NOT COMPLETED|Overall Study||1
11391919|NCT03615924|12585975|FG000|STARTED|Overall Study||101
11391920|NCT03615924|12585976|FG001|STARTED|Overall Study||92
11391921|NCT03615924|12585975|FG000|Received Treatment|Overall Study||101
11391922|NCT03615924|12585976|FG001|Received Treatment|Overall Study||92
11391923|NCT03615924|12585975|FG000|COMPLETED|Overall Study||0
11391924|NCT03615924|12585976|FG001|COMPLETED|Overall Study||0
11391925|NCT03615924|12585975|FG000|NOT COMPLETED|Overall Study||101
11391926|NCT03615924|12585976|FG001|NOT COMPLETED|Overall Study||92
11391927|NCT03616106|12585984|FG000|STARTED|Overall Study||56
11391928|NCT03616106|12585985|FG001|STARTED|Overall Study||3
11391929|NCT03616106|12585984|FG000|COMPLETED|Overall Study||42
11391930|NCT03616106|12585985|FG001|COMPLETED|Overall Study||2
11391931|NCT03616106|12585984|FG000|NOT COMPLETED|Overall Study||14
11391932|NCT03616106|12585985|FG001|NOT COMPLETED|Overall Study||1
11391933|NCT03616171|12585992|FG000|STARTED|Overall Study||4
11391934|NCT03616171|12585993|FG001|STARTED|Overall Study||2
11391935|NCT03616171|12585992|FG000|COMPLETED|Overall Study||4
11391936|NCT03616171|12585993|FG001|COMPLETED|Overall Study||2
11391937|NCT03616171|12585992|FG000|NOT COMPLETED|Overall Study||0
11391938|NCT03616171|12585993|FG001|NOT COMPLETED|Overall Study||0
11391939|NCT03616600|12586002|FG000|STARTED|Overall Study||16
11391940|NCT03616600|12586003|FG001|STARTED|Overall Study||15
11391941|NCT03616600|12586002|FG000|COMPLETED|Overall Study||15
11391942|NCT03616600|12586003|FG001|COMPLETED|Overall Study||15
11391943|NCT03616600|12586002|FG000|NOT COMPLETED|Overall Study||1
11391944|NCT03616600|12586003|FG001|NOT COMPLETED|Overall Study||0
11391945|NCT03616899|12586012|FG000|STARTED|Overall Study||447
11391946|NCT03616899|12586013|FG001|STARTED|Overall Study||454
11391947|NCT03616899|12586012|FG000|COMPLETED|Overall Study||437
11391948|NCT03616899|12586013|FG001|COMPLETED|Overall Study||453
11391949|NCT03616899|12586012|FG000|NOT COMPLETED|Overall Study||10
11391950|NCT03616899|12586013|FG001|NOT COMPLETED|Overall Study||1
11391951|NCT03616977|12586019|FG000|STARTED|Period 1||34
11391952|NCT03616977|12586020|FG001|STARTED|Period 1||35
11391953|NCT03616977|12586019|FG000|Received at Least One Dose of Study Drug|Period 1||34
11391954|NCT03616977|12586020|FG001|Received at Least One Dose of Study Drug|Period 1||34
11391955|NCT03616977|12586019|FG000|COMPLETED|Period 1||34
11391956|NCT03616977|12586020|FG001|COMPLETED|Period 1||34
11391957|NCT03616977|12586019|FG000|NOT COMPLETED|Period 1||0
11391958|NCT03616977|12586020|FG001|NOT COMPLETED|Period 1||1
11391959|NCT03616977|12586019|FG000|STARTED|Period 2||34
11391960|NCT03616977|12586020|FG001|STARTED|Period 2||34
11391961|NCT03616977|12586019|FG000|COMPLETED|Period 2||34
11391962|NCT03616977|12586020|FG001|COMPLETED|Period 2||34
11391963|NCT03616977|12586019|FG000|NOT COMPLETED|Period 2||0
11391964|NCT03616977|12586020|FG001|NOT COMPLETED|Period 2||0
11391965|NCT03616977|12586019|FG000|STARTED|Period 3||34
11391966|NCT03616977|12586020|FG001|STARTED|Period 3|Participant completed Period 2 and withdrew from the study.|33
11391967|NCT03616977|12586019|FG000|Received Study Drug|Period 3|Participant not dosed due to adverse event.|33
11391968|NCT03616977|12586020|FG001|Received Study Drug|Period 3|Participant not dosed due to adverse event.|32
11391969|NCT03616977|12586019|FG000|COMPLETED|Period 3||33
11391970|NCT03616977|12586020|FG001|COMPLETED|Period 3||32
11391971|NCT03616977|12586019|FG000|NOT COMPLETED|Period 3||1
11391972|NCT03616977|12586020|FG001|NOT COMPLETED|Period 3||1
11391973|NCT03616977|12586019|FG000|STARTED|Period 4||33
11391974|NCT03616977|12586020|FG001|STARTED|Period 4||32
11391975|NCT03616977|12586019|FG000|COMPLETED|Period 4||33
11391976|NCT03616977|12586020|FG001|COMPLETED|Period 4||32
11391977|NCT03616977|12586019|FG000|NOT COMPLETED|Period 4||0
11391978|NCT03616977|12586020|FG001|NOT COMPLETED|Period 4||0
11391979|NCT03617419|12586027|FG000|STARTED|Part 1||2
11391980|NCT03617419|12586027|FG000|COMPLETED|Part 1||2
11391981|NCT03617419|12586027|FG000|NOT COMPLETED|Part 1||0
11391982|NCT03617419|12586027|FG000|STARTED|Part 2||14
11391983|NCT03617419|12586027|FG000|COMPLETED|Part 2||14
11391984|NCT03617419|12586027|FG000|NOT COMPLETED|Part 2||0
11391985|NCT03617588|12586033|FG000|STARTED|Overall Study||20
11391986|NCT03617588|12586034|FG001|STARTED|Overall Study||29
11391987|NCT03617588|12586033|FG000|COMPLETED|Overall Study||19
11391988|NCT03617588|12586034|FG001|COMPLETED|Overall Study||29
11391989|NCT03617588|12586033|FG000|NOT COMPLETED|Overall Study||1
11391990|NCT03617588|12586034|FG001|NOT COMPLETED|Overall Study||0
11391991|NCT03617770|12586046|FG000|STARTED|Overall Study|9|9
11391992|NCT03617770|12586047|FG001|STARTED|Overall Study|5|5
11391993|NCT03617770|12586046|FG000|COMPLETED|Overall Study|8|8
11391994|NCT03617770|12586047|FG001|COMPLETED|Overall Study||5
11391995|NCT03617770|12586046|FG000|NOT COMPLETED|Overall Study||1
11391996|NCT03617770|12586047|FG001|NOT COMPLETED|Overall Study||0
11391997|NCT03617861|12586055|FG000|STARTED|First Intervention (1 Day)||5
11391998|NCT03617861|12586056|FG001|STARTED|First Intervention (1 Day)||5
11391999|NCT03617861|12586057|FG002|STARTED|First Intervention (1 Day)||5
11392000|NCT03617861|12586058|FG003|STARTED|First Intervention (1 Day)||5
11392001|NCT03617861|12586055|FG000|COMPLETED|First Intervention (1 Day)||5
11392002|NCT03617861|12586056|FG001|COMPLETED|First Intervention (1 Day)||5
11392003|NCT03617861|12586057|FG002|COMPLETED|First Intervention (1 Day)||5
11392004|NCT03617861|12586058|FG003|COMPLETED|First Intervention (1 Day)||5
11392005|NCT03617861|12586055|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11392006|NCT03617861|12586056|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11392007|NCT03617861|12586057|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11392008|NCT03617861|12586058|FG003|NOT COMPLETED|First Intervention (1 Day)||0
11392009|NCT03617861|12586055|FG000|STARTED|Washout (1 to 4 Weeks)||5
11392010|NCT03617861|12586056|FG001|STARTED|Washout (1 to 4 Weeks)||5
11392011|NCT03617861|12586057|FG002|STARTED|Washout (1 to 4 Weeks)||5
11392012|NCT03617861|12586058|FG003|STARTED|Washout (1 to 4 Weeks)||5
11392013|NCT03617861|12586055|FG000|COMPLETED|Washout (1 to 4 Weeks)||5
11392014|NCT03617861|12586056|FG001|COMPLETED|Washout (1 to 4 Weeks)||5
11392015|NCT03617861|12586057|FG002|COMPLETED|Washout (1 to 4 Weeks)||5
11392016|NCT03617861|12586058|FG003|COMPLETED|Washout (1 to 4 Weeks)||5
11392017|NCT03617861|12586055|FG000|NOT COMPLETED|Washout (1 to 4 Weeks)||0
11392018|NCT03617861|12586056|FG001|NOT COMPLETED|Washout (1 to 4 Weeks)||0
11392019|NCT03617861|12586057|FG002|NOT COMPLETED|Washout (1 to 4 Weeks)||0
11392020|NCT03617861|12586058|FG003|NOT COMPLETED|Washout (1 to 4 Weeks)||0
11392021|NCT03617861|12586055|FG000|STARTED|Second Intervention (1 Day)||5
11392022|NCT03617861|12586056|FG001|STARTED|Second Intervention (1 Day)||5
11392023|NCT03617861|12586057|FG002|STARTED|Second Intervention (1 Day)||5
11392024|NCT03617861|12586058|FG003|STARTED|Second Intervention (1 Day)||5
11392025|NCT03617861|12586055|FG000|COMPLETED|Second Intervention (1 Day)||5
11392026|NCT03617861|12586056|FG001|COMPLETED|Second Intervention (1 Day)||5
11392027|NCT03617861|12586057|FG002|COMPLETED|Second Intervention (1 Day)||4
11392028|NCT03617861|12586058|FG003|COMPLETED|Second Intervention (1 Day)||5
11392029|NCT03617861|12586055|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11392030|NCT03617861|12586056|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11392031|NCT03617861|12586057|FG002|NOT COMPLETED|Second Intervention (1 Day)||1
11392032|NCT03617861|12586058|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
11392033|NCT03617913|12586068|FG000|STARTED|Overall Study||2
11392034|NCT03617913|12586068|FG000|COMPLETED|Overall Study||2
11392035|NCT03617913|12586068|FG000|NOT COMPLETED|Overall Study||0
11392036|NCT03618017|12586074|FG000|STARTED|Overall Study||33
11392037|NCT03618017|12586075|FG001|STARTED|Overall Study||33
11392038|NCT03618017|12586074|FG000|COMPLETED|Overall Study||26
11392039|NCT03618017|12586075|FG001|COMPLETED|Overall Study||28
11392040|NCT03618017|12586074|FG000|NOT COMPLETED|Overall Study||7
11392041|NCT03618017|12586075|FG001|NOT COMPLETED|Overall Study||5
11392042|NCT03618030|12586085|FG000|STARTED|Overall Study||15
11392043|NCT03618030|12586086|FG001|STARTED|Overall Study||14
11392044|NCT03618030|12586087|FG002|STARTED|Overall Study||21
11392045|NCT03618030|12586088|FG003|STARTED|Overall Study||39
11392046|NCT03618030|12586089|FG004|STARTED|Overall Study||36
11392047|NCT03618030|12586090|FG005|STARTED|Overall Study||27
11392048|NCT03618030|12586091|FG006|STARTED|Overall Study||18
11392049|NCT03618030|12586092|FG007|STARTED|Overall Study||118
11392050|NCT03618030|12586085|FG000|COMPLETED|Overall Study||3
11392051|NCT03618030|12586086|FG001|COMPLETED|Overall Study||3
11392052|NCT03618030|12586087|FG002|COMPLETED|Overall Study||13
11392053|NCT03618030|12586088|FG003|COMPLETED|Overall Study||30
11392054|NCT03618030|12586089|FG004|COMPLETED|Overall Study||29
11392055|NCT03618030|12586090|FG005|COMPLETED|Overall Study||21
11392056|NCT03618030|12586091|FG006|COMPLETED|Overall Study||14
11392057|NCT03618030|12586092|FG007|COMPLETED|Overall Study||108
11392058|NCT03618030|12586085|FG000|NOT COMPLETED|Overall Study||12
11392059|NCT03618030|12586086|FG001|NOT COMPLETED|Overall Study||11
11392060|NCT03618030|12586087|FG002|NOT COMPLETED|Overall Study||8
11392061|NCT03618030|12586088|FG003|NOT COMPLETED|Overall Study||9
11392062|NCT03618030|12586089|FG004|NOT COMPLETED|Overall Study||7
11392063|NCT03618030|12586090|FG005|NOT COMPLETED|Overall Study||6
11392064|NCT03618030|12586091|FG006|NOT COMPLETED|Overall Study||4
11392065|NCT03618030|12586092|FG007|NOT COMPLETED|Overall Study||10
11392066|NCT03618147|12586105|FG000|STARTED|Overall Study||314
11392067|NCT03618147|12586105|FG000|COMPLETED|Overall Study||314
11392068|NCT03618147|12586105|FG000|NOT COMPLETED|Overall Study||0
11392069|NCT03618628|12586110|FG000|STARTED|Overall Study||3
11392070|NCT03618628|12586110|FG000|COMPLETED|Overall Study||1
11392071|NCT03618628|12586110|FG000|NOT COMPLETED|Overall Study||2
11392072|NCT03618823|12586116|FG000|STARTED|Overall Study||132
11392073|NCT03618823|12586117|FG001|STARTED|Overall Study||136
11392074|NCT03618823|12586116|FG000|COMPLETED|Overall Study||69
11392075|NCT03618823|12586117|FG001|COMPLETED|Overall Study||75
11392076|NCT03618823|12586116|FG000|NOT COMPLETED|Overall Study||63
11392077|NCT03618823|12586117|FG001|NOT COMPLETED|Overall Study||61
11392078|NCT03619135|12586128|FG000|STARTED|Overall Study||50
11392079|NCT03619135|12586129|FG001|STARTED|Overall Study||50
11392080|NCT03619135|12586128|FG000|COMPLETED|Overall Study||50
11392081|NCT03619135|12586129|FG001|COMPLETED|Overall Study||50
11392082|NCT03619135|12586128|FG000|NOT COMPLETED|Overall Study||0
11392083|NCT03619135|12586129|FG001|NOT COMPLETED|Overall Study||0
11392084|NCT03619590|12586135|FG000|STARTED|Overall Study||103
11392085|NCT03619590|12586135|FG000|COMPLETED|Overall Study||103
11392086|NCT03619590|12586135|FG000|NOT COMPLETED|Overall Study||0
11392087|NCT03619811|12586139|FG000|STARTED|Overall Study||43
11392088|NCT03619811|12586139|FG000|COMPLETED|Overall Study||31
11392089|NCT03619811|12586139|FG000|NOT COMPLETED|Overall Study||12
11392090|NCT03619837|12586143|FG000|STARTED|Screening||122
11392091|NCT03619837|12586143|FG000|COMPLETED|Screening||24
11392092|NCT03619837|12586143|FG000|NOT COMPLETED|Screening||98
11392093|NCT03619837|12586143|FG000|STARTED|Main Study||24
11392094|NCT03619837|12586143|FG000|COMPLETED|Main Study||24
11392095|NCT03619837|12586143|FG000|NOT COMPLETED|Main Study||0
11392096|NCT03619889|12586149|FG000|STARTED|Overall Study||37
11392097|NCT03619889|12586150|FG001|STARTED|Overall Study||37
11392098|NCT03619889|12586149|FG000|COMPLETED|Overall Study||35
11392099|NCT03619889|12586150|FG001|COMPLETED|Overall Study||37
11392100|NCT03619889|12586149|FG000|NOT COMPLETED|Overall Study||2
11392101|NCT03619889|12586150|FG001|NOT COMPLETED|Overall Study||0
11392102|NCT03620162|12586161|FG000|STARTED|Overall Study||179
11392103|NCT03620162|12586162|FG001|STARTED|Overall Study||181
11392104|NCT03620162|12586163|FG002|STARTED|Overall Study||180
11392105|NCT03620162|12586164|FG003|STARTED|Overall Study||180
11392106|NCT03620162|12586165|FG004|STARTED|Overall Study||180
11392107|NCT03620162|12586161|FG000|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
11392108|NCT03620162|12586162|FG001|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||181
11392109|NCT03620162|12586163|FG002|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||178
11392110|NCT03620162|12586164|FG003|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
11392111|NCT03620162|12586165|FG004|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
11392112|NCT03620162|12586161|FG000|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||176
11392113|NCT03620162|12586162|FG001|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||175
11392114|NCT03620162|12586163|FG002|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||166
11392115|NCT03620162|12586164|FG003|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||169
11392116|NCT03620162|12586165|FG004|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||173
11392117|NCT03620162|12586161|FG000|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||175
11392118|NCT03620162|12586162|FG001|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||174
11392119|NCT03620162|12586163|FG002|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||161
11392120|NCT03620162|12586164|FG003|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||167
11392121|NCT03620162|12586165|FG004|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||173
11392122|NCT03620162|12586161|FG000|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||165
11392123|NCT03620162|12586162|FG001|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
11392124|NCT03620162|12586163|FG002|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||150
11392125|NCT03620162|12586164|FG003|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||162
11392126|NCT03620162|12586165|FG004|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
11392127|NCT03620162|12586161|FG000|COMPLETED|Overall Study||164
11392128|NCT03620162|12586162|FG001|COMPLETED|Overall Study||167
11392129|NCT03620162|12586163|FG002|COMPLETED|Overall Study||147
11392130|NCT03620162|12586164|FG003|COMPLETED|Overall Study||160
11392131|NCT03620162|12586165|FG004|COMPLETED|Overall Study||167
11392132|NCT03620162|12586161|FG000|NOT COMPLETED|Overall Study||15
11392133|NCT03620162|12586162|FG001|NOT COMPLETED|Overall Study||14
11392134|NCT03620162|12586163|FG002|NOT COMPLETED|Overall Study||33
11392135|NCT03620162|12586164|FG003|NOT COMPLETED|Overall Study||20
11392136|NCT03620162|12586165|FG004|NOT COMPLETED|Overall Study||13
11392137|NCT03620383|12586181|FG000|STARTED|Overall Study||30
11392138|NCT03620383|12586182|FG001|STARTED|Overall Study||15
11392139|NCT03620383|12586181|FG000|COMPLETED|Overall Study||30
11392140|NCT03620383|12586182|FG001|COMPLETED|Overall Study||15
11392141|NCT03620383|12586181|FG000|NOT COMPLETED|Overall Study||0
11392142|NCT03620383|12586182|FG001|NOT COMPLETED|Overall Study||0
11392143|NCT03620708|12586191|FG000|STARTED|Overall Study||19
11392144|NCT03620708|12586192|FG001|STARTED|Overall Study||19
11392145|NCT03620708|12586193|FG002|STARTED|Overall Study||20
11392146|NCT03620708|12586191|FG000|COMPLETED|Overall Study||18
11392147|NCT03620708|12586192|FG001|COMPLETED|Overall Study||18
11392148|NCT03620708|12586193|FG002|COMPLETED|Overall Study||17
11392149|NCT03620708|12586191|FG000|NOT COMPLETED|Overall Study||1
11392150|NCT03620708|12586192|FG001|NOT COMPLETED|Overall Study||1
11392151|NCT03620708|12586193|FG002|NOT COMPLETED|Overall Study||3
11392152|NCT03620890|12586203|FG000|STARTED|Overall Study||57
11392153|NCT03620890|12586204|FG001|STARTED|Overall Study||51
11392154|NCT03620890|12586203|FG000|First Trimester Miscarriage|Overall Study||2
11392155|NCT03620890|12586204|FG001|First Trimester Miscarriage|Overall Study||1
11392156|NCT03620890|12586203|FG000|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||1
11392157|NCT03620890|12586204|FG001|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||0
11392158|NCT03620890|12586203|FG000|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||1
11392159|NCT03620890|12586204|FG001|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||0
11392160|NCT03620890|12586203|FG000|COMPLETED|Overall Study||53
11392161|NCT03620890|12586204|FG001|COMPLETED|Overall Study||50
11392162|NCT03620890|12586203|FG000|NOT COMPLETED|Overall Study||4
11392163|NCT03620890|12586204|FG001|NOT COMPLETED|Overall Study||1
11392164|NCT03621085|12586210|FG000|STARTED|Enrollment||22
11392165|NCT03621085|12586211|FG001|STARTED|Enrollment||21
11392166|NCT03621085|12586210|FG000|COMPLETED|Enrollment||16
11392167|NCT03621085|12586211|FG001|COMPLETED|Enrollment||14
11392168|NCT03621085|12586210|FG000|NOT COMPLETED|Enrollment||6
11392169|NCT03621085|12586211|FG001|NOT COMPLETED|Enrollment||7
11392170|NCT03621085|12586210|FG000|STARTED|First Visit||16
11392171|NCT03621085|12586211|FG001|STARTED|First Visit||14
11392172|NCT03621085|12586210|FG000|COMPLETED|First Visit||16
11392173|NCT03621085|12586211|FG001|COMPLETED|First Visit||14
11392174|NCT03621085|12586210|FG000|NOT COMPLETED|First Visit||0
11392175|NCT03621085|12586211|FG001|NOT COMPLETED|First Visit||0
11392176|NCT03621085|12586210|FG000|STARTED|Washout (at Least 48 Hours)||16
11392177|NCT03621085|12586211|FG001|STARTED|Washout (at Least 48 Hours)||14
11392178|NCT03621085|12586210|FG000|COMPLETED|Washout (at Least 48 Hours)||16
11392179|NCT03621085|12586211|FG001|COMPLETED|Washout (at Least 48 Hours)||14
11392180|NCT03621085|12586210|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0
11392181|NCT03621085|12586211|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0
11392182|NCT03621085|12586210|FG000|STARTED|Second Visit||16
11392183|NCT03621085|12586211|FG001|STARTED|Second Visit||14
11392184|NCT03621085|12586210|FG000|COMPLETED|Second Visit||16
11392185|NCT03621085|12586211|FG001|COMPLETED|Second Visit||14
11392186|NCT03621085|12586210|FG000|NOT COMPLETED|Second Visit||0
11392187|NCT03621085|12586211|FG001|NOT COMPLETED|Second Visit||0
11392188|NCT03621189|12586219|FG000|STARTED|Overall Study||40
11392189|NCT03621189|12586220|FG001|STARTED|Overall Study||40
11392190|NCT03621189|12586219|FG000|COMPLETED|Overall Study||40
11392191|NCT03621189|12586220|FG001|COMPLETED|Overall Study||35
11392192|NCT03621189|12586219|FG000|NOT COMPLETED|Overall Study||0
11392193|NCT03621189|12586220|FG001|NOT COMPLETED|Overall Study||5
11392194|NCT03621202|12586227|FG000|STARTED|Overall Study||66
11392195|NCT03621202|12586227|FG000|COMPLETED|Overall Study||60
11392196|NCT03621202|12586227|FG000|NOT COMPLETED|Overall Study||6
11392197|NCT03621787|12586231|FG000|STARTED|Overall Study||9
11392198|NCT03621787|12586231|FG000|COMPLETED|Overall Study||9
11392199|NCT03621787|12586231|FG000|NOT COMPLETED|Overall Study||0
11392200|NCT03621878|12586238|FG000|STARTED|Overall Study||17
11392201|NCT03621878|12586239|FG001|STARTED|Overall Study||17
11392202|NCT03621878|12586240|FG002|STARTED|Overall Study||17
11392203|NCT03621878|12586238|FG000|COMPLETED|Overall Study||17
11392204|NCT03621878|12586239|FG001|COMPLETED|Overall Study||17
11392205|NCT03621878|12586240|FG002|COMPLETED|Overall Study||17
11392206|NCT03621878|12586238|FG000|NOT COMPLETED|Overall Study||0
11392207|NCT03621878|12586239|FG001|NOT COMPLETED|Overall Study||0
11392208|NCT03621878|12586240|FG002|NOT COMPLETED|Overall Study||0
11392209|NCT03622112|12586255|FG000|STARTED|Overall Study||110
11392210|NCT03622112|12586256|FG001|STARTED|Overall Study||112
11392211|NCT03622112|12586257|FG002|STARTED|Overall Study||111
11392212|NCT03622112|12586258|FG003|STARTED|Overall Study||113
11392213|NCT03622112|12586259|FG004|STARTED|Overall Study||134
11392214|NCT03622112|12586260|FG005|STARTED|Overall Study||113
11392215|NCT03622112|12586261|FG006|STARTED|Overall Study||112
11392216|NCT03622112|12586255|FG000|COMPLETED|Overall Study||85
11392217|NCT03622112|12586256|FG001|COMPLETED|Overall Study||92
11392218|NCT03622112|12586257|FG002|COMPLETED|Overall Study||95
11392219|NCT03622112|12586258|FG003|COMPLETED|Overall Study||91
11392220|NCT03622112|12586259|FG004|COMPLETED|Overall Study||124
11392221|NCT03622112|12586260|FG005|COMPLETED|Overall Study||71
11392222|NCT03622112|12586261|FG006|COMPLETED|Overall Study||103
11392223|NCT03622112|12586255|FG000|NOT COMPLETED|Overall Study||25
11392224|NCT03622112|12586256|FG001|NOT COMPLETED|Overall Study||20
11392225|NCT03622112|12586257|FG002|NOT COMPLETED|Overall Study||16
11392226|NCT03622112|12586258|FG003|NOT COMPLETED|Overall Study||22
11392227|NCT03622112|12586259|FG004|NOT COMPLETED|Overall Study||10
11392228|NCT03622112|12586260|FG005|NOT COMPLETED|Overall Study||42
11392229|NCT03622112|12586261|FG006|NOT COMPLETED|Overall Study||9
11392230|NCT03622619|12586279|FG000|STARTED|Overall Study||23
11392231|NCT03622619|12586280|FG001|STARTED|Overall Study||23
11392232|NCT03622619|12586279|FG000|COMPLETED|Overall Study||21
11392233|NCT03622619|12586280|FG001|COMPLETED|Overall Study||21
11392234|NCT03622619|12586279|FG000|NOT COMPLETED|Overall Study||2
11392235|NCT03622619|12586280|FG001|NOT COMPLETED|Overall Study||2
11392236|NCT03623035|12586286|FG000|STARTED|Overall Study||10
11392237|NCT03623035|12586286|FG000|COMPLETED|Overall Study||10
11392238|NCT03623035|12586286|FG000|NOT COMPLETED|Overall Study||0
11392239|NCT03623334|12586293|FG000|STARTED|Overall Study||15
11392240|NCT03623334|12586294|FG001|STARTED|Overall Study||21
11392241|NCT03623334|12586295|FG002|STARTED|Overall Study||19
11392242|NCT03623334|12586293|FG000|COMPLETED|Overall Study||15
11392243|NCT03623334|12586294|FG001|COMPLETED|Overall Study||21
11392244|NCT03623334|12586295|FG002|COMPLETED|Overall Study||19
11392245|NCT03623334|12586293|FG000|NOT COMPLETED|Overall Study||0
11392246|NCT03623334|12586294|FG001|NOT COMPLETED|Overall Study||0
11392247|NCT03623334|12586295|FG002|NOT COMPLETED|Overall Study||0
11392248|NCT03623698|12586303|FG000|STARTED|Overall Study||24
11392249|NCT03623698|12586303|FG000|COMPLETED|Overall Study||24
11392250|NCT03623698|12586303|FG000|NOT COMPLETED|Overall Study||0
11392251|NCT03624192|12586314|FG000|STARTED|Overall Study||3
11392252|NCT03624192|12586315|FG001|STARTED|Overall Study||3
11392253|NCT03624192|12586314|FG000|COMPLETED|Overall Study||2
11392254|NCT03624192|12586315|FG001|COMPLETED|Overall Study||2
11392255|NCT03624192|12586314|FG000|NOT COMPLETED|Overall Study||1
11392256|NCT03624192|12586315|FG001|NOT COMPLETED|Overall Study||1
11392257|NCT03624504|12586323|FG000|STARTED|Overall Study||82
11392258|NCT03624504|12586323|FG000|COMPLETED|Overall Study||81
11392259|NCT03624504|12586323|FG000|NOT COMPLETED|Overall Study||1
11392260|NCT03624920|12586333|FG000|STARTED|Overall Study||14
11392261|NCT03624920|12586334|FG001|STARTED|Overall Study||14
11392262|NCT03624920|12586335|FG002|STARTED|Overall Study||13
11392263|NCT03624920|12586336|FG003|STARTED|Overall Study||13
11392264|NCT03624920|12586337|FG004|STARTED|Overall Study||11
11392265|NCT03624920|12586338|FG005|STARTED|Overall Study||12
11392266|NCT03624920|12586333|FG000|COMPLETED|Overall Study||13
11392267|NCT03624920|12586334|FG001|COMPLETED|Overall Study||12
11392268|NCT03624920|12586335|FG002|COMPLETED|Overall Study||12
11392269|NCT03624920|12586336|FG003|COMPLETED|Overall Study||12
11392270|NCT03624920|12586337|FG004|COMPLETED|Overall Study||7
11392271|NCT03624920|12586338|FG005|COMPLETED|Overall Study||11
11392272|NCT03624920|12586333|FG000|NOT COMPLETED|Overall Study||1
11392273|NCT03624920|12586334|FG001|NOT COMPLETED|Overall Study||2
11392274|NCT03624920|12586335|FG002|NOT COMPLETED|Overall Study||1
11392275|NCT03624920|12586336|FG003|NOT COMPLETED|Overall Study||1
11392276|NCT03624920|12586337|FG004|NOT COMPLETED|Overall Study||4
11392277|NCT03624920|12586338|FG005|NOT COMPLETED|Overall Study||1
11392278|NCT03624946|12586348|FG000|STARTED|Overall Study||19
11392279|NCT03624946|12586349|FG001|STARTED|Overall Study||11
11392280|NCT03624946|12586348|FG000|COMPLETED|Overall Study||19
11392281|NCT03624946|12586349|FG001|COMPLETED|Overall Study||10
11392282|NCT03624946|12586348|FG000|NOT COMPLETED|Overall Study||0
11392283|NCT03624946|12586349|FG001|NOT COMPLETED|Overall Study||1
11392284|NCT03624972|12586362|FG000|STARTED|Overall Study||71
11392285|NCT03624972|12586363|FG001|STARTED|Overall Study||73
11392286|NCT03624972|12586364|FG002|STARTED|Overall Study||9
11392287|NCT03624972|12586362|FG000|COMPLETED|Overall Study||69
11392288|NCT03624972|12586363|FG001|COMPLETED|Overall Study||71
11392289|NCT03624972|12586364|FG002|COMPLETED|Overall Study||9
11392290|NCT03624972|12586362|FG000|NOT COMPLETED|Overall Study||2
11392291|NCT03624972|12586363|FG001|NOT COMPLETED|Overall Study||2
11392292|NCT03624972|12586364|FG002|NOT COMPLETED|Overall Study||0
11392293|NCT03626415|12586376|FG000|STARTED|Overall Study||8
11392294|NCT03626415|12586377|FG001|STARTED|Overall Study||8
11392295|NCT03626415|12586378|FG002|STARTED|Overall Study||8
11392296|NCT03626415|12586376|FG000|COMPLETED|Overall Study||8
11392297|NCT03626415|12586377|FG001|COMPLETED|Overall Study||8
11392298|NCT03626415|12586378|FG002|COMPLETED|Overall Study||8
11392299|NCT03626415|12586376|FG000|NOT COMPLETED|Overall Study||0
11392300|NCT03626415|12586377|FG001|NOT COMPLETED|Overall Study||0
11392301|NCT03626415|12586378|FG002|NOT COMPLETED|Overall Study||0
11392302|NCT03626623|12586388|FG000|STARTED|Overall Study||5
11392303|NCT03626623|12586389|FG001|STARTED|Overall Study||10
11392304|NCT03626623|12586388|FG000|COMPLETED|Overall Study||0
11392305|NCT03626623|12586389|FG001|COMPLETED|Overall Study||0
11392306|NCT03626623|12586388|FG000|NOT COMPLETED|Overall Study||5
11392307|NCT03626623|12586389|FG001|NOT COMPLETED|Overall Study||10
11392308|NCT03626714|12586395|FG000|STARTED|Overall Study||8
11392309|NCT03626714|12586395|FG000|COMPLETED|Overall Study||8
11392310|NCT03626714|12586395|FG000|NOT COMPLETED|Overall Study||0
11392311|NCT03627065|12586399|FG000|STARTED|Overall Study||10
11392312|NCT03627065|12586399|FG000|COMPLETED|Overall Study||7
11392313|NCT03627065|12586399|FG000|NOT COMPLETED|Overall Study||3
11392314|NCT03627195|12586409|FG000|STARTED|Overall Study||6
11392315|NCT03627195|12586410|FG001|STARTED|Overall Study||6
11392316|NCT03627195|12586411|FG002|STARTED|Overall Study||6
11392317|NCT03627195|12586412|FG003|STARTED|Overall Study||6
11392318|NCT03627195|12586413|FG004|STARTED|Overall Study||6
11392319|NCT03627195|12586414|FG005|STARTED|Overall Study||10
11392320|NCT03627195|12586409|FG000|COMPLETED|Overall Study||5
11392321|NCT03627195|12586410|FG001|COMPLETED|Overall Study||6
11392322|NCT03627195|12586411|FG002|COMPLETED|Overall Study||6
11392323|NCT03627195|12586412|FG003|COMPLETED|Overall Study||6
11392324|NCT03627195|12586413|FG004|COMPLETED|Overall Study||6
11392325|NCT03627195|12586414|FG005|COMPLETED|Overall Study||10
11392326|NCT03627195|12586409|FG000|NOT COMPLETED|Overall Study||1
11392327|NCT03627195|12586410|FG001|NOT COMPLETED|Overall Study||0
11392328|NCT03627195|12586411|FG002|NOT COMPLETED|Overall Study||0
11392329|NCT03627195|12586412|FG003|NOT COMPLETED|Overall Study||0
11392330|NCT03627195|12586413|FG004|NOT COMPLETED|Overall Study||0
11392331|NCT03627195|12586414|FG005|NOT COMPLETED|Overall Study||0
11392332|NCT03627299|12586428|FG000|STARTED|Overall Study||10
11392333|NCT03627299|12586428|FG000|COMPLETED|Overall Study||10
11392334|NCT03627299|12586428|FG000|NOT COMPLETED|Overall Study||0
11392335|NCT03627416|12586434|FG000|STARTED|Overall Study||8
11392336|NCT03627416|12586435|FG001|STARTED|Overall Study||7
11392337|NCT03627416|12586434|FG000|COMPLETED|Overall Study||8
11392338|NCT03627416|12586435|FG001|COMPLETED|Overall Study||6
11392339|NCT03627416|12586434|FG000|NOT COMPLETED|Overall Study||0
11392340|NCT03627416|12586435|FG001|NOT COMPLETED|Overall Study||1
11392341|NCT03627494|12586453|FG000|STARTED|Part A Period 1 (4 Days)||3
11392342|NCT03627494|12586454|FG001|STARTED|Part A Period 1 (4 Days)||3
11392343|NCT03627494|12586455|FG002|STARTED|Part A Period 1 (4 Days)||3
11392344|NCT03627494|12586456|FG003|STARTED|Part A Period 1 (4 Days)||3
11392345|NCT03627494|12586457|FG004|STARTED|Part A Period 1 (4 Days)||3
11392346|NCT03627494|12586458|FG005|STARTED|Part A Period 1 (4 Days)||3
11392347|NCT03627494|12586459|FG006|STARTED|Part A Period 1 (4 Days)||0
11392348|NCT03627494|12586460|FG007|STARTED|Part A Period 1 (4 Days)||0
11392349|NCT03627494|12586461|FG008|STARTED|Part A Period 1 (4 Days)||0
11392350|NCT03627494|12586462|FG009|STARTED|Part A Period 1 (4 Days)||0
11392351|NCT03627494|12586463|FG010|STARTED|Part A Period 1 (4 Days)||0
11392352|NCT03627494|12586464|FG011|STARTED|Part A Period 1 (4 Days)||0
11392353|NCT03627494|12586453|FG000|COMPLETED|Part A Period 1 (4 Days)||3
11392354|NCT03627494|12586454|FG001|COMPLETED|Part A Period 1 (4 Days)||3
11392355|NCT03627494|12586455|FG002|COMPLETED|Part A Period 1 (4 Days)||3
11392356|NCT03627494|12586456|FG003|COMPLETED|Part A Period 1 (4 Days)||3
11392357|NCT03627494|12586457|FG004|COMPLETED|Part A Period 1 (4 Days)||3
11392358|NCT03627494|12586458|FG005|COMPLETED|Part A Period 1 (4 Days)||3
11392359|NCT03627494|12586459|FG006|COMPLETED|Part A Period 1 (4 Days)||0
11392360|NCT03627494|12586460|FG007|COMPLETED|Part A Period 1 (4 Days)||0
11392361|NCT03627494|12586461|FG008|COMPLETED|Part A Period 1 (4 Days)||0
11392362|NCT03627494|12586462|FG009|COMPLETED|Part A Period 1 (4 Days)||0
11392363|NCT03627494|12586463|FG010|COMPLETED|Part A Period 1 (4 Days)||0
11392364|NCT03627494|12586464|FG011|COMPLETED|Part A Period 1 (4 Days)||0
11392365|NCT03627494|12586453|FG000|NOT COMPLETED|Part A Period 1 (4 Days)||0
11392366|NCT03627494|12586454|FG001|NOT COMPLETED|Part A Period 1 (4 Days)||0
11392367|NCT03627494|12586455|FG002|NOT COMPLETED|Part A Period 1 (4 Days)||0
11392368|NCT03627494|12586456|FG003|NOT COMPLETED|Part A Period 1 (4 Days)||0
11392369|NCT03627494|12586457|FG004|NOT COMPLETED|Part A Period 1 (4 Days)||0
11392370|NCT03627494|12586458|FG005|NOT COMPLETED|Part A Period 1 (4 Days)||0
11392371|NCT03627494|12586459|FG006|NOT COMPLETED|Part A Period 1 (4 Days)||0
11392372|NCT03627494|12586460|FG007|NOT COMPLETED|Part A Period 1 (4 Days)||0
11392373|NCT03627494|12586461|FG008|NOT COMPLETED|Part A Period 1 (4 Days)||0
11392374|NCT03627494|12586462|FG009|NOT COMPLETED|Part A Period 1 (4 Days)||0
11392375|NCT03627494|12586463|FG010|NOT COMPLETED|Part A Period 1 (4 Days)||0
11392376|NCT03627494|12586464|FG011|NOT COMPLETED|Part A Period 1 (4 Days)||0
11392377|NCT03627494|12586453|FG000|STARTED|Part A Washout 1 (7 Days)||3
11392378|NCT03627494|12586454|FG001|STARTED|Part A Washout 1 (7 Days)||3
11392379|NCT03627494|12586455|FG002|STARTED|Part A Washout 1 (7 Days)||3
11392380|NCT03627494|12586456|FG003|STARTED|Part A Washout 1 (7 Days)||3
11392381|NCT03627494|12586457|FG004|STARTED|Part A Washout 1 (7 Days)||3
11392382|NCT03627494|12586458|FG005|STARTED|Part A Washout 1 (7 Days)||3
11392383|NCT03627494|12586459|FG006|STARTED|Part A Washout 1 (7 Days)||0
11392384|NCT03627494|12586460|FG007|STARTED|Part A Washout 1 (7 Days)||0
11392385|NCT03627494|12586461|FG008|STARTED|Part A Washout 1 (7 Days)||0
11392386|NCT03627494|12586462|FG009|STARTED|Part A Washout 1 (7 Days)||0
11392387|NCT03627494|12586463|FG010|STARTED|Part A Washout 1 (7 Days)||0
11392388|NCT03627494|12586464|FG011|STARTED|Part A Washout 1 (7 Days)||0
11392389|NCT03627494|12586453|FG000|COMPLETED|Part A Washout 1 (7 Days)||3
11392390|NCT03627494|12586454|FG001|COMPLETED|Part A Washout 1 (7 Days)||3
11392391|NCT03627494|12586455|FG002|COMPLETED|Part A Washout 1 (7 Days)||3
11392392|NCT03627494|12586456|FG003|COMPLETED|Part A Washout 1 (7 Days)||3
11392393|NCT03627494|12586457|FG004|COMPLETED|Part A Washout 1 (7 Days)||3
11392394|NCT03627494|12586458|FG005|COMPLETED|Part A Washout 1 (7 Days)||3
11392395|NCT03627494|12586459|FG006|COMPLETED|Part A Washout 1 (7 Days)||0
11392396|NCT03627494|12586460|FG007|COMPLETED|Part A Washout 1 (7 Days)||0
11392397|NCT03627494|12586461|FG008|COMPLETED|Part A Washout 1 (7 Days)||0
11392398|NCT03627494|12586462|FG009|COMPLETED|Part A Washout 1 (7 Days)||0
11392399|NCT03627494|12586463|FG010|COMPLETED|Part A Washout 1 (7 Days)||0
11392400|NCT03627494|12586464|FG011|COMPLETED|Part A Washout 1 (7 Days)||0
11392401|NCT03627494|12586453|FG000|NOT COMPLETED|Part A Washout 1 (7 Days)||0
11392402|NCT03627494|12586454|FG001|NOT COMPLETED|Part A Washout 1 (7 Days)||0
11392403|NCT03627494|12586455|FG002|NOT COMPLETED|Part A Washout 1 (7 Days)||0
11392404|NCT03627494|12586456|FG003|NOT COMPLETED|Part A Washout 1 (7 Days)||0
11392405|NCT03627494|12586457|FG004|NOT COMPLETED|Part A Washout 1 (7 Days)||0
11392406|NCT03627494|12586458|FG005|NOT COMPLETED|Part A Washout 1 (7 Days)||0
11392407|NCT03627494|12586459|FG006|NOT COMPLETED|Part A Washout 1 (7 Days)||0
11392408|NCT03627494|12586460|FG007|NOT COMPLETED|Part A Washout 1 (7 Days)||0
11392409|NCT03627494|12586461|FG008|NOT COMPLETED|Part A Washout 1 (7 Days)||0
11392410|NCT03627494|12586462|FG009|NOT COMPLETED|Part A Washout 1 (7 Days)||0
11392411|NCT03627494|12586463|FG010|NOT COMPLETED|Part A Washout 1 (7 Days)||0
11392412|NCT03627494|12586464|FG011|NOT COMPLETED|Part A Washout 1 (7 Days)||0
11392413|NCT03627494|12586453|FG000|STARTED|Part A Period 2 (4 Days)||3
11392414|NCT03627494|12586454|FG001|STARTED|Part A Period 2 (4 Days)||3
11392415|NCT03627494|12586455|FG002|STARTED|Part A Period 2 (4 Days)||3
11392416|NCT03627494|12586456|FG003|STARTED|Part A Period 2 (4 Days)||3
11392417|NCT03627494|12586457|FG004|STARTED|Part A Period 2 (4 Days)||3
11392418|NCT03627494|12586458|FG005|STARTED|Part A Period 2 (4 Days)||3
11392419|NCT03627494|12586459|FG006|STARTED|Part A Period 2 (4 Days)||0
11392420|NCT03627494|12586460|FG007|STARTED|Part A Period 2 (4 Days)||0
11392421|NCT03627494|12586461|FG008|STARTED|Part A Period 2 (4 Days)||0
11392422|NCT03627494|12586462|FG009|STARTED|Part A Period 2 (4 Days)||0
11392423|NCT03627494|12586463|FG010|STARTED|Part A Period 2 (4 Days)||0
11392424|NCT03627494|12586464|FG011|STARTED|Part A Period 2 (4 Days)||0
11392425|NCT03627494|12586453|FG000|COMPLETED|Part A Period 2 (4 Days)||3
11392426|NCT03627494|12586454|FG001|COMPLETED|Part A Period 2 (4 Days)||3
11392427|NCT03627494|12586455|FG002|COMPLETED|Part A Period 2 (4 Days)||3
11392428|NCT03627494|12586456|FG003|COMPLETED|Part A Period 2 (4 Days)||3
11392429|NCT03627494|12586457|FG004|COMPLETED|Part A Period 2 (4 Days)||3
11392430|NCT03627494|12586458|FG005|COMPLETED|Part A Period 2 (4 Days)||3
11392431|NCT03627494|12586459|FG006|COMPLETED|Part A Period 2 (4 Days)||0
11392432|NCT03627494|12586460|FG007|COMPLETED|Part A Period 2 (4 Days)||0
11392433|NCT03627494|12586461|FG008|COMPLETED|Part A Period 2 (4 Days)||0
11392434|NCT03627494|12586462|FG009|COMPLETED|Part A Period 2 (4 Days)||0
11392435|NCT03627494|12586463|FG010|COMPLETED|Part A Period 2 (4 Days)||0
11392436|NCT03627494|12586464|FG011|COMPLETED|Part A Period 2 (4 Days)||0
11392437|NCT03627494|12586453|FG000|NOT COMPLETED|Part A Period 2 (4 Days)||0
11392438|NCT03627494|12586454|FG001|NOT COMPLETED|Part A Period 2 (4 Days)||0
11392439|NCT03627494|12586455|FG002|NOT COMPLETED|Part A Period 2 (4 Days)||0
11392440|NCT03627494|12586456|FG003|NOT COMPLETED|Part A Period 2 (4 Days)||0
11392441|NCT03627494|12586457|FG004|NOT COMPLETED|Part A Period 2 (4 Days)||0
11392442|NCT03627494|12586458|FG005|NOT COMPLETED|Part A Period 2 (4 Days)||0
11392443|NCT03627494|12586459|FG006|NOT COMPLETED|Part A Period 2 (4 Days)||0
11392444|NCT03627494|12586460|FG007|NOT COMPLETED|Part A Period 2 (4 Days)||0
11392445|NCT03627494|12586461|FG008|NOT COMPLETED|Part A Period 2 (4 Days)||0
11392446|NCT03627494|12586462|FG009|NOT COMPLETED|Part A Period 2 (4 Days)||0
11392447|NCT03627494|12586463|FG010|NOT COMPLETED|Part A Period 2 (4 Days)||0
11392448|NCT03627494|12586464|FG011|NOT COMPLETED|Part A Period 2 (4 Days)||0
11392449|NCT03627494|12586453|FG000|STARTED|Part A Washout 2 (7 Days)||3
11392450|NCT03627494|12586454|FG001|STARTED|Part A Washout 2 (7 Days)||3
11392451|NCT03627494|12586455|FG002|STARTED|Part A Washout 2 (7 Days)||3
11392452|NCT03627494|12586456|FG003|STARTED|Part A Washout 2 (7 Days)||3
11392453|NCT03627494|12586457|FG004|STARTED|Part A Washout 2 (7 Days)||3
11392454|NCT03627494|12586458|FG005|STARTED|Part A Washout 2 (7 Days)||3
11392455|NCT03627494|12586459|FG006|STARTED|Part A Washout 2 (7 Days)||0
11392456|NCT03627494|12586460|FG007|STARTED|Part A Washout 2 (7 Days)||0
11392457|NCT03627494|12586461|FG008|STARTED|Part A Washout 2 (7 Days)||0
11392458|NCT03627494|12586462|FG009|STARTED|Part A Washout 2 (7 Days)||0
11392459|NCT03627494|12586463|FG010|STARTED|Part A Washout 2 (7 Days)||0
11392460|NCT03627494|12586464|FG011|STARTED|Part A Washout 2 (7 Days)||0
11392461|NCT03627494|12586453|FG000|COMPLETED|Part A Washout 2 (7 Days)||2
11392462|NCT03627494|12586454|FG001|COMPLETED|Part A Washout 2 (7 Days)||3
11392463|NCT03627494|12586455|FG002|COMPLETED|Part A Washout 2 (7 Days)||2
11392464|NCT03627494|12586456|FG003|COMPLETED|Part A Washout 2 (7 Days)||3
11392465|NCT03627494|12586457|FG004|COMPLETED|Part A Washout 2 (7 Days)||3
11392466|NCT03627494|12586458|FG005|COMPLETED|Part A Washout 2 (7 Days)||3
11392467|NCT03627494|12586459|FG006|COMPLETED|Part A Washout 2 (7 Days)||0
11392468|NCT03627494|12586460|FG007|COMPLETED|Part A Washout 2 (7 Days)||0
11392469|NCT03627494|12586461|FG008|COMPLETED|Part A Washout 2 (7 Days)||0
11392470|NCT03627494|12586462|FG009|COMPLETED|Part A Washout 2 (7 Days)||0
11392471|NCT03627494|12586463|FG010|COMPLETED|Part A Washout 2 (7 Days)||0
11392472|NCT03627494|12586464|FG011|COMPLETED|Part A Washout 2 (7 Days)||0
11392473|NCT03627494|12586453|FG000|NOT COMPLETED|Part A Washout 2 (7 Days)||1
11392474|NCT03627494|12586454|FG001|NOT COMPLETED|Part A Washout 2 (7 Days)||0
11392475|NCT03627494|12586455|FG002|NOT COMPLETED|Part A Washout 2 (7 Days)||1
11392476|NCT03627494|12586456|FG003|NOT COMPLETED|Part A Washout 2 (7 Days)||0
11392477|NCT03627494|12586457|FG004|NOT COMPLETED|Part A Washout 2 (7 Days)||0
11392478|NCT03627494|12586458|FG005|NOT COMPLETED|Part A Washout 2 (7 Days)||0
11392479|NCT03627494|12586459|FG006|NOT COMPLETED|Part A Washout 2 (7 Days)||0
11392480|NCT03627494|12586460|FG007|NOT COMPLETED|Part A Washout 2 (7 Days)||0
11392481|NCT03627494|12586461|FG008|NOT COMPLETED|Part A Washout 2 (7 Days)||0
11392482|NCT03627494|12586462|FG009|NOT COMPLETED|Part A Washout 2 (7 Days)||0
11392483|NCT03627494|12586463|FG010|NOT COMPLETED|Part A Washout 2 (7 Days)||0
11392484|NCT03627494|12586464|FG011|NOT COMPLETED|Part A Washout 2 (7 Days)||0
11392485|NCT03627494|12586453|FG000|STARTED|Part A Period3(4days)+Follow-up(14days)||2
11392486|NCT03627494|12586454|FG001|STARTED|Part A Period3(4days)+Follow-up(14days)||3
11392487|NCT03627494|12586455|FG002|STARTED|Part A Period3(4days)+Follow-up(14days)||2
11392488|NCT03627494|12586456|FG003|STARTED|Part A Period3(4days)+Follow-up(14days)||3
11392489|NCT03627494|12586457|FG004|STARTED|Part A Period3(4days)+Follow-up(14days)||3
11392490|NCT03627494|12586458|FG005|STARTED|Part A Period3(4days)+Follow-up(14days)||3
11392491|NCT03627494|12586459|FG006|STARTED|Part A Period3(4days)+Follow-up(14days)||0
11392492|NCT03627494|12586460|FG007|STARTED|Part A Period3(4days)+Follow-up(14days)||0
11392493|NCT03627494|12586461|FG008|STARTED|Part A Period3(4days)+Follow-up(14days)||0
11392494|NCT03627494|12586462|FG009|STARTED|Part A Period3(4days)+Follow-up(14days)||0
11392495|NCT03627494|12586463|FG010|STARTED|Part A Period3(4days)+Follow-up(14days)||0
11392496|NCT03627494|12586464|FG011|STARTED|Part A Period3(4days)+Follow-up(14days)||0
11392497|NCT03627494|12586453|FG000|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
11392498|NCT03627494|12586454|FG001|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
11392499|NCT03627494|12586455|FG002|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
11392500|NCT03627494|12586456|FG003|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
11392501|NCT03627494|12586457|FG004|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
11392502|NCT03627494|12586458|FG005|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
11392503|NCT03627494|12586459|FG006|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392504|NCT03627494|12586460|FG007|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392505|NCT03627494|12586461|FG008|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392506|NCT03627494|12586462|FG009|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392507|NCT03627494|12586463|FG010|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392508|NCT03627494|12586464|FG011|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392509|NCT03627494|12586453|FG000|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392510|NCT03627494|12586454|FG001|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392511|NCT03627494|12586455|FG002|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392512|NCT03627494|12586456|FG003|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392513|NCT03627494|12586457|FG004|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392514|NCT03627494|12586458|FG005|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392515|NCT03627494|12586459|FG006|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392516|NCT03627494|12586460|FG007|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392517|NCT03627494|12586461|FG008|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392518|NCT03627494|12586462|FG009|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392519|NCT03627494|12586463|FG010|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392520|NCT03627494|12586464|FG011|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
11392521|NCT03627494|12586453|FG000|STARTED|Part B (Maximum of 34 Days)||0
11392522|NCT03627494|12586454|FG001|STARTED|Part B (Maximum of 34 Days)||0
11392523|NCT03627494|12586455|FG002|STARTED|Part B (Maximum of 34 Days)||0
11392524|NCT03627494|12586456|FG003|STARTED|Part B (Maximum of 34 Days)||0
11392525|NCT03627494|12586457|FG004|STARTED|Part B (Maximum of 34 Days)||0
11392526|NCT03627494|12586458|FG005|STARTED|Part B (Maximum of 34 Days)||0
11392527|NCT03627494|12586459|FG006|STARTED|Part B (Maximum of 34 Days)||9
11392528|NCT03627494|12586460|FG007|STARTED|Part B (Maximum of 34 Days)||9
11392529|NCT03627494|12586461|FG008|STARTED|Part B (Maximum of 34 Days)||9
11392530|NCT03627494|12586462|FG009|STARTED|Part B (Maximum of 34 Days)||9
11392531|NCT03627494|12586463|FG010|STARTED|Part B (Maximum of 34 Days)||0
11392532|NCT03627494|12586464|FG011|STARTED|Part B (Maximum of 34 Days)||0
11392533|NCT03627494|12586453|FG000|COMPLETED|Part B (Maximum of 34 Days)||0
11392534|NCT03627494|12586454|FG001|COMPLETED|Part B (Maximum of 34 Days)||0
11392535|NCT03627494|12586455|FG002|COMPLETED|Part B (Maximum of 34 Days)||0
11392536|NCT03627494|12586456|FG003|COMPLETED|Part B (Maximum of 34 Days)||0
11392537|NCT03627494|12586457|FG004|COMPLETED|Part B (Maximum of 34 Days)||0
11392538|NCT03627494|12586458|FG005|COMPLETED|Part B (Maximum of 34 Days)||0
11392539|NCT03627494|12586459|FG006|COMPLETED|Part B (Maximum of 34 Days)||9
11392540|NCT03627494|12586460|FG007|COMPLETED|Part B (Maximum of 34 Days)||9
11392541|NCT03627494|12586461|FG008|COMPLETED|Part B (Maximum of 34 Days)||7
11392542|NCT03627494|12586462|FG009|COMPLETED|Part B (Maximum of 34 Days)||9
11392543|NCT03627494|12586463|FG010|COMPLETED|Part B (Maximum of 34 Days)||0
11392544|NCT03627494|12586464|FG011|COMPLETED|Part B (Maximum of 34 Days)||0
11392545|NCT03627494|12586453|FG000|NOT COMPLETED|Part B (Maximum of 34 Days)||0
11392546|NCT03627494|12586454|FG001|NOT COMPLETED|Part B (Maximum of 34 Days)||0
11392547|NCT03627494|12586455|FG002|NOT COMPLETED|Part B (Maximum of 34 Days)||0
11392548|NCT03627494|12586456|FG003|NOT COMPLETED|Part B (Maximum of 34 Days)||0
11392549|NCT03627494|12586457|FG004|NOT COMPLETED|Part B (Maximum of 34 Days)||0
11392550|NCT03627494|12586458|FG005|NOT COMPLETED|Part B (Maximum of 34 Days)||0
11392551|NCT03627494|12586459|FG006|NOT COMPLETED|Part B (Maximum of 34 Days)||0
11392552|NCT03627494|12586460|FG007|NOT COMPLETED|Part B (Maximum of 34 Days)||0
11392553|NCT03627494|12586461|FG008|NOT COMPLETED|Part B (Maximum of 34 Days)||2
11392554|NCT03627494|12586462|FG009|NOT COMPLETED|Part B (Maximum of 34 Days)||0
11392555|NCT03627494|12586463|FG010|NOT COMPLETED|Part B (Maximum of 34 Days)||0
11392556|NCT03627494|12586464|FG011|NOT COMPLETED|Part B (Maximum of 34 Days)||0
11392557|NCT03627494|12586453|FG000|STARTED|Part C Period 1 (4 Days)||0
11392558|NCT03627494|12586454|FG001|STARTED|Part C Period 1 (4 Days)||0
11392559|NCT03627494|12586455|FG002|STARTED|Part C Period 1 (4 Days)||0
11392560|NCT03627494|12586456|FG003|STARTED|Part C Period 1 (4 Days)||0
11392561|NCT03627494|12586457|FG004|STARTED|Part C Period 1 (4 Days)||0
11392562|NCT03627494|12586458|FG005|STARTED|Part C Period 1 (4 Days)||0
11392563|NCT03627494|12586459|FG006|STARTED|Part C Period 1 (4 Days)||0
11392564|NCT03627494|12586460|FG007|STARTED|Part C Period 1 (4 Days)||0
11392565|NCT03627494|12586461|FG008|STARTED|Part C Period 1 (4 Days)||0
11392566|NCT03627494|12586462|FG009|STARTED|Part C Period 1 (4 Days)||0
11392567|NCT03627494|12586463|FG010|STARTED|Part C Period 1 (4 Days)||6
11392568|NCT03627494|12586464|FG011|STARTED|Part C Period 1 (4 Days)||6
11392569|NCT03627494|12586453|FG000|COMPLETED|Part C Period 1 (4 Days)||0
11392570|NCT03627494|12586454|FG001|COMPLETED|Part C Period 1 (4 Days)||0
11392571|NCT03627494|12586455|FG002|COMPLETED|Part C Period 1 (4 Days)||0
11392572|NCT03627494|12586456|FG003|COMPLETED|Part C Period 1 (4 Days)||0
11392573|NCT03627494|12586457|FG004|COMPLETED|Part C Period 1 (4 Days)||0
11392574|NCT03627494|12586458|FG005|COMPLETED|Part C Period 1 (4 Days)||0
11392575|NCT03627494|12586459|FG006|COMPLETED|Part C Period 1 (4 Days)||0
11392576|NCT03627494|12586460|FG007|COMPLETED|Part C Period 1 (4 Days)||0
11392577|NCT03627494|12586461|FG008|COMPLETED|Part C Period 1 (4 Days)||0
11392578|NCT03627494|12586462|FG009|COMPLETED|Part C Period 1 (4 Days)||0
11392579|NCT03627494|12586463|FG010|COMPLETED|Part C Period 1 (4 Days)||6
11392580|NCT03627494|12586464|FG011|COMPLETED|Part C Period 1 (4 Days)||6
11392581|NCT03627494|12586453|FG000|NOT COMPLETED|Part C Period 1 (4 Days)||0
11392582|NCT03627494|12586454|FG001|NOT COMPLETED|Part C Period 1 (4 Days)||0
11392583|NCT03627494|12586455|FG002|NOT COMPLETED|Part C Period 1 (4 Days)||0
11392584|NCT03627494|12586456|FG003|NOT COMPLETED|Part C Period 1 (4 Days)||0
11392585|NCT03627494|12586457|FG004|NOT COMPLETED|Part C Period 1 (4 Days)||0
11392586|NCT03627494|12586458|FG005|NOT COMPLETED|Part C Period 1 (4 Days)||0
11392587|NCT03627494|12586459|FG006|NOT COMPLETED|Part C Period 1 (4 Days)||0
11392588|NCT03627494|12586460|FG007|NOT COMPLETED|Part C Period 1 (4 Days)||0
11392589|NCT03627494|12586461|FG008|NOT COMPLETED|Part C Period 1 (4 Days)||0
11392590|NCT03627494|12586462|FG009|NOT COMPLETED|Part C Period 1 (4 Days)||0
11392591|NCT03627494|12586463|FG010|NOT COMPLETED|Part C Period 1 (4 Days)||0
11392592|NCT03627494|12586464|FG011|NOT COMPLETED|Part C Period 1 (4 Days)||0
11392593|NCT03627494|12586453|FG000|STARTED|Part C Washout 1 (7 Days)||0
11392594|NCT03627494|12586454|FG001|STARTED|Part C Washout 1 (7 Days)||0
11392595|NCT03627494|12586455|FG002|STARTED|Part C Washout 1 (7 Days)||0
11392596|NCT03627494|12586456|FG003|STARTED|Part C Washout 1 (7 Days)||0
11392597|NCT03627494|12586457|FG004|STARTED|Part C Washout 1 (7 Days)||0
11392598|NCT03627494|12586458|FG005|STARTED|Part C Washout 1 (7 Days)||0
11392599|NCT03627494|12586459|FG006|STARTED|Part C Washout 1 (7 Days)||0
11392600|NCT03627494|12586460|FG007|STARTED|Part C Washout 1 (7 Days)||0
11392601|NCT03627494|12586461|FG008|STARTED|Part C Washout 1 (7 Days)||0
11392602|NCT03627494|12586462|FG009|STARTED|Part C Washout 1 (7 Days)||0
11392603|NCT03627494|12586463|FG010|STARTED|Part C Washout 1 (7 Days)||6
11392604|NCT03627494|12586464|FG011|STARTED|Part C Washout 1 (7 Days)||6
11392605|NCT03627494|12586453|FG000|COMPLETED|Part C Washout 1 (7 Days)||0
11392606|NCT03627494|12586454|FG001|COMPLETED|Part C Washout 1 (7 Days)||0
11392607|NCT03627494|12586455|FG002|COMPLETED|Part C Washout 1 (7 Days)||0
11392608|NCT03627494|12586456|FG003|COMPLETED|Part C Washout 1 (7 Days)||0
11392609|NCT03627494|12586457|FG004|COMPLETED|Part C Washout 1 (7 Days)||0
11392610|NCT03627494|12586458|FG005|COMPLETED|Part C Washout 1 (7 Days)||0
11392611|NCT03627494|12586459|FG006|COMPLETED|Part C Washout 1 (7 Days)||0
11392612|NCT03627494|12586460|FG007|COMPLETED|Part C Washout 1 (7 Days)||0
11392613|NCT03627494|12586461|FG008|COMPLETED|Part C Washout 1 (7 Days)||0
11392614|NCT03627494|12586462|FG009|COMPLETED|Part C Washout 1 (7 Days)||0
11392615|NCT03627494|12586463|FG010|COMPLETED|Part C Washout 1 (7 Days)||5
11392616|NCT03627494|12586464|FG011|COMPLETED|Part C Washout 1 (7 Days)||5
11392617|NCT03627494|12586453|FG000|NOT COMPLETED|Part C Washout 1 (7 Days)||0
11392618|NCT03627494|12586454|FG001|NOT COMPLETED|Part C Washout 1 (7 Days)||0
11392619|NCT03627494|12586455|FG002|NOT COMPLETED|Part C Washout 1 (7 Days)||0
11392620|NCT03627494|12586456|FG003|NOT COMPLETED|Part C Washout 1 (7 Days)||0
11392621|NCT03627494|12586457|FG004|NOT COMPLETED|Part C Washout 1 (7 Days)||0
11392622|NCT03627494|12586458|FG005|NOT COMPLETED|Part C Washout 1 (7 Days)||0
11392623|NCT03627494|12586459|FG006|NOT COMPLETED|Part C Washout 1 (7 Days)||0
11392624|NCT03627494|12586460|FG007|NOT COMPLETED|Part C Washout 1 (7 Days)||0
11392625|NCT03627494|12586461|FG008|NOT COMPLETED|Part C Washout 1 (7 Days)||0
11392626|NCT03627494|12586462|FG009|NOT COMPLETED|Part C Washout 1 (7 Days)||0
11392627|NCT03627494|12586463|FG010|NOT COMPLETED|Part C Washout 1 (7 Days)||1
11392628|NCT03627494|12586464|FG011|NOT COMPLETED|Part C Washout 1 (7 Days)||1
11392629|NCT03627494|12586453|FG000|STARTED|Part C Period2(4days)+Follow-up(14days)||0
11392630|NCT03627494|12586454|FG001|STARTED|Part C Period2(4days)+Follow-up(14days)||0
11392631|NCT03627494|12586455|FG002|STARTED|Part C Period2(4days)+Follow-up(14days)||0
11392632|NCT03627494|12586456|FG003|STARTED|Part C Period2(4days)+Follow-up(14days)||0
11392633|NCT03627494|12586457|FG004|STARTED|Part C Period2(4days)+Follow-up(14days)||0
11392634|NCT03627494|12586458|FG005|STARTED|Part C Period2(4days)+Follow-up(14days)||0
11392635|NCT03627494|12586459|FG006|STARTED|Part C Period2(4days)+Follow-up(14days)||0
11392636|NCT03627494|12586460|FG007|STARTED|Part C Period2(4days)+Follow-up(14days)||0
11392637|NCT03627494|12586461|FG008|STARTED|Part C Period2(4days)+Follow-up(14days)||0
11392638|NCT03627494|12586462|FG009|STARTED|Part C Period2(4days)+Follow-up(14days)||0
11392639|NCT03627494|12586463|FG010|STARTED|Part C Period2(4days)+Follow-up(14days)||5
11392640|NCT03627494|12586464|FG011|STARTED|Part C Period2(4days)+Follow-up(14days)||5
11392641|NCT03627494|12586453|FG000|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392642|NCT03627494|12586454|FG001|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392643|NCT03627494|12586455|FG002|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392644|NCT03627494|12586456|FG003|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392645|NCT03627494|12586457|FG004|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392646|NCT03627494|12586458|FG005|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392647|NCT03627494|12586459|FG006|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392648|NCT03627494|12586460|FG007|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392649|NCT03627494|12586461|FG008|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392650|NCT03627494|12586462|FG009|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392651|NCT03627494|12586463|FG010|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
11392652|NCT03627494|12586464|FG011|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
11392653|NCT03627494|12586453|FG000|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392654|NCT03627494|12586454|FG001|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392655|NCT03627494|12586455|FG002|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392656|NCT03627494|12586456|FG003|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392657|NCT03627494|12586457|FG004|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392658|NCT03627494|12586458|FG005|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392659|NCT03627494|12586459|FG006|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392660|NCT03627494|12586460|FG007|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392661|NCT03627494|12586461|FG008|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392662|NCT03627494|12586462|FG009|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392663|NCT03627494|12586463|FG010|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392664|NCT03627494|12586464|FG011|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
11392665|NCT03627767|12586506|FG000|STARTED|Open-label (OL) Run-in Period (12 Weeks)||1235
11392666|NCT03627767|12586507|FG001|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
11392667|NCT03627767|12586508|FG002|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
11392668|NCT03627767|12586509|FG003|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
11392669|NCT03627767|12586510|FG004|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
11392670|NCT03627767|12586506|FG000|Treated|Open-label (OL) Run-in Period (12 Weeks)||1233
11392671|NCT03627767|12586507|FG001|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
11392672|NCT03627767|12586508|FG002|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
11392673|NCT03627767|12586509|FG003|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
11392674|NCT03627767|12586510|FG004|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
11392675|NCT03627767|12586506|FG000|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||798
11392676|NCT03627767|12586507|FG001|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
11392677|NCT03627767|12586508|FG002|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
11392678|NCT03627767|12586509|FG003|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
11392679|NCT03627767|12586510|FG004|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
11392680|NCT03627767|12586506|FG000|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||437
11392681|NCT03627767|12586507|FG001|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
11392682|NCT03627767|12586508|FG002|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
11392683|NCT03627767|12586509|FG003|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
11392684|NCT03627767|12586510|FG004|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
11392685|NCT03627767|12586506|FG000|STARTED|Double-blind Treatment Period (40 Weeks)|Participants did not enter into the DB period.|0
11392686|NCT03627767|12586507|FG001|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|267
11392687|NCT03627767|12586508|FG002|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|265
11392688|NCT03627767|12586509|FG003|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|266
11392689|NCT03627767|12586510|FG004|STARTED|Double-blind Treatment Period (40 Weeks)||0
11392690|NCT03627767|12586506|FG000|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0
11392691|NCT03627767|12586507|FG001|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||208
11392692|NCT03627767|12586508|FG002|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||109
11392693|NCT03627767|12586509|FG003|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||44
11392694|NCT03627767|12586510|FG004|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0
11392695|NCT03627767|12586506|FG000|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
11392696|NCT03627767|12586507|FG001|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||201
11392697|NCT03627767|12586508|FG002|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||99
11392698|NCT03627767|12586509|FG003|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||41
11392699|NCT03627767|12586510|FG004|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
11392700|NCT03627767|12586506|FG000|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
11392701|NCT03627767|12586507|FG001|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||43
11392702|NCT03627767|12586508|FG002|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||134
11392703|NCT03627767|12586509|FG003|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||187
11392704|NCT03627767|12586510|FG004|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
11392705|NCT03627767|12586506|FG000|COMPLETED|Double-blind Treatment Period (40 Weeks)||0
11392706|NCT03627767|12586507|FG001|COMPLETED|Double-blind Treatment Period (40 Weeks)|208 entered RP+43 completed study in DB period|251
11392707|NCT03627767|12586508|FG002|COMPLETED|Double-blind Treatment Period (40 Weeks)|109 entered RP+134 completed study in DB period|243
11392708|NCT03627767|12586509|FG003|COMPLETED|Double-blind Treatment Period (40 Weeks)|44 entered RP+187 completed study in DB period|231
11392709|NCT03627767|12586510|FG004|COMPLETED|Double-blind Treatment Period (40 Weeks)||0
11392710|NCT03627767|12586506|FG000|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0
11392711|NCT03627767|12586507|FG001|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||16
11392712|NCT03627767|12586508|FG002|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||22
11392713|NCT03627767|12586509|FG003|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||35
11392714|NCT03627767|12586510|FG004|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0
11392715|NCT03627767|12586506|FG000|STARTED|Open-label Rescue Period (12 Weeks)||0
11392716|NCT03627767|12586507|FG001|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
11392717|NCT03627767|12586508|FG002|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
11392718|NCT03627767|12586509|FG003|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
11392719|NCT03627767|12586510|FG004|STARTED|Open-label Rescue Period (12 Weeks)|Participants who met the pre-defined criteria for OL- Rescue Period.|361
11392720|NCT03627767|12586506|FG000|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
11392721|NCT03627767|12586507|FG001|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
11392722|NCT03627767|12586508|FG002|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
11392723|NCT03627767|12586509|FG003|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
11392724|NCT03627767|12586510|FG004|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||351
11392725|NCT03627767|12586506|FG000|COMPLETED|Open-label Rescue Period (12 Weeks)||0
11392726|NCT03627767|12586507|FG001|COMPLETED|Open-label Rescue Period (12 Weeks)||0
11392727|NCT03627767|12586508|FG002|COMPLETED|Open-label Rescue Period (12 Weeks)||0
11392728|NCT03627767|12586509|FG003|COMPLETED|Open-label Rescue Period (12 Weeks)||0
11392729|NCT03627767|12586510|FG004|COMPLETED|Open-label Rescue Period (12 Weeks)||341
11392730|NCT03627767|12586506|FG000|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
11392731|NCT03627767|12586507|FG001|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
11392732|NCT03627767|12586508|FG002|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
11392733|NCT03627767|12586509|FG003|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
11392734|NCT03627767|12586510|FG004|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||20
11392735|NCT03627832|12586523|FG000|STARTED|Overall Study||28
11392736|NCT03627832|12586524|FG001|STARTED|Overall Study||28
11392737|NCT03627832|12586523|FG000|COMPLETED|Overall Study||18
11392738|NCT03627832|12586524|FG001|COMPLETED|Overall Study||27
11392739|NCT03627832|12586523|FG000|NOT COMPLETED|Overall Study||10
11392740|NCT03627832|12586524|FG001|NOT COMPLETED|Overall Study||1
11392741|NCT03628417|12586530|FG000|STARTED|Overall Study||7
11392742|NCT03628417|12586531|FG001|STARTED|Overall Study||7
11392743|NCT03628417|12586530|FG000|Day 0|Overall Study||7
11392744|NCT03628417|12586531|FG001|Day 0|Overall Study||7
11392745|NCT03628417|12586530|FG000|Day 7|Overall Study||7
11392746|NCT03628417|12586531|FG001|Day 7|Overall Study||7
11392747|NCT03628417|12586530|FG000|Day 15|Overall Study||7
11392748|NCT03628417|12586531|FG001|Day 15|Overall Study||7
11392749|NCT03628417|12586530|FG000|Day 30|Overall Study||7
11392750|NCT03628417|12586531|FG001|Day 30|Overall Study||7
11392751|NCT03628417|12586530|FG000|Day 60|Overall Study||7
11392752|NCT03628417|12586531|FG001|Day 60|Overall Study||7
11392753|NCT03628417|12586530|FG000|Day 90|Overall Study||7
11392754|NCT03628417|12586531|FG001|Day 90|Overall Study||7
11392755|NCT03628417|12586530|FG000|Day 180|Overall Study||7
11392756|NCT03628417|12586531|FG001|Day 180|Overall Study||7
11392757|NCT03628417|12586530|FG000|COMPLETED|Overall Study|One patient died and 3 more Ca electroporated lesions were removed before the one-year closing visit|6
11392758|NCT03628417|12586531|FG001|COMPLETED|Overall Study|One patient died before the one-year closing visit,this is why decreased the number of metastases|6
11392759|NCT03628417|12586530|FG000|NOT COMPLETED|Overall Study||1
11392760|NCT03628417|12586531|FG001|NOT COMPLETED|Overall Study||1
11392761|NCT03628456|12586541|FG000|STARTED|Overall Study||10
11392762|NCT03628456|12586541|FG000|COMPLETED|Overall Study||10
11392763|NCT03628456|12586541|FG000|NOT COMPLETED|Overall Study||0
11392764|NCT03628508|12586549|FG000|STARTED|Overall Study||40
11392765|NCT03628508|12586549|FG000|COMPLETED|Overall Study||39
11392766|NCT03628508|12586549|FG000|NOT COMPLETED|Overall Study||1
11392767|NCT03628599|12586555|FG000|STARTED|Overall Study||18
11392768|NCT03628599|12586556|FG001|STARTED|Overall Study||19
11392769|NCT03628599|12586555|FG000|COMPLETED|Overall Study||18
11392770|NCT03628599|12586556|FG001|COMPLETED|Overall Study||18
11392771|NCT03628599|12586555|FG000|NOT COMPLETED|Overall Study||0
11392772|NCT03628599|12586556|FG001|NOT COMPLETED|Overall Study||1
11392773|NCT03628885|12586569|FG000|STARTED|Overall Study||306
11392774|NCT03628885|12586570|FG001|STARTED|Overall Study||299
11392775|NCT03628885|12586571|FG002|STARTED|Overall Study||303
11392776|NCT03628885|12586569|FG000|COMPLETED|Overall Study||267
11392777|NCT03628885|12586570|FG001|COMPLETED|Overall Study||252
11392778|NCT03628885|12586571|FG002|COMPLETED|Overall Study||243
11392779|NCT03628885|12586569|FG000|NOT COMPLETED|Overall Study||39
11392780|NCT03628885|12586570|FG001|NOT COMPLETED|Overall Study||47
11392781|NCT03628885|12586571|FG002|NOT COMPLETED|Overall Study||60
11392782|NCT03628898|12586579|FG000|STARTED|Overall Study||27
11392783|NCT03628898|12586579|FG000|COMPLETED|Overall Study||26
11392784|NCT03628898|12586579|FG000|NOT COMPLETED|Overall Study||1
11392785|NCT03628924|12586586|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||62
11392786|NCT03628924|12586587|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||59
11392787|NCT03628924|12586588|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||60
11392788|NCT03628924|12586589|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||0
11392789|NCT03628924|12586590|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||0
11392790|NCT03628924|12586591|FG005|STARTED|Placebo Controlled Period (Week 0 - 16)||0
11392791|NCT03628924|12586592|FG006|STARTED|Placebo Controlled Period (Week 0 - 16)||0
11392792|NCT03628924|12586586|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
11392793|NCT03628924|12586587|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
11392794|NCT03628924|12586588|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||57
11392795|NCT03628924|12586589|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
11392796|NCT03628924|12586590|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
11392797|NCT03628924|12586591|FG005|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
11392798|NCT03628924|12586592|FG006|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
11392799|NCT03628924|12586586|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||6
11392800|NCT03628924|12586587|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
11392801|NCT03628924|12586588|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
11392802|NCT03628924|12586589|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
11392803|NCT03628924|12586590|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
11392804|NCT03628924|12586591|FG005|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
11392805|NCT03628924|12586592|FG006|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
11392806|NCT03628924|12586586|FG000|STARTED|Active Treatment Period (Week 16-48)||0
11392807|NCT03628924|12586587|FG001|STARTED|Active Treatment Period (Week 16-48)||0
11392808|NCT03628924|12586588|FG002|STARTED|Active Treatment Period (Week 16-48)||0
11392809|NCT03628924|12586589|FG003|STARTED|Active Treatment Period (Week 16-48)||28
11392810|NCT03628924|12586590|FG004|STARTED|Active Treatment Period (Week 16-48)||28
11392811|NCT03628924|12586591|FG005|STARTED|Active Treatment Period (Week 16-48)||56
11392812|NCT03628924|12586592|FG006|STARTED|Active Treatment Period (Week 16-48)||57
11392813|NCT03628924|12586586|FG000|COMPLETED|Active Treatment Period (Week 16-48)||0
11392814|NCT03628924|12586587|FG001|COMPLETED|Active Treatment Period (Week 16-48)||0
11392815|NCT03628924|12586588|FG002|COMPLETED|Active Treatment Period (Week 16-48)||0
11392816|NCT03628924|12586589|FG003|COMPLETED|Active Treatment Period (Week 16-48)||20
11392817|NCT03628924|12586590|FG004|COMPLETED|Active Treatment Period (Week 16-48)||24
11392818|NCT03628924|12586591|FG005|COMPLETED|Active Treatment Period (Week 16-48)||43
11392819|NCT03628924|12586592|FG006|COMPLETED|Active Treatment Period (Week 16-48)||46
11392820|NCT03628924|12586586|FG000|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
11392821|NCT03628924|12586587|FG001|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
11392822|NCT03628924|12586588|FG002|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
11392823|NCT03628924|12586589|FG003|NOT COMPLETED|Active Treatment Period (Week 16-48)||8
11392824|NCT03628924|12586590|FG004|NOT COMPLETED|Active Treatment Period (Week 16-48)||4
11392825|NCT03628924|12586591|FG005|NOT COMPLETED|Active Treatment Period (Week 16-48)||13
11392826|NCT03628924|12586592|FG006|NOT COMPLETED|Active Treatment Period (Week 16-48)||11
11392827|NCT03629028|12586606|FG000|STARTED|Overall Study||141
11392828|NCT03629028|12586607|FG001|STARTED|Overall Study||141
11392829|NCT03629028|12586606|FG000|COMPLETED|Overall Study||109
11392830|NCT03629028|12586607|FG001|COMPLETED|Overall Study||116
11392831|NCT03629028|12586606|FG000|NOT COMPLETED|Overall Study||32
11392832|NCT03629028|12586607|FG001|NOT COMPLETED|Overall Study||25
11392833|NCT03629041|12586623|FG000|STARTED|Visit 1||4
11392834|NCT03629041|12586624|FG001|STARTED|Visit 1||4
11392835|NCT03629041|12586625|FG002|STARTED|Visit 1||4
11392836|NCT03629041|12586626|FG003|STARTED|Visit 1||4
11392837|NCT03629041|12586623|FG000|COMPLETED|Visit 1||4
11392838|NCT03629041|12586624|FG001|COMPLETED|Visit 1||4
11392839|NCT03629041|12586625|FG002|COMPLETED|Visit 1||4
11392840|NCT03629041|12586626|FG003|COMPLETED|Visit 1||4
11392841|NCT03629041|12586623|FG000|NOT COMPLETED|Visit 1||0
11392842|NCT03629041|12586624|FG001|NOT COMPLETED|Visit 1||0
11392843|NCT03629041|12586625|FG002|NOT COMPLETED|Visit 1||0
11392844|NCT03629041|12586626|FG003|NOT COMPLETED|Visit 1||0
11392845|NCT03629041|12586623|FG000|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
11392846|NCT03629041|12586624|FG001|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
11392847|NCT03629041|12586625|FG002|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
11392848|NCT03629041|12586626|FG003|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
11392849|NCT03629041|12586623|FG000|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
11392850|NCT03629041|12586624|FG001|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3
11392851|NCT03629041|12586625|FG002|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
11392852|NCT03629041|12586626|FG003|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
11392853|NCT03629041|12586623|FG000|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
11392854|NCT03629041|12586624|FG001|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1
11392855|NCT03629041|12586625|FG002|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
11392856|NCT03629041|12586626|FG003|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
11392857|NCT03629054|12586646|FG000|STARTED|Period 1 (4 Days)|Started this period|15
11392858|NCT03629054|12586647|FG001|STARTED|Period 1 (4 Days)|Started this period|15
11392859|NCT03629054|12586646|FG000|COMPLETED|Period 1 (4 Days)||15
11392860|NCT03629054|12586647|FG001|COMPLETED|Period 1 (4 Days)||15
11392861|NCT03629054|12586646|FG000|NOT COMPLETED|Period 1 (4 Days)||0
11392862|NCT03629054|12586647|FG001|NOT COMPLETED|Period 1 (4 Days)||0
11392863|NCT03629054|12586646|FG000|STARTED|Wasout Period (35 Days)|Started this period|15
11392864|NCT03629054|12586647|FG001|STARTED|Wasout Period (35 Days)|Started this period|15
11392865|NCT03629054|12586646|FG000|COMPLETED|Wasout Period (35 Days)||15
11392866|NCT03629054|12586647|FG001|COMPLETED|Wasout Period (35 Days)||15
11392867|NCT03629054|12586646|FG000|NOT COMPLETED|Wasout Period (35 Days)||0
11392868|NCT03629054|12586647|FG001|NOT COMPLETED|Wasout Period (35 Days)||0
11392869|NCT03629054|12586646|FG000|STARTED|Period 2 (4 Days)|Started this period|15
11392870|NCT03629054|12586647|FG001|STARTED|Period 2 (4 Days)|Started this period|15
11392871|NCT03629054|12586646|FG000|Treated|Period 2 (4 Days)||15
11392872|NCT03629054|12586647|FG001|Treated|Period 2 (4 Days)||14
11392873|NCT03629054|12586646|FG000|COMPLETED|Period 2 (4 Days)||15
11392874|NCT03629054|12586647|FG001|COMPLETED|Period 2 (4 Days)||14
11392875|NCT03629054|12586646|FG000|NOT COMPLETED|Period 2 (4 Days)||0
11006175|NCT00726999|12183943|FG001|COMPLETED|Overall Study||30
11006176|NCT00726999|12183942|FG000|NOT COMPLETED|Overall Study||3
11006177|NCT00726999|12183943|FG001|NOT COMPLETED|Overall Study||1
11006178|NCT00727025|12183951|FG000|STARTED|Overall Study||74
11006179|NCT00727025|12183951|FG000|COMPLETED|Overall Study||51
11392876|NCT03629054|12586647|FG001|NOT COMPLETED|Period 2 (4 Days)||1
11392877|NCT03629184|12586655|FG000|STARTED|Overall Study||115
11392878|NCT03629184|12586656|FG001|STARTED|Overall Study||58
11392879|NCT03629184|12586655|FG000|COMPLETED|Overall Study||112
11392880|NCT03629184|12586656|FG001|COMPLETED|Overall Study||57
11392881|NCT03629184|12586655|FG000|NOT COMPLETED|Overall Study||3
11392882|NCT03629184|12586656|FG001|NOT COMPLETED|Overall Study||1
11392883|NCT03629249|12586665|FG000|STARTED|Overall Study||201
11392884|NCT03629249|12586666|FG001|STARTED|Overall Study||201
11392885|NCT03629249|12586667|FG002|STARTED|Overall Study||202
11392886|NCT03629249|12586665|FG000|Full Analysis Set (FAS)|Overall Study||201
11392887|NCT03629249|12586666|FG001|Full Analysis Set (FAS)|Overall Study||200
11392888|NCT03629249|12586667|FG002|Full Analysis Set (FAS)|Overall Study||201
11392889|NCT03629249|12586665|FG000|Safety Set (SAF)|Overall Study||201
11392890|NCT03629249|12586666|FG001|Safety Set (SAF)|Overall Study||200
11392891|NCT03629249|12586667|FG002|Safety Set (SAF)|Overall Study||201
11006180|NCT00727025|12183951|FG000|NOT COMPLETED|Overall Study||23
11006181|NCT00727064|12183961|FG000|STARTED|Overall Study||7
11006182|NCT00727064|12183962|FG001|STARTED|Overall Study||7
11006183|NCT00727064|12183961|FG000|COMPLETED|Overall Study||7
11006184|NCT00727064|12183962|FG001|COMPLETED|Overall Study||7
11006185|NCT00727064|12183961|FG000|NOT COMPLETED|Overall Study||0
11006186|NCT00727064|12183962|FG001|NOT COMPLETED|Overall Study||0
11392892|NCT03629249|12586665|FG000|COMPLETED|Overall Study||0
11392893|NCT03629249|12586666|FG001|COMPLETED|Overall Study||0
11392894|NCT03629249|12586667|FG002|COMPLETED|Overall Study||0
11392895|NCT03629249|12586665|FG000|NOT COMPLETED|Overall Study||201
11392896|NCT03629249|12586666|FG001|NOT COMPLETED|Overall Study||201
11392897|NCT03629249|12586667|FG002|NOT COMPLETED|Overall Study||202
11392898|NCT03629535|12586675|FG000|STARTED|Overall Study||8
11392899|NCT03629535|12586675|FG000|COMPLETED|Overall Study||8
11392900|NCT03629535|12586675|FG000|NOT COMPLETED|Overall Study||0
11392901|NCT03629886|12586681|FG000|STARTED|Overall Study||1671
11392902|NCT03629886|12586682|FG001|STARTED|Overall Study||1866
11392903|NCT03629886|12586681|FG000|COMPLETED|Overall Study||1671
11392904|NCT03629886|12586682|FG001|COMPLETED|Overall Study||1686
11392905|NCT03629886|12586681|FG000|NOT COMPLETED|Overall Study||0
11392906|NCT03629886|12586682|FG001|NOT COMPLETED|Overall Study||180
11392907|NCT03629925|12586691|FG000|STARTED|Overall Study||179
11392908|NCT03629925|12586692|FG001|STARTED|Overall Study||178
11392909|NCT03629925|12586691|FG000|COMPLETED|Overall Study||0
11392910|NCT03629925|12586692|FG001|COMPLETED|Overall Study||0
11392911|NCT03629925|12586691|FG000|NOT COMPLETED|Overall Study||179
11392912|NCT03629925|12586692|FG001|NOT COMPLETED|Overall Study||178
11392913|NCT03630016|12586698|FG000|STARTED|Overall Study||11
11392914|NCT03630016|12586698|FG000|COMPLETED|Overall Study||10
11392915|NCT03630016|12586698|FG000|NOT COMPLETED|Overall Study||1
11392916|NCT03630185|12586704|FG000|STARTED|Overall Study||4
11392917|NCT03630185|12586705|FG001|STARTED|Overall Study||4
11392918|NCT03630185|12586704|FG000|30 Day Follow up|Overall Study||1
11392919|NCT03630185|12586705|FG001|30 Day Follow up|Overall Study||1
11392920|NCT03630185|12586704|FG000|90 Day Follow up|Overall Study||0
11392921|NCT03630185|12586705|FG001|90 Day Follow up|Overall Study||1
11392922|NCT03630185|12586704|FG000|6 Month Follow up|Overall Study||0
11392923|NCT03630185|12586705|FG001|6 Month Follow up|Overall Study||0
11392924|NCT03630185|12586704|FG000|COMPLETED|Overall Study||0
11392925|NCT03630185|12586705|FG001|COMPLETED|Overall Study||0
11392926|NCT03630185|12586704|FG000|NOT COMPLETED|Overall Study||4
11392927|NCT03630185|12586705|FG001|NOT COMPLETED|Overall Study||4
11392928|NCT03630198|12586713|FG000|STARTED|Overall Study||13
11392929|NCT03630198|12586714|FG001|STARTED|Overall Study||18
11392930|NCT03630198|12586713|FG000|COMPLETED|Overall Study||13
11392931|NCT03630198|12586714|FG001|COMPLETED|Overall Study||18
11392932|NCT03630198|12586713|FG000|NOT COMPLETED|Overall Study||0
11392933|NCT03630198|12586714|FG001|NOT COMPLETED|Overall Study||0
11392934|NCT03630302|12586720|FG000|STARTED|Surgery||10
11392935|NCT03630302|12586720|FG000|COMPLETED|Surgery||9
11392936|NCT03630302|12586720|FG000|NOT COMPLETED|Surgery||1
11392937|NCT03630302|12586720|FG000|STARTED|3 Month Visit||9
11392938|NCT03630302|12586720|FG000|COMPLETED|3 Month Visit||7
11392939|NCT03630302|12586720|FG000|NOT COMPLETED|3 Month Visit||2
11392940|NCT03630302|12586720|FG000|STARTED|Data Post Analyses||7
11392941|NCT03630302|12586720|FG000|COMPLETED|Data Post Analyses||5
11392942|NCT03630302|12586720|FG000|NOT COMPLETED|Data Post Analyses||2
11392943|NCT03630679|12586726|FG000|STARTED|Overall Study||20
11392944|NCT03630679|12586727|FG001|STARTED|Overall Study||25
11392945|NCT03630679|12586726|FG000|COMPLETED|Overall Study||13
11392946|NCT03630679|12586727|FG001|COMPLETED|Overall Study||13
11392947|NCT03630679|12586726|FG000|NOT COMPLETED|Overall Study||7
11392948|NCT03630679|12586727|FG001|NOT COMPLETED|Overall Study||12
11392949|NCT03631355|12586735|FG000|STARTED|Overall Study||55
11392950|NCT03631355|12586736|FG001|STARTED|Overall Study||55
11392951|NCT03631355|12586735|FG000|COMPLETED|Overall Study||54
11392952|NCT03631355|12586736|FG001|COMPLETED|Overall Study||53
11392953|NCT03631355|12586735|FG000|NOT COMPLETED|Overall Study||1
11392954|NCT03631355|12586736|FG001|NOT COMPLETED|Overall Study||2
11392955|NCT03631433|12586744|FG000|STARTED|Overall Study||49
11392956|NCT03631433|12586745|FG001|STARTED|Overall Study||53
11392957|NCT03631433|12586744|FG000|COMPLETED|Overall Study||49
11392958|NCT03631433|12586745|FG001|COMPLETED|Overall Study||53
11392959|NCT03631433|12586744|FG000|NOT COMPLETED|Overall Study||0
11392960|NCT03631433|12586745|FG001|NOT COMPLETED|Overall Study||0
11392961|NCT03631732|12586753|FG000|STARTED|Randomized Phase Up to Week 24||331
11392962|NCT03631732|12586754|FG001|STARTED|Randomized Phase Up to Week 24||165
11392963|NCT03631732|12586753|FG000|COMPLETED|Randomized Phase Up to Week 24||324
11392964|NCT03631732|12586754|FG001|COMPLETED|Randomized Phase Up to Week 24||163
11392965|NCT03631732|12586753|FG000|NOT COMPLETED|Randomized Phase Up to Week 24||7
11392966|NCT03631732|12586754|FG001|NOT COMPLETED|Randomized Phase Up to Week 24||2
11392967|NCT03631732|12586753|FG000|STARTED|B/F/TAF Treatment Phase (After Week 24)|5 participants completed 24 weeks of the study, but did not receive study treatment after Week 24.|319
11392968|NCT03631732|12586754|FG001|STARTED|B/F/TAF Treatment Phase (After Week 24)||163
11392969|NCT03631732|12586753|FG000|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||303
11392970|NCT03631732|12586754|FG001|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||158
11392971|NCT03631732|12586753|FG000|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||16
11392972|NCT03631732|12586754|FG001|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||5
11392973|NCT03631927|12586764|FG000|STARTED|Overall Study||5094
11392974|NCT03631927|12586764|FG000|COMPLETED|Overall Study||4669
11392975|NCT03631927|12586764|FG000|NOT COMPLETED|Overall Study||425
11392976|NCT03632083|12586768|FG000|STARTED|First Intervention||5
11392977|NCT03632083|12586769|FG001|STARTED|First Intervention||5
11392978|NCT03632083|12586770|FG002|STARTED|First Intervention||7
11392979|NCT03632083|12586771|FG003|STARTED|First Intervention||7
11392980|NCT03632083|12586772|FG004|STARTED|First Intervention||9
11392981|NCT03632083|12586773|FG005|STARTED|First Intervention||9
11392982|NCT03632083|12586774|FG006|STARTED|First Intervention||7
11392983|NCT03632083|12586775|FG007|STARTED|First Intervention||7
11392984|NCT03632083|12586768|FG000|COMPLETED|First Intervention||5
11392985|NCT03632083|12586769|FG001|COMPLETED|First Intervention||5
11392986|NCT03632083|12586770|FG002|COMPLETED|First Intervention||7
11392987|NCT03632083|12586771|FG003|COMPLETED|First Intervention||7
11392988|NCT03632083|12586772|FG004|COMPLETED|First Intervention||9
11392989|NCT03632083|12586773|FG005|COMPLETED|First Intervention||9
11392990|NCT03632083|12586774|FG006|COMPLETED|First Intervention||7
11392991|NCT03632083|12586775|FG007|COMPLETED|First Intervention||7
11392992|NCT03632083|12586768|FG000|NOT COMPLETED|First Intervention||0
11392993|NCT03632083|12586769|FG001|NOT COMPLETED|First Intervention||0
11006187|NCT00727194|12183968|FG000|STARTED|Screening Period||7
11006188|NCT00727194|12183969|FG001|STARTED|Screening Period||7
11006189|NCT00727194|12183970|FG002|STARTED|Screening Period||16
11006190|NCT00727194|12183968|FG000|COMPLETED|Screening Period||7
11006191|NCT00727194|12183969|FG001|COMPLETED|Screening Period||7
11006192|NCT00727194|12183970|FG002|COMPLETED|Screening Period||0
11006193|NCT00727194|12183968|FG000|NOT COMPLETED|Screening Period||0
11006194|NCT00727194|12183969|FG001|NOT COMPLETED|Screening Period||0
11006195|NCT00727194|12183970|FG002|NOT COMPLETED|Screening Period||16
11392994|NCT03632083|12586770|FG002|NOT COMPLETED|First Intervention||0
11392995|NCT03632083|12586771|FG003|NOT COMPLETED|First Intervention||0
11392996|NCT03632083|12586772|FG004|NOT COMPLETED|First Intervention||0
11392997|NCT03632083|12586773|FG005|NOT COMPLETED|First Intervention||0
11392998|NCT03632083|12586774|FG006|NOT COMPLETED|First Intervention||0
11392999|NCT03632083|12586775|FG007|NOT COMPLETED|First Intervention||0
11393000|NCT03632083|12586768|FG000|STARTED|Second Intervention||5
11393001|NCT03632083|12586769|FG001|STARTED|Second Intervention||5
11393002|NCT03632083|12586770|FG002|STARTED|Second Intervention||7
11393003|NCT03632083|12586771|FG003|STARTED|Second Intervention||7
11393004|NCT03632083|12586772|FG004|STARTED|Second Intervention||9
11393005|NCT03632083|12586773|FG005|STARTED|Second Intervention||9
11393006|NCT03632083|12586774|FG006|STARTED|Second Intervention||7
11393007|NCT03632083|12586775|FG007|STARTED|Second Intervention||7
11393008|NCT03632083|12586768|FG000|COMPLETED|Second Intervention||5
11393009|NCT03632083|12586769|FG001|COMPLETED|Second Intervention||5
11393010|NCT03632083|12586770|FG002|COMPLETED|Second Intervention||7
11393011|NCT03632083|12586771|FG003|COMPLETED|Second Intervention||7
11393012|NCT03632083|12586772|FG004|COMPLETED|Second Intervention||9
11393013|NCT03632083|12586773|FG005|COMPLETED|Second Intervention||9
11393014|NCT03632083|12586774|FG006|COMPLETED|Second Intervention||7
11393015|NCT03632083|12586775|FG007|COMPLETED|Second Intervention||5
11393016|NCT03632083|12586768|FG000|NOT COMPLETED|Second Intervention||0
11393017|NCT03632083|12586769|FG001|NOT COMPLETED|Second Intervention||0
11393018|NCT03632083|12586770|FG002|NOT COMPLETED|Second Intervention||0
11393019|NCT03632083|12586771|FG003|NOT COMPLETED|Second Intervention||0
11393020|NCT03632083|12586772|FG004|NOT COMPLETED|Second Intervention||0
11393021|NCT03632083|12586773|FG005|NOT COMPLETED|Second Intervention||0
11393022|NCT03632083|12586774|FG006|NOT COMPLETED|Second Intervention||0
11393023|NCT03632083|12586775|FG007|NOT COMPLETED|Second Intervention||2
11393024|NCT03632109|12586787|FG000|STARTED|Overall Study||13
11393025|NCT03632109|12586787|FG000|COMPLETED|Overall Study||13
11393026|NCT03632109|12586787|FG000|NOT COMPLETED|Overall Study||0
11393027|NCT03632954|12586793|FG000|STARTED|Overall Study||37
11393028|NCT03632954|12586793|FG000|COMPLETED|Overall Study||3
11393029|NCT03632954|12586793|FG000|NOT COMPLETED|Overall Study||34
11393030|NCT03633084|12586800|FG000|STARTED|Overall Study||3
11393031|NCT03633084|12586801|FG001|STARTED|Overall Study||3
11393032|NCT03633084|12586802|FG002|STARTED|Overall Study||3
11393033|NCT03633084|12586800|FG000|COMPLETED|Overall Study||3
11393034|NCT03633084|12586801|FG001|COMPLETED|Overall Study||3
11393035|NCT03633084|12586802|FG002|COMPLETED|Overall Study||3
11393036|NCT03633084|12586800|FG000|NOT COMPLETED|Overall Study||0
11393037|NCT03633084|12586801|FG001|NOT COMPLETED|Overall Study||0
11393038|NCT03633084|12586802|FG002|NOT COMPLETED|Overall Study||0
11006196|NCT00727194|12183968|FG000|STARTED|Treatment Period 1||7
11006197|NCT00727194|12183969|FG001|STARTED|Treatment Period 1||7
11006198|NCT00727194|12183970|FG002|STARTED|Treatment Period 1||0
11006199|NCT00727194|12183968|FG000|COMPLETED|Treatment Period 1||7
11006200|NCT00727194|12183969|FG001|COMPLETED|Treatment Period 1||7
11006201|NCT00727194|12183970|FG002|COMPLETED|Treatment Period 1||0
11393039|NCT03633331|12586811|FG000|STARTED|Overall Study||93
11393040|NCT03633331|12586811|FG000|COMPLETED|Overall Study||92
11393041|NCT03633331|12586811|FG000|NOT COMPLETED|Overall Study||1
11393042|NCT03633344|12586817|FG000|STARTED|Overall Study||120
11393043|NCT03633344|12586818|FG001|STARTED|Overall Study||24
11393044|NCT03633344|12586817|FG000|COMPLETED|Overall Study||120
11393045|NCT03633344|12586818|FG001|COMPLETED|Overall Study||24
11393046|NCT03633344|12586817|FG000|NOT COMPLETED|Overall Study||0
11393047|NCT03633344|12586818|FG001|NOT COMPLETED|Overall Study||0
11393048|NCT03633448|12586828|FG000|STARTED|Period 1 (1 Day)||12
11393049|NCT03633448|12586829|FG001|STARTED|Period 1 (1 Day)||12
11393050|NCT03633448|12586828|FG000|COMPLETED|Period 1 (1 Day)||12
11393051|NCT03633448|12586829|FG001|COMPLETED|Period 1 (1 Day)||12
11393052|NCT03633448|12586828|FG000|NOT COMPLETED|Period 1 (1 Day)||0
11393053|NCT03633448|12586829|FG001|NOT COMPLETED|Period 1 (1 Day)||0
11393054|NCT03633448|12586828|FG000|STARTED|Washout (7 Days)||12
11393055|NCT03633448|12586829|FG001|STARTED|Washout (7 Days)||12
11393056|NCT03633448|12586828|FG000|COMPLETED|Washout (7 Days)||12
11393057|NCT03633448|12586829|FG001|COMPLETED|Washout (7 Days)||12
11393058|NCT03633448|12586828|FG000|NOT COMPLETED|Washout (7 Days)||0
11393059|NCT03633448|12586829|FG001|NOT COMPLETED|Washout (7 Days)||0
11393060|NCT03633448|12586828|FG000|STARTED|Period 2 (1 Day)||12
11393061|NCT03633448|12586829|FG001|STARTED|Period 2 (1 Day)||12
11393062|NCT03633448|12586828|FG000|COMPLETED|Period 2 (1 Day)||12
11393063|NCT03633448|12586829|FG001|COMPLETED|Period 2 (1 Day)||12
11393064|NCT03633448|12586828|FG000|NOT COMPLETED|Period 2 (1 Day)||0
11393065|NCT03633448|12586829|FG001|NOT COMPLETED|Period 2 (1 Day)||0
11393066|NCT03633487|12586839|FG000|STARTED|Overall Study||24
11393067|NCT03633487|12586839|FG000|COMPLETED|Overall Study||24
11393068|NCT03633487|12586839|FG000|NOT COMPLETED|Overall Study||0
11393069|NCT03633526|12586843|FG000|STARTED|Overall Study||16
11393070|NCT03633526|12586843|FG000|COMPLETED|Overall Study||16
11393071|NCT03633526|12586843|FG000|NOT COMPLETED|Overall Study||0
11393072|NCT03633825|12586849|FG000|STARTED|Enrollment||19838
11393073|NCT03633825|12586850|FG001|STARTED|Enrollment||19612
11393074|NCT03633825|12586849|FG000|COMPLETED|Enrollment||805
11393075|NCT03633825|12586850|FG001|COMPLETED|Enrollment||775
11393076|NCT03633825|12586849|FG000|NOT COMPLETED|Enrollment||19033
11393077|NCT03633825|12586850|FG001|NOT COMPLETED|Enrollment||18837
11393078|NCT03633825|12586849|FG000|STARTED|Allocation||805
11393079|NCT03633825|12586850|FG001|STARTED|Allocation||775
11393080|NCT03633825|12586849|FG000|COMPLETED|Allocation||805
11393081|NCT03633825|12586850|FG001|COMPLETED|Allocation||775
11393082|NCT03633825|12586849|FG000|NOT COMPLETED|Allocation||0
11393083|NCT03633825|12586850|FG001|NOT COMPLETED|Allocation||0
11393084|NCT03633825|12586849|FG000|STARTED|Follow up||805
11393085|NCT03633825|12586850|FG001|STARTED|Follow up||775
11393086|NCT03633825|12586849|FG000|COMPLETED|Follow up||327
11393087|NCT03633825|12586850|FG001|COMPLETED|Follow up||325
11393088|NCT03633825|12586849|FG000|NOT COMPLETED|Follow up||478
11393089|NCT03633825|12586850|FG001|NOT COMPLETED|Follow up||450
11393090|NCT03633825|12586849|FG000|STARTED|Analysis||327
11393091|NCT03633825|12586850|FG001|STARTED|Analysis||325
11393092|NCT03633825|12586849|FG000|COMPLETED|Analysis||327
11393093|NCT03633825|12586850|FG001|COMPLETED|Analysis||325
11393094|NCT03633825|12586849|FG000|NOT COMPLETED|Analysis||0
11393095|NCT03633825|12586850|FG001|NOT COMPLETED|Analysis||0
11393096|NCT03633903|12586858|FG000|STARTED|Overall Study||22
11393097|NCT03633903|12586859|FG001|STARTED|Overall Study||18
11393098|NCT03633903|12586858|FG000|Intent to Treat|Overall Study||0
11393099|NCT03633903|12586859|FG001|Intent to Treat|Overall Study||18
11393100|NCT03633903|12586858|FG000|COMPLETED|Overall Study||16
11393101|NCT03633903|12586859|FG001|COMPLETED|Overall Study||11
11393102|NCT03633903|12586858|FG000|NOT COMPLETED|Overall Study||6
11393103|NCT03633903|12586859|FG001|NOT COMPLETED|Overall Study||7
11142137|NCT01466595|12328864|FG000|STARTED|Overall Study||49
11142138|NCT01466595|12328865|FG001|STARTED|Overall Study||24
11142139|NCT01466595|12328864|FG000|COMPLETED|Overall Study||49
11142140|NCT01466595|12328865|FG001|COMPLETED|Overall Study||23
11142141|NCT01466595|12328864|FG000|NOT COMPLETED|Overall Study||0
11142142|NCT01466595|12328865|FG001|NOT COMPLETED|Overall Study||1
11142143|NCT01466660|12328873|FG000|STARTED|Overall Study||160
11142144|NCT01466660|12328874|FG001|STARTED|Overall Study||159
11142145|NCT01466660|12328873|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
11142146|NCT01466660|12328874|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
11142147|NCT01466660|12328873|FG000|NOT COMPLETED|Overall Study||160
11142148|NCT01466660|12328874|FG001|NOT COMPLETED|Overall Study||159
11142149|NCT01466673|12328882|FG000|STARTED|Overall Study||100
11142150|NCT01466673|12328883|FG001|STARTED|Overall Study||101
11393104|NCT03633929|12586865|FG000|STARTED|Overall Study||19
11393105|NCT03633929|12586865|FG000|COMPLETED|Overall Study||15
11393106|NCT03633929|12586865|FG000|NOT COMPLETED|Overall Study||4
11393107|NCT03634085|12586871|FG000|STARTED|Overall Study||8
11142151|NCT01466673|12328882|FG000|COMPLETED|Overall Study||93
11142152|NCT01466673|12328883|FG001|COMPLETED|Overall Study||95
11393108|NCT03634085|12586872|FG001|STARTED|Overall Study||8
11393109|NCT03634085|12586871|FG000|Period 1|Overall Study|8 subjects started BDM2-50 mg and 8 subjects completed BDM2-50 mg including matching placebo.|8
11393110|NCT03634085|12586872|FG001|Period 1|Overall Study|8 subjects started BDM2 - 150mg and 8 subjects completed BDM2 - 150 mg including matching placebo|8
11393111|NCT03634085|12586871|FG000|Period 2|Overall Study|8 subjects started BDM2 - 450 mg and 7 subjects completed BDM2 - 450 mg (drop out; 1 active)|8
11393112|NCT03634085|12586872|FG001|Period 2|Overall Study|8 subjects started BDM2 - 900 mg fasted and 8 subjects completed BDM2 - 900 mg fasted|8
11393113|NCT03634085|12586871|FG000|Period 3|Overall Study|8 subjects started BDM2 - 1800 mg and 7 subjects completed BDM2 - 1800 mg (drop out; 1 active)|8
11393114|NCT03634085|12586872|FG001|Period 3|Overall Study|8 subjects started and 6 subjects completed BDM2 - 900 mg fed (dropout; 1 active 1 placebo)|8
11393115|NCT03634085|12586871|FG000|Period 4|Overall Study|8 subjects started BDM2 - 3100 mg and 7 subjects completed BDM2 - 3100 mg (drop out; 1 active)|8
11393116|NCT03634085|12586872|FG001|Period 4|Overall Study|this period is not applicable for Cohort B|0
11393117|NCT03634085|12586871|FG000|COMPLETED|Overall Study|1 subject dropped out due to car accident|7
11393118|NCT03634085|12586872|FG001|COMPLETED|Overall Study|"1 subject dropped out due to personal emergency~1 subject dropped out due to personal circumstances"|6
11393119|NCT03634085|12586871|FG000|NOT COMPLETED|Overall Study||1
11393120|NCT03634085|12586872|FG001|NOT COMPLETED|Overall Study||2
11393121|NCT03634306|12586888|FG000|STARTED|Overall Study||15
11393122|NCT03634306|12586889|FG001|STARTED|Overall Study||15
11393123|NCT03634306|12586890|FG002|STARTED|Overall Study||5
11393124|NCT03634306|12586888|FG000|COMPLETED|Overall Study||15
11393125|NCT03634306|12586889|FG001|COMPLETED|Overall Study||15
11393126|NCT03634306|12586890|FG002|COMPLETED|Overall Study||5
11393127|NCT03634306|12586888|FG000|NOT COMPLETED|Overall Study||0
11393128|NCT03634306|12586889|FG001|NOT COMPLETED|Overall Study||0
11393129|NCT03634306|12586890|FG002|NOT COMPLETED|Overall Study||0
11393130|NCT03634579|12586898|FG000|STARTED|Overall Study||9
11393131|NCT03634579|12586898|FG000|COMPLETED|Overall Study||0
11393132|NCT03634579|12586898|FG000|NOT COMPLETED|Overall Study||9
11393133|NCT03634800|12586902|FG000|STARTED|Overall Study||6
11393134|NCT03634800|12586902|FG000|COMPLETED|Overall Study||0
11393135|NCT03634800|12586902|FG000|NOT COMPLETED|Overall Study||6
11393136|NCT03634813|12586908|FG000|STARTED|Overall Study||49
11393137|NCT03634813|12586909|FG001|STARTED|Overall Study||51
11393138|NCT03634813|12586908|FG000|COMPLETED|Overall Study||49
11393139|NCT03634813|12586909|FG001|COMPLETED|Overall Study||51
11393140|NCT03634813|12586908|FG000|NOT COMPLETED|Overall Study||0
11393141|NCT03634813|12586909|FG001|NOT COMPLETED|Overall Study||0
11393142|NCT03635086|12586921|FG000|STARTED|Overall Study||12
11393143|NCT03635086|12586922|FG001|STARTED|Overall Study||12
11393144|NCT03635086|12586923|FG002|STARTED|Overall Study||12
11393145|NCT03635086|12586924|FG003|STARTED|Overall Study||12
11393146|NCT03635086|12586925|FG004|STARTED|Overall Study||12
11393147|NCT03635086|12586921|FG000|COMPLETED|Overall Study||11
11393148|NCT03635086|12586922|FG001|COMPLETED|Overall Study||11
11393149|NCT03635086|12586923|FG002|COMPLETED|Overall Study||11
11393150|NCT03635086|12586924|FG003|COMPLETED|Overall Study||12
11393151|NCT03635086|12586925|FG004|COMPLETED|Overall Study||12
11393152|NCT03635086|12586921|FG000|NOT COMPLETED|Overall Study||1
11393153|NCT03635086|12586922|FG001|NOT COMPLETED|Overall Study||1
11393154|NCT03635086|12586923|FG002|NOT COMPLETED|Overall Study||1
11393155|NCT03635086|12586924|FG003|NOT COMPLETED|Overall Study||0
11393156|NCT03635086|12586925|FG004|NOT COMPLETED|Overall Study||0
11393157|NCT03635320|12586940|FG000|STARTED|Overall Study||94
11393158|NCT03635320|12586941|FG001|STARTED|Overall Study||94
11393159|NCT03635320|12586940|FG000|FAS|Overall Study|1 subject was not implanted the device|93
11393160|NCT03635320|12586941|FG001|FAS|Overall Study|2 subjects were not implant the device|92
11393161|NCT03635320|12586940|FG000|PPS|Overall Study|11 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject had a risk of unblinding, which was excluded from the PPS.|81
11393162|NCT03635320|12586941|FG001|PPS|Overall Study|6 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject didn't undergo the evaluation or laboratory examination required by the clinical trial, 1 subject violated the inclusion/exclusion criteria and 1 subject used the device beyond the scope of the specifications, which were excluded from the PPS.|83
11393163|NCT03635320|12586940|FG000|COMPLETED|Overall Study||82
11393164|NCT03635320|12586941|FG001|COMPLETED|Overall Study||86
11006202|NCT00727194|12183968|FG000|NOT COMPLETED|Treatment Period 1||0
11006203|NCT00727194|12183969|FG001|NOT COMPLETED|Treatment Period 1||0
11006204|NCT00727194|12183970|FG002|NOT COMPLETED|Treatment Period 1||0
11006205|NCT00727194|12183968|FG000|STARTED|Washout Period||7
11006206|NCT00727194|12183969|FG001|STARTED|Washout Period||7
11006207|NCT00727194|12183970|FG002|STARTED|Washout Period||0
11006208|NCT00727194|12183968|FG000|COMPLETED|Washout Period||7
11393165|NCT03635320|12586940|FG000|NOT COMPLETED|Overall Study||12
11006209|NCT00727194|12183969|FG001|COMPLETED|Washout Period||7
11393166|NCT03635320|12586941|FG001|NOT COMPLETED|Overall Study||8
11393167|NCT03635775|12586951|FG000|STARTED|Overall Study||5
11393168|NCT03635775|12586952|FG001|STARTED|Overall Study||0
11393169|NCT03635775|12586953|FG002|STARTED|Overall Study||5
11393170|NCT03635775|12586954|FG003|STARTED|Overall Study||10
11393171|NCT03635775|12586951|FG000|COMPLETED|Overall Study||5
11393172|NCT03635775|12586952|FG001|COMPLETED|Overall Study||0
11393173|NCT03635775|12586953|FG002|COMPLETED|Overall Study||5
11393174|NCT03635775|12586954|FG003|COMPLETED|Overall Study||9
11393175|NCT03635775|12586951|FG000|NOT COMPLETED|Overall Study||0
11393176|NCT03635775|12586952|FG001|NOT COMPLETED|Overall Study||0
11393177|NCT03635775|12586953|FG002|NOT COMPLETED|Overall Study||0
11393178|NCT03635775|12586954|FG003|NOT COMPLETED|Overall Study||1
11393179|NCT03635957|12586964|FG000|STARTED|Run-In Period||15
11393180|NCT03635957|12586964|FG000|COMPLETED|Run-In Period||14
11393181|NCT03635957|12586964|FG000|NOT COMPLETED|Run-In Period||1
11393182|NCT03635957|12586964|FG000|STARTED|Pegloticase + IMM Period||14
11393183|NCT03635957|12586964|FG000|Completed Study at 24 Weeks-Amendment 1|Pegloticase + IMM Period||1
11393184|NCT03635957|12586964|FG000|Completed Study at 52 Weeks-Amendment 2|Pegloticase + IMM Period||10
11393185|NCT03635957|12586964|FG000|Discontinued Study Treatment Early|Pegloticase + IMM Period||5
11393186|NCT03635957|12586964|FG000|Had 3-Month Follow-up|Pegloticase + IMM Period||7
11393187|NCT03635957|12586964|FG000|Had 6-Month Follow-up|Pegloticase + IMM Period||6
11393188|NCT03635957|12586964|FG000|COMPLETED|Pegloticase + IMM Period||11
11393189|NCT03635957|12586964|FG000|NOT COMPLETED|Pegloticase + IMM Period||3
11393190|NCT03636061|12586973|FG000|STARTED|Overall Study||47
11393191|NCT03636061|12586974|FG001|STARTED|Overall Study||48
11393192|NCT03636061|12586975|FG002|STARTED|Overall Study||44
11393193|NCT03636061|12586976|FG003|STARTED|Overall Study||43
11393194|NCT03636061|12586973|FG000|COMPLETED|Overall Study||47
11393195|NCT03636061|12586974|FG001|COMPLETED|Overall Study||46
11393196|NCT03636061|12586975|FG002|COMPLETED|Overall Study||40
11393197|NCT03636061|12586976|FG003|COMPLETED|Overall Study||43
11393198|NCT03636061|12586973|FG000|NOT COMPLETED|Overall Study||0
11393199|NCT03636061|12586974|FG001|NOT COMPLETED|Overall Study||2
11393200|NCT03636061|12586975|FG002|NOT COMPLETED|Overall Study||4
11393201|NCT03636061|12586976|FG003|NOT COMPLETED|Overall Study||0
11393202|NCT03636386|12586991|FG000|STARTED|Overall Study||24
11393203|NCT03636386|12586992|FG001|STARTED|Overall Study||24
11393204|NCT03636386|12586991|FG000|COMPLETED|Overall Study||24
11393205|NCT03636386|12586992|FG001|COMPLETED|Overall Study||24
11393206|NCT03636386|12586991|FG000|NOT COMPLETED|Overall Study||0
11393207|NCT03636386|12586992|FG001|NOT COMPLETED|Overall Study||0
11393208|NCT03636893|12587000|FG000|STARTED|Overall Study||40
11393209|NCT03636893|12587001|FG001|STARTED|Overall Study||34
11393210|NCT03636893|12587000|FG000|COMPLETED|Overall Study||31
11393211|NCT03636893|12587001|FG001|COMPLETED|Overall Study||24
11393212|NCT03636893|12587000|FG000|NOT COMPLETED|Overall Study||9
11393213|NCT03636893|12587001|FG001|NOT COMPLETED|Overall Study||10
11393214|NCT03637296|12587009|FG000|STARTED|Overall Study||10
11393215|NCT03637296|12587010|FG001|STARTED|Overall Study||5
11393216|NCT03637296|12587009|FG000|COMPLETED|Overall Study||10
11393217|NCT03637296|12587010|FG001|COMPLETED|Overall Study||5
11393218|NCT03637296|12587009|FG000|NOT COMPLETED|Overall Study||0
11393219|NCT03637296|12587010|FG001|NOT COMPLETED|Overall Study||0
11393220|NCT03637348|12587016|FG000|STARTED|Overall Study||45
11393221|NCT03637348|12587016|FG000|COMPLETED|Overall Study||45
11393222|NCT03637348|12587016|FG000|NOT COMPLETED|Overall Study||0
11393223|NCT03637517|12587024|FG000|STARTED|Overall Study||14
11393224|NCT03637517|12587025|FG001|STARTED|Overall Study||14
11393225|NCT03637517|12587026|FG002|STARTED|Overall Study||14
11393226|NCT03637517|12587024|FG000|COMPLETED|Overall Study||14
11393227|NCT03637517|12587025|FG001|COMPLETED|Overall Study||14
11393228|NCT03637517|12587026|FG002|COMPLETED|Overall Study||14
11393229|NCT03637517|12587024|FG000|NOT COMPLETED|Overall Study||0
11393230|NCT03637517|12587025|FG001|NOT COMPLETED|Overall Study||0
11393231|NCT03637517|12587026|FG002|NOT COMPLETED|Overall Study||0
11393232|NCT03637699|12587036|FG000|STARTED|Overall Study||15
11393233|NCT03637699|12587037|FG001|STARTED|Overall Study||15
11393234|NCT03637699|12587036|FG000|COMPLETED|Overall Study||14
11393235|NCT03637699|12587037|FG001|COMPLETED|Overall Study||14
11393236|NCT03637699|12587036|FG000|NOT COMPLETED|Overall Study||1
11393237|NCT03637699|12587037|FG001|NOT COMPLETED|Overall Study||1
11393238|NCT03637842|12587046|FG000|STARTED|Overall Study||2
11393239|NCT03637842|12587047|FG001|STARTED|Overall Study||2
11393240|NCT03637842|12587046|FG000|COMPLETED|Overall Study||2
11393241|NCT03637842|12587047|FG001|COMPLETED|Overall Study||2
11393242|NCT03637842|12587046|FG000|NOT COMPLETED|Overall Study||0
11393243|NCT03637842|12587047|FG001|NOT COMPLETED|Overall Study||0
11393244|NCT03638323|12587055|FG000|STARTED|Overall Study||38
11393245|NCT03638323|12587055|FG000|COMPLETED|Overall Study||37
11393246|NCT03638323|12587055|FG000|NOT COMPLETED|Overall Study||1
11393247|NCT03638622|12587062|FG000|STARTED|Overall Study||30
11393248|NCT03638622|12587062|FG000|COMPLETED|Overall Study||29
11393249|NCT03638622|12587062|FG000|NOT COMPLETED|Overall Study||1
11393250|NCT03638635|12587068|FG000|STARTED|Initial Hospitalization||39
11393251|NCT03638635|12587069|FG001|STARTED|Initial Hospitalization||24
11393252|NCT03638635|12587068|FG000|COMPLETED|Initial Hospitalization||39
11393253|NCT03638635|12587069|FG001|COMPLETED|Initial Hospitalization||22
11393254|NCT03638635|12587068|FG000|NOT COMPLETED|Initial Hospitalization||0
11393255|NCT03638635|12587069|FG001|NOT COMPLETED|Initial Hospitalization||2
11393256|NCT03638635|12587068|FG000|STARTED|Follow-Up (30 Days After Discharge)||39
11393257|NCT03638635|12587069|FG001|STARTED|Follow-Up (30 Days After Discharge)||22
11393258|NCT03638635|12587068|FG000|COMPLETED|Follow-Up (30 Days After Discharge)||0
11393259|NCT03638635|12587069|FG001|COMPLETED|Follow-Up (30 Days After Discharge)||0
11393260|NCT03638635|12587068|FG000|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39
11393261|NCT03638635|12587069|FG001|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22
11393262|NCT03638908|12587075|FG000|STARTED|Overall Study||8
11393263|NCT03638908|12587075|FG000|COMPLETED|Overall Study||7
11393264|NCT03638908|12587075|FG000|NOT COMPLETED|Overall Study||1
11393265|NCT03639675|12587083|FG000|STARTED|Overall Study||16
11393266|NCT03639675|12587083|FG000|Received Treatment|Overall Study||16
11393267|NCT03639675|12587083|FG000|COMPLETED|Overall Study||15
11393268|NCT03639675|12587083|FG000|NOT COMPLETED|Overall Study||1
11393269|NCT03639766|12587087|FG000|STARTED|Overall Study||3
11393270|NCT03639766|12587087|FG000|COMPLETED|Overall Study||3
11393271|NCT03639766|12587087|FG000|NOT COMPLETED|Overall Study||0
11393272|NCT03639779|12587093|FG000|STARTED|Overall Study||5
11393273|NCT03639779|12587093|FG000|Baseline|Overall Study||5
11393274|NCT03639779|12587093|FG000|Month 1|Overall Study||5
11393275|NCT03639779|12587093|FG000|Month 2|Overall Study||4
11393276|NCT03639779|12587093|FG000|Month 3|Overall Study||4
11393277|NCT03639779|12587093|FG000|COMPLETED|Overall Study||4
11393278|NCT03639779|12587093|FG000|NOT COMPLETED|Overall Study||1
11393279|NCT03639857|12587099|FG000|STARTED|Overall Study||1
11393280|NCT03639857|12587100|FG001|STARTED|Overall Study||3
11393281|NCT03639857|12587101|FG002|STARTED|Overall Study||3
11393282|NCT03639857|12587099|FG000|COMPLETED|Overall Study||1
11393283|NCT03639857|12587100|FG001|COMPLETED|Overall Study||3
11393284|NCT03639857|12587101|FG002|COMPLETED|Overall Study||3
11393285|NCT03639857|12587099|FG000|NOT COMPLETED|Overall Study||0
11393286|NCT03639857|12587100|FG001|NOT COMPLETED|Overall Study||0
11393287|NCT03639857|12587101|FG002|NOT COMPLETED|Overall Study||0
11393288|NCT03639987|12587111|FG000|STARTED|Overall Study||26
11393289|NCT03639987|12587112|FG001|STARTED|Overall Study||26
11393290|NCT03639987|12587111|FG000|COMPLETED|Overall Study||0
11393291|NCT03639987|12587112|FG001|COMPLETED|Overall Study||0
11393292|NCT03639987|12587111|FG000|NOT COMPLETED|Overall Study||26
11393293|NCT03639987|12587112|FG001|NOT COMPLETED|Overall Study||26
11393294|NCT03640052|12587118|FG000|STARTED|Overall Study||2
11393295|NCT03640052|12587119|FG001|STARTED|Overall Study||1
11393296|NCT03640052|12587120|FG002|STARTED|Overall Study||1
11393297|NCT03640052|12587121|FG003|STARTED|Overall Study||1
11393298|NCT03640052|12587122|FG004|STARTED|Overall Study||1
11393299|NCT03640052|12587118|FG000|COMPLETED|Overall Study||2
11393300|NCT03640052|12587119|FG001|COMPLETED|Overall Study|the patient performed 4 out of 5 nights|0
11393301|NCT03640052|12587120|FG002|COMPLETED|Overall Study||1
11393302|NCT03640052|12587121|FG003|COMPLETED|Overall Study||1
11393303|NCT03640052|12587122|FG004|COMPLETED|Overall Study||1
11393304|NCT03640052|12587118|FG000|NOT COMPLETED|Overall Study||0
11393305|NCT03640052|12587119|FG001|NOT COMPLETED|Overall Study||1
11393306|NCT03640052|12587120|FG002|NOT COMPLETED|Overall Study||0
11393307|NCT03640052|12587121|FG003|NOT COMPLETED|Overall Study||0
11393308|NCT03640052|12587122|FG004|NOT COMPLETED|Overall Study||0
11393309|NCT03640507|12587137|FG000|STARTED|Overall Study||10
11393310|NCT03640507|12587138|FG001|STARTED|Overall Study||9
11393311|NCT03640507|12587139|FG002|STARTED|Overall Study||11
11393312|NCT03640507|12587137|FG000|COMPLETED|Overall Study||10
11393313|NCT03640507|12587138|FG001|COMPLETED|Overall Study||9
11393314|NCT03640507|12587139|FG002|COMPLETED|Overall Study||10
11393315|NCT03640507|12587137|FG000|NOT COMPLETED|Overall Study||0
11393316|NCT03640507|12587138|FG001|NOT COMPLETED|Overall Study||0
11393317|NCT03640507|12587139|FG002|NOT COMPLETED|Overall Study||1
11393318|NCT03640559|12587149|FG000|STARTED|Overall Study||25
11393319|NCT03640559|12587150|FG001|STARTED|Overall Study||25
11393320|NCT03640559|12587149|FG000|COMPLETED|Overall Study||23
11393321|NCT03640559|12587150|FG001|COMPLETED|Overall Study||24
11393322|NCT03640559|12587149|FG000|NOT COMPLETED|Overall Study||2
11393323|NCT03640559|12587150|FG001|NOT COMPLETED|Overall Study||1
11393324|NCT03640832|12587158|FG000|STARTED|Overall Study||44
11393325|NCT03640832|12587159|FG001|STARTED|Overall Study||46
11393326|NCT03640832|12587158|FG000|COMPLETED|Overall Study||44
11393327|NCT03640832|12587159|FG001|COMPLETED|Overall Study||46
11393328|NCT03640832|12587158|FG000|NOT COMPLETED|Overall Study||0
11393329|NCT03640832|12587159|FG001|NOT COMPLETED|Overall Study||0
11393330|NCT03641508|12587167|FG000|STARTED|First Injection||37
11393331|NCT03641508|12587168|FG001|STARTED|First Injection||32
11393332|NCT03641508|12587167|FG000|COMPLETED|First Injection||35
11393333|NCT03641508|12587168|FG001|COMPLETED|First Injection||32
11393334|NCT03641508|12587167|FG000|NOT COMPLETED|First Injection||2
11393335|NCT03641508|12587168|FG001|NOT COMPLETED|First Injection||0
11393336|NCT03641508|12587167|FG000|STARTED|Follow-up/Second Injection||2
11393337|NCT03641508|12587168|FG001|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
11393338|NCT03641508|12587167|FG000|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2
11393339|NCT03641508|12587168|FG001|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
11393340|NCT03641508|12587167|FG000|NOT COMPLETED|Follow-up/Second Injection||0
11393341|NCT03641508|12587168|FG001|NOT COMPLETED|Follow-up/Second Injection||0
11393342|NCT03641716|12587174|FG000|STARTED|Overall Study||20
11393343|NCT03641716|12587174|FG000|COMPLETED|Overall Study||15
11393344|NCT03641716|12587174|FG000|NOT COMPLETED|Overall Study||5
11393345|NCT03642262|12587178|FG000|STARTED|Period 1||12
11393346|NCT03642262|12587179|FG001|STARTED|Period 1||18
11393347|NCT03642262|12587178|FG000|COMPLETED|Period 1||11
11393348|NCT03642262|12587179|FG001|COMPLETED|Period 1||16
11393349|NCT03642262|12587178|FG000|NOT COMPLETED|Period 1||1
11006210|NCT00727194|12183970|FG002|COMPLETED|Washout Period||0
11006211|NCT00727194|12183968|FG000|NOT COMPLETED|Washout Period||0
11006212|NCT00727194|12183969|FG001|NOT COMPLETED|Washout Period||0
11393350|NCT03642262|12587179|FG001|NOT COMPLETED|Period 1||2
11393351|NCT03642262|12587178|FG000|STARTED|Washout: 7 Days||11
11393352|NCT03642262|12587179|FG001|STARTED|Washout: 7 Days||16
11393353|NCT03642262|12587178|FG000|COMPLETED|Washout: 7 Days||11
11393354|NCT03642262|12587179|FG001|COMPLETED|Washout: 7 Days||16
11393355|NCT03642262|12587178|FG000|NOT COMPLETED|Washout: 7 Days||0
11393356|NCT03642262|12587179|FG001|NOT COMPLETED|Washout: 7 Days||0
11393357|NCT03642262|12587178|FG000|STARTED|Period 2||11
11393358|NCT03642262|12587179|FG001|STARTED|Period 2||16
11393359|NCT03642262|12587178|FG000|COMPLETED|Period 2||11
11393360|NCT03642262|12587179|FG001|COMPLETED|Period 2||16
11393361|NCT03642262|12587178|FG000|NOT COMPLETED|Period 2||0
11393362|NCT03642262|12587179|FG001|NOT COMPLETED|Period 2||0
11393363|NCT03642457|12587188|FG000|STARTED|Overall Study||35
11393364|NCT03642457|12587189|FG001|STARTED|Overall Study||30
11393365|NCT03642457|12587188|FG000|COMPLETED|Overall Study||35
11393366|NCT03642457|12587189|FG001|COMPLETED|Overall Study||30
11393367|NCT03642457|12587188|FG000|NOT COMPLETED|Overall Study||0
11393368|NCT03642457|12587189|FG001|NOT COMPLETED|Overall Study||0
11393369|NCT03642717|12587195|FG000|STARTED|Overall Study||658
11393370|NCT03642717|12587195|FG000|COMPLETED|Overall Study||620
11393371|NCT03642717|12587195|FG000|NOT COMPLETED|Overall Study||38
11393372|NCT03642873|12587200|FG000|STARTED|First Intervention (1 Day)||4
11393373|NCT03642873|12587201|FG001|STARTED|First Intervention (1 Day)||4
11393374|NCT03642873|12587202|FG002|STARTED|First Intervention (1 Day)||4
11393375|NCT03642873|12587203|FG003|STARTED|First Intervention (1 Day)||4
11393376|NCT03642873|12587204|FG004|STARTED|First Intervention (1 Day)||4
11393377|NCT03642873|12587205|FG005|STARTED|First Intervention (1 Day)||4
11393378|NCT03642873|12587200|FG000|COMPLETED|First Intervention (1 Day)||4
11393379|NCT03642873|12587201|FG001|COMPLETED|First Intervention (1 Day)||4
11393380|NCT03642873|12587202|FG002|COMPLETED|First Intervention (1 Day)||4
11393381|NCT03642873|12587203|FG003|COMPLETED|First Intervention (1 Day)||4
11393382|NCT03642873|12587204|FG004|COMPLETED|First Intervention (1 Day)||4
11393383|NCT03642873|12587205|FG005|COMPLETED|First Intervention (1 Day)||4
11393384|NCT03642873|12587200|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11393385|NCT03642873|12587201|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11393386|NCT03642873|12587202|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11393387|NCT03642873|12587203|FG003|NOT COMPLETED|First Intervention (1 Day)||0
11393388|NCT03642873|12587204|FG004|NOT COMPLETED|First Intervention (1 Day)||0
11393389|NCT03642873|12587205|FG005|NOT COMPLETED|First Intervention (1 Day)||0
11393390|NCT03642873|12587200|FG000|STARTED|Washout (7 Days)||4
11393391|NCT03642873|12587201|FG001|STARTED|Washout (7 Days)||4
11393392|NCT03642873|12587202|FG002|STARTED|Washout (7 Days)||4
11393393|NCT03642873|12587203|FG003|STARTED|Washout (7 Days)||4
11393394|NCT03642873|12587204|FG004|STARTED|Washout (7 Days)||4
11393395|NCT03642873|12587205|FG005|STARTED|Washout (7 Days)||4
11393396|NCT03642873|12587200|FG000|COMPLETED|Washout (7 Days)||4
11393397|NCT03642873|12587201|FG001|COMPLETED|Washout (7 Days)||4
11393398|NCT03642873|12587202|FG002|COMPLETED|Washout (7 Days)||4
11393399|NCT03642873|12587203|FG003|COMPLETED|Washout (7 Days)||4
11393400|NCT03642873|12587204|FG004|COMPLETED|Washout (7 Days)||4
11393401|NCT03642873|12587205|FG005|COMPLETED|Washout (7 Days)||4
11393402|NCT03642873|12587200|FG000|NOT COMPLETED|Washout (7 Days)||0
11393403|NCT03642873|12587201|FG001|NOT COMPLETED|Washout (7 Days)||0
11393404|NCT03642873|12587202|FG002|NOT COMPLETED|Washout (7 Days)||0
11393405|NCT03642873|12587203|FG003|NOT COMPLETED|Washout (7 Days)||0
11393406|NCT03642873|12587204|FG004|NOT COMPLETED|Washout (7 Days)||0
11393407|NCT03642873|12587205|FG005|NOT COMPLETED|Washout (7 Days)||0
11393408|NCT03642873|12587200|FG000|STARTED|Second Intervention (1 Day)||4
11393409|NCT03642873|12587201|FG001|STARTED|Second Intervention (1 Day)||4
11393410|NCT03642873|12587202|FG002|STARTED|Second Intervention (1 Day)||4
11393411|NCT03642873|12587203|FG003|STARTED|Second Intervention (1 Day)||4
11393412|NCT03642873|12587204|FG004|STARTED|Second Intervention (1 Day)||4
11393413|NCT03642873|12587205|FG005|STARTED|Second Intervention (1 Day)||4
11393414|NCT03642873|12587200|FG000|COMPLETED|Second Intervention (1 Day)||4
11393415|NCT03642873|12587201|FG001|COMPLETED|Second Intervention (1 Day)||4
11393416|NCT03642873|12587202|FG002|COMPLETED|Second Intervention (1 Day)||4
11393417|NCT03642873|12587203|FG003|COMPLETED|Second Intervention (1 Day)||4
11393418|NCT03642873|12587204|FG004|COMPLETED|Second Intervention (1 Day)||4
11393419|NCT03642873|12587205|FG005|COMPLETED|Second Intervention (1 Day)||4
11393420|NCT03642873|12587200|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11393421|NCT03642873|12587201|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11393422|NCT03642873|12587202|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11393423|NCT03642873|12587203|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
11393424|NCT03642873|12587204|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
11393425|NCT03642873|12587205|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
11393426|NCT03642873|12587200|FG000|STARTED|Washout (7 Days)||4
11393427|NCT03642873|12587201|FG001|STARTED|Washout (7 Days)||4
11393428|NCT03642873|12587202|FG002|STARTED|Washout (7 Days)||4
11393429|NCT03642873|12587203|FG003|STARTED|Washout (7 Days)||4
11393430|NCT03642873|12587204|FG004|STARTED|Washout (7 Days)||4
11393431|NCT03642873|12587205|FG005|STARTED|Washout (7 Days)||4
11393432|NCT03642873|12587200|FG000|COMPLETED|Washout (7 Days)||4
11393433|NCT03642873|12587201|FG001|COMPLETED|Washout (7 Days)||4
11393434|NCT03642873|12587202|FG002|COMPLETED|Washout (7 Days)||4
11393435|NCT03642873|12587203|FG003|COMPLETED|Washout (7 Days)||4
11393436|NCT03642873|12587204|FG004|COMPLETED|Washout (7 Days)||4
11393437|NCT03642873|12587205|FG005|COMPLETED|Washout (7 Days)||4
11393438|NCT03642873|12587200|FG000|NOT COMPLETED|Washout (7 Days)||0
11393439|NCT03642873|12587201|FG001|NOT COMPLETED|Washout (7 Days)||0
11393440|NCT03642873|12587202|FG002|NOT COMPLETED|Washout (7 Days)||0
11393441|NCT03642873|12587203|FG003|NOT COMPLETED|Washout (7 Days)||0
11393442|NCT03642873|12587204|FG004|NOT COMPLETED|Washout (7 Days)||0
11393443|NCT03642873|12587205|FG005|NOT COMPLETED|Washout (7 Days)||0
11393444|NCT03642873|12587200|FG000|STARTED|Third Intervention (1 Day)||4
11393445|NCT03642873|12587201|FG001|STARTED|Third Intervention (1 Day)||4
11393446|NCT03642873|12587202|FG002|STARTED|Third Intervention (1 Day)||4
11393447|NCT03642873|12587203|FG003|STARTED|Third Intervention (1 Day)||4
11393448|NCT03642873|12587204|FG004|STARTED|Third Intervention (1 Day)||4
11393449|NCT03642873|12587205|FG005|STARTED|Third Intervention (1 Day)||4
11393450|NCT03642873|12587200|FG000|COMPLETED|Third Intervention (1 Day)||4
11393451|NCT03642873|12587201|FG001|COMPLETED|Third Intervention (1 Day)||4
11393452|NCT03642873|12587202|FG002|COMPLETED|Third Intervention (1 Day)||4
11393453|NCT03642873|12587203|FG003|COMPLETED|Third Intervention (1 Day)||4
11393454|NCT03642873|12587204|FG004|COMPLETED|Third Intervention (1 Day)||3
11393455|NCT03642873|12587205|FG005|COMPLETED|Third Intervention (1 Day)||4
11393456|NCT03642873|12587200|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11393457|NCT03642873|12587201|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11393458|NCT03642873|12587202|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
11393459|NCT03642873|12587203|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
11393460|NCT03642873|12587204|FG004|NOT COMPLETED|Third Intervention (1 Day)||1
11393461|NCT03642873|12587205|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
11393462|NCT03643432|12587219|FG000|STARTED|Overall Study||27
11393463|NCT03643432|12587220|FG001|STARTED|Overall Study||21
11393464|NCT03643432|12587219|FG000|COMPLETED|Overall Study||26
11393465|NCT03643432|12587220|FG001|COMPLETED|Overall Study||21
11393466|NCT03643432|12587219|FG000|NOT COMPLETED|Overall Study||1
11393467|NCT03643432|12587220|FG001|NOT COMPLETED|Overall Study||0
11393468|NCT03643575|12587226|FG000|STARTED|Period 1||5
11393469|NCT03643575|12587227|FG001|STARTED|Period 1||5
11393470|NCT03643575|12587228|FG002|STARTED|Period 1||5
11393471|NCT03643575|12587229|FG003|STARTED|Period 1||5
11393472|NCT03643575|12587230|FG004|STARTED|Period 1||5
11393473|NCT03643575|12587231|FG005|STARTED|Period 1||5
11393474|NCT03643575|12587226|FG000|COMPLETED|Period 1||5
11393475|NCT03643575|12587227|FG001|COMPLETED|Period 1||5
11393476|NCT03643575|12587228|FG002|COMPLETED|Period 1||5
11393477|NCT03643575|12587229|FG003|COMPLETED|Period 1||5
11393478|NCT03643575|12587230|FG004|COMPLETED|Period 1||5
11393479|NCT03643575|12587231|FG005|COMPLETED|Period 1||5
11393480|NCT03643575|12587226|FG000|NOT COMPLETED|Period 1||0
11393481|NCT03643575|12587227|FG001|NOT COMPLETED|Period 1||0
11393482|NCT03643575|12587228|FG002|NOT COMPLETED|Period 1||0
11393483|NCT03643575|12587229|FG003|NOT COMPLETED|Period 1||0
11393484|NCT03643575|12587230|FG004|NOT COMPLETED|Period 1||0
11393485|NCT03643575|12587231|FG005|NOT COMPLETED|Period 1||0
11393486|NCT03643575|12587226|FG000|STARTED|Washout: 7 Days||5
11393487|NCT03643575|12587227|FG001|STARTED|Washout: 7 Days||5
11393488|NCT03643575|12587228|FG002|STARTED|Washout: 7 Days||5
11393489|NCT03643575|12587229|FG003|STARTED|Washout: 7 Days||5
11393490|NCT03643575|12587230|FG004|STARTED|Washout: 7 Days||5
11393491|NCT03643575|12587231|FG005|STARTED|Washout: 7 Days||5
11393492|NCT03643575|12587226|FG000|COMPLETED|Washout: 7 Days||4
11393493|NCT03643575|12587227|FG001|COMPLETED|Washout: 7 Days||5
11393494|NCT03643575|12587228|FG002|COMPLETED|Washout: 7 Days||5
11393495|NCT03643575|12587229|FG003|COMPLETED|Washout: 7 Days||4
11393496|NCT03643575|12587230|FG004|COMPLETED|Washout: 7 Days||5
11393497|NCT03643575|12587231|FG005|COMPLETED|Washout: 7 Days||5
11393498|NCT03643575|12587226|FG000|NOT COMPLETED|Washout: 7 Days||1
11393499|NCT03643575|12587227|FG001|NOT COMPLETED|Washout: 7 Days||0
11393500|NCT03643575|12587228|FG002|NOT COMPLETED|Washout: 7 Days||0
11393501|NCT03643575|12587229|FG003|NOT COMPLETED|Washout: 7 Days||1
11393502|NCT03643575|12587230|FG004|NOT COMPLETED|Washout: 7 Days||0
11393503|NCT03643575|12587231|FG005|NOT COMPLETED|Washout: 7 Days||0
11393504|NCT03643575|12587226|FG000|STARTED|Period 2||4
11393505|NCT03643575|12587227|FG001|STARTED|Period 2||5
11393506|NCT03643575|12587228|FG002|STARTED|Period 2||5
11393507|NCT03643575|12587229|FG003|STARTED|Period 2||4
11393508|NCT03643575|12587230|FG004|STARTED|Period 2||5
11393509|NCT03643575|12587231|FG005|STARTED|Period 2||5
11393510|NCT03643575|12587226|FG000|COMPLETED|Period 2||4
11393511|NCT03643575|12587227|FG001|COMPLETED|Period 2||5
11393512|NCT03643575|12587228|FG002|COMPLETED|Period 2||5
11393513|NCT03643575|12587229|FG003|COMPLETED|Period 2||4
11393514|NCT03643575|12587230|FG004|COMPLETED|Period 2||5
11393515|NCT03643575|12587231|FG005|COMPLETED|Period 2||5
11393516|NCT03643575|12587226|FG000|NOT COMPLETED|Period 2||0
11393517|NCT03643575|12587227|FG001|NOT COMPLETED|Period 2||0
11393518|NCT03643575|12587228|FG002|NOT COMPLETED|Period 2||0
11393519|NCT03643575|12587229|FG003|NOT COMPLETED|Period 2||0
11393520|NCT03643575|12587230|FG004|NOT COMPLETED|Period 2||0
11393521|NCT03643575|12587231|FG005|NOT COMPLETED|Period 2||0
11393522|NCT03643575|12587226|FG000|STARTED|Washout: 7 Days||4
11393523|NCT03643575|12587227|FG001|STARTED|Washout: 7 Days||5
11393524|NCT03643575|12587228|FG002|STARTED|Washout: 7 Days||5
11393525|NCT03643575|12587229|FG003|STARTED|Washout: 7 Days||4
11393526|NCT03643575|12587230|FG004|STARTED|Washout: 7 Days||5
11393527|NCT03643575|12587231|FG005|STARTED|Washout: 7 Days||5
11393528|NCT03643575|12587226|FG000|COMPLETED|Washout: 7 Days||4
11393529|NCT03643575|12587227|FG001|COMPLETED|Washout: 7 Days||4
11393530|NCT03643575|12587228|FG002|COMPLETED|Washout: 7 Days||5
11393531|NCT03643575|12587229|FG003|COMPLETED|Washout: 7 Days||4
11393532|NCT03643575|12587230|FG004|COMPLETED|Washout: 7 Days||5
11393533|NCT03643575|12587231|FG005|COMPLETED|Washout: 7 Days||5
11393534|NCT03643575|12587226|FG000|NOT COMPLETED|Washout: 7 Days||0
11393535|NCT03643575|12587227|FG001|NOT COMPLETED|Washout: 7 Days||1
11393536|NCT03643575|12587228|FG002|NOT COMPLETED|Washout: 7 Days||0
11393537|NCT03643575|12587229|FG003|NOT COMPLETED|Washout: 7 Days||0
11393538|NCT03643575|12587230|FG004|NOT COMPLETED|Washout: 7 Days||0
11393539|NCT03643575|12587231|FG005|NOT COMPLETED|Washout: 7 Days||0
11393540|NCT03643575|12587226|FG000|STARTED|Period 3||4
11393541|NCT03643575|12587227|FG001|STARTED|Period 3||4
11393542|NCT03643575|12587228|FG002|STARTED|Period 3||5
11393543|NCT03643575|12587229|FG003|STARTED|Period 3||4
11393544|NCT03643575|12587230|FG004|STARTED|Period 3||5
11393545|NCT03643575|12587231|FG005|STARTED|Period 3||5
11393546|NCT03643575|12587226|FG000|COMPLETED|Period 3||4
11393547|NCT03643575|12587227|FG001|COMPLETED|Period 3||4
11393548|NCT03643575|12587228|FG002|COMPLETED|Period 3||5
11393549|NCT03643575|12587229|FG003|COMPLETED|Period 3||4
11393550|NCT03643575|12587230|FG004|COMPLETED|Period 3||5
11393551|NCT03643575|12587231|FG005|COMPLETED|Period 3||5
11393552|NCT03643575|12587226|FG000|NOT COMPLETED|Period 3||0
11393553|NCT03643575|12587227|FG001|NOT COMPLETED|Period 3||0
11393554|NCT03643575|12587228|FG002|NOT COMPLETED|Period 3||0
11393555|NCT03643575|12587229|FG003|NOT COMPLETED|Period 3||0
11393556|NCT03643575|12587230|FG004|NOT COMPLETED|Period 3||0
11393557|NCT03643575|12587231|FG005|NOT COMPLETED|Period 3||0
11393558|NCT03643692|12587239|FG000|STARTED|Overall Study||12
11393559|NCT03643692|12587239|FG000|COMPLETED|Overall Study||12
11393560|NCT03643692|12587239|FG000|NOT COMPLETED|Overall Study||0
11393561|NCT03643952|12587243|FG000|STARTED|Overall Study||18
11393562|NCT03643952|12587243|FG000|COMPLETED|Overall Study||17
11393563|NCT03643952|12587243|FG000|NOT COMPLETED|Overall Study||1
11393564|NCT03644095|12587255|FG000|STARTED|Period 1||15
11393565|NCT03644095|12587256|FG001|STARTED|Period 1||15
11393566|NCT03644095|12587255|FG000|COMPLETED|Period 1||15
11393567|NCT03644095|12587256|FG001|COMPLETED|Period 1||15
11393568|NCT03644095|12587255|FG000|NOT COMPLETED|Period 1||0
11393569|NCT03644095|12587256|FG001|NOT COMPLETED|Period 1||0
11393570|NCT03644095|12587255|FG000|STARTED|Washout (7 Days)||15
11393571|NCT03644095|12587256|FG001|STARTED|Washout (7 Days)||15
11393572|NCT03644095|12587255|FG000|COMPLETED|Washout (7 Days)||15
11393573|NCT03644095|12587256|FG001|COMPLETED|Washout (7 Days)||15
11393574|NCT03644095|12587255|FG000|NOT COMPLETED|Washout (7 Days)||0
11393575|NCT03644095|12587256|FG001|NOT COMPLETED|Washout (7 Days)||0
11393576|NCT03644095|12587255|FG000|STARTED|Period 2||15
11393577|NCT03644095|12587256|FG001|STARTED|Period 2||15
11393578|NCT03644095|12587255|FG000|COMPLETED|Period 2||15
11393579|NCT03644095|12587256|FG001|COMPLETED|Period 2||15
11393580|NCT03644095|12587255|FG000|NOT COMPLETED|Period 2||0
11393581|NCT03644095|12587256|FG001|NOT COMPLETED|Period 2||0
11393582|NCT03644108|12587262|FG000|STARTED|Overall Study||30
11393583|NCT03644108|12587262|FG000|COMPLETED|Overall Study||30
11393584|NCT03644108|12587262|FG000|NOT COMPLETED|Overall Study||0
11393585|NCT03644173|12587266|FG000|STARTED|Participants at Last Visit (Pre-surveys)||37
11393586|NCT03644173|12587266|FG000|COMPLETED|Participants at Last Visit (Pre-surveys)||16
11393587|NCT03644173|12587266|FG000|NOT COMPLETED|Participants at Last Visit (Pre-surveys)||21
11393588|NCT03644173|12587266|FG000|STARTED|Participants at the 1-month Follow up||16
11393589|NCT03644173|12587266|FG000|COMPLETED|Participants at the 1-month Follow up||12
11393590|NCT03644173|12587266|FG000|NOT COMPLETED|Participants at the 1-month Follow up||4
11393591|NCT03644173|12587266|FG000|STARTED|Participants at the 3-month Follow up||12
11393592|NCT03644173|12587266|FG000|COMPLETED|Participants at the 3-month Follow up||10
11393593|NCT03644173|12587266|FG000|NOT COMPLETED|Participants at the 3-month Follow up||2
11393594|NCT03644212|12587273|FG000|STARTED|Overall Study||63
11393595|NCT03644212|12587274|FG001|STARTED|Overall Study||16
11393596|NCT03644212|12587273|FG000|COMPLETED|Overall Study||63
11393597|NCT03644212|12587274|FG001|COMPLETED|Overall Study||16
11393598|NCT03644212|12587273|FG000|NOT COMPLETED|Overall Study||0
11393599|NCT03644212|12587274|FG001|NOT COMPLETED|Overall Study||0
11393600|NCT03645421|12587284|FG000|STARTED|Overall Study||16
11393601|NCT03645421|12587285|FG001|STARTED|Overall Study||15
11393602|NCT03645421|12587286|FG002|STARTED|Overall Study||15
11393603|NCT03645421|12587287|FG003|STARTED|Overall Study||15
11393604|NCT03645421|12587284|FG000|Received Investigational Product (IP)|Overall Study||16
11393605|NCT03645421|12587285|FG001|Received Investigational Product (IP)|Overall Study||15
11393606|NCT03645421|12587286|FG002|Received Investigational Product (IP)|Overall Study||15
11393607|NCT03645421|12587287|FG003|Received Investigational Product (IP)|Overall Study||15
11393608|NCT03645421|12587284|FG000|COMPLETED|Overall Study||16
11393609|NCT03645421|12587285|FG001|COMPLETED|Overall Study||15
11393610|NCT03645421|12587286|FG002|COMPLETED|Overall Study||10
11393611|NCT03645421|12587287|FG003|COMPLETED|Overall Study||11
11393612|NCT03645421|12587284|FG000|NOT COMPLETED|Overall Study||0
11393613|NCT03645421|12587285|FG001|NOT COMPLETED|Overall Study||0
11393614|NCT03645421|12587286|FG002|NOT COMPLETED|Overall Study||5
11393615|NCT03645421|12587287|FG003|NOT COMPLETED|Overall Study||4
11393616|NCT03645434|12587300|FG000|STARTED|Period 1||12
11393617|NCT03645434|12587301|FG001|STARTED|Period 1||13
11393618|NCT03645434|12587302|FG002|STARTED|Period 1||13
11393619|NCT03645434|12587303|FG003|STARTED|Period 1||11
11393620|NCT03645434|12587304|FG004|STARTED|Period 1||12
11393621|NCT03645434|12587305|FG005|STARTED|Period 1||12
11393622|NCT03645434|12587300|FG000|COMPLETED|Period 1||12
11393623|NCT03645434|12587301|FG001|COMPLETED|Period 1||13
11393624|NCT03645434|12587302|FG002|COMPLETED|Period 1||13
11393625|NCT03645434|12587303|FG003|COMPLETED|Period 1||10
11393626|NCT03645434|12587304|FG004|COMPLETED|Period 1||11
11393627|NCT03645434|12587305|FG005|COMPLETED|Period 1||12
11393628|NCT03645434|12587300|FG000|NOT COMPLETED|Period 1||0
11393629|NCT03645434|12587301|FG001|NOT COMPLETED|Period 1||0
11393630|NCT03645434|12587302|FG002|NOT COMPLETED|Period 1||0
11393631|NCT03645434|12587303|FG003|NOT COMPLETED|Period 1||1
11393632|NCT03645434|12587304|FG004|NOT COMPLETED|Period 1||1
11393633|NCT03645434|12587305|FG005|NOT COMPLETED|Period 1||0
11393634|NCT03645434|12587300|FG000|STARTED|Period 2|2 subject discontinued as they did not meet stability or FEV1 variability.|10
11393635|NCT03645434|12587301|FG001|STARTED|Period 2||13
11393636|NCT03645434|12587302|FG002|STARTED|Period 2||13
11393637|NCT03645434|12587303|FG003|STARTED|Period 2||10
11393638|NCT03645434|12587304|FG004|STARTED|Period 2||11
11393639|NCT03645434|12587305|FG005|STARTED|Period 2|1 subject completed Period 1 but not allowed to enter Period 2 due to physician decision.|11
11393640|NCT03645434|12587300|FG000|COMPLETED|Period 2||10
11393641|NCT03645434|12587301|FG001|COMPLETED|Period 2||13
11393642|NCT03645434|12587302|FG002|COMPLETED|Period 2||13
11393643|NCT03645434|12587303|FG003|COMPLETED|Period 2||10
11393644|NCT03645434|12587304|FG004|COMPLETED|Period 2||11
11393645|NCT03645434|12587305|FG005|COMPLETED|Period 2||11
11393646|NCT03645434|12587300|FG000|NOT COMPLETED|Period 2||0
11393647|NCT03645434|12587301|FG001|NOT COMPLETED|Period 2||0
11393648|NCT03645434|12587302|FG002|NOT COMPLETED|Period 2||0
11393649|NCT03645434|12587303|FG003|NOT COMPLETED|Period 2||0
11393650|NCT03645434|12587304|FG004|NOT COMPLETED|Period 2||0
11393651|NCT03645434|12587305|FG005|NOT COMPLETED|Period 2||0
11393652|NCT03645434|12587300|FG000|STARTED|Period 3||10
11393653|NCT03645434|12587301|FG001|STARTED|Period 3||13
11393654|NCT03645434|12587302|FG002|STARTED|Period 3|2 subjects discontinued as they did not meet FEV1 stability criteria or pfts variability criteria.|11
11393655|NCT03645434|12587303|FG003|STARTED|Period 3||10
11393656|NCT03645434|12587304|FG004|STARTED|Period 3||11
11393657|NCT03645434|12587305|FG005|STARTED|Period 3||11
11393658|NCT03645434|12587300|FG000|COMPLETED|Period 3||10
11393659|NCT03645434|12587301|FG001|COMPLETED|Period 3||13
11393660|NCT03645434|12587302|FG002|COMPLETED|Period 3||11
11393661|NCT03645434|12587303|FG003|COMPLETED|Period 3||10
11393662|NCT03645434|12587304|FG004|COMPLETED|Period 3||11
11393663|NCT03645434|12587305|FG005|COMPLETED|Period 3||11
11393664|NCT03645434|12587300|FG000|NOT COMPLETED|Period 3||0
11393665|NCT03645434|12587301|FG001|NOT COMPLETED|Period 3||0
11393666|NCT03645434|12587302|FG002|NOT COMPLETED|Period 3||0
11393667|NCT03645434|12587303|FG003|NOT COMPLETED|Period 3||0
11393668|NCT03645434|12587304|FG004|NOT COMPLETED|Period 3||0
11393669|NCT03645434|12587305|FG005|NOT COMPLETED|Period 3||0
11393670|NCT03645785|12587313|FG000|STARTED|Day 1 (Normal Fluid Intake and Diet)||23
11393671|NCT03645785|12587313|FG000|COMPLETED|Day 1 (Normal Fluid Intake and Diet)||23
11393672|NCT03645785|12587313|FG000|NOT COMPLETED|Day 1 (Normal Fluid Intake and Diet)||0
11393673|NCT03645785|12587313|FG000|STARTED|Day 2-4 (Double Fluid and Add Citrate)||23
11393674|NCT03645785|12587313|FG000|COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||23
11393675|NCT03645785|12587313|FG000|NOT COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||0
11393676|NCT03645811|12587332|FG000|STARTED|Overall Study||32
11393677|NCT03645811|12587333|FG001|STARTED|Overall Study||32
11393678|NCT03645811|12587334|FG002|STARTED|Overall Study||32
11393679|NCT03645811|12587332|FG000|COMPLETED|Overall Study||30
11393680|NCT03645811|12587333|FG001|COMPLETED|Overall Study||30
11393681|NCT03645811|12587334|FG002|COMPLETED|Overall Study||30
11393682|NCT03645811|12587332|FG000|NOT COMPLETED|Overall Study||2
11393683|NCT03645811|12587333|FG001|NOT COMPLETED|Overall Study||2
11393684|NCT03645811|12587334|FG002|NOT COMPLETED|Overall Study||2
11393685|NCT03645954|12587344|FG000|STARTED|Overall Study||40
11393686|NCT03645954|12587345|FG001|STARTED|Overall Study||40
11393687|NCT03645954|12587344|FG000|COMPLETED|Overall Study||37
11393688|NCT03645954|12587345|FG001|COMPLETED|Overall Study||40
11393689|NCT03645954|12587344|FG000|NOT COMPLETED|Overall Study||3
11393690|NCT03645954|12587345|FG001|NOT COMPLETED|Overall Study||0
11393691|NCT03646305|12587355|FG000|STARTED|Overall Study||32
11393692|NCT03646305|12587356|FG001|STARTED|Overall Study||35
11393693|NCT03646305|12587357|FG002|STARTED|Overall Study||33
11393694|NCT03646305|12587358|FG003|STARTED|Overall Study||33
11393695|NCT03646305|12587355|FG000|Received Treatment|Overall Study||31
11393696|NCT03646305|12587356|FG001|Received Treatment|Overall Study||35
11393697|NCT03646305|12587357|FG002|Received Treatment|Overall Study||32
11393698|NCT03646305|12587358|FG003|Received Treatment|Overall Study||32
11393699|NCT03646305|12587355|FG000|No Treatment Recieved|Overall Study||1
11393700|NCT03646305|12587356|FG001|No Treatment Recieved|Overall Study||0
11393701|NCT03646305|12587357|FG002|No Treatment Recieved|Overall Study||1
11393702|NCT03646305|12587358|FG003|No Treatment Recieved|Overall Study||1
11393703|NCT03646305|12587355|FG000|COMPLETED|Overall Study||27
11393704|NCT03646305|12587356|FG001|COMPLETED|Overall Study||33
11393705|NCT03646305|12587357|FG002|COMPLETED|Overall Study||31
11393706|NCT03646305|12587358|FG003|COMPLETED|Overall Study||31
11393707|NCT03646305|12587355|FG000|NOT COMPLETED|Overall Study||5
11393708|NCT03646305|12587356|FG001|NOT COMPLETED|Overall Study||2
11393709|NCT03646305|12587357|FG002|NOT COMPLETED|Overall Study||2
11393710|NCT03646305|12587358|FG003|NOT COMPLETED|Overall Study||2
11393711|NCT03646656|12587374|FG000|STARTED|Overall Study||12
11393712|NCT03646656|12587375|FG001|STARTED|Overall Study||3
11393713|NCT03646656|12587374|FG000|Attended 1st Group Session|Overall Study||10
11393714|NCT03646656|12587375|FG001|Attended 1st Group Session|Overall Study||3
11393715|NCT03646656|12587374|FG000|COMPLETED|Overall Study||9
11393716|NCT03646656|12587375|FG001|COMPLETED|Overall Study||3
11393717|NCT03646656|12587374|FG000|NOT COMPLETED|Overall Study||3
11393718|NCT03646656|12587375|FG001|NOT COMPLETED|Overall Study||0
11393719|NCT03647033|12587387|FG000|STARTED|Overall Study||16
11393720|NCT03647033|12587388|FG001|STARTED|Overall Study||16
11393721|NCT03647033|12587387|FG000|COMPLETED|Overall Study||16
11393722|NCT03647033|12587388|FG001|COMPLETED|Overall Study||16
11393723|NCT03647033|12587387|FG000|NOT COMPLETED|Overall Study||0
11393724|NCT03647033|12587388|FG001|NOT COMPLETED|Overall Study||0
11393725|NCT03647046|12587394|FG000|STARTED|Overall Study||12
11393726|NCT03647046|12587394|FG000|COMPLETED|Overall Study||8
11393727|NCT03647046|12587394|FG000|NOT COMPLETED|Overall Study||4
11393728|NCT03647475|12587398|FG000|STARTED|Overall Study||752
11393729|NCT03647475|12587398|FG000|NCT03647475 - Included in One Month Clear Analysis Population|Overall Study||601
11393730|NCT03647475|12587398|FG000|NCT03344653- Included in One Month Clear Analysis Population|Overall Study||905
11393731|NCT03647475|12587398|FG000|COMPLETED|Overall Study||75
11393732|NCT03647475|12587398|FG000|NOT COMPLETED|Overall Study||677
11393733|NCT03647709|12587402|FG000|STARTED|Overall Study||400
11393734|NCT03647709|12587402|FG000|COMPLETED|Overall Study||386
11393735|NCT03647709|12587402|FG000|NOT COMPLETED|Overall Study||14
11393736|NCT03648853|12587408|FG000|STARTED|Overall Study||12
11393737|NCT03648853|12587408|FG000|COMPLETED|Overall Study||12
11393738|NCT03648853|12587408|FG000|NOT COMPLETED|Overall Study||0
11393739|NCT03648879|12587412|FG000|STARTED|Overall Study||37
11393740|NCT03648879|12587412|FG000|COMPLETED|Overall Study||36
11393741|NCT03648879|12587412|FG000|NOT COMPLETED|Overall Study||1
11393742|NCT03649412|12587418|FG000|STARTED|Part A, Period 1 (4 Days)||16
11393743|NCT03649412|12587419|FG001|STARTED|Part A, Period 1 (4 Days)||0
11393744|NCT03649412|12587418|FG000|COMPLETED|Part A, Period 1 (4 Days)||16
11393745|NCT03649412|12587419|FG001|COMPLETED|Part A, Period 1 (4 Days)||0
11393746|NCT03649412|12587418|FG000|NOT COMPLETED|Part A, Period 1 (4 Days)||0
11393747|NCT03649412|12587419|FG001|NOT COMPLETED|Part A, Period 1 (4 Days)||0
11393748|NCT03649412|12587418|FG000|STARTED|Part A, Washout Period 1 (7 Days)||16
11393749|NCT03649412|12587419|FG001|STARTED|Part A, Washout Period 1 (7 Days)||0
11393750|NCT03649412|12587418|FG000|COMPLETED|Part A, Washout Period 1 (7 Days)||15
11393751|NCT03649412|12587419|FG001|COMPLETED|Part A, Washout Period 1 (7 Days)||0
11393752|NCT03649412|12587418|FG000|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||1
11393753|NCT03649412|12587419|FG001|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||0
11393754|NCT03649412|12587418|FG000|STARTED|Part A, Period 2 (3 Days)|1 Replacement par. was enrolled & dosed|16
11393755|NCT03649412|12587419|FG001|STARTED|Part A, Period 2 (3 Days)||0
11393756|NCT03649412|12587418|FG000|COMPLETED|Part A, Period 2 (3 Days)||16
11393757|NCT03649412|12587419|FG001|COMPLETED|Part A, Period 2 (3 Days)||0
11393758|NCT03649412|12587418|FG000|NOT COMPLETED|Part A, Period 2 (3 Days)||0
11393759|NCT03649412|12587419|FG001|NOT COMPLETED|Part A, Period 2 (3 Days)||0
11393760|NCT03649412|12587418|FG000|STARTED|Part A, Washout Period 2 (7 Days)||16
11393761|NCT03649412|12587419|FG001|STARTED|Part A, Washout Period 2 (7 Days)||0
11393762|NCT03649412|12587418|FG000|COMPLETED|Part A, Washout Period 2 (7 Days)||16
11393763|NCT03649412|12587419|FG001|COMPLETED|Part A, Washout Period 2 (7 Days)||0
11393764|NCT03649412|12587418|FG000|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
11393765|NCT03649412|12587419|FG001|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
11393766|NCT03649412|12587418|FG000|STARTED|Part A, Period 3 (4 Days)||16
11393767|NCT03649412|12587419|FG001|STARTED|Part A, Period 3 (4 Days)||0
11393768|NCT03649412|12587418|FG000|COMPLETED|Part A, Period 3 (4 Days)||16
11393769|NCT03649412|12587419|FG001|COMPLETED|Part A, Period 3 (4 Days)||0
11393770|NCT03649412|12587418|FG000|NOT COMPLETED|Part A, Period 3 (4 Days)||0
11393771|NCT03649412|12587419|FG001|NOT COMPLETED|Part A, Period 3 (4 Days)||0
11393772|NCT03649412|12587418|FG000|STARTED|Part A, Washout Period 3 (7 Days)||16
11393773|NCT03649412|12587419|FG001|STARTED|Part A, Washout Period 3 (7 Days)||0
11393774|NCT03649412|12587418|FG000|COMPLETED|Part A, Washout Period 3 (7 Days)||16
11393775|NCT03649412|12587419|FG001|COMPLETED|Part A, Washout Period 3 (7 Days)||0
11393776|NCT03649412|12587418|FG000|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
11393777|NCT03649412|12587419|FG001|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
11393778|NCT03649412|12587418|FG000|STARTED|Part A, Period 4 (4 Days)||16
11393779|NCT03649412|12587419|FG001|STARTED|Part A, Period 4 (4 Days)||0
11393780|NCT03649412|12587418|FG000|COMPLETED|Part A, Period 4 (4 Days)||16
11393781|NCT03649412|12587419|FG001|COMPLETED|Part A, Period 4 (4 Days)||0
11393782|NCT03649412|12587418|FG000|NOT COMPLETED|Part A, Period 4 (4 Days)||0
11393783|NCT03649412|12587419|FG001|NOT COMPLETED|Part A, Period 4 (4 Days)||0
11393784|NCT03649412|12587418|FG000|STARTED|Part A, Washout Period 4 (7 Days)||16
11393785|NCT03649412|12587419|FG001|STARTED|Part A, Washout Period 4 (7 Days)||0
11393786|NCT03649412|12587418|FG000|COMPLETED|Part A, Washout Period 4 (7 Days)||14
11393787|NCT03649412|12587419|FG001|COMPLETED|Part A, Washout Period 4 (7 Days)||0
11393788|NCT03649412|12587418|FG000|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||2
11393789|NCT03649412|12587419|FG001|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||0
11393790|NCT03649412|12587418|FG000|STARTED|Part A, Period 5 (4 Days)|Two participant did not start in Period 5|12
11393791|NCT03649412|12587419|FG001|STARTED|Part A, Period 5 (4 Days)||0
11393792|NCT03649412|12587418|FG000|COMPLETED|Part A, Period 5 (4 Days)||12
11393793|NCT03649412|12587419|FG001|COMPLETED|Part A, Period 5 (4 Days)||0
11393794|NCT03649412|12587418|FG000|NOT COMPLETED|Part A, Period 5 (4 Days)||0
11393795|NCT03649412|12587419|FG001|NOT COMPLETED|Part A, Period 5 (4 Days)||0
11393796|NCT03649412|12587418|FG000|STARTED|Part A, Washout Period 5 (7 Days)||12
11393797|NCT03649412|12587419|FG001|STARTED|Part A, Washout Period 5 (7 Days)||0
11393798|NCT03649412|12587418|FG000|COMPLETED|Part A, Washout Period 5 (7 Days)||11
11393799|NCT03649412|12587419|FG001|COMPLETED|Part A, Washout Period 5 (7 Days)||0
11393800|NCT03649412|12587418|FG000|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||1
11393801|NCT03649412|12587419|FG001|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||0
11393802|NCT03649412|12587418|FG000|STARTED|Part A, Period 6 (4 Days)|1 of the participant who did not start Period 5 directly joined into Period 6|12
11393803|NCT03649412|12587419|FG001|STARTED|Part A, Period 6 (4 Days)||0
11393804|NCT03649412|12587418|FG000|COMPLETED|Part A, Period 6 (4 Days)||12
11393805|NCT03649412|12587419|FG001|COMPLETED|Part A, Period 6 (4 Days)||0
11393806|NCT03649412|12587418|FG000|NOT COMPLETED|Part A, Period 6 (4 Days)||0
11393807|NCT03649412|12587419|FG001|NOT COMPLETED|Part A, Period 6 (4 Days)||0
11393808|NCT03649412|12587418|FG000|STARTED|Part B, Period 1 (4 Days)|Participants in Part A did not enter Part B|0
11393809|NCT03649412|12587419|FG001|STARTED|Part B, Period 1 (4 Days)|16 new participants enrolled in Part B|16
11393810|NCT03649412|12587418|FG000|COMPLETED|Part B, Period 1 (4 Days)||0
11393811|NCT03649412|12587419|FG001|COMPLETED|Part B, Period 1 (4 Days)||16
11393812|NCT03649412|12587418|FG000|NOT COMPLETED|Part B, Period 1 (4 Days)||0
11393813|NCT03649412|12587419|FG001|NOT COMPLETED|Part B, Period 1 (4 Days)||0
11393814|NCT03649412|12587418|FG000|STARTED|Part B, Washout Period 1 (7 Days)||0
11393815|NCT03649412|12587419|FG001|STARTED|Part B, Washout Period 1 (7 Days)||16
11393816|NCT03649412|12587418|FG000|COMPLETED|Part B, Washout Period 1 (7 Days)||0
11393817|NCT03649412|12587419|FG001|COMPLETED|Part B, Washout Period 1 (7 Days)||15
11393818|NCT03649412|12587418|FG000|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||0
11393819|NCT03649412|12587419|FG001|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||1
11393820|NCT03649412|12587418|FG000|STARTED|Part B, Period 2 (4 Days)||0
11393821|NCT03649412|12587419|FG001|STARTED|Part B, Period 2 (4 Days)||15
11393822|NCT03649412|12587418|FG000|COMPLETED|Part B, Period 2 (4 Days)||0
11393823|NCT03649412|12587419|FG001|COMPLETED|Part B, Period 2 (4 Days)||15
11393824|NCT03649412|12587418|FG000|NOT COMPLETED|Part B, Period 2 (4 Days)||0
11393825|NCT03649412|12587419|FG001|NOT COMPLETED|Part B, Period 2 (4 Days)||0
11393826|NCT03649412|12587418|FG000|STARTED|Part B, Washout Period 2 (7 Days)||0
11393827|NCT03649412|12587419|FG001|STARTED|Part B, Washout Period 2 (7 Days)||15
11393828|NCT03649412|12587418|FG000|COMPLETED|Part B, Washout Period 2 (7 Days)||0
11393829|NCT03649412|12587419|FG001|COMPLETED|Part B, Washout Period 2 (7 Days)||15
11393830|NCT03649412|12587418|FG000|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
11393831|NCT03649412|12587419|FG001|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
11393832|NCT03649412|12587418|FG000|STARTED|Part B, Period 3 (4 Days)||0
11393833|NCT03649412|12587419|FG001|STARTED|Part B, Period 3 (4 Days)||15
11393834|NCT03649412|12587418|FG000|COMPLETED|Part B, Period 3 (4 Days)||0
11393835|NCT03649412|12587419|FG001|COMPLETED|Part B, Period 3 (4 Days)||15
11393836|NCT03649412|12587418|FG000|NOT COMPLETED|Part B, Period 3 (4 Days)||0
11393837|NCT03649412|12587419|FG001|NOT COMPLETED|Part B, Period 3 (4 Days)||0
11393838|NCT03649412|12587418|FG000|STARTED|Part B, Washout Period 3 (7 Days)||0
11393839|NCT03649412|12587419|FG001|STARTED|Part B, Washout Period 3 (7 Days)||15
11393840|NCT03649412|12587418|FG000|COMPLETED|Part B, Washout Period 3 (7 Days)||0
11393841|NCT03649412|12587419|FG001|COMPLETED|Part B, Washout Period 3 (7 Days)||15
11393842|NCT03649412|12587418|FG000|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
11393843|NCT03649412|12587419|FG001|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
11393844|NCT03649412|12587418|FG000|STARTED|Part B, Period 4 (4 Days)||0
11393845|NCT03649412|12587419|FG001|STARTED|Part B, Period 4 (4 Days)||15
11393846|NCT03649412|12587418|FG000|COMPLETED|Part B, Period 4 (4 Days)||0
11393847|NCT03649412|12587419|FG001|COMPLETED|Part B, Period 4 (4 Days)||15
11393848|NCT03649412|12587418|FG000|NOT COMPLETED|Part B, Period 4 (4 Days)||0
11393849|NCT03649412|12587419|FG001|NOT COMPLETED|Part B, Period 4 (4 Days)||0
11393850|NCT03649412|12587418|FG000|STARTED|Part B, Washout Period 4 (7 Days)||0
11393851|NCT03649412|12587419|FG001|STARTED|Part B, Washout Period 4 (7 Days)||15
11393852|NCT03649412|12587418|FG000|COMPLETED|Part B, Washout Period 4 (7 Days)||0
11393853|NCT03649412|12587419|FG001|COMPLETED|Part B, Washout Period 4 (7 Days)||15
11393854|NCT03649412|12587418|FG000|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
11393855|NCT03649412|12587419|FG001|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
11393856|NCT03649412|12587418|FG000|STARTED|Part B, Period 5 (4 Days)||0
11393857|NCT03649412|12587419|FG001|STARTED|Part B, Period 5 (4 Days)|One participant did not start in Period 5|14
11393858|NCT03649412|12587418|FG000|COMPLETED|Part B, Period 5 (4 Days)||0
11393859|NCT03649412|12587419|FG001|COMPLETED|Part B, Period 5 (4 Days)||14
11393860|NCT03649412|12587418|FG000|NOT COMPLETED|Part B, Period 5 (4 Days)||0
11393861|NCT03649412|12587419|FG001|NOT COMPLETED|Part B, Period 5 (4 Days)||0
11393862|NCT03649412|12587418|FG000|STARTED|Part B, Washout Period 5 (7 Days)||0
11393863|NCT03649412|12587419|FG001|STARTED|Part B, Washout Period 5 (7 Days)||14
11393864|NCT03649412|12587418|FG000|COMPLETED|Part B, Washout Period 5 (7 Days)||0
11393865|NCT03649412|12587419|FG001|COMPLETED|Part B, Washout Period 5 (7 Days)||13
11393866|NCT03649412|12587418|FG000|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||0
11393867|NCT03649412|12587419|FG001|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||1
11393868|NCT03649412|12587418|FG000|STARTED|Part B, Period 6 (4days)||0
11393869|NCT03649412|12587419|FG001|STARTED|Part B, Period 6 (4days)|Participant who did not start Period 5 directly joined into Period 6|14
11393870|NCT03649412|12587418|FG000|COMPLETED|Part B, Period 6 (4days)||0
11393871|NCT03649412|12587419|FG001|COMPLETED|Part B, Period 6 (4days)||14
11393872|NCT03649412|12587418|FG000|NOT COMPLETED|Part B, Period 6 (4days)||0
11393873|NCT03649412|12587419|FG001|NOT COMPLETED|Part B, Period 6 (4days)||0
11393874|NCT03649646|12587462|FG000|STARTED|Overall Study||4542
11393875|NCT03649646|12587462|FG000|COMPLETED|Overall Study||4075
11393876|NCT03649646|12587462|FG000|NOT COMPLETED|Overall Study||467
11393877|NCT03649750|12587466|FG000|STARTED|Period 1||12
11393878|NCT03649750|12587467|FG001|STARTED|Period 1||24
11393879|NCT03649750|12587466|FG000|COMPLETED|Period 1||12
11393880|NCT03649750|12587467|FG001|COMPLETED|Period 1||24
11393881|NCT03649750|12587466|FG000|NOT COMPLETED|Period 1||0
11393882|NCT03649750|12587467|FG001|NOT COMPLETED|Period 1||0
11393883|NCT03649750|12587466|FG000|STARTED|Washout: 7 Days||12
11393884|NCT03649750|12587467|FG001|STARTED|Washout: 7 Days||24
11393885|NCT03649750|12587466|FG000|COMPLETED|Washout: 7 Days||12
11393886|NCT03649750|12587467|FG001|COMPLETED|Washout: 7 Days||24
11393887|NCT03649750|12587466|FG000|NOT COMPLETED|Washout: 7 Days||0
11393888|NCT03649750|12587467|FG001|NOT COMPLETED|Washout: 7 Days||0
11393889|NCT03649750|12587466|FG000|STARTED|Period 2||12
11393890|NCT03649750|12587467|FG001|STARTED|Period 2||24
11393891|NCT03649750|12587466|FG000|COMPLETED|Period 2||12
11393892|NCT03649750|12587467|FG001|COMPLETED|Period 2||24
11393893|NCT03649750|12587466|FG000|NOT COMPLETED|Period 2||0
11393894|NCT03649750|12587467|FG001|NOT COMPLETED|Period 2||0
11393895|NCT03649815|12587474|FG000|STARTED|Overall Study||38
11393896|NCT03649815|12587474|FG000|COMPLETED|Overall Study||38
11393897|NCT03649815|12587474|FG000|NOT COMPLETED|Overall Study||0
11393898|NCT03649867|12587478|FG000|STARTED|Overall Study||13
11393899|NCT03649867|12587478|FG000|COMPLETED|Overall Study||13
11393900|NCT03649867|12587478|FG000|NOT COMPLETED|Overall Study||0
11393901|NCT03649932|12587485|FG000|STARTED|Overall Study||14
11393902|NCT03649932|12587486|FG001|STARTED|Overall Study||14
11393903|NCT03649932|12587487|FG002|STARTED|Overall Study||14
11393904|NCT03649932|12587485|FG000|COMPLETED|Overall Study||14
11393905|NCT03649932|12587486|FG001|COMPLETED|Overall Study||13
11393906|NCT03649932|12587487|FG002|COMPLETED|Overall Study||13
11393907|NCT03649932|12587485|FG000|NOT COMPLETED|Overall Study||0
11393908|NCT03649932|12587486|FG001|NOT COMPLETED|Overall Study||1
11393909|NCT03649932|12587487|FG002|NOT COMPLETED|Overall Study||1
11393910|NCT03650192|12587495|FG000|STARTED|Overall Study||40
11393911|NCT03650192|12587495|FG000|COMPLETED|Overall Study||40
11393912|NCT03650192|12587495|FG000|NOT COMPLETED|Overall Study||0
11393913|NCT03650387|12587499|FG000|STARTED|Overall Study||207
11393914|NCT03650387|12587499|FG000|COMPLETED|Overall Study||173
11393915|NCT03650387|12587499|FG000|NOT COMPLETED|Overall Study||34
11393916|NCT03650400|12587514|FG000|STARTED|Overall Study||6
11393917|NCT03650400|12587515|FG001|STARTED|Overall Study||5
11393918|NCT03650400|12587514|FG000|COMPLETED|Overall Study||6
11393919|NCT03650400|12587515|FG001|COMPLETED|Overall Study||0
11393920|NCT03650400|12587514|FG000|NOT COMPLETED|Overall Study||0
11393921|NCT03650400|12587515|FG001|NOT COMPLETED|Overall Study||5
11393922|NCT03650452|12587523|FG000|STARTED|Overall Study||70
11393923|NCT03650452|12587524|FG001|STARTED|Overall Study||71
11393924|NCT03650452|12587523|FG000|COMPLETED|Overall Study||60
11393925|NCT03650452|12587524|FG001|COMPLETED|Overall Study||66
11393926|NCT03650452|12587523|FG000|NOT COMPLETED|Overall Study||10
11393927|NCT03650452|12587524|FG001|NOT COMPLETED|Overall Study||5
11393928|NCT03650842|12587530|FG000|STARTED|Overall Study||25
11393929|NCT03650842|12587530|FG000|COMPLETED|Overall Study||25
11393930|NCT03650842|12587530|FG000|NOT COMPLETED|Overall Study||0
11393931|NCT03651479|12587536|FG000|STARTED|Overall Study||20
11393932|NCT03651479|12587537|FG001|STARTED|Overall Study||20
11393933|NCT03651479|12587536|FG000|COMPLETED|Overall Study||20
11393934|NCT03651479|12587537|FG001|COMPLETED|Overall Study||20
11393935|NCT03651479|12587536|FG000|NOT COMPLETED|Overall Study||0
11393936|NCT03651479|12587537|FG001|NOT COMPLETED|Overall Study||0
11393937|NCT03651856|12587543|FG000|STARTED|Overall Study||10
11393938|NCT03651856|12587543|FG000|COMPLETED|Overall Study||10
11393939|NCT03651856|12587543|FG000|NOT COMPLETED|Overall Study||0
11393940|NCT03652610|12587549|FG000|STARTED|Overall Study||490
11393941|NCT03652610|12587550|FG001|STARTED|Overall Study||489
11393942|NCT03652610|12587549|FG000|COMPLETED|Overall Study||486
11393943|NCT03652610|12587550|FG001|COMPLETED|Overall Study||484
11393944|NCT03652610|12587549|FG000|NOT COMPLETED|Overall Study||4
11393945|NCT03652610|12587550|FG001|NOT COMPLETED|Overall Study||5
11393946|NCT03652662|12587558|FG000|STARTED|Overall Study||18
11393947|NCT03652662|12587559|FG001|STARTED|Overall Study||16
11393948|NCT03652662|12587558|FG000|COMPLETED|Overall Study||15
11393949|NCT03652662|12587559|FG001|COMPLETED|Overall Study||15
11393950|NCT03652662|12587558|FG000|NOT COMPLETED|Overall Study||3
11393951|NCT03652662|12587559|FG001|NOT COMPLETED|Overall Study||1
11393952|NCT03652675|12587567|FG000|STARTED|Overall Study||16
11393953|NCT03652675|12587568|FG001|STARTED|Overall Study||15
11393954|NCT03652675|12587567|FG000|COMPLETED|Overall Study||12
11393955|NCT03652675|12587568|FG001|COMPLETED|Overall Study||11
11393956|NCT03652675|12587567|FG000|NOT COMPLETED|Overall Study||4
11393957|NCT03652675|12587568|FG001|NOT COMPLETED|Overall Study||4
11393958|NCT03652818|12587579|FG000|STARTED|Overall Study||24
11393959|NCT03652818|12587580|FG001|STARTED|Overall Study||23
11393960|NCT03652818|12587581|FG002|STARTED|Overall Study||22
11393961|NCT03652818|12587582|FG003|STARTED|Overall Study||23
11393962|NCT03652818|12587583|FG004|STARTED|Overall Study||23
11393963|NCT03652818|12587579|FG000|COMPLETED|Overall Study||22
11393964|NCT03652818|12587580|FG001|COMPLETED|Overall Study||22
11393965|NCT03652818|12587581|FG002|COMPLETED|Overall Study||20
11393966|NCT03652818|12587582|FG003|COMPLETED|Overall Study||22
11393967|NCT03652818|12587583|FG004|COMPLETED|Overall Study||22
11393968|NCT03652818|12587579|FG000|NOT COMPLETED|Overall Study||2
11393969|NCT03652818|12587580|FG001|NOT COMPLETED|Overall Study||1
11393970|NCT03652818|12587581|FG002|NOT COMPLETED|Overall Study||2
11393971|NCT03652818|12587582|FG003|NOT COMPLETED|Overall Study||1
11393972|NCT03652818|12587583|FG004|NOT COMPLETED|Overall Study||1
11393973|NCT03653208|12587604|FG000|STARTED|Overall Study||3
11393974|NCT03653208|12587605|FG001|STARTED|Overall Study||3
11393975|NCT03653208|12587606|FG002|STARTED|Overall Study||6
11393976|NCT03653208|12587607|FG003|STARTED|Overall Study||6
11393977|NCT03653208|12587608|FG004|STARTED|Overall Study||6
11393978|NCT03653208|12587609|FG005|STARTED|Overall Study||6
11393979|NCT03653208|12587610|FG006|STARTED|Overall Study||6
11393980|NCT03653208|12587611|FG007|STARTED|Overall Study||6
11393981|NCT03653208|12587612|FG008|STARTED|Overall Study||14
11393982|NCT03653208|12587604|FG000|COMPLETED|Overall Study||3
11393983|NCT03653208|12587605|FG001|COMPLETED|Overall Study||3
11393984|NCT03653208|12587606|FG002|COMPLETED|Overall Study||6
11393985|NCT03653208|12587607|FG003|COMPLETED|Overall Study||6
11393986|NCT03653208|12587608|FG004|COMPLETED|Overall Study||5
11393987|NCT03653208|12587609|FG005|COMPLETED|Overall Study||6
11393988|NCT03653208|12587610|FG006|COMPLETED|Overall Study||6
11393989|NCT03653208|12587611|FG007|COMPLETED|Overall Study||5
11393990|NCT03653208|12587612|FG008|COMPLETED|Overall Study||13
11393991|NCT03653208|12587604|FG000|NOT COMPLETED|Overall Study||0
11393992|NCT03653208|12587605|FG001|NOT COMPLETED|Overall Study||0
11393993|NCT03653208|12587606|FG002|NOT COMPLETED|Overall Study||0
11393994|NCT03653208|12587607|FG003|NOT COMPLETED|Overall Study||0
11393995|NCT03653208|12587608|FG004|NOT COMPLETED|Overall Study||1
11393996|NCT03653208|12587609|FG005|NOT COMPLETED|Overall Study||0
11393997|NCT03653208|12587610|FG006|NOT COMPLETED|Overall Study||0
11393998|NCT03653208|12587611|FG007|NOT COMPLETED|Overall Study||1
11393999|NCT03653208|12587612|FG008|NOT COMPLETED|Overall Study||1
11394000|NCT03653351|12587634|FG000|STARTED|Overall Study||14
11394001|NCT03653351|12587635|FG001|STARTED|Overall Study||12
11394002|NCT03653351|12587634|FG000|COMPLETED|Overall Study||13
11394003|NCT03653351|12587635|FG001|COMPLETED|Overall Study||10
11394004|NCT03653351|12587634|FG000|NOT COMPLETED|Overall Study||1
11394005|NCT03653351|12587635|FG001|NOT COMPLETED|Overall Study||2
11394006|NCT03653416|12587643|FG000|STARTED|Overall Study||52
11394007|NCT03653416|12587644|FG001|STARTED|Overall Study||47
11394008|NCT03653416|12587643|FG000|COMPLETED|Overall Study||46
11394009|NCT03653416|12587644|FG001|COMPLETED|Overall Study||46
11394010|NCT03653416|12587643|FG000|NOT COMPLETED|Overall Study||6
11394011|NCT03653416|12587644|FG001|NOT COMPLETED|Overall Study||1
11394012|NCT03653429|12587652|FG000|STARTED|Overall Study||49
11394013|NCT03653429|12587653|FG001|STARTED|Overall Study||51
11394014|NCT03653429|12587652|FG000|COMPLETED|Overall Study||45
11394015|NCT03653429|12587653|FG001|COMPLETED|Overall Study||41
11394016|NCT03653429|12587652|FG000|NOT COMPLETED|Overall Study||4
11394017|NCT03653429|12587653|FG001|NOT COMPLETED|Overall Study||10
11394018|NCT03654326|12587661|FG000|STARTED|Overall Study||94
11394019|NCT03654326|12587662|FG001|STARTED|Overall Study||93
11394020|NCT03654326|12587661|FG000|COMPLETED|Overall Study||88
11394021|NCT03654326|12587662|FG001|COMPLETED|Overall Study||87
11394022|NCT03654326|12587661|FG000|NOT COMPLETED|Overall Study||6
11394023|NCT03654326|12587662|FG001|NOT COMPLETED|Overall Study||6
11394024|NCT03654417|12587670|FG000|STARTED|Overall Study||19
11394025|NCT03654417|12587671|FG001|STARTED|Overall Study||18
11394026|NCT03654417|12587670|FG000|COMPLETED|Overall Study||19
11394027|NCT03654417|12587671|FG001|COMPLETED|Overall Study||18
11394028|NCT03654417|12587670|FG000|NOT COMPLETED|Overall Study||0
11394029|NCT03654417|12587671|FG001|NOT COMPLETED|Overall Study||0
11394030|NCT03654560|12587679|FG000|STARTED|Overall Study||118
11394031|NCT03654560|12587680|FG001|STARTED|Overall Study||118
11394032|NCT03654560|12587679|FG000|COMPLETED|Overall Study||114
11394033|NCT03654560|12587680|FG001|COMPLETED|Overall Study||117
11394034|NCT03654560|12587679|FG000|NOT COMPLETED|Overall Study||4
11394035|NCT03654560|12587680|FG001|NOT COMPLETED|Overall Study||1
11394036|NCT03655080|12587686|FG000|STARTED|Overall Study||2
11394037|NCT03655080|12587686|FG000|COMPLETED|Overall Study||2
11394038|NCT03655080|12587686|FG000|NOT COMPLETED|Overall Study||0
11394039|NCT03655106|12587692|FG000|STARTED|Overall Study||135
11394040|NCT03655106|12587693|FG001|STARTED|Overall Study||135
11394041|NCT03655106|12587692|FG000|COMPLETED|Overall Study||126
11394042|NCT03655106|12587693|FG001|COMPLETED|Overall Study||131
11394043|NCT03655106|12587692|FG000|NOT COMPLETED|Overall Study||9
11394044|NCT03655106|12587693|FG001|NOT COMPLETED|Overall Study||4
11394045|NCT03655301|12587699|FG000|STARTED|Overall Study||13
11394046|NCT03655301|12587699|FG000|COMPLETED|Overall Study||13
11394047|NCT03655301|12587699|FG000|NOT COMPLETED|Overall Study||0
11394048|NCT03655405|12587705|FG000|STARTED|Overall Study||32
11394049|NCT03655405|12587706|FG001|STARTED|Overall Study||30
11394050|NCT03655405|12587705|FG000|COMPLETED|Overall Study||27
11394051|NCT03655405|12587706|FG001|COMPLETED|Overall Study||25
11394052|NCT03655405|12587705|FG000|NOT COMPLETED|Overall Study||5
11394053|NCT03655405|12587706|FG001|NOT COMPLETED|Overall Study||5
11394054|NCT03655444|12587714|FG000|STARTED|Overall Study||3
11394055|NCT03655444|12587715|FG001|STARTED|Overall Study||3
11394056|NCT03655444|12587714|FG000|COMPLETED|Overall Study||3
11394057|NCT03655444|12587715|FG001|COMPLETED|Overall Study||3
11394058|NCT03655444|12587714|FG000|NOT COMPLETED|Overall Study||0
11394059|NCT03655444|12587715|FG001|NOT COMPLETED|Overall Study||0
11394060|NCT03655951|12587723|FG000|STARTED|Overall Study||358
11394061|NCT03655951|12587724|FG001|STARTED|Overall Study||372
11394062|NCT03655951|12587723|FG000|Completed Pretest|Overall Study||344
11394063|NCT03655951|12587724|FG001|Completed Pretest|Overall Study||366
11394064|NCT03655951|12587723|FG000|COMPLETED|Overall Study||319
11394065|NCT03655951|12587724|FG001|COMPLETED|Overall Study||351
11394066|NCT03655951|12587723|FG000|NOT COMPLETED|Overall Study||39
11394067|NCT03655951|12587724|FG001|NOT COMPLETED|Overall Study||21
11394068|NCT03656939|12587730|FG000|STARTED|Overall Study||21240
11394069|NCT03656939|12587730|FG000|Main Study Cohort|Overall Study||21240
11394070|NCT03656939|12587730|FG000|Main Study Cohort: Participants Who Received Dose 1|Overall Study||20318
11394071|NCT03656939|12587730|FG000|Main Study Cohort: Participants Who Received Dose 2|Overall Study||19387
11394072|NCT03656939|12587730|FG000|Main Study Cohort: Participants Who Received Dose 3|Overall Study||18415
11394073|NCT03656939|12587730|FG000|Main Study Cohort: Participants Who Received Dose 4|Overall Study||12944
11394074|NCT03656939|12587730|FG000|Prospective Study Cohort|Overall Study||2300
11394075|NCT03656939|12587730|FG000|Prospective Study Cohort: Participants Who Received Dose 1|Overall Study||2300
11394076|NCT03656939|12587730|FG000|Prospective Study Cohort: Participants Who Received Dose 2|Overall Study||2203
11394077|NCT03656939|12587730|FG000|Prospective Study Cohort: Participants Who Received Dose 3|Overall Study||2047
11394078|NCT03656939|12587730|FG000|Prospective Study Cohort: Participants Who Received Dose 4|Overall Study||1291
11394079|NCT03656939|12587730|FG000|COMPLETED|Overall Study||21240
11394080|NCT03656939|12587730|FG000|NOT COMPLETED|Overall Study||0
11394081|NCT03657095|12587738|FG000|STARTED|Overall Study||59
11394082|NCT03657095|12587739|FG001|STARTED|Overall Study||53
11394083|NCT03657095|12587738|FG000|Received at Least 1 Dose of Study Drug|Overall Study||59
11394084|NCT03657095|12587739|FG001|Received at Least 1 Dose of Study Drug|Overall Study||53
11394085|NCT03657095|12587738|FG000|COMPLETED|Overall Study||0
11394086|NCT03657095|12587739|FG001|COMPLETED|Overall Study||0
11394087|NCT03657095|12587738|FG000|NOT COMPLETED|Overall Study||59
11394088|NCT03657095|12587739|FG001|NOT COMPLETED|Overall Study||53
11394089|NCT03657134|12587745|FG000|STARTED|Overall Study||20
11394090|NCT03657134|12587745|FG000|COMPLETED|Overall Study||20
11394091|NCT03657134|12587745|FG000|NOT COMPLETED|Overall Study||0
11394092|NCT03657277|12587750|FG000|STARTED|Overall Study||46
11394093|NCT03657277|12587750|FG000|COMPLETED|Overall Study||35
11394094|NCT03657277|12587750|FG000|NOT COMPLETED|Overall Study||11
11394095|NCT03657407|12587756|FG000|STARTED|Overall Study||29
11394096|NCT03657407|12587757|FG001|STARTED|Overall Study||27
11394097|NCT03657407|12587756|FG000|COMPLETED|Overall Study||29
11394098|NCT03657407|12587757|FG001|COMPLETED|Overall Study||27
11394099|NCT03657407|12587756|FG000|NOT COMPLETED|Overall Study||0
11394100|NCT03657407|12587757|FG001|NOT COMPLETED|Overall Study||0
11394101|NCT03658811|12587763|FG000|STARTED|Overall Study||19
11394102|NCT03658811|12587763|FG000|COMPLETED|Overall Study||16
11394103|NCT03658811|12587763|FG000|NOT COMPLETED|Overall Study||3
11394104|NCT03658876|12587769|FG000|STARTED|Overall Study||88
11394105|NCT03658876|12587770|FG001|STARTED|Overall Study||96
11394106|NCT03658876|12587769|FG000|COMPLETED|Overall Study||76
11394107|NCT03658876|12587770|FG001|COMPLETED|Overall Study||84
11394108|NCT03658876|12587769|FG000|NOT COMPLETED|Overall Study||12
11394109|NCT03658876|12587770|FG001|NOT COMPLETED|Overall Study||12
11394110|NCT03660787|12587780|FG000|STARTED|Overall Study||26
11394111|NCT03660787|12587781|FG001|STARTED|Overall Study||26
11394112|NCT03660787|12587782|FG002|STARTED|Overall Study||26
11394113|NCT03660787|12587783|FG003|STARTED|Overall Study||26
11394114|NCT03660787|12587780|FG000|COMPLETED|Overall Study||25
11394115|NCT03660787|12587781|FG001|COMPLETED|Overall Study||25
11394116|NCT03660787|12587782|FG002|COMPLETED|Overall Study||25
11394117|NCT03660787|12587783|FG003|COMPLETED|Overall Study||26
11394118|NCT03660787|12587780|FG000|NOT COMPLETED|Overall Study||1
11394119|NCT03660787|12587781|FG001|NOT COMPLETED|Overall Study||1
11394120|NCT03660787|12587782|FG002|NOT COMPLETED|Overall Study||1
11394121|NCT03660787|12587783|FG003|NOT COMPLETED|Overall Study||0
11394122|NCT03661346|12587795|FG000|STARTED|Overall Study|Esmolol administration|13
11394123|NCT03661346|12587796|FG001|STARTED|Overall Study||15
11394124|NCT03661346|12587795|FG000|COMPLETED|Overall Study||13
11394125|NCT03661346|12587796|FG001|COMPLETED|Overall Study||15
11394126|NCT03661346|12587795|FG000|NOT COMPLETED|Overall Study||0
11394127|NCT03661346|12587796|FG001|NOT COMPLETED|Overall Study||0
11394128|NCT03661541|12587805|FG000|STARTED|Overall Study||12
11394129|NCT03661541|12587806|FG001|STARTED|Overall Study||12
11394130|NCT03661541|12587807|FG002|STARTED|Overall Study||12
11394131|NCT03661541|12587805|FG000|COMPLETED|Overall Study||10
11394132|NCT03661541|12587806|FG001|COMPLETED|Overall Study||10
11394133|NCT03661541|12587807|FG002|COMPLETED|Overall Study||10
11394134|NCT03661541|12587805|FG000|NOT COMPLETED|Overall Study||2
11394135|NCT03661541|12587806|FG001|NOT COMPLETED|Overall Study||2
11394136|NCT03661541|12587807|FG002|NOT COMPLETED|Overall Study||2
11394137|NCT03661697|12587821|FG000|STARTED|Overall Study||7
11394138|NCT03661697|12587822|FG001|STARTED|Overall Study||7
11394139|NCT03661697|12587821|FG000|COMPLETED|Overall Study||7
11394140|NCT03661697|12587822|FG001|COMPLETED|Overall Study||7
11394141|NCT03661697|12587821|FG000|NOT COMPLETED|Overall Study||0
11394142|NCT03661697|12587822|FG001|NOT COMPLETED|Overall Study||0
11394143|NCT03661762|12587828|FG000|STARTED|Overall Study||18
11394144|NCT03661762|12587828|FG000|COMPLETED|Overall Study||10
11394145|NCT03661762|12587828|FG000|NOT COMPLETED|Overall Study||8
11394146|NCT03661814|12587835|FG000|STARTED|Overall Study||2
11394147|NCT03661814|12587836|FG001|STARTED|Overall Study||5
11394148|NCT03661814|12587835|FG000|COMPLETED|Overall Study||2
11394149|NCT03661814|12587836|FG001|COMPLETED|Overall Study||5
11394150|NCT03661814|12587835|FG000|NOT COMPLETED|Overall Study||0
11394151|NCT03661814|12587836|FG001|NOT COMPLETED|Overall Study||0
11394152|NCT03661983|12587842|FG000|STARTED|Open Label Stabilization Phase||36
11394153|NCT03661983|12587843|FG001|STARTED|Open Label Stabilization Phase||0
11394154|NCT03661983|12587844|FG002|STARTED|Open Label Stabilization Phase||0
11394155|NCT03661983|12587845|FG003|STARTED|Open Label Stabilization Phase||0
11394156|NCT03661983|12587842|FG000|COMPLETED|Open Label Stabilization Phase||25
11394157|NCT03661983|12587843|FG001|COMPLETED|Open Label Stabilization Phase||0
11394158|NCT03661983|12587844|FG002|COMPLETED|Open Label Stabilization Phase||0
11394159|NCT03661983|12587845|FG003|COMPLETED|Open Label Stabilization Phase||0
11394160|NCT03661983|12587842|FG000|NOT COMPLETED|Open Label Stabilization Phase||11
11394161|NCT03661983|12587843|FG001|NOT COMPLETED|Open Label Stabilization Phase||0
11394162|NCT03661983|12587844|FG002|NOT COMPLETED|Open Label Stabilization Phase||0
11394163|NCT03661983|12587845|FG003|NOT COMPLETED|Open Label Stabilization Phase||0
11394164|NCT03661983|12587842|FG000|STARTED|Double-blind Randomized Phase||0
11394165|NCT03661983|12587843|FG001|STARTED|Double-blind Randomized Phase||9
11394166|NCT03661983|12587844|FG002|STARTED|Double-blind Randomized Phase||8
11394167|NCT03661983|12587845|FG003|STARTED|Double-blind Randomized Phase||8
11394168|NCT03661983|12587842|FG000|COMPLETED|Double-blind Randomized Phase||0
11394169|NCT03661983|12587843|FG001|COMPLETED|Double-blind Randomized Phase||7
11394170|NCT03661983|12587844|FG002|COMPLETED|Double-blind Randomized Phase||7
11394171|NCT03661983|12587845|FG003|COMPLETED|Double-blind Randomized Phase||0
11394172|NCT03661983|12587842|FG000|NOT COMPLETED|Double-blind Randomized Phase||0
11394173|NCT03661983|12587843|FG001|NOT COMPLETED|Double-blind Randomized Phase||2
11394174|NCT03661983|12587844|FG002|NOT COMPLETED|Double-blind Randomized Phase||1
11394175|NCT03661983|12587845|FG003|NOT COMPLETED|Double-blind Randomized Phase||8
11394176|NCT03662139|12587856|FG000|STARTED|Overall Study||16
11394177|NCT03662139|12587857|FG001|STARTED|Overall Study||16
11394178|NCT03662139|12587856|FG000|COMPLETED|Overall Study||16
11394179|NCT03662139|12587857|FG001|COMPLETED|Overall Study||16
11394180|NCT03662139|12587856|FG000|NOT COMPLETED|Overall Study||0
11394181|NCT03662139|12587857|FG001|NOT COMPLETED|Overall Study||0
11394182|NCT03662282|12587865|FG000|STARTED|Overall Study||2
11394183|NCT03662282|12587865|FG000|COMPLETED|Overall Study||2
11394184|NCT03662282|12587865|FG000|NOT COMPLETED|Overall Study||0
11394185|NCT03662334|12587871|FG000|STARTED|Part 1: Treatment Period 1||0
11394186|NCT03662334|12587872|FG001|STARTED|Part 1: Treatment Period 1||0
11394187|NCT03662334|12587871|FG000|COMPLETED|Part 1: Treatment Period 1||0
11394188|NCT03662334|12587872|FG001|COMPLETED|Part 1: Treatment Period 1||0
11394189|NCT03662334|12587871|FG000|NOT COMPLETED|Part 1: Treatment Period 1||0
11394190|NCT03662334|12587872|FG001|NOT COMPLETED|Part 1: Treatment Period 1||0
11394191|NCT03662334|12587871|FG000|STARTED|Part 1: Treatment Period 2||0
11394192|NCT03662334|12587872|FG001|STARTED|Part 1: Treatment Period 2||0
11394193|NCT03662334|12587871|FG000|COMPLETED|Part 1: Treatment Period 2||0
11394194|NCT03662334|12587872|FG001|COMPLETED|Part 1: Treatment Period 2||0
11394195|NCT03662334|12587871|FG000|NOT COMPLETED|Part 1: Treatment Period 2||0
11394196|NCT03662334|12587872|FG001|NOT COMPLETED|Part 1: Treatment Period 2||0
11394197|NCT03662334|12587871|FG000|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
11394198|NCT03662334|12587872|FG001|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
11394199|NCT03662334|12587871|FG000|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
11394200|NCT03662334|12587872|FG001|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
11394201|NCT03662334|12587871|FG000|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
11394202|NCT03662334|12587872|FG001|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
11394203|NCT03662334|12587871|FG000|STARTED|Part 2: Treatment Period 2 (2 Days)||7
11394204|NCT03662334|12587872|FG001|STARTED|Part 2: Treatment Period 2 (2 Days)||7
11394205|NCT03662334|12587871|FG000|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6
11394206|NCT03662334|12587872|FG001|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7
11394207|NCT03662334|12587871|FG000|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1
11394208|NCT03662334|12587872|FG001|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0
11394209|NCT03662334|12587871|FG000|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
11394210|NCT03662334|12587872|FG001|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
11394211|NCT03662334|12587871|FG000|COMPLETED|Part 3: Treatment Period 1||0
11394212|NCT03662334|12587872|FG001|COMPLETED|Part 3: Treatment Period 1||0
11394213|NCT03662334|12587871|FG000|NOT COMPLETED|Part 3: Treatment Period 1||0
11394214|NCT03662334|12587872|FG001|NOT COMPLETED|Part 3: Treatment Period 1||0
11394215|NCT03662334|12587871|FG000|STARTED|Part 3: Treatment Period 2||0
11394216|NCT03662334|12587872|FG001|STARTED|Part 3: Treatment Period 2||0
11394217|NCT03662334|12587871|FG000|COMPLETED|Part 3: Treatment Period 2||0
11394218|NCT03662334|12587872|FG001|COMPLETED|Part 3: Treatment Period 2||0
11394219|NCT03662334|12587871|FG000|NOT COMPLETED|Part 3: Treatment Period 2||0
11394220|NCT03662334|12587872|FG001|NOT COMPLETED|Part 3: Treatment Period 2||0
11394221|NCT03662360|12587880|FG000|STARTED|Overall Study||16
11394222|NCT03662360|12587881|FG001|STARTED|Overall Study||16
11394223|NCT03662360|12587880|FG000|COMPLETED|Overall Study||16
11394224|NCT03662360|12587881|FG001|COMPLETED|Overall Study||14
11394225|NCT03662360|12587880|FG000|NOT COMPLETED|Overall Study||0
11394226|NCT03662360|12587881|FG001|NOT COMPLETED|Overall Study||2
11394227|NCT03662750|12587888|FG000|STARTED|Overall Study||3
11394228|NCT03662750|12587888|FG000|COMPLETED|Overall Study||2
11394229|NCT03662750|12587888|FG000|NOT COMPLETED|Overall Study||1
11394230|NCT03662789|12587894|FG000|STARTED|Overall Study|Baseline|52
11394231|NCT03662789|12587895|FG001|STARTED|Overall Study|Baseline|50
11394232|NCT03662789|12587894|FG000|COMPLETED|Overall Study|Follow-up at 6 months|47
11394233|NCT03662789|12587895|FG001|COMPLETED|Overall Study|Follow-up at 6 months|43
11394234|NCT03662789|12587894|FG000|NOT COMPLETED|Overall Study||5
11394235|NCT03662789|12587895|FG001|NOT COMPLETED|Overall Study||7
11394236|NCT03662997|12587905|FG000|STARTED|Overall Study||11
11394237|NCT03662997|12587906|FG001|STARTED|Overall Study||10
11394238|NCT03662997|12587907|FG002|STARTED|Overall Study||11
11394239|NCT03662997|12587908|FG003|STARTED|Overall Study||8
11394240|NCT03662997|12587905|FG000|COMPLETED|Overall Study||11
11394241|NCT03662997|12587906|FG001|COMPLETED|Overall Study||8
11394242|NCT03662997|12587907|FG002|COMPLETED|Overall Study||11
11394243|NCT03662997|12587908|FG003|COMPLETED|Overall Study||8
11394244|NCT03662997|12587905|FG000|NOT COMPLETED|Overall Study||0
11394245|NCT03662997|12587906|FG001|NOT COMPLETED|Overall Study||2
11394246|NCT03662997|12587907|FG002|NOT COMPLETED|Overall Study||0
11394247|NCT03662997|12587908|FG003|NOT COMPLETED|Overall Study||0
11394248|NCT03663101|12587924|FG000|STARTED|Overall Study||4
11394249|NCT03663101|12587925|FG001|STARTED|Overall Study||3
11394250|NCT03663101|12587926|FG002|STARTED|Overall Study||5
11394251|NCT03663101|12587927|FG003|STARTED|Overall Study||4
11394252|NCT03663101|12587924|FG000|COMPLETED|Overall Study||4
11394253|NCT03663101|12587925|FG001|COMPLETED|Overall Study||3
11394254|NCT03663101|12587926|FG002|COMPLETED|Overall Study||5
11394255|NCT03663101|12587927|FG003|COMPLETED|Overall Study||4
11394256|NCT03663101|12587924|FG000|NOT COMPLETED|Overall Study||0
11394257|NCT03663101|12587925|FG001|NOT COMPLETED|Overall Study||0
11394258|NCT03663101|12587926|FG002|NOT COMPLETED|Overall Study||0
11394259|NCT03663101|12587927|FG003|NOT COMPLETED|Overall Study||0
11394260|NCT03663231|12587939|FG000|STARTED|First Intervention||16
11394261|NCT03663231|12587940|FG001|STARTED|First Intervention||13
11394262|NCT03663231|12587939|FG000|COMPLETED|First Intervention||14
11394263|NCT03663231|12587940|FG001|COMPLETED|First Intervention||12
11394264|NCT03663231|12587939|FG000|NOT COMPLETED|First Intervention||2
11394265|NCT03663231|12587940|FG001|NOT COMPLETED|First Intervention||1
11394266|NCT03663231|12587939|FG000|STARTED|Washout||14
11394267|NCT03663231|12587940|FG001|STARTED|Washout||12
11394268|NCT03663231|12587939|FG000|COMPLETED|Washout||14
11394269|NCT03663231|12587940|FG001|COMPLETED|Washout||12
11394270|NCT03663231|12587939|FG000|NOT COMPLETED|Washout||0
11394271|NCT03663231|12587940|FG001|NOT COMPLETED|Washout||0
11394272|NCT03663231|12587939|FG000|STARTED|Second Intervention||14
11394273|NCT03663231|12587940|FG001|STARTED|Second Intervention||12
11394274|NCT03663231|12587939|FG000|COMPLETED|Second Intervention||14
11394275|NCT03663231|12587940|FG001|COMPLETED|Second Intervention||12
11394276|NCT03663231|12587939|FG000|NOT COMPLETED|Second Intervention||0
11394277|NCT03663231|12587940|FG001|NOT COMPLETED|Second Intervention||0
11394278|NCT03663283|12587948|FG000|STARTED|Overall Study||52
11394279|NCT03663283|12587949|FG001|STARTED|Overall Study||52
11394280|NCT03663283|12587948|FG000|COMPLETED|Overall Study||52
11394281|NCT03663283|12587949|FG001|COMPLETED|Overall Study||52
11394282|NCT03663283|12587948|FG000|NOT COMPLETED|Overall Study||0
11394283|NCT03663283|12587949|FG001|NOT COMPLETED|Overall Study||0
11394284|NCT03663569|12587955|FG000|STARTED|Overall Study||4819
11394285|NCT03663569|12587955|FG000|COMPLETED|Overall Study||4756
11394286|NCT03663569|12587955|FG000|NOT COMPLETED|Overall Study||63
11394287|NCT03663582|12587959|FG000|STARTED|Overall Study||7
11394288|NCT03663582|12587959|FG000|COMPLETED|Overall Study||6
11394289|NCT03663582|12587959|FG000|NOT COMPLETED|Overall Study||1
11394290|NCT03663816|12587963|FG000|STARTED|Overall Study||15
11394291|NCT03663816|12587963|FG000|COMPLETED|Overall Study||15
11394292|NCT03663816|12587963|FG000|NOT COMPLETED|Overall Study||0
11394293|NCT03664193|12587967|FG000|STARTED|Overall Study||30
11394294|NCT03664193|12587967|FG000|COMPLETED|Overall Study||30
11394295|NCT03664193|12587967|FG000|NOT COMPLETED|Overall Study||0
11394296|NCT03664544|12587973|FG000|STARTED|Overall Study||6
11394297|NCT03664544|12587974|FG001|STARTED|Overall Study||6
11394298|NCT03664544|12587973|FG000|COMPLETED|Overall Study||6
11394299|NCT03664544|12587974|FG001|COMPLETED|Overall Study||6
11394300|NCT03664544|12587973|FG000|NOT COMPLETED|Overall Study||0
11394301|NCT03664544|12587974|FG001|NOT COMPLETED|Overall Study||0
11394302|NCT03665155|12587983|FG000|STARTED|Overall Study||3
11394303|NCT03665155|12587984|FG001|STARTED|Overall Study||7
11394304|NCT03665155|12587985|FG002|STARTED|Overall Study||1
11394305|NCT03665155|12587983|FG000|COMPLETED|Overall Study||3
11394306|NCT03665155|12587984|FG001|COMPLETED|Overall Study||7
11394307|NCT03665155|12587985|FG002|COMPLETED|Overall Study||1
11394308|NCT03665155|12587983|FG000|NOT COMPLETED|Overall Study||0
11394309|NCT03665155|12587984|FG001|NOT COMPLETED|Overall Study||0
11394310|NCT03665155|12587985|FG002|NOT COMPLETED|Overall Study||0
11394311|NCT03666026|12587995|FG000|STARTED|Overall Study||41070
11394312|NCT03666026|12587996|FG001|STARTED|Overall Study||41055
11394313|NCT03666026|12587997|FG002|STARTED|Overall Study||41046
11394314|NCT03666026|12587998|FG003|STARTED|Overall Study||41034
11394315|NCT03666026|12587995|FG000|COMPLETED|Overall Study||41070
11394316|NCT03666026|12587996|FG001|COMPLETED|Overall Study||41055
11394317|NCT03666026|12587997|FG002|COMPLETED|Overall Study||41046
11394318|NCT03666026|12587998|FG003|COMPLETED|Overall Study||41034
11394319|NCT03666026|12587995|FG000|NOT COMPLETED|Overall Study||0
11394320|NCT03666026|12587996|FG001|NOT COMPLETED|Overall Study||0
11394321|NCT03666026|12587997|FG002|NOT COMPLETED|Overall Study||0
11394322|NCT03666026|12587998|FG003|NOT COMPLETED|Overall Study||0
11394323|NCT03666663|12588012|FG000|STARTED|Overall Study||3
11394324|NCT03666663|12588013|FG001|STARTED|Overall Study||1
11394325|NCT03666663|12588014|FG002|STARTED|Overall Study||3
11394326|NCT03666663|12588015|FG003|STARTED|Overall Study||3
11394327|NCT03666663|12588012|FG000|COMPLETED|Overall Study||3
11394328|NCT03666663|12588013|FG001|COMPLETED|Overall Study||1
11394329|NCT03666663|12588014|FG002|COMPLETED|Overall Study||1
11394330|NCT03666663|12588015|FG003|COMPLETED|Overall Study||1
11394331|NCT03666663|12588012|FG000|NOT COMPLETED|Overall Study||0
11394332|NCT03666663|12588013|FG001|NOT COMPLETED|Overall Study||0
11394333|NCT03666663|12588014|FG002|NOT COMPLETED|Overall Study||2
11394334|NCT03666663|12588015|FG003|NOT COMPLETED|Overall Study||2
11394335|NCT03666858|12588025|FG000|STARTED|Cohort 1|All participants with TTH who had reported at least one headache and Neosaldina intake.|216
11394336|NCT03666858|12588026|FG001|STARTED|Cohort 1||0
11394337|NCT03666858|12588025|FG000|COMPLETED|Cohort 1||215
11394338|NCT03666858|12588026|FG001|COMPLETED|Cohort 1||0
11394339|NCT03666858|12588025|FG000|NOT COMPLETED|Cohort 1||1
11394340|NCT03666858|12588026|FG001|NOT COMPLETED|Cohort 1||0
11394341|NCT03666858|12588025|FG000|STARTED|Cohort 2||0
11394342|NCT03666858|12588026|FG001|STARTED|Cohort 2|Cohort 1 participants with pain intensity at 0,120minutes after Neosaldina/0 pain before 120minutes.|138
11394343|NCT03666858|12588025|FG000|COMPLETED|Cohort 2||0
11394344|NCT03666858|12588026|FG001|COMPLETED|Cohort 2||137
11394345|NCT03666858|12588025|FG000|NOT COMPLETED|Cohort 2||0
11394346|NCT03666858|12588026|FG001|NOT COMPLETED|Cohort 2||1
11394347|NCT03667053|12588035|FG000|STARTED|Overall Study||21
11394348|NCT03667053|12588036|FG001|STARTED|Overall Study||11
11394349|NCT03667053|12588037|FG002|STARTED|Overall Study||10
11394350|NCT03667053|12588035|FG000|Randomized and Treated|Overall Study||20
11394351|NCT03667053|12588036|FG001|Randomized and Treated|Overall Study||11
11394352|NCT03667053|12588037|FG002|Randomized and Treated|Overall Study||10
11394353|NCT03667053|12588035|FG000|COMPLETED|Overall Study||20
11394354|NCT03667053|12588036|FG001|COMPLETED|Overall Study||11
11394355|NCT03667053|12588037|FG002|COMPLETED|Overall Study||10
11394356|NCT03667053|12588035|FG000|NOT COMPLETED|Overall Study||1
11394357|NCT03667053|12588036|FG001|NOT COMPLETED|Overall Study||0
11394358|NCT03667053|12588037|FG002|NOT COMPLETED|Overall Study||0
11394359|NCT03667547|12588052|FG000|STARTED|Overall Study||12
11394360|NCT03667547|12588052|FG000|COMPLETED|Overall Study||12
11394361|NCT03667547|12588052|FG000|NOT COMPLETED|Overall Study||0
11394362|NCT03668600|12588056|FG000|STARTED|Overall Study||230
11394363|NCT03668600|12588056|FG000|COMPLETED|Overall Study||0
11394364|NCT03668600|12588056|FG000|NOT COMPLETED|Overall Study||230
11394365|NCT03668613|12588062|FG000|STARTED|Overall Study||42
11394366|NCT03668613|12588063|FG001|STARTED|Overall Study||42
11394367|NCT03668613|12588062|FG000|COMPLETED|Overall Study||42
11394368|NCT03668613|12588063|FG001|COMPLETED|Overall Study||39
11394369|NCT03668613|12588062|FG000|NOT COMPLETED|Overall Study||0
11394370|NCT03668613|12588063|FG001|NOT COMPLETED|Overall Study||3
11394371|NCT03669081|12588072|FG000|STARTED|Overall Study||34
11394372|NCT03669081|12588073|FG001|STARTED|Overall Study||30
11394373|NCT03669081|12588072|FG000|COMPLETED|Overall Study||33
11394374|NCT03669081|12588073|FG001|COMPLETED|Overall Study||29
11394375|NCT03669081|12588072|FG000|NOT COMPLETED|Overall Study||1
11394376|NCT03669081|12588073|FG001|NOT COMPLETED|Overall Study||1
11394377|NCT03669354|12588083|FG000|STARTED|Overall Study||73
11394378|NCT03669354|12588084|FG001|STARTED|Overall Study||22
11394379|NCT03669354|12588085|FG002|STARTED|Overall Study||47
11394380|NCT03669354|12588086|FG003|STARTED|Overall Study||53
11394381|NCT03669354|12588083|FG000|COMPLETED|Overall Study||73
11394382|NCT03669354|12588084|FG001|COMPLETED|Overall Study||22
11394383|NCT03669354|12588085|FG002|COMPLETED|Overall Study||47
11394384|NCT03669354|12588086|FG003|COMPLETED|Overall Study||53
11394385|NCT03669354|12588083|FG000|NOT COMPLETED|Overall Study||0
11394386|NCT03669354|12588084|FG001|NOT COMPLETED|Overall Study||0
11394387|NCT03669354|12588085|FG002|NOT COMPLETED|Overall Study||0
11394388|NCT03669354|12588086|FG003|NOT COMPLETED|Overall Study||0
11394389|NCT03669549|12588097|FG000|STARTED|Overall Study||15
11394390|NCT03669549|12588097|FG000|COMPLETED|Overall Study||9
11394391|NCT03669549|12588097|FG000|NOT COMPLETED|Overall Study||6
11394392|NCT03669861|12588105|FG000|STARTED|Overall Study||10
11394393|NCT03669861|12588105|FG000|COMPLETED|Overall Study||3
11394394|NCT03669861|12588105|FG000|NOT COMPLETED|Overall Study||7
11394395|NCT03670017|12588109|FG000|STARTED|Overall Study||68
11394396|NCT03670017|12588109|FG000|COMPLETED|Overall Study||50
11394397|NCT03670017|12588109|FG000|NOT COMPLETED|Overall Study||18
11394398|NCT03670030|12588113|FG000|STARTED|Overall Study||5
11394399|NCT03670030|12588113|FG000|COMPLETED|Overall Study||5
11394400|NCT03670030|12588113|FG000|NOT COMPLETED|Overall Study||0
11394401|NCT03670160|12588119|FG000|STARTED|Overall Study||11
11394402|NCT03670160|12588120|FG001|STARTED|Overall Study||14
11394403|NCT03670160|12588119|FG000|COMPLETED|Overall Study||11
11394404|NCT03670160|12588120|FG001|COMPLETED|Overall Study||14
11394405|NCT03670160|12588119|FG000|NOT COMPLETED|Overall Study||0
11394406|NCT03670160|12588120|FG001|NOT COMPLETED|Overall Study||0
11394407|NCT03670264|12588129|FG000|STARTED|Overall Study||5
11394408|NCT03670264|12588130|FG001|STARTED|Overall Study||5
11394409|NCT03670264|12588131|FG002|STARTED|Overall Study||5
11394410|NCT03670264|12588129|FG000|COMPLETED|Overall Study||5
11394411|NCT03670264|12588130|FG001|COMPLETED|Overall Study||5
11394412|NCT03670264|12588131|FG002|COMPLETED|Overall Study||5
11394413|NCT03670264|12588129|FG000|NOT COMPLETED|Overall Study||0
11394414|NCT03670264|12588130|FG001|NOT COMPLETED|Overall Study||0
11394415|NCT03670264|12588131|FG002|NOT COMPLETED|Overall Study||0
11394416|NCT03670537|12588139|FG000|STARTED|Overall Study||102
11394417|NCT03670537|12588139|FG000|COMPLETED|Overall Study||101
11394418|NCT03670537|12588139|FG000|NOT COMPLETED|Overall Study||1
11394419|NCT03670641|12588143|FG000|STARTED|Overall Study||10
11394420|NCT03670641|12588143|FG000|COMPLETED|Overall Study|3 participants were lost to follow up by 12 months|7
11394421|NCT03670641|12588143|FG000|NOT COMPLETED|Overall Study||3
11394422|NCT03672006|12588152|FG000|STARTED|Overall Study||10
11394423|NCT03672006|12588153|FG001|STARTED|Overall Study||10
11394424|NCT03672006|12588152|FG000|COMPLETED|Overall Study||10
11394425|NCT03672006|12588153|FG001|COMPLETED|Overall Study||9
11394426|NCT03672006|12588152|FG000|NOT COMPLETED|Overall Study||0
11394427|NCT03672006|12588153|FG001|NOT COMPLETED|Overall Study||1
11394428|NCT03672032|12588163|FG000|STARTED|Overall Study||67
11394429|NCT03672032|12588164|FG001|STARTED|Overall Study||67
11394430|NCT03672032|12588163|FG000|COMPLETED|Overall Study||67
11394431|NCT03672032|12588164|FG001|COMPLETED|Overall Study||67
11394432|NCT03672032|12588163|FG000|NOT COMPLETED|Overall Study||0
11394433|NCT03672032|12588164|FG001|NOT COMPLETED|Overall Study||0
11394434|NCT03672097|12588170|FG000|STARTED|Period 1||204
11394435|NCT03672097|12588170|FG000|COMPLETED|Period 1||200
11394436|NCT03672097|12588170|FG000|NOT COMPLETED|Period 1||4
11394437|NCT03672097|12588170|FG000|STARTED|Period 2||200
11394438|NCT03672097|12588170|FG000|COMPLETED|Period 2||196
11394439|NCT03672097|12588170|FG000|NOT COMPLETED|Period 2||4
11394440|NCT03672370|12588174|FG000|STARTED|Overall Study|11 hips did not receive the study devices acc. to the protocol and therefore had to be excluded.|89
11394441|NCT03672370|12588174|FG000|COMPLETED|Overall Study||42
11394442|NCT03672370|12588174|FG000|NOT COMPLETED|Overall Study||47
11394443|NCT03672396|12588178|FG000|STARTED|Overall Study||22
11394444|NCT03672396|12588178|FG000|COMPLETED|Overall Study||16
11394445|NCT03672396|12588178|FG000|NOT COMPLETED|Overall Study||6
11394446|NCT03673670|12588188|FG000|STARTED|Treatment Period 1 (3 Days)||14
11394447|NCT03673670|12588189|FG001|STARTED|Treatment Period 1 (3 Days)||14
11394448|NCT03673670|12588190|FG002|STARTED|Treatment Period 1 (3 Days)||13
11394449|NCT03673670|12588191|FG003|STARTED|Treatment Period 1 (3 Days)||12
11394450|NCT03673670|12588192|FG004|STARTED|Treatment Period 1 (3 Days)||13
11394451|NCT03673670|12588193|FG005|STARTED|Treatment Period 1 (3 Days)||13
11394452|NCT03673670|12588188|FG000|COMPLETED|Treatment Period 1 (3 Days)||13
11394453|NCT03673670|12588189|FG001|COMPLETED|Treatment Period 1 (3 Days)||14
11394454|NCT03673670|12588190|FG002|COMPLETED|Treatment Period 1 (3 Days)||12
11394455|NCT03673670|12588191|FG003|COMPLETED|Treatment Period 1 (3 Days)||12
11394456|NCT03673670|12588192|FG004|COMPLETED|Treatment Period 1 (3 Days)||13
11394457|NCT03673670|12588193|FG005|COMPLETED|Treatment Period 1 (3 Days)||11
11394458|NCT03673670|12588188|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||1
11394459|NCT03673670|12588189|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
11394460|NCT03673670|12588190|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||1
11394461|NCT03673670|12588191|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0
11394462|NCT03673670|12588192|FG004|NOT COMPLETED|Treatment Period 1 (3 Days)||0
11394463|NCT03673670|12588193|FG005|NOT COMPLETED|Treatment Period 1 (3 Days)||2
11394464|NCT03673670|12588188|FG000|STARTED|Washout Period 1 (7-14 Days)||13
11394465|NCT03673670|12588189|FG001|STARTED|Washout Period 1 (7-14 Days)||14
11394466|NCT03673670|12588190|FG002|STARTED|Washout Period 1 (7-14 Days)||12
11394467|NCT03673670|12588191|FG003|STARTED|Washout Period 1 (7-14 Days)||12
11394468|NCT03673670|12588192|FG004|STARTED|Washout Period 1 (7-14 Days)||13
11394469|NCT03673670|12588193|FG005|STARTED|Washout Period 1 (7-14 Days)||11
11394470|NCT03673670|12588188|FG000|COMPLETED|Washout Period 1 (7-14 Days)||13
11394471|NCT03673670|12588189|FG001|COMPLETED|Washout Period 1 (7-14 Days)||14
11394472|NCT03673670|12588190|FG002|COMPLETED|Washout Period 1 (7-14 Days)||12
11394473|NCT03673670|12588191|FG003|COMPLETED|Washout Period 1 (7-14 Days)||12
11394474|NCT03673670|12588192|FG004|COMPLETED|Washout Period 1 (7-14 Days)||13
11394475|NCT03673670|12588193|FG005|COMPLETED|Washout Period 1 (7-14 Days)||11
11394476|NCT03673670|12588188|FG000|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
11394477|NCT03673670|12588189|FG001|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
11394478|NCT03673670|12588190|FG002|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
11394479|NCT03673670|12588191|FG003|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
11394480|NCT03673670|12588192|FG004|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
11394481|NCT03673670|12588193|FG005|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
11394482|NCT03673670|12588188|FG000|STARTED|Treatment Period 2 (3 Days)||13
11394483|NCT03673670|12588189|FG001|STARTED|Treatment Period 2 (3 Days)||14
11394484|NCT03673670|12588190|FG002|STARTED|Treatment Period 2 (3 Days)||12
11394485|NCT03673670|12588191|FG003|STARTED|Treatment Period 2 (3 Days)||12
11394486|NCT03673670|12588192|FG004|STARTED|Treatment Period 2 (3 Days)||13
11394487|NCT03673670|12588193|FG005|STARTED|Treatment Period 2 (3 Days)||11
11394488|NCT03673670|12588188|FG000|COMPLETED|Treatment Period 2 (3 Days)||13
11394489|NCT03673670|12588189|FG001|COMPLETED|Treatment Period 2 (3 Days)||14
11394490|NCT03673670|12588190|FG002|COMPLETED|Treatment Period 2 (3 Days)||11
11394491|NCT03673670|12588191|FG003|COMPLETED|Treatment Period 2 (3 Days)||12
11394492|NCT03673670|12588192|FG004|COMPLETED|Treatment Period 2 (3 Days)||12
11394493|NCT03673670|12588193|FG005|COMPLETED|Treatment Period 2 (3 Days)||11
11394494|NCT03673670|12588188|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
11394495|NCT03673670|12588189|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0
11394496|NCT03673670|12588190|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||1
11394497|NCT03673670|12588191|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0
11394498|NCT03673670|12588192|FG004|NOT COMPLETED|Treatment Period 2 (3 Days)||1
11394499|NCT03673670|12588193|FG005|NOT COMPLETED|Treatment Period 2 (3 Days)||0
11394500|NCT03673670|12588188|FG000|STARTED|Washout Period 2 (7-14 Days)||13
11394501|NCT03673670|12588189|FG001|STARTED|Washout Period 2 (7-14 Days)||14
11394502|NCT03673670|12588190|FG002|STARTED|Washout Period 2 (7-14 Days)||11
11394503|NCT03673670|12588191|FG003|STARTED|Washout Period 2 (7-14 Days)||12
11394504|NCT03673670|12588192|FG004|STARTED|Washout Period 2 (7-14 Days)||12
11394505|NCT03673670|12588193|FG005|STARTED|Washout Period 2 (7-14 Days)||11
11394506|NCT03673670|12588188|FG000|COMPLETED|Washout Period 2 (7-14 Days)||13
11394507|NCT03673670|12588189|FG001|COMPLETED|Washout Period 2 (7-14 Days)||14
11394508|NCT03673670|12588190|FG002|COMPLETED|Washout Period 2 (7-14 Days)||11
11394509|NCT03673670|12588191|FG003|COMPLETED|Washout Period 2 (7-14 Days)||12
11394510|NCT03673670|12588192|FG004|COMPLETED|Washout Period 2 (7-14 Days)||11
11394511|NCT03673670|12588193|FG005|COMPLETED|Washout Period 2 (7-14 Days)||11
11394512|NCT03673670|12588188|FG000|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
11394513|NCT03673670|12588189|FG001|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
11394514|NCT03673670|12588190|FG002|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
11394515|NCT03673670|12588191|FG003|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
11394516|NCT03673670|12588192|FG004|NOT COMPLETED|Washout Period 2 (7-14 Days)||1
11394517|NCT03673670|12588193|FG005|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
11394518|NCT03673670|12588188|FG000|STARTED|Treatment Period 3 (3 Days)||13
11394519|NCT03673670|12588189|FG001|STARTED|Treatment Period 3 (3 Days)||14
11394520|NCT03673670|12588190|FG002|STARTED|Treatment Period 3 (3 Days)||11
11394521|NCT03673670|12588191|FG003|STARTED|Treatment Period 3 (3 Days)||12
11394522|NCT03673670|12588192|FG004|STARTED|Treatment Period 3 (3 Days)||11
11394523|NCT03673670|12588193|FG005|STARTED|Treatment Period 3 (3 Days)||11
11394524|NCT03673670|12588188|FG000|COMPLETED|Treatment Period 3 (3 Days)||13
11394525|NCT03673670|12588189|FG001|COMPLETED|Treatment Period 3 (3 Days)||14
11394526|NCT03673670|12588190|FG002|COMPLETED|Treatment Period 3 (3 Days)||11
11394527|NCT03673670|12588191|FG003|COMPLETED|Treatment Period 3 (3 Days)||12
11394528|NCT03673670|12588192|FG004|COMPLETED|Treatment Period 3 (3 Days)||10
11394529|NCT03673670|12588193|FG005|COMPLETED|Treatment Period 3 (3 Days)||11
11394530|NCT03673670|12588188|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
11394531|NCT03673670|12588189|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
11394532|NCT03673670|12588190|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
11394533|NCT03673670|12588191|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0
11394534|NCT03673670|12588192|FG004|NOT COMPLETED|Treatment Period 3 (3 Days)||1
11394535|NCT03673670|12588193|FG005|NOT COMPLETED|Treatment Period 3 (3 Days)||0
11394536|NCT03674177|12588214|FG000|STARTED|Overall Study||124
11394537|NCT03674177|12588215|FG001|STARTED|Overall Study||126
11394538|NCT03674177|12588216|FG002|STARTED|Overall Study||126
11394539|NCT03674177|12588217|FG003|STARTED|Overall Study||126
11394540|NCT03674177|12588214|FG000|COMPLETED|Overall Study||122
11394541|NCT03674177|12588215|FG001|COMPLETED|Overall Study||125
11394542|NCT03674177|12588216|FG002|COMPLETED|Overall Study||126
11394543|NCT03674177|12588217|FG003|COMPLETED|Overall Study||124
11394544|NCT03674177|12588214|FG000|NOT COMPLETED|Overall Study||2
11394545|NCT03674177|12588215|FG001|NOT COMPLETED|Overall Study||1
11394546|NCT03674177|12588216|FG002|NOT COMPLETED|Overall Study||0
11394547|NCT03674177|12588217|FG003|NOT COMPLETED|Overall Study||2
11394548|NCT03674281|12588230|FG000|STARTED|Overall Study||18
11394549|NCT03674281|12588231|FG001|STARTED|Overall Study||16
11394550|NCT03674281|12588232|FG002|STARTED|Overall Study||16
11394551|NCT03674281|12588230|FG000|COMPLETED|Overall Study||15
11394552|NCT03674281|12588231|FG001|COMPLETED|Overall Study||13
11394553|NCT03674281|12588232|FG002|COMPLETED|Overall Study||13
11394554|NCT03674281|12588230|FG000|NOT COMPLETED|Overall Study||3
11394555|NCT03674281|12588231|FG001|NOT COMPLETED|Overall Study||3
11394556|NCT03674281|12588232|FG002|NOT COMPLETED|Overall Study||3
11394557|NCT03674970|12588251|FG000|STARTED|Overall Study||15
11394558|NCT03674970|12588252|FG001|STARTED|Overall Study||15
11394559|NCT03674970|12588253|FG002|STARTED|Overall Study||15
11394560|NCT03674970|12588251|FG000|COMPLETED|Overall Study||12
11394561|NCT03674970|12588252|FG001|COMPLETED|Overall Study||8
11394562|NCT03674970|12588253|FG002|COMPLETED|Overall Study||12
11394563|NCT03674970|12588251|FG000|NOT COMPLETED|Overall Study||3
11394564|NCT03674970|12588252|FG001|NOT COMPLETED|Overall Study||7
11394565|NCT03674970|12588253|FG002|NOT COMPLETED|Overall Study||3
11394566|NCT03675451|12588261|FG000|STARTED|Overall Study||20
11394567|NCT03675451|12588261|FG000|COMPLETED|Overall Study||20
11394568|NCT03675451|12588261|FG000|NOT COMPLETED|Overall Study||0
11394569|NCT03675581|12588272|FG000|STARTED|Period 1: Microgynon Alone||17
11394570|NCT03675581|12588272|FG000|COMPLETED|Period 1: Microgynon Alone||17
11394571|NCT03675581|12588272|FG000|NOT COMPLETED|Period 1: Microgynon Alone||0
11394572|NCT03675581|12588272|FG000|STARTED|Period 2: Microgynon + Nintedanib||17
11394573|NCT03675581|12588272|FG000|COMPLETED|Period 2: Microgynon + Nintedanib||17
11394574|NCT03675581|12588272|FG000|NOT COMPLETED|Period 2: Microgynon + Nintedanib||0
11394575|NCT03675685|12588280|FG000|STARTED|Overall Study||12
11394576|NCT03675685|12588280|FG000|COMPLETED|Overall Study||12
11394577|NCT03675685|12588280|FG000|NOT COMPLETED|Overall Study||0
11394578|NCT03675776|12588291|FG000|STARTED|Double Blind Treatment Period||15
11394579|NCT03675776|12588292|FG001|STARTED|Double Blind Treatment Period||17
11394580|NCT03675776|12588293|FG002|STARTED|Double Blind Treatment Period||18
11394581|NCT03675776|12588291|FG000|COMPLETED|Double Blind Treatment Period||9
11394582|NCT03675776|12588292|FG001|COMPLETED|Double Blind Treatment Period||11
11394583|NCT03675776|12588293|FG002|COMPLETED|Double Blind Treatment Period||10
11394584|NCT03675776|12588291|FG000|NOT COMPLETED|Double Blind Treatment Period||6
11394585|NCT03675776|12588292|FG001|NOT COMPLETED|Double Blind Treatment Period||6
11394586|NCT03675776|12588293|FG002|NOT COMPLETED|Double Blind Treatment Period||8
11394587|NCT03675776|12588291|FG000|STARTED|Safety Follow-up Period||6
11394588|NCT03675776|12588292|FG001|STARTED|Safety Follow-up Period||8
11394589|NCT03675776|12588293|FG002|STARTED|Safety Follow-up Period||7
11394590|NCT03675776|12588291|FG000|COMPLETED|Safety Follow-up Period||6
11394591|NCT03675776|12588292|FG001|COMPLETED|Safety Follow-up Period||8
11394592|NCT03675776|12588293|FG002|COMPLETED|Safety Follow-up Period||7
11394593|NCT03675776|12588291|FG000|NOT COMPLETED|Safety Follow-up Period||0
11394594|NCT03675776|12588292|FG001|NOT COMPLETED|Safety Follow-up Period||0
11394595|NCT03675776|12588293|FG002|NOT COMPLETED|Safety Follow-up Period||0
11394596|NCT03676270|12588301|FG000|STARTED|Overall Study||6915
11394597|NCT03676270|12588301|FG000|COMPLETED|Overall Study||6915
11394598|NCT03676270|12588301|FG000|NOT COMPLETED|Overall Study||0
11394599|NCT03676634|12588305|FG000|STARTED|Overall Study||32
11394600|NCT03676634|12588305|FG000|Screening|Overall Study||32
11394601|NCT03676634|12588305|FG000|Participants Received rBV A/B Injection|Overall Study||32
11394602|NCT03676634|12588305|FG000|Participants Included in the Plasma-donating Population|Overall Study||32
11394603|NCT03676634|12588305|FG000|Participants Completed Follow up|Overall Study||32
11394604|NCT03676634|12588305|FG000|COMPLETED|Overall Study||29
11394605|NCT03676634|12588305|FG000|NOT COMPLETED|Overall Study||3
11394606|NCT03676725|12588315|FG000|STARTED|Overall Study||23
11394607|NCT03676725|12588316|FG001|STARTED|Overall Study||14
11394608|NCT03676725|12588317|FG002|STARTED|Overall Study||22
11394609|NCT03676725|12588318|FG003|STARTED|Overall Study||5
11394610|NCT03676725|12588319|FG004|STARTED|Overall Study||15
11394611|NCT03676725|12588320|FG005|STARTED|Overall Study||11
11394612|NCT03676725|12588315|FG000|COMPLETED|Overall Study||23
11394613|NCT03676725|12588316|FG001|COMPLETED|Overall Study||14
11394614|NCT03676725|12588317|FG002|COMPLETED|Overall Study||22
11394615|NCT03676725|12588318|FG003|COMPLETED|Overall Study||5
11394616|NCT03676725|12588319|FG004|COMPLETED|Overall Study||15
11394617|NCT03676725|12588320|FG005|COMPLETED|Overall Study||11
11394618|NCT03676725|12588315|FG000|NOT COMPLETED|Overall Study||0
11394619|NCT03676725|12588316|FG001|NOT COMPLETED|Overall Study||0
11394620|NCT03676725|12588317|FG002|NOT COMPLETED|Overall Study||0
11394621|NCT03676725|12588318|FG003|NOT COMPLETED|Overall Study||0
11394622|NCT03676725|12588319|FG004|NOT COMPLETED|Overall Study||0
11394623|NCT03676725|12588320|FG005|NOT COMPLETED|Overall Study||0
11394624|NCT03676803|12588331|FG000|STARTED|Overall Study||15
11394625|NCT03676803|12588332|FG001|STARTED|Overall Study||16
11394626|NCT03676803|12588331|FG000|COMPLETED|Overall Study||15
11394627|NCT03676803|12588332|FG001|COMPLETED|Overall Study||16
11394628|NCT03676803|12588331|FG000|NOT COMPLETED|Overall Study||0
11394629|NCT03676803|12588332|FG001|NOT COMPLETED|Overall Study||0
11394630|NCT03676972|12588340|FG000|STARTED|Overall Study||60
11394631|NCT03676972|12588340|FG000|COMPLETED|Overall Study||58
11394632|NCT03676972|12588340|FG000|NOT COMPLETED|Overall Study||2
11394633|NCT03677089|12588344|FG000|STARTED|Overall Study||148
11394634|NCT03677089|12588344|FG000|Baseline/Pre-Intervention|Overall Study||137
11394635|NCT03677089|12588344|FG000|Mid-Intervention|Overall Study||120
11394636|NCT03677089|12588344|FG000|Post-Intervention|Overall Study||117
11394637|NCT03677089|12588344|FG000|Follow-Up|Overall Study||114
11394638|NCT03677089|12588344|FG000|COMPLETED|Overall Study||114
11394639|NCT03677089|12588344|FG000|NOT COMPLETED|Overall Study||34
11394640|NCT03677245|12588352|FG000|STARTED|Overall Study||8
11394641|NCT03677245|12588352|FG000|COMPLETED|Overall Study||8
11394642|NCT03677245|12588352|FG000|NOT COMPLETED|Overall Study||0
11394643|NCT03677375|12588357|FG000|STARTED|Overall Study||93
11394644|NCT03677375|12588357|FG000|COMPLETED|Overall Study||81
11394645|NCT03677375|12588357|FG000|NOT COMPLETED|Overall Study||12
11394646|NCT03677401|12588363|FG000|STARTED|Overall Study||148
11394647|NCT03677401|12588364|FG001|STARTED|Overall Study||147
11394648|NCT03677401|12588363|FG000|COMPLETED|Overall Study||138
11394649|NCT03677401|12588364|FG001|COMPLETED|Overall Study||129
11394650|NCT03677401|12588363|FG000|NOT COMPLETED|Overall Study||10
11394651|NCT03677401|12588364|FG001|NOT COMPLETED|Overall Study||18
11394652|NCT03678103|12588370|FG000|STARTED|Overall Study||30
11394653|NCT03678103|12588370|FG000|COMPLETED|Overall Study||26
11394654|NCT03678103|12588370|FG000|NOT COMPLETED|Overall Study||4
11394655|NCT03678285|12588374|FG000|STARTED|Overall Study||42
11394656|NCT03678285|12588374|FG000|Started Workout|Overall Study||40
11394657|NCT03678285|12588374|FG000|COMPLETED|Overall Study||38
11394658|NCT03678285|12588374|FG000|NOT COMPLETED|Overall Study||4
11394659|NCT03678311|12588378|FG000|STARTED|Overall Study||9
11394660|NCT03678311|12588378|FG000|COMPLETED|Overall Study||9
11394661|NCT03678311|12588378|FG000|NOT COMPLETED|Overall Study||0
11394662|NCT03678870|12588384|FG000|STARTED|Overall Study||97
11394663|NCT03678870|12588385|FG001|STARTED|Overall Study||99
11394664|NCT03678870|12588384|FG000|COMPLETED|Overall Study||84
11394665|NCT03678870|12588385|FG001|COMPLETED|Overall Study||91
11394666|NCT03678870|12588384|FG000|NOT COMPLETED|Overall Study||13
11394667|NCT03678870|12588385|FG001|NOT COMPLETED|Overall Study||8
11394668|NCT03679494|12588393|FG000|STARTED|Overall Study||67
11394669|NCT03679494|12588394|FG001|STARTED|Overall Study||63
11394670|NCT03679494|12588393|FG000|COMPLETED|Overall Study||67
11394671|NCT03679494|12588394|FG001|COMPLETED|Overall Study||63
11394672|NCT03679494|12588393|FG000|NOT COMPLETED|Overall Study||0
11394673|NCT03679494|12588394|FG001|NOT COMPLETED|Overall Study||0
11394674|NCT03679741|12588400|FG000|STARTED|Period 1||59
11394675|NCT03679741|12588401|FG001|STARTED|Period 1||61
11394676|NCT03679741|12588400|FG000|COMPLETED|Period 1||57
11394677|NCT03679741|12588401|FG001|COMPLETED|Period 1||58
11394678|NCT03679741|12588400|FG000|NOT COMPLETED|Period 1||2
11394679|NCT03679741|12588401|FG001|NOT COMPLETED|Period 1||3
11394680|NCT03679741|12588400|FG000|STARTED|Period 2||57
11394681|NCT03679741|12588401|FG001|STARTED|Period 2||58
11394682|NCT03679741|12588400|FG000|COMPLETED|Period 2||54
11394683|NCT03679741|12588401|FG001|COMPLETED|Period 2||56
11394684|NCT03679741|12588400|FG000|NOT COMPLETED|Period 2||3
11394685|NCT03679741|12588401|FG001|NOT COMPLETED|Period 2||2
11394686|NCT03679741|12588400|FG000|STARTED|Period 3||54
11394687|NCT03679741|12588401|FG001|STARTED|Period 3||56
11394688|NCT03679741|12588400|FG000|COMPLETED|Period 3||54
11394689|NCT03679741|12588401|FG001|COMPLETED|Period 3||56
11394690|NCT03679741|12588400|FG000|NOT COMPLETED|Period 3||0
11394691|NCT03679741|12588401|FG001|NOT COMPLETED|Period 3||0
11394692|NCT03679975|12588407|FG000|STARTED|Overall Study||9
11394693|NCT03679975|12588407|FG000|COMPLETED|Overall Study||9
11394694|NCT03679975|12588407|FG000|NOT COMPLETED|Overall Study||0
11394695|NCT03680105|12588420|FG000|STARTED|Overall Study||8
11394696|NCT03680105|12588421|FG001|STARTED|Overall Study||8
11394697|NCT03680105|12588422|FG002|STARTED|Overall Study||8
11394698|NCT03680105|12588423|FG003|STARTED|Overall Study||8
11394699|NCT03680105|12588424|FG004|STARTED|Overall Study||8
11394700|NCT03680105|12588425|FG005|STARTED|Overall Study||12
11394701|NCT03680105|12588426|FG006|STARTED|Overall Study||8
11394702|NCT03680105|12588427|FG007|STARTED|Overall Study||8
11394703|NCT03680105|12588428|FG008|STARTED|Overall Study||8
11394704|NCT03680105|12588420|FG000|COMPLETED|Overall Study||8
11394705|NCT03680105|12588421|FG001|COMPLETED|Overall Study||8
11394706|NCT03680105|12588422|FG002|COMPLETED|Overall Study||8
11394707|NCT03680105|12588423|FG003|COMPLETED|Overall Study||8
11394708|NCT03680105|12588424|FG004|COMPLETED|Overall Study||8
11394709|NCT03680105|12588425|FG005|COMPLETED|Overall Study||12
11394710|NCT03680105|12588426|FG006|COMPLETED|Overall Study||8
11394711|NCT03680105|12588427|FG007|COMPLETED|Overall Study||8
11394712|NCT03680105|12588428|FG008|COMPLETED|Overall Study||8
11394713|NCT03680105|12588420|FG000|NOT COMPLETED|Overall Study||0
11394714|NCT03680105|12588421|FG001|NOT COMPLETED|Overall Study||0
11394715|NCT03680105|12588422|FG002|NOT COMPLETED|Overall Study||0
11394716|NCT03680105|12588423|FG003|NOT COMPLETED|Overall Study||0
11394717|NCT03680105|12588424|FG004|NOT COMPLETED|Overall Study||0
11394718|NCT03680105|12588425|FG005|NOT COMPLETED|Overall Study||0
11394719|NCT03680105|12588426|FG006|NOT COMPLETED|Overall Study||0
11394720|NCT03680105|12588427|FG007|NOT COMPLETED|Overall Study||0
11394721|NCT03680105|12588428|FG008|NOT COMPLETED|Overall Study||0
11394722|NCT03680521|12588454|FG000|STARTED|Overall Study||7
11394723|NCT03680521|12588455|FG001|STARTED|Overall Study||13
11394724|NCT03680521|12588454|FG000|COMPLETED|Overall Study||0
11394725|NCT03680521|12588455|FG001|COMPLETED|Overall Study||2
11394726|NCT03680521|12588454|FG000|NOT COMPLETED|Overall Study||7
11394727|NCT03680521|12588455|FG001|NOT COMPLETED|Overall Study||11
11394728|NCT03680742|12588464|FG000|STARTED|Overall Study||34
11394729|NCT03680742|12588464|FG000|COMPLETED|Overall Study||32
11394730|NCT03680742|12588464|FG000|NOT COMPLETED|Overall Study||2
11394731|NCT03681093|12588471|FG000|STARTED|Overall Study||32
11394732|NCT03681093|12588472|FG001|STARTED|Overall Study||34
11394733|NCT03681093|12588473|FG002|STARTED|Overall Study||32
11394734|NCT03681093|12588471|FG000|Full Analysis Set (FAS)|Overall Study||31
11394735|NCT03681093|12588472|FG001|Full Analysis Set (FAS)|Overall Study||32
11394736|NCT03681093|12588473|FG002|Full Analysis Set (FAS)|Overall Study||28
11394737|NCT03681093|12588471|FG000|Safety Analysis Set (SAF)|Overall Study||32
11394738|NCT03681093|12588472|FG001|Safety Analysis Set (SAF)|Overall Study||34
11394739|NCT03681093|12588473|FG002|Safety Analysis Set (SAF)|Overall Study||32
11394740|NCT03681093|12588471|FG000|COMPLETED|Overall Study||32
11394741|NCT03681093|12588472|FG001|COMPLETED|Overall Study||32
11394742|NCT03681093|12588473|FG002|COMPLETED|Overall Study||31
11394743|NCT03681093|12588471|FG000|NOT COMPLETED|Overall Study||0
11394744|NCT03681093|12588472|FG001|NOT COMPLETED|Overall Study||2
11394745|NCT03681093|12588473|FG002|NOT COMPLETED|Overall Study||1
11394746|NCT03681119|12588483|FG000|STARTED|Overall Study||72
11394747|NCT03681119|12588484|FG001|STARTED|Overall Study||11
11394748|NCT03681119|12588483|FG000|COMPLETED|Overall Study||66
11394749|NCT03681119|12588484|FG001|COMPLETED|Overall Study||11
11394750|NCT03681119|12588483|FG000|NOT COMPLETED|Overall Study||6
11394751|NCT03681119|12588484|FG001|NOT COMPLETED|Overall Study||0
11394752|NCT03681353|12588488|FG000|STARTED|Overall Study||25
11394753|NCT03681353|12588488|FG000|COMPLETED|Overall Study||18
11394754|NCT03681353|12588488|FG000|NOT COMPLETED|Overall Study||7
11394755|NCT03681405|12588494|FG000|STARTED|Overall Study||14
11394756|NCT03681405|12588495|FG001|STARTED|Overall Study||17
11394757|NCT03681405|12588494|FG000|COMPLETED|Overall Study||13
11394758|NCT03681405|12588495|FG001|COMPLETED|Overall Study||17
11394759|NCT03681405|12588494|FG000|NOT COMPLETED|Overall Study||1
11394760|NCT03681405|12588495|FG001|NOT COMPLETED|Overall Study||0
11394761|NCT03681808|12588505|FG000|STARTED|Overall Study||123
11394762|NCT03681808|12588506|FG001|STARTED|Overall Study||119
11394763|NCT03681808|12588505|FG000|COMPLETED|Overall Study||109
11394764|NCT03681808|12588506|FG001|COMPLETED|Overall Study||102
11394765|NCT03681808|12588505|FG000|NOT COMPLETED|Overall Study||14
11394766|NCT03681808|12588506|FG001|NOT COMPLETED|Overall Study||17
11394767|NCT03681886|12588512|FG000|STARTED|Overall Study||78
11394768|NCT03681886|12588512|FG000|Successful Implantation|Overall Study||76
11394769|NCT03681886|12588512|FG000|Failed Implantation|Overall Study||2
11394770|NCT03681886|12588512|FG000|Underwent Optic Exchange|Overall Study||4
11394771|NCT03681886|12588512|FG000|COMPLETED|Overall Study||76
11394772|NCT03681886|12588512|FG000|NOT COMPLETED|Overall Study||2
11394773|NCT03681951|12588541|FG000|STARTED|Part1: Monotherapy DE (Up to Day 95)||8
11394774|NCT03681951|12588542|FG001|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
11394775|NCT03681951|12588543|FG002|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID."|0
11394776|NCT03681951|12588544|FG003|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
11394777|NCT03681951|12588545|FG004|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
11394778|NCT03681951|12588546|FG005|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 2 was not initiated as this study was terminated during Part 1|0
11394779|NCT03681951|12588547|FG006|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 3 was not initiated as this study was terminated during Part 1|0
11394780|NCT03681951|12588548|FG007|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 4 was not initiated as this study was terminated during Part 1|0
11394781|NCT03681951|12588541|FG000|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394782|NCT03681951|12588542|FG001|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394783|NCT03681951|12588543|FG002|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394784|NCT03681951|12588544|FG003|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394785|NCT03681951|12588545|FG004|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394786|NCT03681951|12588546|FG005|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394787|NCT03681951|12588547|FG006|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394788|NCT03681951|12588548|FG007|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394789|NCT03681951|12588541|FG000|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||8
11394790|NCT03681951|12588542|FG001|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394791|NCT03681951|12588543|FG002|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394792|NCT03681951|12588544|FG003|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394793|NCT03681951|12588545|FG004|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394794|NCT03681951|12588546|FG005|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394795|NCT03681951|12588547|FG006|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394796|NCT03681951|12588548|FG007|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
11394797|NCT03681951|12588541|FG000|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
11394798|NCT03681951|12588542|FG001|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
11394799|NCT03681951|12588543|FG002|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
11394800|NCT03681951|12588544|FG003|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
11394801|NCT03681951|12588545|FG004|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
11394802|NCT03681951|12588546|FG005|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
11394803|NCT03681951|12588547|FG006|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
11394804|NCT03681951|12588548|FG007|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
11394805|NCT03681951|12588541|FG000|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394806|NCT03681951|12588542|FG001|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394807|NCT03681951|12588543|FG002|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394808|NCT03681951|12588544|FG003|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394809|NCT03681951|12588545|FG004|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11006213|NCT00727194|12183970|FG002|NOT COMPLETED|Washout Period||0
11006214|NCT00727194|12183968|FG000|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
11394810|NCT03681951|12588546|FG005|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394811|NCT03681951|12588547|FG006|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394812|NCT03681951|12588548|FG007|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394813|NCT03681951|12588541|FG000|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394814|NCT03681951|12588542|FG001|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394815|NCT03681951|12588543|FG002|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394816|NCT03681951|12588544|FG003|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394817|NCT03681951|12588545|FG004|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394818|NCT03681951|12588546|FG005|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394819|NCT03681951|12588547|FG006|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394820|NCT03681951|12588548|FG007|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
11394821|NCT03681951|12588541|FG000|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394822|NCT03681951|12588542|FG001|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394823|NCT03681951|12588543|FG002|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394824|NCT03681951|12588544|FG003|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394825|NCT03681951|12588545|FG004|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394826|NCT03681951|12588546|FG005|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394827|NCT03681951|12588547|FG006|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394828|NCT03681951|12588548|FG007|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394829|NCT03681951|12588541|FG000|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394830|NCT03681951|12588542|FG001|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394831|NCT03681951|12588543|FG002|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394832|NCT03681951|12588544|FG003|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394833|NCT03681951|12588545|FG004|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394834|NCT03681951|12588546|FG005|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394835|NCT03681951|12588547|FG006|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394836|NCT03681951|12588548|FG007|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394837|NCT03681951|12588541|FG000|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394838|NCT03681951|12588542|FG001|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394839|NCT03681951|12588543|FG002|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394840|NCT03681951|12588544|FG003|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394841|NCT03681951|12588545|FG004|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394842|NCT03681951|12588546|FG005|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394843|NCT03681951|12588547|FG006|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394844|NCT03681951|12588548|FG007|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
11394845|NCT03681951|12588541|FG000|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394846|NCT03681951|12588542|FG001|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394847|NCT03681951|12588543|FG002|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394848|NCT03681951|12588544|FG003|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394849|NCT03681951|12588545|FG004|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394850|NCT03681951|12588546|FG005|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394851|NCT03681951|12588547|FG006|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394852|NCT03681951|12588548|FG007|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394853|NCT03681951|12588541|FG000|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394854|NCT03681951|12588542|FG001|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394855|NCT03681951|12588543|FG002|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394856|NCT03681951|12588544|FG003|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394857|NCT03681951|12588545|FG004|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394858|NCT03681951|12588546|FG005|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394859|NCT03681951|12588547|FG006|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394860|NCT03681951|12588548|FG007|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394861|NCT03681951|12588541|FG000|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394862|NCT03681951|12588542|FG001|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394863|NCT03681951|12588543|FG002|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394864|NCT03681951|12588544|FG003|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394865|NCT03681951|12588545|FG004|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394866|NCT03681951|12588546|FG005|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394867|NCT03681951|12588547|FG006|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394868|NCT03681951|12588548|FG007|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
11394869|NCT03682107|12588576|FG000|STARTED|Overall Study||10
11394870|NCT03682107|12588577|FG001|STARTED|Overall Study||10
11394871|NCT03682107|12588578|FG002|STARTED|Overall Study||10
11394872|NCT03682107|12588579|FG003|STARTED|Overall Study||10
11394873|NCT03682107|12588580|FG004|STARTED|Overall Study||8
11394874|NCT03682107|12588576|FG000|COMPLETED|Overall Study||10
11394875|NCT03682107|12588577|FG001|COMPLETED|Overall Study||9
11394876|NCT03682107|12588578|FG002|COMPLETED|Overall Study||10
11394877|NCT03682107|12588579|FG003|COMPLETED|Overall Study||10
11394878|NCT03682107|12588580|FG004|COMPLETED|Overall Study||8
11394879|NCT03682107|12588576|FG000|NOT COMPLETED|Overall Study||0
11394880|NCT03682107|12588577|FG001|NOT COMPLETED|Overall Study||1
11394881|NCT03682107|12588578|FG002|NOT COMPLETED|Overall Study||0
11394882|NCT03682107|12588579|FG003|NOT COMPLETED|Overall Study||0
11394883|NCT03682107|12588580|FG004|NOT COMPLETED|Overall Study||0
11394884|NCT03682120|12588596|FG000|STARTED|Overall Study||105
11394885|NCT03682120|12588597|FG001|STARTED|Overall Study||105
11394886|NCT03682120|12588598|FG002|STARTED|Overall Study||105
11394887|NCT03682120|12588599|FG003|STARTED|Overall Study||57
11394888|NCT03682120|12588596|FG000|COMPLETED|Overall Study||92
11394889|NCT03682120|12588597|FG001|COMPLETED|Overall Study||97
11394890|NCT03682120|12588598|FG002|COMPLETED|Overall Study||97
11394891|NCT03682120|12588599|FG003|COMPLETED|Overall Study||55
11394892|NCT03682120|12588596|FG000|NOT COMPLETED|Overall Study||13
11394893|NCT03682120|12588597|FG001|NOT COMPLETED|Overall Study||8
11394894|NCT03682120|12588598|FG002|NOT COMPLETED|Overall Study||8
11394895|NCT03682120|12588599|FG003|NOT COMPLETED|Overall Study||2
11394896|NCT03682302|12588615|FG000|STARTED|Overall Study||31
11394897|NCT03682302|12588616|FG001|STARTED|Overall Study||30
11394898|NCT03682302|12588617|FG002|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|6
11394899|NCT03682302|12588618|FG003|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|30
11394900|NCT03682302|12588615|FG000|COMPLETED|Overall Study||30
11394901|NCT03682302|12588616|FG001|COMPLETED|Overall Study||28
11394902|NCT03682302|12588617|FG002|COMPLETED|Overall Study||5
11394903|NCT03682302|12588618|FG003|COMPLETED|Overall Study||28
11394904|NCT03682302|12588615|FG000|NOT COMPLETED|Overall Study||1
11394905|NCT03682302|12588616|FG001|NOT COMPLETED|Overall Study||2
11394906|NCT03682302|12588617|FG002|NOT COMPLETED|Overall Study||1
11394907|NCT03682302|12588618|FG003|NOT COMPLETED|Overall Study||2
11394908|NCT03682705|12588634|FG000|STARTED|Overall Study||19
11394909|NCT03682705|12588635|FG001|STARTED|Overall Study||62
11394910|NCT03682705|12588636|FG002|STARTED|Overall Study||41
11394911|NCT03682705|12588637|FG003|STARTED|Overall Study||39
11394912|NCT03682705|12588638|FG004|STARTED|Overall Study||41
11394913|NCT03682705|12588639|FG005|STARTED|Overall Study||40
11394914|NCT03682705|12588634|FG000|COMPLETED|Overall Study||17
11394915|NCT03682705|12588635|FG001|COMPLETED|Overall Study||58
11394916|NCT03682705|12588636|FG002|COMPLETED|Overall Study||38
11394917|NCT03682705|12588637|FG003|COMPLETED|Overall Study||34
11394918|NCT03682705|12588638|FG004|COMPLETED|Overall Study||35
11394919|NCT03682705|12588639|FG005|COMPLETED|Overall Study||38
11394920|NCT03682705|12588634|FG000|NOT COMPLETED|Overall Study||2
11394921|NCT03682705|12588635|FG001|NOT COMPLETED|Overall Study||4
11394922|NCT03682705|12588636|FG002|NOT COMPLETED|Overall Study||3
11394923|NCT03682705|12588637|FG003|NOT COMPLETED|Overall Study||5
11394924|NCT03682705|12588638|FG004|NOT COMPLETED|Overall Study||6
11394925|NCT03682705|12588639|FG005|NOT COMPLETED|Overall Study||2
11394926|NCT03682809|12588655|FG000|STARTED|Overall Study||22
11394927|NCT03682809|12588656|FG001|STARTED|Overall Study||24
11394928|NCT03682809|12588655|FG000|COMPLETED|Overall Study||22
11394929|NCT03682809|12588656|FG001|COMPLETED|Overall Study||24
11394930|NCT03682809|12588655|FG000|NOT COMPLETED|Overall Study||0
11394931|NCT03682809|12588656|FG001|NOT COMPLETED|Overall Study||0
11394932|NCT03682965|12588664|FG000|STARTED|Overall Study||11
11394933|NCT03682965|12588665|FG001|STARTED|Overall Study||10
11394934|NCT03682965|12588664|FG000|COMPLETED|Overall Study||11
11394935|NCT03682965|12588665|FG001|COMPLETED|Overall Study||10
11394936|NCT03682965|12588664|FG000|NOT COMPLETED|Overall Study||0
11394937|NCT03682965|12588665|FG001|NOT COMPLETED|Overall Study||0
11394938|NCT03683576|12588675|FG000|STARTED|Overall Study||120
11394939|NCT03683576|12588676|FG001|STARTED|Overall Study||120
11394940|NCT03683576|12588677|FG002|STARTED|Overall Study||118
11394941|NCT03683576|12588678|FG003|STARTED|Overall Study||122
11394942|NCT03683576|12588675|FG000|COMPLETED|Overall Study||114
11394943|NCT03683576|12588676|FG001|COMPLETED|Overall Study||116
11394944|NCT03683576|12588677|FG002|COMPLETED|Overall Study||106
11394945|NCT03683576|12588678|FG003|COMPLETED|Overall Study||114
11394946|NCT03683576|12588675|FG000|NOT COMPLETED|Overall Study||6
11394947|NCT03683576|12588676|FG001|NOT COMPLETED|Overall Study||4
11394948|NCT03683576|12588677|FG002|NOT COMPLETED|Overall Study||12
11394949|NCT03683576|12588678|FG003|NOT COMPLETED|Overall Study||8
11394950|NCT03683719|12588693|FG000|STARTED|Overall Study||52
11394951|NCT03683719|12588694|FG001|STARTED|Overall Study||51
11394952|NCT03683719|12588695|FG002|STARTED|Overall Study||52
11394953|NCT03683719|12588696|FG003|STARTED|Overall Study||53
11394954|NCT03683719|12588697|FG004|STARTED|Overall Study||50
11394955|NCT03683719|12588693|FG000|COMPLETED|Overall Study||40
11394956|NCT03683719|12588694|FG001|COMPLETED|Overall Study||38
11394957|NCT03683719|12588695|FG002|COMPLETED|Overall Study||44
11394958|NCT03683719|12588696|FG003|COMPLETED|Overall Study||46
11394959|NCT03683719|12588697|FG004|COMPLETED|Overall Study||36
11394960|NCT03683719|12588693|FG000|NOT COMPLETED|Overall Study||12
11394961|NCT03683719|12588694|FG001|NOT COMPLETED|Overall Study||13
11394962|NCT03683719|12588695|FG002|NOT COMPLETED|Overall Study||8
11394963|NCT03683719|12588696|FG003|NOT COMPLETED|Overall Study||7
11394964|NCT03683719|12588697|FG004|NOT COMPLETED|Overall Study||14
11394965|NCT03683758|12588711|FG000|STARTED|Overall Study||11
11394966|NCT03683758|12588712|FG001|STARTED|Overall Study||10
11394967|NCT03683758|12588711|FG000|COMPLETED|Overall Study||8
11394968|NCT03683758|12588712|FG001|COMPLETED|Overall Study||7
11394969|NCT03683758|12588711|FG000|NOT COMPLETED|Overall Study||3
11394970|NCT03683758|12588712|FG001|NOT COMPLETED|Overall Study||3
11394971|NCT03683901|12588718|FG000|STARTED|Overall Study||10
11394972|NCT03683901|12588718|FG000|COMPLETED|Overall Study||10
11394973|NCT03683901|12588718|FG000|NOT COMPLETED|Overall Study||0
11394974|NCT03684044|12588726|FG000|STARTED|Overall Study||239
11394975|NCT03684044|12588727|FG001|STARTED|Overall Study||124
11394976|NCT03684044|12588726|FG000|COMPLETED|Overall Study||217
11394977|NCT03684044|12588727|FG001|COMPLETED|Overall Study||104
11394978|NCT03684044|12588726|FG000|NOT COMPLETED|Overall Study||22
11394979|NCT03684044|12588727|FG001|NOT COMPLETED|Overall Study||20
11394980|NCT03684265|12588735|FG000|STARTED|Treatment Period 1||13
11394981|NCT03684265|12588736|FG001|STARTED|Treatment Period 1||13
11394982|NCT03684265|12588735|FG000|COMPLETED|Treatment Period 1||13
11394983|NCT03684265|12588736|FG001|COMPLETED|Treatment Period 1||13
11394984|NCT03684265|12588735|FG000|NOT COMPLETED|Treatment Period 1||0
11394985|NCT03684265|12588736|FG001|NOT COMPLETED|Treatment Period 1||0
11394986|NCT03684265|12588735|FG000|STARTED|Washout Period of 1 Week||13
11394987|NCT03684265|12588736|FG001|STARTED|Washout Period of 1 Week||13
11394988|NCT03684265|12588735|FG000|COMPLETED|Washout Period of 1 Week||13
11394989|NCT03684265|12588736|FG001|COMPLETED|Washout Period of 1 Week||13
11394990|NCT03684265|12588735|FG000|NOT COMPLETED|Washout Period of 1 Week||0
11394991|NCT03684265|12588736|FG001|NOT COMPLETED|Washout Period of 1 Week||0
11394992|NCT03684265|12588735|FG000|STARTED|Treatment Period 2||13
11394993|NCT03684265|12588736|FG001|STARTED|Treatment Period 2||13
11394994|NCT03684265|12588735|FG000|COMPLETED|Treatment Period 2||13
11394995|NCT03684265|12588736|FG001|COMPLETED|Treatment Period 2||13
11394996|NCT03684265|12588735|FG000|NOT COMPLETED|Treatment Period 2||0
11394997|NCT03684265|12588736|FG001|NOT COMPLETED|Treatment Period 2||0
11394998|NCT03684642|12588745|FG000|STARTED|Overall Study||303
11394999|NCT03684642|12588746|FG001|STARTED|Overall Study||302
11395000|NCT03684642|12588747|FG002|STARTED|Overall Study||303
11395001|NCT03684642|12588745|FG000|Treated|Overall Study||303
11395002|NCT03684642|12588746|FG001|Treated|Overall Study||302
11395003|NCT03684642|12588747|FG002|Treated|Overall Study||302
11395004|NCT03684642|12588745|FG000|Safety Population|Overall Study|For safety analysis participants are included in the treatment group that they are exposed for longer duration. 10 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration, and considered in the Efpeglenatide 4 mg group for safety analysis.|313
11395005|NCT03684642|12588746|FG001|Safety Population|Overall Study||292
11395006|NCT03684642|12588747|FG002|Safety Population|Overall Study||302
11395007|NCT03684642|12588745|FG000|COMPLETED|Overall Study||200
11395008|NCT03684642|12588746|FG001|COMPLETED|Overall Study||169
11395009|NCT03684642|12588747|FG002|COMPLETED|Overall Study||197
11395010|NCT03684642|12588745|FG000|NOT COMPLETED|Overall Study||103
11395011|NCT03684642|12588746|FG001|NOT COMPLETED|Overall Study||133
11395012|NCT03684642|12588747|FG002|NOT COMPLETED|Overall Study||106
11395013|NCT03684928|12588755|FG000|STARTED|First Intervention||23
11395014|NCT03684928|12588756|FG001|STARTED|First Intervention||22
11395015|NCT03684928|12588755|FG000|COMPLETED|First Intervention||23
11395016|NCT03684928|12588756|FG001|COMPLETED|First Intervention||19
11395017|NCT03684928|12588755|FG000|NOT COMPLETED|First Intervention||0
11395018|NCT03684928|12588756|FG001|NOT COMPLETED|First Intervention||3
11395019|NCT03684928|12588755|FG000|STARTED|Second Intervention|Two participants discontinued between the first intervention and second intervention.|21
11395020|NCT03684928|12588756|FG001|STARTED|Second Intervention||19
11395021|NCT03684928|12588755|FG000|COMPLETED|Second Intervention||20
11395022|NCT03684928|12588756|FG001|COMPLETED|Second Intervention||19
11395023|NCT03684928|12588755|FG000|NOT COMPLETED|Second Intervention||1
11395024|NCT03684928|12588756|FG001|NOT COMPLETED|Second Intervention||0
11395025|NCT03685344|12588766|FG000|STARTED|Overall Study||3
11395026|NCT03685344|12588767|FG001|STARTED|Overall Study||3
11395027|NCT03685344|12588768|FG002|STARTED|Overall Study||7
11395028|NCT03685344|12588769|FG003|STARTED|Overall Study||0
11395029|NCT03685344|12588766|FG000|Received Treatment|Overall Study||3
11395030|NCT03685344|12588767|FG001|Received Treatment|Overall Study||3
11395031|NCT03685344|12588768|FG002|Received Treatment|Overall Study||7
11395032|NCT03685344|12588769|FG003|Received Treatment|Overall Study||0
11395033|NCT03685344|12588766|FG000|COMPLETED|Overall Study||0
11395034|NCT03685344|12588767|FG001|COMPLETED|Overall Study||0
11395035|NCT03685344|12588768|FG002|COMPLETED|Overall Study||0
11395036|NCT03685344|12588769|FG003|COMPLETED|Overall Study||0
11395037|NCT03685344|12588766|FG000|NOT COMPLETED|Overall Study||3
11395038|NCT03685344|12588767|FG001|NOT COMPLETED|Overall Study||3
11395039|NCT03685344|12588768|FG002|NOT COMPLETED|Overall Study||7
11395040|NCT03685344|12588769|FG003|NOT COMPLETED|Overall Study||0
11395041|NCT03685396|12588781|FG000|STARTED|Overall Study||21
11395042|NCT03685396|12588782|FG001|STARTED|Overall Study||21
11395043|NCT03685396|12588781|FG000|COMPLETED|Overall Study||21
11395044|NCT03685396|12588782|FG001|COMPLETED|Overall Study||21
11395045|NCT03685396|12588781|FG000|NOT COMPLETED|Overall Study||0
11395046|NCT03685396|12588782|FG001|NOT COMPLETED|Overall Study||0
11395047|NCT03685643|12588790|FG000|STARTED|Overall Study||290
11395048|NCT03685643|12588791|FG001|STARTED|Overall Study||288
11395049|NCT03685643|12588790|FG000|COMPLETED|Overall Study||276
11395050|NCT03685643|12588791|FG001|COMPLETED|Overall Study||266
11395051|NCT03685643|12588790|FG000|NOT COMPLETED|Overall Study||14
11395052|NCT03685643|12588791|FG001|NOT COMPLETED|Overall Study||22
11395053|NCT03685968|12588800|FG000|STARTED|Overall Study||75
11395054|NCT03685968|12588801|FG001|STARTED|Overall Study||75
11395055|NCT03685968|12588802|FG002|STARTED|Overall Study||75
11395056|NCT03685968|12588800|FG000|COMPLETED|Overall Study||75
11395057|NCT03685968|12588801|FG001|COMPLETED|Overall Study||75
11395058|NCT03685968|12588802|FG002|COMPLETED|Overall Study||75
11395059|NCT03685968|12588800|FG000|NOT COMPLETED|Overall Study||0
11395060|NCT03685968|12588801|FG001|NOT COMPLETED|Overall Study||0
11395061|NCT03685968|12588802|FG002|NOT COMPLETED|Overall Study||0
11395062|NCT03686033|12588810|FG000|STARTED|Treatment Period 1 (1 Day)||1
11395063|NCT03686033|12588811|FG001|STARTED|Treatment Period 1 (1 Day)||1
11395064|NCT03686033|12588812|FG002|STARTED|Treatment Period 1 (1 Day)||1
11395065|NCT03686033|12588813|FG003|STARTED|Treatment Period 1 (1 Day)||1
11395066|NCT03686033|12588814|FG004|STARTED|Treatment Period 1 (1 Day)||1
11395067|NCT03686033|12588815|FG005|STARTED|Treatment Period 1 (1 Day)||0
11395068|NCT03686033|12588810|FG000|COMPLETED|Treatment Period 1 (1 Day)||1
11395069|NCT03686033|12588811|FG001|COMPLETED|Treatment Period 1 (1 Day)||1
11395070|NCT03686033|12588812|FG002|COMPLETED|Treatment Period 1 (1 Day)||1
11395071|NCT03686033|12588813|FG003|COMPLETED|Treatment Period 1 (1 Day)||1
11395072|NCT03686033|12588814|FG004|COMPLETED|Treatment Period 1 (1 Day)||1
11395073|NCT03686033|12588815|FG005|COMPLETED|Treatment Period 1 (1 Day)||0
11395074|NCT03686033|12588810|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11395075|NCT03686033|12588811|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11395076|NCT03686033|12588812|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11395077|NCT03686033|12588813|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11395078|NCT03686033|12588814|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11395079|NCT03686033|12588815|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11395080|NCT03686033|12588810|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
11395081|NCT03686033|12588811|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
11395082|NCT03686033|12588812|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
11395083|NCT03686033|12588813|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
11395084|NCT03686033|12588814|FG004|STARTED|Washout Phase (at Least 2 Weeks)||1
11395085|NCT03686033|12588815|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
11395086|NCT03686033|12588810|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
11395087|NCT03686033|12588811|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
11395088|NCT03686033|12588812|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
11395089|NCT03686033|12588813|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
11395090|NCT03686033|12588814|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||1
11395091|NCT03686033|12588815|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395092|NCT03686033|12588810|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395093|NCT03686033|12588811|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395094|NCT03686033|12588812|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395095|NCT03686033|12588813|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395096|NCT03686033|12588814|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395097|NCT03686033|12588815|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395098|NCT03686033|12588810|FG000|STARTED|Treatment Period 2 (1 Day)||1
11395099|NCT03686033|12588811|FG001|STARTED|Treatment Period 2 (1 Day)||1
11395100|NCT03686033|12588812|FG002|STARTED|Treatment Period 2 (1 Day)||1
11395101|NCT03686033|12588813|FG003|STARTED|Treatment Period 2 (1 Day)||1
11395102|NCT03686033|12588814|FG004|STARTED|Treatment Period 2 (1 Day)||1
11395103|NCT03686033|12588815|FG005|STARTED|Treatment Period 2 (1 Day)||0
11395104|NCT03686033|12588810|FG000|COMPLETED|Treatment Period 2 (1 Day)||1
11395105|NCT03686033|12588811|FG001|COMPLETED|Treatment Period 2 (1 Day)||1
11395106|NCT03686033|12588812|FG002|COMPLETED|Treatment Period 2 (1 Day)||1
11395107|NCT03686033|12588813|FG003|COMPLETED|Treatment Period 2 (1 Day)||1
11395108|NCT03686033|12588814|FG004|COMPLETED|Treatment Period 2 (1 Day)||0
11395109|NCT03686033|12588815|FG005|COMPLETED|Treatment Period 2 (1 Day)||0
11395110|NCT03686033|12588810|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11395111|NCT03686033|12588811|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11395112|NCT03686033|12588812|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11395113|NCT03686033|12588813|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11395114|NCT03686033|12588814|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||1
11395115|NCT03686033|12588815|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11395116|NCT03686033|12588810|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
11395117|NCT03686033|12588811|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
11395118|NCT03686033|12588812|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
11395119|NCT03686033|12588813|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
11395120|NCT03686033|12588814|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0
11395121|NCT03686033|12588815|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
11395122|NCT03686033|12588810|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
11395123|NCT03686033|12588811|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
11395124|NCT03686033|12588812|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
11395125|NCT03686033|12588813|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
11395126|NCT03686033|12588814|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395127|NCT03686033|12588815|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395128|NCT03686033|12588810|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395129|NCT03686033|12588811|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395130|NCT03686033|12588812|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395131|NCT03686033|12588813|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395132|NCT03686033|12588814|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395133|NCT03686033|12588815|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395134|NCT03686033|12588810|FG000|STARTED|Treatment Period 3 (1 Day)||1
11395135|NCT03686033|12588811|FG001|STARTED|Treatment Period 3 (1 Day)||1
11395136|NCT03686033|12588812|FG002|STARTED|Treatment Period 3 (1 Day)||1
11395137|NCT03686033|12588813|FG003|STARTED|Treatment Period 3 (1 Day)||1
11395138|NCT03686033|12588814|FG004|STARTED|Treatment Period 3 (1 Day)||0
11395139|NCT03686033|12588815|FG005|STARTED|Treatment Period 3 (1 Day)||0
11395140|NCT03686033|12588810|FG000|COMPLETED|Treatment Period 3 (1 Day)||1
11395141|NCT03686033|12588811|FG001|COMPLETED|Treatment Period 3 (1 Day)||1
11395142|NCT03686033|12588812|FG002|COMPLETED|Treatment Period 3 (1 Day)||1
11395143|NCT03686033|12588813|FG003|COMPLETED|Treatment Period 3 (1 Day)||1
11395144|NCT03686033|12588814|FG004|COMPLETED|Treatment Period 3 (1 Day)||0
11395145|NCT03686033|12588815|FG005|COMPLETED|Treatment Period 3 (1 Day)||0
11395146|NCT03686033|12588810|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11395147|NCT03686033|12588811|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11395148|NCT03686033|12588812|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11395149|NCT03686033|12588813|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11395150|NCT03686033|12588814|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11395151|NCT03686033|12588815|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11006215|NCT00727194|12183969|FG001|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
11006216|NCT00727194|12183970|FG002|STARTED|Treatment Period 2||0
11006217|NCT00727194|12183968|FG000|COMPLETED|Treatment Period 2||6
11006218|NCT00727194|12183969|FG001|COMPLETED|Treatment Period 2||5
11006219|NCT00727194|12183970|FG002|COMPLETED|Treatment Period 2||0
11006220|NCT00727194|12183968|FG000|NOT COMPLETED|Treatment Period 2||0
11006221|NCT00727194|12183969|FG001|NOT COMPLETED|Treatment Period 2||1
11006222|NCT00727194|12183970|FG002|NOT COMPLETED|Treatment Period 2||0
11006223|NCT00727220|12183986|FG000|STARTED|Overall Study||21
11006224|NCT00727220|12183987|FG001|STARTED|Overall Study||21
11006225|NCT00727220|12183986|FG000|COMPLETED|Overall Study||20
11395152|NCT03686033|12588810|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
11395153|NCT03686033|12588811|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
11395154|NCT03686033|12588812|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
11395155|NCT03686033|12588813|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
11395156|NCT03686033|12588814|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0
11395157|NCT03686033|12588815|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
11395158|NCT03686033|12588810|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
11395159|NCT03686033|12588811|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
11395160|NCT03686033|12588812|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
11395161|NCT03686033|12588813|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
11395162|NCT03686033|12588814|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395163|NCT03686033|12588815|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395164|NCT03686033|12588810|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395165|NCT03686033|12588811|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395166|NCT03686033|12588812|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395167|NCT03686033|12588813|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395168|NCT03686033|12588814|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395169|NCT03686033|12588815|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
11395170|NCT03686033|12588810|FG000|STARTED|Treatment Period 4 (1 Day)||1
11395171|NCT03686033|12588811|FG001|STARTED|Treatment Period 4 (1 Day)||1
11395172|NCT03686033|12588812|FG002|STARTED|Treatment Period 4 (1 Day)||1
11395173|NCT03686033|12588813|FG003|STARTED|Treatment Period 4 (1 Day)||1
11395174|NCT03686033|12588814|FG004|STARTED|Treatment Period 4 (1 Day)||0
11395175|NCT03686033|12588815|FG005|STARTED|Treatment Period 4 (1 Day)||0
11395176|NCT03686033|12588810|FG000|COMPLETED|Treatment Period 4 (1 Day)||1
11395177|NCT03686033|12588811|FG001|COMPLETED|Treatment Period 4 (1 Day)||1
11395178|NCT03686033|12588812|FG002|COMPLETED|Treatment Period 4 (1 Day)||1
11395179|NCT03686033|12588813|FG003|COMPLETED|Treatment Period 4 (1 Day)||1
11395180|NCT03686033|12588814|FG004|COMPLETED|Treatment Period 4 (1 Day)||0
11395181|NCT03686033|12588815|FG005|COMPLETED|Treatment Period 4 (1 Day)||0
11395182|NCT03686033|12588810|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0
11395183|NCT03686033|12588811|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0
11395184|NCT03686033|12588812|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0
11395185|NCT03686033|12588813|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0
11395186|NCT03686033|12588814|FG004|NOT COMPLETED|Treatment Period 4 (1 Day)||0
11395187|NCT03686033|12588815|FG005|NOT COMPLETED|Treatment Period 4 (1 Day)||0
11395188|NCT03686176|12588832|FG000|STARTED|Overall Study||19
11006226|NCT00727220|12183987|FG001|COMPLETED|Overall Study||17
11006227|NCT00727220|12183986|FG000|NOT COMPLETED|Overall Study||1
11006228|NCT00727220|12183987|FG001|NOT COMPLETED|Overall Study||4
11006229|NCT00727246|12183997|FG000|STARTED|Overall Study||3
11006230|NCT00727246|12183998|FG001|STARTED|Overall Study||3
11006231|NCT00727246|12183999|FG002|STARTED|Overall Study||8
11395189|NCT03686176|12588833|FG001|STARTED|Overall Study||25
11395190|NCT03686176|12588834|FG002|STARTED|Overall Study||20
11395191|NCT03686176|12588832|FG000|COMPLETED|Overall Study||17
11395192|NCT03686176|12588833|FG001|COMPLETED|Overall Study||25
11395193|NCT03686176|12588834|FG002|COMPLETED|Overall Study||20
11395194|NCT03686176|12588832|FG000|NOT COMPLETED|Overall Study||2
11395195|NCT03686176|12588833|FG001|NOT COMPLETED|Overall Study||0
11395196|NCT03686176|12588834|FG002|NOT COMPLETED|Overall Study||0
11395197|NCT03687125|12588844|FG000|STARTED|Overall Study||3
11395198|NCT03687125|12588845|FG001|STARTED|Overall Study||3
11395199|NCT03687125|12588844|FG000|COMPLETED|Overall Study||0
11395200|NCT03687125|12588845|FG001|COMPLETED|Overall Study||2
11395201|NCT03687125|12588844|FG000|NOT COMPLETED|Overall Study||3
11395202|NCT03687125|12588845|FG001|NOT COMPLETED|Overall Study||1
11395203|NCT03687372|12588855|FG000|STARTED|Overall Study||254
11395204|NCT03687372|12588856|FG001|STARTED|Overall Study||249
11395205|NCT03687372|12588855|FG000|COMPLETED|Overall Study||237
11395206|NCT03687372|12588856|FG001|COMPLETED|Overall Study||210
11395207|NCT03687372|12588855|FG000|NOT COMPLETED|Overall Study||17
11395208|NCT03687372|12588856|FG001|NOT COMPLETED|Overall Study||39
11395209|NCT03687450|12588866|FG000|STARTED|Overall Study||38
11395210|NCT03687450|12588867|FG001|STARTED|Overall Study||18
11395211|NCT03687450|12588866|FG000|Post-Program Follow-Up|Overall Study|1 withdrew, 9 lost to follow-up|28
11395212|NCT03687450|12588867|FG001|Post-Program Follow-Up|Overall Study|3 lost to follow-up|15
11395213|NCT03687450|12588866|FG000|Two-month Follow-up|Overall Study|2 lost to follow-up|26
11395214|NCT03687450|12588867|FG001|Two-month Follow-up|Overall Study|2 lost to follow-up (N.B. 1 participant completed 2-month follow-up but not post-program follow-up)|16
11395215|NCT03687450|12588866|FG000|COMPLETED|Overall Study||26
11395216|NCT03687450|12588867|FG001|COMPLETED|Overall Study||16
11395217|NCT03687450|12588866|FG000|NOT COMPLETED|Overall Study||12
11395218|NCT03687450|12588867|FG001|NOT COMPLETED|Overall Study||2
11395219|NCT03687684|12588882|FG000|STARTED|Overall Study||4
11395220|NCT03687684|12588883|FG001|STARTED|Overall Study||2
11395221|NCT03687684|12588884|FG002|STARTED|Overall Study||2
11395222|NCT03687684|12588885|FG003|STARTED|Overall Study||6
11395223|NCT03687684|12588886|FG004|STARTED|Overall Study||6
11395224|NCT03687684|12588887|FG005|STARTED|Overall Study||6
11395225|NCT03687684|12588888|FG006|STARTED|Overall Study||6
11395226|NCT03687684|12588889|FG007|STARTED|Overall Study||2
11395227|NCT03687684|12588890|FG008|STARTED|Overall Study||6
11395228|NCT03687684|12588882|FG000|COMPLETED|Overall Study||4
11395229|NCT03687684|12588883|FG001|COMPLETED|Overall Study||2
11395230|NCT03687684|12588884|FG002|COMPLETED|Overall Study||2
11395231|NCT03687684|12588885|FG003|COMPLETED|Overall Study||6
11395232|NCT03687684|12588886|FG004|COMPLETED|Overall Study||6
11395233|NCT03687684|12588887|FG005|COMPLETED|Overall Study||6
11395234|NCT03687684|12588888|FG006|COMPLETED|Overall Study||6
11395235|NCT03687684|12588889|FG007|COMPLETED|Overall Study||2
11395236|NCT03687684|12588890|FG008|COMPLETED|Overall Study||6
11395237|NCT03687684|12588882|FG000|NOT COMPLETED|Overall Study||0
11395238|NCT03687684|12588883|FG001|NOT COMPLETED|Overall Study||0
11395239|NCT03687684|12588884|FG002|NOT COMPLETED|Overall Study||0
11395240|NCT03687684|12588885|FG003|NOT COMPLETED|Overall Study||0
11395241|NCT03687684|12588886|FG004|NOT COMPLETED|Overall Study||0
11395242|NCT03687684|12588887|FG005|NOT COMPLETED|Overall Study||0
11395243|NCT03687684|12588888|FG006|NOT COMPLETED|Overall Study||0
11395244|NCT03687684|12588889|FG007|NOT COMPLETED|Overall Study||0
11395245|NCT03687684|12588890|FG008|NOT COMPLETED|Overall Study||0
11395246|NCT03687827|12588920|FG000|STARTED|Treatment Period 1||249
11395247|NCT03687827|12588921|FG001|STARTED|Treatment Period 1||249
11395248|NCT03687827|12588920|FG000|Full Analysis Set (FAS)|Treatment Period 1||249
11395249|NCT03687827|12588921|FG001|Full Analysis Set (FAS)|Treatment Period 1||249
11395250|NCT03687827|12588920|FG000|Safety Analysis Set (SAS)|Treatment Period 1||249
11395251|NCT03687827|12588921|FG001|Safety Analysis Set (SAS)|Treatment Period 1||249
11395252|NCT03687827|12588920|FG000|Per Protocol Set|Treatment Period 1||219
11395253|NCT03687827|12588921|FG001|Per Protocol Set|Treatment Period 1||229
11395254|NCT03687827|12588920|FG000|COMPLETED|Treatment Period 1||235
11395255|NCT03687827|12588921|FG001|COMPLETED|Treatment Period 1||241
11395256|NCT03687827|12588920|FG000|NOT COMPLETED|Treatment Period 1||14
11395257|NCT03687827|12588921|FG001|NOT COMPLETED|Treatment Period 1||8
11395258|NCT03687827|12588920|FG000|STARTED|Treatment Period 2||235
11395259|NCT03687827|12588921|FG001|STARTED|Treatment Period 2||241
11395260|NCT03687827|12588920|FG000|COMPLETED|Treatment Period 2||230
11395261|NCT03687827|12588921|FG001|COMPLETED|Treatment Period 2||238
11395262|NCT03687827|12588920|FG000|NOT COMPLETED|Treatment Period 2||5
11395263|NCT03687827|12588921|FG001|NOT COMPLETED|Treatment Period 2||3
11395264|NCT03687970|12588929|FG000|STARTED|Overall Study||22
11395265|NCT03687970|12588930|FG001|STARTED|Overall Study||20
11395266|NCT03687970|12588929|FG000|COMPLETED|Overall Study||20
11395267|NCT03687970|12588930|FG001|COMPLETED|Overall Study||20
11395268|NCT03687970|12588929|FG000|NOT COMPLETED|Overall Study||2
11395269|NCT03687970|12588930|FG001|NOT COMPLETED|Overall Study||0
11395270|NCT03688282|12588938|FG000|STARTED|Sham Treatment for 30 Minutes||18
11395271|NCT03688282|12588938|FG000|COMPLETED|Sham Treatment for 30 Minutes||17
11395272|NCT03688282|12588938|FG000|NOT COMPLETED|Sham Treatment for 30 Minutes||1
11395273|NCT03688282|12588938|FG000|STARTED|Washout (7 Days)||17
11395274|NCT03688282|12588938|FG000|COMPLETED|Washout (7 Days)||17
11395275|NCT03688282|12588938|FG000|NOT COMPLETED|Washout (7 Days)||0
11395276|NCT03688282|12588938|FG000|STARTED|Active Treatment for 30 Minutes||17
11395277|NCT03688282|12588938|FG000|COMPLETED|Active Treatment for 30 Minutes||17
11395278|NCT03688282|12588938|FG000|NOT COMPLETED|Active Treatment for 30 Minutes||0
11395279|NCT03688542|12588946|FG000|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|
11395280|NCT03688542|12588947|FG001|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|
11395281|NCT03688542|12588946|FG000|COMPLETED|Overall Study|No individual participants were recruited, only nursing homes.|
11395282|NCT03688542|12588947|FG001|COMPLETED|Overall Study|"1 nursing home withdrew from the study.~No individual participants were recruited, only nursing homes."|
11395283|NCT03688542|12588946|FG000|NOT COMPLETED|Overall Study||
11395284|NCT03688542|12588947|FG001|NOT COMPLETED|Overall Study||
11395285|NCT03688620|12588956|FG000|STARTED|Overall Study||329
11395286|NCT03688620|12588957|FG001|STARTED|Overall Study||278
11395287|NCT03688620|12588958|FG002|STARTED|Overall Study||453
11395288|NCT03688620|12588956|FG000|COMPLETED|Overall Study||313
11395289|NCT03688620|12588957|FG001|COMPLETED|Overall Study||277
11395290|NCT03688620|12588958|FG002|COMPLETED|Overall Study||445
11395291|NCT03688620|12588956|FG000|NOT COMPLETED|Overall Study||16
11395292|NCT03688620|12588957|FG001|NOT COMPLETED|Overall Study||1
11395293|NCT03688620|12588958|FG002|NOT COMPLETED|Overall Study||8
11395294|NCT03688685|12588968|FG000|STARTED|Overall Study||25
11395295|NCT03688685|12588968|FG000|COMPLETED|Overall Study||21
11395296|NCT03688685|12588968|FG000|NOT COMPLETED|Overall Study||4
11395297|NCT03688711|12588974|FG000|STARTED|Overall Study||34
11395298|NCT03688711|12588975|FG001|STARTED|Overall Study||11
11395299|NCT03688711|12588974|FG000|COMPLETED|Overall Study||34
11395300|NCT03688711|12588975|FG001|COMPLETED|Overall Study||10
11395301|NCT03688711|12588974|FG000|NOT COMPLETED|Overall Study||0
11395302|NCT03688711|12588975|FG001|NOT COMPLETED|Overall Study||1
11395303|NCT03688880|12588983|FG000|STARTED|Overall Study||29
11395304|NCT03688880|12588984|FG001|STARTED|Overall Study||60
11395305|NCT03688880|12588983|FG000|COMPLETED|Overall Study||15
11395306|NCT03688880|12588984|FG001|COMPLETED|Overall Study||29
11395307|NCT03688880|12588983|FG000|NOT COMPLETED|Overall Study||14
11395308|NCT03688880|12588984|FG001|NOT COMPLETED|Overall Study||31
11395309|NCT03689452|12588992|FG000|STARTED|Overall Study||15
11395310|NCT03689452|12588993|FG001|STARTED|Overall Study||15
11395311|NCT03689452|12588992|FG000|COMPLETED|Overall Study||14
11395312|NCT03689452|12588993|FG001|COMPLETED|Overall Study||14
11395313|NCT03689452|12588992|FG000|NOT COMPLETED|Overall Study||1
11395314|NCT03689452|12588993|FG001|NOT COMPLETED|Overall Study||1
11395315|NCT03689504|12589001|FG000|STARTED|Overall Study||70
11395316|NCT03689504|12589002|FG001|STARTED|Overall Study||70
11395317|NCT03689504|12589001|FG000|COMPLETED|Overall Study||65
11395318|NCT03689504|12589002|FG001|COMPLETED|Overall Study||70
11395319|NCT03689504|12589001|FG000|NOT COMPLETED|Overall Study||5
11395320|NCT03689504|12589002|FG001|NOT COMPLETED|Overall Study||0
11395321|NCT03690375|12589010|FG000|STARTED|Overall Study||10
11395322|NCT03690375|12589011|FG001|STARTED|Overall Study||10
11395323|NCT03690375|12589010|FG000|COMPLETED|Overall Study||10
11395324|NCT03690375|12589011|FG001|COMPLETED|Overall Study||10
11395325|NCT03690375|12589010|FG000|NOT COMPLETED|Overall Study||0
11395326|NCT03690375|12589011|FG001|NOT COMPLETED|Overall Study||0
11395327|NCT03691779|12589020|FG000|STARTED|Part A (15 Days)||16
11395328|NCT03691779|12589021|FG001|STARTED|Part A (15 Days)||0
11395329|NCT03691779|12589020|FG000|COMPLETED|Part A (15 Days)||16
11395330|NCT03691779|12589021|FG001|COMPLETED|Part A (15 Days)||0
11395331|NCT03691779|12589020|FG000|NOT COMPLETED|Part A (15 Days)||0
11395332|NCT03691779|12589021|FG001|NOT COMPLETED|Part A (15 Days)||0
11395333|NCT03691779|12589020|FG000|STARTED|Part B (24 Weeks)||0
11395334|NCT03691779|12589021|FG001|STARTED|Part B (24 Weeks)|Out of the 16 participants from Part A, 11 participants also participated in Part B of the study.|66
11395335|NCT03691779|12589020|FG000|COMPLETED|Part B (24 Weeks)||0
11395336|NCT03691779|12589021|FG001|COMPLETED|Part B (24 Weeks)||64
11395337|NCT03691779|12589020|FG000|NOT COMPLETED|Part B (24 Weeks)||0
11395338|NCT03691779|12589021|FG001|NOT COMPLETED|Part B (24 Weeks)||2
11395339|NCT03691831|12589030|FG000|STARTED|Overall Study||251
11395340|NCT03691831|12589031|FG001|STARTED|Overall Study||251
11395341|NCT03691831|12589030|FG000|COMPLETED|Overall Study||224
11395342|NCT03691831|12589031|FG001|COMPLETED|Overall Study||220
11395343|NCT03691831|12589030|FG000|NOT COMPLETED|Overall Study||27
11395344|NCT03691831|12589031|FG001|NOT COMPLETED|Overall Study||31
11395345|NCT03691844|12589041|FG000|STARTED|Overall Study||121
11395346|NCT03691844|12589042|FG001|STARTED|Overall Study||121
11395347|NCT03691844|12589043|FG002|STARTED|Overall Study||121
11395348|NCT03691844|12589044|FG003|STARTED|Overall Study||81
11395349|NCT03691844|12589041|FG000|COMPLETED|Overall Study||114
11395350|NCT03691844|12589042|FG001|COMPLETED|Overall Study||109
11395351|NCT03691844|12589043|FG002|COMPLETED|Overall Study||108
11395352|NCT03691844|12589044|FG003|COMPLETED|Overall Study||70
11395353|NCT03691844|12589041|FG000|NOT COMPLETED|Overall Study||7
11395354|NCT03691844|12589042|FG001|NOT COMPLETED|Overall Study||12
11395355|NCT03691844|12589043|FG002|NOT COMPLETED|Overall Study||13
11395356|NCT03691844|12589044|FG003|NOT COMPLETED|Overall Study||11
11395357|NCT03691948|12589058|FG000|STARTED|Overall Study||27
11395358|NCT03691948|12589059|FG001|STARTED|Overall Study||33
11395359|NCT03691948|12589058|FG000|COMPLETED|Overall Study||26
11395360|NCT03691948|12589059|FG001|COMPLETED|Overall Study||30
11395361|NCT03691948|12589058|FG000|NOT COMPLETED|Overall Study||1
11395362|NCT03691948|12589059|FG001|NOT COMPLETED|Overall Study||3
11395363|NCT03692676|12589070|FG000|STARTED|Overall Study||10365
11395364|NCT03692676|12589071|FG001|STARTED|Overall Study||51142
11395365|NCT03692676|12589072|FG002|STARTED|Overall Study||49479
11395366|NCT03692676|12589073|FG003|STARTED|Overall Study||5147
11395367|NCT03692676|12589070|FG000|COMPLETED|Overall Study||940
11395368|NCT03692676|12589071|FG001|COMPLETED|Overall Study||3704
11395369|NCT03692676|12589072|FG002|COMPLETED|Overall Study||11135
11395370|NCT03692676|12589073|FG003|COMPLETED|Overall Study||1561
11395371|NCT03692676|12589070|FG000|NOT COMPLETED|Overall Study||9425
11395372|NCT03692676|12589071|FG001|NOT COMPLETED|Overall Study||47438
11395373|NCT03692676|12589072|FG002|NOT COMPLETED|Overall Study||38344
11395374|NCT03692676|12589073|FG003|NOT COMPLETED|Overall Study||3586
11395375|NCT03693625|12589085|FG000|STARTED|Overall Study||23
11395376|NCT03693625|12589086|FG001|STARTED|Overall Study||8
11395377|NCT03693625|12589085|FG000|COMPLETED|Overall Study||0
11395378|NCT03693625|12589086|FG001|COMPLETED|Overall Study||0
11395379|NCT03693625|12589085|FG000|NOT COMPLETED|Overall Study||23
11395380|NCT03693625|12589086|FG001|NOT COMPLETED|Overall Study||8
11395381|NCT03693742|12589094|FG000|STARTED|Overall Study||7
11395382|NCT03693742|12589095|FG001|STARTED|Overall Study||3
11395383|NCT03693742|12589094|FG000|COMPLETED|Overall Study||7
11395384|NCT03693742|12589095|FG001|COMPLETED|Overall Study||3
11395385|NCT03693742|12589094|FG000|NOT COMPLETED|Overall Study||0
11395386|NCT03693742|12589095|FG001|NOT COMPLETED|Overall Study||0
11395387|NCT03693937|12589103|FG000|STARTED|Overall Study||776
11395388|NCT03693937|12589103|FG000|COMPLETED|Overall Study||776
11395389|NCT03693937|12589103|FG000|NOT COMPLETED|Overall Study||0
11395390|NCT03693950|12589109|FG000|STARTED|Overall Study||29
11395391|NCT03693950|12589110|FG001|STARTED|Overall Study||28
11395392|NCT03693950|12589109|FG000|COMPLETED|Overall Study||28
11395393|NCT03693950|12589110|FG001|COMPLETED|Overall Study||28
11395394|NCT03693950|12589109|FG000|NOT COMPLETED|Overall Study||1
11395395|NCT03693950|12589110|FG001|NOT COMPLETED|Overall Study||0
11395396|NCT03693989|12589118|FG000|STARTED|Overall Study||88
11395397|NCT03693989|12589119|FG001|STARTED|Overall Study||90
11395398|NCT03693989|12589118|FG000|COMPLETED|Overall Study||85
11395399|NCT03693989|12589119|FG001|COMPLETED|Overall Study||86
11395400|NCT03693989|12589118|FG000|NOT COMPLETED|Overall Study||3
11395401|NCT03693989|12589119|FG001|NOT COMPLETED|Overall Study||4
11006232|NCT00727246|12184000|FG003|STARTED|Overall Study||5
11006233|NCT00727246|12183997|FG000|COMPLETED|Overall Study||3
11006234|NCT00727246|12183998|FG001|COMPLETED|Overall Study||2
11395402|NCT03694197|12589125|FG000|STARTED|Overall Study||1385
11395403|NCT03694197|12589125|FG000|COMPLETED|Overall Study||0
11395404|NCT03694197|12589125|FG000|NOT COMPLETED|Overall Study||1385
11395405|NCT03694210|12589129|FG000|STARTED|Overall Study||37
11395406|NCT03694210|12589129|FG000|COMPLETED|Overall Study||29
11395407|NCT03694210|12589129|FG000|NOT COMPLETED|Overall Study||8
11395408|NCT03694548|12589137|FG000|STARTED|Part A Survey||18
11395409|NCT03694548|12589138|FG001|STARTED|Part A Survey||17
11395410|NCT03694548|12589139|FG002|STARTED|Part A Survey||0
11395411|NCT03694548|12589137|FG000|COMPLETED|Part A Survey||15
11395412|NCT03694548|12589138|FG001|COMPLETED|Part A Survey||14
11395413|NCT03694548|12589139|FG002|COMPLETED|Part A Survey||0
11395414|NCT03694548|12589137|FG000|NOT COMPLETED|Part A Survey||3
11395415|NCT03694548|12589138|FG001|NOT COMPLETED|Part A Survey||3
11395416|NCT03694548|12589139|FG002|NOT COMPLETED|Part A Survey||0
11395417|NCT03694548|12589137|FG000|STARTED|Part B Yoga Program||0
11395418|NCT03694548|12589138|FG001|STARTED|Part B Yoga Program||0
11395419|NCT03694548|12589139|FG002|STARTED|Part B Yoga Program||12
11395420|NCT03694548|12589137|FG000|COMPLETED|Part B Yoga Program||0
11395421|NCT03694548|12589138|FG001|COMPLETED|Part B Yoga Program||0
11395422|NCT03694548|12589139|FG002|COMPLETED|Part B Yoga Program||1
11395423|NCT03694548|12589137|FG000|NOT COMPLETED|Part B Yoga Program||0
11395424|NCT03694548|12589138|FG001|NOT COMPLETED|Part B Yoga Program||0
11395425|NCT03694548|12589139|FG002|NOT COMPLETED|Part B Yoga Program||11
11395426|NCT03694613|12589149|FG000|STARTED|Overall Study||65
11395427|NCT03694613|12589149|FG000|COMPLETED|Overall Study|65 samples were collected and analyzed. at least 3 ml were collected.|65
11395428|NCT03694613|12589149|FG000|NOT COMPLETED|Overall Study||0
11395429|NCT03694925|12589165|FG000|STARTED|Overall Study||30
11395430|NCT03694925|12589166|FG001|STARTED|Overall Study||73
11395431|NCT03694925|12589167|FG002|STARTED|Overall Study||53
11395432|NCT03694925|12589165|FG000|COMPLETED|Overall Study||30
11395433|NCT03694925|12589166|FG001|COMPLETED|Overall Study||70
11395434|NCT03694925|12589167|FG002|COMPLETED|Overall Study||53
11395435|NCT03694925|12589165|FG000|NOT COMPLETED|Overall Study||0
11395436|NCT03694925|12589166|FG001|NOT COMPLETED|Overall Study||3
11395437|NCT03694925|12589167|FG002|NOT COMPLETED|Overall Study||0
11395438|NCT03695094|12589179|FG000|STARTED|Overall Study||16
11395439|NCT03695094|12589180|FG001|STARTED|Overall Study||15
11395440|NCT03695094|12589179|FG000|COMPLETED|Overall Study||14
11395441|NCT03695094|12589180|FG001|COMPLETED|Overall Study||14
11006235|NCT00727246|12183999|FG002|COMPLETED|Overall Study||7
11395442|NCT03695094|12589179|FG000|NOT COMPLETED|Overall Study||2
11395443|NCT03695094|12589180|FG001|NOT COMPLETED|Overall Study||1
11395444|NCT03695367|12589190|FG000|STARTED|Overall Study||33
11395445|NCT03695367|12589191|FG001|STARTED|Overall Study||30
11395446|NCT03695367|12589190|FG000|COMPLETED|Overall Study||32
11395447|NCT03695367|12589191|FG001|COMPLETED|Overall Study||26
11395448|NCT03695367|12589190|FG000|NOT COMPLETED|Overall Study||1
11395449|NCT03695367|12589191|FG001|NOT COMPLETED|Overall Study||4
11395450|NCT03695393|12589199|FG000|STARTED|Overall Study||67
11395451|NCT03695393|12589200|FG001|STARTED|Overall Study||33
11395452|NCT03695393|12589199|FG000|1-month|Overall Study||66
11395453|NCT03695393|12589200|FG001|1-month|Overall Study||32
11395454|NCT03695393|12589199|FG000|6-month|Overall Study||64
11395455|NCT03695393|12589200|FG001|6-month|Overall Study||31
11395456|NCT03695393|12589199|FG000|COMPLETED|Overall Study||64
11395457|NCT03695393|12589200|FG001|COMPLETED|Overall Study||31
11395458|NCT03695393|12589199|FG000|NOT COMPLETED|Overall Study||3
11395459|NCT03695393|12589200|FG001|NOT COMPLETED|Overall Study||2
11395460|NCT03695913|12589206|FG000|STARTED|Overall Study||15
11395461|NCT03695913|12589206|FG000|COMPLETED|Overall Study||15
11395462|NCT03695913|12589206|FG000|NOT COMPLETED|Overall Study||0
11395463|NCT03696108|12589212|FG000|STARTED|Overall Study||84
11395464|NCT03696108|12589213|FG001|STARTED|Overall Study||85
11395465|NCT03696108|12589212|FG000|COMPLETED|Overall Study||80
11395466|NCT03696108|12589213|FG001|COMPLETED|Overall Study||79
11395467|NCT03696108|12589212|FG000|NOT COMPLETED|Overall Study||4
11395468|NCT03696108|12589213|FG001|NOT COMPLETED|Overall Study||6
11395469|NCT03696342|12589221|FG000|STARTED|Overall Study||23
11395470|NCT03696342|12589222|FG001|STARTED|Overall Study||23
11395471|NCT03696342|12589221|FG000|COMPLETED|Overall Study||22
11395472|NCT03696342|12589222|FG001|COMPLETED|Overall Study||23
11395473|NCT03696342|12589221|FG000|NOT COMPLETED|Overall Study||1
11395474|NCT03696342|12589222|FG001|NOT COMPLETED|Overall Study||0
11395475|NCT03696576|12589230|FG000|STARTED|Overall Study||13
11395476|NCT03696576|12589231|FG001|STARTED|Overall Study||11
11395477|NCT03696576|12589230|FG000|COMPLETED|Overall Study||10
11395478|NCT03696576|12589231|FG001|COMPLETED|Overall Study||6
11395479|NCT03696576|12589230|FG000|NOT COMPLETED|Overall Study||3
11395480|NCT03696576|12589231|FG001|NOT COMPLETED|Overall Study||5
11395481|NCT03696589|12589237|FG000|STARTED|Overall Study||13
11395482|NCT03696589|12589237|FG000|COMPLETED|Overall Study||12
11395483|NCT03696589|12589237|FG000|NOT COMPLETED|Overall Study||1
11395484|NCT03696758|12589250|FG000|STARTED|First Intervention||3
11395485|NCT03696758|12589251|FG001|STARTED|First Intervention||6
11395486|NCT03696758|12589250|FG000|COMPLETED|First Intervention||3
11395487|NCT03696758|12589251|FG001|COMPLETED|First Intervention||6
11395488|NCT03696758|12589250|FG000|NOT COMPLETED|First Intervention||0
11395489|NCT03696758|12589251|FG001|NOT COMPLETED|First Intervention||0
11395490|NCT03696758|12589250|FG000|STARTED|Wash Out>12 Hours||3
11395491|NCT03696758|12589251|FG001|STARTED|Wash Out>12 Hours||6
11395492|NCT03696758|12589250|FG000|COMPLETED|Wash Out>12 Hours||3
11395493|NCT03696758|12589251|FG001|COMPLETED|Wash Out>12 Hours||6
11395494|NCT03696758|12589250|FG000|NOT COMPLETED|Wash Out>12 Hours||0
11395495|NCT03696758|12589251|FG001|NOT COMPLETED|Wash Out>12 Hours||0
11395496|NCT03696758|12589250|FG000|STARTED|Second Intervention||3
11395497|NCT03696758|12589251|FG001|STARTED|Second Intervention||6
11395498|NCT03696758|12589250|FG000|COMPLETED|Second Intervention||3
11395499|NCT03696758|12589251|FG001|COMPLETED|Second Intervention||6
11395500|NCT03696758|12589250|FG000|NOT COMPLETED|Second Intervention||0
11395501|NCT03696758|12589251|FG001|NOT COMPLETED|Second Intervention||0
11395502|NCT03697083|12589260|FG000|STARTED|Overall Study||262
11395503|NCT03697083|12589261|FG001|STARTED|Overall Study||260
11395504|NCT03697083|12589262|FG002|STARTED|Overall Study||255
11395505|NCT03697083|12589260|FG000|COMPLETED|Overall Study||262
11395506|NCT03697083|12589261|FG001|COMPLETED|Overall Study||250
11395507|NCT03697083|12589262|FG002|COMPLETED|Overall Study||255
11395508|NCT03697083|12589260|FG000|NOT COMPLETED|Overall Study||0
11395509|NCT03697083|12589261|FG001|NOT COMPLETED|Overall Study||10
11395510|NCT03697083|12589262|FG002|NOT COMPLETED|Overall Study||0
11395511|NCT03697122|12589270|FG000|STARTED|Overall Study||14
11395512|NCT03697122|12589270|FG000|COMPLETED|Overall Study||14
11395513|NCT03697122|12589270|FG000|NOT COMPLETED|Overall Study||0
11395514|NCT03697252|12589276|FG000|STARTED|Overall Study||90
11395515|NCT03697252|12589277|FG001|STARTED|Overall Study||92
11395516|NCT03697252|12589276|FG000|COMPLETED|Overall Study||72
11395517|NCT03697252|12589277|FG001|COMPLETED|Overall Study||73
11395518|NCT03697252|12589276|FG000|NOT COMPLETED|Overall Study||18
11395519|NCT03697252|12589277|FG001|NOT COMPLETED|Overall Study||19
11395520|NCT03697460|12589283|FG000|STARTED|Overall Study||12
11395521|NCT03697460|12589283|FG000|COMPLETED|Overall Study||9
11395522|NCT03697460|12589283|FG000|NOT COMPLETED|Overall Study||3
11395523|NCT03697993|12589289|FG000|STARTED|Overall Study||32
11395524|NCT03697993|12589290|FG001|STARTED|Overall Study||30
11395525|NCT03697993|12589289|FG000|Initiated Treatment|Overall Study||30
11395526|NCT03697993|12589290|FG001|Initiated Treatment|Overall Study||28
11395527|NCT03697993|12589289|FG000|Switched Treatment|Overall Study||0
11395528|NCT03697993|12589290|FG001|Switched Treatment|Overall Study|Five (5) participants switched to Fosfomycin; 1 participant switched to Cefixime.|6
11395529|NCT03697993|12589289|FG000|Treated With at Least Two Dose of Fosfomycin|Overall Study||27
11395530|NCT03697993|12589290|FG001|Treated With at Least Two Dose of Fosfomycin|Overall Study||4
11395531|NCT03697993|12589289|FG000|COMPLETED|Overall Study||22
11395532|NCT03697993|12589290|FG001|COMPLETED|Overall Study||25
11395533|NCT03697993|12589289|FG000|NOT COMPLETED|Overall Study||10
11395534|NCT03697993|12589290|FG001|NOT COMPLETED|Overall Study||5
11395535|NCT03698331|12589299|FG000|STARTED|Overall Study||44
11395536|NCT03698331|12589300|FG001|STARTED|Overall Study||45
11395537|NCT03698331|12589299|FG000|Entered Withdrawal Period|Overall Study||42
11395538|NCT03698331|12589300|FG001|Entered Withdrawal Period|Overall Study||39
11395539|NCT03698331|12589299|FG000|COMPLETED|Overall Study||40
11395540|NCT03698331|12589300|FG001|COMPLETED|Overall Study||39
11395541|NCT03698331|12589299|FG000|NOT COMPLETED|Overall Study||4
11395542|NCT03698331|12589300|FG001|NOT COMPLETED|Overall Study||6
11395543|NCT03698591|12589308|FG000|STARTED|Overall Study||20
11395544|NCT03698591|12589309|FG001|STARTED|Overall Study||20
11395545|NCT03698591|12589308|FG000|COMPLETED|Overall Study||15
11395546|NCT03698591|12589309|FG001|COMPLETED|Overall Study||15
11395547|NCT03698591|12589308|FG000|NOT COMPLETED|Overall Study||5
11395548|NCT03698591|12589309|FG001|NOT COMPLETED|Overall Study||5
11395549|NCT03699124|12589318|FG000|STARTED|Overall Study||377
11395550|NCT03699124|12589319|FG001|STARTED|Overall Study||375
11395551|NCT03699124|12589320|FG002|STARTED|Overall Study||377
11395552|NCT03699124|12589318|FG000|COMPLETED|Overall Study||332
11395553|NCT03699124|12589319|FG001|COMPLETED|Overall Study||335
11395554|NCT03699124|12589320|FG002|COMPLETED|Overall Study||337
11395555|NCT03699124|12589318|FG000|NOT COMPLETED|Overall Study||45
11395556|NCT03699124|12589319|FG001|NOT COMPLETED|Overall Study||40
11395557|NCT03699124|12589320|FG002|NOT COMPLETED|Overall Study||40
11395558|NCT03700320|12589330|FG000|STARTED|Overall Study||198
11395559|NCT03700320|12589331|FG001|STARTED|Overall Study||546
11395560|NCT03700320|12589330|FG000|Safety Population; Received Treatment|Overall Study||196
11395561|NCT03700320|12589331|FG001|Safety Population; Received Treatment|Overall Study||543
11395562|NCT03700320|12589330|FG000|Entered Safety Follow-up|Overall Study||159
11395563|NCT03700320|12589331|FG001|Entered Safety Follow-up|Overall Study||472
11395564|NCT03700320|12589330|FG000|COMPLETED|Overall Study||136
11395565|NCT03700320|12589331|FG001|COMPLETED|Overall Study||373
11395566|NCT03700320|12589330|FG000|NOT COMPLETED|Overall Study||62
11395567|NCT03700320|12589331|FG001|NOT COMPLETED|Overall Study||173
11395568|NCT03700372|12589337|FG000|STARTED|Overall Study||7
11395569|NCT03700372|12589337|FG000|COMPLETED|Overall Study||7
11395570|NCT03700372|12589337|FG000|NOT COMPLETED|Overall Study||0
11395571|NCT03700385|12589341|FG000|STARTED|Overall Study||40
11395572|NCT03700385|12589341|FG000|COMPLETED|Overall Study||39
11395573|NCT03700385|12589341|FG000|NOT COMPLETED|Overall Study||1
11395574|NCT03700671|12589347|FG000|STARTED|Overall Study||21
11395575|NCT03700671|12589348|FG001|STARTED|Overall Study||21
11395576|NCT03700671|12589347|FG000|COMPLETED|Overall Study||20
11395577|NCT03700671|12589348|FG001|COMPLETED|Overall Study||19
11395578|NCT03700671|12589347|FG000|NOT COMPLETED|Overall Study||1
11395579|NCT03700671|12589348|FG001|NOT COMPLETED|Overall Study||2
11395580|NCT03700736|12589358|FG000|STARTED|Overall Study||30
11395581|NCT03700736|12589359|FG001|STARTED|Overall Study||32
11395582|NCT03700736|12589358|FG000|COMPLETED|Overall Study||27
11395583|NCT03700736|12589359|FG001|COMPLETED|Overall Study||25
11395584|NCT03700736|12589358|FG000|NOT COMPLETED|Overall Study||3
11395585|NCT03700736|12589359|FG001|NOT COMPLETED|Overall Study||7
11395586|NCT03700892|12589370|FG000|STARTED|Baseline||15
11395587|NCT03700892|12589371|FG001|STARTED|Baseline||0
11395588|NCT03700892|12589372|FG002|STARTED|Baseline||4
11395589|NCT03700892|12589370|FG000|COMPLETED|Baseline||15
11395590|NCT03700892|12589371|FG001|COMPLETED|Baseline||0
11395591|NCT03700892|12589372|FG002|COMPLETED|Baseline||4
11395592|NCT03700892|12589370|FG000|NOT COMPLETED|Baseline||0
11395593|NCT03700892|12589371|FG001|NOT COMPLETED|Baseline||0
11395594|NCT03700892|12589372|FG002|NOT COMPLETED|Baseline||0
11395595|NCT03700892|12589370|FG000|STARTED|First Intervention (Single 1-Day Visit)||1
11395596|NCT03700892|12589371|FG001|STARTED|First Intervention (Single 1-Day Visit)||4
11395597|NCT03700892|12589372|FG002|STARTED|First Intervention (Single 1-Day Visit)||0
11395598|NCT03700892|12589370|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||1
11395599|NCT03700892|12589371|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||4
11395600|NCT03700892|12589372|FG002|COMPLETED|First Intervention (Single 1-Day Visit)||0
11395601|NCT03700892|12589370|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
11395602|NCT03700892|12589371|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
11395603|NCT03700892|12589372|FG002|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
11395604|NCT03700892|12589370|FG000|STARTED|Washout (2-3 Weeks)||1
11395605|NCT03700892|12589371|FG001|STARTED|Washout (2-3 Weeks)||4
11395606|NCT03700892|12589372|FG002|STARTED|Washout (2-3 Weeks)||0
11395607|NCT03700892|12589370|FG000|COMPLETED|Washout (2-3 Weeks)||1
11395608|NCT03700892|12589371|FG001|COMPLETED|Washout (2-3 Weeks)||4
11395609|NCT03700892|12589372|FG002|COMPLETED|Washout (2-3 Weeks)||0
11395610|NCT03700892|12589370|FG000|NOT COMPLETED|Washout (2-3 Weeks)||0
11395611|NCT03700892|12589371|FG001|NOT COMPLETED|Washout (2-3 Weeks)||0
11395612|NCT03700892|12589372|FG002|NOT COMPLETED|Washout (2-3 Weeks)||0
11395613|NCT03700892|12589370|FG000|STARTED|Second Intervention (Single 1-Day Visit)||1
11395614|NCT03700892|12589371|FG001|STARTED|Second Intervention (Single 1-Day Visit)||4
11395615|NCT03700892|12589372|FG002|STARTED|Second Intervention (Single 1-Day Visit)||0
11395616|NCT03700892|12589370|FG000|Received Intervention|Second Intervention (Single 1-Day Visit)||1
11395617|NCT03700892|12589371|FG001|Received Intervention|Second Intervention (Single 1-Day Visit)||3
11395618|NCT03700892|12589372|FG002|Received Intervention|Second Intervention (Single 1-Day Visit)||0
11395619|NCT03700892|12589370|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||1
11395620|NCT03700892|12589371|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3
11395621|NCT03700892|12589372|FG002|COMPLETED|Second Intervention (Single 1-Day Visit)||0
11395622|NCT03700892|12589370|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
11395623|NCT03700892|12589371|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||1
11395624|NCT03700892|12589372|FG002|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
11395625|NCT03701061|12589383|FG000|STARTED|Overall Study||9
11395626|NCT03701061|12589384|FG001|STARTED|Overall Study||3
11395627|NCT03701061|12589383|FG000|COMPLETED|Overall Study||9
11395628|NCT03701061|12589384|FG001|COMPLETED|Overall Study||3
11395629|NCT03701061|12589383|FG000|NOT COMPLETED|Overall Study||0
11395630|NCT03701061|12589384|FG001|NOT COMPLETED|Overall Study||0
11395631|NCT03701074|12589392|FG000|STARTED|Overall Study||1
11395632|NCT03701074|12589393|FG001|STARTED|Overall Study||0
11395633|NCT03701074|12589392|FG000|COMPLETED|Overall Study|Treatment was withdrawn after the 10th dose of oral medication (acetaminophen), on day 3 of treatment, as the infant developed mild abdominal distension which was as per the study protocol|0
11395634|NCT03701074|12589393|FG001|COMPLETED|Overall Study||0
11395635|NCT03701074|12589392|FG000|NOT COMPLETED|Overall Study||1
11395636|NCT03701074|12589393|FG001|NOT COMPLETED|Overall Study||0
11395637|NCT03702010|12589401|FG000|STARTED|First Stimulation (5 Days)||13
11395638|NCT03702010|12589402|FG001|STARTED|First Stimulation (5 Days)||14
11395639|NCT03702010|12589401|FG000|COMPLETED|First Stimulation (5 Days)||13
11395640|NCT03702010|12589402|FG001|COMPLETED|First Stimulation (5 Days)||14
11395641|NCT03702010|12589401|FG000|NOT COMPLETED|First Stimulation (5 Days)||0
11395642|NCT03702010|12589402|FG001|NOT COMPLETED|First Stimulation (5 Days)||0
11395643|NCT03702010|12589401|FG000|STARTED|Washout + Second Stimulation (2+5days)||13
11395644|NCT03702010|12589402|FG001|STARTED|Washout + Second Stimulation (2+5days)||14
11395645|NCT03702010|12589401|FG000|COMPLETED|Washout + Second Stimulation (2+5days)||13
11395646|NCT03702010|12589402|FG001|COMPLETED|Washout + Second Stimulation (2+5days)||14
11395647|NCT03702010|12589401|FG000|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0
11395648|NCT03702010|12589402|FG001|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0
11395649|NCT03702010|12589401|FG000|STARTED|Follow-up (30days)||13
11006236|NCT00727246|12184000|FG003|COMPLETED|Overall Study||3
11006237|NCT00727246|12183997|FG000|NOT COMPLETED|Overall Study||0
11006238|NCT00727246|12183998|FG001|NOT COMPLETED|Overall Study||1
11006239|NCT00727246|12183999|FG002|NOT COMPLETED|Overall Study||1
11006240|NCT00727246|12184000|FG003|NOT COMPLETED|Overall Study||2
11006241|NCT00727259|12184010|FG000|STARTED|Overall Study||1995
11006242|NCT00727259|12184010|FG000|COMPLETED|Overall Study||940
11006243|NCT00727259|12184010|FG000|NOT COMPLETED|Overall Study||1055
11006244|NCT00727272|12184015|FG000|STARTED|Period I||9
11006245|NCT00727272|12184016|FG001|STARTED|Period I||9
11006246|NCT00727272|12184017|FG002|STARTED|Period I||9
11006247|NCT00727272|12184015|FG000|COMPLETED|Period I||9
11006248|NCT00727272|12184016|FG001|COMPLETED|Period I||9
11006249|NCT00727272|12184017|FG002|COMPLETED|Period I||9
11006250|NCT00727272|12184015|FG000|NOT COMPLETED|Period I||0
11006251|NCT00727272|12184016|FG001|NOT COMPLETED|Period I||0
11006252|NCT00727272|12184017|FG002|NOT COMPLETED|Period I||0
11006253|NCT00727272|12184015|FG000|STARTED|Washout Period A||9
11006254|NCT00727272|12184016|FG001|STARTED|Washout Period A||9
11006255|NCT00727272|12184017|FG002|STARTED|Washout Period A||9
11006256|NCT00727272|12184015|FG000|COMPLETED|Washout Period A||9
11006257|NCT00727272|12184016|FG001|COMPLETED|Washout Period A||9
11006258|NCT00727272|12184017|FG002|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
11006259|NCT00727272|12184015|FG000|NOT COMPLETED|Washout Period A||0
11006260|NCT00727272|12184016|FG001|NOT COMPLETED|Washout Period A||0
11006261|NCT00727272|12184017|FG002|NOT COMPLETED|Washout Period A||1
11006262|NCT00727272|12184015|FG000|STARTED|Period II||9
11006263|NCT00727272|12184016|FG001|STARTED|Period II||9
11006264|NCT00727272|12184017|FG002|STARTED|Period II||8
11006265|NCT00727272|12184015|FG000|COMPLETED|Period II||9
11006266|NCT00727272|12184016|FG001|COMPLETED|Period II||9
11006267|NCT00727272|12184017|FG002|COMPLETED|Period II||8
11395650|NCT03702010|12589402|FG001|STARTED|Follow-up (30days)||14
11395651|NCT03702010|12589401|FG000|COMPLETED|Follow-up (30days)||11
11395652|NCT03702010|12589402|FG001|COMPLETED|Follow-up (30days)||12
11395653|NCT03702010|12589401|FG000|NOT COMPLETED|Follow-up (30days)||2
11395654|NCT03702010|12589402|FG001|NOT COMPLETED|Follow-up (30days)||2
11395655|NCT03702166|12589414|FG000|STARTED|Overall Study||10
11395656|NCT03702166|12589414|FG000|COMPLETED|Overall Study||8
11395657|NCT03702166|12589414|FG000|NOT COMPLETED|Overall Study||2
11395658|NCT03702608|12589419|FG000|STARTED|Overall Study||50
11395659|NCT03702608|12589419|FG000|COMPLETED|Overall Study||50
11395660|NCT03702608|12589419|FG000|NOT COMPLETED|Overall Study||0
11395661|NCT03703336|12589425|FG000|STARTED|Overall Study||552
11395662|NCT03703336|12589426|FG001|STARTED|Overall Study||273
11395663|NCT03703336|12589425|FG000|Received Dose 1|Overall Study||552
11395664|NCT03703336|12589426|FG001|Received Dose 1|Overall Study||273
11006268|NCT00727272|12184015|FG000|NOT COMPLETED|Period II||0
11006269|NCT00727272|12184016|FG001|NOT COMPLETED|Period II||0
11006270|NCT00727272|12184017|FG002|NOT COMPLETED|Period II||0
11006271|NCT00727272|12184015|FG000|STARTED|Washout Period B||9
11006272|NCT00727272|12184016|FG001|STARTED|Washout Period B||9
11006273|NCT00727272|12184017|FG002|STARTED|Washout Period B||8
11006274|NCT00727272|12184015|FG000|COMPLETED|Washout Period B||9
11006275|NCT00727272|12184016|FG001|COMPLETED|Washout Period B||9
11006276|NCT00727272|12184017|FG002|COMPLETED|Washout Period B|personal reasons|7
11006277|NCT00727272|12184015|FG000|NOT COMPLETED|Washout Period B||0
11006278|NCT00727272|12184016|FG001|NOT COMPLETED|Washout Period B||0
11006279|NCT00727272|12184017|FG002|NOT COMPLETED|Washout Period B||1
11006280|NCT00727272|12184015|FG000|STARTED|Period III||9
11006281|NCT00727272|12184016|FG001|STARTED|Period III||9
11006282|NCT00727272|12184017|FG002|STARTED|Period III||7
11006283|NCT00727272|12184015|FG000|COMPLETED|Period III||9
11006284|NCT00727272|12184016|FG001|COMPLETED|Period III||9
11006285|NCT00727272|12184017|FG002|COMPLETED|Period III||7
11006286|NCT00727272|12184015|FG000|NOT COMPLETED|Period III||0
11395665|NCT03703336|12589425|FG000|Received Dose 2|Overall Study||518
11006287|NCT00727272|12184016|FG001|NOT COMPLETED|Period III||0
11006288|NCT00727272|12184017|FG002|NOT COMPLETED|Period III||0
11006289|NCT00727298|12184027|FG000|STARTED|Overall Study||4485
11006290|NCT00727298|12184027|FG000|COMPLETED|Overall Study||3228
11006291|NCT00727298|12184027|FG000|NOT COMPLETED|Overall Study||1257
11006292|NCT00727311|12184031|FG000|STARTED|Overall Study||2302
11006293|NCT00727311|12184031|FG000|COMPLETED|Overall Study||1195
11395666|NCT03703336|12589426|FG001|Received Dose 2|Overall Study||263
11395667|NCT03703336|12589425|FG000|Safety Population|Overall Study||551
11006294|NCT00727311|12184031|FG000|NOT COMPLETED|Overall Study||1107
11395668|NCT03703336|12589426|FG001|Safety Population|Overall Study||274
11395669|NCT03703336|12589425|FG000|COMPLETED|Overall Study||514
11395670|NCT03703336|12589426|FG001|COMPLETED|Overall Study||259
11395671|NCT03703336|12589425|FG000|NOT COMPLETED|Overall Study||38
11395672|NCT03703336|12589426|FG001|NOT COMPLETED|Overall Study||14
11395673|NCT03703817|12589434|FG000|STARTED|Overall Study||288
11395674|NCT03703817|12589435|FG001|STARTED|Overall Study||133
11395675|NCT03703817|12589434|FG000|COMPLETED|Overall Study||281
11395676|NCT03703817|12589435|FG001|COMPLETED|Overall Study||129
11395677|NCT03703817|12589434|FG000|NOT COMPLETED|Overall Study||7
11395678|NCT03703817|12589435|FG001|NOT COMPLETED|Overall Study||4
11395679|NCT03704194|12589443|FG000|STARTED|Overall Study||8
11395680|NCT03704194|12589444|FG001|STARTED|Overall Study||9
11395681|NCT03704194|12589443|FG000|COMPLETED|Overall Study||8
11395682|NCT03704194|12589444|FG001|COMPLETED|Overall Study||8
11395683|NCT03704194|12589443|FG000|NOT COMPLETED|Overall Study||0
11395684|NCT03704194|12589444|FG001|NOT COMPLETED|Overall Study||1
11395685|NCT03704376|12589454|FG000|STARTED|Overall Study||42
11395686|NCT03704376|12589455|FG001|STARTED|Overall Study||44
11395687|NCT03704376|12589454|FG000|COMPLETED|Overall Study||38
11395688|NCT03704376|12589455|FG001|COMPLETED|Overall Study||40
11395689|NCT03704376|12589454|FG000|NOT COMPLETED|Overall Study||4
11395690|NCT03704376|12589455|FG001|NOT COMPLETED|Overall Study||4
11395691|NCT03704467|12589461|FG000|STARTED|Overall Study||3
11395692|NCT03704467|12589461|FG000|COMPLETED|Overall Study||3
11395693|NCT03704467|12589461|FG000|NOT COMPLETED|Overall Study||0
11006295|NCT00727337|12184039|FG000|STARTED|Overall Study||68
11006296|NCT00727337|12184040|FG001|STARTED|Overall Study||65
11006297|NCT00727337|12184041|FG002|STARTED|Overall Study||73
11006298|NCT00727337|12184042|FG003|STARTED|Overall Study||73
11006299|NCT00727337|12184039|FG000|COMPLETED|Overall Study||61
11006300|NCT00727337|12184040|FG001|COMPLETED|Overall Study||55
11006301|NCT00727337|12184041|FG002|COMPLETED|Overall Study||63
11006302|NCT00727337|12184042|FG003|COMPLETED|Overall Study||64
11395694|NCT03705273|12589467|FG000|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20
11395695|NCT03705273|12589468|FG001|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20
11395696|NCT03705273|12589467|FG000|COMPLETED|Overall Study||20
11142153|NCT01466673|12328882|FG000|NOT COMPLETED|Overall Study||7
11142154|NCT01466673|12328883|FG001|NOT COMPLETED|Overall Study||6
11142155|NCT01466751|12328891|FG000|STARTED|Overall Study||14
11142156|NCT01466751|12328892|FG001|STARTED|Overall Study||14
11142157|NCT01466751|12328891|FG000|COMPLETED|Overall Study||13
11142158|NCT01466751|12328892|FG001|COMPLETED|Overall Study||14
11142159|NCT01466751|12328891|FG000|NOT COMPLETED|Overall Study||1
11142160|NCT01466751|12328892|FG001|NOT COMPLETED|Overall Study||0
11142161|NCT01466764|12328902|FG000|STARTED|Overall Study||5
11142162|NCT01466764|12328903|FG001|STARTED|Overall Study||5
11142163|NCT01466764|12328902|FG000|COMPLETED|Overall Study||5
11142164|NCT01466764|12328903|FG001|COMPLETED|Overall Study||5
11142165|NCT01466764|12328902|FG000|NOT COMPLETED|Overall Study||0
11142166|NCT01466764|12328903|FG001|NOT COMPLETED|Overall Study||0
11142167|NCT01466790|12328917|FG000|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
11142168|NCT01466790|12328918|FG001|STARTED|Overall Study||15
11142169|NCT01466790|12328919|FG002|STARTED|Overall Study||27
11142170|NCT01466790|12328920|FG003|STARTED|Overall Study||14
11006303|NCT00727337|12184039|FG000|NOT COMPLETED|Overall Study||7
11142171|NCT01466790|12328921|FG004|STARTED|Overall Study||30
11142172|NCT01466790|12328922|FG005|STARTED|Overall Study||16
11142173|NCT01466790|12328923|FG006|STARTED|Overall Study||27
11142174|NCT01466790|12328924|FG007|STARTED|Overall Study||14
11142175|NCT01466790|12328917|FG000|COMPLETED|Overall Study||20
11142176|NCT01466790|12328918|FG001|COMPLETED|Overall Study||14
11142177|NCT01466790|12328919|FG002|COMPLETED|Overall Study||27
11142178|NCT01466790|12328920|FG003|COMPLETED|Overall Study||14
11142179|NCT01466790|12328921|FG004|COMPLETED|Overall Study||27
11142180|NCT01466790|12328922|FG005|COMPLETED|Overall Study||16
11142181|NCT01466790|12328923|FG006|COMPLETED|Overall Study||26
11142182|NCT01466790|12328924|FG007|COMPLETED|Overall Study||13
11142183|NCT01466790|12328917|FG000|NOT COMPLETED|Overall Study||4
11142184|NCT01466790|12328918|FG001|NOT COMPLETED|Overall Study||1
11142185|NCT01466790|12328919|FG002|NOT COMPLETED|Overall Study||0
11142186|NCT01466790|12328920|FG003|NOT COMPLETED|Overall Study||0
11142187|NCT01466790|12328921|FG004|NOT COMPLETED|Overall Study||3
11142188|NCT01466790|12328922|FG005|NOT COMPLETED|Overall Study||0
11142189|NCT01466790|12328923|FG006|NOT COMPLETED|Overall Study||1
11142190|NCT01466790|12328924|FG007|NOT COMPLETED|Overall Study||1
11142191|NCT01466881|12328938|FG000|STARTED|Overall Study||42
11142192|NCT01466881|12328938|FG000|Eligible and Treated|Overall Study||37
11142193|NCT01466881|12328938|FG000|COMPLETED|Overall Study||2
11142194|NCT01466881|12328938|FG000|NOT COMPLETED|Overall Study||40
11142195|NCT01466972|12328944|FG000|STARTED|Overall Study||30
11142196|NCT01466972|12328944|FG000|COMPLETED|Overall Study||30
11142197|NCT01466972|12328944|FG000|NOT COMPLETED|Overall Study||0
11142198|NCT01466985|12328951|FG000|STARTED|Overall Study||6
11142199|NCT01466985|12328952|FG001|STARTED|Overall Study||6
11142200|NCT01466985|12328953|FG002|STARTED|Overall Study||6
11142201|NCT01466985|12328951|FG000|COMPLETED|Overall Study||6
11142202|NCT01466985|12328952|FG001|COMPLETED|Overall Study||6
11142203|NCT01466985|12328953|FG002|COMPLETED|Overall Study||6
11142204|NCT01466985|12328951|FG000|NOT COMPLETED|Overall Study||0
11142205|NCT01466985|12328952|FG001|NOT COMPLETED|Overall Study||0
11142206|NCT01466985|12328953|FG002|NOT COMPLETED|Overall Study||0
11142207|NCT01467037|12328964|FG000|STARTED|Overall Study||374
11142208|NCT01467037|12328964|FG000|COMPLETED|Overall Study||374
11142209|NCT01467037|12328964|FG000|NOT COMPLETED|Overall Study||0
11263683|NCT02271984|12459072|FG011|COMPLETED|Washout Period 3 (7 Days)||3
11263684|NCT02271984|12459061|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
11142210|NCT01467063|12328971|FG000|STARTED|Overall Study||6
11142211|NCT01467063|12328972|FG001|STARTED|Overall Study||7
11142212|NCT01467063|12328971|FG000|COMPLETED|Overall Study||5
11142213|NCT01467063|12328972|FG001|COMPLETED|Overall Study||7
11142214|NCT01467063|12328971|FG000|NOT COMPLETED|Overall Study||1
11142215|NCT01467063|12328972|FG001|NOT COMPLETED|Overall Study||0
11142216|NCT01467076|12328981|FG000|STARTED|Overall Study||3
11142217|NCT01467076|12328982|FG001|STARTED|Overall Study||2
11142218|NCT01467076|12328983|FG002|STARTED|Overall Study||2
11142219|NCT01467076|12328981|FG000|COMPLETED|Overall Study||2
11142220|NCT01467076|12328982|FG001|COMPLETED|Overall Study||2
11142221|NCT01467076|12328983|FG002|COMPLETED|Overall Study||2
11142222|NCT01467076|12328981|FG000|NOT COMPLETED|Overall Study||1
11142223|NCT01467076|12328982|FG001|NOT COMPLETED|Overall Study||0
11142224|NCT01467076|12328983|FG002|NOT COMPLETED|Overall Study||0
11142225|NCT01467271|12328991|FG000|STARTED|Overall Study||540
11142226|NCT01467271|12328991|FG000|COMPLETED|Overall Study||338
11142227|NCT01467271|12328991|FG000|NOT COMPLETED|Overall Study||202
11142228|NCT01467427|12328997|FG000|STARTED|Overall Study||12
11142229|NCT01467427|12328998|FG001|STARTED|Overall Study||13
11142230|NCT01467427|12328997|FG000|Completed Main Phase|Overall Study||11
11142231|NCT01467427|12328998|FG001|Completed Main Phase|Overall Study||13
11142232|NCT01467427|12328997|FG000|COMPLETED|Overall Study||0
11142233|NCT01467427|12328998|FG001|COMPLETED|Overall Study||0
11142234|NCT01467427|12328997|FG000|NOT COMPLETED|Overall Study||12
11142235|NCT01467427|12328998|FG001|NOT COMPLETED|Overall Study||13
11142236|NCT01467479|12329007|FG000|STARTED|Overall Study||55
11142237|NCT01467479|12329008|FG001|STARTED|Overall Study||69
11142238|NCT01467479|12329009|FG002|STARTED|Overall Study||61
11142239|NCT01467479|12329007|FG000|Treated|Overall Study||54
11142240|NCT01467479|12329008|FG001|Treated|Overall Study||69
11142241|NCT01467479|12329009|FG002|Treated|Overall Study||59
11142242|NCT01467479|12329007|FG000|COMPLETED|Overall Study||46
11142243|NCT01467479|12329008|FG001|COMPLETED|Overall Study||52
11142244|NCT01467479|12329009|FG002|COMPLETED|Overall Study||45
11142245|NCT01467479|12329007|FG000|NOT COMPLETED|Overall Study||9
11142246|NCT01467479|12329008|FG001|NOT COMPLETED|Overall Study||17
11142247|NCT01467479|12329009|FG002|NOT COMPLETED|Overall Study||16
11142248|NCT01467492|12329020|FG000|STARTED|Overall Study||83
11142249|NCT01467492|12329021|FG001|STARTED|Overall Study||38
11142250|NCT01467492|12329020|FG000|COMPLETED|Overall Study||61
11142251|NCT01467492|12329021|FG001|COMPLETED|Overall Study||25
11142252|NCT01467492|12329020|FG000|NOT COMPLETED|Overall Study||22
11142253|NCT01467492|12329021|FG001|NOT COMPLETED|Overall Study||13
11142254|NCT01467505|12329030|FG000|STARTED|Overall Study||51
11142255|NCT01467505|12329031|FG001|STARTED|Overall Study||10
11142256|NCT01467505|12329030|FG000|COMPLETED|Overall Study||18
11142257|NCT01467505|12329031|FG001|COMPLETED|Overall Study||7
11142258|NCT01467505|12329030|FG000|NOT COMPLETED|Overall Study||33
11142259|NCT01467505|12329031|FG001|NOT COMPLETED|Overall Study||3
11142260|NCT01467557|12329039|FG000|STARTED|Overall Study||601
11142261|NCT01467557|12329040|FG001|STARTED|Overall Study||570
11142262|NCT01467557|12329039|FG000|2 Week Survey Completed|Overall Study||551
11142263|NCT01467557|12329040|FG001|2 Week Survey Completed|Overall Study||522
11142264|NCT01467557|12329039|FG000|4 Month Survey Completed|Overall Study||533
11142265|NCT01467557|12329040|FG001|4 Month Survey Completed|Overall Study||493
11142266|NCT01467557|12329039|FG000|12 Month Survey Completed|Overall Study||502
11142267|NCT01467557|12329040|FG001|12 Month Survey Completed|Overall Study||463
11142268|NCT01467557|12329039|FG000|COMPLETED|Overall Study||502
11142269|NCT01467557|12329040|FG001|COMPLETED|Overall Study||463
11142270|NCT01467557|12329039|FG000|NOT COMPLETED|Overall Study||99
11142271|NCT01467557|12329040|FG001|NOT COMPLETED|Overall Study||107
11142272|NCT01467570|12329048|FG000|STARTED|Overall Study||75
11142273|NCT01467570|12329049|FG001|STARTED|Overall Study||72
11142274|NCT01467570|12329048|FG000|COMPLETED|Overall Study||67
11142275|NCT01467570|12329049|FG001|COMPLETED|Overall Study||63
11142276|NCT01467570|12329048|FG000|NOT COMPLETED|Overall Study||8
11142277|NCT01467570|12329049|FG001|NOT COMPLETED|Overall Study||9
11142278|NCT01467583|12329060|FG000|STARTED|Overall Study||16
11142279|NCT01467583|12329061|FG001|STARTED|Overall Study||4
11142280|NCT01467583|12329062|FG002|STARTED|Overall Study||12
11142281|NCT01467583|12329060|FG000|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
11142282|NCT01467583|12329061|FG001|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
11142283|NCT01467583|12329062|FG002|COMPLETED|Overall Study||10
11142284|NCT01467583|12329060|FG000|NOT COMPLETED|Overall Study||2
11142285|NCT01467583|12329061|FG001|NOT COMPLETED|Overall Study||1
11142286|NCT01467583|12329062|FG002|NOT COMPLETED|Overall Study||2
11142287|NCT01467661|12329073|FG000|STARTED|Overall Study||53
11142288|NCT01467661|12329073|FG000|Completed SPD422-308 (NCT01214915)|Overall Study||42
11142289|NCT01467661|12329073|FG000|Started SPD422-309 (NCT01467661)|Overall Study||41
11142290|NCT01467661|12329073|FG000|Started Post Marketing Trial|Overall Study||33
11142291|NCT01467661|12329073|FG000|COMPLETED|Overall Study||32
11142292|NCT01467661|12329073|FG000|NOT COMPLETED|Overall Study||21
11142293|NCT01467700|12329083|FG000|STARTED|Overall Study||115
11142294|NCT01467700|12329084|FG001|STARTED|Overall Study||128
11142295|NCT01467700|12329085|FG002|STARTED|Overall Study||124
11142296|NCT01467700|12329086|FG003|STARTED|Overall Study||123
11142297|NCT01467700|12329083|FG000|Safety Set - Received Treatment|Overall Study||115
11142298|NCT01467700|12329084|FG001|Safety Set - Received Treatment|Overall Study||127
11142299|NCT01467700|12329085|FG002|Safety Set - Received Treatment|Overall Study||124
11142300|NCT01467700|12329086|FG003|Safety Set - Received Treatment|Overall Study||123
11142301|NCT01467700|12329083|FG000|COMPLETED|Overall Study||86
11142302|NCT01467700|12329084|FG001|COMPLETED|Overall Study||100
11142303|NCT01467700|12329085|FG002|COMPLETED|Overall Study||97
11142304|NCT01467700|12329086|FG003|COMPLETED|Overall Study||96
11142305|NCT01467700|12329083|FG000|NOT COMPLETED|Overall Study||29
11142306|NCT01467700|12329084|FG001|NOT COMPLETED|Overall Study||28
11142307|NCT01467700|12329085|FG002|NOT COMPLETED|Overall Study||27
11142308|NCT01467700|12329086|FG003|NOT COMPLETED|Overall Study||27
11142309|NCT01467713|12329100|FG000|STARTED|Overall Study||164
11142310|NCT01467713|12329101|FG001|STARTED|Overall Study||164
11142311|NCT01467713|12329102|FG002|STARTED|Overall Study||160
11142312|NCT01467713|12329103|FG003|STARTED|Overall Study||154
11142313|NCT01467713|12329100|FG000|Safety Analysis Set: Received Treatment|Overall Study||163
11142314|NCT01467713|12329101|FG001|Safety Analysis Set: Received Treatment|Overall Study||164
11142315|NCT01467713|12329102|FG002|Safety Analysis Set: Received Treatment|Overall Study||159
11142316|NCT01467713|12329103|FG003|Safety Analysis Set: Received Treatment|Overall Study||154
11142317|NCT01467713|12329100|FG000|COMPLETED|Overall Study||62
11142318|NCT01467713|12329101|FG001|COMPLETED|Overall Study||60
11142319|NCT01467713|12329102|FG002|COMPLETED|Overall Study||58
11142320|NCT01467713|12329103|FG003|COMPLETED|Overall Study||45
11142321|NCT01467713|12329100|FG000|NOT COMPLETED|Overall Study||102
11142322|NCT01467713|12329101|FG001|NOT COMPLETED|Overall Study||104
11142323|NCT01467713|12329102|FG002|NOT COMPLETED|Overall Study||102
11142324|NCT01467713|12329103|FG003|NOT COMPLETED|Overall Study||109
11142325|NCT01467882|12329113|FG000|STARTED|Overall Study||44
11142326|NCT01467882|12329113|FG000|COMPLETED|Overall Study||44
11142327|NCT01467882|12329113|FG000|NOT COMPLETED|Overall Study||0
11142328|NCT01467934|12329127|FG000|STARTED|Overall Study||208
11142329|NCT01467934|12329128|FG001|STARTED|Overall Study||212
11142330|NCT01467934|12329129|FG002|STARTED|Overall Study||110
11142331|NCT01467934|12329127|FG000|COMPLETED|Overall Study||208
11142332|NCT01467934|12329128|FG001|COMPLETED|Overall Study||212
11142333|NCT01467934|12329129|FG002|COMPLETED|Overall Study||110
11142334|NCT01467934|12329127|FG000|NOT COMPLETED|Overall Study||0
11142335|NCT01467934|12329128|FG001|NOT COMPLETED|Overall Study||0
11142336|NCT01467934|12329129|FG002|NOT COMPLETED|Overall Study||0
11142337|NCT01467947|12329137|FG000|STARTED|Overall Study||46
11142338|NCT01467947|12329137|FG000|COMPLETED|Overall Study||46
11142339|NCT01467947|12329137|FG000|NOT COMPLETED|Overall Study||0
11142340|NCT01467960|12329147|FG000|STARTED|Overall Study||30
11142341|NCT01467960|12329148|FG001|STARTED|Overall Study||30
11142342|NCT01467960|12329149|FG002|STARTED|Overall Study||30
11142343|NCT01467960|12329150|FG003|STARTED|Overall Study||30
11142344|NCT01467960|12329151|FG004|STARTED|Overall Study||30
11142345|NCT01467960|12329152|FG005|STARTED|Overall Study||30
11142346|NCT01467960|12329147|FG000|COMPLETED|Overall Study||30
11142347|NCT01467960|12329148|FG001|COMPLETED|Overall Study||30
11142348|NCT01467960|12329149|FG002|COMPLETED|Overall Study||30
11395697|NCT03705273|12589468|FG001|COMPLETED|Overall Study||20
11395698|NCT03705273|12589467|FG000|NOT COMPLETED|Overall Study||0
11395699|NCT03705273|12589468|FG001|NOT COMPLETED|Overall Study||0
11395700|NCT03705481|12589474|FG000|STARTED|Overall Study||5
11395701|NCT03705481|12589474|FG000|COMPLETED|Overall Study||5
11395702|NCT03705481|12589474|FG000|NOT COMPLETED|Overall Study||0
11142349|NCT01467960|12329150|FG003|COMPLETED|Overall Study||0
11395703|NCT03705494|12589483|FG000|STARTED|Overall Study||10
11395704|NCT03705494|12589484|FG001|STARTED|Overall Study||10
11395705|NCT03705494|12589483|FG000|COMPLETED|Overall Study||3
11395706|NCT03705494|12589484|FG001|COMPLETED|Overall Study||7
11395707|NCT03705494|12589483|FG000|NOT COMPLETED|Overall Study||7
11395708|NCT03705494|12589484|FG001|NOT COMPLETED|Overall Study||3
11395709|NCT03706040|12589493|FG000|STARTED|Period A (Week 0 to Week 16)||34
11395710|NCT03706040|12589494|FG001|STARTED|Period A (Week 0 to Week 16)||69
11395711|NCT03706040|12589495|FG002|STARTED|Period A (Week 0 to Week 16)||69
11395712|NCT03706040|12589496|FG003|STARTED|Period A (Week 0 to Week 16)||0
11395713|NCT03706040|12589497|FG004|STARTED|Period A (Week 0 to Week 16)||0
11395714|NCT03706040|12589498|FG005|STARTED|Period A (Week 0 to Week 16)||0
11395715|NCT03706040|12589499|FG006|STARTED|Period A (Week 0 to Week 16)||0
11395716|NCT03706040|12589493|FG000|Received Study Drug|Period A (Week 0 to Week 16)||34
11395717|NCT03706040|12589494|FG001|Received Study Drug|Period A (Week 0 to Week 16)||69
11395718|NCT03706040|12589495|FG002|Received Study Drug|Period A (Week 0 to Week 16)||69
11395719|NCT03706040|12589496|FG003|Received Study Drug|Period A (Week 0 to Week 16)||0
11395720|NCT03706040|12589497|FG004|Received Study Drug|Period A (Week 0 to Week 16)||0
11395721|NCT03706040|12589498|FG005|Received Study Drug|Period A (Week 0 to Week 16)||0
11395722|NCT03706040|12589499|FG006|Received Study Drug|Period A (Week 0 to Week 16)||0
11395723|NCT03706040|12589493|FG000|COMPLETED|Period A (Week 0 to Week 16)||25
11395724|NCT03706040|12589494|FG001|COMPLETED|Period A (Week 0 to Week 16)||61
11395725|NCT03706040|12589495|FG002|COMPLETED|Period A (Week 0 to Week 16)||58
11395726|NCT03706040|12589496|FG003|COMPLETED|Period A (Week 0 to Week 16)||0
11395727|NCT03706040|12589497|FG004|COMPLETED|Period A (Week 0 to Week 16)||0
11395728|NCT03706040|12589498|FG005|COMPLETED|Period A (Week 0 to Week 16)||0
11395729|NCT03706040|12589499|FG006|COMPLETED|Period A (Week 0 to Week 16)||0
11395730|NCT03706040|12589493|FG000|NOT COMPLETED|Period A (Week 0 to Week 16)||9
11395731|NCT03706040|12589494|FG001|NOT COMPLETED|Period A (Week 0 to Week 16)||8
11395732|NCT03706040|12589495|FG002|NOT COMPLETED|Period A (Week 0 to Week 16)||11
11395733|NCT03706040|12589496|FG003|NOT COMPLETED|Period A (Week 0 to Week 16)||0
11006304|NCT00727337|12184040|FG001|NOT COMPLETED|Overall Study||10
11006305|NCT00727337|12184041|FG002|NOT COMPLETED|Overall Study||10
11006306|NCT00727337|12184042|FG003|NOT COMPLETED|Overall Study||9
11006307|NCT00727402|12184057|FG000|STARTED|Overall Study||205
11006308|NCT00727402|12184057|FG000|COMPLETED|Overall Study||89
11006309|NCT00727402|12184057|FG000|NOT COMPLETED|Overall Study||116
11006310|NCT00727415|12184061|FG000|STARTED|Phase I||9
11006311|NCT00727415|12184061|FG000|COMPLETED|Phase I||7
11006312|NCT00727415|12184061|FG000|NOT COMPLETED|Phase I||2
11006313|NCT00727415|12184061|FG000|STARTED|Phase II||33
11395734|NCT03706040|12589497|FG004|NOT COMPLETED|Period A (Week 0 to Week 16)||0
11395735|NCT03706040|12589498|FG005|NOT COMPLETED|Period A (Week 0 to Week 16)||0
11395736|NCT03706040|12589499|FG006|NOT COMPLETED|Period A (Week 0 to Week 16)||0
11395737|NCT03706040|12589493|FG000|STARTED|Period B (Week 16 to Week 52)||0
11395738|NCT03706040|12589494|FG001|STARTED|Period B (Week 16 to Week 52)||0
11395739|NCT03706040|12589495|FG002|STARTED|Period B (Week 16 to Week 52)||0
11395740|NCT03706040|12589496|FG003|STARTED|Period B (Week 16 to Week 52)||13
11395741|NCT03706040|12589497|FG004|STARTED|Period B (Week 16 to Week 52)||12
11395742|NCT03706040|12589498|FG005|STARTED|Period B (Week 16 to Week 52)||61
11395743|NCT03706040|12589499|FG006|STARTED|Period B (Week 16 to Week 52)||58
11395744|NCT03706040|12589493|FG000|Received Study Drug|Period B (Week 16 to Week 52)||0
11395745|NCT03706040|12589494|FG001|Received Study Drug|Period B (Week 16 to Week 52)||0
11395746|NCT03706040|12589495|FG002|Received Study Drug|Period B (Week 16 to Week 52)||0
11395747|NCT03706040|12589496|FG003|Received Study Drug|Period B (Week 16 to Week 52)||13
11395748|NCT03706040|12589497|FG004|Received Study Drug|Period B (Week 16 to Week 52)||11
11395749|NCT03706040|12589498|FG005|Received Study Drug|Period B (Week 16 to Week 52)||61
11395750|NCT03706040|12589499|FG006|Received Study Drug|Period B (Week 16 to Week 52)||57
11395751|NCT03706040|12589493|FG000|COMPLETED|Period B (Week 16 to Week 52)||0
11395752|NCT03706040|12589494|FG001|COMPLETED|Period B (Week 16 to Week 52)||0
11395753|NCT03706040|12589495|FG002|COMPLETED|Period B (Week 16 to Week 52)||0
11395754|NCT03706040|12589496|FG003|COMPLETED|Period B (Week 16 to Week 52)||5
11395755|NCT03706040|12589497|FG004|COMPLETED|Period B (Week 16 to Week 52)||3
11395756|NCT03706040|12589498|FG005|COMPLETED|Period B (Week 16 to Week 52)||33
11395757|NCT03706040|12589499|FG006|COMPLETED|Period B (Week 16 to Week 52)||30
11395758|NCT03706040|12589493|FG000|NOT COMPLETED|Period B (Week 16 to Week 52)||0
11395759|NCT03706040|12589494|FG001|NOT COMPLETED|Period B (Week 16 to Week 52)||0
11395760|NCT03706040|12589495|FG002|NOT COMPLETED|Period B (Week 16 to Week 52)||0
11395761|NCT03706040|12589496|FG003|NOT COMPLETED|Period B (Week 16 to Week 52)||8
11395762|NCT03706040|12589497|FG004|NOT COMPLETED|Period B (Week 16 to Week 52)||9
11395763|NCT03706040|12589498|FG005|NOT COMPLETED|Period B (Week 16 to Week 52)||28
11395764|NCT03706040|12589499|FG006|NOT COMPLETED|Period B (Week 16 to Week 52)||28
11395765|NCT03706313|12589517|FG000|STARTED|Overall Study||20
11395766|NCT03706313|12589518|FG001|STARTED|Overall Study||20
11395767|NCT03706313|12589517|FG000|COMPLETED|Overall Study||20
11395768|NCT03706313|12589518|FG001|COMPLETED|Overall Study||20
11395769|NCT03706313|12589517|FG000|NOT COMPLETED|Overall Study||0
11395770|NCT03706313|12589518|FG001|NOT COMPLETED|Overall Study||0
11395771|NCT03706469|12589528|FG000|STARTED|Overall Study||4
11395772|NCT03706469|12589529|FG001|STARTED|Overall Study||4
11395773|NCT03706469|12589530|FG002|STARTED|Overall Study||4
11395774|NCT03706469|12589531|FG003|STARTED|Overall Study||4
11395775|NCT03706469|12589528|FG000|COMPLETED|Overall Study||4
11395776|NCT03706469|12589529|FG001|COMPLETED|Overall Study||4
11395777|NCT03706469|12589530|FG002|COMPLETED|Overall Study||4
11395778|NCT03706469|12589531|FG003|COMPLETED|Overall Study||4
11395779|NCT03706469|12589528|FG000|NOT COMPLETED|Overall Study||0
11395780|NCT03706469|12589529|FG001|NOT COMPLETED|Overall Study||0
11395781|NCT03706469|12589530|FG002|NOT COMPLETED|Overall Study||0
11395782|NCT03706469|12589531|FG003|NOT COMPLETED|Overall Study||0
11395783|NCT03707041|12589548|FG000|STARTED|Overall Study||6
11395784|NCT03707041|12589549|FG001|STARTED|Overall Study||2
11395785|NCT03707041|12589550|FG002|STARTED|Overall Study||9
11395786|NCT03707041|12589551|FG003|STARTED|Overall Study||3
11395787|NCT03707041|12589552|FG004|STARTED|Overall Study||9
11395788|NCT03707041|12589553|FG005|STARTED|Overall Study||3
11395789|NCT03707041|12589548|FG000|COMPLETED|Overall Study||6
11395790|NCT03707041|12589549|FG001|COMPLETED|Overall Study||2
11395791|NCT03707041|12589550|FG002|COMPLETED|Overall Study||9
11395792|NCT03707041|12589551|FG003|COMPLETED|Overall Study||3
11395793|NCT03707041|12589552|FG004|COMPLETED|Overall Study||9
11395794|NCT03707041|12589553|FG005|COMPLETED|Overall Study||3
11395795|NCT03707041|12589548|FG000|NOT COMPLETED|Overall Study||0
11395796|NCT03707041|12589549|FG001|NOT COMPLETED|Overall Study||0
11395797|NCT03707041|12589550|FG002|NOT COMPLETED|Overall Study||0
11395798|NCT03707041|12589551|FG003|NOT COMPLETED|Overall Study||0
11395799|NCT03707041|12589552|FG004|NOT COMPLETED|Overall Study||0
11395800|NCT03707041|12589553|FG005|NOT COMPLETED|Overall Study||0
11395801|NCT03707522|12589572|FG000|STARTED|Overall Study||31
11395802|NCT03707522|12589573|FG001|STARTED|Overall Study||36
11395803|NCT03707522|12589574|FG002|STARTED|Overall Study||52
11395804|NCT03707522|12589575|FG003|STARTED|Overall Study||43
11395805|NCT03707522|12589572|FG000|COMPLETED|Overall Study||7
11395806|NCT03707522|12589573|FG001|COMPLETED|Overall Study||9
11395807|NCT03707522|12589574|FG002|COMPLETED|Overall Study||11
11395808|NCT03707522|12589575|FG003|COMPLETED|Overall Study||7
11395809|NCT03707522|12589572|FG000|NOT COMPLETED|Overall Study||24
11395810|NCT03707522|12589573|FG001|NOT COMPLETED|Overall Study||27
11395811|NCT03707522|12589574|FG002|NOT COMPLETED|Overall Study||41
11395812|NCT03707522|12589575|FG003|NOT COMPLETED|Overall Study||36
11395813|NCT03707821|12589587|FG000|STARTED|Overall Study||125
11395814|NCT03707821|12589588|FG001|STARTED|Overall Study||126
11395815|NCT03707821|12589587|FG000|COMPLETED|Overall Study||123
11395816|NCT03707821|12589588|FG001|COMPLETED|Overall Study||125
11395817|NCT03707821|12589587|FG000|NOT COMPLETED|Overall Study||2
11395818|NCT03707821|12589588|FG001|NOT COMPLETED|Overall Study||1
11395819|NCT03707912|12589596|FG000|STARTED|Overall Study||104
11395820|NCT03707912|12589597|FG001|STARTED|Overall Study||100
11395821|NCT03707912|12589596|FG000|COMPLETED|Overall Study||103
11395822|NCT03707912|12589597|FG001|COMPLETED|Overall Study||100
11395823|NCT03707912|12589596|FG000|NOT COMPLETED|Overall Study||1
11395824|NCT03707912|12589597|FG001|NOT COMPLETED|Overall Study||0
11395825|NCT03708211|12589605|FG000|STARTED|Overall Study||12
11395826|NCT03708211|12589606|FG001|STARTED|Overall Study||8
11395827|NCT03708211|12589605|FG000|COMPLETED|Overall Study||0
11395828|NCT03708211|12589606|FG001|COMPLETED|Overall Study||0
11395829|NCT03708211|12589605|FG000|NOT COMPLETED|Overall Study||12
11395830|NCT03708211|12589606|FG001|NOT COMPLETED|Overall Study||8
11395831|NCT03708367|12589616|FG000|STARTED|Overall Study||59
11395832|NCT03708367|12589617|FG001|STARTED|Overall Study||58
11395833|NCT03708367|12589616|FG000|COMPLETED|Overall Study||58
11395834|NCT03708367|12589617|FG001|COMPLETED|Overall Study||57
11395835|NCT03708367|12589616|FG000|NOT COMPLETED|Overall Study||1
11395836|NCT03708367|12589617|FG001|NOT COMPLETED|Overall Study||1
11395837|NCT03708393|12589624|FG000|STARTED|Overall Study||155
11395838|NCT03708393|12589624|FG000|COMPLETED|Overall Study||155
11395839|NCT03708393|12589624|FG000|NOT COMPLETED|Overall Study||0
11395840|NCT03708562|12589633|FG000|STARTED|Overall Study||24
11395841|NCT03708562|12589633|FG000|COMPLETED|Overall Study||12
11395842|NCT03708562|12589633|FG000|NOT COMPLETED|Overall Study||12
11395843|NCT03708744|12589637|FG000|STARTED|Overall Study||7
11395844|NCT03708744|12589638|FG001|STARTED|Overall Study||6
11395845|NCT03708744|12589639|FG002|STARTED|Overall Study||5
11395846|NCT03708744|12589640|FG003|STARTED|Overall Study||6
11395847|NCT03708744|12589637|FG000|COMPLETED|Overall Study||7
11395848|NCT03708744|12589638|FG001|COMPLETED|Overall Study||6
11395849|NCT03708744|12589639|FG002|COMPLETED|Overall Study||4
11395850|NCT03708744|12589640|FG003|COMPLETED|Overall Study||6
11395851|NCT03708744|12589637|FG000|NOT COMPLETED|Overall Study||0
11395852|NCT03708744|12589638|FG001|NOT COMPLETED|Overall Study||0
11395853|NCT03708744|12589639|FG002|NOT COMPLETED|Overall Study||1
11395854|NCT03708744|12589640|FG003|NOT COMPLETED|Overall Study||0
11395855|NCT03708770|12589650|FG000|STARTED|Overall Study||32
11395856|NCT03708770|12589650|FG000|COMPLETED|Overall Study||22
11395857|NCT03708770|12589650|FG000|NOT COMPLETED|Overall Study||10
11395858|NCT03709602|12589657|FG000|STARTED|Overall Study|Adolescents recruited for qualitative interviews.|16
11395859|NCT03709602|12589658|FG001|STARTED|Overall Study|Parents recruited for qualitative interviews.|16
11395860|NCT03709602|12589659|FG002|STARTED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
11395861|NCT03709602|12589657|FG000|COMPLETED|Overall Study|Adolescents recruited for qualitative interviews.|16
11395862|NCT03709602|12589658|FG001|COMPLETED|Overall Study|Parents recruited for qualitative interviews.|16
11395863|NCT03709602|12589659|FG002|COMPLETED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
11395864|NCT03709602|12589657|FG000|NOT COMPLETED|Overall Study||0
11395865|NCT03709602|12589658|FG001|NOT COMPLETED|Overall Study||0
11395866|NCT03709602|12589659|FG002|NOT COMPLETED|Overall Study||0
11395867|NCT03709654|12589667|FG000|STARTED|Overall Study||23
11395868|NCT03709654|12589668|FG001|STARTED|Overall Study||13
11395869|NCT03709654|12589667|FG000|COMPLETED|Overall Study||20
11395870|NCT03709654|12589668|FG001|COMPLETED|Overall Study||11
11395871|NCT03709654|12589667|FG000|NOT COMPLETED|Overall Study||3
11395872|NCT03709654|12589668|FG001|NOT COMPLETED|Overall Study||2
11395873|NCT03709810|12589674|FG000|STARTED|Treatment Period 1 (Visit 2)||24
11395874|NCT03709810|12589675|FG001|STARTED|Treatment Period 1 (Visit 2)||24
11395875|NCT03709810|12589674|FG000|COMPLETED|Treatment Period 1 (Visit 2)||24
11395876|NCT03709810|12589675|FG001|COMPLETED|Treatment Period 1 (Visit 2)||24
11395877|NCT03709810|12589674|FG000|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
11395878|NCT03709810|12589675|FG001|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
11395879|NCT03709810|12589674|FG000|STARTED|Treatment Period 2 (Visit 3)||24
11395880|NCT03709810|12589675|FG001|STARTED|Treatment Period 2 (Visit 3)||24
11395881|NCT03709810|12589674|FG000|COMPLETED|Treatment Period 2 (Visit 3)||24
11395882|NCT03709810|12589675|FG001|COMPLETED|Treatment Period 2 (Visit 3)||24
11395883|NCT03709810|12589674|FG000|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
11395884|NCT03709810|12589675|FG001|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
11395885|NCT03709823|12589687|FG000|STARTED|Overall Study||51
11395886|NCT03709823|12589688|FG001|STARTED|Overall Study||50
11395887|NCT03709823|12589689|FG002|STARTED|Overall Study||25
11395888|NCT03709823|12589690|FG003|STARTED|Overall Study||52
11395889|NCT03709823|12589691|FG004|STARTED|Overall Study||50
11395890|NCT03709823|12589692|FG005|STARTED|Overall Study||26
11395891|NCT03709823|12589687|FG000|COMPLETED|Overall Study||48
11395892|NCT03709823|12589688|FG001|COMPLETED|Overall Study||45
11395893|NCT03709823|12589689|FG002|COMPLETED|Overall Study||22
11395894|NCT03709823|12589690|FG003|COMPLETED|Overall Study||50
11395895|NCT03709823|12589691|FG004|COMPLETED|Overall Study||49
11395896|NCT03709823|12589692|FG005|COMPLETED|Overall Study||26
11395897|NCT03709823|12589687|FG000|NOT COMPLETED|Overall Study||3
11395898|NCT03709823|12589688|FG001|NOT COMPLETED|Overall Study||5
11395899|NCT03709823|12589689|FG002|NOT COMPLETED|Overall Study||3
11395900|NCT03709823|12589690|FG003|NOT COMPLETED|Overall Study||2
11395901|NCT03709823|12589691|FG004|NOT COMPLETED|Overall Study||1
11395902|NCT03709823|12589692|FG005|NOT COMPLETED|Overall Study||0
11395903|NCT03710083|12589709|FG000|STARTED|Overall Study||66
11395904|NCT03710083|12589709|FG000|COMPLETED|Overall Study||63
11395905|NCT03710083|12589709|FG000|NOT COMPLETED|Overall Study||3
11395906|NCT03710161|12589715|FG000|STARTED|Overall Study||3
11395907|NCT03710161|12589716|FG001|STARTED|Overall Study||2
11395908|NCT03710161|12589715|FG000|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
11395909|NCT03710161|12589716|FG001|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
11395910|NCT03710161|12589715|FG000|NOT COMPLETED|Overall Study||3
11395911|NCT03710161|12589716|FG001|NOT COMPLETED|Overall Study||2
11395912|NCT03710187|12589724|FG000|STARTED|Overall Study||41
11395913|NCT03710187|12589725|FG001|STARTED|Overall Study||43
11395914|NCT03710187|12589724|FG000|COMPLETED|Overall Study||41
11395915|NCT03710187|12589725|FG001|COMPLETED|Overall Study||43
11395916|NCT03710187|12589724|FG000|NOT COMPLETED|Overall Study||0
11395917|NCT03710187|12589725|FG001|NOT COMPLETED|Overall Study||0
11395918|NCT03710577|12589733|FG000|STARTED|First Intervention||8
11395919|NCT03710577|12589734|FG001|STARTED|First Intervention||4
11395920|NCT03710577|12589733|FG000|COMPLETED|First Intervention||8
11395921|NCT03710577|12589734|FG001|COMPLETED|First Intervention||4
11395922|NCT03710577|12589733|FG000|NOT COMPLETED|First Intervention||0
11395923|NCT03710577|12589734|FG001|NOT COMPLETED|First Intervention||0
11395924|NCT03710577|12589733|FG000|STARTED|Time Between Sessions (2-5 Days)||8
11395925|NCT03710577|12589734|FG001|STARTED|Time Between Sessions (2-5 Days)||4
11395926|NCT03710577|12589733|FG000|COMPLETED|Time Between Sessions (2-5 Days)||8
11395927|NCT03710577|12589734|FG001|COMPLETED|Time Between Sessions (2-5 Days)||4
11395928|NCT03710577|12589733|FG000|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
11395929|NCT03710577|12589734|FG001|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
11395930|NCT03710577|12589733|FG000|STARTED|Second Intervention||8
11395931|NCT03710577|12589734|FG001|STARTED|Second Intervention||4
11395932|NCT03710577|12589733|FG000|COMPLETED|Second Intervention||8
11395933|NCT03710577|12589734|FG001|COMPLETED|Second Intervention||4
11395934|NCT03710577|12589733|FG000|NOT COMPLETED|Second Intervention||0
11395935|NCT03710577|12589734|FG001|NOT COMPLETED|Second Intervention||0
11395936|NCT03710590|12589742|FG000|STARTED|Overall Study||22
11395937|NCT03710590|12589743|FG001|STARTED|Overall Study||23
11395938|NCT03710590|12589742|FG000|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||12
11395939|NCT03710590|12589743|FG001|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||15
11395940|NCT03710590|12589742|FG000|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||12
11395941|NCT03710590|12589743|FG001|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||15
11395942|NCT03710590|12589742|FG000|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||12
11395943|NCT03710590|12589743|FG001|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||15
11395944|NCT03710590|12589742|FG000|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||12
11395945|NCT03710590|12589743|FG001|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||15
11395946|NCT03710590|12589742|FG000|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||12
11395947|NCT03710590|12589743|FG001|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||15
11395948|NCT03710590|12589742|FG000|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||12
11395949|NCT03710590|12589743|FG001|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||15
11395950|NCT03710590|12589742|FG000|COMPLETED|Overall Study||12
11395951|NCT03710590|12589743|FG001|COMPLETED|Overall Study||15
11395952|NCT03710590|12589742|FG000|NOT COMPLETED|Overall Study||10
11395953|NCT03710590|12589743|FG001|NOT COMPLETED|Overall Study||8
11395954|NCT03710889|12589749|FG000|STARTED|Overall Study||23
11395955|NCT03710889|12589749|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
11395956|NCT03710889|12589749|FG000|Bone-Biopsy Population|Overall Study||19
11395957|NCT03710889|12589749|FG000|COMPLETED|Overall Study||20
11395958|NCT03710889|12589749|FG000|NOT COMPLETED|Overall Study||3
11395959|NCT03711396|12589753|FG000|STARTED|Overall Study||13
11395960|NCT03711396|12589754|FG001|STARTED|Overall Study||13
11395961|NCT03711396|12589753|FG000|COMPLETED|Overall Study||13
11395962|NCT03711396|12589754|FG001|COMPLETED|Overall Study||13
11395963|NCT03711396|12589753|FG000|NOT COMPLETED|Overall Study||0
11395964|NCT03711396|12589754|FG001|NOT COMPLETED|Overall Study||0
11395965|NCT03711578|12589761|FG000|STARTED|Overall Study||20
11395966|NCT03711578|12589761|FG000|COMPLETED|Overall Study||20
11395967|NCT03711578|12589761|FG000|NOT COMPLETED|Overall Study||0
11395968|NCT03712189|12589767|FG000|STARTED|Overall Study||15
11395969|NCT03712189|12589768|FG001|STARTED|Overall Study||15
11395970|NCT03712189|12589767|FG000|COMPLETED|Overall Study||15
11395971|NCT03712189|12589768|FG001|COMPLETED|Overall Study||15
11395972|NCT03712189|12589767|FG000|NOT COMPLETED|Overall Study||0
11395973|NCT03712189|12589768|FG001|NOT COMPLETED|Overall Study||0
11395974|NCT03712280|12589778|FG000|STARTED|Overall Study||12
11395975|NCT03712280|12589779|FG001|STARTED|Overall Study||12
11395976|NCT03712280|12589780|FG002|STARTED|Overall Study||13
11395977|NCT03712280|12589781|FG003|STARTED|Overall Study||13
11395978|NCT03712280|12589778|FG000|Safety Population|Overall Study||12
11395979|NCT03712280|12589779|FG001|Safety Population|Overall Study||11
11395980|NCT03712280|12589780|FG002|Safety Population|Overall Study||13
11395981|NCT03712280|12589781|FG003|Safety Population|Overall Study||12
11395982|NCT03712280|12589778|FG000|Modified Intent to Treat Population|Overall Study||12
11395983|NCT03712280|12589779|FG001|Modified Intent to Treat Population|Overall Study||11
11395984|NCT03712280|12589780|FG002|Modified Intent to Treat Population|Overall Study||13
11395985|NCT03712280|12589781|FG003|Modified Intent to Treat Population|Overall Study||12
11395986|NCT03712280|12589778|FG000|Completed 5 Day Treatment|Overall Study||11
11395987|NCT03712280|12589779|FG001|Completed 5 Day Treatment|Overall Study||11
11395988|NCT03712280|12589780|FG002|Completed 5 Day Treatment|Overall Study||12
11395989|NCT03712280|12589781|FG003|Completed 5 Day Treatment|Overall Study||12
11395990|NCT03712280|12589778|FG000|COMPLETED|Overall Study||11
11395991|NCT03712280|12589779|FG001|COMPLETED|Overall Study||11
11395992|NCT03712280|12589780|FG002|COMPLETED|Overall Study||12
11395993|NCT03712280|12589781|FG003|COMPLETED|Overall Study||12
11395994|NCT03712280|12589778|FG000|NOT COMPLETED|Overall Study||1
11395995|NCT03712280|12589779|FG001|NOT COMPLETED|Overall Study||1
11395996|NCT03712280|12589780|FG002|NOT COMPLETED|Overall Study||1
11395997|NCT03712280|12589781|FG003|NOT COMPLETED|Overall Study||1
11395998|NCT03712449|12589793|FG000|STARTED|Overall Study||13
11395999|NCT03712449|12589794|FG001|STARTED|Overall Study||46
11396000|NCT03712449|12589793|FG000|Full Analysis Population|Overall Study||13
11396001|NCT03712449|12589794|FG001|Full Analysis Population|Overall Study||45
11396002|NCT03712449|12589793|FG000|COMPLETED|Overall Study||13
11396003|NCT03712449|12589794|FG001|COMPLETED|Overall Study||45
11396004|NCT03712449|12589793|FG000|NOT COMPLETED|Overall Study||0
11396005|NCT03712449|12589794|FG001|NOT COMPLETED|Overall Study||1
11396006|NCT03712852|12589803|FG000|STARTED|Overall Study||20
11396007|NCT03712852|12589804|FG001|STARTED|Overall Study||20
11396008|NCT03712852|12589805|FG002|STARTED|Overall Study||20
11396009|NCT03712852|12589803|FG000|COMPLETED|Overall Study||20
11396010|NCT03712852|12589804|FG001|COMPLETED|Overall Study||20
11396011|NCT03712852|12589805|FG002|COMPLETED|Overall Study||20
11396012|NCT03712852|12589803|FG000|NOT COMPLETED|Overall Study||0
11396013|NCT03712852|12589804|FG001|NOT COMPLETED|Overall Study||0
11396014|NCT03712852|12589805|FG002|NOT COMPLETED|Overall Study||0
11396015|NCT03712917|12589816|FG000|STARTED|Overall Study||40
11396016|NCT03712917|12589817|FG001|STARTED|Overall Study||40
11396017|NCT03712917|12589818|FG002|STARTED|Overall Study||40
11396018|NCT03712917|12589816|FG000|COMPLETED|Overall Study||31
11396019|NCT03712917|12589817|FG001|COMPLETED|Overall Study||32
11396020|NCT03712917|12589818|FG002|COMPLETED|Overall Study||31
11396021|NCT03712917|12589816|FG000|NOT COMPLETED|Overall Study||9
11396022|NCT03712917|12589817|FG001|NOT COMPLETED|Overall Study||8
11396023|NCT03712917|12589818|FG002|NOT COMPLETED|Overall Study||9
11396024|NCT03712930|12589826|FG000|STARTED|Overall Study||13
11396025|NCT03712930|12589826|FG000|COMPLETED|Overall Study||0
11396026|NCT03712930|12589826|FG000|NOT COMPLETED|Overall Study||13
11396027|NCT03713398|12589832|FG000|STARTED|Overall Study||50
11396028|NCT03713398|12589833|FG001|STARTED|Overall Study||50
11396029|NCT03713398|12589832|FG000|COMPLETED|Overall Study||24
11396030|NCT03713398|12589833|FG001|COMPLETED|Overall Study||23
11396031|NCT03713398|12589832|FG000|NOT COMPLETED|Overall Study||26
11396032|NCT03713398|12589833|FG001|NOT COMPLETED|Overall Study||27
11396033|NCT03714022|12589841|FG000|STARTED|Overall Study||70
11396034|NCT03714022|12589842|FG001|STARTED|Overall Study||70
11396035|NCT03714022|12589841|FG000|COMPLETED|Overall Study||66
11396036|NCT03714022|12589842|FG001|COMPLETED|Overall Study||67
11396037|NCT03714022|12589841|FG000|NOT COMPLETED|Overall Study||4
11396038|NCT03714022|12589842|FG001|NOT COMPLETED|Overall Study||3
11396039|NCT03714256|12589850|FG000|STARTED|Overall Study||14
11396040|NCT03714256|12589851|FG001|STARTED|Overall Study||19
11396041|NCT03714256|12589850|FG000|COMPLETED|Overall Study||14
11396042|NCT03714256|12589851|FG001|COMPLETED|Overall Study||19
11396043|NCT03714256|12589850|FG000|NOT COMPLETED|Overall Study||0
11396044|NCT03714256|12589851|FG001|NOT COMPLETED|Overall Study||0
11396045|NCT03714659|12589857|FG000|STARTED|Overall Study||20
11396046|NCT03714659|12589857|FG000|COMPLETED|Overall Study||19
11396047|NCT03714659|12589857|FG000|NOT COMPLETED|Overall Study||1
11396048|NCT03714672|12589865|FG000|STARTED|Overall Study||209
11396049|NCT03714672|12589866|FG001|STARTED|Overall Study||206
11396050|NCT03714672|12589867|FG002|STARTED|Overall Study||206
11396051|NCT03714672|12589868|FG003|STARTED|Overall Study||208
11396052|NCT03714672|12589865|FG000|Safety Set|Overall Study||208
11396053|NCT03714672|12589866|FG001|Safety Set|Overall Study||205
11396054|NCT03714672|12589867|FG002|Safety Set|Overall Study||206
11396055|NCT03714672|12589868|FG003|Safety Set|Overall Study||207
11396056|NCT03714672|12589865|FG000|COMPLETED|Overall Study||207
11396057|NCT03714672|12589866|FG001|COMPLETED|Overall Study||202
11396058|NCT03714672|12589867|FG002|COMPLETED|Overall Study||202
11396059|NCT03714672|12589868|FG003|COMPLETED|Overall Study||207
11396060|NCT03714672|12589865|FG000|NOT COMPLETED|Overall Study||2
11396061|NCT03714672|12589866|FG001|NOT COMPLETED|Overall Study||4
11396062|NCT03714672|12589867|FG002|NOT COMPLETED|Overall Study||4
11396063|NCT03714672|12589868|FG003|NOT COMPLETED|Overall Study||1
11396064|NCT03714919|12589879|FG000|STARTED|Overall Study||10
11396065|NCT03714919|12589879|FG000|COMPLETED|Overall Study||10
11396066|NCT03714919|12589879|FG000|NOT COMPLETED|Overall Study||0
11396067|NCT03715426|12589885|FG000|STARTED|Overall Study||133
11396068|NCT03715426|12589886|FG001|STARTED|Overall Study||117
11396069|NCT03715426|12589885|FG000|1-Month Follow-Up Survey|Overall Study||113
11396070|NCT03715426|12589886|FG001|1-Month Follow-Up Survey|Overall Study||97
11396071|NCT03715426|12589885|FG000|4-Month Follow-Up Survey|Overall Study||112
11006314|NCT00727415|12184061|FG000|COMPLETED|Phase II||33
11006315|NCT00727415|12184061|FG000|NOT COMPLETED|Phase II||0
11396072|NCT03715426|12589886|FG001|4-Month Follow-Up Survey|Overall Study||92
11396073|NCT03715426|12589885|FG000|COMPLETED|Overall Study||112
11396074|NCT03715426|12589886|FG001|COMPLETED|Overall Study||92
11142350|NCT01467960|12329151|FG004|COMPLETED|Overall Study||0
11142351|NCT01467960|12329152|FG005|COMPLETED|Overall Study||0
11396075|NCT03715426|12589885|FG000|NOT COMPLETED|Overall Study||21
11396076|NCT03715426|12589886|FG001|NOT COMPLETED|Overall Study||25
11396077|NCT03715452|12589892|FG000|STARTED|Overall Study||114
11396078|NCT03715452|12589892|FG000|COMPLETED|Overall Study||114
11396079|NCT03715452|12589892|FG000|NOT COMPLETED|Overall Study||0
11396080|NCT03715530|12589899|FG000|STARTED|Overall Study||33
11396081|NCT03715530|12589900|FG001|STARTED|Overall Study||42
11396082|NCT03715530|12589901|FG002|STARTED|Overall Study||87
11396083|NCT03715530|12589899|FG000|COMPLETED|Overall Study||30
11396084|NCT03715530|12589900|FG001|COMPLETED|Overall Study||41
11396085|NCT03715530|12589901|FG002|COMPLETED|Overall Study||85
11396086|NCT03715530|12589899|FG000|NOT COMPLETED|Overall Study||3
11396087|NCT03715530|12589900|FG001|NOT COMPLETED|Overall Study||1
11396088|NCT03715530|12589901|FG002|NOT COMPLETED|Overall Study||2
11396089|NCT03715803|12589911|FG000|STARTED|Overall Study||91
11396090|NCT03715803|12589912|FG001|STARTED|Overall Study||126
11396091|NCT03715803|12589911|FG000|COMPLETED|Overall Study||91
11396092|NCT03715803|12589912|FG001|COMPLETED|Overall Study||126
11396093|NCT03715803|12589911|FG000|NOT COMPLETED|Overall Study||0
11396094|NCT03715803|12589912|FG001|NOT COMPLETED|Overall Study||0
11396095|NCT03716024|12589920|FG000|STARTED|Overall Study||118
11396096|NCT03716024|12589921|FG001|STARTED|Overall Study||116
11396097|NCT03716024|12589920|FG000|COMPLETED|Overall Study||107
11396098|NCT03716024|12589921|FG001|COMPLETED|Overall Study||98
11396099|NCT03716024|12589920|FG000|NOT COMPLETED|Overall Study||11
11396100|NCT03716024|12589921|FG001|NOT COMPLETED|Overall Study||18
11396101|NCT03716050|12589935|FG000|STARTED|Overall Study||2
11396102|NCT03716050|12589936|FG001|STARTED|Overall Study||4
11396103|NCT03716050|12589937|FG002|STARTED|Overall Study||1
11396104|NCT03716050|12589938|FG003|STARTED|Overall Study||3
11396105|NCT03716050|12589939|FG004|STARTED|Overall Study||1
11006316|NCT00727441|12184068|FG000|STARTED|Overall Study||29
11006317|NCT00727441|12184069|FG001|STARTED|Overall Study||28
11006318|NCT00727441|12184070|FG002|STARTED|Overall Study||30
11006319|NCT00727441|12184068|FG000|COMPLETED|Overall Study||11
11006320|NCT00727441|12184069|FG001|COMPLETED|Overall Study||6
11006321|NCT00727441|12184070|FG002|COMPLETED|Overall Study||5
11006322|NCT00727441|12184068|FG000|NOT COMPLETED|Overall Study||18
11006323|NCT00727441|12184069|FG001|NOT COMPLETED|Overall Study||22
11006324|NCT00727441|12184070|FG002|NOT COMPLETED|Overall Study||25
11006325|NCT00727506|12184087|FG000|STARTED|Overall Study|Entered|6
11006326|NCT00727506|12184088|FG001|STARTED|Overall Study|Entered|8
11006327|NCT00727506|12184089|FG002|STARTED|Overall Study|Entered|18
11006328|NCT00727506|12184090|FG003|STARTED|Overall Study|Randomized|39
11006329|NCT00727506|12184091|FG004|STARTED|Overall Study|Randomized|41
11006330|NCT00727506|12184092|FG005|STARTED|Overall Study|Randomized|39
11006331|NCT00727506|12184087|FG000|COMPLETED|Overall Study||0
11006332|NCT00727506|12184088|FG001|COMPLETED|Overall Study||0
11006333|NCT00727506|12184089|FG002|COMPLETED|Overall Study||0
11006334|NCT00727506|12184090|FG003|COMPLETED|Overall Study||0
11006335|NCT00727506|12184091|FG004|COMPLETED|Overall Study||0
11006336|NCT00727506|12184092|FG005|COMPLETED|Overall Study||0
11006337|NCT00727506|12184087|FG000|NOT COMPLETED|Overall Study||6
11006338|NCT00727506|12184088|FG001|NOT COMPLETED|Overall Study||8
11006339|NCT00727506|12184089|FG002|NOT COMPLETED|Overall Study||18
11006340|NCT00727506|12184090|FG003|NOT COMPLETED|Overall Study||39
11006341|NCT00727506|12184091|FG004|NOT COMPLETED|Overall Study||41
11006342|NCT00727506|12184092|FG005|NOT COMPLETED|Overall Study||39
11006343|NCT00727532|12184112|FG000|STARTED|Overall Study||9
11006344|NCT00727532|12184112|FG000|COMPLETED|Overall Study||7
11006345|NCT00727532|12184112|FG000|NOT COMPLETED|Overall Study||2
11006346|NCT00727558|12184118|FG000|STARTED|Overall Study||127
11006347|NCT00727558|12184119|FG001|STARTED|Overall Study||121
11006348|NCT00727558|12184118|FG000|COMPLETED|Overall Study||125
11006349|NCT00727558|12184119|FG001|COMPLETED|Overall Study||118
11006350|NCT00727558|12184118|FG000|NOT COMPLETED|Overall Study||2
11006351|NCT00727558|12184119|FG001|NOT COMPLETED|Overall Study||3
11006352|NCT00727571|12184129|FG000|STARTED|Overall Study||232
11006353|NCT00727571|12184130|FG001|STARTED|Overall Study||228
11006354|NCT00727571|12184131|FG002|STARTED|Overall Study||165
11006355|NCT00727571|12184132|FG003|STARTED|Overall Study||169
11006356|NCT00727571|12184129|FG000|COMPLETED|Overall Study||231
11006357|NCT00727571|12184130|FG001|COMPLETED|Overall Study||173
11006358|NCT00727571|12184131|FG002|COMPLETED|Overall Study||135
11006359|NCT00727571|12184132|FG003|COMPLETED|Overall Study||163
11006360|NCT00727571|12184129|FG000|NOT COMPLETED|Overall Study||1
11006361|NCT00727571|12184130|FG001|NOT COMPLETED|Overall Study||55
11006362|NCT00727571|12184131|FG002|NOT COMPLETED|Overall Study||30
11006363|NCT00727571|12184132|FG003|NOT COMPLETED|Overall Study||6
11006364|NCT00727597|12184144|FG000|STARTED|Overall Study||51
11006365|NCT00727597|12184145|FG001|STARTED|Overall Study||50
11006366|NCT00727597|12184144|FG000|COMPLETED|Overall Study||51
11006367|NCT00727597|12184145|FG001|COMPLETED|Overall Study||50
11006368|NCT00727597|12184144|FG000|NOT COMPLETED|Overall Study||0
11006369|NCT00727597|12184145|FG001|NOT COMPLETED|Overall Study||0
11396106|NCT03716050|12589940|FG005|STARTED|Overall Study||0
11396107|NCT03716050|12589941|FG006|STARTED|Overall Study||4
11396108|NCT03716050|12589942|FG007|STARTED|Overall Study||2
11396109|NCT03716050|12589935|FG000|COMPLETED|Overall Study||2
11006370|NCT00727636|12184153|FG000|STARTED|Overall Study||37
11006371|NCT00727636|12184154|FG001|STARTED|Overall Study||15
11006372|NCT00727636|12184153|FG000|COMPLETED|Overall Study||33
11006373|NCT00727636|12184154|FG001|COMPLETED|Overall Study||15
11006374|NCT00727636|12184153|FG000|NOT COMPLETED|Overall Study||4
11006375|NCT00727636|12184154|FG001|NOT COMPLETED|Overall Study||0
11006376|NCT00727649|12184162|FG000|STARTED|First Intervention (4-weeks)||37
11006377|NCT00727649|12184163|FG001|STARTED|First Intervention (4-weeks)||43
11006378|NCT00727649|12184162|FG000|COMPLETED|First Intervention (4-weeks)||34
11006379|NCT00727649|12184163|FG001|COMPLETED|First Intervention (4-weeks)||40
11006380|NCT00727649|12184162|FG000|NOT COMPLETED|First Intervention (4-weeks)||3
11006381|NCT00727649|12184163|FG001|NOT COMPLETED|First Intervention (4-weeks)||3
11396110|NCT03716050|12589936|FG001|COMPLETED|Overall Study||4
11396111|NCT03716050|12589937|FG002|COMPLETED|Overall Study||0
11396112|NCT03716050|12589938|FG003|COMPLETED|Overall Study||1
11396113|NCT03716050|12589939|FG004|COMPLETED|Overall Study||1
11396114|NCT03716050|12589940|FG005|COMPLETED|Overall Study||0
11396115|NCT03716050|12589941|FG006|COMPLETED|Overall Study||4
11396116|NCT03716050|12589942|FG007|COMPLETED|Overall Study||0
11006382|NCT00727649|12184162|FG000|STARTED|Wash-out (2-weeks)||34
11006383|NCT00727649|12184163|FG001|STARTED|Wash-out (2-weeks)||40
11006384|NCT00727649|12184162|FG000|COMPLETED|Wash-out (2-weeks)||30
11006385|NCT00727649|12184163|FG001|COMPLETED|Wash-out (2-weeks)||37
11006386|NCT00727649|12184162|FG000|NOT COMPLETED|Wash-out (2-weeks)||4
11006387|NCT00727649|12184163|FG001|NOT COMPLETED|Wash-out (2-weeks)||3
11006388|NCT00727649|12184162|FG000|STARTED|Second Intervention (4-weeks)||30
11006389|NCT00727649|12184163|FG001|STARTED|Second Intervention (4-weeks)||37
11006390|NCT00727649|12184162|FG000|COMPLETED|Second Intervention (4-weeks)||29
11006391|NCT00727649|12184163|FG001|COMPLETED|Second Intervention (4-weeks)||34
11006392|NCT00727649|12184162|FG000|NOT COMPLETED|Second Intervention (4-weeks)||1
11006393|NCT00727649|12184163|FG001|NOT COMPLETED|Second Intervention (4-weeks)||3
11006394|NCT00727714|12184171|FG000|STARTED|Overall Study||95
11006395|NCT00727714|12184171|FG000|COMPLETED|Overall Study||93
11006396|NCT00727714|12184171|FG000|NOT COMPLETED|Overall Study||2
11006397|NCT00727740|12184177|FG000|STARTED|Overall Study||56
11006398|NCT00727740|12184178|FG001|STARTED|Overall Study||61
11006399|NCT00727740|12184177|FG000|COMPLETED|Overall Study||56
11006400|NCT00727740|12184178|FG001|COMPLETED|Overall Study||61
11006401|NCT00727740|12184177|FG000|NOT COMPLETED|Overall Study||0
11006402|NCT00727740|12184178|FG001|NOT COMPLETED|Overall Study||0
11006403|NCT00727844|12184186|FG000|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
11006404|NCT00727844|12184187|FG001|STARTED|Initial Randomization||20
11006405|NCT00727844|12184188|FG002|STARTED|Initial Randomization||0
11006406|NCT00727844|12184189|FG003|STARTED|Initial Randomization||0
11006407|NCT00727844|12184186|FG000|Included in MITT Analysis|Initial Randomization||19
11006408|NCT00727844|12184187|FG001|Included in MITT Analysis|Initial Randomization||20
11006409|NCT00727844|12184188|FG002|Included in MITT Analysis|Initial Randomization||0
11006410|NCT00727844|12184189|FG003|Included in MITT Analysis|Initial Randomization||0
11006411|NCT00727844|12184186|FG000|COMPLETED|Initial Randomization||19
11006412|NCT00727844|12184187|FG001|COMPLETED|Initial Randomization||20
11006413|NCT00727844|12184188|FG002|COMPLETED|Initial Randomization||0
11006414|NCT00727844|12184189|FG003|COMPLETED|Initial Randomization||0
11006415|NCT00727844|12184186|FG000|NOT COMPLETED|Initial Randomization||2
11006416|NCT00727844|12184187|FG001|NOT COMPLETED|Initial Randomization||0
11006417|NCT00727844|12184188|FG002|NOT COMPLETED|Initial Randomization||0
11006418|NCT00727844|12184189|FG003|NOT COMPLETED|Initial Randomization||0
11006419|NCT00727844|12184186|FG000|STARTED|Second Randomization||0
11006420|NCT00727844|12184187|FG001|STARTED|Second Randomization||0
11006421|NCT00727844|12184188|FG002|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
11006422|NCT00727844|12184189|FG003|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
11006423|NCT00727844|12184186|FG000|COMPLETED|Second Randomization||0
11006424|NCT00727844|12184187|FG001|COMPLETED|Second Randomization||0
11006425|NCT00727844|12184188|FG002|COMPLETED|Second Randomization||17
11006426|NCT00727844|12184189|FG003|COMPLETED|Second Randomization||16
11006427|NCT00727844|12184186|FG000|NOT COMPLETED|Second Randomization||0
11006428|NCT00727844|12184187|FG001|NOT COMPLETED|Second Randomization||0
11006429|NCT00727844|12184188|FG002|NOT COMPLETED|Second Randomization||0
11006430|NCT00727844|12184189|FG003|NOT COMPLETED|Second Randomization||0
11006431|NCT00727857|12184197|FG000|STARTED|Overall Study||201
11006432|NCT00727857|12184198|FG001|STARTED|Overall Study||189
11006433|NCT00727857|12184199|FG002|STARTED|Overall Study||210
11006434|NCT00727857|12184197|FG000|COMPLETED|Overall Study||157
11006435|NCT00727857|12184198|FG001|COMPLETED|Overall Study||125
11006436|NCT00727857|12184199|FG002|COMPLETED|Overall Study||142
11006437|NCT00727857|12184197|FG000|NOT COMPLETED|Overall Study||44
11006438|NCT00727857|12184198|FG001|NOT COMPLETED|Overall Study||64
11006439|NCT00727857|12184199|FG002|NOT COMPLETED|Overall Study||68
11006440|NCT00727909|12184208|FG000|STARTED|Overall Study||65
11006441|NCT00727909|12184209|FG001|STARTED|Overall Study||72
11006442|NCT00727909|12184210|FG002|STARTED|Overall Study||67
11006443|NCT00727909|12184211|FG003|STARTED|Overall Study||75
11006444|NCT00727909|12184208|FG000|COMPLETED|Overall Study||60
11006445|NCT00727909|12184209|FG001|COMPLETED|Overall Study||61
11396117|NCT03716050|12589935|FG000|NOT COMPLETED|Overall Study||0
11396118|NCT03716050|12589936|FG001|NOT COMPLETED|Overall Study||0
11006446|NCT00727909|12184210|FG002|COMPLETED|Overall Study||58
11006447|NCT00727909|12184211|FG003|COMPLETED|Overall Study||70
11006448|NCT00727909|12184208|FG000|NOT COMPLETED|Overall Study||5
11006449|NCT00727909|12184209|FG001|NOT COMPLETED|Overall Study||11
11006450|NCT00727909|12184210|FG002|NOT COMPLETED|Overall Study||9
11006451|NCT00727909|12184211|FG003|NOT COMPLETED|Overall Study||5
11006452|NCT00727961|12184215|FG000|STARTED|Overall Study||58
11006453|NCT00727961|12184215|FG000|COMPLETED|Overall Study||21
11006454|NCT00727961|12184215|FG000|NOT COMPLETED|Overall Study||37
11006455|NCT00728130|12184219|FG000|STARTED|Overall Study||22
11006456|NCT00728130|12184219|FG000|COMPLETED|Overall Study||19
11006457|NCT00728130|12184219|FG000|NOT COMPLETED|Overall Study||3
11006458|NCT00728182|12184225|FG000|STARTED|Overall Study||92
11006459|NCT00728182|12184226|FG001|STARTED|Overall Study||93
11006460|NCT00728182|12184225|FG000|COMPLETED|Overall Study||89
11006461|NCT00728182|12184226|FG001|COMPLETED|Overall Study||90
11006462|NCT00728182|12184225|FG000|NOT COMPLETED|Overall Study||3
11006463|NCT00728182|12184226|FG001|NOT COMPLETED|Overall Study||3
11006464|NCT00728260|12184234|FG000|STARTED|Overall Study||1421
11006465|NCT00728260|12184234|FG000|COMPLETED|Overall Study||1421
11006466|NCT00728260|12184234|FG000|NOT COMPLETED|Overall Study||0
11006467|NCT00728468|12184238|FG000|STARTED|Overall Study||16
11006468|NCT00728468|12184238|FG000|Treated|Overall Study||15
11006469|NCT00728468|12184238|FG000|COMPLETED|Overall Study||0
11006470|NCT00728468|12184238|FG000|NOT COMPLETED|Overall Study||16
11006471|NCT00728481|12184244|FG000|STARTED|Overall Study||19
11006472|NCT00728481|12184245|FG001|STARTED|Overall Study||32
11006473|NCT00728481|12184244|FG000|COMPLETED|Overall Study||18
11006474|NCT00728481|12184245|FG001|COMPLETED|Overall Study||28
11006475|NCT00728481|12184244|FG000|NOT COMPLETED|Overall Study||1
11006476|NCT00728481|12184245|FG001|NOT COMPLETED|Overall Study||4
11006477|NCT00728494|12184253|FG000|STARTED|Overall Study||60
11006478|NCT00728494|12184254|FG001|STARTED|Overall Study||39
11006479|NCT00728494|12184253|FG000|COMPLETED|Overall Study||51
11006480|NCT00728494|12184254|FG001|COMPLETED|Overall Study||32
11006481|NCT00728494|12184253|FG000|NOT COMPLETED|Overall Study||9
11006482|NCT00728494|12184254|FG001|NOT COMPLETED|Overall Study||7
11006483|NCT00728507|12184262|FG000|STARTED|Overall Study||62
11006484|NCT00728507|12184263|FG001|STARTED|Overall Study||59
11006485|NCT00728507|12184262|FG000|COMPLETED|Overall Study||60
11006486|NCT00728507|12184263|FG001|COMPLETED|Overall Study||51
11006487|NCT00728507|12184262|FG000|NOT COMPLETED|Overall Study||2
11006488|NCT00728507|12184263|FG001|NOT COMPLETED|Overall Study||8
11006489|NCT00728689|12184271|FG000|STARTED|First Intervention (Days 1 - 3)||6
11006490|NCT00728689|12184272|FG001|STARTED|First Intervention (Days 1 - 3)||6
11006491|NCT00728689|12184271|FG000|COMPLETED|First Intervention (Days 1 - 3)||6
11006492|NCT00728689|12184272|FG001|COMPLETED|First Intervention (Days 1 - 3)||6
11006493|NCT00728689|12184271|FG000|NOT COMPLETED|First Intervention (Days 1 - 3)||0
11006494|NCT00728689|12184272|FG001|NOT COMPLETED|First Intervention (Days 1 - 3)||0
11006495|NCT00728689|12184271|FG000|STARTED|Washout Period (Days 4 - 10)||6
11006496|NCT00728689|12184272|FG001|STARTED|Washout Period (Days 4 - 10)||6
11006497|NCT00728689|12184271|FG000|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
11006498|NCT00728689|12184272|FG001|COMPLETED|Washout Period (Days 4 - 10)||6
11006499|NCT00728689|12184271|FG000|NOT COMPLETED|Washout Period (Days 4 - 10)||1
11006500|NCT00728689|12184272|FG001|NOT COMPLETED|Washout Period (Days 4 - 10)||0
11006501|NCT00728689|12184271|FG000|STARTED|Second Intervention (Days 11 - 13)||5
11006502|NCT00728689|12184272|FG001|STARTED|Second Intervention (Days 11 - 13)||6
11006503|NCT00728689|12184271|FG000|COMPLETED|Second Intervention (Days 11 - 13)||5
11006504|NCT00728689|12184272|FG001|COMPLETED|Second Intervention (Days 11 - 13)||6
11006505|NCT00728689|12184271|FG000|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
11006506|NCT00728689|12184272|FG001|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
11006507|NCT00728728|12184282|FG000|STARTED|Overall Study||42
11006508|NCT00728728|12184283|FG001|STARTED|Overall Study||46
11006509|NCT00728728|12184282|FG000|COMPLETED|Overall Study||38
11006510|NCT00728728|12184283|FG001|COMPLETED|Overall Study||34
11006511|NCT00728728|12184282|FG000|NOT COMPLETED|Overall Study||4
11006512|NCT00728728|12184283|FG001|NOT COMPLETED|Overall Study||12
11006513|NCT00728819|12184292|FG000|STARTED|Overall Study||171
11006514|NCT00728819|12184293|FG001|STARTED|Overall Study||168
11006515|NCT00728819|12184292|FG000|COMPLETED|Overall Study||135
11006516|NCT00728819|12184293|FG001|COMPLETED|Overall Study||139
11006517|NCT00728819|12184292|FG000|NOT COMPLETED|Overall Study||36
11396119|NCT03716050|12589937|FG002|NOT COMPLETED|Overall Study||1
11396120|NCT03716050|12589938|FG003|NOT COMPLETED|Overall Study||2
11396121|NCT03716050|12589939|FG004|NOT COMPLETED|Overall Study||0
11006518|NCT00728819|12184293|FG001|NOT COMPLETED|Overall Study||29
11006519|NCT00728910|12184299|FG000|STARTED|Atorvastatin||25
11006520|NCT00728910|12184299|FG000|COMPLETED|Atorvastatin||22
11006521|NCT00728910|12184299|FG000|NOT COMPLETED|Atorvastatin||3
11006522|NCT00728910|12184299|FG000|STARTED|Atorvastatin+ABT335||22
11006523|NCT00728910|12184299|FG000|COMPLETED|Atorvastatin+ABT335||22
11006524|NCT00728910|12184299|FG000|NOT COMPLETED|Atorvastatin+ABT335||0
11006525|NCT00728910|12184299|FG000|STARTED|Atorvastatin+ABT335+ER Niacin||22
11006526|NCT00728910|12184299|FG000|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
11006527|NCT00728910|12184299|FG000|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
11006528|NCT00728923|12184308|FG000|STARTED|Overall Study||9
11006529|NCT00728923|12184308|FG000|COMPLETED|Overall Study||9
11396122|NCT03716050|12589940|FG005|NOT COMPLETED|Overall Study||0
11006530|NCT00728923|12184308|FG000|NOT COMPLETED|Overall Study||0
11006531|NCT00728936|12184319|FG000|STARTED|Overall Study||10
11006532|NCT00728936|12184320|FG001|STARTED|Overall Study||8
11006533|NCT00728936|12184321|FG002|STARTED|Overall Study||9
11006534|NCT00728936|12184322|FG003|STARTED|Overall Study||8
11006535|NCT00728936|12184323|FG004|STARTED|Overall Study||8
11006536|NCT00728936|12184324|FG005|STARTED|Overall Study||8
11006537|NCT00728936|12184325|FG006|STARTED|Overall Study||7
11006538|NCT00728936|12184319|FG000|COMPLETED|Overall Study||10
11006539|NCT00728936|12184320|FG001|COMPLETED|Overall Study||8
11006540|NCT00728936|12184321|FG002|COMPLETED|Overall Study||9
11006541|NCT00728936|12184322|FG003|COMPLETED|Overall Study||8
11006542|NCT00728936|12184323|FG004|COMPLETED|Overall Study||8
11006543|NCT00728936|12184324|FG005|COMPLETED|Overall Study||7
11006544|NCT00728936|12184325|FG006|COMPLETED|Overall Study||7
11006545|NCT00728936|12184319|FG000|NOT COMPLETED|Overall Study||0
11006546|NCT00728936|12184320|FG001|NOT COMPLETED|Overall Study||0
11006547|NCT00728936|12184321|FG002|NOT COMPLETED|Overall Study||0
11396123|NCT03716050|12589941|FG006|NOT COMPLETED|Overall Study||0
11396124|NCT03716050|12589942|FG007|NOT COMPLETED|Overall Study||2
11396125|NCT03716076|12589961|FG000|STARTED|Overall Study||25
11006548|NCT00728936|12184322|FG003|NOT COMPLETED|Overall Study||0
11006549|NCT00728936|12184323|FG004|NOT COMPLETED|Overall Study||0
11006550|NCT00728936|12184324|FG005|NOT COMPLETED|Overall Study||1
11006551|NCT00728936|12184325|FG006|NOT COMPLETED|Overall Study||0
11006552|NCT00728949|12184343|FG000|STARTED|Overall Study||62
11006553|NCT00728949|12184344|FG001|STARTED|Overall Study||31
11006554|NCT00728949|12184343|FG000|COMPLETED|Overall Study||51
11006555|NCT00728949|12184344|FG001|COMPLETED|Overall Study||27
11006556|NCT00728949|12184343|FG000|NOT COMPLETED|Overall Study||11
11396126|NCT03716076|12589962|FG001|STARTED|Overall Study||25
11396127|NCT03716076|12589961|FG000|COMPLETED|Overall Study||22
11396128|NCT03716076|12589962|FG001|COMPLETED|Overall Study||19
11006557|NCT00728949|12184344|FG001|NOT COMPLETED|Overall Study||4
11006558|NCT00728988|12184352|FG000|STARTED|Overall Study||247
11006559|NCT00728988|12184353|FG001|STARTED|Overall Study||252
11006560|NCT00728988|12184352|FG000|Treated|Overall Study||245
11006561|NCT00728988|12184353|FG001|Treated|Overall Study||250
11006562|NCT00728988|12184352|FG000|Full Analysis Set|Overall Study||163
11006563|NCT00728988|12184353|FG001|Full Analysis Set|Overall Study||172
11006564|NCT00728988|12184352|FG000|COMPLETED|Overall Study||154
11006565|NCT00728988|12184353|FG001|COMPLETED|Overall Study||164
11006566|NCT00728988|12184352|FG000|NOT COMPLETED|Overall Study||93
11006567|NCT00728988|12184353|FG001|NOT COMPLETED|Overall Study||88
11006568|NCT00729053|12184364|FG000|STARTED|Overall Study||23
11006569|NCT00729053|12184365|FG001|STARTED|Overall Study||23
11006570|NCT00729053|12184366|FG002|STARTED|Overall Study||23
11006571|NCT00729053|12184367|FG003|STARTED|Overall Study||23
11006572|NCT00729053|12184364|FG000|COMPLETED|Overall Study||23
11006573|NCT00729053|12184365|FG001|COMPLETED|Overall Study||23
11006574|NCT00729053|12184366|FG002|COMPLETED|Overall Study||23
11006575|NCT00729053|12184367|FG003|COMPLETED|Overall Study||23
11006576|NCT00729053|12184364|FG000|NOT COMPLETED|Overall Study||0
11006577|NCT00729053|12184365|FG001|NOT COMPLETED|Overall Study||0
11006578|NCT00729053|12184366|FG002|NOT COMPLETED|Overall Study||0
11006579|NCT00729053|12184367|FG003|NOT COMPLETED|Overall Study||0
11006580|NCT00729157|12184377|FG000|STARTED|Overall Study||41
11006581|NCT00729157|12184377|FG000|COMPLETED|Overall Study||40
11006582|NCT00729157|12184377|FG000|NOT COMPLETED|Overall Study||1
11006583|NCT00729183|12184383|FG000|STARTED|Overall Study||109
11006584|NCT00729183|12184384|FG001|STARTED|Overall Study||105
11006585|NCT00729183|12184383|FG000|COMPLETED|Overall Study|Completed 24 month visit|84
11006586|NCT00729183|12184384|FG001|COMPLETED|Overall Study|Completed 24 month visit|90
11006587|NCT00729183|12184383|FG000|NOT COMPLETED|Overall Study||25
11006588|NCT00729183|12184384|FG001|NOT COMPLETED|Overall Study||15
11006589|NCT00729248|12184390|FG000|STARTED|Overall Study||12
11006590|NCT00729248|12184390|FG000|COMPLETED|Overall Study||10
11006591|NCT00729248|12184390|FG000|NOT COMPLETED|Overall Study||2
11006592|NCT00729326|12184397|FG000|STARTED|Overall Study||41
11006593|NCT00729326|12184398|FG001|STARTED|Overall Study||42
11006594|NCT00729326|12184397|FG000|COMPLETED|Overall Study||31
11006595|NCT00729326|12184398|FG001|COMPLETED|Overall Study||33
11006596|NCT00729326|12184397|FG000|NOT COMPLETED|Overall Study||10
11006597|NCT00729326|12184398|FG001|NOT COMPLETED|Overall Study||9
11006598|NCT00729378|12184406|FG000|STARTED|Baseline||430
11006599|NCT00729378|12184407|FG001|STARTED|Baseline||309
11006600|NCT00729378|12184406|FG000|COMPLETED|Baseline||292
11006601|NCT00729378|12184407|FG001|COMPLETED|Baseline||217
11006602|NCT00729378|12184406|FG000|NOT COMPLETED|Baseline||138
11006603|NCT00729378|12184407|FG001|NOT COMPLETED|Baseline||92
11006604|NCT00729378|12184406|FG000|STARTED|12-months||292
11006605|NCT00729378|12184407|FG001|STARTED|12-months||217
11006606|NCT00729378|12184406|FG000|COMPLETED|12-months||192
11006607|NCT00729378|12184407|FG001|COMPLETED|12-months||152
11006608|NCT00729378|12184406|FG000|NOT COMPLETED|12-months||100
11006609|NCT00729378|12184407|FG001|NOT COMPLETED|12-months||65
11006610|NCT00729378|12184406|FG000|STARTED|24-months||192
11006611|NCT00729378|12184407|FG001|STARTED|24-months||152
11006612|NCT00729378|12184406|FG000|COMPLETED|24-months||120
11006613|NCT00729378|12184407|FG001|COMPLETED|24-months||101
11006614|NCT00729378|12184406|FG000|NOT COMPLETED|24-months||72
11006615|NCT00729378|12184407|FG001|NOT COMPLETED|24-months||51
11006616|NCT00729378|12184406|FG000|STARTED|36-months||120
11396129|NCT03716076|12589961|FG000|NOT COMPLETED|Overall Study||3
11006617|NCT00729378|12184407|FG001|STARTED|36-months||101
11006618|NCT00729378|12184406|FG000|COMPLETED|36-months||105
11006619|NCT00729378|12184407|FG001|COMPLETED|36-months||95
11006620|NCT00729378|12184406|FG000|NOT COMPLETED|36-months||15
11006621|NCT00729378|12184407|FG001|NOT COMPLETED|36-months||6
11006622|NCT00729430|12184418|FG000|STARTED|Overall Study||180
11006623|NCT00729430|12184419|FG001|STARTED|Overall Study||178
11006624|NCT00729430|12184418|FG000|COMPLETED|Overall Study||133
11006625|NCT00729430|12184419|FG001|COMPLETED|Overall Study||128
11006626|NCT00729430|12184418|FG000|NOT COMPLETED|Overall Study||47
11006627|NCT00729430|12184419|FG001|NOT COMPLETED|Overall Study||50
11006628|NCT00729469|12184428|FG000|STARTED|Overall Study||456
11006629|NCT00729469|12184429|FG001|STARTED|Overall Study||463
11006630|NCT00729469|12184428|FG000|COMPLETED|Overall Study||403
11006631|NCT00729469|12184429|FG001|COMPLETED|Overall Study||416
11006632|NCT00729469|12184428|FG000|NOT COMPLETED|Overall Study||53
11006633|NCT00729469|12184429|FG001|NOT COMPLETED|Overall Study||47
11006634|NCT00729482|12184435|FG000|STARTED|Overall Study||54
11006635|NCT00729482|12184435|FG000|COMPLETED|Overall Study||54
11396130|NCT03716076|12589962|FG001|NOT COMPLETED|Overall Study||6
11396131|NCT03717012|12589970|FG000|STARTED|Overall Study||9
11396132|NCT03717012|12589971|FG001|STARTED|Overall Study||10
11006636|NCT00729482|12184435|FG000|NOT COMPLETED|Overall Study||0
11006637|NCT00729521|12184442|FG000|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
11006638|NCT00729521|12184443|FG001|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
11006639|NCT00729521|12184444|FG002|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
11006640|NCT00729521|12184442|FG000|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
11006641|NCT00729521|12184443|FG001|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
11006642|NCT00729521|12184444|FG002|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
11006643|NCT00729521|12184442|FG000|NOT COMPLETED|Overall Study||0
11006644|NCT00729521|12184443|FG001|NOT COMPLETED|Overall Study||0
11006645|NCT00729521|12184444|FG002|NOT COMPLETED|Overall Study||0
11006646|NCT00729586|12184454|FG000|STARTED|Overall Study||51
11006647|NCT00729586|12184455|FG001|STARTED|Overall Study||22
11396133|NCT03717012|12589970|FG000|COMPLETED|Overall Study||8
11006648|NCT00729586|12184454|FG000|COMPLETED|Overall Study|Eligible and treated patients|50
11006649|NCT00729586|12184455|FG001|COMPLETED|Overall Study|Eligible and treated patients|21
11006650|NCT00729586|12184454|FG000|NOT COMPLETED|Overall Study||1
11006651|NCT00729586|12184455|FG001|NOT COMPLETED|Overall Study||1
11006652|NCT00729612|12184462|FG000|STARTED|Overall Study||63
11006653|NCT00729612|12184462|FG000|Died Before Cycle 1|Overall Study||1
11006654|NCT00729612|12184462|FG000|Received Cycle 1|Overall Study||62
11006655|NCT00729612|12184462|FG000|Did Not Receive Cycle 2|Overall Study||7
11006656|NCT00729612|12184462|FG000|Received Cycle 2|Overall Study||54
11006657|NCT00729612|12184462|FG000|Died After Cycle 2 Before Response Eval|Overall Study||1
11006658|NCT00729612|12184462|FG000|COMPLETED|Overall Study||53
11006659|NCT00729612|12184462|FG000|NOT COMPLETED|Overall Study||10
11006660|NCT00729677|12184466|FG000|STARTED|Overall Study||64
11006661|NCT00729677|12184466|FG000|COMPLETED|Overall Study||64
11006662|NCT00729677|12184466|FG000|NOT COMPLETED|Overall Study||0
11006663|NCT00729690|12184480|FG000|STARTED|Overall Study||16
11006664|NCT00729690|12184481|FG001|STARTED|Overall Study||16
11006665|NCT00729690|12184482|FG002|STARTED|Overall Study||16
11006666|NCT00729690|12184480|FG000|COMPLETED|Overall Study||16
11006667|NCT00729690|12184481|FG001|COMPLETED|Overall Study||14
11006668|NCT00729690|12184482|FG002|COMPLETED|Overall Study||14
11006669|NCT00729690|12184480|FG000|NOT COMPLETED|Overall Study||0
11006670|NCT00729690|12184481|FG001|NOT COMPLETED|Overall Study||2
11006671|NCT00729690|12184482|FG002|NOT COMPLETED|Overall Study||2
11006672|NCT00729781|12184490|FG000|STARTED|Original Study||45
11006673|NCT00729781|12184490|FG000|COMPLETED|Original Study||45
11006674|NCT00729781|12184490|FG000|NOT COMPLETED|Original Study||0
11006675|NCT00729781|12184490|FG000|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
11006676|NCT00729781|12184490|FG000|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
11006677|NCT00729781|12184490|FG000|NOT COMPLETED|Long-term Follow-up Study||0
11006678|NCT00729807|12184494|FG000|STARTED|Overall Study||6
11006679|NCT00729807|12184494|FG000|COMPLETED|Overall Study||6
11006680|NCT00729807|12184494|FG000|NOT COMPLETED|Overall Study||0
11006681|NCT00729833|12184498|FG000|STARTED|Overall Study||20
11006682|NCT00729833|12184499|FG001|STARTED|Overall Study||7
11006683|NCT00729833|12184500|FG002|STARTED|Overall Study||12
11006684|NCT00729833|12184501|FG003|STARTED|Overall Study||6
11006685|NCT00729833|12184498|FG000|COMPLETED|Overall Study||0
11006686|NCT00729833|12184499|FG001|COMPLETED|Overall Study||0
11006687|NCT00729833|12184500|FG002|COMPLETED|Overall Study||0
11006688|NCT00729833|12184501|FG003|COMPLETED|Overall Study||0
11006689|NCT00729833|12184498|FG000|NOT COMPLETED|Overall Study||20
11006690|NCT00729833|12184499|FG001|NOT COMPLETED|Overall Study||7
11006691|NCT00729833|12184500|FG002|NOT COMPLETED|Overall Study||12
11006692|NCT00729833|12184501|FG003|NOT COMPLETED|Overall Study||6
11006693|NCT00729846|12184514|FG000|STARTED|Overall Study||11
11006694|NCT00729846|12184515|FG001|STARTED|Overall Study||11
11006695|NCT00729846|12184514|FG000|COMPLETED|Overall Study||11
11006696|NCT00729846|12184515|FG001|COMPLETED|Overall Study||11
11396134|NCT03717012|12589971|FG001|COMPLETED|Overall Study||4
11006697|NCT00729846|12184514|FG000|NOT COMPLETED|Overall Study||0
11006698|NCT00729846|12184515|FG001|NOT COMPLETED|Overall Study||0
11006699|NCT00729859|12184524|FG000|STARTED|Overall Study||8
11006700|NCT00729859|12184525|FG001|STARTED|Overall Study||8
11006701|NCT00729859|12184526|FG002|STARTED|Overall Study||8
11006702|NCT00729859|12184524|FG000|COMPLETED|Overall Study||8
11006703|NCT00729859|12184525|FG001|COMPLETED|Overall Study||6
11006704|NCT00729859|12184526|FG002|COMPLETED|Overall Study||8
11006705|NCT00729859|12184524|FG000|NOT COMPLETED|Overall Study||0
11006706|NCT00729859|12184525|FG001|NOT COMPLETED|Overall Study||2
11006707|NCT00729859|12184526|FG002|NOT COMPLETED|Overall Study||0
11006708|NCT00729924|12184542|FG000|STARTED|Overall Study||40
11006709|NCT00729924|12184542|FG000|COMPLETED|Overall Study||40
11396135|NCT03717012|12589970|FG000|NOT COMPLETED|Overall Study||1
11396136|NCT03717012|12589971|FG001|NOT COMPLETED|Overall Study||6
11396137|NCT03717051|12589979|FG000|STARTED|Overall Study||352
11006710|NCT00729924|12184542|FG000|NOT COMPLETED|Overall Study||0
11006711|NCT00729937|12184555|FG000|STARTED|Overall Study||629
11006712|NCT00729937|12184556|FG001|STARTED|Overall Study||636
11006713|NCT00729937|12184557|FG002|STARTED|Overall Study||251
11006714|NCT00729937|12184558|FG003|STARTED|Overall Study||249
11006715|NCT00729937|12184559|FG004|STARTED|Overall Study||249
11006716|NCT00729937|12184560|FG005|STARTED|Overall Study||251
11006717|NCT00729937|12184555|FG000|COMPLETED|Overall Study||555
11006718|NCT00729937|12184556|FG001|COMPLETED|Overall Study||548
11006719|NCT00729937|12184557|FG002|COMPLETED|Overall Study||222
11006720|NCT00729937|12184558|FG003|COMPLETED|Overall Study||215
11006721|NCT00729937|12184559|FG004|COMPLETED|Overall Study||221
11006722|NCT00729937|12184560|FG005|COMPLETED|Overall Study||214
11006723|NCT00729937|12184555|FG000|NOT COMPLETED|Overall Study||74
11006724|NCT00729937|12184556|FG001|NOT COMPLETED|Overall Study||88
11006725|NCT00729937|12184557|FG002|NOT COMPLETED|Overall Study||29
11006726|NCT00729937|12184558|FG003|NOT COMPLETED|Overall Study||34
11396138|NCT03717051|12589980|FG001|STARTED|Overall Study||482
11006727|NCT00729937|12184559|FG004|NOT COMPLETED|Overall Study||28
11006728|NCT00729937|12184560|FG005|NOT COMPLETED|Overall Study||37
11006729|NCT00730015|12184577|FG000|STARTED|Overall Study||217
11006730|NCT00730015|12184578|FG001|STARTED|Overall Study||217
11006731|NCT00730015|12184579|FG002|STARTED|Overall Study||209
11006732|NCT00730015|12184577|FG000|COMPLETED|Overall Study||186
11006733|NCT00730015|12184578|FG001|COMPLETED|Overall Study||177
11006734|NCT00730015|12184579|FG002|COMPLETED|Overall Study||177
11006735|NCT00730015|12184577|FG000|NOT COMPLETED|Overall Study||31
11006736|NCT00730015|12184578|FG001|NOT COMPLETED|Overall Study||40
11006737|NCT00730015|12184579|FG002|NOT COMPLETED|Overall Study||32
11006738|NCT00730028|12184597|FG000|STARTED|Overall Study||264
11006739|NCT00730028|12184598|FG001|STARTED|Overall Study||260
11006740|NCT00730028|12184599|FG002|STARTED|Overall Study||266
11006741|NCT00730028|12184600|FG003|STARTED|Overall Study||263
11006742|NCT00730028|12184601|FG004|STARTED|Overall Study||257
11006743|NCT00730028|12184597|FG000|COMPLETED|Overall Study||204
11396139|NCT03717051|12589979|FG000|COMPLETED|Overall Study||352
11396140|NCT03717051|12589980|FG001|COMPLETED|Overall Study||482
11396141|NCT03717051|12589979|FG000|NOT COMPLETED|Overall Study||0
11396142|NCT03717051|12589980|FG001|NOT COMPLETED|Overall Study||0
11396143|NCT03717064|12589986|FG000|STARTED|Period 1||18
11396144|NCT03717064|12589986|FG000|COMPLETED|Period 1||18
11396145|NCT03717064|12589986|FG000|NOT COMPLETED|Period 1||0
11396146|NCT03717064|12589986|FG000|STARTED|Period 2||18
11396147|NCT03717064|12589986|FG000|COMPLETED|Period 2||17
11396148|NCT03717064|12589986|FG000|NOT COMPLETED|Period 2||1
11396149|NCT03717506|12589993|FG000|STARTED|Overall Study||496
11396150|NCT03717506|12589994|FG001|STARTED|Overall Study||491
11396151|NCT03717506|12589995|FG002|STARTED|Overall Study||249
11396152|NCT03717506|12589993|FG000|COMPLETED|Overall Study||447
11396153|NCT03717506|12589994|FG001|COMPLETED|Overall Study||441
11006744|NCT00730028|12184598|FG001|COMPLETED|Overall Study||194
11006745|NCT00730028|12184599|FG002|COMPLETED|Overall Study||221
11006746|NCT00730028|12184600|FG003|COMPLETED|Overall Study||207
11006747|NCT00730028|12184601|FG004|COMPLETED|Overall Study||175
11006748|NCT00730028|12184597|FG000|NOT COMPLETED|Overall Study||60
11006749|NCT00730028|12184598|FG001|NOT COMPLETED|Overall Study||66
11006750|NCT00730028|12184599|FG002|NOT COMPLETED|Overall Study||45
11006751|NCT00730028|12184600|FG003|NOT COMPLETED|Overall Study||56
11006752|NCT00730028|12184601|FG004|NOT COMPLETED|Overall Study||82
11006753|NCT00730041|12184615|FG000|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
11006754|NCT00730041|12184616|FG001|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
11006755|NCT00730041|12184615|FG000|COMPLETED|Overall Study||26
11006756|NCT00730041|12184616|FG001|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
11006757|NCT00730041|12184615|FG000|NOT COMPLETED|Overall Study||0
11006758|NCT00730041|12184616|FG001|NOT COMPLETED|Overall Study||2
11006759|NCT00730158|12184624|FG000|STARTED|Overall Study||17
11006760|NCT00730158|12184625|FG001|STARTED|Overall Study||16
11006761|NCT00730158|12184624|FG000|COMPLETED|Overall Study||16
11006762|NCT00730158|12184625|FG001|COMPLETED|Overall Study||15
11006763|NCT00730158|12184624|FG000|NOT COMPLETED|Overall Study||1
11006764|NCT00730158|12184625|FG001|NOT COMPLETED|Overall Study||1
11006765|NCT00730171|12184635|FG000|STARTED|Overall Study||1725
11006766|NCT00730171|12184635|FG000|CC Safety Population|Overall Study||607
11006767|NCT00730171|12184635|FG000|IBS-C Safety Population|Overall Study||1119
11006768|NCT00730171|12184635|FG000|COMPLETED|Overall Study||954
11396154|NCT03717506|12589995|FG002|COMPLETED|Overall Study||222
11006769|NCT00730171|12184635|FG000|NOT COMPLETED|Overall Study||771
11006770|NCT00730236|12184643|FG000|STARTED|Overall Study||29
11006771|NCT00730236|12184643|FG000|COMPLETED|Overall Study||23
11006772|NCT00730236|12184643|FG000|NOT COMPLETED|Overall Study||6
11006773|NCT00730275|12184651|FG000|STARTED|Overall Study||9
11006774|NCT00730275|12184652|FG001|STARTED|Overall Study||9
11006775|NCT00730275|12184653|FG002|STARTED|Overall Study||8
11006776|NCT00730275|12184654|FG003|STARTED|Overall Study||9
11006777|NCT00730275|12184651|FG000|COMPLETED|Overall Study||9
11006778|NCT00730275|12184652|FG001|COMPLETED|Overall Study||9
11006779|NCT00730275|12184653|FG002|COMPLETED|Overall Study||8
11006780|NCT00730275|12184654|FG003|COMPLETED|Overall Study||8
11006781|NCT00730275|12184651|FG000|NOT COMPLETED|Overall Study||0
11396155|NCT03717506|12589993|FG000|NOT COMPLETED|Overall Study||49
11396156|NCT03717506|12589994|FG001|NOT COMPLETED|Overall Study||50
11396157|NCT03717506|12589995|FG002|NOT COMPLETED|Overall Study||27
11006782|NCT00730275|12184652|FG001|NOT COMPLETED|Overall Study||0
11006783|NCT00730275|12184653|FG002|NOT COMPLETED|Overall Study||0
11006784|NCT00730275|12184654|FG003|NOT COMPLETED|Overall Study||1
11006785|NCT00730327|12184667|FG000|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
11006786|NCT00730327|12184668|FG001|STARTED|Overall Study||130
11006787|NCT00730327|12184667|FG000|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
11006788|NCT00730327|12184668|FG001|Completed Week 26|Overall Study||99
11006789|NCT00730327|12184667|FG000|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
11006790|NCT00730327|12184668|FG001|COMPLETED|Overall Study||93
11006791|NCT00730327|12184667|FG000|NOT COMPLETED|Overall Study||27
11006792|NCT00730327|12184668|FG001|NOT COMPLETED|Overall Study||37
11056466|NCT00994214|12238018|FG002|COMPLETED|ITT (Intention-to-Treat) - Part B||0
11056467|NCT00994214|12238019|FG003|COMPLETED|ITT (Intention-to-Treat) - Part B||0
11056468|NCT00994214|12238016|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
11056469|NCT00994214|12238017|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
11396158|NCT03718871|12590005|FG000|STARTED|Overall Study||250
11396159|NCT03718871|12590006|FG001|STARTED|Overall Study||250
11396160|NCT03718871|12590005|FG000|COMPLETED|Overall Study||250
11396161|NCT03718871|12590006|FG001|COMPLETED|Overall Study||250
11056470|NCT00994214|12238018|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
11056471|NCT00994214|12238019|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
11056472|NCT00994240|12238049|FG000|STARTED|Overall Study||41
11056473|NCT00994240|12238050|FG001|STARTED|Overall Study||44
11056474|NCT00994240|12238049|FG000|COMPLETED|Overall Study||35
11056475|NCT00994240|12238050|FG001|COMPLETED|Overall Study||39
11056476|NCT00994240|12238049|FG000|NOT COMPLETED|Overall Study||6
11056477|NCT00994240|12238050|FG001|NOT COMPLETED|Overall Study||5
11056478|NCT00994279|12238058|FG000|STARTED|Overall Study||22
11056479|NCT00994279|12238059|FG001|STARTED|Overall Study||18
11056480|NCT00994279|12238058|FG000|COMPLETED|Overall Study||18
11056481|NCT00994279|12238059|FG001|COMPLETED|Overall Study||13
11056482|NCT00994279|12238058|FG000|NOT COMPLETED|Overall Study||4
11056483|NCT00994279|12238059|FG001|NOT COMPLETED|Overall Study||5
11056484|NCT00994318|12238068|FG000|STARTED|Overall Study||155
11056485|NCT00994318|12238069|FG001|STARTED|Overall Study||154
11056486|NCT00994318|12238070|FG002|STARTED|Overall Study||317
11056487|NCT00994318|12238068|FG000|COMPLETED|Overall Study||133
11056488|NCT00994318|12238069|FG001|COMPLETED|Overall Study||136
11056489|NCT00994318|12238070|FG002|COMPLETED|Overall Study||250
11056490|NCT00994318|12238068|FG000|NOT COMPLETED|Overall Study||22
11056491|NCT00994318|12238069|FG001|NOT COMPLETED|Overall Study||18
11056492|NCT00994318|12238070|FG002|NOT COMPLETED|Overall Study||67
11056493|NCT00994422|12238080|FG000|STARTED|Overall Study||192
11056494|NCT00994422|12238081|FG001|STARTED|Overall Study||55
11056495|NCT00994422|12238080|FG000|COMPLETED|Overall Study||185
11056496|NCT00994422|12238081|FG001|COMPLETED|Overall Study||54
11056497|NCT00994422|12238080|FG000|NOT COMPLETED|Overall Study||7
11056498|NCT00994422|12238081|FG001|NOT COMPLETED|Overall Study||1
11056499|NCT00994448|12238091|FG000|STARTED|Overall Study||12
11056500|NCT00994448|12238092|FG001|STARTED|Overall Study||7
11056501|NCT00994448|12238091|FG000|COMPLETED|Overall Study||4
11056502|NCT00994448|12238092|FG001|COMPLETED|Overall Study||5
11056503|NCT00994448|12238091|FG000|NOT COMPLETED|Overall Study||8
11056504|NCT00994448|12238092|FG001|NOT COMPLETED|Overall Study||2
11056505|NCT00994461|12238101|FG000|STARTED|Overall Study||76
11056506|NCT00994461|12238102|FG001|STARTED|Overall Study||76
11056507|NCT00994461|12238103|FG002|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
11056508|NCT00994461|12238101|FG000|COMPLETED|Overall Study||74
11056509|NCT00994461|12238102|FG001|COMPLETED|Overall Study||75
11056510|NCT00994461|12238103|FG002|COMPLETED|Overall Study||37
11056511|NCT00994461|12238101|FG000|NOT COMPLETED|Overall Study||2
11056512|NCT00994461|12238102|FG001|NOT COMPLETED|Overall Study||1
11056513|NCT00994461|12238103|FG002|NOT COMPLETED|Overall Study||0
11056514|NCT00994604|12238111|FG000|STARTED|Overall Study||51
11056515|NCT00994604|12238111|FG000|COMPLETED|Overall Study||45
11396162|NCT03718871|12590005|FG000|NOT COMPLETED|Overall Study||0
11056516|NCT00994604|12238111|FG000|NOT COMPLETED|Overall Study||6
11056517|NCT00994643|12238118|FG000|STARTED|Overall Study||11
11056518|NCT00994643|12238118|FG000|COMPLETED|Overall Study||10
11056519|NCT00994643|12238118|FG000|NOT COMPLETED|Overall Study||1
11056520|NCT00994682|12238124|FG000|STARTED|Double Bilnd||51
11056521|NCT00994682|12238125|FG001|STARTED|Double Bilnd||50
11006793|NCT00730353|12184674|FG000|STARTED|Overall Study||28
11006794|NCT00730353|12184674|FG000|COMPLETED|Overall Study||28
11006795|NCT00730353|12184674|FG000|NOT COMPLETED|Overall Study||0
11006796|NCT00730405|12184683|FG000|STARTED|Overall Study-Treatment Phase||116
11006797|NCT00730405|12184684|FG001|STARTED|Overall Study-Treatment Phase||117
11006798|NCT00730405|12184685|FG002|STARTED|Overall Study-Treatment Phase||117
11006799|NCT00730405|12184686|FG003|STARTED|Overall Study-Treatment Phase||117
11006800|NCT00730405|12184687|FG004|STARTED|Overall Study-Treatment Phase||115
11006801|NCT00730405|12184683|FG000|COMPLETED|Overall Study-Treatment Phase||97
11006802|NCT00730405|12184684|FG001|COMPLETED|Overall Study-Treatment Phase||96
11006803|NCT00730405|12184685|FG002|COMPLETED|Overall Study-Treatment Phase||96
11006804|NCT00730405|12184686|FG003|COMPLETED|Overall Study-Treatment Phase||98
11006805|NCT00730405|12184687|FG004|COMPLETED|Overall Study-Treatment Phase||95
11006806|NCT00730405|12184683|FG000|NOT COMPLETED|Overall Study-Treatment Phase||19
11396163|NCT03718871|12590006|FG001|NOT COMPLETED|Overall Study||0
11006807|NCT00730405|12184684|FG001|NOT COMPLETED|Overall Study-Treatment Phase||21
11006808|NCT00730405|12184685|FG002|NOT COMPLETED|Overall Study-Treatment Phase||21
11006809|NCT00730405|12184686|FG003|NOT COMPLETED|Overall Study-Treatment Phase||19
11006810|NCT00730405|12184687|FG004|NOT COMPLETED|Overall Study-Treatment Phase||20
11006811|NCT00730405|12184683|FG000|STARTED|Overall Study-follow-up Phase||116
11006812|NCT00730405|12184684|FG001|STARTED|Overall Study-follow-up Phase||117
11006813|NCT00730405|12184685|FG002|STARTED|Overall Study-follow-up Phase||117
11006814|NCT00730405|12184686|FG003|STARTED|Overall Study-follow-up Phase||117
11006815|NCT00730405|12184687|FG004|STARTED|Overall Study-follow-up Phase||115
11006816|NCT00730405|12184683|FG000|COMPLETED|Overall Study-follow-up Phase||95
11006817|NCT00730405|12184684|FG001|COMPLETED|Overall Study-follow-up Phase||96
11006818|NCT00730405|12184685|FG002|COMPLETED|Overall Study-follow-up Phase||94
11006819|NCT00730405|12184686|FG003|COMPLETED|Overall Study-follow-up Phase||100
11006820|NCT00730405|12184687|FG004|COMPLETED|Overall Study-follow-up Phase||93
11006821|NCT00730405|12184683|FG000|NOT COMPLETED|Overall Study-follow-up Phase||21
11006822|NCT00730405|12184684|FG001|NOT COMPLETED|Overall Study-follow-up Phase||21
11006823|NCT00730405|12184685|FG002|NOT COMPLETED|Overall Study-follow-up Phase||23
11006824|NCT00730405|12184686|FG003|NOT COMPLETED|Overall Study-follow-up Phase||17
11006825|NCT00730405|12184687|FG004|NOT COMPLETED|Overall Study-follow-up Phase||22
11006826|NCT00730483|12184701|FG000|STARTED|Overall Study||13
11006827|NCT00730483|12184701|FG000|1 Month After First DEB-TACE|Overall Study||13
11006828|NCT00730483|12184701|FG000|6 Months After First DEB-TACE|Overall Study||10
11006829|NCT00730483|12184701|FG000|COMPLETED|Overall Study||6
11006830|NCT00730483|12184701|FG000|NOT COMPLETED|Overall Study||7
11006831|NCT00730522|12184708|FG000|STARTED|Overall Study||28
11006832|NCT00730522|12184709|FG001|STARTED|Overall Study||27
11006833|NCT00730522|12184708|FG000|COMPLETED|Overall Study||28
11006834|NCT00730522|12184709|FG001|COMPLETED|Overall Study||27
11006835|NCT00730522|12184708|FG000|NOT COMPLETED|Overall Study||0
11006836|NCT00730522|12184709|FG001|NOT COMPLETED|Overall Study||0
11006837|NCT00730691|12184722|FG000|STARTED|Overall Study||157
11006838|NCT00730691|12184723|FG001|STARTED|Overall Study||156
11006839|NCT00730691|12184724|FG002|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
11006840|NCT00730691|12184725|FG003|STARTED|Overall Study||156
11006841|NCT00730691|12184726|FG004|STARTED|Overall Study||156
11006842|NCT00730691|12184722|FG000|COMPLETED|Overall Study||121
11006843|NCT00730691|12184723|FG001|COMPLETED|Overall Study||120
11006844|NCT00730691|12184724|FG002|COMPLETED|Overall Study||117
11006845|NCT00730691|12184725|FG003|COMPLETED|Overall Study||111
11006846|NCT00730691|12184726|FG004|COMPLETED|Overall Study||106
11006847|NCT00730691|12184722|FG000|NOT COMPLETED|Overall Study||36
11006848|NCT00730691|12184723|FG001|NOT COMPLETED|Overall Study||36
11006849|NCT00730691|12184724|FG002|NOT COMPLETED|Overall Study||39
11006850|NCT00730691|12184725|FG003|NOT COMPLETED|Overall Study||45
11006851|NCT00730691|12184726|FG004|NOT COMPLETED|Overall Study||50
11006852|NCT00730730|12184738|FG000|STARTED|Overall Study||50
11006853|NCT00730730|12184738|FG000|COMPLETED|Overall Study||50
11006854|NCT00730730|12184738|FG000|NOT COMPLETED|Overall Study||0
11006855|NCT00730756|12184744|FG000|STARTED|Overall Study||49
11006856|NCT00730756|12184745|FG001|STARTED|Overall Study||53
11006857|NCT00730756|12184744|FG000|COMPLETED|Overall Study||45
11006858|NCT00730756|12184745|FG001|COMPLETED|Overall Study||48
11006859|NCT00730756|12184744|FG000|NOT COMPLETED|Overall Study||4
11006860|NCT00730756|12184745|FG001|NOT COMPLETED|Overall Study||5
11006861|NCT00730847|12184751|FG000|STARTED|Overall Study||596
11006862|NCT00730847|12184751|FG000|COMPLETED|Overall Study||465
11006863|NCT00730847|12184751|FG000|NOT COMPLETED|Overall Study||131
11006864|NCT00730912|12184758|FG000|STARTED|Overall Study||53
11006865|NCT00730912|12184759|FG001|STARTED|Overall Study||104
11006866|NCT00730912|12184760|FG002|STARTED|Overall Study||104
11006867|NCT00730912|12184758|FG000|COMPLETED|Overall Study||53
11006868|NCT00730912|12184759|FG001|COMPLETED|Overall Study||104
11006869|NCT00730912|12184760|FG002|COMPLETED|Overall Study||103
11006870|NCT00730912|12184758|FG000|NOT COMPLETED|Overall Study||0
11006871|NCT00730912|12184759|FG001|NOT COMPLETED|Overall Study||0
11006872|NCT00730912|12184760|FG002|NOT COMPLETED|Overall Study||1
11006873|NCT00730925|12184768|FG000|STARTED|Overall Study||41
11006874|NCT00730925|12184768|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
11006875|NCT00730925|12184768|FG000|NOT COMPLETED|Overall Study||41
11006876|NCT00730964|12184772|FG000|STARTED|Overall Study||1039
11006877|NCT00730964|12184772|FG000|COMPLETED|Overall Study||1039
11006878|NCT00730964|12184772|FG000|NOT COMPLETED|Overall Study||0
11006879|NCT00731042|12184779|FG000|STARTED|First Intervention||16
11006880|NCT00731042|12184780|FG001|STARTED|First Intervention||17
11142352|NCT01467960|12329147|FG000|NOT COMPLETED|Overall Study||0
11142353|NCT01467960|12329148|FG001|NOT COMPLETED|Overall Study||0
11142354|NCT01467960|12329149|FG002|NOT COMPLETED|Overall Study||0
11142355|NCT01467960|12329150|FG003|NOT COMPLETED|Overall Study||30
11142356|NCT01467960|12329151|FG004|NOT COMPLETED|Overall Study||30
11142357|NCT01467960|12329152|FG005|NOT COMPLETED|Overall Study||30
11142358|NCT01467999|12329166|FG000|STARTED|Overall Study||22
11142359|NCT01467999|12329166|FG000|COMPLETED|Overall Study||9
11142360|NCT01467999|12329166|FG000|NOT COMPLETED|Overall Study||13
11142361|NCT01468012|12329173|FG000|STARTED|Overall Study||9
11142362|NCT01468012|12329174|FG001|STARTED|Overall Study||10
11142363|NCT01468012|12329175|FG002|STARTED|Overall Study||4
11142364|NCT01468012|12329173|FG000|COMPLETED|Overall Study||7
11142365|NCT01468012|12329174|FG001|COMPLETED|Overall Study||9
11142366|NCT01468012|12329175|FG002|COMPLETED|Overall Study||0
11142367|NCT01468012|12329173|FG000|NOT COMPLETED|Overall Study||2
11006881|NCT00731042|12184779|FG000|COMPLETED|First Intervention||16
11006882|NCT00731042|12184780|FG001|COMPLETED|First Intervention||17
11006883|NCT00731042|12184779|FG000|NOT COMPLETED|First Intervention||0
11006884|NCT00731042|12184780|FG001|NOT COMPLETED|First Intervention||0
11006885|NCT00731042|12184779|FG000|STARTED|Wash-out||16
11006886|NCT00731042|12184780|FG001|STARTED|Wash-out||17
11006887|NCT00731042|12184779|FG000|COMPLETED|Wash-out||16
11006888|NCT00731042|12184780|FG001|COMPLETED|Wash-out||17
11006889|NCT00731042|12184779|FG000|NOT COMPLETED|Wash-out||0
11006890|NCT00731042|12184780|FG001|NOT COMPLETED|Wash-out||0
11006891|NCT00731042|12184779|FG000|STARTED|Second Intervention||16
11006892|NCT00731042|12184780|FG001|STARTED|Second Intervention||17
11142368|NCT01468012|12329174|FG001|NOT COMPLETED|Overall Study||1
11006893|NCT00731042|12184779|FG000|COMPLETED|Second Intervention||16
11006894|NCT00731042|12184780|FG001|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
11006895|NCT00731042|12184779|FG000|NOT COMPLETED|Second Intervention||0
11006896|NCT00731042|12184780|FG001|NOT COMPLETED|Second Intervention||2
11006897|NCT00731055|12184786|FG000|STARTED|Overall Study|This is a within-subjects study design.|16
11006898|NCT00731055|12184786|FG000|Received Placebo|Overall Study||16
11006899|NCT00731055|12184786|FG000|Received Varenicline 0.5 mg|Overall Study||16
11006900|NCT00731055|12184786|FG000|Received Varenicline 1.0 mg|Overall Study||16
11006901|NCT00731055|12184786|FG000|Received Varenicline 2.0 mg|Overall Study||16
11006902|NCT00731055|12184786|FG000|COMPLETED|Overall Study||16
11006903|NCT00731055|12184786|FG000|NOT COMPLETED|Overall Study||0
11006904|NCT00731094|12184795|FG000|STARTED|Overall Study||116
11006905|NCT00731094|12184796|FG001|STARTED|Overall Study||116
11006906|NCT00731094|12184795|FG000|Month 6|Overall Study||101
11006907|NCT00731094|12184796|FG001|Month 6|Overall Study||107
11006908|NCT00731094|12184795|FG000|COMPLETED|Overall Study||98
11006909|NCT00731094|12184796|FG001|COMPLETED|Overall Study||105
11006910|NCT00731094|12184795|FG000|NOT COMPLETED|Overall Study||18
11006911|NCT00731094|12184796|FG001|NOT COMPLETED|Overall Study||11
11006912|NCT00731120|12184805|FG000|STARTED|Overall Study||153
11006913|NCT00731120|12184806|FG001|STARTED|Overall Study||152
11142369|NCT01468012|12329175|FG002|NOT COMPLETED|Overall Study||4
11142370|NCT01468077|12329186|FG000|STARTED|Overall Study||22
11142371|NCT01468077|12329187|FG001|STARTED|Overall Study||25
11142372|NCT01468077|12329186|FG000|COMPLETED|Overall Study||18
11142373|NCT01468077|12329187|FG001|COMPLETED|Overall Study||22
11142374|NCT01468077|12329186|FG000|NOT COMPLETED|Overall Study||4
11142375|NCT01468077|12329187|FG001|NOT COMPLETED|Overall Study||3
11142376|NCT01468181|12329198|FG000|STARTED|Overall Study||131
11142377|NCT01468181|12329199|FG001|STARTED|Overall Study||61
11142378|NCT01468181|12329200|FG002|STARTED|Overall Study||65
11142379|NCT01468181|12329201|FG003|STARTED|Overall Study||66
11142380|NCT01468181|12329202|FG004|STARTED|Overall Study||71
11142381|NCT01468181|12329198|FG000|Received at Least 1 Dose of Study Drug|Overall Study||131
11142382|NCT01468181|12329199|FG001|Received at Least 1 Dose of Study Drug|Overall Study||61
11142383|NCT01468181|12329200|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65
11142384|NCT01468181|12329201|FG003|Received at Least 1 Dose of Study Drug|Overall Study||66
11142385|NCT01468181|12329202|FG004|Received at Least 1 Dose of Study Drug|Overall Study||71
11142386|NCT01468181|12329198|FG000|COMPLETED|Overall Study||121
11142387|NCT01468181|12329199|FG001|COMPLETED|Overall Study||59
11142388|NCT01468181|12329200|FG002|COMPLETED|Overall Study||57
11142389|NCT01468181|12329201|FG003|COMPLETED|Overall Study||63
11142390|NCT01468181|12329202|FG004|COMPLETED|Overall Study||66
11142391|NCT01468181|12329198|FG000|NOT COMPLETED|Overall Study||10
11142392|NCT01468181|12329199|FG001|NOT COMPLETED|Overall Study||2
11142393|NCT01468181|12329200|FG002|NOT COMPLETED|Overall Study||8
11142394|NCT01468181|12329201|FG003|NOT COMPLETED|Overall Study||3
11142395|NCT01468181|12329202|FG004|NOT COMPLETED|Overall Study||5
11142396|NCT01468207|12329216|FG000|STARTED|Treatment Period 1||154
11142397|NCT01468207|12329217|FG001|STARTED|Treatment Period 1||153
11142398|NCT01468207|12329218|FG002|STARTED|Treatment Period 1||0
11142399|NCT01468207|12329219|FG003|STARTED|Treatment Period 1||0
11142400|NCT01468207|12329220|FG004|STARTED|Treatment Period 1||0
11142401|NCT01468207|12329221|FG005|STARTED|Treatment Period 1||0
11142402|NCT01468207|12329216|FG000|Received Study Drug|Treatment Period 1||152
11142403|NCT01468207|12329217|FG001|Received Study Drug|Treatment Period 1||153
11142404|NCT01468207|12329218|FG002|Received Study Drug|Treatment Period 1||0
11142405|NCT01468207|12329219|FG003|Received Study Drug|Treatment Period 1||0
11142406|NCT01468207|12329220|FG004|Received Study Drug|Treatment Period 1||0
11142407|NCT01468207|12329221|FG005|Received Study Drug|Treatment Period 1||0
11142408|NCT01468207|12329216|FG000|COMPLETED|Treatment Period 1||145
11142409|NCT01468207|12329217|FG001|COMPLETED|Treatment Period 1||145
11142410|NCT01468207|12329218|FG002|COMPLETED|Treatment Period 1||0
11142411|NCT01468207|12329219|FG003|COMPLETED|Treatment Period 1||0
11142412|NCT01468207|12329220|FG004|COMPLETED|Treatment Period 1||0
11396164|NCT03719300|12590013|FG000|STARTED|Overall Study||32
11396165|NCT03719300|12590013|FG000|COMPLETED|Overall Study||32
11396166|NCT03719300|12590013|FG000|NOT COMPLETED|Overall Study||0
11396167|NCT03719378|12590019|FG000|STARTED|Overall Study||75
11396168|NCT03719378|12590020|FG001|STARTED|Overall Study||75
11006914|NCT00731120|12184807|FG002|STARTED|Overall Study||152
11006915|NCT00731120|12184805|FG000|Treated|Overall Study||153
11006916|NCT00731120|12184806|FG001|Treated|Overall Study||151
11006917|NCT00731120|12184807|FG002|Treated|Overall Study||152
11006918|NCT00731120|12184805|FG000|COMPLETED|Overall Study||111
11006919|NCT00731120|12184806|FG001|COMPLETED|Overall Study||109
11006920|NCT00731120|12184807|FG002|COMPLETED|Overall Study||116
11006921|NCT00731120|12184805|FG000|NOT COMPLETED|Overall Study||42
11142413|NCT01468207|12329221|FG005|COMPLETED|Treatment Period 1||0
11142414|NCT01468207|12329216|FG000|NOT COMPLETED|Treatment Period 1||9
11142415|NCT01468207|12329217|FG001|NOT COMPLETED|Treatment Period 1||8
11142416|NCT01468207|12329218|FG002|NOT COMPLETED|Treatment Period 1||0
11142417|NCT01468207|12329219|FG003|NOT COMPLETED|Treatment Period 1||0
11142418|NCT01468207|12329220|FG004|NOT COMPLETED|Treatment Period 1||0
11142419|NCT01468207|12329221|FG005|NOT COMPLETED|Treatment Period 1||0
11142420|NCT01468207|12329216|FG000|STARTED|Treatment Period 2||0
11142421|NCT01468207|12329217|FG001|STARTED|Treatment Period 2||0
11142422|NCT01468207|12329218|FG002|STARTED|Treatment Period 2||145
11396169|NCT03719378|12590019|FG000|COMPLETED|Overall Study||65
11396170|NCT03719378|12590020|FG001|COMPLETED|Overall Study||65
11396171|NCT03719378|12590019|FG000|NOT COMPLETED|Overall Study||10
11006922|NCT00731120|12184806|FG001|NOT COMPLETED|Overall Study||43
11006923|NCT00731120|12184807|FG002|NOT COMPLETED|Overall Study||36
11396172|NCT03719378|12590020|FG001|NOT COMPLETED|Overall Study||10
11396173|NCT03719586|12590030|FG000|STARTED|Overall Study||177
11396174|NCT03719586|12590031|FG001|STARTED|Overall Study||176
11396175|NCT03719586|12590032|FG002|STARTED|Overall Study|The REGN-EB3 arm was added in 1/2019 after the trial had initially begun in November 2018.|158
11396176|NCT03719586|12590033|FG003|STARTED|Overall Study||169
11006924|NCT00731133|12184815|FG000|STARTED|Overall Study||15
11006925|NCT00731133|12184815|FG000|COMPLETED|Overall Study||5
11006926|NCT00731133|12184815|FG000|NOT COMPLETED|Overall Study||10
11006927|NCT00731198|12184821|FG000|STARTED|Overall Study||325
11006928|NCT00731198|12184822|FG001|STARTED|Overall Study||325
11006929|NCT00731198|12184821|FG000|COMPLETED|Overall Study||319
11006930|NCT00731198|12184822|FG001|COMPLETED|Overall Study||319
11006931|NCT00731198|12184821|FG000|NOT COMPLETED|Overall Study||6
11006932|NCT00731198|12184822|FG001|NOT COMPLETED|Overall Study||6
11006933|NCT00731211|12184828|FG000|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
11006934|NCT00731211|12184828|FG000|COMPLETED|Overall Study||55
11006935|NCT00731211|12184828|FG000|NOT COMPLETED|Overall Study||0
11006936|NCT00731341|12184832|FG000|STARTED|Overall Study||3
11006937|NCT00731341|12184832|FG000|COMPLETED|Overall Study||3
11006938|NCT00731341|12184832|FG000|NOT COMPLETED|Overall Study||0
11006939|NCT00731484|12184836|FG000|STARTED|Overall Study||233
11006940|NCT00731484|12184836|FG000|COMPLETED|Overall Study||233
11006941|NCT00731484|12184836|FG000|NOT COMPLETED|Overall Study||0
11006942|NCT00731549|12184840|FG000|STARTED|Overall Study||1081
11006943|NCT00731549|12184840|FG000|COMPLETED|Overall Study||858
11006944|NCT00731549|12184840|FG000|NOT COMPLETED|Overall Study||223
11006945|NCT00731588|12184846|FG000|STARTED|Overall Study||9
11006946|NCT00731588|12184847|FG001|STARTED|Overall Study||95
11006947|NCT00731588|12184846|FG000|COMPLETED|Overall Study||9
11006948|NCT00731588|12184847|FG001|COMPLETED|Overall Study||53
11006949|NCT00731588|12184846|FG000|NOT COMPLETED|Overall Study||0
11006950|NCT00731588|12184847|FG001|NOT COMPLETED|Overall Study||42
11006951|NCT00731614|12184856|FG000|STARTED|Overall Study||23
11006952|NCT00731614|12184857|FG001|STARTED|Overall Study||31
11006953|NCT00731614|12184856|FG000|End of Treatment|Overall Study||16
11006954|NCT00731614|12184857|FG001|End of Treatment|Overall Study||24
11006955|NCT00731614|12184856|FG000|12 Weeks Posttreatment|Overall Study||18
11006956|NCT00731614|12184857|FG001|12 Weeks Posttreatment|Overall Study||23
11006957|NCT00731614|12184856|FG000|COMPLETED|Overall Study||16
11006958|NCT00731614|12184857|FG001|COMPLETED|Overall Study||18
11006959|NCT00731614|12184856|FG000|NOT COMPLETED|Overall Study||7
11006960|NCT00731614|12184857|FG001|NOT COMPLETED|Overall Study||13
11006961|NCT00731640|12184865|FG000|STARTED|Overall Study||20
11006962|NCT00731640|12184866|FG001|STARTED|Overall Study||32
11006963|NCT00731640|12184865|FG000|COMPLETED|Overall Study||20
11006964|NCT00731640|12184866|FG001|COMPLETED|Overall Study||32
11006965|NCT00731640|12184865|FG000|NOT COMPLETED|Overall Study||0
11006966|NCT00731640|12184866|FG001|NOT COMPLETED|Overall Study||0
11006967|NCT00731653|12184872|FG000|STARTED|Overall Study||81
11006968|NCT00731653|12184872|FG000|COMPLETED|Overall Study||72
11006969|NCT00731653|12184872|FG000|NOT COMPLETED|Overall Study||9
11006970|NCT00731666|12184876|FG000|STARTED|Overall Study||40
11006971|NCT00731666|12184876|FG000|COMPLETED|Overall Study||28
11006972|NCT00731666|12184876|FG000|NOT COMPLETED|Overall Study||12
11006973|NCT00731679|12184882|FG000|STARTED|Overall Study||314
11006974|NCT00731679|12184883|FG001|STARTED|Overall Study||309
11006975|NCT00731679|12184882|FG000|COMPLETED|Overall Study||292
11006976|NCT00731679|12184883|FG001|COMPLETED|Overall Study||283
11006977|NCT00731679|12184882|FG000|NOT COMPLETED|Overall Study||22
11006978|NCT00731679|12184883|FG001|NOT COMPLETED|Overall Study||26
11006979|NCT00731692|12184892|FG000|STARTED|Core Study (36 Months)||147
11006980|NCT00731692|12184893|FG001|STARTED|Core Study (36 Months)||336
11006981|NCT00731692|12184894|FG002|STARTED|Core Study (36 Months)||487
11006982|NCT00731692|12184892|FG000|Safety Set (SAF)|Core Study (36 Months)||0
11006983|NCT00731692|12184893|FG001|Safety Set (SAF)|Core Study (36 Months)||336
11006984|NCT00731692|12184894|FG002|Safety Set (SAF)|Core Study (36 Months)||487
11006985|NCT00731692|12184892|FG000|Full Analysis Set (FAS)|Core Study (36 Months)||0
11396177|NCT03719586|12590030|FG000|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
11006986|NCT00731692|12184893|FG001|Full Analysis Set (FAS)|Core Study (36 Months)||336
11006987|NCT00731692|12184894|FG002|Full Analysis Set (FAS)|Core Study (36 Months)||487
11006988|NCT00731692|12184892|FG000|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
11006989|NCT00731692|12184893|FG001|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
11006990|NCT00731692|12184894|FG002|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
11006991|NCT00731692|12184892|FG000|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
11006992|NCT00731692|12184893|FG001|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
11006993|NCT00731692|12184894|FG002|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
11006994|NCT00731692|12184892|FG000|COMPLETED|Core Study (36 Months)||79
11006995|NCT00731692|12184893|FG001|COMPLETED|Core Study (36 Months)||220
11006996|NCT00731692|12184894|FG002|COMPLETED|Core Study (36 Months)||317
11006997|NCT00731692|12184892|FG000|NOT COMPLETED|Core Study (36 Months)||68
11396178|NCT03719586|12590031|FG001|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
11006998|NCT00731692|12184893|FG001|NOT COMPLETED|Core Study (36 Months)||116
11006999|NCT00731692|12184894|FG002|NOT COMPLETED|Core Study (36 Months)||170
11007000|NCT00731692|12184892|FG000|STARTED|Extension Phase||74
11007001|NCT00731692|12184893|FG001|STARTED|Extension Phase||196
11007002|NCT00731692|12184894|FG002|STARTED|Extension Phase||301
11007003|NCT00731692|12184892|FG000|COMPLETED|Extension Phase||0
11007004|NCT00731692|12184893|FG001|COMPLETED|Extension Phase||0
11007005|NCT00731692|12184894|FG002|COMPLETED|Extension Phase||0
11142423|NCT01468207|12329219|FG003|STARTED|Treatment Period 2||49
11142424|NCT01468207|12329220|FG004|STARTED|Treatment Period 2||48
11142425|NCT01468207|12329221|FG005|STARTED|Treatment Period 2||48
11142426|NCT01468207|12329216|FG000|COMPLETED|Treatment Period 2||0
11142427|NCT01468207|12329217|FG001|COMPLETED|Treatment Period 2||0
11142428|NCT01468207|12329218|FG002|COMPLETED|Treatment Period 2||93
11142429|NCT01468207|12329219|FG003|COMPLETED|Treatment Period 2||22
11142430|NCT01468207|12329220|FG004|COMPLETED|Treatment Period 2||27
11142431|NCT01468207|12329221|FG005|COMPLETED|Treatment Period 2||28
11142432|NCT01468207|12329216|FG000|NOT COMPLETED|Treatment Period 2||0
11142433|NCT01468207|12329217|FG001|NOT COMPLETED|Treatment Period 2||0
11142434|NCT01468207|12329218|FG002|NOT COMPLETED|Treatment Period 2||52
11142435|NCT01468207|12329219|FG003|NOT COMPLETED|Treatment Period 2||27
11142436|NCT01468207|12329220|FG004|NOT COMPLETED|Treatment Period 2||21
11142437|NCT01468207|12329221|FG005|NOT COMPLETED|Treatment Period 2||20
11142438|NCT01468233|12329241|FG000|STARTED|Treatment Period 1||163
11142439|NCT01468233|12329242|FG001|STARTED|Treatment Period 1||163
11142440|NCT01468233|12329243|FG002|STARTED|Treatment Period 1||0
11142441|NCT01468233|12329244|FG003|STARTED|Treatment Period 1||0
11142442|NCT01468233|12329245|FG004|STARTED|Treatment Period 1||0
11142443|NCT01468233|12329246|FG005|STARTED|Treatment Period 1||0
11142444|NCT01468233|12329241|FG000|COMPLETED|Treatment Period 1||151
11142445|NCT01468233|12329242|FG001|COMPLETED|Treatment Period 1||155
11142446|NCT01468233|12329243|FG002|COMPLETED|Treatment Period 1||0
11142447|NCT01468233|12329244|FG003|COMPLETED|Treatment Period 1||0
11142448|NCT01468233|12329245|FG004|COMPLETED|Treatment Period 1||0
11142449|NCT01468233|12329246|FG005|COMPLETED|Treatment Period 1||0
11142450|NCT01468233|12329241|FG000|NOT COMPLETED|Treatment Period 1||12
11142451|NCT01468233|12329242|FG001|NOT COMPLETED|Treatment Period 1||8
11142452|NCT01468233|12329243|FG002|NOT COMPLETED|Treatment Period 1||0
11142453|NCT01468233|12329244|FG003|NOT COMPLETED|Treatment Period 1||0
11142454|NCT01468233|12329245|FG004|NOT COMPLETED|Treatment Period 1||0
11142455|NCT01468233|12329246|FG005|NOT COMPLETED|Treatment Period 1||0
11142456|NCT01468233|12329241|FG000|STARTED|Treatment Period 2||0
11142457|NCT01468233|12329242|FG001|STARTED|Treatment Period 2||0
11142458|NCT01468233|12329243|FG002|STARTED|Treatment Period 2||151
11142459|NCT01468233|12329244|FG003|STARTED|Treatment Period 2||51
11142460|NCT01468233|12329245|FG004|STARTED|Treatment Period 2||53
11142461|NCT01468233|12329246|FG005|STARTED|Treatment Period 2||51
11142462|NCT01468233|12329241|FG000|COMPLETED|Treatment Period 2||0
11142463|NCT01468233|12329242|FG001|COMPLETED|Treatment Period 2||0
11142464|NCT01468233|12329243|FG002|COMPLETED|Treatment Period 2||40
11142465|NCT01468233|12329244|FG003|COMPLETED|Treatment Period 2||23
11142466|NCT01468233|12329245|FG004|COMPLETED|Treatment Period 2||25
11142467|NCT01468233|12329246|FG005|COMPLETED|Treatment Period 2||28
11142468|NCT01468233|12329241|FG000|NOT COMPLETED|Treatment Period 2||0
11142469|NCT01468233|12329242|FG001|NOT COMPLETED|Treatment Period 2||0
11142470|NCT01468233|12329243|FG002|NOT COMPLETED|Treatment Period 2||111
11142471|NCT01468233|12329244|FG003|NOT COMPLETED|Treatment Period 2||28
11142472|NCT01468233|12329245|FG004|NOT COMPLETED|Treatment Period 2||28
11142473|NCT01468233|12329246|FG005|NOT COMPLETED|Treatment Period 2||23
11142474|NCT01468311|12329264|FG000|STARTED|Overall Study||6
11142475|NCT01468311|12329264|FG000|COMPLETED|Overall Study||4
11142476|NCT01468311|12329264|FG000|NOT COMPLETED|Overall Study||2
11142477|NCT01468337|12329268|FG000|STARTED|Overall Study||5
11142478|NCT01468337|12329268|FG000|Week 2|Overall Study||5
11142479|NCT01468337|12329268|FG000|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
11142480|NCT01468337|12329268|FG000|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
11142481|NCT01468337|12329268|FG000|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
11142482|NCT01468337|12329268|FG000|COMPLETED|Overall Study||5
11142483|NCT01468337|12329268|FG000|NOT COMPLETED|Overall Study||0
11142484|NCT01468350|12329276|FG000|STARTED|(PART A) Day 1, Day 3||6
11007006|NCT00731692|12184892|FG000|NOT COMPLETED|Extension Phase||74
11007007|NCT00731692|12184893|FG001|NOT COMPLETED|Extension Phase||196
11007008|NCT00731692|12184894|FG002|NOT COMPLETED|Extension Phase||301
11007009|NCT00731783|12184912|FG000|STARTED|One Month Follow-Up Visit||92
11142485|NCT01468350|12329277|FG001|STARTED|(PART A) Day 1, Day 3||5
11142486|NCT01468350|12329278|FG002|STARTED|(PART A) Day 1, Day 3||0
11142487|NCT01468350|12329279|FG003|STARTED|(PART A) Day 1, Day 3||0
11142488|NCT01468350|12329276|FG000|COMPLETED|(PART A) Day 1, Day 3||6
11142489|NCT01468350|12329277|FG001|COMPLETED|(PART A) Day 1, Day 3||5
11142490|NCT01468350|12329278|FG002|COMPLETED|(PART A) Day 1, Day 3||0
11142491|NCT01468350|12329279|FG003|COMPLETED|(PART A) Day 1, Day 3||0
11142492|NCT01468350|12329276|FG000|NOT COMPLETED|(PART A) Day 1, Day 3||0
11263685|NCT02271984|12459062|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
11396179|NCT03719586|12590032|FG002|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|154
11007010|NCT00731783|12184913|FG001|STARTED|One Month Follow-Up Visit||91
11007011|NCT00731783|12184912|FG000|COMPLETED|One Month Follow-Up Visit||78
11007012|NCT00731783|12184913|FG001|COMPLETED|One Month Follow-Up Visit||69
11007013|NCT00731783|12184912|FG000|NOT COMPLETED|One Month Follow-Up Visit||14
11007014|NCT00731783|12184913|FG001|NOT COMPLETED|One Month Follow-Up Visit||22
11007015|NCT00731783|12184912|FG000|STARTED|Three Month Follow-Up Visit||79
11007016|NCT00731783|12184913|FG001|STARTED|Three Month Follow-Up Visit||73
11007017|NCT00731783|12184912|FG000|COMPLETED|Three Month Follow-Up Visit||72
11007018|NCT00731783|12184913|FG001|COMPLETED|Three Month Follow-Up Visit||57
11007019|NCT00731783|12184912|FG000|NOT COMPLETED|Three Month Follow-Up Visit||7
11007020|NCT00731783|12184913|FG001|NOT COMPLETED|Three Month Follow-Up Visit||16
11007021|NCT00731783|12184912|FG000|STARTED|Six Month Follow-Up Visit||77
11007022|NCT00731783|12184913|FG001|STARTED|Six Month Follow-Up Visit||67
11007023|NCT00731783|12184912|FG000|COMPLETED|Six Month Follow-Up Visit||71
11007024|NCT00731783|12184913|FG001|COMPLETED|Six Month Follow-Up Visit||64
11007025|NCT00731783|12184912|FG000|NOT COMPLETED|Six Month Follow-Up Visit||6
11396180|NCT03719586|12590033|FG003|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
11007026|NCT00731783|12184913|FG001|NOT COMPLETED|Six Month Follow-Up Visit||3
11007027|NCT00731783|12184912|FG000|STARTED|12 Month Follow-Up Visit||74
11007028|NCT00731783|12184913|FG001|STARTED|12 Month Follow-Up Visit||65
11007029|NCT00731783|12184912|FG000|COMPLETED|12 Month Follow-Up Visit||68
11007030|NCT00731783|12184913|FG001|COMPLETED|12 Month Follow-Up Visit||58
11007031|NCT00731783|12184912|FG000|NOT COMPLETED|12 Month Follow-Up Visit||6
11007032|NCT00731783|12184913|FG001|NOT COMPLETED|12 Month Follow-Up Visit||7
11007033|NCT00731822|12184921|FG000|STARTED|Overall Study||20
11007034|NCT00731822|12184922|FG001|STARTED|Overall Study||40
11007035|NCT00731822|12184921|FG000|COMPLETED|Overall Study||16
11007036|NCT00731822|12184922|FG001|COMPLETED|Overall Study||39
11007037|NCT00731822|12184921|FG000|NOT COMPLETED|Overall Study||4
11007038|NCT00731822|12184922|FG001|NOT COMPLETED|Overall Study||1
11007039|NCT00731874|12184930|FG000|STARTED|Overall Study||10
11007040|NCT00731874|12184931|FG001|STARTED|Overall Study||13
11007041|NCT00731874|12184930|FG000|COMPLETED|Overall Study||10
11007042|NCT00731874|12184931|FG001|COMPLETED|Overall Study||13
11007043|NCT00731874|12184930|FG000|NOT COMPLETED|Overall Study||0
11007044|NCT00731874|12184931|FG001|NOT COMPLETED|Overall Study||0
11007045|NCT00731939|12184937|FG000|STARTED|Overall Study||124
11007046|NCT00731939|12184937|FG000|COMPLETED|Overall Study||90
11007047|NCT00731939|12184937|FG000|NOT COMPLETED|Overall Study||34
11007048|NCT00732030|12184941|FG000|STARTED|Overall Study||26
11007049|NCT00732030|12184941|FG000|COMPLETED|Overall Study||24
11007050|NCT00732030|12184941|FG000|NOT COMPLETED|Overall Study||2
11007051|NCT00732069|12184945|FG000|STARTED|First Study Drug||3
11007052|NCT00732069|12184946|FG001|STARTED|First Study Drug||3
11007053|NCT00732069|12184947|FG002|STARTED|First Study Drug||3
11007054|NCT00732069|12184948|FG003|STARTED|First Study Drug||2
11007055|NCT00732069|12184949|FG004|STARTED|First Study Drug||3
11007056|NCT00732069|12184950|FG005|STARTED|First Study Drug||2
11007057|NCT00732069|12184945|FG000|COMPLETED|First Study Drug||3
11007058|NCT00732069|12184946|FG001|COMPLETED|First Study Drug||3
11007059|NCT00732069|12184947|FG002|COMPLETED|First Study Drug||3
11007060|NCT00732069|12184948|FG003|COMPLETED|First Study Drug||2
11007061|NCT00732069|12184949|FG004|COMPLETED|First Study Drug||3
11007062|NCT00732069|12184950|FG005|COMPLETED|First Study Drug||2
11007063|NCT00732069|12184945|FG000|NOT COMPLETED|First Study Drug||0
11007064|NCT00732069|12184946|FG001|NOT COMPLETED|First Study Drug||0
11007065|NCT00732069|12184947|FG002|NOT COMPLETED|First Study Drug||0
11007066|NCT00732069|12184948|FG003|NOT COMPLETED|First Study Drug||0
11007067|NCT00732069|12184949|FG004|NOT COMPLETED|First Study Drug||0
11007068|NCT00732069|12184950|FG005|NOT COMPLETED|First Study Drug||0
11007069|NCT00732069|12184945|FG000|STARTED|Washout After First Study Drug||3
11007070|NCT00732069|12184946|FG001|STARTED|Washout After First Study Drug||3
11007071|NCT00732069|12184947|FG002|STARTED|Washout After First Study Drug||3
11007072|NCT00732069|12184948|FG003|STARTED|Washout After First Study Drug||2
11007073|NCT00732069|12184949|FG004|STARTED|Washout After First Study Drug||3
11007074|NCT00732069|12184950|FG005|STARTED|Washout After First Study Drug||2
11007075|NCT00732069|12184945|FG000|COMPLETED|Washout After First Study Drug||2
11007076|NCT00732069|12184946|FG001|COMPLETED|Washout After First Study Drug||3
11007077|NCT00732069|12184947|FG002|COMPLETED|Washout After First Study Drug||3
11007078|NCT00732069|12184948|FG003|COMPLETED|Washout After First Study Drug||2
11007079|NCT00732069|12184949|FG004|COMPLETED|Washout After First Study Drug||3
11007080|NCT00732069|12184950|FG005|COMPLETED|Washout After First Study Drug||2
11007081|NCT00732069|12184945|FG000|NOT COMPLETED|Washout After First Study Drug||1
11007082|NCT00732069|12184946|FG001|NOT COMPLETED|Washout After First Study Drug||0
11007083|NCT00732069|12184947|FG002|NOT COMPLETED|Washout After First Study Drug||0
11007084|NCT00732069|12184948|FG003|NOT COMPLETED|Washout After First Study Drug||0
11007085|NCT00732069|12184949|FG004|NOT COMPLETED|Washout After First Study Drug||0
11007086|NCT00732069|12184950|FG005|NOT COMPLETED|Washout After First Study Drug||0
11007087|NCT00732069|12184945|FG000|STARTED|Second Study Drug||2
11007088|NCT00732069|12184946|FG001|STARTED|Second Study Drug||3
11007089|NCT00732069|12184947|FG002|STARTED|Second Study Drug||3
11007090|NCT00732069|12184948|FG003|STARTED|Second Study Drug||2
11007091|NCT00732069|12184949|FG004|STARTED|Second Study Drug||3
11007092|NCT00732069|12184950|FG005|STARTED|Second Study Drug||2
11007093|NCT00732069|12184945|FG000|COMPLETED|Second Study Drug||2
11007094|NCT00732069|12184946|FG001|COMPLETED|Second Study Drug||3
11007095|NCT00732069|12184947|FG002|COMPLETED|Second Study Drug||3
11007096|NCT00732069|12184948|FG003|COMPLETED|Second Study Drug||2
11007097|NCT00732069|12184949|FG004|COMPLETED|Second Study Drug||3
11007098|NCT00732069|12184950|FG005|COMPLETED|Second Study Drug||2
11007099|NCT00732069|12184945|FG000|NOT COMPLETED|Second Study Drug||0
11007100|NCT00732069|12184946|FG001|NOT COMPLETED|Second Study Drug||0
11007101|NCT00732069|12184947|FG002|NOT COMPLETED|Second Study Drug||0
11007102|NCT00732069|12184948|FG003|NOT COMPLETED|Second Study Drug||0
11007103|NCT00732069|12184949|FG004|NOT COMPLETED|Second Study Drug||0
11007104|NCT00732069|12184950|FG005|NOT COMPLETED|Second Study Drug||0
11007105|NCT00732069|12184945|FG000|STARTED|Washout After Second Study Drug||2
11007106|NCT00732069|12184946|FG001|STARTED|Washout After Second Study Drug||3
11007107|NCT00732069|12184947|FG002|STARTED|Washout After Second Study Drug||3
11007108|NCT00732069|12184948|FG003|STARTED|Washout After Second Study Drug||2
11007109|NCT00732069|12184949|FG004|STARTED|Washout After Second Study Drug||3
11007110|NCT00732069|12184950|FG005|STARTED|Washout After Second Study Drug||2
11007111|NCT00732069|12184945|FG000|COMPLETED|Washout After Second Study Drug||2
11007112|NCT00732069|12184946|FG001|COMPLETED|Washout After Second Study Drug||3
11007113|NCT00732069|12184947|FG002|COMPLETED|Washout After Second Study Drug||3
11007114|NCT00732069|12184948|FG003|COMPLETED|Washout After Second Study Drug||2
11007115|NCT00732069|12184949|FG004|COMPLETED|Washout After Second Study Drug||3
11007116|NCT00732069|12184950|FG005|COMPLETED|Washout After Second Study Drug||2
11007117|NCT00732069|12184945|FG000|NOT COMPLETED|Washout After Second Study Drug||0
11007118|NCT00732069|12184946|FG001|NOT COMPLETED|Washout After Second Study Drug||0
11007119|NCT00732069|12184947|FG002|NOT COMPLETED|Washout After Second Study Drug||0
11007120|NCT00732069|12184948|FG003|NOT COMPLETED|Washout After Second Study Drug||0
11007121|NCT00732069|12184949|FG004|NOT COMPLETED|Washout After Second Study Drug||0
11007122|NCT00732069|12184950|FG005|NOT COMPLETED|Washout After Second Study Drug||0
11007123|NCT00732069|12184945|FG000|STARTED|Third Study Drug||2
11007124|NCT00732069|12184946|FG001|STARTED|Third Study Drug||3
11007125|NCT00732069|12184947|FG002|STARTED|Third Study Drug||3
11007126|NCT00732069|12184948|FG003|STARTED|Third Study Drug||2
11007127|NCT00732069|12184949|FG004|STARTED|Third Study Drug||3
11007128|NCT00732069|12184950|FG005|STARTED|Third Study Drug||2
11142493|NCT01468350|12329277|FG001|NOT COMPLETED|(PART A) Day 1, Day 3||0
11142494|NCT01468350|12329278|FG002|NOT COMPLETED|(PART A) Day 1, Day 3||0
11142495|NCT01468350|12329279|FG003|NOT COMPLETED|(PART A) Day 1, Day 3||0
11142496|NCT01468350|12329276|FG000|STARTED|(PART B) Day 1, Day 15||0
11142497|NCT01468350|12329277|FG001|STARTED|(PART B) Day 1, Day 15||0
11142498|NCT01468350|12329278|FG002|STARTED|(PART B) Day 1, Day 15||12
11142499|NCT01468350|12329279|FG003|STARTED|(PART B) Day 1, Day 15||12
11142500|NCT01468350|12329276|FG000|COMPLETED|(PART B) Day 1, Day 15||0
11142501|NCT01468350|12329277|FG001|COMPLETED|(PART B) Day 1, Day 15||0
11142502|NCT01468350|12329278|FG002|COMPLETED|(PART B) Day 1, Day 15||12
11396181|NCT03719586|12590030|FG000|NOT COMPLETED|Overall Study||8
11396182|NCT03719586|12590031|FG001|NOT COMPLETED|Overall Study||7
11396183|NCT03719586|12590032|FG002|NOT COMPLETED|Overall Study||4
11396184|NCT03719586|12590033|FG003|NOT COMPLETED|Overall Study||0
11396185|NCT03719612|12590043|FG000|STARTED|Overall Study||160
11396186|NCT03719612|12590043|FG000|COMPLETED|Overall Study||148
11142503|NCT01468350|12329279|FG003|COMPLETED|(PART B) Day 1, Day 15||12
11142504|NCT01468350|12329276|FG000|NOT COMPLETED|(PART B) Day 1, Day 15||0
11142505|NCT01468350|12329277|FG001|NOT COMPLETED|(PART B) Day 1, Day 15||0
11007129|NCT00732069|12184945|FG000|COMPLETED|Third Study Drug||2
11007130|NCT00732069|12184946|FG001|COMPLETED|Third Study Drug||3
11007131|NCT00732069|12184947|FG002|COMPLETED|Third Study Drug||3
11007132|NCT00732069|12184948|FG003|COMPLETED|Third Study Drug||2
11007133|NCT00732069|12184949|FG004|COMPLETED|Third Study Drug||3
11007134|NCT00732069|12184950|FG005|COMPLETED|Third Study Drug||2
11007135|NCT00732069|12184945|FG000|NOT COMPLETED|Third Study Drug||0
11007136|NCT00732069|12184946|FG001|NOT COMPLETED|Third Study Drug||0
11007137|NCT00732069|12184947|FG002|NOT COMPLETED|Third Study Drug||0
11007138|NCT00732069|12184948|FG003|NOT COMPLETED|Third Study Drug||0
11007139|NCT00732069|12184949|FG004|NOT COMPLETED|Third Study Drug||0
11007140|NCT00732069|12184950|FG005|NOT COMPLETED|Third Study Drug||0
11007141|NCT00732160|12184962|FG000|STARTED|Overall Study||7
11396187|NCT03719612|12590043|FG000|NOT COMPLETED|Overall Study||12
11396188|NCT03719677|12590049|FG000|STARTED|Overall Study||7
11007142|NCT00732160|12184963|FG001|STARTED|Overall Study||5
11007143|NCT00732160|12184964|FG002|STARTED|Overall Study||6
11007144|NCT00732160|12184965|FG003|STARTED|Overall Study||5
11007145|NCT00732160|12184962|FG000|HS Vehicle|Overall Study||7
11007146|NCT00732160|12184963|FG001|HS Vehicle|Overall Study||5
11007147|NCT00732160|12184964|FG002|HS Vehicle|Overall Study||3
11007148|NCT00732160|12184965|FG003|HS Vehicle|Overall Study||3
11007149|NCT00732160|12184962|FG000|HS Aldosterone|Overall Study||7
11007150|NCT00732160|12184963|FG001|HS Aldosterone|Overall Study||5
11007151|NCT00732160|12184964|FG002|HS Aldosterone|Overall Study||3
11007152|NCT00732160|12184965|FG003|HS Aldosterone|Overall Study||3
11007153|NCT00732160|12184962|FG000|LS Vehicle|Overall Study||2
11007154|NCT00732160|12184963|FG001|LS Vehicle|Overall Study||1
11007155|NCT00732160|12184964|FG002|LS Vehicle|Overall Study||6
11007156|NCT00732160|12184965|FG003|LS Vehicle|Overall Study||5
11007157|NCT00732160|12184962|FG000|LS Aldosterone|Overall Study||2
11007158|NCT00732160|12184963|FG001|LS Aldosterone|Overall Study||1
11007159|NCT00732160|12184964|FG002|LS Aldosterone|Overall Study||6
11007160|NCT00732160|12184965|FG003|LS Aldosterone|Overall Study||5
11007161|NCT00732160|12184962|FG000|COMPLETED|Overall Study||2
11007162|NCT00732160|12184963|FG001|COMPLETED|Overall Study||1
11007163|NCT00732160|12184964|FG002|COMPLETED|Overall Study||3
11007164|NCT00732160|12184965|FG003|COMPLETED|Overall Study||3
11007165|NCT00732160|12184962|FG000|NOT COMPLETED|Overall Study||5
11007166|NCT00732160|12184963|FG001|NOT COMPLETED|Overall Study||4
11007167|NCT00732160|12184964|FG002|NOT COMPLETED|Overall Study||3
11007168|NCT00732160|12184965|FG003|NOT COMPLETED|Overall Study||2
11007169|NCT00732199|12184977|FG000|STARTED|Overall Study||50
11007170|NCT00732199|12184978|FG001|STARTED|Overall Study||42
11007171|NCT00732199|12184977|FG000|COMPLETED|Overall Study||16
11007172|NCT00732199|12184978|FG001|COMPLETED|Overall Study||16
11007173|NCT00732199|12184977|FG000|NOT COMPLETED|Overall Study||34
11007174|NCT00732199|12184978|FG001|NOT COMPLETED|Overall Study||26
11007175|NCT00732225|12184992|FG000|STARTED|Overall Study|76 eyes of 71 patients|71
11007176|NCT00732225|12184993|FG001|STARTED|Overall Study|41 eyes of 40 patients|40
11007177|NCT00732225|12184994|FG002|STARTED|Overall Study|26 eyes of 26 patients|26
11007178|NCT00732225|12184995|FG003|STARTED|Overall Study|33 eyes of 33 patients|33
11007179|NCT00732225|12184996|FG004|STARTED|Overall Study|55 eyes of 54 patients|54
11007180|NCT00732225|12184992|FG000|COMPLETED|Overall Study|64 eyes of 60 patients|60
11007181|NCT00732225|12184993|FG001|COMPLETED|Overall Study|33 eyes of 32 patients|32
11007182|NCT00732225|12184994|FG002|COMPLETED|Overall Study|23 eyes of 23 patients|23
11007183|NCT00732225|12184995|FG003|COMPLETED|Overall Study|29 eyes of 29 patients|29
11007184|NCT00732225|12184996|FG004|COMPLETED|Overall Study|48 eyes of 48 patients|48
11007185|NCT00732225|12184992|FG000|NOT COMPLETED|Overall Study||11
11007186|NCT00732225|12184993|FG001|NOT COMPLETED|Overall Study||8
11007187|NCT00732225|12184994|FG002|NOT COMPLETED|Overall Study||3
11007188|NCT00732225|12184995|FG003|NOT COMPLETED|Overall Study||4
11007189|NCT00732225|12184996|FG004|NOT COMPLETED|Overall Study||6
11007190|NCT00732238|12185010|FG000|STARTED|Overall Study||33
11007191|NCT00732238|12185011|FG001|STARTED|Overall Study||28
11007192|NCT00732238|12185010|FG000|COMPLETED|Overall Study||28
11007193|NCT00732238|12185011|FG001|COMPLETED|Overall Study||27
11007194|NCT00732238|12185010|FG000|NOT COMPLETED|Overall Study||5
11007195|NCT00732238|12185011|FG001|NOT COMPLETED|Overall Study||1
11007196|NCT00732251|12185019|FG000|STARTED|Overall Study||8
11007197|NCT00732251|12185019|FG000|COMPLETED|Overall Study||1
11007198|NCT00732251|12185019|FG000|NOT COMPLETED|Overall Study||7
11007199|NCT00732303|12185023|FG000|STARTED|Overall Study||8
11007200|NCT00732303|12185023|FG000|COMPLETED|Overall Study||6
11007201|NCT00732303|12185023|FG000|NOT COMPLETED|Overall Study||2
11007202|NCT00732472|12185031|FG000|STARTED|Overall Study||9
11007203|NCT00732472|12185032|FG001|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
11007204|NCT00732472|12185033|FG002|STARTED|Overall Study||10
11007205|NCT00732472|12185034|FG003|STARTED|Overall Study||9
11007206|NCT00732472|12185031|FG000|COMPLETED|Overall Study||9
11007207|NCT00732472|12185032|FG001|COMPLETED|Overall Study||7
11007208|NCT00732472|12185033|FG002|COMPLETED|Overall Study||9
11007209|NCT00732472|12185034|FG003|COMPLETED|Overall Study||6
11007210|NCT00732472|12185031|FG000|NOT COMPLETED|Overall Study||0
11007211|NCT00732472|12185032|FG001|NOT COMPLETED|Overall Study||3
11007212|NCT00732472|12185033|FG002|NOT COMPLETED|Overall Study||1
11007213|NCT00732472|12185034|FG003|NOT COMPLETED|Overall Study||3
11007214|NCT00732498|12185045|FG000|STARTED|Overall Study||28
11007215|NCT00732498|12185045|FG000|COMPLETED|Overall Study||22
11007216|NCT00732498|12185045|FG000|NOT COMPLETED|Overall Study||6
11007217|NCT00732615|12185051|FG000|STARTED|Overall Study||40
11007218|NCT00732615|12185052|FG001|STARTED|Overall Study||84
11007219|NCT00732615|12185051|FG000|COMPLETED|Overall Study||33
11007220|NCT00732615|12185052|FG001|COMPLETED|Overall Study||79
11007221|NCT00732615|12185051|FG000|NOT COMPLETED|Overall Study||7
11007222|NCT00732615|12185052|FG001|NOT COMPLETED|Overall Study||5
11007223|NCT00732641|12185061|FG000|STARTED|Overall Study||123
11007224|NCT00732641|12185062|FG001|STARTED|Overall Study||121
11007225|NCT00732641|12185061|FG000|COMPLETED|Overall Study||17
11007226|NCT00732641|12185062|FG001|COMPLETED|Overall Study||9
11007227|NCT00732641|12185061|FG000|NOT COMPLETED|Overall Study||106
11007228|NCT00732641|12185062|FG001|NOT COMPLETED|Overall Study||112
11007229|NCT00732654|12185071|FG000|STARTED|Overall Study||10
11007230|NCT00732654|12185072|FG001|STARTED|Overall Study||10
11007231|NCT00732654|12185073|FG002|STARTED|Overall Study||10
11007232|NCT00732654|12185071|FG000|COMPLETED|Overall Study||10
11007233|NCT00732654|12185072|FG001|COMPLETED|Overall Study||9
11007234|NCT00732654|12185073|FG002|COMPLETED|Overall Study||10
11007235|NCT00732654|12185071|FG000|NOT COMPLETED|Overall Study||0
11007236|NCT00732654|12185072|FG001|NOT COMPLETED|Overall Study||1
11007237|NCT00732654|12185073|FG002|NOT COMPLETED|Overall Study||0
11007238|NCT00732758|12185083|FG000|STARTED|Overall Study||78
11142506|NCT01468350|12329278|FG002|NOT COMPLETED|(PART B) Day 1, Day 15||0
11007239|NCT00732758|12185084|FG001|STARTED|Overall Study||79
11007240|NCT00732758|12185083|FG000|COMPLETED|Overall Study||70
11007241|NCT00732758|12185084|FG001|COMPLETED|Overall Study||63
11142507|NCT01468350|12329279|FG003|NOT COMPLETED|(PART B) Day 1, Day 15||0
11142508|NCT01468454|12329289|FG000|STARTED|Overall Study||128
11007242|NCT00732758|12185083|FG000|NOT COMPLETED|Overall Study||8
11007243|NCT00732758|12185084|FG001|NOT COMPLETED|Overall Study||16
11007244|NCT00732875|12185090|FG000|STARTED|Overall Study||92
11007245|NCT00732875|12185090|FG000|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
11007246|NCT00732875|12185090|FG000|NOT COMPLETED|Overall Study||35
11007247|NCT00732901|12185096|FG000|STARTED|Overall Study||11
11007248|NCT00732901|12185097|FG001|STARTED|Overall Study||12
11007249|NCT00732901|12185096|FG000|COMPLETED|Overall Study||11
11007250|NCT00732901|12185097|FG001|COMPLETED|Overall Study||12
11007251|NCT00732901|12185096|FG000|NOT COMPLETED|Overall Study||0
11007252|NCT00732901|12185097|FG001|NOT COMPLETED|Overall Study||0
11007253|NCT00732940|12185105|FG000|STARTED|Overall Study||28
11007254|NCT00732940|12185106|FG001|STARTED|Overall Study||28
11007255|NCT00732940|12185105|FG000|COMPLETED|Overall Study||26
11007256|NCT00732940|12185106|FG001|COMPLETED|Overall Study||25
11007257|NCT00732940|12185105|FG000|NOT COMPLETED|Overall Study||2
11007258|NCT00732940|12185106|FG001|NOT COMPLETED|Overall Study||3
11007259|NCT00732992|12185114|FG000|STARTED|Overall Study||6
11007260|NCT00732992|12185115|FG001|STARTED|Overall Study||6
11007261|NCT00732992|12185114|FG000|COMPLETED|Overall Study||0
11007262|NCT00732992|12185115|FG001|COMPLETED|Overall Study||0
11007263|NCT00732992|12185114|FG000|NOT COMPLETED|Overall Study||6
11007264|NCT00732992|12185115|FG001|NOT COMPLETED|Overall Study||6
11007265|NCT00733096|12185125|FG000|STARTED|Overall Study||28
11007266|NCT00733096|12185126|FG001|STARTED|Overall Study||26
11007267|NCT00733096|12185127|FG002|STARTED|Overall Study||30
11007268|NCT00733096|12185125|FG000|COMPLETED|Overall Study||28
11007269|NCT00733096|12185126|FG001|COMPLETED|Overall Study||26
11007270|NCT00733096|12185127|FG002|COMPLETED|Overall Study||30
11007271|NCT00733096|12185125|FG000|NOT COMPLETED|Overall Study||0
11007272|NCT00733096|12185126|FG001|NOT COMPLETED|Overall Study||0
11007273|NCT00733096|12185127|FG002|NOT COMPLETED|Overall Study||0
11007274|NCT00733135|12185135|FG000|STARTED|Overall Study||133
11007275|NCT00733135|12185135|FG000|COMPLETED|Overall Study||131
11007276|NCT00733135|12185135|FG000|NOT COMPLETED|Overall Study||2
11007277|NCT00733226|12185143|FG000|STARTED|Overall Study||40
11007278|NCT00733226|12185144|FG001|STARTED|Overall Study||40
11007279|NCT00733226|12185143|FG000|COMPLETED|Overall Study||35
11007280|NCT00733226|12185144|FG001|COMPLETED|Overall Study||40
11007281|NCT00733226|12185143|FG000|NOT COMPLETED|Overall Study||5
11007282|NCT00733226|12185144|FG001|NOT COMPLETED|Overall Study||0
11007283|NCT00733278|12185150|FG000|STARTED|Overall Study||7
11007284|NCT00733278|12185150|FG000|COMPLETED|Overall Study||7
11007285|NCT00733278|12185150|FG000|NOT COMPLETED|Overall Study||0
11007286|NCT00733291|12185157|FG000|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
11007287|NCT00733291|12185158|FG001|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
11007288|NCT00733291|12185159|FG002|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
11007289|NCT00733291|12185160|FG003|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
11007290|NCT00733291|12185157|FG000|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
11007291|NCT00733291|12185158|FG001|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
11007292|NCT00733291|12185159|FG002|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
11007293|NCT00733291|12185160|FG003|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
11007294|NCT00733291|12185157|FG000|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
11007295|NCT00733291|12185158|FG001|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
11007296|NCT00733291|12185159|FG002|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
11007297|NCT00733291|12185160|FG003|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
11007298|NCT00733291|12185157|FG000|STARTED|Washout Period, 3 Days (+/-1 Day)||13
11007299|NCT00733291|12185158|FG001|STARTED|Washout Period, 3 Days (+/-1 Day)||17
11007300|NCT00733291|12185159|FG002|STARTED|Washout Period, 3 Days (+/-1 Day)||17
11007301|NCT00733291|12185160|FG003|STARTED|Washout Period, 3 Days (+/-1 Day)||17
11007302|NCT00733291|12185157|FG000|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
11007303|NCT00733291|12185158|FG001|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
11007304|NCT00733291|12185159|FG002|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
11007305|NCT00733291|12185160|FG003|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
11007306|NCT00733291|12185157|FG000|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
11007307|NCT00733291|12185158|FG001|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
11007308|NCT00733291|12185159|FG002|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
11007309|NCT00733291|12185160|FG003|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
11007310|NCT00733291|12185157|FG000|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
11007311|NCT00733291|12185158|FG001|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
11007312|NCT00733291|12185159|FG002|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
11007313|NCT00733291|12185160|FG003|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
11007314|NCT00733291|12185157|FG000|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
11007315|NCT00733291|12185158|FG001|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
11007316|NCT00733291|12185159|FG002|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
11007317|NCT00733291|12185160|FG003|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
11007318|NCT00733291|12185157|FG000|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
11007319|NCT00733291|12185158|FG001|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
11007320|NCT00733291|12185159|FG002|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
11007321|NCT00733291|12185160|FG003|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
11007322|NCT00733304|12185174|FG000|STARTED|Overall Study||19
11007323|NCT00733304|12185175|FG001|STARTED|Overall Study||15
11007324|NCT00733304|12185176|FG002|STARTED|Overall Study||8
11007325|NCT00733304|12185174|FG000|COMPLETED|Overall Study||12
11007326|NCT00733304|12185175|FG001|COMPLETED|Overall Study||12
11007327|NCT00733304|12185176|FG002|COMPLETED|Overall Study||3
11007328|NCT00733304|12185174|FG000|NOT COMPLETED|Overall Study||7
11007329|NCT00733304|12185175|FG001|NOT COMPLETED|Overall Study||3
11007330|NCT00733304|12185176|FG002|NOT COMPLETED|Overall Study||5
11007331|NCT00733330|12185186|FG000|STARTED|Overall Study||32
11007332|NCT00733330|12185187|FG001|STARTED|Overall Study||52
11007333|NCT00733330|12185186|FG000|COMPLETED|Overall Study||30
11007334|NCT00733330|12185187|FG001|COMPLETED|Overall Study||48
11007335|NCT00733330|12185186|FG000|NOT COMPLETED|Overall Study||2
11007336|NCT00733330|12185187|FG001|NOT COMPLETED|Overall Study||4
11007337|NCT00733343|12185197|FG000|STARTED|Overall Study||666
11007338|NCT00733343|12185198|FG001|STARTED|Overall Study||659
11007339|NCT00733343|12185197|FG000|COMPLETED|Overall Study||583
11007340|NCT00733343|12185198|FG001|COMPLETED|Overall Study||578
11007341|NCT00733343|12185197|FG000|NOT COMPLETED|Overall Study||83
11007342|NCT00733343|12185198|FG001|NOT COMPLETED|Overall Study||81
11007343|NCT00733356|12185205|FG000|STARTED|Vyvanse Dose Titration||28
11007344|NCT00733356|12185205|FG000|COMPLETED|Vyvanse Dose Titration||26
11007345|NCT00733356|12185205|FG000|NOT COMPLETED|Vyvanse Dose Titration||2
11007346|NCT00733356|12185205|FG000|STARTED|Modified Lab School, Reading Evaluation||26
11007347|NCT00733356|12185205|FG000|COMPLETED|Modified Lab School, Reading Evaluation||26
11007348|NCT00733356|12185205|FG000|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
11007349|NCT00733369|12185211|FG000|STARTED|Overall Study||50
11007350|NCT00733369|12185212|FG001|STARTED|Overall Study||56
11007351|NCT00733369|12185211|FG000|COMPLETED|Overall Study||40
11007352|NCT00733369|12185212|FG001|COMPLETED|Overall Study||47
11007353|NCT00733369|12185211|FG000|NOT COMPLETED|Overall Study||10
11007354|NCT00733369|12185212|FG001|NOT COMPLETED|Overall Study||9
11007355|NCT00733408|12185218|FG000|STARTED|Overall Study||59
11007356|NCT00733408|12185218|FG000|COMPLETED|Overall Study||55
11007357|NCT00733408|12185218|FG000|NOT COMPLETED|Overall Study||4
11007358|NCT00733421|12185224|FG000|STARTED|Overall Study|November 2008|50
11007359|NCT00733421|12185225|FG001|STARTED|Overall Study|November 2008|50
11007360|NCT00733421|12185224|FG000|COMPLETED|Overall Study|All but one randomsied patient|49
11007361|NCT00733421|12185225|FG001|COMPLETED|Overall Study|All but one randomised patient|49
11007362|NCT00733421|12185224|FG000|NOT COMPLETED|Overall Study||1
11007363|NCT00733421|12185225|FG001|NOT COMPLETED|Overall Study||1
11007364|NCT00733499|12185233|FG000|STARTED|Pre-operative||102
11007365|NCT00733499|12185234|FG001|STARTED|Pre-operative|A death occurred prior to surgery which left a total of 102 participants|103
11007366|NCT00733499|12185233|FG000|COMPLETED|Pre-operative||102
11007367|NCT00733499|12185234|FG001|COMPLETED|Pre-operative||102
11007368|NCT00733499|12185233|FG000|NOT COMPLETED|Pre-operative||0
11007369|NCT00733499|12185234|FG001|NOT COMPLETED|Pre-operative||1
11007370|NCT00733499|12185233|FG000|STARTED|3 Months Follow-up||102
11007371|NCT00733499|12185234|FG001|STARTED|3 Months Follow-up||102
11007372|NCT00733499|12185233|FG000|COMPLETED|3 Months Follow-up||101
11007373|NCT00733499|12185234|FG001|COMPLETED|3 Months Follow-up||100
11007374|NCT00733499|12185233|FG000|NOT COMPLETED|3 Months Follow-up||1
11007375|NCT00733499|12185234|FG001|NOT COMPLETED|3 Months Follow-up||2
11007376|NCT00733499|12185233|FG000|STARTED|6 Months Follow-up||101
11007377|NCT00733499|12185234|FG001|STARTED|6 Months Follow-up||100
11007378|NCT00733499|12185233|FG000|COMPLETED|6 Months Follow-up||101
11007379|NCT00733499|12185234|FG001|COMPLETED|6 Months Follow-up||97
11007380|NCT00733499|12185233|FG000|NOT COMPLETED|6 Months Follow-up||0
11007381|NCT00733499|12185234|FG001|NOT COMPLETED|6 Months Follow-up||3
11007382|NCT00733499|12185233|FG000|STARTED|12 Months Follow-up||101
11007383|NCT00733499|12185234|FG001|STARTED|12 Months Follow-up||97
11007384|NCT00733499|12185233|FG000|COMPLETED|12 Months Follow-up||99
11007385|NCT00733499|12185234|FG001|COMPLETED|12 Months Follow-up||96
11007386|NCT00733499|12185233|FG000|NOT COMPLETED|12 Months Follow-up||2
11007387|NCT00733499|12185234|FG001|NOT COMPLETED|12 Months Follow-up||1
11007388|NCT00733499|12185233|FG000|STARTED|24 Months Follow-up||99
11007389|NCT00733499|12185234|FG001|STARTED|24 Months Follow-up||96
11007390|NCT00733499|12185233|FG000|COMPLETED|24 Months Follow-up||99
11007391|NCT00733499|12185234|FG001|COMPLETED|24 Months Follow-up||95
11007392|NCT00733499|12185233|FG000|NOT COMPLETED|24 Months Follow-up||0
11007393|NCT00733499|12185234|FG001|NOT COMPLETED|24 Months Follow-up||1
11007394|NCT00733499|12185233|FG000|STARTED|5 Year Followup||91
11007395|NCT00733499|12185234|FG001|STARTED|5 Year Followup||78
11007396|NCT00733499|12185233|FG000|COMPLETED|5 Year Followup||70
11007397|NCT00733499|12185234|FG001|COMPLETED|5 Year Followup||53
11007398|NCT00733499|12185233|FG000|NOT COMPLETED|5 Year Followup||21
11007399|NCT00733499|12185234|FG001|NOT COMPLETED|5 Year Followup||25
11007400|NCT00733499|12185233|FG000|STARTED|10 Year Followup||46
11007401|NCT00733499|12185234|FG001|STARTED|10 Year Followup||32
11007402|NCT00733499|12185233|FG000|COMPLETED|10 Year Followup||26
11007403|NCT00733499|12185234|FG001|COMPLETED|10 Year Followup||13
11007404|NCT00733499|12185233|FG000|NOT COMPLETED|10 Year Followup||20
11007405|NCT00733499|12185234|FG001|NOT COMPLETED|10 Year Followup||19
11007406|NCT00733512|12185240|FG000|STARTED|Overall Study||146
11007407|NCT00733512|12185240|FG000|COMPLETED|Overall Study||146
11007408|NCT00733512|12185240|FG000|NOT COMPLETED|Overall Study||0
11007409|NCT00733746|12185244|FG000|STARTED|Overall Study||119
11007410|NCT00733746|12185244|FG000|COMPLETED|Overall Study||114
11007411|NCT00733746|12185244|FG000|NOT COMPLETED|Overall Study||5
11007412|NCT00733824|12185253|FG000|STARTED|Phase I||10
11007413|NCT00733824|12185254|FG001|STARTED|Phase I||3
11007414|NCT00733824|12185255|FG002|STARTED|Phase I||6
11007415|NCT00733824|12185256|FG003|STARTED|Phase I||6
11007416|NCT00733824|12185257|FG004|STARTED|Phase I||0
11007417|NCT00733824|12185253|FG000|COMPLETED|Phase I||9
11007418|NCT00733824|12185254|FG001|COMPLETED|Phase I||3
11007419|NCT00733824|12185255|FG002|COMPLETED|Phase I||6
11007420|NCT00733824|12185256|FG003|COMPLETED|Phase I||6
11007421|NCT00733824|12185257|FG004|COMPLETED|Phase I||0
11007422|NCT00733824|12185253|FG000|NOT COMPLETED|Phase I||1
11007423|NCT00733824|12185254|FG001|NOT COMPLETED|Phase I||0
11007424|NCT00733824|12185255|FG002|NOT COMPLETED|Phase I||0
11007425|NCT00733824|12185256|FG003|NOT COMPLETED|Phase I||0
11007426|NCT00733824|12185257|FG004|NOT COMPLETED|Phase I||0
11007427|NCT00733824|12185253|FG000|STARTED|Phase II||0
11007428|NCT00733824|12185254|FG001|STARTED|Phase II||0
11007429|NCT00733824|12185255|FG002|STARTED|Phase II||0
11007430|NCT00733824|12185256|FG003|STARTED|Phase II||0
11007431|NCT00733824|12185257|FG004|STARTED|Phase II||36
11007432|NCT00733824|12185253|FG000|COMPLETED|Phase II||0
11007433|NCT00733824|12185254|FG001|COMPLETED|Phase II||0
11007434|NCT00733824|12185255|FG002|COMPLETED|Phase II||0
11007435|NCT00733824|12185256|FG003|COMPLETED|Phase II||0
11007436|NCT00733824|12185257|FG004|COMPLETED|Phase II||36
11007437|NCT00733824|12185253|FG000|NOT COMPLETED|Phase II||0
11396189|NCT03719677|12590049|FG000|COMPLETED|Overall Study||7
11396190|NCT03719677|12590049|FG000|NOT COMPLETED|Overall Study||0
11007438|NCT00733824|12185254|FG001|NOT COMPLETED|Phase II||0
11007439|NCT00733824|12185255|FG002|NOT COMPLETED|Phase II||0
11007440|NCT00733824|12185256|FG003|NOT COMPLETED|Phase II||0
11007441|NCT00733824|12185257|FG004|NOT COMPLETED|Phase II||0
11007442|NCT00733902|12185275|FG000|STARTED|Overall Study||174
11007443|NCT00733902|12185276|FG001|STARTED|Overall Study||174
11007444|NCT00733902|12185277|FG002|STARTED|Overall Study||174
11007445|NCT00733902|12185278|FG003|STARTED|Overall Study||175
11007446|NCT00733902|12185275|FG000|Treated|Overall Study||172
11007447|NCT00733902|12185276|FG001|Treated|Overall Study||172
11007448|NCT00733902|12185277|FG002|Treated|Overall Study||172
11007449|NCT00733902|12185278|FG003|Treated|Overall Study||174
11007450|NCT00733902|12185275|FG000|COMPLETED|Overall Study||10
11007451|NCT00733902|12185276|FG001|COMPLETED|Overall Study||12
11007452|NCT00733902|12185277|FG002|COMPLETED|Overall Study||13
11007453|NCT00733902|12185278|FG003|COMPLETED|Overall Study||11
11007454|NCT00733902|12185275|FG000|NOT COMPLETED|Overall Study||164
11007455|NCT00733902|12185276|FG001|NOT COMPLETED|Overall Study||162
11007456|NCT00733902|12185277|FG002|NOT COMPLETED|Overall Study||161
11007457|NCT00733902|12185278|FG003|NOT COMPLETED|Overall Study||164
11007458|NCT00733980|12185290|FG000|STARTED|Overall Study||74
11007459|NCT00733980|12185291|FG001|STARTED|Overall Study||76
11007460|NCT00733980|12185290|FG000|COMPLETED|Overall Study||52
11007461|NCT00733980|12185291|FG001|COMPLETED|Overall Study||55
11007462|NCT00733980|12185290|FG000|NOT COMPLETED|Overall Study||22
11007463|NCT00733980|12185291|FG001|NOT COMPLETED|Overall Study||21
11007464|NCT00733993|12185300|FG000|STARTED|Overall Study||13
11007465|NCT00733993|12185301|FG001|STARTED|Overall Study||10
11007466|NCT00733993|12185300|FG000|COMPLETED|Overall Study||13
11007467|NCT00733993|12185301|FG001|COMPLETED|Overall Study||10
11007468|NCT00733993|12185300|FG000|NOT COMPLETED|Overall Study||0
11007469|NCT00733993|12185301|FG001|NOT COMPLETED|Overall Study||0
11007470|NCT00734032|12185316|FG000|STARTED|Overall Study||25
11007471|NCT00734032|12185317|FG001|STARTED|Overall Study||28
11007472|NCT00734032|12185318|FG002|STARTED|Overall Study||28
11007473|NCT00734032|12185319|FG003|STARTED|Overall Study||26
11007474|NCT00734032|12185316|FG000|COMPLETED|Overall Study||25
11007475|NCT00734032|12185317|FG001|COMPLETED|Overall Study||27
11007476|NCT00734032|12185318|FG002|COMPLETED|Overall Study||28
11007477|NCT00734032|12185319|FG003|COMPLETED|Overall Study||26
11007478|NCT00734032|12185316|FG000|NOT COMPLETED|Overall Study||0
11007479|NCT00734032|12185317|FG001|NOT COMPLETED|Overall Study||1
11007480|NCT00734032|12185318|FG002|NOT COMPLETED|Overall Study||0
11007481|NCT00734032|12185319|FG003|NOT COMPLETED|Overall Study||0
11007482|NCT00734071|12185331|FG000|STARTED|Overall Study||152
11007483|NCT00734071|12185332|FG001|STARTED|Overall Study||152
11007484|NCT00734071|12185331|FG000|Treated|Overall Study||151
11007485|NCT00734071|12185332|FG001|Treated|Overall Study||148
11007486|NCT00734071|12185331|FG000|COMPLETED|Overall Study||114
11007487|NCT00734071|12185332|FG001|COMPLETED|Overall Study||125
11007488|NCT00734071|12185331|FG000|NOT COMPLETED|Overall Study||38
11007489|NCT00734071|12185332|FG001|NOT COMPLETED|Overall Study||27
11007490|NCT00734097|12185338|FG000|STARTED|Screening||337
11007491|NCT00734097|12185338|FG000|COMPLETED|Screening|20 participants were screening failure.|317
11007492|NCT00734097|12185338|FG000|NOT COMPLETED|Screening||20
11007493|NCT00734097|12185338|FG000|STARTED|Open Label|Full analysis performed in 311|317
11007494|NCT00734097|12185338|FG000|Safety Analysis|Open Label||317
11007495|NCT00734097|12185338|FG000|Full Analysis|Open Label||311
11007496|NCT00734097|12185338|FG000|Per Protocol|Open Label||301
11396191|NCT03719885|12590053|FG000|STARTED|Overall Study||55
11396192|NCT03719885|12590053|FG000|COMPLETED|Overall Study||35
11007497|NCT00734097|12185338|FG000|COMPLETED|Open Label|16 patients discontinued after randomization|301
11007498|NCT00734097|12185338|FG000|NOT COMPLETED|Open Label||16
11007499|NCT00734149|12185342|FG000|STARTED|Overall Study||45
11007500|NCT00734149|12185342|FG000|COMPLETED|Overall Study||44
11007501|NCT00734149|12185342|FG000|NOT COMPLETED|Overall Study||1
11007502|NCT00734162|12185352|FG000|STARTED|Randomized Phase (Through Week 72)||10
11007503|NCT00734162|12185353|FG001|STARTED|Randomized Phase (Through Week 72)||42
11007504|NCT00734162|12185354|FG002|STARTED|Randomized Phase (Through Week 72)||13
11396193|NCT03719885|12590053|FG000|NOT COMPLETED|Overall Study||20
11396194|NCT03720119|12590059|FG000|STARTED|Overall Study||78
11396195|NCT03720119|12590059|FG000|COMPLETED|Overall Study||69
11007505|NCT00734162|12185355|FG003|STARTED|Randomized Phase (Through Week 72)||41
11007506|NCT00734162|12185352|FG000|COMPLETED|Randomized Phase (Through Week 72)||10
11007507|NCT00734162|12185353|FG001|COMPLETED|Randomized Phase (Through Week 72)||41
11007508|NCT00734162|12185354|FG002|COMPLETED|Randomized Phase (Through Week 72)||13
11007509|NCT00734162|12185355|FG003|COMPLETED|Randomized Phase (Through Week 72)||37
11007510|NCT00734162|12185352|FG000|NOT COMPLETED|Randomized Phase (Through Week 72)||0
11007511|NCT00734162|12185353|FG001|NOT COMPLETED|Randomized Phase (Through Week 72)||1
11007512|NCT00734162|12185354|FG002|NOT COMPLETED|Randomized Phase (Through Week 72)||0
11007513|NCT00734162|12185355|FG003|NOT COMPLETED|Randomized Phase (Through Week 72)||4
11007514|NCT00734162|12185352|FG000|STARTED|Open-Label Phase||10
11007515|NCT00734162|12185353|FG001|STARTED|Open-Label Phase||41
11007516|NCT00734162|12185354|FG002|STARTED|Open-Label Phase||13
11007517|NCT00734162|12185355|FG003|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
11007518|NCT00734162|12185352|FG000|COMPLETED|Open-Label Phase||7
11007519|NCT00734162|12185353|FG001|COMPLETED|Open-Label Phase||39
11007520|NCT00734162|12185354|FG002|COMPLETED|Open-Label Phase||12
11007521|NCT00734162|12185355|FG003|COMPLETED|Open-Label Phase||36
11007522|NCT00734162|12185352|FG000|NOT COMPLETED|Open-Label Phase||3
11007523|NCT00734162|12185353|FG001|NOT COMPLETED|Open-Label Phase||2
11007524|NCT00734162|12185354|FG002|NOT COMPLETED|Open-Label Phase||1
11007525|NCT00734162|12185355|FG003|NOT COMPLETED|Open-Label Phase||3
11007526|NCT00734214|12185371|FG000|STARTED|Overall Study||128
11007527|NCT00734214|12185372|FG001|STARTED|Overall Study||130
11007528|NCT00734214|12185371|FG000|COMPLETED|Overall Study||124
11007529|NCT00734214|12185372|FG001|COMPLETED|Overall Study||126
11007530|NCT00734214|12185371|FG000|NOT COMPLETED|Overall Study||4
11007531|NCT00734214|12185372|FG001|NOT COMPLETED|Overall Study||4
11007532|NCT00734305|12185380|FG000|STARTED|Overall Study||7
11007533|NCT00734305|12185381|FG001|STARTED|Overall Study||3
11007534|NCT00734305|12185382|FG002|STARTED|Overall Study||4
11007535|NCT00734305|12185383|FG003|STARTED|Overall Study||3
11007536|NCT00734305|12185384|FG004|STARTED|Overall Study||5
11007537|NCT00734305|12185385|FG005|STARTED|Overall Study||4
11007538|NCT00734305|12185386|FG006|STARTED|Overall Study||18
11007539|NCT00734305|12185380|FG000|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
11007540|NCT00734305|12185381|FG001|COMPLETED|Overall Study||3
11007541|NCT00734305|12185382|FG002|COMPLETED|Overall Study||4
11007542|NCT00734305|12185383|FG003|COMPLETED|Overall Study||3
11007543|NCT00734305|12185384|FG004|COMPLETED|Overall Study||5
11007544|NCT00734305|12185385|FG005|COMPLETED|Overall Study||4
11007545|NCT00734305|12185386|FG006|COMPLETED|Overall Study||18
11007546|NCT00734305|12185380|FG000|NOT COMPLETED|Overall Study||1
11007547|NCT00734305|12185381|FG001|NOT COMPLETED|Overall Study||0
11007548|NCT00734305|12185382|FG002|NOT COMPLETED|Overall Study||0
11007549|NCT00734305|12185383|FG003|NOT COMPLETED|Overall Study||0
11007550|NCT00734305|12185384|FG004|NOT COMPLETED|Overall Study||0
11007551|NCT00734305|12185385|FG005|NOT COMPLETED|Overall Study||0
11007552|NCT00734305|12185386|FG006|NOT COMPLETED|Overall Study||0
11007553|NCT00734344|12185406|FG000|STARTED|Overall Study||9
11007554|NCT00734344|12185407|FG001|STARTED|Overall Study||9
11007555|NCT00734344|12185406|FG000|COMPLETED|Overall Study||9
11007556|NCT00734344|12185407|FG001|COMPLETED|Overall Study||9
11007557|NCT00734344|12185406|FG000|NOT COMPLETED|Overall Study||0
11007558|NCT00734344|12185407|FG001|NOT COMPLETED|Overall Study||0
11007559|NCT00734409|12185417|FG000|STARTED|Overall Study||155
11007560|NCT00734409|12185418|FG001|STARTED|Overall Study||145
11007561|NCT00734409|12185417|FG000|COMPLETED|Overall Study||155
11007562|NCT00734409|12185418|FG001|COMPLETED|Overall Study||145
11007563|NCT00734409|12185417|FG000|NOT COMPLETED|Overall Study||0
11007564|NCT00734409|12185418|FG001|NOT COMPLETED|Overall Study||0
11007565|NCT00734474|12185433|FG000|STARTED|Overall Study||15
11007566|NCT00734474|12185434|FG001|STARTED|Overall Study||30
11007567|NCT00734474|12185435|FG002|STARTED|Overall Study||304
11007568|NCT00734474|12185436|FG003|STARTED|Overall Study||10
11007569|NCT00734474|12185437|FG004|STARTED|Overall Study||302
11007570|NCT00734474|12185438|FG005|STARTED|Overall Study||25
11007571|NCT00734474|12185439|FG006|STARTED|Overall Study||24
11007572|NCT00734474|12185440|FG007|STARTED|Overall Study||315
11007573|NCT00734474|12185441|FG008|STARTED|Overall Study||177
11007574|NCT00734474|12185433|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
11007575|NCT00734474|12185434|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30
11007576|NCT00734474|12185435|FG002|Received at Least 1 Dose of Study Drug|Overall Study||304
11007577|NCT00734474|12185436|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
11007578|NCT00734474|12185437|FG004|Received at Least 1 Dose of Study Drug|Overall Study||302
11007579|NCT00734474|12185438|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
11007580|NCT00734474|12185439|FG006|Received at Least 1 Dose of Study Drug|Overall Study||24
11007581|NCT00734474|12185440|FG007|Received at Least 1 Dose of Study Drug|Overall Study||315
11007582|NCT00734474|12185441|FG008|Received at Least 1 Dose of Study Drug|Overall Study||177
11007583|NCT00734474|12185433|FG000|Entered Study Before Dose Decision Point|Overall Study||15
11007584|NCT00734474|12185434|FG001|Entered Study Before Dose Decision Point|Overall Study||30
11007585|NCT00734474|12185435|FG002|Entered Study Before Dose Decision Point|Overall Study||25
11007586|NCT00734474|12185436|FG003|Entered Study Before Dose Decision Point|Overall Study||10
11007587|NCT00734474|12185437|FG004|Entered Study Before Dose Decision Point|Overall Study||21
11007588|NCT00734474|12185438|FG005|Entered Study Before Dose Decision Point|Overall Study||25
11396196|NCT03720119|12590059|FG000|NOT COMPLETED|Overall Study||9
11007589|NCT00734474|12185439|FG006|Entered Study Before Dose Decision Point|Overall Study||24
11007590|NCT00734474|12185440|FG007|Entered Study Before Dose Decision Point|Overall Study||42
11007591|NCT00734474|12185441|FG008|Entered Study Before Dose Decision Point|Overall Study||38
11007592|NCT00734474|12185433|FG000|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
11007593|NCT00734474|12185434|FG001|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
11007594|NCT00734474|12185435|FG002|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
11007595|NCT00734474|12185436|FG003|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
11007596|NCT00734474|12185437|FG004|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
11007597|NCT00734474|12185438|FG005|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
11007598|NCT00734474|12185439|FG006|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
11007599|NCT00734474|12185440|FG007|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
11007600|NCT00734474|12185441|FG008|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
11007601|NCT00734474|12185433|FG000|Entered Study After Dose Decision Point|Overall Study||0
11007602|NCT00734474|12185434|FG001|Entered Study After Dose Decision Point|Overall Study||0
11007603|NCT00734474|12185435|FG002|Entered Study After Dose Decision Point|Overall Study||279
11007604|NCT00734474|12185436|FG003|Entered Study After Dose Decision Point|Overall Study||0
11007605|NCT00734474|12185437|FG004|Entered Study After Dose Decision Point|Overall Study||281
11007606|NCT00734474|12185438|FG005|Entered Study After Dose Decision Point|Overall Study||0
11007607|NCT00734474|12185439|FG006|Entered Study After Dose Decision Point|Overall Study||0
11007608|NCT00734474|12185440|FG007|Entered Study After Dose Decision Point|Overall Study||273
11007609|NCT00734474|12185441|FG008|Entered Study After Dose Decision Point|Overall Study||139
11007610|NCT00734474|12185433|FG000|Completed 26-Week Visit|Overall Study||0
11007611|NCT00734474|12185434|FG001|Completed 26-Week Visit|Overall Study||0
11007612|NCT00734474|12185435|FG002|Completed 26-Week Visit|Overall Study||258
11007613|NCT00734474|12185436|FG003|Completed 26-Week Visit|Overall Study||2
11007614|NCT00734474|12185437|FG004|Completed 26-Week Visit|Overall Study||268
11007615|NCT00734474|12185438|FG005|Completed 26-Week Visit|Overall Study||2
11007616|NCT00734474|12185439|FG006|Completed 26-Week Visit|Overall Study||2
11007617|NCT00734474|12185440|FG007|Completed 26-Week Visit|Overall Study||270
11007618|NCT00734474|12185441|FG008|Completed 26-Week Visit|Overall Study||124
11007619|NCT00734474|12185433|FG000|Completed 52-Week Visit|Overall Study||0
11007620|NCT00734474|12185434|FG001|Completed 52-Week Visit|Overall Study||0
11007621|NCT00734474|12185435|FG002|Completed 52-Week Visit|Overall Study||238
11007622|NCT00734474|12185436|FG003|Completed 52-Week Visit|Overall Study||0
11007623|NCT00734474|12185437|FG004|Completed 52-Week Visit|Overall Study||243
11007624|NCT00734474|12185438|FG005|Completed 52-Week Visit|Overall Study||0
11007625|NCT00734474|12185439|FG006|Completed 52-Week Visit|Overall Study||0
11007626|NCT00734474|12185440|FG007|Completed 52-Week Visit|Overall Study||238
11007627|NCT00734474|12185441|FG008|Completed 52-Week Visit|Overall Study||112
11396197|NCT03720470|12590067|FG000|STARTED|Treatment Period: First Part 16 Weeks||131
11396198|NCT03720470|12590068|FG001|STARTED|Treatment Period: First Part 16 Weeks||0
11396199|NCT03720470|12590069|FG002|STARTED|Treatment Period: First Part 16 Weeks||0
11142509|NCT01468454|12329289|FG000|PETs Completed|Overall Study||128
11007628|NCT00734474|12185433|FG000|COMPLETED|Overall Study||0
11007629|NCT00734474|12185434|FG001|COMPLETED|Overall Study||0
11142510|NCT01468454|12329289|FG000|Had Both PET and Surgery|Overall Study||119
11142511|NCT01468454|12329289|FG000|COMPLETED|Overall Study||119
11142512|NCT01468454|12329289|FG000|NOT COMPLETED|Overall Study||9
11396200|NCT03720470|12590070|FG003|STARTED|Treatment Period: First Part 16 Weeks||238
11396201|NCT03720470|12590071|FG004|STARTED|Treatment Period: First Part 16 Weeks||226
11396202|NCT03720470|12590072|FG005|STARTED|Treatment Period: First Part 16 Weeks||243
11396203|NCT03720470|12590067|FG000|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||131
11396204|NCT03720470|12590068|FG001|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
11396205|NCT03720470|12590069|FG002|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
11396206|NCT03720470|12590070|FG003|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||238
11007630|NCT00734474|12185435|FG002|COMPLETED|Overall Study||192
11007631|NCT00734474|12185436|FG003|COMPLETED|Overall Study||0
11007632|NCT00734474|12185437|FG004|COMPLETED|Overall Study||184
11007633|NCT00734474|12185438|FG005|COMPLETED|Overall Study||0
11007634|NCT00734474|12185439|FG006|COMPLETED|Overall Study||0
11007635|NCT00734474|12185440|FG007|COMPLETED|Overall Study||186
11007636|NCT00734474|12185441|FG008|COMPLETED|Overall Study||95
11007637|NCT00734474|12185433|FG000|NOT COMPLETED|Overall Study||15
11396207|NCT03720470|12590071|FG004|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||226
11396208|NCT03720470|12590072|FG005|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||242
11007638|NCT00734474|12185434|FG001|NOT COMPLETED|Overall Study||30
11007639|NCT00734474|12185435|FG002|NOT COMPLETED|Overall Study||112
11007640|NCT00734474|12185436|FG003|NOT COMPLETED|Overall Study||10
11007641|NCT00734474|12185437|FG004|NOT COMPLETED|Overall Study||118
11007642|NCT00734474|12185438|FG005|NOT COMPLETED|Overall Study||25
11007643|NCT00734474|12185439|FG006|NOT COMPLETED|Overall Study||24
11007644|NCT00734474|12185440|FG007|NOT COMPLETED|Overall Study||129
11007645|NCT00734474|12185441|FG008|NOT COMPLETED|Overall Study||82
11007646|NCT00734500|12185467|FG000|STARTED|Overall Study||15
11007647|NCT00734500|12185467|FG000|COMPLETED|Overall Study||14
11007648|NCT00734500|12185467|FG000|NOT COMPLETED|Overall Study||1
11007649|NCT00734539|12185473|FG000|STARTED|Main Study||189
11007650|NCT00734539|12185474|FG001|STARTED|Main Study||173
11007651|NCT00734539|12185473|FG000|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
11007652|NCT00734539|12185474|FG001|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
11007653|NCT00734539|12185473|FG000|NOT COMPLETED|Main Study||37
11007654|NCT00734539|12185474|FG001|NOT COMPLETED|Main Study||35
11007655|NCT00734539|12185473|FG000|STARTED|Long Term Follow up||152
11007656|NCT00734539|12185474|FG001|STARTED|Long Term Follow up||138
11007657|NCT00734539|12185473|FG000|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
11007658|NCT00734539|12185474|FG001|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
11007659|NCT00734539|12185473|FG000|NOT COMPLETED|Long Term Follow up||34
11007660|NCT00734539|12185474|FG001|NOT COMPLETED|Long Term Follow up||31
11007661|NCT00734578|12185486|FG000|STARTED|Overall Study||154
11007662|NCT00734578|12185487|FG001|STARTED|Overall Study||153
11007663|NCT00734578|12185488|FG002|STARTED|Overall Study||154
11007664|NCT00734578|12185486|FG000|COMPLETED|Overall Study||121
11007665|NCT00734578|12185487|FG001|COMPLETED|Overall Study||128
11007666|NCT00734578|12185488|FG002|COMPLETED|Overall Study||129
11007667|NCT00734578|12185486|FG000|NOT COMPLETED|Overall Study||33
11007668|NCT00734578|12185487|FG001|NOT COMPLETED|Overall Study||25
11007669|NCT00734578|12185488|FG002|NOT COMPLETED|Overall Study||25
11007670|NCT00734591|12185498|FG000|STARTED|Retrospective Period||3875
11007671|NCT00734591|12185499|FG001|STARTED|Retrospective Period||3564
11007672|NCT00734591|12185498|FG000|COMPLETED|Retrospective Period||3875
11007673|NCT00734591|12185499|FG001|COMPLETED|Retrospective Period||3564
11007674|NCT00734591|12185498|FG000|NOT COMPLETED|Retrospective Period||0
11007675|NCT00734591|12185499|FG001|NOT COMPLETED|Retrospective Period||0
11007676|NCT00734591|12185498|FG000|STARTED|Screening for Prospective Period||3875
11007677|NCT00734591|12185499|FG001|STARTED|Screening for Prospective Period||3564
11007678|NCT00734591|12185498|FG000|COMPLETED|Screening for Prospective Period||1358
11007679|NCT00734591|12185499|FG001|COMPLETED|Screening for Prospective Period||1273
11007680|NCT00734591|12185498|FG000|NOT COMPLETED|Screening for Prospective Period||2517
11007681|NCT00734591|12185499|FG001|NOT COMPLETED|Screening for Prospective Period||2291
11007682|NCT00734591|12185498|FG000|STARTED|Prospective Period||1358
11007683|NCT00734591|12185499|FG001|STARTED|Prospective Period||1273
11007684|NCT00734591|12185498|FG000|COMPLETED|Prospective Period||1307
11007685|NCT00734591|12185499|FG001|COMPLETED|Prospective Period||1229
11007686|NCT00734591|12185498|FG000|NOT COMPLETED|Prospective Period||51
11007687|NCT00734591|12185499|FG001|NOT COMPLETED|Prospective Period||44
11007688|NCT00734604|12185511|FG000|STARTED|Overall Study||62
11007689|NCT00734604|12185512|FG001|STARTED|Overall Study||63
11007690|NCT00734604|12185513|FG002|STARTED|Overall Study||63
11007691|NCT00734604|12185514|FG003|STARTED|Overall Study||63
11007692|NCT00734604|12185515|FG004|STARTED|Overall Study||63
11007693|NCT00734604|12185516|FG005|STARTED|Overall Study||64
11007694|NCT00734604|12185511|FG000|COMPLETED|Overall Study||59
11007695|NCT00734604|12185512|FG001|COMPLETED|Overall Study||51
11007696|NCT00734604|12185513|FG002|COMPLETED|Overall Study||57
11007697|NCT00734604|12185514|FG003|COMPLETED|Overall Study||54
11007698|NCT00734604|12185515|FG004|COMPLETED|Overall Study||55
11007699|NCT00734604|12185516|FG005|COMPLETED|Overall Study||58
11007700|NCT00734604|12185511|FG000|NOT COMPLETED|Overall Study||3
11007701|NCT00734604|12185512|FG001|NOT COMPLETED|Overall Study||12
11007702|NCT00734604|12185513|FG002|NOT COMPLETED|Overall Study||6
11007703|NCT00734604|12185514|FG003|NOT COMPLETED|Overall Study||9
11007704|NCT00734604|12185515|FG004|NOT COMPLETED|Overall Study||8
11007705|NCT00734604|12185516|FG005|NOT COMPLETED|Overall Study||6
11007706|NCT00734617|12185529|FG000|STARTED|Overall Study||249
11007707|NCT00734617|12185530|FG001|STARTED|Overall Study||230
11007708|NCT00734617|12185529|FG000|COMPLETED|Overall Study||142
11007709|NCT00734617|12185530|FG001|COMPLETED|Overall Study||128
11007710|NCT00734617|12185529|FG000|NOT COMPLETED|Overall Study||107
11007711|NCT00734617|12185530|FG001|NOT COMPLETED|Overall Study||102
11007712|NCT00734630|12185538|FG000|STARTED|Overall Study||258
11007713|NCT00734630|12185539|FG001|STARTED|Overall Study||233
11007714|NCT00734630|12185538|FG000|COMPLETED|Overall Study||229
11007715|NCT00734630|12185539|FG001|COMPLETED|Overall Study||200
11007716|NCT00734630|12185538|FG000|NOT COMPLETED|Overall Study||29
11007717|NCT00734630|12185539|FG001|NOT COMPLETED|Overall Study||33
11007718|NCT00734656|12185545|FG000|STARTED|Lab Session 1||24
11396209|NCT03720470|12590067|FG000|Full Analysis Set|Treatment Period: First Part 16 Weeks||131
11007719|NCT00734656|12185546|FG001|STARTED|Lab Session 1||23
11007720|NCT00734656|12185547|FG002|STARTED|Lab Session 1||26
11007721|NCT00734656|12185548|FG003|STARTED|Lab Session 1||21
11007722|NCT00734656|12185545|FG000|COMPLETED|Lab Session 1||22
11007723|NCT00734656|12185546|FG001|COMPLETED|Lab Session 1||23
11007724|NCT00734656|12185547|FG002|COMPLETED|Lab Session 1||26
11007725|NCT00734656|12185548|FG003|COMPLETED|Lab Session 1||21
11007726|NCT00734656|12185545|FG000|NOT COMPLETED|Lab Session 1||2
11007727|NCT00734656|12185546|FG001|NOT COMPLETED|Lab Session 1||0
11007728|NCT00734656|12185547|FG002|NOT COMPLETED|Lab Session 1||0
11007729|NCT00734656|12185548|FG003|NOT COMPLETED|Lab Session 1||0
11007730|NCT00734656|12185545|FG000|STARTED|Washout 1||22
11007731|NCT00734656|12185546|FG001|STARTED|Washout 1||23
11007732|NCT00734656|12185547|FG002|STARTED|Washout 1||26
11396210|NCT03720470|12590068|FG001|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
11396211|NCT03720470|12590069|FG002|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
11396212|NCT03720470|12590070|FG003|Full Analysis Set|Treatment Period: First Part 16 Weeks||238
11396213|NCT03720470|12590071|FG004|Full Analysis Set|Treatment Period: First Part 16 Weeks||226
11007733|NCT00734656|12185548|FG003|STARTED|Washout 1||21
11007734|NCT00734656|12185545|FG000|COMPLETED|Washout 1||21
11007735|NCT00734656|12185546|FG001|COMPLETED|Washout 1||18
11007736|NCT00734656|12185547|FG002|COMPLETED|Washout 1||24
11007737|NCT00734656|12185548|FG003|COMPLETED|Washout 1||18
11396214|NCT03720470|12590072|FG005|Full Analysis Set|Treatment Period: First Part 16 Weeks||242
11396215|NCT03720470|12590067|FG000|COMPLETED|Treatment Period: First Part 16 Weeks||117
11396216|NCT03720470|12590068|FG001|COMPLETED|Treatment Period: First Part 16 Weeks||0
11396217|NCT03720470|12590069|FG002|COMPLETED|Treatment Period: First Part 16 Weeks||0
11396218|NCT03720470|12590070|FG003|COMPLETED|Treatment Period: First Part 16 Weeks||217
11007738|NCT00734656|12185545|FG000|NOT COMPLETED|Washout 1||1
11007739|NCT00734656|12185546|FG001|NOT COMPLETED|Washout 1||5
11007740|NCT00734656|12185547|FG002|NOT COMPLETED|Washout 1||2
11007741|NCT00734656|12185548|FG003|NOT COMPLETED|Washout 1||3
11007742|NCT00734656|12185545|FG000|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
11007743|NCT00734656|12185546|FG001|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
11007744|NCT00734656|12185547|FG002|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
11007745|NCT00734656|12185548|FG003|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
11007746|NCT00734656|12185545|FG000|COMPLETED|Lab Session 2||18
11007747|NCT00734656|12185546|FG001|COMPLETED|Lab Session 2||21
11007748|NCT00734656|12185547|FG002|COMPLETED|Lab Session 2||21
11007749|NCT00734656|12185548|FG003|COMPLETED|Lab Session 2||19
11007750|NCT00734656|12185545|FG000|NOT COMPLETED|Lab Session 2||1
11007751|NCT00734656|12185546|FG001|NOT COMPLETED|Lab Session 2||0
11007752|NCT00734656|12185547|FG002|NOT COMPLETED|Lab Session 2||0
11007753|NCT00734656|12185548|FG003|NOT COMPLETED|Lab Session 2||1
11007754|NCT00734656|12185545|FG000|STARTED|Washout 2||18
11007755|NCT00734656|12185546|FG001|STARTED|Washout 2||21
11007756|NCT00734656|12185547|FG002|STARTED|Washout 2||21
11007757|NCT00734656|12185548|FG003|STARTED|Washout 2||19
11007758|NCT00734656|12185545|FG000|COMPLETED|Washout 2||17
11007759|NCT00734656|12185546|FG001|COMPLETED|Washout 2||20
11007760|NCT00734656|12185547|FG002|COMPLETED|Washout 2||20
11007761|NCT00734656|12185548|FG003|COMPLETED|Washout 2||19
11007762|NCT00734656|12185545|FG000|NOT COMPLETED|Washout 2||1
11007763|NCT00734656|12185546|FG001|NOT COMPLETED|Washout 2||1
11007764|NCT00734656|12185547|FG002|NOT COMPLETED|Washout 2||1
11007765|NCT00734656|12185548|FG003|NOT COMPLETED|Washout 2||0
11007766|NCT00734656|12185545|FG000|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
11007767|NCT00734656|12185546|FG001|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
11007768|NCT00734656|12185547|FG002|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
11007769|NCT00734656|12185548|FG003|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
11007770|NCT00734656|12185545|FG000|COMPLETED|Lab Session 3||18
11396219|NCT03720470|12590071|FG004|COMPLETED|Treatment Period: First Part 16 Weeks||208
11396220|NCT03720470|12590072|FG005|COMPLETED|Treatment Period: First Part 16 Weeks||223
11396221|NCT03720470|12590067|FG000|NOT COMPLETED|Treatment Period: First Part 16 Weeks||14
11396222|NCT03720470|12590068|FG001|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
11396223|NCT03720470|12590069|FG002|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
11396224|NCT03720470|12590070|FG003|NOT COMPLETED|Treatment Period: First Part 16 Weeks||21
11396225|NCT03720470|12590071|FG004|NOT COMPLETED|Treatment Period: First Part 16 Weeks||18
11396226|NCT03720470|12590072|FG005|NOT COMPLETED|Treatment Period: First Part 16 Weeks||20
11007771|NCT00734656|12185546|FG001|COMPLETED|Lab Session 3||19
11007772|NCT00734656|12185547|FG002|COMPLETED|Lab Session 3||20
11007773|NCT00734656|12185548|FG003|COMPLETED|Lab Session 3||19
11007774|NCT00734656|12185545|FG000|NOT COMPLETED|Lab Session 3||0
11007775|NCT00734656|12185546|FG001|NOT COMPLETED|Lab Session 3||0
11007776|NCT00734656|12185547|FG002|NOT COMPLETED|Lab Session 3||0
11007777|NCT00734656|12185548|FG003|NOT COMPLETED|Lab Session 3||0
11007778|NCT00734656|12185545|FG000|STARTED|Washout 3||18
11007779|NCT00734656|12185546|FG001|STARTED|Washout 3||19
11007780|NCT00734656|12185547|FG002|STARTED|Washout 3||20
11007781|NCT00734656|12185548|FG003|STARTED|Washout 3||19
11007782|NCT00734656|12185545|FG000|COMPLETED|Washout 3||17
11007783|NCT00734656|12185546|FG001|COMPLETED|Washout 3||19
11007784|NCT00734656|12185547|FG002|COMPLETED|Washout 3||20
11007785|NCT00734656|12185548|FG003|COMPLETED|Washout 3||18
11007786|NCT00734656|12185545|FG000|NOT COMPLETED|Washout 3||1
11007787|NCT00734656|12185546|FG001|NOT COMPLETED|Washout 3||0
11007788|NCT00734656|12185547|FG002|NOT COMPLETED|Washout 3||0
11007789|NCT00734656|12185548|FG003|NOT COMPLETED|Washout 3||1
11007790|NCT00734656|12185545|FG000|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
11007791|NCT00734656|12185546|FG001|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
11007792|NCT00734656|12185547|FG002|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
11007793|NCT00734656|12185548|FG003|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
11007794|NCT00734656|12185545|FG000|COMPLETED|Lab Session 4||20
11007795|NCT00734656|12185546|FG001|COMPLETED|Lab Session 4||18
11007796|NCT00734656|12185547|FG002|COMPLETED|Lab Session 4||16
11007797|NCT00734656|12185548|FG003|COMPLETED|Lab Session 4||19
11007798|NCT00734656|12185545|FG000|NOT COMPLETED|Lab Session 4||0
11007799|NCT00734656|12185546|FG001|NOT COMPLETED|Lab Session 4||0
11007800|NCT00734656|12185547|FG002|NOT COMPLETED|Lab Session 4||0
11007801|NCT00734656|12185548|FG003|NOT COMPLETED|Lab Session 4||1
11007802|NCT00734734|12185558|FG000|STARTED|Overall Study||64
11007803|NCT00734734|12185558|FG000|COMPLETED|Overall Study||64
11007804|NCT00734734|12185558|FG000|NOT COMPLETED|Overall Study||0
11007805|NCT00734747|12185563|FG000|STARTED|SRS Procedure||72
11007806|NCT00734747|12185563|FG000|COMPLETED|SRS Procedure||69
11007807|NCT00734747|12185563|FG000|NOT COMPLETED|SRS Procedure||3
11007808|NCT00734747|12185563|FG000|STARTED|6 Month Follow-up||69
11007809|NCT00734747|12185563|FG000|COMPLETED|6 Month Follow-up||66
11007810|NCT00734747|12185563|FG000|NOT COMPLETED|6 Month Follow-up||3
11007811|NCT00734799|12185569|FG000|STARTED|Overall Study||9
11007812|NCT00734799|12185570|FG001|STARTED|Overall Study||13
11007813|NCT00734799|12185569|FG000|COMPLETED|Overall Study||9
11007814|NCT00734799|12185570|FG001|COMPLETED|Overall Study||9
11007815|NCT00734799|12185569|FG000|NOT COMPLETED|Overall Study||0
11007816|NCT00734799|12185570|FG001|NOT COMPLETED|Overall Study||4
11007817|NCT00734851|12185576|FG000|STARTED|Overall Study||34
11007818|NCT00734851|12185576|FG000|COMPLETED|Overall Study||13
11007819|NCT00734851|12185576|FG000|NOT COMPLETED|Overall Study||21
11007820|NCT00734903|12185582|FG000|STARTED|Overall Study||33
11007821|NCT00734903|12185583|FG001|STARTED|Overall Study||33
11007822|NCT00734903|12185582|FG000|Completed End of Treatment Assessment|Overall Study||21
11007823|NCT00734903|12185583|FG001|Completed End of Treatment Assessment|Overall Study||23
11007824|NCT00734903|12185582|FG000|Completed 3-month Followup|Overall Study||14
11007825|NCT00734903|12185583|FG001|Completed 3-month Followup|Overall Study||15
11007826|NCT00734903|12185582|FG000|COMPLETED|Overall Study||30
11007827|NCT00734903|12185583|FG001|COMPLETED|Overall Study||32
11007828|NCT00734903|12185582|FG000|NOT COMPLETED|Overall Study||3
11007829|NCT00734903|12185583|FG001|NOT COMPLETED|Overall Study||1
11007830|NCT00734929|12185591|FG000|STARTED|Overall Study||57
11007831|NCT00734929|12185592|FG001|STARTED|Overall Study||58
11007832|NCT00734929|12185591|FG000|COMPLETED|Overall Study||51
11007833|NCT00734929|12185592|FG001|COMPLETED|Overall Study||53
11007834|NCT00734929|12185591|FG000|NOT COMPLETED|Overall Study||6
11007835|NCT00734929|12185592|FG001|NOT COMPLETED|Overall Study||5
11007836|NCT00734968|12185602|FG000|STARTED|Overall Study||77
11007837|NCT00734968|12185603|FG001|STARTED|Overall Study||76
11007838|NCT00734968|12185602|FG000|COMPLETED|Overall Study||76
11007839|NCT00734968|12185603|FG001|COMPLETED|Overall Study||75
11007840|NCT00734968|12185602|FG000|NOT COMPLETED|Overall Study||1
11007841|NCT00734968|12185603|FG001|NOT COMPLETED|Overall Study||1
11007842|NCT00734994|12185609|FG000|STARTED|Overall Study||15
11007843|NCT00734994|12185609|FG000|COMPLETED|Overall Study||14
11007844|NCT00734994|12185609|FG000|NOT COMPLETED|Overall Study||1
11007845|NCT00735007|12185614|FG000|STARTED|Overall Study||106
11007846|NCT00735007|12185614|FG000|COMPLETED|Overall Study||101
11007847|NCT00735007|12185614|FG000|NOT COMPLETED|Overall Study||5
11007848|NCT00735072|12185620|FG000|STARTED|Overall Study||23
11007849|NCT00735072|12185621|FG001|STARTED|Overall Study||22
11007850|NCT00735072|12185620|FG000|COMPLETED|Overall Study||22
11007851|NCT00735072|12185621|FG001|COMPLETED|Overall Study||21
11007852|NCT00735072|12185620|FG000|NOT COMPLETED|Overall Study||1
11007853|NCT00735072|12185621|FG001|NOT COMPLETED|Overall Study||1
11007854|NCT00735306|12185629|FG000|STARTED|Overall Study||12
11007855|NCT00735306|12185629|FG000|COMPLETED|Overall Study||12
11007856|NCT00735306|12185629|FG000|NOT COMPLETED|Overall Study||0
11007857|NCT00735371|12185638|FG000|STARTED|Overall Study||78
11007858|NCT00735371|12185639|FG001|STARTED|Overall Study||79
11007859|NCT00735371|12185640|FG002|STARTED|Overall Study||78
11007860|NCT00735371|12185641|FG003|STARTED|Overall Study||79
11007861|NCT00735371|12185638|FG000|COMPLETED|Overall Study||63
11007862|NCT00735371|12185639|FG001|COMPLETED|Overall Study||66
11007863|NCT00735371|12185640|FG002|COMPLETED|Overall Study||67
11007864|NCT00735371|12185641|FG003|COMPLETED|Overall Study||69
11007865|NCT00735371|12185638|FG000|NOT COMPLETED|Overall Study||15
11007866|NCT00735371|12185639|FG001|NOT COMPLETED|Overall Study||13
11007867|NCT00735371|12185640|FG002|NOT COMPLETED|Overall Study||11
11007868|NCT00735371|12185641|FG003|NOT COMPLETED|Overall Study||10
11007869|NCT00735397|12185651|FG000|STARTED|Overall Study||1218
11007870|NCT00735397|12185651|FG000|COMPLETED|Overall Study||35
11007871|NCT00735397|12185651|FG000|NOT COMPLETED|Overall Study||1183
11056522|NCT00994682|12238124|FG000|COMPLETED|Double Bilnd||42
11056523|NCT00994682|12238125|FG001|COMPLETED|Double Bilnd||41
11056524|NCT00994682|12238124|FG000|NOT COMPLETED|Double Bilnd||9
11056525|NCT00994682|12238125|FG001|NOT COMPLETED|Double Bilnd||9
11056526|NCT00994682|12238124|FG000|STARTED|Pioglitazone Open Label||42
11056527|NCT00994682|12238125|FG001|STARTED|Pioglitazone Open Label||41
11056528|NCT00994682|12238124|FG000|COMPLETED|Pioglitazone Open Label||29
11056529|NCT00994682|12238125|FG001|COMPLETED|Pioglitazone Open Label||34
11056530|NCT00994682|12238124|FG000|NOT COMPLETED|Pioglitazone Open Label||13
11056531|NCT00994682|12238125|FG001|NOT COMPLETED|Pioglitazone Open Label||7
11056532|NCT00994760|12238135|FG000|STARTED|Overall Study||131
11056533|NCT00994760|12238135|FG000|COMPLETED|Overall Study||107
11056534|NCT00994760|12238135|FG000|NOT COMPLETED|Overall Study||24
11056535|NCT00994890|12238156|FG000|STARTED|Overall Study||231
11056536|NCT00994890|12238157|FG001|STARTED|Overall Study||222
11056537|NCT00994890|12238158|FG002|STARTED|Overall Study||226
11056538|NCT00994890|12238156|FG000|Treated|Overall Study||230
11056539|NCT00994890|12238157|FG001|Treated|Overall Study||222
11056540|NCT00994890|12238158|FG002|Treated|Overall Study||226
11056541|NCT00994890|12238156|FG000|COMPLETED|Overall Study||0
11056542|NCT00994890|12238157|FG001|COMPLETED|Overall Study||0
11056543|NCT00994890|12238158|FG002|COMPLETED|Overall Study||0
11056544|NCT00994890|12238156|FG000|NOT COMPLETED|Overall Study||231
11056545|NCT00994890|12238157|FG001|NOT COMPLETED|Overall Study||222
11056546|NCT00994890|12238158|FG002|NOT COMPLETED|Overall Study||226
11056547|NCT00994929|12238166|FG000|STARTED|Overall Study||9
11056548|NCT00994929|12238166|FG000|COMPLETED|Overall Study||9
11056549|NCT00994929|12238166|FG000|NOT COMPLETED|Overall Study||0
11056550|NCT00995007|12238173|FG000|STARTED|Overall Study||56
11056551|NCT00995007|12238174|FG001|STARTED|Overall Study||56
11056552|NCT00995007|12238173|FG000|Crossover to Vandetanib|Overall Study||42
11056553|NCT00995007|12238174|FG001|Crossover to Vandetanib|Overall Study||0
11056554|NCT00995007|12238173|FG000|COMPLETED|Overall Study||39
11056555|NCT00995007|12238174|FG001|COMPLETED|Overall Study||54
11056556|NCT00995007|12238173|FG000|NOT COMPLETED|Overall Study||17
11056557|NCT00995007|12238174|FG001|NOT COMPLETED|Overall Study||2
11056558|NCT00995020|12238191|FG000|STARTED|Overall Study||51
11056559|NCT00995020|12238192|FG001|STARTED|Overall Study||52
11056560|NCT00995020|12238191|FG000|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
11056561|NCT00995020|12238192|FG001|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
11007872|NCT00735436|12185658|FG000|STARTED|Overall Study||18
11007873|NCT00735436|12185658|FG000|COMPLETED|Overall Study||18
11007874|NCT00735436|12185658|FG000|NOT COMPLETED|Overall Study||0
11007875|NCT00735449|12185665|FG000|STARTED|Overall Study||102
11007876|NCT00735449|12185666|FG001|STARTED|Overall Study||102
11007877|NCT00735449|12185665|FG000|COMPLETED|Overall Study||95
11007878|NCT00735449|12185666|FG001|COMPLETED|Overall Study||96
11007879|NCT00735449|12185665|FG000|NOT COMPLETED|Overall Study||7
11007880|NCT00735449|12185666|FG001|NOT COMPLETED|Overall Study||6
11007881|NCT00735462|12185675|FG000|STARTED|Overall Study||202
11007882|NCT00735462|12185676|FG001|STARTED|Overall Study||204
11007883|NCT00735462|12185677|FG002|STARTED|Overall Study||105
11007884|NCT00735462|12185675|FG000|COMPLETED|Overall Study||139
11007885|NCT00735462|12185676|FG001|COMPLETED|Overall Study||149
11007886|NCT00735462|12185677|FG002|COMPLETED|Overall Study||77
11007887|NCT00735462|12185675|FG000|NOT COMPLETED|Overall Study||63
11007888|NCT00735462|12185676|FG001|NOT COMPLETED|Overall Study||55
11007889|NCT00735462|12185677|FG002|NOT COMPLETED|Overall Study||28
11007890|NCT00735475|12185687|FG000|STARTED|Overall Study||631
11007891|NCT00735475|12185688|FG001|STARTED|Overall Study||637
11007892|NCT00735475|12185687|FG000|COMPLETED|Overall Study||623
11007893|NCT00735475|12185688|FG001|COMPLETED|Overall Study||626
11007894|NCT00735475|12185687|FG000|NOT COMPLETED|Overall Study||8
11007895|NCT00735475|12185688|FG001|NOT COMPLETED|Overall Study||11
11007896|NCT00735618|12185694|FG000|STARTED|Overall Study||19
11007897|NCT00735618|12185694|FG000|COMPLETED|Overall Study||19
11007898|NCT00735618|12185694|FG000|NOT COMPLETED|Overall Study||0
11007899|NCT00735644|12185703|FG000|STARTED|Overall Study||303
11007900|NCT00735644|12185704|FG001|STARTED|Overall Study||300
11007901|NCT00735644|12185705|FG002|STARTED|Overall Study||296
11142513|NCT01468532|12329294|FG000|STARTED|Overall Study||18
11142514|NCT01468532|12329294|FG000|COMPLETED|Overall Study||18
11142515|NCT01468532|12329294|FG000|NOT COMPLETED|Overall Study||0
11142516|NCT01468558|12329298|FG000|STARTED|Overall Study||24
11263686|NCT02271984|12459063|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
11263687|NCT02271984|12459064|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
11263688|NCT02271984|12459065|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
11396227|NCT03720470|12590067|FG000|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|0
11396228|NCT03720470|12590068|FG001|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|60
11396229|NCT03720470|12590069|FG002|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|57
11396230|NCT03720470|12590070|FG003|STARTED|Treatment Period: Final 4 Weeks||217
11396231|NCT03720470|12590071|FG004|STARTED|Treatment Period: Final 4 Weeks||208
11142517|NCT01468558|12329298|FG000|COMPLETED|Overall Study||22
11142518|NCT01468558|12329298|FG000|NOT COMPLETED|Overall Study||2
11142519|NCT01468584|12329306|FG000|STARTED|Overall Study||10
11142520|NCT01468584|12329306|FG000|COMPLETED|Overall Study||10
11142521|NCT01468584|12329306|FG000|NOT COMPLETED|Overall Study||0
11142522|NCT01468597|12329310|FG000|STARTED|Overall Study||184
11142523|NCT01468597|12329310|FG000|COMPLETED|Overall Study||149
11142524|NCT01468597|12329310|FG000|NOT COMPLETED|Overall Study||35
11142525|NCT01468675|12329316|FG000|STARTED|Overall Study||2699
11142526|NCT01468675|12329317|FG001|STARTED|Overall Study||3376
11142527|NCT01468675|12329316|FG000|COMPLETED|Overall Study||1699
11142528|NCT01468675|12329317|FG001|COMPLETED|Overall Study||2004
11142529|NCT01468675|12329316|FG000|NOT COMPLETED|Overall Study||1000
11142530|NCT01468675|12329317|FG001|NOT COMPLETED|Overall Study||1372
11142531|NCT01468701|12329340|FG000|STARTED|Overall Study||4964
11142532|NCT01468701|12329341|FG001|STARTED|Overall Study||5103
11142533|NCT01468701|12329342|FG002|STARTED|Overall Study||1784
11142534|NCT01468701|12329343|FG003|STARTED|Overall Study||715
11142535|NCT01468701|12329344|FG004|STARTED|Overall Study||1736
11142536|NCT01468701|12329345|FG005|STARTED|Overall Study||128
11142537|NCT01468701|12329346|FG006|STARTED|Overall Study||1209
11142538|NCT01468701|12329347|FG007|STARTED|Overall Study||5
11142539|NCT01468701|12329348|FG008|STARTED|Overall Study||3879
11142540|NCT01468701|12329349|FG009|STARTED|Overall Study||4962
11142541|NCT01468701|12329350|FG010|STARTED|Overall Study||4054
11142542|NCT01468701|12329351|FG011|STARTED|Overall Study||4538
11142543|NCT01468701|12329352|FG012|STARTED|Overall Study||333
11142544|NCT01468701|12329353|FG013|STARTED|Overall Study||2182
11142545|NCT01468701|12329354|FG014|STARTED|Overall Study||214
11142546|NCT01468701|12329355|FG015|STARTED|Overall Study||1418
11007902|NCT00735644|12185706|FG003|STARTED|Overall Study||199
11007903|NCT00735644|12185707|FG004|STARTED|Overall Study||102
11007904|NCT00735644|12185703|FG000|COMPLETED|Overall Study||303
11007905|NCT00735644|12185704|FG001|COMPLETED|Overall Study||298
11007906|NCT00735644|12185705|FG002|COMPLETED|Overall Study||295
11007907|NCT00735644|12185706|FG003|COMPLETED|Overall Study||198
11007908|NCT00735644|12185707|FG004|COMPLETED|Overall Study||102
11142547|NCT01468701|12329356|FG016|STARTED|Overall Study||11
11142548|NCT01468701|12329340|FG000|All Eligible Patient|Overall Study||4873
11142549|NCT01468701|12329341|FG001|All Eligible Patient|Overall Study||4963
11142550|NCT01468701|12329342|FG002|All Eligible Patient|Overall Study||1755
11142551|NCT01468701|12329343|FG003|All Eligible Patient|Overall Study||703
11142552|NCT01468701|12329344|FG004|All Eligible Patient|Overall Study||1714
11142553|NCT01468701|12329345|FG005|All Eligible Patient|Overall Study||126
11142554|NCT01468701|12329346|FG006|All Eligible Patient|Overall Study||1170
11142555|NCT01468701|12329347|FG007|All Eligible Patient|Overall Study||4
11396232|NCT03720470|12590072|FG005|STARTED|Treatment Period: Final 4 Weeks||223
11396233|NCT03720470|12590067|FG000|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||0
11396234|NCT03720470|12590068|FG001|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||60
11396235|NCT03720470|12590069|FG002|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||57
11396236|NCT03720470|12590070|FG003|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||217
11396237|NCT03720470|12590071|FG004|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||208
11396238|NCT03720470|12590072|FG005|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||223
11396239|NCT03720470|12590067|FG000|Full Analysis Set|Treatment Period: Final 4 Weeks||0
11007909|NCT00735644|12185703|FG000|NOT COMPLETED|Overall Study||0
11007910|NCT00735644|12185704|FG001|NOT COMPLETED|Overall Study||2
11007911|NCT00735644|12185705|FG002|NOT COMPLETED|Overall Study||1
11007912|NCT00735644|12185706|FG003|NOT COMPLETED|Overall Study||1
11007913|NCT00735644|12185707|FG004|NOT COMPLETED|Overall Study||0
11007914|NCT00735670|12185728|FG000|STARTED|Overall Study||10
11007915|NCT00735670|12185729|FG001|STARTED|Overall Study||11
11007916|NCT00735670|12185728|FG000|COMPLETED|Overall Study||6
11007917|NCT00735670|12185729|FG001|COMPLETED|Overall Study||6
11007918|NCT00735670|12185728|FG000|NOT COMPLETED|Overall Study||4
11007919|NCT00735670|12185729|FG001|NOT COMPLETED|Overall Study||5
11007920|NCT00735696|12185735|FG000|STARTED|Overall Study||41
11007921|NCT00735696|12185735|FG000|Received Any Quantity of Study Drug|Overall Study||40
11007922|NCT00735696|12185735|FG000|COMPLETED|Overall Study||39
11007923|NCT00735696|12185735|FG000|NOT COMPLETED|Overall Study||2
11007924|NCT00735709|12185743|FG000|STARTED|Overall Study||140
11007925|NCT00735709|12185744|FG001|STARTED|Overall Study||140
11007926|NCT00735709|12185745|FG002|STARTED|Overall Study||140
11007927|NCT00735709|12185746|FG003|STARTED|Overall Study||140
11007928|NCT00735709|12185743|FG000|Treated|Overall Study||140
11007929|NCT00735709|12185744|FG001|Treated|Overall Study||140
11007930|NCT00735709|12185745|FG002|Treated|Overall Study||140
11007931|NCT00735709|12185746|FG003|Treated|Overall Study||139
11007932|NCT00735709|12185743|FG000|COMPLETED|Overall Study||127
11007933|NCT00735709|12185744|FG001|COMPLETED|Overall Study||127
11007934|NCT00735709|12185745|FG002|COMPLETED|Overall Study||129
11007935|NCT00735709|12185746|FG003|COMPLETED|Overall Study||122
11007936|NCT00735709|12185743|FG000|NOT COMPLETED|Overall Study||13
11142556|NCT01468701|12329348|FG008|All Eligible Patient|Overall Study||3839
11142557|NCT01468701|12329349|FG009|All Eligible Patient|Overall Study||4836
11142558|NCT01468701|12329350|FG010|All Eligible Patient|Overall Study||4015
11142559|NCT01468701|12329351|FG011|All Eligible Patient|Overall Study||4505
11142560|NCT01468701|12329352|FG012|All Eligible Patient|Overall Study||332
11142561|NCT01468701|12329353|FG013|All Eligible Patient|Overall Study||2163
11142562|NCT01468701|12329354|FG014|All Eligible Patient|Overall Study||213
11142563|NCT01468701|12329355|FG015|All Eligible Patient|Overall Study||1386
11142564|NCT01468701|12329356|FG016|All Eligible Patient|Overall Study||11
11142565|NCT01468701|12329340|FG000|COMPLETED|Overall Study||3965
11263689|NCT02271984|12459066|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0
11263690|NCT02271984|12459067|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
11263691|NCT02271984|12459068|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
11007937|NCT00735709|12185744|FG001|NOT COMPLETED|Overall Study||13
11007938|NCT00735709|12185745|FG002|NOT COMPLETED|Overall Study||11
11007939|NCT00735709|12185746|FG003|NOT COMPLETED|Overall Study||18
11263692|NCT02271984|12459069|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
11263693|NCT02271984|12459070|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
11263694|NCT02271984|12459071|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0
11263695|NCT02271984|12459072|FG011|NOT COMPLETED|Washout Period 3 (7 Days)||0
11263696|NCT02271984|12459061|FG000|STARTED|Fourth Intervention Period (Day 1)||3
11263697|NCT02271984|12459062|FG001|STARTED|Fourth Intervention Period (Day 1)||3
11263698|NCT02271984|12459063|FG002|STARTED|Fourth Intervention Period (Day 1)||3
11263699|NCT02271984|12459064|FG003|STARTED|Fourth Intervention Period (Day 1)||3
11263700|NCT02271984|12459065|FG004|STARTED|Fourth Intervention Period (Day 1)||3
11007940|NCT00735787|12185758|FG000|STARTED|Period 1||23
11007941|NCT00735787|12185759|FG001|STARTED|Period 1||49
11007942|NCT00735787|12185758|FG000|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
11007943|NCT00735787|12185759|FG001|COMPLETED|Period 1||41
11007944|NCT00735787|12185758|FG000|NOT COMPLETED|Period 1||6
11007945|NCT00735787|12185759|FG001|NOT COMPLETED|Period 1||8
11007946|NCT00735787|12185758|FG000|STARTED|Period 2||18
11007947|NCT00735787|12185759|FG001|STARTED|Period 2||41
11007948|NCT00735787|12185758|FG000|COMPLETED|Period 2||13
11007949|NCT00735787|12185759|FG001|COMPLETED|Period 2||40
11007950|NCT00735787|12185758|FG000|NOT COMPLETED|Period 2||5
11007951|NCT00735787|12185759|FG001|NOT COMPLETED|Period 2||1
11007952|NCT00735826|12185765|FG000|STARTED|Overall Study||10
11007953|NCT00735826|12185765|FG000|COMPLETED|Overall Study||10
11007954|NCT00735826|12185765|FG000|NOT COMPLETED|Overall Study||0
11007955|NCT00735839|12185773|FG000|STARTED|Overall Study||30
11007956|NCT00735839|12185774|FG001|STARTED|Overall Study||10
11007957|NCT00735839|12185773|FG000|COMPLETED|Overall Study||30
11007958|NCT00735839|12185774|FG001|COMPLETED|Overall Study||10
11007959|NCT00735839|12185773|FG000|NOT COMPLETED|Overall Study||0
11007960|NCT00735839|12185774|FG001|NOT COMPLETED|Overall Study||0
11007961|NCT00735878|12185783|FG000|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
11007962|NCT00735878|12185784|FG001|STARTED|Phase I- Dose Determination||7
11007963|NCT00735878|12185785|FG002|STARTED|Phase I- Dose Determination||5
11007964|NCT00735878|12185783|FG000|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
11007965|NCT00735878|12185784|FG001|COMPLETED|Phase I- Dose Determination||7
11007966|NCT00735878|12185785|FG002|COMPLETED|Phase I- Dose Determination||4
11007967|NCT00735878|12185783|FG000|NOT COMPLETED|Phase I- Dose Determination||0
11007968|NCT00735878|12185784|FG001|NOT COMPLETED|Phase I- Dose Determination||0
11007969|NCT00735878|12185785|FG002|NOT COMPLETED|Phase I- Dose Determination||1
11007970|NCT00735878|12185783|FG000|STARTED|Phase II- Determined Dose||0
11007971|NCT00735878|12185784|FG001|STARTED|Phase II- Determined Dose||7
11007972|NCT00735878|12185785|FG002|STARTED|Phase II- Determined Dose||0
11007973|NCT00735878|12185783|FG000|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
11007974|NCT00735878|12185784|FG001|COMPLETED|Phase II- Determined Dose||7
11007975|NCT00735878|12185785|FG002|COMPLETED|Phase II- Determined Dose||0
11007976|NCT00735878|12185783|FG000|NOT COMPLETED|Phase II- Determined Dose||0
11007977|NCT00735878|12185784|FG001|NOT COMPLETED|Phase II- Determined Dose||0
11007978|NCT00735878|12185785|FG002|NOT COMPLETED|Phase II- Determined Dose||0
11007979|NCT00735904|12185796|FG000|STARTED|Overall Study||38
11007980|NCT00735904|12185796|FG000|COMPLETED|Overall Study||0
11007981|NCT00735904|12185796|FG000|NOT COMPLETED|Overall Study||38
11007982|NCT00735917|12185800|FG000|STARTED|Overall Study||19
11007983|NCT00735917|12185800|FG000|COMPLETED|Overall Study||19
11007984|NCT00735917|12185800|FG000|NOT COMPLETED|Overall Study||0
11007985|NCT00735943|12185804|FG000|STARTED|Overall Study||22
11007986|NCT00735943|12185804|FG000|COMPLETED|Overall Study||20
11007987|NCT00735943|12185804|FG000|NOT COMPLETED|Overall Study||2
11007988|NCT00735969|12185808|FG000|STARTED|Overall Study||21
11007989|NCT00735969|12185808|FG000|COMPLETED|Overall Study||21
11007990|NCT00735969|12185808|FG000|NOT COMPLETED|Overall Study||0
11007991|NCT00736034|12185812|FG000|STARTED|Overall Study||18
11007992|NCT00736034|12185812|FG000|COMPLETED|Overall Study||16
11007993|NCT00736034|12185812|FG000|NOT COMPLETED|Overall Study||2
11007994|NCT00736073|12185818|FG000|STARTED|Overall Study||34
11007995|NCT00736073|12185819|FG001|STARTED|Overall Study||39
11007996|NCT00736073|12185818|FG000|COMPLETED|Overall Study||34
11007997|NCT00736073|12185819|FG001|COMPLETED|Overall Study||39
11007998|NCT00736073|12185818|FG000|NOT COMPLETED|Overall Study||0
11007999|NCT00736073|12185819|FG001|NOT COMPLETED|Overall Study||0
11008000|NCT00736099|12185828|FG000|STARTED|Overall Study|Number who started treatment.|1532
11008001|NCT00736099|12185829|FG001|STARTED|Overall Study|Number who started treatment.|589
11008002|NCT00736099|12185828|FG000|COMPLETED|Overall Study|Number who completed treatment.|1349
11008003|NCT00736099|12185829|FG001|COMPLETED|Overall Study|Number who completed treatment.|531
11008004|NCT00736099|12185828|FG000|NOT COMPLETED|Overall Study||183
11008005|NCT00736099|12185829|FG001|NOT COMPLETED|Overall Study||58
11008006|NCT00736125|12185837|FG000|STARTED|Overall Study||10
11008007|NCT00736125|12185838|FG001|STARTED|Overall Study||10
11008008|NCT00736125|12185837|FG000|COMPLETED|Overall Study||9
11008009|NCT00736125|12185838|FG001|COMPLETED|Overall Study||8
11008010|NCT00736125|12185837|FG000|NOT COMPLETED|Overall Study||1
11008011|NCT00736125|12185838|FG001|NOT COMPLETED|Overall Study||2
11008012|NCT00736190|12185844|FG000|STARTED|Overall Study||90
11008013|NCT00736190|12185844|FG000|COMPLETED|Overall Study||87
11008014|NCT00736190|12185844|FG000|NOT COMPLETED|Overall Study||3
11008015|NCT00736229|12185851|FG000|STARTED|Overall Study|Actively Enrolled|40
11008016|NCT00736229|12185852|FG001|STARTED|Overall Study|Historic control|71
11008017|NCT00736229|12185853|FG002|STARTED|Overall Study|Historic Control|84
11008018|NCT00736229|12185851|FG000|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
11008019|NCT00736229|12185852|FG001|COMPLETED|Overall Study||71
11008020|NCT00736229|12185853|FG002|COMPLETED|Overall Study||84
11008021|NCT00736229|12185851|FG000|NOT COMPLETED|Overall Study||0
11008022|NCT00736229|12185852|FG001|NOT COMPLETED|Overall Study||0
11008023|NCT00736229|12185853|FG002|NOT COMPLETED|Overall Study||0
11008024|NCT00736242|12185862|FG000|STARTED|Overall Study||232
11008025|NCT00736242|12185862|FG000|Participants in Safety Analysis Set|Overall Study||229
11008026|NCT00736242|12185862|FG000|COMPLETED|Overall Study||107
11008027|NCT00736242|12185862|FG000|NOT COMPLETED|Overall Study||125
11008028|NCT00736255|12185868|FG000|STARTED|Overall Study||17
11008029|NCT00736255|12185869|FG001|STARTED|Overall Study||15
11008030|NCT00736255|12185868|FG000|COMPLETED|Overall Study||14
11008031|NCT00736255|12185869|FG001|COMPLETED|Overall Study||14
11008032|NCT00736255|12185868|FG000|NOT COMPLETED|Overall Study||3
11008033|NCT00736255|12185869|FG001|NOT COMPLETED|Overall Study||1
11008034|NCT00736333|12185875|FG000|STARTED|Overall Study||167
11008035|NCT00736333|12185875|FG000|COMPLETED|Overall Study||56
11008036|NCT00736333|12185875|FG000|NOT COMPLETED|Overall Study||111
11008037|NCT00736450|12185879|FG000|STARTED|Overall Study||37
11008038|NCT00736450|12185879|FG000|COMPLETED|Overall Study||12
11008039|NCT00736450|12185879|FG000|NOT COMPLETED|Overall Study||25
11008040|NCT00736476|12185885|FG000|STARTED|Overall Study||36
11008041|NCT00736476|12185886|FG001|STARTED|Overall Study||27
11008042|NCT00736476|12185885|FG000|COMPLETED|Overall Study||35
11008043|NCT00736476|12185886|FG001|COMPLETED|Overall Study||27
11008044|NCT00736476|12185885|FG000|NOT COMPLETED|Overall Study||1
11008045|NCT00736476|12185886|FG001|NOT COMPLETED|Overall Study||0
11008046|NCT00736489|12185898|FG000|STARTED|Period 1|Cross-over study|6
11008047|NCT00736489|12185899|FG001|STARTED|Period 1||5
11008048|NCT00736489|12185900|FG002|STARTED|Period 1||6
11008049|NCT00736489|12185901|FG003|STARTED|Period 1||7
11008050|NCT00736489|12185902|FG004|STARTED|Period 1||7
11008051|NCT00736489|12185903|FG005|STARTED|Period 1||6
11008052|NCT00736489|12185898|FG000|COMPLETED|Period 1||5
11008053|NCT00736489|12185899|FG001|COMPLETED|Period 1||5
11008054|NCT00736489|12185900|FG002|COMPLETED|Period 1||6
11008055|NCT00736489|12185901|FG003|COMPLETED|Period 1||7
11008056|NCT00736489|12185902|FG004|COMPLETED|Period 1||7
11008057|NCT00736489|12185903|FG005|COMPLETED|Period 1||5
11008058|NCT00736489|12185898|FG000|NOT COMPLETED|Period 1||1
11008059|NCT00736489|12185899|FG001|NOT COMPLETED|Period 1||0
11008060|NCT00736489|12185900|FG002|NOT COMPLETED|Period 1||0
11008061|NCT00736489|12185901|FG003|NOT COMPLETED|Period 1||0
11008062|NCT00736489|12185902|FG004|NOT COMPLETED|Period 1||0
11008063|NCT00736489|12185903|FG005|NOT COMPLETED|Period 1||1
11008064|NCT00736489|12185898|FG000|STARTED|Period 2||5
11008065|NCT00736489|12185899|FG001|STARTED|Period 2||5
11008066|NCT00736489|12185900|FG002|STARTED|Period 2||6
11008067|NCT00736489|12185901|FG003|STARTED|Period 2||7
11008068|NCT00736489|12185902|FG004|STARTED|Period 2||7
11008069|NCT00736489|12185903|FG005|STARTED|Period 2||5
11008070|NCT00736489|12185898|FG000|COMPLETED|Period 2||5
11008071|NCT00736489|12185899|FG001|COMPLETED|Period 2||5
11008072|NCT00736489|12185900|FG002|COMPLETED|Period 2||6
11008073|NCT00736489|12185901|FG003|COMPLETED|Period 2||7
11008074|NCT00736489|12185902|FG004|COMPLETED|Period 2||7
11008075|NCT00736489|12185903|FG005|COMPLETED|Period 2||5
11008076|NCT00736489|12185898|FG000|NOT COMPLETED|Period 2||0
11008077|NCT00736489|12185899|FG001|NOT COMPLETED|Period 2||0
11008078|NCT00736489|12185900|FG002|NOT COMPLETED|Period 2||0
11008079|NCT00736489|12185901|FG003|NOT COMPLETED|Period 2||0
11008080|NCT00736489|12185902|FG004|NOT COMPLETED|Period 2||0
11008081|NCT00736489|12185903|FG005|NOT COMPLETED|Period 2||0
11008082|NCT00736489|12185898|FG000|STARTED|Period 3||5
11008083|NCT00736489|12185899|FG001|STARTED|Period 3||5
11008084|NCT00736489|12185900|FG002|STARTED|Period 3||6
11008085|NCT00736489|12185901|FG003|STARTED|Period 3||7
11008086|NCT00736489|12185902|FG004|STARTED|Period 3||7
11008087|NCT00736489|12185903|FG005|STARTED|Period 3||5
11008088|NCT00736489|12185898|FG000|COMPLETED|Period 3||5
11008089|NCT00736489|12185899|FG001|COMPLETED|Period 3||5
11008090|NCT00736489|12185900|FG002|COMPLETED|Period 3||6
11008091|NCT00736489|12185901|FG003|COMPLETED|Period 3||7
11008092|NCT00736489|12185902|FG004|COMPLETED|Period 3||7
11008093|NCT00736489|12185903|FG005|COMPLETED|Period 3||5
11008094|NCT00736489|12185898|FG000|NOT COMPLETED|Period 3||0
11008095|NCT00736489|12185899|FG001|NOT COMPLETED|Period 3||0
11008096|NCT00736489|12185900|FG002|NOT COMPLETED|Period 3||0
11008097|NCT00736489|12185901|FG003|NOT COMPLETED|Period 3||0
11008098|NCT00736489|12185902|FG004|NOT COMPLETED|Period 3||0
11008099|NCT00736489|12185903|FG005|NOT COMPLETED|Period 3||0
11008100|NCT00736489|12185898|FG000|STARTED|Period 4||5
11008101|NCT00736489|12185899|FG001|STARTED|Period 4||5
11008102|NCT00736489|12185900|FG002|STARTED|Period 4||6
11008103|NCT00736489|12185901|FG003|STARTED|Period 4||7
11008104|NCT00736489|12185902|FG004|STARTED|Period 4||7
11008105|NCT00736489|12185903|FG005|STARTED|Period 4||5
11008106|NCT00736489|12185898|FG000|COMPLETED|Period 4||5
11008107|NCT00736489|12185899|FG001|COMPLETED|Period 4||5
11008108|NCT00736489|12185900|FG002|COMPLETED|Period 4||6
11008109|NCT00736489|12185901|FG003|COMPLETED|Period 4||7
11008110|NCT00736489|12185902|FG004|COMPLETED|Period 4||7
11008111|NCT00736489|12185903|FG005|COMPLETED|Period 4||5
11008112|NCT00736489|12185898|FG000|NOT COMPLETED|Period 4||0
11008113|NCT00736489|12185899|FG001|NOT COMPLETED|Period 4||0
11008114|NCT00736489|12185900|FG002|NOT COMPLETED|Period 4||0
11008115|NCT00736489|12185901|FG003|NOT COMPLETED|Period 4||0
11008116|NCT00736489|12185902|FG004|NOT COMPLETED|Period 4||0
11008117|NCT00736489|12185903|FG005|NOT COMPLETED|Period 4||0
11008118|NCT00736489|12185898|FG000|STARTED|Period 5||5
11008119|NCT00736489|12185899|FG001|STARTED|Period 5||5
11008120|NCT00736489|12185900|FG002|STARTED|Period 5||6
11008121|NCT00736489|12185901|FG003|STARTED|Period 5||7
11008122|NCT00736489|12185902|FG004|STARTED|Period 5||7
11008123|NCT00736489|12185903|FG005|STARTED|Period 5||5
11008124|NCT00736489|12185898|FG000|COMPLETED|Period 5||5
11008125|NCT00736489|12185899|FG001|COMPLETED|Period 5||5
11008126|NCT00736489|12185900|FG002|COMPLETED|Period 5||6
11008127|NCT00736489|12185901|FG003|COMPLETED|Period 5||7
11008128|NCT00736489|12185902|FG004|COMPLETED|Period 5||7
11008129|NCT00736489|12185903|FG005|COMPLETED|Period 5||5
11008130|NCT00736489|12185898|FG000|NOT COMPLETED|Period 5||0
11008131|NCT00736489|12185899|FG001|NOT COMPLETED|Period 5||0
11008132|NCT00736489|12185900|FG002|NOT COMPLETED|Period 5||0
11008133|NCT00736489|12185901|FG003|NOT COMPLETED|Period 5||0
11008134|NCT00736489|12185902|FG004|NOT COMPLETED|Period 5||0
11008135|NCT00736489|12185903|FG005|NOT COMPLETED|Period 5||0
11008136|NCT00736489|12185898|FG000|STARTED|Period 6||5
11008137|NCT00736489|12185899|FG001|STARTED|Period 6||5
11008138|NCT00736489|12185900|FG002|STARTED|Period 6||6
11008139|NCT00736489|12185901|FG003|STARTED|Period 6||7
11008140|NCT00736489|12185902|FG004|STARTED|Period 6||7
11008141|NCT00736489|12185903|FG005|STARTED|Period 6||5
11008142|NCT00736489|12185898|FG000|COMPLETED|Period 6||5
11008143|NCT00736489|12185899|FG001|COMPLETED|Period 6||5
11142566|NCT01468701|12329341|FG001|COMPLETED|Overall Study||0
11142567|NCT01468701|12329342|FG002|COMPLETED|Overall Study||0
11142568|NCT01468701|12329343|FG003|COMPLETED|Overall Study||0
11396240|NCT03720470|12590068|FG001|Full Analysis Set|Treatment Period: Final 4 Weeks||60
11396241|NCT03720470|12590069|FG002|Full Analysis Set|Treatment Period: Final 4 Weeks||57
11396242|NCT03720470|12590070|FG003|Full Analysis Set|Treatment Period: Final 4 Weeks||217
11396243|NCT03720470|12590071|FG004|Full Analysis Set|Treatment Period: Final 4 Weeks||208
11142569|NCT01468701|12329344|FG004|COMPLETED|Overall Study||0
11142570|NCT01468701|12329345|FG005|COMPLETED|Overall Study||0
11142571|NCT01468701|12329346|FG006|COMPLETED|Overall Study||0
11142572|NCT01468701|12329347|FG007|COMPLETED|Overall Study||0
11142573|NCT01468701|12329348|FG008|COMPLETED|Overall Study||3219
11142574|NCT01468701|12329349|FG009|COMPLETED|Overall Study||3780
11142575|NCT01468701|12329350|FG010|COMPLETED|Overall Study||3256
11142576|NCT01468701|12329351|FG011|COMPLETED|Overall Study||3672
11142577|NCT01468701|12329352|FG012|COMPLETED|Overall Study||284
11142578|NCT01468701|12329353|FG013|COMPLETED|Overall Study||1712
11142579|NCT01468701|12329354|FG014|COMPLETED|Overall Study||151
11142580|NCT01468701|12329355|FG015|COMPLETED|Overall Study||1056
11142581|NCT01468701|12329356|FG016|COMPLETED|Overall Study||10
11142582|NCT01468701|12329340|FG000|NOT COMPLETED|Overall Study||999
11142583|NCT01468701|12329341|FG001|NOT COMPLETED|Overall Study||5103
11142584|NCT01468701|12329342|FG002|NOT COMPLETED|Overall Study||1784
11142585|NCT01468701|12329343|FG003|NOT COMPLETED|Overall Study||715
11142586|NCT01468701|12329344|FG004|NOT COMPLETED|Overall Study||1736
11142587|NCT01468701|12329345|FG005|NOT COMPLETED|Overall Study||128
11142588|NCT01468701|12329346|FG006|NOT COMPLETED|Overall Study||1209
11142589|NCT01468701|12329347|FG007|NOT COMPLETED|Overall Study||5
11142590|NCT01468701|12329348|FG008|NOT COMPLETED|Overall Study||660
11142591|NCT01468701|12329349|FG009|NOT COMPLETED|Overall Study||1182
11142592|NCT01468701|12329350|FG010|NOT COMPLETED|Overall Study||798
11142593|NCT01468701|12329351|FG011|NOT COMPLETED|Overall Study||866
11142594|NCT01468701|12329352|FG012|NOT COMPLETED|Overall Study||49
11142595|NCT01468701|12329353|FG013|NOT COMPLETED|Overall Study||470
11142596|NCT01468701|12329354|FG014|NOT COMPLETED|Overall Study||63
11142597|NCT01468701|12329355|FG015|NOT COMPLETED|Overall Study||362
11142598|NCT01468701|12329356|FG016|NOT COMPLETED|Overall Study||1
11142599|NCT01468818|12329369|FG000|STARTED|Overall Study||18
11396244|NCT03720470|12590072|FG005|Full Analysis Set|Treatment Period: Final 4 Weeks||223
11396245|NCT03720470|12590067|FG000|COMPLETED|Treatment Period: Final 4 Weeks||0
11396246|NCT03720470|12590068|FG001|COMPLETED|Treatment Period: Final 4 Weeks||58
11396247|NCT03720470|12590069|FG002|COMPLETED|Treatment Period: Final 4 Weeks||55
11396248|NCT03720470|12590070|FG003|COMPLETED|Treatment Period: Final 4 Weeks||210
11396249|NCT03720470|12590071|FG004|COMPLETED|Treatment Period: Final 4 Weeks||204
11396250|NCT03720470|12590072|FG005|COMPLETED|Treatment Period: Final 4 Weeks||218
11396251|NCT03720470|12590067|FG000|NOT COMPLETED|Treatment Period: Final 4 Weeks||0
11008144|NCT00736489|12185900|FG002|COMPLETED|Period 6||6
11142600|NCT01468818|12329369|FG000|COMPLETED|Overall Study||16
11396252|NCT03720470|12590068|FG001|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
11142601|NCT01468818|12329369|FG000|NOT COMPLETED|Overall Study||2
11142602|NCT01468844|12329375|FG000|STARTED|Overall Study||4
11142603|NCT01468844|12329376|FG001|STARTED|Overall Study||2
11142604|NCT01468844|12329375|FG000|COMPLETED|Overall Study||2
11142605|NCT01468844|12329376|FG001|COMPLETED|Overall Study||2
11142606|NCT01468844|12329375|FG000|NOT COMPLETED|Overall Study||2
11396253|NCT03720470|12590069|FG002|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
11396254|NCT03720470|12590070|FG003|NOT COMPLETED|Treatment Period: Final 4 Weeks||7
11396255|NCT03720470|12590071|FG004|NOT COMPLETED|Treatment Period: Final 4 Weeks||4
11008145|NCT00736489|12185901|FG003|COMPLETED|Period 6||7
11008146|NCT00736489|12185902|FG004|COMPLETED|Period 6||7
11008147|NCT00736489|12185903|FG005|COMPLETED|Period 6||5
11008148|NCT00736489|12185898|FG000|NOT COMPLETED|Period 6||0
11008149|NCT00736489|12185899|FG001|NOT COMPLETED|Period 6||0
11008150|NCT00736489|12185900|FG002|NOT COMPLETED|Period 6||0
11396256|NCT03720470|12590072|FG005|NOT COMPLETED|Treatment Period: Final 4 Weeks||5
11396257|NCT03720652|12590094|FG000|STARTED|Overall Study||12
11396258|NCT03720652|12590095|FG001|STARTED|Overall Study||27
11396259|NCT03720652|12590094|FG000|Baseline Interview|Overall Study||12
11008151|NCT00736489|12185901|FG003|NOT COMPLETED|Period 6||0
11008152|NCT00736489|12185902|FG004|NOT COMPLETED|Period 6||0
11008153|NCT00736489|12185903|FG005|NOT COMPLETED|Period 6||0
11008154|NCT00736502|12185917|FG000|STARTED|Overall Study|Entered and treated.|278
11008155|NCT00736502|12185917|FG000|COMPLETED|Overall Study||213
11008156|NCT00736502|12185917|FG000|NOT COMPLETED|Overall Study||65
11008157|NCT00736580|12185923|FG000|STARTED|Overall Study||117
11008158|NCT00736580|12185924|FG001|STARTED|Overall Study||123
11008159|NCT00736580|12185923|FG000|COMPLETED|Overall Study||117
11008160|NCT00736580|12185924|FG001|COMPLETED|Overall Study||123
11008161|NCT00736580|12185923|FG000|NOT COMPLETED|Overall Study||0
11008162|NCT00736580|12185924|FG001|NOT COMPLETED|Overall Study||0
11008163|NCT00736632|12185933|FG000|STARTED|Overall Study||44
11008164|NCT00736632|12185934|FG001|STARTED|Overall Study||50
11008165|NCT00736632|12185935|FG002|STARTED|Overall Study||31
11008166|NCT00736632|12185933|FG000|COMPLETED|Overall Study||44
11008167|NCT00736632|12185934|FG001|COMPLETED|Overall Study||50
11008168|NCT00736632|12185935|FG002|COMPLETED|Overall Study||31
11008169|NCT00736632|12185933|FG000|NOT COMPLETED|Overall Study||0
11008170|NCT00736632|12185934|FG001|NOT COMPLETED|Overall Study||0
11008171|NCT00736632|12185935|FG002|NOT COMPLETED|Overall Study||0
11008172|NCT00736645|12185945|FG000|STARTED|Overall Study||13
11008173|NCT00736645|12185946|FG001|STARTED|Overall Study||15
11008174|NCT00736645|12185947|FG002|STARTED|Overall Study||14
11008175|NCT00736645|12185948|FG003|STARTED|Overall Study||13
11008176|NCT00736645|12185945|FG000|COMPLETED|Overall Study||13
11008177|NCT00736645|12185946|FG001|COMPLETED|Overall Study||13
11008178|NCT00736645|12185947|FG002|COMPLETED|Overall Study||14
11008179|NCT00736645|12185948|FG003|COMPLETED|Overall Study||13
11008180|NCT00736645|12185945|FG000|NOT COMPLETED|Overall Study||0
11008181|NCT00736645|12185946|FG001|NOT COMPLETED|Overall Study||2
11008182|NCT00736645|12185947|FG002|NOT COMPLETED|Overall Study||0
11008183|NCT00736645|12185948|FG003|NOT COMPLETED|Overall Study||0
11008184|NCT00736723|12185960|FG000|STARTED|Overall Study||30
11008185|NCT00736723|12185961|FG001|STARTED|Overall Study||21
11008186|NCT00736723|12185960|FG000|COMPLETED|Overall Study||26
11008187|NCT00736723|12185961|FG001|COMPLETED|Overall Study||18
11008188|NCT00736723|12185960|FG000|NOT COMPLETED|Overall Study||4
11008189|NCT00736723|12185961|FG001|NOT COMPLETED|Overall Study||3
11008190|NCT00736840|12185967|FG000|STARTED|Overall Study||414
11008191|NCT00736840|12185967|FG000|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
11008192|NCT00736840|12185967|FG000|NOT COMPLETED|Overall Study||13
11008193|NCT00736853|12185971|FG000|STARTED|Open-Label Period||319
11008194|NCT00736853|12185972|FG001|STARTED|Open-Label Period||0
11008195|NCT00736853|12185973|FG002|STARTED|Open-Label Period||0
11008196|NCT00736853|12185971|FG000|Treated|Open-Label Period||277
11008197|NCT00736853|12185972|FG001|Treated|Open-Label Period||0
11008198|NCT00736853|12185973|FG002|Treated|Open-Label Period||0
11008199|NCT00736853|12185971|FG000|COMPLETED|Open-Label Period||187
11008200|NCT00736853|12185972|FG001|COMPLETED|Open-Label Period||0
11008201|NCT00736853|12185973|FG002|COMPLETED|Open-Label Period||0
11008202|NCT00736853|12185971|FG000|NOT COMPLETED|Open-Label Period||132
11008203|NCT00736853|12185972|FG001|NOT COMPLETED|Open-Label Period||0
11008204|NCT00736853|12185973|FG002|NOT COMPLETED|Open-Label Period||0
11008205|NCT00736853|12185971|FG000|STARTED|Double-Blind Period||0
11008206|NCT00736853|12185972|FG001|STARTED|Double-Blind Period||94
11008207|NCT00736853|12185973|FG002|STARTED|Double-Blind Period||93
11008208|NCT00736853|12185971|FG000|COMPLETED|Double-Blind Period||0
11008209|NCT00736853|12185972|FG001|COMPLETED|Double-Blind Period||70
11008210|NCT00736853|12185973|FG002|COMPLETED|Double-Blind Period||45
11008211|NCT00736853|12185971|FG000|NOT COMPLETED|Double-Blind Period||0
11008212|NCT00736853|12185972|FG001|NOT COMPLETED|Double-Blind Period||24
11008213|NCT00736853|12185973|FG002|NOT COMPLETED|Double-Blind Period||48
11008214|NCT00736879|12185986|FG000|STARTED|Double Blind Treatment Period||68
11008215|NCT00736879|12185987|FG001|STARTED|Double Blind Treatment Period||72
11008216|NCT00736879|12185988|FG002|STARTED|Double Blind Treatment Period||74
11008217|NCT00736879|12185989|FG003|STARTED|Double Blind Treatment Period||68
11008218|NCT00736879|12185986|FG000|COMPLETED|Double Blind Treatment Period||65
11008219|NCT00736879|12185987|FG001|COMPLETED|Double Blind Treatment Period||68
11008220|NCT00736879|12185988|FG002|COMPLETED|Double Blind Treatment Period||67
11008221|NCT00736879|12185989|FG003|COMPLETED|Double Blind Treatment Period||63
11008222|NCT00736879|12185986|FG000|NOT COMPLETED|Double Blind Treatment Period||3
11008223|NCT00736879|12185987|FG001|NOT COMPLETED|Double Blind Treatment Period||4
11008224|NCT00736879|12185988|FG002|NOT COMPLETED|Double Blind Treatment Period||7
11008225|NCT00736879|12185989|FG003|NOT COMPLETED|Double Blind Treatment Period||5
11396260|NCT03720652|12590095|FG001|Baseline Interview|Overall Study||22
11396261|NCT03720652|12590094|FG000|Start Intervention|Overall Study||11
11008226|NCT00736879|12185986|FG000|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
11008227|NCT00736879|12185987|FG001|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
11008228|NCT00736879|12185988|FG002|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
11008229|NCT00736879|12185989|FG003|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
11008230|NCT00736879|12185986|FG000|COMPLETED|Follow up Period - No Drug Treatment||65
11008231|NCT00736879|12185987|FG001|COMPLETED|Follow up Period - No Drug Treatment||67
11008232|NCT00736879|12185988|FG002|COMPLETED|Follow up Period - No Drug Treatment||66
11008233|NCT00736879|12185989|FG003|COMPLETED|Follow up Period - No Drug Treatment||62
11008234|NCT00736879|12185986|FG000|NOT COMPLETED|Follow up Period - No Drug Treatment||1
11008235|NCT00736879|12185987|FG001|NOT COMPLETED|Follow up Period - No Drug Treatment||3
11008236|NCT00736879|12185988|FG002|NOT COMPLETED|Follow up Period - No Drug Treatment||0
11008237|NCT00736879|12185989|FG003|NOT COMPLETED|Follow up Period - No Drug Treatment||0
11008238|NCT00736944|12186002|FG000|STARTED|Induction||30
11008239|NCT00736944|12186002|FG000|COMPLETED|Induction||29
11008240|NCT00736944|12186002|FG000|NOT COMPLETED|Induction||1
11008241|NCT00736944|12186002|FG000|STARTED|Definitive Treatment||29
11008242|NCT00736944|12186002|FG000|COMPLETED|Definitive Treatment||28
11008243|NCT00736944|12186002|FG000|NOT COMPLETED|Definitive Treatment||1
11008244|NCT00736957|12186009|FG000|STARTED|Overall Study||219
11008245|NCT00736957|12186009|FG000|Treated|Overall Study||190
11008246|NCT00736957|12186009|FG000|COMPLETED|Overall Study||97
11008247|NCT00736957|12186009|FG000|NOT COMPLETED|Overall Study||122
11008248|NCT00736996|12186016|FG000|STARTED|Overall Study||25
11008249|NCT00736996|12186017|FG001|STARTED|Overall Study||26
11008250|NCT00736996|12186018|FG002|STARTED|Overall Study||27
11008251|NCT00736996|12186016|FG000|COMPLETED|Overall Study||24
11008252|NCT00736996|12186017|FG001|COMPLETED|Overall Study||17
11008253|NCT00736996|12186018|FG002|COMPLETED|Overall Study||25
11008254|NCT00736996|12186016|FG000|NOT COMPLETED|Overall Study||1
11008255|NCT00736996|12186017|FG001|NOT COMPLETED|Overall Study||9
11008256|NCT00736996|12186018|FG002|NOT COMPLETED|Overall Study||2
11008257|NCT00737048|12186029|FG000|STARTED|Overall Study||132
11008258|NCT00737048|12186030|FG001|STARTED|Overall Study||66
11008259|NCT00737048|12186031|FG002|STARTED|Overall Study||130
11008260|NCT00737048|12186029|FG000|COMPLETED|Overall Study||129
11008261|NCT00737048|12186030|FG001|COMPLETED|Overall Study||60
11008262|NCT00737048|12186031|FG002|COMPLETED|Overall Study||126
11008263|NCT00737048|12186029|FG000|NOT COMPLETED|Overall Study||3
11008264|NCT00737048|12186030|FG001|NOT COMPLETED|Overall Study||6
11008265|NCT00737048|12186031|FG002|NOT COMPLETED|Overall Study||4
11008266|NCT00737061|12186039|FG000|STARTED|Waiting Period||645
11008267|NCT00737061|12186039|FG000|COMPLETED|Waiting Period||570
11008268|NCT00737061|12186039|FG000|NOT COMPLETED|Waiting Period||75
11008269|NCT00737061|12186039|FG000|STARTED|1 Year Wearing Period||570
11008270|NCT00737061|12186039|FG000|COMPLETED|1 Year Wearing Period||553
11008271|NCT00737061|12186039|FG000|NOT COMPLETED|1 Year Wearing Period||17
11008272|NCT00737100|12186046|FG000|STARTED|Overall Study||168
11008273|NCT00737100|12186047|FG001|STARTED|Overall Study||166
11008274|NCT00737100|12186048|FG002|STARTED|Overall Study||176
11008275|NCT00737100|12186046|FG000|COMPLETED|Overall Study||161
11008276|NCT00737100|12186047|FG001|COMPLETED|Overall Study||159
11008277|NCT00737100|12186048|FG002|COMPLETED|Overall Study||169
11008278|NCT00737100|12186046|FG000|NOT COMPLETED|Overall Study||7
11008279|NCT00737100|12186047|FG001|NOT COMPLETED|Overall Study||7
11008280|NCT00737100|12186048|FG002|NOT COMPLETED|Overall Study||7
11008281|NCT00737178|12186060|FG000|STARTED|Overall Study||71
11008282|NCT00737178|12186061|FG001|STARTED|Overall Study||85
11008283|NCT00737178|12186060|FG000|COMPLETED|Overall Study||66
11008284|NCT00737178|12186061|FG001|COMPLETED|Overall Study||76
11008285|NCT00737178|12186060|FG000|NOT COMPLETED|Overall Study||5
11008286|NCT00737178|12186061|FG001|NOT COMPLETED|Overall Study||9
11008287|NCT00737204|12186069|FG000|STARTED|Overall Study||36
11008288|NCT00737204|12186070|FG001|STARTED|Overall Study||34
11008289|NCT00737204|12186069|FG000|COMPLETED|Overall Study||36
11008290|NCT00737204|12186070|FG001|COMPLETED|Overall Study||28
11008291|NCT00737204|12186069|FG000|NOT COMPLETED|Overall Study||0
11008292|NCT00737204|12186070|FG001|NOT COMPLETED|Overall Study||6
11008293|NCT00737243|12186076|FG000|STARTED|Overall Study||289
11008294|NCT00737243|12186076|FG000|Successful Assay Performed|Overall Study||252
11008295|NCT00737243|12186076|FG000|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
11008296|NCT00737243|12186076|FG000|Treated|Overall Study||223
11008297|NCT00737243|12186076|FG000|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
11008298|NCT00737243|12186076|FG000|Site Specific Therapy More Responsive|Overall Study||115
11008299|NCT00737243|12186076|FG000|Site Specific Therapy Less Responsive|Overall Study||79
11008300|NCT00737243|12186076|FG000|Empiric CUP Therapy|Overall Study||29
11008301|NCT00737243|12186076|FG000|COMPLETED|Overall Study||194
11008302|NCT00737243|12186076|FG000|NOT COMPLETED|Overall Study||95
11008303|NCT00737360|12186082|FG000|STARTED|Overall Study||27
11008304|NCT00737360|12186082|FG000|COMPLETED|Overall Study||27
11008305|NCT00737360|12186082|FG000|NOT COMPLETED|Overall Study||0
11008306|NCT00737438|12186086|FG000|STARTED|Overall Study||23
11008307|NCT00737438|12186086|FG000|COMPLETED|Overall Study||20
11008308|NCT00737438|12186086|FG000|NOT COMPLETED|Overall Study||3
11008309|NCT00737464|12186090|FG000|STARTED|Overall Study||132
11008310|NCT00737464|12186090|FG000|COMPLETED|Overall Study||114
11008311|NCT00737464|12186090|FG000|NOT COMPLETED|Overall Study||18
11008312|NCT00737477|12186094|FG000|STARTED|Overall Study||96
11008313|NCT00737477|12186094|FG000|COMPLETED|Overall Study||62
11008314|NCT00737477|12186094|FG000|NOT COMPLETED|Overall Study||34
11008315|NCT00737529|12186098|FG000|STARTED|Overall Study||134
11008316|NCT00737529|12186098|FG000|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
11008317|NCT00737529|12186098|FG000|NOT COMPLETED|Overall Study||133
11008318|NCT00737568|12186104|FG000|STARTED|Treatment Period Through Week 240||141
11008319|NCT00737568|12186105|FG001|STARTED|Treatment Period Through Week 240||139
11008320|NCT00737568|12186104|FG000|COMPLETED|Treatment Period Through Week 240||121
11008321|NCT00737568|12186105|FG001|COMPLETED|Treatment Period Through Week 240||118
11008322|NCT00737568|12186104|FG000|NOT COMPLETED|Treatment Period Through Week 240||20
11008323|NCT00737568|12186105|FG001|NOT COMPLETED|Treatment Period Through Week 240||21
11008324|NCT00737568|12186104|FG000|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
11008325|NCT00737568|12186105|FG001|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
11008326|NCT00737568|12186104|FG000|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
11008327|NCT00737568|12186105|FG001|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
11008328|NCT00737568|12186104|FG000|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
11008329|NCT00737568|12186105|FG001|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
11008330|NCT00737633|12186113|FG000|STARTED|Overall Study||44
11008331|NCT00737633|12186114|FG001|STARTED|Overall Study||57
11008332|NCT00737633|12186113|FG000|COMPLETED|Overall Study||0
11008333|NCT00737633|12186114|FG001|COMPLETED|Overall Study||0
11008334|NCT00737633|12186113|FG000|NOT COMPLETED|Overall Study||44
11008335|NCT00737633|12186114|FG001|NOT COMPLETED|Overall Study||57
11008336|NCT00737672|12186122|FG000|STARTED|Overall Study||145
11008337|NCT00737672|12186123|FG001|STARTED|Overall Study||148
11008338|NCT00737672|12186122|FG000|Exclusions Due to Protocol Deviations|Overall Study||14
11008339|NCT00737672|12186123|FG001|Exclusions Due to Protocol Deviations|Overall Study||10
11008340|NCT00737672|12186122|FG000|Per Protocol Population|Overall Study||131
11008341|NCT00737672|12186123|FG001|Per Protocol Population|Overall Study||138
11008342|NCT00737672|12186122|FG000|COMPLETED|Overall Study||65
11008343|NCT00737672|12186123|FG001|COMPLETED|Overall Study||65
11008344|NCT00737672|12186122|FG000|NOT COMPLETED|Overall Study||80
11008345|NCT00737672|12186123|FG001|NOT COMPLETED|Overall Study||83
11008346|NCT00737698|12186132|FG000|STARTED|Overall Study||23
11008347|NCT00737698|12186133|FG001|STARTED|Overall Study||42
11008348|NCT00737698|12186134|FG002|STARTED|Overall Study||21
11008349|NCT00737698|12186132|FG000|COMPLETED|Overall Study||17
11008350|NCT00737698|12186133|FG001|COMPLETED|Overall Study||37
11008351|NCT00737698|12186134|FG002|COMPLETED|Overall Study||17
11008352|NCT00737698|12186132|FG000|NOT COMPLETED|Overall Study||6
11008353|NCT00737698|12186133|FG001|NOT COMPLETED|Overall Study||5
11008354|NCT00737698|12186134|FG002|NOT COMPLETED|Overall Study||4
11008355|NCT00737711|12186142|FG000|STARTED|Overall Study||189
11008356|NCT00737711|12186142|FG000|COMPLETED|Overall Study||158
11008357|NCT00737711|12186142|FG000|NOT COMPLETED|Overall Study||31
11008358|NCT00737737|12186148|FG000|STARTED|Overall Study||2
11008359|NCT00737737|12186149|FG001|STARTED|Overall Study||2
11008360|NCT00737737|12186148|FG000|COMPLETED|Overall Study||2
11008361|NCT00737737|12186149|FG001|COMPLETED|Overall Study||2
11008362|NCT00737737|12186148|FG000|NOT COMPLETED|Overall Study||0
11008363|NCT00737737|12186149|FG001|NOT COMPLETED|Overall Study||0
11008364|NCT00737893|12186157|FG000|STARTED|Overall Study||29
11008365|NCT00737893|12186158|FG001|STARTED|Overall Study||27
11008366|NCT00737893|12186157|FG000|COMPLETED|Overall Study||29
11008367|NCT00737893|12186158|FG001|COMPLETED|Overall Study||27
11008368|NCT00737893|12186157|FG000|NOT COMPLETED|Overall Study||0
11008369|NCT00737893|12186158|FG001|NOT COMPLETED|Overall Study||0
11008370|NCT00738023|12186166|FG000|STARTED|Intralipid Infusion||19
11008371|NCT00738023|12186167|FG001|STARTED|Intralipid Infusion||13
11008372|NCT00738023|12186166|FG000|COMPLETED|Intralipid Infusion||19
11008373|NCT00738023|12186167|FG001|COMPLETED|Intralipid Infusion||13
11008374|NCT00738023|12186166|FG000|NOT COMPLETED|Intralipid Infusion||0
11008375|NCT00738023|12186167|FG001|NOT COMPLETED|Intralipid Infusion||0
11008376|NCT00738023|12186166|FG000|STARTED|Saline Infusion||19
11008377|NCT00738023|12186167|FG001|STARTED|Saline Infusion||0
11008378|NCT00738023|12186166|FG000|COMPLETED|Saline Infusion||19
11008379|NCT00738023|12186167|FG001|COMPLETED|Saline Infusion||0
11008380|NCT00738023|12186166|FG000|NOT COMPLETED|Saline Infusion||0
11008381|NCT00738023|12186167|FG001|NOT COMPLETED|Saline Infusion||0
11008382|NCT00738023|12186166|FG000|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
11008383|NCT00738023|12186167|FG001|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
11008384|NCT00738023|12186166|FG000|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
11008385|NCT00738023|12186167|FG001|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
11008386|NCT00738023|12186166|FG000|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
11008387|NCT00738023|12186167|FG001|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
11008388|NCT00738049|12186176|FG000|STARTED|1st Intervention(14 Days)||13
11008389|NCT00738049|12186177|FG001|STARTED|1st Intervention(14 Days)||7
11008390|NCT00738049|12186176|FG000|COMPLETED|1st Intervention(14 Days)||13
11008391|NCT00738049|12186177|FG001|COMPLETED|1st Intervention(14 Days)||7
11008392|NCT00738049|12186176|FG000|NOT COMPLETED|1st Intervention(14 Days)||0
11008393|NCT00738049|12186177|FG001|NOT COMPLETED|1st Intervention(14 Days)||0
11396262|NCT03720652|12590095|FG001|Start Intervention|Overall Study||21
11396263|NCT03720652|12590094|FG000|Complete Intervention|Overall Study||10
11396264|NCT03720652|12590095|FG001|Complete Intervention|Overall Study||20
11396265|NCT03720652|12590094|FG000|3-Month Follow Up Interview|Overall Study||10
11396266|NCT03720652|12590095|FG001|3-Month Follow Up Interview|Overall Study||19
11396267|NCT03720652|12590094|FG000|6-Month Follow Up Interview|Overall Study||10
11396268|NCT03720652|12590095|FG001|6-Month Follow Up Interview|Overall Study||16
11396269|NCT03720652|12590094|FG000|COMPLETED|Overall Study||10
11396270|NCT03720652|12590095|FG001|COMPLETED|Overall Study||16
11008394|NCT00738049|12186176|FG000|STARTED|2nd Intervention(14 Days)||13
11008395|NCT00738049|12186177|FG001|STARTED|2nd Intervention(14 Days)||7
11396271|NCT03720652|12590094|FG000|NOT COMPLETED|Overall Study||2
11396272|NCT03720652|12590095|FG001|NOT COMPLETED|Overall Study||11
11008396|NCT00738049|12186176|FG000|COMPLETED|2nd Intervention(14 Days)||13
11008397|NCT00738049|12186177|FG001|COMPLETED|2nd Intervention(14 Days)||7
11008398|NCT00738049|12186176|FG000|NOT COMPLETED|2nd Intervention(14 Days)||0
11008399|NCT00738049|12186177|FG001|NOT COMPLETED|2nd Intervention(14 Days)||0
11008400|NCT00738049|12186176|FG000|STARTED|Washout||13
11008401|NCT00738049|12186177|FG001|STARTED|Washout||7
11008402|NCT00738049|12186176|FG000|COMPLETED|Washout||13
11008403|NCT00738049|12186177|FG001|COMPLETED|Washout||7
11008404|NCT00738049|12186176|FG000|NOT COMPLETED|Washout||0
11008405|NCT00738049|12186177|FG001|NOT COMPLETED|Washout||0
11008406|NCT00738062|12186192|FG000|STARTED|Open Label Treatment||103
11008407|NCT00738062|12186193|FG001|STARTED|Open Label Treatment||0
11008408|NCT00738062|12186194|FG002|STARTED|Open Label Treatment||0
11008409|NCT00738062|12186192|FG000|COMPLETED|Open Label Treatment||75
11008410|NCT00738062|12186193|FG001|COMPLETED|Open Label Treatment||0
11008411|NCT00738062|12186194|FG002|COMPLETED|Open Label Treatment||0
11008412|NCT00738062|12186192|FG000|NOT COMPLETED|Open Label Treatment||28
11008413|NCT00738062|12186193|FG001|NOT COMPLETED|Open Label Treatment||0
11008414|NCT00738062|12186194|FG002|NOT COMPLETED|Open Label Treatment||0
11008415|NCT00738062|12186192|FG000|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
11008416|NCT00738062|12186193|FG001|STARTED|2 Week Randomized Withdrawal||38
11008417|NCT00738062|12186194|FG002|STARTED|2 Week Randomized Withdrawal||37
11008418|NCT00738062|12186192|FG000|COMPLETED|2 Week Randomized Withdrawal||0
11008419|NCT00738062|12186193|FG001|COMPLETED|2 Week Randomized Withdrawal||38
11008420|NCT00738062|12186194|FG002|COMPLETED|2 Week Randomized Withdrawal||37
11008421|NCT00738062|12186192|FG000|NOT COMPLETED|2 Week Randomized Withdrawal||0
11008422|NCT00738062|12186193|FG001|NOT COMPLETED|2 Week Randomized Withdrawal||0
11008423|NCT00738062|12186194|FG002|NOT COMPLETED|2 Week Randomized Withdrawal||0
11008424|NCT00738062|12186192|FG000|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
11008425|NCT00738062|12186193|FG001|STARTED|Open-Label Extension||0
11008426|NCT00738062|12186194|FG002|STARTED|Open-Label Extension||0
11008427|NCT00738062|12186192|FG000|COMPLETED|Open-Label Extension||57
11008428|NCT00738062|12186193|FG001|COMPLETED|Open-Label Extension||0
11008429|NCT00738062|12186194|FG002|COMPLETED|Open-Label Extension||0
11008430|NCT00738062|12186192|FG000|NOT COMPLETED|Open-Label Extension||17
11008431|NCT00738062|12186193|FG001|NOT COMPLETED|Open-Label Extension||0
11008432|NCT00738062|12186194|FG002|NOT COMPLETED|Open-Label Extension||0
11008433|NCT00738101|12186203|FG000|STARTED|Overall Study||293
11008434|NCT00738101|12186203|FG000|COMPLETED|Overall Study|7 exclusions. 5 primary liver or unrelated disease, 1 died before Omegaven, 1 repeat enrollment|286
11008435|NCT00738101|12186203|FG000|NOT COMPLETED|Overall Study||7
11008436|NCT00738283|12186207|FG000|STARTED|Overall Study||17
11008437|NCT00738283|12186207|FG000|COMPLETED|Overall Study||13
11008438|NCT00738283|12186207|FG000|NOT COMPLETED|Overall Study||4
11008439|NCT00738361|12186211|FG000|STARTED|Overall Study||4
11008440|NCT00738361|12186211|FG000|COMPLETED|Overall Study||4
11008441|NCT00738361|12186211|FG000|NOT COMPLETED|Overall Study||0
11008442|NCT00738374|12186219|FG000|STARTED|Induction Treatment Phase||97
11008443|NCT00738374|12186220|FG001|STARTED|Induction Treatment Phase||0
11008444|NCT00738374|12186221|FG002|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
11008445|NCT00738374|12186222|FG003|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
11008446|NCT00738374|12186219|FG000|COMPLETED|Induction Treatment Phase||73
11008447|NCT00738374|12186220|FG001|COMPLETED|Induction Treatment Phase||0
11008448|NCT00738374|12186221|FG002|COMPLETED|Induction Treatment Phase||0
11008449|NCT00738374|12186222|FG003|COMPLETED|Induction Treatment Phase||0
11008450|NCT00738374|12186219|FG000|NOT COMPLETED|Induction Treatment Phase||24
11008451|NCT00738374|12186220|FG001|NOT COMPLETED|Induction Treatment Phase||0
11008452|NCT00738374|12186221|FG002|NOT COMPLETED|Induction Treatment Phase||0
11008453|NCT00738374|12186222|FG003|NOT COMPLETED|Induction Treatment Phase||0
11396273|NCT03720847|12590103|FG000|STARTED|Condition 1||15
11396274|NCT03720847|12590104|FG001|STARTED|Condition 1||15
11008454|NCT00738374|12186219|FG000|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
11008455|NCT00738374|12186220|FG001|STARTED|Maintenance Treatment/Observation Phase||7
11008456|NCT00738374|12186221|FG002|STARTED|Maintenance Treatment/Observation Phase||34
11008457|NCT00738374|12186222|FG003|STARTED|Maintenance Treatment/Observation Phase||32
11008458|NCT00738374|12186219|FG000|COMPLETED|Maintenance Treatment/Observation Phase||0
11008459|NCT00738374|12186220|FG001|COMPLETED|Maintenance Treatment/Observation Phase||0
11008460|NCT00738374|12186221|FG002|COMPLETED|Maintenance Treatment/Observation Phase||27
11008461|NCT00738374|12186222|FG003|COMPLETED|Maintenance Treatment/Observation Phase||20
11008462|NCT00738374|12186219|FG000|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
11008463|NCT00738374|12186220|FG001|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
11008464|NCT00738374|12186221|FG002|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
11008465|NCT00738374|12186222|FG003|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
11008466|NCT00738400|12186233|FG000|STARTED|Overall Study||76
11008467|NCT00738400|12186234|FG001|STARTED|Overall Study||74
11008468|NCT00738400|12186233|FG000|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
11008469|NCT00738400|12186234|FG001|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
11008470|NCT00738400|12186233|FG000|ITT (Intent To Treatment) Population|Overall Study||75
11396275|NCT03720847|12590103|FG000|COMPLETED|Condition 1||15
11008471|NCT00738400|12186234|FG001|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
11008472|NCT00738400|12186233|FG000|COMPLETED|Overall Study||72
11008473|NCT00738400|12186234|FG001|COMPLETED|Overall Study||67
11008474|NCT00738400|12186233|FG000|NOT COMPLETED|Overall Study||4
11396276|NCT03720847|12590104|FG001|COMPLETED|Condition 1||15
11008475|NCT00738400|12186234|FG001|NOT COMPLETED|Overall Study||7
11008476|NCT00738426|12186242|FG000|STARTED|Overall Study||37
11008477|NCT00738426|12186243|FG001|STARTED|Overall Study||35
11008478|NCT00738426|12186242|FG000|COMPLETED|Overall Study||35
11008479|NCT00738426|12186243|FG001|COMPLETED|Overall Study||32
11008480|NCT00738426|12186242|FG000|NOT COMPLETED|Overall Study||2
11008481|NCT00738426|12186243|FG001|NOT COMPLETED|Overall Study||3
11008482|NCT00738530|12186251|FG000|STARTED|Overall Study||327
11008483|NCT00738530|12186252|FG001|STARTED|Overall Study||322
11008484|NCT00738530|12186251|FG000|Treated|Overall Study||325
11008485|NCT00738530|12186252|FG001|Treated|Overall Study||316
11008486|NCT00738530|12186251|FG000|COMPLETED|Overall Study||93
11008487|NCT00738530|12186252|FG001|COMPLETED|Overall Study||84
11008488|NCT00738530|12186251|FG000|NOT COMPLETED|Overall Study||234
11008489|NCT00738530|12186252|FG001|NOT COMPLETED|Overall Study||238
11008490|NCT00738543|12186258|FG000|STARTED|Povidone Iodine||48
11008491|NCT00738543|12186258|FG000|COMPLETED|Povidone Iodine||48
11008492|NCT00738543|12186258|FG000|NOT COMPLETED|Povidone Iodine||0
11008493|NCT00738543|12186258|FG000|STARTED|Sodium Hypochlorite||48
11008494|NCT00738543|12186258|FG000|COMPLETED|Sodium Hypochlorite||48
11008495|NCT00738543|12186258|FG000|NOT COMPLETED|Sodium Hypochlorite||0
11008496|NCT00738543|12186258|FG000|STARTED|Control||48
11008497|NCT00738543|12186258|FG000|COMPLETED|Control||48
11008498|NCT00738543|12186258|FG000|NOT COMPLETED|Control||0
11008499|NCT00738673|12186264|FG000|STARTED|Overall Study||25
11008500|NCT00738673|12186265|FG001|STARTED|Overall Study||12
11008501|NCT00738673|12186264|FG000|Intent to Treat Population|Overall Study||24
11008502|NCT00738673|12186265|FG001|Intent to Treat Population|Overall Study||12
11008503|NCT00738673|12186264|FG000|COMPLETED|Overall Study||1
11008504|NCT00738673|12186265|FG001|COMPLETED|Overall Study||1
11008505|NCT00738673|12186264|FG000|NOT COMPLETED|Overall Study||24
11008506|NCT00738673|12186265|FG001|NOT COMPLETED|Overall Study||11
11008507|NCT00738699|12186273|FG000|STARTED|Overall Study||275
11008508|NCT00738699|12186274|FG001|STARTED|Overall Study||140
11008509|NCT00738699|12186273|FG000|Participants Not Treated|Overall Study||2
11008510|NCT00738699|12186274|FG001|Participants Not Treated|Overall Study||1
11008511|NCT00738699|12186273|FG000|Participants Treated|Overall Study||273
11008512|NCT00738699|12186274|FG001|Participants Treated|Overall Study||139
11008513|NCT00738699|12186273|FG000|COMPLETED|Overall Study||0
11008514|NCT00738699|12186274|FG001|COMPLETED|Overall Study||0
11008515|NCT00738699|12186273|FG000|NOT COMPLETED|Overall Study||275
11008516|NCT00738699|12186274|FG001|NOT COMPLETED|Overall Study||140
11008517|NCT00738881|12186282|FG000|STARTED|Overall Study||11
11008518|NCT00738881|12186283|FG001|STARTED|Overall Study||12
11008519|NCT00738881|12186282|FG000|COMPLETED|Overall Study||11
11008520|NCT00738881|12186283|FG001|COMPLETED|Overall Study||10
11008521|NCT00738881|12186282|FG000|NOT COMPLETED|Overall Study||0
11008522|NCT00738881|12186283|FG001|NOT COMPLETED|Overall Study||2
11008523|NCT00738894|12186291|FG000|STARTED|Overall Study||441
11008524|NCT00738894|12186292|FG001|STARTED|Overall Study||223
11008525|NCT00738894|12186291|FG000|COMPLETED|Overall Study||402
11008526|NCT00738894|12186292|FG001|COMPLETED|Overall Study||190
11008527|NCT00738894|12186291|FG000|NOT COMPLETED|Overall Study||39
11008528|NCT00738894|12186292|FG001|NOT COMPLETED|Overall Study||33
11008529|NCT00739102|12186298|FG000|STARTED|Overall Study||250
11008530|NCT00739102|12186298|FG000|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
11008531|NCT00739102|12186298|FG000|NOT COMPLETED|Overall Study||15
11008532|NCT00739297|12186302|FG000|STARTED|First Intervention (Visit 3 to Visit 4)||17
11008533|NCT00739297|12186303|FG001|STARTED|First Intervention (Visit 3 to Visit 4)||11
11008534|NCT00739297|12186304|FG002|STARTED|First Intervention (Visit 3 to Visit 4)||6
11008535|NCT00739297|12186305|FG003|STARTED|First Intervention (Visit 3 to Visit 4)||19
11008536|NCT00739297|12186306|FG004|STARTED|First Intervention (Visit 3 to Visit 4)||6
11008537|NCT00739297|12186307|FG005|STARTED|First Intervention (Visit 3 to Visit 4)||9
11008538|NCT00739297|12186308|FG006|STARTED|First Intervention (Visit 3 to Visit 4)||68
11008539|NCT00739297|12186302|FG000|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
11008540|NCT00739297|12186303|FG001|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
11008541|NCT00739297|12186304|FG002|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
11008542|NCT00739297|12186305|FG003|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
11008543|NCT00739297|12186306|FG004|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
11008544|NCT00739297|12186307|FG005|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
11008545|NCT00739297|12186308|FG006|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
11008546|NCT00739297|12186302|FG000|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
11008547|NCT00739297|12186303|FG001|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
11008548|NCT00739297|12186304|FG002|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
11008549|NCT00739297|12186305|FG003|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
11008550|NCT00739297|12186306|FG004|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
11008551|NCT00739297|12186307|FG005|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
11008552|NCT00739297|12186308|FG006|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
11008553|NCT00739297|12186302|FG000|STARTED|First Washout Period of 4-7 Days||17
11008554|NCT00739297|12186303|FG001|STARTED|First Washout Period of 4-7 Days||11
11008555|NCT00739297|12186304|FG002|STARTED|First Washout Period of 4-7 Days||6
11008556|NCT00739297|12186305|FG003|STARTED|First Washout Period of 4-7 Days||19
11008557|NCT00739297|12186306|FG004|STARTED|First Washout Period of 4-7 Days||6
11008558|NCT00739297|12186307|FG005|STARTED|First Washout Period of 4-7 Days||9
11008559|NCT00739297|12186308|FG006|STARTED|First Washout Period of 4-7 Days||68
11008560|NCT00739297|12186302|FG000|COMPLETED|First Washout Period of 4-7 Days||17
11008561|NCT00739297|12186303|FG001|COMPLETED|First Washout Period of 4-7 Days||11
11008562|NCT00739297|12186304|FG002|COMPLETED|First Washout Period of 4-7 Days||6
11008563|NCT00739297|12186305|FG003|COMPLETED|First Washout Period of 4-7 Days||17
11008564|NCT00739297|12186306|FG004|COMPLETED|First Washout Period of 4-7 Days||6
11008565|NCT00739297|12186307|FG005|COMPLETED|First Washout Period of 4-7 Days||9
11008566|NCT00739297|12186308|FG006|COMPLETED|First Washout Period of 4-7 Days||66
11008567|NCT00739297|12186302|FG000|NOT COMPLETED|First Washout Period of 4-7 Days||0
11008568|NCT00739297|12186303|FG001|NOT COMPLETED|First Washout Period of 4-7 Days||0
11008569|NCT00739297|12186304|FG002|NOT COMPLETED|First Washout Period of 4-7 Days||0
11008570|NCT00739297|12186305|FG003|NOT COMPLETED|First Washout Period of 4-7 Days||2
11008571|NCT00739297|12186306|FG004|NOT COMPLETED|First Washout Period of 4-7 Days||0
11008572|NCT00739297|12186307|FG005|NOT COMPLETED|First Washout Period of 4-7 Days||0
11008573|NCT00739297|12186308|FG006|NOT COMPLETED|First Washout Period of 4-7 Days||2
11008574|NCT00739297|12186302|FG000|STARTED|Second Intervention (Visit 5 to Visit 6)||18
11008575|NCT00739297|12186303|FG001|STARTED|Second Intervention (Visit 5 to Visit 6)||8
11008576|NCT00739297|12186304|FG002|STARTED|Second Intervention (Visit 5 to Visit 6)||10
11008577|NCT00739297|12186305|FG003|STARTED|Second Intervention (Visit 5 to Visit 6)||14
11008578|NCT00739297|12186306|FG004|STARTED|Second Intervention (Visit 5 to Visit 6)||6
11008579|NCT00739297|12186307|FG005|STARTED|Second Intervention (Visit 5 to Visit 6)||10
11008580|NCT00739297|12186308|FG006|STARTED|Second Intervention (Visit 5 to Visit 6)||66
11008581|NCT00739297|12186302|FG000|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
11008582|NCT00739297|12186303|FG001|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
11008583|NCT00739297|12186304|FG002|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
11008584|NCT00739297|12186305|FG003|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
11008585|NCT00739297|12186306|FG004|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
11008586|NCT00739297|12186307|FG005|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
11008587|NCT00739297|12186308|FG006|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
11008588|NCT00739297|12186302|FG000|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
11008589|NCT00739297|12186303|FG001|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
11008590|NCT00739297|12186304|FG002|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
11008591|NCT00739297|12186305|FG003|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
11008592|NCT00739297|12186306|FG004|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
11008593|NCT00739297|12186307|FG005|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
11008594|NCT00739297|12186308|FG006|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
11008595|NCT00739297|12186302|FG000|STARTED|Second Washout Period of 4-7 Days||18
11008596|NCT00739297|12186303|FG001|STARTED|Second Washout Period of 4-7 Days||8
11008597|NCT00739297|12186304|FG002|STARTED|Second Washout Period of 4-7 Days||10
11008598|NCT00739297|12186305|FG003|STARTED|Second Washout Period of 4-7 Days||14
11008599|NCT00739297|12186306|FG004|STARTED|Second Washout Period of 4-7 Days||6
11008600|NCT00739297|12186307|FG005|STARTED|Second Washout Period of 4-7 Days||10
11008601|NCT00739297|12186308|FG006|STARTED|Second Washout Period of 4-7 Days||66
11008602|NCT00739297|12186302|FG000|COMPLETED|Second Washout Period of 4-7 Days||18
11008603|NCT00739297|12186303|FG001|COMPLETED|Second Washout Period of 4-7 Days||8
11008604|NCT00739297|12186304|FG002|COMPLETED|Second Washout Period of 4-7 Days||10
11008605|NCT00739297|12186305|FG003|COMPLETED|Second Washout Period of 4-7 Days||14
11008606|NCT00739297|12186306|FG004|COMPLETED|Second Washout Period of 4-7 Days||6
11008607|NCT00739297|12186307|FG005|COMPLETED|Second Washout Period of 4-7 Days||10
11008608|NCT00739297|12186308|FG006|COMPLETED|Second Washout Period of 4-7 Days||66
11008609|NCT00739297|12186302|FG000|NOT COMPLETED|Second Washout Period of 4-7 Days||0
11008610|NCT00739297|12186303|FG001|NOT COMPLETED|Second Washout Period of 4-7 Days||0
11008611|NCT00739297|12186304|FG002|NOT COMPLETED|Second Washout Period of 4-7 Days||0
11008612|NCT00739297|12186305|FG003|NOT COMPLETED|Second Washout Period of 4-7 Days||0
11008613|NCT00739297|12186306|FG004|NOT COMPLETED|Second Washout Period of 4-7 Days||0
11008614|NCT00739297|12186307|FG005|NOT COMPLETED|Second Washout Period of 4-7 Days||0
11008615|NCT00739297|12186308|FG006|NOT COMPLETED|Second Washout Period of 4-7 Days||0
11008616|NCT00739297|12186302|FG000|STARTED|Third Intervention (Visit 7 to Visit 8)||16
11008617|NCT00739297|12186303|FG001|STARTED|Third Intervention (Visit 7 to Visit 8)||12
11008618|NCT00739297|12186304|FG002|STARTED|Third Intervention (Visit 7 to Visit 8)||6
11008619|NCT00739297|12186305|FG003|STARTED|Third Intervention (Visit 7 to Visit 8)||18
11008620|NCT00739297|12186306|FG004|STARTED|Third Intervention (Visit 7 to Visit 8)||6
11008621|NCT00739297|12186307|FG005|STARTED|Third Intervention (Visit 7 to Visit 8)||8
11008622|NCT00739297|12186308|FG006|STARTED|Third Intervention (Visit 7 to Visit 8)||66
11008623|NCT00739297|12186302|FG000|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
11008624|NCT00739297|12186303|FG001|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
11008625|NCT00739297|12186304|FG002|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
11008626|NCT00739297|12186305|FG003|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
11008627|NCT00739297|12186306|FG004|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
11008628|NCT00739297|12186307|FG005|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
11008629|NCT00739297|12186308|FG006|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
11008630|NCT00739297|12186302|FG000|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
11008631|NCT00739297|12186303|FG001|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
11008632|NCT00739297|12186304|FG002|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
11008633|NCT00739297|12186305|FG003|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
11008634|NCT00739297|12186306|FG004|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
11008635|NCT00739297|12186307|FG005|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
11008636|NCT00739297|12186308|FG006|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
11008637|NCT00739297|12186302|FG000|STARTED|Third Washout Period of 4-7 Days||16
11008638|NCT00739297|12186303|FG001|STARTED|Third Washout Period of 4-7 Days||12
11008639|NCT00739297|12186304|FG002|STARTED|Third Washout Period of 4-7 Days||6
11008640|NCT00739297|12186305|FG003|STARTED|Third Washout Period of 4-7 Days||18
11008641|NCT00739297|12186306|FG004|STARTED|Third Washout Period of 4-7 Days||6
11008642|NCT00739297|12186307|FG005|STARTED|Third Washout Period of 4-7 Days||8
11008643|NCT00739297|12186308|FG006|STARTED|Third Washout Period of 4-7 Days||66
11008644|NCT00739297|12186302|FG000|COMPLETED|Third Washout Period of 4-7 Days||16
11008645|NCT00739297|12186303|FG001|COMPLETED|Third Washout Period of 4-7 Days||12
11008646|NCT00739297|12186304|FG002|COMPLETED|Third Washout Period of 4-7 Days||6
11008647|NCT00739297|12186305|FG003|COMPLETED|Third Washout Period of 4-7 Days||18
11008648|NCT00739297|12186306|FG004|COMPLETED|Third Washout Period of 4-7 Days||6
11008649|NCT00739297|12186307|FG005|COMPLETED|Third Washout Period of 4-7 Days||8
11008650|NCT00739297|12186308|FG006|COMPLETED|Third Washout Period of 4-7 Days||66
11008651|NCT00739297|12186302|FG000|NOT COMPLETED|Third Washout Period of 4-7 Days||0
11008652|NCT00739297|12186303|FG001|NOT COMPLETED|Third Washout Period of 4-7 Days||0
11008653|NCT00739297|12186304|FG002|NOT COMPLETED|Third Washout Period of 4-7 Days||0
11008654|NCT00739297|12186305|FG003|NOT COMPLETED|Third Washout Period of 4-7 Days||0
11008655|NCT00739297|12186306|FG004|NOT COMPLETED|Third Washout Period of 4-7 Days||0
11008656|NCT00739297|12186307|FG005|NOT COMPLETED|Third Washout Period of 4-7 Days||0
11008657|NCT00739297|12186308|FG006|NOT COMPLETED|Third Washout Period of 4-7 Days||0
11008658|NCT00739297|12186302|FG000|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
11008659|NCT00739297|12186303|FG001|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
11008660|NCT00739297|12186304|FG002|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
11008661|NCT00739297|12186305|FG003|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
11008662|NCT00739297|12186306|FG004|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
11142607|NCT01468844|12329376|FG001|NOT COMPLETED|Overall Study||0
11142608|NCT01468909|12329387|FG000|STARTED|Overall Study||52
11142609|NCT01468909|12329388|FG001|STARTED|Overall Study||54
11008663|NCT00739297|12186307|FG005|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
11142610|NCT01468909|12329387|FG000|COMPLETED|Overall Study||50
11008664|NCT00739297|12186308|FG006|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
11008665|NCT00739297|12186302|FG000|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
11008666|NCT00739297|12186303|FG001|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
11008667|NCT00739297|12186304|FG002|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
11008668|NCT00739297|12186305|FG003|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
11142611|NCT01468909|12329388|FG001|COMPLETED|Overall Study||52
11008669|NCT00739297|12186306|FG004|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
11008670|NCT00739297|12186307|FG005|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
11008671|NCT00739297|12186308|FG006|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
11008672|NCT00739297|12186302|FG000|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
11142612|NCT01468909|12329387|FG000|NOT COMPLETED|Overall Study||2
11142613|NCT01468909|12329388|FG001|NOT COMPLETED|Overall Study||2
11142614|NCT01468974|12329394|FG000|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35
11142615|NCT01468974|12329394|FG000|COMPLETED|1 Month Follow-up||34
11142616|NCT01468974|12329394|FG000|NOT COMPLETED|1 Month Follow-up||1
11142617|NCT01468974|12329394|FG000|STARTED|6 Months Follow-up||34
11142618|NCT01468974|12329394|FG000|COMPLETED|6 Months Follow-up||34
11142619|NCT01468974|12329394|FG000|NOT COMPLETED|6 Months Follow-up||0
11142620|NCT01468974|12329394|FG000|STARTED|1 Year Follow-up||34
11142621|NCT01468974|12329394|FG000|COMPLETED|1 Year Follow-up||34
11142622|NCT01468974|12329394|FG000|NOT COMPLETED|1 Year Follow-up||0
11142623|NCT01468974|12329394|FG000|STARTED|2 Years Follow-up||34
11142624|NCT01468974|12329394|FG000|COMPLETED|2 Years Follow-up||32
11142625|NCT01468974|12329394|FG000|NOT COMPLETED|2 Years Follow-up||2
11142626|NCT01468974|12329394|FG000|STARTED|3 Years Follow-up||32
11142627|NCT01468974|12329394|FG000|COMPLETED|3 Years Follow-up||26
11142628|NCT01468974|12329394|FG000|NOT COMPLETED|3 Years Follow-up||6
11142629|NCT01468987|12329400|FG000|STARTED|Overall Study||691
11142630|NCT01468987|12329401|FG001|STARTED|Overall Study||678
11142631|NCT01468987|12329400|FG000|Received at Least 1 Dose of Study Drug|Overall Study||691
11142632|NCT01468987|12329401|FG001|Received at Least 1 Dose of Study Drug|Overall Study||677
11142633|NCT01468987|12329400|FG000|COMPLETED|Overall Study||620
11142634|NCT01468987|12329401|FG001|COMPLETED|Overall Study||618
11142635|NCT01468987|12329400|FG000|NOT COMPLETED|Overall Study||71
11142636|NCT01468987|12329401|FG001|NOT COMPLETED|Overall Study||60
11142637|NCT01469000|12329411|FG000|STARTED|Overall Study||129
11142638|NCT01469000|12329412|FG001|STARTED|Overall Study||66
11142639|NCT01469000|12329411|FG000|Received at Least 1 Dose of Study Drug|Overall Study||126
11142640|NCT01469000|12329412|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65
11142641|NCT01469000|12329411|FG000|COMPLETED|Overall Study||109
11142642|NCT01469000|12329412|FG001|COMPLETED|Overall Study||62
11142643|NCT01469000|12329411|FG000|NOT COMPLETED|Overall Study||20
11142644|NCT01469000|12329412|FG001|NOT COMPLETED|Overall Study||4
11142645|NCT01469013|12329423|FG000|STARTED|Part A (Treatment Period)||24
11142646|NCT01469013|12329424|FG001|STARTED|Part A (Treatment Period)||24
11263701|NCT02271984|12459066|FG005|STARTED|Fourth Intervention Period (Day 1)||3
11263702|NCT02271984|12459067|FG006|STARTED|Fourth Intervention Period (Day 1)||3
11263703|NCT02271984|12459068|FG007|STARTED|Fourth Intervention Period (Day 1)||3
11263704|NCT02271984|12459069|FG008|STARTED|Fourth Intervention Period (Day 1)||3
11263705|NCT02271984|12459070|FG009|STARTED|Fourth Intervention Period (Day 1)||3
11263706|NCT02271984|12459071|FG010|STARTED|Fourth Intervention Period (Day 1)||3
11263707|NCT02271984|12459072|FG011|STARTED|Fourth Intervention Period (Day 1)||3
11263708|NCT02271984|12459061|FG000|COMPLETED|Fourth Intervention Period (Day 1)||3
11263709|NCT02271984|12459062|FG001|COMPLETED|Fourth Intervention Period (Day 1)||3
11263710|NCT02271984|12459063|FG002|COMPLETED|Fourth Intervention Period (Day 1)||3
11263711|NCT02271984|12459064|FG003|COMPLETED|Fourth Intervention Period (Day 1)||3
11263712|NCT02271984|12459065|FG004|COMPLETED|Fourth Intervention Period (Day 1)||3
11263713|NCT02271984|12459066|FG005|COMPLETED|Fourth Intervention Period (Day 1)||3
11263714|NCT02271984|12459067|FG006|COMPLETED|Fourth Intervention Period (Day 1)||3
11263715|NCT02271984|12459068|FG007|COMPLETED|Fourth Intervention Period (Day 1)||3
11263716|NCT02271984|12459069|FG008|COMPLETED|Fourth Intervention Period (Day 1)||3
11263717|NCT02271984|12459070|FG009|COMPLETED|Fourth Intervention Period (Day 1)||3
11263718|NCT02271984|12459071|FG010|COMPLETED|Fourth Intervention Period (Day 1)||3
11263719|NCT02271984|12459072|FG011|COMPLETED|Fourth Intervention Period (Day 1)||3
11263720|NCT02271984|12459061|FG000|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
11263721|NCT02271984|12459062|FG001|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
11263722|NCT02271984|12459063|FG002|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
11008673|NCT00739297|12186303|FG001|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
11008674|NCT00739297|12186304|FG002|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
11008675|NCT00739297|12186305|FG003|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
11008676|NCT00739297|12186306|FG004|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
11008677|NCT00739297|12186307|FG005|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
11263723|NCT02271984|12459064|FG003|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
11263724|NCT02271984|12459065|FG004|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
11263725|NCT02271984|12459066|FG005|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
11263726|NCT02271984|12459067|FG006|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
11263727|NCT02271984|12459068|FG007|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
11263728|NCT02271984|12459069|FG008|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
11263729|NCT02271984|12459070|FG009|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
11263730|NCT02271984|12459071|FG010|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
11263731|NCT02271984|12459072|FG011|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
11263732|NCT02271984|12459061|FG000|STARTED|Washout Period 4 (7 Days)||3
11008678|NCT00739297|12186308|FG006|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
11008679|NCT00739310|12186324|FG000|STARTED|Overall Study||29
11008680|NCT00739310|12186324|FG000|COMPLETED|Overall Study||22
11008681|NCT00739310|12186324|FG000|NOT COMPLETED|Overall Study||7
11008682|NCT00739336|12186331|FG000|STARTED|Overall Study||21
11008683|NCT00739336|12186332|FG001|STARTED|Overall Study||24
11008684|NCT00739336|12186331|FG000|COMPLETED|Overall Study||17
11008685|NCT00739336|12186332|FG001|COMPLETED|Overall Study||24
11396277|NCT03720847|12590103|FG000|NOT COMPLETED|Condition 1||0
11396278|NCT03720847|12590104|FG001|NOT COMPLETED|Condition 1||0
11396279|NCT03720847|12590103|FG000|STARTED|Washout||15
11396280|NCT03720847|12590104|FG001|STARTED|Washout||15
11396281|NCT03720847|12590103|FG000|COMPLETED|Washout||14
11396282|NCT03720847|12590104|FG001|COMPLETED|Washout||13
11008686|NCT00739336|12186331|FG000|NOT COMPLETED|Overall Study||4
11008687|NCT00739336|12186332|FG001|NOT COMPLETED|Overall Study||0
11008688|NCT00739583|12186340|FG000|STARTED|Overall Study||10
11008689|NCT00739583|12186341|FG001|STARTED|Overall Study||10
11008690|NCT00739583|12186340|FG000|COMPLETED|Overall Study||10
11008691|NCT00739583|12186341|FG001|COMPLETED|Overall Study||10
11008692|NCT00739583|12186340|FG000|NOT COMPLETED|Overall Study||0
11008693|NCT00739583|12186341|FG001|NOT COMPLETED|Overall Study||0
11008694|NCT00739596|12186349|FG000|STARTED|Overall Study||166
11008695|NCT00739596|12186350|FG001|STARTED|Overall Study||166
11008696|NCT00739596|12186349|FG000|COMPLETED|Overall Study||141
11008697|NCT00739596|12186350|FG001|COMPLETED|Overall Study||149
11008698|NCT00739596|12186349|FG000|NOT COMPLETED|Overall Study||25
11008699|NCT00739596|12186350|FG001|NOT COMPLETED|Overall Study||17
11008700|NCT00739648|12186358|FG000|STARTED|Overall Study||108
11008701|NCT00739648|12186359|FG001|STARTED|Overall Study||214
11008702|NCT00739648|12186358|FG000|COMPLETED|Overall Study||82
11008703|NCT00739648|12186359|FG001|COMPLETED|Overall Study||161
11008704|NCT00739648|12186358|FG000|NOT COMPLETED|Overall Study||26
11008705|NCT00739648|12186359|FG001|NOT COMPLETED|Overall Study||53
11008706|NCT00739661|12186371|FG000|STARTED|Overall Study||52
11008707|NCT00739661|12186372|FG001|STARTED|Overall Study||52
11008708|NCT00739661|12186371|FG000|COMPLETED|Overall Study||6
11008709|NCT00739661|12186372|FG001|COMPLETED|Overall Study||10
11008710|NCT00739661|12186371|FG000|NOT COMPLETED|Overall Study||46
11008711|NCT00739661|12186372|FG001|NOT COMPLETED|Overall Study||42
11008712|NCT00739752|12186384|FG000|STARTED|Overall Study||299
11008713|NCT00739752|12186385|FG001|STARTED|Overall Study||284
11008714|NCT00739752|12186386|FG002|STARTED|Overall Study||292
11008715|NCT00739752|12186387|FG003|STARTED|Overall Study||288
11008716|NCT00739752|12186388|FG004|STARTED|Overall Study||291
11008717|NCT00739752|12186389|FG005|STARTED|Overall Study||293
11008718|NCT00739752|12186384|FG000|COMPLETED|Overall Study||299
11008719|NCT00739752|12186385|FG001|COMPLETED|Overall Study||284
11008720|NCT00739752|12186386|FG002|COMPLETED|Overall Study||292
11008721|NCT00739752|12186387|FG003|COMPLETED|Overall Study||288
11008722|NCT00739752|12186388|FG004|COMPLETED|Overall Study||291
11008723|NCT00739752|12186389|FG005|COMPLETED|Overall Study||293
11008724|NCT00739752|12186384|FG000|NOT COMPLETED|Overall Study||0
11008725|NCT00739752|12186385|FG001|NOT COMPLETED|Overall Study||0
11008726|NCT00739752|12186386|FG002|NOT COMPLETED|Overall Study||0
11008727|NCT00739752|12186387|FG003|NOT COMPLETED|Overall Study||0
11008728|NCT00739752|12186388|FG004|NOT COMPLETED|Overall Study||0
11008729|NCT00739752|12186389|FG005|NOT COMPLETED|Overall Study||0
11008730|NCT00739765|12186406|FG000|STARTED|Overall Study||40
11008731|NCT00739765|12186407|FG001|STARTED|Overall Study||38
11008732|NCT00739765|12186408|FG002|STARTED|Overall Study||32
11008733|NCT00739765|12186406|FG000|COMPLETED|Overall Study||34
11008734|NCT00739765|12186407|FG001|COMPLETED|Overall Study||27
11008735|NCT00739765|12186408|FG002|COMPLETED|Overall Study||21
11008736|NCT00739765|12186406|FG000|NOT COMPLETED|Overall Study||6
11008737|NCT00739765|12186407|FG001|NOT COMPLETED|Overall Study||11
11008738|NCT00739765|12186408|FG002|NOT COMPLETED|Overall Study||11
11008739|NCT00739908|12186418|FG000|STARTED|Overall Study||142
11008740|NCT00739908|12186419|FG001|STARTED|Overall Study||143
11008741|NCT00739908|12186418|FG000|COMPLETED|Overall Study||117
11008742|NCT00739908|12186419|FG001|COMPLETED|Overall Study||118
11008743|NCT00739908|12186418|FG000|NOT COMPLETED|Overall Study||25
11008744|NCT00739908|12186419|FG001|NOT COMPLETED|Overall Study||25
11008745|NCT00739934|12186427|FG000|STARTED|Voriconazole IV||40
11008746|NCT00739934|12186427|FG000|COMPLETED|Voriconazole IV||34
11008747|NCT00739934|12186427|FG000|NOT COMPLETED|Voriconazole IV||6
11008748|NCT00739934|12186427|FG000|STARTED|Voriconazole Oral||34
11008749|NCT00739934|12186427|FG000|COMPLETED|Voriconazole Oral||31
11008750|NCT00739934|12186427|FG000|NOT COMPLETED|Voriconazole Oral||3
11008751|NCT00739960|12186436|FG000|STARTED|Overall Study||1
11008752|NCT00739960|12186436|FG000|COMPLETED|Overall Study||1
11008753|NCT00739960|12186436|FG000|NOT COMPLETED|Overall Study||0
11008754|NCT00739973|12186449|FG000|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
11008755|NCT00739973|12186450|FG001|STARTED|Single-blind Period (2 to 4 Weeks)||0
11396283|NCT03720847|12590103|FG000|NOT COMPLETED|Washout||1
11008756|NCT00739973|12186451|FG002|STARTED|Single-blind Period (2 to 4 Weeks)||0
11008757|NCT00739973|12186452|FG003|STARTED|Single-blind Period (2 to 4 Weeks)||0
11008758|NCT00739973|12186453|FG004|STARTED|Single-blind Period (2 to 4 Weeks)||0
11008759|NCT00739973|12186454|FG005|STARTED|Single-blind Period (2 to 4 Weeks)||0
11008760|NCT00739973|12186455|FG006|STARTED|Single-blind Period (2 to 4 Weeks)||0
11396284|NCT03720847|12590104|FG001|NOT COMPLETED|Washout||2
11396285|NCT03720847|12590103|FG000|STARTED|Condition 2||14
11008761|NCT00739973|12186456|FG007|STARTED|Single-blind Period (2 to 4 Weeks)||0
11008762|NCT00739973|12186457|FG008|STARTED|Single-blind Period (2 to 4 Weeks)||0
11008763|NCT00739973|12186449|FG000|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
11008764|NCT00739973|12186450|FG001|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008765|NCT00739973|12186451|FG002|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008766|NCT00739973|12186452|FG003|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008767|NCT00739973|12186453|FG004|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008768|NCT00739973|12186454|FG005|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008769|NCT00739973|12186455|FG006|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008770|NCT00739973|12186456|FG007|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008771|NCT00739973|12186457|FG008|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008772|NCT00739973|12186449|FG000|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
11008773|NCT00739973|12186450|FG001|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008774|NCT00739973|12186451|FG002|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008775|NCT00739973|12186452|FG003|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008776|NCT00739973|12186453|FG004|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008777|NCT00739973|12186454|FG005|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008778|NCT00739973|12186455|FG006|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008779|NCT00739973|12186456|FG007|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008780|NCT00739973|12186457|FG008|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
11008781|NCT00739973|12186449|FG000|STARTED|Double-blind:Randomized Period (8 Weeks)||198
11008782|NCT00739973|12186450|FG001|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
11008783|NCT00739973|12186451|FG002|STARTED|Double-blind:Randomized Period (8 Weeks)||203
11008784|NCT00739973|12186452|FG003|STARTED|Double-blind:Randomized Period (8 Weeks)||185
11008785|NCT00739973|12186453|FG004|STARTED|Double-blind:Randomized Period (8 Weeks)||181
11008786|NCT00739973|12186454|FG005|STARTED|Double-blind:Randomized Period (8 Weeks)||181
11008787|NCT00739973|12186455|FG006|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
11008788|NCT00739973|12186456|FG007|STARTED|Double-blind:Randomized Period (8 Weeks)||178
11008789|NCT00739973|12186457|FG008|STARTED|Double-blind:Randomized Period (8 Weeks)||184
11008790|NCT00739973|12186449|FG000|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
11008791|NCT00739973|12186450|FG001|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
11008792|NCT00739973|12186451|FG002|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
11008793|NCT00739973|12186452|FG003|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
11008794|NCT00739973|12186453|FG004|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
11008795|NCT00739973|12186454|FG005|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
11008796|NCT00739973|12186455|FG006|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
11008797|NCT00739973|12186456|FG007|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
11008798|NCT00739973|12186457|FG008|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
11008799|NCT00739973|12186449|FG000|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
11008800|NCT00739973|12186450|FG001|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
11008801|NCT00739973|12186451|FG002|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
11008802|NCT00739973|12186452|FG003|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
11008803|NCT00739973|12186453|FG004|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
11008804|NCT00739973|12186454|FG005|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
11008805|NCT00739973|12186455|FG006|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
11008806|NCT00739973|12186456|FG007|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
11008807|NCT00739973|12186457|FG008|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
11008808|NCT00739999|12186487|FG000|STARTED|Overall Study||15
11008809|NCT00739999|12186488|FG001|STARTED|Overall Study||24
11008810|NCT00739999|12186487|FG000|COMPLETED|Overall Study||15
11008811|NCT00739999|12186488|FG001|COMPLETED|Overall Study||24
11396286|NCT03720847|12590104|FG001|STARTED|Condition 2||13
11396287|NCT03720847|12590103|FG000|COMPLETED|Condition 2||14
11396288|NCT03720847|12590104|FG001|COMPLETED|Condition 2||13
11396289|NCT03720847|12590103|FG000|NOT COMPLETED|Condition 2||0
11008812|NCT00739999|12186487|FG000|NOT COMPLETED|Overall Study||0
11008813|NCT00739999|12186488|FG001|NOT COMPLETED|Overall Study||0
11008814|NCT00740051|12186501|FG000|STARTED|Overall Study||76
11008815|NCT00740051|12186502|FG001|STARTED|Overall Study||151
11008816|NCT00740051|12186501|FG000|COMPLETED|Overall Study||58
11008817|NCT00740051|12186502|FG001|COMPLETED|Overall Study||119
11008818|NCT00740051|12186501|FG000|NOT COMPLETED|Overall Study||18
11008819|NCT00740051|12186502|FG001|NOT COMPLETED|Overall Study||32
11008820|NCT00740129|12186509|FG000|STARTED|Overall Study||6
11008821|NCT00740129|12186509|FG000|COMPLETED|Overall Study||6
11008822|NCT00740129|12186509|FG000|NOT COMPLETED|Overall Study||0
11008823|NCT00740207|12186516|FG000|STARTED|Overall Study||17
11396290|NCT03720847|12590104|FG001|NOT COMPLETED|Condition 2||0
11008824|NCT00740207|12186517|FG001|STARTED|Overall Study||16
11008825|NCT00740207|12186516|FG000|COMPLETED|Overall Study||17
11008826|NCT00740207|12186517|FG001|COMPLETED|Overall Study||16
11396291|NCT03720938|12590113|FG000|STARTED|Overall Study||242
11396292|NCT03720938|12590114|FG001|STARTED|Overall Study||676
11008827|NCT00740207|12186516|FG000|NOT COMPLETED|Overall Study||0
11008828|NCT00740207|12186517|FG001|NOT COMPLETED|Overall Study||0
11008829|NCT00740220|12186527|FG000|STARTED|Overall Study||97
11008830|NCT00740220|12186527|FG000|COMPLETED|Overall Study||88
11008831|NCT00740220|12186527|FG000|NOT COMPLETED|Overall Study||9
11008832|NCT00740376|12186533|FG000|STARTED|Overall Study||22
11008833|NCT00740376|12186534|FG001|STARTED|Overall Study||15
11008834|NCT00740376|12186533|FG000|COMPLETED|Overall Study||19
11008835|NCT00740376|12186534|FG001|COMPLETED|Overall Study||12
11008836|NCT00740376|12186533|FG000|NOT COMPLETED|Overall Study||3
11008837|NCT00740376|12186534|FG001|NOT COMPLETED|Overall Study||3
11008838|NCT00740584|12186540|FG000|STARTED|Overall Study||12
11008839|NCT00740584|12186540|FG000|COMPLETED|Overall Study||11
11008840|NCT00740584|12186540|FG000|NOT COMPLETED|Overall Study||1
11008841|NCT00740636|12186547|FG000|STARTED|Overall Study||25
11008842|NCT00740636|12186548|FG001|STARTED|Overall Study||67
11008843|NCT00740636|12186547|FG000|COMPLETED|Overall Study||23
11008844|NCT00740636|12186548|FG001|COMPLETED|Overall Study||63
11008845|NCT00740636|12186547|FG000|NOT COMPLETED|Overall Study||2
11008846|NCT00740636|12186548|FG001|NOT COMPLETED|Overall Study||4
11008847|NCT00740714|12186557|FG000|STARTED|Overall Study|Randomized throughout the recruitment period|196
11008848|NCT00740714|12186558|FG001|STARTED|Overall Study|Randomized throughout the recruitment period|201
11008849|NCT00740714|12186559|FG002|STARTED|Overall Study|Randomized throughout the recruitment period|203
11008850|NCT00740714|12186557|FG000|Reaching Endpoint Before May 6, 2011|Overall Study||86
11008851|NCT00740714|12186558|FG001|Reaching Endpoint Before May 6, 2011|Overall Study||87
11008852|NCT00740714|12186559|FG002|Reaching Endpoint Before May 6, 2011|Overall Study||94
11008853|NCT00740714|12186557|FG000|Active Patients at Study Termination|Overall Study||24
11008854|NCT00740714|12186558|FG001|Active Patients at Study Termination|Overall Study||12
11008855|NCT00740714|12186559|FG002|Active Patients at Study Termination|Overall Study||33
11008856|NCT00740714|12186557|FG000|COMPLETED|Overall Study||179
11008857|NCT00740714|12186558|FG001|COMPLETED|Overall Study||182
11008858|NCT00740714|12186559|FG002|COMPLETED|Overall Study||174
11008859|NCT00740714|12186557|FG000|NOT COMPLETED|Overall Study||17
11008860|NCT00740714|12186558|FG001|NOT COMPLETED|Overall Study||19
11008861|NCT00740714|12186559|FG002|NOT COMPLETED|Overall Study||29
11008862|NCT00740779|12186570|FG000|STARTED|Overall Study||52
11008863|NCT00740779|12186571|FG001|STARTED|Overall Study||45
11008864|NCT00740779|12186572|FG002|STARTED|Overall Study||54
11008865|NCT00740779|12186570|FG000|COMPLETED|Overall Study||43
11008866|NCT00740779|12186571|FG001|COMPLETED|Overall Study||31
11008867|NCT00740779|12186572|FG002|COMPLETED|Overall Study||41
11008868|NCT00740779|12186570|FG000|NOT COMPLETED|Overall Study||9
11008869|NCT00740779|12186571|FG001|NOT COMPLETED|Overall Study||14
11008870|NCT00740779|12186572|FG002|NOT COMPLETED|Overall Study||13
11008871|NCT00740792|12186584|FG000|STARTED|Overall Study||193
11008872|NCT00740792|12186585|FG001|STARTED|Overall Study||194
11008873|NCT00740792|12186586|FG002|STARTED|Overall Study||189
11008874|NCT00740792|12186587|FG003|STARTED|Overall Study||200
11008875|NCT00740792|12186584|FG000|COMPLETED|Overall Study||183
11008876|NCT00740792|12186585|FG001|COMPLETED|Overall Study||186
11008877|NCT00740792|12186586|FG002|COMPLETED|Overall Study||180
11008878|NCT00740792|12186587|FG003|COMPLETED|Overall Study||190
11008879|NCT00740792|12186584|FG000|NOT COMPLETED|Overall Study||10
11008880|NCT00740792|12186585|FG001|NOT COMPLETED|Overall Study||8
11008881|NCT00740792|12186586|FG002|NOT COMPLETED|Overall Study||9
11008882|NCT00740792|12186587|FG003|NOT COMPLETED|Overall Study||10
11008883|NCT00740831|12186600|FG000|STARTED|Overall Study|Safety population|97
11008884|NCT00740831|12186601|FG001|STARTED|Overall Study|Safety population|103
11008885|NCT00740831|12186602|FG002|STARTED|Overall Study|Safety population|101
11008886|NCT00740831|12186600|FG000|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
11008887|NCT00740831|12186601|FG001|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
11008888|NCT00740831|12186602|FG002|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
11008889|NCT00740831|12186600|FG000|NOT COMPLETED|Overall Study||4
11008890|NCT00740831|12186601|FG001|NOT COMPLETED|Overall Study||3
11008891|NCT00740831|12186602|FG002|NOT COMPLETED|Overall Study||6
11008892|NCT00740857|12186613|FG000|STARTED|Overall Study||33
11008893|NCT00740857|12186614|FG001|STARTED|Overall Study||88
11008894|NCT00740857|12186615|FG002|STARTED|Overall Study||90
11008895|NCT00740857|12186613|FG000|COMPLETED|Overall Study||32
11008896|NCT00740857|12186614|FG001|COMPLETED|Overall Study||88
11008897|NCT00740857|12186615|FG002|COMPLETED|Overall Study||90
11008898|NCT00740857|12186613|FG000|NOT COMPLETED|Overall Study||1
11008899|NCT00740857|12186614|FG001|NOT COMPLETED|Overall Study||0
11008900|NCT00740857|12186615|FG002|NOT COMPLETED|Overall Study||0
11056562|NCT00995020|12238191|FG000|NOT COMPLETED|Overall Study||3
11056563|NCT00995020|12238192|FG001|NOT COMPLETED|Overall Study||7
11056564|NCT00995072|12238202|FG000|STARTED|Overall Study||10
11056565|NCT00995072|12238203|FG001|STARTED|Overall Study||15
11056566|NCT00995072|12238202|FG000|COMPLETED|Overall Study||9
11056567|NCT00995072|12238203|FG001|COMPLETED|Overall Study||12
11056568|NCT00995072|12238202|FG000|NOT COMPLETED|Overall Study||1
11056569|NCT00995072|12238203|FG001|NOT COMPLETED|Overall Study||3
11056570|NCT00995085|12238209|FG000|STARTED|Overall Study||43
11056571|NCT00995085|12238209|FG000|COMPLETED|Overall Study||38
11056572|NCT00995085|12238209|FG000|NOT COMPLETED|Overall Study||5
11056573|NCT00995215|12238213|FG000|STARTED|Overall Study||6
11056574|NCT00995215|12238213|FG000|COMPLETED|Overall Study||6
11056575|NCT00995215|12238213|FG000|NOT COMPLETED|Overall Study||0
11056576|NCT00995345|12238223|FG000|STARTED|Overall Study||81
11056577|NCT00995345|12238224|FG001|STARTED|Overall Study||81
11056578|NCT00995345|12238225|FG002|STARTED|Overall Study||80
11056579|NCT00995345|12238226|FG003|STARTED|Overall Study||81
11056580|NCT00995345|12238227|FG004|STARTED|Overall Study||80
11056581|NCT00995345|12238223|FG000|COMPLETED|Overall Study||70
11056582|NCT00995345|12238224|FG001|COMPLETED|Overall Study||74
11056583|NCT00995345|12238225|FG002|COMPLETED|Overall Study||73
11056584|NCT00995345|12238226|FG003|COMPLETED|Overall Study||76
11056585|NCT00995345|12238227|FG004|COMPLETED|Overall Study||75
11056586|NCT00995345|12238223|FG000|NOT COMPLETED|Overall Study||11
11056587|NCT00995345|12238224|FG001|NOT COMPLETED|Overall Study||7
11056588|NCT00995345|12238225|FG002|NOT COMPLETED|Overall Study||7
11056589|NCT00995345|12238226|FG003|NOT COMPLETED|Overall Study||5
11056590|NCT00995345|12238227|FG004|NOT COMPLETED|Overall Study||5
11056591|NCT00995371|12238241|FG000|STARTED|Prior to ESI Cross-over, 6 Weeks||21
11056592|NCT00995371|12238242|FG001|STARTED|Prior to ESI Cross-over, 6 Weeks||17
11056593|NCT00995371|12238241|FG000|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
11056594|NCT00995371|12238242|FG001|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
11056595|NCT00995371|12238241|FG000|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
11056596|NCT00995371|12238242|FG001|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
11056597|NCT00995371|12238241|FG000|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
11056598|NCT00995371|12238242|FG001|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
11056599|NCT00995371|12238241|FG000|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
11056600|NCT00995371|12238242|FG001|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
11396293|NCT03720938|12590113|FG000|COMPLETED|Overall Study||53
11396294|NCT03720938|12590114|FG001|COMPLETED|Overall Study||53
11396295|NCT03720938|12590113|FG000|NOT COMPLETED|Overall Study||189
11396296|NCT03720938|12590114|FG001|NOT COMPLETED|Overall Study||623
11396297|NCT03721549|12590133|FG000|STARTED|Overall Study||8
11396298|NCT03721549|12590134|FG001|STARTED|Overall Study||8
11396299|NCT03721549|12590133|FG000|COMPLETED|Overall Study||7
11396300|NCT03721549|12590134|FG001|COMPLETED|Overall Study||8
11396301|NCT03721549|12590133|FG000|NOT COMPLETED|Overall Study||1
11056601|NCT00995371|12238241|FG000|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
11056602|NCT00995371|12238242|FG001|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
11056603|NCT00995410|12238250|FG000|STARTED|Overall Study||380
11056604|NCT00995410|12238250|FG000|Treated|Overall Study||379
11056605|NCT00995410|12238250|FG000|COMPLETED|Overall Study||292
11056606|NCT00995410|12238250|FG000|NOT COMPLETED|Overall Study||88
11396302|NCT03721549|12590134|FG001|NOT COMPLETED|Overall Study||0
11056607|NCT00995436|12238257|FG000|STARTED|Overall Study|25|25
11056608|NCT00995436|12238258|FG001|STARTED|Overall Study||27
11056609|NCT00995436|12238259|FG002|STARTED|Overall Study||26
11056610|NCT00995436|12238257|FG000|COMPLETED|Overall Study||23
11056611|NCT00995436|12238258|FG001|COMPLETED|Overall Study||22
11056612|NCT00995436|12238259|FG002|COMPLETED|Overall Study||26
11056613|NCT00995436|12238257|FG000|NOT COMPLETED|Overall Study||2
11056614|NCT00995436|12238258|FG001|NOT COMPLETED|Overall Study||5
11056615|NCT00995436|12238259|FG002|NOT COMPLETED|Overall Study||0
11056616|NCT00995449|12238271|FG000|STARTED|Overall Study||0
11056617|NCT00995449|12238272|FG001|STARTED|Overall Study||0
11056618|NCT00995449|12238273|FG002|STARTED|Overall Study||7
11056619|NCT00995449|12238274|FG003|STARTED|Overall Study||2
11056620|NCT00995449|12238271|FG000|COMPLETED|Overall Study||0
11056621|NCT00995449|12238272|FG001|COMPLETED|Overall Study||0
11056622|NCT00995449|12238273|FG002|COMPLETED|Overall Study||5
11056623|NCT00995449|12238274|FG003|COMPLETED|Overall Study||2
11056624|NCT00995449|12238271|FG000|NOT COMPLETED|Overall Study||0
11056625|NCT00995449|12238272|FG001|NOT COMPLETED|Overall Study||0
11056626|NCT00995449|12238273|FG002|NOT COMPLETED|Overall Study||2
11056627|NCT00995449|12238274|FG003|NOT COMPLETED|Overall Study||0
11056628|NCT00995475|12238282|FG000|STARTED|First Intervention||9
11056629|NCT00995475|12238283|FG001|STARTED|First Intervention||9
11056630|NCT00995475|12238282|FG000|COMPLETED|First Intervention||9
11056631|NCT00995475|12238283|FG001|COMPLETED|First Intervention||9
11056632|NCT00995475|12238282|FG000|NOT COMPLETED|First Intervention||0
11396303|NCT03722030|12590142|FG000|STARTED|Overall Study||20
11008901|NCT00740870|12186623|FG000|STARTED|Overall Study||171
11396304|NCT03722030|12590143|FG001|STARTED|Overall Study||20
11008902|NCT00740870|12186623|FG000|COMPLETED|Overall Study||150
11008903|NCT00740870|12186623|FG000|NOT COMPLETED|Overall Study||21
11008904|NCT00741013|12186633|FG000|STARTED|Overall Study||7
11008905|NCT00741013|12186634|FG001|STARTED|Overall Study||8
11008906|NCT00741013|12186635|FG002|STARTED|Overall Study||7
11008907|NCT00741013|12186633|FG000|COMPLETED|Overall Study||6
11008908|NCT00741013|12186634|FG001|COMPLETED|Overall Study||6
11008909|NCT00741013|12186635|FG002|COMPLETED|Overall Study||6
11008910|NCT00741013|12186633|FG000|NOT COMPLETED|Overall Study||1
11008911|NCT00741013|12186634|FG001|NOT COMPLETED|Overall Study||2
11008912|NCT00741013|12186635|FG002|NOT COMPLETED|Overall Study||1
11008913|NCT00741026|12186643|FG000|STARTED|Overall Study||15
11008914|NCT00741026|12186643|FG000|COMPLETED|Overall Study||15
11008915|NCT00741026|12186643|FG000|NOT COMPLETED|Overall Study||0
11008916|NCT00741039|12186651|FG000|STARTED|Overall Study||102
11008917|NCT00741039|12186652|FG001|STARTED|Overall Study||25
11008918|NCT00741039|12186651|FG000|COMPLETED|Overall Study||100
11396305|NCT03722030|12590142|FG000|COMPLETED|Overall Study||19
11396306|NCT03722030|12590143|FG001|COMPLETED|Overall Study||20
11008919|NCT00741039|12186652|FG001|COMPLETED|Overall Study||25
11008920|NCT00741039|12186651|FG000|NOT COMPLETED|Overall Study||2
11008921|NCT00741039|12186652|FG001|NOT COMPLETED|Overall Study||0
11396307|NCT03722030|12590142|FG000|NOT COMPLETED|Overall Study||1
11396308|NCT03722030|12590143|FG001|NOT COMPLETED|Overall Study||0
11396309|NCT03722238|12590152|FG000|STARTED|Overall Study||608
11396310|NCT03722238|12590153|FG001|STARTED|Overall Study||5
11396311|NCT03722238|12590152|FG000|Safety Set|Overall Study||198
11008922|NCT00741091|12186658|FG000|STARTED|Overall Study||1097
11008923|NCT00741091|12186658|FG000|COMPLETED|Overall Study||1040
11008924|NCT00741091|12186658|FG000|NOT COMPLETED|Overall Study||57
11008925|NCT00741104|12186662|FG000|STARTED|Overall Study||363
11008926|NCT00741104|12186662|FG000|COMPLETED|Overall Study||363
11008927|NCT00741104|12186662|FG000|NOT COMPLETED|Overall Study||0
11008928|NCT00741156|12186666|FG000|STARTED|Overall Study||12
11008929|NCT00741156|12186666|FG000|COMPLETED|Overall Study||12
11008930|NCT00741156|12186666|FG000|NOT COMPLETED|Overall Study||0
11008931|NCT00741260|12186688|FG000|STARTED|Overall Study||6
11008932|NCT00741260|12186689|FG001|STARTED|Overall Study||8
11008933|NCT00741260|12186690|FG002|STARTED|Overall Study||4
11008934|NCT00741260|12186691|FG003|STARTED|Overall Study||6
11008935|NCT00741260|12186692|FG004|STARTED|Overall Study||9
11008936|NCT00741260|12186693|FG005|STARTED|Overall Study||65
11008937|NCT00741260|12186694|FG006|STARTED|Overall Study||7
11008938|NCT00741260|12186688|FG000|COMPLETED|Overall Study||0
11008939|NCT00741260|12186689|FG001|COMPLETED|Overall Study||0
11008940|NCT00741260|12186690|FG002|COMPLETED|Overall Study||0
11008941|NCT00741260|12186691|FG003|COMPLETED|Overall Study||0
11008942|NCT00741260|12186692|FG004|COMPLETED|Overall Study||0
11008943|NCT00741260|12186693|FG005|COMPLETED|Overall Study||20
11008944|NCT00741260|12186694|FG006|COMPLETED|Overall Study||0
11008945|NCT00741260|12186688|FG000|NOT COMPLETED|Overall Study||6
11008946|NCT00741260|12186689|FG001|NOT COMPLETED|Overall Study||8
11008947|NCT00741260|12186690|FG002|NOT COMPLETED|Overall Study||4
11008948|NCT00741260|12186691|FG003|NOT COMPLETED|Overall Study||6
11008949|NCT00741260|12186692|FG004|NOT COMPLETED|Overall Study||9
11008950|NCT00741260|12186693|FG005|NOT COMPLETED|Overall Study||45
11008951|NCT00741260|12186694|FG006|NOT COMPLETED|Overall Study||7
11008952|NCT00741273|12186717|FG000|STARTED|Overall Study||8
11008953|NCT00741273|12186718|FG001|STARTED|Overall Study||8
11008954|NCT00741273|12186717|FG000|COMPLETED|Overall Study||8
11008955|NCT00741273|12186718|FG001|COMPLETED|Overall Study||8
11008956|NCT00741273|12186717|FG000|NOT COMPLETED|Overall Study||0
11008957|NCT00741273|12186718|FG001|NOT COMPLETED|Overall Study||0
11008958|NCT00741286|12186730|FG000|STARTED|Overall Study||103
11008959|NCT00741286|12186731|FG001|STARTED|Overall Study||100
11008960|NCT00741286|12186730|FG000|COMPLETED|Overall Study||83
11008961|NCT00741286|12186731|FG001|COMPLETED|Overall Study||81
11008962|NCT00741286|12186730|FG000|NOT COMPLETED|Overall Study||20
11008963|NCT00741286|12186731|FG001|NOT COMPLETED|Overall Study||19
11008964|NCT00741338|12186739|FG000|STARTED|Overall Study||3
11008965|NCT00741338|12186740|FG001|STARTED|Overall Study||3
11008966|NCT00741338|12186739|FG000|COMPLETED|Overall Study||3
11008967|NCT00741338|12186740|FG001|COMPLETED|Overall Study||2
11008968|NCT00741338|12186739|FG000|NOT COMPLETED|Overall Study||0
11008969|NCT00741338|12186740|FG001|NOT COMPLETED|Overall Study||1
11008970|NCT00741390|12186746|FG000|STARTED|Visit 1||62
11008971|NCT00741390|12186747|FG001|STARTED|Visit 1||63
11008972|NCT00741390|12186748|FG002|STARTED|Visit 1||62
11008973|NCT00741390|12186749|FG003|STARTED|Visit 1||63
11008974|NCT00741390|12186746|FG000|COMPLETED|Visit 1||60
11008975|NCT00741390|12186747|FG001|COMPLETED|Visit 1||63
11008976|NCT00741390|12186748|FG002|COMPLETED|Visit 1||55
11008977|NCT00741390|12186749|FG003|COMPLETED|Visit 1||62
11008978|NCT00741390|12186746|FG000|NOT COMPLETED|Visit 1||2
11008979|NCT00741390|12186747|FG001|NOT COMPLETED|Visit 1||0
11008980|NCT00741390|12186748|FG002|NOT COMPLETED|Visit 1||7
11008981|NCT00741390|12186749|FG003|NOT COMPLETED|Visit 1||1
11008982|NCT00741390|12186746|FG000|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
11008983|NCT00741390|12186747|FG001|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
11008984|NCT00741390|12186748|FG002|STARTED|Visit 2||55
11396312|NCT03722238|12590153|FG001|Safety Set|Overall Study||5
11396313|NCT03722238|12590152|FG000|Actual Drug Users|Overall Study||179
11008985|NCT00741390|12186749|FG003|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
11008986|NCT00741390|12186746|FG000|COMPLETED|Visit 2||59
11008987|NCT00741390|12186747|FG001|COMPLETED|Visit 2||61
11008988|NCT00741390|12186748|FG002|COMPLETED|Visit 2||54
11008989|NCT00741390|12186749|FG003|COMPLETED|Visit 2||60
11008990|NCT00741390|12186746|FG000|NOT COMPLETED|Visit 2||0
11008991|NCT00741390|12186747|FG001|NOT COMPLETED|Visit 2||0
11008992|NCT00741390|12186748|FG002|NOT COMPLETED|Visit 2||1
11008993|NCT00741390|12186749|FG003|NOT COMPLETED|Visit 2||1
11008994|NCT00741455|12186768|FG000|STARTED|Overall Study||18
11008995|NCT00741455|12186768|FG000|COMPLETED|Overall Study||17
11008996|NCT00741455|12186768|FG000|NOT COMPLETED|Overall Study||1
11008997|NCT00741468|12186772|FG000|STARTED|Overall Study||18
11008998|NCT00741468|12186772|FG000|COMPLETED|Overall Study||18
11008999|NCT00741468|12186772|FG000|NOT COMPLETED|Overall Study||0
11009000|NCT00741598|12186782|FG000|STARTED|Overall Study||33
11009001|NCT00741598|12186783|FG001|STARTED|Overall Study||39
11009002|NCT00741598|12186782|FG000|COMPLETED|Overall Study||24
11009003|NCT00741598|12186783|FG001|COMPLETED|Overall Study||30
11009004|NCT00741598|12186782|FG000|NOT COMPLETED|Overall Study||9
11009005|NCT00741598|12186783|FG001|NOT COMPLETED|Overall Study||9
11009006|NCT00741611|12186793|FG000|STARTED|Overall Study||4
11009007|NCT00741611|12186794|FG001|STARTED|Overall Study||3
11009008|NCT00741611|12186795|FG002|STARTED|Overall Study||29
11009009|NCT00741611|12186793|FG000|COMPLETED|Overall Study||4
11009010|NCT00741611|12186794|FG001|COMPLETED|Overall Study||1
11009011|NCT00741611|12186795|FG002|COMPLETED|Overall Study||26
11009012|NCT00741611|12186793|FG000|NOT COMPLETED|Overall Study||0
11009013|NCT00741611|12186794|FG001|NOT COMPLETED|Overall Study||2
11009014|NCT00741611|12186795|FG002|NOT COMPLETED|Overall Study||3
11009015|NCT00741819|12186804|FG000|STARTED|Overall Study||73
11009016|NCT00741819|12186804|FG000|COMPLETED|Overall Study||65
11009017|NCT00741819|12186804|FG000|NOT COMPLETED|Overall Study||8
11009018|NCT00741858|12186812|FG000|STARTED|Overall Study||16
11009019|NCT00741858|12186813|FG001|STARTED|Overall Study||18
11009020|NCT00741858|12186812|FG000|COMPLETED|Overall Study||16
11009021|NCT00741858|12186813|FG001|COMPLETED|Overall Study||18
11009022|NCT00741858|12186812|FG000|NOT COMPLETED|Overall Study||0
11009023|NCT00741858|12186813|FG001|NOT COMPLETED|Overall Study||0
11009024|NCT00741936|12186821|FG000|STARTED|Overall Study||60
11009025|NCT00741936|12186822|FG001|STARTED|Overall Study||60
11009026|NCT00741936|12186821|FG000|COMPLETED|Overall Study||51
11009027|NCT00741936|12186822|FG001|COMPLETED|Overall Study||52
11009028|NCT00741936|12186821|FG000|NOT COMPLETED|Overall Study||9
11009029|NCT00741936|12186822|FG001|NOT COMPLETED|Overall Study||8
11009030|NCT00742001|12186831|FG000|STARTED|Overall Study||4
11009031|NCT00742001|12186832|FG001|STARTED|Overall Study||4
11009032|NCT00742001|12186833|FG002|STARTED|Overall Study||4
11009033|NCT00742001|12186831|FG000|COMPLETED|Overall Study||4
11009034|NCT00742001|12186832|FG001|COMPLETED|Overall Study||4
11009035|NCT00742001|12186833|FG002|COMPLETED|Overall Study||3
11009036|NCT00742001|12186831|FG000|NOT COMPLETED|Overall Study||0
11009037|NCT00742001|12186832|FG001|NOT COMPLETED|Overall Study||0
11009038|NCT00742001|12186833|FG002|NOT COMPLETED|Overall Study||1
11009039|NCT00742027|12186844|FG000|STARTED|Overall Study||129
11009040|NCT00742027|12186844|FG000|COMPLETED|Overall Study||0
11009041|NCT00742027|12186844|FG000|NOT COMPLETED|Overall Study||129
11009042|NCT00742053|12186848|FG000|STARTED|Overall Study||7
11009043|NCT00742053|12186848|FG000|COMPLETED|Overall Study||7
11009044|NCT00742053|12186848|FG000|NOT COMPLETED|Overall Study||0
11009045|NCT00742079|12186854|FG000|STARTED|Overall Study||11
11009046|NCT00742079|12186855|FG001|STARTED|Overall Study||10
11142647|NCT01469013|12329425|FG002|STARTED|Part A (Treatment Period)||24
11142648|NCT01469013|12329426|FG003|STARTED|Part A (Treatment Period)||24
11142649|NCT01469013|12329427|FG004|STARTED|Part A (Treatment Period)||49
11142650|NCT01469013|12329428|FG005|STARTED|Part A (Treatment Period)||0
11142651|NCT01469013|12329429|FG006|STARTED|Part A (Treatment Period)||0
11142652|NCT01469013|12329430|FG007|STARTED|Part A (Treatment Period)||0
11142653|NCT01469013|12329431|FG008|STARTED|Part A (Treatment Period)||0
11142654|NCT01469013|12329432|FG009|STARTED|Part A (Treatment Period)||0
11142655|NCT01469013|12329433|FG010|STARTED|Part A (Treatment Period)||0
11142656|NCT01469013|12329434|FG011|STARTED|Part A (Treatment Period)||0
11142657|NCT01469013|12329435|FG012|STARTED|Part A (Treatment Period)||0
11142658|NCT01469013|12329423|FG000|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
11142659|NCT01469013|12329424|FG001|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
11142660|NCT01469013|12329425|FG002|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
11142661|NCT01469013|12329426|FG003|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
11142662|NCT01469013|12329427|FG004|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
11142663|NCT01469013|12329428|FG005|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
11142664|NCT01469013|12329429|FG006|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
11142665|NCT01469013|12329430|FG007|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
11142666|NCT01469013|12329431|FG008|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
11142667|NCT01469013|12329432|FG009|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
11142668|NCT01469013|12329433|FG010|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
11142669|NCT01469013|12329434|FG011|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
11142670|NCT01469013|12329435|FG012|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
11009047|NCT00742079|12186854|FG000|Baseline/Week 1 (Received Dose 1)|Overall Study||11
11142671|NCT01469013|12329423|FG000|COMPLETED|Part A (Treatment Period)||23
11142672|NCT01469013|12329424|FG001|COMPLETED|Part A (Treatment Period)||24
11142673|NCT01469013|12329425|FG002|COMPLETED|Part A (Treatment Period)||23
11142674|NCT01469013|12329426|FG003|COMPLETED|Part A (Treatment Period)||24
11142675|NCT01469013|12329427|FG004|COMPLETED|Part A (Treatment Period)||48
11142676|NCT01469013|12329428|FG005|COMPLETED|Part A (Treatment Period)||0
11142677|NCT01469013|12329429|FG006|COMPLETED|Part A (Treatment Period)||0
11009048|NCT00742079|12186855|FG001|Baseline/Week 1 (Received Dose 1)|Overall Study||9
11009049|NCT00742079|12186854|FG000|Week 2 (Received Dose 2)|Overall Study||11
11009050|NCT00742079|12186855|FG001|Week 2 (Received Dose 2)|Overall Study||9
11009051|NCT00742079|12186854|FG000|COMPLETED|Overall Study||11
11009052|NCT00742079|12186855|FG001|COMPLETED|Overall Study||9
11009053|NCT00742079|12186854|FG000|NOT COMPLETED|Overall Study||0
11009054|NCT00742079|12186855|FG001|NOT COMPLETED|Overall Study||1
11142678|NCT01469013|12329430|FG007|COMPLETED|Part A (Treatment Period)||0
11142679|NCT01469013|12329431|FG008|COMPLETED|Part A (Treatment Period)||0
11142680|NCT01469013|12329432|FG009|COMPLETED|Part A (Treatment Period)||0
11142681|NCT01469013|12329433|FG010|COMPLETED|Part A (Treatment Period)||0
11142682|NCT01469013|12329434|FG011|COMPLETED|Part A (Treatment Period)||0
11009055|NCT00742170|12186863|FG000|STARTED|Overall Study||26
11009056|NCT00742170|12186864|FG001|STARTED|Overall Study||29
11009057|NCT00742170|12186863|FG000|COMPLETED|Overall Study||24
11009058|NCT00742170|12186864|FG001|COMPLETED|Overall Study||24
11009059|NCT00742170|12186863|FG000|NOT COMPLETED|Overall Study||2
11009060|NCT00742170|12186864|FG001|NOT COMPLETED|Overall Study||5
11009061|NCT00742183|12186872|FG000|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
11009062|NCT00742183|12186873|FG001|STARTED|Overall Study||51
11009063|NCT00742183|12186872|FG000|COMPLETED|Overall Study||40
11009064|NCT00742183|12186873|FG001|COMPLETED|Overall Study||39
11009065|NCT00742183|12186872|FG000|NOT COMPLETED|Overall Study||9
11009066|NCT00742183|12186873|FG001|NOT COMPLETED|Overall Study||12
11009067|NCT00742209|12186884|FG000|STARTED|Overall Study||129
11009068|NCT00742209|12186885|FG001|STARTED|Overall Study||67
11009069|NCT00742209|12186886|FG002|STARTED|Overall Study||134
11009070|NCT00742209|12186887|FG003|STARTED|Overall Study||134
11009071|NCT00742209|12186888|FG004|STARTED|Overall Study||62
11009072|NCT00742209|12186884|FG000|COMPLETED|Overall Study||95
11009073|NCT00742209|12186885|FG001|COMPLETED|Overall Study||49
11009074|NCT00742209|12186886|FG002|COMPLETED|Overall Study||88
11009075|NCT00742209|12186887|FG003|COMPLETED|Overall Study||97
11009076|NCT00742209|12186888|FG004|COMPLETED|Overall Study||37
11009077|NCT00742209|12186884|FG000|NOT COMPLETED|Overall Study||34
11009078|NCT00742209|12186885|FG001|NOT COMPLETED|Overall Study||18
11009079|NCT00742209|12186886|FG002|NOT COMPLETED|Overall Study||46
11009080|NCT00742209|12186887|FG003|NOT COMPLETED|Overall Study||37
11009081|NCT00742209|12186888|FG004|NOT COMPLETED|Overall Study||25
11009082|NCT00742235|12186903|FG000|STARTED|Overall Study||32
11009083|NCT00742235|12186904|FG001|STARTED|Overall Study||67
11009084|NCT00742235|12186903|FG000|COMPLETED|Overall Study||32
11009085|NCT00742235|12186904|FG001|COMPLETED|Overall Study||36
11009086|NCT00742235|12186903|FG000|NOT COMPLETED|Overall Study||0
11009087|NCT00742235|12186904|FG001|NOT COMPLETED|Overall Study||31
11009088|NCT00742274|12186912|FG000|STARTED|Overall Study||30
11009089|NCT00742274|12186913|FG001|STARTED|Overall Study||31
11009090|NCT00742274|12186912|FG000|COMPLETED|Overall Study||27
11009091|NCT00742274|12186913|FG001|COMPLETED|Overall Study||28
11009092|NCT00742274|12186912|FG000|NOT COMPLETED|Overall Study||3
11009093|NCT00742274|12186913|FG001|NOT COMPLETED|Overall Study||3
11009094|NCT00742313|12186921|FG000|STARTED|Overall Study||25
11009095|NCT00742313|12186922|FG001|STARTED|Overall Study||19
11009096|NCT00742313|12186921|FG000|COMPLETED|Overall Study||24
11009097|NCT00742313|12186922|FG001|COMPLETED|Overall Study||19
11009098|NCT00742313|12186921|FG000|NOT COMPLETED|Overall Study||1
11009099|NCT00742313|12186922|FG001|NOT COMPLETED|Overall Study||0
11009100|NCT00742326|12186930|FG000|STARTED|Overall Study||6
11009101|NCT00742326|12186931|FG001|STARTED|Overall Study||7
11009102|NCT00742326|12186930|FG000|COMPLETED|Overall Study||6
11009103|NCT00742326|12186931|FG001|COMPLETED|Overall Study||6
11009104|NCT00742326|12186930|FG000|NOT COMPLETED|Overall Study||0
11009105|NCT00742326|12186931|FG001|NOT COMPLETED|Overall Study||1
11009106|NCT00742391|12186939|FG000|STARTED|Overall Study||126
11009107|NCT00742391|12186940|FG001|STARTED|Overall Study||129
11009108|NCT00742391|12186939|FG000|COMPLETED|Overall Study||122
11009109|NCT00742391|12186940|FG001|COMPLETED|Overall Study||128
11009110|NCT00742391|12186939|FG000|NOT COMPLETED|Overall Study||4
11009111|NCT00742391|12186940|FG001|NOT COMPLETED|Overall Study||1
11009112|NCT00742417|12186948|FG000|STARTED|Randomized||21
11009113|NCT00742417|12186949|FG001|STARTED|Randomized||21
11009114|NCT00742417|12186948|FG000|COMPLETED|Randomized||19
11009115|NCT00742417|12186949|FG001|COMPLETED|Randomized||20
11009116|NCT00742417|12186948|FG000|NOT COMPLETED|Randomized||2
11009117|NCT00742417|12186949|FG001|NOT COMPLETED|Randomized||1
11009118|NCT00742417|12186948|FG000|STARTED|Intensive Period||19
11009119|NCT00742417|12186949|FG001|STARTED|Intensive Period||20
11009120|NCT00742417|12186948|FG000|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
11056633|NCT00995475|12238283|FG001|NOT COMPLETED|First Intervention||0
11009121|NCT00742417|12186949|FG001|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
11009122|NCT00742417|12186948|FG000|NOT COMPLETED|Intensive Period||3
11009123|NCT00742417|12186949|FG001|NOT COMPLETED|Intensive Period||1
11009124|NCT00742417|12186948|FG000|STARTED|Maintenance I||16
11009125|NCT00742417|12186949|FG001|STARTED|Maintenance I||19
11009126|NCT00742417|12186948|FG000|COMPLETED|Maintenance I||16
11009127|NCT00742417|12186949|FG001|COMPLETED|Maintenance I||19
11009128|NCT00742417|12186948|FG000|NOT COMPLETED|Maintenance I||0
11009129|NCT00742417|12186949|FG001|NOT COMPLETED|Maintenance I||0
11009130|NCT00742417|12186948|FG000|STARTED|Maintenance II||16
11009131|NCT00742417|12186949|FG001|STARTED|Maintenance II||19
11009132|NCT00742417|12186948|FG000|COMPLETED|Maintenance II||16
11009133|NCT00742417|12186949|FG001|COMPLETED|Maintenance II||19
11009134|NCT00742417|12186948|FG000|NOT COMPLETED|Maintenance II||0
11009135|NCT00742417|12186949|FG001|NOT COMPLETED|Maintenance II||0
11009136|NCT00742469|12186959|FG000|STARTED|Overall Study||106
11009137|NCT00742469|12186960|FG001|STARTED|Overall Study||104
11009138|NCT00742469|12186959|FG000|COMPLETED|Overall Study||88
11009139|NCT00742469|12186960|FG001|COMPLETED|Overall Study||69
11009140|NCT00742469|12186959|FG000|NOT COMPLETED|Overall Study||18
11009141|NCT00742469|12186960|FG001|NOT COMPLETED|Overall Study||35
11009142|NCT00742508|12186968|FG000|STARTED|8-Week Primary Evaluation Period||22
11009143|NCT00742508|12186969|FG001|STARTED|8-Week Primary Evaluation Period||19
11009144|NCT00742508|12186968|FG000|COMPLETED|8-Week Primary Evaluation Period||11
11009145|NCT00742508|12186969|FG001|COMPLETED|8-Week Primary Evaluation Period||8
11009146|NCT00742508|12186968|FG000|NOT COMPLETED|8-Week Primary Evaluation Period||11
11009147|NCT00742508|12186969|FG001|NOT COMPLETED|8-Week Primary Evaluation Period||11
11009148|NCT00742508|12186968|FG000|STARTED|4-Week Exploratory Evaluation Period||0
11009149|NCT00742508|12186969|FG001|STARTED|4-Week Exploratory Evaluation Period||8
11009150|NCT00742508|12186968|FG000|COMPLETED|4-Week Exploratory Evaluation Period||0
11009151|NCT00742508|12186969|FG001|COMPLETED|4-Week Exploratory Evaluation Period||7
11009152|NCT00742508|12186968|FG000|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
11009153|NCT00742508|12186969|FG001|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
11009154|NCT00742560|12186980|FG000|STARTED|Overall Study||3
11009155|NCT00742560|12186981|FG001|STARTED|Overall Study||3
11009156|NCT00742560|12186982|FG002|STARTED|Overall Study||22
11009157|NCT00742560|12186983|FG003|STARTED|Overall Study||36
11009158|NCT00742560|12186984|FG004|STARTED|Overall Study||37
11009159|NCT00742560|12186980|FG000|COMPLETED|Overall Study||0
11009160|NCT00742560|12186981|FG001|COMPLETED|Overall Study||0
11009161|NCT00742560|12186982|FG002|COMPLETED|Overall Study||0
11009162|NCT00742560|12186983|FG003|COMPLETED|Overall Study||0
11009163|NCT00742560|12186984|FG004|COMPLETED|Overall Study||0
11009164|NCT00742560|12186980|FG000|NOT COMPLETED|Overall Study||3
11009165|NCT00742560|12186981|FG001|NOT COMPLETED|Overall Study||3
11009166|NCT00742560|12186982|FG002|NOT COMPLETED|Overall Study||22
11009167|NCT00742560|12186983|FG003|NOT COMPLETED|Overall Study||36
11009168|NCT00742560|12186984|FG004|NOT COMPLETED|Overall Study||37
11009169|NCT00742573|12187017|FG000|STARTED|Overall Study||83
11009170|NCT00742573|12187018|FG001|STARTED|Overall Study||87
11009171|NCT00742573|12187017|FG000|Week 12|Overall Study||46
11009172|NCT00742573|12187018|FG001|Week 12|Overall Study||51
11009173|NCT00742573|12187017|FG000|Week 24|Overall Study||39
11009174|NCT00742573|12187018|FG001|Week 24|Overall Study||37
11009175|NCT00742573|12187017|FG000|Week 52|Overall Study||26
11009176|NCT00742573|12187018|FG001|Week 52|Overall Study||25
11009177|NCT00742573|12187017|FG000|COMPLETED|Overall Study||26
11009178|NCT00742573|12187018|FG001|COMPLETED|Overall Study||25
11009179|NCT00742573|12187017|FG000|NOT COMPLETED|Overall Study||57
11009180|NCT00742573|12187018|FG001|NOT COMPLETED|Overall Study||62
11009181|NCT00742625|12187024|FG000|STARTED|Remission Induction||95
11009182|NCT00742625|12187024|FG000|COMPLETED|Remission Induction||41
11009183|NCT00742625|12187024|FG000|NOT COMPLETED|Remission Induction||54
11009184|NCT00742625|12187024|FG000|STARTED|Consolidation||41
11009185|NCT00742625|12187024|FG000|COMPLETED|Consolidation||20
11009186|NCT00742625|12187024|FG000|NOT COMPLETED|Consolidation||21
11009187|NCT00742781|12187031|FG000|STARTED|Overall Study||21
11009188|NCT00742781|12187031|FG000|COMPLETED|Overall Study||18
11009189|NCT00742781|12187031|FG000|NOT COMPLETED|Overall Study||3
11009190|NCT00742859|12187040|FG000|STARTED|Overall Study||127
11009191|NCT00742859|12187041|FG001|STARTED|Overall Study||127
11009192|NCT00742859|12187042|FG002|STARTED|Overall Study||127
11009193|NCT00742859|12187043|FG003|STARTED|Overall Study||127
11009194|NCT00742859|12187040|FG000|COMPLETED|Overall Study||116
11009195|NCT00742859|12187041|FG001|COMPLETED|Overall Study||115
11009196|NCT00742859|12187042|FG002|COMPLETED|Overall Study||116
11009197|NCT00742859|12187043|FG003|COMPLETED|Overall Study||119
11009198|NCT00742859|12187040|FG000|NOT COMPLETED|Overall Study||11
11009199|NCT00742859|12187041|FG001|NOT COMPLETED|Overall Study||12
11009200|NCT00742859|12187042|FG002|NOT COMPLETED|Overall Study||11
11009201|NCT00742859|12187043|FG003|NOT COMPLETED|Overall Study||8
11009202|NCT00742872|12187055|FG000|STARTED|Overall Study||21
11009203|NCT00742872|12187056|FG001|STARTED|Overall Study||20
11009204|NCT00742872|12187055|FG000|COMPLETED|Overall Study||9
11009205|NCT00742872|12187056|FG001|COMPLETED|Overall Study||12
11009206|NCT00742872|12187055|FG000|NOT COMPLETED|Overall Study||12
11009207|NCT00742872|12187056|FG001|NOT COMPLETED|Overall Study||8
11009208|NCT00742885|12187064|FG000|STARTED|Overall Study||50
11009209|NCT00742885|12187065|FG001|STARTED|Overall Study||50
11009210|NCT00742885|12187064|FG000|COMPLETED|Overall Study|to Day 182|49
11009211|NCT00742885|12187065|FG001|COMPLETED|Overall Study|to Day 182|50
11009212|NCT00742885|12187064|FG000|NOT COMPLETED|Overall Study||1
11009213|NCT00742885|12187065|FG001|NOT COMPLETED|Overall Study||0
11009214|NCT00742924|12187078|FG000|STARTED|Overall Study||6
11009215|NCT00742924|12187079|FG001|STARTED|Overall Study||6
11009216|NCT00742924|12187080|FG002|STARTED|Overall Study||6
11009217|NCT00742924|12187081|FG003|STARTED|Overall Study||6
11009218|NCT00742924|12187078|FG000|COMPLETED|Overall Study||1
11009219|NCT00742924|12187079|FG001|COMPLETED|Overall Study||4
11009220|NCT00742924|12187080|FG002|COMPLETED|Overall Study||2
11009221|NCT00742924|12187081|FG003|COMPLETED|Overall Study||0
11009222|NCT00742924|12187078|FG000|NOT COMPLETED|Overall Study||5
11009223|NCT00742924|12187079|FG001|NOT COMPLETED|Overall Study||2
11009224|NCT00742924|12187080|FG002|NOT COMPLETED|Overall Study||4
11009225|NCT00742924|12187081|FG003|NOT COMPLETED|Overall Study||6
11009226|NCT00742963|12187091|FG000|STARTED|Overall Study||101
11009227|NCT00742963|12187091|FG000|Completed All Treatment Cycles|Overall Study||68
11009228|NCT00742963|12187091|FG000|COMPLETED|Overall Study||68
11009229|NCT00742963|12187091|FG000|NOT COMPLETED|Overall Study||33
11009230|NCT00743093|12187097|FG000|STARTED|Base Study Period||224
11009231|NCT00743093|12187098|FG001|STARTED|Base Study Period||52
11009232|NCT00743093|12187097|FG000|COMPLETED|Base Study Period||205
11009233|NCT00743093|12187098|FG001|COMPLETED|Base Study Period||47
11009234|NCT00743093|12187097|FG000|NOT COMPLETED|Base Study Period||19
11009235|NCT00743093|12187098|FG001|NOT COMPLETED|Base Study Period||5
11009236|NCT00743093|12187097|FG000|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
11009237|NCT00743093|12187098|FG001|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
11009238|NCT00743093|12187097|FG000|COMPLETED|Extended Dosing Period||48
11009239|NCT00743093|12187098|FG001|COMPLETED|Extended Dosing Period||1
11009240|NCT00743093|12187097|FG000|NOT COMPLETED|Extended Dosing Period||3
11009241|NCT00743093|12187098|FG001|NOT COMPLETED|Extended Dosing Period||0
11009242|NCT00743106|12187106|FG000|STARTED|Overall Study||42
11009243|NCT00743106|12187107|FG001|STARTED|Overall Study||48
11009244|NCT00743106|12187106|FG000|COMPLETED|Overall Study||34
11009245|NCT00743106|12187107|FG001|COMPLETED|Overall Study||43
11009246|NCT00743106|12187106|FG000|NOT COMPLETED|Overall Study||8
11009247|NCT00743106|12187107|FG001|NOT COMPLETED|Overall Study||5
11009248|NCT00743119|12187113|FG000|STARTED|Overall Study||34
11009249|NCT00743119|12187113|FG000|COMPLETED|Overall Study||30
11009250|NCT00743119|12187113|FG000|NOT COMPLETED|Overall Study||4
11009251|NCT00743145|12187125|FG000|STARTED|Overall Study||23
11009252|NCT00743145|12187125|FG000|COMPLETED|Overall Study||19
11009253|NCT00743145|12187125|FG000|NOT COMPLETED|Overall Study||4
11009254|NCT00743249|12187141|FG000|STARTED|Overall Study||30
11009255|NCT00743249|12187142|FG001|STARTED|Overall Study||30
11009256|NCT00743249|12187141|FG000|COMPLETED|Overall Study||28
11009257|NCT00743249|12187142|FG001|COMPLETED|Overall Study||24
11009258|NCT00743249|12187141|FG000|NOT COMPLETED|Overall Study||2
11009259|NCT00743249|12187142|FG001|NOT COMPLETED|Overall Study||6
11009260|NCT00743262|12187148|FG000|STARTED|Overall Study||15
11009261|NCT00743262|12187148|FG000|COMPLETED|Overall Study||15
11009262|NCT00743262|12187148|FG000|NOT COMPLETED|Overall Study||0
11009263|NCT00743275|12187154|FG000|STARTED|Overall Study||59
11009264|NCT00743275|12187155|FG001|STARTED|Overall Study||61
11009265|NCT00743275|12187154|FG000|COMPLETED|Overall Study||59
11009266|NCT00743275|12187155|FG001|COMPLETED|Overall Study||60
11009267|NCT00743275|12187154|FG000|NOT COMPLETED|Overall Study||0
11009268|NCT00743275|12187155|FG001|NOT COMPLETED|Overall Study||1
11009269|NCT00743288|12187161|FG000|STARTED|Overall Study||3
11009270|NCT00743288|12187162|FG001|STARTED|Overall Study||3
11009271|NCT00743288|12187163|FG002|STARTED|Overall Study||6
11009272|NCT00743288|12187164|FG003|STARTED|Overall Study||7
11009273|NCT00743288|12187165|FG004|STARTED|Overall Study||6
11009274|NCT00743288|12187166|FG005|STARTED|Overall Study||6
11009275|NCT00743288|12187167|FG006|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
11009276|NCT00743288|12187161|FG000|COMPLETED|Overall Study||0
11009277|NCT00743288|12187162|FG001|COMPLETED|Overall Study||0
11009278|NCT00743288|12187163|FG002|COMPLETED|Overall Study||1
11009279|NCT00743288|12187164|FG003|COMPLETED|Overall Study||0
11009280|NCT00743288|12187165|FG004|COMPLETED|Overall Study||0
11009281|NCT00743288|12187166|FG005|COMPLETED|Overall Study||1
11009282|NCT00743288|12187167|FG006|COMPLETED|Overall Study||0
11009283|NCT00743288|12187161|FG000|NOT COMPLETED|Overall Study||3
11009284|NCT00743288|12187162|FG001|NOT COMPLETED|Overall Study||3
11009285|NCT00743288|12187163|FG002|NOT COMPLETED|Overall Study||5
11009286|NCT00743288|12187164|FG003|NOT COMPLETED|Overall Study||7
11009287|NCT00743288|12187165|FG004|NOT COMPLETED|Overall Study||6
11009288|NCT00743288|12187166|FG005|NOT COMPLETED|Overall Study||5
11009289|NCT00743288|12187167|FG006|NOT COMPLETED|Overall Study||9
11009290|NCT00743340|12187178|FG000|STARTED|Overall Study||50
11009291|NCT00743340|12187178|FG000|COMPLETED|Overall Study||9
11009292|NCT00743340|12187178|FG000|NOT COMPLETED|Overall Study||41
11009293|NCT00743366|12187182|FG000|STARTED|Intervention 1 (8 Days)||10
11009294|NCT00743366|12187183|FG001|STARTED|Intervention 1 (8 Days)||10
11009295|NCT00743366|12187182|FG000|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
11009296|NCT00743366|12187183|FG001|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
11009297|NCT00743366|12187182|FG000|NOT COMPLETED|Intervention 1 (8 Days)||3
11009298|NCT00743366|12187183|FG001|NOT COMPLETED|Intervention 1 (8 Days)||3
11009299|NCT00743366|12187182|FG000|STARTED|Intervention 2 (8 Days)||7
11009300|NCT00743366|12187183|FG001|STARTED|Intervention 2 (8 Days)||7
11009301|NCT00743366|12187182|FG000|COMPLETED|Intervention 2 (8 Days)||7
11009302|NCT00743366|12187183|FG001|COMPLETED|Intervention 2 (8 Days)||7
11009303|NCT00743366|12187182|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0
11009304|NCT00743366|12187183|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0
11009305|NCT00743431|12187189|FG000|STARTED|Overall Study||224
11009306|NCT00743431|12187189|FG000|COMPLETED|Overall Study||98
11009307|NCT00743431|12187189|FG000|NOT COMPLETED|Overall Study||126
11009308|NCT00743444|12187193|FG000|STARTED|First Intervention||14
11009309|NCT00743444|12187194|FG001|STARTED|First Intervention||13
11009310|NCT00743444|12187193|FG000|COMPLETED|First Intervention||14
11009311|NCT00743444|12187194|FG001|COMPLETED|First Intervention||12
11009312|NCT00743444|12187193|FG000|NOT COMPLETED|First Intervention||0
11009313|NCT00743444|12187194|FG001|NOT COMPLETED|First Intervention||1
11009314|NCT00743444|12187193|FG000|STARTED|Washout Period||14
11009315|NCT00743444|12187194|FG001|STARTED|Washout Period||12
11009316|NCT00743444|12187193|FG000|COMPLETED|Washout Period||14
11009317|NCT00743444|12187194|FG001|COMPLETED|Washout Period||11
11009318|NCT00743444|12187193|FG000|NOT COMPLETED|Washout Period||0
11009319|NCT00743444|12187194|FG001|NOT COMPLETED|Washout Period||1
11009320|NCT00743444|12187193|FG000|STARTED|Second Intervention||14
11009321|NCT00743444|12187194|FG001|STARTED|Second Intervention||11
11009322|NCT00743444|12187193|FG000|COMPLETED|Second Intervention||14
11009323|NCT00743444|12187194|FG001|COMPLETED|Second Intervention||11
11009324|NCT00743444|12187193|FG000|NOT COMPLETED|Second Intervention||0
11009325|NCT00743444|12187194|FG001|NOT COMPLETED|Second Intervention||0
11009326|NCT00743483|12187200|FG000|STARTED|Baseline Period||15
11009327|NCT00743483|12187200|FG000|COMPLETED|Baseline Period||14
11009328|NCT00743483|12187200|FG000|NOT COMPLETED|Baseline Period||1
11009329|NCT00743483|12187200|FG000|STARTED|Treatment Period||14
11009330|NCT00743483|12187200|FG000|COMPLETED|Treatment Period||13
11009331|NCT00743483|12187200|FG000|NOT COMPLETED|Treatment Period||1
11009332|NCT00743509|12187204|FG000|STARTED|Overall Study||49
11009333|NCT00743509|12187204|FG000|COMPLETED|Overall Study||47
11009334|NCT00743509|12187204|FG000|NOT COMPLETED|Overall Study||2
11009335|NCT00743574|12187208|FG000|STARTED|Overall Study||36
11009336|NCT00743574|12187208|FG000|Dropped Out Before Eligibility Testing|Overall Study||13
11009337|NCT00743574|12187208|FG000|Further Exclusions|Overall Study||8
11009338|NCT00743574|12187208|FG000|Dropped Out After Initiating Trial|Overall Study||3
11009339|NCT00743574|12187208|FG000|COMPLETED|Overall Study||12
11009340|NCT00743574|12187208|FG000|NOT COMPLETED|Overall Study||24
11009341|NCT00743652|12187217|FG000|STARTED|Overall Study||151
11009342|NCT00743652|12187218|FG001|STARTED|Overall Study||51
11009343|NCT00743652|12187219|FG002|STARTED|Overall Study||25
11009344|NCT00743652|12187220|FG003|STARTED|Overall Study||67
11009345|NCT00743652|12187221|FG004|STARTED|Overall Study||79
11009346|NCT00743652|12187217|FG000|Vaccinated Dose 1|Overall Study||151
11009347|NCT00743652|12187218|FG001|Vaccinated Dose 1|Overall Study||51
11009348|NCT00743652|12187219|FG002|Vaccinated Dose 1|Overall Study||25
11009349|NCT00743652|12187220|FG003|Vaccinated Dose 1|Overall Study||66
11009350|NCT00743652|12187221|FG004|Vaccinated Dose 1|Overall Study||79
11009351|NCT00743652|12187217|FG000|Vaccinated Dose 2|Overall Study||112
11009352|NCT00743652|12187218|FG001|Vaccinated Dose 2|Overall Study||41
11009353|NCT00743652|12187219|FG002|Vaccinated Dose 2|Overall Study||0
11009354|NCT00743652|12187220|FG003|Vaccinated Dose 2|Overall Study||49
11009355|NCT00743652|12187221|FG004|Vaccinated Dose 2|Overall Study||0
11009356|NCT00743652|12187217|FG000|Vaccinated Dose 3|Overall Study||74
11009357|NCT00743652|12187218|FG001|Vaccinated Dose 3|Overall Study||0
11009358|NCT00743652|12187219|FG002|Vaccinated Dose 3|Overall Study||0
11009359|NCT00743652|12187220|FG003|Vaccinated Dose 3|Overall Study||0
11009360|NCT00743652|12187221|FG004|Vaccinated Dose 3|Overall Study||0
11009361|NCT00743652|12187217|FG000|Toddler Dose|Overall Study||15
11009362|NCT00743652|12187218|FG001|Toddler Dose|Overall Study||23
11009363|NCT00743652|12187219|FG002|Toddler Dose|Overall Study||16
11009364|NCT00743652|12187220|FG003|Toddler Dose|Overall Study||0
11009365|NCT00743652|12187221|FG004|Toddler Dose|Overall Study||0
11009366|NCT00743652|12187217|FG000|COMPLETED|Overall Study||141
11009367|NCT00743652|12187218|FG001|COMPLETED|Overall Study||48
11009368|NCT00743652|12187219|FG002|COMPLETED|Overall Study||23
11009369|NCT00743652|12187220|FG003|COMPLETED|Overall Study||63
11009370|NCT00743652|12187221|FG004|COMPLETED|Overall Study||79
11009371|NCT00743652|12187217|FG000|NOT COMPLETED|Overall Study||10
11009372|NCT00743652|12187218|FG001|NOT COMPLETED|Overall Study||3
11009373|NCT00743652|12187219|FG002|NOT COMPLETED|Overall Study||2
11009374|NCT00743652|12187220|FG003|NOT COMPLETED|Overall Study||4
11009375|NCT00743652|12187221|FG004|NOT COMPLETED|Overall Study||0
11009376|NCT00743717|12187239|FG000|STARTED|Overall Study||2
11009377|NCT00743717|12187240|FG001|STARTED|Overall Study||2
11009378|NCT00743717|12187239|FG000|COMPLETED|Overall Study||2
11009379|NCT00743717|12187240|FG001|COMPLETED|Overall Study||2
11009380|NCT00743717|12187239|FG000|NOT COMPLETED|Overall Study||0
11009381|NCT00743717|12187240|FG001|NOT COMPLETED|Overall Study||0
11009382|NCT00743730|12187249|FG000|STARTED|Overall Study||27
11009383|NCT00743730|12187250|FG001|STARTED|Overall Study||34
11009384|NCT00743730|12187251|FG002|STARTED|Overall Study||33
11009385|NCT00743730|12187249|FG000|COMPLETED|Overall Study||22
11009386|NCT00743730|12187250|FG001|COMPLETED|Overall Study||30
11009387|NCT00743730|12187251|FG002|COMPLETED|Overall Study||28
11009388|NCT00743730|12187249|FG000|NOT COMPLETED|Overall Study||5
11009389|NCT00743730|12187250|FG001|NOT COMPLETED|Overall Study||4
11009390|NCT00743730|12187251|FG002|NOT COMPLETED|Overall Study||5
11009391|NCT00744042|12187263|FG000|STARTED|Overall Study||11
11009392|NCT00744042|12187263|FG000|COMPLETED|Overall Study||10
11009393|NCT00744042|12187263|FG000|NOT COMPLETED|Overall Study||1
11009394|NCT00744055|12187275|FG000|STARTED|Overall Study||50
11009395|NCT00744055|12187276|FG001|STARTED|Overall Study||46
11009396|NCT00744055|12187275|FG000|COMPLETED|Overall Study||43
11009397|NCT00744055|12187276|FG001|COMPLETED|Overall Study||32
11009398|NCT00744055|12187275|FG000|NOT COMPLETED|Overall Study||7
11009399|NCT00744055|12187276|FG001|NOT COMPLETED|Overall Study||14
11009400|NCT00744211|12187285|FG000|STARTED|Baseline||10
11009401|NCT00744211|12187286|FG001|STARTED|Baseline||9
11009402|NCT00744211|12187287|FG002|STARTED|Baseline||10
11009403|NCT00744211|12187285|FG000|COMPLETED|Baseline||10
11009404|NCT00744211|12187286|FG001|COMPLETED|Baseline||9
11009405|NCT00744211|12187287|FG002|COMPLETED|Baseline||10
11009406|NCT00744211|12187285|FG000|NOT COMPLETED|Baseline||0
11009407|NCT00744211|12187286|FG001|NOT COMPLETED|Baseline||0
11009408|NCT00744211|12187287|FG002|NOT COMPLETED|Baseline||0
11009409|NCT00744211|12187285|FG000|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
11009410|NCT00744211|12187286|FG001|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
11009411|NCT00744211|12187287|FG002|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
11009412|NCT00744211|12187285|FG000|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
11009413|NCT00744211|12187286|FG001|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
11009414|NCT00744211|12187287|FG002|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
11009415|NCT00744211|12187285|FG000|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
11009416|NCT00744211|12187286|FG001|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
11009417|NCT00744211|12187287|FG002|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
11009418|NCT00744211|12187285|FG000|STARTED|6 Hours After Cardiopulmonary Bypass||10
11009419|NCT00744211|12187286|FG001|STARTED|6 Hours After Cardiopulmonary Bypass||9
11009420|NCT00744211|12187287|FG002|STARTED|6 Hours After Cardiopulmonary Bypass||10
11009421|NCT00744211|12187285|FG000|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
11009422|NCT00744211|12187286|FG001|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
11009423|NCT00744211|12187287|FG002|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
11009424|NCT00744211|12187285|FG000|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
11009425|NCT00744211|12187286|FG001|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
11009426|NCT00744211|12187287|FG002|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
11009427|NCT00744211|12187285|FG000|STARTED|12 Hours After Cardiopulmonary Bypass||10
11009428|NCT00744211|12187286|FG001|STARTED|12 Hours After Cardiopulmonary Bypass||9
11009429|NCT00744211|12187287|FG002|STARTED|12 Hours After Cardiopulmonary Bypass||10
11009430|NCT00744211|12187285|FG000|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
11009431|NCT00744211|12187286|FG001|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
11009432|NCT00744211|12187287|FG002|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
11009433|NCT00744211|12187285|FG000|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
11009434|NCT00744211|12187286|FG001|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
11009435|NCT00744211|12187287|FG002|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
11009436|NCT00744211|12187285|FG000|STARTED|24 Hours After Cardiopulmonary Bypass||10
11009437|NCT00744211|12187286|FG001|STARTED|24 Hours After Cardiopulmonary Bypass||9
11009438|NCT00744211|12187287|FG002|STARTED|24 Hours After Cardiopulmonary Bypass||10
11009439|NCT00744211|12187285|FG000|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
11009440|NCT00744211|12187286|FG001|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
11009441|NCT00744211|12187287|FG002|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
11009442|NCT00744211|12187285|FG000|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
11009443|NCT00744211|12187286|FG001|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
11009444|NCT00744211|12187287|FG002|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
11009445|NCT00744237|12187301|FG000|STARTED|Overall Study||83
11009446|NCT00744237|12187302|FG001|STARTED|Overall Study||73
11009447|NCT00744237|12187303|FG002|STARTED|Overall Study||74
11396314|NCT03722238|12590153|FG001|Actual Drug Users|Overall Study||5
11396315|NCT03722238|12590152|FG000|COMPLETED|Overall Study||143
11396316|NCT03722238|12590153|FG001|COMPLETED|Overall Study||4
11396317|NCT03722238|12590152|FG000|NOT COMPLETED|Overall Study||465
11396318|NCT03722238|12590153|FG001|NOT COMPLETED|Overall Study||1
11396319|NCT03722264|12590159|FG000|STARTED|Overall Study||12
11396320|NCT03722264|12590159|FG000|COMPLETED|Overall Study||9
11396321|NCT03722264|12590159|FG000|NOT COMPLETED|Overall Study||3
11396322|NCT03722446|12590167|FG000|STARTED|Overall Study||135
11009448|NCT00744237|12187301|FG000|COMPLETED|Overall Study||56
11009449|NCT00744237|12187302|FG001|COMPLETED|Overall Study||46
11009450|NCT00744237|12187303|FG002|COMPLETED|Overall Study||59
11009451|NCT00744237|12187301|FG000|NOT COMPLETED|Overall Study||27
11009452|NCT00744237|12187302|FG001|NOT COMPLETED|Overall Study||27
11009453|NCT00744237|12187303|FG002|NOT COMPLETED|Overall Study||15
11009454|NCT00744263|12187313|FG000|STARTED|Overall Study||42240
11009455|NCT00744263|12187314|FG001|STARTED|Overall Study||42256
11009456|NCT00744263|12187313|FG000|COMPLETED|Overall Study||37004
11009457|NCT00744263|12187314|FG001|COMPLETED|Overall Study||36936
11009458|NCT00744263|12187313|FG000|NOT COMPLETED|Overall Study||5236
11009459|NCT00744263|12187314|FG001|NOT COMPLETED|Overall Study||5320
11396323|NCT03722446|12590168|FG001|STARTED|Overall Study||122
11396324|NCT03722446|12590167|FG000|COMPLETED|Overall Study||120
11009460|NCT00744328|12187325|FG000|STARTED|Overall Study||26
11009461|NCT00744328|12187326|FG001|STARTED|Overall Study||30
11009462|NCT00744328|12187327|FG002|STARTED|Overall Study||29
11009463|NCT00744328|12187325|FG000|COMPLETED|Overall Study||19
11009464|NCT00744328|12187326|FG001|COMPLETED|Overall Study||22
11009465|NCT00744328|12187327|FG002|COMPLETED|Overall Study||21
11009466|NCT00744328|12187325|FG000|NOT COMPLETED|Overall Study||7
11009467|NCT00744328|12187326|FG001|NOT COMPLETED|Overall Study||8
11009468|NCT00744328|12187327|FG002|NOT COMPLETED|Overall Study||8
11009469|NCT00744380|12187337|FG000|STARTED|Overall Study||12
11009470|NCT00744380|12187338|FG001|STARTED|Overall Study||11
11009471|NCT00744380|12187337|FG000|COMPLETED|Overall Study||12
11009472|NCT00744380|12187338|FG001|COMPLETED|Overall Study||11
11009473|NCT00744380|12187337|FG000|NOT COMPLETED|Overall Study||0
11009474|NCT00744380|12187338|FG001|NOT COMPLETED|Overall Study||0
11009475|NCT00744471|12187349|FG000|STARTED|Overall Study||156
11009476|NCT00744471|12187350|FG001|STARTED|Overall Study||156
11009477|NCT00744471|12187351|FG002|STARTED|Overall Study||158
11009478|NCT00744471|12187352|FG003|STARTED|Overall Study||157
11009479|NCT00744471|12187349|FG000|Treated|Overall Study||155
11009480|NCT00744471|12187350|FG001|Treated|Overall Study||155
11009481|NCT00744471|12187351|FG002|Treated|Overall Study||154
11009482|NCT00744471|12187352|FG003|Treated|Overall Study||157
11009483|NCT00744471|12187349|FG000|COMPLETED|Overall Study||13
11009484|NCT00744471|12187350|FG001|COMPLETED|Overall Study||11
11009485|NCT00744471|12187351|FG002|COMPLETED|Overall Study||6
11009486|NCT00744471|12187352|FG003|COMPLETED|Overall Study||9
11009487|NCT00744471|12187349|FG000|NOT COMPLETED|Overall Study||143
11009488|NCT00744471|12187350|FG001|NOT COMPLETED|Overall Study||145
11009489|NCT00744471|12187351|FG002|NOT COMPLETED|Overall Study||152
11009490|NCT00744471|12187352|FG003|NOT COMPLETED|Overall Study||148
11009491|NCT00744497|12187364|FG000|STARTED|Overall Study|Randomized|760
11009492|NCT00744497|12187365|FG001|STARTED|Overall Study|Randomized|762
11009493|NCT00744497|12187364|FG000|Received Treatment|Overall Study||757
11009494|NCT00744497|12187365|FG001|Received Treatment|Overall Study||761
11009495|NCT00744497|12187364|FG000|COMPLETED|Overall Study||0
11009496|NCT00744497|12187365|FG001|COMPLETED|Overall Study||0
11009497|NCT00744497|12187364|FG000|NOT COMPLETED|Overall Study||760
11009498|NCT00744497|12187365|FG001|NOT COMPLETED|Overall Study||762
11009499|NCT00744523|12187373|FG000|STARTED|Procedure||37
11009500|NCT00744523|12187374|FG001|STARTED|Procedure||225
11009501|NCT00744523|12187373|FG000|COMPLETED|Procedure||37
11009502|NCT00744523|12187374|FG001|COMPLETED|Procedure||225
11009503|NCT00744523|12187373|FG000|NOT COMPLETED|Procedure||0
11009504|NCT00744523|12187374|FG001|NOT COMPLETED|Procedure||0
11009505|NCT00744523|12187373|FG000|STARTED|30 Days After the Procedure||37
11009506|NCT00744523|12187374|FG001|STARTED|30 Days After the Procedure||225
11009507|NCT00744523|12187373|FG000|COMPLETED|30 Days After the Procedure||37
11009508|NCT00744523|12187374|FG001|COMPLETED|30 Days After the Procedure||220
11009509|NCT00744523|12187373|FG000|NOT COMPLETED|30 Days After the Procedure||0
11009510|NCT00744523|12187374|FG001|NOT COMPLETED|30 Days After the Procedure||5
11009511|NCT00744627|12187384|FG000|STARTED|Overall Study||151
11009512|NCT00744627|12187385|FG001|STARTED|Overall Study||150
11009513|NCT00744627|12187384|FG000|Treated|Overall Study||150
11009514|NCT00744627|12187385|FG001|Treated|Overall Study||150
11009515|NCT00744627|12187384|FG000|COMPLETED|Overall Study||126
11009516|NCT00744627|12187385|FG001|COMPLETED|Overall Study||128
11009517|NCT00744627|12187384|FG000|NOT COMPLETED|Overall Study||25
11009518|NCT00744627|12187385|FG001|NOT COMPLETED|Overall Study||22
11009519|NCT00744653|12187391|FG000|STARTED|Overall Study||17
11009520|NCT00744653|12187391|FG000|COMPLETED|Overall Study||1
11009521|NCT00744653|12187391|FG000|NOT COMPLETED|Overall Study||16
11009522|NCT00744692|12187396|FG000|STARTED|Overall Study||22
11009523|NCT00744692|12187396|FG000|COMPLETED|Overall Study||22
11009524|NCT00744692|12187396|FG000|NOT COMPLETED|Overall Study||0
11009525|NCT00744757|12187400|FG000|STARTED|Overall Study||37
11009526|NCT00744757|12187400|FG000|COMPLETED|Overall Study||16
11009527|NCT00744757|12187400|FG000|NOT COMPLETED|Overall Study||21
11009528|NCT00744796|12187404|FG000|STARTED|Pre-operative||21
11009529|NCT00744796|12187404|FG000|COMPLETED|Pre-operative||21
11009530|NCT00744796|12187404|FG000|NOT COMPLETED|Pre-operative||0
11009531|NCT00744796|12187404|FG000|STARTED|Post-Operative Day 1||21
11009532|NCT00744796|12187404|FG000|COMPLETED|Post-Operative Day 1||21
11009533|NCT00744796|12187404|FG000|NOT COMPLETED|Post-Operative Day 1||0
11009534|NCT00744796|12187404|FG000|STARTED|Post-Operative 3-6 Months||21
11009535|NCT00744796|12187404|FG000|COMPLETED|Post-Operative 3-6 Months||21
11009536|NCT00744796|12187404|FG000|NOT COMPLETED|Post-Operative 3-6 Months||0
11009537|NCT00744796|12187404|FG000|STARTED|Post-Operative 6-9 Months||21
11009538|NCT00744796|12187404|FG000|COMPLETED|Post-Operative 6-9 Months||9
11009539|NCT00744796|12187404|FG000|NOT COMPLETED|Post-Operative 6-9 Months||12
11009540|NCT00744848|12187410|FG000|STARTED|Overall Study||103
11009541|NCT00744848|12187411|FG001|STARTED|Overall Study||101
11009542|NCT00744848|12187410|FG000|COMPLETED|Overall Study||103
11009543|NCT00744848|12187411|FG001|COMPLETED|Overall Study||101
11009544|NCT00744848|12187410|FG000|NOT COMPLETED|Overall Study||0
11009545|NCT00744848|12187411|FG001|NOT COMPLETED|Overall Study||0
11009546|NCT00744861|12187421|FG000|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|8
11009547|NCT00744861|12187422|FG001|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|10
11009548|NCT00744861|12187423|FG002|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
11009549|NCT00744861|12187424|FG003|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
11009550|NCT00744861|12187421|FG000|COMPLETED|Feasibility Stage 1||7
11009551|NCT00744861|12187422|FG001|COMPLETED|Feasibility Stage 1||8
11009552|NCT00744861|12187423|FG002|COMPLETED|Feasibility Stage 1||0
11009553|NCT00744861|12187424|FG003|COMPLETED|Feasibility Stage 1||0
11009554|NCT00744861|12187421|FG000|NOT COMPLETED|Feasibility Stage 1||1
11009555|NCT00744861|12187422|FG001|NOT COMPLETED|Feasibility Stage 1||2
11009556|NCT00744861|12187423|FG002|NOT COMPLETED|Feasibility Stage 1||0
11009557|NCT00744861|12187424|FG003|NOT COMPLETED|Feasibility Stage 1||0
11009558|NCT00744861|12187421|FG000|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
11009559|NCT00744861|12187422|FG001|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
11009560|NCT00744861|12187423|FG002|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|154
11009561|NCT00744861|12187424|FG003|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|156
11009562|NCT00744861|12187421|FG000|COMPLETED|Pivotal Stage 2||0
11009563|NCT00744861|12187422|FG001|COMPLETED|Pivotal Stage 2||0
11009564|NCT00744861|12187423|FG002|COMPLETED|Pivotal Stage 2||52
11009565|NCT00744861|12187424|FG003|COMPLETED|Pivotal Stage 2||51
11396325|NCT03722446|12590168|FG001|COMPLETED|Overall Study||120
11396326|NCT03722446|12590167|FG000|NOT COMPLETED|Overall Study||15
11396327|NCT03722446|12590168|FG001|NOT COMPLETED|Overall Study||2
11009566|NCT00744861|12187421|FG000|NOT COMPLETED|Pivotal Stage 2||0
11009567|NCT00744861|12187422|FG001|NOT COMPLETED|Pivotal Stage 2||0
11009568|NCT00744861|12187423|FG002|NOT COMPLETED|Pivotal Stage 2||102
11009569|NCT00744861|12187424|FG003|NOT COMPLETED|Pivotal Stage 2||105
11009570|NCT00744874|12187432|FG000|STARTED|Overall Study||55
11009571|NCT00744874|12187432|FG000|COMPLETED|Overall Study||51
11009572|NCT00744874|12187432|FG000|NOT COMPLETED|Overall Study||4
11009573|NCT00744939|12187447|FG000|STARTED|Overall Study||168
11009574|NCT00744939|12187447|FG000|Treatment Received|Overall Study||141
11009575|NCT00744939|12187447|FG000|COMPLETED|Overall Study||77
11009576|NCT00744939|12187447|FG000|NOT COMPLETED|Overall Study||91
11009577|NCT00744965|12187461|FG000|STARTED|Overall Study||197
11009578|NCT00744965|12187462|FG001|STARTED|Overall Study||198
11009579|NCT00744965|12187461|FG000|COMPLETED|Overall Study||186
11009580|NCT00744965|12187462|FG001|COMPLETED|Overall Study||189
11009581|NCT00744965|12187461|FG000|NOT COMPLETED|Overall Study||11
11009582|NCT00744965|12187462|FG001|NOT COMPLETED|Overall Study||9
11009583|NCT00744978|12187470|FG000|STARTED|Period 1||32
11009584|NCT00744978|12187471|FG001|STARTED|Period 1||34
11009585|NCT00744978|12187470|FG000|Treated|Period 1||31
11009586|NCT00744978|12187471|FG001|Treated|Period 1||33
11009587|NCT00744978|12187470|FG000|COMPLETED|Period 1||26
11009588|NCT00744978|12187471|FG001|COMPLETED|Period 1||29
11009589|NCT00744978|12187470|FG000|NOT COMPLETED|Period 1||6
11009590|NCT00744978|12187471|FG001|NOT COMPLETED|Period 1||5
11009591|NCT00744978|12187470|FG000|STARTED|Placebo Washout||26
11009592|NCT00744978|12187471|FG001|STARTED|Placebo Washout||29
11009593|NCT00744978|12187470|FG000|COMPLETED|Placebo Washout||26
11009594|NCT00744978|12187471|FG001|COMPLETED|Placebo Washout||29
11009595|NCT00744978|12187470|FG000|NOT COMPLETED|Placebo Washout||0
11009596|NCT00744978|12187471|FG001|NOT COMPLETED|Placebo Washout||0
11009597|NCT00744978|12187470|FG000|STARTED|Period 2||26
11009598|NCT00744978|12187471|FG001|STARTED|Period 2||29
11009599|NCT00744978|12187470|FG000|COMPLETED|Period 2||26
11009600|NCT00744978|12187471|FG001|COMPLETED|Period 2||28
11009601|NCT00744978|12187470|FG000|NOT COMPLETED|Period 2||0
11009602|NCT00744978|12187471|FG001|NOT COMPLETED|Period 2||1
11009603|NCT00744991|12187477|FG000|STARTED|Overall Study||25
11009604|NCT00744991|12187477|FG000|Received at Least 1 Dose|Overall Study||25
11009605|NCT00744991|12187477|FG000|COMPLETED|Overall Study||0
11009606|NCT00744991|12187477|FG000|NOT COMPLETED|Overall Study||25
11009607|NCT00745095|12187490|FG000|STARTED|Overall Study||15
11009608|NCT00745095|12187491|FG001|STARTED|Overall Study||15
11009609|NCT00745095|12187492|FG002|STARTED|Overall Study||15
11009610|NCT00745095|12187493|FG003|STARTED|Overall Study||15
11009611|NCT00745095|12187494|FG004|STARTED|Overall Study||150
11009612|NCT00745095|12187495|FG005|STARTED|Overall Study||150
11009613|NCT00745095|12187490|FG000|COMPLETED|Overall Study||14
11009614|NCT00745095|12187491|FG001|COMPLETED|Overall Study||13
11009615|NCT00745095|12187492|FG002|COMPLETED|Overall Study||12
11009616|NCT00745095|12187493|FG003|COMPLETED|Overall Study||12
11009617|NCT00745095|12187494|FG004|COMPLETED|Overall Study||28
11009618|NCT00745095|12187495|FG005|COMPLETED|Overall Study||27
11009619|NCT00745095|12187490|FG000|NOT COMPLETED|Overall Study||1
11009620|NCT00745095|12187491|FG001|NOT COMPLETED|Overall Study||2
11009621|NCT00745095|12187492|FG002|NOT COMPLETED|Overall Study||3
11009622|NCT00745095|12187493|FG003|NOT COMPLETED|Overall Study||3
11009623|NCT00745095|12187494|FG004|NOT COMPLETED|Overall Study||122
11009624|NCT00745095|12187495|FG005|NOT COMPLETED|Overall Study||123
11009625|NCT00745121|12187514|FG000|STARTED|Overall Study||20
11009626|NCT00745121|12187515|FG001|STARTED|Overall Study||28
11009627|NCT00745121|12187514|FG000|COMPLETED|Overall Study||11
11396328|NCT03722524|12590174|FG000|STARTED|Overall Study||1247
11396329|NCT03722524|12590174|FG000|COMPLETED|Overall Study||1148
11009628|NCT00745121|12187515|FG001|COMPLETED|Overall Study||26
11009629|NCT00745121|12187514|FG000|NOT COMPLETED|Overall Study||9
11009630|NCT00745121|12187515|FG001|NOT COMPLETED|Overall Study||2
11009631|NCT00745251|12187523|FG000|STARTED|Overall Study||23
11009632|NCT00745251|12187524|FG001|STARTED|Overall Study||22
11009633|NCT00745251|12187523|FG000|COMPLETED|Overall Study||21
11009634|NCT00745251|12187524|FG001|COMPLETED|Overall Study||19
11009635|NCT00745251|12187523|FG000|NOT COMPLETED|Overall Study||2
11009636|NCT00745251|12187524|FG001|NOT COMPLETED|Overall Study||3
11009637|NCT00745290|12187532|FG000|STARTED|Overall Study||123
11009638|NCT00745290|12187533|FG001|STARTED|Overall Study||122
11009639|NCT00745290|12187532|FG000|COMPLETED|Overall Study||123
11009640|NCT00745290|12187533|FG001|COMPLETED|Overall Study||122
11009641|NCT00745290|12187532|FG000|NOT COMPLETED|Overall Study||0
11009642|NCT00745290|12187533|FG001|NOT COMPLETED|Overall Study||0
11009643|NCT00745368|12187539|FG000|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
11009644|NCT00745368|12187539|FG000|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
11009645|NCT00745368|12187539|FG000|NOT COMPLETED|Overall Study||3
11009646|NCT00745420|12187543|FG000|STARTED|Overall Study||30
11009647|NCT00745420|12187543|FG000|COMPLETED|Overall Study||29
11009648|NCT00745420|12187543|FG000|NOT COMPLETED|Overall Study||1
11009649|NCT00745498|12187550|FG000|STARTED|Overall Study||41
11009650|NCT00745498|12187551|FG001|STARTED|Overall Study||43
11009651|NCT00745498|12187552|FG002|STARTED|Overall Study||42
11009652|NCT00745498|12187550|FG000|COMPLETED|Overall Study||36
11009653|NCT00745498|12187551|FG001|COMPLETED|Overall Study||37
11009654|NCT00745498|12187552|FG002|COMPLETED|Overall Study||34
11009655|NCT00745498|12187550|FG000|NOT COMPLETED|Overall Study||5
11009656|NCT00745498|12187551|FG001|NOT COMPLETED|Overall Study||6
11009657|NCT00745498|12187552|FG002|NOT COMPLETED|Overall Study||8
11009658|NCT00745615|12187564|FG000|STARTED|Double-Blind Extension (36 Weeks)||80
11009659|NCT00745615|12187565|FG001|STARTED|Double-Blind Extension (36 Weeks)||94
11009660|NCT00745615|12187566|FG002|STARTED|Double-Blind Extension (36 Weeks)||39
11009661|NCT00745615|12187567|FG003|STARTED|Double-Blind Extension (36 Weeks)||44
11009662|NCT00745615|12187568|FG004|STARTED|Double-Blind Extension (36 Weeks)||0
11009663|NCT00745615|12187569|FG005|STARTED|Double-Blind Extension (36 Weeks)||0
11009664|NCT00745615|12187564|FG000|COMPLETED|Double-Blind Extension (36 Weeks)||75
11009665|NCT00745615|12187565|FG001|COMPLETED|Double-Blind Extension (36 Weeks)||87
11009666|NCT00745615|12187566|FG002|COMPLETED|Double-Blind Extension (36 Weeks)||38
11009667|NCT00745615|12187567|FG003|COMPLETED|Double-Blind Extension (36 Weeks)||39
11009668|NCT00745615|12187568|FG004|COMPLETED|Double-Blind Extension (36 Weeks)||0
11009669|NCT00745615|12187569|FG005|COMPLETED|Double-Blind Extension (36 Weeks)||0
11009670|NCT00745615|12187564|FG000|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
11009671|NCT00745615|12187565|FG001|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7
11009672|NCT00745615|12187566|FG002|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1
11009673|NCT00745615|12187567|FG003|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
11009674|NCT00745615|12187568|FG004|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
11009675|NCT00745615|12187569|FG005|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
11009676|NCT00745615|12187564|FG000|STARTED|Open-Label (up to Approx 10.5 Years)||0
11009677|NCT00745615|12187565|FG001|STARTED|Open-Label (up to Approx 10.5 Years)||0
11009678|NCT00745615|12187566|FG002|STARTED|Open-Label (up to Approx 10.5 Years)||0
11009679|NCT00745615|12187567|FG003|STARTED|Open-Label (up to Approx 10.5 Years)||0
11009680|NCT00745615|12187568|FG004|STARTED|Open-Label (up to Approx 10.5 Years)||96
11009681|NCT00745615|12187569|FG005|STARTED|Open-Label (up to Approx 10.5 Years)||113
11009682|NCT00745615|12187564|FG000|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
11009683|NCT00745615|12187565|FG001|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
11009684|NCT00745615|12187566|FG002|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
11009685|NCT00745615|12187567|FG003|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
11009686|NCT00745615|12187568|FG004|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
11009687|NCT00745615|12187569|FG005|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
11009688|NCT00745615|12187564|FG000|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
11009689|NCT00745615|12187565|FG001|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
11009690|NCT00745615|12187566|FG002|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
11009691|NCT00745615|12187567|FG003|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
11009692|NCT00745615|12187568|FG004|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91
11009693|NCT00745615|12187569|FG005|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108
11009694|NCT00745823|12187583|FG000|STARTED|Overall Study||386
11009695|NCT00745823|12187584|FG001|STARTED|Overall Study||389
11009696|NCT00745823|12187583|FG000|TREATED Week 0 - 96|Overall Study||382
11009697|NCT00745823|12187584|FG001|TREATED Week 0 - 96|Overall Study||388
11009698|NCT00745823|12187583|FG000|COMPLETED|Overall Study||1
11009699|NCT00745823|12187584|FG001|COMPLETED|Overall Study||3
11009700|NCT00745823|12187583|FG000|NOT COMPLETED|Overall Study||385
11009701|NCT00745823|12187584|FG001|NOT COMPLETED|Overall Study||386
11009702|NCT00745849|12187592|FG000|STARTED|First Intervention||21
11009703|NCT00745849|12187593|FG001|STARTED|First Intervention||22
11009704|NCT00745849|12187592|FG000|COMPLETED|First Intervention||20
11009705|NCT00745849|12187593|FG001|COMPLETED|First Intervention||20
11009706|NCT00745849|12187592|FG000|NOT COMPLETED|First Intervention||1
11009707|NCT00745849|12187593|FG001|NOT COMPLETED|First Intervention||2
11009708|NCT00745849|12187592|FG000|STARTED|Washout Period||20
11009709|NCT00745849|12187593|FG001|STARTED|Washout Period||20
11009710|NCT00745849|12187592|FG000|COMPLETED|Washout Period||20
11009711|NCT00745849|12187593|FG001|COMPLETED|Washout Period||20
11009712|NCT00745849|12187592|FG000|NOT COMPLETED|Washout Period||0
11009713|NCT00745849|12187593|FG001|NOT COMPLETED|Washout Period||0
11009714|NCT00745849|12187592|FG000|STARTED|Second Intervention||20
11009715|NCT00745849|12187593|FG001|STARTED|Second Intervention||20
11396330|NCT03722524|12590174|FG000|NOT COMPLETED|Overall Study||99
11396331|NCT03722576|12590178|FG000|STARTED|Overall Study||18
11396332|NCT03722576|12590178|FG000|COMPLETED|Overall Study||11
11009716|NCT00745849|12187592|FG000|COMPLETED|Second Intervention||18
11009717|NCT00745849|12187593|FG001|COMPLETED|Second Intervention||19
11009718|NCT00745849|12187592|FG000|NOT COMPLETED|Second Intervention||2
11009719|NCT00745849|12187593|FG001|NOT COMPLETED|Second Intervention||1
11009720|NCT00745875|12187601|FG000|STARTED|Overall Study|Started - Number of patients randomised|36
11009721|NCT00745875|12187602|FG001|STARTED|Overall Study|Started - Number of patients randomised|30
11009722|NCT00745875|12187601|FG000|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
11009723|NCT00745875|12187602|FG001|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
11009724|NCT00745875|12187601|FG000|NOT COMPLETED|Overall Study||4
11009725|NCT00745875|12187602|FG001|NOT COMPLETED|Overall Study||4
11009726|NCT00745901|12187610|FG000|STARTED|Overall Study|Number of Patients Randomized|178
11009727|NCT00745901|12187611|FG001|STARTED|Overall Study|Number of Patients Randomized|177
11009728|NCT00745901|12187610|FG000|COMPLETED|Overall Study||154
11009729|NCT00745901|12187611|FG001|COMPLETED|Overall Study||156
11009730|NCT00745901|12187610|FG000|NOT COMPLETED|Overall Study||24
11009731|NCT00745901|12187611|FG001|NOT COMPLETED|Overall Study||21
11009732|NCT00745940|12187619|FG000|STARTED|Overall Study||57
11009733|NCT00745940|12187620|FG001|STARTED|Overall Study||48
11009734|NCT00745940|12187619|FG000|COMPLETED|Overall Study||38
11009735|NCT00745940|12187620|FG001|COMPLETED|Overall Study||38
11009736|NCT00745940|12187619|FG000|NOT COMPLETED|Overall Study||19
11009737|NCT00745940|12187620|FG001|NOT COMPLETED|Overall Study||10
11009738|NCT00746096|12187628|FG000|STARTED|Overall Study||58
11142683|NCT01469013|12329435|FG012|COMPLETED|Part A (Treatment Period)||0
11142684|NCT01469013|12329423|FG000|NOT COMPLETED|Part A (Treatment Period)||1
11142685|NCT01469013|12329424|FG001|NOT COMPLETED|Part A (Treatment Period)||0
11142686|NCT01469013|12329425|FG002|NOT COMPLETED|Part A (Treatment Period)||1
11142687|NCT01469013|12329426|FG003|NOT COMPLETED|Part A (Treatment Period)||0
11142688|NCT01469013|12329427|FG004|NOT COMPLETED|Part A (Treatment Period)||1
11142689|NCT01469013|12329428|FG005|NOT COMPLETED|Part A (Treatment Period)||0
11142690|NCT01469013|12329429|FG006|NOT COMPLETED|Part A (Treatment Period)||0
11142691|NCT01469013|12329430|FG007|NOT COMPLETED|Part A (Treatment Period)||0
11142692|NCT01469013|12329431|FG008|NOT COMPLETED|Part A (Treatment Period)||0
11142693|NCT01469013|12329432|FG009|NOT COMPLETED|Part A (Treatment Period)||0
11142694|NCT01469013|12329433|FG010|NOT COMPLETED|Part A (Treatment Period)||0
11142695|NCT01469013|12329434|FG011|NOT COMPLETED|Part A (Treatment Period)||0
11142696|NCT01469013|12329435|FG012|NOT COMPLETED|Part A (Treatment Period)||0
11142697|NCT01469013|12329423|FG000|STARTED|Part B (Extension Period)||0
11142698|NCT01469013|12329424|FG001|STARTED|Part B (Extension Period)||0
11142699|NCT01469013|12329425|FG002|STARTED|Part B (Extension Period)||0
11142700|NCT01469013|12329426|FG003|STARTED|Part B (Extension Period)||0
11142701|NCT01469013|12329427|FG004|STARTED|Part B (Extension Period)||0
11142702|NCT01469013|12329428|FG005|STARTED|Part B (Extension Period)||12
11142703|NCT01469013|12329429|FG006|STARTED|Part B (Extension Period)||12
11142704|NCT01469013|12329430|FG007|STARTED|Part B (Extension Period)||23
11142705|NCT01469013|12329431|FG008|STARTED|Part B (Extension Period)||24
11142706|NCT01469013|12329432|FG009|STARTED|Part B (Extension Period)||11
11142707|NCT01469013|12329433|FG010|STARTED|Part B (Extension Period)||12
11142708|NCT01469013|12329434|FG011|STARTED|Part B (Extension Period)||24
11142709|NCT01469013|12329435|FG012|STARTED|Part B (Extension Period)||24
11142710|NCT01469013|12329423|FG000|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
11142711|NCT01469013|12329424|FG001|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
11009739|NCT00746096|12187629|FG001|STARTED|Overall Study||57
11009740|NCT00746096|12187628|FG000|COMPLETED|Overall Study||48
11009741|NCT00746096|12187629|FG001|COMPLETED|Overall Study||54
11009742|NCT00746096|12187628|FG000|NOT COMPLETED|Overall Study||10
11009743|NCT00746096|12187629|FG001|NOT COMPLETED|Overall Study||3
11009744|NCT00746122|12187637|FG000|STARTED|Overall Study||297
11009745|NCT00746122|12187638|FG001|STARTED|Overall Study|After 600 recruitment target 13 more patients were randomised before sites could be closed down.|316
11009746|NCT00746122|12187637|FG000|COMPLETED|Overall Study||297
11009747|NCT00746122|12187638|FG001|COMPLETED|Overall Study||316
11009748|NCT00746122|12187637|FG000|NOT COMPLETED|Overall Study||0
11009749|NCT00746122|12187638|FG001|NOT COMPLETED|Overall Study||0
11009750|NCT00746187|12187646|FG000|STARTED|Overall Study||18
11009751|NCT00746187|12187647|FG001|STARTED|Overall Study||18
11009752|NCT00746187|12187646|FG000|COMPLETED|Overall Study||15
11142712|NCT01469013|12329425|FG002|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
11142713|NCT01469013|12329426|FG003|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
11142714|NCT01469013|12329427|FG004|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
11142715|NCT01469013|12329428|FG005|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
11396333|NCT03722576|12590178|FG000|NOT COMPLETED|Overall Study||7
11396334|NCT03722784|12590184|FG000|STARTED|Overall Study||58
11009753|NCT00746187|12187647|FG001|COMPLETED|Overall Study||16
11009754|NCT00746187|12187646|FG000|NOT COMPLETED|Overall Study||3
11009755|NCT00746187|12187647|FG001|NOT COMPLETED|Overall Study||2
11009756|NCT00746252|12187655|FG000|STARTED|Overall Study||1
11009757|NCT00746252|12187656|FG001|STARTED|Overall Study||2
11009758|NCT00746252|12187655|FG000|COMPLETED|Overall Study||0
11009759|NCT00746252|12187656|FG001|COMPLETED|Overall Study||0
11009760|NCT00746252|12187655|FG000|NOT COMPLETED|Overall Study||1
11205256|NCT01858363|12396007|FG000|STARTED|Overall Study||222
11009761|NCT00746252|12187656|FG001|NOT COMPLETED|Overall Study||2
11056634|NCT00995475|12238282|FG000|STARTED|Wash-out Two Week||9
11056635|NCT00995475|12238283|FG001|STARTED|Wash-out Two Week||9
11056636|NCT00995475|12238282|FG000|COMPLETED|Wash-out Two Week||9
11056637|NCT00995475|12238283|FG001|COMPLETED|Wash-out Two Week||9
11056638|NCT00995475|12238282|FG000|NOT COMPLETED|Wash-out Two Week||0
11056639|NCT00995475|12238283|FG001|NOT COMPLETED|Wash-out Two Week||0
11056640|NCT00995475|12238282|FG000|STARTED|Second Intervention||9
11056641|NCT00995475|12238283|FG001|STARTED|Second Intervention||9
11056642|NCT00995475|12238282|FG000|COMPLETED|Second Intervention||9
11056643|NCT00995475|12238283|FG001|COMPLETED|Second Intervention||9
11056644|NCT00995475|12238282|FG000|NOT COMPLETED|Second Intervention||0
11056645|NCT00995475|12238283|FG001|NOT COMPLETED|Second Intervention||0
11056646|NCT00995488|12238289|FG000|STARTED|Overall Study||16
11056647|NCT00995488|12238289|FG000|COMPLETED|Overall Study||15
11056648|NCT00995488|12238289|FG000|NOT COMPLETED|Overall Study||1
11056649|NCT00995501|12238301|FG000|STARTED|Overall Study||52
11056650|NCT00995501|12238302|FG001|STARTED|Overall Study||51
11056651|NCT00995501|12238303|FG002|STARTED|Overall Study||47
11056652|NCT00995501|12238304|FG003|STARTED|Overall Study||46
11056653|NCT00995501|12238305|FG004|STARTED|Overall Study||46
11056654|NCT00995501|12238306|FG005|STARTED|Overall Study||44
11056655|NCT00995501|12238307|FG006|STARTED|Overall Study||49
11056656|NCT00995501|12238308|FG007|STARTED|Overall Study||46
11056657|NCT00995501|12238301|FG000|COMPLETED|Overall Study||52
11056658|NCT00995501|12238302|FG001|COMPLETED|Overall Study||51
11056659|NCT00995501|12238303|FG002|COMPLETED|Overall Study||47
11056660|NCT00995501|12238304|FG003|COMPLETED|Overall Study||46
11056661|NCT00995501|12238305|FG004|COMPLETED|Overall Study||46
11056662|NCT00995501|12238306|FG005|COMPLETED|Overall Study||44
11056663|NCT00995501|12238307|FG006|COMPLETED|Overall Study||49
11056664|NCT00995501|12238308|FG007|COMPLETED|Overall Study||46
11056665|NCT00995501|12238301|FG000|NOT COMPLETED|Overall Study||0
11056666|NCT00995501|12238302|FG001|NOT COMPLETED|Overall Study||0
11056667|NCT00995501|12238303|FG002|NOT COMPLETED|Overall Study||0
11056668|NCT00995501|12238304|FG003|NOT COMPLETED|Overall Study||0
11056669|NCT00995501|12238305|FG004|NOT COMPLETED|Overall Study||0
11056670|NCT00995501|12238306|FG005|NOT COMPLETED|Overall Study||0
11056671|NCT00995501|12238307|FG006|NOT COMPLETED|Overall Study||0
11056672|NCT00995501|12238308|FG007|NOT COMPLETED|Overall Study||0
11056673|NCT00995553|12238328|FG000|STARTED|Overall Study||40
11056674|NCT00995553|12238329|FG001|STARTED|Overall Study||41
11056675|NCT00995553|12238328|FG000|COMPLETED|Overall Study||38
11056676|NCT00995553|12238329|FG001|COMPLETED|Overall Study||35
11056677|NCT00995553|12238328|FG000|NOT COMPLETED|Overall Study||2
11056678|NCT00995553|12238329|FG001|NOT COMPLETED|Overall Study||6
11056679|NCT00995566|12238335|FG000|STARTED|Overall Study||54
11056680|NCT00995566|12238335|FG000|COMPLETED|Overall Study||0
11056681|NCT00995566|12238335|FG000|NOT COMPLETED|Overall Study||54
11056682|NCT00995670|12238342|FG000|STARTED|Overall Study||26
11056683|NCT00995670|12238343|FG001|STARTED|Overall Study||16
11056684|NCT00995670|12238344|FG002|STARTED|Overall Study||17
11056685|NCT00995670|12238342|FG000|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
11056686|NCT00995670|12238343|FG001|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
11056687|NCT00995670|12238344|FG002|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
11056688|NCT00995670|12238342|FG000|NOT COMPLETED|Overall Study||1
11056689|NCT00995670|12238343|FG001|NOT COMPLETED|Overall Study||0
11056690|NCT00995670|12238344|FG002|NOT COMPLETED|Overall Study||3
11056691|NCT00995709|12238355|FG000|STARTED|Overall Study||39
11056692|NCT00995709|12238356|FG001|STARTED|Overall Study||40
11056693|NCT00995709|12238357|FG002|STARTED|Overall Study||39
11056694|NCT00995709|12238355|FG000|COMPLETED|Overall Study||32
11056695|NCT00995709|12238356|FG001|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
11056696|NCT00995709|12238357|FG002|COMPLETED|Overall Study||34
11056697|NCT00995709|12238355|FG000|NOT COMPLETED|Overall Study||7
11056698|NCT00995709|12238356|FG001|NOT COMPLETED|Overall Study||9
11056699|NCT00995709|12238357|FG002|NOT COMPLETED|Overall Study||5
11056700|NCT00995722|12238367|FG000|STARTED|Double Blinded: 16 Weeks||6
11056701|NCT00995722|12238368|FG001|STARTED|Double Blinded: 16 Weeks||5
11009762|NCT00746330|12187666|FG000|STARTED|Period 1||7
11009763|NCT00746330|12187667|FG001|STARTED|Period 1||9
11009764|NCT00746330|12187668|FG002|STARTED|Period 1||9
11009765|NCT00746330|12187669|FG003|STARTED|Period 1||7
11009766|NCT00746330|12187666|FG000|COMPLETED|Period 1||7
11009767|NCT00746330|12187667|FG001|COMPLETED|Period 1||9
11009768|NCT00746330|12187668|FG002|COMPLETED|Period 1||8
11009769|NCT00746330|12187669|FG003|COMPLETED|Period 1||7
11009770|NCT00746330|12187666|FG000|NOT COMPLETED|Period 1||0
11009771|NCT00746330|12187667|FG001|NOT COMPLETED|Period 1||0
11009772|NCT00746330|12187668|FG002|NOT COMPLETED|Period 1||1
11009773|NCT00746330|12187669|FG003|NOT COMPLETED|Period 1||0
11009774|NCT00746330|12187666|FG000|STARTED|Period 2||7
11009775|NCT00746330|12187667|FG001|STARTED|Period 2||9
11009776|NCT00746330|12187668|FG002|STARTED|Period 2||8
11009777|NCT00746330|12187669|FG003|STARTED|Period 2||7
11009778|NCT00746330|12187666|FG000|COMPLETED|Period 2||7
11009779|NCT00746330|12187667|FG001|COMPLETED|Period 2||9
11009780|NCT00746330|12187668|FG002|COMPLETED|Period 2||8
11009781|NCT00746330|12187669|FG003|COMPLETED|Period 2||7
11009782|NCT00746330|12187666|FG000|NOT COMPLETED|Period 2||0
11009783|NCT00746330|12187667|FG001|NOT COMPLETED|Period 2||0
11009784|NCT00746330|12187668|FG002|NOT COMPLETED|Period 2||0
11009785|NCT00746330|12187669|FG003|NOT COMPLETED|Period 2||0
11009786|NCT00746330|12187666|FG000|STARTED|Period 3||7
11009787|NCT00746330|12187667|FG001|STARTED|Period 3||9
11009788|NCT00746330|12187668|FG002|STARTED|Period 3||8
11009789|NCT00746330|12187669|FG003|STARTED|Period 3||7
11009790|NCT00746330|12187666|FG000|COMPLETED|Period 3||7
11009791|NCT00746330|12187667|FG001|COMPLETED|Period 3||9
11009792|NCT00746330|12187668|FG002|COMPLETED|Period 3||8
11009793|NCT00746330|12187669|FG003|COMPLETED|Period 3||7
11009794|NCT00746330|12187666|FG000|NOT COMPLETED|Period 3||0
11009795|NCT00746330|12187667|FG001|NOT COMPLETED|Period 3||0
11009796|NCT00746330|12187668|FG002|NOT COMPLETED|Period 3||0
11009797|NCT00746330|12187669|FG003|NOT COMPLETED|Period 3||0
11009798|NCT00746330|12187666|FG000|STARTED|Period 4||7
11009799|NCT00746330|12187667|FG001|STARTED|Period 4||9
11009800|NCT00746330|12187668|FG002|STARTED|Period 4||8
11009801|NCT00746330|12187669|FG003|STARTED|Period 4||7
11009802|NCT00746330|12187666|FG000|COMPLETED|Period 4||7
11009803|NCT00746330|12187667|FG001|COMPLETED|Period 4||9
11009804|NCT00746330|12187668|FG002|COMPLETED|Period 4||8
11009805|NCT00746330|12187669|FG003|COMPLETED|Period 4||7
11009806|NCT00746330|12187666|FG000|NOT COMPLETED|Period 4||0
11009807|NCT00746330|12187667|FG001|NOT COMPLETED|Period 4||0
11009808|NCT00746330|12187668|FG002|NOT COMPLETED|Period 4||0
11009809|NCT00746330|12187669|FG003|NOT COMPLETED|Period 4||0
11009810|NCT00746356|12187680|FG000|STARTED|Overall Study||81
11009811|NCT00746356|12187681|FG001|STARTED|Overall Study||47
11009812|NCT00746356|12187680|FG000|COMPLETED|Overall Study||70
11009813|NCT00746356|12187681|FG001|COMPLETED|Overall Study||40
11142716|NCT01469013|12329429|FG006|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
11142717|NCT01469013|12329430|FG007|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
11142718|NCT01469013|12329431|FG008|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
11142719|NCT01469013|12329432|FG009|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
11142720|NCT01469013|12329433|FG010|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
11142721|NCT01469013|12329434|FG011|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
11202613|NCT01841593|12393024|FG000|STARTED|Second Intervention (Days 8 to 14)||12
11009814|NCT00746356|12187680|FG000|NOT COMPLETED|Overall Study||11
11009815|NCT00746356|12187681|FG001|NOT COMPLETED|Overall Study||7
11009816|NCT00746395|12187691|FG000|STARTED|Overall Study||20
11009817|NCT00746395|12187692|FG001|STARTED|Overall Study||20
11009818|NCT00746395|12187691|FG000|COMPLETED|Overall Study||20
11009819|NCT00746395|12187692|FG001|COMPLETED|Overall Study||20
11009820|NCT00746395|12187691|FG000|NOT COMPLETED|Overall Study||0
11009821|NCT00746395|12187692|FG001|NOT COMPLETED|Overall Study||0
11009822|NCT00746421|12187700|FG000|STARTED|Overall Study||12
11009823|NCT00746421|12187701|FG001|STARTED|Overall Study||11
11009824|NCT00746421|12187700|FG000|COMPLETED|Overall Study||5
11009825|NCT00746421|12187701|FG001|COMPLETED|Overall Study||9
11009826|NCT00746421|12187700|FG000|NOT COMPLETED|Overall Study||7
11009827|NCT00746421|12187701|FG001|NOT COMPLETED|Overall Study||2
11009828|NCT00746512|12187711|FG000|STARTED|Overall Study||8
11009829|NCT00746512|12187712|FG001|STARTED|Overall Study||10
11009830|NCT00746512|12187713|FG002|STARTED|Overall Study||18
11009831|NCT00746512|12187714|FG003|STARTED|Overall Study||9
11009832|NCT00746512|12187711|FG000|COMPLETED|Overall Study||8
11009833|NCT00746512|12187712|FG001|COMPLETED|Overall Study||10
11009834|NCT00746512|12187713|FG002|COMPLETED|Overall Study||18
11009835|NCT00746512|12187714|FG003|COMPLETED|Overall Study||9
11009836|NCT00746512|12187711|FG000|NOT COMPLETED|Overall Study||0
11009837|NCT00746512|12187712|FG001|NOT COMPLETED|Overall Study||0
11009838|NCT00746512|12187713|FG002|NOT COMPLETED|Overall Study||0
11009839|NCT00746512|12187714|FG003|NOT COMPLETED|Overall Study||0
11009840|NCT00746551|12187726|FG000|STARTED|At Gestational Age of 36 Weeks||40
11009841|NCT00746551|12187727|FG001|STARTED|At Gestational Age of 36 Weeks||40
11009842|NCT00746551|12187726|FG000|COMPLETED|At Gestational Age of 36 Weeks||38
11202614|NCT01841593|12393025|FG001|STARTED|Second Intervention (Days 8 to 14)||6
11009843|NCT00746551|12187727|FG001|COMPLETED|At Gestational Age of 36 Weeks||36
11009844|NCT00746551|12187726|FG000|NOT COMPLETED|At Gestational Age of 36 Weeks||2
11009845|NCT00746551|12187727|FG001|NOT COMPLETED|At Gestational Age of 36 Weeks||4
11009846|NCT00746551|12187726|FG000|STARTED|At Delivery (GA of 39 Weeks)||40
11009847|NCT00746551|12187727|FG001|STARTED|At Delivery (GA of 39 Weeks)||40
11009848|NCT00746551|12187726|FG000|COMPLETED|At Delivery (GA of 39 Weeks)||25
11009849|NCT00746551|12187727|FG001|COMPLETED|At Delivery (GA of 39 Weeks)||25
11009850|NCT00746551|12187726|FG000|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
11009851|NCT00746551|12187727|FG001|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
11009852|NCT00746564|12187733|FG000|STARTED|Overall Study||75
11009853|NCT00746564|12187733|FG000|COMPLETED|Overall Study||73
11009854|NCT00746564|12187733|FG000|NOT COMPLETED|Overall Study||2
11009855|NCT00746668|12187739|FG000|STARTED|Overall Study||6
11009856|NCT00746668|12187740|FG001|STARTED|Overall Study||5
11009857|NCT00746668|12187741|FG002|STARTED|Overall Study||5
11009858|NCT00746668|12187742|FG003|STARTED|Overall Study||5
11009859|NCT00746668|12187743|FG004|STARTED|Overall Study||5
11009860|NCT00746668|12187744|FG005|STARTED|Overall Study||5
11009861|NCT00746668|12187745|FG006|STARTED|Overall Study||5
11009862|NCT00746668|12187739|FG000|COMPLETED|Overall Study||6
11009863|NCT00746668|12187740|FG001|COMPLETED|Overall Study||5
11009864|NCT00746668|12187741|FG002|COMPLETED|Overall Study||5
11009865|NCT00746668|12187742|FG003|COMPLETED|Overall Study||5
11009866|NCT00746668|12187743|FG004|COMPLETED|Overall Study||5
11009867|NCT00746668|12187744|FG005|COMPLETED|Overall Study||5
11009868|NCT00746668|12187745|FG006|COMPLETED|Overall Study||5
11009869|NCT00746668|12187739|FG000|NOT COMPLETED|Overall Study||0
11009870|NCT00746668|12187740|FG001|NOT COMPLETED|Overall Study||0
11009871|NCT00746668|12187741|FG002|NOT COMPLETED|Overall Study||0
11009872|NCT00746668|12187742|FG003|NOT COMPLETED|Overall Study||0
11009873|NCT00746668|12187743|FG004|NOT COMPLETED|Overall Study||0
11009874|NCT00746668|12187744|FG005|NOT COMPLETED|Overall Study||0
11009875|NCT00746668|12187745|FG006|NOT COMPLETED|Overall Study||0
11009876|NCT00746694|12187758|FG000|STARTED|Overall Study||154
11009877|NCT00746694|12187758|FG000|COMPLETED|Overall Study||154
11009878|NCT00746694|12187758|FG000|NOT COMPLETED|Overall Study||0
11009879|NCT00746733|12187762|FG000|STARTED|First Intervention||12
11009880|NCT00746733|12187763|FG001|STARTED|First Intervention||12
11009881|NCT00746733|12187762|FG000|COMPLETED|First Intervention||12
11009882|NCT00746733|12187763|FG001|COMPLETED|First Intervention||12
11009883|NCT00746733|12187762|FG000|NOT COMPLETED|First Intervention||0
11009884|NCT00746733|12187763|FG001|NOT COMPLETED|First Intervention||0
11009885|NCT00746733|12187762|FG000|STARTED|Second Intervention||12
11009886|NCT00746733|12187763|FG001|STARTED|Second Intervention||12
11009887|NCT00746733|12187762|FG000|COMPLETED|Second Intervention||11
11009888|NCT00746733|12187763|FG001|COMPLETED|Second Intervention||12
11009889|NCT00746733|12187762|FG000|NOT COMPLETED|Second Intervention||1
11009890|NCT00746733|12187763|FG001|NOT COMPLETED|Second Intervention||0
11009891|NCT00746733|12187762|FG000|STARTED|Third Intervention||11
11009892|NCT00746733|12187763|FG001|STARTED|Third Intervention||12
11009893|NCT00746733|12187762|FG000|COMPLETED|Third Intervention||10
11009894|NCT00746733|12187763|FG001|COMPLETED|Third Intervention||11
11009895|NCT00746733|12187762|FG000|NOT COMPLETED|Third Intervention||1
11009896|NCT00746733|12187763|FG001|NOT COMPLETED|Third Intervention||1
11009897|NCT00746733|12187762|FG000|STARTED|Fourth Intervention||10
11009898|NCT00746733|12187763|FG001|STARTED|Fourth Intervention||11
11009899|NCT00746733|12187762|FG000|COMPLETED|Fourth Intervention||10
11009900|NCT00746733|12187763|FG001|COMPLETED|Fourth Intervention||11
11009901|NCT00746733|12187762|FG000|NOT COMPLETED|Fourth Intervention||0
11009902|NCT00746733|12187763|FG001|NOT COMPLETED|Fourth Intervention||0
11009903|NCT00746785|12187779|FG000|STARTED|Overall Study||43
11009904|NCT00746785|12187780|FG001|STARTED|Overall Study||46
11009905|NCT00746785|12187781|FG002|STARTED|Overall Study||40
11009906|NCT00746785|12187779|FG000|COMPLETED|Overall Study||14
11009907|NCT00746785|12187780|FG001|COMPLETED|Overall Study||21
11009908|NCT00746785|12187781|FG002|COMPLETED|Overall Study||13
11009909|NCT00746785|12187779|FG000|NOT COMPLETED|Overall Study||29
11009910|NCT00746785|12187780|FG001|NOT COMPLETED|Overall Study||25
11009911|NCT00746785|12187781|FG002|NOT COMPLETED|Overall Study||27
11009912|NCT00746798|12187793|FG000|STARTED|Overall Study||122
11009913|NCT00746798|12187794|FG001|STARTED|Overall Study||124
11009914|NCT00746798|12187795|FG002|STARTED|Overall Study||113
11009915|NCT00746798|12187796|FG003|STARTED|Overall Study||120
11009916|NCT00746798|12187793|FG000|COMPLETED|Overall Study||121
11009917|NCT00746798|12187794|FG001|COMPLETED|Overall Study||122
11009918|NCT00746798|12187795|FG002|COMPLETED|Overall Study||110
11009919|NCT00746798|12187796|FG003|COMPLETED|Overall Study||120
11009920|NCT00746798|12187793|FG000|NOT COMPLETED|Overall Study||1
11009921|NCT00746798|12187794|FG001|NOT COMPLETED|Overall Study||2
11009922|NCT00746798|12187795|FG002|NOT COMPLETED|Overall Study||3
11009923|NCT00746798|12187796|FG003|NOT COMPLETED|Overall Study||0
11009924|NCT00746863|12187808|FG000|STARTED|Overall Study||21
11009925|NCT00746863|12187809|FG001|STARTED|Overall Study||21
11009926|NCT00746863|12187808|FG000|COMPLETED|Overall Study||21
11009927|NCT00746863|12187809|FG001|COMPLETED|Overall Study||21
11009928|NCT00746863|12187808|FG000|NOT COMPLETED|Overall Study||0
11009929|NCT00746863|12187809|FG001|NOT COMPLETED|Overall Study||0
11009930|NCT00746889|12187817|FG000|STARTED|Overall Study||40
11009931|NCT00746889|12187818|FG001|STARTED|Overall Study||39
11009932|NCT00746889|12187817|FG000|COMPLETED|Overall Study||36
11009933|NCT00746889|12187818|FG001|COMPLETED|Overall Study||35
11009934|NCT00746889|12187817|FG000|NOT COMPLETED|Overall Study||4
11009935|NCT00746889|12187818|FG001|NOT COMPLETED|Overall Study||4
11009936|NCT00746941|12187830|FG000|STARTED|Overall Study||7
11009937|NCT00746941|12187831|FG001|STARTED|Overall Study||5
11009938|NCT00746941|12187832|FG002|STARTED|Overall Study||5
11009939|NCT00746941|12187833|FG003|STARTED|Overall Study||20
11009940|NCT00746941|12187830|FG000|COMPLETED|Overall Study||0
11009941|NCT00746941|12187831|FG001|COMPLETED|Overall Study||1
11009942|NCT00746941|12187832|FG002|COMPLETED|Overall Study||3
11009943|NCT00746941|12187833|FG003|COMPLETED|Overall Study||7
11009944|NCT00746941|12187830|FG000|NOT COMPLETED|Overall Study||7
11009945|NCT00746941|12187831|FG001|NOT COMPLETED|Overall Study||4
11009946|NCT00746941|12187832|FG002|NOT COMPLETED|Overall Study||2
11009947|NCT00746941|12187833|FG003|NOT COMPLETED|Overall Study||13
11009948|NCT00746954|12187842|FG000|STARTED|Overall Study||3
11009949|NCT00746954|12187843|FG001|STARTED|Overall Study||3
11009950|NCT00746954|12187844|FG002|STARTED|Overall Study||2
11009951|NCT00746954|12187842|FG000|COMPLETED|Overall Study||3
11009952|NCT00746954|12187843|FG001|COMPLETED|Overall Study||3
11009953|NCT00746954|12187844|FG002|COMPLETED|Overall Study||2
11009954|NCT00746954|12187842|FG000|NOT COMPLETED|Overall Study||0
11009955|NCT00746954|12187843|FG001|NOT COMPLETED|Overall Study||0
11009956|NCT00746954|12187844|FG002|NOT COMPLETED|Overall Study||0
11009957|NCT00747006|12187853|FG000|STARTED|Overall Study||7
11009958|NCT00747006|12187854|FG001|STARTED|Overall Study||8
11009959|NCT00747006|12187855|FG002|STARTED|Overall Study||3
11009960|NCT00747006|12187853|FG000|COMPLETED|Overall Study||4
11009961|NCT00747006|12187854|FG001|COMPLETED|Overall Study||7
11009962|NCT00747006|12187855|FG002|COMPLETED|Overall Study||2
11009963|NCT00747006|12187853|FG000|NOT COMPLETED|Overall Study||3
11009964|NCT00747006|12187854|FG001|NOT COMPLETED|Overall Study||1
11009965|NCT00747006|12187855|FG002|NOT COMPLETED|Overall Study||1
11009966|NCT00747149|12187868|FG000|STARTED|Overall Study||154
11009967|NCT00747149|12187869|FG001|STARTED|Overall Study||444
11009968|NCT00747149|12187868|FG000|COMPLETED|Overall Study||153
11009969|NCT00747149|12187869|FG001|COMPLETED|Overall Study||401
11009970|NCT00747149|12187868|FG000|NOT COMPLETED|Overall Study||1
11009971|NCT00747149|12187869|FG001|NOT COMPLETED|Overall Study||43
11009972|NCT00747214|12187883|FG000|STARTED|Overall Study||27
11009973|NCT00747214|12187884|FG001|STARTED|Overall Study||32
11009974|NCT00747214|12187883|FG000|COMPLETED|Overall Study||19
11009975|NCT00747214|12187884|FG001|COMPLETED|Overall Study||29
11009976|NCT00747214|12187883|FG000|NOT COMPLETED|Overall Study||8
11009977|NCT00747214|12187884|FG001|NOT COMPLETED|Overall Study||3
11009978|NCT00747227|12187892|FG000|STARTED|Overall Study||126
11009979|NCT00747227|12187893|FG001|STARTED|Overall Study||124
11009980|NCT00747227|12187892|FG000|COMPLETED|Overall Study||120
11009981|NCT00747227|12187893|FG001|COMPLETED|Overall Study||120
11009982|NCT00747227|12187892|FG000|NOT COMPLETED|Overall Study||6
11009983|NCT00747227|12187893|FG001|NOT COMPLETED|Overall Study||4
11009984|NCT00747344|12187901|FG000|STARTED|Controlled Period||60
11009985|NCT00747344|12187902|FG001|STARTED|Controlled Period||61
11009986|NCT00747344|12187903|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
11009987|NCT00747344|12187904|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
11009988|NCT00747344|12187901|FG000|COMPLETED|Controlled Period||55
11009989|NCT00747344|12187902|FG001|COMPLETED|Controlled Period||57
11009990|NCT00747344|12187903|FG002|COMPLETED|Controlled Period||0
11009991|NCT00747344|12187904|FG003|COMPLETED|Controlled Period||0
11009992|NCT00747344|12187901|FG000|NOT COMPLETED|Controlled Period||5
11009993|NCT00747344|12187902|FG001|NOT COMPLETED|Controlled Period||4
11009994|NCT00747344|12187903|FG002|NOT COMPLETED|Controlled Period||0
11009995|NCT00747344|12187904|FG003|NOT COMPLETED|Controlled Period||0
11009996|NCT00747344|12187901|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
11009997|NCT00747344|12187902|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
11009998|NCT00747344|12187903|FG002|STARTED|After Controlled Period||55
11009999|NCT00747344|12187904|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
11010000|NCT00747344|12187901|FG000|COMPLETED|After Controlled Period||0
11010001|NCT00747344|12187902|FG001|COMPLETED|After Controlled Period||0
11010002|NCT00747344|12187903|FG002|COMPLETED|After Controlled Period||55
11010003|NCT00747344|12187904|FG003|COMPLETED|After Controlled Period||56
11010004|NCT00747344|12187901|FG000|NOT COMPLETED|After Controlled Period||0
11010005|NCT00747344|12187902|FG001|NOT COMPLETED|After Controlled Period||0
11010006|NCT00747344|12187903|FG002|NOT COMPLETED|After Controlled Period||0
11010007|NCT00747344|12187904|FG003|NOT COMPLETED|After Controlled Period||1
11010008|NCT00747435|12187912|FG000|STARTED|Overall Study||73
11010009|NCT00747435|12187912|FG000|COMPLETED|Overall Study||67
11010010|NCT00747435|12187912|FG000|NOT COMPLETED|Overall Study||6
11010011|NCT00747474|12187916|FG000|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
11010012|NCT00747474|12187917|FG001|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
11010013|NCT00747474|12187918|FG002|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
11010014|NCT00747474|12187919|FG003|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
11010015|NCT00747474|12187920|FG004|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
11010016|NCT00747474|12187921|FG005|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
11010017|NCT00747474|12187922|FG006|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
11010018|NCT00747474|12187923|FG007|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
11010019|NCT00747474|12187924|FG008|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
11010020|NCT00747474|12187925|FG009|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
11010021|NCT00747474|12187926|FG010|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
11010022|NCT00747474|12187927|FG011|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
11010023|NCT00747474|12187916|FG000|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
11010024|NCT00747474|12187917|FG001|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010025|NCT00747474|12187918|FG002|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010026|NCT00747474|12187919|FG003|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010027|NCT00747474|12187920|FG004|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010028|NCT00747474|12187921|FG005|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010029|NCT00747474|12187922|FG006|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010030|NCT00747474|12187923|FG007|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010031|NCT00747474|12187924|FG008|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010032|NCT00747474|12187925|FG009|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010033|NCT00747474|12187926|FG010|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010034|NCT00747474|12187927|FG011|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010035|NCT00747474|12187916|FG000|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010036|NCT00747474|12187917|FG001|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010037|NCT00747474|12187918|FG002|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010038|NCT00747474|12187919|FG003|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010039|NCT00747474|12187920|FG004|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010040|NCT00747474|12187921|FG005|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010041|NCT00747474|12187922|FG006|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010042|NCT00747474|12187923|FG007|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010043|NCT00747474|12187924|FG008|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010044|NCT00747474|12187925|FG009|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010045|NCT00747474|12187926|FG010|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010046|NCT00747474|12187927|FG011|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
11010047|NCT00747474|12187916|FG000|STARTED|Cohort 2 (3 mg/m^2) Period||0
11010048|NCT00747474|12187917|FG001|STARTED|Cohort 2 (3 mg/m^2) Period||4
11010049|NCT00747474|12187918|FG002|STARTED|Cohort 2 (3 mg/m^2) Period||0
11010050|NCT00747474|12187919|FG003|STARTED|Cohort 2 (3 mg/m^2) Period||0
11010051|NCT00747474|12187920|FG004|STARTED|Cohort 2 (3 mg/m^2) Period||0
11010052|NCT00747474|12187921|FG005|STARTED|Cohort 2 (3 mg/m^2) Period||0
11010053|NCT00747474|12187922|FG006|STARTED|Cohort 2 (3 mg/m^2) Period||0
11010054|NCT00747474|12187923|FG007|STARTED|Cohort 2 (3 mg/m^2) Period||0
11010055|NCT00747474|12187924|FG008|STARTED|Cohort 2 (3 mg/m^2) Period||0
11010056|NCT00747474|12187925|FG009|STARTED|Cohort 2 (3 mg/m^2) Period||0
11010057|NCT00747474|12187926|FG010|STARTED|Cohort 2 (3 mg/m^2) Period||0
11010058|NCT00747474|12187927|FG011|STARTED|Cohort 2 (3 mg/m^2) Period||0
11010059|NCT00747474|12187916|FG000|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010060|NCT00747474|12187917|FG001|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
11010061|NCT00747474|12187918|FG002|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010062|NCT00747474|12187919|FG003|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010063|NCT00747474|12187920|FG004|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010064|NCT00747474|12187921|FG005|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010065|NCT00747474|12187922|FG006|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010066|NCT00747474|12187923|FG007|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010067|NCT00747474|12187924|FG008|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010068|NCT00747474|12187925|FG009|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010069|NCT00747474|12187926|FG010|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010070|NCT00747474|12187927|FG011|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010071|NCT00747474|12187916|FG000|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010072|NCT00747474|12187917|FG001|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010073|NCT00747474|12187918|FG002|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010074|NCT00747474|12187919|FG003|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010075|NCT00747474|12187920|FG004|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010076|NCT00747474|12187921|FG005|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010077|NCT00747474|12187922|FG006|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010078|NCT00747474|12187923|FG007|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010079|NCT00747474|12187924|FG008|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010080|NCT00747474|12187925|FG009|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010081|NCT00747474|12187926|FG010|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010082|NCT00747474|12187927|FG011|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
11010083|NCT00747474|12187916|FG000|STARTED|Cohort 3 (6 mg/m^2) Period||0
11010084|NCT00747474|12187917|FG001|STARTED|Cohort 3 (6 mg/m^2) Period||0
11010085|NCT00747474|12187918|FG002|STARTED|Cohort 3 (6 mg/m^2) Period||3
11010086|NCT00747474|12187919|FG003|STARTED|Cohort 3 (6 mg/m^2) Period||0
11010087|NCT00747474|12187920|FG004|STARTED|Cohort 3 (6 mg/m^2) Period||0
11010088|NCT00747474|12187921|FG005|STARTED|Cohort 3 (6 mg/m^2) Period||0
11010089|NCT00747474|12187922|FG006|STARTED|Cohort 3 (6 mg/m^2) Period||0
11010090|NCT00747474|12187923|FG007|STARTED|Cohort 3 (6 mg/m^2) Period||0
11010091|NCT00747474|12187924|FG008|STARTED|Cohort 3 (6 mg/m^2) Period||0
11010092|NCT00747474|12187925|FG009|STARTED|Cohort 3 (6 mg/m^2) Period||0
11010093|NCT00747474|12187926|FG010|STARTED|Cohort 3 (6 mg/m^2) Period||0
11010094|NCT00747474|12187927|FG011|STARTED|Cohort 3 (6 mg/m^2) Period||0
11010095|NCT00747474|12187916|FG000|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010096|NCT00747474|12187917|FG001|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010097|NCT00747474|12187918|FG002|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
11010098|NCT00747474|12187919|FG003|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010099|NCT00747474|12187920|FG004|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010100|NCT00747474|12187921|FG005|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010101|NCT00747474|12187922|FG006|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010102|NCT00747474|12187923|FG007|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010103|NCT00747474|12187924|FG008|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010104|NCT00747474|12187925|FG009|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010105|NCT00747474|12187926|FG010|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010106|NCT00747474|12187927|FG011|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010107|NCT00747474|12187916|FG000|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010108|NCT00747474|12187917|FG001|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010109|NCT00747474|12187918|FG002|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010110|NCT00747474|12187919|FG003|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010111|NCT00747474|12187920|FG004|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010112|NCT00747474|12187921|FG005|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010113|NCT00747474|12187922|FG006|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010114|NCT00747474|12187923|FG007|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010115|NCT00747474|12187924|FG008|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010116|NCT00747474|12187925|FG009|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010117|NCT00747474|12187926|FG010|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010118|NCT00747474|12187927|FG011|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
11010119|NCT00747474|12187916|FG000|STARTED|Cohort 4 (9 mg/m^2) Period||0
11010120|NCT00747474|12187917|FG001|STARTED|Cohort 4 (9 mg/m^2) Period||0
11010121|NCT00747474|12187918|FG002|STARTED|Cohort 4 (9 mg/m^2) Period||0
11010122|NCT00747474|12187919|FG003|STARTED|Cohort 4 (9 mg/m^2) Period||4
11010123|NCT00747474|12187920|FG004|STARTED|Cohort 4 (9 mg/m^2) Period||0
11010124|NCT00747474|12187921|FG005|STARTED|Cohort 4 (9 mg/m^2) Period||0
11010125|NCT00747474|12187922|FG006|STARTED|Cohort 4 (9 mg/m^2) Period||0
11010126|NCT00747474|12187923|FG007|STARTED|Cohort 4 (9 mg/m^2) Period||0
11010127|NCT00747474|12187924|FG008|STARTED|Cohort 4 (9 mg/m^2) Period||0
11142722|NCT01469013|12329435|FG012|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
11142723|NCT01469013|12329423|FG000|COMPLETED|Part B (Extension Period)||0
11010128|NCT00747474|12187925|FG009|STARTED|Cohort 4 (9 mg/m^2) Period||0
11010129|NCT00747474|12187926|FG010|STARTED|Cohort 4 (9 mg/m^2) Period||0
11010130|NCT00747474|12187927|FG011|STARTED|Cohort 4 (9 mg/m^2) Period||0
11010131|NCT00747474|12187916|FG000|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010132|NCT00747474|12187917|FG001|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010133|NCT00747474|12187918|FG002|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010134|NCT00747474|12187919|FG003|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
11010135|NCT00747474|12187920|FG004|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010136|NCT00747474|12187921|FG005|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010137|NCT00747474|12187922|FG006|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010138|NCT00747474|12187923|FG007|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010139|NCT00747474|12187924|FG008|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010140|NCT00747474|12187925|FG009|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010141|NCT00747474|12187926|FG010|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010142|NCT00747474|12187927|FG011|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010143|NCT00747474|12187916|FG000|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010144|NCT00747474|12187917|FG001|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010145|NCT00747474|12187918|FG002|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010146|NCT00747474|12187919|FG003|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010147|NCT00747474|12187920|FG004|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010148|NCT00747474|12187921|FG005|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010149|NCT00747474|12187922|FG006|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010150|NCT00747474|12187923|FG007|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010151|NCT00747474|12187924|FG008|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010152|NCT00747474|12187925|FG009|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010153|NCT00747474|12187926|FG010|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010154|NCT00747474|12187927|FG011|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
11010155|NCT00747474|12187916|FG000|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
11010156|NCT00747474|12187917|FG001|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
11010157|NCT00747474|12187918|FG002|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
11010158|NCT00747474|12187919|FG003|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
11010159|NCT00747474|12187920|FG004|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
11010160|NCT00747474|12187921|FG005|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
11010161|NCT00747474|12187922|FG006|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
11010162|NCT00747474|12187923|FG007|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
11010163|NCT00747474|12187924|FG008|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
11010164|NCT00747474|12187925|FG009|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
11010165|NCT00747474|12187926|FG010|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
11010166|NCT00747474|12187927|FG011|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
11010167|NCT00747474|12187916|FG000|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010168|NCT00747474|12187917|FG001|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010169|NCT00747474|12187918|FG002|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010170|NCT00747474|12187919|FG003|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010171|NCT00747474|12187920|FG004|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
11010172|NCT00747474|12187921|FG005|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010173|NCT00747474|12187922|FG006|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010174|NCT00747474|12187923|FG007|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010175|NCT00747474|12187924|FG008|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010176|NCT00747474|12187925|FG009|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010177|NCT00747474|12187926|FG010|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010178|NCT00747474|12187927|FG011|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010179|NCT00747474|12187916|FG000|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010180|NCT00747474|12187917|FG001|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010181|NCT00747474|12187918|FG002|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010182|NCT00747474|12187919|FG003|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010183|NCT00747474|12187920|FG004|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010184|NCT00747474|12187921|FG005|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010185|NCT00747474|12187922|FG006|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010186|NCT00747474|12187923|FG007|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010187|NCT00747474|12187924|FG008|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010188|NCT00747474|12187925|FG009|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010189|NCT00747474|12187926|FG010|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010190|NCT00747474|12187927|FG011|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
11010191|NCT00747474|12187916|FG000|STARTED|Cohort 6 (20 mg/m^2) Period||0
11010192|NCT00747474|12187917|FG001|STARTED|Cohort 6 (20 mg/m^2) Period||0
11010193|NCT00747474|12187918|FG002|STARTED|Cohort 6 (20 mg/m^2) Period||0
11010194|NCT00747474|12187919|FG003|STARTED|Cohort 6 (20 mg/m^2) Period||0
11010195|NCT00747474|12187920|FG004|STARTED|Cohort 6 (20 mg/m^2) Period||0
11010196|NCT00747474|12187921|FG005|STARTED|Cohort 6 (20 mg/m^2) Period||4
11010197|NCT00747474|12187922|FG006|STARTED|Cohort 6 (20 mg/m^2) Period||0
11010198|NCT00747474|12187923|FG007|STARTED|Cohort 6 (20 mg/m^2) Period||0
11010199|NCT00747474|12187924|FG008|STARTED|Cohort 6 (20 mg/m^2) Period||0
11010200|NCT00747474|12187925|FG009|STARTED|Cohort 6 (20 mg/m^2) Period||0
11010201|NCT00747474|12187926|FG010|STARTED|Cohort 6 (20 mg/m^2) Period||0
11010202|NCT00747474|12187927|FG011|STARTED|Cohort 6 (20 mg/m^2) Period||0
11010203|NCT00747474|12187916|FG000|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010204|NCT00747474|12187917|FG001|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010205|NCT00747474|12187918|FG002|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010206|NCT00747474|12187919|FG003|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010207|NCT00747474|12187920|FG004|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010208|NCT00747474|12187921|FG005|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
11010209|NCT00747474|12187922|FG006|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010210|NCT00747474|12187923|FG007|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010211|NCT00747474|12187924|FG008|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010212|NCT00747474|12187925|FG009|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010213|NCT00747474|12187926|FG010|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010214|NCT00747474|12187927|FG011|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010215|NCT00747474|12187916|FG000|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010216|NCT00747474|12187917|FG001|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010217|NCT00747474|12187918|FG002|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010218|NCT00747474|12187919|FG003|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010219|NCT00747474|12187920|FG004|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010220|NCT00747474|12187921|FG005|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010221|NCT00747474|12187922|FG006|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010222|NCT00747474|12187923|FG007|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010223|NCT00747474|12187924|FG008|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010224|NCT00747474|12187925|FG009|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010225|NCT00747474|12187926|FG010|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010226|NCT00747474|12187927|FG011|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
11010227|NCT00747474|12187916|FG000|STARTED|Cohort 7 (30 mg/m^2) Period||0
11010228|NCT00747474|12187917|FG001|STARTED|Cohort 7 (30 mg/m^2) Period||0
11010229|NCT00747474|12187918|FG002|STARTED|Cohort 7 (30 mg/m^2) Period||0
11010230|NCT00747474|12187919|FG003|STARTED|Cohort 7 (30 mg/m^2) Period||0
11010231|NCT00747474|12187920|FG004|STARTED|Cohort 7 (30 mg/m^2) Period||0
11010232|NCT00747474|12187921|FG005|STARTED|Cohort 7 (30 mg/m^2) Period||0
11010233|NCT00747474|12187922|FG006|STARTED|Cohort 7 (30 mg/m^2) Period||4
11010234|NCT00747474|12187923|FG007|STARTED|Cohort 7 (30 mg/m^2) Period||0
11010235|NCT00747474|12187924|FG008|STARTED|Cohort 7 (30 mg/m^2) Period||0
11010236|NCT00747474|12187925|FG009|STARTED|Cohort 7 (30 mg/m^2) Period||0
11010237|NCT00747474|12187926|FG010|STARTED|Cohort 7 (30 mg/m^2) Period||0
11010238|NCT00747474|12187927|FG011|STARTED|Cohort 7 (30 mg/m^2) Period||0
11010239|NCT00747474|12187916|FG000|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010240|NCT00747474|12187917|FG001|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010241|NCT00747474|12187918|FG002|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010242|NCT00747474|12187919|FG003|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010243|NCT00747474|12187920|FG004|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010244|NCT00747474|12187921|FG005|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010245|NCT00747474|12187922|FG006|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
11010246|NCT00747474|12187923|FG007|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010247|NCT00747474|12187924|FG008|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010248|NCT00747474|12187925|FG009|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010249|NCT00747474|12187926|FG010|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010250|NCT00747474|12187927|FG011|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010251|NCT00747474|12187916|FG000|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010252|NCT00747474|12187917|FG001|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010253|NCT00747474|12187918|FG002|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010254|NCT00747474|12187919|FG003|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010255|NCT00747474|12187920|FG004|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010256|NCT00747474|12187921|FG005|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010257|NCT00747474|12187922|FG006|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010258|NCT00747474|12187923|FG007|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010259|NCT00747474|12187924|FG008|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010260|NCT00747474|12187925|FG009|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010261|NCT00747474|12187926|FG010|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010262|NCT00747474|12187927|FG011|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
11010263|NCT00747474|12187916|FG000|STARTED|Cohort 8 (40 mg/m^2) Period||0
11010264|NCT00747474|12187917|FG001|STARTED|Cohort 8 (40 mg/m^2) Period||0
11010265|NCT00747474|12187918|FG002|STARTED|Cohort 8 (40 mg/m^2) Period||0
11010266|NCT00747474|12187919|FG003|STARTED|Cohort 8 (40 mg/m^2) Period||0
11010267|NCT00747474|12187920|FG004|STARTED|Cohort 8 (40 mg/m^2) Period||0
11010268|NCT00747474|12187921|FG005|STARTED|Cohort 8 (40 mg/m^2) Period||0
11010269|NCT00747474|12187922|FG006|STARTED|Cohort 8 (40 mg/m^2) Period||0
11010270|NCT00747474|12187923|FG007|STARTED|Cohort 8 (40 mg/m^2) Period||6
11010271|NCT00747474|12187924|FG008|STARTED|Cohort 8 (40 mg/m^2) Period||0
11010272|NCT00747474|12187925|FG009|STARTED|Cohort 8 (40 mg/m^2) Period||0
11010273|NCT00747474|12187926|FG010|STARTED|Cohort 8 (40 mg/m^2) Period||0
11010274|NCT00747474|12187927|FG011|STARTED|Cohort 8 (40 mg/m^2) Period||0
11010275|NCT00747474|12187916|FG000|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010276|NCT00747474|12187917|FG001|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010277|NCT00747474|12187918|FG002|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010278|NCT00747474|12187919|FG003|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010279|NCT00747474|12187920|FG004|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010280|NCT00747474|12187921|FG005|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010281|NCT00747474|12187922|FG006|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010282|NCT00747474|12187923|FG007|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
11010283|NCT00747474|12187924|FG008|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010284|NCT00747474|12187925|FG009|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010285|NCT00747474|12187926|FG010|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010286|NCT00747474|12187927|FG011|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010287|NCT00747474|12187916|FG000|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010288|NCT00747474|12187917|FG001|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010289|NCT00747474|12187918|FG002|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010290|NCT00747474|12187919|FG003|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010291|NCT00747474|12187920|FG004|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010292|NCT00747474|12187921|FG005|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010293|NCT00747474|12187922|FG006|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010294|NCT00747474|12187923|FG007|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
11010295|NCT00747474|12187924|FG008|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010296|NCT00747474|12187925|FG009|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010297|NCT00747474|12187926|FG010|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010298|NCT00747474|12187927|FG011|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
11010299|NCT00747474|12187916|FG000|STARTED|Cohort 9 (35 mg/m^2) Period||0
11010300|NCT00747474|12187917|FG001|STARTED|Cohort 9 (35 mg/m^2) Period||0
11010301|NCT00747474|12187918|FG002|STARTED|Cohort 9 (35 mg/m^2) Period||0
11010302|NCT00747474|12187919|FG003|STARTED|Cohort 9 (35 mg/m^2) Period||0
11010303|NCT00747474|12187920|FG004|STARTED|Cohort 9 (35 mg/m^2) Period||0
11010304|NCT00747474|12187921|FG005|STARTED|Cohort 9 (35 mg/m^2) Period||0
11010305|NCT00747474|12187922|FG006|STARTED|Cohort 9 (35 mg/m^2) Period||0
11010306|NCT00747474|12187923|FG007|STARTED|Cohort 9 (35 mg/m^2) Period||0
11010307|NCT00747474|12187924|FG008|STARTED|Cohort 9 (35 mg/m^2) Period||4
11010308|NCT00747474|12187925|FG009|STARTED|Cohort 9 (35 mg/m^2) Period||0
11010309|NCT00747474|12187926|FG010|STARTED|Cohort 9 (35 mg/m^2) Period||0
11010310|NCT00747474|12187927|FG011|STARTED|Cohort 9 (35 mg/m^2) Period||0
11010311|NCT00747474|12187916|FG000|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010312|NCT00747474|12187917|FG001|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010313|NCT00747474|12187918|FG002|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010314|NCT00747474|12187919|FG003|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010315|NCT00747474|12187920|FG004|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010316|NCT00747474|12187921|FG005|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010317|NCT00747474|12187922|FG006|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010318|NCT00747474|12187923|FG007|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010319|NCT00747474|12187924|FG008|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
11010320|NCT00747474|12187925|FG009|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010321|NCT00747474|12187926|FG010|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010322|NCT00747474|12187927|FG011|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010323|NCT00747474|12187916|FG000|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010324|NCT00747474|12187917|FG001|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010325|NCT00747474|12187918|FG002|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010326|NCT00747474|12187919|FG003|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010327|NCT00747474|12187920|FG004|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010328|NCT00747474|12187921|FG005|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010329|NCT00747474|12187922|FG006|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010330|NCT00747474|12187923|FG007|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010331|NCT00747474|12187924|FG008|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010332|NCT00747474|12187925|FG009|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010333|NCT00747474|12187926|FG010|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010334|NCT00747474|12187927|FG011|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
11010335|NCT00747474|12187916|FG000|STARTED|Cohort 10 (40 mg/m^2) Period||0
11010336|NCT00747474|12187917|FG001|STARTED|Cohort 10 (40 mg/m^2) Period||0
11010337|NCT00747474|12187918|FG002|STARTED|Cohort 10 (40 mg/m^2) Period||0
11010338|NCT00747474|12187919|FG003|STARTED|Cohort 10 (40 mg/m^2) Period||0
11010339|NCT00747474|12187920|FG004|STARTED|Cohort 10 (40 mg/m^2) Period||0
11010340|NCT00747474|12187921|FG005|STARTED|Cohort 10 (40 mg/m^2) Period||0
11010341|NCT00747474|12187922|FG006|STARTED|Cohort 10 (40 mg/m^2) Period||0
11010342|NCT00747474|12187923|FG007|STARTED|Cohort 10 (40 mg/m^2) Period||0
11010343|NCT00747474|12187924|FG008|STARTED|Cohort 10 (40 mg/m^2) Period||0
11010344|NCT00747474|12187925|FG009|STARTED|Cohort 10 (40 mg/m^2) Period||7
11010345|NCT00747474|12187926|FG010|STARTED|Cohort 10 (40 mg/m^2) Period||0
11010346|NCT00747474|12187927|FG011|STARTED|Cohort 10 (40 mg/m^2) Period||0
11010347|NCT00747474|12187916|FG000|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010348|NCT00747474|12187917|FG001|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010349|NCT00747474|12187918|FG002|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010350|NCT00747474|12187919|FG003|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010351|NCT00747474|12187920|FG004|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010352|NCT00747474|12187921|FG005|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010353|NCT00747474|12187922|FG006|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010354|NCT00747474|12187923|FG007|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010355|NCT00747474|12187924|FG008|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010356|NCT00747474|12187925|FG009|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
11010357|NCT00747474|12187926|FG010|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010358|NCT00747474|12187927|FG011|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010359|NCT00747474|12187916|FG000|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010360|NCT00747474|12187917|FG001|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010361|NCT00747474|12187918|FG002|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010362|NCT00747474|12187919|FG003|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010363|NCT00747474|12187920|FG004|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010364|NCT00747474|12187921|FG005|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010365|NCT00747474|12187922|FG006|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010366|NCT00747474|12187923|FG007|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010367|NCT00747474|12187924|FG008|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010368|NCT00747474|12187925|FG009|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010369|NCT00747474|12187926|FG010|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010370|NCT00747474|12187927|FG011|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
11010371|NCT00747474|12187916|FG000|STARTED|Cohort 11 (50 mg/m^2) Period||0
11010372|NCT00747474|12187917|FG001|STARTED|Cohort 11 (50 mg/m^2) Period||0
11010373|NCT00747474|12187918|FG002|STARTED|Cohort 11 (50 mg/m^2) Period||0
11010374|NCT00747474|12187919|FG003|STARTED|Cohort 11 (50 mg/m^2) Period||0
11010375|NCT00747474|12187920|FG004|STARTED|Cohort 11 (50 mg/m^2) Period||0
11010376|NCT00747474|12187921|FG005|STARTED|Cohort 11 (50 mg/m^2) Period||0
11010377|NCT00747474|12187922|FG006|STARTED|Cohort 11 (50 mg/m^2) Period||0
11010378|NCT00747474|12187923|FG007|STARTED|Cohort 11 (50 mg/m^2) Period||0
11010379|NCT00747474|12187924|FG008|STARTED|Cohort 11 (50 mg/m^2) Period||0
11010380|NCT00747474|12187925|FG009|STARTED|Cohort 11 (50 mg/m^2) Period||0
11010381|NCT00747474|12187926|FG010|STARTED|Cohort 11 (50 mg/m^2) Period||5
11010382|NCT00747474|12187927|FG011|STARTED|Cohort 11 (50 mg/m^2) Period||0
11010383|NCT00747474|12187916|FG000|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010384|NCT00747474|12187917|FG001|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010385|NCT00747474|12187918|FG002|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010386|NCT00747474|12187919|FG003|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010387|NCT00747474|12187920|FG004|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010388|NCT00747474|12187921|FG005|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010389|NCT00747474|12187922|FG006|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010390|NCT00747474|12187923|FG007|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010391|NCT00747474|12187924|FG008|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010392|NCT00747474|12187925|FG009|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010393|NCT00747474|12187926|FG010|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
11010394|NCT00747474|12187927|FG011|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010395|NCT00747474|12187916|FG000|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010396|NCT00747474|12187917|FG001|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010397|NCT00747474|12187918|FG002|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010398|NCT00747474|12187919|FG003|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010399|NCT00747474|12187920|FG004|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010400|NCT00747474|12187921|FG005|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010401|NCT00747474|12187922|FG006|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010402|NCT00747474|12187923|FG007|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010403|NCT00747474|12187924|FG008|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010404|NCT00747474|12187925|FG009|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010405|NCT00747474|12187926|FG010|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010406|NCT00747474|12187927|FG011|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
11010407|NCT00747474|12187916|FG000|STARTED|Cohort 12 (60 mg/m^2) Period||0
11010408|NCT00747474|12187917|FG001|STARTED|Cohort 12 (60 mg/m^2) Period||0
11010409|NCT00747474|12187918|FG002|STARTED|Cohort 12 (60 mg/m^2) Period||0
11010410|NCT00747474|12187919|FG003|STARTED|Cohort 12 (60 mg/m^2) Period||0
11010411|NCT00747474|12187920|FG004|STARTED|Cohort 12 (60 mg/m^2) Period||0
11010412|NCT00747474|12187921|FG005|STARTED|Cohort 12 (60 mg/m^2) Period||0
11010413|NCT00747474|12187922|FG006|STARTED|Cohort 12 (60 mg/m^2) Period||0
11010414|NCT00747474|12187923|FG007|STARTED|Cohort 12 (60 mg/m^2) Period||0
11010415|NCT00747474|12187924|FG008|STARTED|Cohort 12 (60 mg/m^2) Period||0
11010416|NCT00747474|12187925|FG009|STARTED|Cohort 12 (60 mg/m^2) Period||0
11010417|NCT00747474|12187926|FG010|STARTED|Cohort 12 (60 mg/m^2) Period||0
11010418|NCT00747474|12187927|FG011|STARTED|Cohort 12 (60 mg/m^2) Period||6
11010419|NCT00747474|12187916|FG000|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010420|NCT00747474|12187917|FG001|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010421|NCT00747474|12187918|FG002|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010422|NCT00747474|12187919|FG003|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010423|NCT00747474|12187920|FG004|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010424|NCT00747474|12187921|FG005|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010425|NCT00747474|12187922|FG006|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010426|NCT00747474|12187923|FG007|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010427|NCT00747474|12187924|FG008|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010428|NCT00747474|12187925|FG009|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010429|NCT00747474|12187926|FG010|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010430|NCT00747474|12187927|FG011|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
11010431|NCT00747474|12187916|FG000|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010432|NCT00747474|12187917|FG001|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010433|NCT00747474|12187918|FG002|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010434|NCT00747474|12187919|FG003|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010435|NCT00747474|12187920|FG004|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010436|NCT00747474|12187921|FG005|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010437|NCT00747474|12187922|FG006|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010438|NCT00747474|12187923|FG007|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010439|NCT00747474|12187924|FG008|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010440|NCT00747474|12187925|FG009|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010441|NCT00747474|12187926|FG010|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010442|NCT00747474|12187927|FG011|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
11010443|NCT00747552|12187932|FG000|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
11010444|NCT00747552|12187932|FG000|COMPLETED|Overall Study||30
11010445|NCT00747552|12187932|FG000|NOT COMPLETED|Overall Study||0
11010446|NCT00747565|12187938|FG000|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
11010447|NCT00747565|12187939|FG001|STARTED|Overall Study||123
11010448|NCT00747565|12187938|FG000|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
11010449|NCT00747565|12187939|FG001|COMPLETED|Overall Study||116
11010450|NCT00747565|12187938|FG000|NOT COMPLETED|Overall Study||14
11010451|NCT00747565|12187939|FG001|NOT COMPLETED|Overall Study||7
11010452|NCT00747617|12187947|FG000|STARTED|Overall Study||13
11010453|NCT00747617|12187948|FG001|STARTED|Overall Study||12
11010454|NCT00747617|12187947|FG000|COMPLETED|Overall Study||10
11010455|NCT00747617|12187948|FG001|COMPLETED|Overall Study||11
11010456|NCT00747617|12187947|FG000|NOT COMPLETED|Overall Study||3
11010457|NCT00747617|12187948|FG001|NOT COMPLETED|Overall Study||1
11010458|NCT00747643|12187956|FG000|STARTED|Overall Study||82
11010459|NCT00747643|12187957|FG001|STARTED|Overall Study||81
11010460|NCT00747643|12187956|FG000|COMPLETED|Overall Study||46
11010461|NCT00747643|12187957|FG001|COMPLETED|Overall Study||54
11010462|NCT00747643|12187956|FG000|NOT COMPLETED|Overall Study||36
11010463|NCT00747643|12187957|FG001|NOT COMPLETED|Overall Study||27
11010464|NCT00747747|12187966|FG000|STARTED|Overall Study||14
11010465|NCT00747747|12187967|FG001|STARTED|Overall Study||14
11010466|NCT00747747|12187968|FG002|STARTED|Overall Study||21
11010467|NCT00747747|12187966|FG000|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
11010468|NCT00747747|12187967|FG001|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
11010469|NCT00747747|12187968|FG002|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
11010470|NCT00747747|12187966|FG000|NOT COMPLETED|Overall Study||0
11010471|NCT00747747|12187967|FG001|NOT COMPLETED|Overall Study||0
11010472|NCT00747747|12187968|FG002|NOT COMPLETED|Overall Study||0
11010473|NCT00747812|12187978|FG000|STARTED|Overall Study||5
11010474|NCT00747812|12187979|FG001|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
11010475|NCT00747812|12187978|FG000|COMPLETED|Overall Study||0
11010476|NCT00747812|12187979|FG001|COMPLETED|Overall Study||0
11010477|NCT00747812|12187978|FG000|NOT COMPLETED|Overall Study||5
11010478|NCT00747812|12187979|FG001|NOT COMPLETED|Overall Study||3
11010479|NCT00748033|12187987|FG000|STARTED|Overall Study||12
11010480|NCT00748033|12187988|FG001|STARTED|Overall Study||13
11010481|NCT00748033|12187987|FG000|COMPLETED|Overall Study||12
11010482|NCT00748033|12187988|FG001|COMPLETED|Overall Study|One subject participated only in 2 arms due to an adverse event.|12
11010483|NCT00748033|12187987|FG000|NOT COMPLETED|Overall Study||0
11010484|NCT00748033|12187988|FG001|NOT COMPLETED|Overall Study||1
11010485|NCT00748072|12188004|FG000|STARTED|Overall Study||82
11010486|NCT00748072|12188005|FG001|STARTED|Overall Study||80
11010487|NCT00748072|12188004|FG000|COMPLETED|Overall Study||82
11010488|NCT00748072|12188005|FG001|COMPLETED|Overall Study||80
11010489|NCT00748072|12188004|FG000|NOT COMPLETED|Overall Study||0
11010490|NCT00748072|12188005|FG001|NOT COMPLETED|Overall Study||0
11010491|NCT00748098|12188011|FG000|STARTED|First Treatment Intervention Period||69
11010492|NCT00748098|12188012|FG001|STARTED|First Treatment Intervention Period||67
11010493|NCT00748098|12188011|FG000|COMPLETED|First Treatment Intervention Period||64
11010494|NCT00748098|12188012|FG001|COMPLETED|First Treatment Intervention Period||66
11010495|NCT00748098|12188011|FG000|NOT COMPLETED|First Treatment Intervention Period||5
11010496|NCT00748098|12188012|FG001|NOT COMPLETED|First Treatment Intervention Period||1
11010497|NCT00748098|12188011|FG000|STARTED|First Taper Period||64
11010498|NCT00748098|12188012|FG001|STARTED|First Taper Period||66
11010499|NCT00748098|12188011|FG000|COMPLETED|First Taper Period||61
11010500|NCT00748098|12188012|FG001|COMPLETED|First Taper Period||65
11010501|NCT00748098|12188011|FG000|NOT COMPLETED|First Taper Period||3
11010502|NCT00748098|12188012|FG001|NOT COMPLETED|First Taper Period||1
11010503|NCT00748098|12188011|FG000|STARTED|1-Week Washout Period||61
11010504|NCT00748098|12188012|FG001|STARTED|1-Week Washout Period||65
11010505|NCT00748098|12188011|FG000|COMPLETED|1-Week Washout Period||59
11010506|NCT00748098|12188012|FG001|COMPLETED|1-Week Washout Period||64
11010507|NCT00748098|12188011|FG000|NOT COMPLETED|1-Week Washout Period||2
11010508|NCT00748098|12188012|FG001|NOT COMPLETED|1-Week Washout Period||1
11010509|NCT00748098|12188011|FG000|STARTED|Second Treatment Intervention Period||59
11010510|NCT00748098|12188012|FG001|STARTED|Second Treatment Intervention Period||64
11010511|NCT00748098|12188011|FG000|COMPLETED|Second Treatment Intervention Period||53
11010512|NCT00748098|12188012|FG001|COMPLETED|Second Treatment Intervention Period||61
11010513|NCT00748098|12188011|FG000|NOT COMPLETED|Second Treatment Intervention Period||6
11010514|NCT00748098|12188012|FG001|NOT COMPLETED|Second Treatment Intervention Period||3
11010515|NCT00748098|12188011|FG000|STARTED|Second Taper Period||53
11010516|NCT00748098|12188012|FG001|STARTED|Second Taper Period||61
11010517|NCT00748098|12188011|FG000|COMPLETED|Second Taper Period||53
11010518|NCT00748098|12188012|FG001|COMPLETED|Second Taper Period||61
11010519|NCT00748098|12188011|FG000|NOT COMPLETED|Second Taper Period||0
11010520|NCT00748098|12188012|FG001|NOT COMPLETED|Second Taper Period||0
11010521|NCT00748189|12188021|FG000|STARTED|Overall Study||226
11010522|NCT00748189|12188022|FG001|STARTED|Overall Study||221
11010523|NCT00748189|12188021|FG000|COMPLETED|Overall Study||10
11010524|NCT00748189|12188022|FG001|COMPLETED|Overall Study||9
11010525|NCT00748189|12188021|FG000|NOT COMPLETED|Overall Study||216
11010526|NCT00748189|12188022|FG001|NOT COMPLETED|Overall Study||212
11010527|NCT00748215|12188035|FG000|STARTED|Overall Study||50
11010528|NCT00748215|12188036|FG001|STARTED|Overall Study||50
11010529|NCT00748215|12188035|FG000|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||22
11010530|NCT00748215|12188036|FG001|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||17
11010531|NCT00748215|12188035|FG000|COMPLETED|Overall Study||41
11010532|NCT00748215|12188036|FG001|COMPLETED|Overall Study||32
11010533|NCT00748215|12188035|FG000|NOT COMPLETED|Overall Study||9
11010534|NCT00748215|12188036|FG001|NOT COMPLETED|Overall Study||18
11010535|NCT00748241|12188042|FG000|STARTED|Overall Study||19
11010536|NCT00748241|12188042|FG000|COMPLETED|Overall Study||11
11010537|NCT00748241|12188042|FG000|NOT COMPLETED|Overall Study||8
11010538|NCT00748410|12188048|FG000|STARTED|Overall Study||1
11010539|NCT00748410|12188049|FG001|STARTED|Overall Study||2
11010540|NCT00748410|12188048|FG000|COMPLETED|Overall Study||1
11010541|NCT00748410|12188049|FG001|COMPLETED|Overall Study||2
11010542|NCT00748410|12188048|FG000|NOT COMPLETED|Overall Study||0
11010543|NCT00748410|12188049|FG001|NOT COMPLETED|Overall Study||0
11010544|NCT00748540|12188055|FG000|STARTED|Overall Study||50
11010545|NCT00748540|12188055|FG000|COMPLETED|Overall Study||49
11010546|NCT00748540|12188055|FG000|NOT COMPLETED|Overall Study||1
11010547|NCT00748553|12188061|FG000|STARTED|Overall Study||16
11010548|NCT00748553|12188062|FG001|STARTED|Overall Study||14
11010549|NCT00748553|12188061|FG000|COMPLETED|Overall Study||13
11010550|NCT00748553|12188062|FG001|COMPLETED|Overall Study||13
11010551|NCT00748553|12188061|FG000|NOT COMPLETED|Overall Study||3
11010552|NCT00748553|12188062|FG001|NOT COMPLETED|Overall Study||1
11010553|NCT00748566|12188067|FG000|STARTED|Overall Study||172
11010554|NCT00748566|12188067|FG000|COMPLETED|Overall Study||60
11010555|NCT00748566|12188067|FG000|NOT COMPLETED|Overall Study||112
11010556|NCT00748657|12188071|FG000|STARTED|Overall Study||36
11010557|NCT00748657|12188071|FG000|COMPLETED|Overall Study||36
11010558|NCT00748657|12188071|FG000|NOT COMPLETED|Overall Study||0
11010559|NCT00748709|12188081|FG000|STARTED|Overall Study|Treated|20
11010560|NCT00748709|12188081|FG000|COMPLETED|Overall Study||0
11010561|NCT00748709|12188081|FG000|NOT COMPLETED|Overall Study||20
11010562|NCT00748826|12188085|FG000|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
11010563|NCT00748826|12188085|FG000|COMPLETED|Overall Study||207
11010564|NCT00748826|12188085|FG000|NOT COMPLETED|Overall Study||301
11010565|NCT00748865|12188089|FG000|STARTED|Overall Study||10
11010566|NCT00748865|12188090|FG001|STARTED|Overall Study||10
11010567|NCT00748865|12188089|FG000|COMPLETED|Overall Study||10
11010568|NCT00748865|12188090|FG001|COMPLETED|Overall Study||10
11010569|NCT00748865|12188089|FG000|NOT COMPLETED|Overall Study||0
11010570|NCT00748865|12188090|FG001|NOT COMPLETED|Overall Study||0
11010571|NCT00748956|12188099|FG000|STARTED|Overall Study||0
11010572|NCT00748956|12188100|FG001|STARTED|Overall Study||5
11010573|NCT00748956|12188101|FG002|STARTED|Overall Study||5
11010574|NCT00748956|12188099|FG000|COMPLETED|Overall Study||0
11010575|NCT00748956|12188100|FG001|COMPLETED|Overall Study||5
11010576|NCT00748956|12188101|FG002|COMPLETED|Overall Study||5
11010577|NCT00748956|12188099|FG000|NOT COMPLETED|Overall Study||0
11010578|NCT00748956|12188100|FG001|NOT COMPLETED|Overall Study||0
11010579|NCT00748956|12188101|FG002|NOT COMPLETED|Overall Study||0
11010580|NCT00748969|12188111|FG000|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
11010581|NCT00748969|12188112|FG001|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
11010582|NCT00748969|12188111|FG000|COMPLETED|Overall Study||0
11010583|NCT00748969|12188112|FG001|COMPLETED|Overall Study||0
11010584|NCT00748969|12188111|FG000|NOT COMPLETED|Overall Study||1
11010585|NCT00748969|12188112|FG001|NOT COMPLETED|Overall Study||1
11010586|NCT00748982|12188120|FG000|STARTED|Overall Study||12
11010587|NCT00748982|12188121|FG001|STARTED|Overall Study||4
11010588|NCT00748982|12188120|FG000|COMPLETED|Overall Study||12
11010589|NCT00748982|12188121|FG001|COMPLETED|Overall Study||4
11010590|NCT00748982|12188120|FG000|NOT COMPLETED|Overall Study||0
11010591|NCT00748982|12188121|FG001|NOT COMPLETED|Overall Study||0
11010592|NCT00749073|12188127|FG000|STARTED|Overall Study||10
11010593|NCT00749073|12188127|FG000|COMPLETED|Overall Study||10
11010594|NCT00749073|12188127|FG000|NOT COMPLETED|Overall Study||0
11010595|NCT00749125|12188134|FG000|STARTED|Overall Study||47
11010596|NCT00749125|12188135|FG001|STARTED|Overall Study||52
11010597|NCT00749125|12188134|FG000|COMPLETED|Overall Study||36
11010598|NCT00749125|12188135|FG001|COMPLETED|Overall Study||34
11010599|NCT00749125|12188134|FG000|NOT COMPLETED|Overall Study||11
11010600|NCT00749125|12188135|FG001|NOT COMPLETED|Overall Study||18
11010601|NCT00749190|12188148|FG000|STARTED|Overall Study||71
11010602|NCT00749190|12188149|FG001|STARTED|Overall Study||71
11010603|NCT00749190|12188150|FG002|STARTED|Overall Study||71
11010604|NCT00749190|12188151|FG003|STARTED|Overall Study||71
11010605|NCT00749190|12188152|FG004|STARTED|Overall Study||70
11010606|NCT00749190|12188153|FG005|STARTED|Overall Study||70
11010607|NCT00749190|12188154|FG006|STARTED|Overall Study||71
11010608|NCT00749190|12188148|FG000|COMPLETED|Overall Study||66
11010609|NCT00749190|12188149|FG001|COMPLETED|Overall Study||66
11010610|NCT00749190|12188150|FG002|COMPLETED|Overall Study||70
11010611|NCT00749190|12188151|FG003|COMPLETED|Overall Study||66
11010612|NCT00749190|12188152|FG004|COMPLETED|Overall Study||70
11010613|NCT00749190|12188153|FG005|COMPLETED|Overall Study||65
11010614|NCT00749190|12188154|FG006|COMPLETED|Overall Study||70
11010615|NCT00749190|12188148|FG000|NOT COMPLETED|Overall Study||5
11010616|NCT00749190|12188149|FG001|NOT COMPLETED|Overall Study||5
11010617|NCT00749190|12188150|FG002|NOT COMPLETED|Overall Study||1
11010618|NCT00749190|12188151|FG003|NOT COMPLETED|Overall Study||5
11010619|NCT00749190|12188152|FG004|NOT COMPLETED|Overall Study||0
11010620|NCT00749190|12188153|FG005|NOT COMPLETED|Overall Study||5
11010621|NCT00749190|12188154|FG006|NOT COMPLETED|Overall Study||1
11010622|NCT00749203|12188177|FG000|STARTED|First Infusion Day 1||22
11010623|NCT00749203|12188178|FG001|STARTED|First Infusion Day 1||19
11010624|NCT00749203|12188177|FG000|COMPLETED|First Infusion Day 1||22
11010625|NCT00749203|12188178|FG001|COMPLETED|First Infusion Day 1||19
11010626|NCT00749203|12188177|FG000|NOT COMPLETED|First Infusion Day 1||0
11010627|NCT00749203|12188178|FG001|NOT COMPLETED|First Infusion Day 1||0
11010628|NCT00749203|12188177|FG000|STARTED|no Infusion at Week 1||22
11010629|NCT00749203|12188178|FG001|STARTED|no Infusion at Week 1||19
11010630|NCT00749203|12188177|FG000|COMPLETED|no Infusion at Week 1||22
11010631|NCT00749203|12188178|FG001|COMPLETED|no Infusion at Week 1||15
11010632|NCT00749203|12188177|FG000|NOT COMPLETED|no Infusion at Week 1||0
11010633|NCT00749203|12188178|FG001|NOT COMPLETED|no Infusion at Week 1||4
11010634|NCT00749203|12188177|FG000|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
11010635|NCT00749203|12188178|FG001|STARTED|Second Infusion at 2 Weeks||15
11010636|NCT00749203|12188177|FG000|COMPLETED|Second Infusion at 2 Weeks||16
11010637|NCT00749203|12188178|FG001|COMPLETED|Second Infusion at 2 Weeks||13
11010638|NCT00749203|12188177|FG000|NOT COMPLETED|Second Infusion at 2 Weeks||0
11010639|NCT00749203|12188178|FG001|NOT COMPLETED|Second Infusion at 2 Weeks||2
11010640|NCT00749268|12188188|FG000|STARTED|Overall Study||106
11010641|NCT00749268|12188189|FG001|STARTED|Overall Study||110
11010642|NCT00749268|12188188|FG000|COMPLETED|Overall Study||72
11010643|NCT00749268|12188189|FG001|COMPLETED|Overall Study||74
11010644|NCT00749268|12188188|FG000|NOT COMPLETED|Overall Study||34
11010645|NCT00749268|12188189|FG001|NOT COMPLETED|Overall Study||36
11010646|NCT00749398|12188199|FG000|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
11010647|NCT00749398|12188199|FG000|COMPLETED|Overall Study||71
11010648|NCT00749398|12188199|FG000|NOT COMPLETED|Overall Study||53
11010649|NCT00749411|12188205|FG000|STARTED|Overall Study||21
11010650|NCT00749411|12188206|FG001|STARTED|Overall Study||40
11010651|NCT00749411|12188205|FG000|COMPLETED|Overall Study||20
11010652|NCT00749411|12188206|FG001|COMPLETED|Overall Study||35
11010653|NCT00749411|12188205|FG000|NOT COMPLETED|Overall Study||1
11010654|NCT00749411|12188206|FG001|NOT COMPLETED|Overall Study||5
11010655|NCT00749463|12188215|FG000|STARTED|Overall Study||86
11010656|NCT00749463|12188216|FG001|STARTED|Overall Study||64
11010657|NCT00749463|12188217|FG002|STARTED|Overall Study||150
11010658|NCT00749463|12188215|FG000|COMPLETED|Overall Study||85
11010659|NCT00749463|12188216|FG001|COMPLETED|Overall Study||60
11010660|NCT00749463|12188217|FG002|COMPLETED|Overall Study||149
11010661|NCT00749463|12188215|FG000|NOT COMPLETED|Overall Study||1
11010662|NCT00749463|12188216|FG001|NOT COMPLETED|Overall Study||4
11010663|NCT00749463|12188217|FG002|NOT COMPLETED|Overall Study||1
11010664|NCT00749515|12188227|FG000|STARTED|Overall Study||10
11010665|NCT00749515|12188228|FG001|STARTED|Overall Study||5
11010666|NCT00749515|12188227|FG000|COMPLETED|Overall Study||10
11010667|NCT00749515|12188228|FG001|COMPLETED|Overall Study||5
11010668|NCT00749515|12188227|FG000|NOT COMPLETED|Overall Study||0
11010669|NCT00749515|12188228|FG001|NOT COMPLETED|Overall Study||0
11010670|NCT00749580|12188236|FG000|STARTED|Overall Study|September 2008|21
11010671|NCT00749580|12188237|FG001|STARTED|Overall Study||25
11010672|NCT00749580|12188236|FG000|COMPLETED|Overall Study|December 2010|17
11010673|NCT00749580|12188237|FG001|COMPLETED|Overall Study||16
11010674|NCT00749580|12188236|FG000|NOT COMPLETED|Overall Study||4
11010675|NCT00749580|12188237|FG001|NOT COMPLETED|Overall Study||9
11010676|NCT00749606|12188245|FG000|STARTED|Year 1||129
11010677|NCT00749606|12188246|FG001|STARTED|Year 1||128
11010678|NCT00749606|12188245|FG000|COMPLETED|Year 1||74
11010679|NCT00749606|12188246|FG001|COMPLETED|Year 1||80
11010680|NCT00749606|12188245|FG000|NOT COMPLETED|Year 1||55
11010681|NCT00749606|12188246|FG001|NOT COMPLETED|Year 1||48
11010682|NCT00749606|12188245|FG000|STARTED|Year 2||74
11010683|NCT00749606|12188246|FG001|STARTED|Year 2||80
11010684|NCT00749606|12188245|FG000|COMPLETED|Year 2||63
11010685|NCT00749606|12188246|FG001|COMPLETED|Year 2||72
11010686|NCT00749606|12188245|FG000|NOT COMPLETED|Year 2||11
11010687|NCT00749606|12188246|FG001|NOT COMPLETED|Year 2||8
11010688|NCT00749606|12188245|FG000|STARTED|Year 3 (Observation)||63
11010689|NCT00749606|12188246|FG001|STARTED|Year 3 (Observation)||72
11010690|NCT00749606|12188245|FG000|COMPLETED|Year 3 (Observation)||63
11010691|NCT00749606|12188246|FG001|COMPLETED|Year 3 (Observation)||69
11010692|NCT00749606|12188245|FG000|NOT COMPLETED|Year 3 (Observation)||0
11010693|NCT00749606|12188246|FG001|NOT COMPLETED|Year 3 (Observation)||3
11010694|NCT00749671|12188256|FG000|STARTED|Overall Study||11
11010695|NCT00749671|12188257|FG001|STARTED|Overall Study||9
11010696|NCT00749671|12188256|FG000|COMPLETED|Overall Study||11
11010697|NCT00749671|12188257|FG001|COMPLETED|Overall Study||9
11010698|NCT00749671|12188256|FG000|NOT COMPLETED|Overall Study||0
11010699|NCT00749671|12188257|FG001|NOT COMPLETED|Overall Study||0
11010700|NCT00749684|12188265|FG000|STARTED|Overall Study||138
11010701|NCT00749684|12188265|FG000|COMPLETED|Overall Study||56
11010702|NCT00749684|12188265|FG000|NOT COMPLETED|Overall Study||82
11010703|NCT00749749|12188271|FG000|STARTED|Overall Study||14
11010704|NCT00749749|12188272|FG001|STARTED|Overall Study||13
11010705|NCT00749749|12188271|FG000|COMPLETED|Overall Study||14
11010706|NCT00749749|12188272|FG001|COMPLETED|Overall Study||13
11010707|NCT00749749|12188271|FG000|NOT COMPLETED|Overall Study||0
11010708|NCT00749749|12188272|FG001|NOT COMPLETED|Overall Study||0
11010709|NCT00749775|12188278|FG000|STARTED|Overall Study||3317
11010710|NCT00749775|12188278|FG000|COMPLETED|Overall Study||3210
11010711|NCT00749775|12188278|FG000|NOT COMPLETED|Overall Study||107
11010712|NCT00749879|12188292|FG000|STARTED|Overall Study||12
11010713|NCT00749879|12188292|FG000|COMPLETED|Overall Study||12
11010714|NCT00749879|12188292|FG000|NOT COMPLETED|Overall Study||0
11010715|NCT00749892|12188304|FG000|STARTED|Overall Study||34
11010716|NCT00749892|12188304|FG000|COMPLETED|Overall Study||31
11010717|NCT00749892|12188304|FG000|NOT COMPLETED|Overall Study||3
11010718|NCT00749931|12188310|FG000|STARTED|Overall Study||298
11010719|NCT00749931|12188311|FG001|STARTED|Overall Study||298
11010720|NCT00749931|12188312|FG002|STARTED|Overall Study||68
11010721|NCT00749931|12188310|FG000|COMPLETED|Overall Study||298
11010722|NCT00749931|12188311|FG001|COMPLETED|Overall Study||298
11010723|NCT00749931|12188312|FG002|COMPLETED|Overall Study||68
11010724|NCT00749931|12188310|FG000|NOT COMPLETED|Overall Study||0
11010725|NCT00749931|12188311|FG001|NOT COMPLETED|Overall Study||0
11010726|NCT00749931|12188312|FG002|NOT COMPLETED|Overall Study||0
11010727|NCT00749944|12188321|FG000|STARTED|Overall Study||55
11010728|NCT00749944|12188322|FG001|STARTED|Overall Study||55
11010729|NCT00749944|12188321|FG000|COMPLETED|Overall Study||50
11010730|NCT00749944|12188322|FG001|COMPLETED|Overall Study||54
11010731|NCT00749944|12188321|FG000|NOT COMPLETED|Overall Study||5
11010732|NCT00749944|12188322|FG001|NOT COMPLETED|Overall Study||1
11010733|NCT00749957|12188330|FG000|STARTED|Overall Study||6
11010734|NCT00749957|12188331|FG001|STARTED|Overall Study||6
11010735|NCT00749957|12188330|FG000|COMPLETED|Overall Study||6
11010736|NCT00749957|12188331|FG001|COMPLETED|Overall Study||6
11010737|NCT00749957|12188330|FG000|NOT COMPLETED|Overall Study||0
11010738|NCT00749957|12188331|FG001|NOT COMPLETED|Overall Study||0
11010739|NCT00749996|12188341|FG000|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
11010740|NCT00749996|12188342|FG001|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
11010741|NCT00749996|12188341|FG000|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
11010742|NCT00749996|12188342|FG001|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
11010743|NCT00749996|12188341|FG000|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
11010744|NCT00749996|12188342|FG001|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
11010745|NCT00749996|12188341|FG000|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
11010746|NCT00749996|12188342|FG001|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
11010747|NCT00749996|12188341|FG000|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
11010748|NCT00749996|12188342|FG001|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
11010749|NCT00749996|12188341|FG000|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
11010750|NCT00749996|12188342|FG001|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
11010751|NCT00749996|12188341|FG000|COMPLETED|Overall Study||57
11010752|NCT00749996|12188342|FG001|COMPLETED|Overall Study||58
11010753|NCT00749996|12188341|FG000|NOT COMPLETED|Overall Study||18
11010754|NCT00749996|12188342|FG001|NOT COMPLETED|Overall Study||13
11010755|NCT00750061|12188350|FG000|STARTED|Overall Study||20
11010756|NCT00750061|12188351|FG001|STARTED|Overall Study||20
11010757|NCT00750061|12188350|FG000|COMPLETED|Overall Study||18
11010758|NCT00750061|12188351|FG001|COMPLETED|Overall Study||18
11010759|NCT00750061|12188350|FG000|NOT COMPLETED|Overall Study||2
11010760|NCT00750061|12188351|FG001|NOT COMPLETED|Overall Study||2
11010761|NCT00750139|12188361|FG000|STARTED|Overall Study||234
11010762|NCT00750139|12188362|FG001|STARTED|Overall Study||118
11010763|NCT00750139|12188363|FG002|STARTED|Overall Study||236
11010764|NCT00750139|12188364|FG003|STARTED|Overall Study||119
11010765|NCT00750139|12188361|FG000|COMPLETED|Overall Study||145
11010766|NCT00750139|12188362|FG001|COMPLETED|Overall Study||59
11010767|NCT00750139|12188363|FG002|COMPLETED|Overall Study||135
11010768|NCT00750139|12188364|FG003|COMPLETED|Overall Study||73
11010769|NCT00750139|12188361|FG000|NOT COMPLETED|Overall Study||89
11010770|NCT00750139|12188362|FG001|NOT COMPLETED|Overall Study||59
11010771|NCT00750139|12188363|FG002|NOT COMPLETED|Overall Study||101
11010772|NCT00750139|12188364|FG003|NOT COMPLETED|Overall Study||46
11010773|NCT00750152|12188378|FG000|STARTED|Overall Study||166
11010774|NCT00750152|12188379|FG001|STARTED|Overall Study||168
11010775|NCT00750152|12188378|FG000|COMPLETED|Overall Study||144
11010776|NCT00750152|12188379|FG001|COMPLETED|Overall Study||141
11010777|NCT00750152|12188378|FG000|NOT COMPLETED|Overall Study||22
11010778|NCT00750152|12188379|FG001|NOT COMPLETED|Overall Study||27
11010779|NCT00750165|12188385|FG000|STARTED|Overall Study||32
11010780|NCT00750165|12188385|FG000|COMPLETED|Overall Study||21
11010781|NCT00750165|12188385|FG000|NOT COMPLETED|Overall Study||11
11010782|NCT00750191|12188391|FG000|STARTED|Overall Study||27
11010783|NCT00750191|12188392|FG001|STARTED|Overall Study||30
11010784|NCT00750191|12188391|FG000|COMPLETED|Overall Study||22
11010785|NCT00750191|12188392|FG001|COMPLETED|Overall Study||20
11010786|NCT00750191|12188391|FG000|NOT COMPLETED|Overall Study||5
11010787|NCT00750191|12188392|FG001|NOT COMPLETED|Overall Study||10
11010788|NCT00750282|12188402|FG000|STARTED|Overall Study||69
11010789|NCT00750282|12188403|FG001|STARTED|Overall Study||82
11010790|NCT00750282|12188404|FG002|STARTED|Overall Study||126
11010791|NCT00750282|12188405|FG003|STARTED|Overall Study||148
11010792|NCT00750282|12188402|FG000|COMPLETED|Overall Study||69
11010793|NCT00750282|12188403|FG001|COMPLETED|Overall Study||81
11010794|NCT00750282|12188404|FG002|COMPLETED|Overall Study||125
11010795|NCT00750282|12188405|FG003|COMPLETED|Overall Study||147
11010796|NCT00750282|12188402|FG000|NOT COMPLETED|Overall Study||0
11010797|NCT00750282|12188403|FG001|NOT COMPLETED|Overall Study||1
11010798|NCT00750282|12188404|FG002|NOT COMPLETED|Overall Study||1
11010799|NCT00750282|12188405|FG003|NOT COMPLETED|Overall Study||1
11010800|NCT00750308|12188429|FG000|STARTED|First Treatment|One female withdrew due to muscle pain|2
11010801|NCT00750308|12188430|FG001|STARTED|First Treatment||3
11010802|NCT00750308|12188431|FG002|STARTED|First Treatment||2
11010803|NCT00750308|12188432|FG003|STARTED|First Treatment||2
11010804|NCT00750308|12188433|FG004|STARTED|First Treatment||2
11010805|NCT00750308|12188434|FG005|STARTED|First Treatment||3
11010806|NCT00750308|12188435|FG006|STARTED|First Treatment||2
11010807|NCT00750308|12188436|FG007|STARTED|First Treatment||3
11010808|NCT00750308|12188437|FG008|STARTED|First Treatment||2
11010809|NCT00750308|12188438|FG009|STARTED|First Treatment||2
11010810|NCT00750308|12188439|FG010|STARTED|First Treatment||2
11010811|NCT00750308|12188440|FG011|STARTED|First Treatment||2
11010812|NCT00750308|12188429|FG000|COMPLETED|First Treatment||2
11010813|NCT00750308|12188430|FG001|COMPLETED|First Treatment||2
11010814|NCT00750308|12188431|FG002|COMPLETED|First Treatment||2
11010815|NCT00750308|12188432|FG003|COMPLETED|First Treatment||1
11010816|NCT00750308|12188433|FG004|COMPLETED|First Treatment||2
11010817|NCT00750308|12188434|FG005|COMPLETED|First Treatment||3
11010818|NCT00750308|12188435|FG006|COMPLETED|First Treatment||2
11010819|NCT00750308|12188436|FG007|COMPLETED|First Treatment||2
11010820|NCT00750308|12188437|FG008|COMPLETED|First Treatment||2
11010821|NCT00750308|12188438|FG009|COMPLETED|First Treatment||2
11010822|NCT00750308|12188439|FG010|COMPLETED|First Treatment||1
11010823|NCT00750308|12188440|FG011|COMPLETED|First Treatment||1
11010824|NCT00750308|12188429|FG000|NOT COMPLETED|First Treatment||0
11010825|NCT00750308|12188430|FG001|NOT COMPLETED|First Treatment||1
11010826|NCT00750308|12188431|FG002|NOT COMPLETED|First Treatment||0
11010827|NCT00750308|12188432|FG003|NOT COMPLETED|First Treatment||1
11010828|NCT00750308|12188433|FG004|NOT COMPLETED|First Treatment||0
11010829|NCT00750308|12188434|FG005|NOT COMPLETED|First Treatment||0
11010830|NCT00750308|12188435|FG006|NOT COMPLETED|First Treatment||0
11010831|NCT00750308|12188436|FG007|NOT COMPLETED|First Treatment||1
11010832|NCT00750308|12188437|FG008|NOT COMPLETED|First Treatment||0
11010833|NCT00750308|12188438|FG009|NOT COMPLETED|First Treatment||0
11010834|NCT00750308|12188439|FG010|NOT COMPLETED|First Treatment||1
11010835|NCT00750308|12188440|FG011|NOT COMPLETED|First Treatment||1
11010836|NCT00750308|12188429|FG000|STARTED|Washout||2
11010837|NCT00750308|12188430|FG001|STARTED|Washout||2
11010838|NCT00750308|12188431|FG002|STARTED|Washout||2
11010839|NCT00750308|12188432|FG003|STARTED|Washout||1
11010840|NCT00750308|12188433|FG004|STARTED|Washout||2
11010841|NCT00750308|12188434|FG005|STARTED|Washout||3
11010842|NCT00750308|12188435|FG006|STARTED|Washout||2
11010843|NCT00750308|12188436|FG007|STARTED|Washout||2
11010844|NCT00750308|12188437|FG008|STARTED|Washout||2
11010845|NCT00750308|12188438|FG009|STARTED|Washout||2
11010846|NCT00750308|12188439|FG010|STARTED|Washout||1
11010847|NCT00750308|12188440|FG011|STARTED|Washout||1
11010848|NCT00750308|12188429|FG000|COMPLETED|Washout||2
11010849|NCT00750308|12188430|FG001|COMPLETED|Washout||2
11010850|NCT00750308|12188431|FG002|COMPLETED|Washout||2
11010851|NCT00750308|12188432|FG003|COMPLETED|Washout||1
11010852|NCT00750308|12188433|FG004|COMPLETED|Washout||2
11010853|NCT00750308|12188434|FG005|COMPLETED|Washout||3
11010854|NCT00750308|12188435|FG006|COMPLETED|Washout||2
11010855|NCT00750308|12188436|FG007|COMPLETED|Washout||2
11010856|NCT00750308|12188437|FG008|COMPLETED|Washout||2
11010857|NCT00750308|12188438|FG009|COMPLETED|Washout||2
11010858|NCT00750308|12188439|FG010|COMPLETED|Washout||1
11142724|NCT01469013|12329424|FG001|COMPLETED|Part B (Extension Period)||0
11142725|NCT01469013|12329425|FG002|COMPLETED|Part B (Extension Period)||0
11142726|NCT01469013|12329426|FG003|COMPLETED|Part B (Extension Period)||0
11142727|NCT01469013|12329427|FG004|COMPLETED|Part B (Extension Period)||0
11142728|NCT01469013|12329428|FG005|COMPLETED|Part B (Extension Period)||10
11142729|NCT01469013|12329429|FG006|COMPLETED|Part B (Extension Period)||7
11142730|NCT01469013|12329430|FG007|COMPLETED|Part B (Extension Period)||18
11142731|NCT01469013|12329431|FG008|COMPLETED|Part B (Extension Period)||20
11142732|NCT01469013|12329432|FG009|COMPLETED|Part B (Extension Period)||8
11142733|NCT01469013|12329433|FG010|COMPLETED|Part B (Extension Period)||10
11142734|NCT01469013|12329434|FG011|COMPLETED|Part B (Extension Period)||18
11142735|NCT01469013|12329435|FG012|COMPLETED|Part B (Extension Period)||18
11142736|NCT01469013|12329423|FG000|NOT COMPLETED|Part B (Extension Period)||0
11142737|NCT01469013|12329424|FG001|NOT COMPLETED|Part B (Extension Period)||0
11142738|NCT01469013|12329425|FG002|NOT COMPLETED|Part B (Extension Period)||0
11142739|NCT01469013|12329426|FG003|NOT COMPLETED|Part B (Extension Period)||0
11142740|NCT01469013|12329427|FG004|NOT COMPLETED|Part B (Extension Period)||0
11142741|NCT01469013|12329428|FG005|NOT COMPLETED|Part B (Extension Period)||2
11142742|NCT01469013|12329429|FG006|NOT COMPLETED|Part B (Extension Period)||5
11010859|NCT00750308|12188440|FG011|COMPLETED|Washout||1
11010860|NCT00750308|12188429|FG000|NOT COMPLETED|Washout||0
11010861|NCT00750308|12188430|FG001|NOT COMPLETED|Washout||0
11010862|NCT00750308|12188431|FG002|NOT COMPLETED|Washout||0
11010863|NCT00750308|12188432|FG003|NOT COMPLETED|Washout||0
11010864|NCT00750308|12188433|FG004|NOT COMPLETED|Washout||0
11010865|NCT00750308|12188434|FG005|NOT COMPLETED|Washout||0
11010866|NCT00750308|12188435|FG006|NOT COMPLETED|Washout||0
11010867|NCT00750308|12188436|FG007|NOT COMPLETED|Washout||0
11010868|NCT00750308|12188437|FG008|NOT COMPLETED|Washout||0
11010869|NCT00750308|12188438|FG009|NOT COMPLETED|Washout||0
11010870|NCT00750308|12188439|FG010|NOT COMPLETED|Washout||0
11010871|NCT00750308|12188440|FG011|NOT COMPLETED|Washout||0
11010872|NCT00750308|12188429|FG000|STARTED|Second Treatment||2
11010873|NCT00750308|12188430|FG001|STARTED|Second Treatment||2
11010874|NCT00750308|12188431|FG002|STARTED|Second Treatment||2
11010875|NCT00750308|12188432|FG003|STARTED|Second Treatment||1
11010876|NCT00750308|12188433|FG004|STARTED|Second Treatment||2
11010877|NCT00750308|12188434|FG005|STARTED|Second Treatment||3
11010878|NCT00750308|12188435|FG006|STARTED|Second Treatment||2
11010879|NCT00750308|12188436|FG007|STARTED|Second Treatment||2
11010880|NCT00750308|12188437|FG008|STARTED|Second Treatment||2
11010881|NCT00750308|12188438|FG009|STARTED|Second Treatment||2
11010882|NCT00750308|12188439|FG010|STARTED|Second Treatment||1
11010883|NCT00750308|12188440|FG011|STARTED|Second Treatment||1
11010884|NCT00750308|12188429|FG000|COMPLETED|Second Treatment||2
11010885|NCT00750308|12188430|FG001|COMPLETED|Second Treatment||2
11010886|NCT00750308|12188431|FG002|COMPLETED|Second Treatment||2
11010887|NCT00750308|12188432|FG003|COMPLETED|Second Treatment||1
11010888|NCT00750308|12188433|FG004|COMPLETED|Second Treatment||1
11010889|NCT00750308|12188434|FG005|COMPLETED|Second Treatment||2
11010890|NCT00750308|12188435|FG006|COMPLETED|Second Treatment||2
11010891|NCT00750308|12188436|FG007|COMPLETED|Second Treatment||2
11010892|NCT00750308|12188437|FG008|COMPLETED|Second Treatment||1
11142743|NCT01469013|12329430|FG007|NOT COMPLETED|Part B (Extension Period)||5
11142744|NCT01469013|12329431|FG008|NOT COMPLETED|Part B (Extension Period)||4
11142745|NCT01469013|12329432|FG009|NOT COMPLETED|Part B (Extension Period)||3
11142746|NCT01469013|12329433|FG010|NOT COMPLETED|Part B (Extension Period)||2
11142747|NCT01469013|12329434|FG011|NOT COMPLETED|Part B (Extension Period)||6
11142748|NCT01469013|12329435|FG012|NOT COMPLETED|Part B (Extension Period)||6
11142749|NCT01469039|12329465|FG000|STARTED|Overall Study||207
11142750|NCT01469039|12329466|FG001|STARTED|Overall Study||208
11142751|NCT01469039|12329467|FG002|STARTED|Overall Study||208
11142752|NCT01469039|12329465|FG000|COMPLETED|Overall Study||130
11142753|NCT01469039|12329466|FG001|COMPLETED|Overall Study||135
11142754|NCT01469039|12329467|FG002|COMPLETED|Overall Study||95
11142755|NCT01469039|12329465|FG000|NOT COMPLETED|Overall Study||77
11142756|NCT01469039|12329466|FG001|NOT COMPLETED|Overall Study||73
11142757|NCT01469039|12329467|FG002|NOT COMPLETED|Overall Study||113
11142758|NCT01469052|12329481|FG000|STARTED|Overall Study||6
11142759|NCT01469052|12329482|FG001|STARTED|Overall Study||4
11142760|NCT01469052|12329483|FG002|STARTED|Overall Study||6
11142761|NCT01469052|12329484|FG003|STARTED|Overall Study||6
11142762|NCT01469052|12329485|FG004|STARTED|Overall Study||8
11142763|NCT01469052|12329486|FG005|STARTED|Overall Study||6
11142764|NCT01469052|12329481|FG000|COMPLETED|Overall Study||0
11142765|NCT01469052|12329482|FG001|COMPLETED|Overall Study||0
11142766|NCT01469052|12329483|FG002|COMPLETED|Overall Study||0
11142767|NCT01469052|12329484|FG003|COMPLETED|Overall Study||1
11142768|NCT01469052|12329485|FG004|COMPLETED|Overall Study||0
11142769|NCT01469052|12329486|FG005|COMPLETED|Overall Study||0
11142770|NCT01469052|12329481|FG000|NOT COMPLETED|Overall Study||6
11142771|NCT01469052|12329482|FG001|NOT COMPLETED|Overall Study||4
11142772|NCT01469052|12329483|FG002|NOT COMPLETED|Overall Study||6
11142773|NCT01469052|12329484|FG003|NOT COMPLETED|Overall Study||5
11142774|NCT01469052|12329485|FG004|NOT COMPLETED|Overall Study||8
11142775|NCT01469052|12329486|FG005|NOT COMPLETED|Overall Study||6
11142776|NCT01469065|12329503|FG000|STARTED|Overall Study||16
11142777|NCT01469065|12329504|FG001|STARTED|Overall Study||17
11142778|NCT01469065|12329505|FG002|STARTED|Overall Study||16
11142779|NCT01469065|12329506|FG003|STARTED|Overall Study||16
11142780|NCT01469065|12329507|FG004|STARTED|Overall Study||17
11142781|NCT01469065|12329503|FG000|COMPLETED|Overall Study||16
11142782|NCT01469065|12329504|FG001|COMPLETED|Overall Study||16
11142783|NCT01469065|12329505|FG002|COMPLETED|Overall Study||16
11142784|NCT01469065|12329506|FG003|COMPLETED|Overall Study||16
11142785|NCT01469065|12329507|FG004|COMPLETED|Overall Study||16
11142786|NCT01469065|12329503|FG000|NOT COMPLETED|Overall Study||0
11010893|NCT00750308|12188438|FG009|COMPLETED|Second Treatment||2
11010894|NCT00750308|12188439|FG010|COMPLETED|Second Treatment||1
11010895|NCT00750308|12188440|FG011|COMPLETED|Second Treatment||1
11010896|NCT00750308|12188429|FG000|NOT COMPLETED|Second Treatment||0
11010897|NCT00750308|12188430|FG001|NOT COMPLETED|Second Treatment||0
11010898|NCT00750308|12188431|FG002|NOT COMPLETED|Second Treatment||0
11010899|NCT00750308|12188432|FG003|NOT COMPLETED|Second Treatment||0
11010900|NCT00750308|12188433|FG004|NOT COMPLETED|Second Treatment||1
11010901|NCT00750308|12188434|FG005|NOT COMPLETED|Second Treatment||1
11010902|NCT00750308|12188435|FG006|NOT COMPLETED|Second Treatment||0
11010903|NCT00750308|12188436|FG007|NOT COMPLETED|Second Treatment||0
11010904|NCT00750308|12188437|FG008|NOT COMPLETED|Second Treatment||1
11010905|NCT00750308|12188438|FG009|NOT COMPLETED|Second Treatment||0
11010906|NCT00750308|12188439|FG010|NOT COMPLETED|Second Treatment||0
11010907|NCT00750308|12188440|FG011|NOT COMPLETED|Second Treatment||0
11010908|NCT00750308|12188429|FG000|STARTED|Washout||2
11142787|NCT01469065|12329504|FG001|NOT COMPLETED|Overall Study||1
11142788|NCT01469065|12329505|FG002|NOT COMPLETED|Overall Study||0
11142789|NCT01469065|12329506|FG003|NOT COMPLETED|Overall Study||0
11142790|NCT01469065|12329507|FG004|NOT COMPLETED|Overall Study||1
11010909|NCT00750308|12188430|FG001|STARTED|Washout||2
11010910|NCT00750308|12188431|FG002|STARTED|Washout||2
11010911|NCT00750308|12188432|FG003|STARTED|Washout||1
11010912|NCT00750308|12188433|FG004|STARTED|Washout||1
11010913|NCT00750308|12188434|FG005|STARTED|Washout||2
11010914|NCT00750308|12188435|FG006|STARTED|Washout||2
11010915|NCT00750308|12188436|FG007|STARTED|Washout||2
11010916|NCT00750308|12188437|FG008|STARTED|Washout||1
11010917|NCT00750308|12188438|FG009|STARTED|Washout||2
11010918|NCT00750308|12188439|FG010|STARTED|Washout||1
11010919|NCT00750308|12188440|FG011|STARTED|Washout||1
11010920|NCT00750308|12188429|FG000|COMPLETED|Washout||2
11010921|NCT00750308|12188430|FG001|COMPLETED|Washout||2
11010922|NCT00750308|12188431|FG002|COMPLETED|Washout||2
11010923|NCT00750308|12188432|FG003|COMPLETED|Washout||1
11010924|NCT00750308|12188433|FG004|COMPLETED|Washout||1
11010925|NCT00750308|12188434|FG005|COMPLETED|Washout||2
11010926|NCT00750308|12188435|FG006|COMPLETED|Washout||2
11010927|NCT00750308|12188436|FG007|COMPLETED|Washout||2
11010928|NCT00750308|12188437|FG008|COMPLETED|Washout||1
11010929|NCT00750308|12188438|FG009|COMPLETED|Washout||2
11010930|NCT00750308|12188439|FG010|COMPLETED|Washout||1
11010931|NCT00750308|12188440|FG011|COMPLETED|Washout||1
11010932|NCT00750308|12188429|FG000|NOT COMPLETED|Washout||0
11010933|NCT00750308|12188430|FG001|NOT COMPLETED|Washout||0
11010934|NCT00750308|12188431|FG002|NOT COMPLETED|Washout||0
11010935|NCT00750308|12188432|FG003|NOT COMPLETED|Washout||0
11010936|NCT00750308|12188433|FG004|NOT COMPLETED|Washout||0
11010937|NCT00750308|12188434|FG005|NOT COMPLETED|Washout||0
11010938|NCT00750308|12188435|FG006|NOT COMPLETED|Washout||0
11010939|NCT00750308|12188436|FG007|NOT COMPLETED|Washout||0
11010940|NCT00750308|12188437|FG008|NOT COMPLETED|Washout||0
11010941|NCT00750308|12188438|FG009|NOT COMPLETED|Washout||0
11010942|NCT00750308|12188439|FG010|NOT COMPLETED|Washout||0
11010943|NCT00750308|12188440|FG011|NOT COMPLETED|Washout||0
11010944|NCT00750308|12188429|FG000|STARTED|Third Treatment||2
11010945|NCT00750308|12188430|FG001|STARTED|Third Treatment||2
11010946|NCT00750308|12188431|FG002|STARTED|Third Treatment||2
11010947|NCT00750308|12188432|FG003|STARTED|Third Treatment||1
11010948|NCT00750308|12188433|FG004|STARTED|Third Treatment||1
11010949|NCT00750308|12188434|FG005|STARTED|Third Treatment||2
11010950|NCT00750308|12188435|FG006|STARTED|Third Treatment||2
11010951|NCT00750308|12188436|FG007|STARTED|Third Treatment||2
11010952|NCT00750308|12188437|FG008|STARTED|Third Treatment||1
11010953|NCT00750308|12188438|FG009|STARTED|Third Treatment||2
11010954|NCT00750308|12188439|FG010|STARTED|Third Treatment||1
11010955|NCT00750308|12188440|FG011|STARTED|Third Treatment||1
11010956|NCT00750308|12188429|FG000|COMPLETED|Third Treatment||2
11010957|NCT00750308|12188430|FG001|COMPLETED|Third Treatment||1
11010958|NCT00750308|12188431|FG002|COMPLETED|Third Treatment||2
11010959|NCT00750308|12188432|FG003|COMPLETED|Third Treatment||1
11010960|NCT00750308|12188433|FG004|COMPLETED|Third Treatment||1
11010961|NCT00750308|12188434|FG005|COMPLETED|Third Treatment||2
11010962|NCT00750308|12188435|FG006|COMPLETED|Third Treatment||2
11010963|NCT00750308|12188436|FG007|COMPLETED|Third Treatment||2
11010964|NCT00750308|12188437|FG008|COMPLETED|Third Treatment||1
11010965|NCT00750308|12188438|FG009|COMPLETED|Third Treatment||2
11010966|NCT00750308|12188439|FG010|COMPLETED|Third Treatment||1
11010967|NCT00750308|12188440|FG011|COMPLETED|Third Treatment||1
11010968|NCT00750308|12188429|FG000|NOT COMPLETED|Third Treatment||0
11010969|NCT00750308|12188430|FG001|NOT COMPLETED|Third Treatment||1
11010970|NCT00750308|12188431|FG002|NOT COMPLETED|Third Treatment||0
11010971|NCT00750308|12188432|FG003|NOT COMPLETED|Third Treatment||0
11010972|NCT00750308|12188433|FG004|NOT COMPLETED|Third Treatment||0
11010973|NCT00750308|12188434|FG005|NOT COMPLETED|Third Treatment||0
11010974|NCT00750308|12188435|FG006|NOT COMPLETED|Third Treatment||0
11010975|NCT00750308|12188436|FG007|NOT COMPLETED|Third Treatment||0
11010976|NCT00750308|12188437|FG008|NOT COMPLETED|Third Treatment||0
11010977|NCT00750308|12188438|FG009|NOT COMPLETED|Third Treatment||0
11010978|NCT00750308|12188439|FG010|NOT COMPLETED|Third Treatment||0
11010979|NCT00750308|12188440|FG011|NOT COMPLETED|Third Treatment||0
11010980|NCT00750308|12188429|FG000|STARTED|Washout||2
11010981|NCT00750308|12188430|FG001|STARTED|Washout||1
11010982|NCT00750308|12188431|FG002|STARTED|Washout||2
11010983|NCT00750308|12188432|FG003|STARTED|Washout||1
11010984|NCT00750308|12188433|FG004|STARTED|Washout||1
11010985|NCT00750308|12188434|FG005|STARTED|Washout||2
11010986|NCT00750308|12188435|FG006|STARTED|Washout||2
11010987|NCT00750308|12188436|FG007|STARTED|Washout||2
11010988|NCT00750308|12188437|FG008|STARTED|Washout||1
11010989|NCT00750308|12188438|FG009|STARTED|Washout||2
11010990|NCT00750308|12188439|FG010|STARTED|Washout||1
11010991|NCT00750308|12188440|FG011|STARTED|Washout||1
11010992|NCT00750308|12188429|FG000|COMPLETED|Washout||2
11010993|NCT00750308|12188430|FG001|COMPLETED|Washout||1
11010994|NCT00750308|12188431|FG002|COMPLETED|Washout||2
11010995|NCT00750308|12188432|FG003|COMPLETED|Washout||1
11010996|NCT00750308|12188433|FG004|COMPLETED|Washout||1
11010997|NCT00750308|12188434|FG005|COMPLETED|Washout||2
11010998|NCT00750308|12188435|FG006|COMPLETED|Washout||2
11010999|NCT00750308|12188436|FG007|COMPLETED|Washout||2
11011000|NCT00750308|12188437|FG008|COMPLETED|Washout||1
11011001|NCT00750308|12188438|FG009|COMPLETED|Washout||2
11011002|NCT00750308|12188439|FG010|COMPLETED|Washout||1
11011003|NCT00750308|12188440|FG011|COMPLETED|Washout||1
11011004|NCT00750308|12188429|FG000|NOT COMPLETED|Washout||0
11011005|NCT00750308|12188430|FG001|NOT COMPLETED|Washout||0
11011006|NCT00750308|12188431|FG002|NOT COMPLETED|Washout||0
11011007|NCT00750308|12188432|FG003|NOT COMPLETED|Washout||0
11011008|NCT00750308|12188433|FG004|NOT COMPLETED|Washout||0
11011009|NCT00750308|12188434|FG005|NOT COMPLETED|Washout||0
11011010|NCT00750308|12188435|FG006|NOT COMPLETED|Washout||0
11011011|NCT00750308|12188436|FG007|NOT COMPLETED|Washout||0
11011012|NCT00750308|12188437|FG008|NOT COMPLETED|Washout||0
11011013|NCT00750308|12188438|FG009|NOT COMPLETED|Washout||0
11011014|NCT00750308|12188439|FG010|NOT COMPLETED|Washout||0
11011015|NCT00750308|12188440|FG011|NOT COMPLETED|Washout||0
11011016|NCT00750308|12188429|FG000|STARTED|Fourth Treatment||2
11011017|NCT00750308|12188430|FG001|STARTED|Fourth Treatment||1
11011018|NCT00750308|12188431|FG002|STARTED|Fourth Treatment||2
11011019|NCT00750308|12188432|FG003|STARTED|Fourth Treatment||1
11011020|NCT00750308|12188433|FG004|STARTED|Fourth Treatment||1
11011021|NCT00750308|12188434|FG005|STARTED|Fourth Treatment||2
11011022|NCT00750308|12188435|FG006|STARTED|Fourth Treatment||2
11011023|NCT00750308|12188436|FG007|STARTED|Fourth Treatment||2
11011024|NCT00750308|12188437|FG008|STARTED|Fourth Treatment||1
11011025|NCT00750308|12188438|FG009|STARTED|Fourth Treatment||2
11011026|NCT00750308|12188439|FG010|STARTED|Fourth Treatment||1
11011027|NCT00750308|12188440|FG011|STARTED|Fourth Treatment||1
11011028|NCT00750308|12188429|FG000|COMPLETED|Fourth Treatment||2
11011029|NCT00750308|12188430|FG001|COMPLETED|Fourth Treatment||1
11011030|NCT00750308|12188431|FG002|COMPLETED|Fourth Treatment||2
11011031|NCT00750308|12188432|FG003|COMPLETED|Fourth Treatment||1
11011032|NCT00750308|12188433|FG004|COMPLETED|Fourth Treatment||1
11011033|NCT00750308|12188434|FG005|COMPLETED|Fourth Treatment||2
11011034|NCT00750308|12188435|FG006|COMPLETED|Fourth Treatment||2
11011035|NCT00750308|12188436|FG007|COMPLETED|Fourth Treatment||2
11011036|NCT00750308|12188437|FG008|COMPLETED|Fourth Treatment||1
11011037|NCT00750308|12188438|FG009|COMPLETED|Fourth Treatment||2
11011038|NCT00750308|12188439|FG010|COMPLETED|Fourth Treatment||1
11011039|NCT00750308|12188440|FG011|COMPLETED|Fourth Treatment||1
11011040|NCT00750308|12188429|FG000|NOT COMPLETED|Fourth Treatment||0
11011041|NCT00750308|12188430|FG001|NOT COMPLETED|Fourth Treatment||0
11011042|NCT00750308|12188431|FG002|NOT COMPLETED|Fourth Treatment||0
11011043|NCT00750308|12188432|FG003|NOT COMPLETED|Fourth Treatment||0
11011044|NCT00750308|12188433|FG004|NOT COMPLETED|Fourth Treatment||0
11011045|NCT00750308|12188434|FG005|NOT COMPLETED|Fourth Treatment||0
11011046|NCT00750308|12188435|FG006|NOT COMPLETED|Fourth Treatment||0
11011047|NCT00750308|12188436|FG007|NOT COMPLETED|Fourth Treatment||0
11011048|NCT00750308|12188437|FG008|NOT COMPLETED|Fourth Treatment||0
11011049|NCT00750308|12188438|FG009|NOT COMPLETED|Fourth Treatment||0
11011050|NCT00750308|12188439|FG010|NOT COMPLETED|Fourth Treatment||0
11011051|NCT00750308|12188440|FG011|NOT COMPLETED|Fourth Treatment||0
11011052|NCT00750360|12188460|FG000|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
11011053|NCT00750360|12188461|FG001|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
11011054|NCT00750360|12188462|FG002|STARTED|Overall Study||384
11011055|NCT00750360|12188463|FG003|STARTED|Overall Study||79
11011056|NCT00750360|12188464|FG004|STARTED|Overall Study||46
11011057|NCT00750360|12188465|FG005|STARTED|Overall Study||71
11011058|NCT00750360|12188460|FG000|COMPLETED|Overall Study||294
11011059|NCT00750360|12188461|FG001|COMPLETED|Overall Study||1
11011060|NCT00750360|12188462|FG002|COMPLETED|Overall Study||384
11011061|NCT00750360|12188463|FG003|COMPLETED|Overall Study||79
11011062|NCT00750360|12188464|FG004|COMPLETED|Overall Study||46
11011063|NCT00750360|12188465|FG005|COMPLETED|Overall Study||71
11011064|NCT00750360|12188460|FG000|NOT COMPLETED|Overall Study||0
11396335|NCT03722784|12590185|FG001|STARTED|Overall Study||30
11396336|NCT03722784|12590184|FG000|COMPLETED|Overall Study||56
11396337|NCT03722784|12590185|FG001|COMPLETED|Overall Study||28
11011065|NCT00750360|12188461|FG001|NOT COMPLETED|Overall Study||0
11011066|NCT00750360|12188462|FG002|NOT COMPLETED|Overall Study||0
11011067|NCT00750360|12188463|FG003|NOT COMPLETED|Overall Study||0
11011068|NCT00750360|12188464|FG004|NOT COMPLETED|Overall Study||0
11011069|NCT00750360|12188465|FG005|NOT COMPLETED|Overall Study||0
11011070|NCT00750373|12188487|FG000|STARTED|Overall Study||39
11011071|NCT00750373|12188488|FG001|STARTED|Overall Study||37
11011072|NCT00750373|12188487|FG000|COMPLETED|Overall Study||39
11011073|NCT00750373|12188488|FG001|COMPLETED|Overall Study||37
11011074|NCT00750373|12188487|FG000|NOT COMPLETED|Overall Study||0
11011075|NCT00750373|12188488|FG001|NOT COMPLETED|Overall Study||0
11396338|NCT03722784|12590184|FG000|NOT COMPLETED|Overall Study||2
11011076|NCT00750438|12188496|FG000|STARTED|Overall Study||31
11011077|NCT00750438|12188497|FG001|STARTED|Overall Study||29
11011078|NCT00750438|12188496|FG000|COMPLETED|Overall Study||24
11011079|NCT00750438|12188497|FG001|COMPLETED|Overall Study||25
11011080|NCT00750438|12188496|FG000|NOT COMPLETED|Overall Study||7
11011081|NCT00750438|12188497|FG001|NOT COMPLETED|Overall Study||4
11011082|NCT00750737|12188505|FG000|STARTED|Overall Study||24
11011083|NCT00750737|12188506|FG001|STARTED|Overall Study||22
11011084|NCT00750737|12188505|FG000|COMPLETED|Overall Study||21
11011085|NCT00750737|12188506|FG001|COMPLETED|Overall Study||19
11011086|NCT00750737|12188505|FG000|NOT COMPLETED|Overall Study||3
11011087|NCT00750737|12188506|FG001|NOT COMPLETED|Overall Study||3
11011088|NCT00750815|12188514|FG000|STARTED|Overall Study||12
11011089|NCT00750815|12188515|FG001|STARTED|Overall Study||46
11011090|NCT00750815|12188514|FG000|COMPLETED|Overall Study||12
11011091|NCT00750815|12188515|FG001|COMPLETED|Overall Study||46
11011092|NCT00750815|12188514|FG000|NOT COMPLETED|Overall Study||0
11011093|NCT00750815|12188515|FG001|NOT COMPLETED|Overall Study||0
11011094|NCT00750867|12188525|FG000|STARTED|Overall Study||9
11011095|NCT00750867|12188525|FG000|COMPLETED|Overall Study||7
11011096|NCT00750867|12188525|FG000|NOT COMPLETED|Overall Study||2
11011097|NCT00750880|12188529|FG000|STARTED|Overall Study||1681
11011098|NCT00750880|12188529|FG000|COMPLETED|Overall Study||1466
11011099|NCT00750880|12188529|FG000|NOT COMPLETED|Overall Study||215
11011100|NCT00750893|12188534|FG000|STARTED|Overall Study||3111
11011101|NCT00750893|12188534|FG000|COMPLETED|Overall Study||2569
11011102|NCT00750893|12188534|FG000|NOT COMPLETED|Overall Study||542
11011103|NCT00750919|12188538|FG000|STARTED|Overall Study||184
11011104|NCT00750919|12188538|FG000|COMPLETED|Overall Study||126
11011105|NCT00750919|12188538|FG000|NOT COMPLETED|Overall Study||58
11011106|NCT00751023|12188544|FG000|STARTED|Overall Study||20
11011107|NCT00751023|12188545|FG001|STARTED|Overall Study||20
11011108|NCT00751023|12188544|FG000|COMPLETED|Overall Study||9
11011109|NCT00751023|12188545|FG001|COMPLETED|Overall Study||13
11011110|NCT00751023|12188544|FG000|NOT COMPLETED|Overall Study||11
11011111|NCT00751023|12188545|FG001|NOT COMPLETED|Overall Study||7
11011112|NCT00751036|12188553|FG000|STARTED|Overall Study|Started = Treated|48
11011113|NCT00751036|12188554|FG001|STARTED|Overall Study|Started = Treated|46
11011114|NCT00751036|12188553|FG000|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
11011115|NCT00751036|12188554|FG001|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
11011116|NCT00751036|12188553|FG000|NOT COMPLETED|Overall Study||48
11011117|NCT00751036|12188554|FG001|NOT COMPLETED|Overall Study||46
11011118|NCT00751101|12188562|FG000|STARTED|Overall Study||12
11011119|NCT00751101|12188563|FG001|STARTED|Overall Study||12
11011120|NCT00751101|12188562|FG000|Started Capecitabine|Overall Study||11
11011121|NCT00751101|12188563|FG001|Started Capecitabine|Overall Study||11
11011122|NCT00751101|12188562|FG000|COMPLETED|Overall Study||10
11011123|NCT00751101|12188563|FG001|COMPLETED|Overall Study||7
11011124|NCT00751101|12188562|FG000|NOT COMPLETED|Overall Study||2
11011125|NCT00751101|12188563|FG001|NOT COMPLETED|Overall Study||5
11011126|NCT00751114|12188575|FG000|STARTED|Overall Study|randomized|250
11011127|NCT00751114|12188576|FG001|STARTED|Overall Study||265
11011128|NCT00751114|12188575|FG000|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
11011129|NCT00751114|12188576|FG001|TREATED = Safety Population|Overall Study||264
11011130|NCT00751114|12188575|FG000|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
11011131|NCT00751114|12188576|FG001|mITT Population|Overall Study||253
11011132|NCT00751114|12188575|FG000|COMPLETED|Overall Study||212
11011133|NCT00751114|12188576|FG001|COMPLETED|Overall Study||233
11011134|NCT00751114|12188575|FG000|NOT COMPLETED|Overall Study||38
11011135|NCT00751114|12188576|FG001|NOT COMPLETED|Overall Study||32
11011136|NCT00751140|12188582|FG000|STARTED|Overall Study||20
11011137|NCT00751140|12188582|FG000|COMPLETED|Overall Study||19
11011138|NCT00751140|12188582|FG000|NOT COMPLETED|Overall Study||1
11011139|NCT00751179|12188592|FG000|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
11011140|NCT00751179|12188593|FG001|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
11011141|NCT00751179|12188592|FG000|COMPLETED|Overall Study||62
11011142|NCT00751179|12188593|FG001|COMPLETED|Overall Study||70
11011143|NCT00751179|12188592|FG000|NOT COMPLETED|Overall Study||14
11011144|NCT00751179|12188593|FG001|NOT COMPLETED|Overall Study||15
11011145|NCT00751296|12188600|FG000|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
11011146|NCT00751296|12188600|FG000|COMPLETED|Overall Study||25
11011147|NCT00751296|12188600|FG000|NOT COMPLETED|Overall Study||2
11011148|NCT00751348|12188606|FG000|STARTED|Overall Study||313
11011149|NCT00751348|12188607|FG001|STARTED|Overall Study||161
11011150|NCT00751348|12188606|FG000|COMPLETED|Overall Study||307
11011151|NCT00751348|12188607|FG001|COMPLETED|Overall Study||159
11011152|NCT00751348|12188606|FG000|NOT COMPLETED|Overall Study||6
11011153|NCT00751348|12188607|FG001|NOT COMPLETED|Overall Study||2
11011154|NCT00751400|12188613|FG000|STARTED|Overall Study||497
11011155|NCT00751400|12188613|FG000|Subjects Provided Drug|Overall Study||497
11011156|NCT00751400|12188613|FG000|Subjects Consumed Drug|Overall Study||485
11011157|NCT00751400|12188613|FG000|Subjects Provided Detailed Use Data|Overall Study||467
11011158|NCT00751400|12188613|FG000|COMPLETED|Overall Study||487
11011159|NCT00751400|12188613|FG000|NOT COMPLETED|Overall Study||10
11011160|NCT00751530|12188619|FG000|STARTED|Overall Study||332
11011161|NCT00751530|12188620|FG001|STARTED|Overall Study||110
11011162|NCT00751530|12188619|FG000|COMPLETED|Overall Study||332
11011163|NCT00751530|12188620|FG001|COMPLETED|Overall Study||110
11011164|NCT00751530|12188619|FG000|NOT COMPLETED|Overall Study||0
11011165|NCT00751530|12188620|FG001|NOT COMPLETED|Overall Study||0
11011166|NCT00751621|12188626|FG000|STARTED|Overall Study||40
11011167|NCT00751621|12188626|FG000|COMPLETED|Overall Study||36
11011168|NCT00751621|12188626|FG000|NOT COMPLETED|Overall Study||4
11011169|NCT00751634|12188632|FG000|STARTED|Overall Study||20
11011170|NCT00751634|12188632|FG000|COMPLETED|Overall Study||20
11011171|NCT00751634|12188632|FG000|NOT COMPLETED|Overall Study||0
11011172|NCT00751777|12188639|FG000|STARTED|Overall Study||81
11011173|NCT00751777|12188640|FG001|STARTED|Overall Study||39
11011174|NCT00751777|12188639|FG000|COMPLETED|Overall Study|Day 380: study completion for LT group|70
11011175|NCT00751777|12188640|FG001|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
11011176|NCT00751777|12188639|FG000|NOT COMPLETED|Overall Study||11
11011177|NCT00751777|12188640|FG001|NOT COMPLETED|Overall Study||3
11011178|NCT00751790|12188646|FG000|STARTED|Overall Study||120
11011179|NCT00751790|12188646|FG000|COMPLETED|Overall Study||115
11011180|NCT00751790|12188646|FG000|NOT COMPLETED|Overall Study||5
11011181|NCT00751881|12188653|FG000|STARTED|Core Treatment Period|Randomized|389
11011182|NCT00751881|12188654|FG001|STARTED|Core Treatment Period|Randomized|408
11011183|NCT00751881|12188655|FG002|STARTED|Core Treatment Period|Randomized|372
11011184|NCT00751881|12188653|FG000|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
11011185|NCT00751881|12188654|FG001|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
11011186|NCT00751881|12188655|FG002|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
11011187|NCT00751881|12188653|FG000|COMPLETED|Core Treatment Period||263
11011188|NCT00751881|12188654|FG001|COMPLETED|Core Treatment Period||273
11011189|NCT00751881|12188655|FG002|COMPLETED|Core Treatment Period||244
11011190|NCT00751881|12188653|FG000|NOT COMPLETED|Core Treatment Period||126
11011191|NCT00751881|12188654|FG001|NOT COMPLETED|Core Treatment Period||135
11011192|NCT00751881|12188655|FG002|NOT COMPLETED|Core Treatment Period||128
11011193|NCT00751881|12188653|FG000|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
11011194|NCT00751881|12188654|FG001|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
11011195|NCT00751881|12188655|FG002|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
11011196|NCT00751881|12188653|FG000|COMPLETED|Extension Study Period||188
11011197|NCT00751881|12188654|FG001|COMPLETED|Extension Study Period||194
11011198|NCT00751881|12188655|FG002|COMPLETED|Extension Study Period||167
11011199|NCT00751881|12188653|FG000|NOT COMPLETED|Extension Study Period||65
11011200|NCT00751881|12188654|FG001|NOT COMPLETED|Extension Study Period||71
11011201|NCT00751881|12188655|FG002|NOT COMPLETED|Extension Study Period||66
11011202|NCT00751972|12188671|FG000|STARTED|Overall Study||140
11011203|NCT00751972|12188672|FG001|STARTED|Overall Study||499
11011204|NCT00751972|12188671|FG000|COMPLETED|Overall Study||140
11011205|NCT00751972|12188672|FG001|COMPLETED|Overall Study||499
11011206|NCT00751972|12188671|FG000|NOT COMPLETED|Overall Study||0
11011207|NCT00751972|12188672|FG001|NOT COMPLETED|Overall Study||0
11011208|NCT00751998|12188677|FG000|STARTED|Overall Study||297
11011209|NCT00751998|12188677|FG000|COMPLETED|Overall Study||277
11011210|NCT00751998|12188677|FG000|NOT COMPLETED|Overall Study||20
11056702|NCT00995722|12238367|FG000|COMPLETED|Double Blinded: 16 Weeks||5
11056703|NCT00995722|12238368|FG001|COMPLETED|Double Blinded: 16 Weeks||4
11056704|NCT00995722|12238367|FG000|NOT COMPLETED|Double Blinded: 16 Weeks||1
11056705|NCT00995722|12238368|FG001|NOT COMPLETED|Double Blinded: 16 Weeks||1
11056706|NCT00995722|12238367|FG000|STARTED|Overall Study: 36 Weeks||5
11056707|NCT00995722|12238368|FG001|STARTED|Overall Study: 36 Weeks||4
11056708|NCT00995722|12238367|FG000|COMPLETED|Overall Study: 36 Weeks||3
11056709|NCT00995722|12238368|FG001|COMPLETED|Overall Study: 36 Weeks||2
11056710|NCT00995722|12238367|FG000|NOT COMPLETED|Overall Study: 36 Weeks||2
11056711|NCT00995722|12238368|FG001|NOT COMPLETED|Overall Study: 36 Weeks||2
11056712|NCT00995761|12238374|FG000|STARTED|Overall Study||48
11056713|NCT00995761|12238374|FG000|COMPLETED|Overall Study||48
11056714|NCT00995761|12238374|FG000|NOT COMPLETED|Overall Study||0
11056715|NCT00995774|12238380|FG000|STARTED|Training Period 1||7
11056716|NCT00995774|12238381|FG001|STARTED|Training Period 1||5
11056717|NCT00995774|12238380|FG000|COMPLETED|Training Period 1||7
11056718|NCT00995774|12238381|FG001|COMPLETED|Training Period 1||5
11056719|NCT00995774|12238380|FG000|NOT COMPLETED|Training Period 1||0
11056720|NCT00995774|12238381|FG001|NOT COMPLETED|Training Period 1||0
11056721|NCT00995774|12238380|FG000|STARTED|Washout Period||7
11056722|NCT00995774|12238381|FG001|STARTED|Washout Period||5
11056723|NCT00995774|12238380|FG000|COMPLETED|Washout Period||7
11056724|NCT00995774|12238381|FG001|COMPLETED|Washout Period||5
11056725|NCT00995774|12238380|FG000|NOT COMPLETED|Washout Period||0
11056726|NCT00995774|12238381|FG001|NOT COMPLETED|Washout Period||0
11056727|NCT00995774|12238380|FG000|STARTED|Training Period 2||7
11056728|NCT00995774|12238381|FG001|STARTED|Training Period 2||5
11056729|NCT00995774|12238380|FG000|COMPLETED|Training Period 2||5
11056730|NCT00995774|12238381|FG001|COMPLETED|Training Period 2||5
11056731|NCT00995774|12238380|FG000|NOT COMPLETED|Training Period 2||2
11056732|NCT00995774|12238381|FG001|NOT COMPLETED|Training Period 2||0
11056733|NCT00995865|12238390|FG000|STARTED|Overall Study||24
11056734|NCT00995865|12238391|FG001|STARTED|Overall Study||24
11056735|NCT00995865|12238392|FG002|STARTED|Overall Study||12
11056736|NCT00995865|12238390|FG000|COMPLETED|Overall Study||22
11056737|NCT00995865|12238391|FG001|COMPLETED|Overall Study||24
11056738|NCT00995865|12238392|FG002|COMPLETED|Overall Study||11
11056739|NCT00995865|12238390|FG000|NOT COMPLETED|Overall Study||2
11056740|NCT00995865|12238391|FG001|NOT COMPLETED|Overall Study||0
11056741|NCT00995865|12238392|FG002|NOT COMPLETED|Overall Study||1
11056742|NCT00995904|12238405|FG000|STARTED|Visit 2 (Randomization)||4
11011211|NCT00752089|12188681|FG000|STARTED|Overall Study||20
11011212|NCT00752089|12188681|FG000|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
11011213|NCT00752089|12188681|FG000|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
11011214|NCT00752089|12188681|FG000|Received NaF|Overall Study||18
11011215|NCT00752089|12188681|FG000|Received Placebo|Overall Study||18
11011216|NCT00752089|12188681|FG000|COMPLETED|Overall Study||14
11011217|NCT00752089|12188681|FG000|NOT COMPLETED|Overall Study||6
11011218|NCT00752102|12188694|FG000|STARTED|Overall Study||22
11011219|NCT00752102|12188695|FG001|STARTED|Overall Study||22
11011220|NCT00752102|12188694|FG000|COMPLETED|Overall Study||19
11011221|NCT00752102|12188695|FG001|COMPLETED|Overall Study||21
11011222|NCT00752102|12188694|FG000|NOT COMPLETED|Overall Study||3
11011223|NCT00752102|12188695|FG001|NOT COMPLETED|Overall Study||1
11011224|NCT00752128|12188701|FG000|STARTED|Overall Study||2349
11011225|NCT00752128|12188701|FG000|COMPLETED|Overall Study||2345
11011226|NCT00752128|12188701|FG000|NOT COMPLETED|Overall Study||4
11011227|NCT00752206|12188708|FG000|STARTED|Overall Study||19
11011228|NCT00752206|12188709|FG001|STARTED|Overall Study||19
11011229|NCT00752206|12188708|FG000|COMPLETED|Overall Study||10
11011230|NCT00752206|12188709|FG001|COMPLETED|Overall Study||8
11011231|NCT00752206|12188708|FG000|NOT COMPLETED|Overall Study||9
11011232|NCT00752206|12188709|FG001|NOT COMPLETED|Overall Study||11
11011233|NCT00752219|12188717|FG000|STARTED|Overall Study||102
11011234|NCT00752219|12188718|FG001|STARTED|Overall Study||102
11011235|NCT00752219|12188717|FG000|Treated|Overall Study||101
11011236|NCT00752219|12188718|FG001|Treated|Overall Study||102
11011237|NCT00752219|12188717|FG000|COMPLETED|Overall Study||91
11011238|NCT00752219|12188718|FG001|COMPLETED|Overall Study||96
11011239|NCT00752219|12188717|FG000|NOT COMPLETED|Overall Study||11
11011240|NCT00752219|12188718|FG001|NOT COMPLETED|Overall Study||6
11011241|NCT00752232|12188731|FG000|STARTED|Overall Study||6
11011242|NCT00752232|12188732|FG001|STARTED|Overall Study||6
11011243|NCT00752232|12188733|FG002|STARTED|Overall Study||6
11011244|NCT00752232|12188734|FG003|STARTED|Overall Study||6
11011245|NCT00752232|12188735|FG004|STARTED|Overall Study||6
11011246|NCT00752232|12188736|FG005|STARTED|Overall Study||6
11011247|NCT00752232|12188737|FG006|STARTED|Overall Study||4
11011248|NCT00752232|12188731|FG000|COMPLETED|Overall Study||4
11011249|NCT00752232|12188732|FG001|COMPLETED|Overall Study||6
11011250|NCT00752232|12188733|FG002|COMPLETED|Overall Study||5
11011251|NCT00752232|12188734|FG003|COMPLETED|Overall Study||5
11011252|NCT00752232|12188735|FG004|COMPLETED|Overall Study||3
11011253|NCT00752232|12188736|FG005|COMPLETED|Overall Study||5
11011254|NCT00752232|12188737|FG006|COMPLETED|Overall Study||4
11011255|NCT00752232|12188731|FG000|NOT COMPLETED|Overall Study||2
11011256|NCT00752232|12188732|FG001|NOT COMPLETED|Overall Study||0
11011257|NCT00752232|12188733|FG002|NOT COMPLETED|Overall Study||1
11011258|NCT00752232|12188734|FG003|NOT COMPLETED|Overall Study||1
11011259|NCT00752232|12188735|FG004|NOT COMPLETED|Overall Study||3
11011260|NCT00752232|12188736|FG005|NOT COMPLETED|Overall Study||1
11011261|NCT00752232|12188737|FG006|NOT COMPLETED|Overall Study||0
11011262|NCT00752557|12188757|FG000|STARTED|Overall Study||17
11011263|NCT00752557|12188758|FG001|STARTED|Overall Study||16
11011264|NCT00752557|12188759|FG002|STARTED|Overall Study||17
11011265|NCT00752557|12188757|FG000|COMPLETED|Overall Study||12
11011266|NCT00752557|12188758|FG001|COMPLETED|Overall Study||11
11011267|NCT00752557|12188759|FG002|COMPLETED|Overall Study||11
11011268|NCT00752557|12188757|FG000|NOT COMPLETED|Overall Study||5
11011269|NCT00752557|12188758|FG001|NOT COMPLETED|Overall Study||5
11011270|NCT00752557|12188759|FG002|NOT COMPLETED|Overall Study||6
11011271|NCT00752609|12188771|FG000|STARTED|Overall Study||53
11011272|NCT00752609|12188772|FG001|STARTED|Overall Study||49
11011273|NCT00752609|12188771|FG000|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
11011274|NCT00752609|12188772|FG001|Full Analysis Set|Overall Study||49
11011275|NCT00752609|12188771|FG000|COMPLETED|Overall Study||44
11011276|NCT00752609|12188772|FG001|COMPLETED|Overall Study||47
11011277|NCT00752609|12188771|FG000|NOT COMPLETED|Overall Study||9
11011278|NCT00752609|12188772|FG001|NOT COMPLETED|Overall Study||2
11011279|NCT00752622|12188781|FG000|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
11011280|NCT00752622|12188781|FG000|COMPLETED|Induction Phase||65
11011281|NCT00752622|12188781|FG000|NOT COMPLETED|Induction Phase||35
11011282|NCT00752622|12188781|FG000|STARTED|Observational Phase||65
11011283|NCT00752622|12188781|FG000|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
11011284|NCT00752622|12188781|FG000|NOT COMPLETED|Observational Phase||43
11011285|NCT00752622|12188781|FG000|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
11011286|NCT00752622|12188781|FG000|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
11011287|NCT00752622|12188781|FG000|NOT COMPLETED|Interventional Phase||8
11011288|NCT00752726|12188788|FG000|STARTED|Overall Study||65
11011289|NCT00752726|12188789|FG001|STARTED|Overall Study||66
11011290|NCT00752726|12188788|FG000|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
11011291|NCT00752726|12188789|FG001|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
11011292|NCT00752726|12188788|FG000|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
11011293|NCT00752726|12188789|FG001|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
11011294|NCT00752726|12188788|FG000|COMPLETED|Overall Study||54
11011295|NCT00752726|12188789|FG001|COMPLETED|Overall Study||53
11011296|NCT00752726|12188788|FG000|NOT COMPLETED|Overall Study||11
11011297|NCT00752726|12188789|FG001|NOT COMPLETED|Overall Study||13
11011298|NCT00752791|12188795|FG000|STARTED|Overall Study||59
11011299|NCT00752791|12188795|FG000|COMPLETED|Overall Study||43
11011300|NCT00752791|12188795|FG000|NOT COMPLETED|Overall Study||16
11011301|NCT00752856|12188801|FG000|STARTED|Overall Study||26
11011302|NCT00752856|12188802|FG001|STARTED|Overall Study||25
11011303|NCT00752856|12188801|FG000|COMPLETED|Overall Study||26
11011304|NCT00752856|12188802|FG001|COMPLETED|Overall Study||24
11011305|NCT00752856|12188801|FG000|NOT COMPLETED|Overall Study||0
11011306|NCT00752856|12188802|FG001|NOT COMPLETED|Overall Study||1
11011307|NCT00752895|12188810|FG000|STARTED|Overall Study||147
11011308|NCT00752895|12188811|FG001|STARTED|Overall Study||146
11011309|NCT00752895|12188810|FG000|COMPLETED|Overall Study||139
11011310|NCT00752895|12188811|FG001|COMPLETED|Overall Study||143
11011311|NCT00752895|12188810|FG000|NOT COMPLETED|Overall Study||8
11011312|NCT00752895|12188811|FG001|NOT COMPLETED|Overall Study||3
11011313|NCT00752908|12188819|FG000|STARTED|Overall Study||14
11011314|NCT00752908|12188820|FG001|STARTED|Overall Study||13
11011315|NCT00752908|12188819|FG000|COMPLETED|Overall Study||14
11011316|NCT00752908|12188820|FG001|COMPLETED|Overall Study||13
11011317|NCT00752908|12188819|FG000|NOT COMPLETED|Overall Study||0
11011318|NCT00752908|12188820|FG001|NOT COMPLETED|Overall Study||0
11011319|NCT00752973|12188826|FG000|STARTED|Overall Study||12
11011320|NCT00752973|12188826|FG000|COMPLETED|Overall Study||12
11011321|NCT00752973|12188826|FG000|NOT COMPLETED|Overall Study||0
11011322|NCT00753012|12188834|FG000|STARTED|Overall Study||15
11011323|NCT00753012|12188835|FG001|STARTED|Overall Study||9
11011324|NCT00753012|12188834|FG000|COMPLETED|Overall Study||7
11011325|NCT00753012|12188835|FG001|COMPLETED|Overall Study||8
11011326|NCT00753012|12188834|FG000|NOT COMPLETED|Overall Study||8
11011327|NCT00753012|12188835|FG001|NOT COMPLETED|Overall Study||1
11011328|NCT00753142|12188845|FG000|STARTED|Overall Study||8
11011329|NCT00753142|12188846|FG001|STARTED|Overall Study||7
11011330|NCT00753142|12188847|FG002|STARTED|Overall Study||13
11011331|NCT00753142|12188845|FG000|COMPLETED|Overall Study||8
11011332|NCT00753142|12188846|FG001|COMPLETED|Overall Study||7
11011333|NCT00753142|12188847|FG002|COMPLETED|Overall Study||13
11011334|NCT00753142|12188845|FG000|NOT COMPLETED|Overall Study||0
11011335|NCT00753142|12188846|FG001|NOT COMPLETED|Overall Study||0
11011336|NCT00753142|12188847|FG002|NOT COMPLETED|Overall Study||0
11011337|NCT00753220|12188855|FG000|STARTED|Overall Study||7
11011338|NCT00753220|12188855|FG000|COMPLETED|Overall Study||2
11011339|NCT00753220|12188855|FG000|NOT COMPLETED|Overall Study||5
11011340|NCT00753272|12188861|FG000|STARTED|Overall Study||21893
11011341|NCT00753272|12188862|FG001|STARTED|Overall Study||21802
11011342|NCT00753272|12188861|FG000|COMPLETED|Overall Study||16911
11011343|NCT00753272|12188862|FG001|COMPLETED|Overall Study||16895
11011344|NCT00753272|12188861|FG000|NOT COMPLETED|Overall Study||4982
11011345|NCT00753272|12188862|FG001|NOT COMPLETED|Overall Study||4907
11011346|NCT00753298|12188873|FG000|STARTED|Overall Study||97
11011347|NCT00753298|12188874|FG001|STARTED|Overall Study||98
11011348|NCT00753298|12188873|FG000|COMPLETED|Overall Study||89
11011349|NCT00753298|12188874|FG001|COMPLETED|Overall Study||94
11011350|NCT00753298|12188873|FG000|NOT COMPLETED|Overall Study||8
11011351|NCT00753298|12188874|FG001|NOT COMPLETED|Overall Study||4
11011352|NCT00753337|12188880|FG000|STARTED|Overall Study||123
11011353|NCT00753337|12188880|FG000|COMPLETED|Overall Study||123
11011354|NCT00753337|12188880|FG000|NOT COMPLETED|Overall Study||0
11011355|NCT00753363|12188887|FG000|STARTED|Overall Study||59
11011356|NCT00753363|12188888|FG001|STARTED|Overall Study||60
11011357|NCT00753363|12188887|FG000|COMPLETED|Overall Study||19
11011358|NCT00753363|12188888|FG001|COMPLETED|Overall Study||21
11011359|NCT00753363|12188887|FG000|NOT COMPLETED|Overall Study||40
11011360|NCT00753363|12188888|FG001|NOT COMPLETED|Overall Study||39
11011361|NCT00753415|12188899|FG000|STARTED|Part A||3
11011362|NCT00753415|12188900|FG001|STARTED|Part A||3
11011363|NCT00753415|12188901|FG002|STARTED|Part A||10
11011364|NCT00753415|12188902|FG003|STARTED|Part A||11
11011365|NCT00753415|12188903|FG004|STARTED|Part A||10
11011366|NCT00753415|12188904|FG005|STARTED|Part A||0
11011367|NCT00753415|12188905|FG006|STARTED|Part A||0
11011368|NCT00753415|12188906|FG007|STARTED|Part A||0
11011369|NCT00753415|12188907|FG008|STARTED|Part A||0
11011370|NCT00753415|12188908|FG009|STARTED|Part A||0
11011371|NCT00753415|12188899|FG000|COMPLETED|Part A||2
11011372|NCT00753415|12188900|FG001|COMPLETED|Part A||3
11011373|NCT00753415|12188901|FG002|COMPLETED|Part A||8
11011374|NCT00753415|12188902|FG003|COMPLETED|Part A||9
11011375|NCT00753415|12188903|FG004|COMPLETED|Part A||10
11011376|NCT00753415|12188904|FG005|COMPLETED|Part A||0
11011377|NCT00753415|12188905|FG006|COMPLETED|Part A||0
11011378|NCT00753415|12188906|FG007|COMPLETED|Part A||0
11011379|NCT00753415|12188907|FG008|COMPLETED|Part A||0
11011380|NCT00753415|12188908|FG009|COMPLETED|Part A||0
11011381|NCT00753415|12188899|FG000|NOT COMPLETED|Part A||1
11011382|NCT00753415|12188900|FG001|NOT COMPLETED|Part A||0
11011383|NCT00753415|12188901|FG002|NOT COMPLETED|Part A||2
11011384|NCT00753415|12188902|FG003|NOT COMPLETED|Part A||2
11011385|NCT00753415|12188903|FG004|NOT COMPLETED|Part A||0
11011386|NCT00753415|12188904|FG005|NOT COMPLETED|Part A||0
11011387|NCT00753415|12188905|FG006|NOT COMPLETED|Part A||0
11011388|NCT00753415|12188906|FG007|NOT COMPLETED|Part A||0
11011389|NCT00753415|12188907|FG008|NOT COMPLETED|Part A||0
11011390|NCT00753415|12188908|FG009|NOT COMPLETED|Part A||0
11011391|NCT00753415|12188899|FG000|STARTED|Part B||0
11011392|NCT00753415|12188900|FG001|STARTED|Part B||0
11011393|NCT00753415|12188901|FG002|STARTED|Part B||0
11011394|NCT00753415|12188902|FG003|STARTED|Part B||0
11011395|NCT00753415|12188903|FG004|STARTED|Part B||0
11011396|NCT00753415|12188904|FG005|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
11011397|NCT00753415|12188905|FG006|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
11011398|NCT00753415|12188906|FG007|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
11011399|NCT00753415|12188907|FG008|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
11011400|NCT00753415|12188908|FG009|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
11011401|NCT00753415|12188899|FG000|COMPLETED|Part B||0
11011402|NCT00753415|12188900|FG001|COMPLETED|Part B||0
11011403|NCT00753415|12188901|FG002|COMPLETED|Part B||0
11011404|NCT00753415|12188902|FG003|COMPLETED|Part B||0
11011405|NCT00753415|12188903|FG004|COMPLETED|Part B||0
11011406|NCT00753415|12188904|FG005|COMPLETED|Part B||1
11011407|NCT00753415|12188905|FG006|COMPLETED|Part B||2
11011408|NCT00753415|12188906|FG007|COMPLETED|Part B||6
11011409|NCT00753415|12188907|FG008|COMPLETED|Part B||6
11011410|NCT00753415|12188908|FG009|COMPLETED|Part B||8
11011411|NCT00753415|12188899|FG000|NOT COMPLETED|Part B||0
11011412|NCT00753415|12188900|FG001|NOT COMPLETED|Part B||0
11011413|NCT00753415|12188901|FG002|NOT COMPLETED|Part B||0
11011414|NCT00753415|12188902|FG003|NOT COMPLETED|Part B||0
11011415|NCT00753415|12188903|FG004|NOT COMPLETED|Part B||0
11011416|NCT00753415|12188904|FG005|NOT COMPLETED|Part B||0
11011417|NCT00753415|12188905|FG006|NOT COMPLETED|Part B||0
11011418|NCT00753415|12188906|FG007|NOT COMPLETED|Part B||1
11011419|NCT00753415|12188907|FG008|NOT COMPLETED|Part B||3
11011420|NCT00753415|12188908|FG009|NOT COMPLETED|Part B||1
11011421|NCT00753454|12188932|FG000|STARTED|Overall Study||168
11011422|NCT00753454|12188932|FG000|COMPLETED|Overall Study||154
11011423|NCT00753454|12188932|FG000|NOT COMPLETED|Overall Study||14
11011424|NCT00753506|12188938|FG000|STARTED|Overall Study||33
11011425|NCT00753506|12188939|FG001|STARTED|Overall Study||33
11011426|NCT00753506|12188938|FG000|COMPLETED|Overall Study||26
11011427|NCT00753506|12188939|FG001|COMPLETED|Overall Study||31
11011428|NCT00753506|12188938|FG000|NOT COMPLETED|Overall Study||7
11011429|NCT00753506|12188939|FG001|NOT COMPLETED|Overall Study||2
11011430|NCT00753519|12188947|FG000|STARTED|Overall Study||13
11011431|NCT00753519|12188948|FG001|STARTED|Overall Study||15
11011432|NCT00753519|12188947|FG000|COMPLETED|Overall Study||13
11011433|NCT00753519|12188948|FG001|COMPLETED|Overall Study||13
11011434|NCT00753519|12188947|FG000|NOT COMPLETED|Overall Study||0
11011435|NCT00753519|12188948|FG001|NOT COMPLETED|Overall Study||2
11011436|NCT00753623|12188958|FG000|STARTED|Phase I (14 Days)||11
11011437|NCT00753623|12188959|FG001|STARTED|Phase I (14 Days)||12
11011438|NCT00753623|12188958|FG000|COMPLETED|Phase I (14 Days)||9
11011439|NCT00753623|12188959|FG001|COMPLETED|Phase I (14 Days)||8
11011440|NCT00753623|12188958|FG000|NOT COMPLETED|Phase I (14 Days)||2
11011441|NCT00753623|12188959|FG001|NOT COMPLETED|Phase I (14 Days)||4
11011442|NCT00753623|12188958|FG000|STARTED|Washout (7 Days)||9
11011443|NCT00753623|12188959|FG001|STARTED|Washout (7 Days)||8
11011444|NCT00753623|12188958|FG000|COMPLETED|Washout (7 Days)||8
11011445|NCT00753623|12188959|FG001|COMPLETED|Washout (7 Days)||8
11011446|NCT00753623|12188958|FG000|NOT COMPLETED|Washout (7 Days)||1
11011447|NCT00753623|12188959|FG001|NOT COMPLETED|Washout (7 Days)||0
11011448|NCT00753623|12188958|FG000|STARTED|Phase II (14 Days)||8
11011449|NCT00753623|12188959|FG001|STARTED|Phase II (14 Days)||8
11011450|NCT00753623|12188958|FG000|COMPLETED|Phase II (14 Days)||8
11011451|NCT00753623|12188959|FG001|COMPLETED|Phase II (14 Days)||7
11011452|NCT00753623|12188958|FG000|NOT COMPLETED|Phase II (14 Days)||0
11011453|NCT00753623|12188959|FG001|NOT COMPLETED|Phase II (14 Days)||1
11011454|NCT00753636|12188965|FG000|STARTED|Overall Study||31
11011455|NCT00753636|12188965|FG000|COMPLETED|Overall Study||25
11011456|NCT00753636|12188965|FG000|NOT COMPLETED|Overall Study||6
11011457|NCT00753649|12188971|FG000|STARTED|Overall Study||112
11011458|NCT00753649|12188972|FG001|STARTED|Overall Study||112
11011459|NCT00753649|12188971|FG000|COMPLETED|Overall Study||105
11011460|NCT00753649|12188972|FG001|COMPLETED|Overall Study||112
11011461|NCT00753649|12188971|FG000|NOT COMPLETED|Overall Study||7
11011462|NCT00753649|12188972|FG001|NOT COMPLETED|Overall Study||0
11011463|NCT00753675|12188981|FG000|STARTED|Overall Study||59
11011464|NCT00753675|12188982|FG001|STARTED|Overall Study||59
11011465|NCT00753675|12188983|FG002|STARTED|Overall Study||56
11011466|NCT00753675|12188981|FG000|COMPLETED|Overall Study||0
11011467|NCT00753675|12188982|FG001|COMPLETED|Overall Study||0
11011468|NCT00753675|12188983|FG002|COMPLETED|Overall Study||0
11011469|NCT00753675|12188981|FG000|NOT COMPLETED|Overall Study||59
11011470|NCT00753675|12188982|FG001|NOT COMPLETED|Overall Study||59
11011471|NCT00753675|12188983|FG002|NOT COMPLETED|Overall Study||56
11011472|NCT00753688|12188993|FG000|STARTED|Overall Study||123
11011473|NCT00753688|12188994|FG001|STARTED|Overall Study||246
11011474|NCT00753688|12188993|FG000|Ongoing - in Follow-up|Overall Study||15
11011475|NCT00753688|12188994|FG001|Ongoing - in Follow-up|Overall Study||31
11011476|NCT00753688|12188993|FG000|COMPLETED|Overall Study||0
11011477|NCT00753688|12188994|FG001|COMPLETED|Overall Study||0
11011478|NCT00753688|12188993|FG000|NOT COMPLETED|Overall Study||123
11011479|NCT00753688|12188994|FG001|NOT COMPLETED|Overall Study||246
11011480|NCT00753714|12189002|FG000|STARTED|Overall Study||61
11011481|NCT00753714|12189003|FG001|STARTED|Overall Study||63
11011482|NCT00753714|12189002|FG000|COMPLETED|Overall Study||1
11011483|NCT00753714|12189003|FG001|COMPLETED|Overall Study||1
11011484|NCT00753714|12189002|FG000|NOT COMPLETED|Overall Study||60
11011485|NCT00753714|12189003|FG001|NOT COMPLETED|Overall Study||62
11011486|NCT00753766|12189014|FG000|STARTED|Overall Study||1
11011487|NCT00753766|12189015|FG001|STARTED|Overall Study||0
11011488|NCT00753766|12189014|FG000|COMPLETED|Overall Study||0
11011489|NCT00753766|12189015|FG001|COMPLETED|Overall Study||0
11011490|NCT00753766|12189014|FG000|NOT COMPLETED|Overall Study||1
11011491|NCT00753766|12189015|FG001|NOT COMPLETED|Overall Study||0
11011492|NCT00753896|12189022|FG000|STARTED|Overall Study||134
11011493|NCT00753896|12189022|FG000|COMPLETED|Overall Study||118
11011494|NCT00753896|12189022|FG000|NOT COMPLETED|Overall Study||16
11011495|NCT00753922|12189030|FG000|STARTED|Overall Study||552
11011496|NCT00753922|12189031|FG001|STARTED|Overall Study||251
11011497|NCT00753922|12189032|FG002|STARTED|Overall Study||145
11011498|NCT00753922|12189033|FG003|STARTED|Overall Study||60
11011499|NCT00753922|12189030|FG000|COMPLETED|Overall Study||306
11011500|NCT00753922|12189031|FG001|COMPLETED|Overall Study||157
11011501|NCT00753922|12189032|FG002|COMPLETED|Overall Study||82
11011502|NCT00753922|12189033|FG003|COMPLETED|Overall Study||37
11011503|NCT00753922|12189030|FG000|NOT COMPLETED|Overall Study||246
11011504|NCT00753922|12189031|FG001|NOT COMPLETED|Overall Study||94
11011505|NCT00753922|12189032|FG002|NOT COMPLETED|Overall Study||63
11011506|NCT00753922|12189033|FG003|NOT COMPLETED|Overall Study||23
11011507|NCT00753935|12189045|FG000|STARTED|Overall Study||45
11011508|NCT00753935|12189046|FG001|STARTED|Overall Study||47
11011509|NCT00753935|12189045|FG000|COMPLETED|Overall Study||45
11011510|NCT00753935|12189046|FG001|COMPLETED|Overall Study||47
11011511|NCT00753935|12189045|FG000|NOT COMPLETED|Overall Study||0
11011512|NCT00753935|12189046|FG001|NOT COMPLETED|Overall Study||0
11011513|NCT00753948|12189055|FG000|STARTED|Overall Study||9
11011514|NCT00753948|12189056|FG001|STARTED|Overall Study||7
11011515|NCT00753948|12189057|FG002|STARTED|Overall Study||7
11011516|NCT00753948|12189055|FG000|COMPLETED|Overall Study||9
11011517|NCT00753948|12189056|FG001|COMPLETED|Overall Study||7
11011518|NCT00753948|12189057|FG002|COMPLETED|Overall Study||7
11011519|NCT00753948|12189055|FG000|NOT COMPLETED|Overall Study||0
11011520|NCT00753948|12189056|FG001|NOT COMPLETED|Overall Study||0
11011521|NCT00753948|12189057|FG002|NOT COMPLETED|Overall Study||0
11011522|NCT00754065|12189067|FG000|STARTED|Overall Study||203
11011523|NCT00754065|12189068|FG001|STARTED|Overall Study||206
11011524|NCT00754065|12189067|FG000|Participants Received Treatment|Overall Study||191
11011525|NCT00754065|12189068|FG001|Participants Received Treatment|Overall Study||204
11011526|NCT00754065|12189067|FG000|Cycle 6|Overall Study||141
11011527|NCT00754065|12189068|FG001|Cycle 6|Overall Study||153
11011528|NCT00754065|12189067|FG000|COMPLETED|Overall Study||122
11011529|NCT00754065|12189068|FG001|COMPLETED|Overall Study||126
11011530|NCT00754065|12189067|FG000|NOT COMPLETED|Overall Study||81
11011531|NCT00754065|12189068|FG001|NOT COMPLETED|Overall Study||80
11011532|NCT00754130|12189080|FG000|STARTED|Period 1 (5 Days)||2
11011533|NCT00754130|12189081|FG001|STARTED|Period 1 (5 Days)||2
11011534|NCT00754130|12189082|FG002|STARTED|Period 1 (5 Days)||4
11011535|NCT00754130|12189083|FG003|STARTED|Period 1 (5 Days)||2
11011536|NCT00754130|12189084|FG004|STARTED|Period 1 (5 Days)||2
11011537|NCT00754130|12189085|FG005|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
11011538|NCT00754130|12189080|FG000|COMPLETED|Period 1 (5 Days)||2
11011539|NCT00754130|12189081|FG001|COMPLETED|Period 1 (5 Days)||2
11011540|NCT00754130|12189082|FG002|COMPLETED|Period 1 (5 Days)||4
11011541|NCT00754130|12189083|FG003|COMPLETED|Period 1 (5 Days)||2
11011542|NCT00754130|12189084|FG004|COMPLETED|Period 1 (5 Days)||2
11011543|NCT00754130|12189085|FG005|COMPLETED|Period 1 (5 Days)||4
11011544|NCT00754130|12189080|FG000|NOT COMPLETED|Period 1 (5 Days)||0
11011545|NCT00754130|12189081|FG001|NOT COMPLETED|Period 1 (5 Days)||0
11011546|NCT00754130|12189082|FG002|NOT COMPLETED|Period 1 (5 Days)||0
11011547|NCT00754130|12189083|FG003|NOT COMPLETED|Period 1 (5 Days)||0
11011548|NCT00754130|12189084|FG004|NOT COMPLETED|Period 1 (5 Days)||0
11011549|NCT00754130|12189085|FG005|NOT COMPLETED|Period 1 (5 Days)||0
11011550|NCT00754130|12189080|FG000|STARTED|Washout Period (>=8 Days)||2
11011551|NCT00754130|12189081|FG001|STARTED|Washout Period (>=8 Days)||2
11011552|NCT00754130|12189082|FG002|STARTED|Washout Period (>=8 Days)||4
11011553|NCT00754130|12189083|FG003|STARTED|Washout Period (>=8 Days)||2
11011554|NCT00754130|12189084|FG004|STARTED|Washout Period (>=8 Days)||2
11011555|NCT00754130|12189085|FG005|STARTED|Washout Period (>=8 Days)||4
11011556|NCT00754130|12189080|FG000|COMPLETED|Washout Period (>=8 Days)||2
11011557|NCT00754130|12189081|FG001|COMPLETED|Washout Period (>=8 Days)||2
11011558|NCT00754130|12189082|FG002|COMPLETED|Washout Period (>=8 Days)||4
11011559|NCT00754130|12189083|FG003|COMPLETED|Washout Period (>=8 Days)||2
11011560|NCT00754130|12189084|FG004|COMPLETED|Washout Period (>=8 Days)||2
11011561|NCT00754130|12189085|FG005|COMPLETED|Washout Period (>=8 Days)||4
11011562|NCT00754130|12189080|FG000|NOT COMPLETED|Washout Period (>=8 Days)||0
11011563|NCT00754130|12189081|FG001|NOT COMPLETED|Washout Period (>=8 Days)||0
11011564|NCT00754130|12189082|FG002|NOT COMPLETED|Washout Period (>=8 Days)||0
11011565|NCT00754130|12189083|FG003|NOT COMPLETED|Washout Period (>=8 Days)||0
11011566|NCT00754130|12189084|FG004|NOT COMPLETED|Washout Period (>=8 Days)||0
11011567|NCT00754130|12189085|FG005|NOT COMPLETED|Washout Period (>=8 Days)||0
11011568|NCT00754130|12189080|FG000|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
11011569|NCT00754130|12189081|FG001|STARTED|Period 2 (5 Days)||2
11011570|NCT00754130|12189082|FG002|STARTED|Period 2 (5 Days)||4
11011571|NCT00754130|12189083|FG003|STARTED|Period 2 (5 Days)||2
11011572|NCT00754130|12189084|FG004|STARTED|Period 2 (5 Days)||2
11011573|NCT00754130|12189085|FG005|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
11011574|NCT00754130|12189080|FG000|COMPLETED|Period 2 (5 Days)||2
11011575|NCT00754130|12189081|FG001|COMPLETED|Period 2 (5 Days)||2
11011576|NCT00754130|12189082|FG002|COMPLETED|Period 2 (5 Days)||4
11011577|NCT00754130|12189083|FG003|COMPLETED|Period 2 (5 Days)||2
11011578|NCT00754130|12189084|FG004|COMPLETED|Period 2 (5 Days)||2
11011579|NCT00754130|12189085|FG005|COMPLETED|Period 2 (5 Days)||4
11011580|NCT00754130|12189080|FG000|NOT COMPLETED|Period 2 (5 Days)||0
11011581|NCT00754130|12189081|FG001|NOT COMPLETED|Period 2 (5 Days)||0
11011582|NCT00754130|12189082|FG002|NOT COMPLETED|Period 2 (5 Days)||0
11011583|NCT00754130|12189083|FG003|NOT COMPLETED|Period 2 (5 Days)||0
11011584|NCT00754130|12189084|FG004|NOT COMPLETED|Period 2 (5 Days)||0
11011585|NCT00754130|12189085|FG005|NOT COMPLETED|Period 2 (5 Days)||0
11011586|NCT00754156|12189103|FG000|STARTED|Overall Study||8
11011587|NCT00754156|12189104|FG001|STARTED|Overall Study||6
11011588|NCT00754156|12189103|FG000|COMPLETED|Overall Study||8
11011589|NCT00754156|12189104|FG001|COMPLETED|Overall Study||6
11011590|NCT00754156|12189103|FG000|NOT COMPLETED|Overall Study||0
11011591|NCT00754156|12189104|FG001|NOT COMPLETED|Overall Study||0
11011592|NCT00754234|12189116|FG000|STARTED|Overall Study|7 Menus were consumed in randomized order|16
11011593|NCT00754234|12189116|FG000|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
11011594|NCT00754234|12189116|FG000|NOT COMPLETED|Overall Study||3
11011595|NCT00754247|12189123|FG000|STARTED|Overall Study||10
11011596|NCT00754247|12189124|FG001|STARTED|Overall Study||10
11011597|NCT00754247|12189125|FG002|STARTED|Overall Study||10
11011598|NCT00754247|12189123|FG000|COMPLETED|Overall Study||5
11011599|NCT00754247|12189124|FG001|COMPLETED|Overall Study||5
11011600|NCT00754247|12189125|FG002|COMPLETED|Overall Study||5
11011601|NCT00754247|12189123|FG000|NOT COMPLETED|Overall Study||5
11011602|NCT00754247|12189124|FG001|NOT COMPLETED|Overall Study||5
11011603|NCT00754247|12189125|FG002|NOT COMPLETED|Overall Study||5
11011604|NCT00754325|12189135|FG000|STARTED|Initial Treatment||50
11011605|NCT00754325|12189136|FG001|STARTED|Initial Treatment||49
11011606|NCT00754325|12189135|FG000|COMPLETED|Initial Treatment||0
11011607|NCT00754325|12189136|FG001|COMPLETED|Initial Treatment||0
11011608|NCT00754325|12189135|FG000|NOT COMPLETED|Initial Treatment||50
11011609|NCT00754325|12189136|FG001|NOT COMPLETED|Initial Treatment||49
11011610|NCT00754325|12189135|FG000|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
11011611|NCT00754325|12189136|FG001|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
11011612|NCT00754325|12189135|FG000|COMPLETED|Progression and Cross-over||0
11011613|NCT00754325|12189136|FG001|COMPLETED|Progression and Cross-over||0
11011614|NCT00754325|12189135|FG000|NOT COMPLETED|Progression and Cross-over||0
11011615|NCT00754325|12189136|FG001|NOT COMPLETED|Progression and Cross-over||21
11011616|NCT00754338|12189147|FG000|STARTED|First Intervention for Phase1&Phase2||17
11011617|NCT00754338|12189148|FG001|STARTED|First Intervention for Phase1&Phase2||21
11011618|NCT00754338|12189149|FG002|STARTED|First Intervention for Phase1&Phase2||19
11011619|NCT00754338|12189150|FG003|STARTED|First Intervention for Phase1&Phase2||19
11011620|NCT00754338|12189147|FG000|COMPLETED|First Intervention for Phase1&Phase2||17
11011621|NCT00754338|12189148|FG001|COMPLETED|First Intervention for Phase1&Phase2||18
11011622|NCT00754338|12189149|FG002|COMPLETED|First Intervention for Phase1&Phase2||16
11011623|NCT00754338|12189150|FG003|COMPLETED|First Intervention for Phase1&Phase2||19
11011624|NCT00754338|12189147|FG000|NOT COMPLETED|First Intervention for Phase1&Phase2||0
11011625|NCT00754338|12189148|FG001|NOT COMPLETED|First Intervention for Phase1&Phase2||3
11011626|NCT00754338|12189149|FG002|NOT COMPLETED|First Intervention for Phase1&Phase2||3
11011627|NCT00754338|12189150|FG003|NOT COMPLETED|First Intervention for Phase1&Phase2||0
11011628|NCT00754338|12189147|FG000|STARTED|Second Intervention for Phase1&Phase2||17
11011629|NCT00754338|12189148|FG001|STARTED|Second Intervention for Phase1&Phase2||18
11011630|NCT00754338|12189149|FG002|STARTED|Second Intervention for Phase1&Phase2||16
11011631|NCT00754338|12189150|FG003|STARTED|Second Intervention for Phase1&Phase2||19
11011632|NCT00754338|12189147|FG000|COMPLETED|Second Intervention for Phase1&Phase2||17
11011633|NCT00754338|12189148|FG001|COMPLETED|Second Intervention for Phase1&Phase2||17
11011634|NCT00754338|12189149|FG002|COMPLETED|Second Intervention for Phase1&Phase2||16
11011635|NCT00754338|12189150|FG003|COMPLETED|Second Intervention for Phase1&Phase2||18
11011636|NCT00754338|12189147|FG000|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
11011637|NCT00754338|12189148|FG001|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
11011638|NCT00754338|12189149|FG002|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
11011639|NCT00754338|12189150|FG003|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
11011640|NCT00754377|12189164|FG000|STARTED|Overall Study||50
11011641|NCT00754377|12189165|FG001|STARTED|Overall Study||42
11011642|NCT00754377|12189164|FG000|COMPLETED|Overall Study||50
11011643|NCT00754377|12189165|FG001|COMPLETED|Overall Study||42
11011644|NCT00754377|12189164|FG000|NOT COMPLETED|Overall Study||0
11011645|NCT00754377|12189165|FG001|NOT COMPLETED|Overall Study||0
11011646|NCT00754390|12189173|FG000|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
11011647|NCT00754390|12189173|FG000|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
11011648|NCT00754390|12189173|FG000|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
11011649|NCT00754390|12189173|FG000|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
11011650|NCT00754390|12189173|FG000|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
11011651|NCT00754390|12189173|FG000|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
11011652|NCT00754390|12189173|FG000|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
11011653|NCT00754390|12189173|FG000|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
11011654|NCT00754390|12189173|FG000|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
11011655|NCT00754390|12189173|FG000|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
11011656|NCT00754390|12189173|FG000|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
11011657|NCT00754390|12189173|FG000|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
11011658|NCT00754442|12189182|FG000|STARTED|Overall Study|controls 11|11
11011659|NCT00754442|12189183|FG001|STARTED|Overall Study|patients 9|9
11011660|NCT00754442|12189182|FG000|COMPLETED|Overall Study||6
11011661|NCT00754442|12189183|FG001|COMPLETED|Overall Study||6
11011662|NCT00754442|12189182|FG000|NOT COMPLETED|Overall Study||5
11011663|NCT00754442|12189183|FG001|NOT COMPLETED|Overall Study||3
11011664|NCT00754468|12189192|FG000|STARTED|Overall Study||4
11011665|NCT00754468|12189193|FG001|STARTED|Overall Study||3
11011666|NCT00754468|12189192|FG000|COMPLETED|Overall Study||4
11011667|NCT00754468|12189193|FG001|COMPLETED|Overall Study||3
11011668|NCT00754468|12189192|FG000|NOT COMPLETED|Overall Study||0
11011669|NCT00754468|12189193|FG001|NOT COMPLETED|Overall Study||0
11011670|NCT00754494|12189204|FG000|STARTED|Overall Study||15
11011671|NCT00754494|12189205|FG001|STARTED|Overall Study||15
11011672|NCT00754494|12189206|FG002|STARTED|Overall Study||15
11011673|NCT00754494|12189204|FG000|COMPLETED|Overall Study||13
11011674|NCT00754494|12189205|FG001|COMPLETED|Overall Study||15
11011675|NCT00754494|12189206|FG002|COMPLETED|Overall Study||14
11011676|NCT00754494|12189204|FG000|NOT COMPLETED|Overall Study||2
11011677|NCT00754494|12189205|FG001|NOT COMPLETED|Overall Study||0
11011678|NCT00754494|12189206|FG002|NOT COMPLETED|Overall Study||1
11011679|NCT00754546|12189214|FG000|STARTED|Overall Study||20
11011680|NCT00754546|12189214|FG000|COMPLETED|Overall Study||20
11011681|NCT00754546|12189214|FG000|NOT COMPLETED|Overall Study||0
11011682|NCT00754559|12189224|FG000|STARTED|Overall Study||286
11011683|NCT00754559|12189224|FG000|COMPLETED|Overall Study||239
11011684|NCT00754559|12189224|FG000|NOT COMPLETED|Overall Study||47
11011685|NCT00754572|12189231|FG000|STARTED|Overall Study||418
11011686|NCT00754572|12189231|FG000|COMPLETED|Overall Study||347
11011687|NCT00754572|12189231|FG000|NOT COMPLETED|Overall Study||71
11011688|NCT00754624|12189235|FG000|STARTED|Overall Study||229
11011689|NCT00754624|12189235|FG000|COMPLETED|Overall Study||160
11011690|NCT00754624|12189235|FG000|NOT COMPLETED|Overall Study||69
11011691|NCT00754650|12189239|FG000|STARTED|Overall Study||2
11011692|NCT00754650|12189239|FG000|COMPLETED|Overall Study||0
11011693|NCT00754650|12189239|FG000|NOT COMPLETED|Overall Study||2
11011694|NCT00754741|12189246|FG000|STARTED|Overall Study||567
11011695|NCT00754741|12189247|FG001|STARTED|Overall Study||569
11011696|NCT00754741|12189248|FG002|STARTED|Overall Study||556
11011697|NCT00754741|12189246|FG000|COMPLETED|Overall Study||510
11011698|NCT00754741|12189247|FG001|COMPLETED|Overall Study||500
11011699|NCT00754741|12189248|FG002|COMPLETED|Overall Study||502
11011700|NCT00754741|12189246|FG000|NOT COMPLETED|Overall Study||57
11011701|NCT00754741|12189247|FG001|NOT COMPLETED|Overall Study||69
11011702|NCT00754741|12189248|FG002|NOT COMPLETED|Overall Study||54
11011703|NCT00754832|12189256|FG000|STARTED|First 6 Weeks Intervention||26
11011704|NCT00754832|12189257|FG001|STARTED|First 6 Weeks Intervention||30
11011705|NCT00754832|12189256|FG000|COMPLETED|First 6 Weeks Intervention||18
11011706|NCT00754832|12189257|FG001|COMPLETED|First 6 Weeks Intervention||28
11011707|NCT00754832|12189256|FG000|NOT COMPLETED|First 6 Weeks Intervention||8
11011708|NCT00754832|12189257|FG001|NOT COMPLETED|First 6 Weeks Intervention||2
11011709|NCT00754832|12189256|FG000|STARTED|2 Weeks Washout||18
11011710|NCT00754832|12189257|FG001|STARTED|2 Weeks Washout||28
11011711|NCT00754832|12189256|FG000|COMPLETED|2 Weeks Washout||17
11011712|NCT00754832|12189257|FG001|COMPLETED|2 Weeks Washout||26
11011713|NCT00754832|12189256|FG000|NOT COMPLETED|2 Weeks Washout||1
11011714|NCT00754832|12189257|FG001|NOT COMPLETED|2 Weeks Washout||2
11011715|NCT00754832|12189256|FG000|STARTED|Second 6 Weeks Intervention||17
11011716|NCT00754832|12189257|FG001|STARTED|Second 6 Weeks Intervention||26
11011717|NCT00754832|12189256|FG000|COMPLETED|Second 6 Weeks Intervention||17
11011718|NCT00754832|12189257|FG001|COMPLETED|Second 6 Weeks Intervention||24
11011719|NCT00754832|12189256|FG000|NOT COMPLETED|Second 6 Weeks Intervention||0
11011720|NCT00754832|12189257|FG001|NOT COMPLETED|Second 6 Weeks Intervention||2
11011721|NCT00754845|12189265|FG000|STARTED|Overall Study||959
11011722|NCT00754845|12189266|FG001|STARTED|Overall Study||959
11011723|NCT00754845|12189265|FG000|COMPLETED|Overall Study||959
11011724|NCT00754845|12189266|FG001|COMPLETED|Overall Study||959
11011725|NCT00754845|12189265|FG000|NOT COMPLETED|Overall Study||0
11011726|NCT00754845|12189266|FG001|NOT COMPLETED|Overall Study||0
11011727|NCT00754923|12189274|FG000|STARTED|Overall Study||11
11011728|NCT00754923|12189274|FG000|COMPLETED|Overall Study||11
11011729|NCT00754923|12189274|FG000|NOT COMPLETED|Overall Study||0
11011730|NCT00754936|12189278|FG000|STARTED|Overall Study||71
11011731|NCT00754936|12189278|FG000|COMPLETED|Overall Study||59
11011732|NCT00754936|12189278|FG000|NOT COMPLETED|Overall Study||12
11011733|NCT00755040|12189284|FG000|STARTED|Overall Study||83
11011734|NCT00755040|12189285|FG001|STARTED|Overall Study||81
11011735|NCT00755040|12189284|FG000|COMPLETED|Overall Study||40
11011736|NCT00755040|12189285|FG001|COMPLETED|Overall Study||47
11011737|NCT00755040|12189284|FG000|NOT COMPLETED|Overall Study||43
11011738|NCT00755040|12189285|FG001|NOT COMPLETED|Overall Study||34
11011739|NCT00755079|12189293|FG000|STARTED|Overall Study||18
11011740|NCT00755079|12189294|FG001|STARTED|Overall Study||22
11011741|NCT00755079|12189293|FG000|COMPLETED|Overall Study||17
11011742|NCT00755079|12189294|FG001|COMPLETED|Overall Study||16
11011743|NCT00755079|12189293|FG000|NOT COMPLETED|Overall Study||1
11011744|NCT00755079|12189294|FG001|NOT COMPLETED|Overall Study||6
11011745|NCT00755105|12189303|FG000|STARTED|Overall Study||38
11011746|NCT00755105|12189304|FG001|STARTED|Overall Study||30
11011747|NCT00755105|12189305|FG002|STARTED|Overall Study||9
11011748|NCT00755105|12189303|FG000|COMPLETED|Overall Study||29
11011749|NCT00755105|12189304|FG001|COMPLETED|Overall Study||19
11011750|NCT00755105|12189305|FG002|COMPLETED|Overall Study||5
11011751|NCT00755105|12189303|FG000|NOT COMPLETED|Overall Study||9
11011752|NCT00755105|12189304|FG001|NOT COMPLETED|Overall Study||11
11011753|NCT00755105|12189305|FG002|NOT COMPLETED|Overall Study||4
11011754|NCT00755131|12189315|FG000|STARTED|Overall Study||37
11011755|NCT00755131|12189316|FG001|STARTED|Overall Study||38
11011756|NCT00755131|12189315|FG000|COMPLETED|Overall Study||37
11011757|NCT00755131|12189316|FG001|COMPLETED|Overall Study||38
11011758|NCT00755131|12189315|FG000|NOT COMPLETED|Overall Study||0
11011759|NCT00755131|12189316|FG001|NOT COMPLETED|Overall Study||0
11011760|NCT00755183|12189324|FG000|STARTED|Overall Study||30
11011761|NCT00755183|12189325|FG001|STARTED|Overall Study||30
11011762|NCT00755183|12189324|FG000|COMPLETED|Overall Study||23
11011763|NCT00755183|12189325|FG001|COMPLETED|Overall Study||24
11011764|NCT00755183|12189324|FG000|NOT COMPLETED|Overall Study||7
11011765|NCT00755183|12189325|FG001|NOT COMPLETED|Overall Study||6
11011766|NCT00755196|12189333|FG000|STARTED|Overall Study||30
11011767|NCT00755196|12189333|FG000|COMPLETED|Overall Study||28
11011768|NCT00755196|12189333|FG000|NOT COMPLETED|Overall Study||2
11011769|NCT00755222|12189340|FG000|STARTED|Overall Study||111
11011770|NCT00755222|12189341|FG001|STARTED|Overall Study||36
11011771|NCT00755222|12189340|FG000|COMPLETED|Overall Study||103
11011772|NCT00755222|12189341|FG001|COMPLETED|Overall Study||34
11011773|NCT00755222|12189340|FG000|NOT COMPLETED|Overall Study||8
11011774|NCT00755222|12189341|FG001|NOT COMPLETED|Overall Study||2
11011775|NCT00755235|12189349|FG000|STARTED|Overall Study||106
11011776|NCT00755235|12189350|FG001|STARTED|Overall Study||102
11011777|NCT00755235|12189349|FG000|COMPLETED|Overall Study||104
11011778|NCT00755235|12189350|FG001|COMPLETED|Overall Study||93
11011779|NCT00755235|12189349|FG000|NOT COMPLETED|Overall Study||2
11011780|NCT00755235|12189350|FG001|NOT COMPLETED|Overall Study||9
11011781|NCT00755274|12189358|FG000|STARTED|Overall Study||24
11011782|NCT00755274|12189359|FG001|STARTED|Overall Study||8
11011783|NCT00755274|12189358|FG000|COMPLETED|Overall Study||24
11011784|NCT00755274|12189359|FG001|COMPLETED|Overall Study||8
11011785|NCT00755274|12189358|FG000|NOT COMPLETED|Overall Study||0
11011786|NCT00755274|12189359|FG001|NOT COMPLETED|Overall Study||0
11011787|NCT00755326|12189367|FG000|STARTED|Overall Study||47
11011788|NCT00755326|12189368|FG001|STARTED|Overall Study||45
11011789|NCT00755326|12189367|FG000|COMPLETED|Overall Study||45
11011790|NCT00755326|12189368|FG001|COMPLETED|Overall Study||42
11011791|NCT00755326|12189367|FG000|NOT COMPLETED|Overall Study||2
11011792|NCT00755326|12189368|FG001|NOT COMPLETED|Overall Study||3
11011793|NCT00755417|12189378|FG000|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
11011794|NCT00755417|12189379|FG001|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
11011795|NCT00755417|12189380|FG002|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
11011796|NCT00755417|12189378|FG000|COMPLETED|Overall Study||112
11011797|NCT00755417|12189379|FG001|COMPLETED|Overall Study||126
11011798|NCT00755417|12189380|FG002|COMPLETED|Overall Study||135
11011799|NCT00755417|12189378|FG000|NOT COMPLETED|Overall Study||62
11011800|NCT00755417|12189379|FG001|NOT COMPLETED|Overall Study||55
11011801|NCT00755417|12189380|FG002|NOT COMPLETED|Overall Study||42
11011802|NCT00755716|12189391|FG000|STARTED|Overall Study||19
11011803|NCT00755716|12189392|FG001|STARTED|Overall Study||19
11011804|NCT00755716|12189393|FG002|STARTED|Overall Study||19
11011805|NCT00755716|12189391|FG000|COMPLETED|Overall Study||11
11011806|NCT00755716|12189392|FG001|COMPLETED|Overall Study||11
11011807|NCT00755716|12189393|FG002|COMPLETED|Overall Study||16
11011808|NCT00755716|12189391|FG000|NOT COMPLETED|Overall Study||8
11011809|NCT00755716|12189392|FG001|NOT COMPLETED|Overall Study||8
11011810|NCT00755716|12189393|FG002|NOT COMPLETED|Overall Study||3
11011811|NCT00755755|12189404|FG000|STARTED|Overall Study|Safety population|95
11011812|NCT00755755|12189405|FG001|STARTED|Overall Study|Safety population|98
11011813|NCT00755755|12189406|FG002|STARTED|Overall Study|Safety population|48
11011814|NCT00755755|12189404|FG000|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
11011815|NCT00755755|12189405|FG001|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
11011816|NCT00755755|12189406|FG002|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
11011817|NCT00755755|12189404|FG000|NOT COMPLETED|Overall Study||6
11011818|NCT00755755|12189405|FG001|NOT COMPLETED|Overall Study||8
11011819|NCT00755755|12189406|FG002|NOT COMPLETED|Overall Study||3
11011820|NCT00755807|12189416|FG000|STARTED|Acute Phase||118
11011821|NCT00755807|12189417|FG001|STARTED|Acute Phase||121
11011822|NCT00755807|12189416|FG000|COMPLETED|Acute Phase||100
11011823|NCT00755807|12189417|FG001|COMPLETED|Acute Phase||109
11011824|NCT00755807|12189416|FG000|NOT COMPLETED|Acute Phase||18
11011825|NCT00755807|12189417|FG001|NOT COMPLETED|Acute Phase||12
11011826|NCT00755807|12189416|FG000|STARTED|Open-label Extension Phase||100
11396339|NCT03722784|12590185|FG001|NOT COMPLETED|Overall Study||2
11396340|NCT03723915|12590192|FG000|STARTED|Screening||17
11396341|NCT03723915|12590192|FG000|COMPLETED|Screening||15
11396342|NCT03723915|12590192|FG000|NOT COMPLETED|Screening||2
11396343|NCT03723915|12590192|FG000|STARTED|On Treatment||15
11396344|NCT03723915|12590192|FG000|Registered on Study|On Treatment||15
11396345|NCT03723915|12590192|FG000|Received First Dose of Study Drugs|On Treatment||13
11011827|NCT00755807|12189417|FG001|STARTED|Open-label Extension Phase||109
11011828|NCT00755807|12189416|FG000|COMPLETED|Open-label Extension Phase||82
11011829|NCT00755807|12189417|FG001|COMPLETED|Open-label Extension Phase||93
11011830|NCT00755807|12189416|FG000|NOT COMPLETED|Open-label Extension Phase||18
11011831|NCT00755807|12189417|FG001|NOT COMPLETED|Open-label Extension Phase||16
11011832|NCT00755846|12189433|FG000|STARTED|Overall Study||43
11011833|NCT00755846|12189434|FG001|STARTED|Overall Study||44
11011834|NCT00755846|12189435|FG002|STARTED|Overall Study||44
11011835|NCT00755846|12189436|FG003|STARTED|Overall Study||45
11011836|NCT00755846|12189437|FG004|STARTED|Overall Study||44
11011837|NCT00755846|12189438|FG005|STARTED|Overall Study||45
11011838|NCT00755846|12189433|FG000|COMPLETED|Overall Study||18
11011839|NCT00755846|12189434|FG001|COMPLETED|Overall Study||27
11011840|NCT00755846|12189435|FG002|COMPLETED|Overall Study||32
11011841|NCT00755846|12189436|FG003|COMPLETED|Overall Study||32
11011842|NCT00755846|12189437|FG004|COMPLETED|Overall Study||27
11011843|NCT00755846|12189438|FG005|COMPLETED|Overall Study||31
11011844|NCT00755846|12189433|FG000|NOT COMPLETED|Overall Study||25
11011845|NCT00755846|12189434|FG001|NOT COMPLETED|Overall Study||17
11011846|NCT00755846|12189435|FG002|NOT COMPLETED|Overall Study||12
11142791|NCT01469182|12329525|FG000|STARTED|Overall Study||610
11142792|NCT01469182|12329526|FG001|STARTED|Overall Study||304
11142793|NCT01469182|12329525|FG000|Treated|Overall Study||609
11142794|NCT01469182|12329526|FG001|Treated|Overall Study||304
11142795|NCT01469182|12329525|FG000|COMPLETED|Overall Study||575
11142796|NCT01469182|12329526|FG001|COMPLETED|Overall Study||298
11142797|NCT01469182|12329525|FG000|NOT COMPLETED|Overall Study||35
11142798|NCT01469182|12329526|FG001|NOT COMPLETED|Overall Study||6
11142799|NCT01469221|12329534|FG000|STARTED|Open Label Phase||0
11011847|NCT00755846|12189436|FG003|NOT COMPLETED|Overall Study||13
11142800|NCT01469221|12329535|FG001|STARTED|Open Label Phase||0
11396346|NCT03723915|12590192|FG000|COMPLETED|On Treatment||13
11396347|NCT03723915|12590192|FG000|NOT COMPLETED|On Treatment||2
11011848|NCT00755846|12189437|FG004|NOT COMPLETED|Overall Study||17
11011849|NCT00755846|12189438|FG005|NOT COMPLETED|Overall Study||14
11011850|NCT00755911|12189454|FG000|STARTED|Overall Study||12
11011851|NCT00755911|12189455|FG001|STARTED|Overall Study||12
11011852|NCT00755911|12189454|FG000|COMPLETED|Overall Study||12
11011853|NCT00755911|12189455|FG001|COMPLETED|Overall Study||12
11011854|NCT00755911|12189454|FG000|NOT COMPLETED|Overall Study||0
11011855|NCT00755911|12189455|FG001|NOT COMPLETED|Overall Study||0
11011856|NCT00755937|12189461|FG000|STARTED|Recruitment|Subjects registered in the program|556
11011857|NCT00755937|12189461|FG000|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
11011858|NCT00755937|12189461|FG000|NOT COMPLETED|Recruitment||164
11011859|NCT00755937|12189461|FG000|STARTED|Observational Follow-up||392
11011860|NCT00755937|12189461|FG000|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
11011861|NCT00755937|12189461|FG000|NOT COMPLETED|Observational Follow-up||148
11011862|NCT00756002|12189467|FG000|STARTED|Placebo Run-in||488
11011863|NCT00756002|12189468|FG001|STARTED|Placebo Run-in||0
11011864|NCT00756002|12189467|FG000|COMPLETED|Placebo Run-in||259
11011865|NCT00756002|12189468|FG001|COMPLETED|Placebo Run-in||0
11011866|NCT00756002|12189467|FG000|NOT COMPLETED|Placebo Run-in||229
11011867|NCT00756002|12189468|FG001|NOT COMPLETED|Placebo Run-in||0
11011868|NCT00756002|12189467|FG000|STARTED|Double-Blind Treatment Period||129
11011869|NCT00756002|12189468|FG001|STARTED|Double-Blind Treatment Period||130
11011870|NCT00756002|12189467|FG000|COMPLETED|Double-Blind Treatment Period||114
11011871|NCT00756002|12189468|FG001|COMPLETED|Double-Blind Treatment Period||115
11011872|NCT00756002|12189467|FG000|NOT COMPLETED|Double-Blind Treatment Period||15
11011873|NCT00756002|12189468|FG001|NOT COMPLETED|Double-Blind Treatment Period||15
11011874|NCT00756002|12189467|FG000|STARTED|Placebo Run-out||114
11011875|NCT00756002|12189468|FG001|STARTED|Placebo Run-out||0
11011876|NCT00756002|12189467|FG000|COMPLETED|Placebo Run-out||114
11011877|NCT00756002|12189468|FG001|COMPLETED|Placebo Run-out||0
11011878|NCT00756002|12189467|FG000|NOT COMPLETED|Placebo Run-out||0
11011879|NCT00756002|12189468|FG001|NOT COMPLETED|Placebo Run-out||0
11142801|NCT01469221|12329536|FG002|STARTED|Open Label Phase||47
11142802|NCT01469221|12329534|FG000|COMPLETED|Open Label Phase||0
11011880|NCT00756093|12189474|FG000|STARTED|First Intervention||5
11011881|NCT00756093|12189475|FG001|STARTED|First Intervention||5
11011882|NCT00756093|12189476|FG002|STARTED|First Intervention||5
11011883|NCT00756093|12189477|FG003|STARTED|First Intervention||5
11011884|NCT00756093|12189474|FG000|COMPLETED|First Intervention||5
11011885|NCT00756093|12189475|FG001|COMPLETED|First Intervention||5
11142803|NCT01469221|12329535|FG001|COMPLETED|Open Label Phase||0
11142804|NCT01469221|12329536|FG002|COMPLETED|Open Label Phase||44
11142805|NCT01469221|12329534|FG000|NOT COMPLETED|Open Label Phase||0
11142806|NCT01469221|12329535|FG001|NOT COMPLETED|Open Label Phase||0
11142807|NCT01469221|12329536|FG002|NOT COMPLETED|Open Label Phase||3
11142808|NCT01469221|12329534|FG000|STARTED|Double Blind Phase||14
11142809|NCT01469221|12329535|FG001|STARTED|Double Blind Phase||17
11142810|NCT01469221|12329536|FG002|STARTED|Double Blind Phase||0
11142811|NCT01469221|12329534|FG000|COMPLETED|Double Blind Phase||0
11142812|NCT01469221|12329535|FG001|COMPLETED|Double Blind Phase||0
11142813|NCT01469221|12329536|FG002|COMPLETED|Double Blind Phase||0
11142814|NCT01469221|12329534|FG000|NOT COMPLETED|Double Blind Phase||14
11142815|NCT01469221|12329535|FG001|NOT COMPLETED|Double Blind Phase||17
11142816|NCT01469221|12329536|FG002|NOT COMPLETED|Double Blind Phase||0
11142817|NCT01469234|12329546|FG000|STARTED|Overall Study||85
11142818|NCT01469234|12329547|FG001|STARTED|Overall Study||85
11142819|NCT01469234|12329548|FG002|STARTED|Overall Study||85
11142820|NCT01469234|12329546|FG000|COMPLETED|Overall Study||85
11142821|NCT01469234|12329547|FG001|COMPLETED|Overall Study||85
11142822|NCT01469234|12329548|FG002|COMPLETED|Overall Study||85
11142823|NCT01469234|12329546|FG000|NOT COMPLETED|Overall Study||0
11142824|NCT01469234|12329547|FG001|NOT COMPLETED|Overall Study||0
11142825|NCT01469234|12329548|FG002|NOT COMPLETED|Overall Study||0
11142826|NCT01469364|12329556|FG000|STARTED|Overall Study||30
11142827|NCT01469364|12329556|FG000|COMPLETED|Overall Study||28
11142828|NCT01469364|12329556|FG000|NOT COMPLETED|Overall Study||2
11142829|NCT01469377|12329563|FG000|STARTED|Overall Study||269
11142830|NCT01469377|12329564|FG001|STARTED|Overall Study||274
11142831|NCT01469377|12329565|FG002|STARTED|Overall Study||276
11142832|NCT01469377|12329563|FG000|COMPLETED|Overall Study||234
11142833|NCT01469377|12329564|FG001|COMPLETED|Overall Study||226
11142834|NCT01469377|12329565|FG002|COMPLETED|Overall Study||210
11142835|NCT01469377|12329563|FG000|NOT COMPLETED|Overall Study||35
11142836|NCT01469377|12329564|FG001|NOT COMPLETED|Overall Study||48
11142837|NCT01469377|12329565|FG002|NOT COMPLETED|Overall Study||66
11142838|NCT01469546|12329573|FG000|STARTED|Received 5 mg Dose||42
11011886|NCT00756093|12189476|FG002|COMPLETED|First Intervention||5
11142839|NCT01469546|12329573|FG000|Completed First Cycle|Received 5 mg Dose||30
11142840|NCT01469546|12329573|FG000|COMPLETED|Received 5 mg Dose||19
11142841|NCT01469546|12329573|FG000|NOT COMPLETED|Received 5 mg Dose||23
11011887|NCT00756093|12189477|FG003|COMPLETED|First Intervention||5
11011888|NCT00756093|12189474|FG000|NOT COMPLETED|First Intervention||0
11011889|NCT00756093|12189475|FG001|NOT COMPLETED|First Intervention||0
11142842|NCT01469546|12329573|FG000|STARTED|Dose Escalation to 10 mg||19
11142843|NCT01469546|12329573|FG000|COMPLETED|Dose Escalation to 10 mg||19
11142844|NCT01469546|12329573|FG000|NOT COMPLETED|Dose Escalation to 10 mg||0
11142845|NCT01469585|12329579|FG000|STARTED|Overall Study||11
11011890|NCT00756093|12189476|FG002|NOT COMPLETED|First Intervention||0
11011891|NCT00756093|12189477|FG003|NOT COMPLETED|First Intervention||0
11011892|NCT00756093|12189474|FG000|STARTED|Second Intervention||5
11011893|NCT00756093|12189475|FG001|STARTED|Second Intervention||5
11011894|NCT00756093|12189476|FG002|STARTED|Second Intervention||5
11011895|NCT00756093|12189477|FG003|STARTED|Second Intervention||5
11011896|NCT00756093|12189474|FG000|COMPLETED|Second Intervention||5
11011897|NCT00756093|12189475|FG001|COMPLETED|Second Intervention||5
11011898|NCT00756093|12189476|FG002|COMPLETED|Second Intervention||5
11011899|NCT00756093|12189477|FG003|COMPLETED|Second Intervention||5
11011900|NCT00756093|12189474|FG000|NOT COMPLETED|Second Intervention||0
11011901|NCT00756093|12189475|FG001|NOT COMPLETED|Second Intervention||0
11011902|NCT00756093|12189476|FG002|NOT COMPLETED|Second Intervention||0
11011903|NCT00756093|12189477|FG003|NOT COMPLETED|Second Intervention||0
11011904|NCT00756093|12189474|FG000|STARTED|Third Intervention||5
11011905|NCT00756093|12189475|FG001|STARTED|Third Intervention||5
11011906|NCT00756093|12189476|FG002|STARTED|Third Intervention||5
11011907|NCT00756093|12189477|FG003|STARTED|Third Intervention||5
11011908|NCT00756093|12189474|FG000|COMPLETED|Third Intervention||5
11011909|NCT00756093|12189475|FG001|COMPLETED|Third Intervention||5
11011910|NCT00756093|12189476|FG002|COMPLETED|Third Intervention||5
11011911|NCT00756093|12189477|FG003|COMPLETED|Third Intervention||5
11011912|NCT00756093|12189474|FG000|NOT COMPLETED|Third Intervention||0
11011913|NCT00756093|12189475|FG001|NOT COMPLETED|Third Intervention||0
11011914|NCT00756093|12189476|FG002|NOT COMPLETED|Third Intervention||0
11011915|NCT00756093|12189477|FG003|NOT COMPLETED|Third Intervention||0
11011916|NCT00756093|12189474|FG000|STARTED|Fourth Intervention||5
11011917|NCT00756093|12189475|FG001|STARTED|Fourth Intervention||5
11011918|NCT00756093|12189476|FG002|STARTED|Fourth Intervention||5
11011919|NCT00756093|12189477|FG003|STARTED|Fourth Intervention||5
11011920|NCT00756093|12189474|FG000|COMPLETED|Fourth Intervention||5
11011921|NCT00756093|12189475|FG001|COMPLETED|Fourth Intervention||5
11011922|NCT00756093|12189476|FG002|COMPLETED|Fourth Intervention||5
11011923|NCT00756093|12189477|FG003|COMPLETED|Fourth Intervention||5
11011924|NCT00756093|12189474|FG000|NOT COMPLETED|Fourth Intervention||0
11011925|NCT00756093|12189475|FG001|NOT COMPLETED|Fourth Intervention||0
11011926|NCT00756093|12189476|FG002|NOT COMPLETED|Fourth Intervention||0
11011927|NCT00756093|12189477|FG003|NOT COMPLETED|Fourth Intervention||0
11011928|NCT00756106|12189487|FG000|STARTED|Overall Study||15
11011929|NCT00756106|12189487|FG000|COMPLETED|Overall Study||3
11011930|NCT00756106|12189487|FG000|NOT COMPLETED|Overall Study||12
11011931|NCT00756236|12189494|FG000|STARTED|Overall Study||20
11011932|NCT00756236|12189495|FG001|STARTED|Overall Study||20
11011933|NCT00756236|12189496|FG002|STARTED|Overall Study||20
11011934|NCT00756236|12189494|FG000|COMPLETED|Overall Study||20
11011935|NCT00756236|12189495|FG001|COMPLETED|Overall Study||20
11011936|NCT00756236|12189496|FG002|COMPLETED|Overall Study||20
11011937|NCT00756236|12189494|FG000|NOT COMPLETED|Overall Study||0
11011938|NCT00756236|12189495|FG001|NOT COMPLETED|Overall Study||0
11011939|NCT00756236|12189496|FG002|NOT COMPLETED|Overall Study||0
11011940|NCT00756275|12189506|FG000|STARTED|Overall Study||60
11011941|NCT00756275|12189507|FG001|STARTED|Overall Study||77
11011942|NCT00756275|12189506|FG000|COMPLETED|Overall Study||31
11011943|NCT00756275|12189507|FG001|COMPLETED|Overall Study||49
11011944|NCT00756275|12189506|FG000|NOT COMPLETED|Overall Study||29
11011945|NCT00756275|12189507|FG001|NOT COMPLETED|Overall Study||28
11011946|NCT00756314|12189515|FG000|STARTED|Overall Study||123
11011947|NCT00756314|12189516|FG001|STARTED|Overall Study||123
11011948|NCT00756314|12189515|FG000|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
11011949|NCT00756314|12189516|FG001|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
11011950|NCT00756314|12189515|FG000|NOT COMPLETED|Overall Study||2
11011951|NCT00756314|12189516|FG001|NOT COMPLETED|Overall Study||59
11011952|NCT00756444|12189524|FG000|STARTED|Overall Study||33
11011953|NCT00756444|12189525|FG001|STARTED|Overall Study||34
11011954|NCT00756444|12189524|FG000|COMPLETED|Overall Study||18
11011955|NCT00756444|12189525|FG001|COMPLETED|Overall Study||13
11011956|NCT00756444|12189524|FG000|NOT COMPLETED|Overall Study||15
11011957|NCT00756444|12189525|FG001|NOT COMPLETED|Overall Study||21
11011958|NCT00756457|12189534|FG000|STARTED|Overall Study||20
11011959|NCT00756457|12189535|FG001|STARTED|Overall Study||19
11011960|NCT00756457|12189534|FG000|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
11011961|NCT00756457|12189535|FG001|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
11011962|NCT00756457|12189534|FG000|NOT COMPLETED|Overall Study||1
11011963|NCT00756457|12189535|FG001|NOT COMPLETED|Overall Study||2
11011964|NCT00756470|12189557|FG000|STARTED|Overall Study||15
11011965|NCT00756470|12189557|FG000|COMPLETED|Overall Study||10
11011966|NCT00756470|12189557|FG000|NOT COMPLETED|Overall Study||5
11011967|NCT00756496|12189561|FG000|STARTED|Overall Study||442
11011968|NCT00756496|12189561|FG000|COMPLETED|Overall Study||442
11011969|NCT00756496|12189561|FG000|NOT COMPLETED|Overall Study||0
11011970|NCT00756548|12189568|FG000|STARTED|Overall Study||186
11011971|NCT00756548|12189569|FG001|STARTED|Overall Study||185
11011972|NCT00756548|12189568|FG000|COMPLETED|Overall Study||184
11011973|NCT00756548|12189569|FG001|COMPLETED|Overall Study||185
11011974|NCT00756548|12189568|FG000|NOT COMPLETED|Overall Study||2
11011975|NCT00756548|12189569|FG001|NOT COMPLETED|Overall Study||0
11011976|NCT00756561|12189577|FG000|STARTED|Overall Study||10
11011977|NCT00756561|12189577|FG000|COMPLETED|Overall Study||10
11011978|NCT00756561|12189577|FG000|NOT COMPLETED|Overall Study||0
11011979|NCT00756600|12189584|FG000|STARTED|Overall Study||287
11011980|NCT00756600|12189585|FG001|STARTED|Overall Study||356
11011981|NCT00756600|12189584|FG000|COMPLETED|Overall Study||287
11011982|NCT00756600|12189585|FG001|COMPLETED|Overall Study||356
11011983|NCT00756600|12189584|FG000|NOT COMPLETED|Overall Study||0
11011984|NCT00756600|12189585|FG001|NOT COMPLETED|Overall Study||0
11011985|NCT00756613|12189594|FG000|STARTED|Overall Study||512
11011986|NCT00756613|12189595|FG001|STARTED|Overall Study||532
11011987|NCT00756613|12189594|FG000|COMPLETED|Overall Study||426
11011988|NCT00756613|12189595|FG001|COMPLETED|Overall Study||462
11011989|NCT00756613|12189594|FG000|NOT COMPLETED|Overall Study||86
11011990|NCT00756613|12189595|FG001|NOT COMPLETED|Overall Study||70
11011991|NCT00756652|12189604|FG000|STARTED|Original Phase||41452
11011992|NCT00756652|12189605|FG001|STARTED|Original Phase||1039
11011993|NCT00756652|12189604|FG000|COMPLETED|Original Phase|At Year 7|6063
11011994|NCT00756652|12189605|FG001|COMPLETED|Original Phase||118
11011995|NCT00756652|12189604|FG000|NOT COMPLETED|Original Phase||35389
11011996|NCT00756652|12189605|FG001|NOT COMPLETED|Original Phase||921
11011997|NCT00756652|12189604|FG000|STARTED|Re-Op Phase||11101
11011998|NCT00756652|12189605|FG001|STARTED|Re-Op Phase|NA - The Re-Op Phase was limited in scope to data collection for only MemoryGel participants.|0
11011999|NCT00756652|12189604|FG000|COMPLETED|Re-Op Phase||8225
11012000|NCT00756652|12189605|FG001|COMPLETED|Re-Op Phase||0
11012001|NCT00756652|12189604|FG000|NOT COMPLETED|Re-Op Phase||2876
11012002|NCT00756652|12189605|FG001|NOT COMPLETED|Re-Op Phase||0
11012003|NCT00756678|12189609|FG000|STARTED|Overall Study||51
11012004|NCT00756678|12189609|FG000|COMPLETED|Overall Study||50
11012005|NCT00756678|12189609|FG000|NOT COMPLETED|Overall Study||1
11012006|NCT00756717|12189614|FG000|STARTED|Overall Study||22
11012007|NCT00756717|12189614|FG000|COMPLETED|Overall Study||20
11012008|NCT00756717|12189614|FG000|NOT COMPLETED|Overall Study||2
11012009|NCT00756730|12189620|FG000|STARTED|Overall Study||25
11012010|NCT00756730|12189621|FG001|STARTED|Overall Study||24
11012011|NCT00756730|12189620|FG000|COMPLETED|Overall Study||25
11012012|NCT00756730|12189621|FG001|COMPLETED|Overall Study||22
11012013|NCT00756730|12189620|FG000|NOT COMPLETED|Overall Study||0
11012014|NCT00756730|12189621|FG001|NOT COMPLETED|Overall Study||2
11012015|NCT00756886|12189629|FG000|STARTED|Overall Study||41
11012016|NCT00756886|12189630|FG001|STARTED|Overall Study||32
11012017|NCT00756886|12189629|FG000|COMPLETED|Overall Study||30
11012018|NCT00756886|12189630|FG001|COMPLETED|Overall Study||25
11012019|NCT00756886|12189629|FG000|NOT COMPLETED|Overall Study||11
11012020|NCT00756886|12189630|FG001|NOT COMPLETED|Overall Study||7
11012021|NCT00756964|12189638|FG000|STARTED|Overall Study||13
11012022|NCT00756964|12189639|FG001|STARTED|Overall Study||13
11012023|NCT00756964|12189638|FG000|COMPLETED|Overall Study||13
11012024|NCT00756964|12189639|FG001|COMPLETED|Overall Study||13
11012025|NCT00756964|12189638|FG000|NOT COMPLETED|Overall Study||0
11012026|NCT00756964|12189639|FG001|NOT COMPLETED|Overall Study||0
11012027|NCT00756977|12189647|FG000|STARTED|Overall Study||196
11012028|NCT00756977|12189648|FG001|STARTED|Overall Study||198
11012029|NCT00756977|12189647|FG000|COMPLETED|Overall Study||175
11012030|NCT00756977|12189648|FG001|COMPLETED|Overall Study||187
11012031|NCT00756977|12189647|FG000|NOT COMPLETED|Overall Study||21
11012032|NCT00756977|12189648|FG001|NOT COMPLETED|Overall Study||11
11012033|NCT00757003|12189654|FG000|STARTED|Overall Study||100
11012034|NCT00757003|12189654|FG000|COMPLETED|Overall Study||51
11012035|NCT00757003|12189654|FG000|NOT COMPLETED|Overall Study||49
11012036|NCT00757172|12189659|FG000|STARTED|Overall Study||65
11012037|NCT00757172|12189659|FG000|COMPLETED|Overall Study|Participants underwent surgery.|54
11012038|NCT00757172|12189659|FG000|NOT COMPLETED|Overall Study||11
11012039|NCT00757237|12189665|FG000|STARTED|Overall Study||137
11012040|NCT00757237|12189666|FG001|STARTED|Overall Study||136
11012041|NCT00757237|12189665|FG000|Treated|Overall Study||136
11012042|NCT00757237|12189666|FG001|Treated|Overall Study||132
11012043|NCT00757237|12189665|FG000|COMPLETED|Overall Study||124
11012044|NCT00757237|12189666|FG001|COMPLETED|Overall Study||111
11012045|NCT00757237|12189665|FG000|NOT COMPLETED|Overall Study||13
11012046|NCT00757237|12189666|FG001|NOT COMPLETED|Overall Study||25
11056743|NCT00995904|12238406|FG001|STARTED|Visit 2 (Randomization)||3
11056744|NCT00995904|12238407|FG002|STARTED|Visit 2 (Randomization)||4
11056745|NCT00995904|12238408|FG003|STARTED|Visit 2 (Randomization)||5
11056746|NCT00995904|12238409|FG004|STARTED|Visit 2 (Randomization)||5
11056747|NCT00995904|12238410|FG005|STARTED|Visit 2 (Randomization)||4
11056748|NCT00995904|12238405|FG000|COMPLETED|Visit 2 (Randomization)||4
11056749|NCT00995904|12238406|FG001|COMPLETED|Visit 2 (Randomization)||3
11056750|NCT00995904|12238407|FG002|COMPLETED|Visit 2 (Randomization)||4
11056751|NCT00995904|12238408|FG003|COMPLETED|Visit 2 (Randomization)||5
11056752|NCT00995904|12238409|FG004|COMPLETED|Visit 2 (Randomization)||5
11056753|NCT00995904|12238410|FG005|COMPLETED|Visit 2 (Randomization)||4
11056754|NCT00995904|12238405|FG000|NOT COMPLETED|Visit 2 (Randomization)||0
11056755|NCT00995904|12238406|FG001|NOT COMPLETED|Visit 2 (Randomization)||0
11056756|NCT00995904|12238407|FG002|NOT COMPLETED|Visit 2 (Randomization)||0
11056757|NCT00995904|12238408|FG003|NOT COMPLETED|Visit 2 (Randomization)||0
11056758|NCT00995904|12238409|FG004|NOT COMPLETED|Visit 2 (Randomization)||0
11056759|NCT00995904|12238410|FG005|NOT COMPLETED|Visit 2 (Randomization)||0
11056760|NCT00995904|12238405|FG000|STARTED|Visit 3||4
11056761|NCT00995904|12238406|FG001|STARTED|Visit 3||3
11056762|NCT00995904|12238407|FG002|STARTED|Visit 3||4
11056763|NCT00995904|12238408|FG003|STARTED|Visit 3||5
11056764|NCT00995904|12238409|FG004|STARTED|Visit 3||5
11056765|NCT00995904|12238410|FG005|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
11056766|NCT00995904|12238405|FG000|COMPLETED|Visit 3||4
11396348|NCT03723915|12590192|FG000|STARTED|Survival Follow-up||13
11396349|NCT03723915|12590192|FG000|COMPLETED|Survival Follow-up||13
11396350|NCT03723915|12590192|FG000|NOT COMPLETED|Survival Follow-up||0
11396351|NCT03724812|12590196|FG000|STARTED|Overall Study||46
11396352|NCT03724812|12590196|FG000|Discharge|Overall Study||46
11396353|NCT03724812|12590196|FG000|30 Day Follow-Up|Overall Study||45
11396354|NCT03724812|12590196|FG000|6 Month Follow-Up|Overall Study||42
11396355|NCT03724812|12590196|FG000|12-Month Follow-Up|Overall Study||42
11056767|NCT00995904|12238406|FG001|COMPLETED|Visit 3||3
11056768|NCT00995904|12238407|FG002|COMPLETED|Visit 3||4
11056769|NCT00995904|12238408|FG003|COMPLETED|Visit 3||5
11056770|NCT00995904|12238409|FG004|COMPLETED|Visit 3||5
11056771|NCT00995904|12238410|FG005|COMPLETED|Visit 3||3
11056772|NCT00995904|12238405|FG000|NOT COMPLETED|Visit 3||0
11056773|NCT00995904|12238406|FG001|NOT COMPLETED|Visit 3||0
11056774|NCT00995904|12238407|FG002|NOT COMPLETED|Visit 3||0
11056775|NCT00995904|12238408|FG003|NOT COMPLETED|Visit 3||0
11056776|NCT00995904|12238409|FG004|NOT COMPLETED|Visit 3||0
11056777|NCT00995904|12238410|FG005|NOT COMPLETED|Visit 3||0
11056778|NCT00995904|12238405|FG000|STARTED|Visit 4||4
11056779|NCT00995904|12238406|FG001|STARTED|Visit 4||3
11056780|NCT00995904|12238407|FG002|STARTED|Visit 4||4
11056781|NCT00995904|12238408|FG003|STARTED|Visit 4||5
11056782|NCT00995904|12238409|FG004|STARTED|Visit 4||5
11056783|NCT00995904|12238410|FG005|STARTED|Visit 4||3
11056784|NCT00995904|12238405|FG000|COMPLETED|Visit 4||4
11056785|NCT00995904|12238406|FG001|COMPLETED|Visit 4||3
11056786|NCT00995904|12238407|FG002|COMPLETED|Visit 4||4
11056787|NCT00995904|12238408|FG003|COMPLETED|Visit 4||5
11056788|NCT00995904|12238409|FG004|COMPLETED|Visit 4||5
11056789|NCT00995904|12238410|FG005|COMPLETED|Visit 4||3
11056790|NCT00995904|12238405|FG000|NOT COMPLETED|Visit 4||0
11056791|NCT00995904|12238406|FG001|NOT COMPLETED|Visit 4||0
11056792|NCT00995904|12238407|FG002|NOT COMPLETED|Visit 4||0
11056793|NCT00995904|12238408|FG003|NOT COMPLETED|Visit 4||0
11056794|NCT00995904|12238409|FG004|NOT COMPLETED|Visit 4||0
11056795|NCT00995904|12238410|FG005|NOT COMPLETED|Visit 4||0
11056796|NCT00995904|12238405|FG000|STARTED|Follow-up Visit (Final Visit)||4
11056797|NCT00995904|12238406|FG001|STARTED|Follow-up Visit (Final Visit)||3
11056798|NCT00995904|12238407|FG002|STARTED|Follow-up Visit (Final Visit)||4
11396356|NCT03724812|12590196|FG000|COMPLETED|Overall Study||42
11012047|NCT00757484|12189672|FG000|STARTED|Overall Study||491
11012048|NCT00757484|12189672|FG000|COMPLETED|Overall Study||491
11012049|NCT00757484|12189672|FG000|NOT COMPLETED|Overall Study||0
11012050|NCT00757588|12189680|FG000|STARTED|Period 1: Short-term (24-week) Phase||304
11012051|NCT00757588|12189681|FG001|STARTED|Period 1: Short-term (24-week) Phase||151
11012052|NCT00757588|12189680|FG000|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
11012053|NCT00757588|12189681|FG001|COMPLETED|Period 1: Short-term (24-week) Phase||134
11012054|NCT00757588|12189680|FG000|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
11012055|NCT00757588|12189681|FG001|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
11012056|NCT00757588|12189680|FG000|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
11012057|NCT00757588|12189681|FG001|STARTED|Period 2: Long-term (52-week) Phase||134
11012058|NCT00757588|12189680|FG000|COMPLETED|Period 2: Long-term (52-week) Phase||246
11012059|NCT00757588|12189681|FG001|COMPLETED|Period 2: Long-term (52-week) Phase||125
11012060|NCT00757588|12189680|FG000|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
11012061|NCT00757588|12189681|FG001|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
11012062|NCT00757601|12189687|FG000|STARTED|Period 1||2
11012063|NCT00757601|12189688|FG001|STARTED|Period 1||2
11012064|NCT00757601|12189689|FG002|STARTED|Period 1||2
11012065|NCT00757601|12189690|FG003|STARTED|Period 1||2
11012066|NCT00757601|12189691|FG004|STARTED|Period 1||2
11012067|NCT00757601|12189692|FG005|STARTED|Period 1||2
11012068|NCT00757601|12189693|FG006|STARTED|Period 1||2
11012069|NCT00757601|12189694|FG007|STARTED|Period 1||2
11012070|NCT00757601|12189695|FG008|STARTED|Period 1||2
11012071|NCT00757601|12189696|FG009|STARTED|Period 1||2
11012072|NCT00757601|12189697|FG010|STARTED|Period 1||2
11012073|NCT00757601|12189698|FG011|STARTED|Period 1||3
11012074|NCT00757601|12189687|FG000|COMPLETED|Period 1||2
11012075|NCT00757601|12189688|FG001|COMPLETED|Period 1||2
11012076|NCT00757601|12189689|FG002|COMPLETED|Period 1||2
11012077|NCT00757601|12189690|FG003|COMPLETED|Period 1||2
11012078|NCT00757601|12189691|FG004|COMPLETED|Period 1||2
11012079|NCT00757601|12189692|FG005|COMPLETED|Period 1||2
11012080|NCT00757601|12189693|FG006|COMPLETED|Period 1||2
11012081|NCT00757601|12189694|FG007|COMPLETED|Period 1||2
11012082|NCT00757601|12189695|FG008|COMPLETED|Period 1||2
11012083|NCT00757601|12189696|FG009|COMPLETED|Period 1||2
11012084|NCT00757601|12189697|FG010|COMPLETED|Period 1||2
11012085|NCT00757601|12189698|FG011|COMPLETED|Period 1||3
11012086|NCT00757601|12189687|FG000|NOT COMPLETED|Period 1||0
11012087|NCT00757601|12189688|FG001|NOT COMPLETED|Period 1||0
11012088|NCT00757601|12189689|FG002|NOT COMPLETED|Period 1||0
11012089|NCT00757601|12189690|FG003|NOT COMPLETED|Period 1||0
11396357|NCT03724812|12590196|FG000|NOT COMPLETED|Overall Study||4
11012090|NCT00757601|12189691|FG004|NOT COMPLETED|Period 1||0
11012091|NCT00757601|12189692|FG005|NOT COMPLETED|Period 1||0
11012092|NCT00757601|12189693|FG006|NOT COMPLETED|Period 1||0
11012093|NCT00757601|12189694|FG007|NOT COMPLETED|Period 1||0
11012094|NCT00757601|12189695|FG008|NOT COMPLETED|Period 1||0
11012095|NCT00757601|12189696|FG009|NOT COMPLETED|Period 1||0
11012096|NCT00757601|12189697|FG010|NOT COMPLETED|Period 1||0
11012097|NCT00757601|12189698|FG011|NOT COMPLETED|Period 1||0
11012098|NCT00757601|12189687|FG000|STARTED|Period 2||2
11012099|NCT00757601|12189688|FG001|STARTED|Period 2||2
11012100|NCT00757601|12189689|FG002|STARTED|Period 2||2
11012101|NCT00757601|12189690|FG003|STARTED|Period 2||2
11012102|NCT00757601|12189691|FG004|STARTED|Period 2||2
11012103|NCT00757601|12189692|FG005|STARTED|Period 2||2
11012104|NCT00757601|12189693|FG006|STARTED|Period 2||2
11012105|NCT00757601|12189694|FG007|STARTED|Period 2||2
11012106|NCT00757601|12189695|FG008|STARTED|Period 2||2
11012107|NCT00757601|12189696|FG009|STARTED|Period 2||2
11012108|NCT00757601|12189697|FG010|STARTED|Period 2||2
11012109|NCT00757601|12189698|FG011|STARTED|Period 2||3
11012110|NCT00757601|12189687|FG000|COMPLETED|Period 2||2
11012111|NCT00757601|12189688|FG001|COMPLETED|Period 2||2
11012112|NCT00757601|12189689|FG002|COMPLETED|Period 2||2
11012113|NCT00757601|12189690|FG003|COMPLETED|Period 2||2
11012114|NCT00757601|12189691|FG004|COMPLETED|Period 2||2
11012115|NCT00757601|12189692|FG005|COMPLETED|Period 2||2
11012116|NCT00757601|12189693|FG006|COMPLETED|Period 2||2
11012117|NCT00757601|12189694|FG007|COMPLETED|Period 2||2
11012118|NCT00757601|12189695|FG008|COMPLETED|Period 2||2
11012119|NCT00757601|12189696|FG009|COMPLETED|Period 2||2
11012120|NCT00757601|12189697|FG010|COMPLETED|Period 2||2
11012121|NCT00757601|12189698|FG011|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
11012122|NCT00757601|12189687|FG000|NOT COMPLETED|Period 2||0
11012123|NCT00757601|12189688|FG001|NOT COMPLETED|Period 2||0
11012124|NCT00757601|12189689|FG002|NOT COMPLETED|Period 2||0
11012125|NCT00757601|12189690|FG003|NOT COMPLETED|Period 2||0
11012126|NCT00757601|12189691|FG004|NOT COMPLETED|Period 2||0
11012127|NCT00757601|12189692|FG005|NOT COMPLETED|Period 2||0
11012128|NCT00757601|12189693|FG006|NOT COMPLETED|Period 2||0
11012129|NCT00757601|12189694|FG007|NOT COMPLETED|Period 2||0
11012130|NCT00757601|12189695|FG008|NOT COMPLETED|Period 2||0
11012131|NCT00757601|12189696|FG009|NOT COMPLETED|Period 2||0
11012132|NCT00757601|12189697|FG010|NOT COMPLETED|Period 2||0
11012133|NCT00757601|12189698|FG011|NOT COMPLETED|Period 2||1
11012134|NCT00757601|12189687|FG000|STARTED|Period 3||2
11012135|NCT00757601|12189688|FG001|STARTED|Period 3||2
11012136|NCT00757601|12189689|FG002|STARTED|Period 3||2
11012137|NCT00757601|12189690|FG003|STARTED|Period 3||2
11012138|NCT00757601|12189691|FG004|STARTED|Period 3||2
11012139|NCT00757601|12189692|FG005|STARTED|Period 3||2
11012140|NCT00757601|12189693|FG006|STARTED|Period 3||2
11012141|NCT00757601|12189694|FG007|STARTED|Period 3||2
11012142|NCT00757601|12189695|FG008|STARTED|Period 3||2
11012143|NCT00757601|12189696|FG009|STARTED|Period 3||2
11012144|NCT00757601|12189697|FG010|STARTED|Period 3||2
11012145|NCT00757601|12189698|FG011|STARTED|Period 3||2
11012146|NCT00757601|12189687|FG000|COMPLETED|Period 3||2
11012147|NCT00757601|12189688|FG001|COMPLETED|Period 3||2
11012148|NCT00757601|12189689|FG002|COMPLETED|Period 3||2
11012149|NCT00757601|12189690|FG003|COMPLETED|Period 3||2
11012150|NCT00757601|12189691|FG004|COMPLETED|Period 3||2
11012151|NCT00757601|12189692|FG005|COMPLETED|Period 3||2
11012152|NCT00757601|12189693|FG006|COMPLETED|Period 3||2
11012153|NCT00757601|12189694|FG007|COMPLETED|Period 3||2
11012154|NCT00757601|12189695|FG008|COMPLETED|Period 3||2
11012155|NCT00757601|12189696|FG009|COMPLETED|Period 3||2
11012156|NCT00757601|12189697|FG010|COMPLETED|Period 3||2
11012157|NCT00757601|12189698|FG011|COMPLETED|Period 3||2
11012158|NCT00757601|12189687|FG000|NOT COMPLETED|Period 3||0
11012159|NCT00757601|12189688|FG001|NOT COMPLETED|Period 3||0
11012160|NCT00757601|12189689|FG002|NOT COMPLETED|Period 3||0
11012161|NCT00757601|12189690|FG003|NOT COMPLETED|Period 3||0
11012162|NCT00757601|12189691|FG004|NOT COMPLETED|Period 3||0
11012163|NCT00757601|12189692|FG005|NOT COMPLETED|Period 3||0
11012164|NCT00757601|12189693|FG006|NOT COMPLETED|Period 3||0
11012165|NCT00757601|12189694|FG007|NOT COMPLETED|Period 3||0
11012166|NCT00757601|12189695|FG008|NOT COMPLETED|Period 3||0
11012167|NCT00757601|12189696|FG009|NOT COMPLETED|Period 3||0
11012168|NCT00757601|12189697|FG010|NOT COMPLETED|Period 3||0
11012169|NCT00757601|12189698|FG011|NOT COMPLETED|Period 3||0
11012170|NCT00757601|12189687|FG000|STARTED|Period 4||2
11012171|NCT00757601|12189688|FG001|STARTED|Period 4||2
11012172|NCT00757601|12189689|FG002|STARTED|Period 4||2
11012173|NCT00757601|12189690|FG003|STARTED|Period 4||2
11012174|NCT00757601|12189691|FG004|STARTED|Period 4||2
11012175|NCT00757601|12189692|FG005|STARTED|Period 4||2
11012176|NCT00757601|12189693|FG006|STARTED|Period 4||2
11012177|NCT00757601|12189694|FG007|STARTED|Period 4||2
11012178|NCT00757601|12189695|FG008|STARTED|Period 4||2
11012179|NCT00757601|12189696|FG009|STARTED|Period 4||2
11012180|NCT00757601|12189697|FG010|STARTED|Period 4||2
11012181|NCT00757601|12189698|FG011|STARTED|Period 4||2
11012182|NCT00757601|12189687|FG000|COMPLETED|Period 4||2
11012183|NCT00757601|12189688|FG001|COMPLETED|Period 4||2
11012184|NCT00757601|12189689|FG002|COMPLETED|Period 4||2
11012185|NCT00757601|12189690|FG003|COMPLETED|Period 4||2
11012186|NCT00757601|12189691|FG004|COMPLETED|Period 4||2
11012187|NCT00757601|12189692|FG005|COMPLETED|Period 4||2
11012188|NCT00757601|12189693|FG006|COMPLETED|Period 4||2
11012189|NCT00757601|12189694|FG007|COMPLETED|Period 4||2
11012190|NCT00757601|12189695|FG008|COMPLETED|Period 4||2
11012191|NCT00757601|12189696|FG009|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
11012192|NCT00757601|12189697|FG010|COMPLETED|Period 4||2
11012193|NCT00757601|12189698|FG011|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
11012194|NCT00757601|12189687|FG000|NOT COMPLETED|Period 4||0
11012195|NCT00757601|12189688|FG001|NOT COMPLETED|Period 4||0
11012196|NCT00757601|12189689|FG002|NOT COMPLETED|Period 4||0
11012197|NCT00757601|12189690|FG003|NOT COMPLETED|Period 4||0
11012198|NCT00757601|12189691|FG004|NOT COMPLETED|Period 4||0
11012199|NCT00757601|12189692|FG005|NOT COMPLETED|Period 4||0
11012200|NCT00757601|12189693|FG006|NOT COMPLETED|Period 4||0
11012201|NCT00757601|12189694|FG007|NOT COMPLETED|Period 4||0
11012202|NCT00757601|12189695|FG008|NOT COMPLETED|Period 4||0
11012203|NCT00757601|12189696|FG009|NOT COMPLETED|Period 4||1
11012204|NCT00757601|12189697|FG010|NOT COMPLETED|Period 4||0
11012205|NCT00757601|12189698|FG011|NOT COMPLETED|Period 4||1
11012206|NCT00757601|12189687|FG000|STARTED|Period 5||2
11012207|NCT00757601|12189688|FG001|STARTED|Period 5||2
11012208|NCT00757601|12189689|FG002|STARTED|Period 5||2
11012209|NCT00757601|12189690|FG003|STARTED|Period 5||2
11012210|NCT00757601|12189691|FG004|STARTED|Period 5||2
11012211|NCT00757601|12189692|FG005|STARTED|Period 5||2
11012212|NCT00757601|12189693|FG006|STARTED|Period 5||2
11012213|NCT00757601|12189694|FG007|STARTED|Period 5||2
11012214|NCT00757601|12189695|FG008|STARTED|Period 5||2
11012215|NCT00757601|12189696|FG009|STARTED|Period 5||1
11012216|NCT00757601|12189697|FG010|STARTED|Period 5||2
11012217|NCT00757601|12189698|FG011|STARTED|Period 5||1
11012218|NCT00757601|12189687|FG000|COMPLETED|Period 5||2
11012219|NCT00757601|12189688|FG001|COMPLETED|Period 5||2
11012220|NCT00757601|12189689|FG002|COMPLETED|Period 5||2
11012221|NCT00757601|12189690|FG003|COMPLETED|Period 5||2
11012222|NCT00757601|12189691|FG004|COMPLETED|Period 5||2
11012223|NCT00757601|12189692|FG005|COMPLETED|Period 5||2
11012224|NCT00757601|12189693|FG006|COMPLETED|Period 5||2
11012225|NCT00757601|12189694|FG007|COMPLETED|Period 5||2
11012226|NCT00757601|12189695|FG008|COMPLETED|Period 5||2
11012227|NCT00757601|12189696|FG009|COMPLETED|Period 5||1
11012228|NCT00757601|12189697|FG010|COMPLETED|Period 5||2
11012229|NCT00757601|12189698|FG011|COMPLETED|Period 5||1
11012230|NCT00757601|12189687|FG000|NOT COMPLETED|Period 5||0
11012231|NCT00757601|12189688|FG001|NOT COMPLETED|Period 5||0
11012232|NCT00757601|12189689|FG002|NOT COMPLETED|Period 5||0
11012233|NCT00757601|12189690|FG003|NOT COMPLETED|Period 5||0
11012234|NCT00757601|12189691|FG004|NOT COMPLETED|Period 5||0
11012235|NCT00757601|12189692|FG005|NOT COMPLETED|Period 5||0
11012236|NCT00757601|12189693|FG006|NOT COMPLETED|Period 5||0
11012237|NCT00757601|12189694|FG007|NOT COMPLETED|Period 5||0
11012238|NCT00757601|12189695|FG008|NOT COMPLETED|Period 5||0
11012239|NCT00757601|12189696|FG009|NOT COMPLETED|Period 5||0
11012240|NCT00757601|12189697|FG010|NOT COMPLETED|Period 5||0
11012241|NCT00757601|12189698|FG011|NOT COMPLETED|Period 5||0
11012242|NCT00757666|12189730|FG000|STARTED|Overall Study||34
11012243|NCT00757666|12189731|FG001|STARTED|Overall Study||34
11012244|NCT00757666|12189730|FG000|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
11012245|NCT00757666|12189731|FG001|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
11012246|NCT00757666|12189730|FG000|NOT COMPLETED|Overall Study||22
11012247|NCT00757666|12189731|FG001|NOT COMPLETED|Overall Study||23
11012248|NCT00757705|12189741|FG000|STARTED|Overall Study||299
11012249|NCT00757705|12189741|FG000|COMPLETED|Overall Study||178
11012250|NCT00757705|12189741|FG000|NOT COMPLETED|Overall Study||121
11012251|NCT00757783|12189747|FG000|STARTED|Overall Study||34
11012252|NCT00757783|12189748|FG001|STARTED|Overall Study||31
11012253|NCT00757783|12189747|FG000|COMPLETED|Overall Study||29
11012254|NCT00757783|12189748|FG001|COMPLETED|Overall Study||25
11012255|NCT00757783|12189747|FG000|NOT COMPLETED|Overall Study||5
11012256|NCT00757783|12189748|FG001|NOT COMPLETED|Overall Study||6
11012257|NCT00757822|12189756|FG000|STARTED|Overall Study||92
11012258|NCT00757822|12189757|FG001|STARTED|Overall Study||88
11012259|NCT00757822|12189756|FG000|Day of Surgery (DOS) Assessment|Overall Study||92
11012260|NCT00757822|12189757|FG001|Day of Surgery (DOS) Assessment|Overall Study||88
11012261|NCT00757822|12189756|FG000|Withdrawal by Subject-no Intervention|Overall Study||1
11012262|NCT00757822|12189757|FG001|Withdrawal by Subject-no Intervention|Overall Study||3
11012263|NCT00757822|12189756|FG000|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
11012264|NCT00757822|12189757|FG001|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
11012265|NCT00757822|12189756|FG000|Received Study Intervention|Overall Study||85
11012266|NCT00757822|12189757|FG001|Received Study Intervention|Overall Study||74
11012267|NCT00757822|12189756|FG000|DOS: Post-operative Assessments|Overall Study||85
11012268|NCT00757822|12189757|FG001|DOS: Post-operative Assessments|Overall Study||74
11012269|NCT00757822|12189756|FG000|24-48 hr Telephone Assessment|Overall Study||85
11012270|NCT00757822|12189757|FG001|24-48 hr Telephone Assessment|Overall Study||74
11012271|NCT00757822|12189756|FG000|2-6 wk Post-op Assessment|Overall Study||85
11012272|NCT00757822|12189757|FG001|2-6 wk Post-op Assessment|Overall Study||74
11012273|NCT00757822|12189756|FG000|Data Entry, QC Assessment|Overall Study||85
11012274|NCT00757822|12189757|FG001|Data Entry, QC Assessment|Overall Study||74
11012275|NCT00757822|12189756|FG000|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
11012276|NCT00757822|12189757|FG001|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
11012277|NCT00757822|12189756|FG000|Withdrawn-protocol Deviation|Overall Study||9
11012278|NCT00757822|12189757|FG001|Withdrawn-protocol Deviation|Overall Study||8
11012279|NCT00757822|12189756|FG000|Data Lock, Unblinding Analysis|Overall Study||64
11012280|NCT00757822|12189757|FG001|Data Lock, Unblinding Analysis|Overall Study||57
11012281|NCT00757822|12189756|FG000|COMPLETED|Overall Study||64
11012282|NCT00757822|12189757|FG001|COMPLETED|Overall Study||57
11012283|NCT00757822|12189756|FG000|NOT COMPLETED|Overall Study||28
11012284|NCT00757822|12189757|FG001|NOT COMPLETED|Overall Study||31
11012285|NCT00757848|12189768|FG000|STARTED|Overall Study||27
11012286|NCT00757848|12189769|FG001|STARTED|Overall Study||29
11012287|NCT00757848|12189768|FG000|COMPLETED|Overall Study||24
11012288|NCT00757848|12189769|FG001|COMPLETED|Overall Study||27
11012289|NCT00757848|12189768|FG000|NOT COMPLETED|Overall Study||3
11012290|NCT00757848|12189769|FG001|NOT COMPLETED|Overall Study||2
11012291|NCT00758043|12189779|FG000|STARTED|Overall Study||162
11012292|NCT00758043|12189780|FG001|STARTED|Overall Study||160
11012293|NCT00758043|12189781|FG002|STARTED|Overall Study||118
11012294|NCT00758043|12189782|FG003|STARTED|Overall Study||100
11012295|NCT00758043|12189779|FG000|COMPLETED|Overall Study||161
11012296|NCT00758043|12189780|FG001|COMPLETED|Overall Study||119
11012297|NCT00758043|12189781|FG002|COMPLETED|Overall Study||79
11012298|NCT00758043|12189782|FG003|COMPLETED|Overall Study||0
11012299|NCT00758043|12189779|FG000|NOT COMPLETED|Overall Study||1
11012300|NCT00758043|12189780|FG001|NOT COMPLETED|Overall Study||41
11012301|NCT00758043|12189781|FG002|NOT COMPLETED|Overall Study||39
11012302|NCT00758043|12189782|FG003|NOT COMPLETED|Overall Study||100
11012303|NCT00758069|12189801|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
11012304|NCT00758069|12189802|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
11012305|NCT00758069|12189803|FG002|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
11012306|NCT00758069|12189801|FG000|COMPLETED|Overall Study||26
11012307|NCT00758069|12189802|FG001|COMPLETED|Overall Study||25
11012308|NCT00758069|12189803|FG002|COMPLETED|Overall Study||27
11012309|NCT00758069|12189801|FG000|NOT COMPLETED|Overall Study||1
11012310|NCT00758069|12189802|FG001|NOT COMPLETED|Overall Study||0
11012311|NCT00758069|12189803|FG002|NOT COMPLETED|Overall Study||1
11012312|NCT00758160|12189811|FG000|STARTED|Overall Study||296
11012313|NCT00758160|12189811|FG000|COMPLETED|Overall Study||230
11012314|NCT00758160|12189811|FG000|NOT COMPLETED|Overall Study||66
11012315|NCT00758264|12189822|FG000|STARTED|Active Phase||182
11012316|NCT00758264|12189823|FG001|STARTED|Active Phase||91
11012317|NCT00758264|12189824|FG002|STARTED|Active Phase||90
11012318|NCT00758264|12189822|FG000|COMPLETED|Active Phase||181
11012319|NCT00758264|12189823|FG001|COMPLETED|Active Phase||91
11012320|NCT00758264|12189824|FG002|COMPLETED|Active Phase||85
11012321|NCT00758264|12189822|FG000|NOT COMPLETED|Active Phase||1
11012322|NCT00758264|12189823|FG001|NOT COMPLETED|Active Phase||0
11012323|NCT00758264|12189824|FG002|NOT COMPLETED|Active Phase||5
11012324|NCT00758264|12189822|FG000|STARTED|Extended Safety Follow Up (ESFU) Phase||181
11012325|NCT00758264|12189823|FG001|STARTED|Extended Safety Follow Up (ESFU) Phase||90
11012326|NCT00758264|12189824|FG002|STARTED|Extended Safety Follow Up (ESFU) Phase||89
11012327|NCT00758264|12189822|FG000|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
11012328|NCT00758264|12189823|FG001|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
11012329|NCT00758264|12189824|FG002|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
11012330|NCT00758264|12189822|FG000|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
11012331|NCT00758264|12189823|FG001|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
11012332|NCT00758264|12189824|FG002|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
11012333|NCT00758342|12189834|FG000|STARTED|Overall Study||19
11012334|NCT00758342|12189835|FG001|STARTED|Overall Study||18
11012335|NCT00758342|12189834|FG000|COMPLETED|Overall Study||15
11012336|NCT00758342|12189835|FG001|COMPLETED|Overall Study||17
11012337|NCT00758342|12189834|FG000|NOT COMPLETED|Overall Study||4
11012338|NCT00758342|12189835|FG001|NOT COMPLETED|Overall Study||1
11012339|NCT00758394|12189845|FG000|STARTED|1st Intervention||8
11012340|NCT00758394|12189846|FG001|STARTED|1st Intervention||7
11012341|NCT00758394|12189847|FG002|STARTED|1st Intervention||6
11012342|NCT00758394|12189848|FG003|STARTED|1st Intervention||8
11012343|NCT00758394|12189845|FG000|COMPLETED|1st Intervention||8
11012344|NCT00758394|12189846|FG001|COMPLETED|1st Intervention||7
11012345|NCT00758394|12189847|FG002|COMPLETED|1st Intervention||6
11012346|NCT00758394|12189848|FG003|COMPLETED|1st Intervention||8
11012347|NCT00758394|12189845|FG000|NOT COMPLETED|1st Intervention||0
11012348|NCT00758394|12189846|FG001|NOT COMPLETED|1st Intervention||0
11012349|NCT00758394|12189847|FG002|NOT COMPLETED|1st Intervention||0
11012350|NCT00758394|12189848|FG003|NOT COMPLETED|1st Intervention||0
11012351|NCT00758394|12189845|FG000|STARTED|Washout After 1st Intervention||8
11012352|NCT00758394|12189846|FG001|STARTED|Washout After 1st Intervention||7
11012353|NCT00758394|12189847|FG002|STARTED|Washout After 1st Intervention||6
11012354|NCT00758394|12189848|FG003|STARTED|Washout After 1st Intervention||8
11012355|NCT00758394|12189845|FG000|COMPLETED|Washout After 1st Intervention||8
11012356|NCT00758394|12189846|FG001|COMPLETED|Washout After 1st Intervention||7
11012357|NCT00758394|12189847|FG002|COMPLETED|Washout After 1st Intervention||6
11012358|NCT00758394|12189848|FG003|COMPLETED|Washout After 1st Intervention||8
11012359|NCT00758394|12189845|FG000|NOT COMPLETED|Washout After 1st Intervention||0
11012360|NCT00758394|12189846|FG001|NOT COMPLETED|Washout After 1st Intervention||0
11012361|NCT00758394|12189847|FG002|NOT COMPLETED|Washout After 1st Intervention||0
11012362|NCT00758394|12189848|FG003|NOT COMPLETED|Washout After 1st Intervention||0
11012363|NCT00758394|12189845|FG000|STARTED|2nd Intervention Order||8
11012364|NCT00758394|12189846|FG001|STARTED|2nd Intervention Order||7
11012365|NCT00758394|12189847|FG002|STARTED|2nd Intervention Order||6
11012366|NCT00758394|12189848|FG003|STARTED|2nd Intervention Order||8
11012367|NCT00758394|12189845|FG000|COMPLETED|2nd Intervention Order||8
11012368|NCT00758394|12189846|FG001|COMPLETED|2nd Intervention Order||6
11012369|NCT00758394|12189847|FG002|COMPLETED|2nd Intervention Order||6
11012370|NCT00758394|12189848|FG003|COMPLETED|2nd Intervention Order||8
11012371|NCT00758394|12189845|FG000|NOT COMPLETED|2nd Intervention Order||0
11012372|NCT00758394|12189846|FG001|NOT COMPLETED|2nd Intervention Order||1
11012373|NCT00758394|12189847|FG002|NOT COMPLETED|2nd Intervention Order||0
11012374|NCT00758394|12189848|FG003|NOT COMPLETED|2nd Intervention Order||0
11012375|NCT00758394|12189845|FG000|STARTED|Washout After 2nd Intervention||8
11012376|NCT00758394|12189846|FG001|STARTED|Washout After 2nd Intervention||6
11012377|NCT00758394|12189847|FG002|STARTED|Washout After 2nd Intervention||6
11012378|NCT00758394|12189848|FG003|STARTED|Washout After 2nd Intervention||8
11012379|NCT00758394|12189845|FG000|COMPLETED|Washout After 2nd Intervention||8
11012380|NCT00758394|12189846|FG001|COMPLETED|Washout After 2nd Intervention||6
11012381|NCT00758394|12189847|FG002|COMPLETED|Washout After 2nd Intervention||6
11012382|NCT00758394|12189848|FG003|COMPLETED|Washout After 2nd Intervention||8
11012383|NCT00758394|12189845|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
11012384|NCT00758394|12189846|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
11012385|NCT00758394|12189847|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
11012386|NCT00758394|12189848|FG003|NOT COMPLETED|Washout After 2nd Intervention||0
11012387|NCT00758394|12189845|FG000|STARTED|3rd Intervention||8
11012388|NCT00758394|12189846|FG001|STARTED|3rd Intervention||6
11012389|NCT00758394|12189847|FG002|STARTED|3rd Intervention||6
11012390|NCT00758394|12189848|FG003|STARTED|3rd Intervention||8
11012391|NCT00758394|12189845|FG000|COMPLETED|3rd Intervention||7
11012392|NCT00758394|12189846|FG001|COMPLETED|3rd Intervention||6
11012393|NCT00758394|12189847|FG002|COMPLETED|3rd Intervention||6
11012394|NCT00758394|12189848|FG003|COMPLETED|3rd Intervention||7
11012395|NCT00758394|12189845|FG000|NOT COMPLETED|3rd Intervention||1
11012396|NCT00758394|12189846|FG001|NOT COMPLETED|3rd Intervention||0
11012397|NCT00758394|12189847|FG002|NOT COMPLETED|3rd Intervention||0
11012398|NCT00758394|12189848|FG003|NOT COMPLETED|3rd Intervention||1
11012399|NCT00758394|12189845|FG000|STARTED|Washout After 3rd Intervention||7
11012400|NCT00758394|12189846|FG001|STARTED|Washout After 3rd Intervention||6
11012401|NCT00758394|12189847|FG002|STARTED|Washout After 3rd Intervention||6
11012402|NCT00758394|12189848|FG003|STARTED|Washout After 3rd Intervention||7
11012403|NCT00758394|12189845|FG000|COMPLETED|Washout After 3rd Intervention||7
11012404|NCT00758394|12189846|FG001|COMPLETED|Washout After 3rd Intervention||6
11012405|NCT00758394|12189847|FG002|COMPLETED|Washout After 3rd Intervention||6
11012406|NCT00758394|12189848|FG003|COMPLETED|Washout After 3rd Intervention||7
11012407|NCT00758394|12189845|FG000|NOT COMPLETED|Washout After 3rd Intervention||0
11012408|NCT00758394|12189846|FG001|NOT COMPLETED|Washout After 3rd Intervention||0
11012409|NCT00758394|12189847|FG002|NOT COMPLETED|Washout After 3rd Intervention||0
11012410|NCT00758394|12189848|FG003|NOT COMPLETED|Washout After 3rd Intervention||0
11012411|NCT00758394|12189845|FG000|STARTED|4th Intervention||7
11012412|NCT00758394|12189846|FG001|STARTED|4th Intervention||6
11012413|NCT00758394|12189847|FG002|STARTED|4th Intervention||6
11012414|NCT00758394|12189848|FG003|STARTED|4th Intervention||7
11012415|NCT00758394|12189845|FG000|COMPLETED|4th Intervention||7
11012416|NCT00758394|12189846|FG001|COMPLETED|4th Intervention||6
11012417|NCT00758394|12189847|FG002|COMPLETED|4th Intervention||6
11012418|NCT00758394|12189848|FG003|COMPLETED|4th Intervention||7
11012419|NCT00758394|12189845|FG000|NOT COMPLETED|4th Intervention||0
11012420|NCT00758394|12189846|FG001|NOT COMPLETED|4th Intervention||0
11012421|NCT00758394|12189847|FG002|NOT COMPLETED|4th Intervention||0
11012422|NCT00758394|12189848|FG003|NOT COMPLETED|4th Intervention||0
11012423|NCT00758420|12189860|FG000|STARTED|Overall Study||39
11012424|NCT00758420|12189861|FG001|STARTED|Overall Study||38
11012425|NCT00758420|12189860|FG000|COMPLETED|Overall Study||39
11012426|NCT00758420|12189861|FG001|COMPLETED|Overall Study||38
11012427|NCT00758420|12189860|FG000|NOT COMPLETED|Overall Study||0
11012428|NCT00758420|12189861|FG001|NOT COMPLETED|Overall Study||0
11012429|NCT00758459|12189869|FG000|STARTED|Overall Study||35
11012430|NCT00758459|12189870|FG001|STARTED|Overall Study||39
11012431|NCT00758459|12189869|FG000|COMPLETED|Overall Study||32
11012432|NCT00758459|12189870|FG001|COMPLETED|Overall Study||35
11012433|NCT00758459|12189869|FG000|NOT COMPLETED|Overall Study||3
11012434|NCT00758459|12189870|FG001|NOT COMPLETED|Overall Study||4
11012435|NCT00758485|12189878|FG000|STARTED|Overall Study||70
11012436|NCT00758485|12189879|FG001|STARTED|Overall Study||70
11012437|NCT00758485|12189878|FG000|TREATED|Overall Study||69
11012438|NCT00758485|12189879|FG001|TREATED|Overall Study||68
11012439|NCT00758485|12189878|FG000|COMPLETED|Overall Study||69
11012440|NCT00758485|12189879|FG001|COMPLETED|Overall Study||67
11012441|NCT00758485|12189878|FG000|NOT COMPLETED|Overall Study||1
11012442|NCT00758485|12189879|FG001|NOT COMPLETED|Overall Study||3
11012443|NCT00758498|12189889|FG000|STARTED|Overall Study||142
11012444|NCT00758498|12189890|FG001|STARTED|Overall Study||143
11012445|NCT00758498|12189891|FG002|STARTED|Overall Study||142
11012446|NCT00758498|12189889|FG000|COMPLETED|Overall Study||139
11012447|NCT00758498|12189890|FG001|COMPLETED|Overall Study||141
11012448|NCT00758498|12189891|FG002|COMPLETED|Overall Study||137
11012449|NCT00758498|12189889|FG000|NOT COMPLETED|Overall Study||3
11012450|NCT00758498|12189890|FG001|NOT COMPLETED|Overall Study||2
11012451|NCT00758498|12189891|FG002|NOT COMPLETED|Overall Study||5
11012452|NCT00758524|12189905|FG000|STARTED|Core Period (Week 0 to Week 8)||92
11012453|NCT00758524|12189906|FG001|STARTED|Core Period (Week 0 to Week 8)||88
11012454|NCT00758524|12189907|FG002|STARTED|Core Period (Week 0 to Week 8)||86
11012455|NCT00758524|12189908|FG003|STARTED|Core Period (Week 0 to Week 8)|One participant in this arm group was randomized twice and was excluded from Full Analysis Set.|97
11012456|NCT00758524|12189909|FG004|STARTED|Core Period (Week 0 to Week 8)||84
11012457|NCT00758524|12189910|FG005|STARTED|Core Period (Week 0 to Week 8)||77
11012458|NCT00758524|12189911|FG006|STARTED|Core Period (Week 0 to Week 8)||0
11012459|NCT00758524|12189912|FG007|STARTED|Core Period (Week 0 to Week 8)||0
11012460|NCT00758524|12189913|FG008|STARTED|Core Period (Week 0 to Week 8)||0
11012461|NCT00758524|12189914|FG009|STARTED|Core Period (Week 0 to Week 8)||0
11012462|NCT00758524|12189915|FG010|STARTED|Core Period (Week 0 to Week 8)||0
11012463|NCT00758524|12189916|FG011|STARTED|Core Period (Week 0 to Week 8)||0
11012464|NCT00758524|12189917|FG012|STARTED|Core Period (Week 0 to Week 8)||0
11012465|NCT00758524|12189918|FG013|STARTED|Core Period (Week 0 to Week 8)||0
11012466|NCT00758524|12189919|FG014|STARTED|Core Period (Week 0 to Week 8)||0
11012467|NCT00758524|12189920|FG015|STARTED|Core Period (Week 0 to Week 8)||0
11012468|NCT00758524|12189921|FG016|STARTED|Core Period (Week 0 to Week 8)||0
11012469|NCT00758524|12189905|FG000|Treated|Core Period (Week 0 to Week 8)||92
11012470|NCT00758524|12189906|FG001|Treated|Core Period (Week 0 to Week 8)||87
11012471|NCT00758524|12189907|FG002|Treated|Core Period (Week 0 to Week 8)|One participant from LCI699 0.5 mg QD was randomized to LCI699 1.0 mg QD and received LCI699 1.0 mg QD, thus was included in this arm in the Safety Set.|87
11012472|NCT00758524|12189908|FG003|Treated|Core Period (Week 0 to Week 8)||97
11012473|NCT00758524|12189909|FG004|Treated|Core Period (Week 0 to Week 8)||84
11012474|NCT00758524|12189910|FG005|Treated|Core Period (Week 0 to Week 8)||76
11012475|NCT00758524|12189911|FG006|Treated|Core Period (Week 0 to Week 8)||0
11012476|NCT00758524|12189912|FG007|Treated|Core Period (Week 0 to Week 8)||0
11012477|NCT00758524|12189913|FG008|Treated|Core Period (Week 0 to Week 8)||0
11012478|NCT00758524|12189914|FG009|Treated|Core Period (Week 0 to Week 8)||0
11012479|NCT00758524|12189915|FG010|Treated|Core Period (Week 0 to Week 8)||0
11012480|NCT00758524|12189916|FG011|Treated|Core Period (Week 0 to Week 8)||0
11012481|NCT00758524|12189917|FG012|Treated|Core Period (Week 0 to Week 8)||0
11012482|NCT00758524|12189918|FG013|Treated|Core Period (Week 0 to Week 8)||0
11012483|NCT00758524|12189919|FG014|Treated|Core Period (Week 0 to Week 8)||0
11012484|NCT00758524|12189920|FG015|Treated|Core Period (Week 0 to Week 8)||0
11012485|NCT00758524|12189921|FG016|Treated|Core Period (Week 0 to Week 8)||0
11012486|NCT00758524|12189905|FG000|COMPLETED|Core Period (Week 0 to Week 8)||84
11012487|NCT00758524|12189906|FG001|COMPLETED|Core Period (Week 0 to Week 8)||81
11012488|NCT00758524|12189907|FG002|COMPLETED|Core Period (Week 0 to Week 8)||77
11012489|NCT00758524|12189908|FG003|COMPLETED|Core Period (Week 0 to Week 8)||90
11012490|NCT00758524|12189909|FG004|COMPLETED|Core Period (Week 0 to Week 8)||75
11012491|NCT00758524|12189910|FG005|COMPLETED|Core Period (Week 0 to Week 8)||67
11012492|NCT00758524|12189911|FG006|COMPLETED|Core Period (Week 0 to Week 8)||0
11012493|NCT00758524|12189912|FG007|COMPLETED|Core Period (Week 0 to Week 8)||0
11012494|NCT00758524|12189913|FG008|COMPLETED|Core Period (Week 0 to Week 8)||0
11012495|NCT00758524|12189914|FG009|COMPLETED|Core Period (Week 0 to Week 8)||0
11012496|NCT00758524|12189915|FG010|COMPLETED|Core Period (Week 0 to Week 8)||0
11012497|NCT00758524|12189916|FG011|COMPLETED|Core Period (Week 0 to Week 8)||0
11012498|NCT00758524|12189917|FG012|COMPLETED|Core Period (Week 0 to Week 8)||0
11012499|NCT00758524|12189918|FG013|COMPLETED|Core Period (Week 0 to Week 8)||0
11012500|NCT00758524|12189919|FG014|COMPLETED|Core Period (Week 0 to Week 8)||0
11012501|NCT00758524|12189920|FG015|COMPLETED|Core Period (Week 0 to Week 8)||0
11012502|NCT00758524|12189921|FG016|COMPLETED|Core Period (Week 0 to Week 8)||0
11012503|NCT00758524|12189905|FG000|NOT COMPLETED|Core Period (Week 0 to Week 8)||8
11012504|NCT00758524|12189906|FG001|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
11012505|NCT00758524|12189907|FG002|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
11012506|NCT00758524|12189908|FG003|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
11012507|NCT00758524|12189909|FG004|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
11012508|NCT00758524|12189910|FG005|NOT COMPLETED|Core Period (Week 0 to Week 8)||10
11012509|NCT00758524|12189911|FG006|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
11012510|NCT00758524|12189912|FG007|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
11012511|NCT00758524|12189913|FG008|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
11012512|NCT00758524|12189914|FG009|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
11012513|NCT00758524|12189915|FG010|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
11012514|NCT00758524|12189916|FG011|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
11012515|NCT00758524|12189917|FG012|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
11012516|NCT00758524|12189918|FG013|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
11012517|NCT00758524|12189919|FG014|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
11012518|NCT00758524|12189920|FG015|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
11012519|NCT00758524|12189921|FG016|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
11012520|NCT00758524|12189905|FG000|STARTED|Withdrawal Period (Week 8 to Week 9)||0
11012521|NCT00758524|12189906|FG001|STARTED|Withdrawal Period (Week 8 to Week 9)||0
11012522|NCT00758524|12189907|FG002|STARTED|Withdrawal Period (Week 8 to Week 9)||0
11012523|NCT00758524|12189908|FG003|STARTED|Withdrawal Period (Week 8 to Week 9)||0
11012524|NCT00758524|12189909|FG004|STARTED|Withdrawal Period (Week 8 to Week 9)||0
11012525|NCT00758524|12189910|FG005|STARTED|Withdrawal Period (Week 8 to Week 9)||0
11012526|NCT00758524|12189911|FG006|STARTED|Withdrawal Period (Week 8 to Week 9)||46
11012527|NCT00758524|12189912|FG007|STARTED|Withdrawal Period (Week 8 to Week 9)||38
11012528|NCT00758524|12189913|FG008|STARTED|Withdrawal Period (Week 8 to Week 9)||44
11012529|NCT00758524|12189914|FG009|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set.|37
11012530|NCT00758524|12189915|FG010|STARTED|Withdrawal Period (Week 8 to Week 9)||41
11012531|NCT00758524|12189916|FG011|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to LCI699 0.5 mg BID in the core period received LCI699 1.0 mg QD and was considered in the LCI699 1.0 mg QD arm in Randomized Withdrawal Safety Set.|37
11012532|NCT00758524|12189917|FG012|STARTED|Withdrawal Period (Week 8 to Week 9)||45
11012533|NCT00758524|12189918|FG013|STARTED|Withdrawal Period (Week 8 to Week 9)||45
11012534|NCT00758524|12189919|FG014|STARTED|Withdrawal Period (Week 8 to Week 9)||39
11012535|NCT00758524|12189920|FG015|STARTED|Withdrawal Period (Week 8 to Week 9)||36
11012536|NCT00758524|12189921|FG016|STARTED|Withdrawal Period (Week 8 to Week 9)||66
11012537|NCT00758524|12189905|FG000|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
11012538|NCT00758524|12189906|FG001|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
11012539|NCT00758524|12189907|FG002|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
11012540|NCT00758524|12189908|FG003|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
11012541|NCT00758524|12189909|FG004|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
11012542|NCT00758524|12189910|FG005|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
11012543|NCT00758524|12189911|FG006|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
11012544|NCT00758524|12189912|FG007|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||38
11012545|NCT00758524|12189913|FG008|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||43
11012546|NCT00758524|12189914|FG009|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||37
11012547|NCT00758524|12189915|FG010|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||41
11012548|NCT00758524|12189916|FG011|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
11012549|NCT00758524|12189917|FG012|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
11012550|NCT00758524|12189918|FG013|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||44
11012551|NCT00758524|12189919|FG014|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||39
11012552|NCT00758524|12189920|FG015|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
11012553|NCT00758524|12189921|FG016|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set. However, this participant was counted in the Placebo arm (N=67) in the Randomized Withdrawal Set.|67
11012554|NCT00758524|12189905|FG000|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012555|NCT00758524|12189906|FG001|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012556|NCT00758524|12189907|FG002|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012557|NCT00758524|12189908|FG003|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012558|NCT00758524|12189909|FG004|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012559|NCT00758524|12189910|FG005|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012560|NCT00758524|12189911|FG006|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
11012561|NCT00758524|12189912|FG007|COMPLETED|Withdrawal Period (Week 8 to Week 9)||38
11012562|NCT00758524|12189913|FG008|COMPLETED|Withdrawal Period (Week 8 to Week 9)||42
11012563|NCT00758524|12189914|FG009|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
11012564|NCT00758524|12189915|FG010|COMPLETED|Withdrawal Period (Week 8 to Week 9)||41
11012565|NCT00758524|12189916|FG011|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
11012566|NCT00758524|12189917|FG012|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
11012567|NCT00758524|12189918|FG013|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
11012568|NCT00758524|12189919|FG014|COMPLETED|Withdrawal Period (Week 8 to Week 9)||39
11012569|NCT00758524|12189920|FG015|COMPLETED|Withdrawal Period (Week 8 to Week 9)||36
11012570|NCT00758524|12189921|FG016|COMPLETED|Withdrawal Period (Week 8 to Week 9)||66
11012571|NCT00758524|12189905|FG000|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012572|NCT00758524|12189906|FG001|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012573|NCT00758524|12189907|FG002|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012574|NCT00758524|12189908|FG003|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012575|NCT00758524|12189909|FG004|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012576|NCT00758524|12189910|FG005|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012577|NCT00758524|12189911|FG006|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||1
11012578|NCT00758524|12189912|FG007|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012579|NCT00758524|12189913|FG008|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||2
11012580|NCT00758524|12189914|FG009|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012581|NCT00758524|12189915|FG010|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012582|NCT00758524|12189916|FG011|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012583|NCT00758524|12189917|FG012|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012584|NCT00758524|12189918|FG013|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012585|NCT00758524|12189919|FG014|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012586|NCT00758524|12189920|FG015|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012587|NCT00758524|12189921|FG016|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
11012588|NCT00758550|12189961|FG000|STARTED|Overall Study||30
11012589|NCT00758550|12189962|FG001|STARTED|Overall Study||30
11012590|NCT00758550|12189961|FG000|COMPLETED|Overall Study||30
11012591|NCT00758550|12189962|FG001|COMPLETED|Overall Study||30
11012592|NCT00758550|12189961|FG000|NOT COMPLETED|Overall Study||0
11012593|NCT00758550|12189962|FG001|NOT COMPLETED|Overall Study||0
11012594|NCT00758576|12189968|FG000|STARTED|Overall Study||64
11012595|NCT00758576|12189968|FG000|COMPLETED|Overall Study||63
11012596|NCT00758576|12189968|FG000|NOT COMPLETED|Overall Study||1
11012597|NCT00758589|12189976|FG000|STARTED|Overall Study||95
11012598|NCT00758589|12189977|FG001|STARTED|Overall Study||90
11012599|NCT00758589|12189978|FG002|STARTED|Overall Study||92
11012600|NCT00758589|12189979|FG003|STARTED|Overall Study||91
11012601|NCT00758589|12189976|FG000|COMPLETED|Overall Study||92
11012602|NCT00758589|12189977|FG001|COMPLETED|Overall Study||87
11012603|NCT00758589|12189978|FG002|COMPLETED|Overall Study||86
11012604|NCT00758589|12189979|FG003|COMPLETED|Overall Study||85
11012605|NCT00758589|12189976|FG000|NOT COMPLETED|Overall Study||3
11012606|NCT00758589|12189977|FG001|NOT COMPLETED|Overall Study||3
11012607|NCT00758589|12189978|FG002|NOT COMPLETED|Overall Study||6
11012608|NCT00758589|12189979|FG003|NOT COMPLETED|Overall Study||6
11012609|NCT00758602|12189991|FG000|STARTED|Overall Study||104
11012610|NCT00758602|12189992|FG001|STARTED|Overall Study||106
11012611|NCT00758602|12189991|FG000|COMPLETED|Overall Study||85
11012612|NCT00758602|12189992|FG001|COMPLETED|Overall Study||84
11012613|NCT00758602|12189991|FG000|NOT COMPLETED|Overall Study||19
11012614|NCT00758602|12189992|FG001|NOT COMPLETED|Overall Study||22
11012615|NCT00758667|12190001|FG000|STARTED|Overall Study||9
11012616|NCT00758667|12190002|FG001|STARTED|Overall Study||11
11012617|NCT00758667|12190001|FG000|COMPLETED|Overall Study||9
11012618|NCT00758667|12190002|FG001|COMPLETED|Overall Study||11
11012619|NCT00758667|12190001|FG000|NOT COMPLETED|Overall Study||0
11012620|NCT00758667|12190002|FG001|NOT COMPLETED|Overall Study||0
11012621|NCT00758680|12190009|FG000|STARTED|Overall Study||6
11012622|NCT00758680|12190010|FG001|STARTED|Overall Study||6
11012623|NCT00758680|12190011|FG002|STARTED|Overall Study||6
11012624|NCT00758680|12190012|FG003|STARTED|Overall Study||6
11012625|NCT00758680|12190013|FG004|STARTED|Overall Study||6
11012626|NCT00758680|12190014|FG005|STARTED|Overall Study||6
11012627|NCT00758680|12190015|FG006|STARTED|Overall Study||7
11012628|NCT00758680|12190016|FG007|STARTED|Overall Study||20
11012629|NCT00758680|12190017|FG008|STARTED|Overall Study||20
11012630|NCT00758680|12190018|FG009|STARTED|Overall Study||29
11012631|NCT00758680|12190009|FG000|COMPLETED|Overall Study||6
11012632|NCT00758680|12190010|FG001|COMPLETED|Overall Study||6
11012633|NCT00758680|12190011|FG002|COMPLETED|Overall Study||6
11012634|NCT00758680|12190012|FG003|COMPLETED|Overall Study||6
11012635|NCT00758680|12190013|FG004|COMPLETED|Overall Study||6
11012636|NCT00758680|12190014|FG005|COMPLETED|Overall Study||6
11012637|NCT00758680|12190015|FG006|COMPLETED|Overall Study||6
11012638|NCT00758680|12190016|FG007|COMPLETED|Overall Study||19
11012639|NCT00758680|12190017|FG008|COMPLETED|Overall Study||18
11012640|NCT00758680|12190018|FG009|COMPLETED|Overall Study||28
11012641|NCT00758680|12190009|FG000|NOT COMPLETED|Overall Study||0
11012642|NCT00758680|12190010|FG001|NOT COMPLETED|Overall Study||0
11012643|NCT00758680|12190011|FG002|NOT COMPLETED|Overall Study||0
11012644|NCT00758680|12190012|FG003|NOT COMPLETED|Overall Study||0
11012645|NCT00758680|12190013|FG004|NOT COMPLETED|Overall Study||0
11012646|NCT00758680|12190014|FG005|NOT COMPLETED|Overall Study||0
11012647|NCT00758680|12190015|FG006|NOT COMPLETED|Overall Study||1
11012648|NCT00758680|12190016|FG007|NOT COMPLETED|Overall Study||1
11012649|NCT00758680|12190017|FG008|NOT COMPLETED|Overall Study||2
11012650|NCT00758680|12190018|FG009|NOT COMPLETED|Overall Study||1
11012651|NCT00758706|12190043|FG000|STARTED|Overall Study||26
11012652|NCT00758706|12190044|FG001|STARTED|Overall Study||29
11012653|NCT00758706|12190043|FG000|COMPLETED|Overall Study||22
11012654|NCT00758706|12190044|FG001|COMPLETED|Overall Study||25
11012655|NCT00758706|12190043|FG000|NOT COMPLETED|Overall Study||4
11012656|NCT00758706|12190044|FG001|NOT COMPLETED|Overall Study||4
11012657|NCT00758745|12190052|FG000|STARTED|Overall Study||81
11012658|NCT00758745|12190053|FG001|STARTED|Overall Study||81
11012659|NCT00758745|12190052|FG000|COMPLETED|Overall Study||60
11012660|NCT00758745|12190053|FG001|COMPLETED|Overall Study||60
11012661|NCT00758745|12190052|FG000|NOT COMPLETED|Overall Study||21
11012662|NCT00758745|12190053|FG001|NOT COMPLETED|Overall Study||21
11012663|NCT00758758|12190067|FG000|STARTED|Overall Study||14
11012664|NCT00758758|12190068|FG001|STARTED|Overall Study||74
11012665|NCT00758758|12190069|FG002|STARTED|Overall Study||53
11012666|NCT00758758|12190070|FG003|STARTED|Overall Study||6
11012667|NCT00758758|12190071|FG004|STARTED|Overall Study||3
11012668|NCT00758758|12190072|FG005|STARTED|Overall Study||50
11012669|NCT00758758|12190073|FG006|STARTED|Overall Study||31
11012670|NCT00758758|12190074|FG007|STARTED|Overall Study||0
11012671|NCT00758758|12190067|FG000|COMPLETED|Overall Study||11
11012672|NCT00758758|12190068|FG001|COMPLETED|Overall Study||49
11012673|NCT00758758|12190069|FG002|COMPLETED|Overall Study||35
11012674|NCT00758758|12190070|FG003|COMPLETED|Overall Study||4
11012675|NCT00758758|12190071|FG004|COMPLETED|Overall Study||1
11012676|NCT00758758|12190072|FG005|COMPLETED|Overall Study||36
11012677|NCT00758758|12190073|FG006|COMPLETED|Overall Study||17
11012678|NCT00758758|12190074|FG007|COMPLETED|Overall Study||0
11012679|NCT00758758|12190067|FG000|NOT COMPLETED|Overall Study||3
11012680|NCT00758758|12190068|FG001|NOT COMPLETED|Overall Study||25
11012681|NCT00758758|12190069|FG002|NOT COMPLETED|Overall Study||18
11012682|NCT00758758|12190070|FG003|NOT COMPLETED|Overall Study||2
11012683|NCT00758758|12190071|FG004|NOT COMPLETED|Overall Study||2
11012684|NCT00758758|12190072|FG005|NOT COMPLETED|Overall Study||14
11012685|NCT00758758|12190073|FG006|NOT COMPLETED|Overall Study||14
11012686|NCT00758758|12190074|FG007|NOT COMPLETED|Overall Study||0
11012687|NCT00758771|12190102|FG000|STARTED|Overall Study||18
11012688|NCT00758771|12190103|FG001|STARTED|Overall Study||20
11012689|NCT00758771|12190102|FG000|COMPLETED|Overall Study||15
11012690|NCT00758771|12190103|FG001|COMPLETED|Overall Study||15
11012691|NCT00758771|12190102|FG000|NOT COMPLETED|Overall Study||3
11012692|NCT00758771|12190103|FG001|NOT COMPLETED|Overall Study||5
11012693|NCT00758784|12190109|FG000|STARTED|Overall Study||38
11012694|NCT00758784|12190109|FG000|COMPLETED|Overall Study||36
11012695|NCT00758784|12190109|FG000|NOT COMPLETED|Overall Study||2
11012696|NCT00758836|12190117|FG000|STARTED|Overall Study||171
11012697|NCT00758836|12190118|FG001|STARTED|Overall Study||171
11012698|NCT00758836|12190119|FG002|STARTED|Overall Study||171
11012699|NCT00758836|12190120|FG003|STARTED|Overall Study||170
11012700|NCT00758836|12190117|FG000|Treated|Overall Study||147
11012701|NCT00758836|12190118|FG001|Treated|Overall Study||145
11012702|NCT00758836|12190119|FG002|Treated|Overall Study||133
11012703|NCT00758836|12190120|FG003|Treated|Overall Study||138
11012704|NCT00758836|12190117|FG000|COMPLETED|Overall Study||147
11012705|NCT00758836|12190118|FG001|COMPLETED|Overall Study||145
11012706|NCT00758836|12190119|FG002|COMPLETED|Overall Study||133
11012707|NCT00758836|12190120|FG003|COMPLETED|Overall Study||138
11012708|NCT00758836|12190117|FG000|NOT COMPLETED|Overall Study||24
11012709|NCT00758836|12190118|FG001|NOT COMPLETED|Overall Study||26
11012710|NCT00758836|12190119|FG002|NOT COMPLETED|Overall Study||38
11012711|NCT00758836|12190120|FG003|NOT COMPLETED|Overall Study||32
11012712|NCT00758862|12190130|FG000|STARTED|Overall Study||20
11012713|NCT00758862|12190130|FG000|COMPLETED|Overall Study||19
11012714|NCT00758862|12190130|FG000|NOT COMPLETED|Overall Study||1
11012715|NCT00759031|12190136|FG000|STARTED|First Intervention (1 Day)||10
11012716|NCT00759031|12190137|FG001|STARTED|First Intervention (1 Day)||9
11012717|NCT00759031|12190136|FG000|COMPLETED|First Intervention (1 Day)||8
11012718|NCT00759031|12190137|FG001|COMPLETED|First Intervention (1 Day)||8
11012719|NCT00759031|12190136|FG000|NOT COMPLETED|First Intervention (1 Day)||2
11012720|NCT00759031|12190137|FG001|NOT COMPLETED|First Intervention (1 Day)||1
11012721|NCT00759031|12190136|FG000|STARTED|Washout After 1st Intervention (1 Week)||8
11012722|NCT00759031|12190137|FG001|STARTED|Washout After 1st Intervention (1 Week)||8
11012723|NCT00759031|12190136|FG000|COMPLETED|Washout After 1st Intervention (1 Week)||8
11012724|NCT00759031|12190137|FG001|COMPLETED|Washout After 1st Intervention (1 Week)||8
11012725|NCT00759031|12190136|FG000|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
11012726|NCT00759031|12190137|FG001|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
11012727|NCT00759031|12190136|FG000|STARTED|Second Intervention (1 Day)||8
11012728|NCT00759031|12190137|FG001|STARTED|Second Intervention (1 Day)||8
11012729|NCT00759031|12190136|FG000|COMPLETED|Second Intervention (1 Day)||8
11012730|NCT00759031|12190137|FG001|COMPLETED|Second Intervention (1 Day)||8
11012731|NCT00759031|12190136|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11012732|NCT00759031|12190137|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11012733|NCT00759096|12190143|FG000|STARTED|Overall Study||30
11012734|NCT00759096|12190143|FG000|COMPLETED|Overall Study||30
11012735|NCT00759096|12190143|FG000|NOT COMPLETED|Overall Study||0
11012736|NCT00759109|12190149|FG000|STARTED|Overall Study||74
11012737|NCT00759109|12190150|FG001|STARTED|Overall Study||76
11142846|NCT01469585|12329580|FG001|STARTED|Overall Study||9
11142847|NCT01469585|12329579|FG000|COMPLETED|Overall Study||4
11142848|NCT01469585|12329580|FG001|COMPLETED|Overall Study||6
11142849|NCT01469585|12329579|FG000|NOT COMPLETED|Overall Study||7
11142850|NCT01469585|12329580|FG001|NOT COMPLETED|Overall Study||3
11142851|NCT01469637|12329590|FG000|STARTED|First Intervention||22
11142852|NCT01469637|12329591|FG001|STARTED|First Intervention||22
11142853|NCT01469637|12329590|FG000|COMPLETED|First Intervention||22
11012738|NCT00759109|12190149|FG000|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
11012739|NCT00759109|12190150|FG001|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
11012740|NCT00759109|12190149|FG000|NOT COMPLETED|Overall Study||39
11012741|NCT00759109|12190150|FG001|NOT COMPLETED|Overall Study||35
11012742|NCT00759148|12190158|FG000|STARTED|Overall Study||593
11012743|NCT00759148|12190159|FG001|STARTED|Overall Study||586
11142854|NCT01469637|12329591|FG001|COMPLETED|First Intervention||21
11142855|NCT01469637|12329590|FG000|NOT COMPLETED|First Intervention||0
11012744|NCT00759148|12190158|FG000|COMPLETED|Overall Study||579
11012745|NCT00759148|12190159|FG001|COMPLETED|Overall Study||554
11012746|NCT00759148|12190158|FG000|NOT COMPLETED|Overall Study||14
11012747|NCT00759148|12190159|FG001|NOT COMPLETED|Overall Study||32
11012748|NCT00759161|12190165|FG000|STARTED|Overall Study||35
11012749|NCT00759161|12190165|FG000|COMPLETED|Overall Study||35
11012750|NCT00759161|12190165|FG000|NOT COMPLETED|Overall Study||0
11012751|NCT00759174|12190174|FG000|STARTED|Overall Study||76
11012752|NCT00759174|12190175|FG001|STARTED|Overall Study||597
11012753|NCT00759174|12190174|FG000|COMPLETED|Overall Study||76
11012754|NCT00759174|12190175|FG001|COMPLETED|Overall Study||595
11012755|NCT00759174|12190174|FG000|NOT COMPLETED|Overall Study||0
11012756|NCT00759174|12190175|FG001|NOT COMPLETED|Overall Study||2
11012757|NCT00759187|12190185|FG000|STARTED|Overall Study||8
11012758|NCT00759187|12190186|FG001|STARTED|Overall Study||8
11012759|NCT00759187|12190187|FG002|STARTED|Overall Study||9
11012760|NCT00759187|12190185|FG000|COMPLETED|Overall Study||8
11012761|NCT00759187|12190186|FG001|COMPLETED|Overall Study||8
11012762|NCT00759187|12190187|FG002|COMPLETED|Overall Study||9
11012763|NCT00759187|12190185|FG000|NOT COMPLETED|Overall Study||0
11012764|NCT00759187|12190186|FG001|NOT COMPLETED|Overall Study||0
11012765|NCT00759187|12190187|FG002|NOT COMPLETED|Overall Study||0
11012766|NCT00759330|12190199|FG000|STARTED|Overall Study||20
11012767|NCT00759330|12190200|FG001|STARTED|Overall Study||42
11012768|NCT00759330|12190201|FG002|STARTED|Overall Study||22
11012769|NCT00759330|12190202|FG003|STARTED|Overall Study||43
11012770|NCT00759330|12190199|FG000|COMPLETED|Overall Study||19
11012771|NCT00759330|12190200|FG001|COMPLETED|Overall Study||41
11012772|NCT00759330|12190201|FG002|COMPLETED|Overall Study||22
11012773|NCT00759330|12190202|FG003|COMPLETED|Overall Study||41
11012774|NCT00759330|12190199|FG000|NOT COMPLETED|Overall Study||1
11012775|NCT00759330|12190200|FG001|NOT COMPLETED|Overall Study||1
11012776|NCT00759330|12190201|FG002|NOT COMPLETED|Overall Study||0
11012777|NCT00759330|12190202|FG003|NOT COMPLETED|Overall Study||2
11012778|NCT00759356|12190215|FG000|STARTED|Overall Study||18
11012779|NCT00759356|12190216|FG001|STARTED|Overall Study||18
11142856|NCT01469637|12329591|FG001|NOT COMPLETED|First Intervention||1
11012780|NCT00759356|12190215|FG000|COMPLETED|Overall Study||17
11012781|NCT00759356|12190216|FG001|COMPLETED|Overall Study||15
11012782|NCT00759356|12190215|FG000|NOT COMPLETED|Overall Study||1
11012783|NCT00759356|12190216|FG001|NOT COMPLETED|Overall Study||3
11012784|NCT00759395|12190224|FG000|STARTED|Overall Study||13
11012785|NCT00759395|12190225|FG001|STARTED|Overall Study||9
11012786|NCT00759395|12190224|FG000|COMPLETED|Overall Study||11
11012787|NCT00759395|12190225|FG001|COMPLETED|Overall Study||7
11012788|NCT00759395|12190224|FG000|NOT COMPLETED|Overall Study||2
11012789|NCT00759395|12190225|FG001|NOT COMPLETED|Overall Study||2
11012790|NCT00759408|12190231|FG000|STARTED|Overall Study||38
11012791|NCT00759408|12190231|FG000|COMPLETED|Overall Study||19
11012792|NCT00759408|12190231|FG000|NOT COMPLETED|Overall Study||19
11012793|NCT00759473|12190240|FG000|STARTED|Overall Study||10
11012794|NCT00759473|12190241|FG001|STARTED|Overall Study||10
11012795|NCT00759473|12190242|FG002|STARTED|Overall Study||12
11012796|NCT00759473|12190243|FG003|STARTED|Overall Study||23
11012797|NCT00759473|12190244|FG004|STARTED|Overall Study||24
11012798|NCT00759473|12190240|FG000|COMPLETED|Overall Study||10
11012799|NCT00759473|12190241|FG001|COMPLETED|Overall Study||10
11012800|NCT00759473|12190242|FG002|COMPLETED|Overall Study||12
11012801|NCT00759473|12190243|FG003|COMPLETED|Overall Study||23
11012802|NCT00759473|12190244|FG004|COMPLETED|Overall Study||24
11012803|NCT00759473|12190240|FG000|NOT COMPLETED|Overall Study||0
11012804|NCT00759473|12190241|FG001|NOT COMPLETED|Overall Study||0
11012805|NCT00759473|12190242|FG002|NOT COMPLETED|Overall Study||0
11012806|NCT00759473|12190243|FG003|NOT COMPLETED|Overall Study||0
11012807|NCT00759473|12190244|FG004|NOT COMPLETED|Overall Study||0
11012808|NCT00759525|12190256|FG000|STARTED|First Intervention (14 Days)||7
11012809|NCT00759525|12190257|FG001|STARTED|First Intervention (14 Days)||8
11012810|NCT00759525|12190256|FG000|COMPLETED|First Intervention (14 Days)||7
11012811|NCT00759525|12190257|FG001|COMPLETED|First Intervention (14 Days)||8
11012812|NCT00759525|12190256|FG000|NOT COMPLETED|First Intervention (14 Days)||0
11012813|NCT00759525|12190257|FG001|NOT COMPLETED|First Intervention (14 Days)||0
11012814|NCT00759525|12190256|FG000|STARTED|Washout (14 Days)||7
11012815|NCT00759525|12190257|FG001|STARTED|Washout (14 Days)||8
11012816|NCT00759525|12190256|FG000|COMPLETED|Washout (14 Days)||7
11012817|NCT00759525|12190257|FG001|COMPLETED|Washout (14 Days)||8
11012818|NCT00759525|12190256|FG000|NOT COMPLETED|Washout (14 Days)||0
11142857|NCT01469637|12329590|FG000|STARTED|Second Intervention||22
11142858|NCT01469637|12329591|FG001|STARTED|Second Intervention||21
11142859|NCT01469637|12329590|FG000|COMPLETED|Second Intervention||21
11142860|NCT01469637|12329591|FG001|COMPLETED|Second Intervention||21
11142861|NCT01469637|12329590|FG000|NOT COMPLETED|Second Intervention||1
11142862|NCT01469637|12329591|FG001|NOT COMPLETED|Second Intervention||0
11142863|NCT01469715|12329597|FG000|STARTED|Overall Study||16
11142864|NCT01469715|12329597|FG000|COMPLETED|Overall Study||16
11142865|NCT01469715|12329597|FG000|NOT COMPLETED|Overall Study||0
11142866|NCT01469767|12329601|FG000|STARTED|Overall Study||10
11142867|NCT01469767|12329601|FG000|COMPLETED|Overall Study||10
11142868|NCT01469767|12329601|FG000|NOT COMPLETED|Overall Study||0
11012819|NCT00759525|12190257|FG001|NOT COMPLETED|Washout (14 Days)||0
11012820|NCT00759525|12190256|FG000|STARTED|Second Intervention (14 Days)||7
11142869|NCT01469819|12329605|FG000|STARTED|Overall Study||37
11142870|NCT01469819|12329605|FG000|COMPLETED|Overall Study||29
11142871|NCT01469819|12329605|FG000|NOT COMPLETED|Overall Study||8
11142872|NCT01470001|12329617|FG000|STARTED|Overall Study||58
11142873|NCT01470001|12329618|FG001|STARTED|Overall Study||60
11142874|NCT01470001|12329617|FG000|COMPLETED|Overall Study||53
11142875|NCT01470001|12329618|FG001|COMPLETED|Overall Study||58
11142876|NCT01470001|12329617|FG000|NOT COMPLETED|Overall Study||5
11142877|NCT01470001|12329618|FG001|NOT COMPLETED|Overall Study||2
11142878|NCT01470027|12329630|FG000|STARTED|Overall Study||16
11142879|NCT01470027|12329631|FG001|STARTED|Overall Study||15
11142880|NCT01470027|12329632|FG002|STARTED|Overall Study||16
11142881|NCT01470027|12329630|FG000|COMPLETED|Overall Study||15
11142882|NCT01470027|12329631|FG001|COMPLETED|Overall Study||14
11142883|NCT01470027|12329632|FG002|COMPLETED|Overall Study||15
11142884|NCT01470027|12329630|FG000|NOT COMPLETED|Overall Study||1
11142885|NCT01470027|12329631|FG001|NOT COMPLETED|Overall Study||1
11142886|NCT01470027|12329632|FG002|NOT COMPLETED|Overall Study||1
11142887|NCT01470118|12329649|FG000|STARTED|Overall Study||43
11142888|NCT01470118|12329650|FG001|STARTED|Overall Study||43
11142889|NCT01470118|12329651|FG002|STARTED|Overall Study||41
11142890|NCT01470118|12329649|FG000|COMPLETED|Overall Study||38
11142891|NCT01470118|12329650|FG001|COMPLETED|Overall Study||38
11142892|NCT01470118|12329651|FG002|COMPLETED|Overall Study||39
11142893|NCT01470118|12329649|FG000|NOT COMPLETED|Overall Study||5
11142894|NCT01470118|12329650|FG001|NOT COMPLETED|Overall Study||5
11142895|NCT01470118|12329651|FG002|NOT COMPLETED|Overall Study||2
11142896|NCT01470144|12329659|FG000|STARTED|Overall Study||41
11142897|NCT01470144|12329659|FG000|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
11142898|NCT01470144|12329659|FG000|NOT COMPLETED|Overall Study||10
11142899|NCT01470170|12329668|FG000|STARTED|Overall Study||34
11142900|NCT01470170|12329669|FG001|STARTED|Overall Study||35
11142901|NCT01470170|12329670|FG002|STARTED|Overall Study||34
11142902|NCT01470170|12329671|FG003|STARTED|Overall Study||36
11012821|NCT00759525|12190257|FG001|STARTED|Second Intervention (14 Days)||8
11012822|NCT00759525|12190256|FG000|COMPLETED|Second Intervention (14 Days)||7
11012823|NCT00759525|12190257|FG001|COMPLETED|Second Intervention (14 Days)||8
11012824|NCT00759525|12190256|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
11012825|NCT00759525|12190257|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
11012826|NCT00759564|12190268|FG000|STARTED|First Intervention Period (4 Days)||8
11012827|NCT00759564|12190269|FG001|STARTED|First Intervention Period (4 Days)||8
11012828|NCT00759564|12190270|FG002|STARTED|First Intervention Period (4 Days)||8
11012829|NCT00759564|12190271|FG003|STARTED|First Intervention Period (4 Days)||1
11012830|NCT00759564|12190272|FG004|STARTED|First Intervention Period (4 Days)||4
11012831|NCT00759564|12190268|FG000|COMPLETED|First Intervention Period (4 Days)||8
11012832|NCT00759564|12190269|FG001|COMPLETED|First Intervention Period (4 Days)||8
11012833|NCT00759564|12190270|FG002|COMPLETED|First Intervention Period (4 Days)||8
11012834|NCT00759564|12190271|FG003|COMPLETED|First Intervention Period (4 Days)||1
11012835|NCT00759564|12190272|FG004|COMPLETED|First Intervention Period (4 Days)||4
11012836|NCT00759564|12190268|FG000|NOT COMPLETED|First Intervention Period (4 Days)||0
11012837|NCT00759564|12190269|FG001|NOT COMPLETED|First Intervention Period (4 Days)||0
11012838|NCT00759564|12190270|FG002|NOT COMPLETED|First Intervention Period (4 Days)||0
11012839|NCT00759564|12190271|FG003|NOT COMPLETED|First Intervention Period (4 Days)||0
11012840|NCT00759564|12190272|FG004|NOT COMPLETED|First Intervention Period (4 Days)||0
11012841|NCT00759564|12190268|FG000|STARTED|Washout Period (at Least 14 Days)||8
11012842|NCT00759564|12190269|FG001|STARTED|Washout Period (at Least 14 Days)||8
11396358|NCT03725982|12590203|FG000|STARTED|First Intervention||20
11396359|NCT03725982|12590204|FG001|STARTED|First Intervention||19
11396360|NCT03725982|12590203|FG000|COMPLETED|First Intervention||19
11396361|NCT03725982|12590204|FG001|COMPLETED|First Intervention||17
11396362|NCT03725982|12590203|FG000|NOT COMPLETED|First Intervention||1
11396363|NCT03725982|12590204|FG001|NOT COMPLETED|First Intervention||2
11396364|NCT03725982|12590203|FG000|STARTED|Second Intervention||19
11396365|NCT03725982|12590204|FG001|STARTED|Second Intervention||17
11396366|NCT03725982|12590203|FG000|COMPLETED|Second Intervention||19
11396367|NCT03725982|12590204|FG001|COMPLETED|Second Intervention||17
11012843|NCT00759564|12190270|FG002|STARTED|Washout Period (at Least 14 Days)||8
11012844|NCT00759564|12190271|FG003|STARTED|Washout Period (at Least 14 Days)||1
11012845|NCT00759564|12190272|FG004|STARTED|Washout Period (at Least 14 Days)||4
11012846|NCT00759564|12190268|FG000|COMPLETED|Washout Period (at Least 14 Days)||8
11012847|NCT00759564|12190269|FG001|COMPLETED|Washout Period (at Least 14 Days)||8
11012848|NCT00759564|12190270|FG002|COMPLETED|Washout Period (at Least 14 Days)||8
11012849|NCT00759564|12190271|FG003|COMPLETED|Washout Period (at Least 14 Days)||1
11012850|NCT00759564|12190272|FG004|COMPLETED|Washout Period (at Least 14 Days)||3
11012851|NCT00759564|12190268|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11012852|NCT00759564|12190269|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11012853|NCT00759564|12190270|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11012854|NCT00759564|12190271|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11012855|NCT00759564|12190272|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||1
11012856|NCT00759564|12190268|FG000|STARTED|Second Intervention Period (4 Days)||8
11012857|NCT00759564|12190269|FG001|STARTED|Second Intervention Period (4 Days)||8
11142903|NCT01470170|12329672|FG004|STARTED|Overall Study||34
11142904|NCT01470170|12329668|FG000|COMPLETED|Overall Study||34
11142905|NCT01470170|12329669|FG001|COMPLETED|Overall Study||35
11012858|NCT00759564|12190270|FG002|STARTED|Second Intervention Period (4 Days)||8
11012859|NCT00759564|12190271|FG003|STARTED|Second Intervention Period (4 Days)||1
11012860|NCT00759564|12190272|FG004|STARTED|Second Intervention Period (4 Days)||3
11012861|NCT00759564|12190268|FG000|COMPLETED|Second Intervention Period (4 Days)||8
11012862|NCT00759564|12190269|FG001|COMPLETED|Second Intervention Period (4 Days)||8
11012863|NCT00759564|12190270|FG002|COMPLETED|Second Intervention Period (4 Days)||8
11012864|NCT00759564|12190271|FG003|COMPLETED|Second Intervention Period (4 Days)||1
11012865|NCT00759564|12190272|FG004|COMPLETED|Second Intervention Period (4 Days)||3
11396368|NCT03725982|12590203|FG000|NOT COMPLETED|Second Intervention||0
11396369|NCT03725982|12590204|FG001|NOT COMPLETED|Second Intervention||0
11396370|NCT03736967|12590220|FG000|STARTED|Overall Study||51
11012866|NCT00759564|12190268|FG000|NOT COMPLETED|Second Intervention Period (4 Days)||0
11012867|NCT00759564|12190269|FG001|NOT COMPLETED|Second Intervention Period (4 Days)||0
11012868|NCT00759564|12190270|FG002|NOT COMPLETED|Second Intervention Period (4 Days)||0
11012869|NCT00759564|12190271|FG003|NOT COMPLETED|Second Intervention Period (4 Days)||0
11012870|NCT00759564|12190272|FG004|NOT COMPLETED|Second Intervention Period (4 Days)||0
11012871|NCT00759603|12190304|FG000|STARTED|Overall Study||59
11012872|NCT00759603|12190304|FG000|COMPLETED|Overall Study||59
11012873|NCT00759603|12190304|FG000|NOT COMPLETED|Overall Study||0
11012874|NCT00759642|12190308|FG000|STARTED|Overall Study||33
11012875|NCT00759642|12190308|FG000|COMPLETED|Overall Study||33
11012876|NCT00759642|12190308|FG000|NOT COMPLETED|Overall Study||0
11396371|NCT03736967|12590221|FG001|STARTED|Overall Study||52
11396372|NCT03736967|12590222|FG002|STARTED|Overall Study||51
11012877|NCT00759668|12190314|FG000|STARTED|Overall Study||17
11012878|NCT00759668|12190315|FG001|STARTED|Overall Study||18
11012879|NCT00759668|12190314|FG000|COMPLETED|Overall Study||16
11396373|NCT03736967|12590223|FG003|STARTED|Overall Study||52
11396374|NCT03736967|12590220|FG000|Treated|Overall Study||50
11396375|NCT03736967|12590221|FG001|Treated|Overall Study||52
11012880|NCT00759668|12190315|FG001|COMPLETED|Overall Study||15
11012881|NCT00759668|12190314|FG000|NOT COMPLETED|Overall Study||1
11012882|NCT00759668|12190315|FG001|NOT COMPLETED|Overall Study||3
11012883|NCT00759681|12190323|FG000|STARTED|Overall Study||107
11012884|NCT00759681|12190324|FG001|STARTED|Overall Study||110
11012885|NCT00759681|12190323|FG000|COMPLETED|Overall Study||97
11012886|NCT00759681|12190324|FG001|COMPLETED|Overall Study||100
11012887|NCT00759681|12190323|FG000|NOT COMPLETED|Overall Study||10
11012888|NCT00759681|12190324|FG001|NOT COMPLETED|Overall Study||10
11396376|NCT03736967|12590222|FG002|Treated|Overall Study||51
11396377|NCT03736967|12590223|FG003|Treated|Overall Study||52
11396378|NCT03736967|12590220|FG000|COMPLETED|Overall Study||20
11396379|NCT03736967|12590221|FG001|COMPLETED|Overall Study||24
11396380|NCT03736967|12590222|FG002|COMPLETED|Overall Study||27
11396381|NCT03736967|12590223|FG003|COMPLETED|Overall Study||22
11396382|NCT03736967|12590220|FG000|NOT COMPLETED|Overall Study||31
11012889|NCT00759707|12190331|FG000|STARTED|Overall Study||19
11012890|NCT00759707|12190331|FG000|COMPLETED|Overall Study||19
11012891|NCT00759707|12190331|FG000|NOT COMPLETED|Overall Study||0
11012892|NCT00759759|12190337|FG000|STARTED|Overall Study||18
11012893|NCT00759759|12190338|FG001|STARTED|Overall Study||18
11012894|NCT00759759|12190337|FG000|COMPLETED|Overall Study||14
11012895|NCT00759759|12190338|FG001|COMPLETED|Overall Study||17
11012896|NCT00759759|12190337|FG000|NOT COMPLETED|Overall Study||4
11012897|NCT00759759|12190338|FG001|NOT COMPLETED|Overall Study||1
11012898|NCT00759772|12190346|FG000|STARTED|Overall Study||12
11012899|NCT00759772|12190347|FG001|STARTED|Overall Study||11
11012900|NCT00759772|12190346|FG000|COMPLETED|Overall Study||12
11012901|NCT00759772|12190347|FG001|COMPLETED|Overall Study||11
11012902|NCT00759772|12190346|FG000|NOT COMPLETED|Overall Study||0
11012903|NCT00759772|12190347|FG001|NOT COMPLETED|Overall Study||0
11012904|NCT00759785|12190355|FG000|STARTED|Overall Study||26
11012905|NCT00759785|12190356|FG001|STARTED|Overall Study||22
11012906|NCT00759785|12190355|FG000|Treated|Overall Study||25
11012907|NCT00759785|12190356|FG001|Treated|Overall Study||20
11012908|NCT00759785|12190355|FG000|COMPLETED|Overall Study||14
11012909|NCT00759785|12190356|FG001|COMPLETED|Overall Study||17
11012910|NCT00759785|12190355|FG000|NOT COMPLETED|Overall Study||12
11012911|NCT00759785|12190356|FG001|NOT COMPLETED|Overall Study||5
11012912|NCT00759798|12190362|FG000|STARTED|Overall Study||289
11012913|NCT00759798|12190362|FG000|COMPLETED|Overall Study||289
11012914|NCT00759798|12190362|FG000|NOT COMPLETED|Overall Study||0
11012915|NCT00759811|12190368|FG000|STARTED|Overall Study||25
11012916|NCT00759811|12190369|FG001|STARTED|Overall Study||25
11012917|NCT00759811|12190368|FG000|COMPLETED|Overall Study||23
11012918|NCT00759811|12190369|FG001|COMPLETED|Overall Study||24
11012919|NCT00759811|12190368|FG000|NOT COMPLETED|Overall Study||2
11012920|NCT00759811|12190369|FG001|NOT COMPLETED|Overall Study||1
11012921|NCT00759863|12190377|FG000|STARTED|Overall Study||144
11012922|NCT00759863|12190378|FG001|STARTED|Overall Study||98
11012923|NCT00759863|12190377|FG000|COMPLETED|Overall Study||124
11012924|NCT00759863|12190378|FG001|COMPLETED|Overall Study||80
11012925|NCT00759863|12190377|FG000|NOT COMPLETED|Overall Study||20
11012926|NCT00759863|12190378|FG001|NOT COMPLETED|Overall Study||18
11012927|NCT00759876|12190384|FG000|STARTED|Overall Study||36
11012928|NCT00759876|12190384|FG000|As-Treated Population|Overall Study||36
11396383|NCT03736967|12590221|FG001|NOT COMPLETED|Overall Study||28
11012929|NCT00759876|12190384|FG000|Evaluable Population|Overall Study||35
11012930|NCT00759876|12190384|FG000|Ambulatory Evaluable Population|Overall Study||24
11012931|NCT00759876|12190384|FG000|COMPLETED|Overall Study||0
11012932|NCT00759876|12190384|FG000|NOT COMPLETED|Overall Study||36
11012933|NCT00759902|12190390|FG000|STARTED|Overall Study||18
11012934|NCT00759902|12190391|FG001|STARTED|Overall Study||18
11012935|NCT00759902|12190390|FG000|COMPLETED|Overall Study||18
11012936|NCT00759902|12190391|FG001|COMPLETED|Overall Study||17
11012937|NCT00759902|12190390|FG000|NOT COMPLETED|Overall Study||0
11012938|NCT00759902|12190391|FG001|NOT COMPLETED|Overall Study||1
11012939|NCT00759915|12190399|FG000|STARTED|Overall Study||18
11012940|NCT00759915|12190400|FG001|STARTED|Overall Study||18
11012941|NCT00759915|12190399|FG000|COMPLETED|Overall Study||17
11012942|NCT00759915|12190400|FG001|COMPLETED|Overall Study||17
11012943|NCT00759915|12190399|FG000|NOT COMPLETED|Overall Study||1
11012944|NCT00759915|12190400|FG001|NOT COMPLETED|Overall Study||1
11012945|NCT00759941|12190408|FG000|STARTED|Overall Study||42
11012946|NCT00759941|12190409|FG001|STARTED|Overall Study||44
11012947|NCT00759941|12190408|FG000|COMPLETED|Overall Study||39
11012948|NCT00759941|12190409|FG001|COMPLETED|Overall Study||43
11012949|NCT00759941|12190408|FG000|NOT COMPLETED|Overall Study||3
11012950|NCT00759941|12190409|FG001|NOT COMPLETED|Overall Study||1
11012951|NCT00759954|12190417|FG000|STARTED|Overall Study|All assigned participants entered trial|18
11012952|NCT00759954|12190418|FG001|STARTED|Overall Study|All assigned participants entered trial|18
11012953|NCT00759954|12190417|FG000|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
11012954|NCT00759954|12190418|FG001|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
11396384|NCT03736967|12590222|FG002|NOT COMPLETED|Overall Study||24
11396385|NCT03736967|12590223|FG003|NOT COMPLETED|Overall Study||30
11396386|NCT03739840|12590240|FG000|STARTED|Treatment Period: Wk0-16||56
11396387|NCT03739840|12590241|FG001|STARTED|Treatment Period: Wk0-16||60
11012955|NCT00759954|12190417|FG000|NOT COMPLETED|Overall Study||2
11012956|NCT00759954|12190418|FG001|NOT COMPLETED|Overall Study||2
11012957|NCT00759967|12190424|FG000|STARTED|First Intervention||10
11012958|NCT00759967|12190425|FG001|STARTED|First Intervention||9
11012959|NCT00759967|12190424|FG000|COMPLETED|First Intervention||10
11012960|NCT00759967|12190425|FG001|COMPLETED|First Intervention||9
11012961|NCT00759967|12190424|FG000|NOT COMPLETED|First Intervention||0
11012962|NCT00759967|12190425|FG001|NOT COMPLETED|First Intervention||0
11012963|NCT00759967|12190424|FG000|STARTED|Second Intervention||10
11012964|NCT00759967|12190425|FG001|STARTED|Second Intervention||9
11012965|NCT00759967|12190424|FG000|COMPLETED|Second Intervention||8
11012966|NCT00759967|12190425|FG001|COMPLETED|Second Intervention||9
11012967|NCT00759967|12190424|FG000|NOT COMPLETED|Second Intervention||2
11012968|NCT00759967|12190425|FG001|NOT COMPLETED|Second Intervention||0
11012969|NCT00760006|12190437|FG000|STARTED|Overall Study||86
11012970|NCT00760006|12190438|FG001|STARTED|Overall Study||138
11012971|NCT00760006|12190437|FG000|COMPLETED|Overall Study||86
11012972|NCT00760006|12190438|FG001|COMPLETED|Overall Study||138
11012973|NCT00760006|12190437|FG000|NOT COMPLETED|Overall Study||0
11012974|NCT00760006|12190438|FG001|NOT COMPLETED|Overall Study||0
11012975|NCT00760019|12190446|FG000|STARTED|Overall Study||15
11012976|NCT00760019|12190447|FG001|STARTED|Overall Study||15
11012977|NCT00760019|12190448|FG002|STARTED|Overall Study||14
11012978|NCT00760019|12190449|FG003|STARTED|Overall Study||14
11012979|NCT00760019|12190446|FG000|COMPLETED|Overall Study||15
11012980|NCT00760019|12190447|FG001|COMPLETED|Overall Study||15
11012981|NCT00760019|12190448|FG002|COMPLETED|Overall Study||14
11012982|NCT00760019|12190449|FG003|COMPLETED|Overall Study||14
11012983|NCT00760019|12190446|FG000|NOT COMPLETED|Overall Study||0
11012984|NCT00760019|12190447|FG001|NOT COMPLETED|Overall Study||0
11012985|NCT00760019|12190448|FG002|NOT COMPLETED|Overall Study||0
11012986|NCT00760019|12190449|FG003|NOT COMPLETED|Overall Study||0
11012987|NCT00760084|12190455|FG000|STARTED|Overall Study||10
11012988|NCT00760084|12190455|FG000|COMPLETED|Overall Study||0
11012989|NCT00760084|12190455|FG000|NOT COMPLETED|Overall Study||10
11012990|NCT00760214|12190462|FG000|STARTED|Overall Study||295
11012991|NCT00760214|12190463|FG001|STARTED|Overall Study||294
11012992|NCT00760214|12190464|FG002|STARTED|Overall Study||296
11012993|NCT00760214|12190462|FG000|COMPLETED|Overall Study||265
11012994|NCT00760214|12190463|FG001|COMPLETED|Overall Study||264
11012995|NCT00760214|12190464|FG002|COMPLETED|Overall Study||255
11012996|NCT00760214|12190462|FG000|NOT COMPLETED|Overall Study||30
11012997|NCT00760214|12190463|FG001|NOT COMPLETED|Overall Study||30
11012998|NCT00760214|12190464|FG002|NOT COMPLETED|Overall Study||41
11012999|NCT00760266|12190474|FG000|STARTED|Overall Study||228
11013000|NCT00760266|12190475|FG001|STARTED|Overall Study||223
11013001|NCT00760266|12190474|FG000|COMPLETED|Overall Study||204
11013002|NCT00760266|12190475|FG001|COMPLETED|Overall Study||205
11013003|NCT00760266|12190474|FG000|NOT COMPLETED|Overall Study||24
11013004|NCT00760266|12190475|FG001|NOT COMPLETED|Overall Study||18
11013005|NCT00760383|12190483|FG000|STARTED|Overall Study||21
11013006|NCT00760383|12190484|FG001|STARTED|Overall Study||19
11013007|NCT00760383|12190483|FG000|COMPLETED|Overall Study||16
11013008|NCT00760383|12190484|FG001|COMPLETED|Overall Study||12
11013009|NCT00760383|12190483|FG000|NOT COMPLETED|Overall Study||5
11013010|NCT00760383|12190484|FG001|NOT COMPLETED|Overall Study||7
11013011|NCT00760435|12190492|FG000|STARTED|Overall Study||98
11013012|NCT00760435|12190493|FG001|STARTED|Overall Study||98
11013013|NCT00760435|12190492|FG000|COMPLETED|Overall Study||94
11013014|NCT00760435|12190493|FG001|COMPLETED|Overall Study||93
11013015|NCT00760435|12190492|FG000|NOT COMPLETED|Overall Study||4
11013016|NCT00760435|12190493|FG001|NOT COMPLETED|Overall Study||5
11013017|NCT00760474|12190499|FG000|STARTED|Period 1 (P1)||13
11013018|NCT00760474|12190500|FG001|STARTED|Period 1 (P1)||14
11013019|NCT00760474|12190499|FG000|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
11013020|NCT00760474|12190500|FG001|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
11013021|NCT00760474|12190499|FG000|Overall Number of Unique Participants|Period 1 (P1)||12
11013022|NCT00760474|12190500|FG001|Overall Number of Unique Participants|Period 1 (P1)||13
11013023|NCT00760474|12190499|FG000|COMPLETED|Period 1 (P1)||12
11013024|NCT00760474|12190500|FG001|COMPLETED|Period 1 (P1)||13
11013025|NCT00760474|12190499|FG000|NOT COMPLETED|Period 1 (P1)||1
11013026|NCT00760474|12190500|FG001|NOT COMPLETED|Period 1 (P1)||1
11013027|NCT00760474|12190499|FG000|STARTED|Placebo Washout Period||12
11013028|NCT00760474|12190500|FG001|STARTED|Placebo Washout Period||13
11013029|NCT00760474|12190499|FG000|COMPLETED|Placebo Washout Period||12
11013030|NCT00760474|12190500|FG001|COMPLETED|Placebo Washout Period||12
11013031|NCT00760474|12190499|FG000|NOT COMPLETED|Placebo Washout Period||0
11013032|NCT00760474|12190500|FG001|NOT COMPLETED|Placebo Washout Period||1
11013033|NCT00760474|12190499|FG000|STARTED|Period 2 (P2)||12
11013034|NCT00760474|12190500|FG001|STARTED|Period 2 (P2)||12
11013035|NCT00760474|12190499|FG000|COMPLETED|Period 2 (P2)||11
11013036|NCT00760474|12190500|FG001|COMPLETED|Period 2 (P2)||11
11013037|NCT00760474|12190499|FG000|NOT COMPLETED|Period 2 (P2)||1
11013038|NCT00760474|12190500|FG001|NOT COMPLETED|Period 2 (P2)||1
11013039|NCT00760487|12190507|FG000|STARTED|Overall Study||120
11013040|NCT00760487|12190507|FG000|COMPLETED|Overall Study||117
11013041|NCT00760487|12190507|FG000|NOT COMPLETED|Overall Study||3
11013042|NCT00760513|12190513|FG000|STARTED|Overall Study||51
11013043|NCT00760513|12190514|FG001|STARTED|Overall Study||52
11013044|NCT00760513|12190513|FG000|COMPLETED|Overall Study||46
11013045|NCT00760513|12190514|FG001|COMPLETED|Overall Study||45
11013046|NCT00760513|12190513|FG000|NOT COMPLETED|Overall Study||5
11013047|NCT00760513|12190514|FG001|NOT COMPLETED|Overall Study||7
11013048|NCT00760526|12190524|FG000|STARTED|Overall Study||74
11013049|NCT00760526|12190525|FG001|STARTED|Overall Study||72
11013050|NCT00760526|12190524|FG000|COMPLETED|Overall Study||69
11013051|NCT00760526|12190525|FG001|COMPLETED|Overall Study||68
11013052|NCT00760526|12190524|FG000|NOT COMPLETED|Overall Study||5
11013053|NCT00760526|12190525|FG001|NOT COMPLETED|Overall Study||4
11013054|NCT00760552|12190540|FG000|STARTED|Overall Study||61
11013055|NCT00760552|12190541|FG001|STARTED|Overall Study||62
11013056|NCT00760552|12190540|FG000|COMPLETED|Overall Study||48
11013057|NCT00760552|12190541|FG001|COMPLETED|Overall Study||52
11013058|NCT00760552|12190540|FG000|NOT COMPLETED|Overall Study||13
11013059|NCT00760552|12190541|FG001|NOT COMPLETED|Overall Study||10
11013060|NCT00760578|12190551|FG000|STARTED|Overall Study||22
11013061|NCT00760578|12190552|FG001|STARTED|Overall Study||21
11013062|NCT00760578|12190553|FG002|STARTED|Overall Study||21
11013063|NCT00760578|12190554|FG003|STARTED|Overall Study||22
11013064|NCT00760578|12190551|FG000|Entered Drug Treatment Period|Overall Study||21
11013065|NCT00760578|12190552|FG001|Entered Drug Treatment Period|Overall Study||20
11013066|NCT00760578|12190553|FG002|Entered Drug Treatment Period|Overall Study||19
11013067|NCT00760578|12190554|FG003|Entered Drug Treatment Period|Overall Study||22
11013068|NCT00760578|12190551|FG000|COMPLETED|Overall Study||19
11013069|NCT00760578|12190552|FG001|COMPLETED|Overall Study||19
11013070|NCT00760578|12190553|FG002|COMPLETED|Overall Study||16
11013071|NCT00760578|12190554|FG003|COMPLETED|Overall Study||18
11013072|NCT00760578|12190551|FG000|NOT COMPLETED|Overall Study||3
11013073|NCT00760578|12190552|FG001|NOT COMPLETED|Overall Study||2
11013074|NCT00760578|12190553|FG002|NOT COMPLETED|Overall Study||5
11013075|NCT00760578|12190554|FG003|NOT COMPLETED|Overall Study||4
11013076|NCT00760617|12190572|FG000|STARTED|Overall Study||266
11013077|NCT00760617|12190573|FG001|STARTED|Overall Study||144
11013078|NCT00760617|12190574|FG002|STARTED|Overall Study||116
11013079|NCT00760617|12190572|FG000|COMPLETED|Overall Study||261
11013080|NCT00760617|12190573|FG001|COMPLETED|Overall Study||142
11013081|NCT00760617|12190574|FG002|COMPLETED|Overall Study||111
11013082|NCT00760617|12190572|FG000|NOT COMPLETED|Overall Study||5
11013083|NCT00760617|12190573|FG001|NOT COMPLETED|Overall Study||2
11013084|NCT00760617|12190574|FG002|NOT COMPLETED|Overall Study||5
11013085|NCT00760669|12190582|FG000|STARTED|Overall Study||1061
11013086|NCT00760669|12190582|FG000|COMPLETED|Overall Study||1031
11013087|NCT00760669|12190582|FG000|NOT COMPLETED|Overall Study||30
11013088|NCT00760747|12190588|FG000|STARTED|Study Period II||57
11013089|NCT00760747|12190589|FG001|STARTED|Study Period II||55
11013090|NCT00760747|12190588|FG000|Received at Least One Dose of Study Drug|Study Period II||57
11013091|NCT00760747|12190589|FG001|Received at Least One Dose of Study Drug|Study Period II||54
11013092|NCT00760747|12190588|FG000|COMPLETED|Study Period II||44
11013093|NCT00760747|12190589|FG001|COMPLETED|Study Period II||41
11013094|NCT00760747|12190588|FG000|NOT COMPLETED|Study Period II||13
11013095|NCT00760747|12190589|FG001|NOT COMPLETED|Study Period II||14
11013096|NCT00760747|12190588|FG000|STARTED|Study Period III||44
11013097|NCT00760747|12190589|FG001|STARTED|Study Period III||41
11013098|NCT00760747|12190588|FG000|COMPLETED|Study Period III||41
11013099|NCT00760747|12190589|FG001|COMPLETED|Study Period III||38
11013100|NCT00760747|12190588|FG000|NOT COMPLETED|Study Period III||3
11013101|NCT00760747|12190589|FG001|NOT COMPLETED|Study Period III||3
11013102|NCT00760838|12190597|FG000|STARTED|Overall Study||54
11013103|NCT00760838|12190598|FG001|STARTED|Overall Study||55
11013104|NCT00760838|12190597|FG000|COMPLETED|Overall Study||49
11013105|NCT00760838|12190598|FG001|COMPLETED|Overall Study||53
11013106|NCT00760838|12190597|FG000|NOT COMPLETED|Overall Study||5
11013107|NCT00760838|12190598|FG001|NOT COMPLETED|Overall Study||2
11013108|NCT00760877|12190606|FG000|STARTED|Overall Study||104
11013109|NCT00760877|12190607|FG001|STARTED|Overall Study||103
11013110|NCT00760877|12190606|FG000|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
11013111|NCT00760877|12190607|FG001|Cross-over to Nilotinib|Overall Study||46
11013112|NCT00760877|12190606|FG000|Safety Set|Overall Study||101
11013113|NCT00760877|12190607|FG001|Safety Set|Overall Study||103
11013114|NCT00760877|12190606|FG000|COMPLETED|Overall Study||59
11013115|NCT00760877|12190607|FG001|COMPLETED|Overall Study||77
11013116|NCT00760877|12190606|FG000|NOT COMPLETED|Overall Study||45
11013117|NCT00760877|12190607|FG001|NOT COMPLETED|Overall Study||26
11013118|NCT00760929|12190618|FG000|STARTED|Overall Study||26
11013119|NCT00760929|12190619|FG001|STARTED|Overall Study||29
11013120|NCT00760929|12190620|FG002|STARTED|Overall Study||59
11013121|NCT00760929|12190621|FG003|STARTED|Overall Study||57
11013122|NCT00760929|12190618|FG000|COMPLETED|Overall Study||0
11013123|NCT00760929|12190619|FG001|COMPLETED|Overall Study||1
11013124|NCT00760929|12190620|FG002|COMPLETED|Overall Study||1
11013125|NCT00760929|12190621|FG003|COMPLETED|Overall Study||2
11013126|NCT00760929|12190618|FG000|NOT COMPLETED|Overall Study||26
11013127|NCT00760929|12190619|FG001|NOT COMPLETED|Overall Study||28
11013128|NCT00760929|12190620|FG002|NOT COMPLETED|Overall Study||58
11013129|NCT00760929|12190621|FG003|NOT COMPLETED|Overall Study||55
11013130|NCT00760994|12190633|FG000|STARTED|Overall Study||29
11013131|NCT00760994|12190634|FG001|STARTED|Overall Study||31
11013132|NCT00760994|12190635|FG002|STARTED|Overall Study||20
11013133|NCT00760994|12190633|FG000|COMPLETED|Overall Study||25
11013134|NCT00760994|12190634|FG001|COMPLETED|Overall Study||27
11013135|NCT00760994|12190635|FG002|COMPLETED|Overall Study||17
11013136|NCT00760994|12190633|FG000|NOT COMPLETED|Overall Study||4
11013137|NCT00760994|12190634|FG001|NOT COMPLETED|Overall Study||4
11013138|NCT00760994|12190635|FG002|NOT COMPLETED|Overall Study||3
11013139|NCT00761007|12190649|FG000|STARTED|Overall Study||142
11013140|NCT00761007|12190650|FG001|STARTED|Overall Study||135
11013141|NCT00761007|12190651|FG002|STARTED|Overall Study||139
11013142|NCT00761007|12190652|FG003|STARTED|Overall Study||138
11013143|NCT00761007|12190649|FG000|Safety (>=1 Dose of Study Medication)|Overall Study||140
11013144|NCT00761007|12190650|FG001|Safety (>=1 Dose of Study Medication)|Overall Study||135
11013145|NCT00761007|12190651|FG002|Safety (>=1 Dose of Study Medication)|Overall Study||139
11013146|NCT00761007|12190652|FG003|Safety (>=1 Dose of Study Medication)|Overall Study||137
11013147|NCT00761007|12190649|FG000|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
11013148|NCT00761007|12190650|FG001|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
11013149|NCT00761007|12190651|FG002|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
11013150|NCT00761007|12190652|FG003|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
11013151|NCT00761007|12190649|FG000|COMPLETED|Overall Study||129
11013152|NCT00761007|12190650|FG001|COMPLETED|Overall Study||124
11013153|NCT00761007|12190651|FG002|COMPLETED|Overall Study||121
11013154|NCT00761007|12190652|FG003|COMPLETED|Overall Study||131
11013155|NCT00761007|12190649|FG000|NOT COMPLETED|Overall Study||13
11013156|NCT00761007|12190650|FG001|NOT COMPLETED|Overall Study||11
11013157|NCT00761007|12190651|FG002|NOT COMPLETED|Overall Study||18
11013158|NCT00761007|12190652|FG003|NOT COMPLETED|Overall Study||7
11013159|NCT00761085|12190666|FG000|STARTED|Overall Study||12
11013160|NCT00761085|12190667|FG001|STARTED|Overall Study||12
11013161|NCT00761085|12190668|FG002|STARTED|Overall Study||11
11013162|NCT00761085|12190669|FG003|STARTED|Overall Study||12
11013163|NCT00761085|12190666|FG000|COMPLETED|Overall Study||12
11013164|NCT00761085|12190667|FG001|COMPLETED|Overall Study||6
11013165|NCT00761085|12190668|FG002|COMPLETED|Overall Study||11
11013166|NCT00761085|12190669|FG003|COMPLETED|Overall Study||8
11013167|NCT00761085|12190666|FG000|NOT COMPLETED|Overall Study||0
11013168|NCT00761085|12190667|FG001|NOT COMPLETED|Overall Study||6
11013169|NCT00761085|12190668|FG002|NOT COMPLETED|Overall Study||0
11013170|NCT00761085|12190669|FG003|NOT COMPLETED|Overall Study||4
11013171|NCT00761137|12190679|FG000|STARTED|Overall Study||19
11013172|NCT00761137|12190679|FG000|Placebo|Overall Study||19
11013173|NCT00761137|12190679|FG000|0.3 mg Tropicamide|Overall Study||19
11013174|NCT00761137|12190679|FG000|1 mg Tropicamide|Overall Study||19
11013175|NCT00761137|12190679|FG000|3 mg Tropicamide|Overall Study||19
11013176|NCT00761137|12190679|FG000|COMPLETED|Overall Study||19
11013177|NCT00761137|12190679|FG000|NOT COMPLETED|Overall Study||0
11013178|NCT00761150|12190689|FG000|STARTED|Open-label Period||308
11013179|NCT00761150|12190690|FG001|STARTED|Open-label Period||0
11013180|NCT00761150|12190691|FG002|STARTED|Open-label Period||0
11013181|NCT00761150|12190689|FG000|COMPLETED|Open-label Period||238
11013182|NCT00761150|12190690|FG001|COMPLETED|Open-label Period||0
11013183|NCT00761150|12190691|FG002|COMPLETED|Open-label Period||0
11013184|NCT00761150|12190689|FG000|NOT COMPLETED|Open-label Period||70
11013185|NCT00761150|12190690|FG001|NOT COMPLETED|Open-label Period||0
11013186|NCT00761150|12190691|FG002|NOT COMPLETED|Open-label Period||0
11013187|NCT00761150|12190689|FG000|STARTED|Double-blind Period||0
11013188|NCT00761150|12190690|FG001|STARTED|Double-blind Period||120
11013189|NCT00761150|12190691|FG002|STARTED|Double-blind Period||118
11013190|NCT00761150|12190689|FG000|COMPLETED|Double-blind Period||0
11013191|NCT00761150|12190690|FG001|COMPLETED|Double-blind Period||106
11013192|NCT00761150|12190691|FG002|COMPLETED|Double-blind Period||89
11013193|NCT00761150|12190689|FG000|NOT COMPLETED|Double-blind Period||0
11013194|NCT00761150|12190690|FG001|NOT COMPLETED|Double-blind Period||14
11013195|NCT00761150|12190691|FG002|NOT COMPLETED|Double-blind Period||29
11013196|NCT00761189|12190698|FG000|STARTED|Overall Study||491
11013197|NCT00761189|12190698|FG000|COMPLETED|Overall Study||306
11013198|NCT00761189|12190698|FG000|NOT COMPLETED|Overall Study||185
11013199|NCT00761202|12190704|FG000|STARTED|Overall Study||22
11013200|NCT00761202|12190705|FG001|STARTED|Overall Study||28
11013201|NCT00761202|12190704|FG000|COMPLETED|Overall Study||21
11013202|NCT00761202|12190705|FG001|COMPLETED|Overall Study||26
11013203|NCT00761202|12190704|FG000|NOT COMPLETED|Overall Study||1
11013204|NCT00761202|12190705|FG001|NOT COMPLETED|Overall Study||2
11013205|NCT00761215|12190714|FG000|STARTED|Overall Study||64
11013206|NCT00761215|12190715|FG001|STARTED|Overall Study||64
11013207|NCT00761215|12190716|FG002|STARTED|Overall Study||64
11013208|NCT00761215|12190714|FG000|COMPLETED|Overall Study||55
11013209|NCT00761215|12190715|FG001|COMPLETED|Overall Study||60
11013210|NCT00761215|12190716|FG002|COMPLETED|Overall Study||56
11013211|NCT00761215|12190714|FG000|NOT COMPLETED|Overall Study||9
11013212|NCT00761215|12190715|FG001|NOT COMPLETED|Overall Study||4
11013213|NCT00761215|12190716|FG002|NOT COMPLETED|Overall Study||8
11013214|NCT00761267|12190730|FG000|STARTED|Overall Study||20
11013215|NCT00761267|12190731|FG001|STARTED|Overall Study||20
11013216|NCT00761267|12190732|FG002|STARTED|Overall Study||30
11013217|NCT00761267|12190730|FG000|Treated|Overall Study||19
11013218|NCT00761267|12190731|FG001|Treated|Overall Study||19
11013219|NCT00761267|12190732|FG002|Treated|Overall Study||30
11013220|NCT00761267|12190730|FG000|COMPLETED|Overall Study||18
11013221|NCT00761267|12190731|FG001|COMPLETED|Overall Study||16
11013222|NCT00761267|12190732|FG002|COMPLETED|Overall Study||24
11013223|NCT00761267|12190730|FG000|NOT COMPLETED|Overall Study||2
11013224|NCT00761267|12190731|FG001|NOT COMPLETED|Overall Study||4
11013225|NCT00761267|12190732|FG002|NOT COMPLETED|Overall Study||6
11013226|NCT00761280|12190753|FG000|STARTED|Randomization to First Dose||14
11013227|NCT00761280|12190754|FG001|STARTED|Randomization to First Dose||13
11013228|NCT00761280|12190753|FG000|Catheter Surgery|Randomization to First Dose|Safety population|13
11013229|NCT00761280|12190754|FG001|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
11013230|NCT00761280|12190753|FG000|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
11013231|NCT00761280|12190754|FG001|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
11013232|NCT00761280|12190753|FG000|COMPLETED|Randomization to First Dose||12
11013233|NCT00761280|12190754|FG001|COMPLETED|Randomization to First Dose||11
11013234|NCT00761280|12190753|FG000|NOT COMPLETED|Randomization to First Dose||2
11013235|NCT00761280|12190754|FG001|NOT COMPLETED|Randomization to First Dose||2
11013236|NCT00761280|12190753|FG000|STARTED|First Dose to End of Study||12
11013237|NCT00761280|12190754|FG001|STARTED|First Dose to End of Study||11
11056799|NCT00995904|12238408|FG003|STARTED|Follow-up Visit (Final Visit)||5
11013238|NCT00761280|12190753|FG000|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
11013239|NCT00761280|12190754|FG001|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
11013240|NCT00761280|12190753|FG000|NOT COMPLETED|First Dose to End of Study||12
11013241|NCT00761280|12190754|FG001|NOT COMPLETED|First Dose to End of Study||11
11013242|NCT00761306|12190760|FG000|STARTED|Overall Study||74
11013243|NCT00761306|12190760|FG000|COMPLETED|Overall Study||54
11013244|NCT00761306|12190760|FG000|NOT COMPLETED|Overall Study||20
11013245|NCT00761319|12190766|FG000|STARTED|Overall Study||353
11013246|NCT00761319|12190767|FG001|STARTED|Overall Study||352
11013247|NCT00761319|12190766|FG000|COMPLETED|Overall Study||305
11013248|NCT00761319|12190767|FG001|COMPLETED|Overall Study||318
11013249|NCT00761319|12190766|FG000|NOT COMPLETED|Overall Study||48
11013250|NCT00761319|12190767|FG001|NOT COMPLETED|Overall Study||34
11013251|NCT00761345|12190773|FG000|STARTED|Overall Study||27
11013252|NCT00761345|12190773|FG000|COMPLETED|Overall Study||24
11013253|NCT00761345|12190773|FG000|NOT COMPLETED|Overall Study||3
11013254|NCT00761462|12190779|FG000|STARTED|Treatment|Patients enrolled in study group|510
11013255|NCT00761462|12190780|FG001|STARTED|Treatment|Patients enrolled in study group|519
11013256|NCT00761462|12190779|FG000|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
11013257|NCT00761462|12190780|FG001|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
11013258|NCT00761462|12190779|FG000|NOT COMPLETED|Treatment||23
11013259|NCT00761462|12190780|FG001|NOT COMPLETED|Treatment||12
11013260|NCT00761462|12190779|FG000|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
11013261|NCT00761462|12190780|FG001|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
11013262|NCT00761462|12190779|FG000|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
11013263|NCT00761462|12190780|FG001|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
11013264|NCT00761462|12190779|FG000|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
11013265|NCT00761462|12190780|FG001|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
11013266|NCT00761462|12190779|FG000|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
11013267|NCT00761462|12190780|FG001|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
11013268|NCT00761462|12190779|FG000|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
11013269|NCT00761462|12190780|FG001|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
11013270|NCT00761514|12190786|FG000|STARTED|Overall Study||14
11013271|NCT00761514|12190786|FG000|COMPLETED|Overall Study||7
11013272|NCT00761514|12190786|FG000|NOT COMPLETED|Overall Study||7
11013273|NCT00761579|12190790|FG000|STARTED|Overall Study||190
11013274|NCT00761579|12190790|FG000|COMPLETED|Overall Study||98
11013275|NCT00761579|12190790|FG000|NOT COMPLETED|Overall Study||92
11013276|NCT00761592|12190798|FG000|STARTED|Overall Study||32
11013277|NCT00761592|12190799|FG001|STARTED|Overall Study||33
11013278|NCT00761592|12190798|FG000|COMPLETED|Overall Study||31
11013279|NCT00761592|12190799|FG001|COMPLETED|Overall Study||32
11013280|NCT00761592|12190798|FG000|NOT COMPLETED|Overall Study||1
11013281|NCT00761592|12190799|FG001|NOT COMPLETED|Overall Study||1
11013282|NCT00761605|12190805|FG000|STARTED|Overall Study||387
11013283|NCT00761605|12190805|FG000|COMPLETED|Overall Study||246
11013284|NCT00761605|12190805|FG000|NOT COMPLETED|Overall Study||141
11056800|NCT00995904|12238409|FG004|STARTED|Follow-up Visit (Final Visit)||5
11056801|NCT00995904|12238410|FG005|STARTED|Follow-up Visit (Final Visit)||3
11056802|NCT00995904|12238405|FG000|COMPLETED|Follow-up Visit (Final Visit)||4
11056803|NCT00995904|12238406|FG001|COMPLETED|Follow-up Visit (Final Visit)||3
11056804|NCT00995904|12238407|FG002|COMPLETED|Follow-up Visit (Final Visit)||4
11056805|NCT00995904|12238408|FG003|COMPLETED|Follow-up Visit (Final Visit)||5
11056806|NCT00995904|12238409|FG004|COMPLETED|Follow-up Visit (Final Visit)||5
11056807|NCT00995904|12238410|FG005|COMPLETED|Follow-up Visit (Final Visit)||3
11056808|NCT00995904|12238405|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0
11056809|NCT00995904|12238406|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0
11056810|NCT00995904|12238407|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0
11056811|NCT00995904|12238408|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0
11056812|NCT00995904|12238409|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0
11056813|NCT00995904|12238410|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0
11013285|NCT00761631|12190817|FG000|STARTED|Overall Study||126
11013286|NCT00761631|12190818|FG001|STARTED|Overall Study||181
11013287|NCT00761631|12190819|FG002|STARTED|Overall Study||176
11013288|NCT00761631|12190820|FG003|STARTED|Overall Study||119
11013289|NCT00761631|12190821|FG004|STARTED|Overall Study||299
11013290|NCT00761631|12190822|FG005|STARTED|Overall Study||299
11013291|NCT00761631|12190817|FG000|Vaccinated Dose 1|Overall Study||124
11013292|NCT00761631|12190818|FG001|Vaccinated Dose 1|Overall Study||179
11013293|NCT00761631|12190819|FG002|Vaccinated Dose 1|Overall Study||175
11013294|NCT00761631|12190820|FG003|Vaccinated Dose 1|Overall Study||118
11013295|NCT00761631|12190821|FG004|Vaccinated Dose 1|Overall Study||294
11013296|NCT00761631|12190822|FG005|Vaccinated Dose 1|Overall Study||298
11013297|NCT00761631|12190817|FG000|Vaccinated Dose 2|Overall Study||112
11013298|NCT00761631|12190818|FG001|Vaccinated Dose 2|Overall Study||0
11013299|NCT00761631|12190819|FG002|Vaccinated Dose 2|Overall Study||165
11013300|NCT00761631|12190820|FG003|Vaccinated Dose 2|Overall Study||0
11013301|NCT00761631|12190821|FG004|Vaccinated Dose 2|Overall Study||0
11013302|NCT00761631|12190822|FG005|Vaccinated Dose 2|Overall Study||0
11013303|NCT00761631|12190817|FG000|COMPLETED|Overall Study||111
11013304|NCT00761631|12190818|FG001|COMPLETED|Overall Study||174
11013305|NCT00761631|12190819|FG002|COMPLETED|Overall Study||160
11013306|NCT00761631|12190820|FG003|COMPLETED|Overall Study||116
11013307|NCT00761631|12190821|FG004|COMPLETED|Overall Study||277
11013308|NCT00761631|12190822|FG005|COMPLETED|Overall Study||294
11013309|NCT00761631|12190817|FG000|NOT COMPLETED|Overall Study||15
11013310|NCT00761631|12190818|FG001|NOT COMPLETED|Overall Study||7
11013311|NCT00761631|12190819|FG002|NOT COMPLETED|Overall Study||16
11013312|NCT00761631|12190820|FG003|NOT COMPLETED|Overall Study||3
11013313|NCT00761631|12190821|FG004|NOT COMPLETED|Overall Study||22
11013314|NCT00761631|12190822|FG005|NOT COMPLETED|Overall Study||5
11013315|NCT00761657|12190854|FG000|STARTED|Part 1 (up to Day 57)||0
11013316|NCT00761657|12190855|FG001|STARTED|Part 1 (up to Day 57)||0
11013317|NCT00761657|12190856|FG002|STARTED|Part 1 (up to Day 57)||12
11013318|NCT00761657|12190857|FG003|STARTED|Part 1 (up to Day 57)||10
11013319|NCT00761657|12190858|FG004|STARTED|Part 1 (up to Day 57)||0
11013320|NCT00761657|12190859|FG005|STARTED|Part 1 (up to Day 57)||0
11013321|NCT00761657|12190860|FG006|STARTED|Part 1 (up to Day 57)||1
11013322|NCT00761657|12190861|FG007|STARTED|Part 1 (up to Day 57)||2
11013323|NCT00761657|12190862|FG008|STARTED|Part 1 (up to Day 57)||10
11013324|NCT00761657|12190854|FG000|Safety Population|Part 1 (up to Day 57)||0
11013325|NCT00761657|12190855|FG001|Safety Population|Part 1 (up to Day 57)||0
11013326|NCT00761657|12190856|FG002|Safety Population|Part 1 (up to Day 57)||12
11013327|NCT00761657|12190857|FG003|Safety Population|Part 1 (up to Day 57)||9
11013328|NCT00761657|12190858|FG004|Safety Population|Part 1 (up to Day 57)||0
11013329|NCT00761657|12190859|FG005|Safety Population|Part 1 (up to Day 57)||0
11013330|NCT00761657|12190860|FG006|Safety Population|Part 1 (up to Day 57)||1
11013331|NCT00761657|12190861|FG007|Safety Population|Part 1 (up to Day 57)||2
11013332|NCT00761657|12190862|FG008|Safety Population|Part 1 (up to Day 57)||10
11013333|NCT00761657|12190854|FG000|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
11013334|NCT00761657|12190855|FG001|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
11013335|NCT00761657|12190856|FG002|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5
11013336|NCT00761657|12190857|FG003|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5
11013337|NCT00761657|12190858|FG004|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
11013338|NCT00761657|12190859|FG005|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
11013339|NCT00761657|12190860|FG006|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
11013340|NCT00761657|12190861|FG007|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||1
11013341|NCT00761657|12190862|FG008|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||6
11013342|NCT00761657|12190854|FG000|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
11013343|NCT00761657|12190855|FG001|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
11013344|NCT00761657|12190856|FG002|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||5
11013345|NCT00761657|12190857|FG003|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||3
11013346|NCT00761657|12190858|FG004|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
11013347|NCT00761657|12190859|FG005|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
11013348|NCT00761657|12190860|FG006|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||1
11013349|NCT00761657|12190861|FG007|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||2
11013350|NCT00761657|12190862|FG008|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
11013351|NCT00761657|12190854|FG000|COMPLETED|Part 1 (up to Day 57)||0
11013352|NCT00761657|12190855|FG001|COMPLETED|Part 1 (up to Day 57)||0
11013353|NCT00761657|12190856|FG002|COMPLETED|Part 1 (up to Day 57)||8
11013354|NCT00761657|12190857|FG003|COMPLETED|Part 1 (up to Day 57)||4
11013355|NCT00761657|12190858|FG004|COMPLETED|Part 1 (up to Day 57)||0
11013356|NCT00761657|12190859|FG005|COMPLETED|Part 1 (up to Day 57)||0
11013357|NCT00761657|12190860|FG006|COMPLETED|Part 1 (up to Day 57)||0
11013358|NCT00761657|12190861|FG007|COMPLETED|Part 1 (up to Day 57)||1
11013359|NCT00761657|12190862|FG008|COMPLETED|Part 1 (up to Day 57)||9
11013360|NCT00761657|12190854|FG000|NOT COMPLETED|Part 1 (up to Day 57)||0
11013361|NCT00761657|12190855|FG001|NOT COMPLETED|Part 1 (up to Day 57)||0
11013362|NCT00761657|12190856|FG002|NOT COMPLETED|Part 1 (up to Day 57)||4
11013363|NCT00761657|12190857|FG003|NOT COMPLETED|Part 1 (up to Day 57)||6
11013364|NCT00761657|12190858|FG004|NOT COMPLETED|Part 1 (up to Day 57)||0
11013365|NCT00761657|12190859|FG005|NOT COMPLETED|Part 1 (up to Day 57)||0
11013366|NCT00761657|12190860|FG006|NOT COMPLETED|Part 1 (up to Day 57)||1
11013367|NCT00761657|12190861|FG007|NOT COMPLETED|Part 1 (up to Day 57)||1
11013368|NCT00761657|12190862|FG008|NOT COMPLETED|Part 1 (up to Day 57)||1
11013369|NCT00761657|12190854|FG000|STARTED|Part 2 (up to Day 114)||10
11013370|NCT00761657|12190855|FG001|STARTED|Part 2 (up to Day 114)||13
11013371|NCT00761657|12190856|FG002|STARTED|Part 2 (up to Day 114)||0
11013372|NCT00761657|12190857|FG003|STARTED|Part 2 (up to Day 114)||0
11013373|NCT00761657|12190858|FG004|STARTED|Part 2 (up to Day 114)||10
11013374|NCT00761657|12190859|FG005|STARTED|Part 2 (up to Day 114)||11
11013375|NCT00761657|12190860|FG006|STARTED|Part 2 (up to Day 114)||10
11013376|NCT00761657|12190861|FG007|STARTED|Part 2 (up to Day 114)||10
11013377|NCT00761657|12190862|FG008|STARTED|Part 2 (up to Day 114)||18
11013378|NCT00761657|12190854|FG000|Safety Population|Part 2 (up to Day 114)||10
11013379|NCT00761657|12190855|FG001|Safety Population|Part 2 (up to Day 114)||13
11013380|NCT00761657|12190856|FG002|Safety Population|Part 2 (up to Day 114)||0
11013381|NCT00761657|12190857|FG003|Safety Population|Part 2 (up to Day 114)||0
11013382|NCT00761657|12190858|FG004|Safety Population|Part 2 (up to Day 114)||10
11013383|NCT00761657|12190859|FG005|Safety Population|Part 2 (up to Day 114)||11
11013384|NCT00761657|12190860|FG006|Safety Population|Part 2 (up to Day 114)||10
11013385|NCT00761657|12190861|FG007|Safety Population|Part 2 (up to Day 114)||10
11013386|NCT00761657|12190862|FG008|Safety Population|Part 2 (up to Day 114)||18
11013387|NCT00761657|12190854|FG000|EE Population|Part 2 (up to Day 114)||10
11013388|NCT00761657|12190855|FG001|EE Population|Part 2 (up to Day 114)||12
11013389|NCT00761657|12190856|FG002|EE Population|Part 2 (up to Day 114)||0
11013390|NCT00761657|12190857|FG003|EE Population|Part 2 (up to Day 114)||0
11013391|NCT00761657|12190858|FG004|EE Population|Part 2 (up to Day 114)||10
11013392|NCT00761657|12190859|FG005|EE Population|Part 2 (up to Day 114)||11
11013393|NCT00761657|12190860|FG006|EE Population|Part 2 (up to Day 114)||10
11013394|NCT00761657|12190861|FG007|EE Population|Part 2 (up to Day 114)||10
11013395|NCT00761657|12190862|FG008|EE Population|Part 2 (up to Day 114)||11
11013396|NCT00761657|12190854|FG000|PK Population|Part 2 (up to Day 114)||10
11013397|NCT00761657|12190855|FG001|PK Population|Part 2 (up to Day 114)||13
11013398|NCT00761657|12190856|FG002|PK Population|Part 2 (up to Day 114)||0
11013399|NCT00761657|12190857|FG003|PK Population|Part 2 (up to Day 114)||0
11013400|NCT00761657|12190858|FG004|PK Population|Part 2 (up to Day 114)||10
11013401|NCT00761657|12190859|FG005|PK Population|Part 2 (up to Day 114)||11
11013402|NCT00761657|12190860|FG006|PK Population|Part 2 (up to Day 114)||10
11013403|NCT00761657|12190861|FG007|PK Population|Part 2 (up to Day 114)||10
11013404|NCT00761657|12190862|FG008|PK Population|Part 2 (up to Day 114)||0
11013405|NCT00761657|12190854|FG000|COMPLETED|Part 2 (up to Day 114)||10
11013406|NCT00761657|12190855|FG001|COMPLETED|Part 2 (up to Day 114)||13
11013407|NCT00761657|12190856|FG002|COMPLETED|Part 2 (up to Day 114)||0
11013408|NCT00761657|12190857|FG003|COMPLETED|Part 2 (up to Day 114)||0
11013409|NCT00761657|12190858|FG004|COMPLETED|Part 2 (up to Day 114)||10
11013410|NCT00761657|12190859|FG005|COMPLETED|Part 2 (up to Day 114)||11
11013411|NCT00761657|12190860|FG006|COMPLETED|Part 2 (up to Day 114)||10
11013412|NCT00761657|12190861|FG007|COMPLETED|Part 2 (up to Day 114)||10
11013413|NCT00761657|12190862|FG008|COMPLETED|Part 2 (up to Day 114)||17
11013414|NCT00761657|12190854|FG000|NOT COMPLETED|Part 2 (up to Day 114)||0
11013415|NCT00761657|12190855|FG001|NOT COMPLETED|Part 2 (up to Day 114)||0
11013416|NCT00761657|12190856|FG002|NOT COMPLETED|Part 2 (up to Day 114)||0
11013417|NCT00761657|12190857|FG003|NOT COMPLETED|Part 2 (up to Day 114)||0
11013418|NCT00761657|12190858|FG004|NOT COMPLETED|Part 2 (up to Day 114)||0
11013419|NCT00761657|12190859|FG005|NOT COMPLETED|Part 2 (up to Day 114)||0
11013420|NCT00761657|12190860|FG006|NOT COMPLETED|Part 2 (up to Day 114)||0
11013421|NCT00761657|12190861|FG007|NOT COMPLETED|Part 2 (up to Day 114)||0
11013422|NCT00761657|12190862|FG008|NOT COMPLETED|Part 2 (up to Day 114)||1
11013423|NCT00761735|12190892|FG000|STARTED|Overall Study||94
11013424|NCT00761735|12190892|FG000|COMPLETED|Overall Study||80
11013425|NCT00761735|12190892|FG000|NOT COMPLETED|Overall Study||14
11013426|NCT00761748|12190900|FG000|STARTED|First Intervention (21 +/- 3 Days)||20
11013427|NCT00761748|12190901|FG001|STARTED|First Intervention (21 +/- 3 Days)||10
11013428|NCT00761748|12190900|FG000|COMPLETED|First Intervention (21 +/- 3 Days)||17
11013429|NCT00761748|12190901|FG001|COMPLETED|First Intervention (21 +/- 3 Days)||7
11013430|NCT00761748|12190900|FG000|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
11013431|NCT00761748|12190901|FG001|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
11013432|NCT00761748|12190900|FG000|STARTED|Second Intervention (21 +/- 3 Days)||17
11013433|NCT00761748|12190901|FG001|STARTED|Second Intervention (21 +/- 3 Days)||7
11013434|NCT00761748|12190900|FG000|COMPLETED|Second Intervention (21 +/- 3 Days)||17
11013435|NCT00761748|12190901|FG001|COMPLETED|Second Intervention (21 +/- 3 Days)||7
11013436|NCT00761748|12190900|FG000|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
11013437|NCT00761748|12190901|FG001|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
11013438|NCT00761761|12190909|FG000|STARTED|Overall Study||30
11013439|NCT00761761|12190910|FG001|STARTED|Overall Study||30
11013440|NCT00761761|12190909|FG000|COMPLETED|Overall Study||24
11013441|NCT00761761|12190910|FG001|COMPLETED|Overall Study||29
11013442|NCT00761761|12190909|FG000|NOT COMPLETED|Overall Study||6
11013443|NCT00761761|12190910|FG001|NOT COMPLETED|Overall Study||1
11013444|NCT00761774|12190918|FG000|STARTED|Overall Study||108
11013445|NCT00761774|12190918|FG000|COMPLETED|Overall Study||29
11013446|NCT00761774|12190918|FG000|NOT COMPLETED|Overall Study||79
11013447|NCT00761813|12190926|FG000|STARTED|Overall Study||557
11013448|NCT00761813|12190927|FG001|STARTED|Overall Study||551
11013449|NCT00761813|12190926|FG000|COMPLETED|Overall Study||542
11013450|NCT00761813|12190927|FG001|COMPLETED|Overall Study||537
11013451|NCT00761813|12190926|FG000|NOT COMPLETED|Overall Study||15
11013452|NCT00761813|12190927|FG001|NOT COMPLETED|Overall Study||14
11013453|NCT00761865|12190935|FG000|STARTED|Overall Study||16
11013454|NCT00761865|12190936|FG001|STARTED|Overall Study||18
11013455|NCT00761865|12190935|FG000|COMPLETED|Overall Study||8
11013456|NCT00761865|12190936|FG001|COMPLETED|Overall Study||11
11013457|NCT00761865|12190935|FG000|NOT COMPLETED|Overall Study||8
11013458|NCT00761865|12190936|FG001|NOT COMPLETED|Overall Study||7
11013459|NCT00761891|12190942|FG000|STARTED|Overall Study||64
11013460|NCT00761891|12190942|FG000|COMPLETED|Overall Study||54
11013461|NCT00761891|12190942|FG000|NOT COMPLETED|Overall Study||10
11013462|NCT00761930|12190950|FG000|STARTED|Overall Study||34
11013463|NCT00761930|12190951|FG001|STARTED|Overall Study||34
11013464|NCT00761930|12190952|FG002|STARTED|Overall Study||35
11013465|NCT00761930|12190950|FG000|COMPLETED|Overall Study||34
11013466|NCT00761930|12190951|FG001|COMPLETED|Overall Study||34
11013467|NCT00761930|12190952|FG002|COMPLETED|Overall Study||35
11013468|NCT00761930|12190950|FG000|NOT COMPLETED|Overall Study||0
11013469|NCT00761930|12190951|FG001|NOT COMPLETED|Overall Study||0
11013470|NCT00761930|12190952|FG002|NOT COMPLETED|Overall Study||0
11013471|NCT00761956|12190962|FG000|STARTED|Overall Study||87
11013472|NCT00761956|12190963|FG001|STARTED|Overall Study||102
11013473|NCT00761956|12190962|FG000|COMPLETED|Overall Study||52
11013474|NCT00761956|12190963|FG001|COMPLETED|Overall Study||48
11013475|NCT00761956|12190962|FG000|NOT COMPLETED|Overall Study||35
11013476|NCT00761956|12190963|FG001|NOT COMPLETED|Overall Study||54
11013477|NCT00761969|12190971|FG000|STARTED|Overall Study||742
11013478|NCT00761969|12190972|FG001|STARTED|Overall Study||713
11013479|NCT00761969|12190971|FG000|COMPLETED|Overall Study||542
11013480|NCT00761969|12190972|FG001|COMPLETED|Overall Study||573
11013481|NCT00761969|12190971|FG000|NOT COMPLETED|Overall Study||200
11013482|NCT00761969|12190972|FG001|NOT COMPLETED|Overall Study||140
11013483|NCT00762021|12190980|FG000|STARTED|Overall Study||52
11013484|NCT00762021|12190981|FG001|STARTED|Overall Study||52
11013485|NCT00762021|12190980|FG000|COMPLETED|Overall Study||44
11013486|NCT00762021|12190981|FG001|COMPLETED|Overall Study||44
11013487|NCT00762021|12190980|FG000|NOT COMPLETED|Overall Study||8
11013488|NCT00762021|12190981|FG001|NOT COMPLETED|Overall Study||8
11013489|NCT00762034|12190989|FG000|STARTED|Induction Period||472
11013490|NCT00762034|12190990|FG001|STARTED|Induction Period||467
11013491|NCT00762034|12190989|FG000|Received at Least 1 Dose of Study Drug|Induction Period||442
11013492|NCT00762034|12190990|FG001|Received at Least 1 Dose of Study Drug|Induction Period||443
11013493|NCT00762034|12190989|FG000|COMPLETED|Induction Period||294
11013494|NCT00762034|12190990|FG001|COMPLETED|Induction Period||298
11013495|NCT00762034|12190989|FG000|NOT COMPLETED|Induction Period||178
11013496|NCT00762034|12190990|FG001|NOT COMPLETED|Induction Period||169
11013497|NCT00762034|12190989|FG000|STARTED|Maintenance Period||294
11013498|NCT00762034|12190990|FG001|STARTED|Maintenance Period||298
11013499|NCT00762034|12190989|FG000|Received at Least 1 Dose of Study Drug|Maintenance Period||294
11013500|NCT00762034|12190990|FG001|Received at Least 1 Dose of Study Drug|Maintenance Period||298
11013501|NCT00762034|12190989|FG000|COMPLETED|Maintenance Period||0
11013502|NCT00762034|12190990|FG001|COMPLETED|Maintenance Period||0
11013503|NCT00762034|12190989|FG000|NOT COMPLETED|Maintenance Period||294
11013504|NCT00762034|12190990|FG001|NOT COMPLETED|Maintenance Period||298
11013505|NCT00762073|12191008|FG000|STARTED|Overall Study||21
11013506|NCT00762073|12191009|FG001|STARTED|Overall Study||21
11013507|NCT00762073|12191010|FG002|STARTED|Overall Study||20
11013508|NCT00762073|12191011|FG003|STARTED|Overall Study||20
11013509|NCT00762073|12191008|FG000|COMPLETED|Overall Study||17
11013510|NCT00762073|12191009|FG001|COMPLETED|Overall Study||17
11013511|NCT00762073|12191010|FG002|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
11013512|NCT00762073|12191011|FG003|COMPLETED|Overall Study||17
11013513|NCT00762073|12191008|FG000|NOT COMPLETED|Overall Study||4
11013514|NCT00762073|12191009|FG001|NOT COMPLETED|Overall Study||4
11013515|NCT00762073|12191010|FG002|NOT COMPLETED|Overall Study||2
11013516|NCT00762073|12191011|FG003|NOT COMPLETED|Overall Study||3
11013517|NCT00762086|12191030|FG000|STARTED|Overall Study||39
11013518|NCT00762086|12191031|FG001|STARTED|Overall Study||28
11013519|NCT00762086|12191030|FG000|COMPLETED|Overall Study||33
11013520|NCT00762086|12191031|FG001|COMPLETED|Overall Study||24
11013521|NCT00762086|12191030|FG000|NOT COMPLETED|Overall Study||6
11013522|NCT00762086|12191031|FG001|NOT COMPLETED|Overall Study||4
11013523|NCT00762164|12191039|FG000|STARTED|Overall Study||17
11013524|NCT00762164|12191040|FG001|STARTED|Overall Study||17
11013525|NCT00762164|12191039|FG000|COMPLETED|Overall Study||14
11013526|NCT00762164|12191040|FG001|COMPLETED|Overall Study||15
11013527|NCT00762164|12191039|FG000|NOT COMPLETED|Overall Study||3
11013528|NCT00762164|12191040|FG001|NOT COMPLETED|Overall Study||2
11013529|NCT00762177|12191049|FG000|STARTED|1st Treatment Period||8
11013530|NCT00762177|12191050|FG001|STARTED|1st Treatment Period||8
11013531|NCT00762177|12191051|FG002|STARTED|1st Treatment Period||8
11013532|NCT00762177|12191049|FG000|COMPLETED|1st Treatment Period||8
11013533|NCT00762177|12191050|FG001|COMPLETED|1st Treatment Period||8
11013534|NCT00762177|12191051|FG002|COMPLETED|1st Treatment Period||8
11013535|NCT00762177|12191049|FG000|NOT COMPLETED|1st Treatment Period||0
11013536|NCT00762177|12191050|FG001|NOT COMPLETED|1st Treatment Period||0
11013537|NCT00762177|12191051|FG002|NOT COMPLETED|1st Treatment Period||0
11013538|NCT00762177|12191049|FG000|STARTED|Washout After 1st Treatment||8
11013539|NCT00762177|12191050|FG001|STARTED|Washout After 1st Treatment||8
11013540|NCT00762177|12191051|FG002|STARTED|Washout After 1st Treatment||8
11013541|NCT00762177|12191049|FG000|COMPLETED|Washout After 1st Treatment||8
11013542|NCT00762177|12191050|FG001|COMPLETED|Washout After 1st Treatment||8
11013543|NCT00762177|12191051|FG002|COMPLETED|Washout After 1st Treatment||8
11013544|NCT00762177|12191049|FG000|NOT COMPLETED|Washout After 1st Treatment||0
11013545|NCT00762177|12191050|FG001|NOT COMPLETED|Washout After 1st Treatment||0
11013546|NCT00762177|12191051|FG002|NOT COMPLETED|Washout After 1st Treatment||0
11013547|NCT00762177|12191049|FG000|STARTED|2nd Treatment Period||8
11013548|NCT00762177|12191050|FG001|STARTED|2nd Treatment Period||8
11013549|NCT00762177|12191051|FG002|STARTED|2nd Treatment Period||8
11013550|NCT00762177|12191049|FG000|COMPLETED|2nd Treatment Period||8
11013551|NCT00762177|12191050|FG001|COMPLETED|2nd Treatment Period||8
11013552|NCT00762177|12191051|FG002|COMPLETED|2nd Treatment Period||8
11013553|NCT00762177|12191049|FG000|NOT COMPLETED|2nd Treatment Period||0
11013554|NCT00762177|12191050|FG001|NOT COMPLETED|2nd Treatment Period||0
11013555|NCT00762177|12191051|FG002|NOT COMPLETED|2nd Treatment Period||0
11013556|NCT00762177|12191049|FG000|STARTED|Washout After 2nd Treatment||8
11013557|NCT00762177|12191050|FG001|STARTED|Washout After 2nd Treatment||8
11013558|NCT00762177|12191051|FG002|STARTED|Washout After 2nd Treatment||8
11013559|NCT00762177|12191049|FG000|COMPLETED|Washout After 2nd Treatment||8
11013560|NCT00762177|12191050|FG001|COMPLETED|Washout After 2nd Treatment||8
11013561|NCT00762177|12191051|FG002|COMPLETED|Washout After 2nd Treatment||8
11013562|NCT00762177|12191049|FG000|NOT COMPLETED|Washout After 2nd Treatment||0
11013563|NCT00762177|12191050|FG001|NOT COMPLETED|Washout After 2nd Treatment||0
11013564|NCT00762177|12191051|FG002|NOT COMPLETED|Washout After 2nd Treatment||0
11013565|NCT00762177|12191049|FG000|STARTED|3rd Treatment Period||8
11013566|NCT00762177|12191050|FG001|STARTED|3rd Treatment Period||8
11013567|NCT00762177|12191051|FG002|STARTED|3rd Treatment Period||8
11013568|NCT00762177|12191049|FG000|COMPLETED|3rd Treatment Period||8
11013569|NCT00762177|12191050|FG001|COMPLETED|3rd Treatment Period||8
11013570|NCT00762177|12191051|FG002|COMPLETED|3rd Treatment Period||8
11013571|NCT00762177|12191049|FG000|NOT COMPLETED|3rd Treatment Period||0
11013572|NCT00762177|12191050|FG001|NOT COMPLETED|3rd Treatment Period||0
11013573|NCT00762177|12191051|FG002|NOT COMPLETED|3rd Treatment Period||0
11013574|NCT00762216|12191062|FG000|STARTED|Overall Study||71
11013575|NCT00762216|12191062|FG000|COMPLETED|Overall Study||71
11013576|NCT00762216|12191062|FG000|NOT COMPLETED|Overall Study||0
11013577|NCT00762229|12191068|FG000|STARTED|Overall Study||15
11013578|NCT00762229|12191069|FG001|STARTED|Overall Study||24
11013579|NCT00762229|12191068|FG000|COMPLETED|Overall Study||14
11013580|NCT00762229|12191069|FG001|COMPLETED|Overall Study||22
11013581|NCT00762229|12191068|FG000|NOT COMPLETED|Overall Study||1
11013582|NCT00762229|12191069|FG001|NOT COMPLETED|Overall Study||2
11013583|NCT00762268|12191077|FG000|STARTED|Overall Study||12
11013584|NCT00762268|12191078|FG001|STARTED|Overall Study||11
11013585|NCT00762268|12191077|FG000|COMPLETED|Overall Study||9
11013586|NCT00762268|12191078|FG001|COMPLETED|Overall Study||8
11013587|NCT00762268|12191077|FG000|NOT COMPLETED|Overall Study||3
11013588|NCT00762268|12191078|FG001|NOT COMPLETED|Overall Study||3
11013589|NCT00762307|12191088|FG000|STARTED|Overall Study||28
11013590|NCT00762307|12191089|FG001|STARTED|Overall Study||11
11013591|NCT00762307|12191090|FG002|STARTED|Overall Study||11
11013592|NCT00762307|12191091|FG003|STARTED|Overall Study||10
11013593|NCT00762307|12191088|FG000|COMPLETED|Overall Study||26
11013594|NCT00762307|12191089|FG001|COMPLETED|Overall Study||11
11013595|NCT00762307|12191090|FG002|COMPLETED|Overall Study||11
11013596|NCT00762307|12191091|FG003|COMPLETED|Overall Study||9
11013597|NCT00762307|12191088|FG000|NOT COMPLETED|Overall Study||2
11013598|NCT00762307|12191089|FG001|NOT COMPLETED|Overall Study||0
11013599|NCT00762307|12191090|FG002|NOT COMPLETED|Overall Study||0
11013600|NCT00762307|12191091|FG003|NOT COMPLETED|Overall Study||1
11013601|NCT00762320|12191112|FG000|STARTED|Overall Study||8
11013602|NCT00762320|12191112|FG000|COMPLETED|Overall Study||8
11013603|NCT00762320|12191112|FG000|NOT COMPLETED|Overall Study||0
11013604|NCT00762359|12191123|FG000|STARTED|Overall Study||226
11013605|NCT00762359|12191124|FG001|STARTED|Overall Study||235
11396388|NCT03739840|12590242|FG002|STARTED|Treatment Period: Wk0-16||57
11396389|NCT03739840|12590243|FG003|STARTED|Treatment Period: Wk0-16||59
11396390|NCT03739840|12590240|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||54
11013606|NCT00762359|12191123|FG000|COMPLETED|Overall Study||167
11013607|NCT00762359|12191124|FG001|COMPLETED|Overall Study||178
11013608|NCT00762359|12191123|FG000|NOT COMPLETED|Overall Study||59
11013609|NCT00762359|12191124|FG001|NOT COMPLETED|Overall Study||57
11013610|NCT00762372|12191133|FG000|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111
11013611|NCT00762372|12191134|FG001|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55
11013612|NCT00762372|12191135|FG002|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50
11013613|NCT00762372|12191133|FG000|COMPLETED|Overall Study||110
11013614|NCT00762372|12191134|FG001|COMPLETED|Overall Study||55
11013615|NCT00762372|12191135|FG002|COMPLETED|Overall Study||50
11013616|NCT00762372|12191133|FG000|NOT COMPLETED|Overall Study||1
11013617|NCT00762372|12191134|FG001|NOT COMPLETED|Overall Study||0
11013618|NCT00762372|12191135|FG002|NOT COMPLETED|Overall Study||0
11013619|NCT00762385|12191149|FG000|STARTED|First Intervention||51
11013620|NCT00762385|12191150|FG001|STARTED|First Intervention||46
11013621|NCT00762385|12191149|FG000|COMPLETED|First Intervention||49
11013622|NCT00762385|12191150|FG001|COMPLETED|First Intervention||42
11013623|NCT00762385|12191149|FG000|NOT COMPLETED|First Intervention||2
11013624|NCT00762385|12191150|FG001|NOT COMPLETED|First Intervention||4
11013625|NCT00762385|12191149|FG000|STARTED|Second Intervention||49
11013626|NCT00762385|12191150|FG001|STARTED|Second Intervention||42
11013627|NCT00762385|12191149|FG000|COMPLETED|Second Intervention||46
11013628|NCT00762385|12191150|FG001|COMPLETED|Second Intervention||39
11013629|NCT00762385|12191149|FG000|NOT COMPLETED|Second Intervention||3
11013630|NCT00762385|12191150|FG001|NOT COMPLETED|Second Intervention||3
11013631|NCT00762411|12191161|FG000|STARTED|Initial Treatment||556
11013632|NCT00762411|12191162|FG001|STARTED|Initial Treatment||555
11013633|NCT00762411|12191161|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
11013634|NCT00762411|12191162|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
11013635|NCT00762411|12191161|FG000|COMPLETED|Initial Treatment||22
11396391|NCT03739840|12590241|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||58
11396392|NCT03739840|12590242|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||51
11396393|NCT03739840|12590243|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||54
11396394|NCT03739840|12590240|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||46
11396395|NCT03739840|12590241|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||44
11396396|NCT03739840|12590242|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||44
11396397|NCT03739840|12590243|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||36
11396398|NCT03739840|12590240|FG000|COMPLETED|Treatment Period: Wk0-16||46
11396399|NCT03739840|12590241|FG001|COMPLETED|Treatment Period: Wk0-16||44
11396400|NCT03739840|12590242|FG002|COMPLETED|Treatment Period: Wk0-16||44
11013636|NCT00762411|12191162|FG001|COMPLETED|Initial Treatment||34
11013637|NCT00762411|12191161|FG000|NOT COMPLETED|Initial Treatment||534
11142906|NCT01470170|12329670|FG002|COMPLETED|Overall Study||34
11142907|NCT01470170|12329671|FG003|COMPLETED|Overall Study||36
11142908|NCT01470170|12329672|FG004|COMPLETED|Overall Study||34
11013638|NCT00762411|12191162|FG001|NOT COMPLETED|Initial Treatment||521
11396401|NCT03739840|12590243|FG003|COMPLETED|Treatment Period: Wk0-16||36
11396402|NCT03739840|12590240|FG000|NOT COMPLETED|Treatment Period: Wk0-16||10
11396403|NCT03739840|12590241|FG001|NOT COMPLETED|Treatment Period: Wk0-16||16
11013639|NCT00762411|12191161|FG000|STARTED|Delayed Start||22
11013640|NCT00762411|12191162|FG001|STARTED|Delayed Start||34
11013641|NCT00762411|12191161|FG000|COMPLETED|Delayed Start||5
11396404|NCT03739840|12590242|FG002|NOT COMPLETED|Treatment Period: Wk0-16||13
11142909|NCT01470170|12329668|FG000|NOT COMPLETED|Overall Study||0
11142910|NCT01470170|12329669|FG001|NOT COMPLETED|Overall Study||0
11142911|NCT01470170|12329670|FG002|NOT COMPLETED|Overall Study||0
11142912|NCT01470170|12329671|FG003|NOT COMPLETED|Overall Study||0
11142913|NCT01470170|12329672|FG004|NOT COMPLETED|Overall Study||0
11142914|NCT01470196|12329684|FG000|STARTED|Overall Study||31
11142915|NCT01470196|12329684|FG000|COMPLETED|Overall Study||31
11396405|NCT03739840|12590243|FG003|NOT COMPLETED|Treatment Period: Wk0-16||23
11396406|NCT03739840|12590240|FG000|STARTED|Post-Treatment Period: Wk16-23||46
11013642|NCT00762411|12191162|FG001|COMPLETED|Delayed Start||8
11013643|NCT00762411|12191161|FG000|NOT COMPLETED|Delayed Start||17
11013644|NCT00762411|12191162|FG001|NOT COMPLETED|Delayed Start||26
11396407|NCT03739840|12590241|FG001|STARTED|Post-Treatment Period: Wk16-23||44
11013645|NCT00762411|12191161|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
11013646|NCT00762411|12191162|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
11013647|NCT00762411|12191161|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||228
11013648|NCT00762411|12191162|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||312
11013649|NCT00762411|12191161|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
11013650|NCT00762411|12191162|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
11013651|NCT00762424|12191174|FG000|STARTED|Overall Study||28
11013652|NCT00762424|12191175|FG001|STARTED|Overall Study||25
11013653|NCT00762424|12191174|FG000|COMPLETED|Overall Study||28
11013654|NCT00762424|12191175|FG001|COMPLETED|Overall Study||25
11013655|NCT00762424|12191174|FG000|NOT COMPLETED|Overall Study||0
11013656|NCT00762424|12191175|FG001|NOT COMPLETED|Overall Study||0
11013657|NCT00762450|12191184|FG000|STARTED|1st Treatment Period||2
11142916|NCT01470196|12329684|FG000|NOT COMPLETED|Overall Study||0
11142917|NCT01470248|12329688|FG000|STARTED|Overall Study||20
11142918|NCT01470248|12329688|FG000|COMPLETED|Overall Study||19
11013658|NCT00762450|12191185|FG001|STARTED|1st Treatment Period||2
11013659|NCT00762450|12191186|FG002|STARTED|1st Treatment Period||2
11013660|NCT00762450|12191184|FG000|COMPLETED|1st Treatment Period||2
11013661|NCT00762450|12191185|FG001|COMPLETED|1st Treatment Period||2
11013662|NCT00762450|12191186|FG002|COMPLETED|1st Treatment Period||2
11013663|NCT00762450|12191184|FG000|NOT COMPLETED|1st Treatment Period||0
11013664|NCT00762450|12191185|FG001|NOT COMPLETED|1st Treatment Period||0
11013665|NCT00762450|12191186|FG002|NOT COMPLETED|1st Treatment Period||0
11013666|NCT00762450|12191184|FG000|STARTED|Washout After 1st Treatment Period||2
11013667|NCT00762450|12191185|FG001|STARTED|Washout After 1st Treatment Period||2
11013668|NCT00762450|12191186|FG002|STARTED|Washout After 1st Treatment Period||2
11013669|NCT00762450|12191184|FG000|COMPLETED|Washout After 1st Treatment Period||2
11013670|NCT00762450|12191185|FG001|COMPLETED|Washout After 1st Treatment Period||2
11013671|NCT00762450|12191186|FG002|COMPLETED|Washout After 1st Treatment Period||2
11013672|NCT00762450|12191184|FG000|NOT COMPLETED|Washout After 1st Treatment Period||0
11013673|NCT00762450|12191185|FG001|NOT COMPLETED|Washout After 1st Treatment Period||0
11013674|NCT00762450|12191186|FG002|NOT COMPLETED|Washout After 1st Treatment Period||0
11013675|NCT00762450|12191184|FG000|STARTED|2nd Treatment Period||2
11013676|NCT00762450|12191185|FG001|STARTED|2nd Treatment Period||2
11013677|NCT00762450|12191186|FG002|STARTED|2nd Treatment Period||2
11013678|NCT00762450|12191184|FG000|COMPLETED|2nd Treatment Period||2
11396408|NCT03739840|12590242|FG002|STARTED|Post-Treatment Period: Wk16-23||44
11013679|NCT00762450|12191185|FG001|COMPLETED|2nd Treatment Period||2
11013680|NCT00762450|12191186|FG002|COMPLETED|2nd Treatment Period||2
11013681|NCT00762450|12191184|FG000|NOT COMPLETED|2nd Treatment Period||0
11013682|NCT00762450|12191185|FG001|NOT COMPLETED|2nd Treatment Period||0
11013683|NCT00762450|12191186|FG002|NOT COMPLETED|2nd Treatment Period||0
11396409|NCT03739840|12590243|FG003|STARTED|Post-Treatment Period: Wk16-23||36
11396410|NCT03739840|12590240|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||33
11013684|NCT00762450|12191184|FG000|STARTED|Washout After 2nd Treatment Period||2
11013685|NCT00762450|12191185|FG001|STARTED|Washout After 2nd Treatment Period||2
11013686|NCT00762450|12191186|FG002|STARTED|Washout After 2nd Treatment Period||2
11013687|NCT00762450|12191184|FG000|COMPLETED|Washout After 2nd Treatment Period||2
11013688|NCT00762450|12191185|FG001|COMPLETED|Washout After 2nd Treatment Period||2
11013689|NCT00762450|12191186|FG002|COMPLETED|Washout After 2nd Treatment Period||2
11013690|NCT00762450|12191184|FG000|NOT COMPLETED|Washout After 2nd Treatment Period||0
11013691|NCT00762450|12191185|FG001|NOT COMPLETED|Washout After 2nd Treatment Period||0
11013692|NCT00762450|12191186|FG002|NOT COMPLETED|Washout After 2nd Treatment Period||0
11013693|NCT00762450|12191184|FG000|STARTED|3rd Treatment Period||2
11013694|NCT00762450|12191185|FG001|STARTED|3rd Treatment Period||2
11013695|NCT00762450|12191186|FG002|STARTED|3rd Treatment Period||2
11013696|NCT00762450|12191184|FG000|COMPLETED|3rd Treatment Period||2
11013697|NCT00762450|12191185|FG001|COMPLETED|3rd Treatment Period||2
11013698|NCT00762450|12191186|FG002|COMPLETED|3rd Treatment Period||2
11013699|NCT00762450|12191184|FG000|NOT COMPLETED|3rd Treatment Period||0
11013700|NCT00762450|12191185|FG001|NOT COMPLETED|3rd Treatment Period||0
11013701|NCT00762450|12191186|FG002|NOT COMPLETED|3rd Treatment Period||0
11013702|NCT00762463|12191196|FG000|STARTED|Double-blind Phase (Baseline to Week 6)||120
11013703|NCT00762463|12191197|FG001|STARTED|Double-blind Phase (Baseline to Week 6)||120
11013704|NCT00762463|12191198|FG002|STARTED|Double-blind Phase (Baseline to Week 6)||0
11013705|NCT00762463|12191199|FG003|STARTED|Double-blind Phase (Baseline to Week 6)||0
11013706|NCT00762463|12191196|FG000|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
11013707|NCT00762463|12191197|FG001|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
11013708|NCT00762463|12191198|FG002|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
11013709|NCT00762463|12191199|FG003|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
11013710|NCT00762463|12191196|FG000|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
11013711|NCT00762463|12191197|FG001|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
11013712|NCT00762463|12191198|FG002|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
11013713|NCT00762463|12191199|FG003|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
11013714|NCT00762463|12191196|FG000|STARTED|Enrollment in Extension Phase (Week 6)||113
11013715|NCT00762463|12191197|FG001|STARTED|Enrollment in Extension Phase (Week 6)||110
11013716|NCT00762463|12191198|FG002|STARTED|Enrollment in Extension Phase (Week 6)||0
11013717|NCT00762463|12191199|FG003|STARTED|Enrollment in Extension Phase (Week 6)||0
11013718|NCT00762463|12191196|FG000|COMPLETED|Enrollment in Extension Phase (Week 6)||109
11013719|NCT00762463|12191197|FG001|COMPLETED|Enrollment in Extension Phase (Week 6)||109
11013720|NCT00762463|12191198|FG002|COMPLETED|Enrollment in Extension Phase (Week 6)||0
11013721|NCT00762463|12191199|FG003|COMPLETED|Enrollment in Extension Phase (Week 6)||0
11013722|NCT00762463|12191196|FG000|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
11013723|NCT00762463|12191197|FG001|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
11013724|NCT00762463|12191198|FG002|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
11013725|NCT00762463|12191199|FG003|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
11013726|NCT00762463|12191196|FG000|STARTED|Extension Phase (Week 6 to Week 12)||55
11013727|NCT00762463|12191197|FG001|STARTED|Extension Phase (Week 6 to Week 12)||55
11013728|NCT00762463|12191198|FG002|STARTED|Extension Phase (Week 6 to Week 12)||54
11013729|NCT00762463|12191199|FG003|STARTED|Extension Phase (Week 6 to Week 12)||54
11013730|NCT00762463|12191196|FG000|COMPLETED|Extension Phase (Week 6 to Week 12)||52
11013731|NCT00762463|12191197|FG001|COMPLETED|Extension Phase (Week 6 to Week 12)||54
11013732|NCT00762463|12191198|FG002|COMPLETED|Extension Phase (Week 6 to Week 12)||50
11013733|NCT00762463|12191199|FG003|COMPLETED|Extension Phase (Week 6 to Week 12)||52
11013734|NCT00762463|12191196|FG000|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
11013735|NCT00762463|12191197|FG001|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
11013736|NCT00762463|12191198|FG002|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
11013737|NCT00762463|12191199|FG003|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
11013738|NCT00762476|12191214|FG000|STARTED|Overall Study||206
11013739|NCT00762476|12191215|FG001|STARTED|Overall Study||205
11013740|NCT00762476|12191214|FG000|COMPLETED|Overall Study||183
11013741|NCT00762476|12191215|FG001|COMPLETED|Overall Study||169
11013742|NCT00762476|12191214|FG000|NOT COMPLETED|Overall Study||23
11013743|NCT00762476|12191215|FG001|NOT COMPLETED|Overall Study||36
11013744|NCT00762502|12191225|FG000|STARTED|Baseline to Month 3 (Period 1)||36
11013745|NCT00762502|12191226|FG001|STARTED|Baseline to Month 3 (Period 1)||25
11013746|NCT00762502|12191227|FG002|STARTED|Baseline to Month 3 (Period 1)||51
11013747|NCT00762502|12191225|FG000|COMPLETED|Baseline to Month 3 (Period 1)||26
11013748|NCT00762502|12191226|FG001|COMPLETED|Baseline to Month 3 (Period 1)||19
11013749|NCT00762502|12191227|FG002|COMPLETED|Baseline to Month 3 (Period 1)||32
11013750|NCT00762502|12191225|FG000|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
11013751|NCT00762502|12191226|FG001|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
11013752|NCT00762502|12191227|FG002|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
11013753|NCT00762502|12191225|FG000|STARTED|Month 3 to Month 6 (Period 2)||9
11013754|NCT00762502|12191226|FG001|STARTED|Month 3 to Month 6 (Period 2)||5
11013755|NCT00762502|12191227|FG002|STARTED|Month 3 to Month 6 (Period 2)||23
11013756|NCT00762502|12191225|FG000|COMPLETED|Month 3 to Month 6 (Period 2)||9
11013757|NCT00762502|12191226|FG001|COMPLETED|Month 3 to Month 6 (Period 2)||4
11013758|NCT00762502|12191227|FG002|COMPLETED|Month 3 to Month 6 (Period 2)||23
11013759|NCT00762502|12191225|FG000|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
11013760|NCT00762502|12191226|FG001|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
11013761|NCT00762502|12191227|FG002|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
11013762|NCT00762515|12191235|FG000|STARTED|Overall Study||22
11142919|NCT01470248|12329688|FG000|NOT COMPLETED|Overall Study||1
11142920|NCT01470417|12329694|FG000|STARTED|Overall Study||3
11142921|NCT01470417|12329695|FG001|STARTED|Overall Study||7
11142922|NCT01470417|12329694|FG000|COMPLETED|Overall Study||3
11142923|NCT01470417|12329695|FG001|COMPLETED|Overall Study||5
11142924|NCT01470417|12329694|FG000|NOT COMPLETED|Overall Study||0
11142925|NCT01470417|12329695|FG001|NOT COMPLETED|Overall Study||2
11142926|NCT01470469|12329703|FG000|STARTED|Overall Study||21
11142927|NCT01470469|12329704|FG001|STARTED|Overall Study||62
11142928|NCT01470469|12329703|FG000|COMPLETED|Overall Study||11
11142929|NCT01470469|12329704|FG001|COMPLETED|Overall Study||38
11142930|NCT01470469|12329703|FG000|NOT COMPLETED|Overall Study||10
11142931|NCT01470469|12329704|FG001|NOT COMPLETED|Overall Study||24
11142932|NCT01470599|12329712|FG000|STARTED|Overall Study||62
11142933|NCT01470599|12329713|FG001|STARTED|Overall Study||88
11142934|NCT01470599|12329712|FG000|COMPLETED|Overall Study||43
11142935|NCT01470599|12329713|FG001|COMPLETED|Overall Study||45
11142936|NCT01470599|12329712|FG000|NOT COMPLETED|Overall Study||19
11142937|NCT01470599|12329713|FG001|NOT COMPLETED|Overall Study||43
11142938|NCT01470612|12329721|FG000|STARTED|Overall Study||175
11142939|NCT01470612|12329722|FG001|STARTED|Overall Study||769
11142940|NCT01470612|12329721|FG000|COMPLETED|Overall Study||91
11142941|NCT01470612|12329722|FG001|COMPLETED|Overall Study||104
11142942|NCT01470612|12329721|FG000|NOT COMPLETED|Overall Study||84
11142943|NCT01470612|12329722|FG001|NOT COMPLETED|Overall Study||665
11142944|NCT01470651|12329730|FG000|STARTED|Overall Study||13
11142945|NCT01470651|12329731|FG001|STARTED|Overall Study||13
11142946|NCT01470651|12329730|FG000|COMPLETED|Overall Study||6
11142947|NCT01470651|12329731|FG001|COMPLETED|Overall Study||10
11142948|NCT01470651|12329730|FG000|NOT COMPLETED|Overall Study||7
11142949|NCT01470651|12329731|FG001|NOT COMPLETED|Overall Study||3
11142950|NCT01470781|12329739|FG000|STARTED|Overall Study||39
11142951|NCT01470781|12329740|FG001|STARTED|Overall Study||33
11142952|NCT01470781|12329739|FG000|Midpoint Assessment|Overall Study||30
11142953|NCT01470781|12329740|FG001|Midpoint Assessment|Overall Study||30
11142954|NCT01470781|12329739|FG000|Post-Treatment Assessment|Overall Study||22
11142955|NCT01470781|12329740|FG001|Post-Treatment Assessment|Overall Study||23
11142956|NCT01470781|12329739|FG000|COMPLETED|Overall Study||21
11142957|NCT01470781|12329740|FG001|COMPLETED|Overall Study||21
11142958|NCT01470781|12329739|FG000|NOT COMPLETED|Overall Study||18
11142959|NCT01470781|12329740|FG001|NOT COMPLETED|Overall Study||12
11142960|NCT01470859|12329749|FG000|STARTED|Overall Study||15
11142961|NCT01470859|12329750|FG001|STARTED|Overall Study||15
11142962|NCT01470859|12329749|FG000|COMPLETED|Overall Study||14
11142963|NCT01470859|12329750|FG001|COMPLETED|Overall Study||15
11142964|NCT01470859|12329749|FG000|NOT COMPLETED|Overall Study||1
11142965|NCT01470859|12329750|FG001|NOT COMPLETED|Overall Study||0
11142966|NCT01470989|12329758|FG000|STARTED|Overall Study||227
11142967|NCT01470989|12329759|FG001|STARTED|Overall Study||229
11142968|NCT01470989|12329758|FG000|Completed Core Study|Overall Study||208
11142969|NCT01470989|12329759|FG001|Completed Core Study|Overall Study||208
11142970|NCT01470989|12329758|FG000|Entered Extension 1 Study|Overall Study||174
11142971|NCT01470989|12329759|FG001|Entered Extension 1 Study|Overall Study||161
11142972|NCT01470989|12329758|FG000|Completed Extension 1 Study|Overall Study||165
11142973|NCT01470989|12329759|FG001|Completed Extension 1 Study|Overall Study||152
11142974|NCT01470989|12329758|FG000|Entered Extension 2 Study|Overall Study||141
11013763|NCT00762515|12191236|FG001|STARTED|Overall Study||22
11013764|NCT00762515|12191235|FG000|COMPLETED|Overall Study||22
11013765|NCT00762515|12191236|FG001|COMPLETED|Overall Study||22
11013766|NCT00762515|12191235|FG000|NOT COMPLETED|Overall Study||0
11013767|NCT00762515|12191236|FG001|NOT COMPLETED|Overall Study||0
11013768|NCT00762528|12191244|FG000|STARTED|Overall Study||24
11013769|NCT00762528|12191245|FG001|STARTED|Overall Study||25
11013770|NCT00762528|12191244|FG000|COMPLETED|Overall Study||24
11013771|NCT00762528|12191245|FG001|COMPLETED|Overall Study||25
11013772|NCT00762528|12191244|FG000|NOT COMPLETED|Overall Study||0
11013773|NCT00762528|12191245|FG001|NOT COMPLETED|Overall Study||0
11013774|NCT00762606|12191253|FG000|STARTED|Overall Study||55
11013775|NCT00762606|12191254|FG001|STARTED|Overall Study||51
11013776|NCT00762606|12191253|FG000|COMPLETED|Overall Study||37
11013777|NCT00762606|12191254|FG001|COMPLETED|Overall Study||38
11013778|NCT00762606|12191253|FG000|NOT COMPLETED|Overall Study||18
11013779|NCT00762606|12191254|FG001|NOT COMPLETED|Overall Study||13
11013780|NCT00762619|12191262|FG000|STARTED|Overall Study||55
11013781|NCT00762619|12191263|FG001|STARTED|Overall Study||50
11013782|NCT00762619|12191262|FG000|COMPLETED|Overall Study||55
11013783|NCT00762619|12191263|FG001|COMPLETED|Overall Study||50
11013784|NCT00762619|12191262|FG000|NOT COMPLETED|Overall Study||0
11013785|NCT00762619|12191263|FG001|NOT COMPLETED|Overall Study||0
11013786|NCT00762645|12191273|FG000|STARTED|Overall Study||16
11013787|NCT00762645|12191274|FG001|STARTED|Overall Study||14
11013788|NCT00762645|12191273|FG000|COMPLETED|Overall Study||12
11013789|NCT00762645|12191274|FG001|COMPLETED|Overall Study||12
11013790|NCT00762645|12191273|FG000|NOT COMPLETED|Overall Study||4
11013791|NCT00762645|12191274|FG001|NOT COMPLETED|Overall Study||2
11013792|NCT00762710|12191282|FG000|STARTED|Overall Study||48
11013793|NCT00762710|12191283|FG001|STARTED|Overall Study||44
11013794|NCT00762710|12191282|FG000|COMPLETED|Overall Study||27
11013795|NCT00762710|12191283|FG001|COMPLETED|Overall Study||29
11013796|NCT00762710|12191282|FG000|NOT COMPLETED|Overall Study||21
11013797|NCT00762710|12191283|FG001|NOT COMPLETED|Overall Study||15
11013798|NCT00762762|12191291|FG000|STARTED|Overall Study||30
11013799|NCT00762762|12191292|FG001|STARTED|Overall Study||30
11013800|NCT00762762|12191291|FG000|COMPLETED|Overall Study||22
11013801|NCT00762762|12191292|FG001|COMPLETED|Overall Study||20
11013802|NCT00762762|12191291|FG000|NOT COMPLETED|Overall Study||8
11013803|NCT00762762|12191292|FG001|NOT COMPLETED|Overall Study||10
11013804|NCT00762788|12191304|FG000|STARTED|Overall Study||55
11013805|NCT00762788|12191305|FG001|STARTED|Overall Study||58
11013806|NCT00762788|12191306|FG002|STARTED|Overall Study||42
11013807|NCT00762788|12191307|FG003|STARTED|Overall Study||64
11013808|NCT00762788|12191308|FG004|STARTED|Overall Study||43
11013809|NCT00762788|12191309|FG005|STARTED|Overall Study||52
11013810|NCT00762788|12191304|FG000|COMPLETED|Overall Study||29
11013811|NCT00762788|12191305|FG001|COMPLETED|Overall Study||21
11013812|NCT00762788|12191306|FG002|COMPLETED|Overall Study||21
11013813|NCT00762788|12191307|FG003|COMPLETED|Overall Study||38
11013814|NCT00762788|12191308|FG004|COMPLETED|Overall Study||30
11013815|NCT00762788|12191309|FG005|COMPLETED|Overall Study||31
11013816|NCT00762788|12191304|FG000|NOT COMPLETED|Overall Study||26
11013817|NCT00762788|12191305|FG001|NOT COMPLETED|Overall Study||37
11013818|NCT00762788|12191306|FG002|NOT COMPLETED|Overall Study||21
11013819|NCT00762788|12191307|FG003|NOT COMPLETED|Overall Study||26
11013820|NCT00762788|12191308|FG004|NOT COMPLETED|Overall Study||13
11013821|NCT00762788|12191309|FG005|NOT COMPLETED|Overall Study||21
11013822|NCT00762853|12191325|FG000|STARTED|First Treatment Period||10
11013823|NCT00762853|12191326|FG001|STARTED|First Treatment Period||10
11013824|NCT00762853|12191325|FG000|COMPLETED|First Treatment Period||10
11013825|NCT00762853|12191326|FG001|COMPLETED|First Treatment Period||10
11013826|NCT00762853|12191325|FG000|NOT COMPLETED|First Treatment Period||0
11013827|NCT00762853|12191326|FG001|NOT COMPLETED|First Treatment Period||0
11013828|NCT00762853|12191325|FG000|STARTED|1 Week Washout After Treatment 1||10
11013829|NCT00762853|12191326|FG001|STARTED|1 Week Washout After Treatment 1||10
11013830|NCT00762853|12191325|FG000|COMPLETED|1 Week Washout After Treatment 1||10
11013831|NCT00762853|12191326|FG001|COMPLETED|1 Week Washout After Treatment 1||10
11013832|NCT00762853|12191325|FG000|NOT COMPLETED|1 Week Washout After Treatment 1||0
11013833|NCT00762853|12191326|FG001|NOT COMPLETED|1 Week Washout After Treatment 1||0
11013834|NCT00762853|12191325|FG000|STARTED|Second Treatment Period||10
11013835|NCT00762853|12191326|FG001|STARTED|Second Treatment Period||10
11013836|NCT00762853|12191325|FG000|COMPLETED|Second Treatment Period||10
11013837|NCT00762853|12191326|FG001|COMPLETED|Second Treatment Period||10
11013838|NCT00762853|12191325|FG000|NOT COMPLETED|Second Treatment Period||0
11013839|NCT00762853|12191326|FG001|NOT COMPLETED|Second Treatment Period||0
11013840|NCT00762892|12191334|FG000|STARTED|Overall Study||14
11013841|NCT00762892|12191335|FG001|STARTED|Overall Study||14
11013842|NCT00762892|12191334|FG000|COMPLETED|Overall Study||9
11013843|NCT00762892|12191335|FG001|COMPLETED|Overall Study||8
11013844|NCT00762892|12191334|FG000|NOT COMPLETED|Overall Study||5
11013845|NCT00762892|12191335|FG001|NOT COMPLETED|Overall Study||6
11013846|NCT00762931|12191341|FG000|STARTED|Overall Study||25
11013847|NCT00762931|12191341|FG000|COMPLETED|Overall Study||23
11013848|NCT00762931|12191341|FG000|NOT COMPLETED|Overall Study||2
11013849|NCT00762970|12191348|FG000|STARTED|Overall Study||46
11013850|NCT00762970|12191349|FG001|STARTED|Overall Study||44
11013851|NCT00762970|12191350|FG002|STARTED|Overall Study||47
11013852|NCT00762970|12191348|FG000|COMPLETED|Overall Study||34
11013853|NCT00762970|12191349|FG001|COMPLETED|Overall Study||35
11013854|NCT00762970|12191350|FG002|COMPLETED|Overall Study||46
11013855|NCT00762970|12191348|FG000|NOT COMPLETED|Overall Study||12
11013856|NCT00762970|12191349|FG001|NOT COMPLETED|Overall Study||9
11013857|NCT00762970|12191350|FG002|NOT COMPLETED|Overall Study||1
11013858|NCT00762996|12191358|FG000|STARTED|Period One||15
11013859|NCT00762996|12191359|FG001|STARTED|Period One||16
11013860|NCT00762996|12191360|FG002|STARTED|Period One||17
11013861|NCT00762996|12191361|FG003|STARTED|Period One||17
11013862|NCT00762996|12191358|FG000|COMPLETED|Period One||15
11013863|NCT00762996|12191359|FG001|COMPLETED|Period One||16
11013864|NCT00762996|12191360|FG002|COMPLETED|Period One||13
11013865|NCT00762996|12191361|FG003|COMPLETED|Period One||16
11013866|NCT00762996|12191358|FG000|NOT COMPLETED|Period One||0
11013867|NCT00762996|12191359|FG001|NOT COMPLETED|Period One||0
11013868|NCT00762996|12191360|FG002|NOT COMPLETED|Period One||4
11013869|NCT00762996|12191361|FG003|NOT COMPLETED|Period One||1
11013870|NCT00762996|12191358|FG000|STARTED|Period Two||15
11013871|NCT00762996|12191359|FG001|STARTED|Period Two||16
11013872|NCT00762996|12191360|FG002|STARTED|Period Two||13
11013873|NCT00762996|12191361|FG003|STARTED|Period Two||16
11396411|NCT03739840|12590241|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||31
11396412|NCT03739840|12590242|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||29
11396413|NCT03739840|12590243|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||28
11013874|NCT00762996|12191358|FG000|COMPLETED|Period Two||15
11013875|NCT00762996|12191359|FG001|COMPLETED|Period Two||16
11013876|NCT00762996|12191360|FG002|COMPLETED|Period Two||13
11396414|NCT03739840|12590240|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||33
11396415|NCT03739840|12590241|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||31
11396416|NCT03739840|12590242|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||29
11396417|NCT03739840|12590243|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||28
11396418|NCT03739840|12590240|FG000|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||19
11396419|NCT03739840|12590241|FG001|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18
11396420|NCT03739840|12590242|FG002|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||21
11396421|NCT03739840|12590243|FG003|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||13
11396422|NCT03739840|12590240|FG000|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||15
11396423|NCT03739840|12590241|FG001|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||16
11396424|NCT03739840|12590242|FG002|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18
11396425|NCT03739840|12590243|FG003|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||12
11396426|NCT03739840|12590240|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||27
11013877|NCT00762996|12191361|FG003|COMPLETED|Period Two||16
11013878|NCT00762996|12191358|FG000|NOT COMPLETED|Period Two||0
11013879|NCT00762996|12191359|FG001|NOT COMPLETED|Period Two||0
11013880|NCT00762996|12191360|FG002|NOT COMPLETED|Period Two||0
11013881|NCT00762996|12191361|FG003|NOT COMPLETED|Period Two||0
11013882|NCT00763035|12191369|FG000|STARTED|First Intervention||10
11013883|NCT00763035|12191370|FG001|STARTED|First Intervention||4
11013884|NCT00763035|12191369|FG000|COMPLETED|First Intervention||9
11013885|NCT00763035|12191370|FG001|COMPLETED|First Intervention||3
11013886|NCT00763035|12191369|FG000|NOT COMPLETED|First Intervention||1
11013887|NCT00763035|12191370|FG001|NOT COMPLETED|First Intervention||1
11013888|NCT00763035|12191369|FG000|STARTED|Second Intervention||9
11013889|NCT00763035|12191370|FG001|STARTED|Second Intervention||3
11013890|NCT00763035|12191369|FG000|COMPLETED|Second Intervention||6
11013891|NCT00763035|12191370|FG001|COMPLETED|Second Intervention||3
11013892|NCT00763035|12191369|FG000|NOT COMPLETED|Second Intervention||3
11013893|NCT00763035|12191370|FG001|NOT COMPLETED|Second Intervention||0
11013894|NCT00763048|12191378|FG000|STARTED|Overall Study||21
11013895|NCT00763048|12191379|FG001|STARTED|Overall Study||18
11013896|NCT00763048|12191378|FG000|COMPLETED|Overall Study||21
11013897|NCT00763048|12191379|FG001|COMPLETED|Overall Study||18
11013898|NCT00763048|12191378|FG000|NOT COMPLETED|Overall Study||0
11013899|NCT00763048|12191379|FG001|NOT COMPLETED|Overall Study||0
11013900|NCT00763061|12191387|FG000|STARTED|Overall Study||54
11013901|NCT00763061|12191388|FG001|STARTED|Overall Study||57
11013902|NCT00763061|12191387|FG000|COMPLETED|Overall Study||49
11013903|NCT00763061|12191388|FG001|COMPLETED|Overall Study||44
11013904|NCT00763061|12191387|FG000|NOT COMPLETED|Overall Study||5
11013905|NCT00763061|12191388|FG001|NOT COMPLETED|Overall Study||13
11013906|NCT00763139|12191394|FG000|STARTED|Overall Study||17
11013907|NCT00763139|12191395|FG001|STARTED|Overall Study||17
11013908|NCT00763139|12191394|FG000|COMPLETED|Overall Study||12
11013909|NCT00763139|12191395|FG001|COMPLETED|Overall Study||14
11013910|NCT00763139|12191394|FG000|NOT COMPLETED|Overall Study||5
11013911|NCT00763139|12191395|FG001|NOT COMPLETED|Overall Study||3
11013912|NCT00763243|12191406|FG000|STARTED|Waiting Period||9
11013913|NCT00763243|12191406|FG000|COMPLETED|Waiting Period||9
11013914|NCT00763243|12191406|FG000|NOT COMPLETED|Waiting Period||0
11013915|NCT00763243|12191406|FG000|STARTED|Training Period||9
11013916|NCT00763243|12191406|FG000|COMPLETED|Training Period||9
11013917|NCT00763243|12191406|FG000|NOT COMPLETED|Training Period||0
11013918|NCT00763243|12191406|FG000|STARTED|1-Month Follow-Up Period||9
11013919|NCT00763243|12191406|FG000|COMPLETED|1-Month Follow-Up Period||9
11013920|NCT00763243|12191406|FG000|NOT COMPLETED|1-Month Follow-Up Period||0
11013921|NCT00763243|12191406|FG000|STARTED|6-Month Follow-Up Period||9
11013922|NCT00763243|12191406|FG000|COMPLETED|6-Month Follow-Up Period||9
11013923|NCT00763243|12191406|FG000|NOT COMPLETED|6-Month Follow-Up Period||0
11013924|NCT00763256|12191420|FG000|STARTED|Overall Study||15
11013925|NCT00763256|12191421|FG001|STARTED|Overall Study||18
11013926|NCT00763256|12191420|FG000|COMPLETED|Overall Study||8
11013927|NCT00763256|12191421|FG001|COMPLETED|Overall Study||8
11013928|NCT00763256|12191420|FG000|NOT COMPLETED|Overall Study||7
11013929|NCT00763256|12191421|FG001|NOT COMPLETED|Overall Study||10
11013930|NCT00763269|12191429|FG000|STARTED|Overall Study||314
11013931|NCT00763269|12191430|FG001|STARTED|Overall Study||312
11013932|NCT00763269|12191429|FG000|COMPLETED|Overall Study||302
11013933|NCT00763269|12191430|FG001|COMPLETED|Overall Study||299
11013934|NCT00763269|12191429|FG000|NOT COMPLETED|Overall Study||12
11013935|NCT00763269|12191430|FG001|NOT COMPLETED|Overall Study||13
11013936|NCT00763282|12191438|FG000|STARTED|Overall Study||72
11013937|NCT00763282|12191439|FG001|STARTED|Overall Study||72
11013938|NCT00763282|12191438|FG000|COMPLETED|Overall Study||40
11013939|NCT00763282|12191439|FG001|COMPLETED|Overall Study||38
11013940|NCT00763282|12191438|FG000|NOT COMPLETED|Overall Study||32
11013941|NCT00763282|12191439|FG001|NOT COMPLETED|Overall Study||34
11013942|NCT00763321|12191450|FG000|STARTED|Open-label Period||285
11013943|NCT00763321|12191451|FG001|STARTED|Open-label Period||0
11013944|NCT00763321|12191452|FG002|STARTED|Open-label Period||0
11013945|NCT00763321|12191450|FG000|COMPLETED|Open-label Period||222
11013946|NCT00763321|12191451|FG001|COMPLETED|Open-label Period||0
11013947|NCT00763321|12191452|FG002|COMPLETED|Open-label Period||0
11013948|NCT00763321|12191450|FG000|NOT COMPLETED|Open-label Period||63
11013949|NCT00763321|12191451|FG001|NOT COMPLETED|Open-label Period||0
11013950|NCT00763321|12191452|FG002|NOT COMPLETED|Open-label Period||0
11013951|NCT00763321|12191450|FG000|STARTED|Double-blind Period||0
11013952|NCT00763321|12191451|FG001|STARTED|Double-blind Period||109
11013953|NCT00763321|12191452|FG002|STARTED|Double-blind Period||113
11013954|NCT00763321|12191450|FG000|COMPLETED|Double-blind Period||0
11013955|NCT00763321|12191451|FG001|COMPLETED|Double-blind Period||88
11013956|NCT00763321|12191452|FG002|COMPLETED|Double-blind Period||84
11013957|NCT00763321|12191450|FG000|NOT COMPLETED|Double-blind Period||0
11013958|NCT00763321|12191451|FG001|NOT COMPLETED|Double-blind Period||21
11013959|NCT00763321|12191452|FG002|NOT COMPLETED|Double-blind Period||29
11013960|NCT00763360|12191462|FG000|STARTED|Overall Study||61
11013961|NCT00763360|12191463|FG001|STARTED|Overall Study||60
11013962|NCT00763360|12191464|FG002|STARTED|Overall Study||63
11013963|NCT00763360|12191462|FG000|COMPLETED|Overall Study||61
11013964|NCT00763360|12191463|FG001|COMPLETED|Overall Study||58
11013965|NCT00763360|12191464|FG002|COMPLETED|Overall Study||63
11013966|NCT00763360|12191462|FG000|NOT COMPLETED|Overall Study||0
11013967|NCT00763360|12191463|FG001|NOT COMPLETED|Overall Study||2
11013968|NCT00763360|12191464|FG002|NOT COMPLETED|Overall Study||0
11013969|NCT00763386|12191474|FG000|STARTED|Overall Study||164
11013970|NCT00763386|12191475|FG001|STARTED|Overall Study||167
11013971|NCT00763386|12191474|FG000|COMPLETED|Overall Study||116
11013972|NCT00763386|12191475|FG001|COMPLETED|Overall Study||127
11013973|NCT00763386|12191474|FG000|NOT COMPLETED|Overall Study||48
11013974|NCT00763386|12191475|FG001|NOT COMPLETED|Overall Study||40
11013975|NCT00763412|12191483|FG000|STARTED|Overall Study||8
11013976|NCT00763412|12191484|FG001|STARTED|Overall Study||8
11013977|NCT00763412|12191483|FG000|COMPLETED|Overall Study||4
11013978|NCT00763412|12191484|FG001|COMPLETED|Overall Study||4
11013979|NCT00763412|12191483|FG000|NOT COMPLETED|Overall Study||4
11013980|NCT00763412|12191484|FG001|NOT COMPLETED|Overall Study||4
11013981|NCT00763451|12191494|FG000|STARTED|Overall Study|Randomized.|80
11013982|NCT00763451|12191495|FG001|STARTED|Overall Study||82
11013983|NCT00763451|12191496|FG002|STARTED|Overall Study||161
11013984|NCT00763451|12191497|FG003|STARTED|Overall Study||161
11013985|NCT00763451|12191494|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
11013986|NCT00763451|12191495|FG001|Treated/Safety Population|Overall Study||81
11013987|NCT00763451|12191496|FG002|Treated/Safety Population|Overall Study||161
11013988|NCT00763451|12191497|FG003|Treated/Safety Population|Overall Study||161
11013989|NCT00763451|12191494|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
11013990|NCT00763451|12191495|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||80
11013991|NCT00763451|12191496|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||160
11013992|NCT00763451|12191497|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||160
11013993|NCT00763451|12191494|FG000|COMPLETED|Overall Study||67
11013994|NCT00763451|12191495|FG001|COMPLETED|Overall Study||60
11013995|NCT00763451|12191496|FG002|COMPLETED|Overall Study||121
11013996|NCT00763451|12191497|FG003|COMPLETED|Overall Study||131
11013997|NCT00763451|12191494|FG000|NOT COMPLETED|Overall Study||13
11013998|NCT00763451|12191495|FG001|NOT COMPLETED|Overall Study||22
11013999|NCT00763451|12191496|FG002|NOT COMPLETED|Overall Study||40
11014000|NCT00763451|12191497|FG003|NOT COMPLETED|Overall Study||30
11014001|NCT00763490|12191508|FG000|STARTED|Overall Study||20
11014002|NCT00763490|12191508|FG000|COMPLETED|Overall Study||20
11014003|NCT00763490|12191508|FG000|NOT COMPLETED|Overall Study||0
11014004|NCT00763698|12191512|FG000|STARTED|Overall Study||86
11014005|NCT00763698|12191512|FG000|COMPLETED|Overall Study||76
11014006|NCT00763698|12191512|FG000|NOT COMPLETED|Overall Study||10
11014007|NCT00763750|12191517|FG000|STARTED|Overall Study||25
11014008|NCT00763750|12191517|FG000|COMPLETED|Overall Study||25
11014009|NCT00763750|12191517|FG000|NOT COMPLETED|Overall Study||0
11014010|NCT00763815|12191523|FG000|STARTED|Overall Study|Randomized.|161
11014011|NCT00763815|12191524|FG001|STARTED|Overall Study||323
11014012|NCT00763815|12191523|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
11014013|NCT00763815|12191524|FG001|Treated/Safety Population|Overall Study||323
11014014|NCT00763815|12191523|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
11014015|NCT00763815|12191524|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||320
11014016|NCT00763815|12191523|FG000|COMPLETED|Overall Study||109
11014017|NCT00763815|12191524|FG001|COMPLETED|Overall Study||239
11014018|NCT00763815|12191523|FG000|NOT COMPLETED|Overall Study||52
11014019|NCT00763815|12191524|FG001|NOT COMPLETED|Overall Study||84
11014020|NCT00763867|12191532|FG000|STARTED|Overall Study||103
11014021|NCT00763867|12191533|FG001|STARTED|Overall Study||113
11014022|NCT00763867|12191532|FG000|COMPLETED|Overall Study||98
11014023|NCT00763867|12191533|FG001|COMPLETED|Overall Study||101
11014024|NCT00763867|12191532|FG000|NOT COMPLETED|Overall Study||5
11014025|NCT00763867|12191533|FG001|NOT COMPLETED|Overall Study||12
11014026|NCT00763919|12191539|FG000|STARTED|Overall Study||43
11014027|NCT00763919|12191539|FG000|COMPLETED|Overall Study||30
11014028|NCT00763919|12191539|FG000|NOT COMPLETED|Overall Study||13
11014029|NCT00763958|12191545|FG000|STARTED|Overall Study||28
11014030|NCT00763958|12191546|FG001|STARTED|Overall Study||16
11014031|NCT00763958|12191545|FG000|COMPLETED|Overall Study||14
11014032|NCT00763958|12191546|FG001|COMPLETED|Overall Study||5
11014033|NCT00763958|12191545|FG000|NOT COMPLETED|Overall Study||14
11014034|NCT00763958|12191546|FG001|NOT COMPLETED|Overall Study||11
11014035|NCT00763971|12191556|FG000|STARTED|Overall Study||113
11014036|NCT00763971|12191557|FG001|STARTED|Overall Study||112
11014037|NCT00763971|12191558|FG002|STARTED|Overall Study||111
11014038|NCT00763971|12191556|FG000|COMPLETED|Overall Study||80
11014039|NCT00763971|12191557|FG001|COMPLETED|Overall Study||74
11014040|NCT00763971|12191558|FG002|COMPLETED|Overall Study||42
11014041|NCT00763971|12191556|FG000|NOT COMPLETED|Overall Study||33
11014042|NCT00763971|12191557|FG001|NOT COMPLETED|Overall Study||38
11014043|NCT00763971|12191558|FG002|NOT COMPLETED|Overall Study||69
11014044|NCT00764309|12191566|FG000|STARTED|Overall Study|Number of participants treated.|31
11014045|NCT00764309|12191566|FG000|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
11014046|NCT00764309|12191566|FG000|NOT COMPLETED|Overall Study||0
11014047|NCT00764322|12191572|FG000|STARTED|Overall Study||500
11014048|NCT00764322|12191572|FG000|COMPLETED|Overall Study||480
11014049|NCT00764322|12191572|FG000|NOT COMPLETED|Overall Study||20
11014050|NCT00764361|12191591|FG000|STARTED|Overall Study||8
11014051|NCT00764361|12191592|FG001|STARTED|Overall Study||7
11014052|NCT00764361|12191591|FG000|COMPLETED|Overall Study||6
11014053|NCT00764361|12191592|FG001|COMPLETED|Overall Study||3
11014054|NCT00764361|12191591|FG000|NOT COMPLETED|Overall Study||2
11014055|NCT00764361|12191592|FG001|NOT COMPLETED|Overall Study||4
11014056|NCT00764465|12191604|FG000|STARTED|Overall Study||9
11014057|NCT00764465|12191605|FG001|STARTED|Overall Study||7
11014058|NCT00764465|12191606|FG002|STARTED|Overall Study||7
11014059|NCT00764465|12191607|FG003|STARTED|Overall Study||7
11014060|NCT00764465|12191608|FG004|STARTED|Overall Study||7
11014061|NCT00764465|12191609|FG005|STARTED|Overall Study||8
11014062|NCT00764465|12191604|FG000|COMPLETED|Overall Study||7
11014063|NCT00764465|12191605|FG001|COMPLETED|Overall Study||6
11014064|NCT00764465|12191606|FG002|COMPLETED|Overall Study||6
11142975|NCT01470989|12329759|FG001|Entered Extension 2 Study|Overall Study||131
11142976|NCT01470989|12329758|FG000|Completed Extension 2 Study|Overall Study||132
11142977|NCT01470989|12329759|FG001|Completed Extension 2 Study|Overall Study||117
11142978|NCT01470989|12329758|FG000|Entered Extension 3|Overall Study||87
11142979|NCT01470989|12329759|FG001|Entered Extension 3|Overall Study||49
11142980|NCT01470989|12329758|FG000|COMPLETED|Overall Study||79
11142981|NCT01470989|12329759|FG001|COMPLETED|Overall Study||43
11142982|NCT01470989|12329758|FG000|NOT COMPLETED|Overall Study||148
11142983|NCT01470989|12329759|FG001|NOT COMPLETED|Overall Study||186
11142984|NCT01471015|12329770|FG000|STARTED|Overall Study||10
11142985|NCT01471015|12329771|FG001|STARTED|Overall Study||10
11142986|NCT01471015|12329772|FG002|STARTED|Overall Study||10
11142987|NCT01471015|12329770|FG000|COMPLETED|Overall Study||10
11142988|NCT01471015|12329771|FG001|COMPLETED|Overall Study||9
11142989|NCT01471015|12329772|FG002|COMPLETED|Overall Study||9
11142990|NCT01471015|12329770|FG000|NOT COMPLETED|Overall Study||0
11142991|NCT01471015|12329771|FG001|NOT COMPLETED|Overall Study||1
11142992|NCT01471015|12329772|FG002|NOT COMPLETED|Overall Study||1
11142993|NCT01471028|12329782|FG000|STARTED|VTI-208||96
11142994|NCT01471028|12329783|FG001|STARTED|VTI-208||107
11142995|NCT01471028|12329782|FG000|COMPLETED|VTI-208||56
11142996|NCT01471028|12329783|FG001|COMPLETED|VTI-208||63
11142997|NCT01471028|12329782|FG000|NOT COMPLETED|VTI-208||40
11142998|NCT01471028|12329783|FG001|NOT COMPLETED|VTI-208||44
11142999|NCT01471028|12329782|FG000|STARTED|VTI-208E||56
11143000|NCT01471028|12329783|FG001|STARTED|VTI-208E||63
11143001|NCT01471028|12329782|FG000|Database Lock, 31 July 2015|VTI-208E||56
11143002|NCT01471028|12329783|FG001|Database Lock, 31 July 2015|VTI-208E||63
11143003|NCT01471028|12329782|FG000|COMPLETED|VTI-208E||48
11143004|NCT01471028|12329783|FG001|COMPLETED|VTI-208E||51
11143005|NCT01471028|12329782|FG000|NOT COMPLETED|VTI-208E||8
11143006|NCT01471028|12329783|FG001|NOT COMPLETED|VTI-208E||12
11143007|NCT01471041|12329792|FG000|STARTED|Overall Study||54
11143008|NCT01471041|12329792|FG000|COMPLETED|Overall Study||47
11143009|NCT01471041|12329792|FG000|NOT COMPLETED|Overall Study||7
11202615|NCT01841593|12393024|FG000|COMPLETED|Second Intervention (Days 8 to 14)||11
11202616|NCT01841593|12393025|FG001|COMPLETED|Second Intervention (Days 8 to 14)||6
11202617|NCT01841593|12393024|FG000|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
11202618|NCT01841593|12393025|FG001|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
11202619|NCT01841593|12393024|FG000|STARTED|Third Intervention (Days 15 to 21)||11
11202620|NCT01841593|12393025|FG001|STARTED|Third Intervention (Days 15 to 21)||6
11202621|NCT01841593|12393024|FG000|COMPLETED|Third Intervention (Days 15 to 21)||11
11202622|NCT01841593|12393025|FG001|COMPLETED|Third Intervention (Days 15 to 21)||6
11202623|NCT01841593|12393024|FG000|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
11202624|NCT01841593|12393025|FG001|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
11202625|NCT01841606|12393037|FG000|STARTED|Overall Study||25
11202626|NCT01841606|12393038|FG001|STARTED|Overall Study||27
11014065|NCT00764465|12191607|FG003|COMPLETED|Overall Study||6
11014066|NCT00764465|12191608|FG004|COMPLETED|Overall Study||6
11202627|NCT01841606|12393037|FG000|COMPLETED|Overall Study||25
11202628|NCT01841606|12393038|FG001|COMPLETED|Overall Study||27
11202629|NCT01841606|12393037|FG000|NOT COMPLETED|Overall Study||0
11202630|NCT01841606|12393038|FG001|NOT COMPLETED|Overall Study||0
11202631|NCT01841619|12393044|FG000|STARTED|Overall Study||16
11202632|NCT01841619|12393044|FG000|COMPLETED|Overall Study||16
11202633|NCT01841619|12393044|FG000|NOT COMPLETED|Overall Study||0
11202634|NCT01841632|12393048|FG000|STARTED|Overall Study||3
11202635|NCT01841632|12393048|FG000|COMPLETED|Overall Study||3
11202636|NCT01841632|12393048|FG000|NOT COMPLETED|Overall Study||0
11202637|NCT01841697|12393054|FG000|STARTED|Overall Study||322
11143010|NCT01471054|12329798|FG000|STARTED|Overall Study||5
11143011|NCT01471054|12329799|FG001|STARTED|Overall Study||1
11143012|NCT01471054|12329798|FG000|COMPLETED|Overall Study||1
11143013|NCT01471054|12329799|FG001|COMPLETED|Overall Study||1
11143014|NCT01471054|12329798|FG000|NOT COMPLETED|Overall Study||4
11143015|NCT01471054|12329799|FG001|NOT COMPLETED|Overall Study||0
11396427|NCT03739840|12590241|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||26
11396428|NCT03739840|12590242|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23
11396429|NCT03739840|12590243|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23
11014067|NCT00764465|12191609|FG005|COMPLETED|Overall Study||7
11014068|NCT00764465|12191604|FG000|NOT COMPLETED|Overall Study||2
11014069|NCT00764465|12191605|FG001|NOT COMPLETED|Overall Study||1
11014070|NCT00764465|12191606|FG002|NOT COMPLETED|Overall Study||1
11014071|NCT00764465|12191607|FG003|NOT COMPLETED|Overall Study||1
11014072|NCT00764465|12191608|FG004|NOT COMPLETED|Overall Study||1
11014073|NCT00764465|12191609|FG005|NOT COMPLETED|Overall Study||1
11014074|NCT00764491|12191628|FG000|STARTED|Overall Study||123
11014075|NCT00764491|12191629|FG001|STARTED|Overall Study||33
11014076|NCT00764491|12191628|FG000|COMPLETED|Overall Study||88
11014077|NCT00764491|12191629|FG001|COMPLETED|Overall Study||16
11014078|NCT00764491|12191628|FG000|NOT COMPLETED|Overall Study||35
11014079|NCT00764491|12191629|FG001|NOT COMPLETED|Overall Study||17
11014080|NCT00764504|12191638|FG000|STARTED|Overall Study||141
11014081|NCT00764504|12191639|FG001|STARTED|Overall Study||141
11014082|NCT00764504|12191640|FG002|STARTED|Overall Study||234
11014083|NCT00764504|12191638|FG000|COMPLETED|Overall Study||75
11014084|NCT00764504|12191639|FG001|COMPLETED|Overall Study||71
11014085|NCT00764504|12191640|FG002|COMPLETED|Overall Study||131
11014086|NCT00764504|12191638|FG000|NOT COMPLETED|Overall Study||66
11014087|NCT00764504|12191639|FG001|NOT COMPLETED|Overall Study||70
11014088|NCT00764504|12191640|FG002|NOT COMPLETED|Overall Study||103
11014089|NCT00764517|12191650|FG000|STARTED|Overall Study||39
11014090|NCT00764517|12191651|FG001|STARTED|Overall Study||18
11014091|NCT00764517|12191650|FG000|COMPLETED|Overall Study||24
11014092|NCT00764517|12191651|FG001|COMPLETED|Overall Study||4
11014093|NCT00764517|12191650|FG000|NOT COMPLETED|Overall Study||15
11014094|NCT00764517|12191651|FG001|NOT COMPLETED|Overall Study||14
11014095|NCT00764660|12191659|FG000|STARTED|Overall Study||75
11014096|NCT00764660|12191660|FG001|STARTED|Overall Study||66
11014097|NCT00764660|12191659|FG000|COMPLETED|Overall Study||53
11014098|NCT00764660|12191660|FG001|COMPLETED|Overall Study||55
11014099|NCT00764660|12191659|FG000|NOT COMPLETED|Overall Study||22
11014100|NCT00764660|12191660|FG001|NOT COMPLETED|Overall Study||11
11014101|NCT00764673|12191666|FG000|STARTED|Overall Study||71
11014102|NCT00764673|12191666|FG000|COMPLETED|Overall Study||59
11014103|NCT00764673|12191666|FG000|NOT COMPLETED|Overall Study||12
11014104|NCT00764738|12191674|FG000|STARTED|Overall Study||24
11014105|NCT00764738|12191675|FG001|STARTED|Overall Study||28
11014106|NCT00764738|12191676|FG002|STARTED|Overall Study||15
11014107|NCT00764738|12191677|FG003|STARTED|Overall Study||24
11014108|NCT00764738|12191674|FG000|COMPLETED|Overall Study||22
11014109|NCT00764738|12191675|FG001|COMPLETED|Overall Study||25
11014110|NCT00764738|12191676|FG002|COMPLETED|Overall Study||12
11014111|NCT00764738|12191677|FG003|COMPLETED|Overall Study||18
11014112|NCT00764738|12191674|FG000|NOT COMPLETED|Overall Study||2
11014113|NCT00764738|12191675|FG001|NOT COMPLETED|Overall Study||3
11014114|NCT00764738|12191676|FG002|NOT COMPLETED|Overall Study||3
11014115|NCT00764738|12191677|FG003|NOT COMPLETED|Overall Study||6
11014116|NCT00764751|12191689|FG000|STARTED|Overall Study||39
11014117|NCT00764751|12191690|FG001|STARTED|Overall Study||12
11014118|NCT00764751|12191689|FG000|COMPLETED|Overall Study||37
11014119|NCT00764751|12191690|FG001|COMPLETED|Overall Study||11
11014120|NCT00764751|12191689|FG000|NOT COMPLETED|Overall Study||2
11014121|NCT00764751|12191690|FG001|NOT COMPLETED|Overall Study||1
11014122|NCT00764790|12191704|FG000|STARTED|Overall Study||1107
11014123|NCT00764790|12191705|FG001|STARTED|Overall Study||1106
11014124|NCT00764790|12191706|FG002|STARTED|Overall Study||1104
11014125|NCT00764790|12191704|FG000|COMPLETED|Overall Study||1069
11143016|NCT01471093|12329817|FG000|STARTED|Overall Study||25
11143017|NCT01471093|12329818|FG001|STARTED|Overall Study||25
11143018|NCT01471093|12329819|FG002|STARTED|Overall Study||25
11143019|NCT01471093|12329820|FG003|STARTED|Overall Study||25
11143020|NCT01471093|12329817|FG000|COMPLETED|Overall Study||24
11014126|NCT00764790|12191705|FG001|COMPLETED|Overall Study||1065
11014127|NCT00764790|12191706|FG002|COMPLETED|Overall Study||1074
11014128|NCT00764790|12191704|FG000|NOT COMPLETED|Overall Study||38
11014129|NCT00764790|12191705|FG001|NOT COMPLETED|Overall Study||41
11014130|NCT00764790|12191706|FG002|NOT COMPLETED|Overall Study||30
11014131|NCT00764868|12191714|FG000|STARTED|Overall Study||269
11014132|NCT00764868|12191714|FG000|COMPLETED|Overall Study||156
11014133|NCT00764868|12191714|FG000|NOT COMPLETED|Overall Study||113
11014134|NCT00764881|12191720|FG000|STARTED|Overall Study||108
11014135|NCT00764881|12191721|FG001|STARTED|Overall Study||109
11014136|NCT00764881|12191720|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
11014137|NCT00764881|12191721|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
11014138|NCT00764881|12191720|FG000|COMPLETED|Overall Study||92
11014139|NCT00764881|12191721|FG001|COMPLETED|Overall Study||99
11014140|NCT00764881|12191720|FG000|NOT COMPLETED|Overall Study||16
11014141|NCT00764881|12191721|FG001|NOT COMPLETED|Overall Study||10
11014142|NCT00764946|12191730|FG000|STARTED|Overall Study||98
11014143|NCT00764946|12191731|FG001|STARTED|Overall Study||89
11014144|NCT00764946|12191732|FG002|STARTED|Overall Study||22
11014145|NCT00764946|12191730|FG000|TREATED|Overall Study||97
11014146|NCT00764946|12191731|FG001|TREATED|Overall Study||88
11014147|NCT00764946|12191732|FG002|TREATED|Overall Study||21
11014148|NCT00764946|12191730|FG000|COMPLETED|Overall Study||85
11014149|NCT00764946|12191731|FG001|COMPLETED|Overall Study||72
11014150|NCT00764946|12191732|FG002|COMPLETED|Overall Study||18
11014151|NCT00764946|12191730|FG000|NOT COMPLETED|Overall Study||13
11014152|NCT00764946|12191731|FG001|NOT COMPLETED|Overall Study||17
11014153|NCT00764946|12191732|FG002|NOT COMPLETED|Overall Study||4
11014154|NCT00765037|12191746|FG000|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
11014155|NCT00765037|12191746|FG000|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
11014156|NCT00765037|12191746|FG000|NOT COMPLETED|Overall Study||6
11014157|NCT00765063|12191750|FG000|STARTED|Overall Study||62
11014158|NCT00765063|12191750|FG000|COMPLETED|Overall Study||30
11014159|NCT00765063|12191750|FG000|NOT COMPLETED|Overall Study||32
11014160|NCT00765076|12191757|FG000|STARTED|Overall Study||69
11014161|NCT00765076|12191758|FG001|STARTED|Overall Study||73
11014162|NCT00765076|12191759|FG002|STARTED|Overall Study||50
11014163|NCT00765076|12191757|FG000|COMPLETED|Overall Study||68
11014164|NCT00765076|12191758|FG001|COMPLETED|Overall Study||73
11014165|NCT00765076|12191759|FG002|COMPLETED|Overall Study||49
11014166|NCT00765076|12191757|FG000|NOT COMPLETED|Overall Study||1
11014167|NCT00765076|12191758|FG001|NOT COMPLETED|Overall Study||0
11014168|NCT00765076|12191759|FG002|NOT COMPLETED|Overall Study||1
11014169|NCT00765102|12191767|FG000|STARTED|Overall Study||32
11014170|NCT00765102|12191767|FG000|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
11014171|NCT00765102|12191767|FG000|NOT COMPLETED|Overall Study||31
11014172|NCT00765128|12191775|FG000|STARTED|Overall Study||8
11014173|NCT00765128|12191776|FG001|STARTED|Overall Study||9
11014174|NCT00765128|12191775|FG000|COMPLETED|Overall Study||8
11014175|NCT00765128|12191776|FG001|COMPLETED|Overall Study||9
11014176|NCT00765128|12191775|FG000|NOT COMPLETED|Overall Study||0
11014177|NCT00765128|12191776|FG001|NOT COMPLETED|Overall Study||0
11014178|NCT00765193|12191782|FG000|STARTED|Problem Area Examination||14381
11014179|NCT00765193|12191782|FG000|COMPLETED|Problem Area Examination||14381
11014180|NCT00765193|12191782|FG000|NOT COMPLETED|Problem Area Examination||0
11014181|NCT00765193|12191782|FG000|STARTED|Full Body Examination||14381
11014182|NCT00765193|12191782|FG000|COMPLETED|Full Body Examination||14381
11014183|NCT00765193|12191782|FG000|NOT COMPLETED|Full Body Examination||0
11014184|NCT00765206|12191787|FG000|STARTED|First Intervention||15
11014185|NCT00765206|12191788|FG001|STARTED|First Intervention||15
11014186|NCT00765206|12191789|FG002|STARTED|First Intervention||15
11014187|NCT00765206|12191790|FG003|STARTED|First Intervention||15
11014188|NCT00765206|12191787|FG000|COMPLETED|First Intervention||15
11014189|NCT00765206|12191788|FG001|COMPLETED|First Intervention||15
11014190|NCT00765206|12191789|FG002|COMPLETED|First Intervention||15
11014191|NCT00765206|12191790|FG003|COMPLETED|First Intervention||15
11014192|NCT00765206|12191787|FG000|NOT COMPLETED|First Intervention||0
11014193|NCT00765206|12191788|FG001|NOT COMPLETED|First Intervention||0
11014194|NCT00765206|12191789|FG002|NOT COMPLETED|First Intervention||0
11014195|NCT00765206|12191790|FG003|NOT COMPLETED|First Intervention||0
11014196|NCT00765206|12191787|FG000|STARTED|Washout Period of 14 Days||15
11014197|NCT00765206|12191788|FG001|STARTED|Washout Period of 14 Days||15
11014198|NCT00765206|12191789|FG002|STARTED|Washout Period of 14 Days||15
11014199|NCT00765206|12191790|FG003|STARTED|Washout Period of 14 Days||15
11014200|NCT00765206|12191787|FG000|COMPLETED|Washout Period of 14 Days||15
11014201|NCT00765206|12191788|FG001|COMPLETED|Washout Period of 14 Days||15
11014202|NCT00765206|12191789|FG002|COMPLETED|Washout Period of 14 Days||15
11014203|NCT00765206|12191790|FG003|COMPLETED|Washout Period of 14 Days||15
11014204|NCT00765206|12191787|FG000|NOT COMPLETED|Washout Period of 14 Days||0
11014205|NCT00765206|12191788|FG001|NOT COMPLETED|Washout Period of 14 Days||0
11014206|NCT00765206|12191789|FG002|NOT COMPLETED|Washout Period of 14 Days||0
11014207|NCT00765206|12191790|FG003|NOT COMPLETED|Washout Period of 14 Days||0
11014208|NCT00765206|12191787|FG000|STARTED|Second Intervention||15
11014209|NCT00765206|12191788|FG001|STARTED|Second Intervention||15
11014210|NCT00765206|12191789|FG002|STARTED|Second Intervention||15
11014211|NCT00765206|12191790|FG003|STARTED|Second Intervention||15
11014212|NCT00765206|12191787|FG000|COMPLETED|Second Intervention||15
11014213|NCT00765206|12191788|FG001|COMPLETED|Second Intervention||15
11014214|NCT00765206|12191789|FG002|COMPLETED|Second Intervention||15
11014215|NCT00765206|12191790|FG003|COMPLETED|Second Intervention||15
11014216|NCT00765206|12191787|FG000|NOT COMPLETED|Second Intervention||0
11014217|NCT00765206|12191788|FG001|NOT COMPLETED|Second Intervention||0
11014218|NCT00765206|12191789|FG002|NOT COMPLETED|Second Intervention||0
11014219|NCT00765206|12191790|FG003|NOT COMPLETED|Second Intervention||0
11014220|NCT00765232|12191798|FG000|STARTED|Overall Study||57
11014221|NCT00765232|12191799|FG001|STARTED|Overall Study||54
11014222|NCT00765232|12191798|FG000|COMPLETED|Overall Study||57
11014223|NCT00765232|12191799|FG001|COMPLETED|Overall Study||54
11014224|NCT00765232|12191798|FG000|NOT COMPLETED|Overall Study||0
11014225|NCT00765232|12191799|FG001|NOT COMPLETED|Overall Study||0
11014226|NCT00765245|12191807|FG000|STARTED|Overall Study||22
11014227|NCT00765245|12191808|FG001|STARTED|Overall Study||22
11014228|NCT00765245|12191807|FG000|COMPLETED|Overall Study||9
11014229|NCT00765245|12191808|FG001|COMPLETED|Overall Study||20
11014230|NCT00765245|12191807|FG000|NOT COMPLETED|Overall Study||13
11014231|NCT00765245|12191808|FG001|NOT COMPLETED|Overall Study||2
11014232|NCT00765336|12191816|FG000|STARTED|Overall Study||91
11014233|NCT00765336|12191817|FG001|STARTED|Overall Study||89
11014234|NCT00765336|12191816|FG000|COMPLETED|Overall Study||72
11014235|NCT00765336|12191817|FG001|COMPLETED|Overall Study||73
11014236|NCT00765336|12191816|FG000|NOT COMPLETED|Overall Study||19
11014237|NCT00765336|12191817|FG001|NOT COMPLETED|Overall Study||16
11014238|NCT00765362|12191823|FG000|STARTED|Overall Study||419
11014239|NCT00765362|12191823|FG000|COMPLETED|Overall Study||282
11014240|NCT00765362|12191823|FG000|NOT COMPLETED|Overall Study||137
11014241|NCT00765375|12191827|FG000|STARTED|Overall Study||5
11014242|NCT00765375|12191827|FG000|COMPLETED|Overall Study||5
11014243|NCT00765375|12191827|FG000|NOT COMPLETED|Overall Study||0
11014244|NCT00765388|12191833|FG000|STARTED|Period 1|A cross-over study|16
11014245|NCT00765388|12191834|FG001|STARTED|Period 1||11
11014246|NCT00765388|12191833|FG000|COMPLETED|Period 1||15
11014247|NCT00765388|12191834|FG001|COMPLETED|Period 1||6
11014248|NCT00765388|12191833|FG000|NOT COMPLETED|Period 1||1
11014249|NCT00765388|12191834|FG001|NOT COMPLETED|Period 1||5
11014250|NCT00765388|12191833|FG000|STARTED|Period 2||15
11014251|NCT00765388|12191834|FG001|STARTED|Period 2||6
11014252|NCT00765388|12191833|FG000|COMPLETED|Period 2||15
11014253|NCT00765388|12191834|FG001|COMPLETED|Period 2||6
11014254|NCT00765388|12191833|FG000|NOT COMPLETED|Period 2||0
11014255|NCT00765388|12191834|FG001|NOT COMPLETED|Period 2||0
11014256|NCT00765570|12191842|FG000|STARTED|Overall Study||9
11014257|NCT00765570|12191843|FG001|STARTED|Overall Study||3
11014258|NCT00765570|12191842|FG000|COMPLETED|Overall Study||7
11014259|NCT00765570|12191843|FG001|COMPLETED|Overall Study||3
11014260|NCT00765570|12191842|FG000|NOT COMPLETED|Overall Study||2
11014261|NCT00765570|12191843|FG001|NOT COMPLETED|Overall Study||0
11014262|NCT00765648|12191851|FG000|STARTED|Overall Study||110
11014263|NCT00765648|12191852|FG001|STARTED|Overall Study||116
11014264|NCT00765648|12191851|FG000|COMPLETED|Overall Study||109
11014265|NCT00765648|12191852|FG001|COMPLETED|Overall Study||114
11014266|NCT00765648|12191851|FG000|NOT COMPLETED|Overall Study||1
11014267|NCT00765648|12191852|FG001|NOT COMPLETED|Overall Study||2
11014268|NCT00765661|12191860|FG000|STARTED|Overall Study||32
11014269|NCT00765661|12191861|FG001|STARTED|Overall Study||31
11014270|NCT00765661|12191860|FG000|COMPLETED|Overall Study||32
11014271|NCT00765661|12191861|FG001|COMPLETED|Overall Study||31
11014272|NCT00765661|12191860|FG000|NOT COMPLETED|Overall Study||0
11014273|NCT00765661|12191861|FG001|NOT COMPLETED|Overall Study||0
11014274|NCT00765674|12191871|FG000|STARTED|Overall Study||287
11014275|NCT00765674|12191872|FG001|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
11014276|NCT00765674|12191873|FG002|STARTED|Overall Study||296
11014277|NCT00765674|12191874|FG003|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
11014278|NCT00765674|12191871|FG000|COMPLETED|Overall Study||266
11014279|NCT00765674|12191872|FG001|COMPLETED|Overall Study||276
11014280|NCT00765674|12191873|FG002|COMPLETED|Overall Study||279
11014281|NCT00765674|12191874|FG003|COMPLETED|Overall Study||285
11014282|NCT00765674|12191871|FG000|NOT COMPLETED|Overall Study||21
11014283|NCT00765674|12191872|FG001|NOT COMPLETED|Overall Study||22
11014284|NCT00765674|12191873|FG002|NOT COMPLETED|Overall Study||17
11014285|NCT00765674|12191874|FG003|NOT COMPLETED|Overall Study||25
11014286|NCT00765726|12191884|FG000|STARTED|Overall Study||12
11014287|NCT00765726|12191884|FG000|COMPLETED|Overall Study||3
11014288|NCT00765726|12191884|FG000|NOT COMPLETED|Overall Study||9
11014289|NCT00765817|12191890|FG000|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
11014290|NCT00765817|12191891|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
11014291|NCT00765817|12191890|FG000|COMPLETED|Overall Study||112
11014292|NCT00765817|12191891|FG001|COMPLETED|Overall Study||101
11014293|NCT00765817|12191890|FG000|NOT COMPLETED|Overall Study||26
11014294|NCT00765817|12191891|FG001|NOT COMPLETED|Overall Study||22
11056814|NCT00995930|12238423|FG000|STARTED|Overall Study||94
11056815|NCT00995930|12238424|FG001|STARTED|Overall Study||95
11014295|NCT00765843|12191900|FG000|STARTED|Overall Study||26
11014296|NCT00765843|12191901|FG001|STARTED|Overall Study||25
11014297|NCT00765843|12191902|FG002|STARTED|Overall Study||26
11014298|NCT00765843|12191900|FG000|COMPLETED|Overall Study||25
11014299|NCT00765843|12191901|FG001|COMPLETED|Overall Study||21
11014300|NCT00765843|12191902|FG002|COMPLETED|Overall Study||23
11014301|NCT00765843|12191900|FG000|NOT COMPLETED|Overall Study||1
11014302|NCT00765843|12191901|FG001|NOT COMPLETED|Overall Study||4
11014303|NCT00765843|12191902|FG002|NOT COMPLETED|Overall Study||3
11014304|NCT00765856|12191910|FG000|STARTED|Titration Period||27
11014305|NCT00765856|12191910|FG000|COMPLETED|Titration Period||24
11014306|NCT00765856|12191910|FG000|NOT COMPLETED|Titration Period||3
11014307|NCT00765856|12191910|FG000|STARTED|Maintenance Period||24
11014308|NCT00765856|12191910|FG000|COMPLETED|Maintenance Period||18
11014309|NCT00765856|12191910|FG000|NOT COMPLETED|Maintenance Period||6
11014310|NCT00765882|12191920|FG000|STARTED|Overall Study||215
11014311|NCT00765882|12191921|FG001|STARTED|Overall Study||213
11014312|NCT00765882|12191922|FG002|STARTED|Overall Study||205
11014313|NCT00765882|12191920|FG000|COMPLETED|Overall Study||191
11014314|NCT00765882|12191921|FG001|COMPLETED|Overall Study||173
11014315|NCT00765882|12191922|FG002|COMPLETED|Overall Study||169
11014316|NCT00765882|12191920|FG000|NOT COMPLETED|Overall Study||24
11014317|NCT00765882|12191921|FG001|NOT COMPLETED|Overall Study||40
11014318|NCT00765882|12191922|FG002|NOT COMPLETED|Overall Study||36
11014319|NCT00765895|12191932|FG000|STARTED|Overall Study||65
11014320|NCT00765895|12191933|FG001|STARTED|Overall Study||65
11014321|NCT00765895|12191932|FG000|COMPLETED|Overall Study||65
11014322|NCT00765895|12191933|FG001|COMPLETED|Overall Study||65
11014323|NCT00765895|12191932|FG000|NOT COMPLETED|Overall Study||0
11014324|NCT00765895|12191933|FG001|NOT COMPLETED|Overall Study||0
11014325|NCT00765947|12191939|FG000|STARTED|Overall Study||256
11014326|NCT00765947|12191939|FG000|COMPLETED|Overall Study||232
11014327|NCT00765947|12191939|FG000|NOT COMPLETED|Overall Study||24
11014328|NCT00765999|12191945|FG000|STARTED|Overall Study||1554
11014329|NCT00765999|12191945|FG000|COMPLETED|Overall Study||770
11014330|NCT00765999|12191945|FG000|NOT COMPLETED|Overall Study||784
11014331|NCT00766038|12191953|FG000|STARTED|Overall Study||31
11014332|NCT00766038|12191954|FG001|STARTED|Overall Study||32
11014333|NCT00766038|12191953|FG000|COMPLETED|Overall Study||16
11014334|NCT00766038|12191954|FG001|COMPLETED|Overall Study||18
11014335|NCT00766038|12191953|FG000|NOT COMPLETED|Overall Study||15
11014336|NCT00766038|12191954|FG001|NOT COMPLETED|Overall Study||14
11014337|NCT00766051|12191964|FG000|STARTED|Overall Study||12
11014338|NCT00766051|12191965|FG001|STARTED|Overall Study||10
11014339|NCT00766051|12191964|FG000|COMPLETED|Overall Study||10
11014340|NCT00766051|12191965|FG001|COMPLETED|Overall Study||10
11014341|NCT00766051|12191964|FG000|NOT COMPLETED|Overall Study||2
11014342|NCT00766051|12191965|FG001|NOT COMPLETED|Overall Study||0
11014343|NCT00766090|12191975|FG000|STARTED|Treatment Period 1 (28 Days)||25
11014344|NCT00766090|12191976|FG001|STARTED|Treatment Period 1 (28 Days)||27
11014345|NCT00766090|12191977|FG002|STARTED|Treatment Period 1 (28 Days)||23
11014346|NCT00766090|12191978|FG003|STARTED|Treatment Period 1 (28 Days)||26
11014347|NCT00766090|12191979|FG004|STARTED|Treatment Period 1 (28 Days)||23
11014348|NCT00766090|12191980|FG005|STARTED|Treatment Period 1 (28 Days)||23
11014349|NCT00766090|12191981|FG006|STARTED|Treatment Period 1 (28 Days)||6
11014350|NCT00766090|12191982|FG007|STARTED|Treatment Period 1 (28 Days)||8
11014351|NCT00766090|12191983|FG008|STARTED|Treatment Period 1 (28 Days)||7
11014352|NCT00766090|12191984|FG009|STARTED|Treatment Period 1 (28 Days)||8
11014353|NCT00766090|12191985|FG010|STARTED|Treatment Period 1 (28 Days)||7
11014354|NCT00766090|12191986|FG011|STARTED|Treatment Period 1 (28 Days)||7
11014355|NCT00766090|12191975|FG000|COMPLETED|Treatment Period 1 (28 Days)||22
11014356|NCT00766090|12191976|FG001|COMPLETED|Treatment Period 1 (28 Days)||27
11014357|NCT00766090|12191977|FG002|COMPLETED|Treatment Period 1 (28 Days)||23
11014358|NCT00766090|12191978|FG003|COMPLETED|Treatment Period 1 (28 Days)||25
11014359|NCT00766090|12191979|FG004|COMPLETED|Treatment Period 1 (28 Days)||23
11014360|NCT00766090|12191980|FG005|COMPLETED|Treatment Period 1 (28 Days)||23
11014361|NCT00766090|12191981|FG006|COMPLETED|Treatment Period 1 (28 Days)||6
11014362|NCT00766090|12191982|FG007|COMPLETED|Treatment Period 1 (28 Days)||8
11014363|NCT00766090|12191983|FG008|COMPLETED|Treatment Period 1 (28 Days)||6
11014364|NCT00766090|12191984|FG009|COMPLETED|Treatment Period 1 (28 Days)||8
11014365|NCT00766090|12191985|FG010|COMPLETED|Treatment Period 1 (28 Days)||7
11014366|NCT00766090|12191986|FG011|COMPLETED|Treatment Period 1 (28 Days)||7
11014367|NCT00766090|12191975|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||3
11014368|NCT00766090|12191976|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11014369|NCT00766090|12191977|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11014370|NCT00766090|12191978|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||1
11014371|NCT00766090|12191979|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11014372|NCT00766090|12191980|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11014373|NCT00766090|12191981|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11014374|NCT00766090|12191982|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11014375|NCT00766090|12191983|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||1
11014376|NCT00766090|12191984|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11014377|NCT00766090|12191985|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11014378|NCT00766090|12191986|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11014379|NCT00766090|12191975|FG000|STARTED|Washout Period 1 (14 Days)||22
11014380|NCT00766090|12191976|FG001|STARTED|Washout Period 1 (14 Days)||27
11014381|NCT00766090|12191977|FG002|STARTED|Washout Period 1 (14 Days)||23
11014382|NCT00766090|12191978|FG003|STARTED|Washout Period 1 (14 Days)||25
11014383|NCT00766090|12191979|FG004|STARTED|Washout Period 1 (14 Days)||23
11014384|NCT00766090|12191980|FG005|STARTED|Washout Period 1 (14 Days)||23
11014385|NCT00766090|12191981|FG006|STARTED|Washout Period 1 (14 Days)||6
11143021|NCT01471093|12329818|FG001|COMPLETED|Overall Study||25
11143022|NCT01471093|12329819|FG002|COMPLETED|Overall Study||25
11143023|NCT01471093|12329820|FG003|COMPLETED|Overall Study||25
11014386|NCT00766090|12191982|FG007|STARTED|Washout Period 1 (14 Days)||8
11014387|NCT00766090|12191983|FG008|STARTED|Washout Period 1 (14 Days)||6
11014388|NCT00766090|12191984|FG009|STARTED|Washout Period 1 (14 Days)||8
11014389|NCT00766090|12191985|FG010|STARTED|Washout Period 1 (14 Days)||7
11014390|NCT00766090|12191986|FG011|STARTED|Washout Period 1 (14 Days)||7
11014391|NCT00766090|12191975|FG000|COMPLETED|Washout Period 1 (14 Days)||22
11014392|NCT00766090|12191976|FG001|COMPLETED|Washout Period 1 (14 Days)||27
11014393|NCT00766090|12191977|FG002|COMPLETED|Washout Period 1 (14 Days)||22
11014394|NCT00766090|12191978|FG003|COMPLETED|Washout Period 1 (14 Days)||25
11014395|NCT00766090|12191979|FG004|COMPLETED|Washout Period 1 (14 Days)||23
11014396|NCT00766090|12191980|FG005|COMPLETED|Washout Period 1 (14 Days)||23
11014397|NCT00766090|12191981|FG006|COMPLETED|Washout Period 1 (14 Days)||6
11014398|NCT00766090|12191982|FG007|COMPLETED|Washout Period 1 (14 Days)||8
11014399|NCT00766090|12191983|FG008|COMPLETED|Washout Period 1 (14 Days)||6
11014400|NCT00766090|12191984|FG009|COMPLETED|Washout Period 1 (14 Days)||8
11014401|NCT00766090|12191985|FG010|COMPLETED|Washout Period 1 (14 Days)||7
11014402|NCT00766090|12191986|FG011|COMPLETED|Washout Period 1 (14 Days)||7
11014403|NCT00766090|12191975|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
11014404|NCT00766090|12191976|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
11014405|NCT00766090|12191977|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||1
11014406|NCT00766090|12191978|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
11014407|NCT00766090|12191979|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
11014408|NCT00766090|12191980|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0
11014409|NCT00766090|12191981|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0
11014410|NCT00766090|12191982|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0
11014411|NCT00766090|12191983|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0
11014412|NCT00766090|12191984|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0
11014413|NCT00766090|12191985|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0
11014414|NCT00766090|12191986|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0
11014415|NCT00766090|12191975|FG000|STARTED|Treatment Period 2 (28 Days)||22
11014416|NCT00766090|12191976|FG001|STARTED|Treatment Period 2 (28 Days)||27
11014417|NCT00766090|12191977|FG002|STARTED|Treatment Period 2 (28 Days)||22
11014418|NCT00766090|12191978|FG003|STARTED|Treatment Period 2 (28 Days)||25
11014419|NCT00766090|12191979|FG004|STARTED|Treatment Period 2 (28 Days)||23
11014420|NCT00766090|12191980|FG005|STARTED|Treatment Period 2 (28 Days)||23
11014421|NCT00766090|12191981|FG006|STARTED|Treatment Period 2 (28 Days)||6
11014422|NCT00766090|12191982|FG007|STARTED|Treatment Period 2 (28 Days)||8
11014423|NCT00766090|12191983|FG008|STARTED|Treatment Period 2 (28 Days)||6
11014424|NCT00766090|12191984|FG009|STARTED|Treatment Period 2 (28 Days)||8
11014425|NCT00766090|12191985|FG010|STARTED|Treatment Period 2 (28 Days)||7
11014426|NCT00766090|12191986|FG011|STARTED|Treatment Period 2 (28 Days)||7
11014427|NCT00766090|12191975|FG000|COMPLETED|Treatment Period 2 (28 Days)||22
11014428|NCT00766090|12191976|FG001|COMPLETED|Treatment Period 2 (28 Days)||27
11014429|NCT00766090|12191977|FG002|COMPLETED|Treatment Period 2 (28 Days)||21
11014430|NCT00766090|12191978|FG003|COMPLETED|Treatment Period 2 (28 Days)||25
11014431|NCT00766090|12191979|FG004|COMPLETED|Treatment Period 2 (28 Days)||21
11014432|NCT00766090|12191980|FG005|COMPLETED|Treatment Period 2 (28 Days)||23
11014433|NCT00766090|12191981|FG006|COMPLETED|Treatment Period 2 (28 Days)||6
11014434|NCT00766090|12191982|FG007|COMPLETED|Treatment Period 2 (28 Days)||8
11014435|NCT00766090|12191983|FG008|COMPLETED|Treatment Period 2 (28 Days)||6
11014436|NCT00766090|12191984|FG009|COMPLETED|Treatment Period 2 (28 Days)||8
11014437|NCT00766090|12191985|FG010|COMPLETED|Treatment Period 2 (28 Days)||7
11014438|NCT00766090|12191986|FG011|COMPLETED|Treatment Period 2 (28 Days)||7
11014439|NCT00766090|12191975|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11014440|NCT00766090|12191976|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11014441|NCT00766090|12191977|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1
11014442|NCT00766090|12191978|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11014443|NCT00766090|12191979|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||2
11014444|NCT00766090|12191980|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11014445|NCT00766090|12191981|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11014446|NCT00766090|12191982|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11014447|NCT00766090|12191983|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11014448|NCT00766090|12191984|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11014449|NCT00766090|12191985|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11014450|NCT00766090|12191986|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11014451|NCT00766090|12191975|FG000|STARTED|Washout Period 2 (14 Days)||22
11014452|NCT00766090|12191976|FG001|STARTED|Washout Period 2 (14 Days)||27
11014453|NCT00766090|12191977|FG002|STARTED|Washout Period 2 (14 Days)||21
11014454|NCT00766090|12191978|FG003|STARTED|Washout Period 2 (14 Days)||25
11014455|NCT00766090|12191979|FG004|STARTED|Washout Period 2 (14 Days)||21
11014456|NCT00766090|12191980|FG005|STARTED|Washout Period 2 (14 Days)||23
11014457|NCT00766090|12191981|FG006|STARTED|Washout Period 2 (14 Days)||6
11014458|NCT00766090|12191982|FG007|STARTED|Washout Period 2 (14 Days)||8
11014459|NCT00766090|12191983|FG008|STARTED|Washout Period 2 (14 Days)||6
11014460|NCT00766090|12191984|FG009|STARTED|Washout Period 2 (14 Days)||8
11014461|NCT00766090|12191985|FG010|STARTED|Washout Period 2 (14 Days)||7
11014462|NCT00766090|12191986|FG011|STARTED|Washout Period 2 (14 Days)||7
11014463|NCT00766090|12191975|FG000|COMPLETED|Washout Period 2 (14 Days)||22
11014464|NCT00766090|12191976|FG001|COMPLETED|Washout Period 2 (14 Days)||27
11014465|NCT00766090|12191977|FG002|COMPLETED|Washout Period 2 (14 Days)||20
11014466|NCT00766090|12191978|FG003|COMPLETED|Washout Period 2 (14 Days)||25
11014467|NCT00766090|12191979|FG004|COMPLETED|Washout Period 2 (14 Days)||21
11014468|NCT00766090|12191980|FG005|COMPLETED|Washout Period 2 (14 Days)||23
11014469|NCT00766090|12191981|FG006|COMPLETED|Washout Period 2 (14 Days)||6
11014470|NCT00766090|12191982|FG007|COMPLETED|Washout Period 2 (14 Days)||8
11014471|NCT00766090|12191983|FG008|COMPLETED|Washout Period 2 (14 Days)||6
11014472|NCT00766090|12191984|FG009|COMPLETED|Washout Period 2 (14 Days)||8
11014473|NCT00766090|12191985|FG010|COMPLETED|Washout Period 2 (14 Days)||7
11014474|NCT00766090|12191986|FG011|COMPLETED|Washout Period 2 (14 Days)||7
11014475|NCT00766090|12191975|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0
11014476|NCT00766090|12191976|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
11014477|NCT00766090|12191977|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||1
11014478|NCT00766090|12191978|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
11014479|NCT00766090|12191979|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
11014480|NCT00766090|12191980|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0
11014481|NCT00766090|12191981|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0
11014482|NCT00766090|12191982|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0
11014483|NCT00766090|12191983|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0
11014484|NCT00766090|12191984|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0
11014485|NCT00766090|12191985|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0
11014486|NCT00766090|12191986|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0
11014487|NCT00766090|12191975|FG000|STARTED|Treatment Period 3 (28 Days)||22
11014488|NCT00766090|12191976|FG001|STARTED|Treatment Period 3 (28 Days)||27
11014489|NCT00766090|12191977|FG002|STARTED|Treatment Period 3 (28 Days)||20
11014490|NCT00766090|12191978|FG003|STARTED|Treatment Period 3 (28 Days)||25
11014491|NCT00766090|12191979|FG004|STARTED|Treatment Period 3 (28 Days)||21
11014492|NCT00766090|12191980|FG005|STARTED|Treatment Period 3 (28 Days)||23
11014493|NCT00766090|12191981|FG006|STARTED|Treatment Period 3 (28 Days)||6
11014494|NCT00766090|12191982|FG007|STARTED|Treatment Period 3 (28 Days)||8
11014495|NCT00766090|12191983|FG008|STARTED|Treatment Period 3 (28 Days)||6
11014496|NCT00766090|12191984|FG009|STARTED|Treatment Period 3 (28 Days)||8
11014497|NCT00766090|12191985|FG010|STARTED|Treatment Period 3 (28 Days)||7
11014498|NCT00766090|12191986|FG011|STARTED|Treatment Period 3 (28 Days)||7
11014499|NCT00766090|12191975|FG000|COMPLETED|Treatment Period 3 (28 Days)||22
11014500|NCT00766090|12191976|FG001|COMPLETED|Treatment Period 3 (28 Days)||26
11014501|NCT00766090|12191977|FG002|COMPLETED|Treatment Period 3 (28 Days)||20
11014502|NCT00766090|12191978|FG003|COMPLETED|Treatment Period 3 (28 Days)||24
11014503|NCT00766090|12191979|FG004|COMPLETED|Treatment Period 3 (28 Days)||20
11014504|NCT00766090|12191980|FG005|COMPLETED|Treatment Period 3 (28 Days)||22
11014505|NCT00766090|12191981|FG006|COMPLETED|Treatment Period 3 (28 Days)||6
11014506|NCT00766090|12191982|FG007|COMPLETED|Treatment Period 3 (28 Days)||8
11014507|NCT00766090|12191983|FG008|COMPLETED|Treatment Period 3 (28 Days)||6
11014508|NCT00766090|12191984|FG009|COMPLETED|Treatment Period 3 (28 Days)||8
11014509|NCT00766090|12191985|FG010|COMPLETED|Treatment Period 3 (28 Days)||7
11014510|NCT00766090|12191986|FG011|COMPLETED|Treatment Period 3 (28 Days)||6
11014511|NCT00766090|12191975|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11014512|NCT00766090|12191976|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||1
11014513|NCT00766090|12191977|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11014514|NCT00766090|12191978|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||1
11014515|NCT00766090|12191979|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||1
11014516|NCT00766090|12191980|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||1
11014517|NCT00766090|12191981|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11014518|NCT00766090|12191982|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11014519|NCT00766090|12191983|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11014520|NCT00766090|12191984|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11014521|NCT00766090|12191985|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11014522|NCT00766090|12191986|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||1
11014523|NCT00766116|12192000|FG000|STARTED|Overall Study||50
11014524|NCT00766116|12192000|FG000|COMPLETED|Overall Study||50
11014525|NCT00766116|12192000|FG000|NOT COMPLETED|Overall Study||0
11014526|NCT00766142|12192007|FG000|STARTED|Overall Study||18
11014527|NCT00766142|12192007|FG000|COMPLETED|Overall Study||14
11014528|NCT00766142|12192007|FG000|NOT COMPLETED|Overall Study||4
11014529|NCT00766363|12192015|FG000|STARTED|Overall Study||12
11014530|NCT00766363|12192016|FG001|STARTED|Overall Study||13
11014531|NCT00766363|12192017|FG002|STARTED|Overall Study|Number randomized.|12
11014532|NCT00766363|12192018|FG003|STARTED|Overall Study|Number randomized.|12
11014533|NCT00766363|12192015|FG000|SAFETY POPULATION|Overall Study||12
11014534|NCT00766363|12192016|FG001|SAFETY POPULATION|Overall Study||13
11014535|NCT00766363|12192017|FG002|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
11014536|NCT00766363|12192018|FG003|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
11014537|NCT00766363|12192015|FG000|PK POPULATION|Overall Study||12
11014538|NCT00766363|12192016|FG001|PK POPULATION|Overall Study||13
11014539|NCT00766363|12192017|FG002|PK POPULATION|Overall Study||10
11014540|NCT00766363|12192018|FG003|PK POPULATION|Overall Study||13
11014541|NCT00766363|12192015|FG000|COMPLETED|Overall Study||11
11014542|NCT00766363|12192016|FG001|COMPLETED|Overall Study||12
11014543|NCT00766363|12192017|FG002|COMPLETED|Overall Study||12
11014544|NCT00766363|12192018|FG003|COMPLETED|Overall Study||12
11014545|NCT00766363|12192015|FG000|NOT COMPLETED|Overall Study||1
11014546|NCT00766363|12192016|FG001|NOT COMPLETED|Overall Study||1
11014547|NCT00766363|12192017|FG002|NOT COMPLETED|Overall Study||0
11014548|NCT00766363|12192018|FG003|NOT COMPLETED|Overall Study||0
11014549|NCT00766376|12192029|FG000|STARTED|Overall Study||151
11014550|NCT00766376|12192029|FG000|COMPLETED|Overall Study||124
11014551|NCT00766376|12192029|FG000|NOT COMPLETED|Overall Study||27
11014552|NCT00766415|12192035|FG000|STARTED|Overall Study||25
11014553|NCT00766415|12192036|FG001|STARTED|Overall Study||27
11014554|NCT00766415|12192035|FG000|COMPLETED|Overall Study||25
11014555|NCT00766415|12192036|FG001|COMPLETED|Overall Study||26
11014556|NCT00766415|12192035|FG000|NOT COMPLETED|Overall Study||0
11014557|NCT00766415|12192036|FG001|NOT COMPLETED|Overall Study||1
11014558|NCT00766467|12192044|FG000|STARTED|Overall Study||42
11014559|NCT00766467|12192045|FG001|STARTED|Overall Study||39
11014560|NCT00766467|12192044|FG000|Initiated Treatment|Overall Study||39
11014561|NCT00766467|12192045|FG001|Initiated Treatment|Overall Study||38
11014562|NCT00766467|12192044|FG000|COMPLETED|Overall Study||31
11014563|NCT00766467|12192045|FG001|COMPLETED|Overall Study||31
11014564|NCT00766467|12192044|FG000|NOT COMPLETED|Overall Study||11
11014565|NCT00766467|12192045|FG001|NOT COMPLETED|Overall Study||8
11014566|NCT00766493|12192051|FG000|STARTED|Pre-Discharge||250
11014567|NCT00766493|12192051|FG000|COMPLETED|Pre-Discharge||250
11014568|NCT00766493|12192051|FG000|NOT COMPLETED|Pre-Discharge||0
11014569|NCT00766493|12192051|FG000|STARTED|30 Days Post-Procedure||250
11014570|NCT00766493|12192051|FG000|COMPLETED|30 Days Post-Procedure||238
11014571|NCT00766493|12192051|FG000|NOT COMPLETED|30 Days Post-Procedure||12
11014572|NCT00766506|12192057|FG000|STARTED|Overall Study||58
11014573|NCT00766506|12192058|FG001|STARTED|Overall Study||50
11014574|NCT00766506|12192057|FG000|COMPLETED|Overall Study||53
11014575|NCT00766506|12192058|FG001|COMPLETED|Overall Study||48
11014576|NCT00766506|12192057|FG000|NOT COMPLETED|Overall Study||5
11014577|NCT00766506|12192058|FG001|NOT COMPLETED|Overall Study||2
11014578|NCT00766532|12192064|FG000|STARTED|Overall Study||12
11014579|NCT00766532|12192064|FG000|COMPLETED|Overall Study||10
11014580|NCT00766532|12192064|FG000|NOT COMPLETED|Overall Study||2
11014581|NCT00766597|12192068|FG000|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
11014582|NCT00766597|12192068|FG000|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
11014583|NCT00766597|12192068|FG000|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
11014584|NCT00766597|12192068|FG000|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
11014585|NCT00766597|12192068|FG000|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
11014586|NCT00766597|12192068|FG000|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
11014587|NCT00766597|12192068|FG000|NOT COMPLETED|Overall Study||9
11014588|NCT00766649|12192074|FG000|STARTED|Overall Study||11
11014589|NCT00766649|12192074|FG000|COMPLETED|Overall Study||1
11014590|NCT00766649|12192074|FG000|NOT COMPLETED|Overall Study||10
11014591|NCT00766675|12192078|FG000|STARTED|Overall Study||80
11014592|NCT00766675|12192078|FG000|COMPLETED|Overall Study||40
11014593|NCT00766675|12192078|FG000|NOT COMPLETED|Overall Study||40
11014594|NCT00766727|12192082|FG000|STARTED|Overall Study||12
11014595|NCT00766727|12192082|FG000|COMPLETED|Overall Study||9
11014596|NCT00766727|12192082|FG000|NOT COMPLETED|Overall Study||3
11014597|NCT00766753|12192090|FG000|STARTED|Overall Study||11
11014598|NCT00766753|12192091|FG001|STARTED|Overall Study||11
11014599|NCT00766753|12192090|FG000|Received at Least One Vaccine|Overall Study||11
11014600|NCT00766753|12192091|FG001|Received at Least One Vaccine|Overall Study||11
11014601|NCT00766753|12192090|FG000|Completed at Least Four Vaccines|Overall Study||10
11014602|NCT00766753|12192091|FG001|Completed at Least Four Vaccines|Overall Study||9
11014603|NCT00766753|12192090|FG000|COMPLETED|Overall Study||11
11014604|NCT00766753|12192091|FG001|COMPLETED|Overall Study||11
11014605|NCT00766753|12192090|FG000|NOT COMPLETED|Overall Study||0
11014606|NCT00766753|12192091|FG001|NOT COMPLETED|Overall Study||0
11014607|NCT00766831|12192098|FG000|STARTED|Overall Study||190
11014608|NCT00766831|12192098|FG000|COMPLETED|Overall Study||75
11014609|NCT00766831|12192098|FG000|NOT COMPLETED|Overall Study||115
11014610|NCT00767000|12192107|FG000|STARTED|54-week Study||119
11014611|NCT00767000|12192108|FG001|STARTED|54-week Study||117
11014612|NCT00767000|12192109|FG002|STARTED|54-week Study||117
11014613|NCT00767000|12192110|FG003|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
11014614|NCT00767000|12192111|FG004|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
11014615|NCT00767000|12192107|FG000|COMPLETED|54-week Study||11
11014616|NCT00767000|12192108|FG001|COMPLETED|54-week Study||4
11014617|NCT00767000|12192109|FG002|COMPLETED|54-week Study||8
11014618|NCT00767000|12192110|FG003|COMPLETED|54-week Study||4
11014619|NCT00767000|12192111|FG004|COMPLETED|54-week Study||7
11014620|NCT00767000|12192107|FG000|NOT COMPLETED|54-week Study||108
11014621|NCT00767000|12192108|FG001|NOT COMPLETED|54-week Study||113
11143024|NCT01471093|12329817|FG000|NOT COMPLETED|Overall Study||1
11014622|NCT00767000|12192109|FG002|NOT COMPLETED|54-week Study||109
11014623|NCT00767000|12192110|FG003|NOT COMPLETED|54-week Study||225
11014624|NCT00767000|12192111|FG004|NOT COMPLETED|54-week Study||224
11014625|NCT00767000|12192107|FG000|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
11014626|NCT00767000|12192108|FG001|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
11014627|NCT00767000|12192109|FG002|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
11014628|NCT00767000|12192110|FG003|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
11014629|NCT00767000|12192111|FG004|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
11014630|NCT00767000|12192107|FG000|COMPLETED|Optional 104-week Extension||0
11014631|NCT00767000|12192108|FG001|COMPLETED|Optional 104-week Extension||0
11014632|NCT00767000|12192109|FG002|COMPLETED|Optional 104-week Extension||0
11014633|NCT00767000|12192110|FG003|COMPLETED|Optional 104-week Extension||0
11014634|NCT00767000|12192111|FG004|COMPLETED|Optional 104-week Extension||0
11014635|NCT00767000|12192107|FG000|NOT COMPLETED|Optional 104-week Extension||7
11014636|NCT00767000|12192108|FG001|NOT COMPLETED|Optional 104-week Extension||3
11014637|NCT00767000|12192109|FG002|NOT COMPLETED|Optional 104-week Extension||7
11014638|NCT00767000|12192110|FG003|NOT COMPLETED|Optional 104-week Extension||2
11014639|NCT00767000|12192111|FG004|NOT COMPLETED|Optional 104-week Extension||4
11014640|NCT00767039|12192125|FG000|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
11014641|NCT00767039|12192126|FG001|STARTED|Overall Study||25
11014642|NCT00767039|12192125|FG000|COMPLETED|Overall Study||22
11014643|NCT00767039|12192126|FG001|COMPLETED|Overall Study||23
11014644|NCT00767039|12192125|FG000|NOT COMPLETED|Overall Study||5
11014645|NCT00767039|12192126|FG001|NOT COMPLETED|Overall Study||2
11014646|NCT00767104|12192134|FG000|STARTED|Overall Study||20
11014647|NCT00767104|12192135|FG001|STARTED|Overall Study||20
11014648|NCT00767104|12192134|FG000|COMPLETED|Overall Study||19
11014649|NCT00767104|12192135|FG001|COMPLETED|Overall Study||18
11014650|NCT00767104|12192134|FG000|NOT COMPLETED|Overall Study||1
11014651|NCT00767104|12192135|FG001|NOT COMPLETED|Overall Study||2
11014652|NCT00767325|12192143|FG000|STARTED|Overall Study||104
11014653|NCT00767325|12192143|FG000|COMPLETED|Overall Study||89
11014654|NCT00767325|12192143|FG000|NOT COMPLETED|Overall Study||15
11014655|NCT00767338|12192151|FG000|STARTED|Overall Study||1
11014656|NCT00767338|12192152|FG001|STARTED|Overall Study||2
11014657|NCT00767338|12192153|FG002|STARTED|Overall Study||0
11014658|NCT00767338|12192154|FG003|STARTED|Overall Study||0
11014659|NCT00767338|12192151|FG000|COMPLETED|Overall Study||0
11014660|NCT00767338|12192152|FG001|COMPLETED|Overall Study||0
11014661|NCT00767338|12192153|FG002|COMPLETED|Overall Study||0
11014662|NCT00767338|12192154|FG003|COMPLETED|Overall Study||0
11014663|NCT00767338|12192151|FG000|NOT COMPLETED|Overall Study||1
11014664|NCT00767338|12192152|FG001|NOT COMPLETED|Overall Study||2
11014665|NCT00767338|12192153|FG002|NOT COMPLETED|Overall Study||0
11014666|NCT00767338|12192154|FG003|NOT COMPLETED|Overall Study||0
11014667|NCT00767364|12192166|FG000|STARTED|Overall Study||5
11014668|NCT00767364|12192167|FG001|STARTED|Overall Study||3
11014669|NCT00767364|12192166|FG000|COMPLETED|Overall Study||5
11014670|NCT00767364|12192167|FG001|COMPLETED|Overall Study||3
11014671|NCT00767364|12192166|FG000|NOT COMPLETED|Overall Study||0
11014672|NCT00767364|12192167|FG001|NOT COMPLETED|Overall Study||0
11014673|NCT00767455|12192173|FG000|STARTED|Overall Study||59
11014674|NCT00767455|12192173|FG000|COMPLETED|Overall Study||40
11014675|NCT00767455|12192173|FG000|NOT COMPLETED|Overall Study||19
11014676|NCT00767507|12192183|FG000|STARTED|Overall Study||5
11014677|NCT00767507|12192184|FG001|STARTED|Overall Study||6
11014678|NCT00767507|12192185|FG002|STARTED|Overall Study||106
11014679|NCT00767507|12192186|FG003|STARTED|Overall Study||104
11014680|NCT00767507|12192183|FG000|COMPLETED|Overall Study||5
11014681|NCT00767507|12192184|FG001|COMPLETED|Overall Study||6
11014682|NCT00767507|12192185|FG002|COMPLETED|Overall Study||106
11014683|NCT00767507|12192186|FG003|COMPLETED|Overall Study||101
11014684|NCT00767507|12192183|FG000|NOT COMPLETED|Overall Study||0
11014685|NCT00767507|12192184|FG001|NOT COMPLETED|Overall Study||0
11014686|NCT00767507|12192185|FG002|NOT COMPLETED|Overall Study||0
11014687|NCT00767507|12192186|FG003|NOT COMPLETED|Overall Study||3
11014688|NCT00767520|12192205|FG000|STARTED|Overall Study||79
11014689|NCT00767520|12192206|FG001|STARTED|Overall Study||78
11014690|NCT00767520|12192205|FG000|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
11014691|NCT00767520|12192206|FG001|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
11014692|NCT00767520|12192205|FG000|NOT COMPLETED|Overall Study||11
11014693|NCT00767520|12192206|FG001|NOT COMPLETED|Overall Study||17
11014694|NCT00767572|12192212|FG000|STARTED|First Intervention (12 Weeks)||12
11014695|NCT00767572|12192212|FG000|COMPLETED|First Intervention (12 Weeks)||12
11014696|NCT00767572|12192212|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
11014697|NCT00767572|12192212|FG000|STARTED|Washout (4 Weeks)||12
11014698|NCT00767572|12192212|FG000|COMPLETED|Washout (4 Weeks)||12
11014699|NCT00767572|12192212|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11014700|NCT00767572|12192212|FG000|STARTED|Second Intervention (12 Weeks)||12
11014701|NCT00767572|12192212|FG000|COMPLETED|Second Intervention (12 Weeks)||12
11014702|NCT00767572|12192212|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
11014703|NCT00767624|12192220|FG000|STARTED|Overall Study||75
11014704|NCT00767624|12192221|FG001|STARTED|Overall Study||75
11014705|NCT00767624|12192220|FG000|COMPLETED|Overall Study||51
11014706|NCT00767624|12192221|FG001|COMPLETED|Overall Study||58
11014707|NCT00767624|12192220|FG000|NOT COMPLETED|Overall Study||24
11014708|NCT00767624|12192221|FG001|NOT COMPLETED|Overall Study||17
11014709|NCT00767676|12192227|FG000|STARTED|Overall Study||259
11014710|NCT00767676|12192227|FG000|COMPLETED|Overall Study||205
11014711|NCT00767676|12192227|FG000|NOT COMPLETED|Overall Study||54
11014712|NCT00767767|12192236|FG000|STARTED|Overall Study||21
11014713|NCT00767767|12192237|FG001|STARTED|Overall Study||20
11014714|NCT00767767|12192238|FG002|STARTED|Overall Study||20
11014715|NCT00767767|12192239|FG003|STARTED|Overall Study||3
11014716|NCT00767767|12192240|FG004|STARTED|Overall Study||3
11014717|NCT00767767|12192236|FG000|COMPLETED|Overall Study||21
11014718|NCT00767767|12192237|FG001|COMPLETED|Overall Study||20
11014719|NCT00767767|12192238|FG002|COMPLETED|Overall Study||20
11014720|NCT00767767|12192239|FG003|COMPLETED|Overall Study||3
11014721|NCT00767767|12192240|FG004|COMPLETED|Overall Study||3
11014722|NCT00767767|12192236|FG000|NOT COMPLETED|Overall Study||0
11014723|NCT00767767|12192237|FG001|NOT COMPLETED|Overall Study||0
11014724|NCT00767767|12192238|FG002|NOT COMPLETED|Overall Study||0
11014725|NCT00767767|12192239|FG003|NOT COMPLETED|Overall Study||0
11014726|NCT00767767|12192240|FG004|NOT COMPLETED|Overall Study||0
11014727|NCT00767806|12192254|FG000|STARTED|Overall Study||198
11014728|NCT00767806|12192255|FG001|STARTED|Overall Study||203
11014729|NCT00767806|12192254|FG000|COMPLETED|Overall Study||147
11014730|NCT00767806|12192255|FG001|COMPLETED|Overall Study||156
11014731|NCT00767806|12192254|FG000|NOT COMPLETED|Overall Study||51
11014732|NCT00767806|12192255|FG001|NOT COMPLETED|Overall Study||47
11014733|NCT00767819|12192264|FG000|STARTED|Overall Study||37
11014734|NCT00767819|12192265|FG001|STARTED|Overall Study||24
11014735|NCT00767819|12192266|FG002|STARTED|Overall Study||10
11014736|NCT00767819|12192264|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||37
11014737|NCT00767819|12192265|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||24
11014738|NCT00767819|12192266|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||10
11014739|NCT00767819|12192264|FG000|Safety Analysis Set (SAF)|Overall Study||37
11014740|NCT00767819|12192265|FG001|Safety Analysis Set (SAF)|Overall Study||24
11014741|NCT00767819|12192266|FG002|Safety Analysis Set (SAF)|Overall Study||10
11014742|NCT00767819|12192264|FG000|COMPLETED|Overall Study||12
11014743|NCT00767819|12192265|FG001|COMPLETED|Overall Study||5
11014744|NCT00767819|12192266|FG002|COMPLETED|Overall Study||10
11014745|NCT00767819|12192264|FG000|NOT COMPLETED|Overall Study||25
11014746|NCT00767819|12192265|FG001|NOT COMPLETED|Overall Study||19
11014747|NCT00767819|12192266|FG002|NOT COMPLETED|Overall Study||0
11014748|NCT00768053|12192274|FG000|STARTED|Overall Study||108
11014749|NCT00768053|12192274|FG000|COMPLETED|Overall Study||97
11014750|NCT00768053|12192274|FG000|NOT COMPLETED|Overall Study||11
11014751|NCT00768066|12192281|FG000|STARTED|Overall Study||22
11014752|NCT00768066|12192282|FG001|STARTED|Overall Study||22
11014753|NCT00768066|12192283|FG002|STARTED|Overall Study||21
11014754|NCT00768066|12192281|FG000|COMPLETED|Overall Study||19
11014755|NCT00768066|12192282|FG001|COMPLETED|Overall Study||19
11014756|NCT00768066|12192283|FG002|COMPLETED|Overall Study||21
11014757|NCT00768066|12192281|FG000|NOT COMPLETED|Overall Study||3
11014758|NCT00768066|12192282|FG001|NOT COMPLETED|Overall Study||3
11014759|NCT00768066|12192283|FG002|NOT COMPLETED|Overall Study||0
11014760|NCT00768079|12192294|FG000|STARTED|Overall Study||38
11014761|NCT00768079|12192295|FG001|STARTED|Overall Study||36
11014762|NCT00768079|12192296|FG002|STARTED|Overall Study||36
11014763|NCT00768079|12192294|FG000|COMPLETED|Overall Study||36
11014764|NCT00768079|12192295|FG001|COMPLETED|Overall Study||35
11014765|NCT00768079|12192296|FG002|COMPLETED|Overall Study||32
11014766|NCT00768079|12192294|FG000|NOT COMPLETED|Overall Study||2
11014767|NCT00768079|12192295|FG001|NOT COMPLETED|Overall Study||1
11014768|NCT00768079|12192296|FG002|NOT COMPLETED|Overall Study||4
11014769|NCT00768118|12192306|FG000|STARTED|Overall Study||11
11014770|NCT00768118|12192306|FG000|COMPLETED|Overall Study||11
11014771|NCT00768118|12192306|FG000|NOT COMPLETED|Overall Study||0
11014772|NCT00768144|12192310|FG000|STARTED|Overall Study||36
11014773|NCT00768144|12192310|FG000|COMPLETED|Overall Study||0
11014774|NCT00768144|12192310|FG000|NOT COMPLETED|Overall Study||36
11014775|NCT00768222|12192316|FG000|STARTED|Overall Study||50
11014776|NCT00768222|12192317|FG001|STARTED|Overall Study||51
11014777|NCT00768222|12192316|FG000|COMPLETED|Overall Study||46
11014778|NCT00768222|12192317|FG001|COMPLETED|Overall Study||47
11014779|NCT00768222|12192316|FG000|NOT COMPLETED|Overall Study||4
11014780|NCT00768222|12192317|FG001|NOT COMPLETED|Overall Study||4
11014781|NCT00768261|12192327|FG000|STARTED|Overall Study||14
11014782|NCT00768261|12192328|FG001|STARTED|Overall Study||18
11014783|NCT00768261|12192329|FG002|STARTED|Overall Study||39
11263733|NCT02271984|12459062|FG001|STARTED|Washout Period 4 (7 Days)||3
11263734|NCT02271984|12459063|FG002|STARTED|Washout Period 4 (7 Days)||3
11263735|NCT02271984|12459064|FG003|STARTED|Washout Period 4 (7 Days)||3
11263736|NCT02271984|12459065|FG004|STARTED|Washout Period 4 (7 Days)||3
11263737|NCT02271984|12459066|FG005|STARTED|Washout Period 4 (7 Days)||3
11263738|NCT02271984|12459067|FG006|STARTED|Washout Period 4 (7 Days)||3
11014784|NCT00768261|12192330|FG003|STARTED|Overall Study||56
11014785|NCT00768261|12192327|FG000|COMPLETED|Overall Study||14
11014786|NCT00768261|12192328|FG001|COMPLETED|Overall Study||18
11014787|NCT00768261|12192329|FG002|COMPLETED|Overall Study||14
11014788|NCT00768261|12192330|FG003|COMPLETED|Overall Study||56
11014789|NCT00768261|12192327|FG000|NOT COMPLETED|Overall Study||0
11014790|NCT00768261|12192328|FG001|NOT COMPLETED|Overall Study||0
11014791|NCT00768261|12192329|FG002|NOT COMPLETED|Overall Study||25
11014792|NCT00768261|12192330|FG003|NOT COMPLETED|Overall Study||0
11014793|NCT00768287|12192343|FG000|STARTED|Pharmacokinetic Study||16
11014794|NCT00768287|12192344|FG001|STARTED|Pharmacokinetic Study||16
11014795|NCT00768287|12192345|FG002|STARTED|Pharmacokinetic Study||0
11014796|NCT00768287|12192346|FG003|STARTED|Pharmacokinetic Study||0
11014797|NCT00768287|12192347|FG004|STARTED|Pharmacokinetic Study||0
11014798|NCT00768287|12192348|FG005|STARTED|Pharmacokinetic Study||0
11014799|NCT00768287|12192343|FG000|COMPLETED|Pharmacokinetic Study||16
11014800|NCT00768287|12192344|FG001|COMPLETED|Pharmacokinetic Study||16
11014801|NCT00768287|12192345|FG002|COMPLETED|Pharmacokinetic Study||0
11014802|NCT00768287|12192346|FG003|COMPLETED|Pharmacokinetic Study||0
11014803|NCT00768287|12192347|FG004|COMPLETED|Pharmacokinetic Study||0
11014804|NCT00768287|12192348|FG005|COMPLETED|Pharmacokinetic Study||0
11014805|NCT00768287|12192343|FG000|NOT COMPLETED|Pharmacokinetic Study||0
11014806|NCT00768287|12192344|FG001|NOT COMPLETED|Pharmacokinetic Study||0
11014807|NCT00768287|12192345|FG002|NOT COMPLETED|Pharmacokinetic Study||0
11014808|NCT00768287|12192346|FG003|NOT COMPLETED|Pharmacokinetic Study||0
11014809|NCT00768287|12192347|FG004|NOT COMPLETED|Pharmacokinetic Study||0
11014810|NCT00768287|12192348|FG005|NOT COMPLETED|Pharmacokinetic Study||0
11014811|NCT00768287|12192343|FG000|STARTED|Repeat Pharmacokinetic Study||0
11014812|NCT00768287|12192344|FG001|STARTED|Repeat Pharmacokinetic Study||0
11014813|NCT00768287|12192345|FG002|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
11014814|NCT00768287|12192346|FG003|STARTED|Repeat Pharmacokinetic Study||0
11014815|NCT00768287|12192347|FG004|STARTED|Repeat Pharmacokinetic Study||0
11014816|NCT00768287|12192348|FG005|STARTED|Repeat Pharmacokinetic Study||0
11014817|NCT00768287|12192343|FG000|COMPLETED|Repeat Pharmacokinetic Study||0
11014818|NCT00768287|12192344|FG001|COMPLETED|Repeat Pharmacokinetic Study||0
11014819|NCT00768287|12192345|FG002|COMPLETED|Repeat Pharmacokinetic Study||14
11014820|NCT00768287|12192346|FG003|COMPLETED|Repeat Pharmacokinetic Study||0
11014821|NCT00768287|12192347|FG004|COMPLETED|Repeat Pharmacokinetic Study||0
11014822|NCT00768287|12192348|FG005|COMPLETED|Repeat Pharmacokinetic Study||0
11014823|NCT00768287|12192343|FG000|NOT COMPLETED|Repeat Pharmacokinetic Study||0
11014824|NCT00768287|12192344|FG001|NOT COMPLETED|Repeat Pharmacokinetic Study||0
11014825|NCT00768287|12192345|FG002|NOT COMPLETED|Repeat Pharmacokinetic Study||0
11014826|NCT00768287|12192346|FG003|NOT COMPLETED|Repeat Pharmacokinetic Study||0
11014827|NCT00768287|12192347|FG004|NOT COMPLETED|Repeat Pharmacokinetic Study||0
11014828|NCT00768287|12192348|FG005|NOT COMPLETED|Repeat Pharmacokinetic Study||0
11014829|NCT00768287|12192343|FG000|STARTED|Treatment Study||0
11014830|NCT00768287|12192344|FG001|STARTED|Treatment Study||0
11014831|NCT00768287|12192345|FG002|STARTED|Treatment Study||0
11014832|NCT00768287|12192346|FG003|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
11014833|NCT00768287|12192347|FG004|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
11014834|NCT00768287|12192348|FG005|STARTED|Treatment Study||0
11014835|NCT00768287|12192343|FG000|Treated|Treatment Study||0
11014836|NCT00768287|12192344|FG001|Treated|Treatment Study||0
11014837|NCT00768287|12192345|FG002|Treated|Treatment Study||0
11014838|NCT00768287|12192346|FG003|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
11014839|NCT00768287|12192347|FG004|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
11014840|NCT00768287|12192348|FG005|Treated|Treatment Study||0
11014841|NCT00768287|12192343|FG000|COMPLETED|Treatment Study||0
11014842|NCT00768287|12192344|FG001|COMPLETED|Treatment Study||0
11014843|NCT00768287|12192345|FG002|COMPLETED|Treatment Study||0
11014844|NCT00768287|12192346|FG003|COMPLETED|Treatment Study||58
11014845|NCT00768287|12192347|FG004|COMPLETED|Treatment Study||9
11014846|NCT00768287|12192348|FG005|COMPLETED|Treatment Study||0
11014847|NCT00768287|12192343|FG000|NOT COMPLETED|Treatment Study||0
11014848|NCT00768287|12192344|FG001|NOT COMPLETED|Treatment Study||0
11014849|NCT00768287|12192345|FG002|NOT COMPLETED|Treatment Study||0
11014850|NCT00768287|12192346|FG003|NOT COMPLETED|Treatment Study||0
11014851|NCT00768287|12192347|FG004|NOT COMPLETED|Treatment Study||0
11014852|NCT00768287|12192348|FG005|NOT COMPLETED|Treatment Study||0
11014853|NCT00768287|12192343|FG000|STARTED|Surgical Sub-study||0
11014854|NCT00768287|12192344|FG001|STARTED|Surgical Sub-study||0
11014855|NCT00768287|12192345|FG002|STARTED|Surgical Sub-study||0
11014856|NCT00768287|12192346|FG003|STARTED|Surgical Sub-study||0
11014857|NCT00768287|12192347|FG004|STARTED|Surgical Sub-study||0
11014858|NCT00768287|12192348|FG005|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
11014859|NCT00768287|12192343|FG000|COMPLETED|Surgical Sub-study||0
11014860|NCT00768287|12192344|FG001|COMPLETED|Surgical Sub-study||0
11014861|NCT00768287|12192345|FG002|COMPLETED|Surgical Sub-study||0
11014862|NCT00768287|12192346|FG003|COMPLETED|Surgical Sub-study||0
11014863|NCT00768287|12192347|FG004|COMPLETED|Surgical Sub-study||0
11014864|NCT00768287|12192348|FG005|COMPLETED|Surgical Sub-study||17
11014865|NCT00768287|12192343|FG000|NOT COMPLETED|Surgical Sub-study||0
11014866|NCT00768287|12192344|FG001|NOT COMPLETED|Surgical Sub-study||0
11014867|NCT00768287|12192345|FG002|NOT COMPLETED|Surgical Sub-study||0
11014868|NCT00768287|12192346|FG003|NOT COMPLETED|Surgical Sub-study||0
11014869|NCT00768287|12192347|FG004|NOT COMPLETED|Surgical Sub-study||0
11014870|NCT00768287|12192348|FG005|NOT COMPLETED|Surgical Sub-study||0
11014871|NCT00768300|12192362|FG000|STARTED|Overall Study||330
11014872|NCT00768300|12192363|FG001|STARTED|Overall Study||164
11014873|NCT00768300|12192362|FG000|Randomized and Treated|Overall Study||329
11014874|NCT00768300|12192363|FG001|Randomized and Treated|Overall Study||163
11014875|NCT00768300|12192362|FG000|COMPLETED|Overall Study||1
11014876|NCT00768300|12192363|FG001|COMPLETED|Overall Study||1
11014877|NCT00768300|12192362|FG000|NOT COMPLETED|Overall Study||329
11014878|NCT00768300|12192363|FG001|NOT COMPLETED|Overall Study||163
11014879|NCT00768430|12192371|FG000|STARTED|24 Hour Endpoint||48
11014880|NCT00768430|12192372|FG001|STARTED|24 Hour Endpoint||25
11014881|NCT00768430|12192371|FG000|COMPLETED|24 Hour Endpoint||47
11014882|NCT00768430|12192372|FG001|COMPLETED|24 Hour Endpoint||25
11263739|NCT02271984|12459068|FG007|STARTED|Washout Period 4 (7 Days)||3
11014883|NCT00768430|12192371|FG000|NOT COMPLETED|24 Hour Endpoint||1
11014884|NCT00768430|12192372|FG001|NOT COMPLETED|24 Hour Endpoint||0
11014885|NCT00768430|12192371|FG000|STARTED|7 Day Endpoint||47
11014886|NCT00768430|12192372|FG001|STARTED|7 Day Endpoint||25
11014887|NCT00768430|12192371|FG000|COMPLETED|7 Day Endpoint||45
11014888|NCT00768430|12192372|FG001|COMPLETED|7 Day Endpoint||22
11014889|NCT00768430|12192371|FG000|NOT COMPLETED|7 Day Endpoint||2
11014890|NCT00768430|12192372|FG001|NOT COMPLETED|7 Day Endpoint||3
11014891|NCT00768469|12192380|FG000|STARTED|Overall Study||3
11014892|NCT00768469|12192381|FG001|STARTED|Overall Study||7
11014893|NCT00768469|12192380|FG000|COMPLETED|Overall Study||0
11014894|NCT00768469|12192381|FG001|COMPLETED|Overall Study||0
11014895|NCT00768469|12192380|FG000|NOT COMPLETED|Overall Study||3
11014896|NCT00768469|12192381|FG001|NOT COMPLETED|Overall Study||7
11014897|NCT00768521|12192388|FG000|STARTED|Period 1||9
11014898|NCT00768521|12192389|FG001|STARTED|Period 1||11
11014899|NCT00768521|12192388|FG000|COMPLETED|Period 1||9
11014900|NCT00768521|12192389|FG001|COMPLETED|Period 1||11
11014901|NCT00768521|12192388|FG000|NOT COMPLETED|Period 1||0
11014902|NCT00768521|12192389|FG001|NOT COMPLETED|Period 1||0
11014903|NCT00768521|12192388|FG000|STARTED|Period 2||9
11014904|NCT00768521|12192389|FG001|STARTED|Period 2||11
11014905|NCT00768521|12192388|FG000|COMPLETED|Period 2||9
11014906|NCT00768521|12192389|FG001|COMPLETED|Period 2||11
11014907|NCT00768521|12192388|FG000|NOT COMPLETED|Period 2||0
11014908|NCT00768521|12192389|FG001|NOT COMPLETED|Period 2||0
11014909|NCT00768560|12192401|FG000|STARTED|Intervention Set 1|3-period/treatment crossover|5
11014910|NCT00768560|12192402|FG001|STARTED|Intervention Set 1|3-period/treatment crossover|6
11014911|NCT00768560|12192403|FG002|STARTED|Intervention Set 1|3-period/treatment crossover|6
11014912|NCT00768560|12192404|FG003|STARTED|Intervention Set 1|3-period/treatment crossover|6
11014913|NCT00768560|12192405|FG004|STARTED|Intervention Set 1|3-period/treatment crossover|6
11014914|NCT00768560|12192406|FG005|STARTED|Intervention Set 1|3-period/treatment crossover|6
11014915|NCT00768560|12192401|FG000|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
11014916|NCT00768560|12192402|FG001|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
11014917|NCT00768560|12192403|FG002|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
11014918|NCT00768560|12192404|FG003|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
11014919|NCT00768560|12192405|FG004|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
11014920|NCT00768560|12192406|FG005|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
11014921|NCT00768560|12192401|FG000|COMPLETED|Intervention Set 1||5
11014922|NCT00768560|12192402|FG001|COMPLETED|Intervention Set 1||5
11014923|NCT00768560|12192403|FG002|COMPLETED|Intervention Set 1||6
11014924|NCT00768560|12192404|FG003|COMPLETED|Intervention Set 1||6
11014925|NCT00768560|12192405|FG004|COMPLETED|Intervention Set 1||6
11014926|NCT00768560|12192406|FG005|COMPLETED|Intervention Set 1||6
11014927|NCT00768560|12192401|FG000|NOT COMPLETED|Intervention Set 1||0
11014928|NCT00768560|12192402|FG001|NOT COMPLETED|Intervention Set 1||1
11014929|NCT00768560|12192403|FG002|NOT COMPLETED|Intervention Set 1||0
11014930|NCT00768560|12192404|FG003|NOT COMPLETED|Intervention Set 1||0
11014931|NCT00768560|12192405|FG004|NOT COMPLETED|Intervention Set 1||0
11014932|NCT00768560|12192406|FG005|NOT COMPLETED|Intervention Set 1||0
11014933|NCT00768560|12192401|FG000|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
11014934|NCT00768560|12192402|FG001|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
11014935|NCT00768560|12192403|FG002|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
11014936|NCT00768560|12192404|FG003|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
11014937|NCT00768560|12192405|FG004|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
11014938|NCT00768560|12192406|FG005|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
11014939|NCT00768560|12192401|FG000|COMPLETED|Intervention Set 2||5
11014940|NCT00768560|12192402|FG001|COMPLETED|Intervention Set 2||5
11014941|NCT00768560|12192403|FG002|COMPLETED|Intervention Set 2||6
11014942|NCT00768560|12192404|FG003|COMPLETED|Intervention Set 2||6
11014943|NCT00768560|12192405|FG004|COMPLETED|Intervention Set 2||6
11143025|NCT01471093|12329818|FG001|NOT COMPLETED|Overall Study||0
11143026|NCT01471093|12329819|FG002|NOT COMPLETED|Overall Study||0
11143027|NCT01471093|12329820|FG003|NOT COMPLETED|Overall Study||0
11143028|NCT01471171|12329826|FG000|STARTED|Treatment Period 1||57
11143029|NCT01471171|12329827|FG001|STARTED|Treatment Period 1||55
11143030|NCT01471171|12329826|FG000|COMPLETED|Treatment Period 1||53
11143031|NCT01471171|12329827|FG001|COMPLETED|Treatment Period 1||54
11143032|NCT01471171|12329826|FG000|NOT COMPLETED|Treatment Period 1||4
11143033|NCT01471171|12329827|FG001|NOT COMPLETED|Treatment Period 1||1
11143034|NCT01471171|12329826|FG000|STARTED|Treatment Period 2||53
11143035|NCT01471171|12329827|FG001|STARTED|Treatment Period 2||54
11143036|NCT01471171|12329826|FG000|COMPLETED|Treatment Period 2||52
11143037|NCT01471171|12329827|FG001|COMPLETED|Treatment Period 2||54
11143038|NCT01471171|12329826|FG000|NOT COMPLETED|Treatment Period 2||1
11143039|NCT01471171|12329827|FG001|NOT COMPLETED|Treatment Period 2||0
11143040|NCT01471197|12329835|FG000|STARTED|Overall Study||6
11143041|NCT01471197|12329836|FG001|STARTED|Overall Study||2
11143042|NCT01471197|12329835|FG000|COMPLETED|Overall Study||0
11143043|NCT01471197|12329836|FG001|COMPLETED|Overall Study||0
11143044|NCT01471197|12329835|FG000|NOT COMPLETED|Overall Study||6
11143045|NCT01471197|12329836|FG001|NOT COMPLETED|Overall Study||2
11143046|NCT01471353|12329842|FG000|STARTED|Overall Study||42
11143047|NCT01471353|12329842|FG000|COMPLETED|Overall Study||39
11143048|NCT01471353|12329842|FG000|NOT COMPLETED|Overall Study||3
11143049|NCT01471379|12329849|FG000|STARTED|Overall Study||1
11143050|NCT01471379|12329850|FG001|STARTED|Overall Study||1
11143051|NCT01471379|12329851|FG002|STARTED|Overall Study||0
11143052|NCT01471379|12329849|FG000|COMPLETED|Overall Study||0
11143053|NCT01471379|12329850|FG001|COMPLETED|Overall Study||0
11143054|NCT01471379|12329851|FG002|COMPLETED|Overall Study||0
11143055|NCT01471379|12329849|FG000|NOT COMPLETED|Overall Study||1
11143056|NCT01471379|12329850|FG001|NOT COMPLETED|Overall Study||1
11143057|NCT01471379|12329851|FG002|NOT COMPLETED|Overall Study||0
11143058|NCT01471457|12329862|FG000|STARTED|Overall Study||92
11143059|NCT01471457|12329863|FG001|STARTED|Overall Study||92
11014944|NCT00768560|12192406|FG005|COMPLETED|Intervention Set 2||6
11014945|NCT00768560|12192401|FG000|NOT COMPLETED|Intervention Set 2||0
11014946|NCT00768560|12192402|FG001|NOT COMPLETED|Intervention Set 2||0
11014947|NCT00768560|12192403|FG002|NOT COMPLETED|Intervention Set 2||0
11014948|NCT00768560|12192404|FG003|NOT COMPLETED|Intervention Set 2||0
11014949|NCT00768560|12192405|FG004|NOT COMPLETED|Intervention Set 2||0
11014950|NCT00768560|12192406|FG005|NOT COMPLETED|Intervention Set 2||0
11014951|NCT00768560|12192401|FG000|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
11014952|NCT00768560|12192402|FG001|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
11014953|NCT00768560|12192403|FG002|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
11014954|NCT00768560|12192404|FG003|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
11014955|NCT00768560|12192405|FG004|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
11014956|NCT00768560|12192406|FG005|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
11014957|NCT00768560|12192401|FG000|COMPLETED|Intervention Set 3||5
11014958|NCT00768560|12192402|FG001|COMPLETED|Intervention Set 3||5
11014959|NCT00768560|12192403|FG002|COMPLETED|Intervention Set 3||6
11014960|NCT00768560|12192404|FG003|COMPLETED|Intervention Set 3||6
11014961|NCT00768560|12192405|FG004|COMPLETED|Intervention Set 3||6
11014962|NCT00768560|12192406|FG005|COMPLETED|Intervention Set 3||6
11014963|NCT00768560|12192401|FG000|NOT COMPLETED|Intervention Set 3||0
11014964|NCT00768560|12192402|FG001|NOT COMPLETED|Intervention Set 3||0
11014965|NCT00768560|12192403|FG002|NOT COMPLETED|Intervention Set 3||0
11014966|NCT00768560|12192404|FG003|NOT COMPLETED|Intervention Set 3||0
11014967|NCT00768560|12192405|FG004|NOT COMPLETED|Intervention Set 3||0
11014968|NCT00768560|12192406|FG005|NOT COMPLETED|Intervention Set 3||0
11014969|NCT00768599|12192417|FG000|STARTED|Overall Study||45
11014970|NCT00768599|12192418|FG001|STARTED|Overall Study||43
11014971|NCT00768599|12192419|FG002|STARTED|Overall Study||47
11014972|NCT00768599|12192417|FG000|COMPLETED|Overall Study||34
11014973|NCT00768599|12192418|FG001|COMPLETED|Overall Study||27
11014974|NCT00768599|12192419|FG002|COMPLETED|Overall Study||35
11014975|NCT00768599|12192417|FG000|NOT COMPLETED|Overall Study||11
11014976|NCT00768599|12192418|FG001|NOT COMPLETED|Overall Study||16
11396430|NCT03739840|12590240|FG000|COMPLETED|Post-Treatment Period: Wk16-23||42
11014977|NCT00768599|12192419|FG002|NOT COMPLETED|Overall Study||12
11014978|NCT00768651|12192427|FG000|STARTED|Overall Study||8
11014979|NCT00768651|12192427|FG000|COMPLETED|Overall Study||7
11014980|NCT00768651|12192427|FG000|NOT COMPLETED|Overall Study||1
11014981|NCT00768664|12192432|FG000|STARTED|Overall Study||69
11014982|NCT00768664|12192432|FG000|COMPLETED|Overall Study||0
11014983|NCT00768664|12192432|FG000|NOT COMPLETED|Overall Study||69
11014984|NCT00768716|12192438|FG000|STARTED|Overall Study||54
11014985|NCT00768716|12192439|FG001|STARTED|Overall Study||41
11014986|NCT00768716|12192438|FG000|COMPLETED|Overall Study||54
11014987|NCT00768716|12192439|FG001|COMPLETED|Overall Study||41
11014988|NCT00768716|12192438|FG000|NOT COMPLETED|Overall Study||0
11014989|NCT00768716|12192439|FG001|NOT COMPLETED|Overall Study||0
11014990|NCT00768755|12192452|FG000|STARTED|Phase 1||10
11014991|NCT00768755|12192453|FG001|STARTED|Phase 1||0
11014992|NCT00768755|12192454|FG002|STARTED|Phase 1||0
11014993|NCT00768755|12192455|FG003|STARTED|Phase 1||0
11014994|NCT00768755|12192452|FG000|COMPLETED|Phase 1||0
11014995|NCT00768755|12192453|FG001|COMPLETED|Phase 1||0
11014996|NCT00768755|12192454|FG002|COMPLETED|Phase 1||0
11014997|NCT00768755|12192455|FG003|COMPLETED|Phase 1||0
11014998|NCT00768755|12192452|FG000|NOT COMPLETED|Phase 1||10
11014999|NCT00768755|12192453|FG001|NOT COMPLETED|Phase 1||0
11015000|NCT00768755|12192454|FG002|NOT COMPLETED|Phase 1||0
11015001|NCT00768755|12192455|FG003|NOT COMPLETED|Phase 1||0
11015002|NCT00768755|12192452|FG000|STARTED|Phase 2||0
11015003|NCT00768755|12192453|FG001|STARTED|Phase 2||55
11015004|NCT00768755|12192454|FG002|STARTED|Phase 2||58
11015005|NCT00768755|12192455|FG003|STARTED|Phase 2||57
11015006|NCT00768755|12192452|FG000|Treated|Phase 2||0
11015007|NCT00768755|12192453|FG001|Treated|Phase 2||55
11015008|NCT00768755|12192454|FG002|Treated|Phase 2||58
11015009|NCT00768755|12192455|FG003|Treated|Phase 2||55
11015010|NCT00768755|12192452|FG000|COMPLETED|Phase 2||0
11015011|NCT00768755|12192453|FG001|COMPLETED|Phase 2||0
11015012|NCT00768755|12192454|FG002|COMPLETED|Phase 2||0
11015013|NCT00768755|12192455|FG003|COMPLETED|Phase 2||0
11015014|NCT00768755|12192452|FG000|NOT COMPLETED|Phase 2||0
11015015|NCT00768755|12192453|FG001|NOT COMPLETED|Phase 2||55
11015016|NCT00768755|12192454|FG002|NOT COMPLETED|Phase 2||58
11015017|NCT00768755|12192455|FG003|NOT COMPLETED|Phase 2||57
11015018|NCT00768898|12192464|FG000|STARTED|Overall Study||30
11015019|NCT00768898|12192464|FG000|COMPLETED|Overall Study||28
11015020|NCT00768898|12192464|FG000|NOT COMPLETED|Overall Study||2
11015021|NCT00768989|12192475|FG000|STARTED|Prior to Week 24||63
11015022|NCT00768989|12192476|FG001|STARTED|Prior to Week 24||30
11015023|NCT00768989|12192475|FG000|COMPLETED|Prior to Week 24||59
11015024|NCT00768989|12192476|FG001|COMPLETED|Prior to Week 24||27
11015025|NCT00768989|12192475|FG000|NOT COMPLETED|Prior to Week 24||4
11143060|NCT01471457|12329862|FG000|COMPLETED|Overall Study||73
11015026|NCT00768989|12192476|FG001|NOT COMPLETED|Prior to Week 24||3
11015027|NCT00768989|12192475|FG000|STARTED|Week 24 to Prior to Week 36||59
11015028|NCT00768989|12192476|FG001|STARTED|Week 24 to Prior to Week 36||27
11015029|NCT00768989|12192475|FG000|COMPLETED|Week 24 to Prior to Week 36||51
11015030|NCT00768989|12192476|FG001|COMPLETED|Week 24 to Prior to Week 36||27
11015031|NCT00768989|12192475|FG000|NOT COMPLETED|Week 24 to Prior to Week 36||8
11015032|NCT00768989|12192476|FG001|NOT COMPLETED|Week 24 to Prior to Week 36||0
11015033|NCT00768989|12192475|FG000|STARTED|On or After Week 36||51
11015034|NCT00768989|12192476|FG001|STARTED|On or After Week 36||27
11015035|NCT00768989|12192475|FG000|COMPLETED|On or After Week 36||0
11015036|NCT00768989|12192476|FG001|COMPLETED|On or After Week 36||0
11015037|NCT00768989|12192475|FG000|NOT COMPLETED|On or After Week 36||51
11015038|NCT00768989|12192476|FG001|NOT COMPLETED|On or After Week 36||27
11015039|NCT00769015|12192486|FG000|STARTED|Overall Study||96
11015040|NCT00769015|12192487|FG001|STARTED|Overall Study||92
11015041|NCT00769015|12192486|FG000|COMPLETED|Overall Study||87
11015042|NCT00769015|12192487|FG001|COMPLETED|Overall Study||76
11015043|NCT00769015|12192486|FG000|NOT COMPLETED|Overall Study||9
11015044|NCT00769015|12192487|FG001|NOT COMPLETED|Overall Study||16
11015045|NCT00769067|12192495|FG000|STARTED|Overall Study||94
11015046|NCT00769067|12192496|FG001|STARTED|Overall Study||94
11015047|NCT00769067|12192495|FG000|Treated|Overall Study||94
11015048|NCT00769067|12192496|FG001|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
11015049|NCT00769067|12192495|FG000|COMPLETED|Overall Study||0
11015050|NCT00769067|12192496|FG001|COMPLETED|Overall Study||0
11015051|NCT00769067|12192495|FG000|NOT COMPLETED|Overall Study||94
11015052|NCT00769067|12192496|FG001|NOT COMPLETED|Overall Study||94
11015053|NCT00769119|12192505|FG000|STARTED|Overall Study||22
11015054|NCT00769119|12192506|FG001|STARTED|Overall Study||16
11015055|NCT00769119|12192505|FG000|COMPLETED|Overall Study||20
11015056|NCT00769119|12192506|FG001|COMPLETED|Overall Study||13
11015057|NCT00769119|12192505|FG000|NOT COMPLETED|Overall Study||2
11015058|NCT00769119|12192506|FG001|NOT COMPLETED|Overall Study||3
11015059|NCT00769132|12192512|FG000|STARTED|Period 1||7
11015060|NCT00769132|12192513|FG001|STARTED|Period 1||6
11015061|NCT00769132|12192514|FG002|STARTED|Period 1||6
11015062|NCT00769132|12192515|FG003|STARTED|Period 1||7
11015063|NCT00769132|12192512|FG000|COMPLETED|Period 1||6
11015064|NCT00769132|12192513|FG001|COMPLETED|Period 1||6
11015065|NCT00769132|12192514|FG002|COMPLETED|Period 1||6
11015066|NCT00769132|12192515|FG003|COMPLETED|Period 1||6
11015067|NCT00769132|12192512|FG000|NOT COMPLETED|Period 1||1
11015068|NCT00769132|12192513|FG001|NOT COMPLETED|Period 1||0
11015069|NCT00769132|12192514|FG002|NOT COMPLETED|Period 1||0
11015070|NCT00769132|12192515|FG003|NOT COMPLETED|Period 1||1
11015071|NCT00769132|12192512|FG000|STARTED|Period 2||6
11015072|NCT00769132|12192513|FG001|STARTED|Period 2||6
11015073|NCT00769132|12192514|FG002|STARTED|Period 2||6
11015074|NCT00769132|12192515|FG003|STARTED|Period 2||6
11015075|NCT00769132|12192512|FG000|COMPLETED|Period 2||6
11015076|NCT00769132|12192513|FG001|COMPLETED|Period 2||6
11015077|NCT00769132|12192514|FG002|COMPLETED|Period 2||6
11015078|NCT00769132|12192515|FG003|COMPLETED|Period 2||5
11015079|NCT00769132|12192512|FG000|NOT COMPLETED|Period 2||0
11015080|NCT00769132|12192513|FG001|NOT COMPLETED|Period 2||0
11015081|NCT00769132|12192514|FG002|NOT COMPLETED|Period 2||0
11015082|NCT00769132|12192515|FG003|NOT COMPLETED|Period 2||1
11015083|NCT00769132|12192512|FG000|STARTED|Period 3||6
11015084|NCT00769132|12192513|FG001|STARTED|Period 3||6
11015085|NCT00769132|12192514|FG002|STARTED|Period 3||6
11015086|NCT00769132|12192515|FG003|STARTED|Period 3||5
11396431|NCT03739840|12590241|FG001|COMPLETED|Post-Treatment Period: Wk16-23||42
11396432|NCT03739840|12590242|FG002|COMPLETED|Post-Treatment Period: Wk16-23||41
11396433|NCT03739840|12590243|FG003|COMPLETED|Post-Treatment Period: Wk16-23||35
11396434|NCT03739840|12590240|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||4
11396435|NCT03739840|12590241|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||2
11396436|NCT03739840|12590242|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||3
11015087|NCT00769132|12192512|FG000|COMPLETED|Period 3||5
11015088|NCT00769132|12192513|FG001|COMPLETED|Period 3||6
11015089|NCT00769132|12192514|FG002|COMPLETED|Period 3||6
11015090|NCT00769132|12192515|FG003|COMPLETED|Period 3||5
11015091|NCT00769132|12192512|FG000|NOT COMPLETED|Period 3||1
11015092|NCT00769132|12192513|FG001|NOT COMPLETED|Period 3||0
11015093|NCT00769132|12192514|FG002|NOT COMPLETED|Period 3||0
11015094|NCT00769132|12192515|FG003|NOT COMPLETED|Period 3||0
11015095|NCT00769132|12192512|FG000|STARTED|Period 4||5
11015096|NCT00769132|12192513|FG001|STARTED|Period 4||6
11015097|NCT00769132|12192514|FG002|STARTED|Period 4||6
11015098|NCT00769132|12192515|FG003|STARTED|Period 4||5
11015099|NCT00769132|12192512|FG000|COMPLETED|Period 4||5
11015100|NCT00769132|12192513|FG001|COMPLETED|Period 4||5
11015101|NCT00769132|12192514|FG002|COMPLETED|Period 4||6
11015102|NCT00769132|12192515|FG003|COMPLETED|Period 4||5
11015103|NCT00769132|12192512|FG000|NOT COMPLETED|Period 4||0
11015104|NCT00769132|12192513|FG001|NOT COMPLETED|Period 4||1
11015105|NCT00769132|12192514|FG002|NOT COMPLETED|Period 4||0
11015106|NCT00769132|12192515|FG003|NOT COMPLETED|Period 4||0
11015107|NCT00769184|12192525|FG000|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
11015108|NCT00769184|12192526|FG001|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
11015109|NCT00769184|12192525|FG000|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
11015110|NCT00769184|12192526|FG001|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
11015111|NCT00769184|12192525|FG000|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
11015112|NCT00769184|12192526|FG001|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
11015113|NCT00769184|12192525|FG000|STARTED|+LCD / +Placebo Only (4 Weeks)||6
11015114|NCT00769184|12192526|FG001|STARTED|+LCD / +Placebo Only (4 Weeks)||7
11015115|NCT00769184|12192525|FG000|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
11015116|NCT00769184|12192526|FG001|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
11015117|NCT00769184|12192525|FG000|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
11015118|NCT00769184|12192526|FG001|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
11015119|NCT00769184|12192525|FG000|STARTED|No Treatment (6 Weeks)||6
11015120|NCT00769184|12192526|FG001|STARTED|No Treatment (6 Weeks)||7
11015121|NCT00769184|12192525|FG000|COMPLETED|No Treatment (6 Weeks)||5
11015122|NCT00769184|12192526|FG001|COMPLETED|No Treatment (6 Weeks)||6
11015123|NCT00769184|12192525|FG000|NOT COMPLETED|No Treatment (6 Weeks)||1
11015124|NCT00769184|12192526|FG001|NOT COMPLETED|No Treatment (6 Weeks)||1
11015125|NCT00769314|12192536|FG000|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
11015126|NCT00769314|12192537|FG001|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
11015127|NCT00769314|12192536|FG000|COMPLETED|Overall Study||361
11015128|NCT00769314|12192537|FG001|COMPLETED|Overall Study||384
11015129|NCT00769314|12192536|FG000|NOT COMPLETED|Overall Study||17
11015130|NCT00769314|12192537|FG001|NOT COMPLETED|Overall Study||13
11015131|NCT00769392|12192543|FG000|STARTED|Overall Study||28
11015132|NCT00769392|12192543|FG000|COMPLETED|Overall Study||24
11015133|NCT00769392|12192543|FG000|NOT COMPLETED|Overall Study||4
11015134|NCT00769483|12192553|FG000|STARTED|Overall Study||9
11015135|NCT00769483|12192554|FG001|STARTED|Overall Study||13
11015136|NCT00769483|12192555|FG002|STARTED|Overall Study||15
11015137|NCT00769483|12192556|FG003|STARTED|Overall Study||15
11015138|NCT00769483|12192557|FG004|STARTED|Overall Study||16
11015139|NCT00769483|12192558|FG005|STARTED|Overall Study||9
11015140|NCT00769483|12192553|FG000|COMPLETED|Overall Study||9
11015141|NCT00769483|12192554|FG001|COMPLETED|Overall Study||12
11015142|NCT00769483|12192555|FG002|COMPLETED|Overall Study||15
11015143|NCT00769483|12192556|FG003|COMPLETED|Overall Study||15
11015144|NCT00769483|12192557|FG004|COMPLETED|Overall Study||15
11015145|NCT00769483|12192558|FG005|COMPLETED|Overall Study||9
11015146|NCT00769483|12192553|FG000|NOT COMPLETED|Overall Study||0
11015147|NCT00769483|12192554|FG001|NOT COMPLETED|Overall Study||1
11396437|NCT03739840|12590243|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
11396438|NCT03739983|12590265|FG000|STARTED|Overall Study||2
11015148|NCT00769483|12192555|FG002|NOT COMPLETED|Overall Study||0
11015149|NCT00769483|12192556|FG003|NOT COMPLETED|Overall Study||0
11015150|NCT00769483|12192557|FG004|NOT COMPLETED|Overall Study||1
11015151|NCT00769483|12192558|FG005|NOT COMPLETED|Overall Study||0
11015152|NCT00769561|12192576|FG000|STARTED|Overall Study||29
11015153|NCT00769561|12192577|FG001|STARTED|Overall Study||29
11015154|NCT00769561|12192576|FG000|COMPLETED|Overall Study||26
11015155|NCT00769561|12192577|FG001|COMPLETED|Overall Study||24
11015156|NCT00769561|12192576|FG000|NOT COMPLETED|Overall Study||3
11015157|NCT00769561|12192577|FG001|NOT COMPLETED|Overall Study||5
11015158|NCT00769600|12192585|FG000|STARTED|Overall Study||15
11015159|NCT00769600|12192586|FG001|STARTED|Overall Study||8
11015160|NCT00769600|12192585|FG000|COMPLETED|Overall Study||15
11015161|NCT00769600|12192586|FG001|COMPLETED|Overall Study||8
11015162|NCT00769600|12192585|FG000|NOT COMPLETED|Overall Study||0
11015163|NCT00769600|12192586|FG001|NOT COMPLETED|Overall Study||0
11015164|NCT00769704|12192597|FG000|STARTED|Overall Study||141
11015165|NCT00769704|12192598|FG001|STARTED|Overall Study||296
11015166|NCT00769704|12192597|FG000|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
11015167|NCT00769704|12192598|FG001|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
11015168|NCT00769704|12192597|FG000|Received Treatment|Overall Study||127
11015169|NCT00769704|12192598|FG001|Received Treatment|Overall Study||292
11015170|NCT00769704|12192597|FG000|COMPLETED|Overall Study||30
11015171|NCT00769704|12192598|FG001|COMPLETED|Overall Study||97
11015172|NCT00769704|12192597|FG000|NOT COMPLETED|Overall Study||111
11015173|NCT00769704|12192598|FG001|NOT COMPLETED|Overall Study||199
11015174|NCT00769808|12192605|FG000|STARTED|Overall Study||72
11015175|NCT00769808|12192605|FG000|COMPLETED|Overall Study||64
11015176|NCT00769808|12192605|FG000|NOT COMPLETED|Overall Study||8
11015177|NCT00769860|12192611|FG000|STARTED|Overall Study||16
11015178|NCT00769860|12192612|FG001|STARTED|Overall Study||8
11015179|NCT00769860|12192611|FG000|Month 4|Overall Study||16
11015180|NCT00769860|12192612|FG001|Month 4|Overall Study||8
11015181|NCT00769860|12192611|FG000|Month 8|Overall Study||14
11015182|NCT00769860|12192612|FG001|Month 8|Overall Study||8
11015183|NCT00769860|12192611|FG000|COMPLETED|Overall Study||14
11015184|NCT00769860|12192612|FG001|COMPLETED|Overall Study||8
11015185|NCT00769860|12192611|FG000|NOT COMPLETED|Overall Study||2
11015186|NCT00769860|12192612|FG001|NOT COMPLETED|Overall Study||0
11015187|NCT00769886|12192622|FG000|STARTED|Overall Study||36
11015188|NCT00769886|12192623|FG001|STARTED|Overall Study||36
11015189|NCT00769886|12192624|FG002|STARTED|Overall Study||35
11015190|NCT00769886|12192625|FG003|STARTED|Overall Study||37
11015191|NCT00769886|12192622|FG000|COMPLETED|Overall Study||31
11015192|NCT00769886|12192623|FG001|COMPLETED|Overall Study||32
11015193|NCT00769886|12192624|FG002|COMPLETED|Overall Study||34
11015194|NCT00769886|12192625|FG003|COMPLETED|Overall Study||35
11143061|NCT01471457|12329863|FG001|COMPLETED|Overall Study||74
11143062|NCT01471457|12329862|FG000|NOT COMPLETED|Overall Study||19
11143063|NCT01471457|12329863|FG001|NOT COMPLETED|Overall Study||18
11143064|NCT01471574|12329873|FG000|STARTED|Treatment Period||132
11143065|NCT01471574|12329874|FG001|STARTED|Treatment Period||39
11143066|NCT01471574|12329875|FG002|STARTED|Treatment Period||106
11143067|NCT01471574|12329876|FG003|STARTED|Treatment Period||24
11143068|NCT01471574|12329873|FG000|COMPLETED|Treatment Period||101
11143069|NCT01471574|12329874|FG001|COMPLETED|Treatment Period||29
11143070|NCT01471574|12329875|FG002|COMPLETED|Treatment Period||82
11143071|NCT01471574|12329876|FG003|COMPLETED|Treatment Period||21
11143072|NCT01471574|12329873|FG000|NOT COMPLETED|Treatment Period||31
11143073|NCT01471574|12329874|FG001|NOT COMPLETED|Treatment Period||10
11143074|NCT01471574|12329875|FG002|NOT COMPLETED|Treatment Period||24
11143075|NCT01471574|12329876|FG003|NOT COMPLETED|Treatment Period||3
11015195|NCT00769886|12192622|FG000|NOT COMPLETED|Overall Study||5
11015196|NCT00769886|12192623|FG001|NOT COMPLETED|Overall Study||4
11015197|NCT00769886|12192624|FG002|NOT COMPLETED|Overall Study||1
11143076|NCT01471574|12329873|FG000|STARTED|Follow-up Period||121
11143077|NCT01471574|12329874|FG001|STARTED|Follow-up Period||34
11143078|NCT01471574|12329875|FG002|STARTED|Follow-up Period||102
11143079|NCT01471574|12329876|FG003|STARTED|Follow-up Period||24
11143080|NCT01471574|12329873|FG000|COMPLETED|Follow-up Period||114
11143081|NCT01471574|12329874|FG001|COMPLETED|Follow-up Period||32
11143082|NCT01471574|12329875|FG002|COMPLETED|Follow-up Period||95
11143083|NCT01471574|12329876|FG003|COMPLETED|Follow-up Period||21
11143084|NCT01471574|12329873|FG000|NOT COMPLETED|Follow-up Period||7
11143085|NCT01471574|12329874|FG001|NOT COMPLETED|Follow-up Period||2
11143086|NCT01471574|12329875|FG002|NOT COMPLETED|Follow-up Period||7
11143087|NCT01471574|12329876|FG003|NOT COMPLETED|Follow-up Period||3
11143088|NCT01471626|12329892|FG000|STARTED|Overall Study||21
11015198|NCT00769886|12192625|FG003|NOT COMPLETED|Overall Study||2
11015199|NCT00770029|12192637|FG000|STARTED|Overall Study||184
11015200|NCT00770029|12192638|FG001|STARTED|Overall Study||92
11015201|NCT00770029|12192637|FG000|COMPLETED|Overall Study||178
11015202|NCT00770029|12192638|FG001|COMPLETED|Overall Study||89
11143089|NCT01471626|12329892|FG000|COMPLETED|Overall Study||21
11015203|NCT00770029|12192637|FG000|NOT COMPLETED|Overall Study||6
11015204|NCT00770029|12192638|FG001|NOT COMPLETED|Overall Study||3
11015205|NCT00770120|12192644|FG000|STARTED|Overall Study||61
11015206|NCT00770120|12192644|FG000|Eligible|Overall Study||60
11015207|NCT00770120|12192644|FG000|Not Analyzable|Overall Study||1
11015208|NCT00770120|12192644|FG000|COMPLETED|Overall Study||0
11015209|NCT00770120|12192644|FG000|NOT COMPLETED|Overall Study||61
11015210|NCT00770133|12192653|FG000|STARTED|Overall Study||35
11015211|NCT00770133|12192654|FG001|STARTED|Overall Study||36
11015212|NCT00770133|12192655|FG002|STARTED|Overall Study||35
11015213|NCT00770133|12192656|FG003|STARTED|Overall Study||35
11015214|NCT00770133|12192653|FG000|COMPLETED|Overall Study||32
11015215|NCT00770133|12192654|FG001|COMPLETED|Overall Study||35
11015216|NCT00770133|12192655|FG002|COMPLETED|Overall Study||32
11015217|NCT00770133|12192656|FG003|COMPLETED|Overall Study||32
11015218|NCT00770133|12192653|FG000|NOT COMPLETED|Overall Study||3
11015219|NCT00770133|12192654|FG001|NOT COMPLETED|Overall Study||1
11015220|NCT00770133|12192655|FG002|NOT COMPLETED|Overall Study||3
11015221|NCT00770133|12192656|FG003|NOT COMPLETED|Overall Study||3
11015222|NCT00770146|12192668|FG000|STARTED|Treatment Period||53
11015223|NCT00770146|12192669|FG001|STARTED|Treatment Period||105
11015224|NCT00770146|12192668|FG000|Treated|Treatment Period||52
11015225|NCT00770146|12192669|FG001|Treated|Treatment Period||105
11015226|NCT00770146|12192668|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
11015227|NCT00770146|12192669|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
11015228|NCT00770146|12192668|FG000|COMPLETED|Treatment Period||44
11015229|NCT00770146|12192669|FG001|COMPLETED|Treatment Period||60
11015230|NCT00770146|12192668|FG000|NOT COMPLETED|Treatment Period||9
11015231|NCT00770146|12192669|FG001|NOT COMPLETED|Treatment Period||45
11015232|NCT00770146|12192668|FG000|STARTED|Follow-up Period||53
11015233|NCT00770146|12192669|FG001|STARTED|Follow-up Period||105
11015234|NCT00770146|12192668|FG000|COMPLETED|Follow-up Period||42
11015235|NCT00770146|12192669|FG001|COMPLETED|Follow-up Period||85
11015236|NCT00770146|12192668|FG000|NOT COMPLETED|Follow-up Period||11
11015237|NCT00770146|12192669|FG001|NOT COMPLETED|Follow-up Period||20
11015238|NCT00770211|12192677|FG000|STARTED|Overall Study||182
11015239|NCT00770211|12192678|FG001|STARTED|Overall Study||89
11015240|NCT00770211|12192677|FG000|COMPLETED|Overall Study||181
11015241|NCT00770211|12192678|FG001|COMPLETED|Overall Study||87
11015242|NCT00770211|12192677|FG000|NOT COMPLETED|Overall Study||1
11015243|NCT00770211|12192678|FG001|NOT COMPLETED|Overall Study||2
11015244|NCT00770224|12192684|FG000|STARTED|Step 1: Induction||87
11015245|NCT00770224|12192685|FG001|STARTED|Step 1: Induction||0
11015246|NCT00770224|12192684|FG000|Eligible and Evaluable|Step 1: Induction||84
11015247|NCT00770224|12192685|FG001|Eligible and Evaluable|Step 1: Induction||0
11015248|NCT00770224|12192684|FG000|COMPLETED|Step 1: Induction||73
11015249|NCT00770224|12192685|FG001|COMPLETED|Step 1: Induction||0
11015250|NCT00770224|12192684|FG000|NOT COMPLETED|Step 1: Induction||14
11015251|NCT00770224|12192685|FG001|NOT COMPLETED|Step 1: Induction||0
11015252|NCT00770224|12192684|FG000|STARTED|Step 2: Maintenance||0
11015253|NCT00770224|12192685|FG001|STARTED|Step 2: Maintenance||71
11015254|NCT00770224|12192684|FG000|Eligible and Evaluable|Step 2: Maintenance||0
11015255|NCT00770224|12192685|FG001|Eligible and Evaluable|Step 2: Maintenance||69
11143090|NCT01471626|12329892|FG000|NOT COMPLETED|Overall Study||0
11015256|NCT00770224|12192684|FG000|COMPLETED|Step 2: Maintenance||0
11015257|NCT00770224|12192685|FG001|COMPLETED|Step 2: Maintenance||41
11015258|NCT00770224|12192684|FG000|NOT COMPLETED|Step 2: Maintenance||0
11015259|NCT00770224|12192685|FG001|NOT COMPLETED|Step 2: Maintenance||30
11015260|NCT00770289|12192692|FG000|STARTED|Overall Study||851
11015261|NCT00770289|12192692|FG000|COMPLETED|Overall Study||845
11015262|NCT00770289|12192692|FG000|NOT COMPLETED|Overall Study||6
11015263|NCT00770315|12192705|FG000|STARTED|Overall Study||197
11015264|NCT00770315|12192706|FG001|STARTED|Overall Study||195
11015265|NCT00770315|12192707|FG002|STARTED|Overall Study||194
11015266|NCT00770315|12192708|FG003|STARTED|Overall Study||198
11015267|NCT00770315|12192705|FG000|COMPLETED|Overall Study||157
11015268|NCT00770315|12192706|FG001|COMPLETED|Overall Study||152
11015269|NCT00770315|12192707|FG002|COMPLETED|Overall Study||137
11015270|NCT00770315|12192708|FG003|COMPLETED|Overall Study||160
11015271|NCT00770315|12192705|FG000|NOT COMPLETED|Overall Study||40
11015272|NCT00770315|12192706|FG001|NOT COMPLETED|Overall Study||43
11015273|NCT00770315|12192707|FG002|NOT COMPLETED|Overall Study||57
11015274|NCT00770315|12192708|FG003|NOT COMPLETED|Overall Study||38
11015275|NCT00770328|12192720|FG000|STARTED|Overall Study||22
11015276|NCT00770328|12192721|FG001|STARTED|Overall Study||15
11015277|NCT00770328|12192720|FG000|COMPLETED|Overall Study||9
11015278|NCT00770328|12192721|FG001|COMPLETED|Overall Study||11
11015279|NCT00770328|12192720|FG000|NOT COMPLETED|Overall Study||13
11015280|NCT00770328|12192721|FG001|NOT COMPLETED|Overall Study||4
11015281|NCT00770341|12192730|FG000|STARTED|Overall Study|Number randomized|89
11015282|NCT00770341|12192731|FG001|STARTED|Overall Study|Number randomized|22
11015283|NCT00770341|12192732|FG002|STARTED|Overall Study|Number randomized|11
11015284|NCT00770341|12192730|FG000|COMPLETED|Overall Study||77
11015285|NCT00770341|12192731|FG001|COMPLETED|Overall Study||17
11015286|NCT00770341|12192732|FG002|COMPLETED|Overall Study||8
11015287|NCT00770341|12192730|FG000|NOT COMPLETED|Overall Study||12
11015288|NCT00770341|12192731|FG001|NOT COMPLETED|Overall Study||5
11015289|NCT00770341|12192732|FG002|NOT COMPLETED|Overall Study||3
11015290|NCT00770367|12192743|FG000|STARTED|First Intervention||18
11015291|NCT00770367|12192744|FG001|STARTED|First Intervention||18
11015292|NCT00770367|12192743|FG000|COMPLETED|First Intervention||18
11015293|NCT00770367|12192744|FG001|COMPLETED|First Intervention||16
11015294|NCT00770367|12192743|FG000|NOT COMPLETED|First Intervention||0
11015295|NCT00770367|12192744|FG001|NOT COMPLETED|First Intervention||2
11015296|NCT00770367|12192743|FG000|STARTED|Washout Period of 4 Weeks||18
11015297|NCT00770367|12192744|FG001|STARTED|Washout Period of 4 Weeks||16
11015298|NCT00770367|12192743|FG000|COMPLETED|Washout Period of 4 Weeks||18
11015299|NCT00770367|12192744|FG001|COMPLETED|Washout Period of 4 Weeks||15
11015300|NCT00770367|12192743|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0
11015301|NCT00770367|12192744|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1
11015302|NCT00770367|12192743|FG000|STARTED|Second Intervention||18
11015303|NCT00770367|12192744|FG001|STARTED|Second Intervention||15
11015304|NCT00770367|12192743|FG000|COMPLETED|Second Intervention||16
11015305|NCT00770367|12192744|FG001|COMPLETED|Second Intervention||15
11015306|NCT00770367|12192743|FG000|NOT COMPLETED|Second Intervention||2
11015307|NCT00770367|12192744|FG001|NOT COMPLETED|Second Intervention||0
11015308|NCT00770432|12192754|FG000|STARTED|Overall Study||102
11015309|NCT00770432|12192755|FG001|STARTED|Overall Study||101
11015310|NCT00770432|12192754|FG000|COMPLETED|Overall Study||98
11015311|NCT00770432|12192755|FG001|COMPLETED|Overall Study||94
11015312|NCT00770432|12192754|FG000|NOT COMPLETED|Overall Study||4
11015313|NCT00770432|12192755|FG001|NOT COMPLETED|Overall Study||7
11015314|NCT00770484|12192763|FG000|STARTED|Overall Study||8
11015315|NCT00770484|12192764|FG001|STARTED|Overall Study||4
11015316|NCT00770484|12192763|FG000|COMPLETED|Overall Study||7
11015317|NCT00770484|12192764|FG001|COMPLETED|Overall Study||4
11015318|NCT00770484|12192763|FG000|NOT COMPLETED|Overall Study||1
11015319|NCT00770484|12192764|FG001|NOT COMPLETED|Overall Study||0
11015320|NCT00770510|12192770|FG000|STARTED|Overall Study||72
11015321|NCT00770510|12192770|FG000|COMPLETED|Overall Study||67
11015322|NCT00770510|12192770|FG000|NOT COMPLETED|Overall Study||5
11015323|NCT00770562|12192784|FG000|STARTED|Overall Study||53
11015324|NCT00770562|12192785|FG001|STARTED|Overall Study||50
11015325|NCT00770562|12192784|FG000|COMPLETED|Overall Study||52
11015326|NCT00770562|12192785|FG001|COMPLETED|Overall Study||49
11015327|NCT00770562|12192784|FG000|NOT COMPLETED|Overall Study||1
11015328|NCT00770562|12192785|FG001|NOT COMPLETED|Overall Study||1
11015329|NCT00770588|12192794|FG000|STARTED|Overall Study||148
11015330|NCT00770588|12192795|FG001|STARTED|Overall Study||148
11015331|NCT00770588|12192794|FG000|COMPLETED|Overall Study||67
11015332|NCT00770588|12192795|FG001|COMPLETED|Overall Study||53
11015333|NCT00770588|12192794|FG000|NOT COMPLETED|Overall Study||81
11015334|NCT00770588|12192795|FG001|NOT COMPLETED|Overall Study||95
11015335|NCT00770601|12192802|FG000|STARTED|Overall Study||7
11015336|NCT00770601|12192802|FG000|COMPLETED|Overall Study||6
11015337|NCT00770601|12192802|FG000|NOT COMPLETED|Overall Study||1
11015338|NCT00770653|12192808|FG000|STARTED|Overall Study||155
11015339|NCT00770653|12192809|FG001|STARTED|Overall Study||150
11015340|NCT00770653|12192808|FG000|COMPLETED|Overall Study||123
11015341|NCT00770653|12192809|FG001|COMPLETED|Overall Study||121
11015342|NCT00770653|12192808|FG000|NOT COMPLETED|Overall Study||32
11015343|NCT00770653|12192809|FG001|NOT COMPLETED|Overall Study||29
11015344|NCT00770679|12192815|FG000|STARTED|Overall Study||16
11015345|NCT00770679|12192815|FG000|COMPLETED|Overall Study||10
11015346|NCT00770679|12192815|FG000|NOT COMPLETED|Overall Study||6
11015347|NCT00770692|12192823|FG000|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
11015348|NCT00770692|12192824|FG001|STARTED|Overall Study||83
11015349|NCT00770692|12192825|FG002|STARTED|Overall Study||84
11015350|NCT00770692|12192826|FG003|STARTED|Overall Study||77
11015351|NCT00770692|12192823|FG000|COMPLETED|Overall Study||69
11015352|NCT00770692|12192824|FG001|COMPLETED|Overall Study||74
11015353|NCT00770692|12192825|FG002|COMPLETED|Overall Study||70
11015354|NCT00770692|12192826|FG003|COMPLETED|Overall Study||66
11015355|NCT00770692|12192823|FG000|NOT COMPLETED|Overall Study||12
11015356|NCT00770692|12192824|FG001|NOT COMPLETED|Overall Study||9
11015357|NCT00770692|12192825|FG002|NOT COMPLETED|Overall Study||14
11015358|NCT00770692|12192826|FG003|NOT COMPLETED|Overall Study||11
11015359|NCT00770757|12192836|FG000|STARTED|Overall Study||13
11015360|NCT00770757|12192836|FG000|COMPLETED|Overall Study||13
11015361|NCT00770757|12192836|FG000|NOT COMPLETED|Overall Study||0
11015362|NCT00770770|12192842|FG000|STARTED|Overall Study||14
11263740|NCT02271984|12459069|FG008|STARTED|Washout Period 4 (7 Days)||3
11263741|NCT02271984|12459070|FG009|STARTED|Washout Period 4 (7 Days)||3
11263742|NCT02271984|12459071|FG010|STARTED|Washout Period 4 (7 Days)||3
11263743|NCT02271984|12459072|FG011|STARTED|Washout Period 4 (7 Days)||3
11263744|NCT02271984|12459061|FG000|COMPLETED|Washout Period 4 (7 Days)||3
11263745|NCT02271984|12459062|FG001|COMPLETED|Washout Period 4 (7 Days)||3
11015363|NCT00770770|12192843|FG001|STARTED|Overall Study||6
11015364|NCT00770770|12192842|FG000|COMPLETED|Overall Study||4
11015365|NCT00770770|12192843|FG001|COMPLETED|Overall Study||5
11015366|NCT00770770|12192842|FG000|NOT COMPLETED|Overall Study||10
11015367|NCT00770770|12192843|FG001|NOT COMPLETED|Overall Study||1
11015368|NCT00770861|12192851|FG000|STARTED|Overall Study||141
11015369|NCT00770861|12192852|FG001|STARTED|Overall Study||136
11015370|NCT00770861|12192851|FG000|COMPLETED|Overall Study||131
11015371|NCT00770861|12192852|FG001|COMPLETED|Overall Study||120
11015372|NCT00770861|12192851|FG000|NOT COMPLETED|Overall Study||10
11015373|NCT00770861|12192852|FG001|NOT COMPLETED|Overall Study||16
11015374|NCT00770874|12192860|FG000|STARTED|Overall Study||188
11015375|NCT00770874|12192861|FG001|STARTED|Overall Study||176
11015376|NCT00770874|12192860|FG000|COMPLETED|Overall Study||188
11015377|NCT00770874|12192861|FG001|COMPLETED|Overall Study||176
11015378|NCT00770874|12192860|FG000|NOT COMPLETED|Overall Study||0
11015379|NCT00770874|12192861|FG001|NOT COMPLETED|Overall Study||0
11015380|NCT00770913|12192870|FG000|STARTED|Overall Study||113
11015381|NCT00770913|12192871|FG001|STARTED|Overall Study||111
11015382|NCT00770913|12192872|FG002|STARTED|Overall Study||113
11015383|NCT00770913|12192870|FG000|COMPLETED|Overall Study||102
11015384|NCT00770913|12192871|FG001|COMPLETED|Overall Study||103
11015385|NCT00770913|12192872|FG002|COMPLETED|Overall Study||100
11015386|NCT00770913|12192870|FG000|NOT COMPLETED|Overall Study||11
11015387|NCT00770913|12192871|FG001|NOT COMPLETED|Overall Study||8
11015388|NCT00770913|12192872|FG002|NOT COMPLETED|Overall Study||13
11015389|NCT00770991|12192882|FG000|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
11015390|NCT00770991|12192883|FG001|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
11015391|NCT00770991|12192882|FG000|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
11015392|NCT00770991|12192883|FG001|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
11015393|NCT00770991|12192882|FG000|NOT COMPLETED|Overall Study||5
11015394|NCT00770991|12192883|FG001|NOT COMPLETED|Overall Study||5
11015395|NCT00771030|12192901|FG000|STARTED|Overall Study||6
11015396|NCT00771030|12192902|FG001|STARTED|Overall Study||4
11015397|NCT00771030|12192903|FG002|STARTED|Overall Study||6
11015398|NCT00771030|12192904|FG003|STARTED|Overall Study||6
11015399|NCT00771030|12192905|FG004|STARTED|Overall Study||6
11015400|NCT00771030|12192906|FG005|STARTED|Overall Study||6
11015401|NCT00771030|12192907|FG006|STARTED|Overall Study||6
11015402|NCT00771030|12192901|FG000|Received Study Drug|Overall Study||6
11015403|NCT00771030|12192902|FG001|Received Study Drug|Overall Study||4
11015404|NCT00771030|12192903|FG002|Received Study Drug|Overall Study||6
11015405|NCT00771030|12192904|FG003|Received Study Drug|Overall Study||6
11015406|NCT00771030|12192905|FG004|Received Study Drug|Overall Study||6
11015407|NCT00771030|12192906|FG005|Received Study Drug|Overall Study||6
11015408|NCT00771030|12192907|FG006|Received Study Drug|Overall Study||6
11015409|NCT00771030|12192901|FG000|COMPLETED|Overall Study||6
11015410|NCT00771030|12192902|FG001|COMPLETED|Overall Study||3
11015411|NCT00771030|12192903|FG002|COMPLETED|Overall Study||6
11015412|NCT00771030|12192904|FG003|COMPLETED|Overall Study||6
11015413|NCT00771030|12192905|FG004|COMPLETED|Overall Study||6
11015414|NCT00771030|12192906|FG005|COMPLETED|Overall Study||6
11015415|NCT00771030|12192907|FG006|COMPLETED|Overall Study||6
11015416|NCT00771030|12192901|FG000|NOT COMPLETED|Overall Study||0
11015417|NCT00771030|12192902|FG001|NOT COMPLETED|Overall Study||1
11015418|NCT00771030|12192903|FG002|NOT COMPLETED|Overall Study||0
11015419|NCT00771030|12192904|FG003|NOT COMPLETED|Overall Study||0
11015420|NCT00771030|12192905|FG004|NOT COMPLETED|Overall Study||0
11015421|NCT00771030|12192906|FG005|NOT COMPLETED|Overall Study||0
11015422|NCT00771030|12192907|FG006|NOT COMPLETED|Overall Study||0
11056816|NCT00995930|12238423|FG000|Safety Analysis Set|Overall Study||94
11056817|NCT00995930|12238424|FG001|Safety Analysis Set|Overall Study||95
11056818|NCT00995930|12238423|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0
11056819|NCT00995930|12238424|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||95
11056820|NCT00995930|12238423|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||92
11015423|NCT00771056|12192928|FG000|STARTED|Overall Study||23
11015424|NCT00771056|12192928|FG000|COMPLETED|Overall Study||18
11015425|NCT00771056|12192928|FG000|NOT COMPLETED|Overall Study||5
11015426|NCT00771173|12192934|FG000|STARTED|Overall Study||129
11015427|NCT00771173|12192935|FG001|STARTED|Overall Study||129
11015428|NCT00771173|12192934|FG000|COMPLETED|Overall Study||107
11015429|NCT00771173|12192935|FG001|COMPLETED|Overall Study||112
11015430|NCT00771173|12192934|FG000|NOT COMPLETED|Overall Study||22
11015431|NCT00771173|12192935|FG001|NOT COMPLETED|Overall Study||17
11015432|NCT00771238|12192943|FG000|STARTED|Overall Study||31
11015433|NCT00771238|12192944|FG001|STARTED|Overall Study||21
11015434|NCT00771238|12192943|FG000|COMPLETED|Overall Study||31
11015435|NCT00771238|12192944|FG001|COMPLETED|Overall Study||21
11015436|NCT00771238|12192943|FG000|NOT COMPLETED|Overall Study||0
11015437|NCT00771238|12192944|FG001|NOT COMPLETED|Overall Study||0
11015438|NCT00771264|12192952|FG000|STARTED|Overall Study||110
11015439|NCT00771264|12192953|FG001|STARTED|Overall Study||110
11015440|NCT00771264|12192952|FG000|COMPLETED|Overall Study||103
11015441|NCT00771264|12192953|FG001|COMPLETED|Overall Study||105
11015442|NCT00771264|12192952|FG000|NOT COMPLETED|Overall Study||7
11015443|NCT00771264|12192953|FG001|NOT COMPLETED|Overall Study||5
11015444|NCT00771277|12192959|FG000|STARTED|Overall Study||6
11015445|NCT00771277|12192959|FG000|COMPLETED|Overall Study||6
11015446|NCT00771277|12192959|FG000|NOT COMPLETED|Overall Study||0
11015447|NCT00771407|12192965|FG000|STARTED|Overall Study||60
11015448|NCT00771407|12192966|FG001|STARTED|Overall Study||60
11015449|NCT00771407|12192965|FG000|COMPLETED|Overall Study||40
11015450|NCT00771407|12192966|FG001|COMPLETED|Overall Study||35
11015451|NCT00771407|12192965|FG000|NOT COMPLETED|Overall Study||20
11015452|NCT00771407|12192966|FG001|NOT COMPLETED|Overall Study||25
11015453|NCT00771472|12192972|FG000|STARTED|Overall Study||6
11015454|NCT00771472|12192973|FG001|STARTED|Overall Study||4
11015455|NCT00771472|12192972|FG000|COMPLETED|Overall Study||0
11015456|NCT00771472|12192973|FG001|COMPLETED|Overall Study||0
11015457|NCT00771472|12192972|FG000|NOT COMPLETED|Overall Study||6
11015458|NCT00771472|12192973|FG001|NOT COMPLETED|Overall Study||4
11015459|NCT00771537|12192994|FG000|STARTED|Overall Study||135
11015460|NCT00771537|12192995|FG001|STARTED|Overall Study||124
11015461|NCT00771537|12192996|FG002|STARTED|Overall Study||151
11015462|NCT00771537|12192997|FG003|STARTED|Overall Study||114
11015463|NCT00771537|12192998|FG004|STARTED|Overall Study||127
11015464|NCT00771537|12192999|FG005|STARTED|Overall Study||118
11015465|NCT00771537|12193000|FG006|STARTED|Overall Study||128
11015466|NCT00771537|12193001|FG007|STARTED|Overall Study||132
11015467|NCT00771537|12193002|FG008|STARTED|Overall Study||115
11015468|NCT00771537|12193003|FG009|STARTED|Overall Study||119
11015469|NCT00771537|12193004|FG010|STARTED|Overall Study||133
11015470|NCT00771537|12193005|FG011|STARTED|Overall Study||137
11015471|NCT00771537|12193006|FG012|STARTED|Overall Study||128
11015472|NCT00771537|12193007|FG013|STARTED|Overall Study||124
11015473|NCT00771537|12193008|FG014|STARTED|Overall Study||124
11015474|NCT00771537|12193009|FG015|STARTED|Overall Study||122
11015475|NCT00771537|12192994|FG000|COMPLETED|Overall Study||135
11015476|NCT00771537|12192995|FG001|COMPLETED|Overall Study||124
11015477|NCT00771537|12192996|FG002|COMPLETED|Overall Study||151
11015478|NCT00771537|12192997|FG003|COMPLETED|Overall Study||114
11015479|NCT00771537|12192998|FG004|COMPLETED|Overall Study||127
11015480|NCT00771537|12192999|FG005|COMPLETED|Overall Study||118
11015481|NCT00771537|12193000|FG006|COMPLETED|Overall Study||128
11015482|NCT00771537|12193001|FG007|COMPLETED|Overall Study||132
11015483|NCT00771537|12193002|FG008|COMPLETED|Overall Study||115
11015484|NCT00771537|12193003|FG009|COMPLETED|Overall Study||119
11015485|NCT00771537|12193004|FG010|COMPLETED|Overall Study||133
11015486|NCT00771537|12193005|FG011|COMPLETED|Overall Study||137
11015487|NCT00771537|12193006|FG012|COMPLETED|Overall Study||128
11015488|NCT00771537|12193007|FG013|COMPLETED|Overall Study||124
11015489|NCT00771537|12193008|FG014|COMPLETED|Overall Study||124
11015490|NCT00771537|12193009|FG015|COMPLETED|Overall Study||122
11015491|NCT00771537|12192994|FG000|NOT COMPLETED|Overall Study||0
11015492|NCT00771537|12192995|FG001|NOT COMPLETED|Overall Study||0
11015493|NCT00771537|12192996|FG002|NOT COMPLETED|Overall Study||0
11015494|NCT00771537|12192997|FG003|NOT COMPLETED|Overall Study||0
11015495|NCT00771537|12192998|FG004|NOT COMPLETED|Overall Study||0
11015496|NCT00771537|12192999|FG005|NOT COMPLETED|Overall Study||0
11015497|NCT00771537|12193000|FG006|NOT COMPLETED|Overall Study||0
11015498|NCT00771537|12193001|FG007|NOT COMPLETED|Overall Study||0
11015499|NCT00771537|12193002|FG008|NOT COMPLETED|Overall Study||0
11015500|NCT00771537|12193003|FG009|NOT COMPLETED|Overall Study||0
11015501|NCT00771537|12193004|FG010|NOT COMPLETED|Overall Study||0
11015502|NCT00771537|12193005|FG011|NOT COMPLETED|Overall Study||0
11015503|NCT00771537|12193006|FG012|NOT COMPLETED|Overall Study||0
11015504|NCT00771537|12193007|FG013|NOT COMPLETED|Overall Study||0
11015505|NCT00771537|12193008|FG014|NOT COMPLETED|Overall Study||0
11015506|NCT00771537|12193009|FG015|NOT COMPLETED|Overall Study||0
11015507|NCT00771615|12193044|FG000|STARTED|Overall Study||49
11015508|NCT00771615|12193045|FG001|STARTED|Overall Study||72
11015509|NCT00771615|12193046|FG002|STARTED|Overall Study||41
11015510|NCT00771615|12193047|FG003|STARTED|Overall Study||60
11015511|NCT00771615|12193048|FG004|STARTED|Overall Study||40
11015512|NCT00771615|12193049|FG005|STARTED|Overall Study||61
11015513|NCT00771615|12193050|FG006|STARTED|Overall Study||46
11015514|NCT00771615|12193051|FG007|STARTED|Overall Study||59
11015515|NCT00771615|12193052|FG008|STARTED|Overall Study||41
11015516|NCT00771615|12193044|FG000|COMPLETED|Overall Study|Up to Day 364|48
11015517|NCT00771615|12193045|FG001|COMPLETED|Overall Study|Up to Day 364|70
11015518|NCT00771615|12193046|FG002|COMPLETED|Overall Study|Up to Day 364|40
11015519|NCT00771615|12193047|FG003|COMPLETED|Overall Study|Up to Day 364|59
11015520|NCT00771615|12193048|FG004|COMPLETED|Overall Study|Up to Day 364|40
11015521|NCT00771615|12193049|FG005|COMPLETED|Overall Study|Up to Day 364|60
11015522|NCT00771615|12193050|FG006|COMPLETED|Overall Study|Up to Day 364|45
11015523|NCT00771615|12193051|FG007|COMPLETED|Overall Study|Up to Day 364|58
11015524|NCT00771615|12193052|FG008|COMPLETED|Overall Study|Up to Day 364|41
11015525|NCT00771615|12193044|FG000|NOT COMPLETED|Overall Study||1
11015526|NCT00771615|12193045|FG001|NOT COMPLETED|Overall Study||2
11015527|NCT00771615|12193046|FG002|NOT COMPLETED|Overall Study||1
11015528|NCT00771615|12193047|FG003|NOT COMPLETED|Overall Study||1
11015529|NCT00771615|12193048|FG004|NOT COMPLETED|Overall Study||0
11143091|NCT01471639|12329896|FG000|STARTED|Overall Study||37
11143092|NCT01471639|12329896|FG000|COMPLETED|Overall Study||37
11143093|NCT01471639|12329896|FG000|NOT COMPLETED|Overall Study||0
11143094|NCT01471691|12329902|FG000|STARTED|Overall Study||8
11143095|NCT01471691|12329903|FG001|STARTED|Overall Study||6
11143096|NCT01471691|12329902|FG000|COMPLETED|Overall Study||8
11143097|NCT01471691|12329903|FG001|COMPLETED|Overall Study||5
11143098|NCT01471691|12329902|FG000|NOT COMPLETED|Overall Study||0
11143099|NCT01471691|12329903|FG001|NOT COMPLETED|Overall Study||1
11143100|NCT01471782|12329915|FG000|STARTED|Overall Study||5
11143101|NCT01471782|12329916|FG001|STARTED|Overall Study||7
11015530|NCT00771615|12193049|FG005|NOT COMPLETED|Overall Study||1
11015531|NCT00771615|12193050|FG006|NOT COMPLETED|Overall Study||1
11015532|NCT00771615|12193051|FG007|NOT COMPLETED|Overall Study||1
11015533|NCT00771615|12193052|FG008|NOT COMPLETED|Overall Study||0
11015534|NCT00771667|12193085|FG000|STARTED|Induction Phase||132
11015535|NCT00771667|12193086|FG001|STARTED|Induction Phase||131
11015536|NCT00771667|12193087|FG002|STARTED|Induction Phase||132
11015537|NCT00771667|12193088|FG003|STARTED|Induction Phase||131
11015538|NCT00771667|12193089|FG004|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
11015539|NCT00771667|12193090|FG005|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
11015540|NCT00771667|12193091|FG006|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
11015541|NCT00771667|12193092|FG007|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
11015542|NCT00771667|12193093|FG008|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
11015543|NCT00771667|12193094|FG009|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
11015544|NCT00771667|12193085|FG000|COMPLETED|Induction Phase||113
11015545|NCT00771667|12193086|FG001|COMPLETED|Induction Phase||121
11015546|NCT00771667|12193087|FG002|COMPLETED|Induction Phase||120
11015547|NCT00771667|12193088|FG003|COMPLETED|Induction Phase||123
11015548|NCT00771667|12193089|FG004|COMPLETED|Induction Phase||0
11015549|NCT00771667|12193090|FG005|COMPLETED|Induction Phase||0
11015550|NCT00771667|12193091|FG006|COMPLETED|Induction Phase||0
11015551|NCT00771667|12193092|FG007|COMPLETED|Induction Phase||0
11015552|NCT00771667|12193093|FG008|COMPLETED|Induction Phase||0
11015553|NCT00771667|12193094|FG009|COMPLETED|Induction Phase||0
11015554|NCT00771667|12193085|FG000|NOT COMPLETED|Induction Phase||19
11015555|NCT00771667|12193086|FG001|NOT COMPLETED|Induction Phase||10
11015556|NCT00771667|12193087|FG002|NOT COMPLETED|Induction Phase||12
11015557|NCT00771667|12193088|FG003|NOT COMPLETED|Induction Phase||8
11015558|NCT00771667|12193089|FG004|NOT COMPLETED|Induction Phase||0
11015559|NCT00771667|12193090|FG005|NOT COMPLETED|Induction Phase||0
11015560|NCT00771667|12193091|FG006|NOT COMPLETED|Induction Phase||0
11015561|NCT00771667|12193092|FG007|NOT COMPLETED|Induction Phase||0
11015562|NCT00771667|12193093|FG008|NOT COMPLETED|Induction Phase||0
11015563|NCT00771667|12193094|FG009|NOT COMPLETED|Induction Phase||0
11015564|NCT00771667|12193085|FG000|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
11015565|NCT00771667|12193086|FG001|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
11015566|NCT00771667|12193087|FG002|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
11015567|NCT00771667|12193088|FG003|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
11015568|NCT00771667|12193089|FG004|STARTED|Maintenance Phase||28
11015569|NCT00771667|12193090|FG005|STARTED|Maintenance Phase||85
11015570|NCT00771667|12193091|FG006|STARTED|Maintenance Phase||73
11015571|NCT00771667|12193092|FG007|STARTED|Maintenance Phase||72
11015572|NCT00771667|12193093|FG008|STARTED|Maintenance Phase||110
11015573|NCT00771667|12193094|FG009|STARTED|Maintenance Phase||109
11015574|NCT00771667|12193085|FG000|COMPLETED|Maintenance Phase||0
11015575|NCT00771667|12193086|FG001|COMPLETED|Maintenance Phase||0
11015576|NCT00771667|12193087|FG002|COMPLETED|Maintenance Phase||0
11015577|NCT00771667|12193088|FG003|COMPLETED|Maintenance Phase||0
11015578|NCT00771667|12193089|FG004|COMPLETED|Maintenance Phase||26
11015579|NCT00771667|12193090|FG005|COMPLETED|Maintenance Phase||78
11015580|NCT00771667|12193091|FG006|COMPLETED|Maintenance Phase||63
11015581|NCT00771667|12193092|FG007|COMPLETED|Maintenance Phase||67
11015582|NCT00771667|12193093|FG008|COMPLETED|Maintenance Phase||88
11015583|NCT00771667|12193094|FG009|COMPLETED|Maintenance Phase||92
11015584|NCT00771667|12193085|FG000|NOT COMPLETED|Maintenance Phase||0
11015585|NCT00771667|12193086|FG001|NOT COMPLETED|Maintenance Phase||0
11143102|NCT01471782|12329917|FG002|STARTED|Overall Study||5
11143103|NCT01471782|12329918|FG003|STARTED|Overall Study||6
11015586|NCT00771667|12193087|FG002|NOT COMPLETED|Maintenance Phase||0
11015587|NCT00771667|12193088|FG003|NOT COMPLETED|Maintenance Phase||0
11015588|NCT00771667|12193089|FG004|NOT COMPLETED|Maintenance Phase||2
11015589|NCT00771667|12193090|FG005|NOT COMPLETED|Maintenance Phase||7
11015590|NCT00771667|12193091|FG006|NOT COMPLETED|Maintenance Phase||10
11015591|NCT00771667|12193092|FG007|NOT COMPLETED|Maintenance Phase||5
11015592|NCT00771667|12193093|FG008|NOT COMPLETED|Maintenance Phase||22
11015593|NCT00771667|12193094|FG009|NOT COMPLETED|Maintenance Phase||17
11015594|NCT00771745|12193114|FG000|STARTED|Overall Study||6
11015595|NCT00771745|12193115|FG001|STARTED|Overall Study||5
11015596|NCT00771745|12193114|FG000|COMPLETED|Overall Study||6
11015597|NCT00771745|12193115|FG001|COMPLETED|Overall Study||5
11015598|NCT00771745|12193114|FG000|NOT COMPLETED|Overall Study||0
11015599|NCT00771745|12193115|FG001|NOT COMPLETED|Overall Study||0
11015600|NCT00771758|12193124|FG000|STARTED|Overall Study||44
11015601|NCT00771758|12193125|FG001|STARTED|Overall Study||43
11015602|NCT00771758|12193126|FG002|STARTED|Overall Study||21
11015603|NCT00771758|12193124|FG000|COMPLETED|Overall Study||36
11015604|NCT00771758|12193125|FG001|COMPLETED|Overall Study||31
11015605|NCT00771758|12193126|FG002|COMPLETED|Overall Study||19
11015606|NCT00771758|12193124|FG000|NOT COMPLETED|Overall Study||8
11015607|NCT00771758|12193125|FG001|NOT COMPLETED|Overall Study||12
11015608|NCT00771758|12193126|FG002|NOT COMPLETED|Overall Study||2
11015609|NCT00771810|12193154|FG000|STARTED|Overall Study||10
11015610|NCT00771810|12193155|FG001|STARTED|Overall Study||11
11015611|NCT00771810|12193156|FG002|STARTED|Overall Study||13
11015612|NCT00771810|12193154|FG000|COMPLETED|Overall Study||5
11015613|NCT00771810|12193155|FG001|COMPLETED|Overall Study||6
11015614|NCT00771810|12193156|FG002|COMPLETED|Overall Study||6
11015615|NCT00771810|12193154|FG000|NOT COMPLETED|Overall Study||5
11015616|NCT00771810|12193155|FG001|NOT COMPLETED|Overall Study||5
11015617|NCT00771810|12193156|FG002|NOT COMPLETED|Overall Study||7
11015618|NCT00771849|12193167|FG000|STARTED|Overall Study||52
11015619|NCT00771849|12193168|FG001|STARTED|Overall Study|One subject was not vaccinated|51
11015620|NCT00771849|12193167|FG000|COMPLETED|Overall Study||50
11015621|NCT00771849|12193168|FG001|COMPLETED|Overall Study||47
11015622|NCT00771849|12193167|FG000|NOT COMPLETED|Overall Study||2
11015623|NCT00771849|12193168|FG001|NOT COMPLETED|Overall Study||4
11015624|NCT00771875|12193177|FG000|STARTED|Overall Study||10
11015625|NCT00771875|12193178|FG001|STARTED|Overall Study||10
11015626|NCT00771875|12193179|FG002|STARTED|Overall Study||10
11015627|NCT00771875|12193177|FG000|COMPLETED|Overall Study||10
11015628|NCT00771875|12193178|FG001|COMPLETED|Overall Study||9
11015629|NCT00771875|12193179|FG002|COMPLETED|Overall Study||10
11015630|NCT00771875|12193177|FG000|NOT COMPLETED|Overall Study||0
11015631|NCT00771875|12193178|FG001|NOT COMPLETED|Overall Study||1
11015632|NCT00771875|12193179|FG002|NOT COMPLETED|Overall Study||0
11015633|NCT00771901|12193190|FG000|STARTED|Overall Study||10
11015634|NCT00771901|12193191|FG001|STARTED|Overall Study||10
11015635|NCT00771901|12193192|FG002|STARTED|Overall Study||10
11015636|NCT00771901|12193190|FG000|COMPLETED|Overall Study||10
11015637|NCT00771901|12193191|FG001|COMPLETED|Overall Study||10
11015638|NCT00771901|12193192|FG002|COMPLETED|Overall Study||6
11015639|NCT00771901|12193190|FG000|NOT COMPLETED|Overall Study||0
11015640|NCT00771901|12193191|FG001|NOT COMPLETED|Overall Study||0
11015641|NCT00771901|12193192|FG002|NOT COMPLETED|Overall Study||4
11015642|NCT00771914|12193204|FG000|STARTED|Overall Study||7
11015643|NCT00771914|12193205|FG001|STARTED|Overall Study||6
11015644|NCT00771914|12193206|FG002|STARTED|Overall Study||6
11015645|NCT00771914|12193207|FG003|STARTED|Overall Study||8
11015646|NCT00771914|12193204|FG000|COMPLETED|Overall Study||7
11015647|NCT00771914|12193205|FG001|COMPLETED|Overall Study||6
11015648|NCT00771914|12193206|FG002|COMPLETED|Overall Study||6
11015649|NCT00771914|12193207|FG003|COMPLETED|Overall Study||6
11015650|NCT00771914|12193204|FG000|NOT COMPLETED|Overall Study||0
11015651|NCT00771914|12193205|FG001|NOT COMPLETED|Overall Study||0
11015652|NCT00771914|12193206|FG002|NOT COMPLETED|Overall Study||0
11015653|NCT00771914|12193207|FG003|NOT COMPLETED|Overall Study||2
11015654|NCT00771927|12193219|FG000|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
11015655|NCT00771927|12193220|FG001|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
11015656|NCT00771927|12193219|FG000|COMPLETED|Overall Study||256
11015657|NCT00771927|12193220|FG001|COMPLETED|Overall Study||256
11015658|NCT00771927|12193219|FG000|NOT COMPLETED|Overall Study||255
11015659|NCT00771927|12193220|FG001|NOT COMPLETED|Overall Study||237
11015660|NCT00771953|12193228|FG000|STARTED|Overall Study||36
11015661|NCT00771953|12193229|FG001|STARTED|Overall Study||36
11015662|NCT00771953|12193228|FG000|COMPLETED|Overall Study||26
11015663|NCT00771953|12193229|FG001|COMPLETED|Overall Study||26
11015664|NCT00771953|12193228|FG000|NOT COMPLETED|Overall Study||10
11015665|NCT00771953|12193229|FG001|NOT COMPLETED|Overall Study||10
11015666|NCT00772005|12193241|FG000|STARTED|Overall Study||71
11015667|NCT00772005|12193242|FG001|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
11015668|NCT00772005|12193243|FG002|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
11015669|NCT00772005|12193244|FG003|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
11015670|NCT00772005|12193241|FG000|COMPLETED|Overall Study||46
11015671|NCT00772005|12193242|FG001|COMPLETED|Overall Study||40
11015672|NCT00772005|12193243|FG002|COMPLETED|Overall Study||44
11015673|NCT00772005|12193244|FG003|COMPLETED|Overall Study||46
11015674|NCT00772005|12193241|FG000|NOT COMPLETED|Overall Study||25
11015675|NCT00772005|12193242|FG001|NOT COMPLETED|Overall Study||30
11015676|NCT00772005|12193243|FG002|NOT COMPLETED|Overall Study||28
11015677|NCT00772005|12193244|FG003|NOT COMPLETED|Overall Study||26
11015678|NCT00772031|12193256|FG000|STARTED|Overall Study||96
11015679|NCT00772031|12193257|FG001|STARTED|Overall Study||95
11015680|NCT00772031|12193256|FG000|COMPLETED|Overall Study||64
11015681|NCT00772031|12193257|FG001|COMPLETED|Overall Study||52
11015682|NCT00772031|12193256|FG000|NOT COMPLETED|Overall Study||32
11015683|NCT00772031|12193257|FG001|NOT COMPLETED|Overall Study||43
11015684|NCT00772070|12193271|FG000|STARTED|Overall Study||102
11015685|NCT00772070|12193272|FG001|STARTED|Overall Study||71
11015686|NCT00772070|12193271|FG000|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
11015687|NCT00772070|12193272|FG001|COMPLETED|Overall Study||61
11015688|NCT00772070|12193271|FG000|NOT COMPLETED|Overall Study||2
11015689|NCT00772070|12193272|FG001|NOT COMPLETED|Overall Study||10
11015690|NCT00772109|12193282|FG000|STARTED|Overall Study||956
11015691|NCT00772109|12193283|FG001|STARTED|Overall Study||953
11015692|NCT00772109|12193284|FG002|STARTED|Overall Study||955
11015693|NCT00772109|12193285|FG003|STARTED|Overall Study||1428
11015694|NCT00772109|12193282|FG000|COMPLETED|Overall Study||935
11015695|NCT00772109|12193283|FG001|COMPLETED|Overall Study||934
11015696|NCT00772109|12193284|FG002|COMPLETED|Overall Study||936
11015697|NCT00772109|12193285|FG003|COMPLETED|Overall Study||1397
11015698|NCT00772109|12193282|FG000|NOT COMPLETED|Overall Study||21
11015699|NCT00772109|12193283|FG001|NOT COMPLETED|Overall Study||19
11015700|NCT00772109|12193284|FG002|NOT COMPLETED|Overall Study||19
11015701|NCT00772109|12193285|FG003|NOT COMPLETED|Overall Study||31
11015702|NCT00772148|12193297|FG000|STARTED|Pharmacokinetic Phase (14 Days)||29
11015703|NCT00772148|12193298|FG001|STARTED|Pharmacokinetic Phase (14 Days)||29
11015704|NCT00772148|12193297|FG000|COMPLETED|Pharmacokinetic Phase (14 Days)||21
11015705|NCT00772148|12193298|FG001|COMPLETED|Pharmacokinetic Phase (14 Days)||23
11015706|NCT00772148|12193297|FG000|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
11015707|NCT00772148|12193298|FG001|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
11015708|NCT00772148|12193297|FG000|STARTED|Maintenance Phase (Week 52)||21
11015709|NCT00772148|12193298|FG001|STARTED|Maintenance Phase (Week 52)||23
11015710|NCT00772148|12193297|FG000|COMPLETED|Maintenance Phase (Week 52)||17
11015711|NCT00772148|12193298|FG001|COMPLETED|Maintenance Phase (Week 52)||18
11015712|NCT00772148|12193297|FG000|NOT COMPLETED|Maintenance Phase (Week 52)||4
11015713|NCT00772148|12193298|FG001|NOT COMPLETED|Maintenance Phase (Week 52)||5
11015714|NCT00772304|12193304|FG000|STARTED|Overall Study||102
11015715|NCT00772304|12193304|FG000|COMPLETED|Overall Study||102
11015716|NCT00772304|12193304|FG000|NOT COMPLETED|Overall Study||0
11015717|NCT00772330|12193308|FG000|STARTED|Overall Study||23
11015718|NCT00772330|12193308|FG000|COMPLETED|Overall Study||20
11015719|NCT00772330|12193308|FG000|NOT COMPLETED|Overall Study||3
11015720|NCT00772369|12193315|FG000|STARTED|Overall Study||3214
11015721|NCT00772369|12193315|FG000|COMPLETED|Overall Study||3213
11015722|NCT00772369|12193315|FG000|NOT COMPLETED|Overall Study||1
11015723|NCT00772382|12193319|FG000|STARTED|Overall Study||116
11015724|NCT00772382|12193319|FG000|COMPLETED|Overall Study||61
11015725|NCT00772382|12193319|FG000|NOT COMPLETED|Overall Study||55
11015726|NCT00772447|12193325|FG000|STARTED|Overall Study||131
11015727|NCT00772447|12193326|FG001|STARTED|Overall Study||134
11015728|NCT00772447|12193325|FG000|COMPLETED|Overall Study||111
11015729|NCT00772447|12193326|FG001|COMPLETED|Overall Study||110
11015730|NCT00772447|12193325|FG000|NOT COMPLETED|Overall Study||20
11015731|NCT00772447|12193326|FG001|NOT COMPLETED|Overall Study||24
11015732|NCT00772538|12193335|FG000|STARTED|Overall Study||222
11015733|NCT00772538|12193336|FG001|STARTED|Overall Study||237
11015734|NCT00772538|12193335|FG000|COMPLETED|Overall Study||202
11015735|NCT00772538|12193336|FG001|COMPLETED|Overall Study||211
11015736|NCT00772538|12193335|FG000|NOT COMPLETED|Overall Study||20
11015737|NCT00772538|12193336|FG001|NOT COMPLETED|Overall Study||26
11015738|NCT00772577|12193344|FG000|STARTED|Overall Study||193
11015739|NCT00772577|12193345|FG001|STARTED|Overall Study||193
11015740|NCT00772577|12193344|FG000|COMPLETED|Overall Study||170
11015741|NCT00772577|12193345|FG001|COMPLETED|Overall Study||170
11015742|NCT00772577|12193344|FG000|NOT COMPLETED|Overall Study||23
11015743|NCT00772577|12193345|FG001|NOT COMPLETED|Overall Study||23
11015744|NCT00772590|12193355|FG000|STARTED|Overall Study||19
11015745|NCT00772590|12193356|FG001|STARTED|Overall Study||19
11015746|NCT00772590|12193357|FG002|STARTED|Overall Study||18
11015747|NCT00772590|12193358|FG003|STARTED|Overall Study||17
11015748|NCT00772590|12193355|FG000|COMPLETED|Overall Study||19
11015749|NCT00772590|12193356|FG001|COMPLETED|Overall Study||19
11015750|NCT00772590|12193357|FG002|COMPLETED|Overall Study||18
11015751|NCT00772590|12193358|FG003|COMPLETED|Overall Study||17
11015752|NCT00772590|12193355|FG000|NOT COMPLETED|Overall Study||0
11015753|NCT00772590|12193356|FG001|NOT COMPLETED|Overall Study||0
11015754|NCT00772590|12193357|FG002|NOT COMPLETED|Overall Study||0
11015755|NCT00772590|12193358|FG003|NOT COMPLETED|Overall Study||0
11015756|NCT00772603|12193371|FG000|STARTED|Overall Study||123
11015757|NCT00772603|12193372|FG001|STARTED|Overall Study||122
11015758|NCT00772603|12193373|FG002|STARTED|Overall Study||121
11015759|NCT00772603|12193371|FG000|COMPLETED|Overall Study||71
11015760|NCT00772603|12193372|FG001|COMPLETED|Overall Study||82
11015761|NCT00772603|12193373|FG002|COMPLETED|Overall Study||95
11015762|NCT00772603|12193371|FG000|NOT COMPLETED|Overall Study||52
11015763|NCT00772603|12193372|FG001|NOT COMPLETED|Overall Study||40
11015764|NCT00772603|12193373|FG002|NOT COMPLETED|Overall Study||26
11015765|NCT00772629|12193386|FG000|STARTED|Overall Study||17
11015766|NCT00772629|12193387|FG001|STARTED|Overall Study||1
11015767|NCT00772629|12193386|FG000|COMPLETED|Overall Study||16
11015768|NCT00772629|12193387|FG001|COMPLETED|Overall Study||1
11396439|NCT03739983|12590265|FG000|COMPLETED|Overall Study||2
11396440|NCT03739983|12590265|FG000|NOT COMPLETED|Overall Study||0
11015769|NCT00772629|12193386|FG000|NOT COMPLETED|Overall Study||1
11015770|NCT00772629|12193387|FG001|NOT COMPLETED|Overall Study||0
11015771|NCT00772668|12193393|FG000|STARTED|Overall Study||3
11015772|NCT00772668|12193393|FG000|COMPLETED|Overall Study||0
11015773|NCT00772668|12193393|FG000|NOT COMPLETED|Overall Study||3
11015774|NCT00772707|12193398|FG000|STARTED|Overall Study||114
11143104|NCT01471782|12329919|FG004|STARTED|Overall Study||26
11143105|NCT01471782|12329920|FG005|STARTED|Overall Study||44
11143106|NCT01471782|12329915|FG000|COMPLETED|Overall Study|Completed 5 cycles|0
11015775|NCT00772707|12193398|FG000|COMPLETED|Overall Study||111
11015776|NCT00772707|12193398|FG000|NOT COMPLETED|Overall Study||3
11015777|NCT00772772|12193402|FG000|STARTED|Overall Study||12
11015778|NCT00772772|12193402|FG000|COMPLETED|Overall Study||12
11015779|NCT00772772|12193402|FG000|NOT COMPLETED|Overall Study||0
11015780|NCT00772889|12193410|FG000|STARTED|Overall Study||375
11015781|NCT00772889|12193411|FG001|STARTED|Overall Study||393
11143107|NCT01471782|12329916|FG001|COMPLETED|Overall Study|Completed 5 cycles|1
11396441|NCT03746002|12590271|FG000|STARTED|Overall Study||1
11015782|NCT00772889|12193412|FG002|STARTED|Overall Study||203
11015783|NCT00772889|12193410|FG000|Completed at Day 21|Overall Study||374
11015784|NCT00772889|12193411|FG001|Completed at Day 21|Overall Study||390
11015785|NCT00772889|12193412|FG002|Completed at Day 21|Overall Study||203
11015786|NCT00772889|12193410|FG000|COMPLETED|Overall Study||353
11015787|NCT00772889|12193411|FG001|COMPLETED|Overall Study||375
11015788|NCT00772889|12193412|FG002|COMPLETED|Overall Study||187
11015789|NCT00772889|12193410|FG000|NOT COMPLETED|Overall Study||22
11015790|NCT00772889|12193411|FG001|NOT COMPLETED|Overall Study||18
11015791|NCT00772889|12193412|FG002|NOT COMPLETED|Overall Study||16
11015792|NCT00772915|12193420|FG000|STARTED|Overall Study||38
11015793|NCT00772915|12193420|FG000|COMPLETED|Overall Study||23
11015794|NCT00772915|12193420|FG000|NOT COMPLETED|Overall Study||15
11015795|NCT00772928|12193426|FG000|STARTED|Overall Study||587
11015796|NCT00772928|12193427|FG001|STARTED|Overall Study||579
11015797|NCT00772928|12193426|FG000|COMPLETED|Overall Study||543
11015798|NCT00772928|12193427|FG001|COMPLETED|Overall Study||538
11015799|NCT00772928|12193426|FG000|NOT COMPLETED|Overall Study||44
11015800|NCT00772928|12193427|FG001|NOT COMPLETED|Overall Study||41
11015801|NCT00772941|12193433|FG000|STARTED|Overall Study||3939
11015802|NCT00772941|12193433|FG000|COMPLETED|Overall Study||3257
11015803|NCT00772941|12193433|FG000|NOT COMPLETED|Overall Study||682
11015804|NCT00772954|12193463|FG000|STARTED|Overall Study||12
11015805|NCT00772954|12193464|FG001|STARTED|Overall Study||12
11015806|NCT00772954|12193465|FG002|STARTED|Overall Study||12
11015807|NCT00772954|12193463|FG000|COMPLETED|Overall Study||12
11015808|NCT00772954|12193464|FG001|COMPLETED|Overall Study||12
11015809|NCT00772954|12193465|FG002|COMPLETED|Overall Study||11
11015810|NCT00772954|12193463|FG000|NOT COMPLETED|Overall Study||0
11015811|NCT00772954|12193464|FG001|NOT COMPLETED|Overall Study||0
11015812|NCT00772954|12193465|FG002|NOT COMPLETED|Overall Study||1
11015813|NCT00772967|12193473|FG000|STARTED|Crossover Treatment 1||3
11015814|NCT00772967|12193474|FG001|STARTED|Crossover Treatment 1||5
11015815|NCT00772967|12193475|FG002|STARTED|Crossover Treatment 1||3
11015816|NCT00772967|12193476|FG003|STARTED|Crossover Treatment 1||4
11015817|NCT00772967|12193477|FG004|STARTED|Crossover Treatment 1||4
11015818|NCT00772967|12193478|FG005|STARTED|Crossover Treatment 1||3
11015819|NCT00772967|12193473|FG000|COMPLETED|Crossover Treatment 1||3
11015820|NCT00772967|12193474|FG001|COMPLETED|Crossover Treatment 1||5
11015821|NCT00772967|12193475|FG002|COMPLETED|Crossover Treatment 1||3
11015822|NCT00772967|12193476|FG003|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
11015823|NCT00772967|12193477|FG004|COMPLETED|Crossover Treatment 1||4
11015824|NCT00772967|12193478|FG005|COMPLETED|Crossover Treatment 1||3
11015825|NCT00772967|12193473|FG000|NOT COMPLETED|Crossover Treatment 1||0
11015826|NCT00772967|12193474|FG001|NOT COMPLETED|Crossover Treatment 1||0
11015827|NCT00772967|12193475|FG002|NOT COMPLETED|Crossover Treatment 1||0
11015828|NCT00772967|12193476|FG003|NOT COMPLETED|Crossover Treatment 1||1
11015829|NCT00772967|12193477|FG004|NOT COMPLETED|Crossover Treatment 1||0
11015830|NCT00772967|12193478|FG005|NOT COMPLETED|Crossover Treatment 1||0
11015831|NCT00772967|12193473|FG000|STARTED|Break 1 (4-7 Days)||3
11015832|NCT00772967|12193474|FG001|STARTED|Break 1 (4-7 Days)||5
11015833|NCT00772967|12193475|FG002|STARTED|Break 1 (4-7 Days)||3
11015834|NCT00772967|12193476|FG003|STARTED|Break 1 (4-7 Days)||3
11015835|NCT00772967|12193477|FG004|STARTED|Break 1 (4-7 Days)||4
11015836|NCT00772967|12193478|FG005|STARTED|Break 1 (4-7 Days)||3
11015837|NCT00772967|12193473|FG000|COMPLETED|Break 1 (4-7 Days)||3
11015838|NCT00772967|12193474|FG001|COMPLETED|Break 1 (4-7 Days)||4
11015839|NCT00772967|12193475|FG002|COMPLETED|Break 1 (4-7 Days)||3
11015840|NCT00772967|12193476|FG003|COMPLETED|Break 1 (4-7 Days)||3
11015841|NCT00772967|12193477|FG004|COMPLETED|Break 1 (4-7 Days)||4
11015842|NCT00772967|12193478|FG005|COMPLETED|Break 1 (4-7 Days)||3
11015843|NCT00772967|12193473|FG000|NOT COMPLETED|Break 1 (4-7 Days)||0
11015844|NCT00772967|12193474|FG001|NOT COMPLETED|Break 1 (4-7 Days)||1
11015845|NCT00772967|12193475|FG002|NOT COMPLETED|Break 1 (4-7 Days)||0
11015846|NCT00772967|12193476|FG003|NOT COMPLETED|Break 1 (4-7 Days)||0
11015847|NCT00772967|12193477|FG004|NOT COMPLETED|Break 1 (4-7 Days)||0
11015848|NCT00772967|12193478|FG005|NOT COMPLETED|Break 1 (4-7 Days)||0
11015849|NCT00772967|12193473|FG000|STARTED|Crossover Treatment 2||3
11015850|NCT00772967|12193474|FG001|STARTED|Crossover Treatment 2||4
11015851|NCT00772967|12193475|FG002|STARTED|Crossover Treatment 2||3
11015852|NCT00772967|12193476|FG003|STARTED|Crossover Treatment 2||3
11015853|NCT00772967|12193477|FG004|STARTED|Crossover Treatment 2||4
11015854|NCT00772967|12193478|FG005|STARTED|Crossover Treatment 2||3
11015855|NCT00772967|12193473|FG000|COMPLETED|Crossover Treatment 2||3
11015856|NCT00772967|12193474|FG001|COMPLETED|Crossover Treatment 2||4
11015857|NCT00772967|12193475|FG002|COMPLETED|Crossover Treatment 2||3
11015858|NCT00772967|12193476|FG003|COMPLETED|Crossover Treatment 2||3
11015859|NCT00772967|12193477|FG004|COMPLETED|Crossover Treatment 2||4
11015860|NCT00772967|12193478|FG005|COMPLETED|Crossover Treatment 2||3
11015861|NCT00772967|12193473|FG000|NOT COMPLETED|Crossover Treatment 2||0
11015862|NCT00772967|12193474|FG001|NOT COMPLETED|Crossover Treatment 2||0
11396442|NCT03746002|12590272|FG001|STARTED|Overall Study||2
11396443|NCT03746002|12590271|FG000|COMPLETED|Overall Study||1
11396444|NCT03746002|12590272|FG001|COMPLETED|Overall Study||2
11015863|NCT00772967|12193475|FG002|NOT COMPLETED|Crossover Treatment 2||0
11015864|NCT00772967|12193476|FG003|NOT COMPLETED|Crossover Treatment 2||0
11015865|NCT00772967|12193477|FG004|NOT COMPLETED|Crossover Treatment 2||0
11396445|NCT03746002|12590271|FG000|NOT COMPLETED|Overall Study||0
11015866|NCT00772967|12193478|FG005|NOT COMPLETED|Crossover Treatment 2||0
11015867|NCT00772967|12193473|FG000|STARTED|Break 2 (4-7 Days)||3
11015868|NCT00772967|12193474|FG001|STARTED|Break 2 (4-7 Days)||4
11015869|NCT00772967|12193475|FG002|STARTED|Break 2 (4-7 Days)||3
11015870|NCT00772967|12193476|FG003|STARTED|Break 2 (4-7 Days)||3
11015871|NCT00772967|12193477|FG004|STARTED|Break 2 (4-7 Days)||4
11015872|NCT00772967|12193478|FG005|STARTED|Break 2 (4-7 Days)||3
11015873|NCT00772967|12193473|FG000|COMPLETED|Break 2 (4-7 Days)||3
11015874|NCT00772967|12193474|FG001|COMPLETED|Break 2 (4-7 Days)||4
11396446|NCT03746002|12590272|FG001|NOT COMPLETED|Overall Study||0
11015875|NCT00772967|12193475|FG002|COMPLETED|Break 2 (4-7 Days)||3
11015876|NCT00772967|12193476|FG003|COMPLETED|Break 2 (4-7 Days)||3
11015877|NCT00772967|12193477|FG004|COMPLETED|Break 2 (4-7 Days)||4
11015878|NCT00772967|12193478|FG005|COMPLETED|Break 2 (4-7 Days)||3
11015879|NCT00772967|12193473|FG000|NOT COMPLETED|Break 2 (4-7 Days)||0
11015880|NCT00772967|12193474|FG001|NOT COMPLETED|Break 2 (4-7 Days)||0
11015881|NCT00772967|12193475|FG002|NOT COMPLETED|Break 2 (4-7 Days)||0
11015882|NCT00772967|12193476|FG003|NOT COMPLETED|Break 2 (4-7 Days)||0
11015883|NCT00772967|12193477|FG004|NOT COMPLETED|Break 2 (4-7 Days)||0
11015884|NCT00772967|12193478|FG005|NOT COMPLETED|Break 2 (4-7 Days)||0
11015885|NCT00772967|12193473|FG000|STARTED|Crossover Treatment 3||3
11015886|NCT00772967|12193474|FG001|STARTED|Crossover Treatment 3||4
11015887|NCT00772967|12193475|FG002|STARTED|Crossover Treatment 3||3
11015888|NCT00772967|12193476|FG003|STARTED|Crossover Treatment 3||3
11015889|NCT00772967|12193477|FG004|STARTED|Crossover Treatment 3||4
11015890|NCT00772967|12193478|FG005|STARTED|Crossover Treatment 3||3
11015891|NCT00772967|12193473|FG000|COMPLETED|Crossover Treatment 3||3
11015892|NCT00772967|12193474|FG001|COMPLETED|Crossover Treatment 3||4
11015893|NCT00772967|12193475|FG002|COMPLETED|Crossover Treatment 3||3
11015894|NCT00772967|12193476|FG003|COMPLETED|Crossover Treatment 3||3
11015895|NCT00772967|12193477|FG004|COMPLETED|Crossover Treatment 3||3
11015896|NCT00772967|12193478|FG005|COMPLETED|Crossover Treatment 3||3
11015897|NCT00772967|12193473|FG000|NOT COMPLETED|Crossover Treatment 3||0
11015898|NCT00772967|12193474|FG001|NOT COMPLETED|Crossover Treatment 3||0
11015899|NCT00772967|12193475|FG002|NOT COMPLETED|Crossover Treatment 3||0
11015900|NCT00772967|12193476|FG003|NOT COMPLETED|Crossover Treatment 3||0
11015901|NCT00772967|12193477|FG004|NOT COMPLETED|Crossover Treatment 3||1
11015902|NCT00772967|12193478|FG005|NOT COMPLETED|Crossover Treatment 3||0
11015903|NCT00773097|12193486|FG000|STARTED|Overall Study||46
11015904|NCT00773097|12193486|FG000|COMPLETED|Overall Study||39
11015905|NCT00773097|12193486|FG000|NOT COMPLETED|Overall Study||7
11015906|NCT00773136|12193490|FG000|STARTED|Overall Study||21
11015907|NCT00773136|12193490|FG000|COMPLETED|Overall Study||19
11015908|NCT00773136|12193490|FG000|NOT COMPLETED|Overall Study||2
11015909|NCT00773175|12193497|FG000|STARTED|Overall Study||73
11015910|NCT00773175|12193498|FG001|STARTED|Overall Study||75
11015911|NCT00773175|12193497|FG000|Initial Fluids Via Randomized Route|Overall Study||73
11015912|NCT00773175|12193498|FG001|Initial Fluids Via Randomized Route|Overall Study||59
11015913|NCT00773175|12193497|FG000|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
11015914|NCT00773175|12193498|FG001|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
11015915|NCT00773175|12193497|FG000|No Fluids Received|Overall Study||0
11015916|NCT00773175|12193498|FG001|No Fluids Received|Overall Study||1
11015917|NCT00773175|12193497|FG000|COMPLETED|Overall Study||71
11015918|NCT00773175|12193498|FG001|COMPLETED|Overall Study||73
11015919|NCT00773175|12193497|FG000|NOT COMPLETED|Overall Study||2
11015920|NCT00773175|12193498|FG001|NOT COMPLETED|Overall Study||2
11015921|NCT00773253|12193511|FG000|STARTED|First Intervention (Week 0-24)||5
11015922|NCT00773253|12193512|FG001|STARTED|First Intervention (Week 0-24)||5
11015923|NCT00773253|12193511|FG000|COMPLETED|First Intervention (Week 0-24)||5
11015924|NCT00773253|12193512|FG001|COMPLETED|First Intervention (Week 0-24)||4
11015925|NCT00773253|12193511|FG000|NOT COMPLETED|First Intervention (Week 0-24)||0
11015926|NCT00773253|12193512|FG001|NOT COMPLETED|First Intervention (Week 0-24)||1
11015927|NCT00773253|12193511|FG000|STARTED|Second Intervention (Week 24-48)||5
11015928|NCT00773253|12193512|FG001|STARTED|Second Intervention (Week 24-48)||4
11015929|NCT00773253|12193511|FG000|COMPLETED|Second Intervention (Week 24-48)||5
11015930|NCT00773253|12193512|FG001|COMPLETED|Second Intervention (Week 24-48)||4
11015931|NCT00773253|12193511|FG000|NOT COMPLETED|Second Intervention (Week 24-48)||0
11015932|NCT00773253|12193512|FG001|NOT COMPLETED|Second Intervention (Week 24-48)||0
11015933|NCT00773279|12193520|FG000|STARTED|Period 1||121
11015934|NCT00773279|12193521|FG001|STARTED|Period 1||121
11015935|NCT00773279|12193520|FG000|COMPLETED|Period 1||114
11015936|NCT00773279|12193521|FG001|COMPLETED|Period 1||117
11015937|NCT00773279|12193520|FG000|NOT COMPLETED|Period 1||7
11015938|NCT00773279|12193521|FG001|NOT COMPLETED|Period 1||4
11015939|NCT00773279|12193520|FG000|STARTED|Period 2||114
11015940|NCT00773279|12193521|FG001|STARTED|Period 2||117
11015941|NCT00773279|12193520|FG000|COMPLETED|Period 2||111
11015942|NCT00773279|12193521|FG001|COMPLETED|Period 2||111
11015943|NCT00773279|12193520|FG000|NOT COMPLETED|Period 2||3
11015944|NCT00773279|12193521|FG001|NOT COMPLETED|Period 2||6
11015945|NCT00773292|12193528|FG000|STARTED|Pre-treatment 4 Weeks||7
11015946|NCT00773292|12193528|FG000|COMPLETED|Pre-treatment 4 Weeks||7
11015947|NCT00773292|12193528|FG000|NOT COMPLETED|Pre-treatment 4 Weeks||0
11015948|NCT00773292|12193528|FG000|STARTED|Treatment 48 Weeks||7
11015949|NCT00773292|12193528|FG000|COMPLETED|Treatment 48 Weeks|Two patients discontinued the treatment but remained on the study|5
11015950|NCT00773292|12193528|FG000|NOT COMPLETED|Treatment 48 Weeks||2
11015951|NCT00773292|12193528|FG000|STARTED|Post Treatment 24 Weeks||7
11015952|NCT00773292|12193528|FG000|COMPLETED|Post Treatment 24 Weeks||7
11015953|NCT00773292|12193528|FG000|NOT COMPLETED|Post Treatment 24 Weeks||0
11015954|NCT00773370|12193534|FG000|STARTED|Overall Study||43
11015955|NCT00773370|12193535|FG001|STARTED|Overall Study||33
11015956|NCT00773370|12193534|FG000|COMPLETED|Overall Study||25
11015957|NCT00773370|12193535|FG001|COMPLETED|Overall Study||23
11015958|NCT00773370|12193534|FG000|NOT COMPLETED|Overall Study||18
11015959|NCT00773370|12193535|FG001|NOT COMPLETED|Overall Study||10
11015960|NCT00773383|12193541|FG000|STARTED|Overall Study||35
11015961|NCT00773383|12193541|FG000|Received Study Drug|Overall Study||34
11015962|NCT00773383|12193541|FG000|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
11015963|NCT00773383|12193541|FG000|NOT COMPLETED|Overall Study||31
11015964|NCT00773422|12193552|FG000|STARTED|Overall Study||11
11015965|NCT00773422|12193553|FG001|STARTED|Overall Study||9
11015966|NCT00773422|12193554|FG002|STARTED|Overall Study||10
11015967|NCT00773422|12193552|FG000|COMPLETED|Overall Study||11
11015968|NCT00773422|12193553|FG001|COMPLETED|Overall Study||9
11015969|NCT00773422|12193554|FG002|COMPLETED|Overall Study||10
11015970|NCT00773422|12193552|FG000|NOT COMPLETED|Overall Study||0
11015971|NCT00773422|12193553|FG001|NOT COMPLETED|Overall Study||0
11015972|NCT00773422|12193554|FG002|NOT COMPLETED|Overall Study||0
11015973|NCT00773461|12193564|FG000|STARTED|Overall Study||70
11015974|NCT00773461|12193565|FG001|STARTED|Overall Study||139
11015975|NCT00773461|12193564|FG000|COMPLETED|Overall Study||65
11015976|NCT00773461|12193565|FG001|COMPLETED|Overall Study||135
11015977|NCT00773461|12193564|FG000|NOT COMPLETED|Overall Study||5
11015978|NCT00773461|12193565|FG001|NOT COMPLETED|Overall Study||4
11015979|NCT00773474|12193572|FG000|STARTED|Overall Study||29
11015980|NCT00773474|12193572|FG000|COMPLETED|Overall Study||29
11015981|NCT00773474|12193572|FG000|NOT COMPLETED|Overall Study||0
11015982|NCT00773513|12193578|FG000|STARTED|Overall Study||1413
11015983|NCT00773513|12193579|FG001|STARTED|Overall Study||1412
11015984|NCT00773513|12193578|FG000|Received Study Treatment|Overall Study||1409
11015985|NCT00773513|12193579|FG001|Received Study Treatment|Overall Study||1409
11015986|NCT00773513|12193578|FG000|COMPLETED|Overall Study||312
11015987|NCT00773513|12193579|FG001|COMPLETED|Overall Study||303
11015988|NCT00773513|12193578|FG000|NOT COMPLETED|Overall Study||1101
11015989|NCT00773513|12193579|FG001|NOT COMPLETED|Overall Study||1109
11015990|NCT00773604|12193585|FG000|STARTED|Overall Study||9
11015991|NCT00773604|12193585|FG000|COMPLETED|Overall Study||9
11015992|NCT00773604|12193585|FG000|NOT COMPLETED|Overall Study||0
11015993|NCT00773734|12193593|FG000|STARTED|Core: Placebo Controlled Phase Week 0-16||88
11015994|NCT00773734|12193594|FG001|STARTED|Core: Placebo Controlled Phase Week 0-16||89
11015995|NCT00773734|12193595|FG002|STARTED|Core: Placebo Controlled Phase Week 0-16||87
11015996|NCT00773734|12193596|FG003|STARTED|Core: Placebo Controlled Phase Week 0-16||88
11015997|NCT00773734|12193597|FG004|STARTED|Core: Placebo Controlled Phase Week 0-16||0
11015998|NCT00773734|12193598|FG005|STARTED|Core: Placebo Controlled Phase Week 0-16||0
11015999|NCT00773734|12193593|FG000|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
11016000|NCT00773734|12193594|FG001|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
11016001|NCT00773734|12193595|FG002|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
11016002|NCT00773734|12193596|FG003|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
11016003|NCT00773734|12193597|FG004|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
11016004|NCT00773734|12193598|FG005|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
11016005|NCT00773734|12193593|FG000|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
11016006|NCT00773734|12193594|FG001|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
11016007|NCT00773734|12193595|FG002|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
11016008|NCT00773734|12193596|FG003|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
11016009|NCT00773734|12193597|FG004|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
11016010|NCT00773734|12193598|FG005|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
11056821|NCT00995930|12238424|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||92
11016011|NCT00773734|12193593|FG000|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
11016012|NCT00773734|12193594|FG001|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
11016013|NCT00773734|12193595|FG002|STARTED|Core: Active Treatment Phase Week 16-24||66
11016014|NCT00773734|12193596|FG003|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
11016015|NCT00773734|12193597|FG004|STARTED|Core: Active Treatment Phase Week 16-24||34
11016016|NCT00773734|12193598|FG005|STARTED|Core: Active Treatment Phase Week 16-24||36
11016017|NCT00773734|12193593|FG000|COMPLETED|Core: Active Treatment Phase Week 16-24||0
11016018|NCT00773734|12193594|FG001|COMPLETED|Core: Active Treatment Phase Week 16-24||65
11016019|NCT00773734|12193595|FG002|COMPLETED|Core: Active Treatment Phase Week 16-24||59
11016020|NCT00773734|12193596|FG003|COMPLETED|Core: Active Treatment Phase Week 16-24||65
11016021|NCT00773734|12193597|FG004|COMPLETED|Core: Active Treatment Phase Week 16-24||33
11016022|NCT00773734|12193598|FG005|COMPLETED|Core: Active Treatment Phase Week 16-24||31
11016023|NCT00773734|12193593|FG000|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
11016024|NCT00773734|12193594|FG001|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
11016025|NCT00773734|12193595|FG002|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
11396447|NCT03748771|12590278|FG000|STARTED|Overall Study||20
11396448|NCT03748771|12590278|FG000|COMPLETED|Overall Study||20
11016026|NCT00773734|12193596|FG003|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
11016027|NCT00773734|12193597|FG004|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
11016028|NCT00773734|12193598|FG005|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
11016029|NCT00773734|12193593|FG000|STARTED|Extension: Active Treatment Week 24-52||0
11016030|NCT00773734|12193594|FG001|STARTED|Extension: Active Treatment Week 24-52||47
11016031|NCT00773734|12193595|FG002|STARTED|Extension: Active Treatment Week 24-52||50
11396449|NCT03748771|12590278|FG000|NOT COMPLETED|Overall Study||0
11396450|NCT03752177|12590286|FG000|STARTED|Overall Study||3
11396451|NCT03752177|12590287|FG001|STARTED|Overall Study||3
11396452|NCT03752177|12590288|FG002|STARTED|Overall Study||3
11396453|NCT03752177|12590289|FG003|STARTED|Overall Study||3
11016032|NCT00773734|12193596|FG003|STARTED|Extension: Active Treatment Week 24-52||58
11016033|NCT00773734|12193597|FG004|STARTED|Extension: Active Treatment Week 24-52||27
11016034|NCT00773734|12193598|FG005|STARTED|Extension: Active Treatment Week 24-52||27
11016035|NCT00773734|12193593|FG000|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
11016036|NCT00773734|12193594|FG001|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
11016037|NCT00773734|12193595|FG002|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
11016038|NCT00773734|12193596|FG003|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
11016039|NCT00773734|12193597|FG004|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
11016040|NCT00773734|12193598|FG005|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
11016041|NCT00773734|12193593|FG000|COMPLETED|Extension: Active Treatment Week 24-52||0
11016042|NCT00773734|12193594|FG001|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
11016043|NCT00773734|12193595|FG002|COMPLETED|Extension: Active Treatment Week 24-52||33
11016044|NCT00773734|12193596|FG003|COMPLETED|Extension: Active Treatment Week 24-52||48
11016045|NCT00773734|12193597|FG004|COMPLETED|Extension: Active Treatment Week 24-52||22
11016046|NCT00773734|12193598|FG005|COMPLETED|Extension: Active Treatment Week 24-52||19
11016047|NCT00773734|12193593|FG000|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
11016048|NCT00773734|12193594|FG001|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
11016049|NCT00773734|12193595|FG002|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
11016050|NCT00773734|12193596|FG003|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
11016051|NCT00773734|12193597|FG004|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
11016052|NCT00773734|12193598|FG005|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
11016053|NCT00773734|12193593|FG000|STARTED|LTE Period: Week 52 to 6 Years||0
11016054|NCT00773734|12193594|FG001|STARTED|LTE Period: Week 52 to 6 Years||0
11016055|NCT00773734|12193595|FG002|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
11016056|NCT00773734|12193596|FG003|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
11016057|NCT00773734|12193597|FG004|STARTED|LTE Period: Week 52 to 6 Years||0
11016058|NCT00773734|12193598|FG005|STARTED|LTE Period: Week 52 to 6 Years||0
11016059|NCT00773734|12193593|FG000|COMPLETED|LTE Period: Week 52 to 6 Years||0
11016060|NCT00773734|12193594|FG001|COMPLETED|LTE Period: Week 52 to 6 Years||0
11016061|NCT00773734|12193595|FG002|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
11016062|NCT00773734|12193596|FG003|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
11016063|NCT00773734|12193597|FG004|COMPLETED|LTE Period: Week 52 to 6 Years||0
11016064|NCT00773734|12193598|FG005|COMPLETED|LTE Period: Week 52 to 6 Years||0
11016065|NCT00773734|12193593|FG000|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
11016066|NCT00773734|12193594|FG001|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
11016067|NCT00773734|12193595|FG002|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
11016068|NCT00773734|12193596|FG003|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
11016069|NCT00773734|12193597|FG004|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
11016070|NCT00773734|12193598|FG005|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
11016071|NCT00773747|12193657|FG000|STARTED|Overall Study||317
11016072|NCT00773747|12193658|FG001|STARTED|Overall Study||320
11016073|NCT00773747|12193657|FG000|Treated|Overall Study||315
11016074|NCT00773747|12193658|FG001|Treated|Overall Study||320
11016075|NCT00773747|12193657|FG000|COMPLETED|Overall Study||20
11016076|NCT00773747|12193658|FG001|COMPLETED|Overall Study||24
11016077|NCT00773747|12193657|FG000|NOT COMPLETED|Overall Study||297
11016078|NCT00773747|12193658|FG001|NOT COMPLETED|Overall Study||296
11016079|NCT00773786|12193664|FG000|STARTED|First Intervention (1 Week)||10
11016080|NCT00773786|12193665|FG001|STARTED|First Intervention (1 Week)||10
11396454|NCT03752177|12590286|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11016081|NCT00773786|12193664|FG000|COMPLETED|First Intervention (1 Week)||10
11016082|NCT00773786|12193665|FG001|COMPLETED|First Intervention (1 Week)||10
11016083|NCT00773786|12193664|FG000|NOT COMPLETED|First Intervention (1 Week)||0
11016084|NCT00773786|12193665|FG001|NOT COMPLETED|First Intervention (1 Week)||0
11016085|NCT00773786|12193664|FG000|STARTED|Washout (1 Week)||10
11016086|NCT00773786|12193665|FG001|STARTED|Washout (1 Week)||10
11016087|NCT00773786|12193664|FG000|COMPLETED|Washout (1 Week)||10
11016088|NCT00773786|12193665|FG001|COMPLETED|Washout (1 Week)||10
11016089|NCT00773786|12193664|FG000|NOT COMPLETED|Washout (1 Week)||0
11016090|NCT00773786|12193665|FG001|NOT COMPLETED|Washout (1 Week)||0
11016091|NCT00773786|12193664|FG000|STARTED|Second Intervention (1 Week)||10
11016092|NCT00773786|12193665|FG001|STARTED|Second Intervention (1 Week)||10
11016093|NCT00773786|12193664|FG000|COMPLETED|Second Intervention (1 Week)||10
11016094|NCT00773786|12193665|FG001|COMPLETED|Second Intervention (1 Week)||10
11016095|NCT00773786|12193664|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
11016096|NCT00773786|12193665|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
11016097|NCT00773838|12193672|FG000|STARTED|Overall Study||143
11016098|NCT00773838|12193672|FG000|COMPLETED|Overall Study||0
11016099|NCT00773838|12193672|FG000|NOT COMPLETED|Overall Study||143
11396455|NCT03752177|12590287|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
11016100|NCT00773955|12193676|FG000|STARTED|Overall Study||15
11016101|NCT00773955|12193676|FG000|COMPLETED|Overall Study||15
11016102|NCT00773955|12193676|FG000|NOT COMPLETED|Overall Study||0
11016103|NCT00773968|12193680|FG000|STARTED|Overall Study||140
11016104|NCT00773968|12193680|FG000|Treated|Overall Study||111
11016105|NCT00773968|12193680|FG000|COMPLETED|Overall Study||95
11016106|NCT00773968|12193680|FG000|NOT COMPLETED|Overall Study||45
11016107|NCT00774046|12193684|FG000|STARTED|Screening||116
11016108|NCT00774046|12193684|FG000|COMPLETED|Screening||60
11016109|NCT00774046|12193684|FG000|NOT COMPLETED|Screening||56
11016110|NCT00774046|12193684|FG000|STARTED|Enrollment||60
11016111|NCT00774046|12193684|FG000|COMPLETED|Enrollment||32
11016112|NCT00774046|12193684|FG000|NOT COMPLETED|Enrollment||28
11016113|NCT00774046|12193684|FG000|STARTED|Induction Therapy||32
11016114|NCT00774046|12193684|FG000|COMPLETED|Induction Therapy||32
11016115|NCT00774046|12193684|FG000|NOT COMPLETED|Induction Therapy||0
11016116|NCT00774046|12193684|FG000|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
11016117|NCT00774046|12193684|FG000|COMPLETED|Stem Cell Mobilization||7
11016118|NCT00774046|12193684|FG000|NOT COMPLETED|Stem Cell Mobilization||3
11016119|NCT00774046|12193684|FG000|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
11016120|NCT00774046|12193684|FG000|COMPLETED|Autologous Transplant||4
11016121|NCT00774046|12193684|FG000|NOT COMPLETED|Autologous Transplant||0
11016122|NCT00774163|12193690|FG000|STARTED|Overall Study||30
11016123|NCT00774163|12193691|FG001|STARTED|Overall Study||15
11016124|NCT00774163|12193690|FG000|COMPLETED|Overall Study||30
11016125|NCT00774163|12193691|FG001|COMPLETED|Overall Study||15
11016126|NCT00774163|12193690|FG000|NOT COMPLETED|Overall Study||0
11016127|NCT00774163|12193691|FG001|NOT COMPLETED|Overall Study||0
11016128|NCT00774202|12193699|FG000|STARTED|Overall Study||9
11016129|NCT00774202|12193700|FG001|STARTED|Overall Study||8
11016130|NCT00774202|12193699|FG000|COMPLETED|Overall Study||9
11016131|NCT00774202|12193700|FG001|COMPLETED|Overall Study||8
11016132|NCT00774202|12193699|FG000|NOT COMPLETED|Overall Study||0
11016133|NCT00774202|12193700|FG001|NOT COMPLETED|Overall Study||0
11016134|NCT00774267|12193714|FG000|STARTED|Overall Study||132
11016135|NCT00774267|12193715|FG001|STARTED|Overall Study||111
11016136|NCT00774267|12193716|FG002|STARTED|Overall Study||129
11016137|NCT00774267|12193717|FG003|STARTED|Overall Study||135
11016138|NCT00774267|12193714|FG000|COMPLETED|Overall Study||132
11016139|NCT00774267|12193715|FG001|COMPLETED|Overall Study||111
11016140|NCT00774267|12193716|FG002|COMPLETED|Overall Study||129
11016141|NCT00774267|12193717|FG003|COMPLETED|Overall Study||135
11016142|NCT00774267|12193714|FG000|NOT COMPLETED|Overall Study||0
11016143|NCT00774267|12193715|FG001|NOT COMPLETED|Overall Study||0
11016144|NCT00774267|12193716|FG002|NOT COMPLETED|Overall Study||0
11016145|NCT00774267|12193717|FG003|NOT COMPLETED|Overall Study||0
11016146|NCT00774397|12193734|FG000|STARTED|Overall Study||71
11016147|NCT00774397|12193735|FG001|STARTED|Overall Study||69
11016148|NCT00774397|12193736|FG002|STARTED|Overall Study||143
11016149|NCT00774397|12193737|FG003|STARTED|Overall Study||146
11016150|NCT00774397|12193738|FG004|STARTED|Overall Study||143
11016151|NCT00774397|12193739|FG005|STARTED|Overall Study||76
11016152|NCT00774397|12193740|FG006|STARTED|Overall Study||71
11016153|NCT00774397|12193734|FG000|COMPLETED|Overall Study||57
11016154|NCT00774397|12193735|FG001|COMPLETED|Overall Study||56
11016155|NCT00774397|12193736|FG002|COMPLETED|Overall Study||113
11016156|NCT00774397|12193737|FG003|COMPLETED|Overall Study||129
11016157|NCT00774397|12193738|FG004|COMPLETED|Overall Study||97
11016158|NCT00774397|12193739|FG005|COMPLETED|Overall Study||54
11016159|NCT00774397|12193740|FG006|COMPLETED|Overall Study||41
11016160|NCT00774397|12193734|FG000|NOT COMPLETED|Overall Study||14
11016161|NCT00774397|12193735|FG001|NOT COMPLETED|Overall Study||13
11016162|NCT00774397|12193736|FG002|NOT COMPLETED|Overall Study||30
11016163|NCT00774397|12193737|FG003|NOT COMPLETED|Overall Study||17
11016164|NCT00774397|12193738|FG004|NOT COMPLETED|Overall Study||46
11016165|NCT00774397|12193739|FG005|NOT COMPLETED|Overall Study||22
11016166|NCT00774397|12193740|FG006|NOT COMPLETED|Overall Study||30
11016167|NCT00774566|12193765|FG000|STARTED|Overall Study||159
11016168|NCT00774566|12193766|FG001|STARTED|Overall Study||156
11016169|NCT00774566|12193765|FG000|6 Month Follow up|Overall Study||154
11016170|NCT00774566|12193766|FG001|6 Month Follow up|Overall Study||150
11016171|NCT00774566|12193765|FG000|12 Month Follow up|Overall Study||141
11016172|NCT00774566|12193766|FG001|12 Month Follow up|Overall Study||141
11016173|NCT00774566|12193765|FG000|COMPLETED|Overall Study||141
11016174|NCT00774566|12193766|FG001|COMPLETED|Overall Study||141
11016175|NCT00774566|12193765|FG000|NOT COMPLETED|Overall Study||18
11016176|NCT00774566|12193766|FG001|NOT COMPLETED|Overall Study||15
11016177|NCT00774579|12193774|FG000|STARTED|Overall Study||9
11016178|NCT00774579|12193775|FG001|STARTED|Overall Study||9
11016179|NCT00774579|12193774|FG000|COMPLETED|Overall Study||9
11016180|NCT00774579|12193775|FG001|COMPLETED|Overall Study||9
11016181|NCT00774579|12193774|FG000|NOT COMPLETED|Overall Study||0
11016182|NCT00774579|12193775|FG001|NOT COMPLETED|Overall Study||0
11016183|NCT00774748|12193781|FG000|STARTED|Overall Study||21
11016184|NCT00774748|12193781|FG000|COMPLETED|Overall Study||18
11016185|NCT00774748|12193781|FG000|NOT COMPLETED|Overall Study||3
11016186|NCT00774787|12193789|FG000|STARTED|Overall Study||27
11016187|NCT00774787|12193789|FG000|COMPLETED|Overall Study||26
11016188|NCT00774787|12193789|FG000|NOT COMPLETED|Overall Study||1
11016189|NCT00774800|12193793|FG000|STARTED|Intervention 1||22
11016190|NCT00774800|12193793|FG000|Received at Least One Dose of Study Drug|Intervention 1||22
11016191|NCT00774800|12193793|FG000|COMPLETED|Intervention 1||22
11016192|NCT00774800|12193793|FG000|NOT COMPLETED|Intervention 1||0
11016193|NCT00774800|12193793|FG000|STARTED|Washout (3 to 10 Days)||22
11016194|NCT00774800|12193793|FG000|COMPLETED|Washout (3 to 10 Days)||22
11016195|NCT00774800|12193793|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
11016196|NCT00774800|12193793|FG000|STARTED|Intervention 2||22
11016197|NCT00774800|12193793|FG000|Received at Least One Dose of Study Drug|Intervention 2||22
11016198|NCT00774800|12193793|FG000|COMPLETED|Intervention 2||22
11016199|NCT00774800|12193793|FG000|NOT COMPLETED|Intervention 2||0
11016200|NCT00774800|12193793|FG000|STARTED|Washout (3 to 10 Days)||22
11016201|NCT00774800|12193793|FG000|COMPLETED|Washout (3 to 10 Days)||22
11016202|NCT00774800|12193793|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
11016203|NCT00774800|12193793|FG000|STARTED|Intervention 3||22
11016204|NCT00774800|12193793|FG000|Received at Least One Dose of Study Drug|Intervention 3||22
11016205|NCT00774800|12193793|FG000|COMPLETED|Intervention 3||22
11016206|NCT00774800|12193793|FG000|NOT COMPLETED|Intervention 3||0
11016207|NCT00774800|12193793|FG000|STARTED|Washout (3 to 10 Days)||22
11016208|NCT00774800|12193793|FG000|COMPLETED|Washout (3 to 10 Days)||22
11016209|NCT00774800|12193793|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
11016210|NCT00774800|12193793|FG000|STARTED|Intervention 4||22
11016211|NCT00774800|12193793|FG000|Received at Least One Dose of Study Drug|Intervention 4||21
11016212|NCT00774800|12193793|FG000|COMPLETED|Intervention 4||21
11016213|NCT00774800|12193793|FG000|NOT COMPLETED|Intervention 4||1
11016214|NCT00774852|12193805|FG000|STARTED|Overall Study||69
11016215|NCT00774852|12193806|FG001|STARTED|Overall Study||68
11016216|NCT00774852|12193805|FG000|COMPLETED|Overall Study||24
11016217|NCT00774852|12193806|FG001|COMPLETED|Overall Study||27
11016218|NCT00774852|12193805|FG000|NOT COMPLETED|Overall Study||45
11016219|NCT00774852|12193806|FG001|NOT COMPLETED|Overall Study||41
11016220|NCT00774930|12193824|FG000|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
11016221|NCT00774930|12193825|FG001|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
11016222|NCT00774930|12193824|FG000|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
11016223|NCT00774930|12193825|FG001|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
11016224|NCT00774930|12193824|FG000|NOT COMPLETED|DB Phase||14
11016225|NCT00774930|12193825|FG001|NOT COMPLETED|DB Phase||22
11016226|NCT00774930|12193824|FG000|STARTED|IOL Phase||56
11016227|NCT00774930|12193825|FG001|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
11016228|NCT00774930|12193824|FG000|COMPLETED|IOL Phase||43
11016229|NCT00774930|12193825|FG001|COMPLETED|IOL Phase||37
11016230|NCT00774930|12193824|FG000|NOT COMPLETED|IOL Phase||13
11016231|NCT00774930|12193825|FG001|NOT COMPLETED|IOL Phase||9
11016232|NCT00774930|12193824|FG000|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
11016233|NCT00774930|12193825|FG001|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
11016234|NCT00774930|12193824|FG000|COMPLETED|LTOLE Phase||17
11016235|NCT00774930|12193825|FG001|COMPLETED|LTOLE Phase||8
11016236|NCT00774930|12193824|FG000|NOT COMPLETED|LTOLE Phase||15
11016237|NCT00774930|12193825|FG001|NOT COMPLETED|LTOLE Phase||17
11016238|NCT00774995|12193837|FG000|STARTED|Overall Study||9
11016239|NCT00774995|12193838|FG001|STARTED|Overall Study||16
11016240|NCT00774995|12193839|FG002|STARTED|Overall Study||8
11016241|NCT00774995|12193840|FG003|STARTED|Overall Study||16
11016242|NCT00774995|12193837|FG000|COMPLETED|Overall Study||9
11016243|NCT00774995|12193838|FG001|COMPLETED|Overall Study||16
11016244|NCT00774995|12193839|FG002|COMPLETED|Overall Study||7
11016245|NCT00774995|12193840|FG003|COMPLETED|Overall Study||16
11016246|NCT00774995|12193837|FG000|NOT COMPLETED|Overall Study||0
11016247|NCT00774995|12193838|FG001|NOT COMPLETED|Overall Study||0
11016248|NCT00774995|12193839|FG002|NOT COMPLETED|Overall Study||1
11016249|NCT00774995|12193840|FG003|NOT COMPLETED|Overall Study||0
11016250|NCT00775021|12193850|FG000|STARTED|First Intervention||63
11016251|NCT00775021|12193851|FG001|STARTED|First Intervention||60
11016252|NCT00775021|12193850|FG000|COMPLETED|First Intervention||62
11016253|NCT00775021|12193851|FG001|COMPLETED|First Intervention||60
11016254|NCT00775021|12193850|FG000|NOT COMPLETED|First Intervention||1
11016255|NCT00775021|12193851|FG001|NOT COMPLETED|First Intervention||0
11016256|NCT00775021|12193850|FG000|STARTED|Second Intervention||62
11016257|NCT00775021|12193851|FG001|STARTED|Second Intervention||60
11016258|NCT00775021|12193850|FG000|COMPLETED|Second Intervention||62
11016259|NCT00775021|12193851|FG001|COMPLETED|Second Intervention||59
11016260|NCT00775021|12193850|FG000|NOT COMPLETED|Second Intervention||0
11016261|NCT00775021|12193851|FG001|NOT COMPLETED|Second Intervention||1
11016262|NCT00775138|12193861|FG000|STARTED|Overall Study||24
11016263|NCT00775138|12193862|FG001|STARTED|Overall Study||10
11016264|NCT00775138|12193863|FG002|STARTED|Overall Study||20
11016265|NCT00775138|12193864|FG003|STARTED|Overall Study||10
11016266|NCT00775138|12193861|FG000|COMPLETED|Overall Study||24
11016267|NCT00775138|12193862|FG001|COMPLETED|Overall Study||10
11016268|NCT00775138|12193863|FG002|COMPLETED|Overall Study||17
11016269|NCT00775138|12193864|FG003|COMPLETED|Overall Study||8
11016270|NCT00775138|12193861|FG000|NOT COMPLETED|Overall Study||0
11016271|NCT00775138|12193862|FG001|NOT COMPLETED|Overall Study||0
11016272|NCT00775138|12193863|FG002|NOT COMPLETED|Overall Study||3
11016273|NCT00775138|12193864|FG003|NOT COMPLETED|Overall Study||2
11016274|NCT00775203|12193878|FG000|STARTED|Overall Study||206
11016275|NCT00775203|12193879|FG001|STARTED|Overall Study||206
11016276|NCT00775203|12193878|FG000|Received Study Medication|Overall Study||202
11016277|NCT00775203|12193879|FG001|Received Study Medication|Overall Study||204
11016278|NCT00775203|12193878|FG000|COMPLETED|Overall Study||144
11016279|NCT00775203|12193879|FG001|COMPLETED|Overall Study||163
11016280|NCT00775203|12193878|FG000|NOT COMPLETED|Overall Study||62
11016281|NCT00775203|12193879|FG001|NOT COMPLETED|Overall Study||43
11016282|NCT00775229|12193887|FG000|STARTED|Overall Study||25
11016283|NCT00775229|12193888|FG001|STARTED|Overall Study||26
11016284|NCT00775229|12193887|FG000|COMPLETED|Overall Study||20
11016285|NCT00775229|12193888|FG001|COMPLETED|Overall Study||24
11016286|NCT00775229|12193887|FG000|NOT COMPLETED|Overall Study||5
11016287|NCT00775229|12193888|FG001|NOT COMPLETED|Overall Study||2
11016288|NCT00775268|12193896|FG000|STARTED|Baseline||9
11016289|NCT00775268|12193897|FG001|STARTED|Baseline||22
11016290|NCT00775268|12193896|FG000|COMPLETED|Baseline||8
11016291|NCT00775268|12193897|FG001|COMPLETED|Baseline||21
11016292|NCT00775268|12193896|FG000|NOT COMPLETED|Baseline||1
11016293|NCT00775268|12193897|FG001|NOT COMPLETED|Baseline||1
11016294|NCT00775268|12193896|FG000|STARTED|After 2 Cycles||8
11016295|NCT00775268|12193897|FG001|STARTED|After 2 Cycles|These 21 patients were not scanned after 2-cycles in this Arm. They were only scanned at baseline.|0
11016296|NCT00775268|12193896|FG000|COMPLETED|After 2 Cycles||7
11016297|NCT00775268|12193897|FG001|COMPLETED|After 2 Cycles||0
11016298|NCT00775268|12193896|FG000|NOT COMPLETED|After 2 Cycles||1
11016299|NCT00775268|12193897|FG001|NOT COMPLETED|After 2 Cycles||0
11016300|NCT00775268|12193896|FG000|STARTED|After Completion||7
11016301|NCT00775268|12193897|FG001|STARTED|After Completion||0
11016302|NCT00775268|12193896|FG000|COMPLETED|After Completion||6
11016303|NCT00775268|12193897|FG001|COMPLETED|After Completion||0
11016304|NCT00775268|12193896|FG000|NOT COMPLETED|After Completion||1
11016305|NCT00775268|12193897|FG001|NOT COMPLETED|After Completion||0
11016306|NCT00775346|12193914|FG000|STARTED|Overall Study||92
11016307|NCT00775346|12193914|FG000|COMPLETED|Overall Study||92
11016308|NCT00775346|12193914|FG000|NOT COMPLETED|Overall Study||0
11016309|NCT00775411|12193918|FG000|STARTED|Overall Study||44
11016310|NCT00775411|12193918|FG000|COMPLETED|Overall Study||43
11016311|NCT00775411|12193918|FG000|NOT COMPLETED|Overall Study||1
11016312|NCT00775437|12193922|FG000|STARTED|Overall Study||32
11016313|NCT00775437|12193922|FG000|COMPLETED|Overall Study||26
11016314|NCT00775437|12193922|FG000|NOT COMPLETED|Overall Study||6
11016315|NCT00775450|12193931|FG000|STARTED|Overall Study||295
11016316|NCT00775450|12193932|FG001|STARTED|Overall Study||98
11016317|NCT00775450|12193933|FG002|STARTED|Overall Study||105
11016318|NCT00775450|12193934|FG003|STARTED|Overall Study||108
11016319|NCT00775450|12193935|FG004|STARTED|Overall Study||201
11016320|NCT00775450|12193931|FG000|COMPLETED|Overall Study||292
11016321|NCT00775450|12193932|FG001|COMPLETED|Overall Study||98
11016322|NCT00775450|12193933|FG002|COMPLETED|Overall Study||105
11016323|NCT00775450|12193934|FG003|COMPLETED|Overall Study||108
11016324|NCT00775450|12193935|FG004|COMPLETED|Overall Study||199
11016325|NCT00775450|12193931|FG000|NOT COMPLETED|Overall Study||3
11016326|NCT00775450|12193932|FG001|NOT COMPLETED|Overall Study||0
11016327|NCT00775450|12193933|FG002|NOT COMPLETED|Overall Study||0
11016328|NCT00775450|12193934|FG003|NOT COMPLETED|Overall Study||0
11016329|NCT00775450|12193935|FG004|NOT COMPLETED|Overall Study||2
11016330|NCT00775463|12193949|FG000|STARTED|Overall Study||76
11016331|NCT00775463|12193950|FG001|STARTED|Overall Study||72
11016332|NCT00775463|12193949|FG000|COMPLETED|Overall Study||65
11016333|NCT00775463|12193950|FG001|COMPLETED|Overall Study||59
11016334|NCT00775463|12193949|FG000|NOT COMPLETED|Overall Study||11
11016335|NCT00775463|12193950|FG001|NOT COMPLETED|Overall Study||13
11016336|NCT00775528|12193963|FG000|STARTED|Overall Study|Started means number of patients who consented|19
11016337|NCT00775528|12193963|FG000|COMPLETED|Overall Study||18
11016338|NCT00775528|12193963|FG000|NOT COMPLETED|Overall Study||1
11016339|NCT00775593|12193967|FG000|STARTED|Overall Study||60
11016340|NCT00775593|12193967|FG000|COMPLETED|Overall Study||53
11016341|NCT00775593|12193967|FG000|NOT COMPLETED|Overall Study||7
11016342|NCT00775606|12193973|FG000|STARTED|Overall Study||8
11016343|NCT00775606|12193974|FG001|STARTED|Overall Study||5
11016344|NCT00775606|12193973|FG000|COMPLETED|Overall Study||5
11016345|NCT00775606|12193974|FG001|COMPLETED|Overall Study||5
11016346|NCT00775606|12193973|FG000|NOT COMPLETED|Overall Study||3
11016347|NCT00775606|12193974|FG001|NOT COMPLETED|Overall Study||0
11016348|NCT00775645|12193984|FG000|STARTED|Overall Study||208
11016349|NCT00775645|12193985|FG001|STARTED|Overall Study||201
11016350|NCT00775645|12193984|FG000|COMPLETED|Overall Study||191
11016351|NCT00775645|12193985|FG001|COMPLETED|Overall Study||181
11016352|NCT00775645|12193984|FG000|NOT COMPLETED|Overall Study||17
11016353|NCT00775645|12193985|FG001|NOT COMPLETED|Overall Study||20
11016354|NCT00775658|12193991|FG000|STARTED|First Intervention||10
11016355|NCT00775658|12193992|FG001|STARTED|First Intervention||11
11016356|NCT00775658|12193991|FG000|COMPLETED|First Intervention||10
11016357|NCT00775658|12193992|FG001|COMPLETED|First Intervention||11
11016358|NCT00775658|12193991|FG000|NOT COMPLETED|First Intervention||0
11016359|NCT00775658|12193992|FG001|NOT COMPLETED|First Intervention||0
11016360|NCT00775658|12193991|FG000|STARTED|Second Intervention||10
11016361|NCT00775658|12193992|FG001|STARTED|Second Intervention||11
11016362|NCT00775658|12193991|FG000|COMPLETED|Second Intervention||10
11016363|NCT00775658|12193992|FG001|COMPLETED|Second Intervention||11
11016364|NCT00775658|12193991|FG000|NOT COMPLETED|Second Intervention||0
11016365|NCT00775658|12193992|FG001|NOT COMPLETED|Second Intervention||0
11016366|NCT00775671|12194000|FG000|STARTED|Overall Study||23
11016367|NCT00775671|12194001|FG001|STARTED|Overall Study||23
11016368|NCT00775671|12194000|FG000|COMPLETED|Overall Study||23
11016369|NCT00775671|12194001|FG001|COMPLETED|Overall Study||23
11016370|NCT00775671|12194000|FG000|NOT COMPLETED|Overall Study||0
11016371|NCT00775671|12194001|FG001|NOT COMPLETED|Overall Study||0
11016372|NCT00775931|12194009|FG000|STARTED|Overall Study||6
11016373|NCT00775931|12194010|FG001|STARTED|Overall Study||1
11016374|NCT00775931|12194009|FG000|COMPLETED|Overall Study||6
11016375|NCT00775931|12194010|FG001|COMPLETED|Overall Study||1
11016376|NCT00775931|12194009|FG000|NOT COMPLETED|Overall Study||0
11016377|NCT00775931|12194010|FG001|NOT COMPLETED|Overall Study||0
11016378|NCT00775944|12194020|FG000|STARTED|Overall Study||648
11016379|NCT00775944|12194021|FG001|STARTED|Overall Study||647
11016380|NCT00775944|12194022|FG002|STARTED|Overall Study||648
11016381|NCT00775944|12194023|FG003|STARTED|Overall Study||648
11016382|NCT00775944|12194020|FG000|COMPLETED|Overall Study|15 participants withdrew consent|633
11016383|NCT00775944|12194021|FG001|COMPLETED|Overall Study|9 participants withdrew consent|638
11016384|NCT00775944|12194022|FG002|COMPLETED|Overall Study|16 participants withdrew consent|632
11016385|NCT00775944|12194023|FG003|COMPLETED|Overall Study|16 participants withdrew consent|632
11016386|NCT00775944|12194020|FG000|NOT COMPLETED|Overall Study||15
11016387|NCT00775944|12194021|FG001|NOT COMPLETED|Overall Study||9
11016388|NCT00775944|12194022|FG002|NOT COMPLETED|Overall Study||16
11016389|NCT00775944|12194023|FG003|NOT COMPLETED|Overall Study||16
11016390|NCT00775983|12194035|FG000|STARTED|Overall Study||36
11016391|NCT00775983|12194036|FG001|STARTED|Overall Study||36
11016392|NCT00775983|12194035|FG000|COMPLETED|Overall Study||35
11016393|NCT00775983|12194036|FG001|COMPLETED|Overall Study||34
11016394|NCT00775983|12194035|FG000|NOT COMPLETED|Overall Study||1
11016395|NCT00775983|12194036|FG001|NOT COMPLETED|Overall Study||2
11016396|NCT00776009|12194048|FG000|STARTED|Period 1: First Intervention||26
11016397|NCT00776009|12194049|FG001|STARTED|Period 1: First Intervention||28
11016398|NCT00776009|12194050|FG002|STARTED|Period 1: First Intervention||29
11016399|NCT00776009|12194051|FG003|STARTED|Period 1: First Intervention||27
11016400|NCT00776009|12194052|FG004|STARTED|Period 1: First Intervention||28
11016401|NCT00776009|12194053|FG005|STARTED|Period 1: First Intervention||27
11016402|NCT00776009|12194048|FG000|COMPLETED|Period 1: First Intervention||26
11016403|NCT00776009|12194049|FG001|COMPLETED|Period 1: First Intervention||27
11016404|NCT00776009|12194050|FG002|COMPLETED|Period 1: First Intervention||28
11016405|NCT00776009|12194051|FG003|COMPLETED|Period 1: First Intervention||27
11016406|NCT00776009|12194052|FG004|COMPLETED|Period 1: First Intervention||26
11016407|NCT00776009|12194053|FG005|COMPLETED|Period 1: First Intervention||27
11016408|NCT00776009|12194048|FG000|NOT COMPLETED|Period 1: First Intervention||0
11016409|NCT00776009|12194049|FG001|NOT COMPLETED|Period 1: First Intervention||1
11016410|NCT00776009|12194050|FG002|NOT COMPLETED|Period 1: First Intervention||1
11016411|NCT00776009|12194051|FG003|NOT COMPLETED|Period 1: First Intervention||0
11016412|NCT00776009|12194052|FG004|NOT COMPLETED|Period 1: First Intervention||2
11016413|NCT00776009|12194053|FG005|NOT COMPLETED|Period 1: First Intervention||0
11016414|NCT00776009|12194048|FG000|STARTED|Period 2: Second Intervention||26
11016415|NCT00776009|12194049|FG001|STARTED|Period 2: Second Intervention||27
11016416|NCT00776009|12194050|FG002|STARTED|Period 2: Second Intervention||28
11016417|NCT00776009|12194051|FG003|STARTED|Period 2: Second Intervention||27
11016418|NCT00776009|12194052|FG004|STARTED|Period 2: Second Intervention||26
11016419|NCT00776009|12194053|FG005|STARTED|Period 2: Second Intervention||27
11016420|NCT00776009|12194048|FG000|COMPLETED|Period 2: Second Intervention||25
11016421|NCT00776009|12194049|FG001|COMPLETED|Period 2: Second Intervention||27
11016422|NCT00776009|12194050|FG002|COMPLETED|Period 2: Second Intervention||27
11016423|NCT00776009|12194051|FG003|COMPLETED|Period 2: Second Intervention||27
11016424|NCT00776009|12194052|FG004|COMPLETED|Period 2: Second Intervention||26
11016425|NCT00776009|12194053|FG005|COMPLETED|Period 2: Second Intervention||26
11016426|NCT00776009|12194048|FG000|NOT COMPLETED|Period 2: Second Intervention||1
11016427|NCT00776009|12194049|FG001|NOT COMPLETED|Period 2: Second Intervention||0
11016428|NCT00776009|12194050|FG002|NOT COMPLETED|Period 2: Second Intervention||1
11016429|NCT00776009|12194051|FG003|NOT COMPLETED|Period 2: Second Intervention||0
11016430|NCT00776009|12194052|FG004|NOT COMPLETED|Period 2: Second Intervention||0
11016431|NCT00776009|12194053|FG005|NOT COMPLETED|Period 2: Second Intervention||1
11016432|NCT00776009|12194048|FG000|STARTED|Period 3: Third Intervention||25
11016433|NCT00776009|12194049|FG001|STARTED|Period 3: Third Intervention||27
11016434|NCT00776009|12194050|FG002|STARTED|Period 3: Third Intervention||27
11016435|NCT00776009|12194051|FG003|STARTED|Period 3: Third Intervention||27
11016436|NCT00776009|12194052|FG004|STARTED|Period 3: Third Intervention||26
11016437|NCT00776009|12194053|FG005|STARTED|Period 3: Third Intervention||26
11016438|NCT00776009|12194048|FG000|COMPLETED|Period 3: Third Intervention||24
11016439|NCT00776009|12194049|FG001|COMPLETED|Period 3: Third Intervention||27
11016440|NCT00776009|12194050|FG002|COMPLETED|Period 3: Third Intervention||27
11016441|NCT00776009|12194051|FG003|COMPLETED|Period 3: Third Intervention||27
11016442|NCT00776009|12194052|FG004|COMPLETED|Period 3: Third Intervention||26
11016443|NCT00776009|12194053|FG005|COMPLETED|Period 3: Third Intervention||26
11016444|NCT00776009|12194048|FG000|NOT COMPLETED|Period 3: Third Intervention||1
11016445|NCT00776009|12194049|FG001|NOT COMPLETED|Period 3: Third Intervention||0
11016446|NCT00776009|12194050|FG002|NOT COMPLETED|Period 3: Third Intervention||0
11016447|NCT00776009|12194051|FG003|NOT COMPLETED|Period 3: Third Intervention||0
11016448|NCT00776009|12194052|FG004|NOT COMPLETED|Period 3: Third Intervention||0
11016449|NCT00776009|12194053|FG005|NOT COMPLETED|Period 3: Third Intervention||0
11016450|NCT00776230|12194064|FG000|STARTED|Overall Study||99
11016451|NCT00776230|12194065|FG001|STARTED|Overall Study||103
11016452|NCT00776230|12194066|FG002|STARTED|Overall Study||102
11016453|NCT00776230|12194064|FG000|Enrolled and Vaccinated at Day 0|Overall Study||98
11016454|NCT00776230|12194065|FG001|Enrolled and Vaccinated at Day 0|Overall Study||103
11016455|NCT00776230|12194066|FG002|Enrolled and Vaccinated at Day 0|Overall Study||102
11016456|NCT00776230|12194064|FG000|COMPLETED|Overall Study||96
11016457|NCT00776230|12194065|FG001|COMPLETED|Overall Study||100
11016458|NCT00776230|12194066|FG002|COMPLETED|Overall Study||97
11016459|NCT00776230|12194064|FG000|NOT COMPLETED|Overall Study||3
11016460|NCT00776230|12194065|FG001|NOT COMPLETED|Overall Study||3
11016461|NCT00776230|12194066|FG002|NOT COMPLETED|Overall Study||5
11016462|NCT00776295|12194074|FG000|STARTED|Overall Study||2
11016463|NCT00776295|12194074|FG000|COMPLETED|Overall Study||2
11016464|NCT00776295|12194074|FG000|NOT COMPLETED|Overall Study||0
11016465|NCT00776594|12194080|FG000|STARTED|Overall Study||66
11016466|NCT00776594|12194081|FG001|STARTED|Overall Study||36
11016467|NCT00776594|12194080|FG000|COMPLETED|Overall Study||62
11016468|NCT00776594|12194081|FG001|COMPLETED|Overall Study||34
11016469|NCT00776594|12194080|FG000|NOT COMPLETED|Overall Study||4
11016470|NCT00776594|12194081|FG001|NOT COMPLETED|Overall Study||2
11016471|NCT00776659|12194089|FG000|STARTED|Overall Study||39
11016472|NCT00776659|12194089|FG000|COMPLETED|Overall Study||13
11016473|NCT00776659|12194089|FG000|NOT COMPLETED|Overall Study||26
11016474|NCT00776789|12194095|FG000|STARTED|Overall Study||20
11016475|NCT00776789|12194096|FG001|STARTED|Overall Study||21
11016476|NCT00776789|12194095|FG000|COMPLETED|Overall Study||17
11016477|NCT00776789|12194096|FG001|COMPLETED|Overall Study||18
11016478|NCT00776789|12194095|FG000|NOT COMPLETED|Overall Study||3
11263746|NCT02271984|12459063|FG002|COMPLETED|Washout Period 4 (7 Days)||3
11263747|NCT02271984|12459064|FG003|COMPLETED|Washout Period 4 (7 Days)||3
11263748|NCT02271984|12459065|FG004|COMPLETED|Washout Period 4 (7 Days)||3
11143108|NCT01471782|12329917|FG002|COMPLETED|Overall Study|Completed 5 cycles|0
11143109|NCT01471782|12329918|FG003|COMPLETED|Overall Study|Completed 5 cycles|1
11143110|NCT01471782|12329919|FG004|COMPLETED|Overall Study|Completed 5 cycles|0
11143111|NCT01471782|12329920|FG005|COMPLETED|Overall Study|Completed 5 cycles|3
11143112|NCT01471782|12329915|FG000|NOT COMPLETED|Overall Study||5
11143113|NCT01471782|12329916|FG001|NOT COMPLETED|Overall Study||6
11143114|NCT01471782|12329917|FG002|NOT COMPLETED|Overall Study||5
11143115|NCT01471782|12329918|FG003|NOT COMPLETED|Overall Study||5
11143116|NCT01471782|12329919|FG004|NOT COMPLETED|Overall Study||26
11143117|NCT01471782|12329920|FG005|NOT COMPLETED|Overall Study||41
11143118|NCT01472185|12329947|FG000|STARTED|Overall Study||232
11143119|NCT01472185|12329948|FG001|STARTED|Overall Study||233
11143120|NCT01472185|12329947|FG000|COMPLETED|Overall Study||198
11016479|NCT00776789|12194096|FG001|NOT COMPLETED|Overall Study||3
11056822|NCT00995930|12238423|FG000|Imaging Analysis Set|Overall Study||92
11056823|NCT00995930|12238424|FG001|Imaging Analysis Set|Overall Study||92
11056824|NCT00995930|12238423|FG000|COMPLETED|Overall Study||73
11056825|NCT00995930|12238424|FG001|COMPLETED|Overall Study||67
11056826|NCT00995930|12238423|FG000|NOT COMPLETED|Overall Study||21
11056827|NCT00995930|12238424|FG001|NOT COMPLETED|Overall Study||28
11056828|NCT00996034|12238431|FG000|STARTED|Overall Study||14
11056829|NCT00996034|12238431|FG000|COMPLETED|Overall Study||11
11056830|NCT00996034|12238431|FG000|NOT COMPLETED|Overall Study||3
11056831|NCT00996125|12238437|FG000|STARTED|Overall Study||374
11143121|NCT01472185|12329948|FG001|COMPLETED|Overall Study||199
11143122|NCT01472185|12329947|FG000|NOT COMPLETED|Overall Study||34
11143123|NCT01472185|12329948|FG001|NOT COMPLETED|Overall Study||34
11143124|NCT01472289|12329954|FG000|STARTED|Overall Study||17
11143125|NCT01472289|12329954|FG000|COMPLETED|Overall Study||15
11143126|NCT01472289|12329954|FG000|NOT COMPLETED|Overall Study||2
11143127|NCT01472341|12329958|FG000|STARTED|Overall Study||507
11143128|NCT01472341|12329958|FG000|COMPLETED|Overall Study||235
11143129|NCT01472341|12329958|FG000|NOT COMPLETED|Overall Study||272
11143130|NCT01472380|12329962|FG000|STARTED|Efavirenz Alone||30
11143131|NCT01472380|12329962|FG000|COMPLETED|Efavirenz Alone||29
11143132|NCT01472380|12329962|FG000|NOT COMPLETED|Efavirenz Alone||1
11143133|NCT01472380|12329962|FG000|STARTED|Fenofibric Acid (FFA) Alone||29
11143134|NCT01472380|12329962|FG000|COMPLETED|Fenofibric Acid (FFA) Alone||29
11143135|NCT01472380|12329962|FG000|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
11263749|NCT02271984|12459066|FG005|COMPLETED|Washout Period 4 (7 Days)||2
11396456|NCT03752177|12590288|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
11016480|NCT00776919|12194108|FG000|STARTED|Overall Study||327
11016481|NCT00776919|12194109|FG001|STARTED|Overall Study||328
11016482|NCT00776919|12194110|FG002|STARTED|Overall Study||328
11016483|NCT00776919|12194111|FG003|STARTED|Overall Study||332
11016484|NCT00776919|12194108|FG000|COMPLETED|Overall Study||300
11016485|NCT00776919|12194109|FG001|COMPLETED|Overall Study||295
11016486|NCT00776919|12194110|FG002|COMPLETED|Overall Study||296
11016487|NCT00776919|12194111|FG003|COMPLETED|Overall Study||293
11016488|NCT00776919|12194108|FG000|NOT COMPLETED|Overall Study||27
11016489|NCT00776919|12194109|FG001|NOT COMPLETED|Overall Study||33
11016490|NCT00776919|12194110|FG002|NOT COMPLETED|Overall Study||32
11016491|NCT00776919|12194111|FG003|NOT COMPLETED|Overall Study||39
11016492|NCT00776984|12194123|FG000|STARTED|Overall Study||234
11016493|NCT00776984|12194124|FG001|STARTED|Overall Study||219
11016494|NCT00776984|12194123|FG000|COMPLETED|Overall Study||203
11016495|NCT00776984|12194124|FG001|COMPLETED|Overall Study||198
11016496|NCT00776984|12194123|FG000|NOT COMPLETED|Overall Study||31
11016497|NCT00776984|12194124|FG001|NOT COMPLETED|Overall Study||21
11016498|NCT00776997|12194130|FG000|STARTED|Overall Study||100
11016499|NCT00776997|12194130|FG000|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
11016500|NCT00776997|12194130|FG000|NOT COMPLETED|Overall Study||2
11016501|NCT00777023|12194137|FG000|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
11016502|NCT00777023|12194138|FG001|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
11016503|NCT00777023|12194139|FG002|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
11016504|NCT00777023|12194137|FG000|COMPLETED|Overall Study||151
11016505|NCT00777023|12194138|FG001|COMPLETED|Overall Study||149
11016506|NCT00777023|12194139|FG002|COMPLETED|Overall Study||146
11016507|NCT00777023|12194137|FG000|NOT COMPLETED|Overall Study||35
11016508|NCT00777023|12194138|FG001|NOT COMPLETED|Overall Study||41
11016509|NCT00777023|12194139|FG002|NOT COMPLETED|Overall Study||37
11016510|NCT00777049|12194149|FG000|STARTED|Overall Study||33
11016511|NCT00777049|12194150|FG001|STARTED|Overall Study||21
11016512|NCT00777049|12194149|FG000|COMPLETED|Overall Study||32
11016513|NCT00777049|12194150|FG001|COMPLETED|Overall Study||20
11143136|NCT01472380|12329962|FG000|STARTED|1 Day Period Between Dosing||29
11143137|NCT01472380|12329962|FG000|COMPLETED|1 Day Period Between Dosing||28
11143138|NCT01472380|12329962|FG000|NOT COMPLETED|1 Day Period Between Dosing||1
11143139|NCT01472380|12329962|FG000|STARTED|Efavirenz and FFA||28
11143140|NCT01472380|12329962|FG000|COMPLETED|Efavirenz and FFA||28
11143141|NCT01472380|12329962|FG000|NOT COMPLETED|Efavirenz and FFA||0
11016514|NCT00777049|12194149|FG000|NOT COMPLETED|Overall Study||1
11016515|NCT00777049|12194150|FG001|NOT COMPLETED|Overall Study||1
11016516|NCT00777062|12194158|FG000|STARTED|Overall Study||39
11016517|NCT00777062|12194159|FG001|STARTED|Overall Study||41
11016518|NCT00777062|12194158|FG000|COMPLETED|Overall Study||36
11016519|NCT00777062|12194159|FG001|COMPLETED|Overall Study||36
11016520|NCT00777062|12194158|FG000|NOT COMPLETED|Overall Study||3
11016521|NCT00777062|12194159|FG001|NOT COMPLETED|Overall Study||5
11016522|NCT00777088|12194165|FG000|STARTED|Overall Study||108
11016523|NCT00777088|12194165|FG000|COMPLETED|Overall Study||107
11016524|NCT00777088|12194165|FG000|NOT COMPLETED|Overall Study||1
11016525|NCT00777101|12194172|FG000|STARTED|Overall Study||117
11016526|NCT00777101|12194173|FG001|STARTED|Overall Study||116
11016527|NCT00777101|12194172|FG000|Treated|Overall Study||116
11016528|NCT00777101|12194173|FG001|Treated|Overall Study||115
11016529|NCT00777101|12194172|FG000|COMPLETED|Overall Study||55
11143142|NCT01472432|12329971|FG000|STARTED|Overall Study||53
11016530|NCT00777101|12194173|FG001|COMPLETED|Overall Study||65
11016531|NCT00777101|12194172|FG000|NOT COMPLETED|Overall Study||62
11016532|NCT00777101|12194173|FG001|NOT COMPLETED|Overall Study||51
11016533|NCT00777153|12194183|FG000|STARTED|Overall Study||131
11016534|NCT00777153|12194184|FG001|STARTED|Overall Study||129
11016535|NCT00777153|12194185|FG002|STARTED|Overall Study||65
11016536|NCT00777153|12194183|FG000|COMPLETED|Overall Study||41
11016537|NCT00777153|12194184|FG001|COMPLETED|Overall Study||46
11016538|NCT00777153|12194185|FG002|COMPLETED|Overall Study||28
11016539|NCT00777153|12194183|FG000|NOT COMPLETED|Overall Study||90
11016540|NCT00777153|12194184|FG001|NOT COMPLETED|Overall Study||83
11143143|NCT01472432|12329972|FG001|STARTED|Overall Study||53
11143144|NCT01472432|12329971|FG000|Ulcer Reduction|Overall Study||13
11143145|NCT01472432|12329972|FG001|Ulcer Reduction|Overall Study||33
11143146|NCT01472432|12329971|FG000|COMPLETED|Overall Study||53
11016541|NCT00777153|12194185|FG002|NOT COMPLETED|Overall Study||37
11016542|NCT00777179|12194199|FG000|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
11016543|NCT00777179|12194200|FG001|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
11016544|NCT00777179|12194199|FG000|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
11016545|NCT00777179|12194200|FG001|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
11016546|NCT00777179|12194199|FG000|NOT COMPLETED|Overall Study||0
11143147|NCT01472432|12329972|FG001|COMPLETED|Overall Study||53
11143148|NCT01472432|12329971|FG000|NOT COMPLETED|Overall Study||0
11143149|NCT01472432|12329972|FG001|NOT COMPLETED|Overall Study||0
11143150|NCT01472445|12329982|FG000|STARTED|Overall Study||25
11143151|NCT01472445|12329983|FG001|STARTED|Overall Study||16
11143152|NCT01472445|12329982|FG000|COMPLETED|Overall Study||25
11143153|NCT01472445|12329983|FG001|COMPLETED|Overall Study||16
11143154|NCT01472445|12329982|FG000|NOT COMPLETED|Overall Study||0
11143155|NCT01472445|12329983|FG001|NOT COMPLETED|Overall Study||0
11143156|NCT01472549|12329993|FG000|STARTED|Overall Study||572
11143157|NCT01472549|12329994|FG001|STARTED|Overall Study||575
11143158|NCT01472549|12329993|FG000|COMPLETED|Overall Study||572
11143159|NCT01472549|12329994|FG001|COMPLETED|Overall Study||575
11143160|NCT01472549|12329993|FG000|NOT COMPLETED|Overall Study||0
11143161|NCT01472549|12329994|FG001|NOT COMPLETED|Overall Study||0
11143162|NCT01472718|12330002|FG000|STARTED|Overall Study||104
11143163|NCT01472718|12330003|FG001|STARTED|Overall Study||104
11143164|NCT01472718|12330002|FG000|COMPLETED|Overall Study||98
11143165|NCT01472718|12330003|FG001|COMPLETED|Overall Study||97
11016547|NCT00777179|12194200|FG001|NOT COMPLETED|Overall Study||0
11016548|NCT00777205|12194208|FG000|STARTED|Overall Study||243
11016549|NCT00777205|12194209|FG001|STARTED|Overall Study||200
11016550|NCT00777205|12194208|FG000|Intervention Interruption|Overall Study||0
11016551|NCT00777205|12194209|FG001|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
11016552|NCT00777205|12194208|FG000|COMPLETED|Overall Study||212
11016553|NCT00777205|12194209|FG001|COMPLETED|Overall Study||129
11016554|NCT00777205|12194208|FG000|NOT COMPLETED|Overall Study||31
11016555|NCT00777205|12194209|FG001|NOT COMPLETED|Overall Study||71
11016556|NCT00777257|12194220|FG000|STARTED|Overall Study||444
11016557|NCT00777257|12194221|FG001|STARTED|Overall Study||450
11016558|NCT00777257|12194222|FG002|STARTED|Overall Study||451
11016559|NCT00777257|12194220|FG000|COMPLETED|Overall Study||433
11016560|NCT00777257|12194221|FG001|COMPLETED|Overall Study||438
11016561|NCT00777257|12194222|FG002|COMPLETED|Overall Study||442
11016562|NCT00777257|12194220|FG000|NOT COMPLETED|Overall Study||11
11016563|NCT00777257|12194221|FG001|NOT COMPLETED|Overall Study||12
11016564|NCT00777257|12194222|FG002|NOT COMPLETED|Overall Study||9
11016565|NCT00777296|12194234|FG000|STARTED|Overall Study||21
11016566|NCT00777296|12194235|FG001|STARTED|Overall Study||11
11016567|NCT00777296|12194236|FG002|STARTED|Overall Study||23
11016568|NCT00777296|12194237|FG003|STARTED|Overall Study||11
11016569|NCT00777296|12194234|FG000|COMPLETED|Overall Study||20
11016570|NCT00777296|12194235|FG001|COMPLETED|Overall Study||10
11016571|NCT00777296|12194236|FG002|COMPLETED|Overall Study||21
11016572|NCT00777296|12194237|FG003|COMPLETED|Overall Study||10
11016573|NCT00777296|12194234|FG000|NOT COMPLETED|Overall Study||1
11016574|NCT00777296|12194235|FG001|NOT COMPLETED|Overall Study||1
11016575|NCT00777296|12194236|FG002|NOT COMPLETED|Overall Study||2
11016576|NCT00777296|12194237|FG003|NOT COMPLETED|Overall Study||1
11016577|NCT00777335|12194261|FG000|STARTED|Overall Study||2
11016578|NCT00777335|12194262|FG001|STARTED|Overall Study||2
11016579|NCT00777335|12194261|FG000|COMPLETED|Overall Study||2
11016580|NCT00777335|12194262|FG001|COMPLETED|Overall Study||2
11016581|NCT00777335|12194261|FG000|NOT COMPLETED|Overall Study||0
11016582|NCT00777335|12194262|FG001|NOT COMPLETED|Overall Study||0
11016583|NCT00777556|12194268|FG000|STARTED|Overall Study|Enrolled; signed informed consent|343
11396457|NCT03752177|12590289|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
11396458|NCT03752177|12590286|FG000|COMPLETED|Overall Study||3
11396459|NCT03752177|12590287|FG001|COMPLETED|Overall Study||3
11396460|NCT03752177|12590288|FG002|COMPLETED|Overall Study||3
11396461|NCT03752177|12590289|FG003|COMPLETED|Overall Study||3
11396462|NCT03752177|12590286|FG000|NOT COMPLETED|Overall Study||0
11016584|NCT00777556|12194268|FG000|Dispensed Product|Overall Study||307
11016585|NCT00777556|12194268|FG000|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
11016586|NCT00777556|12194268|FG000|Used Product|Overall Study||297
11016587|NCT00777556|12194268|FG000|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
11016588|NCT00777556|12194268|FG000|NOT COMPLETED|Overall Study||66
11016589|NCT00777608|12194274|FG000|STARTED|Overall Study||53
11016590|NCT00777608|12194275|FG001|STARTED|Overall Study||53
11016591|NCT00777608|12194274|FG000|COMPLETED|Overall Study||49
11016592|NCT00777608|12194275|FG001|COMPLETED|Overall Study||47
11016593|NCT00777608|12194274|FG000|NOT COMPLETED|Overall Study||4
11016594|NCT00777608|12194275|FG001|NOT COMPLETED|Overall Study||6
11016595|NCT00777634|12194283|FG000|STARTED|Overall Study||134
11016596|NCT00777634|12194284|FG001|STARTED|Overall Study||134
11016597|NCT00777634|12194283|FG000|COMPLETED|Overall Study||129
11016598|NCT00777634|12194284|FG001|COMPLETED|Overall Study||133
11016599|NCT00777634|12194283|FG000|NOT COMPLETED|Overall Study||5
11016600|NCT00777634|12194284|FG001|NOT COMPLETED|Overall Study||1
11143166|NCT01472718|12330002|FG000|NOT COMPLETED|Overall Study||6
11396463|NCT03752177|12590287|FG001|NOT COMPLETED|Overall Study||0
11016601|NCT00777764|12194292|FG000|STARTED|Overall Study||30
11396464|NCT03752177|12590288|FG002|NOT COMPLETED|Overall Study||0
11396465|NCT03752177|12590289|FG003|NOT COMPLETED|Overall Study||0
11396466|NCT03753763|12590302|FG000|STARTED|Overall Study||32
11396467|NCT03753763|12590303|FG001|STARTED|Overall Study||17
11396468|NCT03753763|12590302|FG000|COMPLETED|Overall Study||26
11396469|NCT03753763|12590303|FG001|COMPLETED|Overall Study||16
11396470|NCT03753763|12590302|FG000|NOT COMPLETED|Overall Study||6
11396471|NCT03753763|12590303|FG001|NOT COMPLETED|Overall Study||1
11396472|NCT03756571|12590311|FG000|STARTED|Overall Study||10
11396473|NCT03756571|12590312|FG001|STARTED|Overall Study||11
11396474|NCT03756571|12590311|FG000|COMPLETED|Overall Study||9
11396475|NCT03756571|12590312|FG001|COMPLETED|Overall Study||10
11396476|NCT03756571|12590311|FG000|NOT COMPLETED|Overall Study||1
11396477|NCT03756571|12590312|FG001|NOT COMPLETED|Overall Study||1
11396478|NCT03761537|12590320|FG000|STARTED|Overall Study||140
11396479|NCT03761537|12590321|FG001|STARTED|Overall Study||137
11396480|NCT03761537|12590320|FG000|COMPLETED|Overall Study||125
11396481|NCT03761537|12590321|FG001|COMPLETED|Overall Study||120
11396482|NCT03761537|12590320|FG000|NOT COMPLETED|Overall Study||15
11396483|NCT03761537|12590321|FG001|NOT COMPLETED|Overall Study||17
11396484|NCT03763877|12590339|FG000|STARTED|Overall Study||31
11396485|NCT03763877|12590340|FG001|STARTED|Overall Study||30
11016602|NCT00777764|12194293|FG001|STARTED|Overall Study||30
11016603|NCT00777764|12194292|FG000|COMPLETED|Overall Study||30
11016604|NCT00777764|12194293|FG001|COMPLETED|Overall Study||29
11016605|NCT00777764|12194292|FG000|NOT COMPLETED|Overall Study||0
11016606|NCT00777764|12194293|FG001|NOT COMPLETED|Overall Study||1
11016607|NCT00777790|12194304|FG000|STARTED|Overall Study||76
11016608|NCT00777790|12194305|FG001|STARTED|Overall Study||77
11016609|NCT00777790|12194306|FG002|STARTED|Overall Study||88
11016610|NCT00777790|12194304|FG000|COMPLETED|Overall Study||76
11016611|NCT00777790|12194305|FG001|COMPLETED|Overall Study||77
11016612|NCT00777790|12194306|FG002|COMPLETED|Overall Study||88
11016613|NCT00777790|12194304|FG000|NOT COMPLETED|Overall Study||0
11016614|NCT00777790|12194305|FG001|NOT COMPLETED|Overall Study||0
11016615|NCT00777790|12194306|FG002|NOT COMPLETED|Overall Study||0
11016616|NCT00777803|12194316|FG000|STARTED|Overall Study||284
11016617|NCT00777803|12194317|FG001|STARTED|Overall Study||97
11016618|NCT00777803|12194316|FG000|COMPLETED|Overall Study||269
11016619|NCT00777803|12194317|FG001|COMPLETED|Overall Study||90
11016620|NCT00777803|12194316|FG000|NOT COMPLETED|Overall Study||15
11016621|NCT00777803|12194317|FG001|NOT COMPLETED|Overall Study||7
11016622|NCT00777829|12194323|FG000|STARTED|Overall Study||15
11016623|NCT00777829|12194324|FG001|STARTED|Overall Study||15
11016624|NCT00777829|12194323|FG000|Study Orientation|Overall Study||15
11016625|NCT00777829|12194324|FG001|Study Orientation|Overall Study||13
11016626|NCT00777829|12194323|FG000|COMPLETED|Overall Study||15
11016627|NCT00777829|12194324|FG001|COMPLETED|Overall Study||13
11016628|NCT00777829|12194323|FG000|NOT COMPLETED|Overall Study||0
11016629|NCT00777829|12194324|FG001|NOT COMPLETED|Overall Study||2
11016630|NCT00777855|12194332|FG000|STARTED|First Intervention||5
11016631|NCT00777855|12194333|FG001|STARTED|First Intervention||5
11016632|NCT00777855|12194332|FG000|COMPLETED|First Intervention||5
11016633|NCT00777855|12194333|FG001|COMPLETED|First Intervention||5
11016634|NCT00777855|12194332|FG000|NOT COMPLETED|First Intervention||0
11016635|NCT00777855|12194333|FG001|NOT COMPLETED|First Intervention||0
11016636|NCT00777855|12194332|FG000|STARTED|Washout Period (>= 14 Days)||5
11016637|NCT00777855|12194333|FG001|STARTED|Washout Period (>= 14 Days)||5
11016638|NCT00777855|12194332|FG000|COMPLETED|Washout Period (>= 14 Days)||5
11016639|NCT00777855|12194333|FG001|COMPLETED|Washout Period (>= 14 Days)||5
11143167|NCT01472718|12330003|FG001|NOT COMPLETED|Overall Study||7
11143168|NCT01472757|12330013|FG000|STARTED|Overall Study||91
11143169|NCT01472757|12330014|FG001|STARTED|Overall Study||93
11143170|NCT01472757|12330015|FG002|STARTED|Overall Study||95
11143171|NCT01472757|12330016|FG003|STARTED|Overall Study||94
11143172|NCT01472757|12330013|FG000|Full Analysis Set|Overall Study||91
11143173|NCT01472757|12330014|FG001|Full Analysis Set|Overall Study||93
11143174|NCT01472757|12330015|FG002|Full Analysis Set|Overall Study||92
11143175|NCT01472757|12330016|FG003|Full Analysis Set|Overall Study||92
11143176|NCT01472757|12330013|FG000|COMPLETED|Overall Study||61
11143177|NCT01472757|12330014|FG001|COMPLETED|Overall Study||80
11143178|NCT01472757|12330015|FG002|COMPLETED|Overall Study||76
11143179|NCT01472757|12330016|FG003|COMPLETED|Overall Study||75
11143180|NCT01472757|12330013|FG000|NOT COMPLETED|Overall Study||30
11143181|NCT01472757|12330014|FG001|NOT COMPLETED|Overall Study||13
11143182|NCT01472757|12330015|FG002|NOT COMPLETED|Overall Study||19
11143183|NCT01472757|12330016|FG003|NOT COMPLETED|Overall Study||19
11016640|NCT00777855|12194332|FG000|NOT COMPLETED|Washout Period (>= 14 Days)||0
11016641|NCT00777855|12194333|FG001|NOT COMPLETED|Washout Period (>= 14 Days)||0
11016642|NCT00777855|12194332|FG000|STARTED|Second Intervention||5
11016643|NCT00777855|12194333|FG001|STARTED|Second Intervention||5
11016644|NCT00777855|12194332|FG000|COMPLETED|Second Intervention||5
11016645|NCT00777855|12194333|FG001|COMPLETED|Second Intervention||5
11016646|NCT00777855|12194332|FG000|NOT COMPLETED|Second Intervention||0
11016647|NCT00777855|12194333|FG001|NOT COMPLETED|Second Intervention||0
11016648|NCT00777920|12194338|FG000|STARTED|Overall Study||140
11016649|NCT00777920|12194338|FG000|COMPLETED|Overall Study||90
11016650|NCT00777920|12194338|FG000|NOT COMPLETED|Overall Study||50
11396486|NCT03763877|12590341|FG002|STARTED|Overall Study||31
11396487|NCT03763877|12590342|FG003|STARTED|Overall Study||29
11143184|NCT01472822|12330028|FG000|STARTED|Overall Study||30
11143185|NCT01472822|12330029|FG001|STARTED|Overall Study||30
11143186|NCT01472822|12330028|FG000|COMPLETED|Overall Study||28
11143187|NCT01472822|12330029|FG001|COMPLETED|Overall Study||28
11143188|NCT01472822|12330028|FG000|NOT COMPLETED|Overall Study||2
11143189|NCT01472822|12330029|FG001|NOT COMPLETED|Overall Study||2
11143190|NCT01472835|12330037|FG000|STARTED|Overall Study||37
11143191|NCT01472835|12330038|FG001|STARTED|Overall Study||36
11143192|NCT01472835|12330037|FG000|COMPLETED|Overall Study||35
11143193|NCT01472835|12330038|FG001|COMPLETED|Overall Study||36
11143194|NCT01472835|12330037|FG000|NOT COMPLETED|Overall Study||2
11143195|NCT01472835|12330038|FG001|NOT COMPLETED|Overall Study||0
11143196|NCT01472874|12330047|FG000|STARTED|Overall Study||8
11143197|NCT01472874|12330047|FG000|COMPLETED|Overall Study||8
11143198|NCT01472874|12330047|FG000|NOT COMPLETED|Overall Study||0
11143199|NCT01472939|12330055|FG000|STARTED|Overall Study||123
11143200|NCT01472939|12330056|FG001|STARTED|Overall Study||119
11143201|NCT01472939|12330057|FG002|STARTED|Overall Study||119
11143202|NCT01472939|12330058|FG003|STARTED|Overall Study||119
11143203|NCT01472939|12330055|FG000|COMPLETED|Overall Study||103
11143204|NCT01472939|12330056|FG001|COMPLETED|Overall Study||105
11143205|NCT01472939|12330057|FG002|COMPLETED|Overall Study||108
11143206|NCT01472939|12330058|FG003|COMPLETED|Overall Study||99
11143207|NCT01472939|12330055|FG000|NOT COMPLETED|Overall Study||20
11143208|NCT01472939|12330056|FG001|NOT COMPLETED|Overall Study||14
11143209|NCT01472939|12330057|FG002|NOT COMPLETED|Overall Study||11
11143210|NCT01472939|12330058|FG003|NOT COMPLETED|Overall Study||20
11143211|NCT01472965|12330073|FG000|STARTED|Overall Study||49
11143212|NCT01472965|12330074|FG001|STARTED|Overall Study||46
11143213|NCT01472965|12330073|FG000|COMPLETED|Overall Study||48
11143214|NCT01472965|12330074|FG001|COMPLETED|Overall Study||46
11143215|NCT01472965|12330073|FG000|NOT COMPLETED|Overall Study||1
11143216|NCT01472965|12330074|FG001|NOT COMPLETED|Overall Study||0
11143217|NCT01473160|12330080|FG000|STARTED|Overall Study||9
11143218|NCT01473160|12330080|FG000|COMPLETED|Overall Study||9
11143219|NCT01473160|12330080|FG000|NOT COMPLETED|Overall Study||0
11143220|NCT01473355|12330086|FG000|STARTED|Overall Study||45
11143221|NCT01473355|12330086|FG000|COMPLETED|Overall Study||39
11143222|NCT01473355|12330086|FG000|NOT COMPLETED|Overall Study||6
11143223|NCT01473368|12330094|FG000|STARTED|Overall Study||14
11143224|NCT01473368|12330095|FG001|STARTED|Overall Study||12
11143225|NCT01473368|12330096|FG002|STARTED|Overall Study||15
11143226|NCT01473368|12330097|FG003|STARTED|Overall Study||12
11143227|NCT01473368|12330094|FG000|COMPLETED|Overall Study||13
11143228|NCT01473368|12330095|FG001|COMPLETED|Overall Study||12
11143229|NCT01473368|12330096|FG002|COMPLETED|Overall Study||12
11143230|NCT01473368|12330097|FG003|COMPLETED|Overall Study||12
11143231|NCT01473368|12330094|FG000|NOT COMPLETED|Overall Study||1
11143232|NCT01473368|12330095|FG001|NOT COMPLETED|Overall Study||0
11143233|NCT01473368|12330096|FG002|NOT COMPLETED|Overall Study||3
11143234|NCT01473368|12330097|FG003|NOT COMPLETED|Overall Study||0
11143235|NCT01473381|12330127|FG000|STARTED|Overall Study||290
11143236|NCT01473381|12330128|FG001|STARTED|Overall Study||292
11143237|NCT01473381|12330129|FG002|STARTED|Overall Study||291
11143238|NCT01473381|12330130|FG003|STARTED|Overall Study||289
11143239|NCT01473381|12330127|FG000|Safety Population|Overall Study||281
11143240|NCT01473381|12330128|FG001|Safety Population|Overall Study||288
11143241|NCT01473381|12330129|FG002|Safety Population|Overall Study||287
11143242|NCT01473381|12330130|FG003|Safety Population|Overall Study||282
11143243|NCT01473381|12330127|FG000|COMPLETED|Overall Study||210
11143244|NCT01473381|12330128|FG001|COMPLETED|Overall Study||199
11143245|NCT01473381|12330129|FG002|COMPLETED|Overall Study||189
11396488|NCT03763877|12590339|FG000|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||31
11143246|NCT01473381|12330130|FG003|COMPLETED|Overall Study||200
11143247|NCT01473381|12330127|FG000|NOT COMPLETED|Overall Study||80
11143248|NCT01473381|12330128|FG001|NOT COMPLETED|Overall Study||93
11143249|NCT01473381|12330129|FG002|NOT COMPLETED|Overall Study||102
11143250|NCT01473381|12330130|FG003|NOT COMPLETED|Overall Study||89
11143251|NCT01473394|12330143|FG000|STARTED|Overall Study||253
11143252|NCT01473394|12330144|FG001|STARTED|Overall Study||255
11143253|NCT01473394|12330143|FG000|COMPLETED|Overall Study||208
11143254|NCT01473394|12330144|FG001|COMPLETED|Overall Study||212
11143255|NCT01473394|12330143|FG000|NOT COMPLETED|Overall Study||45
11143256|NCT01473394|12330144|FG001|NOT COMPLETED|Overall Study||43
11143257|NCT01473407|12330152|FG000|STARTED|Overall Study||306
11143258|NCT01473407|12330153|FG001|STARTED|Overall Study||306
11143259|NCT01473407|12330152|FG000|COMPLETED|Overall Study||252
11143260|NCT01473407|12330153|FG001|COMPLETED|Overall Study||259
11143261|NCT01473407|12330152|FG000|NOT COMPLETED|Overall Study||54
11143262|NCT01473407|12330153|FG001|NOT COMPLETED|Overall Study||47
11143263|NCT01473420|12330161|FG000|STARTED|Titration Period (18 Weeks)||160
11143264|NCT01473420|12330162|FG001|STARTED|Titration Period (18 Weeks)||160
11143265|NCT01473420|12330161|FG000|Treated|Titration Period (18 Weeks)||80
11143266|NCT01473420|12330162|FG001|Treated|Titration Period (18 Weeks)||86
11056832|NCT00996125|12238438|FG001|STARTED|Overall Study||376
11143267|NCT01473420|12330161|FG000|COMPLETED|Titration Period (18 Weeks)||124
11143268|NCT01473420|12330162|FG001|COMPLETED|Titration Period (18 Weeks)||122
11143269|NCT01473420|12330161|FG000|NOT COMPLETED|Titration Period (18 Weeks)||36
11143270|NCT01473420|12330162|FG001|NOT COMPLETED|Titration Period (18 Weeks)||38
11143271|NCT01473420|12330161|FG000|STARTED|Maintenance Period (16 Weeks)||124
11143272|NCT01473420|12330162|FG001|STARTED|Maintenance Period (16 Weeks)||122
11143273|NCT01473420|12330161|FG000|COMPLETED|Maintenance Period (16 Weeks)||106
11143274|NCT01473420|12330162|FG001|COMPLETED|Maintenance Period (16 Weeks)||105
11143275|NCT01473420|12330161|FG000|NOT COMPLETED|Maintenance Period (16 Weeks)||18
11143276|NCT01473420|12330162|FG001|NOT COMPLETED|Maintenance Period (16 Weeks)||17
11143277|NCT01473524|12330177|FG000|STARTED|DB Phase||71
11143278|NCT01473524|12330178|FG001|STARTED|DB Phase||73
11016651|NCT00777946|12194345|FG000|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
11396489|NCT03763877|12590340|FG001|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30
11396490|NCT03763877|12590341|FG002|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30
11396491|NCT03763877|12590342|FG003|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||29
11396492|NCT03763877|12590339|FG000|Completed the Double-blind Period|Overall Study||27
11396493|NCT03763877|12590340|FG001|Completed the Double-blind Period|Overall Study||26
11396494|NCT03763877|12590341|FG002|Completed the Double-blind Period|Overall Study||25
11016652|NCT00777946|12194346|FG001|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
11016653|NCT00777946|12194347|FG002|STARTED|Overall Study||260
11016654|NCT00777946|12194345|FG000|Safety & Full Analysis Sets|Overall Study||282
11016655|NCT00777946|12194346|FG001|Safety & Full Analysis Sets|Overall Study||276
11016656|NCT00777946|12194347|FG002|Safety & Full Analysis Sets|Overall Study||260
11016657|NCT00777946|12194345|FG000|COMPLETED|Overall Study||262
11016658|NCT00777946|12194346|FG001|COMPLETED|Overall Study||271
11016659|NCT00777946|12194347|FG002|COMPLETED|Overall Study||244
11016660|NCT00777946|12194345|FG000|NOT COMPLETED|Overall Study||21
11016661|NCT00777946|12194346|FG001|NOT COMPLETED|Overall Study||6
11016662|NCT00777946|12194347|FG002|NOT COMPLETED|Overall Study||16
11016663|NCT00778102|12194357|FG000|STARTED|Overall Study||39
11016664|NCT00778102|12194358|FG001|STARTED|Overall Study||41
11016665|NCT00778102|12194357|FG000|COMPLETED|Overall Study||18
11016666|NCT00778102|12194358|FG001|COMPLETED|Overall Study||19
11016667|NCT00778102|12194357|FG000|NOT COMPLETED|Overall Study||21
11016668|NCT00778102|12194358|FG001|NOT COMPLETED|Overall Study||22
11016669|NCT00778167|12194367|FG000|STARTED|Overall Study||6
11016670|NCT00778167|12194368|FG001|STARTED|Overall Study||8
11016671|NCT00778167|12194369|FG002|STARTED|Overall Study||4
11016672|NCT00778167|12194367|FG000|COMPLETED|Overall Study||6
11016673|NCT00778167|12194368|FG001|COMPLETED|Overall Study||8
11016674|NCT00778167|12194369|FG002|COMPLETED|Overall Study||4
11016675|NCT00778167|12194367|FG000|NOT COMPLETED|Overall Study||0
11016676|NCT00778167|12194368|FG001|NOT COMPLETED|Overall Study||0
11016677|NCT00778167|12194369|FG002|NOT COMPLETED|Overall Study||0
11016678|NCT00778258|12194386|FG000|STARTED|Overall Study||16
11016679|NCT00778258|12194387|FG001|STARTED|Overall Study||5
11016680|NCT00778258|12194388|FG002|STARTED|Overall Study||20
11016681|NCT00778258|12194389|FG003|STARTED|Overall Study||15
11016682|NCT00778258|12194390|FG004|STARTED|Overall Study||6
11016683|NCT00778258|12194391|FG005|STARTED|Overall Study||23
11016684|NCT00778258|12194392|FG006|STARTED|Overall Study||34
11016685|NCT00778258|12194393|FG007|STARTED|Overall Study||41
11016686|NCT00778258|12194394|FG008|STARTED|Overall Study||10
11016687|NCT00778258|12194386|FG000|COMPLETED|Overall Study||9
11016688|NCT00778258|12194387|FG001|COMPLETED|Overall Study||3
11016689|NCT00778258|12194388|FG002|COMPLETED|Overall Study||10
11016690|NCT00778258|12194389|FG003|COMPLETED|Overall Study||12
11016691|NCT00778258|12194390|FG004|COMPLETED|Overall Study||6
11016692|NCT00778258|12194391|FG005|COMPLETED|Overall Study||13
11016693|NCT00778258|12194392|FG006|COMPLETED|Overall Study||19
11016694|NCT00778258|12194393|FG007|COMPLETED|Overall Study||26
11016695|NCT00778258|12194394|FG008|COMPLETED|Overall Study||6
11016696|NCT00778258|12194386|FG000|NOT COMPLETED|Overall Study||7
11016697|NCT00778258|12194387|FG001|NOT COMPLETED|Overall Study||2
11016698|NCT00778258|12194388|FG002|NOT COMPLETED|Overall Study||10
11016699|NCT00778258|12194389|FG003|NOT COMPLETED|Overall Study||3
11016700|NCT00778258|12194390|FG004|NOT COMPLETED|Overall Study||0
11016701|NCT00778258|12194391|FG005|NOT COMPLETED|Overall Study||10
11016702|NCT00778258|12194392|FG006|NOT COMPLETED|Overall Study||15
11016703|NCT00778258|12194393|FG007|NOT COMPLETED|Overall Study||15
11016704|NCT00778258|12194394|FG008|NOT COMPLETED|Overall Study||4
11016705|NCT00778310|12194422|FG000|STARTED|Overall Study||17
11016706|NCT00778310|12194423|FG001|STARTED|Overall Study||26
11016707|NCT00778310|12194422|FG000|Usable Data|Overall Study||14
11016708|NCT00778310|12194423|FG001|Usable Data|Overall Study||21
11016709|NCT00778310|12194422|FG000|COMPLETED|Overall Study||17
11016710|NCT00778310|12194423|FG001|COMPLETED|Overall Study||26
11016711|NCT00778310|12194422|FG000|NOT COMPLETED|Overall Study||0
11016712|NCT00778310|12194423|FG001|NOT COMPLETED|Overall Study||0
11016713|NCT00778336|12194435|FG000|STARTED|Index Procedure-Discharge||198
11016714|NCT00778336|12194436|FG001|STARTED|Index Procedure-Discharge||170
11016715|NCT00778336|12194437|FG002|STARTED|Index Procedure-Discharge||72
11016716|NCT00778336|12194438|FG003|STARTED|Index Procedure-Discharge||12
11016717|NCT00778336|12194435|FG000|COMPLETED|Index Procedure-Discharge||192
11016718|NCT00778336|12194436|FG001|COMPLETED|Index Procedure-Discharge||167
11016719|NCT00778336|12194437|FG002|COMPLETED|Index Procedure-Discharge||70
11016720|NCT00778336|12194438|FG003|COMPLETED|Index Procedure-Discharge||12
11016721|NCT00778336|12194435|FG000|NOT COMPLETED|Index Procedure-Discharge||6
11016722|NCT00778336|12194436|FG001|NOT COMPLETED|Index Procedure-Discharge||3
11016723|NCT00778336|12194437|FG002|NOT COMPLETED|Index Procedure-Discharge||2
11016724|NCT00778336|12194438|FG003|NOT COMPLETED|Index Procedure-Discharge||0
11016725|NCT00778336|12194435|FG000|STARTED|3 Month Follow Up||192
11016726|NCT00778336|12194436|FG001|STARTED|3 Month Follow Up||167
11016727|NCT00778336|12194437|FG002|STARTED|3 Month Follow Up||70
11016728|NCT00778336|12194438|FG003|STARTED|3 Month Follow Up||12
11016729|NCT00778336|12194435|FG000|COMPLETED|3 Month Follow Up||169
11016730|NCT00778336|12194436|FG001|COMPLETED|3 Month Follow Up||144
11016731|NCT00778336|12194437|FG002|COMPLETED|3 Month Follow Up||65
11016732|NCT00778336|12194438|FG003|COMPLETED|3 Month Follow Up||12
11016733|NCT00778336|12194435|FG000|NOT COMPLETED|3 Month Follow Up||23
11016734|NCT00778336|12194436|FG001|NOT COMPLETED|3 Month Follow Up||23
11016735|NCT00778336|12194437|FG002|NOT COMPLETED|3 Month Follow Up||5
11016736|NCT00778336|12194438|FG003|NOT COMPLETED|3 Month Follow Up||0
11016737|NCT00778375|12194448|FG000|STARTED|Overall Study||122
11016738|NCT00778375|12194448|FG000|COMPLETED|Overall Study||119
11016739|NCT00778375|12194448|FG000|NOT COMPLETED|Overall Study||3
11016740|NCT00778622|12194457|FG000|STARTED|Overall Study||125
11016741|NCT00778622|12194458|FG001|STARTED|Overall Study||122
11016742|NCT00778622|12194459|FG002|STARTED|Overall Study||124
11016743|NCT00778622|12194457|FG000|COMPLETED|Overall Study||109
11016744|NCT00778622|12194458|FG001|COMPLETED|Overall Study||107
11016745|NCT00778622|12194459|FG002|COMPLETED|Overall Study||109
11016746|NCT00778622|12194457|FG000|NOT COMPLETED|Overall Study||16
11016747|NCT00778622|12194458|FG001|NOT COMPLETED|Overall Study||15
11016748|NCT00778622|12194459|FG002|NOT COMPLETED|Overall Study||15
11016749|NCT00778648|12194473|FG000|STARTED|Overall Study||272
11016750|NCT00778648|12194474|FG001|STARTED|Overall Study||271
11016751|NCT00778648|12194473|FG000|COMPLETED|Overall Study||263
11016752|NCT00778648|12194474|FG001|COMPLETED|Overall Study||266
11016753|NCT00778648|12194473|FG000|NOT COMPLETED|Overall Study||9
11016754|NCT00778648|12194474|FG001|NOT COMPLETED|Overall Study||5
11016755|NCT00778817|12194480|FG000|STARTED|Overall Study||20
11016756|NCT00778817|12194480|FG000|COMPLETED|Overall Study||16
11016757|NCT00778817|12194480|FG000|NOT COMPLETED|Overall Study||4
11016758|NCT00778830|12194486|FG000|STARTED|Overall Study||101
11016759|NCT00778830|12194487|FG001|STARTED|Overall Study||188
11016760|NCT00778830|12194486|FG000|COMPLETED|Overall Study||101
11016761|NCT00778830|12194487|FG001|COMPLETED|Overall Study||187
11016762|NCT00778830|12194486|FG000|NOT COMPLETED|Overall Study||0
11016763|NCT00778830|12194487|FG001|NOT COMPLETED|Overall Study||1
11016764|NCT00778869|12194493|FG000|STARTED|Overall Study||10
11016765|NCT00778869|12194493|FG000|COMPLETED|Overall Study||10
11016766|NCT00778869|12194493|FG000|NOT COMPLETED|Overall Study||0
11016767|NCT00778895|12194500|FG000|STARTED|Active Phase||164
11016768|NCT00778895|12194501|FG001|STARTED|Active Phase||167
11016769|NCT00778895|12194502|FG002|STARTED|Active Phase||43
11016770|NCT00778895|12194500|FG000|COMPLETED|Active Phase||157
11016771|NCT00778895|12194501|FG001|COMPLETED|Active Phase||161
11016772|NCT00778895|12194502|FG002|COMPLETED|Active Phase||43
11016773|NCT00778895|12194500|FG000|NOT COMPLETED|Active Phase||7
11016774|NCT00778895|12194501|FG001|NOT COMPLETED|Active Phase||6
11016775|NCT00778895|12194502|FG002|NOT COMPLETED|Active Phase||0
11016776|NCT00778895|12194500|FG000|STARTED|ESFU Phase||164
11016777|NCT00778895|12194501|FG001|STARTED|ESFU Phase||167
11016778|NCT00778895|12194502|FG002|STARTED|ESFU Phase||43
11016779|NCT00778895|12194500|FG000|COMPLETED|ESFU Phase||153
11016780|NCT00778895|12194501|FG001|COMPLETED|ESFU Phase||155
11016781|NCT00778895|12194502|FG002|COMPLETED|ESFU Phase||41
11016782|NCT00778895|12194500|FG000|NOT COMPLETED|ESFU Phase||11
11016783|NCT00778895|12194501|FG001|NOT COMPLETED|ESFU Phase||12
11016784|NCT00778895|12194502|FG002|NOT COMPLETED|ESFU Phase||2
11016785|NCT00778921|12194514|FG000|STARTED|Overall Study||279
11016786|NCT00778921|12194515|FG001|STARTED|Overall Study||285
11016787|NCT00778921|12194516|FG002|STARTED|Overall Study||283
11016788|NCT00778921|12194514|FG000|COMPLETED|Overall Study||261
11016789|NCT00778921|12194515|FG001|COMPLETED|Overall Study||266
11016790|NCT00778921|12194516|FG002|COMPLETED|Overall Study||255
11016791|NCT00778921|12194514|FG000|NOT COMPLETED|Overall Study||18
11016792|NCT00778921|12194515|FG001|NOT COMPLETED|Overall Study||19
11016793|NCT00778921|12194516|FG002|NOT COMPLETED|Overall Study||28
11016794|NCT00779025|12194524|FG000|STARTED|Overall Study||82
11016795|NCT00779025|12194524|FG000|COMPLETED|Overall Study||81
11016796|NCT00779025|12194524|FG000|NOT COMPLETED|Overall Study||1
11016797|NCT00779103|12194529|FG000|STARTED|Overall Study|Initial Phase (First Implant) - 36 Completed|36
11016798|NCT00779103|12194529|FG000|Second & Third Implant|Overall Study|Initial Extension Phase/Extended Access Phase (Second and Third Implant) - 22 Completed|31
11016799|NCT00779103|12194529|FG000|Fourth Implant|Overall Study|Second Extension Phase (4th Implant with Yearly Implantations till no longer required): 11 Completed|13
11016800|NCT00779103|12194529|FG000|No Treatment|Overall Study|Optional Long Term Follow-up Phase (No Treatment)|9
11016801|NCT00779103|12194529|FG000|COMPLETED|Overall Study|Initial Phase (First Implant)|36
11016802|NCT00779103|12194529|FG000|NOT COMPLETED|Overall Study||0
11016803|NCT00779142|12194537|FG000|STARTED|Overall Study|5 patients signed consent and were screened.|5
11016804|NCT00779142|12194537|FG000|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
11016805|NCT00779142|12194537|FG000|NOT COMPLETED|Overall Study||3
11016806|NCT00779155|12194544|FG000|STARTED|Overall Study||6
11016807|NCT00779155|12194545|FG001|STARTED|Overall Study||6
11016808|NCT00779155|12194544|FG000|COMPLETED|Overall Study||6
11016809|NCT00779155|12194545|FG001|COMPLETED|Overall Study||6
11016810|NCT00779155|12194544|FG000|NOT COMPLETED|Overall Study||0
11016811|NCT00779155|12194545|FG001|NOT COMPLETED|Overall Study||0
11016812|NCT00779246|12194553|FG000|STARTED|Overall Study||750
11016813|NCT00779246|12194554|FG001|STARTED|Overall Study||768
11016814|NCT00779246|12194553|FG000|COMPLETED|Overall Study||717
11016815|NCT00779246|12194554|FG001|COMPLETED|Overall Study||715
11016816|NCT00779246|12194553|FG000|NOT COMPLETED|Overall Study||33
11016817|NCT00779246|12194554|FG001|NOT COMPLETED|Overall Study||53
11016818|NCT00779259|12194560|FG000|STARTED|Theophylline Alone||24
11016819|NCT00779259|12194560|FG000|COMPLETED|Theophylline Alone||24
11016820|NCT00779259|12194560|FG000|NOT COMPLETED|Theophylline Alone||0
11016821|NCT00779259|12194560|FG000|STARTED|4 Day Washout Period||24
11016822|NCT00779259|12194560|FG000|COMPLETED|4 Day Washout Period||24
11016823|NCT00779259|12194560|FG000|NOT COMPLETED|4 Day Washout Period||0
11016824|NCT00779259|12194560|FG000|STARTED|Quinine Alone||24
11016825|NCT00779259|12194560|FG000|COMPLETED|Quinine Alone||22
11016826|NCT00779259|12194560|FG000|NOT COMPLETED|Quinine Alone||2
11016827|NCT00779259|12194560|FG000|STARTED|Theophylline With Quinine||22
11016828|NCT00779259|12194560|FG000|COMPLETED|Theophylline With Quinine||22
11016829|NCT00779259|12194560|FG000|NOT COMPLETED|Theophylline With Quinine||0
11016830|NCT00779285|12194578|FG000|STARTED|Overall Study||1
11016831|NCT00779285|12194578|FG000|COMPLETED|Overall Study||1
11016832|NCT00779285|12194578|FG000|NOT COMPLETED|Overall Study||0
11016833|NCT00779311|12194587|FG000|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
11016834|NCT00779311|12194588|FG001|STARTED|Overall Study||0
11016835|NCT00779311|12194589|FG002|STARTED|Overall Study||0
11016836|NCT00779311|12194590|FG003|STARTED|Overall Study||0
11016837|NCT00779311|12194591|FG004|STARTED|Overall Study||0
11016838|NCT00779311|12194587|FG000|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
11016839|NCT00779311|12194588|FG001|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
11016840|NCT00779311|12194589|FG002|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
11016841|NCT00779311|12194590|FG003|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
11016842|NCT00779311|12194591|FG004|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
11016843|NCT00779311|12194587|FG000|COMPLETED|Overall Study||8
11016844|NCT00779311|12194588|FG001|COMPLETED|Overall Study||0
11016845|NCT00779311|12194589|FG002|COMPLETED|Overall Study||0
11016846|NCT00779311|12194590|FG003|COMPLETED|Overall Study||0
11016847|NCT00779311|12194591|FG004|COMPLETED|Overall Study||0
11016848|NCT00779311|12194587|FG000|NOT COMPLETED|Overall Study||0
11016849|NCT00779311|12194588|FG001|NOT COMPLETED|Overall Study||0
11016850|NCT00779311|12194589|FG002|NOT COMPLETED|Overall Study||0
11016851|NCT00779311|12194590|FG003|NOT COMPLETED|Overall Study||0
11016852|NCT00779311|12194591|FG004|NOT COMPLETED|Overall Study||0
11016853|NCT00779402|12194605|FG000|STARTED|Treatment Phase 1||117
11016854|NCT00779402|12194606|FG001|STARTED|Treatment Phase 1||59
11016855|NCT00779402|12194605|FG000|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
11016856|NCT00779402|12194606|FG001|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
11016857|NCT00779402|12194605|FG000|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
11016858|NCT00779402|12194606|FG001|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
11016859|NCT00779402|12194605|FG000|Received Booster Infusion|Treatment Phase 1||50
11016860|NCT00779402|12194606|FG001|Received Booster Infusion|Treatment Phase 1||30
11016861|NCT00779402|12194605|FG000|COMPLETED|Treatment Phase 1||84
11016862|NCT00779402|12194606|FG001|COMPLETED|Treatment Phase 1||44
11016863|NCT00779402|12194605|FG000|NOT COMPLETED|Treatment Phase 1||33
11016864|NCT00779402|12194606|FG001|NOT COMPLETED|Treatment Phase 1||15
11016865|NCT00779402|12194605|FG000|STARTED|Surveillance Phase||84
11016866|NCT00779402|12194606|FG001|STARTED|Surveillance Phase||44
11016867|NCT00779402|12194605|FG000|COMPLETED|Surveillance Phase||41
11016868|NCT00779402|12194606|FG001|COMPLETED|Surveillance Phase||13
11016869|NCT00779402|12194605|FG000|NOT COMPLETED|Surveillance Phase||43
11016870|NCT00779402|12194606|FG001|NOT COMPLETED|Surveillance Phase||31
11016871|NCT00779402|12194605|FG000|STARTED|Long-term Follow-up||41
11016872|NCT00779402|12194606|FG001|STARTED|Long-term Follow-up||13
11016873|NCT00779402|12194605|FG000|COMPLETED|Long-term Follow-up||20
11016874|NCT00779402|12194606|FG001|COMPLETED|Long-term Follow-up||7
11016875|NCT00779402|12194605|FG000|NOT COMPLETED|Long-term Follow-up||21
11016876|NCT00779402|12194606|FG001|NOT COMPLETED|Long-term Follow-up||6
11016877|NCT00779467|12194616|FG000|STARTED|Overall Study||53
11016878|NCT00779467|12194617|FG001|STARTED|Overall Study||45
11016879|NCT00779467|12194618|FG002|STARTED|Overall Study||48
11016880|NCT00779467|12194619|FG003|STARTED|Overall Study||54
11016881|NCT00779467|12194616|FG000|COMPLETED|Overall Study||38
11016882|NCT00779467|12194617|FG001|COMPLETED|Overall Study||40
11016883|NCT00779467|12194618|FG002|COMPLETED|Overall Study||38
11016884|NCT00779467|12194619|FG003|COMPLETED|Overall Study||35
11016885|NCT00779467|12194616|FG000|NOT COMPLETED|Overall Study||15
11016886|NCT00779467|12194617|FG001|NOT COMPLETED|Overall Study||5
11016887|NCT00779467|12194618|FG002|NOT COMPLETED|Overall Study||10
11016888|NCT00779467|12194619|FG003|NOT COMPLETED|Overall Study||19
11016889|NCT00779506|12194629|FG000|STARTED|Overall Study||96
11016890|NCT00779506|12194629|FG000|Enrolled|Overall Study||96
11016891|NCT00779506|12194629|FG000|Screen Failed|Overall Study||2
11016892|NCT00779506|12194629|FG000|Assigned|Overall Study||94
11016893|NCT00779506|12194629|FG000|MITT|Overall Study||89
11016894|NCT00779506|12194629|FG000|Treatment Complete|Overall Study||67
11016895|NCT00779506|12194629|FG000|Withdrawal Treatment|Overall Study||27
11016896|NCT00779506|12194629|FG000|COMPLETED|Overall Study||67
11016897|NCT00779506|12194629|FG000|NOT COMPLETED|Overall Study||29
11016898|NCT00779558|12194635|FG000|STARTED|Overall Study||57
11016899|NCT00779558|12194636|FG001|STARTED|Overall Study||44
11016900|NCT00779558|12194635|FG000|COMPLETED|Overall Study||53
11016901|NCT00779558|12194636|FG001|COMPLETED|Overall Study||37
11016902|NCT00779558|12194635|FG000|NOT COMPLETED|Overall Study||4
11016903|NCT00779558|12194636|FG001|NOT COMPLETED|Overall Study||7
11016904|NCT00779584|12194651|FG000|STARTED|Overall Study||3
11016905|NCT00779584|12194652|FG001|STARTED|Overall Study||3
11016906|NCT00779584|12194653|FG002|STARTED|Overall Study||7
11016907|NCT00779584|12194654|FG003|STARTED|Overall Study||6
11016908|NCT00779584|12194655|FG004|STARTED|Overall Study||7
11016909|NCT00779584|12194656|FG005|STARTED|Overall Study||6
11016910|NCT00779584|12194657|FG006|STARTED|Overall Study||8
11016911|NCT00779584|12194658|FG007|STARTED|Overall Study||3
11016912|NCT00779584|12194659|FG008|STARTED|Overall Study||2
11016913|NCT00779584|12194651|FG000|Treated|Overall Study||3
11016914|NCT00779584|12194652|FG001|Treated|Overall Study||3
11016915|NCT00779584|12194653|FG002|Treated|Overall Study||7
11016916|NCT00779584|12194654|FG003|Treated|Overall Study||6
11396495|NCT03763877|12590342|FG003|Completed the Double-blind Period|Overall Study||24
11396496|NCT03763877|12590339|FG000|COMPLETED|Overall Study||26
11396497|NCT03763877|12590340|FG001|COMPLETED|Overall Study||26
11396498|NCT03763877|12590341|FG002|COMPLETED|Overall Study||24
11396499|NCT03763877|12590342|FG003|COMPLETED|Overall Study||24
11396500|NCT03763877|12590339|FG000|NOT COMPLETED|Overall Study||5
11396501|NCT03763877|12590340|FG001|NOT COMPLETED|Overall Study||4
11396502|NCT03763877|12590341|FG002|NOT COMPLETED|Overall Study||7
11016917|NCT00779584|12194655|FG004|Treated|Overall Study||7
11016918|NCT00779584|12194656|FG005|Treated|Overall Study||4
11016919|NCT00779584|12194657|FG006|Treated|Overall Study||8
11016920|NCT00779584|12194658|FG007|Treated|Overall Study||3
11016921|NCT00779584|12194659|FG008|Treated|Overall Study||2
11016922|NCT00779584|12194651|FG000|COMPLETED|Overall Study||0
11016923|NCT00779584|12194652|FG001|COMPLETED|Overall Study||0
11016924|NCT00779584|12194653|FG002|COMPLETED|Overall Study||0
11396503|NCT03763877|12590342|FG003|NOT COMPLETED|Overall Study||5
11396504|NCT03764007|12590356|FG000|STARTED|Overall Study||98
11396505|NCT03764007|12590356|FG000|Imaging Completed|Overall Study||98
11396506|NCT03764007|12590356|FG000|Underwent Parathyroidectomy Surgery|Overall Study||77
11396507|NCT03764007|12590356|FG000|COMPLETED|Overall Study||77
11396508|NCT03764007|12590356|FG000|NOT COMPLETED|Overall Study||21
11396509|NCT03772587|12590365|FG000|STARTED|Overall Study||14
11396510|NCT03772587|12590366|FG001|STARTED|Overall Study||14
11396511|NCT03772587|12590367|FG002|STARTED|Overall Study||13
11396512|NCT03772587|12590368|FG003|STARTED|Overall Study||13
11396513|NCT03772587|12590369|FG004|STARTED|Overall Study||14
11396514|NCT03772587|12590365|FG000|COMPLETED|Overall Study||13
11396515|NCT03772587|12590366|FG001|COMPLETED|Overall Study||14
11396516|NCT03772587|12590367|FG002|COMPLETED|Overall Study||12
11396517|NCT03772587|12590368|FG003|COMPLETED|Overall Study||12
11396518|NCT03772587|12590369|FG004|COMPLETED|Overall Study||14
11396519|NCT03772587|12590365|FG000|NOT COMPLETED|Overall Study||1
11396520|NCT03772587|12590366|FG001|NOT COMPLETED|Overall Study||0
11396521|NCT03772587|12590367|FG002|NOT COMPLETED|Overall Study||1
11396522|NCT03772587|12590368|FG003|NOT COMPLETED|Overall Study||1
11396523|NCT03772587|12590369|FG004|NOT COMPLETED|Overall Study||0
11396524|NCT03789292|12590393|FG000|STARTED|Treatment Period I (Week 0 to Week 26)||324
11396525|NCT03789292|12590394|FG001|STARTED|Treatment Period I (Week 0 to Week 26)||324
11396526|NCT03789292|12590395|FG002|STARTED|Treatment Period I (Week 0 to Week 26)||0
11396527|NCT03789292|12590393|FG000|COMPLETED|Treatment Period I (Week 0 to Week 26)||303
11396528|NCT03789292|12590394|FG001|COMPLETED|Treatment Period I (Week 0 to Week 26)||305
11396529|NCT03789292|12590395|FG002|COMPLETED|Treatment Period I (Week 0 to Week 26)||0
11396530|NCT03789292|12590393|FG000|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||21
11396531|NCT03789292|12590394|FG001|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||19
11396532|NCT03789292|12590395|FG002|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||0
11396533|NCT03789292|12590393|FG000|STARTED|Treatment Period II (Week 26 to Week 52)||303
11396534|NCT03789292|12590394|FG001|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|153
11396535|NCT03789292|12590395|FG002|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|152
11396536|NCT03789292|12590393|FG000|COMPLETED|Treatment Period II (Week 26 to Week 52)||287
11396537|NCT03789292|12590394|FG001|COMPLETED|Treatment Period II (Week 26 to Week 52)||147
11396538|NCT03789292|12590395|FG002|COMPLETED|Treatment Period II (Week 26 to Week 52)||143
11396539|NCT03789292|12590393|FG000|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||16
11396540|NCT03789292|12590394|FG001|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||6
11396541|NCT03789292|12590395|FG002|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||9
11396542|NCT03799289|12590411|FG000|STARTED|Initial Weight Loss Program (Weeks 1-12)||30
11396543|NCT03799289|12590412|FG001|STARTED|Initial Weight Loss Program (Weeks 1-12)||30
11396544|NCT03799289|12590411|FG000|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||24
11396545|NCT03799289|12590412|FG001|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||27
11016925|NCT00779584|12194654|FG003|COMPLETED|Overall Study||0
11016926|NCT00779584|12194655|FG004|COMPLETED|Overall Study||0
11016927|NCT00779584|12194656|FG005|COMPLETED|Overall Study||0
11016928|NCT00779584|12194657|FG006|COMPLETED|Overall Study||0
11016929|NCT00779584|12194658|FG007|COMPLETED|Overall Study||0
11016930|NCT00779584|12194659|FG008|COMPLETED|Overall Study||0
11016931|NCT00779584|12194651|FG000|NOT COMPLETED|Overall Study||3
11016932|NCT00779584|12194652|FG001|NOT COMPLETED|Overall Study||3
11016933|NCT00779584|12194653|FG002|NOT COMPLETED|Overall Study||7
11396546|NCT03799289|12590411|FG000|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||6
11396547|NCT03799289|12590412|FG001|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||3
11396548|NCT03799289|12590411|FG000|STARTED|Maintenance Intervention (Weeks 13-24)||24
11396549|NCT03799289|12590412|FG001|STARTED|Maintenance Intervention (Weeks 13-24)||27
11396550|NCT03799289|12590411|FG000|COMPLETED|Maintenance Intervention (Weeks 13-24)||24
11396551|NCT03799289|12590412|FG001|COMPLETED|Maintenance Intervention (Weeks 13-24)||27
11396552|NCT03799289|12590411|FG000|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0
11396553|NCT03799289|12590412|FG001|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0
11396554|NCT03801408|12590418|FG000|STARTED|Overall Study||145
11396555|NCT03801408|12590418|FG000|COMPLETED|Overall Study||145
11396556|NCT03801408|12590418|FG000|NOT COMPLETED|Overall Study||0
11396557|NCT03805438|12590422|FG000|STARTED|Overall Study||47
11396558|NCT03805438|12590422|FG000|COMPLETED|Overall Study||45
11396559|NCT03805438|12590422|FG000|NOT COMPLETED|Overall Study||2
11396560|NCT03808948|12590426|FG000|STARTED|Overall Study||50
11396561|NCT03808948|12590426|FG000|COMPLETED|Overall Study||50
11396562|NCT03808948|12590426|FG000|NOT COMPLETED|Overall Study||0
11396563|NCT03810053|12590430|FG000|STARTED|Overall Study||290
11396564|NCT03810053|12590430|FG000|COMPLETED|Overall Study||290
11396565|NCT03810053|12590430|FG000|NOT COMPLETED|Overall Study||0
11396566|NCT03817528|12590434|FG000|STARTED|Overall Study||4
11143279|NCT01473524|12330179|FG002|STARTED|DB Phase||73
11143280|NCT01473524|12330180|FG003|STARTED|DB Phase||0
11143281|NCT01473524|12330181|FG004|STARTED|DB Phase||0
11143282|NCT01473524|12330182|FG005|STARTED|DB Phase||0
11143283|NCT01473524|12330177|FG000|Received at Least 1 Dose of Study Drug|DB Phase||70
11396567|NCT03817528|12590434|FG000|COMPLETED|Overall Study||1
11396568|NCT03817528|12590434|FG000|NOT COMPLETED|Overall Study||3
11396569|NCT03817580|12590441|FG000|STARTED|Overall Study||57
11396570|NCT03817580|12590442|FG001|STARTED|Overall Study||56
11396571|NCT03817580|12590443|FG002|STARTED|Overall Study||57
11396572|NCT03817580|12590441|FG000|COMPLETED|Overall Study||57
11396573|NCT03817580|12590442|FG001|COMPLETED|Overall Study||56
11396574|NCT03817580|12590443|FG002|COMPLETED|Overall Study||57
11396575|NCT03817580|12590441|FG000|NOT COMPLETED|Overall Study||0
11396576|NCT03817580|12590442|FG001|NOT COMPLETED|Overall Study||0
11396577|NCT03817580|12590443|FG002|NOT COMPLETED|Overall Study||0
11396578|NCT03828422|12590453|FG000|STARTED|Overall Study||40
11396579|NCT03828422|12590454|FG001|STARTED|Overall Study||42
11016934|NCT00779584|12194654|FG003|NOT COMPLETED|Overall Study||6
11016935|NCT00779584|12194655|FG004|NOT COMPLETED|Overall Study||7
11016936|NCT00779584|12194656|FG005|NOT COMPLETED|Overall Study||6
11016937|NCT00779584|12194657|FG006|NOT COMPLETED|Overall Study||8
11016938|NCT00779584|12194658|FG007|NOT COMPLETED|Overall Study||3
11016939|NCT00779584|12194659|FG008|NOT COMPLETED|Overall Study||2
11016940|NCT00779675|12194679|FG000|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
11016941|NCT00779675|12194679|FG000|COMPLETED|Treatment Period||328
11016942|NCT00779675|12194679|FG000|NOT COMPLETED|Treatment Period||332
11016943|NCT00779675|12194679|FG000|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
11016944|NCT00779675|12194679|FG000|COMPLETED|Extended Treatment Period||147
11016945|NCT00779675|12194679|FG000|NOT COMPLETED|Extended Treatment Period||46
11016946|NCT00779701|12194687|FG000|STARTED|Overall Study||27
11016947|NCT00779701|12194687|FG000|COMPLETED|Overall Study||27
11016948|NCT00779701|12194687|FG000|NOT COMPLETED|Overall Study||0
11016949|NCT00779766|12194693|FG000|STARTED|Month 24||3026
11016950|NCT00779766|12194694|FG001|STARTED|Month 24||3025
11016951|NCT00779766|12194693|FG000|COMPLETED|Month 24||2694
11016952|NCT00779766|12194694|FG001|COMPLETED|Month 24||2693
11016953|NCT00779766|12194693|FG000|NOT COMPLETED|Month 24||332
11016954|NCT00779766|12194694|FG001|NOT COMPLETED|Month 24||332
11016955|NCT00779766|12194693|FG000|STARTED|Month 48||2703
11016956|NCT00779766|12194694|FG001|STARTED|Month 48||2727
11016957|NCT00779766|12194693|FG000|COMPLETED|Month 48||2529
11016958|NCT00779766|12194694|FG001|COMPLETED|Month 48||2559
11016959|NCT00779766|12194693|FG000|NOT COMPLETED|Month 48||174
11016960|NCT00779766|12194694|FG001|NOT COMPLETED|Month 48||168
11016961|NCT00779766|12194693|FG000|STARTED|Month 72||2319
11016962|NCT00779766|12194694|FG001|STARTED|Month 72||2347
11016963|NCT00779766|12194693|FG000|COMPLETED|Month 72||2134
11016964|NCT00779766|12194694|FG001|COMPLETED|Month 72||2158
11396580|NCT03828422|12590453|FG000|COMPLETED|Overall Study||36
11396581|NCT03828422|12590454|FG001|COMPLETED|Overall Study||38
11396582|NCT03828422|12590453|FG000|NOT COMPLETED|Overall Study||4
11396583|NCT03828422|12590454|FG001|NOT COMPLETED|Overall Study||4
11396584|NCT03829228|12590461|FG000|STARTED|Overall Study||30
11396585|NCT03829228|12590461|FG000|COMPLETED|Overall Study||29
11396586|NCT03829228|12590461|FG000|NOT COMPLETED|Overall Study||1
11396587|NCT03829618|12590468|FG000|STARTED|Overall Study||15
11016965|NCT00779766|12194693|FG000|NOT COMPLETED|Month 72||185
11016966|NCT00779766|12194694|FG001|NOT COMPLETED|Month 72||189
11016967|NCT00779779|12194701|FG000|STARTED|Overall Study||522
11016968|NCT00779779|12194701|FG000|COMPLETED|Overall Study||498
11143284|NCT01473524|12330178|FG001|Received at Least 1 Dose of Study Drug|DB Phase||73
11396588|NCT03829618|12590469|FG001|STARTED|Overall Study||7
11016969|NCT00779779|12194701|FG000|NOT COMPLETED|Overall Study||24
11016970|NCT00779857|12194705|FG000|STARTED|Overall Study|70 patients treated|70
11016971|NCT00779857|12194705|FG000|30 Day Post Procedure|Overall Study|2 missed Visit|68
11396589|NCT03829618|12590470|FG002|STARTED|Overall Study||7
11396590|NCT03829618|12590468|FG000|COMPLETED|Overall Study||15
11396591|NCT03829618|12590469|FG001|COMPLETED|Overall Study||7
11016972|NCT00779857|12194705|FG000|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
11016973|NCT00779857|12194705|FG000|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
11016974|NCT00779857|12194705|FG000|NOT COMPLETED|Overall Study||6
11016975|NCT00779870|12194712|FG000|STARTED|Overall Study||5
11016976|NCT00779870|12194713|FG001|STARTED|Overall Study||6
11016977|NCT00779870|12194714|FG002|STARTED|Overall Study||7
11016978|NCT00779870|12194712|FG000|COMPLETED|Overall Study||5
11016979|NCT00779870|12194713|FG001|COMPLETED|Overall Study||6
11016980|NCT00779870|12194714|FG002|COMPLETED|Overall Study||7
11016981|NCT00779870|12194712|FG000|NOT COMPLETED|Overall Study||0
11016982|NCT00779870|12194713|FG001|NOT COMPLETED|Overall Study||0
11016983|NCT00779870|12194714|FG002|NOT COMPLETED|Overall Study||0
11016984|NCT00779909|12194726|FG000|STARTED|Overall Study||10
11016985|NCT00779909|12194727|FG001|STARTED|Overall Study||9
11016986|NCT00779909|12194728|FG002|STARTED|Overall Study||8
11016987|NCT00779909|12194729|FG003|STARTED|Overall Study||8
11016988|NCT00779909|12194726|FG000|COMPLETED|Overall Study||9
11016989|NCT00779909|12194727|FG001|COMPLETED|Overall Study||8
11016990|NCT00779909|12194728|FG002|COMPLETED|Overall Study||8
11016991|NCT00779909|12194729|FG003|COMPLETED|Overall Study||7
11016992|NCT00779909|12194726|FG000|NOT COMPLETED|Overall Study||1
11016993|NCT00779909|12194727|FG001|NOT COMPLETED|Overall Study||1
11016994|NCT00779909|12194728|FG002|NOT COMPLETED|Overall Study||0
11016995|NCT00779909|12194729|FG003|NOT COMPLETED|Overall Study||1
11016996|NCT00780026|12194748|FG000|STARTED|Overall Study||50
11016997|NCT00780026|12194749|FG001|STARTED|Overall Study||50
11016998|NCT00780026|12194748|FG000|COMPLETED|Overall Study||50
11016999|NCT00780026|12194749|FG001|COMPLETED|Overall Study||50
11017000|NCT00780026|12194748|FG000|NOT COMPLETED|Overall Study||0
11017001|NCT00780026|12194749|FG001|NOT COMPLETED|Overall Study||0
11017002|NCT00780143|12194755|FG000|STARTED|Overall Study||3
11017003|NCT00780143|12194755|FG000|COMPLETED|Overall Study||0
11017004|NCT00780143|12194755|FG000|NOT COMPLETED|Overall Study||3
11017005|NCT00780208|12194759|FG000|STARTED|Overall Study||14
11017006|NCT00780208|12194759|FG000|COMPLETED|Overall Study||8
11017007|NCT00780208|12194759|FG000|NOT COMPLETED|Overall Study||6
11017008|NCT00780234|12194765|FG000|STARTED|Overall Study||47
11017009|NCT00780234|12194766|FG001|STARTED|Overall Study||45
11017010|NCT00780234|12194765|FG000|COMPLETED|Overall Study||39
11017011|NCT00780234|12194766|FG001|COMPLETED|Overall Study||37
11017012|NCT00780234|12194765|FG000|NOT COMPLETED|Overall Study||8
11017013|NCT00780234|12194766|FG001|NOT COMPLETED|Overall Study||8
11017014|NCT00780273|12194772|FG000|STARTED|Overall Study||19
11017015|NCT00780273|12194772|FG000|COMPLETED|Overall Study||17
11017016|NCT00780273|12194772|FG000|NOT COMPLETED|Overall Study||2
11017017|NCT00780338|12194779|FG000|STARTED|Baseline to Mid (1 Year)||174
11017018|NCT00780338|12194780|FG001|STARTED|Baseline to Mid (1 Year)||202
11017019|NCT00780338|12194779|FG000|COMPLETED|Baseline to Mid (1 Year)||169
11017020|NCT00780338|12194780|FG001|COMPLETED|Baseline to Mid (1 Year)||164
11017021|NCT00780338|12194779|FG000|NOT COMPLETED|Baseline to Mid (1 Year)||5
11017022|NCT00780338|12194780|FG001|NOT COMPLETED|Baseline to Mid (1 Year)||38
11017023|NCT00780338|12194779|FG000|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
11017024|NCT00780338|12194780|FG001|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
11017025|NCT00780338|12194779|FG000|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
11017026|NCT00780338|12194780|FG001|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
11017027|NCT00780338|12194779|FG000|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
11017028|NCT00780338|12194780|FG001|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
11017029|NCT00780416|12194792|FG000|STARTED|Overall Study||126
11017030|NCT00780416|12194793|FG001|STARTED|Overall Study||63
11017031|NCT00780416|12194792|FG000|COMPLETED|Overall Study||114
11017032|NCT00780416|12194793|FG001|COMPLETED|Overall Study||54
11017033|NCT00780416|12194792|FG000|NOT COMPLETED|Overall Study||12
11017034|NCT00780416|12194793|FG001|NOT COMPLETED|Overall Study||9
11017035|NCT00780442|12194801|FG000|STARTED|Overall Study||12
11017036|NCT00780442|12194802|FG001|STARTED|Overall Study||15
11017037|NCT00780442|12194801|FG000|COMPLETED|Overall Study||12
11017038|NCT00780442|12194802|FG001|COMPLETED|Overall Study||15
11017039|NCT00780442|12194801|FG000|NOT COMPLETED|Overall Study||0
11017040|NCT00780442|12194802|FG001|NOT COMPLETED|Overall Study||0
11017041|NCT00780494|12194808|FG000|STARTED|Overall Study||35
11017042|NCT00780494|12194808|FG000|COMPLETED|Overall Study||35
11017043|NCT00780494|12194808|FG000|NOT COMPLETED|Overall Study||0
11017044|NCT00780559|12194814|FG000|STARTED|Overall Study||32
11017045|NCT00780559|12194815|FG001|STARTED|Overall Study||40
11017046|NCT00780559|12194814|FG000|COMPLETED|Overall Study||29
11017047|NCT00780559|12194815|FG001|COMPLETED|Overall Study||33
11017048|NCT00780559|12194814|FG000|NOT COMPLETED|Overall Study||3
11017049|NCT00780559|12194815|FG001|NOT COMPLETED|Overall Study||7
11017050|NCT00780572|12194825|FG000|STARTED|Overall Study||297
11017051|NCT00780572|12194826|FG001|STARTED|Overall Study||298
11017052|NCT00780572|12194825|FG000|COMPLETED|Overall Study||297
11017053|NCT00780572|12194826|FG001|COMPLETED|Overall Study||298
11017054|NCT00780572|12194825|FG000|NOT COMPLETED|Overall Study||0
11017055|NCT00780572|12194826|FG001|NOT COMPLETED|Overall Study||0
11017056|NCT00780676|12194837|FG000|STARTED|Overall Study||9
11017057|NCT00780676|12194838|FG001|STARTED|Overall Study||8
11017058|NCT00780676|12194839|FG002|STARTED|Overall Study||13
11017059|NCT00780676|12194840|FG003|STARTED|Overall Study||0
11017060|NCT00780676|12194841|FG004|STARTED|Overall Study||0
11017061|NCT00780676|12194837|FG000|COMPLETED|Overall Study||9
11017062|NCT00780676|12194838|FG001|COMPLETED|Overall Study||8
11017063|NCT00780676|12194839|FG002|COMPLETED|Overall Study||13
11017064|NCT00780676|12194840|FG003|COMPLETED|Overall Study||0
11017065|NCT00780676|12194841|FG004|COMPLETED|Overall Study||0
11017066|NCT00780676|12194837|FG000|NOT COMPLETED|Overall Study||0
11017067|NCT00780676|12194838|FG001|NOT COMPLETED|Overall Study||0
11017068|NCT00780676|12194839|FG002|NOT COMPLETED|Overall Study||0
11017069|NCT00780676|12194840|FG003|NOT COMPLETED|Overall Study||0
11017070|NCT00780676|12194841|FG004|NOT COMPLETED|Overall Study||0
11017071|NCT00780715|12194851|FG000|STARTED|Overall Study||6
11396592|NCT03829618|12590470|FG002|COMPLETED|Overall Study||7
11396593|NCT03829618|12590468|FG000|NOT COMPLETED|Overall Study||0
11396594|NCT03829618|12590469|FG001|NOT COMPLETED|Overall Study||0
11396595|NCT03829618|12590470|FG002|NOT COMPLETED|Overall Study||0
11017072|NCT00780715|12194852|FG001|STARTED|Overall Study||6
11017073|NCT00780715|12194853|FG002|STARTED|Overall Study||6
11017074|NCT00780715|12194854|FG003|STARTED|Overall Study||11
11017075|NCT00780715|12194851|FG000|COMPLETED|Overall Study||6
11017076|NCT00780715|12194852|FG001|COMPLETED|Overall Study||6
11017077|NCT00780715|12194853|FG002|COMPLETED|Overall Study||6
11017078|NCT00780715|12194854|FG003|COMPLETED|Overall Study||11
11017079|NCT00780715|12194851|FG000|NOT COMPLETED|Overall Study||0
11017080|NCT00780715|12194852|FG001|NOT COMPLETED|Overall Study||0
11017081|NCT00780715|12194853|FG002|NOT COMPLETED|Overall Study||0
11017082|NCT00780715|12194854|FG003|NOT COMPLETED|Overall Study||0
11017083|NCT00780741|12194866|FG000|STARTED|Overall Study|randomized|82
11017084|NCT00780741|12194867|FG001|STARTED|Overall Study|randomized|81
11017085|NCT00780741|12194866|FG000|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
11017086|NCT00780741|12194867|FG001|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
11017087|NCT00780741|12194866|FG000|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
11017088|NCT00780741|12194867|FG001|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
11017089|NCT00780741|12194866|FG000|NOT COMPLETED|Overall Study||7
11017090|NCT00780741|12194867|FG001|NOT COMPLETED|Overall Study||10
11017091|NCT00780910|12194874|FG000|STARTED|Overall Study||109
11017092|NCT00780910|12194874|FG000|COMPLETED|Overall Study||107
11017093|NCT00780910|12194874|FG000|NOT COMPLETED|Overall Study||2
11017094|NCT00780962|12194880|FG000|STARTED|Overall Study||200
11017095|NCT00780962|12194881|FG001|STARTED|Overall Study||199
11017096|NCT00780962|12194880|FG000|Second Blood Draw (Outcome Measurement)|Overall Study||185
11017097|NCT00780962|12194881|FG001|Second Blood Draw (Outcome Measurement)|Overall Study||172
11017098|NCT00780962|12194880|FG000|COMPLETED|Overall Study||185
11017099|NCT00780962|12194881|FG001|COMPLETED|Overall Study||172
11017100|NCT00780962|12194880|FG000|NOT COMPLETED|Overall Study||15
11017101|NCT00780962|12194881|FG001|NOT COMPLETED|Overall Study||27
11017102|NCT00780975|12194887|FG000|STARTED|Overall Study||8
11017103|NCT00780975|12194887|FG000|COMPLETED|Overall Study||0
11017104|NCT00780975|12194887|FG000|NOT COMPLETED|Overall Study||8
11017105|NCT00781079|12194893|FG000|STARTED|Overall Study||149
11263750|NCT02271984|12459067|FG006|COMPLETED|Washout Period 4 (7 Days)||3
11263751|NCT02271984|12459068|FG007|COMPLETED|Washout Period 4 (7 Days)||2
11263752|NCT02271984|12459069|FG008|COMPLETED|Washout Period 4 (7 Days)||3
11263753|NCT02271984|12459070|FG009|COMPLETED|Washout Period 4 (7 Days)||3
11263754|NCT02271984|12459071|FG010|COMPLETED|Washout Period 4 (7 Days)||3
11263755|NCT02271984|12459072|FG011|COMPLETED|Washout Period 4 (7 Days)||3
11263756|NCT02271984|12459061|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0
11263757|NCT02271984|12459062|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0
11263758|NCT02271984|12459063|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0
11263759|NCT02271984|12459064|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0
11263760|NCT02271984|12459065|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0
11263761|NCT02271984|12459066|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||1
11263762|NCT02271984|12459067|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0
11263763|NCT02271984|12459068|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||1
11263764|NCT02271984|12459069|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0
11263765|NCT02271984|12459070|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0
11263766|NCT02271984|12459071|FG010|NOT COMPLETED|Washout Period 4 (7 Days)||0
11263767|NCT02271984|12459072|FG011|NOT COMPLETED|Washout Period 4 (7 Days)||0
11263768|NCT02271984|12459061|FG000|STARTED|Fifth Intervention Period (1 Day)||3
11396596|NCT03830333|12590480|FG000|STARTED|Overall Study||134
11017106|NCT00781079|12194894|FG001|STARTED|Overall Study||133
11017107|NCT00781079|12194893|FG000|COMPLETED|Overall Study||122
11017108|NCT00781079|12194894|FG001|COMPLETED|Overall Study||116
11017109|NCT00781079|12194893|FG000|NOT COMPLETED|Overall Study||27
11017110|NCT00781079|12194894|FG001|NOT COMPLETED|Overall Study||17
11017111|NCT00781274|12194900|FG000|STARTED|Overall Study||32
11017112|NCT00781274|12194900|FG000|COMPLETED|Overall Study||30
11143285|NCT01473524|12330179|FG002|Received at Least 1 Dose of Study Drug|DB Phase||73
11143286|NCT01473524|12330180|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0
11143287|NCT01473524|12330181|FG004|Received at Least 1 Dose of Study Drug|DB Phase||0
11143288|NCT01473524|12330182|FG005|Received at Least 1 Dose of Study Drug|DB Phase||0
11143289|NCT01473524|12330177|FG000|COMPLETED|DB Phase||64
11143290|NCT01473524|12330178|FG001|COMPLETED|DB Phase||64
11143291|NCT01473524|12330179|FG002|COMPLETED|DB Phase||70
11143292|NCT01473524|12330180|FG003|COMPLETED|DB Phase||0
11143293|NCT01473524|12330181|FG004|COMPLETED|DB Phase||0
11143294|NCT01473524|12330182|FG005|COMPLETED|DB Phase||0
11263769|NCT02271984|12459062|FG001|STARTED|Fifth Intervention Period (1 Day)||3
11263770|NCT02271984|12459063|FG002|STARTED|Fifth Intervention Period (1 Day)||3
11143295|NCT01473524|12330177|FG000|NOT COMPLETED|DB Phase||7
11143296|NCT01473524|12330178|FG001|NOT COMPLETED|DB Phase||9
11143297|NCT01473524|12330179|FG002|NOT COMPLETED|DB Phase||3
11143298|NCT01473524|12330180|FG003|NOT COMPLETED|DB Phase||0
11143299|NCT01473524|12330181|FG004|NOT COMPLETED|DB Phase||0
11143300|NCT01473524|12330182|FG005|NOT COMPLETED|DB Phase||0
11143301|NCT01473524|12330177|FG000|STARTED|LTSE Phase||0
11143302|NCT01473524|12330178|FG001|STARTED|LTSE Phase||0
11143303|NCT01473524|12330179|FG002|STARTED|LTSE Phase||0
11143304|NCT01473524|12330180|FG003|STARTED|LTSE Phase|One participant in the double-blind OCA 5-10 mg group did not enroll in the LTSE phase.|63
11143305|NCT01473524|12330181|FG004|STARTED|LTSE Phase||64
11143306|NCT01473524|12330182|FG005|STARTED|LTSE Phase|Four participants in the double-blind placebo group did not enroll in the LTSE phase.|66
11143307|NCT01473524|12330177|FG000|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
11143308|NCT01473524|12330178|FG001|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
11143309|NCT01473524|12330179|FG002|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
11017113|NCT00781274|12194900|FG000|NOT COMPLETED|Overall Study||2
11017114|NCT00781326|12194904|FG000|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
11017115|NCT00781326|12194904|FG000|COMPLETED|Phase I||2
11017116|NCT00781326|12194904|FG000|NOT COMPLETED|Phase I||4
11017117|NCT00781326|12194904|FG000|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
11017118|NCT00781326|12194904|FG000|COMPLETED|Phase 2||0
11017119|NCT00781326|12194904|FG000|NOT COMPLETED|Phase 2||0
11017120|NCT00781365|12194910|FG000|STARTED|Overall Study||228
11017121|NCT00781365|12194911|FG001|STARTED|Overall Study||222
11017122|NCT00781365|12194910|FG000|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
11017123|NCT00781365|12194911|FG001|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
11017124|NCT00781365|12194910|FG000|NOT COMPLETED|Overall Study||34
11017125|NCT00781365|12194911|FG001|NOT COMPLETED|Overall Study||36
11017126|NCT00781391|12194920|FG000|STARTED|Overall Study||7036
11017127|NCT00781391|12194921|FG001|STARTED|Overall Study||7035
11017128|NCT00781391|12194922|FG002|STARTED|Overall Study||7034
11017129|NCT00781391|12194920|FG000|Safety Analysis Set (Received Drug)|Overall Study||7012
11017130|NCT00781391|12194921|FG001|Safety Analysis Set (Received Drug)|Overall Study||7012
11017131|NCT00781391|12194922|FG002|Safety Analysis Set (Received Drug)|Overall Study||7002
11017132|NCT00781391|12194920|FG000|mITT Analysis Set (Received Drug)|Overall Study||7012
11017133|NCT00781391|12194921|FG001|mITT Analysis Set (Received Drug)|Overall Study||7012
11017134|NCT00781391|12194922|FG002|mITT Analysis Set (Received Drug)|Overall Study||7002
11017135|NCT00781391|12194920|FG000|Per Protocol Analysis Set|Overall Study||6993
11017136|NCT00781391|12194921|FG001|Per Protocol Analysis Set|Overall Study||6995
11017137|NCT00781391|12194922|FG002|Per Protocol Analysis Set|Overall Study||6982
11017138|NCT00781391|12194920|FG000|COMPLETED|Overall Study||6157
11017139|NCT00781391|12194921|FG001|COMPLETED|Overall Study||6228
11396597|NCT03830333|12590481|FG001|STARTED|Overall Study||134
11396598|NCT03830333|12590480|FG000|Clinically Evaluable Population|Overall Study||105
11396599|NCT03830333|12590481|FG001|Clinically Evaluable Population|Overall Study||116
11396600|NCT03830333|12590480|FG000|COMPLETED|Overall Study||126
11017140|NCT00781391|12194922|FG002|COMPLETED|Overall Study||6250
11017141|NCT00781391|12194920|FG000|NOT COMPLETED|Overall Study||879
11143310|NCT01473524|12330180|FG003|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||63
11143311|NCT01473524|12330181|FG004|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||64
11143312|NCT01473524|12330182|FG005|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||66
11143313|NCT01473524|12330177|FG000|COMPLETED|LTSE Phase||0
11143314|NCT01473524|12330178|FG001|COMPLETED|LTSE Phase||0
11143315|NCT01473524|12330179|FG002|COMPLETED|LTSE Phase||0
11143316|NCT01473524|12330180|FG003|COMPLETED|LTSE Phase||54
11143317|NCT01473524|12330181|FG004|COMPLETED|LTSE Phase||47
11143318|NCT01473524|12330182|FG005|COMPLETED|LTSE Phase||45
11143319|NCT01473524|12330177|FG000|NOT COMPLETED|LTSE Phase||0
11143320|NCT01473524|12330178|FG001|NOT COMPLETED|LTSE Phase||0
11143321|NCT01473524|12330179|FG002|NOT COMPLETED|LTSE Phase||0
11143322|NCT01473524|12330180|FG003|NOT COMPLETED|LTSE Phase||9
11143323|NCT01473524|12330181|FG004|NOT COMPLETED|LTSE Phase||17
11143324|NCT01473524|12330182|FG005|NOT COMPLETED|LTSE Phase||21
11143325|NCT01473563|12330204|FG000|STARTED|Overall Study||52
11143326|NCT01473563|12330204|FG000|Received at Least 1 Dose of Study Drug|Overall Study||52
11143327|NCT01473563|12330204|FG000|COMPLETED|Overall Study||51
11143328|NCT01473563|12330204|FG000|NOT COMPLETED|Overall Study||1
11396601|NCT03830333|12590481|FG001|COMPLETED|Overall Study||130
11396602|NCT03830333|12590480|FG000|NOT COMPLETED|Overall Study||8
11017142|NCT00781391|12194921|FG001|NOT COMPLETED|Overall Study||807
11017143|NCT00781391|12194922|FG002|NOT COMPLETED|Overall Study||784
11017144|NCT00781456|12194932|FG000|STARTED|Overall Study||58
11017145|NCT00781456|12194933|FG001|STARTED|Overall Study||51
11017146|NCT00781456|12194932|FG000|Received Study Drug|Overall Study||57
11017147|NCT00781456|12194933|FG001|Received Study Drug|Overall Study||49
11017148|NCT00781456|12194932|FG000|COMPLETED|Overall Study||37
11017149|NCT00781456|12194933|FG001|COMPLETED|Overall Study||35
11017150|NCT00781456|12194932|FG000|NOT COMPLETED|Overall Study||21
11017151|NCT00781456|12194933|FG001|NOT COMPLETED|Overall Study||16
11056833|NCT00996125|12238437|FG000|COMPLETED|Overall Study||369
11143329|NCT01473589|12330210|FG000|STARTED|Overall Study||60
11143330|NCT01473589|12330211|FG001|STARTED|Overall Study||62
11143331|NCT01473589|12330210|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
11202638|NCT01841697|12393055|FG001|STARTED|Overall Study||320
11017152|NCT00781508|12194941|FG000|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
11017153|NCT00781508|12194942|FG001|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
11017154|NCT00781508|12194941|FG000|COMPLETED|Overall Study||5
11017155|NCT00781508|12194942|FG001|COMPLETED|Overall Study||5
11017156|NCT00781508|12194941|FG000|NOT COMPLETED|Overall Study||0
11017157|NCT00781508|12194942|FG001|NOT COMPLETED|Overall Study||0
11017158|NCT00781599|12194952|FG000|STARTED|Overall Study||36
11017159|NCT00781599|12194953|FG001|STARTED|Overall Study||36
11017160|NCT00781599|12194952|FG000|COMPLETED|Overall Study||29
11017161|NCT00781599|12194953|FG001|COMPLETED|Overall Study||32
11017162|NCT00781599|12194952|FG000|NOT COMPLETED|Overall Study||7
11017163|NCT00781599|12194953|FG001|NOT COMPLETED|Overall Study||4
11017164|NCT00781768|12194961|FG000|STARTED|Overall Study||89
11017165|NCT00781768|12194962|FG001|STARTED|Overall Study||92
11017166|NCT00781768|12194961|FG000|COMPLETED|Overall Study||89
11017167|NCT00781768|12194962|FG001|COMPLETED|Overall Study||90
11017168|NCT00781768|12194961|FG000|NOT COMPLETED|Overall Study||0
11017169|NCT00781768|12194962|FG001|NOT COMPLETED|Overall Study||2
11017170|NCT00781859|12194970|FG000|STARTED|Overall Study||219
11017171|NCT00781859|12194971|FG001|STARTED|Overall Study||107
11017172|NCT00781859|12194970|FG000|COMPLETED|Overall Study||200
11017173|NCT00781859|12194971|FG001|COMPLETED|Overall Study||98
11017174|NCT00781859|12194970|FG000|NOT COMPLETED|Overall Study||19
11017175|NCT00781859|12194971|FG001|NOT COMPLETED|Overall Study||9
11017176|NCT00781885|12194977|FG000|STARTED|Overall Study||19
11017177|NCT00781885|12194977|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19
11017178|NCT00781885|12194977|FG000|COMPLETED|Overall Study||18
11017179|NCT00781885|12194977|FG000|NOT COMPLETED|Overall Study||1
11017180|NCT00781898|12194983|FG000|STARTED|Overall Study||153
11017181|NCT00781898|12194984|FG001|STARTED|Overall Study||155
11017182|NCT00781898|12194983|FG000|COMPLETED|Overall Study||119
11017183|NCT00781898|12194984|FG001|COMPLETED|Overall Study||126
11143332|NCT01473589|12330211|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
11143333|NCT01473589|12330210|FG000|Completed 6 Months|Overall Study||51
11143334|NCT01473589|12330211|FG001|Completed 6 Months|Overall Study||54
11143335|NCT01473589|12330210|FG000|Completed 12 Months|Overall Study||49
11143336|NCT01473589|12330211|FG001|Completed 12 Months|Overall Study||48
11143337|NCT01473589|12330210|FG000|COMPLETED|Overall Study||49
11143338|NCT01473589|12330211|FG001|COMPLETED|Overall Study||46
11143339|NCT01473589|12330210|FG000|NOT COMPLETED|Overall Study||11
11143340|NCT01473589|12330211|FG001|NOT COMPLETED|Overall Study||16
11143341|NCT01473602|12330221|FG000|STARTED|Overall Study||18
11143342|NCT01473602|12330222|FG001|STARTED|Overall Study||21
11143343|NCT01473602|12330221|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
11143344|NCT01473602|12330222|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
11143345|NCT01473602|12330221|FG000|Completed 6 Months|Overall Study||12
11143346|NCT01473602|12330222|FG001|Completed 6 Months|Overall Study||15
11143347|NCT01473602|12330221|FG000|Completed 12 Months|Overall Study||10
11143348|NCT01473602|12330222|FG001|Completed 12 Months|Overall Study||13
11143349|NCT01473602|12330221|FG000|COMPLETED|Overall Study||10
11143350|NCT01473602|12330222|FG001|COMPLETED|Overall Study||13
11143351|NCT01473602|12330221|FG000|NOT COMPLETED|Overall Study||8
11143352|NCT01473602|12330222|FG001|NOT COMPLETED|Overall Study||8
11143353|NCT01473745|12330232|FG000|STARTED|Overall Study||24
11143354|NCT01473745|12330233|FG001|STARTED|Overall Study||24
11143355|NCT01473745|12330232|FG000|COMPLETED|Overall Study||24
11143356|NCT01473745|12330233|FG001|COMPLETED|Overall Study||24
11143357|NCT01473745|12330232|FG000|NOT COMPLETED|Overall Study||0
11143358|NCT01473745|12330233|FG001|NOT COMPLETED|Overall Study||0
11143359|NCT01473758|12330241|FG000|STARTED|Cycle 1||38
11143360|NCT01473758|12330242|FG001|STARTED|Cycle 1||43
11143361|NCT01473758|12330243|FG002|STARTED|Cycle 1||0
11143362|NCT01473758|12330244|FG003|STARTED|Cycle 1||0
11143363|NCT01473758|12330241|FG000|COMPLETED|Cycle 1||27
11143364|NCT01473758|12330242|FG001|COMPLETED|Cycle 1||40
11396603|NCT03830333|12590481|FG001|NOT COMPLETED|Overall Study||4
11396604|NCT03831880|12590489|FG000|STARTED|Period 1 (12 Weeks)||43
11396605|NCT03831880|12590490|FG001|STARTED|Period 1 (12 Weeks)||44
11396606|NCT03831880|12590489|FG000|COMPLETED|Period 1 (12 Weeks)||43
11396607|NCT03831880|12590490|FG001|COMPLETED|Period 1 (12 Weeks)||43
11017184|NCT00781898|12194983|FG000|NOT COMPLETED|Overall Study||34
11017185|NCT00781898|12194984|FG001|NOT COMPLETED|Overall Study||29
11017186|NCT00781911|12194992|FG000|STARTED|Overall Study||31
11396608|NCT03831880|12590489|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
11396609|NCT03831880|12590490|FG001|NOT COMPLETED|Period 1 (12 Weeks)||1
11396610|NCT03831880|12590489|FG000|STARTED|Period 2 (12 Weeks)||43
11017187|NCT00781911|12194993|FG001|STARTED|Overall Study||12
11017188|NCT00781911|12194992|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
11017189|NCT00781911|12194993|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12
11017190|NCT00781911|12194992|FG000|COMPLETED|Overall Study||25
11143365|NCT01473758|12330243|FG002|COMPLETED|Cycle 1||0
11143366|NCT01473758|12330244|FG003|COMPLETED|Cycle 1||0
11143367|NCT01473758|12330241|FG000|NOT COMPLETED|Cycle 1||11
11143368|NCT01473758|12330242|FG001|NOT COMPLETED|Cycle 1||3
11143369|NCT01473758|12330243|FG002|NOT COMPLETED|Cycle 1||0
11396611|NCT03831880|12590490|FG001|STARTED|Period 2 (12 Weeks)||43
11396612|NCT03831880|12590489|FG000|COMPLETED|Period 2 (12 Weeks)||43
11396613|NCT03831880|12590490|FG001|COMPLETED|Period 2 (12 Weeks)||42
11143370|NCT01473758|12330244|FG003|NOT COMPLETED|Cycle 1||0
11396614|NCT03831880|12590489|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
11017191|NCT00781911|12194993|FG001|COMPLETED|Overall Study||4
11017192|NCT00781911|12194992|FG000|NOT COMPLETED|Overall Study||6
11017193|NCT00781911|12194993|FG001|NOT COMPLETED|Overall Study||8
11017194|NCT00781937|12195003|FG000|STARTED|Main Trial Period Through Week 56||212
11017195|NCT00781937|12195004|FG001|STARTED|Main Trial Period Through Week 56||210
11017196|NCT00781937|12195003|FG000|COMPLETED|Main Trial Period Through Week 56||159
11017197|NCT00781937|12195004|FG001|COMPLETED|Main Trial Period Through Week 56||146
11017198|NCT00781937|12195003|FG000|NOT COMPLETED|Main Trial Period Through Week 56||53
11017199|NCT00781937|12195004|FG001|NOT COMPLETED|Main Trial Period Through Week 56||64
11017200|NCT00781937|12195003|FG000|STARTED|Follow up Period (Week 56-68)||159
11017201|NCT00781937|12195004|FG001|STARTED|Follow up Period (Week 56-68)||146
11017202|NCT00781937|12195003|FG000|COMPLETED|Follow up Period (Week 56-68)||153
11017203|NCT00781937|12195004|FG001|COMPLETED|Follow up Period (Week 56-68)||141
11017204|NCT00781937|12195003|FG000|NOT COMPLETED|Follow up Period (Week 56-68)||6
11017205|NCT00781937|12195004|FG001|NOT COMPLETED|Follow up Period (Week 56-68)||5
11017206|NCT00781950|12195012|FG000|STARTED|Overall Study||52
11017207|NCT00781950|12195013|FG001|STARTED|Overall Study||58
11017208|NCT00781950|12195012|FG000|COMPLETED|Overall Study||41
11017209|NCT00781950|12195013|FG001|COMPLETED|Overall Study||45
11017210|NCT00781950|12195012|FG000|NOT COMPLETED|Overall Study||11
11017211|NCT00781950|12195013|FG001|NOT COMPLETED|Overall Study||13
11017212|NCT00781963|12195022|FG000|STARTED|Overall Study||106
11017213|NCT00781963|12195023|FG001|STARTED|Overall Study||53
11017214|NCT00781963|12195022|FG000|COMPLETED|Overall Study||89
11017215|NCT00781963|12195023|FG001|COMPLETED|Overall Study||51
11017216|NCT00781963|12195022|FG000|NOT COMPLETED|Overall Study||17
11017217|NCT00781963|12195023|FG001|NOT COMPLETED|Overall Study||2
11017218|NCT00782067|12195029|FG000|STARTED|Overall Study||116
11017219|NCT00782067|12195029|FG000|Safety Set (SS)|Overall Study||116
11017220|NCT00782067|12195029|FG000|Primary Efficacy Population (PEP)|Overall Study||89
11017221|NCT00782067|12195029|FG000|COMPLETED|Overall Study||0
11017222|NCT00782067|12195029|FG000|NOT COMPLETED|Overall Study||116
11017223|NCT00782171|12195035|FG000|STARTED|Overall Study||146
11017224|NCT00782171|12195036|FG001|STARTED|Overall Study||134
11017225|NCT00782171|12195035|FG000|20-23 Weeks|Overall Study||135
11017226|NCT00782171|12195036|FG001|20-23 Weeks|Overall Study||124
11017227|NCT00782171|12195035|FG000|1 Year|Overall Study||131
11017228|NCT00782171|12195036|FG001|1 Year|Overall Study||120
11017229|NCT00782171|12195035|FG000|Surgery (Baseline)|Overall Study||138
11017230|NCT00782171|12195036|FG001|Surgery (Baseline)|Overall Study||128
11017231|NCT00782171|12195035|FG000|COMPLETED|Overall Study||124
11017232|NCT00782171|12195036|FG001|COMPLETED|Overall Study||115
11017233|NCT00782171|12195035|FG000|NOT COMPLETED|Overall Study||22
11017234|NCT00782171|12195036|FG001|NOT COMPLETED|Overall Study||19
11017235|NCT00782210|12195045|FG000|STARTED|Overall Study||209
11017236|NCT00782210|12195046|FG001|STARTED|Overall Study||208
11017237|NCT00782210|12195047|FG002|STARTED|Overall Study||207
11017238|NCT00782210|12195045|FG000|COMPLETED|Overall Study||159
11017239|NCT00782210|12195046|FG001|COMPLETED|Overall Study||173
11017240|NCT00782210|12195047|FG002|COMPLETED|Overall Study||172
11017241|NCT00782210|12195045|FG000|NOT COMPLETED|Overall Study||50
11017242|NCT00782210|12195046|FG001|NOT COMPLETED|Overall Study||35
11017243|NCT00782210|12195047|FG002|NOT COMPLETED|Overall Study||35
11017244|NCT00782275|12195064|FG000|STARTED|Overall Study||41
11017245|NCT00782275|12195064|FG000|Treated|Overall Study||40
11017246|NCT00782275|12195064|FG000|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
11017247|NCT00782275|12195064|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
11017248|NCT00782275|12195064|FG000|NOT COMPLETED|Overall Study||41
11017249|NCT00782340|12195071|FG000|STARTED|Open Label Titration||263
11017250|NCT00782340|12195072|FG001|STARTED|Open Label Titration||0
11017251|NCT00782340|12195073|FG002|STARTED|Open Label Titration||0
11396615|NCT03831880|12590490|FG001|NOT COMPLETED|Period 2 (12 Weeks)||1
11017252|NCT00782340|12195071|FG000|COMPLETED|Open Label Titration||162
11017253|NCT00782340|12195072|FG001|COMPLETED|Open Label Titration||0
11017254|NCT00782340|12195073|FG002|COMPLETED|Open Label Titration||0
11017255|NCT00782340|12195071|FG000|NOT COMPLETED|Open Label Titration||101
11017256|NCT00782340|12195072|FG001|NOT COMPLETED|Open Label Titration||0
11017257|NCT00782340|12195073|FG002|NOT COMPLETED|Open Label Titration||0
11017258|NCT00782340|12195071|FG000|STARTED|Randomized Double Blind||0
11017259|NCT00782340|12195072|FG001|STARTED|Randomized Double Blind||82
11017260|NCT00782340|12195073|FG002|STARTED|Randomized Double Blind||80
11017261|NCT00782340|12195071|FG000|COMPLETED|Randomized Double Blind||0
11017262|NCT00782340|12195072|FG001|COMPLETED|Randomized Double Blind||82
11017263|NCT00782340|12195073|FG002|COMPLETED|Randomized Double Blind||80
11017264|NCT00782340|12195071|FG000|NOT COMPLETED|Randomized Double Blind||0
11017265|NCT00782340|12195072|FG001|NOT COMPLETED|Randomized Double Blind||0
11017266|NCT00782340|12195073|FG002|NOT COMPLETED|Randomized Double Blind||0
11017267|NCT00782379|12195080|FG000|STARTED|Overall Study||20
11017268|NCT00782379|12195080|FG000|COMPLETED|Overall Study||20
11017269|NCT00782379|12195080|FG000|NOT COMPLETED|Overall Study||0
11017270|NCT00782418|12195084|FG000|STARTED|Period 1 Procedure/Treatment Groups||3
11017271|NCT00782418|12195085|FG001|STARTED|Period 1 Procedure/Treatment Groups||4
11017272|NCT00782418|12195086|FG002|STARTED|Period 1 Procedure/Treatment Groups||4
11017273|NCT00782418|12195087|FG003|STARTED|Period 1 Procedure/Treatment Groups||2
11017274|NCT00782418|12195088|FG004|STARTED|Period 1 Procedure/Treatment Groups||5
11017275|NCT00782418|12195089|FG005|STARTED|Period 1 Procedure/Treatment Groups||5
11017276|NCT00782418|12195090|FG006|STARTED|Period 1 Procedure/Treatment Groups||4
11017277|NCT00782418|12195084|FG000|COMPLETED|Period 1 Procedure/Treatment Groups||1
11017278|NCT00782418|12195085|FG001|COMPLETED|Period 1 Procedure/Treatment Groups||4
11017279|NCT00782418|12195086|FG002|COMPLETED|Period 1 Procedure/Treatment Groups||4
11017280|NCT00782418|12195087|FG003|COMPLETED|Period 1 Procedure/Treatment Groups||2
11017281|NCT00782418|12195088|FG004|COMPLETED|Period 1 Procedure/Treatment Groups||4
11017282|NCT00782418|12195089|FG005|COMPLETED|Period 1 Procedure/Treatment Groups||4
11017283|NCT00782418|12195090|FG006|COMPLETED|Period 1 Procedure/Treatment Groups||4
11017284|NCT00782418|12195084|FG000|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
11017285|NCT00782418|12195085|FG001|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
11017286|NCT00782418|12195086|FG002|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
11017287|NCT00782418|12195087|FG003|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
11017288|NCT00782418|12195088|FG004|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
11017289|NCT00782418|12195089|FG005|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
11017290|NCT00782418|12195090|FG006|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
11017291|NCT00782418|12195084|FG000|STARTED|Period 2 Procedure/Treatment Groups||3
11017292|NCT00782418|12195085|FG001|STARTED|Period 2 Procedure/Treatment Groups||4
11017293|NCT00782418|12195086|FG002|STARTED|Period 2 Procedure/Treatment Groups||4
11017294|NCT00782418|12195087|FG003|STARTED|Period 2 Procedure/Treatment Groups||1
11017295|NCT00782418|12195088|FG004|STARTED|Period 2 Procedure/Treatment Groups||3
11017296|NCT00782418|12195089|FG005|STARTED|Period 2 Procedure/Treatment Groups||4
11017297|NCT00782418|12195090|FG006|STARTED|Period 2 Procedure/Treatment Groups||4
11017298|NCT00782418|12195084|FG000|COMPLETED|Period 2 Procedure/Treatment Groups||3
11017299|NCT00782418|12195085|FG001|COMPLETED|Period 2 Procedure/Treatment Groups||4
11017300|NCT00782418|12195086|FG002|COMPLETED|Period 2 Procedure/Treatment Groups||4
11017301|NCT00782418|12195087|FG003|COMPLETED|Period 2 Procedure/Treatment Groups||1
11017302|NCT00782418|12195088|FG004|COMPLETED|Period 2 Procedure/Treatment Groups||3
11017303|NCT00782418|12195089|FG005|COMPLETED|Period 2 Procedure/Treatment Groups||4
11017304|NCT00782418|12195090|FG006|COMPLETED|Period 2 Procedure/Treatment Groups||4
11017305|NCT00782418|12195084|FG000|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
11017306|NCT00782418|12195085|FG001|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
11017307|NCT00782418|12195086|FG002|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
11017308|NCT00782418|12195087|FG003|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
11017309|NCT00782418|12195088|FG004|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
11017310|NCT00782418|12195089|FG005|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
11017311|NCT00782418|12195090|FG006|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
11017312|NCT00782496|12195106|FG000|STARTED|Overall Study||106
11017313|NCT00782496|12195107|FG001|STARTED|Overall Study||105
11017314|NCT00782496|12195106|FG000|COMPLETED|Overall Study||92
11017315|NCT00782496|12195107|FG001|COMPLETED|Overall Study||90
11017316|NCT00782496|12195106|FG000|NOT COMPLETED|Overall Study||14
11017317|NCT00782496|12195107|FG001|NOT COMPLETED|Overall Study||15
11017318|NCT00782509|12195117|FG000|STARTED|Overall Study||216
11017319|NCT00782509|12195118|FG001|STARTED|Overall Study||209
11017320|NCT00782509|12195119|FG002|STARTED|Overall Study||217
11017321|NCT00782509|12195117|FG000|COMPLETED|Overall Study||175
11017322|NCT00782509|12195118|FG001|COMPLETED|Overall Study||185
11017323|NCT00782509|12195119|FG002|COMPLETED|Overall Study||181
11017324|NCT00782509|12195117|FG000|NOT COMPLETED|Overall Study||41
11017325|NCT00782509|12195118|FG001|NOT COMPLETED|Overall Study||24
11017326|NCT00782509|12195119|FG002|NOT COMPLETED|Overall Study||36
11017327|NCT00782626|12195134|FG000|STARTED|Overall Study||23
11017328|NCT00782626|12195134|FG000|COMPLETED|Overall Study||16
11017329|NCT00782626|12195134|FG000|NOT COMPLETED|Overall Study||7
11056834|NCT00996125|12238438|FG001|COMPLETED|Overall Study||365
11056835|NCT00996125|12238437|FG000|NOT COMPLETED|Overall Study||5
11056836|NCT00996125|12238438|FG001|NOT COMPLETED|Overall Study||11
11056837|NCT00996164|12238446|FG000|STARTED|Overall Study||543
11056838|NCT00996164|12238447|FG001|STARTED|Overall Study||547
11056839|NCT00996164|12238446|FG000|COMPLETED|Overall Study||408
11056840|NCT00996164|12238447|FG001|COMPLETED|Overall Study||446
11056841|NCT00996164|12238446|FG000|NOT COMPLETED|Overall Study||135
11056842|NCT00996164|12238447|FG001|NOT COMPLETED|Overall Study||101
11056843|NCT00996203|12238453|FG000|STARTED|Overall Study||201
11056844|NCT00996203|12238453|FG000|COMPLETED|Overall Study||194
11056845|NCT00996203|12238453|FG000|NOT COMPLETED|Overall Study||7
11056846|NCT00996216|12238458|FG000|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
11056847|NCT00996216|12238458|FG000|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
11056848|NCT00996216|12238458|FG000|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
11056849|NCT00996216|12238458|FG000|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn't qualify to begin antiviral treatment in Part 2.|25
11056850|NCT00996216|12238458|FG000|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
11056851|NCT00996216|12238458|FG000|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
11056852|NCT00996281|12238465|FG000|STARTED|Overall Study||418
11056853|NCT00996281|12238466|FG001|STARTED|Overall Study||419
11056854|NCT00996281|12238465|FG000|COMPLETED|Overall Study||287
11056855|NCT00996281|12238466|FG001|COMPLETED|Overall Study||330
11056856|NCT00996281|12238465|FG000|NOT COMPLETED|Overall Study||131
11056857|NCT00996281|12238466|FG001|NOT COMPLETED|Overall Study||89
11056858|NCT00996307|12238476|FG000|STARTED|Overall Study||164
11056859|NCT00996307|12238477|FG001|STARTED|Overall Study||165
11056860|NCT00996307|12238478|FG002|STARTED|Overall Study||160
11017330|NCT00782639|12195140|FG000|STARTED|Overall Study||12
11017331|NCT00782639|12195141|FG001|STARTED|Overall Study||11
11017332|NCT00782639|12195140|FG000|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
11017333|NCT00782639|12195141|FG001|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
11017334|NCT00782639|12195140|FG000|NOT COMPLETED|Overall Study||0
11017335|NCT00782639|12195141|FG001|NOT COMPLETED|Overall Study||0
11017336|NCT00782717|12195151|FG000|STARTED|Overall Study||133
11017337|NCT00782717|12195152|FG001|STARTED|Overall Study||130
11017338|NCT00782717|12195151|FG000|COMPLETED|Overall Study||118
11017339|NCT00782717|12195152|FG001|COMPLETED|Overall Study||102
11017340|NCT00782717|12195151|FG000|NOT COMPLETED|Overall Study||15
11017341|NCT00782717|12195152|FG001|NOT COMPLETED|Overall Study||28
11017342|NCT00782756|12195158|FG000|STARTED|Overall Study||40
11017343|NCT00782756|12195158|FG000|COMPLETED|Overall Study||40
11017344|NCT00782756|12195158|FG000|NOT COMPLETED|Overall Study||0
11017345|NCT00782795|12195164|FG000|STARTED|Overall Study||17
11017346|NCT00782795|12195165|FG001|STARTED|Overall Study||8
11396616|NCT03831880|12590489|FG000|STARTED|Follow-up (5 Weeks)||43
11396617|NCT03831880|12590490|FG001|STARTED|Follow-up (5 Weeks)|1 participant who discontinued from Period 1 completed follow-up visit.|43
11396618|NCT03831880|12590489|FG000|COMPLETED|Follow-up (5 Weeks)||43
11396619|NCT03831880|12590490|FG001|COMPLETED|Follow-up (5 Weeks)||43
11396620|NCT03831880|12590489|FG000|NOT COMPLETED|Follow-up (5 Weeks)||0
11396621|NCT03831880|12590490|FG001|NOT COMPLETED|Follow-up (5 Weeks)||0
11017347|NCT00782795|12195164|FG000|6 Weeks (1st Apptment)|Overall Study||16
11017348|NCT00782795|12195165|FG001|6 Weeks (1st Apptment)|Overall Study||7
11017349|NCT00782795|12195164|FG000|24 Week Appointment|Overall Study||16
11017350|NCT00782795|12195165|FG001|24 Week Appointment|Overall Study||7
11017351|NCT00782795|12195164|FG000|COMPLETED|Overall Study||16
11017352|NCT00782795|12195165|FG001|COMPLETED|Overall Study||6
11017353|NCT00782795|12195164|FG000|NOT COMPLETED|Overall Study||1
11017354|NCT00782795|12195165|FG001|NOT COMPLETED|Overall Study||2
11017355|NCT00782821|12195175|FG000|STARTED|Overall Study||10
11017356|NCT00782821|12195176|FG001|STARTED|Overall Study||10
11017357|NCT00782821|12195177|FG002|STARTED|Overall Study||10
11017358|NCT00782821|12195178|FG003|STARTED|Overall Study||10
11017359|NCT00782821|12195175|FG000|COMPLETED|Overall Study||10
11017360|NCT00782821|12195176|FG001|COMPLETED|Overall Study||10
11017361|NCT00782821|12195177|FG002|COMPLETED|Overall Study||9
11017362|NCT00782821|12195178|FG003|COMPLETED|Overall Study||8
11017363|NCT00782821|12195175|FG000|NOT COMPLETED|Overall Study||0
11017364|NCT00782821|12195176|FG001|NOT COMPLETED|Overall Study||0
11017365|NCT00782821|12195177|FG002|NOT COMPLETED|Overall Study||1
11017366|NCT00782821|12195178|FG003|NOT COMPLETED|Overall Study||2
11017367|NCT00782834|12195195|FG000|STARTED|Screened Patients||15
11017368|NCT00782834|12195195|FG000|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
11017369|NCT00782834|12195195|FG000|NOT COMPLETED|Screened Patients||1
11017370|NCT00782834|12195195|FG000|STARTED|Treatment Phase||14
11017371|NCT00782834|12195195|FG000|COMPLETED|Treatment Phase||13
11017372|NCT00782834|12195195|FG000|NOT COMPLETED|Treatment Phase||1
11017373|NCT00783094|12195202|FG000|STARTED|Randomized Double-Blind Treatment Period||142
11017374|NCT00783094|12195203|FG001|STARTED|Randomized Double-Blind Treatment Period||140
11017375|NCT00783094|12195204|FG002|STARTED|Randomized Double-Blind Treatment Period||140
11017376|NCT00783094|12195202|FG000|COMPLETED|Randomized Double-Blind Treatment Period||135
11017377|NCT00783094|12195203|FG001|COMPLETED|Randomized Double-Blind Treatment Period||128
11017378|NCT00783094|12195204|FG002|COMPLETED|Randomized Double-Blind Treatment Period||131
11017379|NCT00783094|12195202|FG000|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
11017380|NCT00783094|12195203|FG001|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
11017381|NCT00783094|12195204|FG002|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
11396622|NCT03831945|12590500|FG000|STARTED|Overall Study||10
11396623|NCT03831945|12590501|FG001|STARTED|Overall Study||10
11396624|NCT03831945|12590500|FG000|COMPLETED|Overall Study||3
11396625|NCT03831945|12590501|FG001|COMPLETED|Overall Study||4
11017382|NCT00783094|12195202|FG000|STARTED|Open-Label Extension Period||135
11017383|NCT00783094|12195203|FG001|STARTED|Open-Label Extension Period||128
11017384|NCT00783094|12195204|FG002|STARTED|Open-Label Extension Period||131
11017385|NCT00783094|12195202|FG000|COMPLETED|Open-Label Extension Period||113
11017386|NCT00783094|12195203|FG001|COMPLETED|Open-Label Extension Period||109
11017387|NCT00783094|12195204|FG002|COMPLETED|Open-Label Extension Period||101
11017388|NCT00783094|12195202|FG000|NOT COMPLETED|Open-Label Extension Period||22
11017389|NCT00783094|12195203|FG001|NOT COMPLETED|Open-Label Extension Period||19
11017390|NCT00783094|12195204|FG002|NOT COMPLETED|Open-Label Extension Period||30
11017391|NCT00783198|12195218|FG000|STARTED|Overall Study||190
11017392|NCT00783198|12195219|FG001|STARTED|Overall Study||187
11017393|NCT00783198|12195220|FG002|STARTED|Overall Study||188
11017394|NCT00783198|12195218|FG000|COMPLETED|Overall Study||133
11017395|NCT00783198|12195219|FG001|COMPLETED|Overall Study||144
11017396|NCT00783198|12195220|FG002|COMPLETED|Overall Study||146
11017397|NCT00783198|12195218|FG000|NOT COMPLETED|Overall Study||57
11017398|NCT00783198|12195219|FG001|NOT COMPLETED|Overall Study||43
11017399|NCT00783198|12195220|FG002|NOT COMPLETED|Overall Study||42
11017400|NCT00783289|12195232|FG000|STARTED|Overall Study||6
11396626|NCT03831945|12590500|FG000|NOT COMPLETED|Overall Study||7
11396627|NCT03831945|12590501|FG001|NOT COMPLETED|Overall Study||6
11396628|NCT03835728|12590509|FG000|STARTED|Overall Study||2
11396629|NCT03835728|12590510|FG001|STARTED|Overall Study||1
11396630|NCT03835728|12590509|FG000|COMPLETED|Overall Study||2
11396631|NCT03835728|12590510|FG001|COMPLETED|Overall Study||1
11396632|NCT03835728|12590509|FG000|NOT COMPLETED|Overall Study||0
11396633|NCT03835728|12590510|FG001|NOT COMPLETED|Overall Study||0
11396634|NCT03840174|12590520|FG000|STARTED|Overall Study||6
11396635|NCT03840174|12590521|FG001|STARTED|Overall Study||6
11396636|NCT03840174|12590522|FG002|STARTED|Overall Study||3
11396637|NCT03840174|12590523|FG003|STARTED|Overall Study||3
11396638|NCT03840174|12590520|FG000|Vaccination 1|Overall Study||6
11396639|NCT03840174|12590521|FG001|Vaccination 1|Overall Study||6
11396640|NCT03840174|12590522|FG002|Vaccination 1|Overall Study||3
11396641|NCT03840174|12590523|FG003|Vaccination 1|Overall Study||3
11396642|NCT03840174|12590520|FG000|Vaccination 2|Overall Study||5
11396643|NCT03840174|12590521|FG001|Vaccination 2|Overall Study||6
11396644|NCT03840174|12590522|FG002|Vaccination 2|Overall Study||3
11396645|NCT03840174|12590523|FG003|Vaccination 2|Overall Study||3
11396646|NCT03840174|12590520|FG000|Vaccination 3|Overall Study||5
11017401|NCT00783289|12195233|FG001|STARTED|Overall Study||7
11017402|NCT00783289|12195234|FG002|STARTED|Overall Study||6
11017403|NCT00783289|12195235|FG003|STARTED|Overall Study||6
11017404|NCT00783289|12195232|FG000|COMPLETED|Overall Study||6
11017405|NCT00783289|12195233|FG001|COMPLETED|Overall Study||6
11017406|NCT00783289|12195234|FG002|COMPLETED|Overall Study||6
11017407|NCT00783289|12195235|FG003|COMPLETED|Overall Study||6
11017408|NCT00783289|12195232|FG000|NOT COMPLETED|Overall Study||0
11017409|NCT00783289|12195233|FG001|NOT COMPLETED|Overall Study||1
11017410|NCT00783289|12195234|FG002|NOT COMPLETED|Overall Study||0
11017411|NCT00783289|12195235|FG003|NOT COMPLETED|Overall Study||0
11017412|NCT00783302|12195248|FG000|STARTED|Overall Study||885
11017413|NCT00783302|12195248|FG000|COMPLETED|Overall Study||850
11017414|NCT00783302|12195248|FG000|NOT COMPLETED|Overall Study||35
11017415|NCT00783432|12195268|FG000|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
11017416|NCT00783432|12195269|FG001|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
11017417|NCT00783432|12195268|FG000|COMPLETED|Overall Study||345
11396647|NCT03840174|12590521|FG001|Vaccination 3|Overall Study||6
11396648|NCT03840174|12590522|FG002|Vaccination 3|Overall Study||3
11396649|NCT03840174|12590523|FG003|Vaccination 3|Overall Study||3
11396650|NCT03840174|12590520|FG000|COMPLETED|Overall Study||5
11396651|NCT03840174|12590521|FG001|COMPLETED|Overall Study||6
11396652|NCT03840174|12590522|FG002|COMPLETED|Overall Study||3
11396653|NCT03840174|12590523|FG003|COMPLETED|Overall Study||3
11396654|NCT03840174|12590520|FG000|NOT COMPLETED|Overall Study||1
11396655|NCT03840174|12590521|FG001|NOT COMPLETED|Overall Study||0
11396656|NCT03840174|12590522|FG002|NOT COMPLETED|Overall Study||0
11396657|NCT03840174|12590523|FG003|NOT COMPLETED|Overall Study||0
11017418|NCT00783432|12195269|FG001|COMPLETED|Overall Study||354
11017419|NCT00783432|12195268|FG000|NOT COMPLETED|Overall Study||85
11017420|NCT00783432|12195269|FG001|NOT COMPLETED|Overall Study||78
11017421|NCT00783614|12195279|FG000|STARTED|Overall Study||6
11017422|NCT00783614|12195280|FG001|STARTED|Overall Study||6
11017423|NCT00783614|12195281|FG002|STARTED|Overall Study||5
11017424|NCT00783614|12195282|FG003|STARTED|Overall Study||5
11017425|NCT00783614|12195279|FG000|COMPLETED|Overall Study||6
11017426|NCT00783614|12195280|FG001|COMPLETED|Overall Study||6
11017427|NCT00783614|12195281|FG002|COMPLETED|Overall Study||5
11017428|NCT00783614|12195282|FG003|COMPLETED|Overall Study||5
11017429|NCT00783614|12195279|FG000|NOT COMPLETED|Overall Study||0
11017430|NCT00783614|12195280|FG001|NOT COMPLETED|Overall Study||0
11017431|NCT00783614|12195281|FG002|NOT COMPLETED|Overall Study||0
11017432|NCT00783614|12195282|FG003|NOT COMPLETED|Overall Study||0
11017433|NCT00783692|12195295|FG000|STARTED|Induction Phase||148
11017434|NCT00783692|12195296|FG001|STARTED|Induction Phase||220
11017435|NCT00783692|12195297|FG002|STARTED|Induction Phase||748
11017436|NCT00783692|12195298|FG003|STARTED|Induction Phase||0
11017437|NCT00783692|12195299|FG004|STARTED|Induction Phase||0
11017438|NCT00783692|12195300|FG005|STARTED|Induction Phase||0
11017439|NCT00783692|12195301|FG006|STARTED|Induction Phase||0
11017440|NCT00783692|12195295|FG000|Treated|Induction Phase||148
11017441|NCT00783692|12195296|FG001|Treated|Induction Phase||220
11017442|NCT00783692|12195297|FG002|Treated|Induction Phase||747
11017443|NCT00783692|12195298|FG003|Treated|Induction Phase||0
11017444|NCT00783692|12195299|FG004|Treated|Induction Phase||0
11017445|NCT00783692|12195300|FG005|Treated|Induction Phase||0
11017446|NCT00783692|12195301|FG006|Treated|Induction Phase||0
11017447|NCT00783692|12195295|FG000|COMPLETED|Induction Phase||137
11017448|NCT00783692|12195296|FG001|COMPLETED|Induction Phase||199
11017449|NCT00783692|12195297|FG002|COMPLETED|Induction Phase||674
11017450|NCT00783692|12195298|FG003|COMPLETED|Induction Phase||0
11017451|NCT00783692|12195299|FG004|COMPLETED|Induction Phase||0
11017452|NCT00783692|12195300|FG005|COMPLETED|Induction Phase||0
11017453|NCT00783692|12195301|FG006|COMPLETED|Induction Phase||0
11017454|NCT00783692|12195295|FG000|NOT COMPLETED|Induction Phase||11
11017455|NCT00783692|12195296|FG001|NOT COMPLETED|Induction Phase||21
11017456|NCT00783692|12195297|FG002|NOT COMPLETED|Induction Phase||74
11017457|NCT00783692|12195298|FG003|NOT COMPLETED|Induction Phase||0
11017458|NCT00783692|12195299|FG004|NOT COMPLETED|Induction Phase||0
11017459|NCT00783692|12195300|FG005|NOT COMPLETED|Induction Phase||0
11017460|NCT00783692|12195301|FG006|NOT COMPLETED|Induction Phase||0
11017461|NCT00783692|12195295|FG000|STARTED|Maintenance Phase||137
11017462|NCT00783692|12195296|FG001|STARTED|Maintenance Phase||0
11017463|NCT00783692|12195297|FG002|STARTED|Maintenance Phase||0
11017464|NCT00783692|12195298|FG003|STARTED|Maintenance Phase||153
11017465|NCT00783692|12195299|FG004|STARTED|Maintenance Phase||154
11017466|NCT00783692|12195300|FG005|STARTED|Maintenance Phase||154
11017467|NCT00783692|12195301|FG006|STARTED|Maintenance Phase||412
11017468|NCT00783692|12195295|FG000|COMPLETED|Maintenance Phase||42
11017469|NCT00783692|12195296|FG001|COMPLETED|Maintenance Phase||0
11017470|NCT00783692|12195297|FG002|COMPLETED|Maintenance Phase||0
11017471|NCT00783692|12195298|FG003|COMPLETED|Maintenance Phase||64
11017472|NCT00783692|12195299|FG004|COMPLETED|Maintenance Phase||73
11017473|NCT00783692|12195300|FG005|COMPLETED|Maintenance Phase||82
11017474|NCT00783692|12195301|FG006|COMPLETED|Maintenance Phase||163
11017475|NCT00783692|12195295|FG000|NOT COMPLETED|Maintenance Phase||95
11017476|NCT00783692|12195296|FG001|NOT COMPLETED|Maintenance Phase||0
11017477|NCT00783692|12195297|FG002|NOT COMPLETED|Maintenance Phase||0
11017478|NCT00783692|12195298|FG003|NOT COMPLETED|Maintenance Phase||89
11017479|NCT00783692|12195299|FG004|NOT COMPLETED|Maintenance Phase||81
11017480|NCT00783692|12195300|FG005|NOT COMPLETED|Maintenance Phase||72
11017481|NCT00783692|12195301|FG006|NOT COMPLETED|Maintenance Phase||249
11017482|NCT00783705|12195316|FG000|STARTED|Overall Study||44
11017483|NCT00783705|12195317|FG001|STARTED|Overall Study||41
11017484|NCT00783705|12195316|FG000|COMPLETED|Overall Study||38
11017485|NCT00783705|12195317|FG001|COMPLETED|Overall Study||36
11017486|NCT00783705|12195316|FG000|NOT COMPLETED|Overall Study||6
11017487|NCT00783705|12195317|FG001|NOT COMPLETED|Overall Study||5
11017488|NCT00783718|12195326|FG000|STARTED|Induction Phase||149
11017489|NCT00783718|12195327|FG001|STARTED|Induction Phase||225
11017490|NCT00783718|12195328|FG002|STARTED|Induction Phase||521
11017491|NCT00783718|12195329|FG003|STARTED|Induction Phase||0
11017492|NCT00783718|12195330|FG004|STARTED|Induction Phase||0
11017493|NCT00783718|12195331|FG005|STARTED|Induction Phase||0
11017494|NCT00783718|12195332|FG006|STARTED|Induction Phase||0
11017495|NCT00783718|12195326|FG000|COMPLETED|Induction Phase||135
11017496|NCT00783718|12195327|FG001|COMPLETED|Induction Phase||218
11017497|NCT00783718|12195328|FG002|COMPLETED|Induction Phase||485
11017498|NCT00783718|12195329|FG003|COMPLETED|Induction Phase||0
11017499|NCT00783718|12195330|FG004|COMPLETED|Induction Phase||0
11017500|NCT00783718|12195331|FG005|COMPLETED|Induction Phase||0
11017501|NCT00783718|12195332|FG006|COMPLETED|Induction Phase||0
11396658|NCT03848910|12590534|FG000|STARTED|Overall Study||11
11396659|NCT03848910|12590534|FG000|COMPLETED|Overall Study||11
11017502|NCT00783718|12195326|FG000|NOT COMPLETED|Induction Phase||14
11017503|NCT00783718|12195327|FG001|NOT COMPLETED|Induction Phase||7
11017504|NCT00783718|12195328|FG002|NOT COMPLETED|Induction Phase||36
11017505|NCT00783718|12195329|FG003|NOT COMPLETED|Induction Phase||0
11017506|NCT00783718|12195330|FG004|NOT COMPLETED|Induction Phase||0
11017507|NCT00783718|12195331|FG005|NOT COMPLETED|Induction Phase||0
11017508|NCT00783718|12195332|FG006|NOT COMPLETED|Induction Phase||0
11017509|NCT00783718|12195326|FG000|STARTED|Maintenance Phase||135
11017510|NCT00783718|12195327|FG001|STARTED|Maintenance Phase||0
11017511|NCT00783718|12195328|FG002|STARTED|Maintenance Phase||0
11017512|NCT00783718|12195329|FG003|STARTED|Maintenance Phase||126
11017513|NCT00783718|12195330|FG004|STARTED|Maintenance Phase||122
11017514|NCT00783718|12195331|FG005|STARTED|Maintenance Phase||125
11017515|NCT00783718|12195332|FG006|STARTED|Maintenance Phase||330
11017516|NCT00783718|12195326|FG000|COMPLETED|Maintenance Phase||30
11017517|NCT00783718|12195327|FG001|COMPLETED|Maintenance Phase||0
11017518|NCT00783718|12195328|FG002|COMPLETED|Maintenance Phase||0
11017519|NCT00783718|12195329|FG003|COMPLETED|Maintenance Phase||48
11017520|NCT00783718|12195330|FG004|COMPLETED|Maintenance Phase||77
11017521|NCT00783718|12195331|FG005|COMPLETED|Maintenance Phase||84
11017522|NCT00783718|12195332|FG006|COMPLETED|Maintenance Phase||135
11017523|NCT00783718|12195326|FG000|NOT COMPLETED|Maintenance Phase||105
11017524|NCT00783718|12195327|FG001|NOT COMPLETED|Maintenance Phase||0
11017525|NCT00783718|12195328|FG002|NOT COMPLETED|Maintenance Phase||0
11017526|NCT00783718|12195329|FG003|NOT COMPLETED|Maintenance Phase||78
11017527|NCT00783718|12195330|FG004|NOT COMPLETED|Maintenance Phase||45
11017528|NCT00783718|12195331|FG005|NOT COMPLETED|Maintenance Phase||41
11017529|NCT00783718|12195332|FG006|NOT COMPLETED|Maintenance Phase||195
11017530|NCT00783796|12195342|FG000|STARTED|Overall Study||150
11017531|NCT00783796|12195342|FG000|COMPLETED|Overall Study||144
11017532|NCT00783796|12195342|FG000|NOT COMPLETED|Overall Study||6
11017533|NCT00783835|12195348|FG000|STARTED|Overall Study||60
11017534|NCT00783835|12195348|FG000|COMPLETED|Overall Study||50
11017535|NCT00783835|12195348|FG000|NOT COMPLETED|Overall Study||10
11017536|NCT00783952|12195352|FG000|STARTED|Overall Study||8
11017537|NCT00783952|12195352|FG000|COMPLETED|Overall Study||8
11017538|NCT00783952|12195352|FG000|NOT COMPLETED|Overall Study||0
11017539|NCT00783965|12195359|FG000|STARTED|First Intervention (12 Months)||5
11017540|NCT00783965|12195360|FG001|STARTED|First Intervention (12 Months)||29
11017541|NCT00783965|12195359|FG000|COMPLETED|First Intervention (12 Months)||2
11017542|NCT00783965|12195360|FG001|COMPLETED|First Intervention (12 Months)||25
11017543|NCT00783965|12195359|FG000|NOT COMPLETED|First Intervention (12 Months)||3
11017544|NCT00783965|12195360|FG001|NOT COMPLETED|First Intervention (12 Months)||4
11017545|NCT00783965|12195359|FG000|STARTED|Second Intervention (24 Months)||2
11017546|NCT00783965|12195360|FG001|STARTED|Second Intervention (24 Months)||25
11017547|NCT00783965|12195359|FG000|COMPLETED|Second Intervention (24 Months)||2
11017548|NCT00783965|12195360|FG001|COMPLETED|Second Intervention (24 Months)||16
11017549|NCT00783965|12195359|FG000|NOT COMPLETED|Second Intervention (24 Months)||0
11017550|NCT00783965|12195360|FG001|NOT COMPLETED|Second Intervention (24 Months)||9
11017551|NCT00784030|12195368|FG000|STARTED|Overall Study||13
11017552|NCT00784030|12195369|FG001|STARTED|Overall Study||10
11017553|NCT00784030|12195368|FG000|COMPLETED|Overall Study||13
11017554|NCT00784030|12195369|FG001|COMPLETED|Overall Study||10
11017555|NCT00784030|12195368|FG000|NOT COMPLETED|Overall Study||0
11017556|NCT00784030|12195369|FG001|NOT COMPLETED|Overall Study||0
11017557|NCT00784095|12195378|FG000|STARTED|Overall Study||12
11017558|NCT00784095|12195379|FG001|STARTED|Overall Study||12
11017559|NCT00784095|12195380|FG002|STARTED|Overall Study||12
11017560|NCT00784095|12195378|FG000|COMPLETED|Overall Study||12
11017561|NCT00784095|12195379|FG001|COMPLETED|Overall Study||11
11017562|NCT00784095|12195380|FG002|COMPLETED|Overall Study||11
11017563|NCT00784095|12195378|FG000|NOT COMPLETED|Overall Study||0
11017564|NCT00784095|12195379|FG001|NOT COMPLETED|Overall Study||1
11017565|NCT00784095|12195380|FG002|NOT COMPLETED|Overall Study||1
11017566|NCT00784134|12195393|FG000|STARTED|Overall Study||249
11017567|NCT00784134|12195394|FG001|STARTED|Overall Study||251
11017568|NCT00784134|12195393|FG000|COMPLETED|Overall Study||246
11017569|NCT00784134|12195394|FG001|COMPLETED|Overall Study||245
11017570|NCT00784134|12195393|FG000|NOT COMPLETED|Overall Study||3
11017571|NCT00784134|12195394|FG001|NOT COMPLETED|Overall Study||6
11017572|NCT00784147|12195402|FG000|STARTED|Overall Study||59
11017573|NCT00784147|12195403|FG001|STARTED|Overall Study||54
11017574|NCT00784147|12195402|FG000|COMPLETED|Overall Study||51
11017575|NCT00784147|12195403|FG001|COMPLETED|Overall Study||45
11017576|NCT00784147|12195402|FG000|NOT COMPLETED|Overall Study||8
11017577|NCT00784147|12195403|FG001|NOT COMPLETED|Overall Study||9
11017578|NCT00784225|12195413|FG000|STARTED|Overall Study||3375
11017579|NCT00784225|12195414|FG001|STARTED|Overall Study||3357
11017580|NCT00784225|12195415|FG002|STARTED|Overall Study||3369
11017581|NCT00784225|12195416|FG003|STARTED|Overall Study||3374
11017582|NCT00784225|12195413|FG000|COMPLETED|Overall Study||3375
11017583|NCT00784225|12195414|FG001|COMPLETED|Overall Study||3357
11017584|NCT00784225|12195415|FG002|COMPLETED|Overall Study||3369
11017585|NCT00784225|12195416|FG003|COMPLETED|Overall Study||3374
11017586|NCT00784225|12195413|FG000|NOT COMPLETED|Overall Study||0
11017587|NCT00784225|12195414|FG001|NOT COMPLETED|Overall Study||0
11017588|NCT00784225|12195415|FG002|NOT COMPLETED|Overall Study||0
11017589|NCT00784225|12195416|FG003|NOT COMPLETED|Overall Study||0
11017590|NCT00784238|12195430|FG000|STARTED|Overall Study||289
11017591|NCT00784238|12195430|FG000|COMPLETED|Overall Study||170
11017592|NCT00784238|12195430|FG000|NOT COMPLETED|Overall Study||119
11017593|NCT00784277|12195441|FG000|STARTED|IR Treatment||148
11017594|NCT00784277|12195442|FG001|STARTED|IR Treatment||151
11017595|NCT00784277|12195443|FG002|STARTED|IR Treatment||154
11017596|NCT00784277|12195444|FG003|STARTED|IR Treatment||143
11017597|NCT00784277|12195445|FG004|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
11017598|NCT00784277|12195446|FG005|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
11017599|NCT00784277|12195447|FG006|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
11017600|NCT00784277|12195441|FG000|COMPLETED|IR Treatment||132
11017601|NCT00784277|12195442|FG001|COMPLETED|IR Treatment||134
11017602|NCT00784277|12195443|FG002|COMPLETED|IR Treatment||126
11017603|NCT00784277|12195444|FG003|COMPLETED|IR Treatment||100
11017604|NCT00784277|12195445|FG004|COMPLETED|IR Treatment||0
11017605|NCT00784277|12195446|FG005|COMPLETED|IR Treatment||0
11017606|NCT00784277|12195447|FG006|COMPLETED|IR Treatment||0
11017607|NCT00784277|12195441|FG000|NOT COMPLETED|IR Treatment||16
11017608|NCT00784277|12195442|FG001|NOT COMPLETED|IR Treatment||17
11017609|NCT00784277|12195443|FG002|NOT COMPLETED|IR Treatment||28
11396660|NCT03848910|12590534|FG000|NOT COMPLETED|Overall Study||0
11396661|NCT03852524|12590541|FG000|STARTED|Overall Study||41
11396662|NCT03852524|12590542|FG001|STARTED|Overall Study||41
11396663|NCT03852524|12590541|FG000|COMPLETED|Overall Study||41
11396664|NCT03852524|12590542|FG001|COMPLETED|Overall Study||41
11396665|NCT03852524|12590541|FG000|NOT COMPLETED|Overall Study||0
11017610|NCT00784277|12195444|FG003|NOT COMPLETED|IR Treatment||43
11017611|NCT00784277|12195445|FG004|NOT COMPLETED|IR Treatment||0
11017612|NCT00784277|12195446|FG005|NOT COMPLETED|IR Treatment||0
11017613|NCT00784277|12195447|FG006|NOT COMPLETED|IR Treatment||0
11056861|NCT00996307|12238479|FG003|STARTED|Overall Study||165
11396666|NCT03852524|12590542|FG001|NOT COMPLETED|Overall Study||0
11017614|NCT00784277|12195441|FG000|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
11017615|NCT00784277|12195442|FG001|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
11017616|NCT00784277|12195443|FG002|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
11017617|NCT00784277|12195444|FG003|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
11017618|NCT00784277|12195445|FG004|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
11017619|NCT00784277|12195446|FG005|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
11017620|NCT00784277|12195447|FG006|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
11017621|NCT00784277|12195441|FG000|COMPLETED|ER Treatment||0
11017622|NCT00784277|12195442|FG001|COMPLETED|ER Treatment||0
11017623|NCT00784277|12195443|FG002|COMPLETED|ER Treatment||0
11017624|NCT00784277|12195444|FG003|COMPLETED|ER Treatment||0
11017625|NCT00784277|12195445|FG004|COMPLETED|ER Treatment||113
11017626|NCT00784277|12195446|FG005|COMPLETED|ER Treatment||226
11017627|NCT00784277|12195447|FG006|COMPLETED|ER Treatment||76
11017628|NCT00784277|12195441|FG000|NOT COMPLETED|ER Treatment||0
11017629|NCT00784277|12195442|FG001|NOT COMPLETED|ER Treatment||0
11017630|NCT00784277|12195443|FG002|NOT COMPLETED|ER Treatment||0
11017631|NCT00784277|12195444|FG003|NOT COMPLETED|ER Treatment||0
11017632|NCT00784277|12195445|FG004|NOT COMPLETED|ER Treatment||9
11017633|NCT00784277|12195446|FG005|NOT COMPLETED|ER Treatment||24
11017634|NCT00784277|12195447|FG006|NOT COMPLETED|ER Treatment||15
11017635|NCT00784303|12195462|FG000|STARTED|Overall Study||58
11017636|NCT00784303|12195463|FG001|STARTED|Overall Study||59
11017637|NCT00784303|12195462|FG000|COMPLETED|Overall Study||58
11017638|NCT00784303|12195463|FG001|COMPLETED|Overall Study||59
11017639|NCT00784303|12195462|FG000|NOT COMPLETED|Overall Study||0
11017640|NCT00784303|12195463|FG001|NOT COMPLETED|Overall Study||0
11017641|NCT00784368|12195473|FG000|STARTED|Overall Study||16
11017642|NCT00784368|12195474|FG001|STARTED|Overall Study||16
11017643|NCT00784368|12195475|FG002|STARTED|Overall Study||23
11017644|NCT00784368|12195473|FG000|COMPLETED|Overall Study||8
11017645|NCT00784368|12195474|FG001|COMPLETED|Overall Study||5
11017646|NCT00784368|12195475|FG002|COMPLETED|Overall Study||12
11017647|NCT00784368|12195473|FG000|NOT COMPLETED|Overall Study||8
11017648|NCT00784368|12195474|FG001|NOT COMPLETED|Overall Study||11
11017649|NCT00784368|12195475|FG002|NOT COMPLETED|Overall Study||11
11017650|NCT00784459|12195488|FG000|STARTED|Overall Study||11
11396667|NCT03857841|12590552|FG000|STARTED|Overall Study||2
11396668|NCT03857841|12590553|FG001|STARTED|Overall Study||0
11396669|NCT03857841|12590554|FG002|STARTED|Overall Study||0
11396670|NCT03857841|12590555|FG003|STARTED|Overall Study||1
11017651|NCT00784459|12195489|FG001|STARTED|Overall Study||13
11017652|NCT00784459|12195488|FG000|COMPLETED|Overall Study||11
11017653|NCT00784459|12195489|FG001|COMPLETED|Overall Study||11
11396671|NCT03857841|12590552|FG000|COMPLETED|Overall Study||0
11017654|NCT00784459|12195488|FG000|NOT COMPLETED|Overall Study||0
11017655|NCT00784459|12195489|FG001|NOT COMPLETED|Overall Study||2
11017656|NCT00784524|12195495|FG000|STARTED|Overall Study||14
11017657|NCT00784524|12195495|FG000|COMPLETED|Overall Study||14
11017658|NCT00784524|12195495|FG000|NOT COMPLETED|Overall Study||0
11017659|NCT00784550|12195501|FG000|STARTED|Overall Study||173
11396672|NCT03857841|12590553|FG001|COMPLETED|Overall Study||0
11396673|NCT03857841|12590554|FG002|COMPLETED|Overall Study||0
11017660|NCT00784550|12195502|FG001|STARTED|Overall Study||169
11017661|NCT00784550|12195501|FG000|COMPLETED|Overall Study||137
11017662|NCT00784550|12195502|FG001|COMPLETED|Overall Study||127
11017663|NCT00784550|12195501|FG000|NOT COMPLETED|Overall Study||36
11017664|NCT00784550|12195502|FG001|NOT COMPLETED|Overall Study||42
11017665|NCT00784563|12195511|FG000|STARTED|Years 1 & 2||21
11017666|NCT00784563|12195512|FG001|STARTED|Years 1 & 2||22
11017667|NCT00784563|12195513|FG002|STARTED|Years 1 & 2||0
11017668|NCT00784563|12195511|FG000|COMPLETED|Years 1 & 2||18
11017669|NCT00784563|12195512|FG001|COMPLETED|Years 1 & 2||17
11017670|NCT00784563|12195513|FG002|COMPLETED|Years 1 & 2||0
11017671|NCT00784563|12195511|FG000|NOT COMPLETED|Years 1 & 2||3
11017672|NCT00784563|12195512|FG001|NOT COMPLETED|Years 1 & 2||5
11017673|NCT00784563|12195513|FG002|NOT COMPLETED|Years 1 & 2||0
11017674|NCT00784563|12195511|FG000|STARTED|Year 3||0
11017675|NCT00784563|12195512|FG001|STARTED|Year 3||0
11017676|NCT00784563|12195513|FG002|STARTED|Year 3||17
11017677|NCT00784563|12195511|FG000|COMPLETED|Year 3||0
11017678|NCT00784563|12195512|FG001|COMPLETED|Year 3||0
11017679|NCT00784563|12195513|FG002|COMPLETED|Year 3||14
11017680|NCT00784563|12195511|FG000|NOT COMPLETED|Year 3||0
11017681|NCT00784563|12195512|FG001|NOT COMPLETED|Year 3||0
11017682|NCT00784563|12195513|FG002|NOT COMPLETED|Year 3||3
11017683|NCT00784641|12195522|FG000|STARTED|Overall Study||189
11017684|NCT00784641|12195523|FG001|STARTED|Overall Study||189
11017685|NCT00784641|12195524|FG002|STARTED|Overall Study||189
11396674|NCT03857841|12590555|FG003|COMPLETED|Overall Study||1
11017686|NCT00784641|12195522|FG000|COMPLETED|Overall Study||183
11017687|NCT00784641|12195523|FG001|COMPLETED|Overall Study||186
11017688|NCT00784641|12195524|FG002|COMPLETED|Overall Study||187
11017689|NCT00784641|12195522|FG000|NOT COMPLETED|Overall Study||6
11017690|NCT00784641|12195523|FG001|NOT COMPLETED|Overall Study||3
11017691|NCT00784641|12195524|FG002|NOT COMPLETED|Overall Study||2
11017692|NCT00784654|12195532|FG000|STARTED|Open-Label Period (Non-Randomized)||276
11017693|NCT00784654|12195533|FG001|STARTED|Open-Label Period (Non-Randomized)||0
11017694|NCT00784654|12195534|FG002|STARTED|Open-Label Period (Non-Randomized)||0
11017695|NCT00784654|12195532|FG000|COMPLETED|Open-Label Period (Non-Randomized)||165
11017696|NCT00784654|12195533|FG001|COMPLETED|Open-Label Period (Non-Randomized)||0
11017697|NCT00784654|12195534|FG002|COMPLETED|Open-Label Period (Non-Randomized)||0
11017698|NCT00784654|12195532|FG000|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
11017699|NCT00784654|12195533|FG001|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
11017700|NCT00784654|12195534|FG002|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
11017701|NCT00784654|12195532|FG000|STARTED|Randomized Withdrawal Period||0
11017702|NCT00784654|12195533|FG001|STARTED|Randomized Withdrawal Period||78
11017703|NCT00784654|12195534|FG002|STARTED|Randomized Withdrawal Period||79
11017704|NCT00784654|12195532|FG000|COMPLETED|Randomized Withdrawal Period||0
11017705|NCT00784654|12195533|FG001|COMPLETED|Randomized Withdrawal Period||60
11017706|NCT00784654|12195534|FG002|COMPLETED|Randomized Withdrawal Period||16
11017707|NCT00784654|12195532|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
11017708|NCT00784654|12195533|FG001|NOT COMPLETED|Randomized Withdrawal Period||18
11017709|NCT00784654|12195534|FG002|NOT COMPLETED|Randomized Withdrawal Period||63
11017710|NCT00784693|12195547|FG000|STARTED|Overall Study||23
11017711|NCT00784693|12195548|FG001|STARTED|Overall Study||25
11017712|NCT00784693|12195547|FG000|Treated|Overall Study||22
11017713|NCT00784693|12195548|FG001|Treated|Overall Study||25
11017714|NCT00784693|12195547|FG000|COMPLETED|Overall Study||20
11017715|NCT00784693|12195548|FG001|COMPLETED|Overall Study||19
11017716|NCT00784693|12195547|FG000|NOT COMPLETED|Overall Study||3
11017717|NCT00784693|12195548|FG001|NOT COMPLETED|Overall Study||6
11017718|NCT00784719|12195561|FG000|STARTED|Overall Study||47
11017719|NCT00784719|12195562|FG001|STARTED|Overall Study||46
11396675|NCT03857841|12590552|FG000|NOT COMPLETED|Overall Study||2
11396676|NCT03857841|12590553|FG001|NOT COMPLETED|Overall Study||0
11017720|NCT00784719|12195563|FG002|STARTED|Overall Study||47
11017721|NCT00784719|12195564|FG003|STARTED|Overall Study||48
11017722|NCT00784719|12195565|FG004|STARTED|Overall Study||48
11017723|NCT00784719|12195566|FG005|STARTED|Overall Study||44
11017724|NCT00784719|12195567|FG006|STARTED|Overall Study||47
11017725|NCT00784719|12195561|FG000|COMPLETED|Overall Study||44
11017726|NCT00784719|12195562|FG001|COMPLETED|Overall Study||43
11017727|NCT00784719|12195563|FG002|COMPLETED|Overall Study||46
11017728|NCT00784719|12195564|FG003|COMPLETED|Overall Study||48
11017729|NCT00784719|12195565|FG004|COMPLETED|Overall Study||42
11017730|NCT00784719|12195566|FG005|COMPLETED|Overall Study||41
11017731|NCT00784719|12195567|FG006|COMPLETED|Overall Study||42
11396677|NCT03857841|12590554|FG002|NOT COMPLETED|Overall Study||0
11017732|NCT00784719|12195561|FG000|NOT COMPLETED|Overall Study||3
11017733|NCT00784719|12195562|FG001|NOT COMPLETED|Overall Study||3
11017734|NCT00784719|12195563|FG002|NOT COMPLETED|Overall Study||1
11017735|NCT00784719|12195564|FG003|NOT COMPLETED|Overall Study||0
11017736|NCT00784719|12195565|FG004|NOT COMPLETED|Overall Study||6
11017737|NCT00784719|12195566|FG005|NOT COMPLETED|Overall Study||3
11017738|NCT00784719|12195567|FG006|NOT COMPLETED|Overall Study||5
11017739|NCT00784758|12195585|FG000|STARTED|Overall Study||42
11017740|NCT00784758|12195586|FG001|STARTED|Overall Study||39
11017741|NCT00784758|12195585|FG000|Began Treatment|Overall Study||41
11017742|NCT00784758|12195586|FG001|Began Treatment|Overall Study||39
11017743|NCT00784758|12195585|FG000|Completed Treatment|Overall Study||40
11017744|NCT00784758|12195586|FG001|Completed Treatment|Overall Study||39
11017745|NCT00784758|12195585|FG000|COMPLETED|Overall Study||38
11017746|NCT00784758|12195586|FG001|COMPLETED|Overall Study||39
11017747|NCT00784758|12195585|FG000|NOT COMPLETED|Overall Study||4
11017748|NCT00784758|12195586|FG001|NOT COMPLETED|Overall Study||0
11017749|NCT00784784|12195596|FG000|STARTED|Overall Study||22
11017750|NCT00784784|12195597|FG001|STARTED|Overall Study||42
11017751|NCT00784784|12195596|FG000|COMPLETED|Overall Study||20
11017752|NCT00784784|12195597|FG001|COMPLETED|Overall Study||40
11017753|NCT00784784|12195596|FG000|NOT COMPLETED|Overall Study||2
11017754|NCT00784784|12195597|FG001|NOT COMPLETED|Overall Study||2
11017755|NCT00784810|12195605|FG000|STARTED|Overall Study||124
11017756|NCT00784810|12195606|FG001|STARTED|Overall Study||123
11017757|NCT00784810|12195605|FG000|COMPLETED|Overall Study||61
11017758|NCT00784810|12195606|FG001|COMPLETED|Overall Study||74
11017759|NCT00784810|12195605|FG000|NOT COMPLETED|Overall Study||63
11017760|NCT00784810|12195606|FG001|NOT COMPLETED|Overall Study||49
11017761|NCT00784836|12195612|FG000|STARTED|Overall Study||3
11017762|NCT00784836|12195612|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
11017763|NCT00784836|12195612|FG000|NOT COMPLETED|Overall Study||3
11017764|NCT00784849|12195616|FG000|STARTED|Overall Study||62
11017765|NCT00784849|12195616|FG000|COMPLETED|Overall Study||62
11017766|NCT00784849|12195616|FG000|NOT COMPLETED|Overall Study||0
11017767|NCT00784875|12195624|FG000|STARTED|Period A - Baseline||0
11017768|NCT00784875|12195625|FG001|STARTED|Period A - Baseline||0
11017769|NCT00784875|12195626|FG002|STARTED|Period A - Baseline||0
11017770|NCT00784875|12195627|FG003|STARTED|Period A - Baseline||643
11017771|NCT00784875|12195624|FG000|COMPLETED|Period A - Baseline||0
11017772|NCT00784875|12195625|FG001|COMPLETED|Period A - Baseline||0
11017773|NCT00784875|12195626|FG002|COMPLETED|Period A - Baseline||0
11017774|NCT00784875|12195627|FG003|COMPLETED|Period A - Baseline||461
11017775|NCT00784875|12195624|FG000|NOT COMPLETED|Period A - Baseline||0
11017776|NCT00784875|12195625|FG001|NOT COMPLETED|Period A - Baseline||0
11017777|NCT00784875|12195626|FG002|NOT COMPLETED|Period A - Baseline||0
11017778|NCT00784875|12195627|FG003|NOT COMPLETED|Period A - Baseline||182
11017779|NCT00784875|12195624|FG000|STARTED|Period B - Efficacy Endpoint||114
11017780|NCT00784875|12195625|FG001|STARTED|Period B - Efficacy Endpoint||113
11017781|NCT00784875|12195626|FG002|STARTED|Period B - Efficacy Endpoint||117
11017782|NCT00784875|12195627|FG003|STARTED|Period B - Efficacy Endpoint||117
11017783|NCT00784875|12195624|FG000|Cohort 2|Period B - Efficacy Endpoint||102
11017784|NCT00784875|12195625|FG001|Cohort 2|Period B - Efficacy Endpoint||102
11017785|NCT00784875|12195626|FG002|Cohort 2|Period B - Efficacy Endpoint||102
11017786|NCT00784875|12195627|FG003|Cohort 2|Period B - Efficacy Endpoint||101
11017787|NCT00784875|12195624|FG000|COMPLETED|Period B - Efficacy Endpoint||100
11017788|NCT00784875|12195625|FG001|COMPLETED|Period B - Efficacy Endpoint||101
11017789|NCT00784875|12195626|FG002|COMPLETED|Period B - Efficacy Endpoint||96
11017790|NCT00784875|12195627|FG003|COMPLETED|Period B - Efficacy Endpoint||98
11017791|NCT00784875|12195624|FG000|NOT COMPLETED|Period B - Efficacy Endpoint||14
11017792|NCT00784875|12195625|FG001|NOT COMPLETED|Period B - Efficacy Endpoint||12
11017793|NCT00784875|12195626|FG002|NOT COMPLETED|Period B - Efficacy Endpoint||21
11017794|NCT00784875|12195627|FG003|NOT COMPLETED|Period B - Efficacy Endpoint||19
11017795|NCT00784875|12195624|FG000|STARTED|Period C||103
11017796|NCT00784875|12195625|FG001|STARTED|Period C||97
11017797|NCT00784875|12195626|FG002|STARTED|Period C||97
11017798|NCT00784875|12195627|FG003|STARTED|Period C||98
11017799|NCT00784875|12195624|FG000|COMPLETED|Period C||96
11017800|NCT00784875|12195625|FG001|COMPLETED|Period C||91
11017801|NCT00784875|12195626|FG002|COMPLETED|Period C||84
11017802|NCT00784875|12195627|FG003|COMPLETED|Period C||91
11017803|NCT00784875|12195624|FG000|NOT COMPLETED|Period C||7
11017804|NCT00784875|12195625|FG001|NOT COMPLETED|Period C||6
11017805|NCT00784875|12195626|FG002|NOT COMPLETED|Period C||13
11017806|NCT00784875|12195627|FG003|NOT COMPLETED|Period C||7
11017807|NCT00784875|12195624|FG000|STARTED|Period D||91
11017808|NCT00784875|12195625|FG001|STARTED|Period D||89
11017809|NCT00784875|12195626|FG002|STARTED|Period D||94
11017810|NCT00784875|12195627|FG003|STARTED|Period D||88
11017811|NCT00784875|12195624|FG000|COMPLETED|Period D||86
11017812|NCT00784875|12195625|FG001|COMPLETED|Period D||85
11017813|NCT00784875|12195626|FG002|COMPLETED|Period D||88
11017814|NCT00784875|12195627|FG003|COMPLETED|Period D||87
11017815|NCT00784875|12195624|FG000|NOT COMPLETED|Period D||5
11017816|NCT00784875|12195625|FG001|NOT COMPLETED|Period D||4
11017817|NCT00784875|12195626|FG002|NOT COMPLETED|Period D||6
11017818|NCT00784875|12195627|FG003|NOT COMPLETED|Period D||1
11017819|NCT00784927|12195650|FG000|STARTED|Overall Study||36
11017820|NCT00784927|12195650|FG000|COMPLETED|Overall Study||33
11017821|NCT00784927|12195650|FG000|NOT COMPLETED|Overall Study||3
11017822|NCT00784979|12195655|FG000|STARTED|Overall Study||26
11017823|NCT00784979|12195655|FG000|COMPLETED|Overall Study||20
11017824|NCT00784979|12195655|FG000|NOT COMPLETED|Overall Study||6
11017825|NCT00785044|12195659|FG000|STARTED|Overall Study|Eligible to participate in MBG313|964
11396678|NCT03857841|12590555|FG003|NOT COMPLETED|Overall Study||0
11396679|NCT03861780|12590568|FG000|STARTED|Overall Study||51
11017826|NCT00785044|12195659|FG000|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
11017827|NCT00785044|12195659|FG000|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
11017828|NCT00785044|12195659|FG000|NOT COMPLETED|Overall Study||496
11017829|NCT00785213|12195664|FG000|STARTED|Rosiglitazone Alone||23
11017830|NCT00785213|12195664|FG000|COMPLETED|Rosiglitazone Alone||23
11017831|NCT00785213|12195664|FG000|NOT COMPLETED|Rosiglitazone Alone||0
11017832|NCT00785213|12195664|FG000|STARTED|2 Day Washout Period||23
11017833|NCT00785213|12195664|FG000|COMPLETED|2 Day Washout Period||23
11017834|NCT00785213|12195664|FG000|NOT COMPLETED|2 Day Washout Period||0
11017835|NCT00785213|12195664|FG000|STARTED|Quinine Sulfate Alone||23
11017836|NCT00785213|12195664|FG000|COMPLETED|Quinine Sulfate Alone||19
11017837|NCT00785213|12195664|FG000|NOT COMPLETED|Quinine Sulfate Alone||4
11017838|NCT00785213|12195664|FG000|STARTED|Rosiglitazone With Quinine Sulfate||19
11017839|NCT00785213|12195664|FG000|COMPLETED|Rosiglitazone With Quinine Sulfate||18
11017840|NCT00785213|12195664|FG000|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
11017841|NCT00785486|12195671|FG000|STARTED|Midazolam Alone||24
11017842|NCT00785486|12195671|FG000|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
11017843|NCT00785486|12195671|FG000|NOT COMPLETED|Midazolam Alone||1
11017844|NCT00785486|12195671|FG000|STARTED|3 Day Washout||23
11017845|NCT00785486|12195671|FG000|COMPLETED|3 Day Washout||23
11017846|NCT00785486|12195671|FG000|NOT COMPLETED|3 Day Washout||0
11017847|NCT00785486|12195671|FG000|STARTED|Qualaquin Alone at Steady State||23
11017848|NCT00785486|12195671|FG000|COMPLETED|Qualaquin Alone at Steady State||23
11017849|NCT00785486|12195671|FG000|NOT COMPLETED|Qualaquin Alone at Steady State||0
11017850|NCT00785486|12195671|FG000|STARTED|Midazolam With Qualaquin at Steady State||23
11017851|NCT00785486|12195671|FG000|COMPLETED|Midazolam With Qualaquin at Steady State||23
11017852|NCT00785486|12195671|FG000|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
11017853|NCT00785512|12195694|FG000|STARTED|Overall Study||102
11017854|NCT00785512|12195695|FG001|STARTED|Overall Study||105
11017855|NCT00785512|12195694|FG000|COMPLETED|Overall Study||99
11017856|NCT00785512|12195695|FG001|COMPLETED|Overall Study||101
11017857|NCT00785512|12195694|FG000|NOT COMPLETED|Overall Study||3
11017858|NCT00785512|12195695|FG001|NOT COMPLETED|Overall Study||4
11017859|NCT00785538|12195706|FG000|STARTED|PK Period||7
11017860|NCT00785538|12195707|FG001|STARTED|PK Period||1
11017861|NCT00785538|12195708|FG002|STARTED|PK Period||1
11017862|NCT00785538|12195709|FG003|STARTED|PK Period||0
11017863|NCT00785538|12195706|FG000|COMPLETED|PK Period||7
11017864|NCT00785538|12195707|FG001|COMPLETED|PK Period||1
11017865|NCT00785538|12195708|FG002|COMPLETED|PK Period||1
11017866|NCT00785538|12195709|FG003|COMPLETED|PK Period||0
11017867|NCT00785538|12195706|FG000|NOT COMPLETED|PK Period||0
11017868|NCT00785538|12195707|FG001|NOT COMPLETED|PK Period||0
11017869|NCT00785538|12195708|FG002|NOT COMPLETED|PK Period||0
11017870|NCT00785538|12195709|FG003|NOT COMPLETED|PK Period||0
11017871|NCT00785538|12195706|FG000|STARTED|Treatment Period||7
11017872|NCT00785538|12195707|FG001|STARTED|Treatment Period||9
11017873|NCT00785538|12195708|FG002|STARTED|Treatment Period||6
11017874|NCT00785538|12195709|FG003|STARTED|Treatment Period||2
11017875|NCT00785538|12195706|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||7
11017876|NCT00785538|12195707|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||9
11017877|NCT00785538|12195708|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||6
11017878|NCT00785538|12195709|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||2
11017879|NCT00785538|12195706|FG000|COMPLETED|Treatment Period||6
11017880|NCT00785538|12195707|FG001|COMPLETED|Treatment Period||7
11017881|NCT00785538|12195708|FG002|COMPLETED|Treatment Period||4
11017882|NCT00785538|12195709|FG003|COMPLETED|Treatment Period||1
11017883|NCT00785538|12195706|FG000|NOT COMPLETED|Treatment Period||1
11017884|NCT00785538|12195707|FG001|NOT COMPLETED|Treatment Period||2
11017885|NCT00785538|12195708|FG002|NOT COMPLETED|Treatment Period||2
11017886|NCT00785538|12195709|FG003|NOT COMPLETED|Treatment Period||1
11017887|NCT00785577|12195725|FG000|STARTED|Study Period 2: Therapy Phase||89
11017888|NCT00785577|12195726|FG001|STARTED|Study Period 2: Therapy Phase||45
11017889|NCT00785577|12195727|FG002|STARTED|Study Period 2: Therapy Phase||43
11017890|NCT00785577|12195728|FG003|STARTED|Study Period 2: Therapy Phase||49
11017891|NCT00785577|12195729|FG004|STARTED|Study Period 2: Therapy Phase||47
11017892|NCT00785577|12195725|FG000|COMPLETED|Study Period 2: Therapy Phase||78
11017893|NCT00785577|12195726|FG001|COMPLETED|Study Period 2: Therapy Phase||36
11017894|NCT00785577|12195727|FG002|COMPLETED|Study Period 2: Therapy Phase||25
11017895|NCT00785577|12195728|FG003|COMPLETED|Study Period 2: Therapy Phase||36
11017896|NCT00785577|12195729|FG004|COMPLETED|Study Period 2: Therapy Phase||27
11017897|NCT00785577|12195725|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||11
11017898|NCT00785577|12195726|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||9
11017899|NCT00785577|12195727|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||18
11017900|NCT00785577|12195728|FG003|NOT COMPLETED|Study Period 2: Therapy Phase||13
11017901|NCT00785577|12195729|FG004|NOT COMPLETED|Study Period 2: Therapy Phase||20
11017902|NCT00785577|12195725|FG000|STARTED|Study Period 3: 1-Week Washout Phase||78
11017903|NCT00785577|12195726|FG001|STARTED|Study Period 3: 1-Week Washout Phase||36
11017904|NCT00785577|12195727|FG002|STARTED|Study Period 3: 1-Week Washout Phase||25
11017905|NCT00785577|12195728|FG003|STARTED|Study Period 3: 1-Week Washout Phase||36
11017906|NCT00785577|12195729|FG004|STARTED|Study Period 3: 1-Week Washout Phase||27
11017907|NCT00785577|12195725|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||78
11017908|NCT00785577|12195726|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||36
11017909|NCT00785577|12195727|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||25
11017910|NCT00785577|12195728|FG003|COMPLETED|Study Period 3: 1-Week Washout Phase||35
11017911|NCT00785577|12195729|FG004|COMPLETED|Study Period 3: 1-Week Washout Phase||26
11017912|NCT00785577|12195725|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
11017913|NCT00785577|12195726|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
11017914|NCT00785577|12195727|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
11017915|NCT00785577|12195728|FG003|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
11017916|NCT00785577|12195729|FG004|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
11017917|NCT00785629|12195755|FG000|STARTED|Overall Study||30
11017918|NCT00785629|12195756|FG001|STARTED|Overall Study||30
11017919|NCT00785629|12195757|FG002|STARTED|Overall Study||28
11017920|NCT00785629|12195758|FG003|STARTED|Overall Study||57
11017921|NCT00785629|12195755|FG000|COMPLETED|Overall Study|8 not completed|22
11017922|NCT00785629|12195756|FG001|COMPLETED|Overall Study|5 not completed|25
11017923|NCT00785629|12195757|FG002|COMPLETED|Overall Study|10 not completed|18
11017924|NCT00785629|12195758|FG003|COMPLETED|Overall Study|16 not completed|41
11017925|NCT00785629|12195755|FG000|NOT COMPLETED|Overall Study||8
11017926|NCT00785629|12195756|FG001|NOT COMPLETED|Overall Study||5
11017927|NCT00785629|12195757|FG002|NOT COMPLETED|Overall Study||10
11017928|NCT00785629|12195758|FG003|NOT COMPLETED|Overall Study||16
11017929|NCT00785707|12195766|FG000|STARTED|Overall Study||31
11017930|NCT00785707|12195766|FG000|COMPLETED|Overall Study||24
11017931|NCT00785707|12195766|FG000|NOT COMPLETED|Overall Study||7
11017932|NCT00785772|12195770|FG000|STARTED|Overall Study||1
11017933|NCT00785772|12195770|FG000|COMPLETED|Overall Study||1
11017934|NCT00785772|12195770|FG000|NOT COMPLETED|Overall Study||0
11017935|NCT00785785|12195776|FG000|STARTED|Core Phase up to 36 Months||324
11017936|NCT00785785|12195777|FG001|STARTED|Core Phase up to 36 Months||320
11017937|NCT00785785|12195776|FG000|COMPLETED|Core Phase up to 36 Months||0
11017938|NCT00785785|12195777|FG001|COMPLETED|Core Phase up to 36 Months||0
11017939|NCT00785785|12195776|FG000|NOT COMPLETED|Core Phase up to 36 Months||324
11017940|NCT00785785|12195777|FG001|NOT COMPLETED|Core Phase up to 36 Months||320
11017941|NCT00785785|12195776|FG000|STARTED|Optional Extension Phase|crossover extension phase was optional|39
11017942|NCT00785785|12195777|FG001|STARTED|Optional Extension Phase|crossover extension phase was optional|125
11017943|NCT00785785|12195776|FG000|COMPLETED|Optional Extension Phase||0
11017944|NCT00785785|12195777|FG001|COMPLETED|Optional Extension Phase||0
11017945|NCT00785785|12195776|FG000|NOT COMPLETED|Optional Extension Phase||39
11017946|NCT00785785|12195777|FG001|NOT COMPLETED|Optional Extension Phase||125
11017947|NCT00785928|12195792|FG000|STARTED|Treatment Phase||36
11017948|NCT00785928|12195793|FG001|STARTED|Treatment Phase||30
11017949|NCT00785928|12195794|FG002|STARTED|Treatment Phase||20
11017950|NCT00785928|12195795|FG003|STARTED|Treatment Phase||15
11017951|NCT00785928|12195796|FG004|STARTED|Treatment Phase||18
11017952|NCT00785928|12195797|FG005|STARTED|Treatment Phase||13
11017953|NCT00785928|12195798|FG006|STARTED|Treatment Phase||26
11017954|NCT00785928|12195792|FG000|COMPLETED|Treatment Phase||33
11017955|NCT00785928|12195793|FG001|COMPLETED|Treatment Phase||25
11017956|NCT00785928|12195794|FG002|COMPLETED|Treatment Phase||17
11017957|NCT00785928|12195795|FG003|COMPLETED|Treatment Phase||15
11017958|NCT00785928|12195796|FG004|COMPLETED|Treatment Phase||16
11017959|NCT00785928|12195797|FG005|COMPLETED|Treatment Phase||13
11017960|NCT00785928|12195798|FG006|COMPLETED|Treatment Phase||23
11017961|NCT00785928|12195792|FG000|NOT COMPLETED|Treatment Phase||3
11017962|NCT00785928|12195793|FG001|NOT COMPLETED|Treatment Phase||5
11017963|NCT00785928|12195794|FG002|NOT COMPLETED|Treatment Phase||3
11143371|NCT01473758|12330241|FG000|STARTED|Cycle 2||0
11143372|NCT01473758|12330242|FG001|STARTED|Cycle 2||0
11143373|NCT01473758|12330243|FG002|STARTED|Cycle 2||10
11143374|NCT01473758|12330244|FG003|STARTED|Cycle 2||4
11143375|NCT01473758|12330241|FG000|COMPLETED|Cycle 2||0
11143376|NCT01473758|12330242|FG001|COMPLETED|Cycle 2||0
11143377|NCT01473758|12330243|FG002|COMPLETED|Cycle 2||5
11143378|NCT01473758|12330244|FG003|COMPLETED|Cycle 2||4
11143379|NCT01473758|12330241|FG000|NOT COMPLETED|Cycle 2||0
11143380|NCT01473758|12330242|FG001|NOT COMPLETED|Cycle 2||0
11017964|NCT00785928|12195795|FG003|NOT COMPLETED|Treatment Phase||0
11017965|NCT00785928|12195796|FG004|NOT COMPLETED|Treatment Phase||2
11017966|NCT00785928|12195797|FG005|NOT COMPLETED|Treatment Phase||0
11017967|NCT00785928|12195798|FG006|NOT COMPLETED|Treatment Phase||3
11017968|NCT00785928|12195792|FG000|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
11017969|NCT00785928|12195793|FG001|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
11017970|NCT00785928|12195794|FG002|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
11017971|NCT00785928|12195795|FG003|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
11017972|NCT00785928|12195796|FG004|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
11017973|NCT00785928|12195797|FG005|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
11017974|NCT00785928|12195798|FG006|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
11017975|NCT00785928|12195792|FG000|COMPLETED|Follow-up Phases (Weeks 24-72)||7
11017976|NCT00785928|12195793|FG001|COMPLETED|Follow-up Phases (Weeks 24-72)||5
11017977|NCT00785928|12195794|FG002|COMPLETED|Follow-up Phases (Weeks 24-72)||4
11017978|NCT00785928|12195795|FG003|COMPLETED|Follow-up Phases (Weeks 24-72)||4
11017979|NCT00785928|12195796|FG004|COMPLETED|Follow-up Phases (Weeks 24-72)||4
11017980|NCT00785928|12195797|FG005|COMPLETED|Follow-up Phases (Weeks 24-72)||0
11017981|NCT00785928|12195798|FG006|COMPLETED|Follow-up Phases (Weeks 24-72)||9
11017982|NCT00785928|12195792|FG000|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
11017983|NCT00785928|12195793|FG001|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
11017984|NCT00785928|12195794|FG002|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
11017985|NCT00785928|12195795|FG003|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
11017986|NCT00785928|12195796|FG004|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
11017987|NCT00785928|12195797|FG005|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
11017988|NCT00785928|12195798|FG006|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
11017989|NCT00785980|12195836|FG000|STARTED|Quinine Sulfate Alone||24
11017990|NCT00785980|12195836|FG000|COMPLETED|Quinine Sulfate Alone||24
11143381|NCT01473758|12330243|FG002|NOT COMPLETED|Cycle 2||5
11263771|NCT02271984|12459064|FG003|STARTED|Fifth Intervention Period (1 Day)||3
11263772|NCT02271984|12459065|FG004|STARTED|Fifth Intervention Period (1 Day)||3
11263773|NCT02271984|12459066|FG005|STARTED|Fifth Intervention Period (1 Day)||2
11263774|NCT02271984|12459067|FG006|STARTED|Fifth Intervention Period (1 Day)||3
11143382|NCT01473758|12330244|FG003|NOT COMPLETED|Cycle 2||0
11143383|NCT01473836|12330252|FG000|STARTED|Overall Study||38
11143384|NCT01473836|12330252|FG000|COMPLETED|Overall Study||32
11017991|NCT00785980|12195836|FG000|NOT COMPLETED|Quinine Sulfate Alone||0
11017992|NCT00785980|12195836|FG000|STARTED|7 Day Washout Period||24
11017993|NCT00785980|12195836|FG000|COMPLETED|7 Day Washout Period||21
11017994|NCT00785980|12195836|FG000|NOT COMPLETED|7 Day Washout Period||3
11017995|NCT00785980|12195836|FG000|STARTED|Ciprofloxacin Alone||21
11017996|NCT00785980|12195836|FG000|COMPLETED|Ciprofloxacin Alone||21
11017997|NCT00785980|12195836|FG000|NOT COMPLETED|Ciprofloxacin Alone||0
11017998|NCT00785980|12195836|FG000|STARTED|Quinine Sulfate With Ciprofloxacin||21
11017999|NCT00785980|12195836|FG000|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
11018000|NCT00785980|12195836|FG000|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
11018001|NCT00786019|12195845|FG000|STARTED|Overall Study||20
11018002|NCT00786019|12195846|FG001|STARTED|Overall Study||27
11018003|NCT00786019|12195845|FG000|COMPLETED|Overall Study||15
11018004|NCT00786019|12195846|FG001|COMPLETED|Overall Study||17
11018005|NCT00786019|12195845|FG000|NOT COMPLETED|Overall Study||5
11018006|NCT00786019|12195846|FG001|NOT COMPLETED|Overall Study||10
11018007|NCT00786032|12195854|FG000|STARTED|Overall Study||27
11018008|NCT00786032|12195854|FG000|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
11018009|NCT00786032|12195854|FG000|COMPLETED|Overall Study||3
11018010|NCT00786032|12195854|FG000|NOT COMPLETED|Overall Study||24
11018011|NCT00786188|12195862|FG000|STARTED|Overall Study||50
11018012|NCT00786188|12195863|FG001|STARTED|Overall Study||52
11018013|NCT00786188|12195862|FG000|COMPLETED|Overall Study||45
11018014|NCT00786188|12195863|FG001|COMPLETED|Overall Study||51
11018015|NCT00786188|12195862|FG000|NOT COMPLETED|Overall Study||5
11018016|NCT00786188|12195863|FG001|NOT COMPLETED|Overall Study||1
11018017|NCT00786409|12195871|FG000|STARTED|Overall Study||27
11018018|NCT00786409|12195871|FG000|COMPLETED|Overall Study||20
11018019|NCT00786409|12195871|FG000|NOT COMPLETED|Overall Study||7
11018020|NCT00786422|12195875|FG000|STARTED|Rivaroxaban Treatment||25
11018021|NCT00786422|12195875|FG000|COMPLETED|Rivaroxaban Treatment||14
11018022|NCT00786422|12195875|FG000|NOT COMPLETED|Rivaroxaban Treatment||11
11018023|NCT00786422|12195875|FG000|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
11018024|NCT00786422|12195875|FG000|COMPLETED|Follow-up Period||17
11018025|NCT00786422|12195875|FG000|NOT COMPLETED|Follow-up Period||3
11018026|NCT00786474|12195883|FG000|STARTED|Overall Study||950
11018027|NCT00786474|12195884|FG001|STARTED|Overall Study||934
11018028|NCT00786474|12195883|FG000|COMPLETED|Overall Study||913
11018029|NCT00786474|12195884|FG001|COMPLETED|Overall Study||891
11018030|NCT00786474|12195883|FG000|NOT COMPLETED|Overall Study||37
11018031|NCT00786474|12195884|FG001|NOT COMPLETED|Overall Study||43
11018032|NCT00786487|12195894|FG000|STARTED|Overall Study||10
11018033|NCT00786487|12195895|FG001|STARTED|Overall Study||7
11018034|NCT00786487|12195896|FG002|STARTED|Overall Study||9
11018035|NCT00786487|12195897|FG003|STARTED|Overall Study||7
11018036|NCT00786487|12195894|FG000|COMPLETED|Overall Study||10
11018037|NCT00786487|12195895|FG001|COMPLETED|Overall Study||7
11018038|NCT00786487|12195896|FG002|COMPLETED|Overall Study||9
11018039|NCT00786487|12195897|FG003|COMPLETED|Overall Study||7
11018040|NCT00786487|12195894|FG000|NOT COMPLETED|Overall Study||0
11018041|NCT00786487|12195895|FG001|NOT COMPLETED|Overall Study||0
11018042|NCT00786487|12195896|FG002|NOT COMPLETED|Overall Study||0
11018043|NCT00786487|12195897|FG003|NOT COMPLETED|Overall Study||0
11018044|NCT00786565|12195907|FG000|STARTED|Enrollment Prior to Surgery||75
11018045|NCT00786565|12195907|FG000|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
11018046|NCT00786565|12195907|FG000|NOT COMPLETED|Enrollment Prior to Surgery||6
11263775|NCT02271984|12459068|FG007|STARTED|Fifth Intervention Period (1 Day)||2
11018047|NCT00786565|12195907|FG000|STARTED|Post Surgery||69
11018048|NCT00786565|12195907|FG000|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
11263776|NCT02271984|12459069|FG008|STARTED|Fifth Intervention Period (1 Day)||3
11018049|NCT00786565|12195907|FG000|NOT COMPLETED|Post Surgery||2
11018050|NCT00786643|12195915|FG000|STARTED|Overall Study||20
11018051|NCT00786643|12195916|FG001|STARTED|Overall Study||28
11018052|NCT00786643|12195915|FG000|COMPLETED|Overall Study||20
11018053|NCT00786643|12195916|FG001|COMPLETED|Overall Study||28
11018054|NCT00786643|12195915|FG000|NOT COMPLETED|Overall Study||0
11018055|NCT00786643|12195916|FG001|NOT COMPLETED|Overall Study||0
11018056|NCT00786799|12195924|FG000|STARTED|Overall Study||14
11018057|NCT00786799|12195925|FG001|STARTED|Overall Study||13
11018058|NCT00786799|12195924|FG000|COMPLETED|Overall Study||13
11018059|NCT00786799|12195925|FG001|COMPLETED|Overall Study||12
11018060|NCT00786799|12195924|FG000|NOT COMPLETED|Overall Study||1
11018061|NCT00786799|12195925|FG001|NOT COMPLETED|Overall Study||1
11018062|NCT00786825|12195938|FG000|STARTED|Overall Study||5
11018063|NCT00786825|12195939|FG001|STARTED|Overall Study||5
11018064|NCT00786825|12195938|FG000|COMPLETED|Overall Study||5
11018065|NCT00786825|12195939|FG001|COMPLETED|Overall Study||5
11018066|NCT00786825|12195938|FG000|NOT COMPLETED|Overall Study||0
11018067|NCT00786825|12195939|FG001|NOT COMPLETED|Overall Study||0
11018068|NCT00786838|12195945|FG000|STARTED|Overall Study||75
11018069|NCT00786838|12195945|FG000|COMPLETED|Overall Study||26
11018070|NCT00786838|12195945|FG000|NOT COMPLETED|Overall Study||49
11018071|NCT00786864|12195956|FG000|STARTED|Overall Study||39
11018072|NCT00786864|12195957|FG001|STARTED|Overall Study||33
11018073|NCT00786864|12195956|FG000|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
11018074|NCT00786864|12195957|FG001|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
11018075|NCT00786864|12195956|FG000|NOT COMPLETED|Overall Study||1
11018076|NCT00786864|12195957|FG001|NOT COMPLETED|Overall Study||1
11018077|NCT00786916|12195966|FG000|STARTED|Overall Study||39
11018078|NCT00786916|12195967|FG001|STARTED|Overall Study||36
11018079|NCT00786916|12195968|FG002|STARTED|Overall Study||34
11018080|NCT00786916|12195966|FG000|COMPLETED|Overall Study||39
11018081|NCT00786916|12195967|FG001|COMPLETED|Overall Study||36
11018082|NCT00786916|12195968|FG002|COMPLETED|Overall Study||34
11018083|NCT00786916|12195966|FG000|NOT COMPLETED|Overall Study||0
11018084|NCT00786916|12195967|FG001|NOT COMPLETED|Overall Study||0
11018085|NCT00786916|12195968|FG002|NOT COMPLETED|Overall Study||0
11018086|NCT00786994|12195980|FG000|STARTED|Overall Study||57
11018087|NCT00786994|12195981|FG001|STARTED|Overall Study||54
11018088|NCT00786994|12195982|FG002|STARTED|Overall Study||26
11018089|NCT00786994|12195983|FG003|STARTED|Overall Study||28
11018090|NCT00786994|12195980|FG000|ITT|Overall Study||53
11018091|NCT00786994|12195981|FG001|ITT|Overall Study||51
11018092|NCT00786994|12195982|FG002|ITT|Overall Study||25
11018093|NCT00786994|12195983|FG003|ITT|Overall Study||28
11018094|NCT00786994|12195980|FG000|COMPLETED|Overall Study||47
11018095|NCT00786994|12195981|FG001|COMPLETED|Overall Study||39
11018096|NCT00786994|12195982|FG002|COMPLETED|Overall Study||24
11018097|NCT00786994|12195983|FG003|COMPLETED|Overall Study||22
11018098|NCT00786994|12195980|FG000|NOT COMPLETED|Overall Study||10
11018099|NCT00786994|12195981|FG001|NOT COMPLETED|Overall Study||15
11018100|NCT00786994|12195982|FG002|NOT COMPLETED|Overall Study||2
11396680|NCT03861780|12590569|FG001|STARTED|Overall Study||50
11396681|NCT03861780|12590570|FG002|STARTED|Overall Study||51
11396682|NCT03861780|12590568|FG000|COMPLETED|Overall Study||51
11396683|NCT03861780|12590569|FG001|COMPLETED|Overall Study||50
11396684|NCT03861780|12590570|FG002|COMPLETED|Overall Study||51
11018101|NCT00786994|12195983|FG003|NOT COMPLETED|Overall Study||6
11018102|NCT00787020|12195994|FG000|STARTED|Overall Study||24
11018103|NCT00787020|12195995|FG001|STARTED|Overall Study||13
11018104|NCT00787020|12195994|FG000|COMPLETED|Overall Study||24
11018105|NCT00787020|12195995|FG001|COMPLETED|Overall Study||13
11018106|NCT00787020|12195994|FG000|NOT COMPLETED|Overall Study||0
11018107|NCT00787020|12195995|FG001|NOT COMPLETED|Overall Study||0
11018108|NCT00787137|12196004|FG000|STARTED|Overall Study||6
11018109|NCT00787137|12196005|FG001|STARTED|Overall Study||6
11018110|NCT00787137|12196006|FG002|STARTED|Overall Study||5
11018111|NCT00787137|12196004|FG000|COMPLETED|Overall Study||6
11018112|NCT00787137|12196005|FG001|COMPLETED|Overall Study||6
11018113|NCT00787137|12196006|FG002|COMPLETED|Overall Study||4
11018114|NCT00787137|12196004|FG000|NOT COMPLETED|Overall Study||0
11018115|NCT00787137|12196005|FG001|NOT COMPLETED|Overall Study||0
11018116|NCT00787137|12196006|FG002|NOT COMPLETED|Overall Study||1
11018117|NCT00787150|12196017|FG000|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
11018118|NCT00787150|12196018|FG001|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
11018119|NCT00787150|12196019|FG002|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
11018120|NCT00787150|12196017|FG000|COMPLETED|Overall Study||66
11018121|NCT00787150|12196018|FG001|COMPLETED|Overall Study||65
11018122|NCT00787150|12196019|FG002|COMPLETED|Overall Study||66
11018123|NCT00787150|12196017|FG000|NOT COMPLETED|Overall Study||9
11018124|NCT00787150|12196018|FG001|NOT COMPLETED|Overall Study||7
11018125|NCT00787150|12196019|FG002|NOT COMPLETED|Overall Study||5
11018126|NCT00787189|12196031|FG000|STARTED|Overall Study||32
11018127|NCT00787189|12196032|FG001|STARTED|Overall Study||32
11018128|NCT00787189|12196031|FG000|COMPLETED|Overall Study|To study end point.|30
11018129|NCT00787189|12196032|FG001|COMPLETED|Overall Study|To study end point.|30
11018130|NCT00787189|12196031|FG000|NOT COMPLETED|Overall Study||2
11018131|NCT00787189|12196032|FG001|NOT COMPLETED|Overall Study||2
11018132|NCT00787202|12196043|FG000|STARTED|Overall Study||49
11018133|NCT00787202|12196044|FG001|STARTED|Overall Study||31
11018134|NCT00787202|12196045|FG002|STARTED|Overall Study||33
11018135|NCT00787202|12196046|FG003|STARTED|Overall Study||33
11018136|NCT00787202|12196047|FG004|STARTED|Overall Study||49
11396685|NCT03861780|12590568|FG000|NOT COMPLETED|Overall Study||0
11018137|NCT00787202|12196043|FG000|Treated|Overall Study||48
11018138|NCT00787202|12196044|FG001|Treated|Overall Study||31
11018139|NCT00787202|12196045|FG002|Treated|Overall Study||33
11018140|NCT00787202|12196046|FG003|Treated|Overall Study||33
11018141|NCT00787202|12196047|FG004|Treated|Overall Study||49
11018142|NCT00787202|12196043|FG000|COMPLETED|Overall Study||35
11018143|NCT00787202|12196044|FG001|COMPLETED|Overall Study||20
11018144|NCT00787202|12196045|FG002|COMPLETED|Overall Study||26
11018145|NCT00787202|12196046|FG003|COMPLETED|Overall Study||31
11018146|NCT00787202|12196047|FG004|COMPLETED|Overall Study||45
11018147|NCT00787202|12196043|FG000|NOT COMPLETED|Overall Study||14
11018148|NCT00787202|12196044|FG001|NOT COMPLETED|Overall Study||11
11018149|NCT00787202|12196045|FG002|NOT COMPLETED|Overall Study||7
11018150|NCT00787202|12196046|FG003|NOT COMPLETED|Overall Study||2
11018151|NCT00787202|12196047|FG004|NOT COMPLETED|Overall Study||4
11018152|NCT00787241|12196066|FG000|STARTED|Overall Study||261
11018153|NCT00787241|12196067|FG001|STARTED|Overall Study||143
11018154|NCT00787241|12196068|FG002|STARTED|Overall Study||41
11018155|NCT00787241|12196066|FG000|COMPLETED|Overall Study||261
11018156|NCT00787241|12196067|FG001|COMPLETED|Overall Study||143
11018157|NCT00787241|12196068|FG002|COMPLETED|Overall Study||41
11396686|NCT03861780|12590569|FG001|NOT COMPLETED|Overall Study||0
11018158|NCT00787241|12196066|FG000|NOT COMPLETED|Overall Study||0
11018159|NCT00787241|12196067|FG001|NOT COMPLETED|Overall Study||0
11018160|NCT00787241|12196068|FG002|NOT COMPLETED|Overall Study||0
11018161|NCT00787254|12196078|FG000|STARTED|Overall Study||185
11018162|NCT00787254|12196079|FG001|STARTED|Overall Study||181
11018163|NCT00787254|12196078|FG000|COMPLETED|Overall Study||109
11018164|NCT00787254|12196079|FG001|COMPLETED|Overall Study||99
11018165|NCT00787254|12196078|FG000|NOT COMPLETED|Overall Study||76
11018166|NCT00787254|12196079|FG001|NOT COMPLETED|Overall Study||82
11018167|NCT00787267|12196085|FG000|STARTED|Overall Study|Signed a consent form|37
11018168|NCT00787267|12196085|FG000|COMPLETED|Overall Study|Received at least one dose of study drug|25
11018169|NCT00787267|12196085|FG000|NOT COMPLETED|Overall Study||12
11018170|NCT00787319|12196089|FG000|STARTED|Overall Study||108
11018171|NCT00787319|12196089|FG000|COMPLETED|Overall Study||45
11018172|NCT00787319|12196089|FG000|NOT COMPLETED|Overall Study||63
11018173|NCT00787332|12196095|FG000|STARTED|Overall Study||8
11018174|NCT00787332|12196096|FG001|STARTED|Overall Study||8
11018175|NCT00787332|12196095|FG000|COMPLETED|Overall Study||8
11018176|NCT00787332|12196096|FG001|COMPLETED|Overall Study||8
11018177|NCT00787332|12196095|FG000|NOT COMPLETED|Overall Study||0
11018178|NCT00787332|12196096|FG001|NOT COMPLETED|Overall Study||0
11018179|NCT00787527|12196102|FG000|STARTED|Overall Study||14
11018180|NCT00787527|12196102|FG000|COMPLETED|Overall Study||11
11018181|NCT00787527|12196102|FG000|NOT COMPLETED|Overall Study||3
11018182|NCT00787566|12196113|FG000|STARTED|Overall Study||21
11018183|NCT00787566|12196114|FG001|STARTED|Overall Study||25
11018184|NCT00787566|12196115|FG002|STARTED|Overall Study||22
11018185|NCT00787566|12196113|FG000|COMPLETED|Overall Study||21
11018186|NCT00787566|12196114|FG001|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
11018187|NCT00787566|12196115|FG002|COMPLETED|Overall Study||22
11018188|NCT00787566|12196113|FG000|NOT COMPLETED|Overall Study||0
11018189|NCT00787566|12196114|FG001|NOT COMPLETED|Overall Study||1
11018190|NCT00787566|12196115|FG002|NOT COMPLETED|Overall Study||0
11018191|NCT00787605|12196125|FG000|STARTED|Overall Study||428
11018192|NCT00787605|12196126|FG001|STARTED|Overall Study||432
11018193|NCT00787605|12196125|FG000|COMPLETED|Overall Study||382
11018194|NCT00787605|12196126|FG001|COMPLETED|Overall Study||376
11018195|NCT00787605|12196125|FG000|NOT COMPLETED|Overall Study||46
11018196|NCT00787605|12196126|FG001|NOT COMPLETED|Overall Study||56
11018197|NCT00787644|12196134|FG000|STARTED|Overall Study||12
11018198|NCT00787644|12196135|FG001|STARTED|Overall Study||11
11018199|NCT00787644|12196134|FG000|COMPLETED|Overall Study||10
11018200|NCT00787644|12196135|FG001|COMPLETED|Overall Study||9
11018201|NCT00787644|12196134|FG000|NOT COMPLETED|Overall Study||2
11018202|NCT00787644|12196135|FG001|NOT COMPLETED|Overall Study||2
11018203|NCT00787722|12196141|FG000|STARTED|Overall Study||13
11018204|NCT00787722|12196141|FG000|COMPLETED|Overall Study||12
11018205|NCT00787722|12196141|FG000|NOT COMPLETED|Overall Study||1
11018206|NCT00787761|12196146|FG000|STARTED|Overall Study||24
11018207|NCT00787761|12196146|FG000|COMPLETED|Overall Study||24
11018208|NCT00787761|12196146|FG000|NOT COMPLETED|Overall Study||0
11018209|NCT00787787|12196152|FG000|STARTED|Overall Study||7
11018210|NCT00787787|12196152|FG000|COMPLETED|Overall Study||0
11018211|NCT00787787|12196152|FG000|NOT COMPLETED|Overall Study||7
11018212|NCT00787800|12196158|FG000|STARTED|Overall Study||50
11018213|NCT00787800|12196159|FG001|STARTED|Overall Study||50
11018214|NCT00787800|12196158|FG000|COMPLETED|Overall Study||47
11018215|NCT00787800|12196159|FG001|COMPLETED|Overall Study||43
11018216|NCT00787800|12196158|FG000|NOT COMPLETED|Overall Study||3
11018217|NCT00787800|12196159|FG001|NOT COMPLETED|Overall Study||7
11018218|NCT00787839|12196166|FG000|STARTED|Overall Study||1939
11018219|NCT00787839|12196166|FG000|Consented|Overall Study|consented|1939
11018220|NCT00787839|12196166|FG000|Completed GCT Screening|Overall Study||1876
11018221|NCT00787839|12196166|FG000|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
11018222|NCT00787839|12196166|FG000|COMPLETED|Overall Study||1535
11018223|NCT00787839|12196166|FG000|NOT COMPLETED|Overall Study||404
11018224|NCT00787852|12196189|FG000|STARTED|Overall Study||6
11018225|NCT00787852|12196190|FG001|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
11018226|NCT00787852|12196189|FG000|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
11018227|NCT00787852|12196190|FG001|COMPLETED|Overall Study||5
11018228|NCT00787852|12196189|FG000|NOT COMPLETED|Overall Study||1
11018229|NCT00787852|12196190|FG001|NOT COMPLETED|Overall Study||0
11018230|NCT00787891|12196198|FG000|STARTED|Short-term Double-blind Phase (Part 1)||65
11018231|NCT00787891|12196199|FG001|STARTED|Short-term Double-blind Phase (Part 1)||62
11018232|NCT00787891|12196198|FG000|COMPLETED|Short-term Double-blind Phase (Part 1)||55
11018233|NCT00787891|12196199|FG001|COMPLETED|Short-term Double-blind Phase (Part 1)||53
11018234|NCT00787891|12196198|FG000|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
11018235|NCT00787891|12196199|FG001|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
11018236|NCT00787891|12196198|FG000|STARTED|Maintenance Double-blind Phase (Part 2)||33
11018237|NCT00787891|12196199|FG001|STARTED|Maintenance Double-blind Phase (Part 2)||31
11018238|NCT00787891|12196198|FG000|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
11018239|NCT00787891|12196199|FG001|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
11018240|NCT00787891|12196198|FG000|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
11018241|NCT00787891|12196199|FG001|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
11018242|NCT00787904|12196209|FG000|STARTED|Overall Study||6
11018243|NCT00787904|12196210|FG001|STARTED|Overall Study||13
11018244|NCT00787904|12196209|FG000|COMPLETED|Overall Study||6
11018245|NCT00787904|12196210|FG001|COMPLETED|Overall Study||13
11018246|NCT00787904|12196209|FG000|NOT COMPLETED|Overall Study||0
11018247|NCT00787904|12196210|FG001|NOT COMPLETED|Overall Study||0
11018248|NCT00787930|12196216|FG000|STARTED|Acute Treatment -- 3 Weeks||19
11018249|NCT00787930|12196216|FG000|COMPLETED|Acute Treatment -- 3 Weeks||19
11018250|NCT00787930|12196216|FG000|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
11018251|NCT00787930|12196216|FG000|STARTED|Continuation Treatment -- up to 12 Month||19
11018252|NCT00787930|12196216|FG000|COMPLETED|Continuation Treatment -- up to 12 Month||16
11018253|NCT00787930|12196216|FG000|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
11018254|NCT00787943|12196226|FG000|STARTED|Overall Study||10
11018255|NCT00787943|12196226|FG000|COMPLETED|Overall Study||10
11018256|NCT00787943|12196226|FG000|NOT COMPLETED|Overall Study||0
11018257|NCT00788008|12196236|FG000|STARTED|Overall Study||98
11018258|NCT00788008|12196237|FG001|STARTED|Overall Study||101
11018259|NCT00788008|12196236|FG000|COMPLETED|Overall Study||98
11018260|NCT00788008|12196237|FG001|COMPLETED|Overall Study||101
11018261|NCT00788008|12196236|FG000|NOT COMPLETED|Overall Study||0
11018262|NCT00788008|12196237|FG001|NOT COMPLETED|Overall Study||0
11018263|NCT00788073|12196245|FG000|STARTED|STX209 Then Placebo||30
11018264|NCT00788073|12196246|FG001|STARTED|STX209 Then Placebo||33
11018265|NCT00788073|12196245|FG000|COMPLETED|STX209 Then Placebo||29
11018266|NCT00788073|12196246|FG001|COMPLETED|STX209 Then Placebo||30
11018267|NCT00788073|12196245|FG000|NOT COMPLETED|STX209 Then Placebo||1
11018268|NCT00788073|12196246|FG001|NOT COMPLETED|STX209 Then Placebo||3
11018269|NCT00788073|12196245|FG000|STARTED|Placebo Then STX209||29
11018270|NCT00788073|12196246|FG001|STARTED|Placebo Then STX209||30
11018271|NCT00788073|12196245|FG000|COMPLETED|Placebo Then STX209||27
11018272|NCT00788073|12196246|FG001|COMPLETED|Placebo Then STX209||29
11018273|NCT00788073|12196245|FG000|NOT COMPLETED|Placebo Then STX209||2
11018274|NCT00788073|12196246|FG001|NOT COMPLETED|Placebo Then STX209||1
11018275|NCT00788255|12196252|FG000|STARTED|Overall Study||25
11018276|NCT00788255|12196252|FG000|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
11018277|NCT00788255|12196252|FG000|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
11018278|NCT00788255|12196252|FG000|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
11018279|NCT00788255|12196252|FG000|Oxytocin: 0 μU/mL|Overall Study||25
11018280|NCT00788255|12196252|FG000|COMPLETED|Overall Study||25
11018281|NCT00788255|12196252|FG000|NOT COMPLETED|Overall Study||0
11018282|NCT00788372|12196259|FG000|STARTED|Period 1 (up to 4 Weeks)||142
11018283|NCT00788372|12196259|FG000|COMPLETED|Period 1 (up to 4 Weeks)||111
11018284|NCT00788372|12196259|FG000|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
11018285|NCT00788372|12196259|FG000|STARTED|Period 2 (Week 4 to Week 52)||111
11018286|NCT00788372|12196259|FG000|COMPLETED|Period 2 (Week 4 to Week 52)||79
11018287|NCT00788372|12196259|FG000|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
11018288|NCT00788593|12196263|FG000|STARTED|Placebo Run-in Phase||82
11018289|NCT00788593|12196264|FG001|STARTED|Placebo Run-in Phase||0
11018290|NCT00788593|12196265|FG002|STARTED|Placebo Run-in Phase||0
11018291|NCT00788593|12196263|FG000|COMPLETED|Placebo Run-in Phase||76
11018292|NCT00788593|12196264|FG001|COMPLETED|Placebo Run-in Phase||0
11018293|NCT00788593|12196265|FG002|COMPLETED|Placebo Run-in Phase||0
11018294|NCT00788593|12196263|FG000|NOT COMPLETED|Placebo Run-in Phase||6
11018295|NCT00788593|12196264|FG001|NOT COMPLETED|Placebo Run-in Phase||0
11018296|NCT00788593|12196265|FG002|NOT COMPLETED|Placebo Run-in Phase||0
11018297|NCT00788593|12196263|FG000|STARTED|First Intervention Period||0
11018298|NCT00788593|12196264|FG001|STARTED|First Intervention Period||39
11018299|NCT00788593|12196265|FG002|STARTED|First Intervention Period||37
11018300|NCT00788593|12196263|FG000|COMPLETED|First Intervention Period||0
11018301|NCT00788593|12196264|FG001|COMPLETED|First Intervention Period||38
11018302|NCT00788593|12196265|FG002|COMPLETED|First Intervention Period||37
11018303|NCT00788593|12196263|FG000|NOT COMPLETED|First Intervention Period||0
11018304|NCT00788593|12196264|FG001|NOT COMPLETED|First Intervention Period||1
11018305|NCT00788593|12196265|FG002|NOT COMPLETED|First Intervention Period||0
11018306|NCT00788593|12196263|FG000|STARTED|Second Intervention Period||0
11018307|NCT00788593|12196264|FG001|STARTED|Second Intervention Period||38
11018308|NCT00788593|12196265|FG002|STARTED|Second Intervention Period||37
11018309|NCT00788593|12196263|FG000|COMPLETED|Second Intervention Period||0
11018310|NCT00788593|12196264|FG001|COMPLETED|Second Intervention Period||37
11018311|NCT00788593|12196265|FG002|COMPLETED|Second Intervention Period||36
11018312|NCT00788593|12196263|FG000|NOT COMPLETED|Second Intervention Period||0
11018313|NCT00788593|12196264|FG001|NOT COMPLETED|Second Intervention Period||1
11018314|NCT00788593|12196265|FG002|NOT COMPLETED|Second Intervention Period||1
11056862|NCT00996307|12238476|FG000|COMPLETED|Overall Study||144
11056863|NCT00996307|12238477|FG001|COMPLETED|Overall Study||148
11056864|NCT00996307|12238478|FG002|COMPLETED|Overall Study||146
11056865|NCT00996307|12238479|FG003|COMPLETED|Overall Study||144
11056866|NCT00996307|12238476|FG000|NOT COMPLETED|Overall Study||20
11056867|NCT00996307|12238477|FG001|NOT COMPLETED|Overall Study||17
11056868|NCT00996307|12238478|FG002|NOT COMPLETED|Overall Study||14
11056869|NCT00996307|12238479|FG003|NOT COMPLETED|Overall Study||21
11056870|NCT00996346|12238510|FG000|STARTED|Overall Study||6
11018315|NCT00788697|12196275|FG000|STARTED|Overall Study||349
11018316|NCT00788697|12196275|FG000|COMPLETED|Overall Study||240
11018317|NCT00788697|12196275|FG000|NOT COMPLETED|Overall Study||109
11018318|NCT00788775|12196289|FG000|STARTED|Overall Study||11
11018319|NCT00788775|12196290|FG001|STARTED|Overall Study||9
11018320|NCT00788775|12196289|FG000|Treated|Overall Study||11
11018321|NCT00788775|12196290|FG001|Treated|Overall Study||8
11018322|NCT00788775|12196289|FG000|COMPLETED|Overall Study||1
11018323|NCT00788775|12196290|FG001|COMPLETED|Overall Study||1
11018324|NCT00788775|12196289|FG000|NOT COMPLETED|Overall Study||10
11018325|NCT00788775|12196290|FG001|NOT COMPLETED|Overall Study||8
11018326|NCT00788827|12196296|FG000|STARTED|Overall Study||7
11018327|NCT00788827|12196296|FG000|COMPLETED|Overall Study||5
11018328|NCT00788827|12196296|FG000|NOT COMPLETED|Overall Study||2
11018329|NCT00788892|12196304|FG000|STARTED|Overall Study||85
11018330|NCT00788892|12196305|FG001|STARTED|Overall Study||41
11018331|NCT00788892|12196304|FG000|COMPLETED|Overall Study||36
11018332|NCT00788892|12196305|FG001|COMPLETED|Overall Study||18
11018333|NCT00788892|12196304|FG000|NOT COMPLETED|Overall Study||49
11018334|NCT00788892|12196305|FG001|NOT COMPLETED|Overall Study||23
11018335|NCT00788957|12196315|FG000|STARTED|Part 1||11
11018336|NCT00788957|12196316|FG001|STARTED|Part 1||0
11018337|NCT00788957|12196317|FG002|STARTED|Part 1||0
11018338|NCT00788957|12196318|FG003|STARTED|Part 1||0
11018339|NCT00788957|12196319|FG004|STARTED|Part 1||0
11018340|NCT00788957|12196320|FG005|STARTED|Part 1||0
11018341|NCT00788957|12196315|FG000|COMPLETED|Part 1|Completed the safety follow-up visit|2
11018342|NCT00788957|12196316|FG001|COMPLETED|Part 1||0
11018343|NCT00788957|12196317|FG002|COMPLETED|Part 1||0
11018344|NCT00788957|12196318|FG003|COMPLETED|Part 1||0
11018345|NCT00788957|12196319|FG004|COMPLETED|Part 1||0
11396687|NCT03861780|12590570|FG002|NOT COMPLETED|Overall Study||0
11018346|NCT00788957|12196320|FG005|COMPLETED|Part 1||0
11018347|NCT00788957|12196315|FG000|NOT COMPLETED|Part 1||9
11018348|NCT00788957|12196316|FG001|NOT COMPLETED|Part 1||0
11018349|NCT00788957|12196317|FG002|NOT COMPLETED|Part 1||0
11018350|NCT00788957|12196318|FG003|NOT COMPLETED|Part 1||0
11018351|NCT00788957|12196319|FG004|NOT COMPLETED|Part 1||0
11018352|NCT00788957|12196320|FG005|NOT COMPLETED|Part 1||0
11018353|NCT00788957|12196315|FG000|STARTED|Part 2||0
11018354|NCT00788957|12196316|FG001|STARTED|Part 2||48
11018355|NCT00788957|12196317|FG002|STARTED|Part 2||48
11018356|NCT00788957|12196318|FG003|STARTED|Part 2||46
11018357|NCT00788957|12196319|FG004|STARTED|Part 2||0
11018358|NCT00788957|12196320|FG005|STARTED|Part 2||0
11018359|NCT00788957|12196315|FG000|COMPLETED|Part 2||0
11018360|NCT00788957|12196316|FG001|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
11018361|NCT00788957|12196317|FG002|COMPLETED|Part 2|Completed the safety follow-up visit|4
11018362|NCT00788957|12196318|FG003|COMPLETED|Part 2|Completed the safety follow-up visit|5
11018363|NCT00788957|12196319|FG004|COMPLETED|Part 2||0
11018364|NCT00788957|12196320|FG005|COMPLETED|Part 2||0
11018365|NCT00788957|12196315|FG000|NOT COMPLETED|Part 2||0
11018366|NCT00788957|12196316|FG001|NOT COMPLETED|Part 2||42
11018367|NCT00788957|12196317|FG002|NOT COMPLETED|Part 2||44
11018368|NCT00788957|12196318|FG003|NOT COMPLETED|Part 2||41
11018369|NCT00788957|12196319|FG004|NOT COMPLETED|Part 2||0
11018370|NCT00788957|12196320|FG005|NOT COMPLETED|Part 2||0
11018371|NCT00788957|12196315|FG000|STARTED|Part 3||0
11018372|NCT00788957|12196316|FG001|STARTED|Part 3||0
11018373|NCT00788957|12196317|FG002|STARTED|Part 3||0
11018374|NCT00788957|12196318|FG003|STARTED|Part 3||0
11018375|NCT00788957|12196319|FG004|STARTED|Part 3||13
11018376|NCT00788957|12196320|FG005|STARTED|Part 3||12
11018377|NCT00788957|12196315|FG000|COMPLETED|Part 3||0
11018378|NCT00788957|12196316|FG001|COMPLETED|Part 3||0
11018379|NCT00788957|12196317|FG002|COMPLETED|Part 3||0
11018380|NCT00788957|12196318|FG003|COMPLETED|Part 3||0
11018381|NCT00788957|12196319|FG004|COMPLETED|Part 3|Completed the safety follow-up visit|4
11018382|NCT00788957|12196320|FG005|COMPLETED|Part 3|Completed the safety follow-up visit|1
11018383|NCT00788957|12196315|FG000|NOT COMPLETED|Part 3||0
11018384|NCT00788957|12196316|FG001|NOT COMPLETED|Part 3||0
11018385|NCT00788957|12196317|FG002|NOT COMPLETED|Part 3||0
11018386|NCT00788957|12196318|FG003|NOT COMPLETED|Part 3||0
11018387|NCT00788957|12196319|FG004|NOT COMPLETED|Part 3||9
11018388|NCT00788957|12196320|FG005|NOT COMPLETED|Part 3||11
11018389|NCT00789035|12196342|FG000|STARTED|Overall Study||82
11018390|NCT00789035|12196343|FG001|STARTED|Overall Study||81
11018391|NCT00789035|12196344|FG002|STARTED|Overall Study||81
11018392|NCT00789035|12196345|FG003|STARTED|Overall Study||82
11018393|NCT00789035|12196346|FG004|STARTED|Overall Study||80
11018394|NCT00789035|12196342|FG000|COMPLETED|Overall Study||76
11018395|NCT00789035|12196343|FG001|COMPLETED|Overall Study||74
11018396|NCT00789035|12196344|FG002|COMPLETED|Overall Study||80
11018397|NCT00789035|12196345|FG003|COMPLETED|Overall Study||81
11018398|NCT00789035|12196346|FG004|COMPLETED|Overall Study||74
11018399|NCT00789035|12196342|FG000|NOT COMPLETED|Overall Study||6
11018400|NCT00789035|12196343|FG001|NOT COMPLETED|Overall Study||7
11018401|NCT00789035|12196344|FG002|NOT COMPLETED|Overall Study||1
11018402|NCT00789035|12196345|FG003|NOT COMPLETED|Overall Study||1
11018403|NCT00789035|12196346|FG004|NOT COMPLETED|Overall Study||6
11018404|NCT00789074|12196363|FG000|STARTED|Overall Study||53
11018405|NCT00789074|12196364|FG001|STARTED|Overall Study||48
11018406|NCT00789074|12196363|FG000|COMPLETED|Overall Study||42
11018407|NCT00789074|12196364|FG001|COMPLETED|Overall Study||35
11018408|NCT00789074|12196363|FG000|NOT COMPLETED|Overall Study||11
11018409|NCT00789074|12196364|FG001|NOT COMPLETED|Overall Study||13
11018410|NCT00789113|12196373|FG000|STARTED|Overall Study||12
11018411|NCT00789113|12196373|FG000|COMPLETED|Overall Study||12
11018412|NCT00789113|12196373|FG000|NOT COMPLETED|Overall Study||0
11018413|NCT00789191|12196380|FG000|STARTED|Overall Study||111
11018414|NCT00789191|12196381|FG001|STARTED|Overall Study||111
11018415|NCT00789191|12196380|FG000|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
11018416|NCT00789191|12196381|FG001|Exposed|Overall Study|1 non-compliance|110
11018417|NCT00789191|12196380|FG000|COMPLETED|Overall Study||97
11018418|NCT00789191|12196381|FG001|COMPLETED|Overall Study||92
11018419|NCT00789191|12196380|FG000|NOT COMPLETED|Overall Study||14
11018420|NCT00789191|12196381|FG001|NOT COMPLETED|Overall Study||19
11018421|NCT00789256|12196389|FG000|STARTED|Overall Study||14
11018422|NCT00789256|12196390|FG001|STARTED|Overall Study||12
11018423|NCT00789256|12196389|FG000|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
11018424|NCT00789256|12196390|FG001|COMPLETED|Overall Study||12
11018425|NCT00789256|12196389|FG000|NOT COMPLETED|Overall Study||0
11018426|NCT00789256|12196390|FG001|NOT COMPLETED|Overall Study||0
11018427|NCT00789321|12196401|FG000|STARTED|Overall Study||24
11018428|NCT00789321|12196402|FG001|STARTED|Overall Study||23
11018429|NCT00789321|12196401|FG000|COMPLETED|Overall Study||24
11018430|NCT00789321|12196402|FG001|COMPLETED|Overall Study||22
11018431|NCT00789321|12196401|FG000|NOT COMPLETED|Overall Study||0
11018432|NCT00789321|12196402|FG001|NOT COMPLETED|Overall Study||1
11018433|NCT00789360|12196410|FG000|STARTED|Overall Study||15
11018434|NCT00789360|12196411|FG001|STARTED|Overall Study||15
11018435|NCT00789360|12196410|FG000|COMPLETED|Overall Study||12
11018436|NCT00789360|12196411|FG001|COMPLETED|Overall Study||14
11018437|NCT00789360|12196410|FG000|NOT COMPLETED|Overall Study||3
11018438|NCT00789360|12196411|FG001|NOT COMPLETED|Overall Study||1
11018439|NCT00789373|12196418|FG000|STARTED|Induction||939
11018440|NCT00789373|12196419|FG001|STARTED|Induction||0
11018441|NCT00789373|12196420|FG002|STARTED|Induction||0
11018442|NCT00789373|12196418|FG000|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
11018443|NCT00789373|12196419|FG001|COMPLETED|Induction||0
11018444|NCT00789373|12196420|FG002|COMPLETED|Induction||0
11018445|NCT00789373|12196418|FG000|NOT COMPLETED|Induction||399
11018446|NCT00789373|12196419|FG001|NOT COMPLETED|Induction||0
11018447|NCT00789373|12196420|FG002|NOT COMPLETED|Induction||0
11018448|NCT00789373|12196418|FG000|STARTED|Maintenance||0
11018449|NCT00789373|12196419|FG001|STARTED|Maintenance||359
11018450|NCT00789373|12196420|FG002|STARTED|Maintenance||180
11018451|NCT00789373|12196418|FG000|COMPLETED|Maintenance||0
11018452|NCT00789373|12196419|FG001|COMPLETED|Maintenance||0
11018453|NCT00789373|12196420|FG002|COMPLETED|Maintenance||0
11018454|NCT00789373|12196418|FG000|NOT COMPLETED|Maintenance||0
11018455|NCT00789373|12196419|FG001|NOT COMPLETED|Maintenance||359
11018456|NCT00789373|12196420|FG002|NOT COMPLETED|Maintenance||180
11143385|NCT01473836|12330252|FG000|NOT COMPLETED|Overall Study||6
11018457|NCT00789438|12196434|FG000|STARTED|Overall Study||21
11018458|NCT00789438|12196435|FG001|STARTED|Overall Study||20
11018459|NCT00789438|12196436|FG002|STARTED|Overall Study||28
11018460|NCT00789438|12196434|FG000|COMPLETED|Overall Study||21
11018461|NCT00789438|12196435|FG001|COMPLETED|Overall Study||20
11018462|NCT00789438|12196436|FG002|COMPLETED|Overall Study||28
11018463|NCT00789438|12196434|FG000|NOT COMPLETED|Overall Study||0
11018464|NCT00789438|12196435|FG001|NOT COMPLETED|Overall Study||0
11018465|NCT00789438|12196436|FG002|NOT COMPLETED|Overall Study||0
11018466|NCT00789477|12196449|FG000|STARTED|Overall Study|randomized|44
11018467|NCT00789477|12196450|FG001|STARTED|Overall Study|randomized|44
11018468|NCT00789477|12196451|FG002|STARTED|Overall Study|randomized|44
11018469|NCT00789477|12196452|FG003|STARTED|Overall Study|randomized|44
11018470|NCT00789477|12196453|FG004|STARTED|Overall Study|randomized|45
11018471|NCT00789477|12196449|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
11018472|NCT00789477|12196450|FG001|Participants Received Treatment|Overall Study|SAF|44
11018473|NCT00789477|12196451|FG002|Participants Received Treatment|Overall Study|SAF|44
11018474|NCT00789477|12196452|FG003|Participants Received Treatment|Overall Study|SAF|42
11018475|NCT00789477|12196453|FG004|Participants Received Treatment|Overall Study|SAF|45
11018476|NCT00789477|12196449|FG000|COMPLETED|Overall Study||33
11018477|NCT00789477|12196450|FG001|COMPLETED|Overall Study||38
11018478|NCT00789477|12196451|FG002|COMPLETED|Overall Study||33
11018479|NCT00789477|12196452|FG003|COMPLETED|Overall Study||34
11018480|NCT00789477|12196453|FG004|COMPLETED|Overall Study||38
11018481|NCT00789477|12196449|FG000|NOT COMPLETED|Overall Study||11
11018482|NCT00789477|12196450|FG001|NOT COMPLETED|Overall Study||6
11018483|NCT00789477|12196451|FG002|NOT COMPLETED|Overall Study||11
11018484|NCT00789477|12196452|FG003|NOT COMPLETED|Overall Study||10
11018485|NCT00789477|12196453|FG004|NOT COMPLETED|Overall Study||7
11018486|NCT00789529|12196469|FG000|STARTED|Overall Study||16
11018487|NCT00789529|12196470|FG001|STARTED|Overall Study||16
11018488|NCT00789529|12196469|FG000|COMPLETED|Overall Study||15
11018489|NCT00789529|12196470|FG001|COMPLETED|Overall Study||15
11018490|NCT00789529|12196469|FG000|NOT COMPLETED|Overall Study||1
11018491|NCT00789529|12196470|FG001|NOT COMPLETED|Overall Study||1
11018492|NCT00789555|12196479|FG000|STARTED|Overall Study||421
11018493|NCT00789555|12196480|FG001|STARTED|Overall Study||417
11018494|NCT00789555|12196481|FG002|STARTED|Overall Study||422
11018495|NCT00789555|12196479|FG000|COMPLETED|Overall Study||262
11018496|NCT00789555|12196480|FG001|COMPLETED|Overall Study||278
11018497|NCT00789555|12196481|FG002|COMPLETED|Overall Study||263
11018498|NCT00789555|12196479|FG000|NOT COMPLETED|Overall Study||159
11018499|NCT00789555|12196480|FG001|NOT COMPLETED|Overall Study||139
11018500|NCT00789555|12196481|FG002|NOT COMPLETED|Overall Study||159
11018501|NCT00789581|12196491|FG000|STARTED|AC Therapy||306
11018502|NCT00789581|12196492|FG001|STARTED|AC Therapy||308
11018503|NCT00789581|12196491|FG000|COMPLETED|AC Therapy||295
11018504|NCT00789581|12196492|FG001|COMPLETED|AC Therapy||291
11018505|NCT00789581|12196491|FG000|NOT COMPLETED|AC Therapy||11
11018506|NCT00789581|12196492|FG001|NOT COMPLETED|AC Therapy||17
11018507|NCT00789581|12196491|FG000|STARTED|Adjuvant Therapy||295
11018508|NCT00789581|12196492|FG001|STARTED|Adjuvant Therapy||291
11018509|NCT00789581|12196491|FG000|COMPLETED|Adjuvant Therapy||255
11018510|NCT00789581|12196492|FG001|COMPLETED|Adjuvant Therapy||234
11018511|NCT00789581|12196491|FG000|NOT COMPLETED|Adjuvant Therapy||40
11018512|NCT00789581|12196492|FG001|NOT COMPLETED|Adjuvant Therapy||57
11018513|NCT00789672|12196501|FG000|STARTED|Overall Study||16
11018514|NCT00789672|12196502|FG001|STARTED|Overall Study||17
11018515|NCT00789672|12196501|FG000|COMPLETED|Overall Study||16
11018516|NCT00789672|12196502|FG001|COMPLETED|Overall Study||17
11018517|NCT00789672|12196501|FG000|NOT COMPLETED|Overall Study||0
11018518|NCT00789672|12196502|FG001|NOT COMPLETED|Overall Study||0
11143386|NCT01473940|12330260|FG000|STARTED|Induction Therapy||3
11143387|NCT01473940|12330261|FG001|STARTED|Induction Therapy||4
11143388|NCT01473940|12330262|FG002|STARTED|Induction Therapy||6
11143389|NCT01473940|12330263|FG003|STARTED|Induction Therapy||8
11143390|NCT01473940|12330260|FG000|Started Treatment|Induction Therapy||3
11143391|NCT01473940|12330261|FG001|Started Treatment|Induction Therapy||4
11143392|NCT01473940|12330262|FG002|Started Treatment|Induction Therapy||6
11143393|NCT01473940|12330263|FG003|Started Treatment|Induction Therapy||8
11143394|NCT01473940|12330260|FG000|Completed Induction- 12 Weeks|Induction Therapy||3
11143395|NCT01473940|12330261|FG001|Completed Induction- 12 Weeks|Induction Therapy||3
11143396|NCT01473940|12330262|FG002|Completed Induction- 12 Weeks|Induction Therapy||4
11143397|NCT01473940|12330263|FG003|Completed Induction- 12 Weeks|Induction Therapy||7
11143398|NCT01473940|12330260|FG000|COMPLETED|Induction Therapy||3
11143399|NCT01473940|12330261|FG001|COMPLETED|Induction Therapy||3
11143400|NCT01473940|12330262|FG002|COMPLETED|Induction Therapy||4
11143401|NCT01473940|12330263|FG003|COMPLETED|Induction Therapy||7
11143402|NCT01473940|12330260|FG000|NOT COMPLETED|Induction Therapy||0
11143403|NCT01473940|12330261|FG001|NOT COMPLETED|Induction Therapy||1
11143404|NCT01473940|12330262|FG002|NOT COMPLETED|Induction Therapy||2
11143405|NCT01473940|12330263|FG003|NOT COMPLETED|Induction Therapy||1
11143406|NCT01473940|12330260|FG000|STARTED|Maintenance Therapy||3
11143407|NCT01473940|12330261|FG001|STARTED|Maintenance Therapy||3
11143408|NCT01473940|12330262|FG002|STARTED|Maintenance Therapy||4
11018519|NCT00789685|12196508|FG000|STARTED|Overall Study||37
11018520|NCT00789685|12196508|FG000|COMPLETED|Overall Study|Completed the study to Day 28|25
11018521|NCT00789685|12196508|FG000|NOT COMPLETED|Overall Study||12
11018522|NCT00789698|12196516|FG000|STARTED|Overall Study||72
11018523|NCT00789698|12196517|FG001|STARTED|Overall Study||79
11018524|NCT00789698|12196518|FG002|STARTED|Overall Study||56
11018525|NCT00789698|12196519|FG003|STARTED|Overall Study||85
11018526|NCT00789698|12196516|FG000|COMPLETED|Overall Study||32
11018527|NCT00789698|12196517|FG001|COMPLETED|Overall Study||46
11018528|NCT00789698|12196518|FG002|COMPLETED|Overall Study||29
11018529|NCT00789698|12196519|FG003|COMPLETED|Overall Study||33
11143409|NCT01473940|12330263|FG003|STARTED|Maintenance Therapy||7
11143410|NCT01473940|12330260|FG000|Evaluated for Response|Maintenance Therapy||3
11018530|NCT00789698|12196516|FG000|NOT COMPLETED|Overall Study||40
11018531|NCT00789698|12196517|FG001|NOT COMPLETED|Overall Study||33
11018532|NCT00789698|12196518|FG002|NOT COMPLETED|Overall Study||27
11018533|NCT00789698|12196519|FG003|NOT COMPLETED|Overall Study||52
11018534|NCT00789724|12196530|FG000|STARTED|Overall Study||5
11018535|NCT00789724|12196531|FG001|STARTED|Overall Study||5
11018536|NCT00789724|12196530|FG000|COMPLETED|Overall Study||5
11018537|NCT00789724|12196531|FG001|COMPLETED|Overall Study||5
11018538|NCT00789724|12196530|FG000|NOT COMPLETED|Overall Study||0
11018539|NCT00789724|12196531|FG001|NOT COMPLETED|Overall Study||0
11018540|NCT00789737|12196539|FG000|STARTED|Overall Study||176
11018541|NCT00789737|12196540|FG001|STARTED|Overall Study||181
11018542|NCT00789737|12196539|FG000|COMPLETED|Overall Study||128
11018543|NCT00789737|12196540|FG001|COMPLETED|Overall Study||126
11018544|NCT00789737|12196539|FG000|NOT COMPLETED|Overall Study||48
11018545|NCT00789737|12196540|FG001|NOT COMPLETED|Overall Study||55
11018546|NCT00789750|12196548|FG000|STARTED|Overall Study||280
11018547|NCT00789750|12196549|FG001|STARTED|Overall Study||282
11018548|NCT00789750|12196548|FG000|Dropped During run-in Period|Overall Study||6
11018549|NCT00789750|12196549|FG001|Dropped During run-in Period|Overall Study||5
11018550|NCT00789750|12196548|FG000|Safety Set|Overall Study||274
11018551|NCT00789750|12196549|FG001|Safety Set|Overall Study||277
11018552|NCT00789750|12196548|FG000|Intent to Treat Set|Overall Study||271
11018553|NCT00789750|12196549|FG001|Intent to Treat Set|Overall Study||276
11018554|NCT00789750|12196548|FG000|COMPLETED|Overall Study||221
11018555|NCT00789750|12196549|FG001|COMPLETED|Overall Study||222
11018556|NCT00789750|12196548|FG000|NOT COMPLETED|Overall Study||59
11018557|NCT00789750|12196549|FG001|NOT COMPLETED|Overall Study||60
11018558|NCT00789776|12196557|FG000|STARTED|Overall Study||5
11018559|NCT00789776|12196558|FG001|STARTED|Overall Study||36
11018560|NCT00789776|12196557|FG000|COMPLETED|Overall Study||5
11018561|NCT00789776|12196558|FG001|COMPLETED|Overall Study||35
11018562|NCT00789776|12196557|FG000|NOT COMPLETED|Overall Study||0
11018563|NCT00789776|12196558|FG001|NOT COMPLETED|Overall Study||1
11018564|NCT00789802|12196567|FG000|STARTED|Overall Study||44
11018565|NCT00789802|12196568|FG001|STARTED|Overall Study||42
11018566|NCT00789802|12196569|FG002|STARTED|Overall Study||43
11018567|NCT00789802|12196567|FG000|COMPLETED|Overall Study||34
11018568|NCT00789802|12196568|FG001|COMPLETED|Overall Study||35
11018569|NCT00789802|12196569|FG002|COMPLETED|Overall Study||37
11018570|NCT00789802|12196567|FG000|NOT COMPLETED|Overall Study||10
11018571|NCT00789802|12196568|FG001|NOT COMPLETED|Overall Study||7
11018572|NCT00789802|12196569|FG002|NOT COMPLETED|Overall Study||6
11018573|NCT00789815|12196582|FG000|STARTED|Overall Study||250
11018574|NCT00789815|12196583|FG001|STARTED|Overall Study||250
11018575|NCT00789815|12196582|FG000|COMPLETED|Overall Study||243
11018576|NCT00789815|12196583|FG001|COMPLETED|Overall Study||249
11018577|NCT00789815|12196582|FG000|NOT COMPLETED|Overall Study||7
11018578|NCT00789815|12196583|FG001|NOT COMPLETED|Overall Study||1
11018579|NCT00789828|12196591|FG000|STARTED|Core Period (48 Weeks)||78
11018580|NCT00789828|12196592|FG001|STARTED|Core Period (48 Weeks)||39
11018581|NCT00789828|12196591|FG000|COMPLETED|Core Period (48 Weeks)||78
11018582|NCT00789828|12196592|FG001|COMPLETED|Core Period (48 Weeks)||33
11018583|NCT00789828|12196591|FG000|NOT COMPLETED|Core Period (48 Weeks)||0
11018584|NCT00789828|12196592|FG001|NOT COMPLETED|Core Period (48 Weeks)||6
11018585|NCT00789828|12196591|FG000|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
11018586|NCT00789828|12196592|FG001|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
11018587|NCT00789828|12196591|FG000|COMPLETED|Open-label Extension Period (4 Years)||82
11018588|NCT00789828|12196592|FG001|COMPLETED|Open-label Extension Period (4 Years)||0
11018589|NCT00789828|12196591|FG000|NOT COMPLETED|Open-label Extension Period (4 Years)||29
11018590|NCT00789828|12196592|FG001|NOT COMPLETED|Open-label Extension Period (4 Years)||0
11018591|NCT00789854|12196604|FG000|STARTED|Overall Study||228
11018592|NCT00789854|12196605|FG001|STARTED|Overall Study||231
11018593|NCT00789854|12196606|FG002|STARTED|Overall Study||229
11018594|NCT00789854|12196604|FG000|COMPLETED|Overall Study||179
11018595|NCT00789854|12196605|FG001|COMPLETED|Overall Study||196
11018596|NCT00789854|12196606|FG002|COMPLETED|Overall Study||182
11018597|NCT00789854|12196604|FG000|NOT COMPLETED|Overall Study||49
11018598|NCT00789854|12196605|FG001|NOT COMPLETED|Overall Study||35
11018599|NCT00789854|12196606|FG002|NOT COMPLETED|Overall Study||47
11018600|NCT00789867|12196617|FG000|STARTED|Overall Study||17
11018601|NCT00789867|12196618|FG001|STARTED|Overall Study||10
11018602|NCT00789867|12196619|FG002|STARTED|Overall Study||8
11018603|NCT00789867|12196617|FG000|COMPLETED|Overall Study||17
11018604|NCT00789867|12196618|FG001|COMPLETED|Overall Study||10
11018605|NCT00789867|12196619|FG002|COMPLETED|Overall Study||8
11018606|NCT00789867|12196617|FG000|NOT COMPLETED|Overall Study||0
11018607|NCT00789867|12196618|FG001|NOT COMPLETED|Overall Study||0
11018608|NCT00789867|12196619|FG002|NOT COMPLETED|Overall Study||0
11018609|NCT00789880|12196634|FG000|STARTED|Overall Study||16
11018610|NCT00789880|12196635|FG001|STARTED|Overall Study||16
11018611|NCT00789880|12196636|FG002|STARTED|Overall Study||8
11018612|NCT00789880|12196637|FG003|STARTED|Overall Study||16
11018613|NCT00789880|12196638|FG004|STARTED|Overall Study||18
11018614|NCT00789880|12196639|FG005|STARTED|Overall Study||8
11018615|NCT00789880|12196634|FG000|COMPLETED|Overall Study||15
11018616|NCT00789880|12196635|FG001|COMPLETED|Overall Study||15
11018617|NCT00789880|12196636|FG002|COMPLETED|Overall Study||8
11018618|NCT00789880|12196637|FG003|COMPLETED|Overall Study||15
11018619|NCT00789880|12196638|FG004|COMPLETED|Overall Study||15
11018620|NCT00789880|12196639|FG005|COMPLETED|Overall Study||8
11018621|NCT00789880|12196634|FG000|NOT COMPLETED|Overall Study||1
11018622|NCT00789880|12196635|FG001|NOT COMPLETED|Overall Study||1
11018623|NCT00789880|12196636|FG002|NOT COMPLETED|Overall Study||0
11018624|NCT00789880|12196637|FG003|NOT COMPLETED|Overall Study||1
11018625|NCT00789880|12196638|FG004|NOT COMPLETED|Overall Study||3
11018626|NCT00789880|12196639|FG005|NOT COMPLETED|Overall Study||0
11018627|NCT00789958|12196653|FG000|STARTED|Overall Study||105
11018628|NCT00789958|12196653|FG000|Eligible and Analyzable|Overall Study||79
11018629|NCT00789958|12196653|FG000|COMPLETED|Overall Study||68
11018630|NCT00789958|12196653|FG000|NOT COMPLETED|Overall Study||37
11018631|NCT00789997|12196661|FG000|STARTED|Overall Study||41
11018632|NCT00789997|12196662|FG001|STARTED|Overall Study||40
11018633|NCT00789997|12196661|FG000|COMPLETED|Overall Study||40
11018634|NCT00789997|12196662|FG001|COMPLETED|Overall Study||38
11018635|NCT00789997|12196661|FG000|NOT COMPLETED|Overall Study||1
11018636|NCT00789997|12196662|FG001|NOT COMPLETED|Overall Study||2
11018637|NCT00790023|12196671|FG000|STARTED|Overall Study||237
11018638|NCT00790023|12196672|FG001|STARTED|Overall Study||235
11018639|NCT00790023|12196673|FG002|STARTED|Overall Study||235
11018640|NCT00790023|12196671|FG000|COMPLETED|Overall Study||226
11018641|NCT00790023|12196672|FG001|COMPLETED|Overall Study||225
11018642|NCT00790023|12196673|FG002|COMPLETED|Overall Study||214
11018643|NCT00790023|12196671|FG000|NOT COMPLETED|Overall Study||11
11018644|NCT00790023|12196672|FG001|NOT COMPLETED|Overall Study||10
11018645|NCT00790023|12196673|FG002|NOT COMPLETED|Overall Study||21
11018646|NCT00790036|12196684|FG000|STARTED|Overall Study||372
11018647|NCT00790036|12196685|FG001|STARTED|Overall Study||370
11018648|NCT00790036|12196684|FG000|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
11018649|NCT00790036|12196685|FG001|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
11018650|NCT00790036|12196684|FG000|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
11018651|NCT00790036|12196685|FG001|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
11018652|NCT00790036|12196684|FG000|NOT COMPLETED|Overall Study||195
11018653|NCT00790036|12196685|FG001|NOT COMPLETED|Overall Study||121
11018654|NCT00790062|12196695|FG000|STARTED|Overall Study||659
11018655|NCT00790062|12196696|FG001|STARTED|Overall Study||481
11018656|NCT00790062|12196697|FG002|STARTED|Overall Study||658
11018657|NCT00790062|12196695|FG000|COMPLETED|Overall Study||659
11018658|NCT00790062|12196696|FG001|COMPLETED|Overall Study||481
11018659|NCT00790062|12196697|FG002|COMPLETED|Overall Study||658
11018660|NCT00790062|12196695|FG000|NOT COMPLETED|Overall Study||0
11018661|NCT00790062|12196696|FG001|NOT COMPLETED|Overall Study||0
11018662|NCT00790062|12196697|FG002|NOT COMPLETED|Overall Study||0
11018663|NCT00790088|12196714|FG000|STARTED|Overall Study||274
11018664|NCT00790088|12196714|FG000|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263
11018665|NCT00790088|12196714|FG000|COMPLETED|Overall Study||235
11018666|NCT00790088|12196714|FG000|NOT COMPLETED|Overall Study||39
11018667|NCT00790192|12196724|FG000|STARTED|Overall Study||125
11018668|NCT00790192|12196725|FG001|STARTED|Overall Study||121
11018669|NCT00790192|12196726|FG002|STARTED|Overall Study||120
11018670|NCT00790192|12196727|FG003|STARTED|Overall Study||122
11018671|NCT00790192|12196724|FG000|COMPLETED|Overall Study||89
11018672|NCT00790192|12196725|FG001|COMPLETED|Overall Study||93
11018673|NCT00790192|12196726|FG002|COMPLETED|Overall Study||97
11018674|NCT00790192|12196727|FG003|COMPLETED|Overall Study||74
11018675|NCT00790192|12196724|FG000|NOT COMPLETED|Overall Study||36
11018676|NCT00790192|12196725|FG001|NOT COMPLETED|Overall Study||28
11018677|NCT00790192|12196726|FG002|NOT COMPLETED|Overall Study||23
11018678|NCT00790192|12196727|FG003|NOT COMPLETED|Overall Study||48
11018679|NCT00790205|12196739|FG000|STARTED|Overall Study||7332
11018680|NCT00790205|12196740|FG001|STARTED|Overall Study||7339
11018681|NCT00790205|12196739|FG000|Treated|Overall Study||7266
11018682|NCT00790205|12196740|FG001|Treated|Overall Study||7274
11018683|NCT00790205|12196739|FG000|COMPLETED|Overall Study||6972
11018684|NCT00790205|12196740|FG001|COMPLETED|Overall Study||6905
11018685|NCT00790205|12196739|FG000|NOT COMPLETED|Overall Study||360
11018686|NCT00790205|12196740|FG001|NOT COMPLETED|Overall Study||434
11018687|NCT00790270|12196749|FG000|STARTED|Overall Study||21
11018688|NCT00790270|12196750|FG001|STARTED|Overall Study||20
11018689|NCT00790270|12196751|FG002|STARTED|Overall Study||20
11018690|NCT00790270|12196749|FG000|COMPLETED|Overall Study||21
11018691|NCT00790270|12196750|FG001|COMPLETED|Overall Study||20
11018692|NCT00790270|12196751|FG002|COMPLETED|Overall Study||20
11018693|NCT00790270|12196749|FG000|NOT COMPLETED|Overall Study||0
11018694|NCT00790270|12196750|FG001|NOT COMPLETED|Overall Study||0
11018695|NCT00790270|12196751|FG002|NOT COMPLETED|Overall Study||0
11018696|NCT00790296|12196761|FG000|STARTED|Overall Study||5
11018697|NCT00790296|12196762|FG001|STARTED|Overall Study||6
11018698|NCT00790296|12196761|FG000|COMPLETED|Overall Study||4
11018699|NCT00790296|12196762|FG001|COMPLETED|Overall Study||4
11018700|NCT00790296|12196761|FG000|NOT COMPLETED|Overall Study||1
11018701|NCT00790296|12196762|FG001|NOT COMPLETED|Overall Study||2
11018702|NCT00790335|12196770|FG000|STARTED|Overall Study||337
11018703|NCT00790335|12196771|FG001|STARTED|Overall Study||355
11018704|NCT00790335|12196770|FG000|COMPLETED|Overall Study||257
11018705|NCT00790335|12196771|FG001|COMPLETED|Overall Study||243
11018706|NCT00790335|12196770|FG000|NOT COMPLETED|Overall Study||80
11018707|NCT00790335|12196771|FG001|NOT COMPLETED|Overall Study||112
11018708|NCT00790400|12196779|FG000|STARTED|Double-blind Period (Core Phase)||79
11018709|NCT00790400|12196780|FG001|STARTED|Double-blind Period (Core Phase)||39
11018710|NCT00790400|12196779|FG000|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
11018711|NCT00790400|12196780|FG001|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
11018712|NCT00790400|12196779|FG000|NOT COMPLETED|Double-blind Period (Core Phase)||7
11018713|NCT00790400|12196780|FG001|NOT COMPLETED|Double-blind Period (Core Phase)||13
11018714|NCT00790400|12196779|FG000|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
11018715|NCT00790400|12196780|FG001|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
11018716|NCT00790400|12196779|FG000|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
11018717|NCT00790400|12196780|FG001|COMPLETED|Everolimus Period (Core or Extension)||0
11018718|NCT00790400|12196779|FG000|NOT COMPLETED|Everolimus Period (Core or Extension)||29
11018719|NCT00790400|12196780|FG001|NOT COMPLETED|Everolimus Period (Core or Extension)||0
11018720|NCT00790556|12196789|FG000|STARTED|Treatment Period 1||8
11018721|NCT00790556|12196790|FG001|STARTED|Treatment Period 1||6
11018722|NCT00790556|12196789|FG000|COMPLETED|Treatment Period 1||6
11018723|NCT00790556|12196790|FG001|COMPLETED|Treatment Period 1||6
11018724|NCT00790556|12196789|FG000|NOT COMPLETED|Treatment Period 1||2
11018725|NCT00790556|12196790|FG001|NOT COMPLETED|Treatment Period 1||0
11018726|NCT00790556|12196789|FG000|STARTED|Washout After Period 1||6
11018727|NCT00790556|12196790|FG001|STARTED|Washout After Period 1||6
11018728|NCT00790556|12196789|FG000|COMPLETED|Washout After Period 1||6
11018729|NCT00790556|12196790|FG001|COMPLETED|Washout After Period 1||6
11018730|NCT00790556|12196789|FG000|NOT COMPLETED|Washout After Period 1||0
11018731|NCT00790556|12196790|FG001|NOT COMPLETED|Washout After Period 1||0
11018732|NCT00790556|12196789|FG000|STARTED|Treatment Period 2||6
11018733|NCT00790556|12196790|FG001|STARTED|Treatment Period 2||6
11018734|NCT00790556|12196789|FG000|COMPLETED|Treatment Period 2||6
11018735|NCT00790556|12196790|FG001|COMPLETED|Treatment Period 2||6
11018736|NCT00790556|12196789|FG000|NOT COMPLETED|Treatment Period 2||0
11018737|NCT00790556|12196790|FG001|NOT COMPLETED|Treatment Period 2||0
11018738|NCT00790569|12196799|FG000|STARTED|End of Treatment (6 Month Interview)||137
11018739|NCT00790569|12196800|FG001|STARTED|End of Treatment (6 Month Interview)||45
11018740|NCT00790569|12196801|FG002|STARTED|End of Treatment (6 Month Interview)||133
11018741|NCT00790569|12196799|FG000|COMPLETED|End of Treatment (6 Month Interview)||115
11018742|NCT00790569|12196800|FG001|COMPLETED|End of Treatment (6 Month Interview)||35
11018743|NCT00790569|12196801|FG002|COMPLETED|End of Treatment (6 Month Interview)||107
11018744|NCT00790569|12196799|FG000|NOT COMPLETED|End of Treatment (6 Month Interview)||22
11018745|NCT00790569|12196800|FG001|NOT COMPLETED|End of Treatment (6 Month Interview)||10
11018746|NCT00790569|12196801|FG002|NOT COMPLETED|End of Treatment (6 Month Interview)||26
11018747|NCT00790569|12196799|FG000|STARTED|End of Study (12 Month Interview)||137
11018748|NCT00790569|12196800|FG001|STARTED|End of Study (12 Month Interview)||45
11018749|NCT00790569|12196801|FG002|STARTED|End of Study (12 Month Interview)||133
11018750|NCT00790569|12196799|FG000|COMPLETED|End of Study (12 Month Interview)||71
11018751|NCT00790569|12196800|FG001|COMPLETED|End of Study (12 Month Interview)||26
11018752|NCT00790569|12196801|FG002|COMPLETED|End of Study (12 Month Interview)||83
11018753|NCT00790569|12196799|FG000|NOT COMPLETED|End of Study (12 Month Interview)||66
11018754|NCT00790569|12196800|FG001|NOT COMPLETED|End of Study (12 Month Interview)||19
11018755|NCT00790569|12196801|FG002|NOT COMPLETED|End of Study (12 Month Interview)||50
11018756|NCT00790582|12196811|FG000|STARTED|Overall Study||109
11018757|NCT00790582|12196812|FG001|STARTED|Overall Study||249
11018758|NCT00790582|12196811|FG000|COMPLETED|Overall Study||78
11018759|NCT00790582|12196812|FG001|COMPLETED|Overall Study||162
11018760|NCT00790582|12196811|FG000|NOT COMPLETED|Overall Study||31
11018761|NCT00790582|12196812|FG001|NOT COMPLETED|Overall Study||87
11018762|NCT00790647|12196820|FG000|STARTED|Overall Study||10
11018763|NCT00790647|12196820|FG000|COMPLETED|Overall Study||9
11018764|NCT00790647|12196820|FG000|NOT COMPLETED|Overall Study||1
11018765|NCT00790673|12196830|FG000|STARTED|Overall Study||6
11018766|NCT00790673|12196831|FG001|STARTED|Overall Study||6
11143411|NCT01473940|12330261|FG001|Evaluated for Response|Maintenance Therapy||3
11143412|NCT01473940|12330262|FG002|Evaluated for Response|Maintenance Therapy||4
11143413|NCT01473940|12330263|FG003|Evaluated for Response|Maintenance Therapy||7
11143414|NCT01473940|12330260|FG000|Went on to Start Maintenance Therapy|Maintenance Therapy||2
11143415|NCT01473940|12330261|FG001|Went on to Start Maintenance Therapy|Maintenance Therapy||1
11143416|NCT01473940|12330262|FG002|Went on to Start Maintenance Therapy|Maintenance Therapy||3
11143417|NCT01473940|12330263|FG003|Went on to Start Maintenance Therapy|Maintenance Therapy||3
11143418|NCT01473940|12330260|FG000|COMPLETED|Maintenance Therapy||2
11143419|NCT01473940|12330261|FG001|COMPLETED|Maintenance Therapy||1
11018767|NCT00790673|12196832|FG002|STARTED|Overall Study||12
11018768|NCT00790673|12196833|FG003|STARTED|Overall Study||8
11018769|NCT00790673|12196830|FG000|COMPLETED|Overall Study||6
11018770|NCT00790673|12196831|FG001|COMPLETED|Overall Study||6
11018771|NCT00790673|12196832|FG002|COMPLETED|Overall Study||12
11018772|NCT00790673|12196833|FG003|COMPLETED|Overall Study||8
11018773|NCT00790673|12196830|FG000|NOT COMPLETED|Overall Study||0
11018774|NCT00790673|12196831|FG001|NOT COMPLETED|Overall Study||0
11143420|NCT01473940|12330262|FG002|COMPLETED|Maintenance Therapy||3
11018775|NCT00790673|12196832|FG002|NOT COMPLETED|Overall Study||0
11018776|NCT00790673|12196833|FG003|NOT COMPLETED|Overall Study||0
11018777|NCT00790699|12196845|FG000|STARTED|Overall Study||17
11018778|NCT00790699|12196846|FG001|STARTED|Overall Study||14
11018779|NCT00790699|12196845|FG000|COMPLETED|Overall Study||16
11018780|NCT00790699|12196846|FG001|COMPLETED|Overall Study||14
11018781|NCT00790699|12196845|FG000|NOT COMPLETED|Overall Study||1
11018782|NCT00790699|12196846|FG001|NOT COMPLETED|Overall Study||0
11018783|NCT00790738|12196856|FG000|STARTED|Overall Study||5
11018784|NCT00790738|12196857|FG001|STARTED|Overall Study||6
11018785|NCT00790738|12196856|FG000|COMPLETED|Overall Study||3
11018786|NCT00790738|12196857|FG001|COMPLETED|Overall Study||3
11018787|NCT00790738|12196856|FG000|NOT COMPLETED|Overall Study||2
11018788|NCT00790738|12196857|FG001|NOT COMPLETED|Overall Study||3
11018789|NCT00790751|12196867|FG000|STARTED|Overall Study||162
11018790|NCT00790751|12196868|FG001|STARTED|Overall Study||161
11018791|NCT00790751|12196869|FG002|STARTED|Overall Study||161
11018792|NCT00790751|12196870|FG003|STARTED|Overall Study||162
11018793|NCT00790751|12196867|FG000|COMPLETED|Overall Study||137
11018794|NCT00790751|12196868|FG001|COMPLETED|Overall Study||131
11018795|NCT00790751|12196869|FG002|COMPLETED|Overall Study||141
11018796|NCT00790751|12196870|FG003|COMPLETED|Overall Study||141
11018797|NCT00790751|12196867|FG000|NOT COMPLETED|Overall Study||25
11018798|NCT00790751|12196868|FG001|NOT COMPLETED|Overall Study||30
11018799|NCT00790751|12196869|FG002|NOT COMPLETED|Overall Study||20
11018800|NCT00790751|12196870|FG003|NOT COMPLETED|Overall Study||21
11018801|NCT00790790|12196883|FG000|STARTED|Study Period 2: Therapy Phase||49
11018802|NCT00790790|12196884|FG001|STARTED|Study Period 2: Therapy Phase||50
11018803|NCT00790790|12196885|FG002|STARTED|Study Period 2: Therapy Phase||48
11018804|NCT00790790|12196883|FG000|COMPLETED|Study Period 2: Therapy Phase||37
11018805|NCT00790790|12196884|FG001|COMPLETED|Study Period 2: Therapy Phase||32
11018806|NCT00790790|12196885|FG002|COMPLETED|Study Period 2: Therapy Phase||27
11018807|NCT00790790|12196883|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||12
11018808|NCT00790790|12196884|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||18
11018809|NCT00790790|12196885|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||21
11018810|NCT00790790|12196883|FG000|STARTED|Study Period 3: 1-Week Washout Phase||37
11018811|NCT00790790|12196884|FG001|STARTED|Study Period 3: 1-Week Washout Phase||32
11018812|NCT00790790|12196885|FG002|STARTED|Study Period 3: 1-Week Washout Phase||27
11018813|NCT00790790|12196883|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||37
11018814|NCT00790790|12196884|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||31
11018815|NCT00790790|12196885|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||26
11018816|NCT00790790|12196883|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
11018817|NCT00790790|12196884|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
11018818|NCT00790790|12196885|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
11018819|NCT00790842|12196901|FG000|STARTED|Dose Level 1||6
11018820|NCT00790842|12196902|FG001|STARTED|Dose Level 1||0
11018821|NCT00790842|12196903|FG002|STARTED|Dose Level 1||0
11018822|NCT00790842|12196904|FG003|STARTED|Dose Level 1||3
11018823|NCT00790842|12196905|FG004|STARTED|Dose Level 1||0
11018824|NCT00790842|12196906|FG005|STARTED|Dose Level 1||0
11018825|NCT00790842|12196907|FG006|STARTED|Dose Level 1||0
11018826|NCT00790842|12196908|FG007|STARTED|Dose Level 1||3
11018827|NCT00790842|12196909|FG008|STARTED|Dose Level 1||0
11018828|NCT00790842|12196910|FG009|STARTED|Dose Level 1||0
11018829|NCT00790842|12196911|FG010|STARTED|Dose Level 1||0
11018830|NCT00790842|12196901|FG000|Began Treatment|Dose Level 1||6
11018831|NCT00790842|12196902|FG001|Began Treatment|Dose Level 1||0
11018832|NCT00790842|12196903|FG002|Began Treatment|Dose Level 1||0
11018833|NCT00790842|12196904|FG003|Began Treatment|Dose Level 1||3
11018834|NCT00790842|12196905|FG004|Began Treatment|Dose Level 1||0
11018835|NCT00790842|12196906|FG005|Began Treatment|Dose Level 1||0
11018836|NCT00790842|12196907|FG006|Began Treatment|Dose Level 1||0
11018837|NCT00790842|12196908|FG007|Began Treatment|Dose Level 1||3
11018838|NCT00790842|12196909|FG008|Began Treatment|Dose Level 1||0
11018839|NCT00790842|12196910|FG009|Began Treatment|Dose Level 1||0
11018840|NCT00790842|12196911|FG010|Began Treatment|Dose Level 1||0
11018841|NCT00790842|12196901|FG000|COMPLETED|Dose Level 1||3
11018842|NCT00790842|12196902|FG001|COMPLETED|Dose Level 1||0
11018843|NCT00790842|12196903|FG002|COMPLETED|Dose Level 1||0
11018844|NCT00790842|12196904|FG003|COMPLETED|Dose Level 1||1
11018845|NCT00790842|12196905|FG004|COMPLETED|Dose Level 1||0
11018846|NCT00790842|12196906|FG005|COMPLETED|Dose Level 1||0
11143421|NCT01473940|12330263|FG003|COMPLETED|Maintenance Therapy||3
11143422|NCT01473940|12330260|FG000|NOT COMPLETED|Maintenance Therapy||1
11143423|NCT01473940|12330261|FG001|NOT COMPLETED|Maintenance Therapy||2
11143424|NCT01473940|12330262|FG002|NOT COMPLETED|Maintenance Therapy||1
11143425|NCT01473940|12330263|FG003|NOT COMPLETED|Maintenance Therapy||4
11143426|NCT01473940|12330260|FG000|STARTED|Follow-up Until Death||3
11143427|NCT01473940|12330261|FG001|STARTED|Follow-up Until Death||4
11018847|NCT00790842|12196907|FG006|COMPLETED|Dose Level 1||0
11018848|NCT00790842|12196908|FG007|COMPLETED|Dose Level 1||1
11018849|NCT00790842|12196909|FG008|COMPLETED|Dose Level 1||0
11018850|NCT00790842|12196910|FG009|COMPLETED|Dose Level 1||0
11018851|NCT00790842|12196911|FG010|COMPLETED|Dose Level 1||0
11018852|NCT00790842|12196901|FG000|NOT COMPLETED|Dose Level 1||3
11018853|NCT00790842|12196902|FG001|NOT COMPLETED|Dose Level 1||0
11018854|NCT00790842|12196903|FG002|NOT COMPLETED|Dose Level 1||0
11018855|NCT00790842|12196904|FG003|NOT COMPLETED|Dose Level 1||2
11018856|NCT00790842|12196905|FG004|NOT COMPLETED|Dose Level 1||0
11018857|NCT00790842|12196906|FG005|NOT COMPLETED|Dose Level 1||0
11018858|NCT00790842|12196907|FG006|NOT COMPLETED|Dose Level 1||0
11018859|NCT00790842|12196908|FG007|NOT COMPLETED|Dose Level 1||2
11018860|NCT00790842|12196909|FG008|NOT COMPLETED|Dose Level 1||0
11018861|NCT00790842|12196910|FG009|NOT COMPLETED|Dose Level 1||0
11018862|NCT00790842|12196911|FG010|NOT COMPLETED|Dose Level 1||0
11018863|NCT00790842|12196901|FG000|STARTED|Dose Level 2||0
11018864|NCT00790842|12196902|FG001|STARTED|Dose Level 2||3
11018865|NCT00790842|12196903|FG002|STARTED|Dose Level 2||0
11018866|NCT00790842|12196904|FG003|STARTED|Dose Level 2||0
11018867|NCT00790842|12196905|FG004|STARTED|Dose Level 2||3
11018868|NCT00790842|12196906|FG005|STARTED|Dose Level 2||0
11018869|NCT00790842|12196907|FG006|STARTED|Dose Level 2||0
11018870|NCT00790842|12196908|FG007|STARTED|Dose Level 2||0
11018871|NCT00790842|12196909|FG008|STARTED|Dose Level 2||3
11018872|NCT00790842|12196910|FG009|STARTED|Dose Level 2||0
11018873|NCT00790842|12196911|FG010|STARTED|Dose Level 2||0
11018874|NCT00790842|12196901|FG000|Began Treatment|Dose Level 2||0
11018875|NCT00790842|12196902|FG001|Began Treatment|Dose Level 2||3
11018876|NCT00790842|12196903|FG002|Began Treatment|Dose Level 2||0
11018877|NCT00790842|12196904|FG003|Began Treatment|Dose Level 2||0
11018878|NCT00790842|12196905|FG004|Began Treatment|Dose Level 2||3
11018879|NCT00790842|12196906|FG005|Began Treatment|Dose Level 2||0
11018880|NCT00790842|12196907|FG006|Began Treatment|Dose Level 2||0
11018881|NCT00790842|12196908|FG007|Began Treatment|Dose Level 2||0
11018882|NCT00790842|12196909|FG008|Began Treatment|Dose Level 2||3
11018883|NCT00790842|12196910|FG009|Began Treatment|Dose Level 2||0
11018884|NCT00790842|12196911|FG010|Began Treatment|Dose Level 2||0
11018885|NCT00790842|12196901|FG000|COMPLETED|Dose Level 2||0
11018886|NCT00790842|12196902|FG001|COMPLETED|Dose Level 2||0
11018887|NCT00790842|12196903|FG002|COMPLETED|Dose Level 2||0
11018888|NCT00790842|12196904|FG003|COMPLETED|Dose Level 2||0
11018889|NCT00790842|12196905|FG004|COMPLETED|Dose Level 2||2
11018890|NCT00790842|12196906|FG005|COMPLETED|Dose Level 2||0
11018891|NCT00790842|12196907|FG006|COMPLETED|Dose Level 2||0
11018892|NCT00790842|12196908|FG007|COMPLETED|Dose Level 2||0
11018893|NCT00790842|12196909|FG008|COMPLETED|Dose Level 2||1
11018894|NCT00790842|12196910|FG009|COMPLETED|Dose Level 2||0
11018895|NCT00790842|12196911|FG010|COMPLETED|Dose Level 2||0
11018896|NCT00790842|12196901|FG000|NOT COMPLETED|Dose Level 2||0
11018897|NCT00790842|12196902|FG001|NOT COMPLETED|Dose Level 2||3
11018898|NCT00790842|12196903|FG002|NOT COMPLETED|Dose Level 2||0
11018899|NCT00790842|12196904|FG003|NOT COMPLETED|Dose Level 2||0
11018900|NCT00790842|12196905|FG004|NOT COMPLETED|Dose Level 2||1
11018901|NCT00790842|12196906|FG005|NOT COMPLETED|Dose Level 2||0
11018902|NCT00790842|12196907|FG006|NOT COMPLETED|Dose Level 2||0
11018903|NCT00790842|12196908|FG007|NOT COMPLETED|Dose Level 2||0
11018904|NCT00790842|12196909|FG008|NOT COMPLETED|Dose Level 2||2
11018905|NCT00790842|12196910|FG009|NOT COMPLETED|Dose Level 2||0
11018906|NCT00790842|12196911|FG010|NOT COMPLETED|Dose Level 2||0
11018907|NCT00790842|12196901|FG000|STARTED|Dose Level 3||0
11018908|NCT00790842|12196902|FG001|STARTED|Dose Level 3||0
11018909|NCT00790842|12196903|FG002|STARTED|Dose Level 3||7
11018910|NCT00790842|12196904|FG003|STARTED|Dose Level 3||0
11018911|NCT00790842|12196905|FG004|STARTED|Dose Level 3||0
11018912|NCT00790842|12196906|FG005|STARTED|Dose Level 3||3
11143428|NCT01473940|12330262|FG002|STARTED|Follow-up Until Death||5
11143429|NCT01473940|12330263|FG003|STARTED|Follow-up Until Death||7
11143430|NCT01473940|12330260|FG000|COMPLETED|Follow-up Until Death||3
11143431|NCT01473940|12330261|FG001|COMPLETED|Follow-up Until Death||4
11143432|NCT01473940|12330262|FG002|COMPLETED|Follow-up Until Death||5
11143433|NCT01473940|12330263|FG003|COMPLETED|Follow-up Until Death||7
11143434|NCT01473940|12330260|FG000|NOT COMPLETED|Follow-up Until Death||0
11396688|NCT03862625|12590580|FG000|STARTED|Overall Study||15
11018913|NCT00790842|12196907|FG006|STARTED|Dose Level 3||0
11018914|NCT00790842|12196908|FG007|STARTED|Dose Level 3||0
11018915|NCT00790842|12196909|FG008|STARTED|Dose Level 3||0
11018916|NCT00790842|12196910|FG009|STARTED|Dose Level 3||3
11018917|NCT00790842|12196911|FG010|STARTED|Dose Level 3||0
11018918|NCT00790842|12196901|FG000|Began Treatment|Dose Level 3||0
11018919|NCT00790842|12196902|FG001|Began Treatment|Dose Level 3||0
11018920|NCT00790842|12196903|FG002|Began Treatment|Dose Level 3||6
11018921|NCT00790842|12196904|FG003|Began Treatment|Dose Level 3||0
11018922|NCT00790842|12196905|FG004|Began Treatment|Dose Level 3||0
11018923|NCT00790842|12196906|FG005|Began Treatment|Dose Level 3||3
11396689|NCT03862625|12590581|FG001|STARTED|Overall Study||15
11396690|NCT03862625|12590580|FG000|COMPLETED|Overall Study||15
11396691|NCT03862625|12590581|FG001|COMPLETED|Overall Study||14
11018924|NCT00790842|12196907|FG006|Began Treatment|Dose Level 3||0
11018925|NCT00790842|12196908|FG007|Began Treatment|Dose Level 3||0
11018926|NCT00790842|12196909|FG008|Began Treatment|Dose Level 3||0
11018927|NCT00790842|12196910|FG009|Began Treatment|Dose Level 3||3
11018928|NCT00790842|12196911|FG010|Began Treatment|Dose Level 3||0
11018929|NCT00790842|12196901|FG000|COMPLETED|Dose Level 3||0
11018930|NCT00790842|12196902|FG001|COMPLETED|Dose Level 3||0
11018931|NCT00790842|12196903|FG002|COMPLETED|Dose Level 3||2
11018932|NCT00790842|12196904|FG003|COMPLETED|Dose Level 3||0
11018933|NCT00790842|12196905|FG004|COMPLETED|Dose Level 3||0
11018934|NCT00790842|12196906|FG005|COMPLETED|Dose Level 3||2
11018935|NCT00790842|12196907|FG006|COMPLETED|Dose Level 3||0
11018936|NCT00790842|12196908|FG007|COMPLETED|Dose Level 3||0
11018937|NCT00790842|12196909|FG008|COMPLETED|Dose Level 3||0
11018938|NCT00790842|12196910|FG009|COMPLETED|Dose Level 3||1
11018939|NCT00790842|12196911|FG010|COMPLETED|Dose Level 3||0
11018940|NCT00790842|12196901|FG000|NOT COMPLETED|Dose Level 3||0
11018941|NCT00790842|12196902|FG001|NOT COMPLETED|Dose Level 3||0
11018942|NCT00790842|12196903|FG002|NOT COMPLETED|Dose Level 3||5
11018943|NCT00790842|12196904|FG003|NOT COMPLETED|Dose Level 3||0
11018944|NCT00790842|12196905|FG004|NOT COMPLETED|Dose Level 3||0
11018945|NCT00790842|12196906|FG005|NOT COMPLETED|Dose Level 3||1
11018946|NCT00790842|12196907|FG006|NOT COMPLETED|Dose Level 3||0
11018947|NCT00790842|12196908|FG007|NOT COMPLETED|Dose Level 3||0
11018948|NCT00790842|12196909|FG008|NOT COMPLETED|Dose Level 3||0
11018949|NCT00790842|12196910|FG009|NOT COMPLETED|Dose Level 3||2
11018950|NCT00790842|12196911|FG010|NOT COMPLETED|Dose Level 3||0
11018951|NCT00790842|12196901|FG000|STARTED|Dose Level 4||0
11018952|NCT00790842|12196902|FG001|STARTED|Dose Level 4||0
11018953|NCT00790842|12196903|FG002|STARTED|Dose Level 4||0
11018954|NCT00790842|12196904|FG003|STARTED|Dose Level 4||0
11018955|NCT00790842|12196905|FG004|STARTED|Dose Level 4||0
11018956|NCT00790842|12196906|FG005|STARTED|Dose Level 4||0
11018957|NCT00790842|12196907|FG006|STARTED|Dose Level 4||8
11018958|NCT00790842|12196908|FG007|STARTED|Dose Level 4||0
11018959|NCT00790842|12196909|FG008|STARTED|Dose Level 4||0
11018960|NCT00790842|12196910|FG009|STARTED|Dose Level 4||0
11018961|NCT00790842|12196911|FG010|STARTED|Dose Level 4||5
11018962|NCT00790842|12196901|FG000|Began Treatment|Dose Level 4||0
11018963|NCT00790842|12196902|FG001|Began Treatment|Dose Level 4||0
11018964|NCT00790842|12196903|FG002|Began Treatment|Dose Level 4||0
11018965|NCT00790842|12196904|FG003|Began Treatment|Dose Level 4||0
11018966|NCT00790842|12196905|FG004|Began Treatment|Dose Level 4||0
11018967|NCT00790842|12196906|FG005|Began Treatment|Dose Level 4||0
11018968|NCT00790842|12196907|FG006|Began Treatment|Dose Level 4||8
11018969|NCT00790842|12196908|FG007|Began Treatment|Dose Level 4||0
11018970|NCT00790842|12196909|FG008|Began Treatment|Dose Level 4||0
11018971|NCT00790842|12196910|FG009|Began Treatment|Dose Level 4||0
11018972|NCT00790842|12196911|FG010|Began Treatment|Dose Level 4||5
11018973|NCT00790842|12196901|FG000|COMPLETED|Dose Level 4||0
11018974|NCT00790842|12196902|FG001|COMPLETED|Dose Level 4||0
11018975|NCT00790842|12196903|FG002|COMPLETED|Dose Level 4||0
11018976|NCT00790842|12196904|FG003|COMPLETED|Dose Level 4||0
11018977|NCT00790842|12196905|FG004|COMPLETED|Dose Level 4||0
11018978|NCT00790842|12196906|FG005|COMPLETED|Dose Level 4||0
11018979|NCT00790842|12196907|FG006|COMPLETED|Dose Level 4||6
11396692|NCT03862625|12590580|FG000|NOT COMPLETED|Overall Study||0
11396693|NCT03862625|12590581|FG001|NOT COMPLETED|Overall Study||1
11396694|NCT03862755|12590587|FG000|STARTED|Overall Study||581
11396695|NCT03862755|12590587|FG000|COMPLETED|Overall Study||581
11396696|NCT03862755|12590587|FG000|NOT COMPLETED|Overall Study||0
11396697|NCT03869541|12590594|FG000|STARTED|Overall Study||40
11018980|NCT00790842|12196908|FG007|COMPLETED|Dose Level 4||0
11018981|NCT00790842|12196909|FG008|COMPLETED|Dose Level 4||0
11396698|NCT03869541|12590595|FG001|STARTED|Overall Study||50
11396699|NCT03869541|12590596|FG002|STARTED|Overall Study||10
11396700|NCT03869541|12590594|FG000|COMPLETED|Overall Study||40
11018982|NCT00790842|12196910|FG009|COMPLETED|Dose Level 4||0
11396701|NCT03869541|12590595|FG001|COMPLETED|Overall Study||50
11396702|NCT03869541|12590596|FG002|COMPLETED|Overall Study||10
11018983|NCT00790842|12196911|FG010|COMPLETED|Dose Level 4||3
11018984|NCT00790842|12196901|FG000|NOT COMPLETED|Dose Level 4||0
11018985|NCT00790842|12196902|FG001|NOT COMPLETED|Dose Level 4||0
11018986|NCT00790842|12196903|FG002|NOT COMPLETED|Dose Level 4||0
11396703|NCT03869541|12590594|FG000|NOT COMPLETED|Overall Study||0
11396704|NCT03869541|12590595|FG001|NOT COMPLETED|Overall Study||0
11018987|NCT00790842|12196904|FG003|NOT COMPLETED|Dose Level 4||0
11018988|NCT00790842|12196905|FG004|NOT COMPLETED|Dose Level 4||0
11018989|NCT00790842|12196906|FG005|NOT COMPLETED|Dose Level 4||0
11018990|NCT00790842|12196907|FG006|NOT COMPLETED|Dose Level 4||2
11018991|NCT00790842|12196908|FG007|NOT COMPLETED|Dose Level 4||0
11018992|NCT00790842|12196909|FG008|NOT COMPLETED|Dose Level 4||0
11018993|NCT00790842|12196910|FG009|NOT COMPLETED|Dose Level 4||0
11018994|NCT00790842|12196911|FG010|NOT COMPLETED|Dose Level 4||2
11018995|NCT00790842|12196901|FG000|STARTED|Expansion Cohort||0
11018996|NCT00790842|12196902|FG001|STARTED|Expansion Cohort||0
11018997|NCT00790842|12196903|FG002|STARTED|Expansion Cohort||14
11396705|NCT03869541|12590596|FG002|NOT COMPLETED|Overall Study||0
11396706|NCT03877224|12590609|FG000|STARTED|Overall Study||253
11396707|NCT03877224|12590610|FG001|STARTED|Overall Study||251
11396708|NCT03877224|12590609|FG000|Treated|Overall Study||252
11396709|NCT03877224|12590610|FG001|Treated|Overall Study||249
11396710|NCT03877224|12590609|FG000|COMPLETED|Overall Study||248
11018998|NCT00790842|12196904|FG003|STARTED|Expansion Cohort||0
11018999|NCT00790842|12196905|FG004|STARTED|Expansion Cohort||0
11019000|NCT00790842|12196906|FG005|STARTED|Expansion Cohort||0
11019001|NCT00790842|12196907|FG006|STARTED|Expansion Cohort||2
11019002|NCT00790842|12196908|FG007|STARTED|Expansion Cohort||0
11019003|NCT00790842|12196909|FG008|STARTED|Expansion Cohort||0
11019004|NCT00790842|12196910|FG009|STARTED|Expansion Cohort||0
11019005|NCT00790842|12196911|FG010|STARTED|Expansion Cohort||0
11019006|NCT00790842|12196901|FG000|Began Treatment|Expansion Cohort||0
11019007|NCT00790842|12196902|FG001|Began Treatment|Expansion Cohort||0
11019008|NCT00790842|12196903|FG002|Began Treatment|Expansion Cohort||14
11019009|NCT00790842|12196904|FG003|Began Treatment|Expansion Cohort||0
11019010|NCT00790842|12196905|FG004|Began Treatment|Expansion Cohort||0
11019011|NCT00790842|12196906|FG005|Began Treatment|Expansion Cohort||0
11019012|NCT00790842|12196907|FG006|Began Treatment|Expansion Cohort||2
11019013|NCT00790842|12196908|FG007|Began Treatment|Expansion Cohort||0
11019014|NCT00790842|12196909|FG008|Began Treatment|Expansion Cohort||0
11019015|NCT00790842|12196910|FG009|Began Treatment|Expansion Cohort||0
11019016|NCT00790842|12196911|FG010|Began Treatment|Expansion Cohort||0
11019017|NCT00790842|12196901|FG000|COMPLETED|Expansion Cohort||0
11019018|NCT00790842|12196902|FG001|COMPLETED|Expansion Cohort||0
11019019|NCT00790842|12196903|FG002|COMPLETED|Expansion Cohort||7
11019020|NCT00790842|12196904|FG003|COMPLETED|Expansion Cohort||0
11019021|NCT00790842|12196905|FG004|COMPLETED|Expansion Cohort||0
11019022|NCT00790842|12196906|FG005|COMPLETED|Expansion Cohort||0
11019023|NCT00790842|12196907|FG006|COMPLETED|Expansion Cohort||1
11019024|NCT00790842|12196908|FG007|COMPLETED|Expansion Cohort||0
11019025|NCT00790842|12196909|FG008|COMPLETED|Expansion Cohort||0
11019026|NCT00790842|12196910|FG009|COMPLETED|Expansion Cohort||0
11019027|NCT00790842|12196911|FG010|COMPLETED|Expansion Cohort||0
11019028|NCT00790842|12196901|FG000|NOT COMPLETED|Expansion Cohort||0
11019029|NCT00790842|12196902|FG001|NOT COMPLETED|Expansion Cohort||0
11019030|NCT00790842|12196903|FG002|NOT COMPLETED|Expansion Cohort||7
11019031|NCT00790842|12196904|FG003|NOT COMPLETED|Expansion Cohort||0
11019032|NCT00790842|12196905|FG004|NOT COMPLETED|Expansion Cohort||0
11019033|NCT00790842|12196906|FG005|NOT COMPLETED|Expansion Cohort||0
11019034|NCT00790842|12196907|FG006|NOT COMPLETED|Expansion Cohort||1
11019035|NCT00790842|12196908|FG007|NOT COMPLETED|Expansion Cohort||0
11019036|NCT00790842|12196909|FG008|NOT COMPLETED|Expansion Cohort||0
11019037|NCT00790842|12196910|FG009|NOT COMPLETED|Expansion Cohort||0
11019038|NCT00790842|12196911|FG010|NOT COMPLETED|Expansion Cohort||0
11019039|NCT00790855|12196959|FG000|STARTED|Overall Study||25
11019040|NCT00790855|12196959|FG000|COMPLETED|Overall Study||25
11019041|NCT00790855|12196959|FG000|NOT COMPLETED|Overall Study||0
11396711|NCT03877224|12590610|FG001|COMPLETED|Overall Study||243
11019042|NCT00790868|12196966|FG000|STARTED|Overall Study||88
11019043|NCT00790868|12196967|FG001|STARTED|Overall Study||92
11019044|NCT00790868|12196966|FG000|COMPLETED|Overall Study||82
11019045|NCT00790868|12196967|FG001|COMPLETED|Overall Study||75
11019046|NCT00790868|12196966|FG000|NOT COMPLETED|Overall Study||6
11019047|NCT00790868|12196967|FG001|NOT COMPLETED|Overall Study||17
11019048|NCT00790907|12196978|FG000|STARTED|Overall Study||1209
11019049|NCT00790907|12196979|FG001|STARTED|Overall Study||1024
11019050|NCT00790907|12196980|FG002|STARTED|Overall Study||1002
11019051|NCT00790907|12196978|FG000|COMPLETED|Overall Study||754
11396712|NCT03877224|12590609|FG000|NOT COMPLETED|Overall Study||5
11396713|NCT03877224|12590610|FG001|NOT COMPLETED|Overall Study||8
11019052|NCT00790907|12196979|FG001|COMPLETED|Overall Study||684
11019053|NCT00790907|12196980|FG002|COMPLETED|Overall Study||663
11019054|NCT00790907|12196978|FG000|NOT COMPLETED|Overall Study||455
11019055|NCT00790907|12196979|FG001|NOT COMPLETED|Overall Study||340
11019056|NCT00790907|12196980|FG002|NOT COMPLETED|Overall Study||339
11019057|NCT00791037|12196987|FG000|STARTED|Overall Study||23
11019058|NCT00791037|12196987|FG000|Primary Outcome|Overall Study||19
11019059|NCT00791037|12196987|FG000|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
11019060|NCT00791037|12196987|FG000|COMPLETED|Overall Study||23
11019061|NCT00791037|12196987|FG000|NOT COMPLETED|Overall Study||0
11019062|NCT00791089|12196995|FG000|STARTED|Overall Study||6
11019063|NCT00791089|12196996|FG001|STARTED|Overall Study||6
11019064|NCT00791089|12196995|FG000|Began Actually Taking Fish Oil or Placeb|Overall Study||6
11019065|NCT00791089|12196996|FG001|Began Actually Taking Fish Oil or Placeb|Overall Study||5
11019066|NCT00791089|12196995|FG000|Six-month Data Collected|Overall Study||6
11019067|NCT00791089|12196996|FG001|Six-month Data Collected|Overall Study||5
11019068|NCT00791089|12196995|FG000|COMPLETED|Overall Study||0
11019069|NCT00791089|12196996|FG001|COMPLETED|Overall Study||0
11019070|NCT00791089|12196995|FG000|NOT COMPLETED|Overall Study||6
11019071|NCT00791089|12196996|FG001|NOT COMPLETED|Overall Study||6
11019072|NCT00791102|12197002|FG000|STARTED|Period 1||10
11019073|NCT00791102|12197003|FG001|STARTED|Period 1||10
11019074|NCT00791102|12197002|FG000|COMPLETED|Period 1||10
11019075|NCT00791102|12197003|FG001|COMPLETED|Period 1||10
11019076|NCT00791102|12197002|FG000|NOT COMPLETED|Period 1||0
11019077|NCT00791102|12197003|FG001|NOT COMPLETED|Period 1||0
11019078|NCT00791102|12197002|FG000|STARTED|Washout Period of 2 Weeks||10
11019079|NCT00791102|12197003|FG001|STARTED|Washout Period of 2 Weeks||10
11019080|NCT00791102|12197002|FG000|COMPLETED|Washout Period of 2 Weeks||10
11019081|NCT00791102|12197003|FG001|COMPLETED|Washout Period of 2 Weeks||10
11019082|NCT00791102|12197002|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
11019083|NCT00791102|12197003|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
11019084|NCT00791102|12197002|FG000|STARTED|Period 2||10
11019085|NCT00791102|12197003|FG001|STARTED|Period 2||10
11019086|NCT00791102|12197002|FG000|COMPLETED|Period 2||10
11019087|NCT00791102|12197003|FG001|COMPLETED|Period 2||10
11019088|NCT00791102|12197002|FG000|NOT COMPLETED|Period 2||0
11019089|NCT00791102|12197003|FG001|NOT COMPLETED|Period 2||0
11019090|NCT00791128|12197009|FG000|STARTED|Overall Study||22
11019091|NCT00791128|12197009|FG000|COMPLETED|Overall Study||13
11019092|NCT00791128|12197009|FG000|NOT COMPLETED|Overall Study||9
11019093|NCT00791219|12197016|FG000|STARTED|Overall Study||24
11019094|NCT00791219|12197017|FG001|STARTED|Overall Study||76
11019095|NCT00791219|12197018|FG002|STARTED|Overall Study||75
11019096|NCT00791219|12197016|FG000|COMPLETED|Overall Study||19
11019097|NCT00791219|12197017|FG001|COMPLETED|Overall Study||60
11019098|NCT00791219|12197018|FG002|COMPLETED|Overall Study||61
11019099|NCT00791219|12197016|FG000|NOT COMPLETED|Overall Study||5
11019100|NCT00791219|12197017|FG001|NOT COMPLETED|Overall Study||16
11019101|NCT00791219|12197018|FG002|NOT COMPLETED|Overall Study||14
11019102|NCT00791258|12197026|FG000|STARTED|Overall Study||999
11019103|NCT00791258|12197026|FG000|COMPLETED|Overall Study||736
11019104|NCT00791258|12197026|FG000|NOT COMPLETED|Overall Study||263
11019105|NCT00791323|12197032|FG000|STARTED|Overall Study||6
11019106|NCT00791323|12197033|FG001|STARTED|Overall Study||3
11019107|NCT00791323|12197032|FG000|COMPLETED|Overall Study||6
11019108|NCT00791323|12197033|FG001|COMPLETED|Overall Study||3
11019109|NCT00791323|12197032|FG000|NOT COMPLETED|Overall Study||0
11019110|NCT00791323|12197033|FG001|NOT COMPLETED|Overall Study||0
11396714|NCT03883607|12590618|FG000|STARTED|Overall Study||5
11019111|NCT00791388|12197044|FG000|STARTED|Period 1 - 50 mg Dose Group||3
11019112|NCT00791388|12197045|FG001|STARTED|Period 1 - 50 mg Dose Group||8
11019113|NCT00791388|12197046|FG002|STARTED|Period 1 - 50 mg Dose Group||0
11019114|NCT00791388|12197047|FG003|STARTED|Period 1 - 50 mg Dose Group||0
11019115|NCT00791388|12197048|FG004|STARTED|Period 1 - 50 mg Dose Group||0
11019116|NCT00791388|12197044|FG000|COMPLETED|Period 1 - 50 mg Dose Group||3
11019117|NCT00791388|12197045|FG001|COMPLETED|Period 1 - 50 mg Dose Group||7
11019118|NCT00791388|12197046|FG002|COMPLETED|Period 1 - 50 mg Dose Group||0
11019119|NCT00791388|12197047|FG003|COMPLETED|Period 1 - 50 mg Dose Group||0
11019120|NCT00791388|12197048|FG004|COMPLETED|Period 1 - 50 mg Dose Group||0
11019121|NCT00791388|12197044|FG000|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
11019122|NCT00791388|12197045|FG001|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
11019123|NCT00791388|12197046|FG002|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
11019124|NCT00791388|12197047|FG003|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
11019125|NCT00791388|12197048|FG004|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
11019126|NCT00791388|12197044|FG000|STARTED|Period 2 - 100 mg Dose Group||3
11019127|NCT00791388|12197045|FG001|STARTED|Period 2 - 100 mg Dose Group||0
11019128|NCT00791388|12197046|FG002|STARTED|Period 2 - 100 mg Dose Group||8
11019129|NCT00791388|12197047|FG003|STARTED|Period 2 - 100 mg Dose Group||0
11019130|NCT00791388|12197048|FG004|STARTED|Period 2 - 100 mg Dose Group||0
11019131|NCT00791388|12197044|FG000|COMPLETED|Period 2 - 100 mg Dose Group||2
11019132|NCT00791388|12197045|FG001|COMPLETED|Period 2 - 100 mg Dose Group||0
11019133|NCT00791388|12197046|FG002|COMPLETED|Period 2 - 100 mg Dose Group||8
11019134|NCT00791388|12197047|FG003|COMPLETED|Period 2 - 100 mg Dose Group||0
11019135|NCT00791388|12197048|FG004|COMPLETED|Period 2 - 100 mg Dose Group||0
11019136|NCT00791388|12197044|FG000|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
11019137|NCT00791388|12197045|FG001|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
11019138|NCT00791388|12197046|FG002|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
11019139|NCT00791388|12197047|FG003|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
11019140|NCT00791388|12197048|FG004|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
11019141|NCT00791388|12197044|FG000|STARTED|Period 3 - 200 mg Dose Group||3
11019142|NCT00791388|12197045|FG001|STARTED|Period 3 - 200 mg Dose Group||0
11019143|NCT00791388|12197046|FG002|STARTED|Period 3 - 200 mg Dose Group||0
11019144|NCT00791388|12197047|FG003|STARTED|Period 3 - 200 mg Dose Group||8
11019145|NCT00791388|12197048|FG004|STARTED|Period 3 - 200 mg Dose Group||0
11019146|NCT00791388|12197044|FG000|COMPLETED|Period 3 - 200 mg Dose Group||3
11019147|NCT00791388|12197045|FG001|COMPLETED|Period 3 - 200 mg Dose Group||0
11019148|NCT00791388|12197046|FG002|COMPLETED|Period 3 - 200 mg Dose Group||0
11019149|NCT00791388|12197047|FG003|COMPLETED|Period 3 - 200 mg Dose Group||8
11019150|NCT00791388|12197048|FG004|COMPLETED|Period 3 - 200 mg Dose Group||0
11019151|NCT00791388|12197044|FG000|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
11019152|NCT00791388|12197045|FG001|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
11019153|NCT00791388|12197046|FG002|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
11019154|NCT00791388|12197047|FG003|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
11019155|NCT00791388|12197048|FG004|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
11019156|NCT00791388|12197044|FG000|STARTED|Period 4 - 400 mg Dose Group||4
11019157|NCT00791388|12197045|FG001|STARTED|Period 4 - 400 mg Dose Group||0
11019158|NCT00791388|12197046|FG002|STARTED|Period 4 - 400 mg Dose Group||0
11019159|NCT00791388|12197047|FG003|STARTED|Period 4 - 400 mg Dose Group||0
11019160|NCT00791388|12197048|FG004|STARTED|Period 4 - 400 mg Dose Group||8
11019161|NCT00791388|12197044|FG000|COMPLETED|Period 4 - 400 mg Dose Group||4
11019162|NCT00791388|12197045|FG001|COMPLETED|Period 4 - 400 mg Dose Group||0
11019163|NCT00791388|12197046|FG002|COMPLETED|Period 4 - 400 mg Dose Group||0
11019164|NCT00791388|12197047|FG003|COMPLETED|Period 4 - 400 mg Dose Group||0
11019165|NCT00791388|12197048|FG004|COMPLETED|Period 4 - 400 mg Dose Group||4
11019166|NCT00791388|12197044|FG000|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
11019167|NCT00791388|12197045|FG001|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
11019168|NCT00791388|12197046|FG002|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
11019169|NCT00791388|12197047|FG003|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
11019170|NCT00791388|12197048|FG004|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
11019171|NCT00791479|12197066|FG000|STARTED|Overall Study||35
11019172|NCT00791479|12197067|FG001|STARTED|Overall Study||34
11019173|NCT00791479|12197068|FG002|STARTED|Overall Study||34
11019174|NCT00791479|12197069|FG003|STARTED|Overall Study||29
11019175|NCT00791479|12197070|FG004|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
11019176|NCT00791479|12197071|FG005|STARTED|Overall Study||32
11019177|NCT00791479|12197066|FG000|Received at Least One Dose of Study Drug|Overall Study||35
11019178|NCT00791479|12197067|FG001|Received at Least One Dose of Study Drug|Overall Study||34
11019179|NCT00791479|12197068|FG002|Received at Least One Dose of Study Drug|Overall Study||34
11019180|NCT00791479|12197069|FG003|Received at Least One Dose of Study Drug|Overall Study||29
11019181|NCT00791479|12197070|FG004|Received at Least One Dose of Study Drug|Overall Study||3
11019182|NCT00791479|12197071|FG005|Received at Least One Dose of Study Drug|Overall Study||32
11019183|NCT00791479|12197066|FG000|COMPLETED|Overall Study||33
11019184|NCT00791479|12197067|FG001|COMPLETED|Overall Study||31
11019185|NCT00791479|12197068|FG002|COMPLETED|Overall Study||34
11019186|NCT00791479|12197069|FG003|COMPLETED|Overall Study||25
11019187|NCT00791479|12197070|FG004|COMPLETED|Overall Study||0
11019188|NCT00791479|12197071|FG005|COMPLETED|Overall Study||29
11019189|NCT00791479|12197066|FG000|NOT COMPLETED|Overall Study||2
11019190|NCT00791479|12197067|FG001|NOT COMPLETED|Overall Study||3
11019191|NCT00791479|12197068|FG002|NOT COMPLETED|Overall Study||0
11019192|NCT00791479|12197069|FG003|NOT COMPLETED|Overall Study||4
11019193|NCT00791479|12197070|FG004|NOT COMPLETED|Overall Study||3
11019194|NCT00791479|12197071|FG005|NOT COMPLETED|Overall Study||3
11019195|NCT00791492|12197094|FG000|STARTED|Overall Study||45
11019196|NCT00791492|12197095|FG001|STARTED|Overall Study||41
11019197|NCT00791492|12197094|FG000|TREATED|Overall Study||44
11019198|NCT00791492|12197095|FG001|TREATED|Overall Study||41
11019199|NCT00791492|12197094|FG000|COMPLETED|Overall Study||39
11019200|NCT00791492|12197095|FG001|COMPLETED|Overall Study||38
11019201|NCT00791492|12197094|FG000|NOT COMPLETED|Overall Study||6
11019202|NCT00791492|12197095|FG001|NOT COMPLETED|Overall Study||3
11019203|NCT00791518|12197101|FG000|STARTED|Overall Study||1084
11019204|NCT00791518|12197101|FG000|COMPLETED|Overall Study||991
11019205|NCT00791518|12197101|FG000|NOT COMPLETED|Overall Study||93
11019206|NCT00791557|12197120|FG000|STARTED|Overall Study||2
11019207|NCT00791557|12197120|FG000|COMPLETED|Overall Study||1
11019208|NCT00791557|12197120|FG000|NOT COMPLETED|Overall Study||1
11019209|NCT00791648|12197126|FG000|STARTED|Overall Study||308
11019210|NCT00791648|12197127|FG001|STARTED|Overall Study||309
11019211|NCT00791648|12197126|FG000|COMPLETED|Overall Study||308
11019212|NCT00791648|12197127|FG001|COMPLETED|Overall Study||307
11019213|NCT00791648|12197126|FG000|NOT COMPLETED|Overall Study||0
11019214|NCT00791648|12197127|FG001|NOT COMPLETED|Overall Study||2
11019215|NCT00791661|12197136|FG000|STARTED|Period 1||8
11019216|NCT00791661|12197137|FG001|STARTED|Period 1||8
11019217|NCT00791661|12197138|FG002|STARTED|Period 1||8
11019218|NCT00791661|12197136|FG000|Received MK-1006|Period 1||6
11019219|NCT00791661|12197137|FG001|Received MK-1006|Period 1||6
11019220|NCT00791661|12197138|FG002|Received MK-1006|Period 1||6
11019221|NCT00791661|12197136|FG000|Received Matching Placebo to MK-1006|Period 1||2
11019222|NCT00791661|12197137|FG001|Received Matching Placebo to MK-1006|Period 1||2
11019223|NCT00791661|12197138|FG002|Received Matching Placebo to MK-1006|Period 1||2
11019224|NCT00791661|12197136|FG000|COMPLETED|Period 1||8
11019225|NCT00791661|12197137|FG001|COMPLETED|Period 1||8
11019226|NCT00791661|12197138|FG002|COMPLETED|Period 1||8
11019227|NCT00791661|12197136|FG000|NOT COMPLETED|Period 1||0
11019228|NCT00791661|12197137|FG001|NOT COMPLETED|Period 1||0
11019229|NCT00791661|12197138|FG002|NOT COMPLETED|Period 1||0
11019230|NCT00791661|12197136|FG000|STARTED|7 Day Wash-out||8
11019231|NCT00791661|12197137|FG001|STARTED|7 Day Wash-out||8
11019232|NCT00791661|12197138|FG002|STARTED|7 Day Wash-out||8
11019233|NCT00791661|12197136|FG000|COMPLETED|7 Day Wash-out||8
11019234|NCT00791661|12197137|FG001|COMPLETED|7 Day Wash-out||8
11019235|NCT00791661|12197138|FG002|COMPLETED|7 Day Wash-out||6
11019236|NCT00791661|12197136|FG000|NOT COMPLETED|7 Day Wash-out||0
11019237|NCT00791661|12197137|FG001|NOT COMPLETED|7 Day Wash-out||0
11019238|NCT00791661|12197138|FG002|NOT COMPLETED|7 Day Wash-out||2
11019239|NCT00791661|12197136|FG000|STARTED|Period 2||8
11019240|NCT00791661|12197137|FG001|STARTED|Period 2||8
11019241|NCT00791661|12197138|FG002|STARTED|Period 2||6
11019242|NCT00791661|12197136|FG000|Received MK-1006|Period 2||6
11019243|NCT00791661|12197137|FG001|Received MK-1006|Period 2||6
11019244|NCT00791661|12197138|FG002|Received MK-1006|Period 2||4
11019245|NCT00791661|12197136|FG000|Received Matching Placebo to MK-1006|Period 2||2
11019246|NCT00791661|12197137|FG001|Received Matching Placebo to MK-1006|Period 2||2
11019247|NCT00791661|12197138|FG002|Received Matching Placebo to MK-1006|Period 2||2
11019248|NCT00791661|12197136|FG000|COMPLETED|Period 2||8
11019249|NCT00791661|12197137|FG001|COMPLETED|Period 2||8
11019250|NCT00791661|12197138|FG002|COMPLETED|Period 2||6
11019251|NCT00791661|12197136|FG000|NOT COMPLETED|Period 2||0
11019252|NCT00791661|12197137|FG001|NOT COMPLETED|Period 2||0
11019253|NCT00791661|12197138|FG002|NOT COMPLETED|Period 2||0
11019254|NCT00791661|12197136|FG000|STARTED|7 Day Wash-out||8
11019255|NCT00791661|12197137|FG001|STARTED|7 Day Wash-out||8
11019256|NCT00791661|12197138|FG002|STARTED|7 Day Wash-out||6
11019257|NCT00791661|12197136|FG000|COMPLETED|7 Day Wash-out||8
11019258|NCT00791661|12197137|FG001|COMPLETED|7 Day Wash-out||8
11019259|NCT00791661|12197138|FG002|COMPLETED|7 Day Wash-out||6
11019260|NCT00791661|12197136|FG000|NOT COMPLETED|7 Day Wash-out||0
11019261|NCT00791661|12197137|FG001|NOT COMPLETED|7 Day Wash-out||0
11019262|NCT00791661|12197138|FG002|NOT COMPLETED|7 Day Wash-out||0
11019263|NCT00791661|12197136|FG000|STARTED|Period 3||8
11019264|NCT00791661|12197137|FG001|STARTED|Period 3||8
11019265|NCT00791661|12197138|FG002|STARTED|Period 3||6
11019266|NCT00791661|12197136|FG000|Received MK-1006|Period 3||6
11019267|NCT00791661|12197137|FG001|Received MK-1006|Period 3||6
11019268|NCT00791661|12197138|FG002|Received MK-1006|Period 3||5
11019269|NCT00791661|12197136|FG000|Received Matching Placebo to MK-1006|Period 3||2
11019270|NCT00791661|12197137|FG001|Received Matching Placebo to MK-1006|Period 3||2
11019271|NCT00791661|12197138|FG002|Received Matching Placebo to MK-1006|Period 3||1
11019272|NCT00791661|12197136|FG000|COMPLETED|Period 3||8
11019273|NCT00791661|12197137|FG001|COMPLETED|Period 3||8
11019274|NCT00791661|12197138|FG002|COMPLETED|Period 3||6
11396715|NCT03883607|12590619|FG001|STARTED|Overall Study||5
11019275|NCT00791661|12197136|FG000|NOT COMPLETED|Period 3||0
11019276|NCT00791661|12197137|FG001|NOT COMPLETED|Period 3||0
11019277|NCT00791661|12197138|FG002|NOT COMPLETED|Period 3||0
11019278|NCT00791700|12197166|FG000|STARTED|Overall Study||16
11019279|NCT00791700|12197167|FG001|STARTED|Overall Study||31
11019280|NCT00791700|12197168|FG002|STARTED|Overall Study||13
11019281|NCT00791700|12197169|FG003|STARTED|Overall Study||43
11019282|NCT00791700|12197166|FG000|COMPLETED|Overall Study||10
11396716|NCT03883607|12590618|FG000|COMPLETED|Overall Study||5
11143435|NCT01473940|12330261|FG001|NOT COMPLETED|Follow-up Until Death||0
11143436|NCT01473940|12330262|FG002|NOT COMPLETED|Follow-up Until Death||0
11143437|NCT01473940|12330263|FG003|NOT COMPLETED|Follow-up Until Death||0
11143438|NCT01473953|12330281|FG000|STARTED|Overall Study||6
11143439|NCT01473953|12330282|FG001|STARTED|Overall Study||6
11143440|NCT01473953|12330283|FG002|STARTED|Overall Study||6
11143441|NCT01473953|12330284|FG003|STARTED|Overall Study||5
11143442|NCT01473953|12330285|FG004|STARTED|Overall Study||8
11143443|NCT01473953|12330281|FG000|COMPLETED|Overall Study||5
11143444|NCT01473953|12330282|FG001|COMPLETED|Overall Study||6
11143445|NCT01473953|12330283|FG002|COMPLETED|Overall Study||6
11143446|NCT01473953|12330284|FG003|COMPLETED|Overall Study||5
11143447|NCT01473953|12330285|FG004|COMPLETED|Overall Study||8
11143448|NCT01473953|12330281|FG000|NOT COMPLETED|Overall Study||1
11143449|NCT01473953|12330282|FG001|NOT COMPLETED|Overall Study||0
11143450|NCT01473953|12330283|FG002|NOT COMPLETED|Overall Study||0
11143451|NCT01473953|12330284|FG003|NOT COMPLETED|Overall Study||0
11143452|NCT01473953|12330285|FG004|NOT COMPLETED|Overall Study||0
11143453|NCT01473992|12330299|FG000|STARTED|Overall Study||10
11143454|NCT01473992|12330300|FG001|STARTED|Overall Study||10
11143455|NCT01473992|12330301|FG002|STARTED|Overall Study||5
11143456|NCT01473992|12330299|FG000|COMPLETED|Overall Study||10
11143457|NCT01473992|12330300|FG001|COMPLETED|Overall Study||10
11143458|NCT01473992|12330301|FG002|COMPLETED|Overall Study||5
11143459|NCT01473992|12330299|FG000|NOT COMPLETED|Overall Study||0
11143460|NCT01473992|12330300|FG001|NOT COMPLETED|Overall Study||0
11143461|NCT01473992|12330301|FG002|NOT COMPLETED|Overall Study||0
11143462|NCT01474018|12330311|FG000|STARTED|Overall Study||5
11143463|NCT01474018|12330312|FG001|STARTED|Overall Study||10
11143464|NCT01474018|12330311|FG000|COMPLETED|Overall Study|Writing paper|5
11143465|NCT01474018|12330312|FG001|COMPLETED|Overall Study||7
11143466|NCT01474018|12330311|FG000|NOT COMPLETED|Overall Study||0
11143467|NCT01474018|12330312|FG001|NOT COMPLETED|Overall Study||3
11143468|NCT01474109|12330321|FG000|STARTED|Period 1: Baseline to Week 16||95
11143469|NCT01474109|12330322|FG001|STARTED|Period 1: Baseline to Week 16||97
11143470|NCT01474109|12330323|FG002|STARTED|Period 1: Baseline to Week 16||97
11143471|NCT01474109|12330321|FG000|COMPLETED|Period 1: Baseline to Week 16||88
11143472|NCT01474109|12330322|FG001|COMPLETED|Period 1: Baseline to Week 16||91
11143473|NCT01474109|12330323|FG002|COMPLETED|Period 1: Baseline to Week 16||95
11143474|NCT01474109|12330321|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||7
11143475|NCT01474109|12330322|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||6
11143476|NCT01474109|12330323|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||2
11143477|NCT01474109|12330321|FG000|STARTED|Period 2: Week 16 to End of Study||88
11143478|NCT01474109|12330322|FG001|STARTED|Period 2: Week 16 to End of Study||91
11143479|NCT01474109|12330323|FG002|STARTED|Period 2: Week 16 to End of Study||95
11143480|NCT01474109|12330321|FG000|COMPLETED|Period 2: Week 16 to End of Study||70
11143481|NCT01474109|12330322|FG001|COMPLETED|Period 2: Week 16 to End of Study||73
11143482|NCT01474109|12330323|FG002|COMPLETED|Period 2: Week 16 to End of Study||83
11143483|NCT01474109|12330321|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||18
11143484|NCT01474109|12330322|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||18
11143485|NCT01474109|12330323|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||12
11143486|NCT01474122|12330334|FG000|STARTED|Period 1: Baseline to Week 16||88
11143487|NCT01474122|12330335|FG001|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
11143488|NCT01474122|12330336|FG002|STARTED|Period 1: Baseline to Week 16||89
11143489|NCT01474122|12330334|FG000|COMPLETED|Period 1: Baseline to Week 16||87
11143490|NCT01474122|12330335|FG001|COMPLETED|Period 1: Baseline to Week 16||86
11143491|NCT01474122|12330336|FG002|COMPLETED|Period 1: Baseline to Week 16||88
11396717|NCT03883607|12590619|FG001|COMPLETED|Overall Study||5
11019283|NCT00791700|12197167|FG001|COMPLETED|Overall Study||20
11019284|NCT00791700|12197168|FG002|COMPLETED|Overall Study||7
11019285|NCT00791700|12197169|FG003|COMPLETED|Overall Study||13
11019286|NCT00791700|12197166|FG000|NOT COMPLETED|Overall Study||6
11019287|NCT00791700|12197167|FG001|NOT COMPLETED|Overall Study||11
11143492|NCT01474122|12330334|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||1
11143493|NCT01474122|12330335|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||2
11019288|NCT00791700|12197168|FG002|NOT COMPLETED|Overall Study||6
11019289|NCT00791700|12197169|FG003|NOT COMPLETED|Overall Study||30
11019290|NCT00791765|12197192|FG000|STARTED|Weeks 1 to 12||62
11019291|NCT00791765|12197193|FG001|STARTED|Weeks 1 to 12||62
11019292|NCT00791765|12197192|FG000|Treated|Weeks 1 to 12||62
11019293|NCT00791765|12197193|FG001|Treated|Weeks 1 to 12||59
11019294|NCT00791765|12197192|FG000|COMPLETED|Weeks 1 to 12||54
11019295|NCT00791765|12197193|FG001|COMPLETED|Weeks 1 to 12||58
11019296|NCT00791765|12197192|FG000|NOT COMPLETED|Weeks 1 to 12||8
11019297|NCT00791765|12197193|FG001|NOT COMPLETED|Weeks 1 to 12||4
11019298|NCT00791765|12197192|FG000|STARTED|Weeks 13 to 24||54
11019299|NCT00791765|12197193|FG001|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
11019300|NCT00791765|12197192|FG000|COMPLETED|Weeks 13 to 24||49
11019301|NCT00791765|12197193|FG001|COMPLETED|Weeks 13 to 24||49
11019302|NCT00791765|12197192|FG000|NOT COMPLETED|Weeks 13 to 24||5
11019303|NCT00791765|12197193|FG001|NOT COMPLETED|Weeks 13 to 24||8
11019304|NCT00791778|12197201|FG000|STARTED|Double-blind Treatment||123
11019305|NCT00791778|12197202|FG001|STARTED|Double-blind Treatment||123
11019306|NCT00791778|12197201|FG000|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
11143494|NCT01474122|12330336|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||1
11019307|NCT00791778|12197202|FG001|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
11019308|NCT00791778|12197201|FG000|NOT COMPLETED|Double-blind Treatment||77
11019309|NCT00791778|12197202|FG001|NOT COMPLETED|Double-blind Treatment||48
11019310|NCT00791778|12197201|FG000|STARTED|Follow-up||100
11019311|NCT00791778|12197202|FG001|STARTED|Follow-up||91
11019312|NCT00791778|12197201|FG000|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
11019313|NCT00791778|12197202|FG001|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
11019314|NCT00791778|12197201|FG000|NOT COMPLETED|Follow-up||5
11019315|NCT00791778|12197202|FG001|NOT COMPLETED|Follow-up||1
11019316|NCT00791817|12197210|FG000|STARTED|1: Single Dose Followed by Week Washout||5
11019317|NCT00791817|12197211|FG001|STARTED|1: Single Dose Followed by Week Washout||5
11019318|NCT00791817|12197210|FG000|COMPLETED|1: Single Dose Followed by Week Washout||5
11019319|NCT00791817|12197211|FG001|COMPLETED|1: Single Dose Followed by Week Washout||5
11019320|NCT00791817|12197210|FG000|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
11019321|NCT00791817|12197211|FG001|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
11019322|NCT00791817|12197210|FG000|STARTED|2: Single Dose||5
11019323|NCT00791817|12197211|FG001|STARTED|2: Single Dose||5
11019324|NCT00791817|12197210|FG000|COMPLETED|2: Single Dose||5
11019325|NCT00791817|12197211|FG001|COMPLETED|2: Single Dose||5
11019326|NCT00791817|12197210|FG000|NOT COMPLETED|2: Single Dose||0
11019327|NCT00791817|12197211|FG001|NOT COMPLETED|2: Single Dose||0
11019328|NCT00791908|12197217|FG000|STARTED|Overall Study||15
11019329|NCT00791908|12197217|FG000|COMPLETED|Overall Study||15
11019330|NCT00791908|12197217|FG000|NOT COMPLETED|Overall Study||0
11019331|NCT00791921|12197227|FG000|STARTED|Overall Study||116
11019332|NCT00791921|12197228|FG001|STARTED|Overall Study||114
11019333|NCT00791921|12197227|FG000|COMPLETED|Overall Study||82
11019334|NCT00791921|12197228|FG001|COMPLETED|Overall Study||18
11019335|NCT00791921|12197227|FG000|NOT COMPLETED|Overall Study||34
11019336|NCT00791921|12197228|FG001|NOT COMPLETED|Overall Study||96
11019337|NCT00791934|12197234|FG000|STARTED|Overall Study||63
11019338|NCT00791934|12197234|FG000|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
11019339|NCT00791934|12197234|FG000|NOT COMPLETED|Overall Study||15
11019340|NCT00791973|12197240|FG000|STARTED|First Intervention (1 Week)||8
11019341|NCT00791973|12197241|FG001|STARTED|First Intervention (1 Week)||7
11019342|NCT00791973|12197240|FG000|COMPLETED|First Intervention (1 Week)||8
11019343|NCT00791973|12197241|FG001|COMPLETED|First Intervention (1 Week)||7
11019344|NCT00791973|12197240|FG000|NOT COMPLETED|First Intervention (1 Week)||0
11019345|NCT00791973|12197241|FG001|NOT COMPLETED|First Intervention (1 Week)||0
11019346|NCT00791973|12197240|FG000|STARTED|Washout (1 Week)||8
11019347|NCT00791973|12197241|FG001|STARTED|Washout (1 Week)||7
11019348|NCT00791973|12197240|FG000|COMPLETED|Washout (1 Week)||8
11396718|NCT03883607|12590618|FG000|NOT COMPLETED|Overall Study||0
11396719|NCT03883607|12590619|FG001|NOT COMPLETED|Overall Study||0
11396720|NCT03885596|12590629|FG000|STARTED|Overall Study||9
11396721|NCT03885596|12590630|FG001|STARTED|Overall Study||9
11396722|NCT03885596|12590631|FG002|STARTED|Overall Study||9
11019349|NCT00791973|12197241|FG001|COMPLETED|Washout (1 Week)||7
11019350|NCT00791973|12197240|FG000|NOT COMPLETED|Washout (1 Week)||0
11019351|NCT00791973|12197241|FG001|NOT COMPLETED|Washout (1 Week)||0
11019352|NCT00791973|12197240|FG000|STARTED|Second Intervention (1 Week)||8
11019353|NCT00791973|12197241|FG001|STARTED|Second Intervention (1 Week)||7
11019354|NCT00791973|12197240|FG000|COMPLETED|Second Intervention (1 Week)||8
11019355|NCT00791973|12197241|FG001|COMPLETED|Second Intervention (1 Week)||7
11019356|NCT00791973|12197240|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
11019357|NCT00791973|12197241|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
11019358|NCT00791999|12197251|FG000|STARTED|Overall Study||72
11019359|NCT00791999|12197252|FG001|STARTED|Overall Study||82
11019360|NCT00791999|12197253|FG002|STARTED|Overall Study||85
11019361|NCT00791999|12197254|FG003|STARTED|Overall Study||77
11019362|NCT00791999|12197251|FG000|COMPLETED|Overall Study||51
11019363|NCT00791999|12197252|FG001|COMPLETED|Overall Study||66
11019364|NCT00791999|12197253|FG002|COMPLETED|Overall Study||65
11019365|NCT00791999|12197254|FG003|COMPLETED|Overall Study||25
11019366|NCT00791999|12197251|FG000|NOT COMPLETED|Overall Study||21
11019367|NCT00791999|12197252|FG001|NOT COMPLETED|Overall Study||16
11019368|NCT00791999|12197253|FG002|NOT COMPLETED|Overall Study||20
11019369|NCT00791999|12197254|FG003|NOT COMPLETED|Overall Study||52
11396723|NCT03885596|12590632|FG003|STARTED|Overall Study||9
11396724|NCT03885596|12590629|FG000|COMPLETED|Overall Study||7
11019370|NCT00792077|12197264|FG000|STARTED|Overall Study||6
11019371|NCT00792077|12197264|FG000|Day 15+/- 3 Days|Overall Study||6
11019372|NCT00792077|12197264|FG000|Day 29+/-3 Days|Overall Study||6
11019373|NCT00792077|12197264|FG000|Day 43+/-3 Days|Overall Study||6
11019374|NCT00792077|12197264|FG000|Day 57+/-3 Days|Overall Study||6
11019375|NCT00792077|12197264|FG000|COMPLETED|Overall Study||6
11019376|NCT00792077|12197264|FG000|NOT COMPLETED|Overall Study||0
11019377|NCT00792103|12197268|FG000|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
11019378|NCT00792103|12197268|FG000|COMPLETED|Overall Study||65
11019379|NCT00792103|12197268|FG000|NOT COMPLETED|Overall Study||133
11019380|NCT00792142|12197272|FG000|STARTED|Overall Study||45
11019381|NCT00792142|12197272|FG000|COMPLETED|Overall Study||45
11019382|NCT00792142|12197272|FG000|NOT COMPLETED|Overall Study||0
11019383|NCT00792298|12197276|FG000|STARTED|Treatment Period 1||31
11019384|NCT00792298|12197277|FG001|STARTED|Treatment Period 1||32
11019385|NCT00792298|12197278|FG002|STARTED|Treatment Period 1||33
11019386|NCT00792298|12197279|FG003|STARTED|Treatment Period 1||32
11019387|NCT00792298|12197280|FG004|STARTED|Treatment Period 1||32
11019388|NCT00792298|12197281|FG005|STARTED|Treatment Period 1||32
11019389|NCT00792298|12197282|FG006|STARTED|Treatment Period 1||31
11019390|NCT00792298|12197283|FG007|STARTED|Treatment Period 1||31
11019391|NCT00792298|12197276|FG000|COMPLETED|Treatment Period 1||30
11019392|NCT00792298|12197277|FG001|COMPLETED|Treatment Period 1||31
11019393|NCT00792298|12197278|FG002|COMPLETED|Treatment Period 1||31
11019394|NCT00792298|12197279|FG003|COMPLETED|Treatment Period 1||28
11019395|NCT00792298|12197280|FG004|COMPLETED|Treatment Period 1||32
11019396|NCT00792298|12197281|FG005|COMPLETED|Treatment Period 1||29
11019397|NCT00792298|12197282|FG006|COMPLETED|Treatment Period 1||27
11019398|NCT00792298|12197283|FG007|COMPLETED|Treatment Period 1||30
11019399|NCT00792298|12197276|FG000|NOT COMPLETED|Treatment Period 1||1
11019400|NCT00792298|12197277|FG001|NOT COMPLETED|Treatment Period 1||1
11019401|NCT00792298|12197278|FG002|NOT COMPLETED|Treatment Period 1||2
11019402|NCT00792298|12197279|FG003|NOT COMPLETED|Treatment Period 1||4
11019403|NCT00792298|12197280|FG004|NOT COMPLETED|Treatment Period 1||0
11019404|NCT00792298|12197281|FG005|NOT COMPLETED|Treatment Period 1||3
11019405|NCT00792298|12197282|FG006|NOT COMPLETED|Treatment Period 1||4
11019406|NCT00792298|12197283|FG007|NOT COMPLETED|Treatment Period 1||1
11019407|NCT00792298|12197276|FG000|STARTED|Washout||30
11019408|NCT00792298|12197277|FG001|STARTED|Washout||31
11019409|NCT00792298|12197278|FG002|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
11019410|NCT00792298|12197279|FG003|STARTED|Washout||28
11019411|NCT00792298|12197280|FG004|STARTED|Washout||32
11019412|NCT00792298|12197281|FG005|STARTED|Washout||29
11019413|NCT00792298|12197282|FG006|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
11019414|NCT00792298|12197283|FG007|STARTED|Washout||30
11019415|NCT00792298|12197276|FG000|COMPLETED|Washout||30
11019416|NCT00792298|12197277|FG001|COMPLETED|Washout||31
11019417|NCT00792298|12197278|FG002|COMPLETED|Washout||31
11019418|NCT00792298|12197279|FG003|COMPLETED|Washout||28
11019419|NCT00792298|12197280|FG004|COMPLETED|Washout||32
11019420|NCT00792298|12197281|FG005|COMPLETED|Washout||27
11019421|NCT00792298|12197282|FG006|COMPLETED|Washout||29
11019422|NCT00792298|12197283|FG007|COMPLETED|Washout||30
11019423|NCT00792298|12197276|FG000|NOT COMPLETED|Washout||0
11019424|NCT00792298|12197277|FG001|NOT COMPLETED|Washout||0
11019425|NCT00792298|12197278|FG002|NOT COMPLETED|Washout||1
11019426|NCT00792298|12197279|FG003|NOT COMPLETED|Washout||0
11019427|NCT00792298|12197280|FG004|NOT COMPLETED|Washout||0
11019428|NCT00792298|12197281|FG005|NOT COMPLETED|Washout||2
11019429|NCT00792298|12197282|FG006|NOT COMPLETED|Washout||0
11019430|NCT00792298|12197283|FG007|NOT COMPLETED|Washout||0
11019431|NCT00792298|12197276|FG000|STARTED|Treatment Period 2||30
11019432|NCT00792298|12197277|FG001|STARTED|Treatment Period 2||31
11019433|NCT00792298|12197278|FG002|STARTED|Treatment Period 2||31
11019434|NCT00792298|12197279|FG003|STARTED|Treatment Period 2||28
11019435|NCT00792298|12197280|FG004|STARTED|Treatment Period 2||32
11019436|NCT00792298|12197281|FG005|STARTED|Treatment Period 2||27
11019437|NCT00792298|12197282|FG006|STARTED|Treatment Period 2||29
11019438|NCT00792298|12197283|FG007|STARTED|Treatment Period 2||30
11019439|NCT00792298|12197276|FG000|COMPLETED|Treatment Period 2||29
11019440|NCT00792298|12197277|FG001|COMPLETED|Treatment Period 2||30
11019441|NCT00792298|12197278|FG002|COMPLETED|Treatment Period 2||30
11019442|NCT00792298|12197279|FG003|COMPLETED|Treatment Period 2||26
11019443|NCT00792298|12197280|FG004|COMPLETED|Treatment Period 2||30
11019444|NCT00792298|12197281|FG005|COMPLETED|Treatment Period 2||27
11019445|NCT00792298|12197282|FG006|COMPLETED|Treatment Period 2||28
11019446|NCT00792298|12197283|FG007|COMPLETED|Treatment Period 2||28
11019447|NCT00792298|12197276|FG000|NOT COMPLETED|Treatment Period 2||1
11019448|NCT00792298|12197277|FG001|NOT COMPLETED|Treatment Period 2||1
11019449|NCT00792298|12197278|FG002|NOT COMPLETED|Treatment Period 2||1
11019450|NCT00792298|12197279|FG003|NOT COMPLETED|Treatment Period 2||2
11019451|NCT00792298|12197280|FG004|NOT COMPLETED|Treatment Period 2||2
11019452|NCT00792298|12197281|FG005|NOT COMPLETED|Treatment Period 2||0
11019453|NCT00792298|12197282|FG006|NOT COMPLETED|Treatment Period 2||1
11019454|NCT00792298|12197283|FG007|NOT COMPLETED|Treatment Period 2||2
11019455|NCT00792428|12197302|FG000|STARTED|Overall Study||10
11019456|NCT00792428|12197303|FG001|STARTED|Overall Study||10
11019457|NCT00792428|12197302|FG000|COMPLETED|Overall Study||10
11019458|NCT00792428|12197303|FG001|COMPLETED|Overall Study||10
11019459|NCT00792428|12197302|FG000|NOT COMPLETED|Overall Study||0
11019460|NCT00792428|12197303|FG001|NOT COMPLETED|Overall Study||0
11019461|NCT00792467|12197309|FG000|STARTED|Overall Study||24
11019462|NCT00792467|12197309|FG000|COMPLETED|Overall Study||2
11019463|NCT00792467|12197309|FG000|NOT COMPLETED|Overall Study||22
11019464|NCT00792571|12197314|FG000|STARTED|Overall Study||18
11019465|NCT00792571|12197314|FG000|COMPLETED|Overall Study||8
11019466|NCT00792571|12197314|FG000|NOT COMPLETED|Overall Study||10
11019467|NCT00792610|12197318|FG000|STARTED|Overall Study||127
11019468|NCT00792610|12197318|FG000|Youths|Overall Study||127
11019469|NCT00792610|12197318|FG000|COMPLETED|Overall Study||127
11019470|NCT00792610|12197318|FG000|NOT COMPLETED|Overall Study||0
11019471|NCT00792623|12197322|FG000|STARTED|Overall Study||29
11019472|NCT00792623|12197322|FG000|COMPLETED|Overall Study||22
11019473|NCT00792623|12197322|FG000|NOT COMPLETED|Overall Study||7
11019474|NCT00792636|12197330|FG000|STARTED|Overall Study||135
11019475|NCT00792636|12197331|FG001|STARTED|Overall Study||136
11019476|NCT00792636|12197332|FG002|STARTED|Overall Study||136
11019477|NCT00792636|12197330|FG000|COMPLETED|Overall Study||67
11019478|NCT00792636|12197331|FG001|COMPLETED|Overall Study||55
11019479|NCT00792636|12197332|FG002|COMPLETED|Overall Study||55
11019480|NCT00792636|12197330|FG000|NOT COMPLETED|Overall Study||68
11019481|NCT00792636|12197331|FG001|NOT COMPLETED|Overall Study||81
11019482|NCT00792636|12197332|FG002|NOT COMPLETED|Overall Study||81
11019483|NCT00792688|12197345|FG000|STARTED|Overall Study||9
11019484|NCT00792688|12197346|FG001|STARTED|Overall Study||8
11019485|NCT00792688|12197347|FG002|STARTED|Overall Study||9
11019486|NCT00792688|12197345|FG000|COMPLETED|Overall Study||9
11019487|NCT00792688|12197346|FG001|COMPLETED|Overall Study||8
11019488|NCT00792688|12197347|FG002|COMPLETED|Overall Study||9
11019489|NCT00792688|12197345|FG000|NOT COMPLETED|Overall Study||0
11019490|NCT00792688|12197346|FG001|NOT COMPLETED|Overall Study||0
11019491|NCT00792688|12197347|FG002|NOT COMPLETED|Overall Study||0
11019492|NCT00792701|12197357|FG000|STARTED|Overall Study||19
11019493|NCT00792701|12197358|FG001|STARTED|Overall Study||66
11019494|NCT00792701|12197357|FG000|Eligible|Overall Study||18
11019495|NCT00792701|12197358|FG001|Eligible|Overall Study||63
11019496|NCT00792701|12197357|FG000|Eligible and Analyzable|Overall Study||17
11019497|NCT00792701|12197358|FG001|Eligible and Analyzable|Overall Study||44
11019498|NCT00792701|12197357|FG000|COMPLETED|Overall Study||0
11019499|NCT00792701|12197358|FG001|COMPLETED|Overall Study||22
11019500|NCT00792701|12197357|FG000|NOT COMPLETED|Overall Study||19
11019501|NCT00792701|12197358|FG001|NOT COMPLETED|Overall Study||44
11019502|NCT00792805|12197369|FG000|STARTED|Overall Study||188
11019503|NCT00792805|12197370|FG001|STARTED|Overall Study||188
11019504|NCT00792805|12197371|FG002|STARTED|Overall Study||187
11019505|NCT00792805|12197369|FG000|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
11019506|NCT00792805|12197370|FG001|Exposed to Study Medication or Placebo|Overall Study||188
11019507|NCT00792805|12197371|FG002|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
11019508|NCT00792805|12197369|FG000|COMPLETED|Overall Study||166
11019509|NCT00792805|12197370|FG001|COMPLETED|Overall Study||162
11019510|NCT00792805|12197371|FG002|COMPLETED|Overall Study||154
11019511|NCT00792805|12197369|FG000|NOT COMPLETED|Overall Study||22
11019512|NCT00792805|12197370|FG001|NOT COMPLETED|Overall Study||26
11019513|NCT00792805|12197371|FG002|NOT COMPLETED|Overall Study||33
11019514|NCT00792909|12197382|FG000|STARTED|Overall Study||51
11019515|NCT00792909|12197383|FG001|STARTED|Overall Study||59
11019516|NCT00792909|12197384|FG002|STARTED|Overall Study||62
11019517|NCT00792909|12197382|FG000|COMPLETED|Overall Study||51
11019518|NCT00792909|12197383|FG001|COMPLETED|Overall Study||58
11019519|NCT00792909|12197384|FG002|COMPLETED|Overall Study||62
11019520|NCT00792909|12197382|FG000|NOT COMPLETED|Overall Study||0
11019521|NCT00792909|12197383|FG001|NOT COMPLETED|Overall Study||1
11019522|NCT00792909|12197384|FG002|NOT COMPLETED|Overall Study||0
11019523|NCT00792922|12197399|FG000|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
11019524|NCT00792922|12197400|FG001|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
11019525|NCT00792922|12197401|FG002|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
11019526|NCT00792922|12197402|FG003|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
11019527|NCT00792922|12197399|FG000|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
11019528|NCT00792922|12197400|FG001|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
11019529|NCT00792922|12197401|FG002|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
11019530|NCT00792922|12197402|FG003|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
11019531|NCT00792922|12197399|FG000|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
11019532|NCT00792922|12197400|FG001|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
11019533|NCT00792922|12197401|FG002|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
11019534|NCT00792922|12197402|FG003|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
11019535|NCT00792922|12197399|FG000|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
11019536|NCT00792922|12197400|FG001|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
11019537|NCT00792922|12197401|FG002|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
11019538|NCT00792922|12197402|FG003|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
11019539|NCT00792922|12197399|FG000|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
11019540|NCT00792922|12197400|FG001|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
11019541|NCT00792922|12197401|FG002|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
11019542|NCT00792922|12197402|FG003|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
11019543|NCT00792922|12197399|FG000|NOT COMPLETED|At Baseline||
11263777|NCT02271984|12459070|FG009|STARTED|Fifth Intervention Period (1 Day)||3
11263778|NCT02271984|12459071|FG010|STARTED|Fifth Intervention Period (1 Day)||3
11263779|NCT02271984|12459072|FG011|STARTED|Fifth Intervention Period (1 Day)||3
11263780|NCT02271984|12459061|FG000|COMPLETED|Fifth Intervention Period (1 Day)||3
11396725|NCT03885596|12590630|FG001|COMPLETED|Overall Study||8
11019544|NCT00792922|12197400|FG001|NOT COMPLETED|At Baseline||
11019545|NCT00792922|12197401|FG002|NOT COMPLETED|At Baseline||
11019546|NCT00792922|12197402|FG003|NOT COMPLETED|At Baseline||
11019547|NCT00792922|12197399|FG000|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
11019548|NCT00792922|12197400|FG001|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
11019549|NCT00792922|12197401|FG002|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
11019550|NCT00792922|12197402|FG003|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
11019551|NCT00792922|12197399|FG000|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019552|NCT00792922|12197400|FG001|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019553|NCT00792922|12197401|FG002|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019554|NCT00792922|12197402|FG003|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019555|NCT00792922|12197399|FG000|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019556|NCT00792922|12197400|FG001|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019557|NCT00792922|12197401|FG002|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019558|NCT00792922|12197402|FG003|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019559|NCT00792922|12197399|FG000|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019560|NCT00792922|12197400|FG001|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019561|NCT00792922|12197401|FG002|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019562|NCT00792922|12197402|FG003|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019563|NCT00792922|12197399|FG000|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019564|NCT00792922|12197400|FG001|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019565|NCT00792922|12197401|FG002|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019566|NCT00792922|12197402|FG003|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
11019567|NCT00792922|12197399|FG000|NOT COMPLETED|At 3 Years||
11019568|NCT00792922|12197400|FG001|NOT COMPLETED|At 3 Years||
11019569|NCT00792922|12197401|FG002|NOT COMPLETED|At 3 Years||
11019570|NCT00792922|12197402|FG003|NOT COMPLETED|At 3 Years||
11019571|NCT00792935|12197416|FG000|STARTED|Overall Study||72
11019572|NCT00792935|12197417|FG001|STARTED|Overall Study||71
11396726|NCT03885596|12590631|FG002|COMPLETED|Overall Study||9
11396727|NCT03885596|12590632|FG003|COMPLETED|Overall Study||9
11396728|NCT03885596|12590629|FG000|NOT COMPLETED|Overall Study||2
11396729|NCT03885596|12590630|FG001|NOT COMPLETED|Overall Study||1
11019573|NCT00792935|12197416|FG000|COMPLETED|Overall Study||68
11019574|NCT00792935|12197417|FG001|COMPLETED|Overall Study||68
11019575|NCT00792935|12197416|FG000|NOT COMPLETED|Overall Study||4
11019576|NCT00792935|12197417|FG001|NOT COMPLETED|Overall Study||3
11019577|NCT00793104|12197423|FG000|STARTED|Overall Study||10
11019578|NCT00793104|12197423|FG000|COMPLETED|Overall Study||9
11019579|NCT00793104|12197423|FG000|NOT COMPLETED|Overall Study||1
11019580|NCT00793182|12197429|FG000|STARTED|Overall Study||2
11019581|NCT00793182|12197430|FG001|STARTED|Overall Study||4
11019582|NCT00793182|12197429|FG000|COMPLETED|Overall Study||2
11019583|NCT00793182|12197430|FG001|COMPLETED|Overall Study||3
11019584|NCT00793182|12197429|FG000|NOT COMPLETED|Overall Study||0
11019585|NCT00793182|12197430|FG001|NOT COMPLETED|Overall Study||1
11019586|NCT00793325|12197436|FG000|STARTED|Overall Study||909
11019587|NCT00793325|12197436|FG000|COMPLETED|Overall Study||890
11019588|NCT00793325|12197436|FG000|NOT COMPLETED|Overall Study||19
11019589|NCT00793403|12197459|FG000|STARTED|Overall Study||293
11019590|NCT00793403|12197459|FG000|COMPLETED|Overall Study||220
11019591|NCT00793403|12197459|FG000|NOT COMPLETED|Overall Study||73
11019592|NCT00793455|12197465|FG000|STARTED|Overall Study||314
11019593|NCT00793455|12197466|FG001|STARTED|Overall Study||314
11019594|NCT00793455|12197465|FG000|COMPLETED|Overall Study||314
11019595|NCT00793455|12197466|FG001|COMPLETED|Overall Study||314
11019596|NCT00793455|12197465|FG000|NOT COMPLETED|Overall Study||0
11019597|NCT00793455|12197466|FG001|NOT COMPLETED|Overall Study||0
11056871|NCT00996346|12238511|FG001|STARTED|Overall Study||8
11056872|NCT00996346|12238512|FG002|STARTED|Overall Study||3
11056873|NCT00996346|12238510|FG000|COMPLETED|Overall Study||6
11056874|NCT00996346|12238511|FG001|COMPLETED|Overall Study||8
11056875|NCT00996346|12238512|FG002|COMPLETED|Overall Study||3
11056876|NCT00996346|12238510|FG000|NOT COMPLETED|Overall Study||0
11056877|NCT00996346|12238511|FG001|NOT COMPLETED|Overall Study||0
11056878|NCT00996346|12238512|FG002|NOT COMPLETED|Overall Study||0
11263781|NCT02271984|12459062|FG001|COMPLETED|Fifth Intervention Period (1 Day)||3
11056879|NCT00996372|12238520|FG000|STARTED|Overall Study||468
11056880|NCT00996372|12238521|FG001|STARTED|Overall Study||481
11056881|NCT00996372|12238520|FG000|COMPLETED|Overall Study||365
11056882|NCT00996372|12238521|FG001|COMPLETED|Overall Study||397
11396730|NCT03885596|12590631|FG002|NOT COMPLETED|Overall Study||0
11019598|NCT00793546|12197475|FG000|STARTED|Overall Study||14
11143495|NCT01474122|12330334|FG000|STARTED|Period 2: Week 16 to End of Study||87
11143496|NCT01474122|12330335|FG001|STARTED|Period 2: Week 16 to End of Study||86
11019599|NCT00793546|12197476|FG001|STARTED|Overall Study||28
11019600|NCT00793546|12197475|FG000|COMPLETED|Overall Study||0
11019601|NCT00793546|12197476|FG001|COMPLETED|Overall Study||0
11019602|NCT00793546|12197475|FG000|NOT COMPLETED|Overall Study||14
11019603|NCT00793546|12197476|FG001|NOT COMPLETED|Overall Study||28
11019604|NCT00793572|12197484|FG000|STARTED|Overall Study||32
11019605|NCT00793572|12197484|FG000|COMPLETED|Overall Study||32
11019606|NCT00793572|12197484|FG000|NOT COMPLETED|Overall Study||0
11019607|NCT00793585|12197490|FG000|STARTED|Overall Study||19
11019608|NCT00793585|12197491|FG001|STARTED|Overall Study||21
11019609|NCT00793585|12197490|FG000|COMPLETED|Overall Study||17
11019610|NCT00793585|12197491|FG001|COMPLETED|Overall Study||18
11019611|NCT00793585|12197490|FG000|NOT COMPLETED|Overall Study||2
11019612|NCT00793585|12197491|FG001|NOT COMPLETED|Overall Study||3
11019613|NCT00793598|12197502|FG000|STARTED|Overall Study||1
11019614|NCT00793598|12197503|FG001|STARTED|Overall Study||1
11019615|NCT00793598|12197504|FG002|STARTED|Overall Study||1
11019616|NCT00793598|12197505|FG003|STARTED|Overall Study||2
11019617|NCT00793598|12197506|FG004|STARTED|Overall Study||8
11019618|NCT00793598|12197507|FG005|STARTED|Overall Study||8
11019619|NCT00793598|12197508|FG006|STARTED|Overall Study||4
11019620|NCT00793598|12197509|FG007|STARTED|Overall Study||4
11019621|NCT00793598|12197502|FG000|COMPLETED|Overall Study||1
11019622|NCT00793598|12197503|FG001|COMPLETED|Overall Study||0
11019623|NCT00793598|12197504|FG002|COMPLETED|Overall Study||1
11019624|NCT00793598|12197505|FG003|COMPLETED|Overall Study||2
11019625|NCT00793598|12197506|FG004|COMPLETED|Overall Study||8
11019626|NCT00793598|12197507|FG005|COMPLETED|Overall Study||7
11019627|NCT00793598|12197508|FG006|COMPLETED|Overall Study||4
11019628|NCT00793598|12197509|FG007|COMPLETED|Overall Study||3
11019629|NCT00793598|12197502|FG000|NOT COMPLETED|Overall Study||0
11019630|NCT00793598|12197503|FG001|NOT COMPLETED|Overall Study||1
11019631|NCT00793598|12197504|FG002|NOT COMPLETED|Overall Study||0
11019632|NCT00793598|12197505|FG003|NOT COMPLETED|Overall Study||0
11019633|NCT00793598|12197506|FG004|NOT COMPLETED|Overall Study||0
11019634|NCT00793598|12197507|FG005|NOT COMPLETED|Overall Study||1
11019635|NCT00793598|12197508|FG006|NOT COMPLETED|Overall Study||0
11019636|NCT00793598|12197509|FG007|NOT COMPLETED|Overall Study||1
11019637|NCT00793611|12197533|FG000|STARTED|Overall Study||10
11019638|NCT00793611|12197534|FG001|STARTED|Overall Study||10
11019639|NCT00793611|12197533|FG000|COMPLETED|Overall Study||10
11019640|NCT00793611|12197534|FG001|COMPLETED|Overall Study||10
11019641|NCT00793611|12197533|FG000|NOT COMPLETED|Overall Study||0
11019642|NCT00793611|12197534|FG001|NOT COMPLETED|Overall Study||0
11019643|NCT00793624|12197544|FG000|STARTED|Overall Study||225
11019644|NCT00793624|12197545|FG001|STARTED|Overall Study||227
11019645|NCT00793624|12197546|FG002|STARTED|Overall Study||225
11019646|NCT00793624|12197547|FG003|STARTED|Overall Study||227
11019647|NCT00793624|12197544|FG000|COMPLETED|Overall Study||168
11019648|NCT00793624|12197545|FG001|COMPLETED|Overall Study||191
11019649|NCT00793624|12197546|FG002|COMPLETED|Overall Study||186
11019650|NCT00793624|12197547|FG003|COMPLETED|Overall Study||184
11019651|NCT00793624|12197544|FG000|NOT COMPLETED|Overall Study||57
11019652|NCT00793624|12197545|FG001|NOT COMPLETED|Overall Study||36
11019653|NCT00793624|12197546|FG002|NOT COMPLETED|Overall Study||39
11019654|NCT00793624|12197547|FG003|NOT COMPLETED|Overall Study||43
11019655|NCT00793650|12197567|FG000|STARTED|Overall Study||19
11019656|NCT00793650|12197568|FG001|STARTED|Overall Study||20
11019657|NCT00793650|12197567|FG000|COMPLETED|Overall Study||19
11019658|NCT00793650|12197568|FG001|COMPLETED|Overall Study||20
11019659|NCT00793650|12197567|FG000|NOT COMPLETED|Overall Study||0
11143497|NCT01474122|12330336|FG002|STARTED|Period 2: Week 16 to End of Study||88
11019660|NCT00793650|12197568|FG001|NOT COMPLETED|Overall Study||0
11019661|NCT00793780|12197578|FG000|STARTED|Overall Study||12
11019662|NCT00793780|12197579|FG001|STARTED|Overall Study||12
11019663|NCT00793780|12197578|FG000|Randomization|Overall Study||12
11019664|NCT00793780|12197579|FG001|Randomization|Overall Study||12
11019665|NCT00793780|12197578|FG000|Collected Baseline Data|Overall Study||11
11019666|NCT00793780|12197579|FG001|Collected Baseline Data|Overall Study||12
11019667|NCT00793780|12197578|FG000|COMPLETED|Overall Study||10
11019668|NCT00793780|12197579|FG001|COMPLETED|Overall Study||11
11019669|NCT00793780|12197578|FG000|NOT COMPLETED|Overall Study||2
11019670|NCT00793780|12197579|FG001|NOT COMPLETED|Overall Study||1
11019671|NCT00793793|12197597|FG000|STARTED|Overall Study||8
11019672|NCT00793793|12197598|FG001|STARTED|Overall Study||6
11019673|NCT00793793|12197599|FG002|STARTED|Overall Study||7
11019674|NCT00793793|12197600|FG003|STARTED|Overall Study||7
11019675|NCT00793793|12197601|FG004|STARTED|Overall Study||6
11019676|NCT00793793|12197602|FG005|STARTED|Overall Study||6
11019677|NCT00793793|12197603|FG006|STARTED|Overall Study||7
11019678|NCT00793793|12197604|FG007|STARTED|Overall Study||6
11019679|NCT00793793|12197605|FG008|STARTED|Overall Study||15
11019680|NCT00793793|12197606|FG009|STARTED|Overall Study||15
11019681|NCT00793793|12197607|FG010|STARTED|Overall Study||6
11019682|NCT00793793|12197608|FG011|STARTED|Overall Study||7
11019683|NCT00793793|12197597|FG000|COMPLETED|Overall Study||8
11019684|NCT00793793|12197598|FG001|COMPLETED|Overall Study||5
11019685|NCT00793793|12197599|FG002|COMPLETED|Overall Study||5
11019686|NCT00793793|12197600|FG003|COMPLETED|Overall Study||4
11019687|NCT00793793|12197601|FG004|COMPLETED|Overall Study||4
11019688|NCT00793793|12197602|FG005|COMPLETED|Overall Study||4
11019689|NCT00793793|12197603|FG006|COMPLETED|Overall Study||3
11019690|NCT00793793|12197604|FG007|COMPLETED|Overall Study||6
11019691|NCT00793793|12197605|FG008|COMPLETED|Overall Study||6
11019692|NCT00793793|12197606|FG009|COMPLETED|Overall Study||6
11019693|NCT00793793|12197607|FG010|COMPLETED|Overall Study||3
11019694|NCT00793793|12197608|FG011|COMPLETED|Overall Study||1
11019695|NCT00793793|12197597|FG000|NOT COMPLETED|Overall Study||0
11019696|NCT00793793|12197598|FG001|NOT COMPLETED|Overall Study||1
11019697|NCT00793793|12197599|FG002|NOT COMPLETED|Overall Study||2
11019698|NCT00793793|12197600|FG003|NOT COMPLETED|Overall Study||3
11019699|NCT00793793|12197601|FG004|NOT COMPLETED|Overall Study||2
11019700|NCT00793793|12197602|FG005|NOT COMPLETED|Overall Study||2
11019701|NCT00793793|12197603|FG006|NOT COMPLETED|Overall Study||4
11019702|NCT00793793|12197604|FG007|NOT COMPLETED|Overall Study||0
11019703|NCT00793793|12197605|FG008|NOT COMPLETED|Overall Study||9
11019704|NCT00793793|12197606|FG009|NOT COMPLETED|Overall Study||9
11019705|NCT00793793|12197607|FG010|NOT COMPLETED|Overall Study||3
11019706|NCT00793793|12197608|FG011|NOT COMPLETED|Overall Study||6
11019707|NCT00793819|12197656|FG000|STARTED|Overall Study||111
11019708|NCT00793819|12197657|FG001|STARTED|Overall Study||98
11019709|NCT00793819|12197656|FG000|COMPLETED|Overall Study||97
11019710|NCT00793819|12197657|FG001|COMPLETED|Overall Study||89
11019711|NCT00793819|12197656|FG000|NOT COMPLETED|Overall Study||14
11019712|NCT00793819|12197657|FG001|NOT COMPLETED|Overall Study||9
11019713|NCT00793871|12197663|FG000|STARTED|Overall Study||60
11019714|NCT00793871|12197663|FG000|Received Treatment|Overall Study||59
11019715|NCT00793871|12197663|FG000|COMPLETED|Overall Study||0
11019716|NCT00793871|12197663|FG000|NOT COMPLETED|Overall Study||60
11019717|NCT00793910|12197669|FG000|STARTED|Overall Study||53
11019718|NCT00793910|12197670|FG001|STARTED|Overall Study||53
11019719|NCT00793910|12197669|FG000|COMPLETED|Overall Study||48
11019720|NCT00793910|12197670|FG001|COMPLETED|Overall Study||46
11019721|NCT00793910|12197669|FG000|NOT COMPLETED|Overall Study||5
11019722|NCT00793910|12197670|FG001|NOT COMPLETED|Overall Study||7
11019723|NCT00794040|12197678|FG000|STARTED|Overall Study||25
11019724|NCT00794040|12197679|FG001|STARTED|Overall Study||28
11019725|NCT00794040|12197678|FG000|COMPLETED|Overall Study||22
11019726|NCT00794040|12197679|FG001|COMPLETED|Overall Study||23
11019727|NCT00794040|12197678|FG000|NOT COMPLETED|Overall Study||3
11019728|NCT00794040|12197679|FG001|NOT COMPLETED|Overall Study||5
11019729|NCT00794118|12197685|FG000|STARTED|Overall Study||299
11019730|NCT00794118|12197685|FG000|COMPLETED|Overall Study||272
11019731|NCT00794118|12197685|FG000|NOT COMPLETED|Overall Study||27
11019732|NCT00794144|12197691|FG000|STARTED|Overall Study||66
11019733|NCT00794144|12197692|FG001|STARTED|Overall Study||66
11019734|NCT00794144|12197691|FG000|COMPLETED|Overall Study||63
11019735|NCT00794144|12197692|FG001|COMPLETED|Overall Study||63
11019736|NCT00794144|12197691|FG000|NOT COMPLETED|Overall Study||3
11019737|NCT00794144|12197692|FG001|NOT COMPLETED|Overall Study||3
11019738|NCT00794157|12197701|FG000|STARTED|Overall Study||114
11019739|NCT00794157|12197702|FG001|STARTED|Overall Study||116
11019740|NCT00794157|12197703|FG002|STARTED|Overall Study||117
11019741|NCT00794157|12197701|FG000|COMPLETED|Overall Study||104
11019742|NCT00794157|12197702|FG001|COMPLETED|Overall Study||106
11019743|NCT00794157|12197703|FG002|COMPLETED|Overall Study||98
11019744|NCT00794157|12197701|FG000|NOT COMPLETED|Overall Study||10
11019745|NCT00794157|12197702|FG001|NOT COMPLETED|Overall Study||10
11019746|NCT00794157|12197703|FG002|NOT COMPLETED|Overall Study||19
11019747|NCT00794170|12197713|FG000|STARTED|Overall Study||157
11019748|NCT00794170|12197714|FG001|STARTED|Overall Study||155
11019749|NCT00794170|12197713|FG000|COMPLETED|Overall Study||150
11019750|NCT00794170|12197714|FG001|COMPLETED|Overall Study||152
11019751|NCT00794170|12197713|FG000|NOT COMPLETED|Overall Study||7
11019752|NCT00794170|12197714|FG001|NOT COMPLETED|Overall Study||3
11019753|NCT00794196|12197722|FG000|STARTED|Overall Study||92
11019754|NCT00794196|12197723|FG001|STARTED|Overall Study||87
11019755|NCT00794196|12197722|FG000|COMPLETED|Overall Study||87
11019756|NCT00794196|12197723|FG001|COMPLETED|Overall Study||64
11019757|NCT00794196|12197722|FG000|NOT COMPLETED|Overall Study||5
11019758|NCT00794196|12197723|FG001|NOT COMPLETED|Overall Study||23
11019759|NCT00794313|12197729|FG000|STARTED|Overall Study||1
11019760|NCT00794313|12197730|FG001|STARTED|Overall Study||1
11019761|NCT00794313|12197731|FG002|STARTED|Overall Study||1
11019762|NCT00794313|12197729|FG000|COMPLETED|Overall Study||1
11019763|NCT00794313|12197730|FG001|COMPLETED|Overall Study||1
11019764|NCT00794313|12197731|FG002|COMPLETED|Overall Study||1
11019765|NCT00794313|12197729|FG000|NOT COMPLETED|Overall Study||0
11019766|NCT00794313|12197730|FG001|NOT COMPLETED|Overall Study||0
11019767|NCT00794313|12197731|FG002|NOT COMPLETED|Overall Study||0
11019768|NCT00794339|12197742|FG000|STARTED|Overall Study||73
11019769|NCT00794339|12197742|FG000|Eligible|Overall Study||69
11019770|NCT00794339|12197742|FG000|Evaluable|Overall Study||59
11019771|NCT00794339|12197742|FG000|COMPLETED|Overall Study||59
11019772|NCT00794339|12197742|FG000|NOT COMPLETED|Overall Study||14
11019773|NCT00794365|12197763|FG000|STARTED|Overall Study||330
11019774|NCT00794365|12197763|FG000|COMPLETED|Overall Study||251
11019775|NCT00794365|12197763|FG000|NOT COMPLETED|Overall Study||79
11019776|NCT00794417|12197771|FG000|STARTED|Phase 1: Baseline (Day 1) up to Day 751||4
11019777|NCT00794417|12197772|FG001|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
11019778|NCT00794417|12197773|FG002|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
11019779|NCT00794417|12197774|FG003|STARTED|Phase 1: Baseline (Day 1) up to Day 751||0
11019780|NCT00794417|12197771|FG000|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||1
11019781|NCT00794417|12197772|FG001|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
11019782|NCT00794417|12197773|FG002|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
11019783|NCT00794417|12197774|FG003|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
11019784|NCT00794417|12197771|FG000|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
11019785|NCT00794417|12197772|FG001|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
11019786|NCT00794417|12197773|FG002|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
11019787|NCT00794417|12197774|FG003|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
11019788|NCT00794417|12197771|FG000|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
11019789|NCT00794417|12197772|FG001|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
11019790|NCT00794417|12197773|FG002|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
11019791|NCT00794417|12197774|FG003|STARTED|Phase 2: Baseline (Day 421) to Day 972||42
11019792|NCT00794417|12197771|FG000|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
11019793|NCT00794417|12197772|FG001|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
11019794|NCT00794417|12197773|FG002|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
11019795|NCT00794417|12197774|FG003|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||7
11019796|NCT00794417|12197771|FG000|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
11019797|NCT00794417|12197772|FG001|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
11019798|NCT00794417|12197773|FG002|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
11019799|NCT00794417|12197774|FG003|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||35
11019800|NCT00794469|12197786|FG000|STARTED|Overall Study||21
11019801|NCT00794469|12197786|FG000|COMPLETED|Overall Study||21
11019802|NCT00794469|12197786|FG000|NOT COMPLETED|Overall Study||0
11019803|NCT00794508|12197790|FG000|STARTED|Overall Study||10
11019804|NCT00794508|12197790|FG000|COMPLETED|Overall Study||10
11019805|NCT00794508|12197790|FG000|NOT COMPLETED|Overall Study||0
11019806|NCT00794547|12197794|FG000|STARTED|Overall Study||18
11019807|NCT00794547|12197795|FG001|STARTED|Overall Study||16
11019808|NCT00794547|12197794|FG000|COMPLETED|Overall Study||18
11019809|NCT00794547|12197795|FG001|COMPLETED|Overall Study||16
11019810|NCT00794547|12197794|FG000|NOT COMPLETED|Overall Study||0
11019811|NCT00794547|12197795|FG001|NOT COMPLETED|Overall Study||0
11019812|NCT00794560|12197803|FG000|STARTED|Overall Study||36
11019813|NCT00794560|12197804|FG001|STARTED|Overall Study||36
11019814|NCT00794560|12197805|FG002|STARTED|Overall Study||44
11019815|NCT00794560|12197806|FG003|STARTED|Overall Study||38
11019816|NCT00794560|12197803|FG000|COMPLETED|Overall Study||33
11019817|NCT00794560|12197804|FG001|COMPLETED|Overall Study||32
11019818|NCT00794560|12197805|FG002|COMPLETED|Overall Study||40
11019819|NCT00794560|12197806|FG003|COMPLETED|Overall Study||34
11019820|NCT00794560|12197803|FG000|NOT COMPLETED|Overall Study||3
11019821|NCT00794560|12197804|FG001|NOT COMPLETED|Overall Study||4
11019822|NCT00794560|12197805|FG002|NOT COMPLETED|Overall Study||4
11019823|NCT00794560|12197806|FG003|NOT COMPLETED|Overall Study||4
11019824|NCT00794573|12197818|FG000|STARTED|Overall Study||151
11019825|NCT00794573|12197819|FG001|STARTED|Overall Study||151
11019826|NCT00794573|12197818|FG000|COMPLETED|Overall Study||113
11019827|NCT00794573|12197819|FG001|COMPLETED|Overall Study||106
11019828|NCT00794573|12197818|FG000|NOT COMPLETED|Overall Study||38
11019829|NCT00794573|12197819|FG001|NOT COMPLETED|Overall Study||45
11019830|NCT00794664|12197827|FG000|STARTED|Treatment Period||19
11019831|NCT00794664|12197828|FG001|STARTED|Treatment Period||39
11019832|NCT00794664|12197827|FG000|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
11019833|NCT00794664|12197828|FG001|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
11019834|NCT00794664|12197827|FG000|NOT COMPLETED|Treatment Period||1
11019835|NCT00794664|12197828|FG001|NOT COMPLETED|Treatment Period||12
11019836|NCT00794664|12197827|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
11019837|NCT00794664|12197828|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
11019838|NCT00794664|12197827|FG000|COMPLETED|Follow-up Period||15
11019839|NCT00794664|12197828|FG001|COMPLETED|Follow-up Period||28
11019840|NCT00794664|12197827|FG000|NOT COMPLETED|Follow-up Period||1
11019841|NCT00794664|12197828|FG001|NOT COMPLETED|Follow-up Period||5
11019842|NCT00794820|12197834|FG000|STARTED|Overall Study||66
11019843|NCT00794820|12197834|FG000|COMPLETED|Overall Study||50
11019844|NCT00794820|12197834|FG000|NOT COMPLETED|Overall Study||16
11019845|NCT00794950|12197838|FG000|STARTED|BCG Induction||43
11019846|NCT00794950|12197838|FG000|COMPLETED|BCG Induction||36
11019847|NCT00794950|12197838|FG000|NOT COMPLETED|BCG Induction||7
11019848|NCT00794950|12197838|FG000|STARTED|Beginning Sunitinib Treatment||36
11019849|NCT00794950|12197838|FG000|COMPLETED|Beginning Sunitinib Treatment||24
11019850|NCT00794950|12197838|FG000|NOT COMPLETED|Beginning Sunitinib Treatment||12
11019851|NCT00794963|12197845|FG000|STARTED|Overall Study||4
11019852|NCT00794963|12197846|FG001|STARTED|Overall Study||4
11019853|NCT00794963|12197845|FG000|COMPLETED|Overall Study||3
11019854|NCT00794963|12197846|FG001|COMPLETED|Overall Study||0
11019855|NCT00794963|12197845|FG000|NOT COMPLETED|Overall Study||1
11019856|NCT00794963|12197846|FG001|NOT COMPLETED|Overall Study||4
11019857|NCT00795002|12197854|FG000|STARTED|Overall Study||37
11019858|NCT00795002|12197855|FG001|STARTED|Overall Study||37
11019859|NCT00795002|12197854|FG000|COMPLETED|Overall Study||37
11019860|NCT00795002|12197855|FG001|COMPLETED|Overall Study||37
11019861|NCT00795002|12197854|FG000|NOT COMPLETED|Overall Study||0
11019862|NCT00795002|12197855|FG001|NOT COMPLETED|Overall Study||0
11019863|NCT00795132|12197861|FG000|STARTED|Overall Study||47
11019864|NCT00795132|12197861|FG000|COMPLETED|Overall Study||44
11019865|NCT00795132|12197861|FG000|NOT COMPLETED|Overall Study||3
11019866|NCT00795145|12197875|FG000|STARTED|Cohort 1||3
11019867|NCT00795145|12197876|FG001|STARTED|Cohort 1||3
11019868|NCT00795145|12197877|FG002|STARTED|Cohort 1||3
11019869|NCT00795145|12197878|FG003|STARTED|Cohort 1||0
11019870|NCT00795145|12197879|FG004|STARTED|Cohort 1||0
11019871|NCT00795145|12197880|FG005|STARTED|Cohort 1||0
11019872|NCT00795145|12197881|FG006|STARTED|Cohort 1||0
11019873|NCT00795145|12197875|FG000|COMPLETED|Cohort 1||3
11019874|NCT00795145|12197876|FG001|COMPLETED|Cohort 1||3
11019875|NCT00795145|12197877|FG002|COMPLETED|Cohort 1||3
11019876|NCT00795145|12197878|FG003|COMPLETED|Cohort 1||0
11019877|NCT00795145|12197879|FG004|COMPLETED|Cohort 1||0
11019878|NCT00795145|12197880|FG005|COMPLETED|Cohort 1||0
11019879|NCT00795145|12197881|FG006|COMPLETED|Cohort 1||0
11019880|NCT00795145|12197875|FG000|NOT COMPLETED|Cohort 1||0
11019881|NCT00795145|12197876|FG001|NOT COMPLETED|Cohort 1||0
11143498|NCT01474122|12330334|FG000|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
11143499|NCT01474122|12330335|FG001|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
11143500|NCT01474122|12330336|FG002|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
11143501|NCT01474122|12330334|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||17
11143502|NCT01474122|12330335|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||13
11143503|NCT01474122|12330336|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||15
11143504|NCT01474200|12330348|FG000|STARTED|Overall Study||110
11143505|NCT01474200|12330349|FG001|STARTED|Overall Study||114
11143506|NCT01474200|12330348|FG000|COMPLETED|Overall Study||81
11143507|NCT01474200|12330349|FG001|COMPLETED|Overall Study||84
11143508|NCT01474200|12330348|FG000|NOT COMPLETED|Overall Study||29
11143509|NCT01474200|12330349|FG001|NOT COMPLETED|Overall Study||30
11143510|NCT01474213|12330357|FG000|STARTED|Overall Study||20
11143511|NCT01474213|12330358|FG001|STARTED|Overall Study||20
11396731|NCT03885596|12590632|FG003|NOT COMPLETED|Overall Study||0
11396732|NCT03885661|12590647|FG000|STARTED|Overall Study||12
11019882|NCT00795145|12197877|FG002|NOT COMPLETED|Cohort 1||0
11143512|NCT01474213|12330357|FG000|COMPLETED|Overall Study||20
11143513|NCT01474213|12330358|FG001|COMPLETED|Overall Study||20
11143514|NCT01474213|12330357|FG000|NOT COMPLETED|Overall Study||0
11143515|NCT01474213|12330358|FG001|NOT COMPLETED|Overall Study||0
11143516|NCT01474239|12330370|FG000|STARTED|Overall Study||59
11143517|NCT01474239|12330371|FG001|STARTED|Overall Study||32
11143518|NCT01474239|12330370|FG000|COMPLETED|Overall Study||0
11143519|NCT01474239|12330371|FG001|COMPLETED|Overall Study||0
11143520|NCT01474239|12330370|FG000|NOT COMPLETED|Overall Study||59
11143521|NCT01474239|12330371|FG001|NOT COMPLETED|Overall Study||32
11143522|NCT01474291|12330379|FG000|STARTED|Overall Study||603
11143523|NCT01474291|12330379|FG000|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
11143524|NCT01474291|12330379|FG000|COMPLETED|Overall Study||383
11143525|NCT01474291|12330379|FG000|NOT COMPLETED|Overall Study||220
11143526|NCT01474317|12330386|FG000|STARTED|Overall Study||226
11396733|NCT03885661|12590648|FG001|STARTED|Overall Study||8
11019883|NCT00795145|12197878|FG003|NOT COMPLETED|Cohort 1||0
11019884|NCT00795145|12197879|FG004|NOT COMPLETED|Cohort 1||0
11019885|NCT00795145|12197880|FG005|NOT COMPLETED|Cohort 1||0
11019886|NCT00795145|12197881|FG006|NOT COMPLETED|Cohort 1||0
11019887|NCT00795145|12197875|FG000|STARTED|Cohort 2||0
11019888|NCT00795145|12197876|FG001|STARTED|Cohort 2||0
11019889|NCT00795145|12197877|FG002|STARTED|Cohort 2||0
11019890|NCT00795145|12197878|FG003|STARTED|Cohort 2||10
11019891|NCT00795145|12197879|FG004|STARTED|Cohort 2||10
11019892|NCT00795145|12197880|FG005|STARTED|Cohort 2||10
11019893|NCT00795145|12197881|FG006|STARTED|Cohort 2||10
11019894|NCT00795145|12197875|FG000|COMPLETED|Cohort 2||0
11019895|NCT00795145|12197876|FG001|COMPLETED|Cohort 2||0
11019896|NCT00795145|12197877|FG002|COMPLETED|Cohort 2||0
11019897|NCT00795145|12197878|FG003|COMPLETED|Cohort 2||10
11019898|NCT00795145|12197879|FG004|COMPLETED|Cohort 2||10
11019899|NCT00795145|12197880|FG005|COMPLETED|Cohort 2||10
11019900|NCT00795145|12197881|FG006|COMPLETED|Cohort 2||10
11019901|NCT00795145|12197875|FG000|NOT COMPLETED|Cohort 2||0
11019902|NCT00795145|12197876|FG001|NOT COMPLETED|Cohort 2||0
11019903|NCT00795145|12197877|FG002|NOT COMPLETED|Cohort 2||0
11019904|NCT00795145|12197878|FG003|NOT COMPLETED|Cohort 2||0
11019905|NCT00795145|12197879|FG004|NOT COMPLETED|Cohort 2||0
11019906|NCT00795145|12197880|FG005|NOT COMPLETED|Cohort 2||0
11019907|NCT00795145|12197881|FG006|NOT COMPLETED|Cohort 2||0
11019908|NCT00795184|12197908|FG000|STARTED|Overall Study||65
11019909|NCT00795184|12197909|FG001|STARTED|Overall Study||57
11019910|NCT00795184|12197908|FG000|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
11019911|NCT00795184|12197909|FG001|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
11019912|NCT00795184|12197908|FG000|NOT COMPLETED|Overall Study||8
11019913|NCT00795184|12197909|FG001|NOT COMPLETED|Overall Study||13
11019914|NCT00795210|12197921|FG000|STARTED|Overall Study||8
11396734|NCT03885661|12590647|FG000|Baseline|Overall Study||12
11019915|NCT00795210|12197922|FG001|STARTED|Overall Study||12
11019916|NCT00795210|12197923|FG002|STARTED|Overall Study||5
11019917|NCT00795210|12197921|FG000|COMPLETED|Overall Study||8
11019918|NCT00795210|12197922|FG001|COMPLETED|Overall Study||11
11019919|NCT00795210|12197923|FG002|COMPLETED|Overall Study||3
11019920|NCT00795210|12197921|FG000|NOT COMPLETED|Overall Study||0
11019921|NCT00795210|12197922|FG001|NOT COMPLETED|Overall Study||1
11019922|NCT00795210|12197923|FG002|NOT COMPLETED|Overall Study||2
11019923|NCT00795275|12197933|FG000|STARTED|Overall Study||11
11019924|NCT00795275|12197934|FG001|STARTED|Overall Study||15
11019925|NCT00795275|12197933|FG000|COMPLETED|Overall Study||10
11019926|NCT00795275|12197934|FG001|COMPLETED|Overall Study||13
11019927|NCT00795275|12197933|FG000|NOT COMPLETED|Overall Study||1
11019928|NCT00795275|12197934|FG001|NOT COMPLETED|Overall Study||2
11019929|NCT00795288|12197944|FG000|STARTED|Overall Study||21
11019930|NCT00795288|12197945|FG001|STARTED|Overall Study||21
11019931|NCT00795288|12197944|FG000|COMPLETED|Overall Study||21
11019932|NCT00795288|12197945|FG001|COMPLETED|Overall Study||21
11019933|NCT00795288|12197944|FG000|NOT COMPLETED|Overall Study||0
11019934|NCT00795288|12197945|FG001|NOT COMPLETED|Overall Study||0
11019935|NCT00795340|12197955|FG000|STARTED|Overall Study||153
11019936|NCT00795340|12197956|FG001|STARTED|Overall Study||153
11019937|NCT00795340|12197955|FG000|COMPLETED|Overall Study||146
11019938|NCT00795340|12197956|FG001|COMPLETED|Overall Study||153
11019939|NCT00795340|12197955|FG000|NOT COMPLETED|Overall Study||7
11019940|NCT00795340|12197956|FG001|NOT COMPLETED|Overall Study||0
11019941|NCT00795366|12197964|FG000|STARTED|Overall Study||42
11019942|NCT00795366|12197965|FG001|STARTED|Overall Study||54
11019943|NCT00795366|12197964|FG000|COMPLETED|Overall Study||42
11019944|NCT00795366|12197965|FG001|COMPLETED|Overall Study||54
11019945|NCT00795366|12197964|FG000|NOT COMPLETED|Overall Study||0
11019946|NCT00795366|12197965|FG001|NOT COMPLETED|Overall Study||0
11019947|NCT00795509|12197971|FG000|STARTED|Overall Study||374
11019948|NCT00795509|12197971|FG000|COMPLETED|Overall Study||343
11019949|NCT00795509|12197971|FG000|NOT COMPLETED|Overall Study||31
11019950|NCT00795535|12197975|FG000|STARTED|Overall Study||95
11019951|NCT00795535|12197975|FG000|COMPLETED|Overall Study||75
11019952|NCT00795535|12197975|FG000|NOT COMPLETED|Overall Study||20
11019953|NCT00795600|12197981|FG000|STARTED|Overall Study||25
11019954|NCT00795600|12197982|FG001|STARTED|Overall Study||35
11019955|NCT00795600|12197981|FG000|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
11019956|NCT00795600|12197982|FG001|Exposed to Drug|Overall Study||35
11019957|NCT00795600|12197981|FG000|COMPLETED|Overall Study||21
11019958|NCT00795600|12197982|FG001|COMPLETED|Overall Study||31
11019959|NCT00795600|12197981|FG000|NOT COMPLETED|Overall Study||4
11019960|NCT00795600|12197982|FG001|NOT COMPLETED|Overall Study||4
11019961|NCT00795639|12197990|FG000|STARTED|Overall Study||91
11019962|NCT00795639|12197991|FG001|STARTED|Overall Study||92
11019963|NCT00795639|12197990|FG000|Randomized and Not Treated|Overall Study||0
11019964|NCT00795639|12197991|FG001|Randomized and Not Treated|Overall Study||1
11019965|NCT00795639|12197990|FG000|COMPLETED|Overall Study||70
11019966|NCT00795639|12197991|FG001|COMPLETED|Overall Study||66
11019967|NCT00795639|12197990|FG000|NOT COMPLETED|Overall Study||21
11019968|NCT00795639|12197991|FG001|NOT COMPLETED|Overall Study||26
11019969|NCT00795704|12197999|FG000|STARTED|Overall Study||12
11019970|NCT00795704|12198000|FG001|STARTED|Overall Study||12
11019971|NCT00795704|12197999|FG000|COMPLETED|Overall Study||8
11019972|NCT00795704|12198000|FG001|COMPLETED|Overall Study||9
11019973|NCT00795704|12197999|FG000|NOT COMPLETED|Overall Study||4
11019974|NCT00795704|12198000|FG001|NOT COMPLETED|Overall Study||3
11019975|NCT00795717|12198008|FG000|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
11019976|NCT00795717|12198009|FG001|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
11019977|NCT00795717|12198008|FG000|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
11019978|NCT00795717|12198009|FG001|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
11019979|NCT00795717|12198008|FG000|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
11019980|NCT00795717|12198009|FG001|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
11019981|NCT00795717|12198008|FG000|STARTED|Phase II||18
11019982|NCT00795717|12198009|FG001|STARTED|Phase II||19
11019983|NCT00795717|12198008|FG000|COMPLETED|Phase II||18
11019984|NCT00795717|12198009|FG001|COMPLETED|Phase II||18
11019985|NCT00795717|12198008|FG000|NOT COMPLETED|Phase II||0
11019986|NCT00795717|12198009|FG001|NOT COMPLETED|Phase II||1
11019987|NCT00795769|12198016|FG000|STARTED|Overall Study||49
11019988|NCT00795769|12198016|FG000|COMPLETED|Overall Study||49
11019989|NCT00795769|12198016|FG000|NOT COMPLETED|Overall Study||0
11019990|NCT00795821|12198022|FG000|STARTED|Acute Treatment Phase||250
11019991|NCT00795821|12198023|FG001|STARTED|Acute Treatment Phase||245
11019992|NCT00795821|12198022|FG000|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
11019993|NCT00795821|12198023|FG001|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
11019994|NCT00795821|12198022|FG000|NOT COMPLETED|Acute Treatment Phase||56
11019995|NCT00795821|12198023|FG001|NOT COMPLETED|Acute Treatment Phase||31
11019996|NCT00795821|12198022|FG000|STARTED|Long-term Extension Phase||190
11019997|NCT00795821|12198023|FG001|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
11019998|NCT00795821|12198022|FG000|COMPLETED|Long-term Extension Phase||100
11019999|NCT00795821|12198023|FG001|COMPLETED|Long-term Extension Phase||115
11020000|NCT00795821|12198022|FG000|NOT COMPLETED|Long-term Extension Phase||90
11020001|NCT00795821|12198023|FG001|NOT COMPLETED|Long-term Extension Phase||92
11020002|NCT00795821|12198022|FG000|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
11020003|NCT00795821|12198023|FG001|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
11020004|NCT00795821|12198022|FG000|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
11020005|NCT00795821|12198023|FG001|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
11020006|NCT00795821|12198022|FG000|NOT COMPLETED|Taper Phase||9
11020007|NCT00795821|12198023|FG001|NOT COMPLETED|Taper Phase||0
11020008|NCT00795886|12198039|FG000|STARTED|Overall Study||63
11020009|NCT00795886|12198039|FG000|COMPLETED|Overall Study||53
11020010|NCT00795886|12198039|FG000|NOT COMPLETED|Overall Study||10
11020011|NCT00795951|12198044|FG000|STARTED|Overall Study||102
11020012|NCT00795951|12198044|FG000|COMPLETED|Overall Study||100
11020013|NCT00795951|12198044|FG000|NOT COMPLETED|Overall Study||2
11020014|NCT00796003|12198051|FG000|STARTED|Overall Study|Number of participants enrolled|3
11020015|NCT00796003|12198052|FG001|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
11020016|NCT00796003|12198051|FG000|Treated|Overall Study|Number of participants treated|3
11020017|NCT00796003|12198052|FG001|Treated|Overall Study|Number of participants treated|34
11020018|NCT00796003|12198051|FG000|COMPLETED|Overall Study||0
11020019|NCT00796003|12198052|FG001|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
11020020|NCT00796003|12198051|FG000|NOT COMPLETED|Overall Study||3
11020021|NCT00796003|12198052|FG001|NOT COMPLETED|Overall Study||29
11020022|NCT00796120|12198063|FG000|STARTED|Overall Study||61
11020023|NCT00796120|12198064|FG001|STARTED|Overall Study||60
11020024|NCT00796120|12198063|FG000|Treated|Overall Study||61
11020025|NCT00796120|12198064|FG001|Treated|Overall Study||57
11020026|NCT00796120|12198063|FG000|COMPLETED|Overall Study||0
11020027|NCT00796120|12198064|FG001|COMPLETED|Overall Study||0
11020028|NCT00796120|12198063|FG000|NOT COMPLETED|Overall Study||61
11020029|NCT00796120|12198064|FG001|NOT COMPLETED|Overall Study||60
11020030|NCT00796224|12198072|FG000|STARTED|Overall Study||19
11020031|NCT00796224|12198073|FG001|STARTED|Overall Study||19
11020032|NCT00796224|12198072|FG000|COMPLETED|Overall Study||18
11020033|NCT00796224|12198073|FG001|COMPLETED|Overall Study||18
11020034|NCT00796224|12198072|FG000|NOT COMPLETED|Overall Study||1
11020035|NCT00796224|12198073|FG001|NOT COMPLETED|Overall Study||1
11020036|NCT00796302|12198083|FG000|STARTED|Overall Study||84
11020037|NCT00796302|12198084|FG001|STARTED|Overall Study||84
11020038|NCT00796302|12198083|FG000|COMPLETED|Overall Study||71
11020039|NCT00796302|12198084|FG001|COMPLETED|Overall Study||66
11020040|NCT00796302|12198083|FG000|NOT COMPLETED|Overall Study||13
11020041|NCT00796302|12198084|FG001|NOT COMPLETED|Overall Study||18
11020042|NCT00796315|12198091|FG000|STARTED|Overall Study||9
11020043|NCT00796315|12198092|FG001|STARTED|Overall Study||17
11020044|NCT00796315|12198093|FG002|STARTED|Overall Study||15
11020045|NCT00796315|12198091|FG000|COMPLETED|Overall Study||9
11020046|NCT00796315|12198092|FG001|COMPLETED|Overall Study||16
11020047|NCT00796315|12198093|FG002|COMPLETED|Overall Study||15
11020048|NCT00796315|12198091|FG000|NOT COMPLETED|Overall Study||0
11020049|NCT00796315|12198092|FG001|NOT COMPLETED|Overall Study||1
11020050|NCT00796315|12198093|FG002|NOT COMPLETED|Overall Study||0
11020051|NCT00796328|12198104|FG000|STARTED|Overall Study||46
11020052|NCT00796328|12198104|FG000|COMPLETED|Overall Study||40
11020053|NCT00796328|12198104|FG000|NOT COMPLETED|Overall Study||6
11020054|NCT00796367|12198111|FG000|STARTED|Overall Study||227
11020055|NCT00796367|12198112|FG001|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
11020056|NCT00796367|12198113|FG002|STARTED|Overall Study||295
11020057|NCT00796367|12198111|FG000|COMPLETED|Overall Study||197
11020058|NCT00796367|12198112|FG001|COMPLETED|Overall Study||129
11020059|NCT00796367|12198113|FG002|COMPLETED|Overall Study||248
11020060|NCT00796367|12198111|FG000|NOT COMPLETED|Overall Study||30
11020061|NCT00796367|12198112|FG001|NOT COMPLETED|Overall Study||25
11020062|NCT00796367|12198113|FG002|NOT COMPLETED|Overall Study||47
11020063|NCT00796419|12198123|FG000|STARTED|Overall Study||13
11020064|NCT00796419|12198124|FG001|STARTED|Overall Study||14
11020065|NCT00796419|12198123|FG000|COMPLETED|Overall Study||13
11020066|NCT00796419|12198124|FG001|COMPLETED|Overall Study||13
11020067|NCT00796419|12198123|FG000|NOT COMPLETED|Overall Study||0
11020068|NCT00796419|12198124|FG001|NOT COMPLETED|Overall Study||1
11020069|NCT00796445|12198132|FG000|STARTED|Overall Study||895
11020070|NCT00796445|12198133|FG001|STARTED|Overall Study||450
11020071|NCT00796445|12198132|FG000|COMPLETED|Overall Study||310
11020072|NCT00796445|12198133|FG001|COMPLETED|Overall Study||158
11020073|NCT00796445|12198132|FG000|NOT COMPLETED|Overall Study||585
11020074|NCT00796445|12198133|FG001|NOT COMPLETED|Overall Study||292
11020075|NCT00796549|12198147|FG000|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
11020076|NCT00796549|12198147|FG000|Entered|Overall Study|entered and treated|69
11020077|NCT00796549|12198147|FG000|COMPLETED|Overall Study||0
11020078|NCT00796549|12198147|FG000|NOT COMPLETED|Overall Study||218
11020079|NCT00796562|12198153|FG000|STARTED|Overall Study||96
11020080|NCT00796562|12198153|FG000|COMPLETED|Overall Study||47
11020081|NCT00796562|12198153|FG000|NOT COMPLETED|Overall Study||49
11020082|NCT00796614|12198161|FG000|STARTED|Overall Study||41
11020083|NCT00796614|12198162|FG001|STARTED|Overall Study||40
11020084|NCT00796614|12198163|FG002|STARTED|Overall Study||39
11020085|NCT00796614|12198164|FG003|STARTED|Overall Study||41
11020086|NCT00796614|12198161|FG000|Not Treated|Overall Study||0
11020087|NCT00796614|12198162|FG001|Not Treated|Overall Study||0
11020088|NCT00796614|12198163|FG002|Not Treated|Overall Study||1
11020089|NCT00796614|12198164|FG003|Not Treated|Overall Study||0
11020090|NCT00796614|12198161|FG000|COMPLETED|Overall Study||36
11020091|NCT00796614|12198162|FG001|COMPLETED|Overall Study||36
11020092|NCT00796614|12198163|FG002|COMPLETED|Overall Study||36
11020093|NCT00796614|12198164|FG003|COMPLETED|Overall Study||40
11020094|NCT00796614|12198161|FG000|NOT COMPLETED|Overall Study||5
11020095|NCT00796614|12198162|FG001|NOT COMPLETED|Overall Study||4
11020096|NCT00796614|12198163|FG002|NOT COMPLETED|Overall Study||3
11020097|NCT00796614|12198164|FG003|NOT COMPLETED|Overall Study||1
11020098|NCT00796627|12198176|FG000|STARTED|Overall Study||10
11020099|NCT00796627|12198177|FG001|STARTED|Overall Study||31
11020100|NCT00796627|12198176|FG000|COMPLETED|Overall Study||10
11020101|NCT00796627|12198177|FG001|COMPLETED|Overall Study||31
11020102|NCT00796627|12198176|FG000|NOT COMPLETED|Overall Study||0
11020103|NCT00796627|12198177|FG001|NOT COMPLETED|Overall Study||0
11020104|NCT00796653|12198187|FG000|STARTED|Overall Study||235
11020105|NCT00796653|12198188|FG001|STARTED|Overall Study||232
11020106|NCT00796653|12198189|FG002|STARTED|Overall Study||234
11020107|NCT00796653|12198190|FG003|STARTED|Overall Study||233
11020108|NCT00796653|12198187|FG000|COMPLETED|Overall Study||184
11020109|NCT00796653|12198188|FG001|COMPLETED|Overall Study||195
11020110|NCT00796653|12198189|FG002|COMPLETED|Overall Study||198
11020111|NCT00796653|12198190|FG003|COMPLETED|Overall Study||193
11020112|NCT00796653|12198187|FG000|NOT COMPLETED|Overall Study||51
11020113|NCT00796653|12198188|FG001|NOT COMPLETED|Overall Study||37
11020114|NCT00796653|12198189|FG002|NOT COMPLETED|Overall Study||36
11020115|NCT00796653|12198190|FG003|NOT COMPLETED|Overall Study||40
11020116|NCT00796666|12198210|FG000|STARTED|Overall Study||67
11020117|NCT00796666|12198211|FG001|STARTED|Overall Study||64
11020118|NCT00796666|12198210|FG000|Treated|Overall Study||66
11020119|NCT00796666|12198211|FG001|Treated|Overall Study||64
11020120|NCT00796666|12198210|FG000|Randomized and Not Treated|Overall Study||1
11020121|NCT00796666|12198211|FG001|Randomized and Not Treated|Overall Study||0
11020122|NCT00796666|12198210|FG000|COMPLETED|Overall Study||0
11020123|NCT00796666|12198211|FG001|COMPLETED|Overall Study||0
11020124|NCT00796666|12198210|FG000|NOT COMPLETED|Overall Study||67
11020125|NCT00796666|12198211|FG001|NOT COMPLETED|Overall Study||64
11020126|NCT00796705|12198221|FG000|STARTED|Overall Study||3
11020127|NCT00796705|12198222|FG001|STARTED|Overall Study||4
11020128|NCT00796705|12198223|FG002|STARTED|Overall Study||4
11020129|NCT00796705|12198224|FG003|STARTED|Overall Study||2
11020130|NCT00796705|12198221|FG000|COMPLETED|Overall Study||3
11020131|NCT00796705|12198222|FG001|COMPLETED|Overall Study||4
11020132|NCT00796705|12198223|FG002|COMPLETED|Overall Study||4
11020133|NCT00796705|12198224|FG003|COMPLETED|Overall Study||2
11020134|NCT00796705|12198221|FG000|NOT COMPLETED|Overall Study||0
11020135|NCT00796705|12198222|FG001|NOT COMPLETED|Overall Study||0
11020136|NCT00796705|12198223|FG002|NOT COMPLETED|Overall Study||0
11020137|NCT00796705|12198224|FG003|NOT COMPLETED|Overall Study||0
11020138|NCT00796718|12198236|FG000|STARTED|Overall Study||62
11020139|NCT00796718|12198236|FG000|COMPLETED|Overall Study||53
11020140|NCT00796718|12198236|FG000|NOT COMPLETED|Overall Study||9
11020141|NCT00796744|12198243|FG000|STARTED|Overall Study||24
11020142|NCT00796744|12198244|FG001|STARTED|Overall Study||26
11020143|NCT00796744|12198245|FG002|STARTED|Overall Study||28
11020144|NCT00796744|12198243|FG000|COMPLETED|Overall Study||24
11020145|NCT00796744|12198244|FG001|COMPLETED|Overall Study||26
11020146|NCT00796744|12198245|FG002|COMPLETED|Overall Study||27
11020147|NCT00796744|12198243|FG000|NOT COMPLETED|Overall Study||0
11020148|NCT00796744|12198244|FG001|NOT COMPLETED|Overall Study||0
11020149|NCT00796744|12198245|FG002|NOT COMPLETED|Overall Study||1
11020150|NCT00796757|12198255|FG000|STARTED|Overall Study||146
11020151|NCT00796757|12198255|FG000|COMPLETED|Overall Study||60
11020152|NCT00796757|12198255|FG000|NOT COMPLETED|Overall Study||86
11020153|NCT00796822|12198261|FG000|STARTED|Overall Study||13
11020154|NCT00796822|12198262|FG001|STARTED|Overall Study||13
11020155|NCT00796822|12198261|FG000|COMPLETED|Overall Study||10
11020156|NCT00796822|12198262|FG001|COMPLETED|Overall Study||13
11020157|NCT00796822|12198261|FG000|NOT COMPLETED|Overall Study||3
11020158|NCT00796822|12198262|FG001|NOT COMPLETED|Overall Study||0
11020159|NCT00796926|12198270|FG000|STARTED|Overall Study||15
11020160|NCT00796926|12198271|FG001|STARTED|Overall Study||15
11020161|NCT00796926|12198270|FG000|COMPLETED|Overall Study||14
11020162|NCT00796926|12198271|FG001|COMPLETED|Overall Study||15
11020163|NCT00796926|12198270|FG000|NOT COMPLETED|Overall Study||1
11020164|NCT00796926|12198271|FG001|NOT COMPLETED|Overall Study||0
11020165|NCT00796978|12198277|FG000|STARTED|Overall Study||56
11020166|NCT00796978|12198277|FG000|COMPLETED|Overall Study||44
11020167|NCT00796978|12198277|FG000|NOT COMPLETED|Overall Study||12
11020168|NCT00796991|12198284|FG000|STARTED|Overall Study||20
11020169|NCT00796991|12198285|FG001|STARTED|Overall Study||19
11020170|NCT00796991|12198286|FG002|STARTED|Overall Study||20
11020171|NCT00796991|12198284|FG000|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
11020172|NCT00796991|12198285|FG001|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
11020173|NCT00796991|12198286|FG002|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
11020174|NCT00796991|12198284|FG000|NOT COMPLETED|Overall Study||15
11020175|NCT00796991|12198285|FG001|NOT COMPLETED|Overall Study||12
11020176|NCT00796991|12198286|FG002|NOT COMPLETED|Overall Study||14
11020177|NCT00797108|12198297|FG000|STARTED|Overall Study||12
11020178|NCT00797108|12198298|FG001|STARTED|Overall Study||11
11020179|NCT00797108|12198299|FG002|STARTED|Overall Study||12
11020180|NCT00797108|12198297|FG000|Treated|Overall Study||10
11020181|NCT00797108|12198298|FG001|Treated|Overall Study||11
11020182|NCT00797108|12198299|FG002|Treated|Overall Study||12
11020183|NCT00797108|12198297|FG000|COMPLETED|Overall Study||8
11020184|NCT00797108|12198298|FG001|COMPLETED|Overall Study||9
11020185|NCT00797108|12198299|FG002|COMPLETED|Overall Study||6
11020186|NCT00797108|12198297|FG000|NOT COMPLETED|Overall Study||4
11020187|NCT00797108|12198298|FG001|NOT COMPLETED|Overall Study||2
11020188|NCT00797108|12198299|FG002|NOT COMPLETED|Overall Study||6
11020189|NCT00797212|12198307|FG000|STARTED|Overall Study||50
11020190|NCT00797212|12198307|FG000|COMPLETED|Overall Study||50
11020191|NCT00797212|12198307|FG000|NOT COMPLETED|Overall Study||0
11020192|NCT00797225|12198315|FG000|STARTED|Weeks 1 to 12||43
11020193|NCT00797225|12198316|FG001|STARTED|Weeks 1 to 12||43
11020194|NCT00797225|12198317|FG002|STARTED|Weeks 1 to 12||44
11020195|NCT00797225|12198318|FG003|STARTED|Weeks 1 to 12||44
11020196|NCT00797225|12198319|FG004|STARTED|Weeks 1 to 12||0
11143527|NCT01474317|12330386|FG000|COMPLETED|Overall Study||224
11143528|NCT01474317|12330386|FG000|NOT COMPLETED|Overall Study||2
11143529|NCT01474434|12330394|FG000|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
11143530|NCT01474434|12330395|FG001|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
11143531|NCT01474434|12330396|FG002|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
11143532|NCT01474434|12330397|FG003|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
11143533|NCT01474434|12330394|FG000|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
11143534|NCT01474434|12330395|FG001|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
11143535|NCT01474434|12330396|FG002|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
11143536|NCT01474434|12330397|FG003|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
11143537|NCT01474434|12330394|FG000|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
11143538|NCT01474434|12330395|FG001|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
11143539|NCT01474434|12330396|FG002|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
11143540|NCT01474434|12330397|FG003|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
11143541|NCT01474434|12330394|FG000|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
11143542|NCT01474434|12330395|FG001|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
11143543|NCT01474434|12330396|FG002|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
11143544|NCT01474434|12330397|FG003|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
11143545|NCT01474434|12330394|FG000|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
11143546|NCT01474434|12330395|FG001|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
11143547|NCT01474434|12330396|FG002|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
11143548|NCT01474434|12330397|FG003|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
11143549|NCT01474434|12330394|FG000|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
11143550|NCT01474434|12330395|FG001|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
11143551|NCT01474434|12330396|FG002|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
11143552|NCT01474434|12330397|FG003|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
11143553|NCT01474486|12330411|FG000|STARTED|Overall Study||28
11143554|NCT01474486|12330411|FG000|Treated|Overall Study||22
11143555|NCT01474486|12330411|FG000|COMPLETED|Overall Study||20
11396735|NCT03885661|12590648|FG001|Baseline|Overall Study||8
11396736|NCT03885661|12590647|FG000|Treatment Visit (12 Week)|Overall Study||11
11396737|NCT03885661|12590648|FG001|Treatment Visit (12 Week)|Overall Study||7
11396738|NCT03885661|12590647|FG000|COMPLETED|Overall Study||11
11396739|NCT03885661|12590648|FG001|COMPLETED|Overall Study||7
11020197|NCT00797225|12198320|FG005|STARTED|Weeks 1 to 12||0
11020198|NCT00797225|12198321|FG006|STARTED|Weeks 1 to 12||0
11020199|NCT00797225|12198322|FG007|STARTED|Weeks 1 to 12||0
11020200|NCT00797225|12198315|FG000|Received Study Drug|Weeks 1 to 12||43
11020201|NCT00797225|12198316|FG001|Received Study Drug|Weeks 1 to 12||43
11020202|NCT00797225|12198317|FG002|Received Study Drug|Weeks 1 to 12||44
11020203|NCT00797225|12198318|FG003|Received Study Drug|Weeks 1 to 12||44
11020204|NCT00797225|12198319|FG004|Received Study Drug|Weeks 1 to 12||0
11020205|NCT00797225|12198320|FG005|Received Study Drug|Weeks 1 to 12||0
11020206|NCT00797225|12198321|FG006|Received Study Drug|Weeks 1 to 12||0
11020207|NCT00797225|12198322|FG007|Received Study Drug|Weeks 1 to 12||0
11020208|NCT00797225|12198315|FG000|COMPLETED|Weeks 1 to 12||41
11020209|NCT00797225|12198316|FG001|COMPLETED|Weeks 1 to 12||42
11020210|NCT00797225|12198317|FG002|COMPLETED|Weeks 1 to 12||43
11020211|NCT00797225|12198318|FG003|COMPLETED|Weeks 1 to 12||44
11020212|NCT00797225|12198319|FG004|COMPLETED|Weeks 1 to 12||0
11020213|NCT00797225|12198320|FG005|COMPLETED|Weeks 1 to 12||0
11020214|NCT00797225|12198321|FG006|COMPLETED|Weeks 1 to 12||0
11396740|NCT03885661|12590647|FG000|NOT COMPLETED|Overall Study||1
11396741|NCT03885661|12590648|FG001|NOT COMPLETED|Overall Study||1
11396742|NCT03886493|12590654|FG000|STARTED|Overall Study||7
11396743|NCT03886493|12590654|FG000|COMPLETED|Overall Study||6
11396744|NCT03886493|12590654|FG000|NOT COMPLETED|Overall Study||1
11396745|NCT03888235|12590661|FG000|STARTED|Overall Study|1 Participant dropped out after the first visit and was replaced.|21
11396746|NCT03888235|12590662|FG001|STARTED|Overall Study|1 participants dropped out after the first visit and was replaced|21
11396747|NCT03888235|12590663|FG002|STARTED|Overall Study||20
11396748|NCT03888235|12590661|FG000|COMPLETED|Overall Study||20
11396749|NCT03888235|12590662|FG001|COMPLETED|Overall Study||20
11020215|NCT00797225|12198322|FG007|COMPLETED|Weeks 1 to 12||0
11020216|NCT00797225|12198315|FG000|NOT COMPLETED|Weeks 1 to 12||2
11020217|NCT00797225|12198316|FG001|NOT COMPLETED|Weeks 1 to 12||1
11143556|NCT01474486|12330411|FG000|NOT COMPLETED|Overall Study||8
11396750|NCT03888235|12590663|FG002|COMPLETED|Overall Study||20
11020218|NCT00797225|12198317|FG002|NOT COMPLETED|Weeks 1 to 12||1
11020219|NCT00797225|12198318|FG003|NOT COMPLETED|Weeks 1 to 12||0
11020220|NCT00797225|12198319|FG004|NOT COMPLETED|Weeks 1 to 12||0
11020221|NCT00797225|12198320|FG005|NOT COMPLETED|Weeks 1 to 12||0
11020222|NCT00797225|12198321|FG006|NOT COMPLETED|Weeks 1 to 12||0
11020223|NCT00797225|12198322|FG007|NOT COMPLETED|Weeks 1 to 12||0
11020224|NCT00797225|12198315|FG000|STARTED|Weeks 13 to 24||0
11020225|NCT00797225|12198316|FG001|STARTED|Weeks 13 to 24||42
11020226|NCT00797225|12198317|FG002|STARTED|Weeks 13 to 24||43
11020227|NCT00797225|12198318|FG003|STARTED|Weeks 13 to 24||0
11020228|NCT00797225|12198319|FG004|STARTED|Weeks 13 to 24||20
11020229|NCT00797225|12198320|FG005|STARTED|Weeks 13 to 24||21
11020230|NCT00797225|12198321|FG006|STARTED|Weeks 13 to 24||22
11020231|NCT00797225|12198322|FG007|STARTED|Weeks 13 to 24||22
11020232|NCT00797225|12198315|FG000|COMPLETED|Weeks 13 to 24||0
11020233|NCT00797225|12198316|FG001|COMPLETED|Weeks 13 to 24||38
11020234|NCT00797225|12198317|FG002|COMPLETED|Weeks 13 to 24||41
11020235|NCT00797225|12198318|FG003|COMPLETED|Weeks 13 to 24||0
11020236|NCT00797225|12198319|FG004|COMPLETED|Weeks 13 to 24||19
11020237|NCT00797225|12198320|FG005|COMPLETED|Weeks 13 to 24||21
11020238|NCT00797225|12198321|FG006|COMPLETED|Weeks 13 to 24||20
11020239|NCT00797225|12198322|FG007|COMPLETED|Weeks 13 to 24||22
11020240|NCT00797225|12198315|FG000|NOT COMPLETED|Weeks 13 to 24||0
11020241|NCT00797225|12198316|FG001|NOT COMPLETED|Weeks 13 to 24||4
11020242|NCT00797225|12198317|FG002|NOT COMPLETED|Weeks 13 to 24||2
11020243|NCT00797225|12198318|FG003|NOT COMPLETED|Weeks 13 to 24||0
11020244|NCT00797225|12198319|FG004|NOT COMPLETED|Weeks 13 to 24||1
11020245|NCT00797225|12198320|FG005|NOT COMPLETED|Weeks 13 to 24||0
11020246|NCT00797225|12198321|FG006|NOT COMPLETED|Weeks 13 to 24||2
11020247|NCT00797225|12198322|FG007|NOT COMPLETED|Weeks 13 to 24||0
11020248|NCT00797277|12198340|FG000|STARTED|Overall Study||37
11020249|NCT00797277|12198341|FG001|STARTED|Overall Study||30
11020250|NCT00797277|12198340|FG000|COMPLETED|Overall Study||37
11020251|NCT00797277|12198341|FG001|COMPLETED|Overall Study||30
11020252|NCT00797277|12198340|FG000|NOT COMPLETED|Overall Study||0
11020253|NCT00797277|12198341|FG001|NOT COMPLETED|Overall Study||0
11020254|NCT00797316|12198350|FG000|STARTED|Overall Study||267
11020255|NCT00797316|12198351|FG001|STARTED|Overall Study||265
11020256|NCT00797316|12198350|FG000|COMPLETED|Overall Study||244
11020257|NCT00797316|12198351|FG001|COMPLETED|Overall Study||233
11020258|NCT00797316|12198350|FG000|NOT COMPLETED|Overall Study||23
11396751|NCT03888235|12590661|FG000|NOT COMPLETED|Overall Study||1
11396752|NCT03888235|12590662|FG001|NOT COMPLETED|Overall Study||1
11396753|NCT03888235|12590663|FG002|NOT COMPLETED|Overall Study||0
11396754|NCT03889158|12590696|FG000|STARTED|Overall Study||20
11396755|NCT03889158|12590697|FG001|STARTED|Overall Study||15
11396756|NCT03889158|12590696|FG000|COMPLETED|Overall Study||16
11020259|NCT00797316|12198351|FG001|NOT COMPLETED|Overall Study||32
11020260|NCT00797459|12198357|FG000|STARTED|Overall Study||60
11020261|NCT00797459|12198357|FG000|COMPLETED|Overall Study||60
11020262|NCT00797459|12198357|FG000|NOT COMPLETED|Overall Study||0
11020263|NCT00797511|12198365|FG000|STARTED|Overall Study||132
11020264|NCT00797511|12198365|FG000|COMPLETED|Overall Study||131
11020265|NCT00797511|12198365|FG000|NOT COMPLETED|Overall Study||1
11020266|NCT00797563|12198370|FG000|STARTED|Overall Study|number of subjects|102
11020267|NCT00797563|12198370|FG000|COMPLETED|Overall Study||101
11020268|NCT00797563|12198370|FG000|NOT COMPLETED|Overall Study||1
11020269|NCT00797667|12198377|FG000|STARTED|Overall Study||265
11020270|NCT00797667|12198378|FG001|STARTED|Overall Study||264
11020271|NCT00797667|12198379|FG002|STARTED|Overall Study||131
11020272|NCT00797667|12198377|FG000|Treated|Overall Study||263
11020273|NCT00797667|12198378|FG001|Treated|Overall Study||263
11020274|NCT00797667|12198379|FG002|Treated|Overall Study||130
11020275|NCT00797667|12198377|FG000|COMPLETED|Overall Study||5
11020276|NCT00797667|12198378|FG001|COMPLETED|Overall Study||5
11020277|NCT00797667|12198379|FG002|COMPLETED|Overall Study||4
11020278|NCT00797667|12198377|FG000|NOT COMPLETED|Overall Study||260
11020279|NCT00797667|12198378|FG001|NOT COMPLETED|Overall Study||259
11020280|NCT00797667|12198379|FG002|NOT COMPLETED|Overall Study||127
11020281|NCT00797732|12198389|FG000|STARTED|Overall Study||21
11020282|NCT00797732|12198390|FG001|STARTED|Overall Study||21
11020283|NCT00797732|12198391|FG002|STARTED|Overall Study||154
11020284|NCT00797732|12198389|FG000|Evaluable at Baseline|Overall Study||18
11020285|NCT00797732|12198390|FG001|Evaluable at Baseline|Overall Study||18
11020286|NCT00797732|12198391|FG002|Evaluable at Baseline|Overall Study||0
11020287|NCT00797732|12198389|FG000|Evaluable at 20 Weeks|Overall Study||17
11020288|NCT00797732|12198390|FG001|Evaluable at 20 Weeks|Overall Study||18
11020289|NCT00797732|12198391|FG002|Evaluable at 20 Weeks|Overall Study||0
11020290|NCT00797732|12198389|FG000|Evaluable at 12 Months|Overall Study||17
11020291|NCT00797732|12198390|FG001|Evaluable at 12 Months|Overall Study||18
11020292|NCT00797732|12198391|FG002|Evaluable at 12 Months|Overall Study||0
11020293|NCT00797732|12198389|FG000|COMPLETED|Overall Study||16
11020294|NCT00797732|12198390|FG001|COMPLETED|Overall Study||18
11020295|NCT00797732|12198391|FG002|COMPLETED|Overall Study||0
11020296|NCT00797732|12198389|FG000|NOT COMPLETED|Overall Study||5
11020297|NCT00797732|12198390|FG001|NOT COMPLETED|Overall Study||3
11020298|NCT00797732|12198391|FG002|NOT COMPLETED|Overall Study||154
11020299|NCT00797797|12198399|FG000|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
11020300|NCT00797797|12198400|FG001|STARTED|Overall Study||184
11396757|NCT03889158|12590697|FG001|COMPLETED|Overall Study||9
11396758|NCT03889158|12590696|FG000|NOT COMPLETED|Overall Study||4
11020301|NCT00797797|12198399|FG000|COMPLETED|Overall Study||123
11020302|NCT00797797|12198400|FG001|COMPLETED|Overall Study||141
11020303|NCT00797797|12198399|FG000|NOT COMPLETED|Overall Study||55
11020304|NCT00797797|12198400|FG001|NOT COMPLETED|Overall Study||43
11020305|NCT00797823|12198409|FG000|STARTED|Pilot Studies|Not involved in pilot studies|0
11020306|NCT00797823|12198410|FG001|STARTED|Pilot Studies|Not involved in pilot studies|0
11020307|NCT00797823|12198411|FG002|STARTED|Pilot Studies||6
11020308|NCT00797823|12198409|FG000|COMPLETED|Pilot Studies||0
11020309|NCT00797823|12198410|FG001|COMPLETED|Pilot Studies||0
11020310|NCT00797823|12198411|FG002|COMPLETED|Pilot Studies||6
11020311|NCT00797823|12198409|FG000|NOT COMPLETED|Pilot Studies||0
11020312|NCT00797823|12198410|FG001|NOT COMPLETED|Pilot Studies||0
11020313|NCT00797823|12198411|FG002|NOT COMPLETED|Pilot Studies||0
11020314|NCT00797823|12198409|FG000|STARTED|First Period (Initial Randomization)||4
11020315|NCT00797823|12198410|FG001|STARTED|First Period (Initial Randomization)||4
11020316|NCT00797823|12198411|FG002|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
11020317|NCT00797823|12198409|FG000|COMPLETED|First Period (Initial Randomization)||3
11020318|NCT00797823|12198410|FG001|COMPLETED|First Period (Initial Randomization)||4
11020319|NCT00797823|12198411|FG002|COMPLETED|First Period (Initial Randomization)||0
11020320|NCT00797823|12198409|FG000|NOT COMPLETED|First Period (Initial Randomization)||1
11020321|NCT00797823|12198410|FG001|NOT COMPLETED|First Period (Initial Randomization)||0
11020322|NCT00797823|12198411|FG002|NOT COMPLETED|First Period (Initial Randomization)||0
11020323|NCT00797823|12198409|FG000|STARTED|Second Period (Crossover)||3
11020324|NCT00797823|12198410|FG001|STARTED|Second Period (Crossover)||4
11020325|NCT00797823|12198411|FG002|STARTED|Second Period (Crossover)||0
11020326|NCT00797823|12198409|FG000|COMPLETED|Second Period (Crossover)||3
11020327|NCT00797823|12198410|FG001|COMPLETED|Second Period (Crossover)||4
11396759|NCT03889158|12590697|FG001|NOT COMPLETED|Overall Study||6
11020328|NCT00797823|12198411|FG002|COMPLETED|Second Period (Crossover)||0
11020329|NCT00797823|12198409|FG000|NOT COMPLETED|Second Period (Crossover)||0
11020330|NCT00797823|12198410|FG001|NOT COMPLETED|Second Period (Crossover)||0
11020331|NCT00797823|12198411|FG002|NOT COMPLETED|Second Period (Crossover)||0
11020332|NCT00797862|12198421|FG000|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
11020333|NCT00797862|12198422|FG001|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
11020334|NCT00797862|12198423|FG002|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
11020335|NCT00797862|12198421|FG000|Entered Double-Blind Treatment (FAS)|Overall Study||617
11020336|NCT00797862|12198422|FG001|Entered Double-Blind Treatment (FAS)|Overall Study||315
11020337|NCT00797862|12198423|FG002|Entered Double-Blind Treatment (FAS)|Overall Study||315
11020338|NCT00797862|12198421|FG000|COMPLETED|Overall Study||496
11020339|NCT00797862|12198422|FG001|COMPLETED|Overall Study||250
11020340|NCT00797862|12198423|FG002|COMPLETED|Overall Study||230
11020341|NCT00797862|12198421|FG000|NOT COMPLETED|Overall Study||124
11020342|NCT00797862|12198422|FG001|NOT COMPLETED|Overall Study||68
11020343|NCT00797862|12198423|FG002|NOT COMPLETED|Overall Study||86
11020344|NCT00797966|12198435|FG000|STARTED|Phase A||0
11020345|NCT00797966|12198436|FG001|STARTED|Phase A||0
11020346|NCT00797966|12198437|FG002|STARTED|Phase A||0
11020347|NCT00797966|12198438|FG003|STARTED|Phase A||0
11020348|NCT00797966|12198439|FG004|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
11020349|NCT00797966|12198440|FG005|STARTED|Phase A||0
11020350|NCT00797966|12198435|FG000|COMPLETED|Phase A||0
11020351|NCT00797966|12198436|FG001|COMPLETED|Phase A||0
11020352|NCT00797966|12198437|FG002|COMPLETED|Phase A||0
11020353|NCT00797966|12198438|FG003|COMPLETED|Phase A||0
11020354|NCT00797966|12198439|FG004|COMPLETED|Phase A||664
11020355|NCT00797966|12198440|FG005|COMPLETED|Phase A||0
11020356|NCT00797966|12198435|FG000|NOT COMPLETED|Phase A||0
11020357|NCT00797966|12198436|FG001|NOT COMPLETED|Phase A||0
11020358|NCT00797966|12198437|FG002|NOT COMPLETED|Phase A||0
11020359|NCT00797966|12198438|FG003|NOT COMPLETED|Phase A||0
11020360|NCT00797966|12198439|FG004|NOT COMPLETED|Phase A||185
11020361|NCT00797966|12198440|FG005|NOT COMPLETED|Phase A||0
11020362|NCT00797966|12198435|FG000|STARTED|Phase B|Randomized participants.|62
11020363|NCT00797966|12198436|FG001|STARTED|Phase B|Randomized participants.|120
11020364|NCT00797966|12198437|FG002|STARTED|Phase B|Randomized participants.|121
11020365|NCT00797966|12198438|FG003|STARTED|Phase B|Randomized participants.|126
11020366|NCT00797966|12198439|FG004|STARTED|Phase B||0
11020367|NCT00797966|12198440|FG005|STARTED|Phase B||0
11020368|NCT00797966|12198435|FG000|COMPLETED|Phase B||51
11020369|NCT00797966|12198436|FG001|COMPLETED|Phase B||102
11020370|NCT00797966|12198437|FG002|COMPLETED|Phase B||100
11020371|NCT00797966|12198438|FG003|COMPLETED|Phase B||110
11020372|NCT00797966|12198439|FG004|COMPLETED|Phase B||0
11020373|NCT00797966|12198440|FG005|COMPLETED|Phase B||0
11020374|NCT00797966|12198435|FG000|NOT COMPLETED|Phase B||11
11020375|NCT00797966|12198436|FG001|NOT COMPLETED|Phase B||18
11020376|NCT00797966|12198437|FG002|NOT COMPLETED|Phase B||21
11020377|NCT00797966|12198438|FG003|NOT COMPLETED|Phase B||16
11020378|NCT00797966|12198439|FG004|NOT COMPLETED|Phase B||0
11020379|NCT00797966|12198440|FG005|NOT COMPLETED|Phase B||0
11020380|NCT00797966|12198435|FG000|STARTED|Phase A+||0
11020381|NCT00797966|12198436|FG001|STARTED|Phase A+||0
11020382|NCT00797966|12198437|FG002|STARTED|Phase A+||0
11020383|NCT00797966|12198438|FG003|STARTED|Phase A+||0
11020384|NCT00797966|12198439|FG004|STARTED|Phase A+||0
11020385|NCT00797966|12198440|FG005|STARTED|Phase A+||235
11020386|NCT00797966|12198435|FG000|COMPLETED|Phase A+||0
11020387|NCT00797966|12198436|FG001|COMPLETED|Phase A+||0
11020388|NCT00797966|12198437|FG002|COMPLETED|Phase A+||0
11020389|NCT00797966|12198438|FG003|COMPLETED|Phase A+||0
11020390|NCT00797966|12198439|FG004|COMPLETED|Phase A+||0
11020391|NCT00797966|12198440|FG005|COMPLETED|Phase A+||207
11020392|NCT00797966|12198435|FG000|NOT COMPLETED|Phase A+||0
11020393|NCT00797966|12198436|FG001|NOT COMPLETED|Phase A+||0
11020394|NCT00797966|12198437|FG002|NOT COMPLETED|Phase A+||0
11020395|NCT00797966|12198438|FG003|NOT COMPLETED|Phase A+||0
11020396|NCT00797966|12198439|FG004|NOT COMPLETED|Phase A+||0
11020397|NCT00797966|12198440|FG005|NOT COMPLETED|Phase A+||28
11020398|NCT00798018|12198456|FG000|STARTED|Overall Study||25
11020399|NCT00798018|12198457|FG001|STARTED|Overall Study||25
11020400|NCT00798018|12198458|FG002|STARTED|Overall Study||25
11020401|NCT00798018|12198459|FG003|STARTED|Overall Study||25
11020402|NCT00798018|12198456|FG000|COMPLETED|Overall Study||25
11020403|NCT00798018|12198457|FG001|COMPLETED|Overall Study||25
11020404|NCT00798018|12198458|FG002|COMPLETED|Overall Study||25
11020405|NCT00798018|12198459|FG003|COMPLETED|Overall Study||25
11020406|NCT00798018|12198456|FG000|NOT COMPLETED|Overall Study||0
11020407|NCT00798018|12198457|FG001|NOT COMPLETED|Overall Study||0
11020408|NCT00798018|12198458|FG002|NOT COMPLETED|Overall Study||0
11020409|NCT00798018|12198459|FG003|NOT COMPLETED|Overall Study||0
11020410|NCT00798096|12198469|FG000|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
11020411|NCT00798096|12198469|FG000|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
11020412|NCT00798096|12198469|FG000|NOT COMPLETED|Overall Study||2
11020413|NCT00798135|12198473|FG000|STARTED|Overall Study||13
11020414|NCT00798135|12198473|FG000|COMPLETED|Overall Study||0
11020415|NCT00798135|12198473|FG000|NOT COMPLETED|Overall Study||13
11020416|NCT00798161|12198484|FG000|STARTED|Overall Study||72
11020417|NCT00798161|12198485|FG001|STARTED|Overall Study||144
11020418|NCT00798161|12198486|FG002|STARTED|Overall Study||147
11020419|NCT00798161|12198487|FG003|STARTED|Overall Study||142
11020420|NCT00798161|12198488|FG004|STARTED|Overall Study||143
11020421|NCT00798161|12198489|FG005|STARTED|Overall Study||143
11020422|NCT00798161|12198490|FG006|STARTED|Overall Study||66
11020423|NCT00798161|12198484|FG000|COMPLETED|Overall Study||54
11020424|NCT00798161|12198485|FG001|COMPLETED|Overall Study||127
11020425|NCT00798161|12198486|FG002|COMPLETED|Overall Study||126
11020426|NCT00798161|12198487|FG003|COMPLETED|Overall Study||121
11020427|NCT00798161|12198488|FG004|COMPLETED|Overall Study||127
11020428|NCT00798161|12198489|FG005|COMPLETED|Overall Study||132
11020429|NCT00798161|12198490|FG006|COMPLETED|Overall Study||56
11020430|NCT00798161|12198484|FG000|NOT COMPLETED|Overall Study||18
11020431|NCT00798161|12198485|FG001|NOT COMPLETED|Overall Study||17
11020432|NCT00798161|12198486|FG002|NOT COMPLETED|Overall Study||21
11020433|NCT00798161|12198487|FG003|NOT COMPLETED|Overall Study||21
11020434|NCT00798161|12198488|FG004|NOT COMPLETED|Overall Study||16
11020435|NCT00798161|12198489|FG005|NOT COMPLETED|Overall Study||11
11020436|NCT00798161|12198490|FG006|NOT COMPLETED|Overall Study||10
11020437|NCT00798174|12198506|FG000|STARTED|Overall Study||16
11020438|NCT00798174|12198507|FG001|STARTED|Overall Study||16
11020439|NCT00798174|12198506|FG000|COMPLETED|Overall Study||12
11020440|NCT00798174|12198507|FG001|COMPLETED|Overall Study||13
11020441|NCT00798174|12198506|FG000|NOT COMPLETED|Overall Study||4
11020442|NCT00798174|12198507|FG001|NOT COMPLETED|Overall Study||3
11020443|NCT00798304|12198514|FG000|STARTED|Overall Study||14
11020444|NCT00798304|12198515|FG001|STARTED|Overall Study||22
11020445|NCT00798304|12198516|FG002|STARTED|Overall Study||10
11020446|NCT00798304|12198514|FG000|COMPLETED|Overall Study||0
11020447|NCT00798304|12198515|FG001|COMPLETED|Overall Study||0
11020448|NCT00798304|12198516|FG002|COMPLETED|Overall Study||0
11020449|NCT00798304|12198514|FG000|NOT COMPLETED|Overall Study||14
11396760|NCT03890419|12590707|FG000|STARTED|Overall Study||34
11396761|NCT03890419|12590708|FG001|STARTED|Overall Study||30
11396762|NCT03890419|12590709|FG002|STARTED|Overall Study||30
11396763|NCT03890419|12590707|FG000|COMPLETED|Overall Study||27
11396764|NCT03890419|12590708|FG001|COMPLETED|Overall Study||27
11020450|NCT00798304|12198515|FG001|NOT COMPLETED|Overall Study||22
11020451|NCT00798304|12198516|FG002|NOT COMPLETED|Overall Study||10
11020452|NCT00798317|12198526|FG000|STARTED|Overall Study||245
11020453|NCT00798317|12198527|FG001|STARTED|Overall Study||81
11020454|NCT00798317|12198526|FG000|COMPLETED|Overall Study||235
11020455|NCT00798317|12198527|FG001|COMPLETED|Overall Study||74
11020456|NCT00798317|12198526|FG000|NOT COMPLETED|Overall Study||10
11020457|NCT00798317|12198527|FG001|NOT COMPLETED|Overall Study||7
11020458|NCT00798369|12198539|FG000|STARTED|Overall Study||28
11020459|NCT00798369|12198540|FG001|STARTED|Overall Study||29
11020460|NCT00798369|12198541|FG002|STARTED|Overall Study||29
11020461|NCT00798369|12198542|FG003|STARTED|Overall Study||29
11020462|NCT00798369|12198543|FG004|STARTED|Overall Study||28
11020463|NCT00798369|12198544|FG005|STARTED|Overall Study||57
11020464|NCT00798369|12198539|FG000|COMPLETED|Overall Study||27
11020465|NCT00798369|12198540|FG001|COMPLETED|Overall Study||28
11020466|NCT00798369|12198541|FG002|COMPLETED|Overall Study||27
11020467|NCT00798369|12198542|FG003|COMPLETED|Overall Study||28
11020468|NCT00798369|12198543|FG004|COMPLETED|Overall Study||27
11020469|NCT00798369|12198544|FG005|COMPLETED|Overall Study||54
11396765|NCT03890419|12590709|FG002|COMPLETED|Overall Study||25
11020470|NCT00798369|12198539|FG000|NOT COMPLETED|Overall Study||1
11020471|NCT00798369|12198540|FG001|NOT COMPLETED|Overall Study||1
11020472|NCT00798369|12198541|FG002|NOT COMPLETED|Overall Study||2
11020473|NCT00798369|12198542|FG003|NOT COMPLETED|Overall Study||1
11020474|NCT00798369|12198543|FG004|NOT COMPLETED|Overall Study||1
11020475|NCT00798369|12198544|FG005|NOT COMPLETED|Overall Study||3
11020476|NCT00798434|12198561|FG000|STARTED|Double-Blind||396
11020477|NCT00798434|12198562|FG001|STARTED|Double-Blind||398
11020478|NCT00798434|12198561|FG000|Received Treatment|Double-Blind||393
11020479|NCT00798434|12198562|FG001|Received Treatment|Double-Blind||392
11020480|NCT00798434|12198561|FG000|COMPLETED|Double-Blind||341
11020481|NCT00798434|12198562|FG001|COMPLETED|Double-Blind||314
11020482|NCT00798434|12198561|FG000|NOT COMPLETED|Double-Blind||55
11020483|NCT00798434|12198562|FG001|NOT COMPLETED|Double-Blind||84
11020484|NCT00798434|12198561|FG000|STARTED|Open-Label||341
11020485|NCT00798434|12198562|FG001|STARTED|Open-Label||314
11020486|NCT00798434|12198561|FG000|Received Treatment|Open-Label||341
11020487|NCT00798434|12198562|FG001|Received Treatment|Open-Label||313
11020488|NCT00798434|12198561|FG000|COMPLETED|Open-Label||299
11020489|NCT00798434|12198562|FG001|COMPLETED|Open-Label||282
11020490|NCT00798434|12198561|FG000|NOT COMPLETED|Open-Label||42
11020491|NCT00798434|12198562|FG001|NOT COMPLETED|Open-Label||32
11020492|NCT00798486|12198573|FG000|STARTED|Overall Study||110
11020493|NCT00798486|12198573|FG000|COMPLETED|Overall Study||110
11020494|NCT00798486|12198573|FG000|NOT COMPLETED|Overall Study||0
11020495|NCT00798577|12198579|FG000|STARTED|Overall Study||17
11020496|NCT00798577|12198580|FG001|STARTED|Overall Study||7
11020497|NCT00798577|12198579|FG000|COMPLETED|Overall Study||17
11020498|NCT00798577|12198580|FG001|COMPLETED|Overall Study||7
11020499|NCT00798577|12198579|FG000|NOT COMPLETED|Overall Study||0
11020500|NCT00798577|12198580|FG001|NOT COMPLETED|Overall Study||0
11020501|NCT00798603|12198586|FG000|STARTED|Overall Study||62
11020502|NCT00798603|12198586|FG000|COMPLETED|Overall Study||27
11020503|NCT00798603|12198586|FG000|NOT COMPLETED|Overall Study||35
11020504|NCT00798655|12198590|FG000|STARTED|Overall Study||46
11020505|NCT00798655|12198590|FG000|COMPLETED|Overall Study||44
11020506|NCT00798655|12198590|FG000|NOT COMPLETED|Overall Study||2
11056883|NCT00996372|12238520|FG000|NOT COMPLETED|Overall Study||103
11396766|NCT03890419|12590707|FG000|NOT COMPLETED|Overall Study||7
11396767|NCT03890419|12590708|FG001|NOT COMPLETED|Overall Study||3
11396768|NCT03890419|12590709|FG002|NOT COMPLETED|Overall Study||5
11056884|NCT00996372|12238521|FG001|NOT COMPLETED|Overall Study||84
11056885|NCT00996437|12238531|FG000|STARTED|Overall Study||125
11056886|NCT00996437|12238532|FG001|STARTED|Overall Study||136
11056887|NCT00996437|12238531|FG000|COMPLETED|Overall Study||120
11056888|NCT00996437|12238532|FG001|COMPLETED|Overall Study||129
11056889|NCT00996437|12238531|FG000|NOT COMPLETED|Overall Study||5
11056890|NCT00996437|12238532|FG001|NOT COMPLETED|Overall Study||7
11056891|NCT00996476|12238543|FG000|STARTED|Overall Study||27
11056892|NCT00996476|12238544|FG001|STARTED|Overall Study||26
11056893|NCT00996476|12238545|FG002|STARTED|Overall Study||13
11056894|NCT00996476|12238546|FG003|STARTED|Overall Study||13
11056895|NCT00996476|12238547|FG004|STARTED|Overall Study||13
11056896|NCT00996476|12238543|FG000|COMPLETED|Overall Study||26
11056897|NCT00996476|12238544|FG001|COMPLETED|Overall Study||23
11056898|NCT00996476|12238545|FG002|COMPLETED|Overall Study||12
11056899|NCT00996476|12238546|FG003|COMPLETED|Overall Study||13
11056900|NCT00996476|12238547|FG004|COMPLETED|Overall Study||11
11056901|NCT00996476|12238543|FG000|NOT COMPLETED|Overall Study||1
11396769|NCT03900416|12590719|FG000|STARTED|Baseline||72
11396770|NCT03900416|12590720|FG001|STARTED|Baseline||80
11056902|NCT00996476|12238544|FG001|NOT COMPLETED|Overall Study||3
11056903|NCT00996476|12238545|FG002|NOT COMPLETED|Overall Study||1
11056904|NCT00996476|12238546|FG003|NOT COMPLETED|Overall Study||0
11056905|NCT00996476|12238547|FG004|NOT COMPLETED|Overall Study||2
11056906|NCT00996489|12238564|FG000|STARTED|Overall Study||459
11056907|NCT00996489|12238564|FG000|COMPLETED|Overall Study||298
11056908|NCT00996489|12238564|FG000|NOT COMPLETED|Overall Study||161
11056909|NCT00996580|12238568|FG000|STARTED|Overall Study||3597
11056910|NCT00996580|12238568|FG000|Pregnancy Intent-to-Treat Population|Overall Study||3019
11056911|NCT00996580|12238568|FG000|COMPLETED|Overall Study||2144
11056912|NCT00996580|12238568|FG000|NOT COMPLETED|Overall Study||1453
11056913|NCT00996593|12238575|FG000|STARTED|Dosimetric and Therapeutic Treatment||43
11056914|NCT00996593|12238575|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
11056915|NCT00996593|12238575|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
11056916|NCT00996593|12238575|FG000|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
11056917|NCT00996593|12238575|FG000|COMPLETED|Long-Term Follow-Up||6
11056918|NCT00996593|12238575|FG000|NOT COMPLETED|Long-Term Follow-Up||3
11056919|NCT00996606|12238579|FG000|STARTED|Overall Study||58
11056920|NCT00996606|12238579|FG000|COMPLETED|Overall Study||50
11056921|NCT00996606|12238579|FG000|NOT COMPLETED|Overall Study||8
11056922|NCT00996632|12238585|FG000|STARTED|Overall Study||38
11056923|NCT00996632|12238586|FG001|STARTED|Overall Study||56
11056924|NCT00996632|12238585|FG000|COMPLETED|Overall Study||38
11056925|NCT00996632|12238586|FG001|COMPLETED|Overall Study||56
11056926|NCT00996632|12238585|FG000|NOT COMPLETED|Overall Study||0
11056927|NCT00996632|12238586|FG001|NOT COMPLETED|Overall Study||0
11056928|NCT00996658|12238594|FG000|STARTED|Overall Study||92
11056929|NCT00996658|12238595|FG001|STARTED|Overall Study||186
11056930|NCT00996658|12238594|FG000|COMPLETED|Overall Study||76
11020507|NCT00798694|12198596|FG000|STARTED|Overall Study||30
11020508|NCT00798694|12198597|FG001|STARTED|Overall Study||28
11020509|NCT00798694|12198596|FG000|COMPLETED|Overall Study||28
11020510|NCT00798694|12198597|FG001|COMPLETED|Overall Study||27
11020511|NCT00798694|12198596|FG000|NOT COMPLETED|Overall Study||2
11020512|NCT00798694|12198597|FG001|NOT COMPLETED|Overall Study||1
11020513|NCT00798707|12198612|FG000|STARTED|Overall Study||235
11020514|NCT00798707|12198613|FG001|STARTED|Overall Study||237
11020515|NCT00798707|12198614|FG002|STARTED|Overall Study||237
11020516|NCT00798707|12198612|FG000|Treated|Overall Study||231
11020517|NCT00798707|12198613|FG001|Treated|Overall Study||232
11020518|NCT00798707|12198614|FG002|Treated|Overall Study||236
11020519|NCT00798707|12198612|FG000|COMPLETED|Overall Study||209
11020520|NCT00798707|12198613|FG001|COMPLETED|Overall Study||204
11020521|NCT00798707|12198614|FG002|COMPLETED|Overall Study||215
11020522|NCT00798707|12198612|FG000|NOT COMPLETED|Overall Study||26
11020523|NCT00798707|12198613|FG001|NOT COMPLETED|Overall Study||33
11020524|NCT00798707|12198614|FG002|NOT COMPLETED|Overall Study||22
11020525|NCT00798720|12198622|FG000|STARTED|Overall Study||18
11020526|NCT00798720|12198622|FG000|COMPLETED|Overall Study||18
11020527|NCT00798720|12198622|FG000|NOT COMPLETED|Overall Study||0
11020528|NCT00798759|12198628|FG000|STARTED|Overall Study||117
11020529|NCT00798759|12198629|FG001|STARTED|Overall Study||119
11020530|NCT00798759|12198628|FG000|COMPLETED|Overall Study||109
11020531|NCT00798759|12198629|FG001|COMPLETED|Overall Study||106
11020532|NCT00798759|12198628|FG000|NOT COMPLETED|Overall Study||8
11020533|NCT00798759|12198629|FG001|NOT COMPLETED|Overall Study||13
11020534|NCT00798889|12198635|FG000|STARTED|Overall Study||314
11020535|NCT00798889|12198635|FG000|Treated|Overall Study||311
11020536|NCT00798889|12198635|FG000|COMPLETED|Overall Study||0
11020537|NCT00798889|12198635|FG000|NOT COMPLETED|Overall Study||314
11020538|NCT00798967|12198641|FG000|STARTED|Overall Study||43
11020539|NCT00798967|12198642|FG001|STARTED|Overall Study||43
11020540|NCT00798967|12198641|FG000|Discontinued During Dosing Period|Overall Study||4
11020541|NCT00798967|12198642|FG001|Discontinued During Dosing Period|Overall Study||4
11020542|NCT00798967|12198641|FG000|COMPLETED|Overall Study||39
11020543|NCT00798967|12198642|FG001|COMPLETED|Overall Study||39
11020544|NCT00798967|12198641|FG000|NOT COMPLETED|Overall Study||4
11020545|NCT00798967|12198642|FG001|NOT COMPLETED|Overall Study||4
11020546|NCT00799227|12198649|FG000|STARTED|Overall Study||56
11020547|NCT00799227|12198649|FG000|COMPLETED|Overall Study||53
11020548|NCT00799227|12198649|FG000|NOT COMPLETED|Overall Study||3
11020549|NCT00799383|12198655|FG000|STARTED|Overall Study||23
11020550|NCT00799383|12198656|FG001|STARTED|Overall Study||24
11020551|NCT00799383|12198655|FG000|COMPLETED|Overall Study||20
11020552|NCT00799383|12198656|FG001|COMPLETED|Overall Study||18
11020553|NCT00799383|12198655|FG000|NOT COMPLETED|Overall Study||3
11020554|NCT00799383|12198656|FG001|NOT COMPLETED|Overall Study||6
11396771|NCT03900416|12590719|FG000|COMPLETED|Baseline||72
11020555|NCT00799409|12198665|FG000|STARTED|Overall Study||7
11020556|NCT00799409|12198666|FG001|STARTED|Overall Study||36
11020557|NCT00799409|12198667|FG002|STARTED|Overall Study||35
11020558|NCT00799409|12198665|FG000|COMPLETED|Overall Study||0
11020559|NCT00799409|12198666|FG001|COMPLETED|Overall Study||36
11020560|NCT00799409|12198667|FG002|COMPLETED|Overall Study||35
11020561|NCT00799409|12198665|FG000|NOT COMPLETED|Overall Study||7
11020562|NCT00799409|12198666|FG001|NOT COMPLETED|Overall Study||0
11020563|NCT00799409|12198667|FG002|NOT COMPLETED|Overall Study||0
11020564|NCT00799422|12198675|FG000|STARTED|First Week of Wear||4
11020565|NCT00799422|12198676|FG001|STARTED|First Week of Wear||4
11020566|NCT00799422|12198677|FG002|STARTED|First Week of Wear||4
11020567|NCT00799422|12198678|FG003|STARTED|First Week of Wear||5
11020568|NCT00799422|12198679|FG004|STARTED|First Week of Wear||4
11020569|NCT00799422|12198680|FG005|STARTED|First Week of Wear||5
11020570|NCT00799422|12198675|FG000|COMPLETED|First Week of Wear||4
11020571|NCT00799422|12198676|FG001|COMPLETED|First Week of Wear||4
11020572|NCT00799422|12198677|FG002|COMPLETED|First Week of Wear||3
11020573|NCT00799422|12198678|FG003|COMPLETED|First Week of Wear||4
11020574|NCT00799422|12198679|FG004|COMPLETED|First Week of Wear||4
11020575|NCT00799422|12198680|FG005|COMPLETED|First Week of Wear||5
11020576|NCT00799422|12198675|FG000|NOT COMPLETED|First Week of Wear||0
11020577|NCT00799422|12198676|FG001|NOT COMPLETED|First Week of Wear||0
11020578|NCT00799422|12198677|FG002|NOT COMPLETED|First Week of Wear||1
11020579|NCT00799422|12198678|FG003|NOT COMPLETED|First Week of Wear||1
11020580|NCT00799422|12198679|FG004|NOT COMPLETED|First Week of Wear||0
11020581|NCT00799422|12198680|FG005|NOT COMPLETED|First Week of Wear||0
11020582|NCT00799422|12198675|FG000|STARTED|Second Week of Wear||4
11020583|NCT00799422|12198676|FG001|STARTED|Second Week of Wear||4
11020584|NCT00799422|12198677|FG002|STARTED|Second Week of Wear||3
11020585|NCT00799422|12198678|FG003|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
11020586|NCT00799422|12198679|FG004|STARTED|Second Week of Wear||4
11020587|NCT00799422|12198680|FG005|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
11020588|NCT00799422|12198675|FG000|COMPLETED|Second Week of Wear||4
11020589|NCT00799422|12198676|FG001|COMPLETED|Second Week of Wear||4
11020590|NCT00799422|12198677|FG002|COMPLETED|Second Week of Wear||3
11020591|NCT00799422|12198678|FG003|COMPLETED|Second Week of Wear||3
11020592|NCT00799422|12198679|FG004|COMPLETED|Second Week of Wear||4
11020593|NCT00799422|12198680|FG005|COMPLETED|Second Week of Wear||4
11020594|NCT00799422|12198675|FG000|NOT COMPLETED|Second Week of Wear||0
11020595|NCT00799422|12198676|FG001|NOT COMPLETED|Second Week of Wear||0
11020596|NCT00799422|12198677|FG002|NOT COMPLETED|Second Week of Wear||0
11020597|NCT00799422|12198678|FG003|NOT COMPLETED|Second Week of Wear||0
11020598|NCT00799422|12198679|FG004|NOT COMPLETED|Second Week of Wear||0
11020599|NCT00799422|12198680|FG005|NOT COMPLETED|Second Week of Wear||0
11020600|NCT00799422|12198675|FG000|STARTED|Third Week of Wear||4
11020601|NCT00799422|12198676|FG001|STARTED|Third Week of Wear||4
11020602|NCT00799422|12198677|FG002|STARTED|Third Week of Wear||3
11020603|NCT00799422|12198678|FG003|STARTED|Third Week of Wear||3
11020604|NCT00799422|12198679|FG004|STARTED|Third Week of Wear||4
11020605|NCT00799422|12198680|FG005|STARTED|Third Week of Wear||4
11020606|NCT00799422|12198675|FG000|COMPLETED|Third Week of Wear||4
11020607|NCT00799422|12198676|FG001|COMPLETED|Third Week of Wear||4
11020608|NCT00799422|12198677|FG002|COMPLETED|Third Week of Wear||3
11020609|NCT00799422|12198678|FG003|COMPLETED|Third Week of Wear||3
11020610|NCT00799422|12198679|FG004|COMPLETED|Third Week of Wear||4
11020611|NCT00799422|12198680|FG005|COMPLETED|Third Week of Wear||4
11020612|NCT00799422|12198675|FG000|NOT COMPLETED|Third Week of Wear||0
11020613|NCT00799422|12198676|FG001|NOT COMPLETED|Third Week of Wear||0
11020614|NCT00799422|12198677|FG002|NOT COMPLETED|Third Week of Wear||0
11020615|NCT00799422|12198678|FG003|NOT COMPLETED|Third Week of Wear||0
11020616|NCT00799422|12198679|FG004|NOT COMPLETED|Third Week of Wear||0
11020617|NCT00799422|12198680|FG005|NOT COMPLETED|Third Week of Wear||0
11020618|NCT00799435|12198690|FG000|STARTED|Overall Study||1
11020619|NCT00799435|12198691|FG001|STARTED|Overall Study||1
11020620|NCT00799435|12198690|FG000|COMPLETED|Overall Study||1
11020621|NCT00799435|12198691|FG001|COMPLETED|Overall Study||1
11020622|NCT00799435|12198690|FG000|NOT COMPLETED|Overall Study||0
11020623|NCT00799435|12198691|FG001|NOT COMPLETED|Overall Study||0
11020624|NCT00799474|12198697|FG000|STARTED|Overall Study||609
11020625|NCT00799474|12198697|FG000|COMPLETED|Overall Study||609
11020626|NCT00799474|12198697|FG000|NOT COMPLETED|Overall Study||0
11020627|NCT00799487|12198704|FG000|STARTED|Dose Adjustment Period||21
11020628|NCT00799487|12198705|FG001|STARTED|Dose Adjustment Period||34
11020629|NCT00799487|12198706|FG002|STARTED|Dose Adjustment Period||34
11020630|NCT00799487|12198704|FG000|COMPLETED|Dose Adjustment Period||0
11020631|NCT00799487|12198705|FG001|COMPLETED|Dose Adjustment Period||34
11020632|NCT00799487|12198706|FG002|COMPLETED|Dose Adjustment Period||34
11020633|NCT00799487|12198704|FG000|NOT COMPLETED|Dose Adjustment Period||21
11020634|NCT00799487|12198705|FG001|NOT COMPLETED|Dose Adjustment Period||0
11020635|NCT00799487|12198706|FG002|NOT COMPLETED|Dose Adjustment Period||0
11020636|NCT00799487|12198704|FG000|STARTED|Double-Blind Assessment Period||0
11020637|NCT00799487|12198705|FG001|STARTED|Double-Blind Assessment Period||34
11020638|NCT00799487|12198706|FG002|STARTED|Double-Blind Assessment Period||34
11020639|NCT00799487|12198704|FG000|COMPLETED|Double-Blind Assessment Period||0
11020640|NCT00799487|12198705|FG001|COMPLETED|Double-Blind Assessment Period||33
11020641|NCT00799487|12198706|FG002|COMPLETED|Double-Blind Assessment Period||32
11020642|NCT00799487|12198704|FG000|NOT COMPLETED|Double-Blind Assessment Period||0
11020643|NCT00799487|12198705|FG001|NOT COMPLETED|Double-Blind Assessment Period||1
11020644|NCT00799487|12198706|FG002|NOT COMPLETED|Double-Blind Assessment Period||2
11020645|NCT00799578|12198717|FG000|STARTED|Overall Study||13
11020646|NCT00799578|12198717|FG000|COMPLETED|Overall Study||11
11020647|NCT00799578|12198717|FG000|NOT COMPLETED|Overall Study||2
11020648|NCT00799591|12198721|FG000|STARTED|Overall Study||156
11020649|NCT00799591|12198721|FG000|COMPLETED|Overall Study||90
11020650|NCT00799591|12198721|FG000|NOT COMPLETED|Overall Study||66
11020651|NCT00799604|12198728|FG000|STARTED|Bolus 1 (Pre-anesthesia)||10
11020652|NCT00799604|12198729|FG001|STARTED|Bolus 1 (Pre-anesthesia)||10
11020653|NCT00799604|12198730|FG002|STARTED|Bolus 1 (Pre-anesthesia)||10
11020654|NCT00799604|12198728|FG000|COMPLETED|Bolus 1 (Pre-anesthesia)||10
11020655|NCT00799604|12198729|FG001|COMPLETED|Bolus 1 (Pre-anesthesia)||10
11020656|NCT00799604|12198730|FG002|COMPLETED|Bolus 1 (Pre-anesthesia)||10
11020657|NCT00799604|12198728|FG000|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
11020658|NCT00799604|12198729|FG001|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
11020659|NCT00799604|12198730|FG002|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
11020660|NCT00799604|12198728|FG000|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
11020661|NCT00799604|12198729|FG001|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
11020662|NCT00799604|12198730|FG002|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
11020663|NCT00799604|12198728|FG000|COMPLETED|Bolus 2 (With Anesthesia)||6
11020664|NCT00799604|12198729|FG001|COMPLETED|Bolus 2 (With Anesthesia)||12
11020665|NCT00799604|12198730|FG002|COMPLETED|Bolus 2 (With Anesthesia)||3
11020666|NCT00799604|12198728|FG000|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
11020667|NCT00799604|12198729|FG001|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
11020668|NCT00799604|12198730|FG002|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
11020669|NCT00799617|12198740|FG000|STARTED|Main Testosterone Trial||395
11020670|NCT00799617|12198741|FG001|STARTED|Main Testosterone Trial||395
11020671|NCT00799617|12198740|FG000|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
11020672|NCT00799617|12198741|FG001|COMPLETED|Main Testosterone Trial||374
11020673|NCT00799617|12198740|FG000|NOT COMPLETED|Main Testosterone Trial||19
11020674|NCT00799617|12198741|FG001|NOT COMPLETED|Main Testosterone Trial||21
11020675|NCT00799617|12198740|FG000|STARTED|Sexual Funtion Trial||234
11020676|NCT00799617|12198741|FG001|STARTED|Sexual Funtion Trial||236
11020677|NCT00799617|12198740|FG000|COMPLETED|Sexual Funtion Trial||218
11020678|NCT00799617|12198741|FG001|COMPLETED|Sexual Funtion Trial||215
11020679|NCT00799617|12198740|FG000|NOT COMPLETED|Sexual Funtion Trial||16
11020680|NCT00799617|12198741|FG001|NOT COMPLETED|Sexual Funtion Trial||21
11020681|NCT00799617|12198740|FG000|STARTED|Physical Function Trial||191
11020682|NCT00799617|12198741|FG001|STARTED|Physical Function Trial||196
11020683|NCT00799617|12198740|FG000|COMPLETED|Physical Function Trial||185
11020684|NCT00799617|12198741|FG001|COMPLETED|Physical Function Trial||185
11020685|NCT00799617|12198740|FG000|NOT COMPLETED|Physical Function Trial||6
11020686|NCT00799617|12198741|FG001|NOT COMPLETED|Physical Function Trial||11
11020687|NCT00799617|12198740|FG000|STARTED|Vitality Trial||236
11020688|NCT00799617|12198741|FG001|STARTED|Vitality Trial||238
11020689|NCT00799617|12198740|FG000|COMPLETED|Vitality Trial||229
11020690|NCT00799617|12198741|FG001|COMPLETED|Vitality Trial||216
11020691|NCT00799617|12198740|FG000|NOT COMPLETED|Vitality Trial||7
11020692|NCT00799617|12198741|FG001|NOT COMPLETED|Vitality Trial||22
11020693|NCT00799617|12198740|FG000|STARTED|Cardiovascular Trial||88
11020694|NCT00799617|12198741|FG001|STARTED|Cardiovascular Trial||82
11020695|NCT00799617|12198740|FG000|COMPLETED|Cardiovascular Trial||73
11020696|NCT00799617|12198741|FG001|COMPLETED|Cardiovascular Trial||65
11020697|NCT00799617|12198740|FG000|NOT COMPLETED|Cardiovascular Trial||15
11020698|NCT00799617|12198741|FG001|NOT COMPLETED|Cardiovascular Trial||17
11020699|NCT00799617|12198740|FG000|STARTED|Bone Trial||110
11020700|NCT00799617|12198741|FG001|STARTED|Bone Trial||101
11020701|NCT00799617|12198740|FG000|COMPLETED|Bone Trial||104
11020702|NCT00799617|12198741|FG001|COMPLETED|Bone Trial||85
11020703|NCT00799617|12198740|FG000|NOT COMPLETED|Bone Trial||6
11020704|NCT00799617|12198741|FG001|NOT COMPLETED|Bone Trial||16
11020705|NCT00799617|12198740|FG000|STARTED|Cognitive Function Trial||247
11020706|NCT00799617|12198741|FG001|STARTED|Cognitive Function Trial||246
11020707|NCT00799617|12198740|FG000|COMPLETED|Cognitive Function Trial||247
11020708|NCT00799617|12198741|FG001|COMPLETED|Cognitive Function Trial||245
11020709|NCT00799617|12198740|FG000|NOT COMPLETED|Cognitive Function Trial||0
11020710|NCT00799617|12198741|FG001|NOT COMPLETED|Cognitive Function Trial||1
11020711|NCT00799617|12198740|FG000|STARTED|Anemia Trial||27
11020712|NCT00799617|12198741|FG001|STARTED|Anemia Trial||35
11020713|NCT00799617|12198740|FG000|COMPLETED|Anemia Trial||24
11020714|NCT00799617|12198741|FG001|COMPLETED|Anemia Trial||32
11020715|NCT00799617|12198740|FG000|NOT COMPLETED|Anemia Trial||3
11020716|NCT00799617|12198741|FG001|NOT COMPLETED|Anemia Trial||3
11020717|NCT00799643|12198749|FG000|STARTED|Overall Study||140
11020718|NCT00799643|12198750|FG001|STARTED|Overall Study||146
11020719|NCT00799643|12198749|FG000|COMPLETED|Overall Study||115
11020720|NCT00799643|12198750|FG001|COMPLETED|Overall Study||119
11020721|NCT00799643|12198749|FG000|NOT COMPLETED|Overall Study||25
11020722|NCT00799643|12198750|FG001|NOT COMPLETED|Overall Study||27
11020723|NCT00799708|12198760|FG000|STARTED|Overall Study||10
11020724|NCT00799708|12198761|FG001|STARTED|Overall Study||6
11020725|NCT00799708|12198762|FG002|STARTED|Overall Study||11
11020726|NCT00799708|12198760|FG000|COMPLETED|Overall Study||9
11020727|NCT00799708|12198761|FG001|COMPLETED|Overall Study||6
11020728|NCT00799708|12198762|FG002|COMPLETED|Overall Study||11
11020729|NCT00799708|12198760|FG000|NOT COMPLETED|Overall Study||1
11020730|NCT00799708|12198761|FG001|NOT COMPLETED|Overall Study||0
11020731|NCT00799708|12198762|FG002|NOT COMPLETED|Overall Study||0
11020732|NCT00799812|12198772|FG000|STARTED|Overall Study||335
11020733|NCT00799812|12198772|FG000|CHG Swabstick (3 @ Once)|Overall Study||139
11020734|NCT00799812|12198772|FG000|CHG Swabstick Sequential|Overall Study||138
11020735|NCT00799812|12198772|FG000|Hibiclens|Overall Study||133
11020736|NCT00799812|12198772|FG000|Sterile Water Swab (3 @ Once)|Overall Study||132
11020737|NCT00799812|12198772|FG000|Sterile Water Swabstick (Sequential)|Overall Study||126
11020738|NCT00799812|12198772|FG000|COMPLETED|Overall Study||335
11020739|NCT00799812|12198772|FG000|NOT COMPLETED|Overall Study||0
11020740|NCT00799825|12198784|FG000|STARTED|Overall Study||344
11020741|NCT00799825|12198784|FG000|COMPLETED|Overall Study||296
11020742|NCT00799825|12198784|FG000|NOT COMPLETED|Overall Study||48
11020743|NCT00799903|12198790|FG000|STARTED|Overall Study||7904
11020744|NCT00799903|12198791|FG001|STARTED|Overall Study||7924
11020745|NCT00799903|12198790|FG000|COMPLETED|Overall Study||7631
11020746|NCT00799903|12198791|FG001|COMPLETED|Overall Study||7646
11020747|NCT00799903|12198790|FG000|NOT COMPLETED|Overall Study||273
11020748|NCT00799903|12198791|FG001|NOT COMPLETED|Overall Study||278
11020749|NCT00799981|12198797|FG000|STARTED|Overall Study||10
11020750|NCT00799981|12198798|FG001|STARTED|Overall Study||9
11020751|NCT00799981|12198799|FG002|STARTED|Overall Study||10
11020752|NCT00799981|12198800|FG003|STARTED|Overall Study||10
11020753|NCT00799981|12198801|FG004|STARTED|Overall Study||11
11020754|NCT00799981|12198802|FG005|STARTED|Overall Study||10
11020755|NCT00799981|12198797|FG000|COMPLETED|Overall Study||10
11020756|NCT00799981|12198798|FG001|COMPLETED|Overall Study||9
11020757|NCT00799981|12198799|FG002|COMPLETED|Overall Study||10
11020758|NCT00799981|12198800|FG003|COMPLETED|Overall Study||10
11020759|NCT00799981|12198801|FG004|COMPLETED|Overall Study||11
11020760|NCT00799981|12198802|FG005|COMPLETED|Overall Study||10
11020761|NCT00799981|12198797|FG000|NOT COMPLETED|Overall Study||0
11020762|NCT00799981|12198798|FG001|NOT COMPLETED|Overall Study||0
11020763|NCT00799981|12198799|FG002|NOT COMPLETED|Overall Study||0
11020764|NCT00799981|12198800|FG003|NOT COMPLETED|Overall Study||0
11020765|NCT00799981|12198801|FG004|NOT COMPLETED|Overall Study||0
11020766|NCT00799981|12198802|FG005|NOT COMPLETED|Overall Study||0
11020767|NCT00800176|12198817|FG000|STARTED|Overall Study||66
11020768|NCT00800176|12198818|FG001|STARTED|Overall Study||66
11020769|NCT00800176|12198819|FG002|STARTED|Overall Study||65
11020770|NCT00800176|12198820|FG003|STARTED|Overall Study||66
11020771|NCT00800176|12198821|FG004|STARTED|Overall Study||64
11020772|NCT00800176|12198822|FG005|STARTED|Overall Study||67
11020773|NCT00800176|12198817|FG000|COMPLETED|Overall Study||57
11020774|NCT00800176|12198818|FG001|COMPLETED|Overall Study||60
11020775|NCT00800176|12198819|FG002|COMPLETED|Overall Study||65
11020776|NCT00800176|12198820|FG003|COMPLETED|Overall Study||62
11020777|NCT00800176|12198821|FG004|COMPLETED|Overall Study||60
11020778|NCT00800176|12198822|FG005|COMPLETED|Overall Study||62
11020779|NCT00800176|12198817|FG000|NOT COMPLETED|Overall Study||9
11020780|NCT00800176|12198818|FG001|NOT COMPLETED|Overall Study||6
11020781|NCT00800176|12198819|FG002|NOT COMPLETED|Overall Study||0
11020782|NCT00800176|12198820|FG003|NOT COMPLETED|Overall Study||4
11020783|NCT00800176|12198821|FG004|NOT COMPLETED|Overall Study||4
11020784|NCT00800176|12198822|FG005|NOT COMPLETED|Overall Study||5
11020785|NCT00800202|12198838|FG000|STARTED|Overall Study||67
11020786|NCT00800202|12198839|FG001|STARTED|Overall Study||24
11020787|NCT00800202|12198838|FG000|COMPLETED|Overall Study||0
11020788|NCT00800202|12198839|FG001|COMPLETED|Overall Study||0
11020789|NCT00800202|12198838|FG000|NOT COMPLETED|Overall Study||67
11020790|NCT00800202|12198839|FG001|NOT COMPLETED|Overall Study||24
11020791|NCT00800254|12198847|FG000|STARTED|Overall Study||35
11020792|NCT00800254|12198848|FG001|STARTED|Overall Study||31
11020793|NCT00800254|12198847|FG000|3.5 Weeks Post-operatively|Overall Study||31
11020794|NCT00800254|12198848|FG001|3.5 Weeks Post-operatively|Overall Study||31
11020795|NCT00800254|12198847|FG000|COMPLETED|Overall Study||30
11020796|NCT00800254|12198848|FG001|COMPLETED|Overall Study||25
11020797|NCT00800254|12198847|FG000|NOT COMPLETED|Overall Study||5
11020798|NCT00800254|12198848|FG001|NOT COMPLETED|Overall Study||6
11020799|NCT00800345|12198854|FG000|STARTED|Overall Study||33
11020800|NCT00800345|12198854|FG000|COMPLETED|Overall Study||33
11020801|NCT00800345|12198854|FG000|NOT COMPLETED|Overall Study||0
11020802|NCT00800384|12198860|FG000|STARTED|Overall Study||1247
11020803|NCT00800384|12198861|FG001|STARTED|Overall Study||1253
11020804|NCT00800384|12198860|FG000|COMPLETED|Overall Study||1206
11020805|NCT00800384|12198861|FG001|COMPLETED|Overall Study||1210
11020806|NCT00800384|12198860|FG000|NOT COMPLETED|Overall Study||41
11020807|NCT00800384|12198861|FG001|NOT COMPLETED|Overall Study||43
11020808|NCT00800436|12198875|FG000|STARTED|Overall Study||6
11020809|NCT00800436|12198876|FG001|STARTED|Overall Study||6
11020810|NCT00800436|12198877|FG002|STARTED|Overall Study||6
11020811|NCT00800436|12198878|FG003|STARTED|Overall Study||6
11020812|NCT00800436|12198879|FG004|STARTED|Overall Study||6
11020813|NCT00800436|12198880|FG005|STARTED|Overall Study||20
11020814|NCT00800436|12198881|FG006|STARTED|Overall Study||20
11020815|NCT00800436|12198875|FG000|COMPLETED|Overall Study||6
11020816|NCT00800436|12198876|FG001|COMPLETED|Overall Study||6
11020817|NCT00800436|12198877|FG002|COMPLETED|Overall Study||5
11020818|NCT00800436|12198878|FG003|COMPLETED|Overall Study||5
11020819|NCT00800436|12198879|FG004|COMPLETED|Overall Study||6
11020820|NCT00800436|12198880|FG005|COMPLETED|Overall Study||20
11020821|NCT00800436|12198881|FG006|COMPLETED|Overall Study||20
11020822|NCT00800436|12198875|FG000|NOT COMPLETED|Overall Study||0
11020823|NCT00800436|12198876|FG001|NOT COMPLETED|Overall Study||0
11020824|NCT00800436|12198877|FG002|NOT COMPLETED|Overall Study||1
11020825|NCT00800436|12198878|FG003|NOT COMPLETED|Overall Study||1
11020826|NCT00800436|12198879|FG004|NOT COMPLETED|Overall Study||0
11020827|NCT00800436|12198880|FG005|NOT COMPLETED|Overall Study||0
11020828|NCT00800436|12198881|FG006|NOT COMPLETED|Overall Study||0
11020829|NCT00800540|12198897|FG000|STARTED|Period One: 6 Weeks||17
11020830|NCT00800540|12198898|FG001|STARTED|Period One: 6 Weeks||18
11020831|NCT00800540|12198897|FG000|COMPLETED|Period One: 6 Weeks||16
11020832|NCT00800540|12198898|FG001|COMPLETED|Period One: 6 Weeks||17
11020833|NCT00800540|12198897|FG000|NOT COMPLETED|Period One: 6 Weeks||1
11020834|NCT00800540|12198898|FG001|NOT COMPLETED|Period One: 6 Weeks||1
11020835|NCT00800540|12198897|FG000|STARTED|Washout: 4 Weeks||16
11020836|NCT00800540|12198898|FG001|STARTED|Washout: 4 Weeks||17
11020837|NCT00800540|12198897|FG000|COMPLETED|Washout: 4 Weeks||16
11020838|NCT00800540|12198898|FG001|COMPLETED|Washout: 4 Weeks||17
11020839|NCT00800540|12198897|FG000|NOT COMPLETED|Washout: 4 Weeks||0
11020840|NCT00800540|12198898|FG001|NOT COMPLETED|Washout: 4 Weeks||0
11020841|NCT00800540|12198897|FG000|STARTED|Period 2: 6 Weeks||16
11020842|NCT00800540|12198898|FG001|STARTED|Period 2: 6 Weeks||17
11020843|NCT00800540|12198897|FG000|COMPLETED|Period 2: 6 Weeks||16
11020844|NCT00800540|12198898|FG001|COMPLETED|Period 2: 6 Weeks||16
11020845|NCT00800540|12198897|FG000|NOT COMPLETED|Period 2: 6 Weeks||0
11020846|NCT00800540|12198898|FG001|NOT COMPLETED|Period 2: 6 Weeks||1
11020847|NCT00800683|12198906|FG000|STARTED|Overall Study|Number who started treatment|65
11020848|NCT00800683|12198907|FG001|STARTED|Overall Study|Number who started treatment|68
11020849|NCT00800683|12198906|FG000|COMPLETED|Overall Study|Number who completed treatment|48
11020850|NCT00800683|12198907|FG001|COMPLETED|Overall Study|Number who completed treatment|49
11020851|NCT00800683|12198906|FG000|NOT COMPLETED|Overall Study||17
11020852|NCT00800683|12198907|FG001|NOT COMPLETED|Overall Study||19
11020853|NCT00800735|12198913|FG000|STARTED|Overall Study||30
11020854|NCT00800735|12198913|FG000|COMPLETED|Overall Study||16
11020855|NCT00800735|12198913|FG000|NOT COMPLETED|Overall Study||14
11020856|NCT00800839|12198917|FG000|STARTED|Overall Study||56
11396772|NCT03900416|12590720|FG001|COMPLETED|Baseline||80
11396773|NCT03900416|12590719|FG000|NOT COMPLETED|Baseline||0
11020857|NCT00800839|12198917|FG000|COMPLETED|Overall Study||49
11020858|NCT00800839|12198917|FG000|NOT COMPLETED|Overall Study||7
11020859|NCT00800865|12198923|FG000|STARTED|Overall Study||15
11396774|NCT03900416|12590720|FG001|NOT COMPLETED|Baseline||0
11020860|NCT00800865|12198924|FG001|STARTED|Overall Study||16
11020861|NCT00800865|12198923|FG000|COMPLETED|Overall Study||15
11020862|NCT00800865|12198924|FG001|COMPLETED|Overall Study||16
11020863|NCT00800865|12198923|FG000|NOT COMPLETED|Overall Study||0
11020864|NCT00800865|12198924|FG001|NOT COMPLETED|Overall Study||0
11020865|NCT00800982|12198932|FG000|STARTED|Overall Study||15
11020866|NCT00800982|12198933|FG001|STARTED|Overall Study||15
11020867|NCT00800982|12198932|FG000|COMPLETED|Overall Study||13
11020868|NCT00800982|12198933|FG001|COMPLETED|Overall Study||12
11020869|NCT00800982|12198932|FG000|NOT COMPLETED|Overall Study||2
11020870|NCT00800982|12198933|FG001|NOT COMPLETED|Overall Study||3
11020871|NCT00801099|12198939|FG000|STARTED|Overall Study||276
11020872|NCT00801099|12198939|FG000|COMPLETED|Overall Study||175
11020873|NCT00801099|12198939|FG000|NOT COMPLETED|Overall Study||101
11020874|NCT00801138|12198947|FG000|STARTED|Overall Study||54
11020875|NCT00801138|12198948|FG001|STARTED|Overall Study||56
11020876|NCT00801138|12198949|FG002|STARTED|Overall Study||54
11020877|NCT00801138|12198950|FG003|STARTED|Overall Study||54
11020878|NCT00801138|12198947|FG000|COMPLETED|Overall Study||54
11020879|NCT00801138|12198948|FG001|COMPLETED|Overall Study||56
11020880|NCT00801138|12198949|FG002|COMPLETED|Overall Study||54
11020881|NCT00801138|12198950|FG003|COMPLETED|Overall Study||54
11020882|NCT00801138|12198947|FG000|NOT COMPLETED|Overall Study||0
11020883|NCT00801138|12198948|FG001|NOT COMPLETED|Overall Study||0
11020884|NCT00801138|12198949|FG002|NOT COMPLETED|Overall Study||0
11020885|NCT00801138|12198950|FG003|NOT COMPLETED|Overall Study||0
11020886|NCT00801229|12198962|FG000|STARTED|Signed Consent||38
11020887|NCT00801229|12198963|FG001|STARTED|Signed Consent||37
11020888|NCT00801229|12198962|FG000|COMPLETED|Signed Consent||35
11020889|NCT00801229|12198963|FG001|COMPLETED|Signed Consent||34
11020890|NCT00801229|12198962|FG000|NOT COMPLETED|Signed Consent||3
11020891|NCT00801229|12198963|FG001|NOT COMPLETED|Signed Consent||3
11020892|NCT00801229|12198962|FG000|STARTED|Received Study Drug/Placebo||35
11020893|NCT00801229|12198963|FG001|STARTED|Received Study Drug/Placebo||34
11396775|NCT03900416|12590719|FG000|STARTED|Post||72
11020894|NCT00801229|12198962|FG000|COMPLETED|Received Study Drug/Placebo||31
11020895|NCT00801229|12198963|FG001|COMPLETED|Received Study Drug/Placebo||30
11396776|NCT03900416|12590720|FG001|STARTED|Post||80
11396777|NCT03900416|12590719|FG000|COMPLETED|Post||72
11396778|NCT03900416|12590720|FG001|COMPLETED|Post||80
11396779|NCT03900416|12590719|FG000|NOT COMPLETED|Post||0
11396780|NCT03900416|12590720|FG001|NOT COMPLETED|Post||0
11396781|NCT03900416|12590719|FG000|STARTED|Six Week Follow-up||72
11396782|NCT03900416|12590720|FG001|STARTED|Six Week Follow-up||80
11396783|NCT03900416|12590719|FG000|COMPLETED|Six Week Follow-up||70
11020896|NCT00801229|12198962|FG000|NOT COMPLETED|Received Study Drug/Placebo||4
11020897|NCT00801229|12198963|FG001|NOT COMPLETED|Received Study Drug/Placebo||4
11020898|NCT00801242|12198969|FG000|STARTED|Overall Study|Randomized participants.|220
11020899|NCT00801242|12198969|FG000|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
11020900|NCT00801242|12198969|FG000|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
11020901|NCT00801242|12198969|FG000|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
11020902|NCT00801242|12198969|FG000|Started Cycle 2|Overall Study||35
11020903|NCT00801242|12198969|FG000|Started Cycle 3|Overall Study||2
11020904|NCT00801242|12198969|FG000|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
11020905|NCT00801242|12198969|FG000|NOT COMPLETED|Overall Study||52
11020906|NCT00801398|12198979|FG000|STARTED|Overall Study||13
11020907|NCT00801398|12198980|FG001|STARTED|Overall Study||9
11020908|NCT00801398|12198981|FG002|STARTED|Overall Study||11
11143557|NCT01474512|12330422|FG000|STARTED|Induction Period||431
11143558|NCT01474512|12330423|FG001|STARTED|Induction Period||432
11143559|NCT01474512|12330424|FG002|STARTED|Induction Period||433
11143560|NCT01474512|12330425|FG003|STARTED|Induction Period||0
11143561|NCT01474512|12330426|FG004|STARTED|Induction Period||0
11143562|NCT01474512|12330427|FG005|STARTED|Induction Period||0
11143563|NCT01474512|12330428|FG006|STARTED|Induction Period||0
11143564|NCT01474512|12330429|FG007|STARTED|Induction Period||0
11143565|NCT01474512|12330430|FG008|STARTED|Induction Period||0
11143566|NCT01474512|12330431|FG009|STARTED|Induction Period||0
11143567|NCT01474512|12330432|FG010|STARTED|Induction Period||0
11143568|NCT01474512|12330433|FG011|STARTED|Induction Period||0
11143569|NCT01474512|12330434|FG012|STARTED|Induction Period||0
11143570|NCT01474512|12330435|FG013|STARTED|Induction Period||0
11143571|NCT01474512|12330436|FG014|STARTED|Induction Period||0
11020909|NCT00801398|12198982|FG003|STARTED|Overall Study||9
11020910|NCT00801398|12198983|FG004|STARTED|Overall Study||8
11020911|NCT00801398|12198984|FG005|STARTED|Overall Study||8
11020912|NCT00801398|12198979|FG000|COMPLETED|Overall Study||7
11020913|NCT00801398|12198980|FG001|COMPLETED|Overall Study||0
11020914|NCT00801398|12198981|FG002|COMPLETED|Overall Study||4
11020915|NCT00801398|12198982|FG003|COMPLETED|Overall Study||3
11143572|NCT01474512|12330437|FG015|STARTED|Induction Period||0
11143573|NCT01474512|12330438|FG016|STARTED|Induction Period||0
11143574|NCT01474512|12330439|FG017|STARTED|Induction Period||0
11143575|NCT01474512|12330422|FG000|Received Study Drug|Induction Period||431
11143576|NCT01474512|12330423|FG001|Received Study Drug|Induction Period||432
11143577|NCT01474512|12330424|FG002|Received Study Drug|Induction Period||433
11143578|NCT01474512|12330425|FG003|Received Study Drug|Induction Period||0
11143579|NCT01474512|12330426|FG004|Received Study Drug|Induction Period||0
11143580|NCT01474512|12330427|FG005|Received Study Drug|Induction Period||0
11143581|NCT01474512|12330428|FG006|Received Study Drug|Induction Period||0
11143582|NCT01474512|12330429|FG007|Received Study Drug|Induction Period||0
11143583|NCT01474512|12330430|FG008|Received Study Drug|Induction Period||0
11143584|NCT01474512|12330431|FG009|Received Study Drug|Induction Period||0
11143585|NCT01474512|12330432|FG010|Received Study Drug|Induction Period||0
11143586|NCT01474512|12330433|FG011|Received Study Drug|Induction Period||0
11143587|NCT01474512|12330434|FG012|Received Study Drug|Induction Period||0
11143588|NCT01474512|12330435|FG013|Received Study Drug|Induction Period||0
11143589|NCT01474512|12330436|FG014|Received Study Drug|Induction Period||0
11143590|NCT01474512|12330437|FG015|Received Study Drug|Induction Period||0
11396784|NCT03900416|12590720|FG001|COMPLETED|Six Week Follow-up||80
11396785|NCT03900416|12590719|FG000|NOT COMPLETED|Six Week Follow-up||2
11396786|NCT03900416|12590720|FG001|NOT COMPLETED|Six Week Follow-up||0
11396787|NCT03900416|12590719|FG000|STARTED|Twelve Week Follow-up||70
11396788|NCT03900416|12590720|FG001|STARTED|Twelve Week Follow-up||80
11396789|NCT03900416|12590719|FG000|COMPLETED|Twelve Week Follow-up||69
11396790|NCT03900416|12590720|FG001|COMPLETED|Twelve Week Follow-up||76
11143591|NCT01474512|12330438|FG016|Received Study Drug|Induction Period||0
11143592|NCT01474512|12330439|FG017|Received Study Drug|Induction Period||0
11143593|NCT01474512|12330422|FG000|COMPLETED|Induction Period||407
11143594|NCT01474512|12330423|FG001|COMPLETED|Induction Period||408
11143595|NCT01474512|12330424|FG002|COMPLETED|Induction Period||415
11143596|NCT01474512|12330425|FG003|COMPLETED|Induction Period||0
11143597|NCT01474512|12330426|FG004|COMPLETED|Induction Period||0
11143598|NCT01474512|12330427|FG005|COMPLETED|Induction Period||0
11143599|NCT01474512|12330428|FG006|COMPLETED|Induction Period||0
11143600|NCT01474512|12330429|FG007|COMPLETED|Induction Period||0
11143601|NCT01474512|12330430|FG008|COMPLETED|Induction Period||0
11143602|NCT01474512|12330431|FG009|COMPLETED|Induction Period||0
11143603|NCT01474512|12330432|FG010|COMPLETED|Induction Period||0
11143604|NCT01474512|12330433|FG011|COMPLETED|Induction Period||0
11143605|NCT01474512|12330434|FG012|COMPLETED|Induction Period||0
11143606|NCT01474512|12330435|FG013|COMPLETED|Induction Period||0
11143607|NCT01474512|12330436|FG014|COMPLETED|Induction Period||0
11143608|NCT01474512|12330437|FG015|COMPLETED|Induction Period||0
11143609|NCT01474512|12330438|FG016|COMPLETED|Induction Period||0
11143610|NCT01474512|12330439|FG017|COMPLETED|Induction Period||0
11396791|NCT03900416|12590719|FG000|NOT COMPLETED|Twelve Week Follow-up||1
11396792|NCT03900416|12590720|FG001|NOT COMPLETED|Twelve Week Follow-up||4
11396793|NCT03900416|12590719|FG000|STARTED|Six Month Follow-up||69
11143611|NCT01474512|12330422|FG000|NOT COMPLETED|Induction Period||24
11020916|NCT00801398|12198983|FG004|COMPLETED|Overall Study||1
11020917|NCT00801398|12198984|FG005|COMPLETED|Overall Study||5
11020918|NCT00801398|12198979|FG000|NOT COMPLETED|Overall Study||6
11020919|NCT00801398|12198980|FG001|NOT COMPLETED|Overall Study||9
11020920|NCT00801398|12198981|FG002|NOT COMPLETED|Overall Study||7
11020921|NCT00801398|12198982|FG003|NOT COMPLETED|Overall Study||6
11020922|NCT00801398|12198983|FG004|NOT COMPLETED|Overall Study||7
11020923|NCT00801398|12198984|FG005|NOT COMPLETED|Overall Study||3
11020924|NCT00801632|12199012|FG000|STARTED|Overall Study||5
11020925|NCT00801632|12199012|FG000|COMPLETED|Overall Study||4
11020926|NCT00801632|12199012|FG000|NOT COMPLETED|Overall Study||1
11020927|NCT00801684|12199016|FG000|STARTED|Overall Study||24
11020928|NCT00801684|12199016|FG000|COMPLETED|Overall Study||24
11020929|NCT00801684|12199016|FG000|NOT COMPLETED|Overall Study||0
11020930|NCT00801723|12199035|FG000|STARTED|Overall Study||61
11020931|NCT00801723|12199036|FG001|STARTED|Overall Study||62
11020932|NCT00801723|12199035|FG000|COMPLETED|Overall Study||25
11020933|NCT00801723|12199036|FG001|COMPLETED|Overall Study||27
11020934|NCT00801723|12199035|FG000|NOT COMPLETED|Overall Study||36
11020935|NCT00801723|12199036|FG001|NOT COMPLETED|Overall Study||35
11020936|NCT00801801|12199042|FG000|STARTED|Overall Study||5
11020937|NCT00801801|12199042|FG000|COMPLETED|Overall Study||5
11020938|NCT00801801|12199042|FG000|NOT COMPLETED|Overall Study||0
11020939|NCT00801827|12199047|FG000|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
11020940|NCT00801827|12199047|FG000|COMPLETED|Overall Study||5
11020941|NCT00801827|12199047|FG000|NOT COMPLETED|Overall Study||0
11020942|NCT00801892|12199053|FG000|STARTED|Main Study Period||12
11020943|NCT00801892|12199054|FG001|STARTED|Main Study Period||11
11020944|NCT00801892|12199053|FG000|COMPLETED|Main Study Period||12
11020945|NCT00801892|12199054|FG001|COMPLETED|Main Study Period||10
11020946|NCT00801892|12199053|FG000|NOT COMPLETED|Main Study Period||0
11020947|NCT00801892|12199054|FG001|NOT COMPLETED|Main Study Period||1
11020948|NCT00801892|12199053|FG000|STARTED|Sham Crossover Period||0
11020949|NCT00801892|12199054|FG001|STARTED|Sham Crossover Period||7
11020950|NCT00801892|12199053|FG000|COMPLETED|Sham Crossover Period||0
11020951|NCT00801892|12199054|FG001|COMPLETED|Sham Crossover Period||5
11020952|NCT00801892|12199053|FG000|NOT COMPLETED|Sham Crossover Period||0
11143612|NCT01474512|12330423|FG001|NOT COMPLETED|Induction Period||24
11143613|NCT01474512|12330424|FG002|NOT COMPLETED|Induction Period||18
11143614|NCT01474512|12330425|FG003|NOT COMPLETED|Induction Period||0
11143615|NCT01474512|12330426|FG004|NOT COMPLETED|Induction Period||0
11396794|NCT03900416|12590720|FG001|STARTED|Six Month Follow-up||76
11020953|NCT00801892|12199054|FG001|NOT COMPLETED|Sham Crossover Period||2
11020954|NCT00801983|12199064|FG000|STARTED|Period 1||44
11020955|NCT00801983|12199065|FG001|STARTED|Period 1||41
11020956|NCT00801983|12199064|FG000|COMPLETED|Period 1||40
11020957|NCT00801983|12199065|FG001|COMPLETED|Period 1||33
11020958|NCT00801983|12199064|FG000|NOT COMPLETED|Period 1||4
11020959|NCT00801983|12199065|FG001|NOT COMPLETED|Period 1||8
11020960|NCT00801983|12199064|FG000|STARTED|Period 2||40
11020961|NCT00801983|12199065|FG001|STARTED|Period 2||33
11020962|NCT00801983|12199064|FG000|COMPLETED|Period 2||38
11020963|NCT00801983|12199065|FG001|COMPLETED|Period 2||32
11020964|NCT00801983|12199064|FG000|NOT COMPLETED|Period 2||2
11020965|NCT00801983|12199065|FG001|NOT COMPLETED|Period 2||1
11020966|NCT00802074|12199077|FG000|STARTED|Overall Study||9
11020967|NCT00802074|12199078|FG001|STARTED|Overall Study||8
11020968|NCT00802074|12199079|FG002|STARTED|Overall Study||7
11020969|NCT00802074|12199080|FG003|STARTED|Overall Study||7
11020970|NCT00802074|12199081|FG004|STARTED|Overall Study||7
11020971|NCT00802074|12199082|FG005|STARTED|Overall Study||7
11020972|NCT00802074|12199077|FG000|COMPLETED|Overall Study||7
11020973|NCT00802074|12199078|FG001|COMPLETED|Overall Study||7
11020974|NCT00802074|12199079|FG002|COMPLETED|Overall Study||6
11020975|NCT00802074|12199080|FG003|COMPLETED|Overall Study||7
11020976|NCT00802074|12199081|FG004|COMPLETED|Overall Study||7
11020977|NCT00802074|12199082|FG005|COMPLETED|Overall Study||7
11020978|NCT00802074|12199077|FG000|NOT COMPLETED|Overall Study||2
11020979|NCT00802074|12199078|FG001|NOT COMPLETED|Overall Study||1
11020980|NCT00802074|12199079|FG002|NOT COMPLETED|Overall Study||1
11020981|NCT00802074|12199080|FG003|NOT COMPLETED|Overall Study||0
11020982|NCT00802074|12199081|FG004|NOT COMPLETED|Overall Study||0
11020983|NCT00802074|12199082|FG005|NOT COMPLETED|Overall Study||0
11020984|NCT00802100|12199102|FG000|STARTED|Overall Study||6
11020985|NCT00802100|12199103|FG001|STARTED|Overall Study||9
11020986|NCT00802100|12199104|FG002|STARTED|Overall Study||6
11020987|NCT00802100|12199102|FG000|COMPLETED|Overall Study||0
11020988|NCT00802100|12199103|FG001|COMPLETED|Overall Study||2
11020989|NCT00802100|12199104|FG002|COMPLETED|Overall Study||2
11020990|NCT00802100|12199102|FG000|NOT COMPLETED|Overall Study||6
11020991|NCT00802100|12199103|FG001|NOT COMPLETED|Overall Study||7
11020992|NCT00802100|12199104|FG002|NOT COMPLETED|Overall Study||4
11020993|NCT00802113|12199115|FG000|STARTED|Overall Study||6
11020994|NCT00802113|12199116|FG001|STARTED|Overall Study||17
11020995|NCT00802113|12199115|FG000|COMPLETED|Overall Study||6
11020996|NCT00802113|12199116|FG001|COMPLETED|Overall Study||17
11020997|NCT00802113|12199115|FG000|NOT COMPLETED|Overall Study||0
11020998|NCT00802113|12199116|FG001|NOT COMPLETED|Overall Study||0
11020999|NCT00802178|12199122|FG000|STARTED|Overall Study||2448
11021000|NCT00802178|12199122|FG000|COMPLETED|Overall Study||2335
11021001|NCT00802178|12199122|FG000|NOT COMPLETED|Overall Study||113
11021002|NCT00802204|12199128|FG000|STARTED|Overall Study||9
11021003|NCT00802204|12199129|FG001|STARTED|Overall Study||19
11021004|NCT00802204|12199128|FG000|COMPLETED|Overall Study||8
11021005|NCT00802204|12199129|FG001|COMPLETED|Overall Study||18
11021006|NCT00802204|12199128|FG000|NOT COMPLETED|Overall Study||1
11021007|NCT00802204|12199129|FG001|NOT COMPLETED|Overall Study||1
11021008|NCT00802360|12199142|FG000|STARTED|Overall Study||42
11021009|NCT00802360|12199143|FG001|STARTED|Overall Study||42
11021010|NCT00802360|12199144|FG002|STARTED|Overall Study||42
11021011|NCT00802360|12199145|FG003|STARTED|Overall Study||39
11021012|NCT00802360|12199142|FG000|COMPLETED|Overall Study||18
11021013|NCT00802360|12199143|FG001|COMPLETED|Overall Study||16
11021014|NCT00802360|12199144|FG002|COMPLETED|Overall Study||17
11021015|NCT00802360|12199145|FG003|COMPLETED|Overall Study||17
11021016|NCT00802360|12199142|FG000|NOT COMPLETED|Overall Study||24
11021017|NCT00802360|12199143|FG001|NOT COMPLETED|Overall Study||26
11021018|NCT00802360|12199144|FG002|NOT COMPLETED|Overall Study||25
11021019|NCT00802360|12199145|FG003|NOT COMPLETED|Overall Study||22
11021020|NCT00802412|12199159|FG000|STARTED|Overall Study||65
11021021|NCT00802412|12199160|FG001|STARTED|Overall Study||67
11021022|NCT00802412|12199159|FG000|COMPLETED|Overall Study||63
11021023|NCT00802412|12199160|FG001|COMPLETED|Overall Study||66
11021024|NCT00802412|12199159|FG000|NOT COMPLETED|Overall Study||2
11021025|NCT00802412|12199160|FG001|NOT COMPLETED|Overall Study||1
11021026|NCT00802438|12199166|FG000|STARTED|Overall Study||38
11021027|NCT00802438|12199166|FG000|COMPLETED|Overall Study||10
11021028|NCT00802438|12199166|FG000|NOT COMPLETED|Overall Study||28
11021029|NCT00802464|12199174|FG000|STARTED|Month 0 - Month 8||38
11021030|NCT00802464|12199175|FG001|STARTED|Month 0 - Month 8||73
11021031|NCT00802464|12199176|FG002|STARTED|Month 0 - Month 8||149
11021032|NCT00802464|12199177|FG003|STARTED|Month 0 - Month 8||150
11021033|NCT00802464|12199174|FG000|COMPLETED|Month 0 - Month 8||38
11021034|NCT00802464|12199175|FG001|COMPLETED|Month 0 - Month 8||70
11021035|NCT00802464|12199176|FG002|COMPLETED|Month 0 - Month 8||142
11021036|NCT00802464|12199177|FG003|COMPLETED|Month 0 - Month 8||141
11021037|NCT00802464|12199174|FG000|NOT COMPLETED|Month 0 - Month 8||0
11021038|NCT00802464|12199175|FG001|NOT COMPLETED|Month 0 - Month 8||3
11021039|NCT00802464|12199176|FG002|NOT COMPLETED|Month 0 - Month 8||7
11021040|NCT00802464|12199177|FG003|NOT COMPLETED|Month 0 - Month 8||9
11021041|NCT00802464|12199174|FG000|STARTED|Month 8 - Month 14||34
11021042|NCT00802464|12199175|FG001|STARTED|Month 8 - Month 14||65
11021043|NCT00802464|12199176|FG002|STARTED|Month 8 - Month 14||130
11021044|NCT00802464|12199177|FG003|STARTED|Month 8 - Month 14||126
11021045|NCT00802464|12199174|FG000|COMPLETED|Month 8 - Month 14||33
11021046|NCT00802464|12199175|FG001|COMPLETED|Month 8 - Month 14||63
11021047|NCT00802464|12199176|FG002|COMPLETED|Month 8 - Month 14||129
11021048|NCT00802464|12199177|FG003|COMPLETED|Month 8 - Month 14||126
11021049|NCT00802464|12199174|FG000|NOT COMPLETED|Month 8 - Month 14||1
11021050|NCT00802464|12199175|FG001|NOT COMPLETED|Month 8 - Month 14||2
11021051|NCT00802464|12199176|FG002|NOT COMPLETED|Month 8 - Month 14||1
11021052|NCT00802464|12199177|FG003|NOT COMPLETED|Month 8 - Month 14||0
11021053|NCT00802503|12199191|FG000|STARTED|Overall Study||152
11021054|NCT00802503|12199192|FG001|STARTED|Overall Study||153
11021055|NCT00802503|12199191|FG000|COMPLETED|Overall Study||142
11021056|NCT00802503|12199192|FG001|COMPLETED|Overall Study||133
11021057|NCT00802503|12199191|FG000|NOT COMPLETED|Overall Study||10
11021058|NCT00802503|12199192|FG001|NOT COMPLETED|Overall Study||20
11021059|NCT00802529|12199204|FG000|STARTED|Overall Study||30
11021060|NCT00802529|12199205|FG001|STARTED|Overall Study||30
11021061|NCT00802529|12199204|FG000|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
11021062|NCT00802529|12199205|FG001|COMPLETED|Overall Study||29
11021063|NCT00802529|12199204|FG000|NOT COMPLETED|Overall Study||0
11021064|NCT00802529|12199205|FG001|NOT COMPLETED|Overall Study||1
11021065|NCT00802633|12199213|FG000|STARTED|Overall Study||40
11021066|NCT00802633|12199214|FG001|STARTED|Overall Study||40
11021067|NCT00802633|12199213|FG000|COMPLETED|Overall Study||40
11021068|NCT00802633|12199214|FG001|COMPLETED|Overall Study||40
11021069|NCT00802633|12199213|FG000|NOT COMPLETED|Overall Study||0
11021070|NCT00802633|12199214|FG001|NOT COMPLETED|Overall Study||0
11021071|NCT00802672|12199223|FG000|STARTED|Overall Study||224
11021072|NCT00802672|12199224|FG001|STARTED|Overall Study||226
11021073|NCT00802672|12199225|FG002|STARTED|Overall Study||111
11021074|NCT00802672|12199223|FG000|COMPLETED|Overall Study||156
11021075|NCT00802672|12199224|FG001|COMPLETED|Overall Study||174
11021076|NCT00802672|12199225|FG002|COMPLETED|Overall Study||77
11021077|NCT00802672|12199223|FG000|NOT COMPLETED|Overall Study||68
11021078|NCT00802672|12199224|FG001|NOT COMPLETED|Overall Study||52
11021079|NCT00802672|12199225|FG002|NOT COMPLETED|Overall Study||34
11021080|NCT00802685|12199235|FG000|STARTED|Overall Study||54
11021081|NCT00802685|12199236|FG001|STARTED|Overall Study||51
11021082|NCT00802685|12199235|FG000|COMPLETED|Overall Study||54
11021083|NCT00802685|12199236|FG001|COMPLETED|Overall Study||51
11021084|NCT00802685|12199235|FG000|NOT COMPLETED|Overall Study||0
11021085|NCT00802685|12199236|FG001|NOT COMPLETED|Overall Study||0
11021086|NCT00802737|12199245|FG000|STARTED|Overall Study||17
11021087|NCT00802737|12199246|FG001|STARTED|Overall Study||11
11021088|NCT00802737|12199247|FG002|STARTED|Overall Study||1
11021089|NCT00802737|12199245|FG000|COMPLETED|Overall Study||0
11021090|NCT00802737|12199246|FG001|COMPLETED|Overall Study||0
11021091|NCT00802737|12199247|FG002|COMPLETED|Overall Study||0
11021092|NCT00802737|12199245|FG000|NOT COMPLETED|Overall Study||17
11021093|NCT00802737|12199246|FG001|NOT COMPLETED|Overall Study||11
11021094|NCT00802737|12199247|FG002|NOT COMPLETED|Overall Study||1
11021095|NCT00802841|12199258|FG000|STARTED|Overall Study||96
11021096|NCT00802841|12199259|FG001|STARTED|Overall Study||95
11021097|NCT00802841|12199258|FG000|Full Analysis Set|Overall Study||96
11021098|NCT00802841|12199259|FG001|Full Analysis Set|Overall Study||95
11021099|NCT00802841|12199258|FG000|Safety Set|Overall Study||96
11021100|NCT00802841|12199259|FG001|Safety Set|Overall Study||93
11021101|NCT00802841|12199258|FG000|Cross-over Set|Overall Study||13
11021102|NCT00802841|12199259|FG001|Cross-over Set|Overall Study||56
11021103|NCT00802841|12199258|FG000|COMPLETED|Overall Study||0
11021104|NCT00802841|12199259|FG001|COMPLETED|Overall Study||0
11021105|NCT00802841|12199258|FG000|NOT COMPLETED|Overall Study||96
11021106|NCT00802841|12199259|FG001|NOT COMPLETED|Overall Study||95
11021107|NCT00802854|12199267|FG000|STARTED|Overall Study||244
11021108|NCT00802854|12199267|FG000|COMPLETED|Overall Study||244
11021109|NCT00802854|12199267|FG000|NOT COMPLETED|Overall Study||0
11021110|NCT00802867|12199271|FG000|STARTED|Overall Study||989
11021111|NCT00802867|12199271|FG000|COMPLETED|Overall Study||976
11021112|NCT00802867|12199271|FG000|NOT COMPLETED|Overall Study||13
11021113|NCT00802880|12199275|FG000|STARTED|Overall Study||80
11021114|NCT00802880|12199275|FG000|COMPLETED|Overall Study||80
11021115|NCT00802880|12199275|FG000|NOT COMPLETED|Overall Study||0
11021116|NCT00802919|12199285|FG000|STARTED|Overall Study||45
11021117|NCT00802919|12199286|FG001|STARTED|Overall Study||46
11021118|NCT00802919|12199285|FG000|COMPLETED|Overall Study||42
11021119|NCT00802919|12199286|FG001|COMPLETED|Overall Study||45
11021120|NCT00802919|12199285|FG000|NOT COMPLETED|Overall Study||3
11021121|NCT00802919|12199286|FG001|NOT COMPLETED|Overall Study||1
11021122|NCT00802945|12199295|FG000|STARTED|Overall Study||35
11021123|NCT00802945|12199296|FG001|STARTED|Overall Study||35
11021124|NCT00802945|12199295|FG000|COMPLETED|Overall Study||0
11021125|NCT00802945|12199296|FG001|COMPLETED|Overall Study||0
11021126|NCT00802945|12199295|FG000|NOT COMPLETED|Overall Study||35
11021127|NCT00802945|12199296|FG001|NOT COMPLETED|Overall Study||35
11021128|NCT00802997|12199306|FG000|STARTED|Baseline to 3 Months||34
11021129|NCT00802997|12199307|FG001|STARTED|Baseline to 3 Months||17
11021130|NCT00802997|12199306|FG000|COMPLETED|Baseline to 3 Months||34
11021131|NCT00802997|12199307|FG001|COMPLETED|Baseline to 3 Months||17
11021132|NCT00802997|12199306|FG000|NOT COMPLETED|Baseline to 3 Months||0
11021133|NCT00802997|12199307|FG001|NOT COMPLETED|Baseline to 3 Months||0
11021134|NCT00802997|12199306|FG000|STARTED|3 Months to 6 Months||34
11021135|NCT00802997|12199307|FG001|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
11021136|NCT00802997|12199306|FG000|COMPLETED|3 Months to 6 Months||27
11021137|NCT00802997|12199307|FG001|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
11021138|NCT00802997|12199306|FG000|NOT COMPLETED|3 Months to 6 Months||7
11021139|NCT00802997|12199307|FG001|NOT COMPLETED|3 Months to 6 Months||0
11021140|NCT00802997|12199306|FG000|STARTED|6 Month to 9 Months||27
11021141|NCT00802997|12199307|FG001|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
11021142|NCT00802997|12199306|FG000|COMPLETED|6 Month to 9 Months||25
11021143|NCT00802997|12199307|FG001|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
11021144|NCT00802997|12199306|FG000|NOT COMPLETED|6 Month to 9 Months||2
11021145|NCT00802997|12199307|FG001|NOT COMPLETED|6 Month to 9 Months||0
11021146|NCT00803010|12199315|FG000|STARTED|Overall Study||37
11021147|NCT00803010|12199316|FG001|STARTED|Overall Study||37
11021148|NCT00803010|12199315|FG000|COMPLETED|Overall Study||37
11021149|NCT00803010|12199316|FG001|COMPLETED|Overall Study||37
11021150|NCT00803010|12199315|FG000|NOT COMPLETED|Overall Study||0
11021151|NCT00803010|12199316|FG001|NOT COMPLETED|Overall Study||0
11021152|NCT00803023|12199326|FG000|STARTED|Overall Study||32
11021153|NCT00803023|12199327|FG001|STARTED|Overall Study||33
11021154|NCT00803023|12199328|FG002|STARTED|Overall Study||31
11021155|NCT00803023|12199329|FG003|STARTED|Overall Study||33
11021156|NCT00803023|12199326|FG000|COMPLETED|Overall Study||27
11021157|NCT00803023|12199327|FG001|COMPLETED|Overall Study||25
11021158|NCT00803023|12199328|FG002|COMPLETED|Overall Study||20
11021159|NCT00803023|12199329|FG003|COMPLETED|Overall Study||25
11021160|NCT00803023|12199326|FG000|NOT COMPLETED|Overall Study||5
11021161|NCT00803023|12199327|FG001|NOT COMPLETED|Overall Study||8
11021162|NCT00803023|12199328|FG002|NOT COMPLETED|Overall Study||11
11021163|NCT00803023|12199329|FG003|NOT COMPLETED|Overall Study||8
11021164|NCT00803049|12199343|FG000|STARTED|Overall Study|Randomized in extension study|129
11021165|NCT00803049|12199344|FG001|STARTED|Overall Study|Randomized in extension study|252
11021166|NCT00803049|12199345|FG002|STARTED|Overall Study|Randomized in extension study|108
11021167|NCT00803049|12199346|FG003|STARTED|Overall Study|Randomized in extension study|253
11021168|NCT00803049|12199343|FG000|Treated|Overall Study||129
11143616|NCT01474512|12330427|FG005|NOT COMPLETED|Induction Period||0
11143617|NCT01474512|12330428|FG006|NOT COMPLETED|Induction Period||0
11021169|NCT00803049|12199344|FG001|Treated|Overall Study||252
11021170|NCT00803049|12199345|FG002|Treated|Overall Study||108
11021171|NCT00803049|12199346|FG003|Treated|Overall Study||251
11021172|NCT00803049|12199343|FG000|Safety Population|Overall Study||129
11021173|NCT00803049|12199344|FG001|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
11021174|NCT00803049|12199345|FG002|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
11021175|NCT00803049|12199346|FG003|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
11021176|NCT00803049|12199343|FG000|COMPLETED|Overall Study||68
11021177|NCT00803049|12199344|FG001|COMPLETED|Overall Study||134
11021178|NCT00803049|12199345|FG002|COMPLETED|Overall Study||64
11021179|NCT00803049|12199346|FG003|COMPLETED|Overall Study||151
11021180|NCT00803049|12199343|FG000|NOT COMPLETED|Overall Study||61
11021181|NCT00803049|12199344|FG001|NOT COMPLETED|Overall Study||118
11021182|NCT00803049|12199345|FG002|NOT COMPLETED|Overall Study||44
11021183|NCT00803049|12199346|FG003|NOT COMPLETED|Overall Study||102
11021184|NCT00803062|12199360|FG000|STARTED|Overall Study||114
11021185|NCT00803062|12199361|FG001|STARTED|Overall Study||115
11021186|NCT00803062|12199362|FG002|STARTED|Overall Study||111
11021187|NCT00803062|12199363|FG003|STARTED|Overall Study||112
11021188|NCT00803062|12199360|FG000|COMPLETED|Overall Study||114
11021189|NCT00803062|12199361|FG001|COMPLETED|Overall Study||115
11021190|NCT00803062|12199362|FG002|COMPLETED|Overall Study||111
11021191|NCT00803062|12199363|FG003|COMPLETED|Overall Study||112
11021192|NCT00803062|12199360|FG000|NOT COMPLETED|Overall Study||0
11021193|NCT00803062|12199361|FG001|NOT COMPLETED|Overall Study||0
11021194|NCT00803062|12199362|FG002|NOT COMPLETED|Overall Study||0
11021195|NCT00803062|12199363|FG003|NOT COMPLETED|Overall Study||0
11021196|NCT00803101|12199375|FG000|STARTED|Overall Study||88
11021197|NCT00803101|12199376|FG001|STARTED|Overall Study||88
11021198|NCT00803101|12199375|FG000|COMPLETED|Overall Study||70
11021199|NCT00803101|12199376|FG001|COMPLETED|Overall Study||66
11021200|NCT00803101|12199375|FG000|NOT COMPLETED|Overall Study||18
11021201|NCT00803101|12199376|FG001|NOT COMPLETED|Overall Study||22
11021202|NCT00803205|12199384|FG000|STARTED|Overall Study||120
11021203|NCT00803205|12199385|FG001|STARTED|Overall Study||118
11021204|NCT00803205|12199384|FG000|Completed Week 16|Overall Study||107
11021205|NCT00803205|12199385|FG001|Completed Week 16|Overall Study||113
11021206|NCT00803205|12199384|FG000|Completed Week 24|Overall Study||103
11021207|NCT00803205|12199385|FG001|Completed Week 24|Overall Study||110
11021208|NCT00803205|12199384|FG000|As-Treated Population*|Overall Study||120
11021209|NCT00803205|12199385|FG001|As-Treated Population*|Overall Study||118
11021210|NCT00803205|12199384|FG000|ITT Population|Overall Study||116
11021211|NCT00803205|12199385|FG001|ITT Population|Overall Study||116
11021212|NCT00803205|12199384|FG000|Per Protocol Population|Overall Study||100
11021213|NCT00803205|12199385|FG001|Per Protocol Population|Overall Study||103
11021214|NCT00803205|12199384|FG000|COMPLETED|Overall Study||100
11021215|NCT00803205|12199385|FG001|COMPLETED|Overall Study||104
11021216|NCT00803205|12199384|FG000|NOT COMPLETED|Overall Study||20
11021217|NCT00803205|12199385|FG001|NOT COMPLETED|Overall Study||14
11021218|NCT00803244|12199393|FG000|STARTED|Overall Study||188
11021219|NCT00803244|12199394|FG001|STARTED|Overall Study||193
11021220|NCT00803244|12199393|FG000|COMPLETED|Overall Study||181
11021221|NCT00803244|12199394|FG001|COMPLETED|Overall Study||178
11021222|NCT00803244|12199393|FG000|NOT COMPLETED|Overall Study||7
11021223|NCT00803244|12199394|FG001|NOT COMPLETED|Overall Study||15
11021224|NCT00803270|12199402|FG000|STARTED|Overall Study||13
11021225|NCT00803270|12199403|FG001|STARTED|Overall Study||14
11021226|NCT00803270|12199402|FG000|COMPLETED|Overall Study||12
11021227|NCT00803270|12199403|FG001|COMPLETED|Overall Study||12
11021228|NCT00803270|12199402|FG000|NOT COMPLETED|Overall Study||1
11021229|NCT00803270|12199403|FG001|NOT COMPLETED|Overall Study||2
11021230|NCT00803361|12199411|FG000|STARTED|Overall Study||108
11021231|NCT00803361|12199412|FG001|STARTED|Overall Study||102
11021232|NCT00803361|12199411|FG000|COMPLETED|Overall Study||82
11021233|NCT00803361|12199412|FG001|COMPLETED|Overall Study||74
11021234|NCT00803361|12199411|FG000|NOT COMPLETED|Overall Study||26
11021235|NCT00803361|12199412|FG001|NOT COMPLETED|Overall Study||28
11021236|NCT00803400|12199420|FG000|STARTED|Overall Study||75
11021237|NCT00803400|12199421|FG001|STARTED|Overall Study||75
11021238|NCT00803400|12199420|FG000|COMPLETED|Overall Study||55
11021239|NCT00803400|12199421|FG001|COMPLETED|Overall Study||51
11021240|NCT00803400|12199420|FG000|NOT COMPLETED|Overall Study||20
11021241|NCT00803400|12199421|FG001|NOT COMPLETED|Overall Study||24
11021242|NCT00803452|12199430|FG000|STARTED|Overall Study||9
11021243|NCT00803452|12199431|FG001|STARTED|Overall Study||22
11021244|NCT00803452|12199430|FG000|COMPLETED|Overall Study||9
11021245|NCT00803452|12199431|FG001|COMPLETED|Overall Study||17
11021246|NCT00803452|12199430|FG000|NOT COMPLETED|Overall Study||0
11021247|NCT00803452|12199431|FG001|NOT COMPLETED|Overall Study||5
11021248|NCT00803543|12199439|FG000|STARTED|Overall Study||69
11021249|NCT00803543|12199440|FG001|STARTED|Overall Study||34
11021250|NCT00803543|12199439|FG000|COMPLETED|Overall Study||45
11021251|NCT00803543|12199440|FG001|COMPLETED|Overall Study||22
11021252|NCT00803543|12199439|FG000|NOT COMPLETED|Overall Study||24
11021253|NCT00803543|12199440|FG001|NOT COMPLETED|Overall Study||12
11021254|NCT00803569|12199446|FG000|STARTED|Overall Study||13
11021255|NCT00803569|12199446|FG000|COMPLETED|Overall Study||9
11021256|NCT00803569|12199446|FG000|NOT COMPLETED|Overall Study||4
11021257|NCT00803595|12199453|FG000|STARTED|Overall Study||337
11021258|NCT00803595|12199454|FG001|STARTED|Overall Study||327
11021259|NCT00803595|12199455|FG002|STARTED|Overall Study||338
11021260|NCT00803595|12199453|FG000|COMPLETED|Overall Study||322
11021261|NCT00803595|12199454|FG001|COMPLETED|Overall Study||319
11021262|NCT00803595|12199455|FG002|COMPLETED|Overall Study||322
11021263|NCT00803595|12199453|FG000|NOT COMPLETED|Overall Study||15
11021264|NCT00803595|12199454|FG001|NOT COMPLETED|Overall Study||8
11021265|NCT00803595|12199455|FG002|NOT COMPLETED|Overall Study||16
11021266|NCT00803634|12199465|FG000|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
11021267|NCT00803634|12199466|FG001|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
11021268|NCT00803634|12199465|FG000|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
11021269|NCT00803634|12199466|FG001|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
11021270|NCT00803634|12199465|FG000|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
11021271|NCT00803634|12199466|FG001|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
11021272|NCT00803634|12199465|FG000|NOT COMPLETED|Overall Study||6
11021273|NCT00803634|12199466|FG001|NOT COMPLETED|Overall Study||5
11021274|NCT00803647|12199473|FG000|STARTED|Overall Study||20
11021275|NCT00803647|12199473|FG000|COMPLETED|Overall Study||20
11021276|NCT00803647|12199473|FG000|NOT COMPLETED|Overall Study||0
11021277|NCT00803686|12199481|FG000|STARTED|Part 1, Period 1||6
11021278|NCT00803686|12199482|FG001|STARTED|Part 1, Period 1||6
11021279|NCT00803686|12199483|FG002|STARTED|Part 1, Period 1||0
11021280|NCT00803686|12199484|FG003|STARTED|Part 1, Period 1||0
11021281|NCT00803686|12199481|FG000|COMPLETED|Part 1, Period 1||6
11021282|NCT00803686|12199482|FG001|COMPLETED|Part 1, Period 1||6
11021283|NCT00803686|12199483|FG002|COMPLETED|Part 1, Period 1||0
11021284|NCT00803686|12199484|FG003|COMPLETED|Part 1, Period 1||0
11021285|NCT00803686|12199481|FG000|NOT COMPLETED|Part 1, Period 1||0
11021286|NCT00803686|12199482|FG001|NOT COMPLETED|Part 1, Period 1||0
11021287|NCT00803686|12199483|FG002|NOT COMPLETED|Part 1, Period 1||0
11021288|NCT00803686|12199484|FG003|NOT COMPLETED|Part 1, Period 1||0
11021289|NCT00803686|12199481|FG000|STARTED|Part 1, Period 2||6
11021290|NCT00803686|12199482|FG001|STARTED|Part 1, Period 2||6
11021291|NCT00803686|12199483|FG002|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
11021292|NCT00803686|12199484|FG003|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
11021293|NCT00803686|12199481|FG000|COMPLETED|Part 1, Period 2||6
11021294|NCT00803686|12199482|FG001|COMPLETED|Part 1, Period 2||6
11021295|NCT00803686|12199483|FG002|COMPLETED|Part 1, Period 2|No subjects treated.|0
11021296|NCT00803686|12199484|FG003|COMPLETED|Part 1, Period 2|No subjects treated.|0
11021297|NCT00803686|12199481|FG000|NOT COMPLETED|Part 1, Period 2||0
11021298|NCT00803686|12199482|FG001|NOT COMPLETED|Part 1, Period 2||0
11021299|NCT00803686|12199483|FG002|NOT COMPLETED|Part 1, Period 2||0
11021300|NCT00803686|12199484|FG003|NOT COMPLETED|Part 1, Period 2||0
11021301|NCT00803686|12199481|FG000|STARTED|Part 2, Period 3|No subjects were treated in this period|0
11021302|NCT00803686|12199482|FG001|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
11021303|NCT00803686|12199483|FG002|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
11021304|NCT00803686|12199484|FG003|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
11021305|NCT00803686|12199481|FG000|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
11021306|NCT00803686|12199482|FG001|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
11021307|NCT00803686|12199483|FG002|COMPLETED|Part 2, Period 3|All who started this period completed|5
11021308|NCT00803686|12199484|FG003|COMPLETED|Part 2, Period 3|All who started this period completed|4
11021309|NCT00803686|12199481|FG000|NOT COMPLETED|Part 2, Period 3||0
11021310|NCT00803686|12199482|FG001|NOT COMPLETED|Part 2, Period 3||0
11021311|NCT00803686|12199483|FG002|NOT COMPLETED|Part 2, Period 3||0
11021312|NCT00803686|12199484|FG003|NOT COMPLETED|Part 2, Period 3||0
11021313|NCT00803712|12199498|FG000|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
11021314|NCT00803712|12199499|FG001|STARTED|Overall Study|155 participants were randomized to the control group|155
11021315|NCT00803712|12199498|FG000|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
11021316|NCT00803712|12199499|FG001|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
11021317|NCT00803712|12199498|FG000|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
11021318|NCT00803712|12199499|FG001|Safety Analysis Set|Overall Study|Randomized to the control group|154
11021319|NCT00803712|12199498|FG000|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
11021320|NCT00803712|12199499|FG001|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
11021321|NCT00803712|12199498|FG000|NOT COMPLETED|Overall Study||36
11021322|NCT00803712|12199499|FG001|NOT COMPLETED|Overall Study||27
11021323|NCT00803738|12199507|FG000|STARTED|Overall Study||286
11021324|NCT00803738|12199508|FG001|STARTED|Overall Study||286
11021325|NCT00803738|12199507|FG000|COMPLETED|Overall Study||192
11021326|NCT00803738|12199508|FG001|COMPLETED|Overall Study||176
11021327|NCT00803738|12199507|FG000|NOT COMPLETED|Overall Study||94
11021328|NCT00803738|12199508|FG001|NOT COMPLETED|Overall Study||110
11021329|NCT00803751|12199516|FG000|STARTED|Overall Study||26
11021330|NCT00803751|12199517|FG001|STARTED|Overall Study||23
11021331|NCT00803751|12199516|FG000|COMPLETED|Overall Study||26
11021332|NCT00803751|12199517|FG001|COMPLETED|Overall Study||23
11021333|NCT00803751|12199516|FG000|NOT COMPLETED|Overall Study||0
11021334|NCT00803751|12199517|FG001|NOT COMPLETED|Overall Study||0
11021335|NCT00803777|12199523|FG000|STARTED|Overall Study||147
11021336|NCT00803777|12199523|FG000|COMPLETED|Overall Study||147
11021337|NCT00803777|12199523|FG000|NOT COMPLETED|Overall Study||0
11021338|NCT00803959|12199529|FG000|STARTED|Overall Study||315
11021339|NCT00803959|12199530|FG001|STARTED|Overall Study||315
11021340|NCT00803959|12199529|FG000|ITT Analysis With Primary Outcome Data|Overall Study||266
11021341|NCT00803959|12199530|FG001|ITT Analysis With Primary Outcome Data|Overall Study||272
11021342|NCT00803959|12199529|FG000|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
11021343|NCT00803959|12199530|FG001|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
11021344|NCT00803959|12199529|FG000|NOT COMPLETED|Overall Study||56
11021345|NCT00803959|12199530|FG001|NOT COMPLETED|Overall Study||51
11021346|NCT00804141|12199536|FG000|STARTED|Overall Study||1040
11021347|NCT00804141|12199536|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1034
11021348|NCT00804141|12199536|FG000|COMPLETED|Overall Study||477
11021349|NCT00804141|12199536|FG000|NOT COMPLETED|Overall Study||563
11021350|NCT00804193|12199543|FG000|STARTED|Overall Study||220
11021351|NCT00804193|12199544|FG001|STARTED|Overall Study||224
11021352|NCT00804193|12199545|FG002|STARTED|Overall Study||109
11021353|NCT00804193|12199543|FG000|COMPLETED|Overall Study||181
11021354|NCT00804193|12199544|FG001|COMPLETED|Overall Study||180
11021355|NCT00804193|12199545|FG002|COMPLETED|Overall Study||77
11021356|NCT00804193|12199543|FG000|NOT COMPLETED|Overall Study||39
11021357|NCT00804193|12199544|FG001|NOT COMPLETED|Overall Study||44
11021358|NCT00804193|12199545|FG002|NOT COMPLETED|Overall Study||32
11021359|NCT00804570|12199555|FG000|STARTED|Overall Study||187
11021360|NCT00804570|12199556|FG001|STARTED|Overall Study||188
11021361|NCT00804570|12199555|FG000|COMPLETED|Overall Study||115
11021362|NCT00804570|12199556|FG001|COMPLETED|Overall Study||94
11021363|NCT00804570|12199555|FG000|NOT COMPLETED|Overall Study||72
11021364|NCT00804570|12199556|FG001|NOT COMPLETED|Overall Study||94
11021365|NCT00804596|12199563|FG000|STARTED|Overall Study||74
11021366|NCT00804596|12199563|FG000|COMPLETED|Overall Study||74
11021367|NCT00804596|12199563|FG000|NOT COMPLETED|Overall Study||0
11021368|NCT00804609|12199569|FG000|STARTED|Overall Study||15
11021369|NCT00804609|12199570|FG001|STARTED|Overall Study||15
11021370|NCT00804609|12199569|FG000|COMPLETED|Overall Study||15
11021371|NCT00804609|12199570|FG001|COMPLETED|Overall Study||14
11021372|NCT00804609|12199569|FG000|NOT COMPLETED|Overall Study||0
11021373|NCT00804609|12199570|FG001|NOT COMPLETED|Overall Study||1
11021374|NCT00804648|12199576|FG000|STARTED|First Intervention||3
11021375|NCT00804648|12199577|FG001|STARTED|First Intervention||5
11396795|NCT03900416|12590719|FG000|COMPLETED|Six Month Follow-up||64
11396796|NCT03900416|12590720|FG001|COMPLETED|Six Month Follow-up||72
11396797|NCT03900416|12590719|FG000|NOT COMPLETED|Six Month Follow-up||5
11021376|NCT00804648|12199578|FG002|STARTED|First Intervention||6
11021377|NCT00804648|12199579|FG003|STARTED|First Intervention||4
11021378|NCT00804648|12199580|FG004|STARTED|First Intervention||4
11021379|NCT00804648|12199581|FG005|STARTED|First Intervention||8
11021380|NCT00804648|12199576|FG000|COMPLETED|First Intervention||3
11021381|NCT00804648|12199577|FG001|COMPLETED|First Intervention||5
11021382|NCT00804648|12199578|FG002|COMPLETED|First Intervention||6
11021383|NCT00804648|12199579|FG003|COMPLETED|First Intervention||4
11021384|NCT00804648|12199580|FG004|COMPLETED|First Intervention||4
11021385|NCT00804648|12199581|FG005|COMPLETED|First Intervention||8
11021386|NCT00804648|12199576|FG000|NOT COMPLETED|First Intervention||0
11021387|NCT00804648|12199577|FG001|NOT COMPLETED|First Intervention||0
11021388|NCT00804648|12199578|FG002|NOT COMPLETED|First Intervention||0
11021389|NCT00804648|12199579|FG003|NOT COMPLETED|First Intervention||0
11021390|NCT00804648|12199580|FG004|NOT COMPLETED|First Intervention||0
11021391|NCT00804648|12199581|FG005|NOT COMPLETED|First Intervention||0
11021392|NCT00804648|12199576|FG000|STARTED|Second Intervention||3
11021393|NCT00804648|12199577|FG001|STARTED|Second Intervention||5
11021394|NCT00804648|12199578|FG002|STARTED|Second Intervention||6
11021395|NCT00804648|12199579|FG003|STARTED|Second Intervention||4
11021396|NCT00804648|12199580|FG004|STARTED|Second Intervention||4
11021397|NCT00804648|12199581|FG005|STARTED|Second Intervention||8
11021398|NCT00804648|12199576|FG000|COMPLETED|Second Intervention||3
11021399|NCT00804648|12199577|FG001|COMPLETED|Second Intervention||5
11021400|NCT00804648|12199578|FG002|COMPLETED|Second Intervention||6
11021401|NCT00804648|12199579|FG003|COMPLETED|Second Intervention||4
11021402|NCT00804648|12199580|FG004|COMPLETED|Second Intervention||4
11021403|NCT00804648|12199581|FG005|COMPLETED|Second Intervention||8
11021404|NCT00804648|12199576|FG000|NOT COMPLETED|Second Intervention||0
11021405|NCT00804648|12199577|FG001|NOT COMPLETED|Second Intervention||0
11396798|NCT03900416|12590720|FG001|NOT COMPLETED|Six Month Follow-up||4
11396799|NCT03905863|12590728|FG000|STARTED|Overall Study||64
11396800|NCT03905863|12590729|FG001|STARTED|Overall Study||81
11396801|NCT03905863|12590728|FG000|COMPLETED|Overall Study||59
11396802|NCT03905863|12590729|FG001|COMPLETED|Overall Study||69
11396803|NCT03905863|12590728|FG000|NOT COMPLETED|Overall Study||5
11396804|NCT03905863|12590729|FG001|NOT COMPLETED|Overall Study||12
11396805|NCT03907033|12590737|FG000|STARTED|Overall Study||14
11396806|NCT03907033|12590738|FG001|STARTED|Overall Study||14
11396807|NCT03907033|12590737|FG000|COMPLETED|Overall Study||14
11021406|NCT00804648|12199578|FG002|NOT COMPLETED|Second Intervention||0
11021407|NCT00804648|12199579|FG003|NOT COMPLETED|Second Intervention||0
11021408|NCT00804648|12199580|FG004|NOT COMPLETED|Second Intervention||0
11021409|NCT00804648|12199581|FG005|NOT COMPLETED|Second Intervention||0
11021410|NCT00804648|12199576|FG000|STARTED|Third Invervention||3
11021411|NCT00804648|12199577|FG001|STARTED|Third Invervention||5
11021412|NCT00804648|12199578|FG002|STARTED|Third Invervention||6
11021413|NCT00804648|12199579|FG003|STARTED|Third Invervention||4
11021414|NCT00804648|12199580|FG004|STARTED|Third Invervention||4
11021415|NCT00804648|12199581|FG005|STARTED|Third Invervention||8
11021416|NCT00804648|12199576|FG000|COMPLETED|Third Invervention||3
11021417|NCT00804648|12199577|FG001|COMPLETED|Third Invervention||5
11021418|NCT00804648|12199578|FG002|COMPLETED|Third Invervention||6
11021419|NCT00804648|12199579|FG003|COMPLETED|Third Invervention||4
11021420|NCT00804648|12199580|FG004|COMPLETED|Third Invervention||4
11021421|NCT00804648|12199581|FG005|COMPLETED|Third Invervention||8
11021422|NCT00804648|12199576|FG000|NOT COMPLETED|Third Invervention||0
11021423|NCT00804648|12199577|FG001|NOT COMPLETED|Third Invervention||0
11021424|NCT00804648|12199578|FG002|NOT COMPLETED|Third Invervention||0
11021425|NCT00804648|12199579|FG003|NOT COMPLETED|Third Invervention||0
11021426|NCT00804648|12199580|FG004|NOT COMPLETED|Third Invervention||0
11021427|NCT00804648|12199581|FG005|NOT COMPLETED|Third Invervention||0
11021428|NCT00804687|12199589|FG000|STARTED|Period 1: Treatment Period||9
11396808|NCT03907033|12590738|FG001|COMPLETED|Overall Study||14
11396809|NCT03907033|12590737|FG000|NOT COMPLETED|Overall Study||0
11396810|NCT03907033|12590738|FG001|NOT COMPLETED|Overall Study||0
11396811|NCT03909971|12590746|FG000|STARTED|Overall Study||67
11396812|NCT03909971|12590747|FG001|STARTED|Overall Study||42
11396813|NCT03909971|12590746|FG000|COMPLETED|Overall Study||57
11396814|NCT03909971|12590747|FG001|COMPLETED|Overall Study||20
11396815|NCT03909971|12590746|FG000|NOT COMPLETED|Overall Study||10
11021429|NCT00804687|12199590|FG001|STARTED|Period 1: Treatment Period||9
11021430|NCT00804687|12199591|FG002|STARTED|Period 1: Treatment Period||9
11021431|NCT00804687|12199592|FG003|STARTED|Period 1: Treatment Period||9
11021432|NCT00804687|12199593|FG004|STARTED|Period 1: Treatment Period||9
11021433|NCT00804687|12199594|FG005|STARTED|Period 1: Treatment Period||8
11021434|NCT00804687|12199589|FG000|COMPLETED|Period 1: Treatment Period||9
11021435|NCT00804687|12199590|FG001|COMPLETED|Period 1: Treatment Period||9
11021436|NCT00804687|12199591|FG002|COMPLETED|Period 1: Treatment Period||9
11021437|NCT00804687|12199592|FG003|COMPLETED|Period 1: Treatment Period||9
11021438|NCT00804687|12199593|FG004|COMPLETED|Period 1: Treatment Period||9
11021439|NCT00804687|12199594|FG005|COMPLETED|Period 1: Treatment Period||8
11396816|NCT03909971|12590747|FG001|NOT COMPLETED|Overall Study||22
11396817|NCT03920215|12590758|FG000|STARTED|Overall Study||26
11396818|NCT03920215|12590759|FG001|STARTED|Overall Study||29
11396819|NCT03920215|12590760|FG002|STARTED|Overall Study||23
11396820|NCT03920215|12590761|FG003|STARTED|Overall Study||23
11396821|NCT03920215|12590758|FG000|COMPLETED|Overall Study||25
11021440|NCT00804687|12199589|FG000|NOT COMPLETED|Period 1: Treatment Period||0
11021441|NCT00804687|12199590|FG001|NOT COMPLETED|Period 1: Treatment Period||0
11021442|NCT00804687|12199591|FG002|NOT COMPLETED|Period 1: Treatment Period||0
11021443|NCT00804687|12199592|FG003|NOT COMPLETED|Period 1: Treatment Period||0
11021444|NCT00804687|12199593|FG004|NOT COMPLETED|Period 1: Treatment Period||0
11021445|NCT00804687|12199594|FG005|NOT COMPLETED|Period 1: Treatment Period||0
11021446|NCT00804687|12199589|FG000|STARTED|Period 2: Washout Period||9
11021447|NCT00804687|12199590|FG001|STARTED|Period 2: Washout Period||9
11021448|NCT00804687|12199591|FG002|STARTED|Period 2: Washout Period||9
11021449|NCT00804687|12199592|FG003|STARTED|Period 2: Washout Period||9
11021450|NCT00804687|12199593|FG004|STARTED|Period 2: Washout Period||9
11021451|NCT00804687|12199594|FG005|STARTED|Period 2: Washout Period||8
11021452|NCT00804687|12199589|FG000|COMPLETED|Period 2: Washout Period||9
11021453|NCT00804687|12199590|FG001|COMPLETED|Period 2: Washout Period||9
11021454|NCT00804687|12199591|FG002|COMPLETED|Period 2: Washout Period||9
11021455|NCT00804687|12199592|FG003|COMPLETED|Period 2: Washout Period||9
11021456|NCT00804687|12199593|FG004|COMPLETED|Period 2: Washout Period||9
11021457|NCT00804687|12199594|FG005|COMPLETED|Period 2: Washout Period||8
11021458|NCT00804687|12199589|FG000|NOT COMPLETED|Period 2: Washout Period||0
11021459|NCT00804687|12199590|FG001|NOT COMPLETED|Period 2: Washout Period||0
11021460|NCT00804687|12199591|FG002|NOT COMPLETED|Period 2: Washout Period||0
11021461|NCT00804687|12199592|FG003|NOT COMPLETED|Period 2: Washout Period||0
11021462|NCT00804687|12199593|FG004|NOT COMPLETED|Period 2: Washout Period||0
11021463|NCT00804687|12199594|FG005|NOT COMPLETED|Period 2: Washout Period||0
11021464|NCT00804687|12199589|FG000|STARTED|Period 3: Treatment Period||9
11021465|NCT00804687|12199590|FG001|STARTED|Period 3: Treatment Period||9
11021466|NCT00804687|12199591|FG002|STARTED|Period 3: Treatment Period||9
11021467|NCT00804687|12199592|FG003|STARTED|Period 3: Treatment Period||9
11021468|NCT00804687|12199593|FG004|STARTED|Period 3: Treatment Period||9
11021469|NCT00804687|12199594|FG005|STARTED|Period 3: Treatment Period||8
11021470|NCT00804687|12199589|FG000|COMPLETED|Period 3: Treatment Period||9
11021471|NCT00804687|12199590|FG001|COMPLETED|Period 3: Treatment Period||9
11021472|NCT00804687|12199591|FG002|COMPLETED|Period 3: Treatment Period||9
11021473|NCT00804687|12199592|FG003|COMPLETED|Period 3: Treatment Period||8
11021474|NCT00804687|12199593|FG004|COMPLETED|Period 3: Treatment Period||9
11021475|NCT00804687|12199594|FG005|COMPLETED|Period 3: Treatment Period||8
11021476|NCT00804687|12199589|FG000|NOT COMPLETED|Period 3: Treatment Period||0
11021477|NCT00804687|12199590|FG001|NOT COMPLETED|Period 3: Treatment Period||0
11021478|NCT00804687|12199591|FG002|NOT COMPLETED|Period 3: Treatment Period||0
11021479|NCT00804687|12199592|FG003|NOT COMPLETED|Period 3: Treatment Period||1
11021480|NCT00804687|12199593|FG004|NOT COMPLETED|Period 3: Treatment Period||0
11021481|NCT00804687|12199594|FG005|NOT COMPLETED|Period 3: Treatment Period||0
11021482|NCT00804687|12199589|FG000|STARTED|Period 4: Washout Period||9
11021483|NCT00804687|12199590|FG001|STARTED|Period 4: Washout Period||9
11021484|NCT00804687|12199591|FG002|STARTED|Period 4: Washout Period||9
11021485|NCT00804687|12199592|FG003|STARTED|Period 4: Washout Period||8
11021486|NCT00804687|12199593|FG004|STARTED|Period 4: Washout Period||9
11021487|NCT00804687|12199594|FG005|STARTED|Period 4: Washout Period||8
11021488|NCT00804687|12199589|FG000|COMPLETED|Period 4: Washout Period||9
11021489|NCT00804687|12199590|FG001|COMPLETED|Period 4: Washout Period||9
11021490|NCT00804687|12199591|FG002|COMPLETED|Period 4: Washout Period||9
11021491|NCT00804687|12199592|FG003|COMPLETED|Period 4: Washout Period||8
11021492|NCT00804687|12199593|FG004|COMPLETED|Period 4: Washout Period||9
11021493|NCT00804687|12199594|FG005|COMPLETED|Period 4: Washout Period||8
11021494|NCT00804687|12199589|FG000|NOT COMPLETED|Period 4: Washout Period||0
11021495|NCT00804687|12199590|FG001|NOT COMPLETED|Period 4: Washout Period||0
11021496|NCT00804687|12199591|FG002|NOT COMPLETED|Period 4: Washout Period||0
11021497|NCT00804687|12199592|FG003|NOT COMPLETED|Period 4: Washout Period||0
11021498|NCT00804687|12199593|FG004|NOT COMPLETED|Period 4: Washout Period||0
11021499|NCT00804687|12199594|FG005|NOT COMPLETED|Period 4: Washout Period||0
11021500|NCT00804687|12199589|FG000|STARTED|Period 5: Treatment Period||9
11021501|NCT00804687|12199590|FG001|STARTED|Period 5: Treatment Period||9
11021502|NCT00804687|12199591|FG002|STARTED|Period 5: Treatment Period||9
11021503|NCT00804687|12199592|FG003|STARTED|Period 5: Treatment Period||8
11021504|NCT00804687|12199593|FG004|STARTED|Period 5: Treatment Period||9
11021505|NCT00804687|12199594|FG005|STARTED|Period 5: Treatment Period||8
11021506|NCT00804687|12199589|FG000|COMPLETED|Period 5: Treatment Period||8
11021507|NCT00804687|12199590|FG001|COMPLETED|Period 5: Treatment Period||9
11021508|NCT00804687|12199591|FG002|COMPLETED|Period 5: Treatment Period||8
11021509|NCT00804687|12199592|FG003|COMPLETED|Period 5: Treatment Period||8
11021510|NCT00804687|12199593|FG004|COMPLETED|Period 5: Treatment Period||8
11021511|NCT00804687|12199594|FG005|COMPLETED|Period 5: Treatment Period||8
11021512|NCT00804687|12199589|FG000|NOT COMPLETED|Period 5: Treatment Period||1
11021513|NCT00804687|12199590|FG001|NOT COMPLETED|Period 5: Treatment Period||0
11021514|NCT00804687|12199591|FG002|NOT COMPLETED|Period 5: Treatment Period||1
11021515|NCT00804687|12199592|FG003|NOT COMPLETED|Period 5: Treatment Period||0
11021516|NCT00804687|12199593|FG004|NOT COMPLETED|Period 5: Treatment Period||1
11021517|NCT00804687|12199594|FG005|NOT COMPLETED|Period 5: Treatment Period||0
11021518|NCT00804843|12199604|FG000|STARTED|Overall Study||50
11021519|NCT00804843|12199605|FG001|STARTED|Overall Study||50
11021520|NCT00804843|12199604|FG000|COMPLETED|Overall Study||40
11021521|NCT00804843|12199605|FG001|COMPLETED|Overall Study||43
11021522|NCT00804843|12199604|FG000|NOT COMPLETED|Overall Study||10
11021523|NCT00804843|12199605|FG001|NOT COMPLETED|Overall Study||7
11021524|NCT00804908|12199615|FG000|STARTED|Overall Study||115
11021525|NCT00804908|12199616|FG001|STARTED|Overall Study||116
11021526|NCT00804908|12199617|FG002|STARTED|Overall Study||115
11021527|NCT00804908|12199615|FG000|COMPLETED|Overall Study||0
11021528|NCT00804908|12199616|FG001|COMPLETED|Overall Study||0
11021529|NCT00804908|12199617|FG002|COMPLETED|Overall Study||1
11021530|NCT00804908|12199615|FG000|NOT COMPLETED|Overall Study||115
11021531|NCT00804908|12199616|FG001|NOT COMPLETED|Overall Study||116
11021532|NCT00804908|12199617|FG002|NOT COMPLETED|Overall Study||114
11056931|NCT00996658|12238595|FG001|COMPLETED|Overall Study||165
11056932|NCT00996658|12238594|FG000|NOT COMPLETED|Overall Study||16
11056933|NCT00996658|12238595|FG001|NOT COMPLETED|Overall Study||21
11056934|NCT00996736|12238603|FG000|STARTED|Overall Study||162
11056935|NCT00996736|12238604|FG001|STARTED|Overall Study||161
11056936|NCT00996736|12238603|FG000|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
11056937|NCT00996736|12238604|FG001|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
11056938|NCT00996736|12238603|FG000|3-month Visit|Overall Study||146
11056939|NCT00996736|12238604|FG001|3-month Visit|Overall Study||146
11056940|NCT00996736|12238603|FG000|COMPLETED|Overall Study||141
11056941|NCT00996736|12238604|FG001|COMPLETED|Overall Study||143
11056942|NCT00996736|12238603|FG000|NOT COMPLETED|Overall Study||21
11056943|NCT00996736|12238604|FG001|NOT COMPLETED|Overall Study||18
11396822|NCT03920215|12590759|FG001|COMPLETED|Overall Study||27
11396823|NCT03920215|12590760|FG002|COMPLETED|Overall Study||23
11396824|NCT03920215|12590761|FG003|COMPLETED|Overall Study||22
11056944|NCT00996775|12238612|FG000|STARTED|Overall Study||78
11056945|NCT00996775|12238613|FG001|STARTED|Overall Study||89
11056946|NCT00996775|12238612|FG000|COMPLETED|Overall Study||67
11056947|NCT00996775|12238613|FG001|COMPLETED|Overall Study||75
11056948|NCT00996775|12238612|FG000|NOT COMPLETED|Overall Study||11
11056949|NCT00996775|12238613|FG001|NOT COMPLETED|Overall Study||14
11056950|NCT00996801|12238625|FG000|STARTED|Overall Study||88
11396825|NCT03920215|12590758|FG000|NOT COMPLETED|Overall Study||1
11056951|NCT00996801|12238626|FG001|STARTED|Overall Study||88
11056952|NCT00996801|12238627|FG002|STARTED|Overall Study||88
11056953|NCT00996801|12238628|FG003|STARTED|Overall Study||87
11056954|NCT00996801|12238629|FG004|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
11056955|NCT00996801|12238630|FG005|STARTED|Overall Study||87
11396826|NCT03920215|12590759|FG001|NOT COMPLETED|Overall Study||2
11056956|NCT00996801|12238625|FG000|COMPLETED|Overall Study||68
11056957|NCT00996801|12238626|FG001|COMPLETED|Overall Study||72
11056958|NCT00996801|12238627|FG002|COMPLETED|Overall Study||65
11056959|NCT00996801|12238628|FG003|COMPLETED|Overall Study||56
11056960|NCT00996801|12238629|FG004|COMPLETED|Overall Study||0
11056961|NCT00996801|12238630|FG005|COMPLETED|Overall Study||68
11056962|NCT00996801|12238625|FG000|NOT COMPLETED|Overall Study||20
11056963|NCT00996801|12238626|FG001|NOT COMPLETED|Overall Study||16
11056964|NCT00996801|12238627|FG002|NOT COMPLETED|Overall Study||23
11056965|NCT00996801|12238628|FG003|NOT COMPLETED|Overall Study||31
11056966|NCT00996801|12238629|FG004|NOT COMPLETED|Overall Study||88
11056967|NCT00996801|12238630|FG005|NOT COMPLETED|Overall Study||19
11056968|NCT00996840|12238651|FG000|STARTED|Overall Study||20
11056969|NCT00996840|12238652|FG001|STARTED|Overall Study||9
11056970|NCT00996840|12238653|FG002|STARTED|Overall Study||12
11056971|NCT00996840|12238654|FG003|STARTED|Overall Study||18
11056972|NCT00996840|12238655|FG004|STARTED|Overall Study||18
11056973|NCT00996840|12238651|FG000|COMPLETED|Overall Study||19
11056974|NCT00996840|12238652|FG001|COMPLETED|Overall Study||7
11056975|NCT00996840|12238653|FG002|COMPLETED|Overall Study||11
11056976|NCT00996840|12238654|FG003|COMPLETED|Overall Study||17
11056977|NCT00996840|12238655|FG004|COMPLETED|Overall Study||16
11056978|NCT00996840|12238651|FG000|NOT COMPLETED|Overall Study||1
11056979|NCT00996840|12238652|FG001|NOT COMPLETED|Overall Study||2
11056980|NCT00996840|12238653|FG002|NOT COMPLETED|Overall Study||1
11056981|NCT00996840|12238654|FG003|NOT COMPLETED|Overall Study||1
11056982|NCT00996840|12238655|FG004|NOT COMPLETED|Overall Study||2
11056983|NCT00996892|12238671|FG000|STARTED|Dose-Escalation Stage 1||4
11056984|NCT00996892|12238672|FG001|STARTED|Dose-Escalation Stage 1||3
11056985|NCT00996892|12238673|FG002|STARTED|Dose-Escalation Stage 1||3
11056986|NCT00996892|12238674|FG003|STARTED|Dose-Escalation Stage 1||9
11056987|NCT00996892|12238675|FG004|STARTED|Dose-Escalation Stage 1||11
11056988|NCT00996892|12238676|FG005|STARTED|Dose-Escalation Stage 1||10
11056989|NCT00996892|12238677|FG006|STARTED|Dose-Escalation Stage 1||4
11056990|NCT00996892|12238678|FG007|STARTED|Dose-Escalation Stage 1||0
11056991|NCT00996892|12238679|FG008|STARTED|Dose-Escalation Stage 1||0
11056992|NCT00996892|12238680|FG009|STARTED|Dose-Escalation Stage 1||0
11056993|NCT00996892|12238681|FG010|STARTED|Dose-Escalation Stage 1||0
11056994|NCT00996892|12238682|FG011|STARTED|Dose-Escalation Stage 1||0
11056995|NCT00996892|12238683|FG012|STARTED|Dose-Escalation Stage 1||0
11056996|NCT00996892|12238684|FG013|STARTED|Dose-Escalation Stage 1||0
11056997|NCT00996892|12238685|FG014|STARTED|Dose-Escalation Stage 1||0
11056998|NCT00996892|12238686|FG015|STARTED|Dose-Escalation Stage 1||0
11056999|NCT00996892|12238687|FG016|STARTED|Dose-Escalation Stage 1||0
11057000|NCT00996892|12238688|FG017|STARTED|Dose-Escalation Stage 1||0
11057001|NCT00996892|12238689|FG018|STARTED|Dose-Escalation Stage 1||0
11057002|NCT00996892|12238690|FG019|STARTED|Dose-Escalation Stage 1||0
11057003|NCT00996892|12238671|FG000|COMPLETED|Dose-Escalation Stage 1||0
11057004|NCT00996892|12238672|FG001|COMPLETED|Dose-Escalation Stage 1||0
11143618|NCT01474512|12330429|FG007|NOT COMPLETED|Induction Period||0
11143619|NCT01474512|12330430|FG008|NOT COMPLETED|Induction Period||0
11143620|NCT01474512|12330431|FG009|NOT COMPLETED|Induction Period||0
11143621|NCT01474512|12330432|FG010|NOT COMPLETED|Induction Period||0
11143622|NCT01474512|12330433|FG011|NOT COMPLETED|Induction Period||0
11143623|NCT01474512|12330434|FG012|NOT COMPLETED|Induction Period||0
11143624|NCT01474512|12330435|FG013|NOT COMPLETED|Induction Period||0
11143625|NCT01474512|12330436|FG014|NOT COMPLETED|Induction Period||0
11143626|NCT01474512|12330437|FG015|NOT COMPLETED|Induction Period||0
11143627|NCT01474512|12330438|FG016|NOT COMPLETED|Induction Period||0
11143628|NCT01474512|12330439|FG017|NOT COMPLETED|Induction Period||0
11143629|NCT01474512|12330422|FG000|STARTED|Maintenance Period||0
11143630|NCT01474512|12330423|FG001|STARTED|Maintenance Period||0
11143631|NCT01474512|12330424|FG002|STARTED|Maintenance Period||0
11143632|NCT01474512|12330425|FG003|STARTED|Maintenance Period||226
11143633|NCT01474512|12330426|FG004|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
11143634|NCT01474512|12330427|FG005|STARTED|Maintenance Period||229
11143635|NCT01474512|12330428|FG006|STARTED|Maintenance Period||16
11143636|NCT01474512|12330429|FG007|STARTED|Maintenance Period||391
11143637|NCT01474512|12330430|FG008|STARTED|Maintenance Period||78
11143638|NCT01474512|12330431|FG009|STARTED|Maintenance Period||62
11143639|NCT01474512|12330432|FG010|STARTED|Maintenance Period||0
11143640|NCT01474512|12330433|FG011|STARTED|Maintenance Period||0
11143641|NCT01474512|12330434|FG012|STARTED|Maintenance Period||0
11143642|NCT01474512|12330435|FG013|STARTED|Maintenance Period||0
11143643|NCT01474512|12330436|FG014|STARTED|Maintenance Period||0
11143644|NCT01474512|12330437|FG015|STARTED|Maintenance Period||0
11143645|NCT01474512|12330438|FG016|STARTED|Maintenance Period||0
11143646|NCT01474512|12330439|FG017|STARTED|Maintenance Period||0
11143647|NCT01474512|12330422|FG000|Received Study Drug|Maintenance Period||0
11143648|NCT01474512|12330423|FG001|Received Study Drug|Maintenance Period||0
11143649|NCT01474512|12330424|FG002|Received Study Drug|Maintenance Period||0
11143650|NCT01474512|12330425|FG003|Received Study Drug|Maintenance Period||226
11143651|NCT01474512|12330426|FG004|Received Study Drug|Maintenance Period||227
11021533|NCT00804973|12199628|FG000|STARTED|Overall Study||40
11021534|NCT00804973|12199629|FG001|STARTED|Overall Study||40
11021535|NCT00804973|12199630|FG002|STARTED|Overall Study||40
11021536|NCT00804973|12199628|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
11021537|NCT00804973|12199629|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40
11021538|NCT00804973|12199630|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40
11143652|NCT01474512|12330427|FG005|Received Study Drug|Maintenance Period||229
11143653|NCT01474512|12330428|FG006|Received Study Drug|Maintenance Period||16
11143654|NCT01474512|12330429|FG007|Received Study Drug|Maintenance Period||391
11143655|NCT01474512|12330430|FG008|Received Study Drug|Maintenance Period||78
11143656|NCT01474512|12330431|FG009|Received Study Drug|Maintenance Period||62
11143657|NCT01474512|12330432|FG010|Received Study Drug|Maintenance Period||0
11143658|NCT01474512|12330433|FG011|Received Study Drug|Maintenance Period||0
11143659|NCT01474512|12330434|FG012|Received Study Drug|Maintenance Period||0
11143660|NCT01474512|12330435|FG013|Received Study Drug|Maintenance Period||0
11143661|NCT01474512|12330436|FG014|Received Study Drug|Maintenance Period||0
11143662|NCT01474512|12330437|FG015|Received Study Drug|Maintenance Period||0
11143663|NCT01474512|12330438|FG016|Received Study Drug|Maintenance Period||0
11143664|NCT01474512|12330439|FG017|Received Study Drug|Maintenance Period||0
11143665|NCT01474512|12330422|FG000|Relapsed Population Received Drug|Maintenance Period||0
11143666|NCT01474512|12330423|FG001|Relapsed Population Received Drug|Maintenance Period||0
11143667|NCT01474512|12330424|FG002|Relapsed Population Received Drug|Maintenance Period||0
11143668|NCT01474512|12330425|FG003|Relapsed Population Received Drug|Maintenance Period||0
11143669|NCT01474512|12330426|FG004|Relapsed Population Received Drug|Maintenance Period||0
11143670|NCT01474512|12330427|FG005|Relapsed Population Received Drug|Maintenance Period||0
11143671|NCT01474512|12330428|FG006|Relapsed Population Received Drug|Maintenance Period||0
11143672|NCT01474512|12330429|FG007|Relapsed Population Received Drug|Maintenance Period||0
11143673|NCT01474512|12330430|FG008|Relapsed Population Received Drug|Maintenance Period||0
11143674|NCT01474512|12330431|FG009|Relapsed Population Received Drug|Maintenance Period||0
11143675|NCT01474512|12330432|FG010|Relapsed Population Received Drug|Maintenance Period||348
11143676|NCT01474512|12330433|FG011|Relapsed Population Received Drug|Maintenance Period||0
11143677|NCT01474512|12330434|FG012|Relapsed Population Received Drug|Maintenance Period||0
11143678|NCT01474512|12330435|FG013|Relapsed Population Received Drug|Maintenance Period||0
11143679|NCT01474512|12330436|FG014|Relapsed Population Received Drug|Maintenance Period||0
11143680|NCT01474512|12330437|FG015|Relapsed Population Received Drug|Maintenance Period||0
11143681|NCT01474512|12330438|FG016|Relapsed Population Received Drug|Maintenance Period||0
11143682|NCT01474512|12330439|FG017|Relapsed Population Received Drug|Maintenance Period||0
11143683|NCT01474512|12330422|FG000|Relapsed Population Completers|Maintenance Period||0
11143684|NCT01474512|12330423|FG001|Relapsed Population Completers|Maintenance Period||0
11143685|NCT01474512|12330424|FG002|Relapsed Population Completers|Maintenance Period||0
11143686|NCT01474512|12330425|FG003|Relapsed Population Completers|Maintenance Period||0
11263782|NCT02271984|12459063|FG002|COMPLETED|Fifth Intervention Period (1 Day)||3
11143687|NCT01474512|12330426|FG004|Relapsed Population Completers|Maintenance Period||0
11143688|NCT01474512|12330427|FG005|Relapsed Population Completers|Maintenance Period||0
11143689|NCT01474512|12330428|FG006|Relapsed Population Completers|Maintenance Period||0
11143690|NCT01474512|12330429|FG007|Relapsed Population Completers|Maintenance Period||0
11143691|NCT01474512|12330430|FG008|Relapsed Population Completers|Maintenance Period||0
11143692|NCT01474512|12330431|FG009|Relapsed Population Completers|Maintenance Period||0
11143693|NCT01474512|12330432|FG010|Relapsed Population Completers|Maintenance Period||321
11143694|NCT01474512|12330433|FG011|Relapsed Population Completers|Maintenance Period||0
11143695|NCT01474512|12330434|FG012|Relapsed Population Completers|Maintenance Period||0
11263783|NCT02271984|12459064|FG003|COMPLETED|Fifth Intervention Period (1 Day)||3
11263784|NCT02271984|12459065|FG004|COMPLETED|Fifth Intervention Period (1 Day)||3
11263785|NCT02271984|12459066|FG005|COMPLETED|Fifth Intervention Period (1 Day)||2
11263786|NCT02271984|12459067|FG006|COMPLETED|Fifth Intervention Period (1 Day)||3
11263787|NCT02271984|12459068|FG007|COMPLETED|Fifth Intervention Period (1 Day)||2
11263788|NCT02271984|12459069|FG008|COMPLETED|Fifth Intervention Period (1 Day)||3
11263789|NCT02271984|12459070|FG009|COMPLETED|Fifth Intervention Period (1 Day)||3
11263790|NCT02271984|12459071|FG010|COMPLETED|Fifth Intervention Period (1 Day)||3
11263791|NCT02271984|12459072|FG011|COMPLETED|Fifth Intervention Period (1 Day)||3
11263792|NCT02271984|12459061|FG000|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
11263793|NCT02271984|12459062|FG001|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
11263794|NCT02271984|12459063|FG002|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
11263795|NCT02271984|12459064|FG003|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
11263796|NCT02271984|12459065|FG004|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
11263797|NCT02271984|12459066|FG005|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
11263798|NCT02271984|12459067|FG006|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
11263799|NCT02271984|12459068|FG007|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
11263800|NCT02271984|12459069|FG008|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
11263801|NCT02271984|12459070|FG009|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
11263802|NCT02271984|12459071|FG010|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
11263803|NCT02271984|12459072|FG011|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
11263804|NCT02272244|12459089|FG000|STARTED|Overall Study||203
11263805|NCT02272244|12459090|FG001|STARTED|Overall Study||197
11263806|NCT02272244|12459089|FG000|COMPLETED|Overall Study||203
11263807|NCT02272244|12459090|FG001|COMPLETED|Overall Study||197
11263808|NCT02272244|12459089|FG000|NOT COMPLETED|Overall Study||0
11263809|NCT02272244|12459090|FG001|NOT COMPLETED|Overall Study||0
11263810|NCT02272413|12459098|FG000|STARTED|Randomized Through Treatment Start|Started for this period|338
11263811|NCT02272413|12459099|FG001|STARTED|Randomized Through Treatment Start|Started for this period|333
11396827|NCT03920215|12590760|FG002|NOT COMPLETED|Overall Study||0
11396828|NCT03920215|12590761|FG003|NOT COMPLETED|Overall Study||1
11396829|NCT03921151|12590773|FG000|STARTED|Overall Study||46
11396830|NCT03921151|12590774|FG001|STARTED|Overall Study||44
11396831|NCT03921151|12590773|FG000|COMPLETED|Overall Study||35
11396832|NCT03921151|12590774|FG001|COMPLETED|Overall Study||28
11396833|NCT03921151|12590773|FG000|NOT COMPLETED|Overall Study||11
11263812|NCT02272413|12459098|FG000|Treated|Randomized Through Treatment Start||335
11263813|NCT02272413|12459099|FG001|Treated|Randomized Through Treatment Start||328
11263814|NCT02272413|12459098|FG000|COMPLETED|Randomized Through Treatment Start||335
11263815|NCT02272413|12459099|FG001|COMPLETED|Randomized Through Treatment Start||328
11263816|NCT02272413|12459098|FG000|NOT COMPLETED|Randomized Through Treatment Start||3
11263817|NCT02272413|12459099|FG001|NOT COMPLETED|Randomized Through Treatment Start||5
11263818|NCT02272413|12459098|FG000|STARTED|Pre-switch Period|Started for this period|335
11263819|NCT02272413|12459099|FG001|STARTED|Pre-switch Period|Started for this period|328
11263820|NCT02272413|12459098|FG000|COMPLETED|Pre-switch Period||42
11263821|NCT02272413|12459099|FG001|COMPLETED|Pre-switch Period||46
11263822|NCT02272413|12459098|FG000|NOT COMPLETED|Pre-switch Period||293
11263823|NCT02272413|12459099|FG001|NOT COMPLETED|Pre-switch Period||282
11263824|NCT02272413|12459098|FG000|STARTED|Post-switch Period|Started for this period|42
11263825|NCT02272413|12459099|FG001|STARTED|Post-switch Period|Started for this period|46
11263826|NCT02272413|12459098|FG000|COMPLETED|Post-switch Period||0
11263827|NCT02272413|12459099|FG001|COMPLETED|Post-switch Period||0
11263828|NCT02272413|12459098|FG000|NOT COMPLETED|Post-switch Period||42
11396834|NCT03921151|12590774|FG001|NOT COMPLETED|Overall Study||16
11396835|NCT03926039|12590782|FG000|STARTED|Overall Study||35
11396836|NCT03926039|12590783|FG001|STARTED|Overall Study||35
11396837|NCT03926039|12590782|FG000|COMPLETED|Overall Study||35
11263829|NCT02272413|12459099|FG001|NOT COMPLETED|Post-switch Period||46
11263830|NCT02272634|12459110|FG000|STARTED|Overall Study||20
11263831|NCT02272634|12459111|FG001|STARTED|Overall Study||21
11263832|NCT02272634|12459112|FG002|STARTED|Overall Study||20
11263833|NCT02272634|12459110|FG000|COMPLETED|Overall Study||19
11263834|NCT02272634|12459111|FG001|COMPLETED|Overall Study||20
11263835|NCT02272634|12459112|FG002|COMPLETED|Overall Study||19
11263836|NCT02272634|12459110|FG000|NOT COMPLETED|Overall Study||1
11263837|NCT02272634|12459111|FG001|NOT COMPLETED|Overall Study||1
11263838|NCT02272634|12459112|FG002|NOT COMPLETED|Overall Study||1
11263839|NCT02272686|12459123|FG000|STARTED|Overall Study||1
11263840|NCT02272686|12459123|FG000|COMPLETED|Overall Study||1
11263841|NCT02272686|12459123|FG000|NOT COMPLETED|Overall Study||0
11263842|NCT02272725|12459129|FG000|STARTED|Overall Study||49
11263843|NCT02272725|12459130|FG001|STARTED|Overall Study||42
11263844|NCT02272725|12459129|FG000|COMPLETED|Overall Study||47
11396838|NCT03926039|12590783|FG001|COMPLETED|Overall Study||34
11396839|NCT03926039|12590782|FG000|NOT COMPLETED|Overall Study||0
11396840|NCT03926039|12590783|FG001|NOT COMPLETED|Overall Study||1
11263845|NCT02272725|12459130|FG001|COMPLETED|Overall Study||42
11263846|NCT02272725|12459129|FG000|NOT COMPLETED|Overall Study||2
11263847|NCT02272725|12459130|FG001|NOT COMPLETED|Overall Study||0
11263848|NCT02272777|12459138|FG000|STARTED|Overall Study||112
11263849|NCT02272777|12459139|FG001|STARTED|Overall Study||113
11263850|NCT02272777|12459138|FG000|COMPLETED|Overall Study||108
11263851|NCT02272777|12459139|FG001|COMPLETED|Overall Study||109
11263852|NCT02272777|12459138|FG000|NOT COMPLETED|Overall Study||4
11263853|NCT02272777|12459139|FG001|NOT COMPLETED|Overall Study||4
11263854|NCT02272816|12459145|FG000|STARTED|Overall Study||48
11263855|NCT02272816|12459145|FG000|COMPLETED|Overall Study||47
11263856|NCT02272816|12459145|FG000|NOT COMPLETED|Overall Study||1
11263857|NCT02272842|12459151|FG000|STARTED|Overall Study||300
11263858|NCT02272842|12459152|FG001|STARTED|Overall Study||300
11263859|NCT02272842|12459151|FG000|COMPLETED|Overall Study||284
11263860|NCT02272842|12459152|FG001|COMPLETED|Overall Study||290
11263861|NCT02272842|12459151|FG000|NOT COMPLETED|Overall Study||16
11263862|NCT02272842|12459152|FG001|NOT COMPLETED|Overall Study||10
11263863|NCT02272985|12459159|FG000|STARTED|Overall Study||15
11263864|NCT02272985|12459159|FG000|COMPLETED|Overall Study||12
11263865|NCT02272985|12459159|FG000|NOT COMPLETED|Overall Study||3
11263866|NCT02273037|12459166|FG000|STARTED|Overall Study||987
11263867|NCT02273037|12459167|FG001|STARTED|Overall Study||1000
11263868|NCT02273037|12459166|FG000|COMPLETED|Overall Study||979
11263869|NCT02273037|12459167|FG001|COMPLETED|Overall Study||992
11263870|NCT02273037|12459166|FG000|NOT COMPLETED|Overall Study||8
11263871|NCT02273037|12459167|FG001|NOT COMPLETED|Overall Study||8
11263872|NCT02273050|12459178|FG000|STARTED|Overall Study||210
11263873|NCT02273050|12459179|FG001|STARTED|Overall Study||216
11263874|NCT02273050|12459180|FG002|STARTED|Overall Study||214
11263875|NCT02273050|12459178|FG000|COMPLETED|Overall Study||186
11263876|NCT02273050|12459179|FG001|COMPLETED|Overall Study||194
11263877|NCT02273050|12459180|FG002|COMPLETED|Overall Study||185
11263878|NCT02273050|12459178|FG000|NOT COMPLETED|Overall Study||24
11263879|NCT02273050|12459179|FG001|NOT COMPLETED|Overall Study||22
11263880|NCT02273050|12459180|FG002|NOT COMPLETED|Overall Study||29
11396841|NCT03927911|12590795|FG000|STARTED|Overall Study||0
11263881|NCT02273063|12459188|FG000|STARTED|Overall Study||40
11263882|NCT02273063|12459188|FG000|COMPLETED|Overall Study||35
11263883|NCT02273063|12459188|FG000|NOT COMPLETED|Overall Study||5
11263884|NCT02273115|12459197|FG000|STARTED|Overall Study||94
11263885|NCT02273115|12459198|FG001|STARTED|Overall Study||90
11263886|NCT02273115|12459199|FG002|STARTED|Overall Study||67
11263887|NCT02273115|12459200|FG003|STARTED|Overall Study||72
11263888|NCT02273115|12459197|FG000|COMPLETED|Overall Study||94
11263889|NCT02273115|12459198|FG001|COMPLETED|Overall Study||90
11263890|NCT02273115|12459199|FG002|COMPLETED|Overall Study||67
11263891|NCT02273115|12459200|FG003|COMPLETED|Overall Study||71
11263892|NCT02273115|12459197|FG000|NOT COMPLETED|Overall Study||0
11263893|NCT02273115|12459198|FG001|NOT COMPLETED|Overall Study||0
11263894|NCT02273115|12459199|FG002|NOT COMPLETED|Overall Study||0
11263895|NCT02273115|12459200|FG003|NOT COMPLETED|Overall Study||1
11263896|NCT02273141|12459212|FG000|STARTED|Overall Study||257
11263897|NCT02273141|12459213|FG001|STARTED|Overall Study||258
11263898|NCT02273141|12459212|FG000|COMPLETED|Overall Study||240
11263899|NCT02273141|12459213|FG001|COMPLETED|Overall Study||233
11263900|NCT02273141|12459212|FG000|NOT COMPLETED|Overall Study||17
11263901|NCT02273141|12459213|FG001|NOT COMPLETED|Overall Study||25
11263902|NCT02273167|12459222|FG000|STARTED|Overall Study||283
11263903|NCT02273167|12459223|FG001|STARTED|Overall Study||283
11263904|NCT02273167|12459224|FG002|STARTED|Overall Study||283
11263905|NCT02273167|12459222|FG000|COMPLETED|Overall Study||259
11263906|NCT02273167|12459223|FG001|COMPLETED|Overall Study||260
11263907|NCT02273167|12459224|FG002|COMPLETED|Overall Study||262
11263908|NCT02273167|12459222|FG000|NOT COMPLETED|Overall Study||24
11263909|NCT02273167|12459223|FG001|NOT COMPLETED|Overall Study||23
11263910|NCT02273167|12459224|FG002|NOT COMPLETED|Overall Study||21
11263911|NCT02273180|12459235|FG000|STARTED|Overall Study||253
11263912|NCT02273180|12459236|FG001|STARTED|Overall Study||254
11263913|NCT02273180|12459235|FG000|Treated|Overall Study||252
11263914|NCT02273180|12459236|FG001|Treated|Overall Study||254
11263915|NCT02273180|12459235|FG000|COMPLETED|Overall Study||226
11263916|NCT02273180|12459236|FG001|COMPLETED|Overall Study||235
11263917|NCT02273180|12459235|FG000|NOT COMPLETED|Overall Study||27
11263918|NCT02273180|12459236|FG001|NOT COMPLETED|Overall Study||19
11263919|NCT02273206|12459244|FG000|STARTED|Overall Study||378
11263920|NCT02273206|12459245|FG001|STARTED|Overall Study||379
11263921|NCT02273206|12459244|FG000|COMPLETED|Overall Study||353
11263922|NCT02273206|12459245|FG001|COMPLETED|Overall Study||337
11263923|NCT02273206|12459244|FG000|NOT COMPLETED|Overall Study||25
11263924|NCT02273206|12459245|FG001|NOT COMPLETED|Overall Study||42
11263925|NCT02273310|12459253|FG000|STARTED|Overall Study||42
11263926|NCT02273310|12459254|FG001|STARTED|Overall Study||41
11263927|NCT02273310|12459253|FG000|COMPLETED|Overall Study||24
11263928|NCT02273310|12459254|FG001|COMPLETED|Overall Study||38
11263929|NCT02273310|12459253|FG000|NOT COMPLETED|Overall Study||18
11263930|NCT02273310|12459254|FG001|NOT COMPLETED|Overall Study||3
11263931|NCT02273323|12459261|FG000|STARTED|Overall Study||15
11263932|NCT02273323|12459262|FG001|STARTED|Overall Study||15
11263933|NCT02273323|12459261|FG000|COMPLETED|Overall Study||15
11263934|NCT02273323|12459262|FG001|COMPLETED|Overall Study||15
11263935|NCT02273323|12459261|FG000|NOT COMPLETED|Overall Study||0
11263936|NCT02273323|12459262|FG001|NOT COMPLETED|Overall Study||0
11263937|NCT02273596|12459268|FG000|STARTED|24-Week Treatment Period||29
11263938|NCT02273596|12459268|FG000|Received at Least 1 Dose of Study Drug|24-Week Treatment Period||28
11263939|NCT02273596|12459268|FG000|COMPLETED|24-Week Treatment Period||22
11263940|NCT02273596|12459268|FG000|NOT COMPLETED|24-Week Treatment Period||7
11263941|NCT02273596|12459268|FG000|STARTED|Extension Period||22
11263942|NCT02273596|12459268|FG000|Received at Least 1 Dose of Study Drug|Extension Period||22
11263943|NCT02273596|12459268|FG000|COMPLETED|Extension Period||0
11263944|NCT02273596|12459268|FG000|NOT COMPLETED|Extension Period||22
11263945|NCT02273726|12459280|FG000|STARTED|Overall Study||370
11263946|NCT02273726|12459281|FG001|STARTED|Overall Study||371
11263947|NCT02273726|12459280|FG000|Received at Least 1 Dose of Study Drug|Overall Study||370
11263948|NCT02273726|12459281|FG001|Received at Least 1 Dose of Study Drug|Overall Study||370
11263949|NCT02273726|12459280|FG000|COMPLETED|Overall Study||127
11263950|NCT02273726|12459281|FG001|COMPLETED|Overall Study||183
11263951|NCT02273726|12459280|FG000|NOT COMPLETED|Overall Study||243
11263952|NCT02273726|12459281|FG001|NOT COMPLETED|Overall Study||188
11263953|NCT02273739|12459291|FG000|STARTED|Overall Study||3
11263954|NCT02273739|12459292|FG001|STARTED|Overall Study||4
11263955|NCT02273739|12459293|FG002|STARTED|Overall Study||7
11263956|NCT02273739|12459294|FG003|STARTED|Overall Study||7
11263957|NCT02273739|12459291|FG000|COMPLETED|Overall Study||0
11263958|NCT02273739|12459292|FG001|COMPLETED|Overall Study||0
11263959|NCT02273739|12459293|FG002|COMPLETED|Overall Study||0
11263960|NCT02273739|12459294|FG003|COMPLETED|Overall Study||0
11263961|NCT02273739|12459291|FG000|NOT COMPLETED|Overall Study||3
11263962|NCT02273739|12459292|FG001|NOT COMPLETED|Overall Study||4
11263963|NCT02273739|12459293|FG002|NOT COMPLETED|Overall Study||7
11263964|NCT02273739|12459294|FG003|NOT COMPLETED|Overall Study||7
11263965|NCT02273908|12459311|FG000|STARTED|Overall Study||157
11263966|NCT02273908|12459312|FG001|STARTED|Overall Study||174
11263967|NCT02273908|12459311|FG000|COMPLETED|Overall Study||124
11263968|NCT02273908|12459312|FG001|COMPLETED|Overall Study||169
11263969|NCT02273908|12459311|FG000|NOT COMPLETED|Overall Study||33
11263970|NCT02273908|12459312|FG001|NOT COMPLETED|Overall Study||5
11263971|NCT02273960|12459326|FG000|STARTED|Short Term Period||5
11263972|NCT02273960|12459327|FG001|STARTED|Short Term Period||6
11263973|NCT02273960|12459328|FG002|STARTED|Short Term Period||5
11263974|NCT02273960|12459329|FG003|STARTED|Short Term Period||10
11263975|NCT02273960|12459326|FG000|COMPLETED|Short Term Period||0
11263976|NCT02273960|12459327|FG001|COMPLETED|Short Term Period||0
11263977|NCT02273960|12459328|FG002|COMPLETED|Short Term Period||1
11263978|NCT02273960|12459329|FG003|COMPLETED|Short Term Period||4
11263979|NCT02273960|12459326|FG000|NOT COMPLETED|Short Term Period||5
11263980|NCT02273960|12459327|FG001|NOT COMPLETED|Short Term Period||6
11263981|NCT02273960|12459328|FG002|NOT COMPLETED|Short Term Period||4
11263982|NCT02273960|12459329|FG003|NOT COMPLETED|Short Term Period||6
11263983|NCT02273960|12459326|FG000|STARTED|Long Term Extension||0
11263984|NCT02273960|12459327|FG001|STARTED|Long Term Extension||0
11263985|NCT02273960|12459328|FG002|STARTED|Long Term Extension||1
11263986|NCT02273960|12459329|FG003|STARTED|Long Term Extension||4
11263987|NCT02273960|12459326|FG000|COMPLETED|Long Term Extension||0
11263988|NCT02273960|12459327|FG001|COMPLETED|Long Term Extension||0
11263989|NCT02273960|12459328|FG002|COMPLETED|Long Term Extension||1
11263990|NCT02273960|12459329|FG003|COMPLETED|Long Term Extension||3
11263991|NCT02273960|12459326|FG000|NOT COMPLETED|Long Term Extension||0
11263992|NCT02273960|12459327|FG001|NOT COMPLETED|Long Term Extension||0
11263993|NCT02273960|12459328|FG002|NOT COMPLETED|Long Term Extension||0
11263994|NCT02273960|12459329|FG003|NOT COMPLETED|Long Term Extension||1
11263995|NCT02273973|12459341|FG000|STARTED|Overall Study||166
11263996|NCT02273973|12459342|FG001|STARTED|Overall Study||168
11263997|NCT02273973|12459341|FG000|COMPLETED|Overall Study||157
11263998|NCT02273973|12459342|FG001|COMPLETED|Overall Study||160
11263999|NCT02273973|12459341|FG000|NOT COMPLETED|Overall Study||9
11264000|NCT02273973|12459342|FG001|NOT COMPLETED|Overall Study||8
11264001|NCT02274038|12459348|FG000|STARTED|Overall Study||3
11264002|NCT02274038|12459348|FG000|COMPLETED|Overall Study||2
11264003|NCT02274038|12459348|FG000|NOT COMPLETED|Overall Study||1
11264004|NCT02274311|12459354|FG000|STARTED|Three Months of Clomiphene Treatment||16
11264005|NCT02274311|12459354|FG000|COMPLETED|Three Months of Clomiphene Treatment||16
11264006|NCT02274311|12459354|FG000|NOT COMPLETED|Three Months of Clomiphene Treatment||0
11264007|NCT02274311|12459354|FG000|STARTED|Three Months of Clomiphene Wash-out||16
11264008|NCT02274311|12459354|FG000|COMPLETED|Three Months of Clomiphene Wash-out||15
11264009|NCT02274311|12459354|FG000|NOT COMPLETED|Three Months of Clomiphene Wash-out||1
11264010|NCT02274493|12459360|FG000|STARTED|Overall Study||15
11264011|NCT02274493|12459360|FG000|COMPLETED|Overall Study||14
11264012|NCT02274493|12459360|FG000|NOT COMPLETED|Overall Study||1
11264013|NCT02274558|12459367|FG000|STARTED|Overall Study||78
11264014|NCT02274558|12459368|FG001|STARTED|Overall Study||76
11264015|NCT02274558|12459369|FG002|STARTED|Overall Study||80
11264016|NCT02274558|12459367|FG000|Included in the Safety Analysis Set|Overall Study||76
11264017|NCT02274558|12459368|FG001|Included in the Safety Analysis Set|Overall Study||72
11264018|NCT02274558|12459369|FG002|Included in the Safety Analysis Set|Overall Study||79
11264019|NCT02274558|12459367|FG000|COMPLETED|Overall Study||71
11264020|NCT02274558|12459368|FG001|COMPLETED|Overall Study||63
11264021|NCT02274558|12459369|FG002|COMPLETED|Overall Study||71
11264022|NCT02274558|12459367|FG000|NOT COMPLETED|Overall Study||7
11264023|NCT02274558|12459368|FG001|NOT COMPLETED|Overall Study||13
11264024|NCT02274558|12459369|FG002|NOT COMPLETED|Overall Study||9
11264025|NCT02274649|12459381|FG000|STARTED|Overall Study||101
11264026|NCT02274649|12459382|FG001|STARTED|Overall Study||93
11264027|NCT02274649|12459381|FG000|COMPLETED|Overall Study||77
11264028|NCT02274649|12459382|FG001|COMPLETED|Overall Study||81
11264029|NCT02274649|12459381|FG000|NOT COMPLETED|Overall Study||24
11264030|NCT02274649|12459382|FG001|NOT COMPLETED|Overall Study||12
11264031|NCT02274675|12459388|FG000|STARTED|Overall Study||7
11264032|NCT02274675|12459388|FG000|COMPLETED|Overall Study||7
11264033|NCT02274675|12459388|FG000|NOT COMPLETED|Overall Study||0
11264034|NCT02274688|12459394|FG000|STARTED|Overall Study||86
11264035|NCT02274688|12459395|FG001|STARTED|Overall Study||85
11264036|NCT02274688|12459394|FG000|COMPLETED|Overall Study||72
11264037|NCT02274688|12459395|FG001|COMPLETED|Overall Study||72
11264038|NCT02274688|12459394|FG000|NOT COMPLETED|Overall Study||14
11264039|NCT02274688|12459395|FG001|NOT COMPLETED|Overall Study||13
11340100|NCT02918318|12537369|FG000|STARTED|Posttreatment Phase: Up to 24 Weeks||13
11340101|NCT02918318|12537370|FG001|STARTED|Posttreatment Phase: Up to 24 Weeks||11
11340102|NCT02918318|12537371|FG002|STARTED|Posttreatment Phase: Up to 24 Weeks||17
11340103|NCT02918318|12537372|FG003|STARTED|Posttreatment Phase: Up to 24 Weeks||27
11340104|NCT02918318|12537373|FG004|STARTED|Posttreatment Phase: Up to 24 Weeks||0
11340105|NCT02918318|12537369|FG000|COMPLETED|Posttreatment Phase: Up to 24 Weeks||12
11340106|NCT02918318|12537370|FG001|COMPLETED|Posttreatment Phase: Up to 24 Weeks||8
11340107|NCT02918318|12537371|FG002|COMPLETED|Posttreatment Phase: Up to 24 Weeks||16
11340108|NCT02918318|12537372|FG003|COMPLETED|Posttreatment Phase: Up to 24 Weeks||25
11340109|NCT02918318|12537373|FG004|COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
11340110|NCT02918318|12537369|FG000|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
11340111|NCT02918318|12537370|FG001|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||3
11340112|NCT02918318|12537371|FG002|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
11340113|NCT02918318|12537372|FG003|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||2
11340114|NCT02918318|12537373|FG004|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
11340115|NCT02918318|12537369|FG000|STARTED|Open Label Treatment Phase: 4 Weeks||0
11340116|NCT02918318|12537370|FG001|STARTED|Open Label Treatment Phase: 4 Weeks||0
11340117|NCT02918318|12537371|FG002|STARTED|Open Label Treatment Phase: 4 Weeks||0
11340118|NCT02918318|12537372|FG003|STARTED|Open Label Treatment Phase: 4 Weeks||0
11340119|NCT02918318|12537373|FG004|STARTED|Open Label Treatment Phase: 4 Weeks||48
11340120|NCT02918318|12537369|FG000|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
11340121|NCT02918318|12537370|FG001|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
11340122|NCT02918318|12537371|FG002|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
11340123|NCT02918318|12537372|FG003|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
11340124|NCT02918318|12537373|FG004|COMPLETED|Open Label Treatment Phase: 4 Weeks||47
11340125|NCT02918318|12537369|FG000|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
11340126|NCT02918318|12537370|FG001|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
11340127|NCT02918318|12537371|FG002|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
11340128|NCT02918318|12537372|FG003|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
11340129|NCT02918318|12537373|FG004|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||1
11340130|NCT02918318|12537369|FG000|STARTED|Open Label Follow-up Phase: 4 Weeks||0
11340131|NCT02918318|12537370|FG001|STARTED|Open Label Follow-up Phase: 4 Weeks||0
11340132|NCT02918318|12537371|FG002|STARTED|Open Label Follow-up Phase: 4 Weeks||0
11340133|NCT02918318|12537372|FG003|STARTED|Open Label Follow-up Phase: 4 Weeks||0
11340134|NCT02918318|12537373|FG004|STARTED|Open Label Follow-up Phase: 4 Weeks||48
11340135|NCT02918318|12537369|FG000|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
11340136|NCT02918318|12537370|FG001|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
11340137|NCT02918318|12537371|FG002|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
11340138|NCT02918318|12537372|FG003|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
11340139|NCT02918318|12537373|FG004|COMPLETED|Open Label Follow-up Phase: 4 Weeks||47
11340140|NCT02918318|12537369|FG000|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
11340141|NCT02918318|12537370|FG001|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
11340142|NCT02918318|12537371|FG002|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
11340143|NCT02918318|12537372|FG003|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
11340144|NCT02918318|12537373|FG004|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||1
11340145|NCT02918357|12537394|FG000|STARTED|Overall Study||385
11340146|NCT02918357|12537394|FG000|Investigational Drug Administration|Overall Study||385
11340147|NCT02918357|12537394|FG000|PET/CT Scan|Overall Study||385
11340148|NCT02918357|12537394|FG000|COMPLETED|Overall Study||385
11340149|NCT02918357|12537394|FG000|NOT COMPLETED|Overall Study||0
11340150|NCT02918396|12537419|FG000|STARTED|Overall Study||2
11340151|NCT02918396|12537420|FG001|STARTED|Overall Study||1
11340152|NCT02918396|12537421|FG002|STARTED|Overall Study||2
11340153|NCT02918396|12537419|FG000|COMPLETED|Overall Study||2
11340154|NCT02918396|12537420|FG001|COMPLETED|Overall Study||1
11340155|NCT02918396|12537421|FG002|COMPLETED|Overall Study||2
11340156|NCT02918396|12537419|FG000|NOT COMPLETED|Overall Study||0
11340157|NCT02918396|12537420|FG001|NOT COMPLETED|Overall Study||0
11340158|NCT02918396|12537421|FG002|NOT COMPLETED|Overall Study||0
11340159|NCT02918552|12537431|FG000|STARTED|Overall Study||7
11340160|NCT02918552|12537432|FG001|STARTED|Overall Study||8
11340161|NCT02918552|12537431|FG000|COMPLETED|Overall Study||6
11340162|NCT02918552|12537432|FG001|COMPLETED|Overall Study||6
11340163|NCT02918552|12537431|FG000|NOT COMPLETED|Overall Study||1
11340164|NCT02918552|12537432|FG001|NOT COMPLETED|Overall Study||2
11264040|NCT02274766|12459404|FG000|STARTED|Overall Study||39
11264041|NCT02274766|12459405|FG001|STARTED|Overall Study||38
11264042|NCT02274766|12459404|FG000|Received Study Drug|Overall Study||38
11264043|NCT02274766|12459405|FG001|Received Study Drug|Overall Study||37
11264044|NCT02274766|12459404|FG000|COMPLETED|Overall Study||35
11264045|NCT02274766|12459405|FG001|COMPLETED|Overall Study||29
11264046|NCT02274766|12459404|FG000|NOT COMPLETED|Overall Study||4
11264047|NCT02274766|12459405|FG001|NOT COMPLETED|Overall Study||9
11264048|NCT02274792|12459411|FG000|STARTED|Overall Study||132
11264049|NCT02274792|12459411|FG000|Received Treatment|Overall Study||131
11264050|NCT02274792|12459411|FG000|COMPLETED|Overall Study||107
11264051|NCT02274792|12459411|FG000|NOT COMPLETED|Overall Study||25
11264052|NCT02274844|12459417|FG000|STARTED|Overall Study||203
11264053|NCT02274844|12459418|FG001|STARTED|Overall Study||270
11264054|NCT02274844|12459417|FG000|COMPLETED|Overall Study||165
11264055|NCT02274844|12459418|FG001|COMPLETED|Overall Study||238
11264056|NCT02274844|12459417|FG000|NOT COMPLETED|Overall Study||38
11264057|NCT02274844|12459418|FG001|NOT COMPLETED|Overall Study||32
11264058|NCT02274857|12459426|FG000|STARTED|Overall Study||179
11264059|NCT02274857|12459427|FG001|STARTED|Overall Study||171
11264060|NCT02274857|12459426|FG000|Completed Per Protocol|Overall Study||102
11264061|NCT02274857|12459427|FG001|Completed Per Protocol|Overall Study||114
11264062|NCT02274857|12459426|FG000|COMPLETED|Overall Study||159
11264063|NCT02274857|12459427|FG001|COMPLETED|Overall Study||165
11264064|NCT02274857|12459426|FG000|NOT COMPLETED|Overall Study||20
11264065|NCT02274857|12459427|FG001|NOT COMPLETED|Overall Study||6
11264066|NCT02274870|12459436|FG000|STARTED|Overall Study||32
11264067|NCT02274870|12459437|FG001|STARTED|Overall Study||33
11264068|NCT02274870|12459436|FG000|COMPLETED|Overall Study||32
11264069|NCT02274870|12459437|FG001|COMPLETED|Overall Study||33
11264070|NCT02274870|12459436|FG000|NOT COMPLETED|Overall Study||0
11264071|NCT02274870|12459437|FG001|NOT COMPLETED|Overall Study||0
11264072|NCT02274948|12459448|FG000|STARTED|Overall Study||166
11264073|NCT02274948|12459449|FG001|STARTED|Overall Study||173
11264074|NCT02274948|12459448|FG000|COMPLETED|Overall Study||68
11264075|NCT02274948|12459449|FG001|COMPLETED|Overall Study||82
11264076|NCT02274948|12459448|FG000|NOT COMPLETED|Overall Study||98
11264077|NCT02274948|12459449|FG001|NOT COMPLETED|Overall Study||91
11264078|NCT02275026|12459456|FG000|STARTED|Overall Study||104
11264079|NCT02275026|12459456|FG000|COMPLETED|Overall Study||71
11264080|NCT02275026|12459456|FG000|NOT COMPLETED|Overall Study||33
11264081|NCT02275052|12459463|FG000|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
11264082|NCT02275052|12459464|FG001|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
11264083|NCT02275052|12459465|FG002|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
11264084|NCT02275052|12459466|FG003|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
11264085|NCT02275052|12459463|FG000|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
11264086|NCT02275052|12459464|FG001|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
11264087|NCT02275052|12459465|FG002|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
11264088|NCT02275052|12459466|FG003|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
11264089|NCT02275052|12459463|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
11264090|NCT02275052|12459464|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
11264091|NCT02275052|12459465|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
11264092|NCT02275052|12459466|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
11264093|NCT02275052|12459463|FG000|STARTED|Washout Period (12-17 Days)||90
11264094|NCT02275052|12459464|FG001|STARTED|Washout Period (12-17 Days)||93
11264095|NCT02275052|12459465|FG002|STARTED|Washout Period (12-17 Days)||0
11264096|NCT02275052|12459466|FG003|STARTED|Washout Period (12-17 Days)||0
11264097|NCT02275052|12459463|FG000|COMPLETED|Washout Period (12-17 Days)||86
11264098|NCT02275052|12459464|FG001|COMPLETED|Washout Period (12-17 Days)||93
11264099|NCT02275052|12459465|FG002|COMPLETED|Washout Period (12-17 Days)||0
11264100|NCT02275052|12459466|FG003|COMPLETED|Washout Period (12-17 Days)||0
11264101|NCT02275052|12459463|FG000|NOT COMPLETED|Washout Period (12-17 Days)||4
11264102|NCT02275052|12459464|FG001|NOT COMPLETED|Washout Period (12-17 Days)||0
11264103|NCT02275052|12459465|FG002|NOT COMPLETED|Washout Period (12-17 Days)||0
11264104|NCT02275052|12459466|FG003|NOT COMPLETED|Washout Period (12-17 Days)||0
11264105|NCT02275052|12459463|FG000|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
11264106|NCT02275052|12459464|FG001|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
11264107|NCT02275052|12459465|FG002|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
11264108|NCT02275052|12459466|FG003|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
11264109|NCT02275052|12459463|FG000|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
11264110|NCT02275052|12459464|FG001|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
11264111|NCT02275052|12459465|FG002|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
11264112|NCT02275052|12459466|FG003|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
11264113|NCT02275052|12459463|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
11264114|NCT02275052|12459464|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
11264115|NCT02275052|12459465|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
11264116|NCT02275052|12459466|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
11264117|NCT02275065|12459477|FG000|STARTED|Overall Study||5
11264118|NCT02275065|12459478|FG001|STARTED|Overall Study||4
11264119|NCT02275065|12459479|FG002|STARTED|Overall Study||5
11264120|NCT02275065|12459480|FG003|STARTED|Overall Study||5
11264121|NCT02275065|12459481|FG004|STARTED|Overall Study||4
11264122|NCT02275065|12459477|FG000|COMPLETED|Overall Study||4
11264123|NCT02275065|12459478|FG001|COMPLETED|Overall Study||4
11264124|NCT02275065|12459479|FG002|COMPLETED|Overall Study||4
11264125|NCT02275065|12459480|FG003|COMPLETED|Overall Study||4
11264126|NCT02275065|12459481|FG004|COMPLETED|Overall Study||4
11264127|NCT02275065|12459477|FG000|NOT COMPLETED|Overall Study||1
11264128|NCT02275065|12459478|FG001|NOT COMPLETED|Overall Study||0
11264129|NCT02275065|12459479|FG002|NOT COMPLETED|Overall Study||1
11264130|NCT02275065|12459480|FG003|NOT COMPLETED|Overall Study||1
11264131|NCT02275065|12459481|FG004|NOT COMPLETED|Overall Study||0
11264132|NCT02275117|12459498|FG000|STARTED|Overall Study||131
11264133|NCT02275117|12459499|FG001|STARTED|Overall Study||133
11264134|NCT02275117|12459500|FG002|STARTED|Overall Study||134
11264135|NCT02275117|12459501|FG003|STARTED|Overall Study||133
11264136|NCT02275117|12459502|FG004|STARTED|Overall Study||134
11264137|NCT02275117|12459498|FG000|Randomized and Treated|Overall Study||120
11264138|NCT02275117|12459499|FG001|Randomized and Treated|Overall Study||123
11264139|NCT02275117|12459500|FG002|Randomized and Treated|Overall Study||122
11264140|NCT02275117|12459501|FG003|Randomized and Treated|Overall Study||130
11264141|NCT02275117|12459502|FG004|Randomized and Treated|Overall Study||121
11264142|NCT02275117|12459498|FG000|COMPLETED|Overall Study||97
11264143|NCT02275117|12459499|FG001|COMPLETED|Overall Study||96
11264144|NCT02275117|12459500|FG002|COMPLETED|Overall Study||92
11264145|NCT02275117|12459501|FG003|COMPLETED|Overall Study||100
11264146|NCT02275117|12459502|FG004|COMPLETED|Overall Study||98
11264147|NCT02275117|12459498|FG000|NOT COMPLETED|Overall Study||34
11264148|NCT02275117|12459499|FG001|NOT COMPLETED|Overall Study||37
11264149|NCT02275117|12459500|FG002|NOT COMPLETED|Overall Study||42
11264150|NCT02275117|12459501|FG003|NOT COMPLETED|Overall Study||33
11264151|NCT02275117|12459502|FG004|NOT COMPLETED|Overall Study||36
11264152|NCT02275156|12459517|FG000|STARTED|Overall Study||6
11264153|NCT02275156|12459518|FG001|STARTED|Overall Study||6
11264154|NCT02275156|12459519|FG002|STARTED|Overall Study||6
11264155|NCT02275156|12459517|FG000|COMPLETED|Overall Study||6
11264156|NCT02275156|12459518|FG001|COMPLETED|Overall Study||6
11264157|NCT02275156|12459519|FG002|COMPLETED|Overall Study||6
11264158|NCT02275156|12459517|FG000|NOT COMPLETED|Overall Study||0
11264159|NCT02275156|12459518|FG001|NOT COMPLETED|Overall Study||0
11264160|NCT02275156|12459519|FG002|NOT COMPLETED|Overall Study||0
11264161|NCT02275338|12459528|FG000|STARTED|Overall Study||52
11264162|NCT02275338|12459528|FG000|Completed Phase 1|Overall Study||25
11264163|NCT02275338|12459528|FG000|Started Phase 2|Overall Study||21
11264164|NCT02275338|12459528|FG000|COMPLETED|Overall Study||19
11264165|NCT02275338|12459528|FG000|NOT COMPLETED|Overall Study||33
11264166|NCT02275364|12459533|FG000|STARTED|Period 1||14
11264167|NCT02275364|12459534|FG001|STARTED|Period 1||14
11264168|NCT02275364|12459533|FG000|COMPLETED|Period 1||12
11264169|NCT02275364|12459534|FG001|COMPLETED|Period 1||14
11264170|NCT02275364|12459533|FG000|NOT COMPLETED|Period 1||2
11021539|NCT00804973|12199628|FG000|COMPLETED|Overall Study||40
11021540|NCT00804973|12199629|FG001|COMPLETED|Overall Study||40
11021541|NCT00804973|12199630|FG002|COMPLETED|Overall Study||40
11021542|NCT00804973|12199628|FG000|NOT COMPLETED|Overall Study||0
11021543|NCT00804973|12199629|FG001|NOT COMPLETED|Overall Study||0
11021544|NCT00804973|12199630|FG002|NOT COMPLETED|Overall Study||0
11264171|NCT02275364|12459534|FG001|NOT COMPLETED|Period 1||0
11264172|NCT02275364|12459533|FG000|STARTED|Washout Period 1||12
11264173|NCT02275364|12459534|FG001|STARTED|Washout Period 1||14
11264174|NCT02275364|12459533|FG000|COMPLETED|Washout Period 1||12
11264175|NCT02275364|12459534|FG001|COMPLETED|Washout Period 1||14
11264176|NCT02275364|12459533|FG000|NOT COMPLETED|Washout Period 1||0
11264177|NCT02275364|12459534|FG001|NOT COMPLETED|Washout Period 1||0
11264178|NCT02275364|12459533|FG000|STARTED|Period 2||12
11264179|NCT02275364|12459534|FG001|STARTED|Period 2||14
11264180|NCT02275364|12459533|FG000|COMPLETED|Period 2||12
11264181|NCT02275364|12459534|FG001|COMPLETED|Period 2||14
11264182|NCT02275364|12459533|FG000|NOT COMPLETED|Period 2||0
11396842|NCT03927911|12590796|FG001|STARTED|Overall Study||17
11396843|NCT03927911|12590797|FG002|STARTED|Overall Study||0
11396844|NCT03927911|12590798|FG003|STARTED|Overall Study||3
11396845|NCT03927911|12590799|FG004|STARTED|Overall Study||13
11396846|NCT03927911|12590800|FG005|STARTED|Overall Study||32
11396847|NCT03927911|12590795|FG000|COMPLETED|Overall Study||0
11143696|NCT01474512|12330435|FG013|Relapsed Population Completers|Maintenance Period||0
11143697|NCT01474512|12330436|FG014|Relapsed Population Completers|Maintenance Period||0
11143698|NCT01474512|12330437|FG015|Relapsed Population Completers|Maintenance Period||0
11143699|NCT01474512|12330438|FG016|Relapsed Population Completers|Maintenance Period||0
11143700|NCT01474512|12330439|FG017|Relapsed Population Completers|Maintenance Period||0
11143701|NCT01474512|12330422|FG000|COMPLETED|Maintenance Period||0
11143702|NCT01474512|12330423|FG001|COMPLETED|Maintenance Period||0
11143703|NCT01474512|12330424|FG002|COMPLETED|Maintenance Period||0
11264183|NCT02275364|12459534|FG001|NOT COMPLETED|Period 2||0
11264184|NCT02275364|12459533|FG000|STARTED|Washout Period 2||12
11396848|NCT03927911|12590796|FG001|COMPLETED|Overall Study||15
11021545|NCT00804986|12199644|FG000|STARTED|Overall Study||36
11021546|NCT00804986|12199645|FG001|STARTED|Overall Study||43
11021547|NCT00804986|12199646|FG002|STARTED|Overall Study||42
11264185|NCT02275364|12459534|FG001|STARTED|Washout Period 2||14
11396849|NCT03927911|12590797|FG002|COMPLETED|Overall Study||0
11021548|NCT00804986|12199647|FG003|STARTED|Overall Study||42
11021549|NCT00804986|12199648|FG004|STARTED|Overall Study||43
11021550|NCT00804986|12199649|FG005|STARTED|Overall Study||41
11021551|NCT00804986|12199644|FG000|COMPLETED|Overall Study||35
11021552|NCT00804986|12199645|FG001|COMPLETED|Overall Study||35
11264186|NCT02275364|12459533|FG000|COMPLETED|Washout Period 2||12
11264187|NCT02275364|12459534|FG001|COMPLETED|Washout Period 2||14
11264188|NCT02275364|12459533|FG000|NOT COMPLETED|Washout Period 2||0
11264189|NCT02275364|12459534|FG001|NOT COMPLETED|Washout Period 2||0
11264190|NCT02275364|12459533|FG000|STARTED|Period 3||12
11264191|NCT02275364|12459534|FG001|STARTED|Period 3||14
11264192|NCT02275364|12459533|FG000|COMPLETED|Period 3||12
11264193|NCT02275364|12459534|FG001|COMPLETED|Period 3||14
11264194|NCT02275364|12459533|FG000|NOT COMPLETED|Period 3||0
11264195|NCT02275364|12459534|FG001|NOT COMPLETED|Period 3||0
11264196|NCT02275364|12459533|FG000|STARTED|Period 4||12
11264197|NCT02275364|12459534|FG001|STARTED|Period 4||14
11264198|NCT02275364|12459533|FG000|COMPLETED|Period 4||12
11264199|NCT02275364|12459534|FG001|COMPLETED|Period 4||14
11264200|NCT02275364|12459533|FG000|NOT COMPLETED|Period 4||0
11264201|NCT02275364|12459534|FG001|NOT COMPLETED|Period 4||0
11264202|NCT02275611|12459555|FG000|STARTED|Inpatient Withdrawal||5
11143704|NCT01474512|12330425|FG003|COMPLETED|Maintenance Period||24
11143705|NCT01474512|12330426|FG004|COMPLETED|Maintenance Period||108
11264203|NCT02275611|12459556|FG001|STARTED|Inpatient Withdrawal||4
11264204|NCT02275611|12459557|FG002|STARTED|Inpatient Withdrawal||0
11264205|NCT02275611|12459558|FG003|STARTED|Inpatient Withdrawal||0
11264206|NCT02275611|12459555|FG000|COMPLETED|Inpatient Withdrawal||4
11264207|NCT02275611|12459556|FG001|COMPLETED|Inpatient Withdrawal||4
11264208|NCT02275611|12459557|FG002|COMPLETED|Inpatient Withdrawal||0
11264209|NCT02275611|12459558|FG003|COMPLETED|Inpatient Withdrawal||0
11264210|NCT02275611|12459555|FG000|NOT COMPLETED|Inpatient Withdrawal||1
11264211|NCT02275611|12459556|FG001|NOT COMPLETED|Inpatient Withdrawal||0
11264212|NCT02275611|12459557|FG002|NOT COMPLETED|Inpatient Withdrawal||0
11264213|NCT02275611|12459558|FG003|NOT COMPLETED|Inpatient Withdrawal||0
11264214|NCT02275611|12459555|FG000|STARTED|Outpatient Drinking||0
11264215|NCT02275611|12459556|FG001|STARTED|Outpatient Drinking||0
11264216|NCT02275611|12459557|FG002|STARTED|Outpatient Drinking||6
11264217|NCT02275611|12459558|FG003|STARTED|Outpatient Drinking||3
11264218|NCT02275611|12459555|FG000|COMPLETED|Outpatient Drinking||0
11264219|NCT02275611|12459556|FG001|COMPLETED|Outpatient Drinking||0
11264220|NCT02275611|12459557|FG002|COMPLETED|Outpatient Drinking||6
11264221|NCT02275611|12459558|FG003|COMPLETED|Outpatient Drinking||3
11264222|NCT02275611|12459555|FG000|NOT COMPLETED|Outpatient Drinking||0
11264223|NCT02275611|12459556|FG001|NOT COMPLETED|Outpatient Drinking||0
11264224|NCT02275611|12459557|FG002|NOT COMPLETED|Outpatient Drinking||0
11264225|NCT02275611|12459558|FG003|NOT COMPLETED|Outpatient Drinking||0
11264226|NCT02275767|12459573|FG000|STARTED|Overall Study||22
11264227|NCT02275767|12459574|FG001|STARTED|Overall Study||22
11264228|NCT02275767|12459575|FG002|STARTED|Overall Study||22
11264229|NCT02275767|12459573|FG000|COMPLETED|Overall Study||20
11264230|NCT02275767|12459574|FG001|COMPLETED|Overall Study||18
11264231|NCT02275767|12459575|FG002|COMPLETED|Overall Study||19
11264232|NCT02275767|12459573|FG000|NOT COMPLETED|Overall Study||2
11264233|NCT02275767|12459574|FG001|NOT COMPLETED|Overall Study||4
11264234|NCT02275767|12459575|FG002|NOT COMPLETED|Overall Study||3
11264235|NCT02275819|12459585|FG000|STARTED|Overall Study||5
11264236|NCT02275819|12459586|FG001|STARTED|Overall Study||6
11264237|NCT02275819|12459585|FG000|COMPLETED|Overall Study||5
11264238|NCT02275819|12459586|FG001|COMPLETED|Overall Study||5
11264239|NCT02275819|12459585|FG000|NOT COMPLETED|Overall Study||0
11264240|NCT02275819|12459586|FG001|NOT COMPLETED|Overall Study||1
11264241|NCT02275923|12459592|FG000|STARTED|Overall Study||9
11264242|NCT02275923|12459592|FG000|COMPLETED|Overall Study||7
11264243|NCT02275923|12459592|FG000|NOT COMPLETED|Overall Study||2
11264244|NCT02276027|12459600|FG000|STARTED|Overall Study||2
11264245|NCT02276027|12459601|FG001|STARTED|Overall Study||16
11264246|NCT02276027|12459602|FG002|STARTED|Overall Study||26
11264247|NCT02276027|12459603|FG003|STARTED|Overall Study||22
11264248|NCT02276027|12459600|FG000|COMPLETED|Overall Study||0
11264249|NCT02276027|12459601|FG001|COMPLETED|Overall Study||0
11264250|NCT02276027|12459602|FG002|COMPLETED|Overall Study||6
11264251|NCT02276027|12459603|FG003|COMPLETED|Overall Study||0
11264252|NCT02276027|12459600|FG000|NOT COMPLETED|Overall Study||2
11264253|NCT02276027|12459601|FG001|NOT COMPLETED|Overall Study||16
11264254|NCT02276027|12459602|FG002|NOT COMPLETED|Overall Study||20
11264255|NCT02276027|12459603|FG003|NOT COMPLETED|Overall Study||22
11264256|NCT02276040|12459613|FG000|STARTED|Overall Study||26
11264257|NCT02276040|12459613|FG000|COMPLETED|Overall Study||11
11264258|NCT02276040|12459613|FG000|NOT COMPLETED|Overall Study||15
11264259|NCT02276053|12459617|FG000|STARTED|Overall Study||93
11264260|NCT02276053|12459617|FG000|COMPLETED|Overall Study||79
11264261|NCT02276053|12459617|FG000|NOT COMPLETED|Overall Study||14
11264262|NCT02276222|12459624|FG000|STARTED|Overall Study||621
11264263|NCT02276222|12459625|FG001|STARTED|Overall Study||466
11264264|NCT02276222|12459624|FG000|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
11264265|NCT02276222|12459625|FG001|COMPLETED|Overall Study||402
11264266|NCT02276222|12459624|FG000|NOT COMPLETED|Overall Study||185
11264267|NCT02276222|12459625|FG001|NOT COMPLETED|Overall Study||64
11021553|NCT00804986|12199646|FG002|COMPLETED|Overall Study||40
11264268|NCT02276274|12459633|FG000|STARTED|First Intervention Period||6
11264269|NCT02276274|12459634|FG001|STARTED|First Intervention Period||6
11264270|NCT02276274|12459633|FG000|COMPLETED|First Intervention Period||6
11264271|NCT02276274|12459634|FG001|COMPLETED|First Intervention Period||6
11264272|NCT02276274|12459633|FG000|NOT COMPLETED|First Intervention Period||0
11264273|NCT02276274|12459634|FG001|NOT COMPLETED|First Intervention Period||0
11264274|NCT02276274|12459633|FG000|STARTED|Washout Period (at Least 15 Days)||6
11264275|NCT02276274|12459634|FG001|STARTED|Washout Period (at Least 15 Days)||6
11264276|NCT02276274|12459633|FG000|COMPLETED|Washout Period (at Least 15 Days)||6
11264277|NCT02276274|12459634|FG001|COMPLETED|Washout Period (at Least 15 Days)||6
11264278|NCT02276274|12459633|FG000|NOT COMPLETED|Washout Period (at Least 15 Days)||0
11264279|NCT02276274|12459634|FG001|NOT COMPLETED|Washout Period (at Least 15 Days)||0
11264280|NCT02276274|12459633|FG000|STARTED|Second Intervention Period||6
11264281|NCT02276274|12459634|FG001|STARTED|Second Intervention Period||6
11264282|NCT02276274|12459633|FG000|COMPLETED|Second Intervention Period||6
11264283|NCT02276274|12459634|FG001|COMPLETED|Second Intervention Period||6
11264284|NCT02276274|12459633|FG000|NOT COMPLETED|Second Intervention Period||0
11264285|NCT02276274|12459634|FG001|NOT COMPLETED|Second Intervention Period||0
11264286|NCT02276482|12459642|FG000|STARTED|Overall Study||91
11264287|NCT02276482|12459643|FG001|STARTED|Overall Study||29
11264288|NCT02276482|12459642|FG000|COMPLETED|Overall Study||88
11264289|NCT02276482|12459643|FG001|COMPLETED|Overall Study||28
11264290|NCT02276482|12459642|FG000|NOT COMPLETED|Overall Study||3
11264291|NCT02276482|12459643|FG001|NOT COMPLETED|Overall Study||1
11264292|NCT02276612|12459651|FG000|STARTED|Overall Study||50
11264293|NCT02276612|12459652|FG001|STARTED|Overall Study||10
11264294|NCT02276612|12459651|FG000|COMPLETED|Overall Study||46
11264295|NCT02276612|12459652|FG001|COMPLETED|Overall Study||10
11264296|NCT02276612|12459651|FG000|NOT COMPLETED|Overall Study||4
11264297|NCT02276612|12459652|FG001|NOT COMPLETED|Overall Study||0
11264298|NCT02276638|12459661|FG000|STARTED|Overall Study||28
11264299|NCT02276638|12459662|FG001|STARTED|Overall Study||28
11264300|NCT02276638|12459663|FG002|STARTED|Overall Study||23
11264301|NCT02276638|12459661|FG000|COMPLETED|Overall Study||28
11264302|NCT02276638|12459662|FG001|COMPLETED|Overall Study||28
11264303|NCT02276638|12459663|FG002|COMPLETED|Overall Study||23
11264304|NCT02276638|12459661|FG000|NOT COMPLETED|Overall Study||0
11264305|NCT02276638|12459662|FG001|NOT COMPLETED|Overall Study||0
11264306|NCT02276638|12459663|FG002|NOT COMPLETED|Overall Study||0
11264307|NCT02276807|12459673|FG000|STARTED|Overall Study||68
11264308|NCT02276807|12459674|FG001|STARTED|Overall Study||72
11264309|NCT02276807|12459673|FG000|12-week Assessment|Overall Study||57
11264310|NCT02276807|12459674|FG001|12-week Assessment|Overall Study||63
11264311|NCT02276807|12459673|FG000|COMPLETED|Overall Study||50
11264312|NCT02276807|12459674|FG001|COMPLETED|Overall Study||55
11264313|NCT02276807|12459673|FG000|NOT COMPLETED|Overall Study||18
11264314|NCT02276807|12459674|FG001|NOT COMPLETED|Overall Study||17
11264315|NCT02276872|12459683|FG000|STARTED|Overall Study||10
11264316|NCT02276872|12459684|FG001|STARTED|Overall Study||10
11264317|NCT02276872|12459685|FG002|STARTED|Overall Study||12
11264318|NCT02276872|12459683|FG000|COMPLETED|Overall Study||9
11264319|NCT02276872|12459684|FG001|COMPLETED|Overall Study||10
11264320|NCT02276872|12459685|FG002|COMPLETED|Overall Study||12
11264321|NCT02276872|12459683|FG000|NOT COMPLETED|Overall Study||1
11264322|NCT02276872|12459684|FG001|NOT COMPLETED|Overall Study||0
11264323|NCT02276872|12459685|FG002|NOT COMPLETED|Overall Study||0
11264324|NCT02276963|12459698|FG000|STARTED|Overall Study||6
11264325|NCT02276963|12459698|FG000|COMPLETED|Overall Study||3
11264326|NCT02276963|12459698|FG000|NOT COMPLETED|Overall Study||3
11264327|NCT02277054|12459702|FG000|STARTED|Overall Study||5
11264328|NCT02277054|12459702|FG000|COMPLETED|Overall Study||5
11264329|NCT02277054|12459702|FG000|NOT COMPLETED|Overall Study||0
11264330|NCT02277093|12459707|FG000|STARTED|Overall Study||11
11264331|NCT02277093|12459707|FG000|COMPLETED|Overall Study||11
11264332|NCT02277093|12459707|FG000|NOT COMPLETED|Overall Study||0
11264333|NCT02277249|12459713|FG000|STARTED|Overall Study||30
11264334|NCT02277249|12459714|FG001|STARTED|Overall Study||30
11264335|NCT02277249|12459713|FG000|COMPLETED|Overall Study||30
11264336|NCT02277249|12459714|FG001|COMPLETED|Overall Study||30
11264337|NCT02277249|12459713|FG000|NOT COMPLETED|Overall Study||0
11264338|NCT02277249|12459714|FG001|NOT COMPLETED|Overall Study||0
11264339|NCT02277548|12459722|FG000|STARTED|Overall Study||9
11264340|NCT02277548|12459723|FG001|STARTED|Overall Study||11
11264341|NCT02277548|12459722|FG000|COMPLETED|Overall Study||9
11264342|NCT02277548|12459723|FG001|COMPLETED|Overall Study||9
11264343|NCT02277548|12459722|FG000|NOT COMPLETED|Overall Study||0
11264344|NCT02277548|12459723|FG001|NOT COMPLETED|Overall Study||2
11264345|NCT02277626|12459729|FG000|STARTED|Overall Study||6
11264346|NCT02277626|12459730|FG001|STARTED|Overall Study||9
11264347|NCT02277626|12459729|FG000|COMPLETED|Overall Study||6
11264348|NCT02277626|12459730|FG001|COMPLETED|Overall Study||9
11264349|NCT02277626|12459729|FG000|NOT COMPLETED|Overall Study||0
11264350|NCT02277626|12459730|FG001|NOT COMPLETED|Overall Study||0
11396850|NCT03927911|12590798|FG003|COMPLETED|Overall Study||1
11264351|NCT02277639|12459743|FG000|STARTED|Overall Study||0
11264352|NCT02277639|12459744|FG001|STARTED|Overall Study||2
11264353|NCT02277639|12459743|FG000|COMPLETED|Overall Study||0
11264354|NCT02277639|12459744|FG001|COMPLETED|Overall Study||2
11264355|NCT02277639|12459743|FG000|NOT COMPLETED|Overall Study||0
11264356|NCT02277639|12459744|FG001|NOT COMPLETED|Overall Study||0
11264357|NCT02277665|12459752|FG000|STARTED|Overall Study||33
11264358|NCT02277665|12459753|FG001|STARTED|Overall Study||34
11264359|NCT02277665|12459752|FG000|COMPLETED|Overall Study||33
11264360|NCT02277665|12459753|FG001|COMPLETED|Overall Study||34
11264361|NCT02277665|12459752|FG000|NOT COMPLETED|Overall Study||0
11264362|NCT02277665|12459753|FG001|NOT COMPLETED|Overall Study||0
11264363|NCT02277691|12459761|FG000|STARTED|Overall Study||341
11264364|NCT02277691|12459761|FG000|COMPLETED|Overall Study||295
11264365|NCT02277691|12459761|FG000|NOT COMPLETED|Overall Study||46
11264366|NCT02277743|12459768|FG000|STARTED|Overall Study||224
11264367|NCT02277743|12459769|FG001|STARTED|Overall Study||224
11264368|NCT02277743|12459770|FG002|STARTED|Overall Study||223
11264369|NCT02277743|12459768|FG000|Treated|Overall Study||223
11264370|NCT02277743|12459769|FG001|Treated|Overall Study||223
11264371|NCT02277743|12459770|FG002|Treated|Overall Study||223
11264372|NCT02277743|12459768|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
11264373|NCT02277743|12459769|FG001|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
11264374|NCT02277743|12459770|FG002|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
11264375|NCT02277743|12459768|FG000|COMPLETED|Overall Study||184
11264376|NCT02277743|12459769|FG001|COMPLETED|Overall Study||208
11264377|NCT02277743|12459770|FG002|COMPLETED|Overall Study||197
11264378|NCT02277743|12459768|FG000|NOT COMPLETED|Overall Study||40
11264379|NCT02277743|12459769|FG001|NOT COMPLETED|Overall Study||16
11264380|NCT02277743|12459770|FG002|NOT COMPLETED|Overall Study||26
11264381|NCT02277769|12459781|FG000|STARTED|Overall Study||236
11264382|NCT02277769|12459782|FG001|STARTED|Overall Study||233
11264383|NCT02277769|12459783|FG002|STARTED|Overall Study||239
11264384|NCT02277769|12459781|FG000|Treated|Overall Study||235
11264385|NCT02277769|12459782|FG001|Treated|Overall Study||233
11264386|NCT02277769|12459783|FG002|Treated|Overall Study||239
11264387|NCT02277769|12459781|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
11264388|NCT02277769|12459782|FG001|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
11264389|NCT02277769|12459783|FG002|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
11264390|NCT02277769|12459781|FG000|COMPLETED|Overall Study||190
11264391|NCT02277769|12459782|FG001|COMPLETED|Overall Study||220
11264392|NCT02277769|12459783|FG002|COMPLETED|Overall Study||221
11264393|NCT02277769|12459781|FG000|NOT COMPLETED|Overall Study||46
11264394|NCT02277769|12459782|FG001|NOT COMPLETED|Overall Study||13
11264395|NCT02277769|12459783|FG002|NOT COMPLETED|Overall Study||18
11264396|NCT02277925|12459793|FG000|STARTED|Overall Study||102
11264397|NCT02277925|12459794|FG001|STARTED|Overall Study||102
11264398|NCT02277925|12459793|FG000|Surgery|Overall Study||99
11264399|NCT02277925|12459794|FG001|Surgery|Overall Study||101
11264400|NCT02277925|12459793|FG000|COMPLETED|Overall Study||95
11264401|NCT02277925|12459794|FG001|COMPLETED|Overall Study||87
11264402|NCT02277925|12459793|FG000|NOT COMPLETED|Overall Study||7
11264403|NCT02277925|12459794|FG001|NOT COMPLETED|Overall Study||15
11264404|NCT02277990|12459804|FG000|STARTED|Overall Study||3495
11264405|NCT02277990|12459805|FG001|STARTED|Overall Study||3488
11264406|NCT02277990|12459804|FG000|COMPLETED|Overall Study||3129
11264407|NCT02277990|12459805|FG001|COMPLETED|Overall Study||3112
11264408|NCT02277990|12459804|FG000|NOT COMPLETED|Overall Study||366
11264409|NCT02277990|12459805|FG001|NOT COMPLETED|Overall Study||376
11264410|NCT02278003|12459813|FG000|STARTED|Overall Study||49
11264411|NCT02278003|12459814|FG001|STARTED|Overall Study||20
11264412|NCT02278003|12459813|FG000|COMPLETED|Overall Study||30
11264413|NCT02278003|12459814|FG001|COMPLETED|Overall Study||20
11264414|NCT02278003|12459813|FG000|NOT COMPLETED|Overall Study||19
11264415|NCT02278003|12459814|FG001|NOT COMPLETED|Overall Study||0
11264416|NCT02278146|12459822|FG000|STARTED|Overall Study||6
11264417|NCT02278146|12459823|FG001|STARTED|Overall Study||10
11264418|NCT02278146|12459822|FG000|COMPLETED|Overall Study||6
11264419|NCT02278146|12459823|FG001|COMPLETED|Overall Study||8
11264420|NCT02278146|12459822|FG000|NOT COMPLETED|Overall Study||0
11264421|NCT02278146|12459823|FG001|NOT COMPLETED|Overall Study||2
11264422|NCT02278237|12459829|FG000|STARTED|Overall Study||90
11264423|NCT02278237|12459829|FG000|COMPLETED|Overall Study||83
11264424|NCT02278237|12459829|FG000|NOT COMPLETED|Overall Study||7
11264425|NCT02278263|12459836|FG000|STARTED|Overall Study||30
11264426|NCT02278263|12459837|FG001|STARTED|Overall Study||60
11264427|NCT02278263|12459838|FG002|STARTED|Overall Study||60
11264428|NCT02278263|12459836|FG000|COMPLETED|Overall Study||23
11264429|NCT02278263|12459837|FG001|COMPLETED|Overall Study|Correction|60
11264430|NCT02278263|12459838|FG002|COMPLETED|Overall Study||51
11264431|NCT02278263|12459836|FG000|NOT COMPLETED|Overall Study||7
11396851|NCT03927911|12590799|FG004|COMPLETED|Overall Study||13
11396852|NCT03927911|12590800|FG005|COMPLETED|Overall Study||25
11396853|NCT03927911|12590795|FG000|NOT COMPLETED|Overall Study||0
11264432|NCT02278263|12459837|FG001|NOT COMPLETED|Overall Study||0
11264433|NCT02278263|12459838|FG002|NOT COMPLETED|Overall Study||9
11264434|NCT02278289|12459851|FG000|STARTED|Overall Study||30
11264435|NCT02278289|12459852|FG001|STARTED|Overall Study||30
11264436|NCT02278289|12459851|FG000|COMPLETED|Overall Study||24
11264437|NCT02278289|12459852|FG001|COMPLETED|Overall Study||23
11264438|NCT02278289|12459851|FG000|NOT COMPLETED|Overall Study||6
11264439|NCT02278289|12459852|FG001|NOT COMPLETED|Overall Study||7
11264440|NCT02278328|12459858|FG000|STARTED|Neuropsych Screening||10
11396854|NCT03927911|12590796|FG001|NOT COMPLETED|Overall Study||2
11264441|NCT02278328|12459859|FG001|STARTED|Neuropsych Screening||7
11264442|NCT02278328|12459860|FG002|STARTED|Neuropsych Screening||8
11396855|NCT03927911|12590797|FG002|NOT COMPLETED|Overall Study||0
11396856|NCT03927911|12590798|FG003|NOT COMPLETED|Overall Study||2
11396857|NCT03927911|12590799|FG004|NOT COMPLETED|Overall Study||0
11396858|NCT03927911|12590800|FG005|NOT COMPLETED|Overall Study||7
11396859|NCT03937570|12590816|FG000|STARTED|Overall Study||13
11264443|NCT02278328|12459858|FG000|COMPLETED|Neuropsych Screening||9
11264444|NCT02278328|12459859|FG001|COMPLETED|Neuropsych Screening||6
11264445|NCT02278328|12459860|FG002|COMPLETED|Neuropsych Screening||6
11264446|NCT02278328|12459858|FG000|NOT COMPLETED|Neuropsych Screening||1
11264447|NCT02278328|12459859|FG001|NOT COMPLETED|Neuropsych Screening||1
11264448|NCT02278328|12459860|FG002|NOT COMPLETED|Neuropsych Screening||2
11264449|NCT02278328|12459858|FG000|STARTED|First Intervention (1 Day)||9
11264450|NCT02278328|12459859|FG001|STARTED|First Intervention (1 Day)||6
11264451|NCT02278328|12459860|FG002|STARTED|First Intervention (1 Day)||6
11264452|NCT02278328|12459858|FG000|COMPLETED|First Intervention (1 Day)||9
11264453|NCT02278328|12459859|FG001|COMPLETED|First Intervention (1 Day)||6
11264454|NCT02278328|12459860|FG002|COMPLETED|First Intervention (1 Day)||6
11264455|NCT02278328|12459858|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11264456|NCT02278328|12459859|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11264457|NCT02278328|12459860|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11264458|NCT02278328|12459858|FG000|STARTED|Washout (1 Week)||9
11264459|NCT02278328|12459859|FG001|STARTED|Washout (1 Week)||6
11264460|NCT02278328|12459860|FG002|STARTED|Washout (1 Week)||6
11264461|NCT02278328|12459858|FG000|COMPLETED|Washout (1 Week)||9
11264462|NCT02278328|12459859|FG001|COMPLETED|Washout (1 Week)||6
11264463|NCT02278328|12459860|FG002|COMPLETED|Washout (1 Week)||6
11264464|NCT02278328|12459858|FG000|NOT COMPLETED|Washout (1 Week)||0
11264465|NCT02278328|12459859|FG001|NOT COMPLETED|Washout (1 Week)||0
11264466|NCT02278328|12459860|FG002|NOT COMPLETED|Washout (1 Week)||0
11264467|NCT02278328|12459858|FG000|STARTED|Second Intervention (1 Day)||9
11264468|NCT02278328|12459859|FG001|STARTED|Second Intervention (1 Day)||6
11264469|NCT02278328|12459860|FG002|STARTED|Second Intervention (1 Day)||6
11264470|NCT02278328|12459858|FG000|COMPLETED|Second Intervention (1 Day)||9
11264471|NCT02278328|12459859|FG001|COMPLETED|Second Intervention (1 Day)||6
11264472|NCT02278328|12459860|FG002|COMPLETED|Second Intervention (1 Day)||6
11264473|NCT02278328|12459858|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11264474|NCT02278328|12459859|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11264475|NCT02278328|12459860|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11264476|NCT02278328|12459858|FG000|STARTED|Second Washout (1 Week)||9
11264477|NCT02278328|12459859|FG001|STARTED|Second Washout (1 Week)||6
11264478|NCT02278328|12459860|FG002|STARTED|Second Washout (1 Week)||6
11264479|NCT02278328|12459858|FG000|COMPLETED|Second Washout (1 Week)||9
11264480|NCT02278328|12459859|FG001|COMPLETED|Second Washout (1 Week)||6
11264481|NCT02278328|12459860|FG002|COMPLETED|Second Washout (1 Week)||6
11264482|NCT02278328|12459858|FG000|NOT COMPLETED|Second Washout (1 Week)||0
11264483|NCT02278328|12459859|FG001|NOT COMPLETED|Second Washout (1 Week)||0
11264484|NCT02278328|12459860|FG002|NOT COMPLETED|Second Washout (1 Week)||0
11264485|NCT02278328|12459858|FG000|STARTED|Third Intervention (1 Day)||9
11264486|NCT02278328|12459859|FG001|STARTED|Third Intervention (1 Day)||6
11264487|NCT02278328|12459860|FG002|STARTED|Third Intervention (1 Day)||6
11264488|NCT02278328|12459858|FG000|COMPLETED|Third Intervention (1 Day)||9
11264489|NCT02278328|12459859|FG001|COMPLETED|Third Intervention (1 Day)||6
11396860|NCT03937570|12590817|FG001|STARTED|Overall Study||14
11396861|NCT03937570|12590816|FG000|COMPLETED|Overall Study||13
11264490|NCT02278328|12459860|FG002|COMPLETED|Third Intervention (1 Day)||6
11264491|NCT02278328|12459858|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11264492|NCT02278328|12459859|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11264493|NCT02278328|12459860|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
11264494|NCT02278328|12459858|FG000|STARTED|Third Washout (1 Week)||9
11264495|NCT02278328|12459859|FG001|STARTED|Third Washout (1 Week)||6
11264496|NCT02278328|12459860|FG002|STARTED|Third Washout (1 Week)||6
11264497|NCT02278328|12459858|FG000|COMPLETED|Third Washout (1 Week)||9
11264498|NCT02278328|12459859|FG001|COMPLETED|Third Washout (1 Week)||6
11264499|NCT02278328|12459860|FG002|COMPLETED|Third Washout (1 Week)||6
11264500|NCT02278328|12459858|FG000|NOT COMPLETED|Third Washout (1 Week)||0
11264501|NCT02278328|12459859|FG001|NOT COMPLETED|Third Washout (1 Week)||0
11264502|NCT02278328|12459860|FG002|NOT COMPLETED|Third Washout (1 Week)||0
11264503|NCT02278341|12459868|FG000|STARTED|Overall Study||415
11264504|NCT02278341|12459869|FG001|STARTED|Overall Study||421
11264505|NCT02278341|12459868|FG000|Received Treatment|Overall Study||414
11264506|NCT02278341|12459869|FG001|Received Treatment|Overall Study||420
11264507|NCT02278341|12459868|FG000|COMPLETED|Overall Study||297
11264508|NCT02278341|12459869|FG001|COMPLETED|Overall Study||329
11264509|NCT02278341|12459868|FG000|NOT COMPLETED|Overall Study||118
11264510|NCT02278341|12459869|FG001|NOT COMPLETED|Overall Study||92
11264511|NCT02278354|12459878|FG000|STARTED|Overall Study||12
11264512|NCT02278354|12459879|FG001|STARTED|Overall Study||23
11264513|NCT02278354|12459878|FG000|Flortaucipir PET Scan|Overall Study||10
11264514|NCT02278354|12459879|FG001|Flortaucipir PET Scan|Overall Study||20
11264515|NCT02278354|12459878|FG000|COMPLETED|Overall Study||8
11264516|NCT02278354|12459879|FG001|COMPLETED|Overall Study||20
11264517|NCT02278354|12459878|FG000|NOT COMPLETED|Overall Study||4
11396862|NCT03937570|12590817|FG001|COMPLETED|Overall Study||14
11264518|NCT02278354|12459879|FG001|NOT COMPLETED|Overall Study||3
11264519|NCT02278367|12459889|FG000|STARTED|Overall Study||69
11264520|NCT02278367|12459890|FG001|STARTED|Overall Study||110
11264521|NCT02278367|12459889|FG000|COMPLETED|Overall Study||59
11264522|NCT02278367|12459890|FG001|COMPLETED|Overall Study||110
11264523|NCT02278367|12459889|FG000|NOT COMPLETED|Overall Study||10
11264524|NCT02278367|12459890|FG001|NOT COMPLETED|Overall Study||0
11396863|NCT03937570|12590816|FG000|NOT COMPLETED|Overall Study||0
11264525|NCT02278471|12459898|FG000|STARTED|Overall Study||155
11264526|NCT02278471|12459899|FG001|STARTED|Overall Study||148
11264527|NCT02278471|12459898|FG000|COMPLETED|Overall Study||147
11264528|NCT02278471|12459899|FG001|COMPLETED|Overall Study||128
11264529|NCT02278471|12459898|FG000|NOT COMPLETED|Overall Study||8
11264530|NCT02278471|12459899|FG001|NOT COMPLETED|Overall Study||20
11264531|NCT02278484|12459906|FG000|STARTED|Overall Study||50
11264532|NCT02278484|12459906|FG000|COMPLETED|Overall Study||50
11264533|NCT02278484|12459906|FG000|NOT COMPLETED|Overall Study||0
11264534|NCT02278562|12459914|FG000|STARTED|Overall Study||9
11264535|NCT02278562|12459915|FG001|STARTED|Overall Study||7
11264536|NCT02278562|12459916|FG002|STARTED|Overall Study||8
11264537|NCT02278562|12459914|FG000|COMPLETED|Overall Study||9
11264538|NCT02278562|12459915|FG001|COMPLETED|Overall Study||7
11264539|NCT02278562|12459916|FG002|COMPLETED|Overall Study||8
11264540|NCT02278562|12459914|FG000|NOT COMPLETED|Overall Study||0
11264541|NCT02278562|12459915|FG001|NOT COMPLETED|Overall Study||0
11264542|NCT02278562|12459916|FG002|NOT COMPLETED|Overall Study||0
11264543|NCT02278614|12459926|FG000|STARTED|Overall Study||127
11264544|NCT02278614|12459927|FG001|STARTED|Overall Study||115
11264545|NCT02278614|12459926|FG000|COMPLETED|Overall Study||122
11264546|NCT02278614|12459927|FG001|COMPLETED|Overall Study||110
11264547|NCT02278614|12459926|FG000|NOT COMPLETED|Overall Study||5
11264548|NCT02278614|12459927|FG001|NOT COMPLETED|Overall Study||5
11264549|NCT02278640|12459933|FG000|STARTED|Overall Study||40
11264550|NCT02278640|12459933|FG000|COMPLETED|Overall Study||40
11264551|NCT02278640|12459933|FG000|NOT COMPLETED|Overall Study||0
11264552|NCT02278783|12459937|FG000|STARTED|Overall Study||1
11264553|NCT02278783|12459937|FG000|COMPLETED|Overall Study||1
11264554|NCT02278783|12459937|FG000|NOT COMPLETED|Overall Study||0
11264555|NCT02278939|12459943|FG000|STARTED|Overall Study||33
11264556|NCT02278939|12459944|FG001|STARTED|Overall Study||34
11264557|NCT02278939|12459943|FG000|COMPLETED|Overall Study||28
11264558|NCT02278939|12459944|FG001|COMPLETED|Overall Study||33
11264559|NCT02278939|12459943|FG000|NOT COMPLETED|Overall Study||5
11264560|NCT02278939|12459944|FG001|NOT COMPLETED|Overall Study||1
11264561|NCT02278952|12459950|FG000|STARTED|Overall Study|The number of biopsy procedures performed during the time the patient was enrolled in the study.|50
11264562|NCT02278952|12459950|FG000|COMPLETED|Overall Study|The number of biopsy samples assayed during the time the patient was enrolled in the study.|44
11264563|NCT02278952|12459950|FG000|NOT COMPLETED|Overall Study||6
11264564|NCT02279043|12459963|FG000|STARTED|Overall Study||175
11264565|NCT02279043|12459964|FG001|STARTED|Overall Study||315
11264566|NCT02279043|12459965|FG002|STARTED|Overall Study||140
11264567|NCT02279043|12459963|FG000|COMPLETED|Overall Study||128
11264568|NCT02279043|12459964|FG001|COMPLETED|Overall Study||226
11264569|NCT02279043|12459965|FG002|COMPLETED|Overall Study||140
11264570|NCT02279043|12459963|FG000|NOT COMPLETED|Overall Study||47
11264571|NCT02279043|12459964|FG001|NOT COMPLETED|Overall Study||89
11264572|NCT02279043|12459965|FG002|NOT COMPLETED|Overall Study||0
11264573|NCT02279082|12459971|FG000|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
11264574|NCT02279082|12459971|FG000|COMPLETED|Overall Study||134
11264575|NCT02279082|12459971|FG000|NOT COMPLETED|Overall Study||33
11264576|NCT02279108|12459977|FG000|STARTED|Overall Study||50
11264577|NCT02279108|12459978|FG001|STARTED|Overall Study||50
11264578|NCT02279108|12459977|FG000|COMPLETED|Overall Study||50
11264579|NCT02279108|12459978|FG001|COMPLETED|Overall Study||49
11264580|NCT02279108|12459977|FG000|NOT COMPLETED|Overall Study||0
11264581|NCT02279108|12459978|FG001|NOT COMPLETED|Overall Study||1
11264582|NCT02279160|12459986|FG000|STARTED|Overall Study||40
11264583|NCT02279160|12459987|FG001|STARTED|Overall Study||21
11264584|NCT02279160|12459986|FG000|COMPLETED|Overall Study||34
11264585|NCT02279160|12459987|FG001|COMPLETED|Overall Study||19
11264586|NCT02279160|12459986|FG000|NOT COMPLETED|Overall Study||6
11264587|NCT02279160|12459987|FG001|NOT COMPLETED|Overall Study||2
11264588|NCT02279407|12459997|FG000|STARTED|Overall Study||22
11264589|NCT02279407|12459998|FG001|STARTED|Overall Study||21
11264590|NCT02279407|12459999|FG002|STARTED|Overall Study||20
11264591|NCT02279407|12460000|FG003|STARTED|Overall Study||21
11264592|NCT02279407|12459997|FG000|COMPLETED|Overall Study||20
11264593|NCT02279407|12459998|FG001|COMPLETED|Overall Study||20
11264594|NCT02279407|12459999|FG002|COMPLETED|Overall Study||15
11264595|NCT02279407|12460000|FG003|COMPLETED|Overall Study||20
11264596|NCT02279407|12459997|FG000|NOT COMPLETED|Overall Study||2
11264597|NCT02279407|12459998|FG001|NOT COMPLETED|Overall Study||1
11264598|NCT02279407|12459999|FG002|NOT COMPLETED|Overall Study||5
11264599|NCT02279407|12460000|FG003|NOT COMPLETED|Overall Study||1
11264600|NCT02279420|12460010|FG000|STARTED|Overall Study||73
11264601|NCT02279420|12460010|FG000|COMPLETED|Overall Study||50
11264602|NCT02279420|12460010|FG000|NOT COMPLETED|Overall Study||23
11264603|NCT02279498|12460016|FG000|STARTED|Overall Study||65
11264604|NCT02279498|12460017|FG001|STARTED|Overall Study||63
11264605|NCT02279498|12460016|FG000|COMPLETED|Overall Study||47
11264606|NCT02279498|12460017|FG001|COMPLETED|Overall Study||59
11264607|NCT02279498|12460016|FG000|NOT COMPLETED|Overall Study||18
11264608|NCT02279498|12460017|FG001|NOT COMPLETED|Overall Study||4
11264609|NCT02279524|12460027|FG000|STARTED|Overall Study||98
11264610|NCT02279524|12460028|FG001|STARTED|Overall Study||101
11264611|NCT02279524|12460029|FG002|STARTED|Overall Study||48
11264612|NCT02279524|12460027|FG000|COMPLETED|Overall Study||88
11264613|NCT02279524|12460028|FG001|COMPLETED|Overall Study||90
11264614|NCT02279524|12460029|FG002|COMPLETED|Overall Study||41
11264615|NCT02279524|12460027|FG000|NOT COMPLETED|Overall Study||10
11396864|NCT03937570|12590817|FG001|NOT COMPLETED|Overall Study||0
11264616|NCT02279524|12460028|FG001|NOT COMPLETED|Overall Study||11
11264617|NCT02279524|12460029|FG002|NOT COMPLETED|Overall Study||7
11264618|NCT02279641|12460039|FG000|STARTED|Overall Study||6
11264619|NCT02279641|12460040|FG001|STARTED|Overall Study||6
11264620|NCT02279641|12460039|FG000|COMPLETED|Overall Study||6
11264621|NCT02279641|12460040|FG001|COMPLETED|Overall Study||6
11264622|NCT02279641|12460039|FG000|NOT COMPLETED|Overall Study||0
11264623|NCT02279641|12460040|FG001|NOT COMPLETED|Overall Study||0
11264624|NCT02279667|12460059|FG000|STARTED|Overall Study||6
11264625|NCT02279667|12460060|FG001|STARTED|Overall Study||6
11264626|NCT02279667|12460061|FG002|STARTED|Overall Study||6
11264627|NCT02279667|12460059|FG000|COMPLETED|Overall Study||6
11264628|NCT02279667|12460060|FG001|COMPLETED|Overall Study||6
11264629|NCT02279667|12460061|FG002|COMPLETED|Overall Study||6
11264630|NCT02279667|12460059|FG000|NOT COMPLETED|Overall Study||0
11264631|NCT02279667|12460060|FG001|NOT COMPLETED|Overall Study||0
11264632|NCT02279667|12460061|FG002|NOT COMPLETED|Overall Study||0
11264633|NCT02279732|12460072|FG000|STARTED|Overall Study||98
11264634|NCT02279732|12460073|FG001|STARTED|Overall Study||106
11264635|NCT02279732|12460072|FG000|COMPLETED|Overall Study||0
11264636|NCT02279732|12460073|FG001|COMPLETED|Overall Study||0
11264637|NCT02279732|12460072|FG000|NOT COMPLETED|Overall Study||98
11264638|NCT02279732|12460073|FG001|NOT COMPLETED|Overall Study||106
11264639|NCT02279862|12460081|FG000|STARTED|Overall Study||26
11264640|NCT02279862|12460082|FG001|STARTED|Overall Study||27
11264641|NCT02279862|12460081|FG000|Treated|Overall Study||25
11264642|NCT02279862|12460082|FG001|Treated|Overall Study||26
11264643|NCT02279862|12460081|FG000|COMPLETED|Overall Study|Completed treatment in induction period|0
11264644|NCT02279862|12460082|FG001|COMPLETED|Overall Study|Completed treatment in induction period|2
11264645|NCT02279862|12460081|FG000|NOT COMPLETED|Overall Study||26
11264646|NCT02279862|12460082|FG001|NOT COMPLETED|Overall Study||25
11264647|NCT02280044|12460090|FG000|STARTED|Overall Study||15
11264648|NCT02280044|12460091|FG001|STARTED|Overall Study||15
11264649|NCT02280044|12460090|FG000|COMPLETED|Overall Study||15
11264650|NCT02280044|12460091|FG001|COMPLETED|Overall Study||13
11264651|NCT02280044|12460090|FG000|NOT COMPLETED|Overall Study||0
11264652|NCT02280044|12460091|FG001|NOT COMPLETED|Overall Study||2
11264653|NCT02280096|12460099|FG000|STARTED|Overall Study||13
11264654|NCT02280096|12460100|FG001|STARTED|Overall Study||11
11264655|NCT02280096|12460099|FG000|COMPLETED|Overall Study||11
11264656|NCT02280096|12460100|FG001|COMPLETED|Overall Study||10
11264657|NCT02280096|12460099|FG000|NOT COMPLETED|Overall Study||2
11264658|NCT02280096|12460100|FG001|NOT COMPLETED|Overall Study||1
11264659|NCT02280122|12460117|FG000|STARTED|Overall Study||15
11264660|NCT02280122|12460118|FG001|STARTED|Overall Study||15
11264661|NCT02280122|12460119|FG002|STARTED|Overall Study||30
11264662|NCT02280122|12460117|FG000|COMPLETED|Overall Study||15
11264663|NCT02280122|12460118|FG001|COMPLETED|Overall Study||15
11264664|NCT02280122|12460119|FG002|COMPLETED|Overall Study||30
11264665|NCT02280122|12460117|FG000|NOT COMPLETED|Overall Study||0
11264666|NCT02280122|12460118|FG001|NOT COMPLETED|Overall Study||0
11264667|NCT02280122|12460119|FG002|NOT COMPLETED|Overall Study||0
11264668|NCT02280187|12460125|FG000|STARTED|Overall Study||400
11264669|NCT02280187|12460125|FG000|COMPLETED|Overall Study||182
11264670|NCT02280187|12460125|FG000|NOT COMPLETED|Overall Study||218
11264671|NCT02280200|12460131|FG000|STARTED|Overall Study||15
11264672|NCT02280200|12460132|FG001|STARTED|Overall Study||13
11264673|NCT02280200|12460131|FG000|COMPLETED|Overall Study||12
11264674|NCT02280200|12460132|FG001|COMPLETED|Overall Study||10
11264675|NCT02280200|12460131|FG000|NOT COMPLETED|Overall Study||3
11264676|NCT02280200|12460132|FG001|NOT COMPLETED|Overall Study||3
11264677|NCT02280226|12460138|FG000|STARTED|Overall Study||17
11264678|NCT02280226|12460138|FG000|COMPLETED|Overall Study||17
11264679|NCT02280226|12460138|FG000|NOT COMPLETED|Overall Study||0
11264680|NCT02280291|12460146|FG000|STARTED|Overall Study||25
11264681|NCT02280291|12460147|FG001|STARTED|Overall Study||25
11264682|NCT02280291|12460148|FG002|STARTED|Overall Study||24
11264683|NCT02280291|12460149|FG003|STARTED|Overall Study||26
11264684|NCT02280291|12460146|FG000|COMPLETED|Overall Study||21
11264685|NCT02280291|12460147|FG001|COMPLETED|Overall Study||23
11264686|NCT02280291|12460148|FG002|COMPLETED|Overall Study||21
11264687|NCT02280291|12460149|FG003|COMPLETED|Overall Study||18
11264688|NCT02280291|12460146|FG000|NOT COMPLETED|Overall Study||4
11264689|NCT02280291|12460147|FG001|NOT COMPLETED|Overall Study||2
11264690|NCT02280291|12460148|FG002|NOT COMPLETED|Overall Study||3
11264691|NCT02280291|12460149|FG003|NOT COMPLETED|Overall Study||8
11264692|NCT02280304|12460163|FG000|STARTED|Overall Study||19
11264693|NCT02280304|12460164|FG001|STARTED|Overall Study||18
11264694|NCT02280304|12460163|FG000|COMPLETED|Overall Study||12
11264695|NCT02280304|12460164|FG001|COMPLETED|Overall Study|A non completer received the allocated intervention before being lost to follow-up.|10
11264696|NCT02280304|12460163|FG000|NOT COMPLETED|Overall Study||7
11264697|NCT02280304|12460164|FG001|NOT COMPLETED|Overall Study||8
11264698|NCT02280317|12460182|FG000|STARTED|Overall Study|Patients receiving at least one dose.|1
11264699|NCT02280317|12460183|FG001|STARTED|Overall Study|Patients receiving at least one dose.|1
11264700|NCT02280317|12460184|FG002|STARTED|Overall Study|Patients receiving at least one dose.|3
11264701|NCT02280317|12460185|FG003|STARTED|Overall Study|Patients receiving at least one dose.|5
11264702|NCT02280317|12460186|FG004|STARTED|Overall Study|Patients receiving at least one dose.|2
11264703|NCT02280317|12460182|FG000|COMPLETED|Overall Study|Patients completing six cycles.|1
11264704|NCT02280317|12460183|FG001|COMPLETED|Overall Study|Patients completing six cycles.|1
11264705|NCT02280317|12460184|FG002|COMPLETED|Overall Study|Patients completing six cycles.|0
11264706|NCT02280317|12460185|FG003|COMPLETED|Overall Study|Patients completing six cycles.|2
11264707|NCT02280317|12460186|FG004|COMPLETED|Overall Study|Patients completing six cycles.|0
11264708|NCT02280317|12460182|FG000|NOT COMPLETED|Overall Study||0
11264709|NCT02280317|12460183|FG001|NOT COMPLETED|Overall Study||0
11264710|NCT02280317|12460184|FG002|NOT COMPLETED|Overall Study||3
11264711|NCT02280317|12460185|FG003|NOT COMPLETED|Overall Study||3
11264712|NCT02280317|12460186|FG004|NOT COMPLETED|Overall Study||2
11264713|NCT02280408|12460213|FG000|STARTED|Overall Study||10
11264714|NCT02280408|12460214|FG001|STARTED|Overall Study||10
11264715|NCT02280408|12460215|FG002|STARTED|Overall Study||10
11264716|NCT02280408|12460216|FG003|STARTED|Overall Study||9
11264717|NCT02280408|12460213|FG000|Vaccination 1|Overall Study||10
11264718|NCT02280408|12460214|FG001|Vaccination 1|Overall Study||10
11264719|NCT02280408|12460215|FG002|Vaccination 1|Overall Study||10
11264720|NCT02280408|12460216|FG003|Vaccination 1|Overall Study||9
11264721|NCT02280408|12460213|FG000|Vaccination 2|Overall Study||10
11264722|NCT02280408|12460214|FG001|Vaccination 2|Overall Study||10
11264723|NCT02280408|12460215|FG002|Vaccination 2|Overall Study||10
11264724|NCT02280408|12460216|FG003|Vaccination 2|Overall Study||9
11264725|NCT02280408|12460213|FG000|COMPLETED|Overall Study||10
11264726|NCT02280408|12460214|FG001|COMPLETED|Overall Study||8
11264727|NCT02280408|12460215|FG002|COMPLETED|Overall Study||10
11264728|NCT02280408|12460216|FG003|COMPLETED|Overall Study||9
11264729|NCT02280408|12460213|FG000|NOT COMPLETED|Overall Study||0
11264730|NCT02280408|12460214|FG001|NOT COMPLETED|Overall Study||2
11264731|NCT02280408|12460215|FG002|NOT COMPLETED|Overall Study||0
11264732|NCT02280408|12460216|FG003|NOT COMPLETED|Overall Study||0
11264733|NCT02280421|12460228|FG000|STARTED|First Intervention(2 Weeks)||12
11264734|NCT02280421|12460229|FG001|STARTED|First Intervention(2 Weeks)||12
11264735|NCT02280421|12460228|FG000|Received Intervention|First Intervention(2 Weeks)||12
11264736|NCT02280421|12460229|FG001|Received Intervention|First Intervention(2 Weeks)||12
11264737|NCT02280421|12460228|FG000|COMPLETED|First Intervention(2 Weeks)||12
11264738|NCT02280421|12460229|FG001|COMPLETED|First Intervention(2 Weeks)||12
11264739|NCT02280421|12460228|FG000|NOT COMPLETED|First Intervention(2 Weeks)||0
11264740|NCT02280421|12460229|FG001|NOT COMPLETED|First Intervention(2 Weeks)||0
11264741|NCT02280421|12460228|FG000|STARTED|Washout (2 Weeks)||12
11264742|NCT02280421|12460229|FG001|STARTED|Washout (2 Weeks)||12
11264743|NCT02280421|12460228|FG000|COMPLETED|Washout (2 Weeks)||11
11264744|NCT02280421|12460229|FG001|COMPLETED|Washout (2 Weeks)||11
11264745|NCT02280421|12460228|FG000|NOT COMPLETED|Washout (2 Weeks)||1
11264746|NCT02280421|12460229|FG001|NOT COMPLETED|Washout (2 Weeks)||1
11264747|NCT02280421|12460228|FG000|STARTED|Second Intervention(2 Weeks)||12
11264748|NCT02280421|12460229|FG001|STARTED|Second Intervention(2 Weeks)||12
11264749|NCT02280421|12460228|FG000|Received Intervention|Second Intervention(2 Weeks)||12
11264750|NCT02280421|12460229|FG001|Received Intervention|Second Intervention(2 Weeks)||12
11264751|NCT02280421|12460228|FG000|COMPLETED|Second Intervention(2 Weeks)||12
11264752|NCT02280421|12460229|FG001|COMPLETED|Second Intervention(2 Weeks)||12
11264753|NCT02280421|12460228|FG000|NOT COMPLETED|Second Intervention(2 Weeks)||0
11264754|NCT02280421|12460229|FG001|NOT COMPLETED|Second Intervention(2 Weeks)||0
11264755|NCT02280473|12460249|FG000|STARTED|Overall Study||94
11264756|NCT02280473|12460250|FG001|STARTED|Overall Study||94
11264757|NCT02280473|12460249|FG000|COMPLETED|Overall Study||93
11264758|NCT02280473|12460250|FG001|COMPLETED|Overall Study||91
11264759|NCT02280473|12460249|FG000|NOT COMPLETED|Overall Study||1
11264760|NCT02280473|12460250|FG001|NOT COMPLETED|Overall Study||3
11264761|NCT02280499|12460256|FG000|STARTED|Overall Study||87
11264762|NCT02280499|12460256|FG000|COMPLETED|Overall Study||26
11396865|NCT03938857|12590827|FG000|STARTED|Overall Study||6
11396866|NCT03938857|12590828|FG001|STARTED|Overall Study||12
11396867|NCT03938857|12590829|FG002|STARTED|Overall Study||12
11396868|NCT03938857|12590830|FG003|STARTED|Overall Study||0
11396869|NCT03938857|12590827|FG000|COMPLETED|Overall Study||5
11396870|NCT03938857|12590828|FG001|COMPLETED|Overall Study||12
11396871|NCT03938857|12590829|FG002|COMPLETED|Overall Study||12
11396872|NCT03938857|12590830|FG003|COMPLETED|Overall Study||0
11396873|NCT03938857|12590827|FG000|NOT COMPLETED|Overall Study||1
11396874|NCT03938857|12590828|FG001|NOT COMPLETED|Overall Study||0
11396875|NCT03938857|12590829|FG002|NOT COMPLETED|Overall Study||0
11396876|NCT03938857|12590830|FG003|NOT COMPLETED|Overall Study||0
11396877|NCT03941912|12590840|FG000|STARTED|Overall Study||44
11396878|NCT03941912|12590840|FG000|COMPLETED|Overall Study||44
11396879|NCT03941912|12590840|FG000|NOT COMPLETED|Overall Study||0
11396880|NCT03945981|12590844|FG000|STARTED|Overall Study||131
11396881|NCT03945981|12590844|FG000|COMPLETED|Overall Study||108
11264763|NCT02280499|12460256|FG000|NOT COMPLETED|Overall Study||61
11396882|NCT03945981|12590844|FG000|NOT COMPLETED|Overall Study||23
11396883|NCT03950167|12590850|FG000|STARTED|Overall Study||25
11396884|NCT03950167|12590851|FG001|STARTED|Overall Study||25
11396885|NCT03950167|12590850|FG000|COMPLETED|Overall Study||24
11396886|NCT03950167|12590851|FG001|COMPLETED|Overall Study||22
11396887|NCT03950167|12590850|FG000|NOT COMPLETED|Overall Study||1
11396888|NCT03950167|12590851|FG001|NOT COMPLETED|Overall Study||3
11396889|NCT03954834|12590861|FG000|STARTED|Overall Study||121
11264764|NCT02280655|12460262|FG000|STARTED|Overall Study||25
11264765|NCT02280655|12460263|FG001|STARTED|Overall Study||18
11264766|NCT02280655|12460262|FG000|COMPLETED|Overall Study||25
11264767|NCT02280655|12460263|FG001|COMPLETED|Overall Study||18
11264768|NCT02280655|12460262|FG000|NOT COMPLETED|Overall Study||0
11264769|NCT02280655|12460263|FG001|NOT COMPLETED|Overall Study||0
11264770|NCT02280811|12460274|FG000|STARTED|Drug Administration||1
11264771|NCT02280811|12460275|FG001|STARTED|Drug Administration||2
11264772|NCT02280811|12460276|FG002|STARTED|Drug Administration||1
11264773|NCT02280811|12460277|FG003|STARTED|Drug Administration||6
11264774|NCT02280811|12460278|FG004|STARTED|Drug Administration||2
11264775|NCT02280811|12460274|FG000|COMPLETED|Drug Administration||1
11264776|NCT02280811|12460275|FG001|COMPLETED|Drug Administration||2
11264777|NCT02280811|12460276|FG002|COMPLETED|Drug Administration||1
11264778|NCT02280811|12460277|FG003|COMPLETED|Drug Administration||6
11264779|NCT02280811|12460278|FG004|COMPLETED|Drug Administration||2
11264780|NCT02280811|12460274|FG000|NOT COMPLETED|Drug Administration||0
11264781|NCT02280811|12460275|FG001|NOT COMPLETED|Drug Administration||0
11264782|NCT02280811|12460276|FG002|NOT COMPLETED|Drug Administration||0
11264783|NCT02280811|12460277|FG003|NOT COMPLETED|Drug Administration||0
11264784|NCT02280811|12460278|FG004|NOT COMPLETED|Drug Administration||0
11264785|NCT02280811|12460274|FG000|STARTED|Retreated at the MTD||0
11264786|NCT02280811|12460275|FG001|STARTED|Retreated at the MTD||0
11264787|NCT02280811|12460276|FG002|STARTED|Retreated at the MTD||0
11264788|NCT02280811|12460277|FG003|STARTED|Retreated at the MTD||0
11264789|NCT02280811|12460278|FG004|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
11264790|NCT02280811|12460274|FG000|COMPLETED|Retreated at the MTD||0
11264791|NCT02280811|12460275|FG001|COMPLETED|Retreated at the MTD||0
11264792|NCT02280811|12460276|FG002|COMPLETED|Retreated at the MTD||0
11264793|NCT02280811|12460277|FG003|COMPLETED|Retreated at the MTD||0
11264794|NCT02280811|12460278|FG004|COMPLETED|Retreated at the MTD||1
11264795|NCT02280811|12460274|FG000|NOT COMPLETED|Retreated at the MTD||0
11264796|NCT02280811|12460275|FG001|NOT COMPLETED|Retreated at the MTD||0
11264797|NCT02280811|12460276|FG002|NOT COMPLETED|Retreated at the MTD||0
11264798|NCT02280811|12460277|FG003|NOT COMPLETED|Retreated at the MTD||0
11264799|NCT02280811|12460278|FG004|NOT COMPLETED|Retreated at the MTD||0
11264800|NCT02280863|12460294|FG000|STARTED|Android Platform||8
11264801|NCT02280863|12460295|FG001|STARTED|Android Platform||0
11264802|NCT02280863|12460294|FG000|COMPLETED|Android Platform||8
11264803|NCT02280863|12460295|FG001|COMPLETED|Android Platform||0
11264804|NCT02280863|12460294|FG000|NOT COMPLETED|Android Platform||0
11264805|NCT02280863|12460295|FG001|NOT COMPLETED|Android Platform||0
11264806|NCT02280863|12460294|FG000|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
11264807|NCT02280863|12460295|FG001|STARTED|Integrated Platform||15
11264808|NCT02280863|12460294|FG000|COMPLETED|Integrated Platform||9
11264809|NCT02280863|12460295|FG001|COMPLETED|Integrated Platform||14
11264810|NCT02280863|12460294|FG000|NOT COMPLETED|Integrated Platform||0
11264811|NCT02280863|12460295|FG001|NOT COMPLETED|Integrated Platform||1
11264812|NCT02281136|12460305|FG000|STARTED|Overall Study||29
11264813|NCT02281136|12460305|FG000|COMPLETED|Overall Study||29
11264814|NCT02281136|12460305|FG000|NOT COMPLETED|Overall Study||0
11396890|NCT03954834|12590862|FG001|STARTED|Overall Study||121
11396891|NCT03954834|12590863|FG002|STARTED|Overall Study||121
11396892|NCT03954834|12590864|FG003|STARTED|Overall Study||115
11264815|NCT02281318|12460311|FG000|STARTED|Overall Study||277
11264816|NCT02281318|12460312|FG001|STARTED|Overall Study||274
11264817|NCT02281318|12460311|FG000|COMPLETED|Overall Study||263
11264818|NCT02281318|12460312|FG001|COMPLETED|Overall Study||269
11264819|NCT02281318|12460311|FG000|NOT COMPLETED|Overall Study||14
11264820|NCT02281318|12460312|FG001|NOT COMPLETED|Overall Study||5
11264821|NCT02281344|12460318|FG000|STARTED|Overall Study||6
11264822|NCT02281344|12460318|FG000|COMPLETED|Overall Study||6
11396893|NCT03954834|12590861|FG000|Received at Least One Dose of Study Drug|Overall Study||121
11396894|NCT03954834|12590862|FG001|Received at Least One Dose of Study Drug|Overall Study||121
11396895|NCT03954834|12590863|FG002|Received at Least One Dose of Study Drug|Overall Study||121
11396896|NCT03954834|12590864|FG003|Received at Least One Dose of Study Drug|Overall Study||115
11396897|NCT03954834|12590861|FG000|COMPLETED|Overall Study||114
11396898|NCT03954834|12590862|FG001|COMPLETED|Overall Study||112
11396899|NCT03954834|12590863|FG002|COMPLETED|Overall Study||103
11264823|NCT02281344|12460318|FG000|NOT COMPLETED|Overall Study||0
11396900|NCT03954834|12590864|FG003|COMPLETED|Overall Study||99
11396901|NCT03954834|12590861|FG000|NOT COMPLETED|Overall Study||7
11264824|NCT02281357|12460324|FG000|STARTED|Overall Study||70
11264825|NCT02281357|12460325|FG001|STARTED|Overall Study||70
11264826|NCT02281357|12460324|FG000|COMPLETED|Overall Study||63
11264827|NCT02281357|12460325|FG001|COMPLETED|Overall Study||66
11264828|NCT02281357|12460324|FG000|NOT COMPLETED|Overall Study||7
11264829|NCT02281357|12460325|FG001|NOT COMPLETED|Overall Study||4
11264830|NCT02281409|12460335|FG000|STARTED|Overall Study||3
11264831|NCT02281409|12460336|FG001|STARTED|Overall Study||3
11264832|NCT02281409|12460337|FG002|STARTED|Overall Study||5
11264833|NCT02281409|12460338|FG003|STARTED|Overall Study||6
11264834|NCT02281409|12460335|FG000|COMPLETED|Overall Study||3
11264835|NCT02281409|12460336|FG001|COMPLETED|Overall Study||3
11264836|NCT02281409|12460337|FG002|COMPLETED|Overall Study||5
11264837|NCT02281409|12460338|FG003|COMPLETED|Overall Study||6
11264838|NCT02281409|12460335|FG000|NOT COMPLETED|Overall Study||0
11264839|NCT02281409|12460336|FG001|NOT COMPLETED|Overall Study||0
11264840|NCT02281409|12460337|FG002|NOT COMPLETED|Overall Study||0
11264841|NCT02281409|12460338|FG003|NOT COMPLETED|Overall Study||0
11264842|NCT02281422|12460354|FG000|STARTED|Overall Study||8
11264843|NCT02281422|12460355|FG001|STARTED|Overall Study||8
11264844|NCT02281422|12460356|FG002|STARTED|Overall Study||8
11264845|NCT02281422|12460357|FG003|STARTED|Overall Study||8
11264846|NCT02281422|12460358|FG004|STARTED|Overall Study||8
11264847|NCT02281422|12460354|FG000|COMPLETED|Overall Study||8
11264848|NCT02281422|12460355|FG001|COMPLETED|Overall Study||8
11264849|NCT02281422|12460356|FG002|COMPLETED|Overall Study||8
11264850|NCT02281422|12460357|FG003|COMPLETED|Overall Study||8
11264851|NCT02281422|12460358|FG004|COMPLETED|Overall Study||8
11264852|NCT02281422|12460354|FG000|NOT COMPLETED|Overall Study||0
11264853|NCT02281422|12460355|FG001|NOT COMPLETED|Overall Study||0
11264854|NCT02281422|12460356|FG002|NOT COMPLETED|Overall Study||0
11264855|NCT02281422|12460357|FG003|NOT COMPLETED|Overall Study||0
11264856|NCT02281422|12460358|FG004|NOT COMPLETED|Overall Study||0
11264857|NCT02281448|12460372|FG000|STARTED|Overall Study||10
11264858|NCT02281448|12460373|FG001|STARTED|Overall Study||10
11264859|NCT02281448|12460372|FG000|COMPLETED|Overall Study||8
11264860|NCT02281448|12460373|FG001|COMPLETED|Overall Study||9
11264861|NCT02281448|12460372|FG000|NOT COMPLETED|Overall Study||2
11264862|NCT02281448|12460373|FG001|NOT COMPLETED|Overall Study||1
11264863|NCT02281526|12460381|FG000|STARTED|Overall Study||9
11264864|NCT02281526|12460382|FG001|STARTED|Overall Study||8
11264865|NCT02281526|12460381|FG000|COMPLETED|Overall Study||8
11264866|NCT02281526|12460382|FG001|COMPLETED|Overall Study||8
11264867|NCT02281526|12460381|FG000|NOT COMPLETED|Overall Study||1
11264868|NCT02281526|12460382|FG001|NOT COMPLETED|Overall Study||0
11264869|NCT02281552|12460390|FG000|STARTED|Overall Study||104
11264870|NCT02281552|12460391|FG001|STARTED|Overall Study||105
11264871|NCT02281552|12460390|FG000|COMPLETED|Overall Study||100
11264872|NCT02281552|12460391|FG001|COMPLETED|Overall Study||95
11264873|NCT02281552|12460390|FG000|NOT COMPLETED|Overall Study||4
11264874|NCT02281552|12460391|FG001|NOT COMPLETED|Overall Study||10
11264875|NCT02281591|12460401|FG000|STARTED|Overall Study||8
11264876|NCT02281591|12460402|FG001|STARTED|Overall Study||8
11264877|NCT02281591|12460403|FG002|STARTED|Overall Study||8
11264878|NCT02281591|12460404|FG003|STARTED|Overall Study||8
11264879|NCT02281591|12460401|FG000|COMPLETED|Overall Study||8
11264880|NCT02281591|12460402|FG001|COMPLETED|Overall Study||8
11264881|NCT02281591|12460403|FG002|COMPLETED|Overall Study||8
11264882|NCT02281591|12460404|FG003|COMPLETED|Overall Study||8
11264883|NCT02281591|12460401|FG000|NOT COMPLETED|Overall Study||0
11264884|NCT02281591|12460402|FG001|NOT COMPLETED|Overall Study||0
11264885|NCT02281591|12460403|FG002|NOT COMPLETED|Overall Study||0
11264886|NCT02281591|12460404|FG003|NOT COMPLETED|Overall Study||0
11264887|NCT02281760|12460414|FG000|STARTED|Overall Study||6
11264888|NCT02281760|12460414|FG000|COMPLETED|Overall Study||5
11264889|NCT02281760|12460414|FG000|NOT COMPLETED|Overall Study||1
11264890|NCT02281773|12460423|FG000|STARTED|Overall Study||87
11264891|NCT02281773|12460424|FG001|STARTED|Overall Study|Started are the treated patients|85
11264892|NCT02281773|12460425|FG002|STARTED|Overall Study||85
11264893|NCT02281773|12460426|FG003|STARTED|Overall Study||86
11264894|NCT02281773|12460427|FG004|STARTED|Overall Study|Started are the treated patients|173
11264895|NCT02281773|12460423|FG000|COMPLETED|Overall Study||76
11264896|NCT02281773|12460424|FG001|COMPLETED|Overall Study||70
11396902|NCT03954834|12590862|FG001|NOT COMPLETED|Overall Study||9
11396903|NCT03954834|12590863|FG002|NOT COMPLETED|Overall Study||18
11396904|NCT03954834|12590864|FG003|NOT COMPLETED|Overall Study||16
11396905|NCT03958071|12590877|FG000|STARTED|Overall Study||347
11264897|NCT02281773|12460425|FG002|COMPLETED|Overall Study||67
11264898|NCT02281773|12460426|FG003|COMPLETED|Overall Study||65
11264899|NCT02281773|12460427|FG004|COMPLETED|Overall Study||143
11264900|NCT02281773|12460423|FG000|NOT COMPLETED|Overall Study||11
11396906|NCT03958071|12590878|FG001|STARTED|Overall Study||423
11396907|NCT03958071|12590879|FG002|STARTED|Overall Study||12494
11264901|NCT02281773|12460424|FG001|NOT COMPLETED|Overall Study||15
11264902|NCT02281773|12460425|FG002|NOT COMPLETED|Overall Study||18
11264903|NCT02281773|12460426|FG003|NOT COMPLETED|Overall Study||21
11264904|NCT02281773|12460427|FG004|NOT COMPLETED|Overall Study||30
11264905|NCT02281851|12460441|FG000|STARTED|Overall Study||4
11264906|NCT02281851|12460442|FG001|STARTED|Overall Study||10
11264907|NCT02281851|12460441|FG000|COMPLETED|Overall Study||4
11264908|NCT02281851|12460442|FG001|COMPLETED|Overall Study||10
11264909|NCT02281851|12460441|FG000|NOT COMPLETED|Overall Study||0
11264910|NCT02281851|12460442|FG001|NOT COMPLETED|Overall Study||0
11264911|NCT02282111|12460450|FG000|STARTED|Overall Study||26
11264912|NCT02282111|12460451|FG001|STARTED|Overall Study||30
11264913|NCT02282111|12460450|FG000|COMPLETED|Overall Study||19
11264914|NCT02282111|12460451|FG001|COMPLETED|Overall Study||22
11264915|NCT02282111|12460450|FG000|NOT COMPLETED|Overall Study||7
11264916|NCT02282111|12460451|FG001|NOT COMPLETED|Overall Study||8
11264917|NCT02282163|12460457|FG000|STARTED|Overall Study||13
11264918|NCT02282163|12460457|FG000|COMPLETED|Overall Study||12
11264919|NCT02282163|12460457|FG000|NOT COMPLETED|Overall Study||1
11340165|NCT02918617|12537447|FG000|STARTED|Overall Study||21
11340166|NCT02918617|12537448|FG001|STARTED|Overall Study||20
11340167|NCT02918617|12537449|FG002|STARTED|Overall Study||22
11340168|NCT02918617|12537450|FG003|STARTED|Overall Study||22
11340169|NCT02918617|12537451|FG004|STARTED|Overall Study||24
11340170|NCT02918617|12537452|FG005|STARTED|Overall Study||20
11340171|NCT02918617|12537453|FG006|STARTED|Overall Study||22
11340172|NCT02918617|12537454|FG007|STARTED|Overall Study||26
11340173|NCT02918617|12537455|FG008|STARTED|Overall Study||26
11340174|NCT02918617|12537447|FG000|COMPLETED|Overall Study||20
11340175|NCT02918617|12537448|FG001|COMPLETED|Overall Study||20
11340176|NCT02918617|12537449|FG002|COMPLETED|Overall Study||19
11340177|NCT02918617|12537450|FG003|COMPLETED|Overall Study||22
11340178|NCT02918617|12537451|FG004|COMPLETED|Overall Study||24
11340179|NCT02918617|12537452|FG005|COMPLETED|Overall Study||20
11340180|NCT02918617|12537453|FG006|COMPLETED|Overall Study||22
11340181|NCT02918617|12537454|FG007|COMPLETED|Overall Study||25
11340182|NCT02918617|12537455|FG008|COMPLETED|Overall Study||26
11340183|NCT02918617|12537447|FG000|NOT COMPLETED|Overall Study||1
11340184|NCT02918617|12537448|FG001|NOT COMPLETED|Overall Study||0
11340185|NCT02918617|12537449|FG002|NOT COMPLETED|Overall Study||3
11340186|NCT02918617|12537450|FG003|NOT COMPLETED|Overall Study||0
11340187|NCT02918617|12537451|FG004|NOT COMPLETED|Overall Study||0
11340188|NCT02918617|12537452|FG005|NOT COMPLETED|Overall Study||0
11340189|NCT02918617|12537453|FG006|NOT COMPLETED|Overall Study||0
11340190|NCT02918617|12537454|FG007|NOT COMPLETED|Overall Study||1
11340191|NCT02918617|12537455|FG008|NOT COMPLETED|Overall Study||0
11340192|NCT02918630|12537477|FG000|STARTED|Overall Study||4
11340193|NCT02918630|12537478|FG001|STARTED|Overall Study||3
11340194|NCT02918630|12537477|FG000|COMPLETED|Overall Study||4
11340195|NCT02918630|12537478|FG001|COMPLETED|Overall Study||3
11340196|NCT02918630|12537477|FG000|NOT COMPLETED|Overall Study||0
11340197|NCT02918630|12537478|FG001|NOT COMPLETED|Overall Study||0
11340198|NCT02918656|12537487|FG000|STARTED|Overall Study||54
11340199|NCT02918656|12537488|FG001|STARTED|Overall Study||60
11340200|NCT02918656|12537489|FG002|STARTED|Overall Study||57
11340201|NCT02918656|12537487|FG000|COMPLETED|Overall Study||54
11340202|NCT02918656|12537488|FG001|COMPLETED|Overall Study||60
11340203|NCT02918656|12537489|FG002|COMPLETED|Overall Study||57
11340204|NCT02918656|12537487|FG000|NOT COMPLETED|Overall Study||0
11340205|NCT02918656|12537488|FG001|NOT COMPLETED|Overall Study||0
11340206|NCT02918656|12537489|FG002|NOT COMPLETED|Overall Study||0
11340207|NCT02918669|12537497|FG000|STARTED|Overall Study||12
11396908|NCT03958071|12590877|FG000|COMPLETED|Overall Study||347
11396909|NCT03958071|12590878|FG001|COMPLETED|Overall Study||423
11396910|NCT03958071|12590879|FG002|COMPLETED|Overall Study||12494
11396911|NCT03958071|12590877|FG000|NOT COMPLETED|Overall Study||0
11396912|NCT03958071|12590878|FG001|NOT COMPLETED|Overall Study||0
11396913|NCT03958071|12590879|FG002|NOT COMPLETED|Overall Study||0
11396914|NCT03961529|12590891|FG000|STARTED|Overall Study||166
11396915|NCT03961529|12590892|FG001|STARTED|Overall Study||144
11396916|NCT03961529|12590893|FG002|STARTED|Overall Study||56
11396917|NCT03961529|12590891|FG000|COMPLETED|Overall Study||124
11396918|NCT03961529|12590892|FG001|COMPLETED|Overall Study||127
11396919|NCT03961529|12590893|FG002|COMPLETED|Overall Study||51
11396920|NCT03961529|12590891|FG000|NOT COMPLETED|Overall Study||42
11340208|NCT02918669|12537497|FG000|COMPLETED|Overall Study||8
11340209|NCT02918669|12537497|FG000|NOT COMPLETED|Overall Study||4
11340210|NCT02918773|12537503|FG000|STARTED|Overall Study||11
11340211|NCT02918773|12537504|FG001|STARTED|Overall Study||11
11340212|NCT02918773|12537503|FG000|COMPLETED|Overall Study||11
11340213|NCT02918773|12537504|FG001|COMPLETED|Overall Study||11
11340214|NCT02918773|12537503|FG000|NOT COMPLETED|Overall Study||0
11340215|NCT02918773|12537504|FG001|NOT COMPLETED|Overall Study||0
11340216|NCT02918851|12537514|FG000|STARTED|Overall Study||14
11340217|NCT02918851|12537515|FG001|STARTED|Overall Study||14
11340218|NCT02918851|12537516|FG002|STARTED|Overall Study||14
11340219|NCT02918851|12537514|FG000|COMPLETED|Overall Study||10
11340220|NCT02918851|12537515|FG001|COMPLETED|Overall Study||10
11340221|NCT02918851|12537516|FG002|COMPLETED|Overall Study||10
11340222|NCT02918851|12537514|FG000|NOT COMPLETED|Overall Study||4
11340223|NCT02918851|12537515|FG001|NOT COMPLETED|Overall Study||4
11340224|NCT02918851|12537516|FG002|NOT COMPLETED|Overall Study||4
11340225|NCT02918877|12537526|FG000|STARTED|Overall Study||24
11340226|NCT02918877|12537527|FG001|STARTED|Overall Study||25
11340227|NCT02918877|12537526|FG000|COMPLETED|Overall Study||18
11340228|NCT02918877|12537527|FG001|COMPLETED|Overall Study||22
11340229|NCT02918877|12537526|FG000|NOT COMPLETED|Overall Study||6
11396921|NCT03961529|12590892|FG001|NOT COMPLETED|Overall Study||17
11264920|NCT02282293|12460472|FG000|STARTED|Overall Study||100
11264921|NCT02282293|12460473|FG001|STARTED|Overall Study||100
11264922|NCT02282293|12460472|FG000|COMPLETED|Overall Study||97
11264923|NCT02282293|12460473|FG001|COMPLETED|Overall Study||97
11264924|NCT02282293|12460472|FG000|NOT COMPLETED|Overall Study||3
11264925|NCT02282293|12460473|FG001|NOT COMPLETED|Overall Study||3
11264926|NCT02282514|12460479|FG000|STARTED|Overall Study||23
11264927|NCT02282514|12460479|FG000|COMPLETED|Overall Study||23
11264928|NCT02282514|12460479|FG000|NOT COMPLETED|Overall Study||0
11264929|NCT02282527|12460485|FG000|STARTED|Overall Study||16
11264930|NCT02282527|12460486|FG001|STARTED|Overall Study||16
11264931|NCT02282527|12460485|FG000|COMPLETED|Overall Study||15
11264932|NCT02282527|12460486|FG001|COMPLETED|Overall Study||15
11264933|NCT02282527|12460485|FG000|NOT COMPLETED|Overall Study||1
11264934|NCT02282527|12460486|FG001|NOT COMPLETED|Overall Study||1
11264935|NCT02282605|12460498|FG000|STARTED|Overall Study||27
11264936|NCT02282605|12460499|FG001|STARTED|Overall Study||12
11264937|NCT02282605|12460500|FG002|STARTED|Overall Study||24
11264938|NCT02282605|12460498|FG000|COMPLETED|Overall Study||24
11264939|NCT02282605|12460499|FG001|COMPLETED|Overall Study||12
11264940|NCT02282605|12460500|FG002|COMPLETED|Overall Study||24
11264941|NCT02282605|12460498|FG000|NOT COMPLETED|Overall Study||3
11264942|NCT02282605|12460499|FG001|NOT COMPLETED|Overall Study||0
11264943|NCT02282605|12460500|FG002|NOT COMPLETED|Overall Study||0
11264944|NCT02282631|12460510|FG000|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
11264945|NCT02282631|12460511|FG001|STARTED|Overall Study||15
11264946|NCT02282631|12460510|FG000|COMPLETED|Overall Study||12
11264947|NCT02282631|12460511|FG001|COMPLETED|Overall Study||15
11264948|NCT02282631|12460510|FG000|NOT COMPLETED|Overall Study||2
11264949|NCT02282631|12460511|FG001|NOT COMPLETED|Overall Study||0
11264950|NCT02282722|12460525|FG000|STARTED|Overall Study||94
11264951|NCT02282722|12460526|FG001|STARTED|Overall Study||92
11264952|NCT02282722|12460525|FG000|2-week Assessment|Overall Study||79
11264953|NCT02282722|12460526|FG001|2-week Assessment|Overall Study||75
11264954|NCT02282722|12460525|FG000|3-month Assessment|Overall Study||71
11264955|NCT02282722|12460526|FG001|3-month Assessment|Overall Study||73
11264956|NCT02282722|12460525|FG000|COMPLETED|Overall Study||71
11264957|NCT02282722|12460526|FG001|COMPLETED|Overall Study||73
11264958|NCT02282722|12460525|FG000|NOT COMPLETED|Overall Study||23
11264959|NCT02282722|12460526|FG001|NOT COMPLETED|Overall Study||19
11264960|NCT02282813|12460535|FG000|STARTED|Overall Study|ITT Population|103
11264961|NCT02282813|12460536|FG001|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
11264962|NCT02282813|12460537|FG002|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
11264963|NCT02282813|12460535|FG000|COMPLETED|Overall Study||91
11264964|NCT02282813|12460536|FG001|COMPLETED|Overall Study||130
11264965|NCT02282813|12460537|FG002|COMPLETED|Overall Study||39
11264966|NCT02282813|12460535|FG000|NOT COMPLETED|Overall Study||12
11264967|NCT02282813|12460536|FG001|NOT COMPLETED|Overall Study||23
11264968|NCT02282813|12460537|FG002|NOT COMPLETED|Overall Study||3
11264969|NCT02282904|12460547|FG000|STARTED|Overall Study||7
11264970|NCT02282904|12460547|FG000|COMPLETED|Overall Study|Patient accrual was stopped early, and the protocol closed after completing followup|7
11264971|NCT02282904|12460547|FG000|NOT COMPLETED|Overall Study||0
11264972|NCT02282930|12460551|FG000|STARTED|Overall Study||20
11264973|NCT02282930|12460551|FG000|COMPLETED|Overall Study||19
11264974|NCT02282930|12460551|FG000|NOT COMPLETED|Overall Study||1
11264975|NCT02282982|12460555|FG000|STARTED|Overall Study||359
11264976|NCT02282982|12460555|FG000|Attended Visit 1|Overall Study||359
11264977|NCT02282982|12460555|FG000|Attended Visit 2|Overall Study||341
11264978|NCT02282982|12460555|FG000|Attended Visit 3|Overall Study||298
11264979|NCT02282982|12460555|FG000|Attended Visit 4|Overall Study||194
11264980|NCT02282982|12460555|FG000|Attended Visit 5|Overall Study||83
11264981|NCT02282982|12460555|FG000|Attended Follow-up Visit|Overall Study||349
11264982|NCT02282982|12460555|FG000|COMPLETED|Overall Study||153
11264983|NCT02282982|12460555|FG000|NOT COMPLETED|Overall Study||206
11264984|NCT02283268|12460559|FG000|STARTED|Overall Study||15
11264985|NCT02283268|12460559|FG000|COMPLETED|Overall Study||14
11264986|NCT02283268|12460559|FG000|NOT COMPLETED|Overall Study||1
11264987|NCT02283294|12460573|FG000|STARTED|Overall Study||41
11264988|NCT02283294|12460574|FG001|STARTED|Overall Study||47
11264989|NCT02283294|12460573|FG000|Received Allocated Treatment Intervention|Overall Study||38
11264990|NCT02283294|12460574|FG001|Received Allocated Treatment Intervention|Overall Study||31
11264991|NCT02283294|12460573|FG000|COMPLETED|Overall Study||38
11264992|NCT02283294|12460574|FG001|COMPLETED|Overall Study||39
11264993|NCT02283294|12460573|FG000|NOT COMPLETED|Overall Study||3
11264994|NCT02283294|12460574|FG001|NOT COMPLETED|Overall Study||8
11264995|NCT02283333|12460583|FG000|STARTED|Overall Study||77
11264996|NCT02283333|12460584|FG001|STARTED|Overall Study||78
11264997|NCT02283333|12460583|FG000|COMPLETED|Overall Study||63
11264998|NCT02283333|12460584|FG001|COMPLETED|Overall Study||64
11264999|NCT02283333|12460583|FG000|NOT COMPLETED|Overall Study||14
11265000|NCT02283333|12460584|FG001|NOT COMPLETED|Overall Study||14
11265001|NCT02283411|12460590|FG000|STARTED|Overall Study||156
11265002|NCT02283411|12460590|FG000|COMPLETED|Overall Study||125
11265003|NCT02283411|12460590|FG000|NOT COMPLETED|Overall Study||31
11265004|NCT02283528|12460596|FG000|STARTED|Overall Study||26
11265005|NCT02283528|12460597|FG001|STARTED|Overall Study||24
11265006|NCT02283528|12460596|FG000|COMPLETED|Overall Study||26
11265007|NCT02283528|12460597|FG001|COMPLETED|Overall Study||24
11265008|NCT02283528|12460596|FG000|NOT COMPLETED|Overall Study||0
11265009|NCT02283528|12460597|FG001|NOT COMPLETED|Overall Study||0
11265010|NCT02283658|12460603|FG000|STARTED|Overall Study||20
11265011|NCT02283658|12460603|FG000|COMPLETED|Overall Study||19
11265012|NCT02283658|12460603|FG000|NOT COMPLETED|Overall Study||1
11265013|NCT02283749|12460607|FG000|STARTED|Overall Study||5
11265014|NCT02283749|12460607|FG000|COMPLETED|Overall Study||5
11265015|NCT02283749|12460607|FG000|NOT COMPLETED|Overall Study||0
11265016|NCT02283762|12460613|FG000|STARTED|Main Treatment Phase (MT)||60
11265017|NCT02283762|12460614|FG001|STARTED|Main Treatment Phase (MT)||61
11265018|NCT02283762|12460613|FG000|COMPLETED|Main Treatment Phase (MT)||42
11265019|NCT02283762|12460614|FG001|COMPLETED|Main Treatment Phase (MT)||46
11265020|NCT02283762|12460613|FG000|NOT COMPLETED|Main Treatment Phase (MT)||18
11265021|NCT02283762|12460614|FG001|NOT COMPLETED|Main Treatment Phase (MT)||15
11265022|NCT02283762|12460613|FG000|STARTED|Long-term Extension Phase (LTE)||42
11265023|NCT02283762|12460614|FG001|STARTED|Long-term Extension Phase (LTE)|Of the 46 patients who completed the main treatment phase, 1 patient did not enter the LTE phase|45
11265024|NCT02283762|12460613|FG000|COMPLETED|Long-term Extension Phase (LTE)||32
11265025|NCT02283762|12460614|FG001|COMPLETED|Long-term Extension Phase (LTE)||31
11265026|NCT02283762|12460613|FG000|NOT COMPLETED|Long-term Extension Phase (LTE)||10
11265027|NCT02283762|12460614|FG001|NOT COMPLETED|Long-term Extension Phase (LTE)||14
11265028|NCT02283788|12460626|FG000|STARTED|Overall Study||17
11265029|NCT02283788|12460627|FG001|STARTED|Overall Study||17
11265030|NCT02283788|12460628|FG002|STARTED|Overall Study||17
11265031|NCT02283788|12460629|FG003|STARTED|Overall Study||16
11265032|NCT02283788|12460626|FG000|COMPLETED|Overall Study||16
11265033|NCT02283788|12460627|FG001|COMPLETED|Overall Study||13
11265034|NCT02283788|12460628|FG002|COMPLETED|Overall Study||12
11265035|NCT02283788|12460629|FG003|COMPLETED|Overall Study||14
11265036|NCT02283788|12460626|FG000|NOT COMPLETED|Overall Study||1
11265037|NCT02283788|12460627|FG001|NOT COMPLETED|Overall Study||4
11265038|NCT02283788|12460628|FG002|NOT COMPLETED|Overall Study||5
11265039|NCT02283788|12460629|FG003|NOT COMPLETED|Overall Study||2
11265040|NCT02283814|12460641|FG000|STARTED|Overall Study||16
11265041|NCT02283814|12460642|FG001|STARTED|Overall Study||16
11265042|NCT02283814|12460641|FG000|COMPLETED|Overall Study||13
11265043|NCT02283814|12460642|FG001|COMPLETED|Overall Study||14
11265044|NCT02283814|12460641|FG000|NOT COMPLETED|Overall Study||3
11265045|NCT02283814|12460642|FG001|NOT COMPLETED|Overall Study||2
11265046|NCT02283827|12460650|FG000|STARTED|Overall Study||16
11265047|NCT02283827|12460651|FG001|STARTED|Overall Study||16
11265048|NCT02283827|12460650|FG000|COMPLETED|Overall Study||15
11265049|NCT02283827|12460651|FG001|COMPLETED|Overall Study||13
11265050|NCT02283827|12460650|FG000|NOT COMPLETED|Overall Study||1
11265051|NCT02283827|12460651|FG001|NOT COMPLETED|Overall Study||3
11265052|NCT02283840|12460666|FG000|STARTED|Overall Study||20
11265053|NCT02283840|12460667|FG001|STARTED|Overall Study||20
11265054|NCT02283840|12460668|FG002|STARTED|Overall Study||20
11265055|NCT02283840|12460666|FG000|COMPLETED|Overall Study||20
11265056|NCT02283840|12460667|FG001|COMPLETED|Overall Study||19
11265057|NCT02283840|12460668|FG002|COMPLETED|Overall Study||20
11265058|NCT02283840|12460666|FG000|NOT COMPLETED|Overall Study||0
11265059|NCT02283840|12460667|FG001|NOT COMPLETED|Overall Study||1
11265060|NCT02283840|12460668|FG002|NOT COMPLETED|Overall Study||0
11265061|NCT02284009|12460681|FG000|STARTED|Overall Study||17
11265062|NCT02284009|12460682|FG001|STARTED|Overall Study||50
11265063|NCT02284009|12460681|FG000|COMPLETED|Overall Study||11
11265064|NCT02284009|12460682|FG001|COMPLETED|Overall Study||40
11265065|NCT02284009|12460681|FG000|NOT COMPLETED|Overall Study||6
11265066|NCT02284009|12460682|FG001|NOT COMPLETED|Overall Study||10
11265067|NCT02284126|12460692|FG000|STARTED|Overall Study||552
11265068|NCT02284126|12460693|FG001|STARTED|Overall Study||551
11265069|NCT02284126|12460692|FG000|COMPLETED|Overall Study||484
11265070|NCT02284126|12460693|FG001|COMPLETED|Overall Study||489
11265071|NCT02284126|12460692|FG000|NOT COMPLETED|Overall Study||68
11265072|NCT02284126|12460693|FG001|NOT COMPLETED|Overall Study||62
11265073|NCT02284165|12460702|FG000|STARTED|Overall Study||36448
11265074|NCT02284165|12460703|FG001|STARTED|Overall Study||40272
11265075|NCT02284165|12460704|FG002|STARTED|Overall Study||70996
11265076|NCT02284165|12460702|FG000|COMPLETED|Overall Study||36448
11143706|NCT01474512|12330427|FG005|COMPLETED|Maintenance Period||177
11143707|NCT01474512|12330428|FG006|COMPLETED|Maintenance Period||6
11143708|NCT01474512|12330429|FG007|COMPLETED|Maintenance Period||350
11143709|NCT01474512|12330430|FG008|COMPLETED|Maintenance Period||62
11143710|NCT01474512|12330431|FG009|COMPLETED|Maintenance Period||44
11265077|NCT02284165|12460703|FG001|COMPLETED|Overall Study||40272
11265078|NCT02284165|12460704|FG002|COMPLETED|Overall Study||70996
11265079|NCT02284165|12460702|FG000|NOT COMPLETED|Overall Study||0
11143711|NCT01474512|12330432|FG010|COMPLETED|Maintenance Period||0
11143712|NCT01474512|12330433|FG011|COMPLETED|Maintenance Period||0
11265080|NCT02284165|12460703|FG001|NOT COMPLETED|Overall Study||0
11265081|NCT02284165|12460704|FG002|NOT COMPLETED|Overall Study||0
11143713|NCT01474512|12330434|FG012|COMPLETED|Maintenance Period||0
11143714|NCT01474512|12330435|FG013|COMPLETED|Maintenance Period||0
11143715|NCT01474512|12330436|FG014|COMPLETED|Maintenance Period||0
11143716|NCT01474512|12330437|FG015|COMPLETED|Maintenance Period||0
11143717|NCT01474512|12330438|FG016|COMPLETED|Maintenance Period||0
11143718|NCT01474512|12330439|FG017|COMPLETED|Maintenance Period||0
11143719|NCT01474512|12330422|FG000|NOT COMPLETED|Maintenance Period||0
11143720|NCT01474512|12330423|FG001|NOT COMPLETED|Maintenance Period||0
11143721|NCT01474512|12330424|FG002|NOT COMPLETED|Maintenance Period||0
11143722|NCT01474512|12330425|FG003|NOT COMPLETED|Maintenance Period||202
11143723|NCT01474512|12330426|FG004|NOT COMPLETED|Maintenance Period||119
11143724|NCT01474512|12330427|FG005|NOT COMPLETED|Maintenance Period||52
11143725|NCT01474512|12330428|FG006|NOT COMPLETED|Maintenance Period||10
11143726|NCT01474512|12330429|FG007|NOT COMPLETED|Maintenance Period||41
11143727|NCT01474512|12330430|FG008|NOT COMPLETED|Maintenance Period||16
11143728|NCT01474512|12330431|FG009|NOT COMPLETED|Maintenance Period||18
11143729|NCT01474512|12330432|FG010|NOT COMPLETED|Maintenance Period||0
11143730|NCT01474512|12330433|FG011|NOT COMPLETED|Maintenance Period||0
11143731|NCT01474512|12330434|FG012|NOT COMPLETED|Maintenance Period||0
11143732|NCT01474512|12330435|FG013|NOT COMPLETED|Maintenance Period||0
11143733|NCT01474512|12330436|FG014|NOT COMPLETED|Maintenance Period||0
11143734|NCT01474512|12330437|FG015|NOT COMPLETED|Maintenance Period||0
11143735|NCT01474512|12330438|FG016|NOT COMPLETED|Maintenance Period||0
11143736|NCT01474512|12330439|FG017|NOT COMPLETED|Maintenance Period||0
11143737|NCT01474512|12330422|FG000|STARTED|Long-Term Extension Period||0
11143738|NCT01474512|12330423|FG001|STARTED|Long-Term Extension Period||0
11143739|NCT01474512|12330424|FG002|STARTED|Long-Term Extension Period||0
11265082|NCT02284178|12460712|FG000|STARTED|Overall Study||255
11265083|NCT02284178|12460713|FG001|STARTED|Overall Study||258
11265084|NCT02284178|12460712|FG000|COMPLETED|Overall Study||206
11265085|NCT02284178|12460713|FG001|COMPLETED|Overall Study||204
11265086|NCT02284178|12460712|FG000|NOT COMPLETED|Overall Study||49
11265087|NCT02284178|12460713|FG001|NOT COMPLETED|Overall Study||54
11265088|NCT02284243|12460721|FG000|STARTED|Overall Study||84
11265089|NCT02284243|12460722|FG001|STARTED|Overall Study||84
11265090|NCT02284243|12460721|FG000|COMPLETED|Overall Study||80
11265091|NCT02284243|12460722|FG001|COMPLETED|Overall Study||81
11265092|NCT02284243|12460721|FG000|NOT COMPLETED|Overall Study||4
11265093|NCT02284243|12460722|FG001|NOT COMPLETED|Overall Study||3
11265094|NCT02284347|12460728|FG000|STARTED|Overall Study||51
11265095|NCT02284347|12460728|FG000|COMPLETED|Overall Study||48
11265096|NCT02284347|12460728|FG000|NOT COMPLETED|Overall Study||3
11265097|NCT02284386|12460732|FG000|STARTED|Overall Study||15
11265098|NCT02284386|12460732|FG000|COMPLETED|Overall Study||15
11265099|NCT02284386|12460732|FG000|NOT COMPLETED|Overall Study||0
11265100|NCT02284399|12460738|FG000|STARTED|Overall Study||1414
11265101|NCT02284399|12460739|FG001|STARTED|Overall Study||3074
11265102|NCT02284399|12460738|FG000|COMPLETED|Overall Study||1414
11265103|NCT02284399|12460739|FG001|COMPLETED|Overall Study||3074
11265104|NCT02284399|12460738|FG000|NOT COMPLETED|Overall Study||0
11265105|NCT02284399|12460739|FG001|NOT COMPLETED|Overall Study||0
11265106|NCT02284464|12460749|FG000|STARTED|Overall Study||52
11265107|NCT02284464|12460750|FG001|STARTED|Overall Study||53
11265108|NCT02284464|12460749|FG000|COMPLETED|Overall Study||39
11265109|NCT02284464|12460750|FG001|COMPLETED|Overall Study||36
11265110|NCT02284464|12460749|FG000|NOT COMPLETED|Overall Study||13
11265111|NCT02284464|12460750|FG001|NOT COMPLETED|Overall Study||17
11265112|NCT02284516|12460758|FG000|STARTED|Overall Study||356
11265113|NCT02284516|12460759|FG001|STARTED|Overall Study||355
11265114|NCT02284516|12460758|FG000|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
11265115|NCT02284516|12460759|FG001|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
11265116|NCT02284516|12460758|FG000|COMPLETED|Overall Study||318
11265117|NCT02284516|12460759|FG001|COMPLETED|Overall Study||319
11265118|NCT02284516|12460758|FG000|NOT COMPLETED|Overall Study||38
11265119|NCT02284516|12460759|FG001|NOT COMPLETED|Overall Study||36
11265120|NCT02284555|12460765|FG000|STARTED|Overall Study||12
11265121|NCT02284555|12460765|FG000|COMPLETED|Overall Study||12
11265122|NCT02284555|12460765|FG000|NOT COMPLETED|Overall Study||0
11265123|NCT02284828|12460769|FG000|STARTED|Overall Study||26
11265124|NCT02284828|12460769|FG000|COMPLETED|Overall Study||22
11265125|NCT02284828|12460769|FG000|NOT COMPLETED|Overall Study||4
11265126|NCT02284854|12460778|FG000|STARTED|Overall Study||23
11265127|NCT02284854|12460779|FG001|STARTED|Overall Study||20
11265128|NCT02284854|12460778|FG000|COMPLETED|Overall Study||18
11265129|NCT02284854|12460779|FG001|COMPLETED|Overall Study||20
11265130|NCT02284854|12460778|FG000|NOT COMPLETED|Overall Study||5
11265131|NCT02284854|12460779|FG001|NOT COMPLETED|Overall Study||0
11265132|NCT02284867|12460794|FG000|STARTED|Overall Study||30
11265133|NCT02284867|12460795|FG001|STARTED|Overall Study||30
11265134|NCT02284867|12460794|FG000|COMPLETED|Overall Study||30
11265135|NCT02284867|12460795|FG001|COMPLETED|Overall Study||30
11265136|NCT02284867|12460794|FG000|NOT COMPLETED|Overall Study||0
11265137|NCT02284867|12460795|FG001|NOT COMPLETED|Overall Study||0
11265138|NCT02284880|12460803|FG000|STARTED|Overall Study||11
11265139|NCT02284880|12460804|FG001|STARTED|Overall Study||9
11265140|NCT02284880|12460805|FG002|STARTED|Overall Study||10
11143740|NCT01474512|12330425|FG003|STARTED|Long-Term Extension Period||0
11143741|NCT01474512|12330426|FG004|STARTED|Long-Term Extension Period||0
11143742|NCT01474512|12330427|FG005|STARTED|Long-Term Extension Period||0
11265141|NCT02284880|12460806|FG003|STARTED|Overall Study||10
11265142|NCT02284880|12460803|FG000|First Period (4 Days)|Overall Study||11
11265143|NCT02284880|12460804|FG001|First Period (4 Days)|Overall Study||9
11265144|NCT02284880|12460805|FG002|First Period (4 Days)|Overall Study||10
11265145|NCT02284880|12460806|FG003|First Period (4 Days)|Overall Study||10
11265146|NCT02284880|12460803|FG000|Wash-out Period (7 Days)|Overall Study||11
11265147|NCT02284880|12460804|FG001|Wash-out Period (7 Days)|Overall Study||9
11265148|NCT02284880|12460805|FG002|Wash-out Period (7 Days)|Overall Study||10
11265149|NCT02284880|12460806|FG003|Wash-out Period (7 Days)|Overall Study||10
11265150|NCT02284880|12460803|FG000|Second Period (4 Days)|Overall Study||11
11265151|NCT02284880|12460804|FG001|Second Period (4 Days)|Overall Study||9
11265152|NCT02284880|12460805|FG002|Second Period (4 Days)|Overall Study||8
11265153|NCT02284880|12460806|FG003|Second Period (4 Days)|Overall Study||10
11265154|NCT02284880|12460803|FG000|COMPLETED|Overall Study||11
11265155|NCT02284880|12460804|FG001|COMPLETED|Overall Study||9
11265156|NCT02284880|12460805|FG002|COMPLETED|Overall Study||8
11265157|NCT02284880|12460806|FG003|COMPLETED|Overall Study||10
11265158|NCT02284880|12460803|FG000|NOT COMPLETED|Overall Study||0
11265159|NCT02284880|12460804|FG001|NOT COMPLETED|Overall Study||0
11265160|NCT02284880|12460805|FG002|NOT COMPLETED|Overall Study||2
11265161|NCT02284880|12460806|FG003|NOT COMPLETED|Overall Study||0
11265162|NCT02284893|12460818|FG000|STARTED|26 Week (Short Term)||232
11265163|NCT02284893|12460819|FG001|STARTED|26 Week (Short Term)||229
11265164|NCT02284893|12460818|FG000|COMPLETED|26 Week (Short Term)||213
11265165|NCT02284893|12460819|FG001|COMPLETED|26 Week (Short Term)||198
11265166|NCT02284893|12460818|FG000|NOT COMPLETED|26 Week (Short Term)||19
11265167|NCT02284893|12460819|FG001|NOT COMPLETED|26 Week (Short Term)||31
11265168|NCT02284893|12460818|FG000|STARTED|52 Week (Long Term)||209
11265169|NCT02284893|12460819|FG001|STARTED|52 Week (Long Term)||193
11265170|NCT02284893|12460818|FG000|COMPLETED|52 Week (Long Term)||198
11265171|NCT02284893|12460819|FG001|COMPLETED|52 Week (Long Term)||180
11265172|NCT02284893|12460818|FG000|NOT COMPLETED|52 Week (Long Term)||11
11265173|NCT02284893|12460819|FG001|NOT COMPLETED|52 Week (Long Term)||13
11265174|NCT02285010|12460827|FG000|STARTED|Overall Study||63
11265175|NCT02285010|12460828|FG001|STARTED|Overall Study||62
11265176|NCT02285010|12460827|FG000|COMPLETED|Overall Study||58
11265177|NCT02285010|12460828|FG001|COMPLETED|Overall Study||61
11265178|NCT02285010|12460827|FG000|NOT COMPLETED|Overall Study||5
11265179|NCT02285010|12460828|FG001|NOT COMPLETED|Overall Study||1
11265180|NCT02285023|12460834|FG000|STARTED|Overall Study||166
11265181|NCT02285023|12460834|FG000|COMPLETED|Overall Study||166
11265182|NCT02285023|12460834|FG000|NOT COMPLETED|Overall Study||0
11265183|NCT02285153|12460846|FG000|STARTED|Overall Study||7
11265184|NCT02285153|12460847|FG001|STARTED|Overall Study||8
11265185|NCT02285153|12460846|FG000|COMPLETED|Overall Study||6
11265186|NCT02285153|12460847|FG001|COMPLETED|Overall Study||8
11265187|NCT02285153|12460846|FG000|NOT COMPLETED|Overall Study||1
11265188|NCT02285153|12460847|FG001|NOT COMPLETED|Overall Study||0
11265189|NCT02285283|12460855|FG000|STARTED|Overall Study||29
11265190|NCT02285283|12460856|FG001|STARTED|Overall Study||29
11265191|NCT02285283|12460855|FG000|COMPLETED|Overall Study||25
11265192|NCT02285283|12460856|FG001|COMPLETED|Overall Study||20
11265193|NCT02285283|12460855|FG000|NOT COMPLETED|Overall Study||4
11265194|NCT02285283|12460856|FG001|NOT COMPLETED|Overall Study||9
11265195|NCT02285361|12460862|FG000|STARTED|Overall Study||1272
11265196|NCT02285361|12460862|FG000|COMPLETED|Overall Study||1221
11265197|NCT02285361|12460862|FG000|NOT COMPLETED|Overall Study||51
11265198|NCT02285634|12460870|FG000|STARTED|Overall Study||15
11265199|NCT02285634|12460871|FG001|STARTED|Overall Study||20
11265200|NCT02285634|12460872|FG002|STARTED|Overall Study||15
11265201|NCT02285634|12460873|FG003|STARTED|Overall Study||18
11265202|NCT02285634|12460870|FG000|COMPLETED|Overall Study||15
11265203|NCT02285634|12460871|FG001|COMPLETED|Overall Study||20
11265204|NCT02285634|12460872|FG002|COMPLETED|Overall Study||11
11265205|NCT02285634|12460873|FG003|COMPLETED|Overall Study||17
11265206|NCT02285634|12460870|FG000|NOT COMPLETED|Overall Study||0
11265207|NCT02285634|12460871|FG001|NOT COMPLETED|Overall Study||0
11265208|NCT02285634|12460872|FG002|NOT COMPLETED|Overall Study||4
11265209|NCT02285634|12460873|FG003|NOT COMPLETED|Overall Study||1
11265210|NCT02285777|12460886|FG000|STARTED|Overall Study||95
11265211|NCT02285777|12460887|FG001|STARTED|Overall Study||94
11265212|NCT02285777|12460886|FG000|COMPLETED|Overall Study||90
11265213|NCT02285777|12460887|FG001|COMPLETED|Overall Study||91
11265214|NCT02285777|12460886|FG000|NOT COMPLETED|Overall Study||5
11265215|NCT02285777|12460887|FG001|NOT COMPLETED|Overall Study||3
11265216|NCT02285855|12460895|FG000|STARTED|Overall Study||16
11265217|NCT02285855|12460896|FG001|STARTED|Overall Study||2
11265218|NCT02285855|12460895|FG000|Randomized|Overall Study||16
11265219|NCT02285855|12460896|FG001|Randomized|Overall Study||2
11265220|NCT02285855|12460895|FG000|COMPLETED|Overall Study||14
11265221|NCT02285855|12460896|FG001|COMPLETED|Overall Study||1
11265222|NCT02285855|12460895|FG000|NOT COMPLETED|Overall Study||2
11265223|NCT02285855|12460896|FG001|NOT COMPLETED|Overall Study||1
11265224|NCT02285907|12460902|FG000|STARTED|Overall Study||21
11265225|NCT02285907|12460902|FG000|Began 1st Intervention|Overall Study||21
11265226|NCT02285907|12460902|FG000|Began 2nd Intervention|Overall Study||21
11265227|NCT02285907|12460902|FG000|Began 3rd Intervention|Overall Study||21
11265228|NCT02285907|12460902|FG000|Began 4th Intervention|Overall Study||21
11265229|NCT02285907|12460902|FG000|COMPLETED|Overall Study||21
11265230|NCT02285907|12460902|FG000|NOT COMPLETED|Overall Study||0
11265231|NCT02285920|12460919|FG000|STARTED|Overall Study||51
11265232|NCT02285920|12460920|FG001|STARTED|Overall Study||27
11265233|NCT02285920|12460921|FG002|STARTED|Overall Study||26
11265234|NCT02285920|12460922|FG003|STARTED|Overall Study||25
11265235|NCT02285920|12460919|FG000|COMPLETED|Overall Study||47
11265236|NCT02285920|12460920|FG001|COMPLETED|Overall Study||23
11265237|NCT02285920|12460921|FG002|COMPLETED|Overall Study||21
11265238|NCT02285920|12460922|FG003|COMPLETED|Overall Study||24
11265239|NCT02285920|12460919|FG000|NOT COMPLETED|Overall Study||4
11265240|NCT02285920|12460920|FG001|NOT COMPLETED|Overall Study||4
11265241|NCT02285920|12460921|FG002|NOT COMPLETED|Overall Study||5
11265242|NCT02285920|12460922|FG003|NOT COMPLETED|Overall Study||1
11265243|NCT02285998|12460934|FG000|STARTED|Overall Study||4474
11265244|NCT02285998|12460935|FG001|STARTED|Overall Study||4489
11265245|NCT02285998|12460934|FG000|COMPLETED|Overall Study||4228
11265246|NCT02285998|12460935|FG001|COMPLETED|Overall Study||4236
11265247|NCT02285998|12460934|FG000|NOT COMPLETED|Overall Study||246
11265248|NCT02285998|12460935|FG001|NOT COMPLETED|Overall Study||253
11265249|NCT02286102|12460943|FG000|STARTED|Overall Study||36
11265250|NCT02286102|12460944|FG001|STARTED|Overall Study||34
11265251|NCT02286102|12460943|FG000|COMPLETED|Overall Study||35
11265252|NCT02286102|12460944|FG001|COMPLETED|Overall Study||33
11265253|NCT02286102|12460943|FG000|NOT COMPLETED|Overall Study||1
11265254|NCT02286102|12460944|FG001|NOT COMPLETED|Overall Study||1
11265255|NCT02286193|12460950|FG000|STARTED|Overall Study||622
11265256|NCT02286193|12460950|FG000|COMPLETED|Overall Study||418
11265257|NCT02286193|12460950|FG000|NOT COMPLETED|Overall Study||204
11265258|NCT02286466|12460957|FG000|STARTED|Overall Study||72
11265259|NCT02286466|12460958|FG001|STARTED|Overall Study||73
11265260|NCT02286466|12460957|FG000|Baseline Clinician Assessment|Overall Study||72
11265261|NCT02286466|12460958|FG001|Baseline Clinician Assessment|Overall Study||72
11265262|NCT02286466|12460957|FG000|Post Self-report|Overall Study||67
11265263|NCT02286466|12460958|FG001|Post Self-report|Overall Study||68
11265264|NCT02286466|12460957|FG000|COMPLETED|Overall Study||65
11265265|NCT02286466|12460958|FG001|COMPLETED|Overall Study||63
11265266|NCT02286466|12460957|FG000|NOT COMPLETED|Overall Study||7
11265267|NCT02286466|12460958|FG001|NOT COMPLETED|Overall Study||10
11265268|NCT02286518|12460978|FG000|STARTED|All Parts (16 Days)||6
11265269|NCT02286518|12460979|FG001|STARTED|All Parts (16 Days)||6
11265270|NCT02286518|12460980|FG002|STARTED|All Parts (16 Days)||6
11265271|NCT02286518|12460981|FG003|STARTED|All Parts (16 Days)||6
11265272|NCT02286518|12460982|FG004|STARTED|All Parts (16 Days)||6
11265273|NCT02286518|12460983|FG005|STARTED|All Parts (16 Days)||6
11265274|NCT02286518|12460984|FG006|STARTED|All Parts (16 Days)||6
11265275|NCT02286518|12460985|FG007|STARTED|All Parts (16 Days)||6
11265276|NCT02286518|12460986|FG008|STARTED|All Parts (16 Days)||6
11265277|NCT02286518|12460987|FG009|STARTED|All Parts (16 Days)||4
11265278|NCT02286518|12460988|FG010|STARTED|All Parts (16 Days)||6
11265279|NCT02286518|12460989|FG011|STARTED|All Parts (16 Days)||6
11265280|NCT02286518|12460990|FG012|STARTED|All Parts (16 Days)||6
11265281|NCT02286518|12460991|FG013|STARTED|All Parts (16 Days)||6
11265282|NCT02286518|12460978|FG000|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11265283|NCT02286518|12460979|FG001|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11265284|NCT02286518|12460980|FG002|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11265285|NCT02286518|12460981|FG003|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11265286|NCT02286518|12460982|FG004|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11265287|NCT02286518|12460983|FG005|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11265288|NCT02286518|12460984|FG006|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11265289|NCT02286518|12460985|FG007|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
11265290|NCT02286518|12460986|FG008|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
11265291|NCT02286518|12460987|FG009|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
11340230|NCT02918877|12537527|FG001|NOT COMPLETED|Overall Study||3
11265292|NCT02286518|12460988|FG010|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11265293|NCT02286518|12460989|FG011|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11265294|NCT02286518|12460990|FG012|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11265295|NCT02286518|12460991|FG013|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11265296|NCT02286518|12460978|FG000|NOT COMPLETED|All Parts (16 Days)||0
11265297|NCT02286518|12460979|FG001|NOT COMPLETED|All Parts (16 Days)||0
11265298|NCT02286518|12460980|FG002|NOT COMPLETED|All Parts (16 Days)||0
11265299|NCT02286518|12460981|FG003|NOT COMPLETED|All Parts (16 Days)||0
11265300|NCT02286518|12460982|FG004|NOT COMPLETED|All Parts (16 Days)||0
11265301|NCT02286518|12460983|FG005|NOT COMPLETED|All Parts (16 Days)||0
11265302|NCT02286518|12460984|FG006|NOT COMPLETED|All Parts (16 Days)||0
11265303|NCT02286518|12460985|FG007|NOT COMPLETED|All Parts (16 Days)||0
11265304|NCT02286518|12460986|FG008|NOT COMPLETED|All Parts (16 Days)||0
11265305|NCT02286518|12460987|FG009|NOT COMPLETED|All Parts (16 Days)||0
11265306|NCT02286518|12460988|FG010|NOT COMPLETED|All Parts (16 Days)||0
11265307|NCT02286518|12460989|FG011|NOT COMPLETED|All Parts (16 Days)||0
11265308|NCT02286518|12460990|FG012|NOT COMPLETED|All Parts (16 Days)||0
11265309|NCT02286518|12460991|FG013|NOT COMPLETED|All Parts (16 Days)||0
11265310|NCT02286518|12460978|FG000|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11265311|NCT02286518|12460979|FG001|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11265312|NCT02286518|12460980|FG002|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11265313|NCT02286518|12460981|FG003|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11265314|NCT02286518|12460982|FG004|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11265315|NCT02286518|12460983|FG005|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11265316|NCT02286518|12460984|FG006|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11265317|NCT02286518|12460985|FG007|STARTED|Washout Crossover Period(Part 2:14 Days)||6
11265318|NCT02286518|12460986|FG008|STARTED|Washout Crossover Period(Part 2:14 Days)||6
11265319|NCT02286518|12460987|FG009|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11265320|NCT02286518|12460988|FG010|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11265321|NCT02286518|12460989|FG011|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11265322|NCT02286518|12460990|FG012|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11265323|NCT02286518|12460991|FG013|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11265324|NCT02286518|12460978|FG000|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265325|NCT02286518|12460979|FG001|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265326|NCT02286518|12460980|FG002|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265327|NCT02286518|12460981|FG003|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265328|NCT02286518|12460982|FG004|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265329|NCT02286518|12460983|FG005|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265330|NCT02286518|12460984|FG006|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265331|NCT02286518|12460985|FG007|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
11265332|NCT02286518|12460986|FG008|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
11021554|NCT00804986|12199647|FG003|COMPLETED|Overall Study||34
11021555|NCT00804986|12199648|FG004|COMPLETED|Overall Study||34
11021556|NCT00804986|12199649|FG005|COMPLETED|Overall Study||31
11021557|NCT00804986|12199644|FG000|NOT COMPLETED|Overall Study||1
11021558|NCT00804986|12199645|FG001|NOT COMPLETED|Overall Study||8
11021559|NCT00804986|12199646|FG002|NOT COMPLETED|Overall Study||2
11265333|NCT02286518|12460987|FG009|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265334|NCT02286518|12460988|FG010|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265335|NCT02286518|12460989|FG011|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265336|NCT02286518|12460990|FG012|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265337|NCT02286518|12460991|FG013|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265338|NCT02286518|12460978|FG000|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265339|NCT02286518|12460979|FG001|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265340|NCT02286518|12460980|FG002|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265341|NCT02286518|12460981|FG003|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265342|NCT02286518|12460982|FG004|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265343|NCT02286518|12460983|FG005|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265344|NCT02286518|12460984|FG006|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265345|NCT02286518|12460985|FG007|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265346|NCT02286518|12460986|FG008|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265347|NCT02286518|12460987|FG009|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265348|NCT02286518|12460988|FG010|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265349|NCT02286518|12460989|FG011|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265350|NCT02286518|12460990|FG012|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265351|NCT02286518|12460991|FG013|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11265352|NCT02286518|12460978|FG000|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11265353|NCT02286518|12460979|FG001|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11265354|NCT02286518|12460980|FG002|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11265355|NCT02286518|12460981|FG003|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11265356|NCT02286518|12460982|FG004|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11265357|NCT02286518|12460983|FG005|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11265358|NCT02286518|12460984|FG006|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11265359|NCT02286518|12460985|FG007|STARTED|Crossover Treatment (Part 2: 3 Days)||6
11265360|NCT02286518|12460986|FG008|STARTED|Crossover Treatment (Part 2: 3 Days)||6
11265361|NCT02286518|12460987|FG009|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11265362|NCT02286518|12460988|FG010|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11265363|NCT02286518|12460989|FG011|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11265364|NCT02286518|12460990|FG012|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11265365|NCT02286518|12460991|FG013|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11265366|NCT02286518|12460978|FG000|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265367|NCT02286518|12460979|FG001|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265368|NCT02286518|12460980|FG002|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265369|NCT02286518|12460981|FG003|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265370|NCT02286518|12460982|FG004|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265371|NCT02286518|12460983|FG005|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265372|NCT02286518|12460984|FG006|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265373|NCT02286518|12460985|FG007|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
11265374|NCT02286518|12460986|FG008|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
11265375|NCT02286518|12460987|FG009|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265376|NCT02286518|12460988|FG010|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265377|NCT02286518|12460989|FG011|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265378|NCT02286518|12460990|FG012|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265379|NCT02286518|12460991|FG013|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265380|NCT02286518|12460978|FG000|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265381|NCT02286518|12460979|FG001|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265382|NCT02286518|12460980|FG002|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265383|NCT02286518|12460981|FG003|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265384|NCT02286518|12460982|FG004|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265385|NCT02286518|12460983|FG005|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265386|NCT02286518|12460984|FG006|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265387|NCT02286518|12460985|FG007|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265388|NCT02286518|12460986|FG008|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265389|NCT02286518|12460987|FG009|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265390|NCT02286518|12460988|FG010|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265391|NCT02286518|12460989|FG011|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265392|NCT02286518|12460990|FG012|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265393|NCT02286518|12460991|FG013|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11265394|NCT02286713|12461039|FG000|STARTED|One Week Follow-Up||259
11265395|NCT02286713|12461040|FG001|STARTED|One Week Follow-Up||257
11265396|NCT02286713|12461039|FG000|COMPLETED|One Week Follow-Up||235
11265397|NCT02286713|12461040|FG001|COMPLETED|One Week Follow-Up||233
11265398|NCT02286713|12461039|FG000|NOT COMPLETED|One Week Follow-Up||24
11265399|NCT02286713|12461040|FG001|NOT COMPLETED|One Week Follow-Up||24
11265400|NCT02286713|12461039|FG000|STARTED|Three Month Follow-Up||252
11265401|NCT02286713|12461040|FG001|STARTED|Three Month Follow-Up||254
11265402|NCT02286713|12461039|FG000|COMPLETED|Three Month Follow-Up||224
11265403|NCT02286713|12461040|FG001|COMPLETED|Three Month Follow-Up||228
11265404|NCT02286713|12461039|FG000|NOT COMPLETED|Three Month Follow-Up||28
11265405|NCT02286713|12461040|FG001|NOT COMPLETED|Three Month Follow-Up||26
11265406|NCT02286713|12461039|FG000|STARTED|Six Month Follow-Up||250
11265407|NCT02286713|12461040|FG001|STARTED|Six Month Follow-Up||252
11265408|NCT02286713|12461039|FG000|COMPLETED|Six Month Follow-Up||218
11265409|NCT02286713|12461040|FG001|COMPLETED|Six Month Follow-Up||225
11265410|NCT02286713|12461039|FG000|NOT COMPLETED|Six Month Follow-Up||32
11265411|NCT02286713|12461040|FG001|NOT COMPLETED|Six Month Follow-Up||27
11265412|NCT02286726|12461049|FG000|STARTED|Overall Study||16
11265413|NCT02286726|12461050|FG001|STARTED|Overall Study||24
11265414|NCT02286726|12461051|FG002|STARTED|Overall Study||16
11265415|NCT02286726|12461049|FG000|COMPLETED|Overall Study||16
11265416|NCT02286726|12461050|FG001|COMPLETED|Overall Study||24
11265417|NCT02286726|12461051|FG002|COMPLETED|Overall Study||16
11265418|NCT02286726|12461049|FG000|NOT COMPLETED|Overall Study||0
11265419|NCT02286726|12461050|FG001|NOT COMPLETED|Overall Study||0
11265420|NCT02286726|12461051|FG002|NOT COMPLETED|Overall Study||0
11265421|NCT02286843|12461059|FG000|STARTED|Overall Study||49
11265422|NCT02286843|12461059|FG000|COMPLETED|Overall Study||43
11265423|NCT02286843|12461059|FG000|NOT COMPLETED|Overall Study||6
11265424|NCT02286895|12461065|FG000|STARTED|Randomized and Vaccinated||300
11265425|NCT02286895|12461066|FG001|STARTED|Randomized and Vaccinated||300
11265426|NCT02286895|12461065|FG000|COMPLETED|Randomized and Vaccinated||300
11265427|NCT02286895|12461066|FG001|COMPLETED|Randomized and Vaccinated||300
11265428|NCT02286895|12461065|FG000|NOT COMPLETED|Randomized and Vaccinated||0
11265429|NCT02286895|12461066|FG001|NOT COMPLETED|Randomized and Vaccinated||0
11265430|NCT02286895|12461065|FG000|STARTED|Assessed for Measles Seroconversion||300
11265431|NCT02286895|12461066|FG001|STARTED|Assessed for Measles Seroconversion||300
11265432|NCT02286895|12461065|FG000|COMPLETED|Assessed for Measles Seroconversion||252
11265433|NCT02286895|12461066|FG001|COMPLETED|Assessed for Measles Seroconversion||261
11265434|NCT02286895|12461065|FG000|NOT COMPLETED|Assessed for Measles Seroconversion||48
11265435|NCT02286895|12461066|FG001|NOT COMPLETED|Assessed for Measles Seroconversion||39
11265436|NCT02286921|12461074|FG000|STARTED|Overall Study||94
11265437|NCT02286921|12461075|FG001|STARTED|Overall Study||101
11265438|NCT02286921|12461074|FG000|COMPLETED|Overall Study||94
11265439|NCT02286921|12461075|FG001|COMPLETED|Overall Study||101
11265440|NCT02286921|12461074|FG000|NOT COMPLETED|Overall Study||0
11265441|NCT02286921|12461075|FG001|NOT COMPLETED|Overall Study||0
11265442|NCT02286947|12461081|FG000|STARTED|Overall Study||24
11265443|NCT02286947|12461081|FG000|COMPLETED|Overall Study||22
11265444|NCT02286947|12461081|FG000|NOT COMPLETED|Overall Study||2
11265445|NCT02286960|12461089|FG000|STARTED|Overall Study||19
11265446|NCT02286960|12461090|FG001|STARTED|Overall Study||17
11265447|NCT02286960|12461089|FG000|COMPLETED|Overall Study||16
11265448|NCT02286960|12461090|FG001|COMPLETED|Overall Study||14
11265449|NCT02286960|12461089|FG000|NOT COMPLETED|Overall Study||3
11265450|NCT02286960|12461090|FG001|NOT COMPLETED|Overall Study||3
11265451|NCT02287038|12461098|FG000|STARTED|Overall Study||23
11265452|NCT02287038|12461099|FG001|STARTED|Overall Study||21
11265453|NCT02287038|12461098|FG000|COMPLETED|Overall Study||18
11265454|NCT02287038|12461099|FG001|COMPLETED|Overall Study||18
11265455|NCT02287038|12461098|FG000|NOT COMPLETED|Overall Study||5
11265456|NCT02287038|12461099|FG001|NOT COMPLETED|Overall Study||3
11265457|NCT02287350|12461107|FG000|STARTED|Overall Study||51
11265458|NCT02287350|12461107|FG000|COMPLETED|Overall Study||48
11265459|NCT02287350|12461107|FG000|NOT COMPLETED|Overall Study||3
11265460|NCT02287376|12461111|FG000|STARTED|Overall Study||25
11265461|NCT02287376|12461111|FG000|COMPLETED|Overall Study||25
11265462|NCT02287376|12461111|FG000|NOT COMPLETED|Overall Study||0
11265463|NCT02287402|12461115|FG000|STARTED|Treatment Period||197
11265464|NCT02287402|12461115|FG000|COMPLETED|Treatment Period||170
11265465|NCT02287402|12461115|FG000|NOT COMPLETED|Treatment Period||27
11265466|NCT02287402|12461115|FG000|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
11265467|NCT02287402|12461115|FG000|COMPLETED|Follow-up||103
11265468|NCT02287402|12461115|FG000|NOT COMPLETED|Follow-up||3
11265469|NCT02287415|12461119|FG000|STARTED|Overall Study||13
11265470|NCT02287415|12461119|FG000|COMPLETED|Overall Study||13
11265471|NCT02287415|12461119|FG000|NOT COMPLETED|Overall Study||0
11265472|NCT02287467|12461125|FG000|STARTED|Overall Study||168
11265473|NCT02287467|12461126|FG001|STARTED|Overall Study||161
11265474|NCT02287467|12461125|FG000|COMPLETED|Overall Study||156
11265475|NCT02287467|12461126|FG001|COMPLETED|Overall Study||152
11265476|NCT02287467|12461125|FG000|NOT COMPLETED|Overall Study||12
11265477|NCT02287467|12461126|FG001|NOT COMPLETED|Overall Study||9
11265478|NCT02287610|12461135|FG000|STARTED|Overall Study||64
11265479|NCT02287610|12461135|FG000|Per Protocol Follow-Up|Overall Study||56
11265480|NCT02287610|12461135|FG000|COMPLETED|Overall Study||48
11396922|NCT03961529|12590893|FG002|NOT COMPLETED|Overall Study||5
11265481|NCT02287610|12461135|FG000|NOT COMPLETED|Overall Study||16
11265482|NCT02287623|12461141|FG000|STARTED|Overall Study||30
11265483|NCT02287623|12461142|FG001|STARTED|Overall Study||30
11265484|NCT02287623|12461141|FG000|COMPLETED|Overall Study||30
11265485|NCT02287623|12461142|FG001|COMPLETED|Overall Study||29
11265486|NCT02287623|12461141|FG000|NOT COMPLETED|Overall Study||0
11265487|NCT02287623|12461142|FG001|NOT COMPLETED|Overall Study||1
11265488|NCT02287675|12461150|FG000|STARTED|Overall Study||22
11265489|NCT02287675|12461151|FG001|STARTED|Overall Study||18
11265490|NCT02287675|12461150|FG000|COMPLETED|Overall Study||22
11265491|NCT02287675|12461151|FG001|COMPLETED|Overall Study||18
11265492|NCT02287675|12461150|FG000|NOT COMPLETED|Overall Study||0
11265493|NCT02287675|12461151|FG001|NOT COMPLETED|Overall Study||0
11265494|NCT02287688|12461157|FG000|STARTED|Overall Study||138
11265495|NCT02287688|12461157|FG000|COMPLETED|Overall Study||138
11396923|NCT03968159|12590903|FG000|STARTED|Overall Study||148
11396924|NCT03968159|12590904|FG001|STARTED|Overall Study||150
11396925|NCT03968159|12590903|FG000|COMPLETED|Overall Study||135
11396926|NCT03968159|12590904|FG001|COMPLETED|Overall Study||135
11265496|NCT02287688|12461157|FG000|NOT COMPLETED|Overall Study||0
11265497|NCT02287779|12461169|FG000|STARTED|Overall Study||21
11265498|NCT02287779|12461170|FG001|STARTED|Overall Study||9
11265499|NCT02287779|12461171|FG002|STARTED|Overall Study||9
11265500|NCT02287779|12461172|FG003|STARTED|Overall Study||9
11265501|NCT02287779|12461173|FG004|STARTED|Overall Study||9
11265502|NCT02287779|12461174|FG005|STARTED|Overall Study||9
11265503|NCT02287779|12461175|FG006|STARTED|Overall Study||9
11265504|NCT02287779|12461176|FG007|STARTED|Overall Study||9
11265505|NCT02287779|12461169|FG000|COMPLETED|Overall Study||21
11265506|NCT02287779|12461170|FG001|COMPLETED|Overall Study||9
11265507|NCT02287779|12461171|FG002|COMPLETED|Overall Study||9
11265508|NCT02287779|12461172|FG003|COMPLETED|Overall Study||9
11265509|NCT02287779|12461173|FG004|COMPLETED|Overall Study||9
11265510|NCT02287779|12461174|FG005|COMPLETED|Overall Study||9
11265511|NCT02287779|12461175|FG006|COMPLETED|Overall Study||9
11265512|NCT02287779|12461176|FG007|COMPLETED|Overall Study||9
11265513|NCT02287779|12461169|FG000|NOT COMPLETED|Overall Study||0
11265514|NCT02287779|12461170|FG001|NOT COMPLETED|Overall Study||0
11265515|NCT02287779|12461171|FG002|NOT COMPLETED|Overall Study||0
11265516|NCT02287779|12461172|FG003|NOT COMPLETED|Overall Study||0
11265517|NCT02287779|12461173|FG004|NOT COMPLETED|Overall Study||0
11265518|NCT02287779|12461174|FG005|NOT COMPLETED|Overall Study||0
11265519|NCT02287779|12461175|FG006|NOT COMPLETED|Overall Study||0
11265520|NCT02287779|12461176|FG007|NOT COMPLETED|Overall Study||0
11265521|NCT02287883|12461200|FG000|STARTED|Overall Study||1081
11265522|NCT02287883|12461201|FG001|STARTED|Overall Study||1095
11265523|NCT02287883|12461200|FG000|One-year Follow-up Survey|Overall Study||622
11265524|NCT02287883|12461201|FG001|One-year Follow-up Survey|Overall Study||669
11265525|NCT02287883|12461200|FG000|COMPLETED|Overall Study||622
11265526|NCT02287883|12461201|FG001|COMPLETED|Overall Study||669
11265527|NCT02287883|12461200|FG000|NOT COMPLETED|Overall Study||459
11265528|NCT02287883|12461201|FG001|NOT COMPLETED|Overall Study||426
11265529|NCT02287896|12461209|FG000|STARTED|Screening Visit V1||36
11265530|NCT02287896|12461210|FG001|STARTED|Screening Visit V1||26
11265531|NCT02287896|12461209|FG000|COMPLETED|Screening Visit V1||36
11265532|NCT02287896|12461210|FG001|COMPLETED|Screening Visit V1||26
11265533|NCT02287896|12461209|FG000|NOT COMPLETED|Screening Visit V1||0
11396927|NCT03968159|12590903|FG000|NOT COMPLETED|Overall Study||13
11396928|NCT03968159|12590904|FG001|NOT COMPLETED|Overall Study||15
11396929|NCT03968965|12590912|FG000|STARTED|Overall Study||32
11396930|NCT03968965|12590913|FG001|STARTED|Overall Study||32
11265534|NCT02287896|12461210|FG001|NOT COMPLETED|Screening Visit V1||0
11265535|NCT02287896|12461209|FG000|STARTED|First Injection Visit||36
11265536|NCT02287896|12461210|FG001|STARTED|First Injection Visit||26
11265537|NCT02287896|12461209|FG000|COMPLETED|First Injection Visit||36
11265538|NCT02287896|12461210|FG001|COMPLETED|First Injection Visit||26
11396931|NCT03968965|12590912|FG000|COMPLETED|Overall Study||32
11396932|NCT03968965|12590913|FG001|COMPLETED|Overall Study||30
11396933|NCT03968965|12590912|FG000|NOT COMPLETED|Overall Study||0
11396934|NCT03968965|12590913|FG001|NOT COMPLETED|Overall Study||2
11396935|NCT03970824|12590922|FG000|STARTED|Overall Study||103
11396936|NCT03970824|12590923|FG001|STARTED|Overall Study||103
11396937|NCT03970824|12590924|FG002|STARTED|Overall Study||106
11396938|NCT03970824|12590922|FG000|COMPLETED|Overall Study||101
11396939|NCT03970824|12590923|FG001|COMPLETED|Overall Study||100
11396940|NCT03970824|12590924|FG002|COMPLETED|Overall Study||102
11396941|NCT03970824|12590922|FG000|NOT COMPLETED|Overall Study||2
11396942|NCT03970824|12590923|FG001|NOT COMPLETED|Overall Study||3
11396943|NCT03970824|12590924|FG002|NOT COMPLETED|Overall Study||4
11396944|NCT03978403|12590936|FG000|STARTED|Overall Study||6
11396945|NCT03978403|12590937|FG001|STARTED|Overall Study||6
11396946|NCT03978403|12590938|FG002|STARTED|Overall Study||6
11396947|NCT03978403|12590939|FG003|STARTED|Overall Study||6
11396948|NCT03978403|12590936|FG000|COMPLETED|Overall Study||6
11265539|NCT02287896|12461209|FG000|NOT COMPLETED|First Injection Visit||0
11265540|NCT02287896|12461210|FG001|NOT COMPLETED|First Injection Visit||0
11265541|NCT02287896|12461209|FG000|STARTED|Second Injection Visit||36
11265542|NCT02287896|12461210|FG001|STARTED|Second Injection Visit||26
11265543|NCT02287896|12461209|FG000|COMPLETED|Second Injection Visit||36
11265544|NCT02287896|12461210|FG001|COMPLETED|Second Injection Visit||25
11265545|NCT02287896|12461209|FG000|NOT COMPLETED|Second Injection Visit||0
11265546|NCT02287896|12461210|FG001|NOT COMPLETED|Second Injection Visit||1
11265547|NCT02287909|12461226|FG000|STARTED|Overall Study||20
11396949|NCT03978403|12590937|FG001|COMPLETED|Overall Study||6
11396950|NCT03978403|12590938|FG002|COMPLETED|Overall Study||6
11265548|NCT02287909|12461227|FG001|STARTED|Overall Study||20
11265549|NCT02287909|12461228|FG002|STARTED|Overall Study||20
11265550|NCT02287909|12461229|FG003|STARTED|Overall Study||20
11265551|NCT02287909|12461226|FG000|COMPLETED|Overall Study||18
11265552|NCT02287909|12461227|FG001|COMPLETED|Overall Study||19
11265553|NCT02287909|12461228|FG002|COMPLETED|Overall Study||20
11265554|NCT02287909|12461229|FG003|COMPLETED|Overall Study||19
11265555|NCT02287909|12461226|FG000|NOT COMPLETED|Overall Study||2
11265556|NCT02287909|12461227|FG001|NOT COMPLETED|Overall Study||1
11265557|NCT02287909|12461228|FG002|NOT COMPLETED|Overall Study||0
11265558|NCT02287909|12461229|FG003|NOT COMPLETED|Overall Study||1
11265559|NCT02287922|12461243|FG000|STARTED|Overall Study||62
11265560|NCT02287922|12461244|FG001|STARTED|Overall Study||62
11265561|NCT02287922|12461245|FG002|STARTED|Overall Study||63
11265562|NCT02287922|12461246|FG003|STARTED|Overall Study||64
11265563|NCT02287922|12461243|FG000|COMPLETED|Overall Study||59
11265564|NCT02287922|12461244|FG001|COMPLETED|Overall Study||60
11265565|NCT02287922|12461245|FG002|COMPLETED|Overall Study||56
11265566|NCT02287922|12461246|FG003|COMPLETED|Overall Study||57
11265567|NCT02287922|12461243|FG000|NOT COMPLETED|Overall Study||3
11265568|NCT02287922|12461244|FG001|NOT COMPLETED|Overall Study||2
11265569|NCT02287922|12461245|FG002|NOT COMPLETED|Overall Study||7
11265570|NCT02287922|12461246|FG003|NOT COMPLETED|Overall Study||7
11265571|NCT02288091|12461257|FG000|STARTED|Overall Study||32
11265572|NCT02288091|12461257|FG000|Randomized/Treated|Overall Study||25
11265573|NCT02288091|12461257|FG000|COMPLETED|Overall Study||24
11265574|NCT02288091|12461257|FG000|NOT COMPLETED|Overall Study||8
11265575|NCT02288156|12461265|FG000|STARTED|Overall Study||20
11265576|NCT02288156|12461266|FG001|STARTED|Overall Study||20
11265577|NCT02288156|12461267|FG002|STARTED|Overall Study||20
11265578|NCT02288156|12461268|FG003|STARTED|Overall Study||20
11265579|NCT02288156|12461265|FG000|COMPLETED|Overall Study||16
11265580|NCT02288156|12461266|FG001|COMPLETED|Overall Study||16
11265581|NCT02288156|12461267|FG002|COMPLETED|Overall Study||18
11265582|NCT02288156|12461268|FG003|COMPLETED|Overall Study||18
11265583|NCT02288156|12461265|FG000|NOT COMPLETED|Overall Study||4
11265584|NCT02288156|12461266|FG001|NOT COMPLETED|Overall Study||4
11265585|NCT02288156|12461267|FG002|NOT COMPLETED|Overall Study||2
11265586|NCT02288156|12461268|FG003|NOT COMPLETED|Overall Study||2
11265587|NCT02288182|12461282|FG000|STARTED|Overall Study||25
11265588|NCT02288182|12461283|FG001|STARTED|Overall Study||27
11265589|NCT02288182|12461282|FG000|COMPLETED|Overall Study||25
11265590|NCT02288182|12461283|FG001|COMPLETED|Overall Study||25
11265591|NCT02288182|12461282|FG000|NOT COMPLETED|Overall Study||0
11265592|NCT02288182|12461283|FG001|NOT COMPLETED|Overall Study||2
11265593|NCT02288273|12461293|FG000|STARTED|Overall Study||61
11265594|NCT02288273|12461294|FG001|STARTED|Overall Study||56
11265595|NCT02288273|12461293|FG000|COMPLETED|Overall Study||53
11265596|NCT02288273|12461294|FG001|COMPLETED|Overall Study||48
11265597|NCT02288273|12461293|FG000|NOT COMPLETED|Overall Study||8
11265598|NCT02288273|12461294|FG001|NOT COMPLETED|Overall Study||8
11265599|NCT02288312|12461303|FG000|STARTED|Overall Study||6
11265600|NCT02288312|12461304|FG001|STARTED|Overall Study||6
11265601|NCT02288312|12461305|FG002|STARTED|Overall Study||6
11265602|NCT02288312|12461303|FG000|COMPLETED|Overall Study||5
11265603|NCT02288312|12461304|FG001|COMPLETED|Overall Study||6
11265604|NCT02288312|12461305|FG002|COMPLETED|Overall Study||6
11265605|NCT02288312|12461303|FG000|NOT COMPLETED|Overall Study||1
11265606|NCT02288312|12461304|FG001|NOT COMPLETED|Overall Study||0
11265607|NCT02288312|12461305|FG002|NOT COMPLETED|Overall Study||0
11265608|NCT02288325|12461313|FG000|STARTED|Run-in Period||644
11265609|NCT02288325|12461314|FG001|STARTED|Run-in Period||0
11265610|NCT02288325|12461315|FG002|STARTED|Run-in Period||0
11265611|NCT02288325|12461313|FG000|COMPLETED|Run-in Period||499
11265612|NCT02288325|12461314|FG001|COMPLETED|Run-in Period||0
11265613|NCT02288325|12461315|FG002|COMPLETED|Run-in Period||0
11265614|NCT02288325|12461313|FG000|NOT COMPLETED|Run-in Period||145
11265615|NCT02288325|12461314|FG001|NOT COMPLETED|Run-in Period||0
11265616|NCT02288325|12461315|FG002|NOT COMPLETED|Run-in Period||0
11265617|NCT02288325|12461313|FG000|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
11265618|NCT02288325|12461314|FG001|STARTED|Stabilization Period||0
11265619|NCT02288325|12461315|FG002|STARTED|Stabilization Period||0
11265620|NCT02288325|12461313|FG000|COMPLETED|Stabilization Period||331
11265621|NCT02288325|12461314|FG001|COMPLETED|Stabilization Period||0
11265622|NCT02288325|12461315|FG002|COMPLETED|Stabilization Period||0
11265623|NCT02288325|12461313|FG000|NOT COMPLETED|Stabilization Period||98
11265624|NCT02288325|12461314|FG001|NOT COMPLETED|Stabilization Period||0
11265625|NCT02288325|12461315|FG002|NOT COMPLETED|Stabilization Period||0
11265626|NCT02288325|12461313|FG000|STARTED|Double-blind Treatment Period||0
11265627|NCT02288325|12461314|FG001|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
11265628|NCT02288325|12461315|FG002|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
11265629|NCT02288325|12461313|FG000|COMPLETED|Double-blind Treatment Period||0
11265630|NCT02288325|12461314|FG001|COMPLETED|Double-blind Treatment Period||135
11265631|NCT02288325|12461315|FG002|COMPLETED|Double-blind Treatment Period||139
11265632|NCT02288325|12461313|FG000|NOT COMPLETED|Double-blind Treatment Period||0
11265633|NCT02288325|12461314|FG001|NOT COMPLETED|Double-blind Treatment Period||24
11265634|NCT02288325|12461315|FG002|NOT COMPLETED|Double-blind Treatment Period||26
11265635|NCT02288364|12461324|FG000|STARTED|Overall Study||42
11265636|NCT02288364|12461325|FG001|STARTED|Overall Study||44
11265637|NCT02288364|12461324|FG000|COMPLETED|Overall Study||42
11265638|NCT02288364|12461325|FG001|COMPLETED|Overall Study||44
11265639|NCT02288364|12461324|FG000|NOT COMPLETED|Overall Study||0
11265640|NCT02288364|12461325|FG001|NOT COMPLETED|Overall Study||0
11265641|NCT02288377|12461333|FG000|STARTED|Overall Study||26
11265642|NCT02288377|12461334|FG001|STARTED|Overall Study||27
11265643|NCT02288377|12461333|FG000|COMPLETED|Overall Study||25
11265644|NCT02288377|12461334|FG001|COMPLETED|Overall Study||27
11265645|NCT02288377|12461333|FG000|NOT COMPLETED|Overall Study||1
11265646|NCT02288377|12461334|FG001|NOT COMPLETED|Overall Study||0
11265647|NCT02288559|12461344|FG000|STARTED|Overall Study||10
11265648|NCT02288559|12461345|FG001|STARTED|Overall Study||11
11265649|NCT02288559|12461346|FG002|STARTED|Overall Study||46
11265650|NCT02288559|12461347|FG003|STARTED|Overall Study||22
11396951|NCT03978403|12590939|FG003|COMPLETED|Overall Study||6
11265651|NCT02288559|12461344|FG000|COMPLETED|Overall Study||9
11265652|NCT02288559|12461345|FG001|COMPLETED|Overall Study||10
11265653|NCT02288559|12461346|FG002|COMPLETED|Overall Study||35
11265654|NCT02288559|12461347|FG003|COMPLETED|Overall Study||20
11265655|NCT02288559|12461344|FG000|NOT COMPLETED|Overall Study||1
11265656|NCT02288559|12461345|FG001|NOT COMPLETED|Overall Study||1
11265657|NCT02288559|12461346|FG002|NOT COMPLETED|Overall Study||11
11265658|NCT02288559|12461347|FG003|NOT COMPLETED|Overall Study||2
11265659|NCT02288819|12461359|FG000|STARTED|Overall Study||50
11265660|NCT02288819|12461359|FG000|COMPLETED|Overall Study||50
11265661|NCT02288819|12461359|FG000|NOT COMPLETED|Overall Study||0
11265662|NCT02289079|12461365|FG000|STARTED|Overall Study||30
11265663|NCT02289079|12461366|FG001|STARTED|Overall Study||30
11265664|NCT02289079|12461365|FG000|COMPLETED|Overall Study||28
11265665|NCT02289079|12461366|FG001|COMPLETED|Overall Study||29
11265666|NCT02289079|12461365|FG000|NOT COMPLETED|Overall Study||2
11265667|NCT02289079|12461366|FG001|NOT COMPLETED|Overall Study||1
11265668|NCT02289105|12461374|FG000|STARTED|Overall Study||642
11265669|NCT02289105|12461375|FG001|STARTED|Overall Study||637
11265670|NCT02289105|12461374|FG000|COMPLETED|Overall Study||642
11265671|NCT02289105|12461375|FG001|COMPLETED|Overall Study||637
11265672|NCT02289105|12461374|FG000|NOT COMPLETED|Overall Study||0
11265673|NCT02289105|12461375|FG001|NOT COMPLETED|Overall Study||0
11265674|NCT02289157|12461383|FG000|STARTED|Overall Study||222
11265675|NCT02289157|12461384|FG001|STARTED|Overall Study||219
11265676|NCT02289157|12461383|FG000|No Post op Check or Follow up Phone Call|Overall Study||2
11265677|NCT02289157|12461384|FG001|No Post op Check or Follow up Phone Call|Overall Study||4
11265678|NCT02289157|12461383|FG000|COMPLETED|Overall Study||222
11265679|NCT02289157|12461384|FG001|COMPLETED|Overall Study||219
11265680|NCT02289157|12461383|FG000|NOT COMPLETED|Overall Study||0
11265681|NCT02289157|12461384|FG001|NOT COMPLETED|Overall Study||0
11265682|NCT02289222|12461390|FG000|STARTED|Overall Study||48
11265683|NCT02289222|12461390|FG000|COMPLETED|Overall Study||48
11265684|NCT02289222|12461390|FG000|NOT COMPLETED|Overall Study||0
11265685|NCT02289352|12461397|FG000|STARTED|Overall Study||199
11265686|NCT02289352|12461398|FG001|STARTED|Overall Study||199
11265687|NCT02289352|12461399|FG002|STARTED|Overall Study||64
11265688|NCT02289352|12461397|FG000|Safety Population|Overall Study||199
11265689|NCT02289352|12461398|FG001|Safety Population|Overall Study||199
11265690|NCT02289352|12461399|FG002|Safety Population|Overall Study||64
11265691|NCT02289352|12461397|FG000|mITT Population|Overall Study||191
11265692|NCT02289352|12461398|FG001|mITT Population|Overall Study||193
11265693|NCT02289352|12461399|FG002|mITT Population|Overall Study||58
11265694|NCT02289352|12461397|FG000|PP Population|Overall Study||173
11265695|NCT02289352|12461398|FG001|PP Population|Overall Study||173
11265696|NCT02289352|12461399|FG002|PP Population|Overall Study||54
11265697|NCT02289352|12461397|FG000|COMPLETED|Overall Study||198
11265698|NCT02289352|12461398|FG001|COMPLETED|Overall Study||198
11265699|NCT02289352|12461399|FG002|COMPLETED|Overall Study||64
11265700|NCT02289352|12461397|FG000|NOT COMPLETED|Overall Study||1
11265701|NCT02289352|12461398|FG001|NOT COMPLETED|Overall Study||1
11265702|NCT02289352|12461399|FG002|NOT COMPLETED|Overall Study||0
11265703|NCT02289417|12461411|FG000|STARTED|Placebo-Controlled Phase Weeks 0-12||58
11396952|NCT03978403|12590936|FG000|NOT COMPLETED|Overall Study||0
11265704|NCT02289417|12461412|FG001|STARTED|Placebo-Controlled Phase Weeks 0-12||57
11265705|NCT02289417|12461413|FG002|STARTED|Placebo-Controlled Phase Weeks 0-12||55
11265706|NCT02289417|12461414|FG003|STARTED|Placebo-Controlled Phase Weeks 0-12||0
11265707|NCT02289417|12461415|FG004|STARTED|Placebo-Controlled Phase Weeks 0-12||0
11265708|NCT02289417|12461416|FG005|STARTED|Placebo-Controlled Phase Weeks 0-12||0
11265709|NCT02289417|12461417|FG006|STARTED|Placebo-Controlled Phase Weeks 0-12||0
11265710|NCT02289417|12461418|FG007|STARTED|Placebo-Controlled Phase Weeks 0-12||0
11265711|NCT02289417|12461419|FG008|STARTED|Placebo-Controlled Phase Weeks 0-12||0
11265712|NCT02289417|12461411|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-12||51
11265713|NCT02289417|12461412|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-12||53
11265714|NCT02289417|12461413|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-12||52
11265715|NCT02289417|12461414|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
11265716|NCT02289417|12461415|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
11265717|NCT02289417|12461416|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
11265718|NCT02289417|12461417|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
11265719|NCT02289417|12461418|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
11265720|NCT02289417|12461419|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
11265721|NCT02289417|12461411|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||7
11265722|NCT02289417|12461412|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||4
11265723|NCT02289417|12461413|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||3
11265724|NCT02289417|12461414|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
11265725|NCT02289417|12461415|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
11265726|NCT02289417|12461416|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
11265727|NCT02289417|12461417|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
11265728|NCT02289417|12461418|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
11265729|NCT02289417|12461419|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
11265730|NCT02289417|12461411|FG000|STARTED|Active Treatment Phase Weeks 12-52||0
11265731|NCT02289417|12461412|FG001|STARTED|Active Treatment Phase Weeks 12-52||41
11265732|NCT02289417|12461413|FG002|STARTED|Active Treatment Phase Weeks 12-52||42
11265733|NCT02289417|12461414|FG003|STARTED|Active Treatment Phase Weeks 12-52||26
11265734|NCT02289417|12461415|FG004|STARTED|Active Treatment Phase Weeks 12-52||25
11265735|NCT02289417|12461416|FG005|STARTED|Active Treatment Phase Weeks 12-52|1 participant went only to Week 20|12
11265736|NCT02289417|12461417|FG006|STARTED|Active Treatment Phase Weeks 12-52|Week 12 TMS were missing for 3 participants|7
11265737|NCT02289417|12461418|FG007|STARTED|Active Treatment Phase Weeks 12-52||0
11265738|NCT02289417|12461419|FG008|STARTED|Active Treatment Phase Weeks 12-52||0
11265739|NCT02289417|12461411|FG000|COMPLETED|Active Treatment Phase Weeks 12-52||0
11265740|NCT02289417|12461412|FG001|COMPLETED|Active Treatment Phase Weeks 12-52||39
11265741|NCT02289417|12461413|FG002|COMPLETED|Active Treatment Phase Weeks 12-52||32
11265742|NCT02289417|12461414|FG003|COMPLETED|Active Treatment Phase Weeks 12-52||17
11265743|NCT02289417|12461415|FG004|COMPLETED|Active Treatment Phase Weeks 12-52||20
11265744|NCT02289417|12461416|FG005|COMPLETED|Active Treatment Phase Weeks 12-52||7
11265745|NCT02289417|12461417|FG006|COMPLETED|Active Treatment Phase Weeks 12-52||5
11265746|NCT02289417|12461418|FG007|COMPLETED|Active Treatment Phase Weeks 12-52||0
11265747|NCT02289417|12461419|FG008|COMPLETED|Active Treatment Phase Weeks 12-52||0
11265748|NCT02289417|12461411|FG000|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
11265749|NCT02289417|12461412|FG001|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
11265750|NCT02289417|12461413|FG002|NOT COMPLETED|Active Treatment Phase Weeks 12-52||10
11265751|NCT02289417|12461414|FG003|NOT COMPLETED|Active Treatment Phase Weeks 12-52||9
11265752|NCT02289417|12461415|FG004|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
11265753|NCT02289417|12461416|FG005|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
11265754|NCT02289417|12461417|FG006|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
11265755|NCT02289417|12461418|FG007|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
11265756|NCT02289417|12461419|FG008|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
11265757|NCT02289417|12461411|FG000|STARTED|Extension Phase Weeks 52-104||0
11265758|NCT02289417|12461412|FG001|STARTED|Extension Phase Weeks 52-104||0
11265759|NCT02289417|12461413|FG002|STARTED|Extension Phase Weeks 52-104||0
11265760|NCT02289417|12461414|FG003|STARTED|Extension Phase Weeks 52-104||0
11265761|NCT02289417|12461415|FG004|STARTED|Extension Phase Weeks 52-104||0
11265762|NCT02289417|12461416|FG005|STARTED|Extension Phase Weeks 52-104||0
11265763|NCT02289417|12461417|FG006|STARTED|Extension Phase Weeks 52-104||0
11265764|NCT02289417|12461418|FG007|STARTED|Extension Phase Weeks 52-104||45
11265765|NCT02289417|12461419|FG008|STARTED|Extension Phase Weeks 52-104||54
11265766|NCT02289417|12461411|FG000|COMPLETED|Extension Phase Weeks 52-104||0
11396953|NCT03978403|12590937|FG001|NOT COMPLETED|Overall Study||0
11396954|NCT03978403|12590938|FG002|NOT COMPLETED|Overall Study||0
11396955|NCT03978403|12590939|FG003|NOT COMPLETED|Overall Study||0
11396956|NCT03979807|12590952|FG000|STARTED|Overall Study||3876
11396957|NCT03979807|12590953|FG001|STARTED|Overall Study||7420
11396958|NCT03979807|12590952|FG000|COMPLETED|Overall Study||3876
11396959|NCT03979807|12590953|FG001|COMPLETED|Overall Study||7420
11396960|NCT03979807|12590952|FG000|NOT COMPLETED|Overall Study||0
11396961|NCT03979807|12590953|FG001|NOT COMPLETED|Overall Study||0
11396962|NCT03980470|12590959|FG000|STARTED|Overall Study||50
11396963|NCT03980470|12590959|FG000|COMPLETED|Overall Study||50
11396964|NCT03980470|12590959|FG000|NOT COMPLETED|Overall Study||0
11396965|NCT03982069|12590970|FG000|STARTED|Overall Study||108
11396966|NCT03982069|12590971|FG001|STARTED|Overall Study||110
11396967|NCT03982069|12590972|FG002|STARTED|Overall Study||127
11396968|NCT03982069|12590973|FG003|STARTED|Overall Study||120
11396969|NCT03982069|12590970|FG000|COMPLETED|Overall Study||98
11396970|NCT03982069|12590971|FG001|COMPLETED|Overall Study||100
11396971|NCT03982069|12590972|FG002|COMPLETED|Overall Study||118
11396972|NCT03982069|12590973|FG003|COMPLETED|Overall Study||112
11396973|NCT03982069|12590970|FG000|NOT COMPLETED|Overall Study||10
11396974|NCT03982069|12590971|FG001|NOT COMPLETED|Overall Study||10
11396975|NCT03982069|12590972|FG002|NOT COMPLETED|Overall Study||9
11396976|NCT03982069|12590973|FG003|NOT COMPLETED|Overall Study||8
11396977|NCT03984812|12590992|FG000|STARTED|Part 1 (Up to Day 28)||6
11396978|NCT03984812|12590993|FG001|STARTED|Part 1 (Up to Day 28)||6
11265767|NCT02289417|12461412|FG001|COMPLETED|Extension Phase Weeks 52-104||0
11265768|NCT02289417|12461413|FG002|COMPLETED|Extension Phase Weeks 52-104||0
11265769|NCT02289417|12461414|FG003|COMPLETED|Extension Phase Weeks 52-104||0
11265770|NCT02289417|12461415|FG004|COMPLETED|Extension Phase Weeks 52-104||0
11396979|NCT03984812|12590994|FG002|STARTED|Part 1 (Up to Day 28)||6
11396980|NCT03984812|12590995|FG003|STARTED|Part 1 (Up to Day 28)||6
11265771|NCT02289417|12461416|FG005|COMPLETED|Extension Phase Weeks 52-104||0
11265772|NCT02289417|12461417|FG006|COMPLETED|Extension Phase Weeks 52-104||0
11265773|NCT02289417|12461418|FG007|COMPLETED|Extension Phase Weeks 52-104||38
11265774|NCT02289417|12461419|FG008|COMPLETED|Extension Phase Weeks 52-104||48
11265775|NCT02289417|12461411|FG000|NOT COMPLETED|Extension Phase Weeks 52-104||0
11265776|NCT02289417|12461412|FG001|NOT COMPLETED|Extension Phase Weeks 52-104||0
11265777|NCT02289417|12461413|FG002|NOT COMPLETED|Extension Phase Weeks 52-104||0
11265778|NCT02289417|12461414|FG003|NOT COMPLETED|Extension Phase Weeks 52-104||0
11265779|NCT02289417|12461415|FG004|NOT COMPLETED|Extension Phase Weeks 52-104||0
11265780|NCT02289417|12461416|FG005|NOT COMPLETED|Extension Phase Weeks 52-104||0
11265781|NCT02289417|12461417|FG006|NOT COMPLETED|Extension Phase Weeks 52-104||0
11265782|NCT02289417|12461418|FG007|NOT COMPLETED|Extension Phase Weeks 52-104||7
11265783|NCT02289417|12461419|FG008|NOT COMPLETED|Extension Phase Weeks 52-104||6
11265784|NCT02289456|12461435|FG000|STARTED|Induction Period||40
11265785|NCT02289456|12461435|FG000|Treated Population|Induction Period||40
11265786|NCT02289456|12461435|FG000|COMPLETED|Induction Period||16
11265787|NCT02289456|12461435|FG000|NOT COMPLETED|Induction Period||24
11265788|NCT02289456|12461435|FG000|STARTED|Monotherapy Period||16
11265789|NCT02289456|12461435|FG000|COMPLETED|Monotherapy Period||0
11265790|NCT02289456|12461435|FG000|NOT COMPLETED|Monotherapy Period||16
11265791|NCT02289469|12461446|FG000|STARTED|Overall Study||250
11265792|NCT02289469|12461447|FG001|STARTED|Overall Study||244
11265793|NCT02289469|12461446|FG000|COMPLETED|Overall Study||244
11265794|NCT02289469|12461447|FG001|COMPLETED|Overall Study||244
11265795|NCT02289469|12461446|FG000|NOT COMPLETED|Overall Study||6
11265796|NCT02289469|12461447|FG001|NOT COMPLETED|Overall Study||0
11265797|NCT02289690|12461463|FG000|STARTED|Overall Study||4
11265798|NCT02289690|12461464|FG001|STARTED|Overall Study||3
11265799|NCT02289690|12461465|FG002|STARTED|Overall Study||4
11265800|NCT02289690|12461466|FG003|STARTED|Overall Study||3
11265801|NCT02289690|12461467|FG004|STARTED|Overall Study||8
11265802|NCT02289690|12461468|FG005|STARTED|Overall Study||14
11265803|NCT02289690|12461469|FG006|STARTED|Overall Study||4
11396981|NCT03984812|12590996|FG004|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
11396982|NCT03984812|12590997|FG005|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
11265804|NCT02289690|12461470|FG007|STARTED|Overall Study||61
11265805|NCT02289690|12461471|FG008|STARTED|Overall Study||59
11265806|NCT02289690|12461472|FG009|STARTED|Overall Study||61
11265807|NCT02289690|12461463|FG000|Received Study Drug|Overall Study||4
11265808|NCT02289690|12461464|FG001|Received Study Drug|Overall Study||3
11265809|NCT02289690|12461465|FG002|Received Study Drug|Overall Study||4
11265810|NCT02289690|12461466|FG003|Received Study Drug|Overall Study||3
11265811|NCT02289690|12461467|FG004|Received Study Drug|Overall Study||8
11265812|NCT02289690|12461468|FG005|Received Study Drug|Overall Study||14
11265813|NCT02289690|12461469|FG006|Received Study Drug|Overall Study||4
11265814|NCT02289690|12461470|FG007|Received Study Drug|Overall Study||60
11265815|NCT02289690|12461471|FG008|Received Study Drug|Overall Study||58
11265816|NCT02289690|12461472|FG009|Received Study Drug|Overall Study||60
11265817|NCT02289690|12461463|FG000|COMPLETED|Overall Study||0
11265818|NCT02289690|12461464|FG001|COMPLETED|Overall Study||0
11265819|NCT02289690|12461465|FG002|COMPLETED|Overall Study||0
11265820|NCT02289690|12461466|FG003|COMPLETED|Overall Study||0
11265821|NCT02289690|12461467|FG004|COMPLETED|Overall Study||0
11265822|NCT02289690|12461468|FG005|COMPLETED|Overall Study||0
11265823|NCT02289690|12461469|FG006|COMPLETED|Overall Study||0
11265824|NCT02289690|12461470|FG007|COMPLETED|Overall Study||0
11265825|NCT02289690|12461471|FG008|COMPLETED|Overall Study||0
11265826|NCT02289690|12461472|FG009|COMPLETED|Overall Study||0
11265827|NCT02289690|12461463|FG000|NOT COMPLETED|Overall Study||4
11265828|NCT02289690|12461464|FG001|NOT COMPLETED|Overall Study||3
11265829|NCT02289690|12461465|FG002|NOT COMPLETED|Overall Study||4
11265830|NCT02289690|12461466|FG003|NOT COMPLETED|Overall Study||3
11265831|NCT02289690|12461467|FG004|NOT COMPLETED|Overall Study||8
11265832|NCT02289690|12461468|FG005|NOT COMPLETED|Overall Study||14
11265833|NCT02289690|12461469|FG006|NOT COMPLETED|Overall Study||4
11265834|NCT02289690|12461470|FG007|NOT COMPLETED|Overall Study||61
11265835|NCT02289690|12461471|FG008|NOT COMPLETED|Overall Study||59
11265836|NCT02289690|12461472|FG009|NOT COMPLETED|Overall Study||61
11265837|NCT02289729|12461508|FG000|STARTED|Overall Study||59
11265838|NCT02289729|12461508|FG000|COMPLETED|Overall Study||53
11265839|NCT02289729|12461508|FG000|NOT COMPLETED|Overall Study||6
11265840|NCT02289742|12461514|FG000|STARTED|First Wear Period||11
11265841|NCT02289742|12461515|FG001|STARTED|First Wear Period||12
11265842|NCT02289742|12461516|FG002|STARTED|First Wear Period||12
11265843|NCT02289742|12461517|FG003|STARTED|First Wear Period||10
11265844|NCT02289742|12461514|FG000|Treated|First Wear Period||11
11265845|NCT02289742|12461515|FG001|Treated|First Wear Period||11
11265846|NCT02289742|12461516|FG002|Treated|First Wear Period||12
11265847|NCT02289742|12461517|FG003|Treated|First Wear Period||9
11265848|NCT02289742|12461514|FG000|COMPLETED|First Wear Period||11
11265849|NCT02289742|12461515|FG001|COMPLETED|First Wear Period||11
11265850|NCT02289742|12461516|FG002|COMPLETED|First Wear Period||11
11265851|NCT02289742|12461517|FG003|COMPLETED|First Wear Period||9
11265852|NCT02289742|12461514|FG000|NOT COMPLETED|First Wear Period||0
11265853|NCT02289742|12461515|FG001|NOT COMPLETED|First Wear Period||1
11265854|NCT02289742|12461516|FG002|NOT COMPLETED|First Wear Period||1
11265855|NCT02289742|12461517|FG003|NOT COMPLETED|First Wear Period||1
11265856|NCT02289742|12461514|FG000|STARTED|Second Wear Period||11
11265857|NCT02289742|12461515|FG001|STARTED|Second Wear Period||11
11265858|NCT02289742|12461516|FG002|STARTED|Second Wear Period||11
11265859|NCT02289742|12461517|FG003|STARTED|Second Wear Period||9
11265860|NCT02289742|12461514|FG000|COMPLETED|Second Wear Period||11
11265861|NCT02289742|12461515|FG001|COMPLETED|Second Wear Period||11
11265862|NCT02289742|12461516|FG002|COMPLETED|Second Wear Period||11
11265863|NCT02289742|12461517|FG003|COMPLETED|Second Wear Period||9
11265864|NCT02289742|12461514|FG000|NOT COMPLETED|Second Wear Period||0
11265865|NCT02289742|12461515|FG001|NOT COMPLETED|Second Wear Period||0
11265866|NCT02289742|12461516|FG002|NOT COMPLETED|Second Wear Period||0
11265867|NCT02289742|12461517|FG003|NOT COMPLETED|Second Wear Period||0
11265868|NCT02289742|12461514|FG000|STARTED|Third Wear Period||11
11265869|NCT02289742|12461515|FG001|STARTED|Third Wear Period||11
11265870|NCT02289742|12461516|FG002|STARTED|Third Wear Period||11
11265871|NCT02289742|12461517|FG003|STARTED|Third Wear Period||9
11265872|NCT02289742|12461514|FG000|COMPLETED|Third Wear Period||11
11265873|NCT02289742|12461515|FG001|COMPLETED|Third Wear Period||10
11265874|NCT02289742|12461516|FG002|COMPLETED|Third Wear Period||11
11265875|NCT02289742|12461517|FG003|COMPLETED|Third Wear Period||8
11265876|NCT02289742|12461514|FG000|NOT COMPLETED|Third Wear Period||0
11265877|NCT02289742|12461515|FG001|NOT COMPLETED|Third Wear Period||1
11265878|NCT02289742|12461516|FG002|NOT COMPLETED|Third Wear Period||0
11265879|NCT02289742|12461517|FG003|NOT COMPLETED|Third Wear Period||1
11265880|NCT02289755|12461531|FG000|STARTED|Baseline Period [No Treatment, 3 Days]||16
11265881|NCT02289755|12461531|FG000|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
11265882|NCT02289755|12461531|FG000|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
11265883|NCT02289755|12461531|FG000|STARTED|ALLN-177 Treatment Period [4 Days]||16
11265884|NCT02289755|12461531|FG000|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
11265885|NCT02289755|12461531|FG000|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
11265886|NCT02289755|12461531|FG000|STARTED|Follow up Period [4 Days]||16
11265887|NCT02289755|12461531|FG000|COMPLETED|Follow up Period [4 Days]||16
11265888|NCT02289755|12461531|FG000|NOT COMPLETED|Follow up Period [4 Days]||0
11265889|NCT02289820|12461542|FG000|STARTED|Overall Study||39
11265890|NCT02289820|12461543|FG001|STARTED|Overall Study||20
11265891|NCT02289820|12461544|FG002|STARTED|Overall Study||44
11265892|NCT02289820|12461545|FG003|STARTED|Overall Study||39
11265893|NCT02289820|12461546|FG004|STARTED|Overall Study||40
11265894|NCT02289820|12461547|FG005|STARTED|Overall Study||40
11265895|NCT02289820|12461548|FG006|STARTED|Overall Study||39
11265896|NCT02289820|12461542|FG000|COMPLETED|Overall Study||37
11265897|NCT02289820|12461543|FG001|COMPLETED|Overall Study||18
11265898|NCT02289820|12461544|FG002|COMPLETED|Overall Study||38
11265899|NCT02289820|12461545|FG003|COMPLETED|Overall Study||37
11265900|NCT02289820|12461546|FG004|COMPLETED|Overall Study||40
11265901|NCT02289820|12461547|FG005|COMPLETED|Overall Study||39
11265902|NCT02289820|12461548|FG006|COMPLETED|Overall Study||37
11265903|NCT02289820|12461542|FG000|NOT COMPLETED|Overall Study||2
11265904|NCT02289820|12461543|FG001|NOT COMPLETED|Overall Study||2
11265905|NCT02289820|12461544|FG002|NOT COMPLETED|Overall Study||6
11265906|NCT02289820|12461545|FG003|NOT COMPLETED|Overall Study||2
11265907|NCT02289820|12461546|FG004|NOT COMPLETED|Overall Study||0
11265908|NCT02289820|12461547|FG005|NOT COMPLETED|Overall Study||1
11265909|NCT02289820|12461548|FG006|NOT COMPLETED|Overall Study||2
11265910|NCT02289833|12461570|FG000|STARTED|Overall Study||29
11265911|NCT02289833|12461571|FG001|STARTED|Overall Study||20
11265912|NCT02289833|12461570|FG000|COMPLETED|Overall Study||2
11265913|NCT02289833|12461571|FG001|COMPLETED|Overall Study||3
11265914|NCT02289833|12461570|FG000|NOT COMPLETED|Overall Study||27
11265915|NCT02289833|12461571|FG001|NOT COMPLETED|Overall Study||17
11265916|NCT02289898|12461582|FG000|STARTED|Overall Study||68
11265917|NCT02289898|12461583|FG001|STARTED|Overall Study||71
11265918|NCT02289898|12461584|FG002|STARTED|Overall Study||65
11265919|NCT02289898|12461582|FG000|COMPLETED|Overall Study||16
11265920|NCT02289898|12461583|FG001|COMPLETED|Overall Study||18
11265921|NCT02289898|12461584|FG002|COMPLETED|Overall Study||9
11265922|NCT02289898|12461582|FG000|NOT COMPLETED|Overall Study||52
11265923|NCT02289898|12461583|FG001|NOT COMPLETED|Overall Study||53
11265924|NCT02289898|12461584|FG002|NOT COMPLETED|Overall Study||56
11340231|NCT02918968|12537535|FG000|STARTED|1st Line AAT||102
11340232|NCT02918968|12537536|FG001|STARTED|1st Line AAT||104
11340233|NCT02918968|12537535|FG000|Maintained 1st Line AAT Without Progression|1st Line AAT||25
11340234|NCT02918968|12537536|FG001|Maintained 1st Line AAT Without Progression|1st Line AAT||8
11340235|NCT02918968|12537535|FG000|COMPLETED|1st Line AAT||73
11340236|NCT02918968|12537536|FG001|COMPLETED|1st Line AAT||93
11340237|NCT02918968|12537535|FG000|NOT COMPLETED|1st Line AAT||29
11340238|NCT02918968|12537536|FG001|NOT COMPLETED|1st Line AAT||11
11340239|NCT02918968|12537535|FG000|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|48
11396983|NCT03984812|12590998|FG006|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
11340240|NCT02918968|12537536|FG001|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|85
11340241|NCT02918968|12537535|FG000|COMPLETED|2nd Line AAT||23
11340242|NCT02918968|12537536|FG001|COMPLETED|2nd Line AAT||73
11340243|NCT02918968|12537535|FG000|NOT COMPLETED|2nd Line AAT||25
11340244|NCT02918968|12537536|FG001|NOT COMPLETED|2nd Line AAT||12
11340245|NCT02919007|12537544|FG000|STARTED|Overall Study||25
11340246|NCT02919007|12537544|FG000|COMPLETED|Overall Study||25
11340247|NCT02919007|12537544|FG000|NOT COMPLETED|Overall Study||0
11265925|NCT02289950|12461593|FG000|STARTED|Overall Study||142
11265926|NCT02289950|12461594|FG001|STARTED|Overall Study||72
11265927|NCT02289950|12461593|FG000|Treated|Overall Study|1 participant randomized to placebo group but was treated with farletuzumab, and was analyzed in the farletuzumab group in safety analysis set.|140
11265928|NCT02289950|12461594|FG001|Treated|Overall Study||71
11265929|NCT02289950|12461593|FG000|COMPLETED|Overall Study||0
11265930|NCT02289950|12461594|FG001|COMPLETED|Overall Study||0
11265931|NCT02289950|12461593|FG000|NOT COMPLETED|Overall Study||142
11265932|NCT02289950|12461594|FG001|NOT COMPLETED|Overall Study||72
11265933|NCT02289963|12461602|FG000|STARTED|Overall Study|Randomized|102
11265934|NCT02289963|12461603|FG001|STARTED|Overall Study|Randomized|97
11265935|NCT02289963|12461602|FG000|Treated|Overall Study||102
11265936|NCT02289963|12461603|FG001|Treated|Overall Study||97
11265937|NCT02289963|12461602|FG000|COMPLETED|Overall Study||97
11265938|NCT02289963|12461603|FG001|COMPLETED|Overall Study||87
11265939|NCT02289963|12461602|FG000|NOT COMPLETED|Overall Study||5
11265940|NCT02289963|12461603|FG001|NOT COMPLETED|Overall Study||10
11265941|NCT02289989|12461611|FG000|STARTED|Overall Study||0
11265942|NCT02289989|12461612|FG001|STARTED|Overall Study||1
11265943|NCT02289989|12461611|FG000|COMPLETED|Overall Study||0
11265944|NCT02289989|12461612|FG001|COMPLETED|Overall Study||1
11265945|NCT02289989|12461611|FG000|NOT COMPLETED|Overall Study||0
11265946|NCT02289989|12461612|FG001|NOT COMPLETED|Overall Study||0
11265947|NCT02290028|12461618|FG000|STARTED|Overall Study||2226
11265948|NCT02290028|12461618|FG000|COMPLETED|Overall Study||0
11265949|NCT02290028|12461618|FG000|NOT COMPLETED|Overall Study||2226
11265950|NCT02290106|12461627|FG000|STARTED|Overall Study||25
11265951|NCT02290106|12461628|FG001|STARTED|Overall Study||25
11265952|NCT02290106|12461627|FG000|COMPLETED|Overall Study||24
11265953|NCT02290106|12461628|FG001|COMPLETED|Overall Study||23
11265954|NCT02290106|12461627|FG000|NOT COMPLETED|Overall Study||1
11265955|NCT02290106|12461628|FG001|NOT COMPLETED|Overall Study||2
11265956|NCT02290184|12461636|FG000|STARTED|Overall Study||22
11265957|NCT02290184|12461637|FG001|STARTED|Overall Study||23
11265958|NCT02290184|12461636|FG000|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22
11265959|NCT02290184|12461637|FG001|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23
11265960|NCT02290184|12461636|FG000|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22
11265961|NCT02290184|12461637|FG001|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23
11265962|NCT02290184|12461636|FG000|NOT COMPLETED|Overall Study||0
11265963|NCT02290184|12461637|FG001|NOT COMPLETED|Overall Study||0
11265964|NCT02290223|12461651|FG000|STARTED|Baseline||189
11265965|NCT02290223|12461652|FG001|STARTED|Baseline||187
11265966|NCT02290223|12461651|FG000|COMPLETED|Baseline||189
11265967|NCT02290223|12461652|FG001|COMPLETED|Baseline||187
11265968|NCT02290223|12461651|FG000|NOT COMPLETED|Baseline||0
11265969|NCT02290223|12461652|FG001|NOT COMPLETED|Baseline||0
11265970|NCT02290223|12461651|FG000|STARTED|6 Months||189
11265971|NCT02290223|12461652|FG001|STARTED|6 Months||187
11265972|NCT02290223|12461651|FG000|COMPLETED|6 Months||173
11265973|NCT02290223|12461652|FG001|COMPLETED|6 Months||181
11265974|NCT02290223|12461651|FG000|NOT COMPLETED|6 Months||16
11265975|NCT02290223|12461652|FG001|NOT COMPLETED|6 Months||6
11265976|NCT02290223|12461651|FG000|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182
11265977|NCT02290223|12461652|FG001|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187
11265978|NCT02290223|12461651|FG000|COMPLETED|12 Months||166
11265979|NCT02290223|12461652|FG001|COMPLETED|12 Months||176
11265980|NCT02290223|12461651|FG000|NOT COMPLETED|12 Months||16
11265981|NCT02290223|12461652|FG001|NOT COMPLETED|12 Months||11
11265982|NCT02290340|12461662|FG000|STARTED|Overall Study||18
11265983|NCT02290340|12461663|FG001|STARTED|Overall Study||8
11265984|NCT02290340|12461664|FG002|STARTED|Overall Study||31
11265985|NCT02290340|12461665|FG003|STARTED|Overall Study||32
11265986|NCT02290340|12461662|FG000|COMPLETED|Overall Study||16
11265987|NCT02290340|12461663|FG001|COMPLETED|Overall Study||8
11265988|NCT02290340|12461664|FG002|COMPLETED|Overall Study||31
11265989|NCT02290340|12461665|FG003|COMPLETED|Overall Study||30
11265990|NCT02290340|12461662|FG000|NOT COMPLETED|Overall Study||2
11265991|NCT02290340|12461663|FG001|NOT COMPLETED|Overall Study||0
11265992|NCT02290340|12461664|FG002|NOT COMPLETED|Overall Study||0
11265993|NCT02290340|12461665|FG003|NOT COMPLETED|Overall Study||2
11265994|NCT02290405|12461680|FG000|STARTED|Overall Study||36
11265995|NCT02290405|12461681|FG001|STARTED|Overall Study||53
11265996|NCT02290405|12461680|FG000|COMPLETED|Overall Study||35
11265997|NCT02290405|12461681|FG001|COMPLETED|Overall Study||53
11265998|NCT02290405|12461680|FG000|NOT COMPLETED|Overall Study||1
11265999|NCT02290405|12461681|FG001|NOT COMPLETED|Overall Study||0
11266000|NCT02290444|12461689|FG000|STARTED|Overall Study||30
11396984|NCT03984812|12590999|FG007|STARTED|Part 1 (Up to Day 28)||0
11266001|NCT02290444|12461690|FG001|STARTED|Overall Study||34
11266002|NCT02290444|12461689|FG000|COMPLETED|Overall Study||29
11266003|NCT02290444|12461690|FG001|COMPLETED|Overall Study||32
11396985|NCT03984812|12591000|FG008|STARTED|Part 1 (Up to Day 28)||0
11266004|NCT02290444|12461689|FG000|NOT COMPLETED|Overall Study||1
11266005|NCT02290444|12461690|FG001|NOT COMPLETED|Overall Study||2
11266006|NCT02290509|12461698|FG000|STARTED|Overall Study||1011
11266007|NCT02290509|12461699|FG001|STARTED|Overall Study||339
11266008|NCT02290509|12461698|FG000|COMPLETED|Overall Study||962
11266009|NCT02290509|12461699|FG001|COMPLETED|Overall Study||325
11266010|NCT02290509|12461698|FG000|NOT COMPLETED|Overall Study||49
11266011|NCT02290509|12461699|FG001|NOT COMPLETED|Overall Study||14
11266012|NCT02290574|12461705|FG000|STARTED|Overall Study||14
11266013|NCT02290574|12461705|FG000|COMPLETED|Overall Study||13
11266014|NCT02290574|12461705|FG000|NOT COMPLETED|Overall Study||1
11266015|NCT02290613|12461712|FG000|STARTED|Overall Study||19
11266016|NCT02290613|12461713|FG001|STARTED|Overall Study||19
11266017|NCT02290613|12461712|FG000|COMPLETED|Overall Study||17
11266018|NCT02290613|12461713|FG001|COMPLETED|Overall Study||15
11266019|NCT02290613|12461712|FG000|NOT COMPLETED|Overall Study||2
11266020|NCT02290613|12461713|FG001|NOT COMPLETED|Overall Study||4
11266021|NCT02290691|12461721|FG000|STARTED|Overall Study||496
11266022|NCT02290691|12461722|FG001|STARTED|Overall Study||488
11266023|NCT02290691|12461721|FG000|COMPLETED|Overall Study||488
11266024|NCT02290691|12461722|FG001|COMPLETED|Overall Study||479
11266025|NCT02290691|12461721|FG000|NOT COMPLETED|Overall Study||8
11266026|NCT02290691|12461722|FG001|NOT COMPLETED|Overall Study||9
11266027|NCT02290821|12461730|FG000|STARTED|Overall Study||109
11266028|NCT02290821|12461731|FG001|STARTED|Overall Study||106
11266029|NCT02290821|12461730|FG000|COMPLETED|Overall Study||103
11266030|NCT02290821|12461731|FG001|COMPLETED|Overall Study||103
11266031|NCT02290821|12461730|FG000|NOT COMPLETED|Overall Study||6
11266032|NCT02290821|12461731|FG001|NOT COMPLETED|Overall Study||3
11266033|NCT02290873|12461740|FG000|STARTED|Overall Study||298
11266034|NCT02290873|12461741|FG001|STARTED|Overall Study||60
11266035|NCT02290873|12461742|FG002|STARTED|Overall Study||103
11266036|NCT02290873|12461740|FG000|Modified Intention to Treat (mITT)|Overall Study||296
11266037|NCT02290873|12461741|FG001|Modified Intention to Treat (mITT)|Overall Study||60
11266038|NCT02290873|12461742|FG002|Modified Intention to Treat (mITT)|Overall Study||102
11266039|NCT02290873|12461740|FG000|Safety Population|Overall Study||296
11266040|NCT02290873|12461741|FG001|Safety Population|Overall Study||60
11266041|NCT02290873|12461742|FG002|Safety Population|Overall Study||102
11266042|NCT02290873|12461740|FG000|COMPLETED|Overall Study||296
11266043|NCT02290873|12461741|FG001|COMPLETED|Overall Study||59
11266044|NCT02290873|12461742|FG002|COMPLETED|Overall Study||101
11266045|NCT02290873|12461740|FG000|NOT COMPLETED|Overall Study||2
11266046|NCT02290873|12461741|FG001|NOT COMPLETED|Overall Study||1
11266047|NCT02290873|12461742|FG002|NOT COMPLETED|Overall Study||2
11266048|NCT02290925|12461753|FG000|STARTED|First Period of Three Months||62
11266049|NCT02290925|12461754|FG001|STARTED|First Period of Three Months||71
11266050|NCT02290925|12461753|FG000|COMPLETED|First Period of Three Months||58
11266051|NCT02290925|12461754|FG001|COMPLETED|First Period of Three Months||69
11266052|NCT02290925|12461753|FG000|NOT COMPLETED|First Period of Three Months||4
11266053|NCT02290925|12461754|FG001|NOT COMPLETED|First Period of Three Months||2
11266054|NCT02290925|12461753|FG000|STARTED|Second Period of 3 Months||58
11266055|NCT02290925|12461754|FG001|STARTED|Second Period of 3 Months||69
11266056|NCT02290925|12461753|FG000|COMPLETED|Second Period of 3 Months||57
11266057|NCT02290925|12461754|FG001|COMPLETED|Second Period of 3 Months||65
11266058|NCT02290925|12461753|FG000|NOT COMPLETED|Second Period of 3 Months||1
11266059|NCT02290925|12461754|FG001|NOT COMPLETED|Second Period of 3 Months||4
11266060|NCT02291016|12461764|FG000|STARTED|Visit 1||2
11266061|NCT02291016|12461765|FG001|STARTED|Visit 1||5
11266062|NCT02291016|12461764|FG000|COMPLETED|Visit 1||2
11266063|NCT02291016|12461765|FG001|COMPLETED|Visit 1||5
11266064|NCT02291016|12461764|FG000|NOT COMPLETED|Visit 1||0
11266065|NCT02291016|12461765|FG001|NOT COMPLETED|Visit 1||0
11266066|NCT02291016|12461764|FG000|STARTED|Visit 2||2
11266067|NCT02291016|12461765|FG001|STARTED|Visit 2||5
11266068|NCT02291016|12461764|FG000|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1
11266069|NCT02291016|12461765|FG001|COMPLETED|Visit 2||5
11266070|NCT02291016|12461764|FG000|NOT COMPLETED|Visit 2||1
11266071|NCT02291016|12461765|FG001|NOT COMPLETED|Visit 2||0
11266072|NCT02291029|12461778|FG000|STARTED|Overall Study||8
11266073|NCT02291029|12461779|FG001|STARTED|Overall Study||4
11266074|NCT02291029|12461780|FG002|STARTED|Overall Study||21
11266075|NCT02291029|12461781|FG003|STARTED|Overall Study||11
11266076|NCT02291029|12461782|FG004|STARTED|Overall Study||13
11266077|NCT02291029|12461783|FG005|STARTED|Overall Study||12
11266078|NCT02291029|12461778|FG000|COMPLETED|Overall Study||8
11266079|NCT02291029|12461779|FG001|COMPLETED|Overall Study||3
11266080|NCT02291029|12461780|FG002|COMPLETED|Overall Study||20
11266081|NCT02291029|12461781|FG003|COMPLETED|Overall Study||11
11266082|NCT02291029|12461782|FG004|COMPLETED|Overall Study||13
11266083|NCT02291029|12461783|FG005|COMPLETED|Overall Study||12
11266084|NCT02291029|12461778|FG000|NOT COMPLETED|Overall Study||0
11266085|NCT02291029|12461779|FG001|NOT COMPLETED|Overall Study||1
11266086|NCT02291029|12461780|FG002|NOT COMPLETED|Overall Study||1
11266087|NCT02291029|12461781|FG003|NOT COMPLETED|Overall Study||0
11266088|NCT02291029|12461782|FG004|NOT COMPLETED|Overall Study||0
11266089|NCT02291029|12461783|FG005|NOT COMPLETED|Overall Study||0
11266090|NCT02291133|12461797|FG000|STARTED|Overall Study||25
11266091|NCT02291133|12461797|FG000|COMPLETED|Overall Study||24
11266092|NCT02291133|12461797|FG000|NOT COMPLETED|Overall Study||1
11396986|NCT03984812|12591001|FG009|STARTED|Part 1 (Up to Day 28)||0
11396987|NCT03984812|12591002|FG010|STARTED|Part 1 (Up to Day 28)||0
11396988|NCT03984812|12590992|FG000|COMPLETED|Part 1 (Up to Day 28)||6
11266093|NCT02291237|12461803|FG000|STARTED|Overall Study||86
11266094|NCT02291237|12461804|FG001|STARTED|Overall Study||86
11266095|NCT02291237|12461803|FG000|COMPLETED|Overall Study||0
11266096|NCT02291237|12461804|FG001|COMPLETED|Overall Study||0
11266097|NCT02291237|12461803|FG000|NOT COMPLETED|Overall Study||86
11266098|NCT02291237|12461804|FG001|NOT COMPLETED|Overall Study||86
11266099|NCT02291289|12461814|FG000|STARTED|Induction Treatment||60
11266100|NCT02291289|12461815|FG001|STARTED|Induction Treatment||0
11266101|NCT02291289|12461816|FG002|STARTED|Induction Treatment||0
11266102|NCT02291289|12461817|FG003|STARTED|Induction Treatment||445
11266103|NCT02291289|12461818|FG004|STARTED|Induction Treatment||0
11266104|NCT02291289|12461819|FG005|STARTED|Induction Treatment||0
11266105|NCT02291289|12461820|FG006|STARTED|Induction Treatment||5
11396989|NCT03984812|12590993|FG001|COMPLETED|Part 1 (Up to Day 28)||6
11396990|NCT03984812|12590994|FG002|COMPLETED|Part 1 (Up to Day 28)||5
11396991|NCT03984812|12590995|FG003|COMPLETED|Part 1 (Up to Day 28)||6
11266106|NCT02291289|12461821|FG007|STARTED|Induction Treatment||0
11266107|NCT02291289|12461822|FG008|STARTED|Induction Treatment||0
11266108|NCT02291289|12461823|FG009|STARTED|Induction Treatment||99
11266109|NCT02291289|12461824|FG010|STARTED|Induction Treatment||0
11021560|NCT00804986|12199647|FG003|NOT COMPLETED|Overall Study||8
11021561|NCT00804986|12199648|FG004|NOT COMPLETED|Overall Study||9
11021562|NCT00804986|12199649|FG005|NOT COMPLETED|Overall Study||10
11021563|NCT00804999|12199667|FG000|STARTED|Overall Study||15
11021564|NCT00804999|12199668|FG001|STARTED|Overall Study||12
11266110|NCT02291289|12461825|FG011|STARTED|Induction Treatment||0
11266111|NCT02291289|12461814|FG000|COMPLETED|Induction Treatment||58
11266112|NCT02291289|12461815|FG001|COMPLETED|Induction Treatment||0
11266113|NCT02291289|12461816|FG002|COMPLETED|Induction Treatment||0
11266114|NCT02291289|12461817|FG003|COMPLETED|Induction Treatment||436
11266115|NCT02291289|12461818|FG004|COMPLETED|Induction Treatment||0
11266116|NCT02291289|12461819|FG005|COMPLETED|Induction Treatment||0
11266117|NCT02291289|12461820|FG006|COMPLETED|Induction Treatment||5
11266118|NCT02291289|12461821|FG007|COMPLETED|Induction Treatment||0
11266119|NCT02291289|12461822|FG008|COMPLETED|Induction Treatment||0
11266120|NCT02291289|12461823|FG009|COMPLETED|Induction Treatment||98
11266121|NCT02291289|12461824|FG010|COMPLETED|Induction Treatment||0
11396992|NCT03984812|12590996|FG004|COMPLETED|Part 1 (Up to Day 28)||0
11396993|NCT03984812|12590997|FG005|COMPLETED|Part 1 (Up to Day 28)||0
11396994|NCT03984812|12590998|FG006|COMPLETED|Part 1 (Up to Day 28)||0
11266122|NCT02291289|12461825|FG011|COMPLETED|Induction Treatment||0
11266123|NCT02291289|12461814|FG000|NOT COMPLETED|Induction Treatment||2
11266124|NCT02291289|12461815|FG001|NOT COMPLETED|Induction Treatment||0
11266125|NCT02291289|12461816|FG002|NOT COMPLETED|Induction Treatment||0
11266126|NCT02291289|12461817|FG003|NOT COMPLETED|Induction Treatment||9
11266127|NCT02291289|12461818|FG004|NOT COMPLETED|Induction Treatment||0
11266128|NCT02291289|12461819|FG005|NOT COMPLETED|Induction Treatment||0
11266129|NCT02291289|12461820|FG006|NOT COMPLETED|Induction Treatment||0
11266130|NCT02291289|12461821|FG007|NOT COMPLETED|Induction Treatment||0
11266131|NCT02291289|12461822|FG008|NOT COMPLETED|Induction Treatment||0
11266132|NCT02291289|12461823|FG009|NOT COMPLETED|Induction Treatment||1
11266133|NCT02291289|12461824|FG010|NOT COMPLETED|Induction Treatment||0
11266134|NCT02291289|12461825|FG011|NOT COMPLETED|Induction Treatment||0
11266135|NCT02291289|12461814|FG000|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
11266136|NCT02291289|12461815|FG001|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|40
11266137|NCT02291289|12461816|FG002|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|20
11266138|NCT02291289|12461817|FG003|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
11266139|NCT02291289|12461818|FG004|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|297
11021565|NCT00804999|12199669|FG002|STARTED|Overall Study||14
11266140|NCT02291289|12461819|FG005|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|148
11266141|NCT02291289|12461820|FG006|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
11266142|NCT02291289|12461821|FG007|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|3
11266143|NCT02291289|12461822|FG008|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|2
11266144|NCT02291289|12461823|FG009|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
11266145|NCT02291289|12461824|FG010|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|65
11396995|NCT03984812|12590999|FG007|COMPLETED|Part 1 (Up to Day 28)||0
11266146|NCT02291289|12461825|FG011|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|34
11266147|NCT02291289|12461814|FG000|Dosed|Maintenance Treatment Phase||0
11266148|NCT02291289|12461815|FG001|Dosed|Maintenance Treatment Phase||40
11266149|NCT02291289|12461816|FG002|Dosed|Maintenance Treatment Phase||18
11266150|NCT02291289|12461817|FG003|Dosed|Maintenance Treatment Phase||0
11266151|NCT02291289|12461818|FG004|Dosed|Maintenance Treatment Phase||293
11266152|NCT02291289|12461819|FG005|Dosed|Maintenance Treatment Phase||143
11266153|NCT02291289|12461820|FG006|Dosed|Maintenance Treatment Phase||0
11266154|NCT02291289|12461821|FG007|Dosed|Maintenance Treatment Phase||3
11266155|NCT02291289|12461822|FG008|Dosed|Maintenance Treatment Phase||2
11266156|NCT02291289|12461823|FG009|Dosed|Maintenance Treatment Phase||0
11266157|NCT02291289|12461824|FG010|Dosed|Maintenance Treatment Phase||64
11266158|NCT02291289|12461825|FG011|Dosed|Maintenance Treatment Phase||34
11266159|NCT02291289|12461814|FG000|COMPLETED|Maintenance Treatment Phase||0
11266160|NCT02291289|12461815|FG001|COMPLETED|Maintenance Treatment Phase||16
11266161|NCT02291289|12461816|FG002|COMPLETED|Maintenance Treatment Phase||4
11266162|NCT02291289|12461817|FG003|COMPLETED|Maintenance Treatment Phase||0
11266163|NCT02291289|12461818|FG004|COMPLETED|Maintenance Treatment Phase||45
11266164|NCT02291289|12461819|FG005|COMPLETED|Maintenance Treatment Phase||19
11266165|NCT02291289|12461820|FG006|COMPLETED|Maintenance Treatment Phase||0
11266166|NCT02291289|12461821|FG007|COMPLETED|Maintenance Treatment Phase||1
11266167|NCT02291289|12461822|FG008|COMPLETED|Maintenance Treatment Phase||0
11266168|NCT02291289|12461823|FG009|COMPLETED|Maintenance Treatment Phase||0
11266169|NCT02291289|12461824|FG010|COMPLETED|Maintenance Treatment Phase||34
11266170|NCT02291289|12461825|FG011|COMPLETED|Maintenance Treatment Phase||18
11266171|NCT02291289|12461814|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
11266172|NCT02291289|12461815|FG001|NOT COMPLETED|Maintenance Treatment Phase||24
11266173|NCT02291289|12461816|FG002|NOT COMPLETED|Maintenance Treatment Phase||16
11266174|NCT02291289|12461817|FG003|NOT COMPLETED|Maintenance Treatment Phase||0
11266175|NCT02291289|12461818|FG004|NOT COMPLETED|Maintenance Treatment Phase||252
11266176|NCT02291289|12461819|FG005|NOT COMPLETED|Maintenance Treatment Phase||129
11266177|NCT02291289|12461820|FG006|NOT COMPLETED|Maintenance Treatment Phase||0
11266178|NCT02291289|12461821|FG007|NOT COMPLETED|Maintenance Treatment Phase||2
11266179|NCT02291289|12461822|FG008|NOT COMPLETED|Maintenance Treatment Phase||2
11266180|NCT02291289|12461823|FG009|NOT COMPLETED|Maintenance Treatment Phase||0
11266181|NCT02291289|12461824|FG010|NOT COMPLETED|Maintenance Treatment Phase||31
11266182|NCT02291289|12461825|FG011|NOT COMPLETED|Maintenance Treatment Phase||16
11266183|NCT02291302|12461854|FG000|STARTED|Overall Study||59
11266184|NCT02291302|12461855|FG001|STARTED|Overall Study||59
11266185|NCT02291302|12461856|FG002|STARTED|Overall Study||59
11266186|NCT02291302|12461857|FG003|STARTED|Overall Study||59
11266187|NCT02291302|12461854|FG000|COMPLETED|Overall Study||59
11266188|NCT02291302|12461855|FG001|COMPLETED|Overall Study||59
11266189|NCT02291302|12461856|FG002|COMPLETED|Overall Study||59
11266190|NCT02291302|12461857|FG003|COMPLETED|Overall Study||59
11266191|NCT02291302|12461854|FG000|NOT COMPLETED|Overall Study||0
11266192|NCT02291302|12461855|FG001|NOT COMPLETED|Overall Study||0
11266193|NCT02291302|12461856|FG002|NOT COMPLETED|Overall Study||0
11266194|NCT02291302|12461857|FG003|NOT COMPLETED|Overall Study||0
11266195|NCT02291419|12461869|FG000|STARTED|Overall Study||1
11266196|NCT02291419|12461870|FG001|STARTED|Overall Study||5
11266197|NCT02291419|12461869|FG000|COMPLETED|Overall Study||0
11266198|NCT02291419|12461870|FG001|COMPLETED|Overall Study||0
11266199|NCT02291419|12461869|FG000|NOT COMPLETED|Overall Study||1
11266200|NCT02291419|12461870|FG001|NOT COMPLETED|Overall Study||5
11266201|NCT02291432|12461876|FG000|STARTED|Overall Study||25
11266202|NCT02291432|12461876|FG000|Muscle Biopsy|Overall Study||25
11266203|NCT02291432|12461876|FG000|AMDC Injection|Overall Study||23
11266204|NCT02291432|12461876|FG000|1-Month Follow Up|Overall Study||23
11266205|NCT02291432|12461876|FG000|3-Month Follow Up|Overall Study||23
11266206|NCT02291432|12461876|FG000|6-Month Follow Up|Overall Study||23
11266207|NCT02291432|12461876|FG000|12-Month Follow Up|Overall Study||23
11266208|NCT02291432|12461876|FG000|COMPLETED|Overall Study||23
11266209|NCT02291432|12461876|FG000|NOT COMPLETED|Overall Study||2
11266210|NCT02291510|12461884|FG000|STARTED|Overall Study||5
11266211|NCT02291510|12461885|FG001|STARTED|Overall Study||5
11266212|NCT02291510|12461886|FG002|STARTED|Overall Study||5
11266213|NCT02291510|12461887|FG003|STARTED|Overall Study||5
11266214|NCT02291510|12461884|FG000|Completed Treatment A|Overall Study||5
11266215|NCT02291510|12461885|FG001|Completed Treatment A|Overall Study||5
11266216|NCT02291510|12461886|FG002|Completed Treatment A|Overall Study||5
11266217|NCT02291510|12461887|FG003|Completed Treatment A|Overall Study||5
11266218|NCT02291510|12461884|FG000|Completed Treatment B|Overall Study||5
11266219|NCT02291510|12461885|FG001|Completed Treatment B|Overall Study||5
11266220|NCT02291510|12461886|FG002|Completed Treatment B|Overall Study||5
11266221|NCT02291510|12461887|FG003|Completed Treatment B|Overall Study||4
11266222|NCT02291510|12461884|FG000|Completed Treatment C|Overall Study||5
11266223|NCT02291510|12461885|FG001|Completed Treatment C|Overall Study||5
11266224|NCT02291510|12461886|FG002|Completed Treatment C|Overall Study||5
11266225|NCT02291510|12461887|FG003|Completed Treatment C|Overall Study||4
11266226|NCT02291510|12461884|FG000|Completed Treatment D|Overall Study||5
11266227|NCT02291510|12461885|FG001|Completed Treatment D|Overall Study||5
11266228|NCT02291510|12461886|FG002|Completed Treatment D|Overall Study||5
11266229|NCT02291510|12461887|FG003|Completed Treatment D|Overall Study||5
11266230|NCT02291510|12461884|FG000|COMPLETED|Overall Study||5
11266231|NCT02291510|12461885|FG001|COMPLETED|Overall Study||5
11266232|NCT02291510|12461886|FG002|COMPLETED|Overall Study||5
11266233|NCT02291510|12461887|FG003|COMPLETED|Overall Study||4
11266234|NCT02291510|12461884|FG000|NOT COMPLETED|Overall Study||0
11266235|NCT02291510|12461885|FG001|NOT COMPLETED|Overall Study||0
11266236|NCT02291510|12461886|FG002|NOT COMPLETED|Overall Study||0
11266237|NCT02291510|12461887|FG003|NOT COMPLETED|Overall Study||1
11266238|NCT02291549|12461899|FG000|STARTED|Overall Study||201
11266239|NCT02291549|12461900|FG001|STARTED|Overall Study||99
11266240|NCT02291549|12461899|FG000|COMPLETED|Overall Study||200
11266241|NCT02291549|12461900|FG001|COMPLETED|Overall Study||98
11266242|NCT02291549|12461899|FG000|NOT COMPLETED|Overall Study||1
11266243|NCT02291549|12461900|FG001|NOT COMPLETED|Overall Study||1
11266244|NCT02291601|12461908|FG000|STARTED|Abdomen||638
11266245|NCT02291601|12461909|FG001|STARTED|Abdomen||108
11266246|NCT02291601|12461910|FG002|STARTED|Abdomen||642
11266247|NCT02291601|12461908|FG000|COMPLETED|Abdomen|638 participants received CHG cloth|305
11266248|NCT02291601|12461909|FG001|COMPLETED|Abdomen|108 participants received vehicle|54
11266249|NCT02291601|12461910|FG002|COMPLETED|Abdomen|642 participants received comparator CHG|303
11266250|NCT02291601|12461908|FG000|NOT COMPLETED|Abdomen||333
11266251|NCT02291601|12461909|FG001|NOT COMPLETED|Abdomen||54
11266252|NCT02291601|12461910|FG002|NOT COMPLETED|Abdomen||339
11266253|NCT02291601|12461908|FG000|STARTED|Groin||520
11266254|NCT02291601|12461909|FG001|STARTED|Groin||93
11266255|NCT02291601|12461910|FG002|STARTED|Groin||515
11266256|NCT02291601|12461908|FG000|COMPLETED|Groin|520 participants received CHG cloth|337
11266257|NCT02291601|12461909|FG001|COMPLETED|Groin|93 participants received vehicle|63
11266258|NCT02291601|12461910|FG002|COMPLETED|Groin|515 participants received Comparator CHG|338
11266259|NCT02291601|12461908|FG000|NOT COMPLETED|Groin||183
11266260|NCT02291601|12461909|FG001|NOT COMPLETED|Groin||30
11266261|NCT02291601|12461910|FG002|NOT COMPLETED|Groin||177
11266262|NCT02291614|12461932|FG000|STARTED|Overall Study||3
11266263|NCT02291614|12461933|FG001|STARTED|Overall Study||3
11266264|NCT02291614|12461934|FG002|STARTED|Overall Study||3
11266265|NCT02291614|12461935|FG003|STARTED|Overall Study||5
11266266|NCT02291614|12461936|FG004|STARTED|Overall Study||3
11266267|NCT02291614|12461937|FG005|STARTED|Overall Study||3
11266268|NCT02291614|12461938|FG006|STARTED|Overall Study||6
11266269|NCT02291614|12461939|FG007|STARTED|Overall Study||3
11266270|NCT02291614|12461940|FG008|STARTED|Overall Study||3
11266271|NCT02291614|12461941|FG009|STARTED|Overall Study||11
11266272|NCT02291614|12461942|FG010|STARTED|Overall Study||2
11266273|NCT02291614|12461932|FG000|Received AMG 211|Overall Study||3
11266274|NCT02291614|12461933|FG001|Received AMG 211|Overall Study||3
11266275|NCT02291614|12461934|FG002|Received AMG 211|Overall Study||3
11266276|NCT02291614|12461935|FG003|Received AMG 211|Overall Study||5
11266277|NCT02291614|12461936|FG004|Received AMG 211|Overall Study||3
11266278|NCT02291614|12461937|FG005|Received AMG 211|Overall Study||3
11266279|NCT02291614|12461938|FG006|Received AMG 211|Overall Study||6
11266280|NCT02291614|12461939|FG007|Received AMG 211|Overall Study||3
11266281|NCT02291614|12461940|FG008|Received AMG 211|Overall Study||3
11266282|NCT02291614|12461941|FG009|Received AMG 211|Overall Study||10
11266283|NCT02291614|12461942|FG010|Received AMG 211|Overall Study||2
11266284|NCT02291614|12461932|FG000|COMPLETED|Overall Study||3
11266285|NCT02291614|12461933|FG001|COMPLETED|Overall Study||2
11266286|NCT02291614|12461934|FG002|COMPLETED|Overall Study||2
11266287|NCT02291614|12461935|FG003|COMPLETED|Overall Study||4
11266288|NCT02291614|12461936|FG004|COMPLETED|Overall Study||2
11266289|NCT02291614|12461937|FG005|COMPLETED|Overall Study||2
11266290|NCT02291614|12461938|FG006|COMPLETED|Overall Study||5
11266291|NCT02291614|12461939|FG007|COMPLETED|Overall Study||2
11266292|NCT02291614|12461940|FG008|COMPLETED|Overall Study||3
11266293|NCT02291614|12461941|FG009|COMPLETED|Overall Study||9
11266294|NCT02291614|12461942|FG010|COMPLETED|Overall Study||0
11266295|NCT02291614|12461932|FG000|NOT COMPLETED|Overall Study||0
11266296|NCT02291614|12461933|FG001|NOT COMPLETED|Overall Study||1
11266297|NCT02291614|12461934|FG002|NOT COMPLETED|Overall Study||1
11266298|NCT02291614|12461935|FG003|NOT COMPLETED|Overall Study||1
11266299|NCT02291614|12461936|FG004|NOT COMPLETED|Overall Study||1
11396996|NCT03984812|12591000|FG008|COMPLETED|Part 1 (Up to Day 28)||0
11396997|NCT03984812|12591001|FG009|COMPLETED|Part 1 (Up to Day 28)||0
11396998|NCT03984812|12591002|FG010|COMPLETED|Part 1 (Up to Day 28)||0
11396999|NCT03984812|12590992|FG000|NOT COMPLETED|Part 1 (Up to Day 28)||0
11397000|NCT03984812|12590993|FG001|NOT COMPLETED|Part 1 (Up to Day 28)||0
11397001|NCT03984812|12590994|FG002|NOT COMPLETED|Part 1 (Up to Day 28)||1
11397002|NCT03984812|12590995|FG003|NOT COMPLETED|Part 1 (Up to Day 28)||0
11266300|NCT02291614|12461937|FG005|NOT COMPLETED|Overall Study||1
11266301|NCT02291614|12461938|FG006|NOT COMPLETED|Overall Study||1
11397003|NCT03984812|12590996|FG004|NOT COMPLETED|Part 1 (Up to Day 28)||0
11266302|NCT02291614|12461939|FG007|NOT COMPLETED|Overall Study||1
11266303|NCT02291614|12461940|FG008|NOT COMPLETED|Overall Study||0
11266304|NCT02291614|12461941|FG009|NOT COMPLETED|Overall Study||2
11266305|NCT02291614|12461942|FG010|NOT COMPLETED|Overall Study||2
11266306|NCT02291679|12461975|FG000|STARTED|Overall Study||401
11266307|NCT02291679|12461976|FG001|STARTED|Overall Study||411
11397004|NCT03984812|12590997|FG005|NOT COMPLETED|Part 1 (Up to Day 28)||0
11266308|NCT02291679|12461977|FG002|STARTED|Overall Study||411
11266309|NCT02291679|12461975|FG000|COMPLETED|Overall Study||357
11266310|NCT02291679|12461976|FG001|COMPLETED|Overall Study||369
11266311|NCT02291679|12461977|FG002|COMPLETED|Overall Study||352
11266312|NCT02291679|12461975|FG000|NOT COMPLETED|Overall Study||44
11266313|NCT02291679|12461976|FG001|NOT COMPLETED|Overall Study||42
11266314|NCT02291679|12461977|FG002|NOT COMPLETED|Overall Study||59
11266315|NCT02291718|12461987|FG000|STARTED|Overall Study||50
11266316|NCT02291718|12461988|FG001|STARTED|Overall Study||50
11266317|NCT02291718|12461989|FG002|STARTED|Overall Study||50
11266318|NCT02291718|12461987|FG000|COMPLETED|Overall Study||50
11266319|NCT02291718|12461988|FG001|COMPLETED|Overall Study||50
11266320|NCT02291718|12461989|FG002|COMPLETED|Overall Study||50
11266321|NCT02291718|12461987|FG000|NOT COMPLETED|Overall Study||0
11266322|NCT02291718|12461988|FG001|NOT COMPLETED|Overall Study||0
11266323|NCT02291718|12461989|FG002|NOT COMPLETED|Overall Study||0
11266324|NCT02291861|12462001|FG000|STARTED|Overall Study||74
11266325|NCT02291861|12462002|FG001|STARTED|Overall Study||75
11266326|NCT02291861|12462003|FG002|STARTED|Overall Study||74
11266327|NCT02291861|12462004|FG003|STARTED|Overall Study||75
11266328|NCT02291861|12462001|FG000|Safety Population|Overall Study||72
11266329|NCT02291861|12462002|FG001|Safety Population|Overall Study||74
11266330|NCT02291861|12462003|FG002|Safety Population|Overall Study||73
11266331|NCT02291861|12462004|FG003|Safety Population|Overall Study||74
11266332|NCT02291861|12462001|FG000|Modified Intent to Treat Pop (mITT)|Overall Study||58
11266333|NCT02291861|12462002|FG001|Modified Intent to Treat Pop (mITT)|Overall Study||60
11266334|NCT02291861|12462003|FG002|Modified Intent to Treat Pop (mITT)|Overall Study||49
11266335|NCT02291861|12462004|FG003|Modified Intent to Treat Pop (mITT)|Overall Study||55
11266336|NCT02291861|12462001|FG000|COMPLETED|Overall Study||67
11266337|NCT02291861|12462002|FG001|COMPLETED|Overall Study||67
11266338|NCT02291861|12462003|FG002|COMPLETED|Overall Study||65
11266339|NCT02291861|12462004|FG003|COMPLETED|Overall Study||65
11266340|NCT02291861|12462001|FG000|NOT COMPLETED|Overall Study||7
11266341|NCT02291861|12462002|FG001|NOT COMPLETED|Overall Study||8
11266342|NCT02291861|12462003|FG002|NOT COMPLETED|Overall Study||9
11266343|NCT02291861|12462004|FG003|NOT COMPLETED|Overall Study||10
11266344|NCT02291913|12462014|FG000|STARTED|Overall Study||48
11266345|NCT02291913|12462014|FG000|COMPLETED|Overall Study||0
11266346|NCT02291913|12462014|FG000|NOT COMPLETED|Overall Study||48
11266347|NCT02292082|12462020|FG000|STARTED|Overall Study||56
11266348|NCT02292082|12462021|FG001|STARTED|Overall Study||55
11266349|NCT02292082|12462020|FG000|COMPLETED|Overall Study||56
11397005|NCT03984812|12590998|FG006|NOT COMPLETED|Part 1 (Up to Day 28)||0
11397006|NCT03984812|12590999|FG007|NOT COMPLETED|Part 1 (Up to Day 28)||0
11397007|NCT03984812|12591000|FG008|NOT COMPLETED|Part 1 (Up to Day 28)||0
11397008|NCT03984812|12591001|FG009|NOT COMPLETED|Part 1 (Up to Day 28)||0
11397009|NCT03984812|12591002|FG010|NOT COMPLETED|Part 1 (Up to Day 28)||0
11397010|NCT03984812|12590992|FG000|STARTED|Part 2 (Up to Day 49)||0
11397011|NCT03984812|12590993|FG001|STARTED|Part 2 (Up to Day 49)||0
11397012|NCT03984812|12590994|FG002|STARTED|Part 2 (Up to Day 49)||0
11397013|NCT03984812|12590995|FG003|STARTED|Part 2 (Up to Day 49)||0
11397014|NCT03984812|12590996|FG004|STARTED|Part 2 (Up to Day 49)||0
11397015|NCT03984812|12590997|FG005|STARTED|Part 2 (Up to Day 49)||0
11397016|NCT03984812|12590998|FG006|STARTED|Part 2 (Up to Day 49)||0
11397017|NCT03984812|12590999|FG007|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
11397018|NCT03984812|12591000|FG008|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
11397019|NCT03984812|12591001|FG009|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
11397020|NCT03984812|12591002|FG010|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
11397021|NCT03984812|12590992|FG000|COMPLETED|Part 2 (Up to Day 49)||0
11397022|NCT03984812|12590993|FG001|COMPLETED|Part 2 (Up to Day 49)||0
11397023|NCT03984812|12590994|FG002|COMPLETED|Part 2 (Up to Day 49)||0
11397024|NCT03984812|12590995|FG003|COMPLETED|Part 2 (Up to Day 49)||0
11397025|NCT03984812|12590996|FG004|COMPLETED|Part 2 (Up to Day 49)||0
11397026|NCT03984812|12590997|FG005|COMPLETED|Part 2 (Up to Day 49)||0
11397027|NCT03984812|12590998|FG006|COMPLETED|Part 2 (Up to Day 49)||0
11397028|NCT03984812|12590999|FG007|COMPLETED|Part 2 (Up to Day 49)||0
11266350|NCT02292082|12462021|FG001|COMPLETED|Overall Study||55
11266351|NCT02292082|12462020|FG000|NOT COMPLETED|Overall Study||0
11266352|NCT02292082|12462021|FG001|NOT COMPLETED|Overall Study||0
11266353|NCT02292186|12462027|FG000|STARTED|Overall Study||25
11266354|NCT02292186|12462027|FG000|COMPLETED|Overall Study||7
11266355|NCT02292186|12462027|FG000|NOT COMPLETED|Overall Study||18
11266356|NCT02292212|12462031|FG000|STARTED|Pre-ViE Phase||17
11266357|NCT02292212|12462031|FG000|COMPLETED|Pre-ViE Phase||17
11266358|NCT02292212|12462031|FG000|NOT COMPLETED|Pre-ViE Phase||0
11266359|NCT02292212|12462031|FG000|STARTED|ViE Phase||17
11266360|NCT02292212|12462031|FG000|COMPLETED|ViE Phase||14
11266361|NCT02292212|12462031|FG000|NOT COMPLETED|ViE Phase||3
11397029|NCT03984812|12591000|FG008|COMPLETED|Part 2 (Up to Day 49)||0
11397030|NCT03984812|12591001|FG009|COMPLETED|Part 2 (Up to Day 49)||0
11397031|NCT03984812|12591002|FG010|COMPLETED|Part 2 (Up to Day 49)||0
11397032|NCT03984812|12590992|FG000|NOT COMPLETED|Part 2 (Up to Day 49)||0
11397033|NCT03984812|12590993|FG001|NOT COMPLETED|Part 2 (Up to Day 49)||0
11397034|NCT03984812|12590994|FG002|NOT COMPLETED|Part 2 (Up to Day 49)||0
11397035|NCT03984812|12590995|FG003|NOT COMPLETED|Part 2 (Up to Day 49)||0
11397036|NCT03984812|12590996|FG004|NOT COMPLETED|Part 2 (Up to Day 49)||0
11397037|NCT03984812|12590997|FG005|NOT COMPLETED|Part 2 (Up to Day 49)||0
11397038|NCT03984812|12590998|FG006|NOT COMPLETED|Part 2 (Up to Day 49)||0
11397039|NCT03984812|12590999|FG007|NOT COMPLETED|Part 2 (Up to Day 49)||0
11397040|NCT03984812|12591000|FG008|NOT COMPLETED|Part 2 (Up to Day 49)||0
11397041|NCT03984812|12591001|FG009|NOT COMPLETED|Part 2 (Up to Day 49)||0
11397042|NCT03984812|12591002|FG010|NOT COMPLETED|Part 2 (Up to Day 49)||0
11397043|NCT03998163|12591029|FG000|STARTED|Overall Study||222
11397044|NCT03998163|12591029|FG000|COMPLETED|Overall Study||197
11397045|NCT03998163|12591029|FG000|NOT COMPLETED|Overall Study||25
11397046|NCT04000373|12591033|FG000|STARTED|Overall Study||5
11397047|NCT04000373|12591033|FG000|COMPLETED|Overall Study||5
11397048|NCT04000373|12591033|FG000|NOT COMPLETED|Overall Study||0
11397049|NCT04001517|12591040|FG000|STARTED|Overall Study||20
11397050|NCT04001517|12591041|FG001|STARTED|Overall Study||26
11397051|NCT04001517|12591042|FG002|STARTED|Overall Study||27
11397052|NCT04001517|12591043|FG003|STARTED|Overall Study||18
11397053|NCT04001517|12591040|FG000|COMPLETED|Overall Study||20
11397054|NCT04001517|12591041|FG001|COMPLETED|Overall Study||20
11397055|NCT04001517|12591042|FG002|COMPLETED|Overall Study||26
11397056|NCT04001517|12591043|FG003|COMPLETED|Overall Study||15
11397057|NCT04001517|12591040|FG000|NOT COMPLETED|Overall Study||0
11397058|NCT04001517|12591041|FG001|NOT COMPLETED|Overall Study||6
11397059|NCT04001517|12591042|FG002|NOT COMPLETED|Overall Study||1
11397060|NCT04001517|12591043|FG003|NOT COMPLETED|Overall Study||3
11397061|NCT04006171|12591056|FG000|STARTED|Overall Study||48
11397062|NCT04006171|12591057|FG001|STARTED|Overall Study||42
11397063|NCT04006171|12591056|FG000|COMPLETED|Overall Study||36
11397064|NCT04006171|12591057|FG001|COMPLETED|Overall Study||30
11397065|NCT04006171|12591056|FG000|NOT COMPLETED|Overall Study||12
11397066|NCT04006171|12591057|FG001|NOT COMPLETED|Overall Study||12
11397067|NCT04011436|12591066|FG000|STARTED|Overall Study||20
11397068|NCT04011436|12591067|FG001|STARTED|Overall Study||20
11397069|NCT04011436|12591066|FG000|COMPLETED|Overall Study||19
11397070|NCT04011436|12591067|FG001|COMPLETED|Overall Study||19
11397071|NCT04011436|12591066|FG000|NOT COMPLETED|Overall Study||1
11397072|NCT04011436|12591067|FG001|NOT COMPLETED|Overall Study||1
11397073|NCT04011592|12591075|FG000|STARTED|Overall Study||1
11397074|NCT04011592|12591076|FG001|STARTED|Overall Study||0
11397075|NCT04011592|12591075|FG000|COMPLETED|Overall Study||1
11397076|NCT04011592|12591076|FG001|COMPLETED|Overall Study||0
11397077|NCT04011592|12591075|FG000|NOT COMPLETED|Overall Study||0
11397078|NCT04011592|12591076|FG001|NOT COMPLETED|Overall Study||0
11397079|NCT04013529|12591084|FG000|STARTED|Overall Study||20
11397080|NCT04013529|12591085|FG001|STARTED|Overall Study||20
11397081|NCT04013529|12591084|FG000|COMPLETED|Overall Study||19
11397082|NCT04013529|12591085|FG001|COMPLETED|Overall Study||19
11397083|NCT04013529|12591084|FG000|NOT COMPLETED|Overall Study||1
11397084|NCT04013529|12591085|FG001|NOT COMPLETED|Overall Study||1
11397085|NCT04016324|12591091|FG000|STARTED|Overall Study||110
11397086|NCT04016324|12591091|FG000|COMPLETED|Overall Study||107
11397087|NCT04016324|12591091|FG000|NOT COMPLETED|Overall Study||3
11266362|NCT02292212|12462031|FG000|STARTED|Post-ViE Phase||14
11266363|NCT02292212|12462031|FG000|COMPLETED|Post-ViE Phase||14
11266364|NCT02292212|12462031|FG000|NOT COMPLETED|Post-ViE Phase||0
11266365|NCT02292433|12462045|FG000|STARTED|First Intervention Period (7 Days)||4
11266366|NCT02292433|12462046|FG001|STARTED|First Intervention Period (7 Days)||4
11266367|NCT02292433|12462047|FG002|STARTED|First Intervention Period (7 Days)||4
11266368|NCT02292433|12462045|FG000|COMPLETED|First Intervention Period (7 Days)||4
11266369|NCT02292433|12462046|FG001|COMPLETED|First Intervention Period (7 Days)||4
11266370|NCT02292433|12462047|FG002|COMPLETED|First Intervention Period (7 Days)||4
11266371|NCT02292433|12462045|FG000|NOT COMPLETED|First Intervention Period (7 Days)||0
11266372|NCT02292433|12462046|FG001|NOT COMPLETED|First Intervention Period (7 Days)||0
11266373|NCT02292433|12462047|FG002|NOT COMPLETED|First Intervention Period (7 Days)||0
11266374|NCT02292433|12462045|FG000|STARTED|First Washout Period (7 to 14 Days)||4
11266375|NCT02292433|12462046|FG001|STARTED|First Washout Period (7 to 14 Days)||4
11266376|NCT02292433|12462047|FG002|STARTED|First Washout Period (7 to 14 Days)||4
11266377|NCT02292433|12462045|FG000|COMPLETED|First Washout Period (7 to 14 Days)||4
11266378|NCT02292433|12462046|FG001|COMPLETED|First Washout Period (7 to 14 Days)||4
11266379|NCT02292433|12462047|FG002|COMPLETED|First Washout Period (7 to 14 Days)||4
11266380|NCT02292433|12462045|FG000|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
11397088|NCT04017910|12591096|FG000|STARTED|Overall Study||17
11266381|NCT02292433|12462046|FG001|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
11266382|NCT02292433|12462047|FG002|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
11266383|NCT02292433|12462045|FG000|STARTED|Second Intervention Period (7 Days)||4
11266384|NCT02292433|12462046|FG001|STARTED|Second Intervention Period (7 Days)||4
11266385|NCT02292433|12462047|FG002|STARTED|Second Intervention Period (7 Days)||4
11266386|NCT02292433|12462045|FG000|COMPLETED|Second Intervention Period (7 Days)||4
11266387|NCT02292433|12462046|FG001|COMPLETED|Second Intervention Period (7 Days)||4
11266388|NCT02292433|12462047|FG002|COMPLETED|Second Intervention Period (7 Days)||4
11266389|NCT02292433|12462045|FG000|NOT COMPLETED|Second Intervention Period (7 Days)||0
11266390|NCT02292433|12462046|FG001|NOT COMPLETED|Second Intervention Period (7 Days)||0
11266391|NCT02292433|12462047|FG002|NOT COMPLETED|Second Intervention Period (7 Days)||0
11266392|NCT02292433|12462045|FG000|STARTED|Second Washout Period (7 to 14 Days)||4
11266393|NCT02292433|12462046|FG001|STARTED|Second Washout Period (7 to 14 Days)||4
11266394|NCT02292433|12462047|FG002|STARTED|Second Washout Period (7 to 14 Days)||4
11266395|NCT02292433|12462045|FG000|COMPLETED|Second Washout Period (7 to 14 Days)||4
11266396|NCT02292433|12462046|FG001|COMPLETED|Second Washout Period (7 to 14 Days)||4
11266397|NCT02292433|12462047|FG002|COMPLETED|Second Washout Period (7 to 14 Days)||4
11266398|NCT02292433|12462045|FG000|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
11266399|NCT02292433|12462046|FG001|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
11266400|NCT02292433|12462047|FG002|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
11266401|NCT02292433|12462045|FG000|STARTED|Third Intervention Period (7 Days)||4
11266402|NCT02292433|12462046|FG001|STARTED|Third Intervention Period (7 Days)||4
11266403|NCT02292433|12462047|FG002|STARTED|Third Intervention Period (7 Days)||4
11266404|NCT02292433|12462045|FG000|COMPLETED|Third Intervention Period (7 Days)||4
11266405|NCT02292433|12462046|FG001|COMPLETED|Third Intervention Period (7 Days)||4
11266406|NCT02292433|12462047|FG002|COMPLETED|Third Intervention Period (7 Days)||4
11266407|NCT02292433|12462045|FG000|NOT COMPLETED|Third Intervention Period (7 Days)||0
11266408|NCT02292433|12462046|FG001|NOT COMPLETED|Third Intervention Period (7 Days)||0
11266409|NCT02292433|12462047|FG002|NOT COMPLETED|Third Intervention Period (7 Days)||0
11266410|NCT02292446|12462055|FG000|STARTED|Overall Study||161
11266411|NCT02292446|12462055|FG000|COMPLETED|Overall Study||141
11266412|NCT02292446|12462055|FG000|NOT COMPLETED|Overall Study||20
11266413|NCT02292537|12462064|FG000|STARTED|Overall Study||42
11266414|NCT02292537|12462065|FG001|STARTED|Overall Study||84
11266415|NCT02292537|12462064|FG000|Completed Treatment|Overall Study||42
11397089|NCT04017910|12591096|FG000|COMPLETED|Overall Study||17
11397090|NCT04017910|12591096|FG000|NOT COMPLETED|Overall Study||0
11397091|NCT04018066|12591100|FG000|STARTED|Overall Study|34 participants were enrolled in the study|34
11266416|NCT02292537|12462065|FG001|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
11266417|NCT02292537|12462064|FG000|COMPLETED|Overall Study||42
11266418|NCT02292537|12462065|FG001|COMPLETED|Overall Study||84
11266419|NCT02292537|12462064|FG000|NOT COMPLETED|Overall Study||0
11266420|NCT02292537|12462065|FG001|NOT COMPLETED|Overall Study||0
11266421|NCT02292719|12462077|FG000|STARTED|Overall Study||9
11266422|NCT02292719|12462078|FG001|STARTED|Overall Study||11
11266423|NCT02292719|12462079|FG002|STARTED|Overall Study||10
11266424|NCT02292719|12462080|FG003|STARTED|Overall Study||9
11266425|NCT02292719|12462081|FG004|STARTED|Overall Study||21
11266426|NCT02292719|12462082|FG005|STARTED|Overall Study||10
11266427|NCT02292719|12462077|FG000|COMPLETED|Overall Study||9
11266428|NCT02292719|12462078|FG001|COMPLETED|Overall Study||11
11266429|NCT02292719|12462079|FG002|COMPLETED|Overall Study||9
11266430|NCT02292719|12462080|FG003|COMPLETED|Overall Study||8
11266431|NCT02292719|12462081|FG004|COMPLETED|Overall Study||20
11266432|NCT02292719|12462082|FG005|COMPLETED|Overall Study||10
11266433|NCT02292719|12462077|FG000|NOT COMPLETED|Overall Study||0
11266434|NCT02292719|12462078|FG001|NOT COMPLETED|Overall Study||0
11266435|NCT02292719|12462079|FG002|NOT COMPLETED|Overall Study||1
11266436|NCT02292719|12462080|FG003|NOT COMPLETED|Overall Study||1
11266437|NCT02292719|12462081|FG004|NOT COMPLETED|Overall Study||1
11266438|NCT02292719|12462082|FG005|NOT COMPLETED|Overall Study||0
11266439|NCT02292771|12462098|FG000|STARTED|Overall Study||47
11266440|NCT02292771|12462099|FG001|STARTED|Overall Study||50
11266441|NCT02292771|12462098|FG000|COMPLETED|Overall Study||43
11266442|NCT02292771|12462099|FG001|COMPLETED|Overall Study||48
11397092|NCT04018066|12591100|FG000|COMPLETED|Overall Study|30 participants completed the study protocol.|30
11397093|NCT04018066|12591100|FG000|NOT COMPLETED|Overall Study||4
11397094|NCT04018794|12591105|FG000|STARTED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15
11397095|NCT04018794|12591105|FG000|COMPLETED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15
11397096|NCT04018794|12591105|FG000|NOT COMPLETED|Overall Study||0
11397097|NCT04032327|12591111|FG000|STARTED|Overall Study||60
11397098|NCT04032327|12591112|FG001|STARTED|Overall Study||60
11397099|NCT04032327|12591111|FG000|COMPLETED|Overall Study||60
11397100|NCT04032327|12591112|FG001|COMPLETED|Overall Study||60
11397101|NCT04032327|12591111|FG000|NOT COMPLETED|Overall Study||0
11397102|NCT04032327|12591112|FG001|NOT COMPLETED|Overall Study||0
11397103|NCT04033640|12591120|FG000|STARTED|Overall Study||1736
11397104|NCT04033640|12591121|FG001|STARTED|Overall Study||18
11397105|NCT04033640|12591120|FG000|COMPLETED|Overall Study||1736
11397106|NCT04033640|12591121|FG001|COMPLETED|Overall Study||18
11397107|NCT04033640|12591120|FG000|NOT COMPLETED|Overall Study||0
11397108|NCT04033640|12591121|FG001|NOT COMPLETED|Overall Study||0
11021566|NCT00804999|12199670|FG003|STARTED|Overall Study||10
11021567|NCT00804999|12199667|FG000|COMPLETED|Overall Study||15
11266443|NCT02292771|12462098|FG000|NOT COMPLETED|Overall Study||4
11397109|NCT04036292|12591130|FG000|STARTED|Overall Study||260
11397110|NCT04036292|12591131|FG001|STARTED|Overall Study||246
11397111|NCT04036292|12591132|FG002|STARTED|Overall Study||252
11397112|NCT04036292|12591130|FG000|COMPLETED|Overall Study||239
11397113|NCT04036292|12591131|FG001|COMPLETED|Overall Study||212
11397114|NCT04036292|12591132|FG002|COMPLETED|Overall Study||228
11397115|NCT04036292|12591130|FG000|NOT COMPLETED|Overall Study||21
11397116|NCT04036292|12591131|FG001|NOT COMPLETED|Overall Study||34
11266444|NCT02292771|12462099|FG001|NOT COMPLETED|Overall Study||2
11266445|NCT02292784|12462112|FG000|STARTED|Overall Study||5
11266446|NCT02292784|12462113|FG001|STARTED|Overall Study||44
11266447|NCT02292784|12462114|FG002|STARTED|Overall Study||49
11397117|NCT04036292|12591132|FG002|NOT COMPLETED|Overall Study||24
11397118|NCT04041440|12591145|FG000|STARTED|Overall Study||12
11397119|NCT04041440|12591146|FG001|STARTED|Overall Study||22
11397120|NCT04041440|12591145|FG000|COMPLETED|Overall Study||12
11266448|NCT02292784|12462112|FG000|COMPLETED|Overall Study||4
11266449|NCT02292784|12462113|FG001|COMPLETED|Overall Study||24
11266450|NCT02292784|12462114|FG002|COMPLETED|Overall Study||28
11266451|NCT02292784|12462112|FG000|NOT COMPLETED|Overall Study||1
11266452|NCT02292784|12462113|FG001|NOT COMPLETED|Overall Study||20
11266453|NCT02292784|12462114|FG002|NOT COMPLETED|Overall Study||21
11266454|NCT02292849|12462125|FG000|STARTED|Overall Study||11
11266455|NCT02292849|12462126|FG001|STARTED|Overall Study||8
11266456|NCT02292849|12462127|FG002|STARTED|Overall Study||10
11266457|NCT02292849|12462125|FG000|COMPLETED|Overall Study||7
11266458|NCT02292849|12462126|FG001|COMPLETED|Overall Study||6
11021568|NCT00804999|12199668|FG001|COMPLETED|Overall Study||12
11266459|NCT02292849|12462127|FG002|COMPLETED|Overall Study||8
11266460|NCT02292849|12462125|FG000|NOT COMPLETED|Overall Study||4
11266461|NCT02292849|12462126|FG001|NOT COMPLETED|Overall Study||2
11266462|NCT02292849|12462127|FG002|NOT COMPLETED|Overall Study||2
11266463|NCT02292927|12462137|FG000|STARTED|Overall Study||13
11266464|NCT02292927|12462138|FG001|STARTED|Overall Study||12
11266465|NCT02292927|12462137|FG000|COMPLETED|Overall Study||0
11266466|NCT02292927|12462138|FG001|COMPLETED|Overall Study||5
11266467|NCT02292927|12462137|FG000|NOT COMPLETED|Overall Study||13
11266468|NCT02292927|12462138|FG001|NOT COMPLETED|Overall Study||7
11266469|NCT02292940|12462149|FG000|STARTED|Overall Study||165477
11266470|NCT02292940|12462150|FG001|STARTED|Overall Study||3000
11266471|NCT02292940|12462149|FG000|COMPLETED|Overall Study||165477
11266472|NCT02292940|12462150|FG001|COMPLETED|Overall Study||1824
11266473|NCT02292940|12462149|FG000|NOT COMPLETED|Overall Study||0
11266474|NCT02292940|12462150|FG001|NOT COMPLETED|Overall Study||1176
11266475|NCT02293044|12462157|FG000|STARTED|Overall Study||15
11266476|NCT02293044|12462157|FG000|COMPLETED|Overall Study||15
11397121|NCT04041440|12591146|FG001|COMPLETED|Overall Study||20
11397122|NCT04041440|12591145|FG000|NOT COMPLETED|Overall Study||0
11397123|NCT04041440|12591146|FG001|NOT COMPLETED|Overall Study||2
11397124|NCT04041570|12591155|FG000|STARTED|Overall Study||20
11397125|NCT04041570|12591156|FG001|STARTED|Overall Study||20
11266477|NCT02293044|12462157|FG000|NOT COMPLETED|Overall Study||0
11266478|NCT02293096|12462161|FG000|STARTED|Overall Study||140
11266479|NCT02293096|12462161|FG000|COMPLETED|Overall Study||140
11266480|NCT02293096|12462161|FG000|NOT COMPLETED|Overall Study||0
11266481|NCT02293395|12462167|FG000|STARTED|Overall Study||1519
11266482|NCT02293395|12462168|FG001|STARTED|Overall Study||1518
11266483|NCT02293395|12462167|FG000|Treated|Overall Study||1510
11397126|NCT04041570|12591155|FG000|COMPLETED|Overall Study||20
11266484|NCT02293395|12462168|FG001|Treated|Overall Study||1506
11397127|NCT04041570|12591156|FG001|COMPLETED|Overall Study||18
11266485|NCT02293395|12462167|FG000|COMPLETED|Overall Study||1510
11266486|NCT02293395|12462168|FG001|COMPLETED|Overall Study||1511
11266487|NCT02293395|12462167|FG000|NOT COMPLETED|Overall Study||9
11266488|NCT02293395|12462168|FG001|NOT COMPLETED|Overall Study||7
11266489|NCT02293460|12462174|FG000|STARTED|Overall Study||43
11266490|NCT02293460|12462174|FG000|COMPLETED|Overall Study||37
11266491|NCT02293460|12462174|FG000|NOT COMPLETED|Overall Study||6
11266492|NCT02293499|12462181|FG000|STARTED|Baseline - Enrollment||152
11266493|NCT02293499|12462182|FG001|STARTED|Baseline - Enrollment||168
11266494|NCT02293499|12462183|FG002|STARTED|Baseline - Enrollment||51
11266495|NCT02293499|12462181|FG000|COMPLETED|Baseline - Enrollment||152
11397128|NCT04041570|12591155|FG000|NOT COMPLETED|Overall Study||0
11397129|NCT04041570|12591156|FG001|NOT COMPLETED|Overall Study||2
11397130|NCT04043143|12591165|FG000|STARTED|Overall Study||29
11397131|NCT04043143|12591166|FG001|STARTED|Overall Study||27
11397132|NCT04043143|12591165|FG000|COMPLETED|Overall Study||23
11266496|NCT02293499|12462182|FG001|COMPLETED|Baseline - Enrollment||168
11266497|NCT02293499|12462183|FG002|COMPLETED|Baseline - Enrollment||51
11266498|NCT02293499|12462181|FG000|NOT COMPLETED|Baseline - Enrollment||0
11266499|NCT02293499|12462182|FG001|NOT COMPLETED|Baseline - Enrollment||0
11266500|NCT02293499|12462183|FG002|NOT COMPLETED|Baseline - Enrollment||0
11266501|NCT02293499|12462181|FG000|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
11266502|NCT02293499|12462182|FG001|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
11266503|NCT02293499|12462183|FG002|STARTED|Training - Peer Leaders Only||51
11266504|NCT02293499|12462181|FG000|COMPLETED|Training - Peer Leaders Only||0
11266505|NCT02293499|12462182|FG001|COMPLETED|Training - Peer Leaders Only||0
11266506|NCT02293499|12462183|FG002|COMPLETED|Training - Peer Leaders Only||41
11266507|NCT02293499|12462181|FG000|NOT COMPLETED|Training - Peer Leaders Only||0
11266508|NCT02293499|12462182|FG001|NOT COMPLETED|Training - Peer Leaders Only||0
11266509|NCT02293499|12462183|FG002|NOT COMPLETED|Training - Peer Leaders Only||10
11266510|NCT02293499|12462181|FG000|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|152
11266511|NCT02293499|12462182|FG001|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|168
11397133|NCT04043143|12591166|FG001|COMPLETED|Overall Study||22
11266512|NCT02293499|12462183|FG002|STARTED|Intervention - Camp||41
11266513|NCT02293499|12462181|FG000|COMPLETED|Intervention - Camp||125
11266514|NCT02293499|12462182|FG001|COMPLETED|Intervention - Camp||134
11266515|NCT02293499|12462183|FG002|COMPLETED|Intervention - Camp||35
11266516|NCT02293499|12462181|FG000|NOT COMPLETED|Intervention - Camp||27
11266517|NCT02293499|12462182|FG001|NOT COMPLETED|Intervention - Camp||34
11266518|NCT02293499|12462183|FG002|NOT COMPLETED|Intervention - Camp||6
11266519|NCT02293499|12462181|FG000|STARTED|3 Month Follow Up||149
11266520|NCT02293499|12462182|FG001|STARTED|3 Month Follow Up||162
11266521|NCT02293499|12462183|FG002|STARTED|3 Month Follow Up||39
11266522|NCT02293499|12462181|FG000|COMPLETED|3 Month Follow Up||134
11266523|NCT02293499|12462182|FG001|COMPLETED|3 Month Follow Up||147
11266524|NCT02293499|12462183|FG002|COMPLETED|3 Month Follow Up||29
11266525|NCT02293499|12462181|FG000|NOT COMPLETED|3 Month Follow Up||15
11266526|NCT02293499|12462182|FG001|NOT COMPLETED|3 Month Follow Up||15
11266527|NCT02293499|12462183|FG002|NOT COMPLETED|3 Month Follow Up||10
11266528|NCT02293499|12462181|FG000|STARTED|6 Month Follow Up||148
11266529|NCT02293499|12462182|FG001|STARTED|6 Month Follow Up||162
11266530|NCT02293499|12462183|FG002|STARTED|6 Month Follow Up||35
11266531|NCT02293499|12462181|FG000|COMPLETED|6 Month Follow Up||131
11266532|NCT02293499|12462182|FG001|COMPLETED|6 Month Follow Up||135
11266533|NCT02293499|12462183|FG002|COMPLETED|6 Month Follow Up||28
11266534|NCT02293499|12462181|FG000|NOT COMPLETED|6 Month Follow Up||17
11266535|NCT02293499|12462182|FG001|NOT COMPLETED|6 Month Follow Up||27
11266536|NCT02293499|12462183|FG002|NOT COMPLETED|6 Month Follow Up||7
11266537|NCT02293499|12462181|FG000|STARTED|9 Month Follow Up||148
11266538|NCT02293499|12462182|FG001|STARTED|9 Month Follow Up||162
11266539|NCT02293499|12462183|FG002|STARTED|9 Month Follow Up||34
11266540|NCT02293499|12462181|FG000|COMPLETED|9 Month Follow Up||122
11266541|NCT02293499|12462182|FG001|COMPLETED|9 Month Follow Up||134
11266542|NCT02293499|12462183|FG002|COMPLETED|9 Month Follow Up||30
11266543|NCT02293499|12462181|FG000|NOT COMPLETED|9 Month Follow Up||26
11266544|NCT02293499|12462182|FG001|NOT COMPLETED|9 Month Follow Up||28
11266545|NCT02293499|12462183|FG002|NOT COMPLETED|9 Month Follow Up||4
11266546|NCT02293499|12462181|FG000|STARTED|12 Month Follow Up||146
11266547|NCT02293499|12462182|FG001|STARTED|12 Month Follow Up||162
11266548|NCT02293499|12462183|FG002|STARTED|12 Month Follow Up||34
11266549|NCT02293499|12462181|FG000|COMPLETED|12 Month Follow Up||120
11266550|NCT02293499|12462182|FG001|COMPLETED|12 Month Follow Up||136
11266551|NCT02293499|12462183|FG002|COMPLETED|12 Month Follow Up||28
11266552|NCT02293499|12462181|FG000|NOT COMPLETED|12 Month Follow Up||26
11266553|NCT02293499|12462182|FG001|NOT COMPLETED|12 Month Follow Up||26
11397134|NCT04043143|12591165|FG000|NOT COMPLETED|Overall Study||6
11397135|NCT04043143|12591166|FG001|NOT COMPLETED|Overall Study||5
11397136|NCT04049123|12591172|FG000|STARTED|Period 1||5
11397137|NCT04049123|12591173|FG001|STARTED|Period 1||5
11397138|NCT04049123|12591174|FG002|STARTED|Period 1||5
11397139|NCT04049123|12591172|FG000|Received at Least One Dose of Study Drug|Period 1||5
11397140|NCT04049123|12591173|FG001|Received at Least One Dose of Study Drug|Period 1||5
11397141|NCT04049123|12591174|FG002|Received at Least One Dose of Study Drug|Period 1||5
11397142|NCT04049123|12591172|FG000|COMPLETED|Period 1||5
11266554|NCT02293499|12462183|FG002|NOT COMPLETED|12 Month Follow Up||6
11266555|NCT02293499|12462181|FG000|STARTED|15 Month Follow Up||146
11266556|NCT02293499|12462182|FG001|STARTED|15 Month Follow Up||161
11266557|NCT02293499|12462183|FG002|STARTED|15 Month Follow Up||34
11266558|NCT02293499|12462181|FG000|COMPLETED|15 Month Follow Up||124
11266559|NCT02293499|12462182|FG001|COMPLETED|15 Month Follow Up||139
11266560|NCT02293499|12462183|FG002|COMPLETED|15 Month Follow Up||27
11266561|NCT02293499|12462181|FG000|NOT COMPLETED|15 Month Follow Up||22
11266562|NCT02293499|12462182|FG001|NOT COMPLETED|15 Month Follow Up||22
11266563|NCT02293499|12462183|FG002|NOT COMPLETED|15 Month Follow Up||7
11266564|NCT02293512|12462196|FG000|STARTED|Overall Study||10
11266565|NCT02293512|12462197|FG001|STARTED|Overall Study||10
11266566|NCT02293512|12462198|FG002|STARTED|Overall Study||10
11266567|NCT02293512|12462199|FG003|STARTED|Overall Study||10
11266568|NCT02293512|12462196|FG000|COMPLETED|Overall Study||6
11266569|NCT02293512|12462197|FG001|COMPLETED|Overall Study||4
11266570|NCT02293512|12462198|FG002|COMPLETED|Overall Study||7
11266571|NCT02293512|12462199|FG003|COMPLETED|Overall Study||8
11266572|NCT02293512|12462196|FG000|NOT COMPLETED|Overall Study||4
11266573|NCT02293512|12462197|FG001|NOT COMPLETED|Overall Study||6
11266574|NCT02293512|12462198|FG002|NOT COMPLETED|Overall Study||3
11266575|NCT02293512|12462199|FG003|NOT COMPLETED|Overall Study||2
11266576|NCT02293538|12462211|FG000|STARTED|Overall Study||73
11266577|NCT02293538|12462212|FG001|STARTED|Overall Study||71
11266578|NCT02293538|12462211|FG000|COMPLETED|Overall Study||72
11266579|NCT02293538|12462212|FG001|COMPLETED|Overall Study||69
11266580|NCT02293538|12462211|FG000|NOT COMPLETED|Overall Study||1
11266581|NCT02293538|12462212|FG001|NOT COMPLETED|Overall Study||2
11266582|NCT02293798|12462219|FG000|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13
11266583|NCT02293798|12462219|FG000|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13
11397143|NCT04049123|12591173|FG001|COMPLETED|Period 1||5
11266584|NCT02293798|12462219|FG000|NOT COMPLETED|Overall Study||0
11266585|NCT02293837|12462227|FG000|STARTED|Overall Study||54
11266586|NCT02293837|12462228|FG001|STARTED|Overall Study||27
11266587|NCT02293837|12462229|FG002|STARTED|Overall Study|1 randomized adult was never treated|35
11266588|NCT02293837|12462230|FG003|STARTED|Overall Study||20
11266589|NCT02293837|12462227|FG000|COMPLETED|Overall Study||51
11397144|NCT04049123|12591174|FG002|COMPLETED|Period 1||5
11397145|NCT04049123|12591172|FG000|NOT COMPLETED|Period 1||0
11266590|NCT02293837|12462228|FG001|COMPLETED|Overall Study||23
11266591|NCT02293837|12462229|FG002|COMPLETED|Overall Study||31
11266592|NCT02293837|12462230|FG003|COMPLETED|Overall Study||19
11266593|NCT02293837|12462227|FG000|NOT COMPLETED|Overall Study||3
11266594|NCT02293837|12462228|FG001|NOT COMPLETED|Overall Study||4
11266595|NCT02293837|12462229|FG002|NOT COMPLETED|Overall Study||4
11266596|NCT02293837|12462230|FG003|NOT COMPLETED|Overall Study||1
11266597|NCT02293863|12462247|FG000|STARTED|Overall Study||56
11266598|NCT02293863|12462248|FG001|STARTED|Overall Study||55
11266599|NCT02293863|12462249|FG002|STARTED|Overall Study||47
11266600|NCT02293863|12462247|FG000|COMPLETED|Overall Study||47
11266601|NCT02293863|12462248|FG001|COMPLETED|Overall Study||42
11266602|NCT02293863|12462249|FG002|COMPLETED|Overall Study||38
11266603|NCT02293863|12462247|FG000|NOT COMPLETED|Overall Study||9
11266604|NCT02293863|12462248|FG001|NOT COMPLETED|Overall Study||13
11266605|NCT02293863|12462249|FG002|NOT COMPLETED|Overall Study||9
11266606|NCT02293902|12462262|FG000|STARTED|Double-Blind Period (Up to Week 24)||82
11266607|NCT02293902|12462263|FG001|STARTED|Double-Blind Period (Up to Week 24)||81
11266608|NCT02293902|12462264|FG002|STARTED|Double-Blind Period (Up to Week 24)||80
11266609|NCT02293902|12462265|FG003|STARTED|Double-Blind Period (Up to Week 24)||0
11266610|NCT02293902|12462266|FG004|STARTED|Double-Blind Period (Up to Week 24)||0
11266611|NCT02293902|12462262|FG000|Treated|Double-Blind Period (Up to Week 24)||81
11266612|NCT02293902|12462263|FG001|Treated|Double-Blind Period (Up to Week 24)||81
11266613|NCT02293902|12462264|FG002|Treated|Double-Blind Period (Up to Week 24)||80
11266614|NCT02293902|12462265|FG003|Treated|Double-Blind Period (Up to Week 24)||0
11266615|NCT02293902|12462266|FG004|Treated|Double-Blind Period (Up to Week 24)||0
11266616|NCT02293902|12462262|FG000|Rescued|Double-Blind Period (Up to Week 24)||44
11266617|NCT02293902|12462263|FG001|Rescued|Double-Blind Period (Up to Week 24)||6
11266618|NCT02293902|12462264|FG002|Rescued|Double-Blind Period (Up to Week 24)||8
11266619|NCT02293902|12462265|FG003|Rescued|Double-Blind Period (Up to Week 24)||0
11266620|NCT02293902|12462266|FG004|Rescued|Double-Blind Period (Up to Week 24)||0
11266621|NCT02293902|12462262|FG000|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
11266622|NCT02293902|12462263|FG001|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
11266623|NCT02293902|12462264|FG002|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
11266624|NCT02293902|12462265|FG003|COMPLETED|Double-Blind Period (Up to Week 24)||0
11266625|NCT02293902|12462266|FG004|COMPLETED|Double-Blind Period (Up to Week 24)||0
11266626|NCT02293902|12462262|FG000|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
11266627|NCT02293902|12462263|FG001|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
11266628|NCT02293902|12462264|FG002|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
11266629|NCT02293902|12462265|FG003|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
11266630|NCT02293902|12462266|FG004|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
11266631|NCT02293902|12462262|FG000|STARTED|Single-Blind Period (Week 25 to Week 52)||0
11266632|NCT02293902|12462263|FG001|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
11266633|NCT02293902|12462264|FG002|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
11266634|NCT02293902|12462265|FG003|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
11266635|NCT02293902|12462266|FG004|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
11266636|NCT02293902|12462262|FG000|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
11266637|NCT02293902|12462263|FG001|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
11266638|NCT02293902|12462264|FG002|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
11266639|NCT02293902|12462265|FG003|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
11266640|NCT02293902|12462266|FG004|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
11266641|NCT02293902|12462262|FG000|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
11266642|NCT02293902|12462263|FG001|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
11266643|NCT02293902|12462264|FG002|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
11266644|NCT02293902|12462265|FG003|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
11266645|NCT02293902|12462266|FG004|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
11266646|NCT02293993|12462288|FG000|STARTED|Course 1 (DLT Evaluation Period)||4
11266647|NCT02293993|12462289|FG001|STARTED|Course 1 (DLT Evaluation Period)||6
11266648|NCT02293993|12462290|FG002|STARTED|Course 1 (DLT Evaluation Period)||7
11266649|NCT02293993|12462291|FG003|STARTED|Course 1 (DLT Evaluation Period)||4
11266650|NCT02293993|12462288|FG000|COMPLETED|Course 1 (DLT Evaluation Period)||3
11266651|NCT02293993|12462289|FG001|COMPLETED|Course 1 (DLT Evaluation Period)||6
11397146|NCT04049123|12591173|FG001|NOT COMPLETED|Period 1||0
11397147|NCT04049123|12591174|FG002|NOT COMPLETED|Period 1||0
11397148|NCT04049123|12591172|FG000|STARTED|Period 2||5
11397149|NCT04049123|12591173|FG001|STARTED|Period 2||5
11397150|NCT04049123|12591174|FG002|STARTED|Period 2||5
11397151|NCT04049123|12591172|FG000|COMPLETED|Period 2||5
11397152|NCT04049123|12591173|FG001|COMPLETED|Period 2||5
11397153|NCT04049123|12591174|FG002|COMPLETED|Period 2||5
11397154|NCT04049123|12591172|FG000|NOT COMPLETED|Period 2||0
11397155|NCT04049123|12591173|FG001|NOT COMPLETED|Period 2||0
11397156|NCT04049123|12591174|FG002|NOT COMPLETED|Period 2||0
11397157|NCT04049123|12591172|FG000|STARTED|Period 3||5
11397158|NCT04049123|12591173|FG001|STARTED|Period 3||5
11397159|NCT04049123|12591174|FG002|STARTED|Period 3||5
11397160|NCT04049123|12591172|FG000|COMPLETED|Period 3||5
11397161|NCT04049123|12591173|FG001|COMPLETED|Period 3||5
11266652|NCT02293993|12462290|FG002|COMPLETED|Course 1 (DLT Evaluation Period)||7
11266653|NCT02293993|12462291|FG003|COMPLETED|Course 1 (DLT Evaluation Period)||3
11266654|NCT02293993|12462288|FG000|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
11266655|NCT02293993|12462289|FG001|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
11266656|NCT02293993|12462290|FG002|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
11266657|NCT02293993|12462291|FG003|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
11266658|NCT02293993|12462288|FG000|STARTED|Course ≥2 (Extended Treatment Period)||2
11266659|NCT02293993|12462289|FG001|STARTED|Course ≥2 (Extended Treatment Period)||5
11266660|NCT02293993|12462290|FG002|STARTED|Course ≥2 (Extended Treatment Period)||6
11266661|NCT02293993|12462291|FG003|STARTED|Course ≥2 (Extended Treatment Period)||3
11266662|NCT02293993|12462288|FG000|COMPLETED|Course ≥2 (Extended Treatment Period)||0
11266663|NCT02293993|12462289|FG001|COMPLETED|Course ≥2 (Extended Treatment Period)||0
11266664|NCT02293993|12462290|FG002|COMPLETED|Course ≥2 (Extended Treatment Period)||1
11266665|NCT02293993|12462291|FG003|COMPLETED|Course ≥2 (Extended Treatment Period)||2
11266666|NCT02293993|12462288|FG000|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||2
11266667|NCT02293993|12462289|FG001|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
11266668|NCT02293993|12462290|FG002|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
11266669|NCT02293993|12462291|FG003|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||1
11266670|NCT02294019|12462309|FG000|STARTED|Overall Study||738
11266671|NCT02294019|12462309|FG000|COMPLETED|Overall Study||635
11266672|NCT02294019|12462309|FG000|NOT COMPLETED|Overall Study||103
11397162|NCT04049123|12591174|FG002|COMPLETED|Period 3||5
11397163|NCT04049123|12591172|FG000|NOT COMPLETED|Period 3||0
11266673|NCT02294058|12462316|FG000|STARTED|Overall Study||448
11266674|NCT02294058|12462317|FG001|STARTED|Overall Study||451
11266675|NCT02294058|12462318|FG002|STARTED|Overall Study||447
11266676|NCT02294058|12462316|FG000|Safety Population|Overall Study||445
11266677|NCT02294058|12462317|FG001|Safety Population|Overall Study||453
11266678|NCT02294058|12462318|FG002|Safety Population|Overall Study||448
11266679|NCT02294058|12462316|FG000|COMPLETED|Overall Study||412
11266680|NCT02294058|12462317|FG001|COMPLETED|Overall Study||425
11266681|NCT02294058|12462318|FG002|COMPLETED|Overall Study||418
11266682|NCT02294058|12462316|FG000|NOT COMPLETED|Overall Study||36
11266683|NCT02294058|12462317|FG001|NOT COMPLETED|Overall Study||26
11266684|NCT02294058|12462318|FG002|NOT COMPLETED|Overall Study||29
11266685|NCT02294175|12462329|FG000|STARTED|Overall Study||23
11266686|NCT02294175|12462330|FG001|STARTED|Overall Study||22
11266687|NCT02294175|12462329|FG000|COMPLETED|Overall Study||18
11266688|NCT02294175|12462330|FG001|COMPLETED|Overall Study||16
11266689|NCT02294175|12462329|FG000|NOT COMPLETED|Overall Study||5
11266690|NCT02294175|12462330|FG001|NOT COMPLETED|Overall Study||6
11266691|NCT02294227|12462339|FG000|STARTED|Overall Study||114
11266692|NCT02294227|12462340|FG001|STARTED|Overall Study||113
11266693|NCT02294227|12462341|FG002|STARTED|Overall Study||114
11266694|NCT02294227|12462339|FG000|COMPLETED|Overall Study||89
11266695|NCT02294227|12462340|FG001|COMPLETED|Overall Study||88
11266696|NCT02294227|12462341|FG002|COMPLETED|Overall Study||95
11266697|NCT02294227|12462339|FG000|NOT COMPLETED|Overall Study||25
11266698|NCT02294227|12462340|FG001|NOT COMPLETED|Overall Study||25
11266699|NCT02294227|12462341|FG002|NOT COMPLETED|Overall Study||19
11266700|NCT02294253|12462351|FG000|STARTED|Overall Study||30
11266701|NCT02294253|12462351|FG000|COMPLETED|Overall Study||15
11266702|NCT02294253|12462351|FG000|NOT COMPLETED|Overall Study||15
11266703|NCT02294318|12462357|FG000|STARTED|Overall Study||24
11266704|NCT02294318|12462358|FG001|STARTED|Overall Study||23
11266705|NCT02294318|12462357|FG000|COMPLETED|Overall Study||21
11266706|NCT02294318|12462358|FG001|COMPLETED|Overall Study||21
11266707|NCT02294318|12462357|FG000|NOT COMPLETED|Overall Study||3
11266708|NCT02294318|12462358|FG001|NOT COMPLETED|Overall Study||2
11266709|NCT02294396|12462368|FG000|STARTED|Overall Study||167
11266710|NCT02294396|12462369|FG001|STARTED|Overall Study||161
11266711|NCT02294396|12462370|FG002|STARTED|Overall Study||161
11266712|NCT02294396|12462371|FG003|STARTED|Overall Study||160
11266713|NCT02294396|12462368|FG000|COMPLETED|Overall Study||127
11266714|NCT02294396|12462369|FG001|COMPLETED|Overall Study||128
11266715|NCT02294396|12462370|FG002|COMPLETED|Overall Study||126
11397164|NCT04049123|12591173|FG001|NOT COMPLETED|Period 3||0
11266716|NCT02294396|12462371|FG003|COMPLETED|Overall Study||123
11266717|NCT02294396|12462368|FG000|NOT COMPLETED|Overall Study||40
11266718|NCT02294396|12462369|FG001|NOT COMPLETED|Overall Study||33
11266719|NCT02294396|12462370|FG002|NOT COMPLETED|Overall Study||35
11266720|NCT02294396|12462371|FG003|NOT COMPLETED|Overall Study||37
11266721|NCT02294474|12462383|FG000|STARTED|Overall Study||253
11266722|NCT02294474|12462384|FG001|STARTED|Overall Study||252
11266723|NCT02294474|12462383|FG000|COMPLETED|Overall Study||228
11266724|NCT02294474|12462384|FG001|COMPLETED|Overall Study||230
11266725|NCT02294474|12462383|FG000|NOT COMPLETED|Overall Study||25
11266726|NCT02294474|12462384|FG001|NOT COMPLETED|Overall Study||22
11266727|NCT02294604|12462394|FG000|STARTED|Overall Study||80
11266728|NCT02294604|12462395|FG001|STARTED|Overall Study||80
11397165|NCT04049123|12591174|FG002|NOT COMPLETED|Period 3||0
11397166|NCT04051463|12591184|FG000|STARTED|Overall Study||15
11397167|NCT04051463|12591185|FG001|STARTED|Overall Study||14
11397168|NCT04051463|12591184|FG000|COMPLETED|Overall Study||13
11397169|NCT04051463|12591185|FG001|COMPLETED|Overall Study||13
11397170|NCT04051463|12591184|FG000|NOT COMPLETED|Overall Study||2
11266729|NCT02294604|12462396|FG002|STARTED|Overall Study||80
11266730|NCT02294604|12462394|FG000|COMPLETED|Overall Study||79
11266731|NCT02294604|12462395|FG001|COMPLETED|Overall Study||77
11266732|NCT02294604|12462396|FG002|COMPLETED|Overall Study||80
11266733|NCT02294604|12462394|FG000|NOT COMPLETED|Overall Study||1
11266734|NCT02294604|12462395|FG001|NOT COMPLETED|Overall Study||3
11266735|NCT02294604|12462396|FG002|NOT COMPLETED|Overall Study||0
11266736|NCT02294630|12462408|FG000|STARTED|Overall Study||37
11266737|NCT02294630|12462409|FG001|STARTED|Overall Study||38
11266738|NCT02294630|12462410|FG002|STARTED|Overall Study||35
11266739|NCT02294630|12462411|FG003|STARTED|Overall Study||39
11266740|NCT02294630|12462408|FG000|COMPLETED|Overall Study||37
11266741|NCT02294630|12462409|FG001|COMPLETED|Overall Study||38
11266742|NCT02294630|12462410|FG002|COMPLETED|Overall Study||35
11266743|NCT02294630|12462411|FG003|COMPLETED|Overall Study||39
11266744|NCT02294630|12462408|FG000|NOT COMPLETED|Overall Study||0
11266745|NCT02294630|12462409|FG001|NOT COMPLETED|Overall Study||0
11266746|NCT02294630|12462410|FG002|NOT COMPLETED|Overall Study||0
11266747|NCT02294630|12462411|FG003|NOT COMPLETED|Overall Study||0
11397171|NCT04051463|12591185|FG001|NOT COMPLETED|Overall Study||1
11397172|NCT04052204|12591191|FG000|STARTED|Overall Study||3
11397173|NCT04052204|12591192|FG001|STARTED|Overall Study|Arm was not tested due to study termination.|0
11397174|NCT04052204|12591193|FG002|STARTED|Overall Study|Arm was not tested due to study termination.|0
11397175|NCT04052204|12591191|FG000|COMPLETED|Overall Study||0
11397176|NCT04052204|12591192|FG001|COMPLETED|Overall Study||0
11266748|NCT02294682|12462423|FG000|STARTED|Overall Study||53
11266749|NCT02294682|12462424|FG001|STARTED|Overall Study||53
11266750|NCT02294682|12462423|FG000|COMPLETED|Overall Study||52
11266751|NCT02294682|12462424|FG001|COMPLETED|Overall Study||53
11266752|NCT02294682|12462423|FG000|NOT COMPLETED|Overall Study||1
11266753|NCT02294682|12462424|FG001|NOT COMPLETED|Overall Study||0
11266754|NCT02294734|12462432|FG000|STARTED|Overall Study||63
11266755|NCT02294734|12462433|FG001|STARTED|Overall Study||63
11266756|NCT02294734|12462432|FG000|COMPLETED|Overall Study||49
11266757|NCT02294734|12462433|FG001|COMPLETED|Overall Study||55
11266758|NCT02294734|12462432|FG000|NOT COMPLETED|Overall Study||14
11266759|NCT02294734|12462433|FG001|NOT COMPLETED|Overall Study||8
11266760|NCT02294773|12462443|FG000|STARTED|Overall Study||7
11266761|NCT02294773|12462444|FG001|STARTED|Overall Study||6
11266762|NCT02294773|12462443|FG000|COMPLETED|Overall Study||7
11266763|NCT02294773|12462444|FG001|COMPLETED|Overall Study||4
11266764|NCT02294773|12462443|FG000|NOT COMPLETED|Overall Study||0
11266765|NCT02294773|12462444|FG001|NOT COMPLETED|Overall Study||2
11266766|NCT02294786|12462452|FG000|STARTED|Overall Study||30
11266767|NCT02294786|12462453|FG001|STARTED|Overall Study||32
11266768|NCT02294786|12462452|FG000|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29
11266769|NCT02294786|12462453|FG001|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33
11266770|NCT02294786|12462452|FG000|ITT Population|Overall Study||30
11266771|NCT02294786|12462453|FG001|ITT Population|Overall Study||32
11266772|NCT02294786|12462452|FG000|COMPLETED|Overall Study||19
11266773|NCT02294786|12462453|FG001|COMPLETED|Overall Study||18
11266774|NCT02294786|12462452|FG000|NOT COMPLETED|Overall Study||11
11266775|NCT02294786|12462453|FG001|NOT COMPLETED|Overall Study||14
11266776|NCT02295020|12462462|FG000|STARTED|Overall Study||20
11266777|NCT02295020|12462463|FG001|STARTED|Overall Study||20
11266778|NCT02295020|12462462|FG000|COMPLETED|Overall Study||17
11266779|NCT02295020|12462463|FG001|COMPLETED|Overall Study||17
11266780|NCT02295020|12462462|FG000|NOT COMPLETED|Overall Study||3
11266781|NCT02295020|12462463|FG001|NOT COMPLETED|Overall Study||3
11266782|NCT02295280|12462477|FG000|STARTED|Overall Study||35
11266783|NCT02295280|12462478|FG001|STARTED|Overall Study||35
11266784|NCT02295280|12462477|FG000|COMPLETED|Overall Study||35
11266785|NCT02295280|12462478|FG001|COMPLETED|Overall Study||34
11266786|NCT02295280|12462477|FG000|NOT COMPLETED|Overall Study||0
11266787|NCT02295280|12462478|FG001|NOT COMPLETED|Overall Study||1
11266788|NCT02295553|12462488|FG000|STARTED|Overall Study||14
11266789|NCT02295553|12462489|FG001|STARTED|Overall Study||14
11266790|NCT02295553|12462490|FG002|STARTED|Overall Study||14
11266791|NCT02295553|12462491|FG003|STARTED|Overall Study||14
11397177|NCT04052204|12591193|FG002|COMPLETED|Overall Study||0
11397178|NCT04052204|12591191|FG000|NOT COMPLETED|Overall Study||3
11397179|NCT04052204|12591192|FG001|NOT COMPLETED|Overall Study||0
11397180|NCT04052204|12591193|FG002|NOT COMPLETED|Overall Study||0
11266792|NCT02295553|12462488|FG000|COMPLETED|Overall Study||14
11266793|NCT02295553|12462489|FG001|COMPLETED|Overall Study||14
11266794|NCT02295553|12462490|FG002|COMPLETED|Overall Study||13
11266795|NCT02295553|12462491|FG003|COMPLETED|Overall Study||13
11266796|NCT02295553|12462488|FG000|NOT COMPLETED|Overall Study||0
11397181|NCT04054661|12591197|FG000|STARTED|Overall Study||229
11397182|NCT04054661|12591197|FG000|Enrolled in Repeatability Sub-study|Overall Study||15
11397183|NCT04054661|12591197|FG000|Enrolled in Sample Stability Sub-study|Overall Study||3
11397184|NCT04054661|12591197|FG000|COMPLETED|Overall Study||229
11397185|NCT04054661|12591197|FG000|NOT COMPLETED|Overall Study||0
11397186|NCT04067011|12591213|FG000|STARTED|Overall Study||70
11397187|NCT04067011|12591214|FG001|STARTED|Overall Study||71
11397188|NCT04067011|12591215|FG002|STARTED|Overall Study||69
11397189|NCT04067011|12591213|FG000|COMPLETED|Overall Study||51
11397190|NCT04067011|12591214|FG001|COMPLETED|Overall Study||58
11397191|NCT04067011|12591215|FG002|COMPLETED|Overall Study||61
11397192|NCT04067011|12591213|FG000|NOT COMPLETED|Overall Study||19
11397193|NCT04067011|12591214|FG001|NOT COMPLETED|Overall Study||13
11397194|NCT04067011|12591215|FG002|NOT COMPLETED|Overall Study||8
11397195|NCT04072159|12591227|FG000|STARTED|Overall Study||16
11397196|NCT04072159|12591228|FG001|STARTED|Overall Study||17
11397197|NCT04072159|12591227|FG000|COMPLETED|Overall Study||8
11266797|NCT02295553|12462489|FG001|NOT COMPLETED|Overall Study||0
11266798|NCT02295553|12462490|FG002|NOT COMPLETED|Overall Study||1
11266799|NCT02295553|12462491|FG003|NOT COMPLETED|Overall Study||1
11266800|NCT02295644|12462505|FG000|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
11266801|NCT02295644|12462506|FG001|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
11266802|NCT02295644|12462507|FG002|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
11266803|NCT02295644|12462508|FG003|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
11266804|NCT02295644|12462505|FG000|COMPLETED|Overall Study||7
11266805|NCT02295644|12462506|FG001|COMPLETED|Overall Study||7
11266806|NCT02295644|12462507|FG002|COMPLETED|Overall Study||6
11266807|NCT02295644|12462508|FG003|COMPLETED|Overall Study||5
11266808|NCT02295644|12462505|FG000|NOT COMPLETED|Overall Study||0
11266809|NCT02295644|12462506|FG001|NOT COMPLETED|Overall Study||0
11266810|NCT02295644|12462507|FG002|NOT COMPLETED|Overall Study||1
11266811|NCT02295644|12462508|FG003|NOT COMPLETED|Overall Study||2
11266812|NCT02295735|12462520|FG000|STARTED|Overall Study||238
11266813|NCT02295735|12462521|FG001|STARTED|Overall Study||237
11266814|NCT02295735|12462520|FG000|COMPLETED|Overall Study||212
11266815|NCT02295735|12462521|FG001|COMPLETED|Overall Study||210
11266816|NCT02295735|12462520|FG000|NOT COMPLETED|Overall Study||26
11266817|NCT02295735|12462521|FG001|NOT COMPLETED|Overall Study||27
11266818|NCT02295774|12462527|FG000|STARTED|Overall Study||13
11266819|NCT02295774|12462527|FG000|COMPLETED|Overall Study||10
11266820|NCT02295774|12462527|FG000|NOT COMPLETED|Overall Study||3
11266821|NCT02295995|12462534|FG000|STARTED|Overall Study||36
11266822|NCT02295995|12462535|FG001|STARTED|Overall Study||18
11266823|NCT02295995|12462534|FG000|COMPLETED|Overall Study||31
11266824|NCT02295995|12462535|FG001|COMPLETED|Overall Study||17
11266825|NCT02295995|12462534|FG000|NOT COMPLETED|Overall Study||5
11266826|NCT02295995|12462535|FG001|NOT COMPLETED|Overall Study||1
11266827|NCT02296099|12462544|FG000|STARTED|Overall Study||57
11266828|NCT02296099|12462545|FG001|STARTED|Overall Study||57
11266829|NCT02296099|12462544|FG000|COMPLETED|Overall Study||54
11266830|NCT02296099|12462545|FG001|COMPLETED|Overall Study||55
11266831|NCT02296099|12462544|FG000|NOT COMPLETED|Overall Study||3
11266832|NCT02296099|12462545|FG001|NOT COMPLETED|Overall Study||2
11266833|NCT02296112|12462551|FG000|STARTED|Overall Study||9
11266834|NCT02296112|12462551|FG000|COMPLETED|Overall Study||0
11266835|NCT02296112|12462551|FG000|NOT COMPLETED|Overall Study||9
11266836|NCT02296138|12462562|FG000|STARTED|Overall Study||3952
11266837|NCT02296138|12462563|FG001|STARTED|Overall Study||3951
11266838|NCT02296138|12462562|FG000|Treated|Overall Study||3941
11266839|NCT02296138|12462563|FG001|Treated|Overall Study||3939
11266840|NCT02296138|12462562|FG000|COMPLETED|Overall Study||3291
11266841|NCT02296138|12462563|FG001|COMPLETED|Overall Study||3451
11266842|NCT02296138|12462562|FG000|NOT COMPLETED|Overall Study||661
11266843|NCT02296138|12462563|FG001|NOT COMPLETED|Overall Study||500
11266844|NCT02296164|12462569|FG000|STARTED|Overall Study|2 patients not eligible as were not on Valchlor at time of study start|298
11266845|NCT02296164|12462569|FG000|COMPLETED|Overall Study||188
11266846|NCT02296164|12462569|FG000|NOT COMPLETED|Overall Study||110
11266847|NCT02296190|12462579|FG000|STARTED|Overall Study||35
11266848|NCT02296190|12462580|FG001|STARTED|Overall Study||41
11266849|NCT02296190|12462581|FG002|STARTED|Overall Study||35
11266850|NCT02296190|12462582|FG003|STARTED|Overall Study||43
11266851|NCT02296190|12462583|FG004|STARTED|Overall Study||36
11266852|NCT02296190|12462584|FG005|STARTED|Overall Study||9
11397198|NCT04072159|12591228|FG001|COMPLETED|Overall Study||11
11397199|NCT04072159|12591227|FG000|NOT COMPLETED|Overall Study||8
11397200|NCT04072159|12591228|FG001|NOT COMPLETED|Overall Study||6
11397201|NCT04085341|12591238|FG000|STARTED|Overall Study||10
11397202|NCT04085341|12591239|FG001|STARTED|Overall Study||11
11397203|NCT04085341|12591238|FG000|COMPLETED|Overall Study||10
11397204|NCT04085341|12591239|FG001|COMPLETED|Overall Study||11
11397205|NCT04085341|12591238|FG000|NOT COMPLETED|Overall Study||0
11266853|NCT02296190|12462579|FG000|COMPLETED|Overall Study||21
11266854|NCT02296190|12462580|FG001|COMPLETED|Overall Study||20
11397206|NCT04085341|12591239|FG001|NOT COMPLETED|Overall Study||0
11397207|NCT04094870|12591247|FG000|STARTED|Overall Study||40
11266855|NCT02296190|12462581|FG002|COMPLETED|Overall Study||23
11266856|NCT02296190|12462582|FG003|COMPLETED|Overall Study||20
11266857|NCT02296190|12462583|FG004|COMPLETED|Overall Study||20
11397208|NCT04094870|12591248|FG001|STARTED|Overall Study||40
11397209|NCT04094870|12591247|FG000|COMPLETED|Overall Study||39
11397210|NCT04094870|12591248|FG001|COMPLETED|Overall Study||39
11397211|NCT04094870|12591247|FG000|NOT COMPLETED|Overall Study||1
11397212|NCT04094870|12591248|FG001|NOT COMPLETED|Overall Study||1
11397213|NCT04096482|12591261|FG000|STARTED|Overall Study||6
11397214|NCT04096482|12591261|FG000|COMPLETED|Overall Study||6
11397215|NCT04096482|12591261|FG000|NOT COMPLETED|Overall Study||0
11266858|NCT02296190|12462584|FG005|COMPLETED|Overall Study||9
11266859|NCT02296190|12462579|FG000|NOT COMPLETED|Overall Study||14
11266860|NCT02296190|12462580|FG001|NOT COMPLETED|Overall Study||21
11266861|NCT02296190|12462581|FG002|NOT COMPLETED|Overall Study||12
11266862|NCT02296190|12462582|FG003|NOT COMPLETED|Overall Study||23
11266863|NCT02296190|12462583|FG004|NOT COMPLETED|Overall Study||16
11266864|NCT02296190|12462584|FG005|NOT COMPLETED|Overall Study||0
11266865|NCT02296242|12462602|FG000|STARTED|Overall Study||5
11397216|NCT04098172|12591267|FG000|STARTED|Overall Study||39
11397217|NCT04098172|12591267|FG000|COMPLETED|Overall Study||39
11397218|NCT04098172|12591267|FG000|NOT COMPLETED|Overall Study||0
11397219|NCT04103515|12591274|FG000|STARTED|Overall Study||25
11397220|NCT04103515|12591275|FG001|STARTED|Overall Study||25
11397221|NCT04103515|12591274|FG000|COMPLETED|Overall Study||25
11266866|NCT02296242|12462603|FG001|STARTED|Overall Study||6
11266867|NCT02296242|12462604|FG002|STARTED|Overall Study||7
11266868|NCT02296242|12462605|FG003|STARTED|Overall Study||14
11266869|NCT02296242|12462606|FG004|STARTED|Overall Study||21
11266870|NCT02296242|12462602|FG000|COMPLETED|Overall Study||0
11266871|NCT02296242|12462603|FG001|COMPLETED|Overall Study||0
11266872|NCT02296242|12462604|FG002|COMPLETED|Overall Study||0
11266873|NCT02296242|12462605|FG003|COMPLETED|Overall Study||0
11266874|NCT02296242|12462606|FG004|COMPLETED|Overall Study||0
11266875|NCT02296242|12462602|FG000|NOT COMPLETED|Overall Study||5
11021569|NCT00804999|12199669|FG002|COMPLETED|Overall Study||14
11021570|NCT00804999|12199670|FG003|COMPLETED|Overall Study||10
11021571|NCT00804999|12199667|FG000|NOT COMPLETED|Overall Study||0
11021572|NCT00804999|12199668|FG001|NOT COMPLETED|Overall Study||0
11021573|NCT00804999|12199669|FG002|NOT COMPLETED|Overall Study||0
11021574|NCT00804999|12199670|FG003|NOT COMPLETED|Overall Study||0
11266876|NCT02296242|12462603|FG001|NOT COMPLETED|Overall Study||6
11266877|NCT02296242|12462604|FG002|NOT COMPLETED|Overall Study||7
11266878|NCT02296242|12462605|FG003|NOT COMPLETED|Overall Study||14
11266879|NCT02296242|12462606|FG004|NOT COMPLETED|Overall Study||21
11143743|NCT01474512|12330428|FG006|STARTED|Long-Term Extension Period||0
11143744|NCT01474512|12330429|FG007|STARTED|Long-Term Extension Period||0
11143745|NCT01474512|12330430|FG008|STARTED|Long-Term Extension Period||0
11143746|NCT01474512|12330431|FG009|STARTED|Long-Term Extension Period||0
11143747|NCT01474512|12330432|FG010|STARTED|Long-Term Extension Period||0
11266880|NCT02296320|12462629|FG000|STARTED|Overall Study||102
11266881|NCT02296320|12462630|FG001|STARTED|Overall Study||15
11266882|NCT02296320|12462631|FG002|STARTED|Overall Study||96
11266883|NCT02296320|12462629|FG000|Treated|Overall Study||100
11266884|NCT02296320|12462630|FG001|Treated|Overall Study||15
11266885|NCT02296320|12462631|FG002|Treated|Overall Study||96
11266886|NCT02296320|12462629|FG000|COMPLETED|Overall Study||67
11266887|NCT02296320|12462630|FG001|COMPLETED|Overall Study||10
11266888|NCT02296320|12462631|FG002|COMPLETED|Overall Study||59
11266889|NCT02296320|12462629|FG000|NOT COMPLETED|Overall Study||35
11266890|NCT02296320|12462630|FG001|NOT COMPLETED|Overall Study||5
11266891|NCT02296320|12462631|FG002|NOT COMPLETED|Overall Study||37
11266892|NCT02296346|12462643|FG000|STARTED|Overall Study||7
11266893|NCT02296346|12462644|FG001|STARTED|Overall Study||6
11266894|NCT02296346|12462643|FG000|COMPLETED|Overall Study||2
11266895|NCT02296346|12462644|FG001|COMPLETED|Overall Study||0
11266896|NCT02296346|12462643|FG000|NOT COMPLETED|Overall Study||5
11266897|NCT02296346|12462644|FG001|NOT COMPLETED|Overall Study||6
11266898|NCT02296424|12462654|FG000|STARTED|Part 1|16 patients immediately went into Part II|84
11266899|NCT02296424|12462655|FG001|STARTED|Part 1||98
11266900|NCT02296424|12462656|FG002|STARTED|Part 1||0
11266901|NCT02296424|12462657|FG003|STARTED|Part 1||0
11266902|NCT02296424|12462654|FG000|COMPLETED|Part 1||61
11266903|NCT02296424|12462655|FG001|COMPLETED|Part 1||65
11266904|NCT02296424|12462656|FG002|COMPLETED|Part 1||0
11266905|NCT02296424|12462657|FG003|COMPLETED|Part 1||0
11266906|NCT02296424|12462654|FG000|NOT COMPLETED|Part 1||23
11266907|NCT02296424|12462655|FG001|NOT COMPLETED|Part 1||33
11266908|NCT02296424|12462656|FG002|NOT COMPLETED|Part 1||0
11266909|NCT02296424|12462657|FG003|NOT COMPLETED|Part 1||0
11266910|NCT02296424|12462654|FG000|STARTED|Part 2||0
11266911|NCT02296424|12462655|FG001|STARTED|Part 2||0
11266912|NCT02296424|12462656|FG002|STARTED|Part 2||38
11266913|NCT02296424|12462657|FG003|STARTED|Part 2||37
11266914|NCT02296424|12462654|FG000|COMPLETED|Part 2||0
11266915|NCT02296424|12462655|FG001|COMPLETED|Part 2||0
11266916|NCT02296424|12462656|FG002|COMPLETED|Part 2||35
11266917|NCT02296424|12462657|FG003|COMPLETED|Part 2||37
11266918|NCT02296424|12462654|FG000|NOT COMPLETED|Part 2||0
11266919|NCT02296424|12462655|FG001|NOT COMPLETED|Part 2||0
11266920|NCT02296424|12462656|FG002|NOT COMPLETED|Part 2||3
11266921|NCT02296424|12462657|FG003|NOT COMPLETED|Part 2||0
11266922|NCT02296476|12462668|FG000|STARTED|Overall Study||6
11266923|NCT02296476|12462669|FG001|STARTED|Overall Study||4
11266924|NCT02296476|12462670|FG002|STARTED|Overall Study||2
11266925|NCT02296476|12462668|FG000|COMPLETED|Overall Study||0
11266926|NCT02296476|12462669|FG001|COMPLETED|Overall Study||0
11266927|NCT02296476|12462670|FG002|COMPLETED|Overall Study||0
11266928|NCT02296476|12462668|FG000|NOT COMPLETED|Overall Study||6
11266929|NCT02296476|12462669|FG001|NOT COMPLETED|Overall Study||4
11266930|NCT02296476|12462670|FG002|NOT COMPLETED|Overall Study||2
11266931|NCT02296502|12462682|FG000|STARTED|Overall Study||248
11266932|NCT02296502|12462683|FG001|STARTED|Overall Study||1
11266933|NCT02296502|12462684|FG002|STARTED|Overall Study||30
11266934|NCT02296502|12462685|FG003|STARTED|Overall Study||160
11266935|NCT02296502|12462682|FG000|COMPLETED|Overall Study||248
11266936|NCT02296502|12462683|FG001|COMPLETED|Overall Study||1
11266937|NCT02296502|12462684|FG002|COMPLETED|Overall Study||30
11266938|NCT02296502|12462685|FG003|COMPLETED|Overall Study||160
11266939|NCT02296502|12462682|FG000|NOT COMPLETED|Overall Study||0
11266940|NCT02296502|12462683|FG001|NOT COMPLETED|Overall Study||0
11266941|NCT02296502|12462684|FG002|NOT COMPLETED|Overall Study||0
11266942|NCT02296502|12462685|FG003|NOT COMPLETED|Overall Study||0
11266943|NCT02296606|12462698|FG000|STARTED|Overall Study||127
11266944|NCT02296606|12462698|FG000|COMPLETED|Overall Study||127
11266945|NCT02296606|12462698|FG000|NOT COMPLETED|Overall Study||0
11266946|NCT02296775|12462705|FG000|STARTED|Treatment and Evaluation||91
11266947|NCT02296775|12462706|FG001|STARTED|Treatment and Evaluation||92
11266948|NCT02296775|12462707|FG002|STARTED|Treatment and Evaluation||93
11266949|NCT02296775|12462705|FG000|COMPLETED|Treatment and Evaluation||87
11266950|NCT02296775|12462706|FG001|COMPLETED|Treatment and Evaluation||84
11266951|NCT02296775|12462707|FG002|COMPLETED|Treatment and Evaluation||83
11266952|NCT02296775|12462705|FG000|NOT COMPLETED|Treatment and Evaluation||4
11266953|NCT02296775|12462706|FG001|NOT COMPLETED|Treatment and Evaluation||8
11266954|NCT02296775|12462707|FG002|NOT COMPLETED|Treatment and Evaluation||10
11266955|NCT02296775|12462705|FG000|STARTED|Recovery and Follow-up||87
11266956|NCT02296775|12462706|FG001|STARTED|Recovery and Follow-up||84
11266957|NCT02296775|12462707|FG002|STARTED|Recovery and Follow-up||83
11266958|NCT02296775|12462705|FG000|COMPLETED|Recovery and Follow-up||82
11266959|NCT02296775|12462706|FG001|COMPLETED|Recovery and Follow-up||79
11266960|NCT02296775|12462707|FG002|COMPLETED|Recovery and Follow-up||79
11266961|NCT02296775|12462705|FG000|NOT COMPLETED|Recovery and Follow-up||5
11266962|NCT02296775|12462706|FG001|NOT COMPLETED|Recovery and Follow-up||5
11266963|NCT02296775|12462707|FG002|NOT COMPLETED|Recovery and Follow-up||4
11266964|NCT02296840|12462717|FG000|STARTED|Overall Study||18
11266965|NCT02296840|12462718|FG001|STARTED|Overall Study||27
11266966|NCT02296840|12462717|FG000|COMPLETED|Overall Study||9
11266967|NCT02296840|12462718|FG001|COMPLETED|Overall Study||8
11266968|NCT02296840|12462717|FG000|NOT COMPLETED|Overall Study||9
11266969|NCT02296840|12462718|FG001|NOT COMPLETED|Overall Study||19
11266970|NCT02296853|12462726|FG000|STARTED|Overall Study||10
11266971|NCT02296853|12462727|FG001|STARTED|Overall Study||10
11266972|NCT02296853|12462726|FG000|COMPLETED|Overall Study||10
11266973|NCT02296853|12462727|FG001|COMPLETED|Overall Study||10
11266974|NCT02296853|12462726|FG000|NOT COMPLETED|Overall Study||0
11266975|NCT02296853|12462727|FG001|NOT COMPLETED|Overall Study||0
11266976|NCT02296892|12462736|FG000|STARTED|Overall Study||310
11266977|NCT02296892|12462737|FG001|STARTED|Overall Study||63
11266978|NCT02296892|12462738|FG002|STARTED|Overall Study||73
11266979|NCT02296892|12462736|FG000|Safety Population|Overall Study||303
11266980|NCT02296892|12462737|FG001|Safety Population|Overall Study||59
11266981|NCT02296892|12462738|FG002|Safety Population|Overall Study||69
11266982|NCT02296892|12462736|FG000|Complete Trial Treatment Period|Overall Study||303
11266983|NCT02296892|12462737|FG001|Complete Trial Treatment Period|Overall Study||59
11266984|NCT02296892|12462738|FG002|Complete Trial Treatment Period|Overall Study||69
11266985|NCT02296892|12462736|FG000|COMPLETED|Overall Study||298
11266986|NCT02296892|12462737|FG001|COMPLETED|Overall Study||59
11266987|NCT02296892|12462738|FG002|COMPLETED|Overall Study||68
11266988|NCT02296892|12462736|FG000|NOT COMPLETED|Overall Study||12
11266989|NCT02296892|12462737|FG001|NOT COMPLETED|Overall Study||4
11266990|NCT02296892|12462738|FG002|NOT COMPLETED|Overall Study||5
11266991|NCT02296931|12462748|FG000|STARTED|Overall Study||10
11266992|NCT02296931|12462749|FG001|STARTED|Overall Study||24
11266993|NCT02296931|12462748|FG000|COMPLETED|Overall Study||10
11266994|NCT02296931|12462749|FG001|COMPLETED|Overall Study||22
11266995|NCT02296931|12462748|FG000|NOT COMPLETED|Overall Study||0
11266996|NCT02296931|12462749|FG001|NOT COMPLETED|Overall Study||2
11266997|NCT02297100|12462757|FG000|STARTED|Overall Study||13
11266998|NCT02297100|12462758|FG001|STARTED|Overall Study||14
11266999|NCT02297100|12462757|FG000|COMPLETED|Overall Study||13
11267000|NCT02297100|12462758|FG001|COMPLETED|Overall Study||14
11267001|NCT02297100|12462757|FG000|NOT COMPLETED|Overall Study||0
11267002|NCT02297100|12462758|FG001|NOT COMPLETED|Overall Study||0
11267003|NCT02297308|12462764|FG000|STARTED|Overall Study||90
11267004|NCT02297308|12462764|FG000|COMPLETED|Overall Study||90
11267005|NCT02297308|12462764|FG000|NOT COMPLETED|Overall Study||0
11267006|NCT02297516|12462771|FG000|STARTED|Single Treatment Phase (6 Months)||32
11267007|NCT02297516|12462772|FG001|STARTED|Single Treatment Phase (6 Months)||33
11267008|NCT02297516|12462771|FG000|COMPLETED|Single Treatment Phase (6 Months)||31
11267009|NCT02297516|12462772|FG001|COMPLETED|Single Treatment Phase (6 Months)||31
11267010|NCT02297516|12462771|FG000|NOT COMPLETED|Single Treatment Phase (6 Months)||1
11267011|NCT02297516|12462772|FG001|NOT COMPLETED|Single Treatment Phase (6 Months)||2
11143748|NCT01474512|12330433|FG011|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26
11143749|NCT01474512|12330434|FG012|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054
11267012|NCT02297516|12462771|FG000|STARTED|Combination Treatment Phase (up to 18 m)||31
11267013|NCT02297516|12462772|FG001|STARTED|Combination Treatment Phase (up to 18 m)||31
11397222|NCT04103515|12591275|FG001|COMPLETED|Overall Study||25
11397223|NCT04103515|12591274|FG000|NOT COMPLETED|Overall Study||0
11397224|NCT04103515|12591275|FG001|NOT COMPLETED|Overall Study||0
11397225|NCT04111276|12591281|FG000|STARTED|Overall Study||23
11267014|NCT02297516|12462771|FG000|COMPLETED|Combination Treatment Phase (up to 18 m)||31
11267015|NCT02297516|12462772|FG001|COMPLETED|Combination Treatment Phase (up to 18 m)||30
11267016|NCT02297516|12462771|FG000|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0
11267017|NCT02297516|12462772|FG001|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1
11267018|NCT02297815|12462787|FG000|STARTED|Overall Study||1604
11267019|NCT02297815|12462788|FG001|STARTED|Overall Study||868
11267020|NCT02297815|12462787|FG000|5-10 Day Interview|Overall Study||1604
11267021|NCT02297815|12462788|FG001|5-10 Day Interview|Overall Study||868
11267022|NCT02297815|12462787|FG000|14-20 Day Interview|Overall Study||1368
11267023|NCT02297815|12462788|FG001|14-20 Day Interview|Overall Study||728
11267024|NCT02297815|12462787|FG000|COMPLETED|Overall Study||1368
11267025|NCT02297815|12462788|FG001|COMPLETED|Overall Study||728
11267026|NCT02297815|12462787|FG000|NOT COMPLETED|Overall Study||236
11267027|NCT02297815|12462788|FG001|NOT COMPLETED|Overall Study||140
11267028|NCT02297841|12462796|FG000|STARTED|Overall Study||209
11267029|NCT02297841|12462796|FG000|Induction Phase|Overall Study||209
11267030|NCT02297841|12462796|FG000|Challenge Phase|Overall Study||201
11267031|NCT02297841|12462796|FG000|COMPLETED|Overall Study||201
11267032|NCT02297841|12462796|FG000|NOT COMPLETED|Overall Study||8
11340248|NCT02919111|12537548|FG000|STARTED|Overall Study||299
11397226|NCT04111276|12591281|FG000|COMPLETED|Overall Study||20
11397227|NCT04111276|12591281|FG000|NOT COMPLETED|Overall Study||3
11397228|NCT04123405|12591289|FG000|STARTED|Overall Study||235
11397229|NCT04123405|12591290|FG001|STARTED|Overall Study||238
11397230|NCT04123405|12591291|FG002|STARTED|Overall Study||238
11397231|NCT04123405|12591292|FG003|STARTED|Overall Study||233
11397232|NCT04123405|12591289|FG000|Full Analysis Set|Overall Study||235
11397233|NCT04123405|12591290|FG001|Full Analysis Set|Overall Study||236
11397234|NCT04123405|12591291|FG002|Full Analysis Set|Overall Study||238
11267033|NCT02298023|12462803|FG000|STARTED|Overall Study||8
11267034|NCT02298023|12462804|FG001|STARTED|Overall Study||8
11267035|NCT02298023|12462805|FG002|STARTED|Overall Study||8
11267036|NCT02298023|12462803|FG000|Intervention|Overall Study|Withdrawal by participant before intervention.|7
11267037|NCT02298023|12462804|FG001|Intervention|Overall Study||8
11267038|NCT02298023|12462805|FG002|Intervention|Overall Study||8
11397235|NCT04123405|12591292|FG003|Full Analysis Set|Overall Study||230
11397236|NCT04123405|12591289|FG000|Per-protocol Set|Overall Study||213
11397237|NCT04123405|12591290|FG001|Per-protocol Set|Overall Study||215
11397238|NCT04123405|12591291|FG002|Per-protocol Set|Overall Study||212
11397239|NCT04123405|12591292|FG003|Per-protocol Set|Overall Study||207
11397240|NCT04123405|12591289|FG000|Safety Set|Overall Study||235
11267039|NCT02298023|12462803|FG000|COMPLETED|Overall Study||7
11267040|NCT02298023|12462804|FG001|COMPLETED|Overall Study||8
11267041|NCT02298023|12462805|FG002|COMPLETED|Overall Study||8
11267042|NCT02298023|12462803|FG000|NOT COMPLETED|Overall Study||1
11267043|NCT02298023|12462804|FG001|NOT COMPLETED|Overall Study||0
11267044|NCT02298023|12462805|FG002|NOT COMPLETED|Overall Study||0
11267045|NCT02298179|12462828|FG000|STARTED|Overall Study||24
11267046|NCT02298179|12462829|FG001|STARTED|Overall Study||24
11267047|NCT02298179|12462830|FG002|STARTED|Overall Study||24
11267048|NCT02298179|12462831|FG003|STARTED|Overall Study||24
11267049|NCT02298179|12462832|FG004|STARTED|Overall Study||24
11267050|NCT02298179|12462833|FG005|STARTED|Overall Study||24
11267051|NCT02298179|12462834|FG006|STARTED|Overall Study||24
11267052|NCT02298179|12462835|FG007|STARTED|Overall Study||24
11267053|NCT02298179|12462836|FG008|STARTED|Overall Study||24
11267054|NCT02298179|12462837|FG009|STARTED|Overall Study||24
11267055|NCT02298179|12462838|FG010|STARTED|Overall Study||24
11267056|NCT02298179|12462839|FG011|STARTED|Overall Study||24
11267057|NCT02298179|12462828|FG000|COMPLETED|Overall Study||24
11267058|NCT02298179|12462829|FG001|COMPLETED|Overall Study||24
11267059|NCT02298179|12462830|FG002|COMPLETED|Overall Study||23
11267060|NCT02298179|12462831|FG003|COMPLETED|Overall Study||24
11267061|NCT02298179|12462832|FG004|COMPLETED|Overall Study||24
11267062|NCT02298179|12462833|FG005|COMPLETED|Overall Study||24
11267063|NCT02298179|12462834|FG006|COMPLETED|Overall Study||24
11267064|NCT02298179|12462835|FG007|COMPLETED|Overall Study||23
11267065|NCT02298179|12462836|FG008|COMPLETED|Overall Study||24
11267066|NCT02298179|12462837|FG009|COMPLETED|Overall Study||24
11267067|NCT02298179|12462838|FG010|COMPLETED|Overall Study||24
11267068|NCT02298179|12462839|FG011|COMPLETED|Overall Study||24
11267069|NCT02298179|12462828|FG000|NOT COMPLETED|Overall Study||0
11267070|NCT02298179|12462829|FG001|NOT COMPLETED|Overall Study||0
11267071|NCT02298179|12462830|FG002|NOT COMPLETED|Overall Study||1
11267072|NCT02298179|12462831|FG003|NOT COMPLETED|Overall Study||0
11267073|NCT02298179|12462832|FG004|NOT COMPLETED|Overall Study||0
11267074|NCT02298179|12462833|FG005|NOT COMPLETED|Overall Study||0
11267075|NCT02298179|12462834|FG006|NOT COMPLETED|Overall Study||0
11267076|NCT02298179|12462835|FG007|NOT COMPLETED|Overall Study||1
11267077|NCT02298179|12462836|FG008|NOT COMPLETED|Overall Study||0
11267078|NCT02298179|12462837|FG009|NOT COMPLETED|Overall Study||0
11267079|NCT02298179|12462838|FG010|NOT COMPLETED|Overall Study||0
11267080|NCT02298179|12462839|FG011|NOT COMPLETED|Overall Study||0
11267081|NCT02298192|12462867|FG000|STARTED|Overall Study||210
11267082|NCT02298192|12462868|FG001|STARTED|Overall Study||210
11267083|NCT02298192|12462867|FG000|COMPLETED|Overall Study||191
11267084|NCT02298192|12462868|FG001|COMPLETED|Overall Study||204
11267085|NCT02298192|12462867|FG000|NOT COMPLETED|Overall Study||19
11267086|NCT02298192|12462868|FG001|NOT COMPLETED|Overall Study||6
11267087|NCT02298322|12462874|FG000|STARTED|Overall Study||60
11267088|NCT02298322|12462874|FG000|COMPLETED|Overall Study||60
11267089|NCT02298322|12462874|FG000|NOT COMPLETED|Overall Study||0
11267090|NCT02298361|12462884|FG000|STARTED|Overall Study||2240
11267091|NCT02298361|12462885|FG001|STARTED|Overall Study||12784
11267092|NCT02298361|12462886|FG002|STARTED|Overall Study||12227
11267093|NCT02298361|12462884|FG000|COMPLETED|Overall Study||2240
11267094|NCT02298361|12462885|FG001|COMPLETED|Overall Study||12784
11267095|NCT02298361|12462886|FG002|COMPLETED|Overall Study||12227
11267096|NCT02298361|12462884|FG000|NOT COMPLETED|Overall Study||0
11267097|NCT02298361|12462885|FG001|NOT COMPLETED|Overall Study||0
11267098|NCT02298361|12462886|FG002|NOT COMPLETED|Overall Study||0
11267099|NCT02298491|12462894|FG000|STARTED|Overall Study||4
11267100|NCT02298491|12462894|FG000|COMPLETED|Overall Study||3
11267101|NCT02298491|12462894|FG000|NOT COMPLETED|Overall Study||1
11267102|NCT02298803|12462900|FG000|STARTED|Overall Study||30
11267103|NCT02298803|12462900|FG000|COMPLETED|Overall Study||30
11267104|NCT02298803|12462900|FG000|NOT COMPLETED|Overall Study||0
11267105|NCT02298842|12462911|FG000|STARTED|First Platelet Donation (Day 0)||44
11267106|NCT02298842|12462912|FG001|STARTED|First Platelet Donation (Day 0)||41
11267107|NCT02298842|12462911|FG000|COMPLETED|First Platelet Donation (Day 0)||38
11267108|NCT02298842|12462912|FG001|COMPLETED|First Platelet Donation (Day 0)||36
11267109|NCT02298842|12462911|FG000|NOT COMPLETED|First Platelet Donation (Day 0)||6
11267110|NCT02298842|12462912|FG001|NOT COMPLETED|First Platelet Donation (Day 0)||5
11267111|NCT02298842|12462911|FG000|STARTED|Second Platelet Donation (Day 6-8)||38
11267112|NCT02298842|12462912|FG001|STARTED|Second Platelet Donation (Day 6-8)||36
11267113|NCT02298842|12462911|FG000|COMPLETED|Second Platelet Donation (Day 6-8)||30
11267114|NCT02298842|12462912|FG001|COMPLETED|Second Platelet Donation (Day 6-8)||30
11267115|NCT02298842|12462911|FG000|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
11267116|NCT02298842|12462912|FG001|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
11267117|NCT02298868|12462920|FG000|STARTED|Overall Study||10
11267118|NCT02298868|12462920|FG000|COMPLETED|Overall Study||7
11267119|NCT02298868|12462920|FG000|NOT COMPLETED|Overall Study||3
11267120|NCT02298933|12462924|FG000|STARTED|Overall Study||10
11267121|NCT02298933|12462924|FG000|COMPLETED|Overall Study||10
11267122|NCT02298933|12462924|FG000|NOT COMPLETED|Overall Study||0
11267123|NCT02298946|12462930|FG000|STARTED|Overall Study||8
11267124|NCT02298946|12462931|FG001|STARTED|Overall Study||9
11267125|NCT02298946|12462930|FG000|COMPLETED|Overall Study||4
11267126|NCT02298946|12462931|FG001|COMPLETED|Overall Study||8
11267127|NCT02298946|12462930|FG000|NOT COMPLETED|Overall Study||4
11267128|NCT02298946|12462931|FG001|NOT COMPLETED|Overall Study||1
11267129|NCT02299050|12462938|FG000|STARTED|Overall Study||23
11267130|NCT02299050|12462938|FG000|COMPLETED|Overall Study||15
11267131|NCT02299050|12462938|FG000|NOT COMPLETED|Overall Study||8
11267132|NCT02299076|12462944|FG000|STARTED|Overall Study||230
11267133|NCT02299076|12462945|FG001|STARTED|Overall Study||226
11267134|NCT02299076|12462944|FG000|COMPLETED|Overall Study||210
11267135|NCT02299076|12462945|FG001|COMPLETED|Overall Study||212
11267136|NCT02299076|12462944|FG000|NOT COMPLETED|Overall Study||20
11267137|NCT02299076|12462945|FG001|NOT COMPLETED|Overall Study||14
11267138|NCT02299089|12462955|FG000|STARTED|Overall Study||3
11267139|NCT02299089|12462956|FG001|STARTED|Overall Study||4
11267140|NCT02299089|12462957|FG002|STARTED|Overall Study||1
11267141|NCT02299089|12462958|FG003|STARTED|Overall Study||4
11267142|NCT02299089|12462955|FG000|COMPLETED|Overall Study||3
11267143|NCT02299089|12462956|FG001|COMPLETED|Overall Study||4
11267144|NCT02299089|12462957|FG002|COMPLETED|Overall Study||1
11267145|NCT02299089|12462958|FG003|COMPLETED|Overall Study||4
11267146|NCT02299089|12462955|FG000|NOT COMPLETED|Overall Study||0
11267147|NCT02299089|12462956|FG001|NOT COMPLETED|Overall Study||0
11267148|NCT02299089|12462957|FG002|NOT COMPLETED|Overall Study||0
11267149|NCT02299089|12462958|FG003|NOT COMPLETED|Overall Study||0
11267150|NCT02299141|12462978|FG000|STARTED|Overall Study||20
11267151|NCT02299141|12462978|FG000|COMPLETED|Overall Study||20
11267152|NCT02299141|12462978|FG000|NOT COMPLETED|Overall Study||0
11267153|NCT02299167|12462989|FG000|STARTED|Overall Study||35
11267154|NCT02299167|12462989|FG000|Dural Puncture|Overall Study||24
11267155|NCT02299167|12462989|FG000|Success Rate|Overall Study||24
11267156|NCT02299167|12462989|FG000|Adverse Effects|Overall Study||24
11267157|NCT02299167|12462989|FG000|COMPLETED|Overall Study||24
11267158|NCT02299167|12462989|FG000|NOT COMPLETED|Overall Study||11
11267159|NCT02299258|12462995|FG000|STARTED|Overall Study||32
11267160|NCT02299258|12462996|FG001|STARTED|Overall Study||31
11267161|NCT02299258|12462995|FG000|COMPLETED|Overall Study||31
11267162|NCT02299258|12462996|FG001|COMPLETED|Overall Study||30
11267163|NCT02299258|12462995|FG000|NOT COMPLETED|Overall Study||1
11267164|NCT02299258|12462996|FG001|NOT COMPLETED|Overall Study||1
11267165|NCT02299297|12463002|FG000|STARTED|Overall Study||12
11267166|NCT02299297|12463002|FG000|COMPLETED|Overall Study||11
11267167|NCT02299297|12463002|FG000|NOT COMPLETED|Overall Study||1
11267168|NCT02299336|12463006|FG000|STARTED|Overall Study||60
11267169|NCT02299336|12463006|FG000|COMPLETED|Overall Study||46
11397241|NCT04123405|12591290|FG001|Safety Set|Overall Study||238
11397242|NCT04123405|12591291|FG002|Safety Set|Overall Study||238
11397243|NCT04123405|12591292|FG003|Safety Set|Overall Study||233
11397244|NCT04123405|12591289|FG000|COMPLETED|Overall Study||231
11397245|NCT04123405|12591290|FG001|COMPLETED|Overall Study||231
11397246|NCT04123405|12591291|FG002|COMPLETED|Overall Study||235
11397247|NCT04123405|12591292|FG003|COMPLETED|Overall Study||225
11397248|NCT04123405|12591289|FG000|NOT COMPLETED|Overall Study||4
11397249|NCT04123405|12591290|FG001|NOT COMPLETED|Overall Study||7
11397250|NCT04123405|12591291|FG002|NOT COMPLETED|Overall Study||3
11397251|NCT04123405|12591292|FG003|NOT COMPLETED|Overall Study||8
11397252|NCT04128527|12591302|FG000|STARTED|Overall Study||16
11397253|NCT04128527|12591302|FG000|COMPLETED|Overall Study||16
11397254|NCT04128527|12591302|FG000|NOT COMPLETED|Overall Study||0
11397255|NCT04132973|12591306|FG000|STARTED|Overall Study||34
11267170|NCT02299336|12463006|FG000|NOT COMPLETED|Overall Study||14
11267171|NCT02299349|12463012|FG000|STARTED|Overall Study||35
11267172|NCT02299349|12463013|FG001|STARTED|Overall Study||35
11267173|NCT02299349|12463012|FG000|COMPLETED|Overall Study||35
11267174|NCT02299349|12463013|FG001|COMPLETED|Overall Study||35
11267175|NCT02299349|12463012|FG000|NOT COMPLETED|Overall Study||0
11267176|NCT02299349|12463013|FG001|NOT COMPLETED|Overall Study||0
11267177|NCT02299375|12463021|FG000|STARTED|Overall Study||94
11267178|NCT02299375|12463022|FG001|STARTED|Overall Study||90
11267179|NCT02299375|12463021|FG000|COMPLETED|Overall Study||14
11267180|NCT02299375|12463022|FG001|COMPLETED|Overall Study||10
11267181|NCT02299375|12463021|FG000|NOT COMPLETED|Overall Study||80
11267182|NCT02299375|12463022|FG001|NOT COMPLETED|Overall Study||80
11267183|NCT02299388|12463031|FG000|STARTED|Overall Study||6
11267184|NCT02299388|12463032|FG001|STARTED|Overall Study||5
11267185|NCT02299388|12463031|FG000|COMPLETED|Overall Study||6
11267186|NCT02299388|12463032|FG001|COMPLETED|Overall Study||4
11267187|NCT02299388|12463031|FG000|NOT COMPLETED|Overall Study||0
11267188|NCT02299388|12463032|FG001|NOT COMPLETED|Overall Study||1
11267189|NCT02299427|12463040|FG000|STARTED|Overall Study||35
11267190|NCT02299427|12463041|FG001|STARTED|Overall Study||34
11267191|NCT02299427|12463040|FG000|COMPLETED|Overall Study||12
11267192|NCT02299427|12463041|FG001|COMPLETED|Overall Study||31
11267193|NCT02299427|12463040|FG000|NOT COMPLETED|Overall Study||23
11397256|NCT04132973|12591306|FG000|Completed Intervention|Overall Study||11
11397257|NCT04132973|12591306|FG000|COMPLETED|Overall Study||8
11267194|NCT02299427|12463041|FG001|NOT COMPLETED|Overall Study||3
11267195|NCT02299479|12463047|FG000|STARTED|Overall Study||20
11267196|NCT02299479|12463047|FG000|COMPLETED|Overall Study||18
11267197|NCT02299479|12463047|FG000|NOT COMPLETED|Overall Study||2
11267198|NCT02299570|12463054|FG000|STARTED|Overall Study||45
11397258|NCT04132973|12591306|FG000|NOT COMPLETED|Overall Study||26
11397259|NCT04133415|12591310|FG000|STARTED|Overall Study||20
11397260|NCT04133415|12591310|FG000|COMPLETED|Overall Study||20
11397261|NCT04133415|12591310|FG000|NOT COMPLETED|Overall Study||0
11397262|NCT04138758|12591316|FG000|STARTED|Overall Study||2600
11267199|NCT02299570|12463055|FG001|STARTED|Overall Study||44
11267200|NCT02299570|12463056|FG002|STARTED|Overall Study||44
11267201|NCT02299570|12463054|FG000|COMPLETED|Overall Study||31
11267202|NCT02299570|12463055|FG001|COMPLETED|Overall Study||35
11267203|NCT02299570|12463056|FG002|COMPLETED|Overall Study||25
11267204|NCT02299570|12463054|FG000|NOT COMPLETED|Overall Study||14
11021575|NCT00805025|12199680|FG000|STARTED|Overall Study||131
11021576|NCT00805025|12199680|FG000|Enrolled and Treated|Overall Study||89
11021577|NCT00805025|12199680|FG000|COMPLETED|Overall Study||82
11021578|NCT00805025|12199680|FG000|NOT COMPLETED|Overall Study||49
11021579|NCT00805038|12199686|FG000|STARTED|Overall Study||75
11021580|NCT00805038|12199687|FG001|STARTED|Overall Study||92
11021581|NCT00805038|12199686|FG000|COMPLETED|Overall Study||75
11021582|NCT00805038|12199687|FG001|COMPLETED|Overall Study||92
11021583|NCT00805038|12199686|FG000|NOT COMPLETED|Overall Study||0
11021584|NCT00805038|12199687|FG001|NOT COMPLETED|Overall Study||0
11021585|NCT00805142|12199695|FG000|STARTED|Titration Period||36
11021586|NCT00805142|12199696|FG001|STARTED|Titration Period||42
11021587|NCT00805142|12199695|FG000|COMPLETED|Titration Period||30
11021588|NCT00805142|12199696|FG001|COMPLETED|Titration Period||32
11021589|NCT00805142|12199695|FG000|NOT COMPLETED|Titration Period||6
11021590|NCT00805142|12199696|FG001|NOT COMPLETED|Titration Period||10
11021591|NCT00805142|12199695|FG000|STARTED|Maintenance Period||30
11021592|NCT00805142|12199696|FG001|STARTED|Maintenance Period||32
11021593|NCT00805142|12199695|FG000|COMPLETED|Maintenance Period||30
11021594|NCT00805142|12199696|FG001|COMPLETED|Maintenance Period||30
11021595|NCT00805142|12199695|FG000|NOT COMPLETED|Maintenance Period||0
11021596|NCT00805142|12199696|FG001|NOT COMPLETED|Maintenance Period||2
11021597|NCT00805194|12199711|FG000|STARTED|Overall Study|randomised patients|655
11021598|NCT00805194|12199712|FG001|STARTED|Overall Study|randomised patients|659
11267205|NCT02299570|12463055|FG001|NOT COMPLETED|Overall Study||9
11267206|NCT02299570|12463056|FG002|NOT COMPLETED|Overall Study||19
11267207|NCT02299635|12463069|FG000|STARTED|Overall Study||19
11267208|NCT02299635|12463069|FG000|COMPLETED|Overall Study||0
11267209|NCT02299635|12463069|FG000|NOT COMPLETED|Overall Study||19
11267210|NCT02299791|12463075|FG000|STARTED|Overall Study||2053
11267211|NCT02299791|12463076|FG001|STARTED|Overall Study||2803
11267212|NCT02299791|12463075|FG000|COMPLETED|Overall Study||2053
11267213|NCT02299791|12463076|FG001|COMPLETED|Overall Study||2803
11267214|NCT02299791|12463075|FG000|NOT COMPLETED|Overall Study||0
11267215|NCT02299791|12463076|FG001|NOT COMPLETED|Overall Study||0
11267216|NCT02299869|12463086|FG000|STARTED|Overall Study||10
11267217|NCT02299869|12463087|FG001|STARTED|Overall Study||10
11267218|NCT02299869|12463088|FG002|STARTED|Overall Study||10
11267219|NCT02299869|12463089|FG003|STARTED|Overall Study||10
11267220|NCT02299869|12463086|FG000|COMPLETED|Overall Study||10
11267221|NCT02299869|12463087|FG001|COMPLETED|Overall Study||10
11267222|NCT02299869|12463088|FG002|COMPLETED|Overall Study||10
11267223|NCT02299869|12463089|FG003|COMPLETED|Overall Study||10
11267224|NCT02299869|12463086|FG000|NOT COMPLETED|Overall Study||0
11267225|NCT02299869|12463087|FG001|NOT COMPLETED|Overall Study||0
11267226|NCT02299869|12463088|FG002|NOT COMPLETED|Overall Study||0
11267227|NCT02299869|12463089|FG003|NOT COMPLETED|Overall Study||0
11267228|NCT02300025|12463100|FG000|STARTED|Overall Study||10
11267229|NCT02300025|12463101|FG001|STARTED|Overall Study||6
11267230|NCT02300025|12463102|FG002|STARTED|Overall Study||6
11267231|NCT02300025|12463103|FG003|STARTED|Overall Study||6
11267232|NCT02300025|12463100|FG000|COMPLETED|Overall Study||10
11267233|NCT02300025|12463101|FG001|COMPLETED|Overall Study||6
11267234|NCT02300025|12463102|FG002|COMPLETED|Overall Study||6
11267235|NCT02300025|12463103|FG003|COMPLETED|Overall Study||6
11267236|NCT02300025|12463100|FG000|NOT COMPLETED|Overall Study||0
11267237|NCT02300025|12463101|FG001|NOT COMPLETED|Overall Study||0
11267238|NCT02300025|12463102|FG002|NOT COMPLETED|Overall Study||0
11267239|NCT02300025|12463103|FG003|NOT COMPLETED|Overall Study||0
11267240|NCT02300077|12463117|FG000|STARTED|Overall Study||21
11267241|NCT02300077|12463118|FG001|STARTED|Overall Study||18
11267242|NCT02300077|12463119|FG002|STARTED|Overall Study||21
11267243|NCT02300077|12463117|FG000|COMPLETED|Overall Study||21
11267244|NCT02300077|12463118|FG001|COMPLETED|Overall Study||18
11267245|NCT02300077|12463119|FG002|COMPLETED|Overall Study||21
11267246|NCT02300077|12463117|FG000|NOT COMPLETED|Overall Study||0
11267247|NCT02300077|12463118|FG001|NOT COMPLETED|Overall Study||0
11267248|NCT02300077|12463119|FG002|NOT COMPLETED|Overall Study||0
11267249|NCT02300103|12463127|FG000|STARTED|Overall Study||69
11021599|NCT00805194|12199711|FG000|COMPLETED|Overall Study||6
11021600|NCT00805194|12199712|FG001|COMPLETED|Overall Study||5
11267250|NCT02300103|12463127|FG000|COMPLETED|Overall Study||63
11267251|NCT02300103|12463127|FG000|NOT COMPLETED|Overall Study||6
11267252|NCT02300129|12463131|FG000|STARTED|Period 1 Session 1 (Day 1)||11
11267253|NCT02300129|12463132|FG001|STARTED|Period 1 Session 1 (Day 1)||5
11267254|NCT02300129|12463133|FG002|STARTED|Period 1 Session 1 (Day 1)||7
11267255|NCT02300129|12463134|FG003|STARTED|Period 1 Session 1 (Day 1)||11
11267256|NCT02300129|12463131|FG000|COMPLETED|Period 1 Session 1 (Day 1)||11
11267257|NCT02300129|12463132|FG001|COMPLETED|Period 1 Session 1 (Day 1)||5
11267258|NCT02300129|12463133|FG002|COMPLETED|Period 1 Session 1 (Day 1)||7
11267259|NCT02300129|12463134|FG003|COMPLETED|Period 1 Session 1 (Day 1)||11
11267260|NCT02300129|12463131|FG000|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
11267261|NCT02300129|12463132|FG001|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
11267262|NCT02300129|12463133|FG002|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
11267263|NCT02300129|12463134|FG003|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
11267264|NCT02300129|12463131|FG000|STARTED|Period 1 Session 2 (Day 3)||11
11267265|NCT02300129|12463132|FG001|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
11267266|NCT02300129|12463133|FG002|STARTED|Period 1 Session 2 (Day 3)||7
11267267|NCT02300129|12463134|FG003|STARTED|Period 1 Session 2 (Day 3)||11
11267268|NCT02300129|12463131|FG000|COMPLETED|Period 1 Session 2 (Day 3)||11
11267269|NCT02300129|12463132|FG001|COMPLETED|Period 1 Session 2 (Day 3)||4
11267270|NCT02300129|12463133|FG002|COMPLETED|Period 1 Session 2 (Day 3)||7
11267271|NCT02300129|12463134|FG003|COMPLETED|Period 1 Session 2 (Day 3)||11
11267272|NCT02300129|12463131|FG000|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
11267273|NCT02300129|12463132|FG001|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
11267274|NCT02300129|12463133|FG002|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
11267275|NCT02300129|12463134|FG003|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
11267276|NCT02300129|12463131|FG000|STARTED|Period 1 Session 3 (Day 5)||11
11267277|NCT02300129|12463132|FG001|STARTED|Period 1 Session 3 (Day 5)||4
11267278|NCT02300129|12463133|FG002|STARTED|Period 1 Session 3 (Day 5)||7
11267279|NCT02300129|12463134|FG003|STARTED|Period 1 Session 3 (Day 5)||11
11267280|NCT02300129|12463131|FG000|COMPLETED|Period 1 Session 3 (Day 5)||11
11267281|NCT02300129|12463132|FG001|COMPLETED|Period 1 Session 3 (Day 5)||4
11267282|NCT02300129|12463133|FG002|COMPLETED|Period 1 Session 3 (Day 5)||7
11267283|NCT02300129|12463134|FG003|COMPLETED|Period 1 Session 3 (Day 5)||11
11267284|NCT02300129|12463131|FG000|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
11267285|NCT02300129|12463132|FG001|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
11267286|NCT02300129|12463133|FG002|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
11267287|NCT02300129|12463134|FG003|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
11267288|NCT02300129|12463131|FG000|STARTED|Period 2 Treatment 1 (2 Weeks)||11
11267289|NCT02300129|12463132|FG001|STARTED|Period 2 Treatment 1 (2 Weeks)||4
11267290|NCT02300129|12463133|FG002|STARTED|Period 2 Treatment 1 (2 Weeks)||7
11267291|NCT02300129|12463134|FG003|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
11267292|NCT02300129|12463131|FG000|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
11267293|NCT02300129|12463132|FG001|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
11267294|NCT02300129|12463133|FG002|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
11267295|NCT02300129|12463134|FG003|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
11267296|NCT02300129|12463131|FG000|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
11267297|NCT02300129|12463132|FG001|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
11267298|NCT02300129|12463133|FG002|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
11267299|NCT02300129|12463134|FG003|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
11267300|NCT02300129|12463131|FG000|STARTED|Period 2 Treatment 2 (2 Weeks)||10
11267301|NCT02300129|12463132|FG001|STARTED|Period 2 Treatment 2 (2 Weeks)||4
11267302|NCT02300129|12463133|FG002|STARTED|Period 2 Treatment 2 (2 Weeks)||7
11267303|NCT02300129|12463134|FG003|STARTED|Period 2 Treatment 2 (2 Weeks)||10
11267304|NCT02300129|12463131|FG000|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
11267305|NCT02300129|12463132|FG001|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
11267306|NCT02300129|12463133|FG002|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
11267307|NCT02300129|12463134|FG003|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
11267308|NCT02300129|12463131|FG000|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
11267309|NCT02300129|12463132|FG001|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
11267310|NCT02300129|12463133|FG002|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
11267311|NCT02300129|12463134|FG003|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
11267312|NCT02300220|12463146|FG000|STARTED|Overall Study||72
11397263|NCT04138758|12591317|FG001|STARTED|Overall Study||40353
11267313|NCT02300220|12463147|FG001|STARTED|Overall Study||72
11267314|NCT02300220|12463146|FG000|COMPLETED|Overall Study||68
11267315|NCT02300220|12463147|FG001|COMPLETED|Overall Study||65
11267316|NCT02300220|12463146|FG000|NOT COMPLETED|Overall Study||4
11267317|NCT02300220|12463147|FG001|NOT COMPLETED|Overall Study||7
11267318|NCT02300259|12463156|FG000|STARTED|Period 1||16
11267319|NCT02300259|12463157|FG001|STARTED|Period 1||16
11267320|NCT02300259|12463158|FG002|STARTED|Period 1||16
11267321|NCT02300259|12463156|FG000|Received at Least One Dose of Study Drug|Period 1||16
11267322|NCT02300259|12463157|FG001|Received at Least One Dose of Study Drug|Period 1||16
11267323|NCT02300259|12463158|FG002|Received at Least One Dose of Study Drug|Period 1||16
11267324|NCT02300259|12463156|FG000|COMPLETED|Period 1||16
11267325|NCT02300259|12463157|FG001|COMPLETED|Period 1||16
11267326|NCT02300259|12463158|FG002|COMPLETED|Period 1||14
11267327|NCT02300259|12463156|FG000|NOT COMPLETED|Period 1||0
11267328|NCT02300259|12463157|FG001|NOT COMPLETED|Period 1||0
11267329|NCT02300259|12463158|FG002|NOT COMPLETED|Period 1||2
11267330|NCT02300259|12463156|FG000|STARTED|Period 2||16
11267331|NCT02300259|12463157|FG001|STARTED|Period 2|There was no period 2 for Group 2.|0
11267332|NCT02300259|12463158|FG002|STARTED|Period 2||14
11267333|NCT02300259|12463156|FG000|COMPLETED|Period 2||15
11267334|NCT02300259|12463157|FG001|COMPLETED|Period 2||0
11267335|NCT02300259|12463158|FG002|COMPLETED|Period 2||13
11267336|NCT02300259|12463156|FG000|NOT COMPLETED|Period 2||1
11267337|NCT02300259|12463157|FG001|NOT COMPLETED|Period 2||0
11267338|NCT02300259|12463158|FG002|NOT COMPLETED|Period 2||1
11267339|NCT02300285|12463179|FG000|STARTED|Overall Study||3
11267340|NCT02300285|12463180|FG001|STARTED|Overall Study||3
11267341|NCT02300285|12463179|FG000|COMPLETED|Overall Study||3
11267342|NCT02300285|12463180|FG001|COMPLETED|Overall Study||3
11267343|NCT02300285|12463179|FG000|NOT COMPLETED|Overall Study||0
11267344|NCT02300285|12463180|FG001|NOT COMPLETED|Overall Study||0
11267345|NCT02300298|12463186|FG000|STARTED|Disposition for Nintedanib||10
11267346|NCT02300298|12463187|FG001|STARTED|Disposition for Nintedanib||0
11267347|NCT02300298|12463186|FG000|COMPLETED|Disposition for Nintedanib||0
11267348|NCT02300298|12463187|FG001|COMPLETED|Disposition for Nintedanib||0
11267349|NCT02300298|12463186|FG000|NOT COMPLETED|Disposition for Nintedanib||10
11267350|NCT02300298|12463187|FG001|NOT COMPLETED|Disposition for Nintedanib||0
11267351|NCT02300298|12463186|FG000|STARTED|Disposition for Docetaxel||0
11267352|NCT02300298|12463187|FG001|STARTED|Disposition for Docetaxel||10
11267353|NCT02300298|12463186|FG000|COMPLETED|Disposition for Docetaxel||0
11267354|NCT02300298|12463187|FG001|COMPLETED|Disposition for Docetaxel||0
11267355|NCT02300298|12463186|FG000|NOT COMPLETED|Disposition for Docetaxel||0
11267356|NCT02300298|12463187|FG001|NOT COMPLETED|Disposition for Docetaxel||10
11267357|NCT02300311|12463193|FG000|STARTED|Overall Study||69
11267358|NCT02300311|12463194|FG001|STARTED|Overall Study||69
11267359|NCT02300311|12463193|FG000|COMPLETED|Overall Study||50
11267360|NCT02300311|12463194|FG001|COMPLETED|Overall Study||69
11267361|NCT02300311|12463193|FG000|NOT COMPLETED|Overall Study||19
11267362|NCT02300311|12463194|FG001|NOT COMPLETED|Overall Study||0
11267363|NCT02300545|12463200|FG000|STARTED|Overall Study||56
11267364|NCT02300545|12463200|FG000|COMPLETED|Overall Study||56
11267365|NCT02300545|12463200|FG000|NOT COMPLETED|Overall Study||0
11267366|NCT02300558|12463204|FG000|STARTED|Single Blind Phase (24 Weeks)||41
11267367|NCT02300558|12463204|FG000|COMPLETED|Single Blind Phase (24 Weeks)||35
11267368|NCT02300558|12463204|FG000|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
11267369|NCT02300558|12463204|FG000|STARTED|Open-Label (OL) Extension Phase||32
11267370|NCT02300558|12463204|FG000|COMPLETED|Open-Label (OL) Extension Phase||0
11267371|NCT02300558|12463204|FG000|NOT COMPLETED|Open-Label (OL) Extension Phase||32
11267372|NCT02300610|12463215|FG000|STARTED|Overall Study||3
11267373|NCT02300610|12463216|FG001|STARTED|Overall Study||3
11267374|NCT02300610|12463217|FG002|STARTED|Overall Study||4
11267375|NCT02300610|12463215|FG000|COMPLETED|Overall Study||2
11267376|NCT02300610|12463216|FG001|COMPLETED|Overall Study||3
11267377|NCT02300610|12463217|FG002|COMPLETED|Overall Study||3
11267378|NCT02300610|12463215|FG000|NOT COMPLETED|Overall Study||1
11267379|NCT02300610|12463216|FG001|NOT COMPLETED|Overall Study||0
11267380|NCT02300610|12463217|FG002|NOT COMPLETED|Overall Study||1
11267381|NCT02300727|12463233|FG000|STARTED|Overall Study||0
11267382|NCT02300727|12463234|FG001|STARTED|Overall Study||0
11267383|NCT02300727|12463235|FG002|STARTED|Overall Study||3
11267384|NCT02300727|12463236|FG003|STARTED|Overall Study||3
11267385|NCT02300727|12463237|FG004|STARTED|Overall Study||0
11267386|NCT02300727|12463238|FG005|STARTED|Overall Study||0
11267387|NCT02300727|12463233|FG000|COMPLETED|Overall Study||0
11267388|NCT02300727|12463234|FG001|COMPLETED|Overall Study||0
11267389|NCT02300727|12463235|FG002|COMPLETED|Overall Study||3
11267390|NCT02300727|12463236|FG003|COMPLETED|Overall Study||2
11267391|NCT02300727|12463237|FG004|COMPLETED|Overall Study||0
11267392|NCT02300727|12463238|FG005|COMPLETED|Overall Study||0
11397264|NCT04138758|12591316|FG000|COMPLETED|Overall Study||2600
11397265|NCT04138758|12591317|FG001|COMPLETED|Overall Study||40353
11397266|NCT04138758|12591316|FG000|NOT COMPLETED|Overall Study||0
11397267|NCT04138758|12591317|FG001|NOT COMPLETED|Overall Study||0
11397268|NCT04147715|12591335|FG000|STARTED|Overall Study||12
11397269|NCT04147715|12591336|FG001|STARTED|Overall Study||6
11397270|NCT04147715|12591337|FG002|STARTED|Overall Study||6
11397271|NCT04147715|12591338|FG003|STARTED|Overall Study||8
11397272|NCT04147715|12591339|FG004|STARTED|Overall Study||6
11397273|NCT04147715|12591340|FG005|STARTED|Overall Study||6
11397274|NCT04147715|12591341|FG006|STARTED|Overall Study||6
11397275|NCT04147715|12591342|FG007|STARTED|Overall Study||4
11397276|NCT04147715|12591343|FG008|STARTED|Overall Study||8
11397277|NCT04147715|12591344|FG009|STARTED|Overall Study||8
11397278|NCT04147715|12591345|FG010|STARTED|Overall Study||14
11267393|NCT02300727|12463233|FG000|NOT COMPLETED|Overall Study||0
11267394|NCT02300727|12463234|FG001|NOT COMPLETED|Overall Study||0
11267395|NCT02300727|12463235|FG002|NOT COMPLETED|Overall Study||0
11267396|NCT02300727|12463236|FG003|NOT COMPLETED|Overall Study||1
11267397|NCT02300727|12463237|FG004|NOT COMPLETED|Overall Study||0
11267398|NCT02300727|12463238|FG005|NOT COMPLETED|Overall Study||0
11267399|NCT02300987|12463254|FG000|STARTED|Primary Phase : Prior to Cross-over||8
11267400|NCT02300987|12463255|FG001|STARTED|Primary Phase : Prior to Cross-over||2
11267401|NCT02300987|12463254|FG000|COMPLETED|Primary Phase : Prior to Cross-over||2
11267402|NCT02300987|12463255|FG001|COMPLETED|Primary Phase : Prior to Cross-over||0
11267403|NCT02300987|12463254|FG000|NOT COMPLETED|Primary Phase : Prior to Cross-over||6
11267404|NCT02300987|12463255|FG001|NOT COMPLETED|Primary Phase : Prior to Cross-over||2
11267405|NCT02300987|12463254|FG000|STARTED|Secondary Phase : Cross-over to LEE011||1
11267406|NCT02300987|12463255|FG001|STARTED|Secondary Phase : Cross-over to LEE011||2
11267407|NCT02300987|12463254|FG000|COMPLETED|Secondary Phase : Cross-over to LEE011||0
11267408|NCT02300987|12463255|FG001|COMPLETED|Secondary Phase : Cross-over to LEE011||1
11267409|NCT02300987|12463254|FG000|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
11397279|NCT04147715|12591346|FG011|STARTED|Overall Study||14
11267410|NCT02300987|12463255|FG001|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
11267411|NCT02301039|12463265|FG000|STARTED|Overall Study||42
11267412|NCT02301039|12463266|FG001|STARTED|Overall Study||42
11267413|NCT02301039|12463267|FG002|STARTED|Overall Study||60
11397280|NCT04147715|12591335|FG000|COMPLETED|Overall Study||12
11397281|NCT04147715|12591336|FG001|COMPLETED|Overall Study||6
11397282|NCT04147715|12591337|FG002|COMPLETED|Overall Study||6
11397283|NCT04147715|12591338|FG003|COMPLETED|Overall Study||8
11267414|NCT02301039|12463265|FG000|COMPLETED|Overall Study||42
11267415|NCT02301039|12463266|FG001|COMPLETED|Overall Study||42
11267416|NCT02301039|12463267|FG002|COMPLETED|Overall Study||60
11267417|NCT02301039|12463265|FG000|NOT COMPLETED|Overall Study||0
11267418|NCT02301039|12463266|FG001|NOT COMPLETED|Overall Study||0
11267419|NCT02301039|12463267|FG002|NOT COMPLETED|Overall Study||0
11267420|NCT02301143|12463275|FG000|STARTED|Induction Period||107
11267421|NCT02301143|12463276|FG001|STARTED|Induction Period||0
11267422|NCT02301143|12463275|FG000|COMPLETED|Induction Period||62
11267423|NCT02301143|12463276|FG001|COMPLETED|Induction Period||0
11267424|NCT02301143|12463275|FG000|NOT COMPLETED|Induction Period||45
11267425|NCT02301143|12463276|FG001|NOT COMPLETED|Induction Period||0
11397284|NCT04147715|12591339|FG004|COMPLETED|Overall Study||6
11397285|NCT04147715|12591340|FG005|COMPLETED|Overall Study||6
11397286|NCT04147715|12591341|FG006|COMPLETED|Overall Study||6
11397287|NCT04147715|12591342|FG007|COMPLETED|Overall Study||2
11397288|NCT04147715|12591343|FG008|COMPLETED|Overall Study||7
11397289|NCT04147715|12591344|FG009|COMPLETED|Overall Study||8
11267426|NCT02301143|12463275|FG000|STARTED|Investigator's Choice||0
11267427|NCT02301143|12463276|FG001|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47
11267428|NCT02301143|12463275|FG000|COMPLETED|Investigator's Choice||0
11267429|NCT02301143|12463276|FG001|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37
11267430|NCT02301143|12463275|FG000|NOT COMPLETED|Investigator's Choice||0
11267431|NCT02301143|12463276|FG001|NOT COMPLETED|Investigator's Choice||10
11267432|NCT02301169|12463289|FG000|STARTED|Overall Study||21
11267433|NCT02301169|12463290|FG001|STARTED|Overall Study||21
11267434|NCT02301169|12463289|FG000|COMPLETED|Overall Study||20
11267435|NCT02301169|12463290|FG001|COMPLETED|Overall Study||21
11267436|NCT02301169|12463289|FG000|NOT COMPLETED|Overall Study||1
11267437|NCT02301169|12463290|FG001|NOT COMPLETED|Overall Study||0
11397290|NCT04147715|12591345|FG010|COMPLETED|Overall Study||14
11397291|NCT04147715|12591346|FG011|COMPLETED|Overall Study||14
11397292|NCT04147715|12591335|FG000|NOT COMPLETED|Overall Study||0
11267438|NCT02301299|12463296|FG000|STARTED|Overall Study||1322
11267439|NCT02301299|12463296|FG000|COMPLETED|Overall Study||1322
11267440|NCT02301299|12463296|FG000|NOT COMPLETED|Overall Study||0
11267441|NCT02301364|12463303|FG000|STARTED|Overall Study||4
11267442|NCT02301364|12463303|FG000|COMPLETED|Overall Study||4
11267443|NCT02301364|12463303|FG000|NOT COMPLETED|Overall Study||0
11267444|NCT02301377|12463309|FG000|STARTED|Overall Study||3
11267445|NCT02301377|12463310|FG001|STARTED|Overall Study||2
11267446|NCT02301377|12463309|FG000|COMPLETED|Overall Study||3
11267447|NCT02301377|12463310|FG001|COMPLETED|Overall Study||2
11267448|NCT02301377|12463309|FG000|NOT COMPLETED|Overall Study||0
11267449|NCT02301377|12463310|FG001|NOT COMPLETED|Overall Study||0
11267450|NCT02301390|12463318|FG000|STARTED|Overall Study||27
11267451|NCT02301390|12463319|FG001|STARTED|Overall Study||26
11267452|NCT02301390|12463318|FG000|COMPLETED|Overall Study||17
11267453|NCT02301390|12463319|FG001|COMPLETED|Overall Study||13
11267454|NCT02301390|12463318|FG000|NOT COMPLETED|Overall Study||10
11267455|NCT02301390|12463319|FG001|NOT COMPLETED|Overall Study||13
11267456|NCT02301403|12463327|FG000|STARTED|Overall Study||315
11267457|NCT02301403|12463328|FG001|STARTED|Overall Study||308
11267458|NCT02301403|12463327|FG000|COMPLETED|Overall Study||287
11267459|NCT02301403|12463328|FG001|COMPLETED|Overall Study||267
11267460|NCT02301403|12463327|FG000|NOT COMPLETED|Overall Study||28
11267461|NCT02301403|12463328|FG001|NOT COMPLETED|Overall Study||41
11267462|NCT02301416|12463336|FG000|STARTED|Overall Study||25
11267463|NCT02301416|12463337|FG001|STARTED|Overall Study||40
11267464|NCT02301416|12463336|FG000|COMPLETED|Overall Study||15
11267465|NCT02301416|12463337|FG001|COMPLETED|Overall Study||40
11267466|NCT02301416|12463336|FG000|NOT COMPLETED|Overall Study||10
11267467|NCT02301416|12463337|FG001|NOT COMPLETED|Overall Study||0
11267468|NCT02301429|12463343|FG000|STARTED|Overall Study||16
11267469|NCT02301429|12463343|FG000|COMPLETED|Overall Study||13
11267470|NCT02301429|12463343|FG000|NOT COMPLETED|Overall Study||3
11267471|NCT02301546|12463349|FG000|STARTED|Short-term Effectiveness (~13 Weeks)||73
11267472|NCT02301546|12463350|FG001|STARTED|Short-term Effectiveness (~13 Weeks)||73
11267473|NCT02301546|12463349|FG000|COMPLETED|Short-term Effectiveness (~13 Weeks)||55
11267474|NCT02301546|12463350|FG001|COMPLETED|Short-term Effectiveness (~13 Weeks)||58
11397293|NCT04147715|12591336|FG001|NOT COMPLETED|Overall Study||0
11397294|NCT04147715|12591337|FG002|NOT COMPLETED|Overall Study||0
11267475|NCT02301546|12463349|FG000|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||18
11267476|NCT02301546|12463350|FG001|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||15
11267477|NCT02301546|12463349|FG000|STARTED|Long Term Effectiveness (~1 Year)||55
11267478|NCT02301546|12463350|FG001|STARTED|Long Term Effectiveness (~1 Year)||58
11267479|NCT02301546|12463349|FG000|COMPLETED|Long Term Effectiveness (~1 Year)||43
11267480|NCT02301546|12463350|FG001|COMPLETED|Long Term Effectiveness (~1 Year)||51
11267481|NCT02301546|12463349|FG000|NOT COMPLETED|Long Term Effectiveness (~1 Year)||12
11397295|NCT04147715|12591338|FG003|NOT COMPLETED|Overall Study||0
11397296|NCT04147715|12591339|FG004|NOT COMPLETED|Overall Study||0
11397297|NCT04147715|12591340|FG005|NOT COMPLETED|Overall Study||0
11397298|NCT04147715|12591341|FG006|NOT COMPLETED|Overall Study||0
11397299|NCT04147715|12591342|FG007|NOT COMPLETED|Overall Study||2
11397300|NCT04147715|12591343|FG008|NOT COMPLETED|Overall Study||1
11397301|NCT04147715|12591344|FG009|NOT COMPLETED|Overall Study||0
11397302|NCT04147715|12591345|FG010|NOT COMPLETED|Overall Study||0
11397303|NCT04147715|12591346|FG011|NOT COMPLETED|Overall Study||0
11397304|NCT04154605|12591420|FG000|STARTED|Overall Study||68
11267482|NCT02301546|12463350|FG001|NOT COMPLETED|Long Term Effectiveness (~1 Year)||7
11267483|NCT02301624|12463358|FG000|STARTED|Blind Induction Phase||56
11267484|NCT02301624|12463359|FG001|STARTED|Blind Induction Phase||61
11267485|NCT02301624|12463358|FG000|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56
11267486|NCT02301624|12463359|FG001|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61
11267487|NCT02301624|12463358|FG000|COMPLETED|Blind Induction Phase||55
11267488|NCT02301624|12463359|FG001|COMPLETED|Blind Induction Phase||61
11267489|NCT02301624|12463358|FG000|NOT COMPLETED|Blind Induction Phase||1
11267490|NCT02301624|12463359|FG001|NOT COMPLETED|Blind Induction Phase||0
11267491|NCT02301624|12463358|FG000|STARTED|Open-label Maintenance Phase||55
11267492|NCT02301624|12463359|FG001|STARTED|Open-label Maintenance Phase||61
11267493|NCT02301624|12463358|FG000|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55
11267494|NCT02301624|12463359|FG001|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61
11267495|NCT02301624|12463358|FG000|COMPLETED|Open-label Maintenance Phase||43
11267496|NCT02301624|12463359|FG001|COMPLETED|Open-label Maintenance Phase||44
11267497|NCT02301624|12463358|FG000|NOT COMPLETED|Open-label Maintenance Phase||12
11267498|NCT02301624|12463359|FG001|NOT COMPLETED|Open-label Maintenance Phase||17
11267499|NCT02301793|12463368|FG000|STARTED|Pre Education Study Period|Nurses had not been randomized|
11267500|NCT02301793|12463369|FG001|STARTED|Pre Education Study Period|Nurses had not been randomized|
11267501|NCT02301793|12463368|FG000|COMPLETED|Pre Education Study Period|Nurses had not been randomized|
11267502|NCT02301793|12463369|FG001|COMPLETED|Pre Education Study Period|Nurses had not been randomized|
11267503|NCT02301793|12463368|FG000|NOT COMPLETED|Pre Education Study Period||
11267504|NCT02301793|12463369|FG001|NOT COMPLETED|Pre Education Study Period||
11267505|NCT02301793|12463368|FG000|STARTED|During and Post Education Study Period||488
11267506|NCT02301793|12463369|FG001|STARTED|During and Post Education Study Period||445
11267507|NCT02301793|12463368|FG000|COMPLETED|During and Post Education Study Period||405
11267508|NCT02301793|12463369|FG001|COMPLETED|During and Post Education Study Period||396
11267509|NCT02301793|12463368|FG000|NOT COMPLETED|During and Post Education Study Period||83
11267510|NCT02301793|12463369|FG001|NOT COMPLETED|During and Post Education Study Period||49
11267511|NCT02301897|12463378|FG000|STARTED|Treatment Course 1||12
11267512|NCT02301897|12463379|FG001|STARTED|Treatment Course 1||17
11267513|NCT02301897|12463380|FG002|STARTED|Treatment Course 1||14
11267514|NCT02301897|12463378|FG000|COMPLETED|Treatment Course 1||9
11267515|NCT02301897|12463379|FG001|COMPLETED|Treatment Course 1||14
11267516|NCT02301897|12463380|FG002|COMPLETED|Treatment Course 1||8
11267517|NCT02301897|12463378|FG000|NOT COMPLETED|Treatment Course 1||3
11397305|NCT04154605|12591421|FG001|STARTED|Overall Study||65
11397306|NCT04154605|12591420|FG000|COMPLETED|Overall Study||65
11397307|NCT04154605|12591421|FG001|COMPLETED|Overall Study||63
11397308|NCT04154605|12591420|FG000|NOT COMPLETED|Overall Study||3
11397309|NCT04154605|12591421|FG001|NOT COMPLETED|Overall Study||2
11397310|NCT04160091|12591431|FG000|STARTED|Overall Study||7
11267518|NCT02301897|12463379|FG001|NOT COMPLETED|Treatment Course 1||3
11267519|NCT02301897|12463380|FG002|NOT COMPLETED|Treatment Course 1||6
11267520|NCT02301897|12463378|FG000|STARTED|Treatment Course 2||9
11267521|NCT02301897|12463379|FG001|STARTED|Treatment Course 2||14
11267522|NCT02301897|12463380|FG002|STARTED|Treatment Course 2||8
11267523|NCT02301897|12463378|FG000|COMPLETED|Treatment Course 2||8
11267524|NCT02301897|12463379|FG001|COMPLETED|Treatment Course 2||9
11267525|NCT02301897|12463380|FG002|COMPLETED|Treatment Course 2||7
11267526|NCT02301897|12463378|FG000|NOT COMPLETED|Treatment Course 2||1
11397311|NCT04160091|12591432|FG001|STARTED|Overall Study||3
11397312|NCT04160091|12591433|FG002|STARTED|Overall Study||5
11397313|NCT04160091|12591434|FG003|STARTED|Overall Study||4
11397314|NCT04160091|12591431|FG000|COMPLETED|Overall Study||0
11397315|NCT04160091|12591432|FG001|COMPLETED|Overall Study||0
11397316|NCT04160091|12591433|FG002|COMPLETED|Overall Study||0
11397317|NCT04160091|12591434|FG003|COMPLETED|Overall Study||0
11397318|NCT04160091|12591431|FG000|NOT COMPLETED|Overall Study||7
11397319|NCT04160091|12591432|FG001|NOT COMPLETED|Overall Study||3
11267527|NCT02301897|12463379|FG001|NOT COMPLETED|Treatment Course 2||5
11267528|NCT02301897|12463380|FG002|NOT COMPLETED|Treatment Course 2||1
11267529|NCT02301936|12463390|FG000|STARTED|Overall Study||9
11267530|NCT02301936|12463391|FG001|STARTED|Overall Study||1
11267531|NCT02301936|12463390|FG000|COMPLETED|Overall Study||8
11267532|NCT02301936|12463391|FG001|COMPLETED|Overall Study||1
11267533|NCT02301936|12463390|FG000|NOT COMPLETED|Overall Study||1
11267534|NCT02301936|12463391|FG001|NOT COMPLETED|Overall Study||0
11267535|NCT02301975|12463400|FG000|STARTED|Overall Study||504
11267536|NCT02301975|12463401|FG001|STARTED|Overall Study||501
11267537|NCT02301975|12463402|FG002|STARTED|Overall Study||499
11267538|NCT02301975|12463400|FG000|COMPLETED|Overall Study||473
11267539|NCT02301975|12463401|FG001|COMPLETED|Overall Study||476
11267540|NCT02301975|12463402|FG002|COMPLETED|Overall Study||477
11267541|NCT02301975|12463400|FG000|NOT COMPLETED|Overall Study||31
11267542|NCT02301975|12463401|FG001|NOT COMPLETED|Overall Study||25
11267543|NCT02301975|12463402|FG002|NOT COMPLETED|Overall Study||22
11267544|NCT02301988|12463412|FG000|STARTED|Overall Study||76
11267545|NCT02301988|12463413|FG001|STARTED|Overall Study||75
11267546|NCT02301988|12463412|FG000|COMPLETED|Overall Study||66
11267547|NCT02301988|12463413|FG001|COMPLETED|Overall Study||66
11267548|NCT02301988|12463412|FG000|NOT COMPLETED|Overall Study||10
11267549|NCT02301988|12463413|FG001|NOT COMPLETED|Overall Study||9
11267550|NCT02302066|12463423|FG000|STARTED|Overall Study||201
11267551|NCT02302066|12463424|FG001|STARTED|Overall Study||398
11267552|NCT02302066|12463425|FG002|STARTED|Overall Study||1002
11267553|NCT02302066|12463426|FG003|STARTED|Overall Study||199
11267554|NCT02302066|12463423|FG000|Safety Analysis Set|Overall Study||200
11267555|NCT02302066|12463424|FG001|Safety Analysis Set|Overall Study||398
11267556|NCT02302066|12463425|FG002|Safety Analysis Set|Overall Study||998
11267557|NCT02302066|12463426|FG003|Safety Analysis Set|Overall Study||198
11267558|NCT02302066|12463423|FG000|Immunogenicity Subset|Overall Study||92
11267559|NCT02302066|12463424|FG001|Immunogenicity Subset|Overall Study||187
11267560|NCT02302066|12463425|FG002|Immunogenicity Subset|Overall Study||192
11267561|NCT02302066|12463426|FG003|Immunogenicity Subset|Overall Study||94
11267562|NCT02302066|12463423|FG000|Per-Protocol Set (PPS)|Overall Study||83
11267563|NCT02302066|12463424|FG001|Per-Protocol Set (PPS)|Overall Study||171
11267564|NCT02302066|12463425|FG002|Per-Protocol Set (PPS)|Overall Study||174
11267565|NCT02302066|12463426|FG003|Per-Protocol Set (PPS)|Overall Study||81
11267566|NCT02302066|12463423|FG000|COMPLETED|Overall Study||168
11267567|NCT02302066|12463424|FG001|COMPLETED|Overall Study||323
11267568|NCT02302066|12463425|FG002|COMPLETED|Overall Study||830
11267569|NCT02302066|12463426|FG003|COMPLETED|Overall Study||158
11267570|NCT02302066|12463423|FG000|NOT COMPLETED|Overall Study||33
11267571|NCT02302066|12463424|FG001|NOT COMPLETED|Overall Study||75
11267572|NCT02302066|12463425|FG002|NOT COMPLETED|Overall Study||172
11267573|NCT02302066|12463426|FG003|NOT COMPLETED|Overall Study||41
11267574|NCT02302092|12463448|FG000|STARTED|Overall Study||6
11267575|NCT02302092|12463449|FG001|STARTED|Overall Study||7
11267576|NCT02302092|12463448|FG000|COMPLETED|Overall Study||6
11267577|NCT02302092|12463449|FG001|COMPLETED|Overall Study||7
11267578|NCT02302092|12463448|FG000|NOT COMPLETED|Overall Study||0
11267579|NCT02302092|12463449|FG001|NOT COMPLETED|Overall Study||0
11267580|NCT02302157|12463460|FG000|STARTED|Overall Study||3
11267581|NCT02302157|12463461|FG001|STARTED|Overall Study||6
11267582|NCT02302157|12463462|FG002|STARTED|Overall Study||6
11267583|NCT02302157|12463463|FG003|STARTED|Overall Study||6
11267584|NCT02302157|12463464|FG004|STARTED|Overall Study||4
11267585|NCT02302157|12463460|FG000|COMPLETED|Overall Study||3
11267586|NCT02302157|12463461|FG001|COMPLETED|Overall Study||6
11267587|NCT02302157|12463462|FG002|COMPLETED|Overall Study||6
11267588|NCT02302157|12463463|FG003|COMPLETED|Overall Study||6
11267589|NCT02302157|12463464|FG004|COMPLETED|Overall Study||4
11267590|NCT02302157|12463460|FG000|NOT COMPLETED|Overall Study||0
11267591|NCT02302157|12463461|FG001|NOT COMPLETED|Overall Study||0
11267592|NCT02302157|12463462|FG002|NOT COMPLETED|Overall Study||0
11267593|NCT02302157|12463463|FG003|NOT COMPLETED|Overall Study||0
11267594|NCT02302157|12463464|FG004|NOT COMPLETED|Overall Study||0
11267595|NCT02302339|12463485|FG000|STARTED|Overall Study||62
11267596|NCT02302339|12463486|FG001|STARTED|Overall Study||34
11267597|NCT02302339|12463487|FG002|STARTED|Overall Study||29
11267598|NCT02302339|12463488|FG003|STARTED|Overall Study||7
11267599|NCT02302339|12463485|FG000|COMPLETED|Overall Study||61
11267600|NCT02302339|12463486|FG001|COMPLETED|Overall Study||32
11267601|NCT02302339|12463487|FG002|COMPLETED|Overall Study||28
11267602|NCT02302339|12463488|FG003|COMPLETED|Overall Study||7
11267603|NCT02302339|12463485|FG000|NOT COMPLETED|Overall Study||1
11267604|NCT02302339|12463486|FG001|NOT COMPLETED|Overall Study||2
11267605|NCT02302339|12463487|FG002|NOT COMPLETED|Overall Study||1
11267606|NCT02302339|12463488|FG003|NOT COMPLETED|Overall Study||0
11267607|NCT02302365|12463499|FG000|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
11267608|NCT02302365|12463499|FG000|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
11267609|NCT02302365|12463499|FG000|NOT COMPLETED|0-2 Hour Period||2
11397320|NCT04160091|12591433|FG002|NOT COMPLETED|Overall Study||5
11267610|NCT02302365|12463499|FG000|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
11267611|NCT02302365|12463499|FG000|COMPLETED|0-24 Hour Period||32
11267612|NCT02302365|12463499|FG000|NOT COMPLETED|0-24 Hour Period||0
11267613|NCT02302716|12463509|FG000|STARTED|Overall Study||249
11267614|NCT02302716|12463510|FG001|STARTED|Overall Study||244
11267615|NCT02302716|12463509|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249
11267616|NCT02302716|12463510|FG001|Received at Least 1 Dose of Study Drug|Overall Study||244
11267617|NCT02302716|12463509|FG000|COMPLETED|Overall Study||230
11267618|NCT02302716|12463510|FG001|COMPLETED|Overall Study||225
11267619|NCT02302716|12463509|FG000|NOT COMPLETED|Overall Study||19
11267620|NCT02302716|12463510|FG001|NOT COMPLETED|Overall Study||19
11267621|NCT02302807|12463518|FG000|STARTED|Overall Study||464
11267622|NCT02302807|12463519|FG001|STARTED|Overall Study||467
11267623|NCT02302807|12463518|FG000|Received Treatment|Overall Study||443
11267624|NCT02302807|12463519|FG001|Received Treatment|Overall Study||459
11267625|NCT02302807|12463518|FG000|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0
11267626|NCT02302807|12463519|FG001|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0
11267627|NCT02302807|12463518|FG000|NOT COMPLETED|Overall Study||464
11267628|NCT02302807|12463519|FG001|NOT COMPLETED|Overall Study||467
11267629|NCT02302846|12463538|FG000|STARTED|Overall Study||5
11267630|NCT02302846|12463538|FG000|COMPLETED|Overall Study||4
11267631|NCT02302846|12463538|FG000|NOT COMPLETED|Overall Study||1
11267632|NCT02303041|12463544|FG000|STARTED|Overall Study||4
11267633|NCT02303041|12463545|FG001|STARTED|Overall Study||6
11267634|NCT02303041|12463544|FG000|COMPLETED|Overall Study||3
11267635|NCT02303041|12463545|FG001|COMPLETED|Overall Study||4
11267636|NCT02303041|12463544|FG000|NOT COMPLETED|Overall Study||1
11267637|NCT02303041|12463545|FG001|NOT COMPLETED|Overall Study||2
11267638|NCT02303093|12463551|FG000|STARTED|Overall Study||344
11267639|NCT02303093|12463551|FG000|COMPLETED|Overall Study||344
11267640|NCT02303093|12463551|FG000|NOT COMPLETED|Overall Study||0
11267641|NCT02303184|12463569|FG000|STARTED|Overall Study||23
11267642|NCT02303184|12463570|FG001|STARTED|Overall Study||23
11267643|NCT02303184|12463569|FG000|COMPLETED|Overall Study||23
11267644|NCT02303184|12463570|FG001|COMPLETED|Overall Study||23
11267645|NCT02303184|12463569|FG000|NOT COMPLETED|Overall Study||0
11267646|NCT02303184|12463570|FG001|NOT COMPLETED|Overall Study||0
11267647|NCT02303262|12463576|FG000|STARTED|Overall Study||20
11267648|NCT02303262|12463576|FG000|COMPLETED|Overall Study||18
11267649|NCT02303262|12463576|FG000|NOT COMPLETED|Overall Study||2
11267650|NCT02303574|12463592|FG000|STARTED|Part 1a (Fasted State)- SAD||6
11267651|NCT02303574|12463593|FG001|STARTED|Part 1a (Fasted State)- SAD||6
11267652|NCT02303574|12463594|FG002|STARTED|Part 1a (Fasted State)- SAD||6
11267653|NCT02303574|12463595|FG003|STARTED|Part 1a (Fasted State)- SAD||6
11267654|NCT02303574|12463596|FG004|STARTED|Part 1a (Fasted State)- SAD||6
11267655|NCT02303574|12463597|FG005|STARTED|Part 1a (Fasted State)- SAD||0
11267656|NCT02303574|12463598|FG006|STARTED|Part 1a (Fasted State)- SAD||0
11267657|NCT02303574|12463599|FG007|STARTED|Part 1a (Fasted State)- SAD||0
11267658|NCT02303574|12463600|FG008|STARTED|Part 1a (Fasted State)- SAD||0
11267659|NCT02303574|12463601|FG009|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
11267660|NCT02303574|12463592|FG000|COMPLETED|Part 1a (Fasted State)- SAD||6
11267661|NCT02303574|12463593|FG001|COMPLETED|Part 1a (Fasted State)- SAD||6
11267662|NCT02303574|12463594|FG002|COMPLETED|Part 1a (Fasted State)- SAD||5
11267663|NCT02303574|12463595|FG003|COMPLETED|Part 1a (Fasted State)- SAD||6
11267664|NCT02303574|12463596|FG004|COMPLETED|Part 1a (Fasted State)- SAD||6
11267665|NCT02303574|12463597|FG005|COMPLETED|Part 1a (Fasted State)- SAD||0
11267666|NCT02303574|12463598|FG006|COMPLETED|Part 1a (Fasted State)- SAD||0
11267667|NCT02303574|12463599|FG007|COMPLETED|Part 1a (Fasted State)- SAD||0
11267668|NCT02303574|12463600|FG008|COMPLETED|Part 1a (Fasted State)- SAD||0
11267669|NCT02303574|12463601|FG009|COMPLETED|Part 1a (Fasted State)- SAD||15
11267670|NCT02303574|12463592|FG000|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
11267671|NCT02303574|12463593|FG001|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
11267672|NCT02303574|12463594|FG002|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
11267673|NCT02303574|12463595|FG003|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
11267674|NCT02303574|12463596|FG004|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
11267675|NCT02303574|12463597|FG005|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
11267676|NCT02303574|12463598|FG006|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
11267677|NCT02303574|12463599|FG007|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
11267678|NCT02303574|12463600|FG008|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
11267679|NCT02303574|12463601|FG009|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
11267680|NCT02303574|12463592|FG000|STARTED|Part 1b (Fed State) - SAD||0
11267681|NCT02303574|12463593|FG001|STARTED|Part 1b (Fed State) - SAD||0
11267682|NCT02303574|12463594|FG002|STARTED|Part 1b (Fed State) - SAD||0
11267683|NCT02303574|12463595|FG003|STARTED|Part 1b (Fed State) - SAD||0
11267684|NCT02303574|12463596|FG004|STARTED|Part 1b (Fed State) - SAD||0
11267685|NCT02303574|12463597|FG005|STARTED|Part 1b (Fed State) - SAD||5
11267686|NCT02303574|12463598|FG006|STARTED|Part 1b (Fed State) - SAD||0
11267687|NCT02303574|12463599|FG007|STARTED|Part 1b (Fed State) - SAD||0
11267688|NCT02303574|12463600|FG008|STARTED|Part 1b (Fed State) - SAD||0
11267689|NCT02303574|12463601|FG009|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
11267690|NCT02303574|12463592|FG000|COMPLETED|Part 1b (Fed State) - SAD||0
11267691|NCT02303574|12463593|FG001|COMPLETED|Part 1b (Fed State) - SAD||0
11267692|NCT02303574|12463594|FG002|COMPLETED|Part 1b (Fed State) - SAD||0
11267693|NCT02303574|12463595|FG003|COMPLETED|Part 1b (Fed State) - SAD||0
11267694|NCT02303574|12463596|FG004|COMPLETED|Part 1b (Fed State) - SAD||0
11267695|NCT02303574|12463597|FG005|COMPLETED|Part 1b (Fed State) - SAD||5
11267696|NCT02303574|12463598|FG006|COMPLETED|Part 1b (Fed State) - SAD||0
11267697|NCT02303574|12463599|FG007|COMPLETED|Part 1b (Fed State) - SAD||0
11267698|NCT02303574|12463600|FG008|COMPLETED|Part 1b (Fed State) - SAD||0
11267699|NCT02303574|12463601|FG009|COMPLETED|Part 1b (Fed State) - SAD||3
11267700|NCT02303574|12463592|FG000|NOT COMPLETED|Part 1b (Fed State) - SAD||0
11267701|NCT02303574|12463593|FG001|NOT COMPLETED|Part 1b (Fed State) - SAD||0
11267702|NCT02303574|12463594|FG002|NOT COMPLETED|Part 1b (Fed State) - SAD||0
11267703|NCT02303574|12463595|FG003|NOT COMPLETED|Part 1b (Fed State) - SAD||0
11267704|NCT02303574|12463596|FG004|NOT COMPLETED|Part 1b (Fed State) - SAD||0
11267705|NCT02303574|12463597|FG005|NOT COMPLETED|Part 1b (Fed State) - SAD||0
11267706|NCT02303574|12463598|FG006|NOT COMPLETED|Part 1b (Fed State) - SAD||0
11267707|NCT02303574|12463599|FG007|NOT COMPLETED|Part 1b (Fed State) - SAD||0
11267708|NCT02303574|12463600|FG008|NOT COMPLETED|Part 1b (Fed State) - SAD||0
11267709|NCT02303574|12463601|FG009|NOT COMPLETED|Part 1b (Fed State) - SAD||0
11267710|NCT02303574|12463592|FG000|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
11267711|NCT02303574|12463593|FG001|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
11267712|NCT02303574|12463594|FG002|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
11267713|NCT02303574|12463595|FG003|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
11267714|NCT02303574|12463596|FG004|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
11267715|NCT02303574|12463597|FG005|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
11397321|NCT04160091|12591434|FG003|NOT COMPLETED|Overall Study||4
11397322|NCT04160260|12591444|FG000|STARTED|Overall Study||18
11397323|NCT04160260|12591444|FG000|COMPLETED|Overall Study||18
11397324|NCT04160260|12591444|FG000|NOT COMPLETED|Overall Study||0
11397325|NCT04164758|12591451|FG000|STARTED|Overall Study||4
11397326|NCT04164758|12591452|FG001|STARTED|Overall Study||4
11397327|NCT04164758|12591453|FG002|STARTED|Overall Study||3
11397328|NCT04164758|12591451|FG000|COMPLETED|Overall Study||3
11397329|NCT04164758|12591452|FG001|COMPLETED|Overall Study||3
11397330|NCT04164758|12591453|FG002|COMPLETED|Overall Study||3
11397331|NCT04164758|12591451|FG000|NOT COMPLETED|Overall Study||1
11397332|NCT04164758|12591452|FG001|NOT COMPLETED|Overall Study||1
11267716|NCT02303574|12463598|FG006|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
11267717|NCT02303574|12463599|FG007|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
11267718|NCT02303574|12463600|FG008|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
11267719|NCT02303574|12463601|FG009|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
11267720|NCT02303574|12463592|FG000|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267721|NCT02303574|12463593|FG001|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267722|NCT02303574|12463594|FG002|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267723|NCT02303574|12463595|FG003|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267724|NCT02303574|12463596|FG004|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267725|NCT02303574|12463597|FG005|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267726|NCT02303574|12463598|FG006|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
11397333|NCT04164758|12591453|FG002|NOT COMPLETED|Overall Study||0
11397334|NCT04165031|12591467|FG000|STARTED|Overall Study||2
11267727|NCT02303574|12463599|FG007|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
11267728|NCT02303574|12463600|FG008|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
11267729|NCT02303574|12463601|FG009|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
11267730|NCT02303574|12463592|FG000|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267731|NCT02303574|12463593|FG001|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267732|NCT02303574|12463594|FG002|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267733|NCT02303574|12463595|FG003|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267734|NCT02303574|12463596|FG004|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267735|NCT02303574|12463597|FG005|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267736|NCT02303574|12463598|FG006|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267737|NCT02303574|12463599|FG007|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
11267738|NCT02303574|12463600|FG008|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267739|NCT02303574|12463601|FG009|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
11267740|NCT02303704|12463636|FG000|STARTED|Overall Study||220
11267741|NCT02303704|12463637|FG001|STARTED|Overall Study||228
11267742|NCT02303704|12463636|FG000|COMPLETED|Overall Study||215
11267743|NCT02303704|12463637|FG001|COMPLETED|Overall Study||219
11267744|NCT02303704|12463636|FG000|NOT COMPLETED|Overall Study||5
11267745|NCT02303704|12463637|FG001|NOT COMPLETED|Overall Study||9
11267746|NCT02303743|12463645|FG000|STARTED|Overall Study||108
11267747|NCT02303743|12463646|FG001|STARTED|Overall Study||152
11267748|NCT02303743|12463645|FG000|COMPLETED|Overall Study||108
11267749|NCT02303743|12463646|FG001|COMPLETED|Overall Study||152
11267750|NCT02303743|12463645|FG000|NOT COMPLETED|Overall Study||0
11267751|NCT02303743|12463646|FG001|NOT COMPLETED|Overall Study||0
11267752|NCT02303977|12463652|FG000|STARTED|Overall Study||37
11267753|NCT02303977|12463652|FG000|COMPLETED|Overall Study||37
11267754|NCT02303977|12463652|FG000|NOT COMPLETED|Overall Study||0
11267755|NCT02303990|12463657|FG000|STARTED|Overall Study||59
11397335|NCT04165031|12591468|FG001|STARTED|Overall Study||1
11397336|NCT04165031|12591469|FG002|STARTED|Overall Study||2
11397337|NCT04165031|12591470|FG003|STARTED|Overall Study||0
11397338|NCT04165031|12591471|FG004|STARTED|Overall Study||0
11267756|NCT02303990|12463657|FG000|COMPLETED|Overall Study||59
11267757|NCT02303990|12463657|FG000|NOT COMPLETED|Overall Study||0
11267758|NCT02304159|12463663|FG000|STARTED|Overall Study||21
11267759|NCT02304159|12463664|FG001|STARTED|Overall Study||18
11267760|NCT02304159|12463663|FG000|COMPLETED|Overall Study||19
11267761|NCT02304159|12463664|FG001|COMPLETED|Overall Study||16
11267762|NCT02304159|12463663|FG000|NOT COMPLETED|Overall Study||2
11267763|NCT02304159|12463664|FG001|NOT COMPLETED|Overall Study||2
11267764|NCT02304380|12463676|FG000|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
11267765|NCT02304380|12463677|FG001|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
11267766|NCT02304380|12463678|FG002|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
11267767|NCT02304380|12463679|FG003|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
11267768|NCT02304380|12463680|FG004|STARTED|Pediatric Claims Data Analysis (Aim 3)||17356
11267769|NCT02304380|12463681|FG005|STARTED|Pediatric Claims Data Analysis (Aim 3)||47026
11267770|NCT02304380|12463676|FG000|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
11267771|NCT02304380|12463677|FG001|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
11267772|NCT02304380|12463678|FG002|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
11267773|NCT02304380|12463679|FG003|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
11267774|NCT02304380|12463680|FG004|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|2,096 Caregivers of the 17,356 claims were included in the Caregiver Survey.|17356
11267775|NCT02304380|12463681|FG005|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|Not included in any other portion of the study.|47026
11267776|NCT02304380|12463676|FG000|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
11267777|NCT02304380|12463677|FG001|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
11267778|NCT02304380|12463678|FG002|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
11267779|NCT02304380|12463679|FG003|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
11267780|NCT02304380|12463680|FG004|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
11267781|NCT02304380|12463681|FG005|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
11267782|NCT02304380|12463676|FG000|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
11267783|NCT02304380|12463677|FG001|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
11267784|NCT02304380|12463678|FG002|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
11267785|NCT02304380|12463679|FG003|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||2096
11267786|NCT02304380|12463680|FG004|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
11267787|NCT02304380|12463681|FG005|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
11267788|NCT02304380|12463676|FG000|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
11267789|NCT02304380|12463677|FG001|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
11397339|NCT04165031|12591472|FG005|STARTED|Overall Study||0
11397340|NCT04165031|12591467|FG000|Received at Least One Dose of Study Drug|Overall Study||2
11397341|NCT04165031|12591468|FG001|Received at Least One Dose of Study Drug|Overall Study||1
11021601|NCT00805194|12199711|FG000|NOT COMPLETED|Overall Study||649
11021602|NCT00805194|12199712|FG001|NOT COMPLETED|Overall Study||654
11267790|NCT02304380|12463678|FG002|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
11267791|NCT02304380|12463679|FG003|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)|68 Caregivers/Patients of the 2,062 surveyed were included in the Interviews and Focus Group .|2062
11267792|NCT02304380|12463680|FG004|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
11267793|NCT02304380|12463681|FG005|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
11267794|NCT02304380|12463676|FG000|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
11267795|NCT02304380|12463677|FG001|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
11267796|NCT02304380|12463678|FG002|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
11267797|NCT02304380|12463679|FG003|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||34
11267798|NCT02304380|12463680|FG004|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
11267799|NCT02304380|12463681|FG005|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
11267800|NCT02304380|12463676|FG000|STARTED|Interviews & Focus Groups (Aim 1)||0
11267801|NCT02304380|12463677|FG001|STARTED|Interviews & Focus Groups (Aim 1)||35
11267802|NCT02304380|12463678|FG002|STARTED|Interviews & Focus Groups (Aim 1)||33
11267803|NCT02304380|12463679|FG003|STARTED|Interviews & Focus Groups (Aim 1)||0
11267804|NCT02304380|12463680|FG004|STARTED|Interviews & Focus Groups (Aim 1)||0
11267805|NCT02304380|12463681|FG005|STARTED|Interviews & Focus Groups (Aim 1)||0
11267806|NCT02304380|12463676|FG000|COMPLETED|Interviews & Focus Groups (Aim 1)||0
11267807|NCT02304380|12463677|FG001|COMPLETED|Interviews & Focus Groups (Aim 1)||35
11267808|NCT02304380|12463678|FG002|COMPLETED|Interviews & Focus Groups (Aim 1)||33
11267809|NCT02304380|12463679|FG003|COMPLETED|Interviews & Focus Groups (Aim 1)||0
11267810|NCT02304380|12463680|FG004|COMPLETED|Interviews & Focus Groups (Aim 1)||0
11267811|NCT02304380|12463681|FG005|COMPLETED|Interviews & Focus Groups (Aim 1)||0
11267812|NCT02304380|12463676|FG000|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
11267813|NCT02304380|12463677|FG001|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
11267814|NCT02304380|12463678|FG002|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
11267815|NCT02304380|12463679|FG003|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
11267816|NCT02304380|12463680|FG004|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
11267817|NCT02304380|12463681|FG005|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
11267818|NCT02304380|12463676|FG000|STARTED|ACO Stakeholder Interviews (Aim 1)||24
11267819|NCT02304380|12463677|FG001|STARTED|ACO Stakeholder Interviews (Aim 1)||0
11267820|NCT02304380|12463678|FG002|STARTED|ACO Stakeholder Interviews (Aim 1)||0
11267821|NCT02304380|12463679|FG003|STARTED|ACO Stakeholder Interviews (Aim 1)||0
11267822|NCT02304380|12463680|FG004|STARTED|ACO Stakeholder Interviews (Aim 1)||0
11267823|NCT02304380|12463681|FG005|STARTED|ACO Stakeholder Interviews (Aim 1)||0
11397342|NCT04165031|12591469|FG002|Received at Least One Dose of Study Drug|Overall Study||2
11021603|NCT00805207|12199732|FG000|STARTED|Overall Study||1
11397343|NCT04165031|12591470|FG003|Received at Least One Dose of Study Drug|Overall Study||0
11267824|NCT02304380|12463676|FG000|COMPLETED|ACO Stakeholder Interviews (Aim 1)||24
11267825|NCT02304380|12463677|FG001|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
11267826|NCT02304380|12463678|FG002|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
11267827|NCT02304380|12463679|FG003|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
11267828|NCT02304380|12463680|FG004|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
11267829|NCT02304380|12463681|FG005|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
11267830|NCT02304380|12463676|FG000|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
11267831|NCT02304380|12463677|FG001|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
11267832|NCT02304380|12463678|FG002|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
11267833|NCT02304380|12463679|FG003|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
11267834|NCT02304380|12463680|FG004|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
11267835|NCT02304380|12463681|FG005|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
11267836|NCT02304406|12463695|FG000|STARTED|Overall Study||449
11267837|NCT02304406|12463695|FG000|COMPLETED|Overall Study||449
11267838|NCT02304406|12463695|FG000|NOT COMPLETED|Overall Study||0
11267839|NCT02304432|12463699|FG000|STARTED|Open Label DCS||2
11267840|NCT02304432|12463700|FG001|STARTED|Open Label DCS||0
11267841|NCT02304432|12463701|FG002|STARTED|Open Label DCS||0
11267842|NCT02304432|12463702|FG003|STARTED|Open Label DCS||0
11267843|NCT02304432|12463699|FG000|COMPLETED|Open Label DCS||2
11267844|NCT02304432|12463700|FG001|COMPLETED|Open Label DCS||0
11267845|NCT02304432|12463701|FG002|COMPLETED|Open Label DCS||0
11267846|NCT02304432|12463702|FG003|COMPLETED|Open Label DCS||0
11267847|NCT02304432|12463699|FG000|NOT COMPLETED|Open Label DCS||0
11267848|NCT02304432|12463700|FG001|NOT COMPLETED|Open Label DCS||0
11267849|NCT02304432|12463701|FG002|NOT COMPLETED|Open Label DCS||0
11267850|NCT02304432|12463702|FG003|NOT COMPLETED|Open Label DCS||0
11267851|NCT02304432|12463699|FG000|STARTED|Double-Blind DCS Placebo Crossover||0
11267852|NCT02304432|12463700|FG001|STARTED|Double-Blind DCS Placebo Crossover||1
11267853|NCT02304432|12463701|FG002|STARTED|Double-Blind DCS Placebo Crossover||1
11397344|NCT04165031|12591471|FG004|Received at Least One Dose of Study Drug|Overall Study||0
11397345|NCT04165031|12591472|FG005|Received at Least One Dose of Study Drug|Overall Study||0
11397346|NCT04165031|12591467|FG000|COMPLETED|Overall Study||1
11397347|NCT04165031|12591468|FG001|COMPLETED|Overall Study||0
11267854|NCT02304432|12463702|FG003|STARTED|Double-Blind DCS Placebo Crossover||0
11267855|NCT02304432|12463699|FG000|COMPLETED|Double-Blind DCS Placebo Crossover||0
11267856|NCT02304432|12463700|FG001|COMPLETED|Double-Blind DCS Placebo Crossover||1
11267857|NCT02304432|12463701|FG002|COMPLETED|Double-Blind DCS Placebo Crossover||1
11267858|NCT02304432|12463702|FG003|COMPLETED|Double-Blind DCS Placebo Crossover||0
11267859|NCT02304432|12463699|FG000|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
11267860|NCT02304432|12463700|FG001|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
11267861|NCT02304432|12463701|FG002|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
11267862|NCT02304432|12463702|FG003|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
11267863|NCT02304432|12463699|FG000|STARTED|Second Open Label DCS||0
11267864|NCT02304432|12463700|FG001|STARTED|Second Open Label DCS||0
11267865|NCT02304432|12463701|FG002|STARTED|Second Open Label DCS||0
11267866|NCT02304432|12463702|FG003|STARTED|Second Open Label DCS||2
11267867|NCT02304432|12463699|FG000|COMPLETED|Second Open Label DCS||0
11267868|NCT02304432|12463700|FG001|COMPLETED|Second Open Label DCS||0
11267869|NCT02304432|12463701|FG002|COMPLETED|Second Open Label DCS||0
11267870|NCT02304432|12463702|FG003|COMPLETED|Second Open Label DCS||2
11267871|NCT02304432|12463699|FG000|NOT COMPLETED|Second Open Label DCS||0
11267872|NCT02304432|12463700|FG001|NOT COMPLETED|Second Open Label DCS||0
11267873|NCT02304432|12463701|FG002|NOT COMPLETED|Second Open Label DCS||0
11267874|NCT02304432|12463702|FG003|NOT COMPLETED|Second Open Label DCS||0
11267875|NCT02304484|12463717|FG000|STARTED|Overall Study||770
11267876|NCT02304484|12463717|FG000|COMPLETED|Overall Study||745
11267877|NCT02304484|12463717|FG000|NOT COMPLETED|Overall Study||25
11267878|NCT02304705|12463723|FG000|STARTED|Overall Study||16
11267879|NCT02304705|12463724|FG001|STARTED|Overall Study||17
11267880|NCT02304705|12463723|FG000|COMPLETED|Overall Study||12
11267881|NCT02304705|12463724|FG001|COMPLETED|Overall Study||10
11267882|NCT02304705|12463723|FG000|NOT COMPLETED|Overall Study||4
11267883|NCT02304705|12463724|FG001|NOT COMPLETED|Overall Study||7
11267884|NCT02304757|12463732|FG000|STARTED|Overall Study||70
11267885|NCT02304757|12463733|FG001|STARTED|Overall Study||72
11267886|NCT02304757|12463732|FG000|COMPLETED|Overall Study||70
11267887|NCT02304757|12463733|FG001|COMPLETED|Overall Study||72
11267888|NCT02304757|12463732|FG000|NOT COMPLETED|Overall Study||0
11267889|NCT02304757|12463733|FG001|NOT COMPLETED|Overall Study||0
11267890|NCT02304926|12463741|FG000|STARTED|Overall Study||22
11267891|NCT02304926|12463742|FG001|STARTED|Overall Study||20
11267892|NCT02304926|12463741|FG000|COMPLETED|Overall Study||20
11267893|NCT02304926|12463742|FG001|COMPLETED|Overall Study||19
11267894|NCT02304926|12463741|FG000|NOT COMPLETED|Overall Study||2
11267895|NCT02304926|12463742|FG001|NOT COMPLETED|Overall Study||1
11267896|NCT02305017|12463752|FG000|STARTED|Overall Study||14
11267897|NCT02305017|12463753|FG001|STARTED|Overall Study||14
11267898|NCT02305017|12463752|FG000|COMPLETED|Overall Study||14
11267899|NCT02305017|12463753|FG001|COMPLETED|Overall Study||14
11267900|NCT02305017|12463752|FG000|NOT COMPLETED|Overall Study||0
11267901|NCT02305017|12463753|FG001|NOT COMPLETED|Overall Study||0
11267902|NCT02305238|12463766|FG000|STARTED|Overall Study||124
11267903|NCT02305238|12463767|FG001|STARTED|Overall Study||123
11267904|NCT02305238|12463768|FG002|STARTED|Overall Study||8
11267905|NCT02305238|12463766|FG000|Treated|Overall Study||124
11267906|NCT02305238|12463767|FG001|Treated|Overall Study||123
11267907|NCT02305238|12463768|FG002|Treated|Overall Study||7
11267908|NCT02305238|12463766|FG000|Randomized|Overall Study||124
11267909|NCT02305238|12463767|FG001|Randomized|Overall Study||123
11267910|NCT02305238|12463768|FG002|Randomized|Overall Study||0
11267911|NCT02305238|12463766|FG000|BCVA Post-randomization Assessment|Overall Study||123
11267912|NCT02305238|12463767|FG001|BCVA Post-randomization Assessment|Overall Study||123
11267913|NCT02305238|12463768|FG002|BCVA Post-randomization Assessment|Overall Study||0
11267914|NCT02305238|12463766|FG000|COMPLETED|Overall Study||108
11267915|NCT02305238|12463767|FG001|COMPLETED|Overall Study||104
11267916|NCT02305238|12463768|FG002|COMPLETED|Overall Study||0
11267917|NCT02305238|12463766|FG000|NOT COMPLETED|Overall Study||16
11267918|NCT02305238|12463767|FG001|NOT COMPLETED|Overall Study||19
11267919|NCT02305238|12463768|FG002|NOT COMPLETED|Overall Study||8
11267920|NCT02305277|12463781|FG000|STARTED|Overall Study||15
11267921|NCT02305277|12463782|FG001|STARTED|Overall Study||14
11267922|NCT02305277|12463783|FG002|STARTED|Overall Study||14
11267923|NCT02305277|12463784|FG003|STARTED|Overall Study||14
11267924|NCT02305277|12463785|FG004|STARTED|Overall Study||14
11267925|NCT02305277|12463786|FG005|STARTED|Overall Study||14
11267926|NCT02305277|12463781|FG000|Received CM|Overall Study||15
11267927|NCT02305277|12463782|FG001|Received CM|Overall Study||14
11267928|NCT02305277|12463783|FG002|Received CM|Overall Study||14
11267929|NCT02305277|12463784|FG003|Received CM|Overall Study||14
11267930|NCT02305277|12463785|FG004|Received CM|Overall Study||14
11267931|NCT02305277|12463786|FG005|Received CM|Overall Study||14
11267932|NCT02305277|12463781|FG000|Received TBM|Overall Study||15
11267933|NCT02305277|12463782|FG001|Received TBM|Overall Study||14
11267934|NCT02305277|12463783|FG002|Received TBM|Overall Study||14
11267935|NCT02305277|12463784|FG003|Received TBM|Overall Study||14
11267936|NCT02305277|12463785|FG004|Received TBM|Overall Study||14
11267937|NCT02305277|12463786|FG005|Received TBM|Overall Study||14
11267938|NCT02305277|12463781|FG000|COMPLETED|Overall Study||14
11267939|NCT02305277|12463782|FG001|COMPLETED|Overall Study||14
11267940|NCT02305277|12463783|FG002|COMPLETED|Overall Study||14
11267941|NCT02305277|12463784|FG003|COMPLETED|Overall Study||14
11267942|NCT02305277|12463785|FG004|COMPLETED|Overall Study||13
11267943|NCT02305277|12463786|FG005|COMPLETED|Overall Study||14
11267944|NCT02305277|12463781|FG000|NOT COMPLETED|Overall Study||1
11267945|NCT02305277|12463782|FG001|NOT COMPLETED|Overall Study||0
11267946|NCT02305277|12463783|FG002|NOT COMPLETED|Overall Study||0
11267947|NCT02305277|12463784|FG003|NOT COMPLETED|Overall Study||0
11267948|NCT02305277|12463785|FG004|NOT COMPLETED|Overall Study||1
11267949|NCT02305277|12463786|FG005|NOT COMPLETED|Overall Study||0
11267950|NCT02305316|12463802|FG000|STARTED|Overall Study||14
11267951|NCT02305316|12463803|FG001|STARTED|Overall Study||14
11267952|NCT02305316|12463802|FG000|COMPLETED|Overall Study||14
11267953|NCT02305316|12463803|FG001|COMPLETED|Overall Study||14
11267954|NCT02305316|12463802|FG000|NOT COMPLETED|Overall Study||0
11267955|NCT02305316|12463803|FG001|NOT COMPLETED|Overall Study||0
11267956|NCT02305329|12463813|FG000|STARTED|Overall Study||14
11267957|NCT02305329|12463814|FG001|STARTED|Overall Study||14
11267958|NCT02305329|12463815|FG002|STARTED|Overall Study||14
11267959|NCT02305329|12463816|FG003|STARTED|Overall Study||14
11267960|NCT02305329|12463813|FG000|Period 1|Overall Study||14
11267961|NCT02305329|12463814|FG001|Period 1|Overall Study||14
11267962|NCT02305329|12463815|FG002|Period 1|Overall Study||14
11267963|NCT02305329|12463816|FG003|Period 1|Overall Study||14
11267964|NCT02305329|12463813|FG000|Period 2|Overall Study||14
11267965|NCT02305329|12463814|FG001|Period 2|Overall Study||13
11267966|NCT02305329|12463815|FG002|Period 2|Overall Study||14
11267967|NCT02305329|12463816|FG003|Period 2|Overall Study||14
11267968|NCT02305329|12463813|FG000|COMPLETED|Overall Study||14
11267969|NCT02305329|12463814|FG001|COMPLETED|Overall Study||13
11267970|NCT02305329|12463815|FG002|COMPLETED|Overall Study||14
11267971|NCT02305329|12463816|FG003|COMPLETED|Overall Study||14
11267972|NCT02305329|12463813|FG000|NOT COMPLETED|Overall Study||0
11267973|NCT02305329|12463814|FG001|NOT COMPLETED|Overall Study||1
11267974|NCT02305329|12463815|FG002|NOT COMPLETED|Overall Study||0
11267975|NCT02305329|12463816|FG003|NOT COMPLETED|Overall Study||0
11267976|NCT02305381|12463829|FG000|STARTED|Overall Study||132
11267977|NCT02305381|12463830|FG001|STARTED|Overall Study||132
11267978|NCT02305381|12463831|FG002|STARTED|Overall Study||133
11267979|NCT02305381|12463829|FG000|Exposed|Overall Study||132
11267980|NCT02305381|12463830|FG001|Exposed|Overall Study||131
11267981|NCT02305381|12463831|FG002|Exposed|Overall Study||133
11267982|NCT02305381|12463829|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
11267983|NCT02305381|12463830|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
11267984|NCT02305381|12463831|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
11267985|NCT02305381|12463829|FG000|COMPLETED|Overall Study|Subjects who completed the trial.|127
11267986|NCT02305381|12463830|FG001|COMPLETED|Overall Study|Subjects who completed the trial.|127
11267987|NCT02305381|12463831|FG002|COMPLETED|Overall Study|Subjects who completed the trial.|126
11267988|NCT02305381|12463829|FG000|NOT COMPLETED|Overall Study||5
11267989|NCT02305381|12463830|FG001|NOT COMPLETED|Overall Study||5
11267990|NCT02305381|12463831|FG002|NOT COMPLETED|Overall Study||7
11267991|NCT02305446|12463839|FG000|STARTED|Overall Study||55
11267992|NCT02305446|12463839|FG000|COMPLETED|Overall Study||54
11267993|NCT02305446|12463839|FG000|NOT COMPLETED|Overall Study||1
11267994|NCT02305563|12463848|FG000|STARTED|Treatment Period||3
11267995|NCT02305563|12463849|FG001|STARTED|Treatment Period||3
11267996|NCT02305563|12463850|FG002|STARTED|Treatment Period||26
11267997|NCT02305563|12463851|FG003|STARTED|Treatment Period||14
11267998|NCT02305563|12463852|FG004|STARTED|Treatment Period||24
11267999|NCT02305563|12463848|FG000|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1
11268000|NCT02305563|12463849|FG001|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1
11268001|NCT02305563|12463850|FG002|COMPLETED|Treatment Period||0
11268002|NCT02305563|12463851|FG003|COMPLETED|Treatment Period||0
11268003|NCT02305563|12463852|FG004|COMPLETED|Treatment Period||0
11268004|NCT02305563|12463848|FG000|NOT COMPLETED|Treatment Period||2
11268005|NCT02305563|12463849|FG001|NOT COMPLETED|Treatment Period||2
11268006|NCT02305563|12463850|FG002|NOT COMPLETED|Treatment Period||26
11268007|NCT02305563|12463851|FG003|NOT COMPLETED|Treatment Period||14
11268008|NCT02305563|12463852|FG004|NOT COMPLETED|Treatment Period||24
11268009|NCT02305563|12463848|FG000|STARTED|Follow-up Period||3
11268010|NCT02305563|12463849|FG001|STARTED|Follow-up Period||3
11268011|NCT02305563|12463850|FG002|STARTED|Follow-up Period||11
11268012|NCT02305563|12463851|FG003|STARTED|Follow-up Period||6
11268013|NCT02305563|12463852|FG004|STARTED|Follow-up Period||12
11268014|NCT02305563|12463848|FG000|COMPLETED|Follow-up Period||0
11268015|NCT02305563|12463849|FG001|COMPLETED|Follow-up Period||0
11268016|NCT02305563|12463850|FG002|COMPLETED|Follow-up Period||0
11268017|NCT02305563|12463851|FG003|COMPLETED|Follow-up Period||0
11268018|NCT02305563|12463852|FG004|COMPLETED|Follow-up Period||0
11268019|NCT02305563|12463848|FG000|NOT COMPLETED|Follow-up Period||3
11268020|NCT02305563|12463849|FG001|NOT COMPLETED|Follow-up Period||3
11268021|NCT02305563|12463850|FG002|NOT COMPLETED|Follow-up Period||11
11268022|NCT02305563|12463851|FG003|NOT COMPLETED|Follow-up Period||6
11268023|NCT02305563|12463852|FG004|NOT COMPLETED|Follow-up Period||12
11268024|NCT02305732|12463868|FG000|STARTED|Overall Study||90
11268025|NCT02305732|12463868|FG000|COMPLETED|Overall Study||72
11268026|NCT02305732|12463868|FG000|NOT COMPLETED|Overall Study||18
11268027|NCT02305758|12463875|FG000|STARTED|Overall Study||65
11268028|NCT02305758|12463876|FG001|STARTED|Overall Study||65
11268029|NCT02305758|12463875|FG000|COMPLETED|Overall Study||0
11268030|NCT02305758|12463876|FG001|COMPLETED|Overall Study||0
11268031|NCT02305758|12463875|FG000|NOT COMPLETED|Overall Study||65
11268032|NCT02305758|12463876|FG001|NOT COMPLETED|Overall Study||65
11268033|NCT02305797|12463884|FG000|STARTED|Overall Study||247
11268034|NCT02305797|12463885|FG001|STARTED|Overall Study||248
11268035|NCT02305797|12463884|FG000|COMPLETED|Overall Study||202
11268036|NCT02305797|12463885|FG001|COMPLETED|Overall Study||210
11268037|NCT02305797|12463884|FG000|NOT COMPLETED|Overall Study||45
11268038|NCT02305797|12463885|FG001|NOT COMPLETED|Overall Study||38
11268039|NCT02305849|12463894|FG000|STARTED|Overall Study||175
11268040|NCT02305849|12463895|FG001|STARTED|Overall Study||174
11268041|NCT02305849|12463896|FG002|STARTED|Overall Study||85
11268042|NCT02305849|12463897|FG003|STARTED|Overall Study||85
11268043|NCT02305849|12463894|FG000|COMPLETED|Overall Study||148
11268044|NCT02305849|12463895|FG001|COMPLETED|Overall Study||146
11268045|NCT02305849|12463896|FG002|COMPLETED|Overall Study||67
11268046|NCT02305849|12463897|FG003|COMPLETED|Overall Study||66
11268047|NCT02305849|12463894|FG000|NOT COMPLETED|Overall Study||27
11268048|NCT02305849|12463895|FG001|NOT COMPLETED|Overall Study||28
11268049|NCT02305849|12463896|FG002|NOT COMPLETED|Overall Study||18
11268050|NCT02305849|12463897|FG003|NOT COMPLETED|Overall Study||19
11268051|NCT02305888|12463931|FG000|STARTED|Overall Study||63
11268052|NCT02305888|12463932|FG001|STARTED|Overall Study||63
11268053|NCT02305888|12463933|FG002|STARTED|Overall Study||63
11268054|NCT02305888|12463931|FG000|COMPLETED|Overall Study||63
11268055|NCT02305888|12463932|FG001|COMPLETED|Overall Study||62
11268056|NCT02305888|12463933|FG002|COMPLETED|Overall Study||62
11268057|NCT02305888|12463931|FG000|NOT COMPLETED|Overall Study||0
11268058|NCT02305888|12463932|FG001|NOT COMPLETED|Overall Study||1
11268059|NCT02305888|12463933|FG002|NOT COMPLETED|Overall Study||1
11268060|NCT02306265|12463941|FG000|STARTED|Overall Study||250
11268061|NCT02306265|12463941|FG000|COMPLETED|Overall Study||249
11268062|NCT02306265|12463941|FG000|NOT COMPLETED|Overall Study||1
11268063|NCT02306694|12463946|FG000|STARTED|Overall Study||16
11268064|NCT02306694|12463946|FG000|COMPLETED|Overall Study||12
11268065|NCT02306694|12463946|FG000|NOT COMPLETED|Overall Study||4
11268066|NCT02306759|12463952|FG000|STARTED|Overall Study||30
11268067|NCT02306759|12463953|FG001|STARTED|Overall Study||30
11268068|NCT02306759|12463952|FG000|COMPLETED|Overall Study||30
11268069|NCT02306759|12463953|FG001|COMPLETED|Overall Study||30
11268070|NCT02306759|12463952|FG000|NOT COMPLETED|Overall Study||0
11268071|NCT02306759|12463953|FG001|NOT COMPLETED|Overall Study||0
11340249|NCT02919111|12537548|FG000|COMPLETED|Overall Study||299
11340250|NCT02919111|12537548|FG000|NOT COMPLETED|Overall Study||0
11340251|NCT02919267|12537556|FG000|STARTED|Overall Study||10
11340252|NCT02919267|12537557|FG001|STARTED|Overall Study||12
11340253|NCT02919267|12537558|FG002|STARTED|Overall Study||13
11340254|NCT02919267|12537559|FG003|STARTED|Overall Study||14
11340255|NCT02919267|12537556|FG000|COMPLETED|Overall Study||10
11340256|NCT02919267|12537557|FG001|COMPLETED|Overall Study||9
11340257|NCT02919267|12537558|FG002|COMPLETED|Overall Study||10
11340258|NCT02919267|12537559|FG003|COMPLETED|Overall Study||10
11340259|NCT02919267|12537556|FG000|NOT COMPLETED|Overall Study||0
11340260|NCT02919267|12537557|FG001|NOT COMPLETED|Overall Study||3
11340261|NCT02919267|12537558|FG002|NOT COMPLETED|Overall Study||3
11340262|NCT02919267|12537559|FG003|NOT COMPLETED|Overall Study||4
11340263|NCT02919423|12537571|FG000|STARTED|Overall Study||6
11340264|NCT02919423|12537572|FG001|STARTED|Overall Study||25
11340265|NCT02919423|12537571|FG000|COMPLETED|Overall Study||4
11340266|NCT02919423|12537572|FG001|COMPLETED|Overall Study||16
11340267|NCT02919423|12537571|FG000|NOT COMPLETED|Overall Study||2
11340268|NCT02919423|12537572|FG001|NOT COMPLETED|Overall Study||9
11340269|NCT02919475|12537583|FG000|STARTED|Overall Study||52
11340270|NCT02919475|12537584|FG001|STARTED|Overall Study||52
11340271|NCT02919475|12537585|FG002|STARTED|Overall Study||52
11340272|NCT02919475|12537586|FG003|STARTED|Overall Study||51
11340273|NCT02919475|12537587|FG004|STARTED|Overall Study||52
11340274|NCT02919475|12537583|FG000|Started Dosing|Overall Study||51
11340275|NCT02919475|12537584|FG001|Started Dosing|Overall Study||52
11340276|NCT02919475|12537585|FG002|Started Dosing|Overall Study||52
11340277|NCT02919475|12537586|FG003|Started Dosing|Overall Study||51
11340278|NCT02919475|12537587|FG004|Started Dosing|Overall Study||52
11340279|NCT02919475|12537583|FG000|COMPLETED|Overall Study||46
11340280|NCT02919475|12537584|FG001|COMPLETED|Overall Study||44
11340281|NCT02919475|12537585|FG002|COMPLETED|Overall Study||47
11340282|NCT02919475|12537586|FG003|COMPLETED|Overall Study||38
11340283|NCT02919475|12537587|FG004|COMPLETED|Overall Study||48
11340284|NCT02919475|12537583|FG000|NOT COMPLETED|Overall Study||6
11340285|NCT02919475|12537584|FG001|NOT COMPLETED|Overall Study||8
11340286|NCT02919475|12537585|FG002|NOT COMPLETED|Overall Study||5
11340287|NCT02919475|12537586|FG003|NOT COMPLETED|Overall Study||13
11340288|NCT02919475|12537587|FG004|NOT COMPLETED|Overall Study||4
11340289|NCT02919657|12537599|FG000|STARTED|Overall Study|10 Participants|10
11340290|NCT02919657|12537600|FG001|STARTED|Overall Study|10 Participants|10
11340291|NCT02919657|12537599|FG000|COMPLETED|Overall Study|completed with the same initial 10 participants|10
11340292|NCT02919657|12537600|FG001|COMPLETED|Overall Study|completed with the same initial 10 participants|10
11340293|NCT02919657|12537599|FG000|NOT COMPLETED|Overall Study||0
11340294|NCT02919657|12537600|FG001|NOT COMPLETED|Overall Study||0
11340295|NCT02919696|12537608|FG000|STARTED|Overall Study||12
11340296|NCT02919696|12537609|FG001|STARTED|Overall Study||14
11340297|NCT02919696|12537608|FG000|Received at Least One Dose of Study Drug|Overall Study||12
11340298|NCT02919696|12537609|FG001|Received at Least One Dose of Study Drug|Overall Study||13
11340299|NCT02919696|12537608|FG000|PK 100 mg Abemaciclib Dose|Overall Study||5
11340300|NCT02919696|12537609|FG001|PK 100 mg Abemaciclib Dose|Overall Study||0
11340301|NCT02919696|12537608|FG000|PK 150 mg Abemaciclib Dose|Overall Study||0
11340302|NCT02919696|12537609|FG001|PK 150 mg Abemaciclib Dose|Overall Study||2
11340303|NCT02919696|12537608|FG000|Death On Treatment|Overall Study||1
11340304|NCT02919696|12537609|FG001|Death On Treatment|Overall Study||0
11340305|NCT02919696|12537608|FG000|Progressive Disease|Overall Study||7
11340306|NCT02919696|12537609|FG001|Progressive Disease|Overall Study||9
11340307|NCT02919696|12537608|FG000|COMPLETED|Overall Study||8
11340308|NCT02919696|12537609|FG001|COMPLETED|Overall Study||9
11340309|NCT02919696|12537608|FG000|NOT COMPLETED|Overall Study||4
11340310|NCT02919696|12537609|FG001|NOT COMPLETED|Overall Study||5
11343952|NCT02957682|12541259|FG001|NOT COMPLETED|Overall Study||169
11343953|NCT02957747|12541267|FG000|STARTED|Overall Study||76
11343954|NCT02957747|12541268|FG001|STARTED|Overall Study||77
11343955|NCT02957747|12541267|FG000|COMPLETED|Overall Study||66
11343956|NCT02957747|12541268|FG001|COMPLETED|Overall Study||69
11343957|NCT02957747|12541267|FG000|NOT COMPLETED|Overall Study||10
11343958|NCT02957747|12541268|FG001|NOT COMPLETED|Overall Study||8
11343959|NCT02957942|12541277|FG000|STARTED|Overall Study||7
11397348|NCT04165031|12591469|FG002|COMPLETED|Overall Study||1
11268072|NCT02306850|12463961|FG000|STARTED|Overall Study||10
11268073|NCT02306850|12463961|FG000|COMPLETED|Overall Study||8
11268074|NCT02306850|12463961|FG000|NOT COMPLETED|Overall Study||2
11268075|NCT02306928|12463966|FG000|STARTED|Overall Study||15
11268076|NCT02306928|12463966|FG000|COMPLETED|Overall Study||15
11268077|NCT02306928|12463966|FG000|NOT COMPLETED|Overall Study||0
11268078|NCT02307123|12463970|FG000|STARTED|Overall Study||483
11268079|NCT02307123|12463970|FG000|COMPLETED|Overall Study||483
11268080|NCT02307123|12463970|FG000|NOT COMPLETED|Overall Study||0
11268081|NCT02307266|12463977|FG000|STARTED|Overall Study||33
11268082|NCT02307266|12463978|FG001|STARTED|Overall Study||33
11268083|NCT02307266|12463979|FG002|STARTED|Overall Study||31
11268084|NCT02307266|12463977|FG000|COMPLETED|Overall Study||25
11268085|NCT02307266|12463978|FG001|COMPLETED|Overall Study||32
11268086|NCT02307266|12463979|FG002|COMPLETED|Overall Study||25
11268087|NCT02307266|12463977|FG000|NOT COMPLETED|Overall Study||8
11268088|NCT02307266|12463978|FG001|NOT COMPLETED|Overall Study||1
11268089|NCT02307266|12463979|FG002|NOT COMPLETED|Overall Study||6
11268090|NCT02307318|12463987|FG000|STARTED|Overall Study||51
11268091|NCT02307318|12463987|FG000|COMPLETED|Overall Study||51
11268092|NCT02307318|12463987|FG000|NOT COMPLETED|Overall Study||0
11268093|NCT02307370|12463991|FG000|STARTED|Overall Study||44
11268094|NCT02307370|12463991|FG000|30 Day Follow-up|Overall Study||40
11268095|NCT02307370|12463991|FG000|180 Day Patient Telephone Contact|Overall Study||25
11268096|NCT02307370|12463991|FG000|COMPLETED|Overall Study||25
11268097|NCT02307370|12463991|FG000|NOT COMPLETED|Overall Study||19
11268098|NCT02307513|12463999|FG000|STARTED|Placebo Controlled Phase (Weeks 0-12)||103
11268099|NCT02307513|12464000|FG001|STARTED|Placebo Controlled Phase (Weeks 0-12)||104
11268100|NCT02307513|12463999|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83
11268101|NCT02307513|12464000|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96
11268102|NCT02307513|12463999|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20
11268103|NCT02307513|12464000|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8
11268104|NCT02307513|12463999|FG000|STARTED|Active Treatment Phase (Weeks 13-64)||83
11268105|NCT02307513|12464000|FG001|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95
11268106|NCT02307513|12463999|FG000|COMPLETED|Active Treatment Phase (Weeks 13-64)||68
11268107|NCT02307513|12464000|FG001|COMPLETED|Active Treatment Phase (Weeks 13-64)||75
11268108|NCT02307513|12463999|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15
11268109|NCT02307513|12464000|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20
11268110|NCT02307513|12463999|FG000|STARTED|Long-term Extension||2
11268111|NCT02307513|12464000|FG001|STARTED|Long-term Extension||0
11268112|NCT02307513|12463999|FG000|COMPLETED|Long-term Extension||1
11268113|NCT02307513|12464000|FG001|COMPLETED|Long-term Extension||0
11268114|NCT02307513|12463999|FG000|NOT COMPLETED|Long-term Extension||1
11268115|NCT02307513|12464000|FG001|NOT COMPLETED|Long-term Extension||0
11268116|NCT02307526|12464010|FG000|STARTED|Day 1 - No Drug||10
11268117|NCT02307526|12464010|FG000|COMPLETED|Day 1 - No Drug||10
11268118|NCT02307526|12464010|FG000|NOT COMPLETED|Day 1 - No Drug||0
11268119|NCT02307526|12464010|FG000|STARTED|Day 2 - 60 mg of Pyridostigmine||10
11268120|NCT02307526|12464010|FG000|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
11268121|NCT02307526|12464010|FG000|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
11268122|NCT02307552|12464016|FG000|STARTED|Overall Study||1
11268123|NCT02307552|12464016|FG000|COMPLETED|Overall Study||1
11268124|NCT02307552|12464016|FG000|NOT COMPLETED|Overall Study||0
11268125|NCT02307682|12464023|FG000|STARTED|Overall Study||360
11268126|NCT02307682|12464024|FG001|STARTED|Overall Study||361
11268127|NCT02307682|12464025|FG002|STARTED|Overall Study||361
11268128|NCT02307682|12464023|FG000|Randomized and Treated|Overall Study||358
11268129|NCT02307682|12464024|FG001|Randomized and Treated|Overall Study||360
11268130|NCT02307682|12464025|FG002|Randomized and Treated|Overall Study||360
11268131|NCT02307682|12464023|FG000|COMPLETED|Overall Study||310
11268132|NCT02307682|12464024|FG001|COMPLETED|Overall Study||304
11268133|NCT02307682|12464025|FG002|COMPLETED|Overall Study||297
11268134|NCT02307682|12464023|FG000|NOT COMPLETED|Overall Study||50
11268135|NCT02307682|12464024|FG001|NOT COMPLETED|Overall Study||57
11268136|NCT02307682|12464025|FG002|NOT COMPLETED|Overall Study||64
11268137|NCT02307838|12464036|FG000|STARTED|Overall Study||56
11268138|NCT02307838|12464037|FG001|STARTED|Overall Study||64
11268139|NCT02307838|12464038|FG002|STARTED|Overall Study||55
11268140|NCT02307838|12464036|FG000|COMPLETED|Overall Study||56
11268141|NCT02307838|12464037|FG001|COMPLETED|Overall Study||64
11268142|NCT02307838|12464038|FG002|COMPLETED|Overall Study||55
11268143|NCT02307838|12464036|FG000|NOT COMPLETED|Overall Study||0
11268144|NCT02307838|12464037|FG001|NOT COMPLETED|Overall Study||0
11268145|NCT02307838|12464038|FG002|NOT COMPLETED|Overall Study||0
11268146|NCT02307916|12464049|FG000|STARTED|Overall Study||42
11268147|NCT02307916|12464050|FG001|STARTED|Overall Study||15
11268148|NCT02307916|12464049|FG000|COMPLETED|Overall Study||40
11268149|NCT02307916|12464050|FG001|COMPLETED|Overall Study||14
11268150|NCT02307916|12464049|FG000|NOT COMPLETED|Overall Study||2
11268151|NCT02307916|12464050|FG001|NOT COMPLETED|Overall Study||1
11268152|NCT02308007|12464059|FG000|STARTED|Overall Study||159
11268153|NCT02308007|12464060|FG001|STARTED|Overall Study||159
11268154|NCT02308007|12464061|FG002|STARTED|Overall Study||157
11268155|NCT02308007|12464059|FG000|COMPLETED|Overall Study||83
11268156|NCT02308007|12464060|FG001|COMPLETED|Overall Study||84
11268157|NCT02308007|12464061|FG002|COMPLETED|Overall Study||82
11268158|NCT02308007|12464059|FG000|NOT COMPLETED|Overall Study||76
11268159|NCT02308007|12464060|FG001|NOT COMPLETED|Overall Study||75
11268160|NCT02308007|12464061|FG002|NOT COMPLETED|Overall Study||75
11268161|NCT02308020|12464075|FG000|STARTED|Overall Study||27
11268162|NCT02308020|12464076|FG001|STARTED|Overall Study||58
11268163|NCT02308020|12464077|FG002|STARTED|Overall Study||9
11268164|NCT02308020|12464078|FG003|STARTED|Overall Study||28
11268165|NCT02308020|12464079|FG004|STARTED|Overall Study||23
11268166|NCT02308020|12464080|FG005|STARTED|Overall Study||17
11268167|NCT02308020|12464075|FG000|Received at Least One Dose of Study Drug|Overall Study||27
11268168|NCT02308020|12464076|FG001|Received at Least One Dose of Study Drug|Overall Study||58
11268169|NCT02308020|12464077|FG002|Received at Least One Dose of Study Drug|Overall Study||9
11268170|NCT02308020|12464078|FG003|Received at Least One Dose of Study Drug|Overall Study||28
11268171|NCT02308020|12464079|FG004|Received at Least One Dose of Study Drug|Overall Study||23
11268172|NCT02308020|12464080|FG005|Received at Least One Dose of Study Drug|Overall Study||17
11268173|NCT02308020|12464075|FG000|COMPLETED|Overall Study||23
11268174|NCT02308020|12464076|FG001|COMPLETED|Overall Study||38
11268175|NCT02308020|12464077|FG002|COMPLETED|Overall Study||6
11268176|NCT02308020|12464078|FG003|COMPLETED|Overall Study||24
11268177|NCT02308020|12464079|FG004|COMPLETED|Overall Study||19
11268178|NCT02308020|12464080|FG005|COMPLETED|Overall Study||12
11268179|NCT02308020|12464075|FG000|NOT COMPLETED|Overall Study||4
11268180|NCT02308020|12464076|FG001|NOT COMPLETED|Overall Study||20
11268181|NCT02308020|12464077|FG002|NOT COMPLETED|Overall Study||3
11268182|NCT02308020|12464078|FG003|NOT COMPLETED|Overall Study||4
11268183|NCT02308020|12464079|FG004|NOT COMPLETED|Overall Study||4
11268184|NCT02308020|12464080|FG005|NOT COMPLETED|Overall Study||5
11268185|NCT02308033|12464102|FG000|STARTED|Overall Study||102
11268186|NCT02308033|12464103|FG001|STARTED|Overall Study||102
11268187|NCT02308033|12464102|FG000|COMPLETED|Overall Study||76
11268188|NCT02308033|12464103|FG001|COMPLETED|Overall Study||83
11268189|NCT02308033|12464102|FG000|NOT COMPLETED|Overall Study||26
11268190|NCT02308033|12464103|FG001|NOT COMPLETED|Overall Study||19
11268191|NCT02308046|12464111|FG000|STARTED|Overall Study||107
11268192|NCT02308046|12464112|FG001|STARTED|Overall Study||105
11268193|NCT02308046|12464111|FG000|COMPLETED|Overall Study||73
11268194|NCT02308046|12464112|FG001|COMPLETED|Overall Study||67
11268195|NCT02308046|12464111|FG000|NOT COMPLETED|Overall Study||34
11268196|NCT02308046|12464112|FG001|NOT COMPLETED|Overall Study||38
11268197|NCT02308124|12464121|FG000|STARTED|Overall Study||29
11268198|NCT02308124|12464122|FG001|STARTED|Overall Study||29
11268199|NCT02308124|12464123|FG002|STARTED|Overall Study||29
11268200|NCT02308124|12464121|FG000|COMPLETED|Overall Study||23
11268201|NCT02308124|12464122|FG001|COMPLETED|Overall Study||21
11268202|NCT02308124|12464123|FG002|COMPLETED|Overall Study||21
11268203|NCT02308124|12464121|FG000|NOT COMPLETED|Overall Study||6
11268204|NCT02308124|12464122|FG001|NOT COMPLETED|Overall Study||8
11268205|NCT02308124|12464123|FG002|NOT COMPLETED|Overall Study||8
11268206|NCT02308163|12464135|FG000|STARTED|Overall Study||104
11268207|NCT02308163|12464136|FG001|STARTED|Overall Study||102
11268208|NCT02308163|12464137|FG002|STARTED|Overall Study||50
11268209|NCT02308163|12464138|FG003|STARTED|Overall Study||52
11268210|NCT02308163|12464139|FG004|STARTED|Overall Study||201
11268211|NCT02308163|12464135|FG000|COMPLETED|Overall Study||73
11268212|NCT02308163|12464136|FG001|COMPLETED|Overall Study||84
11268213|NCT02308163|12464137|FG002|COMPLETED|Overall Study||36
11268214|NCT02308163|12464138|FG003|COMPLETED|Overall Study||39
11268215|NCT02308163|12464139|FG004|COMPLETED|Overall Study||167
11268216|NCT02308163|12464135|FG000|NOT COMPLETED|Overall Study||31
11268217|NCT02308163|12464136|FG001|NOT COMPLETED|Overall Study||18
11268218|NCT02308163|12464137|FG002|NOT COMPLETED|Overall Study||14
11268219|NCT02308163|12464138|FG003|NOT COMPLETED|Overall Study||13
11268220|NCT02308163|12464139|FG004|NOT COMPLETED|Overall Study||34
11268221|NCT02308189|12464168|FG000|STARTED|Overall Study||17
11268222|NCT02308189|12464169|FG001|STARTED|Overall Study||15
11268223|NCT02308189|12464168|FG000|COMPLETED|Overall Study||16
11268224|NCT02308189|12464169|FG001|COMPLETED|Overall Study||14
11268225|NCT02308189|12464168|FG000|NOT COMPLETED|Overall Study||1
11268226|NCT02308189|12464169|FG001|NOT COMPLETED|Overall Study||1
11268227|NCT02308228|12464177|FG000|STARTED|Overall Study||54
11268228|NCT02308228|12464178|FG001|STARTED|Overall Study||55
11268229|NCT02308228|12464177|FG000|COMPLETED|Overall Study||46
11268230|NCT02308228|12464178|FG001|COMPLETED|Overall Study||48
11268231|NCT02308228|12464177|FG000|NOT COMPLETED|Overall Study||8
11268232|NCT02308228|12464178|FG001|NOT COMPLETED|Overall Study||7
11397349|NCT04165031|12591470|FG003|COMPLETED|Overall Study||0
11397350|NCT04165031|12591471|FG004|COMPLETED|Overall Study||0
11397351|NCT04165031|12591472|FG005|COMPLETED|Overall Study||0
11397352|NCT04165031|12591467|FG000|NOT COMPLETED|Overall Study||1
11268233|NCT02308371|12464186|FG000|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
11268234|NCT02308371|12464187|FG001|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
11268235|NCT02308371|12464186|FG000|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
11268236|NCT02308371|12464187|FG001|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
11268237|NCT02308371|12464186|FG000|NOT COMPLETED|Overall Study||0
11268238|NCT02308371|12464187|FG001|NOT COMPLETED|Overall Study||0
11268239|NCT02308501|12464197|FG000|STARTED|Overall Study|25 participants received one drop of Lastacaft in one eye and Tears Naturale in the other eye.|25
11268240|NCT02308501|12464198|FG001|STARTED|Overall Study||25
11268241|NCT02308501|12464197|FG000|Randomized Participant Eyes|Overall Study||25
11268242|NCT02308501|12464198|FG001|Randomized Participant Eyes|Overall Study||25
11268243|NCT02308501|12464197|FG000|COMPLETED|Overall Study||25
11268244|NCT02308501|12464198|FG001|COMPLETED|Overall Study||25
11268245|NCT02308501|12464197|FG000|NOT COMPLETED|Overall Study||0
11268246|NCT02308501|12464198|FG001|NOT COMPLETED|Overall Study||0
11268247|NCT02308540|12464216|FG000|STARTED|Overall Study||17
11268248|NCT02308540|12464217|FG001|STARTED|Overall Study||17
11268249|NCT02308540|12464218|FG002|STARTED|Overall Study||56
11268250|NCT02308540|12464219|FG003|STARTED|Overall Study||56
11268251|NCT02308540|12464220|FG004|STARTED|Overall Study||100
11268252|NCT02308540|12464221|FG005|STARTED|Overall Study||100
11268253|NCT02308540|12464216|FG000|Randomized|Overall Study||17
11268254|NCT02308540|12464217|FG001|Randomized|Overall Study||17
11268255|NCT02308540|12464218|FG002|Randomized|Overall Study||56
11268256|NCT02308540|12464219|FG003|Randomized|Overall Study||56
11268257|NCT02308540|12464220|FG004|Randomized|Overall Study||100
11268258|NCT02308540|12464221|FG005|Randomized|Overall Study||100
11268259|NCT02308540|12464216|FG000|Vaccinated|Overall Study||17
11268260|NCT02308540|12464217|FG001|Vaccinated|Overall Study||17
11268261|NCT02308540|12464218|FG002|Vaccinated|Overall Study||56
11268262|NCT02308540|12464219|FG003|Vaccinated|Overall Study||56
11268263|NCT02308540|12464220|FG004|Vaccinated|Overall Study||100
11268264|NCT02308540|12464221|FG005|Vaccinated|Overall Study||100
11268265|NCT02308540|12464216|FG000|COMPLETED|Overall Study||17
11268266|NCT02308540|12464217|FG001|COMPLETED|Overall Study||17
11268267|NCT02308540|12464218|FG002|COMPLETED|Overall Study||56
11268268|NCT02308540|12464219|FG003|COMPLETED|Overall Study||56
11268269|NCT02308540|12464220|FG004|COMPLETED|Overall Study||100
11268270|NCT02308540|12464221|FG005|COMPLETED|Overall Study||99
11268271|NCT02308540|12464216|FG000|NOT COMPLETED|Overall Study||0
11268272|NCT02308540|12464217|FG001|NOT COMPLETED|Overall Study||0
11268273|NCT02308540|12464218|FG002|NOT COMPLETED|Overall Study||0
11268274|NCT02308540|12464219|FG003|NOT COMPLETED|Overall Study||0
11268275|NCT02308540|12464220|FG004|NOT COMPLETED|Overall Study||0
11268276|NCT02308540|12464221|FG005|NOT COMPLETED|Overall Study||1
11268277|NCT02308696|12464272|FG000|STARTED|Overall Study||222
11268278|NCT02308696|12464273|FG001|STARTED|Overall Study||234
11268279|NCT02308696|12464272|FG000|COMPLETED|Overall Study||169
11268280|NCT02308696|12464273|FG001|COMPLETED|Overall Study||203
11268281|NCT02308696|12464272|FG000|NOT COMPLETED|Overall Study||53
11268282|NCT02308696|12464273|FG001|NOT COMPLETED|Overall Study||31
11268283|NCT02308748|12464279|FG000|STARTED|Period 1||2
11268284|NCT02308748|12464280|FG001|STARTED|Period 1||2
11268285|NCT02308748|12464281|FG002|STARTED|Period 1||2
11268286|NCT02308748|12464282|FG003|STARTED|Period 1||2
11268287|NCT02308748|12464283|FG004|STARTED|Period 1||2
11268288|NCT02308748|12464284|FG005|STARTED|Period 1||3
11268289|NCT02308748|12464285|FG006|STARTED|Period 1||2
11268290|NCT02308748|12464286|FG007|STARTED|Period 1||2
11268291|NCT02308748|12464287|FG008|STARTED|Period 1||2
11268292|NCT02308748|12464288|FG009|STARTED|Period 1||3
11268293|NCT02308748|12464279|FG000|COMPLETED|Period 1||2
11268294|NCT02308748|12464280|FG001|COMPLETED|Period 1||2
11268295|NCT02308748|12464281|FG002|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
11268296|NCT02308748|12464282|FG003|COMPLETED|Period 1||2
11268297|NCT02308748|12464283|FG004|COMPLETED|Period 1||2
11268298|NCT02308748|12464284|FG005|COMPLETED|Period 1||3
11268299|NCT02308748|12464285|FG006|COMPLETED|Period 1||2
11268300|NCT02308748|12464286|FG007|COMPLETED|Period 1||2
11268301|NCT02308748|12464287|FG008|COMPLETED|Period 1||2
11268302|NCT02308748|12464288|FG009|COMPLETED|Period 1||3
11268303|NCT02308748|12464279|FG000|NOT COMPLETED|Period 1||0
11268304|NCT02308748|12464280|FG001|NOT COMPLETED|Period 1||0
11268305|NCT02308748|12464281|FG002|NOT COMPLETED|Period 1||1
11268306|NCT02308748|12464282|FG003|NOT COMPLETED|Period 1||0
11268307|NCT02308748|12464283|FG004|NOT COMPLETED|Period 1||0
11268308|NCT02308748|12464284|FG005|NOT COMPLETED|Period 1||0
11268309|NCT02308748|12464285|FG006|NOT COMPLETED|Period 1||0
11268310|NCT02308748|12464286|FG007|NOT COMPLETED|Period 1||0
11268311|NCT02308748|12464287|FG008|NOT COMPLETED|Period 1||0
11268312|NCT02308748|12464288|FG009|NOT COMPLETED|Period 1||0
11268313|NCT02308748|12464279|FG000|STARTED|Period 2||2
11268314|NCT02308748|12464280|FG001|STARTED|Period 2||2
11268315|NCT02308748|12464281|FG002|STARTED|Period 2||1
11268316|NCT02308748|12464282|FG003|STARTED|Period 2||2
11268317|NCT02308748|12464283|FG004|STARTED|Period 2||2
11268318|NCT02308748|12464284|FG005|STARTED|Period 2||3
11268319|NCT02308748|12464285|FG006|STARTED|Period 2||2
11268320|NCT02308748|12464286|FG007|STARTED|Period 2||2
11268321|NCT02308748|12464287|FG008|STARTED|Period 2||2
11268322|NCT02308748|12464288|FG009|STARTED|Period 2||3
11268323|NCT02308748|12464279|FG000|COMPLETED|Period 2||2
11268324|NCT02308748|12464280|FG001|COMPLETED|Period 2||2
11268325|NCT02308748|12464281|FG002|COMPLETED|Period 2||1
11268326|NCT02308748|12464282|FG003|COMPLETED|Period 2||2
11268327|NCT02308748|12464283|FG004|COMPLETED|Period 2||2
11268328|NCT02308748|12464284|FG005|COMPLETED|Period 2||3
11268329|NCT02308748|12464285|FG006|COMPLETED|Period 2||2
11268330|NCT02308748|12464286|FG007|COMPLETED|Period 2||1
11268331|NCT02308748|12464287|FG008|COMPLETED|Period 2||2
11268332|NCT02308748|12464288|FG009|COMPLETED|Period 2||3
11268333|NCT02308748|12464279|FG000|NOT COMPLETED|Period 2||0
11268334|NCT02308748|12464280|FG001|NOT COMPLETED|Period 2||0
11268335|NCT02308748|12464281|FG002|NOT COMPLETED|Period 2||0
11268336|NCT02308748|12464282|FG003|NOT COMPLETED|Period 2||0
11268337|NCT02308748|12464283|FG004|NOT COMPLETED|Period 2||0
11268338|NCT02308748|12464284|FG005|NOT COMPLETED|Period 2||0
11268339|NCT02308748|12464285|FG006|NOT COMPLETED|Period 2||0
11268340|NCT02308748|12464286|FG007|NOT COMPLETED|Period 2||1
11268341|NCT02308748|12464287|FG008|NOT COMPLETED|Period 2||0
11268342|NCT02308748|12464288|FG009|NOT COMPLETED|Period 2||0
11268343|NCT02308748|12464279|FG000|STARTED|Period 3||2
11268344|NCT02308748|12464280|FG001|STARTED|Period 3||2
11268345|NCT02308748|12464281|FG002|STARTED|Period 3||1
11268346|NCT02308748|12464282|FG003|STARTED|Period 3||2
11268347|NCT02308748|12464283|FG004|STARTED|Period 3||2
11268348|NCT02308748|12464284|FG005|STARTED|Period 3||3
11268349|NCT02308748|12464285|FG006|STARTED|Period 3||2
11268350|NCT02308748|12464286|FG007|STARTED|Period 3||1
11268351|NCT02308748|12464287|FG008|STARTED|Period 3||2
11268352|NCT02308748|12464288|FG009|STARTED|Period 3||3
11268353|NCT02308748|12464279|FG000|COMPLETED|Period 3||2
11268354|NCT02308748|12464280|FG001|COMPLETED|Period 3||2
11268355|NCT02308748|12464281|FG002|COMPLETED|Period 3||1
11268356|NCT02308748|12464282|FG003|COMPLETED|Period 3||2
11268357|NCT02308748|12464283|FG004|COMPLETED|Period 3||2
11268358|NCT02308748|12464284|FG005|COMPLETED|Period 3||3
11268359|NCT02308748|12464285|FG006|COMPLETED|Period 3||2
11268360|NCT02308748|12464286|FG007|COMPLETED|Period 3||1
11268361|NCT02308748|12464287|FG008|COMPLETED|Period 3||2
11268362|NCT02308748|12464288|FG009|COMPLETED|Period 3||2
11268363|NCT02308748|12464279|FG000|NOT COMPLETED|Period 3||0
11268364|NCT02308748|12464280|FG001|NOT COMPLETED|Period 3||0
11268365|NCT02308748|12464281|FG002|NOT COMPLETED|Period 3||0
11268366|NCT02308748|12464282|FG003|NOT COMPLETED|Period 3||0
11268367|NCT02308748|12464283|FG004|NOT COMPLETED|Period 3||0
11268368|NCT02308748|12464284|FG005|NOT COMPLETED|Period 3||0
11268369|NCT02308748|12464285|FG006|NOT COMPLETED|Period 3||0
11268370|NCT02308748|12464286|FG007|NOT COMPLETED|Period 3||0
11268371|NCT02308748|12464287|FG008|NOT COMPLETED|Period 3||0
11268372|NCT02308748|12464288|FG009|NOT COMPLETED|Period 3||1
11268373|NCT02308748|12464279|FG000|STARTED|Period 4||2
11268374|NCT02308748|12464280|FG001|STARTED|Period 4||2
11268375|NCT02308748|12464281|FG002|STARTED|Period 4||1
11397353|NCT04165031|12591468|FG001|NOT COMPLETED|Overall Study||1
11397354|NCT04165031|12591469|FG002|NOT COMPLETED|Overall Study||1
11397355|NCT04165031|12591470|FG003|NOT COMPLETED|Overall Study||0
11397356|NCT04165031|12591471|FG004|NOT COMPLETED|Overall Study||0
11268376|NCT02308748|12464282|FG003|STARTED|Period 4||2
11397357|NCT04165031|12591472|FG005|NOT COMPLETED|Overall Study||0
11397358|NCT04166032|12591487|FG000|STARTED|Overall Study||15
11397359|NCT04166032|12591487|FG000|COMPLETED|Overall Study||14
11397360|NCT04166032|12591487|FG000|NOT COMPLETED|Overall Study||1
11397361|NCT04171414|12591491|FG000|STARTED|Overall Study||62
11397362|NCT04171414|12591491|FG000|COMPLETED|Overall Study||60
11397363|NCT04171414|12591491|FG000|NOT COMPLETED|Overall Study||2
11397364|NCT04175808|12591495|FG000|STARTED|Part A||70
11397365|NCT04175808|12591496|FG001|STARTED|Part A||0
11397366|NCT04175808|12591497|FG002|STARTED|Part A||0
11397367|NCT04175808|12591498|FG003|STARTED|Part A||0
11397368|NCT04175808|12591499|FG004|STARTED|Part A||0
11268377|NCT02308748|12464283|FG004|STARTED|Period 4||2
11268378|NCT02308748|12464284|FG005|STARTED|Period 4||3
11268379|NCT02308748|12464285|FG006|STARTED|Period 4||2
11268380|NCT02308748|12464286|FG007|STARTED|Period 4||1
11268381|NCT02308748|12464287|FG008|STARTED|Period 4||2
11268382|NCT02308748|12464288|FG009|STARTED|Period 4||2
11268383|NCT02308748|12464279|FG000|COMPLETED|Period 4||2
11268384|NCT02308748|12464280|FG001|COMPLETED|Period 4||2
11268385|NCT02308748|12464281|FG002|COMPLETED|Period 4||1
11268386|NCT02308748|12464282|FG003|COMPLETED|Period 4||2
11268387|NCT02308748|12464283|FG004|COMPLETED|Period 4||2
11268388|NCT02308748|12464284|FG005|COMPLETED|Period 4||3
11268389|NCT02308748|12464285|FG006|COMPLETED|Period 4||2
11268390|NCT02308748|12464286|FG007|COMPLETED|Period 4||1
11397369|NCT04175808|12591500|FG005|STARTED|Part A||0
11397370|NCT04175808|12591501|FG006|STARTED|Part A||0
11397371|NCT04175808|12591495|FG000|COMPLETED|Part A||68
11397372|NCT04175808|12591496|FG001|COMPLETED|Part A||0
11397373|NCT04175808|12591497|FG002|COMPLETED|Part A||0
11397374|NCT04175808|12591498|FG003|COMPLETED|Part A||0
11397375|NCT04175808|12591499|FG004|COMPLETED|Part A||0
11397376|NCT04175808|12591500|FG005|COMPLETED|Part A||0
11397377|NCT04175808|12591501|FG006|COMPLETED|Part A||0
11397378|NCT04175808|12591495|FG000|NOT COMPLETED|Part A||2
11397379|NCT04175808|12591496|FG001|NOT COMPLETED|Part A||0
11397380|NCT04175808|12591497|FG002|NOT COMPLETED|Part A||0
11397381|NCT04175808|12591498|FG003|NOT COMPLETED|Part A||0
11397382|NCT04175808|12591499|FG004|NOT COMPLETED|Part A||0
11397383|NCT04175808|12591500|FG005|NOT COMPLETED|Part A||0
11397384|NCT04175808|12591501|FG006|NOT COMPLETED|Part A||0
11268391|NCT02308748|12464287|FG008|COMPLETED|Period 4||2
11268392|NCT02308748|12464288|FG009|COMPLETED|Period 4||2
11268393|NCT02308748|12464279|FG000|NOT COMPLETED|Period 4||0
11268394|NCT02308748|12464280|FG001|NOT COMPLETED|Period 4||0
11268395|NCT02308748|12464281|FG002|NOT COMPLETED|Period 4||0
11268396|NCT02308748|12464282|FG003|NOT COMPLETED|Period 4||0
11268397|NCT02308748|12464283|FG004|NOT COMPLETED|Period 4||0
11268398|NCT02308748|12464284|FG005|NOT COMPLETED|Period 4||0
11268399|NCT02308748|12464285|FG006|NOT COMPLETED|Period 4||0
11268400|NCT02308748|12464286|FG007|NOT COMPLETED|Period 4||0
11268401|NCT02308748|12464287|FG008|NOT COMPLETED|Period 4||0
11268402|NCT02308748|12464288|FG009|NOT COMPLETED|Period 4||0
11268403|NCT02308748|12464279|FG000|STARTED|Period 5||2
11268404|NCT02308748|12464280|FG001|STARTED|Period 5||2
11268405|NCT02308748|12464281|FG002|STARTED|Period 5||1
11268406|NCT02308748|12464282|FG003|STARTED|Period 5||2
11268407|NCT02308748|12464283|FG004|STARTED|Period 5||2
11268408|NCT02308748|12464284|FG005|STARTED|Period 5||3
11268409|NCT02308748|12464285|FG006|STARTED|Period 5||2
11268410|NCT02308748|12464286|FG007|STARTED|Period 5||1
11268411|NCT02308748|12464287|FG008|STARTED|Period 5||2
11268412|NCT02308748|12464288|FG009|STARTED|Period 5||2
11268413|NCT02308748|12464279|FG000|COMPLETED|Period 5||1
11268414|NCT02308748|12464280|FG001|COMPLETED|Period 5||2
11268415|NCT02308748|12464281|FG002|COMPLETED|Period 5||1
11268416|NCT02308748|12464282|FG003|COMPLETED|Period 5||2
11268417|NCT02308748|12464283|FG004|COMPLETED|Period 5||2
11268418|NCT02308748|12464284|FG005|COMPLETED|Period 5||3
11268419|NCT02308748|12464285|FG006|COMPLETED|Period 5||2
11268420|NCT02308748|12464286|FG007|COMPLETED|Period 5||1
11268421|NCT02308748|12464287|FG008|COMPLETED|Period 5||1
11268422|NCT02308748|12464288|FG009|COMPLETED|Period 5||2
11268423|NCT02308748|12464279|FG000|NOT COMPLETED|Period 5||1
11268424|NCT02308748|12464280|FG001|NOT COMPLETED|Period 5||0
11268425|NCT02308748|12464281|FG002|NOT COMPLETED|Period 5||0
11268426|NCT02308748|12464282|FG003|NOT COMPLETED|Period 5||0
11268427|NCT02308748|12464283|FG004|NOT COMPLETED|Period 5||0
11268428|NCT02308748|12464284|FG005|NOT COMPLETED|Period 5||0
11268429|NCT02308748|12464285|FG006|NOT COMPLETED|Period 5||0
11268430|NCT02308748|12464286|FG007|NOT COMPLETED|Period 5||0
11268431|NCT02308748|12464287|FG008|NOT COMPLETED|Period 5||1
11268432|NCT02308748|12464288|FG009|NOT COMPLETED|Period 5||0
11268433|NCT02308787|12464300|FG000|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
11268434|NCT02308787|12464300|FG000|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
11268435|NCT02308787|12464300|FG000|NOT COMPLETED|Overall Study||0
11268436|NCT02308839|12464304|FG000|STARTED|Overall Study||181
11268437|NCT02308839|12464304|FG000|COMPLETED|Overall Study||72
11268438|NCT02308839|12464304|FG000|NOT COMPLETED|Overall Study||109
11268439|NCT02309099|12464310|FG000|STARTED|Overall Study||7
11268440|NCT02309099|12464311|FG001|STARTED|Overall Study||3
11268441|NCT02309099|12464310|FG000|Cochlear Implantation|Overall Study||7
11268442|NCT02309099|12464311|FG001|Cochlear Implantation|Overall Study||3
11397385|NCT04175808|12591495|FG000|STARTED|Part B||0
11397386|NCT04175808|12591496|FG001|STARTED|Part B||10
11268443|NCT02309099|12464310|FG000|Initial Activation|Overall Study||7
11268444|NCT02309099|12464311|FG001|Initial Activation|Overall Study||3
11268445|NCT02309099|12464310|FG000|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
11268446|NCT02309099|12464311|FG001|Cochlear Implant Use/Follow-Up|Overall Study||3
11268447|NCT02309099|12464310|FG000|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
11268448|NCT02309099|12464311|FG001|COMPLETED|Overall Study||3
11268449|NCT02309099|12464310|FG000|NOT COMPLETED|Overall Study||2
11397387|NCT04175808|12591497|FG002|STARTED|Part B||10
11397388|NCT04175808|12591498|FG003|STARTED|Part B||10
11397389|NCT04175808|12591499|FG004|STARTED|Part B||10
11268450|NCT02309099|12464311|FG001|NOT COMPLETED|Overall Study||0
11268451|NCT02309112|12464320|FG000|STARTED|Overall Study||5
11268452|NCT02309112|12464321|FG001|STARTED|Overall Study||5
11268453|NCT02309112|12464322|FG002|STARTED|Overall Study||5
11268454|NCT02309112|12464320|FG000|Completed Yoga Intervention|Overall Study||4
11268455|NCT02309112|12464321|FG001|Completed Yoga Intervention|Overall Study||5
11268456|NCT02309112|12464322|FG002|Completed Yoga Intervention|Overall Study||4
11268457|NCT02309112|12464320|FG000|COMPLETED|Overall Study||4
11268458|NCT02309112|12464321|FG001|COMPLETED|Overall Study||4
11268459|NCT02309112|12464322|FG002|COMPLETED|Overall Study||4
11268460|NCT02309112|12464320|FG000|NOT COMPLETED|Overall Study||1
11268461|NCT02309112|12464321|FG001|NOT COMPLETED|Overall Study||1
11397390|NCT04175808|12591500|FG005|STARTED|Part B||10
11397391|NCT04175808|12591501|FG006|STARTED|Part B||10
11397392|NCT04175808|12591495|FG000|COMPLETED|Part B||0
11268462|NCT02309112|12464322|FG002|NOT COMPLETED|Overall Study||1
11268463|NCT02309138|12464334|FG000|STARTED|Overall Study||460
11268464|NCT02309138|12464335|FG001|STARTED|Overall Study||461
11268465|NCT02309138|12464334|FG000|COMPLETED|Overall Study||412
11268466|NCT02309138|12464335|FG001|COMPLETED|Overall Study||443
11268467|NCT02309138|12464334|FG000|NOT COMPLETED|Overall Study||48
11268468|NCT02309138|12464335|FG001|NOT COMPLETED|Overall Study||18
11268469|NCT02309294|12464351|FG000|STARTED|Overall Study||43
11268470|NCT02309294|12464351|FG000|COMPLETED|Overall Study||41
11268471|NCT02309294|12464351|FG000|NOT COMPLETED|Overall Study||2
11268472|NCT02309359|12464360|FG000|STARTED|Overall Study||69
11268473|NCT02309359|12464361|FG001|STARTED|Overall Study||70
11268474|NCT02309359|12464362|FG002|STARTED|Overall Study||68
11268475|NCT02309359|12464363|FG003|STARTED|Overall Study||69
11268476|NCT02309359|12464364|FG004|STARTED|Overall Study||69
11268477|NCT02309359|12464360|FG000|COMPLETED|Overall Study||57
11268478|NCT02309359|12464361|FG001|COMPLETED|Overall Study||62
11268479|NCT02309359|12464362|FG002|COMPLETED|Overall Study||57
11268480|NCT02309359|12464363|FG003|COMPLETED|Overall Study||57
11268481|NCT02309359|12464364|FG004|COMPLETED|Overall Study||60
11268482|NCT02309359|12464360|FG000|NOT COMPLETED|Overall Study||12
11268483|NCT02309359|12464361|FG001|NOT COMPLETED|Overall Study||8
11268484|NCT02309359|12464362|FG002|NOT COMPLETED|Overall Study||11
11268485|NCT02309359|12464363|FG003|NOT COMPLETED|Overall Study||12
11268486|NCT02309359|12464364|FG004|NOT COMPLETED|Overall Study||9
11268487|NCT02309372|12464379|FG000|STARTED|Overall Study||27
11268488|NCT02309372|12464380|FG001|STARTED|Overall Study||27
11268489|NCT02309372|12464379|FG000|COMPLETED|Overall Study||24
11268490|NCT02309372|12464380|FG001|COMPLETED|Overall Study||25
11268491|NCT02309372|12464379|FG000|NOT COMPLETED|Overall Study||3
11268492|NCT02309372|12464380|FG001|NOT COMPLETED|Overall Study||2
11268493|NCT02309411|12464389|FG000|STARTED|Overall Study||25
11268494|NCT02309411|12464390|FG001|STARTED|Overall Study||15
11268495|NCT02309411|12464391|FG002|STARTED|Overall Study||6
11268496|NCT02309411|12464389|FG000|COMPLETED|Overall Study||23
11268497|NCT02309411|12464390|FG001|COMPLETED|Overall Study||14
11268498|NCT02309411|12464391|FG002|COMPLETED|Overall Study||6
11268499|NCT02309411|12464389|FG000|NOT COMPLETED|Overall Study||2
11268500|NCT02309411|12464390|FG001|NOT COMPLETED|Overall Study||1
11268501|NCT02309411|12464391|FG002|NOT COMPLETED|Overall Study||0
11268502|NCT02309489|12464400|FG000|STARTED|Overall Study||583
11268503|NCT02309489|12464401|FG001|STARTED|Overall Study||561
11268504|NCT02309489|12464400|FG000|Follow-up at 3 Months Postpartum|Overall Study||560
11268505|NCT02309489|12464401|FG001|Follow-up at 3 Months Postpartum|Overall Study||541
11268506|NCT02309489|12464400|FG000|COMPLETED|Overall Study||568
11268507|NCT02309489|12464401|FG001|COMPLETED|Overall Study||547
11268508|NCT02309489|12464400|FG000|NOT COMPLETED|Overall Study||15
11268509|NCT02309489|12464401|FG001|NOT COMPLETED|Overall Study||14
11268510|NCT02309515|12464409|FG000|STARTED|Overall Study||5
11268511|NCT02309515|12464410|FG001|STARTED|Overall Study||7
11268512|NCT02309515|12464409|FG000|COMPLETED|Overall Study||5
11268513|NCT02309515|12464410|FG001|COMPLETED|Overall Study||6
11268514|NCT02309515|12464409|FG000|NOT COMPLETED|Overall Study||0
11268515|NCT02309515|12464410|FG001|NOT COMPLETED|Overall Study||1
11268516|NCT02309723|12464419|FG000|STARTED|Overall Study||129
11268517|NCT02309723|12464420|FG001|STARTED|Overall Study||128
11268518|NCT02309723|12464421|FG002|STARTED|Overall Study||129
11268519|NCT02309723|12464419|FG000|COMPLETED|Overall Study||105
11268520|NCT02309723|12464420|FG001|COMPLETED|Overall Study||105
11268521|NCT02309723|12464421|FG002|COMPLETED|Overall Study||105
11268522|NCT02309723|12464419|FG000|NOT COMPLETED|Overall Study||24
11268523|NCT02309723|12464420|FG001|NOT COMPLETED|Overall Study||23
11268524|NCT02309723|12464421|FG002|NOT COMPLETED|Overall Study||24
11268525|NCT02309944|12464431|FG000|STARTED|Overall Study||38
11268526|NCT02309944|12464432|FG001|STARTED|Overall Study||43
11268527|NCT02309944|12464431|FG000|COMPLETED|Overall Study||38
11268528|NCT02309944|12464432|FG001|COMPLETED|Overall Study||43
11268529|NCT02309944|12464431|FG000|NOT COMPLETED|Overall Study||0
11268530|NCT02309944|12464432|FG001|NOT COMPLETED|Overall Study||0
11268531|NCT02310100|12464438|FG000|STARTED|Overall Study|First enrollment|178
11268532|NCT02310100|12464438|FG000|COMPLETED|Overall Study||160
11268533|NCT02310100|12464438|FG000|NOT COMPLETED|Overall Study||18
11268534|NCT02310126|12464445|FG000|STARTED|Period 1 (15 Minutes)||94
11268535|NCT02310126|12464446|FG001|STARTED|Period 1 (15 Minutes)||97
11268536|NCT02310126|12464445|FG000|Hyperopes|Period 1 (15 Minutes)||38
11268537|NCT02310126|12464446|FG001|Hyperopes|Period 1 (15 Minutes)||33
11268538|NCT02310126|12464445|FG000|Myopes|Period 1 (15 Minutes)||56
11268539|NCT02310126|12464446|FG001|Myopes|Period 1 (15 Minutes)||64
11268540|NCT02310126|12464445|FG000|COMPLETED|Period 1 (15 Minutes)||94
11268541|NCT02310126|12464446|FG001|COMPLETED|Period 1 (15 Minutes)||95
11268542|NCT02310126|12464445|FG000|NOT COMPLETED|Period 1 (15 Minutes)||0
11268543|NCT02310126|12464446|FG001|NOT COMPLETED|Period 1 (15 Minutes)||2
11268544|NCT02310126|12464445|FG000|STARTED|Period 2 (15 Minutes)||94
11268545|NCT02310126|12464446|FG001|STARTED|Period 2 (15 Minutes)||95
11268546|NCT02310126|12464445|FG000|Hyperopes|Period 2 (15 Minutes)||38
11268547|NCT02310126|12464446|FG001|Hyperopes|Period 2 (15 Minutes)||32
11268548|NCT02310126|12464445|FG000|Myopes|Period 2 (15 Minutes)||56
11268549|NCT02310126|12464446|FG001|Myopes|Period 2 (15 Minutes)||63
11268550|NCT02310126|12464445|FG000|COMPLETED|Period 2 (15 Minutes)||94
11268551|NCT02310126|12464446|FG001|COMPLETED|Period 2 (15 Minutes)||95
11268552|NCT02310126|12464445|FG000|NOT COMPLETED|Period 2 (15 Minutes)||0
11268553|NCT02310126|12464446|FG001|NOT COMPLETED|Period 2 (15 Minutes)||0
11268554|NCT02310568|12464457|FG000|STARTED|Stage 1 ( 4 Weeks)||15
11268555|NCT02310568|12464458|FG001|STARTED|Stage 1 ( 4 Weeks)||15
11268556|NCT02310568|12464459|FG002|STARTED|Stage 1 ( 4 Weeks)||15
11268557|NCT02310568|12464460|FG003|STARTED|Stage 1 ( 4 Weeks)||24
11268558|NCT02310568|12464461|FG004|STARTED|Stage 1 ( 4 Weeks)||21
11268559|NCT02310568|12464457|FG000|COMPLETED|Stage 1 ( 4 Weeks)||12
11268560|NCT02310568|12464458|FG001|COMPLETED|Stage 1 ( 4 Weeks)||13
11268561|NCT02310568|12464459|FG002|COMPLETED|Stage 1 ( 4 Weeks)||14
11268562|NCT02310568|12464460|FG003|COMPLETED|Stage 1 ( 4 Weeks)||22
11268563|NCT02310568|12464461|FG004|COMPLETED|Stage 1 ( 4 Weeks)||20
11268564|NCT02310568|12464457|FG000|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
11268565|NCT02310568|12464458|FG001|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
11268566|NCT02310568|12464459|FG002|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
11268567|NCT02310568|12464460|FG003|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
11268568|NCT02310568|12464461|FG004|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
11268569|NCT02310568|12464457|FG000|STARTED|Stage 2 (4 Weeks)||12
11268570|NCT02310568|12464458|FG001|STARTED|Stage 2 (4 Weeks)||13
11268571|NCT02310568|12464459|FG002|STARTED|Stage 2 (4 Weeks)||14
11268572|NCT02310568|12464460|FG003|STARTED|Stage 2 (4 Weeks)||22
11268573|NCT02310568|12464461|FG004|STARTED|Stage 2 (4 Weeks)||20
11268574|NCT02310568|12464457|FG000|COMPLETED|Stage 2 (4 Weeks)||11
11268575|NCT02310568|12464458|FG001|COMPLETED|Stage 2 (4 Weeks)||12
11268576|NCT02310568|12464459|FG002|COMPLETED|Stage 2 (4 Weeks)||13
11268577|NCT02310568|12464460|FG003|COMPLETED|Stage 2 (4 Weeks)||17
11268578|NCT02310568|12464461|FG004|COMPLETED|Stage 2 (4 Weeks)||19
11268579|NCT02310568|12464457|FG000|NOT COMPLETED|Stage 2 (4 Weeks)||1
11268580|NCT02310568|12464458|FG001|NOT COMPLETED|Stage 2 (4 Weeks)||1
11268581|NCT02310568|12464459|FG002|NOT COMPLETED|Stage 2 (4 Weeks)||1
11268582|NCT02310568|12464460|FG003|NOT COMPLETED|Stage 2 (4 Weeks)||5
11268583|NCT02310568|12464461|FG004|NOT COMPLETED|Stage 2 (4 Weeks)||1
11268584|NCT02310581|12464483|FG000|STARTED|Overall Study||9
11268585|NCT02310581|12464484|FG001|STARTED|Overall Study||11
11268586|NCT02310581|12464485|FG002|STARTED|Overall Study||10
11268587|NCT02310581|12464486|FG003|STARTED|Overall Study||10
11268588|NCT02310581|12464483|FG000|COMPLETED|Overall Study||6
11268589|NCT02310581|12464484|FG001|COMPLETED|Overall Study||9
11268590|NCT02310581|12464485|FG002|COMPLETED|Overall Study||9
11268591|NCT02310581|12464486|FG003|COMPLETED|Overall Study||9
11268592|NCT02310581|12464483|FG000|NOT COMPLETED|Overall Study||3
11268593|NCT02310581|12464484|FG001|NOT COMPLETED|Overall Study||2
11268594|NCT02310581|12464485|FG002|NOT COMPLETED|Overall Study||1
11268595|NCT02310581|12464486|FG003|NOT COMPLETED|Overall Study||1
11268596|NCT02310646|12464498|FG000|STARTED|First Intervention (Day 1 - Day 7)||109
11268597|NCT02310646|12464499|FG001|STARTED|First Intervention (Day 1 - Day 7)||104
11268598|NCT02310646|12464498|FG000|COMPLETED|First Intervention (Day 1 - Day 7)||107
11268599|NCT02310646|12464499|FG001|COMPLETED|First Intervention (Day 1 - Day 7)||104
11268600|NCT02310646|12464498|FG000|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
11268601|NCT02310646|12464499|FG001|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
11268602|NCT02310646|12464498|FG000|STARTED|Second Intervention (Day 8 - Day 14)||107
11268603|NCT02310646|12464499|FG001|STARTED|Second Intervention (Day 8 - Day 14)||104
11268604|NCT02310646|12464498|FG000|COMPLETED|Second Intervention (Day 8 - Day 14)||107
11268605|NCT02310646|12464499|FG001|COMPLETED|Second Intervention (Day 8 - Day 14)||104
11268606|NCT02310646|12464498|FG000|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
11268607|NCT02310646|12464499|FG001|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
11397393|NCT04175808|12591496|FG001|COMPLETED|Part B||10
11397394|NCT04175808|12591497|FG002|COMPLETED|Part B||10
11397395|NCT04175808|12591498|FG003|COMPLETED|Part B||10
11397396|NCT04175808|12591499|FG004|COMPLETED|Part B||10
11397397|NCT04175808|12591500|FG005|COMPLETED|Part B||10
11397398|NCT04175808|12591501|FG006|COMPLETED|Part B||10
11268608|NCT02310672|12464521|FG000|STARTED|Overall Study||87
11268609|NCT02310672|12464521|FG000|COMPLETED|Overall Study||72
11397399|NCT04175808|12591495|FG000|NOT COMPLETED|Part B||0
11397400|NCT04175808|12591496|FG001|NOT COMPLETED|Part B||0
11397401|NCT04175808|12591497|FG002|NOT COMPLETED|Part B||0
11268610|NCT02310672|12464521|FG000|NOT COMPLETED|Overall Study||15
11268611|NCT02310750|12464536|FG000|STARTED|HP Period 1||7
11268612|NCT02310750|12464537|FG001|STARTED|HP Period 1||6
11268613|NCT02310750|12464538|FG002|STARTED|HP Period 1||6
11268614|NCT02310750|12464539|FG003|STARTED|HP Period 1||6
11268615|NCT02310750|12464540|FG004|STARTED|HP Period 1||8
11268616|NCT02310750|12464541|FG005|STARTED|HP Period 1||8
11268617|NCT02310750|12464542|FG006|STARTED|HP Period 1||13
11268618|NCT02310750|12464543|FG007|STARTED|HP Period 1||0
11268619|NCT02310750|12464544|FG008|STARTED|HP Period 1||0
11268620|NCT02310750|12464545|FG009|STARTED|HP Period 1||0
11268621|NCT02310750|12464546|FG010|STARTED|HP Period 1||2
11268622|NCT02310750|12464547|FG011|STARTED|HP Period 1||2
11268623|NCT02310750|12464548|FG012|STARTED|HP Period 1||2
11268624|NCT02310750|12464549|FG013|STARTED|HP Period 1||2
11268625|NCT02310750|12464550|FG014|STARTED|HP Period 1||2
11268626|NCT02310750|12464551|FG015|STARTED|HP Period 1||2
11268627|NCT02310750|12464536|FG000|COMPLETED|HP Period 1||6
11268628|NCT02310750|12464537|FG001|COMPLETED|HP Period 1||6
11268629|NCT02310750|12464538|FG002|COMPLETED|HP Period 1||6
11268630|NCT02310750|12464539|FG003|COMPLETED|HP Period 1||5
11268631|NCT02310750|12464540|FG004|COMPLETED|HP Period 1||8
11268632|NCT02310750|12464541|FG005|COMPLETED|HP Period 1||8
11268633|NCT02310750|12464542|FG006|COMPLETED|HP Period 1||12
11268634|NCT02310750|12464543|FG007|COMPLETED|HP Period 1||0
11268635|NCT02310750|12464544|FG008|COMPLETED|HP Period 1||0
11268636|NCT02310750|12464545|FG009|COMPLETED|HP Period 1||0
11268637|NCT02310750|12464546|FG010|COMPLETED|HP Period 1||2
11268638|NCT02310750|12464547|FG011|COMPLETED|HP Period 1||2
11268639|NCT02310750|12464548|FG012|COMPLETED|HP Period 1||2
11268640|NCT02310750|12464549|FG013|COMPLETED|HP Period 1||2
11268641|NCT02310750|12464550|FG014|COMPLETED|HP Period 1||2
11268642|NCT02310750|12464551|FG015|COMPLETED|HP Period 1||2
11268643|NCT02310750|12464536|FG000|NOT COMPLETED|HP Period 1||1
11268644|NCT02310750|12464537|FG001|NOT COMPLETED|HP Period 1||0
11268645|NCT02310750|12464538|FG002|NOT COMPLETED|HP Period 1||0
11268646|NCT02310750|12464539|FG003|NOT COMPLETED|HP Period 1||1
11268647|NCT02310750|12464540|FG004|NOT COMPLETED|HP Period 1||0
11268648|NCT02310750|12464541|FG005|NOT COMPLETED|HP Period 1||0
11268649|NCT02310750|12464542|FG006|NOT COMPLETED|HP Period 1||1
11268650|NCT02310750|12464543|FG007|NOT COMPLETED|HP Period 1||0
11268651|NCT02310750|12464544|FG008|NOT COMPLETED|HP Period 1||0
11268652|NCT02310750|12464545|FG009|NOT COMPLETED|HP Period 1||0
11268653|NCT02310750|12464546|FG010|NOT COMPLETED|HP Period 1||0
11268654|NCT02310750|12464547|FG011|NOT COMPLETED|HP Period 1||0
11268655|NCT02310750|12464548|FG012|NOT COMPLETED|HP Period 1||0
11268656|NCT02310750|12464549|FG013|NOT COMPLETED|HP Period 1||0
11268657|NCT02310750|12464550|FG014|NOT COMPLETED|HP Period 1||0
11268658|NCT02310750|12464551|FG015|NOT COMPLETED|HP Period 1||0
11268659|NCT02310750|12464536|FG000|STARTED|HP Washout 1||0
11268660|NCT02310750|12464537|FG001|STARTED|HP Washout 1||0
11268661|NCT02310750|12464538|FG002|STARTED|HP Washout 1||6
11268662|NCT02310750|12464539|FG003|STARTED|HP Washout 1||5
11268663|NCT02310750|12464540|FG004|STARTED|HP Washout 1||8
11268664|NCT02310750|12464541|FG005|STARTED|HP Washout 1||8
11268665|NCT02310750|12464542|FG006|STARTED|HP Washout 1||12
11268666|NCT02310750|12464543|FG007|STARTED|HP Washout 1||0
11268667|NCT02310750|12464544|FG008|STARTED|HP Washout 1||0
11268668|NCT02310750|12464545|FG009|STARTED|HP Washout 1||0
11268669|NCT02310750|12464546|FG010|STARTED|HP Washout 1||2
11268670|NCT02310750|12464547|FG011|STARTED|HP Washout 1||2
11268671|NCT02310750|12464548|FG012|STARTED|HP Washout 1||2
11268672|NCT02310750|12464549|FG013|STARTED|HP Washout 1||2
11268673|NCT02310750|12464550|FG014|STARTED|HP Washout 1||2
11268674|NCT02310750|12464551|FG015|STARTED|HP Washout 1||2
11268675|NCT02310750|12464536|FG000|COMPLETED|HP Washout 1||0
11268676|NCT02310750|12464537|FG001|COMPLETED|HP Washout 1||0
11268677|NCT02310750|12464538|FG002|COMPLETED|HP Washout 1||5
11268678|NCT02310750|12464539|FG003|COMPLETED|HP Washout 1||4
11268679|NCT02310750|12464540|FG004|COMPLETED|HP Washout 1||6
11268680|NCT02310750|12464541|FG005|COMPLETED|HP Washout 1||6
11268681|NCT02310750|12464542|FG006|COMPLETED|HP Washout 1||9
11268682|NCT02310750|12464543|FG007|COMPLETED|HP Washout 1||0
11268683|NCT02310750|12464544|FG008|COMPLETED|HP Washout 1||0
11268684|NCT02310750|12464545|FG009|COMPLETED|HP Washout 1||0
11268685|NCT02310750|12464546|FG010|COMPLETED|HP Washout 1||2
11268686|NCT02310750|12464547|FG011|COMPLETED|HP Washout 1||2
11397402|NCT04175808|12591498|FG003|NOT COMPLETED|Part B||0
11397403|NCT04175808|12591499|FG004|NOT COMPLETED|Part B||0
11397404|NCT04175808|12591500|FG005|NOT COMPLETED|Part B||0
11397405|NCT04175808|12591501|FG006|NOT COMPLETED|Part B||0
11397406|NCT04178720|12591519|FG000|STARTED|Overall Study||40
11397407|NCT04178720|12591520|FG001|STARTED|Overall Study||78
11268687|NCT02310750|12464548|FG012|COMPLETED|HP Washout 1||2
11268688|NCT02310750|12464549|FG013|COMPLETED|HP Washout 1||2
11268689|NCT02310750|12464550|FG014|COMPLETED|HP Washout 1||2
11268690|NCT02310750|12464551|FG015|COMPLETED|HP Washout 1||2
11268691|NCT02310750|12464536|FG000|NOT COMPLETED|HP Washout 1||0
11268692|NCT02310750|12464537|FG001|NOT COMPLETED|HP Washout 1||0
11268693|NCT02310750|12464538|FG002|NOT COMPLETED|HP Washout 1||1
11268694|NCT02310750|12464539|FG003|NOT COMPLETED|HP Washout 1||1
11268695|NCT02310750|12464540|FG004|NOT COMPLETED|HP Washout 1||2
11268696|NCT02310750|12464541|FG005|NOT COMPLETED|HP Washout 1||2
11268697|NCT02310750|12464542|FG006|NOT COMPLETED|HP Washout 1||3
11268698|NCT02310750|12464543|FG007|NOT COMPLETED|HP Washout 1||0
11268699|NCT02310750|12464544|FG008|NOT COMPLETED|HP Washout 1||0
11268700|NCT02310750|12464545|FG009|NOT COMPLETED|HP Washout 1||0
11397408|NCT04178720|12591519|FG000|COMPLETED|Overall Study||38
11397409|NCT04178720|12591520|FG001|COMPLETED|Overall Study||77
11397410|NCT04178720|12591519|FG000|NOT COMPLETED|Overall Study||2
11268701|NCT02310750|12464546|FG010|NOT COMPLETED|HP Washout 1||0
11268702|NCT02310750|12464547|FG011|NOT COMPLETED|HP Washout 1||0
11268703|NCT02310750|12464548|FG012|NOT COMPLETED|HP Washout 1||0
11268704|NCT02310750|12464549|FG013|NOT COMPLETED|HP Washout 1||0
11268705|NCT02310750|12464550|FG014|NOT COMPLETED|HP Washout 1||0
11268706|NCT02310750|12464551|FG015|NOT COMPLETED|HP Washout 1||0
11268707|NCT02310750|12464536|FG000|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268708|NCT02310750|12464537|FG001|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268709|NCT02310750|12464538|FG002|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
11268710|NCT02310750|12464539|FG003|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
11268711|NCT02310750|12464540|FG004|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
11268712|NCT02310750|12464541|FG005|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
11397411|NCT04178720|12591520|FG001|NOT COMPLETED|Overall Study||1
11268713|NCT02310750|12464542|FG006|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
11268714|NCT02310750|12464543|FG007|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
11268715|NCT02310750|12464544|FG008|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
11268716|NCT02310750|12464545|FG009|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
11268717|NCT02310750|12464546|FG010|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
11268718|NCT02310750|12464547|FG011|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
11268719|NCT02310750|12464548|FG012|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
11268720|NCT02310750|12464549|FG013|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
11268721|NCT02310750|12464550|FG014|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
11268722|NCT02310750|12464551|FG015|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
11268723|NCT02310750|12464536|FG000|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268724|NCT02310750|12464537|FG001|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268725|NCT02310750|12464538|FG002|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
11268726|NCT02310750|12464539|FG003|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
11268727|NCT02310750|12464540|FG004|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
11268728|NCT02310750|12464541|FG005|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
11268729|NCT02310750|12464542|FG006|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
11268730|NCT02310750|12464543|FG007|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
11268731|NCT02310750|12464544|FG008|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
11268732|NCT02310750|12464545|FG009|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
11268733|NCT02310750|12464546|FG010|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
11268734|NCT02310750|12464547|FG011|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
11268735|NCT02310750|12464548|FG012|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
11268736|NCT02310750|12464549|FG013|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
11268737|NCT02310750|12464550|FG014|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
11268738|NCT02310750|12464551|FG015|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
11268739|NCT02310750|12464536|FG000|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268740|NCT02310750|12464537|FG001|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268741|NCT02310750|12464538|FG002|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268742|NCT02310750|12464539|FG003|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
11268743|NCT02310750|12464540|FG004|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268744|NCT02310750|12464541|FG005|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
11268745|NCT02310750|12464542|FG006|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268746|NCT02310750|12464543|FG007|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
11268747|NCT02310750|12464544|FG008|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
11268748|NCT02310750|12464545|FG009|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
11268749|NCT02310750|12464546|FG010|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268750|NCT02310750|12464547|FG011|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268751|NCT02310750|12464548|FG012|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268752|NCT02310750|12464549|FG013|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268753|NCT02310750|12464550|FG014|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268754|NCT02310750|12464551|FG015|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
11268755|NCT02310750|12464536|FG000|STARTED|HP Washout 2||0
11268756|NCT02310750|12464537|FG001|STARTED|HP Washout 2||0
11268757|NCT02310750|12464538|FG002|STARTED|HP Washout 2||0
11268758|NCT02310750|12464539|FG003|STARTED|HP Washout 2||0
11397412|NCT04184297|12591531|FG000|STARTED|Overall Study||2864
11397413|NCT04184297|12591532|FG001|STARTED|Overall Study||24326
11397414|NCT04184297|12591531|FG000|COMPLETED|Overall Study||2864
11397415|NCT04184297|12591532|FG001|COMPLETED|Overall Study||24326
11397416|NCT04184297|12591531|FG000|NOT COMPLETED|Overall Study||0
11397417|NCT04184297|12591532|FG001|NOT COMPLETED|Overall Study||0
11397418|NCT04189848|12591538|FG000|STARTED|Treatment Period 1 (Day 1)||26
11397419|NCT04189848|12591539|FG001|STARTED|Treatment Period 1 (Day 1)||26
11397420|NCT04189848|12591540|FG002|STARTED|Treatment Period 1 (Day 1)||25
11397421|NCT04189848|12591541|FG003|STARTED|Treatment Period 1 (Day 1)||27
11397422|NCT04189848|12591538|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
11397423|NCT04189848|12591539|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
11397424|NCT04189848|12591540|FG002|COMPLETED|Treatment Period 1 (Day 1)||25
11397425|NCT04189848|12591541|FG003|COMPLETED|Treatment Period 1 (Day 1)||27
11397426|NCT04189848|12591538|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11397427|NCT04189848|12591539|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11268759|NCT02310750|12464540|FG004|STARTED|HP Washout 2||6
11268760|NCT02310750|12464541|FG005|STARTED|HP Washout 2||0
11268761|NCT02310750|12464542|FG006|STARTED|HP Washout 2||9
11397428|NCT04189848|12591540|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11397429|NCT04189848|12591541|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11397430|NCT04189848|12591538|FG000|STARTED|Treatment Period 2 (Day 1)||26
11397431|NCT04189848|12591539|FG001|STARTED|Treatment Period 2 (Day 1)||26
11397432|NCT04189848|12591540|FG002|STARTED|Treatment Period 2 (Day 1)||25
11268762|NCT02310750|12464543|FG007|STARTED|HP Washout 2||0
11268763|NCT02310750|12464544|FG008|STARTED|HP Washout 2||0
11268764|NCT02310750|12464545|FG009|STARTED|HP Washout 2||0
11268765|NCT02310750|12464546|FG010|STARTED|HP Washout 2||2
11268766|NCT02310750|12464547|FG011|STARTED|HP Washout 2||2
11268767|NCT02310750|12464548|FG012|STARTED|HP Washout 2||2
11268768|NCT02310750|12464549|FG013|STARTED|HP Washout 2||2
11268769|NCT02310750|12464550|FG014|STARTED|HP Washout 2||2
11268770|NCT02310750|12464551|FG015|STARTED|HP Washout 2||2
11268771|NCT02310750|12464536|FG000|COMPLETED|HP Washout 2||0
11268772|NCT02310750|12464537|FG001|COMPLETED|HP Washout 2||0
11268773|NCT02310750|12464538|FG002|COMPLETED|HP Washout 2||0
11268774|NCT02310750|12464539|FG003|COMPLETED|HP Washout 2||0
11268775|NCT02310750|12464540|FG004|COMPLETED|HP Washout 2||5
11268776|NCT02310750|12464541|FG005|COMPLETED|HP Washout 2||0
11268777|NCT02310750|12464542|FG006|COMPLETED|HP Washout 2||2
11268778|NCT02310750|12464543|FG007|COMPLETED|HP Washout 2||0
11268779|NCT02310750|12464544|FG008|COMPLETED|HP Washout 2||0
11268780|NCT02310750|12464545|FG009|COMPLETED|HP Washout 2||0
11268781|NCT02310750|12464546|FG010|COMPLETED|HP Washout 2||2
11268782|NCT02310750|12464547|FG011|COMPLETED|HP Washout 2||2
11268783|NCT02310750|12464548|FG012|COMPLETED|HP Washout 2||2
11268784|NCT02310750|12464549|FG013|COMPLETED|HP Washout 2||2
11268785|NCT02310750|12464550|FG014|COMPLETED|HP Washout 2||2
11268786|NCT02310750|12464551|FG015|COMPLETED|HP Washout 2||2
11268787|NCT02310750|12464536|FG000|NOT COMPLETED|HP Washout 2||0
11268788|NCT02310750|12464537|FG001|NOT COMPLETED|HP Washout 2||0
11268789|NCT02310750|12464538|FG002|NOT COMPLETED|HP Washout 2||0
11268790|NCT02310750|12464539|FG003|NOT COMPLETED|HP Washout 2||0
11268791|NCT02310750|12464540|FG004|NOT COMPLETED|HP Washout 2||1
11268792|NCT02310750|12464541|FG005|NOT COMPLETED|HP Washout 2||0
11268793|NCT02310750|12464542|FG006|NOT COMPLETED|HP Washout 2||7
11268794|NCT02310750|12464543|FG007|NOT COMPLETED|HP Washout 2||0
11268795|NCT02310750|12464544|FG008|NOT COMPLETED|HP Washout 2||0
11268796|NCT02310750|12464545|FG009|NOT COMPLETED|HP Washout 2||0
11268797|NCT02310750|12464546|FG010|NOT COMPLETED|HP Washout 2||0
11268798|NCT02310750|12464547|FG011|NOT COMPLETED|HP Washout 2||0
11268799|NCT02310750|12464548|FG012|NOT COMPLETED|HP Washout 2||0
11268800|NCT02310750|12464549|FG013|NOT COMPLETED|HP Washout 2||0
11268801|NCT02310750|12464550|FG014|NOT COMPLETED|HP Washout 2||0
11268802|NCT02310750|12464551|FG015|NOT COMPLETED|HP Washout 2||0
11268803|NCT02310750|12464536|FG000|STARTED|HP MAD and Fasted/Fed||0
11268804|NCT02310750|12464537|FG001|STARTED|HP MAD and Fasted/Fed||0
11268805|NCT02310750|12464538|FG002|STARTED|HP MAD and Fasted/Fed||0
11268806|NCT02310750|12464539|FG003|STARTED|HP MAD and Fasted/Fed||0
11268807|NCT02310750|12464540|FG004|STARTED|HP MAD and Fasted/Fed||5
11268808|NCT02310750|12464541|FG005|STARTED|HP MAD and Fasted/Fed||0
11268809|NCT02310750|12464542|FG006|STARTED|HP MAD and Fasted/Fed||2
11268810|NCT02310750|12464543|FG007|STARTED|HP MAD and Fasted/Fed||0
11268811|NCT02310750|12464544|FG008|STARTED|HP MAD and Fasted/Fed||0
11268812|NCT02310750|12464545|FG009|STARTED|HP MAD and Fasted/Fed||0
11268813|NCT02310750|12464546|FG010|STARTED|HP MAD and Fasted/Fed||2
11268814|NCT02310750|12464547|FG011|STARTED|HP MAD and Fasted/Fed||2
11268815|NCT02310750|12464548|FG012|STARTED|HP MAD and Fasted/Fed||2
11268816|NCT02310750|12464549|FG013|STARTED|HP MAD and Fasted/Fed||2
11268817|NCT02310750|12464550|FG014|STARTED|HP MAD and Fasted/Fed||2
11268818|NCT02310750|12464551|FG015|STARTED|HP MAD and Fasted/Fed||2
11268819|NCT02310750|12464536|FG000|COMPLETED|HP MAD and Fasted/Fed||0
11268820|NCT02310750|12464537|FG001|COMPLETED|HP MAD and Fasted/Fed||0
11268821|NCT02310750|12464538|FG002|COMPLETED|HP MAD and Fasted/Fed||0
11268822|NCT02310750|12464539|FG003|COMPLETED|HP MAD and Fasted/Fed||0
11268823|NCT02310750|12464540|FG004|COMPLETED|HP MAD and Fasted/Fed||4
11268824|NCT02310750|12464541|FG005|COMPLETED|HP MAD and Fasted/Fed||0
11268825|NCT02310750|12464542|FG006|COMPLETED|HP MAD and Fasted/Fed||2
11268826|NCT02310750|12464543|FG007|COMPLETED|HP MAD and Fasted/Fed||0
11268827|NCT02310750|12464544|FG008|COMPLETED|HP MAD and Fasted/Fed||0
11268828|NCT02310750|12464545|FG009|COMPLETED|HP MAD and Fasted/Fed||0
11397433|NCT04189848|12591541|FG003|STARTED|Treatment Period 2 (Day 1)||27
11397434|NCT04189848|12591538|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
11268829|NCT02310750|12464546|FG010|COMPLETED|HP MAD and Fasted/Fed||2
11268830|NCT02310750|12464547|FG011|COMPLETED|HP MAD and Fasted/Fed||2
11397435|NCT04189848|12591539|FG001|COMPLETED|Treatment Period 2 (Day 1)||26
11397436|NCT04189848|12591540|FG002|COMPLETED|Treatment Period 2 (Day 1)||25
11397437|NCT04189848|12591541|FG003|COMPLETED|Treatment Period 2 (Day 1)||27
11268831|NCT02310750|12464548|FG012|COMPLETED|HP MAD and Fasted/Fed||2
11268832|NCT02310750|12464549|FG013|COMPLETED|HP MAD and Fasted/Fed||2
11268833|NCT02310750|12464550|FG014|COMPLETED|HP MAD and Fasted/Fed||2
11268834|NCT02310750|12464551|FG015|COMPLETED|HP MAD and Fasted/Fed||2
11268835|NCT02310750|12464536|FG000|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268836|NCT02310750|12464537|FG001|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268837|NCT02310750|12464538|FG002|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268838|NCT02310750|12464539|FG003|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268839|NCT02310750|12464540|FG004|NOT COMPLETED|HP MAD and Fasted/Fed||1
11268840|NCT02310750|12464541|FG005|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268841|NCT02310750|12464542|FG006|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268842|NCT02310750|12464543|FG007|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268843|NCT02310750|12464544|FG008|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268844|NCT02310750|12464545|FG009|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268845|NCT02310750|12464546|FG010|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268846|NCT02310750|12464547|FG011|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268847|NCT02310750|12464548|FG012|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268848|NCT02310750|12464549|FG013|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268849|NCT02310750|12464550|FG014|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268850|NCT02310750|12464551|FG015|NOT COMPLETED|HP MAD and Fasted/Fed||0
11268851|NCT02310763|12464635|FG000|STARTED|Period 1 (Weeks 1 to 48)||41
11268852|NCT02310763|12464636|FG001|STARTED|Period 1 (Weeks 1 to 48)||39
11268853|NCT02310763|12464637|FG002|STARTED|Period 1 (Weeks 1 to 48)||40
11268854|NCT02310763|12464635|FG000|COMPLETED|Period 1 (Weeks 1 to 48)||38
11268855|NCT02310763|12464636|FG001|COMPLETED|Period 1 (Weeks 1 to 48)||37
11268856|NCT02310763|12464637|FG002|COMPLETED|Period 1 (Weeks 1 to 48)||38
11268857|NCT02310763|12464635|FG000|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3
11268858|NCT02310763|12464636|FG001|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
11268859|NCT02310763|12464637|FG002|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
11268860|NCT02310763|12464635|FG000|STARTED|Period 2 (Weeks 49 to 96)||38
11268861|NCT02310763|12464636|FG001|STARTED|Period 2 (Weeks 49 to 96)||37
11268862|NCT02310763|12464637|FG002|STARTED|Period 2 (Weeks 49 to 96)||38
11268863|NCT02310763|12464635|FG000|COMPLETED|Period 2 (Weeks 49 to 96)||22
11268864|NCT02310763|12464636|FG001|COMPLETED|Period 2 (Weeks 49 to 96)||21
11268865|NCT02310763|12464637|FG002|COMPLETED|Period 2 (Weeks 49 to 96)||22
11268866|NCT02310763|12464635|FG000|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
11268867|NCT02310763|12464636|FG001|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
11268868|NCT02310763|12464637|FG002|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
11268869|NCT02310776|12464663|FG000|STARTED|Overall Study||501
11268870|NCT02310776|12464663|FG000|COMPLETED|Overall Study||501
11268871|NCT02310776|12464663|FG000|NOT COMPLETED|Overall Study||0
11268872|NCT02310789|12464667|FG000|STARTED|Overall Study||8
11268873|NCT02310789|12464667|FG000|COMPLETED|Overall Study||7
11268874|NCT02310789|12464667|FG000|NOT COMPLETED|Overall Study||1
11268875|NCT02310906|12464675|FG000|STARTED|Part 1: Double Blind Phase (12 Weeks)||4
11268876|NCT02310906|12464676|FG001|STARTED|Part 1: Double Blind Phase (12 Weeks)||8
11268877|NCT02310906|12464677|FG002|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
11268878|NCT02310906|12464678|FG003|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
11268879|NCT02310906|12464675|FG000|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
11268880|NCT02310906|12464676|FG001|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
11268881|NCT02310906|12464677|FG002|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
11268882|NCT02310906|12464678|FG003|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
11268883|NCT02310906|12464675|FG000|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
11268884|NCT02310906|12464676|FG001|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
11268885|NCT02310906|12464677|FG002|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
11268886|NCT02310906|12464678|FG003|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
11268887|NCT02310906|12464675|FG000|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
11268888|NCT02310906|12464676|FG001|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
11268889|NCT02310906|12464677|FG002|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
11268890|NCT02310906|12464678|FG003|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
11268891|NCT02310906|12464675|FG000|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
11268892|NCT02310906|12464676|FG001|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
11268893|NCT02310906|12464677|FG002|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
11268894|NCT02310906|12464678|FG003|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
11268895|NCT02310906|12464675|FG000|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||4
11268896|NCT02310906|12464676|FG001|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||8
11268897|NCT02310906|12464677|FG002|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
11268898|NCT02310906|12464678|FG003|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
11268899|NCT02310906|12464675|FG000|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
11268900|NCT02310906|12464676|FG001|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
11268901|NCT02310906|12464677|FG002|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
11268902|NCT02310906|12464678|FG003|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
11268903|NCT02310906|12464675|FG000|STARTED|Part 2: Open Label Phase (168 Weeks)||0
11268904|NCT02310906|12464676|FG001|STARTED|Part 2: Open Label Phase (168 Weeks)||0
11268905|NCT02310906|12464677|FG002|STARTED|Part 2: Open Label Phase (168 Weeks)|4 participants from Part 1(Placebo) + 8 participants from Part 1(Golodirsen) +13 new participants|25
11268906|NCT02310906|12464678|FG003|STARTED|Part 2: Open Label Phase (168 Weeks)||14
11268907|NCT02310906|12464675|FG000|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
11268908|NCT02310906|12464676|FG001|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
11268909|NCT02310906|12464677|FG002|COMPLETED|Part 2: Open Label Phase (168 Weeks)||23
11268910|NCT02310906|12464678|FG003|COMPLETED|Part 2: Open Label Phase (168 Weeks)||6
11268911|NCT02310906|12464675|FG000|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
11268912|NCT02310906|12464676|FG001|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
11268913|NCT02310906|12464677|FG002|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||2
11268914|NCT02310906|12464678|FG003|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||8
11268915|NCT02311153|12464701|FG000|STARTED|Overall Study||53
11268916|NCT02311153|12464702|FG001|STARTED|Overall Study||49
11268917|NCT02311153|12464701|FG000|COMPLETED|Overall Study||48
11268918|NCT02311153|12464702|FG001|COMPLETED|Overall Study||42
11268919|NCT02311153|12464701|FG000|NOT COMPLETED|Overall Study||5
11268920|NCT02311153|12464702|FG001|NOT COMPLETED|Overall Study||7
11268921|NCT02311309|12464711|FG000|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
11268922|NCT02311309|12464712|FG001|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
11268923|NCT02311309|12464713|FG002|STARTED|Overall Study||863
11268924|NCT02311309|12464711|FG000|COMPLETED|Overall Study||541
11268925|NCT02311309|12464712|FG001|COMPLETED|Overall Study||35
11268926|NCT02311309|12464713|FG002|COMPLETED|Overall Study||863
11268927|NCT02311309|12464711|FG000|NOT COMPLETED|Overall Study||0
11268928|NCT02311309|12464712|FG001|NOT COMPLETED|Overall Study||0
11268929|NCT02311309|12464713|FG002|NOT COMPLETED|Overall Study||0
11268930|NCT02311361|12464725|FG000|STARTED|Overall Study||14
11268931|NCT02311361|12464726|FG001|STARTED|Overall Study||11
11268932|NCT02311361|12464727|FG002|STARTED|Overall Study||19
11268933|NCT02311361|12464728|FG003|STARTED|Overall Study||21
11268934|NCT02311361|12464725|FG000|Received Radiation Therapy Only|Overall Study||0
11268935|NCT02311361|12464726|FG001|Received Radiation Therapy Only|Overall Study||1
11268936|NCT02311361|12464727|FG002|Received Radiation Therapy Only|Overall Study||1
11268937|NCT02311361|12464728|FG003|Received Radiation Therapy Only|Overall Study||1
11268938|NCT02311361|12464725|FG000|COMPLETED|Overall Study||14
11268939|NCT02311361|12464726|FG001|COMPLETED|Overall Study||10
11268940|NCT02311361|12464727|FG002|COMPLETED|Overall Study||19
11268941|NCT02311361|12464728|FG003|COMPLETED|Overall Study||20
11268942|NCT02311361|12464725|FG000|NOT COMPLETED|Overall Study||0
11268943|NCT02311361|12464726|FG001|NOT COMPLETED|Overall Study||1
11268944|NCT02311361|12464727|FG002|NOT COMPLETED|Overall Study||0
11268945|NCT02311361|12464728|FG003|NOT COMPLETED|Overall Study||1
11268946|NCT02311881|12464745|FG000|STARTED|Overall Study|Started refers to all randomized participants.|235
11268947|NCT02311881|12464746|FG001|STARTED|Overall Study|Started refers to all randomized participants.|236
11268948|NCT02311881|12464747|FG002|STARTED|Overall Study|Started refers to all randomized participants.|237
11268949|NCT02311881|12464745|FG000|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
11268950|NCT02311881|12464746|FG001|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
11268951|NCT02311881|12464747|FG002|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
11268952|NCT02311881|12464745|FG000|COMPLETED|Overall Study||200
11268953|NCT02311881|12464746|FG001|COMPLETED|Overall Study||193
11268954|NCT02311881|12464747|FG002|COMPLETED|Overall Study||196
11268955|NCT02311881|12464745|FG000|NOT COMPLETED|Overall Study||35
11268956|NCT02311881|12464746|FG001|NOT COMPLETED|Overall Study||43
11268957|NCT02311881|12464747|FG002|NOT COMPLETED|Overall Study||41
11268958|NCT02311894|12464758|FG000|STARTED|Overall Study||82
11268959|NCT02311894|12464758|FG000|Modified ITT Population|Overall Study||81
11268960|NCT02311894|12464758|FG000|COMPLETED|Overall Study||78
11268961|NCT02311894|12464758|FG000|NOT COMPLETED|Overall Study||4
11268962|NCT02311907|12464764|FG000|STARTED|Overall Study||94
11268963|NCT02311907|12464765|FG001|STARTED|Overall Study||91
11268964|NCT02311907|12464764|FG000|COMPLETED|Overall Study||94
11268965|NCT02311907|12464765|FG001|COMPLETED|Overall Study||91
11268966|NCT02311907|12464764|FG000|NOT COMPLETED|Overall Study||0
11268967|NCT02311907|12464765|FG001|NOT COMPLETED|Overall Study||0
11268968|NCT02311933|12464773|FG000|STARTED|Overall Study||41
11268969|NCT02311933|12464774|FG001|STARTED|Overall Study||40
11268970|NCT02311933|12464773|FG000|COMPLETED|Overall Study||41
11268971|NCT02311933|12464774|FG001|COMPLETED|Overall Study||40
11268972|NCT02311933|12464773|FG000|NOT COMPLETED|Overall Study||0
11268973|NCT02311933|12464774|FG001|NOT COMPLETED|Overall Study||0
11268974|NCT02311972|12464782|FG000|STARTED|Overall Study||12
11268975|NCT02311972|12464783|FG001|STARTED|Overall Study||8
11268976|NCT02311972|12464782|FG000|COMPLETED|Overall Study||12
11268977|NCT02311972|12464783|FG001|COMPLETED|Overall Study||8
11268978|NCT02311972|12464782|FG000|NOT COMPLETED|Overall Study||0
11268979|NCT02311972|12464783|FG001|NOT COMPLETED|Overall Study||0
11268980|NCT02312063|12464792|FG000|STARTED|Overall Study||23
11268981|NCT02312063|12464793|FG001|STARTED|Overall Study||25
11268982|NCT02312063|12464792|FG000|COMPLETED|Overall Study||23
11268983|NCT02312063|12464793|FG001|COMPLETED|Overall Study||24
11268984|NCT02312063|12464792|FG000|NOT COMPLETED|Overall Study||0
11268985|NCT02312063|12464793|FG001|NOT COMPLETED|Overall Study||1
11268986|NCT02312154|12464800|FG000|STARTED|Overall Study||25
11268987|NCT02312154|12464800|FG000|COMPLETED|Overall Study||24
11268988|NCT02312154|12464800|FG000|NOT COMPLETED|Overall Study||1
11268989|NCT02312206|12464807|FG000|STARTED|Overall Study||130
11268990|NCT02312206|12464808|FG001|STARTED|Overall Study||130
11268991|NCT02312206|12464807|FG000|Informed Consent Obtained|Overall Study||130
11268992|NCT02312206|12464808|FG001|Informed Consent Obtained|Overall Study||130
11268993|NCT02312206|12464807|FG000|COMPLETED|Overall Study||0
11268994|NCT02312206|12464808|FG001|COMPLETED|Overall Study||0
11268995|NCT02312206|12464807|FG000|NOT COMPLETED|Overall Study||130
11268996|NCT02312206|12464808|FG001|NOT COMPLETED|Overall Study||130
11268997|NCT02312219|12464816|FG000|STARTED|Overall Study||13
11268998|NCT02312219|12464817|FG001|STARTED|Overall Study||22
11268999|NCT02312219|12464816|FG000|COMPLETED|Overall Study||12
11269000|NCT02312219|12464817|FG001|COMPLETED|Overall Study||16
11269001|NCT02312219|12464816|FG000|NOT COMPLETED|Overall Study||1
11269002|NCT02312219|12464817|FG001|NOT COMPLETED|Overall Study||6
11269003|NCT02312310|12464827|FG000|STARTED|Overall Study||53
11269004|NCT02312310|12464828|FG001|STARTED|Overall Study||53
11269005|NCT02312310|12464829|FG002|STARTED|Overall Study||53
11269006|NCT02312310|12464830|FG003|STARTED|Overall Study||52
11269007|NCT02312310|12464827|FG000|COMPLETED|Overall Study||51
11269008|NCT02312310|12464828|FG001|COMPLETED|Overall Study||51
11269009|NCT02312310|12464829|FG002|COMPLETED|Overall Study||50
11269010|NCT02312310|12464830|FG003|COMPLETED|Overall Study||52
11269011|NCT02312310|12464827|FG000|NOT COMPLETED|Overall Study||2
11269012|NCT02312310|12464828|FG001|NOT COMPLETED|Overall Study||2
11269013|NCT02312310|12464829|FG002|NOT COMPLETED|Overall Study||3
11269014|NCT02312310|12464830|FG003|NOT COMPLETED|Overall Study||0
11269015|NCT02312622|12464847|FG000|STARTED|Overall Study||12
11269016|NCT02312622|12464848|FG001|STARTED|Overall Study||3
11269017|NCT02312622|12464849|FG002|STARTED|Overall Study||12
11269018|NCT02312622|12464847|FG000|COMPLETED|Overall Study||12
11269019|NCT02312622|12464848|FG001|COMPLETED|Overall Study||3
11269020|NCT02312622|12464849|FG002|COMPLETED|Overall Study||12
11269021|NCT02312622|12464847|FG000|NOT COMPLETED|Overall Study||0
11269022|NCT02312622|12464848|FG001|NOT COMPLETED|Overall Study||0
11269023|NCT02312622|12464849|FG002|NOT COMPLETED|Overall Study||0
11269024|NCT02312687|12464860|FG000|STARTED|Overall Study||20
11269025|NCT02312687|12464860|FG000|COMPLETED|Overall Study||19
11269026|NCT02312687|12464860|FG000|NOT COMPLETED|Overall Study||1
11269027|NCT02312713|12464867|FG000|STARTED|Overall Study||140
11269028|NCT02312713|12464868|FG001|STARTED|Overall Study||142
11269029|NCT02312713|12464869|FG002|STARTED|Overall Study||68
11269030|NCT02312713|12464867|FG000|COMPLETED|Overall Study||129
11269031|NCT02312713|12464868|FG001|COMPLETED|Overall Study||112
11269032|NCT02312713|12464869|FG002|COMPLETED|Overall Study||63
11269033|NCT02312713|12464867|FG000|NOT COMPLETED|Overall Study||11
11269034|NCT02312713|12464868|FG001|NOT COMPLETED|Overall Study||30
11269035|NCT02312713|12464869|FG002|NOT COMPLETED|Overall Study||5
11269036|NCT02312726|12464877|FG000|STARTED|Overall Study||38
11269037|NCT02312726|12464878|FG001|STARTED|Overall Study||30
11269038|NCT02312726|12464879|FG002|STARTED|Overall Study||67
11269039|NCT02312726|12464877|FG000|COMPLETED|Overall Study||38
11269040|NCT02312726|12464878|FG001|COMPLETED|Overall Study||30
11269041|NCT02312726|12464879|FG002|COMPLETED|Overall Study||0
11269042|NCT02312726|12464877|FG000|NOT COMPLETED|Overall Study||0
11269043|NCT02312726|12464878|FG001|NOT COMPLETED|Overall Study||0
11269044|NCT02312726|12464879|FG002|NOT COMPLETED|Overall Study||67
11269045|NCT02312739|12464888|FG000|STARTED|Overall Study||36
11269046|NCT02312739|12464889|FG001|STARTED|Overall Study||36
11269047|NCT02312739|12464888|FG000|Withdrawn Prior to Procedure|Overall Study||6
11269048|NCT02312739|12464889|FG001|Withdrawn Prior to Procedure|Overall Study||2
11269049|NCT02312739|12464888|FG000|COMPLETED|Overall Study||30
11269050|NCT02312739|12464889|FG001|COMPLETED|Overall Study||34
11269051|NCT02312739|12464888|FG000|NOT COMPLETED|Overall Study||6
11269052|NCT02312739|12464889|FG001|NOT COMPLETED|Overall Study||2
11269053|NCT02312765|12464897|FG000|STARTED|Overall Study||74
11269054|NCT02312765|12464898|FG001|STARTED|Overall Study||72
11269055|NCT02312765|12464897|FG000|COMPLETED|Overall Study||19
11269056|NCT02312765|12464898|FG001|COMPLETED|Overall Study||36
11269057|NCT02312765|12464897|FG000|NOT COMPLETED|Overall Study||55
11269058|NCT02312765|12464898|FG001|NOT COMPLETED|Overall Study||36
11269059|NCT02312856|12464904|FG000|STARTED|Overall Study||34
11269060|NCT02312856|12464904|FG000|COMPLETED|Overall Study||30
11269061|NCT02312856|12464904|FG000|NOT COMPLETED|Overall Study||4
11269062|NCT02312882|12464908|FG000|STARTED|Overall Study||40
11269063|NCT02312882|12464908|FG000|COMPLETED|Overall Study||36
11269064|NCT02312882|12464908|FG000|NOT COMPLETED|Overall Study||4
11269065|NCT02312934|12464914|FG000|STARTED|Overall Study||11
11269066|NCT02312934|12464915|FG001|STARTED|Overall Study||11
11269067|NCT02312934|12464914|FG000|COMPLETED|Overall Study||9
11269068|NCT02312934|12464915|FG001|COMPLETED|Overall Study||11
11269069|NCT02312934|12464914|FG000|NOT COMPLETED|Overall Study||2
11269070|NCT02312934|12464915|FG001|NOT COMPLETED|Overall Study||0
11269071|NCT02312986|12464922|FG000|STARTED|Overall Study||1
11269072|NCT02312986|12464922|FG000|COMPLETED|Overall Study||1
11269073|NCT02312986|12464922|FG000|NOT COMPLETED|Overall Study||0
11269074|NCT02313155|12464928|FG000|STARTED|Overall Study||55
11269075|NCT02313155|12464929|FG001|STARTED|Overall Study||55
11269076|NCT02313155|12464928|FG000|COMPLETED|Overall Study||55
11269077|NCT02313155|12464929|FG001|COMPLETED|Overall Study||54
11269078|NCT02313155|12464928|FG000|NOT COMPLETED|Overall Study||0
11269079|NCT02313155|12464929|FG001|NOT COMPLETED|Overall Study||1
11269080|NCT02313233|12464937|FG000|STARTED|Overall Study||20
11269081|NCT02313233|12464938|FG001|STARTED|Overall Study||21
11269082|NCT02313233|12464937|FG000|COMPLETED|Overall Study||18
11269083|NCT02313233|12464938|FG001|COMPLETED|Overall Study||18
11269084|NCT02313233|12464937|FG000|NOT COMPLETED|Overall Study||2
11269085|NCT02313233|12464938|FG001|NOT COMPLETED|Overall Study||3
11269086|NCT02313454|12464946|FG000|STARTED|Treatment 1||9
11269087|NCT02313454|12464947|FG001|STARTED|Treatment 1||11
11269088|NCT02313454|12464946|FG000|COMPLETED|Treatment 1||9
11269089|NCT02313454|12464947|FG001|COMPLETED|Treatment 1||11
11269090|NCT02313454|12464946|FG000|NOT COMPLETED|Treatment 1||0
11269091|NCT02313454|12464947|FG001|NOT COMPLETED|Treatment 1||0
11269092|NCT02313454|12464946|FG000|STARTED|Treatment 2|1 participant did not receive the second application.|8
11269093|NCT02313454|12464947|FG001|STARTED|Treatment 2|1 participant did not receive the second application.|10
11269094|NCT02313454|12464946|FG000|COMPLETED|Treatment 2||8
11269095|NCT02313454|12464947|FG001|COMPLETED|Treatment 2||10
11269096|NCT02313454|12464946|FG000|NOT COMPLETED|Treatment 2||0
11269097|NCT02313454|12464947|FG001|NOT COMPLETED|Treatment 2||0
11269098|NCT02313506|12464955|FG000|STARTED|Overall Study||17
11269099|NCT02313506|12464956|FG001|STARTED|Overall Study||17
11269100|NCT02313506|12464955|FG000|COMPLETED|Overall Study||17
11269101|NCT02313506|12464956|FG001|COMPLETED|Overall Study||17
11269102|NCT02313506|12464955|FG000|NOT COMPLETED|Overall Study||0
11269103|NCT02313506|12464956|FG001|NOT COMPLETED|Overall Study||0
11269104|NCT02313558|12464965|FG000|STARTED|Overall Study||50
11269105|NCT02313558|12464966|FG001|STARTED|Overall Study||50
11269106|NCT02313558|12464965|FG000|COMPLETED|Overall Study||44
11269107|NCT02313558|12464966|FG001|COMPLETED|Overall Study||46
11269108|NCT02313558|12464965|FG000|NOT COMPLETED|Overall Study||6
11269109|NCT02313558|12464966|FG001|NOT COMPLETED|Overall Study||4
11269110|NCT02313597|12464974|FG000|STARTED|Overall Study||40
11269111|NCT02313597|12464975|FG001|STARTED|Overall Study||40
11269112|NCT02313597|12464974|FG000|COMPLETED|Overall Study||40
11269113|NCT02313597|12464975|FG001|COMPLETED|Overall Study||40
11269114|NCT02313597|12464974|FG000|NOT COMPLETED|Overall Study||0
11269115|NCT02313597|12464975|FG001|NOT COMPLETED|Overall Study||0
11269116|NCT02313675|12464985|FG000|STARTED|Overall Study||11
11269117|NCT02313675|12464986|FG001|STARTED|Overall Study||11
11269118|NCT02313675|12464987|FG002|STARTED|Overall Study||11
11269119|NCT02313675|12464988|FG003|STARTED|Overall Study||11
11269120|NCT02313675|12464985|FG000|COMPLETED|Overall Study||11
11269121|NCT02313675|12464986|FG001|COMPLETED|Overall Study||11
11269122|NCT02313675|12464987|FG002|COMPLETED|Overall Study||11
11269123|NCT02313675|12464988|FG003|COMPLETED|Overall Study||11
11269124|NCT02313675|12464985|FG000|NOT COMPLETED|Overall Study||0
11269125|NCT02313675|12464986|FG001|NOT COMPLETED|Overall Study||0
11269126|NCT02313675|12464987|FG002|NOT COMPLETED|Overall Study||0
11269127|NCT02313675|12464988|FG003|NOT COMPLETED|Overall Study||0
11269128|NCT02313766|12465001|FG000|STARTED|Overall Study||50
11269129|NCT02313766|12465002|FG001|STARTED|Overall Study||50
11269130|NCT02313766|12465003|FG002|STARTED|Overall Study||50
11269131|NCT02313766|12465001|FG000|COMPLETED|Overall Study||49
11269132|NCT02313766|12465002|FG001|COMPLETED|Overall Study||47
11269133|NCT02313766|12465003|FG002|COMPLETED|Overall Study||50
11269134|NCT02313766|12465001|FG000|NOT COMPLETED|Overall Study||1
11269135|NCT02313766|12465002|FG001|NOT COMPLETED|Overall Study||3
11269136|NCT02313766|12465003|FG002|NOT COMPLETED|Overall Study||0
11269137|NCT02313909|12465013|FG000|STARTED|Overall Study||3609
11269138|NCT02313909|12465014|FG001|STARTED|Overall Study||3604
11269139|NCT02313909|12465013|FG000|Treated|Overall Study||3562
11269140|NCT02313909|12465014|FG001|Treated|Overall Study||3559
11269141|NCT02313909|12465013|FG000|COMPLETED|Overall Study||3552
11269142|NCT02313909|12465014|FG001|COMPLETED|Overall Study||3554
11269143|NCT02313909|12465013|FG000|NOT COMPLETED|Overall Study||57
11269144|NCT02313909|12465014|FG001|NOT COMPLETED|Overall Study||50
11269145|NCT02314000|12465022|FG000|STARTED|Overall Study||75
11269146|NCT02314000|12465023|FG001|STARTED|Overall Study||65
11269147|NCT02314000|12465022|FG000|COMPLETED|Overall Study||62
11269148|NCT02314000|12465023|FG001|COMPLETED|Overall Study||57
11269149|NCT02314000|12465022|FG000|NOT COMPLETED|Overall Study||13
11269150|NCT02314000|12465023|FG001|NOT COMPLETED|Overall Study||8
11269151|NCT02314026|12465030|FG000|STARTED|Overall Study||135
11269152|NCT02314026|12465030|FG000|COMPLETED|Overall Study||107
11269153|NCT02314026|12465030|FG000|NOT COMPLETED|Overall Study||28
11269154|NCT02314052|12465034|FG000|STARTED|Cycle One||3
11269155|NCT02314052|12465035|FG001|STARTED|Cycle One||3
11269156|NCT02314052|12465036|FG002|STARTED|Cycle One||3
11269157|NCT02314052|12465037|FG003|STARTED|Cycle One||3
11269158|NCT02314052|12465038|FG004|STARTED|Cycle One||6
11269159|NCT02314052|12465039|FG005|STARTED|Cycle One||3
11269160|NCT02314052|12465034|FG000|COMPLETED|Cycle One||3
11269161|NCT02314052|12465035|FG001|COMPLETED|Cycle One||3
11269162|NCT02314052|12465036|FG002|COMPLETED|Cycle One||3
11269163|NCT02314052|12465037|FG003|COMPLETED|Cycle One||2
11269164|NCT02314052|12465038|FG004|COMPLETED|Cycle One||6
11269165|NCT02314052|12465039|FG005|COMPLETED|Cycle One||3
11269166|NCT02314052|12465034|FG000|NOT COMPLETED|Cycle One||0
11269167|NCT02314052|12465035|FG001|NOT COMPLETED|Cycle One||0
11269168|NCT02314052|12465036|FG002|NOT COMPLETED|Cycle One||0
11269169|NCT02314052|12465037|FG003|NOT COMPLETED|Cycle One||1
11269170|NCT02314052|12465038|FG004|NOT COMPLETED|Cycle One||0
11269171|NCT02314052|12465039|FG005|NOT COMPLETED|Cycle One||0
11269172|NCT02314052|12465034|FG000|STARTED|Cycle Two||3
11269173|NCT02314052|12465035|FG001|STARTED|Cycle Two||3
11397438|NCT04189848|12591538|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
11397439|NCT04189848|12591539|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
11397440|NCT04189848|12591540|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
11397441|NCT04189848|12591541|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
11397442|NCT04210232|12591546|FG000|STARTED|Overall Study||54
11397443|NCT04210232|12591546|FG000|COMPLETED|Overall Study||54
11269174|NCT02314052|12465036|FG002|STARTED|Cycle Two||3
11397444|NCT04210232|12591546|FG000|NOT COMPLETED|Overall Study||0
11397445|NCT04211909|12591552|FG000|STARTED|Overall Study||54
11397446|NCT04211909|12591553|FG001|STARTED|Overall Study||33
11397447|NCT04211909|12591552|FG000|COMPLETED|Overall Study||54
11397448|NCT04211909|12591553|FG001|COMPLETED|Overall Study||33
11397449|NCT04211909|12591552|FG000|NOT COMPLETED|Overall Study||0
11397450|NCT04211909|12591553|FG001|NOT COMPLETED|Overall Study||0
11397451|NCT04218110|12591563|FG000|STARTED|Overall Study||82
11397452|NCT04218110|12591564|FG001|STARTED|Overall Study||81
11397453|NCT04218110|12591565|FG002|STARTED|Overall Study||83
11397454|NCT04218110|12591566|FG003|STARTED|Overall Study||83
11397455|NCT04218110|12591563|FG000|Received Treatment|Overall Study||82
11397456|NCT04218110|12591564|FG001|Received Treatment|Overall Study||81
11397457|NCT04218110|12591565|FG002|Received Treatment|Overall Study||83
11397458|NCT04218110|12591566|FG003|Received Treatment|Overall Study||82
11397459|NCT04218110|12591563|FG000|COMPLETED|Overall Study||82
11397460|NCT04218110|12591564|FG001|COMPLETED|Overall Study||81
11397461|NCT04218110|12591565|FG002|COMPLETED|Overall Study||83
11397462|NCT04218110|12591566|FG003|COMPLETED|Overall Study||82
11397463|NCT04218110|12591563|FG000|NOT COMPLETED|Overall Study||0
11397464|NCT04218110|12591564|FG001|NOT COMPLETED|Overall Study||0
11397465|NCT04218110|12591565|FG002|NOT COMPLETED|Overall Study||0
11397466|NCT04218110|12591566|FG003|NOT COMPLETED|Overall Study||1
11397467|NCT04222725|12591580|FG000|STARTED|Overall Study||8
11397468|NCT04222725|12591581|FG001|STARTED|Overall Study||10
11397469|NCT04222725|12591582|FG002|STARTED|Overall Study||9
11397470|NCT04222725|12591583|FG003|STARTED|Overall Study||10
11397471|NCT04222725|12591580|FG000|COMPLETED|Overall Study||8
11397472|NCT04222725|12591581|FG001|COMPLETED|Overall Study||9
11397473|NCT04222725|12591582|FG002|COMPLETED|Overall Study||9
11397474|NCT04222725|12591583|FG003|COMPLETED|Overall Study||10
11397475|NCT04222725|12591580|FG000|NOT COMPLETED|Overall Study||0
11397476|NCT04222725|12591581|FG001|NOT COMPLETED|Overall Study||1
11397477|NCT04222725|12591582|FG002|NOT COMPLETED|Overall Study||0
11397478|NCT04222725|12591583|FG003|NOT COMPLETED|Overall Study||0
11397479|NCT04223843|12591597|FG000|STARTED|Overall Study||55
11397480|NCT04223843|12591598|FG001|STARTED|Overall Study||55
11397481|NCT04223843|12591599|FG002|STARTED|Overall Study||51
11397482|NCT04223843|12591600|FG003|STARTED|Overall Study||52
11397483|NCT04223843|12591597|FG000|COMPLETED|Overall Study||55
11397484|NCT04223843|12591598|FG001|COMPLETED|Overall Study||55
11397485|NCT04223843|12591599|FG002|COMPLETED|Overall Study||51
11397486|NCT04223843|12591600|FG003|COMPLETED|Overall Study||52
11397487|NCT04223843|12591597|FG000|NOT COMPLETED|Overall Study||0
11397488|NCT04223843|12591598|FG001|NOT COMPLETED|Overall Study||0
11397489|NCT04223843|12591599|FG002|NOT COMPLETED|Overall Study||0
11397490|NCT04223843|12591600|FG003|NOT COMPLETED|Overall Study||0
11397491|NCT04229303|12591617|FG000|STARTED|Overall Study||6
11397492|NCT04229303|12591618|FG001|STARTED|Overall Study||6
11397493|NCT04229303|12591619|FG002|STARTED|Overall Study||6
11397494|NCT04229303|12591620|FG003|STARTED|Overall Study||6
11397495|NCT04229303|12591621|FG004|STARTED|Overall Study||6
11397496|NCT04229303|12591622|FG005|STARTED|Overall Study||6
11397497|NCT04229303|12591623|FG006|STARTED|Overall Study||6
11397498|NCT04229303|12591624|FG007|STARTED|Overall Study||8
11397499|NCT04229303|12591625|FG008|STARTED|Overall Study||8
11397500|NCT04229303|12591617|FG000|COMPLETED|Overall Study||6
11397501|NCT04229303|12591618|FG001|COMPLETED|Overall Study||6
11397502|NCT04229303|12591619|FG002|COMPLETED|Overall Study||6
11397503|NCT04229303|12591620|FG003|COMPLETED|Overall Study||6
11397504|NCT04229303|12591621|FG004|COMPLETED|Overall Study||6
11397505|NCT04229303|12591622|FG005|COMPLETED|Overall Study||6
11397506|NCT04229303|12591623|FG006|COMPLETED|Overall Study||6
11397507|NCT04229303|12591624|FG007|COMPLETED|Overall Study||8
11397508|NCT04229303|12591625|FG008|COMPLETED|Overall Study||8
11397509|NCT04229303|12591617|FG000|NOT COMPLETED|Overall Study||0
11397510|NCT04229303|12591618|FG001|NOT COMPLETED|Overall Study||0
11397511|NCT04229303|12591619|FG002|NOT COMPLETED|Overall Study||0
11397512|NCT04229303|12591620|FG003|NOT COMPLETED|Overall Study||0
11397513|NCT04229303|12591621|FG004|NOT COMPLETED|Overall Study||0
11397514|NCT04229303|12591622|FG005|NOT COMPLETED|Overall Study||0
11397515|NCT04229303|12591623|FG006|NOT COMPLETED|Overall Study||0
11397516|NCT04229303|12591624|FG007|NOT COMPLETED|Overall Study||0
11397517|NCT04229303|12591625|FG008|NOT COMPLETED|Overall Study||0
11397518|NCT04243421|12591653|FG000|STARTED|Overall Study||30
11269175|NCT02314052|12465037|FG003|STARTED|Cycle Two||2
11269176|NCT02314052|12465038|FG004|STARTED|Cycle Two||6
11269177|NCT02314052|12465039|FG005|STARTED|Cycle Two||3
11269178|NCT02314052|12465034|FG000|COMPLETED|Cycle Two||3
11269179|NCT02314052|12465035|FG001|COMPLETED|Cycle Two||2
11269180|NCT02314052|12465036|FG002|COMPLETED|Cycle Two||2
11269181|NCT02314052|12465037|FG003|COMPLETED|Cycle Two||1
11269182|NCT02314052|12465038|FG004|COMPLETED|Cycle Two||2
11269183|NCT02314052|12465039|FG005|COMPLETED|Cycle Two||3
11269184|NCT02314052|12465034|FG000|NOT COMPLETED|Cycle Two||0
11269185|NCT02314052|12465035|FG001|NOT COMPLETED|Cycle Two||1
11269186|NCT02314052|12465036|FG002|NOT COMPLETED|Cycle Two||1
11269187|NCT02314052|12465037|FG003|NOT COMPLETED|Cycle Two||1
11269188|NCT02314052|12465038|FG004|NOT COMPLETED|Cycle Two||4
11269189|NCT02314052|12465039|FG005|NOT COMPLETED|Cycle Two||0
11269190|NCT02314052|12465034|FG000|STARTED|Cycle Three||3
11269191|NCT02314052|12465035|FG001|STARTED|Cycle Three||2
11397519|NCT04243421|12591653|FG000|COMPLETED|Overall Study||30
11397520|NCT04243421|12591653|FG000|NOT COMPLETED|Overall Study||0
11269192|NCT02314052|12465036|FG002|STARTED|Cycle Three||2
11269193|NCT02314052|12465037|FG003|STARTED|Cycle Three||1
11269194|NCT02314052|12465038|FG004|STARTED|Cycle Three||2
11269195|NCT02314052|12465039|FG005|STARTED|Cycle Three||3
11269196|NCT02314052|12465034|FG000|COMPLETED|Cycle Three||3
11269197|NCT02314052|12465035|FG001|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
11269198|NCT02314052|12465036|FG002|COMPLETED|Cycle Three||2
11269199|NCT02314052|12465037|FG003|COMPLETED|Cycle Three||1
11269200|NCT02314052|12465038|FG004|COMPLETED|Cycle Three||2
11269201|NCT02314052|12465039|FG005|COMPLETED|Cycle Three||3
11269202|NCT02314052|12465034|FG000|NOT COMPLETED|Cycle Three||0
11269203|NCT02314052|12465035|FG001|NOT COMPLETED|Cycle Three||0
11269204|NCT02314052|12465036|FG002|NOT COMPLETED|Cycle Three||0
11269205|NCT02314052|12465037|FG003|NOT COMPLETED|Cycle Three||0
11397521|NCT04256603|12591660|FG000|STARTED|Overall Study||21
11397522|NCT04256603|12591661|FG001|STARTED|Overall Study||6
11397523|NCT04256603|12591660|FG000|COMPLETED|Overall Study||21
11397524|NCT04256603|12591661|FG001|COMPLETED|Overall Study||6
11397525|NCT04256603|12591660|FG000|NOT COMPLETED|Overall Study||0
11397526|NCT04256603|12591661|FG001|NOT COMPLETED|Overall Study||0
11397527|NCT04258995|12591669|FG000|STARTED|Overall Study||76
11397528|NCT04258995|12591670|FG001|STARTED|Overall Study||75
11269206|NCT02314052|12465038|FG004|NOT COMPLETED|Cycle Three||0
11269207|NCT02314052|12465039|FG005|NOT COMPLETED|Cycle Three||0
11269208|NCT02314052|12465034|FG000|STARTED|Cycle Four||3
11269209|NCT02314052|12465035|FG001|STARTED|Cycle Four||2
11269210|NCT02314052|12465036|FG002|STARTED|Cycle Four||2
11269211|NCT02314052|12465037|FG003|STARTED|Cycle Four||1
11269212|NCT02314052|12465038|FG004|STARTED|Cycle Four||2
11269213|NCT02314052|12465039|FG005|STARTED|Cycle Four||3
11269214|NCT02314052|12465034|FG000|COMPLETED|Cycle Four||0
11269215|NCT02314052|12465035|FG001|COMPLETED|Cycle Four||2
11269216|NCT02314052|12465036|FG002|COMPLETED|Cycle Four||1
11269217|NCT02314052|12465037|FG003|COMPLETED|Cycle Four||0
11269218|NCT02314052|12465038|FG004|COMPLETED|Cycle Four||2
11269219|NCT02314052|12465039|FG005|COMPLETED|Cycle Four||0
11269220|NCT02314052|12465034|FG000|NOT COMPLETED|Cycle Four||3
11269221|NCT02314052|12465035|FG001|NOT COMPLETED|Cycle Four||0
11269222|NCT02314052|12465036|FG002|NOT COMPLETED|Cycle Four||1
11269223|NCT02314052|12465037|FG003|NOT COMPLETED|Cycle Four||1
11269224|NCT02314052|12465038|FG004|NOT COMPLETED|Cycle Four||0
11269225|NCT02314052|12465039|FG005|NOT COMPLETED|Cycle Four||3
11269226|NCT02314052|12465034|FG000|STARTED|Cycle Five||0
11269227|NCT02314052|12465035|FG001|STARTED|Cycle Five||2
11397529|NCT04258995|12591669|FG000|Vaccinated|Overall Study||76
11269228|NCT02314052|12465036|FG002|STARTED|Cycle Five||1
11269229|NCT02314052|12465037|FG003|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
11269230|NCT02314052|12465038|FG004|STARTED|Cycle Five||2
11269231|NCT02314052|12465039|FG005|STARTED|Cycle Five||0
11269232|NCT02314052|12465034|FG000|COMPLETED|Cycle Five||0
11269233|NCT02314052|12465035|FG001|COMPLETED|Cycle Five||0
11269234|NCT02314052|12465036|FG002|COMPLETED|Cycle Five||0
11269235|NCT02314052|12465037|FG003|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
11269236|NCT02314052|12465038|FG004|COMPLETED|Cycle Five||2
11269237|NCT02314052|12465039|FG005|COMPLETED|Cycle Five||0
11269238|NCT02314052|12465034|FG000|NOT COMPLETED|Cycle Five||0
11269239|NCT02314052|12465035|FG001|NOT COMPLETED|Cycle Five||2
11269240|NCT02314052|12465036|FG002|NOT COMPLETED|Cycle Five||1
11269241|NCT02314052|12465037|FG003|NOT COMPLETED|Cycle Five||0
11269242|NCT02314052|12465038|FG004|NOT COMPLETED|Cycle Five||0
11269243|NCT02314052|12465039|FG005|NOT COMPLETED|Cycle Five||0
11269244|NCT02314052|12465034|FG000|STARTED|Cycles 6 -10.5||0
11269245|NCT02314052|12465035|FG001|STARTED|Cycles 6 -10.5||0
11269246|NCT02314052|12465036|FG002|STARTED|Cycles 6 -10.5||0
11269247|NCT02314052|12465037|FG003|STARTED|Cycles 6 -10.5||1
11269248|NCT02314052|12465038|FG004|STARTED|Cycles 6 -10.5||2
11269249|NCT02314052|12465039|FG005|STARTED|Cycles 6 -10.5||0
11269250|NCT02314052|12465034|FG000|COMPLETED|Cycles 6 -10.5||0
11269251|NCT02314052|12465035|FG001|COMPLETED|Cycles 6 -10.5||0
11269252|NCT02314052|12465036|FG002|COMPLETED|Cycles 6 -10.5||0
11269253|NCT02314052|12465037|FG003|COMPLETED|Cycles 6 -10.5||1
11269254|NCT02314052|12465038|FG004|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
11269255|NCT02314052|12465039|FG005|COMPLETED|Cycles 6 -10.5||0
11269256|NCT02314052|12465034|FG000|NOT COMPLETED|Cycles 6 -10.5||0
11269257|NCT02314052|12465035|FG001|NOT COMPLETED|Cycles 6 -10.5||0
11269258|NCT02314052|12465036|FG002|NOT COMPLETED|Cycles 6 -10.5||0
11269259|NCT02314052|12465037|FG003|NOT COMPLETED|Cycles 6 -10.5||0
11269260|NCT02314052|12465038|FG004|NOT COMPLETED|Cycles 6 -10.5||0
11269261|NCT02314052|12465039|FG005|NOT COMPLETED|Cycles 6 -10.5||0
11269262|NCT02314104|12465056|FG000|STARTED|Overall Study||71
11269263|NCT02314104|12465057|FG001|STARTED|Overall Study||78
11269264|NCT02314104|12465058|FG002|STARTED|Overall Study||71
11269265|NCT02314104|12465056|FG000|COMPLETED|Overall Study||57
11269266|NCT02314104|12465057|FG001|COMPLETED|Overall Study||58
11269267|NCT02314104|12465058|FG002|COMPLETED|Overall Study||53
11269268|NCT02314104|12465056|FG000|NOT COMPLETED|Overall Study||14
11269269|NCT02314104|12465057|FG001|NOT COMPLETED|Overall Study||20
11269270|NCT02314104|12465058|FG002|NOT COMPLETED|Overall Study||18
11269271|NCT02314117|12465068|FG000|STARTED|Overall Study||326
11269272|NCT02314117|12465069|FG001|STARTED|Overall Study||319
11269273|NCT02314117|12465068|FG000|Received at Least One Dose of Study Drug|Overall Study||323
11269274|NCT02314117|12465069|FG001|Received at Least One Dose of Study Drug|Overall Study||315
11269275|NCT02314117|12465068|FG000|COMPLETED|Overall Study||314
11269276|NCT02314117|12465069|FG001|COMPLETED|Overall Study||303
11269277|NCT02314117|12465068|FG000|NOT COMPLETED|Overall Study||12
11269278|NCT02314117|12465069|FG001|NOT COMPLETED|Overall Study||16
11269279|NCT02314143|12465079|FG000|STARTED|Overall Study||16
11269280|NCT02314143|12465080|FG001|STARTED|Overall Study||16
11269281|NCT02314143|12465081|FG002|STARTED|Overall Study||16
11269282|NCT02314143|12465079|FG000|COMPLETED|Overall Study||8
11269283|NCT02314143|12465080|FG001|COMPLETED|Overall Study||6
11269284|NCT02314143|12465081|FG002|COMPLETED|Overall Study||7
11269285|NCT02314143|12465079|FG000|NOT COMPLETED|Overall Study||8
11269286|NCT02314143|12465080|FG001|NOT COMPLETED|Overall Study||10
11269287|NCT02314143|12465081|FG002|NOT COMPLETED|Overall Study||9
11269288|NCT02314247|12465092|FG000|STARTED|Overall Study||9
11269289|NCT02314247|12465093|FG001|STARTED|Overall Study||6
11269290|NCT02314247|12465094|FG002|STARTED|Overall Study||1
11269291|NCT02314247|12465092|FG000|COMPLETED|Overall Study||0
11269292|NCT02314247|12465093|FG001|COMPLETED|Overall Study||0
11269293|NCT02314247|12465094|FG002|COMPLETED|Overall Study||0
11269294|NCT02314247|12465092|FG000|NOT COMPLETED|Overall Study||9
11269295|NCT02314247|12465093|FG001|NOT COMPLETED|Overall Study||6
11269296|NCT02314247|12465094|FG002|NOT COMPLETED|Overall Study||1
11269297|NCT02314260|12465104|FG000|STARTED|Overall Study||80
11269298|NCT02314260|12465104|FG000|COMPLETED|Overall Study||80
11269299|NCT02314260|12465104|FG000|NOT COMPLETED|Overall Study||0
11269300|NCT02314403|12465108|FG000|STARTED|Overall Study||2
11269301|NCT02314403|12465108|FG000|COMPLETED|Overall Study||2
11269302|NCT02314403|12465108|FG000|NOT COMPLETED|Overall Study||0
11269303|NCT02314520|12465114|FG000|STARTED|Overall Study||72
11269304|NCT02314520|12465115|FG001|STARTED|Overall Study||80
11269305|NCT02314520|12465114|FG000|COMPLETED|Overall Study||72
11269306|NCT02314520|12465115|FG001|COMPLETED|Overall Study||80
11269307|NCT02314520|12465114|FG000|NOT COMPLETED|Overall Study||0
11269308|NCT02314520|12465115|FG001|NOT COMPLETED|Overall Study||0
11269309|NCT02314546|12465124|FG000|STARTED|Overall Study||5
11269310|NCT02314546|12465125|FG001|STARTED|Overall Study||5
11269311|NCT02314546|12465126|FG002|STARTED|Overall Study||5
11269312|NCT02314546|12465124|FG000|COMPLETED|Overall Study||5
11269313|NCT02314546|12465125|FG001|COMPLETED|Overall Study||5
11269314|NCT02314546|12465126|FG002|COMPLETED|Overall Study||5
11269315|NCT02314546|12465124|FG000|NOT COMPLETED|Overall Study||0
11269316|NCT02314546|12465125|FG001|NOT COMPLETED|Overall Study||0
11269317|NCT02314546|12465126|FG002|NOT COMPLETED|Overall Study||0
11269318|NCT02314598|12465135|FG000|STARTED|Overall Study||46
11269319|NCT02314598|12465135|FG000|COMPLETED|Overall Study||46
11269320|NCT02314598|12465135|FG000|NOT COMPLETED|Overall Study||0
11269321|NCT02314637|12465141|FG000|STARTED|Overall Study||151
11269322|NCT02314637|12465142|FG001|STARTED|Overall Study||89
11269323|NCT02314637|12465141|FG000|COMPLETED|Overall Study||135
11269324|NCT02314637|12465142|FG001|COMPLETED|Overall Study||75
11269325|NCT02314637|12465141|FG000|NOT COMPLETED|Overall Study||16
11269326|NCT02314637|12465142|FG001|NOT COMPLETED|Overall Study||14
11269327|NCT02314689|12465148|FG000|STARTED|Overall Study||4
11269328|NCT02314689|12465148|FG000|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
11269329|NCT02314689|12465148|FG000|NOT COMPLETED|Overall Study||0
11269330|NCT02314728|12465154|FG000|STARTED|Overall Study||117
11269331|NCT02314728|12465155|FG001|STARTED|Overall Study||113
11269332|NCT02314728|12465154|FG000|COMPLETED|Overall Study||116
11269333|NCT02314728|12465155|FG001|COMPLETED|Overall Study||112
11269334|NCT02314728|12465154|FG000|NOT COMPLETED|Overall Study||1
11269335|NCT02314728|12465155|FG001|NOT COMPLETED|Overall Study||1
11269336|NCT02314780|12465166|FG000|STARTED|Overall Study||9
11269337|NCT02314780|12465167|FG001|STARTED|Overall Study||10
11269338|NCT02314780|12465168|FG002|STARTED|Overall Study||8
11269339|NCT02314780|12465166|FG000|COMPLETED|Overall Study||9
11269340|NCT02314780|12465167|FG001|COMPLETED|Overall Study||7
11269341|NCT02314780|12465168|FG002|COMPLETED|Overall Study||8
11269342|NCT02314780|12465166|FG000|NOT COMPLETED|Overall Study||0
11269343|NCT02314780|12465167|FG001|NOT COMPLETED|Overall Study||3
11269344|NCT02314780|12465168|FG002|NOT COMPLETED|Overall Study||0
11269345|NCT02314936|12465180|FG000|STARTED|Overall Study||48
11269346|NCT02314936|12465181|FG001|STARTED|Overall Study||48
11269347|NCT02314936|12465182|FG002|STARTED|Overall Study||48
11269348|NCT02314936|12465183|FG003|STARTED|Overall Study||48
11269349|NCT02314936|12465180|FG000|COMPLETED|Overall Study||48
11269350|NCT02314936|12465181|FG001|COMPLETED|Overall Study||48
11269351|NCT02314936|12465182|FG002|COMPLETED|Overall Study||46
11269352|NCT02314936|12465183|FG003|COMPLETED|Overall Study||48
11269353|NCT02314936|12465180|FG000|NOT COMPLETED|Overall Study||0
11269354|NCT02314936|12465181|FG001|NOT COMPLETED|Overall Study||0
11269355|NCT02314936|12465182|FG002|NOT COMPLETED|Overall Study||2
11269356|NCT02314936|12465183|FG003|NOT COMPLETED|Overall Study||0
11269357|NCT02315170|12465193|FG000|STARTED|Overall Study||50
11269358|NCT02315170|12465194|FG001|STARTED|Overall Study||50
11269359|NCT02315170|12465193|FG000|COMPLETED|Overall Study||50
11269360|NCT02315170|12465194|FG001|COMPLETED|Overall Study||50
11269361|NCT02315170|12465193|FG000|NOT COMPLETED|Overall Study||0
11269362|NCT02315170|12465194|FG001|NOT COMPLETED|Overall Study||0
11269363|NCT02315261|12465200|FG000|STARTED|Overall Study||364
11269364|NCT02315261|12465200|FG000|COMPLETED|Overall Study||364
11269365|NCT02315261|12465200|FG000|NOT COMPLETED|Overall Study||0
11340311|NCT02919761|12537621|FG000|STARTED|Part 1: Open Label||259
11340312|NCT02919761|12537622|FG001|STARTED|Part 1: Open Label|Part 2 Blinded groups were not evaluated as such during Part 1|0
11340313|NCT02919761|12537623|FG002|STARTED|Part 1: Open Label||0
11340314|NCT02919761|12537621|FG000|mITT Population|Part 1: Open Label||259
11340315|NCT02919761|12537622|FG001|mITT Population|Part 1: Open Label||0
11340316|NCT02919761|12537623|FG002|mITT Population|Part 1: Open Label||0
11340317|NCT02919761|12537621|FG000|Safety Population|Part 1: Open Label||259
11340318|NCT02919761|12537622|FG001|Safety Population|Part 1: Open Label||0
11340319|NCT02919761|12537623|FG002|Safety Population|Part 1: Open Label||0
11340320|NCT02919761|12537621|FG000|Per Protocol Population|Part 1: Open Label||236
11340321|NCT02919761|12537622|FG001|Per Protocol Population|Part 1: Open Label||0
11340322|NCT02919761|12537623|FG002|Per Protocol Population|Part 1: Open Label||0
11340323|NCT02919761|12537621|FG000|COMPLETED|Part 1: Open Label||235
11340324|NCT02919761|12537622|FG001|COMPLETED|Part 1: Open Label||0
11340325|NCT02919761|12537623|FG002|COMPLETED|Part 1: Open Label||0
11340326|NCT02919761|12537621|FG000|NOT COMPLETED|Part 1: Open Label||24
11340327|NCT02919761|12537622|FG001|NOT COMPLETED|Part 1: Open Label||0
11340328|NCT02919761|12537623|FG002|NOT COMPLETED|Part 1: Open Label||0
11340329|NCT02919761|12537621|FG000|STARTED|Part 2: Double-blind|154 of the original Part 1 participants continued to Part 2, randomized to Acthar or placebo|0
11340330|NCT02919761|12537622|FG001|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive Acthar for an additional 12 weeks in Part 2|77
11340331|NCT02919761|12537623|FG002|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive placebo for an additional 12 weeks in Part 2|77
11397530|NCT04258995|12591670|FG001|Vaccinated|Overall Study||75
11397531|NCT04258995|12591669|FG000|COMPLETED|Overall Study||75
11397532|NCT04258995|12591670|FG001|COMPLETED|Overall Study||74
11397533|NCT04258995|12591669|FG000|NOT COMPLETED|Overall Study||1
11397534|NCT04258995|12591670|FG001|NOT COMPLETED|Overall Study||1
11397535|NCT04280445|12591676|FG000|STARTED|Overall Study||3
11397536|NCT04280445|12591676|FG000|COMPLETED|Overall Study||3
11397537|NCT04280445|12591676|FG000|NOT COMPLETED|Overall Study||0
11340332|NCT02919761|12537621|FG000|Safety Population|Part 2: Double-blind||0
11340333|NCT02919761|12537622|FG001|Safety Population|Part 2: Double-blind||77
11340334|NCT02919761|12537623|FG002|Safety Population|Part 2: Double-blind||77
11340335|NCT02919761|12537621|FG000|mITT Population|Part 2: Double-blind||0
11340336|NCT02919761|12537622|FG001|mITT Population|Part 2: Double-blind||77
11340337|NCT02919761|12537623|FG002|mITT Population|Part 2: Double-blind||76
11340338|NCT02919761|12537621|FG000|Per Protocol Population|Part 2: Double-blind||0
11340339|NCT02919761|12537622|FG001|Per Protocol Population|Part 2: Double-blind||76
11340340|NCT02919761|12537623|FG002|Per Protocol Population|Part 2: Double-blind||73
11340341|NCT02919761|12537621|FG000|COMPLETED|Part 2: Double-blind||0
11340342|NCT02919761|12537622|FG001|COMPLETED|Part 2: Double-blind||71
11340343|NCT02919761|12537623|FG002|COMPLETED|Part 2: Double-blind||56
11340344|NCT02919761|12537621|FG000|NOT COMPLETED|Part 2: Double-blind||0
11340345|NCT02919761|12537622|FG001|NOT COMPLETED|Part 2: Double-blind||6
11340346|NCT02919761|12537623|FG002|NOT COMPLETED|Part 2: Double-blind||21
11340347|NCT02919813|12537636|FG000|STARTED|Overall Study||14
11340348|NCT02919813|12537637|FG001|STARTED|Overall Study||17
11340349|NCT02919813|12537636|FG000|COMPLETED|Overall Study||14
11340350|NCT02919813|12537637|FG001|COMPLETED|Overall Study||17
11340351|NCT02919813|12537636|FG000|NOT COMPLETED|Overall Study||0
11340352|NCT02919813|12537637|FG001|NOT COMPLETED|Overall Study||0
11340353|NCT02919826|12537645|FG000|STARTED|Overall Study||10
11340354|NCT02919826|12537646|FG001|STARTED|Overall Study||10
11340355|NCT02919826|12537645|FG000|COMPLETED|Overall Study||10
11340356|NCT02919826|12537646|FG001|COMPLETED|Overall Study||8
11340357|NCT02919826|12537645|FG000|NOT COMPLETED|Overall Study||0
11340358|NCT02919826|12537646|FG001|NOT COMPLETED|Overall Study||2
11397538|NCT04285489|12591680|FG000|STARTED|Overall Study||130
11340359|NCT02919995|12537660|FG000|STARTED|Overall Study||1
11340360|NCT02919995|12537661|FG001|STARTED|Overall Study||2
11340361|NCT02919995|12537662|FG002|STARTED|Overall Study||2
11340362|NCT02919995|12537663|FG003|STARTED|Overall Study||2
11340363|NCT02919995|12537664|FG004|STARTED|Overall Study||1
11340364|NCT02919995|12537665|FG005|STARTED|Overall Study||2
11340365|NCT02919995|12537660|FG000|COMPLETED|Overall Study||1
11340366|NCT02919995|12537661|FG001|COMPLETED|Overall Study||2
11340367|NCT02919995|12537662|FG002|COMPLETED|Overall Study||2
11340368|NCT02919995|12537663|FG003|COMPLETED|Overall Study||2
11340369|NCT02919995|12537664|FG004|COMPLETED|Overall Study||1
11340370|NCT02919995|12537665|FG005|COMPLETED|Overall Study||1
11340371|NCT02919995|12537660|FG000|NOT COMPLETED|Overall Study||0
11340372|NCT02919995|12537661|FG001|NOT COMPLETED|Overall Study||0
11340373|NCT02919995|12537662|FG002|NOT COMPLETED|Overall Study||0
11340374|NCT02919995|12537663|FG003|NOT COMPLETED|Overall Study||0
11340375|NCT02919995|12537664|FG004|NOT COMPLETED|Overall Study||0
11340376|NCT02919995|12537665|FG005|NOT COMPLETED|Overall Study||1
11340377|NCT02920528|12537676|FG000|STARTED|Overall Study||35
11269366|NCT02315352|12465206|FG000|STARTED|First Intervention (Day 1)||24
11269367|NCT02315352|12465207|FG001|STARTED|First Intervention (Day 1)||24
11269368|NCT02315352|12465208|FG002|STARTED|First Intervention (Day 1)||0
11269369|NCT02315352|12465209|FG003|STARTED|First Intervention (Day 1)||0
11269370|NCT02315352|12465210|FG004|STARTED|First Intervention (Day 1)||0
11269371|NCT02315352|12465211|FG005|STARTED|First Intervention (Day 1)||0
11269372|NCT02315352|12465212|FG006|STARTED|First Intervention (Day 1)||0
11269373|NCT02315352|12465213|FG007|STARTED|First Intervention (Day 1)||0
11269374|NCT02315352|12465206|FG000|COMPLETED|First Intervention (Day 1)||24
11269375|NCT02315352|12465207|FG001|COMPLETED|First Intervention (Day 1)||24
11269376|NCT02315352|12465208|FG002|COMPLETED|First Intervention (Day 1)||0
11269377|NCT02315352|12465209|FG003|COMPLETED|First Intervention (Day 1)||0
11269378|NCT02315352|12465210|FG004|COMPLETED|First Intervention (Day 1)||0
11269379|NCT02315352|12465211|FG005|COMPLETED|First Intervention (Day 1)||0
11269380|NCT02315352|12465212|FG006|COMPLETED|First Intervention (Day 1)||0
11269381|NCT02315352|12465213|FG007|COMPLETED|First Intervention (Day 1)||0
11269382|NCT02315352|12465206|FG000|NOT COMPLETED|First Intervention (Day 1)||0
11269383|NCT02315352|12465207|FG001|NOT COMPLETED|First Intervention (Day 1)||0
11269384|NCT02315352|12465208|FG002|NOT COMPLETED|First Intervention (Day 1)||0
11269385|NCT02315352|12465209|FG003|NOT COMPLETED|First Intervention (Day 1)||0
11269386|NCT02315352|12465210|FG004|NOT COMPLETED|First Intervention (Day 1)||0
11269387|NCT02315352|12465211|FG005|NOT COMPLETED|First Intervention (Day 1)||0
11269388|NCT02315352|12465212|FG006|NOT COMPLETED|First Intervention (Day 1)||0
11269389|NCT02315352|12465213|FG007|NOT COMPLETED|First Intervention (Day 1)||0
11269390|NCT02315352|12465206|FG000|STARTED|Second Intervention (Day 1)||24
11269391|NCT02315352|12465207|FG001|STARTED|Second Intervention (Day 1)||24
11269392|NCT02315352|12465208|FG002|STARTED|Second Intervention (Day 1)||0
11269393|NCT02315352|12465209|FG003|STARTED|Second Intervention (Day 1)||0
11269394|NCT02315352|12465210|FG004|STARTED|Second Intervention (Day 1)||0
11269395|NCT02315352|12465211|FG005|STARTED|Second Intervention (Day 1)||0
11269396|NCT02315352|12465212|FG006|STARTED|Second Intervention (Day 1)||0
11269397|NCT02315352|12465213|FG007|STARTED|Second Intervention (Day 1)||0
11269398|NCT02315352|12465206|FG000|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
11269399|NCT02315352|12465207|FG001|COMPLETED|Second Intervention (Day 1)||24
11269400|NCT02315352|12465208|FG002|COMPLETED|Second Intervention (Day 1)||0
11269401|NCT02315352|12465209|FG003|COMPLETED|Second Intervention (Day 1)||0
11269402|NCT02315352|12465210|FG004|COMPLETED|Second Intervention (Day 1)||0
11269403|NCT02315352|12465211|FG005|COMPLETED|Second Intervention (Day 1)||0
11269404|NCT02315352|12465212|FG006|COMPLETED|Second Intervention (Day 1)||0
11269405|NCT02315352|12465213|FG007|COMPLETED|Second Intervention (Day 1)||0
11269406|NCT02315352|12465206|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
11269407|NCT02315352|12465207|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
11269408|NCT02315352|12465208|FG002|NOT COMPLETED|Second Intervention (Day 1)||0
11269409|NCT02315352|12465209|FG003|NOT COMPLETED|Second Intervention (Day 1)||0
11269410|NCT02315352|12465210|FG004|NOT COMPLETED|Second Intervention (Day 1)||0
11269411|NCT02315352|12465211|FG005|NOT COMPLETED|Second Intervention (Day 1)||0
11269412|NCT02315352|12465212|FG006|NOT COMPLETED|Second Intervention (Day 1)||0
11269413|NCT02315352|12465213|FG007|NOT COMPLETED|Second Intervention (Day 1)||0
11269414|NCT02315352|12465206|FG000|STARTED|Third Intervention (Day 2)||0
11397539|NCT04285489|12591680|FG000|COMPLETED|Overall Study|all subjects finished the study before Jul 1, 2020.|130
11269415|NCT02315352|12465207|FG001|STARTED|Third Intervention (Day 2)||0
11269416|NCT02315352|12465208|FG002|STARTED|Third Intervention (Day 2)||7
11269417|NCT02315352|12465209|FG003|STARTED|Third Intervention (Day 2)||8
11269418|NCT02315352|12465210|FG004|STARTED|Third Intervention (Day 2)||8
11269419|NCT02315352|12465211|FG005|STARTED|Third Intervention (Day 2)||7
11269420|NCT02315352|12465212|FG006|STARTED|Third Intervention (Day 2)||9
11269421|NCT02315352|12465213|FG007|STARTED|Third Intervention (Day 2)||8
11269422|NCT02315352|12465206|FG000|COMPLETED|Third Intervention (Day 2)||0
11269423|NCT02315352|12465207|FG001|COMPLETED|Third Intervention (Day 2)||0
11269424|NCT02315352|12465208|FG002|COMPLETED|Third Intervention (Day 2)||7
11269425|NCT02315352|12465209|FG003|COMPLETED|Third Intervention (Day 2)||8
11269426|NCT02315352|12465210|FG004|COMPLETED|Third Intervention (Day 2)||8
11269427|NCT02315352|12465211|FG005|COMPLETED|Third Intervention (Day 2)||7
11269428|NCT02315352|12465212|FG006|COMPLETED|Third Intervention (Day 2)||9
11269429|NCT02315352|12465213|FG007|COMPLETED|Third Intervention (Day 2)||8
11269430|NCT02315352|12465206|FG000|NOT COMPLETED|Third Intervention (Day 2)||0
11269431|NCT02315352|12465207|FG001|NOT COMPLETED|Third Intervention (Day 2)||0
11269432|NCT02315352|12465208|FG002|NOT COMPLETED|Third Intervention (Day 2)||0
11269433|NCT02315352|12465209|FG003|NOT COMPLETED|Third Intervention (Day 2)||0
11269434|NCT02315352|12465210|FG004|NOT COMPLETED|Third Intervention (Day 2)||0
11269435|NCT02315352|12465211|FG005|NOT COMPLETED|Third Intervention (Day 2)||0
11269436|NCT02315352|12465212|FG006|NOT COMPLETED|Third Intervention (Day 2)||0
11269437|NCT02315352|12465213|FG007|NOT COMPLETED|Third Intervention (Day 2)||0
11269438|NCT02315352|12465206|FG000|STARTED|Fourth Intervention (Day 2)||0
11269439|NCT02315352|12465207|FG001|STARTED|Fourth Intervention (Day 2)||0
11269440|NCT02315352|12465208|FG002|STARTED|Fourth Intervention (Day 2)||7
11269441|NCT02315352|12465209|FG003|STARTED|Fourth Intervention (Day 2)||8
11269442|NCT02315352|12465210|FG004|STARTED|Fourth Intervention (Day 2)||8
11269443|NCT02315352|12465211|FG005|STARTED|Fourth Intervention (Day 2)||7
11269444|NCT02315352|12465212|FG006|STARTED|Fourth Intervention (Day 2)||9
11269445|NCT02315352|12465213|FG007|STARTED|Fourth Intervention (Day 2)||8
11269446|NCT02315352|12465206|FG000|COMPLETED|Fourth Intervention (Day 2)||0
11269447|NCT02315352|12465207|FG001|COMPLETED|Fourth Intervention (Day 2)||0
11269448|NCT02315352|12465208|FG002|COMPLETED|Fourth Intervention (Day 2)||7
11269449|NCT02315352|12465209|FG003|COMPLETED|Fourth Intervention (Day 2)||8
11269450|NCT02315352|12465210|FG004|COMPLETED|Fourth Intervention (Day 2)||8
11269451|NCT02315352|12465211|FG005|COMPLETED|Fourth Intervention (Day 2)||7
11269452|NCT02315352|12465212|FG006|COMPLETED|Fourth Intervention (Day 2)||9
11269453|NCT02315352|12465213|FG007|COMPLETED|Fourth Intervention (Day 2)||8
11269454|NCT02315352|12465206|FG000|NOT COMPLETED|Fourth Intervention (Day 2)||0
11269455|NCT02315352|12465207|FG001|NOT COMPLETED|Fourth Intervention (Day 2)||0
11269456|NCT02315352|12465208|FG002|NOT COMPLETED|Fourth Intervention (Day 2)||0
11269457|NCT02315352|12465209|FG003|NOT COMPLETED|Fourth Intervention (Day 2)||0
11269458|NCT02315352|12465210|FG004|NOT COMPLETED|Fourth Intervention (Day 2)||0
11269459|NCT02315352|12465211|FG005|NOT COMPLETED|Fourth Intervention (Day 2)||0
11269460|NCT02315352|12465212|FG006|NOT COMPLETED|Fourth Intervention (Day 2)||0
11269461|NCT02315352|12465213|FG007|NOT COMPLETED|Fourth Intervention (Day 2)||0
11269462|NCT02315352|12465206|FG000|STARTED|Fifth Intervention (Day 2)||0
11269463|NCT02315352|12465207|FG001|STARTED|Fifth Intervention (Day 2)||0
11269464|NCT02315352|12465208|FG002|STARTED|Fifth Intervention (Day 2)||7
11269465|NCT02315352|12465209|FG003|STARTED|Fifth Intervention (Day 2)||8
11269466|NCT02315352|12465210|FG004|STARTED|Fifth Intervention (Day 2)||8
11269467|NCT02315352|12465211|FG005|STARTED|Fifth Intervention (Day 2)||7
11269468|NCT02315352|12465212|FG006|STARTED|Fifth Intervention (Day 2)||9
11269469|NCT02315352|12465213|FG007|STARTED|Fifth Intervention (Day 2)||8
11269470|NCT02315352|12465206|FG000|COMPLETED|Fifth Intervention (Day 2)||0
11269471|NCT02315352|12465207|FG001|COMPLETED|Fifth Intervention (Day 2)||0
11269472|NCT02315352|12465208|FG002|COMPLETED|Fifth Intervention (Day 2)||7
11269473|NCT02315352|12465209|FG003|COMPLETED|Fifth Intervention (Day 2)||8
11269474|NCT02315352|12465210|FG004|COMPLETED|Fifth Intervention (Day 2)||8
11269475|NCT02315352|12465211|FG005|COMPLETED|Fifth Intervention (Day 2)||7
11269476|NCT02315352|12465212|FG006|COMPLETED|Fifth Intervention (Day 2)||9
11269477|NCT02315352|12465213|FG007|COMPLETED|Fifth Intervention (Day 2)||8
11269478|NCT02315352|12465206|FG000|NOT COMPLETED|Fifth Intervention (Day 2)||0
11269479|NCT02315352|12465207|FG001|NOT COMPLETED|Fifth Intervention (Day 2)||0
11397540|NCT04285489|12591680|FG000|NOT COMPLETED|Overall Study||0
11397541|NCT04290494|12591687|FG000|STARTED|Overall Study||10968
11269480|NCT02315352|12465208|FG002|NOT COMPLETED|Fifth Intervention (Day 2)||0
11269481|NCT02315352|12465209|FG003|NOT COMPLETED|Fifth Intervention (Day 2)||0
11269482|NCT02315352|12465210|FG004|NOT COMPLETED|Fifth Intervention (Day 2)||0
11269483|NCT02315352|12465211|FG005|NOT COMPLETED|Fifth Intervention (Day 2)||0
11269484|NCT02315352|12465212|FG006|NOT COMPLETED|Fifth Intervention (Day 2)||0
11269485|NCT02315352|12465213|FG007|NOT COMPLETED|Fifth Intervention (Day 2)||0
11269486|NCT02315430|12465225|FG000|STARTED|Overall Study||13
11269487|NCT02315430|12465225|FG000|COMPLETED|Overall Study||13
11269488|NCT02315430|12465225|FG000|NOT COMPLETED|Overall Study||0
11269489|NCT02315560|12465229|FG000|STARTED|Overall Study||25
11269490|NCT02315560|12465229|FG000|COMPLETED|Overall Study||22
11397542|NCT04290494|12591688|FG001|STARTED|Overall Study||17823
11397543|NCT04290494|12591689|FG002|STARTED|Overall Study||13397
11397544|NCT04290494|12591687|FG000|COMPLETED|Overall Study||10968
11397545|NCT04290494|12591688|FG001|COMPLETED|Overall Study||17823
11269491|NCT02315560|12465229|FG000|NOT COMPLETED|Overall Study||3
11269492|NCT02315625|12465235|FG000|STARTED|First Intervention||14
11269493|NCT02315625|12465236|FG001|STARTED|First Intervention||2
11269494|NCT02315625|12465235|FG000|COMPLETED|First Intervention||13
11269495|NCT02315625|12465236|FG001|COMPLETED|First Intervention||2
11269496|NCT02315625|12465235|FG000|NOT COMPLETED|First Intervention||1
11269497|NCT02315625|12465236|FG001|NOT COMPLETED|First Intervention||0
11269498|NCT02315625|12465235|FG000|STARTED|Second Intervention||13
11269499|NCT02315625|12465236|FG001|STARTED|Second Intervention||2
11269500|NCT02315625|12465235|FG000|COMPLETED|Second Intervention||9
11269501|NCT02315625|12465236|FG001|COMPLETED|Second Intervention||1
11269502|NCT02315625|12465235|FG000|NOT COMPLETED|Second Intervention||4
11269503|NCT02315625|12465236|FG001|NOT COMPLETED|Second Intervention||1
11269504|NCT02315664|12465246|FG000|STARTED|Overall Study||30
11269505|NCT02315664|12465247|FG001|STARTED|Overall Study||31
11269506|NCT02315664|12465246|FG000|COMPLETED|Overall Study||29
11269507|NCT02315664|12465247|FG001|COMPLETED|Overall Study||27
11269508|NCT02315664|12465246|FG000|NOT COMPLETED|Overall Study||1
11269509|NCT02315664|12465247|FG001|NOT COMPLETED|Overall Study||4
11269510|NCT02315755|12465253|FG000|STARTED|Overall Study||102
11269511|NCT02315755|12465253|FG000|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102
11269512|NCT02315755|12465253|FG000|NOT COMPLETED|Overall Study||0
11269513|NCT02315872|12465259|FG000|STARTED|Overall Study||4
11269514|NCT02315872|12465260|FG001|STARTED|Overall Study||4
11269515|NCT02315872|12465259|FG000|COMPLETED|Overall Study||1
11269516|NCT02315872|12465260|FG001|COMPLETED|Overall Study||3
11269517|NCT02315872|12465259|FG000|NOT COMPLETED|Overall Study||3
11269518|NCT02315872|12465260|FG001|NOT COMPLETED|Overall Study||1
11269519|NCT02315989|12465266|FG000|STARTED|Overall Study||6
11269520|NCT02315989|12465266|FG000|COMPLETED|Overall Study||6
11269521|NCT02315989|12465266|FG000|NOT COMPLETED|Overall Study||0
11269522|NCT02316223|12465277|FG000|STARTED|Overall Study||134
11269523|NCT02316223|12465278|FG001|STARTED|Overall Study||133
11269524|NCT02316223|12465279|FG002|STARTED|Overall Study||139
11269525|NCT02316223|12465277|FG000|COMPLETED|Overall Study||90
11269526|NCT02316223|12465278|FG001|COMPLETED|Overall Study||76
11269527|NCT02316223|12465279|FG002|COMPLETED|Overall Study||95
11269528|NCT02316223|12465277|FG000|NOT COMPLETED|Overall Study||44
11269529|NCT02316223|12465278|FG001|NOT COMPLETED|Overall Study||57
11269530|NCT02316223|12465279|FG002|NOT COMPLETED|Overall Study||44
11269531|NCT02316353|12465289|FG000|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
11269532|NCT02316353|12465290|FG001|STARTED|Overall Study||63
11269533|NCT02316353|12465289|FG000|COMPLETED|Overall Study||55
11269534|NCT02316353|12465290|FG001|COMPLETED|Overall Study||55
11269535|NCT02316353|12465289|FG000|NOT COMPLETED|Overall Study||8
11269536|NCT02316353|12465290|FG001|NOT COMPLETED|Overall Study||8
11269537|NCT02316366|12465301|FG000|STARTED|Overall Study||40
11269538|NCT02316366|12465302|FG001|STARTED|Overall Study||40
11269539|NCT02316366|12465301|FG000|COMPLETED|Overall Study||40
11269540|NCT02316366|12465302|FG001|COMPLETED|Overall Study||40
11269541|NCT02316366|12465301|FG000|NOT COMPLETED|Overall Study||0
11269542|NCT02316366|12465302|FG001|NOT COMPLETED|Overall Study||0
11269543|NCT02316470|12465312|FG000|STARTED|Overall Study||148
11269544|NCT02316470|12465313|FG001|STARTED|Overall Study||152
11269545|NCT02316470|12465314|FG002|STARTED|Overall Study||152
11269546|NCT02316470|12465315|FG003|STARTED|Overall Study||48
11269547|NCT02316470|12465312|FG000|COMPLETED|Overall Study||143
11269548|NCT02316470|12465313|FG001|COMPLETED|Overall Study||146
11269549|NCT02316470|12465314|FG002|COMPLETED|Overall Study||147
11269550|NCT02316470|12465315|FG003|COMPLETED|Overall Study||46
11269551|NCT02316470|12465312|FG000|NOT COMPLETED|Overall Study||5
11269552|NCT02316470|12465313|FG001|NOT COMPLETED|Overall Study||6
11269553|NCT02316470|12465314|FG002|NOT COMPLETED|Overall Study||5
11269554|NCT02316470|12465315|FG003|NOT COMPLETED|Overall Study||2
11269555|NCT02316548|12465327|FG000|STARTED|Overall Study|Randomized|6
11269556|NCT02316548|12465328|FG001|STARTED|Overall Study|Randomized|7
11269557|NCT02316548|12465327|FG000|Eligible Population|Overall Study||6
11269558|NCT02316548|12465328|FG001|Eligible Population|Overall Study||6
11269559|NCT02316548|12465327|FG000|Eligible With Disease Assessment|Overall Study||4
11269560|NCT02316548|12465328|FG001|Eligible With Disease Assessment|Overall Study||1
11269561|NCT02316548|12465327|FG000|Eligible With Adverse Event Data|Overall Study||4
11269562|NCT02316548|12465328|FG001|Eligible With Adverse Event Data|Overall Study||2
11269563|NCT02316548|12465327|FG000|COMPLETED|Overall Study|Eligible patients on study until study termination|6
11269564|NCT02316548|12465328|FG001|COMPLETED|Overall Study|Eligible patients on study until study termination|6
11269565|NCT02316548|12465327|FG000|NOT COMPLETED|Overall Study||0
11269566|NCT02316548|12465328|FG001|NOT COMPLETED|Overall Study||1
11269567|NCT02316613|12465334|FG000|STARTED|Overall Study||260
11269568|NCT02316613|12465334|FG000|Safety Population|Overall Study||255
11269569|NCT02316613|12465334|FG000|Overall Population|Overall Study||241
11269570|NCT02316613|12465334|FG000|COMPLETED|Overall Study||156
11269571|NCT02316613|12465334|FG000|NOT COMPLETED|Overall Study||104
11269572|NCT02316678|12465351|FG000|STARTED|Overall Study||1879
11269573|NCT02316678|12465352|FG001|STARTED|Overall Study||7694
11269574|NCT02316678|12465351|FG000|COMPLETED|Overall Study||1879
11269575|NCT02316678|12465352|FG001|COMPLETED|Overall Study||7694
11269576|NCT02316678|12465351|FG000|NOT COMPLETED|Overall Study||0
11269577|NCT02316678|12465352|FG001|NOT COMPLETED|Overall Study||0
11269578|NCT02316717|12465361|FG000|STARTED|Overall Study||43
11269579|NCT02316717|12465362|FG001|STARTED|Overall Study||46
11269580|NCT02316717|12465363|FG002|STARTED|Overall Study||44
11269581|NCT02316717|12465361|FG000|COMPLETED|Overall Study||32
11269582|NCT02316717|12465362|FG001|COMPLETED|Overall Study||39
11269583|NCT02316717|12465363|FG002|COMPLETED|Overall Study||41
11269584|NCT02316717|12465361|FG000|NOT COMPLETED|Overall Study||11
11269585|NCT02316717|12465362|FG001|NOT COMPLETED|Overall Study||7
11269586|NCT02316717|12465363|FG002|NOT COMPLETED|Overall Study||3
11269587|NCT02316769|12465376|FG000|STARTED|Overall Study||33
11269588|NCT02316769|12465377|FG001|STARTED|Overall Study||33
11269589|NCT02316769|12465376|FG000|COMPLETED|Overall Study||31
11269590|NCT02316769|12465377|FG001|COMPLETED|Overall Study||33
11269591|NCT02316769|12465376|FG000|NOT COMPLETED|Overall Study||2
11269592|NCT02316769|12465377|FG001|NOT COMPLETED|Overall Study||0
11269593|NCT02316847|12465385|FG000|STARTED|Overall Study||9
11269594|NCT02316847|12465386|FG001|STARTED|Overall Study||99
11269595|NCT02316847|12465385|FG000|COMPLETED|Overall Study||0
11269596|NCT02316847|12465386|FG001|COMPLETED|Overall Study||13
11269597|NCT02316847|12465385|FG000|NOT COMPLETED|Overall Study||9
11269598|NCT02316847|12465386|FG001|NOT COMPLETED|Overall Study||86
11269599|NCT02317016|12465394|FG000|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
11269600|NCT02317016|12465394|FG000|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
11269601|NCT02317016|12465394|FG000|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
11269602|NCT02317016|12465394|FG000|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
11269603|NCT02317016|12465394|FG000|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
11269604|NCT02317016|12465394|FG000|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
11269605|NCT02317016|12465394|FG000|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
11269606|NCT02317016|12465394|FG000|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
11269607|NCT02317016|12465394|FG000|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
11269608|NCT02317016|12465394|FG000|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
11269609|NCT02317016|12465394|FG000|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
11269610|NCT02317016|12465394|FG000|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
11269611|NCT02317042|12465402|FG000|STARTED|Overall Study||11
11269612|NCT02317042|12465403|FG001|STARTED|Overall Study||14
11269613|NCT02317042|12465402|FG000|COMPLETED|Overall Study||11
11269614|NCT02317042|12465403|FG001|COMPLETED|Overall Study||14
11269615|NCT02317042|12465402|FG000|NOT COMPLETED|Overall Study||0
11269616|NCT02317042|12465403|FG001|NOT COMPLETED|Overall Study||0
11269617|NCT02317432|12465413|FG000|STARTED|Overall Study||153
11269618|NCT02317432|12465414|FG001|STARTED|Overall Study||154
11269619|NCT02317432|12465413|FG000|Completed CBT|Overall Study||118
11269620|NCT02317432|12465414|FG001|Completed CBT|Overall Study|Participants in Enhanced Usual Care did not receive CBT sessions.|0
11269621|NCT02317432|12465413|FG000|Completed InVEST|Overall Study||63
11269622|NCT02317432|12465414|FG001|Completed InVEST|Overall Study|Participants in Enhanced Usual Care did not receive InVEST sessions.|0
11269623|NCT02317432|12465413|FG000|Completed CBT + InVEST Exercise|Overall Study||122
11269624|NCT02317432|12465414|FG001|Completed CBT + InVEST Exercise|Overall Study|Participants in Enhanced Usual Care did not receive either CBT or InVEST sessions.|0
11269625|NCT02317432|12465413|FG000|Completed Enhanced Usual Care|Overall Study|Participants in CBT + InVEST exercise did not receive Enhanced Usual Care.|0
11269626|NCT02317432|12465414|FG001|Completed Enhanced Usual Care|Overall Study||148
11269627|NCT02317432|12465413|FG000|COMPLETED|Overall Study||122
11269628|NCT02317432|12465414|FG001|COMPLETED|Overall Study||148
11269629|NCT02317432|12465413|FG000|NOT COMPLETED|Overall Study||31
11269630|NCT02317432|12465414|FG001|NOT COMPLETED|Overall Study||6
11269631|NCT02317510|12465422|FG000|STARTED|Overall Study||25
11269632|NCT02317510|12465423|FG001|STARTED|Overall Study||25
11269633|NCT02317510|12465422|FG000|COMPLETED|Overall Study||25
11269634|NCT02317510|12465423|FG001|COMPLETED|Overall Study||24
11269635|NCT02317510|12465422|FG000|NOT COMPLETED|Overall Study||0
11269636|NCT02317510|12465423|FG001|NOT COMPLETED|Overall Study||1
11269637|NCT02317549|12465434|FG000|STARTED|Overall Study||5
11269638|NCT02317549|12465435|FG001|STARTED|Overall Study||3
11269639|NCT02317549|12465434|FG000|COMPLETED|Overall Study||5
11269640|NCT02317549|12465435|FG001|COMPLETED|Overall Study||3
11269641|NCT02317549|12465434|FG000|NOT COMPLETED|Overall Study||0
11269642|NCT02317549|12465435|FG001|NOT COMPLETED|Overall Study||0
11269643|NCT02317562|12465441|FG000|STARTED|Overall Study||19
11269644|NCT02317562|12465441|FG000|COMPLETED|Overall Study||5
11269645|NCT02317562|12465441|FG000|NOT COMPLETED|Overall Study||14
11269646|NCT02317575|12465445|FG000|STARTED|Period 1||5
11269647|NCT02317575|12465446|FG001|STARTED|Period 1||6
11269648|NCT02317575|12465447|FG002|STARTED|Period 1||6
11269649|NCT02317575|12465448|FG003|STARTED|Period 1||6
11269650|NCT02317575|12465449|FG004|STARTED|Period 1||6
11269651|NCT02317575|12465445|FG000|Received at Least 1 Dose of Study Drug|Period 1||5
11269652|NCT02317575|12465446|FG001|Received at Least 1 Dose of Study Drug|Period 1||5
11269653|NCT02317575|12465447|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
11269654|NCT02317575|12465448|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
11269655|NCT02317575|12465449|FG004|Received at Least 1 Dose of Study Drug|Period 1||6
11269656|NCT02317575|12465445|FG000|COMPLETED|Period 1||4
11269657|NCT02317575|12465446|FG001|COMPLETED|Period 1||5
11269658|NCT02317575|12465447|FG002|COMPLETED|Period 1||6
11269659|NCT02317575|12465448|FG003|COMPLETED|Period 1||6
11269660|NCT02317575|12465449|FG004|COMPLETED|Period 1||6
11269661|NCT02317575|12465445|FG000|NOT COMPLETED|Period 1||1
11269662|NCT02317575|12465446|FG001|NOT COMPLETED|Period 1||1
11269663|NCT02317575|12465447|FG002|NOT COMPLETED|Period 1||0
11269664|NCT02317575|12465448|FG003|NOT COMPLETED|Period 1||0
11269665|NCT02317575|12465449|FG004|NOT COMPLETED|Period 1||0
11269666|NCT02317575|12465445|FG000|STARTED|Period 2||4
11269667|NCT02317575|12465446|FG001|STARTED|Period 2||5
11269668|NCT02317575|12465447|FG002|STARTED|Period 2||6
11269669|NCT02317575|12465448|FG003|STARTED|Period 2||6
11269670|NCT02317575|12465449|FG004|STARTED|Period 2||6
11269671|NCT02317575|12465445|FG000|COMPLETED|Period 2||4
11269672|NCT02317575|12465446|FG001|COMPLETED|Period 2||5
11269673|NCT02317575|12465447|FG002|COMPLETED|Period 2||6
11269674|NCT02317575|12465448|FG003|COMPLETED|Period 2||6
11269675|NCT02317575|12465449|FG004|COMPLETED|Period 2||6
11269676|NCT02317575|12465445|FG000|NOT COMPLETED|Period 2||0
11269677|NCT02317575|12465446|FG001|NOT COMPLETED|Period 2||0
11269678|NCT02317575|12465447|FG002|NOT COMPLETED|Period 2||0
11269679|NCT02317575|12465448|FG003|NOT COMPLETED|Period 2||0
11269680|NCT02317575|12465449|FG004|NOT COMPLETED|Period 2||0
11269681|NCT02317575|12465445|FG000|STARTED|Period 3||4
11269682|NCT02317575|12465446|FG001|STARTED|Period 3||5
11269683|NCT02317575|12465447|FG002|STARTED|Period 3||6
11269684|NCT02317575|12465448|FG003|STARTED|Period 3||6
11269685|NCT02317575|12465449|FG004|STARTED|Period 3||6
11269686|NCT02317575|12465445|FG000|COMPLETED|Period 3||4
11269687|NCT02317575|12465446|FG001|COMPLETED|Period 3||5
11269688|NCT02317575|12465447|FG002|COMPLETED|Period 3||6
11269689|NCT02317575|12465448|FG003|COMPLETED|Period 3||6
11269690|NCT02317575|12465449|FG004|COMPLETED|Period 3||6
11269691|NCT02317575|12465445|FG000|NOT COMPLETED|Period 3||0
11269692|NCT02317575|12465446|FG001|NOT COMPLETED|Period 3||0
11269693|NCT02317575|12465447|FG002|NOT COMPLETED|Period 3||0
11269694|NCT02317575|12465448|FG003|NOT COMPLETED|Period 3||0
11269695|NCT02317575|12465449|FG004|NOT COMPLETED|Period 3||0
11269696|NCT02317575|12465445|FG000|STARTED|Period 4||4
11269697|NCT02317575|12465446|FG001|STARTED|Period 4||5
11269698|NCT02317575|12465447|FG002|STARTED|Period 4||6
11269699|NCT02317575|12465448|FG003|STARTED|Period 4||6
11269700|NCT02317575|12465449|FG004|STARTED|Period 4||6
11269701|NCT02317575|12465445|FG000|COMPLETED|Period 4||4
11269702|NCT02317575|12465446|FG001|COMPLETED|Period 4||5
11269703|NCT02317575|12465447|FG002|COMPLETED|Period 4||6
11269704|NCT02317575|12465448|FG003|COMPLETED|Period 4||6
11269705|NCT02317575|12465449|FG004|COMPLETED|Period 4||6
11269706|NCT02317575|12465445|FG000|NOT COMPLETED|Period 4||0
11269707|NCT02317575|12465446|FG001|NOT COMPLETED|Period 4||0
11269708|NCT02317575|12465447|FG002|NOT COMPLETED|Period 4||0
11269709|NCT02317575|12465448|FG003|NOT COMPLETED|Period 4||0
11269710|NCT02317575|12465449|FG004|NOT COMPLETED|Period 4||0
11269711|NCT02317575|12465445|FG000|STARTED|Period 5||4
11269712|NCT02317575|12465446|FG001|STARTED|Period 5||5
11269713|NCT02317575|12465447|FG002|STARTED|Period 5||6
11269714|NCT02317575|12465448|FG003|STARTED|Period 5||6
11269715|NCT02317575|12465449|FG004|STARTED|Period 5||6
11269716|NCT02317575|12465445|FG000|COMPLETED|Period 5||4
11269717|NCT02317575|12465446|FG001|COMPLETED|Period 5||5
11269718|NCT02317575|12465447|FG002|COMPLETED|Period 5||6
11269719|NCT02317575|12465448|FG003|COMPLETED|Period 5||6
11269720|NCT02317575|12465449|FG004|COMPLETED|Period 5||6
11269721|NCT02317575|12465445|FG000|NOT COMPLETED|Period 5||0
11269722|NCT02317575|12465446|FG001|NOT COMPLETED|Period 5||0
11269723|NCT02317575|12465447|FG002|NOT COMPLETED|Period 5||0
11269724|NCT02317575|12465448|FG003|NOT COMPLETED|Period 5||0
11269725|NCT02317575|12465449|FG004|NOT COMPLETED|Period 5||0
11269726|NCT02317614|12465469|FG000|STARTED|Overall Study||26
11269727|NCT02317614|12465470|FG001|STARTED|Overall Study||25
11269728|NCT02317614|12465469|FG000|COMPLETED|Overall Study||23
11269729|NCT02317614|12465470|FG001|COMPLETED|Overall Study||23
11269730|NCT02317614|12465469|FG000|NOT COMPLETED|Overall Study||3
11269731|NCT02317614|12465470|FG001|NOT COMPLETED|Overall Study||2
11269732|NCT02317692|12465478|FG000|STARTED|Overall Study||69
11269733|NCT02317692|12465479|FG001|STARTED|Overall Study||77
11269734|NCT02317692|12465478|FG000|COMPLETED|Overall Study||63
11269735|NCT02317692|12465479|FG001|COMPLETED|Overall Study||77
11269736|NCT02317692|12465478|FG000|NOT COMPLETED|Overall Study||6
11269737|NCT02317692|12465479|FG001|NOT COMPLETED|Overall Study||0
11269738|NCT02317744|12465487|FG000|STARTED|Overall Study||12
11269739|NCT02317744|12465488|FG001|STARTED|Overall Study||10
11269740|NCT02317744|12465487|FG000|Completed Treatment|Overall Study||10
11269741|NCT02317744|12465488|FG001|Completed Treatment|Overall Study||7
11269742|NCT02317744|12465487|FG000|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
11269743|NCT02317744|12465488|FG001|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
11269744|NCT02317744|12465487|FG000|NOT COMPLETED|Overall Study||1
11269745|NCT02317744|12465488|FG001|NOT COMPLETED|Overall Study||2
11269746|NCT02317809|12465494|FG000|STARTED|First Intervention Period (8 Days)||17
11269747|NCT02317809|12465495|FG001|STARTED|First Intervention Period (8 Days)||17
11269748|NCT02317809|12465494|FG000|COMPLETED|First Intervention Period (8 Days)||14
11269749|NCT02317809|12465495|FG001|COMPLETED|First Intervention Period (8 Days)||17
11269750|NCT02317809|12465494|FG000|NOT COMPLETED|First Intervention Period (8 Days)||3
11269751|NCT02317809|12465495|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0
11269752|NCT02317809|12465494|FG000|STARTED|Second Intervention Period (8 Days)||14
11269753|NCT02317809|12465495|FG001|STARTED|Second Intervention Period (8 Days)||17
11269754|NCT02317809|12465494|FG000|COMPLETED|Second Intervention Period (8 Days)||14
11269755|NCT02317809|12465495|FG001|COMPLETED|Second Intervention Period (8 Days)||17
11269756|NCT02317809|12465494|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0
11269757|NCT02317809|12465495|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0
11269758|NCT02318134|12465506|FG000|STARTED|Overall Study||30
11269759|NCT02318134|12465507|FG001|STARTED|Overall Study||30
11269760|NCT02318134|12465506|FG000|COMPLETED|Overall Study||28
11269761|NCT02318134|12465507|FG001|COMPLETED|Overall Study||29
11269762|NCT02318134|12465506|FG000|NOT COMPLETED|Overall Study||2
11269763|NCT02318134|12465507|FG001|NOT COMPLETED|Overall Study||1
11269764|NCT02318303|12465522|FG000|STARTED|Overall Study||159
11269765|NCT02318303|12465523|FG001|STARTED|Overall Study||158
11269766|NCT02318303|12465524|FG002|STARTED|Overall Study||160
11269767|NCT02318303|12465525|FG003|STARTED|Overall Study||158
11269768|NCT02318303|12465526|FG004|STARTED|Overall Study||157
11269769|NCT02318303|12465527|FG005|STARTED|Overall Study||159
11269770|NCT02318303|12465528|FG006|STARTED|Overall Study||160
11269771|NCT02318303|12465522|FG000|COMPLETED|Overall Study||155
11269772|NCT02318303|12465523|FG001|COMPLETED|Overall Study||155
11269773|NCT02318303|12465524|FG002|COMPLETED|Overall Study||157
11269774|NCT02318303|12465525|FG003|COMPLETED|Overall Study||155
11269775|NCT02318303|12465526|FG004|COMPLETED|Overall Study||152
11269776|NCT02318303|12465527|FG005|COMPLETED|Overall Study||153
11269777|NCT02318303|12465528|FG006|COMPLETED|Overall Study||158
11269778|NCT02318303|12465522|FG000|NOT COMPLETED|Overall Study||4
11269779|NCT02318303|12465523|FG001|NOT COMPLETED|Overall Study||3
11269780|NCT02318303|12465524|FG002|NOT COMPLETED|Overall Study||3
11269781|NCT02318303|12465525|FG003|NOT COMPLETED|Overall Study||3
11269782|NCT02318303|12465526|FG004|NOT COMPLETED|Overall Study||5
11269783|NCT02318303|12465527|FG005|NOT COMPLETED|Overall Study||6
11269784|NCT02318303|12465528|FG006|NOT COMPLETED|Overall Study||2
11269785|NCT02318368|12465546|FG000|STARTED|Overall Study||7
11269786|NCT02318368|12465547|FG001|STARTED|Overall Study||3
11269787|NCT02318368|12465546|FG000|COMPLETED|Overall Study||0
11269788|NCT02318368|12465547|FG001|COMPLETED|Overall Study||0
11269789|NCT02318368|12465546|FG000|NOT COMPLETED|Overall Study||7
11269790|NCT02318368|12465547|FG001|NOT COMPLETED|Overall Study||3
11269791|NCT02318550|12465553|FG000|STARTED|Overall Study||262
11269792|NCT02318550|12465553|FG000|COMPLETED|Overall Study||262
11269793|NCT02318550|12465553|FG000|NOT COMPLETED|Overall Study||0
11269794|NCT02318602|12465560|FG000|STARTED|Overall Study||9
11269795|NCT02318602|12465561|FG001|STARTED|Overall Study||26
11269796|NCT02318602|12465562|FG002|STARTED|Overall Study||17
11269797|NCT02318602|12465560|FG000|COMPLETED|Overall Study||8
11269798|NCT02318602|12465561|FG001|COMPLETED|Overall Study||22
11269799|NCT02318602|12465562|FG002|COMPLETED|Overall Study||15
11269800|NCT02318602|12465560|FG000|NOT COMPLETED|Overall Study||1
11269801|NCT02318602|12465561|FG001|NOT COMPLETED|Overall Study||4
11269802|NCT02318602|12465562|FG002|NOT COMPLETED|Overall Study||2
11269803|NCT02318667|12465576|FG000|STARTED|Overall Study||38
11269804|NCT02318667|12465576|FG000|COMPLETED|Overall Study||29
11269805|NCT02318667|12465576|FG000|NOT COMPLETED|Overall Study||9
11269806|NCT02318693|12465586|FG000|STARTED|Overall Study||26
11269807|NCT02318693|12465587|FG001|STARTED|Overall Study||27
11269808|NCT02318693|12465586|FG000|Treated|Overall Study||26
11269809|NCT02318693|12465587|FG001|Treated|Overall Study|1 randomized participant did not receive treatment.|26
11269810|NCT02318693|12465586|FG000|COMPLETED|Overall Study||26
11269811|NCT02318693|12465587|FG001|COMPLETED|Overall Study||26
11269812|NCT02318693|12465586|FG000|NOT COMPLETED|Overall Study||0
11269813|NCT02318693|12465587|FG001|NOT COMPLETED|Overall Study||1
11269814|NCT02318706|12465597|FG000|STARTED|Double-blind Phase||334
11269815|NCT02318706|12465598|FG001|STARTED|Double-blind Phase||166
11269816|NCT02318706|12465599|FG002|STARTED|Double-blind Phase||168
11269817|NCT02318706|12465600|FG003|STARTED|Double-blind Phase||166
11269818|NCT02318706|12465601|FG004|STARTED|Double-blind Phase||0
11269819|NCT02318706|12465597|FG000|COMPLETED|Double-blind Phase||309
11269820|NCT02318706|12465598|FG001|COMPLETED|Double-blind Phase||154
11269821|NCT02318706|12465599|FG002|COMPLETED|Double-blind Phase||150
11269822|NCT02318706|12465600|FG003|COMPLETED|Double-blind Phase||142
11269823|NCT02318706|12465601|FG004|COMPLETED|Double-blind Phase||0
11269824|NCT02318706|12465597|FG000|NOT COMPLETED|Double-blind Phase||25
11269825|NCT02318706|12465598|FG001|NOT COMPLETED|Double-blind Phase||12
11269826|NCT02318706|12465599|FG002|NOT COMPLETED|Double-blind Phase||18
11269827|NCT02318706|12465600|FG003|NOT COMPLETED|Double-blind Phase||24
11269828|NCT02318706|12465601|FG004|NOT COMPLETED|Double-blind Phase||0
11269829|NCT02318706|12465597|FG000|STARTED|Open-label Extension Phase||0
11269830|NCT02318706|12465598|FG001|STARTED|Open-label Extension Phase||0
11269831|NCT02318706|12465599|FG002|STARTED|Open-label Extension Phase||0
11269832|NCT02318706|12465600|FG003|STARTED|Open-label Extension Phase||0
11269833|NCT02318706|12465601|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|214
11269834|NCT02318706|12465597|FG000|COMPLETED|Open-label Extension Phase||0
11269835|NCT02318706|12465598|FG001|COMPLETED|Open-label Extension Phase||0
11269836|NCT02318706|12465599|FG002|COMPLETED|Open-label Extension Phase||0
11269837|NCT02318706|12465600|FG003|COMPLETED|Open-label Extension Phase||0
11269838|NCT02318706|12465601|FG004|COMPLETED|Open-label Extension Phase||172
11269839|NCT02318706|12465597|FG000|NOT COMPLETED|Open-label Extension Phase||0
11269840|NCT02318706|12465598|FG001|NOT COMPLETED|Open-label Extension Phase||0
11269841|NCT02318706|12465599|FG002|NOT COMPLETED|Open-label Extension Phase||0
11269842|NCT02318706|12465600|FG003|NOT COMPLETED|Open-label Extension Phase||0
11269843|NCT02318706|12465601|FG004|NOT COMPLETED|Open-label Extension Phase||42
11269844|NCT02318719|12465617|FG000|STARTED|Double-blind Phase||304
11269845|NCT02318719|12465618|FG001|STARTED|Double-blind Phase||153
11269846|NCT02318719|12465619|FG002|STARTED|Double-blind Phase||153
11269847|NCT02318719|12465620|FG003|STARTED|Double-blind Phase||155
11269848|NCT02318719|12465621|FG004|STARTED|Double-blind Phase||0
11269849|NCT02318719|12465617|FG000|Did Not Receive Treatment|Double-blind Phase||1
11269850|NCT02318719|12465618|FG001|Did Not Receive Treatment|Double-blind Phase||1
11269851|NCT02318719|12465619|FG002|Did Not Receive Treatment|Double-blind Phase||0
11269852|NCT02318719|12465620|FG003|Did Not Receive Treatment|Double-blind Phase||0
11269853|NCT02318719|12465621|FG004|Did Not Receive Treatment|Double-blind Phase||0
11269854|NCT02318719|12465617|FG000|COMPLETED|Double-blind Phase||266
11269855|NCT02318719|12465618|FG001|COMPLETED|Double-blind Phase||137
11269856|NCT02318719|12465619|FG002|COMPLETED|Double-blind Phase||128
11269857|NCT02318719|12465620|FG003|COMPLETED|Double-blind Phase||140
11269858|NCT02318719|12465621|FG004|COMPLETED|Double-blind Phase||0
11269859|NCT02318719|12465617|FG000|NOT COMPLETED|Double-blind Phase||38
11269860|NCT02318719|12465618|FG001|NOT COMPLETED|Double-blind Phase||16
11269861|NCT02318719|12465619|FG002|NOT COMPLETED|Double-blind Phase||25
11269862|NCT02318719|12465620|FG003|NOT COMPLETED|Double-blind Phase||15
11269863|NCT02318719|12465621|FG004|NOT COMPLETED|Double-blind Phase||0
11269864|NCT02318719|12465617|FG000|STARTED|Open-label Extension Phase||0
11269865|NCT02318719|12465618|FG001|STARTED|Open-label Extension Phase||0
11269866|NCT02318719|12465619|FG002|STARTED|Open-label Extension Phase||0
11269867|NCT02318719|12465620|FG003|STARTED|Open-label Extension Phase||0
11269868|NCT02318719|12465621|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|239
11269869|NCT02318719|12465617|FG000|COMPLETED|Open-label Extension Phase||0
11269870|NCT02318719|12465618|FG001|COMPLETED|Open-label Extension Phase||0
11269871|NCT02318719|12465619|FG002|COMPLETED|Open-label Extension Phase||0
11269872|NCT02318719|12465620|FG003|COMPLETED|Open-label Extension Phase||0
11269873|NCT02318719|12465621|FG004|COMPLETED|Open-label Extension Phase||184
11269874|NCT02318719|12465617|FG000|NOT COMPLETED|Open-label Extension Phase||0
11269875|NCT02318719|12465618|FG001|NOT COMPLETED|Open-label Extension Phase||0
11269876|NCT02318719|12465619|FG002|NOT COMPLETED|Open-label Extension Phase||0
11269877|NCT02318719|12465620|FG003|NOT COMPLETED|Open-label Extension Phase||0
11269878|NCT02318719|12465621|FG004|NOT COMPLETED|Open-label Extension Phase||55
11269879|NCT02318797|12465635|FG000|STARTED|Overall Study||516
11269880|NCT02318797|12465636|FG001|STARTED|Overall Study||713
11269881|NCT02318797|12465635|FG000|COMPLETED|Overall Study||428
11269882|NCT02318797|12465636|FG001|COMPLETED|Overall Study||611
11269883|NCT02318797|12465635|FG000|NOT COMPLETED|Overall Study||88
11269884|NCT02318797|12465636|FG001|NOT COMPLETED|Overall Study||102
11269885|NCT02318940|12465644|FG000|STARTED|Overall Study|in the last patient we lost the record.|50
11269886|NCT02318940|12465645|FG001|STARTED|Overall Study||50
11269887|NCT02318940|12465644|FG000|COMPLETED|Overall Study||49
11269888|NCT02318940|12465645|FG001|COMPLETED|Overall Study||50
11269889|NCT02318940|12465644|FG000|NOT COMPLETED|Overall Study||1
11269890|NCT02318940|12465645|FG001|NOT COMPLETED|Overall Study||0
11269891|NCT02318979|12465653|FG000|STARTED|Overall Study||15
11269892|NCT02318979|12465654|FG001|STARTED|Overall Study||15
11269893|NCT02318979|12465653|FG000|COMPLETED|Overall Study||15
11269894|NCT02318979|12465654|FG001|COMPLETED|Overall Study||15
11269895|NCT02318979|12465653|FG000|NOT COMPLETED|Overall Study||0
11269896|NCT02318979|12465654|FG001|NOT COMPLETED|Overall Study||0
11269897|NCT02318992|12465667|FG000|STARTED|Overall Study||27
11269898|NCT02318992|12465668|FG001|STARTED|Overall Study||27
11269899|NCT02318992|12465669|FG002|STARTED|Overall Study||24
11269900|NCT02318992|12465667|FG000|COMPLETED|Overall Study||25
11269901|NCT02318992|12465668|FG001|COMPLETED|Overall Study||25
11269902|NCT02318992|12465669|FG002|COMPLETED|Overall Study||20
11269903|NCT02318992|12465667|FG000|NOT COMPLETED|Overall Study||2
11269904|NCT02318992|12465668|FG001|NOT COMPLETED|Overall Study||2
11269905|NCT02318992|12465669|FG002|NOT COMPLETED|Overall Study||4
11269906|NCT02319031|12465679|FG000|STARTED|Treatment Period||24
11269907|NCT02319031|12465680|FG001|STARTED|Treatment Period||26
11269908|NCT02319031|12465679|FG000|COMPLETED|Treatment Period||23
11269909|NCT02319031|12465680|FG001|COMPLETED|Treatment Period||26
11269910|NCT02319031|12465679|FG000|NOT COMPLETED|Treatment Period||1
11397546|NCT04290494|12591689|FG002|COMPLETED|Overall Study||13397
11269911|NCT02319031|12465680|FG001|NOT COMPLETED|Treatment Period||0
11269912|NCT02319031|12465679|FG000|STARTED|Follow-Up Period||23
11269913|NCT02319031|12465680|FG001|STARTED|Follow-Up Period||26
11269914|NCT02319031|12465679|FG000|COMPLETED|Follow-Up Period||23
11269915|NCT02319031|12465680|FG001|COMPLETED|Follow-Up Period||26
11269916|NCT02319031|12465679|FG000|NOT COMPLETED|Follow-Up Period||0
11269917|NCT02319031|12465680|FG001|NOT COMPLETED|Follow-Up Period||0
11269918|NCT02319044|12465689|FG000|STARTED|Overall Study||133
11269919|NCT02319044|12465690|FG001|STARTED|Overall Study||67
11269920|NCT02319044|12465691|FG002|STARTED|Overall Study||67
11269921|NCT02319044|12465689|FG000|COMPLETED|Overall Study||11
11269922|NCT02319044|12465690|FG001|COMPLETED|Overall Study||7
11269923|NCT02319044|12465691|FG002|COMPLETED|Overall Study||0
11269924|NCT02319044|12465689|FG000|NOT COMPLETED|Overall Study||122
11269925|NCT02319044|12465690|FG001|NOT COMPLETED|Overall Study||60
11269926|NCT02319044|12465691|FG002|NOT COMPLETED|Overall Study||67
11269927|NCT02319148|12465703|FG000|STARTED|First Intervention Period||22
11269928|NCT02319148|12465704|FG001|STARTED|First Intervention Period||0
11269929|NCT02319148|12465705|FG002|STARTED|First Intervention Period||0
11269930|NCT02319148|12465706|FG003|STARTED|First Intervention Period||0
11269931|NCT02319148|12465703|FG000|COMPLETED|First Intervention Period||22
11269932|NCT02319148|12465704|FG001|COMPLETED|First Intervention Period||0
11269933|NCT02319148|12465705|FG002|COMPLETED|First Intervention Period||0
11269934|NCT02319148|12465706|FG003|COMPLETED|First Intervention Period||0
11269935|NCT02319148|12465703|FG000|NOT COMPLETED|First Intervention Period||0
11269936|NCT02319148|12465704|FG001|NOT COMPLETED|First Intervention Period||0
11269937|NCT02319148|12465705|FG002|NOT COMPLETED|First Intervention Period||0
11269938|NCT02319148|12465706|FG003|NOT COMPLETED|First Intervention Period||0
11269939|NCT02319148|12465703|FG000|STARTED|Washout Period 4 Days||22
11269940|NCT02319148|12465704|FG001|STARTED|Washout Period 4 Days||0
11269941|NCT02319148|12465705|FG002|STARTED|Washout Period 4 Days||0
11269942|NCT02319148|12465706|FG003|STARTED|Washout Period 4 Days||0
11269943|NCT02319148|12465703|FG000|COMPLETED|Washout Period 4 Days||22
11021604|NCT00805207|12199733|FG001|STARTED|Overall Study||9
11269944|NCT02319148|12465704|FG001|COMPLETED|Washout Period 4 Days||0
11269945|NCT02319148|12465705|FG002|COMPLETED|Washout Period 4 Days||0
11269946|NCT02319148|12465706|FG003|COMPLETED|Washout Period 4 Days||0
11269947|NCT02319148|12465703|FG000|NOT COMPLETED|Washout Period 4 Days||0
11269948|NCT02319148|12465704|FG001|NOT COMPLETED|Washout Period 4 Days||0
11269949|NCT02319148|12465705|FG002|NOT COMPLETED|Washout Period 4 Days||0
11269950|NCT02319148|12465706|FG003|NOT COMPLETED|Washout Period 4 Days||0
11269951|NCT02319148|12465703|FG000|STARTED|Second Intervention Period||0
11269952|NCT02319148|12465704|FG001|STARTED|Second Intervention Period||7
11269953|NCT02319148|12465705|FG002|STARTED|Second Intervention Period||7
11269954|NCT02319148|12465706|FG003|STARTED|Second Intervention Period||8
11269955|NCT02319148|12465703|FG000|COMPLETED|Second Intervention Period||0
11269956|NCT02319148|12465704|FG001|COMPLETED|Second Intervention Period||6
11269957|NCT02319148|12465705|FG002|COMPLETED|Second Intervention Period||6
11269958|NCT02319148|12465706|FG003|COMPLETED|Second Intervention Period||6
11269959|NCT02319148|12465703|FG000|NOT COMPLETED|Second Intervention Period||0
11269960|NCT02319148|12465704|FG001|NOT COMPLETED|Second Intervention Period||1
11269961|NCT02319148|12465705|FG002|NOT COMPLETED|Second Intervention Period||1
11269962|NCT02319148|12465706|FG003|NOT COMPLETED|Second Intervention Period||2
11269963|NCT02319174|12465725|FG000|STARTED|Overall Study||43
11269964|NCT02319174|12465725|FG000|COMPLETED|Overall Study||42
11269965|NCT02319174|12465725|FG000|NOT COMPLETED|Overall Study||1
11269966|NCT02319304|12465730|FG000|STARTED|Overall Study||3
11269967|NCT02319304|12465730|FG000|COMPLETED|Overall Study||2
11269968|NCT02319304|12465730|FG000|NOT COMPLETED|Overall Study||1
11269969|NCT02319317|12465736|FG000|STARTED|Overall Study||31
11021605|NCT00805207|12199734|FG002|STARTED|Overall Study||12
11021606|NCT00805207|12199735|FG003|STARTED|Overall Study||6
11021607|NCT00805207|12199736|FG004|STARTED|Overall Study||3
11269970|NCT02319317|12465737|FG001|STARTED|Overall Study||29
11269971|NCT02319317|12465736|FG000|COMPLETED|Overall Study||31
11269972|NCT02319317|12465737|FG001|COMPLETED|Overall Study||29
11269973|NCT02319317|12465736|FG000|NOT COMPLETED|Overall Study||0
11269974|NCT02319317|12465737|FG001|NOT COMPLETED|Overall Study||0
11397547|NCT04290494|12591687|FG000|NOT COMPLETED|Overall Study||0
11021608|NCT00805207|12199737|FG005|STARTED|Overall Study||12
11021609|NCT00805207|12199738|FG006|STARTED|Overall Study||6
11269975|NCT02319369|12465756|FG000|STARTED|Overall Study||7
11269976|NCT02319369|12465757|FG001|STARTED|Overall Study||6
11269977|NCT02319369|12465758|FG002|STARTED|Overall Study||11
11269978|NCT02319369|12465759|FG003|STARTED|Overall Study||8
11269979|NCT02319369|12465760|FG004|STARTED|Overall Study||5
11269980|NCT02319369|12465761|FG005|STARTED|Overall Study||7
11269981|NCT02319369|12465762|FG006|STARTED|Overall Study||3
11269982|NCT02319369|12465763|FG007|STARTED|Overall Study||6
11269983|NCT02319369|12465764|FG008|STARTED|Overall Study||4
11269984|NCT02319369|12465765|FG009|STARTED|Overall Study||9
11269985|NCT02319369|12465766|FG010|STARTED|Overall Study||3
11269986|NCT02319369|12465767|FG011|STARTED|Overall Study||4
11269987|NCT02319369|12465768|FG012|STARTED|Overall Study||1
11269988|NCT02319369|12465756|FG000|COMPLETED|Overall Study||7
11269989|NCT02319369|12465757|FG001|COMPLETED|Overall Study||6
11269990|NCT02319369|12465758|FG002|COMPLETED|Overall Study||11
11269991|NCT02319369|12465759|FG003|COMPLETED|Overall Study||8
11269992|NCT02319369|12465760|FG004|COMPLETED|Overall Study||5
11269993|NCT02319369|12465761|FG005|COMPLETED|Overall Study||7
11269994|NCT02319369|12465762|FG006|COMPLETED|Overall Study||3
11269995|NCT02319369|12465763|FG007|COMPLETED|Overall Study||6
11269996|NCT02319369|12465764|FG008|COMPLETED|Overall Study||4
11269997|NCT02319369|12465765|FG009|COMPLETED|Overall Study||9
11269998|NCT02319369|12465766|FG010|COMPLETED|Overall Study||3
11269999|NCT02319369|12465767|FG011|COMPLETED|Overall Study||4
11270000|NCT02319369|12465768|FG012|COMPLETED|Overall Study||1
11270001|NCT02319369|12465756|FG000|NOT COMPLETED|Overall Study||0
11270002|NCT02319369|12465757|FG001|NOT COMPLETED|Overall Study||0
11270003|NCT02319369|12465758|FG002|NOT COMPLETED|Overall Study||0
11270004|NCT02319369|12465759|FG003|NOT COMPLETED|Overall Study||0
11270005|NCT02319369|12465760|FG004|NOT COMPLETED|Overall Study||0
11270006|NCT02319369|12465761|FG005|NOT COMPLETED|Overall Study||0
11270007|NCT02319369|12465762|FG006|NOT COMPLETED|Overall Study||0
11270008|NCT02319369|12465763|FG007|NOT COMPLETED|Overall Study||0
11270009|NCT02319369|12465764|FG008|NOT COMPLETED|Overall Study||0
11270010|NCT02319369|12465765|FG009|NOT COMPLETED|Overall Study||0
11270011|NCT02319369|12465766|FG010|NOT COMPLETED|Overall Study||0
11270012|NCT02319369|12465767|FG011|NOT COMPLETED|Overall Study||0
11270013|NCT02319369|12465768|FG012|NOT COMPLETED|Overall Study||0
11270014|NCT02319486|12465806|FG000|STARTED|Overall Study||26
11397548|NCT04290494|12591688|FG001|NOT COMPLETED|Overall Study||0
11397549|NCT04290494|12591689|FG002|NOT COMPLETED|Overall Study||0
11397550|NCT04303156|12591699|FG000|STARTED|Overall Study||6
11397551|NCT04303156|12591700|FG001|STARTED|Overall Study||6
11397552|NCT04303156|12591699|FG000|COMPLETED|Overall Study||6
11397553|NCT04303156|12591700|FG001|COMPLETED|Overall Study||6
11397554|NCT04303156|12591699|FG000|NOT COMPLETED|Overall Study||0
11397555|NCT04303156|12591700|FG001|NOT COMPLETED|Overall Study||0
11397556|NCT04317040|12591709|FG000|STARTED|Overall Study||116
11397557|NCT04317040|12591710|FG001|STARTED|Overall Study||118
11397558|NCT04317040|12591709|FG000|Treated|Overall Study||114
11397559|NCT04317040|12591710|FG001|Treated|Overall Study||115
11397560|NCT04317040|12591709|FG000|COMPLETED|Overall Study||98
11397561|NCT04317040|12591710|FG001|COMPLETED|Overall Study||98
11397562|NCT04317040|12591709|FG000|NOT COMPLETED|Overall Study||18
11397563|NCT04317040|12591710|FG001|NOT COMPLETED|Overall Study||20
11397564|NCT04317313|12591718|FG000|STARTED|Overall Study||100
11397565|NCT04317313|12591719|FG001|STARTED|Overall Study||52
11397566|NCT04317313|12591718|FG000|COMPLETED|Overall Study||100
11397567|NCT04317313|12591719|FG001|COMPLETED|Overall Study||52
11397568|NCT04317313|12591718|FG000|NOT COMPLETED|Overall Study||0
11397569|NCT04317313|12591719|FG001|NOT COMPLETED|Overall Study||0
11270015|NCT02319486|12465806|FG000|COMPLETED|Overall Study||26
11270016|NCT02319486|12465806|FG000|NOT COMPLETED|Overall Study||0
11270017|NCT02319525|12465814|FG000|STARTED|Overall Study||153
11270018|NCT02319525|12465815|FG001|STARTED|Overall Study||148
11270019|NCT02319525|12465814|FG000|Primary Research Completion|Overall Study||151
11270020|NCT02319525|12465815|FG001|Primary Research Completion|Overall Study||147
11270021|NCT02319525|12465814|FG000|COMPLETED|Overall Study||151
11270022|NCT02319525|12465815|FG001|COMPLETED|Overall Study||147
11270023|NCT02319525|12465814|FG000|NOT COMPLETED|Overall Study||2
11270024|NCT02319525|12465815|FG001|NOT COMPLETED|Overall Study||1
11270025|NCT02319642|12465823|FG000|STARTED|Overall Study||95
11270026|NCT02319642|12465824|FG001|STARTED|Overall Study||251
11270027|NCT02319642|12465823|FG000|COMPLETED|Overall Study||91
11270028|NCT02319642|12465824|FG001|COMPLETED|Overall Study||245
11270029|NCT02319642|12465823|FG000|NOT COMPLETED|Overall Study||4
11270030|NCT02319642|12465824|FG001|NOT COMPLETED|Overall Study||6
11270031|NCT02319668|12465834|FG000|STARTED|Overall Study||19
11270032|NCT02319668|12465835|FG001|STARTED|Overall Study||19
11270033|NCT02319668|12465834|FG000|COMPLETED|Overall Study||19
11270034|NCT02319668|12465835|FG001|COMPLETED|Overall Study||17
11270035|NCT02319668|12465834|FG000|NOT COMPLETED|Overall Study||0
11270036|NCT02319668|12465835|FG001|NOT COMPLETED|Overall Study||2
11270037|NCT02319759|12465846|FG000|STARTED|Week 0 - 16||49
11270038|NCT02319759|12465847|FG001|STARTED|Week 0 - 16||0
11270039|NCT02319759|12465848|FG002|STARTED|Week 0 - 16||100
11270040|NCT02319759|12465849|FG003|STARTED|Week 0 - 16||0
11270041|NCT02319759|12465850|FG004|STARTED|Week 0 - 16||0
11270042|NCT02319759|12465846|FG000|COMPLETED|Week 0 - 16||48
11270043|NCT02319759|12465847|FG001|COMPLETED|Week 0 - 16||0
11270044|NCT02319759|12465848|FG002|COMPLETED|Week 0 - 16||99
11270045|NCT02319759|12465849|FG003|COMPLETED|Week 0 - 16||0
11270046|NCT02319759|12465850|FG004|COMPLETED|Week 0 - 16||0
11270047|NCT02319759|12465846|FG000|NOT COMPLETED|Week 0 - 16||1
11270048|NCT02319759|12465847|FG001|NOT COMPLETED|Week 0 - 16||0
11270049|NCT02319759|12465848|FG002|NOT COMPLETED|Week 0 - 16||1
11270050|NCT02319759|12465849|FG003|NOT COMPLETED|Week 0 - 16||0
11021610|NCT00805207|12199739|FG007|STARTED|Overall Study||6
11021611|NCT00805207|12199740|FG008|STARTED|Overall Study||6
11021612|NCT00805207|12199732|FG000|COMPLETED|Overall Study||1
11021613|NCT00805207|12199733|FG001|COMPLETED|Overall Study||7
11021614|NCT00805207|12199734|FG002|COMPLETED|Overall Study||11
11021615|NCT00805207|12199735|FG003|COMPLETED|Overall Study||6
11021616|NCT00805207|12199736|FG004|COMPLETED|Overall Study||2
11021617|NCT00805207|12199737|FG005|COMPLETED|Overall Study||9
11021618|NCT00805207|12199738|FG006|COMPLETED|Overall Study||6
11021619|NCT00805207|12199739|FG007|COMPLETED|Overall Study||6
11021620|NCT00805207|12199740|FG008|COMPLETED|Overall Study||6
11021621|NCT00805207|12199732|FG000|NOT COMPLETED|Overall Study||0
11270051|NCT02319759|12465850|FG004|NOT COMPLETED|Week 0 - 16||0
11270052|NCT02319759|12465846|FG000|STARTED|Week 16 - 24||31
11270053|NCT02319759|12465847|FG001|STARTED|Week 16 - 24||0
11021622|NCT00805207|12199733|FG001|NOT COMPLETED|Overall Study||2
11021623|NCT00805207|12199734|FG002|NOT COMPLETED|Overall Study||1
11021624|NCT00805207|12199735|FG003|NOT COMPLETED|Overall Study||0
11021625|NCT00805207|12199736|FG004|NOT COMPLETED|Overall Study||1
11021626|NCT00805207|12199737|FG005|NOT COMPLETED|Overall Study||3
11021627|NCT00805207|12199738|FG006|NOT COMPLETED|Overall Study||0
11021628|NCT00805207|12199739|FG007|NOT COMPLETED|Overall Study||0
11021629|NCT00805207|12199740|FG008|NOT COMPLETED|Overall Study||0
11021630|NCT00805285|12199764|FG000|STARTED|Overall Study||1
11270054|NCT02319759|12465848|FG002|STARTED|Week 16 - 24||89
11270055|NCT02319759|12465849|FG003|STARTED|Week 16 - 24||17
11270056|NCT02319759|12465850|FG004|STARTED|Week 16 - 24||10
11270057|NCT02319759|12465846|FG000|COMPLETED|Week 16 - 24||29
11270058|NCT02319759|12465847|FG001|COMPLETED|Week 16 - 24||0
11270059|NCT02319759|12465848|FG002|COMPLETED|Week 16 - 24||86
11270060|NCT02319759|12465849|FG003|COMPLETED|Week 16 - 24||17
11270061|NCT02319759|12465850|FG004|COMPLETED|Week 16 - 24||10
11270062|NCT02319759|12465846|FG000|NOT COMPLETED|Week 16 - 24||2
11270063|NCT02319759|12465847|FG001|NOT COMPLETED|Week 16 - 24||0
11270064|NCT02319759|12465848|FG002|NOT COMPLETED|Week 16 - 24||3
11270065|NCT02319759|12465849|FG003|NOT COMPLETED|Week 16 - 24||0
11270066|NCT02319759|12465850|FG004|NOT COMPLETED|Week 16 - 24||0
11270067|NCT02319759|12465846|FG000|STARTED|Week 24 - 56||0
11270068|NCT02319759|12465847|FG001|STARTED|Week 24 - 56||29
11270069|NCT02319759|12465848|FG002|STARTED|Week 24 - 56||86
11270070|NCT02319759|12465849|FG003|STARTED|Week 24 - 56||17
11397570|NCT04319159|12591727|FG000|STARTED|Overall Study||48
11397571|NCT04319159|12591727|FG000|COMPLETED|Overall Study||32
11397572|NCT04319159|12591727|FG000|NOT COMPLETED|Overall Study||16
11397573|NCT04321239|12591735|FG000|STARTED|Overall Study||25
11397574|NCT04321239|12591736|FG001|STARTED|Overall Study||26
11397575|NCT04321239|12591735|FG000|COMPLETED|Overall Study||22
11397576|NCT04321239|12591736|FG001|COMPLETED|Overall Study||24
11397577|NCT04321239|12591735|FG000|NOT COMPLETED|Overall Study||3
11397578|NCT04321239|12591736|FG001|NOT COMPLETED|Overall Study||2
11397579|NCT04323852|12591744|FG000|STARTED|Overall Study||35
11397580|NCT04323852|12591745|FG001|STARTED|Overall Study||35
11397581|NCT04323852|12591744|FG000|COMPLETED|Overall Study||35
11397582|NCT04323852|12591745|FG001|COMPLETED|Overall Study||35
11397583|NCT04323852|12591744|FG000|NOT COMPLETED|Overall Study||0
11397584|NCT04323852|12591745|FG001|NOT COMPLETED|Overall Study||0
11397585|NCT04327843|12591751|FG000|STARTED|Baseline Assessment||19
11397586|NCT04327843|12591751|FG000|COMPLETED|Baseline Assessment||19
11397587|NCT04327843|12591751|FG000|NOT COMPLETED|Baseline Assessment||0
11397588|NCT04327843|12591751|FG000|STARTED|Week 13 Assessment||19
11397589|NCT04327843|12591751|FG000|COMPLETED|Week 13 Assessment||19
11397590|NCT04327843|12591751|FG000|NOT COMPLETED|Week 13 Assessment||0
11397591|NCT04327843|12591751|FG000|STARTED|Week 25 Assessment||19
11397592|NCT04327843|12591751|FG000|COMPLETED|Week 25 Assessment||18
11397593|NCT04327843|12591751|FG000|NOT COMPLETED|Week 25 Assessment||1
11397594|NCT04331899|12591757|FG000|STARTED|Trial Period (28 Days)||60
11397595|NCT04331899|12591758|FG001|STARTED|Trial Period (28 Days)||60
11397596|NCT04331899|12591757|FG000|COMPLETED|Trial Period (28 Days)||58
11021631|NCT00805285|12199764|FG000|COMPLETED|Overall Study||0
11021632|NCT00805285|12199764|FG000|NOT COMPLETED|Overall Study||1
11021633|NCT00805389|12199773|FG000|STARTED|Overall Study||143
11021634|NCT00805389|12199774|FG001|STARTED|Overall Study||142
11397597|NCT04331899|12591758|FG001|COMPLETED|Trial Period (28 Days)||58
11397598|NCT04331899|12591757|FG000|NOT COMPLETED|Trial Period (28 Days)||2
11397599|NCT04331899|12591758|FG001|NOT COMPLETED|Trial Period (28 Days)||2
11397600|NCT04331899|12591757|FG000|STARTED|Follow-up Period (10 Months)|16 participants who completed the trial period did not continue in the follow-up period.|42
11397601|NCT04331899|12591758|FG001|STARTED|Follow-up Period (10 Months)|15 participants who completed the trial period did not continue in the follow-up period.|43
11397602|NCT04331899|12591757|FG000|COMPLETED|Follow-up Period (10 Months)||42
11270071|NCT02319759|12465850|FG004|STARTED|Week 24 - 56||10
11270072|NCT02319759|12465846|FG000|COMPLETED|Week 24 - 56||0
11270073|NCT02319759|12465847|FG001|COMPLETED|Week 24 - 56||28
11270074|NCT02319759|12465848|FG002|COMPLETED|Week 24 - 56||84
11270075|NCT02319759|12465849|FG003|COMPLETED|Week 24 - 56||15
11270076|NCT02319759|12465850|FG004|COMPLETED|Week 24 - 56||8
11270077|NCT02319759|12465846|FG000|NOT COMPLETED|Week 24 - 56||0
11270078|NCT02319759|12465847|FG001|NOT COMPLETED|Week 24 - 56||1
11270079|NCT02319759|12465848|FG002|NOT COMPLETED|Week 24 - 56||2
11270080|NCT02319759|12465849|FG003|NOT COMPLETED|Week 24 - 56||2
11270081|NCT02319759|12465850|FG004|NOT COMPLETED|Week 24 - 56||2
11270082|NCT02319824|12465863|FG000|STARTED|Overall Study||2
11270083|NCT02319824|12465863|FG000|COMPLETED|Overall Study||2
11270084|NCT02319824|12465863|FG000|NOT COMPLETED|Overall Study||0
11270085|NCT02319967|12465871|FG000|STARTED|Overall Study||126
11270086|NCT02319967|12465872|FG001|STARTED|Overall Study||126
11270087|NCT02319967|12465873|FG002|STARTED|Overall Study||121
11270088|NCT02319967|12465871|FG000|COMPLETED|Overall Study||78
11270089|NCT02319967|12465872|FG001|COMPLETED|Overall Study||82
11270090|NCT02319967|12465873|FG002|COMPLETED|Overall Study||76
11270091|NCT02319967|12465871|FG000|NOT COMPLETED|Overall Study||48
11270092|NCT02319967|12465872|FG001|NOT COMPLETED|Overall Study||44
11270093|NCT02319967|12465873|FG002|NOT COMPLETED|Overall Study||45
11270094|NCT02320058|12465883|FG000|STARTED|Overall Study||101
11270095|NCT02320058|12465884|FG001|STARTED|Overall Study||18
11021635|NCT00805389|12199775|FG002|STARTED|Overall Study||141
11021636|NCT00805389|12199776|FG003|STARTED|Overall Study||145
11270096|NCT02320058|12465883|FG000|COMPLETED|Overall Study||59
11270097|NCT02320058|12465884|FG001|COMPLETED|Overall Study||5
11270098|NCT02320058|12465883|FG000|NOT COMPLETED|Overall Study||42
11270099|NCT02320058|12465884|FG001|NOT COMPLETED|Overall Study||13
11270100|NCT02320123|12465892|FG000|STARTED|Overall Study||10
11270101|NCT02320123|12465893|FG001|STARTED|Overall Study||12
11270102|NCT02320123|12465892|FG000|COMPLETED|Overall Study||0
11270103|NCT02320123|12465893|FG001|COMPLETED|Overall Study||1
11270104|NCT02320123|12465892|FG000|NOT COMPLETED|Overall Study||10
11270105|NCT02320123|12465893|FG001|NOT COMPLETED|Overall Study||11
11270106|NCT02320149|12465905|FG000|STARTED|Overall Study||483
11270107|NCT02320149|12465906|FG001|STARTED|Overall Study||485
11270108|NCT02320149|12465905|FG000|COMPLETED|Overall Study||420
11270109|NCT02320149|12465906|FG001|COMPLETED|Overall Study||405
11270110|NCT02320149|12465905|FG000|NOT COMPLETED|Overall Study||63
11270111|NCT02320149|12465906|FG001|NOT COMPLETED|Overall Study||80
11270112|NCT02320175|12465914|FG000|STARTED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
11270113|NCT02320175|12465915|FG001|STARTED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
11270114|NCT02320175|12465914|FG000|COMPLETED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
11270115|NCT02320175|12465915|FG001|COMPLETED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
11270116|NCT02320175|12465914|FG000|NOT COMPLETED|Overall Study||0
11270117|NCT02320175|12465915|FG001|NOT COMPLETED|Overall Study||0
11270118|NCT02320214|12465924|FG000|STARTED|Overall Study||30
11270119|NCT02320214|12465924|FG000|COMPLETED|Overall Study||30
11270120|NCT02320214|12465924|FG000|NOT COMPLETED|Overall Study||0
11270121|NCT02320227|12465928|FG000|STARTED|Overall Study||30
11270122|NCT02320227|12465928|FG000|COMPLETED|Overall Study||30
11270123|NCT02320227|12465928|FG000|NOT COMPLETED|Overall Study||0
11270124|NCT02320253|12465936|FG000|STARTED|Overall Study||69
11270125|NCT02320253|12465937|FG001|STARTED|Overall Study||70
11270126|NCT02320253|12465938|FG002|STARTED|Overall Study||72
11270127|NCT02320253|12465936|FG000|COMPLETED|Overall Study||63
11270128|NCT02320253|12465937|FG001|COMPLETED|Overall Study||68
11270129|NCT02320253|12465938|FG002|COMPLETED|Overall Study||70
11270130|NCT02320253|12465936|FG000|NOT COMPLETED|Overall Study||6
11270131|NCT02320253|12465937|FG001|NOT COMPLETED|Overall Study||2
11270132|NCT02320253|12465938|FG002|NOT COMPLETED|Overall Study||2
11270133|NCT02320487|12465946|FG000|STARTED|Overall Study||102
11270134|NCT02320487|12465946|FG000|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
11270135|NCT02320487|12465946|FG000|NOT COMPLETED|Overall Study||21
11270136|NCT02320695|12465950|FG000|STARTED|Overall Study||60
11270137|NCT02320695|12465950|FG000|Saline|Overall Study||60
11270138|NCT02320695|12465950|FG000|Alcohol|Overall Study||60
11270139|NCT02320695|12465950|FG000|Pain Relieving Cream|Overall Study||59
11270140|NCT02320695|12465950|FG000|Antibiotic/Pain Relieving Ointment|Overall Study||60
11270141|NCT02320695|12465950|FG000|Original Ointment|Overall Study||60
11270142|NCT02320695|12465950|FG000|Pain Relief Ointment|Overall Study||60
11270143|NCT02320695|12465950|FG000|COMPLETED|Overall Study||60
11270144|NCT02320695|12465950|FG000|NOT COMPLETED|Overall Study||0
11270145|NCT02320721|12465961|FG000|STARTED|Overall Study||508
11270146|NCT02320721|12465962|FG001|STARTED|Overall Study||506
11270147|NCT02320721|12465961|FG000|Treated (Safety Population)|Overall Study||508
11270148|NCT02320721|12465962|FG001|Treated (Safety Population)|Overall Study||505
11270149|NCT02320721|12465961|FG000|COMPLETED|Overall Study||481
11270150|NCT02320721|12465962|FG001|COMPLETED|Overall Study||472
11270151|NCT02320721|12465961|FG000|NOT COMPLETED|Overall Study||27
11270152|NCT02320721|12465962|FG001|NOT COMPLETED|Overall Study||34
11270153|NCT02320812|12465968|FG000|STARTED|Overall Study||28
11270154|NCT02320812|12465968|FG000|COMPLETED|Overall Study||28
11270155|NCT02320812|12465968|FG000|NOT COMPLETED|Overall Study||0
11270156|NCT02320838|12465976|FG000|STARTED|First Intervention (1 Day)||8
11270157|NCT02320838|12465977|FG001|STARTED|First Intervention (1 Day)||8
11270158|NCT02320838|12465978|FG002|STARTED|First Intervention (1 Day)||8
11270159|NCT02320838|12465979|FG003|STARTED|First Intervention (1 Day)||7
11397603|NCT04331899|12591758|FG001|COMPLETED|Follow-up Period (10 Months)||43
11270160|NCT02320838|12465980|FG004|STARTED|First Intervention (1 Day)||7
11270161|NCT02320838|12465976|FG000|COMPLETED|First Intervention (1 Day)||8
11270162|NCT02320838|12465977|FG001|COMPLETED|First Intervention (1 Day)||8
11270163|NCT02320838|12465978|FG002|COMPLETED|First Intervention (1 Day)||8
11270164|NCT02320838|12465979|FG003|COMPLETED|First Intervention (1 Day)||7
11270165|NCT02320838|12465980|FG004|COMPLETED|First Intervention (1 Day)||7
11270166|NCT02320838|12465976|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11270167|NCT02320838|12465977|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11270168|NCT02320838|12465978|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11270169|NCT02320838|12465979|FG003|NOT COMPLETED|First Intervention (1 Day)||0
11270170|NCT02320838|12465980|FG004|NOT COMPLETED|First Intervention (1 Day)||0
11270171|NCT02320838|12465976|FG000|STARTED|Washout (1 Day)||8
11270172|NCT02320838|12465977|FG001|STARTED|Washout (1 Day)||8
11270173|NCT02320838|12465978|FG002|STARTED|Washout (1 Day)||8
11270174|NCT02320838|12465979|FG003|STARTED|Washout (1 Day)||7
11270175|NCT02320838|12465980|FG004|STARTED|Washout (1 Day)||7
11270176|NCT02320838|12465976|FG000|COMPLETED|Washout (1 Day)||8
11270177|NCT02320838|12465977|FG001|COMPLETED|Washout (1 Day)||8
11270178|NCT02320838|12465978|FG002|COMPLETED|Washout (1 Day)||8
11270179|NCT02320838|12465979|FG003|COMPLETED|Washout (1 Day)||7
11270180|NCT02320838|12465980|FG004|COMPLETED|Washout (1 Day)||7
11270181|NCT02320838|12465976|FG000|NOT COMPLETED|Washout (1 Day)||0
11270182|NCT02320838|12465977|FG001|NOT COMPLETED|Washout (1 Day)||0
11270183|NCT02320838|12465978|FG002|NOT COMPLETED|Washout (1 Day)||0
11270184|NCT02320838|12465979|FG003|NOT COMPLETED|Washout (1 Day)||0
11270185|NCT02320838|12465980|FG004|NOT COMPLETED|Washout (1 Day)||0
11270186|NCT02320838|12465976|FG000|STARTED|Second Intervention (1 Day)||8
11270187|NCT02320838|12465977|FG001|STARTED|Second Intervention (1 Day)||8
11270188|NCT02320838|12465978|FG002|STARTED|Second Intervention (1 Day)||8
11270189|NCT02320838|12465979|FG003|STARTED|Second Intervention (1 Day)||7
11270190|NCT02320838|12465980|FG004|STARTED|Second Intervention (1 Day)||7
11270191|NCT02320838|12465976|FG000|COMPLETED|Second Intervention (1 Day)||8
11270192|NCT02320838|12465977|FG001|COMPLETED|Second Intervention (1 Day)||8
11270193|NCT02320838|12465978|FG002|COMPLETED|Second Intervention (1 Day)||8
11270194|NCT02320838|12465979|FG003|COMPLETED|Second Intervention (1 Day)||7
11270195|NCT02320838|12465980|FG004|COMPLETED|Second Intervention (1 Day)||7
11270196|NCT02320838|12465976|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11270197|NCT02320838|12465977|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11270198|NCT02320838|12465978|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11270199|NCT02320838|12465979|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
11270200|NCT02320838|12465980|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
11270201|NCT02320838|12465976|FG000|STARTED|Washout (1 Day)||8
11270202|NCT02320838|12465977|FG001|STARTED|Washout (1 Day)||8
11270203|NCT02320838|12465978|FG002|STARTED|Washout (1 Day)||8
11270204|NCT02320838|12465979|FG003|STARTED|Washout (1 Day)||7
11270205|NCT02320838|12465980|FG004|STARTED|Washout (1 Day)||7
11270206|NCT02320838|12465976|FG000|COMPLETED|Washout (1 Day)||8
11270207|NCT02320838|12465977|FG001|COMPLETED|Washout (1 Day)||8
11270208|NCT02320838|12465978|FG002|COMPLETED|Washout (1 Day)||8
11270209|NCT02320838|12465979|FG003|COMPLETED|Washout (1 Day)||7
11270210|NCT02320838|12465980|FG004|COMPLETED|Washout (1 Day)||7
11270211|NCT02320838|12465976|FG000|NOT COMPLETED|Washout (1 Day)||0
11270212|NCT02320838|12465977|FG001|NOT COMPLETED|Washout (1 Day)||0
11270213|NCT02320838|12465978|FG002|NOT COMPLETED|Washout (1 Day)||0
11270214|NCT02320838|12465979|FG003|NOT COMPLETED|Washout (1 Day)||0
11270215|NCT02320838|12465980|FG004|NOT COMPLETED|Washout (1 Day)||0
11270216|NCT02320838|12465976|FG000|STARTED|Third Intervention (1 Day)||8
11270217|NCT02320838|12465977|FG001|STARTED|Third Intervention (1 Day)||8
11270218|NCT02320838|12465978|FG002|STARTED|Third Intervention (1 Day)||8
11270219|NCT02320838|12465979|FG003|STARTED|Third Intervention (1 Day)||7
11270220|NCT02320838|12465980|FG004|STARTED|Third Intervention (1 Day)||7
11270221|NCT02320838|12465976|FG000|COMPLETED|Third Intervention (1 Day)||8
11270222|NCT02320838|12465977|FG001|COMPLETED|Third Intervention (1 Day)||8
11270223|NCT02320838|12465978|FG002|COMPLETED|Third Intervention (1 Day)||8
11270224|NCT02320838|12465979|FG003|COMPLETED|Third Intervention (1 Day)||7
11270225|NCT02320838|12465980|FG004|COMPLETED|Third Intervention (1 Day)||7
11270226|NCT02320838|12465976|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11270227|NCT02320838|12465977|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11270228|NCT02320838|12465978|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
11270229|NCT02320838|12465979|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
11270230|NCT02320838|12465980|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
11270231|NCT02320903|12465991|FG000|STARTED|Overall Study||24
11397604|NCT04331899|12591757|FG000|NOT COMPLETED|Follow-up Period (10 Months)||0
11270232|NCT02320903|12465992|FG001|STARTED|Overall Study||32
11270233|NCT02320903|12465993|FG002|STARTED|Overall Study||32
11270234|NCT02320903|12465991|FG000|COMPLETED|Overall Study||16
11270235|NCT02320903|12465992|FG001|COMPLETED|Overall Study||16
11270236|NCT02320903|12465993|FG002|COMPLETED|Overall Study||16
11270237|NCT02320903|12465991|FG000|NOT COMPLETED|Overall Study||8
11270238|NCT02320903|12465992|FG001|NOT COMPLETED|Overall Study||16
11270239|NCT02320903|12465993|FG002|NOT COMPLETED|Overall Study||16
11270240|NCT02321098|12466005|FG000|STARTED|12 Weeks Treament||26
11270241|NCT02321098|12466006|FG001|STARTED|12 Weeks Treament||24
11270242|NCT02321098|12466007|FG002|STARTED|12 Weeks Treament||0
11270243|NCT02321098|12466005|FG000|COMPLETED|12 Weeks Treament||25
11270244|NCT02321098|12466006|FG001|COMPLETED|12 Weeks Treament||23
11270245|NCT02321098|12466007|FG002|COMPLETED|12 Weeks Treament||0
11270246|NCT02321098|12466005|FG000|NOT COMPLETED|12 Weeks Treament||1
11270247|NCT02321098|12466006|FG001|NOT COMPLETED|12 Weeks Treament||1
11270248|NCT02321098|12466007|FG002|NOT COMPLETED|12 Weeks Treament||0
11270249|NCT02321098|12466005|FG000|STARTED|Additional 15 Months Treatment||0
11270250|NCT02321098|12466006|FG001|STARTED|Additional 15 Months Treatment||0
11270251|NCT02321098|12466007|FG002|STARTED|Additional 15 Months Treatment||29
11270252|NCT02321098|12466005|FG000|COMPLETED|Additional 15 Months Treatment||0
11270253|NCT02321098|12466006|FG001|COMPLETED|Additional 15 Months Treatment||0
11270254|NCT02321098|12466007|FG002|COMPLETED|Additional 15 Months Treatment||21
11270255|NCT02321098|12466005|FG000|NOT COMPLETED|Additional 15 Months Treatment||0
11270256|NCT02321098|12466006|FG001|NOT COMPLETED|Additional 15 Months Treatment||0
11270257|NCT02321098|12466007|FG002|NOT COMPLETED|Additional 15 Months Treatment||8
11270258|NCT02321111|12466016|FG000|STARTED|Infusion1||1
11270259|NCT02321111|12466017|FG001|STARTED|Infusion1||4
11270260|NCT02321111|12466018|FG002|STARTED|Infusion1||4
11270261|NCT02321111|12466019|FG003|STARTED|Infusion1||1
11270262|NCT02321111|12466020|FG004|STARTED|Infusion1||0
11270263|NCT02321111|12466021|FG005|STARTED|Infusion1||0
11270264|NCT02321111|12466016|FG000|COMPLETED|Infusion1||1
11270265|NCT02321111|12466017|FG001|COMPLETED|Infusion1||4
11270266|NCT02321111|12466018|FG002|COMPLETED|Infusion1||4
11270267|NCT02321111|12466019|FG003|COMPLETED|Infusion1||1
11270268|NCT02321111|12466020|FG004|COMPLETED|Infusion1||0
11270269|NCT02321111|12466021|FG005|COMPLETED|Infusion1||0
11270270|NCT02321111|12466016|FG000|NOT COMPLETED|Infusion1||0
11270271|NCT02321111|12466017|FG001|NOT COMPLETED|Infusion1||0
11270272|NCT02321111|12466018|FG002|NOT COMPLETED|Infusion1||0
11270273|NCT02321111|12466019|FG003|NOT COMPLETED|Infusion1||0
11270274|NCT02321111|12466020|FG004|NOT COMPLETED|Infusion1||0
11270275|NCT02321111|12466021|FG005|NOT COMPLETED|Infusion1||0
11270276|NCT02321111|12466016|FG000|STARTED|Washout1 (3-4weeks Between Infusions)||1
11270277|NCT02321111|12466017|FG001|STARTED|Washout1 (3-4weeks Between Infusions)||4
11270278|NCT02321111|12466018|FG002|STARTED|Washout1 (3-4weeks Between Infusions)||4
11270279|NCT02321111|12466019|FG003|STARTED|Washout1 (3-4weeks Between Infusions)||1
11397605|NCT04331899|12591758|FG001|NOT COMPLETED|Follow-up Period (10 Months)||0
11397606|NCT04334148|12591766|FG000|STARTED|Overall Study||683
11397607|NCT04334148|12591767|FG001|STARTED|Overall Study||677
11397608|NCT04334148|12591766|FG000|COMPLETED|Overall Study||683
11397609|NCT04334148|12591767|FG001|COMPLETED|Overall Study||676
11397610|NCT04334148|12591766|FG000|NOT COMPLETED|Overall Study||0
11397611|NCT04334148|12591767|FG001|NOT COMPLETED|Overall Study||1
11397612|NCT04343287|12591775|FG000|STARTED|Overall Study||108
11397613|NCT04343287|12591776|FG001|STARTED|Overall Study||112
11270280|NCT02321111|12466020|FG004|STARTED|Washout1 (3-4weeks Between Infusions)||0
11270281|NCT02321111|12466021|FG005|STARTED|Washout1 (3-4weeks Between Infusions)||0
11270282|NCT02321111|12466016|FG000|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
11270283|NCT02321111|12466017|FG001|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
11270284|NCT02321111|12466018|FG002|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
11270285|NCT02321111|12466019|FG003|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
11270286|NCT02321111|12466020|FG004|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
11270287|NCT02321111|12466021|FG005|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
11270288|NCT02321111|12466016|FG000|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
11270289|NCT02321111|12466017|FG001|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
11270290|NCT02321111|12466018|FG002|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
11270291|NCT02321111|12466019|FG003|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
11270292|NCT02321111|12466020|FG004|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
11270293|NCT02321111|12466021|FG005|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
11270294|NCT02321111|12466016|FG000|STARTED|Infusion2||1
11270295|NCT02321111|12466017|FG001|STARTED|Infusion2||4
11270296|NCT02321111|12466018|FG002|STARTED|Infusion2||4
11270297|NCT02321111|12466019|FG003|STARTED|Infusion2||1
11270298|NCT02321111|12466020|FG004|STARTED|Infusion2||0
11270299|NCT02321111|12466021|FG005|STARTED|Infusion2||0
11270300|NCT02321111|12466016|FG000|COMPLETED|Infusion2||1
11270301|NCT02321111|12466017|FG001|COMPLETED|Infusion2||4
11270302|NCT02321111|12466018|FG002|COMPLETED|Infusion2||4
11270303|NCT02321111|12466019|FG003|COMPLETED|Infusion2||1
11270304|NCT02321111|12466020|FG004|COMPLETED|Infusion2||0
11270305|NCT02321111|12466021|FG005|COMPLETED|Infusion2||0
11397614|NCT04343287|12591775|FG000|COMPLETED|Overall Study||108
11397615|NCT04343287|12591776|FG001|COMPLETED|Overall Study||111
11270306|NCT02321111|12466016|FG000|NOT COMPLETED|Infusion2||0
11270307|NCT02321111|12466017|FG001|NOT COMPLETED|Infusion2||0
11270308|NCT02321111|12466018|FG002|NOT COMPLETED|Infusion2||0
11270309|NCT02321111|12466019|FG003|NOT COMPLETED|Infusion2||0
11270310|NCT02321111|12466020|FG004|NOT COMPLETED|Infusion2||0
11270311|NCT02321111|12466021|FG005|NOT COMPLETED|Infusion2||0
11270312|NCT02321111|12466016|FG000|STARTED|Washout2 (3-4weeks Between Infusions)||1
11397616|NCT04343287|12591775|FG000|NOT COMPLETED|Overall Study||0
11270313|NCT02321111|12466017|FG001|STARTED|Washout2 (3-4weeks Between Infusions)||4
11270314|NCT02321111|12466018|FG002|STARTED|Washout2 (3-4weeks Between Infusions)||4
11270315|NCT02321111|12466019|FG003|STARTED|Washout2 (3-4weeks Between Infusions)||1
11270316|NCT02321111|12466020|FG004|STARTED|Washout2 (3-4weeks Between Infusions)||0
11270317|NCT02321111|12466021|FG005|STARTED|Washout2 (3-4weeks Between Infusions)||0
11270318|NCT02321111|12466016|FG000|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
11270319|NCT02321111|12466017|FG001|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
11270320|NCT02321111|12466018|FG002|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
11270321|NCT02321111|12466019|FG003|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
11270322|NCT02321111|12466020|FG004|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
11270323|NCT02321111|12466021|FG005|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
11270324|NCT02321111|12466016|FG000|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
11270325|NCT02321111|12466017|FG001|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
11270326|NCT02321111|12466018|FG002|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
11270327|NCT02321111|12466019|FG003|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
11270328|NCT02321111|12466020|FG004|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
11270329|NCT02321111|12466021|FG005|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
11270330|NCT02321111|12466016|FG000|STARTED|Infusion3||1
11270331|NCT02321111|12466017|FG001|STARTED|Infusion3||4
11270332|NCT02321111|12466018|FG002|STARTED|Infusion3||4
11270333|NCT02321111|12466019|FG003|STARTED|Infusion3||1
11270334|NCT02321111|12466020|FG004|STARTED|Infusion3||0
11270335|NCT02321111|12466021|FG005|STARTED|Infusion3||0
11270336|NCT02321111|12466016|FG000|COMPLETED|Infusion3||1
11270337|NCT02321111|12466017|FG001|COMPLETED|Infusion3||4
11270338|NCT02321111|12466018|FG002|COMPLETED|Infusion3||4
11270339|NCT02321111|12466019|FG003|COMPLETED|Infusion3||1
11270340|NCT02321111|12466020|FG004|COMPLETED|Infusion3||0
11397617|NCT04343287|12591776|FG001|NOT COMPLETED|Overall Study||1
11270341|NCT02321111|12466021|FG005|COMPLETED|Infusion3||0
11270342|NCT02321111|12466016|FG000|NOT COMPLETED|Infusion3||0
11270343|NCT02321111|12466017|FG001|NOT COMPLETED|Infusion3||0
11270344|NCT02321111|12466018|FG002|NOT COMPLETED|Infusion3||0
11270345|NCT02321111|12466019|FG003|NOT COMPLETED|Infusion3||0
11270346|NCT02321111|12466020|FG004|NOT COMPLETED|Infusion3||0
11270347|NCT02321111|12466021|FG005|NOT COMPLETED|Infusion3||0
11270348|NCT02321319|12466029|FG000|STARTED|Overall Study||5
11270349|NCT02321319|12466029|FG000|COMPLETED|Overall Study||0
11270350|NCT02321319|12466029|FG000|NOT COMPLETED|Overall Study||5
11270351|NCT02321462|12466035|FG000|STARTED|Overall Study||147
11270352|NCT02321462|12466036|FG001|STARTED|Overall Study||149
11270353|NCT02321462|12466035|FG000|ITT Population|Overall Study||146
11270354|NCT02321462|12466036|FG001|ITT Population|Overall Study||148
11270355|NCT02321462|12466035|FG000|Treated Patients|Overall Study||147
11270356|NCT02321462|12466036|FG001|Treated Patients|Overall Study||147
11270357|NCT02321462|12466035|FG000|Safety Population|Overall Study||147
11270358|NCT02321462|12466036|FG001|Safety Population|Overall Study||147
11270359|NCT02321462|12466035|FG000|COMPLETED|Overall Study||141
11270360|NCT02321462|12466036|FG001|COMPLETED|Overall Study||146
11270361|NCT02321462|12466035|FG000|NOT COMPLETED|Overall Study||6
11270362|NCT02321462|12466036|FG001|NOT COMPLETED|Overall Study||3
11270363|NCT02321527|12466043|FG000|STARTED|Overall Study||21
11270364|NCT02321527|12466043|FG000|COMPLETED|Overall Study||20
11270365|NCT02321527|12466043|FG000|NOT COMPLETED|Overall Study||1
11270366|NCT02321748|12466049|FG000|STARTED|Overall Study||12
11270367|NCT02321748|12466050|FG001|STARTED|Overall Study||12
11270368|NCT02321748|12466049|FG000|First Intervention (4 Days)|Overall Study||12
11270369|NCT02321748|12466050|FG001|First Intervention (4 Days)|Overall Study||12
11270370|NCT02321748|12466049|FG000|Wasout (2weeks)|Overall Study||12
11270371|NCT02321748|12466050|FG001|Wasout (2weeks)|Overall Study||12
11270372|NCT02321748|12466049|FG000|Second Intervention (4 Days)|Overall Study||12
11270373|NCT02321748|12466050|FG001|Second Intervention (4 Days)|Overall Study||12
11270374|NCT02321748|12466049|FG000|COMPLETED|Overall Study||12
11270375|NCT02321748|12466050|FG001|COMPLETED|Overall Study||12
11270376|NCT02321748|12466049|FG000|NOT COMPLETED|Overall Study||0
11270377|NCT02321748|12466050|FG001|NOT COMPLETED|Overall Study||0
11270378|NCT02321800|12466061|FG000|STARTED|Overall Study||303
11270379|NCT02321800|12466062|FG001|STARTED|Overall Study||149
11270380|NCT02321800|12466061|FG000|Received Study Drug|Overall Study||300
11270381|NCT02321800|12466062|FG001|Received Study Drug|Overall Study||148
11270382|NCT02321800|12466061|FG000|COMPLETED|Overall Study||283
11270383|NCT02321800|12466062|FG001|COMPLETED|Overall Study||138
11270384|NCT02321800|12466061|FG000|NOT COMPLETED|Overall Study||20
11270385|NCT02321800|12466062|FG001|NOT COMPLETED|Overall Study||11
11270386|NCT02321930|12466068|FG000|STARTED|Overall Study||25
11270387|NCT02321930|12466068|FG000|COMPLETED|Overall Study||24
11270388|NCT02321930|12466068|FG000|NOT COMPLETED|Overall Study||1
11270389|NCT02322021|12466076|FG000|STARTED|Core Phase||17
11270390|NCT02322021|12466077|FG001|STARTED|Core Phase||17
11270391|NCT02322021|12466078|FG002|STARTED|Core Phase||19
11270392|NCT02322021|12466079|FG003|STARTED|Core Phase||17
11270393|NCT02322021|12466080|FG004|STARTED|Core Phase||0
11270394|NCT02322021|12466076|FG000|COMPLETED|Core Phase||12
11270395|NCT02322021|12466077|FG001|COMPLETED|Core Phase||9
11270396|NCT02322021|12466078|FG002|COMPLETED|Core Phase||10
11270397|NCT02322021|12466079|FG003|COMPLETED|Core Phase||12
11270398|NCT02322021|12466080|FG004|COMPLETED|Core Phase||0
11270399|NCT02322021|12466076|FG000|NOT COMPLETED|Core Phase||5
11270400|NCT02322021|12466077|FG001|NOT COMPLETED|Core Phase||8
11397618|NCT04347954|12591787|FG000|STARTED|Overall Study||15
11397619|NCT04347954|12591788|FG001|STARTED|Overall Study||15
11397620|NCT04347954|12591789|FG002|STARTED|Overall Study||17
11397621|NCT04347954|12591787|FG000|Received Allocated Intervention|Overall Study||12
11397622|NCT04347954|12591788|FG001|Received Allocated Intervention|Overall Study||15
11270401|NCT02322021|12466078|FG002|NOT COMPLETED|Core Phase||9
11270402|NCT02322021|12466079|FG003|NOT COMPLETED|Core Phase||5
11270403|NCT02322021|12466080|FG004|NOT COMPLETED|Core Phase||0
11270404|NCT02322021|12466076|FG000|STARTED|Extension Phase||0
11270405|NCT02322021|12466077|FG001|STARTED|Extension Phase||0
11270406|NCT02322021|12466078|FG002|STARTED|Extension Phase||0
11270407|NCT02322021|12466079|FG003|STARTED|Extension Phase||0
11270408|NCT02322021|12466080|FG004|STARTED|Extension Phase|Participants who completed Core Phase, were eligible and gave consent, entered Extension Phase.|41
11270409|NCT02322021|12466076|FG000|COMPLETED|Extension Phase||0
11270410|NCT02322021|12466077|FG001|COMPLETED|Extension Phase||0
11270411|NCT02322021|12466078|FG002|COMPLETED|Extension Phase||0
11270412|NCT02322021|12466079|FG003|COMPLETED|Extension Phase||0
11270413|NCT02322021|12466080|FG004|COMPLETED|Extension Phase||0
11270414|NCT02322021|12466076|FG000|NOT COMPLETED|Extension Phase||0
11270415|NCT02322021|12466077|FG001|NOT COMPLETED|Extension Phase||0
11270416|NCT02322021|12466078|FG002|NOT COMPLETED|Extension Phase||0
11270417|NCT02322021|12466079|FG003|NOT COMPLETED|Extension Phase||0
11270418|NCT02322021|12466080|FG004|NOT COMPLETED|Extension Phase||41
11270419|NCT02322047|12466099|FG000|STARTED|Overall Study||8
11270420|NCT02322047|12466100|FG001|STARTED|Overall Study||7
11270421|NCT02322047|12466101|FG002|STARTED|Overall Study||7
11270422|NCT02322047|12466102|FG003|STARTED|Overall Study||9
11270423|NCT02322047|12466099|FG000|COMPLETED|Overall Study||6
11270424|NCT02322047|12466100|FG001|COMPLETED|Overall Study||6
11270425|NCT02322047|12466101|FG002|COMPLETED|Overall Study||6
11270426|NCT02322047|12466102|FG003|COMPLETED|Overall Study||7
11270427|NCT02322047|12466099|FG000|NOT COMPLETED|Overall Study||2
11270428|NCT02322047|12466100|FG001|NOT COMPLETED|Overall Study||1
11270429|NCT02322047|12466101|FG002|NOT COMPLETED|Overall Study||1
11270430|NCT02322047|12466102|FG003|NOT COMPLETED|Overall Study||2
11270431|NCT02322125|12466112|FG000|STARTED|Overall Study||12
11270432|NCT02322125|12466112|FG000|COMPLETED|Overall Study||10
11270433|NCT02322125|12466112|FG000|NOT COMPLETED|Overall Study||2
11270434|NCT02322190|12466116|FG000|STARTED|Overall Study||5
11270435|NCT02322190|12466117|FG001|STARTED|Overall Study||0
11270436|NCT02322190|12466116|FG000|COMPLETED|Overall Study||4
11270437|NCT02322190|12466117|FG001|COMPLETED|Overall Study||0
11270438|NCT02322190|12466116|FG000|NOT COMPLETED|Overall Study||1
11270439|NCT02322190|12466117|FG001|NOT COMPLETED|Overall Study||0
11270440|NCT02322216|12466124|FG000|STARTED|Overall Study||126
11270441|NCT02322216|12466125|FG001|STARTED|Overall Study||127
11270442|NCT02322216|12466124|FG000|Treated (Safety Set)|Overall Study||126
11270443|NCT02322216|12466125|FG001|Treated (Safety Set)|Overall Study||126
11270444|NCT02322216|12466124|FG000|Per Protocol Set (PPS)|Overall Study||123
11270445|NCT02322216|12466125|FG001|Per Protocol Set (PPS)|Overall Study||122
11270446|NCT02322216|12466124|FG000|COMPLETED|Overall Study||124
11270447|NCT02322216|12466125|FG001|COMPLETED|Overall Study||123
11270448|NCT02322216|12466124|FG000|NOT COMPLETED|Overall Study||2
11270449|NCT02322216|12466125|FG001|NOT COMPLETED|Overall Study||4
11270450|NCT02322229|12466132|FG000|STARTED|Overall Study||52
11270451|NCT02322229|12466132|FG000|COMPLETED|Overall Study||50
11270452|NCT02322229|12466132|FG000|NOT COMPLETED|Overall Study||2
11270453|NCT02322242|12466139|FG000|STARTED|Overall Study||92
11270454|NCT02322242|12466140|FG001|STARTED|Overall Study||90
11270455|NCT02322242|12466139|FG000|Primary Outcome|Overall Study||92
11270456|NCT02322242|12466140|FG001|Primary Outcome|Overall Study||90
11270457|NCT02322242|12466139|FG000|1 Week Follow-up|Overall Study|2 lost to follow-up for secondary outcomes|90
11270458|NCT02322242|12466140|FG001|1 Week Follow-up|Overall Study|1 lost to follow-up for secondary outcomes|89
11270459|NCT02322242|12466139|FG000|COMPLETED|Overall Study||92
11270460|NCT02322242|12466140|FG001|COMPLETED|Overall Study||90
11270461|NCT02322242|12466139|FG000|NOT COMPLETED|Overall Study||0
11270462|NCT02322242|12466140|FG001|NOT COMPLETED|Overall Study||0
11270463|NCT02322281|12466149|FG000|STARTED|Overall Study||53
11270464|NCT02322281|12466150|FG001|STARTED|Overall Study||22
11397623|NCT04347954|12591789|FG002|Received Allocated Intervention|Overall Study||14
11397624|NCT04347954|12591787|FG000|Negative PCR Swab at Baseline|Overall Study||1
11397625|NCT04347954|12591788|FG001|Negative PCR Swab at Baseline|Overall Study||3
11397626|NCT04347954|12591789|FG002|Negative PCR Swab at Baseline|Overall Study||1
11270465|NCT02322281|12466151|FG002|STARTED|Overall Study||74
11270466|NCT02322281|12466149|FG000|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
11270467|NCT02322281|12466150|FG001|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
11270468|NCT02322281|12466151|FG002|Crossed Over to Rociletinib 500 mg BID|Overall Study||36
11270469|NCT02322281|12466149|FG000|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
11270470|NCT02322281|12466150|FG001|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
11270471|NCT02322281|12466151|FG002|Crossed Over to Rociletinib 625 mg BID|Overall Study||3
11270472|NCT02322281|12466149|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0
11270473|NCT02322281|12466150|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0
11270474|NCT02322281|12466151|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0
11270475|NCT02322281|12466149|FG000|NOT COMPLETED|Overall Study||53
11270476|NCT02322281|12466150|FG001|NOT COMPLETED|Overall Study||22
11270477|NCT02322281|12466151|FG002|NOT COMPLETED|Overall Study||74
11270478|NCT02322320|12466164|FG000|STARTED|Overall Study||98
11270479|NCT02322320|12466165|FG001|STARTED|Overall Study||86
11270480|NCT02322320|12466166|FG002|STARTED|Overall Study||89
11270481|NCT02322320|12466164|FG000|COMPLETED|Overall Study||98
11270482|NCT02322320|12466165|FG001|COMPLETED|Overall Study||86
11270483|NCT02322320|12466166|FG002|COMPLETED|Overall Study||89
11270484|NCT02322320|12466164|FG000|NOT COMPLETED|Overall Study||0
11270485|NCT02322320|12466165|FG001|NOT COMPLETED|Overall Study||0
11270486|NCT02322320|12466166|FG002|NOT COMPLETED|Overall Study||0
11270487|NCT02322333|12466176|FG000|STARTED|Overall Study||80
11270488|NCT02322333|12466177|FG001|STARTED|Overall Study||77
11270489|NCT02322333|12466176|FG000|COMPLETED|Overall Study||63
11270490|NCT02322333|12466177|FG001|COMPLETED|Overall Study||61
11270491|NCT02322333|12466176|FG000|NOT COMPLETED|Overall Study||17
11270492|NCT02322333|12466177|FG001|NOT COMPLETED|Overall Study||16
11270493|NCT02322411|12466185|FG000|STARTED|Overall Study||14
11270494|NCT02322411|12466186|FG001|STARTED|Overall Study||16
11270495|NCT02322411|12466185|FG000|Randomized|Overall Study||14
11270496|NCT02322411|12466186|FG001|Randomized|Overall Study||16
11270497|NCT02322411|12466185|FG000|All Baseline Measures Analyzed|Overall Study||13
11270498|NCT02322411|12466186|FG001|All Baseline Measures Analyzed|Overall Study||16
11270499|NCT02322411|12466185|FG000|COMPLETED|Overall Study||9
11270500|NCT02322411|12466186|FG001|COMPLETED|Overall Study||9
11270501|NCT02322411|12466185|FG000|NOT COMPLETED|Overall Study||5
11270502|NCT02322411|12466186|FG001|NOT COMPLETED|Overall Study||7
11270503|NCT02322528|12466192|FG000|STARTED|Overall Study||10
11270504|NCT02322528|12466192|FG000|COMPLETED|Overall Study||10
11270505|NCT02322528|12466192|FG000|NOT COMPLETED|Overall Study||0
11270506|NCT02322749|12466196|FG000|STARTED|Period 1||8
11270507|NCT02322749|12466197|FG001|STARTED|Period 1||8
11270508|NCT02322749|12466198|FG002|STARTED|Period 1||8
11270509|NCT02322749|12466199|FG003|STARTED|Period 1||8
11270510|NCT02322749|12466200|FG004|STARTED|Period 1||8
11270511|NCT02322749|12466201|FG005|STARTED|Period 1||8
11270512|NCT02322749|12466196|FG000|COMPLETED|Period 1||8
11270513|NCT02322749|12466197|FG001|COMPLETED|Period 1||8
11270514|NCT02322749|12466198|FG002|COMPLETED|Period 1||8
11270515|NCT02322749|12466199|FG003|COMPLETED|Period 1||8
11270516|NCT02322749|12466200|FG004|COMPLETED|Period 1||8
11270517|NCT02322749|12466201|FG005|COMPLETED|Period 1||8
11270518|NCT02322749|12466196|FG000|NOT COMPLETED|Period 1||0
11270519|NCT02322749|12466197|FG001|NOT COMPLETED|Period 1||0
11270520|NCT02322749|12466198|FG002|NOT COMPLETED|Period 1||0
11270521|NCT02322749|12466199|FG003|NOT COMPLETED|Period 1||0
11270522|NCT02322749|12466200|FG004|NOT COMPLETED|Period 1||0
11270523|NCT02322749|12466201|FG005|NOT COMPLETED|Period 1||0
11270524|NCT02322749|12466196|FG000|STARTED|Period 2||8
11270525|NCT02322749|12466197|FG001|STARTED|Period 2||8
11270526|NCT02322749|12466198|FG002|STARTED|Period 2||8
11270527|NCT02322749|12466199|FG003|STARTED|Period 2||8
11270528|NCT02322749|12466200|FG004|STARTED|Period 2||8
11270529|NCT02322749|12466201|FG005|STARTED|Period 2||8
11270530|NCT02322749|12466196|FG000|COMPLETED|Period 2||8
11270531|NCT02322749|12466197|FG001|COMPLETED|Period 2||8
11270532|NCT02322749|12466198|FG002|COMPLETED|Period 2||8
11270533|NCT02322749|12466199|FG003|COMPLETED|Period 2||6
11270534|NCT02322749|12466200|FG004|COMPLETED|Period 2||8
11270535|NCT02322749|12466201|FG005|COMPLETED|Period 2||8
11270536|NCT02322749|12466196|FG000|NOT COMPLETED|Period 2||0
11270537|NCT02322749|12466197|FG001|NOT COMPLETED|Period 2||0
11270538|NCT02322749|12466198|FG002|NOT COMPLETED|Period 2||0
11270539|NCT02322749|12466199|FG003|NOT COMPLETED|Period 2||2
11270540|NCT02322749|12466200|FG004|NOT COMPLETED|Period 2||0
11270541|NCT02322749|12466201|FG005|NOT COMPLETED|Period 2||0
11270542|NCT02322749|12466196|FG000|STARTED|Period 3||8
11270543|NCT02322749|12466197|FG001|STARTED|Period 3||8
11270544|NCT02322749|12466198|FG002|STARTED|Period 3||8
11270545|NCT02322749|12466199|FG003|STARTED|Period 3||6
11270546|NCT02322749|12466200|FG004|STARTED|Period 3||8
11270547|NCT02322749|12466201|FG005|STARTED|Period 3||8
11270548|NCT02322749|12466196|FG000|COMPLETED|Period 3||8
11270549|NCT02322749|12466197|FG001|COMPLETED|Period 3||8
11270550|NCT02322749|12466198|FG002|COMPLETED|Period 3||7
11270551|NCT02322749|12466199|FG003|COMPLETED|Period 3||6
11270552|NCT02322749|12466200|FG004|COMPLETED|Period 3||8
11270553|NCT02322749|12466201|FG005|COMPLETED|Period 3||8
11270554|NCT02322749|12466196|FG000|NOT COMPLETED|Period 3||0
11270555|NCT02322749|12466197|FG001|NOT COMPLETED|Period 3||0
11270556|NCT02322749|12466198|FG002|NOT COMPLETED|Period 3||1
11270557|NCT02322749|12466199|FG003|NOT COMPLETED|Period 3||0
11270558|NCT02322749|12466200|FG004|NOT COMPLETED|Period 3||0
11270559|NCT02322749|12466201|FG005|NOT COMPLETED|Period 3||0
11270560|NCT02322775|12466212|FG000|STARTED|Overall Study||106
11270561|NCT02322775|12466213|FG001|STARTED|Overall Study||105
11270562|NCT02322775|12466212|FG000|COMPLETED|Overall Study||101
11270563|NCT02322775|12466213|FG001|COMPLETED|Overall Study||99
11270564|NCT02322775|12466212|FG000|NOT COMPLETED|Overall Study||5
11270565|NCT02322775|12466213|FG001|NOT COMPLETED|Overall Study||6
11270566|NCT02322788|12466219|FG000|STARTED|Visit 3||15
11270567|NCT02322788|12466220|FG001|STARTED|Visit 3||15
11270568|NCT02322788|12466221|FG002|STARTED|Visit 3||14
11270569|NCT02322788|12466222|FG003|STARTED|Visit 3||16
11270570|NCT02322788|12466219|FG000|COMPLETED|Visit 3||15
11270571|NCT02322788|12466220|FG001|COMPLETED|Visit 3||15
11270572|NCT02322788|12466221|FG002|COMPLETED|Visit 3||14
11270573|NCT02322788|12466222|FG003|COMPLETED|Visit 3||16
11270574|NCT02322788|12466219|FG000|NOT COMPLETED|Visit 3||0
11270575|NCT02322788|12466220|FG001|NOT COMPLETED|Visit 3||0
11270576|NCT02322788|12466221|FG002|NOT COMPLETED|Visit 3||0
11270577|NCT02322788|12466222|FG003|NOT COMPLETED|Visit 3||0
11270578|NCT02322788|12466219|FG000|STARTED|Visit 4||15
11270579|NCT02322788|12466220|FG001|STARTED|Visit 4||14
11270580|NCT02322788|12466221|FG002|STARTED|Visit 4||16
11270581|NCT02322788|12466222|FG003|STARTED|Visit 4||15
11270582|NCT02322788|12466219|FG000|COMPLETED|Visit 4||15
11270583|NCT02322788|12466220|FG001|COMPLETED|Visit 4||14
11270584|NCT02322788|12466221|FG002|COMPLETED|Visit 4||16
11270585|NCT02322788|12466222|FG003|COMPLETED|Visit 4||15
11270586|NCT02322788|12466219|FG000|NOT COMPLETED|Visit 4||0
11270587|NCT02322788|12466220|FG001|NOT COMPLETED|Visit 4||0
11270588|NCT02322788|12466221|FG002|NOT COMPLETED|Visit 4||0
11270589|NCT02322788|12466222|FG003|NOT COMPLETED|Visit 4||0
11270590|NCT02322788|12466219|FG000|STARTED|Visit 5||16
11270591|NCT02322788|12466220|FG001|STARTED|Visit 5||15
11270592|NCT02322788|12466221|FG002|STARTED|Visit 5||15
11270593|NCT02322788|12466222|FG003|STARTED|Visit 5||14
11397627|NCT04347954|12591787|FG000|COMPLETED|Overall Study||12
11397628|NCT04347954|12591788|FG001|COMPLETED|Overall Study||14
11397629|NCT04347954|12591789|FG002|COMPLETED|Overall Study||14
11397630|NCT04347954|12591787|FG000|NOT COMPLETED|Overall Study||3
11397631|NCT04347954|12591788|FG001|NOT COMPLETED|Overall Study||1
11397632|NCT04347954|12591789|FG002|NOT COMPLETED|Overall Study||3
11397633|NCT04349098|12591799|FG000|STARTED|Overall Study||103
11270594|NCT02322788|12466219|FG000|COMPLETED|Visit 5||16
11270595|NCT02322788|12466220|FG001|COMPLETED|Visit 5||15
11270596|NCT02322788|12466221|FG002|COMPLETED|Visit 5||15
11270597|NCT02322788|12466222|FG003|COMPLETED|Visit 5||14
11270598|NCT02322788|12466219|FG000|NOT COMPLETED|Visit 5||0
11270599|NCT02322788|12466220|FG001|NOT COMPLETED|Visit 5||0
11270600|NCT02322788|12466221|FG002|NOT COMPLETED|Visit 5||0
11270601|NCT02322788|12466222|FG003|NOT COMPLETED|Visit 5||0
11270602|NCT02322788|12466219|FG000|STARTED|Visit 6||14
11397634|NCT04349098|12591800|FG001|STARTED|Overall Study||87
11270603|NCT02322788|12466220|FG001|STARTED|Visit 6||16
11270604|NCT02322788|12466221|FG002|STARTED|Visit 6||15
11270605|NCT02322788|12466222|FG003|STARTED|Visit 6||15
11270606|NCT02322788|12466219|FG000|COMPLETED|Visit 6||14
11270607|NCT02322788|12466220|FG001|COMPLETED|Visit 6||16
11270608|NCT02322788|12466221|FG002|COMPLETED|Visit 6||15
11270609|NCT02322788|12466222|FG003|COMPLETED|Visit 6||15
11270610|NCT02322788|12466219|FG000|NOT COMPLETED|Visit 6||0
11270611|NCT02322788|12466220|FG001|NOT COMPLETED|Visit 6||0
11270612|NCT02322788|12466221|FG002|NOT COMPLETED|Visit 6||0
11270613|NCT02322788|12466222|FG003|NOT COMPLETED|Visit 6||0
11270614|NCT02322814|12466237|FG000|STARTED|Overall Study||16
11270615|NCT02322814|12466238|FG001|STARTED|Overall Study||43
11270616|NCT02322814|12466239|FG002|STARTED|Overall Study||47
11270617|NCT02322814|12466240|FG003|STARTED|Overall Study||32
11270618|NCT02322814|12466241|FG004|STARTED|Overall Study||31
11270619|NCT02322814|12466237|FG000|COMPLETED|Overall Study||0
11270620|NCT02322814|12466238|FG001|COMPLETED|Overall Study||0
11270621|NCT02322814|12466239|FG002|COMPLETED|Overall Study||0
11270622|NCT02322814|12466240|FG003|COMPLETED|Overall Study||0
11270623|NCT02322814|12466241|FG004|COMPLETED|Overall Study||0
11270624|NCT02322814|12466237|FG000|NOT COMPLETED|Overall Study||16
11270625|NCT02322814|12466238|FG001|NOT COMPLETED|Overall Study||43
11270626|NCT02322814|12466239|FG002|NOT COMPLETED|Overall Study||47
11270627|NCT02322814|12466240|FG003|NOT COMPLETED|Overall Study||32
11270628|NCT02322814|12466241|FG004|NOT COMPLETED|Overall Study||31
11270629|NCT02322866|12466254|FG000|STARTED|Overall Study||515
11270630|NCT02322866|12466255|FG001|STARTED|Overall Study||519
11270631|NCT02322866|12466254|FG000|COMPLETED|Overall Study||444
11270632|NCT02322866|12466255|FG001|COMPLETED|Overall Study||433
11270633|NCT02322866|12466254|FG000|NOT COMPLETED|Overall Study||71
11270634|NCT02322866|12466255|FG001|NOT COMPLETED|Overall Study||86
11270635|NCT02322879|12466263|FG000|STARTED|First Intervention||11
11270636|NCT02322879|12466264|FG001|STARTED|First Intervention||10
11270637|NCT02322879|12466263|FG000|COMPLETED|First Intervention||10
11270638|NCT02322879|12466264|FG001|COMPLETED|First Intervention||10
11270639|NCT02322879|12466263|FG000|NOT COMPLETED|First Intervention||1
11270640|NCT02322879|12466264|FG001|NOT COMPLETED|First Intervention||0
11270641|NCT02322879|12466263|FG000|STARTED|Washout||10
11270642|NCT02322879|12466264|FG001|STARTED|Washout||10
11270643|NCT02322879|12466263|FG000|COMPLETED|Washout||10
11397635|NCT04349098|12591799|FG000|Treated|Overall Study||102
11397636|NCT04349098|12591800|FG001|Treated|Overall Study||86
11397637|NCT04349098|12591799|FG000|COMPLETED|Overall Study||65
11397638|NCT04349098|12591800|FG001|COMPLETED|Overall Study||61
11270644|NCT02322879|12466264|FG001|COMPLETED|Washout||10
11270645|NCT02322879|12466263|FG000|NOT COMPLETED|Washout||0
11270646|NCT02322879|12466264|FG001|NOT COMPLETED|Washout||0
11270647|NCT02322879|12466263|FG000|STARTED|Second Intervention||10
11270648|NCT02322879|12466264|FG001|STARTED|Second Intervention||10
11270649|NCT02322879|12466263|FG000|COMPLETED|Second Intervention||10
11270650|NCT02322879|12466264|FG001|COMPLETED|Second Intervention||10
11270651|NCT02322879|12466263|FG000|NOT COMPLETED|Second Intervention||0
11270652|NCT02322879|12466264|FG001|NOT COMPLETED|Second Intervention||0
11270653|NCT02322892|12466272|FG000|STARTED|Overall Study|Number randomized|35
11270654|NCT02322892|12466273|FG001|STARTED|Overall Study|Number randomized|34
11270655|NCT02322892|12466272|FG000|COMPLETED|Overall Study|Received placebo|33
11270656|NCT02322892|12466273|FG001|COMPLETED|Overall Study|Received thiamine|31
11270657|NCT02322892|12466272|FG000|NOT COMPLETED|Overall Study||2
11270658|NCT02322892|12466273|FG001|NOT COMPLETED|Overall Study||3
11270659|NCT02323048|12466284|FG000|STARTED|Overall Study||25
11270660|NCT02323048|12466285|FG001|STARTED|Overall Study||26
11270661|NCT02323048|12466286|FG002|STARTED|Overall Study||23
11270662|NCT02323048|12466287|FG003|STARTED|Overall Study||7
11270663|NCT02323048|12466288|FG004|STARTED|Overall Study||9
11270664|NCT02323048|12466284|FG000|COMPLETED|Overall Study||24
11270665|NCT02323048|12466285|FG001|COMPLETED|Overall Study||24
11270666|NCT02323048|12466286|FG002|COMPLETED|Overall Study||23
11270667|NCT02323048|12466287|FG003|COMPLETED|Overall Study||7
11270668|NCT02323048|12466288|FG004|COMPLETED|Overall Study||9
11270669|NCT02323048|12466284|FG000|NOT COMPLETED|Overall Study||1
11397639|NCT04349098|12591799|FG000|NOT COMPLETED|Overall Study||38
11397640|NCT04349098|12591800|FG001|NOT COMPLETED|Overall Study||26
11397641|NCT04353037|12591810|FG000|STARTED|Overall Study||6
11397642|NCT04353037|12591811|FG001|STARTED|Overall Study||3
11397643|NCT04353037|12591812|FG002|STARTED|Overall Study||13
11397644|NCT04353037|12591813|FG003|STARTED|Overall Study||17
11270670|NCT02323048|12466285|FG001|NOT COMPLETED|Overall Study||2
11270671|NCT02323048|12466286|FG002|NOT COMPLETED|Overall Study||0
11270672|NCT02323048|12466287|FG003|NOT COMPLETED|Overall Study||0
11270673|NCT02323048|12466288|FG004|NOT COMPLETED|Overall Study||0
11270674|NCT02323113|12466307|FG000|STARTED|Overall Study||4
11270675|NCT02323113|12466308|FG001|STARTED|Overall Study||7
11270676|NCT02323113|12466309|FG002|STARTED|Overall Study||4
11270677|NCT02323113|12466310|FG003|STARTED|Overall Study||5
11270678|NCT02323113|12466311|FG004|STARTED|Overall Study||9
11270679|NCT02323113|12466312|FG005|STARTED|Overall Study||8
11270680|NCT02323113|12466313|FG006|STARTED|Overall Study||6
11270681|NCT02323113|12466314|FG007|STARTED|Overall Study||0
11270682|NCT02323113|12466307|FG000|COMPLETED|Overall Study||0
11270683|NCT02323113|12466308|FG001|COMPLETED|Overall Study||0
11270684|NCT02323113|12466309|FG002|COMPLETED|Overall Study||0
11397645|NCT04353037|12591810|FG000|COMPLETED|Overall Study||6
11270685|NCT02323113|12466310|FG003|COMPLETED|Overall Study||0
11270686|NCT02323113|12466311|FG004|COMPLETED|Overall Study||0
11270687|NCT02323113|12466312|FG005|COMPLETED|Overall Study||0
11270688|NCT02323113|12466313|FG006|COMPLETED|Overall Study||0
11270689|NCT02323113|12466314|FG007|COMPLETED|Overall Study||0
11270690|NCT02323113|12466307|FG000|NOT COMPLETED|Overall Study||4
11270691|NCT02323113|12466308|FG001|NOT COMPLETED|Overall Study||7
11270692|NCT02323113|12466309|FG002|NOT COMPLETED|Overall Study||4
11270693|NCT02323113|12466310|FG003|NOT COMPLETED|Overall Study||5
11270694|NCT02323113|12466311|FG004|NOT COMPLETED|Overall Study||9
11270695|NCT02323113|12466312|FG005|NOT COMPLETED|Overall Study||8
11270696|NCT02323113|12466313|FG006|NOT COMPLETED|Overall Study||6
11270697|NCT02323113|12466314|FG007|NOT COMPLETED|Overall Study||0
11270698|NCT02323204|12466337|FG000|STARTED|Baseline Survey Completion||155
11270699|NCT02323204|12466338|FG001|STARTED|Baseline Survey Completion||155
11270700|NCT02323204|12466339|FG002|STARTED|Baseline Survey Completion||159
11270701|NCT02323204|12466340|FG003|STARTED|Baseline Survey Completion||159
11397646|NCT04353037|12591811|FG001|COMPLETED|Overall Study||0
11397647|NCT04353037|12591812|FG002|COMPLETED|Overall Study||6
11397648|NCT04353037|12591813|FG003|COMPLETED|Overall Study||7
11270702|NCT02323204|12466337|FG000|COMPLETED|Baseline Survey Completion||145
11270703|NCT02323204|12466338|FG001|COMPLETED|Baseline Survey Completion||146
11270704|NCT02323204|12466339|FG002|COMPLETED|Baseline Survey Completion||154
11270705|NCT02323204|12466340|FG003|COMPLETED|Baseline Survey Completion||156
11270706|NCT02323204|12466337|FG000|NOT COMPLETED|Baseline Survey Completion||10
11270707|NCT02323204|12466338|FG001|NOT COMPLETED|Baseline Survey Completion||9
11270708|NCT02323204|12466339|FG002|NOT COMPLETED|Baseline Survey Completion||5
11270709|NCT02323204|12466340|FG003|NOT COMPLETED|Baseline Survey Completion||3
11270710|NCT02323204|12466337|FG000|STARTED|6-week Follow-up Survey Completion||145
11270711|NCT02323204|12466338|FG001|STARTED|6-week Follow-up Survey Completion||146
11270712|NCT02323204|12466339|FG002|STARTED|6-week Follow-up Survey Completion||154
11270713|NCT02323204|12466340|FG003|STARTED|6-week Follow-up Survey Completion||156
11270714|NCT02323204|12466337|FG000|COMPLETED|6-week Follow-up Survey Completion||104
11270715|NCT02323204|12466338|FG001|COMPLETED|6-week Follow-up Survey Completion||110
11270716|NCT02323204|12466339|FG002|COMPLETED|6-week Follow-up Survey Completion||112
11270717|NCT02323204|12466340|FG003|COMPLETED|6-week Follow-up Survey Completion||119
11270718|NCT02323204|12466337|FG000|NOT COMPLETED|6-week Follow-up Survey Completion||41
11270719|NCT02323204|12466338|FG001|NOT COMPLETED|6-week Follow-up Survey Completion||36
11270720|NCT02323204|12466339|FG002|NOT COMPLETED|6-week Follow-up Survey Completion||42
11270721|NCT02323204|12466340|FG003|NOT COMPLETED|6-week Follow-up Survey Completion||37
11270722|NCT02323204|12466337|FG000|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
11270723|NCT02323204|12466338|FG001|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146
11397649|NCT04353037|12591810|FG000|NOT COMPLETED|Overall Study||0
11397650|NCT04353037|12591811|FG001|NOT COMPLETED|Overall Study||3
11397651|NCT04353037|12591812|FG002|NOT COMPLETED|Overall Study||7
11397652|NCT04353037|12591813|FG003|NOT COMPLETED|Overall Study||10
11270724|NCT02323204|12466339|FG002|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
11270725|NCT02323204|12466340|FG003|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156
11270726|NCT02323204|12466337|FG000|COMPLETED|6-week Follow-up Intervention Booster||0
11270727|NCT02323204|12466338|FG001|COMPLETED|6-week Follow-up Intervention Booster||103
11270728|NCT02323204|12466339|FG002|COMPLETED|6-week Follow-up Intervention Booster||0
11270729|NCT02323204|12466340|FG003|COMPLETED|6-week Follow-up Intervention Booster||120
11270730|NCT02323204|12466337|FG000|NOT COMPLETED|6-week Follow-up Intervention Booster||0
11270731|NCT02323204|12466338|FG001|NOT COMPLETED|6-week Follow-up Intervention Booster||43
11270732|NCT02323204|12466339|FG002|NOT COMPLETED|6-week Follow-up Intervention Booster||0
11270733|NCT02323204|12466340|FG003|NOT COMPLETED|6-week Follow-up Intervention Booster||36
11270734|NCT02323204|12466337|FG000|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
11270735|NCT02323204|12466338|FG001|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
11270736|NCT02323204|12466339|FG002|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
11270737|NCT02323204|12466340|FG003|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
11270738|NCT02323204|12466337|FG000|COMPLETED|3-month Follow-up Survey Completion||91
11270739|NCT02323204|12466338|FG001|COMPLETED|3-month Follow-up Survey Completion||99
11270740|NCT02323204|12466339|FG002|COMPLETED|3-month Follow-up Survey Completion||113
11270741|NCT02323204|12466340|FG003|COMPLETED|3-month Follow-up Survey Completion||112
11270742|NCT02323204|12466337|FG000|NOT COMPLETED|3-month Follow-up Survey Completion||54
11270743|NCT02323204|12466338|FG001|NOT COMPLETED|3-month Follow-up Survey Completion||47
11270744|NCT02323204|12466339|FG002|NOT COMPLETED|3-month Follow-up Survey Completion||41
11270745|NCT02323204|12466340|FG003|NOT COMPLETED|3-month Follow-up Survey Completion||44
11270746|NCT02323204|12466337|FG000|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
11270747|NCT02323204|12466338|FG001|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
11397653|NCT04355117|12591825|FG000|STARTED|Overall Study||71
11270748|NCT02323204|12466339|FG002|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
11270749|NCT02323204|12466340|FG003|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
11270750|NCT02323204|12466337|FG000|COMPLETED|6-month Follow-up Survey Completion||96
11270751|NCT02323204|12466338|FG001|COMPLETED|6-month Follow-up Survey Completion||96
11270752|NCT02323204|12466339|FG002|COMPLETED|6-month Follow-up Survey Completion||113
11270753|NCT02323204|12466340|FG003|COMPLETED|6-month Follow-up Survey Completion||112
11270754|NCT02323204|12466337|FG000|NOT COMPLETED|6-month Follow-up Survey Completion||49
11270755|NCT02323204|12466338|FG001|NOT COMPLETED|6-month Follow-up Survey Completion||50
11270756|NCT02323204|12466339|FG002|NOT COMPLETED|6-month Follow-up Survey Completion||41
11270757|NCT02323204|12466340|FG003|NOT COMPLETED|6-month Follow-up Survey Completion||44
11270758|NCT02323217|12466350|FG000|STARTED|Overall Study||18
11270759|NCT02323217|12466350|FG000|COMPLETED|Overall Study||18
11270760|NCT02323217|12466350|FG000|NOT COMPLETED|Overall Study||0
11340378|NCT02920528|12537677|FG001|STARTED|Overall Study||36
11340379|NCT02920528|12537678|FG002|STARTED|Overall Study||35
11340380|NCT02920528|12537676|FG000|COMPLETED|Overall Study||32
11340381|NCT02920528|12537677|FG001|COMPLETED|Overall Study||35
11340382|NCT02920528|12537678|FG002|COMPLETED|Overall Study||30
11340383|NCT02920528|12537676|FG000|NOT COMPLETED|Overall Study||3
11340384|NCT02920528|12537677|FG001|NOT COMPLETED|Overall Study||1
11340385|NCT02920528|12537678|FG002|NOT COMPLETED|Overall Study||5
11340386|NCT02920749|12537690|FG000|STARTED|Overall Study||30
11340387|NCT02920749|12537691|FG001|STARTED|Overall Study||30
11397654|NCT04355117|12591825|FG000|COMPLETED|Overall Study||71
11397655|NCT04355117|12591825|FG000|NOT COMPLETED|Overall Study||0
11397656|NCT04355767|12591833|FG000|STARTED|Overall Study||257
11397657|NCT04355767|12591834|FG001|STARTED|Overall Study||254
11397658|NCT04355767|12591833|FG000|Intention-to-treat Population|Overall Study||257
11397659|NCT04355767|12591834|FG001|Intention-to-treat Population|Overall Study||254
11397660|NCT04355767|12591833|FG000|Had Data for 15-day Outcome|Overall Study||257
11397661|NCT04355767|12591834|FG001|Had Data for 15-day Outcome|Overall Study||254
11397662|NCT04355767|12591833|FG000|COMPLETED|Overall Study||250
11340388|NCT02920749|12537692|FG002|STARTED|Overall Study||30
11340389|NCT02920749|12537693|FG003|STARTED|Overall Study||30
11340390|NCT02920749|12537690|FG000|COMPLETED|Overall Study||30
11340391|NCT02920749|12537691|FG001|COMPLETED|Overall Study||30
11340392|NCT02920749|12537692|FG002|COMPLETED|Overall Study||30
11340393|NCT02920749|12537693|FG003|COMPLETED|Overall Study||30
11340394|NCT02920749|12537690|FG000|NOT COMPLETED|Overall Study||0
11340395|NCT02920749|12537691|FG001|NOT COMPLETED|Overall Study||0
11340396|NCT02920749|12537692|FG002|NOT COMPLETED|Overall Study||0
11340397|NCT02920749|12537693|FG003|NOT COMPLETED|Overall Study||0
11340398|NCT02920918|12537709|FG000|STARTED|Overall Study||17
11397663|NCT04355767|12591834|FG001|COMPLETED|Overall Study||251
11397664|NCT04355767|12591833|FG000|NOT COMPLETED|Overall Study||7
11340399|NCT02920918|12537710|FG001|STARTED|Overall Study||19
11340400|NCT02920918|12537709|FG000|COMPLETED|Overall Study||17
11340401|NCT02920918|12537710|FG001|COMPLETED|Overall Study||19
11340402|NCT02920918|12537709|FG000|NOT COMPLETED|Overall Study||0
11340403|NCT02920918|12537710|FG001|NOT COMPLETED|Overall Study||0
11340404|NCT02920957|12537716|FG000|STARTED|First Intervention : 1 Month||46
11340405|NCT02920957|12537717|FG001|STARTED|First Intervention : 1 Month||41
11340406|NCT02920957|12537716|FG000|COMPLETED|First Intervention : 1 Month||42
11340407|NCT02920957|12537717|FG001|COMPLETED|First Intervention : 1 Month||41
11340408|NCT02920957|12537716|FG000|NOT COMPLETED|First Intervention : 1 Month||4
11340409|NCT02920957|12537717|FG001|NOT COMPLETED|First Intervention : 1 Month||0
11340410|NCT02920957|12537716|FG000|STARTED|Second Intervention: 1 Month||42
11340411|NCT02920957|12537717|FG001|STARTED|Second Intervention: 1 Month||41
11340412|NCT02920957|12537716|FG000|COMPLETED|Second Intervention: 1 Month||42
11340413|NCT02920957|12537717|FG001|COMPLETED|Second Intervention: 1 Month||40
11340414|NCT02920957|12537716|FG000|NOT COMPLETED|Second Intervention: 1 Month||0
11340415|NCT02920957|12537717|FG001|NOT COMPLETED|Second Intervention: 1 Month||1
11340416|NCT02920970|12537734|FG000|STARTED|First Intervention||38
11340417|NCT02920970|12537735|FG001|STARTED|First Intervention||32
11340418|NCT02920970|12537734|FG000|COMPLETED|First Intervention||38
11340419|NCT02920970|12537735|FG001|COMPLETED|First Intervention||30
11340420|NCT02920970|12537734|FG000|NOT COMPLETED|First Intervention||0
11340421|NCT02920970|12537735|FG001|NOT COMPLETED|First Intervention||2
11340422|NCT02920970|12537734|FG000|STARTED|Second Intervention||38
11340423|NCT02920970|12537735|FG001|STARTED|Second Intervention||30
11340424|NCT02920970|12537734|FG000|COMPLETED|Second Intervention||37
11340425|NCT02920970|12537735|FG001|COMPLETED|Second Intervention||30
11340426|NCT02920970|12537734|FG000|NOT COMPLETED|Second Intervention||1
11340427|NCT02920970|12537735|FG001|NOT COMPLETED|Second Intervention||0
11340428|NCT02920983|12537743|FG000|STARTED|Dispense 1||8
11340429|NCT02920983|12537744|FG001|STARTED|Dispense 1||10
11340430|NCT02920983|12537745|FG002|STARTED|Dispense 1||7
11340431|NCT02920983|12537746|FG003|STARTED|Dispense 1||6
11270761|NCT02323334|12466364|FG000|STARTED|Period 1||4
11270762|NCT02323334|12466365|FG001|STARTED|Period 1||4
11270763|NCT02323334|12466366|FG002|STARTED|Period 1||4
11270764|NCT02323334|12466367|FG003|STARTED|Period 1||4
11270765|NCT02323334|12466368|FG004|STARTED|Period 1||4
11270766|NCT02323334|12466369|FG005|STARTED|Period 1||4
11270767|NCT02323334|12466370|FG006|STARTED|Period 1||6
11270768|NCT02323334|12466371|FG007|STARTED|Period 1||6
11270769|NCT02323334|12466372|FG008|STARTED|Period 1||5
11270770|NCT02323334|12466373|FG009|STARTED|Period 1||7
11270771|NCT02323334|12466374|FG010|STARTED|Period 1||5
11270772|NCT02323334|12466375|FG011|STARTED|Period 1||3
11270773|NCT02323334|12466376|FG012|STARTED|Period 1||9
11270774|NCT02323334|12466377|FG013|STARTED|Period 1||9
11270775|NCT02323334|12466378|FG014|STARTED|Period 1||9
11270776|NCT02323334|12466379|FG015|STARTED|Period 1||9
11270777|NCT02323334|12466380|FG016|STARTED|Period 1||2
11270778|NCT02323334|12466364|FG000|Received at Least One Dose of Study Drug|Period 1||4
11270779|NCT02323334|12466365|FG001|Received at Least One Dose of Study Drug|Period 1||4
11270780|NCT02323334|12466366|FG002|Received at Least One Dose of Study Drug|Period 1||4
11270781|NCT02323334|12466367|FG003|Received at Least One Dose of Study Drug|Period 1||4
11270782|NCT02323334|12466368|FG004|Received at Least One Dose of Study Drug|Period 1||4
11270783|NCT02323334|12466369|FG005|Received at Least One Dose of Study Drug|Period 1||4
11270784|NCT02323334|12466370|FG006|Received at Least One Dose of Study Drug|Period 1||6
11270785|NCT02323334|12466371|FG007|Received at Least One Dose of Study Drug|Period 1||6
11270786|NCT02323334|12466372|FG008|Received at Least One Dose of Study Drug|Period 1||5
11270787|NCT02323334|12466373|FG009|Received at Least One Dose of Study Drug|Period 1||7
11270788|NCT02323334|12466374|FG010|Received at Least One Dose of Study Drug|Period 1||5
11270789|NCT02323334|12466375|FG011|Received at Least One Dose of Study Drug|Period 1||3
11270790|NCT02323334|12466376|FG012|Received at Least One Dose of Study Drug|Period 1||9
11270791|NCT02323334|12466377|FG013|Received at Least One Dose of Study Drug|Period 1||9
11270792|NCT02323334|12466378|FG014|Received at Least One Dose of Study Drug|Period 1||9
11270793|NCT02323334|12466379|FG015|Received at Least One Dose of Study Drug|Period 1||9
11270794|NCT02323334|12466380|FG016|Received at Least One Dose of Study Drug|Period 1||2
11270795|NCT02323334|12466364|FG000|COMPLETED|Period 1||4
11270796|NCT02323334|12466365|FG001|COMPLETED|Period 1||4
11270797|NCT02323334|12466366|FG002|COMPLETED|Period 1||4
11270798|NCT02323334|12466367|FG003|COMPLETED|Period 1||4
11270799|NCT02323334|12466368|FG004|COMPLETED|Period 1||4
11270800|NCT02323334|12466369|FG005|COMPLETED|Period 1||4
11270801|NCT02323334|12466370|FG006|COMPLETED|Period 1||6
11270802|NCT02323334|12466371|FG007|COMPLETED|Period 1||6
11270803|NCT02323334|12466372|FG008|COMPLETED|Period 1||5
11270804|NCT02323334|12466373|FG009|COMPLETED|Period 1||7
11270805|NCT02323334|12466374|FG010|COMPLETED|Period 1||5
11270806|NCT02323334|12466375|FG011|COMPLETED|Period 1||3
11270807|NCT02323334|12466376|FG012|COMPLETED|Period 1||9
11270808|NCT02323334|12466377|FG013|COMPLETED|Period 1||9
11270809|NCT02323334|12466378|FG014|COMPLETED|Period 1||9
11270810|NCT02323334|12466379|FG015|COMPLETED|Period 1||9
11270811|NCT02323334|12466380|FG016|COMPLETED|Period 1||2
11270812|NCT02323334|12466364|FG000|NOT COMPLETED|Period 1||0
11270813|NCT02323334|12466365|FG001|NOT COMPLETED|Period 1||0
11270814|NCT02323334|12466366|FG002|NOT COMPLETED|Period 1||0
11270815|NCT02323334|12466367|FG003|NOT COMPLETED|Period 1||0
11270816|NCT02323334|12466368|FG004|NOT COMPLETED|Period 1||0
11270817|NCT02323334|12466369|FG005|NOT COMPLETED|Period 1||0
11270818|NCT02323334|12466370|FG006|NOT COMPLETED|Period 1||0
11270819|NCT02323334|12466371|FG007|NOT COMPLETED|Period 1||0
11270820|NCT02323334|12466372|FG008|NOT COMPLETED|Period 1||0
11270821|NCT02323334|12466373|FG009|NOT COMPLETED|Period 1||0
11270822|NCT02323334|12466374|FG010|NOT COMPLETED|Period 1||0
11270823|NCT02323334|12466375|FG011|NOT COMPLETED|Period 1||0
11270824|NCT02323334|12466376|FG012|NOT COMPLETED|Period 1||0
11270825|NCT02323334|12466377|FG013|NOT COMPLETED|Period 1||0
11270826|NCT02323334|12466378|FG014|NOT COMPLETED|Period 1||0
11270827|NCT02323334|12466379|FG015|NOT COMPLETED|Period 1||0
11270828|NCT02323334|12466380|FG016|NOT COMPLETED|Period 1||0
11270829|NCT02323334|12466364|FG000|STARTED|Period 2||4
11270830|NCT02323334|12466365|FG001|STARTED|Period 2||4
11270831|NCT02323334|12466366|FG002|STARTED|Period 2||4
11270832|NCT02323334|12466367|FG003|STARTED|Period 2||4
11270833|NCT02323334|12466368|FG004|STARTED|Period 2||4
11270834|NCT02323334|12466369|FG005|STARTED|Period 2||4
11270835|NCT02323334|12466370|FG006|STARTED|Period 2||6
11270836|NCT02323334|12466371|FG007|STARTED|Period 2||6
11270837|NCT02323334|12466372|FG008|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
11270838|NCT02323334|12466373|FG009|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
11270839|NCT02323334|12466374|FG010|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
11270840|NCT02323334|12466375|FG011|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
11270841|NCT02323334|12466376|FG012|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
11270842|NCT02323334|12466377|FG013|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
11270843|NCT02323334|12466378|FG014|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
11270844|NCT02323334|12466379|FG015|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
11270845|NCT02323334|12466380|FG016|STARTED|Period 2|Part D was a single period conducted in parallel to Part A and received last dose in Period 1.|0
11270846|NCT02323334|12466364|FG000|COMPLETED|Period 2||4
11270847|NCT02323334|12466365|FG001|COMPLETED|Period 2||4
11270848|NCT02323334|12466366|FG002|COMPLETED|Period 2||4
11270849|NCT02323334|12466367|FG003|COMPLETED|Period 2||4
11270850|NCT02323334|12466368|FG004|COMPLETED|Period 2||4
11270851|NCT02323334|12466369|FG005|COMPLETED|Period 2||4
11270852|NCT02323334|12466370|FG006|COMPLETED|Period 2||6
11270853|NCT02323334|12466371|FG007|COMPLETED|Period 2||6
11270854|NCT02323334|12466372|FG008|COMPLETED|Period 2||0
11270855|NCT02323334|12466373|FG009|COMPLETED|Period 2||0
11270856|NCT02323334|12466374|FG010|COMPLETED|Period 2||0
11270857|NCT02323334|12466375|FG011|COMPLETED|Period 2||0
11270858|NCT02323334|12466376|FG012|COMPLETED|Period 2||0
11270859|NCT02323334|12466377|FG013|COMPLETED|Period 2||0
11270860|NCT02323334|12466378|FG014|COMPLETED|Period 2||0
11270861|NCT02323334|12466379|FG015|COMPLETED|Period 2||0
11270862|NCT02323334|12466380|FG016|COMPLETED|Period 2||0
11270863|NCT02323334|12466364|FG000|NOT COMPLETED|Period 2||0
11270864|NCT02323334|12466365|FG001|NOT COMPLETED|Period 2||0
11270865|NCT02323334|12466366|FG002|NOT COMPLETED|Period 2||0
11270866|NCT02323334|12466367|FG003|NOT COMPLETED|Period 2||0
11270867|NCT02323334|12466368|FG004|NOT COMPLETED|Period 2||0
11270868|NCT02323334|12466369|FG005|NOT COMPLETED|Period 2||0
11270869|NCT02323334|12466370|FG006|NOT COMPLETED|Period 2||0
11270870|NCT02323334|12466371|FG007|NOT COMPLETED|Period 2||0
11270871|NCT02323334|12466372|FG008|NOT COMPLETED|Period 2||0
11270872|NCT02323334|12466373|FG009|NOT COMPLETED|Period 2||0
11270873|NCT02323334|12466374|FG010|NOT COMPLETED|Period 2||0
11270874|NCT02323334|12466375|FG011|NOT COMPLETED|Period 2||0
11270875|NCT02323334|12466376|FG012|NOT COMPLETED|Period 2||0
11270876|NCT02323334|12466377|FG013|NOT COMPLETED|Period 2||0
11270877|NCT02323334|12466378|FG014|NOT COMPLETED|Period 2||0
11270878|NCT02323334|12466379|FG015|NOT COMPLETED|Period 2||0
11270879|NCT02323334|12466380|FG016|NOT COMPLETED|Period 2||0
11270880|NCT02323334|12466364|FG000|STARTED|Period 3||4
11270881|NCT02323334|12466365|FG001|STARTED|Period 3||4
11270882|NCT02323334|12466366|FG002|STARTED|Period 3||4
11270883|NCT02323334|12466367|FG003|STARTED|Period 3||4
11270884|NCT02323334|12466368|FG004|STARTED|Period 3||4
11270885|NCT02323334|12466369|FG005|STARTED|Period 3||4
11270886|NCT02323334|12466370|FG006|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
11270887|NCT02323334|12466371|FG007|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
11270888|NCT02323334|12466372|FG008|STARTED|Period 3||0
11270889|NCT02323334|12466373|FG009|STARTED|Period 3||0
11270890|NCT02323334|12466374|FG010|STARTED|Period 3||0
11270891|NCT02323334|12466375|FG011|STARTED|Period 3||0
11270892|NCT02323334|12466376|FG012|STARTED|Period 3||0
11270893|NCT02323334|12466377|FG013|STARTED|Period 3||0
11270894|NCT02323334|12466378|FG014|STARTED|Period 3||0
11270895|NCT02323334|12466379|FG015|STARTED|Period 3||0
11270896|NCT02323334|12466380|FG016|STARTED|Period 3||0
11270897|NCT02323334|12466364|FG000|COMPLETED|Period 3||3
11270898|NCT02323334|12466365|FG001|COMPLETED|Period 3||4
11270899|NCT02323334|12466366|FG002|COMPLETED|Period 3||3
11270900|NCT02323334|12466367|FG003|COMPLETED|Period 3||4
11270901|NCT02323334|12466368|FG004|COMPLETED|Period 3||4
11270902|NCT02323334|12466369|FG005|COMPLETED|Period 3||4
11270903|NCT02323334|12466370|FG006|COMPLETED|Period 3||0
11270904|NCT02323334|12466371|FG007|COMPLETED|Period 3||0
11270905|NCT02323334|12466372|FG008|COMPLETED|Period 3||0
11270906|NCT02323334|12466373|FG009|COMPLETED|Period 3||0
11270907|NCT02323334|12466374|FG010|COMPLETED|Period 3||0
11270908|NCT02323334|12466375|FG011|COMPLETED|Period 3||0
11270909|NCT02323334|12466376|FG012|COMPLETED|Period 3||0
11270910|NCT02323334|12466377|FG013|COMPLETED|Period 3||0
11270911|NCT02323334|12466378|FG014|COMPLETED|Period 3||0
11270912|NCT02323334|12466379|FG015|COMPLETED|Period 3||0
11270913|NCT02323334|12466380|FG016|COMPLETED|Period 3||0
11270914|NCT02323334|12466364|FG000|NOT COMPLETED|Period 3||1
11270915|NCT02323334|12466365|FG001|NOT COMPLETED|Period 3||0
11270916|NCT02323334|12466366|FG002|NOT COMPLETED|Period 3||1
11270917|NCT02323334|12466367|FG003|NOT COMPLETED|Period 3||0
11270918|NCT02323334|12466368|FG004|NOT COMPLETED|Period 3||0
11270919|NCT02323334|12466369|FG005|NOT COMPLETED|Period 3||0
11270920|NCT02323334|12466370|FG006|NOT COMPLETED|Period 3||0
11270921|NCT02323334|12466371|FG007|NOT COMPLETED|Period 3||0
11270922|NCT02323334|12466372|FG008|NOT COMPLETED|Period 3||0
11270923|NCT02323334|12466373|FG009|NOT COMPLETED|Period 3||0
11270924|NCT02323334|12466374|FG010|NOT COMPLETED|Period 3||0
11270925|NCT02323334|12466375|FG011|NOT COMPLETED|Period 3||0
11270926|NCT02323334|12466376|FG012|NOT COMPLETED|Period 3||0
11270927|NCT02323334|12466377|FG013|NOT COMPLETED|Period 3||0
11270928|NCT02323334|12466378|FG014|NOT COMPLETED|Period 3||0
11270929|NCT02323334|12466379|FG015|NOT COMPLETED|Period 3||0
11270930|NCT02323334|12466380|FG016|NOT COMPLETED|Period 3||0
11270931|NCT02323334|12466364|FG000|STARTED|Period 4||3
11270932|NCT02323334|12466365|FG001|STARTED|Period 4||4
11270933|NCT02323334|12466366|FG002|STARTED|Period 4||3
11270934|NCT02323334|12466367|FG003|STARTED|Period 4||4
11270935|NCT02323334|12466368|FG004|STARTED|Period 4||4
11270936|NCT02323334|12466369|FG005|STARTED|Period 4||4
11270937|NCT02323334|12466370|FG006|STARTED|Period 4||0
11270938|NCT02323334|12466371|FG007|STARTED|Period 4||0
11270939|NCT02323334|12466372|FG008|STARTED|Period 4||0
11270940|NCT02323334|12466373|FG009|STARTED|Period 4||0
11270941|NCT02323334|12466374|FG010|STARTED|Period 4||0
11270942|NCT02323334|12466375|FG011|STARTED|Period 4||0
11270943|NCT02323334|12466376|FG012|STARTED|Period 4||0
11270944|NCT02323334|12466377|FG013|STARTED|Period 4||0
11270945|NCT02323334|12466378|FG014|STARTED|Period 4||0
11270946|NCT02323334|12466379|FG015|STARTED|Period 4||0
11270947|NCT02323334|12466380|FG016|STARTED|Period 4||0
11270948|NCT02323334|12466364|FG000|COMPLETED|Period 4||3
11270949|NCT02323334|12466365|FG001|COMPLETED|Period 4||4
11270950|NCT02323334|12466366|FG002|COMPLETED|Period 4||3
11270951|NCT02323334|12466367|FG003|COMPLETED|Period 4||4
11270952|NCT02323334|12466368|FG004|COMPLETED|Period 4||4
11270953|NCT02323334|12466369|FG005|COMPLETED|Period 4||4
11270954|NCT02323334|12466370|FG006|COMPLETED|Period 4||0
11270955|NCT02323334|12466371|FG007|COMPLETED|Period 4||0
11270956|NCT02323334|12466372|FG008|COMPLETED|Period 4||0
11270957|NCT02323334|12466373|FG009|COMPLETED|Period 4||0
11270958|NCT02323334|12466374|FG010|COMPLETED|Period 4||0
11270959|NCT02323334|12466375|FG011|COMPLETED|Period 4||0
11270960|NCT02323334|12466376|FG012|COMPLETED|Period 4||0
11270961|NCT02323334|12466377|FG013|COMPLETED|Period 4||0
11270962|NCT02323334|12466378|FG014|COMPLETED|Period 4||0
11270963|NCT02323334|12466379|FG015|COMPLETED|Period 4||0
11270964|NCT02323334|12466380|FG016|COMPLETED|Period 4||0
11270965|NCT02323334|12466364|FG000|NOT COMPLETED|Period 4||0
11270966|NCT02323334|12466365|FG001|NOT COMPLETED|Period 4||0
11270967|NCT02323334|12466366|FG002|NOT COMPLETED|Period 4||0
11270968|NCT02323334|12466367|FG003|NOT COMPLETED|Period 4||0
11270969|NCT02323334|12466368|FG004|NOT COMPLETED|Period 4||0
11270970|NCT02323334|12466369|FG005|NOT COMPLETED|Period 4||0
11270971|NCT02323334|12466370|FG006|NOT COMPLETED|Period 4||0
11270972|NCT02323334|12466371|FG007|NOT COMPLETED|Period 4||0
11270973|NCT02323334|12466372|FG008|NOT COMPLETED|Period 4||0
11270974|NCT02323334|12466373|FG009|NOT COMPLETED|Period 4||0
11270975|NCT02323334|12466374|FG010|NOT COMPLETED|Period 4||0
11270976|NCT02323334|12466375|FG011|NOT COMPLETED|Period 4||0
11270977|NCT02323334|12466376|FG012|NOT COMPLETED|Period 4||0
11270978|NCT02323334|12466377|FG013|NOT COMPLETED|Period 4||0
11270979|NCT02323334|12466378|FG014|NOT COMPLETED|Period 4||0
11270980|NCT02323334|12466379|FG015|NOT COMPLETED|Period 4||0
11270981|NCT02323334|12466380|FG016|NOT COMPLETED|Period 4||0
11270982|NCT02323646|12466445|FG000|STARTED|Treatment Course 1||14
11270983|NCT02323646|12466446|FG001|STARTED|Treatment Course 1||13
11270984|NCT02323646|12466447|FG002|STARTED|Treatment Course 1||15
11270985|NCT02323646|12466445|FG000|COMPLETED|Treatment Course 1||11
11270986|NCT02323646|12466446|FG001|COMPLETED|Treatment Course 1||10
11270987|NCT02323646|12466447|FG002|COMPLETED|Treatment Course 1||12
11270988|NCT02323646|12466445|FG000|NOT COMPLETED|Treatment Course 1||3
11270989|NCT02323646|12466446|FG001|NOT COMPLETED|Treatment Course 1||3
11270990|NCT02323646|12466447|FG002|NOT COMPLETED|Treatment Course 1||3
11270991|NCT02323646|12466445|FG000|STARTED|Treatment Course 2||11
11270992|NCT02323646|12466446|FG001|STARTED|Treatment Course 2||10
11270993|NCT02323646|12466447|FG002|STARTED|Treatment Course 2||12
11270994|NCT02323646|12466445|FG000|COMPLETED|Treatment Course 2||10
11270995|NCT02323646|12466446|FG001|COMPLETED|Treatment Course 2||9
11270996|NCT02323646|12466447|FG002|COMPLETED|Treatment Course 2||9
11270997|NCT02323646|12466445|FG000|NOT COMPLETED|Treatment Course 2||1
11270998|NCT02323646|12466446|FG001|NOT COMPLETED|Treatment Course 2||1
11270999|NCT02323646|12466447|FG002|NOT COMPLETED|Treatment Course 2||3
11271000|NCT02323854|12466455|FG000|STARTED|Overall Study||15
11271001|NCT02323854|12466455|FG000|COMPLETED|Overall Study||15
11271002|NCT02323854|12466455|FG000|NOT COMPLETED|Overall Study||0
11271003|NCT02324049|12466459|FG000|STARTED|Part A||11
11271004|NCT02324049|12466459|FG000|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
11271005|NCT02324049|12466459|FG000|COMPLETED|Part A||11
11271006|NCT02324049|12466459|FG000|NOT COMPLETED|Part A||0
11271007|NCT02324049|12466459|FG000|STARTED|Part B||11
11271008|NCT02324049|12466459|FG000|Safety Analysis Set|Part B||11
11271009|NCT02324049|12466459|FG000|COMPLETED|Part B||11
11271010|NCT02324049|12466459|FG000|NOT COMPLETED|Part B||0
11271011|NCT02324049|12466459|FG000|STARTED|Part C||11
11271012|NCT02324049|12466459|FG000|Safety Analysis Set|Part C||11
11271013|NCT02324049|12466459|FG000|COMPLETED|Part C||0
11271014|NCT02324049|12466459|FG000|NOT COMPLETED|Part C||11
11271015|NCT02324075|12466465|FG000|STARTED|Overall Study||612
11271016|NCT02324075|12466466|FG001|STARTED|Overall Study||614
11271017|NCT02324075|12466465|FG000|COMPLETED|Overall Study||609
11271018|NCT02324075|12466466|FG001|COMPLETED|Overall Study||605
11271019|NCT02324075|12466465|FG000|NOT COMPLETED|Overall Study||3
11271020|NCT02324075|12466466|FG001|NOT COMPLETED|Overall Study||9
11271021|NCT02324153|12466475|FG000|STARTED|Overall Study||41
11271022|NCT02324153|12466476|FG001|STARTED|Overall Study||39
11271023|NCT02324153|12466475|FG000|COMPLETED|Overall Study||33
11271024|NCT02324153|12466476|FG001|COMPLETED|Overall Study||38
11271025|NCT02324153|12466475|FG000|NOT COMPLETED|Overall Study||8
11271026|NCT02324153|12466476|FG001|NOT COMPLETED|Overall Study||1
11271027|NCT02324205|12466482|FG000|STARTED|Overall Study||196
11271028|NCT02324205|12466482|FG000|COMPLETED|Overall Study||159
11271029|NCT02324205|12466482|FG000|NOT COMPLETED|Overall Study||37
11271030|NCT02324270|12466489|FG000|STARTED|Overall Study||218
11271031|NCT02324270|12466490|FG001|STARTED|Overall Study||219
11271032|NCT02324270|12466491|FG002|STARTED|Overall Study||221
11271033|NCT02324270|12466489|FG000|Safety Population|Overall Study||214
11271034|NCT02324270|12466490|FG001|Safety Population|Overall Study||216
11271035|NCT02324270|12466491|FG002|Safety Population|Overall Study||217
11271036|NCT02324270|12466489|FG000|mITT Population|Overall Study||214
11271037|NCT02324270|12466490|FG001|mITT Population|Overall Study||216
11271038|NCT02324270|12466491|FG002|mITT Population|Overall Study||217
11271039|NCT02324270|12466489|FG000|PP Population|Overall Study||180
11271040|NCT02324270|12466490|FG001|PP Population|Overall Study||177
11271041|NCT02324270|12466491|FG002|PP Population|Overall Study||171
11271042|NCT02324270|12466489|FG000|COMPLETED|Overall Study||213
11271043|NCT02324270|12466490|FG001|COMPLETED|Overall Study||212
11271044|NCT02324270|12466491|FG002|COMPLETED|Overall Study||216
11271045|NCT02324270|12466489|FG000|NOT COMPLETED|Overall Study||5
11271046|NCT02324270|12466490|FG001|NOT COMPLETED|Overall Study||7
11271047|NCT02324270|12466491|FG002|NOT COMPLETED|Overall Study||5
11271048|NCT02324335|12466501|FG000|STARTED|Overall Study||30
11271049|NCT02324335|12466502|FG001|STARTED|Overall Study||29
11271050|NCT02324335|12466501|FG000|COMPLETED|Overall Study||21
11271051|NCT02324335|12466502|FG001|COMPLETED|Overall Study||20
11271052|NCT02324335|12466501|FG000|NOT COMPLETED|Overall Study||9
11271053|NCT02324335|12466502|FG001|NOT COMPLETED|Overall Study||9
11271054|NCT02324361|12466510|FG000|STARTED|Overall Study||24
11271055|NCT02324361|12466511|FG001|STARTED|Overall Study||24
11271056|NCT02324361|12466510|FG000|COMPLETED|Overall Study||19
11271057|NCT02324361|12466511|FG001|COMPLETED|Overall Study||22
11271058|NCT02324361|12466510|FG000|NOT COMPLETED|Overall Study||5
11271059|NCT02324361|12466511|FG001|NOT COMPLETED|Overall Study||2
11271060|NCT02324465|12466519|FG000|STARTED|Overall Study||18
11271061|NCT02324465|12466520|FG001|STARTED|Overall Study||22
11271062|NCT02324465|12466519|FG000|COMPLETED|Overall Study||18
11271063|NCT02324465|12466520|FG001|COMPLETED|Overall Study||21
11271064|NCT02324465|12466519|FG000|NOT COMPLETED|Overall Study||0
11271065|NCT02324465|12466520|FG001|NOT COMPLETED|Overall Study||1
11271066|NCT02324543|12466532|FG000|STARTED|Overall Study||6
11271067|NCT02324543|12466533|FG001|STARTED|Overall Study||6
11271068|NCT02324543|12466534|FG002|STARTED|Overall Study||3
11271069|NCT02324543|12466535|FG003|STARTED|Overall Study||4
11271070|NCT02324543|12466536|FG004|STARTED|Overall Study||4
11271071|NCT02324543|12466537|FG005|STARTED|Overall Study||24
11271072|NCT02324543|12466532|FG000|COMPLETED|Overall Study||6
11271073|NCT02324543|12466533|FG001|COMPLETED|Overall Study||6
11271074|NCT02324543|12466534|FG002|COMPLETED|Overall Study||3
11271075|NCT02324543|12466535|FG003|COMPLETED|Overall Study||4
11271076|NCT02324543|12466536|FG004|COMPLETED|Overall Study||4
11271077|NCT02324543|12466537|FG005|COMPLETED|Overall Study||24
11271078|NCT02324543|12466532|FG000|NOT COMPLETED|Overall Study||0
11271079|NCT02324543|12466533|FG001|NOT COMPLETED|Overall Study||0
11271080|NCT02324543|12466534|FG002|NOT COMPLETED|Overall Study||0
11271081|NCT02324543|12466535|FG003|NOT COMPLETED|Overall Study||0
11271082|NCT02324543|12466536|FG004|NOT COMPLETED|Overall Study||0
11271083|NCT02324543|12466537|FG005|NOT COMPLETED|Overall Study||0
11271084|NCT02324569|12466549|FG000|STARTED|Overall Study||116
11271085|NCT02324569|12466550|FG001|STARTED|Overall Study||124
11271086|NCT02324569|12466549|FG000|COMPLETED|Overall Study||100
11271087|NCT02324569|12466550|FG001|COMPLETED|Overall Study||103
11271088|NCT02324569|12466549|FG000|NOT COMPLETED|Overall Study||16
11271089|NCT02324569|12466550|FG001|NOT COMPLETED|Overall Study||21
11271090|NCT02324660|12466556|FG000|STARTED|Overall Study||169
11271091|NCT02324660|12466556|FG000|COMPLETED|Overall Study||137
11271092|NCT02324660|12466556|FG000|NOT COMPLETED|Overall Study||32
11271093|NCT02324673|12466564|FG000|STARTED|Overall Study||20
11271094|NCT02324673|12466565|FG001|STARTED|Overall Study||20
11271095|NCT02324673|12466566|FG002|STARTED|Overall Study||21
11271096|NCT02324673|12466564|FG000|COMPLETED|Overall Study||20
11271097|NCT02324673|12466565|FG001|COMPLETED|Overall Study||20
11271098|NCT02324673|12466566|FG002|COMPLETED|Overall Study||21
11271099|NCT02324673|12466564|FG000|NOT COMPLETED|Overall Study||0
11021637|NCT00805389|12199777|FG004|STARTED|Overall Study||142
11021638|NCT00805389|12199773|FG000|COMPLETED|Overall Study||136
11021639|NCT00805389|12199774|FG001|COMPLETED|Overall Study||137
11021640|NCT00805389|12199775|FG002|COMPLETED|Overall Study||129
11021641|NCT00805389|12199776|FG003|COMPLETED|Overall Study||128
11021642|NCT00805389|12199777|FG004|COMPLETED|Overall Study||129
11021643|NCT00805389|12199773|FG000|NOT COMPLETED|Overall Study||7
11021644|NCT00805389|12199774|FG001|NOT COMPLETED|Overall Study||5
11021645|NCT00805389|12199775|FG002|NOT COMPLETED|Overall Study||12
11021646|NCT00805389|12199776|FG003|NOT COMPLETED|Overall Study||17
11021647|NCT00805389|12199777|FG004|NOT COMPLETED|Overall Study||13
11271100|NCT02324673|12466565|FG001|NOT COMPLETED|Overall Study||0
11271101|NCT02324673|12466566|FG002|NOT COMPLETED|Overall Study||0
11271102|NCT02324699|12466574|FG000|STARTED|Overall Study||1
11271103|NCT02324699|12466574|FG000|COMPLETED|Overall Study||0
11271104|NCT02324699|12466574|FG000|NOT COMPLETED|Overall Study||1
11271105|NCT02324842|12466581|FG000|STARTED|Overall Study||15
11271106|NCT02324842|12466582|FG001|STARTED|Overall Study||15
11021648|NCT00805441|12199801|FG000|STARTED|Overall Study||94
11271107|NCT02324842|12466583|FG002|STARTED|Overall Study||15
11271108|NCT02324842|12466581|FG000|COMPLETED|Overall Study||14
11271109|NCT02324842|12466582|FG001|COMPLETED|Overall Study||14
11271110|NCT02324842|12466583|FG002|COMPLETED|Overall Study||13
11271111|NCT02324842|12466581|FG000|NOT COMPLETED|Overall Study||1
11271112|NCT02324842|12466582|FG001|NOT COMPLETED|Overall Study||1
11271113|NCT02324842|12466583|FG002|NOT COMPLETED|Overall Study||2
11271114|NCT02324920|12466593|FG000|STARTED|Overall Study||64
11271115|NCT02324920|12466594|FG001|STARTED|Overall Study||64
11271116|NCT02324920|12466593|FG000|COMPLETED|Overall Study||63
11271117|NCT02324920|12466594|FG001|COMPLETED|Overall Study||64
11271118|NCT02324920|12466593|FG000|NOT COMPLETED|Overall Study||1
11271119|NCT02324920|12466594|FG001|NOT COMPLETED|Overall Study||0
11271120|NCT02324972|12466602|FG000|STARTED|Overall Study||26
11271121|NCT02324972|12466603|FG001|STARTED|Overall Study||28
11271122|NCT02324972|12466602|FG000|COMPLETED|Overall Study||19
11271123|NCT02324972|12466603|FG001|COMPLETED|Overall Study||23
11271124|NCT02324972|12466602|FG000|NOT COMPLETED|Overall Study||7
11271125|NCT02324972|12466603|FG001|NOT COMPLETED|Overall Study||5
11271126|NCT02325219|12466612|FG000|STARTED|Controlled Period (Week 0 - 16)||64
11271127|NCT02325219|12466613|FG001|STARTED|Controlled Period (Week 0 - 16)||65
11271128|NCT02325219|12466614|FG002|STARTED|Controlled Period (Week 0 - 16)||63
11271129|NCT02325219|12466615|FG003|STARTED|Controlled Period (Week 0 - 16)||0
11271130|NCT02325219|12466616|FG004|STARTED|Controlled Period (Week 0 - 16)||0
11271131|NCT02325219|12466612|FG000|COMPLETED|Controlled Period (Week 0 - 16)||52
11271132|NCT02325219|12466613|FG001|COMPLETED|Controlled Period (Week 0 - 16)||63
11271133|NCT02325219|12466614|FG002|COMPLETED|Controlled Period (Week 0 - 16)||62
11271134|NCT02325219|12466615|FG003|COMPLETED|Controlled Period (Week 0 - 16)||0
11271135|NCT02325219|12466616|FG004|COMPLETED|Controlled Period (Week 0 - 16)||0
11271136|NCT02325219|12466612|FG000|NOT COMPLETED|Controlled Period (Week 0 - 16)||12
11271137|NCT02325219|12466613|FG001|NOT COMPLETED|Controlled Period (Week 0 - 16)||2
11271138|NCT02325219|12466614|FG002|NOT COMPLETED|Controlled Period (Week 0 - 16)||1
11271139|NCT02325219|12466615|FG003|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
11271140|NCT02325219|12466616|FG004|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
11271141|NCT02325219|12466612|FG000|STARTED|After Controlled Period (Week 16 - 52)||0
11271142|NCT02325219|12466613|FG001|STARTED|After Controlled Period (Week 16 - 52)||63
11271143|NCT02325219|12466614|FG002|STARTED|After Controlled Period (Week 16 - 52)||62
11271144|NCT02325219|12466615|FG003|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 50 mg.|26
11271145|NCT02325219|12466616|FG004|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 100 mg.|26
11271146|NCT02325219|12466612|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0
11271147|NCT02325219|12466613|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||60
11271148|NCT02325219|12466614|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||62
11271149|NCT02325219|12466615|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||26
11271150|NCT02325219|12466616|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||25
11271151|NCT02325219|12466612|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
11271152|NCT02325219|12466613|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||3
11271153|NCT02325219|12466614|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
11271154|NCT02325219|12466615|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
11271155|NCT02325219|12466616|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||1
11271156|NCT02325401|12466632|FG000|STARTED|Overall Study||6
11271157|NCT02325401|12466633|FG001|STARTED|Overall Study||9
11271158|NCT02325401|12466634|FG002|STARTED|Overall Study||5
11271159|NCT02325401|12466632|FG000|COMPLETED|Overall Study||6
11271160|NCT02325401|12466633|FG001|COMPLETED|Overall Study||8
11271161|NCT02325401|12466634|FG002|COMPLETED|Overall Study||4
11271162|NCT02325401|12466632|FG000|NOT COMPLETED|Overall Study||0
11271163|NCT02325401|12466633|FG001|NOT COMPLETED|Overall Study||1
11271164|NCT02325401|12466634|FG002|NOT COMPLETED|Overall Study||1
11271165|NCT02325414|12466650|FG000|STARTED|Overall Study||30
11271166|NCT02325414|12466651|FG001|STARTED|Overall Study||30
11271167|NCT02325414|12466650|FG000|COMPLETED|Overall Study||22
11271168|NCT02325414|12466651|FG001|COMPLETED|Overall Study||24
11271169|NCT02325414|12466650|FG000|NOT COMPLETED|Overall Study||8
11271170|NCT02325414|12466651|FG001|NOT COMPLETED|Overall Study||6
11271171|NCT02325518|12466661|FG000|STARTED|Overall Study||98
11271172|NCT02325518|12466662|FG001|STARTED|Overall Study||103
11271173|NCT02325518|12466661|FG000|Safety Set|Overall Study||98
11271174|NCT02325518|12466662|FG001|Safety Set|Overall Study||103
11271175|NCT02325518|12466661|FG000|Full Analysis Set (FAS)|Overall Study||98
11271176|NCT02325518|12466662|FG001|Full Analysis Set (FAS)|Overall Study||101
11271177|NCT02325518|12466661|FG000|Per Protocol Set (PPS)|Overall Study||92
11271178|NCT02325518|12466662|FG001|Per Protocol Set (PPS)|Overall Study||97
11271179|NCT02325518|12466661|FG000|COMPLETED|Overall Study||94
11021649|NCT00805441|12199802|FG001|STARTED|Overall Study||96
11021650|NCT00805441|12199801|FG000|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
11021651|NCT00805441|12199802|FG001|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
11021652|NCT00805441|12199801|FG000|COMPLETED|Overall Study||60
11021653|NCT00805441|12199802|FG001|COMPLETED|Overall Study||60
11021654|NCT00805441|12199801|FG000|NOT COMPLETED|Overall Study||34
11271180|NCT02325518|12466662|FG001|COMPLETED|Overall Study||100
11271181|NCT02325518|12466661|FG000|NOT COMPLETED|Overall Study||4
11271182|NCT02325518|12466662|FG001|NOT COMPLETED|Overall Study||3
11271183|NCT02325687|12466672|FG000|STARTED|Overall Study||16
11271184|NCT02325687|12466673|FG001|STARTED|Overall Study||15
11271185|NCT02325687|12466674|FG002|STARTED|Overall Study||19
11271186|NCT02325687|12466672|FG000|COMPLETED|Overall Study||12
11271187|NCT02325687|12466673|FG001|COMPLETED|Overall Study||12
11271188|NCT02325687|12466674|FG002|COMPLETED|Overall Study||13
11271189|NCT02325687|12466672|FG000|NOT COMPLETED|Overall Study||4
11271190|NCT02325687|12466673|FG001|NOT COMPLETED|Overall Study||3
11271191|NCT02325687|12466674|FG002|NOT COMPLETED|Overall Study||6
11271192|NCT02325713|12466698|FG000|STARTED|Intervention Period 1 (2 Days)||2
11271193|NCT02325713|12466699|FG001|STARTED|Intervention Period 1 (2 Days)||2
11271194|NCT02325713|12466700|FG002|STARTED|Intervention Period 1 (2 Days)||2
11271195|NCT02325713|12466701|FG003|STARTED|Intervention Period 1 (2 Days)||2
11271196|NCT02325713|12466702|FG004|STARTED|Intervention Period 1 (2 Days)||2
11271197|NCT02325713|12466703|FG005|STARTED|Intervention Period 1 (2 Days)||2
11271198|NCT02325713|12466704|FG006|STARTED|Intervention Period 1 (2 Days)||2
11271199|NCT02325713|12466705|FG007|STARTED|Intervention Period 1 (2 Days)||2
11271200|NCT02325713|12466706|FG008|STARTED|Intervention Period 1 (2 Days)||2
11271201|NCT02325713|12466707|FG009|STARTED|Intervention Period 1 (2 Days)||2
11271202|NCT02325713|12466708|FG010|STARTED|Intervention Period 1 (2 Days)||2
11271203|NCT02325713|12466709|FG011|STARTED|Intervention Period 1 (2 Days)||2
11271204|NCT02325713|12466710|FG012|STARTED|Intervention Period 1 (2 Days)||2
11271205|NCT02325713|12466711|FG013|STARTED|Intervention Period 1 (2 Days)||2
11271206|NCT02325713|12466712|FG014|STARTED|Intervention Period 1 (2 Days)||2
11271207|NCT02325713|12466713|FG015|STARTED|Intervention Period 1 (2 Days)||2
11271208|NCT02325713|12466698|FG000|COMPLETED|Intervention Period 1 (2 Days)||2
11271209|NCT02325713|12466699|FG001|COMPLETED|Intervention Period 1 (2 Days)||2
11271210|NCT02325713|12466700|FG002|COMPLETED|Intervention Period 1 (2 Days)||2
11271211|NCT02325713|12466701|FG003|COMPLETED|Intervention Period 1 (2 Days)||2
11271212|NCT02325713|12466702|FG004|COMPLETED|Intervention Period 1 (2 Days)||2
11271213|NCT02325713|12466703|FG005|COMPLETED|Intervention Period 1 (2 Days)||2
11271214|NCT02325713|12466704|FG006|COMPLETED|Intervention Period 1 (2 Days)||2
11271215|NCT02325713|12466705|FG007|COMPLETED|Intervention Period 1 (2 Days)||2
11271216|NCT02325713|12466706|FG008|COMPLETED|Intervention Period 1 (2 Days)||2
11271217|NCT02325713|12466707|FG009|COMPLETED|Intervention Period 1 (2 Days)||2
11271218|NCT02325713|12466708|FG010|COMPLETED|Intervention Period 1 (2 Days)||1
11271219|NCT02325713|12466709|FG011|COMPLETED|Intervention Period 1 (2 Days)||2
11271220|NCT02325713|12466710|FG012|COMPLETED|Intervention Period 1 (2 Days)||2
11271221|NCT02325713|12466711|FG013|COMPLETED|Intervention Period 1 (2 Days)||2
11271222|NCT02325713|12466712|FG014|COMPLETED|Intervention Period 1 (2 Days)||2
11271223|NCT02325713|12466713|FG015|COMPLETED|Intervention Period 1 (2 Days)||2
11271224|NCT02325713|12466698|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271225|NCT02325713|12466699|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271226|NCT02325713|12466700|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271227|NCT02325713|12466701|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271228|NCT02325713|12466702|FG004|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271229|NCT02325713|12466703|FG005|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271230|NCT02325713|12466704|FG006|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271231|NCT02325713|12466705|FG007|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271232|NCT02325713|12466706|FG008|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271233|NCT02325713|12466707|FG009|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271234|NCT02325713|12466708|FG010|NOT COMPLETED|Intervention Period 1 (2 Days)||1
11271235|NCT02325713|12466709|FG011|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271236|NCT02325713|12466710|FG012|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271237|NCT02325713|12466711|FG013|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271238|NCT02325713|12466712|FG014|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271239|NCT02325713|12466713|FG015|NOT COMPLETED|Intervention Period 1 (2 Days)||0
11271240|NCT02325713|12466698|FG000|STARTED|Intervention Period 2 (2 Days)||2
11271241|NCT02325713|12466699|FG001|STARTED|Intervention Period 2 (2 Days)||2
11271242|NCT02325713|12466700|FG002|STARTED|Intervention Period 2 (2 Days)||2
11271243|NCT02325713|12466701|FG003|STARTED|Intervention Period 2 (2 Days)||2
11271244|NCT02325713|12466702|FG004|STARTED|Intervention Period 2 (2 Days)||2
11271245|NCT02325713|12466703|FG005|STARTED|Intervention Period 2 (2 Days)||2
11271246|NCT02325713|12466704|FG006|STARTED|Intervention Period 2 (2 Days)||2
11271247|NCT02325713|12466705|FG007|STARTED|Intervention Period 2 (2 Days)||2
11271248|NCT02325713|12466706|FG008|STARTED|Intervention Period 2 (2 Days)||2
11271249|NCT02325713|12466707|FG009|STARTED|Intervention Period 2 (2 Days)||2
11271250|NCT02325713|12466708|FG010|STARTED|Intervention Period 2 (2 Days)||1
11271251|NCT02325713|12466709|FG011|STARTED|Intervention Period 2 (2 Days)||2
11271252|NCT02325713|12466710|FG012|STARTED|Intervention Period 2 (2 Days)||2
11271253|NCT02325713|12466711|FG013|STARTED|Intervention Period 2 (2 Days)||2
11271254|NCT02325713|12466712|FG014|STARTED|Intervention Period 2 (2 Days)||2
11271255|NCT02325713|12466713|FG015|STARTED|Intervention Period 2 (2 Days)||2
11271256|NCT02325713|12466698|FG000|COMPLETED|Intervention Period 2 (2 Days)||1
11271257|NCT02325713|12466699|FG001|COMPLETED|Intervention Period 2 (2 Days)||2
11271258|NCT02325713|12466700|FG002|COMPLETED|Intervention Period 2 (2 Days)||2
11271259|NCT02325713|12466701|FG003|COMPLETED|Intervention Period 2 (2 Days)||2
11271260|NCT02325713|12466702|FG004|COMPLETED|Intervention Period 2 (2 Days)||2
11271261|NCT02325713|12466703|FG005|COMPLETED|Intervention Period 2 (2 Days)||2
11271262|NCT02325713|12466704|FG006|COMPLETED|Intervention Period 2 (2 Days)||2
11271263|NCT02325713|12466705|FG007|COMPLETED|Intervention Period 2 (2 Days)||2
11271264|NCT02325713|12466706|FG008|COMPLETED|Intervention Period 2 (2 Days)||2
11271265|NCT02325713|12466707|FG009|COMPLETED|Intervention Period 2 (2 Days)||2
11271266|NCT02325713|12466708|FG010|COMPLETED|Intervention Period 2 (2 Days)||1
11271267|NCT02325713|12466709|FG011|COMPLETED|Intervention Period 2 (2 Days)||2
11271268|NCT02325713|12466710|FG012|COMPLETED|Intervention Period 2 (2 Days)||2
11271269|NCT02325713|12466711|FG013|COMPLETED|Intervention Period 2 (2 Days)||2
11271270|NCT02325713|12466712|FG014|COMPLETED|Intervention Period 2 (2 Days)||2
11271271|NCT02325713|12466713|FG015|COMPLETED|Intervention Period 2 (2 Days)||2
11271272|NCT02325713|12466698|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1
11271273|NCT02325713|12466699|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11340432|NCT02920983|12537747|FG004|STARTED|Dispense 1||13
11271274|NCT02325713|12466700|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11271275|NCT02325713|12466701|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11271276|NCT02325713|12466702|FG004|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11271277|NCT02325713|12466703|FG005|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11271278|NCT02325713|12466704|FG006|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11271279|NCT02325713|12466705|FG007|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11271280|NCT02325713|12466706|FG008|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11271281|NCT02325713|12466707|FG009|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11271282|NCT02325713|12466708|FG010|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11271283|NCT02325713|12466709|FG011|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11271284|NCT02325713|12466710|FG012|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11271285|NCT02325713|12466711|FG013|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11271286|NCT02325713|12466712|FG014|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11271287|NCT02325713|12466713|FG015|NOT COMPLETED|Intervention Period 2 (2 Days)||0
11271288|NCT02325713|12466698|FG000|STARTED|Intervention Period 3 (2 Days)||1
11271289|NCT02325713|12466699|FG001|STARTED|Intervention Period 3 (2 Days)||2
11271290|NCT02325713|12466700|FG002|STARTED|Intervention Period 3 (2 Days)||2
11271291|NCT02325713|12466701|FG003|STARTED|Intervention Period 3 (2 Days)||2
11271292|NCT02325713|12466702|FG004|STARTED|Intervention Period 3 (2 Days)||2
11271293|NCT02325713|12466703|FG005|STARTED|Intervention Period 3 (2 Days)||2
11271294|NCT02325713|12466704|FG006|STARTED|Intervention Period 3 (2 Days)||2
11271295|NCT02325713|12466705|FG007|STARTED|Intervention Period 3 (2 Days)||2
11271296|NCT02325713|12466706|FG008|STARTED|Intervention Period 3 (2 Days)||2
11271297|NCT02325713|12466707|FG009|STARTED|Intervention Period 3 (2 Days)||2
11271298|NCT02325713|12466708|FG010|STARTED|Intervention Period 3 (2 Days)||1
11271299|NCT02325713|12466709|FG011|STARTED|Intervention Period 3 (2 Days)||2
11271300|NCT02325713|12466710|FG012|STARTED|Intervention Period 3 (2 Days)||2
11271301|NCT02325713|12466711|FG013|STARTED|Intervention Period 3 (2 Days)||2
11271302|NCT02325713|12466712|FG014|STARTED|Intervention Period 3 (2 Days)||2
11271303|NCT02325713|12466713|FG015|STARTED|Intervention Period 3 (2 Days)||2
11271304|NCT02325713|12466698|FG000|COMPLETED|Intervention Period 3 (2 Days)||1
11271305|NCT02325713|12466699|FG001|COMPLETED|Intervention Period 3 (2 Days)||2
11271306|NCT02325713|12466700|FG002|COMPLETED|Intervention Period 3 (2 Days)||2
11271307|NCT02325713|12466701|FG003|COMPLETED|Intervention Period 3 (2 Days)||2
11271308|NCT02325713|12466702|FG004|COMPLETED|Intervention Period 3 (2 Days)||2
11271309|NCT02325713|12466703|FG005|COMPLETED|Intervention Period 3 (2 Days)||2
11271310|NCT02325713|12466704|FG006|COMPLETED|Intervention Period 3 (2 Days)||2
11271311|NCT02325713|12466705|FG007|COMPLETED|Intervention Period 3 (2 Days)||2
11271312|NCT02325713|12466706|FG008|COMPLETED|Intervention Period 3 (2 Days)||2
11271313|NCT02325713|12466707|FG009|COMPLETED|Intervention Period 3 (2 Days)||1
11271314|NCT02325713|12466708|FG010|COMPLETED|Intervention Period 3 (2 Days)||1
11271315|NCT02325713|12466709|FG011|COMPLETED|Intervention Period 3 (2 Days)||2
11271316|NCT02325713|12466710|FG012|COMPLETED|Intervention Period 3 (2 Days)||2
11271317|NCT02325713|12466711|FG013|COMPLETED|Intervention Period 3 (2 Days)||2
11271318|NCT02325713|12466712|FG014|COMPLETED|Intervention Period 3 (2 Days)||2
11271319|NCT02325713|12466713|FG015|COMPLETED|Intervention Period 3 (2 Days)||2
11271320|NCT02325713|12466698|FG000|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11271321|NCT02325713|12466699|FG001|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11271322|NCT02325713|12466700|FG002|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11271323|NCT02325713|12466701|FG003|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11271324|NCT02325713|12466702|FG004|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11271325|NCT02325713|12466703|FG005|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11271326|NCT02325713|12466704|FG006|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11271327|NCT02325713|12466705|FG007|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11271328|NCT02325713|12466706|FG008|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11271329|NCT02325713|12466707|FG009|NOT COMPLETED|Intervention Period 3 (2 Days)||1
11271330|NCT02325713|12466708|FG010|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11271331|NCT02325713|12466709|FG011|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11271332|NCT02325713|12466710|FG012|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11271333|NCT02325713|12466711|FG013|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11397665|NCT04355767|12591834|FG001|NOT COMPLETED|Overall Study||3
11397666|NCT04356573|12591842|FG000|STARTED|Overall Study||7
11397667|NCT04356573|12591843|FG001|STARTED|Overall Study||6
11397668|NCT04356573|12591842|FG000|COMPLETED|Overall Study||6
11397669|NCT04356573|12591843|FG001|COMPLETED|Overall Study||6
11397670|NCT04356573|12591842|FG000|NOT COMPLETED|Overall Study||1
11397671|NCT04356573|12591843|FG001|NOT COMPLETED|Overall Study||0
11397672|NCT04357379|12591849|FG000|STARTED|Overall Study||10
11397673|NCT04357379|12591849|FG000|COMPLETED|Overall Study||10
11271334|NCT02325713|12466712|FG014|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11271335|NCT02325713|12466713|FG015|NOT COMPLETED|Intervention Period 3 (2 Days)||0
11271336|NCT02325713|12466698|FG000|STARTED|Intervention Period 4 (2 Days)||1
11271337|NCT02325713|12466699|FG001|STARTED|Intervention Period 4 (2 Days)||2
11271338|NCT02325713|12466700|FG002|STARTED|Intervention Period 4 (2 Days)||2
11271339|NCT02325713|12466701|FG003|STARTED|Intervention Period 4 (2 Days)||2
11271340|NCT02325713|12466702|FG004|STARTED|Intervention Period 4 (2 Days)||2
11271341|NCT02325713|12466703|FG005|STARTED|Intervention Period 4 (2 Days)||2
11271342|NCT02325713|12466704|FG006|STARTED|Intervention Period 4 (2 Days)||2
11271343|NCT02325713|12466705|FG007|STARTED|Intervention Period 4 (2 Days)||2
11271344|NCT02325713|12466706|FG008|STARTED|Intervention Period 4 (2 Days)||2
11271345|NCT02325713|12466707|FG009|STARTED|Intervention Period 4 (2 Days)||1
11271346|NCT02325713|12466708|FG010|STARTED|Intervention Period 4 (2 Days)||1
11271347|NCT02325713|12466709|FG011|STARTED|Intervention Period 4 (2 Days)||2
11271348|NCT02325713|12466710|FG012|STARTED|Intervention Period 4 (2 Days)||2
11271349|NCT02325713|12466711|FG013|STARTED|Intervention Period 4 (2 Days)||2
11271350|NCT02325713|12466712|FG014|STARTED|Intervention Period 4 (2 Days)||2
11271351|NCT02325713|12466713|FG015|STARTED|Intervention Period 4 (2 Days)||2
11271352|NCT02325713|12466698|FG000|COMPLETED|Intervention Period 4 (2 Days)||1
11271353|NCT02325713|12466699|FG001|COMPLETED|Intervention Period 4 (2 Days)||2
11271354|NCT02325713|12466700|FG002|COMPLETED|Intervention Period 4 (2 Days)||2
11271355|NCT02325713|12466701|FG003|COMPLETED|Intervention Period 4 (2 Days)||2
11271356|NCT02325713|12466702|FG004|COMPLETED|Intervention Period 4 (2 Days)||2
11271357|NCT02325713|12466703|FG005|COMPLETED|Intervention Period 4 (2 Days)||2
11271358|NCT02325713|12466704|FG006|COMPLETED|Intervention Period 4 (2 Days)||2
11397674|NCT04357379|12591849|FG000|NOT COMPLETED|Overall Study||0
11271359|NCT02325713|12466705|FG007|COMPLETED|Intervention Period 4 (2 Days)||2
11271360|NCT02325713|12466706|FG008|COMPLETED|Intervention Period 4 (2 Days)||2
11271361|NCT02325713|12466707|FG009|COMPLETED|Intervention Period 4 (2 Days)||1
11271362|NCT02325713|12466708|FG010|COMPLETED|Intervention Period 4 (2 Days)||1
11271363|NCT02325713|12466709|FG011|COMPLETED|Intervention Period 4 (2 Days)||2
11271364|NCT02325713|12466710|FG012|COMPLETED|Intervention Period 4 (2 Days)||2
11271365|NCT02325713|12466711|FG013|COMPLETED|Intervention Period 4 (2 Days)||2
11271366|NCT02325713|12466712|FG014|COMPLETED|Intervention Period 4 (2 Days)||2
11271367|NCT02325713|12466713|FG015|COMPLETED|Intervention Period 4 (2 Days)||2
11271368|NCT02325713|12466698|FG000|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271369|NCT02325713|12466699|FG001|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271370|NCT02325713|12466700|FG002|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271371|NCT02325713|12466701|FG003|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271372|NCT02325713|12466702|FG004|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271373|NCT02325713|12466703|FG005|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271374|NCT02325713|12466704|FG006|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271375|NCT02325713|12466705|FG007|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271376|NCT02325713|12466706|FG008|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271377|NCT02325713|12466707|FG009|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271378|NCT02325713|12466708|FG010|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271379|NCT02325713|12466709|FG011|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271380|NCT02325713|12466710|FG012|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271381|NCT02325713|12466711|FG013|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271382|NCT02325713|12466712|FG014|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11340433|NCT02920983|12537748|FG005|STARTED|Dispense 1||7
11340434|NCT02920983|12537743|FG000|COMPLETED|Dispense 1||8
11340435|NCT02920983|12537744|FG001|COMPLETED|Dispense 1||10
11340436|NCT02920983|12537745|FG002|COMPLETED|Dispense 1||7
11340437|NCT02920983|12537746|FG003|COMPLETED|Dispense 1||6
11340438|NCT02920983|12537747|FG004|COMPLETED|Dispense 1||12
11340439|NCT02920983|12537748|FG005|COMPLETED|Dispense 1||7
11340440|NCT02920983|12537743|FG000|NOT COMPLETED|Dispense 1||0
11340441|NCT02920983|12537744|FG001|NOT COMPLETED|Dispense 1||0
11340442|NCT02920983|12537745|FG002|NOT COMPLETED|Dispense 1||0
11340443|NCT02920983|12537746|FG003|NOT COMPLETED|Dispense 1||0
11340444|NCT02920983|12537747|FG004|NOT COMPLETED|Dispense 1||1
11397675|NCT04358068|12591855|FG000|STARTED|Overall Study||9
11340445|NCT02920983|12537748|FG005|NOT COMPLETED|Dispense 1||0
11397676|NCT04358068|12591856|FG001|STARTED|Overall Study||11
11397677|NCT04358068|12591855|FG000|COMPLETED|Overall Study||7
11397678|NCT04358068|12591856|FG001|COMPLETED|Overall Study||9
11397679|NCT04358068|12591855|FG000|NOT COMPLETED|Overall Study||2
11397680|NCT04358068|12591856|FG001|NOT COMPLETED|Overall Study||2
11397681|NCT04366349|12591868|FG000|STARTED|Overall Study||13
11397682|NCT04366349|12591869|FG001|STARTED|Overall Study||18
11397683|NCT04366349|12591870|FG002|STARTED|Overall Study||18
11397684|NCT04366349|12591871|FG003|STARTED|Overall Study||4
11397685|NCT04366349|12591872|FG004|STARTED|Overall Study||6
11397686|NCT04366349|12591873|FG005|STARTED|Overall Study||6
11397687|NCT04366349|12591868|FG000|COMPLETED|Overall Study||12
11397688|NCT04366349|12591869|FG001|COMPLETED|Overall Study||18
11397689|NCT04366349|12591870|FG002|COMPLETED|Overall Study||18
11397690|NCT04366349|12591871|FG003|COMPLETED|Overall Study||4
11397691|NCT04366349|12591872|FG004|COMPLETED|Overall Study||6
11397692|NCT04366349|12591873|FG005|COMPLETED|Overall Study||6
11397693|NCT04366349|12591868|FG000|NOT COMPLETED|Overall Study||1
11397694|NCT04366349|12591869|FG001|NOT COMPLETED|Overall Study||0
11397695|NCT04366349|12591870|FG002|NOT COMPLETED|Overall Study||0
11397696|NCT04366349|12591871|FG003|NOT COMPLETED|Overall Study||0
11397697|NCT04366349|12591872|FG004|NOT COMPLETED|Overall Study||0
11397698|NCT04366349|12591873|FG005|NOT COMPLETED|Overall Study||0
11397699|NCT04369885|12591891|FG000|STARTED|Overall Study||12
11397700|NCT04369885|12591891|FG000|COMPLETED|Overall Study||10
11397701|NCT04369885|12591891|FG000|NOT COMPLETED|Overall Study||2
11397702|NCT04373421|12591898|FG000|STARTED|Overall Study||30
11397703|NCT04373421|12591899|FG001|STARTED|Overall Study||30
11397704|NCT04373421|12591900|FG002|STARTED|Overall Study||30
11397705|NCT04373421|12591898|FG000|COMPLETED|Overall Study||26
11397706|NCT04373421|12591899|FG001|COMPLETED|Overall Study||26
11397707|NCT04373421|12591900|FG002|COMPLETED|Overall Study||29
11397708|NCT04373421|12591898|FG000|NOT COMPLETED|Overall Study||4
11397709|NCT04373421|12591899|FG001|NOT COMPLETED|Overall Study||4
11397710|NCT04373421|12591900|FG002|NOT COMPLETED|Overall Study||1
11397711|NCT04381728|12591911|FG000|STARTED|Overall Study||23
11397712|NCT04381728|12591911|FG000|COMPLETED|Overall Study||23
11397713|NCT04381728|12591911|FG000|NOT COMPLETED|Overall Study||0
11397714|NCT04394845|12591915|FG000|STARTED|Overall Study||6
11397715|NCT04394845|12591915|FG000|COMPLETED|Overall Study||6
11397716|NCT04394845|12591915|FG000|NOT COMPLETED|Overall Study||0
11397717|NCT04398732|12591921|FG000|STARTED|Overall Study||486
11397718|NCT04398732|12591921|FG000|COMPLETED|Overall Study||436
11397719|NCT04398732|12591921|FG000|NOT COMPLETED|Overall Study||50
11397720|NCT04401293|12591929|FG000|STARTED|Overall Study||130
11397721|NCT04401293|12591930|FG001|STARTED|Overall Study||127
11397722|NCT04401293|12591929|FG000|COMPLETED|Overall Study||129
11397723|NCT04401293|12591930|FG001|COMPLETED|Overall Study||124
11397724|NCT04401293|12591929|FG000|NOT COMPLETED|Overall Study||1
11397725|NCT04401293|12591930|FG001|NOT COMPLETED|Overall Study||3
11397726|NCT04411628|12591940|FG000|STARTED|Overall Study||7
11397727|NCT04411628|12591941|FG001|STARTED|Overall Study||6
11397728|NCT04411628|12591942|FG002|STARTED|Overall Study||7
11397729|NCT04411628|12591943|FG003|STARTED|Overall Study||6
11271383|NCT02325713|12466713|FG015|NOT COMPLETED|Intervention Period 4 (2 Days)||0
11271384|NCT02325739|12466739|FG000|STARTED|Phase I Part||11
11271385|NCT02325739|12466740|FG001|STARTED|Phase I Part||6
11271386|NCT02325739|12466741|FG002|STARTED|Phase I Part||5
11271387|NCT02325739|12466742|FG003|STARTED|Phase I Part||26
11271388|NCT02325739|12466743|FG004|STARTED|Phase I Part||19
11271389|NCT02325739|12466744|FG005|STARTED|Phase I Part||7
11271390|NCT02325739|12466745|FG006|STARTED|Phase I Part||6
11271391|NCT02325739|12466746|FG007|STARTED|Phase I Part||6
11271392|NCT02325739|12466747|FG008|STARTED|Phase I Part||0
11271393|NCT02325739|12466748|FG009|STARTED|Phase I Part||0
11271394|NCT02325739|12466749|FG010|STARTED|Phase I Part||0
11271395|NCT02325739|12466739|FG000|COMPLETED|Phase I Part||0
11271396|NCT02325739|12466740|FG001|COMPLETED|Phase I Part||0
11271397|NCT02325739|12466741|FG002|COMPLETED|Phase I Part||0
11271398|NCT02325739|12466742|FG003|COMPLETED|Phase I Part||0
11271399|NCT02325739|12466743|FG004|COMPLETED|Phase I Part||0
11271400|NCT02325739|12466744|FG005|COMPLETED|Phase I Part||0
11271401|NCT02325739|12466745|FG006|COMPLETED|Phase I Part||0
11271402|NCT02325739|12466746|FG007|COMPLETED|Phase I Part||0
11271403|NCT02325739|12466747|FG008|COMPLETED|Phase I Part||0
11271404|NCT02325739|12466748|FG009|COMPLETED|Phase I Part||0
11271405|NCT02325739|12466749|FG010|COMPLETED|Phase I Part||0
11271406|NCT02325739|12466739|FG000|NOT COMPLETED|Phase I Part||11
11271407|NCT02325739|12466740|FG001|NOT COMPLETED|Phase I Part||6
11271408|NCT02325739|12466741|FG002|NOT COMPLETED|Phase I Part||5
11271409|NCT02325739|12466742|FG003|NOT COMPLETED|Phase I Part||26
11397730|NCT04411628|12591940|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
11397731|NCT04411628|12591941|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
11397732|NCT04411628|12591942|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11397733|NCT04411628|12591943|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
11397734|NCT04411628|12591940|FG000|COMPLETED|Overall Study||6
11271410|NCT02325739|12466743|FG004|NOT COMPLETED|Phase I Part||19
11271411|NCT02325739|12466744|FG005|NOT COMPLETED|Phase I Part||7
11271412|NCT02325739|12466745|FG006|NOT COMPLETED|Phase I Part||6
11271413|NCT02325739|12466746|FG007|NOT COMPLETED|Phase I Part||6
11271414|NCT02325739|12466747|FG008|NOT COMPLETED|Phase I Part||0
11271415|NCT02325739|12466748|FG009|NOT COMPLETED|Phase I Part||0
11271416|NCT02325739|12466749|FG010|NOT COMPLETED|Phase I Part||0
11271417|NCT02325739|12466739|FG000|STARTED|Phase II Part||0
11271418|NCT02325739|12466740|FG001|STARTED|Phase II Part||0
11271419|NCT02325739|12466741|FG002|STARTED|Phase II Part||0
11271420|NCT02325739|12466742|FG003|STARTED|Phase II Part||0
11271421|NCT02325739|12466743|FG004|STARTED|Phase II Part||0
11271422|NCT02325739|12466744|FG005|STARTED|Phase II Part||0
11271423|NCT02325739|12466745|FG006|STARTED|Phase II Part||0
11271424|NCT02325739|12466746|FG007|STARTED|Phase II Part||0
11271425|NCT02325739|12466747|FG008|STARTED|Phase II Part||30
11271426|NCT02325739|12466748|FG009|STARTED|Phase II Part||36
11271427|NCT02325739|12466749|FG010|STARTED|Phase II Part||20
11271428|NCT02325739|12466739|FG000|COMPLETED|Phase II Part||0
11271429|NCT02325739|12466740|FG001|COMPLETED|Phase II Part||0
11271430|NCT02325739|12466741|FG002|COMPLETED|Phase II Part||0
11271431|NCT02325739|12466742|FG003|COMPLETED|Phase II Part||0
11271432|NCT02325739|12466743|FG004|COMPLETED|Phase II Part||0
11271433|NCT02325739|12466744|FG005|COMPLETED|Phase II Part||0
11271434|NCT02325739|12466745|FG006|COMPLETED|Phase II Part||0
11271435|NCT02325739|12466746|FG007|COMPLETED|Phase II Part||0
11271436|NCT02325739|12466747|FG008|COMPLETED|Phase II Part||0
11271437|NCT02325739|12466748|FG009|COMPLETED|Phase II Part||0
11271438|NCT02325739|12466749|FG010|COMPLETED|Phase II Part||0
11271439|NCT02325739|12466739|FG000|NOT COMPLETED|Phase II Part||0
11271440|NCT02325739|12466740|FG001|NOT COMPLETED|Phase II Part||0
11271441|NCT02325739|12466741|FG002|NOT COMPLETED|Phase II Part||0
11271442|NCT02325739|12466742|FG003|NOT COMPLETED|Phase II Part||0
11271443|NCT02325739|12466743|FG004|NOT COMPLETED|Phase II Part||0
11271444|NCT02325739|12466744|FG005|NOT COMPLETED|Phase II Part||0
11271445|NCT02325739|12466745|FG006|NOT COMPLETED|Phase II Part||0
11271446|NCT02325739|12466746|FG007|NOT COMPLETED|Phase II Part||0
11271447|NCT02325739|12466747|FG008|NOT COMPLETED|Phase II Part||30
11271448|NCT02325739|12466748|FG009|NOT COMPLETED|Phase II Part||36
11271449|NCT02325739|12466749|FG010|NOT COMPLETED|Phase II Part||20
11271450|NCT02325791|12466798|FG000|STARTED|Overall Study||23
11271451|NCT02325791|12466799|FG001|STARTED|Overall Study||383
11271452|NCT02325791|12466800|FG002|STARTED|Overall Study||385
11271453|NCT02325791|12466801|FG003|STARTED|Overall Study||381
11271454|NCT02325791|12466798|FG000|COMPLETED|Overall Study||23
11271455|NCT02325791|12466799|FG001|COMPLETED|Overall Study||358
11271456|NCT02325791|12466800|FG002|COMPLETED|Overall Study||360
11271457|NCT02325791|12466801|FG003|COMPLETED|Overall Study||355
11271458|NCT02325791|12466798|FG000|NOT COMPLETED|Overall Study||0
11271459|NCT02325791|12466799|FG001|NOT COMPLETED|Overall Study||25
11271460|NCT02325791|12466800|FG002|NOT COMPLETED|Overall Study||25
11271461|NCT02325791|12466801|FG003|NOT COMPLETED|Overall Study||26
11271462|NCT02325856|12466816|FG000|STARTED|Overall Study||148
11271463|NCT02325856|12466817|FG001|STARTED|Overall Study||150
11271464|NCT02325856|12466816|FG000|COMPLETED|Overall Study||128
11271465|NCT02325856|12466817|FG001|COMPLETED|Overall Study||123
11271466|NCT02325856|12466816|FG000|NOT COMPLETED|Overall Study||20
11271467|NCT02325856|12466817|FG001|NOT COMPLETED|Overall Study||27
11271468|NCT02326025|12466825|FG000|STARTED|Overall Study||25
11271469|NCT02326025|12466826|FG001|STARTED|Overall Study||24
11271470|NCT02326025|12466825|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25
11271471|NCT02326025|12466826|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24
11271472|NCT02326025|12466825|FG000|COMPLETED|Overall Study||20
11271473|NCT02326025|12466826|FG001|COMPLETED|Overall Study||19
11271474|NCT02326025|12466825|FG000|NOT COMPLETED|Overall Study||5
11271475|NCT02326025|12466826|FG001|NOT COMPLETED|Overall Study||5
11271476|NCT02326220|12466847|FG000|STARTED|Double-blind Treatment Period|Out of 21 participants, 9 participants entered in open label treatment period|21
11271477|NCT02326220|12466848|FG001|STARTED|Double-blind Treatment Period|Out of 41 participants, 20 participants entered in open label treatment period.|41
11271478|NCT02326220|12466849|FG002|STARTED|Double-blind Treatment Period||0
11271479|NCT02326220|12466847|FG000|COMPLETED|Double-blind Treatment Period||20
11271480|NCT02326220|12466848|FG001|COMPLETED|Double-blind Treatment Period||37
11271481|NCT02326220|12466849|FG002|COMPLETED|Double-blind Treatment Period||0
11271482|NCT02326220|12466847|FG000|NOT COMPLETED|Double-blind Treatment Period||1
11271483|NCT02326220|12466848|FG001|NOT COMPLETED|Double-blind Treatment Period||4
11271484|NCT02326220|12466849|FG002|NOT COMPLETED|Double-blind Treatment Period||0
11271485|NCT02326220|12466847|FG000|STARTED|Open-label Treatment Period||0
11271486|NCT02326220|12466848|FG001|STARTED|Open-label Treatment Period||0
11271487|NCT02326220|12466849|FG002|STARTED|Open-label Treatment Period|29 participants: 9 from Placebo and 20 from Alirocumab 150 mg arm entered in open-label period.|29
11271488|NCT02326220|12466847|FG000|COMPLETED|Open-label Treatment Period||0
11271489|NCT02326220|12466848|FG001|COMPLETED|Open-label Treatment Period||0
11271490|NCT02326220|12466849|FG002|COMPLETED|Open-label Treatment Period||27
11271491|NCT02326220|12466847|FG000|NOT COMPLETED|Open-label Treatment Period||0
11271492|NCT02326220|12466848|FG001|NOT COMPLETED|Open-label Treatment Period||0
11271493|NCT02326220|12466849|FG002|NOT COMPLETED|Open-label Treatment Period||2
11271494|NCT02326233|12466861|FG000|STARTED|Overall Study||95
11271495|NCT02326233|12466862|FG001|STARTED|Overall Study||95
11271496|NCT02326233|12466861|FG000|COMPLETED|Overall Study||95
11271497|NCT02326233|12466862|FG001|COMPLETED|Overall Study||94
11271498|NCT02326233|12466861|FG000|NOT COMPLETED|Overall Study||0
11271499|NCT02326233|12466862|FG001|NOT COMPLETED|Overall Study||1
11271500|NCT02326272|12466871|FG000|STARTED|Initial Period (Week 0 to Week 16)||49
11271501|NCT02326272|12466872|FG001|STARTED|Initial Period (Week 0 to Week 16)||91
11271502|NCT02326272|12466873|FG002|STARTED|Initial Period (Week 0 to Week 16)||87
11271503|NCT02326272|12466874|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
11271504|NCT02326272|12466875|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
11271505|NCT02326272|12466876|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
11271506|NCT02326272|12466877|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
11271507|NCT02326272|12466878|FG007|STARTED|Initial Period (Week 0 to Week 16)||0
11271508|NCT02326272|12466879|FG008|STARTED|Initial Period (Week 0 to Week 16)||0
11271509|NCT02326272|12466880|FG009|STARTED|Initial Period (Week 0 to Week 16)||0
11271510|NCT02326272|12466881|FG010|STARTED|Initial Period (Week 0 to Week 16)||0
11271511|NCT02326272|12466882|FG011|STARTED|Initial Period (Week 0 to Week 16)||0
11271512|NCT02326272|12466883|FG012|STARTED|Initial Period (Week 0 to Week 16)||0
11271513|NCT02326272|12466884|FG013|STARTED|Initial Period (Week 0 to Week 16)||0
11271514|NCT02326272|12466885|FG014|STARTED|Initial Period (Week 0 to Week 16)||0
11271515|NCT02326272|12466871|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||45
11271516|NCT02326272|12466872|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||84
11271517|NCT02326272|12466873|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||83
11271518|NCT02326272|12466874|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271519|NCT02326272|12466875|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271520|NCT02326272|12466876|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271521|NCT02326272|12466877|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271522|NCT02326272|12466878|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271523|NCT02326272|12466879|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271524|NCT02326272|12466880|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271525|NCT02326272|12466881|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271526|NCT02326272|12466882|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271527|NCT02326272|12466883|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271528|NCT02326272|12466884|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271529|NCT02326272|12466885|FG014|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271530|NCT02326272|12466871|FG000|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
11271531|NCT02326272|12466872|FG001|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
11271532|NCT02326272|12466873|FG002|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
11271533|NCT02326272|12466874|FG003|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271534|NCT02326272|12466875|FG004|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271535|NCT02326272|12466876|FG005|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271536|NCT02326272|12466877|FG006|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271537|NCT02326272|12466878|FG007|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271538|NCT02326272|12466879|FG008|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271539|NCT02326272|12466880|FG009|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271540|NCT02326272|12466881|FG010|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271541|NCT02326272|12466882|FG011|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271542|NCT02326272|12466883|FG012|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271543|NCT02326272|12466884|FG013|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271544|NCT02326272|12466885|FG014|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271545|NCT02326272|12466871|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||45
11271546|NCT02326272|12466872|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||84
11271547|NCT02326272|12466873|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||81
11271548|NCT02326272|12466874|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271549|NCT02326272|12466875|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271550|NCT02326272|12466876|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271551|NCT02326272|12466877|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271552|NCT02326272|12466878|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271553|NCT02326272|12466879|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271554|NCT02326272|12466880|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271555|NCT02326272|12466881|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271556|NCT02326272|12466882|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271557|NCT02326272|12466883|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271558|NCT02326272|12466884|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271559|NCT02326272|12466885|FG014|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271560|NCT02326272|12466871|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
11271561|NCT02326272|12466872|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
11271562|NCT02326272|12466873|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
11271563|NCT02326272|12466874|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271564|NCT02326272|12466875|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271565|NCT02326272|12466876|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271566|NCT02326272|12466877|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271567|NCT02326272|12466878|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271568|NCT02326272|12466879|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271569|NCT02326272|12466880|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271570|NCT02326272|12466881|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271571|NCT02326272|12466882|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271572|NCT02326272|12466883|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271573|NCT02326272|12466884|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271574|NCT02326272|12466885|FG014|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271575|NCT02326272|12466871|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271576|NCT02326272|12466872|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271577|NCT02326272|12466873|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271578|NCT02326272|12466874|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||6
11271579|NCT02326272|12466875|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5
11271580|NCT02326272|12466876|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||76
11271581|NCT02326272|12466877|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||69
11271582|NCT02326272|12466878|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||34
11271583|NCT02326272|12466879|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||8
11271584|NCT02326272|12466880|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||12
11271585|NCT02326272|12466881|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271586|NCT02326272|12466882|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271587|NCT02326272|12466883|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271588|NCT02326272|12466884|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271589|NCT02326272|12466885|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271590|NCT02326272|12466871|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271591|NCT02326272|12466872|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271592|NCT02326272|12466873|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271593|NCT02326272|12466874|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
11271594|NCT02326272|12466875|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
11271595|NCT02326272|12466876|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64
11271596|NCT02326272|12466877|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61
11271597|NCT02326272|12466878|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27
11271598|NCT02326272|12466879|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
11271599|NCT02326272|12466880|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10
11271600|NCT02326272|12466881|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271601|NCT02326272|12466882|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271602|NCT02326272|12466883|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271603|NCT02326272|12466884|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271604|NCT02326272|12466885|FG014|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271605|NCT02326272|12466871|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271606|NCT02326272|12466872|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271607|NCT02326272|12466873|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271608|NCT02326272|12466874|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
11271609|NCT02326272|12466875|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
11271610|NCT02326272|12466876|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63
11271611|NCT02326272|12466877|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60
11271612|NCT02326272|12466878|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27
11271613|NCT02326272|12466879|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
11271614|NCT02326272|12466880|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10
11271615|NCT02326272|12466881|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271616|NCT02326272|12466882|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271617|NCT02326272|12466883|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271618|NCT02326272|12466884|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271619|NCT02326272|12466885|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271620|NCT02326272|12466871|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271621|NCT02326272|12466872|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271622|NCT02326272|12466873|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271623|NCT02326272|12466874|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
11271624|NCT02326272|12466875|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
11271625|NCT02326272|12466876|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||63
11271626|NCT02326272|12466877|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||60
11271627|NCT02326272|12466878|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
11271628|NCT02326272|12466879|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
11271629|NCT02326272|12466880|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
11271630|NCT02326272|12466881|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271631|NCT02326272|12466882|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271632|NCT02326272|12466883|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271633|NCT02326272|12466884|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271634|NCT02326272|12466885|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271635|NCT02326272|12466871|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271636|NCT02326272|12466872|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271637|NCT02326272|12466873|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271638|NCT02326272|12466874|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
11271639|NCT02326272|12466875|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
11271640|NCT02326272|12466876|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13
11271641|NCT02326272|12466877|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9
11271642|NCT02326272|12466878|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
11271643|NCT02326272|12466879|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
11271644|NCT02326272|12466880|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
11271645|NCT02326272|12466881|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271646|NCT02326272|12466882|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271647|NCT02326272|12466883|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271648|NCT02326272|12466884|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271649|NCT02326272|12466885|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271650|NCT02326272|12466871|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0
11271651|NCT02326272|12466872|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0
11271652|NCT02326272|12466873|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0
11271653|NCT02326272|12466874|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0
11271654|NCT02326272|12466875|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0
11271655|NCT02326272|12466876|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0
11271656|NCT02326272|12466877|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0
11271657|NCT02326272|12466878|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0
11271658|NCT02326272|12466879|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0
11271659|NCT02326272|12466880|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0
11271660|NCT02326272|12466881|FG010|STARTED|Open-label Period (Week 48 to Week 144)||5
11271661|NCT02326272|12466882|FG011|STARTED|Open-label Period (Week 48 to Week 144)||66
11271662|NCT02326272|12466883|FG012|STARTED|Open-label Period (Week 48 to Week 144)||59
11271663|NCT02326272|12466884|FG013|STARTED|Open-label Period (Week 48 to Week 144)||1
11271664|NCT02326272|12466885|FG014|STARTED|Open-label Period (Week 48 to Week 144)||40
11271665|NCT02326272|12466871|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271666|NCT02326272|12466872|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271667|NCT02326272|12466873|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271668|NCT02326272|12466874|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271669|NCT02326272|12466875|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271670|NCT02326272|12466876|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271671|NCT02326272|12466877|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271672|NCT02326272|12466878|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271673|NCT02326272|12466879|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271674|NCT02326272|12466880|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271675|NCT02326272|12466881|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||2
11271676|NCT02326272|12466882|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||51
11271677|NCT02326272|12466883|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||48
11271678|NCT02326272|12466884|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||1
11271679|NCT02326272|12466885|FG014|COMPLETED|Open-label Period (Week 48 to Week 144)||31
11271680|NCT02326272|12466871|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271681|NCT02326272|12466872|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271682|NCT02326272|12466873|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271683|NCT02326272|12466874|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271684|NCT02326272|12466875|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271685|NCT02326272|12466876|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271686|NCT02326272|12466877|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271687|NCT02326272|12466878|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271688|NCT02326272|12466879|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271689|NCT02326272|12466880|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271690|NCT02326272|12466881|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3
11271691|NCT02326272|12466882|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15
11271692|NCT02326272|12466883|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11
11271693|NCT02326272|12466884|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271694|NCT02326272|12466885|FG014|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
11271695|NCT02326298|12466897|FG000|STARTED|Initial Period (Week 0 to Week 16)||51
11271696|NCT02326298|12466898|FG001|STARTED|Initial Period (Week 0 to Week 16)||95
11271697|NCT02326298|12466899|FG002|STARTED|Initial Period (Week 0 to Week 16)||88
11271698|NCT02326298|12466900|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
11271699|NCT02326298|12466901|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
11271700|NCT02326298|12466902|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
11271701|NCT02326298|12466903|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
11271702|NCT02326298|12466904|FG007|STARTED|Initial Period (Week 0 to Week 16)||0
11271703|NCT02326298|12466905|FG008|STARTED|Initial Period (Week 0 to Week 16)||0
11271704|NCT02326298|12466906|FG009|STARTED|Initial Period (Week 0 to Week 16)||0
11271705|NCT02326298|12466907|FG010|STARTED|Initial Period (Week 0 to Week 16)||0
11271706|NCT02326298|12466908|FG011|STARTED|Initial Period (Week 0 to Week 16)||0
11271707|NCT02326298|12466909|FG012|STARTED|Initial Period (Week 0 to Week 16)||0
11271708|NCT02326298|12466910|FG013|STARTED|Initial Period (Week 0 to Week 16)||0
11271709|NCT02326298|12466897|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||46
11271710|NCT02326298|12466898|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||92
11271711|NCT02326298|12466899|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||87
11271712|NCT02326298|12466900|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271713|NCT02326298|12466901|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271714|NCT02326298|12466902|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271715|NCT02326298|12466903|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271716|NCT02326298|12466904|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271717|NCT02326298|12466905|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271718|NCT02326298|12466906|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271719|NCT02326298|12466907|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271720|NCT02326298|12466908|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271721|NCT02326298|12466909|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271722|NCT02326298|12466910|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0
11271723|NCT02326298|12466897|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46
11271724|NCT02326298|12466898|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92
11271725|NCT02326298|12466899|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85
11271726|NCT02326298|12466900|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271727|NCT02326298|12466901|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271728|NCT02326298|12466902|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271729|NCT02326298|12466903|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271730|NCT02326298|12466904|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271731|NCT02326298|12466905|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271732|NCT02326298|12466906|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271733|NCT02326298|12466907|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271734|NCT02326298|12466908|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271735|NCT02326298|12466909|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271736|NCT02326298|12466910|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
11271737|NCT02326298|12466897|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||46
11271738|NCT02326298|12466898|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||92
11271739|NCT02326298|12466899|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||85
11271740|NCT02326298|12466900|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271741|NCT02326298|12466901|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271742|NCT02326298|12466902|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271743|NCT02326298|12466903|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271744|NCT02326298|12466904|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271745|NCT02326298|12466905|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271746|NCT02326298|12466906|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271747|NCT02326298|12466907|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271748|NCT02326298|12466908|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271749|NCT02326298|12466909|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271750|NCT02326298|12466910|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0
11271751|NCT02326298|12466897|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5
11271752|NCT02326298|12466898|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
11271753|NCT02326298|12466899|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
11271754|NCT02326298|12466900|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271755|NCT02326298|12466901|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271756|NCT02326298|12466902|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271757|NCT02326298|12466903|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271758|NCT02326298|12466904|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271759|NCT02326298|12466905|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271760|NCT02326298|12466906|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271761|NCT02326298|12466907|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271762|NCT02326298|12466908|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271763|NCT02326298|12466909|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271764|NCT02326298|12466910|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
11271765|NCT02326298|12466897|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271766|NCT02326298|12466898|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271767|NCT02326298|12466899|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271768|NCT02326298|12466900|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||3
11271769|NCT02326298|12466901|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5
11271770|NCT02326298|12466902|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||74
11271771|NCT02326298|12466903|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||77
11271772|NCT02326298|12466904|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||38
11271773|NCT02326298|12466905|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||18
11271774|NCT02326298|12466906|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||8
11271775|NCT02326298|12466907|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271776|NCT02326298|12466908|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271777|NCT02326298|12466909|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271778|NCT02326298|12466910|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0
11271779|NCT02326298|12466897|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271780|NCT02326298|12466898|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271781|NCT02326298|12466899|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271782|NCT02326298|12466900|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
11271783|NCT02326298|12466901|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
11271784|NCT02326298|12466902|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71
11271785|NCT02326298|12466903|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70
11271786|NCT02326298|12466904|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33
11271787|NCT02326298|12466905|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13
11271788|NCT02326298|12466906|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7
11271789|NCT02326298|12466907|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271790|NCT02326298|12466908|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271791|NCT02326298|12466909|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271792|NCT02326298|12466910|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
11271793|NCT02326298|12466897|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271794|NCT02326298|12466898|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271795|NCT02326298|12466899|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271796|NCT02326298|12466900|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
11271797|NCT02326298|12466901|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
11271798|NCT02326298|12466902|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69
11271799|NCT02326298|12466903|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70
11271800|NCT02326298|12466904|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33
11271801|NCT02326298|12466905|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13
11271802|NCT02326298|12466906|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7
11271803|NCT02326298|12466907|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271804|NCT02326298|12466908|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271805|NCT02326298|12466909|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271806|NCT02326298|12466910|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11271807|NCT02326298|12466897|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271808|NCT02326298|12466898|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271809|NCT02326298|12466899|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271810|NCT02326298|12466900|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
11271811|NCT02326298|12466901|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
11271812|NCT02326298|12466902|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||69
11271813|NCT02326298|12466903|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||70
11271814|NCT02326298|12466904|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||33
11271815|NCT02326298|12466905|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||13
11271816|NCT02326298|12466906|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||7
11271817|NCT02326298|12466907|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271818|NCT02326298|12466908|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271819|NCT02326298|12466909|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271820|NCT02326298|12466910|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271821|NCT02326298|12466897|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271822|NCT02326298|12466898|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271823|NCT02326298|12466899|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271824|NCT02326298|12466900|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271825|NCT02326298|12466901|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271826|NCT02326298|12466902|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
11271827|NCT02326298|12466903|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
11271828|NCT02326298|12466904|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
11271829|NCT02326298|12466905|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
11271830|NCT02326298|12466906|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
11271831|NCT02326298|12466907|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271832|NCT02326298|12466908|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271833|NCT02326298|12466909|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271834|NCT02326298|12466910|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11271835|NCT02326298|12466897|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0
11271836|NCT02326298|12466898|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0
11271837|NCT02326298|12466899|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0
11271838|NCT02326298|12466900|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0
11340446|NCT02920983|12537743|FG000|STARTED|Dispense 2||8
11271839|NCT02326298|12466901|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0
11271840|NCT02326298|12466902|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0
11271841|NCT02326298|12466903|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0
11271842|NCT02326298|12466904|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0
11271843|NCT02326298|12466905|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0
11271844|NCT02326298|12466906|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0
11271845|NCT02326298|12466907|FG010|STARTED|Open-label Period (Week 48 to Week 144)||3
11271846|NCT02326298|12466908|FG011|STARTED|Open-label Period (Week 48 to Week 144)||74
11271847|NCT02326298|12466909|FG012|STARTED|Open-label Period (Week 48 to Week 144)||70
11271848|NCT02326298|12466910|FG013|STARTED|Open-label Period (Week 48 to Week 144)||53
11271849|NCT02326298|12466897|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271850|NCT02326298|12466898|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271851|NCT02326298|12466899|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271852|NCT02326298|12466900|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271853|NCT02326298|12466901|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271854|NCT02326298|12466902|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271855|NCT02326298|12466903|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271856|NCT02326298|12466904|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271857|NCT02326298|12466905|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271858|NCT02326298|12466906|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0
11397735|NCT04411628|12591941|FG001|COMPLETED|Overall Study||4
11397736|NCT04411628|12591942|FG002|COMPLETED|Overall Study||5
11397737|NCT04411628|12591943|FG003|COMPLETED|Overall Study||6
11397738|NCT04411628|12591940|FG000|NOT COMPLETED|Overall Study||1
11397739|NCT04411628|12591941|FG001|NOT COMPLETED|Overall Study||2
11397740|NCT04411628|12591942|FG002|NOT COMPLETED|Overall Study||2
11397741|NCT04411628|12591943|FG003|NOT COMPLETED|Overall Study||0
11397742|NCT04418947|12591961|FG000|STARTED|Overall Study||1108
11397743|NCT04418947|12591962|FG001|STARTED|Overall Study||1351
11397744|NCT04418947|12591963|FG002|STARTED|Overall Study||1351
11397745|NCT04418947|12591964|FG003|STARTED|Overall Study||3655
11397746|NCT04418947|12591965|FG004|STARTED|Overall Study||3655
11397747|NCT04418947|12591961|FG000|COMPLETED|Overall Study||1108
11271859|NCT02326298|12466907|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||3
11271860|NCT02326298|12466908|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||54
11271861|NCT02326298|12466909|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||51
11397748|NCT04418947|12591962|FG001|COMPLETED|Overall Study||1351
11271862|NCT02326298|12466910|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||44
11271863|NCT02326298|12466897|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271864|NCT02326298|12466898|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271865|NCT02326298|12466899|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271866|NCT02326298|12466900|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271867|NCT02326298|12466901|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271868|NCT02326298|12466902|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271869|NCT02326298|12466903|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271870|NCT02326298|12466904|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271871|NCT02326298|12466905|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271872|NCT02326298|12466906|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271873|NCT02326298|12466907|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
11271874|NCT02326298|12466908|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20
11271875|NCT02326298|12466909|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19
11271876|NCT02326298|12466910|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
11271877|NCT02326363|12466921|FG000|STARTED|Overall Study||98
11271878|NCT02326363|12466922|FG001|STARTED|Overall Study||106
11271879|NCT02326363|12466921|FG000|COMPLETED|Overall Study||47
11271880|NCT02326363|12466922|FG001|COMPLETED|Overall Study||50
11271881|NCT02326363|12466921|FG000|NOT COMPLETED|Overall Study||51
11271882|NCT02326363|12466922|FG001|NOT COMPLETED|Overall Study||56
11271883|NCT02326467|12466930|FG000|STARTED|Overall Study||10
11271884|NCT02326467|12466930|FG000|COMPLETED|Overall Study||9
11271885|NCT02326467|12466930|FG000|NOT COMPLETED|Overall Study||1
11271886|NCT02326597|12466937|FG000|STARTED|Overall Study||60
11271887|NCT02326597|12466938|FG001|STARTED|Overall Study||60
11271888|NCT02326597|12466937|FG000|COMPLETED|Overall Study||18
11271889|NCT02326597|12466938|FG001|COMPLETED|Overall Study||28
11271890|NCT02326597|12466937|FG000|NOT COMPLETED|Overall Study||42
11271891|NCT02326597|12466938|FG001|NOT COMPLETED|Overall Study||32
11271892|NCT02326649|12466946|FG000|STARTED|Overall Study||33
11271893|NCT02326649|12466946|FG000|COMPLETED|Overall Study||21
11271894|NCT02326649|12466946|FG000|NOT COMPLETED|Overall Study||12
11271895|NCT02326805|12466952|FG000|STARTED|Overall Study||106
11271896|NCT02326805|12466953|FG001|STARTED|Overall Study||48
11271897|NCT02326805|12466952|FG000|COMPLETED|Overall Study||103
11271898|NCT02326805|12466953|FG001|COMPLETED|Overall Study||47
11271899|NCT02326805|12466952|FG000|NOT COMPLETED|Overall Study||3
11271900|NCT02326805|12466953|FG001|NOT COMPLETED|Overall Study||1
11271901|NCT02326844|12466959|FG000|STARTED|Overall Study||3
11271902|NCT02326844|12466959|FG000|COMPLETED|Overall Study||3
11271903|NCT02326844|12466959|FG000|NOT COMPLETED|Overall Study||0
11397749|NCT04418947|12591963|FG002|COMPLETED|Overall Study||1351
11397750|NCT04418947|12591964|FG003|COMPLETED|Overall Study||3655
11397751|NCT04418947|12591965|FG004|COMPLETED|Overall Study||3655
11397752|NCT04418947|12591961|FG000|NOT COMPLETED|Overall Study||0
11397753|NCT04418947|12591962|FG001|NOT COMPLETED|Overall Study||0
11271904|NCT02326883|12466966|FG000|STARTED|Overall Study||6314
11271905|NCT02326883|12466967|FG001|STARTED|Overall Study||6312
11271906|NCT02326883|12466968|FG002|STARTED|Overall Study||6256
11271907|NCT02326883|12466966|FG000|COMPLETED|Overall Study||6230
11271908|NCT02326883|12466967|FG001|COMPLETED|Overall Study||6227
11271909|NCT02326883|12466968|FG002|COMPLETED|Overall Study||6187
11271910|NCT02326883|12466966|FG000|NOT COMPLETED|Overall Study||84
11271911|NCT02326883|12466967|FG001|NOT COMPLETED|Overall Study||85
11271912|NCT02326883|12466968|FG002|NOT COMPLETED|Overall Study||69
11271913|NCT02327013|12466979|FG000|STARTED|Overall Study||49
11271914|NCT02327013|12466980|FG001|STARTED|Overall Study||45
11271915|NCT02327013|12466981|FG002|STARTED|Overall Study||96
11271916|NCT02327013|12466982|FG003|STARTED|Overall Study||21
11271917|NCT02327013|12466983|FG004|STARTED|Overall Study||16
11271918|NCT02327013|12466979|FG000|COMPLETED|Overall Study||36
11271919|NCT02327013|12466980|FG001|COMPLETED|Overall Study||29
11271920|NCT02327013|12466981|FG002|COMPLETED|Overall Study||54
11271921|NCT02327013|12466982|FG003|COMPLETED|Overall Study||20
11271922|NCT02327013|12466983|FG004|COMPLETED|Overall Study||12
11271923|NCT02327013|12466979|FG000|NOT COMPLETED|Overall Study||13
11271924|NCT02327013|12466980|FG001|NOT COMPLETED|Overall Study||16
11271925|NCT02327013|12466981|FG002|NOT COMPLETED|Overall Study||42
11271926|NCT02327013|12466982|FG003|NOT COMPLETED|Overall Study||1
11271927|NCT02327013|12466983|FG004|NOT COMPLETED|Overall Study||4
11271928|NCT02327052|12467003|FG000|STARTED|Overall Study||58
11271929|NCT02327052|12467003|FG000|COMPLETED|Overall Study||58
11271930|NCT02327052|12467003|FG000|NOT COMPLETED|Overall Study||0
11271931|NCT02327117|12467009|FG000|STARTED|Overall Study||45
11271932|NCT02327117|12467010|FG001|STARTED|Overall Study||45
11271933|NCT02327117|12467009|FG000|COMPLETED|Overall Study||45
11271934|NCT02327117|12467010|FG001|COMPLETED|Overall Study||45
11271935|NCT02327117|12467009|FG000|NOT COMPLETED|Overall Study||0
11397754|NCT04418947|12591963|FG002|NOT COMPLETED|Overall Study||0
11397755|NCT04418947|12591964|FG003|NOT COMPLETED|Overall Study||0
11397756|NCT04418947|12591965|FG004|NOT COMPLETED|Overall Study||0
11397757|NCT04420273|12591979|FG000|STARTED|Overall Study||501
11271936|NCT02327117|12467010|FG001|NOT COMPLETED|Overall Study||0
11271937|NCT02327130|12467016|FG000|STARTED|Overall Study||32
11271938|NCT02327130|12467016|FG000|COMPLETED|Overall Study||20
11271939|NCT02327130|12467016|FG000|NOT COMPLETED|Overall Study||12
11271940|NCT02327143|12467023|FG000|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
11271941|NCT02327143|12467024|FG001|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
11271942|NCT02327143|12467023|FG000|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
11271943|NCT02327143|12467024|FG001|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
11397758|NCT04420273|12591980|FG001|STARTED|Overall Study||499
11271944|NCT02327143|12467023|FG000|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
11271945|NCT02327143|12467024|FG001|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
11271946|NCT02327143|12467023|FG000|STARTED|Day 1: Time 6 Hrs - to Day 9||0
11271947|NCT02327143|12467024|FG001|STARTED|Day 1: Time 6 Hrs - to Day 9||11
11271948|NCT02327143|12467023|FG000|COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
11271949|NCT02327143|12467024|FG001|COMPLETED|Day 1: Time 6 Hrs - to Day 9||11
11271950|NCT02327143|12467023|FG000|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
11271951|NCT02327143|12467024|FG001|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
11271952|NCT02327169|12467045|FG000|STARTED|Overall Study||4
11271953|NCT02327169|12467046|FG001|STARTED|Overall Study||3
11271954|NCT02327169|12467047|FG002|STARTED|Overall Study||7
11271955|NCT02327169|12467048|FG003|STARTED|Overall Study||3
11271956|NCT02327169|12467049|FG004|STARTED|Overall Study||8
11271957|NCT02327169|12467050|FG005|STARTED|Overall Study||4
11271958|NCT02327169|12467051|FG006|STARTED|Overall Study||3
11271959|NCT02327169|12467052|FG007|STARTED|Overall Study||4
11271960|NCT02327169|12467053|FG008|STARTED|Overall Study||6
11271961|NCT02327169|12467054|FG009|STARTED|Overall Study||8
11271962|NCT02327169|12467055|FG010|STARTED|Overall Study||6
11271963|NCT02327169|12467056|FG011|STARTED|Overall Study||7
11271964|NCT02327169|12467057|FG012|STARTED|Overall Study||1
11271965|NCT02327169|12467058|FG013|STARTED|Overall Study||7
11271966|NCT02327169|12467059|FG014|STARTED|Overall Study||10
11271967|NCT02327169|12467045|FG000|COMPLETED|Overall Study||0
11271968|NCT02327169|12467046|FG001|COMPLETED|Overall Study||0
11271969|NCT02327169|12467047|FG002|COMPLETED|Overall Study||0
11271970|NCT02327169|12467048|FG003|COMPLETED|Overall Study||0
11271971|NCT02327169|12467049|FG004|COMPLETED|Overall Study||0
11271972|NCT02327169|12467050|FG005|COMPLETED|Overall Study||0
11271973|NCT02327169|12467051|FG006|COMPLETED|Overall Study||0
11271974|NCT02327169|12467052|FG007|COMPLETED|Overall Study||0
11271975|NCT02327169|12467053|FG008|COMPLETED|Overall Study||0
11271976|NCT02327169|12467054|FG009|COMPLETED|Overall Study||0
11271977|NCT02327169|12467055|FG010|COMPLETED|Overall Study||0
11271978|NCT02327169|12467056|FG011|COMPLETED|Overall Study||0
11271979|NCT02327169|12467057|FG012|COMPLETED|Overall Study||0
11271980|NCT02327169|12467058|FG013|COMPLETED|Overall Study||0
11271981|NCT02327169|12467059|FG014|COMPLETED|Overall Study||0
11271982|NCT02327169|12467045|FG000|NOT COMPLETED|Overall Study||4
11271983|NCT02327169|12467046|FG001|NOT COMPLETED|Overall Study||3
11271984|NCT02327169|12467047|FG002|NOT COMPLETED|Overall Study||7
11271985|NCT02327169|12467048|FG003|NOT COMPLETED|Overall Study||3
11271986|NCT02327169|12467049|FG004|NOT COMPLETED|Overall Study||8
11271987|NCT02327169|12467050|FG005|NOT COMPLETED|Overall Study||4
11271988|NCT02327169|12467051|FG006|NOT COMPLETED|Overall Study||3
11271989|NCT02327169|12467052|FG007|NOT COMPLETED|Overall Study||4
11271990|NCT02327169|12467053|FG008|NOT COMPLETED|Overall Study||6
11271991|NCT02327169|12467054|FG009|NOT COMPLETED|Overall Study||8
11271992|NCT02327169|12467055|FG010|NOT COMPLETED|Overall Study||6
11271993|NCT02327169|12467056|FG011|NOT COMPLETED|Overall Study||7
11271994|NCT02327169|12467057|FG012|NOT COMPLETED|Overall Study||1
11271995|NCT02327169|12467058|FG013|NOT COMPLETED|Overall Study||7
11271996|NCT02327169|12467059|FG014|NOT COMPLETED|Overall Study||10
11271997|NCT02327260|12467104|FG000|STARTED|Overall Study||20
11271998|NCT02327260|12467105|FG001|STARTED|Overall Study||24
11271999|NCT02327260|12467106|FG002|STARTED|Overall Study||17
11272000|NCT02327260|12467104|FG000|COMPLETED|Overall Study||14
11272001|NCT02327260|12467105|FG001|COMPLETED|Overall Study||20
11272002|NCT02327260|12467106|FG002|COMPLETED|Overall Study||15
11272003|NCT02327260|12467104|FG000|NOT COMPLETED|Overall Study||6
11272004|NCT02327260|12467105|FG001|NOT COMPLETED|Overall Study||4
11272005|NCT02327260|12467106|FG002|NOT COMPLETED|Overall Study||2
11272006|NCT02327325|12467118|FG000|STARTED|Overall Study||20
11272007|NCT02327325|12467119|FG001|STARTED|Overall Study||20
11272008|NCT02327325|12467120|FG002|STARTED|Overall Study||20
11272009|NCT02327325|12467118|FG000|COMPLETED|Overall Study||19
11272010|NCT02327325|12467119|FG001|COMPLETED|Overall Study||16
11272011|NCT02327325|12467120|FG002|COMPLETED|Overall Study||15
11272012|NCT02327325|12467118|FG000|NOT COMPLETED|Overall Study||1
11272013|NCT02327325|12467119|FG001|NOT COMPLETED|Overall Study||4
11272014|NCT02327325|12467120|FG002|NOT COMPLETED|Overall Study||5
11272015|NCT02327351|12467128|FG000|STARTED|Overall Study||98
11272016|NCT02327351|12467128|FG000|COMPLETED|Overall Study||98
11272017|NCT02327351|12467128|FG000|NOT COMPLETED|Overall Study||0
11272018|NCT02327429|12467136|FG000|STARTED|Overall Study||19
11272019|NCT02327429|12467136|FG000|COMPLETED|Overall Study||17
11272020|NCT02327429|12467136|FG000|NOT COMPLETED|Overall Study||2
11272021|NCT02327741|12467142|FG000|STARTED|Overall Study||502
11272022|NCT02327741|12467143|FG001|STARTED|Overall Study||508
11272023|NCT02327741|12467142|FG000|COMPLETED|Overall Study||502
11272024|NCT02327741|12467143|FG001|COMPLETED|Overall Study||508
11272025|NCT02327741|12467142|FG000|NOT COMPLETED|Overall Study||0
11272026|NCT02327741|12467143|FG001|NOT COMPLETED|Overall Study||0
11272027|NCT02328027|12467151|FG000|STARTED|Overall Study||5
11272028|NCT02328027|12467152|FG001|STARTED|Overall Study||11
11272029|NCT02328027|12467151|FG000|COMPLETED|Overall Study||5
11272030|NCT02328027|12467152|FG001|COMPLETED|Overall Study||10
11272031|NCT02328027|12467151|FG000|NOT COMPLETED|Overall Study||0
11272032|NCT02328027|12467152|FG001|NOT COMPLETED|Overall Study||1
11272033|NCT02328040|12467159|FG000|STARTED|First Intervention (2 Days)||8
11272034|NCT02328040|12467160|FG001|STARTED|First Intervention (2 Days)||9
11272035|NCT02328040|12467159|FG000|COMPLETED|First Intervention (2 Days)||7
11272036|NCT02328040|12467160|FG001|COMPLETED|First Intervention (2 Days)||8
11272037|NCT02328040|12467159|FG000|NOT COMPLETED|First Intervention (2 Days)||1
11272038|NCT02328040|12467160|FG001|NOT COMPLETED|First Intervention (2 Days)||1
11272039|NCT02328040|12467159|FG000|STARTED|Second Intervention (2 Days)||7
11272040|NCT02328040|12467160|FG001|STARTED|Second Intervention (2 Days)||8
11272041|NCT02328040|12467159|FG000|COMPLETED|Second Intervention (2 Days)||7
11272042|NCT02328040|12467160|FG001|COMPLETED|Second Intervention (2 Days)||8
11272043|NCT02328040|12467159|FG000|NOT COMPLETED|Second Intervention (2 Days)||0
11272044|NCT02328040|12467160|FG001|NOT COMPLETED|Second Intervention (2 Days)||0
11272045|NCT02328326|12467168|FG000|STARTED|Overall Study|3 participant dyads withdrew before 6-month follow up. 3 more care partners withdrew and 1 died.|246
11272046|NCT02328326|12467169|FG001|STARTED|Overall Study|1 participant dyad withdrew from the study between assignment to control arm and 6-month follow up.|232
11397759|NCT04420273|12591979|FG000|COMPLETED|Overall Study||390
11397760|NCT04420273|12591980|FG001|COMPLETED|Overall Study||414
11397761|NCT04420273|12591979|FG000|NOT COMPLETED|Overall Study||111
11397762|NCT04420273|12591980|FG001|NOT COMPLETED|Overall Study||85
11272047|NCT02328326|12467168|FG000|6-month Follow Up|Overall Study|We were unable to reach 15 participants. 1 patient died, 1 care partner withdrew before completion.|221
11272048|NCT02328326|12467169|FG001|6-month Follow Up|Overall Study|We were unable to reach 9 participants. 1 patient died, 1 care partner withdrew before completion.|221
11272049|NCT02328326|12467168|FG000|COMPLETED|Overall Study||224
11272050|NCT02328326|12467169|FG001|COMPLETED|Overall Study||224
11272051|NCT02328326|12467168|FG000|NOT COMPLETED|Overall Study||22
11272052|NCT02328326|12467169|FG001|NOT COMPLETED|Overall Study||8
11272053|NCT02328404|12467179|FG000|STARTED|Overall Study||30
11272054|NCT02328404|12467180|FG001|STARTED|Overall Study||30
11272055|NCT02328404|12467179|FG000|COMPLETED|Overall Study||29
11272056|NCT02328404|12467180|FG001|COMPLETED|Overall Study||29
11272057|NCT02328404|12467179|FG000|NOT COMPLETED|Overall Study||1
11272058|NCT02328404|12467180|FG001|NOT COMPLETED|Overall Study||1
11272059|NCT02328547|12467192|FG000|STARTED|First Intervention (12 Weeks)||25
11272060|NCT02328547|12467193|FG001|STARTED|First Intervention (12 Weeks)||23
11272061|NCT02328547|12467192|FG000|COMPLETED|First Intervention (12 Weeks)||22
11272062|NCT02328547|12467193|FG001|COMPLETED|First Intervention (12 Weeks)||23
11272063|NCT02328547|12467192|FG000|NOT COMPLETED|First Intervention (12 Weeks)||3
11272064|NCT02328547|12467193|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
11272065|NCT02328547|12467192|FG000|STARTED|Second Intervention (12 Weeks)||22
11272066|NCT02328547|12467193|FG001|STARTED|Second Intervention (12 Weeks)||23
11272067|NCT02328547|12467192|FG000|COMPLETED|Second Intervention (12 Weeks)||22
11272068|NCT02328547|12467193|FG001|COMPLETED|Second Intervention (12 Weeks)||23
11272069|NCT02328547|12467192|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
11272070|NCT02328547|12467193|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
11272071|NCT02328755|12467207|FG000|STARTED|Overall Study||3
11272072|NCT02328755|12467208|FG001|STARTED|Overall Study||33
11272073|NCT02328755|12467207|FG000|COMPLETED|Overall Study|Evaluable for the phase II primary endpoint of relapse at 6-months post-HCT|0
11272074|NCT02328755|12467208|FG001|COMPLETED|Overall Study||31
11272075|NCT02328755|12467207|FG000|NOT COMPLETED|Overall Study||3
11272076|NCT02328755|12467208|FG001|NOT COMPLETED|Overall Study||2
11272077|NCT02328807|12467220|FG000|STARTED|Overall Study||6
11272078|NCT02328807|12467220|FG000|COMPLETED|Overall Study||6
11272079|NCT02328807|12467220|FG000|NOT COMPLETED|Overall Study||0
11272080|NCT02328937|12467226|FG000|STARTED|Period 1||7
11272081|NCT02328937|12467227|FG001|STARTED|Period 1||6
11272082|NCT02328937|12467228|FG002|STARTED|Period 1||7
11272083|NCT02328937|12467229|FG003|STARTED|Period 1||6
11272084|NCT02328937|12467230|FG004|STARTED|Period 1||6
11272085|NCT02328937|12467231|FG005|STARTED|Period 1||6
11272086|NCT02328937|12467226|FG000|COMPLETED|Period 1||7
11397763|NCT04420572|12591988|FG000|STARTED|Overall Study||33
11272087|NCT02328937|12467227|FG001|COMPLETED|Period 1||6
11272088|NCT02328937|12467228|FG002|COMPLETED|Period 1||7
11272089|NCT02328937|12467229|FG003|COMPLETED|Period 1||5
11272090|NCT02328937|12467230|FG004|COMPLETED|Period 1||6
11272091|NCT02328937|12467231|FG005|COMPLETED|Period 1||6
11272092|NCT02328937|12467226|FG000|NOT COMPLETED|Period 1||0
11397764|NCT04420572|12591989|FG001|STARTED|Overall Study||30
11272093|NCT02328937|12467227|FG001|NOT COMPLETED|Period 1||0
11272094|NCT02328937|12467228|FG002|NOT COMPLETED|Period 1||0
11272095|NCT02328937|12467229|FG003|NOT COMPLETED|Period 1||1
11272096|NCT02328937|12467230|FG004|NOT COMPLETED|Period 1||0
11272097|NCT02328937|12467231|FG005|NOT COMPLETED|Period 1||0
11397765|NCT04420572|12591988|FG000|COMPLETED|Overall Study||33
11397766|NCT04420572|12591989|FG001|COMPLETED|Overall Study||30
11272098|NCT02328937|12467226|FG000|STARTED|Period 2||7
11272099|NCT02328937|12467227|FG001|STARTED|Period 2||6
11272100|NCT02328937|12467228|FG002|STARTED|Period 2||7
11397767|NCT04420572|12591988|FG000|NOT COMPLETED|Overall Study||0
11397768|NCT04420572|12591989|FG001|NOT COMPLETED|Overall Study||0
11272101|NCT02328937|12467229|FG003|STARTED|Period 2||5
11272102|NCT02328937|12467230|FG004|STARTED|Period 2||6
11272103|NCT02328937|12467231|FG005|STARTED|Period 2||6
11272104|NCT02328937|12467226|FG000|COMPLETED|Period 2||7
11272105|NCT02328937|12467227|FG001|COMPLETED|Period 2||6
11397769|NCT04428411|12591995|FG000|STARTED|Overall Study||486
11272106|NCT02328937|12467228|FG002|COMPLETED|Period 2||6
11272107|NCT02328937|12467229|FG003|COMPLETED|Period 2||5
11272108|NCT02328937|12467230|FG004|COMPLETED|Period 2||6
11272109|NCT02328937|12467231|FG005|COMPLETED|Period 2||6
11272110|NCT02328937|12467226|FG000|NOT COMPLETED|Period 2||0
11272111|NCT02328937|12467227|FG001|NOT COMPLETED|Period 2||0
11272112|NCT02328937|12467228|FG002|NOT COMPLETED|Period 2||1
11272113|NCT02328937|12467229|FG003|NOT COMPLETED|Period 2||0
11272114|NCT02328937|12467230|FG004|NOT COMPLETED|Period 2||0
11397770|NCT04428411|12591995|FG000|Participants With Difficult to Treat Sites|Overall Study||397
11397771|NCT04428411|12591995|FG000|Participants Without Difficulty to Treat Sites|Overall Study||89
11397772|NCT04428411|12591995|FG000|Participants Adherent to Treatment|Overall Study||417
11397773|NCT04428411|12591995|FG000|Participants Not Adherent to Treatment|Overall Study||69
11397774|NCT04428411|12591995|FG000|COMPLETED|Overall Study||372
11397775|NCT04428411|12591995|FG000|NOT COMPLETED|Overall Study||114
11272115|NCT02328937|12467231|FG005|NOT COMPLETED|Period 2||0
11272116|NCT02328937|12467226|FG000|STARTED|Period 3||7
11272117|NCT02328937|12467227|FG001|STARTED|Period 3||6
11272118|NCT02328937|12467228|FG002|STARTED|Period 3||6
11272119|NCT02328937|12467229|FG003|STARTED|Period 3||5
11272120|NCT02328937|12467230|FG004|STARTED|Period 3||6
11272121|NCT02328937|12467231|FG005|STARTED|Period 3||6
11272122|NCT02328937|12467226|FG000|COMPLETED|Period 3||7
11272123|NCT02328937|12467227|FG001|COMPLETED|Period 3||6
11272124|NCT02328937|12467228|FG002|COMPLETED|Period 3||6
11272125|NCT02328937|12467229|FG003|COMPLETED|Period 3||5
11272126|NCT02328937|12467230|FG004|COMPLETED|Period 3||6
11272127|NCT02328937|12467231|FG005|COMPLETED|Period 3||6
11272128|NCT02328937|12467226|FG000|NOT COMPLETED|Period 3||0
11272129|NCT02328937|12467227|FG001|NOT COMPLETED|Period 3||0
11272130|NCT02328937|12467228|FG002|NOT COMPLETED|Period 3||0
11272131|NCT02328937|12467229|FG003|NOT COMPLETED|Period 3||0
11272132|NCT02328937|12467230|FG004|NOT COMPLETED|Period 3||0
11272133|NCT02328937|12467231|FG005|NOT COMPLETED|Period 3||0
11272134|NCT02329015|12467241|FG000|STARTED|Overall Study||48
11272135|NCT02329015|12467242|FG001|STARTED|Overall Study||64
11272136|NCT02329015|12467241|FG000|COMPLETED|Overall Study||48
11272137|NCT02329015|12467242|FG001|COMPLETED|Overall Study||64
11272138|NCT02329015|12467241|FG000|NOT COMPLETED|Overall Study||0
11272139|NCT02329015|12467242|FG001|NOT COMPLETED|Overall Study||0
11272140|NCT02329223|12467251|FG000|STARTED|Overall Study||73
11272141|NCT02329223|12467252|FG001|STARTED|Overall Study||71
11272142|NCT02329223|12467253|FG002|STARTED|Overall Study||74
11272143|NCT02329223|12467251|FG000|Full Analysis Set|Overall Study||73
11272144|NCT02329223|12467252|FG001|Full Analysis Set|Overall Study||70
11272145|NCT02329223|12467253|FG002|Full Analysis Set|Overall Study||74
11272146|NCT02329223|12467251|FG000|Safety Set|Overall Study||73
11272147|NCT02329223|12467252|FG001|Safety Set|Overall Study||71
11272148|NCT02329223|12467253|FG002|Safety Set|Overall Study||74
11272149|NCT02329223|12467251|FG000|COMPLETED|Overall Study||72
11272150|NCT02329223|12467252|FG001|COMPLETED|Overall Study||68
11272151|NCT02329223|12467253|FG002|COMPLETED|Overall Study||68
11272152|NCT02329223|12467251|FG000|NOT COMPLETED|Overall Study||1
11272153|NCT02329223|12467252|FG001|NOT COMPLETED|Overall Study||3
11272154|NCT02329223|12467253|FG002|NOT COMPLETED|Overall Study||6
11272155|NCT02329431|12467263|FG000|STARTED|Overall Study||92
11272156|NCT02329431|12467264|FG001|STARTED|Overall Study||89
11272157|NCT02329431|12467263|FG000|Baseline Interview|Overall Study||87
11272158|NCT02329431|12467264|FG001|Baseline Interview|Overall Study||85
11272159|NCT02329431|12467263|FG000|COMPLETED|Overall Study||72
11272160|NCT02329431|12467264|FG001|COMPLETED|Overall Study||76
11272161|NCT02329431|12467263|FG000|NOT COMPLETED|Overall Study||20
11272162|NCT02329431|12467264|FG001|NOT COMPLETED|Overall Study||13
11272163|NCT02329587|12467272|FG000|STARTED|Baseline Thru Post-treatment Assessment||5
11272164|NCT02329587|12467273|FG001|STARTED|Baseline Thru Post-treatment Assessment||7
11272165|NCT02329587|12467272|FG000|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
11272166|NCT02329587|12467273|FG001|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
11272167|NCT02329587|12467272|FG000|COMPLETED|Baseline Thru Post-treatment Assessment||4
11272168|NCT02329587|12467273|FG001|COMPLETED|Baseline Thru Post-treatment Assessment||6
11272169|NCT02329587|12467272|FG000|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
11272170|NCT02329587|12467273|FG001|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
11272171|NCT02329587|12467272|FG000|STARTED|1-month Follow-up||4
11272172|NCT02329587|12467273|FG001|STARTED|1-month Follow-up||6
11272173|NCT02329587|12467272|FG000|COMPLETED|1-month Follow-up||4
11272174|NCT02329587|12467273|FG001|COMPLETED|1-month Follow-up||5
11021655|NCT00805441|12199802|FG001|NOT COMPLETED|Overall Study||36
11021656|NCT00805467|12199812|FG000|STARTED|Overall Study|Patients who received treatment|1
11021657|NCT00805467|12199813|FG001|STARTED|Overall Study|Patients who received treatment|59
11021658|NCT00805467|12199814|FG002|STARTED|Overall Study|Patients who received treatment|183
11021659|NCT00805467|12199815|FG003|STARTED|Overall Study|Patients who received treatment|381
11021660|NCT00805467|12199812|FG000|Enrolled But Did Not Receive Treatment|Overall Study||0
11021661|NCT00805467|12199813|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0
11021662|NCT00805467|12199814|FG002|Enrolled But Did Not Receive Treatment|Overall Study||0
11021663|NCT00805467|12199815|FG003|Enrolled But Did Not Receive Treatment|Overall Study||0
11021664|NCT00805467|12199812|FG000|COMPLETED|Overall Study|Ongoing when study terminated|1
11021665|NCT00805467|12199813|FG001|COMPLETED|Overall Study|Ongoing when study terminated|25
11021666|NCT00805467|12199814|FG002|COMPLETED|Overall Study|Ongoing when study terminated|80
11021667|NCT00805467|12199815|FG003|COMPLETED|Overall Study|Ongoing when study terminated|144
11021668|NCT00805467|12199812|FG000|NOT COMPLETED|Overall Study||0
11272175|NCT02329587|12467272|FG000|NOT COMPLETED|1-month Follow-up||0
11272176|NCT02329587|12467273|FG001|NOT COMPLETED|1-month Follow-up||1
11272177|NCT02329600|12467282|FG000|STARTED|Overall Study||10
11397776|NCT04435184|12592004|FG000|STARTED|Overall Study||25
11272178|NCT02329600|12467283|FG001|STARTED|Overall Study||15
11272179|NCT02329600|12467284|FG002|STARTED|Overall Study||15
11272180|NCT02329600|12467282|FG000|COMPLETED|Overall Study||10
11272181|NCT02329600|12467283|FG001|COMPLETED|Overall Study||15
11272182|NCT02329600|12467284|FG002|COMPLETED|Overall Study||15
11272183|NCT02329600|12467282|FG000|NOT COMPLETED|Overall Study||0
11272184|NCT02329600|12467283|FG001|NOT COMPLETED|Overall Study||0
11272185|NCT02329600|12467284|FG002|NOT COMPLETED|Overall Study||0
11272186|NCT02329730|12467296|FG000|STARTED|Overall Study||14
11272187|NCT02329730|12467297|FG001|STARTED|Overall Study||14
11272188|NCT02329730|12467298|FG002|STARTED|Overall Study||14
11272189|NCT02329730|12467299|FG003|STARTED|Overall Study||14
11272190|NCT02329730|12467300|FG004|STARTED|Overall Study||14
11272191|NCT02329730|12467301|FG005|STARTED|Overall Study||14
11272192|NCT02329730|12467302|FG006|STARTED|Overall Study||14
11272193|NCT02329730|12467303|FG007|STARTED|Overall Study||14
11272194|NCT02329730|12467304|FG008|STARTED|Overall Study||8
11272195|NCT02329730|12467305|FG009|STARTED|Overall Study||8
11272196|NCT02329730|12467306|FG010|STARTED|Overall Study||8
11272197|NCT02329730|12467307|FG011|STARTED|Overall Study||8
11272198|NCT02329730|12467296|FG000|COMPLETED|Overall Study||14
11272199|NCT02329730|12467297|FG001|COMPLETED|Overall Study||14
11272200|NCT02329730|12467298|FG002|COMPLETED|Overall Study||14
11272201|NCT02329730|12467299|FG003|COMPLETED|Overall Study||14
11272202|NCT02329730|12467300|FG004|COMPLETED|Overall Study||11
11272203|NCT02329730|12467301|FG005|COMPLETED|Overall Study||12
11272204|NCT02329730|12467302|FG006|COMPLETED|Overall Study||13
11272205|NCT02329730|12467303|FG007|COMPLETED|Overall Study||13
11272206|NCT02329730|12467304|FG008|COMPLETED|Overall Study||7
11272207|NCT02329730|12467305|FG009|COMPLETED|Overall Study||7
11272208|NCT02329730|12467306|FG010|COMPLETED|Overall Study||8
11272209|NCT02329730|12467307|FG011|COMPLETED|Overall Study||8
11272210|NCT02329730|12467296|FG000|NOT COMPLETED|Overall Study||0
11272211|NCT02329730|12467297|FG001|NOT COMPLETED|Overall Study||0
11272212|NCT02329730|12467298|FG002|NOT COMPLETED|Overall Study||0
11272213|NCT02329730|12467299|FG003|NOT COMPLETED|Overall Study||0
11272214|NCT02329730|12467300|FG004|NOT COMPLETED|Overall Study||3
11272215|NCT02329730|12467301|FG005|NOT COMPLETED|Overall Study||2
11272216|NCT02329730|12467302|FG006|NOT COMPLETED|Overall Study||1
11272217|NCT02329730|12467303|FG007|NOT COMPLETED|Overall Study||1
11272218|NCT02329730|12467304|FG008|NOT COMPLETED|Overall Study||1
11272219|NCT02329730|12467305|FG009|NOT COMPLETED|Overall Study||1
11272220|NCT02329730|12467306|FG010|NOT COMPLETED|Overall Study||0
11397777|NCT04435184|12592005|FG001|STARTED|Overall Study||25
11397778|NCT04435184|12592004|FG000|COMPLETED|Overall Study||22
11397779|NCT04435184|12592005|FG001|COMPLETED|Overall Study||20
11397780|NCT04435184|12592004|FG000|NOT COMPLETED|Overall Study||3
11397781|NCT04435184|12592005|FG001|NOT COMPLETED|Overall Study||5
11397782|NCT04476784|12592013|FG000|STARTED|First Wear Period (30 Days ± 2 Days)||31
11272221|NCT02329730|12467307|FG011|NOT COMPLETED|Overall Study||0
11272222|NCT02329743|12467328|FG000|STARTED|Overall Study||84
11272223|NCT02329743|12467329|FG001|STARTED|Overall Study||87
11272224|NCT02329743|12467330|FG002|STARTED|Overall Study||85
11272225|NCT02329743|12467328|FG000|COMPLETED|Overall Study||78
11272226|NCT02329743|12467329|FG001|COMPLETED|Overall Study||80
11272227|NCT02329743|12467330|FG002|COMPLETED|Overall Study||77
11272228|NCT02329743|12467328|FG000|NOT COMPLETED|Overall Study||6
11272229|NCT02329743|12467329|FG001|NOT COMPLETED|Overall Study||7
11272230|NCT02329743|12467330|FG002|NOT COMPLETED|Overall Study||8
11272231|NCT02329964|12467340|FG000|STARTED|Overall Study||40
11272232|NCT02329964|12467341|FG001|STARTED|Overall Study||40
11272233|NCT02329964|12467340|FG000|COMPLETED|Overall Study||40
11272234|NCT02329964|12467341|FG001|COMPLETED|Overall Study||40
11272235|NCT02329964|12467340|FG000|NOT COMPLETED|Overall Study||0
11272236|NCT02329964|12467341|FG001|NOT COMPLETED|Overall Study||0
11397783|NCT04476784|12592014|FG001|STARTED|First Wear Period (30 Days ± 2 Days)||35
11397784|NCT04476784|12592013|FG000|COMPLETED|First Wear Period (30 Days ± 2 Days)||30
11397785|NCT04476784|12592014|FG001|COMPLETED|First Wear Period (30 Days ± 2 Days)||35
11397786|NCT04476784|12592013|FG000|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||1
11397787|NCT04476784|12592014|FG001|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||0
11397788|NCT04476784|12592013|FG000|STARTED|Second Wear Period (30 Days ± 2 Days)||30
11397789|NCT04476784|12592014|FG001|STARTED|Second Wear Period (30 Days ± 2 Days)||35
11272237|NCT02330055|12467349|FG000|STARTED|Overall Study||50
11272238|NCT02330055|12467350|FG001|STARTED|Overall Study||49
11272239|NCT02330055|12467349|FG000|COMPLETED|Overall Study||40
11272240|NCT02330055|12467350|FG001|COMPLETED|Overall Study||40
11272241|NCT02330055|12467349|FG000|NOT COMPLETED|Overall Study||10
11272242|NCT02330055|12467350|FG001|NOT COMPLETED|Overall Study||9
11272243|NCT02330081|12467356|FG000|STARTED|Overall Study||22
11272244|NCT02330081|12467356|FG000|COMPLETED|Overall Study||14
11272245|NCT02330081|12467356|FG000|NOT COMPLETED|Overall Study||8
11272246|NCT02330094|12467365|FG000|STARTED|Overall Study||8
11272247|NCT02330094|12467366|FG001|STARTED|Overall Study||8
11397790|NCT04476784|12592013|FG000|COMPLETED|Second Wear Period (30 Days ± 2 Days)||30
11397791|NCT04476784|12592014|FG001|COMPLETED|Second Wear Period (30 Days ± 2 Days)||35
11272248|NCT02330094|12467365|FG000|COMPLETED|Overall Study||8
11272249|NCT02330094|12467366|FG001|COMPLETED|Overall Study||8
11272250|NCT02330094|12467365|FG000|NOT COMPLETED|Overall Study||0
11272251|NCT02330094|12467366|FG001|NOT COMPLETED|Overall Study||0
11272252|NCT02330172|12467374|FG000|STARTED|Overall Study||22
11272253|NCT02330172|12467375|FG001|STARTED|Overall Study||22
11272254|NCT02330172|12467374|FG000|COMPLETED|Overall Study||19
11272255|NCT02330172|12467375|FG001|COMPLETED|Overall Study||21
11272256|NCT02330172|12467374|FG000|NOT COMPLETED|Overall Study||3
11272257|NCT02330172|12467375|FG001|NOT COMPLETED|Overall Study||1
11272258|NCT02330276|12467384|FG000|STARTED|Overall Study||4
11272259|NCT02330276|12467385|FG001|STARTED|Overall Study||4
11272260|NCT02330276|12467386|FG002|STARTED|Overall Study||4
11272261|NCT02330276|12467384|FG000|COMPLETED|Overall Study||4
11272262|NCT02330276|12467385|FG001|COMPLETED|Overall Study||4
11272263|NCT02330276|12467386|FG002|COMPLETED|Overall Study||4
11272264|NCT02330276|12467384|FG000|NOT COMPLETED|Overall Study||0
11397792|NCT04476784|12592013|FG000|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0
11397793|NCT04476784|12592014|FG001|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0
11397794|NCT04484207|12592026|FG000|STARTED|Overall Study||86
11397795|NCT04484207|12592027|FG001|STARTED|Overall Study||44
11397796|NCT04484207|12592028|FG002|STARTED|Overall Study||42
11397797|NCT04484207|12592026|FG000|14-Day Follow-Up|Overall Study||69
11397798|NCT04484207|12592027|FG001|14-Day Follow-Up|Overall Study||40
11397799|NCT04484207|12592028|FG002|14-Day Follow-Up|Overall Study||33
11397800|NCT04484207|12592026|FG000|30-Day Follow-Up|Overall Study||65
11397801|NCT04484207|12592027|FG001|30-Day Follow-Up|Overall Study||34
11397802|NCT04484207|12592028|FG002|30-Day Follow-Up|Overall Study||31
11397803|NCT04484207|12592026|FG000|COMPLETED|Overall Study||65
11397804|NCT04484207|12592027|FG001|COMPLETED|Overall Study||34
11397805|NCT04484207|12592028|FG002|COMPLETED|Overall Study||31
11397806|NCT04484207|12592026|FG000|NOT COMPLETED|Overall Study||21
11397807|NCT04484207|12592027|FG001|NOT COMPLETED|Overall Study||10
11397808|NCT04484207|12592028|FG002|NOT COMPLETED|Overall Study||11
11397809|NCT04485455|12592039|FG000|STARTED|Overall Study||5
11397810|NCT04485455|12592039|FG000|COMPLETED|Overall Study||5
11397811|NCT04485455|12592039|FG000|NOT COMPLETED|Overall Study||0
11397812|NCT04495283|12592046|FG000|STARTED|Overall Study||35
11397813|NCT04495283|12592047|FG001|STARTED|Overall Study||35
11397814|NCT04495283|12592048|FG002|STARTED|Overall Study||17
11397815|NCT04495283|12592046|FG000|COMPLETED|Overall Study||34
11397816|NCT04495283|12592047|FG001|COMPLETED|Overall Study||34
11397817|NCT04495283|12592048|FG002|COMPLETED|Overall Study||14
11397818|NCT04495283|12592046|FG000|NOT COMPLETED|Overall Study||1
11397819|NCT04495283|12592047|FG001|NOT COMPLETED|Overall Study||1
11272265|NCT02330276|12467385|FG001|NOT COMPLETED|Overall Study||0
11397820|NCT04495283|12592048|FG002|NOT COMPLETED|Overall Study||3
11397821|NCT04497948|12592059|FG000|STARTED|Overall Study||9
11397822|NCT04497948|12592059|FG000|COMPLETED|Overall Study||7
11397823|NCT04497948|12592059|FG000|NOT COMPLETED|Overall Study||2
11397824|NCT04501640|12592071|FG000|STARTED|Period 1 (5 Days)||6
11397825|NCT04501640|12592072|FG001|STARTED|Period 1 (5 Days)||6
11397826|NCT04501640|12592073|FG002|STARTED|Period 1 (5 Days)||6
11397827|NCT04501640|12592074|FG003|STARTED|Period 1 (5 Days)||6
11397828|NCT04501640|12592071|FG000|COMPLETED|Period 1 (5 Days)||6
11397829|NCT04501640|12592072|FG001|COMPLETED|Period 1 (5 Days)||6
11397830|NCT04501640|12592073|FG002|COMPLETED|Period 1 (5 Days)||6
11397831|NCT04501640|12592074|FG003|COMPLETED|Period 1 (5 Days)||6
11397832|NCT04501640|12592071|FG000|NOT COMPLETED|Period 1 (5 Days)||0
11397833|NCT04501640|12592072|FG001|NOT COMPLETED|Period 1 (5 Days)||0
11397834|NCT04501640|12592073|FG002|NOT COMPLETED|Period 1 (5 Days)||0
11397835|NCT04501640|12592074|FG003|NOT COMPLETED|Period 1 (5 Days)||0
11397836|NCT04501640|12592071|FG000|STARTED|Washout Period (10 Days)||6
11397837|NCT04501640|12592072|FG001|STARTED|Washout Period (10 Days)||6
11397838|NCT04501640|12592073|FG002|STARTED|Washout Period (10 Days)||6
11397839|NCT04501640|12592074|FG003|STARTED|Washout Period (10 Days)||6
11397840|NCT04501640|12592071|FG000|COMPLETED|Washout Period (10 Days)||6
11397841|NCT04501640|12592072|FG001|COMPLETED|Washout Period (10 Days)||6
11397842|NCT04501640|12592073|FG002|COMPLETED|Washout Period (10 Days)||6
11397843|NCT04501640|12592074|FG003|COMPLETED|Washout Period (10 Days)||6
11397844|NCT04501640|12592071|FG000|NOT COMPLETED|Washout Period (10 Days)||0
11397845|NCT04501640|12592072|FG001|NOT COMPLETED|Washout Period (10 Days)||0
11397846|NCT04501640|12592073|FG002|NOT COMPLETED|Washout Period (10 Days)||0
11397847|NCT04501640|12592074|FG003|NOT COMPLETED|Washout Period (10 Days)||0
11397848|NCT04501640|12592071|FG000|STARTED|Period 2 (5 Days)||6
11397849|NCT04501640|12592072|FG001|STARTED|Period 2 (5 Days)||6
11397850|NCT04501640|12592073|FG002|STARTED|Period 2 (5 Days)||6
11397851|NCT04501640|12592074|FG003|STARTED|Period 2 (5 Days)||6
11397852|NCT04501640|12592071|FG000|COMPLETED|Period 2 (5 Days)||6
11397853|NCT04501640|12592072|FG001|COMPLETED|Period 2 (5 Days)||6
11397854|NCT04501640|12592073|FG002|COMPLETED|Period 2 (5 Days)||6
11397855|NCT04501640|12592074|FG003|COMPLETED|Period 2 (5 Days)||6
11397856|NCT04501640|12592071|FG000|NOT COMPLETED|Period 2 (5 Days)||0
11397857|NCT04501640|12592072|FG001|NOT COMPLETED|Period 2 (5 Days)||0
11397858|NCT04501640|12592073|FG002|NOT COMPLETED|Period 2 (5 Days)||0
11397859|NCT04501640|12592074|FG003|NOT COMPLETED|Period 2 (5 Days)||0
11397860|NCT04501952|12592086|FG000|STARTED|Overall Study||292
11397861|NCT04501952|12592087|FG001|STARTED|Overall Study||292
11272266|NCT02330276|12467386|FG002|NOT COMPLETED|Overall Study||0
11272267|NCT02330341|12467396|FG000|STARTED|Overall Study||12
11272268|NCT02330341|12467397|FG001|STARTED|Overall Study||12
11272269|NCT02330341|12467396|FG000|COMPLETED|Overall Study||12
11272270|NCT02330341|12467397|FG001|COMPLETED|Overall Study||11
11272271|NCT02330341|12467396|FG000|NOT COMPLETED|Overall Study||0
11272272|NCT02330341|12467397|FG001|NOT COMPLETED|Overall Study||1
11272273|NCT02330523|12467405|FG000|STARTED|Overall Study||21
11272274|NCT02330523|12467406|FG001|STARTED|Overall Study||19
11272275|NCT02330523|12467405|FG000|COMPLETED|Overall Study||21
11272276|NCT02330523|12467406|FG001|COMPLETED|Overall Study||19
11272277|NCT02330523|12467405|FG000|NOT COMPLETED|Overall Study||0
11272278|NCT02330523|12467406|FG001|NOT COMPLETED|Overall Study||0
11272279|NCT02330549|12467414|FG000|STARTED|Overall Study||20
11272280|NCT02330549|12467415|FG001|STARTED|Overall Study||25
11272281|NCT02330549|12467414|FG000|COMPLETED|Overall Study||16
11272282|NCT02330549|12467415|FG001|COMPLETED|Overall Study||24
11272283|NCT02330549|12467414|FG000|NOT COMPLETED|Overall Study||4
11272284|NCT02330549|12467415|FG001|NOT COMPLETED|Overall Study||1
11272285|NCT02330588|12467426|FG000|STARTED|Overall Study||44
11272286|NCT02330588|12467427|FG001|STARTED|Overall Study||43
11272287|NCT02330588|12467428|FG002|STARTED|Overall Study||46
11272288|NCT02330588|12467429|FG003|STARTED|Overall Study||46
11272289|NCT02330588|12467430|FG004|STARTED|Overall Study||47
11272290|NCT02330588|12467426|FG000|COMPLETED|Overall Study||28
11272291|NCT02330588|12467427|FG001|COMPLETED|Overall Study||25
11272292|NCT02330588|12467428|FG002|COMPLETED|Overall Study||31
11272293|NCT02330588|12467429|FG003|COMPLETED|Overall Study||24
11272294|NCT02330588|12467430|FG004|COMPLETED|Overall Study||28
11272295|NCT02330588|12467426|FG000|NOT COMPLETED|Overall Study||16
11272296|NCT02330588|12467427|FG001|NOT COMPLETED|Overall Study||18
11272297|NCT02330588|12467428|FG002|NOT COMPLETED|Overall Study||15
11272298|NCT02330588|12467429|FG003|NOT COMPLETED|Overall Study||22
11272299|NCT02330588|12467430|FG004|NOT COMPLETED|Overall Study||19
11272300|NCT02330627|12467452|FG000|STARTED|Overall Study||16
11272301|NCT02330627|12467453|FG001|STARTED|Overall Study||13
11272302|NCT02330627|12467452|FG000|COMPLETED|Overall Study||15
11272303|NCT02330627|12467453|FG001|COMPLETED|Overall Study||12
11272304|NCT02330627|12467452|FG000|NOT COMPLETED|Overall Study||1
11272305|NCT02330627|12467453|FG001|NOT COMPLETED|Overall Study||1
11272306|NCT02330978|12467459|FG000|STARTED|The First Patient Included at Study||1
11272307|NCT02330978|12467459|FG000|COMPLETED|The First Patient Included at Study||1
11272308|NCT02330978|12467459|FG000|NOT COMPLETED|The First Patient Included at Study||0
11272309|NCT02330978|12467459|FG000|STARTED|The Second Patient Included at Study||1
11272310|NCT02330978|12467459|FG000|COMPLETED|The Second Patient Included at Study||1
11272311|NCT02330978|12467459|FG000|NOT COMPLETED|The Second Patient Included at Study||0
11272312|NCT02331095|12467465|FG000|STARTED|Overall Study||11
11272313|NCT02331095|12467466|FG001|STARTED|Overall Study||10
11397862|NCT04501952|12592086|FG000|COMPLETED|Overall Study||266
11272314|NCT02331095|12467465|FG000|COMPLETED|Overall Study||7
11272315|NCT02331095|12467466|FG001|COMPLETED|Overall Study||9
11272316|NCT02331095|12467465|FG000|NOT COMPLETED|Overall Study||4
11272317|NCT02331095|12467466|FG001|NOT COMPLETED|Overall Study||1
11272318|NCT02331108|12467482|FG000|STARTED|Overall Study||51
11272319|NCT02331108|12467483|FG001|STARTED|Overall Study||52
11272320|NCT02331108|12467484|FG002|STARTED|Overall Study||51
11272321|NCT02331108|12467485|FG003|STARTED|Overall Study||51
11272322|NCT02331108|12467486|FG004|STARTED|Overall Study||52
11272323|NCT02331108|12467487|FG005|STARTED|Overall Study||52
11272324|NCT02331108|12467482|FG000|COMPLETED|Overall Study||50
11272325|NCT02331108|12467483|FG001|COMPLETED|Overall Study||50
11272326|NCT02331108|12467484|FG002|COMPLETED|Overall Study||50
11272327|NCT02331108|12467485|FG003|COMPLETED|Overall Study||50
11272328|NCT02331108|12467486|FG004|COMPLETED|Overall Study||50
11272329|NCT02331108|12467487|FG005|COMPLETED|Overall Study||50
11272330|NCT02331108|12467482|FG000|NOT COMPLETED|Overall Study||1
11272331|NCT02331108|12467483|FG001|NOT COMPLETED|Overall Study||2
11272332|NCT02331108|12467484|FG002|NOT COMPLETED|Overall Study||1
11272333|NCT02331108|12467485|FG003|NOT COMPLETED|Overall Study||1
11272334|NCT02331108|12467486|FG004|NOT COMPLETED|Overall Study||2
11272335|NCT02331108|12467487|FG005|NOT COMPLETED|Overall Study||2
11272336|NCT02331368|12467503|FG000|STARTED|Overall Study||32
11272337|NCT02331368|12467503|FG000|COMPLETED|Overall Study||29
11272338|NCT02331368|12467503|FG000|NOT COMPLETED|Overall Study||3
11272339|NCT02331394|12467507|FG000|STARTED|Overall Study||15
11272340|NCT02331394|12467507|FG000|COMPLETED|Overall Study|14 patients, 1 dropped out|14
11272341|NCT02331394|12467507|FG000|NOT COMPLETED|Overall Study||1
11272342|NCT02331407|12467518|FG000|STARTED|Overall Study||9
11272343|NCT02331407|12467518|FG000|COMPLETED|Overall Study||9
11272344|NCT02331407|12467518|FG000|NOT COMPLETED|Overall Study||0
11272345|NCT02331446|12467526|FG000|STARTED|Overall Study||9
11272346|NCT02331446|12467527|FG001|STARTED|Overall Study||11
11272347|NCT02331446|12467528|FG002|STARTED|Overall Study||11
11272348|NCT02331446|12467529|FG003|STARTED|Overall Study||11
11272349|NCT02331446|12467526|FG000|COMPLETED|Overall Study||5
11272350|NCT02331446|12467527|FG001|COMPLETED|Overall Study||6
11272351|NCT02331446|12467528|FG002|COMPLETED|Overall Study||8
11272352|NCT02331446|12467529|FG003|COMPLETED|Overall Study||8
11272353|NCT02331446|12467526|FG000|NOT COMPLETED|Overall Study||4
11272354|NCT02331446|12467527|FG001|NOT COMPLETED|Overall Study||5
11272355|NCT02331446|12467528|FG002|NOT COMPLETED|Overall Study||3
11272356|NCT02331446|12467529|FG003|NOT COMPLETED|Overall Study||3
11272357|NCT02331589|12467541|FG000|STARTED|Overall Study||39
11272358|NCT02331589|12467542|FG001|STARTED|Overall Study||36
11272359|NCT02331589|12467541|FG000|COMPLETED|Overall Study||34
11272360|NCT02331589|12467542|FG001|COMPLETED|Overall Study||31
11272361|NCT02331589|12467541|FG000|NOT COMPLETED|Overall Study||5
11272362|NCT02331589|12467542|FG001|NOT COMPLETED|Overall Study||5
11272363|NCT02331680|12467551|FG000|STARTED|Overall Study||40
11272364|NCT02331680|12467552|FG001|STARTED|Overall Study||40
11272365|NCT02331680|12467553|FG002|STARTED|Overall Study||44
11272366|NCT02331680|12467551|FG000|COMPLETED|Overall Study||34
11272367|NCT02331680|12467552|FG001|COMPLETED|Overall Study||36
11272368|NCT02331680|12467553|FG002|COMPLETED|Overall Study||29
11272369|NCT02331680|12467551|FG000|NOT COMPLETED|Overall Study||6
11272370|NCT02331680|12467552|FG001|NOT COMPLETED|Overall Study||4
11272371|NCT02331680|12467553|FG002|NOT COMPLETED|Overall Study||15
11272372|NCT02331940|12467563|FG000|STARTED|Overall Study||100
11272373|NCT02331940|12467564|FG001|STARTED|Overall Study||100
11272374|NCT02331940|12467563|FG000|COMPLETED|Overall Study||93
11272375|NCT02331940|12467564|FG001|COMPLETED|Overall Study||95
11272376|NCT02331940|12467563|FG000|NOT COMPLETED|Overall Study||7
11272377|NCT02331940|12467564|FG001|NOT COMPLETED|Overall Study||5
11272378|NCT02331992|12467570|FG000|STARTED|Overall Study||34
11272379|NCT02331992|12467570|FG000|COMPLETED|Overall Study||34
11272380|NCT02331992|12467570|FG000|NOT COMPLETED|Overall Study||0
11272381|NCT02332239|12467576|FG000|STARTED|Overall Study||58
11272382|NCT02332239|12467577|FG001|STARTED|Overall Study||58
11272383|NCT02332239|12467576|FG000|COMPLETED|Overall Study||54
11272384|NCT02332239|12467577|FG001|COMPLETED|Overall Study||52
11272385|NCT02332239|12467576|FG000|NOT COMPLETED|Overall Study||4
11272386|NCT02332239|12467577|FG001|NOT COMPLETED|Overall Study||6
11272387|NCT02332291|12467587|FG000|STARTED|Phase 1: Blinded Escitalopram or Placebo||63
11272388|NCT02332291|12467588|FG001|STARTED|Phase 1: Blinded Escitalopram or Placebo||32
11272389|NCT02332291|12467587|FG000|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||59
11272390|NCT02332291|12467588|FG001|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||23
11272391|NCT02332291|12467587|FG000|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||4
11272392|NCT02332291|12467588|FG001|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||9
11272393|NCT02332291|12467587|FG000|STARTED|Phase 2: Open-Label Bupropion||22
11272394|NCT02332291|12467588|FG001|STARTED|Phase 2: Open-Label Bupropion||19
11272395|NCT02332291|12467587|FG000|COMPLETED|Phase 2: Open-Label Bupropion||19
11272396|NCT02332291|12467588|FG001|COMPLETED|Phase 2: Open-Label Bupropion||11
11272397|NCT02332291|12467587|FG000|NOT COMPLETED|Phase 2: Open-Label Bupropion||3
11272398|NCT02332291|12467588|FG001|NOT COMPLETED|Phase 2: Open-Label Bupropion||8
11272399|NCT02332707|12467616|FG000|STARTED|Overall Study||23
11272400|NCT02332707|12467617|FG001|STARTED|Overall Study||24
11272401|NCT02332707|12467618|FG002|STARTED|Overall Study||16
11272402|NCT02332707|12467619|FG003|STARTED|Overall Study||14
11272403|NCT02332707|12467620|FG004|STARTED|Overall Study||23
11272404|NCT02332707|12467621|FG005|STARTED|Overall Study||23
11272405|NCT02332707|12467622|FG006|STARTED|Overall Study||15
11272406|NCT02332707|12467623|FG007|STARTED|Overall Study||16
11272407|NCT02332707|12467624|FG008|STARTED|Overall Study||48
11272408|NCT02332707|12467625|FG009|STARTED|Overall Study||31
11272409|NCT02332707|12467626|FG010|STARTED|Overall Study||31
11272410|NCT02332707|12467627|FG011|STARTED|Overall Study||35
11272411|NCT02332707|12467628|FG012|STARTED|Overall Study||40
11272412|NCT02332707|12467629|FG013|STARTED|Overall Study||15
11272413|NCT02332707|12467630|FG014|STARTED|Overall Study||16
11272414|NCT02332707|12467631|FG015|STARTED|Overall Study||26
11272415|NCT02332707|12467632|FG016|STARTED|Overall Study||30
11272416|NCT02332707|12467633|FG017|STARTED|Overall Study||16
11272417|NCT02332707|12467616|FG000|COMPLETED|Overall Study||23
11272418|NCT02332707|12467617|FG001|COMPLETED|Overall Study||24
11272419|NCT02332707|12467618|FG002|COMPLETED|Overall Study||15
11272420|NCT02332707|12467619|FG003|COMPLETED|Overall Study||13
11272421|NCT02332707|12467620|FG004|COMPLETED|Overall Study||23
11272422|NCT02332707|12467621|FG005|COMPLETED|Overall Study||22
11397863|NCT04501952|12592087|FG001|COMPLETED|Overall Study||272
11397864|NCT04501952|12592086|FG000|NOT COMPLETED|Overall Study||26
11397865|NCT04501952|12592087|FG001|NOT COMPLETED|Overall Study||20
11397866|NCT04504032|12592096|FG000|STARTED|Overall Study||246
11397867|NCT04504032|12592097|FG001|STARTED|Overall Study||251
11397868|NCT04504032|12592096|FG000|COMPLETED|Overall Study||210
11397869|NCT04504032|12592097|FG001|COMPLETED|Overall Study||223
11397870|NCT04504032|12592096|FG000|NOT COMPLETED|Overall Study||36
11397871|NCT04504032|12592097|FG001|NOT COMPLETED|Overall Study||28
11272423|NCT02332707|12467622|FG006|COMPLETED|Overall Study||15
11272424|NCT02332707|12467623|FG007|COMPLETED|Overall Study||16
11272425|NCT02332707|12467624|FG008|COMPLETED|Overall Study||48
11272426|NCT02332707|12467625|FG009|COMPLETED|Overall Study||28
11272427|NCT02332707|12467626|FG010|COMPLETED|Overall Study||29
11397872|NCT04507763|12592103|FG000|STARTED|Overall Study||763
11397873|NCT04507763|12592103|FG000|COMPLETED|Overall Study||562
11272428|NCT02332707|12467627|FG011|COMPLETED|Overall Study||35
11272429|NCT02332707|12467628|FG012|COMPLETED|Overall Study||35
11272430|NCT02332707|12467629|FG013|COMPLETED|Overall Study||15
11272431|NCT02332707|12467630|FG014|COMPLETED|Overall Study||16
11272432|NCT02332707|12467631|FG015|COMPLETED|Overall Study||26
11272433|NCT02332707|12467632|FG016|COMPLETED|Overall Study||30
11272434|NCT02332707|12467633|FG017|COMPLETED|Overall Study||16
11272435|NCT02332707|12467616|FG000|NOT COMPLETED|Overall Study||0
11272436|NCT02332707|12467617|FG001|NOT COMPLETED|Overall Study||0
11272437|NCT02332707|12467618|FG002|NOT COMPLETED|Overall Study||1
11272438|NCT02332707|12467619|FG003|NOT COMPLETED|Overall Study||1
11272439|NCT02332707|12467620|FG004|NOT COMPLETED|Overall Study||0
11272440|NCT02332707|12467621|FG005|NOT COMPLETED|Overall Study||1
11272441|NCT02332707|12467622|FG006|NOT COMPLETED|Overall Study||0
11272442|NCT02332707|12467623|FG007|NOT COMPLETED|Overall Study||0
11272443|NCT02332707|12467624|FG008|NOT COMPLETED|Overall Study||0
11272444|NCT02332707|12467625|FG009|NOT COMPLETED|Overall Study||3
11272445|NCT02332707|12467626|FG010|NOT COMPLETED|Overall Study||2
11272446|NCT02332707|12467627|FG011|NOT COMPLETED|Overall Study||0
11272447|NCT02332707|12467628|FG012|NOT COMPLETED|Overall Study||5
11272448|NCT02332707|12467629|FG013|NOT COMPLETED|Overall Study||0
11272449|NCT02332707|12467630|FG014|NOT COMPLETED|Overall Study||0
11272450|NCT02332707|12467631|FG015|NOT COMPLETED|Overall Study||0
11272451|NCT02332707|12467632|FG016|NOT COMPLETED|Overall Study||0
11272452|NCT02332707|12467633|FG017|NOT COMPLETED|Overall Study||0
11272453|NCT02332720|12467694|FG000|STARTED|Part A and Part B||21
11272454|NCT02332720|12467695|FG001|STARTED|Part A and Part B||21
11272455|NCT02332720|12467696|FG002|STARTED|Part A and Part B||22
11272456|NCT02332720|12467697|FG003|STARTED|Part A and Part B||22
11272457|NCT02332720|12467698|FG004|STARTED|Part A and Part B||16
11272458|NCT02332720|12467699|FG005|STARTED|Part A and Part B||36
11272459|NCT02332720|12467700|FG006|STARTED|Part A and Part B||37
11272460|NCT02332720|12467701|FG007|STARTED|Part A and Part B||35
11272461|NCT02332720|12467702|FG008|STARTED|Part A and Part B||15
11272462|NCT02332720|12467703|FG009|STARTED|Part A and Part B||14
11272463|NCT02332720|12467704|FG010|STARTED|Part A and Part B||14
11397874|NCT04507763|12592103|FG000|NOT COMPLETED|Overall Study||201
11397875|NCT04507867|12592112|FG000|STARTED|Overall Study||40
11397876|NCT04507867|12592113|FG001|STARTED|Overall Study||40
11397877|NCT04507867|12592112|FG000|COMPLETED|Overall Study||33
11397878|NCT04507867|12592113|FG001|COMPLETED|Overall Study||39
11397879|NCT04507867|12592112|FG000|NOT COMPLETED|Overall Study||7
11397880|NCT04507867|12592113|FG001|NOT COMPLETED|Overall Study||1
11397881|NCT04525079|12592140|FG000|STARTED|Overall Study||6
11397882|NCT04525079|12592141|FG001|STARTED|Overall Study||6
11397883|NCT04525079|12592142|FG002|STARTED|Overall Study||6
11397884|NCT04525079|12592143|FG003|STARTED|Overall Study||6
11397885|NCT04525079|12592144|FG004|STARTED|Overall Study||8
11397886|NCT04525079|12592140|FG000|COMPLETED|Overall Study||6
11397887|NCT04525079|12592141|FG001|COMPLETED|Overall Study||6
11397888|NCT04525079|12592142|FG002|COMPLETED|Overall Study||6
11397889|NCT04525079|12592143|FG003|COMPLETED|Overall Study||6
11272464|NCT02332720|12467705|FG011|STARTED|Part A and Part B||15
11272465|NCT02332720|12467706|FG012|STARTED|Part A and Part B||16
11272466|NCT02332720|12467707|FG013|STARTED|Part A and Part B||13
11272467|NCT02332720|12467708|FG014|STARTED|Part A and Part B||16
11272468|NCT02332720|12467709|FG015|STARTED|Part A and Part B||14
11272469|NCT02332720|12467710|FG016|STARTED|Part A and Part B||15
11272470|NCT02332720|12467711|FG017|STARTED|Part A and Part B||14
11272471|NCT02332720|12467712|FG018|STARTED|Part A and Part B||21
11272472|NCT02332720|12467713|FG019|STARTED|Part A and Part B||25
11272473|NCT02332720|12467714|FG020|STARTED|Part A and Part B||7
11272474|NCT02332720|12467715|FG021|STARTED|Part A and Part B||0
11272475|NCT02332720|12467716|FG022|STARTED|Part A and Part B||4
11272476|NCT02332720|12467694|FG000|Treated|Part A and Part B||21
11272477|NCT02332720|12467695|FG001|Treated|Part A and Part B||21
11272478|NCT02332720|12467696|FG002|Treated|Part A and Part B||22
11272479|NCT02332720|12467697|FG003|Treated|Part A and Part B||22
11272480|NCT02332720|12467698|FG004|Treated|Part A and Part B||16
11272481|NCT02332720|12467699|FG005|Treated|Part A and Part B||36
11272482|NCT02332720|12467700|FG006|Treated|Part A and Part B||37
11272483|NCT02332720|12467701|FG007|Treated|Part A and Part B||35
11272484|NCT02332720|12467702|FG008|Treated|Part A and Part B||15
11272485|NCT02332720|12467703|FG009|Treated|Part A and Part B||14
11272486|NCT02332720|12467704|FG010|Treated|Part A and Part B||14
11272487|NCT02332720|12467705|FG011|Treated|Part A and Part B||15
11272488|NCT02332720|12467706|FG012|Treated|Part A and Part B||16
11272489|NCT02332720|12467707|FG013|Treated|Part A and Part B||13
11272490|NCT02332720|12467708|FG014|Treated|Part A and Part B||16
11272491|NCT02332720|12467709|FG015|Treated|Part A and Part B||14
11272492|NCT02332720|12467710|FG016|Treated|Part A and Part B||15
11272493|NCT02332720|12467711|FG017|Treated|Part A and Part B||14
11272494|NCT02332720|12467712|FG018|Treated|Part A and Part B||20
11272495|NCT02332720|12467713|FG019|Treated|Part A and Part B||25
11272496|NCT02332720|12467714|FG020|Treated|Part A and Part B||7
11397890|NCT04525079|12592144|FG004|COMPLETED|Overall Study||8
11397891|NCT04525079|12592140|FG000|NOT COMPLETED|Overall Study||0
11272497|NCT02332720|12467715|FG021|Treated|Part A and Part B||0
11272498|NCT02332720|12467716|FG022|Treated|Part A and Part B||4
11272499|NCT02332720|12467694|FG000|COMPLETED|Part A and Part B||20
11272500|NCT02332720|12467695|FG001|COMPLETED|Part A and Part B||21
11397892|NCT04525079|12592141|FG001|NOT COMPLETED|Overall Study||0
11397893|NCT04525079|12592142|FG002|NOT COMPLETED|Overall Study||0
11397894|NCT04525079|12592143|FG003|NOT COMPLETED|Overall Study||0
11272501|NCT02332720|12467696|FG002|COMPLETED|Part A and Part B||22
11272502|NCT02332720|12467697|FG003|COMPLETED|Part A and Part B||22
11397895|NCT04525079|12592144|FG004|NOT COMPLETED|Overall Study||0
11397896|NCT04527978|12592158|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27
11272503|NCT02332720|12467698|FG004|COMPLETED|Part A and Part B||16
11272504|NCT02332720|12467699|FG005|COMPLETED|Part A and Part B||33
11272505|NCT02332720|12467700|FG006|COMPLETED|Part A and Part B||36
11272506|NCT02332720|12467701|FG007|COMPLETED|Part A and Part B||34
11272507|NCT02332720|12467702|FG008|COMPLETED|Part A and Part B||15
11272508|NCT02332720|12467703|FG009|COMPLETED|Part A and Part B||14
11272509|NCT02332720|12467704|FG010|COMPLETED|Part A and Part B||14
11272510|NCT02332720|12467705|FG011|COMPLETED|Part A and Part B||15
11272511|NCT02332720|12467706|FG012|COMPLETED|Part A and Part B||16
11272512|NCT02332720|12467707|FG013|COMPLETED|Part A and Part B||13
11272513|NCT02332720|12467708|FG014|COMPLETED|Part A and Part B||16
11272514|NCT02332720|12467709|FG015|COMPLETED|Part A and Part B||13
11272515|NCT02332720|12467710|FG016|COMPLETED|Part A and Part B||15
11272516|NCT02332720|12467711|FG017|COMPLETED|Part A and Part B||13
11272517|NCT02332720|12467712|FG018|COMPLETED|Part A and Part B||20
11272518|NCT02332720|12467713|FG019|COMPLETED|Part A and Part B||24
11272519|NCT02332720|12467714|FG020|COMPLETED|Part A and Part B||7
11272520|NCT02332720|12467715|FG021|COMPLETED|Part A and Part B||0
11272521|NCT02332720|12467716|FG022|COMPLETED|Part A and Part B||4
11272522|NCT02332720|12467694|FG000|NOT COMPLETED|Part A and Part B||1
11272523|NCT02332720|12467695|FG001|NOT COMPLETED|Part A and Part B||0
11272524|NCT02332720|12467696|FG002|NOT COMPLETED|Part A and Part B||0
11272525|NCT02332720|12467697|FG003|NOT COMPLETED|Part A and Part B||0
11272526|NCT02332720|12467698|FG004|NOT COMPLETED|Part A and Part B||0
11272527|NCT02332720|12467699|FG005|NOT COMPLETED|Part A and Part B||3
11272528|NCT02332720|12467700|FG006|NOT COMPLETED|Part A and Part B||1
11272529|NCT02332720|12467701|FG007|NOT COMPLETED|Part A and Part B||1
11272530|NCT02332720|12467702|FG008|NOT COMPLETED|Part A and Part B||0
11272531|NCT02332720|12467703|FG009|NOT COMPLETED|Part A and Part B||0
11272532|NCT02332720|12467704|FG010|NOT COMPLETED|Part A and Part B||0
11272533|NCT02332720|12467705|FG011|NOT COMPLETED|Part A and Part B||0
11272534|NCT02332720|12467706|FG012|NOT COMPLETED|Part A and Part B||0
11272535|NCT02332720|12467707|FG013|NOT COMPLETED|Part A and Part B||0
11272536|NCT02332720|12467708|FG014|NOT COMPLETED|Part A and Part B||0
11272537|NCT02332720|12467709|FG015|NOT COMPLETED|Part A and Part B||1
11272538|NCT02332720|12467710|FG016|NOT COMPLETED|Part A and Part B||0
11272539|NCT02332720|12467711|FG017|NOT COMPLETED|Part A and Part B||1
11272540|NCT02332720|12467712|FG018|NOT COMPLETED|Part A and Part B||1
11272541|NCT02332720|12467713|FG019|NOT COMPLETED|Part A and Part B||1
11272542|NCT02332720|12467714|FG020|NOT COMPLETED|Part A and Part B||0
11272543|NCT02332720|12467715|FG021|NOT COMPLETED|Part A and Part B||0
11272544|NCT02332720|12467716|FG022|NOT COMPLETED|Part A and Part B||0
11272545|NCT02332720|12467694|FG000|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
11272546|NCT02332720|12467695|FG001|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
11272547|NCT02332720|12467696|FG002|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
11272548|NCT02332720|12467697|FG003|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
11272549|NCT02332720|12467698|FG004|STARTED|Part C|Part B participants were not included in Part C.|0
11272550|NCT02332720|12467699|FG005|STARTED|Part C|Part B participants were not included in Part C.|0
11272551|NCT02332720|12467700|FG006|STARTED|Part C|Part B participants were not included in Part C.|0
11272552|NCT02332720|12467701|FG007|STARTED|Part C|Part B participants were not included in Part C.|0
11397897|NCT04527978|12592159|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
11272553|NCT02332720|12467702|FG008|STARTED|Part C|Part B participants were not included in Part C.|0
11272554|NCT02332720|12467703|FG009|STARTED|Part C|Part B participants were not included in Part C.|0
11272555|NCT02332720|12467704|FG010|STARTED|Part C|Part B participants were not included in Part C.|0
11272556|NCT02332720|12467705|FG011|STARTED|Part C|Part B participants were not included in Part C.|0
11272557|NCT02332720|12467706|FG012|STARTED|Part C|Part B participants were not included in Part C.|0
11272558|NCT02332720|12467707|FG013|STARTED|Part C|Part B participants were not included in Part C.|0
11272559|NCT02332720|12467708|FG014|STARTED|Part C|Part B participants were not included in Part C.|0
11272560|NCT02332720|12467709|FG015|STARTED|Part C|Part B participants were not included in Part C.|0
11272561|NCT02332720|12467710|FG016|STARTED|Part C|Part B participants were not included in Part C.|0
11272562|NCT02332720|12467711|FG017|STARTED|Part C|Part B participants were not included in Part C.|0
11272563|NCT02332720|12467712|FG018|STARTED|Part C|Part B participants were not included in Part C.|0
11272564|NCT02332720|12467713|FG019|STARTED|Part C|Part B participants were not included in Part C.|0
11272565|NCT02332720|12467714|FG020|STARTED|Part C|Part B participants were not included in Part C.|0
11272566|NCT02332720|12467715|FG021|STARTED|Part C||0
11272567|NCT02332720|12467716|FG022|STARTED|Part C|Part B participants were not included in Part C.|0
11272568|NCT02332720|12467694|FG000|COMPLETED|Part C||2
11272569|NCT02332720|12467695|FG001|COMPLETED|Part C||1
11272570|NCT02332720|12467696|FG002|COMPLETED|Part C||3
11272571|NCT02332720|12467697|FG003|COMPLETED|Part C||2
11272572|NCT02332720|12467698|FG004|COMPLETED|Part C||0
11272573|NCT02332720|12467699|FG005|COMPLETED|Part C||0
11272574|NCT02332720|12467700|FG006|COMPLETED|Part C||0
11272575|NCT02332720|12467701|FG007|COMPLETED|Part C||0
11272576|NCT02332720|12467702|FG008|COMPLETED|Part C||0
11272577|NCT02332720|12467703|FG009|COMPLETED|Part C||0
11272578|NCT02332720|12467704|FG010|COMPLETED|Part C||0
11272579|NCT02332720|12467705|FG011|COMPLETED|Part C||0
11272580|NCT02332720|12467706|FG012|COMPLETED|Part C||0
11272581|NCT02332720|12467707|FG013|COMPLETED|Part C||0
11397898|NCT04527978|12592158|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||26
11272582|NCT02332720|12467708|FG014|COMPLETED|Part C||0
11272583|NCT02332720|12467709|FG015|COMPLETED|Part C||0
11272584|NCT02332720|12467710|FG016|COMPLETED|Part C||0
11272585|NCT02332720|12467711|FG017|COMPLETED|Part C||0
11272586|NCT02332720|12467712|FG018|COMPLETED|Part C||0
11397899|NCT04527978|12592159|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28
11272587|NCT02332720|12467713|FG019|COMPLETED|Part C||0
11272588|NCT02332720|12467714|FG020|COMPLETED|Part C||0
11272589|NCT02332720|12467715|FG021|COMPLETED|Part C||0
11272590|NCT02332720|12467716|FG022|COMPLETED|Part C||0
11272591|NCT02332720|12467694|FG000|NOT COMPLETED|Part C||0
11272592|NCT02332720|12467695|FG001|NOT COMPLETED|Part C||0
11272593|NCT02332720|12467696|FG002|NOT COMPLETED|Part C||0
11272594|NCT02332720|12467697|FG003|NOT COMPLETED|Part C||0
11272595|NCT02332720|12467698|FG004|NOT COMPLETED|Part C||0
11272596|NCT02332720|12467699|FG005|NOT COMPLETED|Part C||0
11272597|NCT02332720|12467700|FG006|NOT COMPLETED|Part C||0
11272598|NCT02332720|12467701|FG007|NOT COMPLETED|Part C||0
11272599|NCT02332720|12467702|FG008|NOT COMPLETED|Part C||0
11272600|NCT02332720|12467703|FG009|NOT COMPLETED|Part C||0
11272601|NCT02332720|12467704|FG010|NOT COMPLETED|Part C||0
11272602|NCT02332720|12467705|FG011|NOT COMPLETED|Part C||0
11272603|NCT02332720|12467706|FG012|NOT COMPLETED|Part C||0
11272604|NCT02332720|12467707|FG013|NOT COMPLETED|Part C||0
11272605|NCT02332720|12467708|FG014|NOT COMPLETED|Part C||0
11272606|NCT02332720|12467709|FG015|NOT COMPLETED|Part C||0
11397900|NCT04527978|12592158|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||1
11397901|NCT04527978|12592159|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
11272607|NCT02332720|12467710|FG016|NOT COMPLETED|Part C||0
11272608|NCT02332720|12467711|FG017|NOT COMPLETED|Part C||0
11272609|NCT02332720|12467712|FG018|NOT COMPLETED|Part C||0
11272610|NCT02332720|12467713|FG019|NOT COMPLETED|Part C||0
11272611|NCT02332720|12467714|FG020|NOT COMPLETED|Part C||0
11272612|NCT02332720|12467715|FG021|NOT COMPLETED|Part C||0
11272613|NCT02332720|12467716|FG022|NOT COMPLETED|Part C||0
11272614|NCT02332798|12467781|FG000|STARTED|Overall Study||13
11272615|NCT02332798|12467782|FG001|STARTED|Overall Study||14
11272616|NCT02332798|12467783|FG002|STARTED|Overall Study||12
11272617|NCT02332798|12467781|FG000|COMPLETED|Overall Study||12
11272618|NCT02332798|12467782|FG001|COMPLETED|Overall Study||12
11272619|NCT02332798|12467783|FG002|COMPLETED|Overall Study||11
11272620|NCT02332798|12467781|FG000|NOT COMPLETED|Overall Study||1
11272621|NCT02332798|12467782|FG001|NOT COMPLETED|Overall Study||2
11272622|NCT02332798|12467783|FG002|NOT COMPLETED|Overall Study||1
11272623|NCT02332824|12467797|FG000|STARTED|Overall Study||67
11272624|NCT02332824|12467798|FG001|STARTED|Overall Study||67
11272625|NCT02332824|12467799|FG002|STARTED|Overall Study||74
11272626|NCT02332824|12467800|FG003|STARTED|Overall Study||68
11272627|NCT02332824|12467801|FG004|STARTED|Overall Study||69
11272628|NCT02332824|12467802|FG005|STARTED|Overall Study||70
11272629|NCT02332824|12467797|FG000|COMPLETED|Overall Study||61
11272630|NCT02332824|12467798|FG001|COMPLETED|Overall Study||66
11272631|NCT02332824|12467799|FG002|COMPLETED|Overall Study||72
11272632|NCT02332824|12467800|FG003|COMPLETED|Overall Study||66
11272633|NCT02332824|12467801|FG004|COMPLETED|Overall Study||65
11272634|NCT02332824|12467802|FG005|COMPLETED|Overall Study||69
11272635|NCT02332824|12467797|FG000|NOT COMPLETED|Overall Study||6
11272636|NCT02332824|12467798|FG001|NOT COMPLETED|Overall Study||1
11272637|NCT02332824|12467799|FG002|NOT COMPLETED|Overall Study||2
11272638|NCT02332824|12467800|FG003|NOT COMPLETED|Overall Study||2
11272639|NCT02332824|12467801|FG004|NOT COMPLETED|Overall Study||4
11272640|NCT02332824|12467802|FG005|NOT COMPLETED|Overall Study||1
11272641|NCT02332863|12467818|FG000|STARTED|Overall Study||22
11272642|NCT02332863|12467819|FG001|STARTED|Overall Study||22
11272643|NCT02332863|12467818|FG000|COMPLETED|Overall Study||22
11272644|NCT02332863|12467819|FG001|COMPLETED|Overall Study||22
11272645|NCT02332863|12467818|FG000|NOT COMPLETED|Overall Study||0
11272646|NCT02332863|12467819|FG001|NOT COMPLETED|Overall Study||0
11272647|NCT02332876|12467827|FG000|STARTED|Overall Study||43
11272648|NCT02332876|12467828|FG001|STARTED|Overall Study||44
11272649|NCT02332876|12467827|FG000|COMPLETED|Overall Study||42
11272650|NCT02332876|12467828|FG001|COMPLETED|Overall Study||43
11397902|NCT04527978|12592158|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||26
11397903|NCT04527978|12592159|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28
11397904|NCT04527978|12592158|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||26
11397905|NCT04527978|12592159|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28
11272651|NCT02332876|12467827|FG000|NOT COMPLETED|Overall Study||1
11272652|NCT02332876|12467828|FG001|NOT COMPLETED|Overall Study||1
11272653|NCT02332889|12467834|FG000|STARTED|Overall Study||1
11272654|NCT02332889|12467834|FG000|COMPLETED|Overall Study||0
11272655|NCT02332889|12467834|FG000|NOT COMPLETED|Overall Study||1
11272656|NCT02332902|12467838|FG000|STARTED|Overall Study||24
11272657|NCT02332902|12467838|FG000|COMPLETED|Overall Study||17
11397906|NCT04527978|12592158|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
11397907|NCT04527978|12592159|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
11397908|NCT04528017|12592170|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27
11272658|NCT02332902|12467838|FG000|NOT COMPLETED|Overall Study||7
11272659|NCT02333045|12467844|FG000|STARTED|Overall Study||1
11272660|NCT02333045|12467845|FG001|STARTED|Overall Study||3
11272661|NCT02333045|12467844|FG000|COMPLETED|Overall Study||1
11272662|NCT02333045|12467845|FG001|COMPLETED|Overall Study||3
11397909|NCT04528017|12592171|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
11397910|NCT04528017|12592170|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||27
11272663|NCT02333045|12467844|FG000|NOT COMPLETED|Overall Study||0
11272664|NCT02333045|12467845|FG001|NOT COMPLETED|Overall Study||0
11272665|NCT02333071|12467853|FG000|STARTED|Core Study||326
11272666|NCT02333071|12467854|FG001|STARTED|Core Study||327
11272667|NCT02333071|12467853|FG000|Received Intervention|Core Study||319
11272668|NCT02333071|12467854|FG001|Received Intervention|Core Study||324
11272669|NCT02333071|12467853|FG000|COMPLETED|Core Study||274
11272670|NCT02333071|12467854|FG001|COMPLETED|Core Study||190
11272671|NCT02333071|12467853|FG000|NOT COMPLETED|Core Study||52
11272672|NCT02333071|12467854|FG001|NOT COMPLETED|Core Study||137
11272673|NCT02333071|12467853|FG000|STARTED|Open Label Extension||239
11272674|NCT02333071|12467854|FG001|STARTED|Open Label Extension||124
11272675|NCT02333071|12467853|FG000|COMPLETED|Open Label Extension||95
11272676|NCT02333071|12467854|FG001|COMPLETED|Open Label Extension||49
11272677|NCT02333071|12467853|FG000|NOT COMPLETED|Open Label Extension||144
11272678|NCT02333071|12467854|FG001|NOT COMPLETED|Open Label Extension||75
11397911|NCT04528017|12592171|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28
11397912|NCT04528017|12592170|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
11397913|NCT04528017|12592171|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
11340447|NCT02920983|12537744|FG001|STARTED|Dispense 2||10
11340448|NCT02920983|12537745|FG002|STARTED|Dispense 2||7
11340449|NCT02920983|12537746|FG003|STARTED|Dispense 2||6
11340450|NCT02920983|12537747|FG004|STARTED|Dispense 2||13
11340451|NCT02920983|12537748|FG005|STARTED|Dispense 2||7
11340452|NCT02920983|12537743|FG000|COMPLETED|Dispense 2||7
11340453|NCT02920983|12537744|FG001|COMPLETED|Dispense 2||10
11340454|NCT02920983|12537745|FG002|COMPLETED|Dispense 2||7
11340455|NCT02920983|12537746|FG003|COMPLETED|Dispense 2||6
11340456|NCT02920983|12537747|FG004|COMPLETED|Dispense 2||12
11340457|NCT02920983|12537748|FG005|COMPLETED|Dispense 2||7
11340458|NCT02920983|12537743|FG000|NOT COMPLETED|Dispense 2||1
11340459|NCT02920983|12537744|FG001|NOT COMPLETED|Dispense 2||0
11340460|NCT02920983|12537745|FG002|NOT COMPLETED|Dispense 2||0
11340461|NCT02920983|12537746|FG003|NOT COMPLETED|Dispense 2||0
11340462|NCT02920983|12537747|FG004|NOT COMPLETED|Dispense 2||1
11340463|NCT02920983|12537748|FG005|NOT COMPLETED|Dispense 2||0
11340464|NCT02920983|12537743|FG000|STARTED|Dispense 3||8
11340465|NCT02920983|12537744|FG001|STARTED|Dispense 3||10
11340466|NCT02920983|12537745|FG002|STARTED|Dispense 3||7
11397914|NCT04528017|12592170|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||27
11397915|NCT04528017|12592171|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28
11397916|NCT04528017|12592170|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||27
11397917|NCT04528017|12592171|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28
11397918|NCT04528017|12592170|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
11397919|NCT04528017|12592171|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
11397920|NCT04529109|12592180|FG000|STARTED|Period 1||27
11340467|NCT02920983|12537746|FG003|STARTED|Dispense 3||6
11340468|NCT02920983|12537747|FG004|STARTED|Dispense 3||13
11340469|NCT02920983|12537748|FG005|STARTED|Dispense 3||7
11397921|NCT04529109|12592181|FG001|STARTED|Period 1||29
11397922|NCT04529109|12592180|FG000|COMPLETED|Period 1||27
11397923|NCT04529109|12592181|FG001|COMPLETED|Period 1||28
11397924|NCT04529109|12592180|FG000|NOT COMPLETED|Period 1||0
11397925|NCT04529109|12592181|FG001|NOT COMPLETED|Period 1||1
11397926|NCT04529109|12592180|FG000|STARTED|Period 2||27
11397927|NCT04529109|12592181|FG001|STARTED|Period 2||28
11397928|NCT04529109|12592180|FG000|COMPLETED|Period 2||27
11397929|NCT04529109|12592181|FG001|COMPLETED|Period 2||28
11397930|NCT04529109|12592180|FG000|NOT COMPLETED|Period 2||0
11397931|NCT04529109|12592181|FG001|NOT COMPLETED|Period 2||0
11397932|NCT04536571|12592187|FG000|STARTED|First Intervention||11
11397933|NCT04536571|12592188|FG001|STARTED|First Intervention||16
11397934|NCT04536571|12592187|FG000|COMPLETED|First Intervention||11
11397935|NCT04536571|12592188|FG001|COMPLETED|First Intervention||16
11397936|NCT04536571|12592187|FG000|NOT COMPLETED|First Intervention||0
11397937|NCT04536571|12592188|FG001|NOT COMPLETED|First Intervention||0
11397938|NCT04536571|12592187|FG000|STARTED|Second Intervention||11
11397939|NCT04536571|12592188|FG001|STARTED|Second Intervention||16
11397940|NCT04536571|12592187|FG000|COMPLETED|Second Intervention||11
11397941|NCT04536571|12592188|FG001|COMPLETED|Second Intervention||16
11397942|NCT04536571|12592187|FG000|NOT COMPLETED|Second Intervention||0
11397943|NCT04536571|12592188|FG001|NOT COMPLETED|Second Intervention||0
11397944|NCT04544787|12592205|FG000|STARTED|Overall Study||50
11397945|NCT04544787|12592206|FG001|STARTED|Overall Study||50
11397946|NCT04544787|12592207|FG002|STARTED|Overall Study||50
11397947|NCT04544787|12592208|FG003|STARTED|Overall Study||50
11397948|NCT04544787|12592209|FG004|STARTED|Overall Study||17
11397949|NCT04544787|12592210|FG005|STARTED|Overall Study||16
11397950|NCT04544787|12592211|FG006|STARTED|Overall Study||17
11397951|NCT04544787|12592205|FG000|Received First Dose of Vaccine|Overall Study||50
11397952|NCT04544787|12592206|FG001|Received First Dose of Vaccine|Overall Study||50
11397953|NCT04544787|12592207|FG002|Received First Dose of Vaccine|Overall Study||50
11397954|NCT04544787|12592208|FG003|Received First Dose of Vaccine|Overall Study||50
11397955|NCT04544787|12592209|FG004|Received First Dose of Vaccine|Overall Study||17
11397956|NCT04544787|12592210|FG005|Received First Dose of Vaccine|Overall Study||16
11397957|NCT04544787|12592211|FG006|Received First Dose of Vaccine|Overall Study||17
11397958|NCT04544787|12592205|FG000|Received Second Dose of Vaccine|Overall Study||0
11272679|NCT02333331|12467869|FG000|STARTED|Overall Study||19
11272680|NCT02333331|12467870|FG001|STARTED|Overall Study||18
11272681|NCT02333331|12467871|FG002|STARTED|Overall Study||113
11272682|NCT02333331|12467872|FG003|STARTED|Overall Study||67
11272683|NCT02333331|12467869|FG000|COMPLETED|Overall Study||17
11272684|NCT02333331|12467870|FG001|COMPLETED|Overall Study||12
11272685|NCT02333331|12467871|FG002|COMPLETED|Overall Study||95
11272686|NCT02333331|12467872|FG003|COMPLETED|Overall Study||64
11272687|NCT02333331|12467869|FG000|NOT COMPLETED|Overall Study||2
11272688|NCT02333331|12467870|FG001|NOT COMPLETED|Overall Study||6
11272689|NCT02333331|12467871|FG002|NOT COMPLETED|Overall Study||18
11272690|NCT02333331|12467872|FG003|NOT COMPLETED|Overall Study||3
11272691|NCT02333383|12467882|FG000|STARTED|Overall Study||201
11272692|NCT02333383|12467882|FG000|COMPLETED|Overall Study||160
11272693|NCT02333383|12467882|FG000|NOT COMPLETED|Overall Study||41
11272694|NCT02333487|12467889|FG000|STARTED|Overall Study||6
11272695|NCT02333487|12467890|FG001|STARTED|Overall Study||8
11272696|NCT02333487|12467891|FG002|STARTED|Overall Study||8
11272697|NCT02333487|12467889|FG000|COMPLETED|Overall Study||6
11272698|NCT02333487|12467890|FG001|COMPLETED|Overall Study||6
11272699|NCT02333487|12467891|FG002|COMPLETED|Overall Study||8
11272700|NCT02333487|12467889|FG000|NOT COMPLETED|Overall Study||0
11272701|NCT02333487|12467890|FG001|NOT COMPLETED|Overall Study||2
11272702|NCT02333487|12467891|FG002|NOT COMPLETED|Overall Study||0
11272703|NCT02333630|12467902|FG000|STARTED|Overall Study||100
11272704|NCT02333630|12467903|FG001|STARTED|Overall Study||100
11272705|NCT02333630|12467902|FG000|COMPLETED|Overall Study||95
11272706|NCT02333630|12467903|FG001|COMPLETED|Overall Study||98
11272707|NCT02333630|12467902|FG000|NOT COMPLETED|Overall Study||5
11272708|NCT02333630|12467903|FG001|NOT COMPLETED|Overall Study||2
11272709|NCT02334059|12467916|FG000|STARTED|Overall Study||37
11272710|NCT02334059|12467917|FG001|STARTED|Overall Study||34
11272711|NCT02334059|12467918|FG002|STARTED|Overall Study||37
11272712|NCT02334059|12467916|FG000|COMPLETED|Overall Study||37
11272713|NCT02334059|12467917|FG001|COMPLETED|Overall Study||34
11272714|NCT02334059|12467918|FG002|COMPLETED|Overall Study||37
11272715|NCT02334059|12467916|FG000|NOT COMPLETED|Overall Study||0
11272716|NCT02334059|12467917|FG001|NOT COMPLETED|Overall Study||0
11272717|NCT02334059|12467918|FG002|NOT COMPLETED|Overall Study||0
11272718|NCT02334215|12467929|FG000|STARTED|Overall Study||75
11272719|NCT02334215|12467930|FG001|STARTED|Overall Study||74
11272720|NCT02334215|12467931|FG002|STARTED|Overall Study||76
11272721|NCT02334215|12467929|FG000|COMPLETED|Overall Study||68
11272722|NCT02334215|12467930|FG001|COMPLETED|Overall Study||68
11272723|NCT02334215|12467931|FG002|COMPLETED|Overall Study||61
11272724|NCT02334215|12467929|FG000|NOT COMPLETED|Overall Study||7
11272725|NCT02334215|12467930|FG001|NOT COMPLETED|Overall Study||6
11272726|NCT02334215|12467931|FG002|NOT COMPLETED|Overall Study||15
11272727|NCT02334267|12467941|FG000|STARTED|Overall Study||6
11272728|NCT02334267|12467942|FG001|STARTED|Overall Study||5
11272729|NCT02334267|12467941|FG000|COMPLETED|Overall Study||5
11397959|NCT04544787|12592206|FG001|Received Second Dose of Vaccine|Overall Study||49
11397960|NCT04544787|12592207|FG002|Received Second Dose of Vaccine|Overall Study||0
11272730|NCT02334267|12467942|FG001|COMPLETED|Overall Study||5
11272731|NCT02334267|12467941|FG000|NOT COMPLETED|Overall Study||1
11272732|NCT02334267|12467942|FG001|NOT COMPLETED|Overall Study||0
11272733|NCT02334306|12467956|FG000|STARTED|Double-blind Period||16
11272734|NCT02334306|12467957|FG001|STARTED|Double-blind Period||16
11272735|NCT02334306|12467956|FG000|COMPLETED|Double-blind Period||15
11272736|NCT02334306|12467957|FG001|COMPLETED|Double-blind Period||14
11272737|NCT02334306|12467956|FG000|NOT COMPLETED|Double-blind Period||1
11272738|NCT02334306|12467957|FG001|NOT COMPLETED|Double-blind Period||2
11272739|NCT02334306|12467956|FG000|STARTED|Open-label Period||15
11272740|NCT02334306|12467957|FG001|STARTED|Open-label Period||14
11272741|NCT02334306|12467956|FG000|COMPLETED|Open-label Period||15
11272742|NCT02334306|12467957|FG001|COMPLETED|Open-label Period||14
11272743|NCT02334306|12467956|FG000|NOT COMPLETED|Open-label Period||0
11272744|NCT02334306|12467957|FG001|NOT COMPLETED|Open-label Period||0
11272745|NCT02334358|12467964|FG000|STARTED|Overall Study||503
11272746|NCT02334358|12467964|FG000|COMPLETED|Overall Study||494
11272747|NCT02334358|12467964|FG000|NOT COMPLETED|Overall Study||9
11272748|NCT02334384|12467970|FG000|STARTED|Overall Study||4
11272749|NCT02334384|12467971|FG001|STARTED|Overall Study||2
11272750|NCT02334384|12467970|FG000|COMPLETED|Overall Study||3
11272751|NCT02334384|12467971|FG001|COMPLETED|Overall Study||1
11272752|NCT02334384|12467970|FG000|NOT COMPLETED|Overall Study||1
11272753|NCT02334384|12467971|FG001|NOT COMPLETED|Overall Study||1
11272754|NCT02334423|12467979|FG000|STARTED|Overall Study||246
11272755|NCT02334423|12467980|FG001|STARTED|Overall Study||84
11272756|NCT02334423|12467979|FG000|COMPLETED|Overall Study||236
11272757|NCT02334423|12467980|FG001|COMPLETED|Overall Study||81
11272758|NCT02334423|12467979|FG000|NOT COMPLETED|Overall Study||10
11272759|NCT02334423|12467980|FG001|NOT COMPLETED|Overall Study||3
11272760|NCT02334436|12467988|FG000|STARTED|Overall Study||246
11272761|NCT02334436|12467989|FG001|STARTED|Overall Study||78
11272762|NCT02334436|12467988|FG000|COMPLETED|Overall Study||237
11272763|NCT02334436|12467989|FG001|COMPLETED|Overall Study||77
11272764|NCT02334436|12467988|FG000|NOT COMPLETED|Overall Study||9
11272765|NCT02334436|12467989|FG001|NOT COMPLETED|Overall Study||1
11272766|NCT02334527|12467995|FG000|STARTED|Overall Study||12
11272767|NCT02334527|12467995|FG000|COMPLETED|Overall Study||12
11272768|NCT02334527|12467995|FG000|NOT COMPLETED|Overall Study||0
11272769|NCT02334683|12468005|FG000|STARTED|First 12 Week Period||10
11272770|NCT02334683|12468006|FG001|STARTED|First 12 Week Period||10
11272771|NCT02334683|12468005|FG000|COMPLETED|First 12 Week Period||9
11272772|NCT02334683|12468006|FG001|COMPLETED|First 12 Week Period||10
11272773|NCT02334683|12468005|FG000|NOT COMPLETED|First 12 Week Period||1
11272774|NCT02334683|12468006|FG001|NOT COMPLETED|First 12 Week Period||0
11272775|NCT02334683|12468005|FG000|STARTED|Second 12 Week Period||9
11272776|NCT02334683|12468006|FG001|STARTED|Second 12 Week Period||10
11272777|NCT02334683|12468005|FG000|COMPLETED|Second 12 Week Period||9
11397961|NCT04544787|12592208|FG003|Received Second Dose of Vaccine|Overall Study||49
11397962|NCT04544787|12592209|FG004|Received Second Dose of Vaccine|Overall Study||17
11397963|NCT04544787|12592210|FG005|Received Second Dose of Vaccine|Overall Study||15
11397964|NCT04544787|12592211|FG006|Received Second Dose of Vaccine|Overall Study||16
11397965|NCT04544787|12592205|FG000|COMPLETED|Overall Study||50
11397966|NCT04544787|12592206|FG001|COMPLETED|Overall Study||50
11397967|NCT04544787|12592207|FG002|COMPLETED|Overall Study||50
11397968|NCT04544787|12592208|FG003|COMPLETED|Overall Study||50
11397969|NCT04544787|12592209|FG004|COMPLETED|Overall Study||17
11397970|NCT04544787|12592210|FG005|COMPLETED|Overall Study||16
11397971|NCT04544787|12592211|FG006|COMPLETED|Overall Study||17
11397972|NCT04544787|12592205|FG000|NOT COMPLETED|Overall Study||0
11397973|NCT04544787|12592206|FG001|NOT COMPLETED|Overall Study||0
11397974|NCT04544787|12592207|FG002|NOT COMPLETED|Overall Study||0
11397975|NCT04544787|12592208|FG003|NOT COMPLETED|Overall Study||0
11397976|NCT04544787|12592209|FG004|NOT COMPLETED|Overall Study||0
11397977|NCT04544787|12592210|FG005|NOT COMPLETED|Overall Study||0
11397978|NCT04544787|12592211|FG006|NOT COMPLETED|Overall Study||0
11397979|NCT04555031|12592250|FG000|STARTED|Overall Study||10
11397980|NCT04555031|12592250|FG000|COMPLETED|Overall Study||10
11397981|NCT04555031|12592250|FG000|NOT COMPLETED|Overall Study||0
11397982|NCT04559282|12592257|FG000|STARTED|Intervention 1 (Day 0)||8
11397983|NCT04559282|12592258|FG001|STARTED|Intervention 1 (Day 0)||8
11397984|NCT04559282|12592257|FG000|COMPLETED|Intervention 1 (Day 0)||8
11397985|NCT04559282|12592258|FG001|COMPLETED|Intervention 1 (Day 0)||8
11397986|NCT04559282|12592257|FG000|NOT COMPLETED|Intervention 1 (Day 0)||0
11397987|NCT04559282|12592258|FG001|NOT COMPLETED|Intervention 1 (Day 0)||0
11397988|NCT04559282|12592257|FG000|STARTED|Intervention 2 (Day 7)||8
11397989|NCT04559282|12592258|FG001|STARTED|Intervention 2 (Day 7)||8
11397990|NCT04559282|12592257|FG000|COMPLETED|Intervention 2 (Day 7)||8
11397991|NCT04559282|12592258|FG001|COMPLETED|Intervention 2 (Day 7)||8
11397992|NCT04559282|12592257|FG000|NOT COMPLETED|Intervention 2 (Day 7)||0
11397993|NCT04559282|12592258|FG001|NOT COMPLETED|Intervention 2 (Day 7)||0
11397994|NCT04559282|12592257|FG000|STARTED|Intervention 3 (Day 14)||8
11397995|NCT04559282|12592258|FG001|STARTED|Intervention 3 (Day 14)||8
11397996|NCT04559282|12592257|FG000|COMPLETED|Intervention 3 (Day 14)||8
11397997|NCT04559282|12592258|FG001|COMPLETED|Intervention 3 (Day 14)||8
11397998|NCT04559282|12592257|FG000|NOT COMPLETED|Intervention 3 (Day 14)||0
11397999|NCT04559282|12592258|FG001|NOT COMPLETED|Intervention 3 (Day 14)||0
11398000|NCT04574297|12592271|FG000|STARTED|Overall Study||180
11398001|NCT04574297|12592272|FG001|STARTED|Overall Study||263
11398002|NCT04574297|12592273|FG002|STARTED|Overall Study||230
11398003|NCT04574297|12592274|FG003|STARTED|Overall Study||125
11398004|NCT04574297|12592271|FG000|COMPLETED|Overall Study||180
11398005|NCT04574297|12592272|FG001|COMPLETED|Overall Study||263
11398006|NCT04574297|12592273|FG002|COMPLETED|Overall Study||230
11398007|NCT04574297|12592274|FG003|COMPLETED|Overall Study||125
11398008|NCT04574297|12592271|FG000|NOT COMPLETED|Overall Study||0
11398009|NCT04574297|12592272|FG001|NOT COMPLETED|Overall Study||0
11398010|NCT04574297|12592273|FG002|NOT COMPLETED|Overall Study||0
11398011|NCT04574297|12592274|FG003|NOT COMPLETED|Overall Study||0
11398012|NCT04580290|12592286|FG000|STARTED|Overall Study||88
11398013|NCT04580290|12592287|FG001|STARTED|Overall Study||32
11398014|NCT04580290|12592286|FG000|COMPLETED|Overall Study||88
11398015|NCT04580290|12592287|FG001|COMPLETED|Overall Study||32
11398016|NCT04580290|12592286|FG000|NOT COMPLETED|Overall Study||0
11398017|NCT04580290|12592287|FG001|NOT COMPLETED|Overall Study||0
11398018|NCT04601103|12592296|FG000|STARTED|Overall Study||18
11398019|NCT04601103|12592297|FG001|STARTED|Overall Study||18
11398020|NCT04601103|12592298|FG002|STARTED|Overall Study||17
11398021|NCT04601103|12592296|FG000|COMPLETED|Overall Study||0
11398022|NCT04601103|12592297|FG001|COMPLETED|Overall Study||0
11398023|NCT04601103|12592298|FG002|COMPLETED|Overall Study||0
11398024|NCT04601103|12592296|FG000|NOT COMPLETED|Overall Study||18
11398025|NCT04601103|12592297|FG001|NOT COMPLETED|Overall Study||18
11398026|NCT04601103|12592298|FG002|NOT COMPLETED|Overall Study||17
11398027|NCT04617574|12592308|FG000|STARTED|Overall Study||30
11398028|NCT04617574|12592309|FG001|STARTED|Overall Study||30
11398029|NCT04617574|12592308|FG000|COMPLETED|Overall Study||30
11272778|NCT02334683|12468006|FG001|COMPLETED|Second 12 Week Period||9
11272779|NCT02334683|12468005|FG000|NOT COMPLETED|Second 12 Week Period||0
11272780|NCT02334683|12468006|FG001|NOT COMPLETED|Second 12 Week Period||1
11272781|NCT02334748|12468012|FG000|STARTED|Overall Study||31
11272782|NCT02334748|12468012|FG000|COMPLETED|Overall Study||23
11272783|NCT02334748|12468012|FG000|NOT COMPLETED|Overall Study||8
11272784|NCT02334787|12468020|FG000|STARTED|Overall Study||8
11272785|NCT02334787|12468021|FG001|STARTED|Overall Study||8
11272786|NCT02334787|12468022|FG002|STARTED|Overall Study||8
11272787|NCT02334787|12468023|FG003|STARTED|Overall Study||8
11272788|NCT02334787|12468020|FG000|COMPLETED|Overall Study||8
11272789|NCT02334787|12468021|FG001|COMPLETED|Overall Study||8
11272790|NCT02334787|12468022|FG002|COMPLETED|Overall Study||8
11272791|NCT02334787|12468023|FG003|COMPLETED|Overall Study||8
11272792|NCT02334787|12468020|FG000|NOT COMPLETED|Overall Study||0
11272793|NCT02334787|12468021|FG001|NOT COMPLETED|Overall Study||0
11272794|NCT02334787|12468022|FG002|NOT COMPLETED|Overall Study||0
11272795|NCT02334787|12468023|FG003|NOT COMPLETED|Overall Study||0
11272796|NCT02334800|12468043|FG000|STARTED|Overall Study||7
11272797|NCT02334800|12468044|FG001|STARTED|Overall Study||7
11272798|NCT02334800|12468045|FG002|STARTED|Overall Study||7
11272799|NCT02334800|12468046|FG003|STARTED|Overall Study||7
11272800|NCT02334800|12468043|FG000|Received Treatment|Overall Study||7
11272801|NCT02334800|12468044|FG001|Received Treatment|Overall Study||7
11272802|NCT02334800|12468045|FG002|Received Treatment|Overall Study||7
11272803|NCT02334800|12468046|FG003|Received Treatment|Overall Study||7
11272804|NCT02334800|12468043|FG000|COMPLETED|Overall Study||7
11272805|NCT02334800|12468044|FG001|COMPLETED|Overall Study||7
11272806|NCT02334800|12468045|FG002|COMPLETED|Overall Study||7
11272807|NCT02334800|12468046|FG003|COMPLETED|Overall Study||7
11272808|NCT02334800|12468043|FG000|NOT COMPLETED|Overall Study||0
11272809|NCT02334800|12468044|FG001|NOT COMPLETED|Overall Study||0
11272810|NCT02334800|12468045|FG002|NOT COMPLETED|Overall Study||0
11272811|NCT02334800|12468046|FG003|NOT COMPLETED|Overall Study||0
11272812|NCT02334813|12468058|FG000|STARTED|Overall Study||12
11272813|NCT02334813|12468059|FG001|STARTED|Overall Study||14
11272814|NCT02334813|12468058|FG000|COMPLETED|Overall Study||9
11272815|NCT02334813|12468059|FG001|COMPLETED|Overall Study||13
11272816|NCT02334813|12468058|FG000|NOT COMPLETED|Overall Study||3
11272817|NCT02334813|12468059|FG001|NOT COMPLETED|Overall Study||1
11272818|NCT02334982|12468072|FG000|STARTED|Overall Study||6
11272819|NCT02334982|12468073|FG001|STARTED|Overall Study||5
11272820|NCT02334982|12468074|FG002|STARTED|Overall Study||6
11272821|NCT02334982|12468075|FG003|STARTED|Overall Study||6
11272822|NCT02334982|12468076|FG004|STARTED|Overall Study||6
11272823|NCT02334982|12468077|FG005|STARTED|Overall Study||6
11272824|NCT02334982|12468078|FG006|STARTED|Overall Study||12
11272825|NCT02334982|12468072|FG000|COMPLETED|Overall Study||6
11272826|NCT02334982|12468073|FG001|COMPLETED|Overall Study||5
11272827|NCT02334982|12468074|FG002|COMPLETED|Overall Study||6
11272828|NCT02334982|12468075|FG003|COMPLETED|Overall Study||6
11272829|NCT02334982|12468076|FG004|COMPLETED|Overall Study||6
11272830|NCT02334982|12468077|FG005|COMPLETED|Overall Study||6
11272831|NCT02334982|12468078|FG006|COMPLETED|Overall Study||12
11272832|NCT02334982|12468072|FG000|NOT COMPLETED|Overall Study||0
11272833|NCT02334982|12468073|FG001|NOT COMPLETED|Overall Study||0
11398030|NCT04617574|12592309|FG001|COMPLETED|Overall Study||30
11398031|NCT04617574|12592308|FG000|NOT COMPLETED|Overall Study||0
11272834|NCT02334982|12468074|FG002|NOT COMPLETED|Overall Study||0
11272835|NCT02334982|12468075|FG003|NOT COMPLETED|Overall Study||0
11272836|NCT02334982|12468076|FG004|NOT COMPLETED|Overall Study||0
11272837|NCT02334982|12468077|FG005|NOT COMPLETED|Overall Study||0
11272838|NCT02334982|12468078|FG006|NOT COMPLETED|Overall Study||0
11272839|NCT02335125|12468107|FG000|STARTED|Overall Study||20
11272840|NCT02335125|12468108|FG001|STARTED|Overall Study||20
11272841|NCT02335125|12468107|FG000|COMPLETED|Overall Study||20
11272842|NCT02335125|12468108|FG001|COMPLETED|Overall Study||20
11272843|NCT02335125|12468107|FG000|NOT COMPLETED|Overall Study||0
11272844|NCT02335125|12468108|FG001|NOT COMPLETED|Overall Study||0
11272845|NCT02335216|12468114|FG000|STARTED|Overall Study||22
11272846|NCT02335216|12468114|FG000|Received Trial System|Overall Study||16
11272847|NCT02335216|12468114|FG000|Received Permanent System|Overall Study||13
11272848|NCT02335216|12468114|FG000|COMPLETED|Overall Study||9
11272849|NCT02335216|12468114|FG000|NOT COMPLETED|Overall Study||13
11272850|NCT02335229|12468118|FG000|STARTED|Overall Study||30
11272851|NCT02335229|12468118|FG000|Received Trial System|Overall Study||10
11272852|NCT02335229|12468118|FG000|Received Permanent System|Overall Study||26
11272853|NCT02335229|12468118|FG000|COMPLETED|Overall Study||23
11398032|NCT04617574|12592309|FG001|NOT COMPLETED|Overall Study||0
11272854|NCT02335229|12468118|FG000|NOT COMPLETED|Overall Study||7
11272855|NCT02335294|12468128|FG000|STARTED|Overall Study||39
11272856|NCT02335294|12468129|FG001|STARTED|Overall Study||42
11272857|NCT02335294|12468130|FG002|STARTED|Overall Study||19
11272858|NCT02335294|12468131|FG003|STARTED|Overall Study||39
11272859|NCT02335294|12468132|FG004|STARTED|Overall Study||41
11272860|NCT02335294|12468133|FG005|STARTED|Overall Study||20
11272861|NCT02335294|12468128|FG000|COMPLETED|Overall Study||36
11272862|NCT02335294|12468129|FG001|COMPLETED|Overall Study||38
11272863|NCT02335294|12468130|FG002|COMPLETED|Overall Study||18
11272864|NCT02335294|12468131|FG003|COMPLETED|Overall Study||36
11272865|NCT02335294|12468132|FG004|COMPLETED|Overall Study||39
11272866|NCT02335294|12468133|FG005|COMPLETED|Overall Study||19
11272867|NCT02335294|12468128|FG000|NOT COMPLETED|Overall Study||3
11272868|NCT02335294|12468129|FG001|NOT COMPLETED|Overall Study||4
11272869|NCT02335294|12468130|FG002|NOT COMPLETED|Overall Study||1
11272870|NCT02335294|12468131|FG003|NOT COMPLETED|Overall Study||3
11272871|NCT02335294|12468132|FG004|NOT COMPLETED|Overall Study||2
11272872|NCT02335294|12468133|FG005|NOT COMPLETED|Overall Study||1
11272873|NCT02335346|12468147|FG000|STARTED|Overall Study||93
11272874|NCT02335346|12468147|FG000|Received At Least 1 Dose of Study Drug|Overall Study||93
11272875|NCT02335346|12468147|FG000|COMPLETED|Overall Study||81
11272876|NCT02335346|12468147|FG000|NOT COMPLETED|Overall Study||12
11272877|NCT02335450|12468151|FG000|STARTED|Overall Study||5
11398033|NCT04658797|12592317|FG000|STARTED|Overall Study||15
11398034|NCT04658797|12592318|FG001|STARTED|Overall Study||15
11398035|NCT04658797|12592317|FG000|COMPLETED|Overall Study||15
11398036|NCT04658797|12592318|FG001|COMPLETED|Overall Study||15
11398037|NCT04658797|12592317|FG000|NOT COMPLETED|Overall Study||0
11398038|NCT04658797|12592318|FG001|NOT COMPLETED|Overall Study||0
11272878|NCT02335450|12468151|FG000|COMPLETED|Overall Study||4
11272879|NCT02335450|12468151|FG000|NOT COMPLETED|Overall Study||1
11272880|NCT02335489|12468161|FG000|STARTED|Overall Study||10
11272881|NCT02335489|12468161|FG000|Received Trial System|Overall Study||9
11272882|NCT02335489|12468161|FG000|Receiving Permanent System|Overall Study||8
11272883|NCT02335489|12468161|FG000|COMPLETED|Overall Study||0
11272884|NCT02335489|12468161|FG000|NOT COMPLETED|Overall Study||10
11272885|NCT02335502|12468165|FG000|STARTED|Overall Study||66
11272886|NCT02335502|12468165|FG000|Received Trial System|Overall Study||65
11272887|NCT02335502|12468165|FG000|Receiving Permanent System|Overall Study||56
11272888|NCT02335502|12468165|FG000|COMPLETED|Overall Study||49
11272889|NCT02335502|12468165|FG000|NOT COMPLETED|Overall Study||17
11272890|NCT02335710|12468171|FG000|STARTED|Overall Study||40
11272891|NCT02335710|12468172|FG001|STARTED|Overall Study||10
11272892|NCT02335710|12468171|FG000|COMPLETED|Overall Study||40
11272893|NCT02335710|12468172|FG001|COMPLETED|Overall Study||10
11272894|NCT02335710|12468171|FG000|NOT COMPLETED|Overall Study||0
11272895|NCT02335710|12468172|FG001|NOT COMPLETED|Overall Study||0
11272896|NCT02335905|12468178|FG000|STARTED|Overall Study||11
11272897|NCT02335905|12468178|FG000|COMPLETED|Overall Study||7
11272898|NCT02335905|12468178|FG000|NOT COMPLETED|Overall Study||4
11272899|NCT02335983|12468188|FG000|STARTED|Overall Study||10
11272900|NCT02335983|12468189|FG001|STARTED|Overall Study||12
11272901|NCT02335983|12468190|FG002|STARTED|Overall Study||34
11272902|NCT02335983|12468191|FG003|STARTED|Overall Study||9
11272903|NCT02335983|12468192|FG004|STARTED|Overall Study||9
11272904|NCT02335983|12468193|FG005|STARTED|Overall Study||33
11272905|NCT02335983|12468188|FG000|COMPLETED|Overall Study||2
11272906|NCT02335983|12468189|FG001|COMPLETED|Overall Study||3
11272907|NCT02335983|12468190|FG002|COMPLETED|Overall Study||2
11272908|NCT02335983|12468191|FG003|COMPLETED|Overall Study||0
11272909|NCT02335983|12468192|FG004|COMPLETED|Overall Study||1
11272910|NCT02335983|12468193|FG005|COMPLETED|Overall Study||1
11272911|NCT02335983|12468188|FG000|NOT COMPLETED|Overall Study||8
11272912|NCT02335983|12468189|FG001|NOT COMPLETED|Overall Study||9
11272913|NCT02335983|12468190|FG002|NOT COMPLETED|Overall Study||32
11398039|NCT04664855|12592326|FG000|STARTED|Overall Study||23
11398040|NCT04664855|12592327|FG001|STARTED|Overall Study||24
11398041|NCT04664855|12592326|FG000|COMPLETED|Overall Study||23
11272914|NCT02335983|12468191|FG003|NOT COMPLETED|Overall Study||9
11272915|NCT02335983|12468192|FG004|NOT COMPLETED|Overall Study||8
11272916|NCT02335983|12468193|FG005|NOT COMPLETED|Overall Study||32
11272917|NCT02336074|12468218|FG000|STARTED|Overall Study||30
11272918|NCT02336074|12468219|FG001|STARTED|Overall Study||30
11272919|NCT02336074|12468218|FG000|COMPLETED|Overall Study||30
11272920|NCT02336074|12468219|FG001|COMPLETED|Overall Study||28
11272921|NCT02336074|12468218|FG000|NOT COMPLETED|Overall Study||0
11272922|NCT02336074|12468219|FG001|NOT COMPLETED|Overall Study||2
11272923|NCT02336165|12468235|FG000|STARTED|Overall Study||40
11272924|NCT02336165|12468236|FG001|STARTED|Overall Study||31
11272925|NCT02336165|12468237|FG002|STARTED|Overall Study||33
11272926|NCT02336165|12468238|FG003|STARTED|Overall Study||33
11272927|NCT02336165|12468239|FG004|STARTED|Overall Study||22
11272928|NCT02336165|12468235|FG000|COMPLETED|Overall Study||6
11272929|NCT02336165|12468236|FG001|COMPLETED|Overall Study||6
11272930|NCT02336165|12468237|FG002|COMPLETED|Overall Study||2
11272931|NCT02336165|12468238|FG003|COMPLETED|Overall Study||2
11272932|NCT02336165|12468239|FG004|COMPLETED|Overall Study||0
11272933|NCT02336165|12468235|FG000|NOT COMPLETED|Overall Study||34
11272934|NCT02336165|12468236|FG001|NOT COMPLETED|Overall Study||25
11272935|NCT02336165|12468237|FG002|NOT COMPLETED|Overall Study||31
11272936|NCT02336165|12468238|FG003|NOT COMPLETED|Overall Study||31
11272937|NCT02336165|12468239|FG004|NOT COMPLETED|Overall Study||22
11272938|NCT02336178|12468255|FG000|STARTED|Overall Study||70
11272939|NCT02336178|12468255|FG000|COMPLETED|Overall Study||66
11272940|NCT02336178|12468255|FG000|NOT COMPLETED|Overall Study||4
11272941|NCT02336282|12468267|FG000|STARTED|Overall Study||33
11272942|NCT02336282|12468267|FG000|COMPLETED|Overall Study||28
11272943|NCT02336282|12468267|FG000|NOT COMPLETED|Overall Study||5
11272944|NCT02336360|12468279|FG000|STARTED|Overall Study||6
11272945|NCT02336360|12468279|FG000|COMPLETED|Overall Study||6
11272946|NCT02336360|12468279|FG000|NOT COMPLETED|Overall Study||0
11272947|NCT02336373|12468283|FG000|STARTED|Overall Study||32
11272948|NCT02336373|12468283|FG000|COMPLETED|Overall Study||14
11272949|NCT02336373|12468283|FG000|NOT COMPLETED|Overall Study||18
11272950|NCT02336438|12468289|FG000|STARTED|Overall Study||11
11272951|NCT02336438|12468289|FG000|COMPLETED|Overall Study||10
11272952|NCT02336438|12468289|FG000|NOT COMPLETED|Overall Study||1
11272953|NCT02336451|12468298|FG000|STARTED|Overall Study||42
11272954|NCT02336451|12468299|FG001|STARTED|Overall Study||40
11272955|NCT02336451|12468300|FG002|STARTED|Overall Study||12
11272956|NCT02336451|12468301|FG003|STARTED|Overall Study||44
11272957|NCT02336451|12468302|FG004|STARTED|Overall Study||18
11272958|NCT02336451|12468298|FG000|COMPLETED|Overall Study||0
11272959|NCT02336451|12468299|FG001|COMPLETED|Overall Study||0
11272960|NCT02336451|12468300|FG002|COMPLETED|Overall Study||0
11272961|NCT02336451|12468301|FG003|COMPLETED|Overall Study||0
11272962|NCT02336451|12468302|FG004|COMPLETED|Overall Study||0
11272963|NCT02336451|12468298|FG000|NOT COMPLETED|Overall Study||42
11272964|NCT02336451|12468299|FG001|NOT COMPLETED|Overall Study||40
11272965|NCT02336451|12468300|FG002|NOT COMPLETED|Overall Study||12
11272966|NCT02336451|12468301|FG003|NOT COMPLETED|Overall Study||44
11272967|NCT02336451|12468302|FG004|NOT COMPLETED|Overall Study||18
11272968|NCT02336555|12468318|FG000|STARTED|Treatment Period 1 (28 Days)||18
11272969|NCT02336555|12468319|FG001|STARTED|Treatment Period 1 (28 Days)||17
11272970|NCT02336555|12468318|FG000|COMPLETED|Treatment Period 1 (28 Days)||16
11272971|NCT02336555|12468319|FG001|COMPLETED|Treatment Period 1 (28 Days)||16
11272972|NCT02336555|12468318|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||2
11272973|NCT02336555|12468319|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||1
11272974|NCT02336555|12468318|FG000|STARTED|Treatment Period 2 (28 Days)||16
11272975|NCT02336555|12468319|FG001|STARTED|Treatment Period 2 (28 Days)||16
11272976|NCT02336555|12468318|FG000|COMPLETED|Treatment Period 2 (28 Days)||16
11272977|NCT02336555|12468319|FG001|COMPLETED|Treatment Period 2 (28 Days)||15
11272978|NCT02336555|12468318|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11272979|NCT02336555|12468319|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1
11272980|NCT02336594|12468329|FG000|STARTED|Overall Study||3
11272981|NCT02336594|12468330|FG001|STARTED|Overall Study||4
11272982|NCT02336594|12468331|FG002|STARTED|Overall Study||4
11272983|NCT02336594|12468332|FG003|STARTED|Overall Study||4
11272984|NCT02336594|12468329|FG000|COMPLETED|Overall Study||3
11272985|NCT02336594|12468330|FG001|COMPLETED|Overall Study||4
11272986|NCT02336594|12468331|FG002|COMPLETED|Overall Study||4
11272987|NCT02336594|12468332|FG003|COMPLETED|Overall Study||4
11272988|NCT02336594|12468329|FG000|NOT COMPLETED|Overall Study||0
11272989|NCT02336594|12468330|FG001|NOT COMPLETED|Overall Study||0
11272990|NCT02336594|12468331|FG002|NOT COMPLETED|Overall Study||0
11272991|NCT02336594|12468332|FG003|NOT COMPLETED|Overall Study||0
11272992|NCT02336607|12468349|FG000|STARTED|Overall Study||85
11272993|NCT02336607|12468350|FG001|STARTED|Overall Study||85
11272994|NCT02336607|12468351|FG002|STARTED|Overall Study||92
11272995|NCT02336607|12468352|FG003|STARTED|Overall Study||267
11272996|NCT02336607|12468349|FG000|Patients Included in ITT Population|Overall Study||84
11272997|NCT02336607|12468350|FG001|Patients Included in ITT Population|Overall Study||84
11272998|NCT02336607|12468351|FG002|Patients Included in ITT Population|Overall Study||91
11272999|NCT02336607|12468352|FG003|Patients Included in ITT Population|Overall Study||222
11273000|NCT02336607|12468349|FG000|Patients Included in PP Population|Overall Study||78
11273001|NCT02336607|12468350|FG001|Patients Included in PP Population|Overall Study||75
11273002|NCT02336607|12468351|FG002|Patients Included in PP Population|Overall Study||75
11273003|NCT02336607|12468352|FG003|Patients Included in PP Population|Overall Study||162
11273004|NCT02336607|12468349|FG000|Patients Included in Safety Population|Overall Study||85
11273005|NCT02336607|12468350|FG001|Patients Included in Safety Population|Overall Study||85
11273006|NCT02336607|12468351|FG002|Patients Included in Safety Population|Overall Study||92
11273007|NCT02336607|12468352|FG003|Patients Included in Safety Population|Overall Study||260
11273008|NCT02336607|12468349|FG000|COMPLETED|Overall Study||81
11273009|NCT02336607|12468350|FG001|COMPLETED|Overall Study||75
11273010|NCT02336607|12468351|FG002|COMPLETED|Overall Study||86
11273011|NCT02336607|12468352|FG003|COMPLETED|Overall Study||180
11273012|NCT02336607|12468349|FG000|NOT COMPLETED|Overall Study||4
11273013|NCT02336607|12468350|FG001|NOT COMPLETED|Overall Study||10
11273014|NCT02336607|12468351|FG002|NOT COMPLETED|Overall Study||6
11273015|NCT02336607|12468352|FG003|NOT COMPLETED|Overall Study||87
11273016|NCT02336737|12468362|FG000|STARTED|Overall Study||160
11273017|NCT02336737|12468362|FG000|COMPLETED|Overall Study||147
11273018|NCT02336737|12468362|FG000|NOT COMPLETED|Overall Study||13
11273019|NCT02336815|12468369|FG000|STARTED|Overall Study||79
11273020|NCT02336815|12468370|FG001|STARTED|Overall Study||123
11273021|NCT02336815|12468369|FG000|COMPLETED|Overall Study||0
11273022|NCT02336815|12468370|FG001|COMPLETED|Overall Study||0
11273023|NCT02336815|12468369|FG000|NOT COMPLETED|Overall Study||79
11273024|NCT02336815|12468370|FG001|NOT COMPLETED|Overall Study||123
11273025|NCT02336958|12468380|FG000|STARTED|Overall Study||20
11273026|NCT02336958|12468381|FG001|STARTED|Overall Study||20
11273027|NCT02336958|12468380|FG000|COMPLETED|Overall Study||20
11273028|NCT02336958|12468381|FG001|COMPLETED|Overall Study||20
11273029|NCT02336958|12468380|FG000|NOT COMPLETED|Overall Study||0
11273030|NCT02336958|12468381|FG001|NOT COMPLETED|Overall Study||0
11273031|NCT02337062|12468389|FG000|STARTED|Overall Study||572
11273032|NCT02337062|12468390|FG001|STARTED|Overall Study||575
11273033|NCT02337062|12468389|FG000|COMPLETED|Overall Study||555
11273034|NCT02337062|12468390|FG001|COMPLETED|Overall Study||556
11273035|NCT02337062|12468389|FG000|NOT COMPLETED|Overall Study||17
11273036|NCT02337062|12468390|FG001|NOT COMPLETED|Overall Study||19
11273037|NCT02337218|12468400|FG000|STARTED|Overall Study||17
11273038|NCT02337218|12468401|FG001|STARTED|Overall Study||11
11273039|NCT02337218|12468400|FG000|COMPLETED|Overall Study||17
11273040|NCT02337218|12468401|FG001|COMPLETED|Overall Study||11
11273041|NCT02337218|12468400|FG000|NOT COMPLETED|Overall Study||0
11273042|NCT02337218|12468401|FG001|NOT COMPLETED|Overall Study||0
11273043|NCT02337361|12468409|FG000|STARTED|Baseline Assessment||99
11273044|NCT02337361|12468410|FG001|STARTED|Baseline Assessment||86
11273045|NCT02337361|12468409|FG000|COMPLETED|Baseline Assessment||99
11273046|NCT02337361|12468410|FG001|COMPLETED|Baseline Assessment||86
11273047|NCT02337361|12468409|FG000|NOT COMPLETED|Baseline Assessment||0
11273048|NCT02337361|12468410|FG001|NOT COMPLETED|Baseline Assessment||0
11273049|NCT02337361|12468409|FG000|STARTED|3-month Follow-up||99
11273050|NCT02337361|12468410|FG001|STARTED|3-month Follow-up||86
11273051|NCT02337361|12468409|FG000|COMPLETED|3-month Follow-up||80
11273052|NCT02337361|12468410|FG001|COMPLETED|3-month Follow-up||72
11273053|NCT02337361|12468409|FG000|NOT COMPLETED|3-month Follow-up||19
11273054|NCT02337361|12468410|FG001|NOT COMPLETED|3-month Follow-up||14
11273055|NCT02337361|12468409|FG000|STARTED|6-month Follow-up||80
11273056|NCT02337361|12468410|FG001|STARTED|6-month Follow-up||72
11273057|NCT02337361|12468409|FG000|COMPLETED|6-month Follow-up||78
11273058|NCT02337361|12468410|FG001|COMPLETED|6-month Follow-up||68
11273059|NCT02337361|12468409|FG000|NOT COMPLETED|6-month Follow-up||2
11273060|NCT02337361|12468410|FG001|NOT COMPLETED|6-month Follow-up||4
11273061|NCT02337387|12468421|FG000|STARTED|Overall Study||14
11273062|NCT02337387|12468422|FG001|STARTED|Overall Study||8
11273063|NCT02337387|12468423|FG002|STARTED|Overall Study||3
11273064|NCT02337387|12468424|FG003|STARTED|Overall Study||3
11273065|NCT02337387|12468421|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14
11273066|NCT02337387|12468422|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
11273067|NCT02337387|12468423|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
11273068|NCT02337387|12468424|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
11273069|NCT02337387|12468421|FG000|COMPLETED|Overall Study||0
11273070|NCT02337387|12468422|FG001|COMPLETED|Overall Study||0
11273071|NCT02337387|12468423|FG002|COMPLETED|Overall Study||0
11273072|NCT02337387|12468424|FG003|COMPLETED|Overall Study||0
11273073|NCT02337387|12468421|FG000|NOT COMPLETED|Overall Study||14
11273074|NCT02337387|12468422|FG001|NOT COMPLETED|Overall Study||8
11273075|NCT02337387|12468423|FG002|NOT COMPLETED|Overall Study||3
11273076|NCT02337387|12468424|FG003|NOT COMPLETED|Overall Study||3
11273077|NCT02337465|12468434|FG000|STARTED|Overall Study||30
11273078|NCT02337465|12468434|FG000|COMPLETED|Overall Study||30
11273079|NCT02337465|12468434|FG000|NOT COMPLETED|Overall Study||0
11273080|NCT02337478|12468438|FG000|STARTED|Overall Study||5
11273081|NCT02337478|12468438|FG000|COMPLETED|Overall Study||0
11273082|NCT02337478|12468438|FG000|NOT COMPLETED|Overall Study||5
11273083|NCT02337491|12468444|FG000|STARTED|Overall Study||50
11273084|NCT02337491|12468445|FG001|STARTED|Overall Study||30
11398042|NCT04664855|12592327|FG001|COMPLETED|Overall Study||22
11398043|NCT04664855|12592326|FG000|NOT COMPLETED|Overall Study||0
11398044|NCT04664855|12592327|FG001|NOT COMPLETED|Overall Study||2
11398045|NCT04701658|12592333|FG000|STARTED|Overall Study||109
11398046|NCT04701658|12592333|FG000|Received Single Dose of Bamlanivimab|Overall Study||109
11398047|NCT04701658|12592333|FG000|COMPLETED|Overall Study||103
11398048|NCT04701658|12592333|FG000|NOT COMPLETED|Overall Study||6
11398049|NCT04706416|12592339|FG000|STARTED|Overall Study||50
11398050|NCT04706416|12592340|FG001|STARTED|Overall Study||100
11398051|NCT04706416|12592339|FG000|COMPLETED|Overall Study||48
11398052|NCT04706416|12592340|FG001|COMPLETED|Overall Study||100
11398053|NCT04706416|12592339|FG000|NOT COMPLETED|Overall Study||2
11398054|NCT04706416|12592340|FG001|NOT COMPLETED|Overall Study||0
11398055|NCT04709484|12592351|FG000|STARTED|Overall Study||34
11398056|NCT04709484|12592352|FG001|STARTED|Overall Study||32
11398057|NCT04709484|12592351|FG000|COMPLETED|Overall Study||34
11398058|NCT04709484|12592352|FG001|COMPLETED|Overall Study||32
11398059|NCT04709484|12592351|FG000|NOT COMPLETED|Overall Study||0
11398060|NCT04709484|12592352|FG001|NOT COMPLETED|Overall Study||0
11398061|NCT04727749|12592360|FG000|STARTED|Overall Study||107
11398062|NCT04727749|12592361|FG001|STARTED|Overall Study||104
11398063|NCT04727749|12592360|FG000|COMPLETED|Overall Study||97
11398064|NCT04727749|12592361|FG001|COMPLETED|Overall Study||101
11398065|NCT04727749|12592360|FG000|NOT COMPLETED|Overall Study||10
11398066|NCT04727749|12592361|FG001|NOT COMPLETED|Overall Study||3
11398067|NCT04777214|12592371|FG000|STARTED|Initial Randomization||5
11398068|NCT04777214|12592372|FG001|STARTED|Initial Randomization||5
11398069|NCT04777214|12592371|FG000|COMPLETED|Initial Randomization||5
11398070|NCT04777214|12592372|FG001|COMPLETED|Initial Randomization||5
11398071|NCT04777214|12592371|FG000|NOT COMPLETED|Initial Randomization||0
11398072|NCT04777214|12592372|FG001|NOT COMPLETED|Initial Randomization||0
11398073|NCT04777214|12592371|FG000|STARTED|Sham Crossover to Active TMS Arm||0
11398074|NCT04777214|12592372|FG001|STARTED|Sham Crossover to Active TMS Arm||5
11398075|NCT04777214|12592371|FG000|COMPLETED|Sham Crossover to Active TMS Arm||0
11398076|NCT04777214|12592372|FG001|COMPLETED|Sham Crossover to Active TMS Arm||5
11398077|NCT04777214|12592371|FG000|NOT COMPLETED|Sham Crossover to Active TMS Arm||0
11398078|NCT04777214|12592372|FG001|NOT COMPLETED|Sham Crossover to Active TMS Arm||0
11398079|NCT04854707|12592383|FG000|STARTED|Overall Study||2625
11398080|NCT04854707|12592384|FG001|STARTED|Overall Study||2183
11398081|NCT04854707|12592385|FG002|STARTED|Overall Study||676
11398082|NCT04854707|12592383|FG000|COMPLETED|Overall Study||2547
11398083|NCT04854707|12592384|FG001|COMPLETED|Overall Study||2124
11398084|NCT04854707|12592385|FG002|COMPLETED|Overall Study||646
11398085|NCT04854707|12592383|FG000|NOT COMPLETED|Overall Study||78
11398086|NCT04854707|12592384|FG001|NOT COMPLETED|Overall Study||59
11398087|NCT04854707|12592385|FG002|NOT COMPLETED|Overall Study||30
11398088|NCT04898166|12592399|FG000|STARTED|Overall Study||220
11398089|NCT04898166|12592400|FG001|STARTED|Overall Study||80
11398090|NCT04898166|12592399|FG000|COMPLETED|Overall Study||220
11398091|NCT04898166|12592400|FG001|COMPLETED|Overall Study||80
11398092|NCT04898166|12592399|FG000|NOT COMPLETED|Overall Study||0
11398093|NCT04898166|12592400|FG001|NOT COMPLETED|Overall Study||0
11398094|NCT04926233|12592420|FG000|STARTED|Overall Study||1280486
11398095|NCT04926233|12592421|FG001|STARTED|Overall Study||90660
11398096|NCT04926233|12592420|FG000|COMPLETED|Overall Study||1280486
11398097|NCT04926233|12592421|FG001|COMPLETED|Overall Study||90660
11398098|NCT04926233|12592420|FG000|NOT COMPLETED|Overall Study||0
11398099|NCT04926233|12592421|FG001|NOT COMPLETED|Overall Study||0
11398100|NCT04943159|12592473|FG000|STARTED|Overall Study||3
11398101|NCT04943159|12592473|FG000|COMPLETED|Overall Study||3
11398102|NCT04943159|12592473|FG000|NOT COMPLETED|Overall Study||0
11398103|NCT04947436|12592480|FG000|STARTED|Overall Study||7
11398104|NCT04947436|12592481|FG001|STARTED|Overall Study||10
11398105|NCT04947436|12592482|FG002|STARTED|Overall Study||11
11398106|NCT04947436|12592480|FG000|COMPLETED|Overall Study||3
11398107|NCT04947436|12592481|FG001|COMPLETED|Overall Study||2
11398108|NCT04947436|12592482|FG002|COMPLETED|Overall Study||5
11398109|NCT04947436|12592480|FG000|NOT COMPLETED|Overall Study||4
11398110|NCT04947436|12592481|FG001|NOT COMPLETED|Overall Study||8
11398111|NCT04947436|12592482|FG002|NOT COMPLETED|Overall Study||6
11273085|NCT02337491|12468444|FG000|COMPLETED|Overall Study||0
11273086|NCT02337491|12468445|FG001|COMPLETED|Overall Study||0
11273087|NCT02337491|12468444|FG000|NOT COMPLETED|Overall Study||50
11273088|NCT02337491|12468445|FG001|NOT COMPLETED|Overall Study||30
11273089|NCT02337517|12468452|FG000|STARTED|Overall Study||6
11273090|NCT02337517|12468452|FG000|COMPLETED|Overall Study||6
11273091|NCT02337517|12468452|FG000|NOT COMPLETED|Overall Study||0
11273092|NCT02337530|12468459|FG000|STARTED|Overall Study||20
11273093|NCT02337530|12468460|FG001|STARTED|Overall Study||21
11273094|NCT02337530|12468461|FG002|STARTED|Overall Study||21
11273095|NCT02337530|12468459|FG000|COMPLETED|Overall Study||20
11273096|NCT02337530|12468460|FG001|COMPLETED|Overall Study||21
11273097|NCT02337530|12468461|FG002|COMPLETED|Overall Study||21
11273098|NCT02337530|12468459|FG000|NOT COMPLETED|Overall Study||0
11273099|NCT02337530|12468460|FG001|NOT COMPLETED|Overall Study||0
11273100|NCT02337530|12468461|FG002|NOT COMPLETED|Overall Study||0
11273101|NCT02337907|12468475|FG000|STARTED|Overall Study||55
11273102|NCT02337907|12468476|FG001|STARTED|Overall Study||53
11273103|NCT02337907|12468477|FG002|STARTED|Overall Study||55
11273104|NCT02337907|12468478|FG003|STARTED|Overall Study||55
11273105|NCT02337907|12468479|FG004|STARTED|Overall Study||106
11273106|NCT02337907|12468480|FG005|STARTED|Overall Study||5
11273107|NCT02337907|12468475|FG000|COMPLETED|Overall Study||51
11273108|NCT02337907|12468476|FG001|COMPLETED|Overall Study||49
11273109|NCT02337907|12468477|FG002|COMPLETED|Overall Study||54
11273110|NCT02337907|12468478|FG003|COMPLETED|Overall Study||51
11273111|NCT02337907|12468479|FG004|COMPLETED|Overall Study||96
11273112|NCT02337907|12468480|FG005|COMPLETED|Overall Study||4
11273113|NCT02337907|12468475|FG000|NOT COMPLETED|Overall Study||4
11273114|NCT02337907|12468476|FG001|NOT COMPLETED|Overall Study||4
11273115|NCT02337907|12468477|FG002|NOT COMPLETED|Overall Study||1
11273116|NCT02337907|12468478|FG003|NOT COMPLETED|Overall Study||4
11273117|NCT02337907|12468479|FG004|NOT COMPLETED|Overall Study||10
11273118|NCT02337907|12468480|FG005|NOT COMPLETED|Overall Study||1
11273119|NCT02337933|12468497|FG000|STARTED|Overall Study||12
11273120|NCT02337933|12468498|FG001|STARTED|Overall Study||12
11273121|NCT02337933|12468497|FG000|COMPLETED|Overall Study||12
11398112|NCT05002972|12592490|FG000|STARTED|Overall Study||63
11398113|NCT05002972|12592490|FG000|COMPLETED|Overall Study||61
11398114|NCT05002972|12592490|FG000|NOT COMPLETED|Overall Study||2
11398115|NCT05002985|12592494|FG000|STARTED|Overall Study||49
11398116|NCT05002985|12592494|FG000|COMPLETED|Overall Study||48
11398117|NCT05002985|12592494|FG000|NOT COMPLETED|Overall Study||1
11273122|NCT02337933|12468498|FG001|COMPLETED|Overall Study||12
11273123|NCT02337933|12468497|FG000|NOT COMPLETED|Overall Study||0
11273124|NCT02337933|12468498|FG001|NOT COMPLETED|Overall Study||0
11398118|NCT04512482|12592500|FG000|STARTED|First Intervention (1 Day)||24
11398119|NCT04512482|12592501|FG001|STARTED|First Intervention (1 Day)||21
11398120|NCT04512482|12592500|FG000|Baseline Plaque Assessment|First Intervention (1 Day)||24
11398121|NCT04512482|12592501|FG001|Baseline Plaque Assessment|First Intervention (1 Day)||21
11398122|NCT04512482|12592500|FG000|Baseline Photographs|First Intervention (1 Day)||24
11398123|NCT04512482|12592501|FG001|Baseline Photographs|First Intervention (1 Day)||21
11398124|NCT04512482|12592500|FG000|Received Rinse Intervention|First Intervention (1 Day)||24
11273125|NCT02337946|12468504|FG000|STARTED|Protocol Treatment 1 Period||164
11273126|NCT02337946|12468505|FG001|STARTED|Protocol Treatment 1 Period||0
11273127|NCT02337946|12468506|FG002|STARTED|Protocol Treatment 1 Period||0
11398125|NCT04512482|12592501|FG001|Received Rinse Intervention|First Intervention (1 Day)||21
11398126|NCT04512482|12592500|FG000|Post-rinse Photographs|First Intervention (1 Day)||24
11398127|NCT04512482|12592501|FG001|Post-rinse Photographs|First Intervention (1 Day)||21
11273128|NCT02337946|12468504|FG000|COMPLETED|Protocol Treatment 1 Period||114
11273129|NCT02337946|12468505|FG001|COMPLETED|Protocol Treatment 1 Period||0
11273130|NCT02337946|12468506|FG002|COMPLETED|Protocol Treatment 1 Period||0
11273131|NCT02337946|12468504|FG000|NOT COMPLETED|Protocol Treatment 1 Period||50
11273132|NCT02337946|12468505|FG001|NOT COMPLETED|Protocol Treatment 1 Period||0
11273133|NCT02337946|12468506|FG002|NOT COMPLETED|Protocol Treatment 1 Period||0
11273134|NCT02337946|12468504|FG000|STARTED|In-between Period||114
11273135|NCT02337946|12468505|FG001|STARTED|In-between Period||0
11273136|NCT02337946|12468506|FG002|STARTED|In-between Period||0
11273137|NCT02337946|12468504|FG000|COMPLETED|In-between Period||113
11273138|NCT02337946|12468505|FG001|COMPLETED|In-between Period||0
11273139|NCT02337946|12468506|FG002|COMPLETED|In-between Period||0
11273140|NCT02337946|12468504|FG000|NOT COMPLETED|In-between Period||1
11273141|NCT02337946|12468505|FG001|NOT COMPLETED|In-between Period||0
11273142|NCT02337946|12468506|FG002|NOT COMPLETED|In-between Period||0
11273143|NCT02337946|12468504|FG000|STARTED|Protocol Treatment 2 Period||0
11273144|NCT02337946|12468505|FG001|STARTED|Protocol Treatment 2 Period||56
11273145|NCT02337946|12468506|FG002|STARTED|Protocol Treatment 2 Period||57
11273146|NCT02337946|12468504|FG000|Safety Population|Protocol Treatment 2 Period||0
11273147|NCT02337946|12468505|FG001|Safety Population|Protocol Treatment 2 Period||56
11273148|NCT02337946|12468506|FG002|Safety Population|Protocol Treatment 2 Period||54
11273149|NCT02337946|12468504|FG000|COMPLETED|Protocol Treatment 2 Period||0
11273150|NCT02337946|12468505|FG001|COMPLETED|Protocol Treatment 2 Period||5
11273151|NCT02337946|12468506|FG002|COMPLETED|Protocol Treatment 2 Period||7
11273152|NCT02337946|12468504|FG000|NOT COMPLETED|Protocol Treatment 2 Period||0
11273153|NCT02337946|12468505|FG001|NOT COMPLETED|Protocol Treatment 2 Period||51
11273154|NCT02337946|12468506|FG002|NOT COMPLETED|Protocol Treatment 2 Period||50
11273155|NCT02337959|12468515|FG000|STARTED|Overall Study||10
11273156|NCT02337959|12468516|FG001|STARTED|Overall Study||10
11273157|NCT02337959|12468517|FG002|STARTED|Overall Study||7
11273158|NCT02337959|12468515|FG000|COMPLETED|Overall Study||10
11273159|NCT02337959|12468516|FG001|COMPLETED|Overall Study||7
11273160|NCT02337959|12468517|FG002|COMPLETED|Overall Study||7
11273161|NCT02337959|12468515|FG000|NOT COMPLETED|Overall Study||0
11273162|NCT02337959|12468516|FG001|NOT COMPLETED|Overall Study||3
11273163|NCT02337959|12468517|FG002|NOT COMPLETED|Overall Study||0
11273164|NCT02338076|12468525|FG000|STARTED|Overall Study||20
11273165|NCT02338076|12468525|FG000|COMPLETED|Overall Study||20
11273166|NCT02338076|12468525|FG000|NOT COMPLETED|Overall Study||0
11273167|NCT02338154|12468531|FG000|STARTED|Overall Study||516
11273168|NCT02338154|12468531|FG000|Enrolled Cohort (Intent to Treat)|Overall Study||516
11273169|NCT02338154|12468531|FG000|INTUITY (Study Valve Cohort)|Overall Study||493
11273170|NCT02338154|12468531|FG000|COMPLETED|Overall Study||373
11273171|NCT02338154|12468531|FG000|NOT COMPLETED|Overall Study||143
11273172|NCT02338193|12468546|FG000|STARTED|Overall Study||20
11273173|NCT02338193|12468547|FG001|STARTED|Overall Study||21
11273174|NCT02338193|12468548|FG002|STARTED|Overall Study||25
11273175|NCT02338193|12468546|FG000|COMPLETED|Overall Study||17
11273176|NCT02338193|12468547|FG001|COMPLETED|Overall Study||17
11273177|NCT02338193|12468548|FG002|COMPLETED|Overall Study||15
11273178|NCT02338193|12468546|FG000|NOT COMPLETED|Overall Study||3
11273179|NCT02338193|12468547|FG001|NOT COMPLETED|Overall Study||4
11273180|NCT02338193|12468548|FG002|NOT COMPLETED|Overall Study||10
11273181|NCT02338336|12468558|FG000|STARTED|Overall Study||26
11273182|NCT02338336|12468559|FG001|STARTED|Overall Study||17
11273183|NCT02338336|12468560|FG002|STARTED|Overall Study||7
11273184|NCT02338336|12468561|FG003|STARTED|Overall Study||4
11273185|NCT02338336|12468558|FG000|COMPLETED|Overall Study||24
11273186|NCT02338336|12468559|FG001|COMPLETED|Overall Study||17
11273187|NCT02338336|12468560|FG002|COMPLETED|Overall Study||7
11273188|NCT02338336|12468561|FG003|COMPLETED|Overall Study||4
11273189|NCT02338336|12468558|FG000|NOT COMPLETED|Overall Study||2
11273190|NCT02338336|12468559|FG001|NOT COMPLETED|Overall Study||0
11273191|NCT02338336|12468560|FG002|NOT COMPLETED|Overall Study||0
11273192|NCT02338336|12468561|FG003|NOT COMPLETED|Overall Study||0
11273193|NCT02338362|12468569|FG000|STARTED|Overall Study||11
11273194|NCT02338362|12468570|FG001|STARTED|Overall Study||11
11273195|NCT02338362|12468569|FG000|COMPLETED|Overall Study||10
11273196|NCT02338362|12468570|FG001|COMPLETED|Overall Study||10
11273197|NCT02338362|12468569|FG000|NOT COMPLETED|Overall Study||1
11273198|NCT02338362|12468570|FG001|NOT COMPLETED|Overall Study||1
11273199|NCT02338492|12468576|FG000|STARTED|Overall Study||81
11273200|NCT02338492|12468576|FG000|Enrolled|Overall Study||81
11273201|NCT02338492|12468576|FG000|Device Implanted|Overall Study||79
11273202|NCT02338492|12468576|FG000|Treatment Failure|Overall Study||2
11273203|NCT02338492|12468576|FG000|COMPLETED|Overall Study||36
11273204|NCT02338492|12468576|FG000|NOT COMPLETED|Overall Study||45
11273205|NCT02338713|12468580|FG000|STARTED|Overall Study||27
11273206|NCT02338713|12468580|FG000|COMPLETED|Overall Study||27
11273207|NCT02338713|12468580|FG000|NOT COMPLETED|Overall Study||0
11273208|NCT02338843|12468588|FG000|STARTED|Overall Study||163
11273209|NCT02338843|12468589|FG001|STARTED|Overall Study||158
11273210|NCT02338843|12468588|FG000|COMPLETED|Overall Study||119
11273211|NCT02338843|12468589|FG001|COMPLETED|Overall Study||100
11273212|NCT02338843|12468588|FG000|NOT COMPLETED|Overall Study||44
11273213|NCT02338843|12468589|FG001|NOT COMPLETED|Overall Study||58
11273214|NCT02338882|12468597|FG000|STARTED|Overall Study||50
11273215|NCT02338882|12468598|FG001|STARTED|Overall Study||50
11273216|NCT02338882|12468597|FG000|COMPLETED|Overall Study||43
11273217|NCT02338882|12468598|FG001|COMPLETED|Overall Study||47
11273218|NCT02338882|12468597|FG000|NOT COMPLETED|Overall Study||7
11273219|NCT02338882|12468598|FG001|NOT COMPLETED|Overall Study||3
11273220|NCT02338960|12468609|FG000|STARTED|Core Study||306
11273221|NCT02338960|12468610|FG001|STARTED|Core Study||308
11273222|NCT02338960|12468609|FG000|Received Intervention|Core Study||303
11273223|NCT02338960|12468610|FG001|Received Intervention|Core Study||301
11273224|NCT02338960|12468609|FG000|COMPLETED|Core Study||219
11273225|NCT02338960|12468610|FG001|COMPLETED|Core Study||173
11273226|NCT02338960|12468609|FG000|NOT COMPLETED|Core Study||87
11273227|NCT02338960|12468610|FG001|NOT COMPLETED|Core Study||135
11273228|NCT02338960|12468609|FG000|STARTED|Open Label Extension||191
11273229|NCT02338960|12468610|FG001|STARTED|Open Label Extension||130
11273230|NCT02338960|12468609|FG000|COMPLETED|Open Label Extension||77
11273231|NCT02338960|12468610|FG001|COMPLETED|Open Label Extension||51
11273232|NCT02338960|12468609|FG000|NOT COMPLETED|Open Label Extension||114
11273233|NCT02338960|12468610|FG001|NOT COMPLETED|Open Label Extension||79
11273234|NCT02338973|12468621|FG000|STARTED|Overall Study||4
11273235|NCT02338973|12468621|FG000|Rod-cone Dystrophy (RCD)|Overall Study||2
11273236|NCT02338973|12468621|FG000|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2
11273237|NCT02338973|12468621|FG000|COMPLETED|Overall Study||4
11273238|NCT02338973|12468621|FG000|NOT COMPLETED|Overall Study||0
11273239|NCT02338999|12468704|FG000|STARTED|First Intervention||39
11273240|NCT02338999|12468705|FG001|STARTED|First Intervention||41
11273241|NCT02338999|12468704|FG000|COMPLETED|First Intervention||36
11273242|NCT02338999|12468705|FG001|COMPLETED|First Intervention||40
11273243|NCT02338999|12468704|FG000|NOT COMPLETED|First Intervention||3
11273244|NCT02338999|12468705|FG001|NOT COMPLETED|First Intervention||1
11273245|NCT02338999|12468704|FG000|STARTED|Washout Period||36
11273246|NCT02338999|12468705|FG001|STARTED|Washout Period||40
11273247|NCT02338999|12468704|FG000|COMPLETED|Washout Period||36
11273248|NCT02338999|12468705|FG001|COMPLETED|Washout Period||38
11273249|NCT02338999|12468704|FG000|NOT COMPLETED|Washout Period||0
11273250|NCT02338999|12468705|FG001|NOT COMPLETED|Washout Period||2
11273251|NCT02338999|12468704|FG000|STARTED|Second Intervention||36
11273252|NCT02338999|12468705|FG001|STARTED|Second Intervention||38
11273253|NCT02338999|12468704|FG000|COMPLETED|Second Intervention||36
11273254|NCT02338999|12468705|FG001|COMPLETED|Second Intervention||36
11273255|NCT02338999|12468704|FG000|NOT COMPLETED|Second Intervention||0
11273256|NCT02338999|12468705|FG001|NOT COMPLETED|Second Intervention||2
11273257|NCT02339038|12468711|FG000|STARTED|Overall Study||600
11273258|NCT02339038|12468711|FG000|COMPLETED|Overall Study||0
11273259|NCT02339038|12468711|FG000|NOT COMPLETED|Overall Study||600
11273260|NCT02339155|12468717|FG000|STARTED|Overall Study||287
11273261|NCT02339155|12468718|FG001|STARTED|Overall Study||286
11273262|NCT02339155|12468717|FG000|Received Study Treatment|Overall Study||286
11273263|NCT02339155|12468718|FG001|Received Study Treatment|Overall Study||280
11273264|NCT02339155|12468717|FG000|COMPLETED|Overall Study||272
11273265|NCT02339155|12468718|FG001|COMPLETED|Overall Study||265
11273266|NCT02339155|12468717|FG000|NOT COMPLETED|Overall Study||15
11273267|NCT02339155|12468718|FG001|NOT COMPLETED|Overall Study||21
11273268|NCT02339246|12468728|FG000|STARTED|First Intervention (7 Days)||0
11273269|NCT02339246|12468729|FG001|STARTED|First Intervention (7 Days)||0
11273270|NCT02339246|12468730|FG002|STARTED|First Intervention (7 Days)||31
11273271|NCT02339246|12468728|FG000|COMPLETED|First Intervention (7 Days)||0
11273272|NCT02339246|12468729|FG001|COMPLETED|First Intervention (7 Days)||0
11273273|NCT02339246|12468730|FG002|COMPLETED|First Intervention (7 Days)||31
11273274|NCT02339246|12468728|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11273275|NCT02339246|12468729|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11273276|NCT02339246|12468730|FG002|NOT COMPLETED|First Intervention (7 Days)||0
11273277|NCT02339246|12468728|FG000|STARTED|Second Intervention (7 Days)||16
11273278|NCT02339246|12468729|FG001|STARTED|Second Intervention (7 Days)||15
11273279|NCT02339246|12468730|FG002|STARTED|Second Intervention (7 Days)||0
11273280|NCT02339246|12468728|FG000|COMPLETED|Second Intervention (7 Days)||16
11273281|NCT02339246|12468729|FG001|COMPLETED|Second Intervention (7 Days)||15
11273282|NCT02339246|12468730|FG002|COMPLETED|Second Intervention (7 Days)||0
11273283|NCT02339246|12468728|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
11273284|NCT02339246|12468729|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11273285|NCT02339246|12468730|FG002|NOT COMPLETED|Second Intervention (7 Days)||0
11273286|NCT02339246|12468728|FG000|STARTED|Third Period (7 Days)||15
11273287|NCT02339246|12468729|FG001|STARTED|Third Period (7 Days)||16
11273288|NCT02339246|12468730|FG002|STARTED|Third Period (7 Days)||0
11273289|NCT02339246|12468728|FG000|COMPLETED|Third Period (7 Days)||15
11273290|NCT02339246|12468729|FG001|COMPLETED|Third Period (7 Days)||16
11273291|NCT02339246|12468730|FG002|COMPLETED|Third Period (7 Days)||0
11273292|NCT02339246|12468728|FG000|NOT COMPLETED|Third Period (7 Days)||0
11273293|NCT02339246|12468729|FG001|NOT COMPLETED|Third Period (7 Days)||0
11273294|NCT02339246|12468730|FG002|NOT COMPLETED|Third Period (7 Days)||0
11273295|NCT02339285|12468741|FG000|STARTED|Overall Study||10
11273296|NCT02339285|12468742|FG001|STARTED|Overall Study||11
11273297|NCT02339285|12468743|FG002|STARTED|Overall Study||11
11273298|NCT02339285|12468741|FG000|Completed Intervention|Overall Study||10
11273299|NCT02339285|12468742|FG001|Completed Intervention|Overall Study||10
11273300|NCT02339285|12468743|FG002|Completed Intervention|Overall Study||10
11273301|NCT02339285|12468741|FG000|2 Week Follow-up|Overall Study||9
11273302|NCT02339285|12468742|FG001|2 Week Follow-up|Overall Study||10
11273303|NCT02339285|12468743|FG002|2 Week Follow-up|Overall Study||10
11273304|NCT02339285|12468741|FG000|4 Week Follow-up Visit|Overall Study||9
11273305|NCT02339285|12468742|FG001|4 Week Follow-up Visit|Overall Study||8
11273306|NCT02339285|12468743|FG002|4 Week Follow-up Visit|Overall Study||9
11273307|NCT02339285|12468741|FG000|COMPLETED|Overall Study||9
11273308|NCT02339285|12468742|FG001|COMPLETED|Overall Study||8
11273309|NCT02339285|12468743|FG002|COMPLETED|Overall Study||9
11273310|NCT02339285|12468741|FG000|NOT COMPLETED|Overall Study||1
11273311|NCT02339285|12468742|FG001|NOT COMPLETED|Overall Study||3
11273312|NCT02339285|12468743|FG002|NOT COMPLETED|Overall Study||2
11273313|NCT02339389|12468751|FG000|STARTED|Overall Study||57
11273314|NCT02339389|12468751|FG000|COMPLETED|Overall Study||41
11273315|NCT02339389|12468751|FG000|NOT COMPLETED|Overall Study||16
11273316|NCT02339415|12468758|FG000|STARTED|First Period||22
11273317|NCT02339415|12468759|FG001|STARTED|First Period||22
11273318|NCT02339415|12468758|FG000|Received at Least One Dose|First Period||21
11273319|NCT02339415|12468759|FG001|Received at Least One Dose|First Period||20
11273320|NCT02339415|12468758|FG000|COMPLETED|First Period||20
11273321|NCT02339415|12468759|FG001|COMPLETED|First Period||20
11273322|NCT02339415|12468758|FG000|NOT COMPLETED|First Period||2
11273323|NCT02339415|12468759|FG001|NOT COMPLETED|First Period||2
11273324|NCT02339415|12468758|FG000|STARTED|Washout||20
11273325|NCT02339415|12468759|FG001|STARTED|Washout||20
11273326|NCT02339415|12468758|FG000|COMPLETED|Washout||20
11273327|NCT02339415|12468759|FG001|COMPLETED|Washout||20
11273328|NCT02339415|12468758|FG000|NOT COMPLETED|Washout||0
11273329|NCT02339415|12468759|FG001|NOT COMPLETED|Washout||0
11273330|NCT02339415|12468758|FG000|STARTED|Second Period||20
11273331|NCT02339415|12468759|FG001|STARTED|Second Period||20
11273332|NCT02339415|12468758|FG000|COMPLETED|Second Period||19
11273333|NCT02339415|12468759|FG001|COMPLETED|Second Period||18
11273334|NCT02339415|12468758|FG000|NOT COMPLETED|Second Period||1
11273335|NCT02339415|12468759|FG001|NOT COMPLETED|Second Period||2
11273336|NCT02339545|12468767|FG000|STARTED|Overall Study||15
11273337|NCT02339545|12468767|FG000|COMPLETED|Overall Study||15
11273338|NCT02339545|12468767|FG000|NOT COMPLETED|Overall Study||0
11273339|NCT02339558|12468772|FG000|STARTED|Overall Study||45
11273340|NCT02339558|12468772|FG000|COMPLETED|Overall Study||45
11273341|NCT02339558|12468772|FG000|NOT COMPLETED|Overall Study||0
11273342|NCT02339584|12468778|FG000|STARTED|Overall Study||188
11273343|NCT02339584|12468779|FG001|STARTED|Overall Study||191
11273344|NCT02339584|12468778|FG000|COMPLETED|Overall Study||173
11273345|NCT02339584|12468779|FG001|COMPLETED|Overall Study||176
11273346|NCT02339584|12468778|FG000|NOT COMPLETED|Overall Study||15
11273347|NCT02339584|12468779|FG001|NOT COMPLETED|Overall Study||15
11273348|NCT02339831|12468787|FG000|STARTED|Overall Study||58
11273349|NCT02339831|12468788|FG001|STARTED|Overall Study||52
11273350|NCT02339831|12468787|FG000|Lost to Follow Up|Overall Study||20
11273351|NCT02339831|12468788|FG001|Lost to Follow Up|Overall Study||7
11273352|NCT02339831|12468787|FG000|COMPLETED|Overall Study||38
11273353|NCT02339831|12468788|FG001|COMPLETED|Overall Study||45
11273354|NCT02339831|12468787|FG000|NOT COMPLETED|Overall Study||20
11273355|NCT02339831|12468788|FG001|NOT COMPLETED|Overall Study||7
11273356|NCT02339909|12468797|FG000|STARTED|Overall Study||524
11273357|NCT02339909|12468798|FG001|STARTED|Overall Study||375
11273358|NCT02339909|12468799|FG002|STARTED|Overall Study||375
11273359|NCT02339909|12468797|FG000|COMPLETED|Overall Study||435
11273360|NCT02339909|12468798|FG001|COMPLETED|Overall Study||312
11273361|NCT02339909|12468799|FG002|COMPLETED|Overall Study||304
11273362|NCT02339909|12468797|FG000|NOT COMPLETED|Overall Study||89
11273363|NCT02339909|12468798|FG001|NOT COMPLETED|Overall Study||63
11273364|NCT02339909|12468799|FG002|NOT COMPLETED|Overall Study||71
11273365|NCT02340000|12468809|FG000|STARTED|Time Period 1||90
11273366|NCT02340000|12468810|FG001|STARTED|Time Period 1||89
11273367|NCT02340000|12468809|FG000|COMPLETED|Time Period 1||78
11273368|NCT02340000|12468810|FG001|COMPLETED|Time Period 1||74
11273369|NCT02340000|12468809|FG000|NOT COMPLETED|Time Period 1||12
11273370|NCT02340000|12468810|FG001|NOT COMPLETED|Time Period 1||15
11273371|NCT02340000|12468809|FG000|STARTED|Time Period 2||69
11273372|NCT02340000|12468810|FG001|STARTED|Time Period 2||67
11273373|NCT02340000|12468809|FG000|COMPLETED|Time Period 2||50
11273374|NCT02340000|12468810|FG001|COMPLETED|Time Period 2||52
11273375|NCT02340000|12468809|FG000|NOT COMPLETED|Time Period 2||19
11273376|NCT02340000|12468810|FG001|NOT COMPLETED|Time Period 2||15
11273377|NCT02340078|12468823|FG000|STARTED|Overall Study||62
11273378|NCT02340078|12468823|FG000|COMPLETED|Overall Study||61
11273379|NCT02340078|12468823|FG000|NOT COMPLETED|Overall Study||1
11273380|NCT02340091|12468828|FG000|STARTED|Overall Study|All Study Participants|62
11273381|NCT02340091|12468828|FG000|COMPLETED|Overall Study||60
11273382|NCT02340091|12468828|FG000|NOT COMPLETED|Overall Study||2
11273383|NCT02340104|12468833|FG000|STARTED|Overall Study||8
11273384|NCT02340104|12468833|FG000|COMPLETED|Overall Study||8
11273385|NCT02340104|12468833|FG000|NOT COMPLETED|Overall Study||0
11273386|NCT02340156|12468838|FG000|STARTED|Overall Study||1
11273387|NCT02340156|12468838|FG000|COMPLETED|Overall Study||1
11273388|NCT02340156|12468838|FG000|NOT COMPLETED|Overall Study||0
11273389|NCT02340299|12468844|FG000|STARTED|Overall Study||4
11273390|NCT02340299|12468845|FG001|STARTED|Overall Study||2
11273391|NCT02340299|12468844|FG000|COMPLETED|Overall Study||4
11273392|NCT02340299|12468845|FG001|COMPLETED|Overall Study||2
11273393|NCT02340299|12468844|FG000|NOT COMPLETED|Overall Study||0
11273394|NCT02340299|12468845|FG001|NOT COMPLETED|Overall Study||0
11273395|NCT02340338|12468858|FG000|STARTED|Overall Study|2 vaccine + 1 placebo|2
11273396|NCT02340338|12468859|FG001|STARTED|Overall Study|2 vaccine + 1 placebo|2
11273397|NCT02340338|12468860|FG002|STARTED|Overall Study|3 vaccine + 1 placebo|3
11273398|NCT02340338|12468861|FG003|STARTED|Overall Study|9 vaccine + 3 placebo|9
11273399|NCT02340338|12468862|FG004|STARTED|Overall Study|9 vaccine + 3 placebo|9
11273400|NCT02340338|12468863|FG005|STARTED|Overall Study|9 vaccine + 3 placebo|9
11273401|NCT02340338|12468864|FG006|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
11273402|NCT02340338|12468858|FG000|COMPLETED|Overall Study||2
11273403|NCT02340338|12468859|FG001|COMPLETED|Overall Study||2
11273404|NCT02340338|12468860|FG002|COMPLETED|Overall Study||3
11273405|NCT02340338|12468861|FG003|COMPLETED|Overall Study||9
11273406|NCT02340338|12468862|FG004|COMPLETED|Overall Study||9
11273407|NCT02340338|12468863|FG005|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
11273408|NCT02340338|12468864|FG006|COMPLETED|Overall Study||12
11273409|NCT02340338|12468858|FG000|NOT COMPLETED|Overall Study||0
11273410|NCT02340338|12468859|FG001|NOT COMPLETED|Overall Study||0
11273411|NCT02340338|12468860|FG002|NOT COMPLETED|Overall Study||0
11273412|NCT02340338|12468861|FG003|NOT COMPLETED|Overall Study||0
11273413|NCT02340338|12468862|FG004|NOT COMPLETED|Overall Study||0
11273414|NCT02340338|12468863|FG005|NOT COMPLETED|Overall Study||0
11273415|NCT02340338|12468864|FG006|NOT COMPLETED|Overall Study||0
11273416|NCT02340520|12468880|FG000|STARTED|Overall Study||11
11273417|NCT02340520|12468880|FG000|COMPLETED|Overall Study||8
11273418|NCT02340520|12468880|FG000|NOT COMPLETED|Overall Study||3
11273419|NCT02340663|12468886|FG000|STARTED|Overall Study||35
11273420|NCT02340663|12468887|FG001|STARTED|Overall Study||32
11273421|NCT02340663|12468886|FG000|Clinical Exam, Impressions|Overall Study||35
11273422|NCT02340663|12468887|FG001|Clinical Exam, Impressions|Overall Study||32
11273423|NCT02340663|12468886|FG000|Splint Delivery, Assessments|Overall Study||33
11273424|NCT02340663|12468887|FG001|Splint Delivery, Assessments|Overall Study||31
11273425|NCT02340663|12468886|FG000|1 Week Follow-up, Assessments|Overall Study||33
11273426|NCT02340663|12468887|FG001|1 Week Follow-up, Assessments|Overall Study||31
11273427|NCT02340663|12468886|FG000|4 Month Follow-up, Assessments|Overall Study||30
11273428|NCT02340663|12468887|FG001|4 Month Follow-up, Assessments|Overall Study||31
11273429|NCT02340663|12468886|FG000|COMPLETED|Overall Study||30
11273430|NCT02340663|12468887|FG001|COMPLETED|Overall Study||31
11273431|NCT02340663|12468886|FG000|NOT COMPLETED|Overall Study||5
11273432|NCT02340663|12468887|FG001|NOT COMPLETED|Overall Study||1
11273433|NCT02340715|12468893|FG000|STARTED|Overall Study|158|158
11273434|NCT02340715|12468893|FG000|COMPLETED|Overall Study|158|158
11273435|NCT02340715|12468893|FG000|NOT COMPLETED|Overall Study||0
11273436|NCT02340767|12468906|FG000|STARTED|Overall Study||28
11273437|NCT02340767|12468907|FG001|STARTED|Overall Study||28
11273438|NCT02340767|12468908|FG002|STARTED|Overall Study||29
11273439|NCT02340767|12468909|FG003|STARTED|Overall Study||500
11273440|NCT02340767|12468910|FG004|STARTED|Overall Study||474
11273441|NCT02340767|12468911|FG005|STARTED|Overall Study||526
11273442|NCT02340767|12468912|FG006|STARTED|Overall Study||525
11398128|NCT04512482|12592500|FG000|Toothbrush Utilization|First Intervention (1 Day)||24
11398129|NCT04512482|12592501|FG001|Toothbrush Utilization|First Intervention (1 Day)||21
11398130|NCT04512482|12592500|FG000|Post-toothbrush Photographs|First Intervention (1 Day)||24
11398131|NCT04512482|12592501|FG001|Post-toothbrush Photographs|First Intervention (1 Day)||21
11398132|NCT04512482|12592500|FG000|Waterpik Utilization|First Intervention (1 Day)||24
11398133|NCT04512482|12592501|FG001|Waterpik Utilization|First Intervention (1 Day)||21
11398134|NCT04512482|12592500|FG000|Post-Waterpik Photographs|First Intervention (1 Day)||24
11398135|NCT04512482|12592501|FG001|Post-Waterpik Photographs|First Intervention (1 Day)||21
11398136|NCT04512482|12592500|FG000|COMPLETED|First Intervention (1 Day)||24
11273443|NCT02340767|12468913|FG007|STARTED|Overall Study||444
11273444|NCT02340767|12468914|FG008|STARTED|Overall Study||531
11273445|NCT02340767|12468906|FG000|COMPLETED|Overall Study||28
11273446|NCT02340767|12468907|FG001|COMPLETED|Overall Study||28
11273447|NCT02340767|12468908|FG002|COMPLETED|Overall Study||29
11273448|NCT02340767|12468909|FG003|COMPLETED|Overall Study||500
11273449|NCT02340767|12468910|FG004|COMPLETED|Overall Study||474
11273450|NCT02340767|12468911|FG005|COMPLETED|Overall Study||526
11273451|NCT02340767|12468912|FG006|COMPLETED|Overall Study||525
11273452|NCT02340767|12468913|FG007|COMPLETED|Overall Study||444
11273453|NCT02340767|12468914|FG008|COMPLETED|Overall Study||531
11273454|NCT02340767|12468906|FG000|NOT COMPLETED|Overall Study||0
11273455|NCT02340767|12468907|FG001|NOT COMPLETED|Overall Study||0
11273456|NCT02340767|12468908|FG002|NOT COMPLETED|Overall Study||0
11273457|NCT02340767|12468909|FG003|NOT COMPLETED|Overall Study||0
11273458|NCT02340767|12468910|FG004|NOT COMPLETED|Overall Study||0
11273459|NCT02340767|12468911|FG005|NOT COMPLETED|Overall Study||0
11273460|NCT02340767|12468912|FG006|NOT COMPLETED|Overall Study||0
11398137|NCT04512482|12592501|FG001|COMPLETED|First Intervention (1 Day)||21
11273461|NCT02340767|12468913|FG007|NOT COMPLETED|Overall Study||0
11273462|NCT02340767|12468914|FG008|NOT COMPLETED|Overall Study||0
11273463|NCT02340780|12468929|FG000|STARTED|Overall Study|A total of 14 patients enrolled, one patient was found ineligible after the enrollment.|14
11273464|NCT02340780|12468929|FG000|COMPLETED|Overall Study||13
11273465|NCT02340780|12468929|FG000|NOT COMPLETED|Overall Study||1
11273466|NCT02340806|12468935|FG000|STARTED|Overall Study||108
11273467|NCT02340806|12468936|FG001|STARTED|Overall Study||112
11273468|NCT02340806|12468935|FG000|COMPLETED|Overall Study||102
11273469|NCT02340806|12468936|FG001|COMPLETED|Overall Study||108
11273470|NCT02340806|12468935|FG000|NOT COMPLETED|Overall Study||6
11273471|NCT02340806|12468936|FG001|NOT COMPLETED|Overall Study||4
11273472|NCT02340819|12468942|FG000|STARTED|Overall Study||11
11273473|NCT02340819|12468942|FG000|Started Stage 2|Overall Study||11
11273474|NCT02340819|12468942|FG000|Completed Stage 2|Overall Study||9
11273475|NCT02340819|12468942|FG000|Started Stage 3|Overall Study||8
11273476|NCT02340819|12468942|FG000|Completed Stage 3|Overall Study||7
11273477|NCT02340819|12468942|FG000|Started Stage 4|Overall Study||7
11273478|NCT02340819|12468942|FG000|Completed Stage 4|Overall Study||7
11273479|NCT02340819|12468942|FG000|COMPLETED|Overall Study||7
11273480|NCT02340819|12468942|FG000|NOT COMPLETED|Overall Study||4
11273481|NCT02340949|12468948|FG000|STARTED|Overall Study||115
11273482|NCT02340949|12468949|FG001|STARTED|Overall Study||65
11273483|NCT02340949|12468948|FG000|COMPLETED|Overall Study||99
11273484|NCT02340949|12468949|FG001|COMPLETED|Overall Study||61
11273485|NCT02340949|12468948|FG000|NOT COMPLETED|Overall Study||16
11273486|NCT02340949|12468949|FG001|NOT COMPLETED|Overall Study||4
11273487|NCT02340962|12468957|FG000|STARTED|Overall Study||13
11273488|NCT02340962|12468958|FG001|STARTED|Overall Study||12
11273489|NCT02340962|12468957|FG000|COMPLETED|Overall Study||12
11273490|NCT02340962|12468958|FG001|COMPLETED|Overall Study||12
11273491|NCT02340962|12468957|FG000|NOT COMPLETED|Overall Study||1
11273492|NCT02340962|12468958|FG001|NOT COMPLETED|Overall Study||0
11273493|NCT02340975|12468970|FG000|STARTED|Overall Study||6
11273494|NCT02340975|12468971|FG001|STARTED|Overall Study||27
11273495|NCT02340975|12468972|FG002|STARTED|Overall Study||24
11273496|NCT02340975|12468973|FG003|STARTED|Overall Study||12
11273497|NCT02340975|12468974|FG004|STARTED|Overall Study||25
11273498|NCT02340975|12468975|FG005|STARTED|Overall Study||19
11273499|NCT02340975|12468970|FG000|COMPLETED|Overall Study||0
11273500|NCT02340975|12468971|FG001|COMPLETED|Overall Study||0
11273501|NCT02340975|12468972|FG002|COMPLETED|Overall Study||0
11273502|NCT02340975|12468973|FG003|COMPLETED|Overall Study||0
11273503|NCT02340975|12468974|FG004|COMPLETED|Overall Study||0
11273504|NCT02340975|12468975|FG005|COMPLETED|Overall Study||0
11273505|NCT02340975|12468970|FG000|NOT COMPLETED|Overall Study||6
11273506|NCT02340975|12468971|FG001|NOT COMPLETED|Overall Study||27
11273507|NCT02340975|12468972|FG002|NOT COMPLETED|Overall Study||24
11273508|NCT02340975|12468973|FG003|NOT COMPLETED|Overall Study||12
11273509|NCT02340975|12468974|FG004|NOT COMPLETED|Overall Study||25
11273510|NCT02340975|12468975|FG005|NOT COMPLETED|Overall Study||19
11273511|NCT02341144|12468992|FG000|STARTED|Overall Study||30
11273512|NCT02341144|12468993|FG001|STARTED|Overall Study||31
11273513|NCT02341144|12468992|FG000|COMPLETED|Overall Study||28
11273514|NCT02341144|12468993|FG001|COMPLETED|Overall Study||30
11273515|NCT02341144|12468992|FG000|NOT COMPLETED|Overall Study||2
11273516|NCT02341144|12468993|FG001|NOT COMPLETED|Overall Study||1
11273517|NCT02341417|12469002|FG000|STARTED|Overall Study||13
11273518|NCT02341417|12469003|FG001|STARTED|Overall Study||14
11273519|NCT02341417|12469004|FG002|STARTED|Overall Study||1
11273520|NCT02341417|12469002|FG000|COMPLETED|Overall Study||11
11273521|NCT02341417|12469003|FG001|COMPLETED|Overall Study||12
11273522|NCT02341417|12469004|FG002|COMPLETED|Overall Study||0
11273523|NCT02341417|12469002|FG000|NOT COMPLETED|Overall Study||2
11273524|NCT02341417|12469003|FG001|NOT COMPLETED|Overall Study||2
11273525|NCT02341417|12469004|FG002|NOT COMPLETED|Overall Study||1
11273526|NCT02341456|12469016|FG000|STARTED|Overall Study||7
11273527|NCT02341456|12469017|FG001|STARTED|Overall Study||6
11273528|NCT02341456|12469018|FG002|STARTED|Overall Study||6
11273529|NCT02341456|12469016|FG000|COMPLETED|Overall Study||3
11273530|NCT02341456|12469017|FG001|COMPLETED|Overall Study||0
11273531|NCT02341456|12469018|FG002|COMPLETED|Overall Study||2
11273532|NCT02341456|12469016|FG000|NOT COMPLETED|Overall Study||4
11273533|NCT02341456|12469017|FG001|NOT COMPLETED|Overall Study||6
11273534|NCT02341456|12469018|FG002|NOT COMPLETED|Overall Study||4
11340470|NCT02920983|12537743|FG000|COMPLETED|Dispense 3||7
11340471|NCT02920983|12537744|FG001|COMPLETED|Dispense 3||9
11340472|NCT02920983|12537745|FG002|COMPLETED|Dispense 3||7
11340473|NCT02920983|12537746|FG003|COMPLETED|Dispense 3||6
11340474|NCT02920983|12537747|FG004|COMPLETED|Dispense 3||12
11340475|NCT02920983|12537748|FG005|COMPLETED|Dispense 3||7
11340476|NCT02920983|12537743|FG000|NOT COMPLETED|Dispense 3||1
11340477|NCT02920983|12537744|FG001|NOT COMPLETED|Dispense 3||1
11340478|NCT02920983|12537745|FG002|NOT COMPLETED|Dispense 3||0
11340479|NCT02920983|12537746|FG003|NOT COMPLETED|Dispense 3||0
11340480|NCT02920983|12537747|FG004|NOT COMPLETED|Dispense 3||1
11340481|NCT02920983|12537748|FG005|NOT COMPLETED|Dispense 3||0
11340482|NCT02921061|12537756|FG000|STARTED|Overall Study||28
11340483|NCT02921061|12537756|FG000|COMPLETED|Overall Study||28
11340484|NCT02921061|12537756|FG000|NOT COMPLETED|Overall Study||0
11340485|NCT02921087|12537762|FG000|STARTED|Overall Study||12
11340486|NCT02921087|12537763|FG001|STARTED|Overall Study||11
11340487|NCT02921087|12537762|FG000|COMPLETED|Overall Study||12
11340488|NCT02921087|12537763|FG001|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10
11340489|NCT02921087|12537762|FG000|NOT COMPLETED|Overall Study||0
11340490|NCT02921087|12537763|FG001|NOT COMPLETED|Overall Study||1
11340491|NCT02921295|12537779|FG000|STARTED|Sidekicks||1
11340492|NCT02921295|12537779|FG000|COMPLETED|Sidekicks||1
11340493|NCT02921295|12537779|FG000|NOT COMPLETED|Sidekicks||0
11340494|NCT02921295|12537779|FG000|STARTED|Conventional Prostheses||1
11340495|NCT02921295|12537779|FG000|COMPLETED|Conventional Prostheses||1
11340496|NCT02921295|12537779|FG000|NOT COMPLETED|Conventional Prostheses||0
11340497|NCT02921386|12537788|FG000|STARTED|Sequence A: Fasting||18
11340498|NCT02921386|12537788|FG000|COMPLETED|Sequence A: Fasting||18
11340499|NCT02921386|12537788|FG000|NOT COMPLETED|Sequence A: Fasting||0
11340500|NCT02921386|12537788|FG000|STARTED|Sequence B: 15 g Fat Breakfast||18
11340501|NCT02921386|12537788|FG000|COMPLETED|Sequence B: 15 g Fat Breakfast||18
11340502|NCT02921386|12537788|FG000|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
11340503|NCT02921386|12537788|FG000|STARTED|Sequence C: 30 g Fat Breakfast||18
11340504|NCT02921386|12537788|FG000|COMPLETED|Sequence C: 30 g Fat Breakfast||18
11340505|NCT02921386|12537788|FG000|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
11340506|NCT02921386|12537788|FG000|STARTED|Sequence D: 45 g Fat Breakfast||18
11340507|NCT02921386|12537788|FG000|COMPLETED|Sequence D: 45 g Fat Breakfast||18
11340508|NCT02921386|12537788|FG000|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
11340509|NCT02921386|12537788|FG000|STARTED|Sequence E: FDA High Fat Breakfast||18
11340510|NCT02921386|12537788|FG000|COMPLETED|Sequence E: FDA High Fat Breakfast||18
11340511|NCT02921386|12537788|FG000|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
11340512|NCT02921412|12537796|FG000|STARTED|Overall Study||36
11340513|NCT02921412|12537796|FG000|COMPLETED|Overall Study||36
11340514|NCT02921412|12537796|FG000|NOT COMPLETED|Overall Study||0
11340515|NCT02921425|12537807|FG000|STARTED|Overall Study||47
11340516|NCT02921425|12537807|FG000|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
11340517|NCT02921425|12537807|FG000|COMPLETED|Overall Study||38
11340518|NCT02921425|12537807|FG000|NOT COMPLETED|Overall Study||9
11340519|NCT02921490|12537811|FG000|STARTED|Overall Study||10
11340520|NCT02921490|12537811|FG000|COMPLETED|Overall Study||10
11340521|NCT02921490|12537811|FG000|NOT COMPLETED|Overall Study||0
11340522|NCT02921737|12537815|FG000|STARTED|Overall Study||7
11340523|NCT02921737|12537815|FG000|COMPLETED|Overall Study||7
11340524|NCT02921737|12537815|FG000|NOT COMPLETED|Overall Study||0
11340525|NCT02921750|12537821|FG000|STARTED|Overall Study||124
11340526|NCT02921750|12537822|FG001|STARTED|Overall Study||124
11340527|NCT02921750|12537821|FG000|Intention to Treat (ITT)|Overall Study||122
11340528|NCT02921750|12537822|FG001|Intention to Treat (ITT)|Overall Study||123
11340529|NCT02921750|12537821|FG000|Per Protocol (PP)|Overall Study||100
11340530|NCT02921750|12537822|FG001|Per Protocol (PP)|Overall Study||107
11340531|NCT02921750|12537821|FG000|Completed 6 Weeks Follow-up (PP)|Overall Study||97
11340532|NCT02921750|12537822|FG001|Completed 6 Weeks Follow-up (PP)|Overall Study||104
11340533|NCT02921750|12537821|FG000|Subgroup Followed for 24 Weeks (ITT)|Overall Study||35
11398138|NCT04512482|12592500|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11398139|NCT04512482|12592501|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11398140|NCT04512482|12592500|FG000|STARTED|Washout (1 Week)||24
11398141|NCT04512482|12592501|FG001|STARTED|Washout (1 Week)||21
11340534|NCT02921750|12537822|FG001|Subgroup Followed for 24 Weeks (ITT)|Overall Study||40
11340535|NCT02921750|12537821|FG000|Subgroup Followed for 24 Weeks (PP)|Overall Study||19
11340536|NCT02921750|12537822|FG001|Subgroup Followed for 24 Weeks (PP)|Overall Study||36
11340537|NCT02921750|12537821|FG000|COMPLETED|Overall Study||115
11340538|NCT02921750|12537822|FG001|COMPLETED|Overall Study||113
11340539|NCT02921750|12537821|FG000|NOT COMPLETED|Overall Study||9
11273535|NCT02341482|12469026|FG000|STARTED|Overall Study||13
11273536|NCT02341482|12469026|FG000|COMPLETED|Overall Study||12
11273537|NCT02341482|12469026|FG000|NOT COMPLETED|Overall Study||1
11273538|NCT02341599|12469040|FG000|STARTED|Overall Study||8
11273539|NCT02341599|12469041|FG001|STARTED|Overall Study||8
11273540|NCT02341599|12469042|FG002|STARTED|Overall Study||8
11273541|NCT02341599|12469043|FG003|STARTED|Overall Study||8
11273542|NCT02341599|12469044|FG004|STARTED|Overall Study||8
11273543|NCT02341599|12469040|FG000|COMPLETED|Overall Study||8
11143750|NCT01474512|12330435|FG013|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075
11143751|NCT01474512|12330436|FG014|STARTED|Long-Term Extension Period||0
11143752|NCT01474512|12330437|FG015|STARTED|Long-Term Extension Period||0
11273544|NCT02341599|12469041|FG001|COMPLETED|Overall Study||8
11273545|NCT02341599|12469042|FG002|COMPLETED|Overall Study||8
11273546|NCT02341599|12469043|FG003|COMPLETED|Overall Study||8
11273547|NCT02341599|12469044|FG004|COMPLETED|Overall Study||8
11273548|NCT02341599|12469040|FG000|NOT COMPLETED|Overall Study||0
11398142|NCT04512482|12592500|FG000|COMPLETED|Washout (1 Week)||24
11273549|NCT02341599|12469041|FG001|NOT COMPLETED|Overall Study||0
11273550|NCT02341599|12469042|FG002|NOT COMPLETED|Overall Study||0
11273551|NCT02341599|12469043|FG003|NOT COMPLETED|Overall Study||0
11273552|NCT02341599|12469044|FG004|NOT COMPLETED|Overall Study||0
11273553|NCT02341859|12469059|FG000|STARTED|First Intervention (1 Day)||10
11273554|NCT02341859|12469060|FG001|STARTED|First Intervention (1 Day)||9
11273555|NCT02341859|12469059|FG000|COMPLETED|First Intervention (1 Day)||10
11273556|NCT02341859|12469060|FG001|COMPLETED|First Intervention (1 Day)||9
11273557|NCT02341859|12469059|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11273558|NCT02341859|12469060|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11273559|NCT02341859|12469059|FG000|STARTED|Second Intervention (1 Day)||10
11273560|NCT02341859|12469060|FG001|STARTED|Second Intervention (1 Day)||9
11273561|NCT02341859|12469059|FG000|COMPLETED|Second Intervention (1 Day)||10
11273562|NCT02341859|12469060|FG001|COMPLETED|Second Intervention (1 Day)||9
11273563|NCT02341859|12469059|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11273564|NCT02341859|12469060|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11273565|NCT02342015|12469073|FG000|STARTED|Overall Study||20
11273566|NCT02342015|12469073|FG000|COMPLETED|Overall Study||20
11273567|NCT02342015|12469073|FG000|NOT COMPLETED|Overall Study||0
11273568|NCT02342171|12469079|FG000|STARTED|Overall Study||99
11273569|NCT02342171|12469080|FG001|STARTED|Overall Study||507
11273570|NCT02342171|12469079|FG000|COMPLETED|Overall Study||84
11273571|NCT02342171|12469080|FG001|COMPLETED|Overall Study||418
11273572|NCT02342171|12469079|FG000|NOT COMPLETED|Overall Study||15
11273573|NCT02342171|12469080|FG001|NOT COMPLETED|Overall Study||89
11273574|NCT02342197|12469087|FG000|STARTED|Overall Study||30
11273575|NCT02342197|12469088|FG001|STARTED|Overall Study||30
11273576|NCT02342197|12469087|FG000|COMPLETED|Overall Study||27
11273577|NCT02342197|12469088|FG001|COMPLETED|Overall Study||28
11273578|NCT02342197|12469087|FG000|NOT COMPLETED|Overall Study||3
11273579|NCT02342197|12469088|FG001|NOT COMPLETED|Overall Study||2
11273580|NCT02342223|12469094|FG000|STARTED|Overall Study||20
11273581|NCT02342223|12469094|FG000|COMPLETED|Overall Study||19
11273582|NCT02342223|12469094|FG000|NOT COMPLETED|Overall Study||1
11273583|NCT02342288|12469100|FG000|STARTED|Overall Study|16 patients were not randomized to either arm.|30
11273584|NCT02342288|12469101|FG001|STARTED|Overall Study|various issues listed below caused removal of subjects|33
11273585|NCT02342288|12469100|FG000|COMPLETED|Overall Study||25
11273586|NCT02342288|12469101|FG001|COMPLETED|Overall Study||27
11273587|NCT02342288|12469100|FG000|NOT COMPLETED|Overall Study||5
11273588|NCT02342288|12469101|FG001|NOT COMPLETED|Overall Study||6
11273589|NCT02342314|12469109|FG000|STARTED|Part A||6
11273590|NCT02342314|12469110|FG001|STARTED|Part A||3
11273591|NCT02342314|12469111|FG002|STARTED|Part A||3
11273592|NCT02342314|12469112|FG003|STARTED|Part A||3
11273593|NCT02342314|12469113|FG004|STARTED|Part A||6
11273594|NCT02342314|12469114|FG005|STARTED|Part A||3
11273595|NCT02342314|12469115|FG006|STARTED|Part A||0
11273596|NCT02342314|12469116|FG007|STARTED|Part A||0
11273597|NCT02342314|12469117|FG008|STARTED|Part A||0
11273598|NCT02342314|12469118|FG009|STARTED|Part A||0
11273599|NCT02342314|12469119|FG010|STARTED|Part A||0
11273600|NCT02342314|12469120|FG011|STARTED|Part A||0
11273601|NCT02342314|12469121|FG012|STARTED|Part A||0
11273602|NCT02342314|12469122|FG013|STARTED|Part A||0
11273603|NCT02342314|12469123|FG014|STARTED|Part A||0
11273604|NCT02342314|12469124|FG015|STARTED|Part A||0
11273605|NCT02342314|12469125|FG016|STARTED|Part A||0
11273606|NCT02342314|12469109|FG000|COMPLETED|Part A||6
11273607|NCT02342314|12469110|FG001|COMPLETED|Part A||3
11273608|NCT02342314|12469111|FG002|COMPLETED|Part A||3
11273609|NCT02342314|12469112|FG003|COMPLETED|Part A||3
11273610|NCT02342314|12469113|FG004|COMPLETED|Part A||6
11273611|NCT02342314|12469114|FG005|COMPLETED|Part A||3
11273612|NCT02342314|12469115|FG006|COMPLETED|Part A||0
11273613|NCT02342314|12469116|FG007|COMPLETED|Part A||0
11273614|NCT02342314|12469117|FG008|COMPLETED|Part A||0
11273615|NCT02342314|12469118|FG009|COMPLETED|Part A||0
11273616|NCT02342314|12469119|FG010|COMPLETED|Part A||0
11273617|NCT02342314|12469120|FG011|COMPLETED|Part A||0
11273618|NCT02342314|12469121|FG012|COMPLETED|Part A||0
11273619|NCT02342314|12469122|FG013|COMPLETED|Part A||0
11273620|NCT02342314|12469123|FG014|COMPLETED|Part A||0
11273621|NCT02342314|12469124|FG015|COMPLETED|Part A||0
11273622|NCT02342314|12469125|FG016|COMPLETED|Part A||0
11273623|NCT02342314|12469109|FG000|NOT COMPLETED|Part A||0
11273624|NCT02342314|12469110|FG001|NOT COMPLETED|Part A||0
11273625|NCT02342314|12469111|FG002|NOT COMPLETED|Part A||0
11273626|NCT02342314|12469112|FG003|NOT COMPLETED|Part A||0
11273627|NCT02342314|12469113|FG004|NOT COMPLETED|Part A||0
11273628|NCT02342314|12469114|FG005|NOT COMPLETED|Part A||0
11273629|NCT02342314|12469115|FG006|NOT COMPLETED|Part A||0
11273630|NCT02342314|12469116|FG007|NOT COMPLETED|Part A||0
11273631|NCT02342314|12469117|FG008|NOT COMPLETED|Part A||0
11273632|NCT02342314|12469118|FG009|NOT COMPLETED|Part A||0
11273633|NCT02342314|12469119|FG010|NOT COMPLETED|Part A||0
11273634|NCT02342314|12469120|FG011|NOT COMPLETED|Part A||0
11273635|NCT02342314|12469121|FG012|NOT COMPLETED|Part A||0
11273636|NCT02342314|12469122|FG013|NOT COMPLETED|Part A||0
11273637|NCT02342314|12469123|FG014|NOT COMPLETED|Part A||0
11273638|NCT02342314|12469124|FG015|NOT COMPLETED|Part A||0
11273639|NCT02342314|12469125|FG016|NOT COMPLETED|Part A||0
11273640|NCT02342314|12469109|FG000|STARTED|Part B|Participants received placebo in Part A.|0
11273641|NCT02342314|12469110|FG001|STARTED|Part B|Participants received LY3143753 in Part A.|0
11273642|NCT02342314|12469111|FG002|STARTED|Part B|Participants received LY3143753 in Part A.|0
11273643|NCT02342314|12469112|FG003|STARTED|Part B|Participants received LY3143753 in Part A.|0
11273644|NCT02342314|12469113|FG004|STARTED|Part B|Participants received LY3143753 in Part A.|0
11273645|NCT02342314|12469114|FG005|STARTED|Part B|Participants received LY3143753 in Part A.|0
11398143|NCT04512482|12592501|FG001|COMPLETED|Washout (1 Week)||21
11398144|NCT04512482|12592500|FG000|NOT COMPLETED|Washout (1 Week)||0
11398145|NCT04512482|12592501|FG001|NOT COMPLETED|Washout (1 Week)||0
11273646|NCT02342314|12469115|FG006|STARTED|Part B|Participants received placebo in Part B.|11
11273647|NCT02342314|12469116|FG007|STARTED|Part B|Participants received LY3185643 in Part B.|3
11273648|NCT02342314|12469117|FG008|STARTED|Part B|Participants received LY3185643 in Part B.|3
11273649|NCT02342314|12469118|FG009|STARTED|Part B|Participants received LY3185643 in Part B.|3
11273650|NCT02342314|12469119|FG010|STARTED|Part B|Participants received LY3185643 in Part B.|3
11273651|NCT02342314|12469120|FG011|STARTED|Part B|Participants received LY3185643 in Part B.|3
11273652|NCT02342314|12469121|FG012|STARTED|Part B|Participants received LY3185643 in Part B.|3
11273653|NCT02342314|12469122|FG013|STARTED|Part B|Participants received LY3185643 in Part B.|3
11273654|NCT02342314|12469123|FG014|STARTED|Part B|Participants received LY3185643 in Part B.|3
11273655|NCT02342314|12469124|FG015|STARTED|Part B|Participants received LY3185643 in Part B.|3
11273656|NCT02342314|12469125|FG016|STARTED|Part B|Participants received rGlucagon in Part B.|6
11273657|NCT02342314|12469109|FG000|COMPLETED|Part B||0
11273658|NCT02342314|12469110|FG001|COMPLETED|Part B||0
11273659|NCT02342314|12469111|FG002|COMPLETED|Part B||0
11273660|NCT02342314|12469112|FG003|COMPLETED|Part B||0
11273661|NCT02342314|12469113|FG004|COMPLETED|Part B||0
11273662|NCT02342314|12469114|FG005|COMPLETED|Part B||0
11273663|NCT02342314|12469115|FG006|COMPLETED|Part B||11
11273664|NCT02342314|12469116|FG007|COMPLETED|Part B||3
11273665|NCT02342314|12469117|FG008|COMPLETED|Part B||3
11273666|NCT02342314|12469118|FG009|COMPLETED|Part B||3
11273667|NCT02342314|12469119|FG010|COMPLETED|Part B||3
11273668|NCT02342314|12469120|FG011|COMPLETED|Part B||3
11273669|NCT02342314|12469121|FG012|COMPLETED|Part B||3
11273670|NCT02342314|12469122|FG013|COMPLETED|Part B||3
11273671|NCT02342314|12469123|FG014|COMPLETED|Part B||3
11273672|NCT02342314|12469124|FG015|COMPLETED|Part B||3
11273673|NCT02342314|12469125|FG016|COMPLETED|Part B||6
11273674|NCT02342314|12469109|FG000|NOT COMPLETED|Part B||0
11273675|NCT02342314|12469110|FG001|NOT COMPLETED|Part B||0
11273676|NCT02342314|12469111|FG002|NOT COMPLETED|Part B||0
11273677|NCT02342314|12469112|FG003|NOT COMPLETED|Part B||0
11273678|NCT02342314|12469113|FG004|NOT COMPLETED|Part B||0
11273679|NCT02342314|12469114|FG005|NOT COMPLETED|Part B||0
11273680|NCT02342314|12469115|FG006|NOT COMPLETED|Part B||0
11273681|NCT02342314|12469116|FG007|NOT COMPLETED|Part B||0
11273682|NCT02342314|12469117|FG008|NOT COMPLETED|Part B||0
11273683|NCT02342314|12469118|FG009|NOT COMPLETED|Part B||0
11273684|NCT02342314|12469119|FG010|NOT COMPLETED|Part B||0
11273685|NCT02342314|12469120|FG011|NOT COMPLETED|Part B||0
11273686|NCT02342314|12469121|FG012|NOT COMPLETED|Part B||0
11273687|NCT02342314|12469122|FG013|NOT COMPLETED|Part B||0
11273688|NCT02342314|12469123|FG014|NOT COMPLETED|Part B||0
11273689|NCT02342314|12469124|FG015|NOT COMPLETED|Part B||0
11273690|NCT02342314|12469125|FG016|NOT COMPLETED|Part B||0
11273691|NCT02342327|12469198|FG000|STARTED|Overall Study||60
11273692|NCT02342327|12469199|FG001|STARTED|Overall Study||62
11273693|NCT02342327|12469198|FG000|Completed Quit Day Visit|Overall Study||54
11273694|NCT02342327|12469199|FG001|Completed Quit Day Visit|Overall Study||53
11273695|NCT02342327|12469198|FG000|COMPLETED|Overall Study||39
11273696|NCT02342327|12469199|FG001|COMPLETED|Overall Study||40
11273697|NCT02342327|12469198|FG000|NOT COMPLETED|Overall Study||21
11273698|NCT02342327|12469199|FG001|NOT COMPLETED|Overall Study||22
11273699|NCT02342379|12469205|FG000|STARTED|Overall Study||35
11273700|NCT02342379|12469205|FG000|COMPLETED|Overall Study||35
11273701|NCT02342379|12469205|FG000|NOT COMPLETED|Overall Study||0
11273702|NCT02342418|12469211|FG000|STARTED|Overall Study||9
11273703|NCT02342418|12469212|FG001|STARTED|Overall Study||10
11273704|NCT02342418|12469211|FG000|COMPLETED|Overall Study||9
11273705|NCT02342418|12469212|FG001|COMPLETED|Overall Study||9
11273706|NCT02342418|12469211|FG000|NOT COMPLETED|Overall Study||0
11273707|NCT02342418|12469212|FG001|NOT COMPLETED|Overall Study||1
11273708|NCT02342535|12469218|FG000|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
11340540|NCT02921750|12537822|FG001|NOT COMPLETED|Overall Study||11
11340541|NCT02921841|12537833|FG000|STARTED|Overall Study||68
11273709|NCT02342535|12469218|FG000|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
11273710|NCT02342535|12469218|FG000|NOT COMPLETED|Overall Study||0
11273711|NCT02342548|12469225|FG000|STARTED|Overall Study||51
11273712|NCT02342548|12469226|FG001|STARTED|Overall Study||71
11273713|NCT02342548|12469227|FG002|STARTED|Overall Study||66
11273714|NCT02342548|12469225|FG000|COMPLETED|Overall Study||17
11273715|NCT02342548|12469226|FG001|COMPLETED|Overall Study||9
11273716|NCT02342548|12469227|FG002|COMPLETED|Overall Study||23
11273717|NCT02342548|12469225|FG000|NOT COMPLETED|Overall Study||34
11398146|NCT04512482|12592500|FG000|STARTED|Second Intervention (1 Day)||24
11398147|NCT04512482|12592501|FG001|STARTED|Second Intervention (1 Day)||21
11398148|NCT04512482|12592500|FG000|Baseline Plaque Assessment|Second Intervention (1 Day)||22
11398149|NCT04512482|12592501|FG001|Baseline Plaque Assessment|Second Intervention (1 Day)||20
11273718|NCT02342548|12469226|FG001|NOT COMPLETED|Overall Study||62
11273719|NCT02342548|12469227|FG002|NOT COMPLETED|Overall Study||43
11273720|NCT02342561|12469235|FG000|STARTED|Overall Study||20
11273721|NCT02342561|12469235|FG000|COMPLETED|Overall Study||20
11273722|NCT02342561|12469235|FG000|NOT COMPLETED|Overall Study||0
11273723|NCT02342639|12469245|FG000|STARTED|Overall Study||19
11273724|NCT02342639|12469246|FG001|STARTED|Overall Study||19
11273725|NCT02342639|12469245|FG000|COMPLETED|Overall Study||17
11273726|NCT02342639|12469246|FG001|COMPLETED|Overall Study||14
11273727|NCT02342639|12469245|FG000|NOT COMPLETED|Overall Study||2
11273728|NCT02342639|12469246|FG001|NOT COMPLETED|Overall Study||5
11273729|NCT02342678|12469256|FG000|STARTED|Overall Study||28
11273730|NCT02342678|12469257|FG001|STARTED|Overall Study||28
11273731|NCT02342678|12469256|FG000|COMPLETED|Overall Study||27
11273732|NCT02342678|12469257|FG001|COMPLETED|Overall Study||23
11273733|NCT02342678|12469256|FG000|NOT COMPLETED|Overall Study||1
11273734|NCT02342678|12469257|FG001|NOT COMPLETED|Overall Study||5
11398150|NCT04512482|12592500|FG000|Baseline Photographs|Second Intervention (1 Day)||22
11273735|NCT02342704|12469265|FG000|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
11273736|NCT02342704|12469266|FG001|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
11273737|NCT02342704|12469265|FG000|COMPLETED|Overall Study||1
11273738|NCT02342704|12469266|FG001|COMPLETED|Overall Study||3
11273739|NCT02342704|12469265|FG000|NOT COMPLETED|Overall Study||53
11273740|NCT02342704|12469266|FG001|NOT COMPLETED|Overall Study||51
11273741|NCT02342743|12469272|FG000|STARTED|Baseline Period||73
11273742|NCT02342743|12469272|FG000|COMPLETED|Baseline Period||58
11273743|NCT02342743|12469272|FG000|NOT COMPLETED|Baseline Period||15
11273744|NCT02342743|12469272|FG000|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58
11273745|NCT02342743|12469272|FG000|COMPLETED|Treatment Period||47
11273746|NCT02342743|12469272|FG000|NOT COMPLETED|Treatment Period||11
11273747|NCT02342886|12469281|FG000|STARTED|Overall Study||65
11273748|NCT02342886|12469282|FG001|STARTED|Overall Study||71
11273749|NCT02342886|12469283|FG002|STARTED|Overall Study||67
11273750|NCT02342886|12469284|FG003|STARTED|Overall Study||68
11273751|NCT02342886|12469285|FG004|STARTED|Overall Study||13
11273752|NCT02342886|12469281|FG000|Completed Month 12 Follow-Up|Overall Study||43
11273753|NCT02342886|12469282|FG001|Completed Month 12 Follow-Up|Overall Study||52
11273754|NCT02342886|12469283|FG002|Completed Month 12 Follow-Up|Overall Study||49
11273755|NCT02342886|12469284|FG003|Completed Month 12 Follow-Up|Overall Study||57
11273756|NCT02342886|12469285|FG004|Completed Month 12 Follow-Up|Overall Study||10
11273757|NCT02342886|12469281|FG000|Completed Month 24 Follow-Up|Overall Study||40
11273758|NCT02342886|12469282|FG001|Completed Month 24 Follow-Up|Overall Study||47
11273759|NCT02342886|12469283|FG002|Completed Month 24 Follow-Up|Overall Study||46
11273760|NCT02342886|12469284|FG003|Completed Month 24 Follow-Up|Overall Study||53
11273761|NCT02342886|12469285|FG004|Completed Month 24 Follow-Up|Overall Study||10
11273762|NCT02342886|12469281|FG000|COMPLETED|Overall Study||57
11273763|NCT02342886|12469282|FG001|COMPLETED|Overall Study||63
11273764|NCT02342886|12469283|FG002|COMPLETED|Overall Study||52
11273765|NCT02342886|12469284|FG003|COMPLETED|Overall Study||59
11273766|NCT02342886|12469285|FG004|COMPLETED|Overall Study||10
11273767|NCT02342886|12469281|FG000|NOT COMPLETED|Overall Study||8
11273768|NCT02342886|12469282|FG001|NOT COMPLETED|Overall Study||8
11273769|NCT02342886|12469283|FG002|NOT COMPLETED|Overall Study||15
11273770|NCT02342886|12469284|FG003|NOT COMPLETED|Overall Study||9
11273771|NCT02342886|12469285|FG004|NOT COMPLETED|Overall Study||3
11273772|NCT02343003|12469299|FG000|STARTED|Overall Study||76
11273773|NCT02343003|12469300|FG001|STARTED|Overall Study||75
11273774|NCT02343003|12469299|FG000|COMPLETED|Overall Study||58
11273775|NCT02343003|12469300|FG001|COMPLETED|Overall Study||68
11273776|NCT02343003|12469299|FG000|NOT COMPLETED|Overall Study||18
11273777|NCT02343003|12469300|FG001|NOT COMPLETED|Overall Study||7
11273778|NCT02343081|12469308|FG000|STARTED|First Intervention (Day 3)||8
11273779|NCT02343081|12469309|FG001|STARTED|First Intervention (Day 3)||8
11273780|NCT02343081|12469308|FG000|Received Intervention|First Intervention (Day 3)||8
11273781|NCT02343081|12469309|FG001|Received Intervention|First Intervention (Day 3)||8
11273782|NCT02343081|12469308|FG000|COMPLETED|First Intervention (Day 3)||8
11273783|NCT02343081|12469309|FG001|COMPLETED|First Intervention (Day 3)||8
11273784|NCT02343081|12469308|FG000|NOT COMPLETED|First Intervention (Day 3)||0
11273785|NCT02343081|12469309|FG001|NOT COMPLETED|First Intervention (Day 3)||0
11273786|NCT02343081|12469308|FG000|STARTED|Washout (10 Hours)||8
11273787|NCT02343081|12469309|FG001|STARTED|Washout (10 Hours)||8
11273788|NCT02343081|12469308|FG000|COMPLETED|Washout (10 Hours)||8
11273789|NCT02343081|12469309|FG001|COMPLETED|Washout (10 Hours)||8
11273790|NCT02343081|12469308|FG000|NOT COMPLETED|Washout (10 Hours)||0
11273791|NCT02343081|12469309|FG001|NOT COMPLETED|Washout (10 Hours)||0
11273792|NCT02343081|12469308|FG000|STARTED|Second Intervention (Day 4)||8
11273793|NCT02343081|12469309|FG001|STARTED|Second Intervention (Day 4)||8
11273794|NCT02343081|12469308|FG000|Received Intervention|Second Intervention (Day 4)||8
11273795|NCT02343081|12469309|FG001|Received Intervention|Second Intervention (Day 4)||8
11273796|NCT02343081|12469308|FG000|COMPLETED|Second Intervention (Day 4)||8
11273797|NCT02343081|12469309|FG001|COMPLETED|Second Intervention (Day 4)||8
11273798|NCT02343081|12469308|FG000|NOT COMPLETED|Second Intervention (Day 4)||0
11273799|NCT02343081|12469309|FG001|NOT COMPLETED|Second Intervention (Day 4)||0
11273800|NCT02343276|12469317|FG000|STARTED|Overall Study||164
11273801|NCT02343276|12469318|FG001|STARTED|Overall Study||164
11273802|NCT02343276|12469317|FG000|COMPLETED|Overall Study||164
11273803|NCT02343276|12469318|FG001|COMPLETED|Overall Study||164
11273804|NCT02343276|12469317|FG000|NOT COMPLETED|Overall Study||0
11273805|NCT02343276|12469318|FG001|NOT COMPLETED|Overall Study||0
11273806|NCT02343380|12469326|FG000|STARTED|Overall Study|Morning test (first week)|10
11273807|NCT02343380|12469327|FG001|STARTED|Overall Study|Evening test (first week)|10
11273808|NCT02343380|12469326|FG000|COMPLETED|Overall Study|Evening test (second week)|10
11273809|NCT02343380|12469327|FG001|COMPLETED|Overall Study|Morning test (second week)|10
11273810|NCT02343380|12469326|FG000|NOT COMPLETED|Overall Study||0
11273811|NCT02343380|12469327|FG001|NOT COMPLETED|Overall Study||0
11273812|NCT02343406|12469348|FG000|STARTED|Overall Study||88
11273813|NCT02343406|12469349|FG001|STARTED|Overall Study||86
11273814|NCT02343406|12469350|FG002|STARTED|Overall Study||60
11273815|NCT02343406|12469351|FG003|STARTED|Overall Study||26
11273816|NCT02343406|12469352|FG004|STARTED|Overall Study||6
11273817|NCT02343406|12469348|FG000|COMPLETED|Overall Study||0
11273818|NCT02343406|12469349|FG001|COMPLETED|Overall Study||0
11273819|NCT02343406|12469350|FG002|COMPLETED|Overall Study||2
11273820|NCT02343406|12469351|FG003|COMPLETED|Overall Study||0
11273821|NCT02343406|12469352|FG004|COMPLETED|Overall Study||1
11273822|NCT02343406|12469348|FG000|NOT COMPLETED|Overall Study||88
11273823|NCT02343406|12469349|FG001|NOT COMPLETED|Overall Study||86
11273824|NCT02343406|12469350|FG002|NOT COMPLETED|Overall Study||58
11273825|NCT02343406|12469351|FG003|NOT COMPLETED|Overall Study||26
11273826|NCT02343406|12469352|FG004|NOT COMPLETED|Overall Study||5
11273827|NCT02343458|12469367|FG000|STARTED|Overall Study||555
11273828|NCT02343458|12469368|FG001|STARTED|Overall Study||483
11273829|NCT02343458|12469369|FG002|STARTED|Overall Study||480
11273830|NCT02343458|12469370|FG003|STARTED|Overall Study||238
11273831|NCT02343458|12469367|FG000|COMPLETED|Overall Study||494
11273832|NCT02343458|12469368|FG001|COMPLETED|Overall Study||417
11273833|NCT02343458|12469369|FG002|COMPLETED|Overall Study||417
11273834|NCT02343458|12469370|FG003|COMPLETED|Overall Study||200
11273835|NCT02343458|12469367|FG000|NOT COMPLETED|Overall Study||61
11273836|NCT02343458|12469368|FG001|NOT COMPLETED|Overall Study||66
11273837|NCT02343458|12469369|FG002|NOT COMPLETED|Overall Study||63
11273838|NCT02343458|12469370|FG003|NOT COMPLETED|Overall Study||38
11273839|NCT02343575|12469382|FG000|STARTED|Overall Study||1
11273840|NCT02343575|12469383|FG001|STARTED|Overall Study||2
11273841|NCT02343575|12469382|FG000|COMPLETED|Overall Study||1
11273842|NCT02343575|12469383|FG001|COMPLETED|Overall Study||2
11273843|NCT02343575|12469382|FG000|NOT COMPLETED|Overall Study||0
11273844|NCT02343575|12469383|FG001|NOT COMPLETED|Overall Study||0
11273845|NCT02343627|12469391|FG000|STARTED|Overall Study||35
11273846|NCT02343627|12469392|FG001|STARTED|Overall Study||12
11273847|NCT02343627|12469391|FG000|COMPLETED|Overall Study||23
11273848|NCT02343627|12469392|FG001|COMPLETED|Overall Study||11
11273849|NCT02343627|12469391|FG000|NOT COMPLETED|Overall Study||12
11273850|NCT02343627|12469392|FG001|NOT COMPLETED|Overall Study||1
11273851|NCT02343939|12469407|FG000|STARTED|Overall Study||3
11273852|NCT02343939|12469408|FG001|STARTED|Overall Study||50
11273853|NCT02343939|12469409|FG002|STARTED|Overall Study||5
11273854|NCT02343939|12469410|FG003|STARTED|Overall Study||6
11273855|NCT02343939|12469411|FG004|STARTED|Overall Study||8
11273856|NCT02343939|12469412|FG005|STARTED|Overall Study||17
11273857|NCT02343939|12469413|FG006|STARTED|Overall Study||15
11273858|NCT02343939|12469414|FG007|STARTED|Overall Study||37
11273859|NCT02343939|12469415|FG008|STARTED|Overall Study||7
11273860|NCT02343939|12469407|FG000|COMPLETED|Overall Study||0
11273861|NCT02343939|12469408|FG001|COMPLETED|Overall Study||2
11273862|NCT02343939|12469409|FG002|COMPLETED|Overall Study||0
11273863|NCT02343939|12469410|FG003|COMPLETED|Overall Study||0
11273864|NCT02343939|12469411|FG004|COMPLETED|Overall Study||0
11273865|NCT02343939|12469412|FG005|COMPLETED|Overall Study||0
11273866|NCT02343939|12469413|FG006|COMPLETED|Overall Study||0
11273867|NCT02343939|12469414|FG007|COMPLETED|Overall Study||0
11273868|NCT02343939|12469415|FG008|COMPLETED|Overall Study||0
11273869|NCT02343939|12469407|FG000|NOT COMPLETED|Overall Study||3
11273870|NCT02343939|12469408|FG001|NOT COMPLETED|Overall Study||48
11273871|NCT02343939|12469409|FG002|NOT COMPLETED|Overall Study||5
11273872|NCT02343939|12469410|FG003|NOT COMPLETED|Overall Study||6
11273873|NCT02343939|12469411|FG004|NOT COMPLETED|Overall Study||8
11273874|NCT02343939|12469412|FG005|NOT COMPLETED|Overall Study||17
11273875|NCT02343939|12469413|FG006|NOT COMPLETED|Overall Study||15
11273876|NCT02343939|12469414|FG007|NOT COMPLETED|Overall Study||37
11273877|NCT02343939|12469415|FG008|NOT COMPLETED|Overall Study||7
11273878|NCT02344004|12469451|FG000|STARTED|Overall Study||224
11273879|NCT02344004|12469452|FG001|STARTED|Overall Study||112
11273880|NCT02344004|12469451|FG000|COMPLETED|Overall Study||163
11273881|NCT02344004|12469452|FG001|COMPLETED|Overall Study||98
11273882|NCT02344004|12469451|FG000|NOT COMPLETED|Overall Study||61
11273883|NCT02344004|12469452|FG001|NOT COMPLETED|Overall Study||14
11273884|NCT02344173|12469459|FG000|STARTED|Enrollment||2035
11273885|NCT02344173|12469459|FG000|COMPLETED|Enrollment||2035
11273886|NCT02344173|12469459|FG000|NOT COMPLETED|Enrollment||0
11273887|NCT02344173|12469459|FG000|STARTED|Procedure||2035
11273888|NCT02344173|12469459|FG000|COMPLETED|Procedure||2028
11273889|NCT02344173|12469459|FG000|NOT COMPLETED|Procedure||7
11273890|NCT02344173|12469459|FG000|STARTED|12-month Visit||2028
11273891|NCT02344173|12469459|FG000|COMPLETED|12-month Visit||1932
11273892|NCT02344173|12469459|FG000|NOT COMPLETED|12-month Visit||96
11273893|NCT02344225|12469468|FG000|STARTED|Overall Study||6
11273894|NCT02344225|12469469|FG001|STARTED|Overall Study||3
11273895|NCT02344225|12469470|FG002|STARTED|Overall Study||5
11273896|NCT02344225|12469468|FG000|COMPLETED|Overall Study||6
11273897|NCT02344225|12469469|FG001|COMPLETED|Overall Study||3
11273898|NCT02344225|12469470|FG002|COMPLETED|Overall Study||5
11273899|NCT02344225|12469468|FG000|NOT COMPLETED|Overall Study||0
11273900|NCT02344225|12469469|FG001|NOT COMPLETED|Overall Study||0
11273901|NCT02344225|12469470|FG002|NOT COMPLETED|Overall Study||0
11273902|NCT02344238|12469481|FG000|STARTED|Overall Study||20
11273903|NCT02344238|12469482|FG001|STARTED|Overall Study||20
11273904|NCT02344238|12469483|FG002|STARTED|Overall Study||20
11273905|NCT02344238|12469481|FG000|COMPLETED|Overall Study||20
11273906|NCT02344238|12469482|FG001|COMPLETED|Overall Study||20
11273907|NCT02344238|12469483|FG002|COMPLETED|Overall Study||20
11273908|NCT02344238|12469481|FG000|NOT COMPLETED|Overall Study||0
11273909|NCT02344238|12469482|FG001|NOT COMPLETED|Overall Study||0
11273910|NCT02344238|12469483|FG002|NOT COMPLETED|Overall Study||0
11273911|NCT02344251|12469494|FG000|STARTED|Overall Study||20
11273912|NCT02344251|12469495|FG001|STARTED|Overall Study||20
11273913|NCT02344251|12469494|FG000|COMPLETED|Overall Study||20
11273914|NCT02344251|12469495|FG001|COMPLETED|Overall Study||20
11273915|NCT02344251|12469494|FG000|NOT COMPLETED|Overall Study||0
11273916|NCT02344251|12469495|FG001|NOT COMPLETED|Overall Study||0
11273917|NCT02344316|12469505|FG000|STARTED|Overall Study||13
11273918|NCT02344316|12469506|FG001|STARTED|Overall Study||13
11273919|NCT02344316|12469505|FG000|COMPLETED|Overall Study||12
11273920|NCT02344316|12469506|FG001|COMPLETED|Overall Study||11
11273921|NCT02344316|12469505|FG000|NOT COMPLETED|Overall Study||1
11273922|NCT02344316|12469506|FG001|NOT COMPLETED|Overall Study||2
11273923|NCT02344342|12469519|FG000|STARTED|Overall Study||13
11273924|NCT02344342|12469520|FG001|STARTED|Overall Study||11
11273925|NCT02344342|12469521|FG002|STARTED|Overall Study||14
11273926|NCT02344342|12469522|FG003|STARTED|Overall Study||13
11273927|NCT02344342|12469519|FG000|COMPLETED|Overall Study||2
11273928|NCT02344342|12469520|FG001|COMPLETED|Overall Study||2
11273929|NCT02344342|12469521|FG002|COMPLETED|Overall Study||0
11273930|NCT02344342|12469522|FG003|COMPLETED|Overall Study||3
11273931|NCT02344342|12469519|FG000|NOT COMPLETED|Overall Study||11
11273932|NCT02344342|12469520|FG001|NOT COMPLETED|Overall Study||9
11273933|NCT02344342|12469521|FG002|NOT COMPLETED|Overall Study||14
11273934|NCT02344342|12469522|FG003|NOT COMPLETED|Overall Study||10
11273935|NCT02344407|12469539|FG000|STARTED|Overall Study||500
11273936|NCT02344407|12469540|FG001|STARTED|Overall Study||500
11273937|NCT02344407|12469541|FG002|STARTED|Overall Study||500
11273938|NCT02344407|12469539|FG000|COMPLETED|Overall Study||492
11273939|NCT02344407|12469540|FG001|COMPLETED|Overall Study||491
11273940|NCT02344407|12469541|FG002|COMPLETED|Overall Study||494
11273941|NCT02344407|12469539|FG000|NOT COMPLETED|Overall Study||8
11273942|NCT02344407|12469540|FG001|NOT COMPLETED|Overall Study||9
11273943|NCT02344407|12469541|FG002|NOT COMPLETED|Overall Study||6
11273944|NCT02344576|12469553|FG000|STARTED|Enrollment|Includes 7 patients who agreed to medical record review only and were excluded from further analysis|142
11273945|NCT02344576|12469554|FG001|STARTED|Enrollment|Includes 8 patients who agreed to medical record review only and were excluded from further analysis|121
11273946|NCT02344576|12469555|FG002|STARTED|Enrollment||111
11273947|NCT02344576|12469556|FG003|STARTED|Enrollment||71
11273948|NCT02344576|12469553|FG000|Agreed to Survey Data Collection|Enrollment||135
11273949|NCT02344576|12469554|FG001|Agreed to Survey Data Collection|Enrollment||113
11273950|NCT02344576|12469555|FG002|Agreed to Survey Data Collection|Enrollment||111
11273951|NCT02344576|12469556|FG003|Agreed to Survey Data Collection|Enrollment||71
11273952|NCT02344576|12469553|FG000|COMPLETED|Enrollment||135
11273953|NCT02344576|12469554|FG001|COMPLETED|Enrollment||113
11273954|NCT02344576|12469555|FG002|COMPLETED|Enrollment||111
11273955|NCT02344576|12469556|FG003|COMPLETED|Enrollment||71
11273956|NCT02344576|12469553|FG000|NOT COMPLETED|Enrollment||7
11273957|NCT02344576|12469554|FG001|NOT COMPLETED|Enrollment||8
11273958|NCT02344576|12469555|FG002|NOT COMPLETED|Enrollment||0
11273959|NCT02344576|12469556|FG003|NOT COMPLETED|Enrollment||0
11273960|NCT02344576|12469553|FG000|STARTED|1-Month Follow-Up||135
11273961|NCT02344576|12469554|FG001|STARTED|1-Month Follow-Up||113
11273962|NCT02344576|12469555|FG002|STARTED|1-Month Follow-Up||111
11273963|NCT02344576|12469556|FG003|STARTED|1-Month Follow-Up||71
11273964|NCT02344576|12469553|FG000|Completed 1-Month Survey|1-Month Follow-Up||104
11273965|NCT02344576|12469554|FG001|Completed 1-Month Survey|1-Month Follow-Up||79
11273966|NCT02344576|12469555|FG002|Completed 1-Month Survey|1-Month Follow-Up||89
11273967|NCT02344576|12469556|FG003|Completed 1-Month Survey|1-Month Follow-Up||53
11273968|NCT02344576|12469553|FG000|COMPLETED|1-Month Follow-Up|Includes 13 patients who were still enrolled at 1-month but did not complete the 1-month survey.|117
11273969|NCT02344576|12469554|FG001|COMPLETED|1-Month Follow-Up|Includes 7 patients who were still enrolled at 1-month but did not complete the 1-month survey.|86
11273970|NCT02344576|12469555|FG002|COMPLETED|1-Month Follow-Up|Includes 3 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|92
11273971|NCT02344576|12469556|FG003|COMPLETED|1-Month Follow-Up|Includes 5 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|58
11273972|NCT02344576|12469553|FG000|NOT COMPLETED|1-Month Follow-Up||18
11273973|NCT02344576|12469554|FG001|NOT COMPLETED|1-Month Follow-Up||27
11273974|NCT02344576|12469555|FG002|NOT COMPLETED|1-Month Follow-Up||19
11273975|NCT02344576|12469556|FG003|NOT COMPLETED|1-Month Follow-Up||13
11273976|NCT02344576|12469553|FG000|STARTED|6-Month Follow-Up||117
11273977|NCT02344576|12469554|FG001|STARTED|6-Month Follow-Up||86
11273978|NCT02344576|12469555|FG002|STARTED|6-Month Follow-Up||92
11273979|NCT02344576|12469556|FG003|STARTED|6-Month Follow-Up||58
11273980|NCT02344576|12469553|FG000|Completed 6-Month Survey|6-Month Follow-Up||98
11273981|NCT02344576|12469554|FG001|Completed 6-Month Survey|6-Month Follow-Up||67
11273982|NCT02344576|12469555|FG002|Completed 6-Month Survey|6-Month Follow-Up||78
11273983|NCT02344576|12469556|FG003|Completed 6-Month Survey|6-Month Follow-Up||50
11273984|NCT02344576|12469553|FG000|COMPLETED|6-Month Follow-Up||98
11273985|NCT02344576|12469554|FG001|COMPLETED|6-Month Follow-Up||67
11273986|NCT02344576|12469555|FG002|COMPLETED|6-Month Follow-Up||78
11273987|NCT02344576|12469556|FG003|COMPLETED|6-Month Follow-Up||50
11273988|NCT02344576|12469553|FG000|NOT COMPLETED|6-Month Follow-Up||19
11273989|NCT02344576|12469554|FG001|NOT COMPLETED|6-Month Follow-Up||19
11273990|NCT02344576|12469555|FG002|NOT COMPLETED|6-Month Follow-Up||14
11273991|NCT02344576|12469556|FG003|NOT COMPLETED|6-Month Follow-Up||8
11273992|NCT02344576|12469553|FG000|STARTED|12-Month Medical Record Follow-Up||98
11273993|NCT02344576|12469554|FG001|STARTED|12-Month Medical Record Follow-Up||67
11273994|NCT02344576|12469555|FG002|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
11273995|NCT02344576|12469556|FG003|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
11273996|NCT02344576|12469553|FG000|COMPLETED|12-Month Medical Record Follow-Up||98
11273997|NCT02344576|12469554|FG001|COMPLETED|12-Month Medical Record Follow-Up||67
11273998|NCT02344576|12469555|FG002|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
11273999|NCT02344576|12469556|FG003|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
11274000|NCT02344576|12469553|FG000|NOT COMPLETED|12-Month Medical Record Follow-Up||0
11274001|NCT02344576|12469554|FG001|NOT COMPLETED|12-Month Medical Record Follow-Up||0
11274002|NCT02344576|12469555|FG002|NOT COMPLETED|12-Month Medical Record Follow-Up||0
11274003|NCT02344576|12469556|FG003|NOT COMPLETED|12-Month Medical Record Follow-Up||0
11274004|NCT02344628|12469570|FG000|STARTED|Overall Study||291
11274005|NCT02344628|12469571|FG001|STARTED|Overall Study||292
11274006|NCT02344628|12469570|FG000|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
11274007|NCT02344628|12469571|FG001|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
11274008|NCT02344628|12469570|FG000|NOT COMPLETED|Overall Study||91
11274009|NCT02344628|12469571|FG001|NOT COMPLETED|Overall Study||86
11274010|NCT02344745|12469579|FG000|STARTED|Overall Study||40
11274011|NCT02344745|12469580|FG001|STARTED|Overall Study||40
11274012|NCT02344745|12469579|FG000|COMPLETED|Overall Study||38
11274013|NCT02344745|12469580|FG001|COMPLETED|Overall Study||40
11274014|NCT02344745|12469579|FG000|NOT COMPLETED|Overall Study||2
11274015|NCT02344745|12469580|FG001|NOT COMPLETED|Overall Study||0
11274016|NCT02345031|12469588|FG000|STARTED|Overall Study||38
11274017|NCT02345031|12469589|FG001|STARTED|Overall Study||40
11274018|NCT02345031|12469588|FG000|COMPLETED|Overall Study||37
11274019|NCT02345031|12469589|FG001|COMPLETED|Overall Study||39
11274020|NCT02345031|12469588|FG000|NOT COMPLETED|Overall Study||1
11274021|NCT02345031|12469589|FG001|NOT COMPLETED|Overall Study||1
11274022|NCT02345161|12469599|FG000|STARTED|Overall Study||911
11274023|NCT02345161|12469600|FG001|STARTED|Overall Study||899
11274024|NCT02345161|12469599|FG000|COMPLETED|Overall Study||866
11274025|NCT02345161|12469600|FG001|COMPLETED|Overall Study||842
11274026|NCT02345161|12469599|FG000|NOT COMPLETED|Overall Study||45
11274027|NCT02345161|12469600|FG001|NOT COMPLETED|Overall Study||57
11274028|NCT02345226|12469613|FG000|STARTED|Double-Blind Phase||440
11274029|NCT02345226|12469614|FG001|STARTED|Double-Blind Phase||441
11274030|NCT02345226|12469613|FG000|COMPLETED|Double-Blind Phase||371
11274031|NCT02345226|12469614|FG001|COMPLETED|Double-Blind Phase||370
11274032|NCT02345226|12469613|FG000|NOT COMPLETED|Double-Blind Phase||69
11274033|NCT02345226|12469614|FG001|NOT COMPLETED|Double-Blind Phase||71
11274034|NCT02345226|12469613|FG000|STARTED|Open-Label Extension Phase|346 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|25
11274035|NCT02345226|12469614|FG001|STARTED|Open-Label Extension Phase|349 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|21
11274036|NCT02345226|12469613|FG000|COMPLETED|Open-Label Extension Phase||25
11274037|NCT02345226|12469614|FG001|COMPLETED|Open-Label Extension Phase||20
11274038|NCT02345226|12469613|FG000|NOT COMPLETED|Open-Label Extension Phase||0
11274039|NCT02345226|12469614|FG001|NOT COMPLETED|Open-Label Extension Phase||1
11274040|NCT02345252|12469624|FG000|STARTED|Double-Blind Phase||316
11274041|NCT02345252|12469625|FG001|STARTED|Double-Blind Phase||316
11274042|NCT02345252|12469624|FG000|COMPLETED|Double-Blind Phase||276
11274043|NCT02345252|12469625|FG001|COMPLETED|Double-Blind Phase||267
11274044|NCT02345252|12469624|FG000|NOT COMPLETED|Double-Blind Phase||40
11274045|NCT02345252|12469625|FG001|NOT COMPLETED|Double-Blind Phase||49
11274046|NCT02345252|12469624|FG000|STARTED|Open-Label Extension Phase|257 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|19
11274047|NCT02345252|12469625|FG001|STARTED|Open-Label Extension Phase|250 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|17
11274048|NCT02345252|12469624|FG000|COMPLETED|Open-Label Extension Phase||19
11274049|NCT02345252|12469625|FG001|COMPLETED|Open-Label Extension Phase||17
11274050|NCT02345252|12469624|FG000|NOT COMPLETED|Open-Label Extension Phase||0
11274051|NCT02345252|12469625|FG001|NOT COMPLETED|Open-Label Extension Phase||0
11274052|NCT02345330|12469633|FG000|STARTED|Overall Study||4
11274053|NCT02345330|12469633|FG000|COMPLETED|Overall Study||1
11274054|NCT02345330|12469633|FG000|NOT COMPLETED|Overall Study||3
11274055|NCT02345434|12469639|FG000|STARTED|Overall Study||763
11274056|NCT02345434|12469640|FG001|STARTED|Overall Study||762
11274057|NCT02345434|12469639|FG000|COMPLETED|Overall Study||758
11274058|NCT02345434|12469640|FG001|COMPLETED|Overall Study||760
11274059|NCT02345434|12469639|FG000|NOT COMPLETED|Overall Study||5
11274060|NCT02345434|12469640|FG001|NOT COMPLETED|Overall Study||2
11274061|NCT02345486|12469648|FG000|STARTED|Overall Study||454
11274062|NCT02345486|12469649|FG001|STARTED|Overall Study||520
11274063|NCT02345486|12469648|FG000|COMPLETED|Overall Study||454
11274064|NCT02345486|12469649|FG001|COMPLETED|Overall Study||520
11274065|NCT02345486|12469648|FG000|NOT COMPLETED|Overall Study||0
11274066|NCT02345486|12469649|FG001|NOT COMPLETED|Overall Study||0
11274067|NCT02345512|12469655|FG000|STARTED|Overall Study||11
11274068|NCT02345512|12469655|FG000|COMPLETED|Overall Study||9
11274069|NCT02345512|12469655|FG000|NOT COMPLETED|Overall Study||2
11274070|NCT02345642|12469666|FG000|STARTED|Overall Study||10
11274071|NCT02345642|12469667|FG001|STARTED|Overall Study||10
11274072|NCT02345642|12469666|FG000|COMPLETED|Overall Study||10
11274073|NCT02345642|12469667|FG001|COMPLETED|Overall Study||10
11274074|NCT02345642|12469666|FG000|NOT COMPLETED|Overall Study||0
11274075|NCT02345642|12469667|FG001|NOT COMPLETED|Overall Study||0
11274076|NCT02345720|12469673|FG000|STARTED|Overall Study||20
11274077|NCT02345720|12469673|FG000|COMPLETED|Overall Study||20
11274078|NCT02345720|12469673|FG000|NOT COMPLETED|Overall Study||0
11274079|NCT02345811|12469677|FG000|STARTED|First Intervention||17
11274080|NCT02345811|12469678|FG001|STARTED|First Intervention||17
11274081|NCT02345811|12469677|FG000|COMPLETED|First Intervention||16
11274082|NCT02345811|12469678|FG001|COMPLETED|First Intervention||16
11274083|NCT02345811|12469677|FG000|NOT COMPLETED|First Intervention||1
11274084|NCT02345811|12469678|FG001|NOT COMPLETED|First Intervention||1
11274085|NCT02345811|12469677|FG000|STARTED|Second Intervention||16
11274086|NCT02345811|12469678|FG001|STARTED|Second Intervention||16
11274087|NCT02345811|12469677|FG000|COMPLETED|Second Intervention||16
11274088|NCT02345811|12469678|FG001|COMPLETED|Second Intervention||16
11274089|NCT02345811|12469677|FG000|NOT COMPLETED|Second Intervention||0
11274090|NCT02345811|12469678|FG001|NOT COMPLETED|Second Intervention||0
11274091|NCT02345889|12469690|FG000|STARTED|Overall Study||316
11274092|NCT02345889|12469691|FG001|STARTED|Overall Study||316
11274093|NCT02345889|12469692|FG002|STARTED|Overall Study||315
11274094|NCT02345889|12469693|FG003|STARTED|Overall Study||315
11274095|NCT02345889|12469690|FG000|COMPLETED|Overall Study||295
11274096|NCT02345889|12469691|FG001|COMPLETED|Overall Study||299
11274097|NCT02345889|12469692|FG002|COMPLETED|Overall Study||295
11274098|NCT02345889|12469693|FG003|COMPLETED|Overall Study||299
11274099|NCT02345889|12469690|FG000|NOT COMPLETED|Overall Study||21
11274100|NCT02345889|12469691|FG001|NOT COMPLETED|Overall Study||17
11274101|NCT02345889|12469692|FG002|NOT COMPLETED|Overall Study||20
11274102|NCT02345889|12469693|FG003|NOT COMPLETED|Overall Study||16
11274103|NCT02346136|12469705|FG000|STARTED|Overall Study||93
11274104|NCT02346136|12469706|FG001|STARTED|Overall Study||87
11274105|NCT02346136|12469705|FG000|COMPLETED|Overall Study||71
11274106|NCT02346136|12469706|FG001|COMPLETED|Overall Study||64
11274107|NCT02346136|12469705|FG000|NOT COMPLETED|Overall Study||22
11274108|NCT02346136|12469706|FG001|NOT COMPLETED|Overall Study||23
11274109|NCT02346240|12469716|FG000|STARTED|Initial Period (Baseline to Week 16)||57
11274110|NCT02346240|12469717|FG001|STARTED|Initial Period (Baseline to Week 16)||170
11274111|NCT02346240|12469718|FG002|STARTED|Initial Period (Baseline to Week 16)||165
11274112|NCT02346240|12469719|FG003|STARTED|Initial Period (Baseline to Week 16)||167
11274113|NCT02346240|12469720|FG004|STARTED|Initial Period (Baseline to Week 16)||0
11274114|NCT02346240|12469721|FG005|STARTED|Initial Period (Baseline to Week 16)||0
11274115|NCT02346240|12469722|FG006|STARTED|Initial Period (Baseline to Week 16)||0
11274116|NCT02346240|12469723|FG007|STARTED|Initial Period (Baseline to Week 16)||0
11274117|NCT02346240|12469724|FG008|STARTED|Initial Period (Baseline to Week 16)||0
11274118|NCT02346240|12469725|FG009|STARTED|Initial Period (Baseline to Week 16)||0
11274119|NCT02346240|12469726|FG010|STARTED|Initial Period (Baseline to Week 16)||0
11274120|NCT02346240|12469727|FG011|STARTED|Initial Period (Baseline to Week 16)||0
11274121|NCT02346240|12469728|FG012|STARTED|Initial Period (Baseline to Week 16)||0
11274122|NCT02346240|12469729|FG013|STARTED|Initial Period (Baseline to Week 16)||0
11274123|NCT02346240|12469730|FG014|STARTED|Initial Period (Baseline to Week 16)||0
11274124|NCT02346240|12469731|FG015|STARTED|Initial Period (Baseline to Week 16)||0
11274125|NCT02346240|12469732|FG016|STARTED|Initial Period (Baseline to Week 16)||0
11274126|NCT02346240|12469733|FG017|STARTED|Initial Period (Baseline to Week 16)||0
11274127|NCT02346240|12469734|FG018|STARTED|Initial Period (Baseline to Week 16)||0
11274128|NCT02346240|12469735|FG019|STARTED|Initial Period (Baseline to Week 16)||0
11274129|NCT02346240|12469736|FG020|STARTED|Initial Period (Baseline to Week 16)||0
11274130|NCT02346240|12469737|FG021|STARTED|Initial Period (Baseline to Week 16)||0
11274131|NCT02346240|12469738|FG022|STARTED|Initial Period (Baseline to Week 16)||0
11274132|NCT02346240|12469739|FG023|STARTED|Initial Period (Baseline to Week 16)||0
11274133|NCT02346240|12469716|FG000|Completed Week 16|Initial Period (Baseline to Week 16)||55
11274134|NCT02346240|12469717|FG001|Completed Week 16|Initial Period (Baseline to Week 16)||159
11274135|NCT02346240|12469718|FG002|Completed Week 16|Initial Period (Baseline to Week 16)||159
11274136|NCT02346240|12469719|FG003|Completed Week 16|Initial Period (Baseline to Week 16)||162
11274137|NCT02346240|12469720|FG004|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274138|NCT02346240|12469721|FG005|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274139|NCT02346240|12469722|FG006|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274140|NCT02346240|12469723|FG007|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274141|NCT02346240|12469724|FG008|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274142|NCT02346240|12469725|FG009|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274143|NCT02346240|12469726|FG010|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274144|NCT02346240|12469727|FG011|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274145|NCT02346240|12469728|FG012|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274146|NCT02346240|12469729|FG013|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274147|NCT02346240|12469730|FG014|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274148|NCT02346240|12469731|FG015|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274149|NCT02346240|12469732|FG016|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274150|NCT02346240|12469733|FG017|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274151|NCT02346240|12469734|FG018|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274152|NCT02346240|12469735|FG019|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274153|NCT02346240|12469736|FG020|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274154|NCT02346240|12469737|FG021|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274155|NCT02346240|12469738|FG022|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274156|NCT02346240|12469739|FG023|Completed Week 16|Initial Period (Baseline to Week 16)||0
11274157|NCT02346240|12469716|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
11274158|NCT02346240|12469717|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
11274159|NCT02346240|12469718|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
11274160|NCT02346240|12469719|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
11274161|NCT02346240|12469720|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274162|NCT02346240|12469721|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274163|NCT02346240|12469722|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274164|NCT02346240|12469723|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274165|NCT02346240|12469724|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274166|NCT02346240|12469725|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274167|NCT02346240|12469726|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274168|NCT02346240|12469727|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274169|NCT02346240|12469728|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274170|NCT02346240|12469729|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274171|NCT02346240|12469730|FG014|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274172|NCT02346240|12469731|FG015|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274173|NCT02346240|12469732|FG016|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274174|NCT02346240|12469733|FG017|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274175|NCT02346240|12469734|FG018|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274176|NCT02346240|12469735|FG019|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274177|NCT02346240|12469736|FG020|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274178|NCT02346240|12469737|FG021|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274179|NCT02346240|12469738|FG022|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274180|NCT02346240|12469739|FG023|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
11274181|NCT02346240|12469716|FG000|COMPLETED|Initial Period (Baseline to Week 16)||55
11274182|NCT02346240|12469717|FG001|COMPLETED|Initial Period (Baseline to Week 16)||159
11274183|NCT02346240|12469718|FG002|COMPLETED|Initial Period (Baseline to Week 16)||159
11274184|NCT02346240|12469719|FG003|COMPLETED|Initial Period (Baseline to Week 16)||160
11274185|NCT02346240|12469720|FG004|COMPLETED|Initial Period (Baseline to Week 16)||0
11274186|NCT02346240|12469721|FG005|COMPLETED|Initial Period (Baseline to Week 16)||0
11398151|NCT04512482|12592501|FG001|Baseline Photographs|Second Intervention (1 Day)||20
11398152|NCT04512482|12592500|FG000|Received Intervention|Second Intervention (1 Day)||22
11398153|NCT04512482|12592501|FG001|Received Intervention|Second Intervention (1 Day)||20
11398154|NCT04512482|12592500|FG000|Post-rinse Photographs|Second Intervention (1 Day)||22
11398155|NCT04512482|12592501|FG001|Post-rinse Photographs|Second Intervention (1 Day)||20
11398156|NCT04512482|12592500|FG000|Toothbrush Utilization|Second Intervention (1 Day)||22
11398157|NCT04512482|12592501|FG001|Toothbrush Utilization|Second Intervention (1 Day)||20
11398158|NCT04512482|12592500|FG000|Post-toothbrush Photographs|Second Intervention (1 Day)||22
11398159|NCT04512482|12592501|FG001|Post-toothbrush Photographs|Second Intervention (1 Day)||20
11398160|NCT04512482|12592500|FG000|Waterpik Utilization|Second Intervention (1 Day)||22
11398161|NCT04512482|12592501|FG001|Waterpik Utilization|Second Intervention (1 Day)||20
11398162|NCT04512482|12592500|FG000|Post-Waterpik Photographs|Second Intervention (1 Day)||22
11398163|NCT04512482|12592501|FG001|Post-Waterpik Photographs|Second Intervention (1 Day)||20
11398164|NCT04512482|12592500|FG000|COMPLETED|Second Intervention (1 Day)||22
11398165|NCT04512482|12592501|FG001|COMPLETED|Second Intervention (1 Day)||20
11398166|NCT04512482|12592500|FG000|NOT COMPLETED|Second Intervention (1 Day)||2
11398167|NCT04512482|12592501|FG001|NOT COMPLETED|Second Intervention (1 Day)||1
11398168|NCT04499599|12592510|FG000|STARTED|Overall Study||35
11398169|NCT04499599|12592511|FG001|STARTED|Overall Study||35
11398170|NCT04499599|12592512|FG002|STARTED|Overall Study||35
11398171|NCT04499599|12592510|FG000|COMPLETED|Overall Study||35
11398172|NCT04499599|12592511|FG001|COMPLETED|Overall Study||35
11398173|NCT04499599|12592512|FG002|COMPLETED|Overall Study||35
11398174|NCT04499599|12592510|FG000|NOT COMPLETED|Overall Study||0
11398175|NCT04499599|12592511|FG001|NOT COMPLETED|Overall Study||0
11274187|NCT02346240|12469722|FG006|COMPLETED|Initial Period (Baseline to Week 16)||0
11274188|NCT02346240|12469723|FG007|COMPLETED|Initial Period (Baseline to Week 16)||0
11274189|NCT02346240|12469724|FG008|COMPLETED|Initial Period (Baseline to Week 16)||0
11274190|NCT02346240|12469725|FG009|COMPLETED|Initial Period (Baseline to Week 16)||0
11274191|NCT02346240|12469726|FG010|COMPLETED|Initial Period (Baseline to Week 16)||0
11274192|NCT02346240|12469727|FG011|COMPLETED|Initial Period (Baseline to Week 16)||0
11274193|NCT02346240|12469728|FG012|COMPLETED|Initial Period (Baseline to Week 16)||0
11274194|NCT02346240|12469729|FG013|COMPLETED|Initial Period (Baseline to Week 16)||0
11274195|NCT02346240|12469730|FG014|COMPLETED|Initial Period (Baseline to Week 16)||0
11274196|NCT02346240|12469731|FG015|COMPLETED|Initial Period (Baseline to Week 16)||0
11274197|NCT02346240|12469732|FG016|COMPLETED|Initial Period (Baseline to Week 16)||0
11274198|NCT02346240|12469733|FG017|COMPLETED|Initial Period (Baseline to Week 16)||0
11274199|NCT02346240|12469734|FG018|COMPLETED|Initial Period (Baseline to Week 16)||0
11274200|NCT02346240|12469735|FG019|COMPLETED|Initial Period (Baseline to Week 16)||0
11274201|NCT02346240|12469736|FG020|COMPLETED|Initial Period (Baseline to Week 16)||0
11274202|NCT02346240|12469737|FG021|COMPLETED|Initial Period (Baseline to Week 16)||0
11274203|NCT02346240|12469738|FG022|COMPLETED|Initial Period (Baseline to Week 16)||0
11274204|NCT02346240|12469739|FG023|COMPLETED|Initial Period (Baseline to Week 16)||0
11274205|NCT02346240|12469716|FG000|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
11274206|NCT02346240|12469717|FG001|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
11274207|NCT02346240|12469718|FG002|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
11274208|NCT02346240|12469719|FG003|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
11274209|NCT02346240|12469720|FG004|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274210|NCT02346240|12469721|FG005|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274211|NCT02346240|12469722|FG006|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11398176|NCT04499599|12592512|FG002|NOT COMPLETED|Overall Study||0
11398177|NCT04525157|12592520|FG000|STARTED|Overall Study||18
11398178|NCT04525157|12592520|FG000|COMPLETED|Overall Study||15
11398179|NCT04525157|12592520|FG000|NOT COMPLETED|Overall Study||3
11398180|NCT04523831|12592526|FG000|STARTED|Overall Study||200
11398181|NCT04523831|12592527|FG001|STARTED|Overall Study||200
11274212|NCT02346240|12469723|FG007|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274213|NCT02346240|12469724|FG008|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274214|NCT02346240|12469725|FG009|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274215|NCT02346240|12469726|FG010|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274216|NCT02346240|12469727|FG011|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274217|NCT02346240|12469728|FG012|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274218|NCT02346240|12469729|FG013|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274219|NCT02346240|12469730|FG014|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274220|NCT02346240|12469731|FG015|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274221|NCT02346240|12469732|FG016|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274222|NCT02346240|12469733|FG017|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274223|NCT02346240|12469734|FG018|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274224|NCT02346240|12469735|FG019|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274225|NCT02346240|12469736|FG020|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274226|NCT02346240|12469737|FG021|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274227|NCT02346240|12469738|FG022|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274228|NCT02346240|12469739|FG023|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
11274229|NCT02346240|12469716|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
11274230|NCT02346240|12469717|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
11274231|NCT02346240|12469718|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
11274232|NCT02346240|12469719|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||0
11274233|NCT02346240|12469720|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||2
11274234|NCT02346240|12469721|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||24
11274235|NCT02346240|12469722|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||50
11274236|NCT02346240|12469723|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||22
11274237|NCT02346240|12469724|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||44
11274238|NCT02346240|12469725|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||44
11274239|NCT02346240|12469726|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||25
11274240|NCT02346240|12469727|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||50
11398182|NCT04523831|12592526|FG000|COMPLETED|Overall Study||183
11274241|NCT02346240|12469728|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||49
11398183|NCT04523831|12592527|FG001|COMPLETED|Overall Study||180
11398184|NCT04523831|12592526|FG000|NOT COMPLETED|Overall Study||17
11398185|NCT04523831|12592527|FG001|NOT COMPLETED|Overall Study||20
11274242|NCT02346240|12469729|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||53
11274243|NCT02346240|12469730|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||85
11274244|NCT02346240|12469731|FG015|STARTED|Maintenance Period (Week 16 to Week 48)||49
11398186|NCT04521777|12592536|FG000|STARTED|Overall Study||24
11398187|NCT04521777|12592536|FG000|COMPLETED|Overall Study||20
11398188|NCT04521777|12592536|FG000|NOT COMPLETED|Overall Study||4
11274245|NCT02346240|12469732|FG016|STARTED|Maintenance Period (Week 16 to Week 48)||36
11274246|NCT02346240|12469733|FG017|STARTED|Maintenance Period (Week 16 to Week 48)||0
11274247|NCT02346240|12469734|FG018|STARTED|Maintenance Period (Week 16 to Week 48)||0
11274248|NCT02346240|12469735|FG019|STARTED|Maintenance Period (Week 16 to Week 48)||0
11274249|NCT02346240|12469736|FG020|STARTED|Maintenance Period (Week 16 to Week 48)||0
11274250|NCT02346240|12469737|FG021|STARTED|Maintenance Period (Week 16 to Week 48)||0
11274251|NCT02346240|12469738|FG022|STARTED|Maintenance Period (Week 16 to Week 48)||0
11274252|NCT02346240|12469739|FG023|STARTED|Maintenance Period (Week 16 to Week 48)||0
11274253|NCT02346240|12469716|FG000|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
11274254|NCT02346240|12469717|FG001|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
11274255|NCT02346240|12469718|FG002|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
11274256|NCT02346240|12469719|FG003|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
11274257|NCT02346240|12469720|FG004|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||2
11274258|NCT02346240|12469721|FG005|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
11274259|NCT02346240|12469722|FG006|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||48
11274260|NCT02346240|12469723|FG007|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||20
11274261|NCT02346240|12469724|FG008|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||40
11274262|NCT02346240|12469725|FG009|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||43
11274263|NCT02346240|12469726|FG010|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
11274264|NCT02346240|12469727|FG011|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||47
11274265|NCT02346240|12469728|FG012|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||49
11274266|NCT02346240|12469729|FG013|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||46
11274267|NCT02346240|12469730|FG014|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||71
11274268|NCT02346240|12469731|FG015|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||36
11274269|NCT02346240|12469732|FG016|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||30
11274270|NCT02346240|12469733|FG017|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
11274271|NCT02346240|12469734|FG018|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
11274272|NCT02346240|12469735|FG019|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
11274273|NCT02346240|12469736|FG020|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
11274274|NCT02346240|12469737|FG021|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
11274275|NCT02346240|12469738|FG022|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
11274276|NCT02346240|12469739|FG023|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
11274277|NCT02346240|12469716|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11274278|NCT02346240|12469717|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11274279|NCT02346240|12469718|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11274280|NCT02346240|12469719|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11274281|NCT02346240|12469720|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||2
11274282|NCT02346240|12469721|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
11274283|NCT02346240|12469722|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||48
11274284|NCT02346240|12469723|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||20
11274285|NCT02346240|12469724|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||40
11274286|NCT02346240|12469725|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||43
11274287|NCT02346240|12469726|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
11274288|NCT02346240|12469727|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||47
11274289|NCT02346240|12469728|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||49
11274290|NCT02346240|12469729|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||45
11274291|NCT02346240|12469730|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||68
11274292|NCT02346240|12469731|FG015|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||35
11274293|NCT02346240|12469732|FG016|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||29
11274294|NCT02346240|12469733|FG017|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11274295|NCT02346240|12469734|FG018|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11274296|NCT02346240|12469735|FG019|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11274297|NCT02346240|12469736|FG020|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11274298|NCT02346240|12469737|FG021|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11274299|NCT02346240|12469738|FG022|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11274300|NCT02346240|12469739|FG023|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
11274301|NCT02346240|12469716|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274302|NCT02346240|12469717|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274303|NCT02346240|12469718|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274304|NCT02346240|12469719|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274305|NCT02346240|12469720|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||2
11274306|NCT02346240|12469721|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
11274307|NCT02346240|12469722|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||48
11274308|NCT02346240|12469723|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||20
11274309|NCT02346240|12469724|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||40
11274310|NCT02346240|12469725|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||43
11274311|NCT02346240|12469726|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
11274312|NCT02346240|12469727|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||47
11274313|NCT02346240|12469728|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||49
11274314|NCT02346240|12469729|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|45
11274315|NCT02346240|12469730|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)|3 subjects completed the Maintenance Period but did not enter the Open-Label Period.|68
11274316|NCT02346240|12469731|FG015|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|35
11274317|NCT02346240|12469732|FG016|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|29
11274318|NCT02346240|12469733|FG017|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274319|NCT02346240|12469734|FG018|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274320|NCT02346240|12469735|FG019|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274321|NCT02346240|12469736|FG020|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274322|NCT02346240|12469737|FG021|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274323|NCT02346240|12469738|FG022|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274324|NCT02346240|12469739|FG023|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274325|NCT02346240|12469716|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274326|NCT02346240|12469717|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274327|NCT02346240|12469718|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274328|NCT02346240|12469719|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274329|NCT02346240|12469720|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274330|NCT02346240|12469721|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
11274331|NCT02346240|12469722|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
11274332|NCT02346240|12469723|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
11274333|NCT02346240|12469724|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||4
11274334|NCT02346240|12469725|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
11274335|NCT02346240|12469726|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
11274336|NCT02346240|12469727|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||3
11274337|NCT02346240|12469728|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274338|NCT02346240|12469729|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8
11274339|NCT02346240|12469730|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||17
11274340|NCT02346240|12469731|FG015|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||14
11274341|NCT02346240|12469732|FG016|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
11274342|NCT02346240|12469733|FG017|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274343|NCT02346240|12469734|FG018|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274344|NCT02346240|12469735|FG019|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274345|NCT02346240|12469736|FG020|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274346|NCT02346240|12469737|FG021|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274347|NCT02346240|12469738|FG022|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274348|NCT02346240|12469739|FG023|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
11274349|NCT02346240|12469716|FG000|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274350|NCT02346240|12469717|FG001|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274351|NCT02346240|12469718|FG002|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274352|NCT02346240|12469719|FG003|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274353|NCT02346240|12469720|FG004|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274354|NCT02346240|12469721|FG005|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274355|NCT02346240|12469722|FG006|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274356|NCT02346240|12469723|FG007|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274357|NCT02346240|12469724|FG008|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274358|NCT02346240|12469725|FG009|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274359|NCT02346240|12469726|FG010|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274360|NCT02346240|12469727|FG011|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274361|NCT02346240|12469728|FG012|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274362|NCT02346240|12469729|FG013|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274363|NCT02346240|12469730|FG014|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274364|NCT02346240|12469731|FG015|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274365|NCT02346240|12469732|FG016|STARTED|Open-Label Period (Week 48 to Week 144)||0
11274366|NCT02346240|12469733|FG017|STARTED|Open-Label Period (Week 48 to Week 144)||34
11274367|NCT02346240|12469734|FG018|STARTED|Open-Label Period (Week 48 to Week 144)||122
11274368|NCT02346240|12469735|FG019|STARTED|Open-Label Period (Week 48 to Week 144)||41
11274369|NCT02346240|12469736|FG020|STARTED|Open-Label Period (Week 48 to Week 144)||48
11274370|NCT02346240|12469737|FG021|STARTED|Open-Label Period (Week 48 to Week 144)||177
11274371|NCT02346240|12469738|FG022|STARTED|Open-Label Period (Week 48 to Week 144)||34
11274372|NCT02346240|12469739|FG023|STARTED|Open-Label Period (Week 48 to Week 144)||16
11274373|NCT02346240|12469716|FG000|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274374|NCT02346240|12469717|FG001|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274375|NCT02346240|12469718|FG002|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274376|NCT02346240|12469719|FG003|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274377|NCT02346240|12469720|FG004|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274378|NCT02346240|12469721|FG005|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274379|NCT02346240|12469722|FG006|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274380|NCT02346240|12469723|FG007|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274381|NCT02346240|12469724|FG008|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274382|NCT02346240|12469725|FG009|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274383|NCT02346240|12469726|FG010|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274384|NCT02346240|12469727|FG011|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274385|NCT02346240|12469728|FG012|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274386|NCT02346240|12469729|FG013|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274387|NCT02346240|12469730|FG014|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274388|NCT02346240|12469731|FG015|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274389|NCT02346240|12469732|FG016|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274390|NCT02346240|12469733|FG017|COMPLETED|Open-Label Period (Week 48 to Week 144)||31
11274391|NCT02346240|12469734|FG018|COMPLETED|Open-Label Period (Week 48 to Week 144)||105
11274392|NCT02346240|12469735|FG019|COMPLETED|Open-Label Period (Week 48 to Week 144)||34
11274393|NCT02346240|12469736|FG020|COMPLETED|Open-Label Period (Week 48 to Week 144)||45
11274394|NCT02346240|12469737|FG021|COMPLETED|Open-Label Period (Week 48 to Week 144)||146
11274395|NCT02346240|12469738|FG022|COMPLETED|Open-Label Period (Week 48 to Week 144)||27
11274396|NCT02346240|12469739|FG023|COMPLETED|Open-Label Period (Week 48 to Week 144)||8
11274397|NCT02346240|12469716|FG000|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274398|NCT02346240|12469717|FG001|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274399|NCT02346240|12469718|FG002|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274400|NCT02346240|12469719|FG003|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274401|NCT02346240|12469720|FG004|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274402|NCT02346240|12469721|FG005|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274403|NCT02346240|12469722|FG006|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274404|NCT02346240|12469723|FG007|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274405|NCT02346240|12469724|FG008|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274406|NCT02346240|12469725|FG009|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274407|NCT02346240|12469726|FG010|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274408|NCT02346240|12469727|FG011|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274409|NCT02346240|12469728|FG012|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274410|NCT02346240|12469729|FG013|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274411|NCT02346240|12469730|FG014|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274412|NCT02346240|12469731|FG015|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274413|NCT02346240|12469732|FG016|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
11274414|NCT02346240|12469733|FG017|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
11021669|NCT00805467|12199813|FG001|NOT COMPLETED|Overall Study||34
11021670|NCT00805467|12199814|FG002|NOT COMPLETED|Overall Study||103
11021671|NCT00805467|12199815|FG003|NOT COMPLETED|Overall Study||237
11021672|NCT00805480|12199829|FG000|STARTED|Overall Study||30
11021673|NCT00805480|12199830|FG001|STARTED|Overall Study||29
11021674|NCT00805480|12199831|FG002|STARTED|Overall Study||31
11274415|NCT02346240|12469734|FG018|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||17
11274416|NCT02346240|12469735|FG019|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
11274417|NCT02346240|12469736|FG020|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
11274418|NCT02346240|12469737|FG021|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||31
11274419|NCT02346240|12469738|FG022|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
11274420|NCT02346240|12469739|FG023|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||8
11274421|NCT02346370|12469764|FG000|STARTED|Overall Study||8
11274422|NCT02346370|12469765|FG001|STARTED|Overall Study||4
11274423|NCT02346370|12469766|FG002|STARTED|Overall Study||4
11274424|NCT02346370|12469764|FG000|COMPLETED|Overall Study||0
11274425|NCT02346370|12469765|FG001|COMPLETED|Overall Study||0
11274426|NCT02346370|12469766|FG002|COMPLETED|Overall Study||0
11274427|NCT02346370|12469764|FG000|NOT COMPLETED|Overall Study||8
11274428|NCT02346370|12469765|FG001|NOT COMPLETED|Overall Study||4
11274429|NCT02346370|12469766|FG002|NOT COMPLETED|Overall Study||4
11274430|NCT02346383|12469776|FG000|STARTED|Overall Study||40
11274431|NCT02346383|12469776|FG000|COMPLETED|Overall Study||40
11274432|NCT02346383|12469776|FG000|NOT COMPLETED|Overall Study||0
11274433|NCT02346461|12469786|FG000|STARTED|Overall Study||6
11274434|NCT02346461|12469787|FG001|STARTED|Overall Study||6
11274435|NCT02346461|12469786|FG000|COMPLETED|Overall Study||6
11274436|NCT02346461|12469787|FG001|COMPLETED|Overall Study||6
11274437|NCT02346461|12469786|FG000|NOT COMPLETED|Overall Study||0
11274438|NCT02346461|12469787|FG001|NOT COMPLETED|Overall Study||0
11274439|NCT02346643|12469794|FG000|STARTED|Overall Study||41
11274440|NCT02346643|12469794|FG000|Received Trial System|Overall Study||29
11274441|NCT02346643|12469794|FG000|Received Permanent System|Overall Study||31
11274442|NCT02346643|12469794|FG000|COMPLETED|Overall Study||6
11274443|NCT02346643|12469794|FG000|NOT COMPLETED|Overall Study||35
11274444|NCT02346708|12469800|FG000|STARTED|Overall Study||24
11274445|NCT02346708|12469801|FG001|STARTED|Overall Study||25
11274446|NCT02346708|12469800|FG000|COMPLETED|Overall Study||22
11274447|NCT02346708|12469801|FG001|COMPLETED|Overall Study||24
11274448|NCT02346708|12469800|FG000|NOT COMPLETED|Overall Study||2
11274449|NCT02346708|12469801|FG001|NOT COMPLETED|Overall Study||1
11274450|NCT02346721|12469808|FG000|STARTED|Overall Study||111
11274451|NCT02346721|12469808|FG000|COMPLETED|Overall Study||107
11274452|NCT02346721|12469808|FG000|NOT COMPLETED|Overall Study||4
11274453|NCT02346903|12469814|FG000|STARTED|Overall Study||99
11274454|NCT02346903|12469814|FG000|COMPLETED|Overall Study||99
11274455|NCT02346903|12469814|FG000|NOT COMPLETED|Overall Study||0
11274456|NCT02346916|12469818|FG000|STARTED|Overall Study||20
11274457|NCT02346916|12469818|FG000|COMPLETED|Overall Study||20
11274458|NCT02346916|12469818|FG000|NOT COMPLETED|Overall Study||0
11274459|NCT02347072|12469822|FG000|STARTED|Overall Study||80
11274460|NCT02347072|12469822|FG000|GFF MDI 14.4/9.6 µg|Overall Study||75
11274461|NCT02347072|12469822|FG000|Placebo MDI|Overall Study||72
11274462|NCT02347072|12469822|FG000|Spiriva Respimat 5 µg|Overall Study||73
11274463|NCT02347072|12469822|FG000|COMPLETED|Overall Study||62
11274464|NCT02347072|12469822|FG000|NOT COMPLETED|Overall Study||18
11274465|NCT02347085|12469830|FG000|STARTED|Overall Study||43
11274466|NCT02347085|12469830|FG000|GFF MDI 14.4/9.6 µg|Overall Study||40
11274467|NCT02347085|12469830|FG000|Placebo MDI|Overall Study||40
11274468|NCT02347085|12469830|FG000|COMPLETED|Overall Study||33
11274469|NCT02347085|12469830|FG000|NOT COMPLETED|Overall Study||10
11274470|NCT02347098|12469838|FG000|STARTED|Overall Study||63
11274471|NCT02347098|12469839|FG001|STARTED|Overall Study||66
11274472|NCT02347098|12469838|FG000|COMPLETED|Overall Study||56
11274473|NCT02347098|12469839|FG001|COMPLETED|Overall Study||58
11274474|NCT02347098|12469838|FG000|NOT COMPLETED|Overall Study||7
11274475|NCT02347098|12469839|FG001|NOT COMPLETED|Overall Study||8
11274476|NCT02347124|12469847|FG000|STARTED|Overall Study||360
11274477|NCT02347124|12469848|FG001|STARTED|Overall Study||358
11274478|NCT02347124|12469847|FG000|2 Month Follow-up|Overall Study||298
11274479|NCT02347124|12469848|FG001|2 Month Follow-up|Overall Study||275
11274480|NCT02347124|12469847|FG000|COMPLETED|Overall Study||267
11274481|NCT02347124|12469848|FG001|COMPLETED|Overall Study||259
11274482|NCT02347124|12469847|FG000|NOT COMPLETED|Overall Study||93
11274483|NCT02347124|12469848|FG001|NOT COMPLETED|Overall Study||99
11274484|NCT02347176|12469858|FG000|STARTED|Overall Study||51
11274485|NCT02347176|12469859|FG001|STARTED|Overall Study||50
11274486|NCT02347176|12469860|FG002|STARTED|Overall Study||51
11274487|NCT02347176|12469861|FG003|STARTED|Overall Study||52
11274488|NCT02347176|12469858|FG000|COMPLETED|Overall Study||39
11274489|NCT02347176|12469859|FG001|COMPLETED|Overall Study||40
11274490|NCT02347176|12469860|FG002|COMPLETED|Overall Study||43
11274491|NCT02347176|12469861|FG003|COMPLETED|Overall Study||48
11274492|NCT02347176|12469858|FG000|NOT COMPLETED|Overall Study||12
11274493|NCT02347176|12469859|FG001|NOT COMPLETED|Overall Study||10
11274494|NCT02347176|12469860|FG002|NOT COMPLETED|Overall Study||8
11274495|NCT02347176|12469861|FG003|NOT COMPLETED|Overall Study||4
11274496|NCT02347189|12469871|FG000|STARTED|Overall Study||39
11274497|NCT02347189|12469871|FG000|Catheterized|Overall Study||39
11274498|NCT02347189|12469871|FG000|Implanted|Overall Study||30
11274499|NCT02347189|12469871|FG000|Implanted > 24 Hours|Overall Study||30
11274500|NCT02347189|12469871|FG000|COMPLETED|Overall Study||28
11274501|NCT02347189|12469871|FG000|NOT COMPLETED|Overall Study||11
11274502|NCT02347332|12469888|FG000|STARTED|Overall Study||230
11274503|NCT02347332|12469889|FG001|STARTED|Overall Study||229
11274504|NCT02347332|12469888|FG000|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0
11274505|NCT02347332|12469889|FG001|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0
11274506|NCT02347332|12469888|FG000|NOT COMPLETED|Overall Study||230
11274507|NCT02347332|12469889|FG001|NOT COMPLETED|Overall Study||229
11274508|NCT02347345|12469898|FG000|STARTED|Overall Study||10
11274509|NCT02347345|12469899|FG001|STARTED|Overall Study||12
11274510|NCT02347345|12469900|FG002|STARTED|Overall Study||12
11274511|NCT02347345|12469898|FG000|COMPLETED|Overall Study||10
11274512|NCT02347345|12469899|FG001|COMPLETED|Overall Study||12
11274513|NCT02347345|12469900|FG002|COMPLETED|Overall Study||12
11274514|NCT02347345|12469898|FG000|NOT COMPLETED|Overall Study||0
11274515|NCT02347345|12469899|FG001|NOT COMPLETED|Overall Study||0
11274516|NCT02347345|12469900|FG002|NOT COMPLETED|Overall Study||0
11274517|NCT02347410|12469911|FG000|STARTED|Overall Study||102
11274518|NCT02347410|12469911|FG000|COMPLETED|Overall Study||98
11274519|NCT02347410|12469911|FG000|NOT COMPLETED|Overall Study||4
11274520|NCT02347488|12469921|FG000|STARTED|Overall Study||30
11274521|NCT02347488|12469921|FG000|COMPLETED|Overall Study||30
11274522|NCT02347488|12469921|FG000|NOT COMPLETED|Overall Study||0
11274523|NCT02347605|12469933|FG000|STARTED|Overall Study||10
11274524|NCT02347605|12469934|FG001|STARTED|Overall Study||10
11274525|NCT02347605|12469935|FG002|STARTED|Overall Study||8
11274526|NCT02347605|12469936|FG003|STARTED|Overall Study||10
11274527|NCT02347605|12469937|FG004|STARTED|Overall Study||9
11274528|NCT02347605|12469938|FG005|STARTED|Overall Study||9
11274529|NCT02347605|12469933|FG000|Completed Lab 1|Overall Study||10
11274530|NCT02347605|12469934|FG001|Completed Lab 1|Overall Study||10
11274531|NCT02347605|12469935|FG002|Completed Lab 1|Overall Study||8
11274532|NCT02347605|12469936|FG003|Completed Lab 1|Overall Study||10
11274533|NCT02347605|12469937|FG004|Completed Lab 1|Overall Study||8
11274534|NCT02347605|12469938|FG005|Completed Lab 1|Overall Study||9
11274535|NCT02347605|12469933|FG000|Completed Lab 2|Overall Study||7
11274536|NCT02347605|12469934|FG001|Completed Lab 2|Overall Study||7
11274537|NCT02347605|12469935|FG002|Completed Lab 2|Overall Study||7
11274538|NCT02347605|12469936|FG003|Completed Lab 2|Overall Study||7
11398189|NCT04512703|12592542|FG000|STARTED|Within 7 Days From Start of Device Wear||6
11398190|NCT04512703|12592543|FG001|STARTED|Within 7 Days From Start of Device Wear||45
11398191|NCT04512703|12592542|FG000|Wore Front Position|Within 7 Days From Start of Device Wear||6
11398192|NCT04512703|12592543|FG001|Wore Front Position|Within 7 Days From Start of Device Wear||45
11398193|NCT04512703|12592542|FG000|Wore Side Position|Within 7 Days From Start of Device Wear||6
11398194|NCT04512703|12592543|FG001|Wore Side Position|Within 7 Days From Start of Device Wear||45
11398195|NCT04512703|12592542|FG000|COMPLETED|Within 7 Days From Start of Device Wear||6
11398196|NCT04512703|12592543|FG001|COMPLETED|Within 7 Days From Start of Device Wear||45
11274539|NCT02347605|12469937|FG004|Completed Lab 2|Overall Study||6
11274540|NCT02347605|12469938|FG005|Completed Lab 2|Overall Study||8
11274541|NCT02347605|12469933|FG000|COMPLETED|Overall Study||7
11274542|NCT02347605|12469934|FG001|COMPLETED|Overall Study||7
11274543|NCT02347605|12469935|FG002|COMPLETED|Overall Study||7
11274544|NCT02347605|12469936|FG003|COMPLETED|Overall Study||6
11274545|NCT02347605|12469937|FG004|COMPLETED|Overall Study||6
11274546|NCT02347605|12469938|FG005|COMPLETED|Overall Study||7
11274547|NCT02347605|12469933|FG000|NOT COMPLETED|Overall Study||3
11274548|NCT02347605|12469934|FG001|NOT COMPLETED|Overall Study||3
11274549|NCT02347605|12469935|FG002|NOT COMPLETED|Overall Study||1
11274550|NCT02347605|12469936|FG003|NOT COMPLETED|Overall Study||4
11274551|NCT02347605|12469937|FG004|NOT COMPLETED|Overall Study||3
11398197|NCT04512703|12592542|FG000|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
11398198|NCT04512703|12592543|FG001|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
11274552|NCT02347605|12469938|FG005|NOT COMPLETED|Overall Study||2
11274553|NCT02347631|12469948|FG000|STARTED|Washout 1 (1 Month)||61
11398199|NCT04512703|12592542|FG000|STARTED|Between 7th and 90th Day of Device Wear||6
11398200|NCT04512703|12592543|FG001|STARTED|Between 7th and 90th Day of Device Wear||45
11398201|NCT04512703|12592542|FG000|Wore Side Position Device|Between 7th and 90th Day of Device Wear||3
11398202|NCT04512703|12592543|FG001|Wore Side Position Device|Between 7th and 90th Day of Device Wear||23
11274554|NCT02347631|12469949|FG001|STARTED|Washout 1 (1 Month)||57
11274555|NCT02347631|12469948|FG000|COMPLETED|Washout 1 (1 Month)||61
11398203|NCT04512703|12592542|FG000|Wore Front Position Device|Between 7th and 90th Day of Device Wear||3
11398204|NCT04512703|12592543|FG001|Wore Front Position Device|Between 7th and 90th Day of Device Wear||22
11398205|NCT04512703|12592542|FG000|COMPLETED|Between 7th and 90th Day of Device Wear||6
11398206|NCT04512703|12592543|FG001|COMPLETED|Between 7th and 90th Day of Device Wear||45
11398207|NCT04512703|12592542|FG000|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
11398208|NCT04512703|12592543|FG001|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
11274556|NCT02347631|12469949|FG001|COMPLETED|Washout 1 (1 Month)||57
11274557|NCT02347631|12469948|FG000|NOT COMPLETED|Washout 1 (1 Month)||0
11274558|NCT02347631|12469949|FG001|NOT COMPLETED|Washout 1 (1 Month)||0
11274559|NCT02347631|12469948|FG000|STARTED|First Intervention (2 Months)||61
11274560|NCT02347631|12469949|FG001|STARTED|First Intervention (2 Months)||57
11274561|NCT02347631|12469948|FG000|COMPLETED|First Intervention (2 Months)||54
11274562|NCT02347631|12469949|FG001|COMPLETED|First Intervention (2 Months)||51
11274563|NCT02347631|12469948|FG000|NOT COMPLETED|First Intervention (2 Months)||7
11274564|NCT02347631|12469949|FG001|NOT COMPLETED|First Intervention (2 Months)||6
11274565|NCT02347631|12469948|FG000|STARTED|Washout 2 (1 Month)||54
11274566|NCT02347631|12469949|FG001|STARTED|Washout 2 (1 Month)||51
11274567|NCT02347631|12469948|FG000|COMPLETED|Washout 2 (1 Month)||52
11274568|NCT02347631|12469949|FG001|COMPLETED|Washout 2 (1 Month)||48
11274569|NCT02347631|12469948|FG000|NOT COMPLETED|Washout 2 (1 Month)||2
11274570|NCT02347631|12469949|FG001|NOT COMPLETED|Washout 2 (1 Month)||3
11274571|NCT02347631|12469948|FG000|STARTED|Second Intervention (2 Months)||52
11274572|NCT02347631|12469949|FG001|STARTED|Second Intervention (2 Months)||48
11274573|NCT02347631|12469948|FG000|COMPLETED|Second Intervention (2 Months)||39
11274574|NCT02347631|12469949|FG001|COMPLETED|Second Intervention (2 Months)||44
11274575|NCT02347631|12469948|FG000|NOT COMPLETED|Second Intervention (2 Months)||13
11274576|NCT02347631|12469949|FG001|NOT COMPLETED|Second Intervention (2 Months)||4
11274577|NCT02347657|12469959|FG000|STARTED|Overall Study||259
11274578|NCT02347657|12469960|FG001|STARTED|Overall Study||251
11274579|NCT02347657|12469959|FG000|Treated|Overall Study||258
11274580|NCT02347657|12469960|FG001|Treated|Overall Study||251
11274581|NCT02347657|12469959|FG000|COMPLETED|Overall Study||241
11274582|NCT02347657|12469960|FG001|COMPLETED|Overall Study||236
11274583|NCT02347657|12469959|FG000|NOT COMPLETED|Overall Study||18
11274584|NCT02347657|12469960|FG001|NOT COMPLETED|Overall Study||15
11274585|NCT02347761|12469970|FG000|STARTED|All Collected||218
11274586|NCT02347761|12469971|FG001|STARTED|All Collected||217
11274587|NCT02347761|12469972|FG002|STARTED|All Collected||218
11274588|NCT02347761|12469970|FG000|COMPLETED|All Collected||201
11274589|NCT02347761|12469971|FG001|COMPLETED|All Collected||203
11274590|NCT02347761|12469972|FG002|COMPLETED|All Collected||191
11274591|NCT02347761|12469970|FG000|NOT COMPLETED|All Collected||17
11274592|NCT02347761|12469971|FG001|NOT COMPLETED|All Collected||14
11274593|NCT02347761|12469972|FG002|NOT COMPLETED|All Collected||27
11274594|NCT02347761|12469970|FG000|STARTED|On Study Treatment||218
11274595|NCT02347761|12469971|FG001|STARTED|On Study Treatment||217
11274596|NCT02347761|12469972|FG002|STARTED|On Study Treatment||218
11274597|NCT02347761|12469970|FG000|COMPLETED|On Study Treatment||191
11274598|NCT02347761|12469971|FG001|COMPLETED|On Study Treatment||194
11274599|NCT02347761|12469972|FG002|COMPLETED|On Study Treatment||176
11274600|NCT02347761|12469970|FG000|NOT COMPLETED|On Study Treatment||27
11274601|NCT02347761|12469971|FG001|NOT COMPLETED|On Study Treatment||23
11274602|NCT02347761|12469972|FG002|NOT COMPLETED|On Study Treatment||42
11274603|NCT02347774|12469983|FG000|STARTED|Study Participation||214
11274604|NCT02347774|12469984|FG001|STARTED|Study Participation||214
11274605|NCT02347774|12469985|FG002|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
11274606|NCT02347774|12469983|FG000|COMPLETED|Study Participation||199
11274607|NCT02347774|12469984|FG001|COMPLETED|Study Participation||193
11274608|NCT02347774|12469985|FG002|COMPLETED|Study Participation||188
11274609|NCT02347774|12469983|FG000|NOT COMPLETED|Study Participation||15
11274610|NCT02347774|12469984|FG001|NOT COMPLETED|Study Participation||21
11274611|NCT02347774|12469985|FG002|NOT COMPLETED|Study Participation||25
11274612|NCT02347774|12469983|FG000|STARTED|On Study Treatment||214
11274613|NCT02347774|12469984|FG001|STARTED|On Study Treatment||214
11274614|NCT02347774|12469985|FG002|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
11274615|NCT02347774|12469983|FG000|COMPLETED|On Study Treatment||190
11274616|NCT02347774|12469984|FG001|COMPLETED|On Study Treatment||183
11274617|NCT02347774|12469985|FG002|COMPLETED|On Study Treatment||177
11274618|NCT02347774|12469983|FG000|NOT COMPLETED|On Study Treatment||24
11274619|NCT02347774|12469984|FG001|NOT COMPLETED|On Study Treatment||31
11274620|NCT02347774|12469985|FG002|NOT COMPLETED|On Study Treatment||36
11274621|NCT02347787|12469995|FG000|STARTED|6 Month Follow-Up||288
11274622|NCT02347787|12469996|FG001|STARTED|6 Month Follow-Up||304
11274623|NCT02347787|12469995|FG000|COMPLETED|6 Month Follow-Up||222
11274624|NCT02347787|12469996|FG001|COMPLETED|6 Month Follow-Up||248
11274625|NCT02347787|12469995|FG000|NOT COMPLETED|6 Month Follow-Up||66
11274626|NCT02347787|12469996|FG001|NOT COMPLETED|6 Month Follow-Up||56
11274627|NCT02347787|12469995|FG000|STARTED|9 Month Follow-Up||288
11274628|NCT02347787|12469996|FG001|STARTED|9 Month Follow-Up||304
11274629|NCT02347787|12469995|FG000|COMPLETED|9 Month Follow-Up||227
11274630|NCT02347787|12469996|FG001|COMPLETED|9 Month Follow-Up||233
11274631|NCT02347787|12469995|FG000|NOT COMPLETED|9 Month Follow-Up||61
11274632|NCT02347787|12469996|FG001|NOT COMPLETED|9 Month Follow-Up||71
11274633|NCT02347813|12470009|FG000|STARTED|First Intervention, 24 Weeks||6
11274634|NCT02347813|12470010|FG001|STARTED|First Intervention, 24 Weeks||6
11274635|NCT02347813|12470009|FG000|COMPLETED|First Intervention, 24 Weeks||4
11274636|NCT02347813|12470010|FG001|COMPLETED|First Intervention, 24 Weeks||4
11274637|NCT02347813|12470009|FG000|NOT COMPLETED|First Intervention, 24 Weeks||2
11274638|NCT02347813|12470010|FG001|NOT COMPLETED|First Intervention, 24 Weeks||2
11274639|NCT02347813|12470009|FG000|STARTED|Second Intervention, 24 Weeks||4
11274640|NCT02347813|12470010|FG001|STARTED|Second Intervention, 24 Weeks||4
11274641|NCT02347813|12470009|FG000|COMPLETED|Second Intervention, 24 Weeks||4
11274642|NCT02347813|12470010|FG001|COMPLETED|Second Intervention, 24 Weeks||4
11274643|NCT02347813|12470009|FG000|NOT COMPLETED|Second Intervention, 24 Weeks||0
11274644|NCT02347813|12470010|FG001|NOT COMPLETED|Second Intervention, 24 Weeks||0
11274645|NCT02348385|12470018|FG000|STARTED|Overall Study||24
11274646|NCT02348385|12470019|FG001|STARTED|Overall Study||25
11274647|NCT02348385|12470018|FG000|COMPLETED|Overall Study||24
11274648|NCT02348385|12470019|FG001|COMPLETED|Overall Study||25
11274649|NCT02348385|12470018|FG000|NOT COMPLETED|Overall Study||0
11274650|NCT02348385|12470019|FG001|NOT COMPLETED|Overall Study||0
11274651|NCT02348489|12470029|FG000|STARTED|Overall Study||408
11274652|NCT02348489|12470030|FG001|STARTED|Overall Study||407
11274653|NCT02348489|12470029|FG000|COMPLETED|Overall Study||55
11274654|NCT02348489|12470030|FG001|COMPLETED|Overall Study||40
11274655|NCT02348489|12470029|FG000|NOT COMPLETED|Overall Study||353
11274656|NCT02348489|12470030|FG001|NOT COMPLETED|Overall Study||367
11274657|NCT02348593|12470042|FG000|STARTED|Overall Study||59
11274658|NCT02348593|12470043|FG001|STARTED|Overall Study||59
11274659|NCT02348593|12470044|FG002|STARTED|Overall Study||59
11274660|NCT02348593|12470045|FG003|STARTED|Overall Study||59
11274661|NCT02348593|12470042|FG000|COMPLETED|Overall Study||49
11274662|NCT02348593|12470043|FG001|COMPLETED|Overall Study||51
11274663|NCT02348593|12470044|FG002|COMPLETED|Overall Study||43
11274664|NCT02348593|12470045|FG003|COMPLETED|Overall Study||52
11274665|NCT02348593|12470042|FG000|NOT COMPLETED|Overall Study||10
11274666|NCT02348593|12470043|FG001|NOT COMPLETED|Overall Study||8
11274667|NCT02348593|12470044|FG002|NOT COMPLETED|Overall Study||16
11274668|NCT02348593|12470045|FG003|NOT COMPLETED|Overall Study||7
11274669|NCT02348606|12470060|FG000|STARTED|Overall Study||58
11274670|NCT02348606|12470061|FG001|STARTED|Overall Study||62
11274671|NCT02348606|12470062|FG002|STARTED|Overall Study||117
11274672|NCT02348606|12470063|FG003|STARTED|Overall Study||118
11274673|NCT02348606|12470064|FG004|STARTED|Overall Study||119
11274674|NCT02348606|12470060|FG000|COMPLETED|Overall Study||49
11274675|NCT02348606|12470061|FG001|COMPLETED|Overall Study||54
11274676|NCT02348606|12470062|FG002|COMPLETED|Overall Study||106
11274677|NCT02348606|12470063|FG003|COMPLETED|Overall Study||94
11274678|NCT02348606|12470064|FG004|COMPLETED|Overall Study||101
11274679|NCT02348606|12470060|FG000|NOT COMPLETED|Overall Study||9
11274680|NCT02348606|12470061|FG001|NOT COMPLETED|Overall Study||8
11274681|NCT02348606|12470062|FG002|NOT COMPLETED|Overall Study||11
11274682|NCT02348606|12470063|FG003|NOT COMPLETED|Overall Study||24
11274683|NCT02348606|12470064|FG004|NOT COMPLETED|Overall Study||18
11274684|NCT02348619|12470076|FG000|STARTED|Titration Phase||174
11274685|NCT02348619|12470077|FG001|STARTED|Titration Phase||0
11274686|NCT02348619|12470076|FG000|COMPLETED|Titration Phase||157
11274687|NCT02348619|12470077|FG001|COMPLETED|Titration Phase||0
11274688|NCT02348619|12470076|FG000|NOT COMPLETED|Titration Phase||17
11274689|NCT02348619|12470077|FG001|NOT COMPLETED|Titration Phase||0
11274690|NCT02348619|12470076|FG000|STARTED|Stable-Dose Phase||157
11274691|NCT02348619|12470077|FG001|STARTED|Stable-Dose Phase||0
11274692|NCT02348619|12470076|FG000|COMPLETED|Stable-Dose Phase||124
11274693|NCT02348619|12470077|FG001|COMPLETED|Stable-Dose Phase||0
11274694|NCT02348619|12470076|FG000|NOT COMPLETED|Stable-Dose Phase||33
11274695|NCT02348619|12470077|FG001|NOT COMPLETED|Stable-Dose Phase||0
11274696|NCT02348619|12470076|FG000|STARTED|Double-Blind Withdrawal Phase||62
11274697|NCT02348619|12470077|FG001|STARTED|Double-Blind Withdrawal Phase||62
11274698|NCT02348619|12470076|FG000|COMPLETED|Double-Blind Withdrawal Phase||60
11274699|NCT02348619|12470077|FG001|COMPLETED|Double-Blind Withdrawal Phase||62
11274700|NCT02348619|12470076|FG000|NOT COMPLETED|Double-Blind Withdrawal Phase||2
11274701|NCT02348619|12470077|FG001|NOT COMPLETED|Double-Blind Withdrawal Phase||0
11274702|NCT02348632|12470083|FG000|STARTED|Open-label Period||643
11274703|NCT02348632|12470084|FG001|STARTED|Open-label Period||0
11274704|NCT02348632|12470083|FG000|COMPLETED|Open-label Period||458
11274705|NCT02348632|12470084|FG001|COMPLETED|Open-label Period||0
11274706|NCT02348632|12470083|FG000|NOT COMPLETED|Open-label Period||185
11274707|NCT02348632|12470084|FG001|NOT COMPLETED|Open-label Period||0
11274708|NCT02348632|12470083|FG000|STARTED|Randomized Withdrawal Period||140
11274709|NCT02348632|12470084|FG001|STARTED|Randomized Withdrawal Period||142
11274710|NCT02348632|12470083|FG000|COMPLETED|Randomized Withdrawal Period||137
11274711|NCT02348632|12470084|FG001|COMPLETED|Randomized Withdrawal Period||141
11274712|NCT02348632|12470083|FG000|NOT COMPLETED|Randomized Withdrawal Period||3
11274713|NCT02348632|12470084|FG001|NOT COMPLETED|Randomized Withdrawal Period||1
11274714|NCT02348658|12470090|FG000|STARTED|Period 1 (7 Days)||6
11274715|NCT02348658|12470091|FG001|STARTED|Period 1 (7 Days)||6
11274716|NCT02348658|12470090|FG000|COMPLETED|Period 1 (7 Days)||6
11274717|NCT02348658|12470091|FG001|COMPLETED|Period 1 (7 Days)||6
11274718|NCT02348658|12470090|FG000|NOT COMPLETED|Period 1 (7 Days)||0
11274719|NCT02348658|12470091|FG001|NOT COMPLETED|Period 1 (7 Days)||0
11274720|NCT02348658|12470090|FG000|STARTED|Washout Period (22 Days)||6
11274721|NCT02348658|12470091|FG001|STARTED|Washout Period (22 Days)||6
11274722|NCT02348658|12470090|FG000|COMPLETED|Washout Period (22 Days)||6
11274723|NCT02348658|12470091|FG001|COMPLETED|Washout Period (22 Days)||6
11274724|NCT02348658|12470090|FG000|NOT COMPLETED|Washout Period (22 Days)||0
11274725|NCT02348658|12470091|FG001|NOT COMPLETED|Washout Period (22 Days)||0
11274726|NCT02348658|12470090|FG000|STARTED|Period 2 (7 Days)||6
11274727|NCT02348658|12470091|FG001|STARTED|Period 2 (7 Days)||6
11274728|NCT02348658|12470090|FG000|COMPLETED|Period 2 (7 Days)||6
11274729|NCT02348658|12470091|FG001|COMPLETED|Period 2 (7 Days)||6
11274730|NCT02348658|12470090|FG000|NOT COMPLETED|Period 2 (7 Days)||0
11274731|NCT02348658|12470091|FG001|NOT COMPLETED|Period 2 (7 Days)||0
11274732|NCT02348684|12470097|FG000|STARTED|Overall Study||20
11274733|NCT02348684|12470097|FG000|COMPLETED|Overall Study||20
11274734|NCT02348684|12470097|FG000|NOT COMPLETED|Overall Study||0
11274735|NCT02348723|12470103|FG000|STARTED|Overall Study||338
11274736|NCT02348723|12470104|FG001|STARTED|Overall Study||338
11274737|NCT02348723|12470103|FG000|COMPLETED|Overall Study||310
11274738|NCT02348723|12470104|FG001|COMPLETED|Overall Study||312
11274739|NCT02348723|12470103|FG000|NOT COMPLETED|Overall Study||28
11274740|NCT02348723|12470104|FG001|NOT COMPLETED|Overall Study||26
11274741|NCT02348775|12470112|FG000|STARTED|Overall Study||8
11274742|NCT02348775|12470113|FG001|STARTED|Overall Study||8
11274743|NCT02348775|12470112|FG000|COMPLETED|Overall Study||8
11274744|NCT02348775|12470113|FG001|COMPLETED|Overall Study||8
11274745|NCT02348775|12470112|FG000|NOT COMPLETED|Overall Study||0
11274746|NCT02348775|12470113|FG001|NOT COMPLETED|Overall Study||0
11274747|NCT02348840|12470123|FG000|STARTED|Overall Study||23
11274748|NCT02348840|12470124|FG001|STARTED|Overall Study||21
11274749|NCT02348840|12470125|FG002|STARTED|Overall Study||425
11274750|NCT02348840|12470126|FG003|STARTED|Overall Study||374
11274751|NCT02348840|12470123|FG000|COMPLETED|Overall Study||21
11274752|NCT02348840|12470124|FG001|COMPLETED|Overall Study||20
11274753|NCT02348840|12470125|FG002|COMPLETED|Overall Study||425
11274754|NCT02348840|12470126|FG003|COMPLETED|Overall Study||374
11274755|NCT02348840|12470123|FG000|NOT COMPLETED|Overall Study||2
11274756|NCT02348840|12470124|FG001|NOT COMPLETED|Overall Study||1
11274757|NCT02348840|12470125|FG002|NOT COMPLETED|Overall Study||0
11274758|NCT02348840|12470126|FG003|NOT COMPLETED|Overall Study||0
11274759|NCT02348918|12470145|FG000|STARTED|Overall Study||39
11274760|NCT02348918|12470146|FG001|STARTED|Overall Study||33
11274761|NCT02348918|12470147|FG002|STARTED|Overall Study||42
11274762|NCT02348918|12470148|FG003|STARTED|Overall Study||24
11274763|NCT02348918|12470149|FG004|STARTED|Overall Study||19
11274764|NCT02348918|12470150|FG005|STARTED|Overall Study||17
11274765|NCT02348918|12470151|FG006|STARTED|Overall Study||13
11274766|NCT02348918|12470152|FG007|STARTED|Overall Study||16
11274767|NCT02348918|12470153|FG008|STARTED|Overall Study||15
11274768|NCT02348918|12470145|FG000|COMPLETED|Overall Study||39
11274769|NCT02348918|12470146|FG001|COMPLETED|Overall Study||33
11274770|NCT02348918|12470147|FG002|COMPLETED|Overall Study||42
11274771|NCT02348918|12470148|FG003|COMPLETED|Overall Study||24
11274772|NCT02348918|12470149|FG004|COMPLETED|Overall Study||19
11274773|NCT02348918|12470150|FG005|COMPLETED|Overall Study||17
11274774|NCT02348918|12470151|FG006|COMPLETED|Overall Study||13
11274775|NCT02348918|12470152|FG007|COMPLETED|Overall Study||16
11274776|NCT02348918|12470153|FG008|COMPLETED|Overall Study||15
11274777|NCT02348918|12470145|FG000|NOT COMPLETED|Overall Study||0
11274778|NCT02348918|12470146|FG001|NOT COMPLETED|Overall Study||0
11274779|NCT02348918|12470147|FG002|NOT COMPLETED|Overall Study||0
11274780|NCT02348918|12470148|FG003|NOT COMPLETED|Overall Study||0
11274781|NCT02348918|12470149|FG004|NOT COMPLETED|Overall Study||0
11274782|NCT02348918|12470150|FG005|NOT COMPLETED|Overall Study||0
11274783|NCT02348918|12470151|FG006|NOT COMPLETED|Overall Study||0
11274784|NCT02348918|12470152|FG007|NOT COMPLETED|Overall Study||0
11274785|NCT02348918|12470153|FG008|NOT COMPLETED|Overall Study||0
11274786|NCT02349048|12470175|FG000|STARTED|Overall Study||59
11274787|NCT02349048|12470176|FG001|STARTED|Overall Study||9
11274788|NCT02349048|12470175|FG000|COMPLETED|Overall Study||54
11274789|NCT02349048|12470176|FG001|COMPLETED|Overall Study||9
11274790|NCT02349048|12470175|FG000|NOT COMPLETED|Overall Study||5
11274791|NCT02349048|12470176|FG001|NOT COMPLETED|Overall Study||0
11274792|NCT02349061|12470184|FG000|STARTED|Main Study: PCP (Up to Week 24)||42
11274793|NCT02349061|12470185|FG001|STARTED|Main Study: PCP (Up to Week 24)||60
11274794|NCT02349061|12470186|FG002|STARTED|Main Study: PCP (Up to Week 24)||0
11274795|NCT02349061|12470184|FG000|COMPLETED|Main Study: PCP (Up to Week 24)||33
11274796|NCT02349061|12470185|FG001|COMPLETED|Main Study: PCP (Up to Week 24)||56
11274797|NCT02349061|12470186|FG002|COMPLETED|Main Study: PCP (Up to Week 24)||0
11274798|NCT02349061|12470184|FG000|NOT COMPLETED|Main Study: PCP (Up to Week 24)||9
11274799|NCT02349061|12470185|FG001|NOT COMPLETED|Main Study: PCP (Up to Week 24)||4
11274800|NCT02349061|12470186|FG002|NOT COMPLETED|Main Study: PCP (Up to Week 24)||0
11274801|NCT02349061|12470184|FG000|STARTED|Main Study: Week 24 to 56||0
11274802|NCT02349061|12470185|FG001|STARTED|Main Study: Week 24 to 56||56
11274803|NCT02349061|12470186|FG002|STARTED|Main Study: Week 24 to 56||33
11274804|NCT02349061|12470184|FG000|COMPLETED|Main Study: Week 24 to 56||0
11274805|NCT02349061|12470185|FG001|COMPLETED|Main Study: Week 24 to 56||53
11274806|NCT02349061|12470186|FG002|COMPLETED|Main Study: Week 24 to 56||30
11274807|NCT02349061|12470184|FG000|NOT COMPLETED|Main Study: Week 24 to 56||0
11274808|NCT02349061|12470185|FG001|NOT COMPLETED|Main Study: Week 24 to 56||3
11274809|NCT02349061|12470186|FG002|NOT COMPLETED|Main Study: Week 24 to 56||3
11274810|NCT02349061|12470184|FG000|STARTED|Study Extension (Week 56 to Week 120)||0
11274811|NCT02349061|12470185|FG001|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|29
11274812|NCT02349061|12470186|FG002|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|17
11274813|NCT02349061|12470184|FG000|COMPLETED|Study Extension (Week 56 to Week 120)||0
11274814|NCT02349061|12470185|FG001|COMPLETED|Study Extension (Week 56 to Week 120)||24
11398209|NCT04511520|12592555|FG000|STARTED|Overall Study||24
11274815|NCT02349061|12470186|FG002|COMPLETED|Study Extension (Week 56 to Week 120)||14
11274816|NCT02349061|12470184|FG000|NOT COMPLETED|Study Extension (Week 56 to Week 120)||0
11274817|NCT02349061|12470185|FG001|NOT COMPLETED|Study Extension (Week 56 to Week 120)||5
11274818|NCT02349061|12470186|FG002|NOT COMPLETED|Study Extension (Week 56 to Week 120)||3
11274819|NCT02349152|12470198|FG000|STARTED|Overall Study||60
11274820|NCT02349152|12470199|FG001|STARTED|Overall Study||56
11274821|NCT02349152|12470198|FG000|COMPLETED|Overall Study||54
11274822|NCT02349152|12470199|FG001|COMPLETED|Overall Study||52
11274823|NCT02349152|12470198|FG000|NOT COMPLETED|Overall Study||6
11274824|NCT02349152|12470199|FG001|NOT COMPLETED|Overall Study||4
11274825|NCT02349178|12470205|FG000|STARTED|Overall Study||6
11274826|NCT02349178|12470205|FG000|COMPLETED|Overall Study||6
11274827|NCT02349178|12470205|FG000|NOT COMPLETED|Overall Study||0
11274828|NCT02349295|12470212|FG000|STARTED|Double Blind Treatment (Week 0-24)||123
11274829|NCT02349295|12470213|FG001|STARTED|Double Blind Treatment (Week 0-24)||122
11274830|NCT02349295|12470214|FG002|STARTED|Double Blind Treatment (Week 0-24)||118
11274831|NCT02349295|12470215|FG003|STARTED|Double Blind Treatment (Week 0-24)||0
11274832|NCT02349295|12470216|FG004|STARTED|Double Blind Treatment (Week 0-24)||0
11274833|NCT02349295|12470217|FG005|STARTED|Double Blind Treatment (Week 0-24)||0
11274834|NCT02349295|12470218|FG006|STARTED|Double Blind Treatment (Week 0-24)||0
11274835|NCT02349295|12470219|FG007|STARTED|Double Blind Treatment (Week 0-24)||0
11274836|NCT02349295|12470220|FG008|STARTED|Double Blind Treatment (Week 0-24)||0
11274837|NCT02349295|12470221|FG009|STARTED|Double Blind Treatment (Week 0-24)||0
11274838|NCT02349295|12470222|FG010|STARTED|Double Blind Treatment (Week 0-24)||0
11274839|NCT02349295|12470223|FG011|STARTED|Double Blind Treatment (Week 0-24)||0
11274840|NCT02349295|12470224|FG012|STARTED|Double Blind Treatment (Week 0-24)||0
11274841|NCT02349295|12470225|FG013|STARTED|Double Blind Treatment (Week 0-24)||0
11274842|NCT02349295|12470212|FG000|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||123
11274843|NCT02349295|12470213|FG001|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||122
11274844|NCT02349295|12470214|FG002|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||118
11274845|NCT02349295|12470215|FG003|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
11274846|NCT02349295|12470216|FG004|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
11274847|NCT02349295|12470217|FG005|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
11274848|NCT02349295|12470218|FG006|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
11274849|NCT02349295|12470219|FG007|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
11274850|NCT02349295|12470220|FG008|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
11274851|NCT02349295|12470221|FG009|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
11274852|NCT02349295|12470222|FG010|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
11274853|NCT02349295|12470223|FG011|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
11274854|NCT02349295|12470224|FG012|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
11274855|NCT02349295|12470225|FG013|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
11274856|NCT02349295|12470212|FG000|COMPLETED|Double Blind Treatment (Week 0-24)||109
11274857|NCT02349295|12470213|FG001|COMPLETED|Double Blind Treatment (Week 0-24)||111
11274858|NCT02349295|12470214|FG002|COMPLETED|Double Blind Treatment (Week 0-24)||94
11274859|NCT02349295|12470215|FG003|COMPLETED|Double Blind Treatment (Week 0-24)||0
11274860|NCT02349295|12470216|FG004|COMPLETED|Double Blind Treatment (Week 0-24)||0
11274861|NCT02349295|12470217|FG005|COMPLETED|Double Blind Treatment (Week 0-24)||0
11274862|NCT02349295|12470218|FG006|COMPLETED|Double Blind Treatment (Week 0-24)||0
11274863|NCT02349295|12470219|FG007|COMPLETED|Double Blind Treatment (Week 0-24)||0
11274864|NCT02349295|12470220|FG008|COMPLETED|Double Blind Treatment (Week 0-24)||0
11274865|NCT02349295|12470221|FG009|COMPLETED|Double Blind Treatment (Week 0-24)||0
11274866|NCT02349295|12470222|FG010|COMPLETED|Double Blind Treatment (Week 0-24)||0
11274867|NCT02349295|12470223|FG011|COMPLETED|Double Blind Treatment (Week 0-24)||0
11274868|NCT02349295|12470224|FG012|COMPLETED|Double Blind Treatment (Week 0-24)||0
11274869|NCT02349295|12470225|FG013|COMPLETED|Double Blind Treatment (Week 0-24)||0
11274870|NCT02349295|12470212|FG000|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
11274871|NCT02349295|12470213|FG001|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
11274872|NCT02349295|12470214|FG002|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
11274873|NCT02349295|12470215|FG003|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
11274874|NCT02349295|12470216|FG004|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
11274875|NCT02349295|12470217|FG005|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
11274876|NCT02349295|12470218|FG006|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
11274877|NCT02349295|12470219|FG007|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
11274878|NCT02349295|12470220|FG008|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
11274879|NCT02349295|12470221|FG009|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
11274880|NCT02349295|12470222|FG010|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
11274881|NCT02349295|12470223|FG011|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
11274882|NCT02349295|12470224|FG012|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
11274883|NCT02349295|12470225|FG013|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
11274884|NCT02349295|12470212|FG000|STARTED|IR (Week 16-24)|Only IR participants were included.|0
11274885|NCT02349295|12470213|FG001|STARTED|IR (Week 16-24)|Only IR participants were included.|0
11274886|NCT02349295|12470214|FG002|STARTED|IR (Week 16-24)|Only IR participants were included.|0
11274887|NCT02349295|12470215|FG003|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q2W only.|17
11274888|NCT02349295|12470216|FG004|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q4W only.|15
11274889|NCT02349295|12470217|FG005|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W.|16
11274890|NCT02349295|12470218|FG006|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W.|16
11274891|NCT02349295|12470219|FG007|STARTED|IR (Week 16-24)||0
11274892|NCT02349295|12470220|FG008|STARTED|IR (Week 16-24)||0
11274893|NCT02349295|12470221|FG009|STARTED|IR (Week 16-24)||0
11274894|NCT02349295|12470222|FG010|STARTED|IR (Week 16-24)||0
11274895|NCT02349295|12470223|FG011|STARTED|IR (Week 16-24)||0
11274896|NCT02349295|12470224|FG012|STARTED|IR (Week 16-24)||0
11274897|NCT02349295|12470225|FG013|STARTED|IR (Week 16-24)||0
11274898|NCT02349295|12470212|FG000|COMPLETED|IR (Week 16-24)||0
11274899|NCT02349295|12470213|FG001|COMPLETED|IR (Week 16-24)||0
11274900|NCT02349295|12470214|FG002|COMPLETED|IR (Week 16-24)||0
11274901|NCT02349295|12470215|FG003|COMPLETED|IR (Week 16-24)||16
11274902|NCT02349295|12470216|FG004|COMPLETED|IR (Week 16-24)||15
11274903|NCT02349295|12470217|FG005|COMPLETED|IR (Week 16-24)||16
11274904|NCT02349295|12470218|FG006|COMPLETED|IR (Week 16-24)||16
11274905|NCT02349295|12470219|FG007|COMPLETED|IR (Week 16-24)||0
11274906|NCT02349295|12470220|FG008|COMPLETED|IR (Week 16-24)||0
11274907|NCT02349295|12470221|FG009|COMPLETED|IR (Week 16-24)||0
11274908|NCT02349295|12470222|FG010|COMPLETED|IR (Week 16-24)||0
11274909|NCT02349295|12470223|FG011|COMPLETED|IR (Week 16-24)||0
11274910|NCT02349295|12470224|FG012|COMPLETED|IR (Week 16-24)||0
11274911|NCT02349295|12470225|FG013|COMPLETED|IR (Week 16-24)||0
11274912|NCT02349295|12470212|FG000|NOT COMPLETED|IR (Week 16-24)||0
11274913|NCT02349295|12470213|FG001|NOT COMPLETED|IR (Week 16-24)||0
11274914|NCT02349295|12470214|FG002|NOT COMPLETED|IR (Week 16-24)||0
11274915|NCT02349295|12470215|FG003|NOT COMPLETED|IR (Week 16-24)||1
11274916|NCT02349295|12470216|FG004|NOT COMPLETED|IR (Week 16-24)||0
11274917|NCT02349295|12470217|FG005|NOT COMPLETED|IR (Week 16-24)||0
11274918|NCT02349295|12470218|FG006|NOT COMPLETED|IR (Week 16-24)||0
11274919|NCT02349295|12470219|FG007|NOT COMPLETED|IR (Week 16-24)||0
11274920|NCT02349295|12470220|FG008|NOT COMPLETED|IR (Week 16-24)||0
11274921|NCT02349295|12470221|FG009|NOT COMPLETED|IR (Week 16-24)||0
11274922|NCT02349295|12470222|FG010|NOT COMPLETED|IR (Week 16-24)||0
11274923|NCT02349295|12470223|FG011|NOT COMPLETED|IR (Week 16-24)||0
11274924|NCT02349295|12470224|FG012|NOT COMPLETED|IR (Week 16-24)||0
11274925|NCT02349295|12470225|FG013|NOT COMPLETED|IR (Week 16-24)||0
11274926|NCT02349295|12470212|FG000|STARTED|Long-Term Extension Period (Week 24-156)||0
11274927|NCT02349295|12470213|FG001|STARTED|Long-Term Extension Period (Week 24-156)||0
11274928|NCT02349295|12470214|FG002|STARTED|Long-Term Extension Period (Week 24-156)||0
11274929|NCT02349295|12470215|FG003|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
11274930|NCT02349295|12470216|FG004|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
11274931|NCT02349295|12470217|FG005|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
11274932|NCT02349295|12470218|FG006|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
11274933|NCT02349295|12470219|FG007|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ2W participants who entered the long-term extension period.|107
11274934|NCT02349295|12470220|FG008|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ4W participants who entered the long-term extension period.|111
11274935|NCT02349295|12470221|FG009|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ2W participants who entered the long-term extension period.|46
11274936|NCT02349295|12470222|FG010|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ4W participants who entered the long-term extension period.|46
11274937|NCT02349295|12470223|FG011|STARTED|Long-Term Extension Period (Week 24-156)||0
11274938|NCT02349295|12470224|FG012|STARTED|Long-Term Extension Period (Week 24-156)||0
11398210|NCT04511520|12592556|FG001|STARTED|Overall Study||24
11398211|NCT04511520|12592557|FG002|STARTED|Overall Study||24
11398212|NCT04511520|12592555|FG000|COMPLETED|Overall Study||24
11398213|NCT04511520|12592556|FG001|COMPLETED|Overall Study||24
11398214|NCT04511520|12592557|FG002|COMPLETED|Overall Study||24
11274939|NCT02349295|12470225|FG013|STARTED|Long-Term Extension Period (Week 24-156)||0
11274940|NCT02349295|12470212|FG000|COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274941|NCT02349295|12470213|FG001|COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274942|NCT02349295|12470214|FG002|COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274943|NCT02349295|12470215|FG003|COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274944|NCT02349295|12470216|FG004|COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274945|NCT02349295|12470217|FG005|COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274946|NCT02349295|12470218|FG006|COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274947|NCT02349295|12470219|FG007|COMPLETED|Long-Term Extension Period (Week 24-156)||55
11274948|NCT02349295|12470220|FG008|COMPLETED|Long-Term Extension Period (Week 24-156)||70
11274949|NCT02349295|12470221|FG009|COMPLETED|Long-Term Extension Period (Week 24-156)||20
11274950|NCT02349295|12470222|FG010|COMPLETED|Long-Term Extension Period (Week 24-156)||23
11274951|NCT02349295|12470223|FG011|COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274952|NCT02349295|12470224|FG012|COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274953|NCT02349295|12470225|FG013|COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274954|NCT02349295|12470212|FG000|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
11398215|NCT04511520|12592555|FG000|NOT COMPLETED|Overall Study||0
11398216|NCT04511520|12592556|FG001|NOT COMPLETED|Overall Study||0
11274955|NCT02349295|12470213|FG001|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274956|NCT02349295|12470214|FG002|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274957|NCT02349295|12470215|FG003|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274958|NCT02349295|12470216|FG004|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274959|NCT02349295|12470217|FG005|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274960|NCT02349295|12470218|FG006|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274961|NCT02349295|12470219|FG007|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||52
11274962|NCT02349295|12470220|FG008|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||41
11274963|NCT02349295|12470221|FG009|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||26
11274964|NCT02349295|12470222|FG010|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||23
11274965|NCT02349295|12470223|FG011|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274966|NCT02349295|12470224|FG012|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274967|NCT02349295|12470225|FG013|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
11274968|NCT02349295|12470212|FG000|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
11274969|NCT02349295|12470213|FG001|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
11274970|NCT02349295|12470214|FG002|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
11274971|NCT02349295|12470215|FG003|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
11274972|NCT02349295|12470216|FG004|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
11274973|NCT02349295|12470217|FG005|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
11274974|NCT02349295|12470218|FG006|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
11274975|NCT02349295|12470219|FG007|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
11274976|NCT02349295|12470220|FG008|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
11274977|NCT02349295|12470221|FG009|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
11274978|NCT02349295|12470222|FG010|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
11274979|NCT02349295|12470223|FG011|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ2W participants who entered post-treatment follow-up.|142
11274980|NCT02349295|12470224|FG012|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ4W participants who entered post-treatment follow-up.|145
11274981|NCT02349295|12470225|FG013|STARTED|Follow-Up Period (Up to 12-24 Weeks)|PBO participants who entered post-treatment follow-up.|17
11274982|NCT02349295|12470212|FG000|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11274983|NCT02349295|12470213|FG001|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11274984|NCT02349295|12470214|FG002|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11274985|NCT02349295|12470215|FG003|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11274986|NCT02349295|12470216|FG004|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11274987|NCT02349295|12470217|FG005|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11274988|NCT02349295|12470218|FG006|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11274989|NCT02349295|12470219|FG007|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11274990|NCT02349295|12470220|FG008|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11274991|NCT02349295|12470221|FG009|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11274992|NCT02349295|12470222|FG010|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11274993|NCT02349295|12470223|FG011|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||133
11274994|NCT02349295|12470224|FG012|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||137
11274995|NCT02349295|12470225|FG013|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||16
11274996|NCT02349295|12470212|FG000|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11274997|NCT02349295|12470213|FG001|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11274998|NCT02349295|12470214|FG002|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11274999|NCT02349295|12470215|FG003|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11275000|NCT02349295|12470216|FG004|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11275001|NCT02349295|12470217|FG005|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11275002|NCT02349295|12470218|FG006|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11275003|NCT02349295|12470219|FG007|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11275004|NCT02349295|12470220|FG008|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11275005|NCT02349295|12470221|FG009|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11275006|NCT02349295|12470222|FG010|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
11275007|NCT02349295|12470223|FG011|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||9
11398217|NCT04511520|12592557|FG002|NOT COMPLETED|Overall Study||0
11398218|NCT04507776|12592566|FG000|STARTED|Overall Study||763
11398219|NCT04507776|12592566|FG000|COMPLETED|Overall Study||562
11398220|NCT04507776|12592566|FG000|NOT COMPLETED|Overall Study||201
11398221|NCT04502979|12592577|FG000|STARTED|Overall Study||37
11275008|NCT02349295|12470224|FG012|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||8
11398222|NCT04502979|12592578|FG001|STARTED|Overall Study||34
11398223|NCT04502979|12592577|FG000|COMPLETED|Overall Study||34
11398224|NCT04502979|12592578|FG001|COMPLETED|Overall Study||30
11275009|NCT02349295|12470225|FG013|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||1
11275010|NCT02349360|12470252|FG000|STARTED|Overall Study||21
11275011|NCT02349360|12470253|FG001|STARTED|Overall Study||21
11275012|NCT02349360|12470252|FG000|COMPLETED|Overall Study||21
11275013|NCT02349360|12470253|FG001|COMPLETED|Overall Study||20
11275014|NCT02349360|12470252|FG000|NOT COMPLETED|Overall Study||0
11275015|NCT02349360|12470253|FG001|NOT COMPLETED|Overall Study||1
11275016|NCT02349412|12470261|FG000|STARTED|Overall Study||202
11398225|NCT04502979|12592577|FG000|NOT COMPLETED|Overall Study||3
11398226|NCT04502979|12592578|FG001|NOT COMPLETED|Overall Study||4
11398227|NCT04502056|12592586|FG000|STARTED|Overall Study||2046
11398228|NCT04502056|12592587|FG001|STARTED|Overall Study||2044
11398229|NCT04502056|12592588|FG002|STARTED|Overall Study||2045
11398230|NCT04502056|12592589|FG003|STARTED|Overall Study||2046
11398231|NCT04502056|12592590|FG004|STARTED|Overall Study||2044
11398232|NCT04502056|12592591|FG005|STARTED|Overall Study||2052
11275017|NCT02349412|12470262|FG001|STARTED|Overall Study||203
11275018|NCT02349412|12470261|FG000|Completed Week-12 QOL Assessment Measure|Overall Study||92
11275019|NCT02349412|12470262|FG001|Completed Week-12 QOL Assessment Measure|Overall Study||101
11275020|NCT02349412|12470261|FG000|Completed Week-24 QOL Assessment Measure|Overall Study||68
11275021|NCT02349412|12470262|FG001|Completed Week-24 QOL Assessment Measure|Overall Study||80
11275022|NCT02349412|12470261|FG000|COMPLETED|Overall Study||195
11275023|NCT02349412|12470262|FG001|COMPLETED|Overall Study||196
11275024|NCT02349412|12470261|FG000|NOT COMPLETED|Overall Study||7
11275025|NCT02349412|12470262|FG001|NOT COMPLETED|Overall Study||7
11275026|NCT02349425|12470272|FG000|STARTED|Period 1||15
11275027|NCT02349425|12470273|FG001|STARTED|Period 1||14
11275028|NCT02349425|12470274|FG002|STARTED|Period 1||15
11275029|NCT02349425|12470275|FG003|STARTED|Period 1||15
11275030|NCT02349425|12470272|FG000|COMPLETED|Period 1||14
11275031|NCT02349425|12470273|FG001|COMPLETED|Period 1||13
11275032|NCT02349425|12470274|FG002|COMPLETED|Period 1||15
11275033|NCT02349425|12470275|FG003|COMPLETED|Period 1||15
11275034|NCT02349425|12470272|FG000|NOT COMPLETED|Period 1||1
11275035|NCT02349425|12470273|FG001|NOT COMPLETED|Period 1||1
11275036|NCT02349425|12470274|FG002|NOT COMPLETED|Period 1||0
11275037|NCT02349425|12470275|FG003|NOT COMPLETED|Period 1||0
11275038|NCT02349425|12470272|FG000|STARTED|Period 2||14
11275039|NCT02349425|12470273|FG001|STARTED|Period 2||13
11275040|NCT02349425|12470274|FG002|STARTED|Period 2||15
11275041|NCT02349425|12470275|FG003|STARTED|Period 2||15
11275042|NCT02349425|12470272|FG000|COMPLETED|Period 2||14
11275043|NCT02349425|12470273|FG001|COMPLETED|Period 2||12
11275044|NCT02349425|12470274|FG002|COMPLETED|Period 2||14
11275045|NCT02349425|12470275|FG003|COMPLETED|Period 2||15
11275046|NCT02349425|12470272|FG000|NOT COMPLETED|Period 2||0
11275047|NCT02349425|12470273|FG001|NOT COMPLETED|Period 2||1
11275048|NCT02349425|12470274|FG002|NOT COMPLETED|Period 2||1
11275049|NCT02349425|12470275|FG003|NOT COMPLETED|Period 2||0
11275050|NCT02349438|12470313|FG000|STARTED|Period 1||11
11275051|NCT02349438|12470314|FG001|STARTED|Period 1||10
11275052|NCT02349438|12470313|FG000|COMPLETED|Period 1||11
11275053|NCT02349438|12470314|FG001|COMPLETED|Period 1||10
11275054|NCT02349438|12470313|FG000|NOT COMPLETED|Period 1||0
11275055|NCT02349438|12470314|FG001|NOT COMPLETED|Period 1||0
11275056|NCT02349438|12470313|FG000|STARTED|Period 2||11
11275057|NCT02349438|12470314|FG001|STARTED|Period 2||10
11275058|NCT02349438|12470313|FG000|COMPLETED|Period 2||11
11275059|NCT02349438|12470314|FG001|COMPLETED|Period 2||10
11275060|NCT02349438|12470313|FG000|NOT COMPLETED|Period 2||0
11275061|NCT02349438|12470314|FG001|NOT COMPLETED|Period 2||0
11340542|NCT02921841|12537834|FG001|STARTED|Overall Study||57
11340543|NCT02921841|12537833|FG000|COMPLETED|Overall Study||52
11340544|NCT02921841|12537834|FG001|COMPLETED|Overall Study||44
11340545|NCT02921841|12537833|FG000|NOT COMPLETED|Overall Study||16
11340546|NCT02921841|12537834|FG001|NOT COMPLETED|Overall Study||13
11340547|NCT02922153|12537842|FG000|STARTED|Overall Study||65
11340548|NCT02922153|12537843|FG001|STARTED|Overall Study||19
11340549|NCT02922153|12537842|FG000|COMPLETED|Overall Study||55
11340550|NCT02922153|12537843|FG001|COMPLETED|Overall Study||17
11340551|NCT02922153|12537842|FG000|NOT COMPLETED|Overall Study||10
11340552|NCT02922153|12537843|FG001|NOT COMPLETED|Overall Study||2
11340553|NCT02922582|12537853|FG000|STARTED|Overall Study||4
11340554|NCT02922582|12537854|FG001|STARTED|Overall Study||4
11340555|NCT02922582|12537855|FG002|STARTED|Overall Study||4
11340556|NCT02922582|12537856|FG003|STARTED|Overall Study||4
11398233|NCT04502056|12592592|FG006|STARTED|Overall Study||2046
11398234|NCT04502056|12592593|FG007|STARTED|Overall Study||2043
11398235|NCT04502056|12592594|FG008|STARTED|Overall Study||1026
11275062|NCT02349451|12470324|FG000|STARTED|Overall Study||24
11275063|NCT02349451|12470325|FG001|STARTED|Overall Study||72
11275064|NCT02349451|12470326|FG002|STARTED|Overall Study||71
11275065|NCT02349451|12470327|FG003|STARTED|Overall Study||73
11275066|NCT02349451|12470324|FG000|COMPLETED|Overall Study||24
11275067|NCT02349451|12470325|FG001|COMPLETED|Overall Study||71
11275068|NCT02349451|12470326|FG002|COMPLETED|Overall Study||69
11275069|NCT02349451|12470327|FG003|COMPLETED|Overall Study||72
11275070|NCT02349451|12470324|FG000|NOT COMPLETED|Overall Study||0
11275071|NCT02349451|12470325|FG001|NOT COMPLETED|Overall Study||1
11275072|NCT02349451|12470326|FG002|NOT COMPLETED|Overall Study||2
11275073|NCT02349451|12470327|FG003|NOT COMPLETED|Overall Study||1
11275074|NCT02349477|12470342|FG000|STARTED|Overall Study||44
11275075|NCT02349477|12470343|FG001|STARTED|Overall Study||46
11275076|NCT02349477|12470342|FG000|COMPLETED|Overall Study||31
11275077|NCT02349477|12470343|FG001|COMPLETED|Overall Study||28
11275078|NCT02349477|12470342|FG000|NOT COMPLETED|Overall Study||13
11275079|NCT02349477|12470343|FG001|NOT COMPLETED|Overall Study||18
11398236|NCT04502056|12592595|FG009|STARTED|Overall Study||1025
11275080|NCT02349542|12470353|FG000|STARTED|Overall Study||20
11275081|NCT02349542|12470353|FG000|COMPLETED|Overall Study||15
11275082|NCT02349542|12470353|FG000|NOT COMPLETED|Overall Study||5
11275083|NCT02349633|12470371|FG000|STARTED|Overall Study||4
11275084|NCT02349633|12470372|FG001|STARTED|Overall Study||3
11275085|NCT02349633|12470373|FG002|STARTED|Overall Study||4
11275086|NCT02349633|12470374|FG003|STARTED|Overall Study||4
11275087|NCT02349633|12470375|FG004|STARTED|Overall Study||3
11275088|NCT02349633|12470376|FG005|STARTED|Overall Study||4
11275089|NCT02349633|12470377|FG006|STARTED|Overall Study||4
11275090|NCT02349633|12470378|FG007|STARTED|Overall Study||29
11275091|NCT02349633|12470379|FG008|STARTED|Overall Study||5
11275092|NCT02349633|12470380|FG009|STARTED|Overall Study||5
11275093|NCT02349633|12470381|FG010|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
11275094|NCT02349633|12470382|FG011|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
11275095|NCT02349633|12470383|FG012|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
11275096|NCT02349633|12470384|FG013|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
11275097|NCT02349633|12470371|FG000|COMPLETED|Overall Study||4
11275098|NCT02349633|12470372|FG001|COMPLETED|Overall Study||2
11275099|NCT02349633|12470373|FG002|COMPLETED|Overall Study||4
11275100|NCT02349633|12470374|FG003|COMPLETED|Overall Study||2
11275101|NCT02349633|12470375|FG004|COMPLETED|Overall Study||1
11275102|NCT02349633|12470376|FG005|COMPLETED|Overall Study||3
11275103|NCT02349633|12470377|FG006|COMPLETED|Overall Study||3
11275104|NCT02349633|12470378|FG007|COMPLETED|Overall Study||13
11275105|NCT02349633|12470379|FG008|COMPLETED|Overall Study||3
11275106|NCT02349633|12470380|FG009|COMPLETED|Overall Study||0
11275107|NCT02349633|12470381|FG010|COMPLETED|Overall Study||0
11275108|NCT02349633|12470382|FG011|COMPLETED|Overall Study||0
11275109|NCT02349633|12470383|FG012|COMPLETED|Overall Study||0
11275110|NCT02349633|12470384|FG013|COMPLETED|Overall Study||0
11275111|NCT02349633|12470371|FG000|NOT COMPLETED|Overall Study||0
11275112|NCT02349633|12470372|FG001|NOT COMPLETED|Overall Study||1
11275113|NCT02349633|12470373|FG002|NOT COMPLETED|Overall Study||0
11275114|NCT02349633|12470374|FG003|NOT COMPLETED|Overall Study||2
11275115|NCT02349633|12470375|FG004|NOT COMPLETED|Overall Study||2
11275116|NCT02349633|12470376|FG005|NOT COMPLETED|Overall Study||1
11275117|NCT02349633|12470377|FG006|NOT COMPLETED|Overall Study||1
11275118|NCT02349633|12470378|FG007|NOT COMPLETED|Overall Study||16
11275119|NCT02349633|12470379|FG008|NOT COMPLETED|Overall Study||2
11275120|NCT02349633|12470380|FG009|NOT COMPLETED|Overall Study||5
11275121|NCT02349633|12470381|FG010|NOT COMPLETED|Overall Study||0
11275122|NCT02349633|12470382|FG011|NOT COMPLETED|Overall Study||0
11275123|NCT02349633|12470383|FG012|NOT COMPLETED|Overall Study||0
11275124|NCT02349633|12470384|FG013|NOT COMPLETED|Overall Study||0
11275125|NCT02349646|12470445|FG000|STARTED|Overall Study||33
11275126|NCT02349646|12470445|FG000|Received Trial System|Overall Study||24
11275127|NCT02349646|12470445|FG000|Receive Permanent System|Overall Study||27
11275128|NCT02349646|12470445|FG000|COMPLETED|Overall Study||16
11275129|NCT02349646|12470445|FG000|NOT COMPLETED|Overall Study||17
11275130|NCT02349685|12470452|FG000|STARTED|Overall Study||89
11275131|NCT02349685|12470453|FG001|STARTED|Overall Study||89
11275132|NCT02349685|12470454|FG002|STARTED|Overall Study||41
11275133|NCT02349685|12470452|FG000|COMPLETED|Overall Study||84
11275134|NCT02349685|12470453|FG001|COMPLETED|Overall Study||87
11275135|NCT02349685|12470454|FG002|COMPLETED|Overall Study||37
11275136|NCT02349685|12470452|FG000|NOT COMPLETED|Overall Study||5
11275137|NCT02349685|12470453|FG001|NOT COMPLETED|Overall Study||2
11275138|NCT02349685|12470454|FG002|NOT COMPLETED|Overall Study||4
11275139|NCT02349711|12470464|FG000|STARTED|Overall Study||87
11275140|NCT02349711|12470465|FG001|STARTED|Overall Study||86
11275141|NCT02349711|12470464|FG000|COMPLETED|Overall Study||84
11275142|NCT02349711|12470465|FG001|COMPLETED|Overall Study||84
11275143|NCT02349711|12470464|FG000|NOT COMPLETED|Overall Study||3
11275144|NCT02349711|12470465|FG001|NOT COMPLETED|Overall Study||2
11275145|NCT02349789|12470471|FG000|STARTED|Overall Study||11
11275146|NCT02349789|12470471|FG000|COMPLETED|Overall Study||9
11275147|NCT02349789|12470471|FG000|NOT COMPLETED|Overall Study||2
11275148|NCT02350127|12470477|FG000|STARTED|4-Month Assessment||44
11275149|NCT02350127|12470478|FG001|STARTED|4-Month Assessment||44
11398237|NCT04502056|12592596|FG010|STARTED|Overall Study||1023
11275150|NCT02350127|12470477|FG000|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to time constraints (n=1) and lack of interest (n=1)|42
11275151|NCT02350127|12470478|FG001|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to health issue (n=1)|43
11275152|NCT02350127|12470477|FG000|COMPLETED|4-Month Assessment||33
11275153|NCT02350127|12470478|FG001|COMPLETED|4-Month Assessment||35
11275154|NCT02350127|12470477|FG000|NOT COMPLETED|4-Month Assessment||11
11275155|NCT02350127|12470478|FG001|NOT COMPLETED|4-Month Assessment||9
11275156|NCT02350127|12470477|FG000|STARTED|8-Month Assessment||33
11275157|NCT02350127|12470478|FG001|STARTED|8-Month Assessment||35
11275158|NCT02350127|12470477|FG000|COMPLETED|8-Month Assessment||27
11275159|NCT02350127|12470478|FG001|COMPLETED|8-Month Assessment||26
11275160|NCT02350127|12470477|FG000|NOT COMPLETED|8-Month Assessment||6
11275161|NCT02350127|12470478|FG001|NOT COMPLETED|8-Month Assessment||9
11275162|NCT02350309|12470491|FG000|STARTED|Treatment Period 1 (2 Days)||12
11275163|NCT02350309|12470492|FG001|STARTED|Treatment Period 1 (2 Days)||11
11275164|NCT02350309|12470493|FG002|STARTED|Treatment Period 1 (2 Days)||11
11275165|NCT02350309|12470494|FG003|STARTED|Treatment Period 1 (2 Days)||11
11275166|NCT02350309|12470495|FG004|STARTED|Treatment Period 1 (2 Days)||12
11275167|NCT02350309|12470496|FG005|STARTED|Treatment Period 1 (2 Days)||12
11275168|NCT02350309|12470491|FG000|COMPLETED|Treatment Period 1 (2 Days)||12
11275169|NCT02350309|12470492|FG001|COMPLETED|Treatment Period 1 (2 Days)||11
11275170|NCT02350309|12470493|FG002|COMPLETED|Treatment Period 1 (2 Days)||10
11275171|NCT02350309|12470494|FG003|COMPLETED|Treatment Period 1 (2 Days)||11
11275172|NCT02350309|12470495|FG004|COMPLETED|Treatment Period 1 (2 Days)||12
11021675|NCT00805480|12199832|FG003|STARTED|Overall Study||10
11021676|NCT00805480|12199829|FG000|Pharmacodynamic Analysis Set|Overall Study||30
11021677|NCT00805480|12199830|FG001|Pharmacodynamic Analysis Set|Overall Study||25
11021678|NCT00805480|12199831|FG002|Pharmacodynamic Analysis Set|Overall Study||29
11021679|NCT00805480|12199832|FG003|Pharmacodynamic Analysis Set|Overall Study||10
11021680|NCT00805480|12199829|FG000|COMPLETED|Overall Study||16
11021681|NCT00805480|12199830|FG001|COMPLETED|Overall Study||22
11021682|NCT00805480|12199831|FG002|COMPLETED|Overall Study||19
11021683|NCT00805480|12199832|FG003|COMPLETED|Overall Study||5
11275173|NCT02350309|12470496|FG005|COMPLETED|Treatment Period 1 (2 Days)||12
11275174|NCT02350309|12470491|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
11275175|NCT02350309|12470492|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
11275176|NCT02350309|12470493|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||1
11275177|NCT02350309|12470494|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
11275178|NCT02350309|12470495|FG004|NOT COMPLETED|Treatment Period 1 (2 Days)||0
11275179|NCT02350309|12470496|FG005|NOT COMPLETED|Treatment Period 1 (2 Days)||0
11275180|NCT02350309|12470491|FG000|STARTED|Washout Period 1 (12-16 Days)||12
11275181|NCT02350309|12470492|FG001|STARTED|Washout Period 1 (12-16 Days)||11
11275182|NCT02350309|12470493|FG002|STARTED|Washout Period 1 (12-16 Days)||10
11275183|NCT02350309|12470494|FG003|STARTED|Washout Period 1 (12-16 Days)||11
11275184|NCT02350309|12470495|FG004|STARTED|Washout Period 1 (12-16 Days)||12
11275185|NCT02350309|12470496|FG005|STARTED|Washout Period 1 (12-16 Days)||12
11275186|NCT02350309|12470491|FG000|COMPLETED|Washout Period 1 (12-16 Days)||12
11275187|NCT02350309|12470492|FG001|COMPLETED|Washout Period 1 (12-16 Days)||11
11275188|NCT02350309|12470493|FG002|COMPLETED|Washout Period 1 (12-16 Days)||10
11275189|NCT02350309|12470494|FG003|COMPLETED|Washout Period 1 (12-16 Days)||11
11275190|NCT02350309|12470495|FG004|COMPLETED|Washout Period 1 (12-16 Days)||12
11275191|NCT02350309|12470496|FG005|COMPLETED|Washout Period 1 (12-16 Days)||12
11275192|NCT02350309|12470491|FG000|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
11275193|NCT02350309|12470492|FG001|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
11275194|NCT02350309|12470493|FG002|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
11275195|NCT02350309|12470494|FG003|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
11275196|NCT02350309|12470495|FG004|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
11275197|NCT02350309|12470496|FG005|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
11275198|NCT02350309|12470491|FG000|STARTED|Treatment Period 2 (2 Days)||12
11275199|NCT02350309|12470492|FG001|STARTED|Treatment Period 2 (2 Days)||11
11275200|NCT02350309|12470493|FG002|STARTED|Treatment Period 2 (2 Days)||10
11275201|NCT02350309|12470494|FG003|STARTED|Treatment Period 2 (2 Days)||11
11275202|NCT02350309|12470495|FG004|STARTED|Treatment Period 2 (2 Days)||12
11275203|NCT02350309|12470496|FG005|STARTED|Treatment Period 2 (2 Days)||12
11275204|NCT02350309|12470491|FG000|COMPLETED|Treatment Period 2 (2 Days)||12
11275205|NCT02350309|12470492|FG001|COMPLETED|Treatment Period 2 (2 Days)||11
11275206|NCT02350309|12470493|FG002|COMPLETED|Treatment Period 2 (2 Days)||10
11275207|NCT02350309|12470494|FG003|COMPLETED|Treatment Period 2 (2 Days)||11
11275208|NCT02350309|12470495|FG004|COMPLETED|Treatment Period 2 (2 Days)||12
11275209|NCT02350309|12470496|FG005|COMPLETED|Treatment Period 2 (2 Days)||12
11275210|NCT02350309|12470491|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
11275211|NCT02350309|12470492|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
11275212|NCT02350309|12470493|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
11275213|NCT02350309|12470494|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
11275214|NCT02350309|12470495|FG004|NOT COMPLETED|Treatment Period 2 (2 Days)||0
11275215|NCT02350309|12470496|FG005|NOT COMPLETED|Treatment Period 2 (2 Days)||0
11275216|NCT02350309|12470491|FG000|STARTED|Washout Period 2 (12-16 Days)||12
11275217|NCT02350309|12470492|FG001|STARTED|Washout Period 2 (12-16 Days)||11
11275218|NCT02350309|12470493|FG002|STARTED|Washout Period 2 (12-16 Days)||10
11275219|NCT02350309|12470494|FG003|STARTED|Washout Period 2 (12-16 Days)||11
11275220|NCT02350309|12470495|FG004|STARTED|Washout Period 2 (12-16 Days)||12
11275221|NCT02350309|12470496|FG005|STARTED|Washout Period 2 (12-16 Days)||12
11275222|NCT02350309|12470491|FG000|COMPLETED|Washout Period 2 (12-16 Days)||12
11275223|NCT02350309|12470492|FG001|COMPLETED|Washout Period 2 (12-16 Days)||11
11275224|NCT02350309|12470493|FG002|COMPLETED|Washout Period 2 (12-16 Days)||10
11275225|NCT02350309|12470494|FG003|COMPLETED|Washout Period 2 (12-16 Days)||11
11275226|NCT02350309|12470495|FG004|COMPLETED|Washout Period 2 (12-16 Days)||12
11275227|NCT02350309|12470496|FG005|COMPLETED|Washout Period 2 (12-16 Days)||12
11275228|NCT02350309|12470491|FG000|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
11275229|NCT02350309|12470492|FG001|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
11275230|NCT02350309|12470493|FG002|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
11275231|NCT02350309|12470494|FG003|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
11275232|NCT02350309|12470495|FG004|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
11275233|NCT02350309|12470496|FG005|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
11275234|NCT02350309|12470491|FG000|STARTED|Treatment Period 3 (2 Days)||12
11398238|NCT04502056|12592597|FG011|STARTED|Overall Study||1020
11021684|NCT00805480|12199829|FG000|NOT COMPLETED|Overall Study||14
11021685|NCT00805480|12199830|FG001|NOT COMPLETED|Overall Study||7
11021686|NCT00805480|12199831|FG002|NOT COMPLETED|Overall Study||12
11275235|NCT02350309|12470492|FG001|STARTED|Treatment Period 3 (2 Days)||11
11275236|NCT02350309|12470493|FG002|STARTED|Treatment Period 3 (2 Days)||10
11275237|NCT02350309|12470494|FG003|STARTED|Treatment Period 3 (2 Days)||11
11275238|NCT02350309|12470495|FG004|STARTED|Treatment Period 3 (2 Days)||12
11275239|NCT02350309|12470496|FG005|STARTED|Treatment Period 3 (2 Days)||12
11275240|NCT02350309|12470491|FG000|COMPLETED|Treatment Period 3 (2 Days)||12
11275241|NCT02350309|12470492|FG001|COMPLETED|Treatment Period 3 (2 Days)||11
11275242|NCT02350309|12470493|FG002|COMPLETED|Treatment Period 3 (2 Days)||10
11275243|NCT02350309|12470494|FG003|COMPLETED|Treatment Period 3 (2 Days)||11
11275244|NCT02350309|12470495|FG004|COMPLETED|Treatment Period 3 (2 Days)||12
11275245|NCT02350309|12470496|FG005|COMPLETED|Treatment Period 3 (2 Days)||12
11275246|NCT02350309|12470491|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
11275247|NCT02350309|12470492|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
11275248|NCT02350309|12470493|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
11275249|NCT02350309|12470494|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
11275250|NCT02350309|12470495|FG004|NOT COMPLETED|Treatment Period 3 (2 Days)||0
11275251|NCT02350309|12470496|FG005|NOT COMPLETED|Treatment Period 3 (2 Days)||0
11275252|NCT02350309|12470491|FG000|STARTED|Washout Period 3 (12-16 Days)||12
11275253|NCT02350309|12470492|FG001|STARTED|Washout Period 3 (12-16 Days)||11
11275254|NCT02350309|12470493|FG002|STARTED|Washout Period 3 (12-16 Days)||10
11275255|NCT02350309|12470494|FG003|STARTED|Washout Period 3 (12-16 Days)||11
11275256|NCT02350309|12470495|FG004|STARTED|Washout Period 3 (12-16 Days)||12
11275257|NCT02350309|12470496|FG005|STARTED|Washout Period 3 (12-16 Days)||12
11275258|NCT02350309|12470491|FG000|COMPLETED|Washout Period 3 (12-16 Days)||12
11275259|NCT02350309|12470492|FG001|COMPLETED|Washout Period 3 (12-16 Days)||11
11275260|NCT02350309|12470493|FG002|COMPLETED|Washout Period 3 (12-16 Days)||10
11275261|NCT02350309|12470494|FG003|COMPLETED|Washout Period 3 (12-16 Days)||11
11275262|NCT02350309|12470495|FG004|COMPLETED|Washout Period 3 (12-16 Days)||12
11275263|NCT02350309|12470496|FG005|COMPLETED|Washout Period 3 (12-16 Days)||12
11275264|NCT02350309|12470491|FG000|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
11275265|NCT02350309|12470492|FG001|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
11275266|NCT02350309|12470493|FG002|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
11275267|NCT02350309|12470494|FG003|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
11275268|NCT02350309|12470495|FG004|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
11275269|NCT02350309|12470496|FG005|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
11275270|NCT02350309|12470491|FG000|STARTED|Treatment Period 4 (2 Days)||12
11275271|NCT02350309|12470492|FG001|STARTED|Treatment Period 4 (2 Days)||11
11275272|NCT02350309|12470493|FG002|STARTED|Treatment Period 4 (2 Days)||10
11275273|NCT02350309|12470494|FG003|STARTED|Treatment Period 4 (2 Days)||11
11275274|NCT02350309|12470495|FG004|STARTED|Treatment Period 4 (2 Days)||12
11275275|NCT02350309|12470496|FG005|STARTED|Treatment Period 4 (2 Days)||12
11275276|NCT02350309|12470491|FG000|COMPLETED|Treatment Period 4 (2 Days)||12
11275277|NCT02350309|12470492|FG001|COMPLETED|Treatment Period 4 (2 Days)||11
11275278|NCT02350309|12470493|FG002|COMPLETED|Treatment Period 4 (2 Days)||10
11275279|NCT02350309|12470494|FG003|COMPLETED|Treatment Period 4 (2 Days)||11
11275280|NCT02350309|12470495|FG004|COMPLETED|Treatment Period 4 (2 Days)||12
11275281|NCT02350309|12470496|FG005|COMPLETED|Treatment Period 4 (2 Days)||11
11275282|NCT02350309|12470491|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0
11275283|NCT02350309|12470492|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
11275284|NCT02350309|12470493|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
11275285|NCT02350309|12470494|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
11275286|NCT02350309|12470495|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0
11275287|NCT02350309|12470496|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||1
11275288|NCT02350478|12470513|FG000|STARTED|Overall Study||25
11275289|NCT02350478|12470514|FG001|STARTED|Overall Study||24
11275290|NCT02350478|12470513|FG000|COMPLETED|Overall Study||20
11275291|NCT02350478|12470514|FG001|COMPLETED|Overall Study||23
11275292|NCT02350478|12470513|FG000|NOT COMPLETED|Overall Study||5
11021687|NCT00805480|12199832|FG003|NOT COMPLETED|Overall Study||5
11275293|NCT02350478|12470514|FG001|NOT COMPLETED|Overall Study||1
11275294|NCT02350569|12470520|FG000|STARTED|Main Study (LDV/SOF 4 Weeks)||16
11275295|NCT02350569|12470520|FG000|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
11275296|NCT02350569|12470520|FG000|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
11340557|NCT02922582|12537853|FG000|COMPLETED|Overall Study||4
11275297|NCT02350569|12470520|FG000|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
11275298|NCT02350569|12470520|FG000|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
11275299|NCT02350569|12470520|FG000|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
11275300|NCT02350647|12470528|FG000|STARTED|Overall Study||32
11275301|NCT02350647|12470529|FG001|STARTED|Overall Study||32
11275302|NCT02350647|12470528|FG000|COMPLETED|Overall Study||26
11275303|NCT02350647|12470529|FG001|COMPLETED|Overall Study||26
11275304|NCT02350647|12470528|FG000|NOT COMPLETED|Overall Study||6
11275305|NCT02350647|12470529|FG001|NOT COMPLETED|Overall Study||6
11275306|NCT02350660|12470537|FG000|STARTED|Overall Study||7
11275307|NCT02350660|12470538|FG001|STARTED|Overall Study||17
11275308|NCT02350660|12470537|FG000|COMPLETED|Overall Study||7
11275309|NCT02350660|12470538|FG001|COMPLETED|Overall Study||17
11275310|NCT02350660|12470537|FG000|NOT COMPLETED|Overall Study||0
11275311|NCT02350660|12470538|FG001|NOT COMPLETED|Overall Study||0
11275312|NCT02350816|12470548|FG000|STARTED|Overall Study||7
11275313|NCT02350816|12470549|FG001|STARTED|Overall Study||6
11275314|NCT02350816|12470550|FG002|STARTED|Overall Study||2
11275315|NCT02350816|12470551|FG003|STARTED|Overall Study||2
11275316|NCT02350816|12470548|FG000|COMPLETED|Overall Study||7
11275317|NCT02350816|12470549|FG001|COMPLETED|Overall Study||6
11275318|NCT02350816|12470550|FG002|COMPLETED|Overall Study||2
11275319|NCT02350816|12470551|FG003|COMPLETED|Overall Study||2
11275320|NCT02350816|12470548|FG000|NOT COMPLETED|Overall Study||0
11275321|NCT02350816|12470549|FG001|NOT COMPLETED|Overall Study||0
11275322|NCT02350816|12470550|FG002|NOT COMPLETED|Overall Study||0
11275323|NCT02350816|12470551|FG003|NOT COMPLETED|Overall Study||0
11275324|NCT02350881|12470561|FG000|STARTED|Overall Study|64 patients were included (6 bilateral)|64
11275325|NCT02350881|12470561|FG000|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
11275326|NCT02350881|12470561|FG000|NOT COMPLETED|Overall Study||0
11275327|NCT02350998|12470586|FG000|STARTED|Overall Study||33
11275328|NCT02350998|12470586|FG000|COMPLETED|Overall Study||33
11275329|NCT02350998|12470586|FG000|NOT COMPLETED|Overall Study||0
11275330|NCT02351037|12470595|FG000|STARTED|Overall Study||7
11275331|NCT02351037|12470596|FG001|STARTED|Overall Study||21
11275332|NCT02351037|12470597|FG002|STARTED|Overall Study||8
11275333|NCT02351037|12470595|FG000|COMPLETED|Overall Study||7
11275334|NCT02351037|12470596|FG001|COMPLETED|Overall Study||21
11275335|NCT02351037|12470597|FG002|COMPLETED|Overall Study||8
11275336|NCT02351037|12470595|FG000|NOT COMPLETED|Overall Study||0
11275337|NCT02351037|12470596|FG001|NOT COMPLETED|Overall Study||0
11275338|NCT02351037|12470597|FG002|NOT COMPLETED|Overall Study||0
11275339|NCT02351115|12470610|FG000|STARTED|Overall Study||1
11275340|NCT02351115|12470611|FG001|STARTED|Overall Study||1
11275341|NCT02351115|12470612|FG002|STARTED|Overall Study||1
11275342|NCT02351115|12470613|FG003|STARTED|Overall Study||1
11275343|NCT02351115|12470614|FG004|STARTED|Overall Study||1
11275344|NCT02351115|12470610|FG000|COMPLETED|Overall Study||1
11275345|NCT02351115|12470611|FG001|COMPLETED|Overall Study||1
11021688|NCT00805493|12199845|FG000|STARTED|Overall Study||3
11021689|NCT00805493|12199846|FG001|STARTED|Overall Study||2
11021690|NCT00805493|12199847|FG002|STARTED|Overall Study||1
11021691|NCT00805493|12199845|FG000|COMPLETED|Overall Study||1
11021692|NCT00805493|12199846|FG001|COMPLETED|Overall Study||2
11021693|NCT00805493|12199847|FG002|COMPLETED|Overall Study||0
11021694|NCT00805493|12199845|FG000|NOT COMPLETED|Overall Study||2
11021695|NCT00805493|12199846|FG001|NOT COMPLETED|Overall Study||0
11021696|NCT00805493|12199847|FG002|NOT COMPLETED|Overall Study||1
11021697|NCT00805532|12199860|FG000|STARTED|Overall Study||42
11021698|NCT00805532|12199861|FG001|STARTED|Overall Study||39
11021699|NCT00805532|12199860|FG000|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
11021700|NCT00805532|12199861|FG001|COMPLETED|Overall Study||38
11021701|NCT00805532|12199860|FG000|NOT COMPLETED|Overall Study||0
11021702|NCT00805532|12199861|FG001|NOT COMPLETED|Overall Study||1
11275346|NCT02351115|12470612|FG002|COMPLETED|Overall Study||1
11275347|NCT02351115|12470613|FG003|COMPLETED|Overall Study||1
11275348|NCT02351115|12470614|FG004|COMPLETED|Overall Study||1
11275349|NCT02351115|12470610|FG000|NOT COMPLETED|Overall Study||0
11275350|NCT02351115|12470611|FG001|NOT COMPLETED|Overall Study||0
11275351|NCT02351115|12470612|FG002|NOT COMPLETED|Overall Study||0
11275352|NCT02351115|12470613|FG003|NOT COMPLETED|Overall Study||0
11275353|NCT02351115|12470614|FG004|NOT COMPLETED|Overall Study||0
11275354|NCT02351167|12470630|FG000|STARTED|Overall Study||275
11021703|NCT00805545|12199871|FG000|STARTED|Overall Study||200
11021704|NCT00805545|12199872|FG001|STARTED|Overall Study||200
11275355|NCT02351167|12470631|FG001|STARTED|Overall Study||274
11275356|NCT02351167|12470632|FG002|STARTED|Overall Study||273
11275357|NCT02351167|12470630|FG000|COMPLETED|Overall Study||256
11275358|NCT02351167|12470631|FG001|COMPLETED|Overall Study||256
11275359|NCT02351167|12470632|FG002|COMPLETED|Overall Study||252
11275360|NCT02351167|12470630|FG000|NOT COMPLETED|Overall Study||19
11275361|NCT02351167|12470631|FG001|NOT COMPLETED|Overall Study||18
11275362|NCT02351167|12470632|FG002|NOT COMPLETED|Overall Study||21
11021705|NCT00805545|12199871|FG000|COMPLETED|Overall Study||194
11021706|NCT00805545|12199872|FG001|COMPLETED|Overall Study||197
11021707|NCT00805545|12199871|FG000|NOT COMPLETED|Overall Study||6
11021708|NCT00805545|12199872|FG001|NOT COMPLETED|Overall Study||3
11021709|NCT00805675|12199881|FG000|STARTED|Overall Study||16
11021710|NCT00805675|12199882|FG001|STARTED|Overall Study||14
11021711|NCT00805675|12199883|FG002|STARTED|Overall Study||16
11275363|NCT02351258|12470641|FG000|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
11275364|NCT02351258|12470642|FG001|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
11275365|NCT02351258|12470641|FG000|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
11275366|NCT02351258|12470642|FG001|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
11275367|NCT02351258|12470641|FG000|NOT COMPLETED|Intervention 1 (12 Months)||
11275368|NCT02351258|12470642|FG001|NOT COMPLETED|Intervention 1 (12 Months)||
11275369|NCT02351258|12470641|FG000|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
11275370|NCT02351258|12470642|FG001|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
11275371|NCT02351258|12470641|FG000|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
11275372|NCT02351258|12470642|FG001|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
11275373|NCT02351258|12470641|FG000|NOT COMPLETED|Washout (2-3 Months)||
11275374|NCT02351258|12470642|FG001|NOT COMPLETED|Washout (2-3 Months)||
11275375|NCT02351258|12470641|FG000|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
11398239|NCT04502056|12592586|FG000|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1859
11398240|NCT04502056|12592587|FG001|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1881
11398241|NCT04502056|12592588|FG002|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1879
11398242|NCT04502056|12592589|FG003|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1886
11398243|NCT04502056|12592590|FG004|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1846
11275376|NCT02351258|12470642|FG001|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
11275377|NCT02351258|12470641|FG000|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
11275378|NCT02351258|12470642|FG001|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
11275379|NCT02351258|12470641|FG000|NOT COMPLETED|Intervention 2 (12 Months)||
11275380|NCT02351258|12470642|FG001|NOT COMPLETED|Intervention 2 (12 Months)||
11275381|NCT02351271|12470649|FG000|STARTED|Overall Study||68
11275382|NCT02351271|12470650|FG001|STARTED|Overall Study||62
11398244|NCT04502056|12592591|FG005|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1877
11275383|NCT02351271|12470649|FG000|COMPLETED|Overall Study||68
11275384|NCT02351271|12470650|FG001|COMPLETED|Overall Study||62
11275385|NCT02351271|12470649|FG000|NOT COMPLETED|Overall Study||0
11275386|NCT02351271|12470650|FG001|NOT COMPLETED|Overall Study||0
11275387|NCT02351349|12470660|FG000|STARTED|Overall Study||6
11275388|NCT02351349|12470661|FG001|STARTED|Overall Study||8
11275389|NCT02351349|12470660|FG000|COMPLETED|Overall Study||4
11275390|NCT02351349|12470661|FG001|COMPLETED|Overall Study||5
11275391|NCT02351349|12470660|FG000|NOT COMPLETED|Overall Study||2
11275392|NCT02351349|12470661|FG001|NOT COMPLETED|Overall Study||3
11275393|NCT02351505|12470672|FG000|STARTED|Overall Study||1
11275394|NCT02351505|12470672|FG000|COMPLETED|Overall Study||1
11275395|NCT02351505|12470672|FG000|NOT COMPLETED|Overall Study||0
11275396|NCT02351700|12470679|FG000|STARTED|Overall Study||28
11275397|NCT02351700|12470680|FG001|STARTED|Overall Study||34
11275398|NCT02351700|12470679|FG000|COMPLETED|Overall Study||28
11275399|NCT02351700|12470680|FG001|COMPLETED|Overall Study||34
11275400|NCT02351700|12470679|FG000|NOT COMPLETED|Overall Study||0
11275401|NCT02351700|12470680|FG001|NOT COMPLETED|Overall Study||0
11275402|NCT02351739|12470690|FG000|STARTED|Overall Study||38
11275403|NCT02351739|12470691|FG001|STARTED|Overall Study||40
11275404|NCT02351739|12470690|FG000|Enrolled|Overall Study||38
11275405|NCT02351739|12470691|FG001|Enrolled|Overall Study||40
11275406|NCT02351739|12470690|FG000|Received Study Medication|Overall Study||35
11275407|NCT02351739|12470691|FG001|Received Study Medication|Overall Study||40
11275408|NCT02351739|12470690|FG000|Discontinued Study|Overall Study||38
11275409|NCT02351739|12470691|FG001|Discontinued Study|Overall Study||40
11275410|NCT02351739|12470690|FG000|COMPLETED|Overall Study||0
11275411|NCT02351739|12470691|FG001|COMPLETED|Overall Study||0
11275412|NCT02351739|12470690|FG000|NOT COMPLETED|Overall Study||38
11275413|NCT02351739|12470691|FG001|NOT COMPLETED|Overall Study||40
11275414|NCT02351817|12470697|FG000|STARTED|Baseline Period||5
11275415|NCT02351817|12470698|FG001|STARTED|Baseline Period||5
11275416|NCT02351817|12470697|FG000|COMPLETED|Baseline Period||5
11275417|NCT02351817|12470698|FG001|COMPLETED|Baseline Period||5
11275418|NCT02351817|12470697|FG000|NOT COMPLETED|Baseline Period||0
11275419|NCT02351817|12470698|FG001|NOT COMPLETED|Baseline Period||0
11275420|NCT02351817|12470697|FG000|STARTED|Period 1||5
11275421|NCT02351817|12470698|FG001|STARTED|Period 1||5
11275422|NCT02351817|12470697|FG000|COMPLETED|Period 1||4
11275423|NCT02351817|12470698|FG001|COMPLETED|Period 1||2
11275424|NCT02351817|12470697|FG000|NOT COMPLETED|Period 1||1
11275425|NCT02351817|12470698|FG001|NOT COMPLETED|Period 1||3
11275426|NCT02351817|12470697|FG000|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
11275427|NCT02351817|12470698|FG001|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
11275428|NCT02351817|12470697|FG000|COMPLETED|Period 2||4
11275429|NCT02351817|12470698|FG001|COMPLETED|Period 2||3
11275430|NCT02351817|12470697|FG000|NOT COMPLETED|Period 2||1
11275431|NCT02351817|12470698|FG001|NOT COMPLETED|Period 2||2
11275432|NCT02351934|12470707|FG000|STARTED|Allocation||62
11275433|NCT02351934|12470708|FG001|STARTED|Allocation||61
11275434|NCT02351934|12470707|FG000|Received Allocation|Allocation||56
11275435|NCT02351934|12470708|FG001|Received Allocation|Allocation||61
11275436|NCT02351934|12470707|FG000|COMPLETED|Allocation||56
11275437|NCT02351934|12470708|FG001|COMPLETED|Allocation||61
11275438|NCT02351934|12470707|FG000|NOT COMPLETED|Allocation||6
11275439|NCT02351934|12470708|FG001|NOT COMPLETED|Allocation||0
11275440|NCT02351934|12470707|FG000|STARTED|Follow-Up||56
11275441|NCT02351934|12470708|FG001|STARTED|Follow-Up||61
11275442|NCT02351934|12470707|FG000|COMPLETED|Follow-Up||44
11275443|NCT02351934|12470708|FG001|COMPLETED|Follow-Up||51
11275444|NCT02351934|12470707|FG000|NOT COMPLETED|Follow-Up||12
11275445|NCT02351934|12470708|FG001|NOT COMPLETED|Follow-Up||10
11275446|NCT02351960|12470716|FG000|STARTED|Overall Study||208
11275447|NCT02351960|12470717|FG001|STARTED|Overall Study||88
11275448|NCT02351960|12470716|FG000|COMPLETED|Overall Study||197
11275449|NCT02351960|12470717|FG001|COMPLETED|Overall Study||76
11275450|NCT02351960|12470716|FG000|NOT COMPLETED|Overall Study||11
11275451|NCT02351960|12470717|FG001|NOT COMPLETED|Overall Study||12
11275452|NCT02352259|12470724|FG000|STARTED|Overall Study||23
11275453|NCT02352259|12470724|FG000|COMPLETED|Overall Study||23
11275454|NCT02352259|12470724|FG000|NOT COMPLETED|Overall Study||0
11275455|NCT02352298|12470728|FG000|STARTED|Overall Study||52
11275456|NCT02352298|12470728|FG000|COMPLETED|Overall Study||52
11275457|NCT02352298|12470728|FG000|NOT COMPLETED|Overall Study||0
11275458|NCT02352363|12470735|FG000|STARTED|Overall Study||278
11275459|NCT02352363|12470736|FG001|STARTED|Overall Study||130
11275460|NCT02352363|12470735|FG000|COMPLETED|Overall Study||271
11275461|NCT02352363|12470736|FG001|COMPLETED|Overall Study||127
11275462|NCT02352363|12470735|FG000|NOT COMPLETED|Overall Study||7
11275463|NCT02352363|12470736|FG001|NOT COMPLETED|Overall Study||3
11275464|NCT02352493|12470760|FG000|STARTED|Overall Study||8
11275465|NCT02352493|12470761|FG001|STARTED|Overall Study||3
11275466|NCT02352493|12470762|FG002|STARTED|Overall Study||3
11275467|NCT02352493|12470763|FG003|STARTED|Overall Study||3
11275468|NCT02352493|12470764|FG004|STARTED|Overall Study||3
11275469|NCT02352493|12470765|FG005|STARTED|Overall Study||3
11275470|NCT02352493|12470766|FG006|STARTED|Overall Study||3
11275471|NCT02352493|12470767|FG007|STARTED|Overall Study||3
11275472|NCT02352493|12470768|FG008|STARTED|Overall Study||3
11275473|NCT02352493|12470769|FG009|STARTED|Overall Study||6
11143753|NCT01474512|12330438|FG016|STARTED|Long-Term Extension Period||0
11143754|NCT01474512|12330439|FG017|STARTED|Long-Term Extension Period||0
11143755|NCT01474512|12330422|FG000|COMPLETED|Long-Term Extension Period||0
11143756|NCT01474512|12330423|FG001|COMPLETED|Long-Term Extension Period||0
11143757|NCT01474512|12330424|FG002|COMPLETED|Long-Term Extension Period||0
11143758|NCT01474512|12330425|FG003|COMPLETED|Long-Term Extension Period||0
11143759|NCT01474512|12330426|FG004|COMPLETED|Long-Term Extension Period||0
11143760|NCT01474512|12330427|FG005|COMPLETED|Long-Term Extension Period||0
11143761|NCT01474512|12330428|FG006|COMPLETED|Long-Term Extension Period||0
11275474|NCT02352493|12470770|FG010|STARTED|Overall Study||3
11275475|NCT02352493|12470771|FG011|STARTED|Overall Study||3
11275476|NCT02352493|12470772|FG012|STARTED|Overall Study||3
11275477|NCT02352493|12470773|FG013|STARTED|Overall Study||3
11275478|NCT02352493|12470774|FG014|STARTED|Overall Study||3
11275479|NCT02352493|12470775|FG015|STARTED|Overall Study||3
11275480|NCT02352493|12470776|FG016|STARTED|Overall Study||3
11275481|NCT02352493|12470777|FG017|STARTED|Overall Study||3
11275482|NCT02352493|12470760|FG000|COMPLETED|Overall Study||8
11275483|NCT02352493|12470761|FG001|COMPLETED|Overall Study||3
11275484|NCT02352493|12470762|FG002|COMPLETED|Overall Study||3
11275485|NCT02352493|12470763|FG003|COMPLETED|Overall Study||3
11275486|NCT02352493|12470764|FG004|COMPLETED|Overall Study||3
11275487|NCT02352493|12470765|FG005|COMPLETED|Overall Study||3
11275488|NCT02352493|12470766|FG006|COMPLETED|Overall Study||2
11275489|NCT02352493|12470767|FG007|COMPLETED|Overall Study||3
11275490|NCT02352493|12470768|FG008|COMPLETED|Overall Study||1
11275491|NCT02352493|12470769|FG009|COMPLETED|Overall Study||5
11275492|NCT02352493|12470770|FG010|COMPLETED|Overall Study||3
11275493|NCT02352493|12470771|FG011|COMPLETED|Overall Study||3
11275494|NCT02352493|12470772|FG012|COMPLETED|Overall Study||2
11275495|NCT02352493|12470773|FG013|COMPLETED|Overall Study||1
11275496|NCT02352493|12470774|FG014|COMPLETED|Overall Study||2
11275497|NCT02352493|12470775|FG015|COMPLETED|Overall Study||3
11275498|NCT02352493|12470776|FG016|COMPLETED|Overall Study||3
11143762|NCT01474512|12330429|FG007|COMPLETED|Long-Term Extension Period||0
11275499|NCT02352493|12470777|FG017|COMPLETED|Overall Study||3
11275500|NCT02352493|12470760|FG000|NOT COMPLETED|Overall Study||0
11275501|NCT02352493|12470761|FG001|NOT COMPLETED|Overall Study||0
11275502|NCT02352493|12470762|FG002|NOT COMPLETED|Overall Study||0
11275503|NCT02352493|12470763|FG003|NOT COMPLETED|Overall Study||0
11275504|NCT02352493|12470764|FG004|NOT COMPLETED|Overall Study||0
11275505|NCT02352493|12470765|FG005|NOT COMPLETED|Overall Study||0
11275506|NCT02352493|12470766|FG006|NOT COMPLETED|Overall Study||1
11275507|NCT02352493|12470767|FG007|NOT COMPLETED|Overall Study||0
11275508|NCT02352493|12470768|FG008|NOT COMPLETED|Overall Study||2
11275509|NCT02352493|12470769|FG009|NOT COMPLETED|Overall Study||1
11275510|NCT02352493|12470770|FG010|NOT COMPLETED|Overall Study||0
11275511|NCT02352493|12470771|FG011|NOT COMPLETED|Overall Study||0
11275512|NCT02352493|12470772|FG012|NOT COMPLETED|Overall Study||1
11275513|NCT02352493|12470773|FG013|NOT COMPLETED|Overall Study||2
11275514|NCT02352493|12470774|FG014|NOT COMPLETED|Overall Study||1
11275515|NCT02352493|12470775|FG015|NOT COMPLETED|Overall Study||0
11275516|NCT02352493|12470776|FG016|NOT COMPLETED|Overall Study||0
11275517|NCT02352493|12470777|FG017|NOT COMPLETED|Overall Study||0
11275518|NCT02352779|12470835|FG000|STARTED|Overall Study||37
11275519|NCT02352779|12470836|FG001|STARTED|Overall Study||36
11275520|NCT02352779|12470837|FG002|STARTED|Overall Study||35
11275521|NCT02352779|12470835|FG000|COMPLETED|Overall Study||29
11275522|NCT02352779|12470836|FG001|COMPLETED|Overall Study||35
11275523|NCT02352779|12470837|FG002|COMPLETED|Overall Study||33
11275524|NCT02352779|12470835|FG000|NOT COMPLETED|Overall Study||8
11275525|NCT02352779|12470836|FG001|NOT COMPLETED|Overall Study||1
11275526|NCT02352779|12470837|FG002|NOT COMPLETED|Overall Study||2
11275527|NCT02352831|12470847|FG000|STARTED|Overall Study||6
11275528|NCT02352831|12470848|FG001|STARTED|Overall Study||10
11275529|NCT02352831|12470847|FG000|COMPLETED|Overall Study||6
11275530|NCT02352831|12470848|FG001|COMPLETED|Overall Study||10
11275531|NCT02352831|12470847|FG000|NOT COMPLETED|Overall Study||0
11275532|NCT02352831|12470848|FG001|NOT COMPLETED|Overall Study||0
11275533|NCT02352844|12470856|FG000|STARTED|Overall Study||12
11275534|NCT02352844|12470856|FG000|COMPLETED|Overall Study||12
11275535|NCT02352844|12470856|FG000|NOT COMPLETED|Overall Study||0
11275536|NCT02352922|12470862|FG000|STARTED|Overall Study||32
11275537|NCT02352922|12470863|FG001|STARTED|Overall Study||32
11275538|NCT02352922|12470862|FG000|COMPLETED|Overall Study|completed POD14 Survey|28
11275539|NCT02352922|12470863|FG001|COMPLETED|Overall Study|Completed POD14 survey|28
11275540|NCT02352922|12470862|FG000|NOT COMPLETED|Overall Study||4
11275541|NCT02352922|12470863|FG001|NOT COMPLETED|Overall Study||4
11275542|NCT02352974|12470869|FG000|STARTED|Main Study||12
11275543|NCT02352974|12470869|FG000|COMPLETED|Main Study||12
11275544|NCT02352974|12470869|FG000|NOT COMPLETED|Main Study||0
11275545|NCT02352974|12470869|FG000|STARTED|Extension|Only 3 out of the 12 patients who completed the main study continued in to the extension period.|3
11275546|NCT02352974|12470869|FG000|COMPLETED|Extension||3
11275547|NCT02352974|12470869|FG000|NOT COMPLETED|Extension||0
11275548|NCT02353091|12470875|FG000|STARTED|Overall Study||13
11275549|NCT02353091|12470876|FG001|STARTED|Overall Study||13
11275550|NCT02353091|12470875|FG000|COMPLETED|Overall Study||13
11275551|NCT02353091|12470876|FG001|COMPLETED|Overall Study||13
11275552|NCT02353091|12470875|FG000|NOT COMPLETED|Overall Study||0
11275553|NCT02353091|12470876|FG001|NOT COMPLETED|Overall Study||0
11275554|NCT02353169|12470895|FG000|STARTED|Overall Study||15
11275555|NCT02353169|12470896|FG001|STARTED|Overall Study||18
11275556|NCT02353169|12470897|FG002|STARTED|Overall Study||16
11275557|NCT02353169|12470898|FG003|STARTED|Overall Study||15
11275558|NCT02353169|12470895|FG000|COMPLETED|Overall Study||12
11275559|NCT02353169|12470896|FG001|COMPLETED|Overall Study||12
11275560|NCT02353169|12470897|FG002|COMPLETED|Overall Study||12
11275561|NCT02353169|12470898|FG003|COMPLETED|Overall Study||12
11275562|NCT02353169|12470895|FG000|NOT COMPLETED|Overall Study||3
11275563|NCT02353169|12470896|FG001|NOT COMPLETED|Overall Study||6
11275564|NCT02353169|12470897|FG002|NOT COMPLETED|Overall Study||4
11275565|NCT02353169|12470898|FG003|NOT COMPLETED|Overall Study||3
11275566|NCT02353299|12470908|FG000|STARTED|First Intervention (1 Night)||13
11275567|NCT02353299|12470909|FG001|STARTED|First Intervention (1 Night)||13
11275568|NCT02353299|12470910|FG002|STARTED|First Intervention (1 Night)||13
11275569|NCT02353299|12470911|FG003|STARTED|First Intervention (1 Night)||13
11275570|NCT02353299|12470908|FG000|COMPLETED|First Intervention (1 Night)||13
11275571|NCT02353299|12470909|FG001|COMPLETED|First Intervention (1 Night)||13
11275572|NCT02353299|12470910|FG002|COMPLETED|First Intervention (1 Night)||13
11275573|NCT02353299|12470911|FG003|COMPLETED|First Intervention (1 Night)||13
11275574|NCT02353299|12470908|FG000|NOT COMPLETED|First Intervention (1 Night)||0
11275575|NCT02353299|12470909|FG001|NOT COMPLETED|First Intervention (1 Night)||0
11275576|NCT02353299|12470910|FG002|NOT COMPLETED|First Intervention (1 Night)||0
11275577|NCT02353299|12470911|FG003|NOT COMPLETED|First Intervention (1 Night)||0
11275578|NCT02353299|12470908|FG000|STARTED|Second Intervention (1 Night)||13
11275579|NCT02353299|12470909|FG001|STARTED|Second Intervention (1 Night)||13
11275580|NCT02353299|12470910|FG002|STARTED|Second Intervention (1 Night)||13
11275581|NCT02353299|12470911|FG003|STARTED|Second Intervention (1 Night)||13
11275582|NCT02353299|12470908|FG000|COMPLETED|Second Intervention (1 Night)||13
11275583|NCT02353299|12470909|FG001|COMPLETED|Second Intervention (1 Night)||13
11275584|NCT02353299|12470910|FG002|COMPLETED|Second Intervention (1 Night)||13
11275585|NCT02353299|12470911|FG003|COMPLETED|Second Intervention (1 Night)||13
11275586|NCT02353299|12470908|FG000|NOT COMPLETED|Second Intervention (1 Night)||0
11275587|NCT02353299|12470909|FG001|NOT COMPLETED|Second Intervention (1 Night)||0
11275588|NCT02353299|12470910|FG002|NOT COMPLETED|Second Intervention (1 Night)||0
11275589|NCT02353299|12470911|FG003|NOT COMPLETED|Second Intervention (1 Night)||0
11275590|NCT02353299|12470908|FG000|STARTED|Third Intervention (1 Night)||13
11275591|NCT02353299|12470909|FG001|STARTED|Third Intervention (1 Night)||13
11275592|NCT02353299|12470910|FG002|STARTED|Third Intervention (1 Night)||13
11275593|NCT02353299|12470911|FG003|STARTED|Third Intervention (1 Night)||13
11275594|NCT02353299|12470908|FG000|COMPLETED|Third Intervention (1 Night)||13
11275595|NCT02353299|12470909|FG001|COMPLETED|Third Intervention (1 Night)||13
11275596|NCT02353299|12470910|FG002|COMPLETED|Third Intervention (1 Night)||13
11275597|NCT02353299|12470911|FG003|COMPLETED|Third Intervention (1 Night)||13
11275598|NCT02353299|12470908|FG000|NOT COMPLETED|Third Intervention (1 Night)||0
11275599|NCT02353299|12470909|FG001|NOT COMPLETED|Third Intervention (1 Night)||0
11275600|NCT02353299|12470910|FG002|NOT COMPLETED|Third Intervention (1 Night)||0
11275601|NCT02353299|12470911|FG003|NOT COMPLETED|Third Intervention (1 Night)||0
11275602|NCT02353299|12470908|FG000|STARTED|Fourth Intervention (1 Night)||13
11275603|NCT02353299|12470909|FG001|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
11275604|NCT02353299|12470910|FG002|STARTED|Fourth Intervention (1 Night)||13
11275605|NCT02353299|12470911|FG003|STARTED|Fourth Intervention (1 Night)||13
11275606|NCT02353299|12470908|FG000|COMPLETED|Fourth Intervention (1 Night)||13
11275607|NCT02353299|12470909|FG001|COMPLETED|Fourth Intervention (1 Night)||12
11275608|NCT02353299|12470910|FG002|COMPLETED|Fourth Intervention (1 Night)||13
11275609|NCT02353299|12470911|FG003|COMPLETED|Fourth Intervention (1 Night)||13
11275610|NCT02353299|12470908|FG000|NOT COMPLETED|Fourth Intervention (1 Night)||0
11275611|NCT02353299|12470909|FG001|NOT COMPLETED|Fourth Intervention (1 Night)||0
11275612|NCT02353299|12470910|FG002|NOT COMPLETED|Fourth Intervention (1 Night)||0
11275613|NCT02353299|12470911|FG003|NOT COMPLETED|Fourth Intervention (1 Night)||0
11275614|NCT02353442|12470931|FG000|STARTED|Overall Study||28
11275615|NCT02353442|12470932|FG001|STARTED|Overall Study||31
11275616|NCT02353442|12470931|FG000|COMPLETED|Overall Study||25
11275617|NCT02353442|12470932|FG001|COMPLETED|Overall Study||27
11275618|NCT02353442|12470931|FG000|NOT COMPLETED|Overall Study||3
11275619|NCT02353442|12470932|FG001|NOT COMPLETED|Overall Study||4
11275620|NCT02353754|12470940|FG000|STARTED|Overall Study||12
11275621|NCT02353754|12470941|FG001|STARTED|Overall Study||0
11275622|NCT02353754|12470940|FG000|COMPLETED|Overall Study||10
11275623|NCT02353754|12470941|FG001|COMPLETED|Overall Study||0
11275624|NCT02353754|12470940|FG000|NOT COMPLETED|Overall Study||2
11275625|NCT02353754|12470941|FG001|NOT COMPLETED|Overall Study||0
11275626|NCT02353780|12470950|FG000|STARTED|Overall Study||3
11275627|NCT02353780|12470951|FG001|STARTED|Overall Study||3
11275628|NCT02353780|12470952|FG002|STARTED|Overall Study||3
11275629|NCT02353780|12470950|FG000|COMPLETED|Overall Study||3
11275630|NCT02353780|12470951|FG001|COMPLETED|Overall Study||3
11275631|NCT02353780|12470952|FG002|COMPLETED|Overall Study||3
11275632|NCT02353780|12470950|FG000|NOT COMPLETED|Overall Study||0
11275633|NCT02353780|12470951|FG001|NOT COMPLETED|Overall Study||0
11275634|NCT02353780|12470952|FG002|NOT COMPLETED|Overall Study||0
11275635|NCT02353806|12470960|FG000|STARTED|Overall Study||16
11275636|NCT02353806|12470960|FG000|COMPLETED|Overall Study||6
11275637|NCT02353806|12470960|FG000|NOT COMPLETED|Overall Study||10
11275638|NCT02354092|12470968|FG000|STARTED|Overall Study||7
11275639|NCT02354092|12470969|FG001|STARTED|Overall Study||7
11275640|NCT02354092|12470968|FG000|COMPLETED|Overall Study||7
11275641|NCT02354092|12470969|FG001|COMPLETED|Overall Study||7
11275642|NCT02354092|12470968|FG000|NOT COMPLETED|Overall Study||0
11275643|NCT02354092|12470969|FG001|NOT COMPLETED|Overall Study||0
11275644|NCT02354144|12470977|FG000|STARTED|Overall Study||127
11275645|NCT02354144|12470978|FG001|STARTED|Overall Study||128
11275646|NCT02354144|12470977|FG000|COMPLETED|Overall Study|Participants completed all 7 study visits.|48
11275647|NCT02354144|12470978|FG001|COMPLETED|Overall Study|Participants completed all 7 study visits.|51
11275648|NCT02354144|12470977|FG000|NOT COMPLETED|Overall Study||79
11275649|NCT02354144|12470978|FG001|NOT COMPLETED|Overall Study||77
11275650|NCT02354222|12470986|FG000|STARTED|Overall Study||77
11275651|NCT02354222|12470987|FG001|STARTED|Overall Study||77
11275652|NCT02354222|12470986|FG000|COMPLETED|Overall Study||73
11275653|NCT02354222|12470987|FG001|COMPLETED|Overall Study||66
11275654|NCT02354222|12470986|FG000|NOT COMPLETED|Overall Study||4
11275655|NCT02354222|12470987|FG001|NOT COMPLETED|Overall Study||11
11275656|NCT02354235|12470995|FG000|STARTED|Overall Study||70
11275657|NCT02354235|12470996|FG001|STARTED|Overall Study||68
11275658|NCT02354235|12470995|FG000|COMPLETED|Overall Study||67
11275659|NCT02354235|12470996|FG001|COMPLETED|Overall Study||61
11275660|NCT02354235|12470995|FG000|NOT COMPLETED|Overall Study||3
11275661|NCT02354235|12470996|FG001|NOT COMPLETED|Overall Study||7
11275662|NCT02354339|12471004|FG000|STARTED|Overall Study||12
11275663|NCT02354339|12471005|FG001|STARTED|Overall Study||12
11275664|NCT02354339|12471004|FG000|COMPLETED|Overall Study||12
11275665|NCT02354339|12471005|FG001|COMPLETED|Overall Study||12
11275666|NCT02354339|12471004|FG000|NOT COMPLETED|Overall Study||0
11275667|NCT02354339|12471005|FG001|NOT COMPLETED|Overall Study||0
11275668|NCT02354352|12471013|FG000|STARTED|Overall Study||26
11275669|NCT02354352|12471014|FG001|STARTED|Overall Study||26
11275670|NCT02354352|12471013|FG000|2 Weeks|Overall Study||26
11275671|NCT02354352|12471014|FG001|2 Weeks|Overall Study||25
11275672|NCT02354352|12471013|FG000|1 Month|Overall Study||24
11275673|NCT02354352|12471014|FG001|1 Month|Overall Study||23
11275674|NCT02354352|12471013|FG000|2 Months|Overall Study||24
11275675|NCT02354352|12471014|FG001|2 Months|Overall Study||22
11275676|NCT02354352|12471013|FG000|3 Months|Overall Study||25
11275677|NCT02354352|12471014|FG001|3 Months|Overall Study||23
11275678|NCT02354352|12471013|FG000|6 Months|Overall Study||25
11275679|NCT02354352|12471014|FG001|6 Months|Overall Study||23
11275680|NCT02354352|12471013|FG000|9 Months|Overall Study||25
11275681|NCT02354352|12471014|FG001|9 Months|Overall Study||23
11275682|NCT02354352|12471013|FG000|COMPLETED|Overall Study||23
11275683|NCT02354352|12471014|FG001|COMPLETED|Overall Study||23
11275684|NCT02354352|12471013|FG000|NOT COMPLETED|Overall Study||3
11275685|NCT02354352|12471014|FG001|NOT COMPLETED|Overall Study||3
11275686|NCT02354378|12471022|FG000|STARTED|Overall Study||64
11275687|NCT02354378|12471023|FG001|STARTED|Overall Study||20
11275688|NCT02354378|12471022|FG000|COMPLETED|Overall Study||30
11275689|NCT02354378|12471023|FG001|COMPLETED|Overall Study||16
11275690|NCT02354378|12471022|FG000|NOT COMPLETED|Overall Study||34
11275691|NCT02354378|12471023|FG001|NOT COMPLETED|Overall Study||4
11275692|NCT02354417|12471029|FG000|STARTED|Overall Study||3
11275693|NCT02354417|12471029|FG000|COMPLETED|Overall Study||2
11275694|NCT02354417|12471029|FG000|NOT COMPLETED|Overall Study||1
11275695|NCT02354443|12471033|FG000|STARTED|Overall Study||1
11275696|NCT02354443|12471033|FG000|COMPLETED|Overall Study||1
11275697|NCT02354443|12471033|FG000|NOT COMPLETED|Overall Study||0
11275698|NCT02354482|12471037|FG000|STARTED|Patient Communication and Care||2158
11275699|NCT02354482|12471037|FG000|COMPLETED|Patient Communication and Care||2158
11275700|NCT02354482|12471037|FG000|NOT COMPLETED|Patient Communication and Care||0
11275701|NCT02354482|12471037|FG000|STARTED|Home-Based Trust and Plain Language||1979
11275702|NCT02354482|12471037|FG000|COMPLETED|Home-Based Trust and Plain Language||1979
11275703|NCT02354482|12471037|FG000|NOT COMPLETED|Home-Based Trust and Plain Language||0
11275704|NCT02354482|12471037|FG000|STARTED|Hospital-Based Trust and Plain Language||2090
11275705|NCT02354482|12471037|FG000|COMPLETED|Hospital-Based Trust and Plain Language||2090
11275706|NCT02354482|12471037|FG000|NOT COMPLETED|Hospital-Based Trust and Plain Language||0
11275707|NCT02354482|12471037|FG000|STARTED|Patient/Family Caregiver Assessment||3093
11275708|NCT02354482|12471037|FG000|COMPLETED|Patient/Family Caregiver Assessment||3093
11275709|NCT02354482|12471037|FG000|NOT COMPLETED|Patient/Family Caregiver Assessment||0
11275710|NCT02354482|12471037|FG000|STARTED|Assessment and Teach Back||508
11275711|NCT02354482|12471037|FG000|COMPLETED|Assessment and Teach Back||508
11275712|NCT02354482|12471037|FG000|NOT COMPLETED|Assessment and Teach Back||0
11275713|NCT02354482|12471037|FG000|STARTED|Reference||2042
11275714|NCT02354482|12471037|FG000|COMPLETED|Reference||2042
11275715|NCT02354482|12471037|FG000|NOT COMPLETED|Reference||0
11275716|NCT02354508|12471054|FG000|STARTED|Period 1: Core Phase||41
11275717|NCT02354508|12471055|FG001|STARTED|Period 1: Core Phase||29
11275718|NCT02354508|12471056|FG002|STARTED|Period 1: Core Phase||53
11275719|NCT02354508|12471054|FG000|COMPLETED|Period 1: Core Phase||39
11275720|NCT02354508|12471055|FG001|COMPLETED|Period 1: Core Phase||27
11275721|NCT02354508|12471056|FG002|COMPLETED|Period 1: Core Phase||47
11275722|NCT02354508|12471054|FG000|NOT COMPLETED|Period 1: Core Phase||2
11275723|NCT02354508|12471055|FG001|NOT COMPLETED|Period 1: Core Phase||2
11275724|NCT02354508|12471056|FG002|NOT COMPLETED|Period 1: Core Phase||6
11275725|NCT02354508|12471054|FG000|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|26
11275726|NCT02354508|12471055|FG001|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|23
11275727|NCT02354508|12471056|FG002|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|39
11275728|NCT02354508|12471054|FG000|COMPLETED|Period 2: Extension Phase||20
11275729|NCT02354508|12471055|FG001|COMPLETED|Period 2: Extension Phase||19
11398245|NCT04502056|12592592|FG006|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1888
11275730|NCT02354508|12471056|FG002|COMPLETED|Period 2: Extension Phase||36
11275731|NCT02354508|12471054|FG000|NOT COMPLETED|Period 2: Extension Phase||6
11275732|NCT02354508|12471055|FG001|NOT COMPLETED|Period 2: Extension Phase||4
11275733|NCT02354508|12471056|FG002|NOT COMPLETED|Period 2: Extension Phase||3
11275734|NCT02354508|12471054|FG000|STARTED|Period 3: Post-treatment Follow up Phase||26
11275735|NCT02354508|12471055|FG001|STARTED|Period 3: Post-treatment Follow up Phase||23
11275736|NCT02354508|12471056|FG002|STARTED|Period 3: Post-treatment Follow up Phase||39
11275737|NCT02354508|12471054|FG000|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|4
11275738|NCT02354508|12471055|FG001|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
11275739|NCT02354508|12471056|FG002|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
11275740|NCT02354508|12471054|FG000|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|22
11275741|NCT02354508|12471055|FG001|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|20
11275742|NCT02354508|12471056|FG002|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|36
11275743|NCT02354508|12471054|FG000|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4
11275744|NCT02354508|12471055|FG001|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
11275745|NCT02354508|12471056|FG002|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
11275746|NCT02354534|12471109|FG000|STARTED|Overall Study||3
11275747|NCT02354534|12471110|FG001|STARTED|Overall Study||9
11275748|NCT02354534|12471111|FG002|STARTED|Overall Study||10
11275749|NCT02354534|12471112|FG003|STARTED|Overall Study||8
11275750|NCT02354534|12471109|FG000|COMPLETED|Overall Study||3
11275751|NCT02354534|12471110|FG001|COMPLETED|Overall Study||9
11275752|NCT02354534|12471111|FG002|COMPLETED|Overall Study||9
11275753|NCT02354534|12471112|FG003|COMPLETED|Overall Study||8
11275754|NCT02354534|12471109|FG000|NOT COMPLETED|Overall Study||0
11275755|NCT02354534|12471110|FG001|NOT COMPLETED|Overall Study||0
11275756|NCT02354534|12471111|FG002|NOT COMPLETED|Overall Study||1
11275757|NCT02354534|12471112|FG003|NOT COMPLETED|Overall Study||0
11275758|NCT02354599|12471128|FG000|STARTED|Overall Study||6
11275759|NCT02354599|12471129|FG001|STARTED|Overall Study||6
11275760|NCT02354599|12471130|FG002|STARTED|Overall Study||6
11275761|NCT02354599|12471131|FG003|STARTED|Overall Study||6
11275762|NCT02354599|12471132|FG004|STARTED|Overall Study||2
11275763|NCT02354599|12471133|FG005|STARTED|Overall Study||6
11275764|NCT02354599|12471128|FG000|COMPLETED|Overall Study||5
11275765|NCT02354599|12471129|FG001|COMPLETED|Overall Study||5
11275766|NCT02354599|12471130|FG002|COMPLETED|Overall Study||6
11398246|NCT04502056|12592593|FG007|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1883
11398247|NCT04502056|12592594|FG008|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||947
11398248|NCT04502056|12592595|FG009|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||942
11398249|NCT04502056|12592596|FG010|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||946
11398250|NCT04502056|12592597|FG011|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||928
11398251|NCT04502056|12592586|FG000|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1799
11398252|NCT04502056|12592587|FG001|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1828
11398253|NCT04502056|12592588|FG002|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1830
11398254|NCT04502056|12592589|FG003|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1835
11398255|NCT04502056|12592590|FG004|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1792
11398256|NCT04502056|12592591|FG005|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1820
11398257|NCT04502056|12592592|FG006|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1821
11275767|NCT02354599|12471131|FG003|COMPLETED|Overall Study||6
11275768|NCT02354599|12471132|FG004|COMPLETED|Overall Study||2
11275769|NCT02354599|12471133|FG005|COMPLETED|Overall Study||5
11275770|NCT02354599|12471128|FG000|NOT COMPLETED|Overall Study||1
11275771|NCT02354599|12471129|FG001|NOT COMPLETED|Overall Study||1
11275772|NCT02354599|12471130|FG002|NOT COMPLETED|Overall Study||0
11275773|NCT02354599|12471131|FG003|NOT COMPLETED|Overall Study||0
11275774|NCT02354599|12471132|FG004|NOT COMPLETED|Overall Study||0
11275775|NCT02354599|12471133|FG005|NOT COMPLETED|Overall Study||1
11275776|NCT02354690|12471153|FG000|STARTED|Overall Study||13
11275777|NCT02354690|12471153|FG000|COMPLETED|Overall Study||12
11275778|NCT02354690|12471153|FG000|NOT COMPLETED|Overall Study||1
11275779|NCT02354781|12471157|FG000|STARTED|Overall Study||3
11275780|NCT02354781|12471157|FG000|COMPLETED|Overall Study||3
11275781|NCT02354781|12471157|FG000|NOT COMPLETED|Overall Study||0
11275782|NCT02354833|12471164|FG000|STARTED|Overall Study||38
11275783|NCT02354833|12471165|FG001|STARTED|Overall Study||43
11275784|NCT02354833|12471164|FG000|COMPLETED|Overall Study||38
11275785|NCT02354833|12471165|FG001|COMPLETED|Overall Study||43
11275786|NCT02354833|12471164|FG000|NOT COMPLETED|Overall Study||0
11275787|NCT02354833|12471165|FG001|NOT COMPLETED|Overall Study||0
11275788|NCT02354859|12471175|FG000|STARTED|Overall Study||60
11275789|NCT02354859|12471176|FG001|STARTED|Overall Study||59
11275790|NCT02354859|12471175|FG000|COMPLETED|Overall Study||60
11275791|NCT02354859|12471176|FG001|COMPLETED|Overall Study||57
11275792|NCT02354859|12471175|FG000|NOT COMPLETED|Overall Study||0
11275793|NCT02354859|12471176|FG001|NOT COMPLETED|Overall Study||2
11275794|NCT02354924|12471184|FG000|STARTED|Overall Study||40
11275795|NCT02354924|12471185|FG001|STARTED|Overall Study||20
11275796|NCT02354924|12471184|FG000|COMPLETED|Overall Study||40
11275797|NCT02354924|12471185|FG001|COMPLETED|Overall Study||20
11275798|NCT02354924|12471184|FG000|NOT COMPLETED|Overall Study||0
11275799|NCT02354924|12471185|FG001|NOT COMPLETED|Overall Study||0
11275800|NCT02354976|12471196|FG000|STARTED|Overall Study||25
11275801|NCT02354976|12471197|FG001|STARTED|Overall Study||27
11275802|NCT02354976|12471198|FG002|STARTED|Overall Study||26
11275803|NCT02354976|12471196|FG000|COMPLETED|Overall Study||23
11275804|NCT02354976|12471197|FG001|COMPLETED|Overall Study||26
11275805|NCT02354976|12471198|FG002|COMPLETED|Overall Study||23
11275806|NCT02354976|12471196|FG000|NOT COMPLETED|Overall Study||2
11275807|NCT02354976|12471197|FG001|NOT COMPLETED|Overall Study||1
11275808|NCT02354976|12471198|FG002|NOT COMPLETED|Overall Study||3
11275809|NCT02355028|12471208|FG000|STARTED|Overall Study||47
11275810|NCT02355028|12471209|FG001|STARTED|Overall Study||46
11275811|NCT02355028|12471208|FG000|Treated|Overall Study||46
11275812|NCT02355028|12471209|FG001|Treated|Overall Study||45
11275813|NCT02355028|12471208|FG000|COMPLETED|Overall Study||36
11275814|NCT02355028|12471209|FG001|COMPLETED|Overall Study||41
11275815|NCT02355028|12471208|FG000|NOT COMPLETED|Overall Study||11
11275816|NCT02355028|12471209|FG001|NOT COMPLETED|Overall Study||5
11275817|NCT02355067|12471222|FG000|STARTED|Overall Study||20
11275818|NCT02355067|12471223|FG001|STARTED|Overall Study||20
11275819|NCT02355067|12471222|FG000|COMPLETED|Overall Study||12
11275820|NCT02355067|12471223|FG001|COMPLETED|Overall Study||12
11275821|NCT02355067|12471222|FG000|NOT COMPLETED|Overall Study||8
11275822|NCT02355067|12471223|FG001|NOT COMPLETED|Overall Study||8
11275823|NCT02355158|12471229|FG000|STARTED|Overall Study||197
11275824|NCT02355158|12471229|FG000|COMPLETED|Overall Study||47
11275825|NCT02355158|12471229|FG000|NOT COMPLETED|Overall Study||150
11275826|NCT02355210|12471239|FG000|STARTED|Overall Study||19
11275827|NCT02355210|12471240|FG001|STARTED|Overall Study||18
11275828|NCT02355210|12471241|FG002|STARTED|Overall Study||16
11275829|NCT02355210|12471242|FG003|STARTED|Overall Study||17
11275830|NCT02355210|12471243|FG004|STARTED|Overall Study||19
11275831|NCT02355210|12471244|FG005|STARTED|Overall Study||18
11275832|NCT02355210|12471239|FG000|COMPLETED|Overall Study||19
11275833|NCT02355210|12471240|FG001|COMPLETED|Overall Study||18
11275834|NCT02355210|12471241|FG002|COMPLETED|Overall Study||16
11275835|NCT02355210|12471242|FG003|COMPLETED|Overall Study||17
11275836|NCT02355210|12471243|FG004|COMPLETED|Overall Study||19
11275837|NCT02355210|12471244|FG005|COMPLETED|Overall Study||18
11275838|NCT02355210|12471239|FG000|NOT COMPLETED|Overall Study||0
11275839|NCT02355210|12471240|FG001|NOT COMPLETED|Overall Study||0
11275840|NCT02355210|12471241|FG002|NOT COMPLETED|Overall Study||0
11275841|NCT02355210|12471242|FG003|NOT COMPLETED|Overall Study||0
11275842|NCT02355210|12471243|FG004|NOT COMPLETED|Overall Study||0
11275843|NCT02355210|12471244|FG005|NOT COMPLETED|Overall Study||0
11275844|NCT02355275|12471258|FG000|STARTED|Overall Study||22
11275845|NCT02355275|12471258|FG000|COMPLETED|Overall Study||14
11275846|NCT02355275|12471258|FG000|NOT COMPLETED|Overall Study||8
11275847|NCT02355665|12471264|FG000|STARTED|Overall Study||601
11275848|NCT02355665|12471265|FG001|STARTED|Overall Study||597
11275849|NCT02355665|12471264|FG000|COMPLETED|Overall Study||352
11275850|NCT02355665|12471265|FG001|COMPLETED|Overall Study||365
11275851|NCT02355665|12471264|FG000|NOT COMPLETED|Overall Study||249
11275852|NCT02355665|12471265|FG001|NOT COMPLETED|Overall Study||232
11275853|NCT02355691|12471273|FG000|STARTED|Overall Study||7
11275854|NCT02355691|12471274|FG001|STARTED|Overall Study||9
11275855|NCT02355691|12471273|FG000|1st Postop Visit|Overall Study||7
11275856|NCT02355691|12471274|FG001|1st Postop Visit|Overall Study||9
11275857|NCT02355691|12471273|FG000|2nd Postop Visit|Overall Study||7
11275858|NCT02355691|12471274|FG001|2nd Postop Visit|Overall Study||9
11275859|NCT02355691|12471273|FG000|COMPLETED|Overall Study||0
11275860|NCT02355691|12471274|FG001|COMPLETED|Overall Study||0
11275861|NCT02355691|12471273|FG000|NOT COMPLETED|Overall Study||7
11275862|NCT02355691|12471274|FG001|NOT COMPLETED|Overall Study||9
11275863|NCT02355743|12471280|FG000|STARTED|Overall Study||8
11275864|NCT02355743|12471280|FG000|COMPLETED|Overall Study||6
11275865|NCT02355743|12471280|FG000|NOT COMPLETED|Overall Study||2
11275866|NCT02355821|12471286|FG000|STARTED|Overall Study||57
11275867|NCT02355821|12471287|FG001|STARTED|Overall Study||57
11275868|NCT02355821|12471286|FG000|COMPLETED|Overall Study||57
11275869|NCT02355821|12471287|FG001|COMPLETED|Overall Study||57
11275870|NCT02355821|12471286|FG000|NOT COMPLETED|Overall Study||0
11275871|NCT02355821|12471287|FG001|NOT COMPLETED|Overall Study||0
11275872|NCT02355886|12471295|FG000|STARTED|Overall Study||13
11275873|NCT02355886|12471296|FG001|STARTED|Overall Study||12
11275874|NCT02355886|12471295|FG000|COMPLETED|Overall Study||13
11275875|NCT02355886|12471296|FG001|COMPLETED|Overall Study||12
11275876|NCT02355886|12471295|FG000|NOT COMPLETED|Overall Study||0
11275877|NCT02355886|12471296|FG001|NOT COMPLETED|Overall Study||0
11275878|NCT02355977|12471305|FG000|STARTED|Overall Study||21
11275879|NCT02355977|12471306|FG001|STARTED|Overall Study||26
11275880|NCT02355977|12471307|FG002|STARTED|Overall Study||23
11275881|NCT02355977|12471305|FG000|COMPLETED|Overall Study||21
11275882|NCT02355977|12471306|FG001|COMPLETED|Overall Study||26
11275883|NCT02355977|12471307|FG002|COMPLETED|Overall Study||23
11275884|NCT02355977|12471305|FG000|NOT COMPLETED|Overall Study||0
11275885|NCT02355977|12471306|FG001|NOT COMPLETED|Overall Study||0
11275886|NCT02355977|12471307|FG002|NOT COMPLETED|Overall Study||0
11275887|NCT02356003|12471315|FG000|STARTED|Overall Study||10
11275888|NCT02356003|12471315|FG000|COMPLETED|Overall Study||10
11275889|NCT02356003|12471315|FG000|NOT COMPLETED|Overall Study||0
11275890|NCT02356107|12471320|FG000|STARTED|Overall Study||15
11275891|NCT02356107|12471320|FG000|COMPLETED|Overall Study||12
11275892|NCT02356107|12471320|FG000|NOT COMPLETED|Overall Study||3
11275893|NCT02356198|12471326|FG000|STARTED|Overall Study||104
11275894|NCT02356198|12471327|FG001|STARTED|Overall Study||105
11275895|NCT02356198|12471326|FG000|COMPLETED|Overall Study||102
11275896|NCT02356198|12471327|FG001|COMPLETED|Overall Study||98
11275897|NCT02356198|12471326|FG000|NOT COMPLETED|Overall Study||2
11275898|NCT02356198|12471327|FG001|NOT COMPLETED|Overall Study||7
11275899|NCT02356211|12471335|FG000|STARTED|Overall Study||57
11275900|NCT02356211|12471336|FG001|STARTED|Overall Study||52
11275901|NCT02356211|12471335|FG000|COMPLETED|Overall Study||54
11275902|NCT02356211|12471336|FG001|COMPLETED|Overall Study||42
11275903|NCT02356211|12471335|FG000|NOT COMPLETED|Overall Study||3
11275904|NCT02356211|12471336|FG001|NOT COMPLETED|Overall Study||10
11275905|NCT02356471|12471342|FG000|STARTED|Overall Study||34
11275906|NCT02356471|12471342|FG000|COMPLETED|Overall Study||28
11275907|NCT02356471|12471342|FG000|NOT COMPLETED|Overall Study||6
11275908|NCT02356484|12471346|FG000|STARTED|Overall Study||138
11275909|NCT02356484|12471346|FG000|COMPLETED|Overall Study||138
11275910|NCT02356484|12471346|FG000|NOT COMPLETED|Overall Study||0
11275911|NCT02356562|12471352|FG000|STARTED|Overall Study||22
11275912|NCT02356562|12471353|FG001|STARTED|Overall Study||7
11275913|NCT02356562|12471352|FG000|COMPLETED|Overall Study||20
11275914|NCT02356562|12471353|FG001|COMPLETED|Overall Study||6
11275915|NCT02356562|12471352|FG000|NOT COMPLETED|Overall Study||2
11275916|NCT02356562|12471353|FG001|NOT COMPLETED|Overall Study||1
11275917|NCT02356588|12471362|FG000|STARTED|Overall Study||107
11275918|NCT02356588|12471363|FG001|STARTED|Overall Study||54
11275919|NCT02356588|12471362|FG000|COMPLETED|Overall Study||102
11275920|NCT02356588|12471363|FG001|COMPLETED|Overall Study||41
11275921|NCT02356588|12471362|FG000|NOT COMPLETED|Overall Study||5
11275922|NCT02356588|12471363|FG001|NOT COMPLETED|Overall Study||13
11275923|NCT02356692|12471369|FG000|STARTED|Overall Study||60
11275924|NCT02356692|12471370|FG001|STARTED|Overall Study||60
11275925|NCT02356692|12471369|FG000|COMPLETED|Overall Study||60
11275926|NCT02356692|12471370|FG001|COMPLETED|Overall Study||60
11275927|NCT02356692|12471369|FG000|NOT COMPLETED|Overall Study||0
11275928|NCT02356692|12471370|FG001|NOT COMPLETED|Overall Study||0
11275929|NCT02356783|12471380|FG000|STARTED|Overall Study||16
11275930|NCT02356783|12471381|FG001|STARTED|Overall Study||17
11275931|NCT02356783|12471380|FG000|COMPLETED|Overall Study||15
11275932|NCT02356783|12471381|FG001|COMPLETED|Overall Study||14
11275933|NCT02356783|12471380|FG000|NOT COMPLETED|Overall Study||1
11275934|NCT02356783|12471381|FG001|NOT COMPLETED|Overall Study||3
11275935|NCT02356887|12471387|FG000|STARTED|Overall Study||12
11275936|NCT02356887|12471387|FG000|COMPLETED|Overall Study||10
11275937|NCT02356887|12471387|FG000|NOT COMPLETED|Overall Study||2
11275938|NCT02356900|12471399|FG000|STARTED|Overall Study||11
11275939|NCT02356900|12471400|FG001|STARTED|Overall Study||10
11275940|NCT02356900|12471399|FG000|COMPLETED|Overall Study||11
11275941|NCT02356900|12471400|FG001|COMPLETED|Overall Study||10
11275942|NCT02356900|12471399|FG000|NOT COMPLETED|Overall Study||0
11275943|NCT02356900|12471400|FG001|NOT COMPLETED|Overall Study||0
11275944|NCT02357043|12471406|FG000|STARTED|Overall Study||368
11275945|NCT02357043|12471406|FG000|COMPLETED|Overall Study||368
11275946|NCT02357043|12471406|FG000|NOT COMPLETED|Overall Study||0
11275947|NCT02357134|12471414|FG000|STARTED|Overall Study||11
11275948|NCT02357134|12471415|FG001|STARTED|Overall Study||11
11275949|NCT02357134|12471416|FG002|STARTED|Overall Study||12
11275950|NCT02357134|12471417|FG003|STARTED|Overall Study||11
11275951|NCT02357134|12471414|FG000|COMPLETED|Overall Study||10
11275952|NCT02357134|12471415|FG001|COMPLETED|Overall Study||11
11275953|NCT02357134|12471416|FG002|COMPLETED|Overall Study||12
11275954|NCT02357134|12471417|FG003|COMPLETED|Overall Study||11
11275955|NCT02357134|12471414|FG000|NOT COMPLETED|Overall Study||1
11275956|NCT02357134|12471415|FG001|NOT COMPLETED|Overall Study||0
11275957|NCT02357134|12471416|FG002|NOT COMPLETED|Overall Study||0
11275958|NCT02357134|12471417|FG003|NOT COMPLETED|Overall Study||0
11275959|NCT02357147|12471429|FG000|STARTED|Combination Treatment Phase||52
11275960|NCT02357147|12471430|FG001|STARTED|Combination Treatment Phase||56
11275961|NCT02357147|12471429|FG000|Treated|Combination Treatment Phase||52
11275962|NCT02357147|12471430|FG001|Treated|Combination Treatment Phase||54
11275963|NCT02357147|12471429|FG000|COMPLETED|Combination Treatment Phase||26
11275964|NCT02357147|12471430|FG001|COMPLETED|Combination Treatment Phase||29
11275965|NCT02357147|12471429|FG000|NOT COMPLETED|Combination Treatment Phase||26
11275966|NCT02357147|12471430|FG001|NOT COMPLETED|Combination Treatment Phase||27
11275967|NCT02357147|12471429|FG000|STARTED|Maintenance Treatment Phase||26
11275968|NCT02357147|12471430|FG001|STARTED|Maintenance Treatment Phase||29
11275969|NCT02357147|12471429|FG000|Treated|Maintenance Treatment Phase||25
11275970|NCT02357147|12471430|FG001|Treated|Maintenance Treatment Phase||29
11275971|NCT02357147|12471429|FG000|COMPLETED|Maintenance Treatment Phase||0
11275972|NCT02357147|12471430|FG001|COMPLETED|Maintenance Treatment Phase||0
11275973|NCT02357147|12471429|FG000|NOT COMPLETED|Maintenance Treatment Phase||26
11275974|NCT02357147|12471430|FG001|NOT COMPLETED|Maintenance Treatment Phase||29
11275975|NCT02357173|12471443|FG000|STARTED|Overall Study||25
11275976|NCT02357173|12471444|FG001|STARTED|Overall Study||21
11275977|NCT02357173|12471445|FG002|STARTED|Overall Study||22
11275978|NCT02357173|12471443|FG000|COMPLETED|Overall Study||19
11275979|NCT02357173|12471444|FG001|COMPLETED|Overall Study||15
11275980|NCT02357173|12471445|FG002|COMPLETED|Overall Study||16
11275981|NCT02357173|12471443|FG000|NOT COMPLETED|Overall Study||6
11275982|NCT02357173|12471444|FG001|NOT COMPLETED|Overall Study||6
11275983|NCT02357173|12471445|FG002|NOT COMPLETED|Overall Study||6
11275984|NCT02357264|12471455|FG000|STARTED|Overall Study||56
11275985|NCT02357264|12471456|FG001|STARTED|Overall Study||130
11275986|NCT02357264|12471455|FG000|COMPLETED|Overall Study||56
11275987|NCT02357264|12471456|FG001|COMPLETED|Overall Study||130
11275988|NCT02357264|12471455|FG000|NOT COMPLETED|Overall Study||0
11275989|NCT02357264|12471456|FG001|NOT COMPLETED|Overall Study||0
11275990|NCT02357290|12471462|FG000|STARTED|Overall Study||40
11275991|NCT02357290|12471462|FG000|Exposed|Overall Study||26
11275992|NCT02357290|12471462|FG000|COMPLETED|Overall Study||14
11275993|NCT02357290|12471462|FG000|NOT COMPLETED|Overall Study||26
11275994|NCT02357342|12471468|FG000|STARTED|First 6 Months||20
11275995|NCT02357342|12471469|FG001|STARTED|First 6 Months||20
11275996|NCT02357342|12471468|FG000|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
11275997|NCT02357342|12471469|FG001|COMPLETED|First 6 Months||20
11275998|NCT02357342|12471468|FG000|NOT COMPLETED|First 6 Months||2
11275999|NCT02357342|12471469|FG001|NOT COMPLETED|First 6 Months||0
11276000|NCT02357342|12471468|FG000|STARTED|Extension Study||4
11276001|NCT02357342|12471469|FG001|STARTED|Extension Study||9
11276002|NCT02357342|12471468|FG000|COMPLETED|Extension Study||4
11276003|NCT02357342|12471469|FG001|COMPLETED|Extension Study||9
11276004|NCT02357342|12471468|FG000|NOT COMPLETED|Extension Study||0
11276005|NCT02357342|12471469|FG001|NOT COMPLETED|Extension Study||0
11276006|NCT02357368|12471479|FG000|STARTED|Overall Study||19
11276007|NCT02357368|12471480|FG001|STARTED|Overall Study||18
11276008|NCT02357368|12471481|FG002|STARTED|Overall Study||14
11276009|NCT02357368|12471482|FG003|STARTED|Overall Study||8
11276010|NCT02357368|12471479|FG000|COMPLETED|Overall Study||13
11276011|NCT02357368|12471480|FG001|COMPLETED|Overall Study||15
11276012|NCT02357368|12471481|FG002|COMPLETED|Overall Study||13
11276013|NCT02357368|12471482|FG003|COMPLETED|Overall Study||5
11276014|NCT02357368|12471479|FG000|NOT COMPLETED|Overall Study||6
11276015|NCT02357368|12471480|FG001|NOT COMPLETED|Overall Study||3
11276016|NCT02357368|12471481|FG002|NOT COMPLETED|Overall Study||1
11276017|NCT02357368|12471482|FG003|NOT COMPLETED|Overall Study||3
11276018|NCT02357394|12471494|FG000|STARTED|Overall Study||4
11398258|NCT04502056|12592593|FG007|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1844
11398259|NCT04502056|12592594|FG008|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||914
11398260|NCT04502056|12592595|FG009|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||912
11276019|NCT02357394|12471495|FG001|STARTED|Overall Study||3
11276020|NCT02357394|12471494|FG000|COMPLETED|Overall Study||4
11276021|NCT02357394|12471495|FG001|COMPLETED|Overall Study||3
11276022|NCT02357394|12471494|FG000|NOT COMPLETED|Overall Study||0
11276023|NCT02357394|12471495|FG001|NOT COMPLETED|Overall Study||0
11276024|NCT02357420|12471505|FG000|STARTED|Overall Study||104
11276025|NCT02357420|12471506|FG001|STARTED|Overall Study||98
11276026|NCT02357420|12471507|FG002|STARTED|Overall Study||109
11276027|NCT02357420|12471508|FG003|STARTED|Overall Study||82
11276028|NCT02357420|12471505|FG000|Full Analysis Set (FAS)|Overall Study||104
11276029|NCT02357420|12471506|FG001|Full Analysis Set (FAS)|Overall Study||98
11276030|NCT02357420|12471507|FG002|Full Analysis Set (FAS)|Overall Study||109
11340558|NCT02922582|12537854|FG001|COMPLETED|Overall Study||3
11340559|NCT02922582|12537855|FG002|COMPLETED|Overall Study||4
11276031|NCT02357420|12471508|FG003|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81
11276032|NCT02357420|12471505|FG000|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92
11276033|NCT02357420|12471506|FG001|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86
11276034|NCT02357420|12471507|FG002|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93
11276035|NCT02357420|12471508|FG003|COMPLETED|Overall Study||63
11276036|NCT02357420|12471505|FG000|NOT COMPLETED|Overall Study||12
11276037|NCT02357420|12471506|FG001|NOT COMPLETED|Overall Study||12
11276038|NCT02357420|12471507|FG002|NOT COMPLETED|Overall Study||16
11276039|NCT02357420|12471508|FG003|NOT COMPLETED|Overall Study||19
11276040|NCT02357459|12471521|FG000|STARTED|Overall Study||161
11276041|NCT02357459|12471522|FG001|STARTED|Overall Study||163
11276042|NCT02357459|12471523|FG002|STARTED|Overall Study||162
11276043|NCT02357459|12471521|FG000|COMPLETED|Overall Study||144
11276044|NCT02357459|12471522|FG001|COMPLETED|Overall Study||149
11276045|NCT02357459|12471523|FG002|COMPLETED|Overall Study||150
11276046|NCT02357459|12471521|FG000|NOT COMPLETED|Overall Study||17
11276047|NCT02357459|12471522|FG001|NOT COMPLETED|Overall Study||14
11276048|NCT02357459|12471523|FG002|NOT COMPLETED|Overall Study||12
11276049|NCT02357485|12471534|FG000|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
11276050|NCT02357485|12471534|FG000|COMPLETED|Overall Study||6
11276051|NCT02357485|12471534|FG000|NOT COMPLETED|Overall Study||0
11276052|NCT02357576|12471541|FG000|STARTED|Treatment Period||12
11276053|NCT02357576|12471542|FG001|STARTED|Treatment Period||9
11276054|NCT02357576|12471541|FG000|COMPLETED|Treatment Period||12
11276055|NCT02357576|12471542|FG001|COMPLETED|Treatment Period||7
11276056|NCT02357576|12471541|FG000|NOT COMPLETED|Treatment Period||0
11276057|NCT02357576|12471542|FG001|NOT COMPLETED|Treatment Period||2
11276058|NCT02357576|12471541|FG000|STARTED|Neurodevelopmental Outcome Follow Up|1 patient exited the study after treatment completion and before returning for follow up visits.|11
11276059|NCT02357576|12471542|FG001|STARTED|Neurodevelopmental Outcome Follow Up||7
11276060|NCT02357576|12471541|FG000|COMPLETED|Neurodevelopmental Outcome Follow Up||6
11276061|NCT02357576|12471542|FG001|COMPLETED|Neurodevelopmental Outcome Follow Up||2
11276062|NCT02357576|12471541|FG000|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
11276063|NCT02357576|12471542|FG001|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
11340560|NCT02922582|12537856|FG003|COMPLETED|Overall Study||4
11340561|NCT02922582|12537853|FG000|NOT COMPLETED|Overall Study||0
11340562|NCT02922582|12537854|FG001|NOT COMPLETED|Overall Study||1
11340563|NCT02922582|12537855|FG002|NOT COMPLETED|Overall Study||0
11340564|NCT02922582|12537856|FG003|NOT COMPLETED|Overall Study||0
11340565|NCT02922634|12537866|FG000|STARTED|Overall Study||229
11340566|NCT02922634|12537866|FG000|COMPLETED|Overall Study||219
11340567|NCT02922634|12537866|FG000|NOT COMPLETED|Overall Study||10
11340568|NCT02922738|12537879|FG000|STARTED|Overall Study|158 patients and 17 providers|175
11340569|NCT02922738|12537880|FG001|STARTED|Overall Study|275 patients and 15 providers|290
11340570|NCT02922738|12537879|FG000|COMPLETED|Overall Study||175
11340571|NCT02922738|12537880|FG001|COMPLETED|Overall Study||290
11340572|NCT02922738|12537879|FG000|NOT COMPLETED|Overall Study||0
11340573|NCT02922738|12537880|FG001|NOT COMPLETED|Overall Study||0
11340574|NCT02922868|12537890|FG000|STARTED|Overall Study||30
11340575|NCT02922868|12537891|FG001|STARTED|Overall Study||30
11340576|NCT02922868|12537890|FG000|COMPLETED|Overall Study||30
11340577|NCT02922868|12537891|FG001|COMPLETED|Overall Study||30
11340578|NCT02922868|12537890|FG000|NOT COMPLETED|Overall Study||0
11340579|NCT02922868|12537891|FG001|NOT COMPLETED|Overall Study||0
11340580|NCT02922959|12537899|FG000|STARTED|Overall Study||40
11340581|NCT02922959|12537900|FG001|STARTED|Overall Study||40
11340582|NCT02922959|12537899|FG000|3 Weeks|Overall Study|n=38 (95.0%)|38
11340583|NCT02922959|12537900|FG001|3 Weeks|Overall Study|n=36 (90.0%)|36
11398261|NCT04502056|12592596|FG010|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||928
11398262|NCT04502056|12592597|FG011|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||900
11398263|NCT04502056|12592586|FG000|Completed the Follow-up Survey|Overall Study||608
11340584|NCT02922959|12537899|FG000|3 Months|Overall Study|n=35 (87.5%)|35
11340585|NCT02922959|12537900|FG001|3 Months|Overall Study|n=31 (77.5%)|31
11340586|NCT02922959|12537899|FG000|6 Months|Overall Study|n=28 (70.0%)|28
11340587|NCT02922959|12537900|FG001|6 Months|Overall Study|n=30 (75.0%)|30
11340588|NCT02922959|12537899|FG000|12 Months|Overall Study|n=21 (52.5%)|21
11340589|NCT02922959|12537900|FG001|12 Months|Overall Study|n=23 (57.5%)|23
11340590|NCT02922959|12537899|FG000|COMPLETED|Overall Study||21
11340591|NCT02922959|12537900|FG001|COMPLETED|Overall Study||23
11340592|NCT02922959|12537899|FG000|NOT COMPLETED|Overall Study||19
11340593|NCT02922959|12537900|FG001|NOT COMPLETED|Overall Study||17
11340594|NCT02923115|12537912|FG000|STARTED|Overall Study||12
11340595|NCT02923115|12537913|FG001|STARTED|Overall Study||16
11340596|NCT02923115|12537914|FG002|STARTED|Overall Study||23
11340597|NCT02923115|12537915|FG003|STARTED|Overall Study||23
11340598|NCT02923115|12537916|FG004|STARTED|Overall Study||22
11340599|NCT02923115|12537917|FG005|STARTED|Overall Study||38
11340600|NCT02923115|12537912|FG000|Treated|Overall Study||12
11340601|NCT02923115|12537913|FG001|Treated|Overall Study||16
11340602|NCT02923115|12537914|FG002|Treated|Overall Study||20
11340603|NCT02923115|12537915|FG003|Treated|Overall Study||22
11340604|NCT02923115|12537916|FG004|Treated|Overall Study||17
11340605|NCT02923115|12537917|FG005|Treated|Overall Study||38
11276064|NCT02357706|12471548|FG000|STARTED|Overall Study||10
11276065|NCT02357706|12471549|FG001|STARTED|Overall Study||10
11276066|NCT02357706|12471548|FG000|COMPLETED|Overall Study||10
11276067|NCT02357706|12471549|FG001|COMPLETED|Overall Study||10
11276068|NCT02357706|12471548|FG000|NOT COMPLETED|Overall Study||0
11276069|NCT02357706|12471549|FG001|NOT COMPLETED|Overall Study||0
11276070|NCT02357758|12471561|FG000|STARTED|Overall Study||25
11276071|NCT02357758|12471562|FG001|STARTED|Overall Study||20
11276072|NCT02357758|12471563|FG002|STARTED|Overall Study||12
11276073|NCT02357758|12471561|FG000|COMPLETED|Overall Study||9
11276074|NCT02357758|12471562|FG001|COMPLETED|Overall Study||20
11276075|NCT02357758|12471563|FG002|COMPLETED|Overall Study||5
11276076|NCT02357758|12471561|FG000|NOT COMPLETED|Overall Study||16
11276077|NCT02357758|12471562|FG001|NOT COMPLETED|Overall Study||0
11276078|NCT02357758|12471563|FG002|NOT COMPLETED|Overall Study||7
11276079|NCT02357836|12471571|FG000|STARTED|Overall Study||13
11276080|NCT02357836|12471571|FG000|COMPLETED|Overall Study||13
11276081|NCT02357836|12471571|FG000|NOT COMPLETED|Overall Study||0
11276082|NCT02357901|12471579|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
11276083|NCT02357901|12471580|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0
11276084|NCT02357901|12471581|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0
11276085|NCT02357901|12471582|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0
11276086|NCT02357901|12471579|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||504
11398264|NCT04502056|12592587|FG001|Completed the Follow-up Survey|Overall Study||607
11398265|NCT04502056|12592588|FG002|Completed the Follow-up Survey|Overall Study||591
11398266|NCT04502056|12592589|FG003|Completed the Follow-up Survey|Overall Study||601
11276087|NCT02357901|12471580|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0
11276088|NCT02357901|12471581|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0
11276089|NCT02357901|12471582|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0
11276090|NCT02357901|12471579|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
11276091|NCT02357901|12471580|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
11276092|NCT02357901|12471581|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
11276093|NCT02357901|12471582|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
11276094|NCT02357901|12471579|FG000|STARTED|Treatment Period (Day 1 to Week 24)||0
11276095|NCT02357901|12471580|FG001|STARTED|Treatment Period (Day 1 to Week 24)||203
11276096|NCT02357901|12471581|FG002|STARTED|Treatment Period (Day 1 to Week 24)||201
11276097|NCT02357901|12471582|FG003|STARTED|Treatment Period (Day 1 to Week 24)||100
11276098|NCT02357901|12471579|FG000|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
11276099|NCT02357901|12471580|FG001|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
11276100|NCT02357901|12471581|FG002|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
11276101|NCT02357901|12471582|FG003|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
11276102|NCT02357901|12471579|FG000|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
11276103|NCT02357901|12471580|FG001|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
11276104|NCT02357901|12471581|FG002|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
11276105|NCT02357901|12471582|FG003|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
11276106|NCT02357901|12471579|FG000|COMPLETED|Treatment Period (Day 1 to Week 24)||0
11276107|NCT02357901|12471580|FG001|COMPLETED|Treatment Period (Day 1 to Week 24)||125
11276108|NCT02357901|12471581|FG002|COMPLETED|Treatment Period (Day 1 to Week 24)||129
11276109|NCT02357901|12471582|FG003|COMPLETED|Treatment Period (Day 1 to Week 24)||34
11276110|NCT02357901|12471579|FG000|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
11276111|NCT02357901|12471580|FG001|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
11276112|NCT02357901|12471581|FG002|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
11276113|NCT02357901|12471582|FG003|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
11276114|NCT02357940|12471592|FG000|STARTED|Overall Study||9
11276115|NCT02357940|12471593|FG001|STARTED|Overall Study||32
11276116|NCT02357940|12471592|FG000|COMPLETED|Overall Study||9
11276117|NCT02357940|12471593|FG001|COMPLETED|Overall Study||30
11276118|NCT02357940|12471592|FG000|NOT COMPLETED|Overall Study||0
11276119|NCT02357940|12471593|FG001|NOT COMPLETED|Overall Study||2
11276120|NCT02357979|12471601|FG000|STARTED|Overall Study||60
11276121|NCT02357979|12471602|FG001|STARTED|Overall Study||60
11276122|NCT02357979|12471601|FG000|COMPLETED|Overall Study||55
11276123|NCT02357979|12471602|FG001|COMPLETED|Overall Study||55
11276124|NCT02357979|12471601|FG000|NOT COMPLETED|Overall Study||5
11276125|NCT02357979|12471602|FG001|NOT COMPLETED|Overall Study||5
11276126|NCT02358044|12471610|FG000|STARTED|Overall Study||129
11276127|NCT02358044|12471611|FG001|STARTED|Overall Study||128
11276128|NCT02358044|12471610|FG000|Treated|Overall Study||129
11276129|NCT02358044|12471611|FG001|Treated|Overall Study||126
11276130|NCT02358044|12471610|FG000|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
11276131|NCT02358044|12471611|FG001|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
11276132|NCT02358044|12471610|FG000|NOT COMPLETED|Overall Study||2
11276133|NCT02358044|12471611|FG001|NOT COMPLETED|Overall Study||7
11276134|NCT02358135|12471619|FG000|STARTED|Overall Study||150
11276135|NCT02358135|12471620|FG001|STARTED|Overall Study||150
11276136|NCT02358135|12471619|FG000|Randomized|Overall Study||148
11276137|NCT02358135|12471620|FG001|Randomized|Overall Study||148
11276138|NCT02358135|12471619|FG000|COMPLETED|Overall Study||135
11276139|NCT02358135|12471620|FG001|COMPLETED|Overall Study||131
11276140|NCT02358135|12471619|FG000|NOT COMPLETED|Overall Study||15
11276141|NCT02358135|12471620|FG001|NOT COMPLETED|Overall Study||19
11276142|NCT02358343|12471631|FG000|STARTED|Screening Intervention|90 completed engagement interview|92
11276143|NCT02358343|12471632|FG001|STARTED|Screening Intervention|89 completed control visit|92
11276144|NCT02358343|12471633|FG002|STARTED|Screening Intervention||0
11276145|NCT02358343|12471634|FG003|STARTED|Screening Intervention||0
11398267|NCT04502056|12592590|FG004|Completed the Follow-up Survey|Overall Study||631
11398268|NCT04502056|12592591|FG005|Completed the Follow-up Survey|Overall Study||598
11398269|NCT04502056|12592592|FG006|Completed the Follow-up Survey|Overall Study||607
11398270|NCT04502056|12592593|FG007|Completed the Follow-up Survey|Overall Study||607
11398271|NCT04502056|12592594|FG008|Completed the Follow-up Survey|Overall Study||301
11398272|NCT04502056|12592595|FG009|Completed the Follow-up Survey|Overall Study||313
11398273|NCT04502056|12592596|FG010|Completed the Follow-up Survey|Overall Study||291
11398274|NCT04502056|12592597|FG011|Completed the Follow-up Survey|Overall Study||316
11398275|NCT04502056|12592586|FG000|COMPLETED|Overall Study||604
11398276|NCT04502056|12592587|FG001|COMPLETED|Overall Study||602
11398277|NCT04502056|12592588|FG002|COMPLETED|Overall Study||586
11398278|NCT04502056|12592589|FG003|COMPLETED|Overall Study||597
11398279|NCT04502056|12592590|FG004|COMPLETED|Overall Study||626
11398280|NCT04502056|12592591|FG005|COMPLETED|Overall Study||596
11276146|NCT02358343|12471635|FG004|STARTED|Screening Intervention||0
11276147|NCT02358343|12471631|FG000|COMPLETED|Screening Intervention||86
11276148|NCT02358343|12471632|FG001|COMPLETED|Screening Intervention||84
11276149|NCT02358343|12471633|FG002|COMPLETED|Screening Intervention||0
11276150|NCT02358343|12471634|FG003|COMPLETED|Screening Intervention||0
11276151|NCT02358343|12471635|FG004|COMPLETED|Screening Intervention||0
11276152|NCT02358343|12471631|FG000|NOT COMPLETED|Screening Intervention||6
11276153|NCT02358343|12471632|FG001|NOT COMPLETED|Screening Intervention||8
11276154|NCT02358343|12471633|FG002|NOT COMPLETED|Screening Intervention||0
11276155|NCT02358343|12471634|FG003|NOT COMPLETED|Screening Intervention||0
11398281|NCT04502056|12592592|FG006|COMPLETED|Overall Study||605
11398282|NCT04502056|12592593|FG007|COMPLETED|Overall Study||603
11398283|NCT04502056|12592594|FG008|COMPLETED|Overall Study||298
11398284|NCT04502056|12592595|FG009|COMPLETED|Overall Study||311
11398285|NCT04502056|12592596|FG010|COMPLETED|Overall Study||288
11398286|NCT04502056|12592597|FG011|COMPLETED|Overall Study||614
11276156|NCT02358343|12471635|FG004|NOT COMPLETED|Screening Intervention||0
11276157|NCT02358343|12471631|FG000|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
11276158|NCT02358343|12471632|FG001|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
11276159|NCT02358343|12471633|FG002|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60
11276160|NCT02358343|12471634|FG003|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60
11276161|NCT02358343|12471635|FG004|STARTED|Comparative Efficacy Trial / Observation||20
11276162|NCT02358343|12471631|FG000|COMPLETED|Comparative Efficacy Trial / Observation||0
11276163|NCT02358343|12471632|FG001|COMPLETED|Comparative Efficacy Trial / Observation||0
11276164|NCT02358343|12471633|FG002|COMPLETED|Comparative Efficacy Trial / Observation||55
11276165|NCT02358343|12471634|FG003|COMPLETED|Comparative Efficacy Trial / Observation||58
11276166|NCT02358343|12471635|FG004|COMPLETED|Comparative Efficacy Trial / Observation||18
11276167|NCT02358343|12471631|FG000|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
11276168|NCT02358343|12471632|FG001|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
11276169|NCT02358343|12471633|FG002|NOT COMPLETED|Comparative Efficacy Trial / Observation||5
11276170|NCT02358343|12471634|FG003|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
11276171|NCT02358343|12471635|FG004|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
11276172|NCT02358369|12471649|FG000|STARTED|Pre-Randomization Washout Period||156
11276173|NCT02358369|12471650|FG001|STARTED|Pre-Randomization Washout Period||0
11276174|NCT02358369|12471651|FG002|STARTED|Pre-Randomization Washout Period||0
11276175|NCT02358369|12471652|FG003|STARTED|Pre-Randomization Washout Period||0
11276176|NCT02358369|12471653|FG004|STARTED|Pre-Randomization Washout Period||0
11276177|NCT02358369|12471649|FG000|COMPLETED|Pre-Randomization Washout Period||121
11276178|NCT02358369|12471650|FG001|COMPLETED|Pre-Randomization Washout Period||0
11276179|NCT02358369|12471651|FG002|COMPLETED|Pre-Randomization Washout Period||0
11276180|NCT02358369|12471652|FG003|COMPLETED|Pre-Randomization Washout Period||0
11276181|NCT02358369|12471653|FG004|COMPLETED|Pre-Randomization Washout Period||0
11276182|NCT02358369|12471649|FG000|NOT COMPLETED|Pre-Randomization Washout Period||35
11276183|NCT02358369|12471650|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0
11276184|NCT02358369|12471651|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0
11276185|NCT02358369|12471652|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0
11276186|NCT02358369|12471653|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0
11276187|NCT02358369|12471649|FG000|STARTED|Treatment Period A/B||0
11276188|NCT02358369|12471650|FG001|STARTED|Treatment Period A/B||40
11276189|NCT02358369|12471651|FG002|STARTED|Treatment Period A/B||40
11276190|NCT02358369|12471652|FG003|STARTED|Treatment Period A/B||41
11276191|NCT02358369|12471653|FG004|STARTED|Treatment Period A/B||0
11276192|NCT02358369|12471649|FG000|COMPLETED|Treatment Period A/B||0
11276193|NCT02358369|12471650|FG001|COMPLETED|Treatment Period A/B||38
11276194|NCT02358369|12471651|FG002|COMPLETED|Treatment Period A/B||38
11276195|NCT02358369|12471652|FG003|COMPLETED|Treatment Period A/B||37
11276196|NCT02358369|12471653|FG004|COMPLETED|Treatment Period A/B||0
11276197|NCT02358369|12471649|FG000|NOT COMPLETED|Treatment Period A/B||0
11276198|NCT02358369|12471650|FG001|NOT COMPLETED|Treatment Period A/B||2
11276199|NCT02358369|12471651|FG002|NOT COMPLETED|Treatment Period A/B||2
11276200|NCT02358369|12471652|FG003|NOT COMPLETED|Treatment Period A/B||4
11276201|NCT02358369|12471653|FG004|NOT COMPLETED|Treatment Period A/B||0
11276202|NCT02358369|12471649|FG000|STARTED|Treatment Period C||0
11276203|NCT02358369|12471650|FG001|STARTED|Treatment Period C||0
11276204|NCT02358369|12471651|FG002|STARTED|Treatment Period C||0
11276205|NCT02358369|12471652|FG003|STARTED|Treatment Period C||0
11276206|NCT02358369|12471653|FG004|STARTED|Treatment Period C||113
11276207|NCT02358369|12471649|FG000|COMPLETED|Treatment Period C||0
11276208|NCT02358369|12471650|FG001|COMPLETED|Treatment Period C||0
11276209|NCT02358369|12471651|FG002|COMPLETED|Treatment Period C||0
11276210|NCT02358369|12471652|FG003|COMPLETED|Treatment Period C||0
11398287|NCT04502056|12592586|FG000|NOT COMPLETED|Overall Study||1442
11398288|NCT04502056|12592587|FG001|NOT COMPLETED|Overall Study||1442
11398289|NCT04502056|12592588|FG002|NOT COMPLETED|Overall Study||1459
11398290|NCT04502056|12592589|FG003|NOT COMPLETED|Overall Study||1449
11398291|NCT04502056|12592590|FG004|NOT COMPLETED|Overall Study||1418
11398292|NCT04502056|12592591|FG005|NOT COMPLETED|Overall Study||1456
11398293|NCT04502056|12592592|FG006|NOT COMPLETED|Overall Study||1441
11276211|NCT02358369|12471653|FG004|COMPLETED|Treatment Period C||106
11276212|NCT02358369|12471649|FG000|NOT COMPLETED|Treatment Period C||0
11276213|NCT02358369|12471650|FG001|NOT COMPLETED|Treatment Period C||0
11276214|NCT02358369|12471651|FG002|NOT COMPLETED|Treatment Period C||0
11398294|NCT04502056|12592593|FG007|NOT COMPLETED|Overall Study||1440
11276215|NCT02358369|12471652|FG003|NOT COMPLETED|Treatment Period C||0
11276216|NCT02358369|12471653|FG004|NOT COMPLETED|Treatment Period C||7
11276217|NCT02358473|12471663|FG000|STARTED|Overall Study||13
11276218|NCT02358473|12471663|FG000|COMPLETED|Overall Study||0
11276219|NCT02358473|12471663|FG000|NOT COMPLETED|Overall Study||13
11276220|NCT02358603|12471669|FG000|STARTED|Overall Study||40
11276221|NCT02358603|12471670|FG001|STARTED|Overall Study||8
11276222|NCT02358603|12471669|FG000|COMPLETED|Overall Study||40
11276223|NCT02358603|12471670|FG001|COMPLETED|Overall Study||8
11276224|NCT02358603|12471669|FG000|NOT COMPLETED|Overall Study||0
11276225|NCT02358603|12471670|FG001|NOT COMPLETED|Overall Study||0
11276226|NCT02358668|12471679|FG000|STARTED|Overall Study||24
11276227|NCT02358668|12471680|FG001|STARTED|Overall Study||24
11276228|NCT02358668|12471681|FG002|STARTED|Overall Study||12
11276229|NCT02358668|12471679|FG000|COMPLETED|Overall Study||22
11276230|NCT02358668|12471680|FG001|COMPLETED|Overall Study||23
11276231|NCT02358668|12471681|FG002|COMPLETED|Overall Study||12
11276232|NCT02358668|12471679|FG000|NOT COMPLETED|Overall Study||2
11276233|NCT02358668|12471680|FG001|NOT COMPLETED|Overall Study||1
11276234|NCT02358668|12471681|FG002|NOT COMPLETED|Overall Study||0
11276235|NCT02358863|12471689|FG000|STARTED|Overall Study||13
11276236|NCT02358863|12471689|FG000|COMPLETED|Overall Study||10
11276237|NCT02358863|12471689|FG000|NOT COMPLETED|Overall Study||3
11276238|NCT02358876|12471693|FG000|STARTED|Overall Study||32
11276239|NCT02358876|12471693|FG000|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
11276240|NCT02358876|12471693|FG000|NOT COMPLETED|Overall Study||2
11276241|NCT02358889|12471700|FG000|STARTED|Overall Study||30
11276242|NCT02358889|12471701|FG001|STARTED|Overall Study||30
11276243|NCT02358889|12471702|FG002|STARTED|Overall Study||28
11276244|NCT02358889|12471700|FG000|COMPLETED|Overall Study||30
11276245|NCT02358889|12471701|FG001|COMPLETED|Overall Study||28
11276246|NCT02358889|12471702|FG002|COMPLETED|Overall Study||27
11276247|NCT02358889|12471700|FG000|NOT COMPLETED|Overall Study||0
11276248|NCT02358889|12471701|FG001|NOT COMPLETED|Overall Study||2
11276249|NCT02358889|12471702|FG002|NOT COMPLETED|Overall Study||1
11276250|NCT02359006|12471712|FG000|STARTED|Overall Study||14
11276251|NCT02359006|12471713|FG001|STARTED|Overall Study||13
11276252|NCT02359006|12471712|FG000|COMPLETED|Overall Study||10
11276253|NCT02359006|12471713|FG001|COMPLETED|Overall Study||10
11276254|NCT02359006|12471712|FG000|NOT COMPLETED|Overall Study||4
11276255|NCT02359006|12471713|FG001|NOT COMPLETED|Overall Study||3
11398295|NCT04502056|12592594|FG008|NOT COMPLETED|Overall Study||728
11276256|NCT02359045|12471723|FG000|STARTED|Overall Study||40
11276257|NCT02359045|12471724|FG001|STARTED|Overall Study||42
11398296|NCT04502056|12592595|FG009|NOT COMPLETED|Overall Study||714
11398297|NCT04502056|12592596|FG010|NOT COMPLETED|Overall Study||735
11398298|NCT04502056|12592597|FG011|NOT COMPLETED|Overall Study||406
11398299|NCT04498403|12592621|FG000|STARTED|Overall Study||30
11398300|NCT04498403|12592622|FG001|STARTED|Overall Study||10
11398301|NCT04498403|12592621|FG000|Completed Follow up|Overall Study||30
11398302|NCT04498403|12592622|FG001|Completed Follow up|Overall Study||10
11398303|NCT04498403|12592621|FG000|COMPLETED|Overall Study||0
11398304|NCT04498403|12592622|FG001|COMPLETED|Overall Study||0
11398305|NCT04498403|12592621|FG000|NOT COMPLETED|Overall Study||30
11398306|NCT04498403|12592622|FG001|NOT COMPLETED|Overall Study||10
11398307|NCT04495374|12592630|FG000|STARTED|Overall Study||30
11398308|NCT04495374|12592631|FG001|STARTED|Overall Study||28
11398309|NCT04495374|12592630|FG000|COMPLETED|Overall Study||28
11398310|NCT04495374|12592631|FG001|COMPLETED|Overall Study||27
11398311|NCT04495374|12592630|FG000|NOT COMPLETED|Overall Study||2
11398312|NCT04495374|12592631|FG001|NOT COMPLETED|Overall Study||1
11398313|NCT04495712|12592639|FG000|STARTED|Overall Study||44
11398314|NCT04495712|12592640|FG001|STARTED|Overall Study||46
11398315|NCT04495712|12592639|FG000|COMPLETED|Overall Study||44
11398316|NCT04495712|12592640|FG001|COMPLETED|Overall Study||46
11398317|NCT04495712|12592639|FG000|NOT COMPLETED|Overall Study||0
11398318|NCT04495712|12592640|FG001|NOT COMPLETED|Overall Study||0
11398319|NCT04492397|12592646|FG000|STARTED|First Intervention||17
11398320|NCT04492397|12592647|FG001|STARTED|First Intervention||18
11398321|NCT04492397|12592646|FG000|COMPLETED|First Intervention||17
11398322|NCT04492397|12592647|FG001|COMPLETED|First Intervention||18
11398323|NCT04492397|12592646|FG000|NOT COMPLETED|First Intervention||0
11398324|NCT04492397|12592647|FG001|NOT COMPLETED|First Intervention||0
11398325|NCT04492397|12592646|FG000|STARTED|Second Intervention||17
11276258|NCT02359045|12471723|FG000|COMPLETED|Overall Study||36
11398326|NCT04492397|12592647|FG001|STARTED|Second Intervention||18
11398327|NCT04492397|12592646|FG000|COMPLETED|Second Intervention||17
11398328|NCT04492397|12592647|FG001|COMPLETED|Second Intervention||18
11398329|NCT04492397|12592646|FG000|NOT COMPLETED|Second Intervention||0
11276259|NCT02359045|12471724|FG001|COMPLETED|Overall Study||39
11276260|NCT02359045|12471723|FG000|NOT COMPLETED|Overall Study||4
11398330|NCT04492397|12592647|FG001|NOT COMPLETED|Second Intervention||0
11276261|NCT02359045|12471724|FG001|NOT COMPLETED|Overall Study||3
11276262|NCT02359058|12471743|FG000|STARTED|Overall Study||6
11276263|NCT02359058|12471744|FG001|STARTED|Overall Study||6
11276264|NCT02359058|12471745|FG002|STARTED|Overall Study||6
11276265|NCT02359058|12471743|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
11276266|NCT02359058|12471744|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
11276267|NCT02359058|12471745|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11276268|NCT02359058|12471743|FG000|COMPLETED|Overall Study||6
11276269|NCT02359058|12471744|FG001|COMPLETED|Overall Study||6
11276270|NCT02359058|12471745|FG002|COMPLETED|Overall Study||6
11276271|NCT02359058|12471743|FG000|NOT COMPLETED|Overall Study||0
11276272|NCT02359058|12471744|FG001|NOT COMPLETED|Overall Study||0
11276273|NCT02359058|12471745|FG002|NOT COMPLETED|Overall Study||0
11276274|NCT02359110|12471756|FG000|STARTED|Overall Study||55
11276275|NCT02359110|12471757|FG001|STARTED|Overall Study||54
11276276|NCT02359110|12471756|FG000|COMPLETED|Overall Study||55
11276277|NCT02359110|12471757|FG001|COMPLETED|Overall Study||54
11276278|NCT02359110|12471756|FG000|NOT COMPLETED|Overall Study||0
11276279|NCT02359110|12471757|FG001|NOT COMPLETED|Overall Study||0
11276280|NCT02359305|12471765|FG000|STARTED|Overall Study||34
11276281|NCT02359305|12471766|FG001|STARTED|Overall Study||34
11276282|NCT02359305|12471765|FG000|COMPLETED|Overall Study||34
11276283|NCT02359305|12471766|FG001|COMPLETED|Overall Study||34
11276284|NCT02359305|12471765|FG000|NOT COMPLETED|Overall Study||0
11276285|NCT02359305|12471766|FG001|NOT COMPLETED|Overall Study||0
11276286|NCT02359435|12471774|FG000|STARTED|Overall Study||220
11276287|NCT02359435|12471775|FG001|STARTED|Overall Study||220
11276288|NCT02359435|12471774|FG000|COMPLETED|Overall Study||216
11276289|NCT02359435|12471775|FG001|COMPLETED|Overall Study||216
11276290|NCT02359435|12471774|FG000|NOT COMPLETED|Overall Study||4
11276291|NCT02359435|12471775|FG001|NOT COMPLETED|Overall Study||4
11276292|NCT02359552|12471783|FG000|STARTED|Overall Study||25
11276293|NCT02359552|12471784|FG001|STARTED|Overall Study||25
11276294|NCT02359552|12471783|FG000|COMPLETED|Overall Study||22
11276295|NCT02359552|12471784|FG001|COMPLETED|Overall Study||21
11276296|NCT02359552|12471783|FG000|NOT COMPLETED|Overall Study||3
11276297|NCT02359552|12471784|FG001|NOT COMPLETED|Overall Study||4
11276298|NCT02359851|12471790|FG000|STARTED|Overall Study||5
11276299|NCT02359851|12471790|FG000|COMPLETED|Overall Study||3
11276300|NCT02359851|12471790|FG000|NOT COMPLETED|Overall Study||2
11276301|NCT02359877|12471798|FG000|STARTED|Overall Study||34
11276302|NCT02359877|12471799|FG001|STARTED|Overall Study||6
11276303|NCT02359877|12471800|FG002|STARTED|Overall Study||6
11276304|NCT02359877|12471801|FG003|STARTED|Overall Study||14
11276305|NCT02359877|12471798|FG000|COMPLETED|Overall Study||33
11276306|NCT02359877|12471799|FG001|COMPLETED|Overall Study||6
11276307|NCT02359877|12471800|FG002|COMPLETED|Overall Study||6
11276308|NCT02359877|12471801|FG003|COMPLETED|Overall Study||11
11276309|NCT02359877|12471798|FG000|NOT COMPLETED|Overall Study||1
11276310|NCT02359877|12471799|FG001|NOT COMPLETED|Overall Study||0
11276311|NCT02359877|12471800|FG002|NOT COMPLETED|Overall Study||0
11398331|NCT04491994|12592655|FG000|STARTED|Overall Study||180
11398332|NCT04491994|12592656|FG001|STARTED|Overall Study||360
11398333|NCT04491994|12592655|FG000|COMPLETED|Overall Study||151
11398334|NCT04491994|12592656|FG001|COMPLETED|Overall Study||349
11398335|NCT04491994|12592655|FG000|NOT COMPLETED|Overall Study||29
11398336|NCT04491994|12592656|FG001|NOT COMPLETED|Overall Study||11
11398337|NCT04491240|12592665|FG000|STARTED|Overall Study||10
11398338|NCT04491240|12592666|FG001|STARTED|Overall Study||10
11276312|NCT02359877|12471801|FG003|NOT COMPLETED|Overall Study||3
11398339|NCT04491240|12592667|FG002|STARTED|Overall Study||10
11398340|NCT04491240|12592665|FG000|COMPLETED|Overall Study||10
11398341|NCT04491240|12592666|FG001|COMPLETED|Overall Study||10
11398342|NCT04491240|12592667|FG002|COMPLETED|Overall Study||10
11398343|NCT04491240|12592665|FG000|NOT COMPLETED|Overall Study||0
11398344|NCT04491240|12592666|FG001|NOT COMPLETED|Overall Study||0
11398345|NCT04491240|12592667|FG002|NOT COMPLETED|Overall Study||0
11398346|NCT04490863|12592675|FG000|STARTED|Overall Study||26
11398347|NCT04490863|12592675|FG000|COMPLETED|Overall Study||26
11398348|NCT04490863|12592675|FG000|NOT COMPLETED|Overall Study||0
11398349|NCT04490239|12592679|FG000|STARTED|1000 U Acute (One Dose, Day 1)||6
11398350|NCT04490239|12592679|FG000|COMPLETED|1000 U Acute (One Dose, Day 1)||6
11398351|NCT04490239|12592679|FG000|NOT COMPLETED|1000 U Acute (One Dose, Day 1)||0
11398352|NCT04490239|12592679|FG000|STARTED|2000 U Acute (One Dose, Day 3)||6
11398353|NCT04490239|12592679|FG000|COMPLETED|2000 U Acute (One Dose, Day 3)||6
11398354|NCT04490239|12592679|FG000|NOT COMPLETED|2000 U Acute (One Dose, Day 3)||0
11276313|NCT02359890|12471829|FG000|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
11276314|NCT02359890|12471829|FG000|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
11276315|NCT02359890|12471829|FG000|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
11276316|NCT02359890|12471829|FG000|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
11276317|NCT02359890|12471829|FG000|COMPLETED|Overall Study||155
11276318|NCT02359890|12471829|FG000|NOT COMPLETED|Overall Study||10
11276319|NCT02359903|12471835|FG000|STARTED|Overall Study||45
11276320|NCT02359903|12471836|FG001|STARTED|Overall Study||45
11276321|NCT02359903|12471835|FG000|COMPLETED|Overall Study||45
11398355|NCT04490239|12592679|FG000|STARTED|2000 U Chronic (Daily, 14 Days)||6
11276322|NCT02359903|12471836|FG001|COMPLETED|Overall Study||43
11276323|NCT02359903|12471835|FG000|NOT COMPLETED|Overall Study||0
11276324|NCT02359903|12471836|FG001|NOT COMPLETED|Overall Study||2
11276325|NCT02359916|12471849|FG000|STARTED|Overall Study|The number of unique individuals in this study is unknown|
11276326|NCT02359916|12471850|FG001|STARTED|Overall Study|The number of unique individuals in this study is unknown|
11276327|NCT02359916|12471851|FG002|STARTED|Overall Study|The number of unique individuals in this study is unknown|
11276328|NCT02359916|12471852|FG003|STARTED|Overall Study|The number of unique individuals in this study is unknown|
11276329|NCT02359916|12471853|FG004|STARTED|Overall Study|The number of unique individuals in this study is unknown|
11276330|NCT02359916|12471854|FG005|STARTED|Overall Study|The number of unique individuals in this study is unknown|
11276331|NCT02359916|12471855|FG006|STARTED|Overall Study|The number of unique individuals in this study is unknown|
11276332|NCT02359916|12471849|FG000|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
11276333|NCT02359916|12471850|FG001|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
11276334|NCT02359916|12471851|FG002|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
11276335|NCT02359916|12471852|FG003|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
11276336|NCT02359916|12471853|FG004|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
11276337|NCT02359916|12471854|FG005|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
11276338|NCT02359916|12471855|FG006|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
11276339|NCT02359916|12471849|FG000|NOT COMPLETED|Overall Study||
11276340|NCT02359916|12471850|FG001|NOT COMPLETED|Overall Study||
11276341|NCT02359916|12471851|FG002|NOT COMPLETED|Overall Study||
11276342|NCT02359916|12471852|FG003|NOT COMPLETED|Overall Study||
11276343|NCT02359916|12471853|FG004|NOT COMPLETED|Overall Study||
11276344|NCT02359916|12471854|FG005|NOT COMPLETED|Overall Study||
11276345|NCT02359916|12471855|FG006|NOT COMPLETED|Overall Study||
11276346|NCT02359955|12471872|FG000|STARTED|Overall Study||10
11276347|NCT02359955|12471873|FG001|STARTED|Overall Study||10
11276348|NCT02359955|12471872|FG000|COMPLETED|Overall Study||10
11276349|NCT02359955|12471873|FG001|COMPLETED|Overall Study||10
11276350|NCT02359955|12471872|FG000|NOT COMPLETED|Overall Study||0
11276351|NCT02359955|12471873|FG001|NOT COMPLETED|Overall Study||0
11276352|NCT02360085|12471889|FG000|STARTED|Overall Study||65
11276353|NCT02360085|12471889|FG000|COMPLETED|Overall Study||49
11276354|NCT02360085|12471889|FG000|NOT COMPLETED|Overall Study||16
11276355|NCT02360098|12471902|FG000|STARTED|Overall Study||36
11276356|NCT02360098|12471902|FG000|COMPLETED|Overall Study||29
11276357|NCT02360098|12471902|FG000|NOT COMPLETED|Overall Study||7
11276358|NCT02360124|12471910|FG000|STARTED|Overall Study||108
11276359|NCT02360124|12471911|FG001|STARTED|Overall Study||107
11276360|NCT02360124|12471912|FG002|STARTED|Overall Study||108
11276361|NCT02360124|12471910|FG000|COMPLETED|Overall Study||80
11276362|NCT02360124|12471911|FG001|COMPLETED|Overall Study||95
11276363|NCT02360124|12471912|FG002|COMPLETED|Overall Study||82
11276364|NCT02360124|12471910|FG000|NOT COMPLETED|Overall Study||28
11276365|NCT02360124|12471911|FG001|NOT COMPLETED|Overall Study||12
11276366|NCT02360124|12471912|FG002|NOT COMPLETED|Overall Study||26
11276367|NCT02360215|12471924|FG000|STARTED|Overall Study||257
11276368|NCT02360215|12471925|FG001|STARTED|Overall Study||261
11276369|NCT02360215|12471924|FG000|All Randomized Participants|Overall Study||257
11276370|NCT02360215|12471925|FG001|All Randomized Participants|Overall Study||261
11398356|NCT04490239|12592679|FG000|COMPLETED|2000 U Chronic (Daily, 14 Days)||6
11398357|NCT04490239|12592679|FG000|NOT COMPLETED|2000 U Chronic (Daily, 14 Days)||0
11398358|NCT04486235|12592685|FG000|STARTED|Overall Study||32
11398359|NCT04486235|12592686|FG001|STARTED|Overall Study||30
11398360|NCT04486235|12592685|FG000|Analysis|Overall Study||30
11398361|NCT04486235|12592686|FG001|Analysis|Overall Study||30
11398362|NCT04486235|12592685|FG000|COMPLETED|Overall Study||30
11398363|NCT04486235|12592686|FG001|COMPLETED|Overall Study||30
11398364|NCT04486235|12592685|FG000|NOT COMPLETED|Overall Study||2
11398365|NCT04486235|12592686|FG001|NOT COMPLETED|Overall Study||0
11398366|NCT04483011|12592695|FG000|STARTED|Intervention Period 1 (8 Days)||9
11398367|NCT04483011|12592696|FG001|STARTED|Intervention Period 1 (8 Days)||9
11276371|NCT02360215|12471924|FG000|Started Protocol Treatment|Overall Study||232
11276372|NCT02360215|12471925|FG001|Started Protocol Treatment|Overall Study||223
11276373|NCT02360215|12471924|FG000|MDASI-BT Symptom Score|Overall Study||249
11276374|NCT02360215|12471925|FG001|MDASI-BT Symptom Score|Overall Study||251
11276375|NCT02360215|12471924|FG000|MDASI-BT Intererence Score|Overall Study||248
11276376|NCT02360215|12471925|FG001|MDASI-BT Intererence Score|Overall Study||251
11276377|NCT02360215|12471924|FG000|MDASI-BT Cognitive Factor Score|Overall Study||249
11276378|NCT02360215|12471925|FG001|MDASI-BT Cognitive Factor Score|Overall Study||251
11276379|NCT02360215|12471924|FG000|MDASI-BT Neurologic Factor Score|Overall Study||249
11276380|NCT02360215|12471925|FG001|MDASI-BT Neurologic Factor Score|Overall Study||251
11276381|NCT02360215|12471924|FG000|HVLT-R Total Recall|Overall Study||256
11276382|NCT02360215|12471925|FG001|HVLT-R Total Recall|Overall Study||259
11398368|NCT04483011|12592695|FG000|COMPLETED|Intervention Period 1 (8 Days)||9
11398369|NCT04483011|12592696|FG001|COMPLETED|Intervention Period 1 (8 Days)||9
11398370|NCT04483011|12592695|FG000|NOT COMPLETED|Intervention Period 1 (8 Days)||0
11276383|NCT02360215|12471924|FG000|HVLT-R Delayed Recall|Overall Study||256
11276384|NCT02360215|12471925|FG001|HVLT-R Delayed Recall|Overall Study||259
11276385|NCT02360215|12471924|FG000|HVLT-R Recognition|Overall Study||255
11276386|NCT02360215|12471925|FG001|HVLT-R Recognition|Overall Study||259
11276387|NCT02360215|12471924|FG000|Trail Making Test (TMT) Part A|Overall Study||256
11276388|NCT02360215|12471925|FG001|Trail Making Test (TMT) Part A|Overall Study||260
11276389|NCT02360215|12471924|FG000|TMT Part B|Overall Study||250
11276390|NCT02360215|12471925|FG001|TMT Part B|Overall Study||257
11276391|NCT02360215|12471924|FG000|Controlled Oral Word Association (COWA)|Overall Study||257
11276392|NCT02360215|12471925|FG001|Controlled Oral Word Association (COWA)|Overall Study||261
11276393|NCT02360215|12471924|FG000|Clinical Trial Battery Composite Score|Overall Study||255
11276394|NCT02360215|12471925|FG001|Clinical Trial Battery Composite Score|Overall Study||259
11276395|NCT02360215|12471924|FG000|EQ-5D-5L Index at 2 Months|Overall Study||142
11276396|NCT02360215|12471925|FG001|EQ-5D-5L Index at 2 Months|Overall Study||125
11276397|NCT02360215|12471924|FG000|EQ-5D-5L Index at 4 Months|Overall Study||110
11276398|NCT02360215|12471925|FG001|EQ-5D-5L Index at 4 Months|Overall Study||96
11276399|NCT02360215|12471924|FG000|EQ-5D-5L Index at 6 Months|Overall Study||79
11276400|NCT02360215|12471925|FG001|EQ-5D-5L Index at 6 Months|Overall Study||70
11276401|NCT02360215|12471924|FG000|EQ-5D-5L Index at 12 Months|Overall Study||56
11276402|NCT02360215|12471925|FG001|EQ-5D-5L Index at 12 Months|Overall Study||45
11276403|NCT02360215|12471924|FG000|EQ-5D-5L VAS at 2 Months|Overall Study||139
11276404|NCT02360215|12471925|FG001|EQ-5D-5L VAS at 2 Months|Overall Study||123
11276405|NCT02360215|12471924|FG000|EQ-5D-5L VAS at 4 Months|Overall Study||104
11276406|NCT02360215|12471925|FG001|EQ-5D-5L VAS at 4 Months|Overall Study||193
11276407|NCT02360215|12471924|FG000|EQ-5D-5L VAS at 6 Months|Overall Study||76
11276408|NCT02360215|12471925|FG001|EQ-5D-5L VAS at 6 Months|Overall Study||69
11276409|NCT02360215|12471924|FG000|EQ-5D-5L VAS at 12 Months|Overall Study||57
11276410|NCT02360215|12471925|FG001|EQ-5D-5L VAS at 12 Months|Overall Study||48
11276411|NCT02360215|12471924|FG000|COMPLETED|Overall Study||257
11276412|NCT02360215|12471925|FG001|COMPLETED|Overall Study||261
11276413|NCT02360215|12471924|FG000|NOT COMPLETED|Overall Study||0
11276414|NCT02360215|12471925|FG001|NOT COMPLETED|Overall Study||0
11276415|NCT02360228|12471935|FG000|STARTED|Overall Study||9
11276416|NCT02360228|12471936|FG001|STARTED|Overall Study||8
11276417|NCT02360228|12471937|FG002|STARTED|Overall Study||8
11276418|NCT02360228|12471935|FG000|COMPLETED|Overall Study||8
11276419|NCT02360228|12471936|FG001|COMPLETED|Overall Study||7
11276420|NCT02360228|12471937|FG002|COMPLETED|Overall Study||7
11276421|NCT02360228|12471935|FG000|NOT COMPLETED|Overall Study||1
11276422|NCT02360228|12471936|FG001|NOT COMPLETED|Overall Study||1
11276423|NCT02360228|12471937|FG002|NOT COMPLETED|Overall Study||1
11276424|NCT02360293|12471947|FG000|STARTED|Overall Study||178
11276425|NCT02360293|12471948|FG001|STARTED|Overall Study||179
11276426|NCT02360293|12471947|FG000|6month f/u Survey|Overall Study||110
11276427|NCT02360293|12471948|FG001|6month f/u Survey|Overall Study||105
11276428|NCT02360293|12471947|FG000|6month Physical Activity|Overall Study||122
11276429|NCT02360293|12471948|FG001|6month Physical Activity|Overall Study||108
11276430|NCT02360293|12471947|FG000|12month f/u Survey|Overall Study||102
11276431|NCT02360293|12471948|FG001|12month f/u Survey|Overall Study||83
11276432|NCT02360293|12471947|FG000|12month Physical Activity|Overall Study||68
11276433|NCT02360293|12471948|FG001|12month Physical Activity|Overall Study||59
11276434|NCT02360293|12471947|FG000|COMPLETED|Overall Study||102
11276435|NCT02360293|12471948|FG001|COMPLETED|Overall Study||83
11276436|NCT02360293|12471947|FG000|NOT COMPLETED|Overall Study||76
11276437|NCT02360293|12471948|FG001|NOT COMPLETED|Overall Study||96
11276438|NCT02360319|12471956|FG000|STARTED|Overall Study||255
11276439|NCT02360319|12471957|FG001|STARTED|Overall Study||234
11276440|NCT02360319|12471956|FG000|COMPLETED|Overall Study||167
11276441|NCT02360319|12471957|FG001|COMPLETED|Overall Study||173
11276442|NCT02360319|12471956|FG000|NOT COMPLETED|Overall Study||88
11276443|NCT02360319|12471957|FG001|NOT COMPLETED|Overall Study||61
11276444|NCT02360371|12471965|FG000|STARTED|Overall Study||13
11276445|NCT02360371|12471966|FG001|STARTED|Overall Study||84
11276446|NCT02360371|12471965|FG000|Placebo (Oral)|Overall Study||13
11276447|NCT02360371|12471966|FG001|Placebo (Oral)|Overall Study||69
11276448|NCT02360371|12471965|FG000|Hydromorphone (Oral) 2mg|Overall Study||13
11276449|NCT02360371|12471966|FG001|Hydromorphone (Oral) 2mg|Overall Study||69
11276450|NCT02360371|12471965|FG000|Hydromorphone (Oral) 4mg|Overall Study||13
11276451|NCT02360371|12471966|FG001|Hydromorphone (Oral) 4mg|Overall Study||69
11276452|NCT02360371|12471965|FG000|Hydromorphone (Oral) 8mg|Overall Study||13
11276453|NCT02360371|12471966|FG001|Hydromorphone (Oral) 8mg|Overall Study||69
11276454|NCT02360371|12471965|FG000|COMPLETED|Overall Study||13
11276455|NCT02360371|12471966|FG001|COMPLETED|Overall Study||69
11276456|NCT02360371|12471965|FG000|NOT COMPLETED|Overall Study||0
11276457|NCT02360371|12471966|FG001|NOT COMPLETED|Overall Study||15
11276458|NCT02360397|12471976|FG000|STARTED|Overall Study||6
11276459|NCT02360397|12471976|FG000|COMPLETED|Overall Study||2
11276460|NCT02360397|12471976|FG000|NOT COMPLETED|Overall Study||4
11276461|NCT02360475|12471985|FG000|STARTED|Overall Study||126
11276462|NCT02360475|12471986|FG001|STARTED|Overall Study||124
11276463|NCT02360475|12471987|FG002|STARTED|Overall Study||125
11276464|NCT02360475|12471988|FG003|STARTED|Overall Study||125
11276465|NCT02360475|12471985|FG000|COMPLETED|Overall Study||122
11276466|NCT02360475|12471986|FG001|COMPLETED|Overall Study||111
11276467|NCT02360475|12471987|FG002|COMPLETED|Overall Study||117
11276468|NCT02360475|12471988|FG003|COMPLETED|Overall Study||120
11276469|NCT02360475|12471985|FG000|NOT COMPLETED|Overall Study||4
11276470|NCT02360475|12471986|FG001|NOT COMPLETED|Overall Study||13
11276471|NCT02360475|12471987|FG002|NOT COMPLETED|Overall Study||8
11276472|NCT02360475|12471988|FG003|NOT COMPLETED|Overall Study||5
11276473|NCT02360488|12472000|FG000|STARTED|Overall Study||62
11276474|NCT02360488|12472001|FG001|STARTED|Overall Study||62
11276475|NCT02360488|12472000|FG000|COMPLETED|Overall Study||59
11276476|NCT02360488|12472001|FG001|COMPLETED|Overall Study||55
11276477|NCT02360488|12472000|FG000|NOT COMPLETED|Overall Study||3
11276478|NCT02360488|12472001|FG001|NOT COMPLETED|Overall Study||7
11276479|NCT02360605|12472009|FG000|STARTED|Overall Study||311
11276480|NCT02360605|12472010|FG001|STARTED|Overall Study||309
11276481|NCT02360605|12472009|FG000|COMPLETED|Overall Study||300
11276482|NCT02360605|12472010|FG001|COMPLETED|Overall Study||291
11276483|NCT02360605|12472009|FG000|NOT COMPLETED|Overall Study||11
11276484|NCT02360605|12472010|FG001|NOT COMPLETED|Overall Study||18
11276485|NCT02360631|12472020|FG000|STARTED|Overall Study||300
11276486|NCT02360631|12472021|FG001|STARTED|Overall Study||200
11276487|NCT02360631|12472020|FG000|Week 12|Overall Study||249
11276488|NCT02360631|12472021|FG001|Week 12|Overall Study||165
11276489|NCT02360631|12472020|FG000|COMPLETED|Overall Study||267
11276490|NCT02360631|12472021|FG001|COMPLETED|Overall Study||174
11276491|NCT02360631|12472020|FG000|NOT COMPLETED|Overall Study||33
11276492|NCT02360631|12472021|FG001|NOT COMPLETED|Overall Study||26
11276493|NCT02360774|12472029|FG000|STARTED|Overall Study||15
11276494|NCT02360774|12472030|FG001|STARTED|Overall Study||15
11276495|NCT02360774|12472029|FG000|COMPLETED|Overall Study||12
11276496|NCT02360774|12472030|FG001|COMPLETED|Overall Study||13
11276497|NCT02360774|12472029|FG000|NOT COMPLETED|Overall Study||3
11276498|NCT02360774|12472030|FG001|NOT COMPLETED|Overall Study||2
11276499|NCT02360995|12472041|FG000|STARTED|Overall Study||43
11398371|NCT04483011|12592696|FG001|NOT COMPLETED|Intervention Period 1 (8 Days)||0
11398372|NCT04483011|12592695|FG000|STARTED|Washout (7 Days)||9
11398373|NCT04483011|12592696|FG001|STARTED|Washout (7 Days)||9
11398374|NCT04483011|12592695|FG000|COMPLETED|Washout (7 Days)||9
11398375|NCT04483011|12592696|FG001|COMPLETED|Washout (7 Days)||8
11276500|NCT02360995|12472042|FG001|STARTED|Overall Study||43
11276501|NCT02360995|12472043|FG002|STARTED|Overall Study||43
11276502|NCT02360995|12472041|FG000|COMPLETED|Overall Study||41
11276503|NCT02360995|12472042|FG001|COMPLETED|Overall Study||42
11276504|NCT02360995|12472043|FG002|COMPLETED|Overall Study||41
11276505|NCT02360995|12472041|FG000|NOT COMPLETED|Overall Study||2
11276506|NCT02360995|12472042|FG001|NOT COMPLETED|Overall Study||1
11276507|NCT02360995|12472043|FG002|NOT COMPLETED|Overall Study||2
11276508|NCT02361216|12472053|FG000|STARTED|3 Day Treatment and 8 Week Follow/up||552
11276509|NCT02361216|12472054|FG001|STARTED|3 Day Treatment and 8 Week Follow/up||177
11276510|NCT02361216|12472053|FG000|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
11276511|NCT02361216|12472054|FG001|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
11276512|NCT02361216|12472053|FG000|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
11276513|NCT02361216|12472054|FG001|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
11276514|NCT02361216|12472053|FG000|STARTED|12-month Follow-up||541
11276515|NCT02361216|12472054|FG001|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
11276516|NCT02361216|12472053|FG000|COMPLETED|12-month Follow-up||489
11276517|NCT02361216|12472054|FG001|COMPLETED|12-month Follow-up||130
11276518|NCT02361216|12472053|FG000|NOT COMPLETED|12-month Follow-up||52
11276519|NCT02361216|12472054|FG001|NOT COMPLETED|12-month Follow-up||27
11276520|NCT02361307|12472065|FG000|STARTED|Overall Study||18
11276521|NCT02361307|12472066|FG001|STARTED|Overall Study||18
11276522|NCT02361307|12472065|FG000|COMPLETED|Overall Study||18
11276523|NCT02361307|12472066|FG001|COMPLETED|Overall Study||17
11276524|NCT02361307|12472065|FG000|NOT COMPLETED|Overall Study||0
11276525|NCT02361307|12472066|FG001|NOT COMPLETED|Overall Study||1
11276526|NCT02361476|12472074|FG000|STARTED|Overall Study||191
11276527|NCT02361476|12472075|FG001|STARTED|Overall Study||188
11276528|NCT02361476|12472074|FG000|COMPLETED|Overall Study||191
11276529|NCT02361476|12472075|FG001|COMPLETED|Overall Study||188
11276530|NCT02361476|12472074|FG000|NOT COMPLETED|Overall Study||0
11276531|NCT02361476|12472075|FG001|NOT COMPLETED|Overall Study||0
11276532|NCT02361736|12472083|FG000|STARTED|Overall Study||60
11276533|NCT02361736|12472084|FG001|STARTED|Overall Study||60
11276534|NCT02361736|12472083|FG000|COMPLETED|Overall Study||59
11276535|NCT02361736|12472084|FG001|COMPLETED|Overall Study||59
11276536|NCT02361736|12472083|FG000|NOT COMPLETED|Overall Study||1
11276537|NCT02361736|12472084|FG001|NOT COMPLETED|Overall Study||1
11276538|NCT02361762|12472092|FG000|STARTED|Overall Study||35
11276539|NCT02361762|12472093|FG001|STARTED|Overall Study||35
11276540|NCT02361762|12472092|FG000|COMPLETED|Overall Study||35
11276541|NCT02361762|12472093|FG001|COMPLETED|Overall Study||33
11276542|NCT02361762|12472092|FG000|NOT COMPLETED|Overall Study||0
11276543|NCT02361762|12472093|FG001|NOT COMPLETED|Overall Study||2
11276544|NCT02362048|12472101|FG000|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37
11276545|NCT02362048|12472102|FG001|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40
11276546|NCT02362048|12472101|FG000|Enrolled|Overall Study||37
11276547|NCT02362048|12472102|FG001|Enrolled|Overall Study||40
11276548|NCT02362048|12472101|FG000|Received Study Medication|Overall Study||35
11276549|NCT02362048|12472102|FG001|Received Study Medication|Overall Study||38
11276550|NCT02362048|12472101|FG000|Discontinued Study|Overall Study||37
11276551|NCT02362048|12472102|FG001|Discontinued Study|Overall Study||40
11276552|NCT02362048|12472101|FG000|COMPLETED|Overall Study||0
11276553|NCT02362048|12472102|FG001|COMPLETED|Overall Study||0
11276554|NCT02362048|12472101|FG000|NOT COMPLETED|Overall Study||37
11276555|NCT02362048|12472102|FG001|NOT COMPLETED|Overall Study||40
11276556|NCT02362191|12472108|FG000|STARTED|Overall Study||5
11276557|NCT02362191|12472108|FG000|COMPLETED|Overall Study||3
11276558|NCT02362191|12472108|FG000|NOT COMPLETED|Overall Study||2
11276559|NCT02362269|12472114|FG000|STARTED|Overall Study||83
11276560|NCT02362269|12472115|FG001|STARTED|Overall Study||86
11276561|NCT02362269|12472114|FG000|COMPLETED|Overall Study||82
11276562|NCT02362269|12472115|FG001|COMPLETED|Overall Study||80
11276563|NCT02362269|12472114|FG000|NOT COMPLETED|Overall Study||1
11276564|NCT02362269|12472115|FG001|NOT COMPLETED|Overall Study||6
11276565|NCT02362282|12472123|FG000|STARTED|Overall Study||5
11276566|NCT02362282|12472124|FG001|STARTED|Overall Study||7
11276567|NCT02362282|12472123|FG000|COMPLETED|Overall Study||4
11276568|NCT02362282|12472124|FG001|COMPLETED|Overall Study||7
11276569|NCT02362282|12472123|FG000|NOT COMPLETED|Overall Study||1
11276570|NCT02362282|12472124|FG001|NOT COMPLETED|Overall Study||0
11276571|NCT02362321|12472132|FG000|STARTED|Overall Study||10
11276572|NCT02362321|12472133|FG001|STARTED|Overall Study||10
11276573|NCT02362321|12472132|FG000|COMPLETED|Overall Study||6
11276574|NCT02362321|12472133|FG001|COMPLETED|Overall Study||10
11276575|NCT02362321|12472132|FG000|NOT COMPLETED|Overall Study||4
11276576|NCT02362321|12472133|FG001|NOT COMPLETED|Overall Study||0
11276577|NCT02362360|12472139|FG000|STARTED|Period 1||26
11276578|NCT02362360|12472140|FG001|STARTED|Period 1||26
11276579|NCT02362360|12472139|FG000|COMPLETED|Period 1||23
11276580|NCT02362360|12472140|FG001|COMPLETED|Period 1||25
11276581|NCT02362360|12472139|FG000|NOT COMPLETED|Period 1||3
11276582|NCT02362360|12472140|FG001|NOT COMPLETED|Period 1||1
11276583|NCT02362360|12472139|FG000|STARTED|Period 2||23
11276584|NCT02362360|12472140|FG001|STARTED|Period 2||25
11276585|NCT02362360|12472139|FG000|COMPLETED|Period 2||23
11276586|NCT02362360|12472140|FG001|COMPLETED|Period 2||25
11276587|NCT02362360|12472139|FG000|NOT COMPLETED|Period 2||0
11276588|NCT02362360|12472140|FG001|NOT COMPLETED|Period 2||0
11276589|NCT02362373|12472146|FG000|STARTED|Overall Study||20
11276590|NCT02362373|12472146|FG000|COMPLETED|Overall Study||20
11276591|NCT02362373|12472146|FG000|NOT COMPLETED|Overall Study||0
11276592|NCT02362412|12472150|FG000|STARTED|Treatment Period II||9
11276593|NCT02362412|12472151|FG001|STARTED|Treatment Period II||11
11276594|NCT02362412|12472150|FG000|TREATED|Treatment Period II||9
11276595|NCT02362412|12472151|FG001|TREATED|Treatment Period II||11
11276596|NCT02362412|12472150|FG000|COMPLETED|Treatment Period II||9
11276597|NCT02362412|12472151|FG001|COMPLETED|Treatment Period II||11
11276598|NCT02362412|12472150|FG000|NOT COMPLETED|Treatment Period II||0
11276599|NCT02362412|12472151|FG001|NOT COMPLETED|Treatment Period II||0
11276600|NCT02362412|12472150|FG000|STARTED|Treatment Period III||9
11276601|NCT02362412|12472151|FG001|STARTED|Treatment Period III||11
11276602|NCT02362412|12472150|FG000|TREATED|Treatment Period III||9
11276603|NCT02362412|12472151|FG001|TREATED|Treatment Period III||11
11276604|NCT02362412|12472150|FG000|COMPLETED|Treatment Period III||9
11276605|NCT02362412|12472151|FG001|COMPLETED|Treatment Period III||10
11276606|NCT02362412|12472150|FG000|NOT COMPLETED|Treatment Period III||0
11276607|NCT02362412|12472151|FG001|NOT COMPLETED|Treatment Period III||1
11276608|NCT02362425|12472167|FG000|STARTED|Phase 1 (up to 6 Months)||53
11276609|NCT02362425|12472168|FG001|STARTED|Phase 1 (up to 6 Months)||10
11276610|NCT02362425|12472169|FG002|STARTED|Phase 1 (up to 6 Months)||0
11276611|NCT02362425|12472170|FG003|STARTED|Phase 1 (up to 6 Months)||0
11276612|NCT02362425|12472167|FG000|COMPLETED|Phase 1 (up to 6 Months)||37
11276613|NCT02362425|12472168|FG001|COMPLETED|Phase 1 (up to 6 Months)||10
11276614|NCT02362425|12472169|FG002|COMPLETED|Phase 1 (up to 6 Months)||0
11276615|NCT02362425|12472170|FG003|COMPLETED|Phase 1 (up to 6 Months)||0
11276616|NCT02362425|12472167|FG000|NOT COMPLETED|Phase 1 (up to 6 Months)||16
11276617|NCT02362425|12472168|FG001|NOT COMPLETED|Phase 1 (up to 6 Months)||0
11276618|NCT02362425|12472169|FG002|NOT COMPLETED|Phase 1 (up to 6 Months)||0
11276619|NCT02362425|12472170|FG003|NOT COMPLETED|Phase 1 (up to 6 Months)||0
11276620|NCT02362425|12472167|FG000|STARTED|Phase 2 (up to 6 Months, Randomized)||0
11276621|NCT02362425|12472168|FG001|STARTED|Phase 2 (up to 6 Months, Randomized)||0
11276622|NCT02362425|12472169|FG002|STARTED|Phase 2 (up to 6 Months, Randomized)||16
11276623|NCT02362425|12472170|FG003|STARTED|Phase 2 (up to 6 Months, Randomized)||17
11276624|NCT02362425|12472167|FG000|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
11276625|NCT02362425|12472168|FG001|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
11276626|NCT02362425|12472169|FG002|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15
11276627|NCT02362425|12472170|FG003|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14
11276628|NCT02362425|12472167|FG000|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
11276629|NCT02362425|12472168|FG001|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
11276630|NCT02362425|12472169|FG002|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1
11276631|NCT02362425|12472170|FG003|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3
11276632|NCT02362646|12472183|FG000|STARTED|Overall Study||106
11276633|NCT02362646|12472184|FG001|STARTED|Overall Study||53
11276634|NCT02362646|12472183|FG000|COMPLETED|Overall Study||68
11276635|NCT02362646|12472184|FG001|COMPLETED|Overall Study||29
11276636|NCT02362646|12472183|FG000|NOT COMPLETED|Overall Study||38
11276637|NCT02362646|12472184|FG001|NOT COMPLETED|Overall Study||24
11276638|NCT02362672|12472194|FG000|STARTED|Titration Phase||1189
11276639|NCT02362672|12472195|FG001|STARTED|Titration Phase||0
11276640|NCT02362672|12472196|FG002|STARTED|Titration Phase||0
11276641|NCT02362672|12472194|FG000|COMPLETED|Titration Phase||610
11398376|NCT04483011|12592695|FG000|NOT COMPLETED|Washout (7 Days)||0
11398377|NCT04483011|12592696|FG001|NOT COMPLETED|Washout (7 Days)||1
11276642|NCT02362672|12472195|FG001|COMPLETED|Titration Phase||0
11276643|NCT02362672|12472196|FG002|COMPLETED|Titration Phase||0
11276644|NCT02362672|12472194|FG000|NOT COMPLETED|Titration Phase||579
11276645|NCT02362672|12472195|FG001|NOT COMPLETED|Titration Phase||0
11276646|NCT02362672|12472196|FG002|NOT COMPLETED|Titration Phase||0
11276647|NCT02362672|12472194|FG000|STARTED|Double-blind Maintenance Phase||0
11276648|NCT02362672|12472195|FG001|STARTED|Double-blind Maintenance Phase||309
11276649|NCT02362672|12472196|FG002|STARTED|Double-blind Maintenance Phase||301
11276650|NCT02362672|12472194|FG000|COMPLETED|Double-blind Maintenance Phase||0
11276651|NCT02362672|12472195|FG001|COMPLETED|Double-blind Maintenance Phase||249
11276652|NCT02362672|12472196|FG002|COMPLETED|Double-blind Maintenance Phase||242
11276653|NCT02362672|12472194|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
11276654|NCT02362672|12472195|FG001|NOT COMPLETED|Double-blind Maintenance Phase||60
11276655|NCT02362672|12472196|FG002|NOT COMPLETED|Double-blind Maintenance Phase||59
11276656|NCT02362724|12472207|FG000|STARTED|Overall Study||59
11276657|NCT02362724|12472208|FG001|STARTED|Overall Study||30
11021712|NCT00805675|12199881|FG000|COMPLETED|Overall Study||16
11021713|NCT00805675|12199882|FG001|COMPLETED|Overall Study||14
11021714|NCT00805675|12199883|FG002|COMPLETED|Overall Study||15
11021715|NCT00805675|12199881|FG000|NOT COMPLETED|Overall Study||0
11398378|NCT04483011|12592695|FG000|STARTED|Intervention Period 2 (8 Days)||9
11398379|NCT04483011|12592696|FG001|STARTED|Intervention Period 2 (8 Days)||8
11398380|NCT04483011|12592695|FG000|COMPLETED|Intervention Period 2 (8 Days)||9
11398381|NCT04483011|12592696|FG001|COMPLETED|Intervention Period 2 (8 Days)||8
11398382|NCT04483011|12592695|FG000|NOT COMPLETED|Intervention Period 2 (8 Days)||0
11021716|NCT00805675|12199882|FG001|NOT COMPLETED|Overall Study||0
11021717|NCT00805675|12199883|FG002|NOT COMPLETED|Overall Study||1
11276658|NCT02362724|12472207|FG000|COMPLETED|Overall Study||53
11276659|NCT02362724|12472208|FG001|COMPLETED|Overall Study||29
11398383|NCT04483011|12592696|FG001|NOT COMPLETED|Intervention Period 2 (8 Days)||0
11398384|NCT04475588|12592706|FG000|STARTED|Overall Study|Stated in protocol apriori, patient not completing 1st infusion were not evaluable & were replaced.|22
11398385|NCT04475588|12592707|FG001|STARTED|Overall Study||10
11398386|NCT04475588|12592706|FG000|COMPLETED|Overall Study||20
11398387|NCT04475588|12592707|FG001|COMPLETED|Overall Study||10
11398388|NCT04475588|12592706|FG000|NOT COMPLETED|Overall Study||2
11398389|NCT04475588|12592707|FG001|NOT COMPLETED|Overall Study||0
11398390|NCT04474496|12592714|FG000|STARTED|Overall Study||120
11398391|NCT04474496|12592714|FG000|COMPLETED|Overall Study|120 individuals were deemed eligible based on inclusion criteria, completed at least 10 survey items, and were included in the final analytical sample|120
11398392|NCT04474496|12592714|FG000|NOT COMPLETED|Overall Study||0
11398393|NCT04448210|12592720|FG000|STARTED|Overall Study||22
11398394|NCT04448210|12592721|FG001|STARTED|Overall Study||20
11398395|NCT04448210|12592720|FG000|COMPLETED|Overall Study||22
11276660|NCT02362724|12472207|FG000|NOT COMPLETED|Overall Study||6
11276661|NCT02362724|12472208|FG001|NOT COMPLETED|Overall Study||1
11276662|NCT02362789|12472216|FG000|STARTED|Run-in Phase (Week 0 to 16)||130
11276663|NCT02362789|12472217|FG001|STARTED|Run-in Phase (Week 0 to 16)||0
11276664|NCT02362789|12472218|FG002|STARTED|Run-in Phase (Week 0 to 16)||0
11276665|NCT02362789|12472216|FG000|COMPLETED|Run-in Phase (Week 0 to 16)||128
11276666|NCT02362789|12472217|FG001|COMPLETED|Run-in Phase (Week 0 to 16)||0
11276667|NCT02362789|12472218|FG002|COMPLETED|Run-in Phase (Week 0 to 16)||0
11276668|NCT02362789|12472216|FG000|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
11276669|NCT02362789|12472217|FG001|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
11276670|NCT02362789|12472218|FG002|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
11276671|NCT02362789|12472216|FG000|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
11276672|NCT02362789|12472217|FG001|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
11276673|NCT02362789|12472218|FG002|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
11276674|NCT02362789|12472216|FG000|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
11276675|NCT02362789|12472217|FG001|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
11276676|NCT02362789|12472218|FG002|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
11276677|NCT02362789|12472216|FG000|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
11276678|NCT02362789|12472217|FG001|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
11276679|NCT02362789|12472218|FG002|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
11276680|NCT02363270|12472227|FG000|STARTED|Overall Study||24
11276681|NCT02363270|12472228|FG001|STARTED|Overall Study||24
11276682|NCT02363270|12472227|FG000|COMPLETED|Overall Study||24
11276683|NCT02363270|12472228|FG001|COMPLETED|Overall Study||24
11276684|NCT02363270|12472227|FG000|NOT COMPLETED|Overall Study||0
11276685|NCT02363270|12472228|FG001|NOT COMPLETED|Overall Study||0
11276686|NCT02363283|12472234|FG000|STARTED|Overall Study||37
11276687|NCT02363283|12472234|FG000|COMPLETED|Overall Study||35
11276688|NCT02363283|12472234|FG000|NOT COMPLETED|Overall Study||2
11276689|NCT02363322|12472240|FG000|STARTED|Overall Study||36
11276690|NCT02363322|12472241|FG001|STARTED|Overall Study||36
11276691|NCT02363322|12472240|FG000|COMPLETED|Overall Study||35
11276692|NCT02363322|12472241|FG001|COMPLETED|Overall Study||36
11276693|NCT02363322|12472240|FG000|NOT COMPLETED|Overall Study||1
11276694|NCT02363322|12472241|FG001|NOT COMPLETED|Overall Study||0
11276695|NCT02363439|12472247|FG000|STARTED|Overall Study||5
11276696|NCT02363439|12472247|FG000|COMPLETED|Overall Study||1
11276697|NCT02363439|12472247|FG000|NOT COMPLETED|Overall Study||4
11276698|NCT02363478|12472251|FG000|STARTED|Overall Study||30
11276699|NCT02363478|12472251|FG000|COMPLETED|Overall Study||22
11276700|NCT02363478|12472251|FG000|NOT COMPLETED|Overall Study||8
11276701|NCT02363621|12472258|FG000|STARTED|Overall Study||51
11276702|NCT02363621|12472259|FG001|STARTED|Overall Study||50
11276703|NCT02363621|12472258|FG000|COMPLETED|Overall Study||50
11276704|NCT02363621|12472259|FG001|COMPLETED|Overall Study||50
11276705|NCT02363621|12472258|FG000|NOT COMPLETED|Overall Study||1
11276706|NCT02363621|12472259|FG001|NOT COMPLETED|Overall Study||0
11276707|NCT02363686|12472265|FG000|STARTED|Overall Study||248
11276708|NCT02363686|12472265|FG000|COMPLETED|Overall Study||213
11276709|NCT02363686|12472265|FG000|NOT COMPLETED|Overall Study||35
11276710|NCT02363738|12472271|FG000|STARTED|Overall Study||29
11276711|NCT02363738|12472272|FG001|STARTED|Overall Study||31
11276712|NCT02363738|12472271|FG000|COMPLETED|Overall Study||21
11276713|NCT02363738|12472272|FG001|COMPLETED|Overall Study||26
11276714|NCT02363738|12472271|FG000|NOT COMPLETED|Overall Study||8
11276715|NCT02363738|12472272|FG001|NOT COMPLETED|Overall Study||5
11276716|NCT02363803|12472280|FG000|STARTED|Period 1||17
11276717|NCT02363803|12472281|FG001|STARTED|Period 1||17
11276718|NCT02363803|12472280|FG000|COMPLETED|Period 1||17
11276719|NCT02363803|12472281|FG001|COMPLETED|Period 1||17
11276720|NCT02363803|12472280|FG000|NOT COMPLETED|Period 1||0
11276721|NCT02363803|12472281|FG001|NOT COMPLETED|Period 1||0
11276722|NCT02363803|12472280|FG000|STARTED|Period 2||17
11276723|NCT02363803|12472281|FG001|STARTED|Period 2|One participant did not return for Period 2 treatment|16
11276724|NCT02363803|12472280|FG000|COMPLETED|Period 2||17
11276725|NCT02363803|12472281|FG001|COMPLETED|Period 2||16
11276726|NCT02363803|12472280|FG000|NOT COMPLETED|Period 2||0
11276727|NCT02363803|12472281|FG001|NOT COMPLETED|Period 2||0
11276728|NCT02363907|12472293|FG000|STARTED|Overall Study||30
11276729|NCT02363907|12472293|FG000|COMPLETED|Overall Study||30
11276730|NCT02363907|12472293|FG000|NOT COMPLETED|Overall Study||0
11276731|NCT02363933|12472297|FG000|STARTED|Overall Study||8
11276732|NCT02363933|12472297|FG000|COMPLETED|Overall Study||2
11276733|NCT02363933|12472297|FG000|NOT COMPLETED|Overall Study||6
11276734|NCT02363946|12472314|FG000|STARTED|Overall Study||4
11276735|NCT02363946|12472315|FG001|STARTED|Overall Study||4
11276736|NCT02363946|12472316|FG002|STARTED|Overall Study||4
11276737|NCT02363946|12472317|FG003|STARTED|Overall Study||4
11276738|NCT02363946|12472318|FG004|STARTED|Overall Study||4
11276739|NCT02363946|12472319|FG005|STARTED|Overall Study||4
11276740|NCT02363946|12472320|FG006|STARTED|Overall Study||4
11276741|NCT02363946|12472321|FG007|STARTED|Overall Study||4
11276742|NCT02363946|12472322|FG008|STARTED|Overall Study||4
11276743|NCT02363946|12472323|FG009|STARTED|Overall Study||18
11276744|NCT02363946|12472324|FG010|STARTED|Overall Study||4
11276745|NCT02363946|12472325|FG011|STARTED|Overall Study||3
11276746|NCT02363946|12472326|FG012|STARTED|Overall Study||4
11276747|NCT02363946|12472314|FG000|COMPLETED|Overall Study||4
11276748|NCT02363946|12472315|FG001|COMPLETED|Overall Study||4
11276749|NCT02363946|12472316|FG002|COMPLETED|Overall Study||4
11276750|NCT02363946|12472317|FG003|COMPLETED|Overall Study||4
11276751|NCT02363946|12472318|FG004|COMPLETED|Overall Study||4
11276752|NCT02363946|12472319|FG005|COMPLETED|Overall Study||4
11276753|NCT02363946|12472320|FG006|COMPLETED|Overall Study||4
11276754|NCT02363946|12472321|FG007|COMPLETED|Overall Study||3
11276755|NCT02363946|12472322|FG008|COMPLETED|Overall Study||4
11276756|NCT02363946|12472323|FG009|COMPLETED|Overall Study||18
11276757|NCT02363946|12472324|FG010|COMPLETED|Overall Study||4
11276758|NCT02363946|12472325|FG011|COMPLETED|Overall Study||3
11276759|NCT02363946|12472326|FG012|COMPLETED|Overall Study||4
11276760|NCT02363946|12472314|FG000|NOT COMPLETED|Overall Study||0
11276761|NCT02363946|12472315|FG001|NOT COMPLETED|Overall Study||0
11276762|NCT02363946|12472316|FG002|NOT COMPLETED|Overall Study||0
11276763|NCT02363946|12472317|FG003|NOT COMPLETED|Overall Study||0
11276764|NCT02363946|12472318|FG004|NOT COMPLETED|Overall Study||0
11276765|NCT02363946|12472319|FG005|NOT COMPLETED|Overall Study||0
11276766|NCT02363946|12472320|FG006|NOT COMPLETED|Overall Study||0
11276767|NCT02363946|12472321|FG007|NOT COMPLETED|Overall Study||1
11276768|NCT02363946|12472322|FG008|NOT COMPLETED|Overall Study||0
11276769|NCT02363946|12472323|FG009|NOT COMPLETED|Overall Study||0
11276770|NCT02363946|12472324|FG010|NOT COMPLETED|Overall Study||0
11276771|NCT02363946|12472325|FG011|NOT COMPLETED|Overall Study||0
11276772|NCT02363946|12472326|FG012|NOT COMPLETED|Overall Study||0
11276773|NCT02363959|12472356|FG000|STARTED|Overall Study||10
11276774|NCT02363959|12472357|FG001|STARTED|Overall Study||10
11276775|NCT02363959|12472356|FG000|COMPLETED|Overall Study||9
11276776|NCT02363959|12472357|FG001|COMPLETED|Overall Study||10
11276777|NCT02363959|12472356|FG000|NOT COMPLETED|Overall Study||1
11276778|NCT02363959|12472357|FG001|NOT COMPLETED|Overall Study||0
11276779|NCT02363972|12472363|FG000|STARTED|Overall Study||103
11276780|NCT02363972|12472363|FG000|COMPLETED|Overall Study||77
11276781|NCT02363972|12472363|FG000|NOT COMPLETED|Overall Study||26
11276782|NCT02364037|12472369|FG000|STARTED|Overall Study||502
11276783|NCT02364037|12472370|FG001|STARTED|Overall Study||506
11276784|NCT02364037|12472369|FG000|COMPLETED|Overall Study||458
11276785|NCT02364037|12472370|FG001|COMPLETED|Overall Study||453
11276786|NCT02364037|12472369|FG000|NOT COMPLETED|Overall Study||44
11398396|NCT04448210|12592721|FG001|COMPLETED|Overall Study||20
11398397|NCT04448210|12592720|FG000|NOT COMPLETED|Overall Study||0
11398398|NCT04448210|12592721|FG001|NOT COMPLETED|Overall Study||0
11398399|NCT04474405|12592733|FG000|STARTED|Overall Study||4
11398400|NCT04474405|12592734|FG001|STARTED|Overall Study||3
11398401|NCT04474405|12592735|FG002|STARTED|Overall Study||5
11398402|NCT04474405|12592736|FG003|STARTED|Overall Study||4
11398403|NCT04474405|12592737|FG004|STARTED|Overall Study||13
11398404|NCT04474405|12592738|FG005|STARTED|Overall Study||7
11398405|NCT04474405|12592733|FG000|Flortaucipir PET Scan|Overall Study||4
11276787|NCT02364037|12472370|FG001|NOT COMPLETED|Overall Study||53
11276788|NCT02364076|12472376|FG000|STARTED|Overall Study||45
11276789|NCT02364076|12472376|FG000|COMPLETED|Overall Study||40
11398406|NCT04474405|12592734|FG001|Flortaucipir PET Scan|Overall Study||3
11276790|NCT02364076|12472376|FG000|NOT COMPLETED|Overall Study||5
11276791|NCT02364180|12472380|FG000|STARTED|Overall Study||11
11276792|NCT02364180|12472380|FG000|COMPLETED|Overall Study||10
11398407|NCT04474405|12592735|FG002|Flortaucipir PET Scan|Overall Study||4
11398408|NCT04474405|12592736|FG003|Flortaucipir PET Scan|Overall Study||4
11398409|NCT04474405|12592737|FG004|Flortaucipir PET Scan|Overall Study||9
11398410|NCT04474405|12592738|FG005|Flortaucipir PET Scan|Overall Study||0
11398411|NCT04474405|12592733|FG000|Florbetapir PET Scan|Overall Study||4
11276793|NCT02364180|12472380|FG000|NOT COMPLETED|Overall Study||1
11276794|NCT02364271|12472386|FG000|STARTED|Overall Study||479
11276795|NCT02364271|12472387|FG001|STARTED|Overall Study||123
11276796|NCT02364271|12472386|FG000|COMPLETED|Overall Study||479
11276797|NCT02364271|12472387|FG001|COMPLETED|Overall Study||123
11276798|NCT02364271|12472386|FG000|NOT COMPLETED|Overall Study||0
11276799|NCT02364271|12472387|FG001|NOT COMPLETED|Overall Study||0
11276800|NCT02364336|12472396|FG000|STARTED|Overall Study||1
11276801|NCT02364336|12472397|FG001|STARTED|Overall Study||12
11276802|NCT02364336|12472396|FG000|6 Hours Post First Peginterferon Inject|Overall Study||1
11276803|NCT02364336|12472397|FG001|6 Hours Post First Peginterferon Inject|Overall Study||12
11276804|NCT02364336|12472396|FG000|End of Peginterferon Treatment|Overall Study||1
11276805|NCT02364336|12472397|FG001|End of Peginterferon Treatment|Overall Study||11
11276806|NCT02364336|12472396|FG000|24 Weeks After End of Peginterferon|Overall Study||1
11276807|NCT02364336|12472397|FG001|24 Weeks After End of Peginterferon|Overall Study||11
11276808|NCT02364336|12472396|FG000|48 Weeks After End of Peginterferon|Overall Study||1
11276809|NCT02364336|12472397|FG001|48 Weeks After End of Peginterferon|Overall Study||10
11276810|NCT02364336|12472396|FG000|COMPLETED|Overall Study||1
11276811|NCT02364336|12472397|FG001|COMPLETED|Overall Study||11
11276812|NCT02364336|12472396|FG000|NOT COMPLETED|Overall Study||0
11276813|NCT02364336|12472397|FG001|NOT COMPLETED|Overall Study||1
11276814|NCT02364388|12472404|FG000|STARTED|Overall Study||217
11276815|NCT02364388|12472404|FG000|Biopsied|Overall Study||209
11276816|NCT02364388|12472404|FG000|Excluded|Overall Study||8
11276817|NCT02364388|12472404|FG000|COMPLETED|Overall Study||209
11276818|NCT02364388|12472404|FG000|NOT COMPLETED|Overall Study||8
11276819|NCT02364570|12472408|FG000|STARTED|Overall Study||1
11276820|NCT02364570|12472409|FG001|STARTED|Overall Study||1
11276821|NCT02364570|12472410|FG002|STARTED|Overall Study||2
11276822|NCT02364570|12472411|FG003|STARTED|Overall Study||1
11276823|NCT02364570|12472412|FG004|STARTED|Overall Study||1
11276824|NCT02364570|12472413|FG005|STARTED|Overall Study||1
11276825|NCT02364570|12472414|FG006|STARTED|Overall Study||2
11276826|NCT02364570|12472415|FG007|STARTED|Overall Study||1
11276827|NCT02364570|12472416|FG008|STARTED|Overall Study||2
11276828|NCT02364570|12472417|FG009|STARTED|Overall Study||1
11398412|NCT04474405|12592734|FG001|Florbetapir PET Scan|Overall Study||3
11398413|NCT04474405|12592735|FG002|Florbetapir PET Scan|Overall Study||0
11398414|NCT04474405|12592736|FG003|Florbetapir PET Scan|Overall Study||4
11398415|NCT04474405|12592737|FG004|Florbetapir PET Scan|Overall Study||0
11398416|NCT04474405|12592738|FG005|Florbetapir PET Scan|Overall Study||4
11398417|NCT04474405|12592733|FG000|COMPLETED|Overall Study||4
11398418|NCT04474405|12592734|FG001|COMPLETED|Overall Study||3
11398419|NCT04474405|12592735|FG002|COMPLETED|Overall Study||4
11398420|NCT04474405|12592736|FG003|COMPLETED|Overall Study||4
11398421|NCT04474405|12592737|FG004|COMPLETED|Overall Study||9
11398422|NCT04474405|12592738|FG005|COMPLETED|Overall Study||7
11398423|NCT04474405|12592733|FG000|NOT COMPLETED|Overall Study||0
11398424|NCT04474405|12592734|FG001|NOT COMPLETED|Overall Study||0
11398425|NCT04474405|12592735|FG002|NOT COMPLETED|Overall Study||1
11398426|NCT04474405|12592736|FG003|NOT COMPLETED|Overall Study||0
11398427|NCT04474405|12592737|FG004|NOT COMPLETED|Overall Study||4
11398428|NCT04474405|12592738|FG005|NOT COMPLETED|Overall Study||0
11398429|NCT04470375|12592752|FG000|STARTED|Overall Study||20
11398430|NCT04470375|12592752|FG000|COMPLETED|Overall Study||20
11398431|NCT04470375|12592752|FG000|NOT COMPLETED|Overall Study||0
11398432|NCT04468347|12592760|FG000|STARTED|Overall Study||6
11398433|NCT04468347|12592761|FG001|STARTED|Overall Study||11
11398434|NCT04468347|12592762|FG002|STARTED|Overall Study||47
11398435|NCT04468347|12592763|FG003|STARTED|Overall Study||25
11398436|NCT04468347|12592760|FG000|Baseline Flortacuipir PET Scan|Overall Study||5
11398437|NCT04468347|12592761|FG001|Baseline Flortacuipir PET Scan|Overall Study||11
11398438|NCT04468347|12592762|FG002|Baseline Flortacuipir PET Scan|Overall Study||45
11398439|NCT04468347|12592763|FG003|Baseline Flortacuipir PET Scan|Overall Study||25
11398440|NCT04468347|12592760|FG000|COMPLETED|Overall Study||4
11398441|NCT04468347|12592761|FG001|COMPLETED|Overall Study||10
11398442|NCT04468347|12592762|FG002|COMPLETED|Overall Study||41
11398443|NCT04468347|12592763|FG003|COMPLETED|Overall Study||21
11398444|NCT04468347|12592760|FG000|NOT COMPLETED|Overall Study||2
11398445|NCT04468347|12592761|FG001|NOT COMPLETED|Overall Study||1
11398446|NCT04468347|12592762|FG002|NOT COMPLETED|Overall Study||6
11398447|NCT04468347|12592763|FG003|NOT COMPLETED|Overall Study||4
11398448|NCT04467424|12592779|FG000|STARTED|Overall Study||100
11398449|NCT04467424|12592780|FG001|STARTED|Overall Study||100
11398450|NCT04467424|12592779|FG000|COMPLETED|Overall Study||100
11398451|NCT04467424|12592780|FG001|COMPLETED|Overall Study||100
11398452|NCT04467424|12592779|FG000|NOT COMPLETED|Overall Study||0
11398453|NCT04467424|12592780|FG001|NOT COMPLETED|Overall Study||0
11398454|NCT04465422|12592788|FG000|STARTED|Overall Study||17
11398455|NCT04465422|12592789|FG001|STARTED|Overall Study||16
11398456|NCT04465422|12592788|FG000|COMPLETED|Overall Study||17
11398457|NCT04465422|12592789|FG001|COMPLETED|Overall Study||14
11398458|NCT04465422|12592788|FG000|NOT COMPLETED|Overall Study||0
11398459|NCT04465422|12592789|FG001|NOT COMPLETED|Overall Study||2
11398460|NCT04463004|12592799|FG000|STARTED|Overall Study||1
11398461|NCT04463004|12592800|FG001|STARTED|Overall Study||1
11398462|NCT04463004|12592799|FG000|COMPLETED|Overall Study||1
11276829|NCT02364570|12472418|FG010|STARTED|Overall Study||1
11276830|NCT02364570|12472419|FG011|STARTED|Overall Study||1
11276831|NCT02364570|12472420|FG012|STARTED|Overall Study||1
11276832|NCT02364570|12472421|FG013|STARTED|Overall Study||2
11276833|NCT02364570|12472422|FG014|STARTED|Overall Study||1
11276834|NCT02364570|12472423|FG015|STARTED|Overall Study||1
11276835|NCT02364570|12472408|FG000|COMPLETED|Overall Study||1
11276836|NCT02364570|12472409|FG001|COMPLETED|Overall Study||1
11276837|NCT02364570|12472410|FG002|COMPLETED|Overall Study||2
11276838|NCT02364570|12472411|FG003|COMPLETED|Overall Study||1
11276839|NCT02364570|12472412|FG004|COMPLETED|Overall Study||1
11276840|NCT02364570|12472413|FG005|COMPLETED|Overall Study||1
11276841|NCT02364570|12472414|FG006|COMPLETED|Overall Study||2
11276842|NCT02364570|12472415|FG007|COMPLETED|Overall Study||1
11276843|NCT02364570|12472416|FG008|COMPLETED|Overall Study||2
11276844|NCT02364570|12472417|FG009|COMPLETED|Overall Study||1
11276845|NCT02364570|12472418|FG010|COMPLETED|Overall Study||1
11276846|NCT02364570|12472419|FG011|COMPLETED|Overall Study||1
11276847|NCT02364570|12472420|FG012|COMPLETED|Overall Study||1
11276848|NCT02364570|12472421|FG013|COMPLETED|Overall Study||2
11276849|NCT02364570|12472422|FG014|COMPLETED|Overall Study||1
11276850|NCT02364570|12472423|FG015|COMPLETED|Overall Study||1
11276851|NCT02364570|12472408|FG000|NOT COMPLETED|Overall Study||0
11276852|NCT02364570|12472409|FG001|NOT COMPLETED|Overall Study||0
11276853|NCT02364570|12472410|FG002|NOT COMPLETED|Overall Study||0
11276854|NCT02364570|12472411|FG003|NOT COMPLETED|Overall Study||0
11276855|NCT02364570|12472412|FG004|NOT COMPLETED|Overall Study||0
11276856|NCT02364570|12472413|FG005|NOT COMPLETED|Overall Study||0
11276857|NCT02364570|12472414|FG006|NOT COMPLETED|Overall Study||0
11276858|NCT02364570|12472415|FG007|NOT COMPLETED|Overall Study||0
11276859|NCT02364570|12472416|FG008|NOT COMPLETED|Overall Study||0
11276860|NCT02364570|12472417|FG009|NOT COMPLETED|Overall Study||0
11276861|NCT02364570|12472418|FG010|NOT COMPLETED|Overall Study||0
11276862|NCT02364570|12472419|FG011|NOT COMPLETED|Overall Study||0
11276863|NCT02364570|12472420|FG012|NOT COMPLETED|Overall Study||0
11276864|NCT02364570|12472421|FG013|NOT COMPLETED|Overall Study||0
11276865|NCT02364570|12472422|FG014|NOT COMPLETED|Overall Study||0
11276866|NCT02364570|12472423|FG015|NOT COMPLETED|Overall Study||0
11276867|NCT02364700|12472433|FG000|STARTED|Overall Study||12
11276868|NCT02364700|12472433|FG000|COMPLETED|Overall Study||12
11276869|NCT02364700|12472433|FG000|NOT COMPLETED|Overall Study||0
11276870|NCT02364778|12472439|FG000|STARTED|Overall Study||30
11276871|NCT02364778|12472439|FG000|COMPLETED|Overall Study||30
11276872|NCT02364778|12472439|FG000|NOT COMPLETED|Overall Study||0
11276873|NCT02364947|12472448|FG000|STARTED|Overall Study||248
11276874|NCT02364947|12472449|FG001|STARTED|Overall Study||184
11276875|NCT02364947|12472450|FG002|STARTED|Overall Study||245
11276876|NCT02364947|12472448|FG000|COMPLETED|Overall Study||189
11276877|NCT02364947|12472449|FG001|COMPLETED|Overall Study||139
11276878|NCT02364947|12472450|FG002|COMPLETED|Overall Study||219
11276879|NCT02364947|12472448|FG000|NOT COMPLETED|Overall Study||59
11276880|NCT02364947|12472449|FG001|NOT COMPLETED|Overall Study||45
11276881|NCT02364947|12472450|FG002|NOT COMPLETED|Overall Study||26
11276882|NCT02364999|12472460|FG000|STARTED|Overall Study||358
11276883|NCT02364999|12472461|FG001|STARTED|Overall Study||361
11276884|NCT02364999|12472460|FG000|Received Treatment|Overall Study||356
11276885|NCT02364999|12472461|FG001|Received Treatment|Overall Study||358
11276886|NCT02364999|12472460|FG000|COMPLETED|Overall Study||193
11276887|NCT02364999|12472461|FG001|COMPLETED|Overall Study||188
11276888|NCT02364999|12472460|FG000|NOT COMPLETED|Overall Study||165
11276889|NCT02364999|12472461|FG001|NOT COMPLETED|Overall Study||173
11276890|NCT02365064|12472470|FG000|STARTED|Overall Study||31
11276891|NCT02365064|12472471|FG001|STARTED|Overall Study||47
11276892|NCT02365064|12472470|FG000|Included in ITT Analysis|Overall Study||29
11276893|NCT02365064|12472471|FG001|Included in ITT Analysis|Overall Study||32
11276894|NCT02365064|12472470|FG000|COMPLETED|Overall Study||21
11276895|NCT02365064|12472471|FG001|COMPLETED|Overall Study||19
11276896|NCT02365064|12472470|FG000|NOT COMPLETED|Overall Study||10
11276897|NCT02365064|12472471|FG001|NOT COMPLETED|Overall Study||28
11276898|NCT02365285|12472481|FG000|STARTED|Overall Study||7
11276899|NCT02365285|12472482|FG001|STARTED|Overall Study||6
11276900|NCT02365285|12472483|FG002|STARTED|Overall Study||7
11276901|NCT02365285|12472484|FG003|STARTED|Overall Study||3
11276902|NCT02365285|12472481|FG000|COMPLETED|Overall Study||7
11276903|NCT02365285|12472482|FG001|COMPLETED|Overall Study||5
11276904|NCT02365285|12472483|FG002|COMPLETED|Overall Study||6
11276905|NCT02365285|12472484|FG003|COMPLETED|Overall Study||1
11276906|NCT02365285|12472481|FG000|NOT COMPLETED|Overall Study||0
11276907|NCT02365285|12472482|FG001|NOT COMPLETED|Overall Study||1
11276908|NCT02365285|12472483|FG002|NOT COMPLETED|Overall Study||1
11276909|NCT02365285|12472484|FG003|NOT COMPLETED|Overall Study||2
11276910|NCT02365298|12472496|FG000|STARTED|Period 1||14
11276911|NCT02365298|12472497|FG001|STARTED|Period 1||14
11276912|NCT02365298|12472496|FG000|COMPLETED|Period 1||14
11276913|NCT02365298|12472497|FG001|COMPLETED|Period 1||14
11276914|NCT02365298|12472496|FG000|NOT COMPLETED|Period 1||0
11276915|NCT02365298|12472497|FG001|NOT COMPLETED|Period 1||0
11276916|NCT02365298|12472496|FG000|STARTED|Period 2||14
11276917|NCT02365298|12472497|FG001|STARTED|Period 2||14
11276918|NCT02365298|12472496|FG000|COMPLETED|Period 2||12
11276919|NCT02365298|12472497|FG001|COMPLETED|Period 2||12
11276920|NCT02365298|12472496|FG000|NOT COMPLETED|Period 2||2
11276921|NCT02365298|12472497|FG001|NOT COMPLETED|Period 2||2
11276922|NCT02365480|12472505|FG000|STARTED|Overall Study||14
11276923|NCT02365480|12472506|FG001|STARTED|Overall Study||4
11276924|NCT02365480|12472505|FG000|COMPLETED|Overall Study||12
11276925|NCT02365480|12472506|FG001|COMPLETED|Overall Study||4
11276926|NCT02365480|12472505|FG000|NOT COMPLETED|Overall Study||2
11276927|NCT02365480|12472506|FG001|NOT COMPLETED|Overall Study||0
11276928|NCT02365506|12472515|FG000|STARTED|Overall Study||4
11276929|NCT02365506|12472516|FG001|STARTED|Overall Study||4
11276930|NCT02365506|12472517|FG002|STARTED|Overall Study||5
11276931|NCT02365506|12472515|FG000|COMPLETED|Overall Study||4
11276932|NCT02365506|12472516|FG001|COMPLETED|Overall Study||4
11276933|NCT02365506|12472517|FG002|COMPLETED|Overall Study||4
11276934|NCT02365506|12472515|FG000|NOT COMPLETED|Overall Study||0
11276935|NCT02365506|12472516|FG001|NOT COMPLETED|Overall Study||0
11276936|NCT02365506|12472517|FG002|NOT COMPLETED|Overall Study||1
11276937|NCT02365519|12472527|FG000|STARTED|Vehicle Run-In||213
11276938|NCT02365519|12472528|FG001|STARTED|Vehicle Run-In||0
11276939|NCT02365519|12472529|FG002|STARTED|Vehicle Run-In||0
11276940|NCT02365519|12472527|FG000|COMPLETED|Vehicle Run-In||134
11276941|NCT02365519|12472528|FG001|COMPLETED|Vehicle Run-In||0
11276942|NCT02365519|12472529|FG002|COMPLETED|Vehicle Run-In||0
11276943|NCT02365519|12472527|FG000|NOT COMPLETED|Vehicle Run-In||79
11276944|NCT02365519|12472528|FG001|NOT COMPLETED|Vehicle Run-In||0
11276945|NCT02365519|12472529|FG002|NOT COMPLETED|Vehicle Run-In||0
11276946|NCT02365519|12472527|FG000|STARTED|Randomized and Treated||0
11276947|NCT02365519|12472528|FG001|STARTED|Randomized and Treated||69
11276948|NCT02365519|12472529|FG002|STARTED|Randomized and Treated||65
11276949|NCT02365519|12472527|FG000|COMPLETED|Randomized and Treated||0
11276950|NCT02365519|12472528|FG001|COMPLETED|Randomized and Treated||67
11276951|NCT02365519|12472529|FG002|COMPLETED|Randomized and Treated||64
11276952|NCT02365519|12472527|FG000|NOT COMPLETED|Randomized and Treated||0
11276953|NCT02365519|12472528|FG001|NOT COMPLETED|Randomized and Treated||2
11276954|NCT02365519|12472529|FG002|NOT COMPLETED|Randomized and Treated||1
11276955|NCT02365558|12472538|FG000|STARTED|Period 1 (Day 1 Through Day 7)||34
11276956|NCT02365558|12472539|FG001|STARTED|Period 1 (Day 1 Through Day 7)||0
11276957|NCT02365558|12472538|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
11276958|NCT02365558|12472539|FG001|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
11276959|NCT02365558|12472538|FG000|COMPLETED|Period 1 (Day 1 Through Day 7)||33
11276960|NCT02365558|12472539|FG001|COMPLETED|Period 1 (Day 1 Through Day 7)||0
11276961|NCT02365558|12472538|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
11276962|NCT02365558|12472539|FG001|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
11276963|NCT02365558|12472538|FG000|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
11276964|NCT02365558|12472539|FG001|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
11276965|NCT02365558|12472538|FG000|COMPLETED|Period 2 (Day 8 Through Day 20)||0
11276966|NCT02365558|12472539|FG001|COMPLETED|Period 2 (Day 8 Through Day 20)||32
11276967|NCT02365558|12472538|FG000|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
11276968|NCT02365558|12472539|FG001|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
11276969|NCT02365584|12472550|FG000|STARTED|Overall Study||21
11276970|NCT02365584|12472551|FG001|STARTED|Overall Study||22
11276971|NCT02365584|12472550|FG000|COMPLETED|Overall Study||9
11276972|NCT02365584|12472551|FG001|COMPLETED|Overall Study||8
11276973|NCT02365584|12472550|FG000|NOT COMPLETED|Overall Study||12
11276974|NCT02365584|12472551|FG001|NOT COMPLETED|Overall Study||14
11276975|NCT02365636|12472560|FG000|STARTED|Overall Study||100
11276976|NCT02365636|12472561|FG001|STARTED|Overall Study||100
11276977|NCT02365636|12472562|FG002|STARTED|Overall Study||100
11276978|NCT02365636|12472560|FG000|Safety Population|Overall Study||100
11276979|NCT02365636|12472561|FG001|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
11276980|NCT02365636|12472562|FG002|Safety Population|Overall Study||100
11276981|NCT02365636|12472560|FG000|Full Analysis Set|Overall Study||100
11276982|NCT02365636|12472561|FG001|Full Analysis Set|Overall Study||98
11276983|NCT02365636|12472562|FG002|Full Analysis Set|Overall Study||100
11276984|NCT02365636|12472560|FG000|COMPLETED|Overall Study||94
11276985|NCT02365636|12472561|FG001|COMPLETED|Overall Study||93
11276986|NCT02365636|12472562|FG002|COMPLETED|Overall Study||97
11276987|NCT02365636|12472560|FG000|NOT COMPLETED|Overall Study||6
11276988|NCT02365636|12472561|FG001|NOT COMPLETED|Overall Study||7
11276989|NCT02365636|12472562|FG002|NOT COMPLETED|Overall Study||3
11276990|NCT02365714|12472570|FG000|STARTED|Overall Study||2
11276991|NCT02365714|12472570|FG000|COMPLETED|Overall Study||2
11276992|NCT02365714|12472570|FG000|NOT COMPLETED|Overall Study||0
11276993|NCT02365870|12472576|FG000|STARTED|Overall Study||1
11276994|NCT02365870|12472577|FG001|STARTED|Overall Study||3
11276995|NCT02365870|12472576|FG000|COMPLETED|Overall Study||1
11276996|NCT02365870|12472577|FG001|COMPLETED|Overall Study||3
11276997|NCT02365870|12472576|FG000|NOT COMPLETED|Overall Study||0
11276998|NCT02365870|12472577|FG001|NOT COMPLETED|Overall Study||0
11276999|NCT02365961|12472585|FG000|STARTED|Overall Study||41
11277000|NCT02365961|12472586|FG001|STARTED|Overall Study||43
11277001|NCT02365961|12472585|FG000|COMPLETED|Overall Study||41
11277002|NCT02365961|12472586|FG001|COMPLETED|Overall Study||43
11277003|NCT02365961|12472585|FG000|NOT COMPLETED|Overall Study||0
11277004|NCT02365961|12472586|FG001|NOT COMPLETED|Overall Study||0
11277005|NCT02366091|12472596|FG000|STARTED|Overall Study||24
11277006|NCT02366091|12472597|FG001|STARTED|Overall Study||23
11277007|NCT02366091|12472598|FG002|STARTED|Overall Study||24
11277008|NCT02366091|12472599|FG003|STARTED|Overall Study||23
11277009|NCT02366091|12472596|FG000|COMPLETED|Overall Study||21
11277010|NCT02366091|12472597|FG001|COMPLETED|Overall Study||16
11277011|NCT02366091|12472598|FG002|COMPLETED|Overall Study||21
11277012|NCT02366091|12472599|FG003|COMPLETED|Overall Study||22
11277013|NCT02366091|12472596|FG000|NOT COMPLETED|Overall Study||3
11277014|NCT02366091|12472597|FG001|NOT COMPLETED|Overall Study||7
11277015|NCT02366091|12472598|FG002|NOT COMPLETED|Overall Study||3
11277016|NCT02366091|12472599|FG003|NOT COMPLETED|Overall Study||1
11340606|NCT02923115|12537912|FG000|COMPLETED|Overall Study||12
11340607|NCT02923115|12537913|FG001|COMPLETED|Overall Study||15
11340608|NCT02923115|12537914|FG002|COMPLETED|Overall Study||20
11340609|NCT02923115|12537915|FG003|COMPLETED|Overall Study||21
11340610|NCT02923115|12537916|FG004|COMPLETED|Overall Study||17
11340611|NCT02923115|12537917|FG005|COMPLETED|Overall Study||38
11340612|NCT02923115|12537912|FG000|NOT COMPLETED|Overall Study||0
11340613|NCT02923115|12537913|FG001|NOT COMPLETED|Overall Study||1
11340614|NCT02923115|12537914|FG002|NOT COMPLETED|Overall Study||3
11340615|NCT02923115|12537915|FG003|NOT COMPLETED|Overall Study||2
11340616|NCT02923115|12537916|FG004|NOT COMPLETED|Overall Study||5
11340617|NCT02923115|12537917|FG005|NOT COMPLETED|Overall Study||0
11340618|NCT02923167|12537931|FG000|STARTED|Overall Study||6
11340619|NCT02923167|12537931|FG000|COMPLETED|Overall Study||4
11340620|NCT02923167|12537931|FG000|NOT COMPLETED|Overall Study||2
11340621|NCT02923245|12537938|FG000|STARTED|Overall Study||60
11340622|NCT02923245|12537939|FG001|STARTED|Overall Study||60
11340623|NCT02923245|12537938|FG000|COMPLETED|Overall Study||58
11340624|NCT02923245|12537939|FG001|COMPLETED|Overall Study||59
11340625|NCT02923245|12537938|FG000|NOT COMPLETED|Overall Study||2
11340626|NCT02923245|12537939|FG001|NOT COMPLETED|Overall Study||1
11340627|NCT02923271|12537948|FG000|STARTED|Overall Study||18
11340628|NCT02923271|12537949|FG001|STARTED|Overall Study||16
11340629|NCT02923271|12537948|FG000|COMPLETED|Overall Study||10
11340630|NCT02923271|12537949|FG001|COMPLETED|Overall Study||14
11340631|NCT02923271|12537948|FG000|NOT COMPLETED|Overall Study||8
11340632|NCT02923271|12537949|FG001|NOT COMPLETED|Overall Study||2
11340633|NCT02923349|12537962|FG000|STARTED|Overall Study||4
11340634|NCT02923349|12537963|FG001|STARTED|Overall Study||4
11340635|NCT02923349|12537964|FG002|STARTED|Overall Study||22
11340636|NCT02923349|12537965|FG003|STARTED|Overall Study||18
11340637|NCT02923349|12537966|FG004|STARTED|Overall Study||23
11340638|NCT02923349|12537967|FG005|STARTED|Overall Study||12
11340639|NCT02923349|12537968|FG006|STARTED|Overall Study||4
11340640|NCT02923349|12537962|FG000|COMPLETED|Overall Study||0
11340641|NCT02923349|12537963|FG001|COMPLETED|Overall Study||0
11340642|NCT02923349|12537964|FG002|COMPLETED|Overall Study||5
11340643|NCT02923349|12537965|FG003|COMPLETED|Overall Study||2
11340644|NCT02923349|12537966|FG004|COMPLETED|Overall Study||4
11340645|NCT02923349|12537967|FG005|COMPLETED|Overall Study||5
11277017|NCT02366130|12472609|FG000|STARTED|Overall Study||45
11277018|NCT02366130|12472609|FG000|COMPLETED|Overall Study||36
11277019|NCT02366130|12472609|FG000|NOT COMPLETED|Overall Study||9
11277020|NCT02366143|12472616|FG000|STARTED|Overall Study||400
11277021|NCT02366143|12472617|FG001|STARTED|Overall Study||400
11277022|NCT02366143|12472618|FG002|STARTED|Overall Study||402
11398463|NCT04463004|12592800|FG001|COMPLETED|Overall Study||1
11398464|NCT04463004|12592799|FG000|NOT COMPLETED|Overall Study||0
11398465|NCT04463004|12592800|FG001|NOT COMPLETED|Overall Study||0
11277023|NCT02366143|12472616|FG000|COMPLETED|Overall Study||0
11277024|NCT02366143|12472617|FG001|COMPLETED|Overall Study||0
11277025|NCT02366143|12472618|FG002|COMPLETED|Overall Study||0
11277026|NCT02366143|12472616|FG000|NOT COMPLETED|Overall Study||400
11277027|NCT02366143|12472617|FG001|NOT COMPLETED|Overall Study||400
11277028|NCT02366143|12472618|FG002|NOT COMPLETED|Overall Study||402
11277029|NCT02366195|12472630|FG000|STARTED|Overall Study||112
11277030|NCT02366195|12472630|FG000|Received Study Drug|Overall Study||111
11277031|NCT02366195|12472630|FG000|COMPLETED|Overall Study||58
11277032|NCT02366195|12472630|FG000|NOT COMPLETED|Overall Study||54
11277033|NCT02366312|12472636|FG000|STARTED|Overall Study||1
11277034|NCT02366312|12472637|FG001|STARTED|Overall Study||1
11277035|NCT02366312|12472636|FG000|COMPLETED|Overall Study||1
11277036|NCT02366312|12472637|FG001|COMPLETED|Overall Study|The subject did not attend the 2-year post-treatment visit (last visit).|0
11277037|NCT02366312|12472636|FG000|NOT COMPLETED|Overall Study||0
11277038|NCT02366312|12472637|FG001|NOT COMPLETED|Overall Study||1
11277039|NCT02366338|12472646|FG000|STARTED|Overall Study||73
11277040|NCT02366338|12472647|FG001|STARTED|Overall Study||39
11398466|NCT04448561|12592808|FG000|STARTED|Overall Study||16
11398467|NCT04448561|12592809|FG001|STARTED|Overall Study||8
11398468|NCT04448561|12592808|FG000|COMPLETED|Overall Study||15
11398469|NCT04448561|12592809|FG001|COMPLETED|Overall Study||8
11398470|NCT04448561|12592808|FG000|NOT COMPLETED|Overall Study||1
11398471|NCT04448561|12592809|FG001|NOT COMPLETED|Overall Study||0
11277041|NCT02366338|12472648|FG002|STARTED|Overall Study||36
11277042|NCT02366338|12472646|FG000|COMPLETED|Overall Study||73
11398472|NCT04462731|12592825|FG000|STARTED|Overall Study||97
11398473|NCT04462731|12592826|FG001|STARTED|Overall Study||97
11398474|NCT04462731|12592825|FG000|COMPLETED|Overall Study||41
11277043|NCT02366338|12472647|FG001|COMPLETED|Overall Study||39
11277044|NCT02366338|12472648|FG002|COMPLETED|Overall Study||36
11277045|NCT02366338|12472646|FG000|NOT COMPLETED|Overall Study||0
11277046|NCT02366338|12472647|FG001|NOT COMPLETED|Overall Study||0
11277047|NCT02366338|12472648|FG002|NOT COMPLETED|Overall Study||0
11277048|NCT02366468|12472658|FG000|STARTED|Overall Study||68
11277049|NCT02366468|12472659|FG001|STARTED|Overall Study||67
11277050|NCT02366468|12472658|FG000|Full Analysis Set (FAS)|Overall Study||67
11277051|NCT02366468|12472659|FG001|Full Analysis Set (FAS)|Overall Study||66
11277052|NCT02366468|12472658|FG000|Per Protocol Set (PPS)|Overall Study||62
11277053|NCT02366468|12472659|FG001|Per Protocol Set (PPS)|Overall Study||61
11277054|NCT02366468|12472658|FG000|COMPLETED|Overall Study||62
11277055|NCT02366468|12472659|FG001|COMPLETED|Overall Study||58
11277056|NCT02366468|12472658|FG000|NOT COMPLETED|Overall Study||6
11277057|NCT02366468|12472659|FG001|NOT COMPLETED|Overall Study||9
11277058|NCT02366611|12472667|FG000|STARTED|Overall Study||10
11277059|NCT02366611|12472668|FG001|STARTED|Overall Study||1
11277060|NCT02366611|12472667|FG000|COMPLETED|Overall Study||8
11277061|NCT02366611|12472668|FG001|COMPLETED|Overall Study||1
11277062|NCT02366611|12472667|FG000|NOT COMPLETED|Overall Study||2
11277063|NCT02366611|12472668|FG001|NOT COMPLETED|Overall Study||0
11277064|NCT02366637|12472675|FG000|STARTED|First Intervention Period||7
11277065|NCT02366637|12472676|FG001|STARTED|First Intervention Period||6
11277066|NCT02366637|12472675|FG000|COMPLETED|First Intervention Period||1
11277067|NCT02366637|12472676|FG001|COMPLETED|First Intervention Period||1
11277068|NCT02366637|12472675|FG000|NOT COMPLETED|First Intervention Period||6
11277069|NCT02366637|12472676|FG001|NOT COMPLETED|First Intervention Period||5
11277070|NCT02366637|12472675|FG000|STARTED|Washout Period 28 to 49 Days||1
11277071|NCT02366637|12472676|FG001|STARTED|Washout Period 28 to 49 Days||1
11277072|NCT02366637|12472675|FG000|COMPLETED|Washout Period 28 to 49 Days||1
11277073|NCT02366637|12472676|FG001|COMPLETED|Washout Period 28 to 49 Days||1
11277074|NCT02366637|12472675|FG000|NOT COMPLETED|Washout Period 28 to 49 Days||0
11277075|NCT02366637|12472676|FG001|NOT COMPLETED|Washout Period 28 to 49 Days||0
11277076|NCT02366637|12472675|FG000|STARTED|Second Intervention Period||1
11277077|NCT02366637|12472676|FG001|STARTED|Second Intervention Period||1
11277078|NCT02366637|12472675|FG000|COMPLETED|Second Intervention Period||0
11277079|NCT02366637|12472676|FG001|COMPLETED|Second Intervention Period||0
11277080|NCT02366637|12472675|FG000|NOT COMPLETED|Second Intervention Period||1
11277081|NCT02366637|12472676|FG001|NOT COMPLETED|Second Intervention Period||1
11277082|NCT02366663|12472684|FG000|STARTED|Overall Study||2
11277083|NCT02366663|12472685|FG001|STARTED|Overall Study||1
11277084|NCT02366663|12472684|FG000|COMPLETED|Overall Study||2
11277085|NCT02366663|12472685|FG001|COMPLETED|Overall Study||1
11277086|NCT02366663|12472684|FG000|NOT COMPLETED|Overall Study||0
11277087|NCT02366663|12472685|FG001|NOT COMPLETED|Overall Study||0
11277088|NCT02366689|12472694|FG000|STARTED|Overall Study||60
11277089|NCT02366689|12472695|FG001|STARTED|Overall Study||58
11277090|NCT02366689|12472696|FG002|STARTED|Overall Study||61
11277091|NCT02366689|12472694|FG000|COMPLETED|Overall Study||56
11277092|NCT02366689|12472695|FG001|COMPLETED|Overall Study||55
11277093|NCT02366689|12472696|FG002|COMPLETED|Overall Study||59
11277094|NCT02366689|12472694|FG000|NOT COMPLETED|Overall Study||4
11277095|NCT02366689|12472695|FG001|NOT COMPLETED|Overall Study||3
11277096|NCT02366689|12472696|FG002|NOT COMPLETED|Overall Study||2
11277097|NCT02366767|12472706|FG000|STARTED|Overall Study||11
11277098|NCT02366767|12472707|FG001|STARTED|Overall Study||10
11277099|NCT02366767|12472706|FG000|COMPLETED|Overall Study||10
11277100|NCT02366767|12472707|FG001|COMPLETED|Overall Study||10
11277101|NCT02366767|12472706|FG000|NOT COMPLETED|Overall Study||1
11277102|NCT02366767|12472707|FG001|NOT COMPLETED|Overall Study||0
11277103|NCT02366845|12472715|FG000|STARTED|Overall Study||25
11277104|NCT02366845|12472716|FG001|STARTED|Overall Study||25
11398475|NCT04462731|12592826|FG001|COMPLETED|Overall Study||51
11398476|NCT04462731|12592825|FG000|NOT COMPLETED|Overall Study||56
11277105|NCT02366845|12472715|FG000|COMPLETED|Overall Study||25
11277106|NCT02366845|12472716|FG001|COMPLETED|Overall Study||25
11277107|NCT02366845|12472715|FG000|NOT COMPLETED|Overall Study||0
11277108|NCT02366845|12472716|FG001|NOT COMPLETED|Overall Study||0
11277109|NCT02366871|12472724|FG000|STARTED|Overall Study||204
11277110|NCT02366871|12472725|FG001|STARTED|Overall Study||196
11277111|NCT02366871|12472724|FG000|COMPLETED|Overall Study||204
11277112|NCT02366871|12472725|FG001|COMPLETED|Overall Study||196
11277113|NCT02366871|12472724|FG000|NOT COMPLETED|Overall Study||0
11277114|NCT02366871|12472725|FG001|NOT COMPLETED|Overall Study||0
11277115|NCT02366910|12472731|FG000|STARTED|Overall Study||26
11277116|NCT02366910|12472731|FG000|COMPLETED|Overall Study||21
11277117|NCT02366910|12472731|FG000|NOT COMPLETED|Overall Study||5
11277118|NCT02366923|12472737|FG000|STARTED|Overall Study||28
11398477|NCT04462731|12592826|FG001|NOT COMPLETED|Overall Study||46
11398478|NCT04459585|12592832|FG000|STARTED|Period 1 (Day 1 to Day 5)||20
11398479|NCT04459585|12592832|FG000|COMPLETED|Period 1 (Day 1 to Day 5)||20
11398480|NCT04459585|12592832|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 5)||0
11398481|NCT04459585|12592832|FG000|STARTED|Period 2 (Day 5 to Day 12)||20
11398482|NCT04459585|12592832|FG000|COMPLETED|Period 2 (Day 5 to Day 12)||20
11398483|NCT04459585|12592832|FG000|NOT COMPLETED|Period 2 (Day 5 to Day 12)||0
11398484|NCT04458818|12592839|FG000|STARTED|Overall Study|May 01 2020|39
11398485|NCT04458818|12592839|FG000|COMPLETED|Overall Study|Jan 30 2021|39
11398486|NCT04458818|12592839|FG000|NOT COMPLETED|Overall Study||0
11398487|NCT04456634|12592845|FG000|STARTED|Overall Study||6
11398488|NCT04456634|12592846|FG001|STARTED|Overall Study||2
11398489|NCT04456634|12592845|FG000|COMPLETED|Overall Study||5
11398490|NCT04456634|12592846|FG001|COMPLETED|Overall Study||2
11398491|NCT04456634|12592845|FG000|NOT COMPLETED|Overall Study||1
11398492|NCT04456634|12592846|FG001|NOT COMPLETED|Overall Study||0
11398493|NCT04454138|12592854|FG000|STARTED|Overall Study||65
11398494|NCT04454138|12592855|FG001|STARTED|Overall Study||77
11398495|NCT04454138|12592854|FG000|COMPLETED|Overall Study||65
11398496|NCT04454138|12592855|FG001|COMPLETED|Overall Study||77
11398497|NCT04454138|12592854|FG000|NOT COMPLETED|Overall Study||0
11398498|NCT04454138|12592855|FG001|NOT COMPLETED|Overall Study||0
11398499|NCT04452435|12592863|FG000|STARTED|Screening||51
11277119|NCT02366923|12472737|FG000|COMPLETED|Overall Study||22
11277120|NCT02366923|12472737|FG000|NOT COMPLETED|Overall Study||6
11277121|NCT02366936|12472742|FG000|STARTED|Overall Study||32
11277122|NCT02366936|12472742|FG000|COMPLETED|Overall Study||24
11277123|NCT02366936|12472742|FG000|NOT COMPLETED|Overall Study||8
11277124|NCT02367014|12472750|FG000|STARTED|Overall Study||9
11277125|NCT02367014|12472751|FG001|STARTED|Overall Study||9
11277126|NCT02367014|12472752|FG002|STARTED|Overall Study||9
11398500|NCT04452435|12592864|FG001|STARTED|Screening||55
11277127|NCT02367014|12472753|FG003|STARTED|Overall Study||9
11398501|NCT04452435|12592863|FG000|COMPLETED|Screening||51
11398502|NCT04452435|12592864|FG001|COMPLETED|Screening||55
11398503|NCT04452435|12592863|FG000|NOT COMPLETED|Screening||0
11398504|NCT04452435|12592864|FG001|NOT COMPLETED|Screening||0
11398505|NCT04452435|12592863|FG000|STARTED|Treatment Period||51
11398506|NCT04452435|12592864|FG001|STARTED|Treatment Period||55
11398507|NCT04452435|12592863|FG000|COMPLETED|Treatment Period||45
11398508|NCT04452435|12592864|FG001|COMPLETED|Treatment Period||43
11398509|NCT04452435|12592863|FG000|NOT COMPLETED|Treatment Period||6
11398510|NCT04452435|12592864|FG001|NOT COMPLETED|Treatment Period||12
11398511|NCT04452435|12592863|FG000|STARTED|Follow-up||45
11398512|NCT04452435|12592864|FG001|STARTED|Follow-up||43
11398513|NCT04452435|12592863|FG000|COMPLETED|Follow-up||45
11398514|NCT04452435|12592864|FG001|COMPLETED|Follow-up||42
11398515|NCT04452435|12592863|FG000|NOT COMPLETED|Follow-up||0
11398516|NCT04452435|12592864|FG001|NOT COMPLETED|Follow-up||1
11277128|NCT02367014|12472750|FG000|COMPLETED|Overall Study||9
11398517|NCT04451707|12592871|FG000|STARTED|Overall Study||67
11398518|NCT04451707|12592871|FG000|COMPLETED|Overall Study||67
11398519|NCT04451707|12592871|FG000|NOT COMPLETED|Overall Study||0
11398520|NCT04449263|12592875|FG000|STARTED|First Intervention||29
11398521|NCT04449263|12592876|FG001|STARTED|First Intervention||30
11398522|NCT04449263|12592875|FG000|COMPLETED|First Intervention||29
11398523|NCT04449263|12592876|FG001|COMPLETED|First Intervention||30
11398524|NCT04449263|12592875|FG000|NOT COMPLETED|First Intervention||0
11398525|NCT04449263|12592876|FG001|NOT COMPLETED|First Intervention||0
11398526|NCT04449263|12592875|FG000|STARTED|Second Intervention||29
11398527|NCT04449263|12592876|FG001|STARTED|Second Intervention||30
11398528|NCT04449263|12592875|FG000|COMPLETED|Second Intervention||29
11398529|NCT04449263|12592876|FG001|COMPLETED|Second Intervention||30
11398530|NCT04449263|12592875|FG000|NOT COMPLETED|Second Intervention||0
11398531|NCT04449263|12592876|FG001|NOT COMPLETED|Second Intervention||0
11398532|NCT04449263|12592875|FG000|STARTED|Third Intervention||29
11398533|NCT04449263|12592876|FG001|STARTED|Third Intervention||30
11398534|NCT04449263|12592875|FG000|COMPLETED|Third Intervention||29
11398535|NCT04449263|12592876|FG001|COMPLETED|Third Intervention||30
11398536|NCT04449263|12592875|FG000|NOT COMPLETED|Third Intervention||0
11398537|NCT04449263|12592876|FG001|NOT COMPLETED|Third Intervention||0
11398538|NCT04450381|12592884|FG000|STARTED|Overall Study||131
11398539|NCT04450381|12592884|FG000|COMPLETED|Overall Study||125
11398540|NCT04450381|12592884|FG000|NOT COMPLETED|Overall Study||6
11398541|NCT04449341|12592890|FG000|STARTED|Overall Study||31
11398542|NCT04449341|12592891|FG001|STARTED|Overall Study||28
11398543|NCT04449341|12592890|FG000|COMPLETED|Overall Study||30
11398544|NCT04449341|12592891|FG001|COMPLETED|Overall Study||28
11398545|NCT04449341|12592890|FG000|NOT COMPLETED|Overall Study||1
11277129|NCT02367014|12472751|FG001|COMPLETED|Overall Study||9
11277130|NCT02367014|12472752|FG002|COMPLETED|Overall Study||9
11277131|NCT02367014|12472753|FG003|COMPLETED|Overall Study||9
11277132|NCT02367014|12472750|FG000|NOT COMPLETED|Overall Study||0
11277133|NCT02367014|12472751|FG001|NOT COMPLETED|Overall Study||0
11277134|NCT02367014|12472752|FG002|NOT COMPLETED|Overall Study||0
11277135|NCT02367014|12472753|FG003|NOT COMPLETED|Overall Study||0
11277136|NCT02367066|12472767|FG000|STARTED|Overall Study||10
11277137|NCT02367066|12472768|FG001|STARTED|Overall Study||10
11277138|NCT02367066|12472767|FG000|COMPLETED|Overall Study||10
11277139|NCT02367066|12472768|FG001|COMPLETED|Overall Study||10
11277140|NCT02367066|12472767|FG000|NOT COMPLETED|Overall Study||0
11277141|NCT02367066|12472768|FG001|NOT COMPLETED|Overall Study||0
11277142|NCT02367131|12472779|FG000|STARTED|Overall Study|Started are the treated patients|423
11277143|NCT02367131|12472779|FG000|COMPLETED|Overall Study||201
11277144|NCT02367131|12472779|FG000|NOT COMPLETED|Overall Study||222
11398546|NCT04449341|12592891|FG001|NOT COMPLETED|Overall Study||0
11398547|NCT04441255|12592899|FG000|STARTED|Period 1 (1 Day)||7
11398548|NCT04441255|12592900|FG001|STARTED|Period 1 (1 Day)||7
11398549|NCT04441255|12592899|FG000|COMPLETED|Period 1 (1 Day)||7
11398550|NCT04441255|12592900|FG001|COMPLETED|Period 1 (1 Day)||7
11277145|NCT02367352|12472783|FG000|STARTED|Overall Study||9
11277146|NCT02367352|12472784|FG001|STARTED|Overall Study||0
11277147|NCT02367352|12472785|FG002|STARTED|Overall Study||0
11277148|NCT02367352|12472783|FG000|COMPLETED|Overall Study||0
11277149|NCT02367352|12472784|FG001|COMPLETED|Overall Study||0
11398551|NCT04441255|12592899|FG000|NOT COMPLETED|Period 1 (1 Day)||0
11398552|NCT04441255|12592900|FG001|NOT COMPLETED|Period 1 (1 Day)||0
11398553|NCT04441255|12592899|FG000|STARTED|Washout Period (10 Days)||7
11398554|NCT04441255|12592900|FG001|STARTED|Washout Period (10 Days)||7
11398555|NCT04441255|12592899|FG000|COMPLETED|Washout Period (10 Days)||7
11398556|NCT04441255|12592900|FG001|COMPLETED|Washout Period (10 Days)||7
11398557|NCT04441255|12592899|FG000|NOT COMPLETED|Washout Period (10 Days)||0
11398558|NCT04441255|12592900|FG001|NOT COMPLETED|Washout Period (10 Days)||0
11398559|NCT04441255|12592899|FG000|STARTED|Period 2 (1 Day)||7
11398560|NCT04441255|12592900|FG001|STARTED|Period 2 (1 Day)||7
11398561|NCT04441255|12592899|FG000|COMPLETED|Period 2 (1 Day)||7
11398562|NCT04441255|12592900|FG001|COMPLETED|Period 2 (1 Day)||7
11398563|NCT04441255|12592899|FG000|NOT COMPLETED|Period 2 (1 Day)||0
11398564|NCT04441255|12592900|FG001|NOT COMPLETED|Period 2 (1 Day)||0
11398565|NCT04439214|12592906|FG000|STARTED|Overall Study||47
11398566|NCT04439214|12592906|FG000|Eligible|Overall Study||42
11398567|NCT04439214|12592906|FG000|Treated|Overall Study||47
11398568|NCT04439214|12592906|FG000|Treated and Reported Adverse Event Data|Overall Study|One patient experienced disease progression in cycle 1 and an AE form was not submitted.|46
11398569|NCT04439214|12592906|FG000|Eligible and Treated|Overall Study||42
11398570|NCT04439214|12592906|FG000|COMPLETED|Overall Study||0
11398571|NCT04439214|12592906|FG000|NOT COMPLETED|Overall Study||47
11398572|NCT04439240|12592910|FG000|STARTED|Overall Study||52
11398573|NCT04439240|12592910|FG000|Started Protocol Therapy|Overall Study||50
11398574|NCT04439240|12592910|FG000|Eligible|Overall Study||49
11398575|NCT04439240|12592910|FG000|Eligible and Started Protocol Therapy|Overall Study||48
11398576|NCT04439240|12592910|FG000|Reported Adverse Events Data|Overall Study||49
11398577|NCT04439240|12592910|FG000|COMPLETED|Overall Study||0
11398578|NCT04439240|12592910|FG000|NOT COMPLETED|Overall Study||52
11398579|NCT04438785|12592916|FG000|STARTED|Overall Study||20
11398580|NCT04438785|12592917|FG001|STARTED|Overall Study||20
11398581|NCT04438785|12592916|FG000|COMPLETED|Overall Study||18
11398582|NCT04438785|12592917|FG001|COMPLETED|Overall Study||10
11398583|NCT04438785|12592916|FG000|NOT COMPLETED|Overall Study||2
11277150|NCT02367352|12472785|FG002|COMPLETED|Overall Study||0
11277151|NCT02367352|12472783|FG000|NOT COMPLETED|Overall Study||9
11277152|NCT02367352|12472784|FG001|NOT COMPLETED|Overall Study||0
11277153|NCT02367352|12472785|FG002|NOT COMPLETED|Overall Study||0
11277154|NCT02367391|12472793|FG000|STARTED|Overall Study||76
11277155|NCT02367391|12472794|FG001|STARTED|Overall Study||76
11277156|NCT02367391|12472793|FG000|COMPLETED|Overall Study||74
11277157|NCT02367391|12472794|FG001|COMPLETED|Overall Study||76
11277158|NCT02367391|12472793|FG000|NOT COMPLETED|Overall Study||2
11277159|NCT02367391|12472794|FG001|NOT COMPLETED|Overall Study||0
11277160|NCT02367430|12472800|FG000|STARTED|Overall Study||14
11277161|NCT02367430|12472800|FG000|COMPLETED|Overall Study||11
11277162|NCT02367430|12472800|FG000|NOT COMPLETED|Overall Study||3
11277163|NCT02367521|12472806|FG000|STARTED|Overall Study||17
11277164|NCT02367521|12472807|FG001|STARTED|Overall Study||17
11277165|NCT02367521|12472806|FG000|COMPLETED|Overall Study||13
11277166|NCT02367521|12472807|FG001|COMPLETED|Overall Study||17
11277167|NCT02367521|12472806|FG000|NOT COMPLETED|Overall Study||4
11277168|NCT02367521|12472807|FG001|NOT COMPLETED|Overall Study||0
11277169|NCT02367599|12472815|FG000|STARTED|Overall Study||48
11277170|NCT02367599|12472816|FG001|STARTED|Overall Study||48
11277171|NCT02367599|12472815|FG000|COMPLETED|Overall Study||48
11277172|NCT02367599|12472816|FG001|COMPLETED|Overall Study||48
11277173|NCT02367599|12472815|FG000|NOT COMPLETED|Overall Study||0
11277174|NCT02367599|12472816|FG001|NOT COMPLETED|Overall Study||0
11277175|NCT02367716|12472822|FG000|STARTED|Overall Study||121
11277176|NCT02367716|12472822|FG000|COMPLETED|Overall Study||120
11277177|NCT02367716|12472822|FG000|NOT COMPLETED|Overall Study||1
11277178|NCT02367729|12472829|FG000|STARTED|Overall Study||60
11277179|NCT02367729|12472830|FG001|STARTED|Overall Study||55
11277180|NCT02367729|12472829|FG000|COMPLETED|Overall Study||57
11277181|NCT02367729|12472830|FG001|COMPLETED|Overall Study||47
11277182|NCT02367729|12472829|FG000|NOT COMPLETED|Overall Study||3
11398584|NCT04438785|12592917|FG001|NOT COMPLETED|Overall Study||10
11398585|NCT04431908|12592925|FG000|STARTED|Overall Study||1042
11277183|NCT02367729|12472830|FG001|NOT COMPLETED|Overall Study||8
11277184|NCT02367781|12472839|FG000|STARTED|Overall Study||483
11277185|NCT02367781|12472840|FG001|STARTED|Overall Study||240
11277186|NCT02367781|12472839|FG000|COMPLETED|Overall Study||0
11277187|NCT02367781|12472840|FG001|COMPLETED|Overall Study||0
11277188|NCT02367781|12472839|FG000|NOT COMPLETED|Overall Study||483
11277189|NCT02367781|12472840|FG001|NOT COMPLETED|Overall Study||240
11277190|NCT02367820|12472852|FG000|STARTED|Overall Study||638
11277191|NCT02367820|12472852|FG000|COMPLETED|Overall Study||402
11277192|NCT02367820|12472852|FG000|NOT COMPLETED|Overall Study||236
11277193|NCT02367833|12472865|FG000|STARTED|Overall Study||9
11277194|NCT02367833|12472866|FG001|STARTED|Overall Study||9
11277195|NCT02367833|12472867|FG002|STARTED|Overall Study||8
11277196|NCT02367833|12472865|FG000|COMPLETED|Overall Study||8
11277197|NCT02367833|12472866|FG001|COMPLETED|Overall Study||8
11277198|NCT02367833|12472867|FG002|COMPLETED|Overall Study||8
11277199|NCT02367833|12472865|FG000|NOT COMPLETED|Overall Study||1
11277200|NCT02367833|12472866|FG001|NOT COMPLETED|Overall Study||1
11277201|NCT02367833|12472867|FG002|NOT COMPLETED|Overall Study||0
11277202|NCT02367859|12472875|FG000|STARTED|Overall Study||1
11277203|NCT02367859|12472875|FG000|COMPLETED|Overall Study||1
11277204|NCT02367859|12472875|FG000|NOT COMPLETED|Overall Study||0
11277205|NCT02367872|12472887|FG000|STARTED|Overall Study||6
11277206|NCT02367872|12472888|FG001|STARTED|Overall Study||6
11277207|NCT02367872|12472889|FG002|STARTED|Overall Study||6
11277208|NCT02367872|12472890|FG003|STARTED|Overall Study||6
11277209|NCT02367872|12472891|FG004|STARTED|Overall Study||6
11277210|NCT02367872|12472892|FG005|STARTED|Overall Study||6
11277211|NCT02367872|12472893|FG006|STARTED|Overall Study||6
11277212|NCT02367872|12472894|FG007|STARTED|Overall Study||6
11277213|NCT02367872|12472887|FG000|COMPLETED|Overall Study||6
11277214|NCT02367872|12472888|FG001|COMPLETED|Overall Study||6
11277215|NCT02367872|12472889|FG002|COMPLETED|Overall Study||6
11277216|NCT02367872|12472890|FG003|COMPLETED|Overall Study||6
11277217|NCT02367872|12472891|FG004|COMPLETED|Overall Study||6
11277218|NCT02367872|12472892|FG005|COMPLETED|Overall Study||6
11277219|NCT02367872|12472893|FG006|COMPLETED|Overall Study||6
11277220|NCT02367872|12472894|FG007|COMPLETED|Overall Study||6
11277221|NCT02367872|12472887|FG000|NOT COMPLETED|Overall Study||0
11277222|NCT02367872|12472888|FG001|NOT COMPLETED|Overall Study||0
11277223|NCT02367872|12472889|FG002|NOT COMPLETED|Overall Study||0
11277224|NCT02367872|12472890|FG003|NOT COMPLETED|Overall Study||0
11277225|NCT02367872|12472891|FG004|NOT COMPLETED|Overall Study||0
11277226|NCT02367872|12472892|FG005|NOT COMPLETED|Overall Study||0
11277227|NCT02367872|12472893|FG006|NOT COMPLETED|Overall Study||0
11277228|NCT02367872|12472894|FG007|NOT COMPLETED|Overall Study||0
11277229|NCT02367885|12472924|FG000|STARTED|Overall Study||33
11277230|NCT02367885|12472925|FG001|STARTED|Overall Study||33
11277231|NCT02367885|12472926|FG002|STARTED|Overall Study||33
11277232|NCT02367885|12472924|FG000|COMPLETED|Overall Study||31
11277233|NCT02367885|12472925|FG001|COMPLETED|Overall Study||33
11277234|NCT02367885|12472926|FG002|COMPLETED|Overall Study||33
11277235|NCT02367885|12472924|FG000|NOT COMPLETED|Overall Study||2
11277236|NCT02367885|12472925|FG001|NOT COMPLETED|Overall Study||0
11277237|NCT02367885|12472926|FG002|NOT COMPLETED|Overall Study||0
11277238|NCT02367911|12472939|FG000|STARTED|Overall Study||71
11277239|NCT02367911|12472940|FG001|STARTED|Overall Study||73
11277240|NCT02367911|12472939|FG000|COMPLETED|Overall Study||66
11277241|NCT02367911|12472940|FG001|COMPLETED|Overall Study||69
11277242|NCT02367911|12472939|FG000|NOT COMPLETED|Overall Study||5
11277243|NCT02367911|12472940|FG001|NOT COMPLETED|Overall Study||4
11277244|NCT02368093|12472948|FG000|STARTED|Overall Study||24
11277245|NCT02368093|12472949|FG001|STARTED|Overall Study||24
11277246|NCT02368093|12472948|FG000|COMPLETED|Overall Study||24
11277247|NCT02368093|12472949|FG001|COMPLETED|Overall Study||24
11277248|NCT02368093|12472948|FG000|NOT COMPLETED|Overall Study||0
11277249|NCT02368093|12472949|FG001|NOT COMPLETED|Overall Study||0
11277250|NCT02368210|12472957|FG000|STARTED|Overall Study||75
11277251|NCT02368210|12472958|FG001|STARTED|Overall Study||76
11277252|NCT02368210|12472957|FG000|COMPLETED|Overall Study||74
11277253|NCT02368210|12472958|FG001|COMPLETED|Overall Study||75
11277254|NCT02368210|12472957|FG000|NOT COMPLETED|Overall Study||1
11277255|NCT02368210|12472958|FG001|NOT COMPLETED|Overall Study||1
11277256|NCT02368314|12472966|FG000|STARTED|Overall Study||64
11277257|NCT02368314|12472967|FG001|STARTED|Overall Study||60
11277258|NCT02368314|12472966|FG000|COMPLETED|Overall Study||61
11277259|NCT02368314|12472967|FG001|COMPLETED|Overall Study||57
11277260|NCT02368314|12472966|FG000|NOT COMPLETED|Overall Study||3
11277261|NCT02368314|12472967|FG001|NOT COMPLETED|Overall Study||3
11277262|NCT02368431|12472975|FG000|STARTED|Overall Study||46
11277263|NCT02368431|12472976|FG001|STARTED|Overall Study||46
11277264|NCT02368431|12472975|FG000|COMPLETED|Overall Study||22
11277265|NCT02368431|12472976|FG001|COMPLETED|Overall Study||27
11277266|NCT02368431|12472975|FG000|NOT COMPLETED|Overall Study||24
11277267|NCT02368431|12472976|FG001|NOT COMPLETED|Overall Study||19
11277268|NCT02368457|12472984|FG000|STARTED|Overall Study||12
11277269|NCT02368457|12472985|FG001|STARTED|Overall Study||12
11277270|NCT02368457|12472984|FG000|COMPLETED|Overall Study||12
11277271|NCT02368457|12472985|FG001|COMPLETED|Overall Study||12
11277272|NCT02368457|12472984|FG000|NOT COMPLETED|Overall Study||0
11277273|NCT02368457|12472985|FG001|NOT COMPLETED|Overall Study||0
11277274|NCT02368691|12472992|FG000|STARTED|Overall Study|32 subjects were enrolled and received at least one dose of study drug|32
11277275|NCT02368691|12472992|FG000|COMPLETED|Overall Study||0
11277276|NCT02368691|12472992|FG000|NOT COMPLETED|Overall Study||32
11277277|NCT02369068|12472998|FG000|STARTED|1 Month||10
11277278|NCT02369068|12472999|FG001|STARTED|1 Month||11
11277279|NCT02369068|12472998|FG000|COMPLETED|1 Month||9
11277280|NCT02369068|12472999|FG001|COMPLETED|1 Month||10
11277281|NCT02369068|12472998|FG000|NOT COMPLETED|1 Month||1
11277282|NCT02369068|12472999|FG001|NOT COMPLETED|1 Month||1
11277283|NCT02369068|12472998|FG000|STARTED|3 Months||9
11277284|NCT02369068|12472999|FG001|STARTED|3 Months||10
11277285|NCT02369068|12472998|FG000|COMPLETED|3 Months||9
11277286|NCT02369068|12472999|FG001|COMPLETED|3 Months||8
11277287|NCT02369068|12472998|FG000|NOT COMPLETED|3 Months||0
11277288|NCT02369068|12472999|FG001|NOT COMPLETED|3 Months||2
11277289|NCT02369068|12472998|FG000|STARTED|6 Months||9
11277290|NCT02369068|12472999|FG001|STARTED|6 Months||8
11277291|NCT02369068|12472998|FG000|COMPLETED|6 Months||9
11277292|NCT02369068|12472999|FG001|COMPLETED|6 Months||7
11277293|NCT02369068|12472998|FG000|NOT COMPLETED|6 Months||0
11277294|NCT02369068|12472999|FG001|NOT COMPLETED|6 Months||1
11277295|NCT02369159|12473007|FG000|STARTED|Overall Study||114
11277296|NCT02369159|12473008|FG001|STARTED|Overall Study||23
11277297|NCT02369159|12473007|FG000|ITT Population|Overall Study||114
11277298|NCT02369159|12473008|FG001|ITT Population|Overall Study||23
11277299|NCT02369159|12473007|FG000|Safety Population|Overall Study||107
11277300|NCT02369159|12473008|FG001|Safety Population|Overall Study||23
11277301|NCT02369159|12473007|FG000|ITTI Population|Overall Study||81
11277302|NCT02369159|12473008|FG001|ITTI Population|Overall Study||16
11277303|NCT02369159|12473007|FG000|E-R Population|Overall Study||80
11277304|NCT02369159|12473008|FG001|E-R Population|Overall Study|Milestone only applied to Peramivir group|0
11277305|NCT02369159|12473007|FG000|COMPLETED|Overall Study||106
11277306|NCT02369159|12473008|FG001|COMPLETED|Overall Study||21
11277307|NCT02369159|12473007|FG000|NOT COMPLETED|Overall Study||8
11277308|NCT02369159|12473008|FG001|NOT COMPLETED|Overall Study||2
11277309|NCT02369172|12473025|FG000|STARTED|Overall Study||24
11277310|NCT02369172|12473025|FG000|COMPLETED|Overall Study||24
11277311|NCT02369172|12473025|FG000|NOT COMPLETED|Overall Study||0
11277312|NCT02369211|12473049|FG000|STARTED|Overall Study||43
11277313|NCT02369211|12473050|FG001|STARTED|Overall Study||43
11277314|NCT02369211|12473049|FG000|COMPLETED|Overall Study||43
11277315|NCT02369211|12473050|FG001|COMPLETED|Overall Study||41
11277316|NCT02369211|12473049|FG000|NOT COMPLETED|Overall Study||0
11277317|NCT02369211|12473050|FG001|NOT COMPLETED|Overall Study||2
11277318|NCT02369341|12473058|FG000|STARTED|Overall Study||63
11277319|NCT02369341|12473059|FG001|STARTED|Overall Study||57
11277320|NCT02369341|12473058|FG000|COMPLETED|Overall Study||62
11277321|NCT02369341|12473059|FG001|COMPLETED|Overall Study||57
11277322|NCT02369341|12473058|FG000|NOT COMPLETED|Overall Study||1
11277323|NCT02369341|12473059|FG001|NOT COMPLETED|Overall Study||0
11277324|NCT02369510|12473072|FG000|STARTED|Overall Study||23
11277325|NCT02369510|12473073|FG001|STARTED|Overall Study||22
11277326|NCT02369510|12473074|FG002|STARTED|Overall Study||23
11277327|NCT02369510|12473072|FG000|COMPLETED|Overall Study||21
11277328|NCT02369510|12473073|FG001|COMPLETED|Overall Study||19
11277329|NCT02369510|12473074|FG002|COMPLETED|Overall Study||17
11277330|NCT02369510|12473072|FG000|NOT COMPLETED|Overall Study||2
11277331|NCT02369510|12473073|FG001|NOT COMPLETED|Overall Study||3
11277332|NCT02369510|12473074|FG002|NOT COMPLETED|Overall Study||6
11277333|NCT02369796|12473087|FG000|STARTED|Overall Study||3
11277334|NCT02369796|12473088|FG001|STARTED|Overall Study||3
11277335|NCT02369796|12473089|FG002|STARTED|Overall Study||3
11277336|NCT02369796|12473090|FG003|STARTED|Overall Study||3
11277337|NCT02369796|12473091|FG004|STARTED|Overall Study||3
11277338|NCT02369796|12473087|FG000|COMPLETED|Overall Study||3
11277339|NCT02369796|12473088|FG001|COMPLETED|Overall Study||3
11277340|NCT02369796|12473089|FG002|COMPLETED|Overall Study||3
11277341|NCT02369796|12473090|FG003|COMPLETED|Overall Study||3
11277342|NCT02369796|12473091|FG004|COMPLETED|Overall Study||3
11277343|NCT02369796|12473087|FG000|NOT COMPLETED|Overall Study||0
11277344|NCT02369796|12473088|FG001|NOT COMPLETED|Overall Study||0
11277345|NCT02369796|12473089|FG002|NOT COMPLETED|Overall Study||0
11277346|NCT02369796|12473090|FG003|NOT COMPLETED|Overall Study||0
11277347|NCT02369796|12473091|FG004|NOT COMPLETED|Overall Study||0
11277348|NCT02369835|12473105|FG000|STARTED|Overall Study||64
11277349|NCT02369835|12473106|FG001|STARTED|Overall Study||68
11277350|NCT02369835|12473105|FG000|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53
11277351|NCT02369835|12473106|FG001|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55
11277352|NCT02369835|12473105|FG000|NOT COMPLETED|Overall Study||11
11277353|NCT02369835|12473106|FG001|NOT COMPLETED|Overall Study||13
11277354|NCT02369848|12473112|FG000|STARTED|Overall Study||60
11277355|NCT02369848|12473112|FG000|30 Day Primary Safety Endpoint|Overall Study||58
11277356|NCT02369848|12473112|FG000|12 Month Primary Endpoint|Overall Study||30
11277357|NCT02369848|12473112|FG000|COMPLETED|Overall Study||56
11277358|NCT02369848|12473112|FG000|NOT COMPLETED|Overall Study||4
11277359|NCT02369874|12473119|FG000|STARTED|Overall Study||247
11277360|NCT02369874|12473120|FG001|STARTED|Overall Study||240
11277361|NCT02369874|12473121|FG002|STARTED|Overall Study||249
11277362|NCT02369874|12473119|FG000|Received Treatment|Overall Study||246
11277363|NCT02369874|12473120|FG001|Received Treatment|Overall Study||237
11277364|NCT02369874|12473121|FG002|Received Treatment|Overall Study||240
11277365|NCT02369874|12473119|FG000|COMPLETED|Overall Study||203
11277366|NCT02369874|12473120|FG001|COMPLETED|Overall Study||183
11277367|NCT02369874|12473121|FG002|COMPLETED|Overall Study||188
11277368|NCT02369874|12473119|FG000|NOT COMPLETED|Overall Study||44
11277369|NCT02369874|12473120|FG001|NOT COMPLETED|Overall Study||57
11277370|NCT02369874|12473121|FG002|NOT COMPLETED|Overall Study||61
11277371|NCT02369900|12473131|FG000|STARTED|Overall Study||18
11277372|NCT02369900|12473132|FG001|STARTED|Overall Study||22
11277373|NCT02369900|12473131|FG000|COMPLETED|Overall Study||18
11277374|NCT02369900|12473132|FG001|COMPLETED|Overall Study||22
11021718|NCT00805740|12199893|FG000|STARTED|Overall Study||28
11021719|NCT00805740|12199894|FG001|STARTED|Overall Study||13
11021720|NCT00805740|12199893|FG000|Treated|Overall Study||26
11021721|NCT00805740|12199894|FG001|Treated|Overall Study||13
11021722|NCT00805740|12199893|FG000|COMPLETED|Overall Study||17
11021723|NCT00805740|12199894|FG001|COMPLETED|Overall Study||9
11021724|NCT00805740|12199893|FG000|NOT COMPLETED|Overall Study||11
11021725|NCT00805740|12199894|FG001|NOT COMPLETED|Overall Study||4
11021726|NCT00805766|12199900|FG000|STARTED|Screening Period||45
11021727|NCT00805766|12199900|FG000|COMPLETED|Screening Period||39
11021728|NCT00805766|12199900|FG000|NOT COMPLETED|Screening Period||6
11021729|NCT00805766|12199900|FG000|STARTED|Increased Dose Period||39
11021730|NCT00805766|12199900|FG000|COMPLETED|Increased Dose Period||26
11021731|NCT00805766|12199900|FG000|NOT COMPLETED|Increased Dose Period||13
11021732|NCT00805792|12199908|FG000|STARTED|Overall Study||33
11021733|NCT00805792|12199908|FG000|COMPLETED|Overall Study||28
11021734|NCT00805792|12199908|FG000|NOT COMPLETED|Overall Study||5
11021735|NCT00805870|12199914|FG000|STARTED|Overall Study||10
11021736|NCT00805870|12199915|FG001|STARTED|Overall Study||10
11021737|NCT00805870|12199914|FG000|COMPLETED|Overall Study||10
11021738|NCT00805870|12199915|FG001|COMPLETED|Overall Study||10
11021739|NCT00805870|12199914|FG000|NOT COMPLETED|Overall Study||0
11021740|NCT00805870|12199915|FG001|NOT COMPLETED|Overall Study||0
11021741|NCT00805935|12199925|FG000|STARTED|Overall Study||25
11021742|NCT00805935|12199926|FG001|STARTED|Overall Study||27
11021743|NCT00805935|12199927|FG002|STARTED|Overall Study||28
11021744|NCT00805935|12199928|FG003|STARTED|Overall Study||30
11021745|NCT00805935|12199925|FG000|COMPLETED|Overall Study||12
11277375|NCT02369900|12473131|FG000|NOT COMPLETED|Overall Study||0
11277376|NCT02369900|12473132|FG001|NOT COMPLETED|Overall Study||0
11277377|NCT02370004|12473138|FG000|STARTED|Overall Study||11
11277378|NCT02370004|12473138|FG000|COMPLETED|Overall Study||10
11277379|NCT02370004|12473138|FG000|NOT COMPLETED|Overall Study||1
11021746|NCT00805935|12199926|FG001|COMPLETED|Overall Study||8
11021747|NCT00805935|12199927|FG002|COMPLETED|Overall Study||13
11277380|NCT02370043|12473147|FG000|STARTED|Overall Study||3
11277381|NCT02370043|12473148|FG001|STARTED|Overall Study||3
11277382|NCT02370043|12473149|FG002|STARTED|Overall Study||3
11277383|NCT02370043|12473150|FG003|STARTED|Overall Study||3
11277384|NCT02370043|12473151|FG004|STARTED|Overall Study||3
11277385|NCT02370043|12473152|FG005|STARTED|Overall Study||4
11277386|NCT02370043|12473147|FG000|COMPLETED|Overall Study||3
11277387|NCT02370043|12473148|FG001|COMPLETED|Overall Study||3
11277388|NCT02370043|12473149|FG002|COMPLETED|Overall Study||3
11277389|NCT02370043|12473150|FG003|COMPLETED|Overall Study||3
11277390|NCT02370043|12473151|FG004|COMPLETED|Overall Study||2
11277391|NCT02370043|12473152|FG005|COMPLETED|Overall Study||3
11277392|NCT02370043|12473147|FG000|NOT COMPLETED|Overall Study||0
11277393|NCT02370043|12473148|FG001|NOT COMPLETED|Overall Study||0
11277394|NCT02370043|12473149|FG002|NOT COMPLETED|Overall Study||0
11277395|NCT02370043|12473150|FG003|NOT COMPLETED|Overall Study||0
11277396|NCT02370043|12473151|FG004|NOT COMPLETED|Overall Study||1
11277397|NCT02370043|12473152|FG005|NOT COMPLETED|Overall Study||1
11277398|NCT02370056|12473182|FG000|STARTED|Overall Study||27
11277399|NCT02370056|12473183|FG001|STARTED|Overall Study||26
11277400|NCT02370056|12473182|FG000|COMPLETED|Overall Study||27
11277401|NCT02370056|12473183|FG001|COMPLETED|Overall Study||26
11277402|NCT02370056|12473182|FG000|NOT COMPLETED|Overall Study||0
11277403|NCT02370056|12473183|FG001|NOT COMPLETED|Overall Study||0
11277404|NCT02370095|12473191|FG000|STARTED|Overall Study||10
11277405|NCT02370095|12473192|FG001|STARTED|Overall Study||4
11277406|NCT02370095|12473191|FG000|COMPLETED|Overall Study||10
11277407|NCT02370095|12473192|FG001|COMPLETED|Overall Study||3
11277408|NCT02370095|12473191|FG000|NOT COMPLETED|Overall Study||0
11277409|NCT02370095|12473192|FG001|NOT COMPLETED|Overall Study||1
11277410|NCT02370121|12473200|FG000|STARTED|Overall Study||12
11277411|NCT02370121|12473201|FG001|STARTED|Overall Study||12
11277412|NCT02370121|12473200|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
11277413|NCT02370121|12473201|FG001|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
11277414|NCT02370121|12473200|FG000|NOT COMPLETED|Overall Study||1
11277415|NCT02370121|12473201|FG001|NOT COMPLETED|Overall Study||1
11277416|NCT02370160|12473207|FG000|STARTED|Overall Study||9
11277417|NCT02370160|12473208|FG001|STARTED|Overall Study||6
11277418|NCT02370160|12473209|FG002|STARTED|Overall Study||3
11277419|NCT02370160|12473207|FG000|COMPLETED|Overall Study||6
11277420|NCT02370160|12473208|FG001|COMPLETED|Overall Study||2
11277421|NCT02370160|12473209|FG002|COMPLETED|Overall Study||2
11277422|NCT02370160|12473207|FG000|NOT COMPLETED|Overall Study||3
11277423|NCT02370160|12473208|FG001|NOT COMPLETED|Overall Study||4
11277424|NCT02370160|12473209|FG002|NOT COMPLETED|Overall Study||1
11277425|NCT02370251|12473222|FG000|STARTED|Overall Study||63
11277426|NCT02370251|12473222|FG000|COMPLETED|Overall Study||52
11277427|NCT02370251|12473222|FG000|NOT COMPLETED|Overall Study||11
11277428|NCT02370368|12473228|FG000|STARTED|Overall Study||14
11277429|NCT02370368|12473229|FG001|STARTED|Overall Study||13
11277430|NCT02370368|12473228|FG000|COMPLETED|Overall Study||8
11277431|NCT02370368|12473229|FG001|COMPLETED|Overall Study||7
11277432|NCT02370368|12473228|FG000|NOT COMPLETED|Overall Study||6
11277433|NCT02370368|12473229|FG001|NOT COMPLETED|Overall Study||6
11277434|NCT02370394|12473237|FG000|STARTED|Overall Study||28
11277435|NCT02370394|12473238|FG001|STARTED|Overall Study||25
11277436|NCT02370394|12473237|FG000|COMPLETED|Overall Study||26
11277437|NCT02370394|12473238|FG001|COMPLETED|Overall Study||23
11277438|NCT02370394|12473237|FG000|NOT COMPLETED|Overall Study||2
11277439|NCT02370394|12473238|FG001|NOT COMPLETED|Overall Study||2
11277440|NCT02370407|12473247|FG000|STARTED|Overall Study||20
11277441|NCT02370407|12473248|FG001|STARTED|Overall Study||20
11277442|NCT02370407|12473247|FG000|COMPLETED|Overall Study||20
11277443|NCT02370407|12473248|FG001|COMPLETED|Overall Study||20
11277444|NCT02370407|12473247|FG000|NOT COMPLETED|Overall Study||0
11277445|NCT02370407|12473248|FG001|NOT COMPLETED|Overall Study||0
11277446|NCT02370420|12473260|FG000|STARTED|Overall Study||29
11277447|NCT02370420|12473261|FG001|STARTED|Overall Study||27
11277448|NCT02370420|12473260|FG000|COMPLETED|Overall Study||15
11277449|NCT02370420|12473261|FG001|COMPLETED|Overall Study||15
11277450|NCT02370420|12473260|FG000|NOT COMPLETED|Overall Study||14
11277451|NCT02370420|12473261|FG001|NOT COMPLETED|Overall Study||12
11277452|NCT02370498|12473269|FG000|STARTED|Overall Study||296
11277453|NCT02370498|12473270|FG001|STARTED|Overall Study||296
11277454|NCT02370498|12473269|FG000|Treated|Overall Study||294
11277455|NCT02370498|12473270|FG001|Treated|Overall Study||276
11277456|NCT02370498|12473269|FG000|PD-L1 Positive Participants|Overall Study||196
11277457|NCT02370498|12473270|FG001|PD-L1 Positive Participants|Overall Study||199
11277458|NCT02370498|12473269|FG000|COMPLETED|Overall Study||0
11277459|NCT02370498|12473270|FG001|COMPLETED|Overall Study||0
11277460|NCT02370498|12473269|FG000|NOT COMPLETED|Overall Study||296
11277461|NCT02370498|12473270|FG001|NOT COMPLETED|Overall Study||296
11277462|NCT02370511|12473280|FG000|STARTED|Overall Study||31
11277463|NCT02370511|12473281|FG001|STARTED|Overall Study||30
11277464|NCT02370511|12473282|FG002|STARTED|Overall Study||30
11277465|NCT02370511|12473280|FG000|COMPLETED|Overall Study||19
11277466|NCT02370511|12473281|FG001|COMPLETED|Overall Study||19
11277467|NCT02370511|12473282|FG002|COMPLETED|Overall Study||29
11277468|NCT02370511|12473280|FG000|NOT COMPLETED|Overall Study||12
11277469|NCT02370511|12473281|FG001|NOT COMPLETED|Overall Study||11
11277470|NCT02370511|12473282|FG002|NOT COMPLETED|Overall Study||1
11277471|NCT02370537|12473293|FG000|STARTED|Part A (Open-label Recruitment)||16
11277472|NCT02370537|12473294|FG001|STARTED|Part A (Open-label Recruitment)||16
11277473|NCT02370537|12473295|FG002|STARTED|Part A (Open-label Recruitment)||283
11277474|NCT02370537|12473293|FG000|COMPLETED|Part A (Open-label Recruitment)||16
11277475|NCT02370537|12473294|FG001|COMPLETED|Part A (Open-label Recruitment)||15
11277476|NCT02370537|12473295|FG002|COMPLETED|Part A (Open-label Recruitment)||282
11277477|NCT02370537|12473293|FG000|NOT COMPLETED|Part A (Open-label Recruitment)||0
11277478|NCT02370537|12473294|FG001|NOT COMPLETED|Part A (Open-label Recruitment)||1
11277479|NCT02370537|12473295|FG002|NOT COMPLETED|Part A (Open-label Recruitment)||1
11277480|NCT02370537|12473293|FG000|STARTED|Part B||16
11277481|NCT02370537|12473294|FG001|STARTED|Part B||15
11277482|NCT02370537|12473295|FG002|STARTED|Part B||282
11277483|NCT02370537|12473293|FG000|Eligible for Randomisation|Part B||15
11277484|NCT02370537|12473294|FG001|Eligible for Randomisation|Part B||13
11277485|NCT02370537|12473295|FG002|Eligible for Randomisation|Part B||23
11277486|NCT02370537|12473293|FG000|Period 1 Sequence AB|Part B||8
11277487|NCT02370537|12473294|FG001|Period 1 Sequence AB|Part B||6
11277488|NCT02370537|12473295|FG002|Period 1 Sequence AB|Part B||11
11277489|NCT02370537|12473293|FG000|Period 1 Sequence BA|Part B||7
11277490|NCT02370537|12473294|FG001|Period 1 Sequence BA|Part B||7
11277491|NCT02370537|12473295|FG002|Period 1 Sequence BA|Part B||12
11277492|NCT02370537|12473293|FG000|Period 2 Sequence AB|Part B||8
11277493|NCT02370537|12473294|FG001|Period 2 Sequence AB|Part B||5
11277494|NCT02370537|12473295|FG002|Period 2 Sequence AB|Part B||11
11277495|NCT02370537|12473293|FG000|Period 2 Sequence BA|Part B||7
11277496|NCT02370537|12473294|FG001|Period 2 Sequence BA|Part B||7
11277497|NCT02370537|12473295|FG002|Period 2 Sequence BA|Part B||12
11277498|NCT02370537|12473293|FG000|COMPLETED|Part B||15
11277499|NCT02370537|12473294|FG001|COMPLETED|Part B||12
11277500|NCT02370537|12473295|FG002|COMPLETED|Part B||23
11277501|NCT02370537|12473293|FG000|NOT COMPLETED|Part B||1
11277502|NCT02370537|12473294|FG001|NOT COMPLETED|Part B||3
11277503|NCT02370537|12473295|FG002|NOT COMPLETED|Part B||259
11277504|NCT02370602|12473318|FG000|STARTED|Overall Study||1
11277505|NCT02370602|12473319|FG001|STARTED|Overall Study||2
11277506|NCT02370602|12473320|FG002|STARTED|Overall Study||2
11277507|NCT02370602|12473321|FG003|STARTED|Overall Study||3
11277508|NCT02370602|12473322|FG004|STARTED|Overall Study||3
11277509|NCT02370602|12473323|FG005|STARTED|Overall Study||2
11277510|NCT02370602|12473318|FG000|COMPLETED|Overall Study||0
11277511|NCT02370602|12473319|FG001|COMPLETED|Overall Study||2
11277512|NCT02370602|12473320|FG002|COMPLETED|Overall Study||2
11277513|NCT02370602|12473321|FG003|COMPLETED|Overall Study||3
11277514|NCT02370602|12473322|FG004|COMPLETED|Overall Study||3
11277515|NCT02370602|12473323|FG005|COMPLETED|Overall Study||2
11277516|NCT02370602|12473318|FG000|NOT COMPLETED|Overall Study||1
11277517|NCT02370602|12473319|FG001|NOT COMPLETED|Overall Study||0
11277518|NCT02370602|12473320|FG002|NOT COMPLETED|Overall Study||0
11277519|NCT02370602|12473321|FG003|NOT COMPLETED|Overall Study||0
11277520|NCT02370602|12473322|FG004|NOT COMPLETED|Overall Study||0
11277521|NCT02370602|12473323|FG005|NOT COMPLETED|Overall Study||0
11277522|NCT02370615|12473342|FG000|STARTED|Overall Study||16
11277523|NCT02370615|12473343|FG001|STARTED|Overall Study||18
11277524|NCT02370615|12473342|FG000|COMPLETED|Overall Study||15
11277525|NCT02370615|12473343|FG001|COMPLETED|Overall Study||18
11277526|NCT02370615|12473342|FG000|NOT COMPLETED|Overall Study||1
11277527|NCT02370615|12473343|FG001|NOT COMPLETED|Overall Study||0
11277528|NCT02370641|12473358|FG000|STARTED|Overall Study||18
11277529|NCT02370641|12473359|FG001|STARTED|Overall Study||8
11277530|NCT02370641|12473358|FG000|COMPLETED|Overall Study||14
11277531|NCT02370641|12473359|FG001|COMPLETED|Overall Study||6
11277532|NCT02370641|12473358|FG000|NOT COMPLETED|Overall Study||4
11277533|NCT02370641|12473359|FG001|NOT COMPLETED|Overall Study||2
11277534|NCT02370667|12473368|FG000|STARTED|Overall Study||10
11277535|NCT02370667|12473369|FG001|STARTED|Overall Study||11
11277536|NCT02370667|12473370|FG002|STARTED|Overall Study||10
11277537|NCT02370667|12473368|FG000|COMPLETED|Overall Study||10
11277538|NCT02370667|12473369|FG001|COMPLETED|Overall Study||10
11277539|NCT02370667|12473370|FG002|COMPLETED|Overall Study||10
11277540|NCT02370667|12473368|FG000|NOT COMPLETED|Overall Study||0
11277541|NCT02370667|12473369|FG001|NOT COMPLETED|Overall Study||1
11277542|NCT02370667|12473370|FG002|NOT COMPLETED|Overall Study||0
11277543|NCT02370693|12473381|FG000|STARTED|Overall Study||3
11277544|NCT02370693|12473382|FG001|STARTED|Overall Study||4
11277545|NCT02370693|12473381|FG000|COMPLETED|Overall Study||2
11277546|NCT02370693|12473382|FG001|COMPLETED|Overall Study||3
11277547|NCT02370693|12473381|FG000|NOT COMPLETED|Overall Study||1
11277548|NCT02370693|12473382|FG001|NOT COMPLETED|Overall Study||1
11277549|NCT02370784|12473390|FG000|STARTED|Overall Study||10
11277550|NCT02370784|12473391|FG001|STARTED|Overall Study||14
11277551|NCT02370784|12473390|FG000|COMPLETED|Overall Study||10
11277552|NCT02370784|12473391|FG001|COMPLETED|Overall Study||13
11277553|NCT02370784|12473390|FG000|NOT COMPLETED|Overall Study||0
11277554|NCT02370784|12473391|FG001|NOT COMPLETED|Overall Study||1
11277555|NCT02370810|12473401|FG000|STARTED|Overall Study||73
11277556|NCT02370810|12473402|FG001|STARTED|Overall Study||73
11277557|NCT02370810|12473401|FG000|COMPLETED|Overall Study||50
11277558|NCT02370810|12473402|FG001|COMPLETED|Overall Study||54
11277559|NCT02370810|12473401|FG000|NOT COMPLETED|Overall Study||23
11277560|NCT02370810|12473402|FG001|NOT COMPLETED|Overall Study||19
11277561|NCT02371187|12473412|FG000|STARTED|Overall Study||18
11277562|NCT02371187|12473413|FG001|STARTED|Overall Study||19
11277563|NCT02371187|12473412|FG000|COMPLETED|Overall Study||15
11277564|NCT02371187|12473413|FG001|COMPLETED|Overall Study||15
11277565|NCT02371187|12473412|FG000|NOT COMPLETED|Overall Study||3
11277566|NCT02371187|12473413|FG001|NOT COMPLETED|Overall Study||4
11277567|NCT02371252|12473421|FG000|STARTED|Overall Study||70
11277568|NCT02371252|12473422|FG001|STARTED|Overall Study||70
11277569|NCT02371252|12473421|FG000|COMPLETED|Overall Study||70
11277570|NCT02371252|12473422|FG001|COMPLETED|Overall Study||70
11277571|NCT02371252|12473421|FG000|NOT COMPLETED|Overall Study||0
11277572|NCT02371252|12473422|FG001|NOT COMPLETED|Overall Study||0
11277573|NCT02371356|12473433|FG000|STARTED|Overall Study||1320
11277574|NCT02371356|12473434|FG001|STARTED|Overall Study||7354
11277575|NCT02371356|12473435|FG002|STARTED|Overall Study||2804
11277576|NCT02371356|12473436|FG003|STARTED|Overall Study||7423
11277577|NCT02371356|12473437|FG004|STARTED|Overall Study||72183
11277578|NCT02371356|12473433|FG000|COMPLETED|Overall Study||1320
11277579|NCT02371356|12473434|FG001|COMPLETED|Overall Study||7354
11277580|NCT02371356|12473435|FG002|COMPLETED|Overall Study||2804
11277581|NCT02371356|12473436|FG003|COMPLETED|Overall Study||7423
11277582|NCT02371356|12473437|FG004|COMPLETED|Overall Study||72183
11277583|NCT02371356|12473433|FG000|NOT COMPLETED|Overall Study||0
11277584|NCT02371356|12473434|FG001|NOT COMPLETED|Overall Study||0
11277585|NCT02371356|12473435|FG002|NOT COMPLETED|Overall Study||0
11277586|NCT02371356|12473436|FG003|NOT COMPLETED|Overall Study||0
11277587|NCT02371356|12473437|FG004|NOT COMPLETED|Overall Study||0
11277588|NCT02371395|12473449|FG000|STARTED|Overall Study||1000
11277589|NCT02371395|12473449|FG000|COMPLETED|Overall Study||1000
11277590|NCT02371395|12473449|FG000|NOT COMPLETED|Overall Study||0
11277591|NCT02371616|12473455|FG000|STARTED|Overall Study||150
11277592|NCT02371616|12473456|FG001|STARTED|Overall Study||154
11277593|NCT02371616|12473455|FG000|COMPLETED|Overall Study||146
11398586|NCT04431908|12592926|FG001|STARTED|Overall Study||278
11277594|NCT02371616|12473456|FG001|COMPLETED|Overall Study||147
11277595|NCT02371616|12473455|FG000|NOT COMPLETED|Overall Study||4
11277596|NCT02371616|12473456|FG001|NOT COMPLETED|Overall Study||7
11277597|NCT02371629|12473464|FG000|STARTED|Overall Study||388
11277598|NCT02371629|12473465|FG001|STARTED|Overall Study||388
11277599|NCT02371629|12473464|FG000|COMPLETED|Overall Study||362
11277600|NCT02371629|12473465|FG001|COMPLETED|Overall Study||363
11277601|NCT02371629|12473464|FG000|NOT COMPLETED|Overall Study||26
11277602|NCT02371629|12473465|FG001|NOT COMPLETED|Overall Study||25
11277603|NCT02371668|12473473|FG000|STARTED|Overall Study||49
11277604|NCT02371668|12473474|FG001|STARTED|Overall Study||42
11277605|NCT02371668|12473473|FG000|COMPLETED|Overall Study||49
11277606|NCT02371668|12473474|FG001|COMPLETED|Overall Study||42
11277607|NCT02371668|12473473|FG000|NOT COMPLETED|Overall Study||0
11277608|NCT02371668|12473474|FG001|NOT COMPLETED|Overall Study||0
11277609|NCT02371746|12473487|FG000|STARTED|Overall Study||7
11277610|NCT02371746|12473488|FG001|STARTED|Overall Study||10
11277611|NCT02371746|12473489|FG002|STARTED|Overall Study||2
11277612|NCT02371746|12473490|FG003|STARTED|Overall Study||2
11277613|NCT02371746|12473491|FG004|STARTED|Overall Study||5
11277614|NCT02371746|12473492|FG005|STARTED|Overall Study||6
11277615|NCT02371746|12473493|FG006|STARTED|Overall Study||9
11277616|NCT02371746|12473487|FG000|COMPLETED|Overall Study||7
11277617|NCT02371746|12473488|FG001|COMPLETED|Overall Study||10
11277618|NCT02371746|12473489|FG002|COMPLETED|Overall Study||2
11277619|NCT02371746|12473490|FG003|COMPLETED|Overall Study||2
11277620|NCT02371746|12473491|FG004|COMPLETED|Overall Study||5
11277621|NCT02371746|12473492|FG005|COMPLETED|Overall Study||6
11277622|NCT02371746|12473493|FG006|COMPLETED|Overall Study||8
11277623|NCT02371746|12473487|FG000|NOT COMPLETED|Overall Study||0
11277624|NCT02371746|12473488|FG001|NOT COMPLETED|Overall Study||0
11277625|NCT02371746|12473489|FG002|NOT COMPLETED|Overall Study||0
11277626|NCT02371746|12473490|FG003|NOT COMPLETED|Overall Study||0
11277627|NCT02371746|12473491|FG004|NOT COMPLETED|Overall Study||0
11277628|NCT02371746|12473492|FG005|NOT COMPLETED|Overall Study||0
11277629|NCT02371746|12473493|FG006|NOT COMPLETED|Overall Study||1
11277630|NCT02371759|12473517|FG000|STARTED|Overall Study||32
11277631|NCT02371759|12473518|FG001|STARTED|Overall Study||31
11277632|NCT02371759|12473519|FG002|STARTED|Overall Study||33
11277633|NCT02371759|12473520|FG003|STARTED|Overall Study||31
11277634|NCT02371759|12473521|FG004|STARTED|Overall Study||27
11277635|NCT02371759|12473522|FG005|STARTED|Overall Study||26
11277636|NCT02371759|12473523|FG006|STARTED|Overall Study||25
11277637|NCT02371759|12473524|FG007|STARTED|Overall Study||28
11277638|NCT02371759|12473517|FG000|COMPLETED|Overall Study||29
11277639|NCT02371759|12473518|FG001|COMPLETED|Overall Study||30
11277640|NCT02371759|12473519|FG002|COMPLETED|Overall Study||32
11277641|NCT02371759|12473520|FG003|COMPLETED|Overall Study||31
11277642|NCT02371759|12473521|FG004|COMPLETED|Overall Study||24
11277643|NCT02371759|12473522|FG005|COMPLETED|Overall Study||25
11398587|NCT04431908|12592925|FG000|COMPLETED|Overall Study||1042
11277644|NCT02371759|12473523|FG006|COMPLETED|Overall Study||25
11277645|NCT02371759|12473524|FG007|COMPLETED|Overall Study||24
11277646|NCT02371759|12473517|FG000|NOT COMPLETED|Overall Study||3
11277647|NCT02371759|12473518|FG001|NOT COMPLETED|Overall Study||1
11277648|NCT02371759|12473519|FG002|NOT COMPLETED|Overall Study||1
11398588|NCT04431908|12592926|FG001|COMPLETED|Overall Study||278
11398589|NCT04431908|12592925|FG000|NOT COMPLETED|Overall Study||0
11398590|NCT04431908|12592926|FG001|NOT COMPLETED|Overall Study||0
11398591|NCT04413929|12592933|FG000|STARTED|Overall Study||8411
11398592|NCT04413929|12592933|FG000|COMPLETED|Overall Study||8411
11398593|NCT04413929|12592933|FG000|NOT COMPLETED|Overall Study||0
11398594|NCT04430634|12592946|FG000|STARTED|Overall Study||5
11398595|NCT04430634|12592947|FG001|STARTED|Overall Study||5
11398596|NCT04430634|12592948|FG002|STARTED|Overall Study||5
11398597|NCT04430634|12592949|FG003|STARTED|Overall Study||5
11398598|NCT04430634|12592950|FG004|STARTED|Overall Study||5
11398599|NCT04430634|12592951|FG005|STARTED|Overall Study||5
11398600|NCT04430634|12592952|FG006|STARTED|Overall Study||5
11398601|NCT04430634|12592953|FG007|STARTED|Overall Study||5
11398602|NCT04430634|12592946|FG000|COMPLETED|Overall Study||5
11398603|NCT04430634|12592947|FG001|COMPLETED|Overall Study||5
11398604|NCT04430634|12592948|FG002|COMPLETED|Overall Study||5
11398605|NCT04430634|12592949|FG003|COMPLETED|Overall Study||4
11398606|NCT04430634|12592950|FG004|COMPLETED|Overall Study||5
11398607|NCT04430634|12592951|FG005|COMPLETED|Overall Study||5
11398608|NCT04430634|12592952|FG006|COMPLETED|Overall Study||4
11398609|NCT04430634|12592953|FG007|COMPLETED|Overall Study||5
11398610|NCT04430634|12592946|FG000|NOT COMPLETED|Overall Study||0
11398611|NCT04430634|12592947|FG001|NOT COMPLETED|Overall Study||0
11398612|NCT04430634|12592948|FG002|NOT COMPLETED|Overall Study||0
11277649|NCT02371759|12473520|FG003|NOT COMPLETED|Overall Study||0
11277650|NCT02371759|12473521|FG004|NOT COMPLETED|Overall Study||3
11277651|NCT02371759|12473522|FG005|NOT COMPLETED|Overall Study||1
11277652|NCT02371759|12473523|FG006|NOT COMPLETED|Overall Study||0
11277653|NCT02371759|12473524|FG007|NOT COMPLETED|Overall Study||4
11277654|NCT02371785|12473542|FG000|STARTED|Overall Study||20
11277655|NCT02371785|12473542|FG000|COMPLETED|Overall Study||20
11277656|NCT02371785|12473542|FG000|NOT COMPLETED|Overall Study||0
11277657|NCT02371850|12473552|FG000|STARTED|Overall Study||10
11277658|NCT02371850|12473552|FG000|COMPLETED|Overall Study||10
11277659|NCT02371850|12473552|FG000|NOT COMPLETED|Overall Study||0
11277660|NCT02371876|12473563|FG000|STARTED|Overall Study||134
11277661|NCT02371876|12473563|FG000|COMPLETED|Overall Study||134
11277662|NCT02371876|12473563|FG000|NOT COMPLETED|Overall Study||0
11277663|NCT02371980|12473571|FG000|STARTED|Open-label Period||1106
11277664|NCT02371980|12473572|FG001|STARTED|Open-label Period||0
11277665|NCT02371980|12473573|FG002|STARTED|Open-label Period||0
11277666|NCT02371980|12473574|FG003|STARTED|Open-label Period||0
11277667|NCT02371980|12473575|FG004|STARTED|Open-label Period||0
11277668|NCT02371980|12473571|FG000|COMPLETED|Open-label Period||580
11277669|NCT02371980|12473572|FG001|COMPLETED|Open-label Period||0
11277670|NCT02371980|12473573|FG002|COMPLETED|Open-label Period||0
11277671|NCT02371980|12473574|FG003|COMPLETED|Open-label Period||0
11277672|NCT02371980|12473575|FG004|COMPLETED|Open-label Period||0
11277673|NCT02371980|12473571|FG000|NOT COMPLETED|Open-label Period||526
11277674|NCT02371980|12473572|FG001|NOT COMPLETED|Open-label Period||0
11277675|NCT02371980|12473573|FG002|NOT COMPLETED|Open-label Period||0
11277676|NCT02371980|12473574|FG003|NOT COMPLETED|Open-label Period||0
11277677|NCT02371980|12473575|FG004|NOT COMPLETED|Open-label Period||0
11277678|NCT02371980|12473571|FG000|STARTED|Double-blind Period||0
11277679|NCT02371980|12473572|FG001|STARTED|Double-blind Period||151
11277680|NCT02371980|12473573|FG002|STARTED|Double-blind Period||140
11277681|NCT02371980|12473574|FG003|STARTED|Double-blind Period||145
11277682|NCT02371980|12473575|FG004|STARTED|Double-blind Period||144
11277683|NCT02371980|12473571|FG000|COMPLETED|Double-blind Period||0
11277684|NCT02371980|12473572|FG001|COMPLETED|Double-blind Period||70
11277685|NCT02371980|12473573|FG002|COMPLETED|Double-blind Period||84
11277686|NCT02371980|12473574|FG003|COMPLETED|Double-blind Period||96
11277687|NCT02371980|12473575|FG004|COMPLETED|Double-blind Period||86
11277688|NCT02371980|12473571|FG000|NOT COMPLETED|Double-blind Period||0
11277689|NCT02371980|12473572|FG001|NOT COMPLETED|Double-blind Period||81
11277690|NCT02371980|12473573|FG002|NOT COMPLETED|Double-blind Period||56
11277691|NCT02371980|12473574|FG003|NOT COMPLETED|Double-blind Period||49
11277692|NCT02371980|12473575|FG004|NOT COMPLETED|Double-blind Period||58
11277693|NCT02372006|12473589|FG000|STARTED|Overall Study||8
11277694|NCT02372006|12473590|FG001|STARTED|Overall Study||9
11277695|NCT02372006|12473591|FG002|STARTED|Overall Study||39
11277696|NCT02372006|12473589|FG000|COMPLETED|Overall Study||0
11277697|NCT02372006|12473590|FG001|COMPLETED|Overall Study||0
11277698|NCT02372006|12473591|FG002|COMPLETED|Overall Study||0
11277699|NCT02372006|12473589|FG000|NOT COMPLETED|Overall Study||8
11277700|NCT02372006|12473590|FG001|NOT COMPLETED|Overall Study||9
11277701|NCT02372006|12473591|FG002|NOT COMPLETED|Overall Study||39
11277702|NCT02372058|12473600|FG000|STARTED|Overall Study||103
11277703|NCT02372058|12473600|FG000|COMPLETED|Overall Study||100
11277704|NCT02372058|12473600|FG000|NOT COMPLETED|Overall Study||3
11277705|NCT02372071|12473606|FG000|STARTED|Overall Study||111
11277706|NCT02372071|12473606|FG000|COMPLETED|Overall Study||93
11277707|NCT02372071|12473606|FG000|NOT COMPLETED|Overall Study||18
11277708|NCT02372097|12473613|FG000|STARTED|First Intervention Period (8 Days)||12
11277709|NCT02372097|12473614|FG001|STARTED|First Intervention Period (8 Days)||12
11277710|NCT02372097|12473613|FG000|COMPLETED|First Intervention Period (8 Days)||12
11277711|NCT02372097|12473614|FG001|COMPLETED|First Intervention Period (8 Days)||12
11277712|NCT02372097|12473613|FG000|NOT COMPLETED|First Intervention Period (8 Days)||0
11398613|NCT04430634|12592949|FG003|NOT COMPLETED|Overall Study||1
11398614|NCT04430634|12592950|FG004|NOT COMPLETED|Overall Study||0
11398615|NCT04430634|12592951|FG005|NOT COMPLETED|Overall Study||0
11277713|NCT02372097|12473614|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0
11277714|NCT02372097|12473613|FG000|STARTED|Wash Out Period (13 Days)||12
11277715|NCT02372097|12473614|FG001|STARTED|Wash Out Period (13 Days)||12
11277716|NCT02372097|12473613|FG000|COMPLETED|Wash Out Period (13 Days)||12
11277717|NCT02372097|12473614|FG001|COMPLETED|Wash Out Period (13 Days)||12
11277718|NCT02372097|12473613|FG000|NOT COMPLETED|Wash Out Period (13 Days)||0
11277719|NCT02372097|12473614|FG001|NOT COMPLETED|Wash Out Period (13 Days)||0
11277720|NCT02372097|12473613|FG000|STARTED|Second Intervention Period (8 Days)||12
11277721|NCT02372097|12473614|FG001|STARTED|Second Intervention Period (8 Days)||12
11277722|NCT02372097|12473613|FG000|COMPLETED|Second Intervention Period (8 Days)||12
11277723|NCT02372097|12473614|FG001|COMPLETED|Second Intervention Period (8 Days)||12
11277724|NCT02372097|12473613|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0
11277725|NCT02372097|12473614|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0
11277726|NCT02372253|12473622|FG000|STARTED|Overall Study||13
11277727|NCT02372253|12473623|FG001|STARTED|Overall Study||13
11277728|NCT02372253|12473622|FG000|COMPLETED|Overall Study||11
11277729|NCT02372253|12473623|FG001|COMPLETED|Overall Study||13
11277730|NCT02372253|12473622|FG000|NOT COMPLETED|Overall Study||2
11277731|NCT02372253|12473623|FG001|NOT COMPLETED|Overall Study||0
11277732|NCT02372344|12473631|FG000|STARTED|Period 1 (Visit 2)||14
11277733|NCT02372344|12473632|FG001|STARTED|Period 1 (Visit 2)||14
11277734|NCT02372344|12473633|FG002|STARTED|Period 1 (Visit 2)||14
11277735|NCT02372344|12473631|FG000|COMPLETED|Period 1 (Visit 2)||14
11277736|NCT02372344|12473632|FG001|COMPLETED|Period 1 (Visit 2)||14
11277737|NCT02372344|12473633|FG002|COMPLETED|Period 1 (Visit 2)||14
11277738|NCT02372344|12473631|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
11277739|NCT02372344|12473632|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
11277740|NCT02372344|12473633|FG002|NOT COMPLETED|Period 1 (Visit 2)||0
11277741|NCT02372344|12473631|FG000|STARTED|Period 2 (Visit 3)||14
11398616|NCT04430634|12592952|FG006|NOT COMPLETED|Overall Study||1
11398617|NCT04430634|12592953|FG007|NOT COMPLETED|Overall Study||0
11398618|NCT04429932|12592980|FG000|STARTED|Overall Study||4
11398619|NCT04429932|12592981|FG001|STARTED|Overall Study||5
11398620|NCT04429932|12592982|FG002|STARTED|Overall Study||5
11398621|NCT04429932|12592983|FG003|STARTED|Overall Study||5
11398622|NCT04429932|12592984|FG004|STARTED|Overall Study||5
11398623|NCT04429932|12592985|FG005|STARTED|Overall Study||5
11398624|NCT04429932|12592986|FG006|STARTED|Overall Study||5
11398625|NCT04429932|12592987|FG007|STARTED|Overall Study||5
11398626|NCT04429932|12592980|FG000|COMPLETED|Overall Study||3
11398627|NCT04429932|12592981|FG001|COMPLETED|Overall Study||5
11277742|NCT02372344|12473632|FG001|STARTED|Period 2 (Visit 3)||14
11277743|NCT02372344|12473633|FG002|STARTED|Period 2 (Visit 3)||14
11277744|NCT02372344|12473631|FG000|COMPLETED|Period 2 (Visit 3)||14
11277745|NCT02372344|12473632|FG001|COMPLETED|Period 2 (Visit 3)||14
11277746|NCT02372344|12473633|FG002|COMPLETED|Period 2 (Visit 3)||14
11277747|NCT02372344|12473631|FG000|NOT COMPLETED|Period 2 (Visit 3)||0
11277748|NCT02372344|12473632|FG001|NOT COMPLETED|Period 2 (Visit 3)||0
11277749|NCT02372344|12473633|FG002|NOT COMPLETED|Period 2 (Visit 3)||0
11277750|NCT02372344|12473631|FG000|STARTED|Period 3 (Visit 4)||14
11277751|NCT02372344|12473632|FG001|STARTED|Period 3 (Visit 4)||14
11277752|NCT02372344|12473633|FG002|STARTED|Period 3 (Visit 4)||14
11277753|NCT02372344|12473631|FG000|COMPLETED|Period 3 (Visit 4)||14
11277754|NCT02372344|12473632|FG001|COMPLETED|Period 3 (Visit 4)||14
11277755|NCT02372344|12473633|FG002|COMPLETED|Period 3 (Visit 4)||14
11277756|NCT02372344|12473631|FG000|NOT COMPLETED|Period 3 (Visit 4)||0
11277757|NCT02372344|12473632|FG001|NOT COMPLETED|Period 3 (Visit 4)||0
11277758|NCT02372344|12473633|FG002|NOT COMPLETED|Period 3 (Visit 4)||0
11277759|NCT02372383|12473643|FG000|STARTED|First Intervention (1 Day)||10
11277760|NCT02372383|12473644|FG001|STARTED|First Intervention (1 Day)||11
11277761|NCT02372383|12473645|FG002|STARTED|First Intervention (1 Day)||10
11277762|NCT02372383|12473643|FG000|COMPLETED|First Intervention (1 Day)||10
11277763|NCT02372383|12473644|FG001|COMPLETED|First Intervention (1 Day)||10
11277764|NCT02372383|12473645|FG002|COMPLETED|First Intervention (1 Day)||10
11277765|NCT02372383|12473643|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11277766|NCT02372383|12473644|FG001|NOT COMPLETED|First Intervention (1 Day)||1
11277767|NCT02372383|12473645|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11277768|NCT02372383|12473643|FG000|STARTED|Washout (14 Days)||10
11277769|NCT02372383|12473644|FG001|STARTED|Washout (14 Days)||10
11277770|NCT02372383|12473645|FG002|STARTED|Washout (14 Days)||10
11277771|NCT02372383|12473643|FG000|COMPLETED|Washout (14 Days)||10
11277772|NCT02372383|12473644|FG001|COMPLETED|Washout (14 Days)||10
11277773|NCT02372383|12473645|FG002|COMPLETED|Washout (14 Days)||10
11277774|NCT02372383|12473643|FG000|NOT COMPLETED|Washout (14 Days)||0
11277775|NCT02372383|12473644|FG001|NOT COMPLETED|Washout (14 Days)||0
11277776|NCT02372383|12473645|FG002|NOT COMPLETED|Washout (14 Days)||0
11277777|NCT02372383|12473643|FG000|STARTED|Second Intervention (1 Day)||10
11277778|NCT02372383|12473644|FG001|STARTED|Second Intervention (1 Day)||10
11277779|NCT02372383|12473645|FG002|STARTED|Second Intervention (1 Day)||10
11277780|NCT02372383|12473643|FG000|COMPLETED|Second Intervention (1 Day)||10
11277781|NCT02372383|12473644|FG001|COMPLETED|Second Intervention (1 Day)||10
11277782|NCT02372383|12473645|FG002|COMPLETED|Second Intervention (1 Day)||10
11277783|NCT02372383|12473643|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11277784|NCT02372383|12473644|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11277785|NCT02372383|12473645|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11277786|NCT02372396|12473657|FG000|STARTED|Overall Study||17
11398628|NCT04429932|12592982|FG002|COMPLETED|Overall Study||5
11277787|NCT02372396|12473658|FG001|STARTED|Overall Study||20
11277788|NCT02372396|12473657|FG000|Began Intervention|Overall Study||14
11277789|NCT02372396|12473658|FG001|Began Intervention|Overall Study||14
11277790|NCT02372396|12473657|FG000|COMPLETED|Overall Study||10
11277791|NCT02372396|12473658|FG001|COMPLETED|Overall Study||11
11277792|NCT02372396|12473657|FG000|NOT COMPLETED|Overall Study||7
11277793|NCT02372396|12473658|FG001|NOT COMPLETED|Overall Study||9
11277794|NCT02372682|12473666|FG000|STARTED|Overall Study||78
11277795|NCT02372682|12473667|FG001|STARTED|Overall Study||93
11277796|NCT02372682|12473666|FG000|COMPLETED|Overall Study||70
11277797|NCT02372682|12473667|FG001|COMPLETED|Overall Study||79
11277798|NCT02372682|12473666|FG000|NOT COMPLETED|Overall Study||8
11398629|NCT04429932|12592983|FG003|COMPLETED|Overall Study||2
11398630|NCT04429932|12592984|FG004|COMPLETED|Overall Study||5
11398631|NCT04429932|12592985|FG005|COMPLETED|Overall Study||5
11398632|NCT04429932|12592986|FG006|COMPLETED|Overall Study||5
11277799|NCT02372682|12473667|FG001|NOT COMPLETED|Overall Study||14
11277800|NCT02372799|12473683|FG000|STARTED|Treatment Period||186
11277801|NCT02372799|12473684|FG001|STARTED|Treatment Period||187
11277802|NCT02372799|12473685|FG002|STARTED|Treatment Period||97
11277803|NCT02372799|12473683|FG000|COMPLETED|Treatment Period||152
11277804|NCT02372799|12473684|FG001|COMPLETED|Treatment Period||155
11277805|NCT02372799|12473685|FG002|COMPLETED|Treatment Period||82
11277806|NCT02372799|12473683|FG000|NOT COMPLETED|Treatment Period||34
11398633|NCT04429932|12592987|FG007|COMPLETED|Overall Study||5
11398634|NCT04429932|12592980|FG000|NOT COMPLETED|Overall Study||1
11277807|NCT02372799|12473684|FG001|NOT COMPLETED|Treatment Period||32
11277808|NCT02372799|12473685|FG002|NOT COMPLETED|Treatment Period||15
11277809|NCT02372799|12473683|FG000|STARTED|Down-taper Period||152
11277810|NCT02372799|12473684|FG001|STARTED|Down-taper Period||159
11277811|NCT02372799|12473685|FG002|STARTED|Down-taper Period||82
11277812|NCT02372799|12473683|FG000|COMPLETED|Down-taper Period||151
11277813|NCT02372799|12473684|FG001|COMPLETED|Down-taper Period||157
11277814|NCT02372799|12473685|FG002|COMPLETED|Down-taper Period||80
11277815|NCT02372799|12473683|FG000|NOT COMPLETED|Down-taper Period||1
11277816|NCT02372799|12473684|FG001|NOT COMPLETED|Down-taper Period||2
11277817|NCT02372799|12473685|FG002|NOT COMPLETED|Down-taper Period||2
11277818|NCT02373098|12473695|FG000|STARTED|Overall Study||66
11277819|NCT02373098|12473696|FG001|STARTED|Overall Study||60
11277820|NCT02373098|12473695|FG000|COMPLETED|Overall Study||54
11277821|NCT02373098|12473696|FG001|COMPLETED|Overall Study||60
11277822|NCT02373098|12473695|FG000|NOT COMPLETED|Overall Study||12
11277823|NCT02373098|12473696|FG001|NOT COMPLETED|Overall Study||0
11277824|NCT02373124|12473708|FG000|STARTED|Overall Study||4
11277825|NCT02373124|12473708|FG000|COMPLETED|Overall Study||3
11277826|NCT02373124|12473708|FG000|NOT COMPLETED|Overall Study||1
11277827|NCT02373137|12473714|FG000|STARTED|Overall Study||19
11277828|NCT02373137|12473715|FG001|STARTED|Overall Study||19
11277829|NCT02373137|12473714|FG000|3-Month Follow-Up|Overall Study||19
11277830|NCT02373137|12473715|FG001|3-Month Follow-Up|Overall Study||19
11277831|NCT02373137|12473714|FG000|6-Month Follow-Up|Overall Study||19
11277832|NCT02373137|12473715|FG001|6-Month Follow-Up|Overall Study||18
11277833|NCT02373137|12473714|FG000|12-Month Follow-Up|Overall Study||19
11277834|NCT02373137|12473715|FG001|12-Month Follow-Up|Overall Study||19
11277835|NCT02373137|12473714|FG000|COMPLETED|Overall Study||18
11277836|NCT02373137|12473715|FG001|COMPLETED|Overall Study||18
11277837|NCT02373137|12473714|FG000|NOT COMPLETED|Overall Study||1
11277838|NCT02373137|12473715|FG001|NOT COMPLETED|Overall Study||1
11277839|NCT02373202|12473726|FG000|STARTED|Overall Study||15
11277840|NCT02373202|12473727|FG001|STARTED|Overall Study||15
11277841|NCT02373202|12473728|FG002|STARTED|Overall Study||30
11277842|NCT02373202|12473729|FG003|STARTED|Overall Study||31
11277843|NCT02373202|12473726|FG000|COMPLETED|Overall Study||13
11277844|NCT02373202|12473727|FG001|COMPLETED|Overall Study||9
11277845|NCT02373202|12473728|FG002|COMPLETED|Overall Study||27
11277846|NCT02373202|12473729|FG003|COMPLETED|Overall Study||30
11277847|NCT02373202|12473726|FG000|NOT COMPLETED|Overall Study||2
11277848|NCT02373202|12473727|FG001|NOT COMPLETED|Overall Study||6
11277849|NCT02373202|12473728|FG002|NOT COMPLETED|Overall Study||3
11277850|NCT02373202|12473729|FG003|NOT COMPLETED|Overall Study||1
11277851|NCT02373371|12473741|FG000|STARTED|Overall Study||13
11277852|NCT02373371|12473742|FG001|STARTED|Overall Study||13
11277853|NCT02373371|12473741|FG000|COMPLETED|Overall Study||13
11277854|NCT02373371|12473742|FG001|COMPLETED|Overall Study||13
11277855|NCT02373371|12473741|FG000|NOT COMPLETED|Overall Study||0
11277856|NCT02373371|12473742|FG001|NOT COMPLETED|Overall Study||0
11277857|NCT02373813|12473751|FG000|STARTED|Run-In Period||371
11277858|NCT02373813|12473752|FG001|STARTED|Run-In Period||0
11277859|NCT02373813|12473753|FG002|STARTED|Run-In Period||0
11277860|NCT02373813|12473754|FG003|STARTED|Run-In Period||0
11277861|NCT02373813|12473751|FG000|Treated|Run-In Period||368
11277862|NCT02373813|12473752|FG001|Treated|Run-In Period||0
11277863|NCT02373813|12473753|FG002|Treated|Run-In Period||0
11277864|NCT02373813|12473754|FG003|Treated|Run-In Period||0
11277865|NCT02373813|12473751|FG000|COMPLETED|Run-In Period|1 participant who completed the run-in period had no end of study case report form.|255
11277866|NCT02373813|12473752|FG001|COMPLETED|Run-In Period||0
11277867|NCT02373813|12473753|FG002|COMPLETED|Run-In Period||0
11277868|NCT02373813|12473754|FG003|COMPLETED|Run-In Period||0
11277869|NCT02373813|12473751|FG000|NOT COMPLETED|Run-In Period||116
11277870|NCT02373813|12473752|FG001|NOT COMPLETED|Run-In Period||0
11277871|NCT02373813|12473753|FG002|NOT COMPLETED|Run-In Period||0
11398635|NCT04429932|12592981|FG001|NOT COMPLETED|Overall Study||0
11277872|NCT02373813|12473754|FG003|NOT COMPLETED|Run-In Period||0
11277873|NCT02373813|12473751|FG000|STARTED|Double-Blind Treatment Period||0
11277874|NCT02373813|12473752|FG001|STARTED|Double-Blind Treatment Period||101
11277875|NCT02373813|12473753|FG002|STARTED|Double-Blind Treatment Period||101
11277876|NCT02373813|12473754|FG003|STARTED|Double-Blind Treatment Period||51
11277877|NCT02373813|12473751|FG000|Received Investigational Product (IP)|Double-Blind Treatment Period||0
11277878|NCT02373813|12473752|FG001|Received Investigational Product (IP)|Double-Blind Treatment Period||101
11277879|NCT02373813|12473753|FG002|Received Investigational Product (IP)|Double-Blind Treatment Period||100
11277880|NCT02373813|12473754|FG003|Received Investigational Product (IP)|Double-Blind Treatment Period||51
11398636|NCT04429932|12592982|FG002|NOT COMPLETED|Overall Study||0
11277881|NCT02373813|12473751|FG000|Received Rescue Treatment|Double-Blind Treatment Period||0
11277882|NCT02373813|12473752|FG001|Received Rescue Treatment|Double-Blind Treatment Period||52
11277883|NCT02373813|12473753|FG002|Received Rescue Treatment|Double-Blind Treatment Period||36
11277884|NCT02373813|12473754|FG003|Received Rescue Treatment|Double-Blind Treatment Period||15
11277885|NCT02373813|12473751|FG000|COMPLETED|Double-Blind Treatment Period||0
11277886|NCT02373813|12473752|FG001|COMPLETED|Double-Blind Treatment Period||88
11277887|NCT02373813|12473753|FG002|COMPLETED|Double-Blind Treatment Period||92
11277888|NCT02373813|12473754|FG003|COMPLETED|Double-Blind Treatment Period||47
11277889|NCT02373813|12473751|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
11277890|NCT02373813|12473752|FG001|NOT COMPLETED|Double-Blind Treatment Period||13
11277891|NCT02373813|12473753|FG002|NOT COMPLETED|Double-Blind Treatment Period||9
11277892|NCT02373813|12473754|FG003|NOT COMPLETED|Double-Blind Treatment Period||4
11340646|NCT02923349|12537968|FG006|COMPLETED|Overall Study||1
11340647|NCT02923349|12537962|FG000|NOT COMPLETED|Overall Study||4
11340648|NCT02923349|12537963|FG001|NOT COMPLETED|Overall Study||4
11340649|NCT02923349|12537964|FG002|NOT COMPLETED|Overall Study||17
11340650|NCT02923349|12537965|FG003|NOT COMPLETED|Overall Study||16
11340651|NCT02923349|12537966|FG004|NOT COMPLETED|Overall Study||19
11340652|NCT02923349|12537967|FG005|NOT COMPLETED|Overall Study||7
11340653|NCT02923349|12537968|FG006|NOT COMPLETED|Overall Study||3
11340654|NCT02923427|12537986|FG000|STARTED|Overall Study||55
11340655|NCT02923427|12537987|FG001|STARTED|Overall Study||57
11340656|NCT02923427|12537986|FG000|COMPLETED|Overall Study|"The reasons:~n= 2 Convert to Laparotomy n=1 Desaturation n=1 LMA-S can not be placed"|51
11340657|NCT02923427|12537987|FG001|COMPLETED|Overall Study|"The reasons:~n = 2 Convert to Laparotomy"|55
11340658|NCT02923427|12537986|FG000|NOT COMPLETED|Overall Study||4
11340659|NCT02923427|12537987|FG001|NOT COMPLETED|Overall Study||2
11340660|NCT02923895|12537995|FG000|STARTED|Overall Study||97
11340661|NCT02923895|12537996|FG001|STARTED|Overall Study||95
11340662|NCT02923895|12537995|FG000|COMPLETED|Overall Study||97
11340663|NCT02923895|12537996|FG001|COMPLETED|Overall Study||95
11340664|NCT02923895|12537995|FG000|NOT COMPLETED|Overall Study||0
11340665|NCT02923895|12537996|FG001|NOT COMPLETED|Overall Study||0
11340666|NCT02923921|12538004|FG000|STARTED|Overall Study||283
11340667|NCT02923921|12538005|FG001|STARTED|Overall Study||284
11340668|NCT02923921|12538004|FG000|Received at Least 1 Dose of Study Drug|Overall Study||278
11340669|NCT02923921|12538005|FG001|Received at Least 1 Dose of Study Drug|Overall Study||251
11340670|NCT02923921|12538004|FG000|Safety Population|Overall Study||278
11340671|NCT02923921|12538005|FG001|Safety Population|Overall Study||251
11340672|NCT02923921|12538004|FG000|COMPLETED|Overall Study||230
11340673|NCT02923921|12538005|FG001|COMPLETED|Overall Study||227
11340674|NCT02923921|12538004|FG000|NOT COMPLETED|Overall Study||53
11340675|NCT02923921|12538005|FG001|NOT COMPLETED|Overall Study||57
11340676|NCT02924051|12538013|FG000|STARTED|Overall Study||82
11340677|NCT02924051|12538014|FG001|STARTED|Overall Study||106
11340678|NCT02924051|12538013|FG000|COMPLETED|Overall Study||81
11340679|NCT02924051|12538014|FG001|COMPLETED|Overall Study||97
11340680|NCT02924051|12538013|FG000|NOT COMPLETED|Overall Study||1
11340681|NCT02924051|12538014|FG001|NOT COMPLETED|Overall Study||9
11340682|NCT02924350|12538024|FG000|STARTED|Overall Study||102
11340683|NCT02924350|12538025|FG001|STARTED|Overall Study||102
11340684|NCT02924350|12538024|FG000|COMPLETED|Overall Study||102
11340685|NCT02924350|12538025|FG001|COMPLETED|Overall Study||100
11340686|NCT02924350|12538024|FG000|NOT COMPLETED|Overall Study||0
11340687|NCT02924350|12538025|FG001|NOT COMPLETED|Overall Study||2
11340688|NCT02924428|12538033|FG000|STARTED|Overall Study||20
11340689|NCT02924428|12538034|FG001|STARTED|Overall Study||19
11340690|NCT02924428|12538033|FG000|COMPLETED|Overall Study||16
11277893|NCT02373852|12473765|FG000|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12
11277894|NCT02373852|12473765|FG000|COMPLETED|Overall Study||11
11277895|NCT02373852|12473765|FG000|NOT COMPLETED|Overall Study||1
11277896|NCT02374060|12473772|FG000|STARTED|Overall Study||65
11277897|NCT02374060|12473773|FG001|STARTED|Overall Study||63
11277898|NCT02374060|12473774|FG002|STARTED|Overall Study||64
11277899|NCT02374060|12473772|FG000|COMPLETED|Overall Study||63
11277900|NCT02374060|12473773|FG001|COMPLETED|Overall Study||62
11277901|NCT02374060|12473774|FG002|COMPLETED|Overall Study||61
11277902|NCT02374060|12473772|FG000|NOT COMPLETED|Overall Study||2
11277903|NCT02374060|12473773|FG001|NOT COMPLETED|Overall Study||1
11277904|NCT02374060|12473774|FG002|NOT COMPLETED|Overall Study||3
11277905|NCT02374099|12473784|FG000|STARTED|Overall Study||48
11277906|NCT02374099|12473785|FG001|STARTED|Overall Study||49
11277907|NCT02374099|12473784|FG000|Participants Treated|Overall Study|2 participants randomized, but not treated|46
11277908|NCT02374099|12473785|FG001|Participants Treated|Overall Study|1 participant randomized, but not treated|48
11277909|NCT02374099|12473784|FG000|COMPLETED|Overall Study||0
11277910|NCT02374099|12473785|FG001|COMPLETED|Overall Study||0
11277911|NCT02374099|12473784|FG000|NOT COMPLETED|Overall Study||48
11277912|NCT02374099|12473785|FG001|NOT COMPLETED|Overall Study||49
11277913|NCT02374138|12473793|FG000|STARTED|Six Month Follow Up||110
11277914|NCT02374138|12473794|FG001|STARTED|Six Month Follow Up||107
11277915|NCT02374138|12473793|FG000|COMPLETED|Six Month Follow Up|6 Month Follow Up|102
11277916|NCT02374138|12473794|FG001|COMPLETED|Six Month Follow Up|6 Month Follow Up|93
11277917|NCT02374138|12473793|FG000|NOT COMPLETED|Six Month Follow Up||8
11277918|NCT02374138|12473794|FG001|NOT COMPLETED|Six Month Follow Up||14
11277919|NCT02374138|12473793|FG000|STARTED|Twelve Month FollowUp||110
11277920|NCT02374138|12473794|FG001|STARTED|Twelve Month FollowUp||107
11277921|NCT02374138|12473793|FG000|COMPLETED|Twelve Month FollowUp||101
11277922|NCT02374138|12473794|FG001|COMPLETED|Twelve Month FollowUp||95
11277923|NCT02374138|12473793|FG000|NOT COMPLETED|Twelve Month FollowUp||9
11277924|NCT02374138|12473794|FG001|NOT COMPLETED|Twelve Month FollowUp||12
11277925|NCT02374164|12473804|FG000|STARTED|Treatment Period 1||12
11277926|NCT02374164|12473805|FG001|STARTED|Treatment Period 1||12
11277927|NCT02374164|12473806|FG002|STARTED|Treatment Period 1||12
11277928|NCT02374164|12473804|FG000|COMPLETED|Treatment Period 1||12
11277929|NCT02374164|12473805|FG001|COMPLETED|Treatment Period 1||12
11277930|NCT02374164|12473806|FG002|COMPLETED|Treatment Period 1||12
11277931|NCT02374164|12473804|FG000|NOT COMPLETED|Treatment Period 1||0
11277932|NCT02374164|12473805|FG001|NOT COMPLETED|Treatment Period 1||0
11277933|NCT02374164|12473806|FG002|NOT COMPLETED|Treatment Period 1||0
11277934|NCT02374164|12473804|FG000|STARTED|Treatment Period 2||12
11277935|NCT02374164|12473805|FG001|STARTED|Treatment Period 2||12
11277936|NCT02374164|12473806|FG002|STARTED|Treatment Period 2||12
11277937|NCT02374164|12473804|FG000|COMPLETED|Treatment Period 2||12
11277938|NCT02374164|12473805|FG001|COMPLETED|Treatment Period 2||12
11277939|NCT02374164|12473806|FG002|COMPLETED|Treatment Period 2||12
11277940|NCT02374164|12473804|FG000|NOT COMPLETED|Treatment Period 2||0
11277941|NCT02374164|12473805|FG001|NOT COMPLETED|Treatment Period 2||0
11277942|NCT02374164|12473806|FG002|NOT COMPLETED|Treatment Period 2||0
11277943|NCT02374164|12473804|FG000|STARTED|Treatment Period 3||12
11277944|NCT02374164|12473805|FG001|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
11277945|NCT02374164|12473806|FG002|STARTED|Treatment Period 3||12
11277946|NCT02374164|12473804|FG000|COMPLETED|Treatment Period 3||12
11277947|NCT02374164|12473805|FG001|COMPLETED|Treatment Period 3||11
11277948|NCT02374164|12473806|FG002|COMPLETED|Treatment Period 3||12
11277949|NCT02374164|12473804|FG000|NOT COMPLETED|Treatment Period 3||0
11277950|NCT02374164|12473805|FG001|NOT COMPLETED|Treatment Period 3||0
11277951|NCT02374164|12473806|FG002|NOT COMPLETED|Treatment Period 3||0
11277952|NCT02374255|12473818|FG000|STARTED|Overall Study||155
11277953|NCT02374255|12473819|FG001|STARTED|Overall Study||110
11277954|NCT02374255|12473820|FG002|STARTED|Overall Study||11
11277955|NCT02374255|12473821|FG003|STARTED|Overall Study||11
11277956|NCT02374255|12473818|FG000|COMPLETED|Overall Study||153
11277957|NCT02374255|12473819|FG001|COMPLETED|Overall Study||110
11277958|NCT02374255|12473820|FG002|COMPLETED|Overall Study||11
11277959|NCT02374255|12473821|FG003|COMPLETED|Overall Study||11
11277960|NCT02374255|12473818|FG000|NOT COMPLETED|Overall Study||2
11277961|NCT02374255|12473819|FG001|NOT COMPLETED|Overall Study||0
11277962|NCT02374255|12473820|FG002|NOT COMPLETED|Overall Study||0
11277963|NCT02374255|12473821|FG003|NOT COMPLETED|Overall Study||0
11277964|NCT02374307|12473839|FG000|STARTED|3-months Follow-up||77
11277965|NCT02374307|12473840|FG001|STARTED|3-months Follow-up||78
11277966|NCT02374307|12473839|FG000|COMPLETED|3-months Follow-up||69
11277967|NCT02374307|12473840|FG001|COMPLETED|3-months Follow-up||69
11277968|NCT02374307|12473839|FG000|NOT COMPLETED|3-months Follow-up||8
11277969|NCT02374307|12473840|FG001|NOT COMPLETED|3-months Follow-up||9
11340691|NCT02924428|12538034|FG001|COMPLETED|Overall Study||14
11398637|NCT04429932|12592983|FG003|NOT COMPLETED|Overall Study||3
11398638|NCT04429932|12592984|FG004|NOT COMPLETED|Overall Study||0
11398639|NCT04429932|12592985|FG005|NOT COMPLETED|Overall Study||0
11340692|NCT02924428|12538033|FG000|NOT COMPLETED|Overall Study||4
11277970|NCT02374307|12473839|FG000|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74
11277971|NCT02374307|12473840|FG001|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70
11277972|NCT02374307|12473839|FG000|COMPLETED|6-months Follow-up||71
11277973|NCT02374307|12473840|FG001|COMPLETED|6-months Follow-up||64
11277974|NCT02374307|12473839|FG000|NOT COMPLETED|6-months Follow-up||3
11277975|NCT02374307|12473840|FG001|NOT COMPLETED|6-months Follow-up||6
11277976|NCT02374346|12473846|FG000|STARTED|Overall Study||494
11277977|NCT02374346|12473846|FG000|COMPLETED|Overall Study||446
11398640|NCT04429932|12592986|FG006|NOT COMPLETED|Overall Study||0
11277978|NCT02374346|12473846|FG000|NOT COMPLETED|Overall Study||48
11277979|NCT02374398|12473856|FG000|STARTED|Overall Study||31
11277980|NCT02374398|12473857|FG001|STARTED|Overall Study||32
11277981|NCT02374398|12473858|FG002|STARTED|Overall Study||32
11277982|NCT02374398|12473859|FG003|STARTED|Overall Study||32
11277983|NCT02374398|12473856|FG000|COMPLETED|Overall Study||29
11277984|NCT02374398|12473857|FG001|COMPLETED|Overall Study||31
11277985|NCT02374398|12473858|FG002|COMPLETED|Overall Study||29
11277986|NCT02374398|12473859|FG003|COMPLETED|Overall Study||32
11277987|NCT02374398|12473856|FG000|NOT COMPLETED|Overall Study||2
11277988|NCT02374398|12473857|FG001|NOT COMPLETED|Overall Study||1
11277989|NCT02374398|12473858|FG002|NOT COMPLETED|Overall Study||3
11277990|NCT02374398|12473859|FG003|NOT COMPLETED|Overall Study||0
11277991|NCT02374463|12473872|FG000|STARTED|Overall Study||15
11277992|NCT02374463|12473873|FG001|STARTED|Overall Study||12
11277993|NCT02374463|12473872|FG000|COMPLETED|Overall Study||12
11277994|NCT02374463|12473873|FG001|COMPLETED|Overall Study||9
11277995|NCT02374463|12473872|FG000|NOT COMPLETED|Overall Study||3
11277996|NCT02374463|12473873|FG001|NOT COMPLETED|Overall Study||3
11277997|NCT02374593|12473882|FG000|STARTED|Overall Study||24
11277998|NCT02374593|12473883|FG001|STARTED|Overall Study||44
11277999|NCT02374593|12473882|FG000|COMPLETED|Overall Study||22
11278000|NCT02374593|12473883|FG001|COMPLETED|Overall Study||44
11278001|NCT02374593|12473882|FG000|NOT COMPLETED|Overall Study||2
11278002|NCT02374593|12473883|FG001|NOT COMPLETED|Overall Study||0
11278003|NCT02374671|12473896|FG000|STARTED|Observation (Deferred Implantation)||0
11278004|NCT02374671|12473897|FG001|STARTED|Observation (Deferred Implantation)||0
11278005|NCT02374671|12473898|FG002|STARTED|Observation (Deferred Implantation)||31
11278006|NCT02374671|12473896|FG000|COMPLETED|Observation (Deferred Implantation)||0
11278007|NCT02374671|12473897|FG001|COMPLETED|Observation (Deferred Implantation)||0
11278008|NCT02374671|12473898|FG002|COMPLETED|Observation (Deferred Implantation)||26
11278009|NCT02374671|12473896|FG000|NOT COMPLETED|Observation (Deferred Implantation)||0
11278010|NCT02374671|12473897|FG001|NOT COMPLETED|Observation (Deferred Implantation)||0
11278011|NCT02374671|12473898|FG002|NOT COMPLETED|Observation (Deferred Implantation)||5
11278012|NCT02374671|12473896|FG000|STARTED|Implantation- Nonrandomized & Randomized|(8) subjects were unilaterally implanted|306
11278013|NCT02374671|12473897|FG001|STARTED|Implantation- Nonrandomized & Randomized|(1) subject was unilaterally implanted|28
11278014|NCT02374671|12473898|FG002|STARTED|Implantation- Nonrandomized & Randomized|(3) subjects were unilaterally implanted|26
11278015|NCT02374671|12473896|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||281
11278016|NCT02374671|12473897|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||27
11278017|NCT02374671|12473898|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) unilaterally implanted subject discontinued (1 eye)|23
11278018|NCT02374671|12473896|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25
11278019|NCT02374671|12473897|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
11278020|NCT02374671|12473898|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3
11278021|NCT02374918|12473908|FG000|STARTED|Overall Study||17
11278022|NCT02374918|12473909|FG001|STARTED|Overall Study||18
11278023|NCT02374918|12473910|FG002|STARTED|Overall Study||22
11278024|NCT02374918|12473911|FG003|STARTED|Overall Study||20
11278025|NCT02374918|12473908|FG000|COMPLETED|Overall Study||14
11278026|NCT02374918|12473909|FG001|COMPLETED|Overall Study||17
11278027|NCT02374918|12473910|FG002|COMPLETED|Overall Study||18
11278028|NCT02374918|12473911|FG003|COMPLETED|Overall Study||18
11278029|NCT02374918|12473908|FG000|NOT COMPLETED|Overall Study||3
11278030|NCT02374918|12473909|FG001|NOT COMPLETED|Overall Study||1
11278031|NCT02374918|12473910|FG002|NOT COMPLETED|Overall Study||4
11278032|NCT02374918|12473911|FG003|NOT COMPLETED|Overall Study||2
11278033|NCT02374957|12473921|FG000|STARTED|Overall Study||11
11278034|NCT02374957|12473922|FG001|STARTED|Overall Study||9
11278035|NCT02374957|12473921|FG000|COMPLETED|Overall Study||10
11278036|NCT02374957|12473922|FG001|COMPLETED|Overall Study||9
11278037|NCT02374957|12473921|FG000|NOT COMPLETED|Overall Study||1
11278038|NCT02374957|12473922|FG001|NOT COMPLETED|Overall Study||0
11278039|NCT02375347|12473928|FG000|STARTED|Overall Study||13
11278040|NCT02375347|12473928|FG000|COMPLETED|Overall Study||12
11278041|NCT02375347|12473928|FG000|NOT COMPLETED|Overall Study||1
11278042|NCT02375373|12473932|FG000|STARTED|Overall Study||12
11278043|NCT02375373|12473932|FG000|COMPLETED|Overall Study||1
11278044|NCT02375373|12473932|FG000|NOT COMPLETED|Overall Study||11
11278045|NCT02375698|12473938|FG000|STARTED|Overall Study||16
11278046|NCT02375698|12473939|FG001|STARTED|Overall Study||6
11278047|NCT02375698|12473938|FG000|COMPLETED|Overall Study||14
11278048|NCT02375698|12473939|FG001|COMPLETED|Overall Study||4
11278049|NCT02375698|12473938|FG000|NOT COMPLETED|Overall Study||2
11278050|NCT02375698|12473939|FG001|NOT COMPLETED|Overall Study||2
11278051|NCT02375724|12473947|FG000|STARTED|Overall Study||135
11278052|NCT02375724|12473948|FG001|STARTED|Overall Study||134
11278053|NCT02375724|12473947|FG000|COMPLETED|Overall Study||129
11278054|NCT02375724|12473948|FG001|COMPLETED|Overall Study||128
11278055|NCT02375724|12473947|FG000|NOT COMPLETED|Overall Study||6
11278056|NCT02375724|12473948|FG001|NOT COMPLETED|Overall Study||6
11278057|NCT02375971|12473957|FG000|STARTED|Treatment (Day 1 - Baseline)||74
11278058|NCT02375971|12473958|FG001|STARTED|Treatment (Day 1 - Baseline)||77
11278059|NCT02375971|12473959|FG002|STARTED|Treatment (Day 1 - Baseline)||74
11278060|NCT02375971|12473957|FG000|Safety Set|Treatment (Day 1 - Baseline)||73
11278061|NCT02375971|12473958|FG001|Safety Set|Treatment (Day 1 - Baseline)||76
11278062|NCT02375971|12473959|FG002|Safety Set|Treatment (Day 1 - Baseline)||69
11278063|NCT02375971|12473957|FG000|VEGF Set|Treatment (Day 1 - Baseline)||19
11278064|NCT02375971|12473958|FG001|VEGF Set|Treatment (Day 1 - Baseline)||26
11278065|NCT02375971|12473959|FG002|VEGF Set|Treatment (Day 1 - Baseline)||51
11278066|NCT02375971|12473957|FG000|PK Set|Treatment (Day 1 - Baseline)||49
11278067|NCT02375971|12473958|FG001|PK Set|Treatment (Day 1 - Baseline)||46
11278068|NCT02375971|12473959|FG002|PK Set|Treatment (Day 1 - Baseline)||0
11278069|NCT02375971|12473957|FG000|COMPLETED|Treatment (Day 1 - Baseline)||73
11278070|NCT02375971|12473958|FG001|COMPLETED|Treatment (Day 1 - Baseline)||76
11278071|NCT02375971|12473959|FG002|COMPLETED|Treatment (Day 1 - Baseline)||69
11278072|NCT02375971|12473957|FG000|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
11278073|NCT02375971|12473958|FG001|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
11278074|NCT02375971|12473959|FG002|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
11278075|NCT02375971|12473957|FG000|STARTED|Follow-Up Phase (up to Day 169)||73
11278076|NCT02375971|12473958|FG001|STARTED|Follow-Up Phase (up to Day 169)||76
11278077|NCT02375971|12473959|FG002|STARTED|Follow-Up Phase (up to Day 169)||69
11278078|NCT02375971|12473957|FG000|COMPLETED|Follow-Up Phase (up to Day 169)||66
11278079|NCT02375971|12473958|FG001|COMPLETED|Follow-Up Phase (up to Day 169)||71
11278080|NCT02375971|12473959|FG002|COMPLETED|Follow-Up Phase (up to Day 169)||64
11278081|NCT02375971|12473957|FG000|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
11278082|NCT02375971|12473958|FG001|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
11278083|NCT02375971|12473959|FG002|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
11278084|NCT02375984|12473967|FG000|STARTED|Overall Study||1
11278085|NCT02375984|12473967|FG000|COMPLETED|Overall Study||1
11278086|NCT02375984|12473967|FG000|NOT COMPLETED|Overall Study||0
11398641|NCT04429932|12592987|FG007|NOT COMPLETED|Overall Study||0
11398642|NCT04428502|12593006|FG000|STARTED|Overall Study||127
11398643|NCT04428502|12593006|FG000|COMPLETED|Overall Study||113
11398644|NCT04428502|12593006|FG000|NOT COMPLETED|Overall Study||14
11278087|NCT02376010|12473973|FG000|STARTED|Overall Study||55
11278088|NCT02376010|12473974|FG001|STARTED|Overall Study||55
11278089|NCT02376010|12473973|FG000|COMPLETED|Overall Study||46
11278090|NCT02376010|12473974|FG001|COMPLETED|Overall Study||51
11278091|NCT02376010|12473973|FG000|NOT COMPLETED|Overall Study||9
11278092|NCT02376010|12473974|FG001|NOT COMPLETED|Overall Study||4
11278093|NCT02376166|12473980|FG000|STARTED|Overall Study||15
11278094|NCT02376166|12473980|FG000|COMPLETED|Overall Study||12
11278095|NCT02376166|12473980|FG000|NOT COMPLETED|Overall Study||3
11278096|NCT02376179|12473984|FG000|STARTED|Overall Study||84
11278097|NCT02376179|12473984|FG000|COMPLETED|Overall Study||84
11278098|NCT02376179|12473984|FG000|NOT COMPLETED|Overall Study||0
11278099|NCT02376257|12473991|FG000|STARTED|Overall Study||13
11278100|NCT02376257|12473992|FG001|STARTED|Overall Study||12
11278101|NCT02376257|12473993|FG002|STARTED|Overall Study||11
11278102|NCT02376257|12473991|FG000|COMPLETED|Overall Study||13
11278103|NCT02376257|12473992|FG001|COMPLETED|Overall Study||12
11278104|NCT02376257|12473993|FG002|COMPLETED|Overall Study||11
11278105|NCT02376257|12473991|FG000|NOT COMPLETED|Overall Study||0
11278106|NCT02376257|12473992|FG001|NOT COMPLETED|Overall Study||0
11278107|NCT02376257|12473993|FG002|NOT COMPLETED|Overall Study||0
11278108|NCT02376283|12474004|FG000|STARTED|Overall Study||27
11278109|NCT02376283|12474005|FG001|STARTED|Overall Study||30
11278110|NCT02376283|12474006|FG002|STARTED|Overall Study||30
11278111|NCT02376283|12474004|FG000|COMPLETED|Overall Study||27
11278112|NCT02376283|12474005|FG001|COMPLETED|Overall Study||30
11278113|NCT02376283|12474006|FG002|COMPLETED|Overall Study||30
11278114|NCT02376283|12474004|FG000|NOT COMPLETED|Overall Study||0
11278115|NCT02376283|12474005|FG001|NOT COMPLETED|Overall Study||0
11278116|NCT02376283|12474006|FG002|NOT COMPLETED|Overall Study||0
11278117|NCT02376361|12474017|FG000|STARTED|Overall Study||229
11278118|NCT02376361|12474018|FG001|STARTED|Overall Study||207
11278119|NCT02376361|12474017|FG000|COMPLETED|Overall Study||58
11278120|NCT02376361|12474018|FG001|COMPLETED|Overall Study||90
11278121|NCT02376361|12474017|FG000|NOT COMPLETED|Overall Study||171
11278122|NCT02376361|12474018|FG001|NOT COMPLETED|Overall Study||117
11278123|NCT02376530|12474028|FG000|STARTED|Overall Study||196
11278124|NCT02376530|12474029|FG001|STARTED|Overall Study||198
11278125|NCT02376530|12474030|FG002|STARTED|Overall Study||197
11278126|NCT02376530|12474031|FG003|STARTED|Overall Study||197
11278127|NCT02376530|12474028|FG000|COMPLETED|Overall Study||196
11278128|NCT02376530|12474029|FG001|COMPLETED|Overall Study||198
11278129|NCT02376530|12474030|FG002|COMPLETED|Overall Study||197
11278130|NCT02376530|12474031|FG003|COMPLETED|Overall Study||197
11278131|NCT02376530|12474028|FG000|NOT COMPLETED|Overall Study||0
11278132|NCT02376530|12474029|FG001|NOT COMPLETED|Overall Study||0
11278133|NCT02376530|12474030|FG002|NOT COMPLETED|Overall Study||0
11278134|NCT02376530|12474031|FG003|NOT COMPLETED|Overall Study||0
11278135|NCT02376998|12474041|FG000|STARTED|Overall Study||20
11278136|NCT02376998|12474041|FG000|COMPLETED|Overall Study||11
11398645|NCT04428424|12593011|FG000|STARTED|Overall Study||1493
11278137|NCT02376998|12474041|FG000|NOT COMPLETED|Overall Study||9
11278138|NCT02377063|12474045|FG000|STARTED|Overall Study||25
11278139|NCT02377063|12474045|FG000|COMPLETED|Overall Study||20
11278140|NCT02377063|12474045|FG000|NOT COMPLETED|Overall Study||5
11278141|NCT02377349|12474051|FG000|STARTED|Overall Study||341
11278142|NCT02377349|12474052|FG001|STARTED|Overall Study||346
11278143|NCT02377349|12474051|FG000|COMPLETED|Overall Study||325
11278144|NCT02377349|12474052|FG001|COMPLETED|Overall Study||335
11278145|NCT02377349|12474051|FG000|NOT COMPLETED|Overall Study||16
11278146|NCT02377349|12474052|FG001|NOT COMPLETED|Overall Study||11
11278147|NCT02377362|12474080|FG000|STARTED|Part A First Treatment||4
11278148|NCT02377362|12474081|FG001|STARTED|Part A First Treatment||4
11278149|NCT02377362|12474082|FG002|STARTED|Part A First Treatment||4
11278150|NCT02377362|12474083|FG003|STARTED|Part A First Treatment||4
11278151|NCT02377362|12474084|FG004|STARTED|Part A First Treatment||4
11278152|NCT02377362|12474085|FG005|STARTED|Part A First Treatment||4
11278153|NCT02377362|12474086|FG006|STARTED|Part A First Treatment||0
11278154|NCT02377362|12474087|FG007|STARTED|Part A First Treatment||0
11278155|NCT02377362|12474088|FG008|STARTED|Part A First Treatment||0
11278156|NCT02377362|12474089|FG009|STARTED|Part A First Treatment||0
11278157|NCT02377362|12474090|FG010|STARTED|Part A First Treatment||0
11278158|NCT02377362|12474091|FG011|STARTED|Part A First Treatment||0
11278159|NCT02377362|12474092|FG012|STARTED|Part A First Treatment||0
11278160|NCT02377362|12474080|FG000|COMPLETED|Part A First Treatment||4
11278161|NCT02377362|12474081|FG001|COMPLETED|Part A First Treatment||4
11278162|NCT02377362|12474082|FG002|COMPLETED|Part A First Treatment||4
11278163|NCT02377362|12474083|FG003|COMPLETED|Part A First Treatment||4
11278164|NCT02377362|12474084|FG004|COMPLETED|Part A First Treatment||4
11278165|NCT02377362|12474085|FG005|COMPLETED|Part A First Treatment||4
11278166|NCT02377362|12474086|FG006|COMPLETED|Part A First Treatment||0
11278167|NCT02377362|12474087|FG007|COMPLETED|Part A First Treatment||0
11278168|NCT02377362|12474088|FG008|COMPLETED|Part A First Treatment||0
11278169|NCT02377362|12474089|FG009|COMPLETED|Part A First Treatment||0
11278170|NCT02377362|12474090|FG010|COMPLETED|Part A First Treatment||0
11278171|NCT02377362|12474091|FG011|COMPLETED|Part A First Treatment||0
11278172|NCT02377362|12474092|FG012|COMPLETED|Part A First Treatment||0
11278173|NCT02377362|12474080|FG000|NOT COMPLETED|Part A First Treatment||0
11278174|NCT02377362|12474081|FG001|NOT COMPLETED|Part A First Treatment||0
11278175|NCT02377362|12474082|FG002|NOT COMPLETED|Part A First Treatment||0
11278176|NCT02377362|12474083|FG003|NOT COMPLETED|Part A First Treatment||0
11278177|NCT02377362|12474084|FG004|NOT COMPLETED|Part A First Treatment||0
11278178|NCT02377362|12474085|FG005|NOT COMPLETED|Part A First Treatment||0
11278179|NCT02377362|12474086|FG006|NOT COMPLETED|Part A First Treatment||0
11278180|NCT02377362|12474087|FG007|NOT COMPLETED|Part A First Treatment||0
11278181|NCT02377362|12474088|FG008|NOT COMPLETED|Part A First Treatment||0
11278182|NCT02377362|12474089|FG009|NOT COMPLETED|Part A First Treatment||0
11278183|NCT02377362|12474090|FG010|NOT COMPLETED|Part A First Treatment||0
11278184|NCT02377362|12474091|FG011|NOT COMPLETED|Part A First Treatment||0
11278185|NCT02377362|12474092|FG012|NOT COMPLETED|Part A First Treatment||0
11278186|NCT02377362|12474080|FG000|STARTED|Part A Second Treatment||4
11278187|NCT02377362|12474081|FG001|STARTED|Part A Second Treatment||4
11278188|NCT02377362|12474082|FG002|STARTED|Part A Second Treatment||4
11278189|NCT02377362|12474083|FG003|STARTED|Part A Second Treatment||4
11278190|NCT02377362|12474084|FG004|STARTED|Part A Second Treatment||4
11278191|NCT02377362|12474085|FG005|STARTED|Part A Second Treatment||4
11278192|NCT02377362|12474086|FG006|STARTED|Part A Second Treatment||0
11278193|NCT02377362|12474087|FG007|STARTED|Part A Second Treatment||0
11278194|NCT02377362|12474088|FG008|STARTED|Part A Second Treatment||0
11278195|NCT02377362|12474089|FG009|STARTED|Part A Second Treatment||0
11278196|NCT02377362|12474090|FG010|STARTED|Part A Second Treatment||0
11278197|NCT02377362|12474091|FG011|STARTED|Part A Second Treatment||0
11278198|NCT02377362|12474092|FG012|STARTED|Part A Second Treatment||0
11278199|NCT02377362|12474080|FG000|COMPLETED|Part A Second Treatment||4
11278200|NCT02377362|12474081|FG001|COMPLETED|Part A Second Treatment||4
11278201|NCT02377362|12474082|FG002|COMPLETED|Part A Second Treatment||4
11278202|NCT02377362|12474083|FG003|COMPLETED|Part A Second Treatment||4
11278203|NCT02377362|12474084|FG004|COMPLETED|Part A Second Treatment||3
11278204|NCT02377362|12474085|FG005|COMPLETED|Part A Second Treatment||4
11278205|NCT02377362|12474086|FG006|COMPLETED|Part A Second Treatment||0
11278206|NCT02377362|12474087|FG007|COMPLETED|Part A Second Treatment||0
11278207|NCT02377362|12474088|FG008|COMPLETED|Part A Second Treatment||0
11278208|NCT02377362|12474089|FG009|COMPLETED|Part A Second Treatment||0
11278209|NCT02377362|12474090|FG010|COMPLETED|Part A Second Treatment||0
11278210|NCT02377362|12474091|FG011|COMPLETED|Part A Second Treatment||0
11278211|NCT02377362|12474092|FG012|COMPLETED|Part A Second Treatment||0
11278212|NCT02377362|12474080|FG000|NOT COMPLETED|Part A Second Treatment||0
11278213|NCT02377362|12474081|FG001|NOT COMPLETED|Part A Second Treatment||0
11278214|NCT02377362|12474082|FG002|NOT COMPLETED|Part A Second Treatment||0
11278215|NCT02377362|12474083|FG003|NOT COMPLETED|Part A Second Treatment||0
11278216|NCT02377362|12474084|FG004|NOT COMPLETED|Part A Second Treatment||1
11278217|NCT02377362|12474085|FG005|NOT COMPLETED|Part A Second Treatment||0
11278218|NCT02377362|12474086|FG006|NOT COMPLETED|Part A Second Treatment||0
11278219|NCT02377362|12474087|FG007|NOT COMPLETED|Part A Second Treatment||0
11278220|NCT02377362|12474088|FG008|NOT COMPLETED|Part A Second Treatment||0
11278221|NCT02377362|12474089|FG009|NOT COMPLETED|Part A Second Treatment||0
11278222|NCT02377362|12474090|FG010|NOT COMPLETED|Part A Second Treatment||0
11278223|NCT02377362|12474091|FG011|NOT COMPLETED|Part A Second Treatment||0
11278224|NCT02377362|12474092|FG012|NOT COMPLETED|Part A Second Treatment||0
11278225|NCT02377362|12474080|FG000|STARTED|Part A Third Treatment||4
11278226|NCT02377362|12474081|FG001|STARTED|Part A Third Treatment||4
11278227|NCT02377362|12474082|FG002|STARTED|Part A Third Treatment||4
11278228|NCT02377362|12474083|FG003|STARTED|Part A Third Treatment||4
11278229|NCT02377362|12474084|FG004|STARTED|Part A Third Treatment||3
11278230|NCT02377362|12474085|FG005|STARTED|Part A Third Treatment||4
11278231|NCT02377362|12474086|FG006|STARTED|Part A Third Treatment||0
11278232|NCT02377362|12474087|FG007|STARTED|Part A Third Treatment||0
11278233|NCT02377362|12474088|FG008|STARTED|Part A Third Treatment||0
11278234|NCT02377362|12474089|FG009|STARTED|Part A Third Treatment||0
11278235|NCT02377362|12474090|FG010|STARTED|Part A Third Treatment||0
11278236|NCT02377362|12474091|FG011|STARTED|Part A Third Treatment||0
11278237|NCT02377362|12474092|FG012|STARTED|Part A Third Treatment||0
11278238|NCT02377362|12474080|FG000|COMPLETED|Part A Third Treatment||4
11278239|NCT02377362|12474081|FG001|COMPLETED|Part A Third Treatment||4
11278240|NCT02377362|12474082|FG002|COMPLETED|Part A Third Treatment||4
11278241|NCT02377362|12474083|FG003|COMPLETED|Part A Third Treatment||0
11278242|NCT02377362|12474084|FG004|COMPLETED|Part A Third Treatment||0
11278243|NCT02377362|12474085|FG005|COMPLETED|Part A Third Treatment||0
11278244|NCT02377362|12474086|FG006|COMPLETED|Part A Third Treatment||0
11278245|NCT02377362|12474087|FG007|COMPLETED|Part A Third Treatment||0
11278246|NCT02377362|12474088|FG008|COMPLETED|Part A Third Treatment||0
11278247|NCT02377362|12474089|FG009|COMPLETED|Part A Third Treatment||0
11278248|NCT02377362|12474090|FG010|COMPLETED|Part A Third Treatment||0
11278249|NCT02377362|12474091|FG011|COMPLETED|Part A Third Treatment||0
11278250|NCT02377362|12474092|FG012|COMPLETED|Part A Third Treatment||0
11278251|NCT02377362|12474080|FG000|NOT COMPLETED|Part A Third Treatment||0
11278252|NCT02377362|12474081|FG001|NOT COMPLETED|Part A Third Treatment||0
11278253|NCT02377362|12474082|FG002|NOT COMPLETED|Part A Third Treatment||0
11278254|NCT02377362|12474083|FG003|NOT COMPLETED|Part A Third Treatment||4
11278255|NCT02377362|12474084|FG004|NOT COMPLETED|Part A Third Treatment||3
11278256|NCT02377362|12474085|FG005|NOT COMPLETED|Part A Third Treatment||4
11278257|NCT02377362|12474086|FG006|NOT COMPLETED|Part A Third Treatment||0
11278258|NCT02377362|12474087|FG007|NOT COMPLETED|Part A Third Treatment||0
11278259|NCT02377362|12474088|FG008|NOT COMPLETED|Part A Third Treatment||0
11278260|NCT02377362|12474089|FG009|NOT COMPLETED|Part A Third Treatment||0
11278261|NCT02377362|12474090|FG010|NOT COMPLETED|Part A Third Treatment||0
11278262|NCT02377362|12474091|FG011|NOT COMPLETED|Part A Third Treatment||0
11278263|NCT02377362|12474092|FG012|NOT COMPLETED|Part A Third Treatment||0
11278264|NCT02377362|12474080|FG000|STARTED|Part B Overall||0
11278265|NCT02377362|12474081|FG001|STARTED|Part B Overall||0
11278266|NCT02377362|12474082|FG002|STARTED|Part B Overall||0
11278267|NCT02377362|12474083|FG003|STARTED|Part B Overall||0
11278268|NCT02377362|12474084|FG004|STARTED|Part B Overall||0
11278269|NCT02377362|12474085|FG005|STARTED|Part B Overall||0
11278270|NCT02377362|12474086|FG006|STARTED|Part B Overall||6
11278271|NCT02377362|12474087|FG007|STARTED|Part B Overall||6
11278272|NCT02377362|12474088|FG008|STARTED|Part B Overall||6
11278273|NCT02377362|12474089|FG009|STARTED|Part B Overall||7
11278274|NCT02377362|12474090|FG010|STARTED|Part B Overall||6
11278275|NCT02377362|12474091|FG011|STARTED|Part B Overall||7
11278276|NCT02377362|12474092|FG012|STARTED|Part B Overall||12
11278277|NCT02377362|12474080|FG000|COMPLETED|Part B Overall||0
11278278|NCT02377362|12474081|FG001|COMPLETED|Part B Overall||0
11278279|NCT02377362|12474082|FG002|COMPLETED|Part B Overall||0
11278280|NCT02377362|12474083|FG003|COMPLETED|Part B Overall||0
11278281|NCT02377362|12474084|FG004|COMPLETED|Part B Overall||0
11278282|NCT02377362|12474085|FG005|COMPLETED|Part B Overall||0
11278283|NCT02377362|12474086|FG006|COMPLETED|Part B Overall||4
11278284|NCT02377362|12474087|FG007|COMPLETED|Part B Overall||5
11398646|NCT04428424|12593011|FG000|COMPLETED|Overall Study||1246
11398647|NCT04428424|12593011|FG000|NOT COMPLETED|Overall Study||247
11398648|NCT04428359|12593017|FG000|STARTED|Overall Study||33
11398649|NCT04428359|12593018|FG001|STARTED|Overall Study||33
11278285|NCT02377362|12474088|FG008|COMPLETED|Part B Overall||6
11278286|NCT02377362|12474089|FG009|COMPLETED|Part B Overall||6
11278287|NCT02377362|12474090|FG010|COMPLETED|Part B Overall||6
11278288|NCT02377362|12474091|FG011|COMPLETED|Part B Overall||6
11278289|NCT02377362|12474092|FG012|COMPLETED|Part B Overall||12
11278290|NCT02377362|12474080|FG000|NOT COMPLETED|Part B Overall||0
11278291|NCT02377362|12474081|FG001|NOT COMPLETED|Part B Overall||0
11278292|NCT02377362|12474082|FG002|NOT COMPLETED|Part B Overall||0
11278293|NCT02377362|12474083|FG003|NOT COMPLETED|Part B Overall||0
11278294|NCT02377362|12474084|FG004|NOT COMPLETED|Part B Overall||0
11398650|NCT04428359|12593017|FG000|COMPLETED|Overall Study||31
11278295|NCT02377362|12474085|FG005|NOT COMPLETED|Part B Overall||0
11278296|NCT02377362|12474086|FG006|NOT COMPLETED|Part B Overall||2
11278297|NCT02377362|12474087|FG007|NOT COMPLETED|Part B Overall||1
11278298|NCT02377362|12474088|FG008|NOT COMPLETED|Part B Overall||0
11278299|NCT02377362|12474089|FG009|NOT COMPLETED|Part B Overall||1
11278300|NCT02377362|12474090|FG010|NOT COMPLETED|Part B Overall||0
11278301|NCT02377362|12474091|FG011|NOT COMPLETED|Part B Overall||1
11278302|NCT02377362|12474092|FG012|NOT COMPLETED|Part B Overall||0
11278303|NCT02377427|12474132|FG000|STARTED|Part A (Up to Week 20)||26
11278304|NCT02377427|12474133|FG001|STARTED|Part A (Up to Week 20)||10
11278305|NCT02377427|12474134|FG002|STARTED|Part A (Up to Week 20)||0
11278306|NCT02377427|12474135|FG003|STARTED|Part A (Up to Week 20)||0
11398651|NCT04428359|12593018|FG001|COMPLETED|Overall Study||30
11278307|NCT02377427|12474136|FG004|STARTED|Part A (Up to Week 20)||0
11278308|NCT02377427|12474132|FG000|COMPLETED|Part A (Up to Week 20)||22
11278309|NCT02377427|12474133|FG001|COMPLETED|Part A (Up to Week 20)||10
11278310|NCT02377427|12474134|FG002|COMPLETED|Part A (Up to Week 20)||0
11278311|NCT02377427|12474135|FG003|COMPLETED|Part A (Up to Week 20)||0
11278312|NCT02377427|12474136|FG004|COMPLETED|Part A (Up to Week 20)||0
11278313|NCT02377427|12474132|FG000|NOT COMPLETED|Part A (Up to Week 20)||4
11278314|NCT02377427|12474133|FG001|NOT COMPLETED|Part A (Up to Week 20)||0
11278315|NCT02377427|12474134|FG002|NOT COMPLETED|Part A (Up to Week 20)||0
11278316|NCT02377427|12474135|FG003|NOT COMPLETED|Part A (Up to Week 20)||0
11278317|NCT02377427|12474136|FG004|NOT COMPLETED|Part A (Up to Week 20)||0
11278318|NCT02377427|12474132|FG000|STARTED|Part B (From Week 20 and up to Week 80)||0
11278319|NCT02377427|12474133|FG001|STARTED|Part B (From Week 20 and up to Week 80)||0
11278320|NCT02377427|12474134|FG002|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
11278321|NCT02377427|12474135|FG003|STARTED|Part B (From Week 20 and up to Week 80)||10
11278322|NCT02377427|12474136|FG004|STARTED|Part B (From Week 20 and up to Week 80)||4
11278323|NCT02377427|12474132|FG000|COMPLETED|Part B (From Week 20 and up to Week 80)||0
11278324|NCT02377427|12474133|FG001|COMPLETED|Part B (From Week 20 and up to Week 80)||0
11278325|NCT02377427|12474134|FG002|COMPLETED|Part B (From Week 20 and up to Week 80)||15
11278326|NCT02377427|12474135|FG003|COMPLETED|Part B (From Week 20 and up to Week 80)||10
11278327|NCT02377427|12474136|FG004|COMPLETED|Part B (From Week 20 and up to Week 80)||4
11278328|NCT02377427|12474132|FG000|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
11278329|NCT02377427|12474133|FG001|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
11278330|NCT02377427|12474134|FG002|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
11278331|NCT02377427|12474135|FG003|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
11278332|NCT02377427|12474136|FG004|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
11278333|NCT02377466|12474151|FG000|STARTED|Overall Study||13
11278334|NCT02377466|12474152|FG001|STARTED|Overall Study||12
11278335|NCT02377466|12474151|FG000|Treated|Overall Study||13
11278336|NCT02377466|12474152|FG001|Treated|Overall Study||10
11278337|NCT02377466|12474151|FG000|COMPLETED|Overall Study||13
11278338|NCT02377466|12474152|FG001|COMPLETED|Overall Study||10
11278339|NCT02377466|12474151|FG000|NOT COMPLETED|Overall Study||0
11278340|NCT02377466|12474152|FG001|NOT COMPLETED|Overall Study||2
11278341|NCT02377674|12474165|FG000|STARTED|Overall Study||5
11278342|NCT02377674|12474165|FG000|COMPLETED|Overall Study||5
11278343|NCT02377674|12474165|FG000|NOT COMPLETED|Overall Study||0
11278344|NCT02377700|12474169|FG000|STARTED|Overall Study||5
11278345|NCT02377700|12474169|FG000|COMPLETED|Overall Study||5
11278346|NCT02377700|12474169|FG000|NOT COMPLETED|Overall Study||0
11278347|NCT02377752|12474177|FG000|STARTED|Overall Study||7
11278348|NCT02377752|12474178|FG001|STARTED|Overall Study||6
11278349|NCT02377752|12474179|FG002|STARTED|Overall Study||6
11278350|NCT02377752|12474180|FG003|STARTED|Overall Study||6
11278351|NCT02377752|12474177|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
11278352|NCT02377752|12474178|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
11278353|NCT02377752|12474179|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11278354|NCT02377752|12474180|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
11278355|NCT02377752|12474177|FG000|COMPLETED|Overall Study||7
11278356|NCT02377752|12474178|FG001|COMPLETED|Overall Study||6
11278357|NCT02377752|12474179|FG002|COMPLETED|Overall Study||6
11278358|NCT02377752|12474180|FG003|COMPLETED|Overall Study||6
11278359|NCT02377752|12474177|FG000|NOT COMPLETED|Overall Study||0
11278360|NCT02377752|12474178|FG001|NOT COMPLETED|Overall Study||0
11278361|NCT02377752|12474179|FG002|NOT COMPLETED|Overall Study||0
11278362|NCT02377752|12474180|FG003|NOT COMPLETED|Overall Study||0
11278363|NCT02377817|12474195|FG000|STARTED|Overall Study||13
11278364|NCT02377817|12474196|FG001|STARTED|Overall Study||10
11278365|NCT02377817|12474195|FG000|COMPLETED|Overall Study||10
11278366|NCT02377817|12474196|FG001|COMPLETED|Overall Study||10
11278367|NCT02377817|12474195|FG000|NOT COMPLETED|Overall Study||3
11278368|NCT02377817|12474196|FG001|NOT COMPLETED|Overall Study||0
11278369|NCT02377921|12474206|FG000|STARTED|Overall Study||45
11278370|NCT02377921|12474207|FG001|STARTED|Overall Study||44
11278371|NCT02377921|12474206|FG000|COMPLETED|Overall Study||44
11278372|NCT02377921|12474207|FG001|COMPLETED|Overall Study||43
11278373|NCT02377921|12474206|FG000|NOT COMPLETED|Overall Study||1
11278374|NCT02377921|12474207|FG001|NOT COMPLETED|Overall Study||1
11278375|NCT02377947|12474213|FG000|STARTED|Overall Study||50
11278376|NCT02377947|12474213|FG000|COMPLETED|Overall Study||50
11278377|NCT02377947|12474213|FG000|NOT COMPLETED|Overall Study||0
11278378|NCT02377986|12474217|FG000|STARTED|Overall Study||5
11278379|NCT02377986|12474217|FG000|COMPLETED|Overall Study||5
11278380|NCT02377986|12474217|FG000|NOT COMPLETED|Overall Study||0
11278381|NCT02378025|12474223|FG000|STARTED|Overall Study||39
11278382|NCT02378025|12474224|FG001|STARTED|Overall Study||36
11278383|NCT02378025|12474223|FG000|COMPLETED|Overall Study||26
11278384|NCT02378025|12474224|FG001|COMPLETED|Overall Study||15
11278385|NCT02378025|12474223|FG000|NOT COMPLETED|Overall Study||13
11278386|NCT02378025|12474224|FG001|NOT COMPLETED|Overall Study||21
11278387|NCT02378038|12474230|FG000|STARTED|Overall Study||5
11278388|NCT02378038|12474230|FG000|COMPLETED|Overall Study||0
11278389|NCT02378038|12474230|FG000|NOT COMPLETED|Overall Study||5
11278390|NCT02378207|12474238|FG000|STARTED|Overall Study||24
11278391|NCT02378207|12474239|FG001|STARTED|Overall Study||24
11278392|NCT02378207|12474240|FG002|STARTED|Overall Study||24
11278393|NCT02378207|12474241|FG003|STARTED|Overall Study||12
11278394|NCT02378207|12474238|FG000|COMPLETED|Overall Study||24
11278395|NCT02378207|12474239|FG001|COMPLETED|Overall Study||21
11278396|NCT02378207|12474240|FG002|COMPLETED|Overall Study||22
11278397|NCT02378207|12474241|FG003|COMPLETED|Overall Study||11
11278398|NCT02378207|12474238|FG000|NOT COMPLETED|Overall Study||0
11278399|NCT02378207|12474239|FG001|NOT COMPLETED|Overall Study||3
11278400|NCT02378207|12474240|FG002|NOT COMPLETED|Overall Study||2
11278401|NCT02378207|12474241|FG003|NOT COMPLETED|Overall Study||1
11278402|NCT02378220|12474253|FG000|STARTED|Overall Study||53
11278403|NCT02378220|12474254|FG001|STARTED|Overall Study||57
11278404|NCT02378220|12474253|FG000|COMPLETED|Overall Study||47
11278405|NCT02378220|12474254|FG001|COMPLETED|Overall Study||56
11278406|NCT02378220|12474253|FG000|NOT COMPLETED|Overall Study||6
11278407|NCT02378220|12474254|FG001|NOT COMPLETED|Overall Study||1
11278408|NCT02378402|12474264|FG000|STARTED|Overall Study||25
11278409|NCT02378402|12474265|FG001|STARTED|Overall Study||25
11278410|NCT02378402|12474266|FG002|STARTED|Overall Study||21
11278411|NCT02378402|12474264|FG000|COMPLETED|Overall Study||25
11278412|NCT02378402|12474265|FG001|COMPLETED|Overall Study||23
11278413|NCT02378402|12474266|FG002|COMPLETED|Overall Study||21
11278414|NCT02378402|12474264|FG000|NOT COMPLETED|Overall Study||0
11278415|NCT02378402|12474265|FG001|NOT COMPLETED|Overall Study||2
11278416|NCT02378402|12474266|FG002|NOT COMPLETED|Overall Study||0
11278417|NCT02378480|12474276|FG000|STARTED|Overall Study||329
11278418|NCT02378480|12474277|FG001|STARTED|Overall Study||326
11278419|NCT02378480|12474276|FG000|COMPLETED|Overall Study||301
11278420|NCT02378480|12474277|FG001|COMPLETED|Overall Study||294
11278421|NCT02378480|12474276|FG000|NOT COMPLETED|Overall Study||28
11278422|NCT02378480|12474277|FG001|NOT COMPLETED|Overall Study||32
11278423|NCT02378506|12474283|FG000|STARTED|Overall Study||188
11278424|NCT02378506|12474283|FG000|Treated|Overall Study||187
11278425|NCT02378506|12474283|FG000|COMPLETED|Overall Study||163
11278426|NCT02378506|12474283|FG000|NOT COMPLETED|Overall Study||25
11278427|NCT02378662|12474289|FG000|STARTED|Overall Study||2
11278428|NCT02378662|12474290|FG001|STARTED|Overall Study||0
11278429|NCT02378662|12474289|FG000|Harvesting|Overall Study||2
11278430|NCT02378662|12474290|FG001|Harvesting|Overall Study||0
11278431|NCT02378662|12474289|FG000|Implantation|Overall Study||2
11278432|NCT02378662|12474290|FG001|Implantation|Overall Study||0
11278433|NCT02378662|12474289|FG000|COMPLETED|Overall Study||0
11278434|NCT02378662|12474290|FG001|COMPLETED|Overall Study||0
11278435|NCT02378662|12474289|FG000|NOT COMPLETED|Overall Study||2
11278436|NCT02378662|12474290|FG001|NOT COMPLETED|Overall Study||0
11278437|NCT02378714|12474300|FG000|STARTED|Overall Study||68
11278438|NCT02378714|12474301|FG001|STARTED|Overall Study||68
11278439|NCT02378714|12474302|FG002|STARTED|Overall Study||81
11278440|NCT02378714|12474303|FG003|STARTED|Overall Study||83
11278441|NCT02378714|12474300|FG000|COMPLETED|Overall Study||39
11278442|NCT02378714|12474301|FG001|COMPLETED|Overall Study||29
11278443|NCT02378714|12474302|FG002|COMPLETED|Overall Study||51
11278444|NCT02378714|12474303|FG003|COMPLETED|Overall Study||51
11278445|NCT02378714|12474300|FG000|NOT COMPLETED|Overall Study||29
11278446|NCT02378714|12474301|FG001|NOT COMPLETED|Overall Study||39
11278447|NCT02378714|12474302|FG002|NOT COMPLETED|Overall Study||30
11278448|NCT02378714|12474303|FG003|NOT COMPLETED|Overall Study||32
11278449|NCT02378753|12474337|FG000|STARTED|Overall Study||4319
11278450|NCT02378753|12474338|FG001|STARTED|Overall Study||4332
11278451|NCT02378753|12474337|FG000|COMPLETED|Overall Study||4101
11278452|NCT02378753|12474338|FG001|COMPLETED|Overall Study||3637
11278453|NCT02378753|12474337|FG000|NOT COMPLETED|Overall Study||218
11278454|NCT02378753|12474338|FG001|NOT COMPLETED|Overall Study||695
11278455|NCT02378844|12474346|FG000|STARTED|Run-in Period||169
11278456|NCT02378844|12474347|FG001|STARTED|Run-in Period||172
11278457|NCT02378844|12474348|FG002|STARTED|Run-in Period||136
11278458|NCT02378844|12474346|FG000|COMPLETED|Run-in Period||165
11278459|NCT02378844|12474347|FG001|COMPLETED|Run-in Period||167
11278460|NCT02378844|12474348|FG002|COMPLETED|Run-in Period||0
11278461|NCT02378844|12474346|FG000|NOT COMPLETED|Run-in Period||4
11278462|NCT02378844|12474347|FG001|NOT COMPLETED|Run-in Period||5
11278463|NCT02378844|12474348|FG002|NOT COMPLETED|Run-in Period||136
11278464|NCT02378844|12474346|FG000|STARTED|Randomized Period (Double Blind)||165
11278465|NCT02378844|12474347|FG001|STARTED|Randomized Period (Double Blind)||167
11278466|NCT02378844|12474348|FG002|STARTED|Randomized Period (Double Blind)||0
11278467|NCT02378844|12474346|FG000|COMPLETED|Randomized Period (Double Blind)||142
11278468|NCT02378844|12474347|FG001|COMPLETED|Randomized Period (Double Blind)||135
11278469|NCT02378844|12474348|FG002|COMPLETED|Randomized Period (Double Blind)||0
11278470|NCT02378844|12474346|FG000|NOT COMPLETED|Randomized Period (Double Blind)||23
11278471|NCT02378844|12474347|FG001|NOT COMPLETED|Randomized Period (Double Blind)||32
11278472|NCT02378844|12474348|FG002|NOT COMPLETED|Randomized Period (Double Blind)||0
11278473|NCT02378844|12474346|FG000|STARTED|Open Label Period||142
11278474|NCT02378844|12474347|FG001|STARTED|Open Label Period||135
11278475|NCT02378844|12474348|FG002|STARTED|Open Label Period||0
11278476|NCT02378844|12474346|FG000|COMPLETED|Open Label Period||99
11278477|NCT02378844|12474347|FG001|COMPLETED|Open Label Period||87
11278478|NCT02378844|12474348|FG002|COMPLETED|Open Label Period||0
11278479|NCT02378844|12474346|FG000|NOT COMPLETED|Open Label Period||43
11278480|NCT02378844|12474347|FG001|NOT COMPLETED|Open Label Period||48
11278481|NCT02378844|12474348|FG002|NOT COMPLETED|Open Label Period||0
11278482|NCT02378883|12474358|FG000|STARTED|Enrollment|Participants consented and assessed for eligibility|121
11278483|NCT02378883|12474358|FG000|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112
11278484|NCT02378883|12474358|FG000|NOT COMPLETED|Enrollment||9
11278485|NCT02378883|12474358|FG000|STARTED|Discharge||112
11278486|NCT02378883|12474358|FG000|COMPLETED|Discharge||112
11278487|NCT02378883|12474358|FG000|NOT COMPLETED|Discharge||0
11278488|NCT02378883|12474358|FG000|STARTED|30 Day Follow-Up||112
11278489|NCT02378883|12474358|FG000|COMPLETED|30 Day Follow-Up||106
11278490|NCT02378883|12474358|FG000|NOT COMPLETED|30 Day Follow-Up||6
11278491|NCT02378883|12474358|FG000|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46
11021748|NCT00805935|12199928|FG003|COMPLETED|Overall Study||19
11021749|NCT00805935|12199925|FG000|NOT COMPLETED|Overall Study||13
11021750|NCT00805935|12199926|FG001|NOT COMPLETED|Overall Study||19
11021751|NCT00805935|12199927|FG002|NOT COMPLETED|Overall Study||15
11021752|NCT00805935|12199928|FG003|NOT COMPLETED|Overall Study||11
11021753|NCT00805948|12199942|FG000|STARTED|Overall Study||154
11021754|NCT00805948|12199943|FG001|STARTED|Overall Study||195
11021755|NCT00805948|12199942|FG000|COMPLETED|Overall Study||86
11278492|NCT02378883|12474358|FG000|COMPLETED|12 Months Follow-Up||41
11278493|NCT02378883|12474358|FG000|NOT COMPLETED|12 Months Follow-Up||5
11278494|NCT02378935|12474370|FG000|STARTED|Overall Study||34
11278495|NCT02378935|12474371|FG001|STARTED|Overall Study||36
11278496|NCT02378935|12474372|FG002|STARTED|Overall Study||33
11278497|NCT02378935|12474373|FG003|STARTED|Overall Study||31
11278498|NCT02378935|12474374|FG004|STARTED|Overall Study||31
11278499|NCT02378935|12474375|FG005|STARTED|Overall Study||32
11278500|NCT02378935|12474376|FG006|STARTED|Overall Study||8
11278501|NCT02378935|12474370|FG000|COMPLETED|Overall Study||24
11278502|NCT02378935|12474371|FG001|COMPLETED|Overall Study||36
11278503|NCT02378935|12474372|FG002|COMPLETED|Overall Study||30
11278504|NCT02378935|12474373|FG003|COMPLETED|Overall Study||25
11278505|NCT02378935|12474374|FG004|COMPLETED|Overall Study||31
11278506|NCT02378935|12474375|FG005|COMPLETED|Overall Study||32
11278507|NCT02378935|12474376|FG006|COMPLETED|Overall Study||8
11278508|NCT02378935|12474370|FG000|NOT COMPLETED|Overall Study||10
11278509|NCT02378935|12474371|FG001|NOT COMPLETED|Overall Study||0
11278510|NCT02378935|12474372|FG002|NOT COMPLETED|Overall Study||3
11278511|NCT02378935|12474373|FG003|NOT COMPLETED|Overall Study||6
11278512|NCT02378935|12474374|FG004|NOT COMPLETED|Overall Study||0
11278513|NCT02378935|12474375|FG005|NOT COMPLETED|Overall Study||0
11278514|NCT02378935|12474376|FG006|NOT COMPLETED|Overall Study||0
11278515|NCT02378961|12474396|FG000|STARTED|Overall Study||33
11278516|NCT02378961|12474397|FG001|STARTED|Overall Study||30
11278517|NCT02378961|12474398|FG002|STARTED|Overall Study||36
11278518|NCT02378961|12474399|FG003|STARTED|Overall Study||29
11278519|NCT02378961|12474396|FG000|COMPLETED|Overall Study||29
11278520|NCT02378961|12474397|FG001|COMPLETED|Overall Study||28
11278521|NCT02378961|12474398|FG002|COMPLETED|Overall Study||35
11278522|NCT02378961|12474399|FG003|COMPLETED|Overall Study||28
11278523|NCT02378961|12474396|FG000|NOT COMPLETED|Overall Study||4
11278524|NCT02378961|12474397|FG001|NOT COMPLETED|Overall Study||2
11278525|NCT02378961|12474398|FG002|NOT COMPLETED|Overall Study||1
11278526|NCT02378961|12474399|FG003|NOT COMPLETED|Overall Study||1
11278527|NCT02379052|12474411|FG000|STARTED|Overall Study||24
11278528|NCT02379052|12474412|FG001|STARTED|Overall Study||23
11278529|NCT02379052|12474411|FG000|COMPLETED|Overall Study||18
11278530|NCT02379052|12474412|FG001|COMPLETED|Overall Study||18
11278531|NCT02379052|12474411|FG000|NOT COMPLETED|Overall Study||6
11278532|NCT02379052|12474412|FG001|NOT COMPLETED|Overall Study||5
11278533|NCT02379078|12474420|FG000|STARTED|Overall Study||111
11278534|NCT02379078|12474421|FG001|STARTED|Overall Study||114
11278535|NCT02379078|12474420|FG000|COMPLETED|Overall Study||72
11278536|NCT02379078|12474421|FG001|COMPLETED|Overall Study||79
11278537|NCT02379078|12474420|FG000|NOT COMPLETED|Overall Study||39
11278538|NCT02379078|12474421|FG001|NOT COMPLETED|Overall Study||35
11278539|NCT02379091|12474431|FG000|STARTED|Overall Study||27
11278540|NCT02379091|12474432|FG001|STARTED|Overall Study||28
11278541|NCT02379091|12474433|FG002|STARTED|Overall Study||25
11398652|NCT04428359|12593017|FG000|NOT COMPLETED|Overall Study||2
11398653|NCT04428359|12593018|FG001|NOT COMPLETED|Overall Study||3
11398654|NCT04410159|12593028|FG000|STARTED|Overall Study||5
11398655|NCT04410159|12593029|FG001|STARTED|Overall Study||5
11398656|NCT04410159|12593030|FG002|STARTED|Overall Study||5
11398657|NCT04410159|12593031|FG003|STARTED|Overall Study||5
11398658|NCT04410159|12593028|FG000|COMPLETED|Overall Study||5
11398659|NCT04410159|12593029|FG001|COMPLETED|Overall Study||5
11398660|NCT04410159|12593030|FG002|COMPLETED|Overall Study||5
11021756|NCT00805948|12199943|FG001|COMPLETED|Overall Study||99
11278542|NCT02379091|12474434|FG003|STARTED|Overall Study||28
11278543|NCT02379091|12474431|FG000|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
11398661|NCT04410159|12593031|FG003|COMPLETED|Overall Study||5
11398662|NCT04410159|12593028|FG000|NOT COMPLETED|Overall Study||0
11398663|NCT04410159|12593029|FG001|NOT COMPLETED|Overall Study||0
11398664|NCT04410159|12593030|FG002|NOT COMPLETED|Overall Study||0
11398665|NCT04410159|12593031|FG003|NOT COMPLETED|Overall Study||0
11278544|NCT02379091|12474432|FG001|Full Analysis Set|Overall Study||28
11278545|NCT02379091|12474433|FG002|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
11278546|NCT02379091|12474434|FG003|Full Analysis Set|Overall Study||28
11278547|NCT02379091|12474431|FG000|COMPLETED|Overall Study||15
11278548|NCT02379091|12474432|FG001|COMPLETED|Overall Study||18
11278549|NCT02379091|12474433|FG002|COMPLETED|Overall Study||18
11278550|NCT02379091|12474434|FG003|COMPLETED|Overall Study||14
11278551|NCT02379091|12474431|FG000|NOT COMPLETED|Overall Study||12
11278552|NCT02379091|12474432|FG001|NOT COMPLETED|Overall Study||10
11278553|NCT02379091|12474433|FG002|NOT COMPLETED|Overall Study||7
11278554|NCT02379091|12474434|FG003|NOT COMPLETED|Overall Study||14
11278555|NCT02379117|12474448|FG000|STARTED|Overall Study||30
11278556|NCT02379117|12474449|FG001|STARTED|Overall Study||31
11278557|NCT02379117|12474448|FG000|COMPLETED|Overall Study||30
11278558|NCT02379117|12474449|FG001|COMPLETED|Overall Study||31
11278559|NCT02379117|12474448|FG000|NOT COMPLETED|Overall Study||0
11278560|NCT02379117|12474449|FG001|NOT COMPLETED|Overall Study||0
11278561|NCT02379195|12474455|FG000|STARTED|Overall Study||12
11278562|NCT02379195|12474455|FG000|COMPLETED|Overall Study||12
11278563|NCT02379195|12474455|FG000|NOT COMPLETED|Overall Study||0
11278564|NCT02379221|12474459|FG000|STARTED|Overall Study||49
11278565|NCT02379221|12474459|FG000|COMPLETED|Overall Study||48
11278566|NCT02379221|12474459|FG000|NOT COMPLETED|Overall Study||1
11278567|NCT02379273|12474468|FG000|STARTED|Overall Study||35
11278568|NCT02379273|12474468|FG000|COMPLETED|Overall Study|Completed 5 years postactivation.|35
11278569|NCT02379273|12474468|FG000|NOT COMPLETED|Overall Study||0
11278570|NCT02379442|12474472|FG000|STARTED|Overall Study||1
11278571|NCT02379442|12474472|FG000|COMPLETED|Overall Study||1
11278572|NCT02379442|12474472|FG000|NOT COMPLETED|Overall Study||0
11278573|NCT02379637|12474478|FG000|STARTED|Overall Study||35
11278574|NCT02379637|12474479|FG001|STARTED|Overall Study||35
11278575|NCT02379637|12474478|FG000|COMPLETED|Overall Study||33
11278576|NCT02379637|12474479|FG001|COMPLETED|Overall Study||34
11278577|NCT02379637|12474478|FG000|NOT COMPLETED|Overall Study||2
11278578|NCT02379637|12474479|FG001|NOT COMPLETED|Overall Study||1
11278579|NCT02379728|12474487|FG000|STARTED|Overall Study||84
11278580|NCT02379728|12474488|FG001|STARTED|Overall Study||16
11278581|NCT02379728|12474489|FG002|STARTED|Overall Study||84
11278582|NCT02379728|12474490|FG003|STARTED|Overall Study||16
11278583|NCT02379728|12474487|FG000|COMPLETED|Overall Study||78
11278584|NCT02379728|12474488|FG001|COMPLETED|Overall Study||16
11278585|NCT02379728|12474489|FG002|COMPLETED|Overall Study||74
11278586|NCT02379728|12474490|FG003|COMPLETED|Overall Study||13
11278587|NCT02379728|12474487|FG000|NOT COMPLETED|Overall Study||6
11278588|NCT02379728|12474488|FG001|NOT COMPLETED|Overall Study||0
11278589|NCT02379728|12474489|FG002|NOT COMPLETED|Overall Study||10
11278590|NCT02379728|12474490|FG003|NOT COMPLETED|Overall Study||3
11278591|NCT02379858|12474501|FG000|STARTED|Overall Study||6
11278592|NCT02379858|12474502|FG001|STARTED|Overall Study||4
11278593|NCT02379858|12474501|FG000|COMPLETED|Overall Study||6
11278594|NCT02379858|12474502|FG001|COMPLETED|Overall Study||4
11278595|NCT02379858|12474501|FG000|NOT COMPLETED|Overall Study||0
11278596|NCT02379858|12474502|FG001|NOT COMPLETED|Overall Study||0
11278597|NCT02379923|12474508|FG000|STARTED|Overall Study||163
11278598|NCT02379923|12474508|FG000|COMPLETED|Overall Study||158
11278599|NCT02379923|12474508|FG000|NOT COMPLETED|Overall Study||5
11278600|NCT02380183|12474517|FG000|STARTED|Overall Study||36
11278601|NCT02380183|12474518|FG001|STARTED|Overall Study||34
11278602|NCT02380183|12474517|FG000|COMPLETED|Overall Study||36
11278603|NCT02380183|12474518|FG001|COMPLETED|Overall Study||34
11278604|NCT02380183|12474517|FG000|NOT COMPLETED|Overall Study||0
11278605|NCT02380183|12474518|FG001|NOT COMPLETED|Overall Study||0
11278606|NCT02380248|12474524|FG000|STARTED|Overall Study||200
11278607|NCT02380248|12474524|FG000|COMPLETED|Overall Study||186
11278608|NCT02380248|12474524|FG000|NOT COMPLETED|Overall Study||14
11278609|NCT02380261|12474529|FG000|STARTED|Overall Study||35
11278610|NCT02380261|12474529|FG000|COMPLETED|Overall Study||35
11278611|NCT02380261|12474529|FG000|NOT COMPLETED|Overall Study||0
11278612|NCT02380287|12474541|FG000|STARTED|Overall Study||1
11278613|NCT02380287|12474542|FG001|STARTED|Overall Study||3
11278614|NCT02380287|12474543|FG002|STARTED|Overall Study||3
11278615|NCT02380287|12474544|FG003|STARTED|Overall Study||3
11278616|NCT02380287|12474545|FG004|STARTED|Overall Study||3
11278617|NCT02380287|12474546|FG005|STARTED|Overall Study||3
11278618|NCT02380287|12474547|FG006|STARTED|Overall Study||3
11278619|NCT02380287|12474548|FG007|STARTED|Overall Study||3
11278620|NCT02380287|12474541|FG000|COMPLETED|Overall Study||1
11278621|NCT02380287|12474542|FG001|COMPLETED|Overall Study||3
11278622|NCT02380287|12474543|FG002|COMPLETED|Overall Study||2
11278623|NCT02380287|12474544|FG003|COMPLETED|Overall Study||3
11278624|NCT02380287|12474545|FG004|COMPLETED|Overall Study||3
11278625|NCT02380287|12474546|FG005|COMPLETED|Overall Study||3
11278626|NCT02380287|12474547|FG006|COMPLETED|Overall Study||3
11278627|NCT02380287|12474548|FG007|COMPLETED|Overall Study||3
11278628|NCT02380287|12474541|FG000|NOT COMPLETED|Overall Study||0
11278629|NCT02380287|12474542|FG001|NOT COMPLETED|Overall Study||0
11278630|NCT02380287|12474543|FG002|NOT COMPLETED|Overall Study||1
11278631|NCT02380287|12474544|FG003|NOT COMPLETED|Overall Study||0
11278632|NCT02380287|12474545|FG004|NOT COMPLETED|Overall Study||0
11278633|NCT02380287|12474546|FG005|NOT COMPLETED|Overall Study||0
11278634|NCT02380287|12474547|FG006|NOT COMPLETED|Overall Study||0
11278635|NCT02380287|12474548|FG007|NOT COMPLETED|Overall Study||0
11278636|NCT02380612|12474573|FG000|STARTED|Overall Study||30
11278637|NCT02380612|12474573|FG000|COMPLETED|Overall Study||27
11278638|NCT02380612|12474573|FG000|NOT COMPLETED|Overall Study||3
11278639|NCT02380677|12474592|FG000|STARTED|Overall Study||1
11278640|NCT02380677|12474593|FG001|STARTED|Overall Study||1
11278641|NCT02380677|12474594|FG002|STARTED|Overall Study||3
11278642|NCT02380677|12474595|FG003|STARTED|Overall Study||3
11278643|NCT02380677|12474596|FG004|STARTED|Overall Study||6
11278644|NCT02380677|12474597|FG005|STARTED|Overall Study||6
11278645|NCT02380677|12474598|FG006|STARTED|Overall Study||3
11278646|NCT02380677|12474599|FG007|STARTED|Overall Study||4
11278647|NCT02380677|12474600|FG008|STARTED|Overall Study||4
11278648|NCT02380677|12474601|FG009|STARTED|Overall Study||2
11278649|NCT02380677|12474602|FG010|STARTED|Overall Study||4
11278650|NCT02380677|12474603|FG011|STARTED|Overall Study||5
11278651|NCT02380677|12474592|FG000|COMPLETED|Overall Study||0
11278652|NCT02380677|12474593|FG001|COMPLETED|Overall Study||0
11278653|NCT02380677|12474594|FG002|COMPLETED|Overall Study||0
11278654|NCT02380677|12474595|FG003|COMPLETED|Overall Study||0
11278655|NCT02380677|12474596|FG004|COMPLETED|Overall Study||0
11278656|NCT02380677|12474597|FG005|COMPLETED|Overall Study||0
11278657|NCT02380677|12474598|FG006|COMPLETED|Overall Study||0
11278658|NCT02380677|12474599|FG007|COMPLETED|Overall Study||0
11278659|NCT02380677|12474600|FG008|COMPLETED|Overall Study||0
11278660|NCT02380677|12474601|FG009|COMPLETED|Overall Study||0
11278661|NCT02380677|12474602|FG010|COMPLETED|Overall Study||0
11278662|NCT02380677|12474603|FG011|COMPLETED|Overall Study||0
11278663|NCT02380677|12474592|FG000|NOT COMPLETED|Overall Study||1
11278664|NCT02380677|12474593|FG001|NOT COMPLETED|Overall Study||1
11278665|NCT02380677|12474594|FG002|NOT COMPLETED|Overall Study||3
11278666|NCT02380677|12474595|FG003|NOT COMPLETED|Overall Study||3
11278667|NCT02380677|12474596|FG004|NOT COMPLETED|Overall Study||6
11278668|NCT02380677|12474597|FG005|NOT COMPLETED|Overall Study||6
11278669|NCT02380677|12474598|FG006|NOT COMPLETED|Overall Study||3
11278670|NCT02380677|12474599|FG007|NOT COMPLETED|Overall Study||4
11278671|NCT02380677|12474600|FG008|NOT COMPLETED|Overall Study||4
11278672|NCT02380677|12474601|FG009|NOT COMPLETED|Overall Study||2
11278673|NCT02380677|12474602|FG010|NOT COMPLETED|Overall Study||4
11278674|NCT02380677|12474603|FG011|NOT COMPLETED|Overall Study||5
11278675|NCT02380690|12474633|FG000|STARTED|Overall Study||119
11278676|NCT02380690|12474634|FG001|STARTED|Overall Study||94
11278677|NCT02380690|12474633|FG000|COMPLETED|Overall Study||85
11278678|NCT02380690|12474634|FG001|COMPLETED|Overall Study||82
11278679|NCT02380690|12474633|FG000|NOT COMPLETED|Overall Study||34
11278680|NCT02380690|12474634|FG001|NOT COMPLETED|Overall Study||12
11278681|NCT02380703|12474642|FG000|STARTED|Overall Study||114
11278682|NCT02380703|12474643|FG001|STARTED|Overall Study||114
11278683|NCT02380703|12474642|FG000|Month 3|Overall Study||104
11278684|NCT02380703|12474643|FG001|Month 3|Overall Study||109
11278685|NCT02380703|12474642|FG000|Month 6|Overall Study||102
11278686|NCT02380703|12474643|FG001|Month 6|Overall Study||107
11278687|NCT02380703|12474642|FG000|Month 12|Overall Study||99
11278688|NCT02380703|12474643|FG001|Month 12|Overall Study||100
11278689|NCT02380703|12474642|FG000|COMPLETED|Overall Study||78
11278690|NCT02380703|12474643|FG001|COMPLETED|Overall Study||78
11278691|NCT02380703|12474642|FG000|NOT COMPLETED|Overall Study||36
11278692|NCT02380703|12474643|FG001|NOT COMPLETED|Overall Study||36
11278693|NCT02380742|12474651|FG000|STARTED|Overall Study||28
11278694|NCT02380742|12474652|FG001|STARTED|Overall Study||26
11278695|NCT02380742|12474651|FG000|COMPLETED|Overall Study||27
11278696|NCT02380742|12474652|FG001|COMPLETED|Overall Study||26
11278697|NCT02380742|12474651|FG000|NOT COMPLETED|Overall Study||1
11278698|NCT02380742|12474652|FG001|NOT COMPLETED|Overall Study||0
11278699|NCT02380859|12474660|FG000|STARTED|Overall Study||19
11278700|NCT02380859|12474661|FG001|STARTED|Overall Study||13
11278701|NCT02380859|12474660|FG000|COMPLETED|Overall Study||17
11278702|NCT02380859|12474661|FG001|COMPLETED|Overall Study||13
11278703|NCT02380859|12474660|FG000|NOT COMPLETED|Overall Study||2
11278704|NCT02380859|12474661|FG001|NOT COMPLETED|Overall Study||0
11278705|NCT02381015|12474671|FG000|STARTED|Visit 1 - Enrollment||175
11278706|NCT02381015|12474672|FG001|STARTED|Visit 1 - Enrollment||175
11278707|NCT02381015|12474673|FG002|STARTED|Visit 1 - Enrollment||175
11278708|NCT02381015|12474674|FG003|STARTED|Visit 1 - Enrollment||175
11278709|NCT02381015|12474671|FG000|COMPLETED|Visit 1 - Enrollment||175
11278710|NCT02381015|12474672|FG001|COMPLETED|Visit 1 - Enrollment||173
11278711|NCT02381015|12474673|FG002|COMPLETED|Visit 1 - Enrollment||175
11278712|NCT02381015|12474674|FG003|COMPLETED|Visit 1 - Enrollment||172
11278713|NCT02381015|12474671|FG000|NOT COMPLETED|Visit 1 - Enrollment||0
11278714|NCT02381015|12474672|FG001|NOT COMPLETED|Visit 1 - Enrollment||2
11278715|NCT02381015|12474673|FG002|NOT COMPLETED|Visit 1 - Enrollment||0
11278716|NCT02381015|12474674|FG003|NOT COMPLETED|Visit 1 - Enrollment||3
11278717|NCT02381015|12474671|FG000|STARTED|Visit 2 - Results DIsclosure||175
11278718|NCT02381015|12474672|FG001|STARTED|Visit 2 - Results DIsclosure||173
11278719|NCT02381015|12474673|FG002|STARTED|Visit 2 - Results DIsclosure||175
11278720|NCT02381015|12474674|FG003|STARTED|Visit 2 - Results DIsclosure||172
11278721|NCT02381015|12474671|FG000|COMPLETED|Visit 2 - Results DIsclosure||172
11278722|NCT02381015|12474672|FG001|COMPLETED|Visit 2 - Results DIsclosure||168
11278723|NCT02381015|12474673|FG002|COMPLETED|Visit 2 - Results DIsclosure||173
11278724|NCT02381015|12474674|FG003|COMPLETED|Visit 2 - Results DIsclosure||169
11278725|NCT02381015|12474671|FG000|NOT COMPLETED|Visit 2 - Results DIsclosure||3
11278726|NCT02381015|12474672|FG001|NOT COMPLETED|Visit 2 - Results DIsclosure||5
11278727|NCT02381015|12474673|FG002|NOT COMPLETED|Visit 2 - Results DIsclosure||2
11278728|NCT02381015|12474674|FG003|NOT COMPLETED|Visit 2 - Results DIsclosure||3
11278729|NCT02381015|12474671|FG000|STARTED|Visit 3 - 3 Months Followup||172
11278730|NCT02381015|12474672|FG001|STARTED|Visit 3 - 3 Months Followup||168
11278731|NCT02381015|12474673|FG002|STARTED|Visit 3 - 3 Months Followup||173
11278732|NCT02381015|12474674|FG003|STARTED|Visit 3 - 3 Months Followup||169
11278733|NCT02381015|12474671|FG000|COMPLETED|Visit 3 - 3 Months Followup||172
11278734|NCT02381015|12474672|FG001|COMPLETED|Visit 3 - 3 Months Followup||168
11278735|NCT02381015|12474673|FG002|COMPLETED|Visit 3 - 3 Months Followup||173
11278736|NCT02381015|12474674|FG003|COMPLETED|Visit 3 - 3 Months Followup||169
11278737|NCT02381015|12474671|FG000|NOT COMPLETED|Visit 3 - 3 Months Followup||0
11278738|NCT02381015|12474672|FG001|NOT COMPLETED|Visit 3 - 3 Months Followup||0
11278739|NCT02381015|12474673|FG002|NOT COMPLETED|Visit 3 - 3 Months Followup||0
11278740|NCT02381015|12474674|FG003|NOT COMPLETED|Visit 3 - 3 Months Followup||0
11278741|NCT02381015|12474671|FG000|STARTED|Year 3 Chart Review||172
11278742|NCT02381015|12474672|FG001|STARTED|Year 3 Chart Review||168
11278743|NCT02381015|12474673|FG002|STARTED|Year 3 Chart Review||173
11278744|NCT02381015|12474674|FG003|STARTED|Year 3 Chart Review||169
11278745|NCT02381015|12474671|FG000|COMPLETED|Year 3 Chart Review||125
11278746|NCT02381015|12474672|FG001|COMPLETED|Year 3 Chart Review||134
11278747|NCT02381015|12474673|FG002|COMPLETED|Year 3 Chart Review||115
11278748|NCT02381015|12474674|FG003|COMPLETED|Year 3 Chart Review||118
11278749|NCT02381015|12474671|FG000|NOT COMPLETED|Year 3 Chart Review||47
11278750|NCT02381015|12474672|FG001|NOT COMPLETED|Year 3 Chart Review||34
11278751|NCT02381015|12474673|FG002|NOT COMPLETED|Year 3 Chart Review||58
11278752|NCT02381015|12474674|FG003|NOT COMPLETED|Year 3 Chart Review||51
11278753|NCT02381288|12474693|FG000|STARTED|Overall Study||5
11278754|NCT02381288|12474694|FG001|STARTED|Overall Study||2
11278755|NCT02381288|12474695|FG002|STARTED|Overall Study||5
11278756|NCT02381288|12474696|FG003|STARTED|Overall Study||5
11278757|NCT02381288|12474693|FG000|COMPLETED|Overall Study||5
11278758|NCT02381288|12474694|FG001|COMPLETED|Overall Study||2
11278759|NCT02381288|12474695|FG002|COMPLETED|Overall Study||5
11278760|NCT02381288|12474696|FG003|COMPLETED|Overall Study||5
11278761|NCT02381288|12474693|FG000|NOT COMPLETED|Overall Study||0
11278762|NCT02381288|12474694|FG001|NOT COMPLETED|Overall Study||0
11278763|NCT02381288|12474695|FG002|NOT COMPLETED|Overall Study||0
11278764|NCT02381288|12474696|FG003|NOT COMPLETED|Overall Study||0
11278765|NCT02381392|12474711|FG000|STARTED|Overall Study||11
11278766|NCT02381392|12474712|FG001|STARTED|Overall Study||12
11278767|NCT02381392|12474711|FG000|COMPLETED|Overall Study||11
11278768|NCT02381392|12474712|FG001|COMPLETED|Overall Study||12
11278769|NCT02381392|12474711|FG000|NOT COMPLETED|Overall Study||0
11278770|NCT02381392|12474712|FG001|NOT COMPLETED|Overall Study||0
11278771|NCT02381418|12474718|FG000|STARTED|Overall Study||120
11278772|NCT02381418|12474718|FG000|COMPLETED|Overall Study||120
11278773|NCT02381418|12474718|FG000|NOT COMPLETED|Overall Study||0
11278774|NCT02381678|12474723|FG000|STARTED|Overall Study||54
11278775|NCT02381678|12474724|FG001|STARTED|Overall Study||139
11278776|NCT02381678|12474725|FG002|STARTED|Overall Study||32
11278777|NCT02381678|12474723|FG000|COMPLETED|Overall Study||54
11278778|NCT02381678|12474724|FG001|COMPLETED|Overall Study||139
11278779|NCT02381678|12474725|FG002|COMPLETED|Overall Study||32
11278780|NCT02381678|12474723|FG000|NOT COMPLETED|Overall Study||0
11278781|NCT02381678|12474724|FG001|NOT COMPLETED|Overall Study||0
11278782|NCT02381678|12474725|FG002|NOT COMPLETED|Overall Study||0
11278783|NCT02381795|12474731|FG000|STARTED|Overall Study||10
11278784|NCT02381795|12474731|FG000|COMPLETED|Overall Study||7
11278785|NCT02381795|12474731|FG000|NOT COMPLETED|Overall Study||3
11278786|NCT02382016|12474737|FG000|STARTED|Double-blind (DB) Treatment Period||43
11278787|NCT02382016|12474738|FG001|STARTED|Double-blind (DB) Treatment Period||42
11278788|NCT02382016|12474737|FG000|COMPLETED|Double-blind (DB) Treatment Period||39
11278789|NCT02382016|12474738|FG001|COMPLETED|Double-blind (DB) Treatment Period||41
11278790|NCT02382016|12474737|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||4
11278791|NCT02382016|12474738|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||1
11278792|NCT02382016|12474737|FG000|STARTED|Open-label (OL) Treatment Period||80
11278793|NCT02382016|12474738|FG001|STARTED|Open-label (OL) Treatment Period||0
11278794|NCT02382016|12474737|FG000|COMPLETED|Open-label (OL) Treatment Period||71
11278795|NCT02382016|12474738|FG001|COMPLETED|Open-label (OL) Treatment Period||0
11278796|NCT02382016|12474737|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||9
11278797|NCT02382016|12474738|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||0
11278798|NCT02382016|12474737|FG000|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33
11278799|NCT02382016|12474738|FG001|STARTED|OL Extension Period||0
11278800|NCT02382016|12474737|FG000|COMPLETED|OL Extension Period||27
11278801|NCT02382016|12474738|FG001|COMPLETED|OL Extension Period||0
11278802|NCT02382016|12474737|FG000|NOT COMPLETED|OL Extension Period||6
11278803|NCT02382016|12474738|FG001|NOT COMPLETED|OL Extension Period||0
11278804|NCT02382133|12474746|FG000|STARTED|Overall Study||43
11278805|NCT02382133|12474746|FG000|COMPLETED|Overall Study||10
11278806|NCT02382133|12474746|FG000|NOT COMPLETED|Overall Study||33
11278807|NCT02382276|12474753|FG000|STARTED|Overall Study||137
11278808|NCT02382276|12474754|FG001|STARTED|Overall Study||94
11278809|NCT02382276|12474755|FG002|STARTED|Overall Study||172
11278810|NCT02382276|12474753|FG000|COMPLETED|Overall Study||126
11278811|NCT02382276|12474754|FG001|COMPLETED|Overall Study||84
11278812|NCT02382276|12474755|FG002|COMPLETED|Overall Study||133
11278813|NCT02382276|12474753|FG000|NOT COMPLETED|Overall Study||11
11278814|NCT02382276|12474754|FG001|NOT COMPLETED|Overall Study||10
11278815|NCT02382276|12474755|FG002|NOT COMPLETED|Overall Study||39
11278816|NCT02382640|12474765|FG000|STARTED|Intervention Period 1 (3 Days)||9
11278817|NCT02382640|12474766|FG001|STARTED|Intervention Period 1 (3 Days)||9
11278818|NCT02382640|12474767|FG002|STARTED|Intervention Period 1 (3 Days)||9
11278819|NCT02382640|12474768|FG003|STARTED|Intervention Period 1 (3 Days)||9
11278820|NCT02382640|12474765|FG000|COMPLETED|Intervention Period 1 (3 Days)||9
11278821|NCT02382640|12474766|FG001|COMPLETED|Intervention Period 1 (3 Days)||9
11278822|NCT02382640|12474767|FG002|COMPLETED|Intervention Period 1 (3 Days)||9
11278823|NCT02382640|12474768|FG003|COMPLETED|Intervention Period 1 (3 Days)||9
11278824|NCT02382640|12474765|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11278825|NCT02382640|12474766|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11278826|NCT02382640|12474767|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11278827|NCT02382640|12474768|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11278828|NCT02382640|12474765|FG000|STARTED|Washout Period 1 (7 Days)||9
11278829|NCT02382640|12474766|FG001|STARTED|Washout Period 1 (7 Days)||9
11278830|NCT02382640|12474767|FG002|STARTED|Washout Period 1 (7 Days)||9
11278831|NCT02382640|12474768|FG003|STARTED|Washout Period 1 (7 Days)||9
11278832|NCT02382640|12474765|FG000|COMPLETED|Washout Period 1 (7 Days)||9
11278833|NCT02382640|12474766|FG001|COMPLETED|Washout Period 1 (7 Days)||9
11278834|NCT02382640|12474767|FG002|COMPLETED|Washout Period 1 (7 Days)||9
11278835|NCT02382640|12474768|FG003|COMPLETED|Washout Period 1 (7 Days)||9
11278836|NCT02382640|12474765|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
11278837|NCT02382640|12474766|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
11278838|NCT02382640|12474767|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
11278839|NCT02382640|12474768|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
11278840|NCT02382640|12474765|FG000|STARTED|Intervention Period 2 (3 Days)||9
11278841|NCT02382640|12474766|FG001|STARTED|Intervention Period 2 (3 Days)||9
11278842|NCT02382640|12474767|FG002|STARTED|Intervention Period 2 (3 Days)||9
11278843|NCT02382640|12474768|FG003|STARTED|Intervention Period 2 (3 Days)||9
11278844|NCT02382640|12474765|FG000|COMPLETED|Intervention Period 2 (3 Days)||9
11278845|NCT02382640|12474766|FG001|COMPLETED|Intervention Period 2 (3 Days)||9
11278846|NCT02382640|12474767|FG002|COMPLETED|Intervention Period 2 (3 Days)||9
11278847|NCT02382640|12474768|FG003|COMPLETED|Intervention Period 2 (3 Days)||9
11278848|NCT02382640|12474765|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11278849|NCT02382640|12474766|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11278850|NCT02382640|12474767|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11278851|NCT02382640|12474768|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11398666|NCT04425850|12593043|FG000|STARTED|Overall Study|Standard prophylactic measures and PPE + iota carrageenan (nasal and buccal) and ivermectin (buccal)|131
11398667|NCT04425850|12593044|FG001|STARTED|Overall Study|Standard prophylactic measures and PPE only|98
11398668|NCT04425850|12593043|FG000|COMPLETED|Overall Study||131
11398669|NCT04425850|12593044|FG001|COMPLETED|Overall Study||98
11398670|NCT04425850|12593043|FG000|NOT COMPLETED|Overall Study||0
11278852|NCT02382640|12474765|FG000|STARTED|Washout Period 2 (7 Days)||9
11278853|NCT02382640|12474766|FG001|STARTED|Washout Period 2 (7 Days)||9
11278854|NCT02382640|12474767|FG002|STARTED|Washout Period 2 (7 Days)||9
11278855|NCT02382640|12474768|FG003|STARTED|Washout Period 2 (7 Days)||9
11278856|NCT02382640|12474765|FG000|COMPLETED|Washout Period 2 (7 Days)||9
11278857|NCT02382640|12474766|FG001|COMPLETED|Washout Period 2 (7 Days)||9
11278858|NCT02382640|12474767|FG002|COMPLETED|Washout Period 2 (7 Days)||9
11278859|NCT02382640|12474768|FG003|COMPLETED|Washout Period 2 (7 Days)||9
11278860|NCT02382640|12474765|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
11278861|NCT02382640|12474766|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
11278862|NCT02382640|12474767|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
11278863|NCT02382640|12474768|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
11278864|NCT02382640|12474765|FG000|STARTED|Intervention Period 3 (3 Days)||9
11278865|NCT02382640|12474766|FG001|STARTED|Intervention Period 3 (3 Days)||9
11278866|NCT02382640|12474767|FG002|STARTED|Intervention Period 3 (3 Days)||9
11278867|NCT02382640|12474768|FG003|STARTED|Intervention Period 3 (3 Days)||9
11278868|NCT02382640|12474765|FG000|COMPLETED|Intervention Period 3 (3 Days)||9
11278869|NCT02382640|12474766|FG001|COMPLETED|Intervention Period 3 (3 Days)||9
11278870|NCT02382640|12474767|FG002|COMPLETED|Intervention Period 3 (3 Days)||9
11278871|NCT02382640|12474768|FG003|COMPLETED|Intervention Period 3 (3 Days)||9
11278872|NCT02382640|12474765|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11278873|NCT02382640|12474766|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11278874|NCT02382640|12474767|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11278875|NCT02382640|12474768|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11278876|NCT02382640|12474765|FG000|STARTED|Washout Period 3 (7 Days)||9
11278877|NCT02382640|12474766|FG001|STARTED|Washout Period 3 (7 Days)||9
11278878|NCT02382640|12474767|FG002|STARTED|Washout Period 3 (7 Days)||9
11278879|NCT02382640|12474768|FG003|STARTED|Washout Period 3 (7 Days)||9
11278880|NCT02382640|12474765|FG000|COMPLETED|Washout Period 3 (7 Days)||9
11278881|NCT02382640|12474766|FG001|COMPLETED|Washout Period 3 (7 Days)||9
11278882|NCT02382640|12474767|FG002|COMPLETED|Washout Period 3 (7 Days)||9
11278883|NCT02382640|12474768|FG003|COMPLETED|Washout Period 3 (7 Days)||9
11278884|NCT02382640|12474765|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
11278885|NCT02382640|12474766|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
11278886|NCT02382640|12474767|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
11278887|NCT02382640|12474768|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
11278888|NCT02382640|12474765|FG000|STARTED|Intervention Period 4 (3 Days)||9
11278889|NCT02382640|12474766|FG001|STARTED|Intervention Period 4 (3 Days)||9
11278890|NCT02382640|12474767|FG002|STARTED|Intervention Period 4 (3 Days)||9
11278891|NCT02382640|12474768|FG003|STARTED|Intervention Period 4 (3 Days)||9
11278892|NCT02382640|12474765|FG000|COMPLETED|Intervention Period 4 (3 Days)||8
11278893|NCT02382640|12474766|FG001|COMPLETED|Intervention Period 4 (3 Days)||9
11278894|NCT02382640|12474767|FG002|COMPLETED|Intervention Period 4 (3 Days)||9
11278895|NCT02382640|12474768|FG003|COMPLETED|Intervention Period 4 (3 Days)||9
11278896|NCT02382640|12474765|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||1
11278897|NCT02382640|12474766|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0
11278898|NCT02382640|12474767|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0
11278899|NCT02382640|12474768|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0
11278900|NCT02382705|12474778|FG000|STARTED|Overall Study||57
11278901|NCT02382705|12474778|FG000|COMPLETED|Overall Study||33
11278902|NCT02382705|12474778|FG000|NOT COMPLETED|Overall Study||24
11278903|NCT02382744|12474784|FG000|STARTED|Overall Study||40
11278904|NCT02382744|12474785|FG001|STARTED|Overall Study||40
11278905|NCT02382744|12474784|FG000|Allocated|Overall Study||40
11278906|NCT02382744|12474785|FG001|Allocated|Overall Study||40
11278907|NCT02382744|12474784|FG000|Analyzed|Overall Study||40
11278908|NCT02382744|12474785|FG001|Analyzed|Overall Study||40
11278909|NCT02382744|12474784|FG000|COMPLETED|Overall Study||40
11278910|NCT02382744|12474785|FG001|COMPLETED|Overall Study||40
11278911|NCT02382744|12474784|FG000|NOT COMPLETED|Overall Study||0
11278912|NCT02382744|12474785|FG001|NOT COMPLETED|Overall Study||0
11278913|NCT02382796|12474795|FG000|STARTED|Overall Study||7
11278914|NCT02382796|12474795|FG000|COMPLETED|Overall Study||0
11278915|NCT02382796|12474795|FG000|NOT COMPLETED|Overall Study||7
11278916|NCT02382848|12474799|FG000|STARTED|First Intervention (3 Weeks)||3
11278917|NCT02382848|12474800|FG001|STARTED|First Intervention (3 Weeks)||5
11278918|NCT02382848|12474799|FG000|COMPLETED|First Intervention (3 Weeks)||3
11278919|NCT02382848|12474800|FG001|COMPLETED|First Intervention (3 Weeks)||5
11278920|NCT02382848|12474799|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
11278921|NCT02382848|12474800|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
11278922|NCT02382848|12474799|FG000|STARTED|Washout (1 Week)||3
11278923|NCT02382848|12474800|FG001|STARTED|Washout (1 Week)||5
11278924|NCT02382848|12474799|FG000|COMPLETED|Washout (1 Week)||3
11278925|NCT02382848|12474800|FG001|COMPLETED|Washout (1 Week)||5
11278926|NCT02382848|12474799|FG000|NOT COMPLETED|Washout (1 Week)||0
11278927|NCT02382848|12474800|FG001|NOT COMPLETED|Washout (1 Week)||0
11278928|NCT02382848|12474799|FG000|STARTED|Second Intervention (3 Weeks)||3
11278929|NCT02382848|12474800|FG001|STARTED|Second Intervention (3 Weeks)||5
11278930|NCT02382848|12474799|FG000|COMPLETED|Second Intervention (3 Weeks)||3
11278931|NCT02382848|12474800|FG001|COMPLETED|Second Intervention (3 Weeks)||5
11278932|NCT02382848|12474799|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
11278933|NCT02382848|12474800|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
11278934|NCT02382913|12474816|FG000|STARTED|Overall Study||27
11278935|NCT02382913|12474817|FG001|STARTED|Overall Study||36
11278936|NCT02382913|12474818|FG002|STARTED|Overall Study||32
11278937|NCT02382913|12474819|FG003|STARTED|Overall Study||27
11278938|NCT02382913|12474820|FG004|STARTED|Overall Study||33
11278939|NCT02382913|12474821|FG005|STARTED|Overall Study||30
11278940|NCT02382913|12474822|FG006|STARTED|Overall Study||37
11278941|NCT02382913|12474823|FG007|STARTED|Overall Study||30
11278942|NCT02382913|12474824|FG008|STARTED|Overall Study||30
11278943|NCT02382913|12474825|FG009|STARTED|Overall Study||33
11278944|NCT02382913|12474816|FG000|COMPLETED|Overall Study||27
11278945|NCT02382913|12474817|FG001|COMPLETED|Overall Study||36
11278946|NCT02382913|12474818|FG002|COMPLETED|Overall Study||32
11278947|NCT02382913|12474819|FG003|COMPLETED|Overall Study||27
11278948|NCT02382913|12474820|FG004|COMPLETED|Overall Study||33
11278949|NCT02382913|12474821|FG005|COMPLETED|Overall Study||30
11278950|NCT02382913|12474822|FG006|COMPLETED|Overall Study||37
11278951|NCT02382913|12474823|FG007|COMPLETED|Overall Study||30
11278952|NCT02382913|12474824|FG008|COMPLETED|Overall Study||30
11278953|NCT02382913|12474825|FG009|COMPLETED|Overall Study||33
11278954|NCT02382913|12474816|FG000|NOT COMPLETED|Overall Study||0
11278955|NCT02382913|12474817|FG001|NOT COMPLETED|Overall Study||0
11278956|NCT02382913|12474818|FG002|NOT COMPLETED|Overall Study||0
11278957|NCT02382913|12474819|FG003|NOT COMPLETED|Overall Study||0
11278958|NCT02382913|12474820|FG004|NOT COMPLETED|Overall Study||0
11278959|NCT02382913|12474821|FG005|NOT COMPLETED|Overall Study||0
11278960|NCT02382913|12474822|FG006|NOT COMPLETED|Overall Study||0
11278961|NCT02382913|12474823|FG007|NOT COMPLETED|Overall Study||0
11278962|NCT02382913|12474824|FG008|NOT COMPLETED|Overall Study||0
11278963|NCT02382913|12474825|FG009|NOT COMPLETED|Overall Study||0
11278964|NCT02382939|12474849|FG000|STARTED|Overall Study||31
11278965|NCT02382939|12474850|FG001|STARTED|Overall Study||61
11278966|NCT02382939|12474849|FG000|Exposed|Overall Study||31
11278967|NCT02382939|12474850|FG001|Exposed|Overall Study||61
11278968|NCT02382939|12474849|FG000|COMPLETED|Overall Study||28
11278969|NCT02382939|12474850|FG001|COMPLETED|Overall Study||58
11278970|NCT02382939|12474849|FG000|NOT COMPLETED|Overall Study||3
11278971|NCT02382939|12474850|FG001|NOT COMPLETED|Overall Study||3
11278972|NCT02382991|12474859|FG000|STARTED|Overall Study||17
11278973|NCT02382991|12474860|FG001|STARTED|Overall Study||18
11278974|NCT02382991|12474859|FG000|COMPLETED|Overall Study||15
11278975|NCT02382991|12474860|FG001|COMPLETED|Overall Study||15
11278976|NCT02382991|12474859|FG000|NOT COMPLETED|Overall Study||2
11278977|NCT02382991|12474860|FG001|NOT COMPLETED|Overall Study||3
11278978|NCT02383017|12474867|FG000|STARTED|Overall Study||15
11278979|NCT02383017|12474868|FG001|STARTED|Overall Study||13
11278980|NCT02383017|12474867|FG000|COMPLETED|Overall Study||10
11278981|NCT02383017|12474868|FG001|COMPLETED|Overall Study||11
11278982|NCT02383017|12474867|FG000|NOT COMPLETED|Overall Study||5
11278983|NCT02383017|12474868|FG001|NOT COMPLETED|Overall Study||2
11278984|NCT02383043|12474877|FG000|STARTED|Overall Study||9
11278985|NCT02383043|12474878|FG001|STARTED|Overall Study||5
11278986|NCT02383043|12474879|FG002|STARTED|Overall Study||4
11278987|NCT02383043|12474877|FG000|COMPLETED|Overall Study||7
11278988|NCT02383043|12474878|FG001|COMPLETED|Overall Study||5
11278989|NCT02383043|12474879|FG002|COMPLETED|Overall Study||4
11278990|NCT02383043|12474877|FG000|NOT COMPLETED|Overall Study||2
11278991|NCT02383043|12474878|FG001|NOT COMPLETED|Overall Study||0
11278992|NCT02383043|12474879|FG002|NOT COMPLETED|Overall Study||0
11278993|NCT02383056|12474890|FG000|STARTED|Overall Study||7
11278994|NCT02383056|12474891|FG001|STARTED|Overall Study||7
11278995|NCT02383056|12474890|FG000|COMPLETED|Overall Study||6
11278996|NCT02383056|12474891|FG001|COMPLETED|Overall Study||5
11278997|NCT02383056|12474890|FG000|NOT COMPLETED|Overall Study||1
11398671|NCT04425850|12593044|FG001|NOT COMPLETED|Overall Study||0
11398672|NCT04425863|12593055|FG000|STARTED|Overall Study||135
11398673|NCT04425863|12593056|FG001|STARTED|Overall Study||12
11398674|NCT04425863|12593057|FG002|STARTED|Overall Study||20
11398675|NCT04425863|12593055|FG000|COMPLETED|Overall Study||135
11398676|NCT04425863|12593056|FG001|COMPLETED|Overall Study||12
11398677|NCT04425863|12593057|FG002|COMPLETED|Overall Study||19
11398678|NCT04425863|12593055|FG000|NOT COMPLETED|Overall Study||0
11398679|NCT04425863|12593056|FG001|NOT COMPLETED|Overall Study||0
11398680|NCT04425863|12593057|FG002|NOT COMPLETED|Overall Study||1
11398681|NCT04425746|12593079|FG000|STARTED|Overall Study||9
11278998|NCT02383056|12474891|FG001|NOT COMPLETED|Overall Study||2
11278999|NCT02383173|12474899|FG000|STARTED|Overall Study||88
11279000|NCT02383173|12474900|FG001|STARTED|Overall Study||46
11279001|NCT02383173|12474899|FG000|COMPLETED|Overall Study||88
11279002|NCT02383173|12474900|FG001|COMPLETED|Overall Study||44
11279003|NCT02383173|12474899|FG000|NOT COMPLETED|Overall Study||0
11279004|NCT02383173|12474900|FG001|NOT COMPLETED|Overall Study||2
11279005|NCT02383355|12474908|FG000|STARTED|Overall Study||19
11279006|NCT02383355|12474909|FG001|STARTED|Overall Study||21
11279007|NCT02383355|12474908|FG000|COMPLETED|Overall Study||17
11279008|NCT02383355|12474909|FG001|COMPLETED|Overall Study||21
11279009|NCT02383355|12474908|FG000|NOT COMPLETED|Overall Study||2
11279010|NCT02383355|12474909|FG001|NOT COMPLETED|Overall Study||0
11279011|NCT02383420|12474918|FG000|STARTED|Overall Study||10
11279012|NCT02383420|12474919|FG001|STARTED|Overall Study||10
11279013|NCT02383420|12474920|FG002|STARTED|Overall Study||3
11279014|NCT02383420|12474918|FG000|COMPLETED|Overall Study||8
11279015|NCT02383420|12474919|FG001|COMPLETED|Overall Study||10
11279016|NCT02383420|12474920|FG002|COMPLETED|Overall Study||3
11279017|NCT02383420|12474918|FG000|NOT COMPLETED|Overall Study||2
11279018|NCT02383420|12474919|FG001|NOT COMPLETED|Overall Study||0
11279019|NCT02383420|12474920|FG002|NOT COMPLETED|Overall Study||0
11279020|NCT02383472|12474930|FG000|STARTED|Overall Study||23
11279021|NCT02383472|12474931|FG001|STARTED|Overall Study||30
11279022|NCT02383472|12474930|FG000|COMPLETED|Overall Study||22
11279023|NCT02383472|12474931|FG001|COMPLETED|Overall Study||29
11279024|NCT02383472|12474930|FG000|NOT COMPLETED|Overall Study||1
11279025|NCT02383472|12474931|FG001|NOT COMPLETED|Overall Study||1
11340693|NCT02924428|12538034|FG001|NOT COMPLETED|Overall Study||5
11340694|NCT02924688|12538046|FG000|STARTED|Overall Study||407
11340695|NCT02924688|12538047|FG001|STARTED|Overall Study||405
11340696|NCT02924688|12538048|FG002|STARTED|Overall Study||406
11340697|NCT02924688|12538049|FG003|STARTED|Overall Study||406
11340698|NCT02924688|12538050|FG004|STARTED|Overall Study||404
11340699|NCT02924688|12538051|FG005|STARTED|Overall Study||408
11340700|NCT02924688|12538046|FG000|COMPLETED|Overall Study||374
11340701|NCT02924688|12538047|FG001|COMPLETED|Overall Study||374
11340702|NCT02924688|12538048|FG002|COMPLETED|Overall Study||383
11340703|NCT02924688|12538049|FG003|COMPLETED|Overall Study||378
11340704|NCT02924688|12538050|FG004|COMPLETED|Overall Study||381
11340705|NCT02924688|12538051|FG005|COMPLETED|Overall Study||384
11340706|NCT02924688|12538046|FG000|NOT COMPLETED|Overall Study||33
11398682|NCT04425746|12593080|FG001|STARTED|Overall Study||7
11398683|NCT04425746|12593079|FG000|COMPLETED|Overall Study||9
11398684|NCT04425746|12593080|FG001|COMPLETED|Overall Study||6
11398685|NCT04425746|12593079|FG000|NOT COMPLETED|Overall Study||0
11398686|NCT04425746|12593080|FG001|NOT COMPLETED|Overall Study||1
11340707|NCT02924688|12538047|FG001|NOT COMPLETED|Overall Study||31
11340708|NCT02924688|12538048|FG002|NOT COMPLETED|Overall Study||23
11340709|NCT02924688|12538049|FG003|NOT COMPLETED|Overall Study||28
11340710|NCT02924688|12538050|FG004|NOT COMPLETED|Overall Study||23
11279026|NCT02383576|12474941|FG000|STARTED|Overall Study||94
11279027|NCT02383576|12474942|FG001|STARTED|Overall Study||91
11279028|NCT02383576|12474941|FG000|COMPLETED|Overall Study||31
11279029|NCT02383576|12474942|FG001|COMPLETED|Overall Study||46
11279030|NCT02383576|12474941|FG000|NOT COMPLETED|Overall Study||63
11279031|NCT02383576|12474942|FG001|NOT COMPLETED|Overall Study||45
11279032|NCT02383589|12474950|FG000|STARTED|Treatment Period||67
11279033|NCT02383589|12474951|FG001|STARTED|Treatment Period||68
11279034|NCT02383589|12474950|FG000|COMPLETED|Treatment Period||66
11279035|NCT02383589|12474951|FG001|COMPLETED|Treatment Period||58
11279036|NCT02383589|12474950|FG000|NOT COMPLETED|Treatment Period||1
11279037|NCT02383589|12474951|FG001|NOT COMPLETED|Treatment Period||10
11279038|NCT02383589|12474950|FG000|STARTED|Safety Follow-up (SFU)||66
11279039|NCT02383589|12474951|FG001|STARTED|Safety Follow-up (SFU)||58
11279040|NCT02383589|12474950|FG000|COMPLETED|Safety Follow-up (SFU)||59
11279041|NCT02383589|12474951|FG001|COMPLETED|Safety Follow-up (SFU)||53
11279042|NCT02383589|12474950|FG000|NOT COMPLETED|Safety Follow-up (SFU)||7
11279043|NCT02383589|12474951|FG001|NOT COMPLETED|Safety Follow-up (SFU)||5
11279044|NCT02383667|12474959|FG000|STARTED|Overall Study||20
11279045|NCT02383667|12474959|FG000|COMPLETED|Overall Study||20
11279046|NCT02383667|12474959|FG000|NOT COMPLETED|Overall Study||0
11279047|NCT02383706|12474963|FG000|STARTED|Overall Study||108
11279048|NCT02383706|12474963|FG000|COMPLETED|Overall Study||80
11279049|NCT02383706|12474963|FG000|NOT COMPLETED|Overall Study||28
11279050|NCT02383719|12474968|FG000|STARTED|Overall Study||18
11279051|NCT02383719|12474968|FG000|COMPLETED|Overall Study||18
11279052|NCT02383719|12474968|FG000|NOT COMPLETED|Overall Study||0
11279053|NCT02383758|12474974|FG000|STARTED|Overall Study||10
11279054|NCT02383758|12474975|FG001|STARTED|Overall Study||10
11279055|NCT02383758|12474974|FG000|COMPLETED|Overall Study||10
11279056|NCT02383758|12474975|FG001|COMPLETED|Overall Study||8
11279057|NCT02383758|12474974|FG000|NOT COMPLETED|Overall Study||0
11279058|NCT02383758|12474975|FG001|NOT COMPLETED|Overall Study||2
11279059|NCT02383862|12474983|FG000|STARTED|Baseline||151
11279060|NCT02383862|12474984|FG001|STARTED|Baseline||149
11279061|NCT02383862|12474983|FG000|COMPLETED|Baseline||151
11279062|NCT02383862|12474984|FG001|COMPLETED|Baseline||149
11279063|NCT02383862|12474983|FG000|NOT COMPLETED|Baseline||0
11279064|NCT02383862|12474984|FG001|NOT COMPLETED|Baseline||0
11279065|NCT02383862|12474983|FG000|STARTED|3 Month Follow up||151
11398687|NCT04422561|12593090|FG000|STARTED|Overall Study||228
11398688|NCT04422561|12593091|FG001|STARTED|Overall Study||112
11279066|NCT02383862|12474984|FG001|STARTED|3 Month Follow up||149
11279067|NCT02383862|12474983|FG000|COMPLETED|3 Month Follow up||128
11279068|NCT02383862|12474984|FG001|COMPLETED|3 Month Follow up||128
11279069|NCT02383862|12474983|FG000|NOT COMPLETED|3 Month Follow up||23
11279070|NCT02383862|12474984|FG001|NOT COMPLETED|3 Month Follow up||21
11279071|NCT02383940|12474999|FG000|STARTED|Overall Study||44
11279072|NCT02383940|12475000|FG001|STARTED|Overall Study||43
11279073|NCT02383940|12474999|FG000|Treated|Overall Study||42
11279074|NCT02383940|12475000|FG001|Treated|Overall Study||43
11279075|NCT02383940|12474999|FG000|COMPLETED|Overall Study||35
11279076|NCT02383940|12475000|FG001|COMPLETED|Overall Study||40
11279077|NCT02383940|12474999|FG000|NOT COMPLETED|Overall Study||9
11279078|NCT02383940|12475000|FG001|NOT COMPLETED|Overall Study||3
11279079|NCT02384044|12475008|FG000|STARTED|Overall Study||15
11279080|NCT02384044|12475009|FG001|STARTED|Overall Study||15
11279081|NCT02384044|12475008|FG000|COMPLETED|Overall Study||15
11279082|NCT02384044|12475009|FG001|COMPLETED|Overall Study||15
11279083|NCT02384044|12475008|FG000|NOT COMPLETED|Overall Study||0
11279084|NCT02384044|12475009|FG001|NOT COMPLETED|Overall Study||0
11279085|NCT02384070|12475018|FG000|STARTED|Overall Study||100
11279086|NCT02384070|12475019|FG001|STARTED|Overall Study||100
11279087|NCT02384070|12475020|FG002|STARTED|Overall Study||100
11279088|NCT02384070|12475018|FG000|COMPLETED|Overall Study||100
11279089|NCT02384070|12475019|FG001|COMPLETED|Overall Study||100
11279090|NCT02384070|12475020|FG002|COMPLETED|Overall Study||100
11279091|NCT02384070|12475018|FG000|NOT COMPLETED|Overall Study||0
11279092|NCT02384070|12475019|FG001|NOT COMPLETED|Overall Study||0
11279093|NCT02384070|12475020|FG002|NOT COMPLETED|Overall Study||0
11279094|NCT02384096|12475030|FG000|STARTED|First Intervention (7 Days)||5
11279095|NCT02384096|12475031|FG001|STARTED|First Intervention (7 Days)||7
11279096|NCT02384096|12475030|FG000|COMPLETED|First Intervention (7 Days)||4
11279097|NCT02384096|12475031|FG001|COMPLETED|First Intervention (7 Days)||7
11279098|NCT02384096|12475030|FG000|NOT COMPLETED|First Intervention (7 Days)||1
11279099|NCT02384096|12475031|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11398689|NCT04422561|12593090|FG000|COMPLETED|Overall Study||203
11279100|NCT02384096|12475030|FG000|STARTED|Second Intervention (7 Days)||4
11279101|NCT02384096|12475031|FG001|STARTED|Second Intervention (7 Days)||7
11279102|NCT02384096|12475030|FG000|COMPLETED|Second Intervention (7 Days)||4
11279103|NCT02384096|12475031|FG001|COMPLETED|Second Intervention (7 Days)||6
11279104|NCT02384096|12475030|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
11279105|NCT02384096|12475031|FG001|NOT COMPLETED|Second Intervention (7 Days)||1
11279106|NCT02384200|12475038|FG000|STARTED|Overall Study||43
11279107|NCT02384200|12475039|FG001|STARTED|Overall Study||43
11279108|NCT02384200|12475038|FG000|COMPLETED|Overall Study||43
11279109|NCT02384200|12475039|FG001|COMPLETED|Overall Study||43
11279110|NCT02384200|12475038|FG000|NOT COMPLETED|Overall Study||0
11279111|NCT02384200|12475039|FG001|NOT COMPLETED|Overall Study||0
11279112|NCT02384382|12475045|FG000|STARTED|Overall Study||23
11279113|NCT02384382|12475045|FG000|COMPLETED|Overall Study||0
11279114|NCT02384382|12475045|FG000|NOT COMPLETED|Overall Study||23
11279115|NCT02384395|12475049|FG000|STARTED|Overall Study||40
11279116|NCT02384395|12475049|FG000|Enrolled|Overall Study||40
11279117|NCT02384395|12475049|FG000|Initiated Treatment|Overall Study||37
11279118|NCT02384395|12475049|FG000|Completed Week 24|Overall Study||34
11279119|NCT02384395|12475049|FG000|Completed Week 48|Overall Study||33
11279120|NCT02384395|12475049|FG000|Completed Week 96|Overall Study||30
11279121|NCT02384395|12475049|FG000|COMPLETED|Overall Study||30
11279122|NCT02384395|12475049|FG000|NOT COMPLETED|Overall Study||10
11279123|NCT02384460|12475055|FG000|STARTED|Overall Study||82
11279124|NCT02384460|12475056|FG001|STARTED|Overall Study||87
11279125|NCT02384460|12475055|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
11279126|NCT02384460|12475056|FG001|Received at Least 1 Dose of Study Drug|Overall Study||87
11279127|NCT02384460|12475055|FG000|COMPLETED|Overall Study||75
11279128|NCT02384460|12475056|FG001|COMPLETED|Overall Study||80
11279129|NCT02384460|12475055|FG000|NOT COMPLETED|Overall Study||7
11398690|NCT04422561|12593091|FG001|COMPLETED|Overall Study||101
11398691|NCT04422561|12593090|FG000|NOT COMPLETED|Overall Study||25
11398692|NCT04422561|12593091|FG001|NOT COMPLETED|Overall Study||11
11398693|NCT04421404|12593099|FG000|STARTED|Overall Study||16
11398694|NCT04421404|12593100|FG001|STARTED|Overall Study||18
11398695|NCT04421404|12593099|FG000|COMPLETED|Overall Study||16
11279130|NCT02384460|12475056|FG001|NOT COMPLETED|Overall Study||7
11279131|NCT02384538|12475064|FG000|STARTED|Overall Study||67
11279132|NCT02384538|12475065|FG001|STARTED|Overall Study||64
11279133|NCT02384538|12475064|FG000|COMPLETED|Overall Study||61
11279134|NCT02384538|12475065|FG001|COMPLETED|Overall Study||49
11279135|NCT02384538|12475064|FG000|NOT COMPLETED|Overall Study||6
11279136|NCT02384538|12475065|FG001|NOT COMPLETED|Overall Study||15
11279137|NCT02384941|12475074|FG000|STARTED|Overall Study||268
11279138|NCT02384941|12475075|FG001|STARTED|Overall Study||263
11279139|NCT02384941|12475076|FG002|STARTED|Overall Study||262
11279140|NCT02384941|12475074|FG000|COMPLETED|Overall Study||218
11279141|NCT02384941|12475075|FG001|COMPLETED|Overall Study||228
11279142|NCT02384941|12475076|FG002|COMPLETED|Overall Study||221
11279143|NCT02384941|12475074|FG000|NOT COMPLETED|Overall Study||50
11279144|NCT02384941|12475075|FG001|NOT COMPLETED|Overall Study||35
11279145|NCT02384941|12475076|FG002|NOT COMPLETED|Overall Study||41
11279146|NCT02385084|12475085|FG000|STARTED|Period 1||3
11279147|NCT02385084|12475086|FG001|STARTED|Period 1||3
11279148|NCT02385084|12475087|FG002|STARTED|Period 1||3
11279149|NCT02385084|12475088|FG003|STARTED|Period 1||3
11279150|NCT02385084|12475089|FG004|STARTED|Period 1||3
11279151|NCT02385084|12475090|FG005|STARTED|Period 1||3
11279152|NCT02385084|12475085|FG000|Received LY2409021|Period 1||3
11279153|NCT02385084|12475086|FG001|Received LY2409021|Period 1||3
11279154|NCT02385084|12475087|FG002|Received LY2409021|Period 1||3
11279155|NCT02385084|12475088|FG003|Received LY2409021|Period 1||3
11279156|NCT02385084|12475089|FG004|Received LY2409021|Period 1||3
11279157|NCT02385084|12475090|FG005|Received LY2409021|Period 1||3
11279158|NCT02385084|12475085|FG000|Washout|Period 1||3
11279159|NCT02385084|12475086|FG001|Washout|Period 1||3
11279160|NCT02385084|12475087|FG002|Washout|Period 1||3
11279161|NCT02385084|12475088|FG003|Washout|Period 1||3
11279162|NCT02385084|12475089|FG004|Washout|Period 1||3
11279163|NCT02385084|12475090|FG005|Washout|Period 1||3
11279164|NCT02385084|12475085|FG000|COMPLETED|Period 1||3
11279165|NCT02385084|12475086|FG001|COMPLETED|Period 1||3
11279166|NCT02385084|12475087|FG002|COMPLETED|Period 1||3
11279167|NCT02385084|12475088|FG003|COMPLETED|Period 1||3
11279168|NCT02385084|12475089|FG004|COMPLETED|Period 1||3
11279169|NCT02385084|12475090|FG005|COMPLETED|Period 1||3
11279170|NCT02385084|12475085|FG000|NOT COMPLETED|Period 1||0
11279171|NCT02385084|12475086|FG001|NOT COMPLETED|Period 1||0
11279172|NCT02385084|12475087|FG002|NOT COMPLETED|Period 1||0
11279173|NCT02385084|12475088|FG003|NOT COMPLETED|Period 1||0
11279174|NCT02385084|12475089|FG004|NOT COMPLETED|Period 1||0
11398696|NCT04421404|12593100|FG001|COMPLETED|Overall Study||18
11398697|NCT04421404|12593099|FG000|NOT COMPLETED|Overall Study||0
11398698|NCT04421404|12593100|FG001|NOT COMPLETED|Overall Study||0
11398699|NCT04419311|12593108|FG000|STARTED|Overall Study||33
11398700|NCT04419311|12593109|FG001|STARTED|Overall Study||33
11279175|NCT02385084|12475090|FG005|NOT COMPLETED|Period 1||0
11279176|NCT02385084|12475085|FG000|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
11279177|NCT02385084|12475086|FG001|STARTED|Period 2||3
11279178|NCT02385084|12475087|FG002|STARTED|Period 2||3
11279179|NCT02385084|12475088|FG003|STARTED|Period 2||3
11279180|NCT02385084|12475089|FG004|STARTED|Period 2||3
11279181|NCT02385084|12475090|FG005|STARTED|Period 2||3
11279182|NCT02385084|12475085|FG000|Received LY2409021|Period 2||2
11398701|NCT04419311|12593108|FG000|COMPLETED|Overall Study||32
11398702|NCT04419311|12593109|FG001|COMPLETED|Overall Study||33
11398703|NCT04419311|12593108|FG000|NOT COMPLETED|Overall Study||1
11398704|NCT04419311|12593109|FG001|NOT COMPLETED|Overall Study||0
11398705|NCT04415489|12593119|FG000|STARTED|Overall Study||50
11279183|NCT02385084|12475086|FG001|Received LY2409021|Period 2||3
11279184|NCT02385084|12475087|FG002|Received LY2409021|Period 2||3
11279185|NCT02385084|12475088|FG003|Received LY2409021|Period 2||3
11279186|NCT02385084|12475089|FG004|Received LY2409021|Period 2||3
11279187|NCT02385084|12475090|FG005|Received LY2409021|Period 2||3
11279188|NCT02385084|12475085|FG000|Washout|Period 2||2
11279189|NCT02385084|12475086|FG001|Washout|Period 2||3
11279190|NCT02385084|12475087|FG002|Washout|Period 2||3
11279191|NCT02385084|12475088|FG003|Washout|Period 2||3
11279192|NCT02385084|12475089|FG004|Washout|Period 2||3
11279193|NCT02385084|12475090|FG005|Washout|Period 2||3
11279194|NCT02385084|12475085|FG000|COMPLETED|Period 2||2
11279195|NCT02385084|12475086|FG001|COMPLETED|Period 2||3
11279196|NCT02385084|12475087|FG002|COMPLETED|Period 2||2
11279197|NCT02385084|12475088|FG003|COMPLETED|Period 2||3
11279198|NCT02385084|12475089|FG004|COMPLETED|Period 2||3
11279199|NCT02385084|12475090|FG005|COMPLETED|Period 2||3
11279200|NCT02385084|12475085|FG000|NOT COMPLETED|Period 2||0
11279201|NCT02385084|12475086|FG001|NOT COMPLETED|Period 2||0
11279202|NCT02385084|12475087|FG002|NOT COMPLETED|Period 2||1
11279203|NCT02385084|12475088|FG003|NOT COMPLETED|Period 2||0
11279204|NCT02385084|12475089|FG004|NOT COMPLETED|Period 2||0
11279205|NCT02385084|12475090|FG005|NOT COMPLETED|Period 2||0
11279206|NCT02385084|12475085|FG000|STARTED|Period 3||2
11279207|NCT02385084|12475086|FG001|STARTED|Period 3||3
11279208|NCT02385084|12475087|FG002|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
11279209|NCT02385084|12475088|FG003|STARTED|Period 3||3
11279210|NCT02385084|12475089|FG004|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
11279211|NCT02385084|12475090|FG005|STARTED|Period 3||3
11279212|NCT02385084|12475085|FG000|Received LY2409021|Period 3||2
11279213|NCT02385084|12475086|FG001|Received LY2409021|Period 3||3
11279214|NCT02385084|12475087|FG002|Received LY2409021|Period 3||1
11279215|NCT02385084|12475088|FG003|Received LY2409021|Period 3||3
11279216|NCT02385084|12475089|FG004|Received LY2409021|Period 3||2
11279217|NCT02385084|12475090|FG005|Received LY2409021|Period 3||3
11279218|NCT02385084|12475085|FG000|Washout|Period 3||2
11279219|NCT02385084|12475086|FG001|Washout|Period 3||3
11279220|NCT02385084|12475087|FG002|Washout|Period 3||1
11279221|NCT02385084|12475088|FG003|Washout|Period 3||3
11279222|NCT02385084|12475089|FG004|Washout|Period 3||2
11279223|NCT02385084|12475090|FG005|Washout|Period 3||3
11279224|NCT02385084|12475085|FG000|COMPLETED|Period 3||2
11279225|NCT02385084|12475086|FG001|COMPLETED|Period 3||3
11279226|NCT02385084|12475087|FG002|COMPLETED|Period 3||1
11279227|NCT02385084|12475088|FG003|COMPLETED|Period 3||3
11279228|NCT02385084|12475089|FG004|COMPLETED|Period 3||2
11279229|NCT02385084|12475090|FG005|COMPLETED|Period 3||3
11279230|NCT02385084|12475085|FG000|NOT COMPLETED|Period 3||0
11279231|NCT02385084|12475086|FG001|NOT COMPLETED|Period 3||0
11279232|NCT02385084|12475087|FG002|NOT COMPLETED|Period 3||0
11279233|NCT02385084|12475088|FG003|NOT COMPLETED|Period 3||0
11279234|NCT02385084|12475089|FG004|NOT COMPLETED|Period 3||0
11279235|NCT02385084|12475090|FG005|NOT COMPLETED|Period 3||0
11279236|NCT02385097|12475101|FG000|STARTED|Overall Study||106
11279237|NCT02385097|12475102|FG001|STARTED|Overall Study||105
11279238|NCT02385097|12475101|FG000|COMPLETED|Overall Study||106
11279239|NCT02385097|12475102|FG001|COMPLETED|Overall Study||105
11279240|NCT02385097|12475101|FG000|NOT COMPLETED|Overall Study||0
11279241|NCT02385097|12475102|FG001|NOT COMPLETED|Overall Study||0
11279242|NCT02385240|12475111|FG000|STARTED|Overall Study||183
11279243|NCT02385240|12475112|FG001|STARTED|Overall Study||184
11279244|NCT02385240|12475113|FG002|STARTED|Overall Study||185
11279245|NCT02385240|12475111|FG000|COMPLETED|Overall Study||182
11279246|NCT02385240|12475112|FG001|COMPLETED|Overall Study||178
11279247|NCT02385240|12475113|FG002|COMPLETED|Overall Study||184
11279248|NCT02385240|12475111|FG000|NOT COMPLETED|Overall Study||1
11279249|NCT02385240|12475112|FG001|NOT COMPLETED|Overall Study||6
11279250|NCT02385240|12475113|FG002|NOT COMPLETED|Overall Study||1
11279251|NCT02385318|12475124|FG000|STARTED|Overall Study||204
11279252|NCT02385318|12475125|FG001|STARTED|Overall Study||210
11279253|NCT02385318|12475126|FG002|STARTED|Overall Study||105
11279254|NCT02385318|12475124|FG000|COMPLETED|Overall Study||200
11279255|NCT02385318|12475125|FG001|COMPLETED|Overall Study||203
11279256|NCT02385318|12475126|FG002|COMPLETED|Overall Study||99
11279257|NCT02385318|12475124|FG000|NOT COMPLETED|Overall Study||4
11279258|NCT02385318|12475125|FG001|NOT COMPLETED|Overall Study||7
11279259|NCT02385318|12475126|FG002|NOT COMPLETED|Overall Study||6
11279260|NCT02385526|12475137|FG000|STARTED|Overall Study||22
11279261|NCT02385526|12475138|FG001|STARTED|Overall Study||20
11279262|NCT02385526|12475139|FG002|STARTED|Overall Study||20
11279263|NCT02385526|12475137|FG000|COMPLETED|Overall Study||20
11279264|NCT02385526|12475138|FG001|COMPLETED|Overall Study||17
11279265|NCT02385526|12475139|FG002|COMPLETED|Overall Study||20
11279266|NCT02385526|12475137|FG000|NOT COMPLETED|Overall Study||2
11279267|NCT02385526|12475138|FG001|NOT COMPLETED|Overall Study||3
11279268|NCT02385526|12475139|FG002|NOT COMPLETED|Overall Study||0
11279269|NCT02385669|12475147|FG000|STARTED|Overall Study||3
11279270|NCT02385669|12475147|FG000|COMPLETED|Overall Study||1
11279271|NCT02385669|12475147|FG000|NOT COMPLETED|Overall Study||2
11279272|NCT02385708|12475153|FG000|STARTED|Overall Study||81
11279273|NCT02385708|12475154|FG001|STARTED|Overall Study||82
11279274|NCT02385708|12475153|FG000|Intervention Started|Overall Study||81
11279275|NCT02385708|12475154|FG001|Intervention Started|Overall Study||82
11279276|NCT02385708|12475153|FG000|COMPLETED|Overall Study||73
11279277|NCT02385708|12475154|FG001|COMPLETED|Overall Study||67
11279278|NCT02385708|12475153|FG000|NOT COMPLETED|Overall Study||8
11279279|NCT02385708|12475154|FG001|NOT COMPLETED|Overall Study||15
11279280|NCT02385721|12475160|FG000|STARTED|Overall Study||601
11279281|NCT02385721|12475160|FG000|COMPLETED|Overall Study||371
11279282|NCT02385721|12475160|FG000|NOT COMPLETED|Overall Study||230
11279283|NCT02385799|12475166|FG000|STARTED|Overall Study||26
11279284|NCT02385799|12475167|FG001|STARTED|Overall Study||32
11279285|NCT02385799|12475166|FG000|Completed End-of-Treatment Visit|Overall Study||21
11279286|NCT02385799|12475167|FG001|Completed End-of-Treatment Visit|Overall Study||26
11279287|NCT02385799|12475166|FG000|COMPLETED|Overall Study||21
11279288|NCT02385799|12475167|FG001|COMPLETED|Overall Study||24
11279289|NCT02385799|12475166|FG000|NOT COMPLETED|Overall Study||5
11279290|NCT02385799|12475167|FG001|NOT COMPLETED|Overall Study||8
11279291|NCT02386098|12475178|FG000|STARTED|Stage 1 (96 Weeks)||43
11279292|NCT02386098|12475179|FG001|STARTED|Stage 1 (96 Weeks)||43
11279293|NCT02386098|12475180|FG002|STARTED|Stage 1 (96 Weeks)||0
11279294|NCT02386098|12475181|FG003|STARTED|Stage 1 (96 Weeks)||0
11279295|NCT02386098|12475182|FG004|STARTED|Stage 1 (96 Weeks)||0
11279296|NCT02386098|12475178|FG000|COMPLETED|Stage 1 (96 Weeks)||0
11279297|NCT02386098|12475179|FG001|COMPLETED|Stage 1 (96 Weeks)||0
11279298|NCT02386098|12475180|FG002|COMPLETED|Stage 1 (96 Weeks)||0
11279299|NCT02386098|12475181|FG003|COMPLETED|Stage 1 (96 Weeks)||0
11279300|NCT02386098|12475182|FG004|COMPLETED|Stage 1 (96 Weeks)||0
11279301|NCT02386098|12475178|FG000|NOT COMPLETED|Stage 1 (96 Weeks)||43
11279302|NCT02386098|12475179|FG001|NOT COMPLETED|Stage 1 (96 Weeks)||43
11279303|NCT02386098|12475180|FG002|NOT COMPLETED|Stage 1 (96 Weeks)||0
11279304|NCT02386098|12475181|FG003|NOT COMPLETED|Stage 1 (96 Weeks)||0
11279305|NCT02386098|12475182|FG004|NOT COMPLETED|Stage 1 (96 Weeks)||0
11279306|NCT02386098|12475178|FG000|STARTED|Stage 2 (96 Weeks)||0
11279307|NCT02386098|12475179|FG001|STARTED|Stage 2 (96 Weeks)||0
11279308|NCT02386098|12475180|FG002|STARTED|Stage 2 (96 Weeks)||0
11279309|NCT02386098|12475181|FG003|STARTED|Stage 2 (96 Weeks)||0
11279310|NCT02386098|12475182|FG004|STARTED|Stage 2 (96 Weeks)||0
11279311|NCT02386098|12475178|FG000|COMPLETED|Stage 2 (96 Weeks)||0
11279312|NCT02386098|12475179|FG001|COMPLETED|Stage 2 (96 Weeks)||0
11279313|NCT02386098|12475180|FG002|COMPLETED|Stage 2 (96 Weeks)||0
11279314|NCT02386098|12475181|FG003|COMPLETED|Stage 2 (96 Weeks)||0
11279315|NCT02386098|12475182|FG004|COMPLETED|Stage 2 (96 Weeks)||0
11279316|NCT02386098|12475178|FG000|NOT COMPLETED|Stage 2 (96 Weeks)||0
11279317|NCT02386098|12475179|FG001|NOT COMPLETED|Stage 2 (96 Weeks)||0
11279318|NCT02386098|12475180|FG002|NOT COMPLETED|Stage 2 (96 Weeks)||0
11279319|NCT02386098|12475181|FG003|NOT COMPLETED|Stage 2 (96 Weeks)||0
11279320|NCT02386098|12475182|FG004|NOT COMPLETED|Stage 2 (96 Weeks)||0
11279321|NCT02386189|12475196|FG000|STARTED|Overall Study||30
11279322|NCT02386189|12475197|FG001|STARTED|Overall Study||33
11279323|NCT02386189|12475196|FG000|COMPLETED|Overall Study||26
11279324|NCT02386189|12475197|FG001|COMPLETED|Overall Study||30
11279325|NCT02386189|12475196|FG000|NOT COMPLETED|Overall Study||4
11279326|NCT02386189|12475197|FG001|NOT COMPLETED|Overall Study||3
11279327|NCT02386319|12475205|FG000|STARTED|Overall Study||18
11279328|NCT02386319|12475206|FG001|STARTED|Overall Study||18
11279329|NCT02386319|12475205|FG000|COMPLETED|Overall Study||16
11279330|NCT02386319|12475206|FG001|COMPLETED|Overall Study||17
11279331|NCT02386319|12475205|FG000|NOT COMPLETED|Overall Study||2
11279332|NCT02386319|12475206|FG001|NOT COMPLETED|Overall Study||1
11279333|NCT02386345|12475212|FG000|STARTED|Overall Study||299
11279334|NCT02386345|12475212|FG000|COMPLETED|Overall Study||197
11279335|NCT02386345|12475212|FG000|NOT COMPLETED|Overall Study||102
11279336|NCT02386605|12475218|FG000|STARTED|Overall Study||41
11279337|NCT02386605|12475219|FG001|STARTED|Overall Study||38
11279338|NCT02386605|12475218|FG000|COMPLETED|Overall Study||34
11279339|NCT02386605|12475219|FG001|COMPLETED|Overall Study||28
11279340|NCT02386605|12475218|FG000|NOT COMPLETED|Overall Study||7
11279341|NCT02386605|12475219|FG001|NOT COMPLETED|Overall Study||10
11279342|NCT02386995|12475225|FG000|STARTED|Overall Study||30
11279343|NCT02386995|12475225|FG000|COMPLETED|Overall Study||30
11279344|NCT02386995|12475225|FG000|NOT COMPLETED|Overall Study||0
11279345|NCT02387008|12475233|FG000|STARTED|Overall Study||2
11279346|NCT02387008|12475234|FG001|STARTED|Overall Study||0
11279347|NCT02387008|12475235|FG002|STARTED|Overall Study||4
11279348|NCT02387008|12475233|FG000|COMPLETED|Overall Study||2
11279349|NCT02387008|12475234|FG001|COMPLETED|Overall Study||0
11279350|NCT02387008|12475235|FG002|COMPLETED|Overall Study||4
11279351|NCT02387008|12475233|FG000|NOT COMPLETED|Overall Study||0
11279352|NCT02387008|12475234|FG001|NOT COMPLETED|Overall Study||0
11279353|NCT02387008|12475235|FG002|NOT COMPLETED|Overall Study||0
11279354|NCT02387164|12475245|FG000|STARTED|Overall Study||13
11279355|NCT02387164|12475246|FG001|STARTED|Overall Study||13
11279356|NCT02387164|12475245|FG000|COMPLETED|Overall Study||10
11279357|NCT02387164|12475246|FG001|COMPLETED|Overall Study||11
11279358|NCT02387164|12475245|FG000|NOT COMPLETED|Overall Study||3
11279359|NCT02387164|12475246|FG001|NOT COMPLETED|Overall Study||2
11279360|NCT02387216|12475254|FG000|STARTED|Overall Study||103
11279361|NCT02387216|12475255|FG001|STARTED|Overall Study||49
11279362|NCT02387216|12475254|FG000|COMPLETED|Overall Study||3
11279363|NCT02387216|12475255|FG001|COMPLETED|Overall Study||2
11279364|NCT02387216|12475254|FG000|NOT COMPLETED|Overall Study||100
11279365|NCT02387216|12475255|FG001|NOT COMPLETED|Overall Study||47
11279366|NCT02387268|12475261|FG000|STARTED|Overall Study||10
11279367|NCT02387268|12475261|FG000|COMPLETED|Overall Study||9
11279368|NCT02387268|12475261|FG000|NOT COMPLETED|Overall Study||1
11279369|NCT02387294|12475267|FG000|STARTED|Overall Study||60
11279370|NCT02387294|12475268|FG001|STARTED|Overall Study||60
11279371|NCT02387294|12475267|FG000|COMPLETED|Overall Study||60
11279372|NCT02387294|12475268|FG001|COMPLETED|Overall Study||60
11279373|NCT02387294|12475267|FG000|NOT COMPLETED|Overall Study||0
11279374|NCT02387294|12475268|FG001|NOT COMPLETED|Overall Study||0
11279375|NCT02387359|12475278|FG000|STARTED|Overall Study||354
11279376|NCT02387359|12475279|FG001|STARTED|Overall Study||351
11279377|NCT02387359|12475280|FG002|STARTED|Overall Study||349
11279378|NCT02387359|12475278|FG000|COMPLETED|Overall Study||295
11279379|NCT02387359|12475279|FG001|COMPLETED|Overall Study||309
11279380|NCT02387359|12475280|FG002|COMPLETED|Overall Study||293
11279381|NCT02387359|12475278|FG000|NOT COMPLETED|Overall Study||59
11279382|NCT02387359|12475279|FG001|NOT COMPLETED|Overall Study||42
11279383|NCT02387359|12475280|FG002|NOT COMPLETED|Overall Study||56
11279384|NCT02387372|12475290|FG000|STARTED|Overall Study||27
11279385|NCT02387372|12475291|FG001|STARTED|Overall Study||10
11279386|NCT02387372|12475290|FG000|Treated|Overall Study||26
11279387|NCT02387372|12475291|FG001|Treated|Overall Study||10
11279388|NCT02387372|12475290|FG000|COMPLETED|Overall Study||26
11279389|NCT02387372|12475291|FG001|COMPLETED|Overall Study||10
11279390|NCT02387372|12475290|FG000|NOT COMPLETED|Overall Study||1
11279391|NCT02387372|12475291|FG001|NOT COMPLETED|Overall Study||0
11279392|NCT02387476|12475307|FG000|STARTED|Overall Study||25
11279393|NCT02387476|12475308|FG001|STARTED|Overall Study||22
11279394|NCT02387476|12475307|FG000|COMPLETED|Overall Study||19
11279395|NCT02387476|12475308|FG001|COMPLETED|Overall Study||17
11279396|NCT02387476|12475307|FG000|NOT COMPLETED|Overall Study||6
11279397|NCT02387476|12475308|FG001|NOT COMPLETED|Overall Study||5
11279398|NCT02387502|12475319|FG000|STARTED|Overall Study||40
11279399|NCT02387502|12475320|FG001|STARTED|Overall Study||40
11279400|NCT02387502|12475321|FG002|STARTED|Overall Study||40
11279401|NCT02387502|12475319|FG000|COMPLETED|Overall Study||40
11279402|NCT02387502|12475320|FG001|COMPLETED|Overall Study||40
11279403|NCT02387502|12475321|FG002|COMPLETED|Overall Study||40
11279404|NCT02387502|12475319|FG000|NOT COMPLETED|Overall Study||0
11279405|NCT02387502|12475320|FG001|NOT COMPLETED|Overall Study||0
11279406|NCT02387502|12475321|FG002|NOT COMPLETED|Overall Study||0
11279407|NCT02387554|12475333|FG000|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
11279408|NCT02387554|12475334|FG001|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
11279409|NCT02387554|12475335|FG002|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
11279410|NCT02387554|12475336|FG003|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
11279411|NCT02387554|12475333|FG000|COMPLETED|Overall Study||7
11279412|NCT02387554|12475334|FG001|COMPLETED|Overall Study||7
11279413|NCT02387554|12475335|FG002|COMPLETED|Overall Study||6
11279414|NCT02387554|12475336|FG003|COMPLETED|Overall Study||6
11279415|NCT02387554|12475333|FG000|NOT COMPLETED|Overall Study||3
11279416|NCT02387554|12475334|FG001|NOT COMPLETED|Overall Study||0
11279417|NCT02387554|12475335|FG002|NOT COMPLETED|Overall Study||2
11279418|NCT02387554|12475336|FG003|NOT COMPLETED|Overall Study||2
11279419|NCT02387580|12475352|FG000|STARTED|Overall Study||8
11279420|NCT02387580|12475353|FG001|STARTED|Overall Study||8
11279421|NCT02387580|12475354|FG002|STARTED|Overall Study||8
11279422|NCT02387580|12475355|FG003|STARTED|Overall Study||8
11279423|NCT02387580|12475356|FG004|STARTED|Overall Study||8
11279424|NCT02387580|12475357|FG005|STARTED|Overall Study||8
11279425|NCT02387580|12475352|FG000|COMPLETED|Overall Study||8
11279426|NCT02387580|12475353|FG001|COMPLETED|Overall Study||8
11279427|NCT02387580|12475354|FG002|COMPLETED|Overall Study||8
11279428|NCT02387580|12475355|FG003|COMPLETED|Overall Study||7
11279429|NCT02387580|12475356|FG004|COMPLETED|Overall Study||8
11279430|NCT02387580|12475357|FG005|COMPLETED|Overall Study||8
11279431|NCT02387580|12475352|FG000|NOT COMPLETED|Overall Study||0
11279432|NCT02387580|12475353|FG001|NOT COMPLETED|Overall Study||0
11279433|NCT02387580|12475354|FG002|NOT COMPLETED|Overall Study||0
11279434|NCT02387580|12475355|FG003|NOT COMPLETED|Overall Study||1
11279435|NCT02387580|12475356|FG004|NOT COMPLETED|Overall Study||0
11279436|NCT02387580|12475357|FG005|NOT COMPLETED|Overall Study||0
11279437|NCT02387710|12475373|FG000|STARTED|First Study Night||9
11279438|NCT02387710|12475374|FG001|STARTED|First Study Night||9
11279439|NCT02387710|12475373|FG000|COMPLETED|First Study Night||9
11279440|NCT02387710|12475374|FG001|COMPLETED|First Study Night||9
11279441|NCT02387710|12475373|FG000|NOT COMPLETED|First Study Night||0
11279442|NCT02387710|12475374|FG001|NOT COMPLETED|First Study Night||0
11279443|NCT02387710|12475373|FG000|STARTED|Second Study Night||9
11279444|NCT02387710|12475374|FG001|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
11279445|NCT02387710|12475373|FG000|COMPLETED|Second Study Night||9
11279446|NCT02387710|12475374|FG001|COMPLETED|Second Study Night||7
11279447|NCT02387710|12475373|FG000|NOT COMPLETED|Second Study Night||0
11279448|NCT02387710|12475374|FG001|NOT COMPLETED|Second Study Night||0
11279449|NCT02387749|12475382|FG000|STARTED|Overall Study||10
11279450|NCT02387749|12475382|FG000|COMPLETED|Overall Study||10
11279451|NCT02387749|12475382|FG000|NOT COMPLETED|Overall Study||0
11279452|NCT02387762|12475393|FG000|STARTED|Overall Study||16
11279453|NCT02387762|12475394|FG001|STARTED|Overall Study||15
11279454|NCT02387762|12475393|FG000|COMPLETED|Overall Study||15
11279455|NCT02387762|12475394|FG001|COMPLETED|Overall Study||15
11279456|NCT02387762|12475393|FG000|NOT COMPLETED|Overall Study||1
11279457|NCT02387762|12475394|FG001|NOT COMPLETED|Overall Study||0
11279458|NCT02387801|12475402|FG000|STARTED|Induction Dosing Period||6
11279459|NCT02387801|12475403|FG001|STARTED|Induction Dosing Period||6
11279460|NCT02387801|12475402|FG000|COMPLETED|Induction Dosing Period||6
11279461|NCT02387801|12475403|FG001|COMPLETED|Induction Dosing Period||6
11279462|NCT02387801|12475402|FG000|NOT COMPLETED|Induction Dosing Period||0
11279463|NCT02387801|12475403|FG001|NOT COMPLETED|Induction Dosing Period||0
11279464|NCT02387801|12475402|FG000|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
11279465|NCT02387801|12475403|FG001|STARTED|Maintenance Dosing Period||12
11279466|NCT02387801|12475402|FG000|COMPLETED|Maintenance Dosing Period||0
11279467|NCT02387801|12475403|FG001|COMPLETED|Maintenance Dosing Period||12
11279468|NCT02387801|12475402|FG000|NOT COMPLETED|Maintenance Dosing Period||0
11279469|NCT02387801|12475403|FG001|NOT COMPLETED|Maintenance Dosing Period||0
11279470|NCT02387801|12475402|FG000|STARTED|Post-Treatment Follow-up||0
11279471|NCT02387801|12475403|FG001|STARTED|Post-Treatment Follow-up||12
11279472|NCT02387801|12475402|FG000|COMPLETED|Post-Treatment Follow-up||0
11279473|NCT02387801|12475403|FG001|COMPLETED|Post-Treatment Follow-up||12
11279474|NCT02387801|12475402|FG000|NOT COMPLETED|Post-Treatment Follow-up||0
11279475|NCT02387801|12475403|FG001|NOT COMPLETED|Post-Treatment Follow-up||0
11279476|NCT02387814|12475415|FG000|STARTED|Overall Study||10
11279477|NCT02387814|12475416|FG001|STARTED|Overall Study||9
11279478|NCT02387814|12475417|FG002|STARTED|Overall Study||10
11279479|NCT02387814|12475418|FG003|STARTED|Overall Study||6
11279480|NCT02387814|12475415|FG000|Received Abemaciclib|Overall Study||10
11279481|NCT02387814|12475416|FG001|Received Abemaciclib|Overall Study||9
11279482|NCT02387814|12475417|FG002|Received Abemaciclib|Overall Study||10
11279483|NCT02387814|12475418|FG003|Received Abemaciclib|Overall Study||6
11279484|NCT02387814|12475415|FG000|COMPLETED|Overall Study||10
11279485|NCT02387814|12475416|FG001|COMPLETED|Overall Study||9
11279486|NCT02387814|12475417|FG002|COMPLETED|Overall Study||10
11279487|NCT02387814|12475418|FG003|COMPLETED|Overall Study||6
11279488|NCT02387814|12475415|FG000|NOT COMPLETED|Overall Study||0
11279489|NCT02387814|12475416|FG001|NOT COMPLETED|Overall Study||0
11279490|NCT02387814|12475417|FG002|NOT COMPLETED|Overall Study||0
11279491|NCT02387814|12475418|FG003|NOT COMPLETED|Overall Study||0
11279492|NCT02387840|12475434|FG000|STARTED|Overall Study||4
11279493|NCT02387840|12475435|FG001|STARTED|Overall Study||6
11279494|NCT02387840|12475436|FG002|STARTED|Overall Study||6
11279495|NCT02387840|12475437|FG003|STARTED|Overall Study||8
11279496|NCT02387840|12475438|FG004|STARTED|Overall Study||4
11279497|NCT02387840|12475439|FG005|STARTED|Overall Study||6
11279498|NCT02387840|12475434|FG000|COMPLETED|Overall Study||4
11279499|NCT02387840|12475435|FG001|COMPLETED|Overall Study||6
11279500|NCT02387840|12475436|FG002|COMPLETED|Overall Study||6
11279501|NCT02387840|12475437|FG003|COMPLETED|Overall Study||8
11279502|NCT02387840|12475438|FG004|COMPLETED|Overall Study||4
11279503|NCT02387840|12475439|FG005|COMPLETED|Overall Study||5
11279504|NCT02387840|12475434|FG000|NOT COMPLETED|Overall Study||0
11398706|NCT04415489|12593120|FG001|STARTED|Overall Study||50
11398707|NCT04415489|12593119|FG000|COMPLETED|Overall Study||50
11279505|NCT02387840|12475435|FG001|NOT COMPLETED|Overall Study||0
11398708|NCT04415489|12593120|FG001|COMPLETED|Overall Study||50
11279506|NCT02387840|12475436|FG002|NOT COMPLETED|Overall Study||0
11279507|NCT02387840|12475437|FG003|NOT COMPLETED|Overall Study||0
11279508|NCT02387840|12475438|FG004|NOT COMPLETED|Overall Study||0
11279509|NCT02387840|12475439|FG005|NOT COMPLETED|Overall Study||1
11279510|NCT02387853|12475459|FG000|STARTED|Overall Study||106
11279511|NCT02387853|12475459|FG000|COMPLETED|Overall Study||103
11398709|NCT04415489|12593119|FG000|NOT COMPLETED|Overall Study||0
11398710|NCT04415489|12593120|FG001|NOT COMPLETED|Overall Study||0
11279512|NCT02387853|12475459|FG000|NOT COMPLETED|Overall Study||3
11279513|NCT02387957|12475466|FG000|STARTED|Overall Study||21
11279514|NCT02387957|12475467|FG001|STARTED|Overall Study||21
11279515|NCT02387957|12475468|FG002|STARTED|Overall Study||21
11279516|NCT02387957|12475466|FG000|COMPLETED|Overall Study|The study was discontinued|0
11279517|NCT02387957|12475467|FG001|COMPLETED|Overall Study|The study was discontinued|0
11279518|NCT02387957|12475468|FG002|COMPLETED|Overall Study|The study was discontinued|1
11279519|NCT02387957|12475466|FG000|NOT COMPLETED|Overall Study||21
11279520|NCT02387957|12475467|FG001|NOT COMPLETED|Overall Study||21
11279521|NCT02387957|12475468|FG002|NOT COMPLETED|Overall Study||20
11279522|NCT02387970|12475478|FG000|STARTED|Overall Study||27
11279523|NCT02387970|12475479|FG001|STARTED|Overall Study||25
11279524|NCT02387970|12475478|FG000|COMPLETED|Overall Study||26
11279525|NCT02387970|12475479|FG001|COMPLETED|Overall Study||23
11279526|NCT02387970|12475478|FG000|NOT COMPLETED|Overall Study||1
11279527|NCT02387970|12475479|FG001|NOT COMPLETED|Overall Study||2
11279528|NCT02387983|12475485|FG000|STARTED|Overall Study||65
11279529|NCT02387983|12475485|FG000|COMPLETED|Overall Study||58
11279530|NCT02387983|12475485|FG000|NOT COMPLETED|Overall Study||7
11279531|NCT02388074|12475489|FG000|STARTED|Overall Study||25
11279532|NCT02388074|12475489|FG000|COMPLETED|Overall Study||22
11279533|NCT02388074|12475489|FG000|NOT COMPLETED|Overall Study||3
11279534|NCT02388165|12475495|FG000|STARTED|Overall Study||1726
11279535|NCT02388165|12475496|FG001|STARTED|Overall Study||1724
11279536|NCT02388165|12475495|FG000|Vaccinated (Safety Population)|Overall Study||1708
11279537|NCT02388165|12475496|FG001|Vaccinated (Safety Population)|Overall Study||1709
11279538|NCT02388165|12475495|FG000|COMPLETED|Overall Study||1599
11279539|NCT02388165|12475496|FG001|COMPLETED|Overall Study||1594
11279540|NCT02388165|12475495|FG000|NOT COMPLETED|Overall Study||127
11398711|NCT04411667|12593129|FG000|STARTED|Overall Study||17
11398712|NCT04411667|12593130|FG001|STARTED|Overall Study||17
11398713|NCT04411667|12593129|FG000|COMPLETED|Overall Study||16
11398714|NCT04411667|12593130|FG001|COMPLETED|Overall Study||17
11279541|NCT02388165|12475496|FG001|NOT COMPLETED|Overall Study||130
11279542|NCT02388191|12475504|FG000|STARTED|Overall Study||59
11279543|NCT02388191|12475505|FG001|STARTED|Overall Study||60
11279544|NCT02388191|12475504|FG000|COMPLETED|Overall Study||58
11279545|NCT02388191|12475505|FG001|COMPLETED|Overall Study||60
11279546|NCT02388191|12475504|FG000|NOT COMPLETED|Overall Study||1
11279547|NCT02388191|12475505|FG001|NOT COMPLETED|Overall Study||0
11279548|NCT02388269|12475515|FG000|STARTED|Overall Study||41
11398715|NCT04411667|12593129|FG000|NOT COMPLETED|Overall Study||1
11398716|NCT04411667|12593130|FG001|NOT COMPLETED|Overall Study||0
11398717|NCT04409886|12593136|FG000|STARTED|Overall Study||1
11398718|NCT04409886|12593136|FG000|COMPLETED|Overall Study||1
11398719|NCT04409886|12593136|FG000|NOT COMPLETED|Overall Study||0
11398720|NCT04407507|12593142|FG000|STARTED|Overall Study||33
11398721|NCT04407507|12593143|FG001|STARTED|Overall Study||33
11398722|NCT04407507|12593142|FG000|COMPLETED|Overall Study||33
11398723|NCT04407507|12593143|FG001|COMPLETED|Overall Study||32
11398724|NCT04407507|12593142|FG000|NOT COMPLETED|Overall Study||0
11398725|NCT04407507|12593143|FG001|NOT COMPLETED|Overall Study||1
11398726|NCT04406194|12593151|FG000|STARTED|Period 1||15
11398727|NCT04406194|12593152|FG001|STARTED|Period 1||15
11398728|NCT04406194|12593151|FG000|COMPLETED|Period 1||15
11398729|NCT04406194|12593152|FG001|COMPLETED|Period 1||14
11398730|NCT04406194|12593151|FG000|NOT COMPLETED|Period 1||0
11398731|NCT04406194|12593152|FG001|NOT COMPLETED|Period 1||1
11398732|NCT04406194|12593151|FG000|STARTED|Period 2||15
11398733|NCT04406194|12593152|FG001|STARTED|Period 2||14
11398734|NCT04406194|12593151|FG000|COMPLETED|Period 2||15
11398735|NCT04406194|12593152|FG001|COMPLETED|Period 2||14
11398736|NCT04406194|12593151|FG000|NOT COMPLETED|Period 2||0
11398737|NCT04406194|12593152|FG001|NOT COMPLETED|Period 2||0
11398738|NCT04404907|12593163|FG000|STARTED|Overall Study||442
11398739|NCT04404907|12593164|FG001|STARTED|Overall Study||95
11398740|NCT04404907|12593163|FG000|Occasional Tan|Overall Study||0
11398741|NCT04404907|12593164|FG001|Occasional Tan|Overall Study||88
11398742|NCT04404907|12593163|FG000|Frequent Tan|Overall Study||0
11398743|NCT04404907|12593164|FG001|Frequent Tan|Overall Study||7
11398744|NCT04404907|12593163|FG000|COMPLETED|Overall Study||442
11398745|NCT04404907|12593164|FG001|COMPLETED|Overall Study||95
11398746|NCT04404907|12593163|FG000|NOT COMPLETED|Overall Study||0
11398747|NCT04404907|12593164|FG001|NOT COMPLETED|Overall Study||0
11398748|NCT04403399|12593172|FG000|STARTED|Period 1||18
11398749|NCT04403399|12593173|FG001|STARTED|Period 1||16
11398750|NCT04403399|12593172|FG000|COMPLETED|Period 1||18
11398751|NCT04403399|12593173|FG001|COMPLETED|Period 1||16
11398752|NCT04403399|12593172|FG000|NOT COMPLETED|Period 1||0
11398753|NCT04403399|12593173|FG001|NOT COMPLETED|Period 1||0
11398754|NCT04403399|12593172|FG000|STARTED|Period 2||18
11398755|NCT04403399|12593173|FG001|STARTED|Period 2||16
11398756|NCT04403399|12593172|FG000|COMPLETED|Period 2||18
11398757|NCT04403399|12593173|FG001|COMPLETED|Period 2||15
11398758|NCT04403399|12593172|FG000|NOT COMPLETED|Period 2||0
11398759|NCT04403399|12593173|FG001|NOT COMPLETED|Period 2||1
11398760|NCT04402970|12593181|FG000|STARTED|Overall Study||10
11398761|NCT04402970|12593182|FG001|STARTED|Overall Study||20
11398762|NCT04402970|12593181|FG000|COMPLETED|Overall Study||10
11398763|NCT04402970|12593182|FG001|COMPLETED|Overall Study||20
11398764|NCT04402970|12593181|FG000|NOT COMPLETED|Overall Study||0
11398765|NCT04402970|12593182|FG001|NOT COMPLETED|Overall Study||0
11398766|NCT04403113|12593190|FG000|STARTED|Overall Study||20
11398767|NCT04403113|12593191|FG001|STARTED|Overall Study||20
11398768|NCT04403113|12593190|FG000|COMPLETED|Overall Study||20
11398769|NCT04403113|12593191|FG001|COMPLETED|Overall Study||20
11398770|NCT04403113|12593190|FG000|NOT COMPLETED|Overall Study||0
11398771|NCT04403113|12593191|FG001|NOT COMPLETED|Overall Study||0
11398772|NCT04401202|12593203|FG000|STARTED|Overall Study||92
11398773|NCT04401202|12593204|FG001|STARTED|Overall Study||91
11398774|NCT04401202|12593203|FG000|COMPLETED|Overall Study||86
11398775|NCT04401202|12593204|FG001|COMPLETED|Overall Study||87
11398776|NCT04401202|12593203|FG000|NOT COMPLETED|Overall Study||6
11398777|NCT04401202|12593204|FG001|NOT COMPLETED|Overall Study||4
11398778|NCT04400682|12593213|FG000|STARTED|Period 1||15
11398779|NCT04400682|12593214|FG001|STARTED|Period 1||15
11398780|NCT04400682|12593213|FG000|COMPLETED|Period 1||14
11398781|NCT04400682|12593214|FG001|COMPLETED|Period 1||11
11398782|NCT04400682|12593213|FG000|NOT COMPLETED|Period 1||1
11398783|NCT04400682|12593214|FG001|NOT COMPLETED|Period 1||4
11398784|NCT04400682|12593213|FG000|STARTED|Period 2||14
11398785|NCT04400682|12593214|FG001|STARTED|Period 2||11
11398786|NCT04400682|12593213|FG000|COMPLETED|Period 2||14
11398787|NCT04400682|12593214|FG001|COMPLETED|Period 2||11
11398788|NCT04400682|12593213|FG000|NOT COMPLETED|Period 2||0
11398789|NCT04400682|12593214|FG001|NOT COMPLETED|Period 2||0
11398790|NCT04399161|12593223|FG000|STARTED|Overall Study||20
11398791|NCT04399161|12593224|FG001|STARTED|Overall Study||20
11398792|NCT04399161|12593225|FG002|STARTED|Overall Study||20
11398793|NCT04399161|12593223|FG000|COMPLETED|Overall Study||18
11279549|NCT02388269|12475516|FG001|STARTED|Overall Study||40
11279550|NCT02388269|12475517|FG002|STARTED|Overall Study||10
11279551|NCT02388269|12475515|FG000|Randomised Period|Overall Study||41
11279552|NCT02388269|12475516|FG001|Randomised Period|Overall Study||40
11279553|NCT02388269|12475517|FG002|Randomised Period|Overall Study||0
11279554|NCT02388269|12475515|FG000|Open Label|Overall Study||37
11279555|NCT02388269|12475516|FG001|Open Label|Overall Study||38
11398794|NCT04399161|12593224|FG001|COMPLETED|Overall Study||18
11398795|NCT04399161|12593225|FG002|COMPLETED|Overall Study||18
11279556|NCT02388269|12475517|FG002|Open Label|Overall Study||0
11279557|NCT02388269|12475515|FG000|COMPLETED|Overall Study||32
11279558|NCT02388269|12475516|FG001|COMPLETED|Overall Study||38
11279559|NCT02388269|12475517|FG002|COMPLETED|Overall Study||0
11279560|NCT02388269|12475515|FG000|NOT COMPLETED|Overall Study||9
11279561|NCT02388269|12475516|FG001|NOT COMPLETED|Overall Study||2
11279562|NCT02388269|12475517|FG002|NOT COMPLETED|Overall Study||10
11279563|NCT02388295|12475544|FG000|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
11279564|NCT02388295|12475545|FG001|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
11279565|NCT02388295|12475546|FG002|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
11279566|NCT02388295|12475544|FG000|COMPLETED|Dose Escalation Week 1||17
11279567|NCT02388295|12475545|FG001|COMPLETED|Dose Escalation Week 1||16
11279568|NCT02388295|12475546|FG002|COMPLETED|Dose Escalation Week 1||18
11279569|NCT02388295|12475544|FG000|NOT COMPLETED|Dose Escalation Week 1||2
11279570|NCT02388295|12475545|FG001|NOT COMPLETED|Dose Escalation Week 1||3
11279571|NCT02388295|12475546|FG002|NOT COMPLETED|Dose Escalation Week 1||2
11279572|NCT02388295|12475544|FG000|STARTED|Dose Escalation Week 2||17
11279573|NCT02388295|12475545|FG001|STARTED|Dose Escalation Week 2||16
11279574|NCT02388295|12475546|FG002|STARTED|Dose Escalation Week 2||18
11279575|NCT02388295|12475544|FG000|COMPLETED|Dose Escalation Week 2||16
11279576|NCT02388295|12475545|FG001|COMPLETED|Dose Escalation Week 2||14
11279577|NCT02388295|12475546|FG002|COMPLETED|Dose Escalation Week 2||17
11279578|NCT02388295|12475544|FG000|NOT COMPLETED|Dose Escalation Week 2||1
11279579|NCT02388295|12475545|FG001|NOT COMPLETED|Dose Escalation Week 2||2
11279580|NCT02388295|12475546|FG002|NOT COMPLETED|Dose Escalation Week 2||1
11279581|NCT02388295|12475544|FG000|STARTED|Treatment Weeks 3 to 12||16
11279582|NCT02388295|12475545|FG001|STARTED|Treatment Weeks 3 to 12||14
11279583|NCT02388295|12475546|FG002|STARTED|Treatment Weeks 3 to 12||17
11279584|NCT02388295|12475544|FG000|COMPLETED|Treatment Weeks 3 to 12||15
11279585|NCT02388295|12475545|FG001|COMPLETED|Treatment Weeks 3 to 12||13
11279586|NCT02388295|12475546|FG002|COMPLETED|Treatment Weeks 3 to 12||17
11279587|NCT02388295|12475544|FG000|NOT COMPLETED|Treatment Weeks 3 to 12||1
11279588|NCT02388295|12475545|FG001|NOT COMPLETED|Treatment Weeks 3 to 12||1
11279589|NCT02388295|12475546|FG002|NOT COMPLETED|Treatment Weeks 3 to 12||0
11279590|NCT02388321|12475556|FG000|STARTED|Overall Study||11
11279591|NCT02388321|12475557|FG001|STARTED|Overall Study||11
11279592|NCT02388321|12475556|FG000|COMPLETED|Overall Study||11
11279593|NCT02388321|12475557|FG001|COMPLETED|Overall Study||11
11279594|NCT02388321|12475556|FG000|NOT COMPLETED|Overall Study||0
11279595|NCT02388321|12475557|FG001|NOT COMPLETED|Overall Study||0
11279596|NCT02388347|12475568|FG000|STARTED|Overall Study||8
11279597|NCT02388347|12475569|FG001|STARTED|Overall Study||6
11279598|NCT02388347|12475570|FG002|STARTED|Overall Study||6
11279599|NCT02388347|12475571|FG003|STARTED|Overall Study||6
11279600|NCT02388347|12475572|FG004|STARTED|Overall Study||6
11279601|NCT02388347|12475568|FG000|COMPLETED|Overall Study||8
11279602|NCT02388347|12475569|FG001|COMPLETED|Overall Study||6
11279603|NCT02388347|12475570|FG002|COMPLETED|Overall Study||5
11279604|NCT02388347|12475571|FG003|COMPLETED|Overall Study||6
11279605|NCT02388347|12475572|FG004|COMPLETED|Overall Study||6
11279606|NCT02388347|12475568|FG000|NOT COMPLETED|Overall Study||0
11279607|NCT02388347|12475569|FG001|NOT COMPLETED|Overall Study||0
11279608|NCT02388347|12475570|FG002|NOT COMPLETED|Overall Study||1
11279609|NCT02388347|12475571|FG003|NOT COMPLETED|Overall Study||0
11279610|NCT02388347|12475572|FG004|NOT COMPLETED|Overall Study||0
11279611|NCT02388386|12475588|FG000|STARTED|Overall Study||10
11279612|NCT02388386|12475588|FG000|COMPLETED|Overall Study||10
11279613|NCT02388386|12475588|FG000|NOT COMPLETED|Overall Study||0
11279614|NCT02388568|12475598|FG000|STARTED|Overall Study||69
11279615|NCT02388568|12475599|FG001|STARTED|Overall Study||68
11279616|NCT02388568|12475598|FG000|COMPLETED|Overall Study||59
11279617|NCT02388568|12475599|FG001|COMPLETED|Overall Study||53
11279618|NCT02388568|12475598|FG000|NOT COMPLETED|Overall Study||10
11279619|NCT02388568|12475599|FG001|NOT COMPLETED|Overall Study||15
11279620|NCT02388633|12475605|FG000|STARTED|Overall Study||8
11279621|NCT02388633|12475605|FG000|COMPLETED|Overall Study||8
11279622|NCT02388633|12475605|FG000|NOT COMPLETED|Overall Study||0
11279623|NCT02388646|12475612|FG000|STARTED|Overall Study||20
11279624|NCT02388646|12475613|FG001|STARTED|Overall Study||20
11279625|NCT02388646|12475614|FG002|STARTED|Overall Study||20
11279626|NCT02388646|12475612|FG000|COMPLETED|Overall Study||16
11279627|NCT02388646|12475613|FG001|COMPLETED|Overall Study||19
11279628|NCT02388646|12475614|FG002|COMPLETED|Overall Study||14
11279629|NCT02388646|12475612|FG000|NOT COMPLETED|Overall Study||4
11279630|NCT02388646|12475613|FG001|NOT COMPLETED|Overall Study||1
11279631|NCT02388646|12475614|FG002|NOT COMPLETED|Overall Study||6
11279632|NCT02388724|12475624|FG000|STARTED|Overall Study||244
11279633|NCT02388724|12475625|FG001|STARTED|Overall Study||237
11279634|NCT02388724|12475624|FG000|Safety Set: Randomized But Not Treated|Overall Study||0
11279635|NCT02388724|12475625|FG001|Safety Set: Randomized But Not Treated|Overall Study||2
11279636|NCT02388724|12475624|FG000|COMPLETED|Overall Study||232
11279637|NCT02388724|12475625|FG001|COMPLETED|Overall Study||224
11279638|NCT02388724|12475624|FG000|NOT COMPLETED|Overall Study||12
11279639|NCT02388724|12475625|FG001|NOT COMPLETED|Overall Study||13
11279640|NCT02388737|12475634|FG000|STARTED|Overall Study||235
11279641|NCT02388737|12475635|FG001|STARTED|Overall Study||226
11279642|NCT02388737|12475636|FG002|STARTED|Overall Study||242
11279643|NCT02388737|12475634|FG000|COMPLETED|Overall Study||181
11279644|NCT02388737|12475635|FG001|COMPLETED|Overall Study||166
11279645|NCT02388737|12475636|FG002|COMPLETED|Overall Study||180
11279646|NCT02388737|12475634|FG000|NOT COMPLETED|Overall Study||54
11279647|NCT02388737|12475635|FG001|NOT COMPLETED|Overall Study||60
11279648|NCT02388737|12475636|FG002|NOT COMPLETED|Overall Study||62
11279649|NCT02388763|12475644|FG000|STARTED|Habitual, 10 Days of Wear||32
11279650|NCT02388763|12475645|FG001|STARTED|Habitual, 10 Days of Wear||32
11279651|NCT02388763|12475644|FG000|COMPLETED|Habitual, 10 Days of Wear||31
11279652|NCT02388763|12475645|FG001|COMPLETED|Habitual, 10 Days of Wear||31
11279653|NCT02388763|12475644|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||1
11279654|NCT02388763|12475645|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||1
11279655|NCT02388763|12475644|FG000|STARTED|Period 1, 10 Days of Wear||31
11279656|NCT02388763|12475645|FG001|STARTED|Period 1, 10 Days of Wear||31
11279657|NCT02388763|12475644|FG000|COMPLETED|Period 1, 10 Days of Wear||30
11279658|NCT02388763|12475645|FG001|COMPLETED|Period 1, 10 Days of Wear||30
11279659|NCT02388763|12475644|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||1
11279660|NCT02388763|12475645|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||1
11279661|NCT02388763|12475644|FG000|STARTED|Period 2, 10 Days of Wear||30
11279662|NCT02388763|12475645|FG001|STARTED|Period 2, 10 Days of Wear||30
11279663|NCT02388763|12475644|FG000|COMPLETED|Period 2, 10 Days of Wear||30
11279664|NCT02388763|12475645|FG001|COMPLETED|Period 2, 10 Days of Wear||30
11279665|NCT02388763|12475644|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||0
11279666|NCT02388763|12475645|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0
11279667|NCT02388815|12475654|FG000|STARTED|Overall Study||89
11279668|NCT02388815|12475654|FG000|COMPLETED|Overall Study||85
11279669|NCT02388815|12475654|FG000|NOT COMPLETED|Overall Study||4
11279670|NCT02388880|12475658|FG000|STARTED|Overall Study||3
11279671|NCT02388880|12475658|FG000|COMPLETED|Overall Study||3
11279672|NCT02388880|12475658|FG000|NOT COMPLETED|Overall Study||0
11279673|NCT02388932|12475662|FG000|STARTED|Overall Study||3
11279674|NCT02388932|12475662|FG000|COMPLETED|Overall Study||2
11279675|NCT02388932|12475662|FG000|NOT COMPLETED|Overall Study||1
11279676|NCT02388997|12475669|FG000|STARTED|Overall Study||15
11279677|NCT02388997|12475670|FG001|STARTED|Overall Study||16
11279678|NCT02388997|12475669|FG000|COMPLETED|Overall Study||12
11279679|NCT02388997|12475670|FG001|COMPLETED|Overall Study||10
11279680|NCT02388997|12475669|FG000|NOT COMPLETED|Overall Study||3
11279681|NCT02388997|12475670|FG001|NOT COMPLETED|Overall Study||6
11279682|NCT02389088|12475676|FG000|STARTED|Overall Study - Phase I||9
11279683|NCT02389088|12475676|FG000|COMPLETED|Overall Study - Phase I||9
11279684|NCT02389088|12475676|FG000|NOT COMPLETED|Overall Study - Phase I||0
11279685|NCT02389088|12475676|FG000|STARTED|Phase II - All Study Participants||9
11279686|NCT02389088|12475676|FG000|COMPLETED|Phase II - All Study Participants||9
11279687|NCT02389088|12475676|FG000|NOT COMPLETED|Phase II - All Study Participants||0
11279688|NCT02389101|12475690|FG000|STARTED|Overall Study||21
11279689|NCT02389101|12475690|FG000|COMPLETED|Overall Study||21
11279690|NCT02389101|12475690|FG000|NOT COMPLETED|Overall Study||0
11279691|NCT02389361|12475696|FG000|STARTED|Overall Study||24
11279692|NCT02389361|12475697|FG001|STARTED|Overall Study||27
11279693|NCT02389361|12475696|FG000|COMPLETED|Overall Study||24
11279694|NCT02389361|12475697|FG001|COMPLETED|Overall Study||27
11279695|NCT02389361|12475696|FG000|NOT COMPLETED|Overall Study||0
11279696|NCT02389361|12475697|FG001|NOT COMPLETED|Overall Study||0
11279697|NCT02389452|12475703|FG000|STARTED|Overall Study||394
11279698|NCT02389452|12475703|FG000|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
11279699|NCT02389452|12475703|FG000|COMPLETED|Overall Study||369
11279700|NCT02389452|12475703|FG000|NOT COMPLETED|Overall Study||25
11279701|NCT02389621|12475710|FG000|STARTED|Treatment Period||108
11279702|NCT02389621|12475711|FG001|STARTED|Treatment Period||107
11279703|NCT02389621|12475710|FG000|Received Study Drug|Treatment Period||107
11279704|NCT02389621|12475711|FG001|Received Study Drug|Treatment Period||107
11279705|NCT02389621|12475710|FG000|COMPLETED|Treatment Period||107
11279706|NCT02389621|12475711|FG001|COMPLETED|Treatment Period||106
11279707|NCT02389621|12475710|FG000|NOT COMPLETED|Treatment Period||1
11279708|NCT02389621|12475711|FG001|NOT COMPLETED|Treatment Period||1
11279709|NCT02389621|12475710|FG000|STARTED|Posttreatment Period||107
11279710|NCT02389621|12475711|FG001|STARTED|Posttreatment Period||106
11398796|NCT04399161|12593223|FG000|NOT COMPLETED|Overall Study||2
11398797|NCT04399161|12593224|FG001|NOT COMPLETED|Overall Study||2
11398798|NCT04399161|12593225|FG002|NOT COMPLETED|Overall Study||2
11398799|NCT04399980|12593235|FG000|STARTED|Overall Study||21
11279711|NCT02389621|12475710|FG000|COMPLETED|Posttreatment Period||98
11279712|NCT02389621|12475711|FG001|COMPLETED|Posttreatment Period||102
11279713|NCT02389621|12475710|FG000|NOT COMPLETED|Posttreatment Period||9
11279714|NCT02389621|12475711|FG001|NOT COMPLETED|Posttreatment Period||4
11279715|NCT02389725|12475723|FG000|STARTED|Overall Study||59
11279716|NCT02389725|12475724|FG001|STARTED|Overall Study||60
11279717|NCT02389725|12475723|FG000|COMPLETED|Overall Study||59
11279718|NCT02389725|12475724|FG001|COMPLETED|Overall Study||60
11279719|NCT02389725|12475723|FG000|NOT COMPLETED|Overall Study||0
11279720|NCT02389725|12475724|FG001|NOT COMPLETED|Overall Study||0
11279721|NCT02389738|12475732|FG000|STARTED|Overall Study||6
11279722|NCT02389738|12475732|FG000|COMPLETED|Overall Study||5
11279723|NCT02389738|12475732|FG000|NOT COMPLETED|Overall Study||1
11279724|NCT02389764|12475736|FG000|STARTED|Overall Study||9
11279725|NCT02389764|12475736|FG000|COMPLETED|Overall Study||0
11279726|NCT02389764|12475736|FG000|NOT COMPLETED|Overall Study||9
11279727|NCT02389816|12475743|FG000|STARTED|Overall Study||164
11398800|NCT04399980|12593236|FG001|STARTED|Overall Study||19
11398801|NCT04399980|12593235|FG000|COMPLETED|Overall Study||21
11279728|NCT02389816|12475744|FG001|STARTED|Overall Study||165
11279729|NCT02389816|12475745|FG002|STARTED|Overall Study||164
11279730|NCT02389816|12475743|FG000|COMPLETED|Overall Study||149
11279731|NCT02389816|12475744|FG001|COMPLETED|Overall Study||152
11279732|NCT02389816|12475745|FG002|COMPLETED|Overall Study||152
11279733|NCT02389816|12475743|FG000|NOT COMPLETED|Overall Study||15
11279734|NCT02389816|12475744|FG001|NOT COMPLETED|Overall Study||13
11279735|NCT02389816|12475745|FG002|NOT COMPLETED|Overall Study||12
11279736|NCT02389829|12475755|FG000|STARTED|Overall Study||64
11279737|NCT02389829|12475756|FG001|STARTED|Overall Study||63
11279738|NCT02389829|12475755|FG000|COMPLETED|Overall Study||64
11279739|NCT02389829|12475756|FG001|COMPLETED|Overall Study||62
11279740|NCT02389829|12475755|FG000|NOT COMPLETED|Overall Study||0
11279741|NCT02389829|12475756|FG001|NOT COMPLETED|Overall Study||1
11279742|NCT02389881|12475769|FG000|STARTED|Overall Study||6
11279743|NCT02389881|12475770|FG001|STARTED|Overall Study||6
11279744|NCT02389881|12475771|FG002|STARTED|Overall Study||6
11279745|NCT02389881|12475772|FG003|STARTED|Overall Study||6
11279746|NCT02389881|12475773|FG004|STARTED|Overall Study||6
11279747|NCT02389881|12475774|FG005|STARTED|Overall Study||8
11279748|NCT02389881|12475775|FG006|STARTED|Overall Study||2
11279749|NCT02389881|12475769|FG000|COMPLETED|Overall Study||6
11279750|NCT02389881|12475770|FG001|COMPLETED|Overall Study||6
11279751|NCT02389881|12475771|FG002|COMPLETED|Overall Study||6
11279752|NCT02389881|12475772|FG003|COMPLETED|Overall Study||6
11279753|NCT02389881|12475773|FG004|COMPLETED|Overall Study||6
11279754|NCT02389881|12475774|FG005|COMPLETED|Overall Study||8
11279755|NCT02389881|12475775|FG006|COMPLETED|Overall Study||2
11279756|NCT02389881|12475769|FG000|NOT COMPLETED|Overall Study||0
11279757|NCT02389881|12475770|FG001|NOT COMPLETED|Overall Study||0
11279758|NCT02389881|12475771|FG002|NOT COMPLETED|Overall Study||0
11279759|NCT02389881|12475772|FG003|NOT COMPLETED|Overall Study||0
11279760|NCT02389881|12475773|FG004|NOT COMPLETED|Overall Study||0
11279761|NCT02389881|12475774|FG005|NOT COMPLETED|Overall Study||0
11279762|NCT02389881|12475775|FG006|NOT COMPLETED|Overall Study||0
11279763|NCT02389894|12475794|FG000|STARTED|Overall Study||133
11279764|NCT02389894|12475795|FG001|STARTED|Overall Study||118
11279765|NCT02389894|12475796|FG002|STARTED|Overall Study||132
11279766|NCT02389894|12475794|FG000|COMPLETED|Overall Study||125
11279767|NCT02389894|12475795|FG001|COMPLETED|Overall Study||108
11279768|NCT02389894|12475796|FG002|COMPLETED|Overall Study||123
11279769|NCT02389894|12475794|FG000|NOT COMPLETED|Overall Study||8
11279770|NCT02389894|12475795|FG001|NOT COMPLETED|Overall Study||10
11279771|NCT02389894|12475796|FG002|NOT COMPLETED|Overall Study||9
11279772|NCT02389959|12475806|FG000|STARTED|Overall Study||20
11279773|NCT02389959|12475807|FG001|STARTED|Overall Study||20
11279774|NCT02389959|12475806|FG000|COMPLETED|Overall Study||18
11279775|NCT02389959|12475807|FG001|COMPLETED|Overall Study||19
11279776|NCT02389959|12475806|FG000|NOT COMPLETED|Overall Study||2
11279777|NCT02389959|12475807|FG001|NOT COMPLETED|Overall Study||1
11279778|NCT02389998|12475815|FG000|STARTED|Overall Study||16
11279779|NCT02389998|12475816|FG001|STARTED|Overall Study||15
11279780|NCT02389998|12475815|FG000|COMPLETED|Overall Study||15
11279781|NCT02389998|12475816|FG001|COMPLETED|Overall Study||15
11279782|NCT02389998|12475815|FG000|NOT COMPLETED|Overall Study||1
11279783|NCT02389998|12475816|FG001|NOT COMPLETED|Overall Study||0
11279784|NCT02390050|12475828|FG000|STARTED|Overall Study||72
11279785|NCT02390050|12475829|FG001|STARTED|Overall Study||72
11279786|NCT02390050|12475830|FG002|STARTED|Overall Study||72
11279787|NCT02390050|12475831|FG003|STARTED|Overall Study||76
11279788|NCT02390050|12475828|FG000|COMPLETED|Overall Study||65
11279789|NCT02390050|12475829|FG001|COMPLETED|Overall Study||67
11279790|NCT02390050|12475830|FG002|COMPLETED|Overall Study||68
11279791|NCT02390050|12475831|FG003|COMPLETED|Overall Study||69
11279792|NCT02390050|12475828|FG000|NOT COMPLETED|Overall Study||7
11279793|NCT02390050|12475829|FG001|NOT COMPLETED|Overall Study||5
11279794|NCT02390050|12475830|FG002|NOT COMPLETED|Overall Study||4
11398802|NCT04399980|12593236|FG001|COMPLETED|Overall Study||19
11279795|NCT02390050|12475831|FG003|NOT COMPLETED|Overall Study||7
11279796|NCT02390076|12475844|FG000|STARTED|Overall Study||18
11279797|NCT02390076|12475845|FG001|STARTED|Overall Study||18
11279798|NCT02390076|12475846|FG002|STARTED|Overall Study||15
11279799|NCT02390076|12475844|FG000|COMPLETED|Overall Study||16
11279800|NCT02390076|12475845|FG001|COMPLETED|Overall Study||17
11279801|NCT02390076|12475846|FG002|COMPLETED|Overall Study||11
11279802|NCT02390076|12475844|FG000|NOT COMPLETED|Overall Study||2
11279803|NCT02390076|12475845|FG001|NOT COMPLETED|Overall Study||1
11279804|NCT02390076|12475846|FG002|NOT COMPLETED|Overall Study||4
11279805|NCT02390167|12475854|FG000|STARTED|Overall Study||376
11279806|NCT02390167|12475854|FG000|With Diabetes|Overall Study||333
11279807|NCT02390167|12475854|FG000|Without Diabetes|Overall Study||43
11279808|NCT02390167|12475854|FG000|COMPLETED|Overall Study||375
11279809|NCT02390167|12475854|FG000|NOT COMPLETED|Overall Study||1
11279810|NCT02390219|12475862|FG000|STARTED|Overall Study||46
11279811|NCT02390219|12475862|FG000|COMPLETED|Overall Study||33
11279812|NCT02390219|12475862|FG000|NOT COMPLETED|Overall Study||13
11279813|NCT02390557|12475869|FG000|STARTED|Wave 1||160
11279814|NCT02390557|12475870|FG001|STARTED|Wave 1||156
11279815|NCT02390557|12475871|FG002|STARTED|Wave 1||135
11279816|NCT02390557|12475869|FG000|COMPLETED|Wave 1||160
11279817|NCT02390557|12475870|FG001|COMPLETED|Wave 1||156
11279818|NCT02390557|12475871|FG002|COMPLETED|Wave 1||135
11279819|NCT02390557|12475869|FG000|NOT COMPLETED|Wave 1||0
11279820|NCT02390557|12475870|FG001|NOT COMPLETED|Wave 1||0
11279821|NCT02390557|12475871|FG002|NOT COMPLETED|Wave 1||0
11279822|NCT02390557|12475869|FG000|STARTED|Wave 2||160
11279823|NCT02390557|12475870|FG001|STARTED|Wave 2||156
11279824|NCT02390557|12475871|FG002|STARTED|Wave 2||135
11279825|NCT02390557|12475869|FG000|COMPLETED|Wave 2||88
11279826|NCT02390557|12475870|FG001|COMPLETED|Wave 2||115
11279827|NCT02390557|12475871|FG002|COMPLETED|Wave 2||112
11279828|NCT02390557|12475869|FG000|NOT COMPLETED|Wave 2||72
11279829|NCT02390557|12475870|FG001|NOT COMPLETED|Wave 2||41
11279830|NCT02390557|12475871|FG002|NOT COMPLETED|Wave 2||23
11279831|NCT02390791|12475881|FG000|STARTED|Overall Study||40
11279832|NCT02390791|12475882|FG001|STARTED|Overall Study||45
11279833|NCT02390791|12475881|FG000|COMPLETED|Overall Study||40
11279834|NCT02390791|12475882|FG001|COMPLETED|Overall Study||45
11279835|NCT02390791|12475881|FG000|NOT COMPLETED|Overall Study||0
11279836|NCT02390791|12475882|FG001|NOT COMPLETED|Overall Study||0
11279837|NCT02390908|12475893|FG000|STARTED|Overall Study||40
11279838|NCT02390908|12475894|FG001|STARTED|Overall Study||22
11279839|NCT02390908|12475895|FG002|STARTED|Overall Study||22
11279840|NCT02390908|12475896|FG003|STARTED|Overall Study||90
11279841|NCT02390908|12475897|FG004|STARTED|Overall Study||120
11143763|NCT01474512|12330430|FG008|COMPLETED|Long-Term Extension Period||0
11143764|NCT01474512|12330431|FG009|COMPLETED|Long-Term Extension Period||0
11143765|NCT01474512|12330432|FG010|COMPLETED|Long-Term Extension Period||0
11143766|NCT01474512|12330433|FG011|COMPLETED|Long-Term Extension Period||0
11143767|NCT01474512|12330434|FG012|COMPLETED|Long-Term Extension Period||836
11279842|NCT02390908|12475893|FG000|COMPLETED|Overall Study||40
11279843|NCT02390908|12475894|FG001|COMPLETED|Overall Study||22
11279844|NCT02390908|12475895|FG002|COMPLETED|Overall Study||22
11279845|NCT02390908|12475896|FG003|COMPLETED|Overall Study||90
11279846|NCT02390908|12475897|FG004|COMPLETED|Overall Study||120
11279847|NCT02390908|12475893|FG000|NOT COMPLETED|Overall Study||0
11279848|NCT02390908|12475894|FG001|NOT COMPLETED|Overall Study||0
11279849|NCT02390908|12475895|FG002|NOT COMPLETED|Overall Study||0
11279850|NCT02390908|12475896|FG003|NOT COMPLETED|Overall Study||0
11279851|NCT02390908|12475897|FG004|NOT COMPLETED|Overall Study||0
11279852|NCT02391038|12475914|FG000|STARTED|Overall Study||3
11279853|NCT02391038|12475915|FG001|STARTED|Overall Study||3
11279854|NCT02391038|12475916|FG002|STARTED|Overall Study||6
11279855|NCT02391038|12475914|FG000|COMPLETED|Overall Study||0
11279856|NCT02391038|12475915|FG001|COMPLETED|Overall Study||0
11279857|NCT02391038|12475916|FG002|COMPLETED|Overall Study||0
11279858|NCT02391038|12475914|FG000|NOT COMPLETED|Overall Study||3
11279859|NCT02391038|12475915|FG001|NOT COMPLETED|Overall Study||3
11279860|NCT02391038|12475916|FG002|NOT COMPLETED|Overall Study||6
11279861|NCT02391116|12475925|FG000|STARTED|Treatment||67
11279862|NCT02391116|12475925|FG000|Included in Per Protocol Set|Treatment||40
11279863|NCT02391116|12475925|FG000|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53
11279864|NCT02391116|12475925|FG000|NOT COMPLETED|Treatment||14
11279865|NCT02391116|12475925|FG000|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56
11279866|NCT02391116|12475925|FG000|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43
11279867|NCT02391116|12475925|FG000|NOT COMPLETED|Safety Follow-up||13
11279868|NCT02391116|12475925|FG000|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9
11279869|NCT02391116|12475925|FG000|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6
11279870|NCT02391116|12475925|FG000|NOT COMPLETED|Active Follow-up||3
11279871|NCT02391116|12475925|FG000|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46
11279872|NCT02391116|12475925|FG000|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42
11279873|NCT02391116|12475925|FG000|NOT COMPLETED|Survival Follow-up||4
11279874|NCT02391311|12475938|FG000|STARTED|Overall Study||21
11279875|NCT02391311|12475939|FG001|STARTED|Overall Study||21
11279876|NCT02391311|12475938|FG000|COMPLETED|Overall Study||18
11279877|NCT02391311|12475939|FG001|COMPLETED|Overall Study||19
11279878|NCT02391311|12475938|FG000|NOT COMPLETED|Overall Study||3
11279879|NCT02391311|12475939|FG001|NOT COMPLETED|Overall Study||2
11279880|NCT02391337|12475947|FG000|STARTED|Baseline||80
11279881|NCT02391337|12475948|FG001|STARTED|Baseline||81
11279882|NCT02391337|12475947|FG000|COMPLETED|Baseline||80
11279883|NCT02391337|12475948|FG001|COMPLETED|Baseline||81
11279884|NCT02391337|12475947|FG000|NOT COMPLETED|Baseline||0
11279885|NCT02391337|12475948|FG001|NOT COMPLETED|Baseline||0
11279886|NCT02391337|12475947|FG000|STARTED|6 Months Follow-up||80
11279887|NCT02391337|12475948|FG001|STARTED|6 Months Follow-up||81
11279888|NCT02391337|12475947|FG000|COMPLETED|6 Months Follow-up||74
11279889|NCT02391337|12475948|FG001|COMPLETED|6 Months Follow-up||76
11279890|NCT02391337|12475947|FG000|NOT COMPLETED|6 Months Follow-up||6
11279891|NCT02391337|12475948|FG001|NOT COMPLETED|6 Months Follow-up||5
11279892|NCT02391337|12475947|FG000|STARTED|12 Months Follow-up||74
11279893|NCT02391337|12475948|FG001|STARTED|12 Months Follow-up||76
11279894|NCT02391337|12475947|FG000|COMPLETED|12 Months Follow-up||72
11279895|NCT02391337|12475948|FG001|COMPLETED|12 Months Follow-up||73
11279896|NCT02391337|12475947|FG000|NOT COMPLETED|12 Months Follow-up||2
11279897|NCT02391337|12475948|FG001|NOT COMPLETED|12 Months Follow-up||3
11279898|NCT02391350|12475956|FG000|STARTED|Overall Study||110
11279899|NCT02391350|12475957|FG001|STARTED|Overall Study||110
11279900|NCT02391350|12475956|FG000|4-week Follow-up|Overall Study||106
11279901|NCT02391350|12475957|FG001|4-week Follow-up|Overall Study||105
11279902|NCT02391350|12475956|FG000|6-month Follow-up|Overall Study||100
11279903|NCT02391350|12475957|FG001|6-month Follow-up|Overall Study||96
11279904|NCT02391350|12475956|FG000|COMPLETED|Overall Study||98
11279905|NCT02391350|12475957|FG001|COMPLETED|Overall Study||93
11279906|NCT02391350|12475956|FG000|NOT COMPLETED|Overall Study||12
11279907|NCT02391350|12475957|FG001|NOT COMPLETED|Overall Study||17
11279908|NCT02391363|12475965|FG000|STARTED|Overall Study||70
11279909|NCT02391363|12475966|FG001|STARTED|Overall Study||64
11279910|NCT02391363|12475965|FG000|COMPLETED|Overall Study||59
11279911|NCT02391363|12475966|FG001|COMPLETED|Overall Study||56
11279912|NCT02391363|12475965|FG000|NOT COMPLETED|Overall Study||11
11279913|NCT02391363|12475966|FG001|NOT COMPLETED|Overall Study||8
11279914|NCT02391545|12475974|FG000|STARTED|Overall Study||27
11279915|NCT02391545|12475975|FG001|STARTED|Overall Study||28
11279916|NCT02391545|12475974|FG000|COMPLETED|Overall Study||1
11279917|NCT02391545|12475975|FG001|COMPLETED|Overall Study||0
11279918|NCT02391545|12475974|FG000|NOT COMPLETED|Overall Study||26
11279919|NCT02391545|12475975|FG001|NOT COMPLETED|Overall Study||28
11279920|NCT02391584|12475984|FG000|STARTED|Primary Endpoint (6-weeks)||31
11279921|NCT02391584|12475985|FG001|STARTED|Primary Endpoint (6-weeks)||29
11279922|NCT02391584|12475984|FG000|COMPLETED|Primary Endpoint (6-weeks)||29
11279923|NCT02391584|12475985|FG001|COMPLETED|Primary Endpoint (6-weeks)||27
11279924|NCT02391584|12475984|FG000|NOT COMPLETED|Primary Endpoint (6-weeks)||2
11279925|NCT02391584|12475985|FG001|NOT COMPLETED|Primary Endpoint (6-weeks)||2
11279926|NCT02391584|12475984|FG000|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
11279927|NCT02391584|12475985|FG001|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
11279928|NCT02391584|12475984|FG000|COMPLETED|3 Month||52
11279929|NCT02391584|12475985|FG001|COMPLETED|3 Month||0
11279930|NCT02391584|12475984|FG000|NOT COMPLETED|3 Month||1
11279931|NCT02391584|12475985|FG001|NOT COMPLETED|3 Month||0
11279932|NCT02391584|12475984|FG000|STARTED|6 Month||52
11279933|NCT02391584|12475985|FG001|STARTED|6 Month||0
11279934|NCT02391584|12475984|FG000|COMPLETED|6 Month||51
11279935|NCT02391584|12475985|FG001|COMPLETED|6 Month||0
11279936|NCT02391584|12475984|FG000|NOT COMPLETED|6 Month||1
11279937|NCT02391584|12475985|FG001|NOT COMPLETED|6 Month||0
11279938|NCT02391584|12475984|FG000|STARTED|12 Month (End of Study)||51
11279939|NCT02391584|12475985|FG001|STARTED|12 Month (End of Study)||0
11279940|NCT02391584|12475984|FG000|COMPLETED|12 Month (End of Study)||49
11279941|NCT02391584|12475985|FG001|COMPLETED|12 Month (End of Study)||0
11279942|NCT02391584|12475984|FG000|NOT COMPLETED|12 Month (End of Study)||2
11279943|NCT02391584|12475985|FG001|NOT COMPLETED|12 Month (End of Study)||0
11340711|NCT02924688|12538051|FG005|NOT COMPLETED|Overall Study||24
11340712|NCT02924883|12538070|FG000|STARTED|Overall Study||133
11340713|NCT02924883|12538071|FG001|STARTED|Overall Study||69
11340714|NCT02924883|12538070|FG000|COMPLETED|Overall Study||0
11340715|NCT02924883|12538071|FG001|COMPLETED|Overall Study||0
11340716|NCT02924883|12538070|FG000|NOT COMPLETED|Overall Study||133
11340717|NCT02924883|12538071|FG001|NOT COMPLETED|Overall Study||69
11340718|NCT02925078|12538081|FG000|STARTED|Overall Study||14
11340719|NCT02925078|12538082|FG001|STARTED|Overall Study||16
11340720|NCT02925078|12538081|FG000|COMPLETED|Overall Study||13
11340721|NCT02925078|12538082|FG001|COMPLETED|Overall Study||13
11340722|NCT02925078|12538081|FG000|NOT COMPLETED|Overall Study||1
11340723|NCT02925078|12538082|FG001|NOT COMPLETED|Overall Study||3
11340724|NCT02925117|12538092|FG000|STARTED|Period 1 (Weeks 0 - 16)||41
11340725|NCT02925117|12538093|FG001|STARTED|Period 1 (Weeks 0 - 16)||42
11340726|NCT02925117|12538094|FG002|STARTED|Period 1 (Weeks 0 - 16)||42
11340727|NCT02925117|12538095|FG003|STARTED|Period 1 (Weeks 0 - 16)||42
11340728|NCT02925117|12538096|FG004|STARTED|Period 1 (Weeks 0 - 16)||0
11340729|NCT02925117|12538097|FG005|STARTED|Period 1 (Weeks 0 - 16)||0
11340730|NCT02925117|12538098|FG006|STARTED|Period 1 (Weeks 0 - 16)||0
11340731|NCT02925117|12538099|FG007|STARTED|Period 1 (Weeks 0 - 16)||0
11340732|NCT02925117|12538100|FG008|STARTED|Period 1 (Weeks 0 - 16)||0
11340733|NCT02925117|12538101|FG009|STARTED|Period 1 (Weeks 0 - 16)||0
11340734|NCT02925117|12538102|FG010|STARTED|Period 1 (Weeks 0 - 16)||0
11340735|NCT02925117|12538103|FG011|STARTED|Period 1 (Weeks 0 - 16)||0
11340736|NCT02925117|12538092|FG000|Received Treatment|Period 1 (Weeks 0 - 16)||40
11340737|NCT02925117|12538093|FG001|Received Treatment|Period 1 (Weeks 0 - 16)||42
11340738|NCT02925117|12538094|FG002|Received Treatment|Period 1 (Weeks 0 - 16)||42
11340739|NCT02925117|12538095|FG003|Received Treatment|Period 1 (Weeks 0 - 16)||42
11340740|NCT02925117|12538096|FG004|Received Treatment|Period 1 (Weeks 0 - 16)||0
11340741|NCT02925117|12538097|FG005|Received Treatment|Period 1 (Weeks 0 - 16)||0
11340742|NCT02925117|12538098|FG006|Received Treatment|Period 1 (Weeks 0 - 16)||0
11340743|NCT02925117|12538099|FG007|Received Treatment|Period 1 (Weeks 0 - 16)||0
11340744|NCT02925117|12538100|FG008|Received Treatment|Period 1 (Weeks 0 - 16)||0
11340745|NCT02925117|12538101|FG009|Received Treatment|Period 1 (Weeks 0 - 16)||0
11340746|NCT02925117|12538102|FG010|Received Treatment|Period 1 (Weeks 0 - 16)||0
11340747|NCT02925117|12538103|FG011|Received Treatment|Period 1 (Weeks 0 - 16)||0
11340748|NCT02925117|12538092|FG000|COMPLETED|Period 1 (Weeks 0 - 16)||23
11340749|NCT02925117|12538093|FG001|COMPLETED|Period 1 (Weeks 0 - 16)||31
11398803|NCT04399980|12593235|FG000|NOT COMPLETED|Overall Study||0
11340750|NCT02925117|12538094|FG002|COMPLETED|Period 1 (Weeks 0 - 16)||37
11340751|NCT02925117|12538095|FG003|COMPLETED|Period 1 (Weeks 0 - 16)||39
11340752|NCT02925117|12538096|FG004|COMPLETED|Period 1 (Weeks 0 - 16)||0
11340753|NCT02925117|12538097|FG005|COMPLETED|Period 1 (Weeks 0 - 16)||0
11340754|NCT02925117|12538098|FG006|COMPLETED|Period 1 (Weeks 0 - 16)||0
11340755|NCT02925117|12538099|FG007|COMPLETED|Period 1 (Weeks 0 - 16)||0
11279944|NCT02391701|12475996|FG000|STARTED|Overall Study||367
11279945|NCT02391701|12475997|FG001|STARTED|Overall Study||353
11279946|NCT02391701|12475996|FG000|COMPLETED|Overall Study||346
11279947|NCT02391701|12475997|FG001|COMPLETED|Overall Study||315
11279948|NCT02391701|12475996|FG000|NOT COMPLETED|Overall Study||21
11279949|NCT02391701|12475997|FG001|NOT COMPLETED|Overall Study||38
11279950|NCT02391714|12476005|FG000|STARTED|Overall Study||40
11279951|NCT02391714|12476006|FG001|STARTED|Overall Study||40
11279952|NCT02391714|12476005|FG000|COMPLETED|Overall Study||40
11279953|NCT02391714|12476006|FG001|COMPLETED|Overall Study||40
11279954|NCT02391714|12476005|FG000|NOT COMPLETED|Overall Study||0
11279955|NCT02391714|12476006|FG001|NOT COMPLETED|Overall Study||0
11279956|NCT02391948|12476019|FG000|STARTED|Baseline||227
11279957|NCT02391948|12476020|FG001|STARTED|Baseline||161
11279958|NCT02391948|12476021|FG002|STARTED|Baseline||80
11279959|NCT02391948|12476022|FG003|STARTED|Baseline||129
11279960|NCT02391948|12476023|FG004|STARTED|Baseline||111
11279961|NCT02391948|12476019|FG000|COMPLETED|Baseline||227
11279962|NCT02391948|12476020|FG001|COMPLETED|Baseline||161
11279963|NCT02391948|12476021|FG002|COMPLETED|Baseline||80
11279964|NCT02391948|12476022|FG003|COMPLETED|Baseline||129
11279965|NCT02391948|12476023|FG004|COMPLETED|Baseline||111
11279966|NCT02391948|12476019|FG000|NOT COMPLETED|Baseline||0
11279967|NCT02391948|12476020|FG001|NOT COMPLETED|Baseline||0
11279968|NCT02391948|12476021|FG002|NOT COMPLETED|Baseline||0
11279969|NCT02391948|12476022|FG003|NOT COMPLETED|Baseline||0
11279970|NCT02391948|12476023|FG004|NOT COMPLETED|Baseline||0
11279971|NCT02391948|12476019|FG000|STARTED|6-month Assessment||227
11279972|NCT02391948|12476020|FG001|STARTED|6-month Assessment||161
11279973|NCT02391948|12476021|FG002|STARTED|6-month Assessment||80
11279974|NCT02391948|12476022|FG003|STARTED|6-month Assessment||129
11279975|NCT02391948|12476023|FG004|STARTED|6-month Assessment||111
11279976|NCT02391948|12476019|FG000|COMPLETED|6-month Assessment||148
11279977|NCT02391948|12476020|FG001|COMPLETED|6-month Assessment||105
11279978|NCT02391948|12476021|FG002|COMPLETED|6-month Assessment||49
11279979|NCT02391948|12476022|FG003|COMPLETED|6-month Assessment||84
11279980|NCT02391948|12476023|FG004|COMPLETED|6-month Assessment||85
11279981|NCT02391948|12476019|FG000|NOT COMPLETED|6-month Assessment||79
11279982|NCT02391948|12476020|FG001|NOT COMPLETED|6-month Assessment||56
11279983|NCT02391948|12476021|FG002|NOT COMPLETED|6-month Assessment||31
11279984|NCT02391948|12476022|FG003|NOT COMPLETED|6-month Assessment||45
11279985|NCT02391948|12476023|FG004|NOT COMPLETED|6-month Assessment||26
11279986|NCT02391948|12476019|FG000|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225
11279987|NCT02391948|12476020|FG001|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156
11279988|NCT02391948|12476021|FG002|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77
11279989|NCT02391948|12476022|FG003|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125
11279990|NCT02391948|12476023|FG004|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109
11279991|NCT02391948|12476019|FG000|COMPLETED|12-month Assessment||217
11279992|NCT02391948|12476020|FG001|COMPLETED|12-month Assessment||147
11279993|NCT02391948|12476021|FG002|COMPLETED|12-month Assessment||73
11279994|NCT02391948|12476022|FG003|COMPLETED|12-month Assessment||116
11279995|NCT02391948|12476023|FG004|COMPLETED|12-month Assessment||103
11279996|NCT02391948|12476019|FG000|NOT COMPLETED|12-month Assessment||8
11279997|NCT02391948|12476020|FG001|NOT COMPLETED|12-month Assessment||9
11279998|NCT02391948|12476021|FG002|NOT COMPLETED|12-month Assessment||4
11279999|NCT02391948|12476022|FG003|NOT COMPLETED|12-month Assessment||9
11280000|NCT02391948|12476023|FG004|NOT COMPLETED|12-month Assessment||6
11280001|NCT02391948|12476019|FG000|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219
11280002|NCT02391948|12476020|FG001|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151
11280003|NCT02391948|12476021|FG002|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74
11280004|NCT02391948|12476022|FG003|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119
11280005|NCT02391948|12476023|FG004|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105
11280006|NCT02391948|12476019|FG000|COMPLETED|18-month Assessment||147
11280007|NCT02391948|12476020|FG001|COMPLETED|18-month Assessment||101
11280008|NCT02391948|12476021|FG002|COMPLETED|18-month Assessment||48
11280009|NCT02391948|12476022|FG003|COMPLETED|18-month Assessment||83
11280010|NCT02391948|12476023|FG004|COMPLETED|18-month Assessment||75
11280011|NCT02391948|12476019|FG000|NOT COMPLETED|18-month Assessment||72
11280012|NCT02391948|12476020|FG001|NOT COMPLETED|18-month Assessment||50
11280013|NCT02391948|12476021|FG002|NOT COMPLETED|18-month Assessment||26
11280014|NCT02391948|12476022|FG003|NOT COMPLETED|18-month Assessment||36
11280015|NCT02391948|12476023|FG004|NOT COMPLETED|18-month Assessment||30
11280016|NCT02391948|12476019|FG000|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149
11340756|NCT02925117|12538100|FG008|COMPLETED|Period 1 (Weeks 0 - 16)||0
11280017|NCT02391948|12476020|FG001|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107
11280018|NCT02391948|12476021|FG002|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51
11280019|NCT02391948|12476022|FG003|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84
11280020|NCT02391948|12476023|FG004|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79
11280021|NCT02391948|12476019|FG000|COMPLETED|24-month Assessment||135
11280022|NCT02391948|12476020|FG001|COMPLETED|24-month Assessment||97
11280023|NCT02391948|12476021|FG002|COMPLETED|24-month Assessment||48
11280024|NCT02391948|12476022|FG003|COMPLETED|24-month Assessment||75
11280025|NCT02391948|12476023|FG004|COMPLETED|24-month Assessment||69
11280026|NCT02391948|12476019|FG000|NOT COMPLETED|24-month Assessment||14
11280027|NCT02391948|12476020|FG001|NOT COMPLETED|24-month Assessment||10
11280028|NCT02391948|12476021|FG002|NOT COMPLETED|24-month Assessment||3
11280029|NCT02391948|12476022|FG003|NOT COMPLETED|24-month Assessment||9
11280030|NCT02391948|12476023|FG004|NOT COMPLETED|24-month Assessment||10
11280031|NCT02391961|12476040|FG000|STARTED|First Intervention (4 Weeks)||10
11280032|NCT02391961|12476041|FG001|STARTED|First Intervention (4 Weeks)||9
11280033|NCT02391961|12476040|FG000|COMPLETED|First Intervention (4 Weeks)||8
11280034|NCT02391961|12476041|FG001|COMPLETED|First Intervention (4 Weeks)||9
11280035|NCT02391961|12476040|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
11280036|NCT02391961|12476041|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
11280037|NCT02391961|12476040|FG000|STARTED|Washout (2 Weeks)||8
11280038|NCT02391961|12476041|FG001|STARTED|Washout (2 Weeks)||9
11280039|NCT02391961|12476040|FG000|COMPLETED|Washout (2 Weeks)||7
11280040|NCT02391961|12476041|FG001|COMPLETED|Washout (2 Weeks)||8
11280041|NCT02391961|12476040|FG000|NOT COMPLETED|Washout (2 Weeks)||1
11280042|NCT02391961|12476041|FG001|NOT COMPLETED|Washout (2 Weeks)||1
11280043|NCT02391961|12476040|FG000|STARTED|Second Intervention (4 Weeks)||7
11280044|NCT02391961|12476041|FG001|STARTED|Second Intervention (4 Weeks)||8
11280045|NCT02391961|12476040|FG000|COMPLETED|Second Intervention (4 Weeks)||6
11280046|NCT02391961|12476041|FG001|COMPLETED|Second Intervention (4 Weeks)||7
11280047|NCT02391961|12476040|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
11280048|NCT02391961|12476041|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
11280049|NCT02391987|12476049|FG000|STARTED|Overall Study||54
11280050|NCT02391987|12476050|FG001|STARTED|Overall Study||58
11280051|NCT02391987|12476049|FG000|COMPLETED|Overall Study||54
11280052|NCT02391987|12476050|FG001|COMPLETED|Overall Study||58
11280053|NCT02391987|12476049|FG000|NOT COMPLETED|Overall Study||0
11280054|NCT02391987|12476050|FG001|NOT COMPLETED|Overall Study||0
11280055|NCT02392000|12476056|FG000|STARTED|Overall Study||38
11280056|NCT02392000|12476056|FG000|COMPLETED|Overall Study||11
11280057|NCT02392000|12476056|FG000|NOT COMPLETED|Overall Study||27
11280058|NCT02392104|12476061|FG000|STARTED|Overall Study|one participant enrolled but was removed prior to starting study protocol|50
11280059|NCT02392104|12476061|FG000|COMPLETED|Overall Study||39
11280060|NCT02392104|12476061|FG000|NOT COMPLETED|Overall Study||11
11280061|NCT02392195|12476065|FG000|STARTED|Overall Study||10
11280062|NCT02392195|12476065|FG000|COMPLETED|Overall Study||2
11280063|NCT02392195|12476065|FG000|NOT COMPLETED|Overall Study||8
11280064|NCT02392208|12476069|FG000|STARTED|Telavancin Before Hemodialysis||8
11280065|NCT02392208|12476069|FG000|COMPLETED|Telavancin Before Hemodialysis||8
11280066|NCT02392208|12476069|FG000|NOT COMPLETED|Telavancin Before Hemodialysis||0
11280067|NCT02392208|12476069|FG000|STARTED|Telavancin After Hemodialysis||8
11280068|NCT02392208|12476069|FG000|COMPLETED|Telavancin After Hemodialysis||8
11280069|NCT02392208|12476069|FG000|NOT COMPLETED|Telavancin After Hemodialysis||0
11280070|NCT02392234|12476080|FG000|STARTED|Treatment Period 1 (8 Weeks)||41
11280071|NCT02392234|12476081|FG001|STARTED|Treatment Period 1 (8 Weeks)||43
11280072|NCT02392234|12476082|FG002|STARTED|Treatment Period 1 (8 Weeks)||40
11280073|NCT02392234|12476083|FG003|STARTED|Treatment Period 1 (8 Weeks)||42
11280074|NCT02392234|12476084|FG004|STARTED|Treatment Period 1 (8 Weeks)||41
11280075|NCT02392234|12476085|FG005|STARTED|Treatment Period 1 (8 Weeks)||41
11280076|NCT02392234|12476080|FG000|Treated|Treatment Period 1 (8 Weeks)||41
11280077|NCT02392234|12476081|FG001|Treated|Treatment Period 1 (8 Weeks)||43
11280078|NCT02392234|12476082|FG002|Treated|Treatment Period 1 (8 Weeks)||39
11280079|NCT02392234|12476083|FG003|Treated|Treatment Period 1 (8 Weeks)||42
11280080|NCT02392234|12476084|FG004|Treated|Treatment Period 1 (8 Weeks)||40
11280081|NCT02392234|12476085|FG005|Treated|Treatment Period 1 (8 Weeks)||41
11280082|NCT02392234|12476080|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||38
11280083|NCT02392234|12476081|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||43
11280084|NCT02392234|12476082|FG002|COMPLETED|Treatment Period 1 (8 Weeks)||38
11280085|NCT02392234|12476083|FG003|COMPLETED|Treatment Period 1 (8 Weeks)||41
11280086|NCT02392234|12476084|FG004|COMPLETED|Treatment Period 1 (8 Weeks)||37
11280087|NCT02392234|12476085|FG005|COMPLETED|Treatment Period 1 (8 Weeks)||38
11280088|NCT02392234|12476080|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
11280089|NCT02392234|12476081|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
11280090|NCT02392234|12476082|FG002|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
11280091|NCT02392234|12476083|FG003|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
11280092|NCT02392234|12476084|FG004|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
11280093|NCT02392234|12476085|FG005|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
11280094|NCT02392234|12476080|FG000|STARTED|Treatment Period 2 (8 Weeks)||38
11280095|NCT02392234|12476081|FG001|STARTED|Treatment Period 2 (8 Weeks)||43
11280096|NCT02392234|12476082|FG002|STARTED|Treatment Period 2 (8 Weeks)||38
11280097|NCT02392234|12476083|FG003|STARTED|Treatment Period 2 (8 Weeks)||41
11280098|NCT02392234|12476084|FG004|STARTED|Treatment Period 2 (8 Weeks)||37
11280099|NCT02392234|12476085|FG005|STARTED|Treatment Period 2 (8 Weeks)||38
11280100|NCT02392234|12476080|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||37
11280101|NCT02392234|12476081|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||43
11280102|NCT02392234|12476082|FG002|COMPLETED|Treatment Period 2 (8 Weeks)||38
11280103|NCT02392234|12476083|FG003|COMPLETED|Treatment Period 2 (8 Weeks)||41
11280104|NCT02392234|12476084|FG004|COMPLETED|Treatment Period 2 (8 Weeks)||37
11280105|NCT02392234|12476085|FG005|COMPLETED|Treatment Period 2 (8 Weeks)||38
11280106|NCT02392234|12476080|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
11280107|NCT02392234|12476081|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
11280108|NCT02392234|12476082|FG002|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
11280109|NCT02392234|12476083|FG003|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
11280110|NCT02392234|12476084|FG004|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
11280111|NCT02392234|12476085|FG005|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
11280112|NCT02392247|12476096|FG000|STARTED|Overall Study||52
11280113|NCT02392247|12476096|FG000|COMPLETED|Overall Study||50
11280114|NCT02392247|12476096|FG000|NOT COMPLETED|Overall Study||2
11280115|NCT02392286|12476102|FG000|STARTED|Overall Study||7
11280116|NCT02392286|12476103|FG001|STARTED|Overall Study||8
11280117|NCT02392286|12476102|FG000|COMPLETED|Overall Study||4
11280118|NCT02392286|12476103|FG001|COMPLETED|Overall Study||6
11280119|NCT02392286|12476102|FG000|NOT COMPLETED|Overall Study||3
11280120|NCT02392286|12476103|FG001|NOT COMPLETED|Overall Study||2
11280121|NCT02392351|12476111|FG000|STARTED|Overall Study||34
11280122|NCT02392351|12476112|FG001|STARTED|Overall Study||17
11280123|NCT02392351|12476111|FG000|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
11280124|NCT02392351|12476112|FG001|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
11280125|NCT02392351|12476111|FG000|NOT COMPLETED|Overall Study||34
11280126|NCT02392351|12476112|FG001|NOT COMPLETED|Overall Study||17
11280127|NCT02392403|12476118|FG000|STARTED|Overall Study||45
11280128|NCT02392403|12476118|FG000|COMPLETED|Overall Study||42
11280129|NCT02392403|12476118|FG000|NOT COMPLETED|Overall Study||3
11280130|NCT02392481|12476126|FG000|STARTED|Overall Study||10
11280131|NCT02392481|12476127|FG001|STARTED|Overall Study||12
11280132|NCT02392481|12476128|FG002|STARTED|Overall Study||20
11280133|NCT02392481|12476129|FG003|STARTED|Overall Study||27
11280134|NCT02392481|12476126|FG000|COMPLETED|Overall Study||10
11280135|NCT02392481|12476127|FG001|COMPLETED|Overall Study||12
11280136|NCT02392481|12476128|FG002|COMPLETED|Overall Study||18
11280137|NCT02392481|12476129|FG003|COMPLETED|Overall Study||25
11280138|NCT02392481|12476126|FG000|NOT COMPLETED|Overall Study||0
11280139|NCT02392481|12476127|FG001|NOT COMPLETED|Overall Study||0
11280140|NCT02392481|12476128|FG002|NOT COMPLETED|Overall Study||2
11280141|NCT02392481|12476129|FG003|NOT COMPLETED|Overall Study||2
11280142|NCT02392494|12476142|FG000|STARTED|Overall Study||3
11280143|NCT02392494|12476143|FG001|STARTED|Overall Study||3
11280144|NCT02392494|12476144|FG002|STARTED|Overall Study||3
11280145|NCT02392494|12476145|FG003|STARTED|Overall Study||0
11280146|NCT02392494|12476142|FG000|COMPLETED|Overall Study||3
11280147|NCT02392494|12476143|FG001|COMPLETED|Overall Study||3
11280148|NCT02392494|12476144|FG002|COMPLETED|Overall Study||3
11280149|NCT02392494|12476145|FG003|COMPLETED|Overall Study||0
11280150|NCT02392494|12476142|FG000|NOT COMPLETED|Overall Study||0
11280151|NCT02392494|12476143|FG001|NOT COMPLETED|Overall Study||0
11280152|NCT02392494|12476144|FG002|NOT COMPLETED|Overall Study||0
11280153|NCT02392494|12476145|FG003|NOT COMPLETED|Overall Study||0
11280154|NCT02392507|12476153|FG000|STARTED|Induction Regimen||54
11280155|NCT02392507|12476153|FG000|Received at Least 1 Dose of Study Drug|Induction Regimen||54
11280156|NCT02392507|12476153|FG000|COMPLETED|Induction Regimen||47
11280157|NCT02392507|12476153|FG000|NOT COMPLETED|Induction Regimen||7
11280158|NCT02392507|12476153|FG000|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34
11280159|NCT02392507|12476153|FG000|COMPLETED|Maintenance Regimen||32
11280160|NCT02392507|12476153|FG000|NOT COMPLETED|Maintenance Regimen||2
11280161|NCT02392559|12476164|FG000|STARTED|Overall Study||53
11280162|NCT02392559|12476165|FG001|STARTED|Overall Study||105
11280163|NCT02392559|12476164|FG000|Randomized and Dosed|Overall Study||53
11280164|NCT02392559|12476165|FG001|Randomized and Dosed|Overall Study||104
11280165|NCT02392559|12476164|FG000|COMPLETED|Overall Study||53
11280166|NCT02392559|12476165|FG001|COMPLETED|Overall Study||104
11280167|NCT02392559|12476164|FG000|NOT COMPLETED|Overall Study||0
11280168|NCT02392559|12476165|FG001|NOT COMPLETED|Overall Study||1
11280169|NCT02392611|12476181|FG000|STARTED|Overall Study||2
11280170|NCT02392611|12476182|FG001|STARTED|Overall Study||1
11280171|NCT02392611|12476183|FG002|STARTED|Overall Study||1
11280172|NCT02392611|12476184|FG003|STARTED|Overall Study||9
11280173|NCT02392611|12476185|FG004|STARTED|Overall Study||6
11280174|NCT02392611|12476186|FG005|STARTED|Overall Study||4
11280175|NCT02392611|12476187|FG006|STARTED|Overall Study||4
11280176|NCT02392611|12476188|FG007|STARTED|Overall Study||3
11280177|NCT02392611|12476189|FG008|STARTED|Overall Study||3
11280178|NCT02392611|12476181|FG000|COMPLETED|Overall Study||1
11280179|NCT02392611|12476182|FG001|COMPLETED|Overall Study||1
11280180|NCT02392611|12476183|FG002|COMPLETED|Overall Study||1
11280181|NCT02392611|12476184|FG003|COMPLETED|Overall Study||3
11280182|NCT02392611|12476185|FG004|COMPLETED|Overall Study||5
11280183|NCT02392611|12476186|FG005|COMPLETED|Overall Study||3
11280184|NCT02392611|12476187|FG006|COMPLETED|Overall Study||3
11280185|NCT02392611|12476188|FG007|COMPLETED|Overall Study||3
11280186|NCT02392611|12476189|FG008|COMPLETED|Overall Study||3
11280187|NCT02392611|12476181|FG000|NOT COMPLETED|Overall Study||1
11280188|NCT02392611|12476182|FG001|NOT COMPLETED|Overall Study||0
11280189|NCT02392611|12476183|FG002|NOT COMPLETED|Overall Study||0
11280190|NCT02392611|12476184|FG003|NOT COMPLETED|Overall Study||6
11280191|NCT02392611|12476185|FG004|NOT COMPLETED|Overall Study||1
11280192|NCT02392611|12476186|FG005|NOT COMPLETED|Overall Study||1
11280193|NCT02392611|12476187|FG006|NOT COMPLETED|Overall Study||1
11280194|NCT02392611|12476188|FG007|NOT COMPLETED|Overall Study||0
11280195|NCT02392611|12476189|FG008|NOT COMPLETED|Overall Study||0
11280196|NCT02392624|12476212|FG000|STARTED|Overall Study||71
11280197|NCT02392624|12476213|FG001|STARTED|Overall Study||81
11280198|NCT02392624|12476214|FG002|STARTED|Overall Study||53
11280199|NCT02392624|12476212|FG000|COMPLETED|Overall Study||0
11280200|NCT02392624|12476213|FG001|COMPLETED|Overall Study||66
11280201|NCT02392624|12476214|FG002|COMPLETED|Overall Study||40
11280202|NCT02392624|12476212|FG000|NOT COMPLETED|Overall Study||71
11280203|NCT02392624|12476213|FG001|NOT COMPLETED|Overall Study||15
11280204|NCT02392624|12476214|FG002|NOT COMPLETED|Overall Study||13
11280205|NCT02392767|12476224|FG000|STARTED|Overall Study||12
11280206|NCT02392767|12476225|FG001|STARTED|Overall Study||13
11280207|NCT02392767|12476224|FG000|COMPLETED|Overall Study||12
11280208|NCT02392767|12476225|FG001|COMPLETED|Overall Study||13
11280209|NCT02392767|12476224|FG000|NOT COMPLETED|Overall Study||0
11280210|NCT02392767|12476225|FG001|NOT COMPLETED|Overall Study||0
11280211|NCT02392806|12476235|FG000|STARTED|Overall Study||22
11280212|NCT02392806|12476236|FG001|STARTED|Overall Study||21
11280213|NCT02392806|12476235|FG000|COMPLETED|Overall Study||22
11280214|NCT02392806|12476236|FG001|COMPLETED|Overall Study||21
11280215|NCT02392806|12476235|FG000|NOT COMPLETED|Overall Study||0
11280216|NCT02392806|12476236|FG001|NOT COMPLETED|Overall Study||0
11280217|NCT02393209|12476244|FG000|STARTED|Overall Study||6
11280218|NCT02393209|12476245|FG001|STARTED|Overall Study||8
11280219|NCT02393209|12476246|FG002|STARTED|Overall Study||0
11280220|NCT02393209|12476247|FG003|STARTED|Overall Study||0
11280221|NCT02393209|12476244|FG000|COMPLETED|Overall Study||0
11280222|NCT02393209|12476245|FG001|COMPLETED|Overall Study||0
11280223|NCT02393209|12476246|FG002|COMPLETED|Overall Study||0
11280224|NCT02393209|12476247|FG003|COMPLETED|Overall Study||0
11280225|NCT02393209|12476244|FG000|NOT COMPLETED|Overall Study||6
11280226|NCT02393209|12476245|FG001|NOT COMPLETED|Overall Study||8
11280227|NCT02393209|12476246|FG002|NOT COMPLETED|Overall Study||0
11280228|NCT02393209|12476247|FG003|NOT COMPLETED|Overall Study||0
11280229|NCT02393339|12476258|FG000|STARTED|Overall Study||58
11280230|NCT02393339|12476259|FG001|STARTED|Overall Study||56
11280231|NCT02393339|12476258|FG000|COMPLETED|Overall Study||51
11280232|NCT02393339|12476259|FG001|COMPLETED|Overall Study||51
11280233|NCT02393339|12476258|FG000|NOT COMPLETED|Overall Study||7
11280234|NCT02393339|12476259|FG001|NOT COMPLETED|Overall Study||5
11280235|NCT02393378|12476267|FG000|STARTED|Overall Study||3
11280236|NCT02393378|12476268|FG001|STARTED|Overall Study||4
11280237|NCT02393378|12476267|FG000|COMPLETED|Overall Study||3
11280238|NCT02393378|12476268|FG001|COMPLETED|Overall Study||4
11280239|NCT02393378|12476267|FG000|NOT COMPLETED|Overall Study||0
11280240|NCT02393378|12476268|FG001|NOT COMPLETED|Overall Study||0
11280241|NCT02393417|12476278|FG000|STARTED|Overall Study||43
11280242|NCT02393417|12476279|FG001|STARTED|Overall Study||45
11280243|NCT02393417|12476280|FG002|STARTED|Overall Study||40
11280244|NCT02393417|12476281|FG003|STARTED|Overall Study||41
11280245|NCT02393417|12476278|FG000|Completed Treatment|Overall Study||30
11280246|NCT02393417|12476279|FG001|Completed Treatment|Overall Study||34
11280247|NCT02393417|12476280|FG002|Completed Treatment|Overall Study||32
11280248|NCT02393417|12476281|FG003|Completed Treatment|Overall Study||30
11280249|NCT02393417|12476278|FG000|COMPLETED|Overall Study||28
11280250|NCT02393417|12476279|FG001|COMPLETED|Overall Study||32
11280251|NCT02393417|12476280|FG002|COMPLETED|Overall Study||30
11280252|NCT02393417|12476281|FG003|COMPLETED|Overall Study||29
11280253|NCT02393417|12476278|FG000|NOT COMPLETED|Overall Study||15
11280254|NCT02393417|12476279|FG001|NOT COMPLETED|Overall Study||13
11280255|NCT02393417|12476280|FG002|NOT COMPLETED|Overall Study||10
11280256|NCT02393417|12476281|FG003|NOT COMPLETED|Overall Study||12
11280257|NCT02393547|12476292|FG000|STARTED|Overall Study||20
11280258|NCT02393547|12476292|FG000|COMPLETED|Overall Study||14
11280259|NCT02393547|12476292|FG000|NOT COMPLETED|Overall Study||6
11280260|NCT02393677|12476298|FG000|STARTED|Overall Study||40
11280261|NCT02393677|12476299|FG001|STARTED|Overall Study||40
11280262|NCT02393677|12476298|FG000|COMPLETED|Overall Study||40
11280263|NCT02393677|12476299|FG001|COMPLETED|Overall Study||40
11280264|NCT02393677|12476298|FG000|NOT COMPLETED|Overall Study||0
11280265|NCT02393677|12476299|FG001|NOT COMPLETED|Overall Study||0
11280266|NCT02393755|12476307|FG000|STARTED|Overall Study||3
11280267|NCT02393755|12476308|FG001|STARTED|Overall Study||39
11280268|NCT02393755|12476307|FG000|COMPLETED|Overall Study||3
11280269|NCT02393755|12476308|FG001|COMPLETED|Overall Study||32
11280270|NCT02393755|12476307|FG000|NOT COMPLETED|Overall Study||0
11280271|NCT02393755|12476308|FG001|NOT COMPLETED|Overall Study||7
11280272|NCT02393950|12476315|FG000|STARTED|Overall Study||9
11280273|NCT02393950|12476316|FG001|STARTED|Overall Study||9
11280274|NCT02393950|12476315|FG000|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
11280275|NCT02393950|12476316|FG001|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
11280276|NCT02393950|12476315|FG000|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
11280277|NCT02393950|12476316|FG001|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
11280278|NCT02393950|12476315|FG000|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
11280279|NCT02393950|12476316|FG001|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
11280280|NCT02393950|12476315|FG000|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
11280281|NCT02393950|12476316|FG001|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
11280282|NCT02393950|12476315|FG000|COMPLETED|Overall Study||8
11280283|NCT02393950|12476316|FG001|COMPLETED|Overall Study||8
11280284|NCT02393950|12476315|FG000|NOT COMPLETED|Overall Study||1
11280285|NCT02393950|12476316|FG001|NOT COMPLETED|Overall Study||1
11280286|NCT02394275|12476351|FG000|STARTED|Overall Study||140
11280287|NCT02394275|12476351|FG000|Safety Population|Overall Study||133
11280288|NCT02394275|12476351|FG000|Evaluable at 13 Weeks|Overall Study||133
11280289|NCT02394275|12476351|FG000|COMPLETED|Overall Study||111
11280290|NCT02394275|12476351|FG000|NOT COMPLETED|Overall Study||29
11280291|NCT02394340|12476356|FG000|STARTED|Overall Study||20
11280292|NCT02394340|12476356|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
11280293|NCT02394340|12476356|FG000|COMPLETED|Overall Study||18
11280294|NCT02394340|12476356|FG000|NOT COMPLETED|Overall Study||2
11280295|NCT02394457|12476362|FG000|STARTED|Overall Study||15
11280296|NCT02394457|12476363|FG001|STARTED|Overall Study||13
11280297|NCT02394457|12476362|FG000|COMPLETED|Overall Study||15
11280298|NCT02394457|12476363|FG001|COMPLETED|Overall Study||13
11280299|NCT02394457|12476362|FG000|NOT COMPLETED|Overall Study||0
11280300|NCT02394457|12476363|FG001|NOT COMPLETED|Overall Study||0
11280301|NCT02394561|12476371|FG000|STARTED|CORE Phase||185
11280302|NCT02394561|12476372|FG001|STARTED|CORE Phase||246
11280303|NCT02394561|12476371|FG000|Full Analysis Set|CORE Phase||185
11280304|NCT02394561|12476372|FG001|Full Analysis Set|CORE Phase||246
11280305|NCT02394561|12476371|FG000|Safety Set|CORE Phase||185
11280306|NCT02394561|12476372|FG001|Safety Set|CORE Phase||246
11280307|NCT02394561|12476371|FG000|ITT Set|CORE Phase||184
11280308|NCT02394561|12476372|FG001|ITT Set|CORE Phase||246
11280309|NCT02394561|12476371|FG000|COMPLETED|CORE Phase||172
11280310|NCT02394561|12476372|FG001|COMPLETED|CORE Phase||227
11280311|NCT02394561|12476371|FG000|NOT COMPLETED|CORE Phase||13
11280312|NCT02394561|12476372|FG001|NOT COMPLETED|CORE Phase||19
11280313|NCT02394561|12476371|FG000|STARTED|Extension Phase||162
11280314|NCT02394561|12476372|FG001|STARTED|Extension Phase||219
11280315|NCT02394561|12476371|FG000|COMPLETED|Extension Phase||151
11280316|NCT02394561|12476372|FG001|COMPLETED|Extension Phase||207
11280317|NCT02394561|12476371|FG000|NOT COMPLETED|Extension Phase||11
11280318|NCT02394561|12476372|FG001|NOT COMPLETED|Extension Phase||12
11280319|NCT02394600|12476383|FG000|STARTED|Overall Study||47
11280320|NCT02394600|12476384|FG001|STARTED|Overall Study||46
11280321|NCT02394600|12476383|FG000|COMPLETED|Overall Study||43
11280322|NCT02394600|12476384|FG001|COMPLETED|Overall Study||44
11280323|NCT02394600|12476383|FG000|NOT COMPLETED|Overall Study||4
11280324|NCT02394600|12476384|FG001|NOT COMPLETED|Overall Study||2
11280325|NCT02394730|12476392|FG000|STARTED|Overall Study||34
11280326|NCT02394730|12476393|FG001|STARTED|Overall Study||31
11280327|NCT02394730|12476392|FG000|COMPLETED|Overall Study||33
11280328|NCT02394730|12476393|FG001|COMPLETED|Overall Study||30
11280329|NCT02394730|12476392|FG000|NOT COMPLETED|Overall Study||1
11280330|NCT02394730|12476393|FG001|NOT COMPLETED|Overall Study||1
11280331|NCT02394756|12476399|FG000|STARTED|Period 1||7
11280332|NCT02394756|12476400|FG001|STARTED|Period 1||7
11280333|NCT02394756|12476401|FG002|STARTED|Period 1||7
11280334|NCT02394756|12476402|FG003|STARTED|Period 1||7
11280335|NCT02394756|12476403|FG004|STARTED|Period 1||7
11280336|NCT02394756|12476404|FG005|STARTED|Period 1||7
11280337|NCT02394756|12476399|FG000|COMPLETED|Period 1||7
11280338|NCT02394756|12476400|FG001|COMPLETED|Period 1||6
11280339|NCT02394756|12476401|FG002|COMPLETED|Period 1||6
11280340|NCT02394756|12476402|FG003|COMPLETED|Period 1||6
11280341|NCT02394756|12476403|FG004|COMPLETED|Period 1||7
11398804|NCT04399980|12593236|FG001|NOT COMPLETED|Overall Study||0
11398805|NCT04399122|12593244|FG000|STARTED|Overall Study||100
11398806|NCT04399122|12593245|FG001|STARTED|Overall Study||100
11398807|NCT04399122|12593244|FG000|COMPLETED|Overall Study||97
11398808|NCT04399122|12593245|FG001|COMPLETED|Overall Study||100
11398809|NCT04399122|12593244|FG000|NOT COMPLETED|Overall Study||3
11280342|NCT02394756|12476404|FG005|COMPLETED|Period 1||6
11280343|NCT02394756|12476399|FG000|NOT COMPLETED|Period 1||0
11280344|NCT02394756|12476400|FG001|NOT COMPLETED|Period 1||1
11280345|NCT02394756|12476401|FG002|NOT COMPLETED|Period 1||1
11280346|NCT02394756|12476402|FG003|NOT COMPLETED|Period 1||1
11280347|NCT02394756|12476403|FG004|NOT COMPLETED|Period 1||0
11398810|NCT04399122|12593245|FG001|NOT COMPLETED|Overall Study||0
11398811|NCT04397445|12593251|FG000|STARTED|Overall Study||5
11398812|NCT04397445|12593252|FG001|STARTED|Overall Study||5
11398813|NCT04397445|12593253|FG002|STARTED|Overall Study||4
11398814|NCT04397445|12593254|FG003|STARTED|Overall Study||4
11398815|NCT04397445|12593251|FG000|COMPLETED|Overall Study||4
11398816|NCT04397445|12593252|FG001|COMPLETED|Overall Study||5
11398817|NCT04397445|12593253|FG002|COMPLETED|Overall Study||4
11398818|NCT04397445|12593254|FG003|COMPLETED|Overall Study||4
11398819|NCT04397445|12593251|FG000|NOT COMPLETED|Overall Study||1
11398820|NCT04397445|12593252|FG001|NOT COMPLETED|Overall Study||0
11398821|NCT04397445|12593253|FG002|NOT COMPLETED|Overall Study||0
11398822|NCT04397445|12593254|FG003|NOT COMPLETED|Overall Study||0
11398823|NCT04397094|12593271|FG000|STARTED|Overall Study||30
11398824|NCT04397094|12593272|FG001|STARTED|Overall Study||30
11398825|NCT04397094|12593271|FG000|COMPLETED|Overall Study||30
11398826|NCT04397094|12593272|FG001|COMPLETED|Overall Study||30
11398827|NCT04397094|12593271|FG000|NOT COMPLETED|Overall Study||0
11398828|NCT04397094|12593272|FG001|NOT COMPLETED|Overall Study||0
11398829|NCT04396639|12593280|FG000|STARTED|Overall Study||50
11398830|NCT04396639|12593280|FG000|Completed Follow up|Overall Study||48
11398831|NCT04396639|12593280|FG000|COMPLETED|Overall Study||48
11398832|NCT04396639|12593280|FG000|NOT COMPLETED|Overall Study||2
11398833|NCT04396665|12593286|FG000|STARTED|Overall Study||134
11398834|NCT04396665|12593287|FG001|STARTED|Overall Study||90
11398835|NCT04396665|12593286|FG000|COMPLETED|Overall Study||99
11398836|NCT04396665|12593287|FG001|COMPLETED|Overall Study||83
11398837|NCT04396665|12593286|FG000|NOT COMPLETED|Overall Study||35
11398838|NCT04396665|12593287|FG001|NOT COMPLETED|Overall Study||7
11398839|NCT04393493|12593299|FG000|STARTED|Follow up||40
11398840|NCT04393493|12593300|FG001|STARTED|Follow up||40
11398841|NCT04393493|12593299|FG000|COMPLETED|Follow up||40
11398842|NCT04393493|12593300|FG001|COMPLETED|Follow up||40
11280348|NCT02394756|12476404|FG005|NOT COMPLETED|Period 1||1
11280349|NCT02394756|12476399|FG000|STARTED|Period 2||7
11280350|NCT02394756|12476400|FG001|STARTED|Period 2||6
11280351|NCT02394756|12476401|FG002|STARTED|Period 2||6
11280352|NCT02394756|12476402|FG003|STARTED|Period 2||6
11280353|NCT02394756|12476403|FG004|STARTED|Period 2||7
11280354|NCT02394756|12476404|FG005|STARTED|Period 2||6
11280355|NCT02394756|12476399|FG000|COMPLETED|Period 2||7
11280356|NCT02394756|12476400|FG001|COMPLETED|Period 2||6
11280357|NCT02394756|12476401|FG002|COMPLETED|Period 2||6
11280358|NCT02394756|12476402|FG003|COMPLETED|Period 2||6
11280359|NCT02394756|12476403|FG004|COMPLETED|Period 2||6
11280360|NCT02394756|12476404|FG005|COMPLETED|Period 2||6
11280361|NCT02394756|12476399|FG000|NOT COMPLETED|Period 2||0
11280362|NCT02394756|12476400|FG001|NOT COMPLETED|Period 2||0
11280363|NCT02394756|12476401|FG002|NOT COMPLETED|Period 2||0
11280364|NCT02394756|12476402|FG003|NOT COMPLETED|Period 2||0
11280365|NCT02394756|12476403|FG004|NOT COMPLETED|Period 2||1
11280366|NCT02394756|12476404|FG005|NOT COMPLETED|Period 2||0
11280367|NCT02394756|12476399|FG000|STARTED|Period 3||7
11280368|NCT02394756|12476400|FG001|STARTED|Period 3||6
11280369|NCT02394756|12476401|FG002|STARTED|Period 3||6
11280370|NCT02394756|12476402|FG003|STARTED|Period 3||6
11280371|NCT02394756|12476403|FG004|STARTED|Period 3||6
11280372|NCT02394756|12476404|FG005|STARTED|Period 3||6
11280373|NCT02394756|12476399|FG000|COMPLETED|Period 3||7
11280374|NCT02394756|12476400|FG001|COMPLETED|Period 3||6
11280375|NCT02394756|12476401|FG002|COMPLETED|Period 3||6
11280376|NCT02394756|12476402|FG003|COMPLETED|Period 3||6
11280377|NCT02394756|12476403|FG004|COMPLETED|Period 3||6
11280378|NCT02394756|12476404|FG005|COMPLETED|Period 3||6
11280379|NCT02394756|12476399|FG000|NOT COMPLETED|Period 3||0
11280380|NCT02394756|12476400|FG001|NOT COMPLETED|Period 3||0
11280381|NCT02394756|12476401|FG002|NOT COMPLETED|Period 3||0
11280382|NCT02394756|12476402|FG003|NOT COMPLETED|Period 3||0
11280383|NCT02394756|12476403|FG004|NOT COMPLETED|Period 3||0
11280384|NCT02394756|12476404|FG005|NOT COMPLETED|Period 3||0
11280385|NCT02394808|12476412|FG000|STARTED|Period 1||25
11280386|NCT02394808|12476413|FG001|STARTED|Period 1||29
11280387|NCT02394808|12476412|FG000|COMPLETED|Period 1||25
11280388|NCT02394808|12476413|FG001|COMPLETED|Period 1||28
11280389|NCT02394808|12476412|FG000|NOT COMPLETED|Period 1||0
11280390|NCT02394808|12476413|FG001|NOT COMPLETED|Period 1||1
11280391|NCT02394808|12476412|FG000|STARTED|Period 2||25
11280392|NCT02394808|12476413|FG001|STARTED|Period 2||28
11280393|NCT02394808|12476412|FG000|COMPLETED|Period 2||24
11280394|NCT02394808|12476413|FG001|COMPLETED|Period 2||28
11280395|NCT02394808|12476412|FG000|NOT COMPLETED|Period 2||1
11398843|NCT04393493|12593299|FG000|NOT COMPLETED|Follow up||0
11398844|NCT04393493|12593300|FG001|NOT COMPLETED|Follow up||0
11398845|NCT04393493|12593299|FG000|STARTED|First 4 Days of Intervention||40
11398846|NCT04393493|12593300|FG001|STARTED|First 4 Days of Intervention||40
11398847|NCT04393493|12593299|FG000|COMPLETED|First 4 Days of Intervention||35
11398848|NCT04393493|12593300|FG001|COMPLETED|First 4 Days of Intervention||33
11280396|NCT02394808|12476413|FG001|NOT COMPLETED|Period 2||0
11280397|NCT02394912|12476419|FG000|STARTED|Overall Study||21
11280398|NCT02394912|12476419|FG000|COMPLETED|Overall Study||21
11280399|NCT02394912|12476419|FG000|NOT COMPLETED|Overall Study||0
11280400|NCT02394925|12476425|FG000|STARTED|Overall Study||108
11280401|NCT02394925|12476425|FG000|COMPLETED|Overall Study||79
11280402|NCT02394925|12476425|FG000|NOT COMPLETED|Overall Study||29
11280403|NCT02394951|12476431|FG000|STARTED|Period I||12
11280404|NCT02394951|12476432|FG001|STARTED|Period I||14
11280405|NCT02394951|12476431|FG000|COMPLETED|Period I||11
11280406|NCT02394951|12476432|FG001|COMPLETED|Period I||13
11280407|NCT02394951|12476431|FG000|NOT COMPLETED|Period I||1
11280408|NCT02394951|12476432|FG001|NOT COMPLETED|Period I||1
11280409|NCT02394951|12476431|FG000|STARTED|Period II||11
11280410|NCT02394951|12476432|FG001|STARTED|Period II||13
11280411|NCT02394951|12476431|FG000|COMPLETED|Period II||11
11280412|NCT02394951|12476432|FG001|COMPLETED|Period II||9
11280413|NCT02394951|12476431|FG000|NOT COMPLETED|Period II||0
11280414|NCT02394951|12476432|FG001|NOT COMPLETED|Period II||4
11280415|NCT02395042|12476441|FG000|STARTED|Treatment 1 Period||12
11280416|NCT02395042|12476442|FG001|STARTED|Treatment 1 Period||31
11280417|NCT02395042|12476443|FG002|STARTED|Treatment 1 Period||16
11280418|NCT02395042|12476441|FG000|COMPLETED|Treatment 1 Period||9
11280419|NCT02395042|12476442|FG001|COMPLETED|Treatment 1 Period||25
11280420|NCT02395042|12476443|FG002|COMPLETED|Treatment 1 Period||14
11280421|NCT02395042|12476441|FG000|NOT COMPLETED|Treatment 1 Period||3
11280422|NCT02395042|12476442|FG001|NOT COMPLETED|Treatment 1 Period||6
11280423|NCT02395042|12476443|FG002|NOT COMPLETED|Treatment 1 Period||2
11280424|NCT02395042|12476441|FG000|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
11280425|NCT02395042|12476442|FG001|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
11280426|NCT02395042|12476443|FG002|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
11280427|NCT02395042|12476441|FG000|COMPLETED|Treatment 2 Period||9
11280428|NCT02395042|12476442|FG001|COMPLETED|Treatment 2 Period||23
11280429|NCT02395042|12476443|FG002|COMPLETED|Treatment 2 Period||13
11280430|NCT02395042|12476441|FG000|NOT COMPLETED|Treatment 2 Period||1
11280431|NCT02395042|12476442|FG001|NOT COMPLETED|Treatment 2 Period||1
11280432|NCT02395042|12476443|FG002|NOT COMPLETED|Treatment 2 Period||0
11280433|NCT02395055|12476456|FG000|STARTED|Overall Study||47
11280434|NCT02395055|12476457|FG001|STARTED|Overall Study||47
11280435|NCT02395055|12476456|FG000|COMPLETED|Overall Study||40
11280436|NCT02395055|12476457|FG001|COMPLETED|Overall Study||44
11280437|NCT02395055|12476456|FG000|NOT COMPLETED|Overall Study||7
11280438|NCT02395055|12476457|FG001|NOT COMPLETED|Overall Study||3
11280439|NCT02395081|12476466|FG000|STARTED|Overall Study||119
11280440|NCT02395081|12476467|FG001|STARTED|Overall Study||121
11280441|NCT02395081|12476468|FG002|STARTED|Overall Study||120
11280442|NCT02395081|12476466|FG000|COMPLETED|Overall Study||112
11280443|NCT02395081|12476467|FG001|COMPLETED|Overall Study||116
11280444|NCT02395081|12476468|FG002|COMPLETED|Overall Study||116
11280445|NCT02395081|12476466|FG000|NOT COMPLETED|Overall Study||7
11280446|NCT02395081|12476467|FG001|NOT COMPLETED|Overall Study||5
11280447|NCT02395081|12476468|FG002|NOT COMPLETED|Overall Study||4
11280448|NCT02395133|12476483|FG000|STARTED|Overall Study||83
11280449|NCT02395133|12476484|FG001|STARTED|Overall Study||84
11280450|NCT02395133|12476485|FG002|STARTED|Overall Study||86
11280451|NCT02395133|12476486|FG003|STARTED|Overall Study||169
11280452|NCT02395133|12476483|FG000|COMPLETED|Overall Study||69
11280453|NCT02395133|12476484|FG001|COMPLETED|Overall Study||75
11280454|NCT02395133|12476485|FG002|COMPLETED|Overall Study||76
11280455|NCT02395133|12476486|FG003|COMPLETED|Overall Study||155
11280456|NCT02395133|12476483|FG000|NOT COMPLETED|Overall Study||14
11280457|NCT02395133|12476484|FG001|NOT COMPLETED|Overall Study||9
11280458|NCT02395133|12476485|FG002|NOT COMPLETED|Overall Study||10
11280459|NCT02395133|12476486|FG003|NOT COMPLETED|Overall Study||14
11280460|NCT02395172|12476498|FG000|STARTED|Overall Study||396
11280461|NCT02395172|12476499|FG001|STARTED|Overall Study||396
11280462|NCT02395172|12476498|FG000|Treated|Overall Study||393
11280463|NCT02395172|12476499|FG001|Treated|Overall Study||365
11280464|NCT02395172|12476498|FG000|COMPLETED|Overall Study||393
11280465|NCT02395172|12476499|FG001|COMPLETED|Overall Study||365
11280466|NCT02395172|12476498|FG000|NOT COMPLETED|Overall Study||3
11280467|NCT02395172|12476499|FG001|NOT COMPLETED|Overall Study||31
11280468|NCT02395185|12476505|FG000|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
11280469|NCT02395185|12476505|FG000|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
11280470|NCT02395185|12476505|FG000|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
11280471|NCT02395185|12476505|FG000|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
11280472|NCT02395185|12476505|FG000|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
11280473|NCT02395185|12476505|FG000|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
11280474|NCT02395185|12476505|FG000|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
11280475|NCT02395185|12476505|FG000|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
11280476|NCT02395185|12476505|FG000|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
11280477|NCT02395185|12476505|FG000|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
11280478|NCT02395185|12476505|FG000|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
11280479|NCT02395185|12476505|FG000|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
11280480|NCT02395185|12476505|FG000|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
11280481|NCT02395185|12476505|FG000|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
11280482|NCT02395185|12476505|FG000|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
11280483|NCT02395185|12476505|FG000|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
11280484|NCT02395185|12476505|FG000|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
11280485|NCT02395185|12476505|FG000|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
11280486|NCT02395185|12476505|FG000|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
11280487|NCT02395185|12476505|FG000|COMPLETED|Overall Study||33
11280488|NCT02395185|12476505|FG000|NOT COMPLETED|Overall Study||0
11280489|NCT02395302|12476513|FG000|STARTED|Overall Study||28
11280490|NCT02395302|12476513|FG000|COMPLETED|Overall Study||14
11280491|NCT02395302|12476513|FG000|NOT COMPLETED|Overall Study||14
11280492|NCT02395471|12476519|FG000|STARTED|Overall Study||129
11280493|NCT02395471|12476520|FG001|STARTED|Overall Study||62
11280494|NCT02395471|12476519|FG000|COMPLETED|Overall Study||122
11280495|NCT02395471|12476520|FG001|COMPLETED|Overall Study||59
11280496|NCT02395471|12476519|FG000|NOT COMPLETED|Overall Study||7
11280497|NCT02395471|12476520|FG001|NOT COMPLETED|Overall Study||3
11280498|NCT02395536|12476537|FG000|STARTED|Overall Study||264
11280499|NCT02395536|12476538|FG001|STARTED|Overall Study||257
11280500|NCT02395536|12476537|FG000|REVEAL LINQ Insertion|Overall Study||251
11280501|NCT02395536|12476538|FG001|REVEAL LINQ Insertion|Overall Study||231
11280502|NCT02395536|12476537|FG000|COMPLETED|Overall Study||244
11280503|NCT02395536|12476538|FG001|COMPLETED|Overall Study||227
11280504|NCT02395536|12476537|FG000|NOT COMPLETED|Overall Study||20
11280505|NCT02395536|12476538|FG001|NOT COMPLETED|Overall Study||30
11280506|NCT02395627|12476547|FG000|STARTED|Overall Study||18
11280507|NCT02395627|12476548|FG001|STARTED|Overall Study||16
11280508|NCT02395627|12476549|FG002|STARTED|Overall Study||4
11280509|NCT02395627|12476547|FG000|COMPLETED|Overall Study||15
11280510|NCT02395627|12476548|FG001|COMPLETED|Overall Study||13
11280511|NCT02395627|12476549|FG002|COMPLETED|Overall Study||4
11280512|NCT02395627|12476547|FG000|NOT COMPLETED|Overall Study||3
11280513|NCT02395627|12476548|FG001|NOT COMPLETED|Overall Study||3
11280514|NCT02395627|12476549|FG002|NOT COMPLETED|Overall Study||0
11280515|NCT02395653|12476559|FG000|STARTED|Overall Study||71
11398849|NCT04393493|12593299|FG000|NOT COMPLETED|First 4 Days of Intervention||5
11398850|NCT04393493|12593300|FG001|NOT COMPLETED|First 4 Days of Intervention||7
11398851|NCT04392362|12593310|FG000|STARTED|Overall Study||23
11398852|NCT04392362|12593311|FG001|STARTED|Overall Study||7
11398853|NCT04392362|12593310|FG000|COMPLETED|Overall Study||23
11398854|NCT04392362|12593311|FG001|COMPLETED|Overall Study||7
11280516|NCT02395653|12476559|FG000|Received at Least 1 Dose of Study Drug|Overall Study||61
11280517|NCT02395653|12476559|FG000|COMPLETED|Overall Study||59
11280518|NCT02395653|12476559|FG000|NOT COMPLETED|Overall Study||12
11280519|NCT02395692|12476563|FG000|STARTED|Overall Study||19
11280520|NCT02395692|12476564|FG001|STARTED|Overall Study||0
11280521|NCT02395692|12476563|FG000|COMPLETED|Overall Study||19
11280522|NCT02395692|12476564|FG001|COMPLETED|Overall Study||0
11280523|NCT02395692|12476563|FG000|NOT COMPLETED|Overall Study||0
11398855|NCT04392362|12593310|FG000|NOT COMPLETED|Overall Study||0
11398856|NCT04392362|12593311|FG001|NOT COMPLETED|Overall Study||0
11398857|NCT04392141|12593319|FG000|STARTED|Overall Study||60
11398858|NCT04392141|12593320|FG001|STARTED|Overall Study||60
11398859|NCT04392141|12593319|FG000|COMPLETED|Overall Study||60
11398860|NCT04392141|12593320|FG001|COMPLETED|Overall Study||60
11398861|NCT04392141|12593319|FG000|NOT COMPLETED|Overall Study||0
11398862|NCT04392141|12593320|FG001|NOT COMPLETED|Overall Study||0
11398863|NCT04392219|12593344|FG000|STARTED|Overall Study||16
11398864|NCT04392219|12593345|FG001|STARTED|Overall Study||6
11398865|NCT04392219|12593346|FG002|STARTED|Overall Study||6
11398866|NCT04392219|12593347|FG003|STARTED|Overall Study||6
11398867|NCT04392219|12593348|FG004|STARTED|Overall Study||6
11398868|NCT04392219|12593349|FG005|STARTED|Overall Study||6
11398869|NCT04392219|12593350|FG006|STARTED|Overall Study||6
11398870|NCT04392219|12593351|FG007|STARTED|Overall Study||6
11398871|NCT04392219|12593352|FG008|STARTED|Overall Study||6
11398872|NCT04392219|12593353|FG009|STARTED|Overall Study||10
11398873|NCT04392219|12593354|FG010|STARTED|Overall Study||14
11398874|NCT04392219|12593355|FG011|STARTED|Overall Study||6
11398875|NCT04392219|12593356|FG012|STARTED|Overall Study||6
11398876|NCT04392219|12593357|FG013|STARTED|Overall Study||6
11398877|NCT04392219|12593358|FG014|STARTED|Overall Study||6
11280524|NCT02395692|12476564|FG001|NOT COMPLETED|Overall Study||0
11280525|NCT02395822|12476571|FG000|STARTED|Overall Study||17
11280526|NCT02395822|12476571|FG000|COMPLETED|Overall Study||15
11280527|NCT02395822|12476571|FG000|NOT COMPLETED|Overall Study||2
11280528|NCT02395978|12476580|FG000|STARTED|Overall Study||6
11280529|NCT02395978|12476581|FG001|STARTED|Overall Study||6
11280530|NCT02395978|12476582|FG002|STARTED|Overall Study||21
11280531|NCT02395978|12476583|FG003|STARTED|Overall Study||19
11280532|NCT02395978|12476584|FG004|STARTED|Overall Study||20
11398878|NCT04392219|12593359|FG015|STARTED|Overall Study||6
11398879|NCT04392219|12593360|FG016|STARTED|Overall Study||6
11280533|NCT02395978|12476580|FG000|COMPLETED|Overall Study||6
11280534|NCT02395978|12476581|FG001|COMPLETED|Overall Study||6
11280535|NCT02395978|12476582|FG002|COMPLETED|Overall Study||19
11280536|NCT02395978|12476583|FG003|COMPLETED|Overall Study||14
11280537|NCT02395978|12476584|FG004|COMPLETED|Overall Study||15
11280538|NCT02395978|12476580|FG000|NOT COMPLETED|Overall Study||0
11280539|NCT02395978|12476581|FG001|NOT COMPLETED|Overall Study||0
11280540|NCT02395978|12476582|FG002|NOT COMPLETED|Overall Study||2
11280541|NCT02395978|12476583|FG003|NOT COMPLETED|Overall Study||5
11280542|NCT02395978|12476584|FG004|NOT COMPLETED|Overall Study||5
11280543|NCT02395991|12476597|FG000|STARTED|Overall Study||60
11280544|NCT02395991|12476597|FG000|COMPLETED|Overall Study||59
11280545|NCT02395991|12476597|FG000|NOT COMPLETED|Overall Study||1
11280546|NCT02396147|12476604|FG000|STARTED|Period 1||27
11280547|NCT02396147|12476605|FG001|STARTED|Period 1||27
11280548|NCT02396147|12476604|FG000|COMPLETED|Period 1||27
11280549|NCT02396147|12476605|FG001|COMPLETED|Period 1||27
11280550|NCT02396147|12476604|FG000|NOT COMPLETED|Period 1||0
11280551|NCT02396147|12476605|FG001|NOT COMPLETED|Period 1||0
11280552|NCT02396147|12476604|FG000|STARTED|Period 2||27
11280553|NCT02396147|12476605|FG001|STARTED|Period 2||27
11280554|NCT02396147|12476604|FG000|COMPLETED|Period 2||27
11280555|NCT02396147|12476605|FG001|COMPLETED|Period 2||27
11280556|NCT02396147|12476604|FG000|NOT COMPLETED|Period 2||0
11280557|NCT02396147|12476605|FG001|NOT COMPLETED|Period 2||0
11280558|NCT02396147|12476604|FG000|STARTED|Period 3||27
11280559|NCT02396147|12476605|FG001|STARTED|Period 3||27
11280560|NCT02396147|12476604|FG000|COMPLETED|Period 3||27
11280561|NCT02396147|12476605|FG001|COMPLETED|Period 3||27
11398880|NCT04392219|12593361|FG017|STARTED|Overall Study||6
11398881|NCT04392219|12593344|FG000|COMPLETED|Overall Study||16
11398882|NCT04392219|12593345|FG001|COMPLETED|Overall Study||6
11398883|NCT04392219|12593346|FG002|COMPLETED|Overall Study||6
11398884|NCT04392219|12593347|FG003|COMPLETED|Overall Study||6
11398885|NCT04392219|12593348|FG004|COMPLETED|Overall Study||6
11280562|NCT02396147|12476604|FG000|NOT COMPLETED|Period 3||0
11280563|NCT02396147|12476605|FG001|NOT COMPLETED|Period 3||0
11280564|NCT02396160|12476621|FG000|STARTED|Overall Study||75
11280565|NCT02396160|12476622|FG001|STARTED|Overall Study||75
11280566|NCT02396160|12476621|FG000|COMPLETED|Overall Study||69
11280567|NCT02396160|12476622|FG001|COMPLETED|Overall Study||73
11280568|NCT02396160|12476621|FG000|NOT COMPLETED|Overall Study||6
11280569|NCT02396160|12476622|FG001|NOT COMPLETED|Overall Study||2
11280570|NCT02396212|12476628|FG000|STARTED|Overall Study||19
11280571|NCT02396212|12476628|FG000|COMPLETED|Overall Study||16
11280572|NCT02396212|12476628|FG000|NOT COMPLETED|Overall Study||3
11280573|NCT02396316|12476634|FG000|STARTED|Overall Study||27
11280574|NCT02396316|12476635|FG001|STARTED|Overall Study||27
11280575|NCT02396316|12476634|FG000|Treated|Overall Study||27
11280576|NCT02396316|12476635|FG001|Treated|Overall Study||27
11280577|NCT02396316|12476634|FG000|Received Sham Injection at Week 1|Overall Study||10
11280578|NCT02396316|12476635|FG001|Received Sham Injection at Week 1|Overall Study||0
11280579|NCT02396316|12476634|FG000|Received AFL Injection at Week 1|Overall Study||0
11280580|NCT02396316|12476635|FG001|Received AFL Injection at Week 1|Overall Study||22
11280581|NCT02396316|12476634|FG000|Received Active Injection at Week 5|Overall Study||4
11280582|NCT02396316|12476635|FG001|Received Active Injection at Week 5|Overall Study||4
11280583|NCT02396316|12476634|FG000|Received Active Injection at Week 9|Overall Study||2
11280584|NCT02396316|12476635|FG001|Received Active Injection at Week 9|Overall Study||1
11280585|NCT02396316|12476634|FG000|COMPLETED|Overall Study||20
11280586|NCT02396316|12476635|FG001|COMPLETED|Overall Study||22
11280587|NCT02396316|12476634|FG000|NOT COMPLETED|Overall Study||7
11280588|NCT02396316|12476635|FG001|NOT COMPLETED|Overall Study||5
11398886|NCT04392219|12593349|FG005|COMPLETED|Overall Study||6
11398887|NCT04392219|12593350|FG006|COMPLETED|Overall Study||6
11398888|NCT04392219|12593351|FG007|COMPLETED|Overall Study||6
11398889|NCT04392219|12593352|FG008|COMPLETED|Overall Study||6
11398890|NCT04392219|12593353|FG009|COMPLETED|Overall Study||10
11280589|NCT02396381|12476647|FG000|STARTED|Overall Study||488
11280590|NCT02396381|12476648|FG001|STARTED|Overall Study||496
11280591|NCT02396381|12476647|FG000|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414
11280592|NCT02396381|12476648|FG001|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443
11280593|NCT02396381|12476647|FG000|COMPLETED|Overall Study||381
11280594|NCT02396381|12476648|FG001|COMPLETED|Overall Study||422
11280595|NCT02396381|12476647|FG000|NOT COMPLETED|Overall Study||107
11280596|NCT02396381|12476648|FG001|NOT COMPLETED|Overall Study||74
11280597|NCT02396420|12476657|FG000|STARTED|Overall Study||2
11280598|NCT02396420|12476657|FG000|1 Month Post PAE|Overall Study||2
11280599|NCT02396420|12476657|FG000|3 Months Post PAE|Overall Study||2
11280600|NCT02396420|12476657|FG000|6 Months Post PAE|Overall Study||2
11280601|NCT02396420|12476657|FG000|COMPLETED|Overall Study||1
11280602|NCT02396420|12476657|FG000|NOT COMPLETED|Overall Study||1
11280603|NCT02396511|12476662|FG000|STARTED|Overall Study||2
11280604|NCT02396511|12476662|FG000|COMPLETED|Overall Study||2
11280605|NCT02396511|12476662|FG000|NOT COMPLETED|Overall Study||0
11280606|NCT02396537|12476668|FG000|STARTED|Overall Study||40
11280607|NCT02396537|12476669|FG001|STARTED|Overall Study||37
11280608|NCT02396537|12476668|FG000|COMPLETED|Overall Study||40
11280609|NCT02396537|12476669|FG001|COMPLETED|Overall Study||36
11280610|NCT02396537|12476668|FG000|NOT COMPLETED|Overall Study||0
11280611|NCT02396537|12476669|FG001|NOT COMPLETED|Overall Study||1
11398891|NCT04392219|12593354|FG010|COMPLETED|Overall Study||14
11398892|NCT04392219|12593355|FG011|COMPLETED|Overall Study||6
11280612|NCT02396732|12476677|FG000|STARTED|Overall Study||14
11280613|NCT02396732|12476678|FG001|STARTED|Overall Study||17
11280614|NCT02396732|12476677|FG000|COMPLETED|Overall Study||14
11280615|NCT02396732|12476678|FG001|COMPLETED|Overall Study||17
11280616|NCT02396732|12476677|FG000|NOT COMPLETED|Overall Study||0
11280617|NCT02396732|12476678|FG001|NOT COMPLETED|Overall Study||0
11280618|NCT02396745|12476684|FG000|STARTED|Overall Study||1
11280619|NCT02396745|12476684|FG000|COMPLETED|Overall Study||1
11280620|NCT02396745|12476684|FG000|NOT COMPLETED|Overall Study||0
11280621|NCT02396758|12476692|FG000|STARTED|Overall Study||38
11280622|NCT02396758|12476693|FG001|STARTED|Overall Study||37
11280623|NCT02396758|12476694|FG002|STARTED|Overall Study||38
11280624|NCT02396758|12476695|FG003|STARTED|Overall Study||18
11280625|NCT02396758|12476692|FG000|COMPLETED|Overall Study||26
11280626|NCT02396758|12476693|FG001|COMPLETED|Overall Study||31
11280627|NCT02396758|12476694|FG002|COMPLETED|Overall Study||34
11280628|NCT02396758|12476695|FG003|COMPLETED|Overall Study||13
11280629|NCT02396758|12476692|FG000|NOT COMPLETED|Overall Study||12
11280630|NCT02396758|12476693|FG001|NOT COMPLETED|Overall Study||6
11280631|NCT02396758|12476694|FG002|NOT COMPLETED|Overall Study||4
11280632|NCT02396758|12476695|FG003|NOT COMPLETED|Overall Study||5
11280633|NCT02396849|12476707|FG000|STARTED|Overall Study||29
11280634|NCT02396849|12476708|FG001|STARTED|Overall Study||30
11280635|NCT02396849|12476707|FG000|COMPLETED|Overall Study||27
11280636|NCT02396849|12476708|FG001|COMPLETED|Overall Study||28
11280637|NCT02396849|12476707|FG000|NOT COMPLETED|Overall Study||2
11280638|NCT02396849|12476708|FG001|NOT COMPLETED|Overall Study||2
11280639|NCT02396953|12476719|FG000|STARTED|Overall Study||9
11280640|NCT02396953|12476720|FG001|STARTED|Overall Study||9
11280641|NCT02396953|12476721|FG002|STARTED|Overall Study||10
11280642|NCT02396953|12476719|FG000|COMPLETED|Overall Study||5
11280643|NCT02396953|12476720|FG001|COMPLETED|Overall Study||6
11280644|NCT02396953|12476721|FG002|COMPLETED|Overall Study||7
11280645|NCT02396953|12476719|FG000|NOT COMPLETED|Overall Study||4
11280646|NCT02396953|12476720|FG001|NOT COMPLETED|Overall Study||3
11280647|NCT02396953|12476721|FG002|NOT COMPLETED|Overall Study||3
11280648|NCT02397057|12476738|FG000|STARTED|Overall Study|"Two Normal Saline participants received Injectafer. The data presented is considered accurate."|105
11280649|NCT02397057|12476739|FG001|STARTED|Overall Study||104
11280650|NCT02397057|12476738|FG000|COMPLETED|Overall Study||94
11280651|NCT02397057|12476739|FG001|COMPLETED|Overall Study||91
11280652|NCT02397057|12476738|FG000|NOT COMPLETED|Overall Study||11
11280653|NCT02397057|12476739|FG001|NOT COMPLETED|Overall Study||13
11280654|NCT02397122|12476747|FG000|STARTED|Overall Study||20
11280655|NCT02397122|12476748|FG001|STARTED|Overall Study||20
11280656|NCT02397122|12476747|FG000|COMPLETED|Overall Study||20
11280657|NCT02397122|12476748|FG001|COMPLETED|Overall Study||20
11280658|NCT02397122|12476747|FG000|NOT COMPLETED|Overall Study||0
11280659|NCT02397122|12476748|FG001|NOT COMPLETED|Overall Study||0
11280660|NCT02397265|12476758|FG000|STARTED|First Intervention of Three||2
11280661|NCT02397265|12476759|FG001|STARTED|First Intervention of Three||2
11280662|NCT02397265|12476760|FG002|STARTED|First Intervention of Three||2
11280663|NCT02397265|12476758|FG000|COMPLETED|First Intervention of Three||2
11280664|NCT02397265|12476759|FG001|COMPLETED|First Intervention of Three||2
11280665|NCT02397265|12476760|FG002|COMPLETED|First Intervention of Three||2
11280666|NCT02397265|12476758|FG000|NOT COMPLETED|First Intervention of Three||0
11280667|NCT02397265|12476759|FG001|NOT COMPLETED|First Intervention of Three||0
11280668|NCT02397265|12476760|FG002|NOT COMPLETED|First Intervention of Three||0
11280669|NCT02397265|12476758|FG000|STARTED|Second Intervention of Three||2
11280670|NCT02397265|12476759|FG001|STARTED|Second Intervention of Three||2
11280671|NCT02397265|12476760|FG002|STARTED|Second Intervention of Three||2
11280672|NCT02397265|12476758|FG000|COMPLETED|Second Intervention of Three||2
11280673|NCT02397265|12476759|FG001|COMPLETED|Second Intervention of Three||2
11280674|NCT02397265|12476760|FG002|COMPLETED|Second Intervention of Three||2
11280675|NCT02397265|12476758|FG000|NOT COMPLETED|Second Intervention of Three||0
11280676|NCT02397265|12476759|FG001|NOT COMPLETED|Second Intervention of Three||0
11280677|NCT02397265|12476760|FG002|NOT COMPLETED|Second Intervention of Three||0
11280678|NCT02397265|12476758|FG000|STARTED|Third Intervention of Three||2
11280679|NCT02397265|12476759|FG001|STARTED|Third Intervention of Three||2
11280680|NCT02397265|12476760|FG002|STARTED|Third Intervention of Three||2
11280681|NCT02397265|12476758|FG000|COMPLETED|Third Intervention of Three||2
11280682|NCT02397265|12476759|FG001|COMPLETED|Third Intervention of Three||2
11280683|NCT02397265|12476760|FG002|COMPLETED|Third Intervention of Three||2
11280684|NCT02397265|12476758|FG000|NOT COMPLETED|Third Intervention of Three||0
11280685|NCT02397265|12476759|FG001|NOT COMPLETED|Third Intervention of Three||0
11280686|NCT02397265|12476760|FG002|NOT COMPLETED|Third Intervention of Three||0
11280687|NCT02397278|12476770|FG000|STARTED|Overall Study||7
11280688|NCT02397278|12476771|FG001|STARTED|Overall Study||8
11280689|NCT02397278|12476770|FG000|COMPLETED|Overall Study||6
11280690|NCT02397278|12476771|FG001|COMPLETED|Overall Study||5
11280691|NCT02397278|12476770|FG000|NOT COMPLETED|Overall Study||1
11280692|NCT02397278|12476771|FG001|NOT COMPLETED|Overall Study||3
11280693|NCT02397291|12476779|FG000|STARTED|Overall Study||19
11280694|NCT02397291|12476780|FG001|STARTED|Overall Study||5
11280695|NCT02397291|12476779|FG000|COMPLETED|Overall Study||19
11280696|NCT02397291|12476780|FG001|COMPLETED|Overall Study||5
11280697|NCT02397291|12476779|FG000|NOT COMPLETED|Overall Study||0
11280698|NCT02397291|12476780|FG001|NOT COMPLETED|Overall Study||0
11280699|NCT02397408|12476786|FG000|STARTED|Overall Study||18
11280700|NCT02397408|12476786|FG000|Completed Surgery Per Protocol|Overall Study||16
11280701|NCT02397408|12476786|FG000|COMPLETED|Overall Study||12
11280702|NCT02397408|12476786|FG000|NOT COMPLETED|Overall Study||6
11280703|NCT02397447|12476792|FG000|STARTED|Overall Study||12
11280704|NCT02397447|12476793|FG001|STARTED|Overall Study||12
11280705|NCT02397447|12476792|FG000|COMPLETED|Overall Study||10
11280706|NCT02397447|12476793|FG001|COMPLETED|Overall Study||10
11280707|NCT02397447|12476792|FG000|NOT COMPLETED|Overall Study||2
11280708|NCT02397447|12476793|FG001|NOT COMPLETED|Overall Study||2
11280709|NCT02397460|12476807|FG000|STARTED|Treatment Period 1||7
11280710|NCT02397460|12476808|FG001|STARTED|Treatment Period 1||7
11280711|NCT02397460|12476809|FG002|STARTED|Treatment Period 1||6
11280712|NCT02397460|12476810|FG003|STARTED|Treatment Period 1||6
11280713|NCT02397460|12476811|FG004|STARTED|Treatment Period 1||6
11280714|NCT02397460|12476812|FG005|STARTED|Treatment Period 1||6
11280715|NCT02397460|12476813|FG006|STARTED|Treatment Period 1||6
11280716|NCT02397460|12476814|FG007|STARTED|Treatment Period 1||6
11280717|NCT02397460|12476807|FG000|COMPLETED|Treatment Period 1||7
11280718|NCT02397460|12476808|FG001|COMPLETED|Treatment Period 1||7
11280719|NCT02397460|12476809|FG002|COMPLETED|Treatment Period 1||6
11280720|NCT02397460|12476810|FG003|COMPLETED|Treatment Period 1||6
11280721|NCT02397460|12476811|FG004|COMPLETED|Treatment Period 1||6
11280722|NCT02397460|12476812|FG005|COMPLETED|Treatment Period 1||6
11280723|NCT02397460|12476813|FG006|COMPLETED|Treatment Period 1||6
11280724|NCT02397460|12476814|FG007|COMPLETED|Treatment Period 1||6
11280725|NCT02397460|12476807|FG000|NOT COMPLETED|Treatment Period 1||0
11280726|NCT02397460|12476808|FG001|NOT COMPLETED|Treatment Period 1||0
11280727|NCT02397460|12476809|FG002|NOT COMPLETED|Treatment Period 1||0
11280728|NCT02397460|12476810|FG003|NOT COMPLETED|Treatment Period 1||0
11280729|NCT02397460|12476811|FG004|NOT COMPLETED|Treatment Period 1||0
11280730|NCT02397460|12476812|FG005|NOT COMPLETED|Treatment Period 1||0
11280731|NCT02397460|12476813|FG006|NOT COMPLETED|Treatment Period 1||0
11280732|NCT02397460|12476814|FG007|NOT COMPLETED|Treatment Period 1||0
11280733|NCT02397460|12476807|FG000|STARTED|Treatment Period 2||7
11280734|NCT02397460|12476808|FG001|STARTED|Treatment Period 2||7
11280735|NCT02397460|12476809|FG002|STARTED|Treatment Period 2||6
11280736|NCT02397460|12476810|FG003|STARTED|Treatment Period 2||6
11280737|NCT02397460|12476811|FG004|STARTED|Treatment Period 2||6
11280738|NCT02397460|12476812|FG005|STARTED|Treatment Period 2||6
11280739|NCT02397460|12476813|FG006|STARTED|Treatment Period 2||6
11280740|NCT02397460|12476814|FG007|STARTED|Treatment Period 2||6
11280741|NCT02397460|12476807|FG000|COMPLETED|Treatment Period 2||7
11280742|NCT02397460|12476808|FG001|COMPLETED|Treatment Period 2||7
11280743|NCT02397460|12476809|FG002|COMPLETED|Treatment Period 2||6
11280744|NCT02397460|12476810|FG003|COMPLETED|Treatment Period 2||6
11280745|NCT02397460|12476811|FG004|COMPLETED|Treatment Period 2||6
11280746|NCT02397460|12476812|FG005|COMPLETED|Treatment Period 2||6
11280747|NCT02397460|12476813|FG006|COMPLETED|Treatment Period 2||6
11280748|NCT02397460|12476814|FG007|COMPLETED|Treatment Period 2||5
11280749|NCT02397460|12476807|FG000|NOT COMPLETED|Treatment Period 2||0
11280750|NCT02397460|12476808|FG001|NOT COMPLETED|Treatment Period 2||0
11280751|NCT02397460|12476809|FG002|NOT COMPLETED|Treatment Period 2||0
11280752|NCT02397460|12476810|FG003|NOT COMPLETED|Treatment Period 2||0
11280753|NCT02397460|12476811|FG004|NOT COMPLETED|Treatment Period 2||0
11280754|NCT02397460|12476812|FG005|NOT COMPLETED|Treatment Period 2||0
11280755|NCT02397460|12476813|FG006|NOT COMPLETED|Treatment Period 2||0
11280756|NCT02397460|12476814|FG007|NOT COMPLETED|Treatment Period 2||1
11280757|NCT02397460|12476807|FG000|STARTED|Treatment Period 3||7
11280758|NCT02397460|12476808|FG001|STARTED|Treatment Period 3||7
11280759|NCT02397460|12476809|FG002|STARTED|Treatment Period 3||6
11280760|NCT02397460|12476810|FG003|STARTED|Treatment Period 3||6
11280761|NCT02397460|12476811|FG004|STARTED|Treatment Period 3||6
11280762|NCT02397460|12476812|FG005|STARTED|Treatment Period 3||6
11280763|NCT02397460|12476813|FG006|STARTED|Treatment Period 3||6
11280764|NCT02397460|12476814|FG007|STARTED|Treatment Period 3||5
11280765|NCT02397460|12476807|FG000|COMPLETED|Treatment Period 3||7
11280766|NCT02397460|12476808|FG001|COMPLETED|Treatment Period 3||7
11280767|NCT02397460|12476809|FG002|COMPLETED|Treatment Period 3||6
11280768|NCT02397460|12476810|FG003|COMPLETED|Treatment Period 3||6
11280769|NCT02397460|12476811|FG004|COMPLETED|Treatment Period 3||6
11280770|NCT02397460|12476812|FG005|COMPLETED|Treatment Period 3||6
11280771|NCT02397460|12476813|FG006|COMPLETED|Treatment Period 3||6
11280772|NCT02397460|12476814|FG007|COMPLETED|Treatment Period 3||5
11280773|NCT02397460|12476807|FG000|NOT COMPLETED|Treatment Period 3||0
11280774|NCT02397460|12476808|FG001|NOT COMPLETED|Treatment Period 3||0
11280775|NCT02397460|12476809|FG002|NOT COMPLETED|Treatment Period 3||0
11280776|NCT02397460|12476810|FG003|NOT COMPLETED|Treatment Period 3||0
11280777|NCT02397460|12476811|FG004|NOT COMPLETED|Treatment Period 3||0
11280778|NCT02397460|12476812|FG005|NOT COMPLETED|Treatment Period 3||0
11280779|NCT02397460|12476813|FG006|NOT COMPLETED|Treatment Period 3||0
11280780|NCT02397460|12476814|FG007|NOT COMPLETED|Treatment Period 3||0
11280781|NCT02397460|12476807|FG000|STARTED|Treatment Period 4||7
11280782|NCT02397460|12476808|FG001|STARTED|Treatment Period 4||7
11280783|NCT02397460|12476809|FG002|STARTED|Treatment Period 4||6
11280784|NCT02397460|12476810|FG003|STARTED|Treatment Period 4||6
11280785|NCT02397460|12476811|FG004|STARTED|Treatment Period 4||6
11280786|NCT02397460|12476812|FG005|STARTED|Treatment Period 4||6
11280787|NCT02397460|12476813|FG006|STARTED|Treatment Period 4||6
11280788|NCT02397460|12476814|FG007|STARTED|Treatment Period 4||5
11280789|NCT02397460|12476807|FG000|COMPLETED|Treatment Period 4||7
11280790|NCT02397460|12476808|FG001|COMPLETED|Treatment Period 4||6
11280791|NCT02397460|12476809|FG002|COMPLETED|Treatment Period 4||6
11280792|NCT02397460|12476810|FG003|COMPLETED|Treatment Period 4||6
11280793|NCT02397460|12476811|FG004|COMPLETED|Treatment Period 4||5
11280794|NCT02397460|12476812|FG005|COMPLETED|Treatment Period 4||6
11280795|NCT02397460|12476813|FG006|COMPLETED|Treatment Period 4||6
11280796|NCT02397460|12476814|FG007|COMPLETED|Treatment Period 4||5
11280797|NCT02397460|12476807|FG000|NOT COMPLETED|Treatment Period 4||0
11280798|NCT02397460|12476808|FG001|NOT COMPLETED|Treatment Period 4||1
11280799|NCT02397460|12476809|FG002|NOT COMPLETED|Treatment Period 4||0
11280800|NCT02397460|12476810|FG003|NOT COMPLETED|Treatment Period 4||0
11280801|NCT02397460|12476811|FG004|NOT COMPLETED|Treatment Period 4||1
11280802|NCT02397460|12476812|FG005|NOT COMPLETED|Treatment Period 4||0
11280803|NCT02397460|12476813|FG006|NOT COMPLETED|Treatment Period 4||0
11280804|NCT02397460|12476814|FG007|NOT COMPLETED|Treatment Period 4||0
11280805|NCT02397473|12476890|FG000|STARTED|Treatment Phase||57
11280806|NCT02397473|12476891|FG001|STARTED|Treatment Phase||52
11280807|NCT02397473|12476890|FG000|Received at Least One Dose of Study Drug|Treatment Phase||57
11280808|NCT02397473|12476891|FG001|Received at Least One Dose of Study Drug|Treatment Phase||49
11280809|NCT02397473|12476890|FG000|COMPLETED|Treatment Phase||45
11280810|NCT02397473|12476891|FG001|COMPLETED|Treatment Phase||45
11280811|NCT02397473|12476890|FG000|NOT COMPLETED|Treatment Phase||12
11280812|NCT02397473|12476891|FG001|NOT COMPLETED|Treatment Phase||7
11280813|NCT02397473|12476890|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50
11280814|NCT02397473|12476891|FG001|STARTED|Post Treatment Follow-up Phase||47
11280815|NCT02397473|12476890|FG000|COMPLETED|Post Treatment Follow-up Phase||47
11280816|NCT02397473|12476891|FG001|COMPLETED|Post Treatment Follow-up Phase||45
11280817|NCT02397473|12476890|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||3
11280818|NCT02397473|12476891|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||2
11280819|NCT02397564|12476900|FG000|STARTED|Overall Study||20
11280820|NCT02397564|12476900|FG000|COMPLETED|Overall Study||16
11280821|NCT02397564|12476900|FG000|NOT COMPLETED|Overall Study||4
11280822|NCT02397655|12476905|FG000|STARTED|Overall Study||12012
11280823|NCT02397655|12476905|FG000|COMPLETED|Overall Study||10711
11280824|NCT02397655|12476905|FG000|NOT COMPLETED|Overall Study||1301
11280825|NCT02397694|12476911|FG000|STARTED|Double-Blinded Phase||65
11398893|NCT04392219|12593356|FG012|COMPLETED|Overall Study||6
11398894|NCT04392219|12593357|FG013|COMPLETED|Overall Study||6
11398895|NCT04392219|12593358|FG014|COMPLETED|Overall Study||6
11398896|NCT04392219|12593359|FG015|COMPLETED|Overall Study||6
11398897|NCT04392219|12593360|FG016|COMPLETED|Overall Study||6
11398898|NCT04392219|12593361|FG017|COMPLETED|Overall Study||6
11280826|NCT02397694|12476912|FG001|STARTED|Double-Blinded Phase||33
11280827|NCT02397694|12476911|FG000|COMPLETED|Double-Blinded Phase||62
11280828|NCT02397694|12476912|FG001|COMPLETED|Double-Blinded Phase||30
11280829|NCT02397694|12476911|FG000|NOT COMPLETED|Double-Blinded Phase||3
11280830|NCT02397694|12476912|FG001|NOT COMPLETED|Double-Blinded Phase||3
11280831|NCT02397694|12476911|FG000|STARTED|Open Label Extension Phase||62
11280832|NCT02397694|12476912|FG001|STARTED|Open Label Extension Phase||30
11280833|NCT02397694|12476911|FG000|COMPLETED|Open Label Extension Phase||54
11280834|NCT02397694|12476912|FG001|COMPLETED|Open Label Extension Phase||29
11280835|NCT02397694|12476911|FG000|NOT COMPLETED|Open Label Extension Phase||8
11280836|NCT02397694|12476912|FG001|NOT COMPLETED|Open Label Extension Phase||1
11280837|NCT02397707|12476925|FG000|STARTED|Overall Study||14
11280838|NCT02397707|12476926|FG001|STARTED|Overall Study||10
11280839|NCT02397707|12476927|FG002|STARTED|Overall Study||9
11280840|NCT02397707|12476925|FG000|COMPLETED|Overall Study||14
11280841|NCT02397707|12476926|FG001|COMPLETED|Overall Study||10
11280842|NCT02397707|12476927|FG002|COMPLETED|Overall Study||9
11280843|NCT02397707|12476925|FG000|NOT COMPLETED|Overall Study||0
11280844|NCT02397707|12476926|FG001|NOT COMPLETED|Overall Study||0
11280845|NCT02397707|12476927|FG002|NOT COMPLETED|Overall Study||0
11398899|NCT04392219|12593344|FG000|NOT COMPLETED|Overall Study||0
11280846|NCT02397785|12476938|FG000|STARTED|Overall Study||24
11280847|NCT02397785|12476939|FG001|STARTED|Overall Study||34
11280848|NCT02397785|12476938|FG000|COMPLETED|Overall Study||22
11398900|NCT04392219|12593345|FG001|NOT COMPLETED|Overall Study||0
11398901|NCT04392219|12593346|FG002|NOT COMPLETED|Overall Study||0
11280849|NCT02397785|12476939|FG001|COMPLETED|Overall Study||25
11280850|NCT02397785|12476938|FG000|NOT COMPLETED|Overall Study||2
11280851|NCT02397785|12476939|FG001|NOT COMPLETED|Overall Study||9
11280852|NCT02397837|12476947|FG000|STARTED|Overall Study||33
11280853|NCT02397837|12476948|FG001|STARTED|Overall Study||30
11280854|NCT02397837|12476947|FG000|COMPLETED|Overall Study||26
11280855|NCT02397837|12476948|FG001|COMPLETED|Overall Study||24
11280856|NCT02397837|12476947|FG000|NOT COMPLETED|Overall Study||7
11280857|NCT02397837|12476948|FG001|NOT COMPLETED|Overall Study||6
11280858|NCT02397889|12476956|FG000|STARTED|Overall Study||15
11280859|NCT02397889|12476957|FG001|STARTED|Overall Study||15
11280860|NCT02397889|12476956|FG000|COMPLETED|Overall Study||14
11280861|NCT02397889|12476957|FG001|COMPLETED|Overall Study||15
11280862|NCT02397889|12476956|FG000|NOT COMPLETED|Overall Study||1
11280863|NCT02397889|12476957|FG001|NOT COMPLETED|Overall Study||0
11280864|NCT02397915|12476963|FG000|STARTED|Period 1||150
11280865|NCT02397915|12476964|FG001|STARTED|Period 1||150
11280866|NCT02397915|12476965|FG002|STARTED|Period 1||0
11398902|NCT04392219|12593347|FG003|NOT COMPLETED|Overall Study||0
11280867|NCT02397915|12476966|FG003|STARTED|Period 1||0
11280868|NCT02397915|12476963|FG000|COMPLETED|Period 1||149
11280869|NCT02397915|12476964|FG001|COMPLETED|Period 1||149
11280870|NCT02397915|12476965|FG002|COMPLETED|Period 1||0
11280871|NCT02397915|12476966|FG003|COMPLETED|Period 1||0
11280872|NCT02397915|12476963|FG000|NOT COMPLETED|Period 1||1
11280873|NCT02397915|12476964|FG001|NOT COMPLETED|Period 1||1
11280874|NCT02397915|12476965|FG002|NOT COMPLETED|Period 1||0
11280875|NCT02397915|12476966|FG003|NOT COMPLETED|Period 1||0
11280876|NCT02397915|12476963|FG000|STARTED|Period 2||0
11280877|NCT02397915|12476964|FG001|STARTED|Period 2||0
11280878|NCT02397915|12476965|FG002|STARTED|Period 2||149
11280879|NCT02397915|12476966|FG003|STARTED|Period 2||149
11280880|NCT02397915|12476963|FG000|COMPLETED|Period 2||0
11280881|NCT02397915|12476964|FG001|COMPLETED|Period 2||0
11280882|NCT02397915|12476965|FG002|COMPLETED|Period 2||149
11280883|NCT02397915|12476966|FG003|COMPLETED|Period 2||149
11280884|NCT02397915|12476963|FG000|NOT COMPLETED|Period 2||0
11280885|NCT02397915|12476964|FG001|NOT COMPLETED|Period 2||0
11280886|NCT02397915|12476965|FG002|NOT COMPLETED|Period 2||0
11280887|NCT02397915|12476966|FG003|NOT COMPLETED|Period 2||0
11280888|NCT02397954|12476974|FG000|STARTED|Overall Study||4
11280889|NCT02397954|12476974|FG000|COMPLETED|Overall Study||4
11280890|NCT02397954|12476974|FG000|NOT COMPLETED|Overall Study||0
11280891|NCT02398188|12476980|FG000|STARTED|Overall Study||398
11280892|NCT02398188|12476981|FG001|STARTED|Overall Study||395
11280893|NCT02398188|12476980|FG000|COMPLETED|Overall Study||371
11280894|NCT02398188|12476981|FG001|COMPLETED|Overall Study||361
11280895|NCT02398188|12476980|FG000|NOT COMPLETED|Overall Study||27
11280896|NCT02398188|12476981|FG001|NOT COMPLETED|Overall Study||34
11280897|NCT02398227|12476989|FG000|STARTED|Overall Study||83
11021757|NCT00805948|12199942|FG000|NOT COMPLETED|Overall Study||68
11021758|NCT00805948|12199943|FG001|NOT COMPLETED|Overall Study||96
11021759|NCT00806026|12199956|FG000|STARTED|Overall Study||185
11021760|NCT00806026|12199957|FG001|STARTED|Overall Study||183
11021761|NCT00806026|12199958|FG002|STARTED|Overall Study||182
11021762|NCT00806026|12199959|FG003|STARTED|Overall Study||61
11021763|NCT00806026|12199960|FG004|STARTED|Overall Study||59
11021764|NCT00806026|12199961|FG005|STARTED|Overall Study||61
11021765|NCT00806026|12199956|FG000|Treated|Overall Study||182
11021766|NCT00806026|12199957|FG001|Treated|Overall Study||178
11021767|NCT00806026|12199958|FG002|Treated|Overall Study||180
11021768|NCT00806026|12199959|FG003|Treated|Overall Study||59
11021769|NCT00806026|12199960|FG004|Treated|Overall Study||59
11021770|NCT00806026|12199961|FG005|Treated|Overall Study||61
11021771|NCT00806026|12199956|FG000|COMPLETED|Overall Study||93
11021772|NCT00806026|12199957|FG001|COMPLETED|Overall Study||82
11021773|NCT00806026|12199958|FG002|COMPLETED|Overall Study||89
11021774|NCT00806026|12199959|FG003|COMPLETED|Overall Study||32
11280898|NCT02398227|12476990|FG001|STARTED|Overall Study||89
11280899|NCT02398227|12476989|FG000|COMPLETED|Overall Study||56
11280900|NCT02398227|12476990|FG001|COMPLETED|Overall Study||71
11280901|NCT02398227|12476989|FG000|NOT COMPLETED|Overall Study||27
11280902|NCT02398227|12476990|FG001|NOT COMPLETED|Overall Study||18
11280903|NCT02398409|12476998|FG000|STARTED|Overall Study||69
11280904|NCT02398409|12476999|FG001|STARTED|Overall Study||68
11280905|NCT02398409|12476998|FG000|COMPLETED|Overall Study||67
11280906|NCT02398409|12476999|FG001|COMPLETED|Overall Study||63
11280907|NCT02398409|12476998|FG000|NOT COMPLETED|Overall Study||2
11280908|NCT02398409|12476999|FG001|NOT COMPLETED|Overall Study||5
11280909|NCT02399085|12477005|FG000|STARTED|Overall Study||81
11021775|NCT00806026|12199960|FG004|COMPLETED|Overall Study||29
11280910|NCT02399085|12477005|FG000|COMPLETED|Overall Study|30 patients completed the combination treatment on both study drugs (12 cycles).|30
11280911|NCT02399085|12477005|FG000|NOT COMPLETED|Overall Study||51
11280912|NCT02399163|12477009|FG000|STARTED|Overall Study||62
11280913|NCT02399163|12477009|FG000|COMPLETED|Overall Study||53
11021776|NCT00806026|12199961|FG005|COMPLETED|Overall Study||29
11021777|NCT00806026|12199956|FG000|NOT COMPLETED|Overall Study||92
11021778|NCT00806026|12199957|FG001|NOT COMPLETED|Overall Study||101
11021779|NCT00806026|12199958|FG002|NOT COMPLETED|Overall Study||93
11280914|NCT02399163|12477009|FG000|NOT COMPLETED|Overall Study||9
11280915|NCT02399228|12477021|FG000|STARTED|Overall Study||13
11280916|NCT02399228|12477021|FG000|COMPLETED|Overall Study||7
11280917|NCT02399228|12477021|FG000|NOT COMPLETED|Overall Study||6
11280918|NCT02399254|12477025|FG000|STARTED|Overall Study||21
11280919|NCT02399254|12477025|FG000|COMPLETED|Overall Study||19
11280920|NCT02399254|12477025|FG000|NOT COMPLETED|Overall Study||2
11280921|NCT02399345|12477030|FG000|STARTED|Overall Study||10
11280922|NCT02399345|12477030|FG000|COMPLETED|Overall Study||10
11280923|NCT02399345|12477030|FG000|NOT COMPLETED|Overall Study||0
11280924|NCT02399475|12477036|FG000|STARTED|Overall Study||7
11280925|NCT02399475|12477037|FG001|STARTED|Overall Study||7
11280926|NCT02399475|12477036|FG000|COMPLETED|Overall Study||6
11280927|NCT02399475|12477037|FG001|COMPLETED|Overall Study||7
11280928|NCT02399475|12477036|FG000|NOT COMPLETED|Overall Study||1
11280929|NCT02399475|12477037|FG001|NOT COMPLETED|Overall Study||0
11280930|NCT02399917|12477046|FG000|STARTED|Overall Study||6
11280931|NCT02399917|12477047|FG001|STARTED|Overall Study||6
11280932|NCT02399917|12477048|FG002|STARTED|Overall Study||24
11280933|NCT02399917|12477046|FG000|COMPLETED|Overall Study||6
11280934|NCT02399917|12477047|FG001|COMPLETED|Overall Study||6
11280935|NCT02399917|12477048|FG002|COMPLETED|Overall Study||24
11280936|NCT02399917|12477046|FG000|NOT COMPLETED|Overall Study||0
11021780|NCT00806026|12199959|FG003|NOT COMPLETED|Overall Study||29
11280937|NCT02399917|12477047|FG001|NOT COMPLETED|Overall Study||0
11280938|NCT02399917|12477048|FG002|NOT COMPLETED|Overall Study||0
11280939|NCT02400073|12477057|FG000|STARTED|Overall Study||122
11280940|NCT02400073|12477057|FG000|COMPLETED|Overall Study||111
11280941|NCT02400073|12477057|FG000|NOT COMPLETED|Overall Study||11
11280942|NCT02400307|12477063|FG000|STARTED|Overall Study||11
11280943|NCT02400307|12477064|FG001|STARTED|Overall Study||8
11280944|NCT02400307|12477063|FG000|COMPLETED|Overall Study||10
11280945|NCT02400307|12477064|FG001|COMPLETED|Overall Study||8
11280946|NCT02400307|12477063|FG000|NOT COMPLETED|Overall Study||1
11280947|NCT02400307|12477064|FG001|NOT COMPLETED|Overall Study||0
11280948|NCT02400333|12477074|FG000|STARTED|Overall Study||9
11280949|NCT02400333|12477075|FG001|STARTED|Overall Study||9
11280950|NCT02400333|12477076|FG002|STARTED|Overall Study||9
11280951|NCT02400333|12477077|FG003|STARTED|Overall Study||9
11280952|NCT02400333|12477074|FG000|COMPLETED|Overall Study||8
11280953|NCT02400333|12477075|FG001|COMPLETED|Overall Study||8
11280954|NCT02400333|12477076|FG002|COMPLETED|Overall Study||7
11280955|NCT02400333|12477077|FG003|COMPLETED|Overall Study||7
11280956|NCT02400333|12477074|FG000|NOT COMPLETED|Overall Study||1
11280957|NCT02400333|12477075|FG001|NOT COMPLETED|Overall Study||1
11280958|NCT02400333|12477076|FG002|NOT COMPLETED|Overall Study||2
11280959|NCT02400333|12477077|FG003|NOT COMPLETED|Overall Study||2
11340757|NCT02925117|12538101|FG009|COMPLETED|Period 1 (Weeks 0 - 16)||0
11340758|NCT02925117|12538102|FG010|COMPLETED|Period 1 (Weeks 0 - 16)||0
11340759|NCT02925117|12538103|FG011|COMPLETED|Period 1 (Weeks 0 - 16)||0
11340760|NCT02925117|12538092|FG000|NOT COMPLETED|Period 1 (Weeks 0 - 16)||18
11340761|NCT02925117|12538093|FG001|NOT COMPLETED|Period 1 (Weeks 0 - 16)||11
11340762|NCT02925117|12538094|FG002|NOT COMPLETED|Period 1 (Weeks 0 - 16)||5
11340763|NCT02925117|12538095|FG003|NOT COMPLETED|Period 1 (Weeks 0 - 16)||3
11340764|NCT02925117|12538096|FG004|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
11340765|NCT02925117|12538097|FG005|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
11340766|NCT02925117|12538098|FG006|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
11340767|NCT02925117|12538099|FG007|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
11340768|NCT02925117|12538100|FG008|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
11340769|NCT02925117|12538101|FG009|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
11340770|NCT02925117|12538102|FG010|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
11340771|NCT02925117|12538103|FG011|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
11340772|NCT02925117|12538092|FG000|STARTED|Period 2 (Weeks 16 - 88)||0
11340773|NCT02925117|12538093|FG001|STARTED|Period 2 (Weeks 16 - 88)||0
11340774|NCT02925117|12538094|FG002|STARTED|Period 2 (Weeks 16 - 88)||0
11340775|NCT02925117|12538095|FG003|STARTED|Period 2 (Weeks 16 - 88)||0
11340776|NCT02925117|12538096|FG004|STARTED|Period 2 (Weeks 16 - 88)||10
11340777|NCT02925117|12538097|FG005|STARTED|Period 2 (Weeks 16 - 88)||10
11340778|NCT02925117|12538098|FG006|STARTED|Period 2 (Weeks 16 - 88)||15
11340779|NCT02925117|12538099|FG007|STARTED|Period 2 (Weeks 16 - 88)||16
11340780|NCT02925117|12538100|FG008|STARTED|Period 2 (Weeks 16 - 88)||19
11340781|NCT02925117|12538101|FG009|STARTED|Period 2 (Weeks 16 - 88)||18
11340782|NCT02925117|12538102|FG010|STARTED|Period 2 (Weeks 16 - 88)||19
11340783|NCT02925117|12538103|FG011|STARTED|Period 2 (Weeks 16 - 88)||19
11340784|NCT02925117|12538092|FG000|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
11340785|NCT02925117|12538093|FG001|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
11340786|NCT02925117|12538094|FG002|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
11340787|NCT02925117|12538095|FG003|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
11340788|NCT02925117|12538096|FG004|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||8
11340789|NCT02925117|12538097|FG005|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||1
11340790|NCT02925117|12538098|FG006|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||13
11340791|NCT02925117|12538099|FG007|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
11340792|NCT02925117|12538100|FG008|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||17
11340793|NCT02925117|12538101|FG009|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
11340794|NCT02925117|12538102|FG010|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||14
11340795|NCT02925117|12538103|FG011|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||4
11340796|NCT02925117|12538092|FG000|COMPLETED|Period 2 (Weeks 16 - 88)||0
11340797|NCT02925117|12538093|FG001|COMPLETED|Period 2 (Weeks 16 - 88)||0
11340798|NCT02925117|12538094|FG002|COMPLETED|Period 2 (Weeks 16 - 88)||0
11340799|NCT02925117|12538095|FG003|COMPLETED|Period 2 (Weeks 16 - 88)||0
11340800|NCT02925117|12538096|FG004|COMPLETED|Period 2 (Weeks 16 - 88)||8
11340801|NCT02925117|12538097|FG005|COMPLETED|Period 2 (Weeks 16 - 88)||5
11340802|NCT02925117|12538098|FG006|COMPLETED|Period 2 (Weeks 16 - 88)||9
11340803|NCT02925117|12538099|FG007|COMPLETED|Period 2 (Weeks 16 - 88)||11
11340804|NCT02925117|12538100|FG008|COMPLETED|Period 2 (Weeks 16 - 88)||13
11340805|NCT02925117|12538101|FG009|COMPLETED|Period 2 (Weeks 16 - 88)||12
11340806|NCT02925117|12538102|FG010|COMPLETED|Period 2 (Weeks 16 - 88)||11
11340807|NCT02925117|12538103|FG011|COMPLETED|Period 2 (Weeks 16 - 88)||14
11340808|NCT02925117|12538092|FG000|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
11340809|NCT02925117|12538093|FG001|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
11340810|NCT02925117|12538094|FG002|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
11340811|NCT02925117|12538095|FG003|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
11340812|NCT02925117|12538096|FG004|NOT COMPLETED|Period 2 (Weeks 16 - 88)||2
11340813|NCT02925117|12538097|FG005|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
11340814|NCT02925117|12538098|FG006|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
11340815|NCT02925117|12538099|FG007|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
11340816|NCT02925117|12538100|FG008|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
11280960|NCT02400346|12477088|FG000|STARTED|Overall Study||132
11280961|NCT02400346|12477088|FG000|COMPLETED|Overall Study||88
11280962|NCT02400346|12477088|FG000|NOT COMPLETED|Overall Study||44
11280963|NCT02400437|12477092|FG000|STARTED|Overall Study||26
11280964|NCT02400437|12477092|FG000|COMPLETED|Overall Study||26
11280965|NCT02400437|12477092|FG000|NOT COMPLETED|Overall Study||0
11280966|NCT02400463|12477098|FG000|STARTED|Overall Study||6
11280967|NCT02400463|12477098|FG000|COMPLETED|Overall Study||6
11280968|NCT02400463|12477098|FG000|NOT COMPLETED|Overall Study||0
11280969|NCT02400580|12477104|FG000|STARTED|Overall Study||91
11280970|NCT02400580|12477105|FG001|STARTED|Overall Study||92
11280971|NCT02400580|12477104|FG000|COMPLETED|Overall Study||89
11280972|NCT02400580|12477105|FG001|COMPLETED|Overall Study||91
11280973|NCT02400580|12477104|FG000|NOT COMPLETED|Overall Study||2
11280974|NCT02400580|12477105|FG001|NOT COMPLETED|Overall Study||1
11280975|NCT02400710|12477113|FG000|STARTED|Overall Study||10
11280976|NCT02400710|12477114|FG001|STARTED|Overall Study||10
11280977|NCT02400710|12477113|FG000|COMPLETED|Overall Study||10
11280978|NCT02400710|12477114|FG001|COMPLETED|Overall Study||10
11280979|NCT02400710|12477113|FG000|NOT COMPLETED|Overall Study||0
11280980|NCT02400710|12477114|FG001|NOT COMPLETED|Overall Study||0
11280981|NCT02400749|12477122|FG000|STARTED|Week 0 -16||50
11280982|NCT02400749|12477123|FG001|STARTED|Week 0 -16||50
11280983|NCT02400749|12477122|FG000|COMPLETED|Week 0 -16||39
11280984|NCT02400749|12477123|FG001|COMPLETED|Week 0 -16||44
11280985|NCT02400749|12477122|FG000|NOT COMPLETED|Week 0 -16||11
11280986|NCT02400749|12477123|FG001|NOT COMPLETED|Week 0 -16||6
11280987|NCT02400749|12477122|FG000|STARTED|Week 17 - 32||39
11280988|NCT02400749|12477123|FG001|STARTED|Week 17 - 32||44
11280989|NCT02400749|12477122|FG000|COMPLETED|Week 17 - 32||34
11280990|NCT02400749|12477123|FG001|COMPLETED|Week 17 - 32||41
11280991|NCT02400749|12477122|FG000|NOT COMPLETED|Week 17 - 32||5
11280992|NCT02400749|12477123|FG001|NOT COMPLETED|Week 17 - 32||3
11280993|NCT02400905|12477129|FG000|STARTED|Overall Study||271
11280994|NCT02400905|12477129|FG000|30-Days Follow-up|Overall Study||268
11280995|NCT02400905|12477129|FG000|12-Months Follow-up|Overall Study||256
11280996|NCT02400905|12477129|FG000|24-Months Follow-up|Overall Study||225
11280997|NCT02400905|12477129|FG000|36 Months-Follow-up|Overall Study||208
11280998|NCT02400905|12477129|FG000|COMPLETED|Overall Study||208
11280999|NCT02400905|12477129|FG000|NOT COMPLETED|Overall Study||63
11281000|NCT02400996|12477134|FG000|STARTED|Overall Study||40
11281001|NCT02400996|12477134|FG000|COMPLETED|Overall Study||40
11281002|NCT02400996|12477134|FG000|NOT COMPLETED|Overall Study||0
11281003|NCT02401022|12477140|FG000|STARTED|Overall Study||104
11281004|NCT02401022|12477141|FG001|STARTED|Overall Study||110
11281005|NCT02401022|12477140|FG000|COMPLETED|Overall Study||89
11281006|NCT02401022|12477141|FG001|COMPLETED|Overall Study||90
11281007|NCT02401022|12477140|FG000|NOT COMPLETED|Overall Study||15
11281008|NCT02401022|12477141|FG001|NOT COMPLETED|Overall Study||20
11281009|NCT02401048|12477149|FG000|STARTED|Overall Study||27
11281010|NCT02401048|12477150|FG001|STARTED|Overall Study||34
11281011|NCT02401048|12477149|FG000|COMPLETED|Overall Study||5
11281012|NCT02401048|12477150|FG001|COMPLETED|Overall Study||4
11281013|NCT02401048|12477149|FG000|NOT COMPLETED|Overall Study||22
11281014|NCT02401048|12477150|FG001|NOT COMPLETED|Overall Study||30
11281015|NCT02401230|12477164|FG000|STARTED|Overall Study||26
11281016|NCT02401230|12477165|FG001|STARTED|Overall Study||25
11281017|NCT02401230|12477166|FG002|STARTED|Overall Study||25
11281018|NCT02401230|12477164|FG000|COMPLETED|Overall Study||20
11281019|NCT02401230|12477165|FG001|COMPLETED|Overall Study||19
11281020|NCT02401230|12477166|FG002|COMPLETED|Overall Study||21
11281021|NCT02401230|12477164|FG000|NOT COMPLETED|Overall Study||6
11281022|NCT02401230|12477165|FG001|NOT COMPLETED|Overall Study||6
11281023|NCT02401230|12477166|FG002|NOT COMPLETED|Overall Study||4
11281024|NCT02401256|12477178|FG000|STARTED|Overall Study||70
11281025|NCT02401256|12477178|FG000|Finished Phase 1|Overall Study||64
11281026|NCT02401256|12477178|FG000|Finished Phase 2|Overall Study||58
11281027|NCT02401256|12477178|FG000|Finished Phase 3|Overall Study||53
11281028|NCT02401256|12477178|FG000|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
11281029|NCT02401256|12477178|FG000|COMPLETED|Overall Study||53
11281030|NCT02401256|12477178|FG000|NOT COMPLETED|Overall Study||17
11281031|NCT02401412|12477186|FG000|STARTED|Overall Study||89
11281032|NCT02401412|12477187|FG001|STARTED|Overall Study||81
11281033|NCT02401412|12477186|FG000|Received Study Device|Overall Study||89
11281034|NCT02401412|12477187|FG001|Received Study Device|Overall Study||80
11281035|NCT02401412|12477186|FG000|COMPLETED|Overall Study||59
11281036|NCT02401412|12477187|FG001|COMPLETED|Overall Study||49
11281037|NCT02401412|12477186|FG000|NOT COMPLETED|Overall Study||30
11281038|NCT02401412|12477187|FG001|NOT COMPLETED|Overall Study||32
11281039|NCT02401464|12477197|FG000|STARTED|Intervention Period 1 (6 Days)||13
11281040|NCT02401464|12477198|FG001|STARTED|Intervention Period 1 (6 Days)||13
11281041|NCT02401464|12477199|FG002|STARTED|Intervention Period 1 (6 Days)||13
11281042|NCT02401464|12477200|FG003|STARTED|Intervention Period 1 (6 Days)||13
11281043|NCT02401464|12477197|FG000|COMPLETED|Intervention Period 1 (6 Days)||13
11281044|NCT02401464|12477198|FG001|COMPLETED|Intervention Period 1 (6 Days)||13
11281045|NCT02401464|12477199|FG002|COMPLETED|Intervention Period 1 (6 Days)||13
11281046|NCT02401464|12477200|FG003|COMPLETED|Intervention Period 1 (6 Days)||13
11281047|NCT02401464|12477197|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
11281048|NCT02401464|12477198|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
11281049|NCT02401464|12477199|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0
11281050|NCT02401464|12477200|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0
11281051|NCT02401464|12477197|FG000|STARTED|Washout Period (At Least 6 Days)||13
11281052|NCT02401464|12477198|FG001|STARTED|Washout Period (At Least 6 Days)||13
11281053|NCT02401464|12477199|FG002|STARTED|Washout Period (At Least 6 Days)||13
11281054|NCT02401464|12477200|FG003|STARTED|Washout Period (At Least 6 Days)||13
11281055|NCT02401464|12477197|FG000|COMPLETED|Washout Period (At Least 6 Days)||13
11281056|NCT02401464|12477198|FG001|COMPLETED|Washout Period (At Least 6 Days)||13
11281057|NCT02401464|12477199|FG002|COMPLETED|Washout Period (At Least 6 Days)||13
11281058|NCT02401464|12477200|FG003|COMPLETED|Washout Period (At Least 6 Days)||13
11281059|NCT02401464|12477197|FG000|NOT COMPLETED|Washout Period (At Least 6 Days)||0
11281060|NCT02401464|12477198|FG001|NOT COMPLETED|Washout Period (At Least 6 Days)||0
11281061|NCT02401464|12477199|FG002|NOT COMPLETED|Washout Period (At Least 6 Days)||0
11281062|NCT02401464|12477200|FG003|NOT COMPLETED|Washout Period (At Least 6 Days)||0
11281063|NCT02401464|12477197|FG000|STARTED|Intervention Period 2 (6 Days)||13
11281064|NCT02401464|12477198|FG001|STARTED|Intervention Period 2 (6 Days)||13
11281065|NCT02401464|12477199|FG002|STARTED|Intervention Period 2 (6 Days)||13
11281066|NCT02401464|12477200|FG003|STARTED|Intervention Period 2 (6 Days)||13
11281067|NCT02401464|12477197|FG000|COMPLETED|Intervention Period 2 (6 Days)||13
11281068|NCT02401464|12477198|FG001|COMPLETED|Intervention Period 2 (6 Days)||13
11281069|NCT02401464|12477199|FG002|COMPLETED|Intervention Period 2 (6 Days)||13
11281070|NCT02401464|12477200|FG003|COMPLETED|Intervention Period 2 (6 Days)||13
11281071|NCT02401464|12477197|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
11281072|NCT02401464|12477198|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
11281073|NCT02401464|12477199|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0
11281074|NCT02401464|12477200|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0
11281075|NCT02401529|12477214|FG000|STARTED|Overall Study||59
11281076|NCT02401529|12477215|FG001|STARTED|Overall Study||57
11281077|NCT02401529|12477214|FG000|COMPLETED|Overall Study||50
11281078|NCT02401529|12477215|FG001|COMPLETED|Overall Study||50
11281079|NCT02401529|12477214|FG000|NOT COMPLETED|Overall Study||9
11281080|NCT02401529|12477215|FG001|NOT COMPLETED|Overall Study||7
11281081|NCT02401542|12477225|FG000|STARTED|Overall Study||41
11281082|NCT02401542|12477226|FG001|STARTED|Overall Study||30
11281083|NCT02401542|12477227|FG002|STARTED|Overall Study||0
11281084|NCT02401542|12477225|FG000|COMPLETED|Overall Study||40
11281085|NCT02401542|12477226|FG001|COMPLETED|Overall Study||30
11281086|NCT02401542|12477227|FG002|COMPLETED|Overall Study||0
11281087|NCT02401542|12477225|FG000|NOT COMPLETED|Overall Study||1
11281088|NCT02401542|12477226|FG001|NOT COMPLETED|Overall Study||0
11281089|NCT02401542|12477227|FG002|NOT COMPLETED|Overall Study||0
11281090|NCT02401555|12477240|FG000|STARTED|Overall Study||87
11281091|NCT02401555|12477241|FG001|STARTED|Overall Study||212
11281092|NCT02401555|12477242|FG002|STARTED|Overall Study||120
11281093|NCT02401555|12477240|FG000|COMPLETED|Overall Study||87
11281094|NCT02401555|12477241|FG001|COMPLETED|Overall Study||212
11281095|NCT02401555|12477242|FG002|COMPLETED|Overall Study||120
11281096|NCT02401555|12477240|FG000|NOT COMPLETED|Overall Study||0
11281097|NCT02401555|12477241|FG001|NOT COMPLETED|Overall Study||0
11281098|NCT02401555|12477242|FG002|NOT COMPLETED|Overall Study||0
11281099|NCT02401672|12477252|FG000|STARTED|Overall Study||22
11281100|NCT02401672|12477253|FG001|STARTED|Overall Study||20
11281101|NCT02401672|12477252|FG000|COMPLETED|Overall Study||21
11281102|NCT02401672|12477253|FG001|COMPLETED|Overall Study||17
11281103|NCT02401672|12477252|FG000|NOT COMPLETED|Overall Study||1
11281104|NCT02401672|12477253|FG001|NOT COMPLETED|Overall Study||3
11281105|NCT02401867|12477259|FG000|STARTED|Enrolled||150
11281106|NCT02401867|12477259|FG000|COMPLETED|Enrolled||150
11281107|NCT02401867|12477259|FG000|NOT COMPLETED|Enrolled||0
11281108|NCT02401867|12477259|FG000|STARTED|Specimen Collection||150
11281109|NCT02401867|12477259|FG000|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
11281110|NCT02401867|12477259|FG000|NOT COMPLETED|Specimen Collection||10
11281111|NCT02401867|12477259|FG000|STARTED|Analysis||140
11281112|NCT02401867|12477259|FG000|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
11281113|NCT02401867|12477259|FG000|NOT COMPLETED|Analysis||9
11281114|NCT02402062|12477264|FG000|STARTED|Overall Study||17
11281115|NCT02402062|12477264|FG000|COMPLETED|Overall Study||17
11281116|NCT02402062|12477264|FG000|NOT COMPLETED|Overall Study||0
11281117|NCT02402127|12477274|FG000|STARTED|First Wear Period (1 Day)||4
11281118|NCT02402127|12477275|FG001|STARTED|First Wear Period (1 Day)||4
11281119|NCT02402127|12477276|FG002|STARTED|First Wear Period (1 Day)||4
11281120|NCT02402127|12477277|FG003|STARTED|First Wear Period (1 Day)||4
11281121|NCT02402127|12477278|FG004|STARTED|First Wear Period (1 Day)||4
11281122|NCT02402127|12477279|FG005|STARTED|First Wear Period (1 Day)||4
11281123|NCT02402127|12477274|FG000|Randomized and Treated|First Wear Period (1 Day)||4
11281124|NCT02402127|12477275|FG001|Randomized and Treated|First Wear Period (1 Day)||4
11281125|NCT02402127|12477276|FG002|Randomized and Treated|First Wear Period (1 Day)||4
11281126|NCT02402127|12477277|FG003|Randomized and Treated|First Wear Period (1 Day)||4
11281127|NCT02402127|12477278|FG004|Randomized and Treated|First Wear Period (1 Day)||4
11281128|NCT02402127|12477279|FG005|Randomized and Treated|First Wear Period (1 Day)||4
11281129|NCT02402127|12477274|FG000|COMPLETED|First Wear Period (1 Day)||4
11281130|NCT02402127|12477275|FG001|COMPLETED|First Wear Period (1 Day)||4
11281131|NCT02402127|12477276|FG002|COMPLETED|First Wear Period (1 Day)||4
11281132|NCT02402127|12477277|FG003|COMPLETED|First Wear Period (1 Day)||4
11281133|NCT02402127|12477278|FG004|COMPLETED|First Wear Period (1 Day)||4
11281134|NCT02402127|12477279|FG005|COMPLETED|First Wear Period (1 Day)||4
11281135|NCT02402127|12477274|FG000|NOT COMPLETED|First Wear Period (1 Day)||0
11281136|NCT02402127|12477275|FG001|NOT COMPLETED|First Wear Period (1 Day)||0
11281137|NCT02402127|12477276|FG002|NOT COMPLETED|First Wear Period (1 Day)||0
11281138|NCT02402127|12477277|FG003|NOT COMPLETED|First Wear Period (1 Day)||0
11281139|NCT02402127|12477278|FG004|NOT COMPLETED|First Wear Period (1 Day)||0
11281140|NCT02402127|12477279|FG005|NOT COMPLETED|First Wear Period (1 Day)||0
11281141|NCT02402127|12477274|FG000|STARTED|Second Wear Period (1 Day)||4
11281142|NCT02402127|12477275|FG001|STARTED|Second Wear Period (1 Day)||4
11281143|NCT02402127|12477276|FG002|STARTED|Second Wear Period (1 Day)||4
11281144|NCT02402127|12477277|FG003|STARTED|Second Wear Period (1 Day)||4
11281145|NCT02402127|12477278|FG004|STARTED|Second Wear Period (1 Day)||4
11281146|NCT02402127|12477279|FG005|STARTED|Second Wear Period (1 Day)||4
11281147|NCT02402127|12477274|FG000|COMPLETED|Second Wear Period (1 Day)||4
11281148|NCT02402127|12477275|FG001|COMPLETED|Second Wear Period (1 Day)||4
11281149|NCT02402127|12477276|FG002|COMPLETED|Second Wear Period (1 Day)||4
11281150|NCT02402127|12477277|FG003|COMPLETED|Second Wear Period (1 Day)||4
11281151|NCT02402127|12477278|FG004|COMPLETED|Second Wear Period (1 Day)||4
11281152|NCT02402127|12477279|FG005|COMPLETED|Second Wear Period (1 Day)||4
11281153|NCT02402127|12477274|FG000|NOT COMPLETED|Second Wear Period (1 Day)||0
11281154|NCT02402127|12477275|FG001|NOT COMPLETED|Second Wear Period (1 Day)||0
11281155|NCT02402127|12477276|FG002|NOT COMPLETED|Second Wear Period (1 Day)||0
11281156|NCT02402127|12477277|FG003|NOT COMPLETED|Second Wear Period (1 Day)||0
11281157|NCT02402127|12477278|FG004|NOT COMPLETED|Second Wear Period (1 Day)||0
11281158|NCT02402127|12477279|FG005|NOT COMPLETED|Second Wear Period (1 Day)||0
11281159|NCT02402127|12477274|FG000|STARTED|Third Wear Period (1 Day)||4
11281160|NCT02402127|12477275|FG001|STARTED|Third Wear Period (1 Day)||4
11281161|NCT02402127|12477276|FG002|STARTED|Third Wear Period (1 Day)||4
11281162|NCT02402127|12477277|FG003|STARTED|Third Wear Period (1 Day)||4
11281163|NCT02402127|12477278|FG004|STARTED|Third Wear Period (1 Day)||4
11281164|NCT02402127|12477279|FG005|STARTED|Third Wear Period (1 Day)||4
11281165|NCT02402127|12477274|FG000|COMPLETED|Third Wear Period (1 Day)||4
11281166|NCT02402127|12477275|FG001|COMPLETED|Third Wear Period (1 Day)||4
11281167|NCT02402127|12477276|FG002|COMPLETED|Third Wear Period (1 Day)||4
11398903|NCT04392219|12593348|FG004|NOT COMPLETED|Overall Study||0
11398904|NCT04392219|12593349|FG005|NOT COMPLETED|Overall Study||0
11398905|NCT04392219|12593350|FG006|NOT COMPLETED|Overall Study||0
11398906|NCT04392219|12593351|FG007|NOT COMPLETED|Overall Study||0
11398907|NCT04392219|12593352|FG008|NOT COMPLETED|Overall Study||0
11398908|NCT04392219|12593353|FG009|NOT COMPLETED|Overall Study||0
11281168|NCT02402127|12477277|FG003|COMPLETED|Third Wear Period (1 Day)||4
11281169|NCT02402127|12477278|FG004|COMPLETED|Third Wear Period (1 Day)||4
11281170|NCT02402127|12477279|FG005|COMPLETED|Third Wear Period (1 Day)||4
11281171|NCT02402127|12477274|FG000|NOT COMPLETED|Third Wear Period (1 Day)||0
11281172|NCT02402127|12477275|FG001|NOT COMPLETED|Third Wear Period (1 Day)||0
11281173|NCT02402127|12477276|FG002|NOT COMPLETED|Third Wear Period (1 Day)||0
11281174|NCT02402127|12477277|FG003|NOT COMPLETED|Third Wear Period (1 Day)||0
11281175|NCT02402127|12477278|FG004|NOT COMPLETED|Third Wear Period (1 Day)||0
11281176|NCT02402127|12477279|FG005|NOT COMPLETED|Third Wear Period (1 Day)||0
11281177|NCT02402153|12477290|FG000|STARTED|Overall Study||18
11281178|NCT02402153|12477290|FG000|COMPLETED|Overall Study||18
11281179|NCT02402153|12477290|FG000|NOT COMPLETED|Overall Study||0
11281180|NCT02402166|12477294|FG000|STARTED|Overall Study||24
11281181|NCT02402166|12477294|FG000|COMPLETED|Overall Study||19
11281182|NCT02402166|12477294|FG000|NOT COMPLETED|Overall Study||5
11281183|NCT02402218|12477315|FG000|STARTED|Overall Study||36
11281184|NCT02402218|12477316|FG001|STARTED|Overall Study||54
11281185|NCT02402218|12477317|FG002|STARTED|Overall Study||54
11281186|NCT02402218|12477315|FG000|Initiated Treatment With LDV/SOF|Overall Study||24
11281187|NCT02402218|12477316|FG001|Initiated Treatment With LDV/SOF|Overall Study||45
11281188|NCT02402218|12477317|FG002|Initiated Treatment With LDV/SOF|Overall Study||41
11281189|NCT02402218|12477315|FG000|Completed Treatment With LDV/SOF|Overall Study||23
11281190|NCT02402218|12477316|FG001|Completed Treatment With LDV/SOF|Overall Study||42
11281191|NCT02402218|12477317|FG002|Completed Treatment With LDV/SOF|Overall Study||39
11281192|NCT02402218|12477315|FG000|Achieved Sustained Virologic Response|Overall Study||22
11281193|NCT02402218|12477316|FG001|Achieved Sustained Virologic Response|Overall Study||41
11281194|NCT02402218|12477317|FG002|Achieved Sustained Virologic Response|Overall Study||37
11281195|NCT02402218|12477315|FG000|COMPLETED|Overall Study||22
11281196|NCT02402218|12477316|FG001|COMPLETED|Overall Study||41
11281197|NCT02402218|12477317|FG002|COMPLETED|Overall Study||37
11281198|NCT02402218|12477315|FG000|NOT COMPLETED|Overall Study||14
11281199|NCT02402218|12477316|FG001|NOT COMPLETED|Overall Study||13
11281200|NCT02402218|12477317|FG002|NOT COMPLETED|Overall Study||17
11281201|NCT02402296|12477327|FG000|STARTED|Overall Study||15
11398909|NCT04392219|12593354|FG010|NOT COMPLETED|Overall Study||0
11398910|NCT04392219|12593355|FG011|NOT COMPLETED|Overall Study||0
11398911|NCT04392219|12593356|FG012|NOT COMPLETED|Overall Study||0
11281202|NCT02402296|12477328|FG001|STARTED|Overall Study||15
11281203|NCT02402296|12477327|FG000|COMPLETED|Overall Study||15
11281204|NCT02402296|12477328|FG001|COMPLETED|Overall Study||15
11281205|NCT02402296|12477327|FG000|NOT COMPLETED|Overall Study||0
11281206|NCT02402296|12477328|FG001|NOT COMPLETED|Overall Study||0
11281207|NCT02402322|12477337|FG000|STARTED|Pretreatment||27
11281208|NCT02402322|12477338|FG001|STARTED|Pretreatment||25
11281209|NCT02402322|12477339|FG002|STARTED|Pretreatment||25
11281210|NCT02402322|12477337|FG000|Posttreatment Measures|Pretreatment||24
11281211|NCT02402322|12477338|FG001|Posttreatment Measures|Pretreatment||24
11281212|NCT02402322|12477339|FG002|Posttreatment Measures|Pretreatment||24
11281213|NCT02402322|12477337|FG000|COMPLETED|Pretreatment||24
11281214|NCT02402322|12477338|FG001|COMPLETED|Pretreatment||24
11281215|NCT02402322|12477339|FG002|COMPLETED|Pretreatment||24
11281216|NCT02402322|12477337|FG000|NOT COMPLETED|Pretreatment||3
11281217|NCT02402322|12477338|FG001|NOT COMPLETED|Pretreatment||1
11281218|NCT02402322|12477339|FG002|NOT COMPLETED|Pretreatment||1
11281219|NCT02402322|12477337|FG000|STARTED|Follow-up||24
11281220|NCT02402322|12477338|FG001|STARTED|Follow-up||24
11281221|NCT02402322|12477339|FG002|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
11281222|NCT02402322|12477337|FG000|COMPLETED|Follow-up||18
11281223|NCT02402322|12477338|FG001|COMPLETED|Follow-up||21
11281224|NCT02402322|12477339|FG002|COMPLETED|Follow-up||0
11281225|NCT02402322|12477337|FG000|NOT COMPLETED|Follow-up||6
11281226|NCT02402322|12477338|FG001|NOT COMPLETED|Follow-up||3
11281227|NCT02402322|12477339|FG002|NOT COMPLETED|Follow-up||24
11281228|NCT02402452|12477349|FG000|STARTED|Overall Study||10
11281229|NCT02402452|12477350|FG001|STARTED|Overall Study||10
11281230|NCT02402452|12477349|FG000|COMPLETED|Overall Study||10
11281231|NCT02402452|12477350|FG001|COMPLETED|Overall Study||10
11281232|NCT02402452|12477349|FG000|NOT COMPLETED|Overall Study||0
11281233|NCT02402452|12477350|FG001|NOT COMPLETED|Overall Study||0
11281234|NCT02402764|12477356|FG000|STARTED|Overall Study||10
11281235|NCT02402764|12477356|FG000|COMPLETED|Overall Study||10
11281236|NCT02402764|12477356|FG000|NOT COMPLETED|Overall Study||0
11281237|NCT02402881|12477362|FG000|STARTED|Pre-Intervention Study Period||2222
11281238|NCT02402881|12477363|FG001|STARTED|Pre-Intervention Study Period||5657
11281239|NCT02402881|12477362|FG000|COMPLETED|Pre-Intervention Study Period||2222
11281240|NCT02402881|12477363|FG001|COMPLETED|Pre-Intervention Study Period||5657
11281241|NCT02402881|12477362|FG000|NOT COMPLETED|Pre-Intervention Study Period||0
11281242|NCT02402881|12477363|FG001|NOT COMPLETED|Pre-Intervention Study Period||0
11281243|NCT02402881|12477362|FG000|STARTED|Post-Intervention Study Period||3111
11281244|NCT02402881|12477363|FG001|STARTED|Post-Intervention Study Period||8662
11281245|NCT02402881|12477362|FG000|COMPLETED|Post-Intervention Study Period||3111
11281246|NCT02402881|12477363|FG001|COMPLETED|Post-Intervention Study Period||8662
11281247|NCT02402881|12477362|FG000|NOT COMPLETED|Post-Intervention Study Period||0
11281248|NCT02402881|12477363|FG001|NOT COMPLETED|Post-Intervention Study Period||0
11281249|NCT02402907|12477371|FG000|STARTED|Overall Study||682
11281250|NCT02402907|12477372|FG001|STARTED|Overall Study||674
11281251|NCT02402907|12477371|FG000|COMPLETED|Overall Study||662
11281252|NCT02402907|12477372|FG001|COMPLETED|Overall Study||647
11281253|NCT02402907|12477371|FG000|NOT COMPLETED|Overall Study||20
11281254|NCT02402907|12477372|FG001|NOT COMPLETED|Overall Study||27
11281255|NCT02402933|12477378|FG000|STARTED|Overall Study||26
11281256|NCT02402933|12477378|FG000|Received at Least One Dose of Study Drug|Overall Study||22
11281257|NCT02402933|12477378|FG000|COMPLETED|Overall Study||12
11281258|NCT02402933|12477378|FG000|NOT COMPLETED|Overall Study||14
11281259|NCT02403180|12477384|FG000|STARTED|Pre-Treatment Period||36
11281260|NCT02403180|12477385|FG001|STARTED|Pre-Treatment Period||34
11281261|NCT02403180|12477384|FG000|COMPLETED|Pre-Treatment Period||36
11281262|NCT02403180|12477385|FG001|COMPLETED|Pre-Treatment Period||33
11281263|NCT02403180|12477384|FG000|NOT COMPLETED|Pre-Treatment Period||0
11281264|NCT02403180|12477385|FG001|NOT COMPLETED|Pre-Treatment Period||1
11281265|NCT02403180|12477384|FG000|STARTED|Period 1 (5 Days)||36
11281266|NCT02403180|12477385|FG001|STARTED|Period 1 (5 Days)||33
11281267|NCT02403180|12477384|FG000|Randomized|Period 1 (5 Days)||36
11398912|NCT04392219|12593357|FG013|NOT COMPLETED|Overall Study||0
11398913|NCT04392219|12593358|FG014|NOT COMPLETED|Overall Study||0
11398914|NCT04392219|12593359|FG015|NOT COMPLETED|Overall Study||0
11281268|NCT02403180|12477385|FG001|Randomized|Period 1 (5 Days)||33
11281269|NCT02403180|12477384|FG000|COMPLETED|Period 1 (5 Days)||36
11281270|NCT02403180|12477385|FG001|COMPLETED|Period 1 (5 Days)||33
11281271|NCT02403180|12477384|FG000|NOT COMPLETED|Period 1 (5 Days)||0
11281272|NCT02403180|12477385|FG001|NOT COMPLETED|Period 1 (5 Days)||0
11281273|NCT02403180|12477384|FG000|STARTED|Period 2 (5 Days)||36
11281274|NCT02403180|12477385|FG001|STARTED|Period 2 (5 Days)||33
11281275|NCT02403180|12477384|FG000|COMPLETED|Period 2 (5 Days)||36
11281276|NCT02403180|12477385|FG001|COMPLETED|Period 2 (5 Days)||32
11281277|NCT02403180|12477384|FG000|NOT COMPLETED|Period 2 (5 Days)||0
11281278|NCT02403180|12477385|FG001|NOT COMPLETED|Period 2 (5 Days)||1
11281279|NCT02403206|12477393|FG000|STARTED|Overall Study||194
11281280|NCT02403206|12477394|FG001|STARTED|Overall Study||196
11281281|NCT02403206|12477393|FG000|Treated Prior to Randomization|Overall Study||0
11281282|NCT02403206|12477394|FG001|Treated Prior to Randomization|Overall Study||1
11281283|NCT02403206|12477393|FG000|Randomized and Treated|Overall Study||188
11281284|NCT02403206|12477394|FG001|Randomized and Treated|Overall Study||190
11281285|NCT02403206|12477393|FG000|COMPLETED|Overall Study||183
11281286|NCT02403206|12477394|FG001|COMPLETED|Overall Study||186
11281287|NCT02403206|12477393|FG000|NOT COMPLETED|Overall Study||11
11281288|NCT02403206|12477394|FG001|NOT COMPLETED|Overall Study||10
11281289|NCT02403271|12477401|FG000|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7
11281290|NCT02403271|12477402|FG001|STARTED|Period 1||0
11281291|NCT02403271|12477401|FG000|COMPLETED|Period 1||6
11281292|NCT02403271|12477402|FG001|COMPLETED|Period 1||0
11281293|NCT02403271|12477401|FG000|NOT COMPLETED|Period 1||1
11281294|NCT02403271|12477402|FG001|NOT COMPLETED|Period 1||0
11281295|NCT02403271|12477401|FG000|STARTED|Period 2||0
11281296|NCT02403271|12477402|FG001|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124
11281297|NCT02403271|12477401|FG000|COMPLETED|Period 2||0
11281298|NCT02403271|12477402|FG001|COMPLETED|Period 2||0
11281299|NCT02403271|12477401|FG000|NOT COMPLETED|Period 2||0
11281300|NCT02403271|12477402|FG001|NOT COMPLETED|Period 2||124
11281301|NCT02403479|12477410|FG000|STARTED|Overall Study||10
11281302|NCT02403479|12477411|FG001|STARTED|Overall Study||12
11281303|NCT02403479|12477410|FG000|COMPLETED|Overall Study||8
11281304|NCT02403479|12477411|FG001|COMPLETED|Overall Study||12
11281305|NCT02403479|12477410|FG000|NOT COMPLETED|Overall Study||2
11281306|NCT02403479|12477411|FG001|NOT COMPLETED|Overall Study||0
11281307|NCT02403622|12477419|FG000|STARTED|Overall Study||15
11281308|NCT02403622|12477419|FG000|COMPLETED|Overall Study||13
11281309|NCT02403622|12477419|FG000|NOT COMPLETED|Overall Study||2
11281310|NCT02403635|12477423|FG000|STARTED|Overall Study||27
11281311|NCT02403635|12477423|FG000|Screening (28 Days)|Overall Study||27
11281312|NCT02403635|12477423|FG000|Received the First Dose|Overall Study||18
11281313|NCT02403635|12477423|FG000|COMPLETED|Overall Study||18
11281314|NCT02403635|12477423|FG000|NOT COMPLETED|Overall Study||9
11281315|NCT02403817|12477445|FG000|STARTED|Overall Study||28
11281316|NCT02403817|12477446|FG001|STARTED|Overall Study||2
11281317|NCT02403817|12477445|FG000|COMPLETED|Overall Study||23
11281318|NCT02403817|12477446|FG001|COMPLETED|Overall Study||2
11281319|NCT02403817|12477445|FG000|NOT COMPLETED|Overall Study||5
11281320|NCT02403817|12477446|FG001|NOT COMPLETED|Overall Study||0
11281321|NCT02403830|12477452|FG000|STARTED|Visit 1||15
11281322|NCT02403830|12477453|FG001|STARTED|Visit 1||15
11281323|NCT02403830|12477452|FG000|COMPLETED|Visit 1||15
11281324|NCT02403830|12477453|FG001|COMPLETED|Visit 1||15
11281325|NCT02403830|12477452|FG000|NOT COMPLETED|Visit 1||0
11281326|NCT02403830|12477453|FG001|NOT COMPLETED|Visit 1||0
11281327|NCT02403830|12477452|FG000|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
11281328|NCT02403830|12477453|FG001|STARTED|Visit 2||15
11281329|NCT02403830|12477452|FG000|COMPLETED|Visit 2||14
11281330|NCT02403830|12477453|FG001|COMPLETED|Visit 2||15
11281331|NCT02403830|12477452|FG000|NOT COMPLETED|Visit 2||0
11281332|NCT02403830|12477453|FG001|NOT COMPLETED|Visit 2||0
11281333|NCT02403895|12477459|FG000|STARTED|Overall Study||11
11281334|NCT02403895|12477459|FG000|COMPLETED|Overall Study||11
11281335|NCT02403895|12477459|FG000|NOT COMPLETED|Overall Study||0
11281336|NCT02403999|12477466|FG000|STARTED|Overall Study||10
11281337|NCT02403999|12477467|FG001|STARTED|Overall Study||10
11281338|NCT02403999|12477468|FG002|STARTED|Overall Study||11
11281339|NCT02403999|12477466|FG000|COMPLETED|Overall Study||10
11281340|NCT02403999|12477467|FG001|COMPLETED|Overall Study||10
11281341|NCT02403999|12477468|FG002|COMPLETED|Overall Study||11
11281342|NCT02403999|12477466|FG000|NOT COMPLETED|Overall Study||0
11281343|NCT02403999|12477467|FG001|NOT COMPLETED|Overall Study||0
11281344|NCT02403999|12477468|FG002|NOT COMPLETED|Overall Study||0
11281345|NCT02404025|12477476|FG000|STARTED|Overall Study||10
11281346|NCT02404025|12477476|FG000|COMPLETED|Overall Study||6
11281347|NCT02404025|12477476|FG000|NOT COMPLETED|Overall Study||4
11281348|NCT02404103|12477482|FG000|STARTED|Overall Study||14
11281349|NCT02404103|12477483|FG001|STARTED|Overall Study||12
11281350|NCT02404103|12477482|FG000|COMPLETED|Overall Study||10
11281351|NCT02404103|12477483|FG001|COMPLETED|Overall Study||9
11281352|NCT02404103|12477482|FG000|NOT COMPLETED|Overall Study||4
11281353|NCT02404103|12477483|FG001|NOT COMPLETED|Overall Study||3
11281354|NCT02404168|12477499|FG000|STARTED|Overall Study||4
11281355|NCT02404168|12477499|FG000|COMPLETED|Overall Study||4
11281356|NCT02404168|12477499|FG000|NOT COMPLETED|Overall Study||0
11281357|NCT02404220|12477509|FG000|STARTED|Overall Study||5
11281358|NCT02404220|12477510|FG001|STARTED|Overall Study||8
11281359|NCT02404220|12477511|FG002|STARTED|Overall Study||7
11281360|NCT02404220|12477512|FG003|STARTED|Overall Study||10
11281361|NCT02404220|12477509|FG000|COMPLETED|Overall Study||0
11281362|NCT02404220|12477510|FG001|COMPLETED|Overall Study||0
11281363|NCT02404220|12477511|FG002|COMPLETED|Overall Study||0
11281364|NCT02404220|12477512|FG003|COMPLETED|Overall Study||0
11281365|NCT02404220|12477509|FG000|NOT COMPLETED|Overall Study||5
11281366|NCT02404220|12477510|FG001|NOT COMPLETED|Overall Study||8
11281367|NCT02404220|12477511|FG002|NOT COMPLETED|Overall Study||7
11281368|NCT02404220|12477512|FG003|NOT COMPLETED|Overall Study||10
11281369|NCT02404285|12477524|FG000|STARTED|Overall Study||33
11281370|NCT02404285|12477525|FG001|STARTED|Overall Study||35
11281371|NCT02404285|12477524|FG000|COMPLETED|Overall Study||31
11281372|NCT02404285|12477525|FG001|COMPLETED|Overall Study||33
11281373|NCT02404285|12477524|FG000|NOT COMPLETED|Overall Study||2
11281374|NCT02404285|12477525|FG001|NOT COMPLETED|Overall Study||2
11281375|NCT02404311|12477542|FG000|STARTED|Part A: Month 0-18||210
11281376|NCT02404311|12477543|FG001|STARTED|Part A: Month 0-18||42
11281377|NCT02404311|12477544|FG002|STARTED|Part A: Month 0-18||0
11281378|NCT02404311|12477545|FG003|STARTED|Part A: Month 0-18||0
11281379|NCT02404311|12477546|FG004|STARTED|Part A: Month 0-18||0
11281380|NCT02404311|12477542|FG000|Per Protocol|Part A: Month 0-18||185
11281381|NCT02404311|12477543|FG001|Per Protocol|Part A: Month 0-18||37
11281382|NCT02404311|12477544|FG002|Per Protocol|Part A: Month 0-18||0
11281383|NCT02404311|12477545|FG003|Per Protocol|Part A: Month 0-18||0
11281384|NCT02404311|12477546|FG004|Per Protocol|Part A: Month 0-18||0
11281385|NCT02404311|12477542|FG000|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||194
11281386|NCT02404311|12477543|FG001|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||37
11281387|NCT02404311|12477544|FG002|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
11281388|NCT02404311|12477545|FG003|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
11281389|NCT02404311|12477546|FG004|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
11281390|NCT02404311|12477542|FG000|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||186
11281391|NCT02404311|12477543|FG001|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||33
11281392|NCT02404311|12477544|FG002|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
11281393|NCT02404311|12477545|FG003|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
11281394|NCT02404311|12477546|FG004|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
11281395|NCT02404311|12477542|FG000|COMPLETED|Part A: Month 0-18||184
11281396|NCT02404311|12477543|FG001|COMPLETED|Part A: Month 0-18||36
11281397|NCT02404311|12477544|FG002|COMPLETED|Part A: Month 0-18||0
11281398|NCT02404311|12477545|FG003|COMPLETED|Part A: Month 0-18||0
11281399|NCT02404311|12477546|FG004|COMPLETED|Part A: Month 0-18||0
11281400|NCT02404311|12477542|FG000|NOT COMPLETED|Part A: Month 0-18||26
11281401|NCT02404311|12477543|FG001|NOT COMPLETED|Part A: Month 0-18||6
11281402|NCT02404311|12477544|FG002|NOT COMPLETED|Part A: Month 0-18||0
11281403|NCT02404311|12477545|FG003|NOT COMPLETED|Part A: Month 0-18||0
11281404|NCT02404311|12477546|FG004|NOT COMPLETED|Part A: Month 0-18||0
11281405|NCT02404311|12477542|FG000|STARTED|Part B: Month 30-36||0
11281406|NCT02404311|12477543|FG001|STARTED|Part B: Month 30-36||0
11281407|NCT02404311|12477544|FG002|STARTED|Part B: Month 30-36||32
11281408|NCT02404311|12477545|FG003|STARTED|Part B: Month 30-36||31
11281409|NCT02404311|12477546|FG004|STARTED|Part B: Month 30-36||7
11281410|NCT02404311|12477542|FG000|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
11281411|NCT02404311|12477543|FG001|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
11281412|NCT02404311|12477544|FG002|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||28
11281413|NCT02404311|12477545|FG003|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||30
11281414|NCT02404311|12477546|FG004|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||6
11281415|NCT02404311|12477542|FG000|COMPLETED|Part B: Month 30-36||0
11281416|NCT02404311|12477543|FG001|COMPLETED|Part B: Month 30-36||0
11281417|NCT02404311|12477544|FG002|COMPLETED|Part B: Month 30-36||32
11281418|NCT02404311|12477545|FG003|COMPLETED|Part B: Month 30-36||31
11281419|NCT02404311|12477546|FG004|COMPLETED|Part B: Month 30-36||7
11281420|NCT02404311|12477542|FG000|NOT COMPLETED|Part B: Month 30-36||0
11281421|NCT02404311|12477543|FG001|NOT COMPLETED|Part B: Month 30-36||0
11281422|NCT02404311|12477544|FG002|NOT COMPLETED|Part B: Month 30-36||0
11281423|NCT02404311|12477545|FG003|NOT COMPLETED|Part B: Month 30-36||0
11281424|NCT02404311|12477546|FG004|NOT COMPLETED|Part B: Month 30-36||0
11281425|NCT02404350|12477562|FG000|STARTED|Overall Study||222
11281426|NCT02404350|12477563|FG001|STARTED|Overall Study||220
11281427|NCT02404350|12477564|FG002|STARTED|Overall Study||222
11281428|NCT02404350|12477565|FG003|STARTED|Overall Study||332
11281429|NCT02404350|12477562|FG000|COMPLETED|Overall Study||207
11281430|NCT02404350|12477563|FG001|COMPLETED|Overall Study||214
11281431|NCT02404350|12477564|FG002|COMPLETED|Overall Study||216
11281432|NCT02404350|12477565|FG003|COMPLETED|Overall Study||295
11281433|NCT02404350|12477562|FG000|NOT COMPLETED|Overall Study||15
11281434|NCT02404350|12477563|FG001|NOT COMPLETED|Overall Study||6
11281435|NCT02404350|12477564|FG002|NOT COMPLETED|Overall Study||6
11281436|NCT02404350|12477565|FG003|NOT COMPLETED|Overall Study||37
11281437|NCT02404389|12477581|FG000|STARTED|Overall Study||20
11281438|NCT02404389|12477582|FG001|STARTED|Overall Study||20
11281439|NCT02404389|12477583|FG002|STARTED|Overall Study||11
11281440|NCT02404389|12477584|FG003|STARTED|Overall Study||10
11281441|NCT02404389|12477585|FG004|STARTED|Overall Study||21
11281442|NCT02404389|12477581|FG000|COMPLETED|Overall Study||18
11281443|NCT02404389|12477582|FG001|COMPLETED|Overall Study||20
11281444|NCT02404389|12477583|FG002|COMPLETED|Overall Study||10
11281445|NCT02404389|12477584|FG003|COMPLETED|Overall Study||9
11281446|NCT02404389|12477585|FG004|COMPLETED|Overall Study||18
11281447|NCT02404389|12477581|FG000|NOT COMPLETED|Overall Study||2
11281448|NCT02404389|12477582|FG001|NOT COMPLETED|Overall Study||0
11281449|NCT02404389|12477583|FG002|NOT COMPLETED|Overall Study||1
11281450|NCT02404389|12477584|FG003|NOT COMPLETED|Overall Study||1
11398915|NCT04392219|12593360|FG016|NOT COMPLETED|Overall Study||0
11281451|NCT02404389|12477585|FG004|NOT COMPLETED|Overall Study||3
11281452|NCT02404493|12477601|FG000|STARTED|Overall Study||17
11281453|NCT02404493|12477602|FG001|STARTED|Overall Study||6
11281454|NCT02404493|12477601|FG000|COMPLETED|Overall Study||16
11281455|NCT02404493|12477602|FG001|COMPLETED|Overall Study||5
11281456|NCT02404493|12477601|FG000|NOT COMPLETED|Overall Study||1
11281457|NCT02404493|12477602|FG001|NOT COMPLETED|Overall Study||1
11281458|NCT02404532|12477608|FG000|STARTED|Overall Study||29
11281459|NCT02404532|12477608|FG000|COMPLETED|Overall Study||29
11281460|NCT02404532|12477608|FG000|NOT COMPLETED|Overall Study||0
11281461|NCT02404610|12477619|FG000|STARTED|Overall Study||54
11281462|NCT02404610|12477620|FG001|STARTED|Overall Study||53
11281463|NCT02404610|12477619|FG000|COMPLETED|Overall Study||54
11281464|NCT02404610|12477620|FG001|COMPLETED|Overall Study||53
11281465|NCT02404610|12477619|FG000|NOT COMPLETED|Overall Study||0
11281466|NCT02404610|12477620|FG001|NOT COMPLETED|Overall Study||0
11281467|NCT02404649|12477628|FG000|STARTED|Overall Study||17
11281468|NCT02404649|12477629|FG001|STARTED|Overall Study||16
11281469|NCT02404649|12477628|FG000|COMPLETED|Overall Study||16
11281470|NCT02404649|12477629|FG001|COMPLETED|Overall Study||14
11281471|NCT02404649|12477628|FG000|NOT COMPLETED|Overall Study||1
11281472|NCT02404649|12477629|FG001|NOT COMPLETED|Overall Study||2
11281473|NCT02404792|12477637|FG000|STARTED|Overall Study||32
11281474|NCT02404792|12477638|FG001|STARTED|Overall Study||37
11281475|NCT02404792|12477637|FG000|COMPLETED|Overall Study||27
11281476|NCT02404792|12477638|FG001|COMPLETED|Overall Study||29
11281477|NCT02404792|12477637|FG000|NOT COMPLETED|Overall Study||5
11281478|NCT02404792|12477638|FG001|NOT COMPLETED|Overall Study||8
11281479|NCT02404805|12477652|FG000|STARTED|Overall Study||5
11281480|NCT02404805|12477653|FG001|STARTED|Overall Study||3
11281481|NCT02404805|12477654|FG002|STARTED|Overall Study||5
11281482|NCT02404805|12477655|FG003|STARTED|Overall Study||5
11398916|NCT04392219|12593361|FG017|NOT COMPLETED|Overall Study||0
11398917|NCT04391842|12593399|FG000|STARTED|Overall Study||34
11398918|NCT04391842|12593399|FG000|COMPLETED|Overall Study||32
11398919|NCT04391842|12593399|FG000|NOT COMPLETED|Overall Study||2
11398920|NCT04390022|12593405|FG000|STARTED|Overall Study||12
11398921|NCT04390022|12593406|FG001|STARTED|Overall Study||12
11398922|NCT04390022|12593405|FG000|COMPLETED|Overall Study||12
11398923|NCT04390022|12593406|FG001|COMPLETED|Overall Study||12
11398924|NCT04390022|12593405|FG000|NOT COMPLETED|Overall Study||0
11398925|NCT04390022|12593406|FG001|NOT COMPLETED|Overall Study||0
11398926|NCT04386902|12593412|FG000|STARTED|Overall Study||60
11398927|NCT04386902|12593412|FG000|COMPLETED|Overall Study||50
11398928|NCT04386902|12593412|FG000|NOT COMPLETED|Overall Study||10
11398929|NCT04385238|12593418|FG000|STARTED|Overall Study||5712
11398930|NCT04385238|12593419|FG001|STARTED|Overall Study||1182
11398931|NCT04385238|12593418|FG000|COMPLETED|Overall Study||5712
11398932|NCT04385238|12593419|FG001|COMPLETED|Overall Study||1182
11398933|NCT04385238|12593418|FG000|NOT COMPLETED|Overall Study||0
11398934|NCT04385238|12593419|FG001|NOT COMPLETED|Overall Study||0
11398935|NCT04384523|12593431|FG000|STARTED|Overall Study||10
11398936|NCT04384523|12593432|FG001|STARTED|Overall Study||6
11398937|NCT04384523|12593433|FG002|STARTED|Overall Study||6
11398938|NCT04384523|12593434|FG003|STARTED|Overall Study||6
11398939|NCT04384523|12593435|FG004|STARTED|Overall Study||7
11398940|NCT04384523|12593436|FG005|STARTED|Overall Study||6
11398941|NCT04384523|12593431|FG000|COMPLETED|Overall Study||9
11398942|NCT04384523|12593432|FG001|COMPLETED|Overall Study||5
11398943|NCT04384523|12593433|FG002|COMPLETED|Overall Study||6
11398944|NCT04384523|12593434|FG003|COMPLETED|Overall Study||6
11398945|NCT04384523|12593435|FG004|COMPLETED|Overall Study||7
11398946|NCT04384523|12593436|FG005|COMPLETED|Overall Study||5
11398947|NCT04384523|12593431|FG000|NOT COMPLETED|Overall Study||1
11398948|NCT04384523|12593432|FG001|NOT COMPLETED|Overall Study||1
11398949|NCT04384523|12593433|FG002|NOT COMPLETED|Overall Study||0
11398950|NCT04384523|12593434|FG003|NOT COMPLETED|Overall Study||0
11398951|NCT04384523|12593435|FG004|NOT COMPLETED|Overall Study||0
11398952|NCT04384523|12593436|FG005|NOT COMPLETED|Overall Study||1
11398953|NCT04383665|12593456|FG000|STARTED|Overall Study||2
11398954|NCT04383665|12593457|FG001|STARTED|Overall Study||2
11398955|NCT04383665|12593458|FG002|STARTED|Overall Study||2
11398956|NCT04383665|12593459|FG003|STARTED|Overall Study||2
11398957|NCT04383665|12593460|FG004|STARTED|Overall Study||2
11398958|NCT04383665|12593461|FG005|STARTED|Overall Study||2
11281483|NCT02404805|12477656|FG004|STARTED|Overall Study||3
11281484|NCT02404805|12477657|FG005|STARTED|Overall Study||4
11281485|NCT02404805|12477652|FG000|COMPLETED|Overall Study||4
11281486|NCT02404805|12477653|FG001|COMPLETED|Overall Study||3
11281487|NCT02404805|12477654|FG002|COMPLETED|Overall Study||5
11281488|NCT02404805|12477655|FG003|COMPLETED|Overall Study||5
11281489|NCT02404805|12477656|FG004|COMPLETED|Overall Study||3
11281490|NCT02404805|12477657|FG005|COMPLETED|Overall Study||4
11281491|NCT02404805|12477652|FG000|NOT COMPLETED|Overall Study||1
11281492|NCT02404805|12477653|FG001|NOT COMPLETED|Overall Study||0
11281493|NCT02404805|12477654|FG002|NOT COMPLETED|Overall Study||0
11281494|NCT02404805|12477655|FG003|NOT COMPLETED|Overall Study||0
11281495|NCT02404805|12477656|FG004|NOT COMPLETED|Overall Study||0
11281496|NCT02404805|12477657|FG005|NOT COMPLETED|Overall Study||0
11281497|NCT02405091|12477669|FG000|STARTED|Overall Study||49
11281498|NCT02405091|12477670|FG001|STARTED|Overall Study||107
11281499|NCT02405091|12477671|FG002|STARTED|Overall Study||11
11398959|NCT04383665|12593456|FG000|COMPLETED|Overall Study||2
11398960|NCT04383665|12593457|FG001|COMPLETED|Overall Study||2
11281500|NCT02405091|12477669|FG000|COMPLETED|Overall Study||20
11281501|NCT02405091|12477670|FG001|COMPLETED|Overall Study||74
11281502|NCT02405091|12477671|FG002|COMPLETED|Overall Study||9
11281503|NCT02405091|12477669|FG000|NOT COMPLETED|Overall Study||29
11281504|NCT02405091|12477670|FG001|NOT COMPLETED|Overall Study||33
11281505|NCT02405091|12477671|FG002|NOT COMPLETED|Overall Study||2
11281506|NCT02405195|12477682|FG000|STARTED|Overall Study||18
11281507|NCT02405195|12477682|FG000|COMPLETED|Overall Study||18
11281508|NCT02405195|12477682|FG000|NOT COMPLETED|Overall Study||0
11281509|NCT02405325|12477688|FG000|STARTED|Overall Study||267
11281510|NCT02405325|12477689|FG001|STARTED|Overall Study||209
11281511|NCT02405325|12477688|FG000|COMPLETED|Overall Study||203
11281512|NCT02405325|12477689|FG001|COMPLETED|Overall Study||175
11281513|NCT02405325|12477688|FG000|NOT COMPLETED|Overall Study||64
11281514|NCT02405325|12477689|FG001|NOT COMPLETED|Overall Study||34
11281515|NCT02405390|12477697|FG000|STARTED|Overall Study||46
11281516|NCT02405390|12477698|FG001|STARTED|Overall Study||46
11281517|NCT02405390|12477697|FG000|COMPLETED|Overall Study||46
11281518|NCT02405390|12477698|FG001|COMPLETED|Overall Study||46
11281519|NCT02405390|12477697|FG000|NOT COMPLETED|Overall Study||0
11281520|NCT02405390|12477698|FG001|NOT COMPLETED|Overall Study||0
11281521|NCT02405429|12477704|FG000|STARTED|Overall Study||49
11281522|NCT02405429|12477704|FG000|COMPLETED|Overall Study||49
11281523|NCT02405429|12477704|FG000|NOT COMPLETED|Overall Study||0
11281524|NCT02405442|12477712|FG000|STARTED|Double-Blind Phase (up to Week 8)||53
11281525|NCT02405442|12477713|FG001|STARTED|Double-Blind Phase (up to Week 8)||53
11281526|NCT02405442|12477714|FG002|STARTED|Double-Blind Phase (up to Week 8)||53
11281527|NCT02405442|12477715|FG003|STARTED|Double-Blind Phase (up to Week 8)||28
11281528|NCT02405442|12477712|FG000|COMPLETED|Double-Blind Phase (up to Week 8)||52
11143768|NCT01474512|12330435|FG013|COMPLETED|Long-Term Extension Period||855
11143769|NCT01474512|12330436|FG014|COMPLETED|Long-Term Extension Period||0
11143770|NCT01474512|12330437|FG015|COMPLETED|Long-Term Extension Period||0
11143771|NCT01474512|12330438|FG016|COMPLETED|Long-Term Extension Period||0
11143772|NCT01474512|12330439|FG017|COMPLETED|Long-Term Extension Period||0
11143773|NCT01474512|12330422|FG000|NOT COMPLETED|Long-Term Extension Period||0
11281529|NCT02405442|12477713|FG001|COMPLETED|Double-Blind Phase (up to Week 8)||48
11281530|NCT02405442|12477714|FG002|COMPLETED|Double-Blind Phase (up to Week 8)||47
11281531|NCT02405442|12477715|FG003|COMPLETED|Double-Blind Phase (up to Week 8)||27
11281532|NCT02405442|12477712|FG000|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
11281533|NCT02405442|12477713|FG001|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5
11281534|NCT02405442|12477714|FG002|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6
11281535|NCT02405442|12477715|FG003|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
11281536|NCT02405442|12477712|FG000|STARTED|Open-Label Phase (up to Week 52)||52
11281537|NCT02405442|12477713|FG001|STARTED|Open-Label Phase (up to Week 52)||48
11281538|NCT02405442|12477714|FG002|STARTED|Open-Label Phase (up to Week 52)||47
11281539|NCT02405442|12477715|FG003|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26
11281540|NCT02405442|12477712|FG000|COMPLETED|Open-Label Phase (up to Week 52)||4
11281541|NCT02405442|12477713|FG001|COMPLETED|Open-Label Phase (up to Week 52)||3
11281542|NCT02405442|12477714|FG002|COMPLETED|Open-Label Phase (up to Week 52)||2
11281543|NCT02405442|12477715|FG003|COMPLETED|Open-Label Phase (up to Week 52)||2
11281544|NCT02405442|12477712|FG000|NOT COMPLETED|Open-Label Phase (up to Week 52)||48
11281545|NCT02405442|12477713|FG001|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
11281546|NCT02405442|12477714|FG002|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
11281547|NCT02405442|12477715|FG003|NOT COMPLETED|Open-Label Phase (up to Week 52)||24
11281548|NCT02405442|12477712|FG000|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3
11281549|NCT02405442|12477713|FG001|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2
11281550|NCT02405442|12477714|FG002|STARTED|Extended Treatment Phase(up to Week 208)||2
11281551|NCT02405442|12477715|FG003|STARTED|Extended Treatment Phase(up to Week 208)||2
11143774|NCT01474512|12330423|FG001|NOT COMPLETED|Long-Term Extension Period||0
11143775|NCT01474512|12330424|FG002|NOT COMPLETED|Long-Term Extension Period||0
11143776|NCT01474512|12330425|FG003|NOT COMPLETED|Long-Term Extension Period||0
11281552|NCT02405442|12477712|FG000|COMPLETED|Extended Treatment Phase(up to Week 208)||0
11281553|NCT02405442|12477713|FG001|COMPLETED|Extended Treatment Phase(up to Week 208)||0
11398961|NCT04383665|12593458|FG002|COMPLETED|Overall Study||2
11281554|NCT02405442|12477714|FG002|COMPLETED|Extended Treatment Phase(up to Week 208)||0
11281555|NCT02405442|12477715|FG003|COMPLETED|Extended Treatment Phase(up to Week 208)||0
11281556|NCT02405442|12477712|FG000|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3
11143777|NCT01474512|12330426|FG004|NOT COMPLETED|Long-Term Extension Period||0
11281557|NCT02405442|12477713|FG001|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
11281558|NCT02405442|12477714|FG002|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
11281559|NCT02405442|12477715|FG003|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
11281560|NCT02405780|12477733|FG000|STARTED|Period I||216
11281561|NCT02405780|12477734|FG001|STARTED|Period I||108
11281562|NCT02405780|12477735|FG002|STARTED|Period I||108
11281563|NCT02405780|12477736|FG003|STARTED|Period I||213
11281564|NCT02405780|12477733|FG000|COMPLETED|Period I||189
11281565|NCT02405780|12477734|FG001|COMPLETED|Period I||100
11281566|NCT02405780|12477735|FG002|COMPLETED|Period I||93
11281567|NCT02405780|12477736|FG003|COMPLETED|Period I||190
11281568|NCT02405780|12477733|FG000|NOT COMPLETED|Period I||27
11281569|NCT02405780|12477734|FG001|NOT COMPLETED|Period I||8
11281570|NCT02405780|12477735|FG002|NOT COMPLETED|Period I||15
11281571|NCT02405780|12477736|FG003|NOT COMPLETED|Period I||23
11281572|NCT02405780|12477733|FG000|STARTED|Period II||189
11281573|NCT02405780|12477734|FG001|STARTED|Period II||100
11281574|NCT02405780|12477735|FG002|STARTED|Period II||93
11281575|NCT02405780|12477736|FG003|STARTED|Period II||190
11281576|NCT02405780|12477733|FG000|COMPLETED|Period II||174
11281577|NCT02405780|12477734|FG001|COMPLETED|Period II||88
11281578|NCT02405780|12477735|FG002|COMPLETED|Period II||81
11281579|NCT02405780|12477736|FG003|COMPLETED|Period II||172
11281580|NCT02405780|12477733|FG000|NOT COMPLETED|Period II||15
11281581|NCT02405780|12477734|FG001|NOT COMPLETED|Period II||12
11281582|NCT02405780|12477735|FG002|NOT COMPLETED|Period II||12
11281583|NCT02405780|12477736|FG003|NOT COMPLETED|Period II||18
11281584|NCT02405962|12477763|FG000|STARTED|Overall Study||84
11281585|NCT02405962|12477764|FG001|STARTED|Overall Study||84
11281586|NCT02405962|12477763|FG000|Post-intervention|Overall Study||80
11281587|NCT02405962|12477764|FG001|Post-intervention|Overall Study||81
11281588|NCT02405962|12477763|FG000|3 Months After the Intervention|Overall Study||80
11281589|NCT02405962|12477764|FG001|3 Months After the Intervention|Overall Study||79
11281590|NCT02405962|12477763|FG000|COMPLETED|Overall Study||83
11281591|NCT02405962|12477764|FG001|COMPLETED|Overall Study||79
11281592|NCT02405962|12477763|FG000|NOT COMPLETED|Overall Study||1
11281593|NCT02405962|12477764|FG001|NOT COMPLETED|Overall Study||5
11281594|NCT02406248|12477770|FG000|STARTED|Overall Study||108
11281595|NCT02406248|12477770|FG000|COMPLETED|Overall Study||99
11281596|NCT02406248|12477770|FG000|NOT COMPLETED|Overall Study||9
11281597|NCT02406261|12477776|FG000|STARTED|Period 1||50
11281598|NCT02406261|12477777|FG001|STARTED|Period 1||32
11281599|NCT02406261|12477776|FG000|Received at Least One Dose of Study Drug|Period 1||50
11281600|NCT02406261|12477777|FG001|Received at Least One Dose of Study Drug|Period 1||32
11281601|NCT02406261|12477776|FG000|COMPLETED|Period 1||47
11281602|NCT02406261|12477777|FG001|COMPLETED|Period 1||32
11281603|NCT02406261|12477776|FG000|NOT COMPLETED|Period 1||3
11281604|NCT02406261|12477777|FG001|NOT COMPLETED|Period 1||0
11281605|NCT02406261|12477776|FG000|STARTED|Period 2|Cohort A participated in Period 1 only|0
11281606|NCT02406261|12477777|FG001|STARTED|Period 2||32
11281607|NCT02406261|12477776|FG000|COMPLETED|Period 2||0
11281608|NCT02406261|12477777|FG001|COMPLETED|Period 2||29
11281609|NCT02406261|12477776|FG000|NOT COMPLETED|Period 2||0
11281610|NCT02406261|12477777|FG001|NOT COMPLETED|Period 2||3
11281611|NCT02406443|12477786|FG000|STARTED|Overall Study||18
11281612|NCT02406443|12477787|FG001|STARTED|Overall Study||18
11281613|NCT02406443|12477786|FG000|COMPLETED|Overall Study||16
11281614|NCT02406443|12477787|FG001|COMPLETED|Overall Study||16
11281615|NCT02406443|12477786|FG000|NOT COMPLETED|Overall Study||2
11281616|NCT02406443|12477787|FG001|NOT COMPLETED|Overall Study||2
11281617|NCT02406495|12477793|FG000|STARTED|Overall Study||40
11281618|NCT02406495|12477793|FG000|COMPLETED|Overall Study||40
11281619|NCT02406495|12477793|FG000|NOT COMPLETED|Overall Study||0
11281620|NCT02406573|12477806|FG000|STARTED|Overall Study||30
11281621|NCT02406573|12477806|FG000|COMPLETED|Overall Study||30
11281622|NCT02406573|12477806|FG000|NOT COMPLETED|Overall Study||0
11281623|NCT02406586|12477813|FG000|STARTED|Overall Study||12
11281624|NCT02406586|12477814|FG001|STARTED|Overall Study||12
11281625|NCT02406586|12477815|FG002|STARTED|Overall Study||12
11281626|NCT02406586|12477813|FG000|COMPLETED|Overall Study||11
11281627|NCT02406586|12477814|FG001|COMPLETED|Overall Study||8
11281628|NCT02406586|12477815|FG002|COMPLETED|Overall Study||10
11281629|NCT02406586|12477813|FG000|NOT COMPLETED|Overall Study||1
11281630|NCT02406586|12477814|FG001|NOT COMPLETED|Overall Study||4
11281631|NCT02406586|12477815|FG002|NOT COMPLETED|Overall Study||2
11281632|NCT02406612|12477828|FG000|STARTED|Overall Study||26
11281633|NCT02406612|12477829|FG001|STARTED|Overall Study||21
11281634|NCT02406612|12477828|FG000|COMPLETED|Overall Study||22
11281635|NCT02406612|12477829|FG001|COMPLETED|Overall Study||17
11281636|NCT02406612|12477828|FG000|NOT COMPLETED|Overall Study||4
11281637|NCT02406612|12477829|FG001|NOT COMPLETED|Overall Study||4
11281638|NCT02406651|12477835|FG000|STARTED|Overall Study||30
11281639|NCT02406651|12477835|FG000|COMPLETED|Overall Study||27
11281640|NCT02406651|12477835|FG000|NOT COMPLETED|Overall Study||3
11281641|NCT02406677|12477842|FG000|STARTED|Overall Study||6436
11281642|NCT02406677|12477843|FG001|STARTED|Overall Study||4565
11281643|NCT02406677|12477842|FG000|COMPLETED|Overall Study||6135
11281644|NCT02406677|12477843|FG001|COMPLETED|Overall Study||3967
11281645|NCT02406677|12477842|FG000|NOT COMPLETED|Overall Study||301
11281646|NCT02406677|12477843|FG001|NOT COMPLETED|Overall Study||598
11281647|NCT02406742|12477856|FG000|STARTED|Overall Study||14
11281648|NCT02406742|12477857|FG001|STARTED|Overall Study||16
11281649|NCT02406742|12477858|FG002|STARTED|Overall Study||16
11281650|NCT02406742|12477856|FG000|Dose Escalation 1|Overall Study||3
11281651|NCT02406742|12477857|FG001|Dose Escalation 1|Overall Study||0
11281652|NCT02406742|12477858|FG002|Dose Escalation 1|Overall Study||0
11281653|NCT02406742|12477856|FG000|Dose Escalation 2|Overall Study||9
11281654|NCT02406742|12477857|FG001|Dose Escalation 2|Overall Study||5
11281655|NCT02406742|12477858|FG002|Dose Escalation 2|Overall Study||3
11281656|NCT02406742|12477856|FG000|Dose Escalation 3|Overall Study||2
11281657|NCT02406742|12477857|FG001|Dose Escalation 3|Overall Study||3
11281658|NCT02406742|12477858|FG002|Dose Escalation 3|Overall Study||3
11281659|NCT02406742|12477856|FG000|Dose Escalation 4|Overall Study||0
11281660|NCT02406742|12477857|FG001|Dose Escalation 4|Overall Study||3
11281661|NCT02406742|12477858|FG002|Dose Escalation 4|Overall Study||3
11281662|NCT02406742|12477856|FG000|Dose Escalation 5|Overall Study||0
11281663|NCT02406742|12477857|FG001|Dose Escalation 5|Overall Study||5
11281664|NCT02406742|12477858|FG002|Dose Escalation 5|Overall Study||5
11281665|NCT02406742|12477856|FG000|COMPLETED|Overall Study||0
11281666|NCT02406742|12477857|FG001|COMPLETED|Overall Study||0
11281667|NCT02406742|12477858|FG002|COMPLETED|Overall Study||0
11281668|NCT02406742|12477856|FG000|NOT COMPLETED|Overall Study||14
11281669|NCT02406742|12477857|FG001|NOT COMPLETED|Overall Study||16
11281670|NCT02406742|12477858|FG002|NOT COMPLETED|Overall Study||16
11281671|NCT02406859|12477869|FG000|STARTED|Part 1 - Manometric Parameters||15
11281672|NCT02406859|12477870|FG001|STARTED|Part 1 - Manometric Parameters||14
11281673|NCT02406859|12477871|FG002|STARTED|Part 1 - Manometric Parameters||21
11281674|NCT02406859|12477869|FG000|COMPLETED|Part 1 - Manometric Parameters||12
11281675|NCT02406859|12477870|FG001|COMPLETED|Part 1 - Manometric Parameters||13
11281676|NCT02406859|12477871|FG002|COMPLETED|Part 1 - Manometric Parameters||17
11281677|NCT02406859|12477869|FG000|NOT COMPLETED|Part 1 - Manometric Parameters||3
11281678|NCT02406859|12477870|FG001|NOT COMPLETED|Part 1 - Manometric Parameters||1
11281679|NCT02406859|12477871|FG002|NOT COMPLETED|Part 1 - Manometric Parameters||4
11281680|NCT02406859|12477869|FG000|STARTED|Part 2 - Biofeedback Training||12
11281681|NCT02406859|12477870|FG001|STARTED|Part 2 - Biofeedback Training||13
11281682|NCT02406859|12477871|FG002|STARTED|Part 2 - Biofeedback Training||17
11281683|NCT02406859|12477869|FG000|COMPLETED|Part 2 - Biofeedback Training||12
11281684|NCT02406859|12477870|FG001|COMPLETED|Part 2 - Biofeedback Training||13
11281685|NCT02406859|12477871|FG002|COMPLETED|Part 2 - Biofeedback Training||17
11281686|NCT02406859|12477869|FG000|NOT COMPLETED|Part 2 - Biofeedback Training||0
11281687|NCT02406859|12477870|FG001|NOT COMPLETED|Part 2 - Biofeedback Training||0
11281688|NCT02406859|12477871|FG002|NOT COMPLETED|Part 2 - Biofeedback Training||0
11281689|NCT02406885|12477890|FG000|STARTED|Overall Study||17
11281690|NCT02406885|12477891|FG001|STARTED|Overall Study||16
11281691|NCT02406885|12477890|FG000|COMPLETED|Overall Study||14
11281692|NCT02406885|12477891|FG001|COMPLETED|Overall Study||14
11281693|NCT02406885|12477890|FG000|NOT COMPLETED|Overall Study||3
11281694|NCT02406885|12477891|FG001|NOT COMPLETED|Overall Study||2
11281695|NCT02406937|12477900|FG000|STARTED|Overall Study||60
11281696|NCT02406937|12477901|FG001|STARTED|Overall Study||60
11281697|NCT02406937|12477902|FG002|STARTED|Overall Study||60
11281698|NCT02406937|12477900|FG000|COMPLETED|Overall Study||59
11281699|NCT02406937|12477901|FG001|COMPLETED|Overall Study||59
11281700|NCT02406937|12477902|FG002|COMPLETED|Overall Study||58
11281701|NCT02406937|12477900|FG000|NOT COMPLETED|Overall Study||1
11281702|NCT02406937|12477901|FG001|NOT COMPLETED|Overall Study||1
11281703|NCT02406937|12477902|FG002|NOT COMPLETED|Overall Study||2
11281704|NCT02407041|12477913|FG000|STARTED|Overall Study||5
11281705|NCT02407041|12477913|FG000|COMPLETED|Overall Study||5
11281706|NCT02407041|12477913|FG000|NOT COMPLETED|Overall Study||0
11281707|NCT02407054|12477920|FG000|STARTED|Overall Study||13
11281708|NCT02407054|12477921|FG001|STARTED|Overall Study||65
11281709|NCT02407054|12477922|FG002|STARTED|Overall Study||64
11281710|NCT02407054|12477920|FG000|Received at Least One Dose of Study Drug|Overall Study||13
11281711|NCT02407054|12477921|FG001|Received at Least One Dose of Study Drug|Overall Study||65
11281712|NCT02407054|12477922|FG002|Received at Least One Dose of Study Drug|Overall Study||64
11281713|NCT02407054|12477920|FG000|COMPLETED|Overall Study||6
11281714|NCT02407054|12477921|FG001|COMPLETED|Overall Study||47
11281715|NCT02407054|12477922|FG002|COMPLETED|Overall Study||57
11281716|NCT02407054|12477920|FG000|NOT COMPLETED|Overall Study||7
11281717|NCT02407054|12477921|FG001|NOT COMPLETED|Overall Study||18
11281718|NCT02407054|12477922|FG002|NOT COMPLETED|Overall Study||7
11281719|NCT02407132|12477933|FG000|STARTED|Immediate Post-intervention||110
11281720|NCT02407132|12477934|FG001|STARTED|Immediate Post-intervention||111
11281721|NCT02407132|12477933|FG000|COMPLETED|Immediate Post-intervention||107
11281722|NCT02407132|12477934|FG001|COMPLETED|Immediate Post-intervention||101
11281723|NCT02407132|12477933|FG000|NOT COMPLETED|Immediate Post-intervention||3
11281724|NCT02407132|12477934|FG001|NOT COMPLETED|Immediate Post-intervention||10
11281725|NCT02407132|12477933|FG000|STARTED|6 Months Post-intervention||107
11281726|NCT02407132|12477934|FG001|STARTED|6 Months Post-intervention||101
11281727|NCT02407132|12477933|FG000|COMPLETED|6 Months Post-intervention||96
11281728|NCT02407132|12477934|FG001|COMPLETED|6 Months Post-intervention||92
11281729|NCT02407132|12477933|FG000|NOT COMPLETED|6 Months Post-intervention||11
11281730|NCT02407132|12477934|FG001|NOT COMPLETED|6 Months Post-intervention||9
11281731|NCT02407132|12477933|FG000|STARTED|12 Months Post-intervention||96
11281732|NCT02407132|12477934|FG001|STARTED|12 Months Post-intervention||92
11281733|NCT02407132|12477933|FG000|COMPLETED|12 Months Post-intervention||83
11281734|NCT02407132|12477934|FG001|COMPLETED|12 Months Post-intervention||90
11281735|NCT02407132|12477933|FG000|NOT COMPLETED|12 Months Post-intervention||13
11281736|NCT02407132|12477934|FG001|NOT COMPLETED|12 Months Post-intervention||2
11281737|NCT02407223|12477943|FG000|STARTED|Overall Study||116
11281738|NCT02407223|12477944|FG001|STARTED|Overall Study||118
11281739|NCT02407223|12477945|FG002|STARTED|Overall Study||122
11281740|NCT02407223|12477943|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22
11281741|NCT02407223|12477944|FG001|Early Escape at Week 16|Overall Study||0
11281742|NCT02407223|12477945|FG002|Early Escape at Week 16|Overall Study||0
11281743|NCT02407223|12477943|FG000|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60
11281744|NCT02407223|12477944|FG001|Cross Over at Week 24|Overall Study||0
11281745|NCT02407223|12477945|FG002|Cross Over at Week 24|Overall Study||0
11281746|NCT02407223|12477943|FG000|Qualified Re-randomization at Week 52|Overall Study||0
11281747|NCT02407223|12477944|FG001|Qualified Re-randomization at Week 52|Overall Study||3
11281748|NCT02407223|12477945|FG002|Qualified Re-randomization at Week 52|Overall Study||2
11281749|NCT02407223|12477943|FG000|COMPLETED|Overall Study||0
11281750|NCT02407223|12477944|FG001|COMPLETED|Overall Study||0
11281751|NCT02407223|12477945|FG002|COMPLETED|Overall Study||0
11281752|NCT02407223|12477943|FG000|NOT COMPLETED|Overall Study||116
11281753|NCT02407223|12477944|FG001|NOT COMPLETED|Overall Study||118
11281754|NCT02407223|12477945|FG002|NOT COMPLETED|Overall Study||122
11281755|NCT02407249|12477955|FG000|STARTED|Overall Study||73
11281756|NCT02407249|12477955|FG000|Treated|Overall Study||60
11281757|NCT02407249|12477955|FG000|COMPLETED|Overall Study||47
11281758|NCT02407249|12477955|FG000|NOT COMPLETED|Overall Study||26
11281759|NCT02407457|12477961|FG000|STARTED|Baseline||235
11281760|NCT02407457|12477962|FG001|STARTED|Baseline||220
11281761|NCT02407457|12477961|FG000|COMPLETED|Baseline||235
11281762|NCT02407457|12477962|FG001|COMPLETED|Baseline||220
11281763|NCT02407457|12477961|FG000|NOT COMPLETED|Baseline||0
11281764|NCT02407457|12477962|FG001|NOT COMPLETED|Baseline||0
11281765|NCT02407457|12477961|FG000|STARTED|1 Month||235
11281766|NCT02407457|12477962|FG001|STARTED|1 Month||220
11281767|NCT02407457|12477961|FG000|COMPLETED|1 Month||229
11281768|NCT02407457|12477962|FG001|COMPLETED|1 Month||213
11281769|NCT02407457|12477961|FG000|NOT COMPLETED|1 Month||6
11281770|NCT02407457|12477962|FG001|NOT COMPLETED|1 Month||7
11281771|NCT02407457|12477961|FG000|STARTED|6-Month||231
11281772|NCT02407457|12477962|FG001|STARTED|6-Month||219
11281773|NCT02407457|12477961|FG000|COMPLETED|6-Month||211
11281774|NCT02407457|12477962|FG001|COMPLETED|6-Month||194
11281775|NCT02407457|12477961|FG000|NOT COMPLETED|6-Month||20
11281776|NCT02407457|12477962|FG001|NOT COMPLETED|6-Month||25
11281777|NCT02407457|12477961|FG000|STARTED|1 Year||227
11281778|NCT02407457|12477962|FG001|STARTED|1 Year||208
11281779|NCT02407457|12477961|FG000|COMPLETED|1 Year||194
11281780|NCT02407457|12477962|FG001|COMPLETED|1 Year||180
11281781|NCT02407457|12477961|FG000|NOT COMPLETED|1 Year||33
11281782|NCT02407457|12477962|FG001|NOT COMPLETED|1 Year||28
11281783|NCT02407457|12477961|FG000|STARTED|2-year||218
11281784|NCT02407457|12477962|FG001|STARTED|2-year||194
11281785|NCT02407457|12477961|FG000|COMPLETED|2-year||184
11281786|NCT02407457|12477962|FG001|COMPLETED|2-year||159
11281787|NCT02407457|12477961|FG000|NOT COMPLETED|2-year||34
11281788|NCT02407457|12477962|FG001|NOT COMPLETED|2-year||35
11281789|NCT02407457|12477961|FG000|STARTED|3-year||198
11281790|NCT02407457|12477962|FG001|STARTED|3-year||175
11281791|NCT02407457|12477961|FG000|COMPLETED|3-year||156
11281792|NCT02407457|12477962|FG001|COMPLETED|3-year||137
11281793|NCT02407457|12477961|FG000|NOT COMPLETED|3-year||42
11281794|NCT02407457|12477962|FG001|NOT COMPLETED|3-year||38
11281795|NCT02407457|12477961|FG000|STARTED|4-year||181
11281796|NCT02407457|12477962|FG001|STARTED|4-year||156
11281797|NCT02407457|12477961|FG000|COMPLETED|4-year||100
11281798|NCT02407457|12477962|FG001|COMPLETED|4-year||95
11281799|NCT02407457|12477961|FG000|NOT COMPLETED|4-year||81
11281800|NCT02407457|12477962|FG001|NOT COMPLETED|4-year||61
11281801|NCT02407457|12477961|FG000|STARTED|5-year||123
11281802|NCT02407457|12477962|FG001|STARTED|5-year||113
11281803|NCT02407457|12477961|FG000|COMPLETED|5-year|Due to the time frame of the study - subjects have not passed 5-year.|31
11281804|NCT02407457|12477962|FG001|COMPLETED|5-year||36
11281805|NCT02407457|12477961|FG000|NOT COMPLETED|5-year||92
11281806|NCT02407457|12477962|FG001|NOT COMPLETED|5-year||77
11281807|NCT02407704|12477972|FG000|STARTED|Overall Study||2
11281808|NCT02407704|12477973|FG001|STARTED|Overall Study||3
11281809|NCT02407704|12477974|FG002|STARTED|Overall Study||5
11281810|NCT02407704|12477975|FG003|STARTED|Overall Study||5
11281811|NCT02407704|12477972|FG000|COMPLETED|Overall Study||2
11281812|NCT02407704|12477973|FG001|COMPLETED|Overall Study||3
11281813|NCT02407704|12477974|FG002|COMPLETED|Overall Study||4
11281814|NCT02407704|12477975|FG003|COMPLETED|Overall Study||2
11281815|NCT02407704|12477972|FG000|NOT COMPLETED|Overall Study||0
11281816|NCT02407704|12477973|FG001|NOT COMPLETED|Overall Study||0
11281817|NCT02407704|12477974|FG002|NOT COMPLETED|Overall Study||1
11281818|NCT02407704|12477975|FG003|NOT COMPLETED|Overall Study||3
11281819|NCT02407756|12477993|FG000|STARTED|Overall Study||20
11281820|NCT02407756|12477994|FG001|STARTED|Overall Study||18
11281821|NCT02407756|12477995|FG002|STARTED|Overall Study||20
11281822|NCT02407756|12477996|FG003|STARTED|Overall Study||19
11281823|NCT02407756|12477993|FG000|Treated|Overall Study||20
11281824|NCT02407756|12477994|FG001|Treated|Overall Study||18
11281825|NCT02407756|12477995|FG002|Treated|Overall Study||20
11281826|NCT02407756|12477996|FG003|Treated|Overall Study||19
11281827|NCT02407756|12477993|FG000|COMPLETED|Overall Study||20
11281828|NCT02407756|12477994|FG001|COMPLETED|Overall Study||18
11281829|NCT02407756|12477995|FG002|COMPLETED|Overall Study||20
11281830|NCT02407756|12477996|FG003|COMPLETED|Overall Study||19
11281831|NCT02407756|12477993|FG000|NOT COMPLETED|Overall Study||0
11281832|NCT02407756|12477994|FG001|NOT COMPLETED|Overall Study||0
11281833|NCT02407756|12477995|FG002|NOT COMPLETED|Overall Study||0
11281834|NCT02407756|12477996|FG003|NOT COMPLETED|Overall Study||0
11281835|NCT02407990|12478014|FG000|STARTED|Overall Study||3
11281836|NCT02407990|12478015|FG001|STARTED|Overall Study||26
11281837|NCT02407990|12478016|FG002|STARTED|Overall Study||26
11281838|NCT02407990|12478017|FG003|STARTED|Overall Study||7
11281839|NCT02407990|12478018|FG004|STARTED|Overall Study||21
11281840|NCT02407990|12478019|FG005|STARTED|Overall Study||20
11281841|NCT02407990|12478020|FG006|STARTED|Overall Study||13
11281842|NCT02407990|12478021|FG007|STARTED|Overall Study||335
11281843|NCT02407990|12478014|FG000|COMPLETED|Overall Study||0
11281844|NCT02407990|12478015|FG001|COMPLETED|Overall Study||0
11281845|NCT02407990|12478016|FG002|COMPLETED|Overall Study||0
11281846|NCT02407990|12478017|FG003|COMPLETED|Overall Study||0
11281847|NCT02407990|12478018|FG004|COMPLETED|Overall Study||0
11281848|NCT02407990|12478019|FG005|COMPLETED|Overall Study||0
11281849|NCT02407990|12478020|FG006|COMPLETED|Overall Study||0
11281850|NCT02407990|12478021|FG007|COMPLETED|Overall Study||0
11281851|NCT02407990|12478014|FG000|NOT COMPLETED|Overall Study||3
11281852|NCT02407990|12478015|FG001|NOT COMPLETED|Overall Study||26
11281853|NCT02407990|12478016|FG002|NOT COMPLETED|Overall Study||26
11281854|NCT02407990|12478017|FG003|NOT COMPLETED|Overall Study||7
11281855|NCT02407990|12478018|FG004|NOT COMPLETED|Overall Study||21
11281856|NCT02407990|12478019|FG005|NOT COMPLETED|Overall Study||20
11281857|NCT02407990|12478020|FG006|NOT COMPLETED|Overall Study||13
11281858|NCT02407990|12478021|FG007|NOT COMPLETED|Overall Study||335
11281859|NCT02408016|12478048|FG000|STARTED|Overall Study||6
11281860|NCT02408016|12478049|FG001|STARTED|Overall Study||4
11281861|NCT02408016|12478050|FG002|STARTED|Overall Study||0
11281862|NCT02408016|12478048|FG000|COMPLETED|Overall Study||0
11281863|NCT02408016|12478049|FG001|COMPLETED|Overall Study||1
11281864|NCT02408016|12478050|FG002|COMPLETED|Overall Study||0
11281865|NCT02408016|12478048|FG000|NOT COMPLETED|Overall Study||6
11281866|NCT02408016|12478049|FG001|NOT COMPLETED|Overall Study||3
11281867|NCT02408016|12478050|FG002|NOT COMPLETED|Overall Study||0
11281868|NCT02408120|12478060|FG000|STARTED|Overall Study||112
11281869|NCT02408120|12478061|FG001|STARTED|Overall Study||112
11281870|NCT02408120|12478060|FG000|COMPLETED|Overall Study||108
11281871|NCT02408120|12478061|FG001|COMPLETED|Overall Study||107
11281872|NCT02408120|12478060|FG000|NOT COMPLETED|Overall Study||4
11281873|NCT02408120|12478061|FG001|NOT COMPLETED|Overall Study||5
11281874|NCT02408198|12478069|FG000|STARTED|Overall Study||13
11281875|NCT02408198|12478070|FG001|STARTED|Overall Study||5
11281876|NCT02408198|12478069|FG000|COMPLETED|Overall Study||10
11281877|NCT02408198|12478070|FG001|COMPLETED|Overall Study||5
11281878|NCT02408198|12478069|FG000|NOT COMPLETED|Overall Study||3
11281879|NCT02408198|12478070|FG001|NOT COMPLETED|Overall Study||0
11281880|NCT02408263|12478076|FG000|STARTED|Overall Study||25
11281881|NCT02408263|12478077|FG001|STARTED|Overall Study||25
11281882|NCT02408263|12478076|FG000|COMPLETED|Overall Study||25
11281883|NCT02408263|12478077|FG001|COMPLETED|Overall Study||25
11281884|NCT02408263|12478076|FG000|NOT COMPLETED|Overall Study||0
11281885|NCT02408263|12478077|FG001|NOT COMPLETED|Overall Study||0
11281886|NCT02408445|12478084|FG000|STARTED|Overall Study||10
11281887|NCT02408445|12478085|FG001|STARTED|Overall Study||10
11281888|NCT02408445|12478084|FG000|COMPLETED|Overall Study||10
11281889|NCT02408445|12478085|FG001|COMPLETED|Overall Study||10
11281890|NCT02408445|12478084|FG000|NOT COMPLETED|Overall Study||0
11281891|NCT02408445|12478085|FG001|NOT COMPLETED|Overall Study||0
11281892|NCT02408484|12478090|FG000|STARTED|Overall Study||15
11281893|NCT02408484|12478090|FG000|SAF Population|Overall Study||14
11281894|NCT02408484|12478090|FG000|FAS Population|Overall Study||14
11281895|NCT02408484|12478090|FG000|PK Population|Overall Study||13
11281896|NCT02408484|12478090|FG000|firstBLEED Population|Overall Study||8
11281897|NCT02408484|12478090|FG000|BLEED Population|Overall Study||8
11281898|NCT02408484|12478090|FG000|SURG Population|Overall Study||3
11281899|NCT02408484|12478090|FG000|COMPLETED|Overall Study||11
11281900|NCT02408484|12478090|FG000|NOT COMPLETED|Overall Study||4
11281901|NCT02408523|12478112|FG000|STARTED|Overall Study||121
11281902|NCT02408523|12478113|FG001|STARTED|Overall Study||121
11281903|NCT02408523|12478112|FG000|Completed Treatment Period|Overall Study||110
11281904|NCT02408523|12478113|FG001|Completed Treatment Period|Overall Study||103
11281905|NCT02408523|12478112|FG000|Enrolled Transition Period|Overall Study||108
11281906|NCT02408523|12478113|FG001|Enrolled Transition Period|Overall Study||101
11281907|NCT02408523|12478112|FG000|Enrolled Taper Period|Overall Study||7
11281908|NCT02408523|12478113|FG001|Enrolled Taper Period|Overall Study||9
11281909|NCT02408523|12478112|FG000|Enrolled Safety Folllow-up Period|Overall Study||10
11281910|NCT02408523|12478113|FG001|Enrolled Safety Folllow-up Period|Overall Study||11
11281911|NCT02408523|12478112|FG000|COMPLETED|Overall Study||110
11281912|NCT02408523|12478113|FG001|COMPLETED|Overall Study||103
11281913|NCT02408523|12478112|FG000|NOT COMPLETED|Overall Study||11
11281914|NCT02408523|12478113|FG001|NOT COMPLETED|Overall Study||18
11281915|NCT02408692|12478130|FG000|STARTED|Overall Study||5
11281916|NCT02408692|12478131|FG001|STARTED|Overall Study||5
11281917|NCT02408692|12478132|FG002|STARTED|Overall Study||5
11281918|NCT02408692|12478130|FG000|COMPLETED|Overall Study||5
11281919|NCT02408692|12478131|FG001|COMPLETED|Overall Study||5
11281920|NCT02408692|12478132|FG002|COMPLETED|Overall Study||5
11281921|NCT02408692|12478130|FG000|NOT COMPLETED|Overall Study||0
11281922|NCT02408692|12478131|FG001|NOT COMPLETED|Overall Study||0
11281923|NCT02408692|12478132|FG002|NOT COMPLETED|Overall Study||0
11281924|NCT02408796|12478140|FG000|STARTED|Overall Study||39
11281925|NCT02408796|12478140|FG000|COMPLETED|Overall Study||39
11281926|NCT02408796|12478140|FG000|NOT COMPLETED|Overall Study||0
11281927|NCT02408965|12478146|FG000|STARTED|Overall Study||140
11281928|NCT02408965|12478147|FG001|STARTED|Overall Study||144
11281929|NCT02408965|12478146|FG000|COMPLETED|Overall Study||140
11281930|NCT02408965|12478147|FG001|COMPLETED|Overall Study||144
11281931|NCT02408965|12478146|FG000|NOT COMPLETED|Overall Study||0
11281932|NCT02408965|12478147|FG001|NOT COMPLETED|Overall Study||0
11281933|NCT02409277|12478156|FG000|STARTED|Overall Study||267
11281934|NCT02409277|12478157|FG001|STARTED|Overall Study||60
11281935|NCT02409277|12478158|FG002|STARTED|Overall Study||599
11281936|NCT02409277|12478156|FG000|3 Months Follow-up|Overall Study||178
11281937|NCT02409277|12478157|FG001|3 Months Follow-up|Overall Study||40
11281938|NCT02409277|12478158|FG002|3 Months Follow-up|Overall Study||599
11281939|NCT02409277|12478156|FG000|6 Months Follow-up|Overall Study||182
11281940|NCT02409277|12478157|FG001|6 Months Follow-up|Overall Study||42
11281941|NCT02409277|12478158|FG002|6 Months Follow-up|Overall Study||599
11281942|NCT02409277|12478156|FG000|12 Months Follow-up|Overall Study||167
11281943|NCT02409277|12478157|FG001|12 Months Follow-up|Overall Study||43
11281944|NCT02409277|12478158|FG002|12 Months Follow-up|Overall Study||599
11281945|NCT02409277|12478156|FG000|COMPLETED|Overall Study||167
11281946|NCT02409277|12478157|FG001|COMPLETED|Overall Study||43
11281947|NCT02409277|12478158|FG002|COMPLETED|Overall Study||599
11281948|NCT02409277|12478156|FG000|NOT COMPLETED|Overall Study||100
11281949|NCT02409277|12478157|FG001|NOT COMPLETED|Overall Study||17
11281950|NCT02409277|12478158|FG002|NOT COMPLETED|Overall Study||0
11281951|NCT02409329|12478186|FG000|STARTED|Overall Study||127
11281952|NCT02409329|12478187|FG001|STARTED|Overall Study||126
11281953|NCT02409329|12478188|FG002|STARTED|Overall Study||253
11281954|NCT02409329|12478186|FG000|COMPLETED|Overall Study||122
11281955|NCT02409329|12478187|FG001|COMPLETED|Overall Study||120
11281956|NCT02409329|12478188|FG002|COMPLETED|Overall Study||244
11281957|NCT02409329|12478186|FG000|NOT COMPLETED|Overall Study||5
11281958|NCT02409329|12478187|FG001|NOT COMPLETED|Overall Study||6
11281959|NCT02409329|12478188|FG002|NOT COMPLETED|Overall Study||9
11281960|NCT02409459|12478199|FG000|STARTED|Overall Study||41
11281961|NCT02409459|12478200|FG001|STARTED|Overall Study||40
11281962|NCT02409459|12478199|FG000|COMPLETED|Overall Study||40
11281963|NCT02409459|12478200|FG001|COMPLETED|Overall Study||39
11281964|NCT02409459|12478199|FG000|NOT COMPLETED|Overall Study||1
11281965|NCT02409459|12478200|FG001|NOT COMPLETED|Overall Study||1
11281966|NCT02409667|12478206|FG000|STARTED|Treatment Period 1, Baseline to Week 24||1647
11281967|NCT02409667|12478207|FG001|STARTED|Treatment Period 1, Baseline to Week 24||0
11281968|NCT02409667|12478208|FG002|STARTED|Treatment Period 1, Baseline to Week 24||0
11281969|NCT02409667|12478209|FG003|STARTED|Treatment Period 1, Baseline to Week 24||0
11281970|NCT02409667|12478210|FG004|STARTED|Treatment Period 1, Baseline to Week 24||0
11281971|NCT02409667|12478206|FG000|COMPLETED|Treatment Period 1, Baseline to Week 24||1526
11281972|NCT02409667|12478207|FG001|COMPLETED|Treatment Period 1, Baseline to Week 24||0
11281973|NCT02409667|12478208|FG002|COMPLETED|Treatment Period 1, Baseline to Week 24||0
11281974|NCT02409667|12478209|FG003|COMPLETED|Treatment Period 1, Baseline to Week 24||0
11281975|NCT02409667|12478210|FG004|COMPLETED|Treatment Period 1, Baseline to Week 24||0
11281976|NCT02409667|12478206|FG000|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121
11281977|NCT02409667|12478207|FG001|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
11281978|NCT02409667|12478208|FG002|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
11281979|NCT02409667|12478209|FG003|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
11281980|NCT02409667|12478210|FG004|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
11281981|NCT02409667|12478206|FG000|STARTED|Treatment Period 2, Week 24 to Week 52)||0
11281982|NCT02409667|12478207|FG001|STARTED|Treatment Period 2, Week 24 to Week 52)||644
11281983|NCT02409667|12478208|FG002|STARTED|Treatment Period 2, Week 24 to Week 52)||662
11281984|NCT02409667|12478209|FG003|STARTED|Treatment Period 2, Week 24 to Week 52)||114
11281985|NCT02409667|12478210|FG004|STARTED|Treatment Period 2, Week 24 to Week 52)||93
11281986|NCT02409667|12478206|FG000|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
11281987|NCT02409667|12478207|FG001|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621
11281988|NCT02409667|12478208|FG002|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641
11281989|NCT02409667|12478209|FG003|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106
11281990|NCT02409667|12478210|FG004|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90
11281991|NCT02409667|12478206|FG000|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
11281992|NCT02409667|12478207|FG001|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23
11281993|NCT02409667|12478208|FG002|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21
11281994|NCT02409667|12478209|FG003|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8
11281995|NCT02409667|12478210|FG004|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3
11281996|NCT02409680|12478223|FG000|STARTED|Overall Study||5990
11281997|NCT02409680|12478224|FG001|STARTED|Overall Study||5986
11281998|NCT02409680|12478223|FG000|Treated|Overall Study||5943
11281999|NCT02409680|12478224|FG001|Treated|Overall Study||5936
11282000|NCT02409680|12478223|FG000|Included in mITT Analysis|Overall Study||5787
11282001|NCT02409680|12478224|FG001|Included in mITT Analysis|Overall Study||5771
11282002|NCT02409680|12478223|FG000|COMPLETED|Overall Study||5975
11282003|NCT02409680|12478224|FG001|COMPLETED|Overall Study||5956
11282004|NCT02409680|12478223|FG000|NOT COMPLETED|Overall Study||15
11282005|NCT02409680|12478224|FG001|NOT COMPLETED|Overall Study||30
11340817|NCT02925117|12538101|FG009|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
11282006|NCT02409719|12478232|FG000|STARTED|Overall Study||31
11282007|NCT02409719|12478233|FG001|STARTED|Overall Study||45
11282008|NCT02409719|12478232|FG000|2 Weeks|Overall Study||28
11282009|NCT02409719|12478233|FG001|2 Weeks|Overall Study||42
11282010|NCT02409719|12478232|FG000|4 Weeks|Overall Study||28
11282011|NCT02409719|12478233|FG001|4 Weeks|Overall Study||42
11282012|NCT02409719|12478232|FG000|6 Weeks|Overall Study||28
11282013|NCT02409719|12478233|FG001|6 Weeks|Overall Study||42
11282014|NCT02409719|12478232|FG000|3 Months|Overall Study||28
11282015|NCT02409719|12478233|FG001|3 Months|Overall Study||42
11282016|NCT02409719|12478232|FG000|6 Months|Overall Study||28
11282017|NCT02409719|12478233|FG001|6 Months|Overall Study||42
11282018|NCT02409719|12478232|FG000|12 Months|Overall Study||28
11282019|NCT02409719|12478233|FG001|12 Months|Overall Study||42
11282020|NCT02409719|12478232|FG000|COMPLETED|Overall Study||28
11282021|NCT02409719|12478233|FG001|COMPLETED|Overall Study||42
11282022|NCT02409719|12478232|FG000|NOT COMPLETED|Overall Study||3
11282023|NCT02409719|12478233|FG001|NOT COMPLETED|Overall Study||3
11282024|NCT02409732|12478239|FG000|STARTED|Overall Study|First patient consented on 4/23/15|20
11282025|NCT02409732|12478239|FG000|COMPLETED|Overall Study||14
11282026|NCT02409732|12478239|FG000|NOT COMPLETED|Overall Study||6
11282027|NCT02409784|12478244|FG000|STARTED|Overall Study||10
11282028|NCT02409784|12478244|FG000|COMPLETED|Overall Study||10
11282029|NCT02409784|12478244|FG000|NOT COMPLETED|Overall Study||0
11282030|NCT02409914|12478249|FG000|STARTED|Overall Study||7
11282031|NCT02409914|12478249|FG000|COMPLETED|Overall Study||7
11282032|NCT02409914|12478249|FG000|NOT COMPLETED|Overall Study||0
11282033|NCT02409927|12478253|FG000|STARTED|Overall Study||10
11282034|NCT02409927|12478253|FG000|COMPLETED|Overall Study||10
11282035|NCT02409927|12478253|FG000|NOT COMPLETED|Overall Study||0
11282036|NCT02410018|12478259|FG000|STARTED|Overall Study||2
11282037|NCT02410018|12478260|FG001|STARTED|Overall Study||1
11282038|NCT02410018|12478259|FG000|COMPLETED|Overall Study||2
11282039|NCT02410018|12478260|FG001|COMPLETED|Overall Study||1
11282040|NCT02410018|12478259|FG000|NOT COMPLETED|Overall Study||0
11282041|NCT02410018|12478260|FG001|NOT COMPLETED|Overall Study||0
11282042|NCT02410161|12478268|FG000|STARTED|Overall Study||10
11282043|NCT02410161|12478269|FG001|STARTED|Overall Study||10
11282044|NCT02410161|12478268|FG000|COMPLETED|Overall Study||10
11282045|NCT02410161|12478269|FG001|COMPLETED|Overall Study||10
11282046|NCT02410161|12478268|FG000|NOT COMPLETED|Overall Study||0
11282047|NCT02410161|12478269|FG001|NOT COMPLETED|Overall Study||0
11282048|NCT02410200|12478275|FG000|STARTED|Overall Study||22
11282049|NCT02410200|12478275|FG000|COMPLETED|Overall Study||20
11282050|NCT02410200|12478275|FG000|NOT COMPLETED|Overall Study||2
11282051|NCT02410252|12478279|FG000|STARTED|Overall Study||25
11282052|NCT02410252|12478279|FG000|COMPLETED|Overall Study||19
11282053|NCT02410252|12478279|FG000|NOT COMPLETED|Overall Study||6
11282054|NCT02410278|12478287|FG000|STARTED|Run-in Period||102
11282055|NCT02410278|12478288|FG001|STARTED|Run-in Period||0
11282056|NCT02410278|12478289|FG002|STARTED|Run-in Period||0
11282057|NCT02410278|12478287|FG000|Received at Least 1 Dose of DMF|Run-in Period||98
11282058|NCT02410278|12478288|FG001|Received at Least 1 Dose of DMF|Run-in Period||0
11282059|NCT02410278|12478289|FG002|Received at Least 1 Dose of DMF|Run-in Period||0
11282060|NCT02410278|12478287|FG000|COMPLETED|Run-in Period||64
11282061|NCT02410278|12478288|FG001|COMPLETED|Run-in Period||0
11282062|NCT02410278|12478289|FG002|COMPLETED|Run-in Period||0
11282063|NCT02410278|12478287|FG000|NOT COMPLETED|Run-in Period||38
11282064|NCT02410278|12478288|FG001|NOT COMPLETED|Run-in Period||0
11282065|NCT02410278|12478289|FG002|NOT COMPLETED|Run-in Period||0
11282066|NCT02410278|12478287|FG000|STARTED|Study Treatment Period||0
11282067|NCT02410278|12478288|FG001|STARTED|Study Treatment Period||31
11282068|NCT02410278|12478289|FG002|STARTED|Study Treatment Period||33
11282069|NCT02410278|12478287|FG000|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
11282070|NCT02410278|12478288|FG001|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
11282071|NCT02410278|12478289|FG002|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
11282072|NCT02410278|12478287|FG000|Completed Randomized Study Treatment|Study Treatment Period||0
11282073|NCT02410278|12478288|FG001|Completed Randomized Study Treatment|Study Treatment Period||20
11282074|NCT02410278|12478289|FG002|Completed Randomized Study Treatment|Study Treatment Period||29
11282075|NCT02410278|12478287|FG000|COMPLETED|Study Treatment Period||0
11282076|NCT02410278|12478288|FG001|COMPLETED|Study Treatment Period||20
11282077|NCT02410278|12478289|FG002|COMPLETED|Study Treatment Period||29
11282078|NCT02410278|12478287|FG000|NOT COMPLETED|Study Treatment Period||0
11282079|NCT02410278|12478288|FG001|NOT COMPLETED|Study Treatment Period||11
11282080|NCT02410278|12478289|FG002|NOT COMPLETED|Study Treatment Period||4
11282081|NCT02410291|12478298|FG000|STARTED|Overall Study||29
11282082|NCT02410291|12478299|FG001|STARTED|Overall Study||29
11282083|NCT02410291|12478298|FG000|COMPLETED|Overall Study||29
11282084|NCT02410291|12478299|FG001|COMPLETED|Overall Study||29
11282085|NCT02410291|12478298|FG000|NOT COMPLETED|Overall Study||0
11282086|NCT02410291|12478299|FG001|NOT COMPLETED|Overall Study||0
11282087|NCT02410382|12478307|FG000|STARTED|Overall Study||0
11282088|NCT02410382|12478308|FG001|STARTED|Overall Study||0
11282089|NCT02410382|12478307|FG000|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0
11282090|NCT02410382|12478308|FG001|COMPLETED|Overall Study||0
11282091|NCT02410382|12478307|FG000|NOT COMPLETED|Overall Study||0
11282092|NCT02410382|12478308|FG001|NOT COMPLETED|Overall Study||0
11282093|NCT02410629|12478316|FG000|STARTED|Overall Study||8
11282094|NCT02410629|12478317|FG001|STARTED|Overall Study||9
11282095|NCT02410629|12478316|FG000|COMPLETED|Overall Study|5 subjects from the music glove group were crossed over to conventional hand exercise group.|5
11282096|NCT02410629|12478317|FG001|COMPLETED|Overall Study|6 subjects from the conventional hand exercise group were crossed over to music glove group.|6
11282097|NCT02410629|12478316|FG000|NOT COMPLETED|Overall Study||3
11282098|NCT02410629|12478317|FG001|NOT COMPLETED|Overall Study||3
11282099|NCT02410707|12478323|FG000|STARTED|Overall Study||43
11282100|NCT02410707|12478323|FG000|COMPLETED|Overall Study||43
11282101|NCT02410707|12478323|FG000|NOT COMPLETED|Overall Study||0
11282102|NCT02410772|12478332|FG000|STARTED|Overall Study||829
11282103|NCT02410772|12478333|FG001|STARTED|Overall Study||838
11282104|NCT02410772|12478334|FG002|STARTED|Overall Study||849
11282105|NCT02410772|12478332|FG000|Microbiologically Eligible Analysis Population|Overall Study||768
11282106|NCT02410772|12478333|FG001|Microbiologically Eligible Analysis Population|Overall Study||784
11282107|NCT02410772|12478334|FG002|Microbiologically Eligible Analysis Population|Overall Study||791
11282108|NCT02410772|12478332|FG000|Assessable Population|Overall Study||726
11282109|NCT02410772|12478333|FG001|Assessable Population|Overall Study||752
11282110|NCT02410772|12478334|FG002|Assessable Population|Overall Study||756
11282111|NCT02410772|12478332|FG000|COMPLETED|Overall Study||726
11282112|NCT02410772|12478333|FG001|COMPLETED|Overall Study||752
11282113|NCT02410772|12478334|FG002|COMPLETED|Overall Study||756
11282114|NCT02410772|12478332|FG000|NOT COMPLETED|Overall Study||103
11282115|NCT02410772|12478333|FG001|NOT COMPLETED|Overall Study||86
11282116|NCT02410772|12478334|FG002|NOT COMPLETED|Overall Study||93
11282117|NCT02410798|12478342|FG000|STARTED|Overall Study||12
11282118|NCT02410798|12478342|FG000|COMPLETED|Overall Study||12
11282119|NCT02410798|12478342|FG000|NOT COMPLETED|Overall Study||0
11282120|NCT02410811|12478351|FG000|STARTED|Overall Study||5
11282121|NCT02410811|12478352|FG001|STARTED|Overall Study||10
11282122|NCT02410811|12478353|FG002|STARTED|Overall Study||11
11282123|NCT02410811|12478354|FG003|STARTED|Overall Study||7
11282124|NCT02410811|12478351|FG000|COMPLETED|Overall Study||5
11282125|NCT02410811|12478352|FG001|COMPLETED|Overall Study||10
11282126|NCT02410811|12478353|FG002|COMPLETED|Overall Study||10
11282127|NCT02410811|12478354|FG003|COMPLETED|Overall Study||7
11282128|NCT02410811|12478351|FG000|NOT COMPLETED|Overall Study||0
11282129|NCT02410811|12478352|FG001|NOT COMPLETED|Overall Study||0
11282130|NCT02410811|12478353|FG002|NOT COMPLETED|Overall Study||1
11282131|NCT02410811|12478354|FG003|NOT COMPLETED|Overall Study||0
11282132|NCT02410824|12478364|FG000|STARTED|First Intervention (One Week)||22
11282133|NCT02410824|12478365|FG001|STARTED|First Intervention (One Week)||23
11282134|NCT02410824|12478364|FG000|COMPLETED|First Intervention (One Week)||22
11282135|NCT02410824|12478365|FG001|COMPLETED|First Intervention (One Week)||22
11282136|NCT02410824|12478364|FG000|NOT COMPLETED|First Intervention (One Week)||0
11282137|NCT02410824|12478365|FG001|NOT COMPLETED|First Intervention (One Week)||1
11282138|NCT02410824|12478364|FG000|STARTED|Second Intervention (One Week)||22
11282139|NCT02410824|12478365|FG001|STARTED|Second Intervention (One Week)||22
11282140|NCT02410824|12478364|FG000|COMPLETED|Second Intervention (One Week)||22
11282141|NCT02410824|12478365|FG001|COMPLETED|Second Intervention (One Week)||22
11282142|NCT02410824|12478364|FG000|NOT COMPLETED|Second Intervention (One Week)||0
11282143|NCT02410824|12478365|FG001|NOT COMPLETED|Second Intervention (One Week)||0
11282144|NCT02410837|12478372|FG000|STARTED|Overall Study||1388
11282145|NCT02410837|12478372|FG000|Procedure|Overall Study||1388
11282146|NCT02410837|12478372|FG000|1-Month|Overall Study||1374
11282147|NCT02410837|12478372|FG000|12-Month|Overall Study||1121
11282148|NCT02410837|12478372|FG000|24-Month|Overall Study||900
11282149|NCT02410837|12478372|FG000|COMPLETED|Overall Study||900
11282150|NCT02410837|12478372|FG000|NOT COMPLETED|Overall Study||488
11282151|NCT02410967|12478378|FG000|STARTED|Treatment Phase (4 Weeks)||27
11282152|NCT02410967|12478379|FG001|STARTED|Treatment Phase (4 Weeks)||26
11282153|NCT02410967|12478378|FG000|COMPLETED|Treatment Phase (4 Weeks)||26
11282154|NCT02410967|12478379|FG001|COMPLETED|Treatment Phase (4 Weeks)||22
11282155|NCT02410967|12478378|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||1
11282156|NCT02410967|12478379|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||4
11282157|NCT02410967|12478378|FG000|STARTED|Follow-up Phase (8 Weeks)||26
11282158|NCT02410967|12478379|FG001|STARTED|Follow-up Phase (8 Weeks)||22
11282159|NCT02410967|12478378|FG000|COMPLETED|Follow-up Phase (8 Weeks)||22
11282160|NCT02410967|12478379|FG001|COMPLETED|Follow-up Phase (8 Weeks)||16
11282161|NCT02410967|12478378|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
11282162|NCT02410967|12478379|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
11282163|NCT02411084|12478387|FG000|STARTED|Overall Study||18
11282164|NCT02411084|12478388|FG001|STARTED|Overall Study||18
11282165|NCT02411084|12478387|FG000|COMPLETED|Overall Study||5
11282166|NCT02411084|12478388|FG001|COMPLETED|Overall Study||5
11282167|NCT02411084|12478387|FG000|NOT COMPLETED|Overall Study||13
11282168|NCT02411084|12478388|FG001|NOT COMPLETED|Overall Study||13
11282169|NCT02411110|12478396|FG000|STARTED|Treatment Period 1||65
11282170|NCT02411110|12478397|FG001|STARTED|Treatment Period 1||66
11282171|NCT02411110|12478396|FG000|COMPLETED|Treatment Period 1||56
11282172|NCT02411110|12478397|FG001|COMPLETED|Treatment Period 1||59
11282173|NCT02411110|12478396|FG000|NOT COMPLETED|Treatment Period 1||9
11282174|NCT02411110|12478397|FG001|NOT COMPLETED|Treatment Period 1||7
11282175|NCT02411110|12478396|FG000|STARTED|Treatment Period 2|Period 2 was optional.|50
11282176|NCT02411110|12478397|FG001|STARTED|Treatment Period 2|Period 2 was optional.|48
11282177|NCT02411110|12478396|FG000|COMPLETED|Treatment Period 2||49
11282178|NCT02411110|12478397|FG001|COMPLETED|Treatment Period 2||44
11282179|NCT02411110|12478396|FG000|NOT COMPLETED|Treatment Period 2||1
11282180|NCT02411110|12478397|FG001|NOT COMPLETED|Treatment Period 2||4
11282181|NCT02411201|12478405|FG000|STARTED|Overall Study||51
11282182|NCT02411201|12478405|FG000|COMPLETED|Overall Study||45
11282183|NCT02411201|12478405|FG000|NOT COMPLETED|Overall Study||6
11282184|NCT02411292|12478411|FG000|STARTED|Overall Study||110
11282185|NCT02411292|12478411|FG000|COMPLETED|Overall Study||89
11282186|NCT02411292|12478411|FG000|NOT COMPLETED|Overall Study||21
11282187|NCT02411396|12478417|FG000|STARTED|Overall Study||483
11282188|NCT02411396|12478417|FG000|COMPLETED|Overall Study||442
11282189|NCT02411396|12478417|FG000|NOT COMPLETED|Overall Study||41
11282190|NCT02411461|12478429|FG000|STARTED|Overall Study||16
11282191|NCT02411461|12478430|FG001|STARTED|Overall Study||8
11282192|NCT02411461|12478431|FG002|STARTED|Overall Study||15
11282193|NCT02411461|12478429|FG000|COMPLETED|Overall Study||16
11282194|NCT02411461|12478430|FG001|COMPLETED|Overall Study||8
11282195|NCT02411461|12478431|FG002|COMPLETED|Overall Study||15
11282196|NCT02411461|12478429|FG000|NOT COMPLETED|Overall Study||0
11282197|NCT02411461|12478430|FG001|NOT COMPLETED|Overall Study||0
11282198|NCT02411461|12478431|FG002|NOT COMPLETED|Overall Study||0
11282199|NCT02411539|12478441|FG000|STARTED|Overall Study||20
11282200|NCT02411539|12478442|FG001|STARTED|Overall Study||20
11282201|NCT02411539|12478441|FG000|COMPLETED|Overall Study||18
11282202|NCT02411539|12478442|FG001|COMPLETED|Overall Study||19
11282203|NCT02411539|12478441|FG000|NOT COMPLETED|Overall Study||2
11282204|NCT02411539|12478442|FG001|NOT COMPLETED|Overall Study||1
11282205|NCT02411565|12478453|FG000|STARTED|Overall Study||1
11282206|NCT02411565|12478454|FG001|STARTED|Overall Study||2
11282207|NCT02411565|12478453|FG000|COMPLETED|Overall Study||1
11282208|NCT02411565|12478454|FG001|COMPLETED|Overall Study||2
11282209|NCT02411565|12478453|FG000|NOT COMPLETED|Overall Study||0
11282210|NCT02411565|12478454|FG001|NOT COMPLETED|Overall Study||0
11282211|NCT02411578|12478462|FG000|STARTED|Crossover Trial Phase||8
11282212|NCT02411578|12478463|FG001|STARTED|Crossover Trial Phase||12
11282213|NCT02411578|12478462|FG000|COMPLETED|Crossover Trial Phase||8
11282214|NCT02411578|12478463|FG001|COMPLETED|Crossover Trial Phase||11
11282215|NCT02411578|12478462|FG000|NOT COMPLETED|Crossover Trial Phase||0
11282216|NCT02411578|12478463|FG001|NOT COMPLETED|Crossover Trial Phase||1
11282217|NCT02411578|12478462|FG000|STARTED|Extension Phase||8
11282218|NCT02411578|12478463|FG001|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
11282219|NCT02411578|12478462|FG000|COMPLETED|Extension Phase||8
11282220|NCT02411578|12478463|FG001|COMPLETED|Extension Phase||9
11282221|NCT02411578|12478462|FG000|NOT COMPLETED|Extension Phase||0
11282222|NCT02411578|12478463|FG001|NOT COMPLETED|Extension Phase||0
11282223|NCT02411591|12478474|FG000|STARTED|Overall Study||3
11282224|NCT02411591|12478475|FG001|STARTED|Overall Study||57
11282225|NCT02411591|12478476|FG002|STARTED|Overall Study||6
11282226|NCT02411591|12478474|FG000|Part A|Overall Study||3
11282227|NCT02411591|12478475|FG001|Part A|Overall Study||6
11282228|NCT02411591|12478476|FG002|Part A|Overall Study||6
11282229|NCT02411591|12478474|FG000|Expansion Cohort Part B|Overall Study||0
11282230|NCT02411591|12478475|FG001|Expansion Cohort Part B|Overall Study||51
11282231|NCT02411591|12478476|FG002|Expansion Cohort Part B|Overall Study||0
11282232|NCT02411591|12478474|FG000|Progressive Disease|Overall Study||3
11282233|NCT02411591|12478475|FG001|Progressive Disease|Overall Study||42
11282234|NCT02411591|12478476|FG002|Progressive Disease|Overall Study||3
11282235|NCT02411591|12478474|FG000|Death|Overall Study||0
11282236|NCT02411591|12478475|FG001|Death|Overall Study||2
11282237|NCT02411591|12478476|FG002|Death|Overall Study||0
11282238|NCT02411591|12478474|FG000|COMPLETED|Overall Study||3
11282239|NCT02411591|12478475|FG001|COMPLETED|Overall Study||47
11282240|NCT02411591|12478476|FG002|COMPLETED|Overall Study||3
11282241|NCT02411591|12478474|FG000|NOT COMPLETED|Overall Study||0
11282242|NCT02411591|12478475|FG001|NOT COMPLETED|Overall Study||10
11282243|NCT02411591|12478476|FG002|NOT COMPLETED|Overall Study||3
11282244|NCT02411747|12478494|FG000|STARTED|Overall Study||16
11282245|NCT02411747|12478495|FG001|STARTED|Overall Study||16
11282246|NCT02411747|12478494|FG000|Simulation Training Completed|Overall Study||16
11282247|NCT02411747|12478495|FG001|Simulation Training Completed|Overall Study||16
11282248|NCT02411747|12478494|FG000|COMPLETED|Overall Study||13
11282249|NCT02411747|12478495|FG001|COMPLETED|Overall Study||12
11282250|NCT02411747|12478494|FG000|NOT COMPLETED|Overall Study||3
11282251|NCT02411747|12478495|FG001|NOT COMPLETED|Overall Study||4
11282252|NCT02411916|12478503|FG000|STARTED|Overall Study||73
11282253|NCT02411916|12478504|FG001|STARTED|Overall Study||70
11282254|NCT02411916|12478503|FG000|COMPLETED|Overall Study||73
11282255|NCT02411916|12478504|FG001|COMPLETED|Overall Study||70
11282256|NCT02411916|12478503|FG000|NOT COMPLETED|Overall Study||0
11282257|NCT02411916|12478504|FG001|NOT COMPLETED|Overall Study||0
11282258|NCT02411929|12478510|FG000|STARTED|Period 1||8
11282259|NCT02411929|12478510|FG000|COMPLETED|Period 1||8
11282260|NCT02411929|12478510|FG000|NOT COMPLETED|Period 1||0
11282261|NCT02411929|12478510|FG000|STARTED|Washout Period||8
11282262|NCT02411929|12478510|FG000|COMPLETED|Washout Period||8
11282263|NCT02411929|12478510|FG000|NOT COMPLETED|Washout Period||0
11282264|NCT02411929|12478510|FG000|STARTED|Period 2||8
11282265|NCT02411929|12478510|FG000|COMPLETED|Period 2||8
11282266|NCT02411929|12478510|FG000|NOT COMPLETED|Period 2||0
11282267|NCT02412098|12478522|FG000|STARTED|Overall Study||14
11282268|NCT02412098|12478523|FG001|STARTED|Overall Study||14
11282269|NCT02412098|12478524|FG002|STARTED|Overall Study||21
11282270|NCT02412098|12478522|FG000|COMPLETED|Overall Study||14
11282271|NCT02412098|12478523|FG001|COMPLETED|Overall Study||14
11282272|NCT02412098|12478524|FG002|COMPLETED|Overall Study||21
11282273|NCT02412098|12478522|FG000|NOT COMPLETED|Overall Study||0
11282274|NCT02412098|12478523|FG001|NOT COMPLETED|Overall Study||0
11282275|NCT02412098|12478524|FG002|NOT COMPLETED|Overall Study||0
11282276|NCT02412111|12478538|FG000|STARTED|Ivacaftor Run-in Period (4 Weeks)||156
11282277|NCT02412111|12478539|FG001|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
11282278|NCT02412111|12478540|FG002|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
11282279|NCT02412111|12478538|FG000|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153
11282280|NCT02412111|12478539|FG001|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
11282281|NCT02412111|12478540|FG002|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
11282282|NCT02412111|12478538|FG000|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3
11282283|NCT02412111|12478539|FG001|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
11282284|NCT02412111|12478540|FG002|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
11282285|NCT02412111|12478538|FG000|STARTED|Active Comparator Period (8 Weeks)||0
11282286|NCT02412111|12478539|FG001|STARTED|Active Comparator Period (8 Weeks)||76
11282287|NCT02412111|12478540|FG002|STARTED|Active Comparator Period (8 Weeks)||75
11282288|NCT02412111|12478538|FG000|Full Analysis Set|Active Comparator Period (8 Weeks)||0
11282289|NCT02412111|12478539|FG001|Full Analysis Set|Active Comparator Period (8 Weeks)||76
11282290|NCT02412111|12478540|FG002|Full Analysis Set|Active Comparator Period (8 Weeks)||74
11282291|NCT02412111|12478538|FG000|COMPLETED|Active Comparator Period (8 Weeks)||0
11282292|NCT02412111|12478539|FG001|COMPLETED|Active Comparator Period (8 Weeks)||75
11282293|NCT02412111|12478540|FG002|COMPLETED|Active Comparator Period (8 Weeks)||69
11282294|NCT02412111|12478538|FG000|NOT COMPLETED|Active Comparator Period (8 Weeks)||0
11282295|NCT02412111|12478539|FG001|NOT COMPLETED|Active Comparator Period (8 Weeks)||1
11282296|NCT02412111|12478540|FG002|NOT COMPLETED|Active Comparator Period (8 Weeks)||6
11282297|NCT02412371|12478556|FG000|STARTED|Overall Study||7
11282298|NCT02412371|12478557|FG001|STARTED|Overall Study||9
11282299|NCT02412371|12478558|FG002|STARTED|Overall Study||7
11282300|NCT02412371|12478559|FG003|STARTED|Overall Study||8
11282301|NCT02412371|12478560|FG004|STARTED|Overall Study||12
11282302|NCT02412371|12478561|FG005|STARTED|Overall Study||5
11282303|NCT02412371|12478556|FG000|COMPLETED|Overall Study||0
11282304|NCT02412371|12478557|FG001|COMPLETED|Overall Study||0
11282305|NCT02412371|12478558|FG002|COMPLETED|Overall Study||0
11398962|NCT04383665|12593459|FG003|COMPLETED|Overall Study||2
11398963|NCT04383665|12593460|FG004|COMPLETED|Overall Study||2
11282306|NCT02412371|12478559|FG003|COMPLETED|Overall Study||0
11282307|NCT02412371|12478560|FG004|COMPLETED|Overall Study||0
11282308|NCT02412371|12478561|FG005|COMPLETED|Overall Study||0
11282309|NCT02412371|12478556|FG000|NOT COMPLETED|Overall Study||7
11282310|NCT02412371|12478557|FG001|NOT COMPLETED|Overall Study||9
11282311|NCT02412371|12478558|FG002|NOT COMPLETED|Overall Study||7
11282312|NCT02412371|12478559|FG003|NOT COMPLETED|Overall Study||8
11282313|NCT02412371|12478560|FG004|NOT COMPLETED|Overall Study||12
11282314|NCT02412371|12478561|FG005|NOT COMPLETED|Overall Study||5
11282315|NCT02412436|12478576|FG000|STARTED|Overall Study||62
11282316|NCT02412436|12478576|FG000|COMPLETED|Overall Study||44
11282317|NCT02412436|12478576|FG000|NOT COMPLETED|Overall Study||18
11282318|NCT02412488|12478580|FG000|STARTED|Overall Study||192
11282319|NCT02412488|12478580|FG000|Reveal LINQ Implanted|Overall Study||191
11282320|NCT02412488|12478580|FG000|COMPLETED|Overall Study||174
11282321|NCT02412488|12478580|FG000|NOT COMPLETED|Overall Study||18
11282322|NCT02412501|12478584|FG000|STARTED|Overall Study||101
11282323|NCT02412501|12478584|FG000|COMPLETED|Overall Study||101
11282324|NCT02412501|12478584|FG000|NOT COMPLETED|Overall Study||0
11282325|NCT02412631|12478591|FG000|STARTED|Overall Study||44
11282326|NCT02412631|12478592|FG001|STARTED|Overall Study||40
11282327|NCT02412631|12478591|FG000|COMPLETED|Overall Study||18
11282328|NCT02412631|12478592|FG001|COMPLETED|Overall Study||16
11282329|NCT02412631|12478591|FG000|NOT COMPLETED|Overall Study||26
11282330|NCT02412631|12478592|FG001|NOT COMPLETED|Overall Study||24
11282331|NCT02412644|12478600|FG000|STARTED|Overall Study||21
11282332|NCT02412644|12478601|FG001|STARTED|Overall Study||8
11282333|NCT02412644|12478600|FG000|COMPLETED|Overall Study||6
11282334|NCT02412644|12478601|FG001|COMPLETED|Overall Study||4
11282335|NCT02412644|12478600|FG000|NOT COMPLETED|Overall Study||15
11282336|NCT02412644|12478601|FG001|NOT COMPLETED|Overall Study||4
11282337|NCT02412657|12478614|FG000|STARTED|Overall Study||25
11282338|NCT02412657|12478615|FG001|STARTED|Overall Study||25
11282339|NCT02412657|12478616|FG002|STARTED|Overall Study||25
11282340|NCT02412657|12478614|FG000|COMPLETED|Overall Study||24
11282341|NCT02412657|12478615|FG001|COMPLETED|Overall Study||23
11282342|NCT02412657|12478616|FG002|COMPLETED|Overall Study||22
11282343|NCT02412657|12478614|FG000|NOT COMPLETED|Overall Study||1
11282344|NCT02412657|12478615|FG001|NOT COMPLETED|Overall Study||2
11282345|NCT02412657|12478616|FG002|NOT COMPLETED|Overall Study||3
11282346|NCT02412722|12478630|FG000|STARTED|Overall Study||11
11282347|NCT02412722|12478631|FG001|STARTED|Overall Study||8
11282348|NCT02412722|12478632|FG002|STARTED|Overall Study||7
11282349|NCT02412722|12478633|FG003|STARTED|Overall Study||15
11282350|NCT02412722|12478634|FG004|STARTED|Overall Study||7
11282351|NCT02412722|12478635|FG005|STARTED|Overall Study||13
11282352|NCT02412722|12478630|FG000|Safety Population|Overall Study||11
11282353|NCT02412722|12478631|FG001|Safety Population|Overall Study||6
11282354|NCT02412722|12478632|FG002|Safety Population|Overall Study||7
11282355|NCT02412722|12478633|FG003|Safety Population|Overall Study||15
11282356|NCT02412722|12478634|FG004|Safety Population|Overall Study||7
11282357|NCT02412722|12478635|FG005|Safety Population|Overall Study||13
11282358|NCT02412722|12478630|FG000|COMPLETED|Overall Study||0
11282359|NCT02412722|12478631|FG001|COMPLETED|Overall Study||0
11282360|NCT02412722|12478632|FG002|COMPLETED|Overall Study||0
11282361|NCT02412722|12478633|FG003|COMPLETED|Overall Study||0
11282362|NCT02412722|12478634|FG004|COMPLETED|Overall Study||0
11282363|NCT02412722|12478635|FG005|COMPLETED|Overall Study||0
11282364|NCT02412722|12478630|FG000|NOT COMPLETED|Overall Study||11
11282365|NCT02412722|12478631|FG001|NOT COMPLETED|Overall Study||8
11282366|NCT02412722|12478632|FG002|NOT COMPLETED|Overall Study||7
11282367|NCT02412722|12478633|FG003|NOT COMPLETED|Overall Study||15
11282368|NCT02412722|12478634|FG004|NOT COMPLETED|Overall Study||7
11282369|NCT02412722|12478635|FG005|NOT COMPLETED|Overall Study||13
11282370|NCT02412761|12478669|FG000|STARTED|First Intervention (2 Weeks)||5
11282371|NCT02412761|12478670|FG001|STARTED|First Intervention (2 Weeks)||6
11282372|NCT02412761|12478671|FG002|STARTED|First Intervention (2 Weeks)||5
11282373|NCT02412761|12478672|FG003|STARTED|First Intervention (2 Weeks)||8
11282374|NCT02412761|12478673|FG004|STARTED|First Intervention (2 Weeks)||4
11282375|NCT02412761|12478674|FG005|STARTED|First Intervention (2 Weeks)||7
11282376|NCT02412761|12478669|FG000|COMPLETED|First Intervention (2 Weeks)||5
11282377|NCT02412761|12478670|FG001|COMPLETED|First Intervention (2 Weeks)||5
11282378|NCT02412761|12478671|FG002|COMPLETED|First Intervention (2 Weeks)||4
11282379|NCT02412761|12478672|FG003|COMPLETED|First Intervention (2 Weeks)||8
11282380|NCT02412761|12478673|FG004|COMPLETED|First Intervention (2 Weeks)||4
11282381|NCT02412761|12478674|FG005|COMPLETED|First Intervention (2 Weeks)||6
11398964|NCT04383665|12593461|FG005|COMPLETED|Overall Study||2
11398965|NCT04383665|12593456|FG000|NOT COMPLETED|Overall Study||0
11282382|NCT02412761|12478669|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
11282383|NCT02412761|12478670|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1
11398966|NCT04383665|12593457|FG001|NOT COMPLETED|Overall Study||0
11282384|NCT02412761|12478671|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1
11282385|NCT02412761|12478672|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0
11282386|NCT02412761|12478673|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0
11282387|NCT02412761|12478674|FG005|NOT COMPLETED|First Intervention (2 Weeks)||1
11282388|NCT02412761|12478669|FG000|STARTED|Second Intervention (2 Weeks)||5
11282389|NCT02412761|12478670|FG001|STARTED|Second Intervention (2 Weeks)||5
11282390|NCT02412761|12478671|FG002|STARTED|Second Intervention (2 Weeks)||4
11282391|NCT02412761|12478672|FG003|STARTED|Second Intervention (2 Weeks)||8
11282392|NCT02412761|12478673|FG004|STARTED|Second Intervention (2 Weeks)||4
11282393|NCT02412761|12478674|FG005|STARTED|Second Intervention (2 Weeks)||6
11282394|NCT02412761|12478669|FG000|COMPLETED|Second Intervention (2 Weeks)||5
11282395|NCT02412761|12478670|FG001|COMPLETED|Second Intervention (2 Weeks)||5
11282396|NCT02412761|12478671|FG002|COMPLETED|Second Intervention (2 Weeks)||4
11282397|NCT02412761|12478672|FG003|COMPLETED|Second Intervention (2 Weeks)||8
11282398|NCT02412761|12478673|FG004|COMPLETED|Second Intervention (2 Weeks)||4
11282399|NCT02412761|12478674|FG005|COMPLETED|Second Intervention (2 Weeks)||6
11282400|NCT02412761|12478669|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
11282401|NCT02412761|12478670|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
11282402|NCT02412761|12478671|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
11282403|NCT02412761|12478672|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0
11282404|NCT02412761|12478673|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0
11282405|NCT02412761|12478674|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||0
11282406|NCT02412761|12478669|FG000|STARTED|Third Intervention (2 Weeks)||5
11282407|NCT02412761|12478670|FG001|STARTED|Third Intervention (2 Weeks)||5
11282408|NCT02412761|12478671|FG002|STARTED|Third Intervention (2 Weeks)||4
11282409|NCT02412761|12478672|FG003|STARTED|Third Intervention (2 Weeks)||8
11282410|NCT02412761|12478673|FG004|STARTED|Third Intervention (2 Weeks)||4
11282411|NCT02412761|12478674|FG005|STARTED|Third Intervention (2 Weeks)||6
11282412|NCT02412761|12478669|FG000|COMPLETED|Third Intervention (2 Weeks)||5
11282413|NCT02412761|12478670|FG001|COMPLETED|Third Intervention (2 Weeks)||5
11282414|NCT02412761|12478671|FG002|COMPLETED|Third Intervention (2 Weeks)||4
11282415|NCT02412761|12478672|FG003|COMPLETED|Third Intervention (2 Weeks)||8
11282416|NCT02412761|12478673|FG004|COMPLETED|Third Intervention (2 Weeks)||4
11282417|NCT02412761|12478674|FG005|COMPLETED|Third Intervention (2 Weeks)||6
11282418|NCT02412761|12478669|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0
11282419|NCT02412761|12478670|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0
11282420|NCT02412761|12478671|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
11282421|NCT02412761|12478672|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0
11282422|NCT02412761|12478673|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0
11282423|NCT02412761|12478674|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0
11282424|NCT02412852|12478686|FG000|STARTED|Overall Study||4
11282425|NCT02412852|12478687|FG001|STARTED|Overall Study||8
11282426|NCT02412852|12478688|FG002|STARTED|Overall Study||5
11282427|NCT02412852|12478689|FG003|STARTED|Overall Study||9
11282428|NCT02412852|12478686|FG000|COMPLETED|Overall Study||4
11282429|NCT02412852|12478687|FG001|COMPLETED|Overall Study||7
11282430|NCT02412852|12478688|FG002|COMPLETED|Overall Study||5
11282431|NCT02412852|12478689|FG003|COMPLETED|Overall Study||8
11282432|NCT02412852|12478686|FG000|NOT COMPLETED|Overall Study||0
11282433|NCT02412852|12478687|FG001|NOT COMPLETED|Overall Study||1
11282434|NCT02412852|12478688|FG002|NOT COMPLETED|Overall Study||0
11282435|NCT02412852|12478689|FG003|NOT COMPLETED|Overall Study||1
11282436|NCT02412956|12478699|FG000|STARTED|Overall Study||44
11282437|NCT02412956|12478700|FG001|STARTED|Overall Study||47
11282438|NCT02412956|12478701|FG002|STARTED|Overall Study||8
11282439|NCT02412956|12478699|FG000|COMPLETED|Overall Study||35
11282440|NCT02412956|12478700|FG001|COMPLETED|Overall Study||30
11282441|NCT02412956|12478701|FG002|COMPLETED|Overall Study||8
11282442|NCT02412956|12478699|FG000|NOT COMPLETED|Overall Study||9
11282443|NCT02412956|12478700|FG001|NOT COMPLETED|Overall Study||17
11282444|NCT02412956|12478701|FG002|NOT COMPLETED|Overall Study||0
11282445|NCT02412982|12478709|FG000|STARTED|Primary Endpoint||51
11282446|NCT02412982|12478710|FG001|STARTED|Primary Endpoint||52
11282447|NCT02412982|12478709|FG000|COMPLETED|Primary Endpoint||47
11282448|NCT02412982|12478710|FG001|COMPLETED|Primary Endpoint||49
11282449|NCT02412982|12478709|FG000|NOT COMPLETED|Primary Endpoint||4
11282450|NCT02412982|12478710|FG001|NOT COMPLETED|Primary Endpoint||3
11282451|NCT02412982|12478709|FG000|STARTED|Intervention Group: Randomization|Control group patients did not undergo randomization (see study protocol section)|0
11282452|NCT02412982|12478710|FG001|STARTED|Intervention Group: Randomization|52 patients in the intervention group underwent 1:1 randomization to the two intervention study arms: 26 patients in 40 mg every 12 hours with escalation to 50 mg every 12 hours and 26 patients in 30 mg every 8 hours.|52
11282453|NCT02412982|12478709|FG000|COMPLETED|Intervention Group: Randomization||0
11282454|NCT02412982|12478710|FG001|COMPLETED|Intervention Group: Randomization||51
11282455|NCT02412982|12478709|FG000|NOT COMPLETED|Intervention Group: Randomization||0
11282456|NCT02412982|12478710|FG001|NOT COMPLETED|Intervention Group: Randomization||1
11282457|NCT02413008|12478718|FG000|STARTED|Overall Study||50
11282458|NCT02413008|12478719|FG001|STARTED|Overall Study||11
11282459|NCT02413008|12478718|FG000|COMPLETED|Overall Study||43
11282460|NCT02413008|12478719|FG001|COMPLETED|Overall Study||9
11282461|NCT02413008|12478718|FG000|NOT COMPLETED|Overall Study||7
11282462|NCT02413008|12478719|FG001|NOT COMPLETED|Overall Study||2
11282463|NCT02413034|12478730|FG000|STARTED|Overall Study||14
11282464|NCT02413034|12478731|FG001|STARTED|Overall Study||14
11282465|NCT02413034|12478730|FG000|COMPLETED|Overall Study||14
11282466|NCT02413034|12478731|FG001|COMPLETED|Overall Study||14
11282467|NCT02413034|12478730|FG000|NOT COMPLETED|Overall Study||0
11282468|NCT02413034|12478731|FG001|NOT COMPLETED|Overall Study||0
11282469|NCT02413151|12478739|FG000|STARTED|Overall Study||32
11282470|NCT02413151|12478740|FG001|STARTED|Overall Study||30
11282471|NCT02413151|12478739|FG000|COMPLETED|Overall Study||22
11282472|NCT02413151|12478740|FG001|COMPLETED|Overall Study||28
11282473|NCT02413151|12478739|FG000|NOT COMPLETED|Overall Study||10
11282474|NCT02413151|12478740|FG001|NOT COMPLETED|Overall Study||2
11282475|NCT02413190|12478747|FG000|STARTED|Overall Study||94
11282476|NCT02413190|12478747|FG000|COMPLETED|Overall Study||94
11282477|NCT02413190|12478747|FG000|NOT COMPLETED|Overall Study||0
11282478|NCT02413203|12478753|FG000|STARTED|Overall Study||10
11282479|NCT02413203|12478754|FG001|STARTED|Overall Study||10
11282480|NCT02413203|12478753|FG000|COMPLETED|Overall Study||10
11282481|NCT02413203|12478754|FG001|COMPLETED|Overall Study||10
11282482|NCT02413203|12478753|FG000|NOT COMPLETED|Overall Study||0
11398967|NCT04383665|12593458|FG002|NOT COMPLETED|Overall Study||0
11398968|NCT04383665|12593459|FG003|NOT COMPLETED|Overall Study||0
11398969|NCT04383665|12593460|FG004|NOT COMPLETED|Overall Study||0
11398970|NCT04383665|12593461|FG005|NOT COMPLETED|Overall Study||0
11398971|NCT04383132|12593471|FG000|STARTED|Overall Study||173
11398972|NCT04383132|12593472|FG001|STARTED|Overall Study||173
11398973|NCT04383132|12593471|FG000|COMPLETED|Overall Study||173
11398974|NCT04383132|12593472|FG001|COMPLETED|Overall Study||173
11398975|NCT04383132|12593471|FG000|NOT COMPLETED|Overall Study||0
11398976|NCT04383132|12593472|FG001|NOT COMPLETED|Overall Study||0
11282483|NCT02413203|12478754|FG001|NOT COMPLETED|Overall Study||0
11282484|NCT02413229|12478768|FG000|STARTED|Overall Study||25
11282485|NCT02413229|12478769|FG001|STARTED|Overall Study||12
11282486|NCT02413229|12478770|FG002|STARTED|Overall Study||26
11282487|NCT02413229|12478771|FG003|STARTED|Overall Study||12
11282488|NCT02413229|12478772|FG004|STARTED|Overall Study||24
11282489|NCT02413229|12478773|FG005|STARTED|Overall Study||12
11282490|NCT02413229|12478774|FG006|STARTED|Overall Study||25
11282491|NCT02413229|12478775|FG007|STARTED|Overall Study||15
11282492|NCT02413229|12478768|FG000|COMPLETED|Overall Study||24
11282493|NCT02413229|12478769|FG001|COMPLETED|Overall Study||11
11282494|NCT02413229|12478770|FG002|COMPLETED|Overall Study||25
11282495|NCT02413229|12478771|FG003|COMPLETED|Overall Study||11
11282496|NCT02413229|12478772|FG004|COMPLETED|Overall Study||21
11282497|NCT02413229|12478773|FG005|COMPLETED|Overall Study||12
11282498|NCT02413229|12478774|FG006|COMPLETED|Overall Study||25
11282499|NCT02413229|12478775|FG007|COMPLETED|Overall Study||11
11282500|NCT02413229|12478768|FG000|NOT COMPLETED|Overall Study||1
11282501|NCT02413229|12478769|FG001|NOT COMPLETED|Overall Study||1
11282502|NCT02413229|12478770|FG002|NOT COMPLETED|Overall Study||1
11282503|NCT02413229|12478771|FG003|NOT COMPLETED|Overall Study||1
11282504|NCT02413229|12478772|FG004|NOT COMPLETED|Overall Study||3
11282505|NCT02413229|12478773|FG005|NOT COMPLETED|Overall Study||0
11282506|NCT02413229|12478774|FG006|NOT COMPLETED|Overall Study||0
11282507|NCT02413229|12478775|FG007|NOT COMPLETED|Overall Study||4
11282508|NCT02413255|12478810|FG000|STARTED|Overall Study||18
11282509|NCT02413255|12478811|FG001|STARTED|Overall Study||6
11282510|NCT02413255|12478812|FG002|STARTED|Overall Study||6
11282511|NCT02413255|12478813|FG003|STARTED|Overall Study||6
11282512|NCT02413255|12478814|FG004|STARTED|Overall Study||6
11282513|NCT02413255|12478815|FG005|STARTED|Overall Study||6
11282514|NCT02413255|12478816|FG006|STARTED|Overall Study||6
11282515|NCT02413255|12478817|FG007|STARTED|Overall Study||6
11282516|NCT02413255|12478818|FG008|STARTED|Overall Study||6
11282517|NCT02413255|12478819|FG009|STARTED|Overall Study||6
11282518|NCT02413255|12478820|FG010|STARTED|Overall Study||12
11282519|NCT02413255|12478821|FG011|STARTED|Overall Study||6
11282520|NCT02413255|12478822|FG012|STARTED|Overall Study||6
11282521|NCT02413255|12478823|FG013|STARTED|Overall Study||6
11282522|NCT02413255|12478824|FG014|STARTED|Overall Study||6
11282523|NCT02413255|12478825|FG015|STARTED|Overall Study||6
11282524|NCT02413255|12478826|FG016|STARTED|Overall Study||6
11282525|NCT02413255|12478810|FG000|COMPLETED|Overall Study||18
11282526|NCT02413255|12478811|FG001|COMPLETED|Overall Study||6
11282527|NCT02413255|12478812|FG002|COMPLETED|Overall Study||6
11282528|NCT02413255|12478813|FG003|COMPLETED|Overall Study||6
11282529|NCT02413255|12478814|FG004|COMPLETED|Overall Study||6
11282530|NCT02413255|12478815|FG005|COMPLETED|Overall Study||6
11282531|NCT02413255|12478816|FG006|COMPLETED|Overall Study||6
11282532|NCT02413255|12478817|FG007|COMPLETED|Overall Study||6
11282533|NCT02413255|12478818|FG008|COMPLETED|Overall Study||6
11282534|NCT02413255|12478819|FG009|COMPLETED|Overall Study||6
11282535|NCT02413255|12478820|FG010|COMPLETED|Overall Study||12
11398977|NCT04381481|12593490|FG000|STARTED|Overall Study||200
11398978|NCT04381481|12593491|FG001|STARTED|Overall Study||205
11398979|NCT04381481|12593492|FG002|STARTED|Overall Study||199
11282536|NCT02413255|12478821|FG011|COMPLETED|Overall Study||6
11398980|NCT04381481|12593493|FG003|STARTED|Overall Study||197
11398981|NCT04381481|12593494|FG004|STARTED|Overall Study||199
11398982|NCT04381481|12593495|FG005|STARTED|Overall Study||195
11398983|NCT04381481|12593496|FG006|STARTED|Overall Study||194
11398984|NCT04381481|12593497|FG007|STARTED|Overall Study||193
11398985|NCT04381481|12593498|FG008|STARTED|Overall Study||214
11398986|NCT04381481|12593499|FG009|STARTED|Overall Study||198
11398987|NCT04381481|12593500|FG010|STARTED|Overall Study||192
11398988|NCT04381481|12593501|FG011|STARTED|Overall Study||188
11398989|NCT04381481|12593490|FG000|COMPLETED|Overall Study||185
11398990|NCT04381481|12593491|FG001|COMPLETED|Overall Study||190
11398991|NCT04381481|12593492|FG002|COMPLETED|Overall Study||190
11282537|NCT02413255|12478822|FG012|COMPLETED|Overall Study||6
11282538|NCT02413255|12478823|FG013|COMPLETED|Overall Study||6
11282539|NCT02413255|12478824|FG014|COMPLETED|Overall Study||5
11282540|NCT02413255|12478825|FG015|COMPLETED|Overall Study||6
11282541|NCT02413255|12478826|FG016|COMPLETED|Overall Study||6
11282542|NCT02413255|12478810|FG000|NOT COMPLETED|Overall Study||0
11282543|NCT02413255|12478811|FG001|NOT COMPLETED|Overall Study||0
11282544|NCT02413255|12478812|FG002|NOT COMPLETED|Overall Study||0
11282545|NCT02413255|12478813|FG003|NOT COMPLETED|Overall Study||0
11282546|NCT02413255|12478814|FG004|NOT COMPLETED|Overall Study||0
11282547|NCT02413255|12478815|FG005|NOT COMPLETED|Overall Study||0
11282548|NCT02413255|12478816|FG006|NOT COMPLETED|Overall Study||0
11282549|NCT02413255|12478817|FG007|NOT COMPLETED|Overall Study||0
11282550|NCT02413255|12478818|FG008|NOT COMPLETED|Overall Study||0
11282551|NCT02413255|12478819|FG009|NOT COMPLETED|Overall Study||0
11282552|NCT02413255|12478820|FG010|NOT COMPLETED|Overall Study||0
11282553|NCT02413255|12478821|FG011|NOT COMPLETED|Overall Study||0
11282554|NCT02413255|12478822|FG012|NOT COMPLETED|Overall Study||0
11282555|NCT02413255|12478823|FG013|NOT COMPLETED|Overall Study||0
11282556|NCT02413255|12478824|FG014|NOT COMPLETED|Overall Study||1
11282557|NCT02413255|12478825|FG015|NOT COMPLETED|Overall Study||0
11282558|NCT02413255|12478826|FG016|NOT COMPLETED|Overall Study||0
11282559|NCT02413294|12478877|FG000|STARTED|Overall Study||12
11282560|NCT02413294|12478877|FG000|COMPLETED|Overall Study||11
11282561|NCT02413294|12478877|FG000|NOT COMPLETED|Overall Study||1
11282562|NCT02413320|12478883|FG000|STARTED|Overall Study||49
11282563|NCT02413320|12478884|FG001|STARTED|Overall Study||52
11282564|NCT02413320|12478883|FG000|COMPLETED|Overall Study||48
11282565|NCT02413320|12478884|FG001|COMPLETED|Overall Study||52
11282566|NCT02413320|12478883|FG000|NOT COMPLETED|Overall Study||1
11282567|NCT02413320|12478884|FG001|NOT COMPLETED|Overall Study||0
11282568|NCT02413333|12478894|FG000|STARTED|Period 1||66
11282569|NCT02413333|12478895|FG001|STARTED|Period 1||66
11282570|NCT02413333|12478894|FG000|Randomized and Treated|Period 1||66
11282571|NCT02413333|12478895|FG001|Randomized and Treated|Period 1||66
11282572|NCT02413333|12478894|FG000|COMPLETED|Period 1||65
11282573|NCT02413333|12478895|FG001|COMPLETED|Period 1||65
11282574|NCT02413333|12478894|FG000|NOT COMPLETED|Period 1||1
11282575|NCT02413333|12478895|FG001|NOT COMPLETED|Period 1||1
11282576|NCT02413333|12478894|FG000|STARTED|Period 2||65
11282577|NCT02413333|12478895|FG001|STARTED|Period 2||65
11282578|NCT02413333|12478894|FG000|COMPLETED|Period 2||64
11282579|NCT02413333|12478895|FG001|COMPLETED|Period 2||65
11282580|NCT02413333|12478894|FG000|NOT COMPLETED|Period 2||1
11282581|NCT02413333|12478895|FG001|NOT COMPLETED|Period 2||0
11282582|NCT02413346|12478903|FG000|STARTED|Overall Study||236
11282583|NCT02413346|12478904|FG001|STARTED|Overall Study||247
11282584|NCT02413346|12478903|FG000|COMPLETED|Overall Study||177
11282585|NCT02413346|12478904|FG001|COMPLETED|Overall Study||177
11282586|NCT02413346|12478903|FG000|NOT COMPLETED|Overall Study||59
11282587|NCT02413346|12478904|FG001|NOT COMPLETED|Overall Study||70
11282588|NCT02413372|12478913|FG000|STARTED|Treatment||25
11282589|NCT02413372|12478914|FG001|STARTED|Treatment||24
11282590|NCT02413372|12478915|FG002|STARTED|Treatment||26
11282591|NCT02413372|12478913|FG000|COMPLETED|Treatment||24
11282592|NCT02413372|12478914|FG001|COMPLETED|Treatment||22
11021781|NCT00806026|12199960|FG004|NOT COMPLETED|Overall Study||30
11021782|NCT00806026|12199961|FG005|NOT COMPLETED|Overall Study||32
11021783|NCT00806078|12199975|FG000|STARTED|First Intervention||9
11021784|NCT00806078|12199976|FG001|STARTED|First Intervention||9
11021785|NCT00806078|12199975|FG000|COMPLETED|First Intervention||9
11021786|NCT00806078|12199976|FG001|COMPLETED|First Intervention||9
11021787|NCT00806078|12199975|FG000|NOT COMPLETED|First Intervention||0
11021788|NCT00806078|12199976|FG001|NOT COMPLETED|First Intervention||0
11282593|NCT02413372|12478915|FG002|COMPLETED|Treatment||25
11282594|NCT02413372|12478913|FG000|NOT COMPLETED|Treatment||1
11282595|NCT02413372|12478914|FG001|NOT COMPLETED|Treatment||2
11282596|NCT02413372|12478915|FG002|NOT COMPLETED|Treatment||1
11282597|NCT02413372|12478913|FG000|STARTED|Follow-up||22
11282598|NCT02413372|12478914|FG001|STARTED|Follow-up||21
11282599|NCT02413372|12478915|FG002|STARTED|Follow-up||25
11282600|NCT02413372|12478913|FG000|COMPLETED|Follow-up||20
11282601|NCT02413372|12478914|FG001|COMPLETED|Follow-up||20
11282602|NCT02413372|12478915|FG002|COMPLETED|Follow-up||23
11282603|NCT02413372|12478913|FG000|NOT COMPLETED|Follow-up||2
11282604|NCT02413372|12478914|FG001|NOT COMPLETED|Follow-up||1
11282605|NCT02413372|12478915|FG002|NOT COMPLETED|Follow-up||2
11282606|NCT02413398|12478925|FG000|STARTED|Overall Study||160
11282607|NCT02413398|12478926|FG001|STARTED|Overall Study||161
11282608|NCT02413398|12478925|FG000|COMPLETED|Overall Study||156
11282609|NCT02413398|12478926|FG001|COMPLETED|Overall Study||154
11282610|NCT02413398|12478925|FG000|NOT COMPLETED|Overall Study||4
11282611|NCT02413398|12478926|FG001|NOT COMPLETED|Overall Study||7
11282612|NCT02413463|12478934|FG000|STARTED|Overall Study||30
11282613|NCT02413463|12478935|FG001|STARTED|Overall Study||30
11282614|NCT02413463|12478934|FG000|COMPLETED|Overall Study||25
11282615|NCT02413463|12478935|FG001|COMPLETED|Overall Study||28
11282616|NCT02413463|12478934|FG000|NOT COMPLETED|Overall Study||5
11282617|NCT02413463|12478935|FG001|NOT COMPLETED|Overall Study||2
11282618|NCT02413489|12478944|FG000|STARTED|Overall Study||15
11282619|NCT02413489|12478945|FG001|STARTED|Overall Study||16
11282620|NCT02413489|12478946|FG002|STARTED|Overall Study||5
11282621|NCT02413489|12478944|FG000|COMPLETED|Overall Study||0
11282622|NCT02413489|12478945|FG001|COMPLETED|Overall Study||0
11282623|NCT02413489|12478946|FG002|COMPLETED|Overall Study||0
11282624|NCT02413489|12478944|FG000|NOT COMPLETED|Overall Study||15
11282625|NCT02413489|12478945|FG001|NOT COMPLETED|Overall Study||16
11282626|NCT02413489|12478946|FG002|NOT COMPLETED|Overall Study||5
11282627|NCT02413580|12478954|FG000|STARTED|Overall Study||49
11282628|NCT02413580|12478954|FG000|COMPLETED|Overall Study||46
11282629|NCT02413580|12478954|FG000|NOT COMPLETED|Overall Study||3
11282630|NCT02413593|12478958|FG000|STARTED|Overall Study||111
11282631|NCT02413593|12478958|FG000|COMPLETED|Overall Study||107
11282632|NCT02413593|12478958|FG000|NOT COMPLETED|Overall Study||4
11282633|NCT02413684|12478962|FG000|STARTED|Overall Study||53
11282634|NCT02413684|12478962|FG000|COMPLETED|Overall Study||40
11282635|NCT02413684|12478962|FG000|NOT COMPLETED|Overall Study||13
11282636|NCT02413879|12478966|FG000|STARTED|Overall Study||86
11282637|NCT02413879|12478966|FG000|COMPLETED|Overall Study||86
11282638|NCT02413879|12478966|FG000|NOT COMPLETED|Overall Study||0
11282639|NCT02413918|12478970|FG000|STARTED|Overall Study||41
11282640|NCT02413918|12478970|FG000|COMPLETED|Overall Study||16
11282641|NCT02413918|12478970|FG000|NOT COMPLETED|Overall Study||25
11282642|NCT02413996|12478979|FG000|STARTED|Overall Study||44
11282643|NCT02413996|12478980|FG001|STARTED|Overall Study||41
11282644|NCT02413996|12478979|FG000|COMPLETED|Overall Study||35
11282645|NCT02413996|12478980|FG001|COMPLETED|Overall Study||39
11282646|NCT02413996|12478979|FG000|NOT COMPLETED|Overall Study||9
11282647|NCT02413996|12478980|FG001|NOT COMPLETED|Overall Study||2
11282648|NCT02414204|12478988|FG000|STARTED|Overall Study||2
11282649|NCT02414204|12478989|FG001|STARTED|Overall Study||2
11282650|NCT02414204|12478988|FG000|COMPLETED|Overall Study||2
11282651|NCT02414204|12478989|FG001|COMPLETED|Overall Study||2
11282652|NCT02414204|12478988|FG000|NOT COMPLETED|Overall Study||0
11282653|NCT02414204|12478989|FG001|NOT COMPLETED|Overall Study||0
11282654|NCT02414243|12478997|FG000|STARTED|Overall Study||19
11282655|NCT02414243|12478998|FG001|STARTED|Overall Study||21
11282656|NCT02414243|12478997|FG000|Moved to the Other Group|Overall Study||17
11282657|NCT02414243|12478998|FG001|Moved to the Other Group|Overall Study||20
11282658|NCT02414243|12478997|FG000|Entered Open Challenge at Home|Overall Study||17
11282659|NCT02414243|12478998|FG001|Entered Open Challenge at Home|Overall Study||20
11282660|NCT02414243|12478997|FG000|COMPLETED|Overall Study||13
11282661|NCT02414243|12478998|FG001|COMPLETED|Overall Study||17
11282662|NCT02414243|12478997|FG000|NOT COMPLETED|Overall Study||6
11282663|NCT02414243|12478998|FG001|NOT COMPLETED|Overall Study||4
11282664|NCT02414633|12479005|FG000|STARTED|Overall Study||148
11282665|NCT02414633|12479005|FG000|COMPLETED|Overall Study||148
11282666|NCT02414633|12479005|FG000|NOT COMPLETED|Overall Study||0
11282667|NCT02414828|12479013|FG000|STARTED|Overall Study||11
11282668|NCT02414828|12479014|FG001|STARTED|Overall Study||10
11282669|NCT02414828|12479015|FG002|STARTED|Overall Study||20
11282670|NCT02414828|12479016|FG003|STARTED|Overall Study||31
11282671|NCT02414828|12479013|FG000|COMPLETED|Overall Study||11
11282672|NCT02414828|12479014|FG001|COMPLETED|Overall Study||9
11282673|NCT02414828|12479015|FG002|COMPLETED|Overall Study||19
11282674|NCT02414828|12479016|FG003|COMPLETED|Overall Study||29
11282675|NCT02414828|12479013|FG000|NOT COMPLETED|Overall Study||0
11282676|NCT02414828|12479014|FG001|NOT COMPLETED|Overall Study||1
11282677|NCT02414828|12479015|FG002|NOT COMPLETED|Overall Study||1
11282678|NCT02414828|12479016|FG003|NOT COMPLETED|Overall Study||2
11282679|NCT02414841|12479029|FG000|STARTED|Overall Study||405
11282680|NCT02414841|12479030|FG001|STARTED|Overall Study||208
11282681|NCT02414841|12479029|FG000|COMPLETED|Overall Study||349
11282682|NCT02414841|12479030|FG001|COMPLETED|Overall Study||175
11282683|NCT02414841|12479029|FG000|NOT COMPLETED|Overall Study||56
11282684|NCT02414841|12479030|FG001|NOT COMPLETED|Overall Study||33
11282685|NCT02414854|12479042|FG000|STARTED|Overall Study||317
11282686|NCT02414854|12479043|FG001|STARTED|Overall Study||631
11282687|NCT02414854|12479044|FG002|STARTED|Overall Study||321
11282688|NCT02414854|12479045|FG003|STARTED|Overall Study||633
11282689|NCT02414854|12479042|FG000|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
11282690|NCT02414854|12479043|FG001|Treated|Overall Study||629
11282691|NCT02414854|12479044|FG002|Treated|Overall Study||321
11282692|NCT02414854|12479045|FG003|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
11282693|NCT02414854|12479042|FG000|COMPLETED|Overall Study||295
11282694|NCT02414854|12479043|FG001|COMPLETED|Overall Study||586
11282695|NCT02414854|12479044|FG002|COMPLETED|Overall Study||301
11282696|NCT02414854|12479045|FG003|COMPLETED|Overall Study||582
11282697|NCT02414854|12479042|FG000|NOT COMPLETED|Overall Study||22
11282698|NCT02414854|12479043|FG001|NOT COMPLETED|Overall Study||45
11282699|NCT02414854|12479044|FG002|NOT COMPLETED|Overall Study||20
11282700|NCT02414854|12479045|FG003|NOT COMPLETED|Overall Study||51
11282701|NCT02414932|12479057|FG000|STARTED|Overall Study||3
11282702|NCT02414932|12479058|FG001|STARTED|Overall Study||3
11282703|NCT02414932|12479057|FG000|COMPLETED|Overall Study||0
11282704|NCT02414932|12479058|FG001|COMPLETED|Overall Study||0
11282705|NCT02414932|12479057|FG000|NOT COMPLETED|Overall Study||3
11282706|NCT02414932|12479058|FG001|NOT COMPLETED|Overall Study||3
11282707|NCT02414958|12479067|FG000|STARTED|Overall Study||243
11282708|NCT02414958|12479068|FG001|STARTED|Overall Study||243
11282709|NCT02414958|12479069|FG002|STARTED|Overall Study||244
11282710|NCT02414958|12479067|FG000|COMPLETED|Overall Study||211
11282711|NCT02414958|12479068|FG001|COMPLETED|Overall Study||223
11282712|NCT02414958|12479069|FG002|COMPLETED|Overall Study||230
11282713|NCT02414958|12479067|FG000|NOT COMPLETED|Overall Study||32
11282714|NCT02414958|12479068|FG001|NOT COMPLETED|Overall Study||20
11282715|NCT02414958|12479069|FG002|NOT COMPLETED|Overall Study||14
11282716|NCT02415127|12479079|FG000|STARTED|Overall Study||47
11282717|NCT02415127|12479080|FG001|STARTED|Overall Study||45
11282718|NCT02415127|12479079|FG000|COMPLETED|Overall Study||46
11282719|NCT02415127|12479080|FG001|COMPLETED|Overall Study||45
11282720|NCT02415127|12479079|FG000|NOT COMPLETED|Overall Study||1
11282721|NCT02415127|12479080|FG001|NOT COMPLETED|Overall Study||0
11282722|NCT02415244|12479088|FG000|STARTED|Overall Study||50
11282723|NCT02415244|12479089|FG001|STARTED|Overall Study||25
11282724|NCT02415244|12479088|FG000|COMPLETED|Overall Study||50
11282725|NCT02415244|12479089|FG001|COMPLETED|Overall Study||25
11282726|NCT02415244|12479088|FG000|NOT COMPLETED|Overall Study||0
11282727|NCT02415244|12479089|FG001|NOT COMPLETED|Overall Study||0
11282728|NCT02415400|12479099|FG000|STARTED|Overall Study||1153
11282729|NCT02415400|12479100|FG001|STARTED|Overall Study||1153
11282730|NCT02415400|12479101|FG002|STARTED|Overall Study||1154
11282731|NCT02415400|12479102|FG003|STARTED|Overall Study||1154
11282732|NCT02415400|12479099|FG000|COMPLETED|Overall Study||1087
11282733|NCT02415400|12479100|FG001|COMPLETED|Overall Study||1091
11282734|NCT02415400|12479101|FG002|COMPLETED|Overall Study||1069
11282735|NCT02415400|12479102|FG003|COMPLETED|Overall Study||1071
11282736|NCT02415400|12479099|FG000|NOT COMPLETED|Overall Study||66
11282737|NCT02415400|12479100|FG001|NOT COMPLETED|Overall Study||62
11282738|NCT02415400|12479101|FG002|NOT COMPLETED|Overall Study||85
11282739|NCT02415400|12479102|FG003|NOT COMPLETED|Overall Study||83
11282740|NCT02415439|12479129|FG000|STARTED|Overall Study||6
11282741|NCT02415439|12479130|FG001|STARTED|Overall Study||6
11282742|NCT02415439|12479131|FG002|STARTED|Overall Study||6
11282743|NCT02415439|12479132|FG003|STARTED|Overall Study||6
11282744|NCT02415439|12479133|FG004|STARTED|Overall Study||6
11282745|NCT02415439|12479134|FG005|STARTED|Overall Study||6
11282746|NCT02415439|12479135|FG006|STARTED|Overall Study||6
11282747|NCT02415439|12479136|FG007|STARTED|Overall Study||12
11282748|NCT02415439|12479137|FG008|STARTED|Overall Study||6
11282749|NCT02415439|12479138|FG009|STARTED|Overall Study||6
11282750|NCT02415439|12479139|FG010|STARTED|Overall Study||6
11282751|NCT02415439|12479140|FG011|STARTED|Overall Study||6
11282752|NCT02415439|12479141|FG012|STARTED|Overall Study||8
11282753|NCT02415439|12479129|FG000|COMPLETED|Overall Study||6
11282754|NCT02415439|12479130|FG001|COMPLETED|Overall Study||6
11282755|NCT02415439|12479131|FG002|COMPLETED|Overall Study||6
11282756|NCT02415439|12479132|FG003|COMPLETED|Overall Study||6
11282757|NCT02415439|12479133|FG004|COMPLETED|Overall Study||6
11282758|NCT02415439|12479134|FG005|COMPLETED|Overall Study||6
11282759|NCT02415439|12479135|FG006|COMPLETED|Overall Study||6
11282760|NCT02415439|12479136|FG007|COMPLETED|Overall Study||12
11282761|NCT02415439|12479137|FG008|COMPLETED|Overall Study||5
11282762|NCT02415439|12479138|FG009|COMPLETED|Overall Study||6
11282763|NCT02415439|12479139|FG010|COMPLETED|Overall Study||6
11282764|NCT02415439|12479140|FG011|COMPLETED|Overall Study||6
11282765|NCT02415439|12479141|FG012|COMPLETED|Overall Study||8
11282766|NCT02415439|12479129|FG000|NOT COMPLETED|Overall Study||0
11398992|NCT04381481|12593493|FG003|COMPLETED|Overall Study||183
11398993|NCT04381481|12593494|FG004|COMPLETED|Overall Study||191
11398994|NCT04381481|12593495|FG005|COMPLETED|Overall Study||180
11398995|NCT04381481|12593496|FG006|COMPLETED|Overall Study||184
11398996|NCT04381481|12593497|FG007|COMPLETED|Overall Study||177
11398997|NCT04381481|12593498|FG008|COMPLETED|Overall Study||195
11398998|NCT04381481|12593499|FG009|COMPLETED|Overall Study||188
11398999|NCT04381481|12593500|FG010|COMPLETED|Overall Study||183
11399000|NCT04381481|12593501|FG011|COMPLETED|Overall Study||173
11399001|NCT04381481|12593490|FG000|NOT COMPLETED|Overall Study||15
11399002|NCT04381481|12593491|FG001|NOT COMPLETED|Overall Study||15
11399003|NCT04381481|12593492|FG002|NOT COMPLETED|Overall Study||9
11399004|NCT04381481|12593493|FG003|NOT COMPLETED|Overall Study||14
11399005|NCT04381481|12593494|FG004|NOT COMPLETED|Overall Study||8
11399006|NCT04381481|12593495|FG005|NOT COMPLETED|Overall Study||15
11399007|NCT04381481|12593496|FG006|NOT COMPLETED|Overall Study||10
11399008|NCT04381481|12593497|FG007|NOT COMPLETED|Overall Study||16
11399009|NCT04381481|12593498|FG008|NOT COMPLETED|Overall Study||19
11399010|NCT04381481|12593499|FG009|NOT COMPLETED|Overall Study||10
11399011|NCT04381481|12593500|FG010|NOT COMPLETED|Overall Study||9
11282767|NCT02415439|12479130|FG001|NOT COMPLETED|Overall Study||0
11282768|NCT02415439|12479131|FG002|NOT COMPLETED|Overall Study||0
11282769|NCT02415439|12479132|FG003|NOT COMPLETED|Overall Study||0
11282770|NCT02415439|12479133|FG004|NOT COMPLETED|Overall Study||0
11282771|NCT02415439|12479134|FG005|NOT COMPLETED|Overall Study||0
11282772|NCT02415439|12479135|FG006|NOT COMPLETED|Overall Study||0
11282773|NCT02415439|12479136|FG007|NOT COMPLETED|Overall Study||0
11282774|NCT02415439|12479137|FG008|NOT COMPLETED|Overall Study||1
11282775|NCT02415439|12479138|FG009|NOT COMPLETED|Overall Study||0
11282776|NCT02415439|12479139|FG010|NOT COMPLETED|Overall Study||0
11282777|NCT02415439|12479140|FG011|NOT COMPLETED|Overall Study||0
11282778|NCT02415439|12479141|FG012|NOT COMPLETED|Overall Study||0
11399012|NCT04381481|12593501|FG011|NOT COMPLETED|Overall Study||15
11399013|NCT04380688|12593529|FG000|STARTED|Overall Study||31
11399014|NCT04380688|12593530|FG001|STARTED|Overall Study||31
11399015|NCT04380688|12593529|FG000|COMPLETED|Overall Study||24
11282779|NCT02415595|12479175|FG000|STARTED|Overall Study||50
11282780|NCT02415595|12479176|FG001|STARTED|Overall Study||52
11282781|NCT02415595|12479177|FG002|STARTED|Overall Study||51
11282782|NCT02415595|12479178|FG003|STARTED|Overall Study||53
11282783|NCT02415595|12479175|FG000|COMPLETED|Overall Study||0
11282784|NCT02415595|12479176|FG001|COMPLETED|Overall Study||0
11282785|NCT02415595|12479177|FG002|COMPLETED|Overall Study||0
11282786|NCT02415595|12479178|FG003|COMPLETED|Overall Study||0
11282787|NCT02415595|12479175|FG000|NOT COMPLETED|Overall Study||50
11282788|NCT02415595|12479176|FG001|NOT COMPLETED|Overall Study||52
11282789|NCT02415595|12479177|FG002|NOT COMPLETED|Overall Study||51
11282790|NCT02415595|12479178|FG003|NOT COMPLETED|Overall Study||53
11282791|NCT02415608|12479191|FG000|STARTED|Overall Study||3
11282792|NCT02415608|12479192|FG001|STARTED|Overall Study||1
11282793|NCT02415608|12479191|FG000|COMPLETED|Overall Study||3
11282794|NCT02415608|12479192|FG001|COMPLETED|Overall Study||1
11282795|NCT02415608|12479191|FG000|NOT COMPLETED|Overall Study||0
11282796|NCT02415608|12479192|FG001|NOT COMPLETED|Overall Study||0
11282797|NCT02415842|12479211|FG000|STARTED|Overall Study||29
11282798|NCT02415842|12479212|FG001|STARTED|Overall Study||29
11282799|NCT02415842|12479213|FG002|STARTED|Overall Study||29
11282800|NCT02415842|12479214|FG003|STARTED|Overall Study||27
11282801|NCT02415842|12479215|FG004|STARTED|Overall Study||30
11282802|NCT02415842|12479216|FG005|STARTED|Overall Study||30
11282803|NCT02415842|12479217|FG006|STARTED|Overall Study||30
11282804|NCT02415842|12479218|FG007|STARTED|Overall Study||26
11282805|NCT02415842|12479219|FG008|STARTED|Overall Study||29
11282806|NCT02415842|12479220|FG009|STARTED|Overall Study||53
11282807|NCT02415842|12479221|FG010|STARTED|Overall Study||49
11282808|NCT02415842|12479222|FG011|STARTED|Overall Study||33
11399016|NCT04380688|12593530|FG001|COMPLETED|Overall Study||22
11282809|NCT02415842|12479223|FG012|STARTED|Overall Study||20
11282810|NCT02415842|12479211|FG000|COMPLETED|Overall Study||29
11282811|NCT02415842|12479212|FG001|COMPLETED|Overall Study||29
11282812|NCT02415842|12479213|FG002|COMPLETED|Overall Study||29
11282813|NCT02415842|12479214|FG003|COMPLETED|Overall Study||27
11282814|NCT02415842|12479215|FG004|COMPLETED|Overall Study||30
11282815|NCT02415842|12479216|FG005|COMPLETED|Overall Study||30
11282816|NCT02415842|12479217|FG006|COMPLETED|Overall Study||30
11282817|NCT02415842|12479218|FG007|COMPLETED|Overall Study||26
11282818|NCT02415842|12479219|FG008|COMPLETED|Overall Study||29
11282819|NCT02415842|12479220|FG009|COMPLETED|Overall Study||53
11282820|NCT02415842|12479221|FG010|COMPLETED|Overall Study||49
11282821|NCT02415842|12479222|FG011|COMPLETED|Overall Study||33
11282822|NCT02415842|12479223|FG012|COMPLETED|Overall Study||20
11282823|NCT02415842|12479211|FG000|NOT COMPLETED|Overall Study||0
11282824|NCT02415842|12479212|FG001|NOT COMPLETED|Overall Study||0
11282825|NCT02415842|12479213|FG002|NOT COMPLETED|Overall Study||0
11282826|NCT02415842|12479214|FG003|NOT COMPLETED|Overall Study||0
11282827|NCT02415842|12479215|FG004|NOT COMPLETED|Overall Study||0
11282828|NCT02415842|12479216|FG005|NOT COMPLETED|Overall Study||0
11282829|NCT02415842|12479217|FG006|NOT COMPLETED|Overall Study||0
11282830|NCT02415842|12479218|FG007|NOT COMPLETED|Overall Study||0
11282831|NCT02415842|12479219|FG008|NOT COMPLETED|Overall Study||0
11282832|NCT02415842|12479220|FG009|NOT COMPLETED|Overall Study||0
11282833|NCT02415842|12479221|FG010|NOT COMPLETED|Overall Study||0
11282834|NCT02415842|12479222|FG011|NOT COMPLETED|Overall Study||0
11282835|NCT02415842|12479223|FG012|NOT COMPLETED|Overall Study||0
11282836|NCT02415855|12479270|FG000|STARTED|Overall Study||37
11282837|NCT02415855|12479271|FG001|STARTED|Overall Study||64
11282838|NCT02415855|12479270|FG000|COMPLETED|Overall Study||34
11282839|NCT02415855|12479271|FG001|COMPLETED|Overall Study||62
11282840|NCT02415855|12479270|FG000|NOT COMPLETED|Overall Study||3
11282841|NCT02415855|12479271|FG001|NOT COMPLETED|Overall Study||2
11282842|NCT02415959|12479282|FG000|STARTED|Overall Study||14
11282843|NCT02415959|12479283|FG001|STARTED|Overall Study||14
11282844|NCT02415959|12479284|FG002|STARTED|Overall Study||14
11282845|NCT02415959|12479285|FG003|STARTED|Overall Study||14
11282846|NCT02415959|12479286|FG004|STARTED|Overall Study||14
11282847|NCT02415959|12479282|FG000|COMPLETED|Overall Study||14
11282848|NCT02415959|12479283|FG001|COMPLETED|Overall Study||13
11282849|NCT02415959|12479284|FG002|COMPLETED|Overall Study||14
11282850|NCT02415959|12479285|FG003|COMPLETED|Overall Study||13
11282851|NCT02415959|12479286|FG004|COMPLETED|Overall Study||14
11282852|NCT02415959|12479282|FG000|NOT COMPLETED|Overall Study||0
11282853|NCT02415959|12479283|FG001|NOT COMPLETED|Overall Study||1
11282854|NCT02415959|12479284|FG002|NOT COMPLETED|Overall Study||0
11282855|NCT02415959|12479285|FG003|NOT COMPLETED|Overall Study||1
11282856|NCT02415959|12479286|FG004|NOT COMPLETED|Overall Study||0
11282857|NCT02415998|12479298|FG000|STARTED|Overall Study||25
11282858|NCT02415998|12479298|FG000|COMPLETED|Overall Study||20
11282859|NCT02415998|12479298|FG000|NOT COMPLETED|Overall Study||5
11282860|NCT02416102|12479305|FG000|STARTED|Overall Study||16
11282861|NCT02416102|12479306|FG001|STARTED|Overall Study||15
11282862|NCT02416102|12479307|FG002|STARTED|Overall Study||0
11282863|NCT02416102|12479305|FG000|COMPLETED|Overall Study||7
11282864|NCT02416102|12479306|FG001|COMPLETED|Overall Study||7
11282865|NCT02416102|12479307|FG002|COMPLETED|Overall Study||0
11282866|NCT02416102|12479305|FG000|NOT COMPLETED|Overall Study||9
11282867|NCT02416102|12479306|FG001|NOT COMPLETED|Overall Study||8
11282868|NCT02416102|12479307|FG002|NOT COMPLETED|Overall Study||0
11282869|NCT02416180|12479315|FG000|STARTED|Overall Study||111
11282870|NCT02416180|12479315|FG000|COMPLETED|Overall Study||110
11282871|NCT02416180|12479315|FG000|NOT COMPLETED|Overall Study||1
11282872|NCT02416193|12479321|FG000|STARTED|Overall Study||15
11282873|NCT02416193|12479322|FG001|STARTED|Overall Study||15
11282874|NCT02416193|12479321|FG000|COMPLETED|Overall Study||15
11282875|NCT02416193|12479322|FG001|COMPLETED|Overall Study||15
11282876|NCT02416193|12479321|FG000|NOT COMPLETED|Overall Study||0
11282877|NCT02416193|12479322|FG001|NOT COMPLETED|Overall Study||0
11282878|NCT02416453|12479339|FG000|STARTED|Overall Study||10
11282879|NCT02416453|12479340|FG001|STARTED|Overall Study||10
11282880|NCT02416453|12479341|FG002|STARTED|Overall Study||10
11282881|NCT02416453|12479342|FG003|STARTED|Overall Study||112
11282882|NCT02416453|12479343|FG004|STARTED|Overall Study||13
11282883|NCT02416453|12479344|FG005|STARTED|Overall Study||114
11282884|NCT02416453|12479345|FG006|STARTED|Overall Study||13
11282885|NCT02416453|12479346|FG007|STARTED|Overall Study||106
11282886|NCT02416453|12479347|FG008|STARTED|Overall Study||18
11282887|NCT02416453|12479348|FG009|STARTED|Overall Study||13
11282888|NCT02416453|12479349|FG010|STARTED|Overall Study||2
11282889|NCT02416453|12479339|FG000|COMPLETED|Overall Study||7
11282890|NCT02416453|12479340|FG001|COMPLETED|Overall Study||7
11282891|NCT02416453|12479341|FG002|COMPLETED|Overall Study||9
11282892|NCT02416453|12479342|FG003|COMPLETED|Overall Study||97
11282893|NCT02416453|12479343|FG004|COMPLETED|Overall Study||12
11282894|NCT02416453|12479344|FG005|COMPLETED|Overall Study||98
11282895|NCT02416453|12479345|FG006|COMPLETED|Overall Study||11
11282896|NCT02416453|12479346|FG007|COMPLETED|Overall Study||94
11282897|NCT02416453|12479347|FG008|COMPLETED|Overall Study||13
11282898|NCT02416453|12479348|FG009|COMPLETED|Overall Study||13
11282899|NCT02416453|12479349|FG010|COMPLETED|Overall Study||2
11282900|NCT02416453|12479339|FG000|NOT COMPLETED|Overall Study||3
11282901|NCT02416453|12479340|FG001|NOT COMPLETED|Overall Study||3
11282902|NCT02416453|12479341|FG002|NOT COMPLETED|Overall Study||1
11282903|NCT02416453|12479342|FG003|NOT COMPLETED|Overall Study||15
11282904|NCT02416453|12479343|FG004|NOT COMPLETED|Overall Study||1
11282905|NCT02416453|12479344|FG005|NOT COMPLETED|Overall Study||16
11282906|NCT02416453|12479345|FG006|NOT COMPLETED|Overall Study||2
11282907|NCT02416453|12479346|FG007|NOT COMPLETED|Overall Study||12
11282908|NCT02416453|12479347|FG008|NOT COMPLETED|Overall Study||5
11282909|NCT02416453|12479348|FG009|NOT COMPLETED|Overall Study||0
11282910|NCT02416453|12479349|FG010|NOT COMPLETED|Overall Study||0
11282911|NCT02416713|12479383|FG000|STARTED|Overall Study||8
11282912|NCT02416713|12479384|FG001|STARTED|Overall Study||9
11282913|NCT02416713|12479385|FG002|STARTED|Overall Study||8
11282914|NCT02416713|12479386|FG003|STARTED|Overall Study||10
11282915|NCT02416713|12479383|FG000|COMPLETED|Overall Study||8
11282916|NCT02416713|12479384|FG001|COMPLETED|Overall Study||9
11282917|NCT02416713|12479385|FG002|COMPLETED|Overall Study||8
11282918|NCT02416713|12479386|FG003|COMPLETED|Overall Study||10
11282919|NCT02416713|12479383|FG000|NOT COMPLETED|Overall Study||0
11282920|NCT02416713|12479384|FG001|NOT COMPLETED|Overall Study||0
11282921|NCT02416713|12479385|FG002|NOT COMPLETED|Overall Study||0
11282922|NCT02416713|12479386|FG003|NOT COMPLETED|Overall Study||0
11282923|NCT02416791|12479399|FG000|STARTED|6 Weeks||3
11282924|NCT02416791|12479400|FG001|STARTED|6 Weeks||3
11282925|NCT02416791|12479401|FG002|STARTED|6 Weeks||3
11282926|NCT02416791|12479399|FG000|COMPLETED|6 Weeks||3
11282927|NCT02416791|12479400|FG001|COMPLETED|6 Weeks||3
11282928|NCT02416791|12479401|FG002|COMPLETED|6 Weeks||3
11282929|NCT02416791|12479399|FG000|NOT COMPLETED|6 Weeks||0
11282930|NCT02416791|12479400|FG001|NOT COMPLETED|6 Weeks||0
11282931|NCT02416791|12479401|FG002|NOT COMPLETED|6 Weeks||0
11282932|NCT02416791|12479399|FG000|STARTED|6 Months||3
11282933|NCT02416791|12479400|FG001|STARTED|6 Months||3
11282934|NCT02416791|12479401|FG002|STARTED|6 Months||3
11282935|NCT02416791|12479399|FG000|COMPLETED|6 Months||3
11282936|NCT02416791|12479400|FG001|COMPLETED|6 Months||3
11282937|NCT02416791|12479401|FG002|COMPLETED|6 Months||2
11282938|NCT02416791|12479399|FG000|NOT COMPLETED|6 Months||0
11282939|NCT02416791|12479400|FG001|NOT COMPLETED|6 Months||0
11282940|NCT02416791|12479401|FG002|NOT COMPLETED|6 Months||1
11282941|NCT02416908|12479412|FG000|STARTED|Dose Escalation Phase||6
11282942|NCT02416908|12479413|FG001|STARTED|Dose Escalation Phase||0
11282943|NCT02416908|12479414|FG002|STARTED|Dose Escalation Phase||34
11282944|NCT02416908|12479415|FG003|STARTED|Dose Escalation Phase||0
11282945|NCT02416908|12479412|FG000|COMPLETED|Dose Escalation Phase||6
11282946|NCT02416908|12479413|FG001|COMPLETED|Dose Escalation Phase||0
11282947|NCT02416908|12479414|FG002|COMPLETED|Dose Escalation Phase||30
11282948|NCT02416908|12479415|FG003|COMPLETED|Dose Escalation Phase||0
11282949|NCT02416908|12479412|FG000|NOT COMPLETED|Dose Escalation Phase||0
11282950|NCT02416908|12479413|FG001|NOT COMPLETED|Dose Escalation Phase||0
11282951|NCT02416908|12479414|FG002|NOT COMPLETED|Dose Escalation Phase||4
11282952|NCT02416908|12479415|FG003|NOT COMPLETED|Dose Escalation Phase||0
11282953|NCT02416908|12479412|FG000|STARTED|Maintenance Phase||0
11282954|NCT02416908|12479413|FG001|STARTED|Maintenance Phase||0
11282955|NCT02416908|12479414|FG002|STARTED|Maintenance Phase||0
11282956|NCT02416908|12479415|FG003|STARTED|Maintenance Phase||2
11282957|NCT02416908|12479412|FG000|COMPLETED|Maintenance Phase||0
11282958|NCT02416908|12479413|FG001|COMPLETED|Maintenance Phase||0
11282959|NCT02416908|12479414|FG002|COMPLETED|Maintenance Phase||0
11282960|NCT02416908|12479415|FG003|COMPLETED|Maintenance Phase||2
11282961|NCT02416908|12479412|FG000|NOT COMPLETED|Maintenance Phase||0
11282962|NCT02416908|12479413|FG001|NOT COMPLETED|Maintenance Phase||0
11282963|NCT02416908|12479414|FG002|NOT COMPLETED|Maintenance Phase||0
11282964|NCT02416908|12479415|FG003|NOT COMPLETED|Maintenance Phase||0
11282965|NCT02416934|12479424|FG000|STARTED|Overall Study||36
11282966|NCT02416934|12479425|FG001|STARTED|Overall Study||38
11282967|NCT02416934|12479424|FG000|Double Blind (0-52 Weeks)|Overall Study||36
11282968|NCT02416934|12479425|FG001|Double Blind (0-52 Weeks)|Overall Study||38
11282969|NCT02416934|12479424|FG000|Last Participant Completed 1 yr|Overall Study||33
11282970|NCT02416934|12479425|FG001|Last Participant Completed 1 yr|Overall Study||31
11282971|NCT02416934|12479424|FG000|COMPLETED|Overall Study||33
11282972|NCT02416934|12479425|FG001|COMPLETED|Overall Study||31
11282973|NCT02416934|12479424|FG000|NOT COMPLETED|Overall Study||3
11282974|NCT02416934|12479425|FG001|NOT COMPLETED|Overall Study||7
11282975|NCT02416973|12479440|FG000|STARTED|Overall Study||14
11282976|NCT02416973|12479441|FG001|STARTED|Overall Study||13
11282977|NCT02416973|12479442|FG002|STARTED|Overall Study||14
11282978|NCT02416973|12479440|FG000|COMPLETED|Overall Study||13
11282979|NCT02416973|12479441|FG001|COMPLETED|Overall Study||10
11282980|NCT02416973|12479442|FG002|COMPLETED|Overall Study||13
11282981|NCT02416973|12479440|FG000|NOT COMPLETED|Overall Study||1
11282982|NCT02416973|12479441|FG001|NOT COMPLETED|Overall Study||3
11282983|NCT02416973|12479442|FG002|NOT COMPLETED|Overall Study||1
11282984|NCT02417064|12479453|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||117
11282985|NCT02417064|12479454|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||116
11282986|NCT02417064|12479455|FG002|STARTED|Double-blind Induction Phase (4 Weeks)||113
11282987|NCT02417064|12479453|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115
11282988|NCT02417064|12479454|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114
11282989|NCT02417064|12479455|FG002|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113
11282990|NCT02417064|12479453|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115
11282991|NCT02417064|12479454|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116
11282992|NCT02417064|12479455|FG002|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113
11282993|NCT02417064|12479453|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||111
11282994|NCT02417064|12479454|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||97
11282995|NCT02417064|12479455|FG002|COMPLETED|Double-blind Induction Phase (4 Weeks)||107
11282996|NCT02417064|12479453|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
11282997|NCT02417064|12479454|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19
11282998|NCT02417064|12479455|FG002|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
11282999|NCT02417064|12479453|FG000|STARTED|Follow-up Phase (24 Weeks)||47
11283000|NCT02417064|12479454|FG001|STARTED|Follow-up Phase (24 Weeks)||52
11283001|NCT02417064|12479455|FG002|STARTED|Follow-up Phase (24 Weeks)||69
11283002|NCT02417064|12479453|FG000|COMPLETED|Follow-up Phase (24 Weeks)||8
11283003|NCT02417064|12479454|FG001|COMPLETED|Follow-up Phase (24 Weeks)||10
11283004|NCT02417064|12479455|FG002|COMPLETED|Follow-up Phase (24 Weeks)||18
11283005|NCT02417064|12479453|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||39
11283006|NCT02417064|12479454|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||42
11283007|NCT02417064|12479455|FG002|NOT COMPLETED|Follow-up Phase (24 Weeks)||51
11283008|NCT02417129|12479466|FG000|STARTED|Overall Study||2
11283009|NCT02417129|12479467|FG001|STARTED|Overall Study||0
11283010|NCT02417129|12479466|FG000|COMPLETED|Overall Study||2
11283011|NCT02417129|12479467|FG001|COMPLETED|Overall Study||0
11283012|NCT02417129|12479466|FG000|NOT COMPLETED|Overall Study||0
11283013|NCT02417129|12479467|FG001|NOT COMPLETED|Overall Study||0
11283014|NCT02417233|12479476|FG000|STARTED|Overall Study||169
11283015|NCT02417233|12479477|FG001|STARTED|Overall Study||289
11283016|NCT02417233|12479478|FG002|STARTED|Overall Study||298
11399017|NCT04380688|12593529|FG000|NOT COMPLETED|Overall Study||7
11399018|NCT04380688|12593530|FG001|NOT COMPLETED|Overall Study||9
11399019|NCT04376060|12593536|FG000|STARTED|Overall Study||15
11399020|NCT04376060|12593536|FG000|COMPLETED|Overall Study||14
11399021|NCT04376060|12593536|FG000|NOT COMPLETED|Overall Study||1
11399022|NCT04374500|12593540|FG000|STARTED|Overall Study||10
11283017|NCT02417233|12479476|FG000|COMPLETED|Overall Study||133
11283018|NCT02417233|12479477|FG001|COMPLETED|Overall Study||238
11283019|NCT02417233|12479478|FG002|COMPLETED|Overall Study||239
11283020|NCT02417233|12479476|FG000|NOT COMPLETED|Overall Study||36
11283021|NCT02417233|12479477|FG001|NOT COMPLETED|Overall Study||51
11283022|NCT02417233|12479478|FG002|NOT COMPLETED|Overall Study||59
11283023|NCT02417246|12479489|FG000|STARTED|Phase 1 Brand Name Metoprolol ER||24
11283024|NCT02417246|12479490|FG001|STARTED|Phase 1 Brand Name Metoprolol ER||24
11283025|NCT02417246|12479489|FG000|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
11283026|NCT02417246|12479490|FG001|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
11283027|NCT02417246|12479489|FG000|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
11283028|NCT02417246|12479490|FG001|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
11283029|NCT02417246|12479489|FG000|STARTED|Phase 2 1st Generic Administered||20
11283030|NCT02417246|12479490|FG001|STARTED|Phase 2 1st Generic Administered||20
11283031|NCT02417246|12479489|FG000|COMPLETED|Phase 2 1st Generic Administered||19
11283032|NCT02417246|12479490|FG001|COMPLETED|Phase 2 1st Generic Administered||20
11283033|NCT02417246|12479489|FG000|NOT COMPLETED|Phase 2 1st Generic Administered||1
11283034|NCT02417246|12479490|FG001|NOT COMPLETED|Phase 2 1st Generic Administered||0
11283035|NCT02417246|12479489|FG000|STARTED|Phase 3 Brand Name Metoprolol ER #2||19
11283036|NCT02417246|12479490|FG001|STARTED|Phase 3 Brand Name Metoprolol ER #2||20
11283037|NCT02417246|12479489|FG000|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18
11283038|NCT02417246|12479490|FG001|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20
11283039|NCT02417246|12479489|FG000|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1
11283040|NCT02417246|12479490|FG001|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0
11283041|NCT02417246|12479489|FG000|STARTED|Phase 4 2nd Generic Administered||18
11283042|NCT02417246|12479490|FG001|STARTED|Phase 4 2nd Generic Administered||20
11283043|NCT02417246|12479489|FG000|COMPLETED|Phase 4 2nd Generic Administered||18
11283044|NCT02417246|12479490|FG001|COMPLETED|Phase 4 2nd Generic Administered||20
11283045|NCT02417246|12479489|FG000|NOT COMPLETED|Phase 4 2nd Generic Administered||0
11283046|NCT02417246|12479490|FG001|NOT COMPLETED|Phase 4 2nd Generic Administered||0
11283047|NCT02417376|12479500|FG000|STARTED|Overall Study||35
11283048|NCT02417376|12479501|FG001|STARTED|Overall Study||35
11283049|NCT02417376|12479500|FG000|COMPLETED|Overall Study||30
11283050|NCT02417376|12479501|FG001|COMPLETED|Overall Study||25
11283051|NCT02417376|12479500|FG000|NOT COMPLETED|Overall Study||5
11283052|NCT02417376|12479501|FG001|NOT COMPLETED|Overall Study||10
11340818|NCT02925117|12538102|FG010|NOT COMPLETED|Period 2 (Weeks 16 - 88)||8
11340819|NCT02925117|12538103|FG011|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
11340820|NCT02925143|12538125|FG000|STARTED|Overall Study||6525
11340821|NCT02925143|12538125|FG000|Participants Receiving Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine)|Overall Study||3099
11340822|NCT02925143|12538125|FG000|Participants Receiving Non-depolarizing Neuromuscular Blocking Agent (NMBA)|Overall Study||3426
11340823|NCT02925143|12538125|FG000|COMPLETED|Overall Study||6525
11340824|NCT02925143|12538125|FG000|NOT COMPLETED|Overall Study||0
11340825|NCT02925312|12538131|FG000|STARTED|Overall Study||125
11340826|NCT02925312|12538132|FG001|STARTED|Overall Study||294
11340827|NCT02925312|12538131|FG000|COMPLETED|Overall Study||98
11340828|NCT02925312|12538132|FG001|COMPLETED|Overall Study||294
11340829|NCT02925312|12538131|FG000|NOT COMPLETED|Overall Study||27
11340830|NCT02925312|12538132|FG001|NOT COMPLETED|Overall Study||0
11340831|NCT02925403|12538140|FG000|STARTED|Overall Study||8
11340832|NCT02925403|12538141|FG001|STARTED|Overall Study||5
11340833|NCT02925403|12538140|FG000|COMPLETED|Overall Study||8
11340834|NCT02925403|12538141|FG001|COMPLETED|Overall Study||4
11340835|NCT02925403|12538140|FG000|NOT COMPLETED|Overall Study||0
11340836|NCT02925403|12538141|FG001|NOT COMPLETED|Overall Study||1
11340837|NCT02925455|12538149|FG000|STARTED|Overall Study||9
11340838|NCT02925455|12538150|FG001|STARTED|Overall Study||6
11340839|NCT02925455|12538149|FG000|COMPLETED|Overall Study||7
11340840|NCT02925455|12538150|FG001|COMPLETED|Overall Study||6
11340841|NCT02925455|12538149|FG000|NOT COMPLETED|Overall Study||2
11340842|NCT02925455|12538150|FG001|NOT COMPLETED|Overall Study||0
11340843|NCT02925494|12538160|FG000|STARTED|Treatment Period||59
11340844|NCT02925494|12538161|FG001|STARTED|Treatment Period||58
11340845|NCT02925494|12538162|FG002|STARTED|Treatment Period||98
11340846|NCT02925494|12538163|FG003|STARTED|Treatment Period||218
11340847|NCT02925494|12538160|FG000|COMPLETED|Treatment Period||50
11340848|NCT02925494|12538161|FG001|COMPLETED|Treatment Period||43
11340849|NCT02925494|12538162|FG002|COMPLETED|Treatment Period||79
11340850|NCT02925494|12538163|FG003|COMPLETED|Treatment Period||182
11340851|NCT02925494|12538160|FG000|NOT COMPLETED|Treatment Period||9
11340852|NCT02925494|12538161|FG001|NOT COMPLETED|Treatment Period||15
11340853|NCT02925494|12538162|FG002|NOT COMPLETED|Treatment Period||19
11340854|NCT02925494|12538163|FG003|NOT COMPLETED|Treatment Period||36
11340855|NCT02925494|12538160|FG000|STARTED|Post-Treatment Follow-Up Period||54
11340856|NCT02925494|12538161|FG001|STARTED|Post-Treatment Follow-Up Period||47
11340857|NCT02925494|12538162|FG002|STARTED|Post-Treatment Follow-Up Period||88
11340858|NCT02925494|12538163|FG003|STARTED|Post-Treatment Follow-Up Period||184
11340859|NCT02925494|12538160|FG000|COMPLETED|Post-Treatment Follow-Up Period||40
11340860|NCT02925494|12538161|FG001|COMPLETED|Post-Treatment Follow-Up Period||37
11340861|NCT02925494|12538162|FG002|COMPLETED|Post-Treatment Follow-Up Period||64
11340862|NCT02925494|12538163|FG003|COMPLETED|Post-Treatment Follow-Up Period||134
11340863|NCT02925494|12538160|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||14
11340864|NCT02925494|12538161|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||10
11340865|NCT02925494|12538162|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||24
11340866|NCT02925494|12538163|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||50
11340867|NCT02925611|12538176|FG000|STARTED|Overall Study||30
11340868|NCT02925611|12538177|FG001|STARTED|Overall Study||30
11340869|NCT02925611|12538176|FG000|COMPLETED|Overall Study||30
11340870|NCT02925611|12538177|FG001|COMPLETED|Overall Study||30
11340871|NCT02925611|12538176|FG000|NOT COMPLETED|Overall Study||0
11340872|NCT02925611|12538177|FG001|NOT COMPLETED|Overall Study||0
11340873|NCT02925741|12538185|FG000|STARTED|Overall Study||1637
11340874|NCT02925741|12538186|FG001|STARTED|Overall Study||1706
11340875|NCT02925741|12538185|FG000|COMPLETED|Overall Study||1626
11340876|NCT02925741|12538186|FG001|COMPLETED|Overall Study||1706
11340877|NCT02925741|12538185|FG000|NOT COMPLETED|Overall Study||11
11340878|NCT02925741|12538186|FG001|NOT COMPLETED|Overall Study||0
11340879|NCT02925858|12538197|FG000|STARTED|Overall Study||42
11340880|NCT02925858|12538198|FG001|STARTED|Overall Study||38
11340881|NCT02925858|12538197|FG000|COMPLETED|Overall Study||42
11340882|NCT02925858|12538198|FG001|COMPLETED|Overall Study||38
11340883|NCT02925858|12538197|FG000|NOT COMPLETED|Overall Study||0
11340884|NCT02925858|12538198|FG001|NOT COMPLETED|Overall Study||0
11340885|NCT02925923|12538206|FG000|STARTED|Overall Study||50
11340886|NCT02925923|12538207|FG001|STARTED|Overall Study||50
11340887|NCT02925923|12538206|FG000|COMPLETED|Overall Study||50
11340888|NCT02925923|12538207|FG001|COMPLETED|Overall Study||48
11340889|NCT02925923|12538206|FG000|NOT COMPLETED|Overall Study||0
11340890|NCT02925923|12538207|FG001|NOT COMPLETED|Overall Study||2
11340891|NCT02926027|12538215|FG000|STARTED|Overall Study||40
11340892|NCT02926027|12538216|FG001|STARTED|Overall Study||40
11340893|NCT02926027|12538215|FG000|COMPLETED|Overall Study||31
11340894|NCT02926027|12538216|FG001|COMPLETED|Overall Study||37
11340895|NCT02926027|12538215|FG000|NOT COMPLETED|Overall Study||9
11340896|NCT02926027|12538216|FG001|NOT COMPLETED|Overall Study||3
11340897|NCT02926209|12538222|FG000|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42
11340898|NCT02926209|12538223|FG001|STARTED|Study Cohort||37
11340899|NCT02926209|12538222|FG000|COMPLETED|Study Cohort||41
11340900|NCT02926209|12538223|FG001|COMPLETED|Study Cohort||37
11340901|NCT02926209|12538222|FG000|NOT COMPLETED|Study Cohort||1
11283053|NCT02417441|12479509|FG000|STARTED|Overall Study||645
11283054|NCT02417441|12479510|FG001|STARTED|Overall Study||325
11283055|NCT02417441|12479509|FG000|COMPLETED|Overall Study||593
11283056|NCT02417441|12479510|FG001|COMPLETED|Overall Study||306
11283057|NCT02417441|12479509|FG000|NOT COMPLETED|Overall Study||52
11283058|NCT02417441|12479510|FG001|NOT COMPLETED|Overall Study||19
11283059|NCT02417532|12479517|FG000|STARTED|Overall Study||56
11283060|NCT02417532|12479517|FG000|COMPLETED|Overall Study||56
11283061|NCT02417532|12479517|FG000|NOT COMPLETED|Overall Study||0
11283062|NCT02417753|12479523|FG000|STARTED|Overall Study||1
11283063|NCT02417753|12479523|FG000|COMPLETED|Overall Study||0
11283064|NCT02417753|12479523|FG000|NOT COMPLETED|Overall Study||1
11283065|NCT02417831|12479527|FG000|STARTED|Period 1: Treatment Period 1 + Washout||17
11283066|NCT02417831|12479528|FG001|STARTED|Period 1: Treatment Period 1 + Washout||17
11283067|NCT02417831|12479527|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||17
11283068|NCT02417831|12479528|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||17
11283069|NCT02417831|12479527|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
11283070|NCT02417831|12479528|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
11283071|NCT02417831|12479527|FG000|STARTED|Period 2: Treatment Period 2 + Washout||17
11283072|NCT02417831|12479528|FG001|STARTED|Period 2: Treatment Period 2 + Washout||17
11283073|NCT02417831|12479527|FG000|COMPLETED|Period 2: Treatment Period 2 + Washout||17
11283074|NCT02417831|12479528|FG001|COMPLETED|Period 2: Treatment Period 2 + Washout||17
11283075|NCT02417831|12479527|FG000|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
11283076|NCT02417831|12479528|FG001|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
11283077|NCT02417844|12479534|FG000|STARTED|Overall Study||17
11283078|NCT02417844|12479535|FG001|STARTED|Overall Study||17
11283079|NCT02417844|12479534|FG000|COMPLETED|Overall Study||17
11283080|NCT02417844|12479535|FG001|COMPLETED|Overall Study||17
11283081|NCT02417844|12479534|FG000|NOT COMPLETED|Overall Study||0
11283082|NCT02417844|12479535|FG001|NOT COMPLETED|Overall Study||0
11283083|NCT02417935|12479543|FG000|STARTED|Treatment Period||151
11283084|NCT02417935|12479544|FG001|STARTED|Treatment Period||153
11283085|NCT02417935|12479543|FG000|Received at Least One Dose of Study Drug|Treatment Period||151
11283086|NCT02417935|12479544|FG001|Received at Least One Dose of Study Drug|Treatment Period||152
11283087|NCT02417935|12479543|FG000|COMPLETED|Treatment Period||130
11283088|NCT02417935|12479544|FG001|COMPLETED|Treatment Period||137
11283089|NCT02417935|12479543|FG000|NOT COMPLETED|Treatment Period||21
11399023|NCT04374500|12593541|FG001|STARTED|Overall Study||10
11399024|NCT04374500|12593542|FG002|STARTED|Overall Study||83
11399025|NCT04374500|12593540|FG000|COMPLETED|Overall Study||10
11399026|NCT04374500|12593541|FG001|COMPLETED|Overall Study||10
11399027|NCT04374500|12593542|FG002|COMPLETED|Overall Study||83
11399028|NCT04374500|12593540|FG000|NOT COMPLETED|Overall Study||0
11283090|NCT02417935|12479544|FG001|NOT COMPLETED|Treatment Period||16
11283091|NCT02417935|12479543|FG000|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
11283092|NCT02417935|12479544|FG001|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
11399029|NCT04374500|12593541|FG001|NOT COMPLETED|Overall Study||0
11283093|NCT02417935|12479543|FG000|COMPLETED|Tapering Period||134
11283094|NCT02417935|12479544|FG001|COMPLETED|Tapering Period||142
11283095|NCT02417935|12479543|FG000|NOT COMPLETED|Tapering Period||0
11283096|NCT02417935|12479544|FG001|NOT COMPLETED|Tapering Period||0
11283097|NCT02417961|12479550|FG000|STARTED|Overall Study||116
11283098|NCT02417961|12479550|FG000|COMPLETED|Overall Study||112
11283099|NCT02417961|12479550|FG000|NOT COMPLETED|Overall Study||4
11283100|NCT02418000|12479559|FG000|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7
11399030|NCT04374500|12593542|FG002|NOT COMPLETED|Overall Study||0
11283101|NCT02418000|12479560|FG001|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
11283102|NCT02418000|12479561|FG002|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
11283103|NCT02418000|12479562|FG003|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
11399031|NCT04372186|12593555|FG000|STARTED|Overall Study||249
11283104|NCT02418000|12479563|FG004|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
11283105|NCT02418000|12479559|FG000|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
11283106|NCT02418000|12479560|FG001|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
11283107|NCT02418000|12479561|FG002|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
11283108|NCT02418000|12479562|FG003|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
11283109|NCT02418000|12479563|FG004|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
11283110|NCT02418000|12479559|FG000|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7
11283111|NCT02418000|12479560|FG001|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
11283112|NCT02418000|12479561|FG002|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
11283113|NCT02418000|12479562|FG003|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
11283114|NCT02418000|12479563|FG004|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
11283115|NCT02418000|12479559|FG000|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
11283116|NCT02418000|12479560|FG001|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10
11399032|NCT04372186|12593556|FG001|STARTED|Overall Study||128
11399033|NCT04372186|12593555|FG000|COMPLETED|Overall Study||225
11399034|NCT04372186|12593556|FG001|COMPLETED|Overall Study||115
11399035|NCT04372186|12593555|FG000|NOT COMPLETED|Overall Study||24
11399036|NCT04372186|12593556|FG001|NOT COMPLETED|Overall Study||13
11399037|NCT04371419|12593564|FG000|STARTED|Overall Study||784
11399038|NCT04371419|12593565|FG001|STARTED|Overall Study||791
11399039|NCT04371419|12593566|FG002|STARTED|Overall Study||780
11283117|NCT02418000|12479561|FG002|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
11283118|NCT02418000|12479562|FG003|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
11283119|NCT02418000|12479563|FG004|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
11283120|NCT02418000|12479559|FG000|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
11283121|NCT02418000|12479560|FG001|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
11283122|NCT02418000|12479561|FG002|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
11283123|NCT02418000|12479562|FG003|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
11283124|NCT02418000|12479563|FG004|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
11283125|NCT02418000|12479559|FG000|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
11283126|NCT02418000|12479560|FG001|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10
11283127|NCT02418000|12479561|FG002|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
11283128|NCT02418000|12479562|FG003|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
11283129|NCT02418000|12479563|FG004|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
11283130|NCT02418000|12479559|FG000|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
11283131|NCT02418000|12479560|FG001|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
11283132|NCT02418000|12479561|FG002|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3
11283133|NCT02418000|12479562|FG003|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
11283134|NCT02418000|12479563|FG004|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
11283135|NCT02418000|12479559|FG000|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
11283136|NCT02418000|12479560|FG001|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
11399040|NCT04371419|12593567|FG003|STARTED|Overall Study||778
11399041|NCT04371419|12593568|FG004|STARTED|Overall Study||777
11283137|NCT02418000|12479561|FG002|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
11283138|NCT02418000|12479562|FG003|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
11283139|NCT02418000|12479563|FG004|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
11283140|NCT02418000|12479559|FG000|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
11283141|NCT02418000|12479560|FG001|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
11283142|NCT02418000|12479561|FG002|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3
11283143|NCT02418000|12479562|FG003|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
11283144|NCT02418000|12479563|FG004|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
11283145|NCT02418000|12479559|FG000|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
11283146|NCT02418000|12479560|FG001|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
11283147|NCT02418000|12479561|FG002|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
11283148|NCT02418000|12479562|FG003|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3
11283149|NCT02418000|12479563|FG004|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
11283150|NCT02418000|12479559|FG000|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
11283151|NCT02418000|12479560|FG001|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
11283152|NCT02418000|12479561|FG002|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
11283153|NCT02418000|12479562|FG003|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
11283154|NCT02418000|12479563|FG004|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
11283155|NCT02418000|12479559|FG000|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
11283156|NCT02418000|12479560|FG001|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
11283157|NCT02418000|12479561|FG002|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
11283158|NCT02418000|12479562|FG003|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3
11283159|NCT02418000|12479563|FG004|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
11283160|NCT02418000|12479559|FG000|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
11283161|NCT02418000|12479560|FG001|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
11283162|NCT02418000|12479561|FG002|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
11283163|NCT02418000|12479562|FG003|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
11283164|NCT02418000|12479563|FG004|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4
11283165|NCT02418000|12479559|FG000|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
11283166|NCT02418000|12479560|FG001|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
11283167|NCT02418000|12479561|FG002|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
11283168|NCT02418000|12479562|FG003|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
11283169|NCT02418000|12479563|FG004|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
11283170|NCT02418000|12479559|FG000|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
11283171|NCT02418000|12479560|FG001|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
11283172|NCT02418000|12479561|FG002|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
11283173|NCT02418000|12479562|FG003|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
11283174|NCT02418000|12479563|FG004|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4
11283175|NCT02418026|12479589|FG000|STARTED|Overall Study||44
11283176|NCT02418026|12479590|FG001|STARTED|Overall Study||35
11283177|NCT02418026|12479589|FG000|COMPLETED|Overall Study||44
11283178|NCT02418026|12479590|FG001|COMPLETED|Overall Study||35
11283179|NCT02418026|12479589|FG000|NOT COMPLETED|Overall Study||0
11283180|NCT02418026|12479590|FG001|NOT COMPLETED|Overall Study||0
11283181|NCT02418156|12479596|FG000|STARTED|Overall Study||38
11283182|NCT02418156|12479596|FG000|COMPLETED|Overall Study||21
11283183|NCT02418156|12479596|FG000|NOT COMPLETED|Overall Study||17
11283184|NCT02418182|12479602|FG000|STARTED|Overall Study||49
11283185|NCT02418182|12479603|FG001|STARTED|Overall Study||50
11283186|NCT02418182|12479602|FG000|COMPLETED|Overall Study||31
11283187|NCT02418182|12479603|FG001|COMPLETED|Overall Study||33
11283188|NCT02418182|12479602|FG000|NOT COMPLETED|Overall Study||18
11283189|NCT02418182|12479603|FG001|NOT COMPLETED|Overall Study||17
11283190|NCT02418234|12479609|FG000|STARTED|Overall Study||314
11283191|NCT02418234|12479609|FG000|COMPLETED|Overall Study||314
11283192|NCT02418234|12479609|FG000|NOT COMPLETED|Overall Study||0
11283193|NCT02418312|12479619|FG000|STARTED|Overall Study||114
11283194|NCT02418312|12479620|FG001|STARTED|Overall Study||114
11283195|NCT02418312|12479619|FG000|COMPLETED|Overall Study||114
11283196|NCT02418312|12479620|FG001|COMPLETED|Overall Study||114
11283197|NCT02418312|12479619|FG000|NOT COMPLETED|Overall Study||0
11283198|NCT02418312|12479620|FG001|NOT COMPLETED|Overall Study||0
11283199|NCT02418455|12479626|FG000|STARTED|48-Week Treatment Period||8
11283200|NCT02418455|12479626|FG000|Emergency IND (eIND)|48-Week Treatment Period||1
11283201|NCT02418455|12479626|FG000|COMPLETED|48-Week Treatment Period||7
11283202|NCT02418455|12479626|FG000|NOT COMPLETED|48-Week Treatment Period||1
11283203|NCT02418455|12479626|FG000|STARTED|Continuation Period||7
11283204|NCT02418455|12479626|FG000|COMPLETED|Continuation Period||0
11283205|NCT02418455|12479626|FG000|NOT COMPLETED|Continuation Period||7
11283206|NCT02418468|12479634|FG000|STARTED|Overall Study||13
11283207|NCT02418468|12479635|FG001|STARTED|Overall Study||11
11283208|NCT02418468|12479634|FG000|COMPLETED|Overall Study||11
11399042|NCT04371419|12593569|FG005|STARTED|Overall Study||788
11399043|NCT04371419|12593570|FG006|STARTED|Overall Study||783
11399044|NCT04371419|12593571|FG007|STARTED|Overall Study||788
11399045|NCT04371419|12593572|FG008|STARTED|Overall Study||779
11399046|NCT04371419|12593573|FG009|STARTED|Overall Study||780
11283209|NCT02418468|12479635|FG001|COMPLETED|Overall Study||10
11283210|NCT02418468|12479634|FG000|NOT COMPLETED|Overall Study||2
11283211|NCT02418468|12479635|FG001|NOT COMPLETED|Overall Study||1
11283212|NCT02418546|12479644|FG000|STARTED|Overall Study||26
11283213|NCT02418546|12479645|FG001|STARTED|Overall Study||26
11399047|NCT04371419|12593574|FG010|STARTED|Overall Study||782
11283214|NCT02418546|12479646|FG002|STARTED|Overall Study||26
11283215|NCT02418546|12479644|FG000|COMPLETED|Overall Study||19
11283216|NCT02418546|12479645|FG001|COMPLETED|Overall Study||20
11283217|NCT02418546|12479646|FG002|COMPLETED|Overall Study||23
11283218|NCT02418546|12479644|FG000|NOT COMPLETED|Overall Study||7
11283219|NCT02418546|12479645|FG001|NOT COMPLETED|Overall Study||6
11283220|NCT02418546|12479646|FG002|NOT COMPLETED|Overall Study||3
11283221|NCT02418585|12479656|FG000|STARTED|Double Blind (DB) Phase (4 Weeks)||116
11283222|NCT02418585|12479657|FG001|STARTED|Double Blind (DB) Phase (4 Weeks)||111
11283223|NCT02418585|12479656|FG000|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115
11283224|NCT02418585|12479657|FG001|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
11283225|NCT02418585|12479656|FG000|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114
11283226|NCT02418585|12479657|FG001|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
11283227|NCT02418585|12479656|FG000|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98
11283228|NCT02418585|12479657|FG001|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99
11283229|NCT02418585|12479656|FG000|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18
11283230|NCT02418585|12479657|FG001|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12
11283231|NCT02418585|12479656|FG000|STARTED|Follow-up Phase (24 Weeks)||34
11283232|NCT02418585|12479657|FG001|STARTED|Follow-up Phase (24 Weeks)||52
11283233|NCT02418585|12479656|FG000|COMPLETED|Follow-up Phase (24 Weeks)||16
11283234|NCT02418585|12479657|FG001|COMPLETED|Follow-up Phase (24 Weeks)||27
11283235|NCT02418585|12479656|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||18
11283236|NCT02418585|12479657|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||25
11283237|NCT02418676|12479668|FG000|STARTED|Overall Study||5
11283238|NCT02418676|12479669|FG001|STARTED|Overall Study||5
11283239|NCT02418676|12479670|FG002|STARTED|Overall Study||5
11283240|NCT02418676|12479668|FG000|COMPLETED|Overall Study||5
11283241|NCT02418676|12479669|FG001|COMPLETED|Overall Study||5
11283242|NCT02418676|12479670|FG002|COMPLETED|Overall Study||5
11283243|NCT02418676|12479668|FG000|NOT COMPLETED|Overall Study||0
11283244|NCT02418676|12479669|FG001|NOT COMPLETED|Overall Study||0
11283245|NCT02418676|12479670|FG002|NOT COMPLETED|Overall Study||0
11283246|NCT02418754|12479681|FG000|STARTED|Period 1 (Day 1 to Week 12)||103
11283247|NCT02418754|12479682|FG001|STARTED|Period 1 (Day 1 to Week 12)||200
11283248|NCT02418754|12479683|FG002|STARTED|Period 1 (Day 1 to Week 12)||202
11283249|NCT02418754|12479684|FG003|STARTED|Period 1 (Day 1 to Week 12)||0
11399048|NCT04371419|12593575|FG011|STARTED|Overall Study||790
11283250|NCT02418754|12479685|FG004|STARTED|Period 1 (Day 1 to Week 12)||0
11399049|NCT04371419|12593576|FG012|STARTED|Overall Study||779
11399050|NCT04371419|12593577|FG013|STARTED|Overall Study||786
11399051|NCT04371419|12593578|FG014|STARTED|Overall Study||781
11399052|NCT04371419|12593579|FG015|STARTED|Overall Study||781
11399053|NCT04371419|12593580|FG016|STARTED|Overall Study||1617
11399054|NCT04371419|12593564|FG000|Completed the Knowledge Questions|Overall Study||663
11399055|NCT04371419|12593565|FG001|Completed the Knowledge Questions|Overall Study||669
11399056|NCT04371419|12593566|FG002|Completed the Knowledge Questions|Overall Study||673
11283251|NCT02418754|12479681|FG000|COMPLETED|Period 1 (Day 1 to Week 12)||101
11283252|NCT02418754|12479682|FG001|COMPLETED|Period 1 (Day 1 to Week 12)||196
11283253|NCT02418754|12479683|FG002|COMPLETED|Period 1 (Day 1 to Week 12)||200
11283254|NCT02418754|12479684|FG003|COMPLETED|Period 1 (Day 1 to Week 12)||0
11283255|NCT02418754|12479685|FG004|COMPLETED|Period 1 (Day 1 to Week 12)||0
11283256|NCT02418754|12479681|FG000|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
11283257|NCT02418754|12479682|FG001|NOT COMPLETED|Period 1 (Day 1 to Week 12)||4
11283258|NCT02418754|12479683|FG002|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
11283259|NCT02418754|12479684|FG003|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
11283260|NCT02418754|12479685|FG004|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
11283261|NCT02418754|12479681|FG000|STARTED|Period 2 (Day 1 to Week 52/End of Study)||103
11283262|NCT02418754|12479682|FG001|STARTED|Period 2 (Day 1 to Week 52/End of Study)||106
11283263|NCT02418754|12479683|FG002|STARTED|Period 2 (Day 1 to Week 52/End of Study)||108
11283264|NCT02418754|12479684|FG003|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
11283265|NCT02418754|12479685|FG004|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
11283266|NCT02418754|12479681|FG000|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||70
11283267|NCT02418754|12479682|FG001|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||64
11283268|NCT02418754|12479683|FG002|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||71
11283269|NCT02418754|12479684|FG003|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
11283270|NCT02418754|12479685|FG004|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
11283271|NCT02418754|12479681|FG000|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||33
11283272|NCT02418754|12479682|FG001|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||42
11283273|NCT02418754|12479683|FG002|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||37
11283274|NCT02418754|12479684|FG003|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
11283275|NCT02418754|12479685|FG004|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
11283276|NCT02418819|12479699|FG000|STARTED|Overall Study||22
11283277|NCT02418819|12479700|FG001|STARTED|Overall Study||16
11283278|NCT02418819|12479701|FG002|STARTED|Overall Study||33
11283279|NCT02418819|12479702|FG003|STARTED|Overall Study||29
11283280|NCT02418819|12479699|FG000|COMPLETED|Overall Study||21
11283281|NCT02418819|12479700|FG001|COMPLETED|Overall Study||16
11283282|NCT02418819|12479701|FG002|COMPLETED|Overall Study||29
11283283|NCT02418819|12479702|FG003|COMPLETED|Overall Study||28
11283284|NCT02418819|12479699|FG000|NOT COMPLETED|Overall Study||1
11283285|NCT02418819|12479700|FG001|NOT COMPLETED|Overall Study||0
11283286|NCT02418819|12479701|FG002|NOT COMPLETED|Overall Study||4
11283287|NCT02418819|12479702|FG003|NOT COMPLETED|Overall Study||1
11283288|NCT02418845|12479714|FG000|STARTED|Overall Study||125
11283289|NCT02418845|12479715|FG001|STARTED|Overall Study||64
11283290|NCT02418845|12479714|FG000|COMPLETED|Overall Study||109
11283291|NCT02418845|12479715|FG001|COMPLETED|Overall Study||52
11283292|NCT02418845|12479714|FG000|NOT COMPLETED|Overall Study||16
11283293|NCT02418845|12479715|FG001|NOT COMPLETED|Overall Study||12
11283294|NCT02418910|12479721|FG000|STARTED|Overall Study||50
11283295|NCT02418910|12479721|FG000|COMPLETED|Overall Study||43
11283296|NCT02418910|12479721|FG000|NOT COMPLETED|Overall Study||7
11283297|NCT02418949|12479729|FG000|STARTED|Overall Study||23
11283298|NCT02418949|12479730|FG001|STARTED|Overall Study||22
11283299|NCT02418949|12479731|FG002|STARTED|Overall Study||26
11399057|NCT04371419|12593567|FG003|Completed the Knowledge Questions|Overall Study||664
11399058|NCT04371419|12593568|FG004|Completed the Knowledge Questions|Overall Study||666
11283300|NCT02418949|12479732|FG003|STARTED|Overall Study||25
11283301|NCT02418949|12479729|FG000|COMPLETED|Overall Study||20
11283302|NCT02418949|12479730|FG001|COMPLETED|Overall Study||21
11283303|NCT02418949|12479731|FG002|COMPLETED|Overall Study||23
11283304|NCT02418949|12479732|FG003|COMPLETED|Overall Study||24
11283305|NCT02418949|12479729|FG000|NOT COMPLETED|Overall Study||3
11283306|NCT02418949|12479730|FG001|NOT COMPLETED|Overall Study||1
11283307|NCT02418949|12479731|FG002|NOT COMPLETED|Overall Study||3
11283308|NCT02418949|12479732|FG003|NOT COMPLETED|Overall Study||1
11283309|NCT02419001|12479744|FG000|STARTED|Period 1- Ceftriaxone Without SYN-004||6
11283310|NCT02419001|12479745|FG001|STARTED|Period 1- Ceftriaxone Without SYN-004||5
11283311|NCT02419001|12479744|FG000|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
11283312|NCT02419001|12479745|FG001|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
11283313|NCT02419001|12479744|FG000|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
11283314|NCT02419001|12479745|FG001|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
11283315|NCT02419001|12479744|FG000|STARTED|Period 2- Ceftriaxone With SYN-004||5
11283316|NCT02419001|12479745|FG001|STARTED|Period 2- Ceftriaxone With SYN-004||5
11283317|NCT02419001|12479744|FG000|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
11283318|NCT02419001|12479745|FG001|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
11283319|NCT02419001|12479744|FG000|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
11283320|NCT02419001|12479745|FG001|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
11283321|NCT02419313|12479751|FG000|STARTED|First Intervention||18
11283322|NCT02419313|12479752|FG001|STARTED|First Intervention||15
11283323|NCT02419313|12479751|FG000|COMPLETED|First Intervention||16
11283324|NCT02419313|12479752|FG001|COMPLETED|First Intervention||15
11283325|NCT02419313|12479751|FG000|NOT COMPLETED|First Intervention||2
11283326|NCT02419313|12479752|FG001|NOT COMPLETED|First Intervention||0
11283327|NCT02419313|12479751|FG000|STARTED|Second Intervention||16
11283328|NCT02419313|12479752|FG001|STARTED|Second Intervention||15
11283329|NCT02419313|12479751|FG000|COMPLETED|Second Intervention||15
11283330|NCT02419313|12479752|FG001|COMPLETED|Second Intervention||15
11283331|NCT02419313|12479751|FG000|NOT COMPLETED|Second Intervention||1
11283332|NCT02419313|12479752|FG001|NOT COMPLETED|Second Intervention||0
11283333|NCT02419469|12479758|FG000|STARTED|Overall Study||1
11283334|NCT02419469|12479758|FG000|COMPLETED|Overall Study||0
11283335|NCT02419469|12479758|FG000|NOT COMPLETED|Overall Study||1
11283336|NCT02419508|12479764|FG000|STARTED|Overall Study||96
11283337|NCT02419508|12479765|FG001|STARTED|Overall Study||92
11283338|NCT02419508|12479764|FG000|Full Analysis Set|Overall Study||95
11283339|NCT02419508|12479765|FG001|Full Analysis Set|Overall Study||92
11283340|NCT02419508|12479764|FG000|Safety Analysis Set|Overall Study||95
11283341|NCT02419508|12479765|FG001|Safety Analysis Set|Overall Study||92
11283342|NCT02419508|12479764|FG000|COMPLETED|Overall Study||86
11283343|NCT02419508|12479765|FG001|COMPLETED|Overall Study||88
11283344|NCT02419508|12479764|FG000|NOT COMPLETED|Overall Study||10
11283345|NCT02419508|12479765|FG001|NOT COMPLETED|Overall Study||4
11283346|NCT02419521|12479771|FG000|STARTED|Overall Study||75
11283347|NCT02419521|12479771|FG000|COMPLETED|Overall Study||74
11283348|NCT02419521|12479771|FG000|NOT COMPLETED|Overall Study||1
11283349|NCT02419547|12479775|FG000|STARTED|Overall Study||11
11283350|NCT02419547|12479775|FG000|COMPLETED|Overall Study||11
11283351|NCT02419547|12479775|FG000|NOT COMPLETED|Overall Study||0
11283352|NCT02419573|12479781|FG000|STARTED|Overall Study||1499
11283353|NCT02419573|12479782|FG001|STARTED|Overall Study||1505
11283354|NCT02419573|12479781|FG000|COMPLETED|Overall Study||1495
11283355|NCT02419573|12479782|FG001|COMPLETED|Overall Study||1505
11283356|NCT02419573|12479781|FG000|NOT COMPLETED|Overall Study||4
11283357|NCT02419573|12479782|FG001|NOT COMPLETED|Overall Study||0
11283358|NCT02419612|12479790|FG000|STARTED|Short-term Treatment Period||227
11283359|NCT02419612|12479791|FG001|STARTED|Short-term Treatment Period||217
11283360|NCT02419612|12479790|FG000|Recevied Treatment|Short-term Treatment Period||227
11283361|NCT02419612|12479791|FG001|Recevied Treatment|Short-term Treatment Period||216
11283362|NCT02419612|12479790|FG000|COMPLETED|Short-term Treatment Period||210
11283363|NCT02419612|12479791|FG001|COMPLETED|Short-term Treatment Period||194
11283364|NCT02419612|12479790|FG000|NOT COMPLETED|Short-term Treatment Period||17
11283365|NCT02419612|12479791|FG001|NOT COMPLETED|Short-term Treatment Period||23
11283366|NCT02419612|12479790|FG000|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|196
11283367|NCT02419612|12479791|FG001|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|186
11283368|NCT02419612|12479790|FG000|Received Treatment|Long-term Treatment Period||196
11283369|NCT02419612|12479791|FG001|Received Treatment|Long-term Treatment Period||183
11283370|NCT02419612|12479790|FG000|COMPLETED|Long-term Treatment Period||174
11399059|NCT04371419|12593569|FG005|Completed the Knowledge Questions|Overall Study||683
11283371|NCT02419612|12479791|FG001|COMPLETED|Long-term Treatment Period||164
11283372|NCT02419612|12479790|FG000|NOT COMPLETED|Long-term Treatment Period||22
11283373|NCT02419612|12479791|FG001|NOT COMPLETED|Long-term Treatment Period||22
11283374|NCT02419690|12479799|FG000|STARTED|Overall Study||122
11283375|NCT02419690|12479800|FG001|STARTED|Overall Study||122
11283376|NCT02419690|12479799|FG000|COMPLETED|Overall Study||122
11283377|NCT02419690|12479800|FG001|COMPLETED|Overall Study||122
11283378|NCT02419690|12479799|FG000|NOT COMPLETED|Overall Study||0
11283379|NCT02419690|12479800|FG001|NOT COMPLETED|Overall Study||0
11283380|NCT02419755|12479808|FG000|STARTED|Overall Study||6
11283381|NCT02419755|12479809|FG001|STARTED|Overall Study||6
11283382|NCT02419755|12479808|FG000|COMPLETED|Overall Study||3
11283383|NCT02419755|12479809|FG001|COMPLETED|Overall Study||2
11283384|NCT02419755|12479808|FG000|NOT COMPLETED|Overall Study||3
11283385|NCT02419755|12479809|FG001|NOT COMPLETED|Overall Study||4
11283386|NCT02419924|12479815|FG000|STARTED|Overall Study||12
11283387|NCT02419924|12479815|FG000|COMPLETED|Overall Study||12
11283388|NCT02419924|12479815|FG000|NOT COMPLETED|Overall Study||0
11283389|NCT02419937|12479821|FG000|STARTED|Overall Study||12
11283390|NCT02419937|12479822|FG001|STARTED|Overall Study||16
11283391|NCT02419937|12479821|FG000|COMPLETED|Overall Study||11
11283392|NCT02419937|12479822|FG001|COMPLETED|Overall Study||16
11283393|NCT02419937|12479821|FG000|NOT COMPLETED|Overall Study||1
11283394|NCT02419937|12479822|FG001|NOT COMPLETED|Overall Study||0
11283395|NCT02420015|12479830|FG000|STARTED|Overall Study||21
11283396|NCT02420015|12479831|FG001|STARTED|Overall Study||13
11283397|NCT02420015|12479830|FG000|COMPLETED|Overall Study||21
11283398|NCT02420015|12479831|FG001|COMPLETED|Overall Study||13
11283399|NCT02420015|12479830|FG000|NOT COMPLETED|Overall Study||0
11283400|NCT02420015|12479831|FG001|NOT COMPLETED|Overall Study||0
11283401|NCT02420041|12479839|FG000|STARTED|Overall Study||14
11283402|NCT02420041|12479840|FG001|STARTED|Overall Study||14
11283403|NCT02420041|12479839|FG000|COMPLETED|Overall Study||14
11283404|NCT02420041|12479840|FG001|COMPLETED|Overall Study||14
11283405|NCT02420041|12479839|FG000|NOT COMPLETED|Overall Study||0
11283406|NCT02420041|12479840|FG001|NOT COMPLETED|Overall Study||0
11283407|NCT02420093|12479848|FG000|STARTED|Overall Study||9
11283408|NCT02420093|12479849|FG001|STARTED|Overall Study||8
11283409|NCT02420093|12479848|FG000|COMPLETED|Overall Study||8
11283410|NCT02420093|12479849|FG001|COMPLETED|Overall Study||7
11283411|NCT02420093|12479848|FG000|NOT COMPLETED|Overall Study||1
11283412|NCT02420093|12479849|FG001|NOT COMPLETED|Overall Study||1
11283413|NCT02420210|12479855|FG000|STARTED|Overall Study||2
11283414|NCT02420210|12479855|FG000|COMPLETED|Overall Study||2
11283415|NCT02420210|12479855|FG000|NOT COMPLETED|Overall Study||0
11283416|NCT02420223|12479861|FG000|STARTED|Overall Study||12
11283417|NCT02420223|12479862|FG001|STARTED|Overall Study||13
11283418|NCT02420223|12479861|FG000|COMPLETED|Overall Study||11
11283419|NCT02420223|12479862|FG001|COMPLETED|Overall Study||11
11283420|NCT02420223|12479861|FG000|NOT COMPLETED|Overall Study||1
11283421|NCT02420223|12479862|FG001|NOT COMPLETED|Overall Study||2
11283422|NCT02420262|12479870|FG000|STARTED|Overall Study||252
11283423|NCT02420262|12479871|FG001|STARTED|Overall Study||254
11283424|NCT02420262|12479870|FG000|Exposed|Overall Study||252
11283425|NCT02420262|12479871|FG001|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
11283426|NCT02420262|12479870|FG000|COMPLETED|Overall Study||250
11283427|NCT02420262|12479871|FG001|COMPLETED|Overall Study||249
11283428|NCT02420262|12479870|FG000|NOT COMPLETED|Overall Study||2
11283429|NCT02420262|12479871|FG001|NOT COMPLETED|Overall Study||5
11283430|NCT02420327|12479877|FG000|STARTED|Overall Study||43
11283431|NCT02420327|12479877|FG000|COMPLETED|Overall Study||27
11283432|NCT02420327|12479877|FG000|NOT COMPLETED|Overall Study||16
11283433|NCT02420353|12479889|FG000|STARTED|Overall Study||10
11283434|NCT02420353|12479890|FG001|STARTED|Overall Study||10
11283435|NCT02420353|12479889|FG000|Allocation to Intervention|Overall Study||10
11283436|NCT02420353|12479890|FG001|Allocation to Intervention|Overall Study||10
11283437|NCT02420353|12479889|FG000|COMPLETED|Overall Study||10
11283438|NCT02420353|12479890|FG001|COMPLETED|Overall Study||9
11283439|NCT02420353|12479889|FG000|NOT COMPLETED|Overall Study||0
11283440|NCT02420353|12479890|FG001|NOT COMPLETED|Overall Study||1
11283441|NCT02420379|12479898|FG000|STARTED|Overall Study||26
11283442|NCT02420379|12479899|FG001|STARTED|Overall Study||7
11283443|NCT02420379|12479898|FG000|COMPLETED|Overall Study||25
11283444|NCT02420379|12479899|FG001|COMPLETED|Overall Study||3
11283445|NCT02420379|12479898|FG000|NOT COMPLETED|Overall Study||1
11283446|NCT02420379|12479899|FG001|NOT COMPLETED|Overall Study||4
11283447|NCT02420639|12479905|FG000|STARTED|Overall Study|Study obtained 12 patients|12
11283448|NCT02420639|12479905|FG000|COMPLETED|Overall Study|Total of 12 patients enrolled|12
11399060|NCT04371419|12593570|FG006|Completed the Knowledge Questions|Overall Study||664
11399061|NCT04371419|12593571|FG007|Completed the Knowledge Questions|Overall Study||679
11399062|NCT04371419|12593572|FG008|Completed the Knowledge Questions|Overall Study||670
11283449|NCT02420639|12479905|FG000|NOT COMPLETED|Overall Study||0
11283450|NCT02420691|12479909|FG000|STARTED|Overall Study||20
11283451|NCT02420691|12479909|FG000|COMPLETED|Overall Study||14
11283452|NCT02420691|12479909|FG000|NOT COMPLETED|Overall Study||6
11283453|NCT02420873|12479916|FG000|STARTED|Overall Study||9
11283454|NCT02420873|12479917|FG001|STARTED|Overall Study||0
11283455|NCT02420873|12479918|FG002|STARTED|Overall Study||0
11283456|NCT02420873|12479916|FG000|COMPLETED|Overall Study||9
11283457|NCT02420873|12479917|FG001|COMPLETED|Overall Study||0
11283458|NCT02420873|12479918|FG002|COMPLETED|Overall Study||0
11283459|NCT02420873|12479916|FG000|NOT COMPLETED|Overall Study||0
11283460|NCT02420873|12479917|FG001|NOT COMPLETED|Overall Study||0
11283461|NCT02420873|12479918|FG002|NOT COMPLETED|Overall Study||0
11283462|NCT02420951|12479928|FG000|STARTED|Overall Study||25
11283463|NCT02420951|12479929|FG001|STARTED|Overall Study||25
11283464|NCT02420951|12479928|FG000|COMPLETED|Overall Study||25
11283465|NCT02420951|12479929|FG001|COMPLETED|Overall Study||25
11283466|NCT02420951|12479928|FG000|NOT COMPLETED|Overall Study||0
11283467|NCT02420951|12479929|FG001|NOT COMPLETED|Overall Study||0
11283468|NCT02421055|12479937|FG000|STARTED|Overall Study||34
11283469|NCT02421055|12479938|FG001|STARTED|Overall Study||50
11283470|NCT02421055|12479939|FG002|STARTED|Overall Study||74
11283471|NCT02421055|12479937|FG000|Pre-operative Serum Sample (Minimum)|Overall Study||34
11283472|NCT02421055|12479938|FG001|Pre-operative Serum Sample (Minimum)|Overall Study||50
11283473|NCT02421055|12479939|FG002|Pre-operative Serum Sample (Minimum)|Overall Study||74
11283474|NCT02421055|12479937|FG000|Pre-operative Complete Sample Set|Overall Study||23
11283475|NCT02421055|12479938|FG001|Pre-operative Complete Sample Set|Overall Study||22
11283476|NCT02421055|12479939|FG002|Pre-operative Complete Sample Set|Overall Study||36
11283477|NCT02421055|12479937|FG000|Post-operative Serum Sample (Minimum)|Overall Study||0
11283478|NCT02421055|12479938|FG001|Post-operative Serum Sample (Minimum)|Overall Study||23
11283479|NCT02421055|12479939|FG002|Post-operative Serum Sample (Minimum)|Overall Study||26
11283480|NCT02421055|12479937|FG000|Post-operative Complete Sample Set|Overall Study||0
11283481|NCT02421055|12479938|FG001|Post-operative Complete Sample Set|Overall Study||13
11283482|NCT02421055|12479939|FG002|Post-operative Complete Sample Set|Overall Study||14
11283483|NCT02421055|12479937|FG000|COMPLETED|Overall Study||0
11283484|NCT02421055|12479938|FG001|COMPLETED|Overall Study||50
11283485|NCT02421055|12479939|FG002|COMPLETED|Overall Study||74
11283486|NCT02421055|12479937|FG000|NOT COMPLETED|Overall Study||34
11283487|NCT02421055|12479938|FG001|NOT COMPLETED|Overall Study||0
11283488|NCT02421055|12479939|FG002|NOT COMPLETED|Overall Study||0
11283489|NCT02421094|12479950|FG000|STARTED|Overall Study||15
11283490|NCT02421094|12479951|FG001|STARTED|Overall Study||15
11283491|NCT02421094|12479950|FG000|COMPLETED|Overall Study||15
11283492|NCT02421094|12479951|FG001|COMPLETED|Overall Study||15
11283493|NCT02421094|12479950|FG000|NOT COMPLETED|Overall Study||0
11283494|NCT02421094|12479951|FG001|NOT COMPLETED|Overall Study||0
11283495|NCT02421120|12479957|FG000|STARTED|Overall Study||21
11283496|NCT02421120|12479957|FG000|COMPLETED|Overall Study||20
11283497|NCT02421120|12479957|FG000|NOT COMPLETED|Overall Study||1
11283498|NCT02421146|12479965|FG000|STARTED|Overall Study||2
11283499|NCT02421146|12479966|FG001|STARTED|Overall Study||4
11283500|NCT02421146|12479967|FG002|STARTED|Overall Study||3
11283501|NCT02421146|12479968|FG003|STARTED|Overall Study||3
11283502|NCT02421146|12479965|FG000|COMPLETED|Overall Study||2
11283503|NCT02421146|12479966|FG001|COMPLETED|Overall Study||4
11283504|NCT02421146|12479967|FG002|COMPLETED|Overall Study||3
11283505|NCT02421146|12479968|FG003|COMPLETED|Overall Study||3
11283506|NCT02421146|12479965|FG000|NOT COMPLETED|Overall Study||0
11283507|NCT02421146|12479966|FG001|NOT COMPLETED|Overall Study||0
11283508|NCT02421146|12479967|FG002|NOT COMPLETED|Overall Study||0
11283509|NCT02421146|12479968|FG003|NOT COMPLETED|Overall Study||0
11283510|NCT02421211|12479980|FG000|STARTED|Overall Study||20
11283511|NCT02421211|12479981|FG001|STARTED|Overall Study||20
11283512|NCT02421211|12479980|FG000|COMPLETED|Overall Study||20
11283513|NCT02421211|12479981|FG001|COMPLETED|Overall Study||20
11283514|NCT02421211|12479980|FG000|NOT COMPLETED|Overall Study||0
11283515|NCT02421211|12479981|FG001|NOT COMPLETED|Overall Study||0
11283516|NCT02421224|12480000|FG000|STARTED|Overall Study||444
11283517|NCT02421224|12480001|FG001|STARTED|Overall Study||397
11283518|NCT02421224|12480002|FG002|STARTED|Overall Study||508
11283519|NCT02421224|12480003|FG003|STARTED|Overall Study||482
11283520|NCT02421224|12480004|FG004|STARTED|Overall Study||495
11283521|NCT02421224|12480005|FG005|STARTED|Overall Study||515
11283522|NCT02421224|12480006|FG006|STARTED|Overall Study||489
11283523|NCT02421224|12480007|FG007|STARTED|Overall Study||364
11283524|NCT02421224|12480008|FG008|STARTED|Overall Study||496
11283525|NCT02421224|12480000|FG000|COMPLETED|Overall Study||442
11283526|NCT02421224|12480001|FG001|COMPLETED|Overall Study||394
11283527|NCT02421224|12480002|FG002|COMPLETED|Overall Study||507
11283528|NCT02421224|12480003|FG003|COMPLETED|Overall Study||479
11283529|NCT02421224|12480004|FG004|COMPLETED|Overall Study||491
11283530|NCT02421224|12480005|FG005|COMPLETED|Overall Study||513
11283531|NCT02421224|12480006|FG006|COMPLETED|Overall Study||489
11283532|NCT02421224|12480007|FG007|COMPLETED|Overall Study||362
11283533|NCT02421224|12480008|FG008|COMPLETED|Overall Study||495
11283534|NCT02421224|12480000|FG000|NOT COMPLETED|Overall Study||2
11283535|NCT02421224|12480001|FG001|NOT COMPLETED|Overall Study||3
11399063|NCT04371419|12593573|FG009|Completed the Knowledge Questions|Overall Study||655
11399064|NCT04371419|12593574|FG010|Completed the Knowledge Questions|Overall Study||656
11399065|NCT04371419|12593575|FG011|Completed the Knowledge Questions|Overall Study||692
11399066|NCT04371419|12593576|FG012|Completed the Knowledge Questions|Overall Study||664
11399067|NCT04371419|12593577|FG013|Completed the Knowledge Questions|Overall Study||687
11399068|NCT04371419|12593578|FG014|Completed the Knowledge Questions|Overall Study||652
11283536|NCT02421224|12480002|FG002|NOT COMPLETED|Overall Study||1
11283537|NCT02421224|12480003|FG003|NOT COMPLETED|Overall Study||3
11283538|NCT02421224|12480004|FG004|NOT COMPLETED|Overall Study||4
11283539|NCT02421224|12480005|FG005|NOT COMPLETED|Overall Study||2
11283540|NCT02421224|12480006|FG006|NOT COMPLETED|Overall Study||0
11283541|NCT02421224|12480007|FG007|NOT COMPLETED|Overall Study||2
11283542|NCT02421224|12480008|FG008|NOT COMPLETED|Overall Study||1
11283543|NCT02421354|12480028|FG000|STARTED|Overall Study||8
11283544|NCT02421354|12480028|FG000|COMPLETED|Overall Study||8
11283545|NCT02421354|12480028|FG000|NOT COMPLETED|Overall Study||0
11283546|NCT02421419|12480035|FG000|STARTED|Overall Study||6
11283547|NCT02421419|12480036|FG001|STARTED|Overall Study||11
11283548|NCT02421419|12480037|FG002|STARTED|Overall Study||9
11283549|NCT02421419|12480035|FG000|COMPLETED|Overall Study||6
11283550|NCT02421419|12480036|FG001|COMPLETED|Overall Study||11
11283551|NCT02421419|12480037|FG002|COMPLETED|Overall Study||8
11283552|NCT02421419|12480035|FG000|NOT COMPLETED|Overall Study||0
11283553|NCT02421419|12480036|FG001|NOT COMPLETED|Overall Study||0
11283554|NCT02421419|12480037|FG002|NOT COMPLETED|Overall Study||1
11283555|NCT02421510|12480048|FG000|STARTED|Overall Study||258
11283556|NCT02421510|12480049|FG001|STARTED|Overall Study||261
11283557|NCT02421510|12480050|FG002|STARTED|Overall Study||263
11283558|NCT02421510|12480048|FG000|Completed the 24 Week Treatment Period|Overall Study||236
11283559|NCT02421510|12480049|FG001|Completed the 24 Week Treatment Period|Overall Study||239
11283560|NCT02421510|12480050|FG002|Completed the 24 Week Treatment Period|Overall Study||240
11283561|NCT02421510|12480048|FG000|COMPLETED|Overall Study||225
11283562|NCT02421510|12480049|FG001|COMPLETED|Overall Study||226
11283563|NCT02421510|12480050|FG002|COMPLETED|Overall Study||227
11283564|NCT02421510|12480048|FG000|NOT COMPLETED|Overall Study||33
11283565|NCT02421510|12480049|FG001|NOT COMPLETED|Overall Study||35
11283566|NCT02421510|12480050|FG002|NOT COMPLETED|Overall Study||36
11283567|NCT02421588|12480060|FG000|STARTED|Overall Study||221
11283568|NCT02421588|12480061|FG001|STARTED|Overall Study||221
11283569|NCT02421588|12480060|FG000|COMPLETED|Overall Study||0
11283570|NCT02421588|12480061|FG001|COMPLETED|Overall Study||0
11283571|NCT02421588|12480060|FG000|NOT COMPLETED|Overall Study||221
11283572|NCT02421588|12480061|FG001|NOT COMPLETED|Overall Study||221
11283573|NCT02421601|12480067|FG000|STARTED|Overall Study||991
11283574|NCT02421601|12480067|FG000|COMPLETED|Overall Study||909
11283575|NCT02421601|12480067|FG000|NOT COMPLETED|Overall Study||82
11283576|NCT02421666|12480073|FG000|STARTED|Overall Study Baseline||272
11283577|NCT02421666|12480074|FG001|STARTED|Overall Study Baseline||260
11283578|NCT02421666|12480073|FG000|COMPLETED|Overall Study Baseline||272
11283579|NCT02421666|12480074|FG001|COMPLETED|Overall Study Baseline||260
11283580|NCT02421666|12480073|FG000|NOT COMPLETED|Overall Study Baseline||0
11283581|NCT02421666|12480074|FG001|NOT COMPLETED|Overall Study Baseline||0
11283582|NCT02421666|12480073|FG000|STARTED|6-month Follow-up||272
11283583|NCT02421666|12480074|FG001|STARTED|6-month Follow-up||260
11283584|NCT02421666|12480073|FG000|COMPLETED|6-month Follow-up||259
11283585|NCT02421666|12480074|FG001|COMPLETED|6-month Follow-up||247
11283586|NCT02421666|12480073|FG000|NOT COMPLETED|6-month Follow-up||13
11283587|NCT02421666|12480074|FG001|NOT COMPLETED|6-month Follow-up||13
11283588|NCT02421666|12480073|FG000|STARTED|12-month Follow-up||259
11283589|NCT02421666|12480074|FG001|STARTED|12-month Follow-up||247
11283590|NCT02421666|12480073|FG000|COMPLETED|12-month Follow-up||248
11283591|NCT02421666|12480074|FG001|COMPLETED|12-month Follow-up||231
11283592|NCT02421666|12480073|FG000|NOT COMPLETED|12-month Follow-up||11
11283593|NCT02421666|12480074|FG001|NOT COMPLETED|12-month Follow-up||16
11283594|NCT02421757|12480082|FG000|STARTED|Overall Study||11
11283595|NCT02421757|12480083|FG001|STARTED|Overall Study||9
11283596|NCT02421757|12480082|FG000|COMPLETED|Overall Study||11
11283597|NCT02421757|12480083|FG001|COMPLETED|Overall Study||9
11283598|NCT02421757|12480082|FG000|NOT COMPLETED|Overall Study||0
11283599|NCT02421757|12480083|FG001|NOT COMPLETED|Overall Study||0
11283600|NCT02421887|12480091|FG000|STARTED|Overall Study||85
11283601|NCT02421887|12480092|FG001|STARTED|Overall Study||86
11283602|NCT02421887|12480091|FG000|COMPLETED|Overall Study||68
11283603|NCT02421887|12480092|FG001|COMPLETED|Overall Study||77
11283604|NCT02421887|12480091|FG000|NOT COMPLETED|Overall Study||17
11283605|NCT02421887|12480092|FG001|NOT COMPLETED|Overall Study||9
11283606|NCT02421952|12480098|FG000|STARTED|Overall Study||208
11283607|NCT02421952|12480098|FG000|Excluded From PACU and Post-Analysis|Overall Study||16
11283608|NCT02421952|12480098|FG000|Included in PACU Analysis|Overall Study||192
11283609|NCT02421952|12480098|FG000|COMPLETED|Overall Study||99
11283610|NCT02421952|12480098|FG000|NOT COMPLETED|Overall Study||109
11283611|NCT02422186|12480107|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||72
11399069|NCT04371419|12593579|FG015|Completed the Knowledge Questions|Overall Study||652
11399070|NCT04371419|12593580|FG016|Completed the Knowledge Questions|Overall Study||1526
11399071|NCT04371419|12593564|FG000|COMPLETED|Overall Study||641
11399072|NCT04371419|12593565|FG001|COMPLETED|Overall Study||636
11399073|NCT04371419|12593566|FG002|COMPLETED|Overall Study||639
11399074|NCT04371419|12593567|FG003|COMPLETED|Overall Study||631
11399075|NCT04371419|12593568|FG004|COMPLETED|Overall Study||644
11399076|NCT04371419|12593569|FG005|COMPLETED|Overall Study||654
11399077|NCT04371419|12593570|FG006|COMPLETED|Overall Study||639
11283612|NCT02422186|12480108|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||66
11283613|NCT02422186|12480107|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72
11283614|NCT02422186|12480108|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65
11283615|NCT02422186|12480107|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72
11283616|NCT02422186|12480108|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65
11283617|NCT02422186|12480107|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||62
11283618|NCT02422186|12480108|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||60
11283619|NCT02422186|12480107|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10
11283620|NCT02422186|12480108|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
11283621|NCT02422186|12480107|FG000|STARTED|Follow-up Phase (2 Weeks)||12
11283622|NCT02422186|12480108|FG001|STARTED|Follow-up Phase (2 Weeks)||3
11283623|NCT02422186|12480107|FG000|COMPLETED|Follow-up Phase (2 Weeks)||8
11283624|NCT02422186|12480108|FG001|COMPLETED|Follow-up Phase (2 Weeks)||3
11283625|NCT02422186|12480107|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
11283626|NCT02422186|12480108|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||0
11283627|NCT02422264|12480118|FG000|STARTED|Overall Study||296
11283628|NCT02422264|12480119|FG001|STARTED|Overall Study||305
11283629|NCT02422264|12480118|FG000|COMPLETED|Overall Study||291
11283630|NCT02422264|12480119|FG001|COMPLETED|Overall Study||301
11283631|NCT02422264|12480118|FG000|NOT COMPLETED|Overall Study||5
11283632|NCT02422264|12480119|FG001|NOT COMPLETED|Overall Study||4
11283633|NCT02422290|12480125|FG000|STARTED|Overall Study||5
11283634|NCT02422290|12480125|FG000|COMPLETED|Overall Study||5
11283635|NCT02422290|12480125|FG000|NOT COMPLETED|Overall Study||0
11283636|NCT02422511|12480137|FG000|STARTED|Overall Study||255
11283637|NCT02422511|12480138|FG001|STARTED|Overall Study||128
11283638|NCT02422511|12480139|FG002|STARTED|Overall Study||257
11283639|NCT02422511|12480140|FG003|STARTED|Overall Study||129
11283640|NCT02422511|12480141|FG004|STARTED|Overall Study||66
11283641|NCT02422511|12480142|FG005|STARTED|Overall Study||33
11399078|NCT04371419|12593571|FG007|COMPLETED|Overall Study||658
11283642|NCT02422511|12480143|FG006|STARTED|Overall Study||68
11283643|NCT02422511|12480144|FG007|STARTED|Overall Study||34
11283644|NCT02422511|12480137|FG000|Received Disclosure|Overall Study||158
11283645|NCT02422511|12480138|FG001|Received Disclosure|Overall Study|Newborns did not receive disclosure|79
11283646|NCT02422511|12480139|FG002|Received Disclosure|Overall Study||194
11283647|NCT02422511|12480140|FG003|Received Disclosure|Overall Study||97
11283648|NCT02422511|12480141|FG004|Received Disclosure|Overall Study||43
11283649|NCT02422511|12480142|FG005|Received Disclosure|Overall Study||21
11283650|NCT02422511|12480143|FG006|Received Disclosure|Overall Study||38
11283651|NCT02422511|12480144|FG007|Received Disclosure|Overall Study||19
11283652|NCT02422511|12480137|FG000|COMPLETED|Overall Study||143
11283653|NCT02422511|12480138|FG001|COMPLETED|Overall Study|Newborns did not complete survey|0
11283654|NCT02422511|12480139|FG002|COMPLETED|Overall Study||168
11283655|NCT02422511|12480140|FG003|COMPLETED|Overall Study|Newborns did not complete survey|0
11283656|NCT02422511|12480141|FG004|COMPLETED|Overall Study||39
11283657|NCT02422511|12480142|FG005|COMPLETED|Overall Study|Newborns did not complete survey|0
11283658|NCT02422511|12480143|FG006|COMPLETED|Overall Study||38
11283659|NCT02422511|12480144|FG007|COMPLETED|Overall Study|Newborns did not complete survey|0
11283660|NCT02422511|12480137|FG000|NOT COMPLETED|Overall Study||112
11283661|NCT02422511|12480138|FG001|NOT COMPLETED|Overall Study||128
11283662|NCT02422511|12480139|FG002|NOT COMPLETED|Overall Study||89
11283663|NCT02422511|12480140|FG003|NOT COMPLETED|Overall Study||129
11283664|NCT02422511|12480141|FG004|NOT COMPLETED|Overall Study||27
11283665|NCT02422511|12480142|FG005|NOT COMPLETED|Overall Study||33
11283666|NCT02422511|12480143|FG006|NOT COMPLETED|Overall Study||30
11283667|NCT02422511|12480144|FG007|NOT COMPLETED|Overall Study||34
11283668|NCT02422940|12480164|FG000|STARTED|Overall Study||152
11283669|NCT02422940|12480165|FG001|STARTED|Overall Study||142
11283670|NCT02422940|12480164|FG000|COMPLETED|Overall Study||31
11283671|NCT02422940|12480165|FG001|COMPLETED|Overall Study||21
11283672|NCT02422940|12480164|FG000|NOT COMPLETED|Overall Study||121
11283673|NCT02422940|12480165|FG001|NOT COMPLETED|Overall Study||121
11283674|NCT02423109|12480171|FG000|STARTED|Lens 1||19
11283675|NCT02423109|12480172|FG001|STARTED|Lens 1||14
11283676|NCT02423109|12480171|FG000|COMPLETED|Lens 1||18
11283677|NCT02423109|12480172|FG001|COMPLETED|Lens 1||14
11283678|NCT02423109|12480171|FG000|NOT COMPLETED|Lens 1||1
11283679|NCT02423109|12480172|FG001|NOT COMPLETED|Lens 1||0
11283680|NCT02423109|12480171|FG000|STARTED|Lens 2||18
11283681|NCT02423109|12480172|FG001|STARTED|Lens 2||14
11283682|NCT02423109|12480171|FG000|COMPLETED|Lens 2||18
11283683|NCT02423109|12480172|FG001|COMPLETED|Lens 2||14
11283684|NCT02423109|12480171|FG000|NOT COMPLETED|Lens 2||0
11283685|NCT02423109|12480172|FG001|NOT COMPLETED|Lens 2||0
11283686|NCT02423122|12480182|FG000|STARTED|Overall Study||9
11283687|NCT02423122|12480183|FG001|STARTED|Overall Study||7
11283688|NCT02423122|12480182|FG000|COMPLETED|Overall Study||9
11283689|NCT02423122|12480183|FG001|COMPLETED|Overall Study||7
11283690|NCT02423122|12480182|FG000|NOT COMPLETED|Overall Study||0
11283691|NCT02423122|12480183|FG001|NOT COMPLETED|Overall Study||0
11283692|NCT02423200|12480191|FG000|STARTED|Overall Study||8
11283693|NCT02423200|12480192|FG001|STARTED|Overall Study||1
11283694|NCT02423200|12480191|FG000|COMPLETED|Overall Study||7
11283695|NCT02423200|12480192|FG001|COMPLETED|Overall Study||1
11283696|NCT02423200|12480191|FG000|NOT COMPLETED|Overall Study||1
11283697|NCT02423200|12480192|FG001|NOT COMPLETED|Overall Study||0
11283698|NCT02423291|12480199|FG000|STARTED|Overall Study|Patients enrolled|15
11283699|NCT02423291|12480199|FG000|COMPLETED|Overall Study|Patients that have completed therapy|0
11283700|NCT02423291|12480199|FG000|NOT COMPLETED|Overall Study||15
11283701|NCT02423317|12480205|FG000|STARTED|Overall Study||30
11283702|NCT02423317|12480206|FG001|STARTED|Overall Study||30
11283703|NCT02423317|12480205|FG000|COMPLETED|Overall Study||30
11283704|NCT02423317|12480206|FG001|COMPLETED|Overall Study||30
11283705|NCT02423317|12480205|FG000|NOT COMPLETED|Overall Study||0
11283706|NCT02423317|12480206|FG001|NOT COMPLETED|Overall Study||0
11283707|NCT02423343|12480218|FG000|STARTED|Overall Study||3
11283708|NCT02423343|12480219|FG001|STARTED|Overall Study||5
11283709|NCT02423343|12480220|FG002|STARTED|Overall Study||3
11283710|NCT02423343|12480221|FG003|STARTED|Overall Study||4
11283711|NCT02423343|12480222|FG004|STARTED|Overall Study||25
11283712|NCT02423343|12480223|FG005|STARTED|Overall Study||1
11283713|NCT02423343|12480218|FG000|Received at Least One Dose of Study Drug|Overall Study||3
11283714|NCT02423343|12480219|FG001|Received at Least One Dose of Study Drug|Overall Study||5
11283715|NCT02423343|12480220|FG002|Received at Least One Dose of Study Drug|Overall Study||3
11283716|NCT02423343|12480221|FG003|Received at Least One Dose of Study Drug|Overall Study||4
11283717|NCT02423343|12480222|FG004|Received at Least One Dose of Study Drug|Overall Study||25
11283718|NCT02423343|12480223|FG005|Received at Least One Dose of Study Drug|Overall Study||1
11283719|NCT02423343|12480218|FG000|COMPLETED|Overall Study||3
11283720|NCT02423343|12480219|FG001|COMPLETED|Overall Study||4
11283721|NCT02423343|12480220|FG002|COMPLETED|Overall Study||3
11283722|NCT02423343|12480221|FG003|COMPLETED|Overall Study||4
11283723|NCT02423343|12480222|FG004|COMPLETED|Overall Study||20
11283724|NCT02423343|12480223|FG005|COMPLETED|Overall Study||1
11283725|NCT02423343|12480218|FG000|NOT COMPLETED|Overall Study||0
11283726|NCT02423343|12480219|FG001|NOT COMPLETED|Overall Study||1
11283727|NCT02423343|12480220|FG002|NOT COMPLETED|Overall Study||0
11283728|NCT02423343|12480221|FG003|NOT COMPLETED|Overall Study||0
11283729|NCT02423343|12480222|FG004|NOT COMPLETED|Overall Study||5
11283730|NCT02423343|12480223|FG005|NOT COMPLETED|Overall Study||0
11283731|NCT02423408|12480253|FG000|STARTED|Overall Study||83
11283732|NCT02423408|12480254|FG001|STARTED|Overall Study||82
11283733|NCT02423408|12480253|FG000|COMPLETED|Overall Study||82
11283734|NCT02423408|12480254|FG001|COMPLETED|Overall Study||80
11283735|NCT02423408|12480253|FG000|NOT COMPLETED|Overall Study||1
11283736|NCT02423408|12480254|FG001|NOT COMPLETED|Overall Study||2
11283737|NCT02423447|12480260|FG000|STARTED|Overall Study||13
11283738|NCT02423447|12480261|FG001|STARTED|Overall Study||12
11283739|NCT02423447|12480260|FG000|COMPLETED|Overall Study||13
11283740|NCT02423447|12480261|FG001|COMPLETED|Overall Study||12
11283741|NCT02423447|12480260|FG000|NOT COMPLETED|Overall Study||0
11283742|NCT02423447|12480261|FG001|NOT COMPLETED|Overall Study||0
11283743|NCT02423577|12480272|FG000|STARTED|Overall Study||53
11283744|NCT02423577|12480273|FG001|STARTED|Overall Study||26
11283745|NCT02423577|12480272|FG000|COMPLETED|Overall Study||53
11283746|NCT02423577|12480273|FG001|COMPLETED|Overall Study||26
11283747|NCT02423577|12480272|FG000|NOT COMPLETED|Overall Study||0
11283748|NCT02423577|12480273|FG001|NOT COMPLETED|Overall Study||0
11283749|NCT02423798|12480279|FG000|STARTED|Overall Study||24
11283750|NCT02423798|12480279|FG000|COMPLETED|Overall Study||21
11283751|NCT02423798|12480279|FG000|NOT COMPLETED|Overall Study||3
11283752|NCT02423980|12480284|FG000|STARTED|Overall Study||7
11283753|NCT02423980|12480284|FG000|COMPLETED|Overall Study||7
11283754|NCT02423980|12480284|FG000|NOT COMPLETED|Overall Study||0
11283755|NCT02423993|12480294|FG000|STARTED|Overall Study||19
11283756|NCT02423993|12480295|FG001|STARTED|Overall Study||16
11283757|NCT02423993|12480296|FG002|STARTED|Overall Study||23
11283758|NCT02423993|12480297|FG003|STARTED|Overall Study||19
11283759|NCT02423993|12480294|FG000|COMPLETED|Overall Study||19
11283760|NCT02423993|12480295|FG001|COMPLETED|Overall Study||16
11283761|NCT02423993|12480296|FG002|COMPLETED|Overall Study||23
11283762|NCT02423993|12480297|FG003|COMPLETED|Overall Study||19
11283763|NCT02423993|12480294|FG000|NOT COMPLETED|Overall Study||0
11283764|NCT02423993|12480295|FG001|NOT COMPLETED|Overall Study||0
11283765|NCT02423993|12480296|FG002|NOT COMPLETED|Overall Study||0
11283766|NCT02423993|12480297|FG003|NOT COMPLETED|Overall Study||0
11283767|NCT02424097|12480309|FG000|STARTED|Overall Study||20
11283768|NCT02424097|12480310|FG001|STARTED|Overall Study||20
11283769|NCT02424097|12480309|FG000|COMPLETED|Overall Study||19
11283770|NCT02424097|12480310|FG001|COMPLETED|Overall Study||18
11283771|NCT02424097|12480309|FG000|NOT COMPLETED|Overall Study||1
11283772|NCT02424097|12480310|FG001|NOT COMPLETED|Overall Study||2
11283773|NCT02424149|12480318|FG000|STARTED|Overall Study||54
11283774|NCT02424149|12480319|FG001|STARTED|Overall Study||53
11283775|NCT02424149|12480318|FG000|COMPLETED|Overall Study||52
11283776|NCT02424149|12480319|FG001|COMPLETED|Overall Study||52
11283777|NCT02424149|12480318|FG000|NOT COMPLETED|Overall Study||2
11283778|NCT02424149|12480319|FG001|NOT COMPLETED|Overall Study||1
11283779|NCT02424175|12480325|FG000|STARTED|Overall Study||10
11283780|NCT02424175|12480325|FG000|COMPLETED|Overall Study||10
11283781|NCT02424175|12480325|FG000|NOT COMPLETED|Overall Study||0
11283782|NCT02424253|12480331|FG000|STARTED|Overall Study||65
11283783|NCT02424253|12480332|FG001|STARTED|Overall Study||33
11283784|NCT02424253|12480331|FG000|COMPLETED|Overall Study||54
11283785|NCT02424253|12480332|FG001|COMPLETED|Overall Study||24
11283786|NCT02424253|12480331|FG000|NOT COMPLETED|Overall Study||11
11283787|NCT02424253|12480332|FG001|NOT COMPLETED|Overall Study||9
11283788|NCT02424344|12480340|FG000|STARTED|Overall Study||134
11283789|NCT02424344|12480341|FG001|STARTED|Overall Study||133
11283790|NCT02424344|12480340|FG000|COMPLETED|Overall Study||127
11283791|NCT02424344|12480341|FG001|COMPLETED|Overall Study||123
11283792|NCT02424344|12480340|FG000|NOT COMPLETED|Overall Study||7
11283793|NCT02424344|12480341|FG001|NOT COMPLETED|Overall Study||10
11283794|NCT02424357|12480349|FG000|STARTED|Overall Study||35
11283795|NCT02424357|12480350|FG001|STARTED|Overall Study||30
11283796|NCT02424357|12480349|FG000|COMPLETED|Overall Study||35
11283797|NCT02424357|12480350|FG001|COMPLETED|Overall Study||30
11283798|NCT02424357|12480349|FG000|NOT COMPLETED|Overall Study||0
11283799|NCT02424357|12480350|FG001|NOT COMPLETED|Overall Study||0
11283800|NCT02424383|12480358|FG000|STARTED|Overall Study||1005
11283801|NCT02424383|12480358|FG000|Per-Protocol Population|Overall Study||966
11283802|NCT02424383|12480358|FG000|COMPLETED|Overall Study||629
11283803|NCT02424383|12480358|FG000|NOT COMPLETED|Overall Study||376
11283804|NCT02424526|12480364|FG000|STARTED|Overall Study||9
11283805|NCT02424526|12480365|FG001|STARTED|Overall Study||10
11283806|NCT02424526|12480364|FG000|COMPLETED|Overall Study||9
11283807|NCT02424526|12480365|FG001|COMPLETED|Overall Study||10
11283808|NCT02424526|12480364|FG000|NOT COMPLETED|Overall Study||0
11283809|NCT02424526|12480365|FG001|NOT COMPLETED|Overall Study||0
11283810|NCT02424539|12480376|FG000|STARTED|Overall Study||120
11283811|NCT02424539|12480377|FG001|STARTED|Overall Study||119
11283812|NCT02424539|12480378|FG002|STARTED|Overall Study||119
11283813|NCT02424539|12480376|FG000|COMPLETED|Overall Study||106
11283814|NCT02424539|12480377|FG001|COMPLETED|Overall Study||111
11283815|NCT02424539|12480378|FG002|COMPLETED|Overall Study||111
11283816|NCT02424539|12480376|FG000|NOT COMPLETED|Overall Study||14
11283817|NCT02424539|12480377|FG001|NOT COMPLETED|Overall Study||8
11399079|NCT04371419|12593572|FG008|COMPLETED|Overall Study||649
11399080|NCT04371419|12593573|FG009|COMPLETED|Overall Study||621
11399081|NCT04371419|12593574|FG010|COMPLETED|Overall Study||626
11399082|NCT04371419|12593575|FG011|COMPLETED|Overall Study||662
11283818|NCT02424539|12480378|FG002|NOT COMPLETED|Overall Study||8
11283819|NCT02424578|12480388|FG000|STARTED|Overall Study||15
11399083|NCT04371419|12593576|FG012|COMPLETED|Overall Study||633
11399084|NCT04371419|12593577|FG013|COMPLETED|Overall Study||660
11399085|NCT04371419|12593578|FG014|COMPLETED|Overall Study||626
11399086|NCT04371419|12593579|FG015|COMPLETED|Overall Study||625
11399087|NCT04371419|12593580|FG016|COMPLETED|Overall Study||1450
11399088|NCT04371419|12593564|FG000|NOT COMPLETED|Overall Study||143
11399089|NCT04371419|12593565|FG001|NOT COMPLETED|Overall Study||155
11399090|NCT04371419|12593566|FG002|NOT COMPLETED|Overall Study||141
11399091|NCT04371419|12593567|FG003|NOT COMPLETED|Overall Study||147
11399092|NCT04371419|12593568|FG004|NOT COMPLETED|Overall Study||133
11399093|NCT04371419|12593569|FG005|NOT COMPLETED|Overall Study||134
11399094|NCT04371419|12593570|FG006|NOT COMPLETED|Overall Study||144
11399095|NCT04371419|12593571|FG007|NOT COMPLETED|Overall Study||130
11399096|NCT04371419|12593572|FG008|NOT COMPLETED|Overall Study||130
11283820|NCT02424578|12480389|FG001|STARTED|Overall Study||15
11283821|NCT02424578|12480388|FG000|COMPLETED|Overall Study||15
11283822|NCT02424578|12480389|FG001|COMPLETED|Overall Study||14
11283823|NCT02424578|12480388|FG000|NOT COMPLETED|Overall Study||0
11283824|NCT02424578|12480389|FG001|NOT COMPLETED|Overall Study||1
11283825|NCT02424591|12480397|FG000|STARTED|Overall Study||22
11283826|NCT02424591|12480398|FG001|STARTED|Overall Study||23
11283827|NCT02424591|12480397|FG000|COMPLETED|Overall Study||20
11283828|NCT02424591|12480398|FG001|COMPLETED|Overall Study||20
11283829|NCT02424591|12480397|FG000|NOT COMPLETED|Overall Study||2
11283830|NCT02424591|12480398|FG001|NOT COMPLETED|Overall Study||3
11283831|NCT02424630|12480406|FG000|STARTED|Overall Study||25
11283832|NCT02424630|12480407|FG001|STARTED|Overall Study||27
11283833|NCT02424630|12480406|FG000|COMPLETED|Overall Study||24
11283834|NCT02424630|12480407|FG001|COMPLETED|Overall Study||24
11283835|NCT02424630|12480406|FG000|NOT COMPLETED|Overall Study||1
11283836|NCT02424630|12480407|FG001|NOT COMPLETED|Overall Study||3
11283837|NCT02424734|12480416|FG000|STARTED|Overall Study||4
11283838|NCT02424734|12480417|FG001|STARTED|Overall Study||5
11283839|NCT02424734|12480418|FG002|STARTED|Overall Study||2
11283840|NCT02424734|12480416|FG000|Treated|Overall Study||4
11283841|NCT02424734|12480417|FG001|Treated|Overall Study||5
11283842|NCT02424734|12480418|FG002|Treated|Overall Study||2
11283843|NCT02424734|12480416|FG000|COMPLETED|Overall Study||2
11283844|NCT02424734|12480417|FG001|COMPLETED|Overall Study||3
11283845|NCT02424734|12480418|FG002|COMPLETED|Overall Study||2
11283846|NCT02424734|12480416|FG000|NOT COMPLETED|Overall Study||2
11283847|NCT02424734|12480417|FG001|NOT COMPLETED|Overall Study||2
11283848|NCT02424734|12480418|FG002|NOT COMPLETED|Overall Study||0
11283849|NCT02424799|12480433|FG000|STARTED|Part A (Up to Day 11)||9
11283850|NCT02424799|12480434|FG001|STARTED|Part A (Up to Day 11)||8
11283851|NCT02424799|12480435|FG002|STARTED|Part A (Up to Day 11)||0
11283852|NCT02424799|12480436|FG003|STARTED|Part A (Up to Day 11)||0
11283853|NCT02424799|12480437|FG004|STARTED|Part A (Up to Day 11)||0
11283854|NCT02424799|12480438|FG005|STARTED|Part A (Up to Day 11)||0
11283855|NCT02424799|12480433|FG000|COMPLETED|Part A (Up to Day 11)||9
11283856|NCT02424799|12480434|FG001|COMPLETED|Part A (Up to Day 11)||8
11283857|NCT02424799|12480435|FG002|COMPLETED|Part A (Up to Day 11)||0
11283858|NCT02424799|12480436|FG003|COMPLETED|Part A (Up to Day 11)||0
11283859|NCT02424799|12480437|FG004|COMPLETED|Part A (Up to Day 11)||0
11283860|NCT02424799|12480438|FG005|COMPLETED|Part A (Up to Day 11)||0
11283861|NCT02424799|12480433|FG000|NOT COMPLETED|Part A (Up to Day 11)||0
11283862|NCT02424799|12480434|FG001|NOT COMPLETED|Part A (Up to Day 11)||0
11283863|NCT02424799|12480435|FG002|NOT COMPLETED|Part A (Up to Day 11)||0
11283864|NCT02424799|12480436|FG003|NOT COMPLETED|Part A (Up to Day 11)||0
11283865|NCT02424799|12480437|FG004|NOT COMPLETED|Part A (Up to Day 11)||0
11283866|NCT02424799|12480438|FG005|NOT COMPLETED|Part A (Up to Day 11)||0
11283867|NCT02424799|12480433|FG000|STARTED|Part B (Up to Day 19)||0
11283868|NCT02424799|12480434|FG001|STARTED|Part B (Up to Day 19)||0
11283869|NCT02424799|12480435|FG002|STARTED|Part B (Up to Day 19)||3
11283870|NCT02424799|12480436|FG003|STARTED|Part B (Up to Day 19)||9
11283871|NCT02424799|12480437|FG004|STARTED|Part B (Up to Day 19)||0
11283872|NCT02424799|12480438|FG005|STARTED|Part B (Up to Day 19)||0
11283873|NCT02424799|12480433|FG000|COMPLETED|Part B (Up to Day 19)||0
11283874|NCT02424799|12480434|FG001|COMPLETED|Part B (Up to Day 19)||0
11283875|NCT02424799|12480435|FG002|COMPLETED|Part B (Up to Day 19)||3
11283876|NCT02424799|12480436|FG003|COMPLETED|Part B (Up to Day 19)||9
11283877|NCT02424799|12480437|FG004|COMPLETED|Part B (Up to Day 19)||0
11283878|NCT02424799|12480438|FG005|COMPLETED|Part B (Up to Day 19)||0
11283879|NCT02424799|12480433|FG000|NOT COMPLETED|Part B (Up to Day 19)||0
11283880|NCT02424799|12480434|FG001|NOT COMPLETED|Part B (Up to Day 19)||0
11283881|NCT02424799|12480435|FG002|NOT COMPLETED|Part B (Up to Day 19)||0
11283882|NCT02424799|12480436|FG003|NOT COMPLETED|Part B (Up to Day 19)||0
11283883|NCT02424799|12480437|FG004|NOT COMPLETED|Part B (Up to Day 19)||0
11283884|NCT02424799|12480438|FG005|NOT COMPLETED|Part B (Up to Day 19)||0
11283885|NCT02424799|12480433|FG000|STARTED|Part C (Up to Day 23)||0
11283886|NCT02424799|12480434|FG001|STARTED|Part C (Up to Day 23)||0
11283887|NCT02424799|12480435|FG002|STARTED|Part C (Up to Day 23)||0
11399097|NCT04371419|12593573|FG009|NOT COMPLETED|Overall Study||159
11399098|NCT04371419|12593574|FG010|NOT COMPLETED|Overall Study||156
11283888|NCT02424799|12480436|FG003|STARTED|Part C (Up to Day 23)||0
11283889|NCT02424799|12480437|FG004|STARTED|Part C (Up to Day 23)||1
11283890|NCT02424799|12480438|FG005|STARTED|Part C (Up to Day 23)||4
11283891|NCT02424799|12480433|FG000|COMPLETED|Part C (Up to Day 23)||0
11283892|NCT02424799|12480434|FG001|COMPLETED|Part C (Up to Day 23)||0
11399099|NCT04371419|12593575|FG011|NOT COMPLETED|Overall Study||128
11399100|NCT04371419|12593576|FG012|NOT COMPLETED|Overall Study||146
11399101|NCT04371419|12593577|FG013|NOT COMPLETED|Overall Study||126
11399102|NCT04371419|12593578|FG014|NOT COMPLETED|Overall Study||155
11283893|NCT02424799|12480435|FG002|COMPLETED|Part C (Up to Day 23)||0
11283894|NCT02424799|12480436|FG003|COMPLETED|Part C (Up to Day 23)||0
11283895|NCT02424799|12480437|FG004|COMPLETED|Part C (Up to Day 23)||1
11283896|NCT02424799|12480438|FG005|COMPLETED|Part C (Up to Day 23)||4
11283897|NCT02424799|12480433|FG000|NOT COMPLETED|Part C (Up to Day 23)||0
11283898|NCT02424799|12480434|FG001|NOT COMPLETED|Part C (Up to Day 23)||0
11283899|NCT02424799|12480435|FG002|NOT COMPLETED|Part C (Up to Day 23)||0
11283900|NCT02424799|12480436|FG003|NOT COMPLETED|Part C (Up to Day 23)||0
11283901|NCT02424799|12480437|FG004|NOT COMPLETED|Part C (Up to Day 23)||0
11283902|NCT02424799|12480438|FG005|NOT COMPLETED|Part C (Up to Day 23)||0
11283903|NCT02424968|12480470|FG000|STARTED|Overall Study||18
11283904|NCT02424968|12480470|FG000|COMPLETED|Overall Study||18
11283905|NCT02424968|12480470|FG000|NOT COMPLETED|Overall Study||0
11283906|NCT02425098|12480476|FG000|STARTED|Overall Study||176
11283907|NCT02425098|12480477|FG001|STARTED|Overall Study||175
11283908|NCT02425098|12480476|FG000|COMPLETED|Overall Study||163
11283909|NCT02425098|12480477|FG001|COMPLETED|Overall Study||159
11283910|NCT02425098|12480476|FG000|NOT COMPLETED|Overall Study||13
11283911|NCT02425098|12480477|FG001|NOT COMPLETED|Overall Study||16
11283912|NCT02425111|12480483|FG000|STARTED|Part A: Treatment Period||101
11283913|NCT02425111|12480483|FG000|COMPLETED|Part A: Treatment Period||78
11283914|NCT02425111|12480483|FG000|NOT COMPLETED|Part A: Treatment Period||23
11283915|NCT02425111|12480483|FG000|STARTED|Part B: Treatment Extension Period||56
11283916|NCT02425111|12480483|FG000|COMPLETED|Part B: Treatment Extension Period||46
11283917|NCT02425111|12480483|FG000|NOT COMPLETED|Part B: Treatment Extension Period||10
11283918|NCT02425449|12480493|FG000|STARTED|Overall Study||0
11283919|NCT02425449|12480494|FG001|STARTED|Overall Study||4
11283920|NCT02425449|12480495|FG002|STARTED|Overall Study||5
11283921|NCT02425449|12480496|FG003|STARTED|Overall Study||5
11283922|NCT02425449|12480497|FG004|STARTED|Overall Study||5
11399103|NCT04371419|12593579|FG015|NOT COMPLETED|Overall Study||156
11399104|NCT04371419|12593580|FG016|NOT COMPLETED|Overall Study||167
11399105|NCT04370834|12593611|FG000|STARTED|Overall Study||1
11283923|NCT02425449|12480493|FG000|COMPLETED|Overall Study||0
11399106|NCT04370834|12593611|FG000|COMPLETED|Overall Study||1
11399107|NCT04370834|12593611|FG000|NOT COMPLETED|Overall Study||0
11399108|NCT04370548|12593623|FG000|STARTED|Overall Study||204
11399109|NCT04370548|12593624|FG001|STARTED|Overall Study||103
11283924|NCT02425449|12480494|FG001|COMPLETED|Overall Study||4
11283925|NCT02425449|12480495|FG002|COMPLETED|Overall Study||5
11283926|NCT02425449|12480496|FG003|COMPLETED|Overall Study||5
11283927|NCT02425449|12480497|FG004|COMPLETED|Overall Study||5
11283928|NCT02425449|12480493|FG000|NOT COMPLETED|Overall Study||0
11283929|NCT02425449|12480494|FG001|NOT COMPLETED|Overall Study||0
11283930|NCT02425449|12480495|FG002|NOT COMPLETED|Overall Study||0
11283931|NCT02425449|12480496|FG003|NOT COMPLETED|Overall Study||0
11283932|NCT02425449|12480497|FG004|NOT COMPLETED|Overall Study||0
11283933|NCT02425956|12480509|FG000|STARTED|Overall Study||21
11283934|NCT02425956|12480509|FG000|COMPLETED|Overall Study||21
11283935|NCT02425956|12480509|FG000|NOT COMPLETED|Overall Study||0
11283936|NCT02426086|12480515|FG000|STARTED|Overall Study||48
11283937|NCT02426086|12480516|FG001|STARTED|Overall Study||59
11283938|NCT02426086|12480515|FG000|Treated|Overall Study||48
11283939|NCT02426086|12480516|FG001|Treated|Overall Study||59
11283940|NCT02426086|12480515|FG000|COMPLETED|Overall Study||0
11283941|NCT02426086|12480516|FG001|COMPLETED|Overall Study||0
11283942|NCT02426086|12480515|FG000|NOT COMPLETED|Overall Study||48
11283943|NCT02426086|12480516|FG001|NOT COMPLETED|Overall Study||59
11340902|NCT02926209|12538223|FG001|NOT COMPLETED|Study Cohort||0
11340903|NCT02926209|12538222|FG000|STARTED|Training Cohort - First Patients||20
11340904|NCT02926209|12538223|FG001|STARTED|Training Cohort - First Patients||0
11340905|NCT02926209|12538222|FG000|COMPLETED|Training Cohort - First Patients||20
11340906|NCT02926209|12538223|FG001|COMPLETED|Training Cohort - First Patients||0
11340907|NCT02926209|12538222|FG000|NOT COMPLETED|Training Cohort - First Patients||0
11340908|NCT02926209|12538223|FG001|NOT COMPLETED|Training Cohort - First Patients||0
11340909|NCT02926573|12538232|FG000|STARTED|Overall Study||55
11340910|NCT02926573|12538233|FG001|STARTED|Overall Study||55
11340911|NCT02926573|12538232|FG000|COMPLETED|Overall Study||44
11340912|NCT02926573|12538233|FG001|COMPLETED|Overall Study||46
11340913|NCT02926573|12538232|FG000|NOT COMPLETED|Overall Study||11
11340914|NCT02926573|12538233|FG001|NOT COMPLETED|Overall Study||9
11340915|NCT02926677|12538242|FG000|STARTED|Overall Study||25
11340916|NCT02926677|12538243|FG001|STARTED|Overall Study||22
11340917|NCT02926677|12538244|FG002|STARTED|Overall Study||26
11340918|NCT02926677|12538242|FG000|COMPLETED|Overall Study||8
11340919|NCT02926677|12538243|FG001|COMPLETED|Overall Study||8
11340920|NCT02926677|12538244|FG002|COMPLETED|Overall Study||6
11340921|NCT02926677|12538242|FG000|NOT COMPLETED|Overall Study||17
11340922|NCT02926677|12538243|FG001|NOT COMPLETED|Overall Study||14
11340923|NCT02926677|12538244|FG002|NOT COMPLETED|Overall Study||20
11340924|NCT02926937|12538256|FG000|STARTED|Overall Study||150
11283944|NCT02426138|12480529|FG000|STARTED|First Intervention (12 Weeks)||21
11283945|NCT02426138|12480530|FG001|STARTED|First Intervention (12 Weeks)||23
11283946|NCT02426138|12480529|FG000|COMPLETED|First Intervention (12 Weeks)||20
11283947|NCT02426138|12480530|FG001|COMPLETED|First Intervention (12 Weeks)||22
11283948|NCT02426138|12480529|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
11283949|NCT02426138|12480530|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
11283950|NCT02426138|12480529|FG000|STARTED|Second Intervention (12 Weeks)||20
11283951|NCT02426138|12480530|FG001|STARTED|Second Intervention (12 Weeks)||22
11283952|NCT02426138|12480529|FG000|COMPLETED|Second Intervention (12 Weeks)||20
11283953|NCT02426138|12480530|FG001|COMPLETED|Second Intervention (12 Weeks)||22
11283954|NCT02426138|12480529|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
11283955|NCT02426138|12480530|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
11283956|NCT02426138|12480529|FG000|STARTED|Intent to Treat Population Milestone||20
11283957|NCT02426138|12480530|FG001|STARTED|Intent to Treat Population Milestone||22
11283958|NCT02426138|12480529|FG000|COMPLETED|Intent to Treat Population Milestone||20
11283959|NCT02426138|12480530|FG001|COMPLETED|Intent to Treat Population Milestone||22
11283960|NCT02426138|12480529|FG000|NOT COMPLETED|Intent to Treat Population Milestone||0
11283961|NCT02426138|12480530|FG001|NOT COMPLETED|Intent to Treat Population Milestone||0
11283962|NCT02426476|12480540|FG000|STARTED|Overall Study||57
11283963|NCT02426476|12480541|FG001|STARTED|Overall Study||56
11283964|NCT02426476|12480540|FG000|COMPLETED|Overall Study||38
11283965|NCT02426476|12480541|FG001|COMPLETED|Overall Study||39
11283966|NCT02426476|12480540|FG000|NOT COMPLETED|Overall Study||19
11283967|NCT02426476|12480541|FG001|NOT COMPLETED|Overall Study||17
11283968|NCT02426541|12480551|FG000|STARTED|Overall Study||16
11283969|NCT02426541|12480552|FG001|STARTED|Overall Study||16
11283970|NCT02426541|12480551|FG000|COMPLETED|Overall Study||15
11283971|NCT02426541|12480552|FG001|COMPLETED|Overall Study||16
11283972|NCT02426541|12480551|FG000|NOT COMPLETED|Overall Study||1
11283973|NCT02426541|12480552|FG001|NOT COMPLETED|Overall Study||0
11283974|NCT02426580|12480560|FG000|STARTED|Overall Study|April 2015|70
11283975|NCT02426580|12480561|FG001|STARTED|Overall Study|January 2014|70
11283976|NCT02426580|12480560|FG000|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59
11283977|NCT02426580|12480561|FG001|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54
11283978|NCT02426580|12480560|FG000|NOT COMPLETED|Overall Study||11
11283979|NCT02426580|12480561|FG001|NOT COMPLETED|Overall Study||16
11283980|NCT02426918|12480570|FG000|STARTED|Overall Study||110
11283981|NCT02426918|12480571|FG001|STARTED|Overall Study||109
11283982|NCT02426918|12480572|FG002|STARTED|Overall Study||111
11283983|NCT02426918|12480570|FG000|Safety Population|Overall Study||110
11283984|NCT02426918|12480571|FG001|Safety Population|Overall Study||107
11283985|NCT02426918|12480572|FG002|Safety Population|Overall Study||107
11283986|NCT02426918|12480570|FG000|COMPLETED|Overall Study||93
11283987|NCT02426918|12480571|FG001|COMPLETED|Overall Study||90
11283988|NCT02426918|12480572|FG002|COMPLETED|Overall Study||97
11283989|NCT02426918|12480570|FG000|NOT COMPLETED|Overall Study||17
11283990|NCT02426918|12480571|FG001|NOT COMPLETED|Overall Study||19
11283991|NCT02426918|12480572|FG002|NOT COMPLETED|Overall Study||14
11283992|NCT02427100|12480582|FG000|STARTED|Overall Study||15
11283993|NCT02427100|12480583|FG001|STARTED|Overall Study||17
11283994|NCT02427100|12480582|FG000|COMPLETED|Overall Study||15
11283995|NCT02427100|12480583|FG001|COMPLETED|Overall Study||15
11283996|NCT02427100|12480582|FG000|NOT COMPLETED|Overall Study||0
11283997|NCT02427100|12480583|FG001|NOT COMPLETED|Overall Study||2
11283998|NCT02427399|12480594|FG000|STARTED|Overall Study||220
11283999|NCT02427399|12480595|FG001|STARTED|Overall Study||220
11284000|NCT02427399|12480596|FG002|STARTED|Overall Study||220
11284001|NCT02427399|12480597|FG003|STARTED|Overall Study||220
11284002|NCT02427399|12480598|FG004|STARTED|Overall Study||220
11284003|NCT02427399|12480594|FG000|COMPLETED|Overall Study||206
11284004|NCT02427399|12480595|FG001|COMPLETED|Overall Study||204
11284005|NCT02427399|12480596|FG002|COMPLETED|Overall Study||208
11284006|NCT02427399|12480597|FG003|COMPLETED|Overall Study||202
11284007|NCT02427399|12480598|FG004|COMPLETED|Overall Study||205
11284008|NCT02427399|12480594|FG000|NOT COMPLETED|Overall Study||14
11284009|NCT02427399|12480595|FG001|NOT COMPLETED|Overall Study||16
11284010|NCT02427399|12480596|FG002|NOT COMPLETED|Overall Study||12
11284011|NCT02427399|12480597|FG003|NOT COMPLETED|Overall Study||18
11284012|NCT02427399|12480598|FG004|NOT COMPLETED|Overall Study||15
11284013|NCT02427477|12480612|FG000|STARTED|Period 1||60
11284014|NCT02427477|12480613|FG001|STARTED|Period 1||60
11284015|NCT02427477|12480612|FG000|COMPLETED|Period 1||59
11284016|NCT02427477|12480613|FG001|COMPLETED|Period 1||60
11284017|NCT02427477|12480612|FG000|NOT COMPLETED|Period 1||1
11284018|NCT02427477|12480613|FG001|NOT COMPLETED|Period 1||0
11284019|NCT02427477|12480612|FG000|STARTED|Period 2||59
11284020|NCT02427477|12480613|FG001|STARTED|Period 2||60
11284021|NCT02427477|12480612|FG000|COMPLETED|Period 2||59
11284022|NCT02427477|12480613|FG001|COMPLETED|Period 2||60
11284023|NCT02427477|12480612|FG000|NOT COMPLETED|Period 2||0
11284024|NCT02427477|12480613|FG001|NOT COMPLETED|Period 2||0
11284025|NCT02427477|12480612|FG000|STARTED|Period 3||59
11284026|NCT02427477|12480613|FG001|STARTED|Period 3||60
11284027|NCT02427477|12480612|FG000|COMPLETED|Period 3||59
11284028|NCT02427477|12480613|FG001|COMPLETED|Period 3||60
11284029|NCT02427477|12480612|FG000|NOT COMPLETED|Period 3||0
11399110|NCT04370548|12593623|FG000|COMPLETED|Overall Study||190
11399111|NCT04370548|12593624|FG001|COMPLETED|Overall Study||100
11399112|NCT04370548|12593623|FG000|NOT COMPLETED|Overall Study||14
11399113|NCT04370548|12593624|FG001|NOT COMPLETED|Overall Study||3
11399114|NCT04370028|12593630|FG000|STARTED|Overall Study||2583
11399115|NCT04370028|12593630|FG000|COMPLETED|Overall Study||1876
11284030|NCT02427477|12480613|FG001|NOT COMPLETED|Period 3||0
11284031|NCT02427607|12480619|FG000|STARTED|Overall Study||7
11284032|NCT02427607|12480619|FG000|COMPLETED|Overall Study||6
11284033|NCT02427607|12480619|FG000|NOT COMPLETED|Overall Study||1
11284034|NCT02427646|12480625|FG000|STARTED|Overall Study||24
11284035|NCT02427646|12480626|FG001|STARTED|Overall Study||28
11284036|NCT02427646|12480625|FG000|COMPLETED|Overall Study||16
11284037|NCT02427646|12480626|FG001|COMPLETED|Overall Study||14
11284038|NCT02427646|12480625|FG000|NOT COMPLETED|Overall Study||8
11284039|NCT02427646|12480626|FG001|NOT COMPLETED|Overall Study||14
11284040|NCT02427672|12480636|FG000|STARTED|Overall Study||40
11284041|NCT02427672|12480637|FG001|STARTED|Overall Study||44
11284042|NCT02427672|12480636|FG000|COMPLETED|Overall Study||39
11284043|NCT02427672|12480637|FG001|COMPLETED|Overall Study||42
11284044|NCT02427672|12480636|FG000|NOT COMPLETED|Overall Study||1
11284045|NCT02427672|12480637|FG001|NOT COMPLETED|Overall Study||2
11284046|NCT02427737|12480645|FG000|STARTED|OSU Baseline Q4FY15||4158
11284047|NCT02427737|12480646|FG001|STARTED|OSU Baseline Q4FY15||3446
11284048|NCT02427737|12480645|FG000|COMPLETED|OSU Baseline Q4FY15||3940
11284049|NCT02427737|12480646|FG001|COMPLETED|OSU Baseline Q4FY15||3230
11284050|NCT02427737|12480645|FG000|NOT COMPLETED|OSU Baseline Q4FY15||218
11284051|NCT02427737|12480646|FG001|NOT COMPLETED|OSU Baseline Q4FY15||216
11284052|NCT02427737|12480645|FG000|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030
11284053|NCT02427737|12480646|FG001|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246
11284054|NCT02427737|12480645|FG000|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815
11284055|NCT02427737|12480646|FG001|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032
11284056|NCT02427737|12480645|FG000|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215
11284057|NCT02427737|12480646|FG001|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214
11284058|NCT02427737|12480645|FG000|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121
11284059|NCT02427737|12480646|FG001|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070
11284060|NCT02427737|12480645|FG000|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907
11284061|NCT02427737|12480646|FG001|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857
11284062|NCT02427737|12480645|FG000|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214
11284063|NCT02427737|12480646|FG001|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213
11284064|NCT02427737|12480645|FG000|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148
11284065|NCT02427737|12480646|FG001|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931
11284066|NCT02427737|12480645|FG000|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928
11284067|NCT02427737|12480646|FG001|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716
11284068|NCT02427737|12480645|FG000|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220
11284069|NCT02427737|12480646|FG001|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215
11284070|NCT02427737|12480645|FG000|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658
11284071|NCT02427737|12480646|FG001|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446
11284072|NCT02427737|12480645|FG000|COMPLETED|Duke Pre- and Post-Training Groups||8879
11284073|NCT02427737|12480646|FG001|COMPLETED|Duke Pre- and Post-Training Groups||4051
11284074|NCT02427737|12480645|FG000|NOT COMPLETED|Duke Pre- and Post-Training Groups||779
11284075|NCT02427737|12480646|FG001|NOT COMPLETED|Duke Pre- and Post-Training Groups||395
11284076|NCT02427750|12480662|FG000|STARTED|Overall Study||63
11284077|NCT02427750|12480663|FG001|STARTED|Overall Study||63
11284078|NCT02427750|12480662|FG000|COMPLETED|Overall Study||63
11284079|NCT02427750|12480663|FG001|COMPLETED|Overall Study||63
11284080|NCT02427750|12480662|FG000|NOT COMPLETED|Overall Study||0
11284081|NCT02427750|12480663|FG001|NOT COMPLETED|Overall Study||0
11284082|NCT02427802|12480673|FG000|STARTED|Overall Study||305
11284083|NCT02427802|12480674|FG001|STARTED|Overall Study||154
11284084|NCT02427802|12480675|FG002|STARTED|Overall Study||153
11284085|NCT02427802|12480673|FG000|COMPLETED|Overall Study||246
11284086|NCT02427802|12480674|FG001|COMPLETED|Overall Study||120
11284087|NCT02427802|12480675|FG002|COMPLETED|Overall Study||110
11284088|NCT02427802|12480673|FG000|NOT COMPLETED|Overall Study||59
11284089|NCT02427802|12480674|FG001|NOT COMPLETED|Overall Study||34
11284090|NCT02427802|12480675|FG002|NOT COMPLETED|Overall Study||43
11284091|NCT02427841|12480683|FG000|STARTED|Overall Study||19
11284092|NCT02427841|12480683|FG000|COMPLETED|Overall Study||11
11284093|NCT02427841|12480683|FG000|NOT COMPLETED|Overall Study||8
11284094|NCT02427984|12480690|FG000|STARTED|Overall Study||53
11284095|NCT02427984|12480691|FG001|STARTED|Overall Study||45
11284096|NCT02427984|12480692|FG002|STARTED|Overall Study||50
11284097|NCT02427984|12480690|FG000|COMPLETED|Overall Study||40
11284098|NCT02427984|12480691|FG001|COMPLETED|Overall Study||40
11284099|NCT02427984|12480692|FG002|COMPLETED|Overall Study||32
11284100|NCT02427984|12480690|FG000|NOT COMPLETED|Overall Study||13
11284101|NCT02427984|12480691|FG001|NOT COMPLETED|Overall Study||5
11284102|NCT02427984|12480692|FG002|NOT COMPLETED|Overall Study||18
11284103|NCT02428296|12480701|FG000|STARTED|Overall Study||39
11284104|NCT02428296|12480701|FG000|Treated|Overall Study||39
11284105|NCT02428296|12480701|FG000|COMPLETED|Overall Study|Number of participants who completed the full course of treatment.|30
11284106|NCT02428296|12480701|FG000|NOT COMPLETED|Overall Study||9
11284107|NCT02428309|12480708|FG000|STARTED|Overall Study||1
11284108|NCT02428309|12480708|FG000|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1
11284109|NCT02428309|12480708|FG000|NOT COMPLETED|Overall Study||0
11284110|NCT02428413|12480715|FG000|STARTED|Overall Study||64
11284111|NCT02428413|12480716|FG001|STARTED|Overall Study||61
11284112|NCT02428413|12480715|FG000|COMPLETED|Overall Study||56
11284113|NCT02428413|12480716|FG001|COMPLETED|Overall Study||52
11284114|NCT02428413|12480715|FG000|NOT COMPLETED|Overall Study||8
11284115|NCT02428413|12480716|FG001|NOT COMPLETED|Overall Study||9
11284116|NCT02428478|12480722|FG000|STARTED|First Study Night||9
11284117|NCT02428478|12480723|FG001|STARTED|First Study Night||8
11284118|NCT02428478|12480722|FG000|COMPLETED|First Study Night||9
11284119|NCT02428478|12480723|FG001|COMPLETED|First Study Night||8
11284120|NCT02428478|12480722|FG000|NOT COMPLETED|First Study Night||0
11284121|NCT02428478|12480723|FG001|NOT COMPLETED|First Study Night||0
11284122|NCT02428478|12480722|FG000|STARTED|Second Study Night|1 participant did not return for the second study night|8
11284123|NCT02428478|12480723|FG001|STARTED|Second Study Night|2 participants did not return for the second study night|6
11284124|NCT02428478|12480722|FG000|COMPLETED|Second Study Night||8
11284125|NCT02428478|12480723|FG001|COMPLETED|Second Study Night||6
11284126|NCT02428478|12480722|FG000|NOT COMPLETED|Second Study Night||0
11284127|NCT02428478|12480723|FG001|NOT COMPLETED|Second Study Night||0
11284128|NCT02428595|12480729|FG000|STARTED|Fitting||137
11284129|NCT02428595|12480729|FG000|COMPLETED|Fitting||73
11284130|NCT02428595|12480729|FG000|NOT COMPLETED|Fitting||64
11284131|NCT02428595|12480729|FG000|STARTED|Treatment||73
11284132|NCT02428595|12480729|FG000|COMPLETED|Treatment||54
11284133|NCT02428595|12480729|FG000|NOT COMPLETED|Treatment||19
11284134|NCT02428608|12480742|FG000|STARTED|Overall Study||570
11284135|NCT02428608|12480742|FG000|COMPLETED|Overall Study||487
11284136|NCT02428608|12480742|FG000|NOT COMPLETED|Overall Study||83
11284137|NCT02428699|12480747|FG000|STARTED|Period 1||25
11284138|NCT02428699|12480748|FG001|STARTED|Period 1||25
11284139|NCT02428699|12480747|FG000|COMPLETED|Period 1||25
11284140|NCT02428699|12480748|FG001|COMPLETED|Period 1||25
11284141|NCT02428699|12480747|FG000|NOT COMPLETED|Period 1||0
11284142|NCT02428699|12480748|FG001|NOT COMPLETED|Period 1||0
11284143|NCT02428699|12480747|FG000|STARTED|Washout Period 1||25
11284144|NCT02428699|12480748|FG001|STARTED|Washout Period 1||25
11284145|NCT02428699|12480747|FG000|COMPLETED|Washout Period 1||24
11284146|NCT02428699|12480748|FG001|COMPLETED|Washout Period 1||23
11284147|NCT02428699|12480747|FG000|NOT COMPLETED|Washout Period 1||1
11284148|NCT02428699|12480748|FG001|NOT COMPLETED|Washout Period 1||2
11284149|NCT02428699|12480747|FG000|STARTED|Period 2||24
11284150|NCT02428699|12480748|FG001|STARTED|Period 2||23
11284151|NCT02428699|12480747|FG000|COMPLETED|Period 2||24
11284152|NCT02428699|12480748|FG001|COMPLETED|Period 2||23
11284153|NCT02428699|12480747|FG000|NOT COMPLETED|Period 2||0
11284154|NCT02428699|12480748|FG001|NOT COMPLETED|Period 2||0
11284155|NCT02428855|12480759|FG000|STARTED|Overall Study||8
11284156|NCT02428855|12480759|FG000|COMPLETED|Overall Study||6
11284157|NCT02428855|12480759|FG000|NOT COMPLETED|Overall Study||2
11284158|NCT02429115|12480769|FG000|STARTED|Overall Study||52
11284159|NCT02429115|12480770|FG001|STARTED|Overall Study||52
11284160|NCT02429115|12480771|FG002|STARTED|Overall Study||51
11284161|NCT02429115|12480772|FG003|STARTED|Overall Study||29
11284162|NCT02429115|12480773|FG004|STARTED|Overall Study||29
11284163|NCT02429115|12480774|FG005|STARTED|Overall Study||28
11284164|NCT02429115|12480769|FG000|COMPLETED|Overall Study||40
11284165|NCT02429115|12480770|FG001|COMPLETED|Overall Study||42
11284166|NCT02429115|12480771|FG002|COMPLETED|Overall Study||35
11284167|NCT02429115|12480772|FG003|COMPLETED|Overall Study||21
11284168|NCT02429115|12480773|FG004|COMPLETED|Overall Study||22
11284169|NCT02429115|12480774|FG005|COMPLETED|Overall Study||27
11284170|NCT02429115|12480769|FG000|NOT COMPLETED|Overall Study||12
11284171|NCT02429115|12480770|FG001|NOT COMPLETED|Overall Study||10
11284172|NCT02429115|12480771|FG002|NOT COMPLETED|Overall Study||16
11284173|NCT02429115|12480772|FG003|NOT COMPLETED|Overall Study||8
11284174|NCT02429115|12480773|FG004|NOT COMPLETED|Overall Study||7
11284175|NCT02429115|12480774|FG005|NOT COMPLETED|Overall Study||1
11284176|NCT02429258|12480790|FG000|STARTED|Overall Study||50
11284177|NCT02429258|12480791|FG001|STARTED|Overall Study||50
11284178|NCT02429258|12480790|FG000|COMPLETED|Overall Study||48
11284179|NCT02429258|12480791|FG001|COMPLETED|Overall Study||49
11284180|NCT02429258|12480790|FG000|NOT COMPLETED|Overall Study||2
11284181|NCT02429258|12480791|FG001|NOT COMPLETED|Overall Study||1
11284182|NCT02429310|12480799|FG000|STARTED|Overall Study||22
11284183|NCT02429310|12480800|FG001|STARTED|Overall Study||20
11284184|NCT02429310|12480799|FG000|COMPLETED|Overall Study||20
11284185|NCT02429310|12480800|FG001|COMPLETED|Overall Study||17
11284186|NCT02429310|12480799|FG000|NOT COMPLETED|Overall Study||2
11284187|NCT02429310|12480800|FG001|NOT COMPLETED|Overall Study||3
11284188|NCT02429427|12480808|FG000|STARTED|Overall Study||1763
11284189|NCT02429427|12480809|FG001|STARTED|Overall Study||876
11284190|NCT02429427|12480808|FG000|COMPLETED|Overall Study||1392
11284191|NCT02429427|12480809|FG001|COMPLETED|Overall Study||697
11284192|NCT02429427|12480808|FG000|NOT COMPLETED|Overall Study||371
11284193|NCT02429427|12480809|FG001|NOT COMPLETED|Overall Study||179
11284194|NCT02429778|12480817|FG000|STARTED|Overall Study||20
11284195|NCT02429778|12480818|FG001|STARTED|Overall Study||20
11284196|NCT02429778|12480817|FG000|COMPLETED|Overall Study||13
11284197|NCT02429778|12480818|FG001|COMPLETED|Overall Study||20
11284198|NCT02429778|12480817|FG000|NOT COMPLETED|Overall Study||7
11284199|NCT02429778|12480818|FG001|NOT COMPLETED|Overall Study||0
11284200|NCT02429856|12480826|FG000|STARTED|Overall Study||49
11284201|NCT02429856|12480827|FG001|STARTED|Overall Study||51
11284202|NCT02429856|12480826|FG000|COMPLETED|Overall Study||30
11284203|NCT02429856|12480827|FG001|COMPLETED|Overall Study||32
11284204|NCT02429856|12480826|FG000|NOT COMPLETED|Overall Study||19
11284205|NCT02429856|12480827|FG001|NOT COMPLETED|Overall Study||19
11284206|NCT02429869|12480835|FG000|STARTED|Overall Study||10
11284207|NCT02429869|12480835|FG000|COMPLETED|Overall Study||10
11284208|NCT02429869|12480835|FG000|NOT COMPLETED|Overall Study||0
11284209|NCT02429934|12480841|FG000|STARTED|Overall Study||15
11284210|NCT02429934|12480842|FG001|STARTED|Overall Study||13
11284211|NCT02429934|12480841|FG000|COMPLETED|Overall Study||11
11284212|NCT02429934|12480842|FG001|COMPLETED|Overall Study||10
11284213|NCT02429934|12480841|FG000|NOT COMPLETED|Overall Study||4
11284214|NCT02429934|12480842|FG001|NOT COMPLETED|Overall Study||3
11284215|NCT02430090|12480853|FG000|STARTED|Overall Study||15
11284216|NCT02430090|12480854|FG001|STARTED|Overall Study||15
11284217|NCT02430090|12480855|FG002|STARTED|Overall Study||15
11284218|NCT02430090|12480853|FG000|COMPLETED|Overall Study||15
11284219|NCT02430090|12480854|FG001|COMPLETED|Overall Study||15
11284220|NCT02430090|12480855|FG002|COMPLETED|Overall Study||15
11284221|NCT02430090|12480853|FG000|NOT COMPLETED|Overall Study||0
11284222|NCT02430090|12480854|FG001|NOT COMPLETED|Overall Study||0
11284223|NCT02430090|12480855|FG002|NOT COMPLETED|Overall Study||0
11284224|NCT02430311|12480865|FG000|STARTED|Part A||20
11284225|NCT02430311|12480866|FG001|STARTED|Part A||16
11284226|NCT02430311|12480865|FG000|Received Olaparib|Part A||20
11284227|NCT02430311|12480866|FG001|Received Olaparib|Part A||16
11284228|NCT02430311|12480865|FG000|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
11284229|NCT02430311|12480866|FG001|Received Paclitaxel|Part A||16
11284230|NCT02430311|12480865|FG000|COMPLETED|Part A||19
11284231|NCT02430311|12480866|FG001|COMPLETED|Part A||15
11284232|NCT02430311|12480865|FG000|NOT COMPLETED|Part A||1
11284233|NCT02430311|12480866|FG001|NOT COMPLETED|Part A||1
11284234|NCT02430311|12480865|FG000|STARTED|Part B||19
11284235|NCT02430311|12480866|FG001|STARTED|Part B||15
11284236|NCT02430311|12480865|FG000|Received Olaparib|Part B||19
11284237|NCT02430311|12480866|FG001|Received Olaparib|Part B||15
11284238|NCT02430311|12480865|FG000|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
11284239|NCT02430311|12480866|FG001|Received Paclitaxel|Part B||14
11284240|NCT02430311|12480865|FG000|COMPLETED|Part B||9
11284241|NCT02430311|12480866|FG001|COMPLETED|Part B||7
11284242|NCT02430311|12480865|FG000|NOT COMPLETED|Part B||10
11284243|NCT02430311|12480866|FG001|NOT COMPLETED|Part B||8
11284244|NCT02430337|12480883|FG000|STARTED|Overall Study||11
11284245|NCT02430337|12480884|FG001|STARTED|Overall Study||20
11284246|NCT02430337|12480883|FG000|COMPLETED|Overall Study||11
11284247|NCT02430337|12480884|FG001|COMPLETED|Overall Study||20
11284248|NCT02430337|12480883|FG000|NOT COMPLETED|Overall Study||0
11284249|NCT02430337|12480884|FG001|NOT COMPLETED|Overall Study||0
11284250|NCT02430389|12480894|FG000|STARTED|Overall Study||10
11284251|NCT02430389|12480895|FG001|STARTED|Overall Study||10
11284252|NCT02430389|12480894|FG000|COMPLETED|Overall Study||10
11284253|NCT02430389|12480895|FG001|COMPLETED|Overall Study||10
11284254|NCT02430389|12480894|FG000|NOT COMPLETED|Overall Study||0
11284255|NCT02430389|12480895|FG001|NOT COMPLETED|Overall Study||0
11284256|NCT02430818|12480905|FG000|STARTED|Overall Study||7
11284257|NCT02430818|12480906|FG001|STARTED|Overall Study||6
11284258|NCT02430818|12480905|FG000|COMPLETED|Overall Study||7
11284259|NCT02430818|12480906|FG001|COMPLETED|Overall Study||6
11284260|NCT02430818|12480905|FG000|NOT COMPLETED|Overall Study||0
11284261|NCT02430818|12480906|FG001|NOT COMPLETED|Overall Study||0
11284262|NCT02430870|12480924|FG000|STARTED|Part 1||6
11284263|NCT02430870|12480925|FG001|STARTED|Part 1||6
11284264|NCT02430870|12480926|FG002|STARTED|Part 1||4
11284265|NCT02430870|12480927|FG003|STARTED|Part 1||0
11284266|NCT02430870|12480928|FG004|STARTED|Part 1||0
11284267|NCT02430870|12480929|FG005|STARTED|Part 1||0
11284268|NCT02430870|12480930|FG006|STARTED|Part 1||0
11284269|NCT02430870|12480931|FG007|STARTED|Part 1||0
11284270|NCT02430870|12480924|FG000|COMPLETED|Part 1||6
11284271|NCT02430870|12480925|FG001|COMPLETED|Part 1||6
11284272|NCT02430870|12480926|FG002|COMPLETED|Part 1||4
11284273|NCT02430870|12480927|FG003|COMPLETED|Part 1||0
11284274|NCT02430870|12480928|FG004|COMPLETED|Part 1||0
11284275|NCT02430870|12480929|FG005|COMPLETED|Part 1||0
11284276|NCT02430870|12480930|FG006|COMPLETED|Part 1||0
11284277|NCT02430870|12480931|FG007|COMPLETED|Part 1||0
11284278|NCT02430870|12480924|FG000|NOT COMPLETED|Part 1||0
11284279|NCT02430870|12480925|FG001|NOT COMPLETED|Part 1||0
11399116|NCT04370028|12593630|FG000|NOT COMPLETED|Overall Study||707
11399117|NCT04366583|12593643|FG000|STARTED|Overall Study||82
11021789|NCT00806078|12199975|FG000|STARTED|7 Day Washout Period||9
11021790|NCT00806078|12199976|FG001|STARTED|7 Day Washout Period||9
11021791|NCT00806078|12199975|FG000|COMPLETED|7 Day Washout Period||9
11284280|NCT02430870|12480926|FG002|NOT COMPLETED|Part 1||0
11284281|NCT02430870|12480927|FG003|NOT COMPLETED|Part 1||0
11284282|NCT02430870|12480928|FG004|NOT COMPLETED|Part 1||0
11284283|NCT02430870|12480929|FG005|NOT COMPLETED|Part 1||0
11284284|NCT02430870|12480930|FG006|NOT COMPLETED|Part 1||0
11284285|NCT02430870|12480931|FG007|NOT COMPLETED|Part 1||0
11284286|NCT02430870|12480924|FG000|STARTED|Part 2||0
11284287|NCT02430870|12480925|FG001|STARTED|Part 2||0
11284288|NCT02430870|12480926|FG002|STARTED|Part 2||0
11284289|NCT02430870|12480927|FG003|STARTED|Part 2||6
11284290|NCT02430870|12480928|FG004|STARTED|Part 2||6
11284291|NCT02430870|12480929|FG005|STARTED|Part 2||6
11284292|NCT02430870|12480930|FG006|STARTED|Part 2||6
11284293|NCT02430870|12480931|FG007|STARTED|Part 2||8
11284294|NCT02430870|12480924|FG000|COMPLETED|Part 2||0
11284295|NCT02430870|12480925|FG001|COMPLETED|Part 2||0
11284296|NCT02430870|12480926|FG002|COMPLETED|Part 2||0
11284297|NCT02430870|12480927|FG003|COMPLETED|Part 2||6
11284298|NCT02430870|12480928|FG004|COMPLETED|Part 2||6
11284299|NCT02430870|12480929|FG005|COMPLETED|Part 2||6
11284300|NCT02430870|12480930|FG006|COMPLETED|Part 2||5
11284301|NCT02430870|12480931|FG007|COMPLETED|Part 2||7
11284302|NCT02430870|12480924|FG000|NOT COMPLETED|Part 2||0
11284303|NCT02430870|12480925|FG001|NOT COMPLETED|Part 2||0
11284304|NCT02430870|12480926|FG002|NOT COMPLETED|Part 2||0
11284305|NCT02430870|12480927|FG003|NOT COMPLETED|Part 2||0
11284306|NCT02430870|12480928|FG004|NOT COMPLETED|Part 2||0
11284307|NCT02430870|12480929|FG005|NOT COMPLETED|Part 2||0
11284308|NCT02430870|12480930|FG006|NOT COMPLETED|Part 2||1
11399118|NCT04366583|12593644|FG001|STARTED|Overall Study||84
11399119|NCT04366583|12593643|FG000|COMPLETED|Overall Study||82
11284309|NCT02430870|12480931|FG007|NOT COMPLETED|Part 2||1
11284310|NCT02431052|12480954|FG000|STARTED|Overall Study||53
11284311|NCT02431052|12480955|FG001|STARTED|Overall Study||50
11284312|NCT02431052|12480956|FG002|STARTED|Overall Study||106
11284313|NCT02431052|12480957|FG003|STARTED|Overall Study||110
11284314|NCT02431052|12480958|FG004|STARTED|Overall Study||101
11284315|NCT02431052|12480954|FG000|COMPLETED|Overall Study||42
11284316|NCT02431052|12480955|FG001|COMPLETED|Overall Study||46
11284317|NCT02431052|12480956|FG002|COMPLETED|Overall Study||94
11284318|NCT02431052|12480957|FG003|COMPLETED|Overall Study||94
11284319|NCT02431052|12480958|FG004|COMPLETED|Overall Study||86
11284320|NCT02431052|12480954|FG000|NOT COMPLETED|Overall Study||11
11284321|NCT02431052|12480955|FG001|NOT COMPLETED|Overall Study||4
11284322|NCT02431052|12480956|FG002|NOT COMPLETED|Overall Study||12
11284323|NCT02431052|12480957|FG003|NOT COMPLETED|Overall Study||16
11284324|NCT02431052|12480958|FG004|NOT COMPLETED|Overall Study||15
11284325|NCT02431260|12480989|FG000|STARTED|Overall Study||4
11284326|NCT02431260|12480990|FG001|STARTED|Overall Study||5
11284327|NCT02431260|12480991|FG002|STARTED|Overall Study||6
11284328|NCT02431260|12480992|FG003|STARTED|Overall Study||5
11284329|NCT02431260|12480993|FG004|STARTED|Overall Study||3
11284330|NCT02431260|12480994|FG005|STARTED|Overall Study||4
11284331|NCT02431260|12480995|FG006|STARTED|Overall Study||4
11284332|NCT02431260|12480996|FG007|STARTED|Overall Study||3
11284333|NCT02431260|12480997|FG008|STARTED|Overall Study||8
11284334|NCT02431260|12480998|FG009|STARTED|Overall Study||8
11284335|NCT02431260|12480999|FG010|STARTED|Overall Study||4
11284336|NCT02431260|12481000|FG011|STARTED|Overall Study||4
11284337|NCT02431260|12481001|FG012|STARTED|Overall Study||10
11284338|NCT02431260|12481002|FG013|STARTED|Overall Study||1
11284339|NCT02431260|12480989|FG000|COMPLETED|Overall Study||0
11284340|NCT02431260|12480990|FG001|COMPLETED|Overall Study||0
11284341|NCT02431260|12480991|FG002|COMPLETED|Overall Study||0
11284342|NCT02431260|12480992|FG003|COMPLETED|Overall Study||0
11284343|NCT02431260|12480993|FG004|COMPLETED|Overall Study||0
11284344|NCT02431260|12480994|FG005|COMPLETED|Overall Study||0
11284345|NCT02431260|12480995|FG006|COMPLETED|Overall Study||0
11284346|NCT02431260|12480996|FG007|COMPLETED|Overall Study||0
11284347|NCT02431260|12480997|FG008|COMPLETED|Overall Study||0
11284348|NCT02431260|12480998|FG009|COMPLETED|Overall Study||0
11284349|NCT02431260|12480999|FG010|COMPLETED|Overall Study||0
11284350|NCT02431260|12481000|FG011|COMPLETED|Overall Study||0
11284351|NCT02431260|12481001|FG012|COMPLETED|Overall Study||0
11284352|NCT02431260|12481002|FG013|COMPLETED|Overall Study||0
11284353|NCT02431260|12480989|FG000|NOT COMPLETED|Overall Study||4
11284354|NCT02431260|12480990|FG001|NOT COMPLETED|Overall Study||5
11284355|NCT02431260|12480991|FG002|NOT COMPLETED|Overall Study||6
11284356|NCT02431260|12480992|FG003|NOT COMPLETED|Overall Study||5
11284357|NCT02431260|12480993|FG004|NOT COMPLETED|Overall Study||3
11284358|NCT02431260|12480994|FG005|NOT COMPLETED|Overall Study||4
11284359|NCT02431260|12480995|FG006|NOT COMPLETED|Overall Study||4
11284360|NCT02431260|12480996|FG007|NOT COMPLETED|Overall Study||3
11284361|NCT02431260|12480997|FG008|NOT COMPLETED|Overall Study||8
11284362|NCT02431260|12480998|FG009|NOT COMPLETED|Overall Study||8
11284363|NCT02431260|12480999|FG010|NOT COMPLETED|Overall Study||4
11399120|NCT04366583|12593644|FG001|COMPLETED|Overall Study||84
11284364|NCT02431260|12481000|FG011|NOT COMPLETED|Overall Study||4
11284365|NCT02431260|12481001|FG012|NOT COMPLETED|Overall Study||10
11284366|NCT02431260|12481002|FG013|NOT COMPLETED|Overall Study||1
11284367|NCT02431273|12481045|FG000|STARTED|TDF (Single IVR)||6
11284368|NCT02431273|12481045|FG000|COMPLETED|TDF (Single IVR)||6
11284369|NCT02431273|12481045|FG000|NOT COMPLETED|TDF (Single IVR)||0
11284370|NCT02431273|12481045|FG000|STARTED|TDF-FTC (Dual IVR)||6
11284371|NCT02431273|12481045|FG000|COMPLETED|TDF-FTC (Dual IVR)||6
11284372|NCT02431273|12481045|FG000|NOT COMPLETED|TDF-FTC (Dual IVR)||0
11284373|NCT02431273|12481045|FG000|STARTED|TDF-FTC-MVC (Triple IVR)||6
11284374|NCT02431273|12481045|FG000|COMPLETED|TDF-FTC-MVC (Triple IVR)||6
11284375|NCT02431273|12481045|FG000|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0
11284376|NCT02431299|12481055|FG000|STARTED|Overall Study||236
11284377|NCT02431299|12481056|FG001|STARTED|Overall Study||63
11284378|NCT02431299|12481055|FG000|COMPLETED|Overall Study||183
11284379|NCT02431299|12481056|FG001|COMPLETED|Overall Study||62
11284380|NCT02431299|12481055|FG000|NOT COMPLETED|Overall Study||53
11284381|NCT02431299|12481056|FG001|NOT COMPLETED|Overall Study||1
11284382|NCT02431364|12481067|FG000|STARTED|Overall Study||8
11284383|NCT02431364|12481068|FG001|STARTED|Overall Study||6
11284384|NCT02431364|12481069|FG002|STARTED|Overall Study||6
11284385|NCT02431364|12481070|FG003|STARTED|Overall Study||7
11284386|NCT02431364|12481071|FG004|STARTED|Overall Study||6
11284387|NCT02431364|12481067|FG000|Treated|Overall Study||8
11284388|NCT02431364|12481068|FG001|Treated|Overall Study||6
11284389|NCT02431364|12481069|FG002|Treated|Overall Study||6
11284390|NCT02431364|12481070|FG003|Treated|Overall Study||6
11284391|NCT02431364|12481071|FG004|Treated|Overall Study||6
11284392|NCT02431364|12481067|FG000|COMPLETED|Overall Study||8
11284393|NCT02431364|12481068|FG001|COMPLETED|Overall Study||5
11284394|NCT02431364|12481069|FG002|COMPLETED|Overall Study||6
11284395|NCT02431364|12481070|FG003|COMPLETED|Overall Study||6
11284396|NCT02431364|12481071|FG004|COMPLETED|Overall Study||6
11284397|NCT02431364|12481067|FG000|NOT COMPLETED|Overall Study||0
11284398|NCT02431364|12481068|FG001|NOT COMPLETED|Overall Study||1
11284399|NCT02431364|12481069|FG002|NOT COMPLETED|Overall Study||0
11284400|NCT02431364|12481070|FG003|NOT COMPLETED|Overall Study||1
11284401|NCT02431364|12481071|FG004|NOT COMPLETED|Overall Study||0
11284402|NCT02431455|12481089|FG000|STARTED|Overall Study||112
11284403|NCT02431455|12481090|FG001|STARTED|Overall Study||112
11284404|NCT02431455|12481089|FG000|COMPLETED|Overall Study||112
11284405|NCT02431455|12481090|FG001|COMPLETED|Overall Study||112
11284406|NCT02431455|12481089|FG000|NOT COMPLETED|Overall Study||0
11284407|NCT02431455|12481090|FG001|NOT COMPLETED|Overall Study||0
11284408|NCT02431468|12481099|FG000|STARTED|Overall Study||46
11284409|NCT02431468|12481100|FG001|STARTED|Overall Study||47
11284410|NCT02431468|12481101|FG002|STARTED|Overall Study||48
11284411|NCT02431468|12481099|FG000|COMPLETED|Overall Study||38
11284412|NCT02431468|12481100|FG001|COMPLETED|Overall Study||29
11284413|NCT02431468|12481101|FG002|COMPLETED|Overall Study||39
11284414|NCT02431468|12481099|FG000|NOT COMPLETED|Overall Study||8
11284415|NCT02431468|12481100|FG001|NOT COMPLETED|Overall Study||18
11284416|NCT02431468|12481101|FG002|NOT COMPLETED|Overall Study||9
11284417|NCT02431533|12481117|FG000|STARTED|Overall Study||25
11284418|NCT02431533|12481118|FG001|STARTED|Overall Study||25
11284419|NCT02431533|12481117|FG000|COMPLETED|Overall Study||23
11284420|NCT02431533|12481118|FG001|COMPLETED|Overall Study||22
11284421|NCT02431533|12481117|FG000|NOT COMPLETED|Overall Study||2
11284422|NCT02431533|12481118|FG001|NOT COMPLETED|Overall Study||3
11284423|NCT02431559|12481128|FG000|STARTED|Overall Study||3
11284424|NCT02431559|12481129|FG001|STARTED|Overall Study||4
11284425|NCT02431559|12481130|FG002|STARTED|Overall Study||6
11284426|NCT02431559|12481131|FG003|STARTED|Overall Study||40
11284427|NCT02431559|12481128|FG000|COMPLETED|Overall Study||1
11284428|NCT02431559|12481129|FG001|COMPLETED|Overall Study||1
11284429|NCT02431559|12481130|FG002|COMPLETED|Overall Study||2
11284430|NCT02431559|12481131|FG003|COMPLETED|Overall Study||9
11399121|NCT04366583|12593643|FG000|NOT COMPLETED|Overall Study||0
11399122|NCT04366583|12593644|FG001|NOT COMPLETED|Overall Study||0
11399123|NCT04365699|12593653|FG000|STARTED|Overall Study||10
11284431|NCT02431559|12481128|FG000|NOT COMPLETED|Overall Study||2
11284432|NCT02431559|12481129|FG001|NOT COMPLETED|Overall Study||3
11284433|NCT02431559|12481130|FG002|NOT COMPLETED|Overall Study||4
11284434|NCT02431559|12481131|FG003|NOT COMPLETED|Overall Study||31
11284435|NCT02431572|12481144|FG000|STARTED|Overall Study||1
11284436|NCT02431572|12481145|FG001|STARTED|Overall Study||1
11284437|NCT02431572|12481146|FG002|STARTED|Overall Study||9
11284438|NCT02431572|12481144|FG000|COMPLETED|Overall Study||0
11284439|NCT02431572|12481145|FG001|COMPLETED|Overall Study||1
11284440|NCT02431572|12481146|FG002|COMPLETED|Overall Study||9
11284441|NCT02431572|12481144|FG000|NOT COMPLETED|Overall Study||1
11284442|NCT02431572|12481145|FG001|NOT COMPLETED|Overall Study||0
11284443|NCT02431572|12481146|FG002|NOT COMPLETED|Overall Study||0
11284444|NCT02431598|12481154|FG000|STARTED|Overall Study||6
11284445|NCT02431598|12481155|FG001|STARTED|Overall Study||9
11284446|NCT02431598|12481156|FG002|STARTED|Overall Study||9
11284447|NCT02431598|12481157|FG003|STARTED|Overall Study||7
11284448|NCT02431598|12481158|FG004|STARTED|Overall Study||7
11284449|NCT02431598|12481159|FG005|STARTED|Overall Study||6
11284450|NCT02431598|12481154|FG000|COMPLETED|Overall Study||6
11284451|NCT02431598|12481155|FG001|COMPLETED|Overall Study||9
11284452|NCT02431598|12481156|FG002|COMPLETED|Overall Study||9
11284453|NCT02431598|12481157|FG003|COMPLETED|Overall Study||7
11284454|NCT02431598|12481158|FG004|COMPLETED|Overall Study||7
11284455|NCT02431598|12481159|FG005|COMPLETED|Overall Study||6
11284456|NCT02431598|12481154|FG000|NOT COMPLETED|Overall Study||0
11284457|NCT02431598|12481155|FG001|NOT COMPLETED|Overall Study||0
11284458|NCT02431598|12481156|FG002|NOT COMPLETED|Overall Study||0
11284459|NCT02431598|12481157|FG003|NOT COMPLETED|Overall Study||0
11284460|NCT02431598|12481158|FG004|NOT COMPLETED|Overall Study||0
11284461|NCT02431598|12481159|FG005|NOT COMPLETED|Overall Study||0
11284462|NCT02431637|12481176|FG000|STARTED|Overall Study||6
11284463|NCT02431637|12481176|FG000|COMPLETED|Overall Study||6
11284464|NCT02431637|12481176|FG000|NOT COMPLETED|Overall Study||0
11284465|NCT02431650|12481182|FG000|STARTED|Overall Study||5
11399124|NCT04365699|12593654|FG001|STARTED|Overall Study||16
11399125|NCT04365699|12593655|FG002|STARTED|Overall Study||55
11399126|NCT04365699|12593653|FG000|COMPLETED|Overall Study||8
11399127|NCT04365699|12593654|FG001|COMPLETED|Overall Study||11
11399128|NCT04365699|12593655|FG002|COMPLETED|Overall Study||40
11399129|NCT04365699|12593653|FG000|NOT COMPLETED|Overall Study||2
11399130|NCT04365699|12593654|FG001|NOT COMPLETED|Overall Study||5
11284466|NCT02431650|12481183|FG001|STARTED|Overall Study||6
11284467|NCT02431650|12481182|FG000|COMPLETED|Overall Study||5
11284468|NCT02431650|12481183|FG001|COMPLETED|Overall Study||6
11284469|NCT02431650|12481182|FG000|NOT COMPLETED|Overall Study||0
11284470|NCT02431650|12481183|FG001|NOT COMPLETED|Overall Study||0
11284471|NCT02431676|12481192|FG000|STARTED|Overall Study||40
11284472|NCT02431676|12481193|FG001|STARTED|Overall Study||39
11284473|NCT02431676|12481194|FG002|STARTED|Overall Study||42
11284474|NCT02431676|12481192|FG000|COMPLETED|Overall Study||40
11284475|NCT02431676|12481193|FG001|COMPLETED|Overall Study||38
11399131|NCT04365699|12593655|FG002|NOT COMPLETED|Overall Study||15
11399132|NCT04365153|12593666|FG000|STARTED|Overall Study||15
11399133|NCT04365153|12593667|FG001|STARTED|Overall Study||14
11399134|NCT04365153|12593668|FG002|STARTED|Overall Study||16
11021792|NCT00806078|12199976|FG001|COMPLETED|7 Day Washout Period||9
11021793|NCT00806078|12199975|FG000|NOT COMPLETED|7 Day Washout Period||0
11021794|NCT00806078|12199976|FG001|NOT COMPLETED|7 Day Washout Period||0
11021795|NCT00806078|12199975|FG000|STARTED|Second Intervention||9
11021796|NCT00806078|12199976|FG001|STARTED|Second Intervention||9
11021797|NCT00806078|12199975|FG000|COMPLETED|Second Intervention||9
11021798|NCT00806078|12199976|FG001|COMPLETED|Second Intervention||9
11021799|NCT00806078|12199975|FG000|NOT COMPLETED|Second Intervention||0
11021800|NCT00806078|12199976|FG001|NOT COMPLETED|Second Intervention||0
11021801|NCT00806156|12199984|FG000|STARTED|Overall Study||39
11284476|NCT02431676|12481194|FG002|COMPLETED|Overall Study||40
11284477|NCT02431676|12481192|FG000|NOT COMPLETED|Overall Study||0
11284478|NCT02431676|12481193|FG001|NOT COMPLETED|Overall Study||1
11284479|NCT02431676|12481194|FG002|NOT COMPLETED|Overall Study||2
11284480|NCT02431741|12481202|FG000|STARTED|Overall Study||14
11284481|NCT02431741|12481202|FG000|COMPLETED|Overall Study||14
11284482|NCT02431741|12481202|FG000|NOT COMPLETED|Overall Study||0
11284483|NCT02431754|12481208|FG000|STARTED|Period 1 (8 Weeks)||85
11284484|NCT02431754|12481209|FG001|STARTED|Period 1 (8 Weeks)||86
11284485|NCT02431754|12481208|FG000|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
11284486|NCT02431754|12481209|FG001|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
11284487|NCT02431754|12481208|FG000|COMPLETED|Period 1 (8 Weeks)||79
11284488|NCT02431754|12481209|FG001|COMPLETED|Period 1 (8 Weeks)||82
11284489|NCT02431754|12481208|FG000|NOT COMPLETED|Period 1 (8 Weeks)||6
11284490|NCT02431754|12481209|FG001|NOT COMPLETED|Period 1 (8 Weeks)||4
11284491|NCT02431754|12481208|FG000|STARTED|Wash-out Period (4 Weeks)||79
11284492|NCT02431754|12481209|FG001|STARTED|Wash-out Period (4 Weeks)||82
11284493|NCT02431754|12481208|FG000|COMPLETED|Wash-out Period (4 Weeks)||75
11284494|NCT02431754|12481209|FG001|COMPLETED|Wash-out Period (4 Weeks)||82
11284495|NCT02431754|12481208|FG000|NOT COMPLETED|Wash-out Period (4 Weeks)||4
11284496|NCT02431754|12481209|FG001|NOT COMPLETED|Wash-out Period (4 Weeks)||0
11284497|NCT02431754|12481208|FG000|STARTED|Period 2 (8 Weeks)||75
11284498|NCT02431754|12481209|FG001|STARTED|Period 2 (8 Weeks)||82
11284499|NCT02431754|12481208|FG000|COMPLETED|Period 2 (8 Weeks)||74
11284500|NCT02431754|12481209|FG001|COMPLETED|Period 2 (8 Weeks)||78
11284501|NCT02431754|12481208|FG000|NOT COMPLETED|Period 2 (8 Weeks)||1
11284502|NCT02431754|12481209|FG001|NOT COMPLETED|Period 2 (8 Weeks)||4
11284503|NCT02431793|12481220|FG000|STARTED|Overall Study||202
11284504|NCT02431793|12481221|FG001|STARTED|Overall Study||243
11284505|NCT02431793|12481222|FG002|STARTED|Overall Study||207
11284506|NCT02431793|12481220|FG000|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136
11284507|NCT02431793|12481221|FG001|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180
11284508|NCT02431793|12481222|FG002|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143
11284509|NCT02431793|12481220|FG000|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95
11284510|NCT02431793|12481221|FG001|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141
11284511|NCT02431793|12481222|FG002|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107
11284512|NCT02431793|12481220|FG000|Completed T3 (30 Days Post Enrollment)|Overall Study||85
11284513|NCT02431793|12481221|FG001|Completed T3 (30 Days Post Enrollment)|Overall Study||113
11284514|NCT02431793|12481222|FG002|Completed T3 (30 Days Post Enrollment)|Overall Study||93
11284515|NCT02431793|12481220|FG000|COMPLETED|Overall Study||83
11284516|NCT02431793|12481221|FG001|COMPLETED|Overall Study||109
11284517|NCT02431793|12481222|FG002|COMPLETED|Overall Study||90
11284518|NCT02431793|12481220|FG000|NOT COMPLETED|Overall Study||119
11284519|NCT02431793|12481221|FG001|NOT COMPLETED|Overall Study||134
11284520|NCT02431793|12481222|FG002|NOT COMPLETED|Overall Study||117
11284521|NCT02431806|12481234|FG000|STARTED|Double-blind Treatment Period||142
11284522|NCT02431806|12481235|FG001|STARTED|Double-blind Treatment Period||136
11284523|NCT02431806|12481236|FG002|STARTED|Double-blind Treatment Period||139
11284524|NCT02431806|12481237|FG003|STARTED|Double-blind Treatment Period||135
11284525|NCT02431806|12481234|FG000|Safety Population|Double-blind Treatment Period||141
11284526|NCT02431806|12481235|FG001|Safety Population|Double-blind Treatment Period||134
11284527|NCT02431806|12481236|FG002|Safety Population|Double-blind Treatment Period||138
11284528|NCT02431806|12481237|FG003|Safety Population|Double-blind Treatment Period||134
11284529|NCT02431806|12481234|FG000|COMPLETED|Double-blind Treatment Period||117
11284530|NCT02431806|12481235|FG001|COMPLETED|Double-blind Treatment Period||115
11284531|NCT02431806|12481236|FG002|COMPLETED|Double-blind Treatment Period||107
11284532|NCT02431806|12481237|FG003|COMPLETED|Double-blind Treatment Period||109
11284533|NCT02431806|12481234|FG000|NOT COMPLETED|Double-blind Treatment Period||25
11284534|NCT02431806|12481235|FG001|NOT COMPLETED|Double-blind Treatment Period||21
11284535|NCT02431806|12481236|FG002|NOT COMPLETED|Double-blind Treatment Period||32
11284536|NCT02431806|12481237|FG003|NOT COMPLETED|Double-blind Treatment Period||26
11284537|NCT02431806|12481234|FG000|STARTED|Double-blind Down-taper Period||111
11284538|NCT02431806|12481235|FG001|STARTED|Double-blind Down-taper Period||109
11284539|NCT02431806|12481236|FG002|STARTED|Double-blind Down-taper Period||104
11284540|NCT02431806|12481237|FG003|STARTED|Double-blind Down-taper Period||107
11284541|NCT02431806|12481234|FG000|COMPLETED|Double-blind Down-taper Period||111
11284542|NCT02431806|12481235|FG001|COMPLETED|Double-blind Down-taper Period||109
11284543|NCT02431806|12481236|FG002|COMPLETED|Double-blind Down-taper Period||104
11284544|NCT02431806|12481237|FG003|COMPLETED|Double-blind Down-taper Period||107
11284545|NCT02431806|12481234|FG000|NOT COMPLETED|Double-blind Down-taper Period||0
11284546|NCT02431806|12481235|FG001|NOT COMPLETED|Double-blind Down-taper Period||0
11284547|NCT02431806|12481236|FG002|NOT COMPLETED|Double-blind Down-taper Period||0
11284548|NCT02431806|12481237|FG003|NOT COMPLETED|Double-blind Down-taper Period||0
11284549|NCT02432040|12481249|FG000|STARTED|Overall Study||14
11284550|NCT02432040|12481250|FG001|STARTED|Overall Study||14
11284551|NCT02432040|12481249|FG000|COMPLETED|Overall Study||6
11284552|NCT02432040|12481250|FG001|COMPLETED|Overall Study||8
11284553|NCT02432040|12481249|FG000|NOT COMPLETED|Overall Study||8
11284554|NCT02432040|12481250|FG001|NOT COMPLETED|Overall Study||6
11284555|NCT02432105|12481259|FG000|STARTED|Overall Study||164
11284556|NCT02432105|12481260|FG001|STARTED|Overall Study||110
11284557|NCT02432105|12481261|FG002|STARTED|Overall Study||111
11284558|NCT02432105|12481259|FG000|COMPLETED|Overall Study||162
11284559|NCT02432105|12481260|FG001|COMPLETED|Overall Study||108
11284560|NCT02432105|12481261|FG002|COMPLETED|Overall Study||108
11284561|NCT02432105|12481259|FG000|NOT COMPLETED|Overall Study||2
11284562|NCT02432105|12481260|FG001|NOT COMPLETED|Overall Study||2
11284563|NCT02432105|12481261|FG002|NOT COMPLETED|Overall Study||3
11284564|NCT02432144|12481270|FG000|STARTED|Overall Study||12
11284565|NCT02432144|12481270|FG000|COMPLETED|Overall Study||11
11284566|NCT02432144|12481270|FG000|NOT COMPLETED|Overall Study||1
11284567|NCT02432183|12481278|FG000|STARTED|Overall Study||44
11284568|NCT02432183|12481279|FG001|STARTED|Overall Study||47
11284569|NCT02432183|12481280|FG002|STARTED|Overall Study||26
11284570|NCT02432183|12481281|FG003|STARTED|Overall Study||17
11284571|NCT02432183|12481278|FG000|COMPLETED|Overall Study||44
11284572|NCT02432183|12481279|FG001|COMPLETED|Overall Study||47
11284573|NCT02432183|12481280|FG002|COMPLETED|Overall Study||26
11284574|NCT02432183|12481281|FG003|COMPLETED|Overall Study||17
11284575|NCT02432183|12481278|FG000|NOT COMPLETED|Overall Study||0
11284576|NCT02432183|12481279|FG001|NOT COMPLETED|Overall Study||0
11284577|NCT02432183|12481280|FG002|NOT COMPLETED|Overall Study||0
11284578|NCT02432183|12481281|FG003|NOT COMPLETED|Overall Study||0
11284579|NCT02432235|12481303|FG000|STARTED|Overall Study||2
11284580|NCT02432235|12481304|FG001|STARTED|Overall Study||2
11284581|NCT02432235|12481305|FG002|STARTED|Overall Study||2
11284582|NCT02432235|12481306|FG003|STARTED|Overall Study||3
11284583|NCT02432235|12481307|FG004|STARTED|Overall Study||2
11284584|NCT02432235|12481308|FG005|STARTED|Overall Study||20
11284585|NCT02432235|12481309|FG006|STARTED|Overall Study||41
11284586|NCT02432235|12481310|FG007|STARTED|Overall Study||29
11284587|NCT02432235|12481311|FG008|STARTED|Overall Study||26
11284588|NCT02432235|12481312|FG009|STARTED|Overall Study||3
11284589|NCT02432235|12481313|FG010|STARTED|Overall Study||2
11284590|NCT02432235|12481314|FG011|STARTED|Overall Study||1
11284591|NCT02432235|12481303|FG000|COMPLETED|Overall Study||1
11284592|NCT02432235|12481304|FG001|COMPLETED|Overall Study||0
11284593|NCT02432235|12481305|FG002|COMPLETED|Overall Study||0
11284594|NCT02432235|12481306|FG003|COMPLETED|Overall Study||1
11284595|NCT02432235|12481307|FG004|COMPLETED|Overall Study||0
11399135|NCT04365153|12593666|FG000|COMPLETED|Overall Study||15
11399136|NCT04365153|12593667|FG001|COMPLETED|Overall Study||14
11399137|NCT04365153|12593668|FG002|COMPLETED|Overall Study||16
11399138|NCT04365153|12593666|FG000|NOT COMPLETED|Overall Study||0
11399139|NCT04365153|12593667|FG001|NOT COMPLETED|Overall Study||0
11399140|NCT04365153|12593668|FG002|NOT COMPLETED|Overall Study||0
11399141|NCT04363879|12593679|FG000|STARTED|Overall Study||78
11399142|NCT04363879|12593680|FG001|STARTED|Overall Study||92
11284596|NCT02432235|12481308|FG005|COMPLETED|Overall Study||8
11284597|NCT02432235|12481309|FG006|COMPLETED|Overall Study||23
11284598|NCT02432235|12481310|FG007|COMPLETED|Overall Study||9
11284599|NCT02432235|12481311|FG008|COMPLETED|Overall Study||5
11284600|NCT02432235|12481312|FG009|COMPLETED|Overall Study||0
11284601|NCT02432235|12481313|FG010|COMPLETED|Overall Study||1
11284602|NCT02432235|12481314|FG011|COMPLETED|Overall Study||0
11399143|NCT04363879|12593679|FG000|COMPLETED|Overall Study||78
11399144|NCT04363879|12593680|FG001|COMPLETED|Overall Study||92
11399145|NCT04363879|12593679|FG000|NOT COMPLETED|Overall Study||0
11399146|NCT04363879|12593680|FG001|NOT COMPLETED|Overall Study||0
11399147|NCT04362137|12593688|FG000|STARTED|Overall Study||287
11399148|NCT04362137|12593689|FG001|STARTED|Overall Study||145
11284603|NCT02432235|12481303|FG000|NOT COMPLETED|Overall Study||1
11284604|NCT02432235|12481304|FG001|NOT COMPLETED|Overall Study||2
11284605|NCT02432235|12481305|FG002|NOT COMPLETED|Overall Study||2
11284606|NCT02432235|12481306|FG003|NOT COMPLETED|Overall Study||2
11284607|NCT02432235|12481307|FG004|NOT COMPLETED|Overall Study||2
11284608|NCT02432235|12481308|FG005|NOT COMPLETED|Overall Study||12
11284609|NCT02432235|12481309|FG006|NOT COMPLETED|Overall Study||18
11284610|NCT02432235|12481310|FG007|NOT COMPLETED|Overall Study||20
11284611|NCT02432235|12481311|FG008|NOT COMPLETED|Overall Study||21
11284612|NCT02432235|12481312|FG009|NOT COMPLETED|Overall Study||3
11284613|NCT02432235|12481313|FG010|NOT COMPLETED|Overall Study||1
11284614|NCT02432235|12481314|FG011|NOT COMPLETED|Overall Study||1
11284615|NCT02432287|12481344|FG000|STARTED|First Intervention||8
11284616|NCT02432287|12481345|FG001|STARTED|First Intervention||8
11284617|NCT02432287|12481344|FG000|COMPLETED|First Intervention||8
11284618|NCT02432287|12481345|FG001|COMPLETED|First Intervention||7
11399149|NCT04362137|12593688|FG000|Safety Set|Overall Study||281
11399150|NCT04362137|12593689|FG001|Safety Set|Overall Study||143
11399151|NCT04362137|12593688|FG000|COMPLETED|Overall Study||269
11399152|NCT04362137|12593689|FG001|COMPLETED|Overall Study||139
11284619|NCT02432287|12481344|FG000|NOT COMPLETED|First Intervention||0
11284620|NCT02432287|12481345|FG001|NOT COMPLETED|First Intervention||1
11284621|NCT02432287|12481344|FG000|STARTED|Washout Period||7
11284622|NCT02432287|12481345|FG001|STARTED|Washout Period||7
11284623|NCT02432287|12481344|FG000|COMPLETED|Washout Period||7
11284624|NCT02432287|12481345|FG001|COMPLETED|Washout Period||7
11284625|NCT02432287|12481344|FG000|NOT COMPLETED|Washout Period||0
11284626|NCT02432287|12481345|FG001|NOT COMPLETED|Washout Period||0
11284627|NCT02432287|12481344|FG000|STARTED|Second Intervention||7
11284628|NCT02432287|12481345|FG001|STARTED|Second Intervention||7
11284629|NCT02432287|12481344|FG000|COMPLETED|Second Intervention||7
11284630|NCT02432287|12481345|FG001|COMPLETED|Second Intervention||7
11284631|NCT02432287|12481344|FG000|NOT COMPLETED|Second Intervention||0
11284632|NCT02432287|12481345|FG001|NOT COMPLETED|Second Intervention||0
11284633|NCT02432300|12481353|FG000|STARTED|Overall Study||17
11284634|NCT02432300|12481353|FG000|COMPLETED|Overall Study||13
11284635|NCT02432300|12481353|FG000|NOT COMPLETED|Overall Study||4
11284636|NCT02432456|12481359|FG000|STARTED|Overall Study||75
11284637|NCT02432456|12481360|FG001|STARTED|Overall Study||75
11284638|NCT02432456|12481359|FG000|COMPLETED|Overall Study||75
11284639|NCT02432456|12481360|FG001|COMPLETED|Overall Study||75
11284640|NCT02432456|12481359|FG000|NOT COMPLETED|Overall Study||0
11284641|NCT02432456|12481360|FG001|NOT COMPLETED|Overall Study||0
11284642|NCT02432703|12481368|FG000|STARTED|Overall Study||75
11284643|NCT02432703|12481369|FG001|STARTED|Overall Study||74
11284644|NCT02432703|12481368|FG000|COMPLETED|Overall Study||53
11284645|NCT02432703|12481369|FG001|COMPLETED|Overall Study||56
11284646|NCT02432703|12481368|FG000|NOT COMPLETED|Overall Study||22
11284647|NCT02432703|12481369|FG001|NOT COMPLETED|Overall Study||18
11284648|NCT02432716|12481375|FG000|STARTED|Overall Study||6
11284649|NCT02432716|12481376|FG001|STARTED|Overall Study||6
11284650|NCT02432716|12481375|FG000|COMPLETED|Overall Study||6
11284651|NCT02432716|12481376|FG001|COMPLETED|Overall Study||6
11284652|NCT02432716|12481375|FG000|NOT COMPLETED|Overall Study||0
11284653|NCT02432716|12481376|FG001|NOT COMPLETED|Overall Study||0
11284654|NCT02432729|12481384|FG000|STARTED|Month 3 Visit||720
11284655|NCT02432729|12481384|FG000|COMPLETED|Month 3 Visit||718
11284656|NCT02432729|12481384|FG000|NOT COMPLETED|Month 3 Visit||2
11284657|NCT02432729|12481384|FG000|STARTED|Month 6 Visit||718
11284658|NCT02432729|12481384|FG000|COMPLETED|Month 6 Visit||632
11284659|NCT02432729|12481384|FG000|NOT COMPLETED|Month 6 Visit||86
11284660|NCT02432729|12481384|FG000|STARTED|Month 12 Visit||632
11284661|NCT02432729|12481384|FG000|COMPLETED|Month 12 Visit||436
11284662|NCT02432729|12481384|FG000|NOT COMPLETED|Month 12 Visit||196
11284663|NCT02433080|12481391|FG000|STARTED|Overall Study||26
11284664|NCT02433080|12481392|FG001|STARTED|Overall Study||28
11284665|NCT02433080|12481391|FG000|8 Weeks|Overall Study||25
11284666|NCT02433080|12481392|FG001|8 Weeks|Overall Study||24
11284667|NCT02433080|12481391|FG000|COMPLETED|Overall Study||25
11284668|NCT02433080|12481392|FG001|COMPLETED|Overall Study||24
11284669|NCT02433080|12481391|FG000|NOT COMPLETED|Overall Study||1
11284670|NCT02433080|12481392|FG001|NOT COMPLETED|Overall Study||4
11284671|NCT02433288|12481401|FG000|STARTED|Overall Study||443
11284672|NCT02433288|12481402|FG001|STARTED|Overall Study||442
11284673|NCT02433288|12481401|FG000|COMPLETED|Overall Study||320
11284674|NCT02433288|12481402|FG001|COMPLETED|Overall Study||316
11284675|NCT02433288|12481401|FG000|NOT COMPLETED|Overall Study||123
11284676|NCT02433288|12481402|FG001|NOT COMPLETED|Overall Study||126
11284677|NCT02433340|12481412|FG000|STARTED|Overall Study||42
11284678|NCT02433340|12481413|FG001|STARTED|Overall Study||37
11284679|NCT02433340|12481414|FG002|STARTED|Overall Study||39
11284680|NCT02433340|12481415|FG003|STARTED|Overall Study||40
11284681|NCT02433340|12481412|FG000|COMPLETED|Overall Study||40
11284682|NCT02433340|12481413|FG001|COMPLETED|Overall Study||35
11284683|NCT02433340|12481414|FG002|COMPLETED|Overall Study||37
11284684|NCT02433340|12481415|FG003|COMPLETED|Overall Study||38
11284685|NCT02433340|12481412|FG000|NOT COMPLETED|Overall Study||2
11284686|NCT02433340|12481413|FG001|NOT COMPLETED|Overall Study||2
11284687|NCT02433340|12481414|FG002|NOT COMPLETED|Overall Study||2
11284688|NCT02433340|12481415|FG003|NOT COMPLETED|Overall Study||2
11284689|NCT02433366|12481429|FG000|STARTED|Overall Study||411
11284690|NCT02433366|12481430|FG001|STARTED|Overall Study||802
11284691|NCT02433366|12481429|FG000|COMPLETED|Overall Study||411
11284692|NCT02433366|12481430|FG001|COMPLETED|Overall Study||802
11284693|NCT02433366|12481429|FG000|NOT COMPLETED|Overall Study||0
11284694|NCT02433366|12481430|FG001|NOT COMPLETED|Overall Study||0
11284695|NCT02433379|12481436|FG000|STARTED|Overall Study||1173
11284696|NCT02433379|12481436|FG000|COMPLETED|Overall Study||852
11284697|NCT02433379|12481436|FG000|NOT COMPLETED|Overall Study||321
11284698|NCT02433483|12481442|FG000|STARTED|Overall Study||2
11284699|NCT02433483|12481442|FG000|COMPLETED|Overall Study||0
11284700|NCT02433483|12481442|FG000|NOT COMPLETED|Overall Study||2
11284701|NCT02433496|12481449|FG000|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
11284702|NCT02433496|12481450|FG001|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
11284703|NCT02433496|12481451|FG002|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
11284704|NCT02433496|12481449|FG000|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
11284705|NCT02433496|12481450|FG001|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
11284706|NCT02433496|12481451|FG002|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
11284707|NCT02433496|12481449|FG000|NOT COMPLETED|Overall Study||0
11284708|NCT02433496|12481450|FG001|NOT COMPLETED|Overall Study||0
11284709|NCT02433496|12481451|FG002|NOT COMPLETED|Overall Study||0
11284710|NCT02433613|12481458|FG000|STARTED|Overall Study||1071
11284711|NCT02433613|12481458|FG000|COMPLETED|Overall Study||1054
11284712|NCT02433613|12481458|FG000|NOT COMPLETED|Overall Study||17
11284713|NCT02433665|12481464|FG000|STARTED|Overall Study||77
11284714|NCT02433665|12481465|FG001|STARTED|Overall Study||79
11284715|NCT02433665|12481464|FG000|COMPLETED|Overall Study||77
11284716|NCT02433665|12481465|FG001|COMPLETED|Overall Study||79
11284717|NCT02433665|12481464|FG000|NOT COMPLETED|Overall Study||0
11284718|NCT02433665|12481465|FG001|NOT COMPLETED|Overall Study||0
11143778|NCT01474512|12330427|FG005|NOT COMPLETED|Long-Term Extension Period||0
11143779|NCT01474512|12330428|FG006|NOT COMPLETED|Long-Term Extension Period||0
11143780|NCT01474512|12330429|FG007|NOT COMPLETED|Long-Term Extension Period||0
11284719|NCT02433678|12481473|FG000|STARTED|Overall Study||26
11284720|NCT02433678|12481474|FG001|STARTED|Overall Study||26
11284721|NCT02433678|12481473|FG000|COMPLETED|Overall Study||25
11284722|NCT02433678|12481474|FG001|COMPLETED|Overall Study||24
11284723|NCT02433678|12481473|FG000|NOT COMPLETED|Overall Study||1
11284724|NCT02433678|12481474|FG001|NOT COMPLETED|Overall Study||2
11399153|NCT04362137|12593688|FG000|NOT COMPLETED|Overall Study||18
11399154|NCT04362137|12593689|FG001|NOT COMPLETED|Overall Study||6
11399155|NCT04359771|12593697|FG000|STARTED|Overall Study|Right eye of every participant was assigned to the diode MPL group|15
11399156|NCT04359771|12593698|FG001|STARTED|Overall Study|Left eye of every participant was assigned to the diode MPL group|15
11399157|NCT04359771|12593697|FG000|COMPLETED|Overall Study|The right eye of each participant was assigned to the diode MPL group|13
11399158|NCT04359771|12593698|FG001|COMPLETED|Overall Study|The left eye of every participant was assigned to the diode MPL group|13
11284725|NCT02433834|12481480|FG000|STARTED|Overall Study||248
11284726|NCT02433834|12481480|FG000|GP MDI 28.8 µg|Overall Study||112
11284727|NCT02433834|12481480|FG000|GP MDI 14.4 µg|Overall Study||230
11284728|NCT02433834|12481480|FG000|GP MDI 7.2 µg|Overall Study||228
11284729|NCT02433834|12481480|FG000|GP MDI 3.6 µg|Overall Study||118
11284730|NCT02433834|12481480|FG000|GP MDI 1.9 µg|Overall Study||107
11284731|NCT02433834|12481480|FG000|Placebo MDI|Overall Study||174
11284732|NCT02433834|12481480|FG000|SAL 50 µg|Overall Study||167
11284733|NCT02433834|12481480|FG000|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
11284734|NCT02433834|12481480|FG000|NOT COMPLETED|Overall Study||37
11284735|NCT02433977|12481496|FG000|STARTED|Overall Study||6
11284736|NCT02433977|12481496|FG000|COMPLETED|Overall Study||6
11284737|NCT02433977|12481496|FG000|NOT COMPLETED|Overall Study||0
11284738|NCT02434328|12481502|FG000|STARTED|Overall Study||372
11284739|NCT02434328|12481503|FG001|STARTED|Overall Study||371
11284740|NCT02434328|12481502|FG000|Randomized and Treated|Overall Study||370
11284741|NCT02434328|12481503|FG001|Randomized and Treated|Overall Study||369
11284742|NCT02434328|12481502|FG000|COMPLETED|Overall Study||342
11284743|NCT02434328|12481503|FG001|COMPLETED|Overall Study||329
11284744|NCT02434328|12481502|FG000|NOT COMPLETED|Overall Study||30
11284745|NCT02434328|12481503|FG001|NOT COMPLETED|Overall Study||42
11284746|NCT02434471|12481510|FG000|STARTED|Overall Study||34
11284747|NCT02434471|12481510|FG000|COMPLETED|Overall Study||25
11284748|NCT02434471|12481510|FG000|NOT COMPLETED|Overall Study||9
11284749|NCT02434497|12481515|FG000|STARTED|Overall Study||9
11284750|NCT02434497|12481515|FG000|COMPLETED|Overall Study||4
11284751|NCT02434497|12481515|FG000|NOT COMPLETED|Overall Study||5
11284752|NCT02434523|12481523|FG000|STARTED|Overall Study||15
11284753|NCT02434523|12481524|FG001|STARTED|Overall Study||15
11284754|NCT02434523|12481523|FG000|COMPLETED|Overall Study||10
11284755|NCT02434523|12481524|FG001|COMPLETED|Overall Study||9
11284756|NCT02434523|12481523|FG000|NOT COMPLETED|Overall Study||5
11284757|NCT02434523|12481524|FG001|NOT COMPLETED|Overall Study||6
11284758|NCT02434770|12481535|FG000|STARTED|Week 1 to Week 18||250
11284759|NCT02434770|12481536|FG001|STARTED|Week 1 to Week 18||250
11284760|NCT02434770|12481537|FG002|STARTED|Week 1 to Week 18||250
11284761|NCT02434770|12481535|FG000|Received at Least One Vaccination|Week 1 to Week 18||249
11284762|NCT02434770|12481536|FG001|Received at Least One Vaccination|Week 1 to Week 18||250
11284763|NCT02434770|12481537|FG002|Received at Least One Vaccination|Week 1 to Week 18||250
11284764|NCT02434770|12481535|FG000|COMPLETED|Week 1 to Week 18||235
11284765|NCT02434770|12481536|FG001|COMPLETED|Week 1 to Week 18||228
11284766|NCT02434770|12481537|FG002|COMPLETED|Week 1 to Week 18||233
11284767|NCT02434770|12481535|FG000|NOT COMPLETED|Week 1 to Week 18||15
11399159|NCT04359771|12593697|FG000|NOT COMPLETED|Overall Study||2
11399160|NCT04359771|12593698|FG001|NOT COMPLETED|Overall Study||2
11399161|NCT04358991|12593704|FG000|STARTED|Overall Study||20
11399162|NCT04358991|12593704|FG000|COMPLETED|Overall Study||20
11399163|NCT04358991|12593704|FG000|NOT COMPLETED|Overall Study||0
11399164|NCT04358081|12593711|FG000|STARTED|Treatment Phase of Study||7
11399165|NCT04358081|12593712|FG001|STARTED|Treatment Phase of Study||7
11399166|NCT04358081|12593713|FG002|STARTED|Treatment Phase of Study||5
11399167|NCT04358081|12593711|FG000|COMPLETED|Treatment Phase of Study||3
11284768|NCT02434770|12481536|FG001|NOT COMPLETED|Week 1 to Week 18||22
11284769|NCT02434770|12481537|FG002|NOT COMPLETED|Week 1 to Week 18||17
11284770|NCT02434770|12481535|FG000|STARTED|Week 18 to Week||235
11284771|NCT02434770|12481536|FG001|STARTED|Week 18 to Week||228
11284772|NCT02434770|12481537|FG002|STARTED|Week 18 to Week||233
11284773|NCT02434770|12481535|FG000|COMPLETED|Week 18 to Week||227
11284774|NCT02434770|12481536|FG001|COMPLETED|Week 18 to Week||220
11284775|NCT02434770|12481537|FG002|COMPLETED|Week 18 to Week||227
11284776|NCT02434770|12481535|FG000|NOT COMPLETED|Week 18 to Week||8
11284777|NCT02434770|12481536|FG001|NOT COMPLETED|Week 18 to Week||8
11284778|NCT02434770|12481537|FG002|NOT COMPLETED|Week 18 to Week||6
11284779|NCT02434939|12481549|FG000|STARTED|Overall Study||120
11284780|NCT02434939|12481550|FG001|STARTED|Overall Study||120
11284781|NCT02434939|12481549|FG000|COMPLETED|Overall Study||83
11284782|NCT02434939|12481550|FG001|COMPLETED|Overall Study||71
11284783|NCT02434939|12481549|FG000|NOT COMPLETED|Overall Study||37
11284784|NCT02434939|12481550|FG001|NOT COMPLETED|Overall Study||49
11284785|NCT02435069|12481557|FG000|STARTED|Preoperative Baseline Phase||5
11284786|NCT02435069|12481558|FG001|STARTED|Preoperative Baseline Phase||0
11284787|NCT02435069|12481559|FG002|STARTED|Preoperative Baseline Phase||0
11284788|NCT02435069|12481560|FG003|STARTED|Preoperative Baseline Phase||0
11284789|NCT02435069|12481561|FG004|STARTED|Preoperative Baseline Phase||0
11284790|NCT02435069|12481557|FG000|COMPLETED|Preoperative Baseline Phase||5
11284791|NCT02435069|12481558|FG001|COMPLETED|Preoperative Baseline Phase||0
11284792|NCT02435069|12481559|FG002|COMPLETED|Preoperative Baseline Phase||0
11284793|NCT02435069|12481560|FG003|COMPLETED|Preoperative Baseline Phase||0
11284794|NCT02435069|12481561|FG004|COMPLETED|Preoperative Baseline Phase||0
11284795|NCT02435069|12481557|FG000|NOT COMPLETED|Preoperative Baseline Phase||0
11284796|NCT02435069|12481558|FG001|NOT COMPLETED|Preoperative Baseline Phase||0
11284797|NCT02435069|12481559|FG002|NOT COMPLETED|Preoperative Baseline Phase||0
11284798|NCT02435069|12481560|FG003|NOT COMPLETED|Preoperative Baseline Phase||0
11284799|NCT02435069|12481561|FG004|NOT COMPLETED|Preoperative Baseline Phase||0
11284800|NCT02435069|12481557|FG000|STARTED|Dose Response - First Intervention||0
11284801|NCT02435069|12481558|FG001|STARTED|Dose Response - First Intervention||3
11284802|NCT02435069|12481559|FG002|STARTED|Dose Response - First Intervention||2
11284803|NCT02435069|12481560|FG003|STARTED|Dose Response - First Intervention||0
11284804|NCT02435069|12481561|FG004|STARTED|Dose Response - First Intervention||0
11284805|NCT02435069|12481557|FG000|COMPLETED|Dose Response - First Intervention||0
11284806|NCT02435069|12481558|FG001|COMPLETED|Dose Response - First Intervention||2
11284807|NCT02435069|12481559|FG002|COMPLETED|Dose Response - First Intervention||1
11284808|NCT02435069|12481560|FG003|COMPLETED|Dose Response - First Intervention||0
11284809|NCT02435069|12481561|FG004|COMPLETED|Dose Response - First Intervention||0
11284810|NCT02435069|12481557|FG000|NOT COMPLETED|Dose Response - First Intervention||0
11284811|NCT02435069|12481558|FG001|NOT COMPLETED|Dose Response - First Intervention||1
11284812|NCT02435069|12481559|FG002|NOT COMPLETED|Dose Response - First Intervention||1
11284813|NCT02435069|12481560|FG003|NOT COMPLETED|Dose Response - First Intervention||0
11284814|NCT02435069|12481561|FG004|NOT COMPLETED|Dose Response - First Intervention||0
11284815|NCT02435069|12481557|FG000|STARTED|Effectiveness - Second Intervention||0
11284816|NCT02435069|12481558|FG001|STARTED|Effectiveness - Second Intervention||0
11284817|NCT02435069|12481559|FG002|STARTED|Effectiveness - Second Intervention||0
11284818|NCT02435069|12481560|FG003|STARTED|Effectiveness - Second Intervention||1
11284819|NCT02435069|12481561|FG004|STARTED|Effectiveness - Second Intervention||1
11284820|NCT02435069|12481557|FG000|COMPLETED|Effectiveness - Second Intervention||0
11284821|NCT02435069|12481558|FG001|COMPLETED|Effectiveness - Second Intervention||0
11284822|NCT02435069|12481559|FG002|COMPLETED|Effectiveness - Second Intervention||0
11284823|NCT02435069|12481560|FG003|COMPLETED|Effectiveness - Second Intervention||1
11284824|NCT02435069|12481561|FG004|COMPLETED|Effectiveness - Second Intervention||0
11284825|NCT02435069|12481557|FG000|NOT COMPLETED|Effectiveness - Second Intervention||0
11284826|NCT02435069|12481558|FG001|NOT COMPLETED|Effectiveness - Second Intervention||0
11284827|NCT02435069|12481559|FG002|NOT COMPLETED|Effectiveness - Second Intervention||0
11284828|NCT02435069|12481560|FG003|NOT COMPLETED|Effectiveness - Second Intervention||0
11284829|NCT02435069|12481561|FG004|NOT COMPLETED|Effectiveness - Second Intervention||1
11284830|NCT02435147|12481581|FG000|STARTED|Overall Study||86
11284831|NCT02435147|12481581|FG000|COMPLETED|Overall Study||75
11284832|NCT02435147|12481581|FG000|NOT COMPLETED|Overall Study||11
11284833|NCT02435277|12481589|FG000|STARTED|Overall Study||12
11284834|NCT02435277|12481590|FG001|STARTED|Overall Study||16
11284835|NCT02435277|12481591|FG002|STARTED|Overall Study||11
11284836|NCT02435277|12481592|FG003|STARTED|Overall Study||11
11284837|NCT02435277|12481589|FG000|COMPLETED|Overall Study||10
11284838|NCT02435277|12481590|FG001|COMPLETED|Overall Study||15
11284839|NCT02435277|12481591|FG002|COMPLETED|Overall Study||11
11284840|NCT02435277|12481592|FG003|COMPLETED|Overall Study||11
11284841|NCT02435277|12481589|FG000|NOT COMPLETED|Overall Study||2
11284842|NCT02435277|12481590|FG001|NOT COMPLETED|Overall Study||1
11284843|NCT02435277|12481591|FG002|NOT COMPLETED|Overall Study||0
11284844|NCT02435277|12481592|FG003|NOT COMPLETED|Overall Study||0
11284845|NCT02435381|12481602|FG000|STARTED|Overall Study||5
11284846|NCT02435381|12481603|FG001|STARTED|Overall Study||6
11284847|NCT02435381|12481602|FG000|COMPLETED|Overall Study||3
11284848|NCT02435381|12481603|FG001|COMPLETED|Overall Study||5
11284849|NCT02435381|12481602|FG000|NOT COMPLETED|Overall Study||2
11284850|NCT02435381|12481603|FG001|NOT COMPLETED|Overall Study||1
11284851|NCT02435524|12481621|FG000|STARTED|Baseline Survey||1111
11284852|NCT02435524|12481622|FG001|STARTED|Baseline Survey||1177
11284853|NCT02435524|12481621|FG000|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
11284854|NCT02435524|12481622|FG001|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
11284855|NCT02435524|12481621|FG000|NOT COMPLETED|Baseline Survey||0
11284856|NCT02435524|12481622|FG001|NOT COMPLETED|Baseline Survey||0
11284857|NCT02435524|12481621|FG000|STARTED|Endline Survey||1092
11284858|NCT02435524|12481622|FG001|STARTED|Endline Survey||1161
11284859|NCT02435524|12481621|FG000|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
11284860|NCT02435524|12481622|FG001|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
11284861|NCT02435524|12481621|FG000|NOT COMPLETED|Endline Survey||0
11284862|NCT02435524|12481622|FG001|NOT COMPLETED|Endline Survey||0
11284863|NCT02435680|12481631|FG000|STARTED|Overall Study||21
11284864|NCT02435680|12481632|FG001|STARTED|Overall Study||13
11284865|NCT02435680|12481633|FG002|STARTED|Overall Study||16
11284866|NCT02435680|12481631|FG000|COMPLETED|Overall Study||0
11284867|NCT02435680|12481632|FG001|COMPLETED|Overall Study||0
11284868|NCT02435680|12481633|FG002|COMPLETED|Overall Study||0
11284869|NCT02435680|12481631|FG000|NOT COMPLETED|Overall Study||21
11284870|NCT02435680|12481632|FG001|NOT COMPLETED|Overall Study||13
11284871|NCT02435680|12481633|FG002|NOT COMPLETED|Overall Study||16
11284872|NCT02435706|12481647|FG000|STARTED|Overall Study||18
11284873|NCT02435706|12481648|FG001|STARTED|Overall Study||21
11284874|NCT02435706|12481647|FG000|COMPLETED|Overall Study||16
11284875|NCT02435706|12481648|FG001|COMPLETED|Overall Study||20
11284876|NCT02435706|12481647|FG000|NOT COMPLETED|Overall Study||2
11284877|NCT02435706|12481648|FG001|NOT COMPLETED|Overall Study||1
11284878|NCT02435836|12481654|FG000|STARTED|Overall Study||631
11284879|NCT02435836|12481654|FG000|COMPLETED|Overall Study||0
11284880|NCT02435836|12481654|FG000|NOT COMPLETED|Overall Study||631
11284881|NCT02435901|12481658|FG000|STARTED|Overall Study||29
11284882|NCT02435901|12481658|FG000|COMPLETED|Overall Study||29
11284883|NCT02435901|12481658|FG000|NOT COMPLETED|Overall Study||0
11284884|NCT02435914|12481667|FG000|STARTED|Overall Study||58
11284885|NCT02435914|12481668|FG001|STARTED|Overall Study||59
11284886|NCT02435914|12481669|FG002|STARTED|Overall Study||60
11284887|NCT02435914|12481670|FG003|STARTED|Overall Study||59
11284888|NCT02435914|12481667|FG000|COMPLETED|Overall Study||57
11284889|NCT02435914|12481668|FG001|COMPLETED|Overall Study||58
11284890|NCT02435914|12481669|FG002|COMPLETED|Overall Study||59
11284891|NCT02435914|12481670|FG003|COMPLETED|Overall Study||59
11284892|NCT02435914|12481667|FG000|NOT COMPLETED|Overall Study||1
11284893|NCT02435914|12481668|FG001|NOT COMPLETED|Overall Study||1
11284894|NCT02435914|12481669|FG002|NOT COMPLETED|Overall Study||1
11284895|NCT02435914|12481670|FG003|NOT COMPLETED|Overall Study||0
11284896|NCT02435966|12481683|FG000|STARTED|Overall Study||47
11284897|NCT02435966|12481684|FG001|STARTED|Overall Study||54
11284898|NCT02435966|12481685|FG002|STARTED|Overall Study||30
11284899|NCT02435966|12481683|FG000|First Intervention|Overall Study||47
11284900|NCT02435966|12481684|FG001|First Intervention|Overall Study||54
11284901|NCT02435966|12481685|FG002|First Intervention|Overall Study||30
11284902|NCT02435966|12481683|FG000|Second Intervention|Overall Study||47
11284903|NCT02435966|12481684|FG001|Second Intervention|Overall Study||53
11284904|NCT02435966|12481685|FG002|Second Intervention|Overall Study||30
11284905|NCT02435966|12481683|FG000|Follow-up|Overall Study||47
11284906|NCT02435966|12481684|FG001|Follow-up|Overall Study||53
11284907|NCT02435966|12481685|FG002|Follow-up|Overall Study||30
11284908|NCT02435966|12481683|FG000|COMPLETED|Overall Study||47
11284909|NCT02435966|12481684|FG001|COMPLETED|Overall Study||53
11284910|NCT02435966|12481685|FG002|COMPLETED|Overall Study||30
11284911|NCT02435966|12481683|FG000|NOT COMPLETED|Overall Study||0
11284912|NCT02435966|12481684|FG001|NOT COMPLETED|Overall Study||1
11284913|NCT02435966|12481685|FG002|NOT COMPLETED|Overall Study||0
11284914|NCT02435992|12481698|FG000|STARTED|Overall Study||429
11284915|NCT02435992|12481699|FG001|STARTED|Overall Study||216
11284916|NCT02435992|12481700|FG002|STARTED|Overall Study||367
11284917|NCT02435992|12481701|FG003|STARTED|Overall Study||0
11284918|NCT02435992|12481702|FG004|STARTED|Overall Study||0
11284919|NCT02435992|12481698|FG000|Transition to Maintenance Period|Overall Study||233
11284920|NCT02435992|12481699|FG001|Transition to Maintenance Period|Overall Study||69
11284921|NCT02435992|12481700|FG002|Transition to Maintenance Period|Overall Study||224
11284922|NCT02435992|12481701|FG003|Transition to Maintenance Period|Overall Study||0
11284923|NCT02435992|12481702|FG004|Transition to Maintenance Period|Overall Study||0
11284924|NCT02435992|12481698|FG000|Treated in Maintenance Period|Overall Study||0
11284925|NCT02435992|12481699|FG001|Treated in Maintenance Period|Overall Study||69
11284926|NCT02435992|12481700|FG002|Treated in Maintenance Period|Overall Study||0
11284927|NCT02435992|12481701|FG003|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|230
11284928|NCT02435992|12481702|FG004|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|227
11284929|NCT02435992|12481698|FG000|COMPLETED|Overall Study||401
11284930|NCT02435992|12481699|FG001|COMPLETED|Overall Study||192
11284931|NCT02435992|12481700|FG002|COMPLETED|Overall Study||324
11284932|NCT02435992|12481701|FG003|COMPLETED|Overall Study||0
11284933|NCT02435992|12481702|FG004|COMPLETED|Overall Study||0
11284934|NCT02435992|12481698|FG000|NOT COMPLETED|Overall Study||28
11284935|NCT02435992|12481699|FG001|NOT COMPLETED|Overall Study||24
11284936|NCT02435992|12481700|FG002|NOT COMPLETED|Overall Study||43
11284937|NCT02435992|12481701|FG003|NOT COMPLETED|Overall Study||0
11284938|NCT02435992|12481702|FG004|NOT COMPLETED|Overall Study||0
11284939|NCT02436005|12481714|FG000|STARTED|First Intervention||12
11284940|NCT02436005|12481715|FG001|STARTED|First Intervention||13
11284941|NCT02436005|12481714|FG000|COMPLETED|First Intervention||12
11284942|NCT02436005|12481715|FG001|COMPLETED|First Intervention||13
11284943|NCT02436005|12481714|FG000|NOT COMPLETED|First Intervention||0
11284944|NCT02436005|12481715|FG001|NOT COMPLETED|First Intervention||0
11284945|NCT02436005|12481714|FG000|STARTED|Second Intervention||12
11284946|NCT02436005|12481715|FG001|STARTED|Second Intervention||13
11284947|NCT02436005|12481714|FG000|COMPLETED|Second Intervention||12
11284948|NCT02436005|12481715|FG001|COMPLETED|Second Intervention||12
11284949|NCT02436005|12481714|FG000|NOT COMPLETED|Second Intervention||0
11284950|NCT02436005|12481715|FG001|NOT COMPLETED|Second Intervention||1
11284951|NCT02436031|12481721|FG000|STARTED|First Study Night||8
11284952|NCT02436031|12481722|FG001|STARTED|First Study Night||8
11284953|NCT02436031|12481721|FG000|COMPLETED|First Study Night||8
11284954|NCT02436031|12481722|FG001|COMPLETED|First Study Night||8
11284955|NCT02436031|12481721|FG000|NOT COMPLETED|First Study Night||0
11284956|NCT02436031|12481722|FG001|NOT COMPLETED|First Study Night||0
11284957|NCT02436031|12481721|FG000|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
11284958|NCT02436031|12481722|FG001|STARTED|Second Study Night||8
11284959|NCT02436031|12481721|FG000|COMPLETED|Second Study Night||7
11284960|NCT02436031|12481722|FG001|COMPLETED|Second Study Night||8
11284961|NCT02436031|12481721|FG000|NOT COMPLETED|Second Study Night||0
11284962|NCT02436031|12481722|FG001|NOT COMPLETED|Second Study Night||0
11284963|NCT02436135|12481730|FG000|STARTED|Overall Study||6
11284964|NCT02436135|12481731|FG001|STARTED|Overall Study||4
11284965|NCT02436135|12481730|FG000|COMPLETED|Overall Study||0
11284966|NCT02436135|12481731|FG001|COMPLETED|Overall Study||0
11284967|NCT02436135|12481730|FG000|NOT COMPLETED|Overall Study||6
11284968|NCT02436135|12481731|FG001|NOT COMPLETED|Overall Study||4
11340925|NCT02926937|12538257|FG001|STARTED|Overall Study||142
11340926|NCT02926937|12538258|FG002|STARTED|Overall Study||107
11340927|NCT02926937|12538256|FG000|COMPLETED|Overall Study||131
11340928|NCT02926937|12538257|FG001|COMPLETED|Overall Study||127
11340929|NCT02926937|12538258|FG002|COMPLETED|Overall Study||96
11340930|NCT02926937|12538256|FG000|NOT COMPLETED|Overall Study||19
11340931|NCT02926937|12538257|FG001|NOT COMPLETED|Overall Study||15
11340932|NCT02926937|12538258|FG002|NOT COMPLETED|Overall Study||11
11340933|NCT02926950|12538269|FG000|STARTED|Overall Study||259
11340934|NCT02926950|12538270|FG001|STARTED|Overall Study||259
11340935|NCT02926950|12538269|FG000|COMPLETED|Overall Study||210
11340936|NCT02926950|12538270|FG001|COMPLETED|Overall Study||211
11340937|NCT02926950|12538269|FG000|NOT COMPLETED|Overall Study||49
11340938|NCT02926950|12538270|FG001|NOT COMPLETED|Overall Study||48
11340939|NCT02927171|12538279|FG000|STARTED|Overall Study||53
11340940|NCT02927171|12538280|FG001|STARTED|Overall Study||51
11340941|NCT02927171|12538279|FG000|COMPLETED|Overall Study||53
11340942|NCT02927171|12538280|FG001|COMPLETED|Overall Study||50
11340943|NCT02927171|12538279|FG000|NOT COMPLETED|Overall Study||0
11340944|NCT02927171|12538280|FG001|NOT COMPLETED|Overall Study||1
11340945|NCT02927223|12538286|FG000|STARTED|Overall Study||6
11340946|NCT02927223|12538286|FG000|COMPLETED|Overall Study||6
11340947|NCT02927223|12538286|FG000|NOT COMPLETED|Overall Study||0
11340948|NCT02927327|12538294|FG000|STARTED|Overall Study||30
11284969|NCT02436200|12481737|FG000|STARTED|Overall Study||21
11284970|NCT02436200|12481737|FG000|COMPLETED|Overall Study||20
11284971|NCT02436200|12481737|FG000|NOT COMPLETED|Overall Study||1
11284972|NCT02436239|12481745|FG000|STARTED|Open-Lable Treatment Period||122
11284973|NCT02436239|12481746|FG001|STARTED|Open-Lable Treatment Period||131
11284974|NCT02436239|12481747|FG002|STARTED|Open-Lable Treatment Period||65
11284975|NCT02436239|12481748|FG003|STARTED|Open-Lable Treatment Period||12
11284976|NCT02436239|12481745|FG000|COMPLETED|Open-Lable Treatment Period||89
11284977|NCT02436239|12481746|FG001|COMPLETED|Open-Lable Treatment Period||97
11284978|NCT02436239|12481747|FG002|COMPLETED|Open-Lable Treatment Period||38
11284979|NCT02436239|12481748|FG003|COMPLETED|Open-Lable Treatment Period||7
11284980|NCT02436239|12481745|FG000|NOT COMPLETED|Open-Lable Treatment Period||33
11284981|NCT02436239|12481746|FG001|NOT COMPLETED|Open-Lable Treatment Period||34
11284982|NCT02436239|12481747|FG002|NOT COMPLETED|Open-Lable Treatment Period||27
11284983|NCT02436239|12481748|FG003|NOT COMPLETED|Open-Lable Treatment Period||5
11284984|NCT02436239|12481745|FG000|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90
11284985|NCT02436239|12481746|FG001|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103
11284986|NCT02436239|12481747|FG002|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44
11284987|NCT02436239|12481748|FG003|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6
11284988|NCT02436239|12481745|FG000|COMPLETED|Down-Taper Period||86
11284989|NCT02436239|12481746|FG001|COMPLETED|Down-Taper Period||99
11284990|NCT02436239|12481747|FG002|COMPLETED|Down-Taper Period||43
11284991|NCT02436239|12481748|FG003|COMPLETED|Down-Taper Period||4
11399168|NCT04358081|12593712|FG001|COMPLETED|Treatment Phase of Study||6
11399169|NCT04358081|12593713|FG002|COMPLETED|Treatment Phase of Study||2
11399170|NCT04358081|12593711|FG000|NOT COMPLETED|Treatment Phase of Study||4
11399171|NCT04358081|12593712|FG001|NOT COMPLETED|Treatment Phase of Study||1
11284992|NCT02436239|12481745|FG000|NOT COMPLETED|Down-Taper Period||4
11284993|NCT02436239|12481746|FG001|NOT COMPLETED|Down-Taper Period||4
11284994|NCT02436239|12481747|FG002|NOT COMPLETED|Down-Taper Period||1
11284995|NCT02436239|12481748|FG003|NOT COMPLETED|Down-Taper Period||2
11284996|NCT02436304|12481761|FG000|STARTED|Overall Study||153
11284997|NCT02436304|12481762|FG001|STARTED|Overall Study||102
11284998|NCT02436304|12481763|FG002|STARTED|Overall Study||101
11284999|NCT02436304|12481761|FG000|COMPLETED|Overall Study||153
11399172|NCT04358081|12593713|FG002|NOT COMPLETED|Treatment Phase of Study||3
11285000|NCT02436304|12481762|FG001|COMPLETED|Overall Study||100
11285001|NCT02436304|12481763|FG002|COMPLETED|Overall Study||100
11399173|NCT04358081|12593711|FG000|STARTED|Study Completion Phase||7
11285002|NCT02436304|12481761|FG000|NOT COMPLETED|Overall Study||0
11285003|NCT02436304|12481762|FG001|NOT COMPLETED|Overall Study||2
11285004|NCT02436304|12481763|FG002|NOT COMPLETED|Overall Study||1
11285005|NCT02436330|12481774|FG000|STARTED|Cohort 1||14
11285006|NCT02436330|12481775|FG001|STARTED|Cohort 1||4
11285007|NCT02436330|12481774|FG000|COMPLETED|Cohort 1||9
11285008|NCT02436330|12481775|FG001|COMPLETED|Cohort 1||1
11285009|NCT02436330|12481774|FG000|NOT COMPLETED|Cohort 1||5
11285010|NCT02436330|12481775|FG001|NOT COMPLETED|Cohort 1||3
11285011|NCT02436330|12481774|FG000|STARTED|Cohort 2||14
11285012|NCT02436330|12481775|FG001|STARTED|Cohort 2||10
11285013|NCT02436330|12481774|FG000|COMPLETED|Cohort 2||10
11285014|NCT02436330|12481775|FG001|COMPLETED|Cohort 2||7
11285015|NCT02436330|12481774|FG000|NOT COMPLETED|Cohort 2||4
11285016|NCT02436330|12481775|FG001|NOT COMPLETED|Cohort 2||3
11285017|NCT02436330|12481774|FG000|STARTED|Cohort 3||12
11285018|NCT02436330|12481775|FG001|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
11285019|NCT02436330|12481774|FG000|COMPLETED|Cohort 3||7
11285020|NCT02436330|12481775|FG001|COMPLETED|Cohort 3||0
11285021|NCT02436330|12481774|FG000|NOT COMPLETED|Cohort 3||5
11285022|NCT02436330|12481775|FG001|NOT COMPLETED|Cohort 3||0
11285023|NCT02436330|12481774|FG000|STARTED|Cohort 4||6
11285024|NCT02436330|12481775|FG001|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
11285025|NCT02436330|12481774|FG000|COMPLETED|Cohort 4||4
11285026|NCT02436330|12481775|FG001|COMPLETED|Cohort 4||0
11285027|NCT02436330|12481774|FG000|NOT COMPLETED|Cohort 4||2
11285028|NCT02436330|12481775|FG001|NOT COMPLETED|Cohort 4||0
11285029|NCT02436330|12481774|FG000|STARTED|Cohort 5||10
11285030|NCT02436330|12481775|FG001|STARTED|Cohort 5||5
11285031|NCT02436330|12481774|FG000|COMPLETED|Cohort 5||4
11285032|NCT02436330|12481775|FG001|COMPLETED|Cohort 5||1
11285033|NCT02436330|12481774|FG000|NOT COMPLETED|Cohort 5||6
11285034|NCT02436330|12481775|FG001|NOT COMPLETED|Cohort 5||4
11285035|NCT02436330|12481774|FG000|STARTED|Cohort 6||4
11285036|NCT02436330|12481775|FG001|STARTED|Cohort 6||5
11285037|NCT02436330|12481774|FG000|COMPLETED|Cohort 6||1
11285038|NCT02436330|12481775|FG001|COMPLETED|Cohort 6||4
11285039|NCT02436330|12481774|FG000|NOT COMPLETED|Cohort 6||3
11285040|NCT02436330|12481775|FG001|NOT COMPLETED|Cohort 6||1
11285041|NCT02436356|12481790|FG000|STARTED|Overall Study||33
11285042|NCT02436356|12481791|FG001|STARTED|Overall Study||11
11285043|NCT02436356|12481792|FG002|STARTED|Overall Study||4
11285044|NCT02436356|12481790|FG000|High Energy Fracture|Overall Study||14
11285045|NCT02436356|12481791|FG001|High Energy Fracture|Overall Study||0
11285046|NCT02436356|12481792|FG002|High Energy Fracture|Overall Study||4
11285047|NCT02436356|12481790|FG000|Low Energy Fracture|Overall Study||19
11285048|NCT02436356|12481791|FG001|Low Energy Fracture|Overall Study||0
11285049|NCT02436356|12481792|FG002|Low Energy Fracture|Overall Study||0
11285050|NCT02436356|12481790|FG000|COMPLETED|Overall Study||28
11285051|NCT02436356|12481791|FG001|COMPLETED|Overall Study||10
11285052|NCT02436356|12481792|FG002|COMPLETED|Overall Study||2
11285053|NCT02436356|12481790|FG000|NOT COMPLETED|Overall Study||5
11285054|NCT02436356|12481791|FG001|NOT COMPLETED|Overall Study||1
11285055|NCT02436356|12481792|FG002|NOT COMPLETED|Overall Study||2
11285056|NCT02436408|12481805|FG000|STARTED|Overall Study||35
11285057|NCT02436408|12481805|FG000|COMPLETED|Overall Study||34
11285058|NCT02436408|12481805|FG000|NOT COMPLETED|Overall Study||1
11285059|NCT02436577|12481815|FG000|STARTED|Overall Study||7
11285060|NCT02436577|12481816|FG001|STARTED|Overall Study||7
11285061|NCT02436577|12481817|FG002|STARTED|Overall Study||7
11285062|NCT02436577|12481818|FG003|STARTED|Overall Study||7
11285063|NCT02436577|12481819|FG004|STARTED|Overall Study||7
11285064|NCT02436577|12481820|FG005|STARTED|Overall Study||7
11285065|NCT02436577|12481815|FG000|COMPLETED|Overall Study||7
11285066|NCT02436577|12481816|FG001|COMPLETED|Overall Study||6
11285067|NCT02436577|12481817|FG002|COMPLETED|Overall Study||7
11285068|NCT02436577|12481818|FG003|COMPLETED|Overall Study||7
11285069|NCT02436577|12481819|FG004|COMPLETED|Overall Study||7
11285070|NCT02436577|12481820|FG005|COMPLETED|Overall Study||7
11285071|NCT02436577|12481815|FG000|NOT COMPLETED|Overall Study||0
11285072|NCT02436577|12481816|FG001|NOT COMPLETED|Overall Study||1
11285073|NCT02436577|12481817|FG002|NOT COMPLETED|Overall Study||0
11285074|NCT02436577|12481818|FG003|NOT COMPLETED|Overall Study||0
11285075|NCT02436577|12481819|FG004|NOT COMPLETED|Overall Study||0
11285076|NCT02436577|12481820|FG005|NOT COMPLETED|Overall Study||0
11285077|NCT02436668|12481830|FG000|STARTED|Overall Study||213
11285078|NCT02436668|12481831|FG001|STARTED|Overall Study||211
11285079|NCT02436668|12481830|FG000|COMPLETED|Overall Study||212
11285080|NCT02436668|12481831|FG001|COMPLETED|Overall Study||207
11285081|NCT02436668|12481830|FG000|NOT COMPLETED|Overall Study||1
11285082|NCT02436668|12481831|FG001|NOT COMPLETED|Overall Study||4
11285083|NCT02436681|12481840|FG000|STARTED|Overall Study||41
11285084|NCT02436681|12481840|FG000|COMPLETED|Overall Study||27
11285085|NCT02436681|12481840|FG000|NOT COMPLETED|Overall Study||14
11285086|NCT02436759|12481846|FG000|STARTED|Overall Study||94
11285087|NCT02436759|12481847|FG001|STARTED|Overall Study||46
11285088|NCT02436759|12481846|FG000|Subjects Randomized|Overall Study||94
11285089|NCT02436759|12481847|FG001|Subjects Randomized|Overall Study||46
11285090|NCT02436759|12481846|FG000|Subjects Treated|Overall Study||94
11285091|NCT02436759|12481847|FG001|Subjects Treated|Overall Study||46
11285092|NCT02436759|12481846|FG000|COMPLETED|Overall Study||90
11285093|NCT02436759|12481847|FG001|COMPLETED|Overall Study||45
11399174|NCT04358081|12593712|FG001|STARTED|Study Completion Phase||7
11399175|NCT04358081|12593713|FG002|STARTED|Study Completion Phase||5
11399176|NCT04358081|12593711|FG000|COMPLETED|Study Completion Phase||6
11399177|NCT04358081|12593712|FG001|COMPLETED|Study Completion Phase||7
11399178|NCT04358081|12593713|FG002|COMPLETED|Study Completion Phase||3
11399179|NCT04358081|12593711|FG000|NOT COMPLETED|Study Completion Phase||1
11399180|NCT04358081|12593712|FG001|NOT COMPLETED|Study Completion Phase||0
11399181|NCT04358081|12593713|FG002|NOT COMPLETED|Study Completion Phase||2
11399182|NCT04356937|12593725|FG000|STARTED|Randomization (Safety Population)||161
11399183|NCT04356937|12593726|FG001|STARTED|Randomization (Safety Population)||82
11399184|NCT04356937|12593725|FG000|COMPLETED|Randomization (Safety Population)||161
11399185|NCT04356937|12593726|FG001|COMPLETED|Randomization (Safety Population)||82
11399186|NCT04356937|12593725|FG000|NOT COMPLETED|Randomization (Safety Population)||0
11399187|NCT04356937|12593726|FG001|NOT COMPLETED|Randomization (Safety Population)||0
11399188|NCT04356937|12593725|FG000|STARTED|Treatment (mITT Population)||161
11399189|NCT04356937|12593726|FG001|STARTED|Treatment (mITT Population)||82
11399190|NCT04356937|12593725|FG000|COMPLETED|Treatment (mITT Population)||161
11399191|NCT04356937|12593726|FG001|COMPLETED|Treatment (mITT Population)||81
11399192|NCT04356937|12593725|FG000|NOT COMPLETED|Treatment (mITT Population)||0
11399193|NCT04356937|12593726|FG001|NOT COMPLETED|Treatment (mITT Population)||1
11399194|NCT04355663|12593735|FG000|STARTED|Overall Study||42
11399195|NCT04355663|12593736|FG001|STARTED|Overall Study||29
11399196|NCT04355663|12593737|FG002|STARTED|Overall Study||21
11399197|NCT04355663|12593735|FG000|COMPLETED|Overall Study||40
11399198|NCT04355663|12593736|FG001|COMPLETED|Overall Study||14
11399199|NCT04355663|12593737|FG002|COMPLETED|Overall Study||17
11399200|NCT04355663|12593735|FG000|NOT COMPLETED|Overall Study||2
11399201|NCT04355663|12593736|FG001|NOT COMPLETED|Overall Study||15
11399202|NCT04355663|12593737|FG002|NOT COMPLETED|Overall Study||4
11399203|NCT04354870|12593747|FG000|STARTED|Overall Study||83
11399204|NCT04354870|12593748|FG001|STARTED|Overall Study||47
11399205|NCT04354870|12593747|FG000|COMPLETED|Overall Study||35
11399206|NCT04354870|12593748|FG001|COMPLETED|Overall Study||14
11399207|NCT04354870|12593747|FG000|NOT COMPLETED|Overall Study||48
11399208|NCT04354870|12593748|FG001|NOT COMPLETED|Overall Study||33
11399209|NCT04350307|12593756|FG000|STARTED|Overall Study||84
11399210|NCT04350307|12593757|FG001|STARTED|Overall Study||78
11399211|NCT04350307|12593756|FG000|COMPLETED|Overall Study||84
11285094|NCT02436759|12481846|FG000|NOT COMPLETED|Overall Study||4
11285095|NCT02436759|12481847|FG001|NOT COMPLETED|Overall Study||1
11285096|NCT02436811|12481856|FG000|STARTED|Overall Study||60
11285097|NCT02436811|12481857|FG001|STARTED|Overall Study||60
11285098|NCT02436811|12481858|FG002|STARTED|Overall Study||60
11285099|NCT02436811|12481856|FG000|COMPLETED|Overall Study||58
11399212|NCT04350307|12593757|FG001|COMPLETED|Overall Study||78
11399213|NCT04350307|12593756|FG000|NOT COMPLETED|Overall Study||0
11399214|NCT04350307|12593757|FG001|NOT COMPLETED|Overall Study||0
11399215|NCT04352660|12593765|FG000|STARTED|Overall Study||50
11399216|NCT04352660|12593766|FG001|STARTED|Overall Study||50
11399217|NCT04352660|12593765|FG000|COMPLETED|Overall Study||36
11399218|NCT04352660|12593766|FG001|COMPLETED|Overall Study||40
11399219|NCT04352660|12593765|FG000|NOT COMPLETED|Overall Study||14
11399220|NCT04352660|12593766|FG001|NOT COMPLETED|Overall Study||10
11399221|NCT04350788|12593774|FG000|STARTED|Overall Study||62
11399222|NCT04350788|12593775|FG001|STARTED|Overall Study||62
11399223|NCT04350788|12593774|FG000|COMPLETED|Overall Study||50
11399224|NCT04350788|12593775|FG001|COMPLETED|Overall Study||56
11399225|NCT04350788|12593774|FG000|NOT COMPLETED|Overall Study||12
11399226|NCT04350788|12593775|FG001|NOT COMPLETED|Overall Study||6
11399227|NCT04349917|12593788|FG000|STARTED|First Intervention (2-4 Hours)||19
11399228|NCT04349917|12593789|FG001|STARTED|First Intervention (2-4 Hours)||18
11399229|NCT04349917|12593788|FG000|Received Intervention|First Intervention (2-4 Hours)||19
11399230|NCT04349917|12593789|FG001|Received Intervention|First Intervention (2-4 Hours)||17
11399231|NCT04349917|12593788|FG000|COMPLETED|First Intervention (2-4 Hours)||19
11399232|NCT04349917|12593789|FG001|COMPLETED|First Intervention (2-4 Hours)||16
11399233|NCT04349917|12593788|FG000|NOT COMPLETED|First Intervention (2-4 Hours)||0
11399234|NCT04349917|12593789|FG001|NOT COMPLETED|First Intervention (2-4 Hours)||2
11399235|NCT04349917|12593788|FG000|STARTED|Washout Period (4-20 Days)||19
11399236|NCT04349917|12593789|FG001|STARTED|Washout Period (4-20 Days)||16
11399237|NCT04349917|12593788|FG000|COMPLETED|Washout Period (4-20 Days)||19
11399238|NCT04349917|12593789|FG001|COMPLETED|Washout Period (4-20 Days)||16
11399239|NCT04349917|12593788|FG000|NOT COMPLETED|Washout Period (4-20 Days)||0
11399240|NCT04349917|12593789|FG001|NOT COMPLETED|Washout Period (4-20 Days)||0
11399241|NCT04349917|12593788|FG000|STARTED|Second Intervention (2-4 Hours)||19
11399242|NCT04349917|12593789|FG001|STARTED|Second Intervention (2-4 Hours)||16
11399243|NCT04349917|12593788|FG000|Received Intervention|Second Intervention (2-4 Hours)||19
11399244|NCT04349917|12593789|FG001|Received Intervention|Second Intervention (2-4 Hours)||16
11399245|NCT04349917|12593788|FG000|COMPLETED|Second Intervention (2-4 Hours)||19
11399246|NCT04349917|12593789|FG001|COMPLETED|Second Intervention (2-4 Hours)||16
11399247|NCT04349917|12593788|FG000|NOT COMPLETED|Second Intervention (2-4 Hours)||0
11399248|NCT04349917|12593789|FG001|NOT COMPLETED|Second Intervention (2-4 Hours)||0
11399249|NCT04348851|12593800|FG000|STARTED|Post-Test 1||13
11399250|NCT04348851|12593801|FG001|STARTED|Post-Test 1||13
11285100|NCT02436811|12481857|FG001|COMPLETED|Overall Study||51
11285101|NCT02436811|12481858|FG002|COMPLETED|Overall Study||53
11285102|NCT02436811|12481856|FG000|NOT COMPLETED|Overall Study||2
11285103|NCT02436811|12481857|FG001|NOT COMPLETED|Overall Study||9
11285104|NCT02436811|12481858|FG002|NOT COMPLETED|Overall Study||7
11285105|NCT02436876|12481870|FG000|STARTED|Overall Study||6
11285106|NCT02436876|12481871|FG001|STARTED|Overall Study||9
11285107|NCT02436876|12481872|FG002|STARTED|Overall Study||7
11285108|NCT02436876|12481873|FG003|STARTED|Overall Study||7
11285109|NCT02436876|12481870|FG000|Treated|Overall Study||6
11285110|NCT02436876|12481871|FG001|Treated|Overall Study||6
11285111|NCT02436876|12481872|FG002|Treated|Overall Study||6
11285112|NCT02436876|12481873|FG003|Treated|Overall Study||7
11285113|NCT02436876|12481870|FG000|COMPLETED|Overall Study||5
11285114|NCT02436876|12481871|FG001|COMPLETED|Overall Study||5
11285115|NCT02436876|12481872|FG002|COMPLETED|Overall Study||5
11285116|NCT02436876|12481873|FG003|COMPLETED|Overall Study||5
11285117|NCT02436876|12481870|FG000|NOT COMPLETED|Overall Study||1
11285118|NCT02436876|12481871|FG001|NOT COMPLETED|Overall Study||4
11285119|NCT02436876|12481872|FG002|NOT COMPLETED|Overall Study||2
11285120|NCT02436876|12481873|FG003|NOT COMPLETED|Overall Study||2
11285121|NCT02436889|12481890|FG000|STARTED|Overall Study||12
11285122|NCT02436889|12481891|FG001|STARTED|Overall Study||11
11285123|NCT02436889|12481890|FG000|COMPLETED|Overall Study||11
11285124|NCT02436889|12481891|FG001|COMPLETED|Overall Study||10
11285125|NCT02436889|12481890|FG000|NOT COMPLETED|Overall Study||1
11285126|NCT02436889|12481891|FG001|NOT COMPLETED|Overall Study||1
11399251|NCT04348851|12593802|FG002|STARTED|Post-Test 1||13
11399252|NCT04348851|12593803|FG003|STARTED|Post-Test 1||14
11399253|NCT04348851|12593800|FG000|COMPLETED|Post-Test 1||13
11399254|NCT04348851|12593801|FG001|COMPLETED|Post-Test 1||11
11399255|NCT04348851|12593802|FG002|COMPLETED|Post-Test 1||13
11399256|NCT04348851|12593803|FG003|COMPLETED|Post-Test 1||14
11399257|NCT04348851|12593800|FG000|NOT COMPLETED|Post-Test 1||0
11399258|NCT04348851|12593801|FG001|NOT COMPLETED|Post-Test 1||2
11399259|NCT04348851|12593802|FG002|NOT COMPLETED|Post-Test 1||0
11285127|NCT02436915|12481899|FG000|STARTED|Overall Study||9
11285128|NCT02436915|12481900|FG001|STARTED|Overall Study||10
11285129|NCT02436915|12481899|FG000|COMPLETED|Overall Study||9
11285130|NCT02436915|12481900|FG001|COMPLETED|Overall Study||9
11285131|NCT02436915|12481899|FG000|NOT COMPLETED|Overall Study||0
11285132|NCT02436915|12481900|FG001|NOT COMPLETED|Overall Study||1
11285133|NCT02437084|12481908|FG000|STARTED|Overall Study||75
11285134|NCT02437084|12481908|FG000|COMPLETED|Overall Study||72
11285135|NCT02437084|12481908|FG000|NOT COMPLETED|Overall Study||3
11285136|NCT02437162|12481915|FG000|STARTED|Overall Study||116
11285137|NCT02437162|12481916|FG001|STARTED|Overall Study||116
11285138|NCT02437162|12481917|FG002|STARTED|Overall Study||115
11285139|NCT02437162|12481915|FG000|Treated|Overall Study||116
11285140|NCT02437162|12481916|FG001|Treated|Overall Study||116
11285141|NCT02437162|12481917|FG002|Treated|Overall Study||114
11285142|NCT02437162|12481915|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
11285143|NCT02437162|12481916|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
11285144|NCT02437162|12481917|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
11285145|NCT02437162|12481915|FG000|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
11285146|NCT02437162|12481916|FG001|Cross Over at Week 24|Overall Study||0
11285147|NCT02437162|12481917|FG002|Cross Over at Week 24|Overall Study||0
11285148|NCT02437162|12481915|FG000|COMPLETED|Overall Study||9
11285149|NCT02437162|12481916|FG001|COMPLETED|Overall Study||8
11285150|NCT02437162|12481917|FG002|COMPLETED|Overall Study||6
11285151|NCT02437162|12481915|FG000|NOT COMPLETED|Overall Study||107
11285152|NCT02437162|12481916|FG001|NOT COMPLETED|Overall Study||108
11285153|NCT02437162|12481917|FG002|NOT COMPLETED|Overall Study||109
11285154|NCT02437188|12481932|FG000|STARTED|Overall Study||44
11285155|NCT02437188|12481933|FG001|STARTED|Overall Study||44
11285156|NCT02437188|12481932|FG000|COMPLETED|Overall Study||40
11285157|NCT02437188|12481933|FG001|COMPLETED|Overall Study||35
11285158|NCT02437188|12481932|FG000|NOT COMPLETED|Overall Study||4
11285159|NCT02437188|12481933|FG001|NOT COMPLETED|Overall Study||9
11285160|NCT02437253|12481944|FG000|STARTED|Overall Study||1
11285161|NCT02437253|12481945|FG001|STARTED|Overall Study||1
11285162|NCT02437253|12481944|FG000|COMPLETED|Overall Study||1
11285163|NCT02437253|12481945|FG001|COMPLETED|Overall Study||1
11285164|NCT02437253|12481944|FG000|NOT COMPLETED|Overall Study||0
11285165|NCT02437253|12481945|FG001|NOT COMPLETED|Overall Study||0
11285166|NCT02437305|12481955|FG000|STARTED|Overall Study||50
11285167|NCT02437305|12481956|FG001|STARTED|Overall Study||50
11285168|NCT02437305|12481955|FG000|COMPLETED|Overall Study||32
11399260|NCT04348851|12593803|FG003|NOT COMPLETED|Post-Test 1||0
11399261|NCT04348851|12593800|FG000|STARTED|Post-Test 2||13
11399262|NCT04348851|12593801|FG001|STARTED|Post-Test 2||11
11399263|NCT04348851|12593802|FG002|STARTED|Post-Test 2||13
11285169|NCT02437305|12481956|FG001|COMPLETED|Overall Study||38
11285170|NCT02437305|12481955|FG000|NOT COMPLETED|Overall Study||18
11285171|NCT02437305|12481956|FG001|NOT COMPLETED|Overall Study||12
11285172|NCT02437344|12481962|FG000|STARTED|Overall Study||16
11399264|NCT04348851|12593803|FG003|STARTED|Post-Test 2||14
11399265|NCT04348851|12593800|FG000|COMPLETED|Post-Test 2||13
11285173|NCT02437344|12481962|FG000|COMPLETED|Overall Study||15
11285174|NCT02437344|12481962|FG000|NOT COMPLETED|Overall Study||1
11285175|NCT02437383|12481968|FG000|STARTED|Overall Study||100
11285176|NCT02437383|12481969|FG001|STARTED|Overall Study||100
11285177|NCT02437383|12481968|FG000|COMPLETED|Overall Study||87
11285178|NCT02437383|12481969|FG001|COMPLETED|Overall Study||87
11285179|NCT02437383|12481968|FG000|NOT COMPLETED|Overall Study||13
11285180|NCT02437383|12481969|FG001|NOT COMPLETED|Overall Study||13
11285181|NCT02437409|12481975|FG000|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
11285182|NCT02437409|12481975|FG000|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
11285183|NCT02437409|12481975|FG000|NOT COMPLETED|Overall Study||15
11285184|NCT02437487|12481982|FG000|STARTED|Overall Study||59
11285185|NCT02437487|12481983|FG001|STARTED|Overall Study||30
11285186|NCT02437487|12481982|FG000|Actual Treatment Received|Overall Study||60
11285187|NCT02437487|12481983|FG001|Actual Treatment Received|Overall Study||29
11285188|NCT02437487|12481982|FG000|Intention-to-Treat Population|Overall Study||59
11285189|NCT02437487|12481983|FG001|Intention-to-Treat Population|Overall Study||30
11285190|NCT02437487|12481982|FG000|COMPLETED|Overall Study||32
11285191|NCT02437487|12481983|FG001|COMPLETED|Overall Study||16
11285192|NCT02437487|12481982|FG000|NOT COMPLETED|Overall Study||27
11285193|NCT02437487|12481983|FG001|NOT COMPLETED|Overall Study||14
11285194|NCT02437513|12481989|FG000|STARTED|Overall Study||2
11285195|NCT02437513|12481989|FG000|COMPLETED|Overall Study||0
11285196|NCT02437513|12481989|FG000|NOT COMPLETED|Overall Study||2
11285197|NCT02437669|12481993|FG000|STARTED|Overall Study||35
11285198|NCT02437669|12481993|FG000|COMPLETED|Overall Study||35
11285199|NCT02437669|12481993|FG000|NOT COMPLETED|Overall Study||0
11285200|NCT02437864|12482000|FG000|STARTED|Overall Study||200
11285201|NCT02437864|12482001|FG001|STARTED|Overall Study||160
11285202|NCT02437864|12482000|FG000|COMPLETED|Overall Study||196
11285203|NCT02437864|12482001|FG001|COMPLETED|Overall Study||160
11285204|NCT02437864|12482000|FG000|NOT COMPLETED|Overall Study||4
11285205|NCT02437864|12482001|FG001|NOT COMPLETED|Overall Study||0
11285206|NCT02437890|12482012|FG000|STARTED|Overall Study||62
11285207|NCT02437890|12482013|FG001|STARTED|Overall Study||64
11285208|NCT02437890|12482014|FG002|STARTED|Overall Study||62
11285209|NCT02437890|12482015|FG003|STARTED|Overall Study||62
11285210|NCT02437890|12482016|FG004|STARTED|Overall Study||62
11285211|NCT02437890|12482012|FG000|COMPLETED|Overall Study||54
11285212|NCT02437890|12482013|FG001|COMPLETED|Overall Study||48
11285213|NCT02437890|12482014|FG002|COMPLETED|Overall Study||47
11285214|NCT02437890|12482015|FG003|COMPLETED|Overall Study||40
11285215|NCT02437890|12482016|FG004|COMPLETED|Overall Study||46
11285216|NCT02437890|12482012|FG000|NOT COMPLETED|Overall Study||8
11285217|NCT02437890|12482013|FG001|NOT COMPLETED|Overall Study||16
11285218|NCT02437890|12482014|FG002|NOT COMPLETED|Overall Study||15
11285219|NCT02437890|12482015|FG003|NOT COMPLETED|Overall Study||22
11285220|NCT02437890|12482016|FG004|NOT COMPLETED|Overall Study||16
11285221|NCT02437903|12482032|FG000|STARTED|Overall Study||30
11285222|NCT02437903|12482032|FG000|COMPLETED|Overall Study||25
11285223|NCT02437903|12482032|FG000|NOT COMPLETED|Overall Study||5
11285224|NCT02438137|12482039|FG000|STARTED|Overall Study||44
11285225|NCT02438137|12482040|FG001|STARTED|Overall Study||21
11285226|NCT02438137|12482039|FG000|COMPLETED|Overall Study||36
11285227|NCT02438137|12482040|FG001|COMPLETED|Overall Study||15
11285228|NCT02438137|12482039|FG000|NOT COMPLETED|Overall Study||8
11285229|NCT02438137|12482040|FG001|NOT COMPLETED|Overall Study||6
11285230|NCT02438280|12482050|FG000|STARTED|Overall Study||14
11285231|NCT02438280|12482051|FG001|STARTED|Overall Study||13
11285232|NCT02438280|12482050|FG000|COMPLETED|Overall Study||13
11285233|NCT02438280|12482051|FG001|COMPLETED|Overall Study||13
11285234|NCT02438280|12482050|FG000|NOT COMPLETED|Overall Study||1
11285235|NCT02438280|12482051|FG001|NOT COMPLETED|Overall Study||0
11285236|NCT02438371|12482060|FG000|STARTED|Overall Study||24
11285237|NCT02438371|12482061|FG001|STARTED|Overall Study||25
11285238|NCT02438371|12482060|FG000|Received Intervention|Overall Study||24
11285239|NCT02438371|12482061|FG001|Received Intervention|Overall Study||25
11285240|NCT02438371|12482060|FG000|COMPLETED|Overall Study||20
11285241|NCT02438371|12482061|FG001|COMPLETED|Overall Study||22
11285242|NCT02438371|12482060|FG000|NOT COMPLETED|Overall Study||4
11285243|NCT02438371|12482061|FG001|NOT COMPLETED|Overall Study||3
11285244|NCT02438384|12482070|FG000|STARTED|Overall Study||25
11285245|NCT02438384|12482071|FG001|STARTED|Overall Study||25
11285246|NCT02438384|12482072|FG002|STARTED|Overall Study||25
11285247|NCT02438384|12482070|FG000|COMPLETED|Overall Study||17
11285248|NCT02438384|12482071|FG001|COMPLETED|Overall Study||19
11285249|NCT02438384|12482072|FG002|COMPLETED|Overall Study||21
11285250|NCT02438384|12482070|FG000|NOT COMPLETED|Overall Study||8
11285251|NCT02438384|12482071|FG001|NOT COMPLETED|Overall Study||6
11285252|NCT02438384|12482072|FG002|NOT COMPLETED|Overall Study||4
11285253|NCT02438423|12482084|FG000|STARTED|Overall Study||25
11285254|NCT02438423|12482085|FG001|STARTED|Overall Study||25
11285255|NCT02438423|12482086|FG002|STARTED|Overall Study||25
11285256|NCT02438423|12482087|FG003|STARTED|Overall Study||25
11285257|NCT02438423|12482084|FG000|COMPLETED|Overall Study||25
11285258|NCT02438423|12482085|FG001|COMPLETED|Overall Study||25
11285259|NCT02438423|12482086|FG002|COMPLETED|Overall Study||25
11285260|NCT02438423|12482087|FG003|COMPLETED|Overall Study||25
11285261|NCT02438423|12482084|FG000|NOT COMPLETED|Overall Study||0
11285262|NCT02438423|12482085|FG001|NOT COMPLETED|Overall Study||0
11285263|NCT02438423|12482086|FG002|NOT COMPLETED|Overall Study||0
11285264|NCT02438423|12482087|FG003|NOT COMPLETED|Overall Study||0
11285265|NCT02438475|12482101|FG000|STARTED|Overall Study||104
11285266|NCT02438475|12482102|FG001|STARTED|Overall Study||104
11285267|NCT02438475|12482101|FG000|COMPLETED|Overall Study||102
11285268|NCT02438475|12482102|FG001|COMPLETED|Overall Study||104
11285269|NCT02438475|12482101|FG000|NOT COMPLETED|Overall Study||2
11285270|NCT02438475|12482102|FG001|NOT COMPLETED|Overall Study||0
11285271|NCT02438540|12482110|FG000|STARTED|Overall Study||19
11285272|NCT02438540|12482111|FG001|STARTED|Overall Study||20
11285273|NCT02438540|12482110|FG000|COMPLETED|Overall Study||19
11285274|NCT02438540|12482111|FG001|COMPLETED|Overall Study||20
11285275|NCT02438540|12482110|FG000|NOT COMPLETED|Overall Study||0
11285276|NCT02438540|12482111|FG001|NOT COMPLETED|Overall Study||0
11285277|NCT02438787|12482121|FG000|STARTED|Overall Study||104
11285278|NCT02438787|12482122|FG001|STARTED|Overall Study||106
11285279|NCT02438787|12482123|FG002|STARTED|Overall Study||105
11285280|NCT02438787|12482121|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
11285281|NCT02438787|12482122|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
11285282|NCT02438787|12482123|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
11285283|NCT02438787|12482121|FG000|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
11285284|NCT02438787|12482122|FG001|Cross Over at Week 24|Overall Study||0
11285285|NCT02438787|12482123|FG002|Cross Over at Week 24|Overall Study||0
11285286|NCT02438787|12482121|FG000|COMPLETED|Overall Study||23
11285287|NCT02438787|12482122|FG001|COMPLETED|Overall Study||23
11285288|NCT02438787|12482123|FG002|COMPLETED|Overall Study||22
11285289|NCT02438787|12482121|FG000|NOT COMPLETED|Overall Study||81
11285290|NCT02438787|12482122|FG001|NOT COMPLETED|Overall Study||83
11285291|NCT02438787|12482123|FG002|NOT COMPLETED|Overall Study||83
11285292|NCT02438813|12482136|FG000|STARTED|Overall Study||1029
11285293|NCT02438813|12482136|FG000|Received Treatment for SMF|Overall Study||676
11285294|NCT02438813|12482136|FG000|Did Not ReceiveTreatment for SMF|Overall Study||353
11285295|NCT02438813|12482136|FG000|COMPLETED|Overall Study||504
11285296|NCT02438813|12482136|FG000|NOT COMPLETED|Overall Study||525
11285297|NCT02438826|12482152|FG000|STARTED|Double-Blind Treatment Phase||123
11285298|NCT02438826|12482153|FG001|STARTED|Double-Blind Treatment Phase||117
11285299|NCT02438826|12482154|FG002|STARTED|Double-Blind Treatment Phase||0
11285300|NCT02438826|12482155|FG003|STARTED|Double-Blind Treatment Phase||0
11285301|NCT02438826|12482152|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||120
11285302|NCT02438826|12482153|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||117
11285303|NCT02438826|12482154|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
11285304|NCT02438826|12482155|FG003|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
11285305|NCT02438826|12482152|FG000|COMPLETED|Double-Blind Treatment Phase||117
11285306|NCT02438826|12482153|FG001|COMPLETED|Double-Blind Treatment Phase||113
11285307|NCT02438826|12482154|FG002|COMPLETED|Double-Blind Treatment Phase||0
11285308|NCT02438826|12482155|FG003|COMPLETED|Double-Blind Treatment Phase||0
11285309|NCT02438826|12482152|FG000|NOT COMPLETED|Double-Blind Treatment Phase||6
11285310|NCT02438826|12482153|FG001|NOT COMPLETED|Double-Blind Treatment Phase||4
11285311|NCT02438826|12482154|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0
11285312|NCT02438826|12482155|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
11285313|NCT02438826|12482152|FG000|STARTED|Open-Label Treatment Phase|This period is optional phase, one participant chose not to enter the open-label phase.|116
11285314|NCT02438826|12482153|FG001|STARTED|Open-Label Treatment Phase||113
11285315|NCT02438826|12482154|FG002|STARTED|Open-Label Treatment Phase||0
11285316|NCT02438826|12482155|FG003|STARTED|Open-Label Treatment Phase||0
11285317|NCT02438826|12482152|FG000|COMPLETED|Open-Label Treatment Phase||72
11285318|NCT02438826|12482153|FG001|COMPLETED|Open-Label Treatment Phase||80
11285319|NCT02438826|12482154|FG002|COMPLETED|Open-Label Treatment Phase||0
11285320|NCT02438826|12482155|FG003|COMPLETED|Open-Label Treatment Phase||0
11285321|NCT02438826|12482152|FG000|NOT COMPLETED|Open-Label Treatment Phase||44
11285322|NCT02438826|12482153|FG001|NOT COMPLETED|Open-Label Treatment Phase||33
11285323|NCT02438826|12482154|FG002|NOT COMPLETED|Open-Label Treatment Phase||0
11285324|NCT02438826|12482155|FG003|NOT COMPLETED|Open-Label Treatment Phase||0
11285325|NCT02438826|12482152|FG000|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
11285326|NCT02438826|12482153|FG001|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
11285327|NCT02438826|12482154|FG002|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|2
11285328|NCT02438826|12482155|FG003|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|4
11285329|NCT02438826|12482152|FG000|COMPLETED|Post-Treatment Phase||84
11285330|NCT02438826|12482153|FG001|COMPLETED|Post-Treatment Phase||92
11285331|NCT02438826|12482154|FG002|COMPLETED|Post-Treatment Phase||2
11285332|NCT02438826|12482155|FG003|COMPLETED|Post-Treatment Phase||4
11285333|NCT02438826|12482152|FG000|NOT COMPLETED|Post-Treatment Phase||9
11285334|NCT02438826|12482153|FG001|NOT COMPLETED|Post-Treatment Phase||1
11285335|NCT02438826|12482154|FG002|NOT COMPLETED|Post-Treatment Phase||0
11285336|NCT02438826|12482155|FG003|NOT COMPLETED|Post-Treatment Phase||0
11285337|NCT02439138|12482170|FG000|STARTED|Overall Study||5
11285338|NCT02439138|12482170|FG000|COMPLETED|Overall Study||2
11285339|NCT02439138|12482170|FG000|NOT COMPLETED|Overall Study||3
11285340|NCT02439164|12482176|FG000|STARTED|Overall Study||18
11285341|NCT02439164|12482177|FG001|STARTED|Overall Study||18
11285342|NCT02439164|12482176|FG000|COMPLETED|Overall Study||18
11285343|NCT02439164|12482177|FG001|COMPLETED|Overall Study||18
11285344|NCT02439164|12482176|FG000|NOT COMPLETED|Overall Study||0
11285345|NCT02439164|12482177|FG001|NOT COMPLETED|Overall Study||0
11285346|NCT02439281|12482186|FG000|STARTED|Overall Study||24
11285347|NCT02439281|12482187|FG001|STARTED|Overall Study||26
11285348|NCT02439281|12482186|FG000|COMPLETED|Overall Study||24
11285349|NCT02439281|12482187|FG001|COMPLETED|Overall Study||26
11285350|NCT02439281|12482186|FG000|NOT COMPLETED|Overall Study||0
11285351|NCT02439281|12482187|FG001|NOT COMPLETED|Overall Study||0
11285352|NCT02439320|12482198|FG000|STARTED|Overall Study||744
11285353|NCT02439320|12482199|FG001|STARTED|Overall Study||745
11285354|NCT02439320|12482200|FG002|STARTED|Overall Study||742
11285355|NCT02439320|12482198|FG000|Confirmed Eligibility|Overall Study||710
11285356|NCT02439320|12482199|FG001|Confirmed Eligibility|Overall Study||695
11285357|NCT02439320|12482200|FG002|Confirmed Eligibility|Overall Study||705
11285358|NCT02439320|12482198|FG000|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630
11285359|NCT02439320|12482199|FG001|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609
11285360|NCT02439320|12482200|FG002|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617
11285361|NCT02439320|12482198|FG000|2nd Dose (After 2 Hour Assessment)|Overall Study||289
11285362|NCT02439320|12482199|FG001|2nd Dose (After 2 Hour Assessment)|Overall Study||238
11285363|NCT02439320|12482200|FG002|2nd Dose (After 2 Hour Assessment)|Overall Study||401
11285364|NCT02439320|12482198|FG000|COMPLETED|Overall Study||648
11285365|NCT02439320|12482199|FG001|COMPLETED|Overall Study||631
11285366|NCT02439320|12482200|FG002|COMPLETED|Overall Study||643
11285367|NCT02439320|12482198|FG000|NOT COMPLETED|Overall Study||96
11285368|NCT02439320|12482199|FG001|NOT COMPLETED|Overall Study||114
11285369|NCT02439320|12482200|FG002|NOT COMPLETED|Overall Study||99
11285370|NCT02439710|12482214|FG000|STARTED|Overall Study||656
11285371|NCT02439710|12482214|FG000|COMPLETED|Overall Study||656
11285372|NCT02439710|12482214|FG000|NOT COMPLETED|Overall Study||0
11285373|NCT02439814|12482220|FG000|STARTED|Overall Study||11
11285374|NCT02439814|12482221|FG001|STARTED|Overall Study||10
11285375|NCT02439814|12482220|FG000|COMPLETED|Overall Study||11
11285376|NCT02439814|12482221|FG001|COMPLETED|Overall Study||10
11285377|NCT02439814|12482220|FG000|NOT COMPLETED|Overall Study||0
11285378|NCT02439814|12482221|FG001|NOT COMPLETED|Overall Study||0
11285379|NCT02439879|12482229|FG000|STARTED|Overall Study||16
11285380|NCT02439879|12482230|FG001|STARTED|Overall Study||17
11285381|NCT02439879|12482229|FG000|COMPLETED|Overall Study||16
11285382|NCT02439879|12482230|FG001|COMPLETED|Overall Study||17
11285383|NCT02439879|12482229|FG000|NOT COMPLETED|Overall Study||0
11285384|NCT02439879|12482230|FG001|NOT COMPLETED|Overall Study||0
11285385|NCT02440022|12482238|FG000|STARTED|Overall Study||141
11285386|NCT02440022|12482239|FG001|STARTED|Overall Study||144
11285387|NCT02440022|12482238|FG000|COMPLETED|Overall Study||114
11285388|NCT02440022|12482239|FG001|COMPLETED|Overall Study||131
11285389|NCT02440022|12482238|FG000|NOT COMPLETED|Overall Study||27
11285390|NCT02440022|12482239|FG001|NOT COMPLETED|Overall Study||13
11285391|NCT02440139|12482245|FG000|STARTED|Overall Study|12 radiologists read 324 CT cases|12
11285392|NCT02440139|12482245|FG000|COMPLETED|Overall Study|12 radiologists read 324 CT cases|12
11285393|NCT02440139|12482245|FG000|NOT COMPLETED|Overall Study||0
11285394|NCT02440178|12482253|FG000|STARTED|Overall Study||66
11285395|NCT02440178|12482253|FG000|COMPLETED|Overall Study||46
11285396|NCT02440178|12482253|FG000|NOT COMPLETED|Overall Study||20
11285397|NCT02440204|12482262|FG000|STARTED|Overall Study||22
11285398|NCT02440204|12482263|FG001|STARTED|Overall Study||24
11285399|NCT02440204|12482264|FG002|STARTED|Overall Study||22
11285400|NCT02440204|12482262|FG000|COMPLETED|Overall Study||22
11285401|NCT02440204|12482263|FG001|COMPLETED|Overall Study||24
11285402|NCT02440204|12482264|FG002|COMPLETED|Overall Study||22
11285403|NCT02440204|12482262|FG000|NOT COMPLETED|Overall Study||0
11285404|NCT02440204|12482263|FG001|NOT COMPLETED|Overall Study||0
11285405|NCT02440204|12482264|FG002|NOT COMPLETED|Overall Study||0
11285406|NCT02440308|12482272|FG000|STARTED|Overall Study||10
11285407|NCT02440308|12482272|FG000|COMPLETED|Overall Study||10
11285408|NCT02440308|12482272|FG000|NOT COMPLETED|Overall Study||0
11285409|NCT02440334|12482276|FG000|STARTED|Overall Study||53
11285410|NCT02440334|12482276|FG000|COMPLETED|Overall Study||53
11285411|NCT02440334|12482276|FG000|NOT COMPLETED|Overall Study||0
11285412|NCT02440451|12482280|FG000|STARTED|Overall Study||15
11285413|NCT02440451|12482280|FG000|COMPLETED|Overall Study||15
11285414|NCT02440451|12482280|FG000|NOT COMPLETED|Overall Study||0
11285415|NCT02440568|12482288|FG000|STARTED|Overall Study||5
11285416|NCT02440568|12482289|FG001|STARTED|Overall Study||4
11285417|NCT02440568|12482290|FG002|STARTED|Overall Study||10
11285418|NCT02440568|12482291|FG003|STARTED|Overall Study||3
11285419|NCT02440568|12482288|FG000|COMPLETED|Overall Study||1
11285420|NCT02440568|12482289|FG001|COMPLETED|Overall Study||1
11285421|NCT02440568|12482290|FG002|COMPLETED|Overall Study||5
11285422|NCT02440568|12482291|FG003|COMPLETED|Overall Study||1
11285423|NCT02440568|12482288|FG000|NOT COMPLETED|Overall Study||4
11285424|NCT02440568|12482289|FG001|NOT COMPLETED|Overall Study||3
11285425|NCT02440568|12482290|FG002|NOT COMPLETED|Overall Study||5
11285426|NCT02440568|12482291|FG003|NOT COMPLETED|Overall Study||2
11285427|NCT02440594|12482310|FG000|STARTED|Overall Study||509
11285428|NCT02440594|12482311|FG001|STARTED|Overall Study||509
11285429|NCT02440594|12482312|FG002|STARTED|Overall Study||436
11285430|NCT02440594|12482313|FG003|STARTED|Overall Study||429
11285431|NCT02440594|12482314|FG004|STARTED|Overall Study||55
11285432|NCT02440594|12482315|FG005|STARTED|Overall Study||54
11285433|NCT02440594|12482316|FG006|STARTED|Overall Study||150
11285434|NCT02440594|12482317|FG007|STARTED|Overall Study||290
11285435|NCT02440594|12482310|FG000|COMPLETED|Overall Study||377
11285436|NCT02440594|12482311|FG001|COMPLETED|Overall Study||401
11285437|NCT02440594|12482312|FG002|COMPLETED|Overall Study||319
11285438|NCT02440594|12482313|FG003|COMPLETED|Overall Study||340
11399266|NCT04348851|12593801|FG001|COMPLETED|Post-Test 2||10
11399267|NCT04348851|12593802|FG002|COMPLETED|Post-Test 2||13
11399268|NCT04348851|12593803|FG003|COMPLETED|Post-Test 2||13
11399269|NCT04348851|12593800|FG000|NOT COMPLETED|Post-Test 2||0
11399270|NCT04348851|12593801|FG001|NOT COMPLETED|Post-Test 2||1
11399271|NCT04348851|12593802|FG002|NOT COMPLETED|Post-Test 2||0
11399272|NCT04348851|12593803|FG003|NOT COMPLETED|Post-Test 2||1
11285439|NCT02440594|12482314|FG004|COMPLETED|Overall Study||46
11285440|NCT02440594|12482315|FG005|COMPLETED|Overall Study||47
11285441|NCT02440594|12482316|FG006|COMPLETED|Overall Study||113
11285442|NCT02440594|12482317|FG007|COMPLETED|Overall Study||234
11285443|NCT02440594|12482310|FG000|NOT COMPLETED|Overall Study||132
11285444|NCT02440594|12482311|FG001|NOT COMPLETED|Overall Study||108
11285445|NCT02440594|12482312|FG002|NOT COMPLETED|Overall Study||117
11285446|NCT02440594|12482313|FG003|NOT COMPLETED|Overall Study||89
11285447|NCT02440594|12482314|FG004|NOT COMPLETED|Overall Study||9
11285448|NCT02440594|12482315|FG005|NOT COMPLETED|Overall Study||7
11285449|NCT02440594|12482316|FG006|NOT COMPLETED|Overall Study||37
11285450|NCT02440594|12482317|FG007|NOT COMPLETED|Overall Study||56
11285451|NCT02440633|12482342|FG000|STARTED|Overall Study||8
11285452|NCT02440633|12482342|FG000|COMPLETED|Overall Study||8
11285453|NCT02440633|12482342|FG000|NOT COMPLETED|Overall Study||0
11285454|NCT02440659|12482352|FG000|STARTED|Overall Study||1997
11285455|NCT02440659|12482353|FG001|STARTED|Overall Study||949
11285456|NCT02440659|12482352|FG000|COMPLETED|Overall Study||1346
11285457|NCT02440659|12482353|FG001|COMPLETED|Overall Study||614
11285458|NCT02440659|12482352|FG000|NOT COMPLETED|Overall Study||651
11285459|NCT02440659|12482353|FG001|NOT COMPLETED|Overall Study||335
11285460|NCT02440789|12482359|FG000|STARTED|Overall Study||32
11285461|NCT02440789|12482359|FG000|Initiated Sirolimus|Overall Study||30
11285462|NCT02440789|12482359|FG000|Completed 20 Weeks of Sirolimus|Overall Study||16
11285463|NCT02440789|12482359|FG000|COMPLETED|Overall Study||28
11285464|NCT02440789|12482359|FG000|NOT COMPLETED|Overall Study||4
11285465|NCT02441062|12482363|FG000|STARTED|Overall Study||122
11285466|NCT02441062|12482363|FG000|COMPLETED|Overall Study||122
11285467|NCT02441062|12482363|FG000|NOT COMPLETED|Overall Study||0
11285468|NCT02441114|12482367|FG000|STARTED|Period1||10
11285469|NCT02441114|12482367|FG000|COMPLETED|Period1||10
11285470|NCT02441114|12482367|FG000|NOT COMPLETED|Period1||0
11285471|NCT02441114|12482367|FG000|STARTED|Washout1||10
11285472|NCT02441114|12482367|FG000|COMPLETED|Washout1||10
11285473|NCT02441114|12482367|FG000|NOT COMPLETED|Washout1||0
11285474|NCT02441114|12482367|FG000|STARTED|Period2||10
11285475|NCT02441114|12482367|FG000|COMPLETED|Period2||10
11285476|NCT02441114|12482367|FG000|NOT COMPLETED|Period2||0
11285477|NCT02441114|12482367|FG000|STARTED|Washout2||10
11285478|NCT02441114|12482367|FG000|COMPLETED|Washout2||6
11285479|NCT02441114|12482367|FG000|NOT COMPLETED|Washout2||4
11285480|NCT02441114|12482367|FG000|STARTED|Period3||6
11285481|NCT02441114|12482367|FG000|COMPLETED|Period3||6
11285482|NCT02441114|12482367|FG000|NOT COMPLETED|Period3||0
11285483|NCT02441179|12482373|FG000|STARTED|Overall Study||18
11285484|NCT02441179|12482374|FG001|STARTED|Overall Study||17
11285485|NCT02441179|12482373|FG000|COMPLETED|Overall Study||17
11285486|NCT02441179|12482374|FG001|COMPLETED|Overall Study||16
11285487|NCT02441179|12482373|FG000|NOT COMPLETED|Overall Study||1
11285488|NCT02441179|12482374|FG001|NOT COMPLETED|Overall Study||1
11285489|NCT02441218|12482383|FG000|STARTED|Overall Study||3241
11285490|NCT02441218|12482384|FG001|STARTED|Overall Study||3264
11285491|NCT02441218|12482383|FG000|COMPLETED|Overall Study||2663
11285492|NCT02441218|12482384|FG001|COMPLETED|Overall Study||2652
11285493|NCT02441218|12482383|FG000|NOT COMPLETED|Overall Study||578
11285494|NCT02441218|12482384|FG001|NOT COMPLETED|Overall Study||612
11285495|NCT02441283|12482390|FG000|STARTED|Overall Study||377
11285496|NCT02441283|12482390|FG000|COMPLETED|Overall Study||287
11399273|NCT04348357|12593815|FG000|STARTED|Overall Study||25
11399274|NCT04348357|12593816|FG001|STARTED|Overall Study||28
11399275|NCT04348357|12593815|FG000|COMPLETED|Overall Study||25
11399276|NCT04348357|12593816|FG001|COMPLETED|Overall Study||16
11399277|NCT04348357|12593815|FG000|NOT COMPLETED|Overall Study||0
11285497|NCT02441283|12482390|FG000|NOT COMPLETED|Overall Study||90
11285498|NCT02441309|12482397|FG000|STARTED|Overall Study||3
11285499|NCT02441309|12482398|FG001|STARTED|Overall Study||2
11285500|NCT02441309|12482399|FG002|STARTED|Overall Study||3
11285501|NCT02441309|12482397|FG000|Received Allocated Intervention|Overall Study||1
11285502|NCT02441309|12482398|FG001|Received Allocated Intervention|Overall Study||2
11285503|NCT02441309|12482399|FG002|Received Allocated Intervention|Overall Study||3
11285504|NCT02441309|12482397|FG000|COMPLETED|Overall Study||0
11285505|NCT02441309|12482398|FG001|COMPLETED|Overall Study||0
11285506|NCT02441309|12482399|FG002|COMPLETED|Overall Study||0
11285507|NCT02441309|12482397|FG000|NOT COMPLETED|Overall Study||3
11285508|NCT02441309|12482398|FG001|NOT COMPLETED|Overall Study||2
11285509|NCT02441309|12482399|FG002|NOT COMPLETED|Overall Study||3
11285510|NCT02441517|12482410|FG000|STARTED|Overall Study||4
11285511|NCT02441517|12482410|FG000|Received Treatment|Overall Study||4
11285512|NCT02441517|12482410|FG000|COMPLETED|Overall Study||0
11285513|NCT02441517|12482410|FG000|NOT COMPLETED|Overall Study||4
11285514|NCT02441946|12482417|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||74
11285515|NCT02441946|12482418|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||76
11285516|NCT02441946|12482419|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||74
11285517|NCT02441946|12482417|FG000|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
11285518|NCT02441946|12482418|FG001|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
11285519|NCT02441946|12482419|FG002|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
11285520|NCT02441946|12482417|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
11285521|NCT02441946|12482418|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
11285522|NCT02441946|12482419|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
11285523|NCT02441946|12482417|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
11285524|NCT02441946|12482418|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
11285525|NCT02441946|12482419|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
11285526|NCT02441946|12482417|FG000|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
11285527|NCT02441946|12482418|FG001|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
11285528|NCT02441946|12482419|FG002|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
11285529|NCT02441946|12482417|FG000|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217
11285530|NCT02441946|12482418|FG001|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
11285531|NCT02441946|12482419|FG002|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
11285532|NCT02441946|12482417|FG000|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5
11285533|NCT02441946|12482418|FG001|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
11285534|NCT02441946|12482419|FG002|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
11285535|NCT02441946|12482417|FG000|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
11285536|NCT02441946|12482418|FG001|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
11285537|NCT02441946|12482419|FG002|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
11285538|NCT02441946|12482417|FG000|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
11285539|NCT02441946|12482418|FG001|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
11285540|NCT02441946|12482419|FG002|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
11285541|NCT02441946|12482417|FG000|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42
11285542|NCT02441946|12482418|FG001|STARTED|Extension Period (8 Weeks)||0
11285543|NCT02441946|12482419|FG002|STARTED|Extension Period (8 Weeks)||0
11285544|NCT02441946|12482417|FG000|COMPLETED|Extension Period (8 Weeks)||40
11285545|NCT02441946|12482418|FG001|COMPLETED|Extension Period (8 Weeks)||0
11285546|NCT02441946|12482419|FG002|COMPLETED|Extension Period (8 Weeks)||0
11285547|NCT02441946|12482417|FG000|NOT COMPLETED|Extension Period (8 Weeks)||2
11285548|NCT02441946|12482418|FG001|NOT COMPLETED|Extension Period (8 Weeks)||0
11285549|NCT02441946|12482419|FG002|NOT COMPLETED|Extension Period (8 Weeks)||0
11285550|NCT02442206|12482432|FG000|STARTED|Period 1||30
11285551|NCT02442206|12482433|FG001|STARTED|Period 1||32
11285552|NCT02442206|12482432|FG000|COMPLETED|Period 1||29
11285553|NCT02442206|12482433|FG001|COMPLETED|Period 1||29
11285554|NCT02442206|12482432|FG000|NOT COMPLETED|Period 1||1
11285555|NCT02442206|12482433|FG001|NOT COMPLETED|Period 1||3
11285556|NCT02442206|12482432|FG000|STARTED|Period 2||29
11285557|NCT02442206|12482433|FG001|STARTED|Period 2||29
11285558|NCT02442206|12482432|FG000|COMPLETED|Period 2||28
11285559|NCT02442206|12482433|FG001|COMPLETED|Period 2||29
11285560|NCT02442206|12482432|FG000|NOT COMPLETED|Period 2||1
11285561|NCT02442206|12482433|FG001|NOT COMPLETED|Period 2||0
11285562|NCT02442271|12482440|FG000|STARTED|Overall Study||222
11285563|NCT02442271|12482440|FG000|COMPLETED|Overall Study||218
11285564|NCT02442271|12482440|FG000|NOT COMPLETED|Overall Study||4
11285565|NCT02442284|12482458|FG000|STARTED|Overall Study||99
11285566|NCT02442284|12482458|FG000|COMPLETED|Overall Study||92
11285567|NCT02442284|12482458|FG000|NOT COMPLETED|Overall Study||7
11285568|NCT02442310|12482462|FG000|STARTED|Overall Study||20
11285569|NCT02442310|12482462|FG000|COMPLETED|Overall Study||17
11285570|NCT02442310|12482462|FG000|NOT COMPLETED|Overall Study||3
11285571|NCT02442336|12482472|FG000|STARTED|Overall Study||80
11285572|NCT02442336|12482472|FG000|Developmental Phase|Overall Study||6
11285573|NCT02442336|12482472|FG000|Evaluation Phase|Overall Study||74
11285574|NCT02442336|12482472|FG000|Provided Access to Intervention|Overall Study||55
11285575|NCT02442336|12482472|FG000|COMPLETED|Overall Study||44
11285576|NCT02442336|12482472|FG000|NOT COMPLETED|Overall Study||36
11285577|NCT02442622|12482478|FG000|STARTED|Overall Study||15
11285578|NCT02442622|12482479|FG001|STARTED|Overall Study||17
11285579|NCT02442622|12482478|FG000|COMPLETED|Overall Study||12
11285580|NCT02442622|12482479|FG001|COMPLETED|Overall Study||16
11285581|NCT02442622|12482478|FG000|NOT COMPLETED|Overall Study||3
11285582|NCT02442622|12482479|FG001|NOT COMPLETED|Overall Study||1
11285583|NCT02442687|12482488|FG000|STARTED|Overall Study||21
11285584|NCT02442687|12482489|FG001|STARTED|Overall Study||22
11285585|NCT02442687|12482490|FG002|STARTED|Overall Study||22
11285586|NCT02442687|12482488|FG000|COMPLETED|Overall Study||13
11285587|NCT02442687|12482489|FG001|COMPLETED|Overall Study||11
11285588|NCT02442687|12482490|FG002|COMPLETED|Overall Study||19
11285589|NCT02442687|12482488|FG000|NOT COMPLETED|Overall Study||8
11285590|NCT02442687|12482489|FG001|NOT COMPLETED|Overall Study||11
11285591|NCT02442687|12482490|FG002|NOT COMPLETED|Overall Study||3
11285592|NCT02442700|12482501|FG000|STARTED|First 12 Weeks||12
11285593|NCT02442700|12482502|FG001|STARTED|First 12 Weeks||12
11285594|NCT02442700|12482501|FG000|COMPLETED|First 12 Weeks||12
11285595|NCT02442700|12482502|FG001|COMPLETED|First 12 Weeks||12
11285596|NCT02442700|12482501|FG000|NOT COMPLETED|First 12 Weeks||0
11285597|NCT02442700|12482502|FG001|NOT COMPLETED|First 12 Weeks||0
11285598|NCT02442700|12482501|FG000|STARTED|Later 12 Weeks||12
11285599|NCT02442700|12482502|FG001|STARTED|Later 12 Weeks||12
11285600|NCT02442700|12482501|FG000|COMPLETED|Later 12 Weeks||12
11285601|NCT02442700|12482502|FG001|COMPLETED|Later 12 Weeks||12
11285602|NCT02442700|12482501|FG000|NOT COMPLETED|Later 12 Weeks||0
11285603|NCT02442700|12482502|FG001|NOT COMPLETED|Later 12 Weeks||0
11285604|NCT02442804|12482510|FG000|STARTED|Overall Study||8
11285605|NCT02442804|12482511|FG001|STARTED|Overall Study||8
11285606|NCT02442804|12482510|FG000|COMPLETED|Overall Study||7
11285607|NCT02442804|12482511|FG001|COMPLETED|Overall Study||7
11399278|NCT04348357|12593816|FG001|NOT COMPLETED|Overall Study||12
11399279|NCT04346199|12593824|FG000|STARTED|Overall Study||89
11399280|NCT04346199|12593825|FG001|STARTED|Overall Study||88
11285608|NCT02442804|12482510|FG000|NOT COMPLETED|Overall Study||1
11285609|NCT02442804|12482511|FG001|NOT COMPLETED|Overall Study||1
11285610|NCT02442830|12482519|FG000|STARTED|Overall Study||42
11285611|NCT02442830|12482520|FG001|STARTED|Overall Study||45
11285612|NCT02442830|12482519|FG000|COMPLETED|Overall Study||42
11285613|NCT02442830|12482520|FG001|COMPLETED|Overall Study||44
11285614|NCT02442830|12482519|FG000|NOT COMPLETED|Overall Study||0
11285615|NCT02442830|12482520|FG001|NOT COMPLETED|Overall Study||1
11285616|NCT02442856|12482527|FG000|STARTED|Overall Study||21
11285617|NCT02442856|12482527|FG000|COMPLETED|Overall Study||21
11285618|NCT02442856|12482527|FG000|NOT COMPLETED|Overall Study||0
11285619|NCT02442869|12482537|FG000|STARTED|Overall Study||18
11285620|NCT02442869|12482538|FG001|STARTED|Overall Study||29
11285621|NCT02442869|12482539|FG002|STARTED|Overall Study||6
11285622|NCT02442869|12482540|FG003|STARTED|Overall Study||2
11285623|NCT02442869|12482541|FG004|STARTED|Overall Study||5
11285624|NCT02442869|12482542|FG005|STARTED|Overall Study||2
11285625|NCT02442869|12482537|FG000|COMPLETED|Overall Study||13
11285626|NCT02442869|12482538|FG001|COMPLETED|Overall Study||20
11285627|NCT02442869|12482539|FG002|COMPLETED|Overall Study||6
11285628|NCT02442869|12482540|FG003|COMPLETED|Overall Study||1
11285629|NCT02442869|12482541|FG004|COMPLETED|Overall Study||3
11285630|NCT02442869|12482542|FG005|COMPLETED|Overall Study||2
11285631|NCT02442869|12482537|FG000|NOT COMPLETED|Overall Study||5
11285632|NCT02442869|12482538|FG001|NOT COMPLETED|Overall Study||9
11285633|NCT02442869|12482539|FG002|NOT COMPLETED|Overall Study||0
11285634|NCT02442869|12482540|FG003|NOT COMPLETED|Overall Study||1
11285635|NCT02442869|12482541|FG004|NOT COMPLETED|Overall Study||2
11285636|NCT02442869|12482542|FG005|NOT COMPLETED|Overall Study||0
11285637|NCT02443103|12482566|FG000|STARTED|Overall Study||4
11285638|NCT02443103|12482566|FG000|COMPLETED|Overall Study||1
11285639|NCT02443103|12482566|FG000|NOT COMPLETED|Overall Study||3
11285640|NCT02443155|12482574|FG000|STARTED|Overall Study||77
11285641|NCT02443155|12482575|FG001|STARTED|Overall Study||77
11285642|NCT02443155|12482576|FG002|STARTED|Overall Study||76
11285643|NCT02443155|12482577|FG003|STARTED|Overall Study||77
11285644|NCT02443155|12482574|FG000|Full Analysis Set|Overall Study||77
11285645|NCT02443155|12482575|FG001|Full Analysis Set|Overall Study||77
11285646|NCT02443155|12482576|FG002|Full Analysis Set|Overall Study||76
11285647|NCT02443155|12482577|FG003|Full Analysis Set|Overall Study||77
11285648|NCT02443155|12482574|FG000|PK Analysis Set|Overall Study||21
11285649|NCT02443155|12482575|FG001|PK Analysis Set|Overall Study||21
11285650|NCT02443155|12482576|FG002|PK Analysis Set|Overall Study||22
11285651|NCT02443155|12482577|FG003|PK Analysis Set|Overall Study||20
11285652|NCT02443155|12482574|FG000|Safety Analysis Set|Overall Study||77
11285653|NCT02443155|12482575|FG001|Safety Analysis Set|Overall Study||77
11285654|NCT02443155|12482576|FG002|Safety Analysis Set|Overall Study||76
11285655|NCT02443155|12482577|FG003|Safety Analysis Set|Overall Study||77
11399281|NCT04346199|12593824|FG000|COMPLETED|Overall Study||74
11399282|NCT04346199|12593825|FG001|COMPLETED|Overall Study||77
11399283|NCT04346199|12593824|FG000|NOT COMPLETED|Overall Study||15
11399284|NCT04346199|12593825|FG001|NOT COMPLETED|Overall Study||11
11399285|NCT04345653|12593831|FG000|STARTED|Overall Study||48
11285656|NCT02443155|12482574|FG000|COMPLETED|Overall Study||65
11285657|NCT02443155|12482575|FG001|COMPLETED|Overall Study||63
11285658|NCT02443155|12482576|FG002|COMPLETED|Overall Study||67
11285659|NCT02443155|12482577|FG003|COMPLETED|Overall Study||61
11285660|NCT02443155|12482574|FG000|NOT COMPLETED|Overall Study||12
11285661|NCT02443155|12482575|FG001|NOT COMPLETED|Overall Study||14
11285662|NCT02443155|12482576|FG002|NOT COMPLETED|Overall Study||9
11285663|NCT02443155|12482577|FG003|NOT COMPLETED|Overall Study||16
11285664|NCT02443298|12482590|FG000|STARTED|Overall Study||105
11285665|NCT02443298|12482591|FG001|STARTED|Overall Study||109
11285666|NCT02443298|12482590|FG000|COMPLETED|Overall Study||101
11285667|NCT02443298|12482591|FG001|COMPLETED|Overall Study||104
11285668|NCT02443298|12482590|FG000|NOT COMPLETED|Overall Study||4
11285669|NCT02443298|12482591|FG001|NOT COMPLETED|Overall Study||5
11285670|NCT02443337|12482599|FG000|STARTED|Overall Study||15
11285671|NCT02443337|12482600|FG001|STARTED|Overall Study||16
11285672|NCT02443337|12482599|FG000|Received at Least One Dose of Study Drug|Overall Study||15
11285673|NCT02443337|12482600|FG001|Received at Least One Dose of Study Drug|Overall Study||16
11285674|NCT02443337|12482599|FG000|COMPLETED|Overall Study||10
11285675|NCT02443337|12482600|FG001|COMPLETED|Overall Study||14
11285676|NCT02443337|12482599|FG000|NOT COMPLETED|Overall Study||5
11285677|NCT02443337|12482600|FG001|NOT COMPLETED|Overall Study||2
11285678|NCT02443402|12482613|FG000|STARTED|Overall Study||36
11285679|NCT02443402|12482614|FG001|STARTED|Overall Study||31
11285680|NCT02443402|12482613|FG000|COMPLETED|Overall Study||32
11285681|NCT02443402|12482614|FG001|COMPLETED|Overall Study||28
11285682|NCT02443402|12482613|FG000|NOT COMPLETED|Overall Study||4
11285683|NCT02443402|12482614|FG001|NOT COMPLETED|Overall Study||3
11285684|NCT02443519|12482622|FG000|STARTED|Overall Study||31
11285685|NCT02443519|12482623|FG001|STARTED|Overall Study||29
11285686|NCT02443519|12482622|FG000|COMPLETED|Overall Study||29
11285687|NCT02443519|12482623|FG001|COMPLETED|Overall Study||26
11285688|NCT02443519|12482622|FG000|NOT COMPLETED|Overall Study||2
11285689|NCT02443519|12482623|FG001|NOT COMPLETED|Overall Study||3
11285690|NCT02443571|12482632|FG000|STARTED|Overall Study||596
11285691|NCT02443571|12482633|FG001|STARTED|Overall Study||95
11285692|NCT02443571|12482634|FG002|STARTED|Overall Study||23
11285693|NCT02443571|12482632|FG000|COMPLETED|Overall Study||596
11285694|NCT02443571|12482633|FG001|COMPLETED|Overall Study||95
11285695|NCT02443571|12482634|FG002|COMPLETED|Overall Study||23
11285696|NCT02443571|12482632|FG000|NOT COMPLETED|Overall Study||0
11285697|NCT02443571|12482633|FG001|NOT COMPLETED|Overall Study||0
11285698|NCT02443571|12482634|FG002|NOT COMPLETED|Overall Study||0
11285699|NCT02443688|12482645|FG000|STARTED|Overall Study||66
11285700|NCT02443688|12482646|FG001|STARTED|Overall Study||67
11285701|NCT02443688|12482647|FG002|STARTED|Overall Study||67
11285702|NCT02443688|12482645|FG000|COMPLETED|Overall Study||54
11285703|NCT02443688|12482646|FG001|COMPLETED|Overall Study||58
11285704|NCT02443688|12482647|FG002|COMPLETED|Overall Study||55
11285705|NCT02443688|12482645|FG000|NOT COMPLETED|Overall Study||12
11285706|NCT02443688|12482646|FG001|NOT COMPLETED|Overall Study||9
11285707|NCT02443688|12482647|FG002|NOT COMPLETED|Overall Study||12
11285708|NCT02443740|12482663|FG000|STARTED|Intervention Period 1 (3 Days)||2
11285709|NCT02443740|12482664|FG001|STARTED|Intervention Period 1 (3 Days)||2
11285710|NCT02443740|12482665|FG002|STARTED|Intervention Period 1 (3 Days)||2
11285711|NCT02443740|12482666|FG003|STARTED|Intervention Period 1 (3 Days)||3
11285712|NCT02443740|12482667|FG004|STARTED|Intervention Period 1 (3 Days)||2
11285713|NCT02443740|12482668|FG005|STARTED|Intervention Period 1 (3 Days)||4
11285714|NCT02443740|12482669|FG006|STARTED|Intervention Period 1 (3 Days)||3
11285715|NCT02443740|12482670|FG007|STARTED|Intervention Period 1 (3 Days)||2
11285716|NCT02443740|12482671|FG008|STARTED|Intervention Period 1 (3 Days)||6
11285717|NCT02443740|12482672|FG009|STARTED|Intervention Period 1 (3 Days)||3
11285718|NCT02443740|12482673|FG010|STARTED|Intervention Period 1 (3 Days)||3
11285719|NCT02443740|12482663|FG000|COMPLETED|Intervention Period 1 (3 Days)||1
11285720|NCT02443740|12482664|FG001|COMPLETED|Intervention Period 1 (3 Days)||2
11285721|NCT02443740|12482665|FG002|COMPLETED|Intervention Period 1 (3 Days)||2
11285722|NCT02443740|12482666|FG003|COMPLETED|Intervention Period 1 (3 Days)||3
11285723|NCT02443740|12482667|FG004|COMPLETED|Intervention Period 1 (3 Days)||2
11285724|NCT02443740|12482668|FG005|COMPLETED|Intervention Period 1 (3 Days)||2
11285725|NCT02443740|12482669|FG006|COMPLETED|Intervention Period 1 (3 Days)||2
11285726|NCT02443740|12482670|FG007|COMPLETED|Intervention Period 1 (3 Days)||2
11285727|NCT02443740|12482671|FG008|COMPLETED|Intervention Period 1 (3 Days)||6
11285728|NCT02443740|12482672|FG009|COMPLETED|Intervention Period 1 (3 Days)||3
11285729|NCT02443740|12482673|FG010|COMPLETED|Intervention Period 1 (3 Days)||3
11285730|NCT02443740|12482663|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||1
11285731|NCT02443740|12482664|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11285732|NCT02443740|12482665|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11285733|NCT02443740|12482666|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11285734|NCT02443740|12482667|FG004|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11285735|NCT02443740|12482668|FG005|NOT COMPLETED|Intervention Period 1 (3 Days)||2
11285736|NCT02443740|12482669|FG006|NOT COMPLETED|Intervention Period 1 (3 Days)||1
11285737|NCT02443740|12482670|FG007|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11285738|NCT02443740|12482671|FG008|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11285739|NCT02443740|12482672|FG009|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11285740|NCT02443740|12482673|FG010|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11285741|NCT02443740|12482663|FG000|STARTED|Washout Period 1 (7 Days)||1
11285742|NCT02443740|12482664|FG001|STARTED|Washout Period 1 (7 Days)||2
11285743|NCT02443740|12482665|FG002|STARTED|Washout Period 1 (7 Days)||2
11285744|NCT02443740|12482666|FG003|STARTED|Washout Period 1 (7 Days)||3
11285745|NCT02443740|12482667|FG004|STARTED|Washout Period 1 (7 Days)||2
11285746|NCT02443740|12482668|FG005|STARTED|Washout Period 1 (7 Days)||2
11285747|NCT02443740|12482669|FG006|STARTED|Washout Period 1 (7 Days)||2
11285748|NCT02443740|12482670|FG007|STARTED|Washout Period 1 (7 Days)||2
11285749|NCT02443740|12482671|FG008|STARTED|Washout Period 1 (7 Days)||0
11285750|NCT02443740|12482672|FG009|STARTED|Washout Period 1 (7 Days)||3
11285751|NCT02443740|12482673|FG010|STARTED|Washout Period 1 (7 Days)||3
11285752|NCT02443740|12482663|FG000|COMPLETED|Washout Period 1 (7 Days)||1
11285753|NCT02443740|12482664|FG001|COMPLETED|Washout Period 1 (7 Days)||2
11285754|NCT02443740|12482665|FG002|COMPLETED|Washout Period 1 (7 Days)||2
11285755|NCT02443740|12482666|FG003|COMPLETED|Washout Period 1 (7 Days)||3
11285756|NCT02443740|12482667|FG004|COMPLETED|Washout Period 1 (7 Days)||2
11285757|NCT02443740|12482668|FG005|COMPLETED|Washout Period 1 (7 Days)||2
11285758|NCT02443740|12482669|FG006|COMPLETED|Washout Period 1 (7 Days)||2
11285759|NCT02443740|12482670|FG007|COMPLETED|Washout Period 1 (7 Days)||2
11285760|NCT02443740|12482671|FG008|COMPLETED|Washout Period 1 (7 Days)||0
11285761|NCT02443740|12482672|FG009|COMPLETED|Washout Period 1 (7 Days)||3
11285762|NCT02443740|12482673|FG010|COMPLETED|Washout Period 1 (7 Days)||3
11285763|NCT02443740|12482663|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
11285764|NCT02443740|12482664|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
11285765|NCT02443740|12482665|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
11285766|NCT02443740|12482666|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
11285767|NCT02443740|12482667|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
11285768|NCT02443740|12482668|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
11285769|NCT02443740|12482669|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
11285770|NCT02443740|12482670|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
11285771|NCT02443740|12482671|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
11285772|NCT02443740|12482672|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
11285773|NCT02443740|12482673|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0
11285774|NCT02443740|12482663|FG000|STARTED|Intervention Period 2 (3 Days)||1
11285775|NCT02443740|12482664|FG001|STARTED|Intervention Period 2 (3 Days)||2
11285776|NCT02443740|12482665|FG002|STARTED|Intervention Period 2 (3 Days)||2
11285777|NCT02443740|12482666|FG003|STARTED|Intervention Period 2 (3 Days)||3
11285778|NCT02443740|12482667|FG004|STARTED|Intervention Period 2 (3 Days)||2
11285779|NCT02443740|12482668|FG005|STARTED|Intervention Period 2 (3 Days)||2
11285780|NCT02443740|12482669|FG006|STARTED|Intervention Period 2 (3 Days)||2
11285781|NCT02443740|12482670|FG007|STARTED|Intervention Period 2 (3 Days)||2
11285782|NCT02443740|12482671|FG008|STARTED|Intervention Period 2 (3 Days)||0
11285783|NCT02443740|12482672|FG009|STARTED|Intervention Period 2 (3 Days)||3
11285784|NCT02443740|12482673|FG010|STARTED|Intervention Period 2 (3 Days)||3
11285785|NCT02443740|12482663|FG000|COMPLETED|Intervention Period 2 (3 Days)||1
11285786|NCT02443740|12482664|FG001|COMPLETED|Intervention Period 2 (3 Days)||2
11285787|NCT02443740|12482665|FG002|COMPLETED|Intervention Period 2 (3 Days)||2
11285788|NCT02443740|12482666|FG003|COMPLETED|Intervention Period 2 (3 Days)||3
11285789|NCT02443740|12482667|FG004|COMPLETED|Intervention Period 2 (3 Days)||2
11285790|NCT02443740|12482668|FG005|COMPLETED|Intervention Period 2 (3 Days)||2
11285791|NCT02443740|12482669|FG006|COMPLETED|Intervention Period 2 (3 Days)||2
11285792|NCT02443740|12482670|FG007|COMPLETED|Intervention Period 2 (3 Days)||2
11285793|NCT02443740|12482671|FG008|COMPLETED|Intervention Period 2 (3 Days)||0
11285794|NCT02443740|12482672|FG009|COMPLETED|Intervention Period 2 (3 Days)||3
11285795|NCT02443740|12482673|FG010|COMPLETED|Intervention Period 2 (3 Days)||3
11285796|NCT02443740|12482663|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11285797|NCT02443740|12482664|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11285798|NCT02443740|12482665|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11285799|NCT02443740|12482666|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11285800|NCT02443740|12482667|FG004|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11285801|NCT02443740|12482668|FG005|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11285802|NCT02443740|12482669|FG006|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11285803|NCT02443740|12482670|FG007|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11285804|NCT02443740|12482671|FG008|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11285805|NCT02443740|12482672|FG009|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11285806|NCT02443740|12482673|FG010|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11285807|NCT02443740|12482663|FG000|STARTED|Washout Period 2 (7 Days)||1
11285808|NCT02443740|12482664|FG001|STARTED|Washout Period 2 (7 Days)||2
11285809|NCT02443740|12482665|FG002|STARTED|Washout Period 2 (7 Days)||2
11285810|NCT02443740|12482666|FG003|STARTED|Washout Period 2 (7 Days)||3
11285811|NCT02443740|12482667|FG004|STARTED|Washout Period 2 (7 Days)||2
11285812|NCT02443740|12482668|FG005|STARTED|Washout Period 2 (7 Days)||2
11285813|NCT02443740|12482669|FG006|STARTED|Washout Period 2 (7 Days)||2
11285814|NCT02443740|12482670|FG007|STARTED|Washout Period 2 (7 Days)||2
11285815|NCT02443740|12482671|FG008|STARTED|Washout Period 2 (7 Days)||0
11285816|NCT02443740|12482672|FG009|STARTED|Washout Period 2 (7 Days)||0
11285817|NCT02443740|12482673|FG010|STARTED|Washout Period 2 (7 Days)||0
11285818|NCT02443740|12482663|FG000|COMPLETED|Washout Period 2 (7 Days)||1
11285819|NCT02443740|12482664|FG001|COMPLETED|Washout Period 2 (7 Days)||2
11285820|NCT02443740|12482665|FG002|COMPLETED|Washout Period 2 (7 Days)||2
11399286|NCT04345653|12593831|FG000|COMPLETED|Overall Study||46
11399287|NCT04345653|12593831|FG000|NOT COMPLETED|Overall Study||2
11399288|NCT04343261|12593836|FG000|STARTED|Overall Study||48
11399289|NCT04343261|12593836|FG000|COMPLETED|Overall Study||40
11285821|NCT02443740|12482666|FG003|COMPLETED|Washout Period 2 (7 Days)||3
11285822|NCT02443740|12482667|FG004|COMPLETED|Washout Period 2 (7 Days)||2
11285823|NCT02443740|12482668|FG005|COMPLETED|Washout Period 2 (7 Days)||2
11285824|NCT02443740|12482669|FG006|COMPLETED|Washout Period 2 (7 Days)||2
11285825|NCT02443740|12482670|FG007|COMPLETED|Washout Period 2 (7 Days)||2
11285826|NCT02443740|12482671|FG008|COMPLETED|Washout Period 2 (7 Days)||0
11399290|NCT04343261|12593836|FG000|NOT COMPLETED|Overall Study||8
11399291|NCT04343222|12593843|FG000|STARTED|Overall Study||16
11399292|NCT04343222|12593844|FG001|STARTED|Overall Study||15
11399293|NCT04343222|12593845|FG002|STARTED|Overall Study||15
11285827|NCT02443740|12482672|FG009|COMPLETED|Washout Period 2 (7 Days)||0
11285828|NCT02443740|12482673|FG010|COMPLETED|Washout Period 2 (7 Days)||0
11285829|NCT02443740|12482663|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
11285830|NCT02443740|12482664|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
11285831|NCT02443740|12482665|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
11285832|NCT02443740|12482666|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
11285833|NCT02443740|12482667|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
11285834|NCT02443740|12482668|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
11285835|NCT02443740|12482669|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
11285836|NCT02443740|12482670|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
11285837|NCT02443740|12482671|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
11285838|NCT02443740|12482672|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0
11285839|NCT02443740|12482673|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0
11285840|NCT02443740|12482663|FG000|STARTED|Intervention Period 3 (3 Days)||1
11285841|NCT02443740|12482664|FG001|STARTED|Intervention Period 3 (3 Days)||2
11285842|NCT02443740|12482665|FG002|STARTED|Intervention Period 3 (3 Days)||2
11285843|NCT02443740|12482666|FG003|STARTED|Intervention Period 3 (3 Days)||3
11285844|NCT02443740|12482667|FG004|STARTED|Intervention Period 3 (3 Days)||2
11285845|NCT02443740|12482668|FG005|STARTED|Intervention Period 3 (3 Days)||2
11285846|NCT02443740|12482669|FG006|STARTED|Intervention Period 3 (3 Days)||2
11285847|NCT02443740|12482670|FG007|STARTED|Intervention Period 3 (3 Days)||2
11285848|NCT02443740|12482671|FG008|STARTED|Intervention Period 3 (3 Days)||0
11285849|NCT02443740|12482672|FG009|STARTED|Intervention Period 3 (3 Days)||0
11285850|NCT02443740|12482673|FG010|STARTED|Intervention Period 3 (3 Days)||0
11285851|NCT02443740|12482663|FG000|COMPLETED|Intervention Period 3 (3 Days)||1
11285852|NCT02443740|12482664|FG001|COMPLETED|Intervention Period 3 (3 Days)||2
11285853|NCT02443740|12482665|FG002|COMPLETED|Intervention Period 3 (3 Days)||2
11285854|NCT02443740|12482666|FG003|COMPLETED|Intervention Period 3 (3 Days)||3
11285855|NCT02443740|12482667|FG004|COMPLETED|Intervention Period 3 (3 Days)||2
11285856|NCT02443740|12482668|FG005|COMPLETED|Intervention Period 3 (3 Days)||2
11285857|NCT02443740|12482669|FG006|COMPLETED|Intervention Period 3 (3 Days)||2
11285858|NCT02443740|12482670|FG007|COMPLETED|Intervention Period 3 (3 Days)||2
11285859|NCT02443740|12482671|FG008|COMPLETED|Intervention Period 3 (3 Days)||0
11285860|NCT02443740|12482672|FG009|COMPLETED|Intervention Period 3 (3 Days)||0
11285861|NCT02443740|12482673|FG010|COMPLETED|Intervention Period 3 (3 Days)||0
11285862|NCT02443740|12482663|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11285863|NCT02443740|12482664|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11285864|NCT02443740|12482665|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11285865|NCT02443740|12482666|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11285866|NCT02443740|12482667|FG004|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11285867|NCT02443740|12482668|FG005|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11285868|NCT02443740|12482669|FG006|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11285869|NCT02443740|12482670|FG007|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11285870|NCT02443740|12482671|FG008|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11285871|NCT02443740|12482672|FG009|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11285872|NCT02443740|12482673|FG010|NOT COMPLETED|Intervention Period 3 (3 Days)||0
11285873|NCT02443740|12482663|FG000|STARTED|Washout Period 3 (7 Days)||1
11285874|NCT02443740|12482664|FG001|STARTED|Washout Period 3 (7 Days)||2
11285875|NCT02443740|12482665|FG002|STARTED|Washout Period 3 (7 Days)||2
11285876|NCT02443740|12482666|FG003|STARTED|Washout Period 3 (7 Days)||3
11285877|NCT02443740|12482667|FG004|STARTED|Washout Period 3 (7 Days)||2
11285878|NCT02443740|12482668|FG005|STARTED|Washout Period 3 (7 Days)||2
11285879|NCT02443740|12482669|FG006|STARTED|Washout Period 3 (7 Days)||2
11285880|NCT02443740|12482670|FG007|STARTED|Washout Period 3 (7 Days)||2
11285881|NCT02443740|12482671|FG008|STARTED|Washout Period 3 (7 Days)||0
11285882|NCT02443740|12482672|FG009|STARTED|Washout Period 3 (7 Days)||0
11285883|NCT02443740|12482673|FG010|STARTED|Washout Period 3 (7 Days)||0
11285884|NCT02443740|12482663|FG000|COMPLETED|Washout Period 3 (7 Days)||1
11285885|NCT02443740|12482664|FG001|COMPLETED|Washout Period 3 (7 Days)||2
11285886|NCT02443740|12482665|FG002|COMPLETED|Washout Period 3 (7 Days)||2
11285887|NCT02443740|12482666|FG003|COMPLETED|Washout Period 3 (7 Days)||3
11285888|NCT02443740|12482667|FG004|COMPLETED|Washout Period 3 (7 Days)||2
11285889|NCT02443740|12482668|FG005|COMPLETED|Washout Period 3 (7 Days)||2
11285890|NCT02443740|12482669|FG006|COMPLETED|Washout Period 3 (7 Days)||2
11285891|NCT02443740|12482670|FG007|COMPLETED|Washout Period 3 (7 Days)||2
11285892|NCT02443740|12482671|FG008|COMPLETED|Washout Period 3 (7 Days)||0
11285893|NCT02443740|12482672|FG009|COMPLETED|Washout Period 3 (7 Days)||0
11285894|NCT02443740|12482673|FG010|COMPLETED|Washout Period 3 (7 Days)||0
11285895|NCT02443740|12482663|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
11285896|NCT02443740|12482664|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
11285897|NCT02443740|12482665|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
11285898|NCT02443740|12482666|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
11285899|NCT02443740|12482667|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
11285900|NCT02443740|12482668|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0
11285901|NCT02443740|12482669|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
11285902|NCT02443740|12482670|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
11285903|NCT02443740|12482671|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
11285904|NCT02443740|12482672|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
11285905|NCT02443740|12482673|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0
11285906|NCT02443740|12482663|FG000|STARTED|Intervention Period 4 (3 Days)||1
11285907|NCT02443740|12482664|FG001|STARTED|Intervention Period 4 (3 Days)||2
11285908|NCT02443740|12482665|FG002|STARTED|Intervention Period 4 (3 Days)||2
11285909|NCT02443740|12482666|FG003|STARTED|Intervention Period 4 (3 Days)||3
11285910|NCT02443740|12482667|FG004|STARTED|Intervention Period 4 (3 Days)||2
11285911|NCT02443740|12482668|FG005|STARTED|Intervention Period 4 (3 Days)||2
11285912|NCT02443740|12482669|FG006|STARTED|Intervention Period 4 (3 Days)||2
11285913|NCT02443740|12482670|FG007|STARTED|Intervention Period 4 (3 Days)||2
11285914|NCT02443740|12482671|FG008|STARTED|Intervention Period 4 (3 Days)||0
11285915|NCT02443740|12482672|FG009|STARTED|Intervention Period 4 (3 Days)||0
11285916|NCT02443740|12482673|FG010|STARTED|Intervention Period 4 (3 Days)||0
11285917|NCT02443740|12482663|FG000|COMPLETED|Intervention Period 4 (3 Days)||1
11285918|NCT02443740|12482664|FG001|COMPLETED|Intervention Period 4 (3 Days)||2
11285919|NCT02443740|12482665|FG002|COMPLETED|Intervention Period 4 (3 Days)||2
11285920|NCT02443740|12482666|FG003|COMPLETED|Intervention Period 4 (3 Days)||3
11285921|NCT02443740|12482667|FG004|COMPLETED|Intervention Period 4 (3 Days)||2
11285922|NCT02443740|12482668|FG005|COMPLETED|Intervention Period 4 (3 Days)||2
11285923|NCT02443740|12482669|FG006|COMPLETED|Intervention Period 4 (3 Days)||2
11285924|NCT02443740|12482670|FG007|COMPLETED|Intervention Period 4 (3 Days)||2
11285925|NCT02443740|12482671|FG008|COMPLETED|Intervention Period 4 (3 Days)||0
11285926|NCT02443740|12482672|FG009|COMPLETED|Intervention Period 4 (3 Days)||0
11285927|NCT02443740|12482673|FG010|COMPLETED|Intervention Period 4 (3 Days)||0
11285928|NCT02443740|12482663|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||0
11285929|NCT02443740|12482664|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0
11285930|NCT02443740|12482665|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0
11285931|NCT02443740|12482666|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0
11285932|NCT02443740|12482667|FG004|NOT COMPLETED|Intervention Period 4 (3 Days)||0
11285933|NCT02443740|12482668|FG005|NOT COMPLETED|Intervention Period 4 (3 Days)||0
11285934|NCT02443740|12482669|FG006|NOT COMPLETED|Intervention Period 4 (3 Days)||0
11285935|NCT02443740|12482670|FG007|NOT COMPLETED|Intervention Period 4 (3 Days)||0
11285936|NCT02443740|12482671|FG008|NOT COMPLETED|Intervention Period 4 (3 Days)||0
11285937|NCT02443740|12482672|FG009|NOT COMPLETED|Intervention Period 4 (3 Days)||0
11285938|NCT02443740|12482673|FG010|NOT COMPLETED|Intervention Period 4 (3 Days)||0
11285939|NCT02443792|12482705|FG000|STARTED|Overall Study||50
11285940|NCT02443792|12482706|FG001|STARTED|Overall Study||25
11285941|NCT02443792|12482705|FG000|COMPLETED|Overall Study||43
11285942|NCT02443792|12482706|FG001|COMPLETED|Overall Study||23
11285943|NCT02443792|12482705|FG000|NOT COMPLETED|Overall Study||7
11285944|NCT02443792|12482706|FG001|NOT COMPLETED|Overall Study||2
11285945|NCT02443805|12482714|FG000|STARTED|Overall Study||802
11285946|NCT02443805|12482715|FG001|STARTED|Overall Study||805
11285947|NCT02443805|12482714|FG000|COMPLETED|Overall Study||589
11285948|NCT02443805|12482715|FG001|COMPLETED|Overall Study||678
11285949|NCT02443805|12482714|FG000|NOT COMPLETED|Overall Study||213
11285950|NCT02443805|12482715|FG001|NOT COMPLETED|Overall Study||127
11285951|NCT02443883|12482725|FG000|STARTED|Overall Study||40
11285952|NCT02443883|12482726|FG001|STARTED|Overall Study||42
11285953|NCT02443883|12482727|FG002|STARTED|Overall Study||41
11285954|NCT02443883|12482728|FG003|STARTED|Overall Study||41
11285955|NCT02443883|12482725|FG000|Received at Least One Dose of Study Drug|Overall Study||38
11285956|NCT02443883|12482726|FG001|Received at Least One Dose of Study Drug|Overall Study||42
11285957|NCT02443883|12482727|FG002|Received at Least One Dose of Study Drug|Overall Study||41
11285958|NCT02443883|12482728|FG003|Received at Least One Dose of Study Drug|Overall Study||40
11285959|NCT02443883|12482725|FG000|COMPLETED|Overall Study||34
11285960|NCT02443883|12482726|FG001|COMPLETED|Overall Study||38
11285961|NCT02443883|12482727|FG002|COMPLETED|Overall Study||40
11285962|NCT02443883|12482728|FG003|COMPLETED|Overall Study||36
11285963|NCT02443883|12482725|FG000|NOT COMPLETED|Overall Study||6
11285964|NCT02443883|12482726|FG001|NOT COMPLETED|Overall Study||4
11285965|NCT02443883|12482727|FG002|NOT COMPLETED|Overall Study||1
11285966|NCT02443883|12482728|FG003|NOT COMPLETED|Overall Study||5
11285967|NCT02444143|12482740|FG000|STARTED|Overall Study||10
11285968|NCT02444143|12482741|FG001|STARTED|Overall Study||10
11285969|NCT02444143|12482740|FG000|COMPLETED|Overall Study||10
11285970|NCT02444143|12482741|FG001|COMPLETED|Overall Study|1 patient withdrawal|9
11399294|NCT04343222|12593843|FG000|COMPLETED|Overall Study||16
11399295|NCT04343222|12593844|FG001|COMPLETED|Overall Study||15
11399296|NCT04343222|12593845|FG002|COMPLETED|Overall Study||15
11399297|NCT04343222|12593843|FG000|NOT COMPLETED|Overall Study||0
11285971|NCT02444143|12482740|FG000|NOT COMPLETED|Overall Study||0
11285972|NCT02444143|12482741|FG001|NOT COMPLETED|Overall Study||1
11285973|NCT02444182|12482751|FG000|STARTED|Overall Study||54
11285974|NCT02444182|12482752|FG001|STARTED|Overall Study||54
11285975|NCT02444182|12482751|FG000|COMPLETED|Overall Study||52
11285976|NCT02444182|12482752|FG001|COMPLETED|Overall Study||49
11285977|NCT02444182|12482751|FG000|NOT COMPLETED|Overall Study||2
11285978|NCT02444182|12482752|FG001|NOT COMPLETED|Overall Study||5
11285979|NCT02444234|12482758|FG000|STARTED|First Intervention (3 Days)||6
11285980|NCT02444234|12482759|FG001|STARTED|First Intervention (3 Days)||5
11285981|NCT02444234|12482758|FG000|COMPLETED|First Intervention (3 Days)||6
11285982|NCT02444234|12482759|FG001|COMPLETED|First Intervention (3 Days)||5
11285983|NCT02444234|12482758|FG000|NOT COMPLETED|First Intervention (3 Days)||0
11285984|NCT02444234|12482759|FG001|NOT COMPLETED|First Intervention (3 Days)||0
11285985|NCT02444234|12482758|FG000|STARTED|Washout (2 Day Minimum)||6
11285986|NCT02444234|12482759|FG001|STARTED|Washout (2 Day Minimum)||5
11285987|NCT02444234|12482758|FG000|COMPLETED|Washout (2 Day Minimum)||6
11399298|NCT04343222|12593844|FG001|NOT COMPLETED|Overall Study||0
11399299|NCT04343222|12593845|FG002|NOT COMPLETED|Overall Study||0
11285988|NCT02444234|12482759|FG001|COMPLETED|Washout (2 Day Minimum)||5
11285989|NCT02444234|12482758|FG000|NOT COMPLETED|Washout (2 Day Minimum)||0
11285990|NCT02444234|12482759|FG001|NOT COMPLETED|Washout (2 Day Minimum)||0
11285991|NCT02444234|12482758|FG000|STARTED|Second Intervention (3 Days)||6
11285992|NCT02444234|12482759|FG001|STARTED|Second Intervention (3 Days)||5
11285993|NCT02444234|12482758|FG000|COMPLETED|Second Intervention (3 Days)||6
11285994|NCT02444234|12482759|FG001|COMPLETED|Second Intervention (3 Days)||5
11285995|NCT02444234|12482758|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
11285996|NCT02444234|12482759|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
11285997|NCT02444533|12482769|FG000|STARTED|Overall Study||17
11285998|NCT02444533|12482770|FG001|STARTED|Overall Study||22
11285999|NCT02444533|12482769|FG000|COMPLETED|Overall Study||15
11286000|NCT02444533|12482770|FG001|COMPLETED|Overall Study||18
11286001|NCT02444533|12482769|FG000|NOT COMPLETED|Overall Study||2
11286002|NCT02444533|12482770|FG001|NOT COMPLETED|Overall Study||4
11286003|NCT02444663|12482776|FG000|STARTED|Clinician Valgus||9
11286004|NCT02444663|12482776|FG000|COMPLETED|Clinician Valgus||9
11286005|NCT02444663|12482776|FG000|NOT COMPLETED|Clinician Valgus||0
11286006|NCT02444663|12482776|FG000|STARTED|Clinician Varus||9
11286007|NCT02444663|12482776|FG000|COMPLETED|Clinician Varus||9
11286008|NCT02444663|12482776|FG000|NOT COMPLETED|Clinician Varus||0
11286009|NCT02444663|12482776|FG000|STARTED|Device Valgus 0N||9
11286010|NCT02444663|12482776|FG000|COMPLETED|Device Valgus 0N||9
11286011|NCT02444663|12482776|FG000|NOT COMPLETED|Device Valgus 0N||0
11286012|NCT02444663|12482776|FG000|STARTED|Device Valgus 10N||9
11286013|NCT02444663|12482776|FG000|COMPLETED|Device Valgus 10N||9
11286014|NCT02444663|12482776|FG000|NOT COMPLETED|Device Valgus 10N||0
11286015|NCT02444663|12482776|FG000|STARTED|Device Valgus 20N||9
11286016|NCT02444663|12482776|FG000|COMPLETED|Device Valgus 20N||9
11286017|NCT02444663|12482776|FG000|NOT COMPLETED|Device Valgus 20N||0
11286018|NCT02444663|12482776|FG000|STARTED|Device Valgus 30N||9
11286019|NCT02444663|12482776|FG000|COMPLETED|Device Valgus 30N||9
11286020|NCT02444663|12482776|FG000|NOT COMPLETED|Device Valgus 30N||0
11286021|NCT02444663|12482776|FG000|STARTED|Device Varus 0N||9
11286022|NCT02444663|12482776|FG000|COMPLETED|Device Varus 0N||9
11286023|NCT02444663|12482776|FG000|NOT COMPLETED|Device Varus 0N||0
11286024|NCT02444663|12482776|FG000|STARTED|Device Varus 10N||9
11286025|NCT02444663|12482776|FG000|COMPLETED|Device Varus 10N||9
11286026|NCT02444663|12482776|FG000|NOT COMPLETED|Device Varus 10N||0
11286027|NCT02444663|12482776|FG000|STARTED|Device Varus 20N||9
11286028|NCT02444663|12482776|FG000|COMPLETED|Device Varus 20N||9
11286029|NCT02444663|12482776|FG000|NOT COMPLETED|Device Varus 20N||0
11286030|NCT02444663|12482776|FG000|STARTED|Device Varus 30N||9
11286031|NCT02444663|12482776|FG000|COMPLETED|Device Varus 30N||9
11286032|NCT02444663|12482776|FG000|NOT COMPLETED|Device Varus 30N||0
11286033|NCT02444715|12482800|FG000|STARTED|Overall Study||46
11286034|NCT02444715|12482801|FG001|STARTED|Overall Study||48
11286035|NCT02444715|12482800|FG000|COMPLETED|Overall Study||36
11286036|NCT02444715|12482801|FG001|COMPLETED|Overall Study||32
11286037|NCT02444715|12482800|FG000|NOT COMPLETED|Overall Study||10
11399300|NCT04343092|12593853|FG000|STARTED|Overall Study||16
11399301|NCT04343092|12593853|FG000|COMPLETED|Overall Study||16
11286038|NCT02444715|12482801|FG001|NOT COMPLETED|Overall Study||16
11286039|NCT02444793|12482812|FG000|STARTED|Overall Study||11
11286040|NCT02444793|12482813|FG001|STARTED|Overall Study||6
11286041|NCT02444793|12482814|FG002|STARTED|Overall Study||4
11286042|NCT02444793|12482815|FG003|STARTED|Overall Study||3
11286043|NCT02444793|12482812|FG000|COMPLETED|Overall Study||0
11286044|NCT02444793|12482813|FG001|COMPLETED|Overall Study||0
11286045|NCT02444793|12482814|FG002|COMPLETED|Overall Study||0
11286046|NCT02444793|12482815|FG003|COMPLETED|Overall Study||0
11286047|NCT02444793|12482812|FG000|NOT COMPLETED|Overall Study||11
11286048|NCT02444793|12482813|FG001|NOT COMPLETED|Overall Study||6
11286049|NCT02444793|12482814|FG002|NOT COMPLETED|Overall Study||4
11286050|NCT02444793|12482815|FG003|NOT COMPLETED|Overall Study||3
11286051|NCT02444936|12482828|FG000|STARTED|Overall Study||10
11286052|NCT02444936|12482829|FG001|STARTED|Overall Study||12
11286053|NCT02444936|12482828|FG000|COMPLETED|Overall Study||10
11286054|NCT02444936|12482829|FG001|COMPLETED|Overall Study||12
11286055|NCT02444936|12482828|FG000|NOT COMPLETED|Overall Study||0
11286056|NCT02444936|12482829|FG001|NOT COMPLETED|Overall Study||0
11286057|NCT02444988|12482837|FG000|STARTED|Overall Study||2646
11286058|NCT02444988|12482838|FG001|STARTED|Overall Study||2735
11286059|NCT02444988|12482837|FG000|COMPLETED|Overall Study||2646
11286060|NCT02444988|12482838|FG001|COMPLETED|Overall Study||2735
11286061|NCT02444988|12482837|FG000|NOT COMPLETED|Overall Study||0
11286062|NCT02444988|12482838|FG001|NOT COMPLETED|Overall Study||0
11286063|NCT02445014|12482844|FG000|STARTED|Overall Study||3
11286064|NCT02445014|12482844|FG000|COMPLETED|Overall Study||3
11286065|NCT02445014|12482844|FG000|NOT COMPLETED|Overall Study||0
11286066|NCT02445027|12482848|FG000|STARTED|Overall Study||60
11286067|NCT02445027|12482848|FG000|COMPLETED|Overall Study||45
11286068|NCT02445027|12482848|FG000|NOT COMPLETED|Overall Study||15
11340949|NCT02927327|12538295|FG001|STARTED|Overall Study||31
11340950|NCT02927327|12538294|FG000|COMPLETED|Overall Study||30
11340951|NCT02927327|12538295|FG001|COMPLETED|Overall Study||31
11340952|NCT02927327|12538294|FG000|NOT COMPLETED|Overall Study||0
11340953|NCT02927327|12538295|FG001|NOT COMPLETED|Overall Study||0
11340954|NCT02927366|12538303|FG000|STARTED|Overall Study||6
11340955|NCT02927366|12538304|FG001|STARTED|Overall Study||2
11340956|NCT02927366|12538303|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6
11340957|NCT02927366|12538304|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||2
11399302|NCT04343092|12593853|FG000|NOT COMPLETED|Overall Study||0
11399303|NCT04342663|12593859|FG000|STARTED|Overall Study||80
11399304|NCT04342663|12593860|FG001|STARTED|Overall Study||72
11399305|NCT04342663|12593859|FG000|COMPLETED|Overall Study||62
11399306|NCT04342663|12593860|FG001|COMPLETED|Overall Study||53
11399307|NCT04342663|12593859|FG000|NOT COMPLETED|Overall Study||18
11399308|NCT04342663|12593860|FG001|NOT COMPLETED|Overall Study||19
11399309|NCT04342897|12593868|FG000|STARTED|Overall Study||47
11399310|NCT04342897|12593869|FG001|STARTED|Overall Study||48
11399311|NCT04342897|12593868|FG000|Received at Least One Dose of Study Drug|Overall Study||47
11399312|NCT04342897|12593869|FG001|Received at Least One Dose of Study Drug|Overall Study||48
11399313|NCT04342897|12593868|FG000|COMPLETED|Overall Study||33
11399314|NCT04342897|12593869|FG001|COMPLETED|Overall Study||36
11399315|NCT04342897|12593868|FG000|NOT COMPLETED|Overall Study||14
11399316|NCT04342897|12593869|FG001|NOT COMPLETED|Overall Study||12
11399317|NCT04342130|12593875|FG000|STARTED|Overall Study||10
11399318|NCT04342130|12593875|FG000|COMPLETED|Overall Study||10
11399319|NCT04342130|12593875|FG000|NOT COMPLETED|Overall Study||0
11399320|NCT04340557|12593881|FG000|STARTED|Overall Study||16
11399321|NCT04340557|12593882|FG001|STARTED|Overall Study||15
11399322|NCT04340557|12593881|FG000|COMPLETED|Overall Study||15
11399323|NCT04340557|12593882|FG001|COMPLETED|Overall Study||13
11399324|NCT04340557|12593881|FG000|NOT COMPLETED|Overall Study||1
11399325|NCT04340557|12593882|FG001|NOT COMPLETED|Overall Study||2
11399326|NCT04339972|12593890|FG000|STARTED|Overall Study||15
11399327|NCT04339972|12593891|FG001|STARTED|Overall Study||14
11399328|NCT04339972|12593890|FG000|COMPLETED|Overall Study||10
11399329|NCT04339972|12593891|FG001|COMPLETED|Overall Study||9
11399330|NCT04339972|12593890|FG000|NOT COMPLETED|Overall Study||5
11399331|NCT04339972|12593891|FG001|NOT COMPLETED|Overall Study||5
11399332|NCT04339296|12593899|FG000|STARTED|Overall Study||24
11399333|NCT04339296|12593900|FG001|STARTED|Overall Study||26
11399334|NCT04339296|12593899|FG000|Completed Baseline|Overall Study||23
11399335|NCT04339296|12593900|FG001|Completed Baseline|Overall Study||25
11399336|NCT04339296|12593899|FG000|Received Allocated Intervention|Overall Study||21
11399337|NCT04339296|12593900|FG001|Received Allocated Intervention|Overall Study||24
11399338|NCT04339296|12593899|FG000|COMPLETED|Overall Study||16
11399339|NCT04339296|12593900|FG001|COMPLETED|Overall Study||17
11399340|NCT04339296|12593899|FG000|NOT COMPLETED|Overall Study||8
11340958|NCT02927366|12538303|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4
11340959|NCT02927366|12538304|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0
11340960|NCT02927366|12538303|FG000|COMPLETED|Overall Study||4
11340961|NCT02927366|12538304|FG001|COMPLETED|Overall Study||2
11399341|NCT04339296|12593900|FG001|NOT COMPLETED|Overall Study||9
11399342|NCT04338009|12593908|FG000|STARTED|Overall Study||77
11399343|NCT04338009|12593909|FG001|STARTED|Overall Study||75
11399344|NCT04338009|12593908|FG000|COMPLETED|Overall Study||77
11399345|NCT04338009|12593909|FG001|COMPLETED|Overall Study||75
11399346|NCT04338009|12593908|FG000|NOT COMPLETED|Overall Study||0
11399347|NCT04338009|12593909|FG001|NOT COMPLETED|Overall Study||0
11399348|NCT04338074|12593917|FG000|STARTED|Overall Study||3
11399349|NCT04338074|12593918|FG001|STARTED|Overall Study||2
11399350|NCT04338074|12593917|FG000|COMPLETED|Overall Study||3
11399351|NCT04338074|12593918|FG001|COMPLETED|Overall Study||2
11399352|NCT04338074|12593917|FG000|NOT COMPLETED|Overall Study||0
11399353|NCT04338074|12593918|FG001|NOT COMPLETED|Overall Study||0
11399354|NCT04337138|12593924|FG000|STARTED|Overall Study||32
11399355|NCT04337138|12593924|FG000|COMPLETED|Overall Study||32
11399356|NCT04337138|12593924|FG000|NOT COMPLETED|Overall Study||0
11399357|NCT04336475|12593930|FG000|STARTED|Overall Study||30
11399358|NCT04336475|12593931|FG001|STARTED|Overall Study||30
11399359|NCT04336475|12593930|FG000|COMPLETED|Overall Study||28
11399360|NCT04336475|12593931|FG001|COMPLETED|Overall Study||28
11399361|NCT04336475|12593930|FG000|NOT COMPLETED|Overall Study||2
11399362|NCT04336475|12593931|FG001|NOT COMPLETED|Overall Study||2
11399363|NCT04335929|12593937|FG000|STARTED|Overall Study||32
11399364|NCT04335929|12593937|FG000|COMPLETED|Overall Study||22
11399365|NCT04335929|12593937|FG000|NOT COMPLETED|Overall Study||10
11399366|NCT04335812|12593943|FG000|STARTED|Overall Study||63
11399367|NCT04335812|12593944|FG001|STARTED|Overall Study||63
11399368|NCT04335812|12593943|FG000|COMPLETED|Overall Study||28
11399369|NCT04335812|12593944|FG001|COMPLETED|Overall Study||30
11399370|NCT04335812|12593943|FG000|NOT COMPLETED|Overall Study||35
11399371|NCT04335812|12593944|FG001|NOT COMPLETED|Overall Study||33
11399372|NCT04335136|12593952|FG000|STARTED|Overall Study||91
11399373|NCT04335136|12593953|FG001|STARTED|Overall Study||90
11399374|NCT04335136|12593952|FG000|Treated|Overall Study||88
11399375|NCT04335136|12593953|FG001|Treated|Overall Study||90
11399376|NCT04335136|12593952|FG000|COMPLETED|Overall Study||77
11399377|NCT04335136|12593953|FG001|COMPLETED|Overall Study||83
11399378|NCT04335136|12593952|FG000|NOT COMPLETED|Overall Study||14
11399379|NCT04335136|12593953|FG001|NOT COMPLETED|Overall Study||7
11399380|NCT04335552|12593963|FG000|STARTED|Overall Study||2
11286069|NCT02445196|12482854|FG000|STARTED|Overall Study||62
11286070|NCT02445196|12482855|FG001|STARTED|Overall Study||58
11286071|NCT02445196|12482854|FG000|COMPLETED|Overall Study||51
11286072|NCT02445196|12482855|FG001|COMPLETED|Overall Study||52
11286073|NCT02445196|12482854|FG000|NOT COMPLETED|Overall Study||11
11286074|NCT02445196|12482855|FG001|NOT COMPLETED|Overall Study||6
11286075|NCT02445287|12482863|FG000|STARTED|Overall Study||35
11286076|NCT02445287|12482864|FG001|STARTED|Overall Study||13
11286077|NCT02445287|12482863|FG000|COMPLETED|Overall Study||35
11286078|NCT02445287|12482864|FG001|COMPLETED|Overall Study||13
11286079|NCT02445287|12482863|FG000|NOT COMPLETED|Overall Study||0
11286080|NCT02445287|12482864|FG001|NOT COMPLETED|Overall Study||0
11286081|NCT02445326|12482877|FG000|STARTED|Overall Study||35
11286082|NCT02445326|12482878|FG001|STARTED|Overall Study||38
11286083|NCT02445326|12482877|FG000|COMPLETED|Overall Study||33
11286084|NCT02445326|12482878|FG001|COMPLETED|Overall Study||37
11286085|NCT02445326|12482877|FG000|NOT COMPLETED|Overall Study||2
11286086|NCT02445326|12482878|FG001|NOT COMPLETED|Overall Study||1
11286087|NCT02445573|12482886|FG000|STARTED|Overall Study||40
11286088|NCT02445573|12482887|FG001|STARTED|Overall Study||40
11286089|NCT02445573|12482886|FG000|COMPLETED|Overall Study||39
11286090|NCT02445573|12482887|FG001|COMPLETED|Overall Study||38
11286091|NCT02445573|12482886|FG000|NOT COMPLETED|Overall Study||1
11286092|NCT02445573|12482887|FG001|NOT COMPLETED|Overall Study||2
11286093|NCT02445586|12482893|FG000|STARTED|Overall Study||52
11286094|NCT02445586|12482893|FG000|Received at Least One Dose of Study Drug|Overall Study||52
11286095|NCT02445586|12482893|FG000|COMPLETED|Overall Study||13
11286096|NCT02445586|12482893|FG000|NOT COMPLETED|Overall Study||39
11286097|NCT02445625|12482897|FG000|STARTED|Overall Study||15
11286098|NCT02445625|12482897|FG000|COMPLETED|Overall Study||15
11286099|NCT02445625|12482897|FG000|NOT COMPLETED|Overall Study||0
11286100|NCT02445755|12482902|FG000|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
11286101|NCT02445755|12482902|FG000|COMPLETED|Overall Study||100
11286102|NCT02445755|12482902|FG000|NOT COMPLETED|Overall Study||13
11286103|NCT02445794|12482913|FG000|STARTED|Overall Study||6
11286104|NCT02445794|12482914|FG001|STARTED|Overall Study||3
11286105|NCT02445794|12482915|FG002|STARTED|Overall Study||7
11286106|NCT02445794|12482916|FG003|STARTED|Overall Study||3
11286107|NCT02445794|12482913|FG000|COMPLETED|Overall Study||6
11286108|NCT02445794|12482914|FG001|COMPLETED|Overall Study||3
11399381|NCT04335552|12593964|FG001|STARTED|Overall Study||4
11399382|NCT04335552|12593965|FG002|STARTED|Overall Study||3
11399383|NCT04335552|12593966|FG003|STARTED|Overall Study||2
11399384|NCT04335552|12593963|FG000|COMPLETED|Overall Study||1
11286109|NCT02445794|12482915|FG002|COMPLETED|Overall Study||5
11286110|NCT02445794|12482916|FG003|COMPLETED|Overall Study||3
11286111|NCT02445794|12482913|FG000|NOT COMPLETED|Overall Study||0
11286112|NCT02445794|12482914|FG001|NOT COMPLETED|Overall Study||0
11286113|NCT02445794|12482915|FG002|NOT COMPLETED|Overall Study||2
11286114|NCT02445794|12482916|FG003|NOT COMPLETED|Overall Study||0
11286115|NCT02445807|12482933|FG000|STARTED|Overall Study||176
11399385|NCT04335552|12593964|FG001|COMPLETED|Overall Study||4
11399386|NCT04335552|12593965|FG002|COMPLETED|Overall Study||3
11399387|NCT04335552|12593966|FG003|COMPLETED|Overall Study||2
11399388|NCT04335552|12593963|FG000|NOT COMPLETED|Overall Study||1
11399389|NCT04335552|12593964|FG001|NOT COMPLETED|Overall Study||0
11399390|NCT04335552|12593965|FG002|NOT COMPLETED|Overall Study||0
11399391|NCT04335552|12593966|FG003|NOT COMPLETED|Overall Study||0
11286116|NCT02445807|12482934|FG001|STARTED|Overall Study||89
11286117|NCT02445807|12482933|FG000|COMPLETED|Overall Study||176
11286118|NCT02445807|12482934|FG001|COMPLETED|Overall Study||89
11286119|NCT02445807|12482933|FG000|NOT COMPLETED|Overall Study||0
11286120|NCT02445807|12482934|FG001|NOT COMPLETED|Overall Study||0
11286121|NCT02445859|12482942|FG000|STARTED|Overall Study||45
11286122|NCT02445859|12482943|FG001|STARTED|Overall Study||45
11286123|NCT02445859|12482942|FG000|COMPLETED|Overall Study||43
11286124|NCT02445859|12482943|FG001|COMPLETED|Overall Study||42
11286125|NCT02445859|12482942|FG000|NOT COMPLETED|Overall Study||2
11286126|NCT02445859|12482943|FG001|NOT COMPLETED|Overall Study||3
11286127|NCT02445911|12482953|FG000|STARTED|Overall Study||20
11286128|NCT02445911|12482954|FG001|STARTED|Overall Study||20
11286129|NCT02445911|12482955|FG002|STARTED|Overall Study||21
11286130|NCT02445911|12482956|FG003|STARTED|Overall Study||20
11286131|NCT02445911|12482953|FG000|COMPLETED|Overall Study||20
11286132|NCT02445911|12482954|FG001|COMPLETED|Overall Study||20
11286133|NCT02445911|12482955|FG002|COMPLETED|Overall Study||21
11286134|NCT02445911|12482956|FG003|COMPLETED|Overall Study||20
11286135|NCT02445911|12482953|FG000|NOT COMPLETED|Overall Study||0
11286136|NCT02445911|12482954|FG001|NOT COMPLETED|Overall Study||0
11286137|NCT02445911|12482955|FG002|NOT COMPLETED|Overall Study||0
11286138|NCT02445911|12482956|FG003|NOT COMPLETED|Overall Study||0
11286139|NCT02445963|12482970|FG000|STARTED|Overall Study||9
11286140|NCT02445963|12482971|FG001|STARTED|Overall Study||9
11286141|NCT02445963|12482972|FG002|STARTED|Overall Study||10
11286142|NCT02445963|12482973|FG003|STARTED|Overall Study||10
11286143|NCT02445963|12482970|FG000|COMPLETED|Overall Study||7
11399392|NCT04334876|12593976|FG000|STARTED|Overall Study||571
11286144|NCT02445963|12482971|FG001|COMPLETED|Overall Study||9
11286145|NCT02445963|12482972|FG002|COMPLETED|Overall Study||9
11286146|NCT02445963|12482973|FG003|COMPLETED|Overall Study||10
11286147|NCT02445963|12482970|FG000|NOT COMPLETED|Overall Study||2
11286148|NCT02445963|12482971|FG001|NOT COMPLETED|Overall Study||0
11286149|NCT02445963|12482972|FG002|NOT COMPLETED|Overall Study||1
11286150|NCT02445963|12482973|FG003|NOT COMPLETED|Overall Study||0
11286151|NCT02446015|12482987|FG000|STARTED|Overall Study||34
11399393|NCT04334876|12593976|FG000|COMPLETED|Overall Study||500
11286152|NCT02446015|12482988|FG001|STARTED|Overall Study||63
11286153|NCT02446015|12482987|FG000|COMPLETED|Overall Study||33
11286154|NCT02446015|12482988|FG001|COMPLETED|Overall Study||62
11286155|NCT02446015|12482987|FG000|NOT COMPLETED|Overall Study||1
11286156|NCT02446015|12482988|FG001|NOT COMPLETED|Overall Study||1
11286157|NCT02446171|12482999|FG000|STARTED|Overall Study||11
11286158|NCT02446171|12483000|FG001|STARTED|Overall Study||11
11286159|NCT02446171|12483001|FG002|STARTED|Overall Study||11
11286160|NCT02446171|12483002|FG003|STARTED|Overall Study||11
11286161|NCT02446171|12482999|FG000|COMPLETED|Overall Study||11
11286162|NCT02446171|12483000|FG001|COMPLETED|Overall Study||11
11286163|NCT02446171|12483001|FG002|COMPLETED|Overall Study||9
11286164|NCT02446171|12483002|FG003|COMPLETED|Overall Study||11
11286165|NCT02446171|12482999|FG000|NOT COMPLETED|Overall Study||0
11286166|NCT02446171|12483000|FG001|NOT COMPLETED|Overall Study||0
11286167|NCT02446171|12483001|FG002|NOT COMPLETED|Overall Study||2
11286168|NCT02446171|12483002|FG003|NOT COMPLETED|Overall Study||0
11286169|NCT02446223|12483014|FG000|STARTED|Overall Study||21
11286170|NCT02446223|12483014|FG000|COMPLETED|Overall Study||20
11286171|NCT02446223|12483014|FG000|NOT COMPLETED|Overall Study||1
11286172|NCT02446314|12483022|FG000|STARTED|Zero to Twelve Weeks.||30
11286173|NCT02446314|12483023|FG001|STARTED|Zero to Twelve Weeks.||30
11286174|NCT02446314|12483024|FG002|STARTED|Zero to Twelve Weeks.||31
11286175|NCT02446314|12483025|FG003|STARTED|Zero to Twelve Weeks.||31
11286176|NCT02446314|12483022|FG000|COMPLETED|Zero to Twelve Weeks.||27
11286177|NCT02446314|12483023|FG001|COMPLETED|Zero to Twelve Weeks.||29
11286178|NCT02446314|12483024|FG002|COMPLETED|Zero to Twelve Weeks.||31
11286179|NCT02446314|12483025|FG003|COMPLETED|Zero to Twelve Weeks.||29
11286180|NCT02446314|12483022|FG000|NOT COMPLETED|Zero to Twelve Weeks.||3
11286181|NCT02446314|12483023|FG001|NOT COMPLETED|Zero to Twelve Weeks.||1
11286182|NCT02446314|12483024|FG002|NOT COMPLETED|Zero to Twelve Weeks.||0
11286183|NCT02446314|12483025|FG003|NOT COMPLETED|Zero to Twelve Weeks.||2
11286184|NCT02446314|12483022|FG000|STARTED|Thirteen to Twenty Four Weeks||27
11286185|NCT02446314|12483023|FG001|STARTED|Thirteen to Twenty Four Weeks||29
11286186|NCT02446314|12483024|FG002|STARTED|Thirteen to Twenty Four Weeks||31
11286187|NCT02446314|12483025|FG003|STARTED|Thirteen to Twenty Four Weeks||29
11286188|NCT02446314|12483022|FG000|COMPLETED|Thirteen to Twenty Four Weeks||27
11286189|NCT02446314|12483023|FG001|COMPLETED|Thirteen to Twenty Four Weeks||28
11286190|NCT02446314|12483024|FG002|COMPLETED|Thirteen to Twenty Four Weeks||29
11286191|NCT02446314|12483025|FG003|COMPLETED|Thirteen to Twenty Four Weeks||28
11286192|NCT02446314|12483022|FG000|NOT COMPLETED|Thirteen to Twenty Four Weeks||0
11286193|NCT02446314|12483023|FG001|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
11286194|NCT02446314|12483024|FG002|NOT COMPLETED|Thirteen to Twenty Four Weeks||2
11286195|NCT02446314|12483025|FG003|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
11286196|NCT02446418|12483041|FG000|STARTED|Overall Study||210
11286197|NCT02446418|12483042|FG001|STARTED|Overall Study||210
11286198|NCT02446418|12483041|FG000|COMPLETED|Overall Study||192
11286199|NCT02446418|12483042|FG001|COMPLETED|Overall Study||194
11286200|NCT02446418|12483041|FG000|NOT COMPLETED|Overall Study||18
11286201|NCT02446418|12483042|FG001|NOT COMPLETED|Overall Study||16
11286202|NCT02446483|12483048|FG000|STARTED|Period 1: Intervention Period 1||30
11286203|NCT02446483|12483049|FG001|STARTED|Period 1: Intervention Period 1||30
11286204|NCT02446483|12483048|FG000|COMPLETED|Period 1: Intervention Period 1||30
11286205|NCT02446483|12483049|FG001|COMPLETED|Period 1: Intervention Period 1||30
11286206|NCT02446483|12483048|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0
11286207|NCT02446483|12483049|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0
11286208|NCT02446483|12483048|FG000|STARTED|Period 2: Washout Period (7 Days)||30
11286209|NCT02446483|12483049|FG001|STARTED|Period 2: Washout Period (7 Days)||30
11286210|NCT02446483|12483048|FG000|COMPLETED|Period 2: Washout Period (7 Days)||30
11286211|NCT02446483|12483049|FG001|COMPLETED|Period 2: Washout Period (7 Days)||30
11286212|NCT02446483|12483048|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
11286213|NCT02446483|12483049|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
11286214|NCT02446483|12483048|FG000|STARTED|Period 3: Intervention Period 2||30
11286215|NCT02446483|12483049|FG001|STARTED|Period 3: Intervention Period 2||30
11286216|NCT02446483|12483048|FG000|COMPLETED|Period 3: Intervention Period 2||30
11286217|NCT02446483|12483049|FG001|COMPLETED|Period 3: Intervention Period 2||30
11286218|NCT02446483|12483048|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
11286219|NCT02446483|12483049|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
11286220|NCT02446496|12483055|FG000|STARTED|Overall Study||24
11286221|NCT02446496|12483055|FG000|COMPLETED|Overall Study||24
11286222|NCT02446496|12483055|FG000|NOT COMPLETED|Overall Study||0
11286223|NCT02446613|12483063|FG000|STARTED|Overall Study||6
11286224|NCT02446613|12483064|FG001|STARTED|Overall Study||10
11286225|NCT02446613|12483063|FG000|COMPLETED|Overall Study||6
11286226|NCT02446613|12483064|FG001|COMPLETED|Overall Study||10
11286227|NCT02446613|12483063|FG000|NOT COMPLETED|Overall Study||0
11286228|NCT02446613|12483064|FG001|NOT COMPLETED|Overall Study||0
11286229|NCT02446691|12483074|FG000|STARTED|Overall Study||128
11286230|NCT02446691|12483074|FG000|COMPLETED|Overall Study||117
11286231|NCT02446691|12483074|FG000|NOT COMPLETED|Overall Study||11
11286232|NCT02446717|12483083|FG000|STARTED|Overall Study||6
11286233|NCT02446717|12483084|FG001|STARTED|Overall Study||22
11286234|NCT02446717|12483085|FG002|STARTED|Overall Study||22
11286235|NCT02446717|12483086|FG003|STARTED|Overall Study||44
11286236|NCT02446717|12483087|FG004|STARTED|Overall Study||47
11286237|NCT02446717|12483083|FG000|COMPLETED|Overall Study||6
11286238|NCT02446717|12483084|FG001|COMPLETED|Overall Study||21
11286239|NCT02446717|12483085|FG002|COMPLETED|Overall Study||20
11286240|NCT02446717|12483086|FG003|COMPLETED|Overall Study||43
11286241|NCT02446717|12483087|FG004|COMPLETED|Overall Study||46
11286242|NCT02446717|12483083|FG000|NOT COMPLETED|Overall Study||0
11286243|NCT02446717|12483084|FG001|NOT COMPLETED|Overall Study||1
11286244|NCT02446717|12483085|FG002|NOT COMPLETED|Overall Study||2
11286245|NCT02446717|12483086|FG003|NOT COMPLETED|Overall Study||1
11286246|NCT02446717|12483087|FG004|NOT COMPLETED|Overall Study||1
11286247|NCT02446743|12483101|FG000|STARTED|Overall Study||276
11021802|NCT00806156|12199985|FG001|STARTED|Overall Study||139
11021803|NCT00806156|12199984|FG000|COMPLETED|Overall Study||0
11021804|NCT00806156|12199985|FG001|COMPLETED|Overall Study||0
11286248|NCT02446743|12483102|FG001|STARTED|Overall Study||255
11286249|NCT02446743|12483101|FG000|COMPLETED|Overall Study||271
11286250|NCT02446743|12483102|FG001|COMPLETED|Overall Study||250
11286251|NCT02446743|12483101|FG000|NOT COMPLETED|Overall Study||5
11286252|NCT02446743|12483102|FG001|NOT COMPLETED|Overall Study||5
11286253|NCT02446769|12483117|FG000|STARTED|Screening Period||18
11286254|NCT02446769|12483118|FG001|STARTED|Screening Period||0
11286255|NCT02446769|12483119|FG002|STARTED|Screening Period||0
11286256|NCT02446769|12483117|FG000|COMPLETED|Screening Period||7
11286257|NCT02446769|12483118|FG001|COMPLETED|Screening Period||0
11286258|NCT02446769|12483119|FG002|COMPLETED|Screening Period||0
11286259|NCT02446769|12483117|FG000|NOT COMPLETED|Screening Period||11
11286260|NCT02446769|12483118|FG001|NOT COMPLETED|Screening Period||0
11286261|NCT02446769|12483119|FG002|NOT COMPLETED|Screening Period||0
11286262|NCT02446769|12483117|FG000|STARTED|Study Period||0
11286263|NCT02446769|12483118|FG001|STARTED|Study Period||4
11286264|NCT02446769|12483119|FG002|STARTED|Study Period||3
11286265|NCT02446769|12483117|FG000|COMPLETED|Study Period||0
11286266|NCT02446769|12483118|FG001|COMPLETED|Study Period||2
11286267|NCT02446769|12483119|FG002|COMPLETED|Study Period||3
11286268|NCT02446769|12483117|FG000|NOT COMPLETED|Study Period||0
11286269|NCT02446769|12483118|FG001|NOT COMPLETED|Study Period||2
11286270|NCT02446769|12483119|FG002|NOT COMPLETED|Study Period||0
11286271|NCT02446847|12483128|FG000|STARTED|Overall Study||8
11286272|NCT02446847|12483129|FG001|STARTED|Overall Study||8
11286273|NCT02446847|12483128|FG000|COMPLETED|Overall Study||8
11286274|NCT02446847|12483129|FG001|COMPLETED|Overall Study||6
11286275|NCT02446847|12483128|FG000|NOT COMPLETED|Overall Study||0
11286276|NCT02446847|12483129|FG001|NOT COMPLETED|Overall Study||2
11286277|NCT02446886|12483137|FG000|STARTED|Overall Study||8
11286278|NCT02446886|12483138|FG001|STARTED|Overall Study||7
11286279|NCT02446886|12483137|FG000|COMPLETED|Overall Study||6
11286280|NCT02446886|12483138|FG001|COMPLETED|Overall Study||3
11286281|NCT02446886|12483137|FG000|NOT COMPLETED|Overall Study||2
11286282|NCT02446886|12483138|FG001|NOT COMPLETED|Overall Study||4
11286283|NCT02446899|12483147|FG000|STARTED|Overall Study||181
11286284|NCT02446899|12483148|FG001|STARTED|Overall Study||184
11286285|NCT02446899|12483147|FG000|Received Study Drug|Overall Study||180
11286286|NCT02446899|12483148|FG001|Received Study Drug|Overall Study||182
11286287|NCT02446899|12483147|FG000|COMPLETED|Overall Study||156
11286288|NCT02446899|12483148|FG001|COMPLETED|Overall Study||136
11286289|NCT02446899|12483147|FG000|NOT COMPLETED|Overall Study||25
11286290|NCT02446899|12483148|FG001|NOT COMPLETED|Overall Study||48
11286291|NCT02446912|12483157|FG000|STARTED|Overall Study||93
11286292|NCT02446912|12483158|FG001|STARTED|Overall Study||180
11286293|NCT02446912|12483159|FG002|STARTED|Overall Study||184
11286294|NCT02446912|12483157|FG000|Participants Who Completed Week 52|Overall Study||80
11286295|NCT02446912|12483158|FG001|Participants Who Completed Week 52|Overall Study||153
11286296|NCT02446912|12483159|FG002|Participants Who Completed Week 52|Overall Study||157
11286297|NCT02446912|12483157|FG000|COMPLETED|Overall Study||75
11286298|NCT02446912|12483158|FG001|COMPLETED|Overall Study||145
11286299|NCT02446912|12483159|FG002|COMPLETED|Overall Study||149
11286300|NCT02446912|12483157|FG000|NOT COMPLETED|Overall Study||18
11286301|NCT02446912|12483158|FG001|NOT COMPLETED|Overall Study||35
11286302|NCT02446912|12483159|FG002|NOT COMPLETED|Overall Study||35
11286303|NCT02446990|12483169|FG000|STARTED|Overall Study||9550
11286304|NCT02446990|12483170|FG001|STARTED|Overall Study||9552
11286305|NCT02446990|12483169|FG000|COMPLETED|Overall Study||8830
11286306|NCT02446990|12483170|FG001|COMPLETED|Overall Study||8894
11286307|NCT02446990|12483169|FG000|NOT COMPLETED|Overall Study||720
11286308|NCT02446990|12483170|FG001|NOT COMPLETED|Overall Study||658
11286309|NCT02447003|12483178|FG000|STARTED|Overall Study||170
11286310|NCT02447003|12483179|FG001|STARTED|Overall Study||84
11286311|NCT02447003|12483178|FG000|COMPLETED|Overall Study||0
11286312|NCT02447003|12483179|FG001|COMPLETED|Overall Study||0
11286313|NCT02447003|12483178|FG000|NOT COMPLETED|Overall Study||170
11286314|NCT02447003|12483179|FG001|NOT COMPLETED|Overall Study||84
11286315|NCT02447029|12483189|FG000|STARTED|Overall Study||72
11286316|NCT02447029|12483190|FG001|STARTED|Overall Study||70
11286317|NCT02447029|12483189|FG000|Treated|Overall Study||69
11286318|NCT02447029|12483190|FG001|Treated|Overall Study||68
11286319|NCT02447029|12483189|FG000|COMPLETED|Overall Study||69
11286320|NCT02447029|12483190|FG001|COMPLETED|Overall Study||68
11286321|NCT02447029|12483189|FG000|NOT COMPLETED|Overall Study||3
11286322|NCT02447029|12483190|FG001|NOT COMPLETED|Overall Study||2
11399394|NCT04334876|12593976|FG000|NOT COMPLETED|Overall Study||71
11399395|NCT04334681|12593982|FG000|STARTED|Overall Study||135
11399396|NCT04334681|12593983|FG001|STARTED|Overall Study||143
11286323|NCT02447081|12483196|FG000|STARTED|Overall Study||1088
11286324|NCT02447081|12483196|FG000|COMPLETED|Overall Study||864
11286325|NCT02447081|12483196|FG000|NOT COMPLETED|Overall Study||224
11286326|NCT02447172|12483203|FG000|STARTED|Overall Study||262
11286327|NCT02447172|12483204|FG001|STARTED|Overall Study||130
11286328|NCT02447172|12483205|FG002|STARTED|Overall Study||132
11286329|NCT02447172|12483203|FG000|COMPLETED|Overall Study||231
11286330|NCT02447172|12483204|FG001|COMPLETED|Overall Study||115
11286331|NCT02447172|12483205|FG002|COMPLETED|Overall Study||114
11286332|NCT02447172|12483203|FG000|NOT COMPLETED|Overall Study||31
11286333|NCT02447172|12483204|FG001|NOT COMPLETED|Overall Study||15
11286334|NCT02447172|12483205|FG002|NOT COMPLETED|Overall Study||18
11286335|NCT02447250|12483213|FG000|STARTED|First Dose (180 mcg Albuterol)||14
11286336|NCT02447250|12483213|FG000|COMPLETED|First Dose (180 mcg Albuterol)||14
11286337|NCT02447250|12483213|FG000|NOT COMPLETED|First Dose (180 mcg Albuterol)||0
11286338|NCT02447250|12483213|FG000|STARTED|Second Dose (270 mcg Albuterol)||14
11286339|NCT02447250|12483213|FG000|COMPLETED|Second Dose (270 mcg Albuterol)||13
11286340|NCT02447250|12483213|FG000|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1
11286341|NCT02447250|12483213|FG000|STARTED|Third Dose (360 mcg Albuterol)||13
11286342|NCT02447250|12483213|FG000|COMPLETED|Third Dose (360 mcg Albuterol)||8
11286343|NCT02447250|12483213|FG000|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5
11286344|NCT02447302|12483221|FG000|STARTED|Overall Study||52
11286345|NCT02447302|12483222|FG001|STARTED|Overall Study||50
11286346|NCT02447302|12483223|FG002|STARTED|Overall Study||54
11286347|NCT02447302|12483221|FG000|COMPLETED|Overall Study||47
11286348|NCT02447302|12483222|FG001|COMPLETED|Overall Study||46
11286349|NCT02447302|12483223|FG002|COMPLETED|Overall Study||48
11286350|NCT02447302|12483221|FG000|NOT COMPLETED|Overall Study||5
11286351|NCT02447302|12483222|FG001|NOT COMPLETED|Overall Study||4
11286352|NCT02447302|12483223|FG002|NOT COMPLETED|Overall Study||6
11286353|NCT02447328|12483231|FG000|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
11286354|NCT02447328|12483231|FG000|COMPLETED|Overall Study||82
11286355|NCT02447328|12483231|FG000|NOT COMPLETED|Overall Study||1
11286356|NCT02447432|12483237|FG000|STARTED|Epoch 001||160
11286357|NCT02447432|12483238|FG001|STARTED|Epoch 001||160
11286358|NCT02447432|12483237|FG000|COMPLETED|Epoch 001||155
11286359|NCT02447432|12483238|FG001|COMPLETED|Epoch 001||147
11286360|NCT02447432|12483237|FG000|NOT COMPLETED|Epoch 001||5
11286361|NCT02447432|12483238|FG001|NOT COMPLETED|Epoch 001||13
11286362|NCT02447432|12483237|FG000|STARTED|Epoch 002||152
11286363|NCT02447432|12483238|FG001|STARTED|Epoch 002||145
11286364|NCT02447432|12483237|FG000|COMPLETED|Epoch 002||152
11286365|NCT02447432|12483238|FG001|COMPLETED|Epoch 002||145
11286366|NCT02447432|12483237|FG000|NOT COMPLETED|Epoch 002||0
11286367|NCT02447432|12483238|FG001|NOT COMPLETED|Epoch 002||0
11286368|NCT02447458|12483250|FG000|STARTED|Overall Study||5
11286369|NCT02447458|12483251|FG001|STARTED|Overall Study||6
11286370|NCT02447458|12483252|FG002|STARTED|Overall Study||6
11399397|NCT04334681|12593982|FG000|COMPLETED|Overall Study||135
11399398|NCT04334681|12593983|FG001|COMPLETED|Overall Study||143
11399399|NCT04334681|12593982|FG000|NOT COMPLETED|Overall Study||0
11399400|NCT04334681|12593983|FG001|NOT COMPLETED|Overall Study||0
11399401|NCT04333225|12593993|FG000|STARTED|Overall Study||101
11399402|NCT04333225|12593994|FG001|STARTED|Overall Study||120
11286371|NCT02447458|12483253|FG003|STARTED|Overall Study||6
11286372|NCT02447458|12483254|FG004|STARTED|Overall Study||6
11286373|NCT02447458|12483255|FG005|STARTED|Overall Study||10
11286374|NCT02447458|12483250|FG000|COMPLETED|Overall Study||5
11286375|NCT02447458|12483251|FG001|COMPLETED|Overall Study||6
11286376|NCT02447458|12483252|FG002|COMPLETED|Overall Study||5
11286377|NCT02447458|12483253|FG003|COMPLETED|Overall Study||6
11286378|NCT02447458|12483254|FG004|COMPLETED|Overall Study||6
11286379|NCT02447458|12483255|FG005|COMPLETED|Overall Study||10
11399403|NCT04333225|12593993|FG000|COMPLETED|Overall Study||98
11286380|NCT02447458|12483250|FG000|NOT COMPLETED|Overall Study||0
11286381|NCT02447458|12483251|FG001|NOT COMPLETED|Overall Study||0
11286382|NCT02447458|12483252|FG002|NOT COMPLETED|Overall Study||1
11286383|NCT02447458|12483253|FG003|NOT COMPLETED|Overall Study||0
11286384|NCT02447458|12483254|FG004|NOT COMPLETED|Overall Study||0
11286385|NCT02447458|12483255|FG005|NOT COMPLETED|Overall Study||0
11286386|NCT02447497|12483278|FG000|STARTED|Overall Study||25
11286387|NCT02447497|12483279|FG001|STARTED|Overall Study||25
11286388|NCT02447497|12483280|FG002|STARTED|Overall Study||23
11286389|NCT02447497|12483281|FG003|STARTED|Overall Study||23
11286390|NCT02447497|12483278|FG000|COMPLETED|Overall Study||19
11286391|NCT02447497|12483279|FG001|COMPLETED|Overall Study||19
11286392|NCT02447497|12483280|FG002|COMPLETED|Overall Study||21
11286393|NCT02447497|12483281|FG003|COMPLETED|Overall Study||21
11286394|NCT02447497|12483278|FG000|NOT COMPLETED|Overall Study||6
11286395|NCT02447497|12483279|FG001|NOT COMPLETED|Overall Study||6
11286396|NCT02447497|12483280|FG002|NOT COMPLETED|Overall Study||2
11286397|NCT02447497|12483281|FG003|NOT COMPLETED|Overall Study||2
11286398|NCT02447575|12483299|FG000|STARTED|Overall Study|23 subjects were enrolled in the study: http://dx.doi.org/10.1016/j.chest.2016.08.017|23
11286399|NCT02447575|12483299|FG000|COMPLETED|Overall Study||23
11286400|NCT02447575|12483299|FG000|NOT COMPLETED|Overall Study||0
11286401|NCT02447744|12483305|FG000|STARTED|Overall Study|6 subjects are enrolled in the mindfulness program after serving on the waiting list control group|21
11286402|NCT02447744|12483306|FG001|STARTED|Overall Study||22
11286403|NCT02447744|12483305|FG000|COMPLETED|Overall Study||15
11286404|NCT02447744|12483306|FG001|COMPLETED|Overall Study||21
11286405|NCT02447744|12483305|FG000|NOT COMPLETED|Overall Study||6
11286406|NCT02447744|12483306|FG001|NOT COMPLETED|Overall Study||1
11286407|NCT02447848|12483312|FG000|STARTED|Overall Study||76
11286408|NCT02447848|12483312|FG000|COMPLETED|Overall Study||65
11286409|NCT02447848|12483312|FG000|NOT COMPLETED|Overall Study||11
11286410|NCT02447926|12483316|FG000|STARTED|Overall Study||1
11286411|NCT02447926|12483316|FG000|COMPLETED|Overall Study||1
11286412|NCT02447926|12483316|FG000|NOT COMPLETED|Overall Study||0
11286413|NCT02447952|12483320|FG000|STARTED|Overall Study||25
11286414|NCT02447952|12483320|FG000|COMPLETED|Overall Study||18
11286415|NCT02447952|12483320|FG000|NOT COMPLETED|Overall Study||7
11286416|NCT02447991|12483326|FG000|STARTED|Overall Study||45
11286417|NCT02447991|12483327|FG001|STARTED|Overall Study||89
11286418|NCT02447991|12483326|FG000|COMPLETED|Overall Study||35
11286419|NCT02447991|12483327|FG001|COMPLETED|Overall Study||59
11286420|NCT02447991|12483326|FG000|NOT COMPLETED|Overall Study||10
11286421|NCT02447991|12483327|FG001|NOT COMPLETED|Overall Study||30
11286422|NCT02448043|12483339|FG000|STARTED|Overall Study||23
11286423|NCT02448043|12483340|FG001|STARTED|Overall Study||22
11286424|NCT02448043|12483339|FG000|COMPLETED|Overall Study||20
11286425|NCT02448043|12483340|FG001|COMPLETED|Overall Study||18
11286426|NCT02448043|12483339|FG000|NOT COMPLETED|Overall Study||3
11286427|NCT02448043|12483340|FG001|NOT COMPLETED|Overall Study||4
11286428|NCT02448303|12483351|FG000|STARTED|Overall Study||38
11286429|NCT02448303|12483352|FG001|STARTED|Overall Study||36
11286430|NCT02448303|12483351|FG000|Enrolled|Overall Study||38
11286431|NCT02448303|12483352|FG001|Enrolled|Overall Study||36
11286432|NCT02448303|12483351|FG000|Received Study Medication|Overall Study||33
11286433|NCT02448303|12483352|FG001|Received Study Medication|Overall Study||35
11286434|NCT02448303|12483351|FG000|Discontinued Study|Overall Study||38
11286435|NCT02448303|12483352|FG001|Discontinued Study|Overall Study||36
11286436|NCT02448303|12483351|FG000|COMPLETED|Overall Study||0
11286437|NCT02448303|12483352|FG001|COMPLETED|Overall Study||0
11286438|NCT02448303|12483351|FG000|NOT COMPLETED|Overall Study||38
11286439|NCT02448303|12483352|FG001|NOT COMPLETED|Overall Study||36
11286440|NCT02448368|12483360|FG000|STARTED|Overall Study||2
11286441|NCT02448368|12483361|FG001|STARTED|Overall Study||2
11286442|NCT02448368|12483362|FG002|STARTED|Overall Study||2
11286443|NCT02448368|12483363|FG003|STARTED|Overall Study||2
11286444|NCT02448368|12483364|FG004|STARTED|Overall Study||2
11286445|NCT02448368|12483365|FG005|STARTED|Overall Study||2
11286446|NCT02448368|12483366|FG006|STARTED|Overall Study||2
11286447|NCT02448368|12483367|FG007|STARTED|Overall Study||2
11286448|NCT02448368|12483368|FG008|STARTED|Overall Study||2
11286449|NCT02448368|12483369|FG009|STARTED|Overall Study||2
11286450|NCT02448368|12483370|FG010|STARTED|Overall Study||5
11286451|NCT02448368|12483371|FG011|STARTED|Overall Study||5
11286452|NCT02448368|12483372|FG012|STARTED|Overall Study||5
11286453|NCT02448368|12483360|FG000|COMPLETED|Overall Study||2
11286454|NCT02448368|12483361|FG001|COMPLETED|Overall Study||2
11286455|NCT02448368|12483362|FG002|COMPLETED|Overall Study||2
11286456|NCT02448368|12483363|FG003|COMPLETED|Overall Study||2
11286457|NCT02448368|12483364|FG004|COMPLETED|Overall Study||2
11286458|NCT02448368|12483365|FG005|COMPLETED|Overall Study||2
11286459|NCT02448368|12483366|FG006|COMPLETED|Overall Study||2
11286460|NCT02448368|12483367|FG007|COMPLETED|Overall Study||2
11286461|NCT02448368|12483368|FG008|COMPLETED|Overall Study||2
11286462|NCT02448368|12483369|FG009|COMPLETED|Overall Study||2
11286463|NCT02448368|12483370|FG010|COMPLETED|Overall Study||5
11286464|NCT02448368|12483371|FG011|COMPLETED|Overall Study||5
11286465|NCT02448368|12483372|FG012|COMPLETED|Overall Study||5
11286466|NCT02448368|12483360|FG000|NOT COMPLETED|Overall Study||0
11286467|NCT02448368|12483361|FG001|NOT COMPLETED|Overall Study||0
11286468|NCT02448368|12483362|FG002|NOT COMPLETED|Overall Study||0
11286469|NCT02448368|12483363|FG003|NOT COMPLETED|Overall Study||0
11286470|NCT02448368|12483364|FG004|NOT COMPLETED|Overall Study||0
11286471|NCT02448368|12483365|FG005|NOT COMPLETED|Overall Study||0
11286472|NCT02448368|12483366|FG006|NOT COMPLETED|Overall Study||0
11286473|NCT02448368|12483367|FG007|NOT COMPLETED|Overall Study||0
11286474|NCT02448368|12483368|FG008|NOT COMPLETED|Overall Study||0
11286475|NCT02448368|12483369|FG009|NOT COMPLETED|Overall Study||0
11286476|NCT02448368|12483370|FG010|NOT COMPLETED|Overall Study||0
11286477|NCT02448368|12483371|FG011|NOT COMPLETED|Overall Study||0
11286478|NCT02448368|12483372|FG012|NOT COMPLETED|Overall Study||0
11286479|NCT02448446|12483399|FG000|STARTED|Overall Study||13
11286480|NCT02448446|12483400|FG001|STARTED|Overall Study||12
11286481|NCT02448446|12483399|FG000|COMPLETED|Overall Study||12
11286482|NCT02448446|12483400|FG001|COMPLETED|Overall Study||12
11286483|NCT02448446|12483399|FG000|NOT COMPLETED|Overall Study||1
11286484|NCT02448446|12483400|FG001|NOT COMPLETED|Overall Study||0
11286485|NCT02448537|12483409|FG000|STARTED|Overall Study||20
11286486|NCT02448537|12483410|FG001|STARTED|Overall Study||10
11286487|NCT02448537|12483411|FG002|STARTED|Overall Study||12
11286488|NCT02448537|12483409|FG000|COMPLETED|Overall Study||19
11286489|NCT02448537|12483410|FG001|COMPLETED|Overall Study||9
11286490|NCT02448537|12483411|FG002|COMPLETED|Overall Study||11
11286491|NCT02448537|12483409|FG000|NOT COMPLETED|Overall Study||1
11286492|NCT02448537|12483410|FG001|NOT COMPLETED|Overall Study||1
11286493|NCT02448537|12483411|FG002|NOT COMPLETED|Overall Study||1
11286494|NCT02448563|12483423|FG000|STARTED|Overall Study|Randomized after completing Visit 2|32
11286495|NCT02448563|12483424|FG001|STARTED|Overall Study|Randomized after completing Visit 2|30
11286496|NCT02448563|12483423|FG000|COMPLETED|Overall Study||16
11286497|NCT02448563|12483424|FG001|COMPLETED|Overall Study||19
11286498|NCT02448563|12483423|FG000|NOT COMPLETED|Overall Study||16
11286499|NCT02448563|12483424|FG001|NOT COMPLETED|Overall Study||11
11286500|NCT02448641|12483437|FG000|STARTED|Overall Study||55
11286501|NCT02448641|12483438|FG001|STARTED|Overall Study||56
11286502|NCT02448641|12483439|FG002|STARTED|Overall Study||52
11286503|NCT02448641|12483437|FG000|COMPLETED|Overall Study||54
11286504|NCT02448641|12483438|FG001|COMPLETED|Overall Study||51
11286505|NCT02448641|12483439|FG002|COMPLETED|Overall Study||48
11286506|NCT02448641|12483437|FG000|NOT COMPLETED|Overall Study||1
11286507|NCT02448641|12483438|FG001|NOT COMPLETED|Overall Study||5
11286508|NCT02448641|12483439|FG002|NOT COMPLETED|Overall Study||4
11286509|NCT02448654|12483456|FG000|STARTED|Overall Study||19
11286510|NCT02448654|12483457|FG001|STARTED|Overall Study||17
11286511|NCT02448654|12483456|FG000|Started Pills (Tolcapone or Placebo)|Overall Study||17
11286512|NCT02448654|12483457|FG001|Started Pills (Tolcapone or Placebo)|Overall Study||15
11286513|NCT02448654|12483456|FG000|COMPLETED|Overall Study||16
11286514|NCT02448654|12483457|FG001|COMPLETED|Overall Study||13
11286515|NCT02448654|12483456|FG000|NOT COMPLETED|Overall Study||3
11286516|NCT02448654|12483457|FG001|NOT COMPLETED|Overall Study||4
11286517|NCT02448706|12483463|FG000|STARTED|Overall Study||25
11286518|NCT02448706|12483464|FG001|STARTED|Overall Study||24
11286519|NCT02448706|12483463|FG000|Withdrew for Personal Reasons|Overall Study||1
11286520|NCT02448706|12483464|FG001|Withdrew for Personal Reasons|Overall Study||1
11286521|NCT02448706|12483463|FG000|Completed Baseline Testing|Overall Study||24
11286522|NCT02448706|12483464|FG001|Completed Baseline Testing|Overall Study||23
11286523|NCT02448706|12483463|FG000|COMPLETED|Overall Study||20
11286524|NCT02448706|12483464|FG001|COMPLETED|Overall Study||20
11286525|NCT02448706|12483463|FG000|NOT COMPLETED|Overall Study||5
11286526|NCT02448706|12483464|FG001|NOT COMPLETED|Overall Study||4
11286527|NCT02448719|12483483|FG000|STARTED|Overall Study||12
11286528|NCT02448719|12483484|FG001|STARTED|Overall Study||6
11286529|NCT02448719|12483485|FG002|STARTED|Overall Study||6
11286530|NCT02448719|12483486|FG003|STARTED|Overall Study||6
11286531|NCT02448719|12483487|FG004|STARTED|Overall Study||6
11286532|NCT02448719|12483488|FG005|STARTED|Overall Study||6
11286533|NCT02448719|12483489|FG006|STARTED|Overall Study||6
11286534|NCT02448719|12483490|FG007|STARTED|Overall Study||6
11286535|NCT02448719|12483491|FG008|STARTED|Overall Study||6
11286536|NCT02448719|12483492|FG009|STARTED|Overall Study||6
11286537|NCT02448719|12483493|FG010|STARTED|Overall Study||6
11286538|NCT02448719|12483483|FG000|COMPLETED|Overall Study||12
11286539|NCT02448719|12483484|FG001|COMPLETED|Overall Study||6
11286540|NCT02448719|12483485|FG002|COMPLETED|Overall Study||6
11286541|NCT02448719|12483486|FG003|COMPLETED|Overall Study||6
11286542|NCT02448719|12483487|FG004|COMPLETED|Overall Study||5
11286543|NCT02448719|12483488|FG005|COMPLETED|Overall Study||6
11286544|NCT02448719|12483489|FG006|COMPLETED|Overall Study||6
11286545|NCT02448719|12483490|FG007|COMPLETED|Overall Study||6
11286546|NCT02448719|12483491|FG008|COMPLETED|Overall Study||6
11286547|NCT02448719|12483492|FG009|COMPLETED|Overall Study||6
11286548|NCT02448719|12483493|FG010|COMPLETED|Overall Study||6
11286549|NCT02448719|12483483|FG000|NOT COMPLETED|Overall Study||0
11286550|NCT02448719|12483484|FG001|NOT COMPLETED|Overall Study||0
11286551|NCT02448719|12483485|FG002|NOT COMPLETED|Overall Study||0
11286552|NCT02448719|12483486|FG003|NOT COMPLETED|Overall Study||0
11286553|NCT02448719|12483487|FG004|NOT COMPLETED|Overall Study||1
11286554|NCT02448719|12483488|FG005|NOT COMPLETED|Overall Study||0
11286555|NCT02448719|12483489|FG006|NOT COMPLETED|Overall Study||0
11286556|NCT02448719|12483490|FG007|NOT COMPLETED|Overall Study||0
11286557|NCT02448719|12483491|FG008|NOT COMPLETED|Overall Study||0
11286558|NCT02448719|12483492|FG009|NOT COMPLETED|Overall Study||0
11286559|NCT02448719|12483493|FG010|NOT COMPLETED|Overall Study||0
11286560|NCT02448810|12483562|FG000|STARTED|Overall Study||3
11286561|NCT02448810|12483563|FG001|STARTED|Overall Study||3
11286562|NCT02448810|12483564|FG002|STARTED|Overall Study||3
11286563|NCT02448810|12483565|FG003|STARTED|Overall Study||3
11286564|NCT02448810|12483566|FG004|STARTED|Overall Study||31
11286565|NCT02448810|12483567|FG005|STARTED|Overall Study||16
11286566|NCT02448810|12483568|FG006|STARTED|Overall Study||18
11286567|NCT02448810|12483569|FG007|STARTED|Overall Study||8
11286568|NCT02448810|12483562|FG000|Treated|Overall Study||3
11286569|NCT02448810|12483563|FG001|Treated|Overall Study||3
11286570|NCT02448810|12483564|FG002|Treated|Overall Study||3
11286571|NCT02448810|12483565|FG003|Treated|Overall Study||3
11286572|NCT02448810|12483566|FG004|Treated|Overall Study||29
11286573|NCT02448810|12483567|FG005|Treated|Overall Study||13
11286574|NCT02448810|12483568|FG006|Treated|Overall Study||18
11286575|NCT02448810|12483569|FG007|Treated|Overall Study||7
11286576|NCT02448810|12483562|FG000|COMPLETED|Overall Study||0
11286577|NCT02448810|12483563|FG001|COMPLETED|Overall Study||0
11286578|NCT02448810|12483564|FG002|COMPLETED|Overall Study||0
11286579|NCT02448810|12483565|FG003|COMPLETED|Overall Study||0
11286580|NCT02448810|12483566|FG004|COMPLETED|Overall Study||0
11286581|NCT02448810|12483567|FG005|COMPLETED|Overall Study||0
11286582|NCT02448810|12483568|FG006|COMPLETED|Overall Study||0
11286583|NCT02448810|12483569|FG007|COMPLETED|Overall Study||0
11286584|NCT02448810|12483562|FG000|NOT COMPLETED|Overall Study||3
11286585|NCT02448810|12483563|FG001|NOT COMPLETED|Overall Study||3
11286586|NCT02448810|12483564|FG002|NOT COMPLETED|Overall Study||3
11286587|NCT02448810|12483565|FG003|NOT COMPLETED|Overall Study||3
11286588|NCT02448810|12483566|FG004|NOT COMPLETED|Overall Study||31
11286589|NCT02448810|12483567|FG005|NOT COMPLETED|Overall Study||16
11286590|NCT02448810|12483568|FG006|NOT COMPLETED|Overall Study||18
11286591|NCT02448810|12483569|FG007|NOT COMPLETED|Overall Study||8
11286592|NCT02448862|12483593|FG000|STARTED|Overall Study||4525
11286593|NCT02448862|12483594|FG001|STARTED|Overall Study||6050
11286594|NCT02448862|12483593|FG000|COMPLETED|Overall Study||4525
11286595|NCT02448862|12483594|FG001|COMPLETED|Overall Study||6050
11286596|NCT02448862|12483593|FG000|NOT COMPLETED|Overall Study||0
11286597|NCT02448862|12483594|FG001|NOT COMPLETED|Overall Study||0
11286598|NCT02448875|12483603|FG000|STARTED|Overall Study||60
11286599|NCT02448875|12483604|FG001|STARTED|Overall Study||21
11286600|NCT02448875|12483605|FG002|STARTED|Overall Study||61
11286601|NCT02448875|12483603|FG000|Completed Dose Selection Phase|Overall Study||20
11286602|NCT02448875|12483604|FG001|Completed Dose Selection Phase|Overall Study||21
11286603|NCT02448875|12483605|FG002|Completed Dose Selection Phase|Overall Study||20
11286604|NCT02448875|12483603|FG000|Full Analysis Set|Overall Study||60
11286605|NCT02448875|12483604|FG001|Full Analysis Set|Overall Study||21
11286606|NCT02448875|12483605|FG002|Full Analysis Set|Overall Study||61
11286607|NCT02448875|12483603|FG000|Safety Analysis Set|Overall Study||60
11286608|NCT02448875|12483604|FG001|Safety Analysis Set|Overall Study||21
11286609|NCT02448875|12483605|FG002|Safety Analysis Set|Overall Study||61
11286610|NCT02448875|12483603|FG000|COMPLETED|Overall Study||53
11286611|NCT02448875|12483604|FG001|COMPLETED|Overall Study||20
11286612|NCT02448875|12483605|FG002|COMPLETED|Overall Study||60
11286613|NCT02448875|12483603|FG000|NOT COMPLETED|Overall Study||7
11286614|NCT02448875|12483604|FG001|NOT COMPLETED|Overall Study||1
11286615|NCT02448875|12483605|FG002|NOT COMPLETED|Overall Study||1
11286616|NCT02448914|12483616|FG000|STARTED|First Intervention (1 Day)||6
11286617|NCT02448914|12483617|FG001|STARTED|First Intervention (1 Day)||5
11286618|NCT02448914|12483616|FG000|COMPLETED|First Intervention (1 Day)||6
11286619|NCT02448914|12483617|FG001|COMPLETED|First Intervention (1 Day)||5
11286620|NCT02448914|12483616|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11286621|NCT02448914|12483617|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11286622|NCT02448914|12483616|FG000|STARTED|Second Intervention (1 Day)||6
11286623|NCT02448914|12483617|FG001|STARTED|Second Intervention (1 Day)||5
11286624|NCT02448914|12483616|FG000|COMPLETED|Second Intervention (1 Day)||6
11286625|NCT02448914|12483617|FG001|COMPLETED|Second Intervention (1 Day)||5
11286626|NCT02448914|12483616|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11286627|NCT02448914|12483617|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11286628|NCT02449018|12483626|FG000|STARTED|Overall Study||64
11286629|NCT02449018|12483627|FG001|STARTED|Overall Study||28
11286630|NCT02449018|12483626|FG000|COMPLETED|Overall Study||52
11286631|NCT02449018|12483627|FG001|COMPLETED|Overall Study||26
11286632|NCT02449018|12483626|FG000|NOT COMPLETED|Overall Study||12
11286633|NCT02449018|12483627|FG001|NOT COMPLETED|Overall Study||2
11286634|NCT02449044|12483633|FG000|STARTED|Overall Study||111
11286635|NCT02449044|12483633|FG000|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
11286636|NCT02449044|12483633|FG000|NOT COMPLETED|Overall Study||64
11286637|NCT02449174|12483639|FG000|STARTED|Overall Study||36
11286638|NCT02449174|12483640|FG001|STARTED|Overall Study||32
11286639|NCT02449174|12483639|FG000|COMPLETED|Overall Study||36
11286640|NCT02449174|12483640|FG001|COMPLETED|Overall Study||32
11286641|NCT02449174|12483639|FG000|NOT COMPLETED|Overall Study||0
11286642|NCT02449174|12483640|FG001|NOT COMPLETED|Overall Study||0
11286643|NCT02449291|12483649|FG000|STARTED|Overall Study||191
11286644|NCT02449291|12483650|FG001|STARTED|Overall Study||188
11286645|NCT02449291|12483651|FG002|STARTED|Overall Study||181
11286646|NCT02449291|12483649|FG000|COMPLETED|Overall Study||186
11286647|NCT02449291|12483650|FG001|COMPLETED|Overall Study||186
11286648|NCT02449291|12483651|FG002|COMPLETED|Overall Study||180
11286649|NCT02449291|12483649|FG000|NOT COMPLETED|Overall Study||5
11286650|NCT02449291|12483650|FG001|NOT COMPLETED|Overall Study||2
11286651|NCT02449291|12483651|FG002|NOT COMPLETED|Overall Study||1
11286652|NCT02449356|12483664|FG000|STARTED|Overall Study||30
11286653|NCT02449356|12483665|FG001|STARTED|Overall Study||30
11286654|NCT02449356|12483664|FG000|COMPLETED|Overall Study||30
11286655|NCT02449356|12483665|FG001|COMPLETED|Overall Study||30
11286656|NCT02449356|12483664|FG000|NOT COMPLETED|Overall Study||0
11286657|NCT02449356|12483665|FG001|NOT COMPLETED|Overall Study||0
11286658|NCT02449434|12483675|FG000|STARTED|Overall Study||300
11286659|NCT02449434|12483676|FG001|STARTED|Overall Study||300
11286660|NCT02449434|12483675|FG000|COMPLETED|Overall Study||300
11286661|NCT02449434|12483676|FG001|COMPLETED|Overall Study||300
11286662|NCT02449434|12483675|FG000|NOT COMPLETED|Overall Study||0
11286663|NCT02449434|12483676|FG001|NOT COMPLETED|Overall Study||0
11286664|NCT02449473|12483684|FG000|STARTED|Overall Study||39
11286665|NCT02449473|12483685|FG001|STARTED|Overall Study||40
11286666|NCT02449473|12483684|FG000|COMPLETED|Overall Study||39
11286667|NCT02449473|12483685|FG001|COMPLETED|Overall Study||40
11286668|NCT02449473|12483684|FG000|NOT COMPLETED|Overall Study||0
11286669|NCT02449473|12483685|FG001|NOT COMPLETED|Overall Study||0
11286670|NCT02449798|12483691|FG000|STARTED|Overall Study||120
11286671|NCT02449798|12483691|FG000|COMPLETED|Overall Study||120
11286672|NCT02449798|12483691|FG000|NOT COMPLETED|Overall Study||0
11286673|NCT02449889|12483698|FG000|STARTED|Overall Study||58
11286674|NCT02449889|12483699|FG001|STARTED|Overall Study||58
11286675|NCT02449889|12483700|FG002|STARTED|Overall Study||60
11286676|NCT02449889|12483698|FG000|COMPLETED|Overall Study||57
11286677|NCT02449889|12483699|FG001|COMPLETED|Overall Study||52
11286678|NCT02449889|12483700|FG002|COMPLETED|Overall Study||59
11286679|NCT02449889|12483698|FG000|NOT COMPLETED|Overall Study||1
11286680|NCT02449889|12483699|FG001|NOT COMPLETED|Overall Study||6
11286681|NCT02449889|12483700|FG002|NOT COMPLETED|Overall Study||1
11286682|NCT02449902|12483710|FG000|STARTED|Overall Study||24
11286683|NCT02449902|12483711|FG001|STARTED|Overall Study||26
11286684|NCT02449902|12483710|FG000|COMPLETED|Overall Study||24
11286685|NCT02449902|12483711|FG001|COMPLETED|Overall Study||24
11286686|NCT02449902|12483710|FG000|NOT COMPLETED|Overall Study||0
11286687|NCT02449902|12483711|FG001|NOT COMPLETED|Overall Study||2
11286688|NCT02449915|12483721|FG000|STARTED|Overall Study||35
11286689|NCT02449915|12483722|FG001|STARTED|Overall Study||35
11286690|NCT02449915|12483721|FG000|COMPLETED|Overall Study||33
11286691|NCT02449915|12483722|FG001|COMPLETED|Overall Study||31
11286692|NCT02449915|12483721|FG000|NOT COMPLETED|Overall Study||2
11286693|NCT02449915|12483722|FG001|NOT COMPLETED|Overall Study||4
11286694|NCT02450383|12483730|FG000|STARTED|Overall Study||10
11286695|NCT02450383|12483731|FG001|STARTED|Overall Study||10
11286696|NCT02450383|12483730|FG000|COMPLETED|Overall Study||10
11286697|NCT02450383|12483731|FG001|COMPLETED|Overall Study||10
11286698|NCT02450383|12483730|FG000|NOT COMPLETED|Overall Study||0
11286699|NCT02450383|12483731|FG001|NOT COMPLETED|Overall Study||0
11286700|NCT02450487|12483737|FG000|STARTED|Overall Study||105
11286701|NCT02450487|12483737|FG000|COMPLETED|Overall Study||102
11286702|NCT02450487|12483737|FG000|NOT COMPLETED|Overall Study||3
11286703|NCT02450526|12483746|FG000|STARTED|DB Period (Cycle 1)||325
11286704|NCT02450526|12483747|FG001|STARTED|DB Period (Cycle 1)||66
11286705|NCT02450526|12483748|FG002|STARTED|DB Period (Cycle 1)||107
11286706|NCT02450526|12483749|FG003|STARTED|DB Period (Cycle 1)||22
11286707|NCT02450526|12483750|FG004|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
11286708|NCT02450526|12483746|FG000|Safety Population|DB Period (Cycle 1)||326
11286709|NCT02450526|12483747|FG001|Safety Population|DB Period (Cycle 1)||66
11286710|NCT02450526|12483748|FG002|Safety Population|DB Period (Cycle 1)||107
11286711|NCT02450526|12483749|FG003|Safety Population|DB Period (Cycle 1)||21
11286712|NCT02450526|12483750|FG004|Safety Population|DB Period (Cycle 1)||0
11286713|NCT02450526|12483746|FG000|COMPLETED|DB Period (Cycle 1)||294
11286714|NCT02450526|12483747|FG001|COMPLETED|DB Period (Cycle 1)||63
11286715|NCT02450526|12483748|FG002|COMPLETED|DB Period (Cycle 1)||97
11286716|NCT02450526|12483749|FG003|COMPLETED|DB Period (Cycle 1)||20
11286717|NCT02450526|12483750|FG004|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
11286718|NCT02450526|12483746|FG000|NOT COMPLETED|DB Period (Cycle 1)||31
11286719|NCT02450526|12483747|FG001|NOT COMPLETED|DB Period (Cycle 1)||3
11286720|NCT02450526|12483748|FG002|NOT COMPLETED|DB Period (Cycle 1)||10
11286721|NCT02450526|12483749|FG003|NOT COMPLETED|DB Period (Cycle 1)||2
11286722|NCT02450526|12483750|FG004|NOT COMPLETED|DB Period (Cycle 1)||0
11286723|NCT02450526|12483746|FG000|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
11286724|NCT02450526|12483747|FG001|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
11286725|NCT02450526|12483748|FG002|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
11286726|NCT02450526|12483749|FG003|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
11286727|NCT02450526|12483750|FG004|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465
11286728|NCT02450526|12483746|FG000|Safety Population|OL Period (Cycles 2-5)||0
11286729|NCT02450526|12483747|FG001|Safety Population|OL Period (Cycles 2-5)||0
11286730|NCT02450526|12483748|FG002|Safety Population|OL Period (Cycles 2-5)||0
11286731|NCT02450526|12483749|FG003|Safety Population|OL Period (Cycles 2-5)||0
11286732|NCT02450526|12483750|FG004|Safety Population|OL Period (Cycles 2-5)||465
11286733|NCT02450526|12483746|FG000|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
11286734|NCT02450526|12483747|FG001|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
11286735|NCT02450526|12483748|FG002|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
11286736|NCT02450526|12483749|FG003|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
11286737|NCT02450526|12483750|FG004|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28
11286738|NCT02450526|12483746|FG000|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
11286739|NCT02450526|12483747|FG001|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
11286740|NCT02450526|12483748|FG002|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
11286741|NCT02450526|12483749|FG003|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
11286742|NCT02450526|12483750|FG004|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11
11399404|NCT04333225|12593994|FG001|COMPLETED|Overall Study||115
11286743|NCT02450526|12483746|FG000|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
11286744|NCT02450526|12483747|FG001|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
11286745|NCT02450526|12483748|FG002|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
11286746|NCT02450526|12483749|FG003|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
11286747|NCT02450526|12483750|FG004|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2
11286748|NCT02450526|12483746|FG000|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
11286749|NCT02450526|12483747|FG001|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
11286750|NCT02450526|12483748|FG002|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
11286751|NCT02450526|12483749|FG003|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
11286752|NCT02450526|12483750|FG004|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
11286753|NCT02450526|12483746|FG000|COMPLETED|OL Period (Cycles 2-5)||0
11286754|NCT02450526|12483747|FG001|COMPLETED|OL Period (Cycles 2-5)||0
11286755|NCT02450526|12483748|FG002|COMPLETED|OL Period (Cycles 2-5)||0
11286756|NCT02450526|12483749|FG003|COMPLETED|OL Period (Cycles 2-5)||0
11286757|NCT02450526|12483750|FG004|COMPLETED|OL Period (Cycles 2-5)||424
11286758|NCT02450526|12483746|FG000|NOT COMPLETED|OL Period (Cycles 2-5)||0
11286759|NCT02450526|12483747|FG001|NOT COMPLETED|OL Period (Cycles 2-5)||0
11286760|NCT02450526|12483748|FG002|NOT COMPLETED|OL Period (Cycles 2-5)||0
11286761|NCT02450526|12483749|FG003|NOT COMPLETED|OL Period (Cycles 2-5)||0
11286762|NCT02450526|12483750|FG004|NOT COMPLETED|OL Period (Cycles 2-5)||41
11286763|NCT02450539|12483772|FG000|STARTED|Overall Study||106
11286764|NCT02450539|12483773|FG001|STARTED|Overall Study||53
11286765|NCT02450539|12483772|FG000|Received at Least One Dose of Study Drug|Overall Study||106
11286766|NCT02450539|12483773|FG001|Received at Least One Dose of Study Drug|Overall Study||52
11286767|NCT02450539|12483772|FG000|COMPLETED|Overall Study||90
11286768|NCT02450539|12483773|FG001|COMPLETED|Overall Study||46
11286769|NCT02450539|12483772|FG000|NOT COMPLETED|Overall Study||16
11286770|NCT02450539|12483773|FG001|NOT COMPLETED|Overall Study||7
11286771|NCT02450552|12483785|FG000|STARTED|Overall Study||19
11286772|NCT02450552|12483786|FG001|STARTED|Overall Study||23
11286773|NCT02450552|12483787|FG002|STARTED|Overall Study||23
11286774|NCT02450552|12483785|FG000|COMPLETED|Overall Study||14
11399405|NCT04333225|12593993|FG000|NOT COMPLETED|Overall Study||3
11399406|NCT04333225|12593994|FG001|NOT COMPLETED|Overall Study||5
11399407|NCT04333199|12594003|FG000|STARTED|Evaluated Patients||1669
11399408|NCT04333199|12594004|FG001|STARTED|Evaluated Patients||1672
11399409|NCT04333199|12594005|FG002|STARTED|Evaluated Patients||1671
11399410|NCT04333199|12594003|FG000|COMPLETED|Evaluated Patients||1669
11399411|NCT04333199|12594004|FG001|COMPLETED|Evaluated Patients||1671
11399412|NCT04333199|12594005|FG002|COMPLETED|Evaluated Patients||1669
11286775|NCT02450552|12483786|FG001|COMPLETED|Overall Study||23
11286776|NCT02450552|12483787|FG002|COMPLETED|Overall Study||18
11286777|NCT02450552|12483785|FG000|NOT COMPLETED|Overall Study||5
11286778|NCT02450552|12483786|FG001|NOT COMPLETED|Overall Study||0
11286779|NCT02450552|12483787|FG002|NOT COMPLETED|Overall Study||5
11286780|NCT02450578|12483799|FG000|STARTED|Overall Study||6
11286781|NCT02450578|12483800|FG001|STARTED|Overall Study||6
11286782|NCT02450578|12483801|FG002|STARTED|Overall Study||6
11286783|NCT02450578|12483802|FG003|STARTED|Overall Study||4
11286784|NCT02450578|12483799|FG000|COMPLETED|Overall Study||5
11286785|NCT02450578|12483800|FG001|COMPLETED|Overall Study||6
11286786|NCT02450578|12483801|FG002|COMPLETED|Overall Study||6
11286787|NCT02450578|12483802|FG003|COMPLETED|Overall Study||4
11286788|NCT02450578|12483799|FG000|NOT COMPLETED|Overall Study||1
11286789|NCT02450578|12483800|FG001|NOT COMPLETED|Overall Study||0
11399413|NCT04333199|12594003|FG000|NOT COMPLETED|Evaluated Patients||0
11286790|NCT02450578|12483801|FG002|NOT COMPLETED|Overall Study||0
11286791|NCT02450578|12483802|FG003|NOT COMPLETED|Overall Study||0
11286792|NCT02450747|12483816|FG000|STARTED|Overall Study||39
11286793|NCT02450747|12483816|FG000|COMPLETED|Overall Study||39
11286794|NCT02450747|12483816|FG000|NOT COMPLETED|Overall Study||0
11286795|NCT02450799|12483827|FG000|STARTED|Overall Study||31
11399414|NCT04333199|12594004|FG001|NOT COMPLETED|Evaluated Patients||1
11399415|NCT04333199|12594005|FG002|NOT COMPLETED|Evaluated Patients||2
11286796|NCT02450799|12483828|FG001|STARTED|Overall Study||37
11286797|NCT02450799|12483829|FG002|STARTED|Overall Study||30
11286798|NCT02450799|12483827|FG000|COMPLETED|Overall Study||31
11286799|NCT02450799|12483828|FG001|COMPLETED|Overall Study||37
11286800|NCT02450799|12483829|FG002|COMPLETED|Overall Study||30
11286801|NCT02450799|12483827|FG000|NOT COMPLETED|Overall Study||0
11286802|NCT02450799|12483828|FG001|NOT COMPLETED|Overall Study||0
11286803|NCT02450799|12483829|FG002|NOT COMPLETED|Overall Study||0
11286804|NCT02450903|12483840|FG000|STARTED|Overall Study||20
11286805|NCT02450903|12483840|FG000|Entered Post-treatment Effic. f/u Phase|Overall Study||4
11286806|NCT02450903|12483840|FG000|Entered Survival Follow-up Phase|Overall Study||15
11286807|NCT02450903|12483840|FG000|COMPLETED|Overall Study||0
11286808|NCT02450903|12483840|FG000|NOT COMPLETED|Overall Study||20
11286809|NCT02451007|12483844|FG000|STARTED|Overall Study||39
11286810|NCT02451007|12483844|FG000|COMPLETED|Overall Study||32
11286811|NCT02451007|12483844|FG000|NOT COMPLETED|Overall Study||7
11286812|NCT02451124|12483848|FG000|STARTED|Overall Study||156
11286813|NCT02451124|12483848|FG000|COMPLETED|Overall Study||155
11286814|NCT02451124|12483848|FG000|NOT COMPLETED|Overall Study||1
11286815|NCT02451137|12483858|FG000|STARTED|Overall Study||1651
11286816|NCT02451137|12483859|FG001|STARTED|Overall Study||1653
11286817|NCT02451137|12483858|FG000|Treated|Overall Study||1632
11286818|NCT02451137|12483859|FG001|Treated|Overall Study||1626
11286819|NCT02451137|12483858|FG000|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637
11286820|NCT02451137|12483859|FG001|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621
11286821|NCT02451137|12483858|FG000|COMPLETED|Overall Study||1405
11286822|NCT02451137|12483859|FG001|COMPLETED|Overall Study||1355
11286823|NCT02451137|12483858|FG000|NOT COMPLETED|Overall Study||246
11286824|NCT02451137|12483859|FG001|NOT COMPLETED|Overall Study||298
11286825|NCT02451150|12483867|FG000|STARTED|Overall Study||3
11286826|NCT02451150|12483868|FG001|STARTED|Overall Study||3
11286827|NCT02451150|12483867|FG000|COMPLETED|Overall Study||3
11286828|NCT02451150|12483868|FG001|COMPLETED|Overall Study||3
11286829|NCT02451150|12483867|FG000|NOT COMPLETED|Overall Study||0
11286830|NCT02451150|12483868|FG001|NOT COMPLETED|Overall Study||0
11286831|NCT02451202|12483876|FG000|STARTED|Overall Study||51
11286832|NCT02451202|12483877|FG001|STARTED|Overall Study||51
11286833|NCT02451202|12483876|FG000|COMPLETED|Overall Study||49
11286834|NCT02451202|12483877|FG001|COMPLETED|Overall Study||48
11286835|NCT02451202|12483876|FG000|NOT COMPLETED|Overall Study||2
11286836|NCT02451202|12483877|FG001|NOT COMPLETED|Overall Study||3
11286837|NCT02451488|12483887|FG000|STARTED|Overall Study||4
11286838|NCT02451488|12483888|FG001|STARTED|Overall Study||4
11286839|NCT02451488|12483887|FG000|COMPLETED|Overall Study||4
11286840|NCT02451488|12483888|FG001|COMPLETED|Overall Study||4
11286841|NCT02451488|12483887|FG000|NOT COMPLETED|Overall Study||0
11286842|NCT02451488|12483888|FG001|NOT COMPLETED|Overall Study||0
11286843|NCT02451514|12483897|FG000|STARTED|Overall Study||33
11286844|NCT02451514|12483898|FG001|STARTED|Overall Study||46
11286845|NCT02451514|12483899|FG002|STARTED|Overall Study||50
11286846|NCT02451514|12483897|FG000|COMPLETED|Overall Study||33
11286847|NCT02451514|12483898|FG001|COMPLETED|Overall Study||46
11286848|NCT02451514|12483899|FG002|COMPLETED|Overall Study||50
11286849|NCT02451514|12483897|FG000|NOT COMPLETED|Overall Study||0
11286850|NCT02451514|12483898|FG001|NOT COMPLETED|Overall Study||0
11286851|NCT02451514|12483899|FG002|NOT COMPLETED|Overall Study||0
11286852|NCT02451670|12483917|FG000|STARTED|Overall Study||5264
11286853|NCT02451670|12483918|FG001|STARTED|Overall Study||5083
11286854|NCT02451670|12483917|FG000|COMPLETED|Overall Study||4550
11286855|NCT02451670|12483918|FG001|COMPLETED|Overall Study||4387
11286856|NCT02451670|12483917|FG000|NOT COMPLETED|Overall Study||714
11286857|NCT02451670|12483918|FG001|NOT COMPLETED|Overall Study||696
11286858|NCT02451696|12483926|FG000|STARTED|Overall Study||5
11286859|NCT02451696|12483927|FG001|STARTED|Overall Study||10
11286860|NCT02451696|12483926|FG000|COMPLETED|Overall Study||4
11286861|NCT02451696|12483927|FG001|COMPLETED|Overall Study||10
11399416|NCT04333199|12594003|FG000|STARTED|Emailed Patients|Patients in this group were not emailed|0
11399417|NCT04333199|12594004|FG001|STARTED|Emailed Patients||1671
11286862|NCT02451696|12483926|FG000|NOT COMPLETED|Overall Study||1
11286863|NCT02451696|12483927|FG001|NOT COMPLETED|Overall Study||0
11286864|NCT02451839|12483935|FG000|STARTED|Overall Study||72
11286865|NCT02451839|12483936|FG001|STARTED|Overall Study||59
11286866|NCT02451839|12483937|FG002|STARTED|Overall Study||37
11286867|NCT02451839|12483935|FG000|Baseline WHODAS Data Recorded|Overall Study||70
11286868|NCT02451839|12483936|FG001|Baseline WHODAS Data Recorded|Overall Study||57
11286869|NCT02451839|12483937|FG002|Baseline WHODAS Data Recorded|Overall Study||37
11286870|NCT02451839|12483935|FG000|COMPLETED|Overall Study||44
11286871|NCT02451839|12483936|FG001|COMPLETED|Overall Study||40
11286872|NCT02451839|12483937|FG002|COMPLETED|Overall Study||30
11286873|NCT02451839|12483935|FG000|NOT COMPLETED|Overall Study||28
11286874|NCT02451839|12483936|FG001|NOT COMPLETED|Overall Study||19
11286875|NCT02451839|12483937|FG002|NOT COMPLETED|Overall Study||7
11286876|NCT02451917|12483947|FG000|STARTED|First Intervention (24 Weeks)||16
11286877|NCT02451917|12483948|FG001|STARTED|First Intervention (24 Weeks)||18
11286878|NCT02451917|12483947|FG000|COMPLETED|First Intervention (24 Weeks)||14
11286879|NCT02451917|12483948|FG001|COMPLETED|First Intervention (24 Weeks)||15
11286880|NCT02451917|12483947|FG000|NOT COMPLETED|First Intervention (24 Weeks)||2
11286881|NCT02451917|12483948|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3
11286882|NCT02451917|12483947|FG000|STARTED|Second Intervention (24 Weeks)||14
11286883|NCT02451917|12483948|FG001|STARTED|Second Intervention (24 Weeks)||15
11286884|NCT02451917|12483947|FG000|COMPLETED|Second Intervention (24 Weeks)||14
11286885|NCT02451917|12483948|FG001|COMPLETED|Second Intervention (24 Weeks)||15
11286886|NCT02451917|12483947|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0
11286887|NCT02451917|12483948|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0
11286888|NCT02451930|12483960|FG000|STARTED|Overall Study||3
11286889|NCT02451930|12483961|FG001|STARTED|Overall Study||68
11286890|NCT02451930|12483960|FG000|Received at Least One Dose of Study Drug|Overall Study||3
11286891|NCT02451930|12483961|FG001|Received at Least One Dose of Study Drug|Overall Study||68
11286892|NCT02451930|12483960|FG000|Part A Cohort 2 Participants|Overall Study||0
11286893|NCT02451930|12483961|FG001|Part A Cohort 2 Participants|Overall Study||6
11286894|NCT02451930|12483960|FG000|Part B Participants|Overall Study||0
11286895|NCT02451930|12483961|FG001|Part B Participants|Overall Study||55
11286896|NCT02451930|12483960|FG000|Part C Participants|Overall Study||0
11286897|NCT02451930|12483961|FG001|Part C Participants|Overall Study||7
11286898|NCT02451930|12483960|FG000|COMPLETED|Overall Study||1
11286899|NCT02451930|12483961|FG001|COMPLETED|Overall Study||38
11286900|NCT02451930|12483960|FG000|NOT COMPLETED|Overall Study||2
11286901|NCT02451930|12483961|FG001|NOT COMPLETED|Overall Study||30
11286902|NCT02451995|12483979|FG000|STARTED|Overall Study||42
11286903|NCT02451995|12483980|FG001|STARTED|Overall Study||41
11286904|NCT02451995|12483979|FG000|COMPLETED|Overall Study||42
11286905|NCT02451995|12483980|FG001|COMPLETED|Overall Study||41
11286906|NCT02451995|12483979|FG000|NOT COMPLETED|Overall Study||0
11286907|NCT02451995|12483980|FG001|NOT COMPLETED|Overall Study||0
11286908|NCT02452034|12483992|FG000|STARTED|Overall Study||16
11286909|NCT02452034|12483993|FG001|STARTED|Overall Study||21
11286910|NCT02452034|12483994|FG002|STARTED|Overall Study||15
11286911|NCT02452034|12483995|FG003|STARTED|Overall Study||17
11286912|NCT02452034|12483996|FG004|STARTED|Overall Study||20
11286913|NCT02452034|12483997|FG005|STARTED|Overall Study||29
11286914|NCT02452034|12483992|FG000|Treated|Overall Study||14
11286915|NCT02452034|12483993|FG001|Treated|Overall Study||21
11286916|NCT02452034|12483994|FG002|Treated|Overall Study||15
11286917|NCT02452034|12483995|FG003|Treated|Overall Study||16
11286918|NCT02452034|12483996|FG004|Treated|Overall Study||20
11286919|NCT02452034|12483997|FG005|Treated|Overall Study||29
11286920|NCT02452034|12483992|FG000|COMPLETED|Overall Study||14
11286921|NCT02452034|12483993|FG001|COMPLETED|Overall Study||20
11286922|NCT02452034|12483994|FG002|COMPLETED|Overall Study||14
11286923|NCT02452034|12483995|FG003|COMPLETED|Overall Study||16
11286924|NCT02452034|12483996|FG004|COMPLETED|Overall Study||19
11286925|NCT02452034|12483997|FG005|COMPLETED|Overall Study||26
11286926|NCT02452034|12483992|FG000|NOT COMPLETED|Overall Study||2
11286927|NCT02452034|12483993|FG001|NOT COMPLETED|Overall Study||1
11286928|NCT02452034|12483994|FG002|NOT COMPLETED|Overall Study||1
11286929|NCT02452034|12483995|FG003|NOT COMPLETED|Overall Study||1
11286930|NCT02452034|12483996|FG004|NOT COMPLETED|Overall Study||1
11286931|NCT02452034|12483997|FG005|NOT COMPLETED|Overall Study||3
11286932|NCT02452047|12484014|FG000|STARTED|Overall Study||31
11286933|NCT02452047|12484015|FG001|STARTED|Overall Study||16
11286934|NCT02452047|12484016|FG002|STARTED|Overall Study||3
11286935|NCT02452047|12484014|FG000|COMPLETED|Overall Study||27
11286936|NCT02452047|12484015|FG001|COMPLETED|Overall Study||11
11286937|NCT02452047|12484016|FG002|COMPLETED|Overall Study||1
11286938|NCT02452047|12484014|FG000|NOT COMPLETED|Overall Study||4
11286939|NCT02452047|12484015|FG001|NOT COMPLETED|Overall Study||5
11286940|NCT02452047|12484016|FG002|NOT COMPLETED|Overall Study||2
11286941|NCT02452060|12484026|FG000|STARTED|Overall Study||46
11286942|NCT02452060|12484027|FG001|STARTED|Overall Study||44
11286943|NCT02452060|12484026|FG000|COMPLETED|Overall Study||46
11286944|NCT02452060|12484027|FG001|COMPLETED|Overall Study||44
11286945|NCT02452060|12484026|FG000|NOT COMPLETED|Overall Study||0
11286946|NCT02452060|12484027|FG001|NOT COMPLETED|Overall Study||0
11286947|NCT02452190|12484035|FG000|STARTED|Overall Study||232
11286948|NCT02452190|12484036|FG001|STARTED|Overall Study||236
11286949|NCT02452190|12484035|FG000|Intent to Treat (ITT) Population|Overall Study||230
11286950|NCT02452190|12484036|FG001|Intent to Treat (ITT) Population|Overall Study||234
11286951|NCT02452190|12484035|FG000|Safety Population|Overall Study||231
11286952|NCT02452190|12484036|FG001|Safety Population|Overall Study||237
11286953|NCT02452190|12484035|FG000|COMPLETED|Overall Study||197
11286954|NCT02452190|12484036|FG001|COMPLETED|Overall Study||212
11286955|NCT02452190|12484035|FG000|NOT COMPLETED|Overall Study||35
11286956|NCT02452190|12484036|FG001|NOT COMPLETED|Overall Study||24
11286957|NCT02452320|12484044|FG000|STARTED|Overall Study||64
11286958|NCT02452320|12484045|FG001|STARTED|Overall Study||64
11286959|NCT02452320|12484044|FG000|COMPLETED|Overall Study||64
11286960|NCT02452320|12484045|FG001|COMPLETED|Overall Study||63
11286961|NCT02452320|12484044|FG000|NOT COMPLETED|Overall Study||0
11286962|NCT02452320|12484045|FG001|NOT COMPLETED|Overall Study||1
11286963|NCT02452346|12484051|FG000|STARTED|Overall Study||12
11286964|NCT02452346|12484051|FG000|COMPLETED|Overall Study||3
11286965|NCT02452346|12484051|FG000|NOT COMPLETED|Overall Study||9
11286966|NCT02452424|12484066|FG000|STARTED|Overall Study||4
11286967|NCT02452424|12484067|FG001|STARTED|Overall Study||3
11286968|NCT02452424|12484068|FG002|STARTED|Overall Study||7
11286969|NCT02452424|12484069|FG003|STARTED|Overall Study||9
11286970|NCT02452424|12484070|FG004|STARTED|Overall Study||4
11286971|NCT02452424|12484071|FG005|STARTED|Overall Study||6
11286972|NCT02452424|12484072|FG006|STARTED|Overall Study||13
11286973|NCT02452424|12484073|FG007|STARTED|Overall Study||8
11286974|NCT02452424|12484074|FG008|STARTED|Overall Study||15
11286975|NCT02452424|12484075|FG009|STARTED|Overall Study||3
11286976|NCT02452424|12484076|FG010|STARTED|Overall Study||6
11286977|NCT02452424|12484066|FG000|COMPLETED|Overall Study||2
11286978|NCT02452424|12484067|FG001|COMPLETED|Overall Study||0
11286979|NCT02452424|12484068|FG002|COMPLETED|Overall Study||0
11286980|NCT02452424|12484069|FG003|COMPLETED|Overall Study||1
11286981|NCT02452424|12484070|FG004|COMPLETED|Overall Study||2
11286982|NCT02452424|12484071|FG005|COMPLETED|Overall Study||5
11286983|NCT02452424|12484072|FG006|COMPLETED|Overall Study||3
11286984|NCT02452424|12484073|FG007|COMPLETED|Overall Study||4
11286985|NCT02452424|12484074|FG008|COMPLETED|Overall Study||9
11286986|NCT02452424|12484075|FG009|COMPLETED|Overall Study||1
11286987|NCT02452424|12484076|FG010|COMPLETED|Overall Study||4
11286988|NCT02452424|12484066|FG000|NOT COMPLETED|Overall Study||2
11286989|NCT02452424|12484067|FG001|NOT COMPLETED|Overall Study||3
11286990|NCT02452424|12484068|FG002|NOT COMPLETED|Overall Study||7
11286991|NCT02452424|12484069|FG003|NOT COMPLETED|Overall Study||8
11286992|NCT02452424|12484070|FG004|NOT COMPLETED|Overall Study||2
11286993|NCT02452424|12484071|FG005|NOT COMPLETED|Overall Study||1
11286994|NCT02452424|12484072|FG006|NOT COMPLETED|Overall Study||10
11286995|NCT02452424|12484073|FG007|NOT COMPLETED|Overall Study||4
11286996|NCT02452424|12484074|FG008|NOT COMPLETED|Overall Study||6
11286997|NCT02452424|12484075|FG009|NOT COMPLETED|Overall Study||2
11286998|NCT02452424|12484076|FG010|NOT COMPLETED|Overall Study||2
11286999|NCT02452463|12484105|FG000|STARTED|Overall Study||5
11287000|NCT02452463|12484106|FG001|STARTED|Overall Study||3
11287001|NCT02452463|12484107|FG002|STARTED|Overall Study|"No participants were enrolled in the Arm III (Nintedanib, Durvalumab) Arm."|0
11287002|NCT02452463|12484105|FG000|COMPLETED|Overall Study||3
11287003|NCT02452463|12484106|FG001|COMPLETED|Overall Study||1
11287004|NCT02452463|12484107|FG002|COMPLETED|Overall Study||0
11287005|NCT02452463|12484105|FG000|NOT COMPLETED|Overall Study||2
11287006|NCT02452463|12484106|FG001|NOT COMPLETED|Overall Study||2
11287007|NCT02452463|12484107|FG002|NOT COMPLETED|Overall Study||0
11340962|NCT02927366|12538303|FG000|NOT COMPLETED|Overall Study||2
11340963|NCT02927366|12538304|FG001|NOT COMPLETED|Overall Study||0
11340964|NCT02927431|12538313|FG000|STARTED|Overall Study||2
11340965|NCT02927431|12538314|FG001|STARTED|Overall Study||4
11340966|NCT02927431|12538315|FG002|STARTED|Overall Study||4
11340967|NCT02927431|12538313|FG000|COMPLETED|Overall Study||2
11340968|NCT02927431|12538314|FG001|COMPLETED|Overall Study||4
11340969|NCT02927431|12538315|FG002|COMPLETED|Overall Study||3
11340970|NCT02927431|12538313|FG000|NOT COMPLETED|Overall Study||0
11340971|NCT02927431|12538314|FG001|NOT COMPLETED|Overall Study||0
11340972|NCT02927431|12538315|FG002|NOT COMPLETED|Overall Study||1
11340973|NCT02927457|12538327|FG000|STARTED|Overall Study||0
11340974|NCT02927457|12538328|FG001|STARTED|Overall Study||11
11340975|NCT02927457|12538327|FG000|COMPLETED|Overall Study||0
11340976|NCT02927457|12538328|FG001|COMPLETED|Overall Study||11
11340977|NCT02927457|12538327|FG000|NOT COMPLETED|Overall Study||0
11340978|NCT02927457|12538328|FG001|NOT COMPLETED|Overall Study||0
11340979|NCT02927639|12538340|FG000|STARTED|Overall Study||83
11340980|NCT02927639|12538341|FG001|STARTED|Overall Study|1 subj was inadvertently enrolled in another interventional study just before enrolling so removed.|82
11340981|NCT02927639|12538340|FG000|COMPLETED|Overall Study||10
11340982|NCT02927639|12538341|FG001|COMPLETED|Overall Study||13
11340983|NCT02927639|12538340|FG000|NOT COMPLETED|Overall Study||73
11287008|NCT02452476|12484117|FG000|STARTED|Overall Study||64
11287009|NCT02452476|12484118|FG001|STARTED|Overall Study||59
11287010|NCT02452476|12484117|FG000|COMPLETED|Overall Study||53
11287011|NCT02452476|12484118|FG001|COMPLETED|Overall Study||49
11287012|NCT02452476|12484117|FG000|NOT COMPLETED|Overall Study||11
11287013|NCT02452476|12484118|FG001|NOT COMPLETED|Overall Study||10
11287014|NCT02452528|12484126|FG000|STARTED|Overall Study||2
11287015|NCT02452528|12484127|FG001|STARTED|Overall Study||2
11287016|NCT02452528|12484126|FG000|COMPLETED|Overall Study||1
11287017|NCT02452528|12484127|FG001|COMPLETED|Overall Study||1
11287018|NCT02452528|12484126|FG000|NOT COMPLETED|Overall Study||1
11287019|NCT02452528|12484127|FG001|NOT COMPLETED|Overall Study||1
11287020|NCT02452762|12484135|FG000|STARTED|Overall Study||45
11287021|NCT02452762|12484136|FG001|STARTED|Overall Study||22
11287022|NCT02452762|12484135|FG000|COMPLETED|Overall Study||40
11287023|NCT02452762|12484136|FG001|COMPLETED|Overall Study||19
11287024|NCT02452762|12484135|FG000|NOT COMPLETED|Overall Study||5
11287025|NCT02452762|12484136|FG001|NOT COMPLETED|Overall Study||3
11287026|NCT02452866|12484143|FG000|STARTED|Overall Study||325
11287027|NCT02452866|12484143|FG000|COMPLETED|Overall Study||321
11287028|NCT02452866|12484143|FG000|NOT COMPLETED|Overall Study||4
11287029|NCT02452892|12484151|FG000|STARTED|Week 1 Initial Randommization||41
11399418|NCT04333199|12594005|FG002|STARTED|Emailed Patients||1669
11399419|NCT04333199|12594003|FG000|Valid Email Address|Emailed Patients|Patients in this group were not emailed|0
11399420|NCT04333199|12594004|FG001|Valid Email Address|Emailed Patients||1495
11399421|NCT04333199|12594005|FG002|Valid Email Address|Emailed Patients||1441
11399422|NCT04333199|12594003|FG000|COMPLETED|Emailed Patients|Patients in this group were not emailed|0
11399423|NCT04333199|12594004|FG001|COMPLETED|Emailed Patients||1399
11399424|NCT04333199|12594005|FG002|COMPLETED|Emailed Patients||1351
11399425|NCT04333199|12594003|FG000|NOT COMPLETED|Emailed Patients||0
11287030|NCT02452892|12484152|FG001|STARTED|Week 1 Initial Randommization||40
11287031|NCT02452892|12484153|FG002|STARTED|Week 1 Initial Randommization||41
11287032|NCT02452892|12484154|FG003|STARTED|Week 1 Initial Randommization||0
11287033|NCT02452892|12484151|FG000|COMPLETED|Week 1 Initial Randommization||40
11287034|NCT02452892|12484152|FG001|COMPLETED|Week 1 Initial Randommization||40
11287035|NCT02452892|12484153|FG002|COMPLETED|Week 1 Initial Randommization||40
11287036|NCT02452892|12484154|FG003|COMPLETED|Week 1 Initial Randommization||0
11287037|NCT02452892|12484151|FG000|NOT COMPLETED|Week 1 Initial Randommization||1
11287038|NCT02452892|12484152|FG001|NOT COMPLETED|Week 1 Initial Randommization||0
11287039|NCT02452892|12484153|FG002|NOT COMPLETED|Week 1 Initial Randommization||1
11287040|NCT02452892|12484154|FG003|NOT COMPLETED|Week 1 Initial Randommization||0
11287041|NCT02452892|12484151|FG000|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
11287042|NCT02452892|12484152|FG001|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
11287043|NCT02452892|12484153|FG002|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
11287044|NCT02452892|12484154|FG003|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
11287045|NCT02452892|12484151|FG000|Non-reponders|Week 2 Stratification & Re-Randomization||38
11287046|NCT02452892|12484152|FG001|Non-reponders|Week 2 Stratification & Re-Randomization||0
11287047|NCT02452892|12484153|FG002|Non-reponders|Week 2 Stratification & Re-Randomization||0
11287048|NCT02452892|12484154|FG003|Non-reponders|Week 2 Stratification & Re-Randomization||41
11287049|NCT02452892|12484151|FG000|Responders|Week 2 Stratification & Re-Randomization||27
11287050|NCT02452892|12484152|FG001|Responders|Week 2 Stratification & Re-Randomization||7
11287051|NCT02452892|12484153|FG002|Responders|Week 2 Stratification & Re-Randomization||7
11287052|NCT02452892|12484154|FG003|Responders|Week 2 Stratification & Re-Randomization||0
11287053|NCT02452892|12484151|FG000|COMPLETED|Week 2 Stratification & Re-Randomization||63
11287054|NCT02452892|12484152|FG001|COMPLETED|Week 2 Stratification & Re-Randomization||7
11287055|NCT02452892|12484153|FG002|COMPLETED|Week 2 Stratification & Re-Randomization||7
11287056|NCT02452892|12484154|FG003|COMPLETED|Week 2 Stratification & Re-Randomization||39
11287057|NCT02452892|12484151|FG000|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
11287058|NCT02452892|12484152|FG001|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
11287059|NCT02452892|12484153|FG002|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
11287060|NCT02452892|12484154|FG003|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
11287061|NCT02452892|12484151|FG000|STARTED|Follow-up||63
11287062|NCT02452892|12484152|FG001|STARTED|Follow-up||7
11287063|NCT02452892|12484153|FG002|STARTED|Follow-up||7
11287064|NCT02452892|12484154|FG003|STARTED|Follow-up||39
11287065|NCT02452892|12484151|FG000|COMPLETED|Follow-up||62
11287066|NCT02452892|12484152|FG001|COMPLETED|Follow-up||7
11287067|NCT02452892|12484153|FG002|COMPLETED|Follow-up||7
11287068|NCT02452892|12484154|FG003|COMPLETED|Follow-up||38
11287069|NCT02452892|12484151|FG000|NOT COMPLETED|Follow-up||1
11287070|NCT02452892|12484152|FG001|NOT COMPLETED|Follow-up||0
11287071|NCT02452892|12484153|FG002|NOT COMPLETED|Follow-up||0
11287072|NCT02452892|12484154|FG003|NOT COMPLETED|Follow-up||1
11287073|NCT02452931|12484167|FG000|STARTED|Overall Study||64
11287074|NCT02452931|12484167|FG000|COMPLETED|Overall Study||60
11287075|NCT02452931|12484167|FG000|NOT COMPLETED|Overall Study||4
11287076|NCT02452944|12484173|FG000|STARTED|Overall Study||31
11287077|NCT02452944|12484174|FG001|STARTED|Overall Study||31
11287078|NCT02452944|12484173|FG000|COMPLETED|Overall Study||31
11287079|NCT02452944|12484174|FG001|COMPLETED|Overall Study||31
11287080|NCT02452944|12484173|FG000|NOT COMPLETED|Overall Study||0
11287081|NCT02452944|12484174|FG001|NOT COMPLETED|Overall Study||0
11287082|NCT02453048|12484187|FG000|STARTED|Overall Study||12
11287083|NCT02453048|12484188|FG001|STARTED|Overall Study||12
11287084|NCT02453048|12484189|FG002|STARTED|Overall Study||12
11287085|NCT02453048|12484190|FG003|STARTED|Overall Study||12
11287086|NCT02453048|12484191|FG004|STARTED|Overall Study||6
11287087|NCT02453048|12484187|FG000|6-month Follow-up|Overall Study||12
11287088|NCT02453048|12484188|FG001|6-month Follow-up|Overall Study||12
11287089|NCT02453048|12484189|FG002|6-month Follow-up|Overall Study||12
11287090|NCT02453048|12484190|FG003|6-month Follow-up|Overall Study||12
11287091|NCT02453048|12484191|FG004|6-month Follow-up|Overall Study||6
11287092|NCT02453048|12484187|FG000|COMPLETED|Overall Study||12
11287093|NCT02453048|12484188|FG001|COMPLETED|Overall Study||11
11287094|NCT02453048|12484189|FG002|COMPLETED|Overall Study||10
11287095|NCT02453048|12484190|FG003|COMPLETED|Overall Study||12
11287096|NCT02453048|12484191|FG004|COMPLETED|Overall Study||0
11287097|NCT02453048|12484187|FG000|NOT COMPLETED|Overall Study||0
11287098|NCT02453048|12484188|FG001|NOT COMPLETED|Overall Study||1
11287099|NCT02453048|12484189|FG002|NOT COMPLETED|Overall Study||2
11287100|NCT02453048|12484190|FG003|NOT COMPLETED|Overall Study||0
11287101|NCT02453048|12484191|FG004|NOT COMPLETED|Overall Study||6
11287102|NCT02453113|12484203|FG000|STARTED|Overall Study||10
11287103|NCT02453113|12484203|FG000|COMPLETED|Overall Study||10
11287104|NCT02453113|12484203|FG000|NOT COMPLETED|Overall Study||0
11287105|NCT02453191|12484207|FG000|STARTED|Overall Study||30
11287106|NCT02453191|12484207|FG000|COMPLETED|Overall Study||29
11287107|NCT02453191|12484207|FG000|NOT COMPLETED|Overall Study||1
11287108|NCT02453256|12484213|FG000|STARTED|Double Blind Period||106
11287109|NCT02453256|12484214|FG001|STARTED|Double Blind Period||104
11287110|NCT02453256|12484213|FG000|COMPLETED|Double Blind Period||93
11287111|NCT02453256|12484214|FG001|COMPLETED|Double Blind Period||95
11287112|NCT02453256|12484213|FG000|NOT COMPLETED|Double Blind Period||13
11287113|NCT02453256|12484214|FG001|NOT COMPLETED|Double Blind Period||9
11287114|NCT02453256|12484213|FG000|STARTED|Open Label Period||89
11287115|NCT02453256|12484214|FG001|STARTED|Open Label Period||92
11287116|NCT02453256|12484213|FG000|COMPLETED|Open Label Period||82
11287117|NCT02453256|12484214|FG001|COMPLETED|Open Label Period||85
11287118|NCT02453256|12484213|FG000|NOT COMPLETED|Open Label Period||7
11287119|NCT02453256|12484214|FG001|NOT COMPLETED|Open Label Period||7
11287120|NCT02453321|12484230|FG000|STARTED|Overall Study||20
11287121|NCT02453321|12484231|FG001|STARTED|Overall Study||21
11287122|NCT02453321|12484232|FG002|STARTED|Overall Study||21
11287123|NCT02453321|12484230|FG000|COMPLETED|Overall Study||19
11287124|NCT02453321|12484231|FG001|COMPLETED|Overall Study||19
11287125|NCT02453321|12484232|FG002|COMPLETED|Overall Study||19
11287126|NCT02453321|12484230|FG000|NOT COMPLETED|Overall Study||1
11287127|NCT02453321|12484231|FG001|NOT COMPLETED|Overall Study||2
11287128|NCT02453321|12484232|FG002|NOT COMPLETED|Overall Study||2
11287129|NCT02453334|12484245|FG000|STARTED|Overall Study||122
11287130|NCT02453334|12484246|FG001|STARTED|Overall Study||122
11287131|NCT02453334|12484245|FG000|COMPLETED|Overall Study||81
11287132|NCT02453334|12484246|FG001|COMPLETED|Overall Study||82
11287133|NCT02453334|12484245|FG000|NOT COMPLETED|Overall Study||41
11287134|NCT02453334|12484246|FG001|NOT COMPLETED|Overall Study||40
11287135|NCT02453347|12484252|FG000|STARTED|Overall Study||6
11287136|NCT02453347|12484252|FG000|COMPLETED|Overall Study||6
11287137|NCT02453347|12484252|FG000|NOT COMPLETED|Overall Study||0
11287138|NCT02453360|12484259|FG000|STARTED|Overall Study||20
11287139|NCT02453360|12484260|FG001|STARTED|Overall Study||20
11287140|NCT02453360|12484261|FG002|STARTED|Overall Study||20
11287141|NCT02453360|12484259|FG000|COMPLETED|Overall Study||20
11287142|NCT02453360|12484260|FG001|COMPLETED|Overall Study||20
11143781|NCT01474512|12330430|FG008|NOT COMPLETED|Long-Term Extension Period||0
11143782|NCT01474512|12330431|FG009|NOT COMPLETED|Long-Term Extension Period||0
11143783|NCT01474512|12330432|FG010|NOT COMPLETED|Long-Term Extension Period||0
11143784|NCT01474512|12330433|FG011|NOT COMPLETED|Long-Term Extension Period||26
11143785|NCT01474512|12330434|FG012|NOT COMPLETED|Long-Term Extension Period||218
11143786|NCT01474512|12330435|FG013|NOT COMPLETED|Long-Term Extension Period||220
11143787|NCT01474512|12330436|FG014|NOT COMPLETED|Long-Term Extension Period||0
11143788|NCT01474512|12330437|FG015|NOT COMPLETED|Long-Term Extension Period||0
11143789|NCT01474512|12330438|FG016|NOT COMPLETED|Long-Term Extension Period||0
11143790|NCT01474512|12330439|FG017|NOT COMPLETED|Long-Term Extension Period||0
11287143|NCT02453360|12484261|FG002|COMPLETED|Overall Study||20
11287144|NCT02453360|12484259|FG000|NOT COMPLETED|Overall Study||0
11287145|NCT02453360|12484260|FG001|NOT COMPLETED|Overall Study||0
11287146|NCT02453360|12484261|FG002|NOT COMPLETED|Overall Study||0
11287147|NCT02453386|12484272|FG000|STARTED|Overall Study||151
11287148|NCT02453386|12484273|FG001|STARTED|Overall Study||149
11143791|NCT01474512|12330422|FG000|STARTED|Post-Treatment Follow-Up||0
11143792|NCT01474512|12330423|FG001|STARTED|Post-Treatment Follow-Up||0
11287149|NCT02453386|12484274|FG002|STARTED|Overall Study||149
11287150|NCT02453386|12484272|FG000|COMPLETED|Overall Study||102
11287151|NCT02453386|12484273|FG001|COMPLETED|Overall Study||100
11287152|NCT02453386|12484274|FG002|COMPLETED|Overall Study||108
11287153|NCT02453386|12484272|FG000|NOT COMPLETED|Overall Study||49
11287154|NCT02453386|12484273|FG001|NOT COMPLETED|Overall Study||49
11287155|NCT02453386|12484274|FG002|NOT COMPLETED|Overall Study||41
11287156|NCT02453555|12484291|FG000|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182
11287157|NCT02453555|12484292|FG001|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93
11287158|NCT02453555|12484293|FG002|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
11287159|NCT02453555|12484294|FG003|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
11287160|NCT02453555|12484295|FG004|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
11287161|NCT02453555|12484296|FG005|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
11287162|NCT02453555|12484291|FG000|COMPLETED|24-week Double-blind Treatment Period||177
11287163|NCT02453555|12484292|FG001|COMPLETED|24-week Double-blind Treatment Period||86
11287164|NCT02453555|12484293|FG002|COMPLETED|24-week Double-blind Treatment Period||0
11287165|NCT02453555|12484294|FG003|COMPLETED|24-week Double-blind Treatment Period||0
11287166|NCT02453555|12484295|FG004|COMPLETED|24-week Double-blind Treatment Period||0
11287167|NCT02453555|12484296|FG005|COMPLETED|24-week Double-blind Treatment Period||0
11287168|NCT02453555|12484291|FG000|NOT COMPLETED|24-week Double-blind Treatment Period||5
11287169|NCT02453555|12484292|FG001|NOT COMPLETED|24-week Double-blind Treatment Period||7
11287170|NCT02453555|12484293|FG002|NOT COMPLETED|24-week Double-blind Treatment Period||0
11287171|NCT02453555|12484294|FG003|NOT COMPLETED|24-week Double-blind Treatment Period||0
11287172|NCT02453555|12484295|FG004|NOT COMPLETED|24-week Double-blind Treatment Period||0
11287173|NCT02453555|12484296|FG005|NOT COMPLETED|24-week Double-blind Treatment Period||0
11287174|NCT02453555|12484291|FG000|STARTED|Extension Period|This reporting group is not applicable in this period.|0
11287175|NCT02453555|12484292|FG001|STARTED|Extension Period|This reporting group is not applicable in this period.|0
11287176|NCT02453555|12484293|FG002|STARTED|Extension Period||126
11287177|NCT02453555|12484294|FG003|STARTED|Extension Period||51
11287178|NCT02453555|12484295|FG004|STARTED|Extension Period||80
11287179|NCT02453555|12484296|FG005|STARTED|Extension Period||6
11287180|NCT02453555|12484291|FG000|COMPLETED|Extension Period||0
11287181|NCT02453555|12484292|FG001|COMPLETED|Extension Period||0
11287182|NCT02453555|12484293|FG002|COMPLETED|Extension Period||123
11287183|NCT02453555|12484294|FG003|COMPLETED|Extension Period||49
11287184|NCT02453555|12484295|FG004|COMPLETED|Extension Period||79
11287185|NCT02453555|12484296|FG005|COMPLETED|Extension Period||5
11287186|NCT02453555|12484291|FG000|NOT COMPLETED|Extension Period||0
11287187|NCT02453555|12484292|FG001|NOT COMPLETED|Extension Period||0
11287188|NCT02453555|12484293|FG002|NOT COMPLETED|Extension Period||3
11287189|NCT02453555|12484294|FG003|NOT COMPLETED|Extension Period||2
11287190|NCT02453555|12484295|FG004|NOT COMPLETED|Extension Period||1
11287191|NCT02453555|12484296|FG005|NOT COMPLETED|Extension Period||1
11287192|NCT02453581|12484306|FG000|STARTED|Overall Study||8
11287193|NCT02453581|12484307|FG001|STARTED|Overall Study||8
11287194|NCT02453581|12484308|FG002|STARTED|Overall Study||8
11287195|NCT02453581|12484306|FG000|COMPLETED|Overall Study||8
11287196|NCT02453581|12484307|FG001|COMPLETED|Overall Study||8
11287197|NCT02453581|12484308|FG002|COMPLETED|Overall Study||8
11287198|NCT02453581|12484306|FG000|NOT COMPLETED|Overall Study||0
11287199|NCT02453581|12484307|FG001|NOT COMPLETED|Overall Study||0
11287200|NCT02453581|12484308|FG002|NOT COMPLETED|Overall Study||0
11287201|NCT02453672|12484328|FG000|STARTED|Overall Study||40
11287202|NCT02453672|12484329|FG001|STARTED|Overall Study||40
11287203|NCT02453672|12484330|FG002|STARTED|Overall Study||39
11287204|NCT02453672|12484328|FG000|COMPLETED|Overall Study||37
11287205|NCT02453672|12484329|FG001|COMPLETED|Overall Study||38
11287206|NCT02453672|12484330|FG002|COMPLETED|Overall Study||38
11287207|NCT02453672|12484328|FG000|NOT COMPLETED|Overall Study||3
11287208|NCT02453672|12484329|FG001|NOT COMPLETED|Overall Study||2
11287209|NCT02453672|12484330|FG002|NOT COMPLETED|Overall Study||1
11287210|NCT02453685|12484340|FG000|STARTED|Overall Study||168
11287211|NCT02453685|12484341|FG001|STARTED|Overall Study||167
11287212|NCT02453685|12484340|FG000|Exposed|Overall Study||166
11287213|NCT02453685|12484341|FG001|Exposed|Overall Study||166
11287214|NCT02453685|12484340|FG000|COMPLETED|Overall Study||149
11287215|NCT02453685|12484341|FG001|COMPLETED|Overall Study||155
11287216|NCT02453685|12484340|FG000|NOT COMPLETED|Overall Study||19
11287217|NCT02453685|12484341|FG001|NOT COMPLETED|Overall Study||12
11287218|NCT02453711|12484356|FG000|STARTED|Overall Study||103
11287219|NCT02453711|12484357|FG001|STARTED|Overall Study||102
11287220|NCT02453711|12484358|FG002|STARTED|Overall Study||103
11287221|NCT02453711|12484359|FG003|STARTED|Overall Study||103
11287222|NCT02453711|12484360|FG004|STARTED|Overall Study||102
11287223|NCT02453711|12484361|FG005|STARTED|Overall Study||102
11287224|NCT02453711|12484362|FG006|STARTED|Overall Study||103
11287225|NCT02453711|12484363|FG007|STARTED|Overall Study||103
11287226|NCT02453711|12484364|FG008|STARTED|Overall Study||136
11287227|NCT02453711|12484356|FG000|Full Analysis Set|Overall Study||103
11287228|NCT02453711|12484357|FG001|Full Analysis Set|Overall Study||102
11287229|NCT02453711|12484358|FG002|Full Analysis Set|Overall Study||103
11287230|NCT02453711|12484359|FG003|Full Analysis Set|Overall Study||103
11287231|NCT02453711|12484360|FG004|Full Analysis Set|Overall Study||102
11287232|NCT02453711|12484361|FG005|Full Analysis Set|Overall Study||102
11287233|NCT02453711|12484362|FG006|Full Analysis Set|Overall Study||103
11287234|NCT02453711|12484363|FG007|Full Analysis Set|Overall Study||103
11287235|NCT02453711|12484364|FG008|Full Analysis Set|Overall Study||136
11287236|NCT02453711|12484356|FG000|Safety Analysis Set|Overall Study||103
11287237|NCT02453711|12484357|FG001|Safety Analysis Set|Overall Study||102
11287238|NCT02453711|12484358|FG002|Safety Analysis Set|Overall Study||103
11287239|NCT02453711|12484359|FG003|Safety Analysis Set|Overall Study||103
11287240|NCT02453711|12484360|FG004|Safety Analysis Set|Overall Study||102
11287241|NCT02453711|12484361|FG005|Safety Analysis Set|Overall Study||102
11287242|NCT02453711|12484362|FG006|Safety Analysis Set|Overall Study||103
11287243|NCT02453711|12484363|FG007|Safety Analysis Set|Overall Study||103
11287244|NCT02453711|12484364|FG008|Safety Analysis Set|Overall Study||136
11287245|NCT02453711|12484356|FG000|COMPLETED|Overall Study||92
11287246|NCT02453711|12484357|FG001|COMPLETED|Overall Study||95
11287247|NCT02453711|12484358|FG002|COMPLETED|Overall Study||94
11287248|NCT02453711|12484359|FG003|COMPLETED|Overall Study||96
11287249|NCT02453711|12484360|FG004|COMPLETED|Overall Study||100
11287250|NCT02453711|12484361|FG005|COMPLETED|Overall Study||96
11287251|NCT02453711|12484362|FG006|COMPLETED|Overall Study||100
11287252|NCT02453711|12484363|FG007|COMPLETED|Overall Study||96
11287253|NCT02453711|12484364|FG008|COMPLETED|Overall Study||123
11287254|NCT02453711|12484356|FG000|NOT COMPLETED|Overall Study||11
11287255|NCT02453711|12484357|FG001|NOT COMPLETED|Overall Study||7
11287256|NCT02453711|12484358|FG002|NOT COMPLETED|Overall Study||9
11287257|NCT02453711|12484359|FG003|NOT COMPLETED|Overall Study||7
11287258|NCT02453711|12484360|FG004|NOT COMPLETED|Overall Study||2
11287259|NCT02453711|12484361|FG005|NOT COMPLETED|Overall Study||6
11287260|NCT02453711|12484362|FG006|NOT COMPLETED|Overall Study||3
11287261|NCT02453711|12484363|FG007|NOT COMPLETED|Overall Study||7
11287262|NCT02453711|12484364|FG008|NOT COMPLETED|Overall Study||13
11287263|NCT02453750|12484384|FG000|STARTED|Overall Study||21
11287264|NCT02453750|12484384|FG000|COMPLETED|Overall Study||21
11287265|NCT02453750|12484384|FG000|NOT COMPLETED|Overall Study||0
11287266|NCT02453841|12484391|FG000|STARTED|Overall Study||30
11287267|NCT02453841|12484391|FG000|COMPLETED|Overall Study||27
11287268|NCT02453841|12484391|FG000|NOT COMPLETED|Overall Study||3
11287269|NCT02454075|12484395|FG000|STARTED|Overall Study||3
11287270|NCT02454075|12484395|FG000|COMPLETED|Overall Study||3
11287271|NCT02454075|12484395|FG000|NOT COMPLETED|Overall Study||0
11287272|NCT02454101|12484403|FG000|STARTED|Overall Study||150
11287273|NCT02454101|12484404|FG001|STARTED|Overall Study||150
11287274|NCT02454101|12484403|FG000|COMPLETED|Overall Study||145
11287275|NCT02454101|12484404|FG001|COMPLETED|Overall Study||143
11287276|NCT02454101|12484403|FG000|NOT COMPLETED|Overall Study||5
11287277|NCT02454101|12484404|FG001|NOT COMPLETED|Overall Study||7
11287278|NCT02454127|12484414|FG000|STARTED|Overall Study||40
11287279|NCT02454127|12484415|FG001|STARTED|Overall Study||40
11287280|NCT02454127|12484416|FG002|STARTED|Overall Study||40
11287281|NCT02454127|12484417|FG003|STARTED|Overall Study||40
11287282|NCT02454127|12484414|FG000|COMPLETED|Overall Study||21
11287283|NCT02454127|12484415|FG001|COMPLETED|Overall Study||26
11287284|NCT02454127|12484416|FG002|COMPLETED|Overall Study||26
11287285|NCT02454127|12484417|FG003|COMPLETED|Overall Study||20
11287286|NCT02454127|12484414|FG000|NOT COMPLETED|Overall Study||19
11287287|NCT02454127|12484415|FG001|NOT COMPLETED|Overall Study||14
11287288|NCT02454127|12484416|FG002|NOT COMPLETED|Overall Study||14
11287289|NCT02454127|12484417|FG003|NOT COMPLETED|Overall Study||20
11287290|NCT02454153|12484429|FG000|STARTED|Overall Study||92
11287291|NCT02454153|12484430|FG001|STARTED|Overall Study||92
11287292|NCT02454153|12484429|FG000|COMPLETED|Overall Study||92
11287293|NCT02454153|12484430|FG001|COMPLETED|Overall Study||92
11287294|NCT02454153|12484429|FG000|NOT COMPLETED|Overall Study||0
11287295|NCT02454153|12484430|FG001|NOT COMPLETED|Overall Study||0
11287296|NCT02454179|12484439|FG000|STARTED|Overall Study||39
11287297|NCT02454179|12484440|FG001|STARTED|Overall Study||39
11287298|NCT02454179|12484439|FG000|Enrolled|Overall Study||39
11287299|NCT02454179|12484440|FG001|Enrolled|Overall Study||39
11287300|NCT02454179|12484439|FG000|Received Study Medication|Overall Study||39
11287301|NCT02454179|12484440|FG001|Received Study Medication|Overall Study||37
11287302|NCT02454179|12484439|FG000|Discontinue Study|Overall Study||39
11287303|NCT02454179|12484440|FG001|Discontinue Study|Overall Study||39
11287304|NCT02454179|12484439|FG000|COMPLETED|Overall Study||0
11287305|NCT02454179|12484440|FG001|COMPLETED|Overall Study||0
11287306|NCT02454179|12484439|FG000|NOT COMPLETED|Overall Study||39
11287307|NCT02454179|12484440|FG001|NOT COMPLETED|Overall Study||39
11287308|NCT02454283|12484448|FG000|STARTED|Overall Study||26
11287309|NCT02454283|12484449|FG001|STARTED|Overall Study||15
11287310|NCT02454283|12484448|FG000|COMPLETED|Overall Study||26
11287311|NCT02454283|12484449|FG001|COMPLETED|Overall Study||15
11287312|NCT02454283|12484448|FG000|NOT COMPLETED|Overall Study||0
11287313|NCT02454283|12484449|FG001|NOT COMPLETED|Overall Study||0
11287314|NCT02454296|12484457|FG000|STARTED|Overall Study||20
11287315|NCT02454296|12484458|FG001|STARTED|Overall Study||21
11287316|NCT02454296|12484457|FG000|COMPLETED|Overall Study||20
11287317|NCT02454296|12484458|FG001|COMPLETED|Overall Study||21
11287318|NCT02454296|12484457|FG000|NOT COMPLETED|Overall Study||0
11287319|NCT02454296|12484458|FG001|NOT COMPLETED|Overall Study||0
11287320|NCT02454478|12484466|FG000|STARTED|Overall Study||7
11287321|NCT02454478|12484466|FG000|COMPLETED|Overall Study||6
11287322|NCT02454478|12484466|FG000|NOT COMPLETED|Overall Study||1
11287323|NCT02454530|12484472|FG000|STARTED|Overall Study||552
11287324|NCT02454530|12484473|FG001|STARTED|Overall Study||608
11287325|NCT02454530|12484472|FG000|COMPLETED|Overall Study||482
11287326|NCT02454530|12484473|FG001|COMPLETED|Overall Study||481
11287327|NCT02454530|12484472|FG000|NOT COMPLETED|Overall Study||70
11287328|NCT02454530|12484473|FG001|NOT COMPLETED|Overall Study||127
11287329|NCT02454608|12484483|FG000|STARTED|Double-Blind Period||15
11287330|NCT02454608|12484484|FG001|STARTED|Double-Blind Period||14
11287331|NCT02454608|12484485|FG002|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
11287332|NCT02454608|12484483|FG000|COMPLETED|Double-Blind Period||15
11287333|NCT02454608|12484484|FG001|COMPLETED|Double-Blind Period||12
11287334|NCT02454608|12484485|FG002|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
11287335|NCT02454608|12484483|FG000|NOT COMPLETED|Double-Blind Period||0
11287336|NCT02454608|12484484|FG001|NOT COMPLETED|Double-Blind Period||2
11287337|NCT02454608|12484485|FG002|NOT COMPLETED|Double-Blind Period||0
11287338|NCT02454608|12484483|FG000|STARTED|Open Label Period|This arm is not part of this period of the study|0
11287339|NCT02454608|12484484|FG001|STARTED|Open Label Period|This arm is not part of this period of the study|0
11287340|NCT02454608|12484485|FG002|STARTED|Open Label Period||29
11287341|NCT02454608|12484483|FG000|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
11287342|NCT02454608|12484484|FG001|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
11287343|NCT02454608|12484485|FG002|COMPLETED|Open Label Period||10
11287344|NCT02454608|12484483|FG000|NOT COMPLETED|Open Label Period||0
11287345|NCT02454608|12484484|FG001|NOT COMPLETED|Open Label Period||0
11287346|NCT02454608|12484485|FG002|NOT COMPLETED|Open Label Period||19
11287347|NCT02454959|12484493|FG000|STARTED|Overall Study||79
11287348|NCT02454959|12484493|FG000|GFF MDI (PT003) With Aerochamber|Overall Study||73
11287349|NCT02454959|12484493|FG000|GFF MDI (PT003) Without Aerochamber|Overall Study||77
11287350|NCT02454959|12484493|FG000|COMPLETED|Overall Study||70
11287351|NCT02454959|12484493|FG000|NOT COMPLETED|Overall Study||9
11287352|NCT02454972|12484508|FG000|STARTED|Overall Study||19
11287353|NCT02454972|12484509|FG001|STARTED|Overall Study||19
11287354|NCT02454972|12484510|FG002|STARTED|Overall Study||76
11287355|NCT02454972|12484511|FG003|STARTED|Overall Study||29
11287356|NCT02454972|12484512|FG004|STARTED|Overall Study||24
11287357|NCT02454972|12484513|FG005|STARTED|Overall Study||15
11287358|NCT02454972|12484514|FG006|STARTED|Overall Study||21
11287359|NCT02454972|12484515|FG007|STARTED|Overall Study||32
11287360|NCT02454972|12484516|FG008|STARTED|Overall Study||110
11287361|NCT02454972|12484508|FG000|Treated|Overall Study||19
11287362|NCT02454972|12484509|FG001|Treated|Overall Study||19
11287363|NCT02454972|12484510|FG002|Treated|Overall Study||73
11287364|NCT02454972|12484511|FG003|Treated|Overall Study||28
11287365|NCT02454972|12484512|FG004|Treated|Overall Study||23
11287366|NCT02454972|12484513|FG005|Treated|Overall Study||15
11287367|NCT02454972|12484514|FG006|Treated|Overall Study||21
11287368|NCT02454972|12484515|FG007|Treated|Overall Study||32
11287369|NCT02454972|12484516|FG008|Treated|Overall Study||105
11287370|NCT02454972|12484508|FG000|COMPLETED|Overall Study||0
11287371|NCT02454972|12484509|FG001|COMPLETED|Overall Study||0
11287372|NCT02454972|12484510|FG002|COMPLETED|Overall Study||0
11287373|NCT02454972|12484511|FG003|COMPLETED|Overall Study||0
11287374|NCT02454972|12484512|FG004|COMPLETED|Overall Study||0
11287375|NCT02454972|12484513|FG005|COMPLETED|Overall Study||0
11287376|NCT02454972|12484514|FG006|COMPLETED|Overall Study||0
11287377|NCT02454972|12484515|FG007|COMPLETED|Overall Study||0
11287378|NCT02454972|12484516|FG008|COMPLETED|Overall Study||0
11287379|NCT02454972|12484508|FG000|NOT COMPLETED|Overall Study||19
11287380|NCT02454972|12484509|FG001|NOT COMPLETED|Overall Study||19
11287381|NCT02454972|12484510|FG002|NOT COMPLETED|Overall Study||76
11287382|NCT02454972|12484511|FG003|NOT COMPLETED|Overall Study||29
11287383|NCT02454972|12484512|FG004|NOT COMPLETED|Overall Study||24
11287384|NCT02454972|12484513|FG005|NOT COMPLETED|Overall Study||15
11287385|NCT02454972|12484514|FG006|NOT COMPLETED|Overall Study||21
11287386|NCT02454972|12484515|FG007|NOT COMPLETED|Overall Study||32
11287387|NCT02454972|12484516|FG008|NOT COMPLETED|Overall Study||110
11287388|NCT02455050|12484532|FG000|STARTED|Treatment Period 1||20
11287389|NCT02455050|12484533|FG001|STARTED|Treatment Period 1||19
11287390|NCT02455050|12484534|FG002|STARTED|Treatment Period 1||20
11287391|NCT02455050|12484535|FG003|STARTED|Treatment Period 1||20
11287392|NCT02455050|12484532|FG000|COMPLETED|Treatment Period 1||19
11287393|NCT02455050|12484533|FG001|COMPLETED|Treatment Period 1||18
11287394|NCT02455050|12484534|FG002|COMPLETED|Treatment Period 1||19
11287395|NCT02455050|12484535|FG003|COMPLETED|Treatment Period 1||18
11287396|NCT02455050|12484532|FG000|NOT COMPLETED|Treatment Period 1||1
11287397|NCT02455050|12484533|FG001|NOT COMPLETED|Treatment Period 1||1
11287398|NCT02455050|12484534|FG002|NOT COMPLETED|Treatment Period 1||1
11287399|NCT02455050|12484535|FG003|NOT COMPLETED|Treatment Period 1||2
11287400|NCT02455050|12484532|FG000|STARTED|Treatment Period 2||19
11287401|NCT02455050|12484533|FG001|STARTED|Treatment Period 2||18
11287402|NCT02455050|12484534|FG002|STARTED|Treatment Period 2||19
11287403|NCT02455050|12484535|FG003|STARTED|Treatment Period 2||18
11287404|NCT02455050|12484532|FG000|COMPLETED|Treatment Period 2||18
11287405|NCT02455050|12484533|FG001|COMPLETED|Treatment Period 2||18
11287406|NCT02455050|12484534|FG002|COMPLETED|Treatment Period 2||17
11287407|NCT02455050|12484535|FG003|COMPLETED|Treatment Period 2||17
11287408|NCT02455050|12484532|FG000|NOT COMPLETED|Treatment Period 2||1
11287409|NCT02455050|12484533|FG001|NOT COMPLETED|Treatment Period 2||0
11287410|NCT02455050|12484534|FG002|NOT COMPLETED|Treatment Period 2||2
11287411|NCT02455050|12484535|FG003|NOT COMPLETED|Treatment Period 2||1
11287412|NCT02455076|12484560|FG000|STARTED|Inpatient||47
11287413|NCT02455076|12484561|FG001|STARTED|Inpatient||51
11287414|NCT02455076|12484562|FG002|STARTED|Inpatient||52
11287415|NCT02455076|12484563|FG003|STARTED|Inpatient||0
11287416|NCT02455076|12484564|FG004|STARTED|Inpatient||0
11287417|NCT02455076|12484560|FG000|COMPLETED|Inpatient||43
11287418|NCT02455076|12484561|FG001|COMPLETED|Inpatient||50
11287419|NCT02455076|12484562|FG002|COMPLETED|Inpatient||52
11287420|NCT02455076|12484563|FG003|COMPLETED|Inpatient||0
11287421|NCT02455076|12484564|FG004|COMPLETED|Inpatient||0
11287422|NCT02455076|12484560|FG000|NOT COMPLETED|Inpatient||4
11287423|NCT02455076|12484561|FG001|NOT COMPLETED|Inpatient||1
11287424|NCT02455076|12484562|FG002|NOT COMPLETED|Inpatient||0
11287425|NCT02455076|12484563|FG003|NOT COMPLETED|Inpatient||0
11287426|NCT02455076|12484564|FG004|NOT COMPLETED|Inpatient||0
11287427|NCT02455076|12484560|FG000|STARTED|Outpatient||0
11287428|NCT02455076|12484561|FG001|STARTED|Outpatient||0
11287429|NCT02455076|12484562|FG002|STARTED|Outpatient||0
11287430|NCT02455076|12484563|FG003|STARTED|Outpatient||48
11287431|NCT02455076|12484564|FG004|STARTED|Outpatient||55
11287432|NCT02455076|12484560|FG000|COMPLETED|Outpatient||0
11287433|NCT02455076|12484561|FG001|COMPLETED|Outpatient||0
11287434|NCT02455076|12484562|FG002|COMPLETED|Outpatient||0
11287435|NCT02455076|12484563|FG003|COMPLETED|Outpatient||42
11287436|NCT02455076|12484564|FG004|COMPLETED|Outpatient||43
11287437|NCT02455076|12484560|FG000|NOT COMPLETED|Outpatient||0
11287438|NCT02455076|12484561|FG001|NOT COMPLETED|Outpatient||0
11287439|NCT02455076|12484562|FG002|NOT COMPLETED|Outpatient||0
11287440|NCT02455076|12484563|FG003|NOT COMPLETED|Outpatient||6
11287441|NCT02455076|12484564|FG004|NOT COMPLETED|Outpatient||12
11287442|NCT02455167|12484576|FG000|STARTED|Overall Study||4
11287443|NCT02455167|12484576|FG000|COMPLETED|Overall Study||4
11287444|NCT02455167|12484576|FG000|NOT COMPLETED|Overall Study||0
11287445|NCT02455336|12484582|FG000|STARTED|Overall Study||15
11287446|NCT02455336|12484583|FG001|STARTED|Overall Study||8
11287447|NCT02455336|12484582|FG000|COMPLETED|Overall Study||10
11287448|NCT02455336|12484583|FG001|COMPLETED|Overall Study||6
11287449|NCT02455336|12484582|FG000|NOT COMPLETED|Overall Study||5
11287450|NCT02455336|12484583|FG001|NOT COMPLETED|Overall Study||2
11287451|NCT02455388|12484591|FG000|STARTED|Overall Study||18
11287452|NCT02455388|12484592|FG001|STARTED|Overall Study||15
11287453|NCT02455388|12484593|FG002|STARTED|Overall Study||337
11287454|NCT02455388|12484591|FG000|COMPLETED|Overall Study||17
11287455|NCT02455388|12484592|FG001|COMPLETED|Overall Study||15
11287456|NCT02455388|12484593|FG002|COMPLETED|Overall Study||326
11287457|NCT02455388|12484591|FG000|NOT COMPLETED|Overall Study||1
11287458|NCT02455388|12484592|FG001|NOT COMPLETED|Overall Study||0
11287459|NCT02455388|12484593|FG002|NOT COMPLETED|Overall Study||11
11287460|NCT02455453|12484601|FG000|STARTED|Overall Study||47
11287461|NCT02455453|12484601|FG000|COMPLETED|Overall Study||47
11287462|NCT02455453|12484601|FG000|NOT COMPLETED|Overall Study||0
11287463|NCT02455518|12484609|FG000|STARTED|Overall Study||104
11287464|NCT02455518|12484610|FG001|STARTED|Overall Study||104
11287465|NCT02455518|12484611|FG002|STARTED|Overall Study||104
11287466|NCT02455518|12484612|FG003|STARTED|Overall Study||104
11287467|NCT02455518|12484609|FG000|COMPLETED|Overall Study||104
11287468|NCT02455518|12484610|FG001|COMPLETED|Overall Study||103
11287469|NCT02455518|12484611|FG002|COMPLETED|Overall Study||103
11287470|NCT02455518|12484612|FG003|COMPLETED|Overall Study||101
11287471|NCT02455518|12484609|FG000|NOT COMPLETED|Overall Study||0
11287472|NCT02455518|12484610|FG001|NOT COMPLETED|Overall Study||1
11287473|NCT02455518|12484611|FG002|NOT COMPLETED|Overall Study||1
11287474|NCT02455518|12484612|FG003|NOT COMPLETED|Overall Study||3
11287475|NCT02456103|12484622|FG000|STARTED|Overall Study||246
11287476|NCT02456103|12484622|FG000|As-Treated Population|Overall Study||245
11287477|NCT02456103|12484622|FG000|Intent-to-treat (ITT) Population|Overall Study||244
11287478|NCT02456103|12484622|FG000|COMPLETED|Overall Study||0
11287479|NCT02456103|12484622|FG000|NOT COMPLETED|Overall Study||246
11287480|NCT02456636|12484629|FG000|STARTED|Overall Study||478
11287481|NCT02456636|12484630|FG001|STARTED|Overall Study||479
11287482|NCT02456636|12484631|FG002|STARTED|Overall Study||475
11287483|NCT02456636|12484629|FG000|6 Month|Overall Study||474
11287484|NCT02456636|12484630|FG001|6 Month|Overall Study||474
11287485|NCT02456636|12484631|FG002|6 Month|Overall Study||468
11287486|NCT02456636|12484629|FG000|18 Month|Overall Study||467
11287487|NCT02456636|12484630|FG001|18 Month|Overall Study||463
11287488|NCT02456636|12484631|FG002|18 Month|Overall Study||461
11287489|NCT02456636|12484629|FG000|COMPLETED|Overall Study||410
11287490|NCT02456636|12484630|FG001|COMPLETED|Overall Study||410
11287491|NCT02456636|12484631|FG002|COMPLETED|Overall Study||400
11287492|NCT02456636|12484629|FG000|NOT COMPLETED|Overall Study||68
11287493|NCT02456636|12484630|FG001|NOT COMPLETED|Overall Study||69
11287494|NCT02456636|12484631|FG002|NOT COMPLETED|Overall Study||75
11287495|NCT02456662|12484641|FG000|STARTED|Overall Study||159
11287496|NCT02456662|12484642|FG001|STARTED|Overall Study||160
11287497|NCT02456662|12484641|FG000|COMPLETED|Overall Study||157
11287498|NCT02456662|12484642|FG001|COMPLETED|Overall Study||159
11287499|NCT02456662|12484641|FG000|NOT COMPLETED|Overall Study||2
11287500|NCT02456662|12484642|FG001|NOT COMPLETED|Overall Study||1
11287501|NCT02456727|12484650|FG000|STARTED|Overall Study||389
11287502|NCT02456727|12484651|FG001|STARTED|Overall Study||390
11287503|NCT02456727|12484650|FG000|Initiated Treatment|Overall Study||346
11287504|NCT02456727|12484651|FG001|Initiated Treatment|Overall Study||360
11287505|NCT02456727|12484650|FG000|6 Week|Overall Study||298
11287506|NCT02456727|12484651|FG001|6 Week|Overall Study||320
11287507|NCT02456727|12484650|FG000|12 Week|Overall Study||295
11287508|NCT02456727|12484651|FG001|12 Week|Overall Study||310
11287509|NCT02456727|12484650|FG000|24 Week|Overall Study||280
11287510|NCT02456727|12484651|FG001|24 Week|Overall Study||284
11287511|NCT02456727|12484650|FG000|COMPLETED|Overall Study||280
11287512|NCT02456727|12484651|FG001|COMPLETED|Overall Study||284
11287513|NCT02456727|12484650|FG000|NOT COMPLETED|Overall Study||109
11287514|NCT02456727|12484651|FG001|NOT COMPLETED|Overall Study||106
11287515|NCT02456896|12484675|FG000|STARTED|Overall Study||25
11287516|NCT02456896|12484676|FG001|STARTED|Overall Study||25
11287517|NCT02456896|12484675|FG000|COMPLETED|Overall Study||19
11287518|NCT02456896|12484676|FG001|COMPLETED|Overall Study||21
11287519|NCT02456896|12484675|FG000|NOT COMPLETED|Overall Study||6
11287520|NCT02456896|12484676|FG001|NOT COMPLETED|Overall Study||4
11287521|NCT02456909|12484684|FG000|STARTED|Overall Study||88
11287522|NCT02456909|12484685|FG001|STARTED|Overall Study||88
11287523|NCT02456909|12484684|FG000|COMPLETED|Overall Study||64
11287524|NCT02456909|12484685|FG001|COMPLETED|Overall Study||61
11287525|NCT02456909|12484684|FG000|NOT COMPLETED|Overall Study||24
11287526|NCT02456909|12484685|FG001|NOT COMPLETED|Overall Study||27
11287527|NCT02457065|12484693|FG000|STARTED|Overall Study||27
11287528|NCT02457065|12484694|FG001|STARTED|Overall Study||27
11287529|NCT02457065|12484693|FG000|COMPLETED|Overall Study||18
11287530|NCT02457065|12484694|FG001|COMPLETED|Overall Study||16
11287531|NCT02457065|12484693|FG000|NOT COMPLETED|Overall Study||9
11287532|NCT02457065|12484694|FG001|NOT COMPLETED|Overall Study||11
11287533|NCT02457182|12484702|FG000|STARTED|Overall Study||9
11287534|NCT02457182|12484703|FG001|STARTED|Overall Study||11
11287535|NCT02457182|12484702|FG000|COMPLETED|Overall Study||8
11287536|NCT02457182|12484703|FG001|COMPLETED|Overall Study||11
11287537|NCT02457182|12484702|FG000|NOT COMPLETED|Overall Study||1
11287538|NCT02457182|12484703|FG001|NOT COMPLETED|Overall Study||0
11287539|NCT02457195|12484709|FG000|STARTED|Overall Study||50
11287540|NCT02457195|12484709|FG000|COMPLETED|Overall Study||41
11287541|NCT02457195|12484709|FG000|NOT COMPLETED|Overall Study||9
11287542|NCT02457247|12484717|FG000|STARTED|Period 1||68
11287543|NCT02457247|12484718|FG001|STARTED|Period 1||70
11287544|NCT02457247|12484719|FG002|STARTED|Period 1||68
11287545|NCT02457247|12484720|FG003|STARTED|Period 1||70
11287546|NCT02457247|12484717|FG000|COMPLETED|Period 1||66
11287547|NCT02457247|12484718|FG001|COMPLETED|Period 1||68
11287548|NCT02457247|12484719|FG002|COMPLETED|Period 1||68
11287549|NCT02457247|12484720|FG003|COMPLETED|Period 1||70
11287550|NCT02457247|12484717|FG000|NOT COMPLETED|Period 1||2
11287551|NCT02457247|12484718|FG001|NOT COMPLETED|Period 1||2
11287552|NCT02457247|12484719|FG002|NOT COMPLETED|Period 1||0
11287553|NCT02457247|12484720|FG003|NOT COMPLETED|Period 1||0
11287554|NCT02457247|12484717|FG000|STARTED|Period 2||66
11287555|NCT02457247|12484718|FG001|STARTED|Period 2||68
11287556|NCT02457247|12484719|FG002|STARTED|Period 2||68
11287557|NCT02457247|12484720|FG003|STARTED|Period 2||70
11287558|NCT02457247|12484717|FG000|COMPLETED|Period 2||64
11287559|NCT02457247|12484718|FG001|COMPLETED|Period 2||65
11287560|NCT02457247|12484719|FG002|COMPLETED|Period 2||68
11287561|NCT02457247|12484720|FG003|COMPLETED|Period 2||70
11287562|NCT02457247|12484717|FG000|NOT COMPLETED|Period 2||2
11287563|NCT02457247|12484718|FG001|NOT COMPLETED|Period 2||3
11287564|NCT02457247|12484719|FG002|NOT COMPLETED|Period 2||0
11287565|NCT02457247|12484720|FG003|NOT COMPLETED|Period 2||0
11287566|NCT02457260|12484739|FG000|STARTED|Overall Study||12
11287567|NCT02457260|12484740|FG001|STARTED|Overall Study||7
11287568|NCT02457260|12484741|FG002|STARTED|Overall Study||2
11287569|NCT02457260|12484739|FG000|COMPLETED|Overall Study||10
11287570|NCT02457260|12484740|FG001|COMPLETED|Overall Study||4
11287571|NCT02457260|12484741|FG002|COMPLETED|Overall Study||1
11287572|NCT02457260|12484739|FG000|NOT COMPLETED|Overall Study||2
11287573|NCT02457260|12484740|FG001|NOT COMPLETED|Overall Study||3
11287574|NCT02457260|12484741|FG002|NOT COMPLETED|Overall Study||1
11287575|NCT02457325|12484752|FG000|STARTED|First Intervention (1 Day)||25
11287576|NCT02457325|12484753|FG001|STARTED|First Intervention (1 Day)||25
11287577|NCT02457325|12484752|FG000|COMPLETED|First Intervention (1 Day)||23
11287578|NCT02457325|12484753|FG001|COMPLETED|First Intervention (1 Day)||23
11287579|NCT02457325|12484752|FG000|NOT COMPLETED|First Intervention (1 Day)||2
11287580|NCT02457325|12484753|FG001|NOT COMPLETED|First Intervention (1 Day)||2
11287581|NCT02457325|12484752|FG000|STARTED|Washout (1-2 Months)||23
11287582|NCT02457325|12484753|FG001|STARTED|Washout (1-2 Months)||23
11287583|NCT02457325|12484752|FG000|COMPLETED|Washout (1-2 Months)||23
11287584|NCT02457325|12484753|FG001|COMPLETED|Washout (1-2 Months)||23
11287585|NCT02457325|12484752|FG000|NOT COMPLETED|Washout (1-2 Months)||0
11287586|NCT02457325|12484753|FG001|NOT COMPLETED|Washout (1-2 Months)||0
11287587|NCT02457325|12484752|FG000|STARTED|Second Intervention (1 Day)||23
11287588|NCT02457325|12484753|FG001|STARTED|Second Intervention (1 Day)||23
11287589|NCT02457325|12484752|FG000|COMPLETED|Second Intervention (1 Day)||23
11287590|NCT02457325|12484753|FG001|COMPLETED|Second Intervention (1 Day)||23
11287591|NCT02457325|12484752|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11287592|NCT02457325|12484753|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11287593|NCT02457403|12484761|FG000|STARTED|Overall Study|34 participants|34
11287594|NCT02457403|12484762|FG001|STARTED|Overall Study|34 historic controls|34
11287595|NCT02457403|12484761|FG000|COMPLETED|Overall Study||34
11287596|NCT02457403|12484762|FG001|COMPLETED|Overall Study||34
11287597|NCT02457403|12484761|FG000|NOT COMPLETED|Overall Study||0
11287598|NCT02457403|12484762|FG001|NOT COMPLETED|Overall Study||0
11287599|NCT02457520|12484770|FG000|STARTED|Active Treatment Phase|All subjects received treatment according to the same regimen.|201
11287600|NCT02457520|12484770|FG000|COMPLETED|Active Treatment Phase||167
11287601|NCT02457520|12484770|FG000|NOT COMPLETED|Active Treatment Phase||34
11287602|NCT02457520|12484770|FG000|STARTED|Post-treatment Period||167
11287603|NCT02457520|12484770|FG000|COMPLETED|Post-treatment Period||119
11287604|NCT02457520|12484770|FG000|NOT COMPLETED|Post-treatment Period||48
11287605|NCT02457546|12484802|FG000|STARTED|Overall Study||114
11287606|NCT02457546|12484803|FG001|STARTED|Overall Study||120
11287607|NCT02457546|12484802|FG000|COMPLETED|Overall Study||105
11287608|NCT02457546|12484803|FG001|COMPLETED|Overall Study||116
11287609|NCT02457546|12484802|FG000|NOT COMPLETED|Overall Study||9
11287610|NCT02457546|12484803|FG001|NOT COMPLETED|Overall Study||4
11287611|NCT02457611|12484809|FG000|STARTED|Overall Study||26
11287612|NCT02457611|12484809|FG000|COMPLETED|Overall Study||23
11287613|NCT02457611|12484809|FG000|NOT COMPLETED|Overall Study||3
11287614|NCT02457637|12484813|FG000|STARTED|Recruitment|2600 is the number of inpatients who met our eligibility.|2600
11399426|NCT04333199|12594004|FG001|NOT COMPLETED|Emailed Patients||272
11399427|NCT04333199|12594005|FG002|NOT COMPLETED|Emailed Patients||318
11287615|NCT02457637|12484813|FG000|COMPLETED|Recruitment|2361 patients were excluded according to our exclusion criteria,2600 patients remained.|2600
11287616|NCT02457637|12484813|FG000|NOT COMPLETED|Recruitment||0
11287617|NCT02457637|12484813|FG000|STARTED|28-Days Hospitalization and Observation||2600
11287618|NCT02457637|12484813|FG000|Liver Transplantation|28-Days Hospitalization and Observation||124
11287619|NCT02457637|12484813|FG000|Death|28-Days Hospitalization and Observation||74
11287620|NCT02457637|12484813|FG000|COMPLETED|28-Days Hospitalization and Observation|Death and receiving Liver transplantation are two end points of our observation.|2600
11287621|NCT02457637|12484813|FG000|NOT COMPLETED|28-Days Hospitalization and Observation||0
11287622|NCT02457637|12484813|FG000|STARTED|Clinic or Telephone Follow-up||2600
11287623|NCT02457637|12484813|FG000|One-year Liver Transplantation|Clinic or Telephone Follow-up||182
11287624|NCT02457637|12484813|FG000|One-year Death|Clinic or Telephone Follow-up||475
11287625|NCT02457637|12484813|FG000|COMPLETED|Clinic or Telephone Follow-up||2529
11287626|NCT02457637|12484813|FG000|NOT COMPLETED|Clinic or Telephone Follow-up||71
11287627|NCT02457728|12484818|FG000|STARTED|Overall Study||34
11287628|NCT02457728|12484818|FG000|COMPLETED|Overall Study||34
11287629|NCT02457728|12484818|FG000|NOT COMPLETED|Overall Study||0
11287630|NCT02457793|12484828|FG000|STARTED|Overall Study||1
11287631|NCT02457793|12484829|FG001|STARTED|Overall Study||5
11287632|NCT02457793|12484830|FG002|STARTED|Overall Study||3
11287633|NCT02457793|12484831|FG003|STARTED|Overall Study||5
11287634|NCT02457793|12484832|FG004|STARTED|Overall Study||4
11287635|NCT02457793|12484833|FG005|STARTED|Overall Study||6
11287636|NCT02457793|12484828|FG000|COMPLETED|Overall Study||0
11287637|NCT02457793|12484829|FG001|COMPLETED|Overall Study||1
11287638|NCT02457793|12484830|FG002|COMPLETED|Overall Study||0
11287639|NCT02457793|12484831|FG003|COMPLETED|Overall Study||0
11287640|NCT02457793|12484832|FG004|COMPLETED|Overall Study||0
11287641|NCT02457793|12484833|FG005|COMPLETED|Overall Study||0
11287642|NCT02457793|12484828|FG000|NOT COMPLETED|Overall Study||1
11287643|NCT02457793|12484829|FG001|NOT COMPLETED|Overall Study||4
11287644|NCT02457793|12484830|FG002|NOT COMPLETED|Overall Study||3
11287645|NCT02457793|12484831|FG003|NOT COMPLETED|Overall Study||5
11287646|NCT02457793|12484832|FG004|NOT COMPLETED|Overall Study||4
11287647|NCT02457793|12484833|FG005|NOT COMPLETED|Overall Study||6
11287648|NCT02457819|12484848|FG000|STARTED|Overall Study||237
11287649|NCT02457819|12484848|FG000|Safety Population|Overall Study||236
11287650|NCT02457819|12484848|FG000|COMPLETED|Overall Study||138
11287651|NCT02457819|12484848|FG000|NOT COMPLETED|Overall Study||99
11287652|NCT02457897|12484852|FG000|STARTED|Part 1 Short-term (2 Weeks) Study||7
11287653|NCT02457897|12484852|FG000|COMPLETED|Part 1 Short-term (2 Weeks) Study||7
11287654|NCT02457897|12484852|FG000|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0
11287655|NCT02457897|12484852|FG000|STARTED|Part 2 Long-term (6 Month) Study|Two patients were not eligible for Part 2 study because their HbA1c was less than 7.|5
11287656|NCT02457897|12484852|FG000|COMPLETED|Part 2 Long-term (6 Month) Study||5
11287657|NCT02457897|12484852|FG000|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0
11287658|NCT02458092|12484858|FG000|STARTED|Overall Study||20
11287659|NCT02458092|12484859|FG001|STARTED|Overall Study||10
11287660|NCT02458092|12484858|FG000|COMPLETED|Overall Study||19
11287661|NCT02458092|12484859|FG001|COMPLETED|Overall Study||10
11287662|NCT02458092|12484858|FG000|NOT COMPLETED|Overall Study||1
11287663|NCT02458092|12484859|FG001|NOT COMPLETED|Overall Study||0
11287664|NCT02458235|12484866|FG000|STARTED|Overall Study||17
11287665|NCT02458235|12484866|FG000|COMPLETED|Overall Study||17
11287666|NCT02458235|12484866|FG000|NOT COMPLETED|Overall Study||0
11287667|NCT02458287|12484874|FG000|STARTED|Overall Study||50
11287668|NCT02458287|12484875|FG001|STARTED|Overall Study||100
11287669|NCT02458287|12484876|FG002|STARTED|Overall Study||49
11287670|NCT02458287|12484877|FG003|STARTED|Overall Study||100
11287671|NCT02458287|12484874|FG000|COMPLETED|Overall Study||50
11287672|NCT02458287|12484875|FG001|COMPLETED|Overall Study||96
11287673|NCT02458287|12484876|FG002|COMPLETED|Overall Study||46
11287674|NCT02458287|12484877|FG003|COMPLETED|Overall Study||97
11287675|NCT02458287|12484874|FG000|NOT COMPLETED|Overall Study||0
11287676|NCT02458287|12484875|FG001|NOT COMPLETED|Overall Study||4
11287677|NCT02458287|12484876|FG002|NOT COMPLETED|Overall Study||3
11287678|NCT02458287|12484877|FG003|NOT COMPLETED|Overall Study||3
11287679|NCT02458352|12484893|FG000|STARTED|Overall Study||105
11287680|NCT02458352|12484893|FG000|COMPLETED|Overall Study||105
11287681|NCT02458352|12484893|FG000|NOT COMPLETED|Overall Study||0
11287682|NCT02458365|12484901|FG000|STARTED|Overall Study||2000
11287683|NCT02458365|12484902|FG001|STARTED|Overall Study||1901
11287684|NCT02458365|12484901|FG000|COMPLETED|Overall Study||1723
11287685|NCT02458365|12484902|FG001|COMPLETED|Overall Study||1607
11287686|NCT02458365|12484901|FG000|NOT COMPLETED|Overall Study||277
11287687|NCT02458365|12484902|FG001|NOT COMPLETED|Overall Study||294
11287688|NCT02458469|12484909|FG000|STARTED|First Intervention (2 Weeks)||3
11287689|NCT02458469|12484910|FG001|STARTED|First Intervention (2 Weeks)||2
11287690|NCT02458469|12484911|FG002|STARTED|First Intervention (2 Weeks)||3
11287691|NCT02458469|12484912|FG003|STARTED|First Intervention (2 Weeks)||0
11287692|NCT02458469|12484913|FG004|STARTED|First Intervention (2 Weeks)||1
11287693|NCT02458469|12484914|FG005|STARTED|First Intervention (2 Weeks)||2
11287694|NCT02458469|12484909|FG000|COMPLETED|First Intervention (2 Weeks)||2
11287695|NCT02458469|12484910|FG001|COMPLETED|First Intervention (2 Weeks)||2
11287696|NCT02458469|12484911|FG002|COMPLETED|First Intervention (2 Weeks)||2
11287697|NCT02458469|12484912|FG003|COMPLETED|First Intervention (2 Weeks)||0
11287698|NCT02458469|12484913|FG004|COMPLETED|First Intervention (2 Weeks)||1
11287699|NCT02458469|12484914|FG005|COMPLETED|First Intervention (2 Weeks)||2
11287700|NCT02458469|12484909|FG000|NOT COMPLETED|First Intervention (2 Weeks)||1
11287701|NCT02458469|12484910|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
11399428|NCT04332991|12594016|FG000|STARTED|Overall Study||242
11287702|NCT02458469|12484911|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1
11287703|NCT02458469|12484912|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0
11287704|NCT02458469|12484913|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0
11287705|NCT02458469|12484914|FG005|NOT COMPLETED|First Intervention (2 Weeks)||0
11287706|NCT02458469|12484909|FG000|STARTED|First Washout (2 Weeks)||2
11287707|NCT02458469|12484910|FG001|STARTED|First Washout (2 Weeks)||2
11287708|NCT02458469|12484911|FG002|STARTED|First Washout (2 Weeks)||2
11287709|NCT02458469|12484912|FG003|STARTED|First Washout (2 Weeks)||0
11287710|NCT02458469|12484913|FG004|STARTED|First Washout (2 Weeks)||1
11287711|NCT02458469|12484914|FG005|STARTED|First Washout (2 Weeks)||2
11287712|NCT02458469|12484909|FG000|COMPLETED|First Washout (2 Weeks)||2
11287713|NCT02458469|12484910|FG001|COMPLETED|First Washout (2 Weeks)||2
11287714|NCT02458469|12484911|FG002|COMPLETED|First Washout (2 Weeks)||2
11287715|NCT02458469|12484912|FG003|COMPLETED|First Washout (2 Weeks)||0
11287716|NCT02458469|12484913|FG004|COMPLETED|First Washout (2 Weeks)||1
11287717|NCT02458469|12484914|FG005|COMPLETED|First Washout (2 Weeks)||2
11287718|NCT02458469|12484909|FG000|NOT COMPLETED|First Washout (2 Weeks)||0
11287719|NCT02458469|12484910|FG001|NOT COMPLETED|First Washout (2 Weeks)||0
11287720|NCT02458469|12484911|FG002|NOT COMPLETED|First Washout (2 Weeks)||0
11287721|NCT02458469|12484912|FG003|NOT COMPLETED|First Washout (2 Weeks)||0
11287722|NCT02458469|12484913|FG004|NOT COMPLETED|First Washout (2 Weeks)||0
11287723|NCT02458469|12484914|FG005|NOT COMPLETED|First Washout (2 Weeks)||0
11287724|NCT02458469|12484909|FG000|STARTED|Second Intervention (2 Weeks)||2
11287725|NCT02458469|12484910|FG001|STARTED|Second Intervention (2 Weeks)||2
11399429|NCT04332991|12594017|FG001|STARTED|Overall Study||237
11399430|NCT04332991|12594016|FG000|COMPLETED|Overall Study||242
11399431|NCT04332991|12594017|FG001|COMPLETED|Overall Study||237
11399432|NCT04332991|12594016|FG000|NOT COMPLETED|Overall Study||0
11399433|NCT04332991|12594017|FG001|NOT COMPLETED|Overall Study||0
11399434|NCT04332614|12594029|FG000|STARTED|~1 Week After Study Launch||2350
11399435|NCT04332614|12594030|FG001|STARTED|~1 Week After Study Launch||2350
11399436|NCT04332614|12594031|FG002|STARTED|~1 Week After Study Launch||2350
11399437|NCT04332614|12594032|FG003|STARTED|~1 Week After Study Launch||2350
11399438|NCT04332614|12594033|FG004|STARTED|~1 Week After Study Launch||2350
11399439|NCT04332614|12594034|FG005|STARTED|~1 Week After Study Launch||2349
11399440|NCT04332614|12594029|FG000|Data in EHR|~1 Week After Study Launch||2245
11287726|NCT02458469|12484911|FG002|STARTED|Second Intervention (2 Weeks)||2
11287727|NCT02458469|12484912|FG003|STARTED|Second Intervention (2 Weeks)||0
11287728|NCT02458469|12484913|FG004|STARTED|Second Intervention (2 Weeks)||1
11287729|NCT02458469|12484914|FG005|STARTED|Second Intervention (2 Weeks)||2
11287730|NCT02458469|12484909|FG000|COMPLETED|Second Intervention (2 Weeks)||2
11287731|NCT02458469|12484910|FG001|COMPLETED|Second Intervention (2 Weeks)||2
11287732|NCT02458469|12484911|FG002|COMPLETED|Second Intervention (2 Weeks)||2
11287733|NCT02458469|12484912|FG003|COMPLETED|Second Intervention (2 Weeks)||0
11287734|NCT02458469|12484913|FG004|COMPLETED|Second Intervention (2 Weeks)||1
11287735|NCT02458469|12484914|FG005|COMPLETED|Second Intervention (2 Weeks)||1
11287736|NCT02458469|12484909|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
11287737|NCT02458469|12484910|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
11287738|NCT02458469|12484911|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
11287739|NCT02458469|12484912|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0
11287740|NCT02458469|12484913|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0
11287741|NCT02458469|12484914|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||1
11287742|NCT02458469|12484909|FG000|STARTED|Second Washout (2 Weeks)||2
11287743|NCT02458469|12484910|FG001|STARTED|Second Washout (2 Weeks)||2
11287744|NCT02458469|12484911|FG002|STARTED|Second Washout (2 Weeks)||2
11287745|NCT02458469|12484912|FG003|STARTED|Second Washout (2 Weeks)||0
11287746|NCT02458469|12484913|FG004|STARTED|Second Washout (2 Weeks)||1
11287747|NCT02458469|12484914|FG005|STARTED|Second Washout (2 Weeks)||1
11287748|NCT02458469|12484909|FG000|COMPLETED|Second Washout (2 Weeks)||2
11287749|NCT02458469|12484910|FG001|COMPLETED|Second Washout (2 Weeks)||2
11287750|NCT02458469|12484911|FG002|COMPLETED|Second Washout (2 Weeks)||2
11287751|NCT02458469|12484912|FG003|COMPLETED|Second Washout (2 Weeks)||0
11287752|NCT02458469|12484913|FG004|COMPLETED|Second Washout (2 Weeks)||1
11287753|NCT02458469|12484914|FG005|COMPLETED|Second Washout (2 Weeks)||1
11287754|NCT02458469|12484909|FG000|NOT COMPLETED|Second Washout (2 Weeks)||0
11287755|NCT02458469|12484910|FG001|NOT COMPLETED|Second Washout (2 Weeks)||0
11399441|NCT04332614|12594030|FG001|Data in EHR|~1 Week After Study Launch||2273
11399442|NCT04332614|12594031|FG002|Data in EHR|~1 Week After Study Launch||2251
11287756|NCT02458469|12484911|FG002|NOT COMPLETED|Second Washout (2 Weeks)||0
11287757|NCT02458469|12484912|FG003|NOT COMPLETED|Second Washout (2 Weeks)||0
11287758|NCT02458469|12484913|FG004|NOT COMPLETED|Second Washout (2 Weeks)||0
11287759|NCT02458469|12484914|FG005|NOT COMPLETED|Second Washout (2 Weeks)||0
11287760|NCT02458469|12484909|FG000|STARTED|Third Intervention (2 Weeks)||2
11287761|NCT02458469|12484910|FG001|STARTED|Third Intervention (2 Weeks)||2
11399443|NCT04332614|12594032|FG003|Data in EHR|~1 Week After Study Launch||2254
11287762|NCT02458469|12484911|FG002|STARTED|Third Intervention (2 Weeks)||2
11287763|NCT02458469|12484912|FG003|STARTED|Third Intervention (2 Weeks)||0
11399444|NCT04332614|12594033|FG004|Data in EHR|~1 Week After Study Launch||2251
11399445|NCT04332614|12594034|FG005|Data in EHR|~1 Week After Study Launch||2249
11399446|NCT04332614|12594029|FG000|COMPLETED|~1 Week After Study Launch||2117
11287764|NCT02458469|12484913|FG004|STARTED|Third Intervention (2 Weeks)||1
11287765|NCT02458469|12484914|FG005|STARTED|Third Intervention (2 Weeks)||1
11287766|NCT02458469|12484909|FG000|COMPLETED|Third Intervention (2 Weeks)||2
11287767|NCT02458469|12484910|FG001|COMPLETED|Third Intervention (2 Weeks)||2
11287768|NCT02458469|12484911|FG002|COMPLETED|Third Intervention (2 Weeks)||2
11287769|NCT02458469|12484912|FG003|COMPLETED|Third Intervention (2 Weeks)||0
11287770|NCT02458469|12484913|FG004|COMPLETED|Third Intervention (2 Weeks)||1
11287771|NCT02458469|12484914|FG005|COMPLETED|Third Intervention (2 Weeks)||1
11287772|NCT02458469|12484909|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0
11287773|NCT02458469|12484910|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0
11287774|NCT02458469|12484911|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
11287775|NCT02458469|12484912|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0
11287776|NCT02458469|12484913|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0
11287777|NCT02458469|12484914|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0
11287778|NCT02458638|12484922|FG000|STARTED|Overall Study||474
11287779|NCT02458638|12484922|FG000|COMPLETED|Overall Study||15
11287780|NCT02458638|12484922|FG000|NOT COMPLETED|Overall Study||459
11287781|NCT02458690|12484928|FG000|STARTED|Overall Study||107
11287782|NCT02458690|12484929|FG001|STARTED|Overall Study||109
11287783|NCT02458690|12484928|FG000|COMPLETED|Overall Study||99
11287784|NCT02458690|12484929|FG001|COMPLETED|Overall Study||100
11287785|NCT02458690|12484928|FG000|NOT COMPLETED|Overall Study||8
11287786|NCT02458690|12484929|FG001|NOT COMPLETED|Overall Study||9
11287787|NCT02458768|12484937|FG000|STARTED|Overall Study||57
11287788|NCT02458768|12484938|FG001|STARTED|Overall Study||55
11287789|NCT02458768|12484937|FG000|COMPLETED|Overall Study||50
11287790|NCT02458768|12484938|FG001|COMPLETED|Overall Study||50
11287791|NCT02458768|12484937|FG000|NOT COMPLETED|Overall Study||7
11287792|NCT02458768|12484938|FG001|NOT COMPLETED|Overall Study||5
11287793|NCT02459093|12484946|FG000|STARTED|Overall Study||275
11287794|NCT02459093|12484947|FG001|STARTED|Overall Study||275
11287795|NCT02459093|12484946|FG000|COMPLETED|Overall Study||263
11287796|NCT02459093|12484947|FG001|COMPLETED|Overall Study||257
11287797|NCT02459093|12484946|FG000|NOT COMPLETED|Overall Study||12
11287798|NCT02459093|12484947|FG001|NOT COMPLETED|Overall Study||18
11287799|NCT02459119|12484953|FG000|STARTED|Overall Study||17
11287800|NCT02459119|12484953|FG000|COMPLETED|Overall Study||17
11287801|NCT02459119|12484953|FG000|NOT COMPLETED|Overall Study||0
11287802|NCT02459197|12484959|FG000|STARTED|Overall Study||58
11287803|NCT02459197|12484960|FG001|STARTED|Overall Study||56
11287804|NCT02459197|12484959|FG000|COMPLETED|Overall Study||58
11287805|NCT02459197|12484960|FG001|COMPLETED|Overall Study||55
11287806|NCT02459197|12484959|FG000|NOT COMPLETED|Overall Study||0
11287807|NCT02459197|12484960|FG001|NOT COMPLETED|Overall Study||1
11287808|NCT02459262|12484977|FG000|STARTED|Overall Study||8
11287809|NCT02459262|12484978|FG001|STARTED|Overall Study||8
11287810|NCT02459262|12484979|FG002|STARTED|Overall Study||8
11399447|NCT04332614|12594030|FG001|COMPLETED|~1 Week After Study Launch||2129
11399448|NCT04332614|12594031|FG002|COMPLETED|~1 Week After Study Launch||2124
11399449|NCT04332614|12594032|FG003|COMPLETED|~1 Week After Study Launch||2131
11399450|NCT04332614|12594033|FG004|COMPLETED|~1 Week After Study Launch||2127
11399451|NCT04332614|12594034|FG005|COMPLETED|~1 Week After Study Launch||2115
11399452|NCT04332614|12594029|FG000|NOT COMPLETED|~1 Week After Study Launch||233
11399453|NCT04332614|12594030|FG001|NOT COMPLETED|~1 Week After Study Launch||221
11399454|NCT04332614|12594031|FG002|NOT COMPLETED|~1 Week After Study Launch||226
11287811|NCT02459262|12484980|FG003|STARTED|Overall Study||8
11287812|NCT02459262|12484981|FG004|STARTED|Overall Study||8
11287813|NCT02459262|12484982|FG005|STARTED|Overall Study||8
11287814|NCT02459262|12484983|FG006|STARTED|Overall Study||12
11287815|NCT02459262|12484984|FG007|STARTED|Overall Study||45
11287816|NCT02459262|12484985|FG008|STARTED|Overall Study||45
11287817|NCT02459262|12484986|FG009|STARTED|Overall Study||45
11287818|NCT02459262|12484987|FG010|STARTED|Overall Study||45
11287819|NCT02459262|12484977|FG000|COMPLETED|Overall Study||8
11287820|NCT02459262|12484978|FG001|COMPLETED|Overall Study||8
11287821|NCT02459262|12484979|FG002|COMPLETED|Overall Study||8
11287822|NCT02459262|12484980|FG003|COMPLETED|Overall Study||8
11287823|NCT02459262|12484981|FG004|COMPLETED|Overall Study||8
11287824|NCT02459262|12484982|FG005|COMPLETED|Overall Study||8
11287825|NCT02459262|12484983|FG006|COMPLETED|Overall Study||12
11287826|NCT02459262|12484984|FG007|COMPLETED|Overall Study||45
11287827|NCT02459262|12484985|FG008|COMPLETED|Overall Study||45
11287828|NCT02459262|12484986|FG009|COMPLETED|Overall Study||44
11287829|NCT02459262|12484987|FG010|COMPLETED|Overall Study||45
11287830|NCT02459262|12484977|FG000|NOT COMPLETED|Overall Study||0
11287831|NCT02459262|12484978|FG001|NOT COMPLETED|Overall Study||0
11287832|NCT02459262|12484979|FG002|NOT COMPLETED|Overall Study||0
11287833|NCT02459262|12484980|FG003|NOT COMPLETED|Overall Study||0
11287834|NCT02459262|12484981|FG004|NOT COMPLETED|Overall Study||0
11287835|NCT02459262|12484982|FG005|NOT COMPLETED|Overall Study||0
11287836|NCT02459262|12484983|FG006|NOT COMPLETED|Overall Study||0
11287837|NCT02459262|12484984|FG007|NOT COMPLETED|Overall Study||0
11287838|NCT02459262|12484985|FG008|NOT COMPLETED|Overall Study||0
11287839|NCT02459262|12484986|FG009|NOT COMPLETED|Overall Study||1
11287840|NCT02459262|12484987|FG010|NOT COMPLETED|Overall Study||0
11287841|NCT02459275|12485013|FG000|STARTED|Overall Study||19
11287842|NCT02459275|12485014|FG001|STARTED|Overall Study||17
11287843|NCT02459275|12485013|FG000|COMPLETED|Overall Study||19
11287844|NCT02459275|12485014|FG001|COMPLETED|Overall Study||17
11287845|NCT02459275|12485013|FG000|NOT COMPLETED|Overall Study||0
11287846|NCT02459275|12485014|FG001|NOT COMPLETED|Overall Study||0
11287847|NCT02459418|12485022|FG000|STARTED|Overall Study||21
11287848|NCT02459418|12485023|FG001|STARTED|Overall Study||21
11287849|NCT02459418|12485022|FG000|Received First Treatment|Overall Study||21
11287850|NCT02459418|12485023|FG001|Received First Treatment|Overall Study||21
11287851|NCT02459418|12485022|FG000|Received Second Treatment|Overall Study||13
11287852|NCT02459418|12485023|FG001|Received Second Treatment|Overall Study||15
11287853|NCT02459418|12485022|FG000|COMPLETED|Overall Study||13
11287854|NCT02459418|12485023|FG001|COMPLETED|Overall Study||15
11287855|NCT02459418|12485022|FG000|NOT COMPLETED|Overall Study||8
11287856|NCT02459418|12485023|FG001|NOT COMPLETED|Overall Study||6
11287857|NCT02459587|12485034|FG000|STARTED|3-Month Follow-up Assessment||157
11287858|NCT02459587|12485035|FG001|STARTED|3-Month Follow-up Assessment||150
11287859|NCT02459587|12485034|FG000|COMPLETED|3-Month Follow-up Assessment||125
11287860|NCT02459587|12485035|FG001|COMPLETED|3-Month Follow-up Assessment||119
11287861|NCT02459587|12485034|FG000|NOT COMPLETED|3-Month Follow-up Assessment||32
11287862|NCT02459587|12485035|FG001|NOT COMPLETED|3-Month Follow-up Assessment||31
11287863|NCT02459587|12485034|FG000|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|152
11287864|NCT02459587|12485035|FG001|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|141
11287865|NCT02459587|12485034|FG000|COMPLETED|6-month Follow-up Assessment||128
11287866|NCT02459587|12485035|FG001|COMPLETED|6-month Follow-up Assessment||116
11287867|NCT02459587|12485034|FG000|NOT COMPLETED|6-month Follow-up Assessment||24
11287868|NCT02459587|12485035|FG001|NOT COMPLETED|6-month Follow-up Assessment||25
11287869|NCT02459587|12485034|FG000|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|149
11287870|NCT02459587|12485035|FG001|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|138
11287871|NCT02459587|12485034|FG000|COMPLETED|12-month Follow-up Assessment||127
11287872|NCT02459587|12485035|FG001|COMPLETED|12-month Follow-up Assessment||111
11287873|NCT02459587|12485034|FG000|NOT COMPLETED|12-month Follow-up Assessment||22
11287874|NCT02459587|12485035|FG001|NOT COMPLETED|12-month Follow-up Assessment||27
11287875|NCT02459665|12485046|FG000|STARTED|Overall Study||17
11287876|NCT02459665|12485047|FG001|STARTED|Overall Study||17
11287877|NCT02459665|12485048|FG002|STARTED|Overall Study||17
11287878|NCT02459665|12485049|FG003|STARTED|Overall Study||17
11287879|NCT02459665|12485046|FG000|Day 7 Visit|Overall Study||17
11287880|NCT02459665|12485047|FG001|Day 7 Visit|Overall Study||17
11287881|NCT02459665|12485048|FG002|Day 7 Visit|Overall Study||17
11287882|NCT02459665|12485049|FG003|Day 7 Visit|Overall Study||16
11287883|NCT02459665|12485046|FG000|Month 1 Visit|Overall Study||17
11287884|NCT02459665|12485047|FG001|Month 1 Visit|Overall Study||17
11287885|NCT02459665|12485048|FG002|Month 1 Visit|Overall Study||17
11287886|NCT02459665|12485049|FG003|Month 1 Visit|Overall Study||16
11287887|NCT02459665|12485046|FG000|Month 2 Visit|Overall Study||17
11287888|NCT02459665|12485047|FG001|Month 2 Visit|Overall Study||16
11287889|NCT02459665|12485048|FG002|Month 2 Visit|Overall Study||17
11287890|NCT02459665|12485049|FG003|Month 2 Visit|Overall Study||16
11287891|NCT02459665|12485046|FG000|Month 6 Visit|Overall Study||17
11287892|NCT02459665|12485047|FG001|Month 6 Visit|Overall Study||16
11287893|NCT02459665|12485048|FG002|Month 6 Visit|Overall Study||16
11287894|NCT02459665|12485049|FG003|Month 6 Visit|Overall Study||15
11287895|NCT02459665|12485046|FG000|COMPLETED|Overall Study||17
11287896|NCT02459665|12485047|FG001|COMPLETED|Overall Study||16
11287897|NCT02459665|12485048|FG002|COMPLETED|Overall Study||16
11287898|NCT02459665|12485049|FG003|COMPLETED|Overall Study||15
11287899|NCT02459665|12485046|FG000|NOT COMPLETED|Overall Study||0
11287900|NCT02459665|12485047|FG001|NOT COMPLETED|Overall Study||1
11287901|NCT02459665|12485048|FG002|NOT COMPLETED|Overall Study||1
11287902|NCT02459665|12485049|FG003|NOT COMPLETED|Overall Study||2
11287903|NCT02459795|12485069|FG000|STARTED|Overall Study||187
11287904|NCT02459795|12485070|FG001|STARTED|Overall Study||189
11287905|NCT02459795|12485071|FG002|STARTED|Overall Study||93
11287906|NCT02459795|12485069|FG000|COMPLETED|Overall Study||181
11287907|NCT02459795|12485070|FG001|COMPLETED|Overall Study||186
11287908|NCT02459795|12485071|FG002|COMPLETED|Overall Study||92
11287909|NCT02459795|12485069|FG000|NOT COMPLETED|Overall Study||6
11287910|NCT02459795|12485070|FG001|NOT COMPLETED|Overall Study||3
11287911|NCT02459795|12485071|FG002|NOT COMPLETED|Overall Study||1
11287912|NCT02459899|12485083|FG000|STARTED|Overall Study||36
11287913|NCT02459899|12485084|FG001|STARTED|Overall Study||35
11287914|NCT02459899|12485085|FG002|STARTED|Overall Study||35
11287915|NCT02459899|12485086|FG003|STARTED|Overall Study||35
11287916|NCT02459899|12485083|FG000|COMPLETED|Overall Study||33
11287917|NCT02459899|12485084|FG001|COMPLETED|Overall Study||29
11287918|NCT02459899|12485085|FG002|COMPLETED|Overall Study||35
11287919|NCT02459899|12485086|FG003|COMPLETED|Overall Study||33
11287920|NCT02459899|12485083|FG000|NOT COMPLETED|Overall Study||3
11287921|NCT02459899|12485084|FG001|NOT COMPLETED|Overall Study||6
11287922|NCT02459899|12485085|FG002|NOT COMPLETED|Overall Study||0
11287923|NCT02459899|12485086|FG003|NOT COMPLETED|Overall Study||2
11287924|NCT02459951|12485096|FG000|STARTED|Overall Study||10
11287925|NCT02459951|12485096|FG000|COMPLETED|Overall Study||9
11287926|NCT02459951|12485096|FG000|NOT COMPLETED|Overall Study||1
11287927|NCT02459964|12485104|FG000|STARTED|Overall Study||42
11287928|NCT02459964|12485105|FG001|STARTED|Overall Study||40
11287929|NCT02459964|12485106|FG002|STARTED|Overall Study||2
11287930|NCT02459964|12485104|FG000|COMPLETED|Overall Study||42
11287931|NCT02459964|12485105|FG001|COMPLETED|Overall Study||40
11287932|NCT02459964|12485106|FG002|COMPLETED|Overall Study||0
11287933|NCT02459964|12485104|FG000|NOT COMPLETED|Overall Study||0
11287934|NCT02459964|12485105|FG001|NOT COMPLETED|Overall Study||0
11287935|NCT02459964|12485106|FG002|NOT COMPLETED|Overall Study||2
11287936|NCT02460172|12485113|FG000|STARTED|Overall Study||25
11287937|NCT02460172|12485113|FG000|COMPLETED|Overall Study||25
11287938|NCT02460172|12485113|FG000|NOT COMPLETED|Overall Study||0
11287939|NCT02460263|12485119|FG000|STARTED|In-Center Period||30
11287940|NCT02460263|12485119|FG000|COMPLETED|In-Center Period||30
11287941|NCT02460263|12485119|FG000|NOT COMPLETED|In-Center Period||0
11287942|NCT02460263|12485119|FG000|STARTED|Transition Period||30
11287943|NCT02460263|12485119|FG000|COMPLETED|Transition Period||28
11287944|NCT02460263|12485119|FG000|NOT COMPLETED|Transition Period||2
11287945|NCT02460263|12485119|FG000|STARTED|In-Home Period||28
11287946|NCT02460263|12485119|FG000|COMPLETED|In-Home Period||28
11287947|NCT02460263|12485119|FG000|NOT COMPLETED|In-Home Period||0
11287948|NCT02460380|12485129|FG000|STARTED|Overall Study||45
11287949|NCT02460380|12485130|FG001|STARTED|Overall Study||23
11287950|NCT02460380|12485129|FG000|COMPLETED|Overall Study||35
11287951|NCT02460380|12485130|FG001|COMPLETED|Overall Study||18
11287952|NCT02460380|12485129|FG000|NOT COMPLETED|Overall Study||10
11287953|NCT02460380|12485130|FG001|NOT COMPLETED|Overall Study||5
11287954|NCT02460562|12485139|FG000|STARTED|Overall Study||74
11287955|NCT02460562|12485140|FG001|STARTED|Overall Study||76
11287956|NCT02460562|12485139|FG000|COMPLETED|Overall Study||59
11287957|NCT02460562|12485140|FG001|COMPLETED|Overall Study||60
11287958|NCT02460562|12485139|FG000|NOT COMPLETED|Overall Study||15
11287959|NCT02460562|12485140|FG001|NOT COMPLETED|Overall Study||16
11287960|NCT02460575|12485148|FG000|STARTED|Overall Study||40
11287961|NCT02460575|12485149|FG001|STARTED|Overall Study||20
11287962|NCT02460575|12485148|FG000|COMPLETED|Overall Study||39
11287963|NCT02460575|12485149|FG001|COMPLETED|Overall Study||20
11287964|NCT02460575|12485148|FG000|NOT COMPLETED|Overall Study||1
11287965|NCT02460575|12485149|FG001|NOT COMPLETED|Overall Study||0
11287966|NCT02460666|12485157|FG000|STARTED|Overall Study||89
11287967|NCT02460666|12485158|FG001|STARTED|Overall Study||89
11287968|NCT02460666|12485157|FG000|COMPLETED|Overall Study||62
11287969|NCT02460666|12485158|FG001|COMPLETED|Overall Study||63
11287970|NCT02460666|12485157|FG000|NOT COMPLETED|Overall Study||27
11287971|NCT02460666|12485158|FG001|NOT COMPLETED|Overall Study||26
11287972|NCT02460679|12485164|FG000|STARTED|Overall Study||19
11287973|NCT02460679|12485164|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19
11287974|NCT02460679|12485164|FG000|COMPLETED|Overall Study||14
11287975|NCT02460679|12485164|FG000|NOT COMPLETED|Overall Study||5
11287976|NCT02460822|12485168|FG000|STARTED|Overall Study||16
11287977|NCT02460822|12485168|FG000|COMPLETED|Overall Study||15
11287978|NCT02460822|12485168|FG000|NOT COMPLETED|Overall Study||1
11287979|NCT02460978|12485175|FG000|STARTED|Overall Study||271
11287980|NCT02460978|12485176|FG001|STARTED|Overall Study||270
11287981|NCT02460978|12485177|FG002|STARTED|Overall Study||272
11287982|NCT02460978|12485175|FG000|COMPLETED|Overall Study||244
11287983|NCT02460978|12485176|FG001|COMPLETED|Overall Study||245
11287984|NCT02460978|12485177|FG002|COMPLETED|Overall Study||239
11287985|NCT02460978|12485175|FG000|NOT COMPLETED|Overall Study||27
11287986|NCT02460978|12485176|FG001|NOT COMPLETED|Overall Study||25
11287987|NCT02460978|12485177|FG002|NOT COMPLETED|Overall Study||33
11287988|NCT02460991|12485187|FG000|STARTED|Overall Study||0
11287989|NCT02460991|12485188|FG001|STARTED|Overall Study||2
11287990|NCT02460991|12485187|FG000|COMPLETED|Overall Study||0
11287991|NCT02460991|12485188|FG001|COMPLETED|Overall Study||0
11287992|NCT02460991|12485187|FG000|NOT COMPLETED|Overall Study||0
11287993|NCT02460991|12485188|FG001|NOT COMPLETED|Overall Study||2
11287994|NCT02461134|12485199|FG000|STARTED|Overall Study||1
11287995|NCT02461134|12485199|FG000|COMPLETED|Overall Study||0
11287996|NCT02461134|12485199|FG000|NOT COMPLETED|Overall Study||1
11287997|NCT02461160|12485216|FG000|STARTED|Overall Study||8
11287998|NCT02461160|12485217|FG001|STARTED|Overall Study||6
11287999|NCT02461160|12485218|FG002|STARTED|Overall Study||6
11288000|NCT02461160|12485219|FG003|STARTED|Overall Study||12
11288001|NCT02461160|12485220|FG004|STARTED|Overall Study||6
11288002|NCT02461160|12485221|FG005|STARTED|Overall Study||6
11288003|NCT02461160|12485222|FG006|STARTED|Overall Study||6
11288004|NCT02461160|12485223|FG007|STARTED|Overall Study||6
11288005|NCT02461160|12485224|FG008|STARTED|Overall Study||12
11288006|NCT02461160|12485225|FG009|STARTED|Overall Study||4
11288007|NCT02461160|12485226|FG010|STARTED|Overall Study||4
11288008|NCT02461160|12485227|FG011|STARTED|Overall Study||4
11288009|NCT02461160|12485228|FG012|STARTED|Overall Study||8
11288010|NCT02461160|12485216|FG000|COMPLETED|Overall Study||8
11288011|NCT02461160|12485217|FG001|COMPLETED|Overall Study||6
11288012|NCT02461160|12485218|FG002|COMPLETED|Overall Study||6
11288013|NCT02461160|12485219|FG003|COMPLETED|Overall Study||12
11288014|NCT02461160|12485220|FG004|COMPLETED|Overall Study||6
11288015|NCT02461160|12485221|FG005|COMPLETED|Overall Study||6
11288016|NCT02461160|12485222|FG006|COMPLETED|Overall Study||6
11288017|NCT02461160|12485223|FG007|COMPLETED|Overall Study||5
11288018|NCT02461160|12485224|FG008|COMPLETED|Overall Study||12
11399455|NCT04332614|12594032|FG003|NOT COMPLETED|~1 Week After Study Launch||219
11288019|NCT02461160|12485225|FG009|COMPLETED|Overall Study||4
11288020|NCT02461160|12485226|FG010|COMPLETED|Overall Study||4
11288021|NCT02461160|12485227|FG011|COMPLETED|Overall Study||4
11288022|NCT02461160|12485228|FG012|COMPLETED|Overall Study||8
11288023|NCT02461160|12485216|FG000|NOT COMPLETED|Overall Study||0
11288024|NCT02461160|12485217|FG001|NOT COMPLETED|Overall Study||0
11288025|NCT02461160|12485218|FG002|NOT COMPLETED|Overall Study||0
11288026|NCT02461160|12485219|FG003|NOT COMPLETED|Overall Study||0
11288027|NCT02461160|12485220|FG004|NOT COMPLETED|Overall Study||0
11288028|NCT02461160|12485221|FG005|NOT COMPLETED|Overall Study||0
11288029|NCT02461160|12485222|FG006|NOT COMPLETED|Overall Study||0
11288030|NCT02461160|12485223|FG007|NOT COMPLETED|Overall Study||1
11288031|NCT02461160|12485224|FG008|NOT COMPLETED|Overall Study||0
11288032|NCT02461160|12485225|FG009|NOT COMPLETED|Overall Study||0
11288033|NCT02461160|12485226|FG010|NOT COMPLETED|Overall Study||0
11288034|NCT02461160|12485227|FG011|NOT COMPLETED|Overall Study||0
11288035|NCT02461160|12485228|FG012|NOT COMPLETED|Overall Study||0
11288036|NCT02461290|12485277|FG000|STARTED|Overall Study||99
11288037|NCT02461290|12485277|FG000|COMPLETED|Overall Study||89
11288038|NCT02461290|12485277|FG000|NOT COMPLETED|Overall Study||10
11288039|NCT02461433|12485283|FG000|STARTED|Overall Study||1
11288040|NCT02461433|12485284|FG001|STARTED|Overall Study||1
11288041|NCT02461433|12485283|FG000|COMPLETED|Overall Study||1
11288042|NCT02461433|12485284|FG001|COMPLETED|Overall Study||1
11288043|NCT02461433|12485283|FG000|NOT COMPLETED|Overall Study||0
11288044|NCT02461433|12485284|FG001|NOT COMPLETED|Overall Study||0
11288045|NCT02461563|12485294|FG000|STARTED|Overall Study||3
11288046|NCT02461563|12485295|FG001|STARTED|Overall Study||3
11288047|NCT02461563|12485296|FG002|STARTED|Overall Study||3
11288048|NCT02461563|12485297|FG003|STARTED|Overall Study||3
11288049|NCT02461563|12485294|FG000|COMPLETED|Overall Study||3
11288050|NCT02461563|12485295|FG001|COMPLETED|Overall Study||3
11288051|NCT02461563|12485296|FG002|COMPLETED|Overall Study||3
11288052|NCT02461563|12485297|FG003|COMPLETED|Overall Study||3
11288053|NCT02461563|12485294|FG000|NOT COMPLETED|Overall Study||0
11288054|NCT02461563|12485295|FG001|NOT COMPLETED|Overall Study||0
11288055|NCT02461563|12485296|FG002|NOT COMPLETED|Overall Study||0
11288056|NCT02461563|12485297|FG003|NOT COMPLETED|Overall Study||0
11288057|NCT02461589|12485323|FG000|STARTED|Overall Study||64
11288058|NCT02461589|12485324|FG001|STARTED|Overall Study||63
11288059|NCT02461589|12485325|FG002|STARTED|Overall Study||65
11288060|NCT02461589|12485326|FG003|STARTED|Overall Study||63
11288061|NCT02461589|12485327|FG004|STARTED|Overall Study||64
11288062|NCT02461589|12485328|FG005|STARTED|Overall Study||64
11288063|NCT02461589|12485329|FG006|STARTED|Overall Study||64
11288064|NCT02461589|12485330|FG007|STARTED|Overall Study||65
11399456|NCT04332614|12594033|FG004|NOT COMPLETED|~1 Week After Study Launch||223
11399457|NCT04332614|12594034|FG005|NOT COMPLETED|~1 Week After Study Launch||234
11399458|NCT04332614|12594029|FG000|STARTED|~1 Month After Study Launch||2117
11399459|NCT04332614|12594030|FG001|STARTED|~1 Month After Study Launch||2129
11399460|NCT04332614|12594031|FG002|STARTED|~1 Month After Study Launch||2124
11399461|NCT04332614|12594032|FG003|STARTED|~1 Month After Study Launch||2131
11288065|NCT02461589|12485331|FG008|STARTED|Overall Study||129
11288066|NCT02461589|12485332|FG009|STARTED|Overall Study||65
11288067|NCT02461589|12485323|FG000|Exposed|Overall Study||64
11288068|NCT02461589|12485324|FG001|Exposed|Overall Study||63
11288069|NCT02461589|12485325|FG002|Exposed|Overall Study||65
11288070|NCT02461589|12485326|FG003|Exposed|Overall Study||63
11399462|NCT04332614|12594033|FG004|STARTED|~1 Month After Study Launch||2127
11399463|NCT04332614|12594034|FG005|STARTED|~1 Month After Study Launch||2115
11399464|NCT04332614|12594029|FG000|COMPLETED|~1 Month After Study Launch||2095
11288071|NCT02461589|12485327|FG004|Exposed|Overall Study||64
11288072|NCT02461589|12485328|FG005|Exposed|Overall Study||64
11288073|NCT02461589|12485329|FG006|Exposed|Overall Study||64
11288074|NCT02461589|12485330|FG007|Exposed|Overall Study||65
11288075|NCT02461589|12485331|FG008|Exposed|Overall Study||129
11288076|NCT02461589|12485332|FG009|Exposed|Overall Study||64
11288077|NCT02461589|12485323|FG000|COMPLETED|Overall Study||58
11288078|NCT02461589|12485324|FG001|COMPLETED|Overall Study||61
11288079|NCT02461589|12485325|FG002|COMPLETED|Overall Study||60
11288080|NCT02461589|12485326|FG003|COMPLETED|Overall Study||58
11288081|NCT02461589|12485327|FG004|COMPLETED|Overall Study||62
11288082|NCT02461589|12485328|FG005|COMPLETED|Overall Study||61
11288083|NCT02461589|12485329|FG006|COMPLETED|Overall Study||58
11288084|NCT02461589|12485330|FG007|COMPLETED|Overall Study||60
11288085|NCT02461589|12485331|FG008|COMPLETED|Overall Study||123
11288086|NCT02461589|12485332|FG009|COMPLETED|Overall Study||60
11288087|NCT02461589|12485323|FG000|NOT COMPLETED|Overall Study||6
11288088|NCT02461589|12485324|FG001|NOT COMPLETED|Overall Study||2
11288089|NCT02461589|12485325|FG002|NOT COMPLETED|Overall Study||5
11288090|NCT02461589|12485326|FG003|NOT COMPLETED|Overall Study||5
11288091|NCT02461589|12485327|FG004|NOT COMPLETED|Overall Study||2
11288092|NCT02461589|12485328|FG005|NOT COMPLETED|Overall Study||3
11399465|NCT04332614|12594030|FG001|COMPLETED|~1 Month After Study Launch||2107
11399466|NCT04332614|12594031|FG002|COMPLETED|~1 Month After Study Launch||2094
11399467|NCT04332614|12594032|FG003|COMPLETED|~1 Month After Study Launch||2107
11399468|NCT04332614|12594033|FG004|COMPLETED|~1 Month After Study Launch||2107
11288093|NCT02461589|12485329|FG006|NOT COMPLETED|Overall Study||6
11288094|NCT02461589|12485330|FG007|NOT COMPLETED|Overall Study||5
11288095|NCT02461589|12485331|FG008|NOT COMPLETED|Overall Study||6
11288096|NCT02461589|12485332|FG009|NOT COMPLETED|Overall Study||5
11340984|NCT02927639|12538341|FG001|NOT COMPLETED|Overall Study||69
11340985|NCT02927795|12538347|FG000|STARTED|Overall Study||257
11340986|NCT02927795|12538347|FG000|Treated|Overall Study||253
11340987|NCT02927795|12538347|FG000|COMPLETED|Overall Study||234
11340988|NCT02927795|12538347|FG000|NOT COMPLETED|Overall Study||23
11340989|NCT02927834|12538354|FG000|STARTED|Overall Study||8
11340990|NCT02927834|12538355|FG001|STARTED|Overall Study||8
11340991|NCT02927834|12538356|FG002|STARTED|Overall Study||8
11340992|NCT02927834|12538354|FG000|COMPLETED|Overall Study||7
11340993|NCT02927834|12538355|FG001|COMPLETED|Overall Study||6
11340994|NCT02927834|12538356|FG002|COMPLETED|Overall Study||6
11340995|NCT02927834|12538354|FG000|NOT COMPLETED|Overall Study||1
11340996|NCT02927834|12538355|FG001|NOT COMPLETED|Overall Study||2
11340997|NCT02927834|12538356|FG002|NOT COMPLETED|Overall Study||2
11340998|NCT02927873|12538370|FG000|STARTED|Overall Study||11
11340999|NCT02927873|12538371|FG001|STARTED|Overall Study||14
11341000|NCT02927873|12538372|FG002|STARTED|Overall Study||18
11341001|NCT02927873|12538373|FG003|STARTED|Overall Study||11
11341002|NCT02927873|12538374|FG004|STARTED|Overall Study||11
11341003|NCT02927873|12538375|FG005|STARTED|Overall Study||17
11341004|NCT02927873|12538370|FG000|COMPLETED|Overall Study||9
11341005|NCT02927873|12538371|FG001|COMPLETED|Overall Study||11
11341006|NCT02927873|12538372|FG002|COMPLETED|Overall Study||18
11341007|NCT02927873|12538373|FG003|COMPLETED|Overall Study||11
11341008|NCT02927873|12538374|FG004|COMPLETED|Overall Study||11
11341009|NCT02927873|12538375|FG005|COMPLETED|Overall Study||16
11341010|NCT02927873|12538370|FG000|NOT COMPLETED|Overall Study||2
11341011|NCT02927873|12538371|FG001|NOT COMPLETED|Overall Study||3
11341012|NCT02927873|12538372|FG002|NOT COMPLETED|Overall Study||0
11341013|NCT02927873|12538373|FG003|NOT COMPLETED|Overall Study||0
11341014|NCT02927873|12538374|FG004|NOT COMPLETED|Overall Study||0
11341015|NCT02927873|12538375|FG005|NOT COMPLETED|Overall Study||1
11341016|NCT02927925|12538389|FG000|STARTED|Overall Study||32
11341017|NCT02927925|12538389|FG000|COMPLETED|Overall Study||0
11341018|NCT02927925|12538389|FG000|NOT COMPLETED|Overall Study||32
11341019|NCT02928029|12538395|FG000|STARTED|Overall Study||3
11341020|NCT02928029|12538396|FG001|STARTED|Overall Study||4
11288097|NCT02461628|12485356|FG000|STARTED|Overall Study||3733
11288098|NCT02461628|12485357|FG001|STARTED|Overall Study||3632
11288099|NCT02461628|12485356|FG000|Baseline Survey|Overall Study||1038
11399469|NCT04332614|12594034|FG005|COMPLETED|~1 Month After Study Launch||2096
11399470|NCT04332614|12594029|FG000|NOT COMPLETED|~1 Month After Study Launch||22
11399471|NCT04332614|12594030|FG001|NOT COMPLETED|~1 Month After Study Launch||22
11399472|NCT04332614|12594031|FG002|NOT COMPLETED|~1 Month After Study Launch||30
11288100|NCT02461628|12485357|FG001|Baseline Survey|Overall Study||974
11288101|NCT02461628|12485356|FG000|6 Month Survey|Overall Study||814
11288102|NCT02461628|12485357|FG001|6 Month Survey|Overall Study||832
11288103|NCT02461628|12485356|FG000|12 Month Survey|Overall Study||882
11288104|NCT02461628|12485357|FG001|12 Month Survey|Overall Study||914
11288105|NCT02461628|12485356|FG000|18 Month Survey|Overall Study||995
11399473|NCT04332614|12594032|FG003|NOT COMPLETED|~1 Month After Study Launch||24
11399474|NCT04332614|12594033|FG004|NOT COMPLETED|~1 Month After Study Launch||20
11288106|NCT02461628|12485357|FG001|18 Month Survey|Overall Study||905
11288107|NCT02461628|12485356|FG000|COMPLETED|Overall Study||3729
11288108|NCT02461628|12485357|FG001|COMPLETED|Overall Study||3625
11399475|NCT04332614|12594034|FG005|NOT COMPLETED|~1 Month After Study Launch||19
11399476|NCT04322968|12594053|FG000|STARTED|Overall Study||11
11399477|NCT04322968|12594054|FG001|STARTED|Overall Study||10
11399478|NCT04322968|12594055|FG002|STARTED|Overall Study||10
11399479|NCT04322968|12594056|FG003|STARTED|Overall Study||10
11399480|NCT04322968|12594053|FG000|COMPLETED|Overall Study||10
11399481|NCT04322968|12594054|FG001|COMPLETED|Overall Study||9
11399482|NCT04322968|12594055|FG002|COMPLETED|Overall Study||10
11399483|NCT04322968|12594056|FG003|COMPLETED|Overall Study||10
11399484|NCT04322968|12594053|FG000|NOT COMPLETED|Overall Study||1
11399485|NCT04322968|12594054|FG001|NOT COMPLETED|Overall Study||1
11399486|NCT04322968|12594055|FG002|NOT COMPLETED|Overall Study||0
11399487|NCT04322968|12594056|FG003|NOT COMPLETED|Overall Study||0
11399488|NCT04332081|12594068|FG000|STARTED|Overall Study||20
11399489|NCT04332081|12594069|FG001|STARTED|Overall Study||60
11399490|NCT04332081|12594068|FG000|COMPLETED|Overall Study||20
11399491|NCT04332081|12594069|FG001|COMPLETED|Overall Study||60
11399492|NCT04332081|12594068|FG000|NOT COMPLETED|Overall Study||0
11399493|NCT04332081|12594069|FG001|NOT COMPLETED|Overall Study||0
11399494|NCT04332107|12594077|FG000|STARTED|Day 3||171
11399495|NCT04332107|12594078|FG001|STARTED|Day 3||92
11399496|NCT04332107|12594077|FG000|COMPLETED|Day 3||145
11399497|NCT04332107|12594078|FG001|COMPLETED|Day 3||72
11399498|NCT04332107|12594077|FG000|NOT COMPLETED|Day 3||26
11399499|NCT04332107|12594078|FG001|NOT COMPLETED|Day 3||20
11399500|NCT04332107|12594077|FG000|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|148
11399501|NCT04332107|12594078|FG001|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|78
11399502|NCT04332107|12594077|FG000|COMPLETED|Day 14||131
11399503|NCT04332107|12594078|FG001|COMPLETED|Day 14||70
11399504|NCT04332107|12594077|FG000|NOT COMPLETED|Day 14||17
11399505|NCT04332107|12594078|FG001|NOT COMPLETED|Day 14||8
11399506|NCT04332107|12594077|FG000|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|135
11399507|NCT04332107|12594078|FG001|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|74
11399508|NCT04332107|12594077|FG000|COMPLETED|Day 21||125
11399509|NCT04332107|12594078|FG001|COMPLETED|Day 21||72
11399510|NCT04332107|12594077|FG000|NOT COMPLETED|Day 21||10
11399511|NCT04332107|12594078|FG001|NOT COMPLETED|Day 21||2
11399512|NCT04323592|12594086|FG000|STARTED|Overall Study||83
11399513|NCT04323592|12594087|FG001|STARTED|Overall Study||90
11399514|NCT04323592|12594086|FG000|COMPLETED|Overall Study||83
11399515|NCT04323592|12594087|FG001|COMPLETED|Overall Study||90
11399516|NCT04323592|12594086|FG000|NOT COMPLETED|Overall Study||0
11399517|NCT04323592|12594087|FG001|NOT COMPLETED|Overall Study||0
11399518|NCT04326842|12594095|FG000|STARTED|Overall Study||40
11399519|NCT04326842|12594096|FG001|STARTED|Overall Study||89
11399520|NCT04326842|12594095|FG000|COMPLETED|Overall Study||31
11399521|NCT04326842|12594096|FG001|COMPLETED|Overall Study||31
11399522|NCT04326842|12594095|FG000|NOT COMPLETED|Overall Study||9
11399523|NCT04326842|12594096|FG001|NOT COMPLETED|Overall Study||58
11399524|NCT04325542|12594102|FG000|STARTED|Overall Study|one participant withdraw consent during the study|743
11399525|NCT04325542|12594102|FG000|COMPLETED|Overall Study||742
11399526|NCT04325542|12594102|FG000|NOT COMPLETED|Overall Study||1
11399527|NCT04329923|12594112|FG000|STARTED|Overall Study||17
11399528|NCT04329923|12594113|FG001|STARTED|Overall Study||17
11399529|NCT04329923|12594114|FG002|STARTED|Overall Study||4
11399530|NCT04329923|12594115|FG003|STARTED|Overall Study||3
11399531|NCT04329923|12594116|FG004|STARTED|Overall Study||66
11399532|NCT04329923|12594117|FG005|STARTED|Overall Study||66
11399533|NCT04329923|12594112|FG000|COMPLETED|Overall Study||16
11399534|NCT04329923|12594113|FG001|COMPLETED|Overall Study||13
11288109|NCT02461628|12485356|FG000|NOT COMPLETED|Overall Study||4
11288110|NCT02461628|12485357|FG001|NOT COMPLETED|Overall Study||7
11399535|NCT04329923|12594114|FG002|COMPLETED|Overall Study||3
11399536|NCT04329923|12594115|FG003|COMPLETED|Overall Study||2
11399537|NCT04329923|12594116|FG004|COMPLETED|Overall Study||64
11399538|NCT04329923|12594117|FG005|COMPLETED|Overall Study||61
11399539|NCT04329923|12594112|FG000|NOT COMPLETED|Overall Study||1
11399540|NCT04329923|12594113|FG001|NOT COMPLETED|Overall Study||4
11399541|NCT04329923|12594114|FG002|NOT COMPLETED|Overall Study||1
11399542|NCT04329923|12594115|FG003|NOT COMPLETED|Overall Study||1
11399543|NCT04329923|12594116|FG004|NOT COMPLETED|Overall Study||2
11399544|NCT04329923|12594117|FG005|NOT COMPLETED|Overall Study||5
11399545|NCT04328467|12594134|FG000|STARTED|Overall Study||494
11399546|NCT04328467|12594135|FG001|STARTED|Overall Study||495
11399547|NCT04328467|12594136|FG002|STARTED|Overall Study||494
11399548|NCT04328467|12594134|FG000|COMPLETED|Overall Study||490
11399549|NCT04328467|12594135|FG001|COMPLETED|Overall Study||493
11399550|NCT04328467|12594136|FG002|COMPLETED|Overall Study||493
11399551|NCT04328467|12594134|FG000|NOT COMPLETED|Overall Study||4
11399552|NCT04328467|12594135|FG001|NOT COMPLETED|Overall Study||2
11399553|NCT04328467|12594136|FG002|NOT COMPLETED|Overall Study||1
11399554|NCT04322526|12594146|FG000|STARTED|First Intervention (1 Day)||13
11399555|NCT04322526|12594147|FG001|STARTED|First Intervention (1 Day)||12
11288111|NCT02461693|12485365|FG000|STARTED|Overall Study||103
11288112|NCT02461693|12485366|FG001|STARTED|Overall Study||102
11288113|NCT02461693|12485365|FG000|COMPLETED|Overall Study||103
11288114|NCT02461693|12485366|FG001|COMPLETED|Overall Study||102
11288115|NCT02461693|12485365|FG000|NOT COMPLETED|Overall Study||0
11288116|NCT02461693|12485366|FG001|NOT COMPLETED|Overall Study||0
11288117|NCT02461745|12485374|FG000|STARTED|Overall Study||130
11288118|NCT02461745|12485375|FG001|STARTED|Overall Study||70
11288119|NCT02461745|12485374|FG000|COMPLETED|Overall Study||116
11288120|NCT02461745|12485375|FG001|COMPLETED|Overall Study||66
11288121|NCT02461745|12485374|FG000|NOT COMPLETED|Overall Study||14
11288122|NCT02461745|12485375|FG001|NOT COMPLETED|Overall Study||4
11288123|NCT02461758|12485387|FG000|STARTED|Overall Study||20
11288124|NCT02461758|12485388|FG001|STARTED|Overall Study||20
11288125|NCT02461758|12485389|FG002|STARTED|Overall Study||26
11288126|NCT02461758|12485390|FG003|STARTED|Overall Study||15
11288127|NCT02461758|12485387|FG000|COMPLETED|Overall Study||20
11288128|NCT02461758|12485388|FG001|COMPLETED|Overall Study||19
11288129|NCT02461758|12485389|FG002|COMPLETED|Overall Study||25
11288130|NCT02461758|12485390|FG003|COMPLETED|Overall Study||15
11288131|NCT02461758|12485387|FG000|NOT COMPLETED|Overall Study||0
11288132|NCT02461758|12485388|FG001|NOT COMPLETED|Overall Study||1
11288133|NCT02461758|12485389|FG002|NOT COMPLETED|Overall Study||1
11288134|NCT02461758|12485390|FG003|NOT COMPLETED|Overall Study||0
11288135|NCT02461771|12485406|FG000|STARTED|Overall Study||3
11288136|NCT02461771|12485407|FG001|STARTED|Overall Study||3
11288137|NCT02461771|12485408|FG002|STARTED|Overall Study||7
11288138|NCT02461771|12485406|FG000|COMPLETED|Overall Study||3
11288139|NCT02461771|12485407|FG001|COMPLETED|Overall Study||3
11288140|NCT02461771|12485408|FG002|COMPLETED|Overall Study||7
11288141|NCT02461771|12485406|FG000|NOT COMPLETED|Overall Study||0
11288142|NCT02461771|12485407|FG001|NOT COMPLETED|Overall Study||0
11288143|NCT02461771|12485408|FG002|NOT COMPLETED|Overall Study||0
11288144|NCT02461966|12485419|FG000|STARTED|Overall Study||160
11288145|NCT02461966|12485420|FG001|STARTED|Overall Study||80
11288146|NCT02461966|12485421|FG002|STARTED|Overall Study||60
11288147|NCT02461966|12485419|FG000|COMPLETED|Overall Study||160
11288148|NCT02461966|12485420|FG001|COMPLETED|Overall Study||80
11288149|NCT02461966|12485421|FG002|COMPLETED|Overall Study||60
11288150|NCT02461966|12485419|FG000|NOT COMPLETED|Overall Study||0
11288151|NCT02461966|12485420|FG001|NOT COMPLETED|Overall Study||0
11288152|NCT02461966|12485421|FG002|NOT COMPLETED|Overall Study||0
11288153|NCT02461992|12485429|FG000|STARTED|Overall Study||13
11288154|NCT02461992|12485429|FG000|COMPLETED|Overall Study||13
11399556|NCT04322526|12594146|FG000|COMPLETED|First Intervention (1 Day)||12
11399557|NCT04322526|12594147|FG001|COMPLETED|First Intervention (1 Day)||11
11288155|NCT02461992|12485429|FG000|NOT COMPLETED|Overall Study||0
11288156|NCT02462057|12485438|FG000|STARTED|Overall Study||791
11288157|NCT02462057|12485439|FG001|STARTED|Overall Study||793
11288158|NCT02462057|12485440|FG002|STARTED|Overall Study||812
11288159|NCT02462057|12485441|FG003|STARTED|Overall Study||752
11288160|NCT02462057|12485442|FG004|STARTED|Overall Study||758
11288161|NCT02462057|12485438|FG000|COMPLETED|Overall Study||737
11288162|NCT02462057|12485439|FG001|COMPLETED|Overall Study||753
11288163|NCT02462057|12485440|FG002|COMPLETED|Overall Study||766
11288164|NCT02462057|12485441|FG003|COMPLETED|Overall Study||701
11288165|NCT02462057|12485442|FG004|COMPLETED|Overall Study||708
11288166|NCT02462057|12485438|FG000|NOT COMPLETED|Overall Study||54
11288167|NCT02462057|12485439|FG001|NOT COMPLETED|Overall Study||40
11288168|NCT02462057|12485440|FG002|NOT COMPLETED|Overall Study||46
11288169|NCT02462057|12485441|FG003|NOT COMPLETED|Overall Study||51
11288170|NCT02462057|12485442|FG004|NOT COMPLETED|Overall Study||50
11288171|NCT02462070|12485456|FG000|STARTED|Overall Study||135
11288172|NCT02462070|12485457|FG001|STARTED|Overall Study||68
11288173|NCT02462070|12485456|FG000|COMPLETED|Overall Study||112
11288174|NCT02462070|12485457|FG001|COMPLETED|Overall Study||57
11288175|NCT02462070|12485456|FG000|NOT COMPLETED|Overall Study||23
11288176|NCT02462070|12485457|FG001|NOT COMPLETED|Overall Study||11
11288177|NCT02462083|12485463|FG000|STARTED|Overall Study||555
11288178|NCT02462083|12485463|FG000|Safety Population|Overall Study||550
11288179|NCT02462083|12485463|FG000|COMPLETED|Overall Study||136
11288180|NCT02462083|12485463|FG000|NOT COMPLETED|Overall Study||419
11288181|NCT02462122|12485469|FG000|STARTED|Overall Study||141
11288182|NCT02462122|12485470|FG001|STARTED|Overall Study||74
11288183|NCT02462122|12485469|FG000|COMPLETED|Overall Study||120
11288184|NCT02462122|12485470|FG001|COMPLETED|Overall Study||61
11288185|NCT02462122|12485469|FG000|NOT COMPLETED|Overall Study||21
11288186|NCT02462122|12485470|FG001|NOT COMPLETED|Overall Study||13
11288187|NCT02462148|12485479|FG000|STARTED|Overall Study||37
11288188|NCT02462148|12485480|FG001|STARTED|Overall Study||36
11288189|NCT02462148|12485481|FG002|STARTED|Overall Study||12
11288190|NCT02462148|12485479|FG000|COMPLETED|Overall Study||36
11288191|NCT02462148|12485480|FG001|COMPLETED|Overall Study||36
11288192|NCT02462148|12485481|FG002|COMPLETED|Overall Study||12
11288193|NCT02462148|12485479|FG000|NOT COMPLETED|Overall Study||1
11288194|NCT02462148|12485480|FG001|NOT COMPLETED|Overall Study||0
11288195|NCT02462148|12485481|FG002|NOT COMPLETED|Overall Study||0
11288196|NCT02462291|12485494|FG000|STARTED|Overall Study||82
11288197|NCT02462291|12485495|FG001|STARTED|Overall Study||81
11288198|NCT02462291|12485494|FG000|COMPLETED|Overall Study||77
11288199|NCT02462291|12485495|FG001|COMPLETED|Overall Study||75
11288200|NCT02462291|12485494|FG000|NOT COMPLETED|Overall Study||5
11288201|NCT02462291|12485495|FG001|NOT COMPLETED|Overall Study||6
11288202|NCT02462382|12485505|FG000|STARTED|Overall Study||24
11288203|NCT02462382|12485506|FG001|STARTED|Overall Study||27
11288204|NCT02462382|12485505|FG000|COMPLETED|Overall Study||24
11288205|NCT02462382|12485506|FG001|COMPLETED|Overall Study||27
11288206|NCT02462382|12485505|FG000|NOT COMPLETED|Overall Study||0
11288207|NCT02462382|12485506|FG001|NOT COMPLETED|Overall Study||0
11288208|NCT02462473|12485512|FG000|STARTED|Overall Study||9
11288209|NCT02462473|12485512|FG000|COMPLETED|Overall Study||5
11399558|NCT04322526|12594146|FG000|NOT COMPLETED|First Intervention (1 Day)||1
11399559|NCT04322526|12594147|FG001|NOT COMPLETED|First Intervention (1 Day)||1
11399560|NCT04322526|12594146|FG000|STARTED|Washout (1 Week)||12
11399561|NCT04322526|12594147|FG001|STARTED|Washout (1 Week)||11
11399562|NCT04322526|12594146|FG000|COMPLETED|Washout (1 Week)||11
11288210|NCT02462473|12485512|FG000|NOT COMPLETED|Overall Study||4
11288211|NCT02462486|12485519|FG000|STARTED|Overall Study||316
11288212|NCT02462486|12485520|FG001|STARTED|Overall Study||315
11399563|NCT04322526|12594147|FG001|COMPLETED|Washout (1 Week)||9
11399564|NCT04322526|12594146|FG000|NOT COMPLETED|Washout (1 Week)||1
11399565|NCT04322526|12594147|FG001|NOT COMPLETED|Washout (1 Week)||2
11288213|NCT02462486|12485521|FG002|STARTED|Overall Study||318
11288214|NCT02462486|12485519|FG000|COMPLETED|Overall Study||222
11288215|NCT02462486|12485520|FG001|COMPLETED|Overall Study||223
11288216|NCT02462486|12485521|FG002|COMPLETED|Overall Study||266
11288217|NCT02462486|12485519|FG000|NOT COMPLETED|Overall Study||94
11288218|NCT02462486|12485520|FG001|NOT COMPLETED|Overall Study||92
11288219|NCT02462486|12485521|FG002|NOT COMPLETED|Overall Study||52
11288220|NCT02462720|12485529|FG000|STARTED|Part 1||18
11399566|NCT04322526|12594146|FG000|STARTED|Second Intervention (1day)||11
11399567|NCT04322526|12594147|FG001|STARTED|Second Intervention (1day)||9
11399568|NCT04322526|12594146|FG000|COMPLETED|Second Intervention (1day)||11
11399569|NCT04322526|12594147|FG001|COMPLETED|Second Intervention (1day)||9
11288221|NCT02462720|12485530|FG001|STARTED|Part 1||17
11288222|NCT02462720|12485529|FG000|COMPLETED|Part 1||18
11288223|NCT02462720|12485530|FG001|COMPLETED|Part 1||17
11288224|NCT02462720|12485529|FG000|NOT COMPLETED|Part 1||0
11288225|NCT02462720|12485530|FG001|NOT COMPLETED|Part 1||0
11288226|NCT02462720|12485529|FG000|STARTED|Part 2||18
11288227|NCT02462720|12485530|FG001|STARTED|Part 2||17
11288228|NCT02462720|12485529|FG000|COMPLETED|Part 2||17
11288229|NCT02462720|12485530|FG001|COMPLETED|Part 2||16
11288230|NCT02462720|12485529|FG000|NOT COMPLETED|Part 2||1
11288231|NCT02462720|12485530|FG001|NOT COMPLETED|Part 2||1
11288232|NCT02462759|12485540|FG000|STARTED|Part 1: Double Blind||7
11288233|NCT02462759|12485541|FG001|STARTED|Part 1: Double Blind||14
11288234|NCT02462759|12485542|FG002|STARTED|Part 1: Double Blind||0
11288235|NCT02462759|12485540|FG000|COMPLETED|Part 1: Double Blind||6
11288236|NCT02462759|12485541|FG001|COMPLETED|Part 1: Double Blind||14
11288237|NCT02462759|12485542|FG002|COMPLETED|Part 1: Double Blind||0
11288238|NCT02462759|12485540|FG000|NOT COMPLETED|Part 1: Double Blind||1
11288239|NCT02462759|12485541|FG001|NOT COMPLETED|Part 1: Double Blind||0
11288240|NCT02462759|12485542|FG002|NOT COMPLETED|Part 1: Double Blind||0
11288241|NCT02462759|12485540|FG000|STARTED|Part 2: Open-Label Phase||0
11288242|NCT02462759|12485541|FG001|STARTED|Part 2: Open-Label Phase||0
11288243|NCT02462759|12485542|FG002|STARTED|Part 2: Open-Label Phase||20
11288244|NCT02462759|12485540|FG000|COMPLETED|Part 2: Open-Label Phase||0
11288245|NCT02462759|12485541|FG001|COMPLETED|Part 2: Open-Label Phase||0
11288246|NCT02462759|12485542|FG002|COMPLETED|Part 2: Open-Label Phase||20
11288247|NCT02462759|12485540|FG000|NOT COMPLETED|Part 2: Open-Label Phase||0
11288248|NCT02462759|12485541|FG001|NOT COMPLETED|Part 2: Open-Label Phase||0
11288249|NCT02462759|12485542|FG002|NOT COMPLETED|Part 2: Open-Label Phase||0
11288250|NCT02462928|12485556|FG000|STARTED|Overall Study||314
11288251|NCT02462928|12485557|FG001|STARTED|Overall Study||313
11288252|NCT02462928|12485558|FG002|STARTED|Overall Study||312
11288253|NCT02462928|12485556|FG000|COMPLETED|Overall Study||224
11288254|NCT02462928|12485557|FG001|COMPLETED|Overall Study||221
11288255|NCT02462928|12485558|FG002|COMPLETED|Overall Study||255
11288256|NCT02462928|12485556|FG000|NOT COMPLETED|Overall Study||90
11288257|NCT02462928|12485557|FG001|NOT COMPLETED|Overall Study||92
11288258|NCT02462928|12485558|FG002|NOT COMPLETED|Overall Study||57
11288259|NCT02462967|12485569|FG000|STARTED|Overall Study||54
11288260|NCT02462967|12485570|FG001|STARTED|Overall Study||54
11288261|NCT02462967|12485571|FG002|STARTED|Overall Study||54
11288262|NCT02462967|12485569|FG000|COMPLETED|Overall Study||52
11288263|NCT02462967|12485570|FG001|COMPLETED|Overall Study||48
11288264|NCT02462967|12485571|FG002|COMPLETED|Overall Study||51
11288265|NCT02462967|12485569|FG000|NOT COMPLETED|Overall Study||2
11288266|NCT02462967|12485570|FG001|NOT COMPLETED|Overall Study||6
11288267|NCT02462967|12485571|FG002|NOT COMPLETED|Overall Study||3
11288268|NCT02463032|12485581|FG000|STARTED|Overall Study||72
11288269|NCT02463032|12485582|FG001|STARTED|Overall Study||64
11288270|NCT02463032|12485581|FG000|COMPLETED|Overall Study||1
11399570|NCT04322526|12594146|FG000|NOT COMPLETED|Second Intervention (1day)||0
11288271|NCT02463032|12485582|FG001|COMPLETED|Overall Study||0
11288272|NCT02463032|12485581|FG000|NOT COMPLETED|Overall Study||71
11288273|NCT02463032|12485582|FG001|NOT COMPLETED|Overall Study||64
11288274|NCT02463071|12485591|FG000|STARTED|Overall Study||152
11288275|NCT02463071|12485592|FG001|STARTED|Overall Study||154
11399571|NCT04322526|12594147|FG001|NOT COMPLETED|Second Intervention (1day)||0
11399572|NCT04322500|12594155|FG000|STARTED|Overall Study||13
11399573|NCT04322500|12594156|FG001|STARTED|Overall Study||13
11399574|NCT04322500|12594155|FG000|COMPLETED|Overall Study||13
11399575|NCT04322500|12594156|FG001|COMPLETED|Overall Study||13
11399576|NCT04322500|12594155|FG000|NOT COMPLETED|Overall Study||0
11399577|NCT04322500|12594156|FG001|NOT COMPLETED|Overall Study||0
11399578|NCT04322682|12594164|FG000|STARTED|Overall Study||2235
11399579|NCT04322682|12594165|FG001|STARTED|Overall Study||2253
11288276|NCT02463071|12485593|FG002|STARTED|Overall Study||77
11288277|NCT02463071|12485591|FG000|COMPLETED|Overall Study||140
11288278|NCT02463071|12485592|FG001|COMPLETED|Overall Study||138
11288279|NCT02463071|12485593|FG002|COMPLETED|Overall Study||71
11288280|NCT02463071|12485591|FG000|NOT COMPLETED|Overall Study||12
11288281|NCT02463071|12485592|FG001|NOT COMPLETED|Overall Study||16
11288282|NCT02463071|12485593|FG002|NOT COMPLETED|Overall Study||6
11288283|NCT02463097|12485601|FG000|STARTED|Overall Study||124
11288284|NCT02463097|12485601|FG000|COMPLETED|Overall Study||123
11288285|NCT02463097|12485601|FG000|NOT COMPLETED|Overall Study||1
11288286|NCT02463227|12485605|FG000|STARTED|Overall Study||14
11288287|NCT02463227|12485605|FG000|COMPLETED|Overall Study||14
11288288|NCT02463227|12485605|FG000|NOT COMPLETED|Overall Study||0
11288289|NCT02463331|12485611|FG000|STARTED|Overall Study||26
11288290|NCT02463331|12485612|FG001|STARTED|Overall Study||31
11288291|NCT02463331|12485611|FG000|COMPLETED|Overall Study||10
11288292|NCT02463331|12485612|FG001|COMPLETED|Overall Study||25
11288293|NCT02463331|12485611|FG000|NOT COMPLETED|Overall Study||16
11288294|NCT02463331|12485612|FG001|NOT COMPLETED|Overall Study||6
11288295|NCT02463357|12485623|FG000|STARTED|Overall Study||20
11288296|NCT02463357|12485624|FG001|STARTED|Overall Study||20
11288297|NCT02463357|12485625|FG002|STARTED|Overall Study||20
11288298|NCT02463357|12485626|FG003|STARTED|Overall Study||19
11288299|NCT02463357|12485627|FG004|STARTED|Overall Study||20
11288300|NCT02463357|12485623|FG000|COMPLETED|Overall Study||19
11288301|NCT02463357|12485624|FG001|COMPLETED|Overall Study||20
11288302|NCT02463357|12485625|FG002|COMPLETED|Overall Study||20
11288303|NCT02463357|12485626|FG003|COMPLETED|Overall Study||19
11288304|NCT02463357|12485627|FG004|COMPLETED|Overall Study||19
11288305|NCT02463357|12485623|FG000|NOT COMPLETED|Overall Study||1
11288306|NCT02463357|12485624|FG001|NOT COMPLETED|Overall Study||0
11288307|NCT02463357|12485625|FG002|NOT COMPLETED|Overall Study||0
11288308|NCT02463357|12485626|FG003|NOT COMPLETED|Overall Study||0
11288309|NCT02463357|12485627|FG004|NOT COMPLETED|Overall Study||1
11288310|NCT02463409|12485639|FG000|STARTED|Overall Study||6
11288311|NCT02463409|12485639|FG000|COMPLETED|Overall Study||4
11288312|NCT02463409|12485639|FG000|NOT COMPLETED|Overall Study||2
11288313|NCT02463487|12485645|FG000|STARTED|Overall Study||75
11288314|NCT02463487|12485646|FG001|STARTED|Overall Study||75
11288315|NCT02463487|12485645|FG000|COMPLETED|Overall Study||65
11288316|NCT02463487|12485646|FG001|COMPLETED|Overall Study||65
11288317|NCT02463487|12485645|FG000|NOT COMPLETED|Overall Study||10
11288318|NCT02463487|12485646|FG001|NOT COMPLETED|Overall Study||10
11288319|NCT02463799|12485654|FG000|STARTED|Overall Study||16
11288320|NCT02463799|12485655|FG001|STARTED|Overall Study||16
11288321|NCT02463799|12485654|FG000|COMPLETED|Overall Study||16
11288322|NCT02463799|12485655|FG001|COMPLETED|Overall Study||16
11288323|NCT02463799|12485654|FG000|NOT COMPLETED|Overall Study||0
11288324|NCT02463799|12485655|FG001|NOT COMPLETED|Overall Study||0
11288325|NCT02464033|12485661|FG000|STARTED|Overall Study||20
11288326|NCT02464033|12485661|FG000|COMPLETED|Overall Study||20
11288327|NCT02464033|12485661|FG000|NOT COMPLETED|Overall Study||0
11288328|NCT02464059|12485666|FG000|STARTED|Overall Study||23
11288329|NCT02464059|12485666|FG000|COMPLETED|Overall Study||17
11288330|NCT02464059|12485666|FG000|NOT COMPLETED|Overall Study||6
11288331|NCT02464163|12485674|FG000|STARTED|Overall Study||102
11288332|NCT02464163|12485675|FG001|STARTED|Overall Study||102
11288333|NCT02464163|12485676|FG002|STARTED|Overall Study||102
11288334|NCT02464163|12485677|FG003|STARTED|Overall Study||101
11288335|NCT02464163|12485674|FG000|COMPLETED|Overall Study||99
11288336|NCT02464163|12485675|FG001|COMPLETED|Overall Study||94
11288337|NCT02464163|12485676|FG002|COMPLETED|Overall Study||97
11288338|NCT02464163|12485677|FG003|COMPLETED|Overall Study||96
11288339|NCT02464163|12485674|FG000|NOT COMPLETED|Overall Study||3
11288340|NCT02464163|12485675|FG001|NOT COMPLETED|Overall Study||8
11288341|NCT02464163|12485676|FG002|NOT COMPLETED|Overall Study||5
11288342|NCT02464163|12485677|FG003|NOT COMPLETED|Overall Study||5
11288343|NCT02464176|12485690|FG000|STARTED|Overall Study||50
11288344|NCT02464176|12485691|FG001|STARTED|Overall Study||50
11288345|NCT02464176|12485692|FG002|STARTED|Overall Study||15
11288346|NCT02464176|12485690|FG000|COMPLETED|Overall Study||50
11288347|NCT02464176|12485691|FG001|COMPLETED|Overall Study||50
11288348|NCT02464176|12485692|FG002|COMPLETED|Overall Study||15
11288349|NCT02464176|12485690|FG000|NOT COMPLETED|Overall Study||0
11288350|NCT02464176|12485691|FG001|NOT COMPLETED|Overall Study||0
11288351|NCT02464176|12485692|FG002|NOT COMPLETED|Overall Study||0
11288352|NCT02464449|12485702|FG000|STARTED|Overall Study||166
11288353|NCT02464449|12485703|FG001|STARTED|Overall Study||112
11288354|NCT02464449|12485702|FG000|COMPLETED|Overall Study||151
11288355|NCT02464449|12485703|FG001|COMPLETED|Overall Study||100
11288356|NCT02464449|12485702|FG000|NOT COMPLETED|Overall Study||15
11288357|NCT02464449|12485703|FG001|NOT COMPLETED|Overall Study||12
11288358|NCT02464540|12485709|FG000|STARTED|Overall Study||11
11288359|NCT02464540|12485710|FG001|STARTED|Overall Study||11
11288360|NCT02464540|12485709|FG000|COMPLETED|Overall Study||11
11288361|NCT02464540|12485710|FG001|COMPLETED|Overall Study||11
11288362|NCT02464540|12485709|FG000|NOT COMPLETED|Overall Study||0
11288363|NCT02464540|12485710|FG001|NOT COMPLETED|Overall Study||0
11288364|NCT02464657|12485719|FG000|STARTED|Overall Study||3
11288365|NCT02464657|12485720|FG001|STARTED|Overall Study||2
11399580|NCT04322682|12594164|FG000|COMPLETED|Overall Study||2192
11399581|NCT04322682|12594165|FG001|COMPLETED|Overall Study||2189
11399582|NCT04322682|12594164|FG000|NOT COMPLETED|Overall Study||43
11399583|NCT04322682|12594165|FG001|NOT COMPLETED|Overall Study||64
11288366|NCT02464657|12485721|FG002|STARTED|Overall Study||39
11288367|NCT02464657|12485719|FG000|COMPLETED|Overall Study||3
11399584|NCT04321980|12594173|FG000|STARTED|Overall Study||4
11399585|NCT04321980|12594174|FG001|STARTED|Overall Study||4
11399586|NCT04321980|12594173|FG000|COMPLETED|Overall Study||4
11399587|NCT04321980|12594174|FG001|COMPLETED|Overall Study||4
11399588|NCT04321980|12594173|FG000|NOT COMPLETED|Overall Study||0
11399589|NCT04321980|12594174|FG001|NOT COMPLETED|Overall Study||0
11399590|NCT04322396|12594182|FG000|STARTED|Overall Study||56
11399591|NCT04322396|12594183|FG001|STARTED|Overall Study||61
11399592|NCT04322396|12594182|FG000|COMPLETED|Overall Study||56
11399593|NCT04322396|12594183|FG001|COMPLETED|Overall Study||61
11399594|NCT04322396|12594182|FG000|NOT COMPLETED|Overall Study||0
11399595|NCT04322396|12594183|FG001|NOT COMPLETED|Overall Study||0
11399596|NCT04320823|12594191|FG000|STARTED|Overall Study||1717
11399597|NCT04320823|12594192|FG001|STARTED|Overall Study||1726
11399598|NCT04320823|12594191|FG000|COMPLETED|Overall Study|Includes 47 donors who withdrew from the study after one or more donations.|1717
11399599|NCT04320823|12594192|FG001|COMPLETED|Overall Study|Includes 38 donors who withdrew from the study after one or more donations.|1726
11399600|NCT04320823|12594191|FG000|NOT COMPLETED|Overall Study||0
11399601|NCT04320823|12594192|FG001|NOT COMPLETED|Overall Study||0
11288368|NCT02464657|12485720|FG001|COMPLETED|Overall Study||2
11288369|NCT02464657|12485721|FG002|COMPLETED|Overall Study||39
11288370|NCT02464657|12485719|FG000|NOT COMPLETED|Overall Study||0
11288371|NCT02464657|12485720|FG001|NOT COMPLETED|Overall Study||0
11288372|NCT02464657|12485721|FG002|NOT COMPLETED|Overall Study||0
11288373|NCT02464917|12485732|FG000|STARTED|Overall Study||35
11288374|NCT02464917|12485733|FG001|STARTED|Overall Study||35
11288375|NCT02464917|12485732|FG000|COMPLETED|Overall Study||35
11288376|NCT02464917|12485733|FG001|COMPLETED|Overall Study||35
11288377|NCT02464917|12485732|FG000|NOT COMPLETED|Overall Study||0
11399602|NCT04320615|12594216|FG000|STARTED|Overall Study||144
11399603|NCT04320615|12594217|FG001|STARTED|Overall Study||294
11399604|NCT04320615|12594216|FG000|COMPLETED|Overall Study||96
11288378|NCT02464917|12485733|FG001|NOT COMPLETED|Overall Study||0
11288379|NCT02465034|12485741|FG000|STARTED|Overall Study||19
11288380|NCT02465034|12485742|FG001|STARTED|Overall Study||26
11288381|NCT02465034|12485741|FG000|Started PAS|Overall Study||12
11288382|NCT02465034|12485742|FG001|Started PAS|Overall Study||21
11288383|NCT02465034|12485741|FG000|Completed PAS|Overall Study||9
11288384|NCT02465034|12485742|FG001|Completed PAS|Overall Study||20
11288385|NCT02465034|12485741|FG000|Started CC-PAS|Overall Study||16
11288386|NCT02465034|12485742|FG001|Started CC-PAS|Overall Study||0
11288387|NCT02465034|12485741|FG000|Completed CC-PAS|Overall Study||16
11288388|NCT02465034|12485742|FG001|Completed CC-PAS|Overall Study||0
11288389|NCT02465034|12485741|FG000|COMPLETED|Overall Study||16
11288390|NCT02465034|12485742|FG001|COMPLETED|Overall Study||20
11288391|NCT02465034|12485741|FG000|NOT COMPLETED|Overall Study||3
11288392|NCT02465034|12485742|FG001|NOT COMPLETED|Overall Study||6
11288393|NCT02465073|12485759|FG000|STARTED|Overall Study||17
11288394|NCT02465073|12485760|FG001|STARTED|Overall Study||16
11288395|NCT02465073|12485761|FG002|STARTED|Overall Study||16
11288396|NCT02465073|12485759|FG000|COMPLETED|Overall Study||15
11288397|NCT02465073|12485760|FG001|COMPLETED|Overall Study||15
11288398|NCT02465073|12485761|FG002|COMPLETED|Overall Study||15
11288399|NCT02465073|12485759|FG000|NOT COMPLETED|Overall Study||2
11288400|NCT02465073|12485760|FG001|NOT COMPLETED|Overall Study||1
11288401|NCT02465073|12485761|FG002|NOT COMPLETED|Overall Study||1
11288402|NCT02465099|12485771|FG000|STARTED|Overall Study||45
11288403|NCT02465099|12485772|FG001|STARTED|Overall Study||19
11288404|NCT02465099|12485771|FG000|COMPLETED|Overall Study||45
11288405|NCT02465099|12485772|FG001|COMPLETED|Overall Study||19
11288406|NCT02465099|12485771|FG000|NOT COMPLETED|Overall Study||0
11288407|NCT02465099|12485772|FG001|NOT COMPLETED|Overall Study||0
11288408|NCT02465203|12485781|FG000|STARTED|Overall Study||56
11288409|NCT02465203|12485782|FG001|STARTED|Overall Study||36
11288410|NCT02465203|12485783|FG002|STARTED|Overall Study||13
11288411|NCT02465203|12485781|FG000|COMPLETED|Overall Study||0
11288412|NCT02465203|12485782|FG001|COMPLETED|Overall Study||0
11288413|NCT02465203|12485783|FG002|COMPLETED|Overall Study||0
11288414|NCT02465203|12485781|FG000|NOT COMPLETED|Overall Study||56
11288415|NCT02465203|12485782|FG001|NOT COMPLETED|Overall Study||36
11288416|NCT02465203|12485783|FG002|NOT COMPLETED|Overall Study||13
11288417|NCT02465216|12485795|FG000|STARTED|Overall Study||15
11288418|NCT02465216|12485796|FG001|STARTED|Overall Study||5
11288419|NCT02465216|12485797|FG002|STARTED|Overall Study||14
11288420|NCT02465216|12485798|FG003|STARTED|Overall Study||14
11288421|NCT02465216|12485799|FG004|STARTED|Overall Study||12
11288422|NCT02465216|12485795|FG000|COMPLETED|Overall Study||12
11288423|NCT02465216|12485796|FG001|COMPLETED|Overall Study||5
11288424|NCT02465216|12485797|FG002|COMPLETED|Overall Study||13
11288425|NCT02465216|12485798|FG003|COMPLETED|Overall Study||12
11288426|NCT02465216|12485799|FG004|COMPLETED|Overall Study||9
11288427|NCT02465216|12485795|FG000|NOT COMPLETED|Overall Study||3
11288428|NCT02465216|12485796|FG001|NOT COMPLETED|Overall Study||0
11288429|NCT02465216|12485797|FG002|NOT COMPLETED|Overall Study||1
11288430|NCT02465216|12485798|FG003|NOT COMPLETED|Overall Study||2
11288431|NCT02465216|12485799|FG004|NOT COMPLETED|Overall Study||3
11288432|NCT02465372|12485813|FG000|STARTED|Overall Study||349
11288433|NCT02465372|12485814|FG001|STARTED|Overall Study||250
11288434|NCT02465372|12485813|FG000|COMPLETED|Overall Study||227
11288435|NCT02465372|12485814|FG001|COMPLETED|Overall Study||153
11288436|NCT02465372|12485813|FG000|NOT COMPLETED|Overall Study||122
11288437|NCT02465372|12485814|FG001|NOT COMPLETED|Overall Study||97
11288438|NCT02465437|12485824|FG000|STARTED|Overall Study||9
11021805|NCT00806156|12199984|FG000|NOT COMPLETED|Overall Study||39
11021806|NCT00806156|12199985|FG001|NOT COMPLETED|Overall Study||139
11021807|NCT00806195|12200007|FG000|STARTED|Overall Study||4363
11021808|NCT00806195|12200008|FG001|STARTED|Overall Study||1483
11021809|NCT00806195|12200009|FG002|STARTED|Overall Study||1409
11021810|NCT00806195|12200010|FG003|STARTED|Overall Study||489
11021811|NCT00806195|12200007|FG000|COMPLETED|Overall Study||3849
11021812|NCT00806195|12200008|FG001|COMPLETED|Overall Study||1321
11021813|NCT00806195|12200009|FG002|COMPLETED|Overall Study||1139
11021814|NCT00806195|12200010|FG003|COMPLETED|Overall Study||383
11288439|NCT02465437|12485825|FG001|STARTED|Overall Study||9
11288440|NCT02465437|12485826|FG002|STARTED|Overall Study||9
11288441|NCT02465437|12485827|FG003|STARTED|Overall Study||15
11288442|NCT02465437|12485824|FG000|COMPLETED|Overall Study||8
11288443|NCT02465437|12485825|FG001|COMPLETED|Overall Study||8
11288444|NCT02465437|12485826|FG002|COMPLETED|Overall Study||8
11288445|NCT02465437|12485827|FG003|COMPLETED|Overall Study||14
11288446|NCT02465437|12485824|FG000|NOT COMPLETED|Overall Study||1
11288447|NCT02465437|12485825|FG001|NOT COMPLETED|Overall Study||1
11288448|NCT02465437|12485826|FG002|NOT COMPLETED|Overall Study||1
11399605|NCT04320615|12594217|FG001|COMPLETED|Overall Study||190
11288449|NCT02465437|12485827|FG003|NOT COMPLETED|Overall Study||1
11288450|NCT02465450|12485838|FG000|STARTED|Treatment Period 1||26
11288451|NCT02465450|12485839|FG001|STARTED|Treatment Period 1||24
11288452|NCT02465450|12485840|FG002|STARTED|Treatment Period 1||35
11288453|NCT02465450|12485841|FG003|STARTED|Treatment Period 1||0
11288454|NCT02465450|12485842|FG004|STARTED|Treatment Period 1||0
11288455|NCT02465450|12485843|FG005|STARTED|Treatment Period 1||0
11288456|NCT02465450|12485838|FG000|COMPLETED|Treatment Period 1||24
11288457|NCT02465450|12485839|FG001|COMPLETED|Treatment Period 1||23
11288458|NCT02465450|12485840|FG002|COMPLETED|Treatment Period 1||34
11021815|NCT00806195|12200007|FG000|NOT COMPLETED|Overall Study||514
11021816|NCT00806195|12200008|FG001|NOT COMPLETED|Overall Study||162
11288459|NCT02465450|12485841|FG003|COMPLETED|Treatment Period 1||0
11288460|NCT02465450|12485842|FG004|COMPLETED|Treatment Period 1||0
11288461|NCT02465450|12485843|FG005|COMPLETED|Treatment Period 1||0
11288462|NCT02465450|12485838|FG000|NOT COMPLETED|Treatment Period 1||2
11288463|NCT02465450|12485839|FG001|NOT COMPLETED|Treatment Period 1||1
11288464|NCT02465450|12485840|FG002|NOT COMPLETED|Treatment Period 1||1
11288465|NCT02465450|12485841|FG003|NOT COMPLETED|Treatment Period 1||0
11288466|NCT02465450|12485842|FG004|NOT COMPLETED|Treatment Period 1||0
11288467|NCT02465450|12485843|FG005|NOT COMPLETED|Treatment Period 1||0
11288468|NCT02465450|12485838|FG000|STARTED|Treatment Period 2||0
11288469|NCT02465450|12485839|FG001|STARTED|Treatment Period 2||0
11288470|NCT02465450|12485840|FG002|STARTED|Treatment Period 2||0
11288471|NCT02465450|12485841|FG003|STARTED|Treatment Period 2||30
11288472|NCT02465450|12485842|FG004|STARTED|Treatment Period 2||28
11288473|NCT02465450|12485843|FG005|STARTED|Treatment Period 2||23
11288474|NCT02465450|12485838|FG000|COMPLETED|Treatment Period 2||0
11288475|NCT02465450|12485839|FG001|COMPLETED|Treatment Period 2||0
11288476|NCT02465450|12485840|FG002|COMPLETED|Treatment Period 2||0
11288477|NCT02465450|12485841|FG003|COMPLETED|Treatment Period 2||27
11288478|NCT02465450|12485842|FG004|COMPLETED|Treatment Period 2||24
11288479|NCT02465450|12485843|FG005|COMPLETED|Treatment Period 2||23
11288480|NCT02465450|12485838|FG000|NOT COMPLETED|Treatment Period 2||0
11288481|NCT02465450|12485839|FG001|NOT COMPLETED|Treatment Period 2||0
11288482|NCT02465450|12485840|FG002|NOT COMPLETED|Treatment Period 2||0
11288483|NCT02465450|12485841|FG003|NOT COMPLETED|Treatment Period 2||3
11288484|NCT02465450|12485842|FG004|NOT COMPLETED|Treatment Period 2||4
11288485|NCT02465450|12485843|FG005|NOT COMPLETED|Treatment Period 2||0
11288486|NCT02465463|12485863|FG000|STARTED|Overall Study||8
11288487|NCT02465463|12485864|FG001|STARTED|Overall Study||5
11288488|NCT02465463|12485863|FG000|COMPLETED|Overall Study||4
11288489|NCT02465463|12485864|FG001|COMPLETED|Overall Study||4
11288490|NCT02465463|12485863|FG000|NOT COMPLETED|Overall Study||4
11288491|NCT02465463|12485864|FG001|NOT COMPLETED|Overall Study||1
11288492|NCT02465489|12485871|FG000|STARTED|Overall Study||20
11288493|NCT02465489|12485871|FG000|COMPLETED|Overall Study||15
11288494|NCT02465489|12485871|FG000|NOT COMPLETED|Overall Study||5
11288495|NCT02465515|12485885|FG000|STARTED|Overall Study||4732
11288496|NCT02465515|12485886|FG001|STARTED|Overall Study||4731
11288497|NCT02465515|12485885|FG000|COMPLETED|Overall Study||4578
11288498|NCT02465515|12485886|FG001|COMPLETED|Overall Study||4620
11288499|NCT02465515|12485885|FG000|NOT COMPLETED|Overall Study||154
11288500|NCT02465515|12485886|FG001|NOT COMPLETED|Overall Study||111
11288501|NCT02465528|12485896|FG000|STARTED|Overall Study||1
11288502|NCT02465528|12485897|FG001|STARTED|Overall Study||4
11288503|NCT02465528|12485898|FG002|STARTED|Overall Study||12
11288504|NCT02465528|12485899|FG003|STARTED|Overall Study||5
11288505|NCT02465528|12485896|FG000|COMPLETED|Overall Study||0
11288506|NCT02465528|12485897|FG001|COMPLETED|Overall Study||0
11288507|NCT02465528|12485898|FG002|COMPLETED|Overall Study||0
11288508|NCT02465528|12485899|FG003|COMPLETED|Overall Study||0
11288509|NCT02465528|12485896|FG000|NOT COMPLETED|Overall Study||1
11288510|NCT02465528|12485897|FG001|NOT COMPLETED|Overall Study||4
11288511|NCT02465528|12485898|FG002|NOT COMPLETED|Overall Study||12
11288512|NCT02465528|12485899|FG003|NOT COMPLETED|Overall Study||5
11288513|NCT02465567|12485915|FG000|STARTED|Overall Study||2157
11288514|NCT02465567|12485916|FG001|STARTED|Overall Study||2137
11288515|NCT02465567|12485917|FG002|STARTED|Overall Study||2143
11288516|NCT02465567|12485918|FG003|STARTED|Overall Study||2151
11288517|NCT02465567|12485915|FG000|COMPLETED|Overall Study||1708
11288518|NCT02465567|12485916|FG001|COMPLETED|Overall Study||1713
11288519|NCT02465567|12485917|FG002|COMPLETED|Overall Study||1580
11288520|NCT02465567|12485918|FG003|COMPLETED|Overall Study||1643
11288521|NCT02465567|12485915|FG000|NOT COMPLETED|Overall Study||449
11288522|NCT02465567|12485916|FG001|NOT COMPLETED|Overall Study||424
11288523|NCT02465567|12485917|FG002|NOT COMPLETED|Overall Study||563
11288524|NCT02465567|12485918|FG003|NOT COMPLETED|Overall Study||508
11288525|NCT02465632|12485931|FG000|STARTED|Overall Study||440
11288526|NCT02465632|12485932|FG001|STARTED|Overall Study||440
11288527|NCT02465632|12485933|FG002|STARTED|Overall Study||220
11288528|NCT02465632|12485931|FG000|COMPLETED|Overall Study||409
11288529|NCT02465632|12485932|FG001|COMPLETED|Overall Study||417
11288530|NCT02465632|12485933|FG002|COMPLETED|Overall Study||203
11288531|NCT02465632|12485931|FG000|NOT COMPLETED|Overall Study||31
11288532|NCT02465632|12485932|FG001|NOT COMPLETED|Overall Study||23
11288533|NCT02465632|12485933|FG002|NOT COMPLETED|Overall Study||17
11288534|NCT02465866|12485942|FG000|STARTED|Period 1||5
11288535|NCT02465866|12485943|FG001|STARTED|Period 1||5
11288536|NCT02465866|12485944|FG002|STARTED|Period 1||5
11288537|NCT02465866|12485945|FG003|STARTED|Period 1||5
11288538|NCT02465866|12485942|FG000|COMPLETED|Period 1||5
11288539|NCT02465866|12485943|FG001|COMPLETED|Period 1||5
11288540|NCT02465866|12485944|FG002|COMPLETED|Period 1||5
11288541|NCT02465866|12485945|FG003|COMPLETED|Period 1||5
11288542|NCT02465866|12485942|FG000|NOT COMPLETED|Period 1||0
11288543|NCT02465866|12485943|FG001|NOT COMPLETED|Period 1||0
11288544|NCT02465866|12485944|FG002|NOT COMPLETED|Period 1||0
11288545|NCT02465866|12485945|FG003|NOT COMPLETED|Period 1||0
11288546|NCT02465866|12485942|FG000|STARTED|Period 1: Washout (14 Days)||5
11288547|NCT02465866|12485943|FG001|STARTED|Period 1: Washout (14 Days)||5
11288548|NCT02465866|12485944|FG002|STARTED|Period 1: Washout (14 Days)||5
11399606|NCT04320615|12594216|FG000|NOT COMPLETED|Overall Study||48
11399607|NCT04320615|12594217|FG001|NOT COMPLETED|Overall Study||104
11288549|NCT02465866|12485945|FG003|STARTED|Period 1: Washout (14 Days)||5
11288550|NCT02465866|12485942|FG000|COMPLETED|Period 1: Washout (14 Days)||5
11288551|NCT02465866|12485943|FG001|COMPLETED|Period 1: Washout (14 Days)||5
11288552|NCT02465866|12485944|FG002|COMPLETED|Period 1: Washout (14 Days)||5
11288553|NCT02465866|12485945|FG003|COMPLETED|Period 1: Washout (14 Days)||5
11399608|NCT04318535|12594227|FG000|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
11399609|NCT04318535|12594228|FG001|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
11399610|NCT04318535|12594229|FG002|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
11399611|NCT04318535|12594227|FG000|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
11399612|NCT04318535|12594228|FG001|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
11399613|NCT04318535|12594229|FG002|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
11288554|NCT02465866|12485942|FG000|NOT COMPLETED|Period 1: Washout (14 Days)||0
11288555|NCT02465866|12485943|FG001|NOT COMPLETED|Period 1: Washout (14 Days)||0
11288556|NCT02465866|12485944|FG002|NOT COMPLETED|Period 1: Washout (14 Days)||0
11288557|NCT02465866|12485945|FG003|NOT COMPLETED|Period 1: Washout (14 Days)||0
11288558|NCT02465866|12485942|FG000|STARTED|Period 2||5
11288559|NCT02465866|12485943|FG001|STARTED|Period 2||5
11288560|NCT02465866|12485944|FG002|STARTED|Period 2||5
11288561|NCT02465866|12485945|FG003|STARTED|Period 2||5
11288562|NCT02465866|12485942|FG000|COMPLETED|Period 2||5
11288563|NCT02465866|12485943|FG001|COMPLETED|Period 2||5
11288564|NCT02465866|12485944|FG002|COMPLETED|Period 2||5
11288565|NCT02465866|12485945|FG003|COMPLETED|Period 2||5
11288566|NCT02465866|12485942|FG000|NOT COMPLETED|Period 2||0
11288567|NCT02465866|12485943|FG001|NOT COMPLETED|Period 2||0
11288568|NCT02465866|12485944|FG002|NOT COMPLETED|Period 2||0
11288569|NCT02465866|12485945|FG003|NOT COMPLETED|Period 2||0
11288570|NCT02465866|12485942|FG000|STARTED|Period 2: Washout (14 Days)||5
11288571|NCT02465866|12485943|FG001|STARTED|Period 2: Washout (14 Days)||5
11288572|NCT02465866|12485944|FG002|STARTED|Period 2: Washout (14 Days)||5
11288573|NCT02465866|12485945|FG003|STARTED|Period 2: Washout (14 Days)||5
11288574|NCT02465866|12485942|FG000|COMPLETED|Period 2: Washout (14 Days)||5
11288575|NCT02465866|12485943|FG001|COMPLETED|Period 2: Washout (14 Days)||5
11288576|NCT02465866|12485944|FG002|COMPLETED|Period 2: Washout (14 Days)||5
11288577|NCT02465866|12485945|FG003|COMPLETED|Period 2: Washout (14 Days)||5
11288578|NCT02465866|12485942|FG000|NOT COMPLETED|Period 2: Washout (14 Days)||0
11288579|NCT02465866|12485943|FG001|NOT COMPLETED|Period 2: Washout (14 Days)||0
11288580|NCT02465866|12485944|FG002|NOT COMPLETED|Period 2: Washout (14 Days)||0
11288581|NCT02465866|12485945|FG003|NOT COMPLETED|Period 2: Washout (14 Days)||0
11288582|NCT02465866|12485942|FG000|STARTED|Period 3||5
11288583|NCT02465866|12485943|FG001|STARTED|Period 3||5
11288584|NCT02465866|12485944|FG002|STARTED|Period 3||5
11288585|NCT02465866|12485945|FG003|STARTED|Period 3||5
11288586|NCT02465866|12485942|FG000|COMPLETED|Period 3||5
11288587|NCT02465866|12485943|FG001|COMPLETED|Period 3||4
11288588|NCT02465866|12485944|FG002|COMPLETED|Period 3||5
11288589|NCT02465866|12485945|FG003|COMPLETED|Period 3||5
11288590|NCT02465866|12485942|FG000|NOT COMPLETED|Period 3||0
11288591|NCT02465866|12485943|FG001|NOT COMPLETED|Period 3||1
11288592|NCT02465866|12485944|FG002|NOT COMPLETED|Period 3||0
11288593|NCT02465866|12485945|FG003|NOT COMPLETED|Period 3||0
11288594|NCT02465866|12485942|FG000|STARTED|Period 3: Washout (14 Days)||5
11288595|NCT02465866|12485943|FG001|STARTED|Period 3: Washout (14 Days)||4
11288596|NCT02465866|12485944|FG002|STARTED|Period 3: Washout (14 Days)||5
11288597|NCT02465866|12485945|FG003|STARTED|Period 3: Washout (14 Days)||5
11288598|NCT02465866|12485942|FG000|COMPLETED|Period 3: Washout (14 Days)||5
11288599|NCT02465866|12485943|FG001|COMPLETED|Period 3: Washout (14 Days)||4
11288600|NCT02465866|12485944|FG002|COMPLETED|Period 3: Washout (14 Days)||5
11288601|NCT02465866|12485945|FG003|COMPLETED|Period 3: Washout (14 Days)||5
11288602|NCT02465866|12485942|FG000|NOT COMPLETED|Period 3: Washout (14 Days)||0
11288603|NCT02465866|12485943|FG001|NOT COMPLETED|Period 3: Washout (14 Days)||0
11288604|NCT02465866|12485944|FG002|NOT COMPLETED|Period 3: Washout (14 Days)||0
11288605|NCT02465866|12485945|FG003|NOT COMPLETED|Period 3: Washout (14 Days)||0
11288606|NCT02465866|12485942|FG000|STARTED|Period 4||5
11288607|NCT02465866|12485943|FG001|STARTED|Period 4||4
11288608|NCT02465866|12485944|FG002|STARTED|Period 4||5
11288609|NCT02465866|12485945|FG003|STARTED|Period 4||5
11288610|NCT02465866|12485942|FG000|COMPLETED|Period 4||5
11288611|NCT02465866|12485943|FG001|COMPLETED|Period 4||4
11288612|NCT02465866|12485944|FG002|COMPLETED|Period 4||5
11288613|NCT02465866|12485945|FG003|COMPLETED|Period 4||5
11288614|NCT02465866|12485942|FG000|NOT COMPLETED|Period 4||0
11288615|NCT02465866|12485943|FG001|NOT COMPLETED|Period 4||0
11288616|NCT02465866|12485944|FG002|NOT COMPLETED|Period 4||0
11288617|NCT02465866|12485945|FG003|NOT COMPLETED|Period 4||0
11288618|NCT02465866|12485942|FG000|STARTED|Period 4: Washout (14 Days)||5
11288619|NCT02465866|12485943|FG001|STARTED|Period 4: Washout (14 Days)||4
11288620|NCT02465866|12485944|FG002|STARTED|Period 4: Washout (14 Days)||5
11288621|NCT02465866|12485945|FG003|STARTED|Period 4: Washout (14 Days)||5
11288622|NCT02465866|12485942|FG000|COMPLETED|Period 4: Washout (14 Days)||5
11288623|NCT02465866|12485943|FG001|COMPLETED|Period 4: Washout (14 Days)||4
11288624|NCT02465866|12485944|FG002|COMPLETED|Period 4: Washout (14 Days)||5
11288625|NCT02465866|12485945|FG003|COMPLETED|Period 4: Washout (14 Days)||5
11288626|NCT02465866|12485942|FG000|NOT COMPLETED|Period 4: Washout (14 Days)||0
11288627|NCT02465866|12485943|FG001|NOT COMPLETED|Period 4: Washout (14 Days)||0
11288628|NCT02465866|12485944|FG002|NOT COMPLETED|Period 4: Washout (14 Days)||0
11288629|NCT02465866|12485945|FG003|NOT COMPLETED|Period 4: Washout (14 Days)||0
11288630|NCT02465931|12485957|FG000|STARTED|Overall Study||55
11288631|NCT02465931|12485958|FG001|STARTED|Overall Study||56
11288632|NCT02465931|12485957|FG000|COMPLETED|Overall Study||44
11288633|NCT02465931|12485958|FG001|COMPLETED|Overall Study||45
11288634|NCT02465931|12485957|FG000|NOT COMPLETED|Overall Study||11
11288635|NCT02465931|12485958|FG001|NOT COMPLETED|Overall Study||11
11288636|NCT02466087|12485964|FG000|STARTED|First Intervention: Weeks 1-6||62
11288637|NCT02466087|12485965|FG001|STARTED|First Intervention: Weeks 1-6||64
11288638|NCT02466087|12485964|FG000|COMPLETED|First Intervention: Weeks 1-6||55
11288639|NCT02466087|12485965|FG001|COMPLETED|First Intervention: Weeks 1-6||57
11288640|NCT02466087|12485964|FG000|NOT COMPLETED|First Intervention: Weeks 1-6||7
11288641|NCT02466087|12485965|FG001|NOT COMPLETED|First Intervention: Weeks 1-6||7
11288642|NCT02466087|12485964|FG000|STARTED|Second Intervention: Weeks 7-12||55
11288643|NCT02466087|12485965|FG001|STARTED|Second Intervention: Weeks 7-12||57
11288644|NCT02466087|12485964|FG000|COMPLETED|Second Intervention: Weeks 7-12||55
11288645|NCT02466087|12485965|FG001|COMPLETED|Second Intervention: Weeks 7-12||57
11288646|NCT02466087|12485964|FG000|NOT COMPLETED|Second Intervention: Weeks 7-12||0
11288647|NCT02466087|12485965|FG001|NOT COMPLETED|Second Intervention: Weeks 7-12||0
11288648|NCT02466126|12485974|FG000|STARTED|Baseline||109
11288649|NCT02466126|12485975|FG001|STARTED|Baseline||80
11288650|NCT02466126|12485974|FG000|COMPLETED|Baseline||109
11288651|NCT02466126|12485975|FG001|COMPLETED|Baseline||80
11288652|NCT02466126|12485974|FG000|NOT COMPLETED|Baseline||0
11288653|NCT02466126|12485975|FG001|NOT COMPLETED|Baseline||0
11288654|NCT02466126|12485974|FG000|STARTED|4 Month Assessment||109
11288655|NCT02466126|12485975|FG001|STARTED|4 Month Assessment||80
11288656|NCT02466126|12485974|FG000|COMPLETED|4 Month Assessment||93
11288657|NCT02466126|12485975|FG001|COMPLETED|4 Month Assessment||71
11288658|NCT02466126|12485974|FG000|NOT COMPLETED|4 Month Assessment||16
11288659|NCT02466126|12485975|FG001|NOT COMPLETED|4 Month Assessment||9
11288660|NCT02466126|12485974|FG000|STARTED|8 Month Assessment||93
11288661|NCT02466126|12485975|FG001|STARTED|8 Month Assessment||71
11288662|NCT02466126|12485974|FG000|COMPLETED|8 Month Assessment||86
11288663|NCT02466126|12485975|FG001|COMPLETED|8 Month Assessment||68
11288664|NCT02466126|12485974|FG000|NOT COMPLETED|8 Month Assessment||7
11288665|NCT02466126|12485975|FG001|NOT COMPLETED|8 Month Assessment||3
11288666|NCT02466126|12485974|FG000|STARTED|12 Month Assessment||86
11288667|NCT02466126|12485975|FG001|STARTED|12 Month Assessment||68
11288668|NCT02466126|12485974|FG000|COMPLETED|12 Month Assessment||85
11288669|NCT02466126|12485975|FG001|COMPLETED|12 Month Assessment||66
11288670|NCT02466126|12485974|FG000|NOT COMPLETED|12 Month Assessment||1
11288671|NCT02466126|12485975|FG001|NOT COMPLETED|12 Month Assessment||2
11288672|NCT02466230|12485981|FG000|STARTED|Overall Study||28
11288673|NCT02466230|12485981|FG000|COMPLETED|Overall Study||28
11288674|NCT02466230|12485981|FG000|NOT COMPLETED|Overall Study||0
11288675|NCT02466386|12485985|FG000|STARTED|Overall Study||113
11288676|NCT02466386|12485985|FG000|COMPLETED|Overall Study||69
11288677|NCT02466386|12485985|FG000|NOT COMPLETED|Overall Study||44
11288678|NCT02466399|12485991|FG000|STARTED|Overall Study||53
11288679|NCT02466399|12485992|FG001|STARTED|Overall Study||27
11288680|NCT02466399|12485991|FG000|COMPLETED|Overall Study||51
11288681|NCT02466399|12485992|FG001|COMPLETED|Overall Study||27
11288682|NCT02466399|12485991|FG000|NOT COMPLETED|Overall Study||2
11288683|NCT02466399|12485992|FG001|NOT COMPLETED|Overall Study||0
11288684|NCT02466412|12486000|FG000|STARTED|Washout Period of 1 Day (Day -1)||24
11288685|NCT02466412|12486001|FG001|STARTED|Washout Period of 1 Day (Day -1)||24
11288686|NCT02466412|12486000|FG000|COMPLETED|Washout Period of 1 Day (Day -1)||24
11288687|NCT02466412|12486001|FG001|COMPLETED|Washout Period of 1 Day (Day -1)||24
11288688|NCT02466412|12486000|FG000|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
11288689|NCT02466412|12486001|FG001|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
11288690|NCT02466412|12486000|FG000|STARTED|First Intervention (Day 1)||24
11288691|NCT02466412|12486001|FG001|STARTED|First Intervention (Day 1)||24
11288692|NCT02466412|12486000|FG000|COMPLETED|First Intervention (Day 1)||24
11288693|NCT02466412|12486001|FG001|COMPLETED|First Intervention (Day 1)||24
11288694|NCT02466412|12486000|FG000|NOT COMPLETED|First Intervention (Day 1)||0
11288695|NCT02466412|12486001|FG001|NOT COMPLETED|First Intervention (Day 1)||0
11288696|NCT02466412|12486000|FG000|STARTED|Washout Period of 1 Day (Day 2)||24
11288697|NCT02466412|12486001|FG001|STARTED|Washout Period of 1 Day (Day 2)||24
11288698|NCT02466412|12486000|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||24
11288699|NCT02466412|12486001|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||24
11288700|NCT02466412|12486000|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11288701|NCT02466412|12486001|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11288702|NCT02466412|12486000|FG000|STARTED|Second Intervention (Day 3)||24
11288703|NCT02466412|12486001|FG001|STARTED|Second Intervention (Day 3)||24
11288704|NCT02466412|12486000|FG000|COMPLETED|Second Intervention (Day 3)||24
11288705|NCT02466412|12486001|FG001|COMPLETED|Second Intervention (Day 3)||24
11288706|NCT02466412|12486000|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
11288707|NCT02466412|12486001|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
11288708|NCT02466425|12486010|FG000|STARTED|Overall Study||132
11288709|NCT02466425|12486011|FG001|STARTED|Overall Study||132
11288710|NCT02466425|12486010|FG000|Treated|Overall Study||131
11288711|NCT02466425|12486011|FG001|Treated|Overall Study||132
11288712|NCT02466425|12486010|FG000|COMPLETED|Overall Study||118
11288713|NCT02466425|12486011|FG001|COMPLETED|Overall Study||116
11288714|NCT02466425|12486010|FG000|NOT COMPLETED|Overall Study||14
11288715|NCT02466425|12486011|FG001|NOT COMPLETED|Overall Study||16
11288716|NCT02466516|12486022|FG000|STARTED|Overall Study||20
11288717|NCT02466516|12486023|FG001|STARTED|Overall Study||22
11288718|NCT02466516|12486024|FG002|STARTED|Overall Study||10
11288719|NCT02466516|12486025|FG003|STARTED|Overall Study||10
11288720|NCT02466516|12486026|FG004|STARTED|Overall Study||10
11288721|NCT02466516|12486022|FG000|COMPLETED|Overall Study||16
11288722|NCT02466516|12486023|FG001|COMPLETED|Overall Study||21
11288723|NCT02466516|12486024|FG002|COMPLETED|Overall Study||9
11288724|NCT02466516|12486025|FG003|COMPLETED|Overall Study||10
11288725|NCT02466516|12486026|FG004|COMPLETED|Overall Study||10
11288726|NCT02466516|12486022|FG000|NOT COMPLETED|Overall Study||4
11288727|NCT02466516|12486023|FG001|NOT COMPLETED|Overall Study||1
11288728|NCT02466516|12486024|FG002|NOT COMPLETED|Overall Study||1
11288729|NCT02466516|12486025|FG003|NOT COMPLETED|Overall Study||0
11288730|NCT02466516|12486026|FG004|NOT COMPLETED|Overall Study||0
11288731|NCT02466555|12486038|FG000|STARTED|Overall Study||30
11288732|NCT02466555|12486038|FG000|COMPLETED|Overall Study||28
11288733|NCT02466555|12486038|FG000|NOT COMPLETED|Overall Study||2
11288734|NCT02466646|12486046|FG000|STARTED|Overall Study||14
11288735|NCT02466646|12486047|FG001|STARTED|Overall Study||14
11288736|NCT02466646|12486048|FG002|STARTED|Overall Study||14
11288737|NCT02466646|12486046|FG000|COMPLETED|Overall Study||14
11288738|NCT02466646|12486047|FG001|COMPLETED|Overall Study||14
11288739|NCT02466646|12486048|FG002|COMPLETED|Overall Study||14
11288740|NCT02466646|12486046|FG000|NOT COMPLETED|Overall Study||0
11288741|NCT02466646|12486047|FG001|NOT COMPLETED|Overall Study||0
11288742|NCT02466646|12486048|FG002|NOT COMPLETED|Overall Study||0
11288743|NCT02466659|12486061|FG000|STARTED|Overall Study||5
11288744|NCT02466659|12486062|FG001|STARTED|Overall Study||3
11288745|NCT02466659|12486061|FG000|COMPLETED|Overall Study||0
11288746|NCT02466659|12486062|FG001|COMPLETED|Overall Study||1
11288747|NCT02466659|12486061|FG000|NOT COMPLETED|Overall Study||5
11288748|NCT02466659|12486062|FG001|NOT COMPLETED|Overall Study||2
11288749|NCT02466958|12486070|FG000|STARTED|Overall Study||17
11288750|NCT02466958|12486071|FG001|STARTED|Overall Study||12
11288751|NCT02466958|12486070|FG000|COMPLETED|Overall Study||7
11288752|NCT02466958|12486071|FG001|COMPLETED|Overall Study||9
11288753|NCT02466958|12486070|FG000|NOT COMPLETED|Overall Study||10
11288754|NCT02466958|12486071|FG001|NOT COMPLETED|Overall Study||3
11288755|NCT02467075|12486079|FG000|STARTED|Initial CT Scan||0
11288756|NCT02467075|12486080|FG001|STARTED|Initial CT Scan||1
11288757|NCT02467075|12486079|FG000|COMPLETED|Initial CT Scan||0
11288758|NCT02467075|12486080|FG001|COMPLETED|Initial CT Scan||1
11288759|NCT02467075|12486079|FG000|NOT COMPLETED|Initial CT Scan||0
11288760|NCT02467075|12486080|FG001|NOT COMPLETED|Initial CT Scan||0
11288761|NCT02467075|12486079|FG000|STARTED|48 Hour Follow-up||0
11288762|NCT02467075|12486080|FG001|STARTED|48 Hour Follow-up||1
11288763|NCT02467075|12486079|FG000|COMPLETED|48 Hour Follow-up||0
11288764|NCT02467075|12486080|FG001|COMPLETED|48 Hour Follow-up||1
11288765|NCT02467075|12486079|FG000|NOT COMPLETED|48 Hour Follow-up||0
11288766|NCT02467075|12486080|FG001|NOT COMPLETED|48 Hour Follow-up||0
11288767|NCT02467075|12486079|FG000|STARTED|72 Hour Follow-up||0
11288768|NCT02467075|12486080|FG001|STARTED|72 Hour Follow-up||1
11288769|NCT02467075|12486079|FG000|COMPLETED|72 Hour Follow-up||0
11288770|NCT02467075|12486080|FG001|COMPLETED|72 Hour Follow-up||1
11288771|NCT02467075|12486079|FG000|NOT COMPLETED|72 Hour Follow-up||0
11288772|NCT02467075|12486080|FG001|NOT COMPLETED|72 Hour Follow-up||0
11288773|NCT02467075|12486079|FG000|STARTED|30 Day Follow-up||0
11288774|NCT02467075|12486080|FG001|STARTED|30 Day Follow-up||1
11288775|NCT02467075|12486079|FG000|COMPLETED|30 Day Follow-up||0
11288776|NCT02467075|12486080|FG001|COMPLETED|30 Day Follow-up||1
11288777|NCT02467075|12486079|FG000|NOT COMPLETED|30 Day Follow-up||0
11288778|NCT02467075|12486080|FG001|NOT COMPLETED|30 Day Follow-up||0
11288779|NCT02467166|12486088|FG000|STARTED|Overall Study||36
11288780|NCT02467166|12486088|FG000|COMPLETED|Overall Study||36
11288781|NCT02467166|12486088|FG000|NOT COMPLETED|Overall Study||0
11288782|NCT02467179|12486094|FG000|STARTED|Overall Study||25
11288783|NCT02467179|12486095|FG001|STARTED|Overall Study||25
11288784|NCT02467179|12486094|FG000|COMPLETED|Overall Study||25
11288785|NCT02467179|12486095|FG001|COMPLETED|Overall Study||25
11288786|NCT02467179|12486094|FG000|NOT COMPLETED|Overall Study||0
11288787|NCT02467179|12486095|FG001|NOT COMPLETED|Overall Study||0
11288788|NCT02467192|12486101|FG000|STARTED|Overall Study||203
11288789|NCT02467192|12486101|FG000|COMPLETED|Overall Study||200
11288790|NCT02467192|12486101|FG000|NOT COMPLETED|Overall Study||3
11288791|NCT02467387|12486109|FG000|STARTED|First Intervention||11
11288792|NCT02467387|12486110|FG001|STARTED|First Intervention||12
11288793|NCT02467387|12486109|FG000|Received Treatment as Randomized|First Intervention||10
11288794|NCT02467387|12486110|FG001|Received Treatment as Randomized|First Intervention||12
11288795|NCT02467387|12486109|FG000|COMPLETED|First Intervention||10
11288796|NCT02467387|12486110|FG001|COMPLETED|First Intervention||12
11288797|NCT02467387|12486109|FG000|NOT COMPLETED|First Intervention||1
11288798|NCT02467387|12486110|FG001|NOT COMPLETED|First Intervention||0
11288799|NCT02467387|12486109|FG000|STARTED|Second Intervention||10
11288800|NCT02467387|12486110|FG001|STARTED|Second Intervention||12
11288801|NCT02467387|12486109|FG000|COMPLETED|Second Intervention||7
11288802|NCT02467387|12486110|FG001|COMPLETED|Second Intervention||12
11288803|NCT02467387|12486109|FG000|NOT COMPLETED|Second Intervention||3
11288804|NCT02467387|12486110|FG001|NOT COMPLETED|Second Intervention||0
11288805|NCT02467465|12486120|FG000|STARTED|Overall Study||15
11288806|NCT02467465|12486121|FG001|STARTED|Overall Study||15
11288807|NCT02467465|12486120|FG000|COMPLETED|Overall Study||15
11288808|NCT02467465|12486121|FG001|COMPLETED|Overall Study||15
11288809|NCT02467465|12486120|FG000|NOT COMPLETED|Overall Study||0
11288810|NCT02467465|12486121|FG001|NOT COMPLETED|Overall Study||0
11288811|NCT02467491|12486129|FG000|STARTED|Overall Study||12
11288812|NCT02467491|12486129|FG000|COMPLETED|Overall Study||12
11288813|NCT02467491|12486129|FG000|NOT COMPLETED|Overall Study||0
11288814|NCT02467504|12486135|FG000|STARTED|Overall Study||23
11288815|NCT02467504|12486136|FG001|STARTED|Overall Study||24
11288816|NCT02467504|12486135|FG000|COMPLETED|Overall Study||17
11288817|NCT02467504|12486136|FG001|COMPLETED|Overall Study||23
11288818|NCT02467504|12486135|FG000|NOT COMPLETED|Overall Study||6
11288819|NCT02467504|12486136|FG001|NOT COMPLETED|Overall Study||1
11288820|NCT02467621|12486144|FG000|STARTED|Overall Study||1645
11288821|NCT02467621|12486145|FG001|STARTED|Overall Study||1653
11288822|NCT02467621|12486144|FG000|COMPLETED|Overall Study||1644
11288823|NCT02467621|12486145|FG001|COMPLETED|Overall Study||1647
11288824|NCT02467621|12486144|FG000|NOT COMPLETED|Overall Study||1
11288825|NCT02467621|12486145|FG001|NOT COMPLETED|Overall Study||6
11288826|NCT02467777|12486153|FG000|STARTED|Overall Study||23
11288827|NCT02467777|12486154|FG001|STARTED|Overall Study||27
11288828|NCT02467777|12486153|FG000|COMPLETED|Overall Study||23
11288829|NCT02467777|12486154|FG001|COMPLETED|Overall Study||27
11288830|NCT02467777|12486153|FG000|NOT COMPLETED|Overall Study||0
11288831|NCT02467777|12486154|FG001|NOT COMPLETED|Overall Study||0
11288832|NCT02467842|12486163|FG000|STARTED|Overall Study||752
11288833|NCT02467842|12486164|FG001|STARTED|Overall Study||373
11288834|NCT02467842|12486165|FG002|STARTED|Overall Study||378
11288835|NCT02467842|12486163|FG000|COMPLETED|Overall Study||752
11288836|NCT02467842|12486164|FG001|COMPLETED|Overall Study||373
11288837|NCT02467842|12486165|FG002|COMPLETED|Overall Study||378
11288838|NCT02467842|12486163|FG000|NOT COMPLETED|Overall Study||0
11288839|NCT02467842|12486164|FG001|NOT COMPLETED|Overall Study||0
11288840|NCT02467842|12486165|FG002|NOT COMPLETED|Overall Study||0
11288841|NCT02468154|12486177|FG000|STARTED|Overall Study||29
11288842|NCT02468154|12486178|FG001|STARTED|Overall Study||28
11288843|NCT02468154|12486177|FG000|COMPLETED|Overall Study||29
11288844|NCT02468154|12486178|FG001|COMPLETED|Overall Study||28
11288845|NCT02468154|12486177|FG000|NOT COMPLETED|Overall Study||0
11288846|NCT02468154|12486178|FG001|NOT COMPLETED|Overall Study||0
11288847|NCT02468193|12486184|FG000|STARTED|Overall Study||9
11288848|NCT02468193|12486184|FG000|Completed Week-12 (Study Period I)|Overall Study||7
11288849|NCT02468193|12486184|FG000|Discontinued at or Prior to Week-12|Overall Study||2
11288850|NCT02468193|12486184|FG000|Completed Week-12, Did Not Enter Per. II|Overall Study||3
11288851|NCT02468193|12486184|FG000|Completed Week-12, Entered Study Per. II|Overall Study||4
11288852|NCT02468193|12486184|FG000|Completed Week-48 (Study Period II)|Overall Study||2
11288853|NCT02468193|12486184|FG000|Discontinued at or Prior to Week48|Overall Study||2
11288854|NCT02468193|12486184|FG000|Compl. Wk-48, Didn't Enter Opt. Ext. Per|Overall Study||0
11288855|NCT02468193|12486184|FG000|Compl. Wk-48, Entered Opt. Ext. Period|Overall Study||2
11288856|NCT02468193|12486184|FG000|Completed Optional Extension Period|Overall Study||0
11288857|NCT02468193|12486184|FG000|Discontinued Study in Optional Ext. Per.|Overall Study||2
11288858|NCT02468193|12486184|FG000|COMPLETED|Overall Study||3
11288859|NCT02468193|12486184|FG000|NOT COMPLETED|Overall Study||6
11288860|NCT02468557|12486204|FG000|STARTED|Overall Study||16
11288861|NCT02468557|12486204|FG000|COMPLETED|Overall Study||0
11288862|NCT02468557|12486204|FG000|NOT COMPLETED|Overall Study||16
11288863|NCT02468570|12486214|FG000|STARTED|Overall Study||6
11288864|NCT02468570|12486215|FG001|STARTED|Overall Study||3
11288865|NCT02468570|12486214|FG000|COMPLETED|Overall Study||6
11288866|NCT02468570|12486215|FG001|COMPLETED|Overall Study||3
11288867|NCT02468570|12486214|FG000|NOT COMPLETED|Overall Study||0
11288868|NCT02468570|12486215|FG001|NOT COMPLETED|Overall Study||0
11288869|NCT02468648|12486221|FG000|STARTED|Overall Study||72
11288870|NCT02468648|12486221|FG000|COMPLETED|Overall Study||71
11288871|NCT02468648|12486221|FG000|NOT COMPLETED|Overall Study||1
11288872|NCT02468674|12486234|FG000|STARTED|Overall Study||5
11288873|NCT02468674|12486235|FG001|STARTED|Overall Study||5
11288874|NCT02468674|12486236|FG002|STARTED|Overall Study||5
11288875|NCT02468674|12486237|FG003|STARTED|Overall Study||4
11288876|NCT02468674|12486238|FG004|STARTED|Overall Study||7
11288877|NCT02468674|12486239|FG005|STARTED|Overall Study||7
11288878|NCT02468674|12486240|FG006|STARTED|Overall Study||15
11288879|NCT02468674|12486241|FG007|STARTED|Overall Study||69
11288880|NCT02468674|12486242|FG008|STARTED|Overall Study||43
11288881|NCT02468674|12486234|FG000|COMPLETED|Overall Study||4
11021817|NCT00806195|12200009|FG002|NOT COMPLETED|Overall Study||270
11021818|NCT00806195|12200010|FG003|NOT COMPLETED|Overall Study||106
11021819|NCT00806221|12200022|FG000|STARTED|Overall Study||22
11021820|NCT00806221|12200022|FG000|COMPLETED|Overall Study||20
11021821|NCT00806221|12200022|FG000|NOT COMPLETED|Overall Study||2
11021822|NCT00806234|12200029|FG000|STARTED|Overall Study||47
11021823|NCT00806234|12200030|FG001|STARTED|Overall Study||31
11021824|NCT00806234|12200031|FG002|STARTED|Overall Study||49
11021825|NCT00806234|12200029|FG000|COMPLETED|Overall Study||34
11288882|NCT02468674|12486235|FG001|COMPLETED|Overall Study||5
11288883|NCT02468674|12486236|FG002|COMPLETED|Overall Study||5
11288884|NCT02468674|12486237|FG003|COMPLETED|Overall Study||3
11288885|NCT02468674|12486238|FG004|COMPLETED|Overall Study||6
11288886|NCT02468674|12486239|FG005|COMPLETED|Overall Study||6
11288887|NCT02468674|12486240|FG006|COMPLETED|Overall Study||14
11288888|NCT02468674|12486241|FG007|COMPLETED|Overall Study||65
11021826|NCT00806234|12200030|FG001|COMPLETED|Overall Study||19
11288889|NCT02468674|12486242|FG008|COMPLETED|Overall Study||40
11021827|NCT00806234|12200031|FG002|COMPLETED|Overall Study||37
11021828|NCT00806234|12200029|FG000|NOT COMPLETED|Overall Study||13
11021829|NCT00806234|12200030|FG001|NOT COMPLETED|Overall Study||12
11021830|NCT00806234|12200031|FG002|NOT COMPLETED|Overall Study||12
11021831|NCT00806260|12200045|FG000|STARTED|Period 1 (1 Day)||15
11021832|NCT00806260|12200046|FG001|STARTED|Period 1 (1 Day)||8
11021833|NCT00806260|12200047|FG002|STARTED|Period 1 (1 Day)||8
11021834|NCT00806260|12200048|FG003|STARTED|Period 1 (1 Day)||14
11021835|NCT00806260|12200049|FG004|STARTED|Period 1 (1 Day)||18
11021836|NCT00806260|12200050|FG005|STARTED|Period 1 (1 Day)||17
11021837|NCT00806260|12200045|FG000|COMPLETED|Period 1 (1 Day)||15
11021838|NCT00806260|12200046|FG001|COMPLETED|Period 1 (1 Day)||8
11021839|NCT00806260|12200047|FG002|COMPLETED|Period 1 (1 Day)||8
11021840|NCT00806260|12200048|FG003|COMPLETED|Period 1 (1 Day)||14
11021841|NCT00806260|12200049|FG004|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
11021842|NCT00806260|12200050|FG005|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
11021843|NCT00806260|12200045|FG000|NOT COMPLETED|Period 1 (1 Day)||0
11021844|NCT00806260|12200046|FG001|NOT COMPLETED|Period 1 (1 Day)||0
11021845|NCT00806260|12200047|FG002|NOT COMPLETED|Period 1 (1 Day)||0
11021846|NCT00806260|12200048|FG003|NOT COMPLETED|Period 1 (1 Day)||0
11021847|NCT00806260|12200049|FG004|NOT COMPLETED|Period 1 (1 Day)||3
11021848|NCT00806260|12200050|FG005|NOT COMPLETED|Period 1 (1 Day)||0
11021849|NCT00806260|12200045|FG000|STARTED|Period 2||15
11021850|NCT00806260|12200046|FG001|STARTED|Period 2||8
11021851|NCT00806260|12200047|FG002|STARTED|Period 2||8
11021852|NCT00806260|12200048|FG003|STARTED|Period 2||14
11021853|NCT00806260|12200049|FG004|STARTED|Period 2||0
11021854|NCT00806260|12200050|FG005|STARTED|Period 2||0
11021855|NCT00806260|12200045|FG000|COMPLETED|Period 2||13
11021856|NCT00806260|12200046|FG001|COMPLETED|Period 2||8
11288890|NCT02468674|12486234|FG000|NOT COMPLETED|Overall Study||1
11288891|NCT02468674|12486235|FG001|NOT COMPLETED|Overall Study||0
11288892|NCT02468674|12486236|FG002|NOT COMPLETED|Overall Study||0
11288893|NCT02468674|12486237|FG003|NOT COMPLETED|Overall Study||1
11288894|NCT02468674|12486238|FG004|NOT COMPLETED|Overall Study||1
11288895|NCT02468674|12486239|FG005|NOT COMPLETED|Overall Study||1
11288896|NCT02468674|12486240|FG006|NOT COMPLETED|Overall Study||1
11288897|NCT02468674|12486241|FG007|NOT COMPLETED|Overall Study||4
11288898|NCT02468674|12486242|FG008|NOT COMPLETED|Overall Study||3
11288899|NCT02468700|12486264|FG000|STARTED|Overall Study||22
11021857|NCT00806260|12200047|FG002|COMPLETED|Period 2||6
11021858|NCT00806260|12200048|FG003|COMPLETED|Period 2||12
11021859|NCT00806260|12200049|FG004|COMPLETED|Period 2||0
11021860|NCT00806260|12200050|FG005|COMPLETED|Period 2||0
11021861|NCT00806260|12200045|FG000|NOT COMPLETED|Period 2||2
11021862|NCT00806260|12200046|FG001|NOT COMPLETED|Period 2||0
11021863|NCT00806260|12200047|FG002|NOT COMPLETED|Period 2||2
11021864|NCT00806260|12200048|FG003|NOT COMPLETED|Period 2||2
11021865|NCT00806260|12200049|FG004|NOT COMPLETED|Period 2||0
11021866|NCT00806260|12200050|FG005|NOT COMPLETED|Period 2||0
11021867|NCT00806260|12200045|FG000|STARTED|Period 3||13
11021868|NCT00806260|12200046|FG001|STARTED|Period 3||8
11021869|NCT00806260|12200047|FG002|STARTED|Period 3||6
11288900|NCT02468700|12486265|FG001|STARTED|Overall Study||21
11288901|NCT02468700|12486264|FG000|COMPLETED|Overall Study||20
11288902|NCT02468700|12486265|FG001|COMPLETED|Overall Study||19
11288903|NCT02468700|12486264|FG000|NOT COMPLETED|Overall Study||2
11288904|NCT02468700|12486265|FG001|NOT COMPLETED|Overall Study||2
11288905|NCT02468804|12486273|FG000|STARTED|Overall Study||37
11288906|NCT02468804|12486274|FG001|STARTED|Overall Study||58
11288907|NCT02468804|12486273|FG000|COMPLETED|Overall Study||36
11399614|NCT04318535|12594227|FG000|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
11399615|NCT04318535|12594228|FG001|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
11399616|NCT04318535|12594229|FG002|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
11399617|NCT04318535|12594227|FG000|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
11288908|NCT02468804|12486274|FG001|COMPLETED|Overall Study||50
11288909|NCT02468804|12486273|FG000|NOT COMPLETED|Overall Study||1
11288910|NCT02468804|12486274|FG001|NOT COMPLETED|Overall Study||8
11288911|NCT02468830|12486280|FG000|STARTED|Overall Study||58
11288912|NCT02468830|12486280|FG000|COMPLETED|Overall Study||55
11288913|NCT02468830|12486280|FG000|NOT COMPLETED|Overall Study||3
11288914|NCT02468934|12486284|FG000|STARTED|Overall Study||27
11288915|NCT02468934|12486284|FG000|Enrolled/Received Leads|Overall Study||24
11288916|NCT02468934|12486284|FG000|Underwent Total Knee Arthroplasty|Overall Study||20
11288917|NCT02468934|12486284|FG000|COMPLETED|Overall Study||20
11288918|NCT02468934|12486284|FG000|NOT COMPLETED|Overall Study||7
11288919|NCT02469038|12486292|FG000|STARTED|Overall Study||26
11288920|NCT02469038|12486293|FG001|STARTED|Overall Study||24
11399618|NCT04318535|12594228|FG001|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
11399619|NCT04318535|12594229|FG002|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
11399620|NCT04318535|12594227|FG000|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
11399621|NCT04318535|12594228|FG001|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
11399622|NCT04318535|12594229|FG002|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
11399623|NCT04318535|12594227|FG000|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
11399624|NCT04318535|12594228|FG001|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
11288921|NCT02469038|12486292|FG000|COMPLETED|Overall Study||22
11288922|NCT02469038|12486293|FG001|COMPLETED|Overall Study||19
11288923|NCT02469038|12486292|FG000|NOT COMPLETED|Overall Study||4
11288924|NCT02469038|12486293|FG001|NOT COMPLETED|Overall Study||5
11288925|NCT02469064|12486301|FG000|STARTED|Overall Study||64
11288926|NCT02469064|12486302|FG001|STARTED|Overall Study||62
11288927|NCT02469064|12486301|FG000|COMPLETED|Overall Study||63
11288928|NCT02469064|12486302|FG001|COMPLETED|Overall Study||59
11288929|NCT02469064|12486301|FG000|NOT COMPLETED|Overall Study||1
11288930|NCT02469064|12486302|FG001|NOT COMPLETED|Overall Study||3
11288931|NCT02469077|12486310|FG000|STARTED|Pre Randomization - Pre Intervention||44
11288932|NCT02469077|12486311|FG001|STARTED|Pre Randomization - Pre Intervention||49
11288933|NCT02469077|12486310|FG000|Pre Intervention Placebo|Pre Randomization - Pre Intervention||44
11288934|NCT02469077|12486311|FG001|Pre Intervention Placebo|Pre Randomization - Pre Intervention||49
11288935|NCT02469077|12486310|FG000|Pre Intervention Morpine|Pre Randomization - Pre Intervention||44
11288936|NCT02469077|12486311|FG001|Pre Intervention Morpine|Pre Randomization - Pre Intervention||49
11288937|NCT02469077|12486310|FG000|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||44
11288938|NCT02469077|12486311|FG001|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||49
11288939|NCT02469077|12486310|FG000|COMPLETED|Pre Randomization - Pre Intervention||44
11288940|NCT02469077|12486311|FG001|COMPLETED|Pre Randomization - Pre Intervention||49
11288941|NCT02469077|12486310|FG000|NOT COMPLETED|Pre Randomization - Pre Intervention||0
11288942|NCT02469077|12486311|FG001|NOT COMPLETED|Pre Randomization - Pre Intervention||0
11288943|NCT02469077|12486310|FG000|STARTED|Post Randomization/Intervention Period||44
11288944|NCT02469077|12486311|FG001|STARTED|Post Randomization/Intervention Period||49
11288945|NCT02469077|12486310|FG000|COMPLETED|Post Randomization/Intervention Period||40
11288946|NCT02469077|12486311|FG001|COMPLETED|Post Randomization/Intervention Period||45
11288947|NCT02469077|12486310|FG000|NOT COMPLETED|Post Randomization/Intervention Period||4
11021870|NCT00806260|12200048|FG003|STARTED|Period 3||12
11021871|NCT00806260|12200049|FG004|STARTED|Period 3||0
11288948|NCT02469077|12486311|FG001|NOT COMPLETED|Post Randomization/Intervention Period||4
11288949|NCT02469077|12486310|FG000|STARTED|Post Intervention /Followup||40
11288950|NCT02469077|12486311|FG001|STARTED|Post Intervention /Followup||45
11288951|NCT02469077|12486310|FG000|Post Intervention Placebo|Post Intervention /Followup||39
11288952|NCT02469077|12486311|FG001|Post Intervention Placebo|Post Intervention /Followup||45
11288953|NCT02469077|12486310|FG000|Post Intervention Morphine|Post Intervention /Followup||40
11288954|NCT02469077|12486311|FG001|Post Intervention Morphine|Post Intervention /Followup||45
11288955|NCT02469077|12486310|FG000|Post Intervention Naloxone|Post Intervention /Followup||39
11288956|NCT02469077|12486311|FG001|Post Intervention Naloxone|Post Intervention /Followup||44
11288957|NCT02469077|12486310|FG000|COMPLETED|Post Intervention /Followup||38
11288958|NCT02469077|12486311|FG001|COMPLETED|Post Intervention /Followup||44
11288959|NCT02469077|12486310|FG000|NOT COMPLETED|Post Intervention /Followup||2
11288960|NCT02469077|12486311|FG001|NOT COMPLETED|Post Intervention /Followup||1
11288961|NCT02469090|12486323|FG000|STARTED|Period 1: Dose Titration Phase||141
11021872|NCT00806260|12200050|FG005|STARTED|Period 3||0
11288962|NCT02469090|12486324|FG001|STARTED|Period 1: Dose Titration Phase||0
11288963|NCT02469090|12486325|FG002|STARTED|Period 1: Dose Titration Phase||0
11288964|NCT02469090|12486323|FG000|COMPLETED|Period 1: Dose Titration Phase||109
11288965|NCT02469090|12486324|FG001|COMPLETED|Period 1: Dose Titration Phase||0
11288966|NCT02469090|12486325|FG002|COMPLETED|Period 1: Dose Titration Phase||0
11288967|NCT02469090|12486323|FG000|NOT COMPLETED|Period 1: Dose Titration Phase||32
11288968|NCT02469090|12486324|FG001|NOT COMPLETED|Period 1: Dose Titration Phase||0
11288969|NCT02469090|12486325|FG002|NOT COMPLETED|Period 1: Dose Titration Phase||0
11288970|NCT02469090|12486323|FG000|STARTED|Period 2: Maintenance Treatment Phase|Subjects who completed the Titration Phase were eligible to proceed to Maintenance Treatment Phase|0
11288971|NCT02469090|12486324|FG001|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to Placebo in the Maintenance Phase|55
11288972|NCT02469090|12486325|FG002|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to APL-130277 Maintenance Phase|54
11288973|NCT02469090|12486323|FG000|COMPLETED|Period 2: Maintenance Treatment Phase||0
11288974|NCT02469090|12486324|FG001|COMPLETED|Period 2: Maintenance Treatment Phase||46
11288975|NCT02469090|12486325|FG002|COMPLETED|Period 2: Maintenance Treatment Phase||34
11288976|NCT02469090|12486323|FG000|NOT COMPLETED|Period 2: Maintenance Treatment Phase||0
11288977|NCT02469090|12486324|FG001|NOT COMPLETED|Period 2: Maintenance Treatment Phase||9
11288978|NCT02469090|12486325|FG002|NOT COMPLETED|Period 2: Maintenance Treatment Phase||20
11288979|NCT02469116|12486332|FG000|STARTED|Overall Study||18
11288980|NCT02469116|12486332|FG000|COMPLETED|Overall Study||18
11288981|NCT02469116|12486332|FG000|NOT COMPLETED|Overall Study||0
11288982|NCT02469168|12486338|FG000|STARTED|Overall Study||1
11288983|NCT02469168|12486339|FG001|STARTED|Overall Study||0
11288984|NCT02469168|12486338|FG000|COMPLETED|Overall Study||0
11288985|NCT02469168|12486339|FG001|COMPLETED|Overall Study||0
11288986|NCT02469168|12486338|FG000|NOT COMPLETED|Overall Study||1
11288987|NCT02469168|12486339|FG001|NOT COMPLETED|Overall Study||0
11288988|NCT02469246|12486347|FG000|STARTED|Double-Blind Phase||285
11288989|NCT02469246|12486348|FG001|STARTED|Double-Blind Phase||282
11288990|NCT02469246|12486347|FG000|COMPLETED|Double-Blind Phase||218
11288991|NCT02469246|12486348|FG001|COMPLETED|Double-Blind Phase||226
11288992|NCT02469246|12486347|FG000|NOT COMPLETED|Double-Blind Phase||67
11288993|NCT02469246|12486348|FG001|NOT COMPLETED|Double-Blind Phase||56
11288994|NCT02469246|12486347|FG000|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6
11288995|NCT02469246|12486348|FG001|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5
11288996|NCT02469246|12486347|FG000|COMPLETED|Open-Label Extension (OLE)||6
11288997|NCT02469246|12486348|FG001|COMPLETED|Open-Label Extension (OLE)||5
11288998|NCT02469246|12486347|FG000|NOT COMPLETED|Open-Label Extension (OLE)||0
11288999|NCT02469246|12486348|FG001|NOT COMPLETED|Open-Label Extension (OLE)||0
11289000|NCT02469298|12486360|FG000|STARTED|Overall Study||15
11289001|NCT02469298|12486361|FG001|STARTED|Overall Study||7
11289002|NCT02469298|12486362|FG002|STARTED|Overall Study||16
11289003|NCT02469298|12486363|FG003|STARTED|Overall Study||7
11289004|NCT02469298|12486360|FG000|COMPLETED|Overall Study||14
11289005|NCT02469298|12486361|FG001|COMPLETED|Overall Study||6
11289006|NCT02469298|12486362|FG002|COMPLETED|Overall Study||14
11289007|NCT02469298|12486363|FG003|COMPLETED|Overall Study||5
11289008|NCT02469298|12486360|FG000|NOT COMPLETED|Overall Study||1
11289009|NCT02469298|12486361|FG001|NOT COMPLETED|Overall Study||1
11289010|NCT02469298|12486362|FG002|NOT COMPLETED|Overall Study||2
11289011|NCT02469298|12486363|FG003|NOT COMPLETED|Overall Study||2
11289012|NCT02469389|12486382|FG000|STARTED|Overall Study||53
11289013|NCT02469389|12486383|FG001|STARTED|Overall Study||52
11289014|NCT02469389|12486382|FG000|Completed 12-week Assessment|Overall Study|13 lost to contact or refused|40
11289015|NCT02469389|12486383|FG001|Completed 12-week Assessment|Overall Study|8 lost to contact or refused|44
11289016|NCT02469389|12486382|FG000|Completed 24-week Assessment|Overall Study|16 lost to contact or refused|37
11289017|NCT02469389|12486383|FG001|Completed 24-week Assessment|Overall Study|6 lost to contact or refused|46
11289018|NCT02469389|12486382|FG000|COMPLETED|Overall Study||37
11289019|NCT02469389|12486383|FG001|COMPLETED|Overall Study||44
11289020|NCT02469389|12486382|FG000|NOT COMPLETED|Overall Study||16
11289021|NCT02469389|12486383|FG001|NOT COMPLETED|Overall Study||8
11289022|NCT02469597|12486391|FG000|STARTED|Overall Study||22
11289023|NCT02469597|12486392|FG001|STARTED|Overall Study||24
11289024|NCT02469597|12486391|FG000|COMPLETED|Overall Study||22
11289025|NCT02469597|12486392|FG001|COMPLETED|Overall Study||24
11289026|NCT02469597|12486391|FG000|NOT COMPLETED|Overall Study||0
11289027|NCT02469597|12486392|FG001|NOT COMPLETED|Overall Study||0
11289028|NCT02469610|12486400|FG000|STARTED|Overall Study||34
11289029|NCT02469610|12486401|FG001|STARTED|Overall Study||31
11289030|NCT02469610|12486400|FG000|COMPLETED|Overall Study||30
11289031|NCT02469610|12486401|FG001|COMPLETED|Overall Study||30
11289032|NCT02469610|12486400|FG000|NOT COMPLETED|Overall Study||4
11289033|NCT02469610|12486401|FG001|NOT COMPLETED|Overall Study||1
11289034|NCT02469623|12486407|FG000|STARTED|Overall Study||85
11289035|NCT02469623|12486407|FG000|COMPLETED|Overall Study||72
11289036|NCT02469623|12486407|FG000|NOT COMPLETED|Overall Study||13
11289037|NCT02469701|12486412|FG000|STARTED|Overall Study||10
11289038|NCT02469701|12486412|FG000|COMPLETED|Overall Study||10
11289039|NCT02469701|12486412|FG000|NOT COMPLETED|Overall Study||0
11289040|NCT02469714|12486418|FG000|STARTED|Overall Study||55
11289041|NCT02469714|12486419|FG001|STARTED|Overall Study||55
11289042|NCT02469714|12486418|FG000|4 Month Follow-Up|Overall Study||50
11289043|NCT02469714|12486419|FG001|4 Month Follow-Up|Overall Study||51
11289044|NCT02469714|12486418|FG000|8 Month Follow-Up|Overall Study||49
11289045|NCT02469714|12486419|FG001|8 Month Follow-Up|Overall Study||50
11289046|NCT02469714|12486418|FG000|COMPLETED|Overall Study||47
11289047|NCT02469714|12486419|FG001|COMPLETED|Overall Study||50
11289048|NCT02469714|12486418|FG000|NOT COMPLETED|Overall Study||8
11289049|NCT02469714|12486419|FG001|NOT COMPLETED|Overall Study||5
11341021|NCT02928029|12538395|FG000|COMPLETED|Overall Study||0
11341022|NCT02928029|12538396|FG001|COMPLETED|Overall Study||0
11341023|NCT02928029|12538395|FG000|NOT COMPLETED|Overall Study||3
11341024|NCT02928029|12538396|FG001|NOT COMPLETED|Overall Study||4
11341025|NCT02928055|12538405|FG000|STARTED|Overall Study||8
11341026|NCT02928055|12538406|FG001|STARTED|Overall Study||8
11341027|NCT02928055|12538407|FG002|STARTED|Overall Study||7
11341028|NCT02928055|12538405|FG000|End of Treatment|Overall Study||8
11341029|NCT02928055|12538406|FG001|End of Treatment|Overall Study||8
11341030|NCT02928055|12538407|FG002|End of Treatment|Overall Study||6
11341031|NCT02928055|12538405|FG000|1 Month Follow up|Overall Study||7
11399625|NCT04318535|12594229|FG002|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
11399626|NCT04318535|12594227|FG000|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
11399627|NCT04318535|12594228|FG001|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
11399628|NCT04318535|12594229|FG002|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
11399629|NCT04318535|12594227|FG000|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
11399630|NCT04318535|12594228|FG001|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
11399631|NCT04318535|12594229|FG002|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
11399632|NCT04318535|12594227|FG000|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
11399633|NCT04318535|12594228|FG001|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
11399634|NCT04318535|12594229|FG002|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
11399635|NCT04318535|12594227|FG000|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
11399636|NCT04318535|12594228|FG001|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
11399637|NCT04318535|12594229|FG002|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
11399638|NCT04318535|12594227|FG000|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
11399639|NCT04318535|12594228|FG001|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||11
11399640|NCT04318535|12594229|FG002|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
11399641|NCT04318535|12594227|FG000|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
11341032|NCT02928055|12538406|FG001|1 Month Follow up|Overall Study||7
11341033|NCT02928055|12538407|FG002|1 Month Follow up|Overall Study||6
11341034|NCT02928055|12538405|FG000|2 Month Follow up|Overall Study||6
11341035|NCT02928055|12538406|FG001|2 Month Follow up|Overall Study||7
11341036|NCT02928055|12538407|FG002|2 Month Follow up|Overall Study||5
11341037|NCT02928055|12538405|FG000|3 Month Follow up|Overall Study||5
11341038|NCT02928055|12538406|FG001|3 Month Follow up|Overall Study||6
11341039|NCT02928055|12538407|FG002|3 Month Follow up|Overall Study||5
11341040|NCT02928055|12538405|FG000|COMPLETED|Overall Study||5
11341041|NCT02928055|12538406|FG001|COMPLETED|Overall Study||6
11341042|NCT02928055|12538407|FG002|COMPLETED|Overall Study||5
11341043|NCT02928055|12538405|FG000|NOT COMPLETED|Overall Study||3
11289050|NCT02469857|12486427|FG000|STARTED|Overall Study||143
11289051|NCT02469857|12486428|FG001|STARTED|Overall Study||147
11289052|NCT02469857|12486427|FG000|COMPLETED|Overall Study||118
11289053|NCT02469857|12486428|FG001|COMPLETED|Overall Study||115
11289054|NCT02469857|12486427|FG000|NOT COMPLETED|Overall Study||25
11289055|NCT02469857|12486428|FG001|NOT COMPLETED|Overall Study||32
11289056|NCT02469870|12486438|FG000|STARTED|Overall Study||77
11289057|NCT02469870|12486439|FG001|STARTED|Overall Study||79
11289058|NCT02469870|12486438|FG000|COMPLETED|Overall Study||73
11289059|NCT02469870|12486439|FG001|COMPLETED|Overall Study||72
11289060|NCT02469870|12486438|FG000|NOT COMPLETED|Overall Study||4
11289061|NCT02469870|12486439|FG001|NOT COMPLETED|Overall Study||7
11289062|NCT02469896|12486450|FG000|STARTED|Overall Study||8
11289063|NCT02469896|12486451|FG001|STARTED|Overall Study||14
11289064|NCT02469896|12486450|FG000|COMPLETED|Overall Study||6
11289065|NCT02469896|12486451|FG001|COMPLETED|Overall Study||14
11289066|NCT02469896|12486450|FG000|NOT COMPLETED|Overall Study||2
11289067|NCT02469896|12486451|FG001|NOT COMPLETED|Overall Study||0
11289068|NCT02469961|12486463|FG000|STARTED|Overall Study||25
11289069|NCT02469961|12486464|FG001|STARTED|Overall Study||25
11289070|NCT02469961|12486463|FG000|COMPLETED|Overall Study||21
11289071|NCT02469961|12486464|FG001|COMPLETED|Overall Study||24
11289072|NCT02469961|12486463|FG000|NOT COMPLETED|Overall Study||4
11289073|NCT02469961|12486464|FG001|NOT COMPLETED|Overall Study||1
11289074|NCT02470234|12486478|FG000|STARTED|Overall Study||5
11289075|NCT02470234|12486479|FG001|STARTED|Overall Study||3
11289076|NCT02470234|12486480|FG002|STARTED|Overall Study||2
11289077|NCT02470234|12486478|FG000|COMPLETED|Overall Study||5
11289078|NCT02470234|12486479|FG001|COMPLETED|Overall Study||3
11289079|NCT02470234|12486480|FG002|COMPLETED|Overall Study||2
11289080|NCT02470234|12486478|FG000|NOT COMPLETED|Overall Study||0
11289081|NCT02470234|12486479|FG001|NOT COMPLETED|Overall Study||0
11289082|NCT02470234|12486480|FG002|NOT COMPLETED|Overall Study||0
11289083|NCT02470312|12486495|FG000|STARTED|Overall Study||147
11289084|NCT02470312|12486496|FG001|STARTED|Overall Study||431
11289085|NCT02470312|12486495|FG000|COMPLETED|Overall Study||142
11289086|NCT02470312|12486496|FG001|COMPLETED|Overall Study||419
11289087|NCT02470312|12486495|FG000|NOT COMPLETED|Overall Study||5
11289088|NCT02470312|12486496|FG001|NOT COMPLETED|Overall Study||12
11289089|NCT02470390|12486504|FG000|STARTED|Overall Study||6
11289090|NCT02470390|12486505|FG001|STARTED|Overall Study||7
11289091|NCT02470390|12486504|FG000|COMPLETED|Overall Study||6
11289092|NCT02470390|12486505|FG001|COMPLETED|Overall Study||6
11289093|NCT02470390|12486504|FG000|NOT COMPLETED|Overall Study||0
11289094|NCT02470390|12486505|FG001|NOT COMPLETED|Overall Study||1
11289095|NCT02470403|12486518|FG000|STARTED|Overall Study||44
11289096|NCT02470403|12486519|FG001|STARTED|Overall Study||44
11289097|NCT02470403|12486520|FG002|STARTED|Overall Study||40
11289098|NCT02470403|12486521|FG003|STARTED|Overall Study||43
11289099|NCT02470403|12486522|FG004|STARTED|Overall Study||10
11289100|NCT02470403|12486518|FG000|Dysglycemic|Overall Study||24
11289101|NCT02470403|12486519|FG001|Dysglycemic|Overall Study||24
11289102|NCT02470403|12486520|FG002|Dysglycemic|Overall Study||20
11289103|NCT02470403|12486521|FG003|Dysglycemic|Overall Study||20
11289104|NCT02470403|12486522|FG004|Dysglycemic|Overall Study||5
11289105|NCT02470403|12486518|FG000|Normoglycemic|Overall Study||20
11289106|NCT02470403|12486519|FG001|Normoglycemic|Overall Study||20
11289107|NCT02470403|12486520|FG002|Normoglycemic|Overall Study||20
11289108|NCT02470403|12486521|FG003|Normoglycemic|Overall Study||23
11289109|NCT02470403|12486522|FG004|Normoglycemic|Overall Study||5
11289110|NCT02470403|12486518|FG000|COMPLETED|Overall Study||42
11289111|NCT02470403|12486519|FG001|COMPLETED|Overall Study||43
11289112|NCT02470403|12486520|FG002|COMPLETED|Overall Study||40
11289113|NCT02470403|12486521|FG003|COMPLETED|Overall Study||39
11289114|NCT02470403|12486522|FG004|COMPLETED|Overall Study||10
11289115|NCT02470403|12486518|FG000|NOT COMPLETED|Overall Study||2
11289116|NCT02470403|12486519|FG001|NOT COMPLETED|Overall Study||1
11289117|NCT02470403|12486520|FG002|NOT COMPLETED|Overall Study||0
11289118|NCT02470403|12486521|FG003|NOT COMPLETED|Overall Study||4
11289119|NCT02470403|12486522|FG004|NOT COMPLETED|Overall Study||0
11289120|NCT02470429|12486539|FG000|STARTED|Overall Study||50
11289121|NCT02470429|12486540|FG001|STARTED|Overall Study||49
11289122|NCT02470429|12486539|FG000|COMPLETED|Overall Study||48
11289123|NCT02470429|12486540|FG001|COMPLETED|Overall Study||49
11289124|NCT02470429|12486539|FG000|NOT COMPLETED|Overall Study||2
11289125|NCT02470429|12486540|FG001|NOT COMPLETED|Overall Study||0
11289126|NCT02470494|12486547|FG000|STARTED|Overall Study||46
11289127|NCT02470494|12486547|FG000|COMPLETED|Overall Study||41
11289128|NCT02470494|12486547|FG000|NOT COMPLETED|Overall Study||5
11289129|NCT02470741|12486553|FG000|STARTED|Overall Study||6
11289130|NCT02470741|12486554|FG001|STARTED|Overall Study||6
11289131|NCT02470741|12486553|FG000|COMPLETED|Overall Study||3
11289132|NCT02470741|12486554|FG001|COMPLETED|Overall Study||4
11289133|NCT02470741|12486553|FG000|NOT COMPLETED|Overall Study||3
11289134|NCT02470741|12486554|FG001|NOT COMPLETED|Overall Study||2
11289135|NCT02470754|12486560|FG000|STARTED|Overall Study||19
11289136|NCT02470754|12486561|FG001|STARTED|Overall Study||19
11289137|NCT02470754|12486560|FG000|COMPLETED|Overall Study||17
11289138|NCT02470754|12486561|FG001|COMPLETED|Overall Study||19
11289139|NCT02470754|12486560|FG000|NOT COMPLETED|Overall Study||2
11289140|NCT02470754|12486561|FG001|NOT COMPLETED|Overall Study||0
11289141|NCT02470806|12486569|FG000|STARTED|Overall Study||80
11289142|NCT02470806|12486570|FG001|STARTED|Overall Study|The Safety analysis included 164, ITT was 161, and Per Protocol was 115 subjects (total both arms).|84
11289143|NCT02470806|12486569|FG000|COMPLETED|Overall Study||62
11289144|NCT02470806|12486570|FG001|COMPLETED|Overall Study||42
11289145|NCT02470806|12486569|FG000|NOT COMPLETED|Overall Study||18
11289146|NCT02470806|12486570|FG001|NOT COMPLETED|Overall Study||42
11289147|NCT02470910|12486576|FG000|STARTED|Overall Study||15
11289148|NCT02470910|12486576|FG000|COMPLETED|Overall Study||15
11289149|NCT02470910|12486576|FG000|NOT COMPLETED|Overall Study||0
11289150|NCT02470949|12486583|FG000|STARTED|First Intervention||4
11289151|NCT02470949|12486584|FG001|STARTED|First Intervention||5
11289152|NCT02470949|12486583|FG000|COMPLETED|First Intervention||4
11289153|NCT02470949|12486584|FG001|COMPLETED|First Intervention||5
11289154|NCT02470949|12486583|FG000|NOT COMPLETED|First Intervention||0
11289155|NCT02470949|12486584|FG001|NOT COMPLETED|First Intervention||0
11289156|NCT02470949|12486583|FG000|STARTED|Washout Period for a Minimum of 4 Weeks||4
11289157|NCT02470949|12486584|FG001|STARTED|Washout Period for a Minimum of 4 Weeks||5
11289158|NCT02470949|12486583|FG000|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
11289159|NCT02470949|12486584|FG001|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
11289160|NCT02470949|12486583|FG000|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
11289161|NCT02470949|12486584|FG001|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
11289162|NCT02470949|12486583|FG000|STARTED|Second Intervention||4
11289163|NCT02470949|12486584|FG001|STARTED|Second Intervention||2
11289164|NCT02470949|12486583|FG000|COMPLETED|Second Intervention||4
11289165|NCT02470949|12486584|FG001|COMPLETED|Second Intervention||2
11289166|NCT02470949|12486583|FG000|NOT COMPLETED|Second Intervention||0
11289167|NCT02470949|12486584|FG001|NOT COMPLETED|Second Intervention||0
11289168|NCT02471014|12486594|FG000|STARTED|Overall Study||25
11289169|NCT02471014|12486595|FG001|STARTED|Overall Study||25
11289170|NCT02471014|12486594|FG000|COMPLETED|Overall Study||23
11289171|NCT02471014|12486595|FG001|COMPLETED|Overall Study||23
11289172|NCT02471014|12486594|FG000|NOT COMPLETED|Overall Study||2
11289173|NCT02471014|12486595|FG001|NOT COMPLETED|Overall Study||2
11289174|NCT02471183|12486601|FG000|STARTED|Main Treatment Period||34
11289175|NCT02471183|12486601|FG000|COMPLETED|Main Treatment Period||32
11289176|NCT02471183|12486601|FG000|NOT COMPLETED|Main Treatment Period||2
11289177|NCT02471183|12486601|FG000|STARTED|Extended Treatment Period||32
11289178|NCT02471183|12486601|FG000|COMPLETED|Extended Treatment Period||31
11289179|NCT02471183|12486601|FG000|NOT COMPLETED|Extended Treatment Period||1
11289180|NCT02471313|12486605|FG000|STARTED|Overall Study||3
11289181|NCT02471313|12486605|FG000|COMPLETED|Overall Study||3
11289182|NCT02471313|12486605|FG000|NOT COMPLETED|Overall Study||0
11289183|NCT02471326|12486609|FG000|STARTED|Overall Study||10
11289184|NCT02471326|12486609|FG000|COMPLETED|Overall Study||9
11289185|NCT02471326|12486609|FG000|NOT COMPLETED|Overall Study||1
11289186|NCT02471404|12486616|FG000|STARTED|Overall Study||314
11289187|NCT02471404|12486617|FG001|STARTED|Overall Study||312
11289188|NCT02471404|12486618|FG002|STARTED|Overall Study||313
11289189|NCT02471404|12486616|FG000|COMPLETED|Overall Study||281
11289190|NCT02471404|12486617|FG001|COMPLETED|Overall Study||298
11289191|NCT02471404|12486618|FG002|COMPLETED|Overall Study||288
11289192|NCT02471404|12486616|FG000|NOT COMPLETED|Overall Study||33
11289193|NCT02471404|12486617|FG001|NOT COMPLETED|Overall Study||14
11289194|NCT02471404|12486618|FG002|NOT COMPLETED|Overall Study||25
11289195|NCT02471521|12486628|FG000|STARTED|Overall Study||60
11289196|NCT02471521|12486629|FG001|STARTED|Overall Study||60
11289197|NCT02471521|12486628|FG000|COMPLETED|Overall Study||60
11289198|NCT02471521|12486629|FG001|COMPLETED|Overall Study||52
11289199|NCT02471521|12486628|FG000|NOT COMPLETED|Overall Study||0
11399642|NCT04318535|12594228|FG001|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||1
11399643|NCT04318535|12594229|FG002|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
11399644|NCT04318535|12594227|FG000|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
11399645|NCT04318535|12594228|FG001|STARTED|Treatment Period 3 (Day 17 to Day 22)||11
11399646|NCT04318535|12594229|FG002|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
11399647|NCT04318535|12594227|FG000|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
11399648|NCT04318535|12594228|FG001|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||11
11399649|NCT04318535|12594229|FG002|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
11399650|NCT04318535|12594227|FG000|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
11399651|NCT04318535|12594228|FG001|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
11399652|NCT04318535|12594229|FG002|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
11399653|NCT04316260|12594240|FG000|STARTED|Overall Study||34
11399654|NCT04316260|12594241|FG001|STARTED|Overall Study||17
11399655|NCT04316260|12594240|FG000|COMPLETED|Overall Study||34
11399656|NCT04316260|12594241|FG001|COMPLETED|Overall Study||17
11399657|NCT04316260|12594240|FG000|NOT COMPLETED|Overall Study||0
11399658|NCT04316260|12594241|FG001|NOT COMPLETED|Overall Study||0
11289200|NCT02471521|12486629|FG001|NOT COMPLETED|Overall Study||8
11289201|NCT02471586|12486638|FG000|STARTED|Overall Study||158
11289202|NCT02471586|12486639|FG001|STARTED|Overall Study||146
11399659|NCT04314037|12594250|FG000|STARTED|Treatment Period 1||18
11399660|NCT04314037|12594251|FG001|STARTED|Treatment Period 1||18
11399661|NCT04314037|12594250|FG000|COMPLETED|Treatment Period 1||18
11399662|NCT04314037|12594251|FG001|COMPLETED|Treatment Period 1||18
11289203|NCT02471586|12486640|FG002|STARTED|Overall Study||146
11289204|NCT02471586|12486638|FG000|COMPLETED|Overall Study||153
11289205|NCT02471586|12486639|FG001|COMPLETED|Overall Study||136
11289206|NCT02471586|12486640|FG002|COMPLETED|Overall Study||142
11289207|NCT02471586|12486638|FG000|NOT COMPLETED|Overall Study||5
11289208|NCT02471586|12486639|FG001|NOT COMPLETED|Overall Study||10
11289209|NCT02471586|12486640|FG002|NOT COMPLETED|Overall Study||4
11289210|NCT02471612|12486650|FG000|STARTED|Overall Study||159
11289211|NCT02471612|12486650|FG000|COMPLETED|Overall Study||157
11289212|NCT02471612|12486650|FG000|NOT COMPLETED|Overall Study||2
11289213|NCT02471651|12486669|FG000|STARTED|Overall Study||20
11289214|NCT02471651|12486670|FG001|STARTED|Overall Study||20
11289215|NCT02471651|12486669|FG000|COMPLETED|Overall Study||15
11289216|NCT02471651|12486670|FG001|COMPLETED|Overall Study||15
11289217|NCT02471651|12486669|FG000|NOT COMPLETED|Overall Study||5
11289218|NCT02471651|12486670|FG001|NOT COMPLETED|Overall Study||5
11289219|NCT02471716|12486681|FG000|STARTED|Overall Study||3
11289220|NCT02471716|12486682|FG001|STARTED|Overall Study||3
11289221|NCT02471716|12486683|FG002|STARTED|Overall Study||3
11289222|NCT02471716|12486684|FG003|STARTED|Overall Study||33
11289223|NCT02471716|12486685|FG004|STARTED|Overall Study||24
11289224|NCT02471716|12486681|FG000|COMPLETED|Overall Study||3
11289225|NCT02471716|12486682|FG001|COMPLETED|Overall Study||2
11289226|NCT02471716|12486683|FG002|COMPLETED|Overall Study||3
11289227|NCT02471716|12486684|FG003|COMPLETED|Overall Study||18
11289228|NCT02471716|12486685|FG004|COMPLETED|Overall Study||8
11289229|NCT02471716|12486681|FG000|NOT COMPLETED|Overall Study||0
11289230|NCT02471716|12486682|FG001|NOT COMPLETED|Overall Study||1
11289231|NCT02471716|12486683|FG002|NOT COMPLETED|Overall Study||0
11289232|NCT02471716|12486684|FG003|NOT COMPLETED|Overall Study||15
11289233|NCT02471716|12486685|FG004|NOT COMPLETED|Overall Study||16
11289234|NCT02471755|12486701|FG000|STARTED|Overall Study||45
11289235|NCT02471755|12486702|FG001|STARTED|Overall Study||45
11289236|NCT02471755|12486701|FG000|COMPLETED|Overall Study||44
11289237|NCT02471755|12486702|FG001|COMPLETED|Overall Study||44
11289238|NCT02471755|12486701|FG000|NOT COMPLETED|Overall Study||1
11289239|NCT02471755|12486702|FG001|NOT COMPLETED|Overall Study||1
11289240|NCT02472145|12486711|FG000|STARTED|Overall Study||10
11289241|NCT02472145|12486712|FG001|STARTED|Overall Study||159
11289242|NCT02472145|12486713|FG002|STARTED|Overall Study||157
11289243|NCT02472145|12486711|FG000|Treated|Overall Study||10
11289244|NCT02472145|12486712|FG001|Treated|Overall Study||156
11289245|NCT02472145|12486713|FG002|Treated|Overall Study||156
11289246|NCT02472145|12486711|FG000|Safety|Overall Study||10
11289247|NCT02472145|12486712|FG001|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165
11289248|NCT02472145|12486713|FG002|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147
11289249|NCT02472145|12486711|FG000|COMPLETED|Overall Study||0
11289250|NCT02472145|12486712|FG001|COMPLETED|Overall Study||0
11289251|NCT02472145|12486713|FG002|COMPLETED|Overall Study||0
11289252|NCT02472145|12486711|FG000|NOT COMPLETED|Overall Study||10
11289253|NCT02472145|12486712|FG001|NOT COMPLETED|Overall Study||159
11289254|NCT02472145|12486713|FG002|NOT COMPLETED|Overall Study||157
11289255|NCT02472223|12486722|FG000|STARTED|Overall Study||16
11289256|NCT02472223|12486723|FG001|STARTED|Overall Study||12
11289257|NCT02472223|12486722|FG000|COMPLETED|Overall Study||10
11289258|NCT02472223|12486723|FG001|COMPLETED|Overall Study||7
11289259|NCT02472223|12486722|FG000|NOT COMPLETED|Overall Study||6
11399663|NCT04314037|12594250|FG000|NOT COMPLETED|Treatment Period 1||0
11399664|NCT04314037|12594251|FG001|NOT COMPLETED|Treatment Period 1||0
11399665|NCT04314037|12594250|FG000|STARTED|Treatment Period 2||18
11399666|NCT04314037|12594251|FG001|STARTED|Treatment Period 2||18
11399667|NCT04314037|12594250|FG000|COMPLETED|Treatment Period 2||17
11399668|NCT04314037|12594251|FG001|COMPLETED|Treatment Period 2||18
11399669|NCT04314037|12594250|FG000|NOT COMPLETED|Treatment Period 2||1
11399670|NCT04314037|12594251|FG001|NOT COMPLETED|Treatment Period 2||0
11399671|NCT04314037|12594250|FG000|STARTED|Treatment Period 3||17
11399672|NCT04314037|12594251|FG001|STARTED|Treatment Period 3||18
11399673|NCT04314037|12594250|FG000|COMPLETED|Treatment Period 3||16
11289260|NCT02472223|12486723|FG001|NOT COMPLETED|Overall Study||5
11289261|NCT02472262|12486732|FG000|STARTED|Overall Study||117
11289262|NCT02472262|12486733|FG001|STARTED|Overall Study||120
11399674|NCT04314037|12594251|FG001|COMPLETED|Treatment Period 3||17
11399675|NCT04314037|12594250|FG000|NOT COMPLETED|Treatment Period 3||1
11289263|NCT02472262|12486734|FG002|STARTED|Overall Study||118
11289264|NCT02472262|12486732|FG000|COMPLETED|Overall Study||99
11289265|NCT02472262|12486733|FG001|COMPLETED|Overall Study||99
11289266|NCT02472262|12486734|FG002|COMPLETED|Overall Study||93
11289267|NCT02472262|12486732|FG000|NOT COMPLETED|Overall Study||18
11289268|NCT02472262|12486733|FG001|NOT COMPLETED|Overall Study||21
11289269|NCT02472262|12486734|FG002|NOT COMPLETED|Overall Study||25
11289270|NCT02472314|12486744|FG000|STARTED|Overall Study||34
11289271|NCT02472314|12486745|FG001|STARTED|Overall Study||36
11289272|NCT02472314|12486744|FG000|COMPLETED|Overall Study||34
11289273|NCT02472314|12486745|FG001|COMPLETED|Overall Study||36
11289274|NCT02472314|12486744|FG000|NOT COMPLETED|Overall Study||0
11289275|NCT02472314|12486745|FG001|NOT COMPLETED|Overall Study||0
11289276|NCT02472353|12486753|FG000|STARTED|Overall Study||14
11289277|NCT02472353|12486754|FG001|STARTED|Overall Study||16
11289278|NCT02472353|12486753|FG000|COMPLETED|Overall Study||10
11289279|NCT02472353|12486754|FG001|COMPLETED|Overall Study||10
11289280|NCT02472353|12486753|FG000|NOT COMPLETED|Overall Study||4
11289281|NCT02472353|12486754|FG001|NOT COMPLETED|Overall Study||6
11289282|NCT02472366|12486762|FG000|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
11289283|NCT02472366|12486763|FG001|STARTED|Overall Study||10
11289284|NCT02472366|12486762|FG000|COMPLETED|Overall Study||5
11289285|NCT02472366|12486763|FG001|COMPLETED|Overall Study||10
11289286|NCT02472366|12486762|FG000|NOT COMPLETED|Overall Study||1
11289287|NCT02472366|12486763|FG001|NOT COMPLETED|Overall Study||0
11289288|NCT02472405|12486769|FG000|STARTED|Overall Study||18
11289289|NCT02472405|12486769|FG000|COMPLETED|Overall Study||8
11289290|NCT02472405|12486769|FG000|NOT COMPLETED|Overall Study||10
11289291|NCT02472457|12486777|FG000|STARTED|Overall Study|1 subject followed the Specific Carbohydrate Diet|8
11289292|NCT02472457|12486778|FG001|STARTED|Overall Study||11
11289293|NCT02472457|12486777|FG000|COMPLETED|Overall Study||8
11289294|NCT02472457|12486778|FG001|COMPLETED|Overall Study||10
11289295|NCT02472457|12486777|FG000|NOT COMPLETED|Overall Study||0
11289296|NCT02472457|12486778|FG001|NOT COMPLETED|Overall Study||1
11289297|NCT02472522|12486786|FG000|STARTED|Overall Study||50
11289298|NCT02472522|12486787|FG001|STARTED|Overall Study||50
11289299|NCT02472522|12486786|FG000|COMPLETED|Overall Study||50
11289300|NCT02472522|12486787|FG001|COMPLETED|Overall Study||50
11289301|NCT02472522|12486786|FG000|NOT COMPLETED|Overall Study||0
11289302|NCT02472522|12486787|FG001|NOT COMPLETED|Overall Study||0
11289303|NCT02472652|12486795|FG000|STARTED|Overall Study||2
11289304|NCT02472652|12486795|FG000|COMPLETED|Overall Study||1
11289305|NCT02472652|12486795|FG000|NOT COMPLETED|Overall Study||1
11289306|NCT02472730|12486801|FG000|STARTED|Overall Study||110
11289307|NCT02472730|12486802|FG001|STARTED|Overall Study||109
11289308|NCT02472730|12486801|FG000|COMPLETED|Overall Study||101
11289309|NCT02472730|12486802|FG001|COMPLETED|Overall Study||102
11289310|NCT02472730|12486801|FG000|NOT COMPLETED|Overall Study||9
11289311|NCT02472730|12486802|FG001|NOT COMPLETED|Overall Study||7
11289312|NCT02472756|12486808|FG000|STARTED|Induction (Approximately 6 Months)||41
11289313|NCT02472756|12486808|FG000|Treated|Induction (Approximately 6 Months)||40
11289314|NCT02472756|12486808|FG000|COMPLETED|Induction (Approximately 6 Months)||39
11289315|NCT02472756|12486808|FG000|NOT COMPLETED|Induction (Approximately 6 Months)||2
11289316|NCT02472756|12486808|FG000|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
11289317|NCT02472756|12486808|FG000|COMPLETED|Maintenance (Approximately 2 Years)||10
11399676|NCT04314037|12594251|FG001|NOT COMPLETED|Treatment Period 3||1
11399677|NCT04314037|12594250|FG000|STARTED|Treatment Period 4||16
11289318|NCT02472756|12486808|FG000|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
11289319|NCT02472795|12486817|FG000|STARTED|Overall Study||12
11289320|NCT02472795|12486818|FG001|STARTED|Overall Study||12
11289321|NCT02472795|12486819|FG002|STARTED|Overall Study||13
11289322|NCT02472795|12486820|FG003|STARTED|Overall Study||13
11289323|NCT02472795|12486821|FG004|STARTED|Overall Study||17
11289324|NCT02472795|12486817|FG000|Pharmacodynamic Set|Overall Study||12
11289325|NCT02472795|12486818|FG001|Pharmacodynamic Set|Overall Study||10
11289326|NCT02472795|12486819|FG002|Pharmacodynamic Set|Overall Study||13
11289327|NCT02472795|12486820|FG003|Pharmacodynamic Set|Overall Study||13
11289328|NCT02472795|12486821|FG004|Pharmacodynamic Set|Overall Study||16
11289329|NCT02472795|12486817|FG000|Modified Pharmacodynamic Analysis Set|Overall Study||12
11289330|NCT02472795|12486818|FG001|Modified Pharmacodynamic Analysis Set|Overall Study||10
11289331|NCT02472795|12486819|FG002|Modified Pharmacodynamic Analysis Set|Overall Study||13
11289332|NCT02472795|12486820|FG003|Modified Pharmacodynamic Analysis Set|Overall Study||9
11289333|NCT02472795|12486821|FG004|Modified Pharmacodynamic Analysis Set|Overall Study||16
11289334|NCT02472795|12486817|FG000|COMPLETED|Overall Study||12
11289335|NCT02472795|12486818|FG001|COMPLETED|Overall Study||11
11289336|NCT02472795|12486819|FG002|COMPLETED|Overall Study||13
11289337|NCT02472795|12486820|FG003|COMPLETED|Overall Study||13
11289338|NCT02472795|12486821|FG004|COMPLETED|Overall Study||14
11289339|NCT02472795|12486817|FG000|NOT COMPLETED|Overall Study||0
11289340|NCT02472795|12486818|FG001|NOT COMPLETED|Overall Study||1
11289341|NCT02472795|12486819|FG002|NOT COMPLETED|Overall Study||0
11289342|NCT02472795|12486820|FG003|NOT COMPLETED|Overall Study||0
11289343|NCT02472795|12486821|FG004|NOT COMPLETED|Overall Study||3
11289344|NCT02472847|12486835|FG000|STARTED|Overall Study||24
11289345|NCT02472847|12486836|FG001|STARTED|Overall Study||26
11289346|NCT02472847|12486835|FG000|COMPLETED|Overall Study||23
11289347|NCT02472847|12486836|FG001|COMPLETED|Overall Study||21
11289348|NCT02472847|12486835|FG000|NOT COMPLETED|Overall Study||1
11289349|NCT02472847|12486836|FG001|NOT COMPLETED|Overall Study||5
11289350|NCT02472886|12486845|FG000|STARTED|Overall Study||67
11289351|NCT02472886|12486846|FG001|STARTED|Overall Study||59
11289352|NCT02472886|12486847|FG002|STARTED|Overall Study||27
11289353|NCT02472886|12486845|FG000|COMPLETED|Overall Study||67
11289354|NCT02472886|12486846|FG001|COMPLETED|Overall Study||57
11289355|NCT02472886|12486847|FG002|COMPLETED|Overall Study||26
11289356|NCT02472886|12486845|FG000|NOT COMPLETED|Overall Study||0
11289357|NCT02472886|12486846|FG001|NOT COMPLETED|Overall Study||2
11289358|NCT02472886|12486847|FG002|NOT COMPLETED|Overall Study||1
11289359|NCT02472977|12486863|FG000|STARTED|Overall Study||6
11289360|NCT02472977|12486864|FG001|STARTED|Overall Study||27
11289361|NCT02472977|12486865|FG002|STARTED|Overall Study||8
11289362|NCT02472977|12486863|FG000|COMPLETED|Overall Study||0
11289363|NCT02472977|12486864|FG001|COMPLETED|Overall Study||0
11289364|NCT02472977|12486865|FG002|COMPLETED|Overall Study||0
11289365|NCT02472977|12486863|FG000|NOT COMPLETED|Overall Study||6
11399678|NCT04314037|12594251|FG001|STARTED|Treatment Period 4||17
11289366|NCT02472977|12486864|FG001|NOT COMPLETED|Overall Study||27
11289367|NCT02472977|12486865|FG002|NOT COMPLETED|Overall Study||8
11289368|NCT02473250|12486873|FG000|STARTED|Overall Study||40
11289369|NCT02473250|12486873|FG000|COMPLETED|Overall Study||20
11289370|NCT02473250|12486873|FG000|NOT COMPLETED|Overall Study||20
11289371|NCT02473289|12486880|FG000|STARTED|Overall Study||99
11289372|NCT02473289|12486881|FG001|STARTED|Overall Study||94
11289373|NCT02473289|12486880|FG000|COMPLETED|Overall Study||88
11289374|NCT02473289|12486881|FG001|COMPLETED|Overall Study||81
11289375|NCT02473289|12486880|FG000|NOT COMPLETED|Overall Study||11
11289376|NCT02473289|12486881|FG001|NOT COMPLETED|Overall Study||13
11289377|NCT02473367|12486887|FG000|STARTED|Period 1||20
11289378|NCT02473367|12486887|FG000|COMPLETED|Period 1||20
11289379|NCT02473367|12486887|FG000|NOT COMPLETED|Period 1||0
11289380|NCT02473367|12486887|FG000|STARTED|Wait 1||20
11289381|NCT02473367|12486887|FG000|COMPLETED|Wait 1||19
11289382|NCT02473367|12486887|FG000|NOT COMPLETED|Wait 1||1
11289383|NCT02473367|12486887|FG000|STARTED|Period 2||19
11289384|NCT02473367|12486887|FG000|COMPLETED|Period 2||19
11289385|NCT02473367|12486887|FG000|NOT COMPLETED|Period 2||0
11289386|NCT02473367|12486887|FG000|STARTED|Wait 2||19
11289387|NCT02473367|12486887|FG000|COMPLETED|Wait 2||19
11289388|NCT02473367|12486887|FG000|NOT COMPLETED|Wait 2||0
11289389|NCT02473367|12486887|FG000|STARTED|Period 3||19
11289390|NCT02473367|12486887|FG000|COMPLETED|Period 3||19
11289391|NCT02473367|12486887|FG000|NOT COMPLETED|Period 3||0
11289392|NCT02473367|12486887|FG000|STARTED|Wait 3||19
11289393|NCT02473367|12486887|FG000|COMPLETED|Wait 3||19
11289394|NCT02473367|12486887|FG000|NOT COMPLETED|Wait 3||0
11289395|NCT02473367|12486887|FG000|STARTED|Period 4||19
11289396|NCT02473367|12486887|FG000|COMPLETED|Period 4||18
11289397|NCT02473367|12486887|FG000|NOT COMPLETED|Period 4||1
11289398|NCT02473393|12486901|FG000|STARTED|Overall Study||5
11289399|NCT02473393|12486902|FG001|STARTED|Overall Study||12
11289400|NCT02473393|12486903|FG002|STARTED|Overall Study||13
11289401|NCT02473393|12486904|FG003|STARTED|Overall Study||13
11289402|NCT02473393|12486901|FG000|COMPLETED|Overall Study||5
11289403|NCT02473393|12486902|FG001|COMPLETED|Overall Study||12
11289404|NCT02473393|12486903|FG002|COMPLETED|Overall Study||11
11289405|NCT02473393|12486904|FG003|COMPLETED|Overall Study||12
11289406|NCT02473393|12486901|FG000|NOT COMPLETED|Overall Study||0
11289407|NCT02473393|12486902|FG001|NOT COMPLETED|Overall Study||0
11289408|NCT02473393|12486903|FG002|NOT COMPLETED|Overall Study||2
11289409|NCT02473393|12486904|FG003|NOT COMPLETED|Overall Study||1
11289410|NCT02473471|12486914|FG000|STARTED|Overall Study||35
11289411|NCT02473471|12486914|FG000|Received Allocated Intervention|Overall Study||33
11289412|NCT02473471|12486914|FG000|Randomized Not Treated|Overall Study||2
11289413|NCT02473471|12486914|FG000|COMPLETED|Overall Study||32
11289414|NCT02473471|12486914|FG000|NOT COMPLETED|Overall Study||3
11289415|NCT02473510|12486926|FG000|STARTED|Overall Study||60
11289416|NCT02473510|12486927|FG001|STARTED|Overall Study||240
11289417|NCT02473510|12486926|FG000|COMPLETED|Overall Study||59
11289418|NCT02473510|12486927|FG001|COMPLETED|Overall Study||238
11289419|NCT02473510|12486926|FG000|NOT COMPLETED|Overall Study||1
11289420|NCT02473510|12486927|FG001|NOT COMPLETED|Overall Study||2
11289421|NCT02473614|12486933|FG000|STARTED|First Intervention (3 Weeks)||6
11289422|NCT02473614|12486934|FG001|STARTED|First Intervention (3 Weeks)||5
11289423|NCT02473614|12486933|FG000|COMPLETED|First Intervention (3 Weeks)||5
11289424|NCT02473614|12486934|FG001|COMPLETED|First Intervention (3 Weeks)||5
11289425|NCT02473614|12486933|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
11289426|NCT02473614|12486934|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
11289427|NCT02473614|12486933|FG000|STARTED|Wash Out Period (3 Weeks)||5
11289428|NCT02473614|12486934|FG001|STARTED|Wash Out Period (3 Weeks)||5
11289429|NCT02473614|12486933|FG000|COMPLETED|Wash Out Period (3 Weeks)||5
11289430|NCT02473614|12486934|FG001|COMPLETED|Wash Out Period (3 Weeks)||5
11289431|NCT02473614|12486933|FG000|NOT COMPLETED|Wash Out Period (3 Weeks)||0
11289432|NCT02473614|12486934|FG001|NOT COMPLETED|Wash Out Period (3 Weeks)||0
11289433|NCT02473614|12486933|FG000|STARTED|Second Intervention (3 Weeks)||5
11289434|NCT02473614|12486934|FG001|STARTED|Second Intervention (3 Weeks)||5
11289435|NCT02473614|12486933|FG000|COMPLETED|Second Intervention (3 Weeks)||5
11289436|NCT02473614|12486934|FG001|COMPLETED|Second Intervention (3 Weeks)||5
11289437|NCT02473614|12486933|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
11289438|NCT02473614|12486934|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
11289439|NCT02473640|12486941|FG000|STARTED|Treatment Period 1||15
11289440|NCT02473640|12486941|FG000|COMPLETED|Treatment Period 1||14
11289441|NCT02473640|12486941|FG000|NOT COMPLETED|Treatment Period 1||1
11289442|NCT02473640|12486941|FG000|STARTED|Run-in Phase||14
11289443|NCT02473640|12486941|FG000|COMPLETED|Run-in Phase||14
11289444|NCT02473640|12486941|FG000|NOT COMPLETED|Run-in Phase||0
11289445|NCT02473640|12486941|FG000|STARTED|Treatment Period 2||14
11289446|NCT02473640|12486941|FG000|COMPLETED|Treatment Period 2||14
11289447|NCT02473640|12486941|FG000|NOT COMPLETED|Treatment Period 2||0
11289448|NCT02473718|12486950|FG000|STARTED|Overall Study||41
11289449|NCT02473718|12486951|FG001|STARTED|Overall Study||41
11289450|NCT02473718|12486950|FG000|COMPLETED|Overall Study||41
11289451|NCT02473718|12486951|FG001|COMPLETED|Overall Study||41
11289452|NCT02473718|12486950|FG000|NOT COMPLETED|Overall Study||0
11289453|NCT02473718|12486951|FG001|NOT COMPLETED|Overall Study||0
11289454|NCT02473783|12486959|FG000|STARTED|Overall Study||20
11289455|NCT02473783|12486960|FG001|STARTED|Overall Study||17
11289456|NCT02473783|12486959|FG000|COMPLETED|Overall Study||20
11289457|NCT02473783|12486960|FG001|COMPLETED|Overall Study||17
11289458|NCT02473783|12486959|FG000|NOT COMPLETED|Overall Study||0
11289459|NCT02473783|12486960|FG001|NOT COMPLETED|Overall Study||0
11289460|NCT02473913|12486969|FG000|STARTED|Overall Study||11
11289461|NCT02473913|12486970|FG001|STARTED|Overall Study||11
11289462|NCT02473913|12486969|FG000|COMPLETED|Overall Study||8
11289463|NCT02473913|12486970|FG001|COMPLETED|Overall Study||8
11289464|NCT02473913|12486969|FG000|NOT COMPLETED|Overall Study||3
11289465|NCT02473913|12486970|FG001|NOT COMPLETED|Overall Study||3
11289466|NCT02473952|12486978|FG000|STARTED|Overall Study||30
11289467|NCT02473952|12486979|FG001|STARTED|Overall Study||32
11289468|NCT02473952|12486978|FG000|COMPLETED|Overall Study||28
11289469|NCT02473952|12486979|FG001|COMPLETED|Overall Study||24
11289470|NCT02473952|12486978|FG000|NOT COMPLETED|Overall Study||2
11289471|NCT02473952|12486979|FG001|NOT COMPLETED|Overall Study||8
11289472|NCT02473965|12486987|FG000|STARTED|Overall Study||30
11289473|NCT02473965|12486988|FG001|STARTED|Overall Study||30
11289474|NCT02473965|12486987|FG000|COMPLETED|Overall Study||18
11289475|NCT02473965|12486988|FG001|COMPLETED|Overall Study||20
11289476|NCT02473965|12486987|FG000|NOT COMPLETED|Overall Study||12
11289477|NCT02473965|12486988|FG001|NOT COMPLETED|Overall Study||10
11289478|NCT02473991|12486994|FG000|STARTED|Overall Study||395
11289479|NCT02473991|12486994|FG000|COMPLETED|Overall Study||395
11289480|NCT02473991|12486994|FG000|NOT COMPLETED|Overall Study||0
11289481|NCT02474069|12486998|FG000|STARTED|Selection Phase (SP)||772
11289482|NCT02474069|12486999|FG001|STARTED|Selection Phase (SP)||0
11289483|NCT02474069|12487000|FG002|STARTED|Selection Phase (SP)||0
11289484|NCT02474069|12486998|FG000|COMPLETED|Selection Phase (SP)||749
11289485|NCT02474069|12486999|FG001|COMPLETED|Selection Phase (SP)||0
11289486|NCT02474069|12487000|FG002|COMPLETED|Selection Phase (SP)||0
11289487|NCT02474069|12486998|FG000|NOT COMPLETED|Selection Phase (SP)||23
11289488|NCT02474069|12486999|FG001|NOT COMPLETED|Selection Phase (SP)||0
11289489|NCT02474069|12487000|FG002|NOT COMPLETED|Selection Phase (SP)||0
11289490|NCT02474069|12486998|FG000|STARTED|Comparative Dosing Phase (CDP)||0
11289491|NCT02474069|12486999|FG001|STARTED|Comparative Dosing Phase (CDP)||162
11289492|NCT02474069|12487000|FG002|STARTED|Comparative Dosing Phase (CDP)||163
11289493|NCT02474069|12486998|FG000|COMPLETED|Comparative Dosing Phase (CDP)||0
11289494|NCT02474069|12486999|FG001|COMPLETED|Comparative Dosing Phase (CDP)||153
11289495|NCT02474069|12487000|FG002|COMPLETED|Comparative Dosing Phase (CDP)||157
11289496|NCT02474069|12486998|FG000|NOT COMPLETED|Comparative Dosing Phase (CDP)||0
11289497|NCT02474069|12486999|FG001|NOT COMPLETED|Comparative Dosing Phase (CDP)||9
11289498|NCT02474069|12487000|FG002|NOT COMPLETED|Comparative Dosing Phase (CDP)||6
11289499|NCT02474082|12487012|FG000|STARTED|Overall Study||105
11289500|NCT02474082|12487013|FG001|STARTED|Overall Study||97
11289501|NCT02474082|12487012|FG000|Full Analysis Set (FAS)|Overall Study||105
11289502|NCT02474082|12487013|FG001|Full Analysis Set (FAS)|Overall Study||95
11289503|NCT02474082|12487012|FG000|COMPLETED|Overall Study||99
11289504|NCT02474082|12487013|FG001|COMPLETED|Overall Study||43
11289505|NCT02474082|12487012|FG000|NOT COMPLETED|Overall Study||6
11289506|NCT02474082|12487013|FG001|NOT COMPLETED|Overall Study||54
11289507|NCT02474199|12487021|FG000|STARTED|Overall Study||5
11289508|NCT02474199|12487022|FG001|STARTED|Overall Study|Insufficient numbers of darTregs for infusion (4 of these 5 participants)|5
11289509|NCT02474199|12487023|FG002|STARTED|Overall Study||2
11289510|NCT02474199|12487024|FG003|STARTED|Overall Study||3
11399679|NCT04314037|12594250|FG000|COMPLETED|Treatment Period 4||16
11289511|NCT02474199|12487021|FG000|COMPLETED|Overall Study||3
11289512|NCT02474199|12487022|FG001|COMPLETED|Overall Study||2
11289513|NCT02474199|12487023|FG002|COMPLETED|Overall Study||0
11289514|NCT02474199|12487024|FG003|COMPLETED|Overall Study||0
11289515|NCT02474199|12487021|FG000|NOT COMPLETED|Overall Study||2
11289516|NCT02474199|12487022|FG001|NOT COMPLETED|Overall Study||3
11289517|NCT02474199|12487023|FG002|NOT COMPLETED|Overall Study||2
11289518|NCT02474199|12487024|FG003|NOT COMPLETED|Overall Study||3
11289519|NCT02474355|12487031|FG000|STARTED|Overall Study||3014
11289520|NCT02474355|12487031|FG000|COMPLETED|Overall Study||1386
11289521|NCT02474355|12487031|FG000|NOT COMPLETED|Overall Study||1628
11289522|NCT02474407|12487035|FG000|STARTED|First Intervention (14 Days)||39
11289523|NCT02474407|12487036|FG001|STARTED|First Intervention (14 Days)||39
11289524|NCT02474407|12487035|FG000|COMPLETED|First Intervention (14 Days)||39
11289525|NCT02474407|12487036|FG001|COMPLETED|First Intervention (14 Days)||39
11289526|NCT02474407|12487035|FG000|NOT COMPLETED|First Intervention (14 Days)||0
11289527|NCT02474407|12487036|FG001|NOT COMPLETED|First Intervention (14 Days)||0
11289528|NCT02474407|12487035|FG000|STARTED|Washout (14 Days)||39
11289529|NCT02474407|12487036|FG001|STARTED|Washout (14 Days)||39
11289530|NCT02474407|12487035|FG000|COMPLETED|Washout (14 Days)||39
11289531|NCT02474407|12487036|FG001|COMPLETED|Washout (14 Days)||39
11289532|NCT02474407|12487035|FG000|NOT COMPLETED|Washout (14 Days)||0
11289533|NCT02474407|12487036|FG001|NOT COMPLETED|Washout (14 Days)||0
11289534|NCT02474407|12487035|FG000|STARTED|Second Intervention (14 Days)||39
11289535|NCT02474407|12487036|FG001|STARTED|Second Intervention (14 Days)||39
11289536|NCT02474407|12487035|FG000|COMPLETED|Second Intervention (14 Days)||39
11289537|NCT02474407|12487036|FG001|COMPLETED|Second Intervention (14 Days)||39
11289538|NCT02474407|12487035|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
11289539|NCT02474407|12487036|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
11289540|NCT02474498|12487065|FG000|STARTED|Overall Study||13
11289541|NCT02474498|12487066|FG001|STARTED|Overall Study||14
11289542|NCT02474498|12487067|FG002|STARTED|Overall Study||14
11289543|NCT02474498|12487065|FG000|COMPLETED|Overall Study||13
11289544|NCT02474498|12487066|FG001|COMPLETED|Overall Study||14
11289545|NCT02474498|12487067|FG002|COMPLETED|Overall Study||14
11289546|NCT02474498|12487065|FG000|NOT COMPLETED|Overall Study||0
11399680|NCT04314037|12594251|FG001|COMPLETED|Treatment Period 4||17
11289547|NCT02474498|12487066|FG001|NOT COMPLETED|Overall Study||0
11289548|NCT02474498|12487067|FG002|NOT COMPLETED|Overall Study||0
11289549|NCT02474589|12487081|FG000|STARTED|Overall Study||359
11289550|NCT02474589|12487082|FG001|STARTED|Overall Study||90
11289551|NCT02474589|12487081|FG000|COMPLETED|Overall Study||334
11289552|NCT02474589|12487082|FG001|COMPLETED|Overall Study||85
11289553|NCT02474589|12487081|FG000|NOT COMPLETED|Overall Study||25
11289554|NCT02474589|12487082|FG001|NOT COMPLETED|Overall Study||5
11289555|NCT02474901|12487090|FG000|STARTED|Overall Study||45
11289556|NCT02474901|12487091|FG001|STARTED|Overall Study||56
11289557|NCT02474901|12487090|FG000|COMPLETED|Overall Study||44
11289558|NCT02474901|12487091|FG001|COMPLETED|Overall Study||56
11289559|NCT02474901|12487090|FG000|NOT COMPLETED|Overall Study||1
11289560|NCT02474901|12487091|FG001|NOT COMPLETED|Overall Study||0
11289561|NCT02475031|12487099|FG000|STARTED|Overall Study||35
11289562|NCT02475031|12487100|FG001|STARTED|Overall Study||35
11289563|NCT02475031|12487099|FG000|COMPLETED|Overall Study||35
11289564|NCT02475031|12487100|FG001|COMPLETED|Overall Study||35
11289565|NCT02475031|12487099|FG000|NOT COMPLETED|Overall Study||0
11289566|NCT02475031|12487100|FG001|NOT COMPLETED|Overall Study||0
11289567|NCT02475070|12487110|FG000|STARTED|Overall Study||17
11289568|NCT02475070|12487111|FG001|STARTED|Overall Study||11
11289569|NCT02475070|12487110|FG000|COMPLETED|Overall Study||17
11289570|NCT02475070|12487111|FG001|COMPLETED|Overall Study||11
11289571|NCT02475070|12487110|FG000|NOT COMPLETED|Overall Study||0
11289572|NCT02475070|12487111|FG001|NOT COMPLETED|Overall Study||0
11289573|NCT02475265|12487118|FG000|STARTED|Overall Study||11
11289574|NCT02475265|12487118|FG000|COMPLETED|Overall Study||8
11289575|NCT02475265|12487118|FG000|NOT COMPLETED|Overall Study||3
11289576|NCT02475278|12487122|FG000|STARTED|Overall Study||50
11289577|NCT02475278|12487122|FG000|COMPLETED|Overall Study||48
11289578|NCT02475278|12487122|FG000|NOT COMPLETED|Overall Study||2
11289579|NCT02475369|12487126|FG000|STARTED|Run-in Washout Period #1 (7 Days)||10
11289580|NCT02475369|12487127|FG001|STARTED|Run-in Washout Period #1 (7 Days)||11
11289581|NCT02475369|12487126|FG000|COMPLETED|Run-in Washout Period #1 (7 Days)||3
11289582|NCT02475369|12487127|FG001|COMPLETED|Run-in Washout Period #1 (7 Days)||9
11289583|NCT02475369|12487126|FG000|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||7
11289584|NCT02475369|12487127|FG001|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||2
11289585|NCT02475369|12487126|FG000|STARTED|Treatment Period #1 (10 Days)||3
11289586|NCT02475369|12487127|FG001|STARTED|Treatment Period #1 (10 Days)||9
11289587|NCT02475369|12487126|FG000|COMPLETED|Treatment Period #1 (10 Days)||3
11289588|NCT02475369|12487127|FG001|COMPLETED|Treatment Period #1 (10 Days)||9
11289589|NCT02475369|12487126|FG000|NOT COMPLETED|Treatment Period #1 (10 Days)||0
11289590|NCT02475369|12487127|FG001|NOT COMPLETED|Treatment Period #1 (10 Days)||0
11289591|NCT02475369|12487126|FG000|STARTED|Run-in Washout Period #2 (7 Days)||3
11289592|NCT02475369|12487127|FG001|STARTED|Run-in Washout Period #2 (7 Days)||9
11289593|NCT02475369|12487126|FG000|COMPLETED|Run-in Washout Period #2 (7 Days)||3
11289594|NCT02475369|12487127|FG001|COMPLETED|Run-in Washout Period #2 (7 Days)||9
11289595|NCT02475369|12487126|FG000|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
11289596|NCT02475369|12487127|FG001|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
11289597|NCT02475369|12487126|FG000|STARTED|Treatment Period #2 (10 Days)||3
11289598|NCT02475369|12487127|FG001|STARTED|Treatment Period #2 (10 Days)||9
11289599|NCT02475369|12487126|FG000|COMPLETED|Treatment Period #2 (10 Days)||3
11289600|NCT02475369|12487127|FG001|COMPLETED|Treatment Period #2 (10 Days)||9
11289601|NCT02475369|12487126|FG000|NOT COMPLETED|Treatment Period #2 (10 Days)||0
11289602|NCT02475369|12487127|FG001|NOT COMPLETED|Treatment Period #2 (10 Days)||0
11289603|NCT02475395|12487140|FG000|STARTED|Overall Study||258
11289604|NCT02475395|12487141|FG001|STARTED|Overall Study||14
11289605|NCT02475395|12487140|FG000|COMPLETED|Overall Study||228
11289606|NCT02475395|12487141|FG001|COMPLETED|Overall Study||11
11289607|NCT02475395|12487140|FG000|NOT COMPLETED|Overall Study||30
11289608|NCT02475395|12487141|FG001|NOT COMPLETED|Overall Study||3
11289609|NCT02475564|12487149|FG000|STARTED|Overall Study||22
11289610|NCT02475564|12487150|FG001|STARTED|Overall Study||22
11289611|NCT02475564|12487149|FG000|COMPLETED|Overall Study||18
11289612|NCT02475564|12487150|FG001|COMPLETED|Overall Study||21
11289613|NCT02475564|12487149|FG000|NOT COMPLETED|Overall Study||4
11289614|NCT02475564|12487150|FG001|NOT COMPLETED|Overall Study||1
11289615|NCT02475629|12487156|FG000|STARTED|Overall Study||40
11289616|NCT02475629|12487156|FG000|COMPLETED|Overall Study||31
11289617|NCT02475629|12487156|FG000|NOT COMPLETED|Overall Study||9
11289618|NCT02475655|12487162|FG000|STARTED|Overall Study||40
11289619|NCT02475655|12487163|FG001|STARTED|Overall Study||20
11289620|NCT02475655|12487162|FG000|COMPLETED|Overall Study||40
11289621|NCT02475655|12487163|FG001|COMPLETED|Overall Study||19
11289622|NCT02475655|12487162|FG000|NOT COMPLETED|Overall Study||0
11289623|NCT02475655|12487163|FG001|NOT COMPLETED|Overall Study||1
11289624|NCT02475733|12487171|FG000|STARTED|Overall Study||61
11289625|NCT02475733|12487172|FG001|STARTED|Overall Study||22
11289626|NCT02475733|12487171|FG000|COMPLETED|Overall Study||59
11289627|NCT02475733|12487172|FG001|COMPLETED|Overall Study||22
11289628|NCT02475733|12487171|FG000|NOT COMPLETED|Overall Study||2
11289629|NCT02475733|12487172|FG001|NOT COMPLETED|Overall Study||0
11289630|NCT02475837|12487180|FG000|STARTED|Overall Study||6
11289631|NCT02475837|12487181|FG001|STARTED|Overall Study||7
11289632|NCT02475837|12487180|FG000|COMPLETED|Overall Study||6
11289633|NCT02475837|12487181|FG001|COMPLETED|Overall Study||7
11289634|NCT02475837|12487180|FG000|NOT COMPLETED|Overall Study||0
11289635|NCT02475837|12487181|FG001|NOT COMPLETED|Overall Study||0
11289636|NCT02475850|12487189|FG000|STARTED|Overall Study||2802
11289637|NCT02475850|12487190|FG001|STARTED|Overall Study||2649
11289638|NCT02475850|12487189|FG000|COMPLETED|Overall Study||2209
11289639|NCT02475850|12487190|FG001|COMPLETED|Overall Study||2165
11399681|NCT04314037|12594250|FG000|NOT COMPLETED|Treatment Period 4||0
11399682|NCT04314037|12594251|FG001|NOT COMPLETED|Treatment Period 4||0
11399683|NCT04315298|12594282|FG000|STARTED|Overall Study||90
11399684|NCT04315298|12594283|FG001|STARTED|Overall Study||187
11399685|NCT04315298|12594284|FG002|STARTED|Overall Study||180
11399686|NCT04315298|12594285|FG003|STARTED|Overall Study||170
11399687|NCT04315298|12594286|FG004|STARTED|Overall Study||242
11399688|NCT04315298|12594287|FG005|STARTED|Overall Study||338
11289640|NCT02475850|12487189|FG000|NOT COMPLETED|Overall Study||593
11289641|NCT02475850|12487190|FG001|NOT COMPLETED|Overall Study||484
11289642|NCT02475954|12487199|FG000|STARTED|Overall Study||87
11289643|NCT02475954|12487200|FG001|STARTED|Overall Study||87
11289644|NCT02475954|12487199|FG000|COMPLETED|Overall Study||73
11289645|NCT02475954|12487200|FG001|COMPLETED|Overall Study||75
11289646|NCT02475954|12487199|FG000|NOT COMPLETED|Overall Study||14
11289647|NCT02475954|12487200|FG001|NOT COMPLETED|Overall Study||12
11289648|NCT02475980|12487207|FG000|STARTED|Overall Study||13
11289649|NCT02475980|12487207|FG000|COMPLETED|Overall Study||8
11289650|NCT02475980|12487207|FG000|NOT COMPLETED|Overall Study||5
11289651|NCT02476032|12487214|FG000|STARTED|Overall Study||20
11289652|NCT02476032|12487215|FG001|STARTED|Overall Study||20
11289653|NCT02476032|12487216|FG002|STARTED|Overall Study||20
11289654|NCT02476032|12487214|FG000|COMPLETED|Overall Study||20
11289655|NCT02476032|12487215|FG001|COMPLETED|Overall Study||19
11289656|NCT02476032|12487216|FG002|COMPLETED|Overall Study||19
11289657|NCT02476032|12487214|FG000|NOT COMPLETED|Overall Study||0
11289658|NCT02476032|12487215|FG001|NOT COMPLETED|Overall Study||1
11289659|NCT02476032|12487216|FG002|NOT COMPLETED|Overall Study||1
11289660|NCT02476175|12487227|FG000|STARTED|Overall Study||35
11289661|NCT02476175|12487227|FG000|COMPLETED|Overall Study||33
11289662|NCT02476175|12487227|FG000|NOT COMPLETED|Overall Study||2
11289663|NCT02476357|12487233|FG000|STARTED|Overall Study||40
11289664|NCT02476357|12487234|FG001|STARTED|Overall Study||40
11289665|NCT02476357|12487233|FG000|COMPLETED|Overall Study||40
11289666|NCT02476357|12487234|FG001|COMPLETED|Overall Study||40
11289667|NCT02476357|12487233|FG000|NOT COMPLETED|Overall Study||0
11289668|NCT02476357|12487234|FG001|NOT COMPLETED|Overall Study||0
11289669|NCT02476422|12487244|FG000|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
11289670|NCT02476422|12487245|FG001|STARTED|Overall Study||162
11289671|NCT02476422|12487244|FG000|COMPLETED|Overall Study||166
11289672|NCT02476422|12487245|FG001|COMPLETED|Overall Study||161
11289673|NCT02476422|12487244|FG000|NOT COMPLETED|Overall Study||0
11289674|NCT02476422|12487245|FG001|NOT COMPLETED|Overall Study||1
11289675|NCT02476448|12487255|FG000|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44
11289676|NCT02476448|12487256|FG001|STARTED|Overall Study||44
11289677|NCT02476448|12487257|FG002|STARTED|Overall Study||44
11289678|NCT02476448|12487258|FG003|STARTED|Overall Study||44
11289679|NCT02476448|12487255|FG000|COMPLETED|Overall Study||44
11289680|NCT02476448|12487256|FG001|COMPLETED|Overall Study||44
11289681|NCT02476448|12487257|FG002|COMPLETED|Overall Study||44
11289682|NCT02476448|12487258|FG003|COMPLETED|Overall Study||44
11289683|NCT02476448|12487255|FG000|NOT COMPLETED|Overall Study||0
11289684|NCT02476448|12487256|FG001|NOT COMPLETED|Overall Study||0
11289685|NCT02476448|12487257|FG002|NOT COMPLETED|Overall Study||0
11289686|NCT02476448|12487258|FG003|NOT COMPLETED|Overall Study||0
11289687|NCT02476565|12487270|FG000|STARTED|Overall Study||20
11289688|NCT02476565|12487271|FG001|STARTED|Overall Study||19
11289689|NCT02476565|12487270|FG000|COMPLETED|Overall Study||20
11289690|NCT02476565|12487271|FG001|COMPLETED|Overall Study||19
11289691|NCT02476565|12487270|FG000|NOT COMPLETED|Overall Study||0
11289692|NCT02476565|12487271|FG001|NOT COMPLETED|Overall Study||0
11289693|NCT02476578|12487279|FG000|STARTED|Overall Study||4310
11289694|NCT02476578|12487280|FG001|STARTED|Overall Study||4274
11289695|NCT02476578|12487279|FG000|Died Before Email Was Sent|Overall Study||35
11289696|NCT02476578|12487280|FG001|Died Before Email Was Sent|Overall Study||43
11289697|NCT02476578|12487279|FG000|Left Before End of Trial|Overall Study||6
11289698|NCT02476578|12487280|FG001|Left Before End of Trial|Overall Study||13
11289699|NCT02476578|12487279|FG000|COMPLETED|Overall Study||4269
11289700|NCT02476578|12487280|FG001|COMPLETED|Overall Study||4218
11289701|NCT02476578|12487279|FG000|NOT COMPLETED|Overall Study||41
11289702|NCT02476578|12487280|FG001|NOT COMPLETED|Overall Study||56
11289703|NCT02476617|12487286|FG000|STARTED|Overall Study||25
11289704|NCT02476617|12487286|FG000|COMPLETED|Overall Study||23
11399689|NCT04315298|12594288|FG006|STARTED|Overall Study||70
11399690|NCT04315298|12594289|FG007|STARTED|Overall Study||140
11289705|NCT02476617|12487286|FG000|NOT COMPLETED|Overall Study||2
11289706|NCT02476890|12487294|FG000|STARTED|Overall Study|Crossover study|6
11289707|NCT02476890|12487295|FG001|STARTED|Overall Study|Crossover study|6
11289708|NCT02476890|12487296|FG002|STARTED|Overall Study|Crossover study|12
11399691|NCT04315298|12594290|FG008|STARTED|Overall Study||137
11289709|NCT02476890|12487297|FG003|STARTED|Overall Study|Crossover study|12
11289710|NCT02476890|12487294|FG000|Washout|Overall Study||6
11289711|NCT02476890|12487295|FG001|Washout|Overall Study||6
11289712|NCT02476890|12487296|FG002|Washout|Overall Study||12
11289713|NCT02476890|12487297|FG003|Washout|Overall Study||12
11289714|NCT02476890|12487294|FG000|COMPLETED|Overall Study||6
11289715|NCT02476890|12487295|FG001|COMPLETED|Overall Study||6
11289716|NCT02476890|12487296|FG002|COMPLETED|Overall Study||12
11289717|NCT02476890|12487297|FG003|COMPLETED|Overall Study||12
11289718|NCT02476890|12487294|FG000|NOT COMPLETED|Overall Study||0
11289719|NCT02476890|12487295|FG001|NOT COMPLETED|Overall Study||0
11289720|NCT02476890|12487296|FG002|NOT COMPLETED|Overall Study||0
11289721|NCT02476890|12487297|FG003|NOT COMPLETED|Overall Study||0
11289722|NCT02477020|12487311|FG000|STARTED|Overall Study||81
11289723|NCT02477020|12487312|FG001|STARTED|Overall Study||83
11289724|NCT02477020|12487311|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
11289725|NCT02477020|12487312|FG001|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
11289726|NCT02477020|12487311|FG000|NOT COMPLETED|Overall Study||30
11289727|NCT02477020|12487312|FG001|NOT COMPLETED|Overall Study||28
11289728|NCT02477111|12487318|FG000|STARTED|Overall Study||150
11289729|NCT02477111|12487318|FG000|COMPLETED|Overall Study|All participants who were assessed for one year|139
11289730|NCT02477111|12487318|FG000|NOT COMPLETED|Overall Study||11
11289731|NCT02477215|12487328|FG000|STARTED|Dose Escalation Phase||4
11289732|NCT02477215|12487329|FG001|STARTED|Dose Escalation Phase||8
11289733|NCT02477215|12487330|FG002|STARTED|Dose Escalation Phase||6
11289734|NCT02477215|12487328|FG000|COMPLETED|Dose Escalation Phase||3
11289735|NCT02477215|12487329|FG001|COMPLETED|Dose Escalation Phase||6
11289736|NCT02477215|12487330|FG002|COMPLETED|Dose Escalation Phase||6
11289737|NCT02477215|12487328|FG000|NOT COMPLETED|Dose Escalation Phase||1
11289738|NCT02477215|12487329|FG001|NOT COMPLETED|Dose Escalation Phase||2
11289739|NCT02477215|12487330|FG002|NOT COMPLETED|Dose Escalation Phase||0
11289740|NCT02477215|12487328|FG000|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
11289741|NCT02477215|12487329|FG001|STARTED|Fixed Dose Phase|Subjects in Period 1 did not continue into Period 2. This is a new subject population.|20
11289742|NCT02477215|12487330|FG002|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
11289743|NCT02477215|12487328|FG000|COMPLETED|Fixed Dose Phase||0
11289744|NCT02477215|12487329|FG001|COMPLETED|Fixed Dose Phase||13
11289745|NCT02477215|12487330|FG002|COMPLETED|Fixed Dose Phase||0
11289746|NCT02477215|12487328|FG000|NOT COMPLETED|Fixed Dose Phase||0
11289747|NCT02477215|12487329|FG001|NOT COMPLETED|Fixed Dose Phase||7
11289748|NCT02477215|12487330|FG002|NOT COMPLETED|Fixed Dose Phase||0
11289749|NCT02477319|12487345|FG000|STARTED|Overall Study||55
11289750|NCT02477319|12487346|FG001|STARTED|Overall Study||40
11289751|NCT02477319|12487347|FG002|STARTED|Overall Study||164
11289752|NCT02477319|12487348|FG003|STARTED|Overall Study||193
11289753|NCT02477319|12487345|FG000|COMPLETED|Overall Study||55
11289754|NCT02477319|12487346|FG001|COMPLETED|Overall Study||37
11289755|NCT02477319|12487347|FG002|COMPLETED|Overall Study||149
11289756|NCT02477319|12487348|FG003|COMPLETED|Overall Study||171
11289757|NCT02477319|12487345|FG000|NOT COMPLETED|Overall Study||0
11289758|NCT02477319|12487346|FG001|NOT COMPLETED|Overall Study||3
11289759|NCT02477319|12487347|FG002|NOT COMPLETED|Overall Study||15
11289760|NCT02477319|12487348|FG003|NOT COMPLETED|Overall Study||22
11289761|NCT02477332|12487361|FG000|STARTED|Overall Study||43
11289762|NCT02477332|12487362|FG001|STARTED|Overall Study||84
11289763|NCT02477332|12487363|FG002|STARTED|Overall Study||85
11289764|NCT02477332|12487364|FG003|STARTED|Overall Study||85
11289765|NCT02477332|12487365|FG004|STARTED|Overall Study||43
11289766|NCT02477332|12487366|FG005|STARTED|Overall Study||42
11289767|NCT02477332|12487361|FG000|COMPLETED|Overall Study||40
11289768|NCT02477332|12487362|FG001|COMPLETED|Overall Study||77
11289769|NCT02477332|12487363|FG002|COMPLETED|Overall Study||73
11289770|NCT02477332|12487364|FG003|COMPLETED|Overall Study||72
11289771|NCT02477332|12487365|FG004|COMPLETED|Overall Study||39
11289772|NCT02477332|12487366|FG005|COMPLETED|Overall Study||37
11289773|NCT02477332|12487361|FG000|NOT COMPLETED|Overall Study||3
11289774|NCT02477332|12487362|FG001|NOT COMPLETED|Overall Study||7
11289775|NCT02477332|12487363|FG002|NOT COMPLETED|Overall Study||12
11289776|NCT02477332|12487364|FG003|NOT COMPLETED|Overall Study||13
11289777|NCT02477332|12487365|FG004|NOT COMPLETED|Overall Study||4
11289778|NCT02477332|12487366|FG005|NOT COMPLETED|Overall Study||5
11289779|NCT02477423|12487384|FG000|STARTED|Overall Study||12
11289780|NCT02477423|12487385|FG001|STARTED|Overall Study||15
11289781|NCT02477423|12487384|FG000|COMPLETED|Overall Study||11
11289782|NCT02477423|12487385|FG001|COMPLETED|Overall Study||11
11289783|NCT02477423|12487384|FG000|NOT COMPLETED|Overall Study||1
11289784|NCT02477423|12487385|FG001|NOT COMPLETED|Overall Study||4
11289785|NCT02477527|12487391|FG000|STARTED|Overall Study||27
11289786|NCT02477527|12487391|FG000|COMPLETED|Overall Study||21
11289787|NCT02477527|12487391|FG000|NOT COMPLETED|Overall Study||6
11289788|NCT02477553|12487397|FG000|STARTED|Overall Study||364
11289789|NCT02477553|12487398|FG001|STARTED|Overall Study||364
11289790|NCT02477553|12487397|FG000|COMPLETED|Overall Study||344
11289791|NCT02477553|12487398|FG001|COMPLETED|Overall Study||344
11289792|NCT02477553|12487397|FG000|NOT COMPLETED|Overall Study||20
11289793|NCT02477553|12487398|FG001|NOT COMPLETED|Overall Study||20
11289794|NCT02477605|12487406|FG000|STARTED|Overall Study||68
11289795|NCT02477605|12487407|FG001|STARTED|Overall Study||68
11289796|NCT02477605|12487406|FG000|Randomized and Treated|Overall Study||67
11289797|NCT02477605|12487407|FG001|Randomized and Treated|Overall Study||68
11289798|NCT02477605|12487406|FG000|COMPLETED|Overall Study||67
11289799|NCT02477605|12487407|FG001|COMPLETED|Overall Study||64
11289800|NCT02477605|12487406|FG000|NOT COMPLETED|Overall Study||1
11289801|NCT02477605|12487407|FG001|NOT COMPLETED|Overall Study||4
11289802|NCT02477670|12487419|FG000|STARTED|Stage 1||47
11289803|NCT02477670|12487420|FG001|STARTED|Stage 1||80
11289804|NCT02477670|12487421|FG002|STARTED|Stage 1||0
11289805|NCT02477670|12487422|FG003|STARTED|Stage 1||0
11289806|NCT02477670|12487423|FG004|STARTED|Stage 1||0
11289807|NCT02477670|12487424|FG005|STARTED|Stage 1||0
11289808|NCT02477670|12487425|FG006|STARTED|Stage 1||0
11289809|NCT02477670|12487419|FG000|COMPLETED|Stage 1||43
11289810|NCT02477670|12487420|FG001|COMPLETED|Stage 1||67
11289811|NCT02477670|12487421|FG002|COMPLETED|Stage 1||0
11289812|NCT02477670|12487422|FG003|COMPLETED|Stage 1||0
11289813|NCT02477670|12487423|FG004|COMPLETED|Stage 1||0
11289814|NCT02477670|12487424|FG005|COMPLETED|Stage 1||0
11289815|NCT02477670|12487425|FG006|COMPLETED|Stage 1||0
11289816|NCT02477670|12487419|FG000|NOT COMPLETED|Stage 1||4
11289817|NCT02477670|12487420|FG001|NOT COMPLETED|Stage 1||13
11289818|NCT02477670|12487421|FG002|NOT COMPLETED|Stage 1||0
11289819|NCT02477670|12487422|FG003|NOT COMPLETED|Stage 1||0
11289820|NCT02477670|12487423|FG004|NOT COMPLETED|Stage 1||0
11289821|NCT02477670|12487424|FG005|NOT COMPLETED|Stage 1||0
11289822|NCT02477670|12487425|FG006|NOT COMPLETED|Stage 1||0
11289823|NCT02477670|12487419|FG000|STARTED|Stage 2||0
11289824|NCT02477670|12487420|FG001|STARTED|Stage 2||0
11289825|NCT02477670|12487421|FG002|STARTED|Stage 2||30
11289826|NCT02477670|12487422|FG003|STARTED|Stage 2||33
11289827|NCT02477670|12487423|FG004|STARTED|Stage 2||2
11289828|NCT02477670|12487424|FG005|STARTED|Stage 2||1
11289829|NCT02477670|12487425|FG006|STARTED|Stage 2||42
11289830|NCT02477670|12487419|FG000|COMPLETED|Stage 2||0
11289831|NCT02477670|12487420|FG001|COMPLETED|Stage 2||0
11289832|NCT02477670|12487421|FG002|COMPLETED|Stage 2||28
11289833|NCT02477670|12487422|FG003|COMPLETED|Stage 2||32
11289834|NCT02477670|12487423|FG004|COMPLETED|Stage 2||2
11289835|NCT02477670|12487424|FG005|COMPLETED|Stage 2||1
11289836|NCT02477670|12487425|FG006|COMPLETED|Stage 2||42
11289837|NCT02477670|12487419|FG000|NOT COMPLETED|Stage 2||0
11289838|NCT02477670|12487420|FG001|NOT COMPLETED|Stage 2||0
11289839|NCT02477670|12487421|FG002|NOT COMPLETED|Stage 2||2
11289840|NCT02477670|12487422|FG003|NOT COMPLETED|Stage 2||1
11289841|NCT02477670|12487423|FG004|NOT COMPLETED|Stage 2||0
11289842|NCT02477670|12487424|FG005|NOT COMPLETED|Stage 2||0
11289843|NCT02477670|12487425|FG006|NOT COMPLETED|Stage 2||0
11289844|NCT02477709|12487436|FG000|STARTED|Overall Study||6
11289845|NCT02477709|12487436|FG000|COMPLETED|Overall Study||6
11289846|NCT02477709|12487436|FG000|NOT COMPLETED|Overall Study||0
11289847|NCT02477800|12487443|FG000|STARTED|Placebo-Controlled Period||545
11289848|NCT02477800|12487444|FG001|STARTED|Placebo-Controlled Period||547
11289849|NCT02477800|12487445|FG002|STARTED|Placebo-Controlled Period||555
11289850|NCT02477800|12487446|FG003|STARTED|Placebo-Controlled Period||0
11289851|NCT02477800|12487447|FG004|STARTED|Placebo-Controlled Period||0
11289852|NCT02477800|12487448|FG005|STARTED|Placebo-Controlled Period||0
11289853|NCT02477800|12487449|FG006|STARTED|Placebo-Controlled Period||0
11289854|NCT02477800|12487443|FG000|COMPLETED|Placebo-Controlled Period||325
11289855|NCT02477800|12487444|FG001|COMPLETED|Placebo-Controlled Period||325
11289856|NCT02477800|12487445|FG002|COMPLETED|Placebo-Controlled Period||288
11289857|NCT02477800|12487446|FG003|COMPLETED|Placebo-Controlled Period||0
11289858|NCT02477800|12487447|FG004|COMPLETED|Placebo-Controlled Period||0
11289859|NCT02477800|12487448|FG005|COMPLETED|Placebo-Controlled Period||0
11289860|NCT02477800|12487449|FG006|COMPLETED|Placebo-Controlled Period||0
11289861|NCT02477800|12487443|FG000|NOT COMPLETED|Placebo-Controlled Period||220
11289862|NCT02477800|12487444|FG001|NOT COMPLETED|Placebo-Controlled Period||222
11289863|NCT02477800|12487445|FG002|NOT COMPLETED|Placebo-Controlled Period||267
11289864|NCT02477800|12487446|FG003|NOT COMPLETED|Placebo-Controlled Period||0
11289865|NCT02477800|12487447|FG004|NOT COMPLETED|Placebo-Controlled Period||0
11289866|NCT02477800|12487448|FG005|NOT COMPLETED|Placebo-Controlled Period||0
11289867|NCT02477800|12487449|FG006|NOT COMPLETED|Placebo-Controlled Period||0
11289868|NCT02477800|12487443|FG000|STARTED|Long Term Extension Period||0
11289869|NCT02477800|12487444|FG001|STARTED|Long Term Extension Period||0
11289870|NCT02477800|12487445|FG002|STARTED|Long Term Extension Period||0
11289871|NCT02477800|12487446|FG003|STARTED|Long Term Extension Period|12 PC completers did not enter LTE.|150
11289872|NCT02477800|12487447|FG004|STARTED|Long Term Extension Period|11 PC completers did not enter LTE.|152
11289873|NCT02477800|12487448|FG005|STARTED|Long Term Extension Period|26 PC completers did not enter LTE.|299
11289874|NCT02477800|12487449|FG006|STARTED|Long Term Extension Period|37 PC completers did not enter LTE.|251
11289875|NCT02477800|12487443|FG000|COMPLETED|Long Term Extension Period||0
11289876|NCT02477800|12487444|FG001|COMPLETED|Long Term Extension Period||0
11289877|NCT02477800|12487445|FG002|COMPLETED|Long Term Extension Period||0
11289878|NCT02477800|12487446|FG003|COMPLETED|Long Term Extension Period||0
11289879|NCT02477800|12487447|FG004|COMPLETED|Long Term Extension Period||0
11289880|NCT02477800|12487448|FG005|COMPLETED|Long Term Extension Period||0
11289881|NCT02477800|12487449|FG006|COMPLETED|Long Term Extension Period||0
11289882|NCT02477800|12487443|FG000|NOT COMPLETED|Long Term Extension Period||0
11289883|NCT02477800|12487444|FG001|NOT COMPLETED|Long Term Extension Period||0
11289884|NCT02477800|12487445|FG002|NOT COMPLETED|Long Term Extension Period||0
11289885|NCT02477800|12487446|FG003|NOT COMPLETED|Long Term Extension Period||150
11399692|NCT04315298|12594291|FG009|STARTED|Overall Study||46
11399693|NCT04315298|12594292|FG010|STARTED|Overall Study||95
11399694|NCT04315298|12594293|FG011|STARTED|Overall Study||92
11289886|NCT02477800|12487447|FG004|NOT COMPLETED|Long Term Extension Period||152
11289887|NCT02477800|12487448|FG005|NOT COMPLETED|Long Term Extension Period||299
11399695|NCT04315298|12594294|FG012|STARTED|Overall Study||8
11289888|NCT02477800|12487449|FG006|NOT COMPLETED|Long Term Extension Period||251
11289889|NCT02477839|12487463|FG000|STARTED|Overall Study||127
11289890|NCT02477839|12487464|FG001|STARTED|Overall Study||128
11289891|NCT02477839|12487463|FG000|Completed Transition Period|Overall Study||124
11289892|NCT02477839|12487464|FG001|Completed Transition Period|Overall Study||117
11289893|NCT02477839|12487463|FG000|Completed Taper After Maintenance|Overall Study||0
11289894|NCT02477839|12487464|FG001|Completed Taper After Maintenance|Overall Study||1
11289895|NCT02477839|12487463|FG000|COMPLETED|Overall Study||124
11289896|NCT02477839|12487464|FG001|COMPLETED|Overall Study||118
11289897|NCT02477839|12487463|FG000|NOT COMPLETED|Overall Study||3
11289898|NCT02477839|12487464|FG001|NOT COMPLETED|Overall Study||10
11341044|NCT02928055|12538406|FG001|NOT COMPLETED|Overall Study||2
11341045|NCT02928055|12538407|FG002|NOT COMPLETED|Overall Study||2
11341046|NCT02928380|12538415|FG000|STARTED|Period 1||13
11341047|NCT02928380|12538416|FG001|STARTED|Period 1||14
11341048|NCT02928380|12538417|FG002|STARTED|Period 1||14
11341049|NCT02928380|12538418|FG003|STARTED|Period 1||14
11341050|NCT02928380|12538419|FG004|STARTED|Period 1||14
11341051|NCT02928380|12538420|FG005|STARTED|Period 1||14
11341052|NCT02928380|12538415|FG000|COMPLETED|Period 1||13
11341053|NCT02928380|12538416|FG001|COMPLETED|Period 1||14
11341054|NCT02928380|12538417|FG002|COMPLETED|Period 1||14
11341055|NCT02928380|12538418|FG003|COMPLETED|Period 1||14
11341056|NCT02928380|12538419|FG004|COMPLETED|Period 1||14
11341057|NCT02928380|12538420|FG005|COMPLETED|Period 1||14
11341058|NCT02928380|12538415|FG000|NOT COMPLETED|Period 1||0
11341059|NCT02928380|12538416|FG001|NOT COMPLETED|Period 1||0
11341060|NCT02928380|12538417|FG002|NOT COMPLETED|Period 1||0
11341061|NCT02928380|12538418|FG003|NOT COMPLETED|Period 1||0
11341062|NCT02928380|12538419|FG004|NOT COMPLETED|Period 1||0
11341063|NCT02928380|12538420|FG005|NOT COMPLETED|Period 1||0
11341064|NCT02928380|12538415|FG000|STARTED|Wash Out Period 1||13
11341065|NCT02928380|12538416|FG001|STARTED|Wash Out Period 1||14
11341066|NCT02928380|12538417|FG002|STARTED|Wash Out Period 1||14
11341067|NCT02928380|12538418|FG003|STARTED|Wash Out Period 1||14
11341068|NCT02928380|12538419|FG004|STARTED|Wash Out Period 1||14
11341069|NCT02928380|12538420|FG005|STARTED|Wash Out Period 1||14
11341070|NCT02928380|12538415|FG000|COMPLETED|Wash Out Period 1||13
11341071|NCT02928380|12538416|FG001|COMPLETED|Wash Out Period 1||14
11341072|NCT02928380|12538417|FG002|COMPLETED|Wash Out Period 1||14
11341073|NCT02928380|12538418|FG003|COMPLETED|Wash Out Period 1||14
11341074|NCT02928380|12538419|FG004|COMPLETED|Wash Out Period 1||14
11341075|NCT02928380|12538420|FG005|COMPLETED|Wash Out Period 1||14
11341076|NCT02928380|12538415|FG000|NOT COMPLETED|Wash Out Period 1||0
11341077|NCT02928380|12538416|FG001|NOT COMPLETED|Wash Out Period 1||0
11341078|NCT02928380|12538417|FG002|NOT COMPLETED|Wash Out Period 1||0
11341079|NCT02928380|12538418|FG003|NOT COMPLETED|Wash Out Period 1||0
11341080|NCT02928380|12538419|FG004|NOT COMPLETED|Wash Out Period 1||0
11341081|NCT02928380|12538420|FG005|NOT COMPLETED|Wash Out Period 1||0
11341082|NCT02928380|12538415|FG000|STARTED|Period 2||13
11341083|NCT02928380|12538416|FG001|STARTED|Period 2||14
11341084|NCT02928380|12538417|FG002|STARTED|Period 2||14
11341085|NCT02928380|12538418|FG003|STARTED|Period 2||14
11341086|NCT02928380|12538419|FG004|STARTED|Period 2||14
11399696|NCT04315298|12594295|FG013|STARTED|Overall Study||12
11399697|NCT04315298|12594296|FG014|STARTED|Overall Study||15
11399698|NCT04315298|12594297|FG015|STARTED|Overall Study||15
11399699|NCT04315298|12594298|FG016|STARTED|Overall Study||16
11399700|NCT04315298|12594299|FG017|STARTED|Overall Study||6
11399701|NCT04315298|12594300|FG018|STARTED|Overall Study||2
11399702|NCT04315298|12594282|FG000|COMPLETED|Overall Study||61
11399703|NCT04315298|12594283|FG001|COMPLETED|Overall Study||117
11399704|NCT04315298|12594284|FG002|COMPLETED|Overall Study||125
11399705|NCT04315298|12594285|FG003|COMPLETED|Overall Study||101
11399706|NCT04315298|12594286|FG004|COMPLETED|Overall Study||157
11399707|NCT04315298|12594287|FG005|COMPLETED|Overall Study||209
11399708|NCT04315298|12594288|FG006|COMPLETED|Overall Study||52
11399709|NCT04315298|12594289|FG007|COMPLETED|Overall Study||111
11399710|NCT04315298|12594290|FG008|COMPLETED|Overall Study||101
11399711|NCT04315298|12594291|FG009|COMPLETED|Overall Study||29
11399712|NCT04315298|12594292|FG010|COMPLETED|Overall Study||53
11399713|NCT04315298|12594293|FG011|COMPLETED|Overall Study||51
11399714|NCT04315298|12594294|FG012|COMPLETED|Overall Study||5
11399715|NCT04315298|12594295|FG013|COMPLETED|Overall Study||8
11399716|NCT04315298|12594296|FG014|COMPLETED|Overall Study||9
11399717|NCT04315298|12594297|FG015|COMPLETED|Overall Study||9
11399718|NCT04315298|12594298|FG016|COMPLETED|Overall Study||13
11341087|NCT02928380|12538420|FG005|STARTED|Period 2||14
11341088|NCT02928380|12538415|FG000|COMPLETED|Period 2||13
11341089|NCT02928380|12538416|FG001|COMPLETED|Period 2||14
11341090|NCT02928380|12538417|FG002|COMPLETED|Period 2||14
11341091|NCT02928380|12538418|FG003|COMPLETED|Period 2||14
11341092|NCT02928380|12538419|FG004|COMPLETED|Period 2||14
11341093|NCT02928380|12538420|FG005|COMPLETED|Period 2||14
11341094|NCT02928380|12538415|FG000|NOT COMPLETED|Period 2||0
11341095|NCT02928380|12538416|FG001|NOT COMPLETED|Period 2||0
11341096|NCT02928380|12538417|FG002|NOT COMPLETED|Period 2||0
11341097|NCT02928380|12538418|FG003|NOT COMPLETED|Period 2||0
11341098|NCT02928380|12538419|FG004|NOT COMPLETED|Period 2||0
11341099|NCT02928380|12538420|FG005|NOT COMPLETED|Period 2||0
11341100|NCT02928380|12538415|FG000|STARTED|Wash Out Period 2||13
11399719|NCT04315298|12594299|FG017|COMPLETED|Overall Study||5
11399720|NCT04315298|12594300|FG018|COMPLETED|Overall Study||2
11399721|NCT04315298|12594282|FG000|NOT COMPLETED|Overall Study||29
11399722|NCT04315298|12594283|FG001|NOT COMPLETED|Overall Study||70
11289899|NCT02478164|12487472|FG000|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
11289900|NCT02478164|12487472|FG000|COMPLETED|Overall Study||0
11289901|NCT02478164|12487472|FG000|NOT COMPLETED|Overall Study||15
11289902|NCT02478359|12487478|FG000|STARTED|Overall Study||1349
11289903|NCT02478359|12487479|FG001|STARTED|Overall Study||1358
11289904|NCT02478359|12487478|FG000|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 106|1243
11289905|NCT02478359|12487479|FG001|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 65|1293
11289906|NCT02478359|12487478|FG000|COMPLETED|Overall Study||1243
11289907|NCT02478359|12487479|FG001|COMPLETED|Overall Study||1293
11289908|NCT02478359|12487478|FG000|NOT COMPLETED|Overall Study||106
11289909|NCT02478359|12487479|FG001|NOT COMPLETED|Overall Study||65
11289910|NCT02478372|12487489|FG000|STARTED|Overall Study||121
11289911|NCT02478372|12487490|FG001|STARTED|Overall Study||121
11289912|NCT02478372|12487489|FG000|Recieved Allocation Intervention|Overall Study||109
11289913|NCT02478372|12487490|FG001|Recieved Allocation Intervention|Overall Study||113
11289914|NCT02478372|12487489|FG000|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
11289915|NCT02478372|12487490|FG001|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
11289916|NCT02478372|12487489|FG000|Reviewed at One Year|Overall Study|Routine follow up at one year|108
11289917|NCT02478372|12487490|FG001|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
11289918|NCT02478372|12487489|FG000|COMPLETED|Overall Study||108
11289919|NCT02478372|12487490|FG001|COMPLETED|Overall Study||107
11289920|NCT02478372|12487489|FG000|NOT COMPLETED|Overall Study||13
11289921|NCT02478372|12487490|FG001|NOT COMPLETED|Overall Study||14
11289922|NCT02478398|12487498|FG000|STARTED|Overall Study||513
11289923|NCT02478398|12487499|FG001|STARTED|Overall Study||512
11289924|NCT02478398|12487498|FG000|Treated|Overall Study||512
11289925|NCT02478398|12487499|FG001|Treated|Overall Study||510
11289926|NCT02478398|12487498|FG000|COMPLETED|Overall Study||461
11289927|NCT02478398|12487499|FG001|COMPLETED|Overall Study||491
11289928|NCT02478398|12487498|FG000|NOT COMPLETED|Overall Study||52
11289929|NCT02478398|12487499|FG001|NOT COMPLETED|Overall Study||21
11289930|NCT02478463|12487506|FG000|STARTED|Treatment Period 1 (Up to Day 29)||19
11289931|NCT02478463|12487506|FG000|COMPLETED|Treatment Period 1 (Up to Day 29)||18
11289932|NCT02478463|12487506|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 29)||1
11289933|NCT02478463|12487506|FG000|STARTED|Washout Period (Up to 42 Days)||18
11289934|NCT02478463|12487506|FG000|COMPLETED|Washout Period (Up to 42 Days)||17
11289935|NCT02478463|12487506|FG000|NOT COMPLETED|Washout Period (Up to 42 Days)||1
11289936|NCT02478463|12487506|FG000|STARTED|Treatment Period 2 (Up to 52 Weeks)||17
11289937|NCT02478463|12487506|FG000|COMPLETED|Treatment Period 2 (Up to 52 Weeks)||16
11289938|NCT02478463|12487506|FG000|NOT COMPLETED|Treatment Period 2 (Up to 52 Weeks)||1
11289939|NCT02478489|12487514|FG000|STARTED|Overall Study||123
11289940|NCT02478489|12487515|FG001|STARTED|Overall Study||125
11289941|NCT02478489|12487514|FG000|COMPLETED|Overall Study||108
11289942|NCT02478489|12487515|FG001|COMPLETED|Overall Study||109
11289943|NCT02478489|12487514|FG000|NOT COMPLETED|Overall Study||15
11289944|NCT02478489|12487515|FG001|NOT COMPLETED|Overall Study||16
11289945|NCT02478580|12487523|FG000|STARTED|Overall Study||34
11289946|NCT02478580|12487524|FG001|STARTED|Overall Study||33
11289947|NCT02478580|12487523|FG000|COMPLETED|Overall Study||34
11289948|NCT02478580|12487524|FG001|COMPLETED|Overall Study||33
11289949|NCT02478580|12487523|FG000|NOT COMPLETED|Overall Study||0
11289950|NCT02478580|12487524|FG001|NOT COMPLETED|Overall Study||0
11289951|NCT02478632|12487534|FG000|STARTED|Early Switch Phase (Up to Week 52)||53
11289952|NCT02478632|12487535|FG001|STARTED|Early Switch Phase (Up to Week 52)||49
11289953|NCT02478632|12487534|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||49
11289954|NCT02478632|12487535|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||44
11289955|NCT02478632|12487534|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4
11289956|NCT02478632|12487535|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5
11289957|NCT02478632|12487534|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||49
11289958|NCT02478632|12487535|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||44
11289959|NCT02478632|12487534|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42
11289960|NCT02478632|12487535|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40
11289961|NCT02478632|12487534|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7
11289962|NCT02478632|12487535|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4
11289963|NCT02478671|12487544|FG000|STARTED|Overall Study||4
11289964|NCT02478671|12487544|FG000|COMPLETED|Overall Study||4
11289965|NCT02478671|12487544|FG000|NOT COMPLETED|Overall Study||0
11289966|NCT02479139|12487555|FG000|STARTED|Overall Study||27
11289967|NCT02479139|12487556|FG001|STARTED|Overall Study||22
11289968|NCT02479139|12487557|FG002|STARTED|Overall Study||28
11289969|NCT02479139|12487558|FG003|STARTED|Overall Study||21
11289970|NCT02479139|12487559|FG004|STARTED|Overall Study||22
11289971|NCT02479139|12487560|FG005|STARTED|Overall Study||25
11289972|NCT02479139|12487555|FG000|COMPLETED|Overall Study||19
11289973|NCT02479139|12487556|FG001|COMPLETED|Overall Study||12
11289974|NCT02479139|12487557|FG002|COMPLETED|Overall Study||21
11289975|NCT02479139|12487558|FG003|COMPLETED|Overall Study||14
11289976|NCT02479139|12487559|FG004|COMPLETED|Overall Study||17
11289977|NCT02479139|12487560|FG005|COMPLETED|Overall Study||19
11289978|NCT02479139|12487555|FG000|NOT COMPLETED|Overall Study||8
11289979|NCT02479139|12487556|FG001|NOT COMPLETED|Overall Study||10
11289980|NCT02479139|12487557|FG002|NOT COMPLETED|Overall Study||7
11289981|NCT02479139|12487558|FG003|NOT COMPLETED|Overall Study||7
11289982|NCT02479139|12487559|FG004|NOT COMPLETED|Overall Study||5
11289983|NCT02479139|12487560|FG005|NOT COMPLETED|Overall Study||6
11289984|NCT02479412|12487583|FG000|STARTED|Overall Study||6
11289985|NCT02479412|12487584|FG001|STARTED|Overall Study||6
11289986|NCT02479412|12487585|FG002|STARTED|Overall Study||6
11289987|NCT02479412|12487586|FG003|STARTED|Overall Study||7
11289988|NCT02479412|12487587|FG004|STARTED|Overall Study||6
11289989|NCT02479412|12487588|FG005|STARTED|Overall Study||5
11289990|NCT02479412|12487589|FG006|STARTED|Overall Study||6
11289991|NCT02479412|12487590|FG007|STARTED|Overall Study||5
11289992|NCT02479412|12487591|FG008|STARTED|Overall Study||7
11289993|NCT02479412|12487583|FG000|COMPLETED|Overall Study||6
11289994|NCT02479412|12487584|FG001|COMPLETED|Overall Study||6
11289995|NCT02479412|12487585|FG002|COMPLETED|Overall Study||4
11289996|NCT02479412|12487586|FG003|COMPLETED|Overall Study||6
11289997|NCT02479412|12487587|FG004|COMPLETED|Overall Study||5
11289998|NCT02479412|12487588|FG005|COMPLETED|Overall Study||5
11289999|NCT02479412|12487589|FG006|COMPLETED|Overall Study||6
11290000|NCT02479412|12487590|FG007|COMPLETED|Overall Study||4
11399723|NCT04315298|12594284|FG002|NOT COMPLETED|Overall Study||55
11399724|NCT04315298|12594285|FG003|NOT COMPLETED|Overall Study||69
11399725|NCT04315298|12594286|FG004|NOT COMPLETED|Overall Study||85
11399726|NCT04315298|12594287|FG005|NOT COMPLETED|Overall Study||129
11399727|NCT04315298|12594288|FG006|NOT COMPLETED|Overall Study||18
11399728|NCT04315298|12594289|FG007|NOT COMPLETED|Overall Study||29
11399729|NCT04315298|12594290|FG008|NOT COMPLETED|Overall Study||36
11399730|NCT04315298|12594291|FG009|NOT COMPLETED|Overall Study||17
11399731|NCT04315298|12594292|FG010|NOT COMPLETED|Overall Study||42
11399732|NCT04315298|12594293|FG011|NOT COMPLETED|Overall Study||41
11290001|NCT02479412|12487591|FG008|COMPLETED|Overall Study||6
11290002|NCT02479412|12487583|FG000|NOT COMPLETED|Overall Study||0
11290003|NCT02479412|12487584|FG001|NOT COMPLETED|Overall Study||0
11290004|NCT02479412|12487585|FG002|NOT COMPLETED|Overall Study||2
11290005|NCT02479412|12487586|FG003|NOT COMPLETED|Overall Study||1
11290006|NCT02479412|12487587|FG004|NOT COMPLETED|Overall Study||1
11290007|NCT02479412|12487588|FG005|NOT COMPLETED|Overall Study||0
11290008|NCT02479412|12487589|FG006|NOT COMPLETED|Overall Study||0
11290009|NCT02479412|12487590|FG007|NOT COMPLETED|Overall Study||1
11290010|NCT02479412|12487591|FG008|NOT COMPLETED|Overall Study||1
11290011|NCT02479763|12487609|FG000|STARTED|Overall Study||53
11290012|NCT02479763|12487610|FG001|STARTED|Overall Study||53
11290013|NCT02479763|12487609|FG000|COMPLETED|Overall Study||50
11290014|NCT02479763|12487610|FG001|COMPLETED|Overall Study||50
11290015|NCT02479763|12487609|FG000|NOT COMPLETED|Overall Study||3
11290016|NCT02479763|12487610|FG001|NOT COMPLETED|Overall Study||3
11290017|NCT02479802|12487616|FG000|STARTED|Overall Study||13
11290018|NCT02479802|12487616|FG000|COMPLETED|Overall Study||11
11290019|NCT02479802|12487616|FG000|NOT COMPLETED|Overall Study||2
11290020|NCT02479880|12487622|FG000|STARTED|Overall Study||15
11290021|NCT02479880|12487623|FG001|STARTED|Overall Study||15
11290022|NCT02479880|12487622|FG000|COMPLETED|Overall Study||2
11290023|NCT02479880|12487623|FG001|COMPLETED|Overall Study||2
11290024|NCT02479880|12487622|FG000|NOT COMPLETED|Overall Study||13
11290025|NCT02479880|12487623|FG001|NOT COMPLETED|Overall Study||13
11290026|NCT02480010|12487631|FG000|STARTED|Overall Study||35
11290027|NCT02480010|12487632|FG001|STARTED|Overall Study||33
11290028|NCT02480010|12487631|FG000|COMPLETED|Overall Study||0
11290029|NCT02480010|12487632|FG001|COMPLETED|Overall Study||0
11290030|NCT02480010|12487631|FG000|NOT COMPLETED|Overall Study||35
11290031|NCT02480010|12487632|FG001|NOT COMPLETED|Overall Study||33
11290032|NCT02480114|12487640|FG000|STARTED|Overall Study||41
11290033|NCT02480114|12487641|FG001|STARTED|Overall Study||38
11290034|NCT02480114|12487640|FG000|COMPLETED|Overall Study||32
11290035|NCT02480114|12487641|FG001|COMPLETED|Overall Study||30
11399733|NCT04315298|12594294|FG012|NOT COMPLETED|Overall Study||3
11399734|NCT04315298|12594295|FG013|NOT COMPLETED|Overall Study||4
11290036|NCT02480114|12487640|FG000|NOT COMPLETED|Overall Study||9
11290037|NCT02480114|12487641|FG001|NOT COMPLETED|Overall Study||8
11290038|NCT02480153|12487649|FG000|STARTED|Period 1: First Dose to Week 26 Pre-dose||297
11290039|NCT02480153|12487650|FG001|STARTED|Period 1: First Dose to Week 26 Pre-dose||300
11290040|NCT02480153|12487651|FG002|STARTED|Period 1: First Dose to Week 26 Pre-dose||0
11290041|NCT02480153|12487649|FG000|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297
11290042|NCT02480153|12487650|FG001|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299
11290043|NCT02480153|12487651|FG002|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0
11290044|NCT02480153|12487649|FG000|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293
11290045|NCT02480153|12487650|FG001|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284
11290046|NCT02480153|12487651|FG002|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
11290047|NCT02480153|12487649|FG000|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4
11290048|NCT02480153|12487650|FG001|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16
11290049|NCT02480153|12487651|FG002|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
11290050|NCT02480153|12487649|FG000|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283
11290051|NCT02480153|12487650|FG001|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135
11290052|NCT02480153|12487651|FG002|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134
11290053|NCT02480153|12487649|FG000|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283
11290054|NCT02480153|12487650|FG001|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135
11290055|NCT02480153|12487651|FG002|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133
11290056|NCT02480153|12487649|FG000|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263
11290057|NCT02480153|12487650|FG001|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122
11290058|NCT02480153|12487651|FG002|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127
11290059|NCT02480153|12487649|FG000|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20
11290060|NCT02480153|12487650|FG001|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13
11290061|NCT02480153|12487651|FG002|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7
11290062|NCT02480153|12487649|FG000|STARTED|Period 3: Week 52 Dosing to Week 78||259
11290063|NCT02480153|12487650|FG001|STARTED|Period 3: Week 52 Dosing to Week 78||121
11290064|NCT02480153|12487651|FG002|STARTED|Period 3: Week 52 Dosing to Week 78||127
11290065|NCT02480153|12487649|FG000|Received Treatment|Period 3: Week 52 Dosing to Week 78||258
11290066|NCT02480153|12487650|FG001|Received Treatment|Period 3: Week 52 Dosing to Week 78||120
11290067|NCT02480153|12487651|FG002|Received Treatment|Period 3: Week 52 Dosing to Week 78||127
11290068|NCT02480153|12487649|FG000|COMPLETED|Period 3: Week 52 Dosing to Week 78||252
11290069|NCT02480153|12487650|FG001|COMPLETED|Period 3: Week 52 Dosing to Week 78||118
11290070|NCT02480153|12487651|FG002|COMPLETED|Period 3: Week 52 Dosing to Week 78||123
11290071|NCT02480153|12487649|FG000|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7
11290072|NCT02480153|12487650|FG001|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3
11290073|NCT02480153|12487651|FG002|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4
11290074|NCT02480166|12487677|FG000|STARTED|Overall Study||20
11290075|NCT02480166|12487678|FG001|STARTED|Overall Study||36
11290076|NCT02480166|12487679|FG002|STARTED|Overall Study||4
11290077|NCT02480166|12487677|FG000|COMPLETED|Overall Study||20
11290078|NCT02480166|12487678|FG001|COMPLETED|Overall Study||36
11290079|NCT02480166|12487679|FG002|COMPLETED|Overall Study||4
11290080|NCT02480166|12487677|FG000|NOT COMPLETED|Overall Study||0
11290081|NCT02480166|12487678|FG001|NOT COMPLETED|Overall Study||0
11290082|NCT02480166|12487679|FG002|NOT COMPLETED|Overall Study||0
11290083|NCT02480439|12487691|FG000|STARTED|Treatment Period 1||8
11290084|NCT02480439|12487692|FG001|STARTED|Treatment Period 1||8
11290085|NCT02480439|12487693|FG002|STARTED|Treatment Period 1||8
11290086|NCT02480439|12487691|FG000|COMPLETED|Treatment Period 1||8
11290087|NCT02480439|12487692|FG001|COMPLETED|Treatment Period 1||8
11290088|NCT02480439|12487693|FG002|COMPLETED|Treatment Period 1||8
11290089|NCT02480439|12487691|FG000|NOT COMPLETED|Treatment Period 1||0
11290090|NCT02480439|12487692|FG001|NOT COMPLETED|Treatment Period 1||0
11290091|NCT02480439|12487693|FG002|NOT COMPLETED|Treatment Period 1||0
11290092|NCT02480439|12487691|FG000|STARTED|Treatment Period 2||8
11290093|NCT02480439|12487692|FG001|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
11290094|NCT02480439|12487693|FG002|STARTED|Treatment Period 2||8
11399735|NCT04315298|12594296|FG014|NOT COMPLETED|Overall Study||6
11290095|NCT02480439|12487691|FG000|COMPLETED|Treatment Period 2||8
11290096|NCT02480439|12487692|FG001|COMPLETED|Treatment Period 2||7
11290097|NCT02480439|12487693|FG002|COMPLETED|Treatment Period 2||8
11290098|NCT02480439|12487691|FG000|NOT COMPLETED|Treatment Period 2||0
11290099|NCT02480439|12487692|FG001|NOT COMPLETED|Treatment Period 2||0
11290100|NCT02480439|12487693|FG002|NOT COMPLETED|Treatment Period 2||0
11290101|NCT02480439|12487691|FG000|STARTED|Treatment Period 3||8
11290102|NCT02480439|12487692|FG001|STARTED|Treatment Period 3||7
11290103|NCT02480439|12487693|FG002|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
11290104|NCT02480439|12487691|FG000|COMPLETED|Treatment Period 3||8
11290105|NCT02480439|12487692|FG001|COMPLETED|Treatment Period 3||7
11290106|NCT02480439|12487693|FG002|COMPLETED|Treatment Period 3||7
11290107|NCT02480439|12487691|FG000|NOT COMPLETED|Treatment Period 3||0
11290108|NCT02480439|12487692|FG001|NOT COMPLETED|Treatment Period 3||0
11290109|NCT02480439|12487693|FG002|NOT COMPLETED|Treatment Period 3||0
11290110|NCT02480582|12487701|FG000|STARTED|Overall Study||7
11290111|NCT02480582|12487702|FG001|STARTED|Overall Study||7
11290112|NCT02480582|12487703|FG002|STARTED|Overall Study||7
11290113|NCT02480582|12487704|FG003|STARTED|Overall Study||7
11290114|NCT02480582|12487705|FG004|STARTED|Overall Study||7
11290115|NCT02480582|12487706|FG005|STARTED|Overall Study||7
11290116|NCT02480582|12487701|FG000|COMPLETED|Overall Study||7
11290117|NCT02480582|12487702|FG001|COMPLETED|Overall Study||7
11290118|NCT02480582|12487703|FG002|COMPLETED|Overall Study||7
11290119|NCT02480582|12487704|FG003|COMPLETED|Overall Study||7
11290120|NCT02480582|12487705|FG004|COMPLETED|Overall Study||7
11290121|NCT02480582|12487706|FG005|COMPLETED|Overall Study||7
11290122|NCT02480582|12487701|FG000|NOT COMPLETED|Overall Study||0
11290123|NCT02480582|12487702|FG001|NOT COMPLETED|Overall Study||0
11290124|NCT02480582|12487703|FG002|NOT COMPLETED|Overall Study||0
11290125|NCT02480582|12487704|FG003|NOT COMPLETED|Overall Study||0
11290126|NCT02480582|12487705|FG004|NOT COMPLETED|Overall Study||0
11290127|NCT02480582|12487706|FG005|NOT COMPLETED|Overall Study||0
11290128|NCT02480621|12487721|FG000|STARTED|Randomization||44
11290129|NCT02480621|12487722|FG001|STARTED|Randomization||40
11290130|NCT02480621|12487721|FG000|COMPLETED|Randomization||43
11290131|NCT02480621|12487722|FG001|COMPLETED|Randomization||39
11290132|NCT02480621|12487721|FG000|NOT COMPLETED|Randomization||1
11290133|NCT02480621|12487722|FG001|NOT COMPLETED|Randomization||1
11290134|NCT02480621|12487721|FG000|STARTED|Follow Up||43
11290135|NCT02480621|12487722|FG001|STARTED|Follow Up||39
11290136|NCT02480621|12487721|FG000|COMPLETED|Follow Up||39
11290137|NCT02480621|12487722|FG001|COMPLETED|Follow Up||37
11290138|NCT02480621|12487721|FG000|NOT COMPLETED|Follow Up||4
11290139|NCT02480621|12487722|FG001|NOT COMPLETED|Follow Up||2
11290140|NCT02480712|12487728|FG000|STARTED|Overall Study||107
11290141|NCT02480712|12487728|FG000|COMPLETED|Overall Study||96
11290142|NCT02480712|12487728|FG000|NOT COMPLETED|Overall Study||11
11290143|NCT02480764|12487741|FG000|STARTED|Overall Study||199
11290144|NCT02480764|12487742|FG001|STARTED|Overall Study||209
11290145|NCT02480764|12487743|FG002|STARTED|Overall Study||204
11290146|NCT02480764|12487741|FG000|COMPLETED|Overall Study||189
11290147|NCT02480764|12487742|FG001|COMPLETED|Overall Study||189
11290148|NCT02480764|12487743|FG002|COMPLETED|Overall Study||183
11290149|NCT02480764|12487741|FG000|NOT COMPLETED|Overall Study||10
11290150|NCT02480764|12487742|FG001|NOT COMPLETED|Overall Study||20
11290151|NCT02480764|12487743|FG002|NOT COMPLETED|Overall Study||21
11290152|NCT02480920|12487751|FG000|STARTED|Overall Study||2738
11290153|NCT02480920|12487751|FG000|COMPLETED|Overall Study||2738
11290154|NCT02480920|12487751|FG000|NOT COMPLETED|Overall Study||0
11290155|NCT02480998|12487757|FG000|STARTED|Overall Study||56
11290156|NCT02480998|12487758|FG001|STARTED|Overall Study||28
11290157|NCT02480998|12487757|FG000|COMPLETED|Overall Study||56
11290158|NCT02480998|12487758|FG001|COMPLETED|Overall Study||28
11290159|NCT02480998|12487757|FG000|NOT COMPLETED|Overall Study||0
11290160|NCT02480998|12487758|FG001|NOT COMPLETED|Overall Study||0
11290161|NCT02481050|12487766|FG000|STARTED|Overall Study||58
11290162|NCT02481050|12487766|FG000|COMPLETED|Overall Study||0
11290163|NCT02481050|12487766|FG000|NOT COMPLETED|Overall Study||58
11290164|NCT02481141|12487772|FG000|STARTED|Overall Study||35
11290165|NCT02481141|12487773|FG001|STARTED|Overall Study||18
11290166|NCT02481141|12487772|FG000|COMPLETED|Overall Study||26
11290167|NCT02481141|12487773|FG001|COMPLETED|Overall Study||13
11399736|NCT04315298|12594297|FG015|NOT COMPLETED|Overall Study||6
11399737|NCT04315298|12594298|FG016|NOT COMPLETED|Overall Study||3
11290168|NCT02481141|12487772|FG000|NOT COMPLETED|Overall Study||9
11290169|NCT02481141|12487773|FG001|NOT COMPLETED|Overall Study||5
11290170|NCT02481206|12487802|FG000|STARTED|Overall Study||34
11290171|NCT02481206|12487803|FG001|STARTED|Overall Study||32
11290172|NCT02481206|12487802|FG000|COMPLETED|Overall Study||29
11290173|NCT02481206|12487803|FG001|COMPLETED|Overall Study||31
11290174|NCT02481206|12487802|FG000|NOT COMPLETED|Overall Study||5
11290175|NCT02481206|12487803|FG001|NOT COMPLETED|Overall Study||1
11290176|NCT02481219|12487813|FG000|STARTED|Overall Study||60
11290177|NCT02481219|12487814|FG001|STARTED|Overall Study||62
11290178|NCT02481219|12487813|FG000|COMPLETED|Overall Study||58
11290179|NCT02481219|12487814|FG001|COMPLETED|Overall Study||61
11290180|NCT02481219|12487813|FG000|NOT COMPLETED|Overall Study||2
11290181|NCT02481219|12487814|FG001|NOT COMPLETED|Overall Study||1
11290182|NCT02481258|12487826|FG000|STARTED|Overall Study||12
11290183|NCT02481258|12487827|FG001|STARTED|Overall Study||11
11290184|NCT02481258|12487826|FG000|COMPLETED|Overall Study||12
11290185|NCT02481258|12487827|FG001|COMPLETED|Overall Study||11
11290186|NCT02481258|12487826|FG000|NOT COMPLETED|Overall Study||0
11290187|NCT02481258|12487827|FG001|NOT COMPLETED|Overall Study||0
11290188|NCT02481297|12487837|FG000|STARTED|Overall Study||1
11290189|NCT02481297|12487838|FG001|STARTED|Overall Study||6
11399738|NCT04315298|12594299|FG017|NOT COMPLETED|Overall Study||1
11290190|NCT02481297|12487837|FG000|COMPLETED|Overall Study||1
11290191|NCT02481297|12487838|FG001|COMPLETED|Overall Study||6
11290192|NCT02481297|12487837|FG000|NOT COMPLETED|Overall Study||0
11290193|NCT02481297|12487838|FG001|NOT COMPLETED|Overall Study||0
11290194|NCT02481375|12487848|FG000|STARTED|Overall Study||206
11399739|NCT04315298|12594300|FG018|NOT COMPLETED|Overall Study||0
11290195|NCT02481375|12487849|FG001|STARTED|Overall Study||202
11290196|NCT02481375|12487850|FG002|STARTED|Overall Study||201
11290197|NCT02481375|12487851|FG003|STARTED|Overall Study||200
11290198|NCT02481375|12487848|FG000|COMPLETED|Overall Study||192
11399740|NCT04313647|12594372|FG000|STARTED|Overall Study||3
11399741|NCT04313647|12594373|FG001|STARTED|Overall Study||3
11290199|NCT02481375|12487849|FG001|COMPLETED|Overall Study||191
11290200|NCT02481375|12487850|FG002|COMPLETED|Overall Study||191
11290201|NCT02481375|12487851|FG003|COMPLETED|Overall Study||186
11290202|NCT02481375|12487848|FG000|NOT COMPLETED|Overall Study||14
11290203|NCT02481375|12487849|FG001|NOT COMPLETED|Overall Study||11
11290204|NCT02481375|12487850|FG002|NOT COMPLETED|Overall Study||10
11290205|NCT02481375|12487851|FG003|NOT COMPLETED|Overall Study||14
11290206|NCT02481440|12487861|FG000|STARTED|Overall Study||102
11290207|NCT02481440|12487861|FG000|COMPLETED|Overall Study||41
11290208|NCT02481440|12487861|FG000|NOT COMPLETED|Overall Study||61
11290209|NCT02481505|12487868|FG000|STARTED|Overall Study||15
11290210|NCT02481505|12487869|FG001|STARTED|Overall Study||15
11290211|NCT02481505|12487870|FG002|STARTED|Overall Study||15
11290212|NCT02481505|12487868|FG000|COMPLETED|Overall Study||15
11290213|NCT02481505|12487869|FG001|COMPLETED|Overall Study||15
11290214|NCT02481505|12487870|FG002|COMPLETED|Overall Study||15
11290215|NCT02481505|12487868|FG000|NOT COMPLETED|Overall Study||0
11290216|NCT02481505|12487869|FG001|NOT COMPLETED|Overall Study||0
11290217|NCT02481505|12487870|FG002|NOT COMPLETED|Overall Study||0
11290218|NCT02481557|12487880|FG000|STARTED|Overall Study||17
11290219|NCT02481557|12487881|FG001|STARTED|Overall Study||19
11290220|NCT02481557|12487880|FG000|COMPLETED|Overall Study||17
11290221|NCT02481557|12487881|FG001|COMPLETED|Overall Study||19
11290222|NCT02481557|12487880|FG000|NOT COMPLETED|Overall Study||0
11290223|NCT02481557|12487881|FG001|NOT COMPLETED|Overall Study||0
11290224|NCT02481596|12487890|FG000|STARTED|Overall Study||126
11290225|NCT02481596|12487891|FG001|STARTED|Overall Study||127
11290226|NCT02481596|12487892|FG002|STARTED|Overall Study||253
11290227|NCT02481596|12487890|FG000|COMPLETED|Overall Study||123
11290228|NCT02481596|12487891|FG001|COMPLETED|Overall Study||126
11290229|NCT02481596|12487892|FG002|COMPLETED|Overall Study||245
11290230|NCT02481596|12487890|FG000|NOT COMPLETED|Overall Study||3
11290231|NCT02481596|12487891|FG001|NOT COMPLETED|Overall Study||1
11290232|NCT02481596|12487892|FG002|NOT COMPLETED|Overall Study||8
11290233|NCT02481713|12487902|FG000|STARTED|Overall Study||56
11290234|NCT02481713|12487903|FG001|STARTED|Overall Study||58
11290235|NCT02481713|12487902|FG000|COMPLETED|Overall Study||40
11290236|NCT02481713|12487903|FG001|COMPLETED|Overall Study||42
11290237|NCT02481713|12487902|FG000|NOT COMPLETED|Overall Study||16
11290238|NCT02481713|12487903|FG001|NOT COMPLETED|Overall Study||16
11290239|NCT02481869|12487911|FG000|STARTED|Overall Study||5
11290240|NCT02481869|12487912|FG001|STARTED|Overall Study||6
11290241|NCT02481869|12487911|FG000|COMPLETED|Overall Study||0
11290242|NCT02481869|12487912|FG001|COMPLETED|Overall Study||2
11290243|NCT02481869|12487911|FG000|NOT COMPLETED|Overall Study||5
11290244|NCT02481869|12487912|FG001|NOT COMPLETED|Overall Study||4
11290245|NCT02481934|12487919|FG000|STARTED|Overall Study||5
11290246|NCT02481934|12487919|FG000|COMPLETED|Overall Study||3
11290247|NCT02481934|12487919|FG000|NOT COMPLETED|Overall Study||2
11290248|NCT02481947|12487925|FG000|STARTED|Overall Study||230
11290249|NCT02481947|12487926|FG001|STARTED|Overall Study||229
11290250|NCT02481947|12487925|FG000|COMPLETED|Overall Study||184
11290251|NCT02481947|12487926|FG001|COMPLETED|Overall Study||193
11399742|NCT04313647|12594374|FG002|STARTED|Overall Study||6
11399743|NCT04313647|12594375|FG003|STARTED|Overall Study||6
11399744|NCT04313647|12594376|FG004|STARTED|Overall Study||6
11290252|NCT02481947|12487925|FG000|NOT COMPLETED|Overall Study||46
11290253|NCT02481947|12487926|FG001|NOT COMPLETED|Overall Study||36
11290254|NCT02482025|12487934|FG000|STARTED|Overall Study||122
11290255|NCT02482025|12487935|FG001|STARTED|Overall Study||118
11290256|NCT02482025|12487934|FG000|COMPLETED|Overall Study||122
11290257|NCT02482025|12487935|FG001|COMPLETED|Overall Study||118
11290258|NCT02482025|12487934|FG000|NOT COMPLETED|Overall Study||0
11290259|NCT02482025|12487935|FG001|NOT COMPLETED|Overall Study||0
11290260|NCT02482129|12487943|FG000|STARTED|Overall Study||32
11290261|NCT02482129|12487944|FG001|STARTED|Overall Study||11
11290262|NCT02482129|12487943|FG000|Treated, as Randomized|Overall Study||30
11290263|NCT02482129|12487944|FG001|Treated, as Randomized|Overall Study||9
11290264|NCT02482129|12487943|FG000|COMPLETED|Overall Study||26
11290265|NCT02482129|12487944|FG001|COMPLETED|Overall Study||9
11290266|NCT02482129|12487943|FG000|NOT COMPLETED|Overall Study||6
11290267|NCT02482129|12487944|FG001|NOT COMPLETED|Overall Study||2
11290268|NCT02482298|12487955|FG000|STARTED|Overall Study||30
11290269|NCT02482298|12487956|FG001|STARTED|Overall Study||27
11290270|NCT02482298|12487957|FG002|STARTED|Overall Study||30
11290271|NCT02482298|12487955|FG000|COMPLETED|Overall Study||28
11290272|NCT02482298|12487956|FG001|COMPLETED|Overall Study||24
11290273|NCT02482298|12487957|FG002|COMPLETED|Overall Study||27
11290274|NCT02482298|12487955|FG000|NOT COMPLETED|Overall Study||2
11290275|NCT02482298|12487956|FG001|NOT COMPLETED|Overall Study||3
11399745|NCT04313647|12594372|FG000|COMPLETED|Overall Study||3
11399746|NCT04313647|12594373|FG001|COMPLETED|Overall Study||3
11399747|NCT04313647|12594374|FG002|COMPLETED|Overall Study||6
11290276|NCT02482298|12487957|FG002|NOT COMPLETED|Overall Study||3
11290277|NCT02482428|12487970|FG000|STARTED|Overall Study||24
11290278|NCT02482428|12487971|FG001|STARTED|Overall Study||22
11290279|NCT02482428|12487972|FG002|STARTED|Overall Study||10
11290280|NCT02482428|12487973|FG003|STARTED|Overall Study||10
11290281|NCT02482428|12487974|FG004|STARTED|Overall Study||22
11290282|NCT02482428|12487970|FG000|COMPLETED|Overall Study||15
11290283|NCT02482428|12487971|FG001|COMPLETED|Overall Study||10
11290284|NCT02482428|12487972|FG002|COMPLETED|Overall Study||9
11290285|NCT02482428|12487973|FG003|COMPLETED|Overall Study||8
11290286|NCT02482428|12487974|FG004|COMPLETED|Overall Study||15
11290287|NCT02482428|12487970|FG000|NOT COMPLETED|Overall Study||9
11290288|NCT02482428|12487971|FG001|NOT COMPLETED|Overall Study||12
11290289|NCT02482428|12487972|FG002|NOT COMPLETED|Overall Study||1
11290290|NCT02482428|12487973|FG003|NOT COMPLETED|Overall Study||2
11290291|NCT02482428|12487974|FG004|NOT COMPLETED|Overall Study||7
11290292|NCT02482571|12487988|FG000|STARTED|Overall Study||25
11290293|NCT02482571|12487988|FG000|COMPLETED|Overall Study||17
11290294|NCT02482571|12487988|FG000|NOT COMPLETED|Overall Study||8
11290295|NCT02482610|12487993|FG000|STARTED|Overall Study||4
11290296|NCT02482610|12487994|FG001|STARTED|Overall Study||5
11290297|NCT02482610|12487995|FG002|STARTED|Overall Study||2
11290298|NCT02482610|12487996|FG003|STARTED|Overall Study||3
11290299|NCT02482610|12487997|FG004|STARTED|Overall Study||3
11290300|NCT02482610|12487998|FG005|STARTED|Overall Study||5
11290301|NCT02482610|12487993|FG000|COMPLETED|Overall Study||4
11290302|NCT02482610|12487994|FG001|COMPLETED|Overall Study||5
11290303|NCT02482610|12487995|FG002|COMPLETED|Overall Study||2
11290304|NCT02482610|12487996|FG003|COMPLETED|Overall Study||3
11290305|NCT02482610|12487997|FG004|COMPLETED|Overall Study||3
11290306|NCT02482610|12487998|FG005|COMPLETED|Overall Study||5
11290307|NCT02482610|12487993|FG000|NOT COMPLETED|Overall Study||0
11290308|NCT02482610|12487994|FG001|NOT COMPLETED|Overall Study||0
11290309|NCT02482610|12487995|FG002|NOT COMPLETED|Overall Study||0
11290310|NCT02482610|12487996|FG003|NOT COMPLETED|Overall Study||0
11290311|NCT02482610|12487997|FG004|NOT COMPLETED|Overall Study||0
11290312|NCT02482610|12487998|FG005|NOT COMPLETED|Overall Study||0
11290313|NCT02482675|12488009|FG000|STARTED|Overall Study||1
11290314|NCT02482675|12488010|FG001|STARTED|Overall Study||1
11290315|NCT02482675|12488011|FG002|STARTED|Overall Study||1
11290316|NCT02482675|12488012|FG003|STARTED|Overall Study||1
11399748|NCT04313647|12594375|FG003|COMPLETED|Overall Study||6
11290317|NCT02482675|12488013|FG004|STARTED|Overall Study||1
11290318|NCT02482675|12488014|FG005|STARTED|Overall Study||1
11290319|NCT02482675|12488015|FG006|STARTED|Overall Study||1
11290320|NCT02482675|12488016|FG007|STARTED|Overall Study||1
11290321|NCT02482675|12488017|FG008|STARTED|Overall Study||1
11290322|NCT02482675|12488018|FG009|STARTED|Overall Study||1
11290323|NCT02482675|12488019|FG010|STARTED|Overall Study||1
11290324|NCT02482675|12488020|FG011|STARTED|Overall Study||1
11290325|NCT02482675|12488021|FG012|STARTED|Overall Study||1
11290326|NCT02482675|12488022|FG013|STARTED|Overall Study||1
11290327|NCT02482675|12488023|FG014|STARTED|Overall Study||1
11290328|NCT02482675|12488024|FG015|STARTED|Overall Study||1
11290329|NCT02482675|12488025|FG016|STARTED|Overall Study||1
11290330|NCT02482675|12488026|FG017|STARTED|Overall Study||1
11290331|NCT02482675|12488027|FG018|STARTED|Overall Study||1
11290332|NCT02482675|12488028|FG019|STARTED|Overall Study||1
11290333|NCT02482675|12488029|FG020|STARTED|Overall Study||1
11290334|NCT02482675|12488030|FG021|STARTED|Overall Study||1
11290335|NCT02482675|12488031|FG022|STARTED|Overall Study||1
11290336|NCT02482675|12488009|FG000|COMPLETED|Overall Study||1
11290337|NCT02482675|12488010|FG001|COMPLETED|Overall Study||1
11290338|NCT02482675|12488011|FG002|COMPLETED|Overall Study||1
11290339|NCT02482675|12488012|FG003|COMPLETED|Overall Study||1
11290340|NCT02482675|12488013|FG004|COMPLETED|Overall Study||1
11290341|NCT02482675|12488014|FG005|COMPLETED|Overall Study||1
11290342|NCT02482675|12488015|FG006|COMPLETED|Overall Study||1
11290343|NCT02482675|12488016|FG007|COMPLETED|Overall Study||1
11290344|NCT02482675|12488017|FG008|COMPLETED|Overall Study||1
11290345|NCT02482675|12488018|FG009|COMPLETED|Overall Study||1
11290346|NCT02482675|12488019|FG010|COMPLETED|Overall Study||1
11290347|NCT02482675|12488020|FG011|COMPLETED|Overall Study||1
11290348|NCT02482675|12488021|FG012|COMPLETED|Overall Study||1
11290349|NCT02482675|12488022|FG013|COMPLETED|Overall Study||1
11290350|NCT02482675|12488023|FG014|COMPLETED|Overall Study||1
11290351|NCT02482675|12488024|FG015|COMPLETED|Overall Study||1
11290352|NCT02482675|12488025|FG016|COMPLETED|Overall Study||1
11290353|NCT02482675|12488026|FG017|COMPLETED|Overall Study||1
11290354|NCT02482675|12488027|FG018|COMPLETED|Overall Study||1
11290355|NCT02482675|12488028|FG019|COMPLETED|Overall Study||1
11290356|NCT02482675|12488029|FG020|COMPLETED|Overall Study||1
11290357|NCT02482675|12488030|FG021|COMPLETED|Overall Study||1
11290358|NCT02482675|12488031|FG022|COMPLETED|Overall Study||1
11290359|NCT02482675|12488009|FG000|NOT COMPLETED|Overall Study||0
11290360|NCT02482675|12488010|FG001|NOT COMPLETED|Overall Study||0
11143793|NCT01474512|12330424|FG002|STARTED|Post-Treatment Follow-Up||0
11143794|NCT01474512|12330425|FG003|STARTED|Post-Treatment Follow-Up||0
11143795|NCT01474512|12330426|FG004|STARTED|Post-Treatment Follow-Up||0
11143796|NCT01474512|12330427|FG005|STARTED|Post-Treatment Follow-Up||0
11290361|NCT02482675|12488011|FG002|NOT COMPLETED|Overall Study||0
11290362|NCT02482675|12488012|FG003|NOT COMPLETED|Overall Study||0
11290363|NCT02482675|12488013|FG004|NOT COMPLETED|Overall Study||0
11290364|NCT02482675|12488014|FG005|NOT COMPLETED|Overall Study||0
11290365|NCT02482675|12488015|FG006|NOT COMPLETED|Overall Study||0
11290366|NCT02482675|12488016|FG007|NOT COMPLETED|Overall Study||0
11143797|NCT01474512|12330428|FG006|STARTED|Post-Treatment Follow-Up||0
11290367|NCT02482675|12488017|FG008|NOT COMPLETED|Overall Study||0
11290368|NCT02482675|12488018|FG009|NOT COMPLETED|Overall Study||0
11290369|NCT02482675|12488019|FG010|NOT COMPLETED|Overall Study||0
11290370|NCT02482675|12488020|FG011|NOT COMPLETED|Overall Study||0
11290371|NCT02482675|12488021|FG012|NOT COMPLETED|Overall Study||0
11290372|NCT02482675|12488022|FG013|NOT COMPLETED|Overall Study||0
11290373|NCT02482675|12488023|FG014|NOT COMPLETED|Overall Study||0
11290374|NCT02482675|12488024|FG015|NOT COMPLETED|Overall Study||0
11290375|NCT02482675|12488025|FG016|NOT COMPLETED|Overall Study||0
11290376|NCT02482675|12488026|FG017|NOT COMPLETED|Overall Study||0
11290377|NCT02482675|12488027|FG018|NOT COMPLETED|Overall Study||0
11290378|NCT02482675|12488028|FG019|NOT COMPLETED|Overall Study||0
11290379|NCT02482675|12488029|FG020|NOT COMPLETED|Overall Study||0
11290380|NCT02482675|12488030|FG021|NOT COMPLETED|Overall Study||0
11290381|NCT02482675|12488031|FG022|NOT COMPLETED|Overall Study||0
11290382|NCT02482805|12488044|FG000|STARTED|Overall Study||26
11290383|NCT02482805|12488045|FG001|STARTED|Overall Study||27
11290384|NCT02482805|12488046|FG002|STARTED|Overall Study||20
11290385|NCT02482805|12488044|FG000|COMPLETED|Overall Study||22
11290386|NCT02482805|12488045|FG001|COMPLETED|Overall Study||23
11290387|NCT02482805|12488046|FG002|COMPLETED|Overall Study||20
11290388|NCT02482805|12488044|FG000|NOT COMPLETED|Overall Study||4
11290389|NCT02482805|12488045|FG001|NOT COMPLETED|Overall Study||4
11290390|NCT02482805|12488046|FG002|NOT COMPLETED|Overall Study||0
11290391|NCT02482870|12488054|FG000|STARTED|Period 1 - First 60 Patients||30
11290392|NCT02482870|12488055|FG001|STARTED|Period 1 - First 60 Patients||30
11290393|NCT02482870|12488054|FG000|COMPLETED|Period 1 - First 60 Patients||30
11290394|NCT02482870|12488055|FG001|COMPLETED|Period 1 - First 60 Patients||30
11290395|NCT02482870|12488054|FG000|NOT COMPLETED|Period 1 - First 60 Patients||0
11290396|NCT02482870|12488055|FG001|NOT COMPLETED|Period 1 - First 60 Patients||0
11290397|NCT02482870|12488054|FG000|STARTED|Period 2 - Rest of the Study||186
11290398|NCT02482870|12488055|FG001|STARTED|Period 2 - Rest of the Study||202
11290399|NCT02482870|12488054|FG000|COMPLETED|Period 2 - Rest of the Study||186
11290400|NCT02482870|12488055|FG001|COMPLETED|Period 2 - Rest of the Study||202
11290401|NCT02482870|12488054|FG000|NOT COMPLETED|Period 2 - Rest of the Study||0
11290402|NCT02482870|12488055|FG001|NOT COMPLETED|Period 2 - Rest of the Study||0
11290403|NCT02482935|12488069|FG000|STARTED|Period 1||15
11290404|NCT02482935|12488070|FG001|STARTED|Period 1||15
11290405|NCT02482935|12488069|FG000|Received Abemaciclib|Period 1||15
11290406|NCT02482935|12488070|FG001|Received Abemaciclib|Period 1||15
11290407|NCT02482935|12488069|FG000|Washout|Period 1||15
11290408|NCT02482935|12488070|FG001|Washout|Period 1||15
11290409|NCT02482935|12488069|FG000|COMPLETED|Period 1||14
11290410|NCT02482935|12488070|FG001|COMPLETED|Period 1||15
11290411|NCT02482935|12488069|FG000|NOT COMPLETED|Period 1||1
11290412|NCT02482935|12488070|FG001|NOT COMPLETED|Period 1||0
11290413|NCT02482935|12488069|FG000|STARTED|Period 2||14
11290414|NCT02482935|12488070|FG001|STARTED|Period 2||15
11290415|NCT02482935|12488069|FG000|Received Abemaciclib|Period 2||14
11290416|NCT02482935|12488070|FG001|Received Abemaciclib|Period 2||15
11290417|NCT02482935|12488069|FG000|Follow-up|Period 2||14
11290418|NCT02482935|12488070|FG001|Follow-up|Period 2||15
11290419|NCT02482935|12488069|FG000|COMPLETED|Period 2||14
11290420|NCT02482935|12488070|FG001|COMPLETED|Period 2||15
11290421|NCT02482935|12488069|FG000|NOT COMPLETED|Period 2||0
11290422|NCT02482935|12488070|FG001|NOT COMPLETED|Period 2||0
11290423|NCT02483000|12488076|FG000|STARTED|Overall Study||3
11290424|NCT02483000|12488076|FG000|COMPLETED|Overall Study||3
11290425|NCT02483000|12488076|FG000|NOT COMPLETED|Overall Study||0
11290426|NCT02483416|12488085|FG000|STARTED|Overall Study||21
11290427|NCT02483416|12488086|FG001|STARTED|Overall Study||7
11290428|NCT02483416|12488085|FG000|COMPLETED|Overall Study||18
11290429|NCT02483416|12488086|FG001|COMPLETED|Overall Study||6
11290430|NCT02483416|12488085|FG000|NOT COMPLETED|Overall Study||3
11290431|NCT02483416|12488086|FG001|NOT COMPLETED|Overall Study||1
11290432|NCT02483520|12488095|FG000|STARTED|Overall Study||92
11290433|NCT02483520|12488096|FG001|STARTED|Overall Study||97
11290434|NCT02483520|12488095|FG000|Caregivers|Overall Study||50
11290435|NCT02483520|12488096|FG001|Caregivers|Overall Study||56
11290436|NCT02483520|12488095|FG000|Persons With Dementia|Overall Study||42
11290437|NCT02483520|12488096|FG001|Persons With Dementia|Overall Study||41
11290438|NCT02483520|12488095|FG000|COMPLETED|Overall Study||81
11290439|NCT02483520|12488096|FG001|COMPLETED|Overall Study||73
11290440|NCT02483520|12488095|FG000|NOT COMPLETED|Overall Study||11
11290441|NCT02483520|12488096|FG001|NOT COMPLETED|Overall Study||24
11290442|NCT02483572|12488104|FG000|STARTED|Overall Study||2
11290443|NCT02483572|12488105|FG001|STARTED|Overall Study||2
11290444|NCT02483572|12488104|FG000|COMPLETED|Overall Study||0
11290445|NCT02483572|12488105|FG001|COMPLETED|Overall Study||1
11290446|NCT02483572|12488104|FG000|NOT COMPLETED|Overall Study||2
11290447|NCT02483572|12488105|FG001|NOT COMPLETED|Overall Study||1
11290448|NCT02483611|12488114|FG000|STARTED|Overall Study||16
11290449|NCT02483611|12488115|FG001|STARTED|Overall Study||16
11290450|NCT02483611|12488116|FG002|STARTED|Overall Study||16
11290451|NCT02483611|12488114|FG000|COMPLETED|Overall Study||16
11290452|NCT02483611|12488115|FG001|COMPLETED|Overall Study||16
11290453|NCT02483611|12488116|FG002|COMPLETED|Overall Study|One patient required decurarization|15
11290454|NCT02483611|12488114|FG000|NOT COMPLETED|Overall Study||0
11290455|NCT02483611|12488115|FG001|NOT COMPLETED|Overall Study||0
11290456|NCT02483611|12488116|FG002|NOT COMPLETED|Overall Study||1
11290457|NCT02483676|12488126|FG000|STARTED|Overall Study||23
11290458|NCT02483676|12488127|FG001|STARTED|Overall Study||22
11290459|NCT02483676|12488126|FG000|COMPLETED|Overall Study||17
11290460|NCT02483676|12488127|FG001|COMPLETED|Overall Study||17
11290461|NCT02483676|12488126|FG000|NOT COMPLETED|Overall Study||6
11290462|NCT02483676|12488127|FG001|NOT COMPLETED|Overall Study||5
11290463|NCT02483975|12488135|FG000|STARTED|Overall Study||56
11290464|NCT02483975|12488136|FG001|STARTED|Overall Study||55
11290465|NCT02483975|12488135|FG000|COMPLETED|Overall Study||54
11290466|NCT02483975|12488136|FG001|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
11290467|NCT02483975|12488135|FG000|NOT COMPLETED|Overall Study||2
11290468|NCT02483975|12488136|FG001|NOT COMPLETED|Overall Study||2
11290469|NCT02484092|12488145|FG000|STARTED|Overall Study||15
11290470|NCT02484092|12488145|FG000|COMPLETED|Overall Study||15
11290471|NCT02484092|12488145|FG000|NOT COMPLETED|Overall Study||0
11290472|NCT02484222|12488149|FG000|STARTED|Overall Study||80
11290473|NCT02484222|12488149|FG000|COMPLETED|Overall Study||77
11290474|NCT02484222|12488149|FG000|NOT COMPLETED|Overall Study||3
11290475|NCT02484547|12488158|FG000|STARTED|Placebo-Controlled Period||548
11290476|NCT02484547|12488159|FG001|STARTED|Placebo-Controlled Period||543
11290477|NCT02484547|12488160|FG002|STARTED|Placebo-Controlled Period||547
11290478|NCT02484547|12488161|FG003|STARTED|Placebo-Controlled Period||0
11290479|NCT02484547|12488162|FG004|STARTED|Placebo-Controlled Period||0
11290480|NCT02484547|12488163|FG005|STARTED|Placebo-Controlled Period||0
11290481|NCT02484547|12488164|FG006|STARTED|Placebo-Controlled Period||0
11290482|NCT02484547|12488158|FG000|COMPLETED|Placebo-Controlled Period||288
11290483|NCT02484547|12488159|FG001|COMPLETED|Placebo-Controlled Period||291
11290484|NCT02484547|12488160|FG002|COMPLETED|Placebo-Controlled Period||295
11290485|NCT02484547|12488161|FG003|COMPLETED|Placebo-Controlled Period||0
11290486|NCT02484547|12488162|FG004|COMPLETED|Placebo-Controlled Period||0
11290487|NCT02484547|12488163|FG005|COMPLETED|Placebo-Controlled Period||0
11290488|NCT02484547|12488164|FG006|COMPLETED|Placebo-Controlled Period||0
11290489|NCT02484547|12488158|FG000|NOT COMPLETED|Placebo-Controlled Period||260
11290490|NCT02484547|12488159|FG001|NOT COMPLETED|Placebo-Controlled Period||252
11290491|NCT02484547|12488160|FG002|NOT COMPLETED|Placebo-Controlled Period||252
11290492|NCT02484547|12488161|FG003|NOT COMPLETED|Placebo-Controlled Period||0
11290493|NCT02484547|12488162|FG004|NOT COMPLETED|Placebo-Controlled Period||0
11290494|NCT02484547|12488163|FG005|NOT COMPLETED|Placebo-Controlled Period||0
11290495|NCT02484547|12488164|FG006|NOT COMPLETED|Placebo-Controlled Period||0
11290496|NCT02484547|12488158|FG000|STARTED|Long-Term Extension Period||0
11290497|NCT02484547|12488159|FG001|STARTED|Long-Term Extension Period||0
11290498|NCT02484547|12488160|FG002|STARTED|Long-Term Extension Period||0
11290499|NCT02484547|12488161|FG003|STARTED|Long-Term Extension Period|11 PC completers did not enter LTE.|131
11290500|NCT02484547|12488162|FG004|STARTED|Long-Term Extension Period|14 PC completers did not enter LTE.|132
11290501|NCT02484547|12488163|FG005|STARTED|Long-Term Extension Period|40 PC completers did not enter LTE.|251
11290502|NCT02484547|12488164|FG006|STARTED|Long-Term Extension Period|38 PC completers did not enter LTE.|257
11290503|NCT02484547|12488158|FG000|COMPLETED|Long-Term Extension Period||0
11290504|NCT02484547|12488159|FG001|COMPLETED|Long-Term Extension Period||0
11290505|NCT02484547|12488160|FG002|COMPLETED|Long-Term Extension Period||0
11290506|NCT02484547|12488161|FG003|COMPLETED|Long-Term Extension Period||0
11290507|NCT02484547|12488162|FG004|COMPLETED|Long-Term Extension Period||0
11290508|NCT02484547|12488163|FG005|COMPLETED|Long-Term Extension Period||0
11290509|NCT02484547|12488164|FG006|COMPLETED|Long-Term Extension Period||0
11290510|NCT02484547|12488158|FG000|NOT COMPLETED|Long-Term Extension Period||0
11290511|NCT02484547|12488159|FG001|NOT COMPLETED|Long-Term Extension Period||0
11290512|NCT02484547|12488160|FG002|NOT COMPLETED|Long-Term Extension Period||0
11290513|NCT02484547|12488161|FG003|NOT COMPLETED|Long-Term Extension Period||131
11290514|NCT02484547|12488162|FG004|NOT COMPLETED|Long-Term Extension Period||132
11290515|NCT02484547|12488163|FG005|NOT COMPLETED|Long-Term Extension Period||251
11290516|NCT02484547|12488164|FG006|NOT COMPLETED|Long-Term Extension Period||257
11290517|NCT02484651|12488178|FG000|STARTED|Overall Study|35 patients were randomized|35
11290518|NCT02484651|12488179|FG001|STARTED|Overall Study|35 patients were randomized|35
11290519|NCT02484651|12488178|FG000|End of Clinical Study|Overall Study||35
11290520|NCT02484651|12488179|FG001|End of Clinical Study|Overall Study||35
11290521|NCT02484651|12488178|FG000|Data Analysis|Overall Study||32
11290522|NCT02484651|12488179|FG001|Data Analysis|Overall Study||31
11290523|NCT02484651|12488178|FG000|COMPLETED|Overall Study||32
11290524|NCT02484651|12488179|FG001|COMPLETED|Overall Study||31
11290525|NCT02484651|12488178|FG000|NOT COMPLETED|Overall Study||3
11290526|NCT02484651|12488179|FG001|NOT COMPLETED|Overall Study||4
11290527|NCT02484690|12488191|FG000|STARTED|Overall Study||68
11290528|NCT02484690|12488192|FG001|STARTED|Overall Study||46
11290529|NCT02484690|12488193|FG002|STARTED|Overall Study||39
11290530|NCT02484690|12488194|FG003|STARTED|Overall Study||46
11290531|NCT02484690|12488195|FG004|STARTED|Overall Study||64
11290532|NCT02484690|12488191|FG000|Received at Least One Dose of Study Drug|Overall Study||67
11290533|NCT02484690|12488192|FG001|Received at Least One Dose of Study Drug|Overall Study||46
11290534|NCT02484690|12488193|FG002|Received at Least One Dose of Study Drug|Overall Study||39
11290535|NCT02484690|12488194|FG003|Received at Least One Dose of Study Drug|Overall Study||46
11290536|NCT02484690|12488195|FG004|Received at Least One Dose of Study Drug|Overall Study||64
11290537|NCT02484690|12488191|FG000|COMPLETED|Overall Study||64
11290538|NCT02484690|12488192|FG001|COMPLETED|Overall Study||40
11290539|NCT02484690|12488193|FG002|COMPLETED|Overall Study||36
11290540|NCT02484690|12488194|FG003|COMPLETED|Overall Study||44
11290541|NCT02484690|12488195|FG004|COMPLETED|Overall Study||58
11290542|NCT02484690|12488191|FG000|NOT COMPLETED|Overall Study||4
11290543|NCT02484690|12488192|FG001|NOT COMPLETED|Overall Study||6
11399749|NCT04313647|12594376|FG004|COMPLETED|Overall Study||6
11290544|NCT02484690|12488193|FG002|NOT COMPLETED|Overall Study||3
11290545|NCT02484690|12488194|FG003|NOT COMPLETED|Overall Study||2
11290546|NCT02484690|12488195|FG004|NOT COMPLETED|Overall Study||6
11290547|NCT02484729|12488218|FG000|STARTED|Overall Study||16
11290548|NCT02484729|12488219|FG001|STARTED|Overall Study||6
11290549|NCT02484729|12488220|FG002|STARTED|Overall Study||6
11290550|NCT02484729|12488221|FG003|STARTED|Overall Study||6
11290551|NCT02484729|12488222|FG004|STARTED|Overall Study||5
11290552|NCT02484729|12488223|FG005|STARTED|Overall Study||6
11290553|NCT02484729|12488224|FG006|STARTED|Overall Study||5
11290554|NCT02484729|12488225|FG007|STARTED|Overall Study||6
11290555|NCT02484729|12488226|FG008|STARTED|Overall Study||6
11290556|NCT02484729|12488227|FG009|STARTED|Overall Study||8
11290557|NCT02484729|12488218|FG000|COMPLETED|Overall Study||16
11290558|NCT02484729|12488219|FG001|COMPLETED|Overall Study||6
11290559|NCT02484729|12488220|FG002|COMPLETED|Overall Study||6
11290560|NCT02484729|12488221|FG003|COMPLETED|Overall Study||6
11290561|NCT02484729|12488222|FG004|COMPLETED|Overall Study||5
11290562|NCT02484729|12488223|FG005|COMPLETED|Overall Study||6
11290563|NCT02484729|12488224|FG006|COMPLETED|Overall Study||5
11290564|NCT02484729|12488225|FG007|COMPLETED|Overall Study||6
11290565|NCT02484729|12488226|FG008|COMPLETED|Overall Study||6
11290566|NCT02484729|12488227|FG009|COMPLETED|Overall Study||7
11290567|NCT02484729|12488218|FG000|NOT COMPLETED|Overall Study||0
11290568|NCT02484729|12488219|FG001|NOT COMPLETED|Overall Study||0
11290569|NCT02484729|12488220|FG002|NOT COMPLETED|Overall Study||0
11290570|NCT02484729|12488221|FG003|NOT COMPLETED|Overall Study||0
11290571|NCT02484729|12488222|FG004|NOT COMPLETED|Overall Study||0
11290572|NCT02484729|12488223|FG005|NOT COMPLETED|Overall Study||0
11290573|NCT02484729|12488224|FG006|NOT COMPLETED|Overall Study||0
11290574|NCT02484729|12488225|FG007|NOT COMPLETED|Overall Study||0
11290575|NCT02484729|12488226|FG008|NOT COMPLETED|Overall Study||0
11290576|NCT02484729|12488227|FG009|NOT COMPLETED|Overall Study||1
11290577|NCT02484807|12488267|FG000|STARTED|Overall Study||39
11290578|NCT02484807|12488268|FG001|STARTED|Overall Study||7
11290579|NCT02484807|12488269|FG002|STARTED|Overall Study||19
11290580|NCT02484807|12488270|FG003|STARTED|Overall Study||21
11290581|NCT02484807|12488271|FG004|STARTED|Overall Study||33
11290582|NCT02484807|12488272|FG005|STARTED|Overall Study||6
11290583|NCT02484807|12488267|FG000|COMPLETED|Overall Study||39
11290584|NCT02484807|12488268|FG001|COMPLETED|Overall Study||7
11290585|NCT02484807|12488269|FG002|COMPLETED|Overall Study||19
11290586|NCT02484807|12488270|FG003|COMPLETED|Overall Study||21
11290587|NCT02484807|12488271|FG004|COMPLETED|Overall Study||33
11290588|NCT02484807|12488272|FG005|COMPLETED|Overall Study||6
11290589|NCT02484807|12488267|FG000|NOT COMPLETED|Overall Study||0
11290590|NCT02484807|12488268|FG001|NOT COMPLETED|Overall Study||0
11290591|NCT02484807|12488269|FG002|NOT COMPLETED|Overall Study||0
11290592|NCT02484807|12488270|FG003|NOT COMPLETED|Overall Study||0
11290593|NCT02484807|12488271|FG004|NOT COMPLETED|Overall Study||0
11290594|NCT02484807|12488272|FG005|NOT COMPLETED|Overall Study||0
11290595|NCT02484859|12488289|FG000|STARTED|Overall Study||44
11290596|NCT02484859|12488290|FG001|STARTED|Overall Study||44
11290597|NCT02484859|12488289|FG000|COMPLETED|Overall Study||44
11290598|NCT02484859|12488290|FG001|COMPLETED|Overall Study||44
11290599|NCT02484859|12488289|FG000|NOT COMPLETED|Overall Study||0
11290600|NCT02484859|12488290|FG001|NOT COMPLETED|Overall Study||0
11290601|NCT02484898|12488298|FG000|STARTED|Overall Study||200
11290602|NCT02484898|12488298|FG000|COMPLETED|Overall Study||182
11290603|NCT02484898|12488298|FG000|NOT COMPLETED|Overall Study||18
11290604|NCT02484911|12488304|FG000|STARTED|Overall Study||60
11290605|NCT02484911|12488305|FG001|STARTED|Overall Study||60
11290606|NCT02484911|12488304|FG000|COMPLETED|Overall Study||56
11290607|NCT02484911|12488305|FG001|COMPLETED|Overall Study||58
11290608|NCT02484911|12488304|FG000|NOT COMPLETED|Overall Study||4
11290609|NCT02484911|12488305|FG001|NOT COMPLETED|Overall Study||2
11290610|NCT02485158|12488312|FG000|STARTED|Overall Study||28
11290611|NCT02485158|12488312|FG000|COMPLETED|Overall Study||24
11290612|NCT02485158|12488312|FG000|NOT COMPLETED|Overall Study||4
11290613|NCT02485301|12488323|FG000|STARTED|Overall Study||1509
11290614|NCT02485301|12488324|FG001|STARTED|Overall Study||1504
11290615|NCT02485301|12488323|FG000|COMPLETED|Overall Study||1471
11290616|NCT02485301|12488324|FG001|COMPLETED|Overall Study||1455
11290617|NCT02485301|12488323|FG000|NOT COMPLETED|Overall Study||38
11290618|NCT02485301|12488324|FG001|NOT COMPLETED|Overall Study||49
11290619|NCT02485353|12488330|FG000|STARTED|Overall Study||2
11290620|NCT02485353|12488330|FG000|COMPLETED|Overall Study||0
11290621|NCT02485353|12488330|FG000|NOT COMPLETED|Overall Study||2
11290622|NCT02485483|12488336|FG000|STARTED|Overall Study||277
11290623|NCT02485483|12488337|FG001|STARTED|Overall Study||1015
11290624|NCT02485483|12488336|FG000|COMPLETED|Overall Study||223
11290625|NCT02485483|12488337|FG001|COMPLETED|Overall Study||1015
11290626|NCT02485483|12488336|FG000|NOT COMPLETED|Overall Study||54
11290627|NCT02485483|12488337|FG001|NOT COMPLETED|Overall Study||0
11290628|NCT02485561|12488346|FG000|STARTED|Overall Study||161
11290629|NCT02485561|12488347|FG001|STARTED|Overall Study||157
11290630|NCT02485561|12488348|FG002|STARTED|Overall Study||159
11290631|NCT02485561|12488346|FG000|Completed 1 mo Survey|Overall Study||145
11290632|NCT02485561|12488347|FG001|Completed 1 mo Survey|Overall Study||138
11290633|NCT02485561|12488348|FG002|Completed 1 mo Survey|Overall Study||144
11290634|NCT02485561|12488346|FG000|COMPLETED|Overall Study||133
11290635|NCT02485561|12488347|FG001|COMPLETED|Overall Study||118
11290636|NCT02485561|12488348|FG002|COMPLETED|Overall Study||136
11290637|NCT02485561|12488346|FG000|NOT COMPLETED|Overall Study||28
11290638|NCT02485561|12488347|FG001|NOT COMPLETED|Overall Study||39
11290639|NCT02485561|12488348|FG002|NOT COMPLETED|Overall Study||23
11290640|NCT02485704|12488358|FG000|STARTED|Overall Study||154
11290641|NCT02485704|12488359|FG001|STARTED|Overall Study||126
11290642|NCT02485704|12488358|FG000|COMPLETED|Overall Study||149
11290643|NCT02485704|12488359|FG001|COMPLETED|Overall Study||118
11290644|NCT02485704|12488358|FG000|NOT COMPLETED|Overall Study||5
11290645|NCT02485704|12488359|FG001|NOT COMPLETED|Overall Study||8
11290646|NCT02485717|12488368|FG000|STARTED|Overall Study||142
11290647|NCT02485717|12488369|FG001|STARTED|Overall Study||129
11290648|NCT02485717|12488370|FG002|STARTED|Overall Study||20
11290649|NCT02485717|12488368|FG000|COMPLETED|Overall Study||136
11290650|NCT02485717|12488369|FG001|COMPLETED|Overall Study||127
11290651|NCT02485717|12488370|FG002|COMPLETED|Overall Study||19
11290652|NCT02485717|12488368|FG000|NOT COMPLETED|Overall Study||6
11290653|NCT02485717|12488369|FG001|NOT COMPLETED|Overall Study||2
11290654|NCT02485717|12488370|FG002|NOT COMPLETED|Overall Study||1
11290655|NCT02485834|12488378|FG000|STARTED|Overall Study||3
11290656|NCT02485834|12488379|FG001|STARTED|Overall Study||2
11290657|NCT02485834|12488378|FG000|COMPLETED|Overall Study||3
11290658|NCT02485834|12488379|FG001|COMPLETED|Overall Study||2
11290659|NCT02485834|12488378|FG000|NOT COMPLETED|Overall Study||0
11290660|NCT02485834|12488379|FG001|NOT COMPLETED|Overall Study||0
11290661|NCT02485912|12488386|FG000|STARTED|Overall Study||20
11290662|NCT02485912|12488387|FG001|STARTED|Overall Study||20
11290663|NCT02485912|12488386|FG000|COMPLETED|Overall Study||20
11290664|NCT02485912|12488387|FG001|COMPLETED|Overall Study||20
11290665|NCT02485912|12488386|FG000|NOT COMPLETED|Overall Study||0
11290666|NCT02485912|12488387|FG001|NOT COMPLETED|Overall Study||0
11290667|NCT02485925|12488393|FG000|STARTED|Overall Study||200
11290668|NCT02485925|12488393|FG000|Safety Population|Overall Study||200
11290669|NCT02485925|12488393|FG000|Intent to Treat (ITT) Population|Overall Study||193
11290670|NCT02485925|12488393|FG000|Per-Protocol Population|Overall Study||166
11290671|NCT02485925|12488393|FG000|COMPLETED|Overall Study||185
11290672|NCT02485925|12488393|FG000|NOT COMPLETED|Overall Study||15
11290673|NCT02485964|12488397|FG000|STARTED|Overall Study||10
11290674|NCT02485964|12488397|FG000|COMPLETED|Overall Study||10
11290675|NCT02485964|12488397|FG000|NOT COMPLETED|Overall Study||0
11290676|NCT02486016|12488401|FG000|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10
11290677|NCT02486016|12488401|FG000|COMPLETED|Overall Study||10
11290678|NCT02486016|12488401|FG000|NOT COMPLETED|Overall Study||0
11290679|NCT02486211|12488411|FG000|STARTED|Overall Study||7
11290680|NCT02486211|12488412|FG001|STARTED|Overall Study||7
11290681|NCT02486211|12488411|FG000|COMPLETED|Overall Study||6
11290682|NCT02486211|12488412|FG001|COMPLETED|Overall Study||7
11290683|NCT02486211|12488411|FG000|NOT COMPLETED|Overall Study||1
11290684|NCT02486211|12488412|FG001|NOT COMPLETED|Overall Study||0
11290685|NCT02486263|12488421|FG000|STARTED|Overall Study||40
11290686|NCT02486263|12488422|FG001|STARTED|Overall Study||36
11290687|NCT02486263|12488421|FG000|COMPLETED|Overall Study||37
11290688|NCT02486263|12488422|FG001|COMPLETED|Overall Study||35
11290689|NCT02486263|12488421|FG000|NOT COMPLETED|Overall Study||3
11290690|NCT02486263|12488422|FG001|NOT COMPLETED|Overall Study||1
11290691|NCT02486302|12488430|FG000|STARTED|Overall Study||1534
11290692|NCT02486302|12488430|FG000|Treated|Overall Study||1523
11290693|NCT02486302|12488430|FG000|COMPLETED|Overall Study||858
11290694|NCT02486302|12488430|FG000|NOT COMPLETED|Overall Study||676
11290695|NCT02486328|12488445|FG000|STARTED|Overall Study||52
11290696|NCT02486328|12488446|FG001|STARTED|Overall Study||51
11290697|NCT02486328|12488445|FG000|COMPLETED|Overall Study||50
11290698|NCT02486328|12488446|FG001|COMPLETED|Overall Study||50
11290699|NCT02486328|12488445|FG000|NOT COMPLETED|Overall Study||2
11290700|NCT02486328|12488446|FG001|NOT COMPLETED|Overall Study||1
11290701|NCT02486406|12488456|FG000|STARTED|Overall Study||12
11290702|NCT02486406|12488457|FG001|STARTED|Overall Study||26
11290703|NCT02486406|12488458|FG002|STARTED|Overall Study||12
11290704|NCT02486406|12488459|FG003|STARTED|Overall Study||14
11290705|NCT02486406|12488456|FG000|COMPLETED|Overall Study||10
11290706|NCT02486406|12488457|FG001|COMPLETED|Overall Study||23
11290707|NCT02486406|12488458|FG002|COMPLETED|Overall Study||10
11290708|NCT02486406|12488459|FG003|COMPLETED|Overall Study||10
11290709|NCT02486406|12488456|FG000|NOT COMPLETED|Overall Study||2
11290710|NCT02486406|12488457|FG001|NOT COMPLETED|Overall Study||3
11290711|NCT02486406|12488458|FG002|NOT COMPLETED|Overall Study||2
11290712|NCT02486406|12488459|FG003|NOT COMPLETED|Overall Study||4
11290713|NCT02486588|12488497|FG000|STARTED|Overall Study||1188
11290714|NCT02486588|12488498|FG001|STARTED|Overall Study||1252
11290715|NCT02486588|12488499|FG002|STARTED|Overall Study||1220
11290716|NCT02486588|12488500|FG003|STARTED|Overall Study||1206
11290717|NCT02486588|12488501|FG004|STARTED|Overall Study||1243
11290718|NCT02486588|12488502|FG005|STARTED|Overall Study||1205
11290719|NCT02486588|12488497|FG000|COMPLETED|Overall Study||450
11290720|NCT02486588|12488498|FG001|COMPLETED|Overall Study||502
11290721|NCT02486588|12488499|FG002|COMPLETED|Overall Study||465
11290722|NCT02486588|12488500|FG003|COMPLETED|Overall Study||468
11290723|NCT02486588|12488501|FG004|COMPLETED|Overall Study||497
11290724|NCT02486588|12488502|FG005|COMPLETED|Overall Study||459
11290725|NCT02486588|12488497|FG000|NOT COMPLETED|Overall Study||738
11399750|NCT04313647|12594372|FG000|NOT COMPLETED|Overall Study||0
11399751|NCT04313647|12594373|FG001|NOT COMPLETED|Overall Study||0
11399752|NCT04313647|12594374|FG002|NOT COMPLETED|Overall Study||0
11399753|NCT04313647|12594375|FG003|NOT COMPLETED|Overall Study||0
11399754|NCT04313647|12594376|FG004|NOT COMPLETED|Overall Study||0
11399755|NCT04310085|12594395|FG000|STARTED|Overall Study||8
11399756|NCT04310085|12594396|FG001|STARTED|Overall Study||8
11399757|NCT04310085|12594395|FG000|COMPLETED|Overall Study||8
11399758|NCT04310085|12594396|FG001|COMPLETED|Overall Study||8
11399759|NCT04310085|12594395|FG000|NOT COMPLETED|Overall Study||0
11399760|NCT04310085|12594396|FG001|NOT COMPLETED|Overall Study||0
11399761|NCT04309617|12594402|FG000|STARTED|Overall Study||618
11399762|NCT04309617|12594402|FG000|Modified High Risk of Recurrence|Overall Study||136
11290726|NCT02486588|12488498|FG001|NOT COMPLETED|Overall Study||750
11290727|NCT02486588|12488499|FG002|NOT COMPLETED|Overall Study||755
11290728|NCT02486588|12488500|FG003|NOT COMPLETED|Overall Study||738
11290729|NCT02486588|12488501|FG004|NOT COMPLETED|Overall Study||746
11290730|NCT02486588|12488502|FG005|NOT COMPLETED|Overall Study||746
11290731|NCT02486627|12488523|FG000|STARTED|Overall Study||306
11290732|NCT02486627|12488524|FG001|STARTED|Overall Study||303
11290733|NCT02486627|12488523|FG000|COMPLETED|Overall Study||299
11290734|NCT02486627|12488524|FG001|COMPLETED|Overall Study||294
11290735|NCT02486627|12488523|FG000|NOT COMPLETED|Overall Study||7
11290736|NCT02486627|12488524|FG001|NOT COMPLETED|Overall Study||9
11290737|NCT02486653|12488532|FG000|STARTED|Overall Study||76
11290738|NCT02486653|12488533|FG001|STARTED|Overall Study||75
11290739|NCT02486653|12488532|FG000|COMPLETED|Overall Study||70
11290740|NCT02486653|12488533|FG001|COMPLETED|Overall Study||71
11290741|NCT02486653|12488532|FG000|NOT COMPLETED|Overall Study||6
11290742|NCT02486653|12488533|FG001|NOT COMPLETED|Overall Study||4
11290743|NCT02486692|12488541|FG000|STARTED|Overall Study||30
11290744|NCT02486692|12488542|FG001|STARTED|Overall Study||30
11290745|NCT02486692|12488541|FG000|COMPLETED|Overall Study||26
11290746|NCT02486692|12488542|FG001|COMPLETED|Overall Study||23
11290747|NCT02486692|12488541|FG000|NOT COMPLETED|Overall Study||4
11290748|NCT02486692|12488542|FG001|NOT COMPLETED|Overall Study||7
11399763|NCT04309617|12594402|FG000|COMPLETED|Overall Study||618
11290749|NCT02486757|12488548|FG000|STARTED|Overall Study||6
11290750|NCT02486757|12488548|FG000|COMPLETED|Overall Study||5
11290751|NCT02486757|12488548|FG000|NOT COMPLETED|Overall Study||1
11290752|NCT02486796|12488554|FG000|STARTED|Overall Study||3
11021873|NCT00806260|12200045|FG000|COMPLETED|Period 3||12
11021874|NCT00806260|12200046|FG001|COMPLETED|Period 3||7
11021875|NCT00806260|12200047|FG002|COMPLETED|Period 3||5
11021876|NCT00806260|12200048|FG003|COMPLETED|Period 3||12
11021877|NCT00806260|12200049|FG004|COMPLETED|Period 3||0
11021878|NCT00806260|12200050|FG005|COMPLETED|Period 3||0
11290753|NCT02486796|12488555|FG001|STARTED|Overall Study||2
11290754|NCT02486796|12488554|FG000|COMPLETED|Overall Study||1
11290755|NCT02486796|12488555|FG001|COMPLETED|Overall Study||1
11290756|NCT02486796|12488554|FG000|NOT COMPLETED|Overall Study||2
11290757|NCT02486796|12488555|FG001|NOT COMPLETED|Overall Study||1
11290758|NCT02486939|12488563|FG000|STARTED|Overall Study||225
11290759|NCT02486939|12488564|FG001|STARTED|Overall Study||134
11290760|NCT02486939|12488563|FG000|COMPLETED|Overall Study||224
11290761|NCT02486939|12488564|FG001|COMPLETED|Overall Study||132
11290762|NCT02486939|12488563|FG000|NOT COMPLETED|Overall Study||1
11290763|NCT02486939|12488564|FG001|NOT COMPLETED|Overall Study||2
11290764|NCT02486952|12488570|FG000|STARTED|Overall Study||154
11290765|NCT02486952|12488570|FG000|Started Induction Therapy|Overall Study||151
11290766|NCT02486952|12488570|FG000|COMPLETED|Overall Study||104
11290767|NCT02486952|12488570|FG000|NOT COMPLETED|Overall Study||50
11290768|NCT02487030|12488581|FG000|STARTED|Overall Study||43
11290769|NCT02487030|12488582|FG001|STARTED|Overall Study||42
11290770|NCT02487030|12488583|FG002|STARTED|Overall Study||43
11290771|NCT02487030|12488584|FG003|STARTED|Overall Study||42
11290772|NCT02487030|12488585|FG004|STARTED|Overall Study||36
11290773|NCT02487030|12488586|FG005|STARTED|Overall Study||38
11290774|NCT02487030|12488587|FG006|STARTED|Overall Study||11
11290775|NCT02487030|12488581|FG000|COMPLETED|Overall Study||41
11290776|NCT02487030|12488582|FG001|COMPLETED|Overall Study||38
11290777|NCT02487030|12488583|FG002|COMPLETED|Overall Study||41
11290778|NCT02487030|12488584|FG003|COMPLETED|Overall Study||40
11290779|NCT02487030|12488585|FG004|COMPLETED|Overall Study||34
11290780|NCT02487030|12488586|FG005|COMPLETED|Overall Study||37
11399764|NCT04309617|12594402|FG000|NOT COMPLETED|Overall Study||0
11399765|NCT04308239|12594410|FG000|STARTED|Pre-intervention Evaluation (1 Week)||20
11399766|NCT04308239|12594411|FG001|STARTED|Pre-intervention Evaluation (1 Week)||14
11290781|NCT02487030|12488587|FG006|COMPLETED|Overall Study||11
11290782|NCT02487030|12488581|FG000|NOT COMPLETED|Overall Study||2
11290783|NCT02487030|12488582|FG001|NOT COMPLETED|Overall Study||4
11290784|NCT02487030|12488583|FG002|NOT COMPLETED|Overall Study||2
11290785|NCT02487030|12488584|FG003|NOT COMPLETED|Overall Study||2
11399767|NCT04308239|12594410|FG000|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|17
11399768|NCT04308239|12594411|FG001|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|11
11290786|NCT02487030|12488585|FG004|NOT COMPLETED|Overall Study||2
11290787|NCT02487030|12488586|FG005|NOT COMPLETED|Overall Study||1
11290788|NCT02487030|12488587|FG006|NOT COMPLETED|Overall Study||0
11290789|NCT02487056|12488604|FG000|STARTED|Overall Study||1622
11290790|NCT02487056|12488604|FG000|COMPLETED|Overall Study||1606
11290791|NCT02487056|12488604|FG000|NOT COMPLETED|Overall Study||16
11290792|NCT02487199|12488611|FG000|STARTED|Overall Study||13
11399769|NCT04308239|12594410|FG000|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
11290793|NCT02487199|12488612|FG001|STARTED|Overall Study||5
11290794|NCT02487199|12488611|FG000|COMPLETED|Overall Study||13
11290795|NCT02487199|12488612|FG001|COMPLETED|Overall Study||4
11290796|NCT02487199|12488611|FG000|NOT COMPLETED|Overall Study||0
11290797|NCT02487199|12488612|FG001|NOT COMPLETED|Overall Study||1
11290798|NCT02487225|12488620|FG000|STARTED|Overall Study||45
11290799|NCT02487225|12488621|FG001|STARTED|Overall Study||38
11290800|NCT02487225|12488620|FG000|COMPLETED|Overall Study||18
11290801|NCT02487225|12488621|FG001|COMPLETED|Overall Study||8
11290802|NCT02487225|12488620|FG000|NOT COMPLETED|Overall Study||27
11290803|NCT02487225|12488621|FG001|NOT COMPLETED|Overall Study||30
11290804|NCT02487303|12488630|FG000|STARTED|Overall Study||49
11290805|NCT02487303|12488631|FG001|STARTED|Overall Study||51
11290806|NCT02487303|12488632|FG002|STARTED|Overall Study||48
11290807|NCT02487303|12488630|FG000|COMPLETED|Overall Study||47
11290808|NCT02487303|12488631|FG001|COMPLETED|Overall Study||47
11290809|NCT02487303|12488632|FG002|COMPLETED|Overall Study||47
11290810|NCT02487303|12488630|FG000|NOT COMPLETED|Overall Study||2
11290811|NCT02487303|12488631|FG001|NOT COMPLETED|Overall Study||4
11290812|NCT02487303|12488632|FG002|NOT COMPLETED|Overall Study||1
11290813|NCT02487446|12488643|FG000|STARTED|Period 1||178
11290814|NCT02487446|12488644|FG001|STARTED|Period 1||179
11290815|NCT02487446|12488643|FG000|COMPLETED|Period 1||165
11290816|NCT02487446|12488644|FG001|COMPLETED|Period 1||171
11290817|NCT02487446|12488643|FG000|NOT COMPLETED|Period 1||13
11399770|NCT04308239|12594411|FG001|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
11399771|NCT04308239|12594410|FG000|STARTED|Intervention (2 Weeks)||20
11399772|NCT04308239|12594411|FG001|STARTED|Intervention (2 Weeks)||14
11399773|NCT04308239|12594410|FG000|COMPLETED|Intervention (2 Weeks)||20
11399774|NCT04308239|12594411|FG001|COMPLETED|Intervention (2 Weeks)||14
11399775|NCT04308239|12594410|FG000|NOT COMPLETED|Intervention (2 Weeks)||0
11399776|NCT04308239|12594411|FG001|NOT COMPLETED|Intervention (2 Weeks)||0
11399777|NCT04308239|12594410|FG000|STARTED|Post-intervention Evaluation (1 Week)||20
11399778|NCT04308239|12594411|FG001|STARTED|Post-intervention Evaluation (1 Week)||14
11399779|NCT04308239|12594410|FG000|COMPLETED|Post-intervention Evaluation (1 Week)||19
11399780|NCT04308239|12594411|FG001|COMPLETED|Post-intervention Evaluation (1 Week)||10
11399781|NCT04308239|12594410|FG000|NOT COMPLETED|Post-intervention Evaluation (1 Week)||1
11399782|NCT04308239|12594411|FG001|NOT COMPLETED|Post-intervention Evaluation (1 Week)||4
11399783|NCT04308668|12594423|FG000|STARTED|Overall Study||658
11399784|NCT04308668|12594424|FG001|STARTED|Overall Study||654
11399785|NCT04308668|12594423|FG000|COMPLETED|Overall Study||622
11399786|NCT04308668|12594424|FG001|COMPLETED|Overall Study||612
11399787|NCT04308668|12594423|FG000|NOT COMPLETED|Overall Study||36
11399788|NCT04308668|12594424|FG001|NOT COMPLETED|Overall Study||42
11399789|NCT04307940|12594433|FG000|STARTED|Overall Study||90
11399790|NCT04307940|12594434|FG001|STARTED|Overall Study||87
11290818|NCT02487446|12488644|FG001|NOT COMPLETED|Period 1||8
11290819|NCT02487446|12488643|FG000|STARTED|Washout||165
11290820|NCT02487446|12488644|FG001|STARTED|Washout||171
11290821|NCT02487446|12488643|FG000|COMPLETED|Washout||162
11290822|NCT02487446|12488644|FG001|COMPLETED|Washout||163
11290823|NCT02487446|12488643|FG000|NOT COMPLETED|Washout||3
11290824|NCT02487446|12488644|FG001|NOT COMPLETED|Washout||8
11290825|NCT02487446|12488643|FG000|STARTED|Period 2||162
11290826|NCT02487446|12488644|FG001|STARTED|Period 2||163
11290827|NCT02487446|12488643|FG000|COMPLETED|Period 2||154
11290828|NCT02487446|12488644|FG001|COMPLETED|Period 2||158
11290829|NCT02487446|12488643|FG000|NOT COMPLETED|Period 2||8
11290830|NCT02487446|12488644|FG001|NOT COMPLETED|Period 2||5
11290831|NCT02487472|12488651|FG000|STARTED|Overall Study||101
11290832|NCT02487472|12488651|FG000|COMPLETED|Overall Study||90
11290833|NCT02487472|12488651|FG000|NOT COMPLETED|Overall Study||11
11290834|NCT02487485|12488659|FG000|STARTED|Overall Study||12
11290835|NCT02487485|12488660|FG001|STARTED|Overall Study||11
11290836|NCT02487485|12488659|FG000|COMPLETED|Overall Study||9
11290837|NCT02487485|12488660|FG001|COMPLETED|Overall Study||8
11290838|NCT02487485|12488659|FG000|NOT COMPLETED|Overall Study||3
11290839|NCT02487485|12488660|FG001|NOT COMPLETED|Overall Study||3
11341101|NCT02928380|12538416|FG001|STARTED|Wash Out Period 2||14
11341102|NCT02928380|12538417|FG002|STARTED|Wash Out Period 2||14
11341103|NCT02928380|12538418|FG003|STARTED|Wash Out Period 2||14
11341104|NCT02928380|12538419|FG004|STARTED|Wash Out Period 2||14
11341105|NCT02928380|12538420|FG005|STARTED|Wash Out Period 2||14
11341106|NCT02928380|12538415|FG000|COMPLETED|Wash Out Period 2||13
11341107|NCT02928380|12538416|FG001|COMPLETED|Wash Out Period 2||14
11341108|NCT02928380|12538417|FG002|COMPLETED|Wash Out Period 2||14
11341109|NCT02928380|12538418|FG003|COMPLETED|Wash Out Period 2||14
11341110|NCT02928380|12538419|FG004|COMPLETED|Wash Out Period 2||14
11341111|NCT02928380|12538420|FG005|COMPLETED|Wash Out Period 2||14
11341112|NCT02928380|12538415|FG000|NOT COMPLETED|Wash Out Period 2||0
11399791|NCT04307940|12594435|FG002|STARTED|Overall Study||44
11399792|NCT04307940|12594433|FG000|COMPLETED|Overall Study||85
11399793|NCT04307940|12594434|FG001|COMPLETED|Overall Study||84
11399794|NCT04307940|12594435|FG002|COMPLETED|Overall Study||42
11341113|NCT02928380|12538416|FG001|NOT COMPLETED|Wash Out Period 2||0
11341114|NCT02928380|12538417|FG002|NOT COMPLETED|Wash Out Period 2||0
11341115|NCT02928380|12538418|FG003|NOT COMPLETED|Wash Out Period 2||0
11341116|NCT02928380|12538419|FG004|NOT COMPLETED|Wash Out Period 2||0
11341117|NCT02928380|12538420|FG005|NOT COMPLETED|Wash Out Period 2||0
11341118|NCT02928380|12538415|FG000|STARTED|Period 3||13
11341119|NCT02928380|12538416|FG001|STARTED|Period 3||14
11341120|NCT02928380|12538417|FG002|STARTED|Period 3||14
11341121|NCT02928380|12538418|FG003|STARTED|Period 3||14
11341122|NCT02928380|12538419|FG004|STARTED|Period 3||14
11341123|NCT02928380|12538420|FG005|STARTED|Period 3||14
11341124|NCT02928380|12538415|FG000|COMPLETED|Period 3||13
11341125|NCT02928380|12538416|FG001|COMPLETED|Period 3||14
11341126|NCT02928380|12538417|FG002|COMPLETED|Period 3||14
11341127|NCT02928380|12538418|FG003|COMPLETED|Period 3||14
11341128|NCT02928380|12538419|FG004|COMPLETED|Period 3||14
11341129|NCT02928380|12538420|FG005|COMPLETED|Period 3||14
11341130|NCT02928380|12538415|FG000|NOT COMPLETED|Period 3||0
11341131|NCT02928380|12538416|FG001|NOT COMPLETED|Period 3||0
11341132|NCT02928380|12538417|FG002|NOT COMPLETED|Period 3||0
11341133|NCT02928380|12538418|FG003|NOT COMPLETED|Period 3||0
11341134|NCT02928380|12538419|FG004|NOT COMPLETED|Period 3||0
11341135|NCT02928380|12538420|FG005|NOT COMPLETED|Period 3||0
11341136|NCT02928536|12538431|FG000|STARTED|Overall Study||11902
11341137|NCT02928536|12538431|FG000|COMPLETED|Overall Study||11902
11341138|NCT02928536|12538431|FG000|NOT COMPLETED|Overall Study||0
11341139|NCT02928770|12538435|FG000|STARTED|Overall Study||32
11341140|NCT02928770|12538435|FG000|COMPLETED|Overall Study||30
11341141|NCT02928770|12538435|FG000|NOT COMPLETED|Overall Study||2
11341142|NCT02928848|12538441|FG000|STARTED|Arm 1||9
11341143|NCT02928848|12538442|FG001|STARTED|Arm 1||7
11341144|NCT02928848|12538441|FG000|COMPLETED|Arm 1||9
11341145|NCT02928848|12538442|FG001|COMPLETED|Arm 1||6
11341146|NCT02928848|12538441|FG000|NOT COMPLETED|Arm 1||0
11341147|NCT02928848|12538442|FG001|NOT COMPLETED|Arm 1||1
11341148|NCT02928848|12538441|FG000|STARTED|Arm 2||9
11341149|NCT02928848|12538442|FG001|STARTED|Arm 2||6
11341150|NCT02928848|12538441|FG000|COMPLETED|Arm 2||8
11341151|NCT02928848|12538442|FG001|COMPLETED|Arm 2||6
11341152|NCT02928848|12538441|FG000|NOT COMPLETED|Arm 2||1
11341153|NCT02928848|12538442|FG001|NOT COMPLETED|Arm 2||0
11341154|NCT02928952|12538452|FG000|STARTED|Overall Study||65
11341155|NCT02928952|12538453|FG001|STARTED|Overall Study||67
11341156|NCT02928952|12538452|FG000|COMPLETED|Overall Study||55
11290840|NCT02487498|12488666|FG000|STARTED|Period: Period 1||178
11290841|NCT02487498|12488667|FG001|STARTED|Period: Period 1||177
11290842|NCT02487498|12488666|FG000|COMPLETED|Period: Period 1||172
11290843|NCT02487498|12488667|FG001|COMPLETED|Period: Period 1||166
11290844|NCT02487498|12488666|FG000|NOT COMPLETED|Period: Period 1||6
11290845|NCT02487498|12488667|FG001|NOT COMPLETED|Period: Period 1||11
11290846|NCT02487498|12488666|FG000|STARTED|Period: Washout||172
11290847|NCT02487498|12488667|FG001|STARTED|Period: Washout||166
11290848|NCT02487498|12488666|FG000|COMPLETED|Period: Washout||170
11290849|NCT02487498|12488667|FG001|COMPLETED|Period: Washout||159
11290850|NCT02487498|12488666|FG000|NOT COMPLETED|Period: Washout||2
11290851|NCT02487498|12488667|FG001|NOT COMPLETED|Period: Washout||7
11290852|NCT02487498|12488666|FG000|STARTED|Period: Period 2||170
11290853|NCT02487498|12488667|FG001|STARTED|Period: Period 2||159
11290854|NCT02487498|12488666|FG000|COMPLETED|Period: Period 2||164
11290855|NCT02487498|12488667|FG001|COMPLETED|Period: Period 2||154
11290856|NCT02487498|12488666|FG000|NOT COMPLETED|Period: Period 2||6
11290857|NCT02487498|12488667|FG001|NOT COMPLETED|Period: Period 2||5
11290858|NCT02487563|12488677|FG000|STARTED|Overall Study||32
11290859|NCT02487563|12488678|FG001|STARTED|Overall Study||33
11290860|NCT02487563|12488679|FG002|STARTED|Overall Study||32
11290861|NCT02487563|12488677|FG000|COMPLETED|Overall Study||30
11290862|NCT02487563|12488678|FG001|COMPLETED|Overall Study||30
11290863|NCT02487563|12488679|FG002|COMPLETED|Overall Study||31
11290864|NCT02487563|12488677|FG000|NOT COMPLETED|Overall Study||2
11290865|NCT02487563|12488678|FG001|NOT COMPLETED|Overall Study||3
11290866|NCT02487563|12488679|FG002|NOT COMPLETED|Overall Study||1
11290867|NCT02487771|12488692|FG000|STARTED|Overall Study||91
11290868|NCT02487771|12488693|FG001|STARTED|Overall Study||99
11290869|NCT02487771|12488692|FG000|COMPLETED|Overall Study||81
11290870|NCT02487771|12488693|FG001|COMPLETED|Overall Study||85
11290871|NCT02487771|12488692|FG000|NOT COMPLETED|Overall Study||10
11290872|NCT02487771|12488693|FG001|NOT COMPLETED|Overall Study||14
11290873|NCT02487810|12488701|FG000|STARTED|Overall Study||98
11290874|NCT02487810|12488702|FG001|STARTED|Overall Study||102
11290875|NCT02487810|12488701|FG000|COMPLETED|Overall Study||97
11290876|NCT02487810|12488702|FG001|COMPLETED|Overall Study||102
11290877|NCT02487810|12488701|FG000|NOT COMPLETED|Overall Study||1
11290878|NCT02487810|12488702|FG001|NOT COMPLETED|Overall Study||0
11290879|NCT02488005|12488708|FG000|STARTED|Overall Study||15
11290880|NCT02488005|12488708|FG000|COMPLETED|Overall Study||13
11290881|NCT02488005|12488708|FG000|NOT COMPLETED|Overall Study||2
11290882|NCT02488018|12488712|FG000|STARTED|Overall Study||10
11290883|NCT02488018|12488712|FG000|COMPLETED|Overall Study||10
11290884|NCT02488018|12488712|FG000|NOT COMPLETED|Overall Study||0
11290885|NCT02488070|12488716|FG000|STARTED|Overall Study||10
11290886|NCT02488070|12488716|FG000|COMPLETED|Overall Study||10
11399795|NCT04307940|12594433|FG000|NOT COMPLETED|Overall Study||5
11399796|NCT04307940|12594434|FG001|NOT COMPLETED|Overall Study||3
11399797|NCT04307940|12594435|FG002|NOT COMPLETED|Overall Study||2
11399798|NCT04302545|12594445|FG000|STARTED|Overall Study||107
11399799|NCT04302545|12594446|FG001|STARTED|Overall Study||107
11399800|NCT04302545|12594445|FG000|COMPLETED|Overall Study||104
11399801|NCT04302545|12594446|FG001|COMPLETED|Overall Study||103
11399802|NCT04302545|12594445|FG000|NOT COMPLETED|Overall Study||3
11399803|NCT04302545|12594446|FG001|NOT COMPLETED|Overall Study||4
11399804|NCT04297631|12594463|FG000|STARTED|Overall Study||20
11399805|NCT04297631|12594463|FG000|COMPLETED|Overall Study||20
11399806|NCT04297631|12594463|FG000|NOT COMPLETED|Overall Study||0
11399807|NCT04297241|12594468|FG000|STARTED|Overall Study||20
11399808|NCT04297241|12594468|FG000|COMPLETED|Overall Study||15
11399809|NCT04297241|12594468|FG000|NOT COMPLETED|Overall Study||5
11399810|NCT04296448|12594484|FG000|STARTED|Overall Study||98
11399811|NCT04296448|12594485|FG001|STARTED|Overall Study||99
11399812|NCT04296448|12594484|FG000|COMPLETED|Overall Study||98
11399813|NCT04296448|12594485|FG001|COMPLETED|Overall Study||99
11399814|NCT04296448|12594484|FG000|NOT COMPLETED|Overall Study||0
11399815|NCT04296448|12594485|FG001|NOT COMPLETED|Overall Study||0
11399816|NCT04296227|12594491|FG000|STARTED|Overall Study||85
11399817|NCT04296227|12594491|FG000|COMPLETED|Overall Study||85
11399818|NCT04296227|12594491|FG000|NOT COMPLETED|Overall Study||0
11399819|NCT04295356|12594497|FG000|STARTED|Overall Study||93
11399820|NCT04295356|12594498|FG001|STARTED|Overall Study||87
11399821|NCT04295356|12594497|FG000|COMPLETED|Overall Study||92
11399822|NCT04295356|12594498|FG001|COMPLETED|Overall Study||83
11399823|NCT04295356|12594497|FG000|NOT COMPLETED|Overall Study||1
11399824|NCT04295356|12594498|FG001|NOT COMPLETED|Overall Study||4
11399825|NCT04292639|12594504|FG000|STARTED|Overall Study||20
11399826|NCT04292639|12594504|FG000|COMPLETED|Overall Study||20
11399827|NCT04292639|12594504|FG000|NOT COMPLETED|Overall Study||0
11290887|NCT02488070|12488716|FG000|NOT COMPLETED|Overall Study||0
11290888|NCT02488109|12488723|FG000|STARTED|Treatment in Hospital||60
11290889|NCT02488109|12488724|FG001|STARTED|Treatment in Hospital||56
11290890|NCT02488109|12488723|FG000|Received Treatment|Treatment in Hospital||60
11290891|NCT02488109|12488724|FG001|Received Treatment|Treatment in Hospital||51
11290892|NCT02488109|12488723|FG000|Included in mITT Analysis|Treatment in Hospital||60
11290893|NCT02488109|12488724|FG001|Included in mITT Analysis|Treatment in Hospital||51
11290894|NCT02488109|12488723|FG000|COMPLETED|Treatment in Hospital||60
11290895|NCT02488109|12488724|FG001|COMPLETED|Treatment in Hospital||51
11290896|NCT02488109|12488723|FG000|NOT COMPLETED|Treatment in Hospital||0
11290897|NCT02488109|12488724|FG001|NOT COMPLETED|Treatment in Hospital||5
11290898|NCT02488109|12488723|FG000|STARTED|12-month Follow-Up||60
11399828|NCT04292535|12594522|FG000|STARTED|Overall Study||8
11399829|NCT04292535|12594523|FG001|STARTED|Overall Study||8
11399830|NCT04292535|12594524|FG002|STARTED|Overall Study||9
11399831|NCT04292535|12594525|FG003|STARTED|Overall Study||8
11399832|NCT04292535|12594526|FG004|STARTED|Overall Study||8
11399833|NCT04292535|12594527|FG005|STARTED|Overall Study||9
11399834|NCT04292535|12594528|FG006|STARTED|Overall Study||8
11399835|NCT04292535|12594529|FG007|STARTED|Overall Study||10
11399836|NCT04292535|12594530|FG008|STARTED|Overall Study||8
11399837|NCT04292535|12594531|FG009|STARTED|Overall Study||8
11399838|NCT04292535|12594532|FG010|STARTED|Overall Study||7
11399839|NCT04292535|12594533|FG011|STARTED|Overall Study||7
11399840|NCT04292535|12594534|FG012|STARTED|Overall Study||9
11399841|NCT04292535|12594535|FG013|STARTED|Overall Study||9
11399842|NCT04292535|12594522|FG000|COMPLETED|Overall Study||8
11399843|NCT04292535|12594523|FG001|COMPLETED|Overall Study||8
11399844|NCT04292535|12594524|FG002|COMPLETED|Overall Study||9
11399845|NCT04292535|12594525|FG003|COMPLETED|Overall Study||8
11399846|NCT04292535|12594526|FG004|COMPLETED|Overall Study||8
11399847|NCT04292535|12594527|FG005|COMPLETED|Overall Study||9
11399848|NCT04292535|12594528|FG006|COMPLETED|Overall Study||8
11399849|NCT04292535|12594529|FG007|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
11399850|NCT04292535|12594530|FG008|COMPLETED|Overall Study||8
11399851|NCT04292535|12594531|FG009|COMPLETED|Overall Study||8
11399852|NCT04292535|12594532|FG010|COMPLETED|Overall Study||7
11399853|NCT04292535|12594533|FG011|COMPLETED|Overall Study||6
11399854|NCT04292535|12594534|FG012|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
11399855|NCT04292535|12594535|FG013|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1) Condition stopped due to Report of Dizziness (n = 1)|7
11399856|NCT04292535|12594522|FG000|NOT COMPLETED|Overall Study||0
11399857|NCT04292535|12594523|FG001|NOT COMPLETED|Overall Study||0
11399858|NCT04292535|12594524|FG002|NOT COMPLETED|Overall Study||0
11399859|NCT04292535|12594525|FG003|NOT COMPLETED|Overall Study||0
11399860|NCT04292535|12594526|FG004|NOT COMPLETED|Overall Study||0
11399861|NCT04292535|12594527|FG005|NOT COMPLETED|Overall Study||0
11399862|NCT04292535|12594528|FG006|NOT COMPLETED|Overall Study||0
11399863|NCT04292535|12594529|FG007|NOT COMPLETED|Overall Study||2
11399864|NCT04292535|12594530|FG008|NOT COMPLETED|Overall Study||0
11399865|NCT04292535|12594531|FG009|NOT COMPLETED|Overall Study||0
11399866|NCT04292535|12594532|FG010|NOT COMPLETED|Overall Study||0
11399867|NCT04292535|12594533|FG011|NOT COMPLETED|Overall Study||1
11399868|NCT04292535|12594534|FG012|NOT COMPLETED|Overall Study||1
11399869|NCT04292535|12594535|FG013|NOT COMPLETED|Overall Study||2
11399870|NCT04292171|12594567|FG000|STARTED|Overall Study||109
11399871|NCT04292171|12594568|FG001|STARTED|Overall Study||110
11399872|NCT04292171|12594567|FG000|COMPLETED|Overall Study||107
11399873|NCT04292171|12594568|FG001|COMPLETED|Overall Study||109
11399874|NCT04292171|12594567|FG000|NOT COMPLETED|Overall Study||2
11399875|NCT04292171|12594568|FG001|NOT COMPLETED|Overall Study||1
11399876|NCT04292899|12594578|FG000|STARTED|Overall Study||200
11399877|NCT04292899|12594579|FG001|STARTED|Overall Study||197
11399878|NCT04292899|12594580|FG002|STARTED|Overall Study||844
11290899|NCT02488109|12488724|FG001|STARTED|12-month Follow-Up||51
11290900|NCT02488109|12488723|FG000|Included in mITT Analysis|12-month Follow-Up||60
11290901|NCT02488109|12488724|FG001|Included in mITT Analysis|12-month Follow-Up||51
11290902|NCT02488109|12488723|FG000|COMPLETED|12-month Follow-Up||56
11290903|NCT02488109|12488724|FG001|COMPLETED|12-month Follow-Up||44
11290904|NCT02488109|12488723|FG000|NOT COMPLETED|12-month Follow-Up||4
11290905|NCT02488109|12488724|FG001|NOT COMPLETED|12-month Follow-Up||7
11290906|NCT02488239|12488732|FG000|STARTED|Overall Study||64
11290907|NCT02488239|12488732|FG000|COMPLETED|Overall Study||54
11290908|NCT02488239|12488732|FG000|NOT COMPLETED|Overall Study||10
11290909|NCT02488317|12488739|FG000|STARTED|Overall Study||117
11290910|NCT02488317|12488740|FG001|STARTED|Overall Study||117
11290911|NCT02488317|12488739|FG000|COMPLETED|Overall Study||63
11290912|NCT02488317|12488740|FG001|COMPLETED|Overall Study||70
11290913|NCT02488317|12488739|FG000|NOT COMPLETED|Overall Study||54
11290914|NCT02488317|12488740|FG001|NOT COMPLETED|Overall Study||47
11290915|NCT02488330|12488750|FG000|STARTED|Overall Study||12
11290916|NCT02488330|12488750|FG000|COMPLETED|Overall Study||0
11290917|NCT02488330|12488750|FG000|NOT COMPLETED|Overall Study||12
11290918|NCT02488681|12488754|FG000|STARTED|Overall Study|Patients with Micra implant attempt|276
11290919|NCT02488681|12488754|FG000|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
11290920|NCT02488681|12488754|FG000|NOT COMPLETED|Overall Study||7
11290921|NCT02488824|12488760|FG000|STARTED|Overall Study||21
11290922|NCT02488824|12488761|FG001|STARTED|Overall Study||20
11290923|NCT02488824|12488760|FG000|COMPLETED|Overall Study||20
11290924|NCT02488824|12488761|FG001|COMPLETED|Overall Study||19
11290925|NCT02488824|12488760|FG000|NOT COMPLETED|Overall Study||1
11290926|NCT02488824|12488761|FG001|NOT COMPLETED|Overall Study||1
11290927|NCT02488915|12488767|FG000|STARTED|Overall Study||228
11290928|NCT02488915|12488767|FG000|COMPLETED|Overall Study||202
11290929|NCT02488915|12488767|FG000|NOT COMPLETED|Overall Study||26
11290930|NCT02488980|12488774|FG000|STARTED|Overall Study||104
11290931|NCT02488980|12488775|FG001|STARTED|Overall Study||101
11290932|NCT02488980|12488776|FG002|STARTED|Overall Study||101
11290933|NCT02488980|12488774|FG000|COMPLETED|Overall Study||102
11021879|NCT00806260|12200045|FG000|NOT COMPLETED|Period 3||1
11021880|NCT00806260|12200046|FG001|NOT COMPLETED|Period 3||1
11021881|NCT00806260|12200047|FG002|NOT COMPLETED|Period 3||1
11021882|NCT00806260|12200048|FG003|NOT COMPLETED|Period 3||0
11021883|NCT00806260|12200049|FG004|NOT COMPLETED|Period 3||0
11021884|NCT00806260|12200050|FG005|NOT COMPLETED|Period 3||0
11021885|NCT00806286|12200065|FG000|STARTED|Overall Study||54
11021886|NCT00806286|12200066|FG001|STARTED|Overall Study||54
11021887|NCT00806286|12200067|FG002|STARTED|Overall Study||3
11290934|NCT02488980|12488775|FG001|COMPLETED|Overall Study||99
11290935|NCT02488980|12488776|FG002|COMPLETED|Overall Study||99
11290936|NCT02488980|12488774|FG000|NOT COMPLETED|Overall Study||2
11290937|NCT02488980|12488775|FG001|NOT COMPLETED|Overall Study||2
11290938|NCT02488980|12488776|FG002|NOT COMPLETED|Overall Study||2
11290939|NCT02489045|12488784|FG000|STARTED|Overall Study||178
11290940|NCT02489045|12488784|FG000|COMPLETED|Overall Study||125
11290941|NCT02489045|12488784|FG000|NOT COMPLETED|Overall Study||53
11021888|NCT00806286|12200065|FG000|COMPLETED|Overall Study||0
11021889|NCT00806286|12200066|FG001|COMPLETED|Overall Study||0
11021890|NCT00806286|12200067|FG002|COMPLETED|Overall Study||0
11290942|NCT02489045|12488784|FG000|STARTED|Follow-up|"Only subjects with portal hypertension in overall study were eligible to progress to follow-up"|21
11290943|NCT02489045|12488784|FG000|COMPLETED|Follow-up||11
11290944|NCT02489045|12488784|FG000|NOT COMPLETED|Follow-up||10
11290945|NCT02489110|12488790|FG000|STARTED|Overall Study||75
11290946|NCT02489110|12488791|FG001|STARTED|Overall Study||75
11290947|NCT02489110|12488790|FG000|COMPLETED|Overall Study||48
11290948|NCT02489110|12488791|FG001|COMPLETED|Overall Study||50
11290949|NCT02489110|12488790|FG000|NOT COMPLETED|Overall Study||27
11290950|NCT02489110|12488791|FG001|NOT COMPLETED|Overall Study||25
11290951|NCT02489123|12488797|FG000|STARTED|Overall Study||8
11290952|NCT02489123|12488797|FG000|COMPLETED|Overall Study||8
11290953|NCT02489123|12488797|FG000|NOT COMPLETED|Overall Study||0
11290954|NCT02489227|12488804|FG000|STARTED|Overall Study||274
11290955|NCT02489227|12488805|FG001|STARTED|Overall Study||135
11290956|NCT02489227|12488806|FG002|STARTED|Overall Study||136
11290957|NCT02489227|12488804|FG000|COMPLETED|Overall Study||220
11290958|NCT02489227|12488805|FG001|COMPLETED|Overall Study||101
11290959|NCT02489227|12488806|FG002|COMPLETED|Overall Study||117
11290960|NCT02489227|12488804|FG000|NOT COMPLETED|Overall Study||54
11290961|NCT02489227|12488805|FG001|NOT COMPLETED|Overall Study||34
11290962|NCT02489227|12488806|FG002|NOT COMPLETED|Overall Study||19
11290963|NCT02489279|12488818|FG000|STARTED|Overall Study||44
11290964|NCT02489279|12488819|FG001|STARTED|Overall Study||41
11290965|NCT02489279|12488818|FG000|COMPLETED|Overall Study||32
11290966|NCT02489279|12488819|FG001|COMPLETED|Overall Study||31
11290967|NCT02489279|12488818|FG000|NOT COMPLETED|Overall Study||12
11290968|NCT02489279|12488819|FG001|NOT COMPLETED|Overall Study||10
11290969|NCT02489344|12488825|FG000|STARTED|ACT13739 (Initial Study): 26 Weeks||11
11290970|NCT02489344|12488825|FG000|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9
11290971|NCT02489344|12488825|FG000|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2
11290972|NCT02489344|12488825|FG000|STARTED|LTS14116 (Extension Study): 31 Months||8
11290973|NCT02489344|12488825|FG000|COMPLETED|LTS14116 (Extension Study): 31 Months||5
11290974|NCT02489344|12488825|FG000|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3
11290975|NCT02489357|12488829|FG000|STARTED|Overall Study||12
11290976|NCT02489357|12488829|FG000|COMPLETED|Overall Study||12
11290977|NCT02489357|12488829|FG000|NOT COMPLETED|Overall Study||0
11290978|NCT02489500|12488835|FG000|STARTED|Overall Study||2
11290979|NCT02489500|12488836|FG001|STARTED|Overall Study||1
11290980|NCT02489500|12488835|FG000|COMPLETED|Overall Study||1
11290981|NCT02489500|12488836|FG001|COMPLETED|Overall Study||0
11290982|NCT02489500|12488835|FG000|NOT COMPLETED|Overall Study||1
11290983|NCT02489500|12488836|FG001|NOT COMPLETED|Overall Study||1
11290984|NCT02489630|12488844|FG000|STARTED|Overall Study||53
11290985|NCT02489630|12488845|FG001|STARTED|Overall Study||63
11290986|NCT02489630|12488844|FG000|COMPLETED|Overall Study||51
11290987|NCT02489630|12488845|FG001|COMPLETED|Overall Study||61
11290988|NCT02489630|12488844|FG000|NOT COMPLETED|Overall Study||2
11290989|NCT02489630|12488845|FG001|NOT COMPLETED|Overall Study||2
11290990|NCT02489734|12488853|FG000|STARTED|Overall Study||56
11290991|NCT02489734|12488854|FG001|STARTED|Overall Study||53
11290992|NCT02489734|12488853|FG000|COMPLETED|Overall Study||39
11290993|NCT02489734|12488854|FG001|COMPLETED|Overall Study||53
11290994|NCT02489734|12488853|FG000|NOT COMPLETED|Overall Study||17
11290995|NCT02489734|12488854|FG001|NOT COMPLETED|Overall Study||0
11290996|NCT02489773|12488862|FG000|STARTED|Overall Study||98
11290997|NCT02489773|12488863|FG001|STARTED|Overall Study||52
11290998|NCT02489773|12488862|FG000|COMPLETED|Overall Study||91
11290999|NCT02489773|12488863|FG001|COMPLETED|Overall Study||50
11291000|NCT02489773|12488862|FG000|NOT COMPLETED|Overall Study||7
11291001|NCT02489773|12488863|FG001|NOT COMPLETED|Overall Study||2
11291002|NCT02489799|12488871|FG000|STARTED|Overall Study||45
11291003|NCT02489799|12488872|FG001|STARTED|Overall Study||47
11291004|NCT02489799|12488871|FG000|Presurgical Consent Visit (V2)|Overall Study||40
11291005|NCT02489799|12488872|FG001|Presurgical Consent Visit (V2)|Overall Study||39
11291006|NCT02489799|12488871|FG000|Postsurgical One Week Visit (V3)|Overall Study||40
11291007|NCT02489799|12488872|FG001|Postsurgical One Week Visit (V3)|Overall Study||39
11291008|NCT02489799|12488871|FG000|COMPLETED|Overall Study||36
11291009|NCT02489799|12488872|FG001|COMPLETED|Overall Study||38
11291010|NCT02489799|12488871|FG000|NOT COMPLETED|Overall Study||9
11291011|NCT02489799|12488872|FG001|NOT COMPLETED|Overall Study||9
11291012|NCT02489968|12488880|FG000|STARTED|Open-label Treatment Period||439
11291013|NCT02489968|12488881|FG001|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
11291014|NCT02489968|12488882|FG002|STARTED|Open-label Treatment Period||0
11291015|NCT02489968|12488883|FG003|STARTED|Open-label Treatment Period||0
11291016|NCT02489968|12488884|FG004|STARTED|Open-label Treatment Period||0
11291017|NCT02489968|12488885|FG005|STARTED|Open-label Treatment Period||0
11291018|NCT02489968|12488880|FG000|COMPLETED|Open-label Treatment Period||215
11291019|NCT02489968|12488881|FG001|COMPLETED|Open-label Treatment Period||232
11291020|NCT02489968|12488882|FG002|COMPLETED|Open-label Treatment Period||0
11291021|NCT02489968|12488883|FG003|COMPLETED|Open-label Treatment Period||0
11291022|NCT02489968|12488884|FG004|COMPLETED|Open-label Treatment Period||0
11291023|NCT02489968|12488885|FG005|COMPLETED|Open-label Treatment Period||0
11291024|NCT02489968|12488880|FG000|NOT COMPLETED|Open-label Treatment Period||224
11291025|NCT02489968|12488881|FG001|NOT COMPLETED|Open-label Treatment Period||208
11399879|NCT04292899|12594581|FG003|STARTED|Overall Study||3597
11399880|NCT04292899|12594578|FG000|COMPLETED|Overall Study||168
11399881|NCT04292899|12594579|FG001|COMPLETED|Overall Study||164
11399882|NCT04292899|12594580|FG002|COMPLETED|Overall Study||621
11399883|NCT04292899|12594581|FG003|COMPLETED|Overall Study||2952
11399884|NCT04292899|12594578|FG000|NOT COMPLETED|Overall Study||32
11399885|NCT04292899|12594579|FG001|NOT COMPLETED|Overall Study||33
11399886|NCT04292899|12594580|FG002|NOT COMPLETED|Overall Study||223
11399887|NCT04292899|12594581|FG003|NOT COMPLETED|Overall Study||645
11399888|NCT04292730|12594593|FG000|STARTED|Overall Study||199
11291026|NCT02489968|12488882|FG002|NOT COMPLETED|Open-label Treatment Period||0
11291027|NCT02489968|12488883|FG003|NOT COMPLETED|Open-label Treatment Period||0
11291028|NCT02489968|12488884|FG004|NOT COMPLETED|Open-label Treatment Period||0
11291029|NCT02489968|12488885|FG005|NOT COMPLETED|Open-label Treatment Period||0
11291030|NCT02489968|12488880|FG000|STARTED|Double-blind Treatment Period||0
11291031|NCT02489968|12488881|FG001|STARTED|Double-blind Treatment Period||0
11291032|NCT02489968|12488882|FG002|STARTED|Double-blind Treatment Period||107
11291033|NCT02489968|12488883|FG003|STARTED|Double-blind Treatment Period||108
11291034|NCT02489968|12488884|FG004|STARTED|Double-blind Treatment Period||116
11399889|NCT04292730|12594594|FG001|STARTED|Overall Study||197
11399890|NCT04292730|12594595|FG002|STARTED|Overall Study||200
11399891|NCT04292730|12594596|FG003|STARTED|Overall Study||517
11399892|NCT04292730|12594593|FG000|COMPLETED|Overall Study||179
11399893|NCT04292730|12594594|FG001|COMPLETED|Overall Study||176
11291035|NCT02489968|12488885|FG005|STARTED|Double-blind Treatment Period||116
11291036|NCT02489968|12488880|FG000|COMPLETED|Double-blind Treatment Period||0
11291037|NCT02489968|12488881|FG001|COMPLETED|Double-blind Treatment Period||0
11291038|NCT02489968|12488882|FG002|COMPLETED|Double-blind Treatment Period||105
11291039|NCT02489968|12488883|FG003|COMPLETED|Double-blind Treatment Period||100
11291040|NCT02489968|12488884|FG004|COMPLETED|Double-blind Treatment Period||110
11291041|NCT02489968|12488885|FG005|COMPLETED|Double-blind Treatment Period||108
11291042|NCT02489968|12488880|FG000|NOT COMPLETED|Double-blind Treatment Period||0
11291043|NCT02489968|12488881|FG001|NOT COMPLETED|Double-blind Treatment Period||0
11291044|NCT02489968|12488882|FG002|NOT COMPLETED|Double-blind Treatment Period||2
11291045|NCT02489968|12488883|FG003|NOT COMPLETED|Double-blind Treatment Period||8
11291046|NCT02489968|12488884|FG004|NOT COMPLETED|Double-blind Treatment Period||6
11291047|NCT02489968|12488885|FG005|NOT COMPLETED|Double-blind Treatment Period||8
11291048|NCT02489981|12488897|FG000|STARTED|Overall Study||340
11291049|NCT02489981|12488897|FG000|COMPLETED|Overall Study||213
11291050|NCT02489981|12488897|FG000|NOT COMPLETED|Overall Study||127
11291051|NCT02490293|12488903|FG000|STARTED|Overall Study||96
11291052|NCT02490293|12488904|FG001|STARTED|Overall Study||102
11291053|NCT02490293|12488903|FG000|COMPLETED|Overall Study||94
11291054|NCT02490293|12488904|FG001|COMPLETED|Overall Study||99
11291055|NCT02490293|12488903|FG000|NOT COMPLETED|Overall Study||2
11291056|NCT02490293|12488904|FG001|NOT COMPLETED|Overall Study||3
11291057|NCT02490371|12488912|FG000|STARTED|Overall Study||12
11291058|NCT02490371|12488913|FG001|STARTED|Overall Study||12
11291059|NCT02490371|12488912|FG000|COMPLETED|Overall Study||11
11399894|NCT04292730|12594595|FG002|COMPLETED|Overall Study||178
11399895|NCT04292730|12594596|FG003|COMPLETED|Overall Study||437
11399896|NCT04292730|12594593|FG000|NOT COMPLETED|Overall Study||20
11399897|NCT04292730|12594594|FG001|NOT COMPLETED|Overall Study||21
11399898|NCT04292730|12594595|FG002|NOT COMPLETED|Overall Study||22
11399899|NCT04292730|12594596|FG003|NOT COMPLETED|Overall Study||80
11399900|NCT04290676|12594605|FG000|STARTED|Overall Study||527
11399901|NCT04290676|12594605|FG000|COMPLETED|Overall Study||527
11291060|NCT02490371|12488913|FG001|COMPLETED|Overall Study||11
11291061|NCT02490371|12488912|FG000|NOT COMPLETED|Overall Study||1
11291062|NCT02490371|12488913|FG001|NOT COMPLETED|Overall Study||1
11291063|NCT02490475|12488923|FG000|STARTED|Period 1: First 6 Cycles||6
11291064|NCT02490475|12488924|FG001|STARTED|Period 1: First 6 Cycles||2
11399902|NCT04290676|12594605|FG000|NOT COMPLETED|Overall Study||0
11399903|NCT04290039|12594612|FG000|STARTED|Period 1 (Visit 1; Day 1)||5
11399904|NCT04290039|12594613|FG001|STARTED|Period 1 (Visit 1; Day 1)||5
11291065|NCT02490475|12488925|FG002|STARTED|Period 1: First 6 Cycles||6
11291066|NCT02490475|12488926|FG003|STARTED|Period 1: First 6 Cycles||5
11291067|NCT02490475|12488923|FG000|COMPLETED|Period 1: First 6 Cycles||0
11291068|NCT02490475|12488924|FG001|COMPLETED|Period 1: First 6 Cycles||0
11291069|NCT02490475|12488925|FG002|COMPLETED|Period 1: First 6 Cycles||0
11291070|NCT02490475|12488926|FG003|COMPLETED|Period 1: First 6 Cycles||0
11291071|NCT02490475|12488923|FG000|NOT COMPLETED|Period 1: First 6 Cycles||6
11291072|NCT02490475|12488924|FG001|NOT COMPLETED|Period 1: First 6 Cycles||2
11291073|NCT02490475|12488925|FG002|NOT COMPLETED|Period 1: First 6 Cycles||6
11399905|NCT04290039|12594614|FG002|STARTED|Period 1 (Visit 1; Day 1)||5
11399906|NCT04290039|12594612|FG000|COMPLETED|Period 1 (Visit 1; Day 1)||5
11399907|NCT04290039|12594613|FG001|COMPLETED|Period 1 (Visit 1; Day 1)||5
11399908|NCT04290039|12594614|FG002|COMPLETED|Period 1 (Visit 1; Day 1)||5
11399909|NCT04290039|12594612|FG000|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
11399910|NCT04290039|12594613|FG001|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
11399911|NCT04290039|12594614|FG002|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
11399912|NCT04290039|12594612|FG000|STARTED|Period 2 (Visit 2; Day 8)||5
11399913|NCT04290039|12594613|FG001|STARTED|Period 2 (Visit 2; Day 8)||5
11399914|NCT04290039|12594614|FG002|STARTED|Period 2 (Visit 2; Day 8)||5
11399915|NCT04290039|12594612|FG000|COMPLETED|Period 2 (Visit 2; Day 8)||5
11399916|NCT04290039|12594613|FG001|COMPLETED|Period 2 (Visit 2; Day 8)||5
11399917|NCT04290039|12594614|FG002|COMPLETED|Period 2 (Visit 2; Day 8)||5
11399918|NCT04290039|12594612|FG000|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
11399919|NCT04290039|12594613|FG001|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
11399920|NCT04290039|12594614|FG002|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
11291074|NCT02490475|12488926|FG003|NOT COMPLETED|Period 1: First 6 Cycles||5
11291075|NCT02490475|12488923|FG000|STARTED|Period 2: Extension Phase||1
11291076|NCT02490475|12488924|FG001|STARTED|Period 2: Extension Phase||0
11291077|NCT02490475|12488925|FG002|STARTED|Period 2: Extension Phase||3
11291078|NCT02490475|12488926|FG003|STARTED|Period 2: Extension Phase||1
11291079|NCT02490475|12488923|FG000|COMPLETED|Period 2: Extension Phase||0
11291080|NCT02490475|12488924|FG001|COMPLETED|Period 2: Extension Phase||0
11291081|NCT02490475|12488925|FG002|COMPLETED|Period 2: Extension Phase||0
11291082|NCT02490475|12488926|FG003|COMPLETED|Period 2: Extension Phase||0
11291083|NCT02490475|12488923|FG000|NOT COMPLETED|Period 2: Extension Phase||1
11291084|NCT02490475|12488924|FG001|NOT COMPLETED|Period 2: Extension Phase||0
11291085|NCT02490475|12488925|FG002|NOT COMPLETED|Period 2: Extension Phase||3
11291086|NCT02490475|12488926|FG003|NOT COMPLETED|Period 2: Extension Phase||1
11291087|NCT02490631|12488949|FG000|STARTED|Overall Study||79
11291088|NCT02490631|12488950|FG001|STARTED|Overall Study||78
11291089|NCT02490631|12488949|FG000|COMPLETED|Overall Study||76
11291090|NCT02490631|12488950|FG001|COMPLETED|Overall Study||75
11291091|NCT02490631|12488949|FG000|NOT COMPLETED|Overall Study||3
11291092|NCT02490631|12488950|FG001|NOT COMPLETED|Overall Study||3
11291093|NCT02490670|12488958|FG000|STARTED|Period 1 (19 Days)||14
11291094|NCT02490670|12488959|FG001|STARTED|Period 1 (19 Days)||14
11291095|NCT02490670|12488958|FG000|COMPLETED|Period 1 (19 Days)||14
11291096|NCT02490670|12488959|FG001|COMPLETED|Period 1 (19 Days)||14
11291097|NCT02490670|12488958|FG000|NOT COMPLETED|Period 1 (19 Days)||0
11291098|NCT02490670|12488959|FG001|NOT COMPLETED|Period 1 (19 Days)||0
11291099|NCT02490670|12488958|FG000|STARTED|Washout Period (7 Days)||14
11291100|NCT02490670|12488959|FG001|STARTED|Washout Period (7 Days)||14
11291101|NCT02490670|12488958|FG000|COMPLETED|Washout Period (7 Days)||14
11291102|NCT02490670|12488959|FG001|COMPLETED|Washout Period (7 Days)||14
11291103|NCT02490670|12488958|FG000|NOT COMPLETED|Washout Period (7 Days)||0
11291104|NCT02490670|12488959|FG001|NOT COMPLETED|Washout Period (7 Days)||0
11291105|NCT02490670|12488958|FG000|STARTED|Period 2 (19 Days)||14
11291106|NCT02490670|12488959|FG001|STARTED|Period 2 (19 Days)||14
11291107|NCT02490670|12488958|FG000|COMPLETED|Period 2 (19 Days)||14
11291108|NCT02490670|12488959|FG001|COMPLETED|Period 2 (19 Days)||14
11291109|NCT02490670|12488958|FG000|NOT COMPLETED|Period 2 (19 Days)||0
11291110|NCT02490670|12488959|FG001|NOT COMPLETED|Period 2 (19 Days)||0
11291111|NCT02490878|12488967|FG000|STARTED|Overall Study||10
11291112|NCT02490878|12488968|FG001|STARTED|Overall Study||9
11291113|NCT02490878|12488967|FG000|Eligible Participants|Overall Study||10
11291114|NCT02490878|12488968|FG001|Eligible Participants|Overall Study||8
11291115|NCT02490878|12488967|FG000|COMPLETED|Overall Study||10
11291116|NCT02490878|12488968|FG001|COMPLETED|Overall Study||6
11291117|NCT02490878|12488967|FG000|NOT COMPLETED|Overall Study||0
11291118|NCT02490878|12488968|FG001|NOT COMPLETED|Overall Study||3
11291119|NCT02491073|12488976|FG000|STARTED|Overall Study||37
11291120|NCT02491073|12488977|FG001|STARTED|Overall Study||34
11291121|NCT02491073|12488976|FG000|COMPLETED|Overall Study||36
11291122|NCT02491073|12488977|FG001|COMPLETED|Overall Study||34
11291123|NCT02491073|12488976|FG000|NOT COMPLETED|Overall Study||1
11291124|NCT02491073|12488977|FG001|NOT COMPLETED|Overall Study||0
11291125|NCT02491359|12488999|FG000|STARTED|Overall Study||20
11291126|NCT02491359|12488999|FG000|COMPLETED|Overall Study||4
11291127|NCT02491359|12488999|FG000|NOT COMPLETED|Overall Study||16
11291128|NCT02491437|12489007|FG000|STARTED|Overall Study||520
11291129|NCT02491437|12489008|FG001|STARTED|Overall Study||514
11291130|NCT02491437|12489007|FG000|Safety Sample|Overall Study||518
11291131|NCT02491437|12489008|FG001|Safety Sample|Overall Study||512
11291132|NCT02491437|12489007|FG000|Full Analysis Sample|Overall Study||494
11291133|NCT02491437|12489008|FG001|Full Analysis Sample|Overall Study||489
11291134|NCT02491437|12489007|FG000|COMPLETED|Overall Study||168
11291135|NCT02491437|12489008|FG001|COMPLETED|Overall Study||157
11291136|NCT02491437|12489007|FG000|NOT COMPLETED|Overall Study||352
11291137|NCT02491437|12489008|FG001|NOT COMPLETED|Overall Study||357
11291138|NCT02491463|12489020|FG000|STARTED|Overall Study||7
11291139|NCT02491463|12489021|FG001|STARTED|Overall Study||31
11291140|NCT02491463|12489022|FG002|STARTED|Overall Study||19
11291141|NCT02491463|12489023|FG003|STARTED|Overall Study||15
11291142|NCT02491463|12489020|FG000|COMPLETED|Overall Study||5
11291143|NCT02491463|12489021|FG001|COMPLETED|Overall Study||21
11399921|NCT04290039|12594612|FG000|STARTED|Period 3 (Visit 3; Day 15)||5
11399922|NCT04290039|12594613|FG001|STARTED|Period 3 (Visit 3; Day 15)||4
11291144|NCT02491463|12489022|FG002|COMPLETED|Overall Study||15
11291145|NCT02491463|12489023|FG003|COMPLETED|Overall Study||14
11291146|NCT02491463|12489020|FG000|NOT COMPLETED|Overall Study||2
11291147|NCT02491463|12489021|FG001|NOT COMPLETED|Overall Study||10
11291148|NCT02491463|12489022|FG002|NOT COMPLETED|Overall Study||4
11291149|NCT02491463|12489023|FG003|NOT COMPLETED|Overall Study||1
11291150|NCT02491671|12489035|FG000|STARTED|Overall Study||129
11291151|NCT02491671|12489036|FG001|STARTED|Overall Study||131
11291152|NCT02491671|12489035|FG000|COMPLETED|Overall Study||118
11291153|NCT02491671|12489036|FG001|COMPLETED|Overall Study||118
11291154|NCT02491671|12489035|FG000|NOT COMPLETED|Overall Study||11
11291155|NCT02491671|12489036|FG001|NOT COMPLETED|Overall Study||13
11291156|NCT02491684|12489044|FG000|STARTED|Pre-treatment Phase||61
11291157|NCT02491684|12489045|FG001|STARTED|Pre-treatment Phase||60
11291158|NCT02491684|12489044|FG000|COMPLETED|Pre-treatment Phase||61
11291159|NCT02491684|12489045|FG001|COMPLETED|Pre-treatment Phase||60
11291160|NCT02491684|12489044|FG000|NOT COMPLETED|Pre-treatment Phase||0
11291161|NCT02491684|12489045|FG001|NOT COMPLETED|Pre-treatment Phase||0
11291162|NCT02491684|12489044|FG000|STARTED|Treatment Phase||61
11291163|NCT02491684|12489045|FG001|STARTED|Treatment Phase||60
11291164|NCT02491684|12489044|FG000|COMPLETED|Treatment Phase||58
11291165|NCT02491684|12489045|FG001|COMPLETED|Treatment Phase||57
11291166|NCT02491684|12489044|FG000|NOT COMPLETED|Treatment Phase||3
11291167|NCT02491684|12489045|FG001|NOT COMPLETED|Treatment Phase||3
11291168|NCT02491788|12489053|FG000|STARTED|Overall Study||8
11291169|NCT02491788|12489054|FG001|STARTED|Overall Study||11
11291170|NCT02491788|12489053|FG000|COMPLETED|Overall Study||8
11291171|NCT02491788|12489054|FG001|COMPLETED|Overall Study||11
11291172|NCT02491788|12489053|FG000|NOT COMPLETED|Overall Study||0
11291173|NCT02491788|12489054|FG001|NOT COMPLETED|Overall Study||0
11291174|NCT02491892|12489062|FG000|STARTED|Overall Study||41
11291175|NCT02491892|12489063|FG001|STARTED|Overall Study||38
11291176|NCT02491892|12489062|FG000|Treated|Overall Study||41
11291177|NCT02491892|12489063|FG001|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
11291178|NCT02491892|12489062|FG000|COMPLETED|Overall Study||0
11291179|NCT02491892|12489063|FG001|COMPLETED|Overall Study||0
11291180|NCT02491892|12489062|FG000|NOT COMPLETED|Overall Study||41
11291181|NCT02491892|12489063|FG001|NOT COMPLETED|Overall Study||38
11291182|NCT02491944|12489069|FG000|STARTED|Overall Study||10
11291183|NCT02491944|12489069|FG000|COMPLETED|Overall Study||10
11291184|NCT02491944|12489069|FG000|NOT COMPLETED|Overall Study||0
11291185|NCT02492100|12489073|FG000|STARTED|Overall Study||47
11291186|NCT02492100|12489073|FG000|COMPLETED|Overall Study||46
11291187|NCT02492100|12489073|FG000|NOT COMPLETED|Overall Study||1
11291188|NCT02492451|12489081|FG000|STARTED|Overall Study||40
11291189|NCT02492451|12489082|FG001|STARTED|Overall Study||39
11291190|NCT02492451|12489083|FG002|STARTED|Overall Study||39
11291191|NCT02492451|12489081|FG000|COMPLETED|Overall Study||40
11291192|NCT02492451|12489082|FG001|COMPLETED|Overall Study||39
11291193|NCT02492451|12489083|FG002|COMPLETED|Overall Study||39
11291194|NCT02492451|12489081|FG000|NOT COMPLETED|Overall Study||0
11291195|NCT02492451|12489082|FG001|NOT COMPLETED|Overall Study||0
11291196|NCT02492451|12489083|FG002|NOT COMPLETED|Overall Study||0
11291197|NCT02492750|12489094|FG000|STARTED|Overall Study||4
11291198|NCT02492750|12489095|FG001|STARTED|Overall Study||4
11291199|NCT02492750|12489096|FG002|STARTED|Overall Study||6
11291200|NCT02492750|12489094|FG000|COMPLETED|Overall Study||4
11291201|NCT02492750|12489095|FG001|COMPLETED|Overall Study||4
11291202|NCT02492750|12489096|FG002|COMPLETED|Overall Study||6
11291203|NCT02492750|12489094|FG000|NOT COMPLETED|Overall Study||0
11291204|NCT02492750|12489095|FG001|NOT COMPLETED|Overall Study||0
11291205|NCT02492750|12489096|FG002|NOT COMPLETED|Overall Study||0
11291206|NCT02492763|12489108|FG000|STARTED|Overall Study||46
11291207|NCT02492763|12489109|FG001|STARTED|Overall Study||44
11291208|NCT02492763|12489110|FG002|STARTED|Overall Study||43
11291209|NCT02492763|12489111|FG003|STARTED|Overall Study||43
11291210|NCT02492763|12489108|FG000|Treated|Overall Study||46
11291211|NCT02492763|12489109|FG001|Treated|Overall Study||44
11291212|NCT02492763|12489110|FG002|Treated|Overall Study||43
11291213|NCT02492763|12489111|FG003|Treated|Overall Study||42
11291214|NCT02492763|12489108|FG000|COMPLETED|Overall Study||30
11291215|NCT02492763|12489109|FG001|COMPLETED|Overall Study||29
11291216|NCT02492763|12489110|FG002|COMPLETED|Overall Study||33
11291217|NCT02492763|12489111|FG003|COMPLETED|Overall Study||30
11291218|NCT02492763|12489108|FG000|NOT COMPLETED|Overall Study||16
11291219|NCT02492763|12489109|FG001|NOT COMPLETED|Overall Study||15
11291220|NCT02492763|12489110|FG002|NOT COMPLETED|Overall Study||10
11291221|NCT02492763|12489111|FG003|NOT COMPLETED|Overall Study||13
11291222|NCT02492802|12489121|FG000|STARTED|Overall Study||64
11291223|NCT02492802|12489121|FG000|COMPLETED|Overall Study||64
11291224|NCT02492802|12489121|FG000|NOT COMPLETED|Overall Study||0
11291225|NCT02492841|12489128|FG000|STARTED|Overall Study||56
11291226|NCT02492841|12489129|FG001|STARTED|Overall Study||53
11291227|NCT02492841|12489130|FG002|STARTED|Overall Study||60
11291228|NCT02492841|12489128|FG000|COMPLETED|Overall Study||22
11291229|NCT02492841|12489129|FG001|COMPLETED|Overall Study||22
11291230|NCT02492841|12489130|FG002|COMPLETED|Overall Study||25
11291231|NCT02492841|12489128|FG000|NOT COMPLETED|Overall Study||34
11291232|NCT02492841|12489129|FG001|NOT COMPLETED|Overall Study||31
11291233|NCT02492841|12489130|FG002|NOT COMPLETED|Overall Study||35
11291234|NCT02492854|12489143|FG000|STARTED|Overall Study||5
11291235|NCT02492854|12489144|FG001|STARTED|Overall Study||3
11291236|NCT02492854|12489143|FG000|COMPLETED|Overall Study||5
11291237|NCT02492854|12489144|FG001|COMPLETED|Overall Study||3
11291238|NCT02492854|12489143|FG000|NOT COMPLETED|Overall Study||0
11291239|NCT02492854|12489144|FG001|NOT COMPLETED|Overall Study||0
11291240|NCT02492880|12489150|FG000|STARTED|Overall Study||15
11291241|NCT02492880|12489150|FG000|COMPLETED|Overall Study||13
11291242|NCT02492880|12489150|FG000|NOT COMPLETED|Overall Study||2
11291243|NCT02492958|12489158|FG000|STARTED|Overall Study||34
11291244|NCT02492958|12489159|FG001|STARTED|Overall Study||34
11291245|NCT02492958|12489160|FG002|STARTED|Overall Study||34
11291246|NCT02492958|12489161|FG003|STARTED|Overall Study||34
11291247|NCT02492958|12489158|FG000|COMPLETED|Overall Study||33
11291248|NCT02492958|12489159|FG001|COMPLETED|Overall Study||34
11291249|NCT02492958|12489160|FG002|COMPLETED|Overall Study||32
11291250|NCT02492958|12489161|FG003|COMPLETED|Overall Study||34
11291251|NCT02492958|12489158|FG000|NOT COMPLETED|Overall Study||1
11291252|NCT02492958|12489159|FG001|NOT COMPLETED|Overall Study||0
11291253|NCT02492958|12489160|FG002|NOT COMPLETED|Overall Study||2
11291254|NCT02492958|12489161|FG003|NOT COMPLETED|Overall Study||0
11291255|NCT02492984|12489173|FG000|STARTED|Overall Study||73
11291256|NCT02492984|12489174|FG001|STARTED|Overall Study||14
11291257|NCT02492984|12489173|FG000|COMPLETED|Overall Study||70
11291258|NCT02492984|12489174|FG001|COMPLETED|Overall Study||14
11291259|NCT02492984|12489173|FG000|NOT COMPLETED|Overall Study||3
11291260|NCT02492984|12489174|FG001|NOT COMPLETED|Overall Study||0
11291261|NCT02492997|12489185|FG000|STARTED|Overall Study||21
11291262|NCT02492997|12489186|FG001|STARTED|Overall Study||21
11291263|NCT02492997|12489185|FG000|COMPLETED|Overall Study||19
11291264|NCT02492997|12489186|FG001|COMPLETED|Overall Study||20
11291265|NCT02492997|12489185|FG000|NOT COMPLETED|Overall Study||2
11291266|NCT02492997|12489186|FG001|NOT COMPLETED|Overall Study||1
11291267|NCT02493036|12489195|FG000|STARTED|Overall Study||17
11291268|NCT02493036|12489196|FG001|STARTED|Overall Study||20
11291269|NCT02493036|12489197|FG002|STARTED|Overall Study||17
11291270|NCT02493036|12489195|FG000|COMPLETED|Overall Study||16
11291271|NCT02493036|12489196|FG001|COMPLETED|Overall Study||18
11291272|NCT02493036|12489197|FG002|COMPLETED|Overall Study||15
11291273|NCT02493036|12489195|FG000|NOT COMPLETED|Overall Study||1
11291274|NCT02493036|12489196|FG001|NOT COMPLETED|Overall Study||2
11291275|NCT02493036|12489197|FG002|NOT COMPLETED|Overall Study||2
11291276|NCT02493062|12489205|FG000|STARTED|Overall Study||35
11291277|NCT02493062|12489205|FG000|COMPLETED|Overall Study||23
11291278|NCT02493062|12489205|FG000|NOT COMPLETED|Overall Study||12
11291279|NCT02493088|12489209|FG000|STARTED|Overall Study||11
11291280|NCT02493088|12489209|FG000|COMPLETED|Overall Study||11
11291281|NCT02493088|12489209|FG000|NOT COMPLETED|Overall Study||0
11291282|NCT02493127|12489215|FG000|STARTED|Overall Study||61
11291283|NCT02493127|12489216|FG001|STARTED|Overall Study||61
11291284|NCT02493127|12489215|FG000|COMPLETED|Overall Study||60
11291285|NCT02493127|12489216|FG001|COMPLETED|Overall Study||60
11291286|NCT02493127|12489215|FG000|NOT COMPLETED|Overall Study||1
11291287|NCT02493127|12489216|FG001|NOT COMPLETED|Overall Study||1
11291288|NCT02493257|12489226|FG000|STARTED|Overall Study||11
11291289|NCT02493257|12489227|FG001|STARTED|Overall Study||11
11291290|NCT02493257|12489226|FG000|4 Week Follow up|Overall Study||11
11291291|NCT02493257|12489227|FG001|4 Week Follow up|Overall Study||11
11291292|NCT02493257|12489226|FG000|12 Week Follow up|Overall Study||10
11291293|NCT02493257|12489227|FG001|12 Week Follow up|Overall Study||10
11291294|NCT02493257|12489226|FG000|COMPLETED|Overall Study||10
11291295|NCT02493257|12489227|FG001|COMPLETED|Overall Study||10
11291296|NCT02493257|12489226|FG000|NOT COMPLETED|Overall Study||1
11291297|NCT02493257|12489227|FG001|NOT COMPLETED|Overall Study||1
11291298|NCT02493361|12489233|FG000|STARTED|Overall Study||24
11291299|NCT02493361|12489233|FG000|Week 24 Assessment|Overall Study||21
11291300|NCT02493361|12489233|FG000|COMPLETED|Overall Study||21
11291301|NCT02493361|12489233|FG000|NOT COMPLETED|Overall Study||3
11291302|NCT02493452|12489240|FG000|STARTED|Overall Study||379
11291303|NCT02493452|12489241|FG001|STARTED|Overall Study||377
11291304|NCT02493452|12489242|FG002|STARTED|Overall Study||379
11291305|NCT02493452|12489240|FG000|COMPLETED|Overall Study||329
11291306|NCT02493452|12489241|FG001|COMPLETED|Overall Study||328
11291307|NCT02493452|12489242|FG002|COMPLETED|Overall Study||325
11291308|NCT02493452|12489240|FG000|NOT COMPLETED|Overall Study||50
11291309|NCT02493452|12489241|FG001|NOT COMPLETED|Overall Study||49
11291310|NCT02493452|12489242|FG002|NOT COMPLETED|Overall Study||54
11291311|NCT02493517|12489252|FG000|STARTED|Overall Study||64
11291312|NCT02493517|12489253|FG001|STARTED|Overall Study||64
11291313|NCT02493517|12489252|FG000|COMPLETED|Overall Study||62
11291314|NCT02493517|12489253|FG001|COMPLETED|Overall Study||57
11291315|NCT02493517|12489252|FG000|NOT COMPLETED|Overall Study||2
11291316|NCT02493517|12489253|FG001|NOT COMPLETED|Overall Study||7
11291317|NCT02493608|12489263|FG000|STARTED|Overall Study||48
11291318|NCT02493608|12489264|FG001|STARTED|Overall Study||48
11291319|NCT02493608|12489263|FG000|COMPLETED|Overall Study||48
11291320|NCT02493608|12489264|FG001|COMPLETED|Overall Study||48
11291321|NCT02493608|12489263|FG000|NOT COMPLETED|Overall Study||0
11291322|NCT02493608|12489264|FG001|NOT COMPLETED|Overall Study||0
11291323|NCT02493621|12489272|FG000|STARTED|Overall Study||58
11291324|NCT02493621|12489273|FG001|STARTED|Overall Study||58
11291325|NCT02493621|12489272|FG000|COMPLETED|Overall Study||58
11291326|NCT02493621|12489273|FG001|COMPLETED|Overall Study||58
11291327|NCT02493621|12489272|FG000|NOT COMPLETED|Overall Study||0
11291328|NCT02493621|12489273|FG001|NOT COMPLETED|Overall Study||0
11291329|NCT02493712|12489282|FG000|STARTED|Overall Study||16
11291330|NCT02493712|12489283|FG001|STARTED|Overall Study||18
11291331|NCT02493712|12489284|FG002|STARTED|Overall Study||17
11291332|NCT02493712|12489282|FG000|COMPLETED|Overall Study||14
11291333|NCT02493712|12489283|FG001|COMPLETED|Overall Study||12
11291334|NCT02493712|12489284|FG002|COMPLETED|Overall Study||11
11291335|NCT02493712|12489282|FG000|NOT COMPLETED|Overall Study||2
11291336|NCT02493712|12489283|FG001|NOT COMPLETED|Overall Study||6
11291337|NCT02493712|12489284|FG002|NOT COMPLETED|Overall Study||6
11291338|NCT02493764|12489294|FG000|STARTED|Overall Study||268
11291339|NCT02493764|12489295|FG001|STARTED|Overall Study||269
11291340|NCT02493764|12489294|FG000|COMPLETED|Overall Study||185
11291341|NCT02493764|12489295|FG001|COMPLETED|Overall Study||187
11291342|NCT02493764|12489294|FG000|NOT COMPLETED|Overall Study||83
11291343|NCT02493764|12489295|FG001|NOT COMPLETED|Overall Study||82
11291344|NCT02493777|12489303|FG000|STARTED|Overall Study||65
11291345|NCT02493777|12489304|FG001|STARTED|Overall Study||54
11291346|NCT02493777|12489303|FG000|COMPLETED|Overall Study||65
11291347|NCT02493777|12489304|FG001|COMPLETED|Overall Study||53
11291348|NCT02493777|12489303|FG000|NOT COMPLETED|Overall Study||0
11291349|NCT02493777|12489304|FG001|NOT COMPLETED|Overall Study||1
11291350|NCT02493855|12489313|FG000|STARTED|Overall Study||21
11291351|NCT02493855|12489314|FG001|STARTED|Overall Study||19
11291352|NCT02493855|12489315|FG002|STARTED|Overall Study||6
11291353|NCT02493855|12489313|FG000|COMPLETED|Overall Study||19
11291354|NCT02493855|12489314|FG001|COMPLETED|Overall Study||18
11291355|NCT02493855|12489315|FG002|COMPLETED|Overall Study||6
11291356|NCT02493855|12489313|FG000|NOT COMPLETED|Overall Study||2
11291357|NCT02493855|12489314|FG001|NOT COMPLETED|Overall Study||1
11291358|NCT02493855|12489315|FG002|NOT COMPLETED|Overall Study||0
11291359|NCT02493868|12489323|FG000|STARTED|Induction Phase: DE Participants||437
11291360|NCT02493868|12489324|FG001|STARTED|Induction Phase: DE Participants||0
11291361|NCT02493868|12489323|FG000|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273
11291362|NCT02493868|12489324|FG001|COMPLETED|Induction Phase: DE Participants||0
11291363|NCT02493868|12489323|FG000|NOT COMPLETED|Induction Phase: DE Participants||164
11291364|NCT02493868|12489324|FG001|NOT COMPLETED|Induction Phase: DE Participants||0
11291365|NCT02493868|12489323|FG000|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455
11291366|NCT02493868|12489324|FG001|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86
11291367|NCT02493868|12489323|FG000|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297
11291368|NCT02493868|12489324|FG001|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54
11291369|NCT02493868|12489323|FG000|NOT COMPLETED|Optimization Phase: DE+TE Participants||158
11291370|NCT02493868|12489324|FG001|NOT COMPLETED|Optimization Phase: DE+TE Participants||32
11291371|NCT02493868|12489323|FG000|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152
11291372|NCT02493868|12489324|FG001|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199
11291373|NCT02493868|12489323|FG000|Stable Remitters|Maintenance Phase: DE+TE Participants||90
11291374|NCT02493868|12489324|FG001|Stable Remitters|Maintenance Phase: DE+TE Participants||86
11291375|NCT02493868|12489323|FG000|Stable Responders|Maintenance Phase: DE+TE Participants||62
11291376|NCT02493868|12489324|FG001|Stable Responders|Maintenance Phase: DE+TE Participants||59
11291377|NCT02493868|12489323|FG000|COMPLETED|Maintenance Phase: DE+TE Participants||139
11291378|NCT02493868|12489324|FG001|COMPLETED|Maintenance Phase: DE+TE Participants||177
11291379|NCT02493868|12489323|FG000|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13
11291380|NCT02493868|12489324|FG001|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22
11291381|NCT02493868|12489323|FG000|STARTED|Follow-up Phase||481
11291382|NCT02493868|12489324|FG001|STARTED|Follow-up Phase||64
11291383|NCT02493868|12489323|FG000|COMPLETED|Follow-up Phase||470
11291384|NCT02493868|12489324|FG001|COMPLETED|Follow-up Phase||62
11291385|NCT02493868|12489323|FG000|NOT COMPLETED|Follow-up Phase||11
11291386|NCT02493868|12489324|FG001|NOT COMPLETED|Follow-up Phase||2
11291387|NCT02494076|12489338|FG000|STARTED|Overall Study||26
11291388|NCT02494076|12489339|FG001|STARTED|Overall Study||26
11291389|NCT02494076|12489338|FG000|COMPLETED|Overall Study||26
11291390|NCT02494076|12489339|FG001|COMPLETED|Overall Study||26
11291391|NCT02494076|12489338|FG000|NOT COMPLETED|Overall Study||0
11291392|NCT02494076|12489339|FG001|NOT COMPLETED|Overall Study||0
11291393|NCT02494102|12489347|FG000|STARTED|Overall Study||42
11291394|NCT02494102|12489348|FG001|STARTED|Overall Study||47
11291395|NCT02494102|12489347|FG000|COMPLETED|Overall Study||42
11291396|NCT02494102|12489348|FG001|COMPLETED|Overall Study||47
11291397|NCT02494102|12489347|FG000|NOT COMPLETED|Overall Study||0
11291398|NCT02494102|12489348|FG001|NOT COMPLETED|Overall Study||0
11399923|NCT04290039|12594614|FG002|STARTED|Period 3 (Visit 3; Day 15)||5
11399924|NCT04290039|12594612|FG000|COMPLETED|Period 3 (Visit 3; Day 15)||5
11291399|NCT02494180|12489356|FG000|STARTED|Overall Study||85
11291400|NCT02494180|12489357|FG001|STARTED|Overall Study||85
11399925|NCT04290039|12594613|FG001|COMPLETED|Period 3 (Visit 3; Day 15)||4
11291401|NCT02494180|12489356|FG000|COMPLETED|Overall Study||85
11291402|NCT02494180|12489357|FG001|COMPLETED|Overall Study||85
11291403|NCT02494180|12489356|FG000|NOT COMPLETED|Overall Study||0
11291404|NCT02494180|12489357|FG001|NOT COMPLETED|Overall Study||0
11399926|NCT04290039|12594614|FG002|COMPLETED|Period 3 (Visit 3; Day 15)||5
11291405|NCT02494297|12489363|FG000|STARTED|Overall Study||1597
11291406|NCT02494297|12489363|FG000|COMPLETED|Overall Study|As there was no Follow-Up in this study, participation equals completion|1597
11291407|NCT02494297|12489363|FG000|NOT COMPLETED|Overall Study||0
11291408|NCT02494323|12489367|FG000|STARTED|Overall Study||70
11291409|NCT02494323|12489367|FG000|COMPLETED|Overall Study||70
11291410|NCT02494323|12489367|FG000|NOT COMPLETED|Overall Study||0
11291411|NCT02494336|12489373|FG000|STARTED|Overall Study||24
11291412|NCT02494336|12489374|FG001|STARTED|Overall Study||24
11291413|NCT02494336|12489373|FG000|COMPLETED|Overall Study||24
11291414|NCT02494336|12489374|FG001|COMPLETED|Overall Study||24
11399927|NCT04290039|12594612|FG000|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
11399928|NCT04290039|12594613|FG001|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
11399929|NCT04290039|12594614|FG002|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
11399930|NCT04289623|12594629|FG000|STARTED|Wave 1 Emails||6782
11291415|NCT02494336|12489373|FG000|NOT COMPLETED|Overall Study||0
11291416|NCT02494336|12489374|FG001|NOT COMPLETED|Overall Study||0
11291417|NCT02494401|12489382|FG000|STARTED|Overall Study||134
11291418|NCT02494401|12489383|FG001|STARTED|Overall Study||133
11291419|NCT02494401|12489382|FG000|Week 16|Overall Study||123
11291420|NCT02494401|12489383|FG001|Week 16|Overall Study||124
11291421|NCT02494401|12489382|FG000|6 Month Follow up|Overall Study||109
11291422|NCT02494401|12489383|FG001|6 Month Follow up|Overall Study||106
11291423|NCT02494401|12489382|FG000|COMPLETED|Overall Study||109
11291424|NCT02494401|12489383|FG001|COMPLETED|Overall Study||106
11291425|NCT02494401|12489382|FG000|NOT COMPLETED|Overall Study||25
11291426|NCT02494401|12489383|FG001|NOT COMPLETED|Overall Study||27
11291427|NCT02494440|12489389|FG000|STARTED|Overall Study||90
11291428|NCT02494440|12489389|FG000|COMPLETED|Overall Study||90
11291429|NCT02494440|12489389|FG000|NOT COMPLETED|Overall Study||0
11291430|NCT02494518|12489396|FG000|STARTED|Overall Study||11
11291431|NCT02494518|12489397|FG001|STARTED|Overall Study||12
11291432|NCT02494518|12489398|FG002|STARTED|Overall Study||11
11291433|NCT02494518|12489396|FG000|COMPLETED|Overall Study||10
11291434|NCT02494518|12489397|FG001|COMPLETED|Overall Study||10
11291435|NCT02494518|12489398|FG002|COMPLETED|Overall Study||8
11291436|NCT02494518|12489396|FG000|NOT COMPLETED|Overall Study||1
11291437|NCT02494518|12489397|FG001|NOT COMPLETED|Overall Study||2
11291438|NCT02494518|12489398|FG002|NOT COMPLETED|Overall Study||3
11291439|NCT02494596|12489406|FG000|STARTED|Overall Study||5
11291440|NCT02494596|12489407|FG001|STARTED|Overall Study||7
11291441|NCT02494596|12489408|FG002|STARTED|Overall Study||7
11291442|NCT02494596|12489406|FG000|COMPLETED|Overall Study||2
11291443|NCT02494596|12489407|FG001|COMPLETED|Overall Study||2
11291444|NCT02494596|12489408|FG002|COMPLETED|Overall Study||6
11291445|NCT02494596|12489406|FG000|NOT COMPLETED|Overall Study||3
11291446|NCT02494596|12489407|FG001|NOT COMPLETED|Overall Study||5
11291447|NCT02494596|12489408|FG002|NOT COMPLETED|Overall Study||1
11291448|NCT02494713|12489419|FG000|STARTED|Overall Study||4
11291449|NCT02494713|12489419|FG000|COMPLETED|Overall Study||4
11291450|NCT02494713|12489419|FG000|NOT COMPLETED|Overall Study||0
11291451|NCT02494778|12489423|FG000|STARTED|Overall Study||248
11291452|NCT02494778|12489423|FG000|COMPLETED|Overall Study||27
11291453|NCT02494778|12489423|FG000|NOT COMPLETED|Overall Study||221
11291454|NCT02494817|12489429|FG000|STARTED|Overall Study|representing 81 couples|162
11291455|NCT02494817|12489430|FG001|STARTED|Overall Study|representing 68 couples|136
11291456|NCT02494817|12489429|FG000|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125
11291457|NCT02494817|12489430|FG001|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92
11291458|NCT02494817|12489429|FG000|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115
11291459|NCT02494817|12489430|FG001|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98
11291460|NCT02494817|12489429|FG000|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107
11291461|NCT02494817|12489430|FG001|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87
11291462|NCT02494817|12489429|FG000|NOT COMPLETED|Overall Study||55
11291463|NCT02494817|12489430|FG001|NOT COMPLETED|Overall Study||49
11291464|NCT02495025|12489438|FG000|STARTED|Overall Study||77
11291465|NCT02495025|12489439|FG001|STARTED|Overall Study||75
11291466|NCT02495025|12489438|FG000|COMPLETED|Overall Study||51
11291467|NCT02495025|12489439|FG001|COMPLETED|Overall Study||61
11291468|NCT02495025|12489438|FG000|NOT COMPLETED|Overall Study||26
11291469|NCT02495025|12489439|FG001|NOT COMPLETED|Overall Study||14
11291470|NCT02495038|12489448|FG000|STARTED|Overall Study||27
11291471|NCT02495038|12489449|FG001|STARTED|Overall Study||27
11291472|NCT02495038|12489450|FG002|STARTED|Overall Study||27
11291473|NCT02495038|12489448|FG000|COMPLETED|Overall Study||27
11291474|NCT02495038|12489449|FG001|COMPLETED|Overall Study||27
11291475|NCT02495038|12489450|FG002|COMPLETED|Overall Study||27
11291476|NCT02495038|12489448|FG000|NOT COMPLETED|Overall Study||0
11291477|NCT02495038|12489449|FG001|NOT COMPLETED|Overall Study||0
11291478|NCT02495038|12489450|FG002|NOT COMPLETED|Overall Study||0
11291479|NCT02495103|12489460|FG000|STARTED|Overall Study||3
11291480|NCT02495103|12489461|FG001|STARTED|Overall Study||4
11291481|NCT02495103|12489460|FG000|COMPLETED|Overall Study||3
11291482|NCT02495103|12489461|FG001|COMPLETED|Overall Study||4
11291483|NCT02495103|12489460|FG000|NOT COMPLETED|Overall Study||0
11291484|NCT02495103|12489461|FG001|NOT COMPLETED|Overall Study||0
11291485|NCT02495168|12489472|FG000|STARTED|Overall Study||504
11291486|NCT02495168|12489473|FG001|STARTED|Overall Study||516
11291487|NCT02495168|12489474|FG002|STARTED|Overall Study||127
11291488|NCT02495168|12489472|FG000|Safety Population|Overall Study||501
11291489|NCT02495168|12489473|FG001|Safety Population|Overall Study||514
11291490|NCT02495168|12489474|FG002|Safety Population|Overall Study||126
11291491|NCT02495168|12489472|FG000|Modified Intent-to-Treat Population|Overall Study||468
11291492|NCT02495168|12489473|FG001|Modified Intent-to-Treat Population|Overall Study||478
11291493|NCT02495168|12489474|FG002|Modified Intent-to-Treat Population|Overall Study||111
11291494|NCT02495168|12489472|FG000|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
11291495|NCT02495168|12489473|FG001|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
11291496|NCT02495168|12489474|FG002|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99
11291497|NCT02495168|12489472|FG000|Day 42 (D42PPS) Population|Overall Study||382
11291498|NCT02495168|12489473|FG001|Day 42 (D42PPS) Population|Overall Study||383
11291499|NCT02495168|12489474|FG002|Day 42 (D42PPS) Population|Overall Study||88
11291500|NCT02495168|12489472|FG000|COMPLETED|Overall Study||466
11291501|NCT02495168|12489473|FG001|COMPLETED|Overall Study||462
11291502|NCT02495168|12489474|FG002|COMPLETED|Overall Study||110
11291503|NCT02495168|12489472|FG000|NOT COMPLETED|Overall Study||38
11291504|NCT02495168|12489473|FG001|NOT COMPLETED|Overall Study||54
11291505|NCT02495168|12489474|FG002|NOT COMPLETED|Overall Study||17
11291506|NCT02495233|12489484|FG000|STARTED|Overall Study||3
11291507|NCT02495233|12489485|FG001|STARTED|Overall Study||7
11291508|NCT02495233|12489484|FG000|COMPLETED|Overall Study||3
11291509|NCT02495233|12489485|FG001|COMPLETED|Overall Study||6
11291510|NCT02495233|12489484|FG000|NOT COMPLETED|Overall Study||0
11291511|NCT02495233|12489485|FG001|NOT COMPLETED|Overall Study||1
11291512|NCT02495259|12489494|FG000|STARTED|Overall Study||7
11291513|NCT02495259|12489495|FG001|STARTED|Overall Study||4
11291514|NCT02495259|12489496|FG002|STARTED|Overall Study||8
11291515|NCT02495259|12489494|FG000|COMPLETED|Overall Study||7
11291516|NCT02495259|12489495|FG001|COMPLETED|Overall Study||3
11291517|NCT02495259|12489496|FG002|COMPLETED|Overall Study||8
11291518|NCT02495259|12489494|FG000|NOT COMPLETED|Overall Study||0
11291519|NCT02495259|12489495|FG001|NOT COMPLETED|Overall Study||1
11291520|NCT02495259|12489496|FG002|NOT COMPLETED|Overall Study||0
11291521|NCT02495389|12489504|FG000|STARTED|Overall Study||84
11291522|NCT02495389|12489504|FG000|COMPLETED|Overall Study||44
11291523|NCT02495389|12489504|FG000|NOT COMPLETED|Overall Study||40
11291524|NCT02495454|12489508|FG000|STARTED|Overall Study||34
11399931|NCT04289623|12594630|FG001|STARTED|Wave 1 Emails||6764
11291525|NCT02495454|12489508|FG000|COMPLETED|Overall Study|One case excluded for violation of inclusion criteria (transformed lymphoma)|33
11291526|NCT02495454|12489508|FG000|NOT COMPLETED|Overall Study||1
11291527|NCT02495467|12489515|FG000|STARTED|First Intervention (4 Weeks)||114
11291528|NCT02495467|12489516|FG001|STARTED|First Intervention (4 Weeks)||118
11291529|NCT02495467|12489515|FG000|COMPLETED|First Intervention (4 Weeks)||114
11291530|NCT02495467|12489516|FG001|COMPLETED|First Intervention (4 Weeks)|One subject completed visits in treatment Period 1 but never used treatment|118
11291531|NCT02495467|12489515|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
11291532|NCT02495467|12489516|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
11291533|NCT02495467|12489515|FG000|STARTED|Washout (1 Week)||114
11291534|NCT02495467|12489516|FG001|STARTED|Washout (1 Week)||118
11291535|NCT02495467|12489515|FG000|COMPLETED|Washout (1 Week)||112
11291536|NCT02495467|12489516|FG001|COMPLETED|Washout (1 Week)||116
11291537|NCT02495467|12489515|FG000|NOT COMPLETED|Washout (1 Week)||2
11291538|NCT02495467|12489516|FG001|NOT COMPLETED|Washout (1 Week)||2
11291539|NCT02495467|12489515|FG000|STARTED|Second Intervention (4 Weeks)||112
11291540|NCT02495467|12489516|FG001|STARTED|Second Intervention (4 Weeks)||116
11291541|NCT02495467|12489515|FG000|COMPLETED|Second Intervention (4 Weeks)||112
11291542|NCT02495467|12489516|FG001|COMPLETED|Second Intervention (4 Weeks)||113
11291543|NCT02495467|12489515|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
11291544|NCT02495467|12489516|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3
11291545|NCT02495623|12489525|FG000|STARTED|Overall Study||25
11291546|NCT02495623|12489526|FG001|STARTED|Overall Study||26
11291547|NCT02495623|12489527|FG002|STARTED|Overall Study||28
11291548|NCT02495623|12489525|FG000|Dosed|Overall Study||22
11291549|NCT02495623|12489526|FG001|Dosed|Overall Study||19
11291550|NCT02495623|12489527|FG002|Dosed|Overall Study||22
11291551|NCT02495623|12489525|FG000|COMPLETED|Overall Study||20
11291552|NCT02495623|12489526|FG001|COMPLETED|Overall Study||17
11291553|NCT02495623|12489527|FG002|COMPLETED|Overall Study||20
11291554|NCT02495623|12489525|FG000|NOT COMPLETED|Overall Study||5
11291555|NCT02495623|12489526|FG001|NOT COMPLETED|Overall Study||9
11291556|NCT02495623|12489527|FG002|NOT COMPLETED|Overall Study||8
11291557|NCT02495779|12489535|FG000|STARTED|Overall Study||54
11291558|NCT02495779|12489535|FG000|COMPLETED|Overall Study||48
11291559|NCT02495779|12489535|FG000|NOT COMPLETED|Overall Study||6
11291560|NCT02495831|12489539|FG000|STARTED|First Intervention||13
11399932|NCT04289623|12594631|FG002|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (rank-and-file) email in Wave 2.|0
11291561|NCT02495831|12489540|FG001|STARTED|First Intervention||10
11291562|NCT02495831|12489539|FG000|COMPLETED|First Intervention||13
11291563|NCT02495831|12489540|FG001|COMPLETED|First Intervention||10
11291564|NCT02495831|12489539|FG000|NOT COMPLETED|First Intervention||0
11291565|NCT02495831|12489540|FG001|NOT COMPLETED|First Intervention||0
11291566|NCT02495831|12489539|FG000|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
11291567|NCT02495831|12489540|FG001|STARTED|Second Intervention||10
11291568|NCT02495831|12489539|FG000|COMPLETED|Second Intervention||12
11291569|NCT02495831|12489540|FG001|COMPLETED|Second Intervention||10
11291570|NCT02495831|12489539|FG000|NOT COMPLETED|Second Intervention||0
11291571|NCT02495831|12489540|FG001|NOT COMPLETED|Second Intervention||0
11291572|NCT02495844|12489548|FG000|STARTED|Overall Study||27
11291573|NCT02495844|12489549|FG001|STARTED|Overall Study||28
11291574|NCT02495844|12489548|FG000|COMPLETED|Overall Study||26
11291575|NCT02495844|12489549|FG001|COMPLETED|Overall Study||24
11291576|NCT02495844|12489548|FG000|NOT COMPLETED|Overall Study||1
11291577|NCT02495844|12489549|FG001|NOT COMPLETED|Overall Study||4
11291578|NCT02495857|12489560|FG000|STARTED|Overall Study||200
11291579|NCT02495857|12489561|FG001|STARTED|Overall Study||200
11291580|NCT02495857|12489562|FG002|STARTED|Overall Study||199
11291581|NCT02495857|12489560|FG000|COMPLETED|Overall Study||178
11291582|NCT02495857|12489561|FG001|COMPLETED|Overall Study||184
11291583|NCT02495857|12489562|FG002|COMPLETED|Overall Study||181
11291584|NCT02495857|12489560|FG000|NOT COMPLETED|Overall Study||22
11291585|NCT02495857|12489561|FG001|NOT COMPLETED|Overall Study||16
11291586|NCT02495857|12489562|FG002|NOT COMPLETED|Overall Study||18
11291587|NCT02495883|12489572|FG000|STARTED|Overall Study||32
11291588|NCT02495883|12489573|FG001|STARTED|Overall Study||24
11291589|NCT02495883|12489572|FG000|COMPLETED|Overall Study||31
11291590|NCT02495883|12489573|FG001|COMPLETED|Overall Study||24
11291591|NCT02495883|12489572|FG000|NOT COMPLETED|Overall Study||1
11291592|NCT02495883|12489573|FG001|NOT COMPLETED|Overall Study||0
11291593|NCT02495948|12489578|FG000|STARTED|Period 1, First 30 Days of Wear||83
11291594|NCT02495948|12489579|FG001|STARTED|Period 1, First 30 Days of Wear||84
11291595|NCT02495948|12489578|FG000|COMPLETED|Period 1, First 30 Days of Wear||83
11291596|NCT02495948|12489579|FG001|COMPLETED|Period 1, First 30 Days of Wear||83
11291597|NCT02495948|12489578|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
11291598|NCT02495948|12489579|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1
11291599|NCT02495948|12489578|FG000|STARTED|Period 2, Second 30 Days of Wear||83
11291600|NCT02495948|12489579|FG001|STARTED|Period 2, Second 30 Days of Wear||83
11291601|NCT02495948|12489578|FG000|COMPLETED|Period 2, Second 30 Days of Wear||82
11291602|NCT02495948|12489579|FG001|COMPLETED|Period 2, Second 30 Days of Wear||82
11291603|NCT02495948|12489578|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
11291604|NCT02495948|12489579|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
11291605|NCT02496000|12489589|FG000|STARTED|Overall Study||64
11291606|NCT02496000|12489590|FG001|STARTED|Overall Study||61
11291607|NCT02496000|12489591|FG002|STARTED|Overall Study||63
11291608|NCT02496000|12489589|FG000|COMPLETED|Overall Study||62
11291609|NCT02496000|12489590|FG001|COMPLETED|Overall Study||56
11291610|NCT02496000|12489591|FG002|COMPLETED|Overall Study||61
11291611|NCT02496000|12489589|FG000|NOT COMPLETED|Overall Study||2
11291612|NCT02496000|12489590|FG001|NOT COMPLETED|Overall Study||5
11291613|NCT02496000|12489591|FG002|NOT COMPLETED|Overall Study||2
11341157|NCT02928952|12538453|FG001|COMPLETED|Overall Study||60
11341158|NCT02928952|12538452|FG000|NOT COMPLETED|Overall Study||10
11341159|NCT02928952|12538453|FG001|NOT COMPLETED|Overall Study||7
11341160|NCT02929329|12538461|FG000|STARTED|Overall Study||4112
11341161|NCT02929329|12538462|FG001|STARTED|Overall Study||4120
11341162|NCT02929329|12538461|FG000|Received Treatment|Overall Study||4101
11341163|NCT02929329|12538462|FG001|Received Treatment|Overall Study||4110
11341164|NCT02929329|12538461|FG000|COMPLETED|Overall Study|7 participants in this group who discontinued the study had unknown vital status at the end of study|3008
11341165|NCT02929329|12538462|FG001|COMPLETED|Overall Study|9 participants in this group who discontinued the study had unknown vital status at the end of study|3028
11341166|NCT02929329|12538461|FG000|NOT COMPLETED|Overall Study||1104
11341167|NCT02929329|12538462|FG001|NOT COMPLETED|Overall Study||1092
11341168|NCT02929407|12538472|FG000|STARTED|Overall Study||4
11341169|NCT02929407|12538472|FG000|COMPLETED|Overall Study||3
11341170|NCT02929407|12538472|FG000|NOT COMPLETED|Overall Study||1
11341171|NCT02929498|12538479|FG000|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5
11341172|NCT02929498|12538480|FG001|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
11341173|NCT02929498|12538481|FG002|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
11341174|NCT02929498|12538479|FG000|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
11341175|NCT02929498|12538480|FG001|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
11341176|NCT02929498|12538481|FG002|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
11341177|NCT02929498|12538479|FG000|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5
11341178|NCT02929498|12538480|FG001|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
11341179|NCT02929498|12538481|FG002|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
11341180|NCT02929498|12538479|FG000|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
11341181|NCT02929498|12538480|FG001|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
11341182|NCT02929498|12538481|FG002|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
11341183|NCT02929498|12538479|FG000|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
11341184|NCT02929498|12538480|FG001|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
11341185|NCT02929498|12538481|FG002|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
11341186|NCT02929498|12538479|FG000|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
11341187|NCT02929498|12538480|FG001|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
11341188|NCT02929498|12538481|FG002|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
11341189|NCT02929667|12538489|FG000|STARTED|Overall Study||11
11341190|NCT02929667|12538490|FG001|STARTED|Overall Study||11
11341191|NCT02929667|12538489|FG000|COMPLETED|Overall Study||11
11341192|NCT02929667|12538490|FG001|COMPLETED|Overall Study||11
11341193|NCT02929667|12538489|FG000|NOT COMPLETED|Overall Study||0
11341194|NCT02929667|12538490|FG001|NOT COMPLETED|Overall Study||0
11341195|NCT02929823|12538501|FG000|STARTED|Overall Study||42
11291614|NCT02496091|12489600|FG000|STARTED|Overall Study||144
11291615|NCT02496091|12489600|FG000|COMPLETED|Overall Study||142
11291616|NCT02496091|12489600|FG000|NOT COMPLETED|Overall Study||2
11291617|NCT02496221|12489605|FG000|STARTED|Treatment Period 1 - 4 Days||10
11291618|NCT02496221|12489606|FG001|STARTED|Treatment Period 1 - 4 Days||10
11291619|NCT02496221|12489605|FG000|COMPLETED|Treatment Period 1 - 4 Days||10
11291620|NCT02496221|12489606|FG001|COMPLETED|Treatment Period 1 - 4 Days||10
11291621|NCT02496221|12489605|FG000|NOT COMPLETED|Treatment Period 1 - 4 Days||0
11291622|NCT02496221|12489606|FG001|NOT COMPLETED|Treatment Period 1 - 4 Days||0
11291623|NCT02496221|12489605|FG000|STARTED|Treatment Period 2 - 4 Days||10
11291624|NCT02496221|12489606|FG001|STARTED|Treatment Period 2 - 4 Days||10
11291625|NCT02496221|12489605|FG000|COMPLETED|Treatment Period 2 - 4 Days||8
11291626|NCT02496221|12489606|FG001|COMPLETED|Treatment Period 2 - 4 Days||9
11291627|NCT02496221|12489605|FG000|NOT COMPLETED|Treatment Period 2 - 4 Days||2
11291628|NCT02496221|12489606|FG001|NOT COMPLETED|Treatment Period 2 - 4 Days||1
11291629|NCT02496533|12489616|FG000|STARTED|Overall Study||105
11291630|NCT02496533|12489617|FG001|STARTED|Overall Study||112
11291631|NCT02496533|12489616|FG000|COMPLETED|Overall Study||102
11291632|NCT02496533|12489617|FG001|COMPLETED|Overall Study||106
11291633|NCT02496533|12489616|FG000|NOT COMPLETED|Overall Study||3
11291634|NCT02496533|12489617|FG001|NOT COMPLETED|Overall Study||6
11291635|NCT02496702|12489625|FG000|STARTED|Overall Study||30
11291636|NCT02496702|12489626|FG001|STARTED|Overall Study||30
11291637|NCT02496702|12489625|FG000|Received Allocated Intervention|Overall Study||21
11291638|NCT02496702|12489626|FG001|Received Allocated Intervention|Overall Study||0
11291639|NCT02496702|12489625|FG000|Did Not Receive Allocated Intervention|Overall Study||9
11291640|NCT02496702|12489626|FG001|Did Not Receive Allocated Intervention|Overall Study||0
11291641|NCT02496702|12489625|FG000|COMPLETED|Overall Study||22
11291642|NCT02496702|12489626|FG001|COMPLETED|Overall Study||22
11291643|NCT02496702|12489625|FG000|NOT COMPLETED|Overall Study||8
11291644|NCT02496702|12489626|FG001|NOT COMPLETED|Overall Study||8
11291645|NCT02496767|12489636|FG000|STARTED|Open-label Lead-in Phase||744
11291646|NCT02496767|12489637|FG001|STARTED|Open-label Lead-in Phase||0
11291647|NCT02496767|12489638|FG002|STARTED|Open-label Lead-in Phase||0
11291648|NCT02496767|12489639|FG003|STARTED|Open-label Lead-in Phase||0
11291649|NCT02496767|12489640|FG004|STARTED|Open-label Lead-in Phase||0
11291650|NCT02496767|12489641|FG005|STARTED|Open-label Lead-in Phase||0
11291651|NCT02496767|12489642|FG006|STARTED|Open-label Lead-in Phase||0
11291652|NCT02496767|12489643|FG007|STARTED|Open-label Lead-in Phase||0
11291653|NCT02496767|12489636|FG000|COMPLETED|Open-label Lead-in Phase||565
11291654|NCT02496767|12489637|FG001|COMPLETED|Open-label Lead-in Phase||0
11291655|NCT02496767|12489638|FG002|COMPLETED|Open-label Lead-in Phase||0
11291656|NCT02496767|12489639|FG003|COMPLETED|Open-label Lead-in Phase||0
11291657|NCT02496767|12489640|FG004|COMPLETED|Open-label Lead-in Phase||0
11291658|NCT02496767|12489641|FG005|COMPLETED|Open-label Lead-in Phase||0
11291659|NCT02496767|12489642|FG006|COMPLETED|Open-label Lead-in Phase||0
11291660|NCT02496767|12489643|FG007|COMPLETED|Open-label Lead-in Phase||0
11291661|NCT02496767|12489636|FG000|NOT COMPLETED|Open-label Lead-in Phase||179
11291662|NCT02496767|12489637|FG001|NOT COMPLETED|Open-label Lead-in Phase||0
11291663|NCT02496767|12489638|FG002|NOT COMPLETED|Open-label Lead-in Phase||0
11291664|NCT02496767|12489639|FG003|NOT COMPLETED|Open-label Lead-in Phase||0
11291665|NCT02496767|12489640|FG004|NOT COMPLETED|Open-label Lead-in Phase||0
11291666|NCT02496767|12489641|FG005|NOT COMPLETED|Open-label Lead-in Phase||0
11291667|NCT02496767|12489642|FG006|NOT COMPLETED|Open-label Lead-in Phase||0
11291668|NCT02496767|12489643|FG007|NOT COMPLETED|Open-label Lead-in Phase||0
11291669|NCT02496767|12489636|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
11291670|NCT02496767|12489637|FG001|STARTED|Double-blind, Placebo-controlled Phase||188
11291671|NCT02496767|12489638|FG002|STARTED|Double-blind, Placebo-controlled Phase||126
11291672|NCT02496767|12489639|FG003|STARTED|Double-blind, Placebo-controlled Phase||126
11291673|NCT02496767|12489640|FG004|STARTED|Double-blind, Placebo-controlled Phase||125
11291674|NCT02496767|12489641|FG005|STARTED|Double-blind, Placebo-controlled Phase||0
11291675|NCT02496767|12489642|FG006|STARTED|Double-blind, Placebo-controlled Phase||0
11291676|NCT02496767|12489643|FG007|STARTED|Double-blind, Placebo-controlled Phase||0
11291677|NCT02496767|12489636|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
11291678|NCT02496767|12489637|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||132
11291679|NCT02496767|12489638|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||80
11291680|NCT02496767|12489639|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||65
11291681|NCT02496767|12489640|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||59
11291682|NCT02496767|12489641|FG005|COMPLETED|Double-blind, Placebo-controlled Phase||0
11291683|NCT02496767|12489642|FG006|COMPLETED|Double-blind, Placebo-controlled Phase||0
11291684|NCT02496767|12489643|FG007|COMPLETED|Double-blind, Placebo-controlled Phase||0
11291685|NCT02496767|12489636|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
11291686|NCT02496767|12489637|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||56
11291687|NCT02496767|12489638|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||46
11291688|NCT02496767|12489639|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||61
11291689|NCT02496767|12489640|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||66
11291690|NCT02496767|12489641|FG005|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
11291691|NCT02496767|12489642|FG006|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
11291692|NCT02496767|12489643|FG007|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
11291693|NCT02496767|12489636|FG000|STARTED|Double-blind, Withdrawal Phase||0
11291694|NCT02496767|12489637|FG001|STARTED|Double-blind, Withdrawal Phase||0
11291695|NCT02496767|12489638|FG002|STARTED|Double-blind, Withdrawal Phase||0
11291696|NCT02496767|12489639|FG003|STARTED|Double-blind, Withdrawal Phase||0
11291697|NCT02496767|12489640|FG004|STARTED|Double-blind, Withdrawal Phase||0
11291698|NCT02496767|12489641|FG005|STARTED|Double-blind, Withdrawal Phase||132
11291699|NCT02496767|12489642|FG006|STARTED|Double-blind, Withdrawal Phase||103
11291700|NCT02496767|12489643|FG007|STARTED|Double-blind, Withdrawal Phase||101
11291701|NCT02496767|12489636|FG000|COMPLETED|Double-blind, Withdrawal Phase||0
11291702|NCT02496767|12489637|FG001|COMPLETED|Double-blind, Withdrawal Phase||0
11291703|NCT02496767|12489638|FG002|COMPLETED|Double-blind, Withdrawal Phase||0
11291704|NCT02496767|12489639|FG003|COMPLETED|Double-blind, Withdrawal Phase||0
11291705|NCT02496767|12489640|FG004|COMPLETED|Double-blind, Withdrawal Phase||0
11291706|NCT02496767|12489641|FG005|COMPLETED|Double-blind, Withdrawal Phase||126
11291707|NCT02496767|12489642|FG006|COMPLETED|Double-blind, Withdrawal Phase||99
11291708|NCT02496767|12489643|FG007|COMPLETED|Double-blind, Withdrawal Phase||96
11291709|NCT02496767|12489636|FG000|NOT COMPLETED|Double-blind, Withdrawal Phase||0
11291710|NCT02496767|12489637|FG001|NOT COMPLETED|Double-blind, Withdrawal Phase||0
11291711|NCT02496767|12489638|FG002|NOT COMPLETED|Double-blind, Withdrawal Phase||0
11291712|NCT02496767|12489639|FG003|NOT COMPLETED|Double-blind, Withdrawal Phase||0
11291713|NCT02496767|12489640|FG004|NOT COMPLETED|Double-blind, Withdrawal Phase||0
11291714|NCT02496767|12489641|FG005|NOT COMPLETED|Double-blind, Withdrawal Phase||6
11291715|NCT02496767|12489642|FG006|NOT COMPLETED|Double-blind, Withdrawal Phase||4
11291716|NCT02496767|12489643|FG007|NOT COMPLETED|Double-blind, Withdrawal Phase||5
11291717|NCT02496884|12489661|FG000|STARTED|Overall Study||17
11291718|NCT02496884|12489662|FG001|STARTED|Overall Study||34
11291719|NCT02496884|12489663|FG002|STARTED|Overall Study||1
11291720|NCT02496884|12489664|FG003|STARTED|Overall Study||4
11291721|NCT02496884|12489661|FG000|Safety Analysis Set|Overall Study||17
11291722|NCT02496884|12489662|FG001|Safety Analysis Set|Overall Study||34
11291723|NCT02496884|12489663|FG002|Safety Analysis Set|Overall Study||1
11291724|NCT02496884|12489664|FG003|Safety Analysis Set|Overall Study||4
11291725|NCT02496884|12489661|FG000|Modified Intent to Treat Set (mITT)|Overall Study||17
11291726|NCT02496884|12489662|FG001|Modified Intent to Treat Set (mITT)|Overall Study||34
11291727|NCT02496884|12489663|FG002|Modified Intent to Treat Set (mITT)|Overall Study||1
11291728|NCT02496884|12489664|FG003|Modified Intent to Treat Set (mITT)|Overall Study||4
11291729|NCT02496884|12489661|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0
11291730|NCT02496884|12489662|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||33
11291731|NCT02496884|12489663|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
11291732|NCT02496884|12489664|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||4
11291733|NCT02496884|12489661|FG000|Completed Treatment Per Protocol|Overall Study||16
11291734|NCT02496884|12489662|FG001|Completed Treatment Per Protocol|Overall Study||27
11291735|NCT02496884|12489663|FG002|Completed Treatment Per Protocol|Overall Study||1
11291736|NCT02496884|12489664|FG003|Completed Treatment Per Protocol|Overall Study||3
11291737|NCT02496884|12489661|FG000|COMPLETED|Overall Study||15
11291738|NCT02496884|12489662|FG001|COMPLETED|Overall Study||31
11291739|NCT02496884|12489663|FG002|COMPLETED|Overall Study||1
11291740|NCT02496884|12489664|FG003|COMPLETED|Overall Study||4
11291741|NCT02496884|12489661|FG000|NOT COMPLETED|Overall Study||2
11291742|NCT02496884|12489662|FG001|NOT COMPLETED|Overall Study||3
11291743|NCT02496884|12489663|FG002|NOT COMPLETED|Overall Study||0
11291744|NCT02496884|12489664|FG003|NOT COMPLETED|Overall Study||0
11291745|NCT02497001|12489678|FG000|STARTED|Overall Study||640
11291746|NCT02497001|12489679|FG001|STARTED|Overall Study||627
11291747|NCT02497001|12489680|FG002|STARTED|Overall Study||316
11291748|NCT02497001|12489681|FG003|STARTED|Overall Study||319
11291749|NCT02497001|12489678|FG000|COMPLETED|Overall Study||566
11291750|NCT02497001|12489679|FG001|COMPLETED|Overall Study||524
11291751|NCT02497001|12489680|FG002|COMPLETED|Overall Study||266
11291752|NCT02497001|12489681|FG003|COMPLETED|Overall Study||278
11291753|NCT02497001|12489678|FG000|NOT COMPLETED|Overall Study||74
11291754|NCT02497001|12489679|FG001|NOT COMPLETED|Overall Study||103
11291755|NCT02497001|12489680|FG002|NOT COMPLETED|Overall Study||50
11291756|NCT02497001|12489681|FG003|NOT COMPLETED|Overall Study||41
11291757|NCT02497040|12489697|FG000|STARTED|Overall Study||30
11291758|NCT02497040|12489698|FG001|STARTED|Overall Study||30
11291759|NCT02497040|12489699|FG002|STARTED|Overall Study||30
11291760|NCT02497040|12489697|FG000|COMPLETED|Overall Study||30
11291761|NCT02497040|12489698|FG001|COMPLETED|Overall Study||30
11291762|NCT02497040|12489699|FG002|COMPLETED|Overall Study||30
11291763|NCT02497040|12489697|FG000|NOT COMPLETED|Overall Study||0
11291764|NCT02497040|12489698|FG001|NOT COMPLETED|Overall Study||0
11291765|NCT02497040|12489699|FG002|NOT COMPLETED|Overall Study||0
11291766|NCT02497235|12489712|FG000|STARTED|Overall Study||2
11291767|NCT02497235|12489713|FG001|STARTED|Overall Study||2
11291768|NCT02497235|12489714|FG002|STARTED|Overall Study||2
11291769|NCT02497235|12489715|FG003|STARTED|Overall Study||2
11021891|NCT00806286|12200065|FG000|NOT COMPLETED|Overall Study||54
11021892|NCT00806286|12200066|FG001|NOT COMPLETED|Overall Study||54
11021893|NCT00806286|12200067|FG002|NOT COMPLETED|Overall Study||3
11021894|NCT00806351|12200077|FG000|STARTED|Overall Study||15
11021895|NCT00806351|12200078|FG001|STARTED|Overall Study||6
11021896|NCT00806351|12200077|FG000|COMPLETED|Overall Study||10
11021897|NCT00806351|12200078|FG001|COMPLETED|Overall Study||2
11021898|NCT00806351|12200077|FG000|NOT COMPLETED|Overall Study||5
11021899|NCT00806351|12200078|FG001|NOT COMPLETED|Overall Study||4
11021900|NCT00806442|12200084|FG000|STARTED|Overall Study||18
11291770|NCT02497235|12489716|FG004|STARTED|Overall Study||3
11291771|NCT02497235|12489712|FG000|COMPLETED|Overall Study||2
11291772|NCT02497235|12489713|FG001|COMPLETED|Overall Study||2
11291773|NCT02497235|12489714|FG002|COMPLETED|Overall Study||2
11291774|NCT02497235|12489715|FG003|COMPLETED|Overall Study||2
11291775|NCT02497235|12489716|FG004|COMPLETED|Overall Study||3
11291776|NCT02497235|12489712|FG000|NOT COMPLETED|Overall Study||0
11291777|NCT02497235|12489713|FG001|NOT COMPLETED|Overall Study||0
11291778|NCT02497235|12489714|FG002|NOT COMPLETED|Overall Study||0
11291779|NCT02497235|12489715|FG003|NOT COMPLETED|Overall Study||0
11291780|NCT02497235|12489716|FG004|NOT COMPLETED|Overall Study||0
11291781|NCT02497287|12489731|FG000|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779
11291782|NCT02497287|12489731|FG000|COMPLETED|Induction Phase (4 Weeks)||580
11291783|NCT02497287|12489731|FG000|NOT COMPLETED|Induction Phase (4 Weeks)||199
11291784|NCT02497287|12489731|FG000|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603
11291785|NCT02497287|12489731|FG000|COMPLETED|Optimization/Maintenance (48 Weeks)||150
11291786|NCT02497287|12489731|FG000|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453
11291787|NCT02497287|12489731|FG000|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357
11291788|NCT02497287|12489731|FG000|COMPLETED|Follow-up Phase (4 Week)||326
11291789|NCT02497287|12489731|FG000|NOT COMPLETED|Follow-up Phase (4 Week)||31
11291790|NCT02497391|12489737|FG000|STARTED|Period 1 (14 Days)||16
11291791|NCT02497391|12489738|FG001|STARTED|Period 1 (14 Days)||15
11291792|NCT02497391|12489739|FG002|STARTED|Period 1 (14 Days)||16
11291793|NCT02497391|12489740|FG003|STARTED|Period 1 (14 Days)||16
11291794|NCT02497391|12489741|FG004|STARTED|Period 1 (14 Days)||16
11291795|NCT02497391|12489742|FG005|STARTED|Period 1 (14 Days)||16
11291796|NCT02497391|12489737|FG000|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
11291797|NCT02497391|12489738|FG001|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
11291798|NCT02497391|12489739|FG002|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
11291799|NCT02497391|12489740|FG003|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
11291800|NCT02497391|12489741|FG004|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
11291801|NCT02497391|12489742|FG005|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
11291802|NCT02497391|12489737|FG000|COMPLETED|Period 1 (14 Days)||16
11291803|NCT02497391|12489738|FG001|COMPLETED|Period 1 (14 Days)||15
11291804|NCT02497391|12489739|FG002|COMPLETED|Period 1 (14 Days)||16
11291805|NCT02497391|12489740|FG003|COMPLETED|Period 1 (14 Days)||16
11291806|NCT02497391|12489741|FG004|COMPLETED|Period 1 (14 Days)||16
11291807|NCT02497391|12489742|FG005|COMPLETED|Period 1 (14 Days)||16
11291808|NCT02497391|12489737|FG000|NOT COMPLETED|Period 1 (14 Days)||0
11291809|NCT02497391|12489738|FG001|NOT COMPLETED|Period 1 (14 Days)||0
11291810|NCT02497391|12489739|FG002|NOT COMPLETED|Period 1 (14 Days)||0
11291811|NCT02497391|12489740|FG003|NOT COMPLETED|Period 1 (14 Days)||0
11291812|NCT02497391|12489741|FG004|NOT COMPLETED|Period 1 (14 Days)||0
11291813|NCT02497391|12489742|FG005|NOT COMPLETED|Period 1 (14 Days)||0
11291814|NCT02497391|12489737|FG000|STARTED|Period 2 (14 Days)||16
11291815|NCT02497391|12489738|FG001|STARTED|Period 2 (14 Days)||15
11291816|NCT02497391|12489739|FG002|STARTED|Period 2 (14 Days)||16
11291817|NCT02497391|12489740|FG003|STARTED|Period 2 (14 Days)||16
11291818|NCT02497391|12489741|FG004|STARTED|Period 2 (14 Days)||16
11291819|NCT02497391|12489742|FG005|STARTED|Period 2 (14 Days)||16
11291820|NCT02497391|12489737|FG000|COMPLETED|Period 2 (14 Days)||12
11291821|NCT02497391|12489738|FG001|COMPLETED|Period 2 (14 Days)||14
11291822|NCT02497391|12489739|FG002|COMPLETED|Period 2 (14 Days)||13
11291823|NCT02497391|12489740|FG003|COMPLETED|Period 2 (14 Days)||13
11291824|NCT02497391|12489741|FG004|COMPLETED|Period 2 (14 Days)||14
11291825|NCT02497391|12489742|FG005|COMPLETED|Period 2 (14 Days)||13
11291826|NCT02497391|12489737|FG000|NOT COMPLETED|Period 2 (14 Days)||4
11021901|NCT00806442|12200085|FG001|STARTED|Overall Study||21
11021902|NCT00806442|12200084|FG000|First Intervention (3 Wks)|Overall Study||18
11291827|NCT02497391|12489738|FG001|NOT COMPLETED|Period 2 (14 Days)||1
11291828|NCT02497391|12489739|FG002|NOT COMPLETED|Period 2 (14 Days)||3
11291829|NCT02497391|12489740|FG003|NOT COMPLETED|Period 2 (14 Days)||3
11291830|NCT02497391|12489741|FG004|NOT COMPLETED|Period 2 (14 Days)||2
11291831|NCT02497391|12489742|FG005|NOT COMPLETED|Period 2 (14 Days)||3
11291832|NCT02497391|12489737|FG000|STARTED|Period 3 (14 Days)||12
11291833|NCT02497391|12489738|FG001|STARTED|Period 3 (14 Days)||14
11291834|NCT02497391|12489739|FG002|STARTED|Period 3 (14 Days)||13
11291835|NCT02497391|12489740|FG003|STARTED|Period 3 (14 Days)||13
11291836|NCT02497391|12489741|FG004|STARTED|Period 3 (14 Days)||14
11291837|NCT02497391|12489742|FG005|STARTED|Period 3 (14 Days)||13
11291838|NCT02497391|12489737|FG000|COMPLETED|Period 3 (14 Days)||12
11291839|NCT02497391|12489738|FG001|COMPLETED|Period 3 (14 Days)||13
11291840|NCT02497391|12489739|FG002|COMPLETED|Period 3 (14 Days)||12
11291841|NCT02497391|12489740|FG003|COMPLETED|Period 3 (14 Days)||13
11291842|NCT02497391|12489741|FG004|COMPLETED|Period 3 (14 Days)||13
11291843|NCT02497391|12489742|FG005|COMPLETED|Period 3 (14 Days)||13
11291844|NCT02497391|12489737|FG000|NOT COMPLETED|Period 3 (14 Days)||0
11291845|NCT02497391|12489738|FG001|NOT COMPLETED|Period 3 (14 Days)||1
11291846|NCT02497391|12489739|FG002|NOT COMPLETED|Period 3 (14 Days)||1
11291847|NCT02497391|12489740|FG003|NOT COMPLETED|Period 3 (14 Days)||0
11291848|NCT02497391|12489741|FG004|NOT COMPLETED|Period 3 (14 Days)||1
11291849|NCT02497391|12489742|FG005|NOT COMPLETED|Period 3 (14 Days)||0
11291850|NCT02497404|12489750|FG000|STARTED|Overall Study||40
11291851|NCT02497404|12489750|FG000|COMPLETED|Overall Study||39
11291852|NCT02497404|12489750|FG000|NOT COMPLETED|Overall Study||1
11291853|NCT02497469|12489756|FG000|STARTED|Overall Study||386
11291854|NCT02497469|12489757|FG001|STARTED|Overall Study||385
11291855|NCT02497469|12489756|FG000|Safety Analysis Set|Overall Study||386
11291856|NCT02497469|12489757|FG001|Safety Analysis Set|Overall Study||383
11291857|NCT02497469|12489756|FG000|COMPLETED|Overall Study||217
11291858|NCT02497469|12489757|FG001|COMPLETED|Overall Study||270
11291859|NCT02497469|12489756|FG000|NOT COMPLETED|Overall Study||169
11291860|NCT02497469|12489757|FG001|NOT COMPLETED|Overall Study||115
11291861|NCT02497755|12489765|FG000|STARTED|Overall Study||18
11291862|NCT02497755|12489766|FG001|STARTED|Overall Study||1
11291863|NCT02497755|12489765|FG000|COMPLETED|Overall Study||17
11291864|NCT02497755|12489766|FG001|COMPLETED|Overall Study||1
11291865|NCT02497755|12489765|FG000|NOT COMPLETED|Overall Study||1
11291866|NCT02497755|12489766|FG001|NOT COMPLETED|Overall Study||0
11291867|NCT02497781|12489775|FG000|STARTED|Overall Study||68
11291868|NCT02497781|12489776|FG001|STARTED|Overall Study||29
11291869|NCT02497781|12489775|FG000|Treated|Overall Study||67
11291870|NCT02497781|12489776|FG001|Treated|Overall Study||28
11291871|NCT02497781|12489775|FG000|COMPLETED|Overall Study||64
11291872|NCT02497781|12489776|FG001|COMPLETED|Overall Study||26
11291873|NCT02497781|12489775|FG000|NOT COMPLETED|Overall Study||4
11291874|NCT02497781|12489776|FG001|NOT COMPLETED|Overall Study||3
11291875|NCT02497937|12489782|FG000|STARTED|Period 1 (Up to 7 Days)||6
11291876|NCT02497937|12489783|FG001|STARTED|Period 1 (Up to 7 Days)||5
11291877|NCT02497937|12489782|FG000|COMPLETED|Period 1 (Up to 7 Days)||6
11291878|NCT02497937|12489783|FG001|COMPLETED|Period 1 (Up to 7 Days)||5
11291879|NCT02497937|12489782|FG000|NOT COMPLETED|Period 1 (Up to 7 Days)||0
11291880|NCT02497937|12489783|FG001|NOT COMPLETED|Period 1 (Up to 7 Days)||0
11291881|NCT02497937|12489782|FG000|STARTED|Washout Period (Up to 14 Days)||6
11291882|NCT02497937|12489783|FG001|STARTED|Washout Period (Up to 14 Days)||5
11291883|NCT02497937|12489782|FG000|COMPLETED|Washout Period (Up to 14 Days)||6
11291884|NCT02497937|12489783|FG001|COMPLETED|Washout Period (Up to 14 Days)||5
11291885|NCT02497937|12489782|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0
11291886|NCT02497937|12489783|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0
11291887|NCT02497937|12489782|FG000|STARTED|Period 2 (Up to 7 Days)||6
11291888|NCT02497937|12489783|FG001|STARTED|Period 2 (Up to 7 Days)||5
11291889|NCT02497937|12489782|FG000|COMPLETED|Period 2 (Up to 7 Days)||6
11291890|NCT02497937|12489783|FG001|COMPLETED|Period 2 (Up to 7 Days)||5
11291891|NCT02497937|12489782|FG000|NOT COMPLETED|Period 2 (Up to 7 Days)||0
11291892|NCT02497937|12489783|FG001|NOT COMPLETED|Period 2 (Up to 7 Days)||0
11291893|NCT02497976|12489792|FG000|STARTED|Overall Study||28
11291894|NCT02497976|12489793|FG001|STARTED|Overall Study||14
11291895|NCT02497976|12489792|FG000|COMPLETED|Overall Study||26
11291896|NCT02497976|12489793|FG001|COMPLETED|Overall Study||13
11291897|NCT02497976|12489792|FG000|NOT COMPLETED|Overall Study||2
11291898|NCT02497976|12489793|FG001|NOT COMPLETED|Overall Study||1
11291899|NCT02498067|12489799|FG000|STARTED|Overall Study||104
11291900|NCT02498067|12489799|FG000|COMPLETED|Overall Study||71
11291901|NCT02498067|12489799|FG000|NOT COMPLETED|Overall Study||33
11291902|NCT02498236|12489813|FG000|STARTED|Overall Study||6
11291903|NCT02498236|12489814|FG001|STARTED|Overall Study||6
11291904|NCT02498236|12489815|FG002|STARTED|Overall Study||6
11291905|NCT02498236|12489816|FG003|STARTED|Overall Study||6
11291906|NCT02498236|12489817|FG004|STARTED|Overall Study||7
11291907|NCT02498236|12489818|FG005|STARTED|Overall Study||6
11291908|NCT02498236|12489819|FG006|STARTED|Overall Study||7
11291909|NCT02498236|12489820|FG007|STARTED|Overall Study||7
11291910|NCT02498236|12489813|FG000|Randomized|Overall Study||6
11291911|NCT02498236|12489814|FG001|Randomized|Overall Study||6
11291912|NCT02498236|12489815|FG002|Randomized|Overall Study||6
11291913|NCT02498236|12489816|FG003|Randomized|Overall Study||6
11291914|NCT02498236|12489817|FG004|Randomized|Overall Study||7
11291915|NCT02498236|12489818|FG005|Randomized|Overall Study||6
11291916|NCT02498236|12489819|FG006|Randomized|Overall Study||7
11291917|NCT02498236|12489820|FG007|Randomized|Overall Study||7
11291918|NCT02498236|12489813|FG000|COMPLETED|Overall Study||5
11291919|NCT02498236|12489814|FG001|COMPLETED|Overall Study||6
11291920|NCT02498236|12489815|FG002|COMPLETED|Overall Study||6
11291921|NCT02498236|12489816|FG003|COMPLETED|Overall Study||6
11291922|NCT02498236|12489817|FG004|COMPLETED|Overall Study||6
11291923|NCT02498236|12489818|FG005|COMPLETED|Overall Study||6
11291924|NCT02498236|12489819|FG006|COMPLETED|Overall Study||6
11291925|NCT02498236|12489820|FG007|COMPLETED|Overall Study||6
11291926|NCT02498236|12489813|FG000|NOT COMPLETED|Overall Study||1
11291927|NCT02498236|12489814|FG001|NOT COMPLETED|Overall Study||0
11291928|NCT02498236|12489815|FG002|NOT COMPLETED|Overall Study||0
11291929|NCT02498236|12489816|FG003|NOT COMPLETED|Overall Study||0
11291930|NCT02498236|12489817|FG004|NOT COMPLETED|Overall Study||1
11291931|NCT02498236|12489818|FG005|NOT COMPLETED|Overall Study||0
11291932|NCT02498236|12489819|FG006|NOT COMPLETED|Overall Study||1
11291933|NCT02498236|12489820|FG007|NOT COMPLETED|Overall Study||1
11291934|NCT02498418|12489844|FG000|STARTED|Overall Study||247
11291935|NCT02498418|12489845|FG001|STARTED|Overall Study||248
11291936|NCT02498418|12489846|FG002|STARTED|Overall Study||244
11399933|NCT04289623|12594632|FG003|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (medical expert) email in Wave 2.|0
11399934|NCT04289623|12594633|FG004|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
11399935|NCT04289623|12594634|FG005|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
11399936|NCT04289623|12594629|FG000|COMPLETED|Wave 1 Emails||6514
11399937|NCT04289623|12594630|FG001|COMPLETED|Wave 1 Emails||6507
11399938|NCT04289623|12594631|FG002|COMPLETED|Wave 1 Emails||0
11399939|NCT04289623|12594632|FG003|COMPLETED|Wave 1 Emails||0
11399940|NCT04289623|12594633|FG004|COMPLETED|Wave 1 Emails||0
11399941|NCT04289623|12594634|FG005|COMPLETED|Wave 1 Emails||0
11399942|NCT04289623|12594629|FG000|NOT COMPLETED|Wave 1 Emails||268
11399943|NCT04289623|12594630|FG001|NOT COMPLETED|Wave 1 Emails||257
11399944|NCT04289623|12594631|FG002|NOT COMPLETED|Wave 1 Emails||0
11399945|NCT04289623|12594632|FG003|NOT COMPLETED|Wave 1 Emails||0
11399946|NCT04289623|12594633|FG004|NOT COMPLETED|Wave 1 Emails||0
11399947|NCT04289623|12594634|FG005|NOT COMPLETED|Wave 1 Emails||0
11399948|NCT04289623|12594629|FG000|STARTED|Wave 2 Emails|Participants were already sent this intervention or the loss frame email in Wave 1.|0
11399949|NCT04289623|12594630|FG001|STARTED|Wave 2 Emails|Participants were already sent this intervention or the standard email in Wave 1.|0
11399950|NCT04289623|12594631|FG002|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6099
11399951|NCT04289623|12594632|FG003|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6117
11399952|NCT04289623|12594633|FG004|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
11399953|NCT04289623|12594634|FG005|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
11399954|NCT04289623|12594629|FG000|COMPLETED|Wave 2 Emails||0
11399955|NCT04289623|12594630|FG001|COMPLETED|Wave 2 Emails||0
11399956|NCT04289623|12594631|FG002|COMPLETED|Wave 2 Emails||6099
11399957|NCT04289623|12594632|FG003|COMPLETED|Wave 2 Emails||6117
11399958|NCT04289623|12594633|FG004|COMPLETED|Wave 2 Emails||0
11399959|NCT04289623|12594634|FG005|COMPLETED|Wave 2 Emails||0
11399960|NCT04289623|12594629|FG000|NOT COMPLETED|Wave 2 Emails||0
11399961|NCT04289623|12594630|FG001|NOT COMPLETED|Wave 2 Emails||0
11399962|NCT04289623|12594631|FG002|NOT COMPLETED|Wave 2 Emails||0
11399963|NCT04289623|12594632|FG003|NOT COMPLETED|Wave 2 Emails||0
11399964|NCT04289623|12594633|FG004|NOT COMPLETED|Wave 2 Emails||0
11399965|NCT04289623|12594634|FG005|NOT COMPLETED|Wave 2 Emails||0
11399966|NCT04276207|12594648|FG000|STARTED|Period 1||15
11399967|NCT04276207|12594649|FG001|STARTED|Period 1||17
11399968|NCT04276207|12594648|FG000|Received at Least One Dose of Study Drug|Period 1||15
11399969|NCT04276207|12594649|FG001|Received at Least One Dose of Study Drug|Period 1||17
11399970|NCT04276207|12594648|FG000|COMPLETED|Period 1||15
11399971|NCT04276207|12594649|FG001|COMPLETED|Period 1||16
11399972|NCT04276207|12594648|FG000|NOT COMPLETED|Period 1||0
11399973|NCT04276207|12594649|FG001|NOT COMPLETED|Period 1||1
11399974|NCT04276207|12594648|FG000|STARTED|Washout (3- 14 Days)||15
11399975|NCT04276207|12594649|FG001|STARTED|Washout (3- 14 Days)||16
11399976|NCT04276207|12594648|FG000|COMPLETED|Washout (3- 14 Days)||15
11399977|NCT04276207|12594649|FG001|COMPLETED|Washout (3- 14 Days)||16
11291937|NCT02498418|12489844|FG000|Safety Population|Overall Study||246
11291938|NCT02498418|12489845|FG001|Safety Population|Overall Study||247
11291939|NCT02498418|12489846|FG002|Safety Population|Overall Study||244
11291940|NCT02498418|12489844|FG000|Modified Intent-to-treat Population|Overall Study||183
11291941|NCT02498418|12489845|FG001|Modified Intent-to-treat Population|Overall Study||186
11291942|NCT02498418|12489846|FG002|Modified Intent-to-treat Population|Overall Study||180
11291943|NCT02498418|12489844|FG000|Per-protocol Analysis Set|Overall Study||182
11291944|NCT02498418|12489845|FG001|Per-protocol Analysis Set|Overall Study||181
11291945|NCT02498418|12489846|FG002|Per-protocol Analysis Set|Overall Study||176
11291946|NCT02498418|12489844|FG000|COMPLETED|Overall Study||245
11291947|NCT02498418|12489845|FG001|COMPLETED|Overall Study||246
11291948|NCT02498418|12489846|FG002|COMPLETED|Overall Study||238
11291949|NCT02498418|12489844|FG000|NOT COMPLETED|Overall Study||2
11291950|NCT02498418|12489845|FG001|NOT COMPLETED|Overall Study||2
11291951|NCT02498418|12489846|FG002|NOT COMPLETED|Overall Study||6
11291952|NCT02498483|12489856|FG000|STARTED|Overall Study||6
11291953|NCT02498483|12489857|FG001|STARTED|Overall Study||5
11291954|NCT02498483|12489856|FG000|COMPLETED|Overall Study||6
11291955|NCT02498483|12489857|FG001|COMPLETED|Overall Study||5
11291956|NCT02498483|12489856|FG000|NOT COMPLETED|Overall Study||0
11291957|NCT02498483|12489857|FG001|NOT COMPLETED|Overall Study||0
11291958|NCT02498522|12489865|FG000|STARTED|Overall Study||85
11291959|NCT02498522|12489866|FG001|STARTED|Overall Study||85
11291960|NCT02498522|12489865|FG000|COMPLETED|Overall Study||83
11291961|NCT02498522|12489866|FG001|COMPLETED|Overall Study||83
11291962|NCT02498522|12489865|FG000|NOT COMPLETED|Overall Study||2
11291963|NCT02498522|12489866|FG001|NOT COMPLETED|Overall Study||2
11291964|NCT02498652|12489874|FG000|STARTED|Overall Study||20
11291965|NCT02498652|12489875|FG001|STARTED|Overall Study||21
11291966|NCT02498652|12489874|FG000|COMPLETED|Overall Study||20
11291967|NCT02498652|12489875|FG001|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
11291968|NCT02498652|12489874|FG000|NOT COMPLETED|Overall Study||0
11399978|NCT04276207|12594648|FG000|NOT COMPLETED|Washout (3- 14 Days)||0
11399979|NCT04276207|12594649|FG001|NOT COMPLETED|Washout (3- 14 Days)||0
11399980|NCT04276207|12594648|FG000|STARTED|Period 2||15
11399981|NCT04276207|12594649|FG001|STARTED|Period 2||16
11399982|NCT04276207|12594648|FG000|COMPLETED|Period 2||15
11399983|NCT04276207|12594649|FG001|COMPLETED|Period 2||16
11399984|NCT04276207|12594648|FG000|NOT COMPLETED|Period 2||0
11399985|NCT04276207|12594649|FG001|NOT COMPLETED|Period 2||0
11399986|NCT04289714|12594658|FG000|STARTED|Overall Study||14
11399987|NCT04289714|12594659|FG001|STARTED|Overall Study||11
11399988|NCT04289714|12594660|FG002|STARTED|Overall Study||10
11399989|NCT04289714|12594658|FG000|COMPLETED|Overall Study||8
11399990|NCT04289714|12594659|FG001|COMPLETED|Overall Study||6
11399991|NCT04289714|12594660|FG002|COMPLETED|Overall Study||4
11399992|NCT04289714|12594658|FG000|NOT COMPLETED|Overall Study||6
11399993|NCT04289714|12594659|FG001|NOT COMPLETED|Overall Study||5
11399994|NCT04289714|12594660|FG002|NOT COMPLETED|Overall Study||6
11399995|NCT04288752|12594670|FG000|STARTED|Overall Study|88 Participants were randomized to the VR101 group. However, one randomized participant (AR33) was unable to place the device and was immediately terminated from the study, prior to any post-randomization data collection. Therefore, 87 participants assigned to the VR101 group entered the treatment phase.|87
11399996|NCT04288752|12594671|FG001|STARTED|Overall Study||88
11399997|NCT04288752|12594670|FG000|COMPLETED|Overall Study||81
11399998|NCT04288752|12594671|FG001|COMPLETED|Overall Study||85
11399999|NCT04288752|12594670|FG000|NOT COMPLETED|Overall Study||6
11400000|NCT04288752|12594671|FG001|NOT COMPLETED|Overall Study||3
11400001|NCT04287517|12594679|FG000|STARTED|Overall Study||19
11400002|NCT04287517|12594680|FG001|STARTED|Overall Study||19
11400003|NCT04287517|12594679|FG000|COMPLETED|Overall Study||18
11400004|NCT04287517|12594680|FG001|COMPLETED|Overall Study||18
11400005|NCT04287517|12594679|FG000|NOT COMPLETED|Overall Study||1
11400006|NCT04287517|12594680|FG001|NOT COMPLETED|Overall Study||1
11400007|NCT04287036|12594686|FG000|STARTED|Period 1||13
11400008|NCT04287036|12594687|FG001|STARTED|Period 1||12
11400009|NCT04287036|12594686|FG000|COMPLETED|Period 1||13
11400010|NCT04287036|12594687|FG001|COMPLETED|Period 1||12
11400011|NCT04287036|12594686|FG000|NOT COMPLETED|Period 1||0
11400012|NCT04287036|12594687|FG001|NOT COMPLETED|Period 1||0
11400013|NCT04287036|12594686|FG000|STARTED|Period 2||13
11400014|NCT04287036|12594687|FG001|STARTED|Period 2||12
11400015|NCT04287036|12594686|FG000|COMPLETED|Period 2||13
11400016|NCT04287036|12594687|FG001|COMPLETED|Period 2||12
11400017|NCT04287036|12594686|FG000|NOT COMPLETED|Period 2||0
11400018|NCT04287036|12594687|FG001|NOT COMPLETED|Period 2||0
11400019|NCT04285411|12594693|FG000|STARTED|Overall Study||10
11400020|NCT04285411|12594693|FG000|COMPLETED|Overall Study||10
11400021|NCT04285411|12594693|FG000|NOT COMPLETED|Overall Study||0
11400022|NCT04284930|12594701|FG000|STARTED|Overall Study||8
11400023|NCT04284930|12594702|FG001|STARTED|Overall Study||5
11400024|NCT04284930|12594703|FG002|STARTED|Overall Study||8
11400025|NCT04284930|12594701|FG000|COMPLETED|Overall Study||8
11400026|NCT04284930|12594702|FG001|COMPLETED|Overall Study||5
11400027|NCT04284930|12594703|FG002|COMPLETED|Overall Study||8
11400028|NCT04284930|12594701|FG000|NOT COMPLETED|Overall Study||0
11400029|NCT04284930|12594702|FG001|NOT COMPLETED|Overall Study||0
11400030|NCT04284930|12594703|FG002|NOT COMPLETED|Overall Study||0
11400031|NCT04283773|12594714|FG000|STARTED|Overall Study||22
11400032|NCT04283773|12594715|FG001|STARTED|Overall Study||20
11400033|NCT04283773|12594716|FG002|STARTED|Overall Study||20
11400034|NCT04283773|12594714|FG000|COMPLETED|Overall Study||22
11400035|NCT04283773|12594715|FG001|COMPLETED|Overall Study||20
11400036|NCT04283773|12594716|FG002|COMPLETED|Overall Study||20
11400037|NCT04283773|12594714|FG000|NOT COMPLETED|Overall Study||0
11291969|NCT02498652|12489875|FG001|NOT COMPLETED|Overall Study||1
11291970|NCT02498678|12489901|FG000|STARTED|Overall Study||25
11291971|NCT02498678|12489902|FG001|STARTED|Overall Study||25
11291972|NCT02498678|12489901|FG000|COMPLETED|Overall Study||25
11291973|NCT02498678|12489902|FG001|COMPLETED|Overall Study||23
11291974|NCT02498678|12489901|FG000|NOT COMPLETED|Overall Study||0
11291975|NCT02498678|12489902|FG001|NOT COMPLETED|Overall Study||2
11291976|NCT02498769|12489910|FG000|STARTED|Overall Study||63
11291977|NCT02498769|12489911|FG001|STARTED|Overall Study||67
11291978|NCT02498769|12489910|FG000|COMPLETED|Overall Study||63
11291979|NCT02498769|12489911|FG001|COMPLETED|Overall Study||67
11291980|NCT02498769|12489910|FG000|NOT COMPLETED|Overall Study||0
11291981|NCT02498769|12489911|FG001|NOT COMPLETED|Overall Study||0
11291982|NCT02498821|12489919|FG000|STARTED|Overall Study||63
11291983|NCT02498821|12489920|FG001|STARTED|Overall Study||65
11291984|NCT02498821|12489919|FG000|COMPLETED|Overall Study||60
11291985|NCT02498821|12489920|FG001|COMPLETED|Overall Study||60
11291986|NCT02498821|12489919|FG000|NOT COMPLETED|Overall Study||3
11291987|NCT02498821|12489920|FG001|NOT COMPLETED|Overall Study||5
11291988|NCT02498834|12489928|FG000|STARTED|Overall Study||185
11291989|NCT02498834|12489929|FG001|STARTED|Overall Study||174
11291990|NCT02498834|12489928|FG000|COMPLETED|Overall Study||175
11291991|NCT02498834|12489929|FG001|COMPLETED|Overall Study||164
11291992|NCT02498834|12489928|FG000|NOT COMPLETED|Overall Study||10
11291993|NCT02498834|12489929|FG001|NOT COMPLETED|Overall Study||10
11291994|NCT02499029|12489937|FG000|STARTED|Overall Study||18
11291995|NCT02499029|12489938|FG001|STARTED|Overall Study||17
11291996|NCT02499029|12489937|FG000|COMPLETED|Overall Study||13
11400038|NCT04283773|12594715|FG001|NOT COMPLETED|Overall Study||0
11400039|NCT04283773|12594716|FG002|NOT COMPLETED|Overall Study||0
11400040|NCT04281901|12594728|FG000|STARTED|Overall Study||12
11291997|NCT02499029|12489938|FG001|COMPLETED|Overall Study||14
11291998|NCT02499029|12489937|FG000|NOT COMPLETED|Overall Study||5
11291999|NCT02499029|12489938|FG001|NOT COMPLETED|Overall Study||3
11292000|NCT02499081|12489944|FG000|STARTED|Overall Study||20
11292001|NCT02499081|12489944|FG000|COMPLETED|Overall Study||1
11292002|NCT02499081|12489944|FG000|NOT COMPLETED|Overall Study||19
11292003|NCT02499159|12489950|FG000|STARTED|Randomization||50
11292004|NCT02499159|12489951|FG001|STARTED|Randomization||50
11292005|NCT02499159|12489950|FG000|COMPLETED|Randomization||49
11292006|NCT02499159|12489951|FG001|COMPLETED|Randomization||49
11292007|NCT02499159|12489950|FG000|NOT COMPLETED|Randomization||1
11292008|NCT02499159|12489951|FG001|NOT COMPLETED|Randomization||1
11292009|NCT02499159|12489950|FG000|STARTED|30-Day Follow-Up Phone Call||49
11292010|NCT02499159|12489951|FG001|STARTED|30-Day Follow-Up Phone Call||49
11292011|NCT02499159|12489950|FG000|COMPLETED|30-Day Follow-Up Phone Call||42
11292012|NCT02499159|12489951|FG001|COMPLETED|30-Day Follow-Up Phone Call||47
11292013|NCT02499159|12489950|FG000|NOT COMPLETED|30-Day Follow-Up Phone Call||7
11292014|NCT02499159|12489951|FG001|NOT COMPLETED|30-Day Follow-Up Phone Call||2
11292015|NCT02499172|12489961|FG000|STARTED|Overall Study||900
11292016|NCT02499172|12489962|FG001|STARTED|Overall Study||899
11292017|NCT02499172|12489963|FG002|STARTED|Overall Study||523
11292018|NCT02499172|12489964|FG003|STARTED|Overall Study||436
11292019|NCT02499172|12489961|FG000|COMPLETED|Overall Study||835
11292020|NCT02499172|12489962|FG001|COMPLETED|Overall Study||835
11292021|NCT02499172|12489963|FG002|COMPLETED|Overall Study||0
11292022|NCT02499172|12489964|FG003|COMPLETED|Overall Study||0
11292023|NCT02499172|12489961|FG000|NOT COMPLETED|Overall Study||65
11292024|NCT02499172|12489962|FG001|NOT COMPLETED|Overall Study||64
11292025|NCT02499172|12489963|FG002|NOT COMPLETED|Overall Study||523
11292026|NCT02499172|12489964|FG003|NOT COMPLETED|Overall Study||436
11292027|NCT02499263|12489974|FG000|STARTED|Overall Study||146
11292028|NCT02499263|12489974|FG000|COMPLETED|Overall Study||84
11292029|NCT02499263|12489974|FG000|NOT COMPLETED|Overall Study||62
11292030|NCT02499380|12489978|FG000|STARTED|Overall Study||20
11292031|NCT02499380|12489978|FG000|COMPLETED|Overall Study||17
11292032|NCT02499380|12489978|FG000|NOT COMPLETED|Overall Study||3
11292033|NCT02499406|12489982|FG000|STARTED|Overall Study||17
11292034|NCT02499406|12489982|FG000|COMPLETED|Overall Study||13
11292035|NCT02499406|12489982|FG000|NOT COMPLETED|Overall Study||4
11292036|NCT02499497|12489990|FG000|STARTED|Overall Study||36
11400041|NCT04281901|12594729|FG001|STARTED|Overall Study||12
11292037|NCT02499497|12489991|FG001|STARTED|Overall Study||28
11292038|NCT02499497|12489992|FG002|STARTED|Overall Study||36
11292039|NCT02499497|12489993|FG003|STARTED|Overall Study||14
11292040|NCT02499497|12489990|FG000|COMPLETED|Overall Study||32
11292041|NCT02499497|12489991|FG001|COMPLETED|Overall Study||22
11292042|NCT02499497|12489992|FG002|COMPLETED|Overall Study||35
11292043|NCT02499497|12489993|FG003|COMPLETED|Overall Study||13
11292044|NCT02499497|12489990|FG000|NOT COMPLETED|Overall Study||4
11292045|NCT02499497|12489991|FG001|NOT COMPLETED|Overall Study||6
11292046|NCT02499497|12489992|FG002|NOT COMPLETED|Overall Study||1
11292047|NCT02499497|12489993|FG003|NOT COMPLETED|Overall Study||1
11292048|NCT02499575|12490005|FG000|STARTED|Overall Study||1
11292049|NCT02499575|12490006|FG001|STARTED|Overall Study||1
11292050|NCT02499575|12490005|FG000|COMPLETED|Overall Study||1
11292051|NCT02499575|12490006|FG001|COMPLETED|Overall Study||0
11292052|NCT02499575|12490005|FG000|NOT COMPLETED|Overall Study||0
11292053|NCT02499575|12490006|FG001|NOT COMPLETED|Overall Study||1
11292054|NCT02499692|12490012|FG000|STARTED|Overall Study||103
11292055|NCT02499692|12490012|FG000|COMPLETED|Overall Study||103
11292056|NCT02499692|12490012|FG000|NOT COMPLETED|Overall Study||0
11292057|NCT02499770|12490018|FG000|STARTED|Overall Study||19
11292058|NCT02499770|12490019|FG001|STARTED|Overall Study||77
11292059|NCT02499770|12490018|FG000|COMPLETED|Overall Study||0
11292060|NCT02499770|12490019|FG001|COMPLETED|Overall Study||0
11292061|NCT02499770|12490018|FG000|NOT COMPLETED|Overall Study||19
11292062|NCT02499770|12490019|FG001|NOT COMPLETED|Overall Study||77
11292063|NCT02499783|12490033|FG000|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102
11292064|NCT02499783|12490034|FG001|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103
11292065|NCT02499783|12490035|FG002|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0
11292066|NCT02499783|12490033|FG000|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
11292067|NCT02499783|12490034|FG001|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
11292068|NCT02499783|12490035|FG002|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
11292069|NCT02499783|12490033|FG000|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4
11292070|NCT02499783|12490034|FG001|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5
11292071|NCT02499783|12490035|FG002|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
11292072|NCT02499783|12490033|FG000|STARTED|DB Period: Weeks 0-8||102
11292073|NCT02499783|12490034|FG001|STARTED|DB Period: Weeks 0-8||103
11292074|NCT02499783|12490035|FG002|STARTED|DB Period: Weeks 0-8||0
11292075|NCT02499783|12490033|FG000|COMPLETED|DB Period: Weeks 0-8||92
11292076|NCT02499783|12490034|FG001|COMPLETED|DB Period: Weeks 0-8||96
11292077|NCT02499783|12490035|FG002|COMPLETED|DB Period: Weeks 0-8||0
11292078|NCT02499783|12490033|FG000|NOT COMPLETED|DB Period: Weeks 0-8||10
11292079|NCT02499783|12490034|FG001|NOT COMPLETED|DB Period: Weeks 0-8||7
11292080|NCT02499783|12490035|FG002|NOT COMPLETED|DB Period: Weeks 0-8||0
11292081|NCT02499783|12490033|FG000|STARTED|Open Label Period: Weeks 8 to 26||0
11292082|NCT02499783|12490034|FG001|STARTED|Open Label Period: Weeks 8 to 26||0
11292083|NCT02499783|12490035|FG002|STARTED|Open Label Period: Weeks 8 to 26||188
11341196|NCT02929823|12538502|FG001|STARTED|Overall Study||46
11292084|NCT02499783|12490033|FG000|COMPLETED|Open Label Period: Weeks 8 to 26||0
11292085|NCT02499783|12490034|FG001|COMPLETED|Open Label Period: Weeks 8 to 26||0
11292086|NCT02499783|12490035|FG002|COMPLETED|Open Label Period: Weeks 8 to 26||159
11292087|NCT02499783|12490033|FG000|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
11292088|NCT02499783|12490034|FG001|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
11292089|NCT02499783|12490035|FG002|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29
11292090|NCT02500043|12490047|FG000|STARTED|Overall Study||337
11292091|NCT02500043|12490048|FG001|STARTED|Overall Study||170
11292092|NCT02500043|12490047|FG000|As-Treated (AT) Population|Overall Study||335
11292093|NCT02500043|12490048|FG001|As-Treated (AT) Population|Overall Study||168
11292094|NCT02500043|12490047|FG000|COMPLETED|Overall Study||0
11292095|NCT02500043|12490048|FG001|COMPLETED|Overall Study||0
11292096|NCT02500043|12490047|FG000|NOT COMPLETED|Overall Study||337
11292097|NCT02500043|12490048|FG001|NOT COMPLETED|Overall Study||170
11292098|NCT02500056|12490056|FG000|STARTED|Overall Study||70
11292099|NCT02500056|12490057|FG001|STARTED|Overall Study||73
11292100|NCT02500056|12490056|FG000|COMPLETED|Overall Study||63
11292101|NCT02500056|12490057|FG001|COMPLETED|Overall Study||65
11292102|NCT02500056|12490056|FG000|NOT COMPLETED|Overall Study||7
11292103|NCT02500056|12490057|FG001|NOT COMPLETED|Overall Study||8
11292104|NCT02500368|12490063|FG000|STARTED|First Intervention (1 Week)||20
11292105|NCT02500368|12490064|FG001|STARTED|First Intervention (1 Week)||20
11292106|NCT02500368|12490063|FG000|COMPLETED|First Intervention (1 Week)||20
11292107|NCT02500368|12490064|FG001|COMPLETED|First Intervention (1 Week)||20
11292108|NCT02500368|12490063|FG000|NOT COMPLETED|First Intervention (1 Week)||0
11292109|NCT02500368|12490064|FG001|NOT COMPLETED|First Intervention (1 Week)||0
11292110|NCT02500368|12490063|FG000|STARTED|Second Intervention (1 Week)||20
11292111|NCT02500368|12490064|FG001|STARTED|Second Intervention (1 Week)||20
11292112|NCT02500368|12490063|FG000|COMPLETED|Second Intervention (1 Week)||20
11292113|NCT02500368|12490064|FG001|COMPLETED|Second Intervention (1 Week)||20
11292114|NCT02500368|12490063|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
11292115|NCT02500368|12490064|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
11292116|NCT02500537|12490072|FG000|STARTED|Overall Study||60
11292117|NCT02500537|12490073|FG001|STARTED|Overall Study||40
11292118|NCT02500537|12490072|FG000|COMPLETED|Overall Study||57
11292119|NCT02500537|12490073|FG001|COMPLETED|Overall Study||39
11292120|NCT02500537|12490072|FG000|NOT COMPLETED|Overall Study||3
11292121|NCT02500537|12490073|FG001|NOT COMPLETED|Overall Study||1
11292122|NCT02500550|12490080|FG000|STARTED|Overall Study||15
11292123|NCT02500550|12490080|FG000|COMPLETED|Overall Study||8
11292124|NCT02500550|12490080|FG000|NOT COMPLETED|Overall Study||7
11292125|NCT02500602|12490086|FG000|STARTED|Treatment Phase||74
11292126|NCT02500602|12490087|FG001|STARTED|Treatment Phase||70
11292127|NCT02500602|12490086|FG000|COMPLETED|Treatment Phase||68
11292128|NCT02500602|12490087|FG001|COMPLETED|Treatment Phase||69
11292129|NCT02500602|12490086|FG000|NOT COMPLETED|Treatment Phase||6
11292130|NCT02500602|12490087|FG001|NOT COMPLETED|Treatment Phase||1
11292131|NCT02500602|12490086|FG000|STARTED|Follow Up Phase||68
11292132|NCT02500602|12490087|FG001|STARTED|Follow Up Phase||69
11292133|NCT02500602|12490086|FG000|COMPLETED|Follow Up Phase||53
11292134|NCT02500602|12490087|FG001|COMPLETED|Follow Up Phase||47
11292135|NCT02500602|12490086|FG000|NOT COMPLETED|Follow Up Phase||15
11292136|NCT02500602|12490087|FG001|NOT COMPLETED|Follow Up Phase||22
11292137|NCT02500628|12490097|FG000|STARTED|Overall Study||38
11292138|NCT02500628|12490098|FG001|STARTED|Overall Study||23
11292139|NCT02500628|12490097|FG000|COMPLETED|Overall Study||38
11292140|NCT02500628|12490098|FG001|COMPLETED|Overall Study||23
11292141|NCT02500628|12490097|FG000|NOT COMPLETED|Overall Study||0
11292142|NCT02500628|12490098|FG001|NOT COMPLETED|Overall Study||0
11292143|NCT02500641|12490108|FG000|STARTED|Overall Study||98
11292144|NCT02500641|12490109|FG001|STARTED|Overall Study||98
11292145|NCT02500641|12490108|FG000|COMPLETED|Overall Study||88
11292146|NCT02500641|12490109|FG001|COMPLETED|Overall Study||86
11292147|NCT02500641|12490108|FG000|NOT COMPLETED|Overall Study||10
11292148|NCT02500641|12490109|FG001|NOT COMPLETED|Overall Study||12
11292149|NCT02500706|12490118|FG000|STARTED|Overall Study||342
11292150|NCT02500706|12490119|FG001|STARTED|Overall Study||341
11292151|NCT02500706|12490120|FG002|STARTED|Overall Study||342
11292152|NCT02500706|12490118|FG000|Exposed|Overall Study||342
11292153|NCT02500706|12490119|FG001|Exposed|Overall Study||341
11292154|NCT02500706|12490120|FG002|Exposed|Overall Study||342
11292155|NCT02500706|12490118|FG000|COMPLETED|Overall Study||338
11292156|NCT02500706|12490119|FG001|COMPLETED|Overall Study||334
11292157|NCT02500706|12490120|FG002|COMPLETED|Overall Study||335
11292158|NCT02500706|12490118|FG000|NOT COMPLETED|Overall Study||4
11292159|NCT02500706|12490119|FG001|NOT COMPLETED|Overall Study||7
11292160|NCT02500706|12490120|FG002|NOT COMPLETED|Overall Study||7
11292161|NCT02500719|12490130|FG000|STARTED|Overall Study||14
11292162|NCT02500719|12490131|FG001|STARTED|Overall Study||16
11292163|NCT02500719|12490130|FG000|COMPLETED|Overall Study||11
11292164|NCT02500719|12490131|FG001|COMPLETED|Overall Study||9
11292165|NCT02500719|12490130|FG000|NOT COMPLETED|Overall Study||3
11292166|NCT02500719|12490131|FG001|NOT COMPLETED|Overall Study||7
11292167|NCT02500732|12490139|FG000|STARTED|Overall Study||27
11292168|NCT02500732|12490140|FG001|STARTED|Overall Study||30
11292169|NCT02500732|12490139|FG000|COMPLETED|Overall Study||27
11292170|NCT02500732|12490140|FG001|COMPLETED|Overall Study|Not true event in 1 participant (pseudosyncope)|29
11292171|NCT02500732|12490139|FG000|NOT COMPLETED|Overall Study||0
11292172|NCT02500732|12490140|FG001|NOT COMPLETED|Overall Study||1
11292173|NCT02500758|12490148|FG000|STARTED|First Intervention (2 Minutes)||15
11292174|NCT02500758|12490149|FG001|STARTED|First Intervention (2 Minutes)||15
11292175|NCT02500758|12490148|FG000|COMPLETED|First Intervention (2 Minutes)||15
11292176|NCT02500758|12490149|FG001|COMPLETED|First Intervention (2 Minutes)||14
11292177|NCT02500758|12490148|FG000|NOT COMPLETED|First Intervention (2 Minutes)||0
11292178|NCT02500758|12490149|FG001|NOT COMPLETED|First Intervention (2 Minutes)||1
11292179|NCT02500758|12490148|FG000|STARTED|Washout (1 Week)||15
11292180|NCT02500758|12490149|FG001|STARTED|Washout (1 Week)||14
11292181|NCT02500758|12490148|FG000|COMPLETED|Washout (1 Week)||13
11292182|NCT02500758|12490149|FG001|COMPLETED|Washout (1 Week)||12
11292183|NCT02500758|12490148|FG000|NOT COMPLETED|Washout (1 Week)||2
11292184|NCT02500758|12490149|FG001|NOT COMPLETED|Washout (1 Week)||2
11292185|NCT02500758|12490148|FG000|STARTED|Second Intervention (2 Minutes)||13
11292186|NCT02500758|12490149|FG001|STARTED|Second Intervention (2 Minutes)||12
11292187|NCT02500758|12490148|FG000|COMPLETED|Second Intervention (2 Minutes)||10
11292188|NCT02500758|12490149|FG001|COMPLETED|Second Intervention (2 Minutes)||10
11292189|NCT02500758|12490148|FG000|NOT COMPLETED|Second Intervention (2 Minutes)||3
11292190|NCT02500758|12490149|FG001|NOT COMPLETED|Second Intervention (2 Minutes)||2
11292191|NCT02500836|12490159|FG000|STARTED|Overall Study||259
11292192|NCT02500836|12490160|FG001|STARTED|Overall Study||259
11292193|NCT02500836|12490161|FG002|STARTED|Overall Study||128
11292194|NCT02500836|12490159|FG000|COMPLETED|Overall Study||256
11292195|NCT02500836|12490160|FG001|COMPLETED|Overall Study||254
11292196|NCT02500836|12490161|FG002|COMPLETED|Overall Study||127
11292197|NCT02500836|12490159|FG000|NOT COMPLETED|Overall Study||3
11292198|NCT02500836|12490160|FG001|NOT COMPLETED|Overall Study||5
11292199|NCT02500836|12490161|FG002|NOT COMPLETED|Overall Study||1
11292200|NCT02500979|12490171|FG000|STARTED|Period 1||16
11292201|NCT02500979|12490172|FG001|STARTED|Period 1||17
11292202|NCT02500979|12490171|FG000|COMPLETED|Period 1||12
11292203|NCT02500979|12490172|FG001|COMPLETED|Period 1||16
11292204|NCT02500979|12490171|FG000|NOT COMPLETED|Period 1||4
11292205|NCT02500979|12490172|FG001|NOT COMPLETED|Period 1||1
11292206|NCT02500979|12490171|FG000|STARTED|Period 2||12
11292207|NCT02500979|12490172|FG001|STARTED|Period 2||16
11292208|NCT02500979|12490171|FG000|COMPLETED|Period 2||11
11292209|NCT02500979|12490172|FG001|COMPLETED|Period 2||16
11292210|NCT02500979|12490171|FG000|NOT COMPLETED|Period 2||1
11292211|NCT02500979|12490172|FG001|NOT COMPLETED|Period 2||0
11292212|NCT02501135|12490178|FG000|STARTED|Overall Study||281
11292213|NCT02501135|12490178|FG000|COMPLETED|Overall Study||281
11292214|NCT02501135|12490178|FG000|NOT COMPLETED|Overall Study||0
11292215|NCT02501161|12490190|FG000|STARTED|Overall Study||506
11292216|NCT02501161|12490191|FG001|STARTED|Overall Study||506
11292217|NCT02501161|12490190|FG000|Exposed|Overall Study||506
11292218|NCT02501161|12490191|FG001|Exposed|Overall Study||504
11292219|NCT02501161|12490190|FG000|COMPLETED|Overall Study||484
11292220|NCT02501161|12490191|FG001|COMPLETED|Overall Study||481
11292221|NCT02501161|12490190|FG000|NOT COMPLETED|Overall Study||22
11292222|NCT02501161|12490191|FG001|NOT COMPLETED|Overall Study||25
11292223|NCT02501265|12490201|FG000|STARTED|Overall Study||63
11292224|NCT02501265|12490202|FG001|STARTED|Overall Study||30
11292225|NCT02501265|12490203|FG002|STARTED|Overall Study||64
11292226|NCT02501265|12490204|FG003|STARTED|Overall Study||31
11292227|NCT02501265|12490201|FG000|COMPLETED|Overall Study||46
11292228|NCT02501265|12490202|FG001|COMPLETED|Overall Study||21
11292229|NCT02501265|12490203|FG002|COMPLETED|Overall Study||46
11292230|NCT02501265|12490204|FG003|COMPLETED|Overall Study||23
11292231|NCT02501265|12490201|FG000|NOT COMPLETED|Overall Study||17
11292232|NCT02501265|12490202|FG001|NOT COMPLETED|Overall Study||9
11292233|NCT02501265|12490203|FG002|NOT COMPLETED|Overall Study||18
11292234|NCT02501265|12490204|FG003|NOT COMPLETED|Overall Study||8
11292235|NCT02501473|12490221|FG000|STARTED|Overall Study||3
11292236|NCT02501473|12490222|FG001|STARTED|Overall Study||3
11292237|NCT02501473|12490223|FG002|STARTED|Overall Study||13
11292238|NCT02501473|12490224|FG003|STARTED|Overall Study||14
11292239|NCT02501473|12490225|FG004|STARTED|Overall Study||4
11292240|NCT02501473|12490226|FG005|STARTED|Overall Study||14
11292241|NCT02501473|12490227|FG006|STARTED|Overall Study||1
11292242|NCT02501473|12490228|FG007|STARTED|Overall Study||0
11292243|NCT02501473|12490221|FG000|Treated|Overall Study||3
11292244|NCT02501473|12490222|FG001|Treated|Overall Study||3
11292245|NCT02501473|12490223|FG002|Treated|Overall Study||13
11292246|NCT02501473|12490224|FG003|Treated|Overall Study||13
11292247|NCT02501473|12490225|FG004|Treated|Overall Study||4
11292248|NCT02501473|12490226|FG005|Treated|Overall Study||14
11292249|NCT02501473|12490227|FG006|Treated|Overall Study||1
11292250|NCT02501473|12490228|FG007|Treated|Overall Study||0
11292251|NCT02501473|12490221|FG000|COMPLETED|Overall Study||0
11292252|NCT02501473|12490222|FG001|COMPLETED|Overall Study||0
11292253|NCT02501473|12490223|FG002|COMPLETED|Overall Study||0
11292254|NCT02501473|12490224|FG003|COMPLETED|Overall Study||0
11292255|NCT02501473|12490225|FG004|COMPLETED|Overall Study||0
11292256|NCT02501473|12490226|FG005|COMPLETED|Overall Study||0
11292257|NCT02501473|12490227|FG006|COMPLETED|Overall Study||0
11292258|NCT02501473|12490228|FG007|COMPLETED|Overall Study||0
11292259|NCT02501473|12490221|FG000|NOT COMPLETED|Overall Study||3
11292260|NCT02501473|12490222|FG001|NOT COMPLETED|Overall Study||3
11292261|NCT02501473|12490223|FG002|NOT COMPLETED|Overall Study||13
11292262|NCT02501473|12490224|FG003|NOT COMPLETED|Overall Study||14
11292263|NCT02501473|12490225|FG004|NOT COMPLETED|Overall Study||4
11292264|NCT02501473|12490226|FG005|NOT COMPLETED|Overall Study||14
11292265|NCT02501473|12490227|FG006|NOT COMPLETED|Overall Study||1
11292266|NCT02501473|12490228|FG007|NOT COMPLETED|Overall Study||0
11292267|NCT02501538|12490244|FG000|STARTED|Overall Study||23
11292268|NCT02501538|12490244|FG000|COMPLETED|Overall Study||20
11292269|NCT02501538|12490244|FG000|NOT COMPLETED|Overall Study||3
11292270|NCT02501590|12490253|FG000|STARTED|Overall Study||13
11292271|NCT02501590|12490254|FG001|STARTED|Overall Study||35
11292272|NCT02501590|12490253|FG000|COMPLETED|Overall Study||13
11292273|NCT02501590|12490254|FG001|COMPLETED|Overall Study||35
11292274|NCT02501590|12490253|FG000|NOT COMPLETED|Overall Study||0
11292275|NCT02501590|12490254|FG001|NOT COMPLETED|Overall Study||0
11292276|NCT02501629|12490262|FG000|STARTED|Overall Study||89
11292277|NCT02501629|12490263|FG001|STARTED|Overall Study||88
11292278|NCT02501629|12490262|FG000|COMPLETED|Overall Study||84
11292279|NCT02501629|12490263|FG001|COMPLETED|Overall Study||81
11292280|NCT02501629|12490262|FG000|NOT COMPLETED|Overall Study||5
11292281|NCT02501629|12490263|FG001|NOT COMPLETED|Overall Study||7
11292282|NCT02501642|12490271|FG000|STARTED|Overall Study|Start of study: 10.1.2014|238
11292283|NCT02501642|12490272|FG001|STARTED|Overall Study|Start of study: 10.1.2014|241
11292284|NCT02501642|12490271|FG000|COMPLETED|Overall Study|Study ended 9.30.2018|231
11292285|NCT02501642|12490272|FG001|COMPLETED|Overall Study|Study ended 9.30.2018|230
11292286|NCT02501642|12490271|FG000|NOT COMPLETED|Overall Study||7
11292287|NCT02501642|12490272|FG001|NOT COMPLETED|Overall Study||11
11292288|NCT02501811|12490282|FG000|STARTED|Overall Study||33
11292289|NCT02501811|12490283|FG001|STARTED|Overall Study||29
11292290|NCT02501811|12490284|FG002|STARTED|Overall Study||31
11292291|NCT02501811|12490285|FG003|STARTED|Overall Study||32
11292292|NCT02501811|12490282|FG000|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|29
11292293|NCT02501811|12490283|FG001|COMPLETED|Overall Study||23
11292294|NCT02501811|12490284|FG002|COMPLETED|Overall Study||25
11292295|NCT02501811|12490285|FG003|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|25
11292296|NCT02501811|12490282|FG000|NOT COMPLETED|Overall Study||4
11292297|NCT02501811|12490283|FG001|NOT COMPLETED|Overall Study||6
11292298|NCT02501811|12490284|FG002|NOT COMPLETED|Overall Study||6
11292299|NCT02501811|12490285|FG003|NOT COMPLETED|Overall Study||7
11292300|NCT02501902|12490303|FG000|STARTED|Overall Study||3
11292301|NCT02501902|12490304|FG001|STARTED|Overall Study||7
11292302|NCT02501902|12490305|FG002|STARTED|Overall Study||4
11292303|NCT02501902|12490306|FG003|STARTED|Overall Study||11
11292304|NCT02501902|12490307|FG004|STARTED|Overall Study||11
11292305|NCT02501902|12490308|FG005|STARTED|Overall Study||11
11292306|NCT02501902|12490309|FG006|STARTED|Overall Study||9
11292307|NCT02501902|12490310|FG007|STARTED|Overall Study||20
11292308|NCT02501902|12490303|FG000|COMPLETED|Overall Study||0
11292309|NCT02501902|12490304|FG001|COMPLETED|Overall Study||0
11292310|NCT02501902|12490305|FG002|COMPLETED|Overall Study||0
11292311|NCT02501902|12490306|FG003|COMPLETED|Overall Study||0
11292312|NCT02501902|12490307|FG004|COMPLETED|Overall Study||0
11292313|NCT02501902|12490308|FG005|COMPLETED|Overall Study||0
11292314|NCT02501902|12490309|FG006|COMPLETED|Overall Study||0
11292315|NCT02501902|12490310|FG007|COMPLETED|Overall Study||0
11292316|NCT02501902|12490303|FG000|NOT COMPLETED|Overall Study||3
11292317|NCT02501902|12490304|FG001|NOT COMPLETED|Overall Study||7
11292318|NCT02501902|12490305|FG002|NOT COMPLETED|Overall Study||4
11292319|NCT02501902|12490306|FG003|NOT COMPLETED|Overall Study||11
11292320|NCT02501902|12490307|FG004|NOT COMPLETED|Overall Study||11
11292321|NCT02501902|12490308|FG005|NOT COMPLETED|Overall Study||11
11292322|NCT02501902|12490309|FG006|NOT COMPLETED|Overall Study||9
11292323|NCT02501902|12490310|FG007|NOT COMPLETED|Overall Study||20
11292324|NCT02501928|12490336|FG000|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
11292325|NCT02501928|12490337|FG001|STARTED|Overall Study||2
11292326|NCT02501928|12490338|FG002|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
11292327|NCT02501928|12490339|FG003|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
11292328|NCT02501928|12490340|FG004|STARTED|Overall Study||7
11292329|NCT02501928|12490341|FG005|STARTED|Overall Study||3
11292330|NCT02501928|12490336|FG000|COMPLETED|Overall Study||0
11292331|NCT02501928|12490337|FG001|COMPLETED|Overall Study||2
11292332|NCT02501928|12490338|FG002|COMPLETED|Overall Study||0
11292333|NCT02501928|12490339|FG003|COMPLETED|Overall Study||0
11292334|NCT02501928|12490340|FG004|COMPLETED|Overall Study||6
11292335|NCT02501928|12490341|FG005|COMPLETED|Overall Study||3
11292336|NCT02501928|12490336|FG000|NOT COMPLETED|Overall Study||0
11292337|NCT02501928|12490337|FG001|NOT COMPLETED|Overall Study||0
11292338|NCT02501928|12490338|FG002|NOT COMPLETED|Overall Study||0
11292339|NCT02501928|12490339|FG003|NOT COMPLETED|Overall Study||0
11292340|NCT02501928|12490340|FG004|NOT COMPLETED|Overall Study||1
11292341|NCT02501928|12490341|FG005|NOT COMPLETED|Overall Study||0
11292342|NCT02502019|12490358|FG000|STARTED|Overall Study||27
11292343|NCT02502019|12490358|FG000|COMPLETED|Overall Study||27
11292344|NCT02502019|12490358|FG000|NOT COMPLETED|Overall Study||0
11292345|NCT02502097|12490366|FG000|STARTED|Period 1||4
11292346|NCT02502097|12490367|FG001|STARTED|Period 1||3
11292347|NCT02502097|12490368|FG002|STARTED|Period 1||22
11292348|NCT02502097|12490369|FG003|STARTED|Period 1||22
11292349|NCT02502097|12490366|FG000|COMPLETED|Period 1||4
11292350|NCT02502097|12490367|FG001|COMPLETED|Period 1||3
11292351|NCT02502097|12490368|FG002|COMPLETED|Period 1||21
11292352|NCT02502097|12490369|FG003|COMPLETED|Period 1||22
11292353|NCT02502097|12490366|FG000|NOT COMPLETED|Period 1||0
11292354|NCT02502097|12490367|FG001|NOT COMPLETED|Period 1||0
11292355|NCT02502097|12490368|FG002|NOT COMPLETED|Period 1||1
11292356|NCT02502097|12490369|FG003|NOT COMPLETED|Period 1||0
11292357|NCT02502097|12490366|FG000|STARTED|Wash Out Period||4
11292358|NCT02502097|12490367|FG001|STARTED|Wash Out Period||3
11292359|NCT02502097|12490368|FG002|STARTED|Wash Out Period||21
11292360|NCT02502097|12490369|FG003|STARTED|Wash Out Period||22
11292361|NCT02502097|12490366|FG000|COMPLETED|Wash Out Period||4
11292362|NCT02502097|12490367|FG001|COMPLETED|Wash Out Period||2
11292363|NCT02502097|12490368|FG002|COMPLETED|Wash Out Period||20
11292364|NCT02502097|12490369|FG003|COMPLETED|Wash Out Period||21
11292365|NCT02502097|12490366|FG000|NOT COMPLETED|Wash Out Period||0
11292366|NCT02502097|12490367|FG001|NOT COMPLETED|Wash Out Period||1
11292367|NCT02502097|12490368|FG002|NOT COMPLETED|Wash Out Period||1
11292368|NCT02502097|12490369|FG003|NOT COMPLETED|Wash Out Period||1
11292369|NCT02502097|12490366|FG000|STARTED|Period 2||4
11292370|NCT02502097|12490367|FG001|STARTED|Period 2||2
11292371|NCT02502097|12490368|FG002|STARTED|Period 2||20
11292372|NCT02502097|12490369|FG003|STARTED|Period 2||21
11292373|NCT02502097|12490366|FG000|COMPLETED|Period 2||4
11292374|NCT02502097|12490367|FG001|COMPLETED|Period 2||2
11292375|NCT02502097|12490368|FG002|COMPLETED|Period 2||19
11292376|NCT02502097|12490369|FG003|COMPLETED|Period 2||21
11292377|NCT02502097|12490366|FG000|NOT COMPLETED|Period 2||0
11292378|NCT02502097|12490367|FG001|NOT COMPLETED|Period 2||0
11292379|NCT02502097|12490368|FG002|NOT COMPLETED|Period 2||1
11292380|NCT02502097|12490369|FG003|NOT COMPLETED|Period 2||0
11292381|NCT02502149|12490376|FG000|STARTED|PK1 Assessment Period||24
11292382|NCT02502149|12490377|FG001|STARTED|PK1 Assessment Period||0
11292383|NCT02502149|12490378|FG002|STARTED|PK1 Assessment Period||0
11292384|NCT02502149|12490379|FG003|STARTED|PK1 Assessment Period||0
11292385|NCT02502149|12490380|FG004|STARTED|PK1 Assessment Period||0
11292386|NCT02502149|12490376|FG000|COMPLETED|PK1 Assessment Period||24
11292387|NCT02502149|12490377|FG001|COMPLETED|PK1 Assessment Period||0
11292388|NCT02502149|12490378|FG002|COMPLETED|PK1 Assessment Period||0
11292389|NCT02502149|12490379|FG003|COMPLETED|PK1 Assessment Period||0
11292390|NCT02502149|12490380|FG004|COMPLETED|PK1 Assessment Period||0
11292391|NCT02502149|12490376|FG000|NOT COMPLETED|PK1 Assessment Period||0
11292392|NCT02502149|12490377|FG001|NOT COMPLETED|PK1 Assessment Period||0
11292393|NCT02502149|12490378|FG002|NOT COMPLETED|PK1 Assessment Period||0
11292394|NCT02502149|12490379|FG003|NOT COMPLETED|PK1 Assessment Period||0
11292395|NCT02502149|12490380|FG004|NOT COMPLETED|PK1 Assessment Period||0
11292396|NCT02502149|12490376|FG000|STARTED|Intermediate||24
11292397|NCT02502149|12490377|FG001|STARTED|Intermediate||0
11292398|NCT02502149|12490378|FG002|STARTED|Intermediate||0
11292399|NCT02502149|12490379|FG003|STARTED|Intermediate||0
11292400|NCT02502149|12490380|FG004|STARTED|Intermediate||0
11292401|NCT02502149|12490376|FG000|COMPLETED|Intermediate||23
11292402|NCT02502149|12490377|FG001|COMPLETED|Intermediate||0
11292403|NCT02502149|12490378|FG002|COMPLETED|Intermediate||0
11292404|NCT02502149|12490379|FG003|COMPLETED|Intermediate||0
11292405|NCT02502149|12490380|FG004|COMPLETED|Intermediate||0
11292406|NCT02502149|12490376|FG000|NOT COMPLETED|Intermediate||1
11292407|NCT02502149|12490377|FG001|NOT COMPLETED|Intermediate||0
11292408|NCT02502149|12490378|FG002|NOT COMPLETED|Intermediate||0
11292409|NCT02502149|12490379|FG003|NOT COMPLETED|Intermediate||0
11292410|NCT02502149|12490380|FG004|NOT COMPLETED|Intermediate||0
11292411|NCT02502149|12490376|FG000|STARTED|PK2 Assessment Period||0
11292412|NCT02502149|12490377|FG001|STARTED|PK2 Assessment Period||11
11292413|NCT02502149|12490378|FG002|STARTED|PK2 Assessment Period||12
11292414|NCT02502149|12490379|FG003|STARTED|PK2 Assessment Period||0
11292415|NCT02502149|12490380|FG004|STARTED|PK2 Assessment Period||0
11292416|NCT02502149|12490376|FG000|COMPLETED|PK2 Assessment Period||0
11292417|NCT02502149|12490377|FG001|COMPLETED|PK2 Assessment Period||11
11292418|NCT02502149|12490378|FG002|COMPLETED|PK2 Assessment Period||12
11292419|NCT02502149|12490379|FG003|COMPLETED|PK2 Assessment Period||0
11292420|NCT02502149|12490380|FG004|COMPLETED|PK2 Assessment Period||0
11292421|NCT02502149|12490376|FG000|NOT COMPLETED|PK2 Assessment Period||0
11292422|NCT02502149|12490377|FG001|NOT COMPLETED|PK2 Assessment Period||0
11292423|NCT02502149|12490378|FG002|NOT COMPLETED|PK2 Assessment Period||0
11292424|NCT02502149|12490379|FG003|NOT COMPLETED|PK2 Assessment Period||0
11292425|NCT02502149|12490380|FG004|NOT COMPLETED|PK2 Assessment Period||0
11292426|NCT02502149|12490376|FG000|STARTED|Treatment Period||0
11292427|NCT02502149|12490377|FG001|STARTED|Treatment Period||0
11292428|NCT02502149|12490378|FG002|STARTED|Treatment Period||0
11292429|NCT02502149|12490379|FG003|STARTED|Treatment Period||11
11292430|NCT02502149|12490380|FG004|STARTED|Treatment Period||12
11292431|NCT02502149|12490376|FG000|COMPLETED|Treatment Period||0
11292432|NCT02502149|12490377|FG001|COMPLETED|Treatment Period||0
11292433|NCT02502149|12490378|FG002|COMPLETED|Treatment Period||0
11292434|NCT02502149|12490379|FG003|COMPLETED|Treatment Period||11
11292435|NCT02502149|12490380|FG004|COMPLETED|Treatment Period||12
11292436|NCT02502149|12490376|FG000|NOT COMPLETED|Treatment Period||0
11292437|NCT02502149|12490377|FG001|NOT COMPLETED|Treatment Period||0
11292438|NCT02502149|12490378|FG002|NOT COMPLETED|Treatment Period||0
11292439|NCT02502149|12490379|FG003|NOT COMPLETED|Treatment Period||0
11292440|NCT02502149|12490380|FG004|NOT COMPLETED|Treatment Period||0
11292441|NCT02502461|12490399|FG000|STARTED|Overall Study||46
11292442|NCT02502461|12490400|FG001|STARTED|Overall Study||44
11292443|NCT02502461|12490399|FG000|COMPLETED|Overall Study||46
11292444|NCT02502461|12490400|FG001|COMPLETED|Overall Study||44
11292445|NCT02502461|12490399|FG000|NOT COMPLETED|Overall Study||0
11292446|NCT02502461|12490400|FG001|NOT COMPLETED|Overall Study||0
11292447|NCT02502487|12490409|FG000|STARTED|Overall Study||86
11292448|NCT02502487|12490410|FG001|STARTED|Overall Study||86
11292449|NCT02502487|12490411|FG002|STARTED|Overall Study||86
11292450|NCT02502487|12490409|FG000|COMPLETED|Overall Study||86
11292451|NCT02502487|12490410|FG001|COMPLETED|Overall Study||86
11292452|NCT02502487|12490411|FG002|COMPLETED|Overall Study||86
11292453|NCT02502487|12490409|FG000|NOT COMPLETED|Overall Study||0
11292454|NCT02502487|12490410|FG001|NOT COMPLETED|Overall Study||0
11292455|NCT02502487|12490411|FG002|NOT COMPLETED|Overall Study||0
11292456|NCT02502526|12490422|FG000|STARTED|Overall Study||62
11292457|NCT02502526|12490423|FG001|STARTED|Overall Study||59
11292458|NCT02502526|12490424|FG002|STARTED|Overall Study||61
11292459|NCT02502526|12490422|FG000|Intent-to-Treat (ITT)|Overall Study||57
11292460|NCT02502526|12490423|FG001|Intent-to-Treat (ITT)|Overall Study||57
11292461|NCT02502526|12490424|FG002|Intent-to-Treat (ITT)|Overall Study||59
11292462|NCT02502526|12490422|FG000|COMPLETED|Overall Study||56
11292463|NCT02502526|12490423|FG001|COMPLETED|Overall Study||55
11292464|NCT02502526|12490424|FG002|COMPLETED|Overall Study||55
11292465|NCT02502526|12490422|FG000|NOT COMPLETED|Overall Study||6
11292466|NCT02502526|12490423|FG001|NOT COMPLETED|Overall Study||4
11292467|NCT02502526|12490424|FG002|NOT COMPLETED|Overall Study||6
11292468|NCT02502734|12490433|FG000|STARTED|Double-blind Treatment Period 1||30
11292469|NCT02502734|12490434|FG001|STARTED|Double-blind Treatment Period 1||30
11292470|NCT02502734|12490433|FG000|COMPLETED|Double-blind Treatment Period 1||29
11292471|NCT02502734|12490434|FG001|COMPLETED|Double-blind Treatment Period 1||30
11292472|NCT02502734|12490433|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1
11292473|NCT02502734|12490434|FG001|NOT COMPLETED|Double-blind Treatment Period 1||0
11292474|NCT02502734|12490433|FG000|STARTED|Washout Period||29
11292475|NCT02502734|12490434|FG001|STARTED|Washout Period||30
11292476|NCT02502734|12490433|FG000|COMPLETED|Washout Period||28
11292477|NCT02502734|12490434|FG001|COMPLETED|Washout Period||30
11292478|NCT02502734|12490433|FG000|NOT COMPLETED|Washout Period||1
11292479|NCT02502734|12490434|FG001|NOT COMPLETED|Washout Period||0
11292480|NCT02502734|12490433|FG000|STARTED|Double-blind Treatment Period 2||28
11292481|NCT02502734|12490434|FG001|STARTED|Double-blind Treatment Period 2||30
11292482|NCT02502734|12490433|FG000|COMPLETED|Double-blind Treatment Period 2||28
11292483|NCT02502734|12490434|FG001|COMPLETED|Double-blind Treatment Period 2||30
11292484|NCT02502734|12490433|FG000|NOT COMPLETED|Double-blind Treatment Period 2||0
11292485|NCT02502734|12490434|FG001|NOT COMPLETED|Double-blind Treatment Period 2||0
11292486|NCT02502864|12490442|FG000|STARTED|Overall Study||9
11292487|NCT02502864|12490442|FG000|COMPLETED|Overall Study||8
11292488|NCT02502864|12490442|FG000|NOT COMPLETED|Overall Study||1
11292489|NCT02503085|12490446|FG000|STARTED|Period 1||7
11292490|NCT02503085|12490447|FG001|STARTED|Period 1||7
11292491|NCT02503085|12490448|FG002|STARTED|Period 1||7
11292492|NCT02503085|12490449|FG003|STARTED|Period 1||7
11292493|NCT02503085|12490446|FG000|COMPLETED|Period 1||7
11292494|NCT02503085|12490447|FG001|COMPLETED|Period 1||7
11292495|NCT02503085|12490448|FG002|COMPLETED|Period 1||7
11292496|NCT02503085|12490449|FG003|COMPLETED|Period 1||7
11292497|NCT02503085|12490446|FG000|NOT COMPLETED|Period 1||0
11292498|NCT02503085|12490447|FG001|NOT COMPLETED|Period 1||0
11292499|NCT02503085|12490448|FG002|NOT COMPLETED|Period 1||0
11292500|NCT02503085|12490449|FG003|NOT COMPLETED|Period 1||0
11292501|NCT02503085|12490446|FG000|STARTED|Period 1: Washout (3 to 7 Days)||7
11292502|NCT02503085|12490447|FG001|STARTED|Period 1: Washout (3 to 7 Days)||7
11292503|NCT02503085|12490448|FG002|STARTED|Period 1: Washout (3 to 7 Days)||7
11292504|NCT02503085|12490449|FG003|STARTED|Period 1: Washout (3 to 7 Days)||7
11292505|NCT02503085|12490446|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||7
11292506|NCT02503085|12490447|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||7
11292507|NCT02503085|12490448|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||7
11292508|NCT02503085|12490449|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||7
11292509|NCT02503085|12490446|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
11292510|NCT02503085|12490447|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
11292511|NCT02503085|12490448|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
11292512|NCT02503085|12490449|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
11292513|NCT02503085|12490446|FG000|STARTED|Period 2||7
11292514|NCT02503085|12490447|FG001|STARTED|Period 2||7
11292515|NCT02503085|12490448|FG002|STARTED|Period 2||7
11292516|NCT02503085|12490449|FG003|STARTED|Period 2||7
11292517|NCT02503085|12490446|FG000|COMPLETED|Period 2||7
11292518|NCT02503085|12490447|FG001|COMPLETED|Period 2||7
11292519|NCT02503085|12490448|FG002|COMPLETED|Period 2||7
11292520|NCT02503085|12490449|FG003|COMPLETED|Period 2||7
11292521|NCT02503085|12490446|FG000|NOT COMPLETED|Period 2||0
11292522|NCT02503085|12490447|FG001|NOT COMPLETED|Period 2||0
11292523|NCT02503085|12490448|FG002|NOT COMPLETED|Period 2||0
11292524|NCT02503085|12490449|FG003|NOT COMPLETED|Period 2||0
11292525|NCT02503085|12490446|FG000|STARTED|Period 2: Washout (3 to 7 Days)||7
11292526|NCT02503085|12490447|FG001|STARTED|Period 2: Washout (3 to 7 Days)||7
11292527|NCT02503085|12490448|FG002|STARTED|Period 2: Washout (3 to 7 Days)||7
11292528|NCT02503085|12490449|FG003|STARTED|Period 2: Washout (3 to 7 Days)||7
11292529|NCT02503085|12490446|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6
11292530|NCT02503085|12490447|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||7
11292531|NCT02503085|12490448|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6
11292532|NCT02503085|12490449|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||7
11292533|NCT02503085|12490446|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
11292534|NCT02503085|12490447|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
11292535|NCT02503085|12490448|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
11292536|NCT02503085|12490449|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
11292537|NCT02503085|12490446|FG000|STARTED|Period 3||6
11292538|NCT02503085|12490447|FG001|STARTED|Period 3||7
11292539|NCT02503085|12490448|FG002|STARTED|Period 3||6
11292540|NCT02503085|12490449|FG003|STARTED|Period 3||7
11292541|NCT02503085|12490446|FG000|COMPLETED|Period 3||6
11292542|NCT02503085|12490447|FG001|COMPLETED|Period 3||7
11292543|NCT02503085|12490448|FG002|COMPLETED|Period 3||6
11292544|NCT02503085|12490449|FG003|COMPLETED|Period 3||7
11292545|NCT02503085|12490446|FG000|NOT COMPLETED|Period 3||0
11292546|NCT02503085|12490447|FG001|NOT COMPLETED|Period 3||0
11292547|NCT02503085|12490448|FG002|NOT COMPLETED|Period 3||0
11292548|NCT02503085|12490449|FG003|NOT COMPLETED|Period 3||0
11292549|NCT02503085|12490446|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6
11292550|NCT02503085|12490447|FG001|STARTED|Period 3: Washout (3 to 7 Days)||7
11292551|NCT02503085|12490448|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6
11292552|NCT02503085|12490449|FG003|STARTED|Period 3: Washout (3 to 7 Days)||7
11292553|NCT02503085|12490446|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6
11292554|NCT02503085|12490447|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||7
11292555|NCT02503085|12490448|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6
11292556|NCT02503085|12490449|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||7
11292557|NCT02503085|12490446|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
11292558|NCT02503085|12490447|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
11292559|NCT02503085|12490448|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
11292560|NCT02503085|12490449|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
11292561|NCT02503085|12490446|FG000|STARTED|Period 4||6
11292562|NCT02503085|12490447|FG001|STARTED|Period 4||7
11292563|NCT02503085|12490448|FG002|STARTED|Period 4||6
11292564|NCT02503085|12490449|FG003|STARTED|Period 4||7
11292565|NCT02503085|12490446|FG000|COMPLETED|Period 4||6
11292566|NCT02503085|12490447|FG001|COMPLETED|Period 4||7
11292567|NCT02503085|12490448|FG002|COMPLETED|Period 4||6
11292568|NCT02503085|12490449|FG003|COMPLETED|Period 4||7
11292569|NCT02503085|12490446|FG000|NOT COMPLETED|Period 4||0
11292570|NCT02503085|12490447|FG001|NOT COMPLETED|Period 4||0
11292571|NCT02503085|12490448|FG002|NOT COMPLETED|Period 4||0
11292572|NCT02503085|12490449|FG003|NOT COMPLETED|Period 4||0
11292573|NCT02503202|12490461|FG000|STARTED|Base Study: Up to Month 6||266
11292574|NCT02503202|12490462|FG001|STARTED|Base Study: Up to Month 6||265
11292575|NCT02503202|12490463|FG002|STARTED|Base Study: Up to Month 6||267
11292576|NCT02503202|12490464|FG003|STARTED|Base Study: Up to Month 6||266
11292577|NCT02503202|12490465|FG004|STARTED|Base Study: Up to Month 6||133
11292578|NCT02503202|12490461|FG000|Vaccinated|Base Study: Up to Month 6||266
11292579|NCT02503202|12490462|FG001|Vaccinated|Base Study: Up to Month 6||265
11292580|NCT02503202|12490463|FG002|Vaccinated|Base Study: Up to Month 6||266
11292581|NCT02503202|12490464|FG003|Vaccinated|Base Study: Up to Month 6||264
11292582|NCT02503202|12490465|FG004|Vaccinated|Base Study: Up to Month 6||133
11292583|NCT02503202|12490461|FG000|COMPLETED|Base Study: Up to Month 6||248
11292584|NCT02503202|12490462|FG001|COMPLETED|Base Study: Up to Month 6||253
11292585|NCT02503202|12490463|FG002|COMPLETED|Base Study: Up to Month 6||252
11292586|NCT02503202|12490464|FG003|COMPLETED|Base Study: Up to Month 6||255
11292587|NCT02503202|12490465|FG004|COMPLETED|Base Study: Up to Month 6||130
11292588|NCT02503202|12490461|FG000|NOT COMPLETED|Base Study: Up to Month 6||18
11292589|NCT02503202|12490462|FG001|NOT COMPLETED|Base Study: Up to Month 6||12
11292590|NCT02503202|12490463|FG002|NOT COMPLETED|Base Study: Up to Month 6||15
11292591|NCT02503202|12490464|FG003|NOT COMPLETED|Base Study: Up to Month 6||11
11292592|NCT02503202|12490465|FG004|NOT COMPLETED|Base Study: Up to Month 6||3
11292593|NCT02503202|12490461|FG000|STARTED|Extension: Month 6 to 24||119
11292594|NCT02503202|12490462|FG001|STARTED|Extension: Month 6 to 24||130
11292595|NCT02503202|12490463|FG002|STARTED|Extension: Month 6 to 24||112
11292596|NCT02503202|12490464|FG003|STARTED|Extension: Month 6 to 24||137
11292597|NCT02503202|12490465|FG004|STARTED|Extension: Month 6 to 24||68
11292598|NCT02503202|12490461|FG000|COMPLETED|Extension: Month 6 to 24||108
11292599|NCT02503202|12490462|FG001|COMPLETED|Extension: Month 6 to 24||114
11292600|NCT02503202|12490463|FG002|COMPLETED|Extension: Month 6 to 24||103
11292601|NCT02503202|12490464|FG003|COMPLETED|Extension: Month 6 to 24||119
11292602|NCT02503202|12490465|FG004|COMPLETED|Extension: Month 6 to 24||67
11292603|NCT02503202|12490461|FG000|NOT COMPLETED|Extension: Month 6 to 24||11
11292604|NCT02503202|12490462|FG001|NOT COMPLETED|Extension: Month 6 to 24||16
11292605|NCT02503202|12490463|FG002|NOT COMPLETED|Extension: Month 6 to 24||9
11292606|NCT02503202|12490464|FG003|NOT COMPLETED|Extension: Month 6 to 24||18
11292607|NCT02503202|12490465|FG004|NOT COMPLETED|Extension: Month 6 to 24||1
11292608|NCT02503215|12490477|FG000|STARTED|Overall Study||17
11292609|NCT02503215|12490477|FG000|COMPLETED|Overall Study||14
11292610|NCT02503215|12490477|FG000|NOT COMPLETED|Overall Study||3
11292611|NCT02503254|12490483|FG000|STARTED|Overall Study||41
11292612|NCT02503254|12490484|FG001|STARTED|Overall Study||39
11292613|NCT02503254|12490483|FG000|COMPLETED|Overall Study||41
11292614|NCT02503254|12490484|FG001|COMPLETED|Overall Study||39
11292615|NCT02503254|12490483|FG000|NOT COMPLETED|Overall Study||0
11292616|NCT02503254|12490484|FG001|NOT COMPLETED|Overall Study||0
11292617|NCT02503332|12490494|FG000|STARTED|Overall Study||86
11292618|NCT02503332|12490495|FG001|STARTED|Overall Study||79
11292619|NCT02503332|12490496|FG002|STARTED|Overall Study||41
11292620|NCT02503332|12490497|FG003|STARTED|Overall Study||40
11292621|NCT02503332|12490494|FG000|COMPLETED|Overall Study||52
11292622|NCT02503332|12490495|FG001|COMPLETED|Overall Study||60
11292623|NCT02503332|12490496|FG002|COMPLETED|Overall Study||33
11292624|NCT02503332|12490497|FG003|COMPLETED|Overall Study||36
11292625|NCT02503332|12490494|FG000|NOT COMPLETED|Overall Study||34
11292626|NCT02503332|12490495|FG001|NOT COMPLETED|Overall Study||19
11292627|NCT02503332|12490496|FG002|NOT COMPLETED|Overall Study||8
11292628|NCT02503332|12490497|FG003|NOT COMPLETED|Overall Study||4
11292629|NCT02503410|12490513|FG000|STARTED|Overall Study||4
11292630|NCT02503410|12490514|FG001|STARTED|Overall Study||3
11292631|NCT02503410|12490513|FG000|COMPLETED|Overall Study||4
11292632|NCT02503410|12490514|FG001|COMPLETED|Overall Study||3
11292633|NCT02503410|12490513|FG000|NOT COMPLETED|Overall Study||0
11292634|NCT02503410|12490514|FG001|NOT COMPLETED|Overall Study||0
11292635|NCT02503501|12490527|FG000|STARTED|Overall Study||19
11292636|NCT02503501|12490528|FG001|STARTED|Overall Study||16
11292637|NCT02503501|12490527|FG000|COMPLETED|Overall Study||18
11292638|NCT02503501|12490528|FG001|COMPLETED|Overall Study||13
11292639|NCT02503501|12490527|FG000|NOT COMPLETED|Overall Study||1
11292640|NCT02503501|12490528|FG001|NOT COMPLETED|Overall Study||3
11292641|NCT02503540|12490534|FG000|STARTED|Overall Study||31
11292642|NCT02503540|12490534|FG000|COMPLETED|Overall Study||28
11292643|NCT02503540|12490534|FG000|NOT COMPLETED|Overall Study||3
11292644|NCT02503735|12490538|FG000|STARTED|Overall Study||10
11292645|NCT02503735|12490538|FG000|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8
11292646|NCT02503735|12490538|FG000|COMPLETED|Overall Study||10
11292647|NCT02503735|12490538|FG000|NOT COMPLETED|Overall Study||0
11292648|NCT02503787|12490548|FG000|STARTED|Enrollment||64
11292649|NCT02503787|12490548|FG000|COMPLETED|Enrollment||44
11292650|NCT02503787|12490548|FG000|NOT COMPLETED|Enrollment||20
11292651|NCT02503787|12490548|FG000|STARTED|Device Trial (HD Programming Trial)||44
11292652|NCT02503787|12490548|FG000|COMPLETED|Device Trial (HD Programming Trial)||37
11292653|NCT02503787|12490548|FG000|NOT COMPLETED|Device Trial (HD Programming Trial)||7
11292654|NCT02503787|12490548|FG000|STARTED|Successful Trial (≥50% Pain Relief)||37
11292655|NCT02503787|12490548|FG000|COMPLETED|Successful Trial (≥50% Pain Relief)||32
11292656|NCT02503787|12490548|FG000|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
11292657|NCT02503787|12490548|FG000|STARTED|Implant to 3 Month Endpoint||32
11292658|NCT02503787|12490548|FG000|COMPLETED|Implant to 3 Month Endpoint||29
11292659|NCT02503787|12490548|FG000|NOT COMPLETED|Implant to 3 Month Endpoint||3
11292660|NCT02503852|12490556|FG000|STARTED|Overall Study||16
11292661|NCT02503852|12490557|FG001|STARTED|Overall Study||22
11292662|NCT02503852|12490558|FG002|STARTED|Overall Study||24
11292663|NCT02503852|12490559|FG003|STARTED|Overall Study||9
11292664|NCT02503852|12490556|FG000|COMPLETED|Overall Study||12
11292665|NCT02503852|12490557|FG001|COMPLETED|Overall Study||19
11292666|NCT02503852|12490558|FG002|COMPLETED|Overall Study||21
11292667|NCT02503852|12490559|FG003|COMPLETED|Overall Study||8
11292668|NCT02503852|12490556|FG000|NOT COMPLETED|Overall Study||4
11292669|NCT02503852|12490557|FG001|NOT COMPLETED|Overall Study||3
11292670|NCT02503852|12490558|FG002|NOT COMPLETED|Overall Study||3
11292671|NCT02503852|12490559|FG003|NOT COMPLETED|Overall Study||1
11292672|NCT02503865|12490572|FG000|STARTED|Overall Study||70
11292673|NCT02503865|12490573|FG001|STARTED|Overall Study||269
11400042|NCT04281901|12594728|FG000|2. Check-up|Overall Study||11
11400043|NCT04281901|12594729|FG001|2. Check-up|Overall Study||11
11400044|NCT04281901|12594728|FG000|3. Check-up|Overall Study||11
11400045|NCT04281901|12594729|FG001|3. Check-up|Overall Study||11
11400046|NCT04281901|12594728|FG000|COMPLETED|Overall Study||11
11400047|NCT04281901|12594729|FG001|COMPLETED|Overall Study||11
11400048|NCT04281901|12594728|FG000|NOT COMPLETED|Overall Study||1
11400049|NCT04281901|12594729|FG001|NOT COMPLETED|Overall Study||1
11400050|NCT04280653|12594735|FG000|STARTED|Overall Study||15
11400051|NCT04280653|12594735|FG000|COMPLETED|Overall Study||15
11400052|NCT04280653|12594735|FG000|NOT COMPLETED|Overall Study||0
11400053|NCT04277936|12594739|FG000|STARTED|Overall Study||1
11400054|NCT04277936|12594739|FG000|COMPLETED|Overall Study||1
11400055|NCT04277936|12594739|FG000|NOT COMPLETED|Overall Study||0
11400056|NCT04275336|12594746|FG000|STARTED|Overall Study||120
11400057|NCT04275336|12594747|FG001|STARTED|Overall Study||118
11400058|NCT04275336|12594748|FG002|STARTED|Overall Study||116
11400059|NCT04275336|12594746|FG000|COMPLETED|Overall Study||103
11400060|NCT04275336|12594747|FG001|COMPLETED|Overall Study||96
11400061|NCT04275336|12594748|FG002|COMPLETED|Overall Study||100
11400062|NCT04275336|12594746|FG000|NOT COMPLETED|Overall Study||17
11400063|NCT04275336|12594747|FG001|NOT COMPLETED|Overall Study||22
11400064|NCT04275336|12594748|FG002|NOT COMPLETED|Overall Study||16
11400065|NCT04272775|12594761|FG000|STARTED|Overall Study||7
11400066|NCT04272775|12594762|FG001|STARTED|Overall Study||7
11400067|NCT04272775|12594761|FG000|COMPLETED|Overall Study||0
11400068|NCT04272775|12594762|FG001|COMPLETED|Overall Study||0
11400069|NCT04272775|12594761|FG000|NOT COMPLETED|Overall Study||7
11400070|NCT04272775|12594762|FG001|NOT COMPLETED|Overall Study||7
11400071|NCT04271020|12594768|FG000|STARTED|Overall Study||12
11292674|NCT02503865|12490574|FG002|STARTED|Overall Study||66
11292675|NCT02503865|12490572|FG000|COMPLETED|Overall Study||65
11400072|NCT04271020|12594768|FG000|COMPLETED|Overall Study||12
11400073|NCT04271020|12594768|FG000|NOT COMPLETED|Overall Study||0
11400074|NCT04274075|12594778|FG000|STARTED|Overall Study||3
11400075|NCT04274075|12594779|FG001|STARTED|Overall Study||3
11400076|NCT04274075|12594780|FG002|STARTED|Overall Study||3
11400077|NCT04274075|12594781|FG003|STARTED|Overall Study||3
11400078|NCT04274075|12594782|FG004|STARTED|Overall Study||3
11400079|NCT04274075|12594783|FG005|STARTED|Overall Study||3
11292676|NCT02503865|12490573|FG001|COMPLETED|Overall Study||222
11292677|NCT02503865|12490574|FG002|COMPLETED|Overall Study||64
11292678|NCT02503865|12490572|FG000|NOT COMPLETED|Overall Study||5
11292679|NCT02503865|12490573|FG001|NOT COMPLETED|Overall Study||47
11292680|NCT02503865|12490574|FG002|NOT COMPLETED|Overall Study||2
11292681|NCT02503982|12490583|FG000|STARTED|Overall Study||13
11292682|NCT02503982|12490583|FG000|COMPLETED|Overall Study||13
11292683|NCT02503982|12490583|FG000|NOT COMPLETED|Overall Study||0
11292684|NCT02504073|12490587|FG000|STARTED|Overall Study||54
11292685|NCT02504073|12490587|FG000|COMPLETED|Overall Study||54
11292686|NCT02504073|12490587|FG000|NOT COMPLETED|Overall Study||0
11292687|NCT02504216|12490594|FG000|STARTED|Overall Study||3286
11292688|NCT02504216|12490595|FG001|STARTED|Overall Study||3278
11292689|NCT02504216|12490594|FG000|Received Treatment|Overall Study||3256
11292690|NCT02504216|12490595|FG001|Received Treatment|Overall Study||3248
11292691|NCT02504216|12490594|FG000|COMPLETED|Overall Study||3275
11292692|NCT02504216|12490595|FG001|COMPLETED|Overall Study||3263
11292693|NCT02504216|12490594|FG000|NOT COMPLETED|Overall Study||11
11292694|NCT02504216|12490595|FG001|NOT COMPLETED|Overall Study||15
11292695|NCT02504268|12490604|FG000|STARTED|Overall Study||451
11292696|NCT02504268|12490605|FG001|STARTED|Overall Study||301
11292697|NCT02504268|12490606|FG002|STARTED|Overall Study||242
11292698|NCT02504268|12490607|FG003|STARTED|Overall Study||0
11292699|NCT02504268|12490608|FG004|STARTED|Overall Study||0
11292700|NCT02504268|12490609|FG005|STARTED|Overall Study||0
11292701|NCT02504268|12490610|FG006|STARTED|Overall Study||0
11292702|NCT02504268|12490611|FG007|STARTED|Overall Study||0
11292703|NCT02504268|12490612|FG008|STARTED|Overall Study||0
11292704|NCT02504268|12490604|FG000|Induction to Open Label|Overall Study||289
11292705|NCT02504268|12490605|FG001|Induction to Open Label|Overall Study||196
11292706|NCT02504268|12490606|FG002|Induction to Open Label|Overall Study||147
11400080|NCT04274075|12594778|FG000|Completed Treatment Period 1 (9 Days)|Overall Study||3
11292707|NCT02504268|12490607|FG003|Induction to Open Label|Overall Study||0
11292708|NCT02504268|12490608|FG004|Induction to Open Label|Overall Study||0
11292709|NCT02504268|12490609|FG005|Induction to Open Label|Overall Study||0
11292710|NCT02504268|12490610|FG006|Induction to Open Label|Overall Study||0
11292711|NCT02504268|12490611|FG007|Induction to Open Label|Overall Study||0
11292712|NCT02504268|12490612|FG008|Induction to Open Label|Overall Study||0
11292713|NCT02504268|12490604|FG000|Early Escaped to Open Label|Overall Study||10
11292714|NCT02504268|12490605|FG001|Early Escaped to Open Label|Overall Study||21
11292715|NCT02504268|12490606|FG002|Early Escaped to Open Label|Overall Study||8
11292716|NCT02504268|12490607|FG003|Early Escaped to Open Label|Overall Study||0
11292717|NCT02504268|12490608|FG004|Early Escaped to Open Label|Overall Study||0
11292718|NCT02504268|12490609|FG005|Early Escaped to Open Label|Overall Study||0
11292719|NCT02504268|12490610|FG006|Early Escaped to Open Label|Overall Study||0
11292720|NCT02504268|12490611|FG007|Early Escaped to Open Label|Overall Study||0
11292721|NCT02504268|12490612|FG008|Early Escaped to Open Label|Overall Study||0
11292722|NCT02504268|12490604|FG000|Induction to De-Escalation|Overall Study||94
11292723|NCT02504268|12490605|FG001|Induction to De-Escalation|Overall Study||37
11292724|NCT02504268|12490606|FG002|Induction to De-Escalation|Overall Study||53
11292725|NCT02504268|12490607|FG003|Induction to De-Escalation|Overall Study||0
11292726|NCT02504268|12490608|FG004|Induction to De-Escalation|Overall Study||0
11292727|NCT02504268|12490609|FG005|Induction to De-Escalation|Overall Study||0
11292728|NCT02504268|12490610|FG006|Induction to De-Escalation|Overall Study||0
11292729|NCT02504268|12490611|FG007|Induction to De-Escalation|Overall Study||0
11292730|NCT02504268|12490612|FG008|Induction to De-Escalation|Overall Study||0
11292731|NCT02504268|12490604|FG000|Randomized in De-Escalation Period|Overall Study||0
11292732|NCT02504268|12490605|FG001|Randomized in De-Escalation Period|Overall Study||0
11292733|NCT02504268|12490606|FG002|Randomized in De-Escalation Period|Overall Study||0
11292734|NCT02504268|12490607|FG003|Randomized in De-Escalation Period|Overall Study||50
11292735|NCT02504268|12490608|FG004|Randomized in De-Escalation Period|Overall Study||50
11292736|NCT02504268|12490609|FG005|Randomized in De-Escalation Period|Overall Study||47
11292737|NCT02504268|12490610|FG006|Randomized in De-Escalation Period|Overall Study||37
11292738|NCT02504268|12490611|FG007|Randomized in De-Escalation Period|Overall Study||0
11292739|NCT02504268|12490612|FG008|Randomized in De-Escalation Period|Overall Study||0
11400081|NCT04274075|12594779|FG001|Completed Treatment Period 1 (9 Days)|Overall Study||3
11400082|NCT04274075|12594780|FG002|Completed Treatment Period 1 (9 Days)|Overall Study||3
11400083|NCT04274075|12594781|FG003|Completed Treatment Period 1 (9 Days)|Overall Study||3
11400084|NCT04274075|12594782|FG004|Completed Treatment Period 1 (9 Days)|Overall Study||3
11292740|NCT02504268|12490604|FG000|De-Escalation to Open Label Extension|Overall Study||0
11292741|NCT02504268|12490605|FG001|De-Escalation to Open Label Extension|Overall Study||0
11292742|NCT02504268|12490606|FG002|De-Escalation to Open Label Extension|Overall Study||0
11292743|NCT02504268|12490607|FG003|De-Escalation to Open Label Extension|Overall Study||36
11292744|NCT02504268|12490608|FG004|De-Escalation to Open Label Extension|Overall Study||30
11292745|NCT02504268|12490609|FG005|De-Escalation to Open Label Extension|Overall Study||32
11292746|NCT02504268|12490610|FG006|De-Escalation to Open Label Extension|Overall Study||22
11292747|NCT02504268|12490611|FG007|De-Escalation to Open Label Extension|Overall Study||0
11292748|NCT02504268|12490612|FG008|De-Escalation to Open Label Extension|Overall Study||0
11292749|NCT02504268|12490604|FG000|Early Escaped De-Escalation to Open Label Period|Overall Study||0
11292750|NCT02504268|12490605|FG001|Early Escaped De-Escalation to Open Label Period|Overall Study||0
11341197|NCT02929823|12538503|FG002|STARTED|Overall Study||42
11292751|NCT02504268|12490606|FG002|Early Escaped De-Escalation to Open Label Period|Overall Study||0
11292752|NCT02504268|12490607|FG003|Early Escaped De-Escalation to Open Label Period|Overall Study||2
11292753|NCT02504268|12490608|FG004|Early Escaped De-Escalation to Open Label Period|Overall Study||5
11292754|NCT02504268|12490609|FG005|Early Escaped De-Escalation to Open Label Period|Overall Study||4
11292755|NCT02504268|12490610|FG006|Early Escaped De-Escalation to Open Label Period|Overall Study||3
11292756|NCT02504268|12490611|FG007|Early Escaped De-Escalation to Open Label Period|Overall Study||0
11292757|NCT02504268|12490612|FG008|Early Escaped De-Escalation to Open Label Period|Overall Study||0
11292758|NCT02504268|12490604|FG000|Open Label and Open Label Extension Period|Overall Study||0
11292759|NCT02504268|12490605|FG001|Open Label and Open Label Extension Period|Overall Study||0
11292760|NCT02504268|12490606|FG002|Open Label and Open Label Extension Period|Overall Study||0
11292761|NCT02504268|12490607|FG003|Open Label and Open Label Extension Period|Overall Study||0
11292762|NCT02504268|12490608|FG004|Open Label and Open Label Extension Period|Overall Study||0
11292763|NCT02504268|12490609|FG005|Open Label and Open Label Extension Period|Overall Study||0
11292764|NCT02504268|12490610|FG006|Open Label and Open Label Extension Period|Overall Study||0
11292765|NCT02504268|12490611|FG007|Open Label and Open Label Extension Period|Overall Study||685
11292766|NCT02504268|12490612|FG008|Open Label and Open Label Extension Period|Overall Study||120
11292767|NCT02504268|12490604|FG000|COMPLETED|Overall Study||388
11292768|NCT02504268|12490605|FG001|COMPLETED|Overall Study||233
11292769|NCT02504268|12490606|FG002|COMPLETED|Overall Study||201
11292770|NCT02504268|12490607|FG003|COMPLETED|Overall Study||0
11292771|NCT02504268|12490608|FG004|COMPLETED|Overall Study||0
11400085|NCT04274075|12594783|FG005|Completed Treatment Period 1 (9 Days)|Overall Study||3
11400086|NCT04274075|12594778|FG000|Completed Treatment Period 2 (9 Days)|Overall Study||3
11292772|NCT02504268|12490609|FG005|COMPLETED|Overall Study||0
11292773|NCT02504268|12490610|FG006|COMPLETED|Overall Study||0
11292774|NCT02504268|12490611|FG007|COMPLETED|Overall Study||0
11292775|NCT02504268|12490612|FG008|COMPLETED|Overall Study||0
11292776|NCT02504268|12490604|FG000|NOT COMPLETED|Overall Study||63
11292777|NCT02504268|12490605|FG001|NOT COMPLETED|Overall Study||68
11292778|NCT02504268|12490606|FG002|NOT COMPLETED|Overall Study||41
11292779|NCT02504268|12490607|FG003|NOT COMPLETED|Overall Study||0
11292780|NCT02504268|12490608|FG004|NOT COMPLETED|Overall Study||0
11292781|NCT02504268|12490609|FG005|NOT COMPLETED|Overall Study||0
11292782|NCT02504268|12490610|FG006|NOT COMPLETED|Overall Study||0
11292783|NCT02504268|12490611|FG007|NOT COMPLETED|Overall Study||0
11292784|NCT02504268|12490612|FG008|NOT COMPLETED|Overall Study||0
11292785|NCT02504294|12490634|FG000|STARTED|Overall Study||212
11292786|NCT02504294|12490635|FG001|STARTED|Overall Study||206
11292787|NCT02504294|12490634|FG000|COMPLETED|Overall Study||156
11292788|NCT02504294|12490635|FG001|COMPLETED|Overall Study||158
11292789|NCT02504294|12490634|FG000|NOT COMPLETED|Overall Study||56
11292790|NCT02504294|12490635|FG001|NOT COMPLETED|Overall Study||48
11292791|NCT02504320|12490645|FG000|STARTED|Treatment Period 1||19
11292792|NCT02504320|12490646|FG001|STARTED|Treatment Period 1||19
11292793|NCT02504320|12490647|FG002|STARTED|Treatment Period 1||20
11292794|NCT02504320|12490648|FG003|STARTED|Treatment Period 1||20
11292795|NCT02504320|12490645|FG000|COMPLETED|Treatment Period 1||19
11292796|NCT02504320|12490646|FG001|COMPLETED|Treatment Period 1||19
11292797|NCT02504320|12490647|FG002|COMPLETED|Treatment Period 1||19
11292798|NCT02504320|12490648|FG003|COMPLETED|Treatment Period 1||20
11292799|NCT02504320|12490645|FG000|NOT COMPLETED|Treatment Period 1||0
11292800|NCT02504320|12490646|FG001|NOT COMPLETED|Treatment Period 1||0
11292801|NCT02504320|12490647|FG002|NOT COMPLETED|Treatment Period 1||1
11292802|NCT02504320|12490648|FG003|NOT COMPLETED|Treatment Period 1||0
11292803|NCT02504320|12490645|FG000|STARTED|Treatment Period 2||19
11292804|NCT02504320|12490646|FG001|STARTED|Treatment Period 2||19
11292805|NCT02504320|12490647|FG002|STARTED|Treatment Period 2||19
11292806|NCT02504320|12490648|FG003|STARTED|Treatment Period 2||20
11292807|NCT02504320|12490645|FG000|COMPLETED|Treatment Period 2||19
11292808|NCT02504320|12490646|FG001|COMPLETED|Treatment Period 2||18
11292809|NCT02504320|12490647|FG002|COMPLETED|Treatment Period 2||19
11292810|NCT02504320|12490648|FG003|COMPLETED|Treatment Period 2||20
11292811|NCT02504320|12490645|FG000|NOT COMPLETED|Treatment Period 2||0
11292812|NCT02504320|12490646|FG001|NOT COMPLETED|Treatment Period 2||1
11292813|NCT02504320|12490647|FG002|NOT COMPLETED|Treatment Period 2||0
11292814|NCT02504320|12490648|FG003|NOT COMPLETED|Treatment Period 2||0
11292815|NCT02504320|12490645|FG000|STARTED|Treatment Period 3||19
11292816|NCT02504320|12490646|FG001|STARTED|Treatment Period 3||18
11292817|NCT02504320|12490647|FG002|STARTED|Treatment Period 3||19
11292818|NCT02504320|12490648|FG003|STARTED|Treatment Period 3||20
11292819|NCT02504320|12490645|FG000|COMPLETED|Treatment Period 3||19
11292820|NCT02504320|12490646|FG001|COMPLETED|Treatment Period 3||18
11292821|NCT02504320|12490647|FG002|COMPLETED|Treatment Period 3||18
11292822|NCT02504320|12490648|FG003|COMPLETED|Treatment Period 3||19
11292823|NCT02504320|12490645|FG000|NOT COMPLETED|Treatment Period 3||0
11292824|NCT02504320|12490646|FG001|NOT COMPLETED|Treatment Period 3||0
11292825|NCT02504320|12490647|FG002|NOT COMPLETED|Treatment Period 3||1
11292826|NCT02504320|12490648|FG003|NOT COMPLETED|Treatment Period 3||1
11292827|NCT02504320|12490645|FG000|STARTED|Treatment Period 4||19
11292828|NCT02504320|12490646|FG001|STARTED|Treatment Period 4||18
11292829|NCT02504320|12490647|FG002|STARTED|Treatment Period 4||18
11292830|NCT02504320|12490648|FG003|STARTED|Treatment Period 4||19
11292831|NCT02504320|12490645|FG000|COMPLETED|Treatment Period 4||19
11292832|NCT02504320|12490646|FG001|COMPLETED|Treatment Period 4||18
11292833|NCT02504320|12490647|FG002|COMPLETED|Treatment Period 4||18
11292834|NCT02504320|12490648|FG003|COMPLETED|Treatment Period 4||19
11292835|NCT02504320|12490645|FG000|NOT COMPLETED|Treatment Period 4||0
11292836|NCT02504320|12490646|FG001|NOT COMPLETED|Treatment Period 4||0
11292837|NCT02504320|12490647|FG002|NOT COMPLETED|Treatment Period 4||0
11292838|NCT02504320|12490648|FG003|NOT COMPLETED|Treatment Period 4||0
11292839|NCT02504424|12490658|FG000|STARTED|Overall Study||50
11292840|NCT02504424|12490658|FG000|COMPLETED|Overall Study||48
11292841|NCT02504424|12490658|FG000|NOT COMPLETED|Overall Study||2
11292842|NCT02504502|12490665|FG000|STARTED|Routine Care vs. Enhanced Report||24
11292843|NCT02504502|12490666|FG001|STARTED|Routine Care vs. Enhanced Report||28
11292844|NCT02504502|12490665|FG000|COMPLETED|Routine Care vs. Enhanced Report||20
11292845|NCT02504502|12490666|FG001|COMPLETED|Routine Care vs. Enhanced Report||21
11292846|NCT02504502|12490665|FG000|NOT COMPLETED|Routine Care vs. Enhanced Report||4
11292847|NCT02504502|12490666|FG001|NOT COMPLETED|Routine Care vs. Enhanced Report||7
11292848|NCT02504502|12490665|FG000|STARTED|Crossover to Enhanced Report||20
11292849|NCT02504502|12490666|FG001|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
11292850|NCT02504502|12490665|FG000|COMPLETED|Crossover to Enhanced Report||15
11292851|NCT02504502|12490666|FG001|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
11292852|NCT02504502|12490665|FG000|NOT COMPLETED|Crossover to Enhanced Report||5
11292853|NCT02504502|12490666|FG001|NOT COMPLETED|Crossover to Enhanced Report||0
11292854|NCT02504541|12490672|FG000|STARTED|Overall Study||133
11292855|NCT02504541|12490672|FG000|COMPLETED|Overall Study||113
11292856|NCT02504541|12490672|FG000|NOT COMPLETED|Overall Study||20
11292857|NCT02504554|12490678|FG000|STARTED|Overall Study|1 participant was switched from the oral group to the rectal group due to nausea/vomiting.|12
11292858|NCT02504554|12490679|FG001|STARTED|Overall Study||6
11292859|NCT02504554|12490678|FG000|COMPLETED|Overall Study||12
11292860|NCT02504554|12490679|FG001|COMPLETED|Overall Study||6
11292861|NCT02504554|12490678|FG000|NOT COMPLETED|Overall Study||0
11292862|NCT02504554|12490679|FG001|NOT COMPLETED|Overall Study||0
11292863|NCT02504619|12490685|FG000|STARTED|Overall Study||1
11292864|NCT02504619|12490685|FG000|COMPLETED|Overall Study||1
11292865|NCT02504619|12490685|FG000|NOT COMPLETED|Overall Study||0
11292866|NCT02504645|12490692|FG000|STARTED|Overall Study||101
11292867|NCT02504645|12490693|FG001|STARTED|Overall Study||101
11292868|NCT02504645|12490692|FG000|COMPLETED|Overall Study||77
11292869|NCT02504645|12490693|FG001|COMPLETED|Overall Study||76
11292870|NCT02504645|12490692|FG000|NOT COMPLETED|Overall Study||24
11292871|NCT02504645|12490693|FG001|NOT COMPLETED|Overall Study||25
11292872|NCT02504671|12490705|FG000|STARTED|Overall Study||37
11292873|NCT02504671|12490706|FG001|STARTED|Overall Study||37
11292874|NCT02504671|12490707|FG002|STARTED|Overall Study||37
11292875|NCT02504671|12490708|FG003|STARTED|Overall Study||37
11292876|NCT02504671|12490709|FG004|STARTED|Overall Study||37
11292877|NCT02504671|12490710|FG005|STARTED|Overall Study||37
11292878|NCT02504671|12490705|FG000|COMPLETED|Overall Study||25
11292879|NCT02504671|12490706|FG001|COMPLETED|Overall Study||23
11292880|NCT02504671|12490707|FG002|COMPLETED|Overall Study||27
11292881|NCT02504671|12490708|FG003|COMPLETED|Overall Study||27
11292882|NCT02504671|12490709|FG004|COMPLETED|Overall Study||25
11292883|NCT02504671|12490710|FG005|COMPLETED|Overall Study||23
11292884|NCT02504671|12490705|FG000|NOT COMPLETED|Overall Study||12
11292885|NCT02504671|12490706|FG001|NOT COMPLETED|Overall Study||14
11292886|NCT02504671|12490707|FG002|NOT COMPLETED|Overall Study||10
11292887|NCT02504671|12490708|FG003|NOT COMPLETED|Overall Study||10
11292888|NCT02504671|12490709|FG004|NOT COMPLETED|Overall Study||12
11292889|NCT02504671|12490710|FG005|NOT COMPLETED|Overall Study||14
11292890|NCT02504723|12490726|FG000|STARTED|Overall Study||60
11292891|NCT02504723|12490727|FG001|STARTED|Overall Study||61
11292892|NCT02504723|12490726|FG000|COMPLETED|Overall Study||60
11292893|NCT02504723|12490727|FG001|COMPLETED|Overall Study||61
11292894|NCT02504723|12490726|FG000|NOT COMPLETED|Overall Study||0
11292895|NCT02504723|12490727|FG001|NOT COMPLETED|Overall Study||0
11292896|NCT02504775|12490733|FG000|STARTED|Period 1||14
11292897|NCT02504775|12490734|FG001|STARTED|Period 1||14
11292898|NCT02504775|12490733|FG000|COMPLETED|Period 1||14
11292899|NCT02504775|12490734|FG001|COMPLETED|Period 1||14
11292900|NCT02504775|12490733|FG000|NOT COMPLETED|Period 1||0
11292901|NCT02504775|12490734|FG001|NOT COMPLETED|Period 1||0
11292902|NCT02504775|12490733|FG000|STARTED|Washout||14
11292903|NCT02504775|12490734|FG001|STARTED|Washout||14
11292904|NCT02504775|12490733|FG000|COMPLETED|Washout||14
11292905|NCT02504775|12490734|FG001|COMPLETED|Washout||14
11292906|NCT02504775|12490733|FG000|NOT COMPLETED|Washout||0
11292907|NCT02504775|12490734|FG001|NOT COMPLETED|Washout||0
11292908|NCT02504775|12490733|FG000|STARTED|Period 2||14
11292909|NCT02504775|12490734|FG001|STARTED|Period 2||14
11292910|NCT02504775|12490733|FG000|COMPLETED|Period 2||14
11292911|NCT02504775|12490734|FG001|COMPLETED|Period 2||14
11292912|NCT02504775|12490733|FG000|NOT COMPLETED|Period 2||0
11292913|NCT02504775|12490734|FG001|NOT COMPLETED|Period 2||0
11292914|NCT02504827|12490742|FG000|STARTED|Overall Study||12
11292915|NCT02504827|12490742|FG000|COMPLETED|Overall Study||11
11292916|NCT02504827|12490742|FG000|NOT COMPLETED|Overall Study||1
11341198|NCT02929823|12538501|FG000|COMPLETED|Overall Study||39
11341199|NCT02929823|12538502|FG001|COMPLETED|Overall Study||40
11341200|NCT02929823|12538503|FG002|COMPLETED|Overall Study||38
11341201|NCT02929823|12538501|FG000|NOT COMPLETED|Overall Study||3
11341202|NCT02929823|12538502|FG001|NOT COMPLETED|Overall Study||6
11292917|NCT02504892|12490746|FG000|STARTED|Overall Study||3
11292918|NCT02504892|12490746|FG000|COMPLETED|Overall Study||1
11292919|NCT02504892|12490746|FG000|NOT COMPLETED|Overall Study||2
11292920|NCT02504931|12490752|FG000|STARTED|Overall Study||26
11292921|NCT02504931|12490753|FG001|STARTED|Overall Study||23
11400087|NCT04274075|12594779|FG001|Completed Treatment Period 2 (9 Days)|Overall Study||3
11400088|NCT04274075|12594780|FG002|Completed Treatment Period 2 (9 Days)|Overall Study||3
11400089|NCT04274075|12594781|FG003|Completed Treatment Period 2 (9 Days)|Overall Study||3
11400090|NCT04274075|12594782|FG004|Completed Treatment Period 2 (9 Days)|Overall Study||3
11400091|NCT04274075|12594783|FG005|Completed Treatment Period 2 (9 Days)|Overall Study||3
11400092|NCT04274075|12594778|FG000|Completed Treatment Period 3 (9 Days)|Overall Study||3
11400093|NCT04274075|12594779|FG001|Completed Treatment Period 3 (9 Days)|Overall Study||3
11400094|NCT04274075|12594780|FG002|Completed Treatment Period 3 (9 Days)|Overall Study||3
11400095|NCT04274075|12594781|FG003|Completed Treatment Period 3 (9 Days)|Overall Study||3
11292922|NCT02504931|12490752|FG000|COMPLETED|Overall Study||14
11292923|NCT02504931|12490753|FG001|COMPLETED|Overall Study||13
11292924|NCT02504931|12490752|FG000|NOT COMPLETED|Overall Study||12
11292925|NCT02504931|12490753|FG001|NOT COMPLETED|Overall Study||10
11292926|NCT02505217|12490761|FG000|STARTED|Overall Study||105
11292927|NCT02505217|12490762|FG001|STARTED|Overall Study||95
11292928|NCT02505217|12490761|FG000|COMPLETED|Overall Study||104
11292929|NCT02505217|12490762|FG001|COMPLETED|Overall Study||93
11292930|NCT02505217|12490761|FG000|NOT COMPLETED|Overall Study||1
11292931|NCT02505217|12490762|FG001|NOT COMPLETED|Overall Study||2
11292932|NCT02505269|12490768|FG000|STARTED|Overall Study||34
11292933|NCT02505269|12490768|FG000|COMPLETED|Overall Study||34
11292934|NCT02505269|12490768|FG000|NOT COMPLETED|Overall Study||0
11292935|NCT02505334|12490774|FG000|STARTED|Main Treatment Period||233
11292936|NCT02505334|12490775|FG001|STARTED|Main Treatment Period||233
11292937|NCT02505334|12490774|FG000|COMPLETED|Main Treatment Period||218
11292938|NCT02505334|12490775|FG001|COMPLETED|Main Treatment Period||194
11292939|NCT02505334|12490774|FG000|NOT COMPLETED|Main Treatment Period||15
11292940|NCT02505334|12490775|FG001|NOT COMPLETED|Main Treatment Period||39
11292941|NCT02505334|12490774|FG000|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
11292942|NCT02505334|12490775|FG001|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
11292943|NCT02505334|12490774|FG000|COMPLETED|Extension Treatment Period||194
11292944|NCT02505334|12490775|FG001|COMPLETED|Extension Treatment Period||0
11292945|NCT02505334|12490774|FG000|NOT COMPLETED|Extension Treatment Period||18
11292946|NCT02505334|12490775|FG001|NOT COMPLETED|Extension Treatment Period||0
11292947|NCT02505542|12490781|FG000|STARTED|Part A: Open-Label Period||736
11292948|NCT02505542|12490782|FG001|STARTED|Part A: Open-Label Period||0
11292949|NCT02505542|12490783|FG002|STARTED|Part A: Open-Label Period||0
11292950|NCT02505542|12490784|FG003|STARTED|Part A: Open-Label Period||0
11292951|NCT02505542|12490781|FG000|COMPLETED|Part A: Open-Label Period||659
11292952|NCT02505542|12490782|FG001|COMPLETED|Part A: Open-Label Period||0
11292953|NCT02505542|12490783|FG002|COMPLETED|Part A: Open-Label Period||0
11292954|NCT02505542|12490784|FG003|COMPLETED|Part A: Open-Label Period||0
11292955|NCT02505542|12490781|FG000|NOT COMPLETED|Part A: Open-Label Period||77
11292956|NCT02505542|12490782|FG001|NOT COMPLETED|Part A: Open-Label Period||0
11292957|NCT02505542|12490783|FG002|NOT COMPLETED|Part A: Open-Label Period||0
11292958|NCT02505542|12490784|FG003|NOT COMPLETED|Part A: Open-Label Period||0
11292959|NCT02505542|12490781|FG000|STARTED|Completed Part A, Did Not Enter Part B||659
11292960|NCT02505542|12490782|FG001|STARTED|Completed Part A, Did Not Enter Part B||0
11292961|NCT02505542|12490783|FG002|STARTED|Completed Part A, Did Not Enter Part B||0
11292962|NCT02505542|12490784|FG003|STARTED|Completed Part A, Did Not Enter Part B||0
11292963|NCT02505542|12490781|FG000|COMPLETED|Completed Part A, Did Not Enter Part B||313
11292964|NCT02505542|12490782|FG001|COMPLETED|Completed Part A, Did Not Enter Part B||0
11292965|NCT02505542|12490783|FG002|COMPLETED|Completed Part A, Did Not Enter Part B||0
11292966|NCT02505542|12490784|FG003|COMPLETED|Completed Part A, Did Not Enter Part B||0
11292967|NCT02505542|12490781|FG000|NOT COMPLETED|Completed Part A, Did Not Enter Part B||346
11292968|NCT02505542|12490782|FG001|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
11292969|NCT02505542|12490783|FG002|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
11292970|NCT02505542|12490784|FG003|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
11292971|NCT02505542|12490781|FG000|STARTED|Part B: Double-Blind Period||0
11292972|NCT02505542|12490782|FG001|STARTED|Part B: Double-Blind Period||104
11292973|NCT02505542|12490783|FG002|STARTED|Part B: Double-Blind Period||104
11292974|NCT02505542|12490784|FG003|STARTED|Part B: Double-Blind Period||105
11341203|NCT02929823|12538503|FG002|NOT COMPLETED|Overall Study||4
11341204|NCT02929979|12538513|FG000|STARTED|Overall Study||52
11341205|NCT02929979|12538514|FG001|STARTED|Overall Study||38
11341206|NCT02929979|12538513|FG000|COMPLETED|Overall Study||25
11341207|NCT02929979|12538514|FG001|COMPLETED|Overall Study||28
11341208|NCT02929979|12538513|FG000|NOT COMPLETED|Overall Study||27
11341209|NCT02929979|12538514|FG001|NOT COMPLETED|Overall Study||10
11341210|NCT02930005|12538523|FG000|STARTED|Overall Study||2
11341211|NCT02930005|12538524|FG001|STARTED|Overall Study||6
11341212|NCT02930005|12538523|FG000|Completed 2 Weeks|Overall Study||2
11341213|NCT02930005|12538524|FG001|Completed 2 Weeks|Overall Study||2
11341214|NCT02930005|12538523|FG000|COMPLETED|Overall Study||1
11341215|NCT02930005|12538524|FG001|COMPLETED|Overall Study||1
11341216|NCT02930005|12538523|FG000|NOT COMPLETED|Overall Study||1
11292975|NCT02505542|12490781|FG000|Started Escape Period|Part B: Double-Blind Period||0
11292976|NCT02505542|12490782|FG001|Started Escape Period|Part B: Double-Blind Period||73
11292977|NCT02505542|12490783|FG002|Started Escape Period|Part B: Double-Blind Period||7
11292978|NCT02505542|12490784|FG003|Started Escape Period|Part B: Double-Blind Period||15
11292979|NCT02505542|12490781|FG000|COMPLETED|Part B: Double-Blind Period||0
11292980|NCT02505542|12490782|FG001|COMPLETED|Part B: Double-Blind Period||92
11292981|NCT02505542|12490783|FG002|COMPLETED|Part B: Double-Blind Period||95
11292982|NCT02505542|12490784|FG003|COMPLETED|Part B: Double-Blind Period||98
11292983|NCT02505542|12490781|FG000|NOT COMPLETED|Part B: Double-Blind Period||0
11292984|NCT02505542|12490782|FG001|NOT COMPLETED|Part B: Double-Blind Period||12
11292985|NCT02505542|12490783|FG002|NOT COMPLETED|Part B: Double-Blind Period||9
11400096|NCT04274075|12594782|FG004|Completed Treatment Period 3 (9 Days)|Overall Study||3
11400097|NCT04274075|12594783|FG005|Completed Treatment Period 3 (9 Days)|Overall Study||3
11292986|NCT02505542|12490784|FG003|NOT COMPLETED|Part B: Double-Blind Period||7
11292987|NCT02505867|12490812|FG000|STARTED|Overall Study||6
11292988|NCT02505867|12490813|FG001|STARTED|Overall Study||6
11292989|NCT02505867|12490812|FG000|COMPLETED|Overall Study||0
11292990|NCT02505867|12490813|FG001|COMPLETED|Overall Study||0
11292991|NCT02505867|12490812|FG000|NOT COMPLETED|Overall Study||6
11292992|NCT02505867|12490813|FG001|NOT COMPLETED|Overall Study||6
11292993|NCT02505919|12490821|FG000|STARTED|Treatment||117
11292994|NCT02505919|12490822|FG001|STARTED|Treatment||67
11292995|NCT02505919|12490821|FG000|COMPLETED|Treatment||116
11292996|NCT02505919|12490822|FG001|COMPLETED|Treatment||65
11292997|NCT02505919|12490821|FG000|NOT COMPLETED|Treatment||1
11292998|NCT02505919|12490822|FG001|NOT COMPLETED|Treatment||2
11292999|NCT02505919|12490821|FG000|STARTED|1 Week Follow-Up||116
11293000|NCT02505919|12490822|FG001|STARTED|1 Week Follow-Up||65
11293001|NCT02505919|12490821|FG000|COMPLETED|1 Week Follow-Up||116
11293002|NCT02505919|12490822|FG001|COMPLETED|1 Week Follow-Up||65
11293003|NCT02505919|12490821|FG000|NOT COMPLETED|1 Week Follow-Up||0
11293004|NCT02505919|12490822|FG001|NOT COMPLETED|1 Week Follow-Up||0
11293005|NCT02505919|12490821|FG000|STARTED|1 Month Follow-Up||116
11293006|NCT02505919|12490822|FG001|STARTED|1 Month Follow-Up||65
11293007|NCT02505919|12490821|FG000|COMPLETED|1 Month Follow-Up||116
11293008|NCT02505919|12490822|FG001|COMPLETED|1 Month Follow-Up||65
11293009|NCT02505919|12490821|FG000|NOT COMPLETED|1 Month Follow-Up||0
11293010|NCT02505919|12490822|FG001|NOT COMPLETED|1 Month Follow-Up||0
11293011|NCT02505919|12490821|FG000|STARTED|3 Months Follow-Up||116
11293012|NCT02505919|12490822|FG001|STARTED|3 Months Follow-Up||65
11293013|NCT02505919|12490821|FG000|COMPLETED|3 Months Follow-Up||116
11293014|NCT02505919|12490822|FG001|COMPLETED|3 Months Follow-Up||65
11293015|NCT02505919|12490821|FG000|NOT COMPLETED|3 Months Follow-Up||0
11293016|NCT02505919|12490822|FG001|NOT COMPLETED|3 Months Follow-Up||0
11293017|NCT02505919|12490821|FG000|STARTED|6 Months Follow-Up||116
11293018|NCT02505919|12490822|FG001|STARTED|6 Months Follow-Up||65
11293019|NCT02505919|12490821|FG000|COMPLETED|6 Months Follow-Up||116
11293020|NCT02505919|12490822|FG001|COMPLETED|6 Months Follow-Up||63
11293021|NCT02505919|12490821|FG000|NOT COMPLETED|6 Months Follow-Up||0
11293022|NCT02505919|12490822|FG001|NOT COMPLETED|6 Months Follow-Up||2
11400098|NCT04274075|12594778|FG000|Completed Follow-up Visit|Overall Study||3
11400099|NCT04274075|12594779|FG001|Completed Follow-up Visit|Overall Study||3
11400100|NCT04274075|12594780|FG002|Completed Follow-up Visit|Overall Study||3
11400101|NCT04274075|12594781|FG003|Completed Follow-up Visit|Overall Study||3
11400102|NCT04274075|12594782|FG004|Completed Follow-up Visit|Overall Study||3
11293023|NCT02505919|12490821|FG000|STARTED|12 Months Follow-Up||116
11293024|NCT02505919|12490822|FG001|STARTED|12 Months Follow-Up||63
11293025|NCT02505919|12490821|FG000|COMPLETED|12 Months Follow-Up||115
11293026|NCT02505919|12490822|FG001|COMPLETED|12 Months Follow-Up||61
11293027|NCT02505919|12490821|FG000|NOT COMPLETED|12 Months Follow-Up||1
11293028|NCT02505919|12490822|FG001|NOT COMPLETED|12 Months Follow-Up||2
11293029|NCT02505919|12490821|FG000|STARTED|24 Months Follow-Up||115
11293030|NCT02505919|12490822|FG001|STARTED|24 Months Follow-Up||61
11293031|NCT02505919|12490821|FG000|COMPLETED|24 Months Follow-Up||112
11293032|NCT02505919|12490822|FG001|COMPLETED|24 Months Follow-Up||60
11293033|NCT02505919|12490821|FG000|NOT COMPLETED|24 Months Follow-Up||3
11293034|NCT02505919|12490822|FG001|NOT COMPLETED|24 Months Follow-Up||1
11293035|NCT02505919|12490821|FG000|STARTED|36 Months Follow-Up||112
11293036|NCT02505919|12490822|FG001|STARTED|36 Months Follow-Up||60
11293037|NCT02505919|12490821|FG000|COMPLETED|36 Months Follow-Up||97
11293038|NCT02505919|12490822|FG001|COMPLETED|36 Months Follow-Up||55
11293039|NCT02505919|12490821|FG000|NOT COMPLETED|36 Months Follow-Up||15
11293040|NCT02505919|12490822|FG001|NOT COMPLETED|36 Months Follow-Up||5
11293041|NCT02505945|12490830|FG000|STARTED|Overall Study||102
11293042|NCT02505945|12490831|FG001|STARTED|Overall Study||50
11293043|NCT02505945|12490830|FG000|COMPLETED|Overall Study||80
11293044|NCT02505945|12490831|FG001|COMPLETED|Overall Study||46
11293045|NCT02505945|12490830|FG000|NOT COMPLETED|Overall Study||22
11293046|NCT02505945|12490831|FG001|NOT COMPLETED|Overall Study||4
11293047|NCT02506036|12490839|FG000|STARTED|First Intervention (4-6 Weeks)||3
11293048|NCT02506036|12490840|FG001|STARTED|First Intervention (4-6 Weeks)||3
11293049|NCT02506036|12490839|FG000|COMPLETED|First Intervention (4-6 Weeks)||2
11293050|NCT02506036|12490840|FG001|COMPLETED|First Intervention (4-6 Weeks)||1
11293051|NCT02506036|12490839|FG000|NOT COMPLETED|First Intervention (4-6 Weeks)||1
11293052|NCT02506036|12490840|FG001|NOT COMPLETED|First Intervention (4-6 Weeks)||2
11293053|NCT02506036|12490839|FG000|STARTED|Washout (1-2 Weeks)||2
11293054|NCT02506036|12490840|FG001|STARTED|Washout (1-2 Weeks)||1
11293055|NCT02506036|12490839|FG000|COMPLETED|Washout (1-2 Weeks)||2
11293056|NCT02506036|12490840|FG001|COMPLETED|Washout (1-2 Weeks)||1
11021903|NCT00806442|12200085|FG001|First Intervention (3 Wks)|Overall Study||21
11021904|NCT00806442|12200084|FG000|Washout (3 Wks)|Overall Study||15
11021905|NCT00806442|12200085|FG001|Washout (3 Wks)|Overall Study||14
11293057|NCT02506036|12490839|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0
11293058|NCT02506036|12490840|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0
11293059|NCT02506036|12490839|FG000|STARTED|Second Intervention (4-6 Weeks)||2
11400103|NCT04274075|12594783|FG005|Completed Follow-up Visit|Overall Study||3
11293060|NCT02506036|12490840|FG001|STARTED|Second Intervention (4-6 Weeks)||1
11293061|NCT02506036|12490839|FG000|COMPLETED|Second Intervention (4-6 Weeks)||2
11293062|NCT02506036|12490840|FG001|COMPLETED|Second Intervention (4-6 Weeks)||1
11293063|NCT02506036|12490839|FG000|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
11293064|NCT02506036|12490840|FG001|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
11293065|NCT02506114|12490849|FG000|STARTED|Overall Study||5
11293066|NCT02506114|12490850|FG001|STARTED|Overall Study||4
11293067|NCT02506114|12490851|FG002|STARTED|Overall Study||6
11293068|NCT02506114|12490849|FG000|COMPLETED|Overall Study||5
11293069|NCT02506114|12490850|FG001|COMPLETED|Overall Study||4
11293070|NCT02506114|12490851|FG002|COMPLETED|Overall Study||6
11293071|NCT02506114|12490849|FG000|NOT COMPLETED|Overall Study||0
11293072|NCT02506114|12490850|FG001|NOT COMPLETED|Overall Study||0
11293073|NCT02506114|12490851|FG002|NOT COMPLETED|Overall Study||0
11293074|NCT02506257|12490863|FG000|STARTED|Overall Study||26
11293075|NCT02506257|12490864|FG001|STARTED|Overall Study||28
11293076|NCT02506257|12490865|FG002|STARTED|Overall Study||27
11293077|NCT02506257|12490866|FG003|STARTED|Overall Study||9
11293078|NCT02506257|12490863|FG000|COMPLETED|Overall Study||26
11293079|NCT02506257|12490864|FG001|COMPLETED|Overall Study||26
11293080|NCT02506257|12490865|FG002|COMPLETED|Overall Study||23
11293081|NCT02506257|12490866|FG003|COMPLETED|Overall Study||9
11293082|NCT02506257|12490863|FG000|NOT COMPLETED|Overall Study||0
11293083|NCT02506257|12490864|FG001|NOT COMPLETED|Overall Study||2
11293084|NCT02506257|12490865|FG002|NOT COMPLETED|Overall Study||4
11293085|NCT02506257|12490866|FG003|NOT COMPLETED|Overall Study||0
11293086|NCT02506309|12490878|FG000|STARTED|Overall Study||84
11293087|NCT02506309|12490879|FG001|STARTED|Overall Study||84
11293088|NCT02506309|12490878|FG000|COMPLETED|Overall Study||66
11293089|NCT02506309|12490879|FG001|COMPLETED|Overall Study||64
11293090|NCT02506309|12490878|FG000|NOT COMPLETED|Overall Study||18
11293091|NCT02506309|12490879|FG001|NOT COMPLETED|Overall Study||20
11293092|NCT02506634|12490893|FG000|STARTED|Overall Study||374
11293093|NCT02506634|12490893|FG000|Participants Who Were Diagnosed as GERD|Overall Study||154
11293094|NCT02506634|12490893|FG000|Participants Who Received PPI Treatment|Overall Study||357
11293095|NCT02506634|12490893|FG000|Participants Who Finished GERDQ|Overall Study||342
11293096|NCT02506634|12490893|FG000|COMPLETED|Overall Study||357
11293097|NCT02506634|12490893|FG000|NOT COMPLETED|Overall Study||17
11293098|NCT02506660|12490933|FG000|STARTED|Overall Study||64
11293099|NCT02506660|12490934|FG001|STARTED|Overall Study||64
11293100|NCT02506660|12490933|FG000|COMPLETED|Overall Study||62
11293101|NCT02506660|12490934|FG001|COMPLETED|Overall Study||63
11293102|NCT02506660|12490933|FG000|NOT COMPLETED|Overall Study||2
11293103|NCT02506660|12490934|FG001|NOT COMPLETED|Overall Study||1
11293104|NCT02506673|12490942|FG000|STARTED|Overall Study||13
11293105|NCT02506673|12490943|FG001|STARTED|Overall Study||13
11293106|NCT02506673|12490942|FG000|COMPLETED|Overall Study||13
11293107|NCT02506673|12490943|FG001|COMPLETED|Overall Study||13
11293108|NCT02506673|12490942|FG000|NOT COMPLETED|Overall Study||0
11293109|NCT02506673|12490943|FG001|NOT COMPLETED|Overall Study||0
11293110|NCT02506816|12490949|FG000|STARTED|Overall Study||36
11293111|NCT02506816|12490949|FG000|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31
11293112|NCT02506816|12490949|FG000|COMPLETED|Overall Study||33
11293113|NCT02506816|12490949|FG000|NOT COMPLETED|Overall Study||3
11293114|NCT02506868|12490955|FG000|STARTED|Main Period of Study (24 Weeks)||98
11293115|NCT02506868|12490956|FG001|STARTED|Main Period of Study (24 Weeks)||98
11293116|NCT02506868|12490955|FG000|mITT Population|Main Period of Study (24 Weeks)||98
11293117|NCT02506868|12490956|FG001|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97
11293118|NCT02506868|12490955|FG000|Per Protocol Population|Main Period of Study (24 Weeks)||86
11293119|NCT02506868|12490956|FG001|Per Protocol Population|Main Period of Study (24 Weeks)||90
11293120|NCT02506868|12490955|FG000|COMPLETED|Main Period of Study (24 Weeks)||86
11293121|NCT02506868|12490956|FG001|COMPLETED|Main Period of Study (24 Weeks)||90
11293122|NCT02506868|12490955|FG000|NOT COMPLETED|Main Period of Study (24 Weeks)||12
11293123|NCT02506868|12490956|FG001|NOT COMPLETED|Main Period of Study (24 Weeks)||8
11293124|NCT02506868|12490955|FG000|STARTED|Additional Period of Study (Until 52W)||86
11293125|NCT02506868|12490956|FG001|STARTED|Additional Period of Study (Until 52W)||90
11293126|NCT02506868|12490955|FG000|COMPLETED|Additional Period of Study (Until 52W)||83
11293127|NCT02506868|12490956|FG001|COMPLETED|Additional Period of Study (Until 52W)||85
11293128|NCT02506868|12490955|FG000|NOT COMPLETED|Additional Period of Study (Until 52W)||3
11293129|NCT02506868|12490956|FG001|NOT COMPLETED|Additional Period of Study (Until 52W)||5
11293130|NCT02506881|12490970|FG000|STARTED|First Intervention (Day 1)||13
11293131|NCT02506881|12490971|FG001|STARTED|First Intervention (Day 1)||12
11293132|NCT02506881|12490972|FG002|STARTED|First Intervention (Day 1)||25
11293133|NCT02506881|12490973|FG003|STARTED|First Intervention (Day 1)||24
11293134|NCT02506881|12490970|FG000|COMPLETED|First Intervention (Day 1)||12
11293135|NCT02506881|12490971|FG001|COMPLETED|First Intervention (Day 1)||12
11293136|NCT02506881|12490972|FG002|COMPLETED|First Intervention (Day 1)||12
11293137|NCT02506881|12490973|FG003|COMPLETED|First Intervention (Day 1)||12
11293138|NCT02506881|12490970|FG000|NOT COMPLETED|First Intervention (Day 1)||1
11293139|NCT02506881|12490971|FG001|NOT COMPLETED|First Intervention (Day 1)||0
11293140|NCT02506881|12490972|FG002|NOT COMPLETED|First Intervention (Day 1)||13
11293141|NCT02506881|12490973|FG003|NOT COMPLETED|First Intervention (Day 1)||12
11293142|NCT02506881|12490970|FG000|STARTED|Washout (at Least 25 Days)||12
11293143|NCT02506881|12490971|FG001|STARTED|Washout (at Least 25 Days)||12
11293144|NCT02506881|12490972|FG002|STARTED|Washout (at Least 25 Days)||12
11293145|NCT02506881|12490973|FG003|STARTED|Washout (at Least 25 Days)||12
11293146|NCT02506881|12490970|FG000|COMPLETED|Washout (at Least 25 Days)||12
11293147|NCT02506881|12490971|FG001|COMPLETED|Washout (at Least 25 Days)||12
11293148|NCT02506881|12490972|FG002|COMPLETED|Washout (at Least 25 Days)||12
11293149|NCT02506881|12490973|FG003|COMPLETED|Washout (at Least 25 Days)||12
11293150|NCT02506881|12490970|FG000|NOT COMPLETED|Washout (at Least 25 Days)||0
11293151|NCT02506881|12490971|FG001|NOT COMPLETED|Washout (at Least 25 Days)||0
11293152|NCT02506881|12490972|FG002|NOT COMPLETED|Washout (at Least 25 Days)||0
11293153|NCT02506881|12490973|FG003|NOT COMPLETED|Washout (at Least 25 Days)||0
11293154|NCT02506881|12490970|FG000|STARTED|Second Intervention (Day 1)||12
11293155|NCT02506881|12490971|FG001|STARTED|Second Intervention (Day 1)||12
11293156|NCT02506881|12490972|FG002|STARTED|Second Intervention (Day 1)||12
11293157|NCT02506881|12490973|FG003|STARTED|Second Intervention (Day 1)||12
11293158|NCT02506881|12490970|FG000|COMPLETED|Second Intervention (Day 1)||12
11293159|NCT02506881|12490971|FG001|COMPLETED|Second Intervention (Day 1)||12
11293160|NCT02506881|12490972|FG002|COMPLETED|Second Intervention (Day 1)||12
11293161|NCT02506881|12490973|FG003|COMPLETED|Second Intervention (Day 1)||12
11293162|NCT02506881|12490970|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
11293163|NCT02506881|12490971|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
11293164|NCT02506881|12490972|FG002|NOT COMPLETED|Second Intervention (Day 1)||0
11293165|NCT02506881|12490973|FG003|NOT COMPLETED|Second Intervention (Day 1)||0
11293166|NCT02507011|12490993|FG000|STARTED|First Intervention||1
11293167|NCT02507011|12490994|FG001|STARTED|First Intervention||1
11293168|NCT02507011|12490993|FG000|COMPLETED|First Intervention||1
11293169|NCT02507011|12490994|FG001|COMPLETED|First Intervention||1
11293170|NCT02507011|12490993|FG000|NOT COMPLETED|First Intervention||0
11293171|NCT02507011|12490994|FG001|NOT COMPLETED|First Intervention||0
11293172|NCT02507011|12490993|FG000|STARTED|Second Intervention||1
11293173|NCT02507011|12490994|FG001|STARTED|Second Intervention||1
11293174|NCT02507011|12490993|FG000|COMPLETED|Second Intervention||1
11293175|NCT02507011|12490994|FG001|COMPLETED|Second Intervention||1
11293176|NCT02507011|12490993|FG000|NOT COMPLETED|Second Intervention||0
11293177|NCT02507011|12490994|FG001|NOT COMPLETED|Second Intervention||0
11400104|NCT04274075|12594778|FG000|COMPLETED|Overall Study||3
11400105|NCT04274075|12594779|FG001|COMPLETED|Overall Study||3
11400106|NCT04274075|12594780|FG002|COMPLETED|Overall Study||3
11293178|NCT02507219|12491000|FG000|STARTED|Overall Study||5
11293179|NCT02507219|12491001|FG001|STARTED|Overall Study||4
11293180|NCT02507219|12491002|FG002|STARTED|Overall Study||3
11293181|NCT02507219|12491003|FG003|STARTED|Overall Study||3
11293182|NCT02507219|12491004|FG004|STARTED|Overall Study||4
11293183|NCT02507219|12491005|FG005|STARTED|Overall Study||3
11293184|NCT02507219|12491000|FG000|COMPLETED|Overall Study||4
11293185|NCT02507219|12491001|FG001|COMPLETED|Overall Study||4
11293186|NCT02507219|12491002|FG002|COMPLETED|Overall Study||3
11293187|NCT02507219|12491003|FG003|COMPLETED|Overall Study||3
11293188|NCT02507219|12491004|FG004|COMPLETED|Overall Study||3
11293189|NCT02507219|12491005|FG005|COMPLETED|Overall Study||3
11293190|NCT02507219|12491000|FG000|NOT COMPLETED|Overall Study||1
11293191|NCT02507219|12491001|FG001|NOT COMPLETED|Overall Study||0
11293192|NCT02507219|12491002|FG002|NOT COMPLETED|Overall Study||0
11293193|NCT02507219|12491003|FG003|NOT COMPLETED|Overall Study||0
11293194|NCT02507219|12491004|FG004|NOT COMPLETED|Overall Study||1
11293195|NCT02507219|12491005|FG005|NOT COMPLETED|Overall Study||0
11293196|NCT02507297|12491015|FG000|STARTED|Overall Study||16
11293197|NCT02507297|12491016|FG001|STARTED|Overall Study||13
11293198|NCT02507297|12491015|FG000|COMPLETED|Overall Study||15
11293199|NCT02507297|12491016|FG001|COMPLETED|Overall Study||12
11293200|NCT02507297|12491015|FG000|NOT COMPLETED|Overall Study||1
11293201|NCT02507297|12491016|FG001|NOT COMPLETED|Overall Study||1
11293202|NCT02507349|12491024|FG000|STARTED|Overall Study||1232
11293203|NCT02507349|12491025|FG001|STARTED|Overall Study||1211
11293204|NCT02507349|12491024|FG000|COMPLETED|Overall Study||1045
11293205|NCT02507349|12491025|FG001|COMPLETED|Overall Study||1050
11293206|NCT02507349|12491024|FG000|NOT COMPLETED|Overall Study||187
11293207|NCT02507349|12491025|FG001|NOT COMPLETED|Overall Study||161
11293208|NCT02507375|12491033|FG000|STARTED|Overall Study||6
11293209|NCT02507375|12491034|FG001|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
11293210|NCT02507375|12491033|FG000|Cycle 1|Overall Study||6
11293211|NCT02507375|12491034|FG001|Cycle 1|Overall Study||9
11400107|NCT04274075|12594781|FG003|COMPLETED|Overall Study||3
11400108|NCT04274075|12594782|FG004|COMPLETED|Overall Study||3
11400109|NCT04274075|12594783|FG005|COMPLETED|Overall Study||3
11400110|NCT04274075|12594778|FG000|NOT COMPLETED|Overall Study||0
11400111|NCT04274075|12594779|FG001|NOT COMPLETED|Overall Study||0
11293212|NCT02507375|12491033|FG000|Received Pertuzumab|Overall Study||6
11293213|NCT02507375|12491034|FG001|Received Pertuzumab|Overall Study||6
11293214|NCT02507375|12491033|FG000|Cycle 2|Overall Study||5
11293215|NCT02507375|12491034|FG001|Cycle 2|Overall Study||5
11293216|NCT02507375|12491033|FG000|Cycle 3|Overall Study||4
11293217|NCT02507375|12491034|FG001|Cycle 3|Overall Study||5
11293218|NCT02507375|12491033|FG000|Cycle 4|Overall Study||4
11293219|NCT02507375|12491034|FG001|Cycle 4|Overall Study||2
11293220|NCT02507375|12491033|FG000|Cycle 5|Overall Study||3
11293221|NCT02507375|12491034|FG001|Cycle 5|Overall Study||1
11293222|NCT02507375|12491033|FG000|Cycle 6|Overall Study||3
11293223|NCT02507375|12491034|FG001|Cycle 6|Overall Study||1
11293224|NCT02507375|12491033|FG000|Extension Period|Overall Study||2
11293225|NCT02507375|12491034|FG001|Extension Period|Overall Study||1
11293226|NCT02507375|12491033|FG000|COMPLETED|Overall Study||2
11293227|NCT02507375|12491034|FG001|COMPLETED|Overall Study||1
11293228|NCT02507375|12491033|FG000|NOT COMPLETED|Overall Study||4
11021906|NCT00806442|12200084|FG000|Second Intervention (3 Wks)|Overall Study||15
11021907|NCT00806442|12200085|FG001|Second Intervention (3 Wks)|Overall Study||14
11021908|NCT00806442|12200084|FG000|COMPLETED|Overall Study||14
11021909|NCT00806442|12200085|FG001|COMPLETED|Overall Study||14
11021910|NCT00806442|12200084|FG000|NOT COMPLETED|Overall Study||4
11021911|NCT00806442|12200085|FG001|NOT COMPLETED|Overall Study||7
11293229|NCT02507375|12491034|FG001|NOT COMPLETED|Overall Study||8
11293230|NCT02507388|12491046|FG000|STARTED|Overall Study||25
11293231|NCT02507388|12491047|FG001|STARTED|Overall Study||25
11293232|NCT02507388|12491046|FG000|COMPLETED|Overall Study||25
11293233|NCT02507388|12491047|FG001|COMPLETED|Overall Study||25
11293234|NCT02507388|12491046|FG000|NOT COMPLETED|Overall Study||0
11293235|NCT02507388|12491047|FG001|NOT COMPLETED|Overall Study||0
11293236|NCT02507752|12491054|FG000|STARTED|Overall Study||72
11293237|NCT02507752|12491054|FG000|COMPLETED|Overall Study||55
11293238|NCT02507752|12491054|FG000|NOT COMPLETED|Overall Study||17
11293239|NCT02508077|12491058|FG000|STARTED|Overall Study||1
11293240|NCT02508077|12491058|FG000|COMPLETED|Overall Study||1
11293241|NCT02508077|12491058|FG000|NOT COMPLETED|Overall Study||0
11293242|NCT02508103|12491064|FG000|STARTED|Overall Study||5
11293243|NCT02508103|12491065|FG001|STARTED|Overall Study||5
11293244|NCT02508103|12491064|FG000|COMPLETED|Overall Study||5
11293245|NCT02508103|12491065|FG001|COMPLETED|Overall Study||5
11293246|NCT02508103|12491064|FG000|NOT COMPLETED|Overall Study||0
11293247|NCT02508103|12491065|FG001|NOT COMPLETED|Overall Study||0
11293248|NCT02508116|12491073|FG000|STARTED|Overall Study||252
11293249|NCT02508116|12491074|FG001|STARTED|Overall Study||257
11293250|NCT02508116|12491073|FG000|Received Intervention as Randomized|Overall Study||249
11293251|NCT02508116|12491074|FG001|Received Intervention as Randomized|Overall Study||255
11293252|NCT02508116|12491073|FG000|COMPLETED|Overall Study||244
11293253|NCT02508116|12491074|FG001|COMPLETED|Overall Study||250
11293254|NCT02508116|12491073|FG000|NOT COMPLETED|Overall Study||8
11293255|NCT02508116|12491074|FG001|NOT COMPLETED|Overall Study||7
11293256|NCT02508194|12491082|FG000|STARTED|Overall Study||949
11293257|NCT02508194|12491083|FG001|STARTED|Overall Study||951
11293258|NCT02508194|12491082|FG000|COMPLETED|Overall Study||897
11293259|NCT02508194|12491083|FG001|COMPLETED|Overall Study||907
11293260|NCT02508194|12491082|FG000|NOT COMPLETED|Overall Study||52
11293261|NCT02508194|12491083|FG001|NOT COMPLETED|Overall Study||44
11293262|NCT02508207|12491091|FG000|STARTED|Overall Study||7
11293263|NCT02508207|12491092|FG001|STARTED|Overall Study||27
11293264|NCT02508207|12491091|FG000|COMPLETED|Overall Study||7
11293265|NCT02508207|12491092|FG001|COMPLETED|Overall Study||27
11293266|NCT02508207|12491091|FG000|NOT COMPLETED|Overall Study||0
11293267|NCT02508207|12491092|FG001|NOT COMPLETED|Overall Study||0
11293268|NCT02508259|12491100|FG000|STARTED|Overall Study||5
11293269|NCT02508259|12491101|FG001|STARTED|Overall Study||5
11293270|NCT02508259|12491100|FG000|COMPLETED|Overall Study||5
11293271|NCT02508259|12491101|FG001|COMPLETED|Overall Study||5
11293272|NCT02508259|12491100|FG000|NOT COMPLETED|Overall Study||0
11293273|NCT02508259|12491101|FG001|NOT COMPLETED|Overall Study||0
11293274|NCT02508389|12491110|FG000|STARTED|Overall Study||73
11293275|NCT02508389|12491111|FG001|STARTED|Overall Study||76
11293276|NCT02508389|12491112|FG002|STARTED|Overall Study||74
11293277|NCT02508389|12491110|FG000|COMPLETED|Overall Study||45
11293278|NCT02508389|12491111|FG001|COMPLETED|Overall Study||45
11293279|NCT02508389|12491112|FG002|COMPLETED|Overall Study||42
11293280|NCT02508389|12491110|FG000|NOT COMPLETED|Overall Study||28
11293281|NCT02508389|12491111|FG001|NOT COMPLETED|Overall Study||31
11293282|NCT02508389|12491112|FG002|NOT COMPLETED|Overall Study||32
11293283|NCT02508428|12491122|FG000|STARTED|Overall Study||114
11293284|NCT02508428|12491123|FG001|STARTED|Overall Study||111
11293285|NCT02508428|12491122|FG000|COMPLETED|Overall Study||62
11293286|NCT02508428|12491123|FG001|COMPLETED|Overall Study||44
11293287|NCT02508428|12491122|FG000|NOT COMPLETED|Overall Study||52
11293288|NCT02508428|12491123|FG001|NOT COMPLETED|Overall Study||67
11293289|NCT02508480|12491131|FG000|STARTED|Overall Study||95
11293290|NCT02508480|12491132|FG001|STARTED|Overall Study||97
11293291|NCT02508480|12491131|FG000|Post-Treatment Assessment|Overall Study||87
11400112|NCT04274075|12594780|FG002|NOT COMPLETED|Overall Study||0
11293292|NCT02508480|12491132|FG001|Post-Treatment Assessment|Overall Study||89
11293293|NCT02508480|12491131|FG000|Three Month Follow-up|Overall Study||84
11293294|NCT02508480|12491132|FG001|Three Month Follow-up|Overall Study||86
11293295|NCT02508480|12491131|FG000|Six-Month Follow-Up|Overall Study||84
11293296|NCT02508480|12491132|FG001|Six-Month Follow-Up|Overall Study||86
11293297|NCT02508480|12491131|FG000|COMPLETED|Overall Study||90
11293298|NCT02508480|12491132|FG001|COMPLETED|Overall Study||93
11293299|NCT02508480|12491131|FG000|NOT COMPLETED|Overall Study||5
11293300|NCT02508480|12491132|FG001|NOT COMPLETED|Overall Study||4
11293301|NCT02508636|12491138|FG000|STARTED|Overall Study||11
11293302|NCT02508636|12491138|FG000|COMPLETED|Overall Study||11
11293303|NCT02508636|12491138|FG000|NOT COMPLETED|Overall Study||0
11293304|NCT02508649|12491146|FG000|STARTED|Overall Study||283
11293305|NCT02508649|12491147|FG001|STARTED|Overall Study||197
11293306|NCT02508649|12491148|FG002|STARTED|Overall Study||189
11293307|NCT02508649|12491149|FG003|STARTED|Overall Study||199
11293308|NCT02508649|12491146|FG000|Dosed|Overall Study||266
11293309|NCT02508649|12491147|FG001|Dosed|Overall Study||191
11293310|NCT02508649|12491148|FG002|Dosed|Overall Study||177
11293311|NCT02508649|12491149|FG003|Dosed|Overall Study||194
11293312|NCT02508649|12491146|FG000|COMPLETED|Overall Study||265
11293313|NCT02508649|12491147|FG001|COMPLETED|Overall Study||184
11293314|NCT02508649|12491148|FG002|COMPLETED|Overall Study||174
11293315|NCT02508649|12491149|FG003|COMPLETED|Overall Study||189
11293316|NCT02508649|12491146|FG000|NOT COMPLETED|Overall Study||18
11293317|NCT02508649|12491147|FG001|NOT COMPLETED|Overall Study||13
11293318|NCT02508649|12491148|FG002|NOT COMPLETED|Overall Study||15
11293319|NCT02508649|12491149|FG003|NOT COMPLETED|Overall Study||10
11293320|NCT02508701|12491166|FG000|STARTED|Overall Study||9
11293321|NCT02508701|12491167|FG001|STARTED|Overall Study||6
11293322|NCT02508701|12491168|FG002|STARTED|Overall Study||5
11293323|NCT02508701|12491169|FG003|STARTED|Overall Study||4
11293324|NCT02508701|12491166|FG000|COMPLETED|Overall Study||0
11293325|NCT02508701|12491167|FG001|COMPLETED|Overall Study||1
11293326|NCT02508701|12491168|FG002|COMPLETED|Overall Study||0
11293327|NCT02508701|12491169|FG003|COMPLETED|Overall Study||1
11293328|NCT02508701|12491166|FG000|NOT COMPLETED|Overall Study||9
11293329|NCT02508701|12491167|FG001|NOT COMPLETED|Overall Study||5
11293330|NCT02508701|12491168|FG002|NOT COMPLETED|Overall Study||5
11293331|NCT02508701|12491169|FG003|NOT COMPLETED|Overall Study||3
11293332|NCT02508935|12491183|FG000|STARTED|Overall Study||23
11293333|NCT02508935|12491183|FG000|COMPLETED|Overall Study||0
11293334|NCT02508935|12491183|FG000|NOT COMPLETED|Overall Study||23
11293335|NCT02509026|12491189|FG000|STARTED|Induction Period (24 Weeks)||210
11293336|NCT02509026|12491189|FG000|Treated|Induction Period (24 Weeks)||209
11293337|NCT02509026|12491189|FG000|COMPLETED|Induction Period (24 Weeks)||188
11293338|NCT02509026|12491189|FG000|NOT COMPLETED|Induction Period (24 Weeks)||22
11293339|NCT02509026|12491189|FG000|STARTED|Withdrawal Period (40 Weeks)|Participants who completed Period 1 and achieved ASDAS-CRP<1.3 were eligible to enter into Period 2|119
11293340|NCT02509026|12491189|FG000|COMPLETED|Withdrawal Period (40 Weeks)||112
11293341|NCT02509026|12491189|FG000|NOT COMPLETED|Withdrawal Period (40 Weeks)||7
11293342|NCT02509026|12491189|FG000|STARTED|Retreatment Period (12 Weeks)|Participants who completed Period 2 and achieved ASDAS-ESR>=2.1 were eligible to enter into Period 3|88
11293343|NCT02509026|12491189|FG000|Treated|Retreatment Period (12 Weeks)||87
11293344|NCT02509026|12491189|FG000|COMPLETED|Retreatment Period (12 Weeks)||84
11293345|NCT02509026|12491189|FG000|NOT COMPLETED|Retreatment Period (12 Weeks)||4
11293346|NCT02509065|12491198|FG000|STARTED|Overall Study||1
11293347|NCT02509065|12491199|FG001|STARTED|Overall Study||1
11293348|NCT02509065|12491200|FG002|STARTED|Overall Study||2
11293349|NCT02509065|12491201|FG003|STARTED|Overall Study||1
11293350|NCT02509065|12491202|FG004|STARTED|Overall Study||1
11293351|NCT02509065|12491203|FG005|STARTED|Overall Study||1
11293352|NCT02509065|12491204|FG006|STARTED|Overall Study||1
11293353|NCT02509065|12491205|FG007|STARTED|Overall Study||1
11293354|NCT02509065|12491206|FG008|STARTED|Overall Study||1
11293355|NCT02509065|12491207|FG009|STARTED|Overall Study||1
11293356|NCT02509065|12491208|FG010|STARTED|Overall Study||1
11293357|NCT02509065|12491209|FG011|STARTED|Overall Study||1
11293358|NCT02509065|12491210|FG012|STARTED|Overall Study||1
11293359|NCT02509065|12491211|FG013|STARTED|Overall Study||1
11293360|NCT02509065|12491212|FG014|STARTED|Overall Study||1
11293361|NCT02509065|12491213|FG015|STARTED|Overall Study||1
11293362|NCT02509065|12491214|FG016|STARTED|Overall Study||1
11293363|NCT02509065|12491215|FG017|STARTED|Overall Study||1
11293364|NCT02509065|12491216|FG018|STARTED|Overall Study||1
11293365|NCT02509065|12491217|FG019|STARTED|Overall Study||1
11293366|NCT02509065|12491218|FG020|STARTED|Overall Study||1
11293367|NCT02509065|12491219|FG021|STARTED|Overall Study||1
11293368|NCT02509065|12491220|FG022|STARTED|Overall Study||1
11293369|NCT02509065|12491198|FG000|COMPLETED|Overall Study||1
11293370|NCT02509065|12491199|FG001|COMPLETED|Overall Study||1
11293371|NCT02509065|12491200|FG002|COMPLETED|Overall Study||2
11293372|NCT02509065|12491201|FG003|COMPLETED|Overall Study||1
11293373|NCT02509065|12491202|FG004|COMPLETED|Overall Study||1
11293374|NCT02509065|12491203|FG005|COMPLETED|Overall Study||1
11293375|NCT02509065|12491204|FG006|COMPLETED|Overall Study||1
11293376|NCT02509065|12491205|FG007|COMPLETED|Overall Study||1
11293377|NCT02509065|12491206|FG008|COMPLETED|Overall Study||1
11293378|NCT02509065|12491207|FG009|COMPLETED|Overall Study||1
11293379|NCT02509065|12491208|FG010|COMPLETED|Overall Study||1
11293380|NCT02509065|12491209|FG011|COMPLETED|Overall Study||1
11293381|NCT02509065|12491210|FG012|COMPLETED|Overall Study||1
11293382|NCT02509065|12491211|FG013|COMPLETED|Overall Study||1
11293383|NCT02509065|12491212|FG014|COMPLETED|Overall Study||1
11293384|NCT02509065|12491213|FG015|COMPLETED|Overall Study||1
11293385|NCT02509065|12491214|FG016|COMPLETED|Overall Study||1
11293386|NCT02509065|12491215|FG017|COMPLETED|Overall Study||1
11293387|NCT02509065|12491216|FG018|COMPLETED|Overall Study||1
11293388|NCT02509065|12491217|FG019|COMPLETED|Overall Study||1
11293389|NCT02509065|12491218|FG020|COMPLETED|Overall Study||1
11293390|NCT02509065|12491219|FG021|COMPLETED|Overall Study||1
11293391|NCT02509065|12491220|FG022|COMPLETED|Overall Study||1
11293392|NCT02509065|12491198|FG000|NOT COMPLETED|Overall Study||0
11293393|NCT02509065|12491199|FG001|NOT COMPLETED|Overall Study||0
11293394|NCT02509065|12491200|FG002|NOT COMPLETED|Overall Study||0
11293395|NCT02509065|12491201|FG003|NOT COMPLETED|Overall Study||0
11293396|NCT02509065|12491202|FG004|NOT COMPLETED|Overall Study||0
11293397|NCT02509065|12491203|FG005|NOT COMPLETED|Overall Study||0
11293398|NCT02509065|12491204|FG006|NOT COMPLETED|Overall Study||0
11293399|NCT02509065|12491205|FG007|NOT COMPLETED|Overall Study||0
11293400|NCT02509065|12491206|FG008|NOT COMPLETED|Overall Study||0
11293401|NCT02509065|12491207|FG009|NOT COMPLETED|Overall Study||0
11293402|NCT02509065|12491208|FG010|NOT COMPLETED|Overall Study||0
11293403|NCT02509065|12491209|FG011|NOT COMPLETED|Overall Study||0
11293404|NCT02509065|12491210|FG012|NOT COMPLETED|Overall Study||0
11293405|NCT02509065|12491211|FG013|NOT COMPLETED|Overall Study||0
11293406|NCT02509065|12491212|FG014|NOT COMPLETED|Overall Study||0
11293407|NCT02509065|12491213|FG015|NOT COMPLETED|Overall Study||0
11293408|NCT02509065|12491214|FG016|NOT COMPLETED|Overall Study||0
11293409|NCT02509065|12491215|FG017|NOT COMPLETED|Overall Study||0
11293410|NCT02509065|12491216|FG018|NOT COMPLETED|Overall Study||0
11293411|NCT02509065|12491217|FG019|NOT COMPLETED|Overall Study||0
11293412|NCT02509065|12491218|FG020|NOT COMPLETED|Overall Study||0
11293413|NCT02509065|12491219|FG021|NOT COMPLETED|Overall Study||0
11293414|NCT02509065|12491220|FG022|NOT COMPLETED|Overall Study||0
11293415|NCT02509078|12491238|FG000|STARTED|Overall Study||502
11293416|NCT02509078|12491239|FG001|STARTED|Overall Study||506
11293417|NCT02509078|12491238|FG000|COMPLETED|Overall Study||501
11293418|NCT02509078|12491239|FG001|COMPLETED|Overall Study||505
11293419|NCT02509078|12491238|FG000|NOT COMPLETED|Overall Study||1
11293420|NCT02509078|12491239|FG001|NOT COMPLETED|Overall Study||1
11293421|NCT02509117|12491257|FG000|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
11293422|NCT02509117|12491258|FG001|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
11293423|NCT02509117|12491259|FG002|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
11293424|NCT02509117|12491260|FG003|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
11293425|NCT02509117|12491261|FG004|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
11293426|NCT02509117|12491262|FG005|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
11293427|NCT02509117|12491263|FG006|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
11293428|NCT02509117|12491264|FG007|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
11293429|NCT02509117|12491265|FG008|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
11293430|NCT02509117|12491266|FG009|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
11293431|NCT02509117|12491257|FG000|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
11293432|NCT02509117|12491258|FG001|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
11293433|NCT02509117|12491259|FG002|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
11293434|NCT02509117|12491260|FG003|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
11293435|NCT02509117|12491261|FG004|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
11293436|NCT02509117|12491262|FG005|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
11293437|NCT02509117|12491263|FG006|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
11293438|NCT02509117|12491264|FG007|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
11293439|NCT02509117|12491265|FG008|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
11293440|NCT02509117|12491266|FG009|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
11293441|NCT02509117|12491257|FG000|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
11293442|NCT02509117|12491258|FG001|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
11293443|NCT02509117|12491259|FG002|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
11293444|NCT02509117|12491260|FG003|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
11293445|NCT02509117|12491261|FG004|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
11293446|NCT02509117|12491262|FG005|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
11293447|NCT02509117|12491263|FG006|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
11293448|NCT02509117|12491264|FG007|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
11293449|NCT02509117|12491265|FG008|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
11293450|NCT02509117|12491266|FG009|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
11293451|NCT02509117|12491257|FG000|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
11293452|NCT02509117|12491258|FG001|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
11293453|NCT02509117|12491259|FG002|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
11293454|NCT02509117|12491260|FG003|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
11293455|NCT02509117|12491261|FG004|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
11293456|NCT02509117|12491262|FG005|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
11293457|NCT02509117|12491263|FG006|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
11293458|NCT02509117|12491264|FG007|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
11293459|NCT02509117|12491265|FG008|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
11293460|NCT02509117|12491266|FG009|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
11293461|NCT02509117|12491257|FG000|STARTED|Washout Period 1 (Part A: 7 Days)||2
11293462|NCT02509117|12491258|FG001|STARTED|Washout Period 1 (Part A: 7 Days)||1
11293463|NCT02509117|12491259|FG002|STARTED|Washout Period 1 (Part A: 7 Days)||2
11293464|NCT02509117|12491260|FG003|STARTED|Washout Period 1 (Part A: 7 Days)||2
11293465|NCT02509117|12491261|FG004|STARTED|Washout Period 1 (Part A: 7 Days)||0
11293466|NCT02509117|12491262|FG005|STARTED|Washout Period 1 (Part A: 7 Days)||0
11293467|NCT02509117|12491263|FG006|STARTED|Washout Period 1 (Part A: 7 Days)||0
11293468|NCT02509117|12491264|FG007|STARTED|Washout Period 1 (Part A: 7 Days)||0
11293469|NCT02509117|12491265|FG008|STARTED|Washout Period 1 (Part A: 7 Days)||0
11293470|NCT02509117|12491266|FG009|STARTED|Washout Period 1 (Part A: 7 Days)||0
11293471|NCT02509117|12491257|FG000|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
11293472|NCT02509117|12491258|FG001|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
11293473|NCT02509117|12491259|FG002|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
11293474|NCT02509117|12491260|FG003|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
11293475|NCT02509117|12491261|FG004|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293476|NCT02509117|12491262|FG005|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293477|NCT02509117|12491263|FG006|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293478|NCT02509117|12491264|FG007|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293479|NCT02509117|12491265|FG008|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293480|NCT02509117|12491266|FG009|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293481|NCT02509117|12491257|FG000|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293482|NCT02509117|12491258|FG001|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293483|NCT02509117|12491259|FG002|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293484|NCT02509117|12491260|FG003|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293485|NCT02509117|12491261|FG004|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293486|NCT02509117|12491262|FG005|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293487|NCT02509117|12491263|FG006|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293488|NCT02509117|12491264|FG007|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293489|NCT02509117|12491265|FG008|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293490|NCT02509117|12491266|FG009|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
11293491|NCT02509117|12491257|FG000|STARTED|Period 2 -Part A: 4 Days||2
11293492|NCT02509117|12491258|FG001|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
11293493|NCT02509117|12491259|FG002|STARTED|Period 2 -Part A: 4 Days||2
11293494|NCT02509117|12491260|FG003|STARTED|Period 2 -Part A: 4 Days||2
11293495|NCT02509117|12491261|FG004|STARTED|Period 2 -Part A: 4 Days||0
11293496|NCT02509117|12491262|FG005|STARTED|Period 2 -Part A: 4 Days||0
11293497|NCT02509117|12491263|FG006|STARTED|Period 2 -Part A: 4 Days||0
11293498|NCT02509117|12491264|FG007|STARTED|Period 2 -Part A: 4 Days||0
11293499|NCT02509117|12491265|FG008|STARTED|Period 2 -Part A: 4 Days||0
11293500|NCT02509117|12491266|FG009|STARTED|Period 2 -Part A: 4 Days||0
11293501|NCT02509117|12491257|FG000|Treated|Period 2 -Part A: 4 Days||2
11293502|NCT02509117|12491258|FG001|Treated|Period 2 -Part A: 4 Days||2
11293503|NCT02509117|12491259|FG002|Treated|Period 2 -Part A: 4 Days||2
11293504|NCT02509117|12491260|FG003|Treated|Period 2 -Part A: 4 Days||2
11293505|NCT02509117|12491261|FG004|Treated|Period 2 -Part A: 4 Days||0
11293506|NCT02509117|12491262|FG005|Treated|Period 2 -Part A: 4 Days||0
11293507|NCT02509117|12491263|FG006|Treated|Period 2 -Part A: 4 Days||0
11293508|NCT02509117|12491264|FG007|Treated|Period 2 -Part A: 4 Days||0
11293509|NCT02509117|12491265|FG008|Treated|Period 2 -Part A: 4 Days||0
11293510|NCT02509117|12491266|FG009|Treated|Period 2 -Part A: 4 Days||0
11293511|NCT02509117|12491257|FG000|COMPLETED|Period 2 -Part A: 4 Days||2
11293512|NCT02509117|12491258|FG001|COMPLETED|Period 2 -Part A: 4 Days||2
11293513|NCT02509117|12491259|FG002|COMPLETED|Period 2 -Part A: 4 Days||2
11293514|NCT02509117|12491260|FG003|COMPLETED|Period 2 -Part A: 4 Days||2
11293515|NCT02509117|12491261|FG004|COMPLETED|Period 2 -Part A: 4 Days||0
11293516|NCT02509117|12491262|FG005|COMPLETED|Period 2 -Part A: 4 Days||0
11293517|NCT02509117|12491263|FG006|COMPLETED|Period 2 -Part A: 4 Days||0
11293518|NCT02509117|12491264|FG007|COMPLETED|Period 2 -Part A: 4 Days||0
11293519|NCT02509117|12491265|FG008|COMPLETED|Period 2 -Part A: 4 Days||0
11293520|NCT02509117|12491266|FG009|COMPLETED|Period 2 -Part A: 4 Days||0
11293521|NCT02509117|12491257|FG000|NOT COMPLETED|Period 2 -Part A: 4 Days||0
11293522|NCT02509117|12491258|FG001|NOT COMPLETED|Period 2 -Part A: 4 Days||0
11293523|NCT02509117|12491259|FG002|NOT COMPLETED|Period 2 -Part A: 4 Days||0
11293524|NCT02509117|12491260|FG003|NOT COMPLETED|Period 2 -Part A: 4 Days||0
11293525|NCT02509117|12491261|FG004|NOT COMPLETED|Period 2 -Part A: 4 Days||0
11293526|NCT02509117|12491262|FG005|NOT COMPLETED|Period 2 -Part A: 4 Days||0
11293527|NCT02509117|12491263|FG006|NOT COMPLETED|Period 2 -Part A: 4 Days||0
11293528|NCT02509117|12491264|FG007|NOT COMPLETED|Period 2 -Part A: 4 Days||0
11293529|NCT02509117|12491265|FG008|NOT COMPLETED|Period 2 -Part A: 4 Days||0
11293530|NCT02509117|12491266|FG009|NOT COMPLETED|Period 2 -Part A: 4 Days||0
11293531|NCT02509117|12491257|FG000|STARTED|Washout Period 2 (Part A: 7 Days)||2
11293532|NCT02509117|12491258|FG001|STARTED|Washout Period 2 (Part A: 7 Days)||2
11293533|NCT02509117|12491259|FG002|STARTED|Washout Period 2 (Part A: 7 Days)||2
11293534|NCT02509117|12491260|FG003|STARTED|Washout Period 2 (Part A: 7 Days)||2
11293535|NCT02509117|12491261|FG004|STARTED|Washout Period 2 (Part A: 7 Days)||0
11293536|NCT02509117|12491262|FG005|STARTED|Washout Period 2 (Part A: 7 Days)||0
11293537|NCT02509117|12491263|FG006|STARTED|Washout Period 2 (Part A: 7 Days)||0
11293538|NCT02509117|12491264|FG007|STARTED|Washout Period 2 (Part A: 7 Days)||0
11293539|NCT02509117|12491265|FG008|STARTED|Washout Period 2 (Part A: 7 Days)||0
11293540|NCT02509117|12491266|FG009|STARTED|Washout Period 2 (Part A: 7 Days)||0
11293541|NCT02509117|12491257|FG000|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
11293542|NCT02509117|12491258|FG001|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
11293543|NCT02509117|12491259|FG002|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
11293544|NCT02509117|12491260|FG003|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
11143798|NCT01474512|12330429|FG007|STARTED|Post-Treatment Follow-Up||0
11143799|NCT01474512|12330430|FG008|STARTED|Post-Treatment Follow-Up||0
11143800|NCT01474512|12330431|FG009|STARTED|Post-Treatment Follow-Up||0
11143801|NCT01474512|12330432|FG010|STARTED|Post-Treatment Follow-Up||0
11143802|NCT01474512|12330433|FG011|STARTED|Post-Treatment Follow-Up||0
11143803|NCT01474512|12330434|FG012|STARTED|Post-Treatment Follow-Up||0
11143804|NCT01474512|12330435|FG013|STARTED|Post-Treatment Follow-Up||0
11143805|NCT01474512|12330436|FG014|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18
11143806|NCT01474512|12330437|FG015|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25
11293545|NCT02509117|12491261|FG004|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293546|NCT02509117|12491262|FG005|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293547|NCT02509117|12491263|FG006|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293548|NCT02509117|12491264|FG007|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293549|NCT02509117|12491265|FG008|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293550|NCT02509117|12491266|FG009|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293551|NCT02509117|12491257|FG000|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293552|NCT02509117|12491258|FG001|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293553|NCT02509117|12491259|FG002|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293554|NCT02509117|12491260|FG003|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293555|NCT02509117|12491261|FG004|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293556|NCT02509117|12491262|FG005|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293557|NCT02509117|12491263|FG006|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293558|NCT02509117|12491264|FG007|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293559|NCT02509117|12491265|FG008|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293560|NCT02509117|12491266|FG009|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
11293561|NCT02509117|12491257|FG000|STARTED|Period 3 -Part A: 4 Days||2
11293562|NCT02509117|12491258|FG001|STARTED|Period 3 -Part A: 4 Days||2
11293563|NCT02509117|12491259|FG002|STARTED|Period 3 -Part A: 4 Days||2
11293564|NCT02509117|12491260|FG003|STARTED|Period 3 -Part A: 4 Days||2
11293565|NCT02509117|12491261|FG004|STARTED|Period 3 -Part A: 4 Days||0
11293566|NCT02509117|12491262|FG005|STARTED|Period 3 -Part A: 4 Days||0
11293567|NCT02509117|12491263|FG006|STARTED|Period 3 -Part A: 4 Days||0
11293568|NCT02509117|12491264|FG007|STARTED|Period 3 -Part A: 4 Days||0
11293569|NCT02509117|12491265|FG008|STARTED|Period 3 -Part A: 4 Days||0
11293570|NCT02509117|12491266|FG009|STARTED|Period 3 -Part A: 4 Days||0
11293571|NCT02509117|12491257|FG000|COMPLETED|Period 3 -Part A: 4 Days||2
11293572|NCT02509117|12491258|FG001|COMPLETED|Period 3 -Part A: 4 Days||2
11293573|NCT02509117|12491259|FG002|COMPLETED|Period 3 -Part A: 4 Days||2
11143807|NCT01474512|12330438|FG016|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700
11143808|NCT01474512|12330439|FG017|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285
11143809|NCT01474512|12330422|FG000|COMPLETED|Post-Treatment Follow-Up||0
11143810|NCT01474512|12330423|FG001|COMPLETED|Post-Treatment Follow-Up||0
11143811|NCT01474512|12330424|FG002|COMPLETED|Post-Treatment Follow-Up||0
11143812|NCT01474512|12330425|FG003|COMPLETED|Post-Treatment Follow-Up||0
11143813|NCT01474512|12330426|FG004|COMPLETED|Post-Treatment Follow-Up||0
11143814|NCT01474512|12330427|FG005|COMPLETED|Post-Treatment Follow-Up||0
11143815|NCT01474512|12330428|FG006|COMPLETED|Post-Treatment Follow-Up||0
11143816|NCT01474512|12330429|FG007|COMPLETED|Post-Treatment Follow-Up||0
11143817|NCT01474512|12330430|FG008|COMPLETED|Post-Treatment Follow-Up||0
11143818|NCT01474512|12330431|FG009|COMPLETED|Post-Treatment Follow-Up||0
11143819|NCT01474512|12330432|FG010|COMPLETED|Post-Treatment Follow-Up||0
11143820|NCT01474512|12330433|FG011|COMPLETED|Post-Treatment Follow-Up||0
11143821|NCT01474512|12330434|FG012|COMPLETED|Post-Treatment Follow-Up||0
11293574|NCT02509117|12491260|FG003|COMPLETED|Period 3 -Part A: 4 Days||2
11293575|NCT02509117|12491261|FG004|COMPLETED|Period 3 -Part A: 4 Days||0
11293576|NCT02509117|12491262|FG005|COMPLETED|Period 3 -Part A: 4 Days||0
11293577|NCT02509117|12491263|FG006|COMPLETED|Period 3 -Part A: 4 Days||0
11293578|NCT02509117|12491264|FG007|COMPLETED|Period 3 -Part A: 4 Days||0
11293579|NCT02509117|12491265|FG008|COMPLETED|Period 3 -Part A: 4 Days||0
11293580|NCT02509117|12491266|FG009|COMPLETED|Period 3 -Part A: 4 Days||0
11293581|NCT02509117|12491257|FG000|NOT COMPLETED|Period 3 -Part A: 4 Days||0
11293582|NCT02509117|12491258|FG001|NOT COMPLETED|Period 3 -Part A: 4 Days||0
11293583|NCT02509117|12491259|FG002|NOT COMPLETED|Period 3 -Part A: 4 Days||0
11293584|NCT02509117|12491260|FG003|NOT COMPLETED|Period 3 -Part A: 4 Days||0
11293585|NCT02509117|12491261|FG004|NOT COMPLETED|Period 3 -Part A: 4 Days||0
11293586|NCT02509117|12491262|FG005|NOT COMPLETED|Period 3 -Part A: 4 Days||0
11293587|NCT02509117|12491263|FG006|NOT COMPLETED|Period 3 -Part A: 4 Days||0
11293588|NCT02509117|12491264|FG007|NOT COMPLETED|Period 3 -Part A: 4 Days||0
11293589|NCT02509117|12491265|FG008|NOT COMPLETED|Period 3 -Part A: 4 Days||0
11293590|NCT02509117|12491266|FG009|NOT COMPLETED|Period 3 -Part A: 4 Days||0
11293591|NCT02509117|12491257|FG000|STARTED|Washout Period 3 (Part A: 7 Days)||2
11293592|NCT02509117|12491258|FG001|STARTED|Washout Period 3 (Part A: 7 Days)||2
11293593|NCT02509117|12491259|FG002|STARTED|Washout Period 3 (Part A: 7 Days)||2
11293594|NCT02509117|12491260|FG003|STARTED|Washout Period 3 (Part A: 7 Days)||2
11293595|NCT02509117|12491261|FG004|STARTED|Washout Period 3 (Part A: 7 Days)||0
11293596|NCT02509117|12491262|FG005|STARTED|Washout Period 3 (Part A: 7 Days)||0
11293597|NCT02509117|12491263|FG006|STARTED|Washout Period 3 (Part A: 7 Days)||0
11293598|NCT02509117|12491264|FG007|STARTED|Washout Period 3 (Part A: 7 Days)||0
11400113|NCT04274075|12594781|FG003|NOT COMPLETED|Overall Study||0
11400114|NCT04274075|12594782|FG004|NOT COMPLETED|Overall Study||0
11400115|NCT04274075|12594783|FG005|NOT COMPLETED|Overall Study||0
11400116|NCT04271605|12594794|FG000|STARTED|Overall Study|Baseline questionnaire and examination were done after enrollment.|5
11400117|NCT04271605|12594794|FG000|COMPLETED|Overall Study||0
11400118|NCT04271605|12594794|FG000|NOT COMPLETED|Overall Study||5
11293599|NCT02509117|12491265|FG008|STARTED|Washout Period 3 (Part A: 7 Days)||0
11293600|NCT02509117|12491266|FG009|STARTED|Washout Period 3 (Part A: 7 Days)||0
11293601|NCT02509117|12491257|FG000|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
11293602|NCT02509117|12491258|FG001|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
11293603|NCT02509117|12491259|FG002|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
11293604|NCT02509117|12491260|FG003|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
11293605|NCT02509117|12491261|FG004|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293606|NCT02509117|12491262|FG005|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293607|NCT02509117|12491263|FG006|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293608|NCT02509117|12491264|FG007|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293609|NCT02509117|12491265|FG008|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293610|NCT02509117|12491266|FG009|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293611|NCT02509117|12491257|FG000|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293612|NCT02509117|12491258|FG001|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293613|NCT02509117|12491259|FG002|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293614|NCT02509117|12491260|FG003|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293615|NCT02509117|12491261|FG004|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293616|NCT02509117|12491262|FG005|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293617|NCT02509117|12491263|FG006|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293618|NCT02509117|12491264|FG007|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293619|NCT02509117|12491265|FG008|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293620|NCT02509117|12491266|FG009|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
11293621|NCT02509117|12491257|FG000|STARTED|Period 4 -Part A: 4 Days||2
11293622|NCT02509117|12491258|FG001|STARTED|Period 4 -Part A: 4 Days||2
11293623|NCT02509117|12491259|FG002|STARTED|Period 4 -Part A: 4 Days||2
11293624|NCT02509117|12491260|FG003|STARTED|Period 4 -Part A: 4 Days||2
11293625|NCT02509117|12491261|FG004|STARTED|Period 4 -Part A: 4 Days||0
11293626|NCT02509117|12491262|FG005|STARTED|Period 4 -Part A: 4 Days||0
11293627|NCT02509117|12491263|FG006|STARTED|Period 4 -Part A: 4 Days||0
11293628|NCT02509117|12491264|FG007|STARTED|Period 4 -Part A: 4 Days||0
11293629|NCT02509117|12491265|FG008|STARTED|Period 4 -Part A: 4 Days||0
11293630|NCT02509117|12491266|FG009|STARTED|Period 4 -Part A: 4 Days||0
11293631|NCT02509117|12491257|FG000|COMPLETED|Period 4 -Part A: 4 Days||2
11293632|NCT02509117|12491258|FG001|COMPLETED|Period 4 -Part A: 4 Days||2
11293633|NCT02509117|12491259|FG002|COMPLETED|Period 4 -Part A: 4 Days||2
11293634|NCT02509117|12491260|FG003|COMPLETED|Period 4 -Part A: 4 Days||2
11293635|NCT02509117|12491261|FG004|COMPLETED|Period 4 -Part A: 4 Days||0
11293636|NCT02509117|12491262|FG005|COMPLETED|Period 4 -Part A: 4 Days||0
11293637|NCT02509117|12491263|FG006|COMPLETED|Period 4 -Part A: 4 Days||0
11293638|NCT02509117|12491264|FG007|COMPLETED|Period 4 -Part A: 4 Days||0
11293639|NCT02509117|12491265|FG008|COMPLETED|Period 4 -Part A: 4 Days||0
11293640|NCT02509117|12491266|FG009|COMPLETED|Period 4 -Part A: 4 Days||0
11293641|NCT02509117|12491257|FG000|NOT COMPLETED|Period 4 -Part A: 4 Days||0
11293642|NCT02509117|12491258|FG001|NOT COMPLETED|Period 4 -Part A: 4 Days||0
11293643|NCT02509117|12491259|FG002|NOT COMPLETED|Period 4 -Part A: 4 Days||0
11293644|NCT02509117|12491260|FG003|NOT COMPLETED|Period 4 -Part A: 4 Days||0
11293645|NCT02509117|12491261|FG004|NOT COMPLETED|Period 4 -Part A: 4 Days||0
11293646|NCT02509117|12491262|FG005|NOT COMPLETED|Period 4 -Part A: 4 Days||0
11293647|NCT02509117|12491263|FG006|NOT COMPLETED|Period 4 -Part A: 4 Days||0
11293648|NCT02509117|12491264|FG007|NOT COMPLETED|Period 4 -Part A: 4 Days||0
11293649|NCT02509117|12491265|FG008|NOT COMPLETED|Period 4 -Part A: 4 Days||0
11293650|NCT02509117|12491266|FG009|NOT COMPLETED|Period 4 -Part A: 4 Days||0
11293651|NCT02509156|12491306|FG000|STARTED|Open-Label Lead-In Phase||6
11293652|NCT02509156|12491307|FG001|STARTED|Open-Label Lead-In Phase||0
11293653|NCT02509156|12491306|FG000|COMPLETED|Open-Label Lead-In Phase||6
11293654|NCT02509156|12491307|FG001|COMPLETED|Open-Label Lead-In Phase||0
11293655|NCT02509156|12491306|FG000|NOT COMPLETED|Open-Label Lead-In Phase||0
11293656|NCT02509156|12491307|FG001|NOT COMPLETED|Open-Label Lead-In Phase||0
11293657|NCT02509156|12491306|FG000|STARTED|Randomized Phase|Includes randomized participants only|14
11293658|NCT02509156|12491307|FG001|STARTED|Randomized Phase||17
11293659|NCT02509156|12491306|FG000|COMPLETED|Randomized Phase||12
11293660|NCT02509156|12491307|FG001|COMPLETED|Randomized Phase||16
11293661|NCT02509156|12491306|FG000|NOT COMPLETED|Randomized Phase||2
11293662|NCT02509156|12491307|FG001|NOT COMPLETED|Randomized Phase||1
11293663|NCT02509481|12491315|FG000|STARTED|Overall Study||1265
11293664|NCT02509481|12491316|FG001|STARTED|Overall Study||1447
11293665|NCT02509481|12491315|FG000|COMPLETED|Overall Study||1265
11293666|NCT02509481|12491316|FG001|COMPLETED|Overall Study||1447
11293667|NCT02509481|12491315|FG000|NOT COMPLETED|Overall Study||0
11293668|NCT02509481|12491316|FG001|NOT COMPLETED|Overall Study||0
11293669|NCT02509585|12491322|FG000|STARTED|Overall Study||18
11293670|NCT02509585|12491322|FG000|COMPLETED|Overall Study||18
11293671|NCT02509585|12491322|FG000|NOT COMPLETED|Overall Study||0
11293672|NCT02509624|12491331|FG000|STARTED|Overall Study||10
11293673|NCT02509624|12491332|FG001|STARTED|Overall Study||10
11293674|NCT02509624|12491333|FG002|STARTED|Overall Study||10
11293675|NCT02509624|12491334|FG003|STARTED|Overall Study||22
11293676|NCT02509624|12491331|FG000|COMPLETED|Overall Study||10
11293677|NCT02509624|12491332|FG001|COMPLETED|Overall Study||10
11293678|NCT02509624|12491333|FG002|COMPLETED|Overall Study||10
11293679|NCT02509624|12491334|FG003|COMPLETED|Overall Study||22
11293680|NCT02509624|12491331|FG000|NOT COMPLETED|Overall Study||0
11293681|NCT02509624|12491332|FG001|NOT COMPLETED|Overall Study||0
11293682|NCT02509624|12491333|FG002|NOT COMPLETED|Overall Study||0
11293683|NCT02509624|12491334|FG003|NOT COMPLETED|Overall Study||0
11293684|NCT02509767|12491349|FG000|STARTED|Overall Study||201
11293685|NCT02509767|12491350|FG001|STARTED|Overall Study||200
11293686|NCT02509767|12491349|FG000|COMPLETED|Overall Study||157
11293687|NCT02509767|12491350|FG001|COMPLETED|Overall Study||159
11293688|NCT02509767|12491349|FG000|NOT COMPLETED|Overall Study||44
11293689|NCT02509767|12491350|FG001|NOT COMPLETED|Overall Study||41
11293690|NCT02509936|12491361|FG000|STARTED|Overall Study||163
11293691|NCT02509936|12491362|FG001|STARTED|Overall Study||161
11293692|NCT02509936|12491361|FG000|COMPLETED|Overall Study||151
11293693|NCT02509936|12491362|FG001|COMPLETED|Overall Study||145
11293694|NCT02509936|12491361|FG000|NOT COMPLETED|Overall Study||12
11293695|NCT02509936|12491362|FG001|NOT COMPLETED|Overall Study||16
11293696|NCT02510001|12491376|FG000|STARTED|Overall Study||6
11293697|NCT02510001|12491377|FG001|STARTED|Overall Study||5
11293698|NCT02510001|12491378|FG002|STARTED|Overall Study||6
11293699|NCT02510001|12491379|FG003|STARTED|Overall Study||8
11293700|NCT02510001|12491380|FG004|STARTED|Overall Study||8
11293701|NCT02510001|12491381|FG005|STARTED|Overall Study||7
11293702|NCT02510001|12491382|FG006|STARTED|Overall Study||5
11293703|NCT02510001|12491383|FG007|STARTED|Overall Study||37
11293704|NCT02510001|12491376|FG000|COMPLETED|Overall Study||6
11293705|NCT02510001|12491377|FG001|COMPLETED|Overall Study||5
11293706|NCT02510001|12491378|FG002|COMPLETED|Overall Study||6
11293707|NCT02510001|12491379|FG003|COMPLETED|Overall Study||6
11293708|NCT02510001|12491380|FG004|COMPLETED|Overall Study||4
11293709|NCT02510001|12491381|FG005|COMPLETED|Overall Study||5
11293710|NCT02510001|12491382|FG006|COMPLETED|Overall Study||3
11293711|NCT02510001|12491383|FG007|COMPLETED|Overall Study||30
11293712|NCT02510001|12491376|FG000|NOT COMPLETED|Overall Study||0
11293713|NCT02510001|12491377|FG001|NOT COMPLETED|Overall Study||0
11293714|NCT02510001|12491378|FG002|NOT COMPLETED|Overall Study||0
11293715|NCT02510001|12491379|FG003|NOT COMPLETED|Overall Study||2
11293716|NCT02510001|12491380|FG004|NOT COMPLETED|Overall Study||4
11293717|NCT02510001|12491381|FG005|NOT COMPLETED|Overall Study||2
11293718|NCT02510001|12491382|FG006|NOT COMPLETED|Overall Study||2
11293719|NCT02510001|12491383|FG007|NOT COMPLETED|Overall Study||7
11293720|NCT02510014|12491421|FG000|STARTED|Run-In Period (Days -14 to Day -1)||508
11293721|NCT02510014|12491422|FG001|STARTED|Run-In Period (Days -14 to Day -1)||267
11293722|NCT02510014|12491421|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||412
11293723|NCT02510014|12491422|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||257
11293724|NCT02510014|12491421|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
11293725|NCT02510014|12491422|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
11293726|NCT02510014|12491421|FG000|STARTED|Treatment Period||412
11293727|NCT02510014|12491422|FG001|STARTED|Treatment Period||257
11293728|NCT02510014|12491421|FG000|COMPLETED|Treatment Period||206
11293729|NCT02510014|12491422|FG001|COMPLETED|Treatment Period||200
11293730|NCT02510014|12491421|FG000|NOT COMPLETED|Treatment Period||206
11293731|NCT02510014|12491422|FG001|NOT COMPLETED|Treatment Period||57
11293732|NCT02510144|12491430|FG000|STARTED|Overall Study||39
11293733|NCT02510144|12491431|FG001|STARTED|Overall Study||41
11400119|NCT04271761|12594798|FG000|STARTED|Overall Study||14
11400120|NCT04271761|12594798|FG000|COMPLETED|Overall Study||14
11400121|NCT04271761|12594798|FG000|NOT COMPLETED|Overall Study||0
11400122|NCT04268316|12594805|FG000|STARTED|Overall Study||5
11400123|NCT04268316|12594806|FG001|STARTED|Overall Study||4
11400124|NCT04268316|12594807|FG002|STARTED|Overall Study||4
11293734|NCT02510144|12491430|FG000|COMPLETED|Overall Study||39
11293735|NCT02510144|12491431|FG001|COMPLETED|Overall Study||41
11293736|NCT02510144|12491430|FG000|NOT COMPLETED|Overall Study||0
11293737|NCT02510144|12491431|FG001|NOT COMPLETED|Overall Study||0
11293738|NCT02510664|12491440|FG000|STARTED|Overall Study||84
11400125|NCT04268316|12594805|FG000|COMPLETED|Overall Study||3
11293739|NCT02510664|12491441|FG001|STARTED|Overall Study||84
11293740|NCT02510664|12491442|FG002|STARTED|Overall Study||4
11293741|NCT02510664|12491440|FG000|COMPLETED|Overall Study||64
11293742|NCT02510664|12491441|FG001|COMPLETED|Overall Study||64
11293743|NCT02510664|12491442|FG002|COMPLETED|Overall Study||4
11293744|NCT02510664|12491440|FG000|NOT COMPLETED|Overall Study||20
11293745|NCT02510664|12491441|FG001|NOT COMPLETED|Overall Study||20
11293746|NCT02510664|12491442|FG002|NOT COMPLETED|Overall Study||0
11293747|NCT02510794|12491459|FG000|STARTED|Overall Study||59
11400126|NCT04268316|12594806|FG001|COMPLETED|Overall Study||3
11293748|NCT02510794|12491460|FG001|STARTED|Overall Study||62
11293749|NCT02510794|12491461|FG002|STARTED|Overall Study||63
11293750|NCT02510794|12491462|FG003|STARTED|Overall Study||41
11293751|NCT02510794|12491459|FG000|COMPLETED|Overall Study||51
11293752|NCT02510794|12491460|FG001|COMPLETED|Overall Study||56
11293753|NCT02510794|12491461|FG002|COMPLETED|Overall Study||56
11293754|NCT02510794|12491462|FG003|COMPLETED|Overall Study||36
11293755|NCT02510794|12491459|FG000|NOT COMPLETED|Overall Study||8
11400127|NCT04268316|12594807|FG002|COMPLETED|Overall Study||4
11293756|NCT02510794|12491460|FG001|NOT COMPLETED|Overall Study||6
11293757|NCT02510794|12491461|FG002|NOT COMPLETED|Overall Study||7
11293758|NCT02510794|12491462|FG003|NOT COMPLETED|Overall Study||5
11293759|NCT02510820|12491474|FG000|STARTED|First Intervention (4 Weeks)||21
11293760|NCT02510820|12491475|FG001|STARTED|First Intervention (4 Weeks)||27
11293761|NCT02510820|12491474|FG000|COMPLETED|First Intervention (4 Weeks)||21
11293762|NCT02510820|12491475|FG001|COMPLETED|First Intervention (4 Weeks)||26
11293763|NCT02510820|12491474|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
11293764|NCT02510820|12491475|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
11293765|NCT02510820|12491474|FG000|STARTED|Washout (1 Week)||21
11021912|NCT00806494|12200093|FG000|STARTED|Overall Study||331
11021913|NCT00806494|12200093|FG000|COMPLETED|Overall Study||251
11021914|NCT00806494|12200093|FG000|NOT COMPLETED|Overall Study||80
11021915|NCT00806546|12200098|FG000|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
11293766|NCT02510820|12491475|FG001|STARTED|Washout (1 Week)||26
11293767|NCT02510820|12491474|FG000|COMPLETED|Washout (1 Week)||21
11293768|NCT02510820|12491475|FG001|COMPLETED|Washout (1 Week)||26
11293769|NCT02510820|12491474|FG000|NOT COMPLETED|Washout (1 Week)||0
11293770|NCT02510820|12491475|FG001|NOT COMPLETED|Washout (1 Week)||0
11293771|NCT02510820|12491474|FG000|STARTED|Second Intervention (4 Weeks)||21
11293772|NCT02510820|12491475|FG001|STARTED|Second Intervention (4 Weeks)||26
11293773|NCT02510820|12491474|FG000|COMPLETED|Second Intervention (4 Weeks)||20
11293774|NCT02510820|12491475|FG001|COMPLETED|Second Intervention (4 Weeks)||26
11293775|NCT02510820|12491474|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
11293776|NCT02510820|12491475|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
11293777|NCT02511184|12491484|FG000|STARTED|Overall Study||2
11293778|NCT02511184|12491485|FG001|STARTED|Overall Study||7
11293779|NCT02511184|12491484|FG000|COMPLETED|Overall Study||0
11293780|NCT02511184|12491485|FG001|COMPLETED|Overall Study||0
11293781|NCT02511184|12491484|FG000|NOT COMPLETED|Overall Study||2
11293782|NCT02511184|12491485|FG001|NOT COMPLETED|Overall Study||7
11293783|NCT02511236|12491494|FG000|STARTED|Overall Study||165
11293784|NCT02511236|12491495|FG001|STARTED|Overall Study||191
11293785|NCT02511236|12491494|FG000|COMPLETED|Overall Study||125
11293786|NCT02511236|12491495|FG001|COMPLETED|Overall Study||146
11293787|NCT02511236|12491494|FG000|NOT COMPLETED|Overall Study||40
11293788|NCT02511236|12491495|FG001|NOT COMPLETED|Overall Study||45
11293789|NCT02511379|12491501|FG000|STARTED|Overall Study||14
11293790|NCT02511379|12491501|FG000|COMPLETED|Overall Study||14
11293791|NCT02511379|12491501|FG000|NOT COMPLETED|Overall Study||0
11293792|NCT02511431|12491511|FG000|STARTED|Treatment||4
11293793|NCT02511431|12491512|FG001|STARTED|Treatment||4
11293794|NCT02511431|12491513|FG002|STARTED|Treatment||4
11293795|NCT02511431|12491514|FG003|STARTED|Treatment||3
11293796|NCT02511431|12491515|FG004|STARTED|Treatment||3
11293797|NCT02511431|12491516|FG005|STARTED|Treatment||3
11293798|NCT02511431|12491511|FG000|COMPLETED|Treatment||4
11293799|NCT02511431|12491512|FG001|COMPLETED|Treatment||4
11293800|NCT02511431|12491513|FG002|COMPLETED|Treatment||3
11293801|NCT02511431|12491514|FG003|COMPLETED|Treatment||3
11293802|NCT02511431|12491515|FG004|COMPLETED|Treatment||3
11293803|NCT02511431|12491516|FG005|COMPLETED|Treatment||2
11293804|NCT02511431|12491511|FG000|NOT COMPLETED|Treatment||0
11293805|NCT02511431|12491512|FG001|NOT COMPLETED|Treatment||0
11293806|NCT02511431|12491513|FG002|NOT COMPLETED|Treatment||1
11293807|NCT02511431|12491514|FG003|NOT COMPLETED|Treatment||0
11293808|NCT02511431|12491515|FG004|NOT COMPLETED|Treatment||0
11293809|NCT02511431|12491516|FG005|NOT COMPLETED|Treatment||1
11293810|NCT02511431|12491511|FG000|STARTED|Post-treatment Follow-up||4
11293811|NCT02511431|12491512|FG001|STARTED|Post-treatment Follow-up||4
11293812|NCT02511431|12491513|FG002|STARTED|Post-treatment Follow-up||3
11293813|NCT02511431|12491514|FG003|STARTED|Post-treatment Follow-up||3
11293814|NCT02511431|12491515|FG004|STARTED|Post-treatment Follow-up||3
11293815|NCT02511431|12491516|FG005|STARTED|Post-treatment Follow-up||2
11293816|NCT02511431|12491511|FG000|COMPLETED|Post-treatment Follow-up||4
11293817|NCT02511431|12491512|FG001|COMPLETED|Post-treatment Follow-up||4
11293818|NCT02511431|12491513|FG002|COMPLETED|Post-treatment Follow-up||3
11293819|NCT02511431|12491514|FG003|COMPLETED|Post-treatment Follow-up||3
11293820|NCT02511431|12491515|FG004|COMPLETED|Post-treatment Follow-up||3
11293821|NCT02511431|12491516|FG005|COMPLETED|Post-treatment Follow-up||2
11400128|NCT04268316|12594805|FG000|NOT COMPLETED|Overall Study||2
11400129|NCT04268316|12594806|FG001|NOT COMPLETED|Overall Study||1
11400130|NCT04268316|12594807|FG002|NOT COMPLETED|Overall Study||0
11400131|NCT04269629|12594815|FG000|STARTED|Overall Study|1425 patients were included in the study (=Visit 1)|1425
11400132|NCT04269629|12594815|FG000|Number of Patients Who Performed VIT|Overall Study|Visit 2 was performed with 1342 patients|1342
11400133|NCT04269629|12594815|FG000|COMPLETED|Overall Study|Visit 3 was performed with 1186 patients|1186
11400134|NCT04269629|12594815|FG000|NOT COMPLETED|Overall Study||239
11400135|NCT04267575|12594823|FG000|STARTED|Overall Study||20
11400136|NCT04267575|12594823|FG000|COMPLETED|Overall Study||20
11400137|NCT04267575|12594823|FG000|NOT COMPLETED|Overall Study||0
11400138|NCT04267770|12594829|FG000|STARTED|Overall Study||9
11293822|NCT02511431|12491511|FG000|NOT COMPLETED|Post-treatment Follow-up||0
11293823|NCT02511431|12491512|FG001|NOT COMPLETED|Post-treatment Follow-up||0
11293824|NCT02511431|12491513|FG002|NOT COMPLETED|Post-treatment Follow-up||0
11293825|NCT02511431|12491514|FG003|NOT COMPLETED|Post-treatment Follow-up||0
11293826|NCT02511431|12491515|FG004|NOT COMPLETED|Post-treatment Follow-up||0
11293827|NCT02511431|12491516|FG005|NOT COMPLETED|Post-treatment Follow-up||0
11293828|NCT02511535|12491534|FG000|STARTED|Overall Study||49
11293829|NCT02511535|12491535|FG001|STARTED|Overall Study||21
11293830|NCT02511535|12491536|FG002|STARTED|Overall Study||49
11293831|NCT02511535|12491534|FG000|COMPLETED|Overall Study||49
11293832|NCT02511535|12491535|FG001|COMPLETED|Overall Study||21
11293833|NCT02511535|12491536|FG002|COMPLETED|Overall Study||49
11293834|NCT02511535|12491534|FG000|NOT COMPLETED|Overall Study||0
11293835|NCT02511535|12491535|FG001|NOT COMPLETED|Overall Study||0
11293836|NCT02511535|12491536|FG002|NOT COMPLETED|Overall Study||0
11293837|NCT02511561|12491547|FG000|STARTED|Overall Study||25
11293838|NCT02511561|12491548|FG001|STARTED|Overall Study||25
11293839|NCT02511561|12491549|FG002|STARTED|Overall Study||25
11293840|NCT02511561|12491547|FG000|COMPLETED|Overall Study||25
11293841|NCT02511561|12491548|FG001|COMPLETED|Overall Study||25
11293842|NCT02511561|12491549|FG002|COMPLETED|Overall Study||25
11293843|NCT02511561|12491547|FG000|NOT COMPLETED|Overall Study||0
11293844|NCT02511561|12491548|FG001|NOT COMPLETED|Overall Study||0
11293845|NCT02511561|12491549|FG002|NOT COMPLETED|Overall Study||0
11293846|NCT02511587|12491560|FG000|STARTED|Overall Study||58
11293847|NCT02511587|12491561|FG001|STARTED|Overall Study||58
11293848|NCT02511587|12491560|FG000|COMPLETED|Overall Study||58
11293849|NCT02511587|12491561|FG001|COMPLETED|Overall Study||58
11293850|NCT02511587|12491560|FG000|NOT COMPLETED|Overall Study||0
11293851|NCT02511587|12491561|FG001|NOT COMPLETED|Overall Study||0
11293852|NCT02511678|12491567|FG000|STARTED|Overall Study||73
11293853|NCT02511678|12491567|FG000|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66
11293854|NCT02511678|12491567|FG000|Participants Discontinued Pre-Treatment|Overall Study||7
11293855|NCT02511678|12491567|FG000|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65
11293856|NCT02511678|12491567|FG000|COMPLETED|Overall Study||37
11293857|NCT02511678|12491567|FG000|NOT COMPLETED|Overall Study||36
11293858|NCT02511717|12491574|FG000|STARTED|Overall Study||10
11293859|NCT02511717|12491575|FG001|STARTED|Overall Study||10
11293860|NCT02511717|12491574|FG000|COMPLETED|Overall Study||8
11293861|NCT02511717|12491575|FG001|COMPLETED|Overall Study||10
11021916|NCT00806546|12200098|FG000|COMPLETED|Overall Study||207
11021917|NCT00806546|12200098|FG000|NOT COMPLETED|Overall Study||307
11021918|NCT00806585|12200107|FG000|STARTED|Overall Study||137
11293862|NCT02511717|12491574|FG000|NOT COMPLETED|Overall Study||2
11293863|NCT02511717|12491575|FG001|NOT COMPLETED|Overall Study||0
11293864|NCT02511730|12491581|FG000|STARTED|First Reading Session||50
11293865|NCT02511730|12491582|FG001|STARTED|First Reading Session||50
11293866|NCT02511730|12491581|FG000|COMPLETED|First Reading Session||50
11293867|NCT02511730|12491582|FG001|COMPLETED|First Reading Session||50
11293868|NCT02511730|12491581|FG000|NOT COMPLETED|First Reading Session||0
11293869|NCT02511730|12491582|FG001|NOT COMPLETED|First Reading Session||0
11293870|NCT02511730|12491581|FG000|STARTED|4 Week Memory Washout Period||50
11293871|NCT02511730|12491582|FG001|STARTED|4 Week Memory Washout Period||50
11293872|NCT02511730|12491581|FG000|COMPLETED|4 Week Memory Washout Period||50
11293873|NCT02511730|12491582|FG001|COMPLETED|4 Week Memory Washout Period||50
11293874|NCT02511730|12491581|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
11293875|NCT02511730|12491582|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
11293876|NCT02511730|12491581|FG000|STARTED|Session Reading Session||50
11293877|NCT02511730|12491582|FG001|STARTED|Session Reading Session||50
11293878|NCT02511730|12491581|FG000|COMPLETED|Session Reading Session||50
11293879|NCT02511730|12491582|FG001|COMPLETED|Session Reading Session||50
11293880|NCT02511730|12491581|FG000|NOT COMPLETED|Session Reading Session||0
11293881|NCT02511730|12491582|FG001|NOT COMPLETED|Session Reading Session||0
11293882|NCT02511782|12491591|FG000|STARTED|Overall Study||51
11293883|NCT02511782|12491592|FG001|STARTED|Overall Study||2
11293884|NCT02511782|12491593|FG002|STARTED|Overall Study||10
11293885|NCT02511782|12491591|FG000|COMPLETED|Overall Study||50
11293886|NCT02511782|12491592|FG001|COMPLETED|Overall Study||2
11293887|NCT02511782|12491593|FG002|COMPLETED|Overall Study||10
11293888|NCT02511782|12491591|FG000|NOT COMPLETED|Overall Study||1
11293889|NCT02511782|12491592|FG001|NOT COMPLETED|Overall Study||0
11293890|NCT02511782|12491593|FG002|NOT COMPLETED|Overall Study||0
11293891|NCT02512042|12491603|FG000|STARTED|Overall Study||495
11293892|NCT02512042|12491604|FG001|STARTED|Overall Study||478
11293893|NCT02512042|12491603|FG000|COMPLETED|Overall Study||472
11293894|NCT02512042|12491604|FG001|COMPLETED|Overall Study||453
11293895|NCT02512042|12491603|FG000|NOT COMPLETED|Overall Study||23
11293896|NCT02512042|12491604|FG001|NOT COMPLETED|Overall Study||25
11293897|NCT02512068|12491612|FG000|STARTED|Overall Study||55
11293898|NCT02512068|12491613|FG001|STARTED|Overall Study||52
11293899|NCT02512068|12491612|FG000|COMPLETED|Overall Study||43
11293900|NCT02512068|12491613|FG001|COMPLETED|Overall Study||39
11293901|NCT02512068|12491612|FG000|NOT COMPLETED|Overall Study||12
11293902|NCT02512068|12491613|FG001|NOT COMPLETED|Overall Study||13
11293903|NCT02512094|12491619|FG000|STARTED|Overall Study||53
11293904|NCT02512094|12491619|FG000|COMPLETED|Overall Study||53
11293905|NCT02512094|12491619|FG000|NOT COMPLETED|Overall Study||0
11293906|NCT02512224|12491625|FG000|STARTED|Overall Study||2912
11293907|NCT02512224|12491626|FG001|STARTED|Overall Study||2912
11293908|NCT02512224|12491625|FG000|COMPLETED|Overall Study||2912
11293909|NCT02512224|12491626|FG001|COMPLETED|Overall Study||2912
11293910|NCT02512224|12491625|FG000|NOT COMPLETED|Overall Study||0
11293911|NCT02512224|12491626|FG001|NOT COMPLETED|Overall Study||0
11293912|NCT02512276|12491634|FG000|STARTED|Overall Study||2038
11293913|NCT02512276|12491635|FG001|STARTED|Overall Study||2040
11293914|NCT02512276|12491634|FG000|COMPLETED|Overall Study||2030
11293915|NCT02512276|12491635|FG001|COMPLETED|Overall Study||2029
11293916|NCT02512276|12491634|FG000|NOT COMPLETED|Overall Study||8
11293917|NCT02512276|12491635|FG001|NOT COMPLETED|Overall Study||11
11293918|NCT02512302|12491641|FG000|STARTED|Period 1||3
11293919|NCT02512302|12491642|FG001|STARTED|Period 1||3
11293920|NCT02512302|12491643|FG002|STARTED|Period 1||4
11293921|NCT02512302|12491644|FG003|STARTED|Period 1||3
11293922|NCT02512302|12491645|FG004|STARTED|Period 1||3
11293923|NCT02512302|12491646|FG005|STARTED|Period 1||3
11293924|NCT02512302|12491647|FG006|STARTED|Period 1||2
11293925|NCT02512302|12491648|FG007|STARTED|Period 1||3
11293926|NCT02512302|12491649|FG008|STARTED|Period 1||3
11293927|NCT02512302|12491650|FG009|STARTED|Period 1||3
11293928|NCT02512302|12491641|FG000|COMPLETED|Period 1||3
11293929|NCT02512302|12491642|FG001|COMPLETED|Period 1||2
11293930|NCT02512302|12491643|FG002|COMPLETED|Period 1||4
11293931|NCT02512302|12491644|FG003|COMPLETED|Period 1||3
11293932|NCT02512302|12491645|FG004|COMPLETED|Period 1||3
11293933|NCT02512302|12491646|FG005|COMPLETED|Period 1||3
11293934|NCT02512302|12491647|FG006|COMPLETED|Period 1||2
11293935|NCT02512302|12491648|FG007|COMPLETED|Period 1||3
11293936|NCT02512302|12491649|FG008|COMPLETED|Period 1||3
11293937|NCT02512302|12491650|FG009|COMPLETED|Period 1||3
11293938|NCT02512302|12491641|FG000|NOT COMPLETED|Period 1||0
11293939|NCT02512302|12491642|FG001|NOT COMPLETED|Period 1||1
11293940|NCT02512302|12491643|FG002|NOT COMPLETED|Period 1||0
11293941|NCT02512302|12491644|FG003|NOT COMPLETED|Period 1||0
11293942|NCT02512302|12491645|FG004|NOT COMPLETED|Period 1||0
11293943|NCT02512302|12491646|FG005|NOT COMPLETED|Period 1||0
11293944|NCT02512302|12491647|FG006|NOT COMPLETED|Period 1||0
11293945|NCT02512302|12491648|FG007|NOT COMPLETED|Period 1||0
11293946|NCT02512302|12491649|FG008|NOT COMPLETED|Period 1||0
11293947|NCT02512302|12491650|FG009|NOT COMPLETED|Period 1||0
11293948|NCT02512302|12491641|FG000|STARTED|Period 2||3
11293949|NCT02512302|12491642|FG001|STARTED|Period 2||2
11293950|NCT02512302|12491643|FG002|STARTED|Period 2||4
11293951|NCT02512302|12491644|FG003|STARTED|Period 2||3
11293952|NCT02512302|12491645|FG004|STARTED|Period 2||3
11293953|NCT02512302|12491646|FG005|STARTED|Period 2||3
11293954|NCT02512302|12491647|FG006|STARTED|Period 2||2
11293955|NCT02512302|12491648|FG007|STARTED|Period 2||3
11293956|NCT02512302|12491649|FG008|STARTED|Period 2||3
11293957|NCT02512302|12491650|FG009|STARTED|Period 2||3
11293958|NCT02512302|12491641|FG000|COMPLETED|Period 2||3
11293959|NCT02512302|12491642|FG001|COMPLETED|Period 2||2
11293960|NCT02512302|12491643|FG002|COMPLETED|Period 2||4
11293961|NCT02512302|12491644|FG003|COMPLETED|Period 2||3
11293962|NCT02512302|12491645|FG004|COMPLETED|Period 2||3
11293963|NCT02512302|12491646|FG005|COMPLETED|Period 2||3
11293964|NCT02512302|12491647|FG006|COMPLETED|Period 2||2
11293965|NCT02512302|12491648|FG007|COMPLETED|Period 2||3
11293966|NCT02512302|12491649|FG008|COMPLETED|Period 2||3
11293967|NCT02512302|12491650|FG009|COMPLETED|Period 2||2
11293968|NCT02512302|12491641|FG000|NOT COMPLETED|Period 2||0
11293969|NCT02512302|12491642|FG001|NOT COMPLETED|Period 2||0
11293970|NCT02512302|12491643|FG002|NOT COMPLETED|Period 2||0
11293971|NCT02512302|12491644|FG003|NOT COMPLETED|Period 2||0
11293972|NCT02512302|12491645|FG004|NOT COMPLETED|Period 2||0
11293973|NCT02512302|12491646|FG005|NOT COMPLETED|Period 2||0
11293974|NCT02512302|12491647|FG006|NOT COMPLETED|Period 2||0
11293975|NCT02512302|12491648|FG007|NOT COMPLETED|Period 2||0
11293976|NCT02512302|12491649|FG008|NOT COMPLETED|Period 2||0
11293977|NCT02512302|12491650|FG009|NOT COMPLETED|Period 2||1
11293978|NCT02512302|12491641|FG000|STARTED|Period 3||3
11293979|NCT02512302|12491642|FG001|STARTED|Period 3||2
11293980|NCT02512302|12491643|FG002|STARTED|Period 3||4
11293981|NCT02512302|12491644|FG003|STARTED|Period 3||3
11293982|NCT02512302|12491645|FG004|STARTED|Period 3||3
11293983|NCT02512302|12491646|FG005|STARTED|Period 3||3
11293984|NCT02512302|12491647|FG006|STARTED|Period 3||2
11293985|NCT02512302|12491648|FG007|STARTED|Period 3||3
11293986|NCT02512302|12491649|FG008|STARTED|Period 3||3
11293987|NCT02512302|12491650|FG009|STARTED|Period 3||2
11293988|NCT02512302|12491641|FG000|COMPLETED|Period 3||3
11293989|NCT02512302|12491642|FG001|COMPLETED|Period 3||2
11293990|NCT02512302|12491643|FG002|COMPLETED|Period 3||3
11293991|NCT02512302|12491644|FG003|COMPLETED|Period 3||3
11293992|NCT02512302|12491645|FG004|COMPLETED|Period 3||3
11293993|NCT02512302|12491646|FG005|COMPLETED|Period 3||3
11293994|NCT02512302|12491647|FG006|COMPLETED|Period 3||2
11293995|NCT02512302|12491648|FG007|COMPLETED|Period 3||3
11293996|NCT02512302|12491649|FG008|COMPLETED|Period 3||3
11293997|NCT02512302|12491650|FG009|COMPLETED|Period 3||2
11293998|NCT02512302|12491641|FG000|NOT COMPLETED|Period 3||0
11293999|NCT02512302|12491642|FG001|NOT COMPLETED|Period 3||0
11294000|NCT02512302|12491643|FG002|NOT COMPLETED|Period 3||1
11294001|NCT02512302|12491644|FG003|NOT COMPLETED|Period 3||0
11294002|NCT02512302|12491645|FG004|NOT COMPLETED|Period 3||0
11294003|NCT02512302|12491646|FG005|NOT COMPLETED|Period 3||0
11294004|NCT02512302|12491647|FG006|NOT COMPLETED|Period 3||0
11294005|NCT02512302|12491648|FG007|NOT COMPLETED|Period 3||0
11294006|NCT02512302|12491649|FG008|NOT COMPLETED|Period 3||0
11294007|NCT02512302|12491650|FG009|NOT COMPLETED|Period 3||0
11294008|NCT02512302|12491641|FG000|STARTED|Period 4||3
11294009|NCT02512302|12491642|FG001|STARTED|Period 4||2
11294010|NCT02512302|12491643|FG002|STARTED|Period 4||3
11294011|NCT02512302|12491644|FG003|STARTED|Period 4||3
11294012|NCT02512302|12491645|FG004|STARTED|Period 4||3
11294013|NCT02512302|12491646|FG005|STARTED|Period 4||3
11294014|NCT02512302|12491647|FG006|STARTED|Period 4||2
11294015|NCT02512302|12491648|FG007|STARTED|Period 4||3
11294016|NCT02512302|12491649|FG008|STARTED|Period 4||3
11294017|NCT02512302|12491650|FG009|STARTED|Period 4||2
11294018|NCT02512302|12491641|FG000|COMPLETED|Period 4||3
11294019|NCT02512302|12491642|FG001|COMPLETED|Period 4||2
11294020|NCT02512302|12491643|FG002|COMPLETED|Period 4||3
11294021|NCT02512302|12491644|FG003|COMPLETED|Period 4||3
11294022|NCT02512302|12491645|FG004|COMPLETED|Period 4||3
11294023|NCT02512302|12491646|FG005|COMPLETED|Period 4||3
11294024|NCT02512302|12491647|FG006|COMPLETED|Period 4||1
11294025|NCT02512302|12491648|FG007|COMPLETED|Period 4||3
11294026|NCT02512302|12491649|FG008|COMPLETED|Period 4||3
11294027|NCT02512302|12491650|FG009|COMPLETED|Period 4||2
11294028|NCT02512302|12491641|FG000|NOT COMPLETED|Period 4||0
11294029|NCT02512302|12491642|FG001|NOT COMPLETED|Period 4||0
11294030|NCT02512302|12491643|FG002|NOT COMPLETED|Period 4||0
11294031|NCT02512302|12491644|FG003|NOT COMPLETED|Period 4||0
11294032|NCT02512302|12491645|FG004|NOT COMPLETED|Period 4||0
11294033|NCT02512302|12491646|FG005|NOT COMPLETED|Period 4||0
11294034|NCT02512302|12491647|FG006|NOT COMPLETED|Period 4||1
11294035|NCT02512302|12491648|FG007|NOT COMPLETED|Period 4||0
11294036|NCT02512302|12491649|FG008|NOT COMPLETED|Period 4||0
11294037|NCT02512302|12491650|FG009|NOT COMPLETED|Period 4||0
11294038|NCT02512302|12491641|FG000|STARTED|Period 5||3
11294039|NCT02512302|12491642|FG001|STARTED|Period 5||2
11294040|NCT02512302|12491643|FG002|STARTED|Period 5||3
11294041|NCT02512302|12491644|FG003|STARTED|Period 5||3
11294042|NCT02512302|12491645|FG004|STARTED|Period 5||3
11294043|NCT02512302|12491646|FG005|STARTED|Period 5||3
11294044|NCT02512302|12491647|FG006|STARTED|Period 5||1
11294045|NCT02512302|12491648|FG007|STARTED|Period 5||3
11294046|NCT02512302|12491649|FG008|STARTED|Period 5||3
11294047|NCT02512302|12491650|FG009|STARTED|Period 5||2
11294048|NCT02512302|12491641|FG000|COMPLETED|Period 5||3
11294049|NCT02512302|12491642|FG001|COMPLETED|Period 5||2
11294050|NCT02512302|12491643|FG002|COMPLETED|Period 5||3
11294051|NCT02512302|12491644|FG003|COMPLETED|Period 5||3
11294052|NCT02512302|12491645|FG004|COMPLETED|Period 5||3
11294053|NCT02512302|12491646|FG005|COMPLETED|Period 5||3
11294054|NCT02512302|12491647|FG006|COMPLETED|Period 5||1
11294055|NCT02512302|12491648|FG007|COMPLETED|Period 5||3
11294056|NCT02512302|12491649|FG008|COMPLETED|Period 5||3
11294057|NCT02512302|12491650|FG009|COMPLETED|Period 5||2
11294058|NCT02512302|12491641|FG000|NOT COMPLETED|Period 5||0
11294059|NCT02512302|12491642|FG001|NOT COMPLETED|Period 5||0
11294060|NCT02512302|12491643|FG002|NOT COMPLETED|Period 5||0
11294061|NCT02512302|12491644|FG003|NOT COMPLETED|Period 5||0
11294062|NCT02512302|12491645|FG004|NOT COMPLETED|Period 5||0
11294063|NCT02512302|12491646|FG005|NOT COMPLETED|Period 5||0
11294064|NCT02512302|12491647|FG006|NOT COMPLETED|Period 5||0
11294065|NCT02512302|12491648|FG007|NOT COMPLETED|Period 5||0
11294066|NCT02512302|12491649|FG008|NOT COMPLETED|Period 5||0
11294067|NCT02512302|12491650|FG009|NOT COMPLETED|Period 5||0
11294068|NCT02512393|12491665|FG000|STARTED|Overall Study||21
11294069|NCT02512393|12491666|FG001|STARTED|Overall Study||20
11294070|NCT02512393|12491665|FG000|COMPLETED|Overall Study||20
11294071|NCT02512393|12491666|FG001|COMPLETED|Overall Study||20
11294072|NCT02512393|12491665|FG000|NOT COMPLETED|Overall Study||1
11294073|NCT02512393|12491666|FG001|NOT COMPLETED|Overall Study||0
11294074|NCT02512419|12491674|FG000|STARTED|Overall Study||24
11294075|NCT02512419|12491675|FG001|STARTED|Overall Study||24
11294076|NCT02512419|12491674|FG000|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22
11294077|NCT02512419|12491675|FG001|COMPLETED|Overall Study||24
11294078|NCT02512419|12491674|FG000|NOT COMPLETED|Overall Study||2
11294079|NCT02512419|12491675|FG001|NOT COMPLETED|Overall Study||0
11294080|NCT02512575|12491691|FG000|STARTED|Overall Study||6
11294081|NCT02512575|12491692|FG001|STARTED|Overall Study||6
11294082|NCT02512575|12491693|FG002|STARTED|Overall Study||6
11294083|NCT02512575|12491694|FG003|STARTED|Overall Study||6
11294084|NCT02512575|12491695|FG004|STARTED|Overall Study||6
11294085|NCT02512575|12491696|FG005|STARTED|Overall Study||6
11294086|NCT02512575|12491697|FG006|STARTED|Overall Study||6
11294087|NCT02512575|12491698|FG007|STARTED|Overall Study||6
11294088|NCT02512575|12491699|FG008|STARTED|Overall Study||6
11294089|NCT02512575|12491700|FG009|STARTED|Overall Study||18
11294090|NCT02512575|12491691|FG000|COMPLETED|Overall Study||6
11294091|NCT02512575|12491692|FG001|COMPLETED|Overall Study||6
11294092|NCT02512575|12491693|FG002|COMPLETED|Overall Study||6
11294093|NCT02512575|12491694|FG003|COMPLETED|Overall Study||6
11294094|NCT02512575|12491695|FG004|COMPLETED|Overall Study||6
11294095|NCT02512575|12491696|FG005|COMPLETED|Overall Study||6
11294096|NCT02512575|12491697|FG006|COMPLETED|Overall Study||6
11294097|NCT02512575|12491698|FG007|COMPLETED|Overall Study||6
11294098|NCT02512575|12491699|FG008|COMPLETED|Overall Study||6
11294099|NCT02512575|12491700|FG009|COMPLETED|Overall Study||18
11294100|NCT02512575|12491691|FG000|NOT COMPLETED|Overall Study||0
11294101|NCT02512575|12491692|FG001|NOT COMPLETED|Overall Study||0
11294102|NCT02512575|12491693|FG002|NOT COMPLETED|Overall Study||0
11294103|NCT02512575|12491694|FG003|NOT COMPLETED|Overall Study||0
11294104|NCT02512575|12491695|FG004|NOT COMPLETED|Overall Study||0
11294105|NCT02512575|12491696|FG005|NOT COMPLETED|Overall Study||0
11294106|NCT02512575|12491697|FG006|NOT COMPLETED|Overall Study||0
11294107|NCT02512575|12491698|FG007|NOT COMPLETED|Overall Study||0
11294108|NCT02512575|12491699|FG008|NOT COMPLETED|Overall Study||0
11294109|NCT02512575|12491700|FG009|NOT COMPLETED|Overall Study||0
11294110|NCT02512679|12491722|FG000|STARTED|Overall Study||20
11294111|NCT02512679|12491723|FG001|STARTED|Overall Study||0
11294112|NCT02512679|12491722|FG000|COMPLETED|Overall Study||20
11294113|NCT02512679|12491723|FG001|COMPLETED|Overall Study||0
11294114|NCT02512679|12491722|FG000|NOT COMPLETED|Overall Study||0
11294115|NCT02512679|12491723|FG001|NOT COMPLETED|Overall Study||0
11294116|NCT02512783|12491729|FG000|STARTED|Overall Study||96
11294117|NCT02512783|12491730|FG001|STARTED|Overall Study||75
11294118|NCT02512783|12491729|FG000|COMPLETED|Overall Study||96
11294119|NCT02512783|12491730|FG001|COMPLETED|Overall Study||75
11294120|NCT02512783|12491729|FG000|NOT COMPLETED|Overall Study||0
11294121|NCT02512783|12491730|FG001|NOT COMPLETED|Overall Study||0
11294122|NCT02512809|12491739|FG000|STARTED|Overall Study||25
11294123|NCT02512809|12491739|FG000|COMPLETED|Overall Study||25
11294124|NCT02512809|12491739|FG000|NOT COMPLETED|Overall Study||0
11294125|NCT02512861|12491745|FG000|STARTED|Overall Study||44
11294126|NCT02512861|12491746|FG001|STARTED|Overall Study||49
11294127|NCT02512861|12491745|FG000|COMPLETED|Overall Study||38
11294128|NCT02512861|12491746|FG001|COMPLETED|Overall Study||40
11294129|NCT02512861|12491745|FG000|NOT COMPLETED|Overall Study||6
11294130|NCT02512861|12491746|FG001|NOT COMPLETED|Overall Study||9
11294131|NCT02512874|12491752|FG000|STARTED|Overall Study||65
11294132|NCT02512874|12491752|FG000|COMPLETED|Overall Study||63
11294133|NCT02512874|12491752|FG000|NOT COMPLETED|Overall Study||2
11294134|NCT02512900|12491758|FG000|STARTED|Overall Study||11
11294135|NCT02512900|12491759|FG001|STARTED|Overall Study||10
11294136|NCT02512900|12491758|FG000|COMPLETED|Overall Study||11
11294137|NCT02512900|12491759|FG001|COMPLETED|Overall Study||10
11294138|NCT02512900|12491758|FG000|NOT COMPLETED|Overall Study||0
11294139|NCT02512900|12491759|FG001|NOT COMPLETED|Overall Study||0
11294140|NCT02512965|12491768|FG000|STARTED|Overall Study||115
11294141|NCT02512965|12491769|FG001|STARTED|Overall Study||114
11294142|NCT02512965|12491768|FG000|COMPLETED|Overall Study||115
11294143|NCT02512965|12491769|FG001|COMPLETED|Overall Study|4 patients did not receive any dose of the assigned treatment.|110
11294144|NCT02512965|12491768|FG000|NOT COMPLETED|Overall Study||0
11294145|NCT02512965|12491769|FG001|NOT COMPLETED|Overall Study||4
11294146|NCT02513095|12491777|FG000|STARTED|Overall Study||17
11294147|NCT02513095|12491778|FG001|STARTED|Overall Study||17
11294148|NCT02513095|12491777|FG000|Treatment Phase - Up to 120 Minutes|Overall Study||17
11294149|NCT02513095|12491778|FG001|Treatment Phase - Up to 120 Minutes|Overall Study||17
11294150|NCT02513095|12491777|FG000|COMPLETED|Overall Study||17
11294151|NCT02513095|12491778|FG001|COMPLETED|Overall Study||17
11294152|NCT02513095|12491777|FG000|NOT COMPLETED|Overall Study||0
11294153|NCT02513095|12491778|FG001|NOT COMPLETED|Overall Study||0
11294154|NCT02513121|12491786|FG000|STARTED|Overall Study||20
11294155|NCT02513121|12491787|FG001|STARTED|Overall Study||20
11294156|NCT02513121|12491786|FG000|COMPLETED|Overall Study||20
11294157|NCT02513121|12491787|FG001|COMPLETED|Overall Study||20
11294158|NCT02513121|12491786|FG000|NOT COMPLETED|Overall Study||0
11294159|NCT02513121|12491787|FG001|NOT COMPLETED|Overall Study||0
11294160|NCT02513160|12491799|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
11294161|NCT02513160|12491800|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0
11294162|NCT02513160|12491801|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0
11294163|NCT02513160|12491802|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0
11294164|NCT02513160|12491799|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||425
11294165|NCT02513160|12491800|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0
11294166|NCT02513160|12491801|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0
11294167|NCT02513160|12491802|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0
11400139|NCT04267770|12594830|FG001|STARTED|Overall Study||8
11400140|NCT04267770|12594829|FG000|COMPLETED|Overall Study||9
11400141|NCT04267770|12594830|FG001|COMPLETED|Overall Study||8
11294168|NCT02513160|12491799|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
11294169|NCT02513160|12491800|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
11294170|NCT02513160|12491801|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
11294171|NCT02513160|12491802|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
11294172|NCT02513160|12491799|FG000|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
11294173|NCT02513160|12491800|FG001|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
11294174|NCT02513160|12491801|FG002|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
11294175|NCT02513160|12491802|FG003|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
11294176|NCT02513160|12491799|FG000|COMPLETED|Treatment Period (Day 0 to Week 6)||101
11294177|NCT02513160|12491800|FG001|COMPLETED|Treatment Period (Day 0 to Week 6)||104
11294178|NCT02513160|12491801|FG002|COMPLETED|Treatment Period (Day 0 to Week 6)||104
11294179|NCT02513160|12491802|FG003|COMPLETED|Treatment Period (Day 0 to Week 6)||103
11294180|NCT02513160|12491799|FG000|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
11294181|NCT02513160|12491800|FG001|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
11294182|NCT02513160|12491801|FG002|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
11294183|NCT02513160|12491802|FG003|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
11294184|NCT02513212|12491815|FG000|STARTED|Overall Study||12
11400142|NCT04267770|12594829|FG000|NOT COMPLETED|Overall Study||0
11294185|NCT02513212|12491816|FG001|STARTED|Overall Study||12
11294186|NCT02513212|12491815|FG000|COMPLETED|Overall Study||11
11294187|NCT02513212|12491816|FG001|COMPLETED|Overall Study||12
11294188|NCT02513212|12491815|FG000|NOT COMPLETED|Overall Study||1
11294189|NCT02513212|12491816|FG001|NOT COMPLETED|Overall Study||0
11294190|NCT02513446|12491824|FG000|STARTED|Period 1||8
11294191|NCT02513446|12491825|FG001|STARTED|Period 1||8
11294192|NCT02513446|12491824|FG000|COMPLETED|Period 1||8
11294193|NCT02513446|12491825|FG001|COMPLETED|Period 1||8
11294194|NCT02513446|12491824|FG000|NOT COMPLETED|Period 1||0
11294195|NCT02513446|12491825|FG001|NOT COMPLETED|Period 1||0
11294196|NCT02513446|12491824|FG000|STARTED|Washout Period of 10 Days||8
11294197|NCT02513446|12491825|FG001|STARTED|Washout Period of 10 Days||8
11294198|NCT02513446|12491824|FG000|COMPLETED|Washout Period of 10 Days||8
11294199|NCT02513446|12491825|FG001|COMPLETED|Washout Period of 10 Days||8
11294200|NCT02513446|12491824|FG000|NOT COMPLETED|Washout Period of 10 Days||0
11294201|NCT02513446|12491825|FG001|NOT COMPLETED|Washout Period of 10 Days||0
11294202|NCT02513446|12491824|FG000|STARTED|Period 2||8
11294203|NCT02513446|12491825|FG001|STARTED|Period 2||8
11294204|NCT02513446|12491824|FG000|COMPLETED|Period 2||8
11294205|NCT02513446|12491825|FG001|COMPLETED|Period 2||8
11294206|NCT02513446|12491824|FG000|NOT COMPLETED|Period 2||0
11400143|NCT04267770|12594830|FG001|NOT COMPLETED|Overall Study||0
11400144|NCT04266925|12594838|FG000|STARTED|1 Referee Game (~1 Hour)||23
11400145|NCT04266925|12594839|FG001|STARTED|1 Referee Game (~1 Hour)||26
11400146|NCT04266925|12594838|FG000|COMPLETED|1 Referee Game (~1 Hour)||23
11400147|NCT04266925|12594839|FG001|COMPLETED|1 Referee Game (~1 Hour)||26
11400148|NCT04266925|12594838|FG000|NOT COMPLETED|1 Referee Game (~1 Hour)||0
11400149|NCT04266925|12594839|FG001|NOT COMPLETED|1 Referee Game (~1 Hour)||0
11400150|NCT04266925|12594838|FG000|STARTED|3 Referee Game (~1 Hour)||23
11400151|NCT04266925|12594839|FG001|STARTED|3 Referee Game (~1 Hour)||26
11400152|NCT04266925|12594838|FG000|COMPLETED|3 Referee Game (~1 Hour)||23
11400153|NCT04266925|12594839|FG001|COMPLETED|3 Referee Game (~1 Hour)||26
11400154|NCT04266925|12594838|FG000|NOT COMPLETED|3 Referee Game (~1 Hour)||0
11400155|NCT04266925|12594839|FG001|NOT COMPLETED|3 Referee Game (~1 Hour)||0
11400156|NCT04263142|12594850|FG000|STARTED|Part 1 Period 1 (Day 1)||9
11400157|NCT04263142|12594851|FG001|STARTED|Part 1 Period 1 (Day 1)||9
11400158|NCT04263142|12594852|FG002|STARTED|Part 1 Period 1 (Day 1)||0
11400159|NCT04263142|12594853|FG003|STARTED|Part 1 Period 1 (Day 1)||0
11400160|NCT04263142|12594854|FG004|STARTED|Part 1 Period 1 (Day 1)||0
11400161|NCT04263142|12594850|FG000|COMPLETED|Part 1 Period 1 (Day 1)||9
11400162|NCT04263142|12594851|FG001|COMPLETED|Part 1 Period 1 (Day 1)||9
11400163|NCT04263142|12594852|FG002|COMPLETED|Part 1 Period 1 (Day 1)||0
11400164|NCT04263142|12594853|FG003|COMPLETED|Part 1 Period 1 (Day 1)||0
11400165|NCT04263142|12594854|FG004|COMPLETED|Part 1 Period 1 (Day 1)||0
11400166|NCT04263142|12594850|FG000|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
11400167|NCT04263142|12594851|FG001|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
11400168|NCT04263142|12594852|FG002|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
11400169|NCT04263142|12594853|FG003|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
11400170|NCT04263142|12594854|FG004|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
11400171|NCT04263142|12594850|FG000|STARTED|Part 1 Period 2 (Up to Day 5)||9
11400172|NCT04263142|12594851|FG001|STARTED|Part 1 Period 2 (Up to Day 5)||9
11400173|NCT04263142|12594852|FG002|STARTED|Part 1 Period 2 (Up to Day 5)||0
11400174|NCT04263142|12594853|FG003|STARTED|Part 1 Period 2 (Up to Day 5)||0
11400175|NCT04263142|12594854|FG004|STARTED|Part 1 Period 2 (Up to Day 5)||0
11400176|NCT04263142|12594850|FG000|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
11400177|NCT04263142|12594851|FG001|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
11400178|NCT04263142|12594852|FG002|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
11400179|NCT04263142|12594853|FG003|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
11400180|NCT04263142|12594854|FG004|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
11400181|NCT04263142|12594850|FG000|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
11400182|NCT04263142|12594851|FG001|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
11400183|NCT04263142|12594852|FG002|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
11400184|NCT04263142|12594853|FG003|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
11400185|NCT04263142|12594854|FG004|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
11400186|NCT04263142|12594850|FG000|STARTED|Part 2 Period 1 (Day 1)||0
11400187|NCT04263142|12594851|FG001|STARTED|Part 2 Period 1 (Day 1)||0
11400188|NCT04263142|12594852|FG002|STARTED|Part 2 Period 1 (Day 1)||7
11400189|NCT04263142|12594853|FG003|STARTED|Part 2 Period 1 (Day 1)||7
11294207|NCT02513446|12491825|FG001|NOT COMPLETED|Period 2||0
11294208|NCT02513459|12491832|FG000|STARTED|Overall Study||65
11294209|NCT02513459|12491832|FG000|COMPLETED|Overall Study||44
11294210|NCT02513459|12491832|FG000|NOT COMPLETED|Overall Study||21
11294211|NCT02513498|12491841|FG000|STARTED|Overall Study||50
11294212|NCT02513498|12491841|FG000|COMPLETED|Overall Study||26
11294213|NCT02513498|12491841|FG000|NOT COMPLETED|Overall Study||24
11294214|NCT02513550|12491853|FG000|STARTED|Double Blind Treatment Period||310
11294215|NCT02513550|12491854|FG001|STARTED|Double Blind Treatment Period||306
11294216|NCT02513550|12491855|FG002|STARTED|Double Blind Treatment Period||611
11294217|NCT02513550|12491856|FG003|STARTED|Double Blind Treatment Period||9
11294218|NCT02513550|12491857|FG004|STARTED|Double Blind Treatment Period||5
11294219|NCT02513550|12491858|FG005|STARTED|Double Blind Treatment Period||16
11294220|NCT02513550|12491853|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
11294221|NCT02513550|12491854|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
11294222|NCT02513550|12491855|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
11294223|NCT02513550|12491856|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
11294224|NCT02513550|12491857|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
11294225|NCT02513550|12491858|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
11294226|NCT02513550|12491853|FG000|COMPLETED|Double Blind Treatment Period||274
11294227|NCT02513550|12491854|FG001|COMPLETED|Double Blind Treatment Period||268
11294228|NCT02513550|12491855|FG002|COMPLETED|Double Blind Treatment Period||537
11400190|NCT04263142|12594854|FG004|STARTED|Part 2 Period 1 (Day 1)||7
11400191|NCT04263142|12594850|FG000|COMPLETED|Part 2 Period 1 (Day 1)||0
11400192|NCT04263142|12594851|FG001|COMPLETED|Part 2 Period 1 (Day 1)||0
11400193|NCT04263142|12594852|FG002|COMPLETED|Part 2 Period 1 (Day 1)||7
11400194|NCT04263142|12594853|FG003|COMPLETED|Part 2 Period 1 (Day 1)||7
11400195|NCT04263142|12594854|FG004|COMPLETED|Part 2 Period 1 (Day 1)||6
11400196|NCT04263142|12594850|FG000|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
11400197|NCT04263142|12594851|FG001|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
11400198|NCT04263142|12594852|FG002|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
11400199|NCT04263142|12594853|FG003|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
11400200|NCT04263142|12594854|FG004|NOT COMPLETED|Part 2 Period 1 (Day 1)||1
11400201|NCT04263142|12594850|FG000|STARTED|Part 2 Period 2 (Day 1)||0
11400202|NCT04263142|12594851|FG001|STARTED|Part 2 Period 2 (Day 1)||0
11400203|NCT04263142|12594852|FG002|STARTED|Part 2 Period 2 (Day 1)||7
11400204|NCT04263142|12594853|FG003|STARTED|Part 2 Period 2 (Day 1)||7
11400205|NCT04263142|12594854|FG004|STARTED|Part 2 Period 2 (Day 1)||6
11400206|NCT04263142|12594850|FG000|COMPLETED|Part 2 Period 2 (Day 1)||0
11400207|NCT04263142|12594851|FG001|COMPLETED|Part 2 Period 2 (Day 1)||0
11400208|NCT04263142|12594852|FG002|COMPLETED|Part 2 Period 2 (Day 1)||7
11400209|NCT04263142|12594853|FG003|COMPLETED|Part 2 Period 2 (Day 1)||7
11400210|NCT04263142|12594854|FG004|COMPLETED|Part 2 Period 2 (Day 1)||5
11400211|NCT04263142|12594850|FG000|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
11400212|NCT04263142|12594851|FG001|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
11400213|NCT04263142|12594852|FG002|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
11400214|NCT04263142|12594853|FG003|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
11400215|NCT04263142|12594854|FG004|NOT COMPLETED|Part 2 Period 2 (Day 1)||1
11400216|NCT04263142|12594850|FG000|STARTED|Part 2 Period 3 (Up to Day 5)||0
11400217|NCT04263142|12594851|FG001|STARTED|Part 2 Period 3 (Up to Day 5)||0
11400218|NCT04263142|12594852|FG002|STARTED|Part 2 Period 3 (Up to Day 5)||7
11400219|NCT04263142|12594853|FG003|STARTED|Part 2 Period 3 (Up to Day 5)||7
11400220|NCT04263142|12594854|FG004|STARTED|Part 2 Period 3 (Up to Day 5)||5
11400221|NCT04263142|12594850|FG000|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
11400222|NCT04263142|12594851|FG001|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
11400223|NCT04263142|12594852|FG002|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
11400224|NCT04263142|12594853|FG003|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
11400225|NCT04263142|12594854|FG004|COMPLETED|Part 2 Period 3 (Up to Day 5)||5
11400226|NCT04263142|12594850|FG000|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
11400227|NCT04263142|12594851|FG001|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
11400228|NCT04263142|12594852|FG002|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
11400229|NCT04263142|12594853|FG003|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
11400230|NCT04263142|12594854|FG004|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
11400231|NCT04256785|12594869|FG000|STARTED|Overall Study||54
11400232|NCT04256785|12594870|FG001|STARTED|Overall Study||56
11400233|NCT04256785|12594869|FG000|COMPLETED|Overall Study||26
11400234|NCT04256785|12594870|FG001|COMPLETED|Overall Study||31
11400235|NCT04256785|12594869|FG000|NOT COMPLETED|Overall Study||28
11400236|NCT04256785|12594870|FG001|NOT COMPLETED|Overall Study||25
11400237|NCT04252092|12594880|FG000|STARTED|Overall Study||15
11400238|NCT04252092|12594881|FG001|STARTED|Overall Study||15
11400239|NCT04252092|12594880|FG000|COMPLETED|Overall Study||15
11400240|NCT04252092|12594881|FG001|COMPLETED|Overall Study||15
11400241|NCT04252092|12594880|FG000|NOT COMPLETED|Overall Study||0
11400242|NCT04252092|12594881|FG001|NOT COMPLETED|Overall Study||0
11400243|NCT04250987|12594887|FG000|STARTED|Overall Study||12
11400244|NCT04250987|12594887|FG000|COMPLETED|Overall Study||12
11400245|NCT04250987|12594887|FG000|NOT COMPLETED|Overall Study||0
11400246|NCT04249336|12594895|FG000|STARTED|Overall Study||35
11294229|NCT02513550|12491856|FG003|COMPLETED|Double Blind Treatment Period||9
11400247|NCT04249336|12594896|FG001|STARTED|Overall Study||35
11294230|NCT02513550|12491857|FG004|COMPLETED|Double Blind Treatment Period||4
11294231|NCT02513550|12491858|FG005|COMPLETED|Double Blind Treatment Period||15
11294232|NCT02513550|12491853|FG000|NOT COMPLETED|Double Blind Treatment Period||36
11294233|NCT02513550|12491854|FG001|NOT COMPLETED|Double Blind Treatment Period||38
11294234|NCT02513550|12491855|FG002|NOT COMPLETED|Double Blind Treatment Period||74
11294235|NCT02513550|12491856|FG003|NOT COMPLETED|Double Blind Treatment Period||0
11400248|NCT04249336|12594897|FG002|STARTED|Overall Study||35
11400249|NCT04249336|12594898|FG003|STARTED|Overall Study||35
11400250|NCT04249336|12594895|FG000|Per Protocol Population Day 3|Overall Study||32
11400251|NCT04249336|12594896|FG001|Per Protocol Population Day 3|Overall Study||32
11400252|NCT04249336|12594897|FG002|Per Protocol Population Day 3|Overall Study||32
11400253|NCT04249336|12594898|FG003|Per Protocol Population Day 3|Overall Study||32
11400254|NCT04249336|12594895|FG000|Per Protocol Population Week 4|Overall Study||33
11400255|NCT04249336|12594896|FG001|Per Protocol Population Week 4|Overall Study||35
11400256|NCT04249336|12594897|FG002|Per Protocol Population Week 4|Overall Study||33
11400257|NCT04249336|12594898|FG003|Per Protocol Population Week 4|Overall Study||34
11400258|NCT04249336|12594895|FG000|COMPLETED|Overall Study||32
11400259|NCT04249336|12594896|FG001|COMPLETED|Overall Study||32
11400260|NCT04249336|12594897|FG002|COMPLETED|Overall Study||32
11400261|NCT04249336|12594898|FG003|COMPLETED|Overall Study||32
11400262|NCT04249336|12594895|FG000|NOT COMPLETED|Overall Study||3
11400263|NCT04249336|12594896|FG001|NOT COMPLETED|Overall Study||3
11400264|NCT04249336|12594897|FG002|NOT COMPLETED|Overall Study||3
11400265|NCT04249336|12594898|FG003|NOT COMPLETED|Overall Study||3
11400266|NCT04247581|12594910|FG000|STARTED|Overall Study||241
11400267|NCT04247581|12594911|FG001|STARTED|Overall Study||305
11400268|NCT04247581|12594910|FG000|COMPLETED|Overall Study||241
11400269|NCT04247581|12594911|FG001|COMPLETED|Overall Study||293
11400270|NCT04247581|12594910|FG000|NOT COMPLETED|Overall Study||0
11400271|NCT04247581|12594911|FG001|NOT COMPLETED|Overall Study||12
11400272|NCT04247061|12594917|FG000|STARTED|Overall Study|13 Subjects completed the required pre-dental appointment study activities and were scheduled to attend the dental clinic|13
11400273|NCT04247061|12594917|FG000|COMPLETED|Overall Study||4
11400274|NCT04247061|12594917|FG000|NOT COMPLETED|Overall Study||9
11400275|NCT04245202|12594923|FG000|STARTED|Overall Study|After getting consent.|48
11400276|NCT04245202|12594924|FG001|STARTED|Overall Study|After getting consent|39
11400277|NCT04245202|12594923|FG000|COMPLETED|Overall Study||38
11400278|NCT04245202|12594924|FG001|COMPLETED|Overall Study||38
11400279|NCT04245202|12594923|FG000|NOT COMPLETED|Overall Study||10
11294236|NCT02513550|12491857|FG004|NOT COMPLETED|Double Blind Treatment Period||1
11294237|NCT02513550|12491858|FG005|NOT COMPLETED|Double Blind Treatment Period||1
11294238|NCT02513550|12491853|FG000|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
11294239|NCT02513550|12491854|FG001|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
11294240|NCT02513550|12491855|FG002|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
11294241|NCT02513550|12491856|FG003|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
11294242|NCT02513550|12491857|FG004|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
11294243|NCT02513550|12491858|FG005|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
11294244|NCT02513550|12491853|FG000|COMPLETED|Post-Treatment Follow-up Period||254
11294245|NCT02513550|12491854|FG001|COMPLETED|Post-Treatment Follow-up Period||244
11294246|NCT02513550|12491855|FG002|COMPLETED|Post-Treatment Follow-up Period||496
11294247|NCT02513550|12491856|FG003|COMPLETED|Post-Treatment Follow-up Period||9
11294248|NCT02513550|12491857|FG004|COMPLETED|Post-Treatment Follow-up Period||4
11294249|NCT02513550|12491858|FG005|COMPLETED|Post-Treatment Follow-up Period||15
11294250|NCT02513550|12491853|FG000|NOT COMPLETED|Post-Treatment Follow-up Period||31
11294251|NCT02513550|12491854|FG001|NOT COMPLETED|Post-Treatment Follow-up Period||39
11294252|NCT02513550|12491855|FG002|NOT COMPLETED|Post-Treatment Follow-up Period||63
11294253|NCT02513550|12491856|FG003|NOT COMPLETED|Post-Treatment Follow-up Period||0
11294254|NCT02513550|12491857|FG004|NOT COMPLETED|Post-Treatment Follow-up Period||0
11294255|NCT02513550|12491858|FG005|NOT COMPLETED|Post-Treatment Follow-up Period||0
11294256|NCT02513641|12491880|FG000|STARTED|Overall Study||8
11294257|NCT02513641|12491880|FG000|COMPLETED|Overall Study||8
11294258|NCT02513641|12491880|FG000|NOT COMPLETED|Overall Study||0
11294259|NCT02513719|12491884|FG000|STARTED|At 8 Months Clinical Follow-up||312
11294260|NCT02513719|12491884|FG000|COMPLETED|At 8 Months Clinical Follow-up||312
11294261|NCT02513719|12491884|FG000|NOT COMPLETED|At 8 Months Clinical Follow-up||0
11294262|NCT02513719|12491884|FG000|STARTED|At 1 Year Clinical Follow-up||312
11294263|NCT02513719|12491884|FG000|COMPLETED|At 1 Year Clinical Follow-up||305
11294264|NCT02513719|12491884|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||7
11294265|NCT02513719|12491884|FG000|STARTED|At 2 Years Clinical Follow-up||305
11294266|NCT02513719|12491884|FG000|COMPLETED|At 2 Years Clinical Follow-up||300
11294267|NCT02513719|12491884|FG000|NOT COMPLETED|At 2 Years Clinical Follow-up||5
11294268|NCT02513719|12491884|FG000|STARTED|At 3 Years Clinical Follow-up||300
11294269|NCT02513719|12491884|FG000|COMPLETED|At 3 Years Clinical Follow-up||289
11294270|NCT02513719|12491884|FG000|NOT COMPLETED|At 3 Years Clinical Follow-up||11
11294271|NCT02513719|12491884|FG000|STARTED|At 4 Years Clinical Follow-up||289
11294272|NCT02513719|12491884|FG000|COMPLETED|At 4 Years Clinical Follow-up||273
11294273|NCT02513719|12491884|FG000|NOT COMPLETED|At 4 Years Clinical Follow-up||16
11294274|NCT02513719|12491884|FG000|STARTED|At 5 Years Clinical Follow-up||273
11294275|NCT02513719|12491884|FG000|COMPLETED|At 5 Years Clinical Follow-up||254
11294276|NCT02513719|12491884|FG000|NOT COMPLETED|At 5 Years Clinical Follow-up||19
11294277|NCT02513732|12491888|FG000|STARTED|Overall Study||100
11294278|NCT02513732|12491888|FG000|COMPLETED|Overall Study||78
11294279|NCT02513732|12491888|FG000|NOT COMPLETED|Overall Study||22
11294280|NCT02513745|12491894|FG000|STARTED|Overall Study||42
11294281|NCT02513745|12491895|FG001|STARTED|Overall Study||42
11294282|NCT02513745|12491894|FG000|COMPLETED|Overall Study||39
11294283|NCT02513745|12491895|FG001|COMPLETED|Overall Study||39
11294284|NCT02513745|12491894|FG000|NOT COMPLETED|Overall Study||3
11294285|NCT02513745|12491895|FG001|NOT COMPLETED|Overall Study||3
11294286|NCT02513771|12491903|FG000|STARTED|Overall Study||45
11294287|NCT02513771|12491904|FG001|STARTED|Overall Study||45
11294288|NCT02513771|12491903|FG000|COMPLETED|Overall Study||43
11294289|NCT02513771|12491904|FG001|COMPLETED|Overall Study||44
11400280|NCT04245202|12594924|FG001|NOT COMPLETED|Overall Study||1
11400281|NCT04243369|12594931|FG000|STARTED|Overall Study||30
11400282|NCT04243369|12594931|FG000|COMPLETED|Overall Study||30
11400283|NCT04243369|12594931|FG000|NOT COMPLETED|Overall Study||0
11294290|NCT02513771|12491903|FG000|NOT COMPLETED|Overall Study||2
11294291|NCT02513771|12491904|FG001|NOT COMPLETED|Overall Study||1
11294292|NCT02513823|12491910|FG000|STARTED|Overall Study||27
11294293|NCT02513823|12491910|FG000|COMPLETED|Overall Study||22
11294294|NCT02513823|12491910|FG000|NOT COMPLETED|Overall Study||5
11294295|NCT02513940|12491914|FG000|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2
11294296|NCT02513940|12491915|FG001|STARTED|Overall Study||3
11294297|NCT02513940|12491916|FG002|STARTED|Overall Study||2
11294298|NCT02513940|12491917|FG003|STARTED|Overall Study||2
11294299|NCT02513940|12491918|FG004|STARTED|Overall Study||2
11294300|NCT02513940|12491919|FG005|STARTED|Overall Study||3
11294301|NCT02513940|12491914|FG000|COMPLETED|Overall Study||2
11294302|NCT02513940|12491915|FG001|COMPLETED|Overall Study||3
11294303|NCT02513940|12491916|FG002|COMPLETED|Overall Study||2
11294304|NCT02513940|12491917|FG003|COMPLETED|Overall Study||2
11294305|NCT02513940|12491918|FG004|COMPLETED|Overall Study||2
11294306|NCT02513940|12491919|FG005|COMPLETED|Overall Study||3
11294307|NCT02513940|12491914|FG000|NOT COMPLETED|Overall Study||0
11294308|NCT02513940|12491915|FG001|NOT COMPLETED|Overall Study||0
11294309|NCT02513940|12491916|FG002|NOT COMPLETED|Overall Study||0
11294310|NCT02513940|12491917|FG003|NOT COMPLETED|Overall Study||0
11294311|NCT02513940|12491918|FG004|NOT COMPLETED|Overall Study||0
11294312|NCT02513940|12491919|FG005|NOT COMPLETED|Overall Study||0
11294313|NCT02514044|12491929|FG000|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
11294314|NCT02514044|12491929|FG000|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
11294315|NCT02514044|12491929|FG000|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
11294316|NCT02514044|12491929|FG000|STARTED|Washout (1 Week)||10
11294317|NCT02514044|12491929|FG000|COMPLETED|Washout (1 Week)||10
11294318|NCT02514044|12491929|FG000|NOT COMPLETED|Washout (1 Week)||0
11294319|NCT02514044|12491929|FG000|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
11294320|NCT02514044|12491929|FG000|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
11294321|NCT02514044|12491929|FG000|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
11294322|NCT02514070|12491939|FG000|STARTED|Weeks 0 to Week 6||19
11294323|NCT02514070|12491940|FG001|STARTED|Weeks 0 to Week 6||20
11294324|NCT02514070|12491939|FG000|COMPLETED|Weeks 0 to Week 6||17
11294325|NCT02514070|12491940|FG001|COMPLETED|Weeks 0 to Week 6||16
11294326|NCT02514070|12491939|FG000|NOT COMPLETED|Weeks 0 to Week 6||2
11294327|NCT02514070|12491940|FG001|NOT COMPLETED|Weeks 0 to Week 6||4
11294328|NCT02514070|12491939|FG000|STARTED|Week 6 to Week 14 - Washout Period||17
11294329|NCT02514070|12491940|FG001|STARTED|Week 6 to Week 14 - Washout Period||16
11294330|NCT02514070|12491939|FG000|COMPLETED|Week 6 to Week 14 - Washout Period||17
11294331|NCT02514070|12491940|FG001|COMPLETED|Week 6 to Week 14 - Washout Period||16
11294332|NCT02514070|12491939|FG000|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
11294333|NCT02514070|12491940|FG001|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
11294334|NCT02514070|12491939|FG000|STARTED|Week 14 to Week 20||17
11294335|NCT02514070|12491940|FG001|STARTED|Week 14 to Week 20||16
11294336|NCT02514070|12491939|FG000|COMPLETED|Week 14 to Week 20||16
11294337|NCT02514070|12491940|FG001|COMPLETED|Week 14 to Week 20||14
11294338|NCT02514070|12491939|FG000|NOT COMPLETED|Week 14 to Week 20||1
11294339|NCT02514070|12491940|FG001|NOT COMPLETED|Week 14 to Week 20||2
11294340|NCT02514122|12491952|FG000|STARTED|Overall Study||32
11294341|NCT02514122|12491953|FG001|STARTED|Overall Study||29
11294342|NCT02514122|12491952|FG000|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
11294343|NCT02514122|12491953|FG001|COMPLETED|Overall Study||29
11294344|NCT02514122|12491952|FG000|NOT COMPLETED|Overall Study||2
11294345|NCT02514122|12491953|FG001|NOT COMPLETED|Overall Study||0
11341217|NCT02930005|12538524|FG001|NOT COMPLETED|Overall Study||5
11400284|NCT04241146|12594937|FG000|STARTED|Overall Study||24
11400285|NCT04241146|12594938|FG001|STARTED|Overall Study||28
11400286|NCT04241146|12594937|FG000|COMPLETED|Overall Study||24
11341218|NCT02930018|12538532|FG000|STARTED|Overall Study||556
11341219|NCT02930018|12538533|FG001|STARTED|Overall Study||549
11341220|NCT02930018|12538532|FG000|COMPLETED|Overall Study||550
11341221|NCT02930018|12538533|FG001|COMPLETED|Overall Study||546
11341222|NCT02930018|12538532|FG000|NOT COMPLETED|Overall Study||6
11341223|NCT02930018|12538533|FG001|NOT COMPLETED|Overall Study||3
11341224|NCT02930174|12538541|FG000|STARTED|Overall Study||12
11341225|NCT02930174|12538542|FG001|STARTED|Overall Study||8
11341226|NCT02930174|12538541|FG000|COMPLETED|Overall Study||12
11341227|NCT02930174|12538542|FG001|COMPLETED|Overall Study||8
11341228|NCT02930174|12538541|FG000|NOT COMPLETED|Overall Study||0
11341229|NCT02930174|12538542|FG001|NOT COMPLETED|Overall Study||0
11341230|NCT02930226|12538556|FG000|STARTED|Overall Study||4
11341231|NCT02930226|12538557|FG001|STARTED|Overall Study||4
11341232|NCT02930226|12538558|FG002|STARTED|Overall Study||4
11341233|NCT02930226|12538559|FG003|STARTED|Overall Study||4
11341234|NCT02930226|12538560|FG004|STARTED|Overall Study||4
11341235|NCT02930226|12538561|FG005|STARTED|Overall Study||4
11341236|NCT02930226|12538556|FG000|COMPLETED|Overall Study||4
11341237|NCT02930226|12538557|FG001|COMPLETED|Overall Study||4
11341238|NCT02930226|12538558|FG002|COMPLETED|Overall Study||4
11341239|NCT02930226|12538559|FG003|COMPLETED|Overall Study||4
11341240|NCT02930226|12538560|FG004|COMPLETED|Overall Study||3
11341241|NCT02930226|12538561|FG005|COMPLETED|Overall Study||4
11341242|NCT02930226|12538556|FG000|NOT COMPLETED|Overall Study||0
11341243|NCT02930226|12538557|FG001|NOT COMPLETED|Overall Study||0
11341244|NCT02930226|12538558|FG002|NOT COMPLETED|Overall Study||0
11400287|NCT04241146|12594938|FG001|COMPLETED|Overall Study||28
11294346|NCT02514174|12491959|FG000|STARTED|Overall Study||25
11294347|NCT02514174|12491959|FG000|COMPLETED|Overall Study||0
11294348|NCT02514174|12491959|FG000|NOT COMPLETED|Overall Study||25
11294349|NCT02514473|12491965|FG000|STARTED|Overall Study||101
11294350|NCT02514473|12491966|FG001|STARTED|Overall Study||103
11294351|NCT02514473|12491965|FG000|COMPLETED|Overall Study||98
11294352|NCT02514473|12491966|FG001|COMPLETED|Overall Study||98
11294353|NCT02514473|12491965|FG000|NOT COMPLETED|Overall Study||3
11294354|NCT02514473|12491966|FG001|NOT COMPLETED|Overall Study||5
11294355|NCT02514551|12491975|FG000|STARTED|Overall Study||123
11294356|NCT02514551|12491976|FG001|STARTED|Overall Study||122
11294357|NCT02514551|12491975|FG000|Received at Least One Dose of Study Drug|Overall Study||123
11294358|NCT02514551|12491976|FG001|Received at Least One Dose of Study Drug|Overall Study||120
11294359|NCT02514551|12491975|FG000|COMPLETED|Overall Study||123
11294360|NCT02514551|12491976|FG001|COMPLETED|Overall Study||119
11294361|NCT02514551|12491975|FG000|NOT COMPLETED|Overall Study||0
11294362|NCT02514551|12491976|FG001|NOT COMPLETED|Overall Study||3
11294363|NCT02514577|12491985|FG000|STARTED|Overall Study||143
11294364|NCT02514577|12491986|FG001|STARTED|Overall Study||74
11294365|NCT02514577|12491985|FG000|Intent-to-Treat (ITT) Population|Overall Study||143
11400288|NCT04241146|12594937|FG000|NOT COMPLETED|Overall Study||0
11294366|NCT02514577|12491986|FG001|Intent-to-Treat (ITT) Population|Overall Study||74
11294367|NCT02514577|12491985|FG000|Safety Population|Overall Study||142
11294368|NCT02514577|12491986|FG001|Safety Population|Overall Study||72
11294369|NCT02514577|12491985|FG000|COMPLETED|Overall Study||129
11400289|NCT04241146|12594938|FG001|NOT COMPLETED|Overall Study||0
11294370|NCT02514577|12491986|FG001|COMPLETED|Overall Study||61
11294371|NCT02514577|12491985|FG000|NOT COMPLETED|Overall Study||14
11294372|NCT02514577|12491986|FG001|NOT COMPLETED|Overall Study||13
11294373|NCT02514746|12491994|FG000|STARTED|Overall Study||437
11294374|NCT02514746|12491995|FG001|STARTED|Overall Study||124
11294375|NCT02514746|12491994|FG000|Valid Serology 3 Years Post Primary Dose|Overall Study||437
11294376|NCT02514746|12491995|FG001|Valid Serology 3 Years Post Primary Dose|Overall Study||123
11294377|NCT02514746|12491994|FG000|Valid Serology 4 Years Post Primary Dose|Overall Study||424
11294378|NCT02514746|12491995|FG001|Valid Serology 4 Years Post Primary Dose|Overall Study||109
11294379|NCT02514746|12491994|FG000|Received CD-JEV Booster Vaccine|Overall Study||424
11294380|NCT02514746|12491995|FG001|Received CD-JEV Booster Vaccine|Overall Study||109
11294381|NCT02514746|12491994|FG000|COMPLETED|Overall Study||415
11294382|NCT02514746|12491995|FG001|COMPLETED|Overall Study||109
11294383|NCT02514746|12491994|FG000|NOT COMPLETED|Overall Study||22
11294384|NCT02514746|12491995|FG001|NOT COMPLETED|Overall Study||15
11294385|NCT02514772|12492005|FG000|STARTED|Overall Study||53
11294386|NCT02514772|12492006|FG001|STARTED|Overall Study||54
11294387|NCT02514772|12492005|FG000|COMPLETED|Overall Study||50
11294388|NCT02514772|12492006|FG001|COMPLETED|Overall Study||52
11294389|NCT02514772|12492005|FG000|NOT COMPLETED|Overall Study||3
11294390|NCT02514772|12492006|FG001|NOT COMPLETED|Overall Study||2
11294391|NCT02514824|12492016|FG000|STARTED|Overall Study||4
11294392|NCT02514824|12492017|FG001|STARTED|Overall Study||5
11294393|NCT02514824|12492018|FG002|STARTED|Overall Study||0
11294394|NCT02514824|12492019|FG003|STARTED|Overall Study||0
11294395|NCT02514824|12492016|FG000|Evaluable for Dose-limiting Toxicity|Overall Study||3
11294396|NCT02514824|12492017|FG001|Evaluable for Dose-limiting Toxicity|Overall Study||5
11294397|NCT02514824|12492018|FG002|Evaluable for Dose-limiting Toxicity|Overall Study||0
11294398|NCT02514824|12492019|FG003|Evaluable for Dose-limiting Toxicity|Overall Study||0
11294399|NCT02514824|12492016|FG000|COMPLETED|Overall Study||3
11294400|NCT02514824|12492017|FG001|COMPLETED|Overall Study||4
11294401|NCT02514824|12492018|FG002|COMPLETED|Overall Study||0
11294402|NCT02514824|12492019|FG003|COMPLETED|Overall Study||0
11294403|NCT02514824|12492016|FG000|NOT COMPLETED|Overall Study||1
11294404|NCT02514824|12492017|FG001|NOT COMPLETED|Overall Study||1
11294405|NCT02514824|12492018|FG002|NOT COMPLETED|Overall Study||0
11294406|NCT02514824|12492019|FG003|NOT COMPLETED|Overall Study||0
11294407|NCT02514889|12492028|FG000|STARTED|Randomization/Allocation to Condition||131
11294408|NCT02514889|12492029|FG001|STARTED|Randomization/Allocation to Condition||130
11294409|NCT02514889|12492028|FG000|COMPLETED|Randomization/Allocation to Condition||111
11294410|NCT02514889|12492029|FG001|COMPLETED|Randomization/Allocation to Condition||106
11294411|NCT02514889|12492028|FG000|NOT COMPLETED|Randomization/Allocation to Condition||20
11294412|NCT02514889|12492029|FG001|NOT COMPLETED|Randomization/Allocation to Condition||24
11294413|NCT02514889|12492028|FG000|STARTED|Intervention Participation||111
11294414|NCT02514889|12492029|FG001|STARTED|Intervention Participation||106
11294415|NCT02514889|12492028|FG000|COMPLETED|Intervention Participation||102
11294416|NCT02514889|12492029|FG001|COMPLETED|Intervention Participation||98
11294417|NCT02514889|12492028|FG000|NOT COMPLETED|Intervention Participation||9
11294418|NCT02514889|12492029|FG001|NOT COMPLETED|Intervention Participation||8
11294419|NCT02514889|12492028|FG000|STARTED|Follow-up Assessment Participation||102
11294420|NCT02514889|12492029|FG001|STARTED|Follow-up Assessment Participation||98
11294421|NCT02514889|12492028|FG000|COMPLETED|Follow-up Assessment Participation||92
11294422|NCT02514889|12492029|FG001|COMPLETED|Follow-up Assessment Participation||86
11294423|NCT02514889|12492028|FG000|NOT COMPLETED|Follow-up Assessment Participation||10
11294424|NCT02514889|12492029|FG001|NOT COMPLETED|Follow-up Assessment Participation||12
11294425|NCT02515045|12492037|FG000|STARTED|Overall Study||29
11294426|NCT02515045|12492038|FG001|STARTED|Overall Study||30
11294427|NCT02515045|12492039|FG002|STARTED|Overall Study||59
11294428|NCT02515045|12492037|FG000|COMPLETED|Overall Study||29
11294429|NCT02515045|12492038|FG001|COMPLETED|Overall Study||26
11294430|NCT02515045|12492039|FG002|COMPLETED|Overall Study||55
11294431|NCT02515045|12492037|FG000|NOT COMPLETED|Overall Study||0
11294432|NCT02515045|12492038|FG001|NOT COMPLETED|Overall Study||4
11294433|NCT02515045|12492039|FG002|NOT COMPLETED|Overall Study||4
11294434|NCT02515058|12492049|FG000|STARTED|Overall Study||21
11294435|NCT02515058|12492050|FG001|STARTED|Overall Study||22
11294436|NCT02515058|12492049|FG000|COMPLETED|Overall Study||18
11294437|NCT02515058|12492050|FG001|COMPLETED|Overall Study||20
11294438|NCT02515058|12492049|FG000|NOT COMPLETED|Overall Study||3
11294439|NCT02515058|12492050|FG001|NOT COMPLETED|Overall Study||2
11294440|NCT02515097|12492058|FG000|STARTED|Overall Study||142
11294441|NCT02515097|12492059|FG001|STARTED|Overall Study||71
11294442|NCT02515097|12492058|FG000|Intent-to-Treat (ITT) Population|Overall Study||142
11294443|NCT02515097|12492059|FG001|Intent-to-Treat (ITT) Population|Overall Study||71
11294444|NCT02515097|12492058|FG000|Safety Population|Overall Study||142
11294445|NCT02515097|12492059|FG001|Safety Population|Overall Study||70
11294446|NCT02515097|12492058|FG000|COMPLETED|Overall Study||135
11294447|NCT02515097|12492059|FG001|COMPLETED|Overall Study||65
11294448|NCT02515097|12492058|FG000|NOT COMPLETED|Overall Study||7
11294449|NCT02515097|12492059|FG001|NOT COMPLETED|Overall Study||6
11294450|NCT02515253|12492067|FG000|STARTED|Overall Study||17
11294451|NCT02515253|12492068|FG001|STARTED|Overall Study||16
11294452|NCT02515253|12492067|FG000|COMPLETED|Overall Study||10
11294453|NCT02515253|12492068|FG001|COMPLETED|Overall Study||8
11294454|NCT02515253|12492067|FG000|NOT COMPLETED|Overall Study||7
11294455|NCT02515253|12492068|FG001|NOT COMPLETED|Overall Study||8
11294456|NCT02515279|12492074|FG000|STARTED|Overall Study||463
11294457|NCT02515279|12492074|FG000|COMPLETED|Overall Study||359
11294458|NCT02515279|12492074|FG000|NOT COMPLETED|Overall Study||104
11294459|NCT02515305|12492081|FG000|STARTED|Overall Study||385
11294460|NCT02515305|12492082|FG001|STARTED|Overall Study||378
11294461|NCT02515305|12492083|FG002|STARTED|Overall Study||127
11294462|NCT02515305|12492081|FG000|COMPLETED|Overall Study||356
11294463|NCT02515305|12492082|FG001|COMPLETED|Overall Study||343
11294464|NCT02515305|12492083|FG002|COMPLETED|Overall Study||113
11294465|NCT02515305|12492081|FG000|NOT COMPLETED|Overall Study||29
11294466|NCT02515305|12492082|FG001|NOT COMPLETED|Overall Study||35
11294467|NCT02515305|12492083|FG002|NOT COMPLETED|Overall Study||14
11294468|NCT02515331|12492094|FG000|STARTED|Overall Study||17
11294469|NCT02515331|12492095|FG001|STARTED|Overall Study||15
11294470|NCT02515331|12492096|FG002|STARTED|Overall Study||32
11294471|NCT02515331|12492094|FG000|Primary Pharmacodynamic Analysis Set|Overall Study||15
11294472|NCT02515331|12492095|FG001|Primary Pharmacodynamic Analysis Set|Overall Study||14
11294473|NCT02515331|12492096|FG002|Primary Pharmacodynamic Analysis Set|Overall Study||29
11294474|NCT02515331|12492094|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||17
11294475|NCT02515331|12492095|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||15
11294476|NCT02515331|12492096|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
11294477|NCT02515331|12492094|FG000|COMPLETED|Overall Study||15
11294478|NCT02515331|12492095|FG001|COMPLETED|Overall Study||15
11294479|NCT02515331|12492096|FG002|COMPLETED|Overall Study||28
11294480|NCT02515331|12492094|FG000|NOT COMPLETED|Overall Study||2
11294481|NCT02515331|12492095|FG001|NOT COMPLETED|Overall Study||0
11294482|NCT02515331|12492096|FG002|NOT COMPLETED|Overall Study||4
11294483|NCT02515630|12492106|FG000|STARTED|Overall Study||41
11294484|NCT02515630|12492106|FG000|COMPLETED|Overall Study||25
11294485|NCT02515630|12492106|FG000|NOT COMPLETED|Overall Study||16
11294486|NCT02515656|12492115|FG000|STARTED|Overall Study||326
11294487|NCT02515656|12492116|FG001|STARTED|Overall Study||332
11294488|NCT02515656|12492115|FG000|Full Analysis Set (FAS)|Overall Study||302
11294489|NCT02515656|12492116|FG001|Full Analysis Set (FAS)|Overall Study||309
11294490|NCT02515656|12492115|FG000|Per Protocol Set (PPS)|Overall Study||277
11294491|NCT02515656|12492116|FG001|Per Protocol Set (PPS)|Overall Study||275
11294492|NCT02515656|12492115|FG000|Safety Population|Overall Study||325
11294493|NCT02515656|12492116|FG001|Safety Population|Overall Study||328
11294494|NCT02515656|12492115|FG000|COMPLETED|Overall Study||270
11294495|NCT02515656|12492116|FG001|COMPLETED|Overall Study||261
11294496|NCT02515656|12492115|FG000|NOT COMPLETED|Overall Study||56
11294497|NCT02515656|12492116|FG001|NOT COMPLETED|Overall Study||71
11294498|NCT02515669|12492126|FG000|STARTED|24 Week Double-Blind Phase||11
11294499|NCT02515669|12492127|FG001|STARTED|24 Week Double-Blind Phase||7
11294500|NCT02515669|12492128|FG002|STARTED|24 Week Double-Blind Phase||6
11294501|NCT02515669|12492129|FG003|STARTED|24 Week Double-Blind Phase||19
11294502|NCT02515669|12492126|FG000|COMPLETED|24 Week Double-Blind Phase||11
11294503|NCT02515669|12492127|FG001|COMPLETED|24 Week Double-Blind Phase||7
11294504|NCT02515669|12492128|FG002|COMPLETED|24 Week Double-Blind Phase||6
11294505|NCT02515669|12492129|FG003|COMPLETED|24 Week Double-Blind Phase||19
11294506|NCT02515669|12492126|FG000|NOT COMPLETED|24 Week Double-Blind Phase||0
11294507|NCT02515669|12492127|FG001|NOT COMPLETED|24 Week Double-Blind Phase||0
11294508|NCT02515669|12492128|FG002|NOT COMPLETED|24 Week Double-Blind Phase||0
11294509|NCT02515669|12492129|FG003|NOT COMPLETED|24 Week Double-Blind Phase||0
11294510|NCT02515669|12492126|FG000|STARTED|228 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
11294511|NCT02515669|12492127|FG001|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9
11294512|NCT02515669|12492128|FG002|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8
11341245|NCT02930226|12538559|FG003|NOT COMPLETED|Overall Study||0
11294513|NCT02515669|12492129|FG003|STARTED|228 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26
11294514|NCT02515669|12492126|FG000|COMPLETED|228 Week Open-Label Phase||0
11294515|NCT02515669|12492127|FG001|COMPLETED|228 Week Open-Label Phase||0
11294516|NCT02515669|12492128|FG002|COMPLETED|228 Week Open-Label Phase||0
11294517|NCT02515669|12492129|FG003|COMPLETED|228 Week Open-Label Phase||0
11294518|NCT02515669|12492126|FG000|NOT COMPLETED|228 Week Open-Label Phase||0
11294519|NCT02515669|12492127|FG001|NOT COMPLETED|228 Week Open-Label Phase||9
11294520|NCT02515669|12492128|FG002|NOT COMPLETED|228 Week Open-Label Phase||8
11294521|NCT02515669|12492129|FG003|NOT COMPLETED|228 Week Open-Label Phase||26
11294522|NCT02515825|12492161|FG000|STARTED|Overall Study||70
11294523|NCT02515825|12492162|FG001|STARTED|Overall Study||31
11294524|NCT02515825|12492161|FG000|COMPLETED|Overall Study||70
11294525|NCT02515825|12492162|FG001|COMPLETED|Overall Study||31
11294526|NCT02515825|12492161|FG000|NOT COMPLETED|Overall Study||0
11294527|NCT02515825|12492162|FG001|NOT COMPLETED|Overall Study||0
11294528|NCT02515890|12492174|FG000|STARTED|Overall Study||7
11294529|NCT02515890|12492175|FG001|STARTED|Overall Study||4
11294530|NCT02515890|12492176|FG002|STARTED|Overall Study||5
11294531|NCT02515890|12492177|FG003|STARTED|Overall Study||8
11294532|NCT02515890|12492178|FG004|STARTED|Overall Study||8
11294533|NCT02515890|12492174|FG000|COMPLETED|Overall Study||7
11294534|NCT02515890|12492175|FG001|COMPLETED|Overall Study||4
11294535|NCT02515890|12492176|FG002|COMPLETED|Overall Study||5
11294536|NCT02515890|12492177|FG003|COMPLETED|Overall Study||8
11294537|NCT02515890|12492178|FG004|COMPLETED|Overall Study||8
11294538|NCT02515890|12492174|FG000|NOT COMPLETED|Overall Study||0
11294539|NCT02515890|12492175|FG001|NOT COMPLETED|Overall Study||0
11294540|NCT02515890|12492176|FG002|NOT COMPLETED|Overall Study||0
11294541|NCT02515890|12492177|FG003|NOT COMPLETED|Overall Study||0
11294542|NCT02515890|12492178|FG004|NOT COMPLETED|Overall Study||0
11294543|NCT02515942|12492192|FG000|STARTED|Overall Study||36
11294544|NCT02515942|12492193|FG001|STARTED|Overall Study||39
11294545|NCT02515942|12492194|FG002|STARTED|Overall Study||39
11294546|NCT02515942|12492192|FG000|Safety Analysis Set|Overall Study||36
11294547|NCT02515942|12492193|FG001|Safety Analysis Set|Overall Study||39
11294548|NCT02515942|12492194|FG002|Safety Analysis Set|Overall Study||39
11294549|NCT02515942|12492192|FG000|Full Analysis Set (FAS)|Overall Study||35
11294550|NCT02515942|12492193|FG001|Full Analysis Set (FAS)|Overall Study||37
11294551|NCT02515942|12492194|FG002|Full Analysis Set (FAS)|Overall Study||38
11294552|NCT02515942|12492192|FG000|Per Protocol Analysis Set (PPS)|Overall Study||30
11294553|NCT02515942|12492193|FG001|Per Protocol Analysis Set (PPS)|Overall Study||35
11294554|NCT02515942|12492194|FG002|Per Protocol Analysis Set (PPS)|Overall Study||34
11294555|NCT02515942|12492192|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||36
11294556|NCT02515942|12492193|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||39
11294557|NCT02515942|12492194|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0
11294558|NCT02515942|12492192|FG000|Completed Day 85|Overall Study||35
11294559|NCT02515942|12492193|FG001|Completed Day 85|Overall Study||38
11294560|NCT02515942|12492194|FG002|Completed Day 85|Overall Study||37
11294561|NCT02515942|12492192|FG000|Completed Day 169|Overall Study||32
11294562|NCT02515942|12492193|FG001|Completed Day 169|Overall Study||37
11294563|NCT02515942|12492194|FG002|Completed Day 169|Overall Study||37
11294564|NCT02515942|12492192|FG000|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
11294565|NCT02515942|12492193|FG001|Completed Day 253|Overall Study||37
11294566|NCT02515942|12492194|FG002|Completed Day 253|Overall Study||36
11294567|NCT02515942|12492192|FG000|Completed Day 337|Overall Study||30
11294568|NCT02515942|12492193|FG001|Completed Day 337|Overall Study||36
11294569|NCT02515942|12492194|FG002|Completed Day 337|Overall Study||35
11294570|NCT02515942|12492192|FG000|COMPLETED|Overall Study||29
11294571|NCT02515942|12492193|FG001|COMPLETED|Overall Study||36
11294572|NCT02515942|12492194|FG002|COMPLETED|Overall Study||35
11294573|NCT02515942|12492192|FG000|NOT COMPLETED|Overall Study||7
11294574|NCT02515942|12492193|FG001|NOT COMPLETED|Overall Study||3
11294575|NCT02515942|12492194|FG002|NOT COMPLETED|Overall Study||4
11294576|NCT02515994|12492206|FG000|STARTED|Overall Study||109
11294577|NCT02515994|12492207|FG001|STARTED|Overall Study||112
11294578|NCT02515994|12492206|FG000|COMPLETED|Overall Study||99
11294579|NCT02515994|12492207|FG001|COMPLETED|Overall Study||105
11294580|NCT02515994|12492206|FG000|NOT COMPLETED|Overall Study||10
11294581|NCT02515994|12492207|FG001|NOT COMPLETED|Overall Study||7
11294582|NCT02516046|12492213|FG000|STARTED|Overall Study|Total number of subjects scanned|156
11294583|NCT02516046|12492213|FG000|Died While on Study|Overall Study||73
11294584|NCT02516046|12492213|FG000|Valid Autopsy Results and PET Scan|Overall Study|includes 3 front-runners|67
11294585|NCT02516046|12492213|FG000|COMPLETED|Overall Study|Completed = included in autopsy cohort|64
11294586|NCT02516046|12492213|FG000|NOT COMPLETED|Overall Study||92
11294587|NCT02516098|12492229|FG000|STARTED|Period 1||28
11294588|NCT02516098|12492230|FG001|STARTED|Period 1||28
11294589|NCT02516098|12492229|FG000|COMPLETED|Period 1||27
11294590|NCT02516098|12492230|FG001|COMPLETED|Period 1||28
11294591|NCT02516098|12492229|FG000|NOT COMPLETED|Period 1||1
11294592|NCT02516098|12492230|FG001|NOT COMPLETED|Period 1||0
11294593|NCT02516098|12492229|FG000|STARTED|Washout After Period 1||27
11294594|NCT02516098|12492230|FG001|STARTED|Washout After Period 1||28
11294595|NCT02516098|12492229|FG000|COMPLETED|Washout After Period 1||27
11294596|NCT02516098|12492230|FG001|COMPLETED|Washout After Period 1||27
11294597|NCT02516098|12492229|FG000|NOT COMPLETED|Washout After Period 1||0
11294598|NCT02516098|12492230|FG001|NOT COMPLETED|Washout After Period 1||1
11294599|NCT02516098|12492229|FG000|STARTED|Period 2||27
11294600|NCT02516098|12492230|FG001|STARTED|Period 2||27
11294601|NCT02516098|12492229|FG000|COMPLETED|Period 2||27
11294602|NCT02516098|12492230|FG001|COMPLETED|Period 2||26
11294603|NCT02516098|12492229|FG000|NOT COMPLETED|Period 2||0
11294604|NCT02516098|12492230|FG001|NOT COMPLETED|Period 2||1
11294605|NCT02516098|12492229|FG000|STARTED|Washout After Period 2||27
11294606|NCT02516098|12492230|FG001|STARTED|Washout After Period 2||26
11294607|NCT02516098|12492229|FG000|COMPLETED|Washout After Period 2||27
11294608|NCT02516098|12492230|FG001|COMPLETED|Washout After Period 2||26
11294609|NCT02516098|12492229|FG000|NOT COMPLETED|Washout After Period 2||0
11294610|NCT02516098|12492230|FG001|NOT COMPLETED|Washout After Period 2||0
11294611|NCT02516150|12492236|FG000|STARTED|Overall Study||15
11294612|NCT02516150|12492236|FG000|COMPLETED|Overall Study||15
11294613|NCT02516150|12492236|FG000|NOT COMPLETED|Overall Study||0
11294614|NCT02516163|12492242|FG000|STARTED|Overall Study||52
11294615|NCT02516163|12492242|FG000|COMPLETED|Overall Study||24
11294616|NCT02516163|12492242|FG000|NOT COMPLETED|Overall Study||28
11294617|NCT02516202|12492249|FG000|STARTED|Overall Study||102
11294618|NCT02516202|12492250|FG001|STARTED|Overall Study||100
11294619|NCT02516202|12492251|FG002|STARTED|Overall Study||100
11294620|NCT02516202|12492249|FG000|COMPLETED|Overall Study||100
11294621|NCT02516202|12492250|FG001|COMPLETED|Overall Study||99
11294622|NCT02516202|12492251|FG002|COMPLETED|Overall Study||97
11294623|NCT02516202|12492249|FG000|NOT COMPLETED|Overall Study||2
11294624|NCT02516202|12492250|FG001|NOT COMPLETED|Overall Study||1
11294625|NCT02516202|12492251|FG002|NOT COMPLETED|Overall Study||3
11294626|NCT02516306|12492261|FG000|STARTED|Period 1: Day 1 - 7||50
11294627|NCT02516306|12492262|FG001|STARTED|Period 1: Day 1 - 7||25
11294628|NCT02516306|12492261|FG000|COMPLETED|Period 1: Day 1 - 7||50
11294629|NCT02516306|12492262|FG001|COMPLETED|Period 1: Day 1 - 7||25
11294630|NCT02516306|12492261|FG000|NOT COMPLETED|Period 1: Day 1 - 7||0
11294631|NCT02516306|12492262|FG001|NOT COMPLETED|Period 1: Day 1 - 7||0
11294632|NCT02516306|12492261|FG000|STARTED|Period 2: Day 8 - 91||50
11294633|NCT02516306|12492262|FG001|STARTED|Period 2: Day 8 - 91||25
11294634|NCT02516306|12492261|FG000|COMPLETED|Period 2: Day 8 - 91||49
11294635|NCT02516306|12492262|FG001|COMPLETED|Period 2: Day 8 - 91||23
11294636|NCT02516306|12492261|FG000|NOT COMPLETED|Period 2: Day 8 - 91||1
11294637|NCT02516306|12492262|FG001|NOT COMPLETED|Period 2: Day 8 - 91||2
11294638|NCT02516332|12492271|FG000|STARTED|Overall Study||52
11294639|NCT02516332|12492272|FG001|STARTED|Overall Study||53
11294640|NCT02516332|12492273|FG002|STARTED|Overall Study||23
11294641|NCT02516332|12492271|FG000|COMPLETED|Overall Study||50
11294642|NCT02516332|12492272|FG001|COMPLETED|Overall Study||52
11294643|NCT02516332|12492273|FG002|COMPLETED|Overall Study||21
11294644|NCT02516332|12492271|FG000|NOT COMPLETED|Overall Study||2
11294645|NCT02516332|12492272|FG001|NOT COMPLETED|Overall Study||1
11294646|NCT02516332|12492273|FG002|NOT COMPLETED|Overall Study||2
11294647|NCT02516410|12492283|FG000|STARTED|Overall Study||85
11294648|NCT02516410|12492284|FG001|STARTED|Overall Study||83
11294649|NCT02516410|12492283|FG000|COMPLETED|Overall Study||85
11400290|NCT04240678|12594946|FG000|STARTED|Overall Study||4141
11400291|NCT04240678|12594947|FG001|STARTED|Overall Study||4158
11400292|NCT04240678|12594946|FG000|COMPLETED|Overall Study||4141
11400293|NCT04240678|12594947|FG001|COMPLETED|Overall Study||4158
11294650|NCT02516410|12492284|FG001|COMPLETED|Overall Study||81
11294651|NCT02516410|12492283|FG000|NOT COMPLETED|Overall Study||0
11294652|NCT02516410|12492284|FG001|NOT COMPLETED|Overall Study||2
11294653|NCT02516579|12492291|FG000|STARTED|Overall Study||1906
11294654|NCT02516579|12492291|FG000|COMPLETED|Overall Study||1906
11294655|NCT02516579|12492291|FG000|NOT COMPLETED|Overall Study||0
11294656|NCT02516592|12492297|FG000|STARTED|Overall Study||251
11294657|NCT02516592|12492298|FG001|STARTED|Overall Study||251
11294658|NCT02516592|12492297|FG000|Full Analysis Set|Overall Study||248
11294659|NCT02516592|12492298|FG001|Full Analysis Set|Overall Study||250
11294660|NCT02516592|12492297|FG000|COMPLETED|Overall Study||235
11294661|NCT02516592|12492298|FG001|COMPLETED|Overall Study||238
11294662|NCT02516592|12492297|FG000|NOT COMPLETED|Overall Study||16
11294663|NCT02516592|12492298|FG001|NOT COMPLETED|Overall Study||13
11294664|NCT02516605|12492309|FG000|STARTED|Overall Study||11
11294665|NCT02516605|12492310|FG001|STARTED|Overall Study||9
11294666|NCT02516605|12492311|FG002|STARTED|Overall Study||12
11294667|NCT02516605|12492312|FG003|STARTED|Overall Study||8
11294668|NCT02516605|12492313|FG004|STARTED|Overall Study||21
11294669|NCT02516605|12492309|FG000|COMPLETED|Overall Study||11
11294670|NCT02516605|12492310|FG001|COMPLETED|Overall Study||9
11294671|NCT02516605|12492311|FG002|COMPLETED|Overall Study||12
11294672|NCT02516605|12492312|FG003|COMPLETED|Overall Study||7
11294673|NCT02516605|12492313|FG004|COMPLETED|Overall Study||20
11294674|NCT02516605|12492309|FG000|NOT COMPLETED|Overall Study||0
11294675|NCT02516605|12492310|FG001|NOT COMPLETED|Overall Study||0
11294676|NCT02516605|12492311|FG002|NOT COMPLETED|Overall Study||0
11294677|NCT02516605|12492312|FG003|NOT COMPLETED|Overall Study||1
11294678|NCT02516605|12492313|FG004|NOT COMPLETED|Overall Study||1
11294679|NCT02516982|12492333|FG000|STARTED|Overall Study||305
11294680|NCT02516982|12492334|FG001|STARTED|Overall Study||292
11294681|NCT02516982|12492335|FG002|STARTED|Overall Study||174
11294682|NCT02516982|12492336|FG003|STARTED|Overall Study||175
11294683|NCT02516982|12492333|FG000|COMPLETED|Overall Study||273
11294684|NCT02516982|12492334|FG001|COMPLETED|Overall Study||257
11294685|NCT02516982|12492335|FG002|COMPLETED|Overall Study||126
11400294|NCT04240678|12594946|FG000|NOT COMPLETED|Overall Study||0
11400295|NCT04240678|12594947|FG001|NOT COMPLETED|Overall Study||0
11294686|NCT02516982|12492336|FG003|COMPLETED|Overall Study||125
11294687|NCT02516982|12492333|FG000|NOT COMPLETED|Overall Study||32
11294688|NCT02516982|12492334|FG001|NOT COMPLETED|Overall Study||35
11294689|NCT02516982|12492335|FG002|NOT COMPLETED|Overall Study||48
11294690|NCT02516982|12492336|FG003|NOT COMPLETED|Overall Study||50
11294691|NCT02517021|12492348|FG000|STARTED|Overall Study||203
11294692|NCT02517021|12492349|FG001|STARTED|Overall Study||202
11294693|NCT02517021|12492348|FG000|COMPLETED|Overall Study||120
11294694|NCT02517021|12492349|FG001|COMPLETED|Overall Study||117
11294695|NCT02517021|12492348|FG000|NOT COMPLETED|Overall Study||83
11294696|NCT02517021|12492349|FG001|NOT COMPLETED|Overall Study||85
11294697|NCT02517047|12492355|FG000|STARTED|Overall Study||26
11294698|NCT02517047|12492355|FG000|COMPLETED|Overall Study||24
11294699|NCT02517047|12492355|FG000|NOT COMPLETED|Overall Study||2
11294700|NCT02517268|12492362|FG000|STARTED|Overall Study||40
11294701|NCT02517268|12492363|FG001|STARTED|Overall Study||37
11294702|NCT02517268|12492362|FG000|COMPLETED|Overall Study||39
11294703|NCT02517268|12492363|FG001|COMPLETED|Overall Study||37
11294704|NCT02517268|12492362|FG000|NOT COMPLETED|Overall Study||1
11294705|NCT02517268|12492363|FG001|NOT COMPLETED|Overall Study||0
11294706|NCT02517463|12492371|FG000|STARTED|Overall Study||369
11294707|NCT02517463|12492372|FG001|STARTED|Overall Study||331
11294708|NCT02517463|12492371|FG000|COMPLETED|Overall Study||364
11294709|NCT02517463|12492372|FG001|COMPLETED|Overall Study||329
11294710|NCT02517463|12492371|FG000|NOT COMPLETED|Overall Study||5
11294711|NCT02517463|12492372|FG001|NOT COMPLETED|Overall Study||2
11294712|NCT02517515|12492380|FG000|STARTED|Overall Study||325
11294713|NCT02517515|12492381|FG001|STARTED|Overall Study||325
11294714|NCT02517515|12492380|FG000|COMPLETED|Overall Study||323
11294715|NCT02517515|12492381|FG001|COMPLETED|Overall Study||323
11294716|NCT02517515|12492380|FG000|NOT COMPLETED|Overall Study||2
11294717|NCT02517515|12492381|FG001|NOT COMPLETED|Overall Study||2
11294718|NCT02517528|12492388|FG000|STARTED|Overall Study||104
11294719|NCT02517528|12492388|FG000|COMPLETED|Overall Study||103
11294720|NCT02517528|12492388|FG000|NOT COMPLETED|Overall Study||1
11294721|NCT02517541|12492392|FG000|STARTED|Baseline Period (Own Product)||74
11294722|NCT02517541|12492392|FG000|COMPLETED|Baseline Period (Own Product)||73
11294723|NCT02517541|12492392|FG000|NOT COMPLETED|Baseline Period (Own Product)||1
11294724|NCT02517541|12492392|FG000|STARTED|Test Period (SenSura Mio Convex Soft)||73
11294725|NCT02517541|12492392|FG000|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
11294726|NCT02517541|12492392|FG000|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
11294727|NCT02517567|12492398|FG000|STARTED|First Exposure (8 Hours)||6
11294728|NCT02517567|12492399|FG001|STARTED|First Exposure (8 Hours)||8
11294729|NCT02517567|12492400|FG002|STARTED|First Exposure (8 Hours)||7
11294730|NCT02517567|12492401|FG003|STARTED|First Exposure (8 Hours)||8
11294731|NCT02517567|12492398|FG000|COMPLETED|First Exposure (8 Hours)||6
11294732|NCT02517567|12492399|FG001|COMPLETED|First Exposure (8 Hours)||8
11294733|NCT02517567|12492400|FG002|COMPLETED|First Exposure (8 Hours)||7
11294734|NCT02517567|12492401|FG003|COMPLETED|First Exposure (8 Hours)||8
11294735|NCT02517567|12492398|FG000|NOT COMPLETED|First Exposure (8 Hours)||0
11294736|NCT02517567|12492399|FG001|NOT COMPLETED|First Exposure (8 Hours)||0
11294737|NCT02517567|12492400|FG002|NOT COMPLETED|First Exposure (8 Hours)||0
11294738|NCT02517567|12492401|FG003|NOT COMPLETED|First Exposure (8 Hours)||0
11294739|NCT02517567|12492398|FG000|STARTED|Second Exposure (8 Hours)||6
11294740|NCT02517567|12492399|FG001|STARTED|Second Exposure (8 Hours)||8
11294741|NCT02517567|12492400|FG002|STARTED|Second Exposure (8 Hours)||7
11294742|NCT02517567|12492401|FG003|STARTED|Second Exposure (8 Hours)||8
11294743|NCT02517567|12492398|FG000|COMPLETED|Second Exposure (8 Hours)||6
11294744|NCT02517567|12492399|FG001|COMPLETED|Second Exposure (8 Hours)||8
11294745|NCT02517567|12492400|FG002|COMPLETED|Second Exposure (8 Hours)||7
11294746|NCT02517567|12492401|FG003|COMPLETED|Second Exposure (8 Hours)||8
11294747|NCT02517567|12492398|FG000|NOT COMPLETED|Second Exposure (8 Hours)||0
11294748|NCT02517567|12492399|FG001|NOT COMPLETED|Second Exposure (8 Hours)||0
11294749|NCT02517567|12492400|FG002|NOT COMPLETED|Second Exposure (8 Hours)||0
11294750|NCT02517567|12492401|FG003|NOT COMPLETED|Second Exposure (8 Hours)||0
11294751|NCT02517567|12492398|FG000|STARTED|Third Exposure (8 Hours)||6
11294752|NCT02517567|12492399|FG001|STARTED|Third Exposure (8 Hours)||8
11294753|NCT02517567|12492400|FG002|STARTED|Third Exposure (8 Hours)||7
11294754|NCT02517567|12492401|FG003|STARTED|Third Exposure (8 Hours)||8
11294755|NCT02517567|12492398|FG000|COMPLETED|Third Exposure (8 Hours)||6
11294756|NCT02517567|12492399|FG001|COMPLETED|Third Exposure (8 Hours)||8
11294757|NCT02517567|12492400|FG002|COMPLETED|Third Exposure (8 Hours)||7
11294758|NCT02517567|12492401|FG003|COMPLETED|Third Exposure (8 Hours)||8
11294759|NCT02517567|12492398|FG000|NOT COMPLETED|Third Exposure (8 Hours)||0
11294760|NCT02517567|12492399|FG001|NOT COMPLETED|Third Exposure (8 Hours)||0
11294761|NCT02517567|12492400|FG002|NOT COMPLETED|Third Exposure (8 Hours)||0
11294762|NCT02517567|12492401|FG003|NOT COMPLETED|Third Exposure (8 Hours)||0
11294763|NCT02517567|12492398|FG000|STARTED|Fourth Exposure (8 Hours)||6
11294764|NCT02517567|12492399|FG001|STARTED|Fourth Exposure (8 Hours)||8
11294765|NCT02517567|12492400|FG002|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
11294766|NCT02517567|12492401|FG003|STARTED|Fourth Exposure (8 Hours)||8
11294767|NCT02517567|12492398|FG000|COMPLETED|Fourth Exposure (8 Hours)||6
11294768|NCT02517567|12492399|FG001|COMPLETED|Fourth Exposure (8 Hours)||8
11294769|NCT02517567|12492400|FG002|COMPLETED|Fourth Exposure (8 Hours)||6
11294770|NCT02517567|12492401|FG003|COMPLETED|Fourth Exposure (8 Hours)||8
11294771|NCT02517567|12492398|FG000|NOT COMPLETED|Fourth Exposure (8 Hours)||0
11294772|NCT02517567|12492399|FG001|NOT COMPLETED|Fourth Exposure (8 Hours)||0
11294773|NCT02517567|12492400|FG002|NOT COMPLETED|Fourth Exposure (8 Hours)||0
11294774|NCT02517567|12492401|FG003|NOT COMPLETED|Fourth Exposure (8 Hours)||0
11294775|NCT02517580|12492410|FG000|STARTED|Overall Study||60
11294776|NCT02517580|12492410|FG000|COMPLETED|Overall Study||56
11294777|NCT02517580|12492410|FG000|NOT COMPLETED|Overall Study||4
11294778|NCT02517658|12492417|FG000|STARTED|Overall Study||33
11294779|NCT02517658|12492418|FG001|STARTED|Overall Study||33
11294780|NCT02517658|12492419|FG002|STARTED|Overall Study||33
11294781|NCT02517658|12492417|FG000|COMPLETED|Overall Study||33
11294782|NCT02517658|12492418|FG001|COMPLETED|Overall Study||33
11294783|NCT02517658|12492419|FG002|COMPLETED|Overall Study||33
11294784|NCT02517658|12492417|FG000|NOT COMPLETED|Overall Study||0
11294785|NCT02517658|12492418|FG001|NOT COMPLETED|Overall Study||0
11294786|NCT02517658|12492419|FG002|NOT COMPLETED|Overall Study||0
11294787|NCT02517866|12492427|FG000|STARTED|Overall Study||289
11294788|NCT02517866|12492428|FG001|STARTED|Overall Study||90
11294789|NCT02517866|12492429|FG002|STARTED|Overall Study||1
11294790|NCT02517866|12492427|FG000|COMPLETED|Overall Study||269
11294791|NCT02517866|12492428|FG001|COMPLETED|Overall Study||84
11294792|NCT02517866|12492429|FG002|COMPLETED|Overall Study||1
11294793|NCT02517866|12492427|FG000|NOT COMPLETED|Overall Study||20
11294794|NCT02517866|12492428|FG001|NOT COMPLETED|Overall Study||6
11294795|NCT02517866|12492429|FG002|NOT COMPLETED|Overall Study||0
11294796|NCT02517905|12492441|FG000|STARTED|Overall Study||107
11294797|NCT02517905|12492442|FG001|STARTED|Overall Study||59
11294798|NCT02517905|12492441|FG000|COMPLETED|Overall Study||97
11294799|NCT02517905|12492442|FG001|COMPLETED|Overall Study||57
11294800|NCT02517905|12492441|FG000|NOT COMPLETED|Overall Study||10
11294801|NCT02517905|12492442|FG001|NOT COMPLETED|Overall Study||2
11294802|NCT02517996|12492450|FG000|STARTED|Overall Study||8
11294803|NCT02517996|12492451|FG001|STARTED|Overall Study||9
11294804|NCT02517996|12492450|FG000|COMPLETED|Overall Study||8
11294805|NCT02517996|12492451|FG001|COMPLETED|Overall Study||9
11294806|NCT02517996|12492450|FG000|NOT COMPLETED|Overall Study||0
11294807|NCT02517996|12492451|FG001|NOT COMPLETED|Overall Study||0
11294808|NCT02518048|12492457|FG000|STARTED|Overall Study||35
11294809|NCT02518048|12492457|FG000|COMPLETED|Overall Study||34
11294810|NCT02518048|12492457|FG000|NOT COMPLETED|Overall Study||1
11294811|NCT02518113|12492466|FG000|STARTED|Overall Study||6
11294812|NCT02518113|12492467|FG001|STARTED|Overall Study||12
11294813|NCT02518113|12492468|FG002|STARTED|Overall Study||15
11294814|NCT02518113|12492469|FG003|STARTED|Overall Study||3
11294815|NCT02518113|12492466|FG000|COMPLETED|Overall Study||3
11294816|NCT02518113|12492467|FG001|COMPLETED|Overall Study||7
11294817|NCT02518113|12492468|FG002|COMPLETED|Overall Study||11
11294818|NCT02518113|12492469|FG003|COMPLETED|Overall Study||3
11294819|NCT02518113|12492466|FG000|NOT COMPLETED|Overall Study||3
11294820|NCT02518113|12492467|FG001|NOT COMPLETED|Overall Study||5
11294821|NCT02518113|12492468|FG002|NOT COMPLETED|Overall Study||4
11294822|NCT02518113|12492469|FG003|NOT COMPLETED|Overall Study||0
11294823|NCT02518191|12492484|FG000|STARTED|Overall Study||171
11294824|NCT02518191|12492485|FG001|STARTED|Overall Study||174
11294825|NCT02518191|12492484|FG000|COMPLETED|Overall Study||165
11294826|NCT02518191|12492485|FG001|COMPLETED|Overall Study||165
11294827|NCT02518191|12492484|FG000|NOT COMPLETED|Overall Study||6
11294828|NCT02518191|12492485|FG001|NOT COMPLETED|Overall Study||9
11294829|NCT02518230|12492495|FG000|STARTED|Overall Study||11
11294830|NCT02518230|12492496|FG001|STARTED|Overall Study||11
11294831|NCT02518230|12492495|FG000|COMPLETED|Overall Study||11
11294832|NCT02518230|12492496|FG001|COMPLETED|Overall Study||11
11294833|NCT02518230|12492495|FG000|NOT COMPLETED|Overall Study||0
11294834|NCT02518230|12492496|FG001|NOT COMPLETED|Overall Study||0
11294835|NCT02518464|12492503|FG000|STARTED|Overall Study||40
11294836|NCT02518464|12492503|FG000|COMPLETED|Overall Study||38
11294837|NCT02518464|12492503|FG000|NOT COMPLETED|Overall Study||2
11294838|NCT02518490|12492507|FG000|STARTED|Overall Study||18
11294839|NCT02518490|12492508|FG001|STARTED|Overall Study||18
11294840|NCT02518490|12492507|FG000|COMPLETED|Overall Study||17
11294841|NCT02518490|12492508|FG001|COMPLETED|Overall Study||17
11294842|NCT02518490|12492507|FG000|NOT COMPLETED|Overall Study||1
11294843|NCT02518490|12492508|FG001|NOT COMPLETED|Overall Study||1
11294844|NCT02518620|12492517|FG000|STARTED|Overall Study||257
11294845|NCT02518620|12492518|FG001|STARTED|Overall Study||149
11294846|NCT02518620|12492517|FG000|COMPLETED|Overall Study||205
11294847|NCT02518620|12492518|FG001|COMPLETED|Overall Study||123
11294848|NCT02518620|12492517|FG000|NOT COMPLETED|Overall Study||52
11294849|NCT02518620|12492518|FG001|NOT COMPLETED|Overall Study||26
11294850|NCT02518685|12492528|FG000|STARTED|Overall Study||213
11294851|NCT02518685|12492529|FG001|STARTED|Overall Study||89
11294852|NCT02518685|12492528|FG000|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203
11294853|NCT02518685|12492529|FG001|Safety Cohort|Overall Study||89
11294854|NCT02518685|12492528|FG000|Randomized Cohort|Overall Study||181
11294855|NCT02518685|12492529|FG001|Randomized Cohort|Overall Study||89
11400296|NCT04238650|12594955|FG000|STARTED|Overall Study||24
11400297|NCT04238650|12594956|FG001|STARTED|Overall Study|One subject was enrolled and randomized to EU Avastin® but the subject was not dosed (subject withdrawal before study drug administration)|25
11400298|NCT04238650|12594955|FG000|COMPLETED|Overall Study||24
11400299|NCT04238650|12594956|FG001|COMPLETED|Overall Study||24
11400300|NCT04238650|12594955|FG000|NOT COMPLETED|Overall Study||0
11400301|NCT04238650|12594956|FG001|NOT COMPLETED|Overall Study||1
11400302|NCT04238663|12594965|FG000|STARTED|Overall Study||38
11400303|NCT04238663|12594966|FG001|STARTED|Overall Study||38
11400304|NCT04238663|12594967|FG002|STARTED|Overall Study||38
11400305|NCT04238663|12594965|FG000|COMPLETED|Overall Study||38
11400306|NCT04238663|12594966|FG001|COMPLETED|Overall Study||37
11400307|NCT04238663|12594967|FG002|COMPLETED|Overall Study||38
11400308|NCT04238663|12594965|FG000|NOT COMPLETED|Overall Study||0
11400309|NCT04238663|12594966|FG001|NOT COMPLETED|Overall Study||1
11400310|NCT04238663|12594967|FG002|NOT COMPLETED|Overall Study||0
11400311|NCT04235582|12594978|FG000|STARTED|Overall Study||12
11400312|NCT04235582|12594979|FG001|STARTED|Overall Study||13
11400313|NCT04235582|12594980|FG002|STARTED|Overall Study||11
11400314|NCT04235582|12594978|FG000|COMPLETED|Overall Study||12
11400315|NCT04235582|12594979|FG001|COMPLETED|Overall Study||12
11400316|NCT04235582|12594980|FG002|COMPLETED|Overall Study||8
11400317|NCT04235582|12594978|FG000|NOT COMPLETED|Overall Study||0
11400318|NCT04235582|12594979|FG001|NOT COMPLETED|Overall Study||1
11400319|NCT04235582|12594980|FG002|NOT COMPLETED|Overall Study||3
11400320|NCT04203225|12594990|FG000|STARTED|Overall Study||21
11400321|NCT04203225|12594991|FG001|STARTED|Overall Study||27
11400322|NCT04203225|12594990|FG000|COMPLETED|Overall Study||21
11400323|NCT04203225|12594991|FG001|COMPLETED|Overall Study||27
11400324|NCT04203225|12594990|FG000|NOT COMPLETED|Overall Study||0
11400325|NCT04203225|12594991|FG001|NOT COMPLETED|Overall Study||0
11400326|NCT04234672|12594997|FG000|STARTED|Treatment Period 1 (Day 1)||6
11400327|NCT04234672|12594997|FG000|COMPLETED|Treatment Period 1 (Day 1)||6
11400328|NCT04234672|12594997|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11400329|NCT04234672|12594997|FG000|STARTED|Washout Period (Day 2 to 8)||6
11400330|NCT04234672|12594997|FG000|COMPLETED|Washout Period (Day 2 to 8)||6
11400331|NCT04234672|12594997|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0
11400332|NCT04234672|12594997|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6
11400333|NCT04234672|12594997|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6
11400334|NCT04234672|12594997|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0
11400335|NCT04223635|12595010|FG000|STARTED|Overall Study||8
11400336|NCT04223635|12595011|FG001|STARTED|Overall Study||8
11400337|NCT04223635|12595010|FG000|COMPLETED|Overall Study||8
11400338|NCT04223635|12595011|FG001|COMPLETED|Overall Study||8
11400339|NCT04223635|12595010|FG000|NOT COMPLETED|Overall Study||0
11400340|NCT04223635|12595011|FG001|NOT COMPLETED|Overall Study||0
11400341|NCT04214951|12595019|FG000|STARTED|Overall Study||50
11400342|NCT04214951|12595020|FG001|STARTED|Overall Study||50
11400343|NCT04214951|12595019|FG000|COMPLETED|Overall Study||10
11400344|NCT04214951|12595020|FG001|COMPLETED|Overall Study||10
11400345|NCT04214951|12595019|FG000|NOT COMPLETED|Overall Study||40
11400346|NCT04214951|12595020|FG001|NOT COMPLETED|Overall Study||40
11400347|NCT04234425|12595026|FG000|STARTED|Overall Study||18
11400348|NCT04234425|12595026|FG000|Midpoint-Week 4|Overall Study||18
11400349|NCT04234425|12595026|FG000|COMPLETED|Overall Study||18
11400350|NCT04234425|12595026|FG000|NOT COMPLETED|Overall Study||0
11400351|NCT04232137|12595034|FG000|STARTED|Overall Study||254
11400352|NCT04232137|12595035|FG001|STARTED|Overall Study||185
11400353|NCT04232137|12595034|FG000|COMPLETED|Overall Study||254
11400354|NCT04232137|12595035|FG001|COMPLETED|Overall Study||185
11400355|NCT04232137|12595034|FG000|NOT COMPLETED|Overall Study||0
11400356|NCT04232137|12595035|FG001|NOT COMPLETED|Overall Study||0
11400357|NCT04222699|12595041|FG000|STARTED|Overall Study||28
11400358|NCT04222699|12595041|FG000|COMPLETED|Overall Study||26
11400359|NCT04222699|12595041|FG000|NOT COMPLETED|Overall Study||2
11400360|NCT04208698|12595050|FG000|STARTED|Overall Study||2
11400361|NCT04208698|12595051|FG001|STARTED|Overall Study||0
11400362|NCT04208698|12595052|FG002|STARTED|Overall Study||0
11400363|NCT04208698|12595053|FG003|STARTED|Overall Study||0
11294856|NCT02518685|12492528|FG000|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213
11294857|NCT02518685|12492529|FG001|Enrolled|Overall Study||89
11294858|NCT02518685|12492528|FG000|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168
11294859|NCT02518685|12492529|FG001|Per Protocol Analysis|Overall Study||89
11341246|NCT02930226|12538560|FG004|NOT COMPLETED|Overall Study||1
11294860|NCT02518685|12492528|FG000|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164
11294861|NCT02518685|12492529|FG001|COMPLETED|Overall Study||79
11294862|NCT02518685|12492528|FG000|NOT COMPLETED|Overall Study||49
11294863|NCT02518685|12492529|FG001|NOT COMPLETED|Overall Study||10
11294864|NCT02518919|12492539|FG000|STARTED|Overall Study||21
11294865|NCT02518919|12492540|FG001|STARTED|Overall Study||21
11294866|NCT02518919|12492541|FG002|STARTED|Overall Study||21
11294867|NCT02518919|12492539|FG000|COMPLETED|Overall Study||20
11294868|NCT02518919|12492540|FG001|COMPLETED|Overall Study||20
11294869|NCT02518919|12492541|FG002|COMPLETED|Overall Study||19
11294870|NCT02518919|12492539|FG000|NOT COMPLETED|Overall Study||1
11294871|NCT02518919|12492540|FG001|NOT COMPLETED|Overall Study||1
11294872|NCT02518919|12492541|FG002|NOT COMPLETED|Overall Study||2
11294873|NCT02518971|12492551|FG000|STARTED|Overall Study||87
11400364|NCT04208698|12595054|FG004|STARTED|Overall Study||0
11400365|NCT04208698|12595050|FG000|COMPLETED|Overall Study||0
11400366|NCT04208698|12595051|FG001|COMPLETED|Overall Study||0
11294874|NCT02518971|12492552|FG001|STARTED|Overall Study||87
11294875|NCT02518971|12492551|FG000|COMPLETED|Overall Study||64
11294876|NCT02518971|12492552|FG001|COMPLETED|Overall Study||67
11294877|NCT02518971|12492551|FG000|NOT COMPLETED|Overall Study||23
11294878|NCT02518971|12492552|FG001|NOT COMPLETED|Overall Study||20
11294879|NCT02518997|12492559|FG000|STARTED|Overall Study||18
11294880|NCT02518997|12492559|FG000|COMPLETED|Overall Study||18
11294881|NCT02518997|12492559|FG000|NOT COMPLETED|Overall Study||0
11294882|NCT02519023|12492568|FG000|STARTED|Overall Study||49
11294883|NCT02519023|12492569|FG001|STARTED|Overall Study||38
11294884|NCT02519023|12492568|FG000|COMPLETED|Overall Study||31
11294885|NCT02519023|12492569|FG001|COMPLETED|Overall Study||31
11294886|NCT02519023|12492568|FG000|NOT COMPLETED|Overall Study||18
11294887|NCT02519023|12492569|FG001|NOT COMPLETED|Overall Study||7
11294888|NCT02519036|12492581|FG000|STARTED|Overall Study||12
11294889|NCT02519036|12492582|FG001|STARTED|Overall Study||3
11294890|NCT02519036|12492583|FG002|STARTED|Overall Study||6
11294891|NCT02519036|12492584|FG003|STARTED|Overall Study||6
11294892|NCT02519036|12492585|FG004|STARTED|Overall Study||9
11294893|NCT02519036|12492586|FG005|STARTED|Overall Study||10
11294894|NCT02519036|12492581|FG000|COMPLETED|Overall Study||12
11294895|NCT02519036|12492582|FG001|COMPLETED|Overall Study||3
11294896|NCT02519036|12492583|FG002|COMPLETED|Overall Study||6
11294897|NCT02519036|12492584|FG003|COMPLETED|Overall Study||6
11294898|NCT02519036|12492585|FG004|COMPLETED|Overall Study||9
11294899|NCT02519036|12492586|FG005|COMPLETED|Overall Study||10
11294900|NCT02519036|12492581|FG000|NOT COMPLETED|Overall Study||0
11294901|NCT02519036|12492582|FG001|NOT COMPLETED|Overall Study||0
11294902|NCT02519036|12492583|FG002|NOT COMPLETED|Overall Study||0
11294903|NCT02519036|12492584|FG003|NOT COMPLETED|Overall Study||0
11294904|NCT02519036|12492585|FG004|NOT COMPLETED|Overall Study||0
11294905|NCT02519036|12492586|FG005|NOT COMPLETED|Overall Study||0
11294906|NCT02519231|12492607|FG000|STARTED|Overall Study||14
11294907|NCT02519231|12492608|FG001|STARTED|Overall Study||14
11294908|NCT02519231|12492607|FG000|COMPLETED|Overall Study|One was lost to follow up and never took the treatment. another never turned in bleeding diary.|12
11294909|NCT02519231|12492608|FG001|COMPLETED|Overall Study|Six participants never turned in their bleeding diaries.|8
11294910|NCT02519231|12492607|FG000|NOT COMPLETED|Overall Study||2
11294911|NCT02519231|12492608|FG001|NOT COMPLETED|Overall Study||6
11294912|NCT02519244|12492616|FG000|STARTED|Overall Study||10
11294913|NCT02519244|12492616|FG000|COMPLETED|Overall Study||10
11294914|NCT02519244|12492616|FG000|NOT COMPLETED|Overall Study||0
11294915|NCT02519387|12492620|FG000|STARTED|Overall Study||78
11294916|NCT02519387|12492620|FG000|COMPLETED|Overall Study||56
11294917|NCT02519387|12492620|FG000|NOT COMPLETED|Overall Study||22
11294918|NCT02519491|12492626|FG000|STARTED|Overall Study||219
11294919|NCT02519491|12492627|FG001|STARTED|Overall Study||219
11294920|NCT02519491|12492626|FG000|COMPLETED|Overall Study||219
11294921|NCT02519491|12492627|FG001|COMPLETED|Overall Study||219
11294922|NCT02519491|12492626|FG000|NOT COMPLETED|Overall Study||0
11294923|NCT02519491|12492627|FG001|NOT COMPLETED|Overall Study||0
11294924|NCT02519504|12492635|FG000|STARTED|Overall Study||319
11294925|NCT02519504|12492636|FG001|STARTED|Overall Study||247
11294926|NCT02519504|12492635|FG000|Attended Direct Testing|Overall Study||212
11294927|NCT02519504|12492636|FG001|Attended Direct Testing|Overall Study||149
11294928|NCT02519504|12492635|FG000|COMPLETED|Overall Study||206
11294929|NCT02519504|12492636|FG001|COMPLETED|Overall Study||144
11294930|NCT02519504|12492635|FG000|NOT COMPLETED|Overall Study||113
11294931|NCT02519504|12492636|FG001|NOT COMPLETED|Overall Study||103
11294932|NCT02519595|12492645|FG000|STARTED|Overall Study||58
11294933|NCT02519595|12492646|FG001|STARTED|Overall Study||57
11294934|NCT02519595|12492647|FG002|STARTED|Overall Study||56
11294935|NCT02519595|12492645|FG000|COMPLETED|Overall Study||50
11294936|NCT02519595|12492646|FG001|COMPLETED|Overall Study||35
11294937|NCT02519595|12492647|FG002|COMPLETED|Overall Study||40
11294938|NCT02519595|12492645|FG000|NOT COMPLETED|Overall Study||8
11294939|NCT02519595|12492646|FG001|NOT COMPLETED|Overall Study||22
11294940|NCT02519595|12492647|FG002|NOT COMPLETED|Overall Study||16
11294941|NCT02519621|12492658|FG000|STARTED|Overall Study||30
11294942|NCT02519621|12492659|FG001|STARTED|Overall Study||30
11294943|NCT02519621|12492660|FG002|STARTED|Overall Study||30
11294944|NCT02519621|12492658|FG000|COMPLETED|Overall Study||30
11294945|NCT02519621|12492659|FG001|COMPLETED|Overall Study||30
11400367|NCT04208698|12595052|FG002|COMPLETED|Overall Study||0
11400368|NCT04208698|12595053|FG003|COMPLETED|Overall Study||0
11400369|NCT04208698|12595054|FG004|COMPLETED|Overall Study||0
11400370|NCT04208698|12595050|FG000|NOT COMPLETED|Overall Study||2
11400371|NCT04208698|12595051|FG001|NOT COMPLETED|Overall Study||0
11400372|NCT04208698|12595052|FG002|NOT COMPLETED|Overall Study||0
11400373|NCT04208698|12595053|FG003|NOT COMPLETED|Overall Study||0
11400374|NCT04208698|12595054|FG004|NOT COMPLETED|Overall Study||0
11400375|NCT04206293|12595064|FG000|STARTED|Overall Study||11
11400376|NCT04206293|12595064|FG000|COMPLETED|Overall Study||10
11400377|NCT04206293|12595064|FG000|NOT COMPLETED|Overall Study||1
11400378|NCT04228302|12595075|FG000|STARTED|Overall Study||6
11400379|NCT04228302|12595076|FG001|STARTED|Overall Study||6
11400380|NCT04228302|12595077|FG002|STARTED|Overall Study||6
11400381|NCT04228302|12595078|FG003|STARTED|Overall Study||6
11400382|NCT04228302|12595079|FG004|STARTED|Overall Study||6
11400383|NCT04228302|12595080|FG005|STARTED|Overall Study||10
11400384|NCT04228302|12595075|FG000|COMPLETED|Overall Study||6
11400385|NCT04228302|12595076|FG001|COMPLETED|Overall Study||6
11400386|NCT04228302|12595077|FG002|COMPLETED|Overall Study||6
11400387|NCT04228302|12595078|FG003|COMPLETED|Overall Study||6
11400388|NCT04228302|12595079|FG004|COMPLETED|Overall Study||5
11400389|NCT04228302|12595080|FG005|COMPLETED|Overall Study||10
11400390|NCT04228302|12595075|FG000|NOT COMPLETED|Overall Study||0
11400391|NCT04228302|12595076|FG001|NOT COMPLETED|Overall Study||0
11400392|NCT04228302|12595077|FG002|NOT COMPLETED|Overall Study||0
11400393|NCT04228302|12595078|FG003|NOT COMPLETED|Overall Study||0
11400394|NCT04228302|12595079|FG004|NOT COMPLETED|Overall Study||1
11400395|NCT04228302|12595080|FG005|NOT COMPLETED|Overall Study||0
11400396|NCT04227119|12595094|FG000|STARTED|Overall Study||11
11400397|NCT04227119|12595094|FG000|COMPLETED|Overall Study||11
11400398|NCT04227119|12595094|FG000|NOT COMPLETED|Overall Study||0
11400399|NCT04224753|12595100|FG000|STARTED|Overall Study||51
11400400|NCT04224753|12595100|FG000|COMPLETED|Overall Study||51
11400401|NCT04224753|12595100|FG000|NOT COMPLETED|Overall Study||0
11400402|NCT04218799|12595104|FG000|STARTED|Overall Study||7
11400403|NCT04218799|12595104|FG000|COMPLETED|Overall Study||7
11400404|NCT04218799|12595104|FG000|NOT COMPLETED|Overall Study||0
11400405|NCT04204057|12595108|FG000|STARTED|Overall Study||21
11400406|NCT04204057|12595108|FG000|COMPLETED|Overall Study||21
11400407|NCT04204057|12595108|FG000|NOT COMPLETED|Overall Study||0
11400408|NCT04195594|12595112|FG000|STARTED|Overall Study||14
11400409|NCT04195594|12595112|FG000|COMPLETED|Overall Study||11
11400410|NCT04195594|12595112|FG000|NOT COMPLETED|Overall Study||3
11400411|NCT04223687|12595118|FG000|STARTED|Overall Study||163
11400412|NCT04223687|12595119|FG001|STARTED|Overall Study||163
11400413|NCT04223687|12595118|FG000|COMPLETED|Overall Study||162
11400414|NCT04223687|12595119|FG001|COMPLETED|Overall Study||163
11400415|NCT04223687|12595118|FG000|NOT COMPLETED|Overall Study||1
11400416|NCT04223687|12595119|FG001|NOT COMPLETED|Overall Study||0
11400417|NCT04223232|12595125|FG000|STARTED|Overall Study||6
11400418|NCT04223232|12595125|FG000|COMPLETED|Overall Study||5
11400419|NCT04223232|12595125|FG000|NOT COMPLETED|Overall Study||1
11400420|NCT04189224|12595129|FG000|STARTED|Period 1||23
11400421|NCT04189224|12595130|FG001|STARTED|Period 1||21
11400422|NCT04189224|12595129|FG000|COMPLETED|Period 1||23
11400423|NCT04189224|12595130|FG001|COMPLETED|Period 1||21
11400424|NCT04189224|12595129|FG000|NOT COMPLETED|Period 1||0
11400425|NCT04189224|12595130|FG001|NOT COMPLETED|Period 1||0
11400426|NCT04189224|12595129|FG000|STARTED|Period 2||23
11400427|NCT04189224|12595130|FG001|STARTED|Period 2||21
11400428|NCT04189224|12595129|FG000|COMPLETED|Period 2||23
11400429|NCT04189224|12595130|FG001|COMPLETED|Period 2||20
11400430|NCT04189224|12595129|FG000|NOT COMPLETED|Period 2||0
11400431|NCT04189224|12595130|FG001|NOT COMPLETED|Period 2||1
11400432|NCT04214600|12595138|FG000|STARTED|Overall Study||50
11400433|NCT04214600|12595139|FG001|STARTED|Overall Study||50
11400434|NCT04214600|12595138|FG000|COMPLETED|Overall Study||41
11400435|NCT04214600|12595139|FG001|COMPLETED|Overall Study||36
11400436|NCT04214600|12595138|FG000|NOT COMPLETED|Overall Study||9
11400437|NCT04214600|12595139|FG001|NOT COMPLETED|Overall Study||14
11400438|NCT04202497|12595146|FG000|STARTED|Baseline Scan (Day-1)||7
11400439|NCT04202497|12595147|FG001|STARTED|Baseline Scan (Day-1)||0
11400440|NCT04202497|12595148|FG002|STARTED|Baseline Scan (Day-1)||0
11400441|NCT04202497|12595149|FG003|STARTED|Baseline Scan (Day-1)||0
11400442|NCT04202497|12595146|FG000|COMPLETED|Baseline Scan (Day-1)||6
11400443|NCT04202497|12595147|FG001|COMPLETED|Baseline Scan (Day-1)||0
11400444|NCT04202497|12595148|FG002|COMPLETED|Baseline Scan (Day-1)||0
11400445|NCT04202497|12595149|FG003|COMPLETED|Baseline Scan (Day-1)||0
11400446|NCT04202497|12595146|FG000|NOT COMPLETED|Baseline Scan (Day-1)||1
11400447|NCT04202497|12595147|FG001|NOT COMPLETED|Baseline Scan (Day-1)||0
11400448|NCT04202497|12595148|FG002|NOT COMPLETED|Baseline Scan (Day-1)||0
11294946|NCT02519621|12492660|FG002|COMPLETED|Overall Study||30
11294947|NCT02519621|12492658|FG000|NOT COMPLETED|Overall Study||0
11294948|NCT02519621|12492659|FG001|NOT COMPLETED|Overall Study||0
11294949|NCT02519621|12492660|FG002|NOT COMPLETED|Overall Study||0
11294950|NCT02519842|12492670|FG000|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
11294951|NCT02519842|12492671|FG001|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
11294952|NCT02519842|12492672|FG002|STARTED|Base Study: Cycle 1||0
11294953|NCT02519842|12492670|FG000|Treated|Base Study: Cycle 1||37
11294954|NCT02519842|12492671|FG001|Treated|Base Study: Cycle 1||34
11294955|NCT02519842|12492672|FG002|Treated|Base Study: Cycle 1||0
11294956|NCT02519842|12492670|FG000|COMPLETED|Base Study: Cycle 1||36
11294957|NCT02519842|12492671|FG001|COMPLETED|Base Study: Cycle 1||34
11294958|NCT02519842|12492672|FG002|COMPLETED|Base Study: Cycle 1||0
11294959|NCT02519842|12492670|FG000|NOT COMPLETED|Base Study: Cycle 1||2
11294960|NCT02519842|12492671|FG001|NOT COMPLETED|Base Study: Cycle 1||3
11294961|NCT02519842|12492672|FG002|NOT COMPLETED|Base Study: Cycle 1||0
11294962|NCT02519842|12492670|FG000|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
11294963|NCT02519842|12492671|FG001|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
11294964|NCT02519842|12492672|FG002|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
11294965|NCT02519842|12492670|FG000|Treated|Optional Extension: Cycles 2-6||0
11294966|NCT02519842|12492671|FG001|Treated|Optional Extension: Cycles 2-6||0
11294967|NCT02519842|12492672|FG002|Treated|Optional Extension: Cycles 2-6||55
11294968|NCT02519842|12492670|FG000|COMPLETED|Optional Extension: Cycles 2-6||0
11294969|NCT02519842|12492671|FG001|COMPLETED|Optional Extension: Cycles 2-6||0
11294970|NCT02519842|12492672|FG002|COMPLETED|Optional Extension: Cycles 2-6||26
11294971|NCT02519842|12492670|FG000|NOT COMPLETED|Optional Extension: Cycles 2-6||0
11294972|NCT02519842|12492671|FG001|NOT COMPLETED|Optional Extension: Cycles 2-6||0
11294973|NCT02519842|12492672|FG002|NOT COMPLETED|Optional Extension: Cycles 2-6||29
11294974|NCT02519855|12492682|FG000|STARTED|Overall Study|Participants are included as treated|441
11294975|NCT02519855|12492683|FG001|STARTED|Overall Study|Participants are included as treated|441
11294976|NCT02519855|12492682|FG000|Vaccinated on Day 1|Overall Study||440
11294977|NCT02519855|12492683|FG001|Vaccinated on Day 1|Overall Study||441
11294978|NCT02519855|12492682|FG000|Vaccinated at Week 4|Overall Study||432
11294979|NCT02519855|12492683|FG001|Vaccinated at Week 4|Overall Study||424
11294980|NCT02519855|12492682|FG000|COMPLETED|Overall Study||438
11294981|NCT02519855|12492683|FG001|COMPLETED|Overall Study||437
11294982|NCT02519855|12492682|FG000|NOT COMPLETED|Overall Study||3
11294983|NCT02519855|12492683|FG001|NOT COMPLETED|Overall Study||4
11400449|NCT04202497|12595149|FG003|NOT COMPLETED|Baseline Scan (Day-1)||0
11400450|NCT04202497|12595146|FG000|STARTED|Treatment Period (Day 1 Through Day 2-3)||0
11400451|NCT04202497|12595147|FG001|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
11400452|NCT04202497|12595148|FG002|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
11400453|NCT04202497|12595149|FG003|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
11400454|NCT04202497|12595146|FG000|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
11400455|NCT04202497|12595147|FG001|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
11400456|NCT04202497|12595148|FG002|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
11400457|NCT04202497|12595149|FG003|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
11400458|NCT04202497|12595146|FG000|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
11400459|NCT04202497|12595147|FG001|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
11400460|NCT04202497|12595148|FG002|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
11400461|NCT04202497|12595149|FG003|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
11400462|NCT04214080|12595165|FG000|STARTED|Overall Study||20
11400463|NCT04214080|12595166|FG001|STARTED|Overall Study||20
11400464|NCT04214080|12595165|FG000|COMPLETED|Overall Study||20
11400465|NCT04214080|12595166|FG001|COMPLETED|Overall Study||20
11400466|NCT04214080|12595165|FG000|NOT COMPLETED|Overall Study||0
11400467|NCT04214080|12595166|FG001|NOT COMPLETED|Overall Study||0
11400468|NCT04209530|12595176|FG000|STARTED|Overall Study||4
11400469|NCT04209530|12595177|FG001|STARTED|Overall Study||3
11400470|NCT04209530|12595176|FG000|COMPLETED|Overall Study||0
11400471|NCT04209530|12595177|FG001|COMPLETED|Overall Study||0
11400472|NCT04209530|12595176|FG000|NOT COMPLETED|Overall Study||4
11400473|NCT04209530|12595177|FG001|NOT COMPLETED|Overall Study||3
11400474|NCT04209335|12595183|FG000|STARTED|Overall Study||48
11400475|NCT04209335|12595183|FG000|COMPLETED|Overall Study||48
11400476|NCT04209335|12595183|FG000|NOT COMPLETED|Overall Study||0
11294984|NCT02520089|12492691|FG000|STARTED|Overall Study||12
11294985|NCT02520089|12492692|FG001|STARTED|Overall Study||11
11294986|NCT02520089|12492691|FG000|COMPLETED|Overall Study||9
11294987|NCT02520089|12492692|FG001|COMPLETED|Overall Study||7
11294988|NCT02520089|12492691|FG000|NOT COMPLETED|Overall Study||3
11294989|NCT02520089|12492692|FG001|NOT COMPLETED|Overall Study||4
11294990|NCT02520284|12492701|FG000|STARTED|Blinded Induction Phase: Up to Week 8||54
11294991|NCT02520284|12492702|FG001|STARTED|Blinded Induction Phase: Up to Week 8||56
11294992|NCT02520284|12492703|FG002|STARTED|Blinded Induction Phase: Up to Week 8||55
11400477|NCT04207333|12595190|FG000|STARTED|First Intervention (Single 1-Day Visit)||3
11400478|NCT04207333|12595191|FG001|STARTED|First Intervention (Single 1-Day Visit)||3
11400479|NCT04207333|12595190|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||3
11400480|NCT04207333|12595191|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||3
11400481|NCT04207333|12595190|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
11400482|NCT04207333|12595191|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
11400483|NCT04207333|12595190|FG000|STARTED|Washout (2-7 Days)||3
11400484|NCT04207333|12595191|FG001|STARTED|Washout (2-7 Days)||3
11400485|NCT04207333|12595190|FG000|COMPLETED|Washout (2-7 Days)||3
11400486|NCT04207333|12595191|FG001|COMPLETED|Washout (2-7 Days)||3
11400487|NCT04207333|12595190|FG000|NOT COMPLETED|Washout (2-7 Days)||0
11400488|NCT04207333|12595191|FG001|NOT COMPLETED|Washout (2-7 Days)||0
11400489|NCT04207333|12595190|FG000|STARTED|Second Intervention (Single 1-Day Visit)||3
11400490|NCT04207333|12595191|FG001|STARTED|Second Intervention (Single 1-Day Visit)||3
11400491|NCT04207333|12595190|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||3
11400492|NCT04207333|12595191|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3
11400493|NCT04207333|12595190|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
11400494|NCT04207333|12595191|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
11400495|NCT04207840|12595197|FG000|STARTED|Treatment Period 1||9
11400496|NCT04207840|12595198|FG001|STARTED|Treatment Period 1||10
11400497|NCT04207840|12595199|FG002|STARTED|Treatment Period 1||9
11400498|NCT04207840|12595197|FG000|COMPLETED|Treatment Period 1||9
11400499|NCT04207840|12595198|FG001|COMPLETED|Treatment Period 1||10
11400500|NCT04207840|12595199|FG002|COMPLETED|Treatment Period 1||9
11400501|NCT04207840|12595197|FG000|NOT COMPLETED|Treatment Period 1||0
11400502|NCT04207840|12595198|FG001|NOT COMPLETED|Treatment Period 1||0
11400503|NCT04207840|12595199|FG002|NOT COMPLETED|Treatment Period 1||0
11400504|NCT04207840|12595197|FG000|STARTED|Washout Period 1 (2-7 Days)||9
11400505|NCT04207840|12595198|FG001|STARTED|Washout Period 1 (2-7 Days)||10
11400506|NCT04207840|12595199|FG002|STARTED|Washout Period 1 (2-7 Days)||9
11400507|NCT04207840|12595197|FG000|COMPLETED|Washout Period 1 (2-7 Days)||9
11400508|NCT04207840|12595198|FG001|COMPLETED|Washout Period 1 (2-7 Days)||10
11400509|NCT04207840|12595199|FG002|COMPLETED|Washout Period 1 (2-7 Days)||8
11400510|NCT04207840|12595197|FG000|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
11400511|NCT04207840|12595198|FG001|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
11400512|NCT04207840|12595199|FG002|NOT COMPLETED|Washout Period 1 (2-7 Days)||1
11400513|NCT04207840|12595197|FG000|STARTED|Treatment Period 2||9
11400514|NCT04207840|12595198|FG001|STARTED|Treatment Period 2||10
11400515|NCT04207840|12595199|FG002|STARTED|Treatment Period 2||8
11400516|NCT04207840|12595197|FG000|COMPLETED|Treatment Period 2||9
11400517|NCT04207840|12595198|FG001|COMPLETED|Treatment Period 2||10
11400518|NCT04207840|12595199|FG002|COMPLETED|Treatment Period 2||8
11400519|NCT04207840|12595197|FG000|NOT COMPLETED|Treatment Period 2||0
11400520|NCT04207840|12595198|FG001|NOT COMPLETED|Treatment Period 2||0
11400521|NCT04207840|12595199|FG002|NOT COMPLETED|Treatment Period 2||0
11400522|NCT04207840|12595197|FG000|STARTED|Washout Period 2 (2-7 Days)||9
11400523|NCT04207840|12595198|FG001|STARTED|Washout Period 2 (2-7 Days)||10
11400524|NCT04207840|12595199|FG002|STARTED|Washout Period 2 (2-7 Days)||8
11400525|NCT04207840|12595197|FG000|COMPLETED|Washout Period 2 (2-7 Days)||9
11400526|NCT04207840|12595198|FG001|COMPLETED|Washout Period 2 (2-7 Days)||10
11400527|NCT04207840|12595199|FG002|COMPLETED|Washout Period 2 (2-7 Days)||7
11400528|NCT04207840|12595197|FG000|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
11400529|NCT04207840|12595198|FG001|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
11400530|NCT04207840|12595199|FG002|NOT COMPLETED|Washout Period 2 (2-7 Days)||1
11400531|NCT04207840|12595197|FG000|STARTED|Treatment Period 3||9
11400532|NCT04207840|12595198|FG001|STARTED|Treatment Period 3||10
11400533|NCT04207840|12595199|FG002|STARTED|Treatment Period 3||7
11400534|NCT04207840|12595197|FG000|COMPLETED|Treatment Period 3||9
11400535|NCT04207840|12595198|FG001|COMPLETED|Treatment Period 3||10
11400536|NCT04207840|12595199|FG002|COMPLETED|Treatment Period 3||7
11400537|NCT04207840|12595197|FG000|NOT COMPLETED|Treatment Period 3||0
11400538|NCT04207840|12595198|FG001|NOT COMPLETED|Treatment Period 3||0
11400539|NCT04207840|12595199|FG002|NOT COMPLETED|Treatment Period 3||0
11400540|NCT04206800|12595209|FG000|STARTED|Overall Study||4
11400541|NCT04206800|12595210|FG001|STARTED|Overall Study||1
11294993|NCT02520284|12492701|FG000|COMPLETED|Blinded Induction Phase: Up to Week 8||52
11294994|NCT02520284|12492702|FG001|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52
11294995|NCT02520284|12492703|FG002|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53
11294996|NCT02520284|12492701|FG000|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
11294997|NCT02520284|12492702|FG001|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4
11294998|NCT02520284|12492703|FG002|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
11294999|NCT02520284|12492701|FG000|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20
11295000|NCT02520284|12492702|FG001|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16
11295001|NCT02520284|12492703|FG002|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18
11295002|NCT02520284|12492701|FG000|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
11295003|NCT02520284|12492702|FG001|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
11295004|NCT02520284|12492703|FG002|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
11295005|NCT02520284|12492701|FG000|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20
11295006|NCT02520284|12492702|FG001|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16
11295007|NCT02520284|12492703|FG002|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18
11295008|NCT02520284|12492701|FG000|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32
11295009|NCT02520284|12492702|FG001|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35
11295010|NCT02520284|12492703|FG002|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34
11295011|NCT02520284|12492701|FG000|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
11295012|NCT02520284|12492702|FG001|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
11295013|NCT02520284|12492703|FG002|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
11295014|NCT02520284|12492701|FG000|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32
11295015|NCT02520284|12492702|FG001|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35
11295016|NCT02520284|12492703|FG002|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34
11295017|NCT02520310|12492717|FG000|STARTED|At 30 Days Clinical Follow-up||30
11295018|NCT02520310|12492717|FG000|COMPLETED|At 30 Days Clinical Follow-up||30
11295019|NCT02520310|12492717|FG000|NOT COMPLETED|At 30 Days Clinical Follow-up||0
11295020|NCT02520310|12492717|FG000|STARTED|At 6 Months Clinical Follow-up||30
11295021|NCT02520310|12492717|FG000|COMPLETED|At 6 Months Clinical Follow-up||29
11295022|NCT02520310|12492717|FG000|NOT COMPLETED|At 6 Months Clinical Follow-up||1
11295023|NCT02520310|12492717|FG000|STARTED|At 1 Year Clinical Follow-up||29
11295024|NCT02520310|12492717|FG000|COMPLETED|At 1 Year Clinical Follow-up||28
11295025|NCT02520310|12492717|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||1
11295026|NCT02520310|12492717|FG000|STARTED|At 2 Year Clinical Follow-up||28
11295027|NCT02520310|12492717|FG000|COMPLETED|At 2 Year Clinical Follow-up||28
11295028|NCT02520310|12492717|FG000|NOT COMPLETED|At 2 Year Clinical Follow-up||0
11295029|NCT02520310|12492717|FG000|STARTED|AT 3 Year Clinical Follow-up||28
11295030|NCT02520310|12492717|FG000|COMPLETED|AT 3 Year Clinical Follow-up||24
11295031|NCT02520310|12492717|FG000|NOT COMPLETED|AT 3 Year Clinical Follow-up||4
11295032|NCT02520310|12492717|FG000|STARTED|AT 4 Year Clinical Follow-up||24
11295033|NCT02520310|12492717|FG000|COMPLETED|AT 4 Year Clinical Follow-up||22
11295034|NCT02520310|12492717|FG000|NOT COMPLETED|AT 4 Year Clinical Follow-up||2
11295035|NCT02520388|12492725|FG000|STARTED|Overall Study||82
11295036|NCT02520388|12492726|FG001|STARTED|Overall Study||81
11295037|NCT02520388|12492725|FG000|Treated|Overall Study||81
11295038|NCT02520388|12492726|FG001|Treated|Overall Study||80
11295039|NCT02520388|12492725|FG000|COMPLETED|Overall Study||73
11295040|NCT02520388|12492726|FG001|COMPLETED|Overall Study||65
11295041|NCT02520388|12492725|FG000|NOT COMPLETED|Overall Study||9
11295042|NCT02520388|12492726|FG001|NOT COMPLETED|Overall Study||16
11295043|NCT02520414|12492732|FG000|STARTED|Overall Study||10
11295044|NCT02520414|12492732|FG000|COMPLETED|Overall Study||10
11295045|NCT02520414|12492732|FG000|NOT COMPLETED|Overall Study||0
11295046|NCT02520518|12492740|FG000|STARTED|Overall Study||3
11295047|NCT02520518|12492741|FG001|STARTED|Overall Study||1
11295048|NCT02520518|12492742|FG002|STARTED|Overall Study||3
11295049|NCT02520518|12492743|FG003|STARTED|Overall Study||2
11295050|NCT02520518|12492740|FG000|COMPLETED|Overall Study||3
11295051|NCT02520518|12492741|FG001|COMPLETED|Overall Study||1
11295052|NCT02520518|12492742|FG002|COMPLETED|Overall Study||1
11295053|NCT02520518|12492743|FG003|COMPLETED|Overall Study||1
11295054|NCT02520518|12492740|FG000|NOT COMPLETED|Overall Study||0
11295055|NCT02520518|12492741|FG001|NOT COMPLETED|Overall Study||0
11295056|NCT02520518|12492742|FG002|NOT COMPLETED|Overall Study||2
11295057|NCT02520518|12492743|FG003|NOT COMPLETED|Overall Study||1
11295058|NCT02520531|12492757|FG000|STARTED|Overall Study||42
11295059|NCT02520531|12492758|FG001|STARTED|Overall Study||42
11295060|NCT02520531|12492757|FG000|COMPLETED|Overall Study||36
11295061|NCT02520531|12492758|FG001|COMPLETED|Overall Study||36
11400542|NCT04206800|12595209|FG000|COMPLETED|Overall Study||4
11400543|NCT04206800|12595210|FG001|COMPLETED|Overall Study||1
11400544|NCT04206800|12595209|FG000|NOT COMPLETED|Overall Study||0
11400545|NCT04206800|12595210|FG001|NOT COMPLETED|Overall Study||0
11400546|NCT04205669|12595218|FG000|STARTED|Overall Study||47
11400547|NCT04205669|12595219|FG001|STARTED|Overall Study||57
11400548|NCT04205669|12595218|FG000|COMPLETED|Overall Study||34
11400549|NCT04205669|12595219|FG001|COMPLETED|Overall Study||45
11400550|NCT04205669|12595218|FG000|NOT COMPLETED|Overall Study||13
11400551|NCT04205669|12595219|FG001|NOT COMPLETED|Overall Study||12
11400552|NCT04198948|12595227|FG000|STARTED|First Period||7
11400553|NCT04198948|12595228|FG001|STARTED|First Period||8
11400554|NCT04198948|12595227|FG000|COMPLETED|First Period||7
11400555|NCT04198948|12595228|FG001|COMPLETED|First Period||8
11400556|NCT04198948|12595227|FG000|NOT COMPLETED|First Period||0
11400557|NCT04198948|12595228|FG001|NOT COMPLETED|First Period||0
11400558|NCT04198948|12595227|FG000|STARTED|Wash-out (10 Days)||7
11400559|NCT04198948|12595228|FG001|STARTED|Wash-out (10 Days)||8
11400560|NCT04198948|12595227|FG000|COMPLETED|Wash-out (10 Days)||7
11400561|NCT04198948|12595228|FG001|COMPLETED|Wash-out (10 Days)||8
11400562|NCT04198948|12595227|FG000|NOT COMPLETED|Wash-out (10 Days)||0
11400563|NCT04198948|12595228|FG001|NOT COMPLETED|Wash-out (10 Days)||0
11400564|NCT04198948|12595227|FG000|STARTED|Second Period||7
11400565|NCT04198948|12595228|FG001|STARTED|Second Period||8
11400566|NCT04198948|12595227|FG000|COMPLETED|Second Period||7
11400567|NCT04198948|12595228|FG001|COMPLETED|Second Period||7
11400568|NCT04198948|12595227|FG000|NOT COMPLETED|Second Period||0
11400569|NCT04198948|12595228|FG001|NOT COMPLETED|Second Period||1
11400570|NCT04206384|12595234|FG000|STARTED|Overall Study||52
11400571|NCT04206384|12595234|FG000|COMPLETED|Overall Study||42
11400572|NCT04206384|12595234|FG000|NOT COMPLETED|Overall Study||10
11400573|NCT04204200|12595241|FG000|STARTED|Overall Study||22
11400574|NCT04204200|12595242|FG001|STARTED|Overall Study||22
11400575|NCT04204200|12595243|FG002|STARTED|Overall Study||22
11400576|NCT04204200|12595241|FG000|COMPLETED|Overall Study||22
11400577|NCT04204200|12595242|FG001|COMPLETED|Overall Study||22
11400578|NCT04204200|12595243|FG002|COMPLETED|Overall Study||22
11400579|NCT04204200|12595241|FG000|NOT COMPLETED|Overall Study||0
11400580|NCT04204200|12595242|FG001|NOT COMPLETED|Overall Study||0
11400581|NCT04204200|12595243|FG002|NOT COMPLETED|Overall Study||0
11400582|NCT04196907|12595251|FG000|STARTED|Overall Study||20
11400583|NCT04196907|12595251|FG000|COMPLETED|Overall Study||20
11400584|NCT04196907|12595251|FG000|NOT COMPLETED|Overall Study||0
11400585|NCT04195893|12595255|FG000|STARTED|First Intervention||27
11400586|NCT04195893|12595256|FG001|STARTED|First Intervention||29
11400587|NCT04195893|12595255|FG000|COMPLETED|First Intervention||27
11400588|NCT04195893|12595256|FG001|COMPLETED|First Intervention||29
11400589|NCT04195893|12595255|FG000|NOT COMPLETED|First Intervention||0
11400590|NCT04195893|12595256|FG001|NOT COMPLETED|First Intervention||0
11400591|NCT04195893|12595255|FG000|STARTED|Second Intervention||27
11400592|NCT04195893|12595256|FG001|STARTED|Second Intervention||29
11400593|NCT04195893|12595255|FG000|COMPLETED|Second Intervention||26
11400594|NCT04195893|12595256|FG001|COMPLETED|Second Intervention||29
11400595|NCT04195893|12595255|FG000|NOT COMPLETED|Second Intervention||1
11400596|NCT04195893|12595256|FG001|NOT COMPLETED|Second Intervention||0
11400597|NCT04195880|12595264|FG000|STARTED|Overall Study||3205
11400598|NCT04195880|12595265|FG001|STARTED|Overall Study||3338
11400599|NCT04195880|12595264|FG000|COMPLETED|Overall Study||3205
11400600|NCT04195880|12595265|FG001|COMPLETED|Overall Study||3338
11400601|NCT04195880|12595264|FG000|NOT COMPLETED|Overall Study||0
11400602|NCT04195880|12595265|FG001|NOT COMPLETED|Overall Study||0
11400603|NCT04195581|12595271|FG000|STARTED|Comfilcon A With All in One Light||28
11400604|NCT04195581|12595271|FG000|COMPLETED|Comfilcon A With All in One Light||24
11400605|NCT04195581|12595271|FG000|NOT COMPLETED|Comfilcon A With All in One Light||4
11021919|NCT00806585|12200108|FG001|STARTED|Overall Study||134
11021920|NCT00806585|12200109|FG002|STARTED|Overall Study||141
11021921|NCT00806585|12200110|FG003|STARTED|Overall Study||71
11295062|NCT02520531|12492757|FG000|NOT COMPLETED|Overall Study||6
11295063|NCT02520531|12492758|FG001|NOT COMPLETED|Overall Study||6
11295064|NCT02521181|12492767|FG000|STARTED|Overall Study||52
11295065|NCT02521181|12492768|FG001|STARTED|Overall Study||90
11295066|NCT02521181|12492769|FG002|STARTED|Overall Study||52
11295067|NCT02521181|12492767|FG000|COMPLETED|Overall Study|All patients included in primary analysis|52
11295068|NCT02521181|12492768|FG001|COMPLETED|Overall Study|All patients included in primary analysis|90
11295069|NCT02521181|12492769|FG002|COMPLETED|Overall Study|All patients included in primary analysis|52
11295070|NCT02521181|12492767|FG000|NOT COMPLETED|Overall Study||0
11295071|NCT02521181|12492768|FG001|NOT COMPLETED|Overall Study||0
11295072|NCT02521181|12492769|FG002|NOT COMPLETED|Overall Study||0
11295073|NCT02521259|12492779|FG000|STARTED|Overall Study||35
11295074|NCT02521259|12492780|FG001|STARTED|Overall Study||33
11295075|NCT02521259|12492779|FG000|COMPLETED|Overall Study||34
11295076|NCT02521259|12492780|FG001|COMPLETED|Overall Study||28
11295077|NCT02521259|12492779|FG000|NOT COMPLETED|Overall Study||1
11295078|NCT02521259|12492780|FG001|NOT COMPLETED|Overall Study||5
11295079|NCT02521376|12492790|FG000|STARTED|Overall Study||8
11295080|NCT02521376|12492791|FG001|STARTED|Overall Study||18
11295081|NCT02521376|12492792|FG002|STARTED|Overall Study||10
11295082|NCT02521376|12492793|FG003|STARTED|Overall Study||20
11295083|NCT02521376|12492790|FG000|COMPLETED|Overall Study||7
11295084|NCT02521376|12492791|FG001|COMPLETED|Overall Study||18
11295085|NCT02521376|12492792|FG002|COMPLETED|Overall Study||10
11295086|NCT02521376|12492793|FG003|COMPLETED|Overall Study||20
11295087|NCT02521376|12492790|FG000|NOT COMPLETED|Overall Study||1
11295088|NCT02521376|12492791|FG001|NOT COMPLETED|Overall Study||0
11295089|NCT02521376|12492792|FG002|NOT COMPLETED|Overall Study||0
11295090|NCT02521376|12492793|FG003|NOT COMPLETED|Overall Study||0
11295091|NCT02521766|12492813|FG000|STARTED|Overall Study||49
11295092|NCT02521766|12492814|FG001|STARTED|Overall Study||65
11295093|NCT02521766|12492813|FG000|Per Protocol|Overall Study||47
11295094|NCT02521766|12492814|FG001|Per Protocol|Overall Study||65
11295095|NCT02521766|12492813|FG000|COMPLETED|Overall Study||44
11295096|NCT02521766|12492814|FG001|COMPLETED|Overall Study||62
11295097|NCT02521766|12492813|FG000|NOT COMPLETED|Overall Study||5
11295098|NCT02521766|12492814|FG001|NOT COMPLETED|Overall Study||3
11295099|NCT02521792|12492831|FG000|STARTED|Overall Study||6
11295100|NCT02521792|12492831|FG000|Received Treatment|Overall Study||4
11295101|NCT02521792|12492831|FG000|COMPLETED|Overall Study||0
11295102|NCT02521792|12492831|FG000|NOT COMPLETED|Overall Study||6
11295103|NCT02521870|12492843|FG000|STARTED|Phase 1: Dose Escalation||6
11295104|NCT02521870|12492844|FG001|STARTED|Phase 1: Dose Escalation||5
11295105|NCT02521870|12492845|FG002|STARTED|Phase 1: Dose Escalation||5
11295106|NCT02521870|12492846|FG003|STARTED|Phase 1: Dose Escalation||6
11295107|NCT02521870|12492847|FG004|STARTED|Phase 1: Dose Escalation||0
11295108|NCT02521870|12492848|FG005|STARTED|Phase 1: Dose Escalation||0
11295109|NCT02521870|12492849|FG006|STARTED|Phase 1: Dose Escalation||0
11295110|NCT02521870|12492850|FG007|STARTED|Phase 1: Dose Escalation||0
11295111|NCT02521870|12492851|FG008|STARTED|Phase 1: Dose Escalation||0
11295112|NCT02521870|12492852|FG009|STARTED|Phase 1: Dose Escalation||0
11295113|NCT02521870|12492853|FG010|STARTED|Phase 1: Dose Escalation||0
11295114|NCT02521870|12492854|FG011|STARTED|Phase 1: Dose Escalation||0
11295115|NCT02521870|12492843|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
11295116|NCT02521870|12492844|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
11295117|NCT02521870|12492845|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
11295118|NCT02521870|12492846|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||1
11295119|NCT02521870|12492847|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
11295120|NCT02521870|12492848|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
11295121|NCT02521870|12492849|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
11295122|NCT02521870|12492850|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
11295123|NCT02521870|12492851|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
11295124|NCT02521870|12492852|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
11295125|NCT02521870|12492853|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
11295126|NCT02521870|12492854|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
11295127|NCT02521870|12492843|FG000|COMPLETED|Phase 1: Dose Escalation||1
11295128|NCT02521870|12492844|FG001|COMPLETED|Phase 1: Dose Escalation||1
11295129|NCT02521870|12492845|FG002|COMPLETED|Phase 1: Dose Escalation||1
11295130|NCT02521870|12492846|FG003|COMPLETED|Phase 1: Dose Escalation||0
11295131|NCT02521870|12492847|FG004|COMPLETED|Phase 1: Dose Escalation||0
11295132|NCT02521870|12492848|FG005|COMPLETED|Phase 1: Dose Escalation||0
11295133|NCT02521870|12492849|FG006|COMPLETED|Phase 1: Dose Escalation||0
11295134|NCT02521870|12492850|FG007|COMPLETED|Phase 1: Dose Escalation||0
11295135|NCT02521870|12492851|FG008|COMPLETED|Phase 1: Dose Escalation||0
11295136|NCT02521870|12492852|FG009|COMPLETED|Phase 1: Dose Escalation||0
11295137|NCT02521870|12492853|FG010|COMPLETED|Phase 1: Dose Escalation||0
11295138|NCT02521870|12492854|FG011|COMPLETED|Phase 1: Dose Escalation||0
11295139|NCT02521870|12492843|FG000|NOT COMPLETED|Phase 1: Dose Escalation||5
11295140|NCT02521870|12492844|FG001|NOT COMPLETED|Phase 1: Dose Escalation||4
11295141|NCT02521870|12492845|FG002|NOT COMPLETED|Phase 1: Dose Escalation||4
11295142|NCT02521870|12492846|FG003|NOT COMPLETED|Phase 1: Dose Escalation||6
11295143|NCT02521870|12492847|FG004|NOT COMPLETED|Phase 1: Dose Escalation||0
11295144|NCT02521870|12492848|FG005|NOT COMPLETED|Phase 1: Dose Escalation||0
11295145|NCT02521870|12492849|FG006|NOT COMPLETED|Phase 1: Dose Escalation||0
11295146|NCT02521870|12492850|FG007|NOT COMPLETED|Phase 1: Dose Escalation||0
11295147|NCT02521870|12492851|FG008|NOT COMPLETED|Phase 1: Dose Escalation||0
11295148|NCT02521870|12492852|FG009|NOT COMPLETED|Phase 1: Dose Escalation||0
11295149|NCT02521870|12492853|FG010|NOT COMPLETED|Phase 1: Dose Escalation||0
11295150|NCT02521870|12492854|FG011|NOT COMPLETED|Phase 1: Dose Escalation||0
11295151|NCT02521870|12492843|FG000|STARTED|Phase 2: Dose Expansion||0
11295152|NCT02521870|12492844|FG001|STARTED|Phase 2: Dose Expansion||0
11295153|NCT02521870|12492845|FG002|STARTED|Phase 2: Dose Expansion||0
11295154|NCT02521870|12492846|FG003|STARTED|Phase 2: Dose Expansion||0
11295155|NCT02521870|12492847|FG004|STARTED|Phase 2: Dose Expansion||57
11295156|NCT02521870|12492848|FG005|STARTED|Phase 2: Dose Expansion||25
11295157|NCT02521870|12492849|FG006|STARTED|Phase 2: Dose Expansion||23
11295158|NCT02521870|12492850|FG007|STARTED|Phase 2: Dose Expansion||9
11295159|NCT02521870|12492851|FG008|STARTED|Phase 2: Dose Expansion||24
11295160|NCT02521870|12492852|FG009|STARTED|Phase 2: Dose Expansion||28
11295161|NCT02521870|12492853|FG010|STARTED|Phase 2: Dose Expansion||23
11295162|NCT02521870|12492854|FG011|STARTED|Phase 2: Dose Expansion||30
11295163|NCT02521870|12492843|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
11295164|NCT02521870|12492844|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
11295165|NCT02521870|12492845|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
11295166|NCT02521870|12492846|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
11295167|NCT02521870|12492847|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||25
11295168|NCT02521870|12492848|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||7
11295169|NCT02521870|12492849|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||3
11295170|NCT02521870|12492850|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||2
11295171|NCT02521870|12492851|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||9
11295172|NCT02521870|12492852|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||5
11295173|NCT02521870|12492853|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||1
11295174|NCT02521870|12492854|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||11
11295175|NCT02521870|12492843|FG000|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
11295176|NCT02521870|12492844|FG001|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
11295177|NCT02521870|12492845|FG002|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
11295178|NCT02521870|12492846|FG003|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
11295179|NCT02521870|12492847|FG004|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||7
11295180|NCT02521870|12492848|FG005|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||1
11295181|NCT02521870|12492849|FG006|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
11295182|NCT02521870|12492850|FG007|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
11295183|NCT02521870|12492851|FG008|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
11295184|NCT02521870|12492852|FG009|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
11295185|NCT02521870|12492853|FG010|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
11295186|NCT02521870|12492854|FG011|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
11295187|NCT02521870|12492843|FG000|COMPLETED|Phase 2: Dose Expansion||0
11295188|NCT02521870|12492844|FG001|COMPLETED|Phase 2: Dose Expansion||0
11295189|NCT02521870|12492845|FG002|COMPLETED|Phase 2: Dose Expansion||0
11295190|NCT02521870|12492846|FG003|COMPLETED|Phase 2: Dose Expansion||0
11295191|NCT02521870|12492847|FG004|COMPLETED|Phase 2: Dose Expansion||5
11295192|NCT02521870|12492848|FG005|COMPLETED|Phase 2: Dose Expansion||0
11295193|NCT02521870|12492849|FG006|COMPLETED|Phase 2: Dose Expansion||0
11295194|NCT02521870|12492850|FG007|COMPLETED|Phase 2: Dose Expansion||0
11295195|NCT02521870|12492851|FG008|COMPLETED|Phase 2: Dose Expansion|4 participants completed pembrolizumab treatment (up to 35 cycles).|2
11295196|NCT02521870|12492852|FG009|COMPLETED|Phase 2: Dose Expansion||0
11295197|NCT02521870|12492853|FG010|COMPLETED|Phase 2: Dose Expansion||0
11295198|NCT02521870|12492854|FG011|COMPLETED|Phase 2: Dose Expansion||0
11295199|NCT02521870|12492843|FG000|NOT COMPLETED|Phase 2: Dose Expansion||0
11295200|NCT02521870|12492844|FG001|NOT COMPLETED|Phase 2: Dose Expansion||0
11295201|NCT02521870|12492845|FG002|NOT COMPLETED|Phase 2: Dose Expansion||0
11295202|NCT02521870|12492846|FG003|NOT COMPLETED|Phase 2: Dose Expansion||0
11295203|NCT02521870|12492847|FG004|NOT COMPLETED|Phase 2: Dose Expansion||52
11295204|NCT02521870|12492848|FG005|NOT COMPLETED|Phase 2: Dose Expansion||25
11295205|NCT02521870|12492849|FG006|NOT COMPLETED|Phase 2: Dose Expansion||23
11295206|NCT02521870|12492850|FG007|NOT COMPLETED|Phase 2: Dose Expansion||9
11295207|NCT02521870|12492851|FG008|NOT COMPLETED|Phase 2: Dose Expansion||22
11295208|NCT02521870|12492852|FG009|NOT COMPLETED|Phase 2: Dose Expansion||28
11295209|NCT02521870|12492853|FG010|NOT COMPLETED|Phase 2: Dose Expansion||23
11295210|NCT02521870|12492854|FG011|NOT COMPLETED|Phase 2: Dose Expansion||30
11295211|NCT02521948|12492884|FG000|STARTED|Overall Study||50
11295212|NCT02521948|12492884|FG000|COMPLETED|Overall Study||37
11295213|NCT02521948|12492884|FG000|NOT COMPLETED|Overall Study||13
11295214|NCT02521974|12492893|FG000|STARTED|Overall Study||50
11295215|NCT02521974|12492894|FG001|STARTED|Overall Study||114
11295216|NCT02521974|12492893|FG000|COMPLETED|Overall Study||47
11295217|NCT02521974|12492894|FG001|COMPLETED|Overall Study||110
11295218|NCT02521974|12492893|FG000|NOT COMPLETED|Overall Study||3
11295219|NCT02521974|12492894|FG001|NOT COMPLETED|Overall Study||4
11295220|NCT02522104|12492904|FG000|STARTED|Overall Study||13
11295221|NCT02522104|12492905|FG001|STARTED|Overall Study||15
11295222|NCT02522104|12492906|FG002|STARTED|Overall Study||12
11295223|NCT02522104|12492904|FG000|COMPLETED|Overall Study||10
11295224|NCT02522104|12492905|FG001|COMPLETED|Overall Study||12
11295225|NCT02522104|12492906|FG002|COMPLETED|Overall Study||5
11295226|NCT02522104|12492904|FG000|NOT COMPLETED|Overall Study||3
11295227|NCT02522104|12492905|FG001|NOT COMPLETED|Overall Study||3
11295228|NCT02522104|12492906|FG002|NOT COMPLETED|Overall Study||7
11295229|NCT02522286|12492921|FG000|STARTED|Overall Study||78
11295230|NCT02522286|12492922|FG001|STARTED|Overall Study||75
11295231|NCT02522286|12492923|FG002|STARTED|Overall Study||75
11295232|NCT02522286|12492924|FG003|STARTED|Overall Study||78
11295233|NCT02522286|12492921|FG000|COMPLETED|Overall Study||75
11295234|NCT02522286|12492922|FG001|COMPLETED|Overall Study||75
11295235|NCT02522286|12492923|FG002|COMPLETED|Overall Study||75
11295236|NCT02522286|12492924|FG003|COMPLETED|Overall Study||75
11295237|NCT02522286|12492921|FG000|NOT COMPLETED|Overall Study||3
11295238|NCT02522286|12492922|FG001|NOT COMPLETED|Overall Study||0
11295239|NCT02522286|12492923|FG002|NOT COMPLETED|Overall Study||0
11295240|NCT02522286|12492924|FG003|NOT COMPLETED|Overall Study||3
11295241|NCT02522299|12492936|FG000|STARTED|Overall Study||22
11295242|NCT02522299|12492937|FG001|STARTED|Overall Study||22
11295243|NCT02522299|12492936|FG000|COMPLETED|Overall Study||18
11295244|NCT02522299|12492937|FG001|COMPLETED|Overall Study||21
11295245|NCT02522299|12492936|FG000|NOT COMPLETED|Overall Study||4
11295246|NCT02522299|12492937|FG001|NOT COMPLETED|Overall Study||1
11295247|NCT02522325|12492957|FG000|STARTED|Overall Study||15
11295248|NCT02522325|12492958|FG001|STARTED|Overall Study||15
11295249|NCT02522325|12492957|FG000|COMPLETED|Overall Study||15
11295250|NCT02522325|12492958|FG001|COMPLETED|Overall Study||14
11295251|NCT02522325|12492957|FG000|NOT COMPLETED|Overall Study||0
11295252|NCT02522325|12492958|FG001|NOT COMPLETED|Overall Study||1
11295253|NCT02522377|12492966|FG000|STARTED|Overall Study||7
11295254|NCT02522377|12492967|FG001|STARTED|Overall Study||5
11295255|NCT02522377|12492966|FG000|COMPLETED|Overall Study||3
11295256|NCT02522377|12492967|FG001|COMPLETED|Overall Study||5
11295257|NCT02522377|12492966|FG000|NOT COMPLETED|Overall Study||4
11295258|NCT02522377|12492967|FG001|NOT COMPLETED|Overall Study||0
11295259|NCT02522403|12492975|FG000|STARTED|Overall Study||17
11295260|NCT02522403|12492976|FG001|STARTED|Overall Study||19
11295261|NCT02522403|12492975|FG000|COMPLETED|Overall Study||13
11295262|NCT02522403|12492976|FG001|COMPLETED|Overall Study||13
11295263|NCT02522403|12492975|FG000|NOT COMPLETED|Overall Study||4
11295264|NCT02522403|12492976|FG001|NOT COMPLETED|Overall Study||6
11295265|NCT02522442|12492984|FG000|STARTED|Overall Study||26
11295266|NCT02522442|12492985|FG001|STARTED|Overall Study||22
11295267|NCT02522442|12492984|FG000|COMPLETED|Overall Study||26
11295268|NCT02522442|12492985|FG001|COMPLETED|Overall Study||22
11295269|NCT02522442|12492984|FG000|NOT COMPLETED|Overall Study||0
11295270|NCT02522442|12492985|FG001|NOT COMPLETED|Overall Study||0
11295271|NCT02522481|12492991|FG000|STARTED|Overall Study||175
11295272|NCT02522481|12492991|FG000|COMPLETED|Overall Study||172
11295273|NCT02522481|12492991|FG000|NOT COMPLETED|Overall Study||3
11295274|NCT02522624|12493004|FG000|STARTED|Overall Study||165
11295275|NCT02522624|12493005|FG001|STARTED|Overall Study||163
11295276|NCT02522624|12493004|FG000|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
11295277|NCT02522624|12493005|FG001|COMPLETED|Overall Study||163
11295278|NCT02522624|12493004|FG000|NOT COMPLETED|Overall Study||1
11295279|NCT02522624|12493005|FG001|NOT COMPLETED|Overall Study||0
11295280|NCT02522728|12493013|FG000|STARTED|Overall Study||28
11295281|NCT02522728|12493014|FG001|STARTED|Overall Study||30
11295282|NCT02522728|12493013|FG000|COMPLETED|Overall Study||16
11295283|NCT02522728|12493014|FG001|COMPLETED|Overall Study||19
11295284|NCT02522728|12493013|FG000|NOT COMPLETED|Overall Study||12
11295285|NCT02522728|12493014|FG001|NOT COMPLETED|Overall Study||11
11295286|NCT02522767|12493022|FG000|STARTED|Double-blind||114
11400606|NCT04195581|12595271|FG000|STARTED|Comfilcon A With Hy-Care||30
11400607|NCT04195581|12595271|FG000|COMPLETED|Comfilcon A With Hy-Care||25
11400608|NCT04195581|12595271|FG000|NOT COMPLETED|Comfilcon A With Hy-Care||5
11400609|NCT04195581|12595271|FG000|STARTED|Comfilcon A With Refine One Step||25
11400610|NCT04195581|12595271|FG000|COMPLETED|Comfilcon A With Refine One Step||24
11400611|NCT04195581|12595271|FG000|NOT COMPLETED|Comfilcon A With Refine One Step||1
11400612|NCT04195581|12595271|FG000|STARTED|Fanfilcon A With All in One Light||28
11400613|NCT04195581|12595271|FG000|COMPLETED|Fanfilcon A With All in One Light||27
11400614|NCT04195581|12595271|FG000|NOT COMPLETED|Fanfilcon A With All in One Light||1
11400615|NCT04195581|12595271|FG000|STARTED|Fanfilcon A With Hy-Care||28
11400616|NCT04195581|12595271|FG000|COMPLETED|Fanfilcon A With Hy-Care||25
11400617|NCT04195581|12595271|FG000|NOT COMPLETED|Fanfilcon A With Hy-Care||3
11400618|NCT04195581|12595271|FG000|STARTED|Fanfilcon A With Refine One Step||29
11400619|NCT04195581|12595271|FG000|COMPLETED|Fanfilcon A With Refine One Step||27
11400620|NCT04195581|12595271|FG000|NOT COMPLETED|Fanfilcon A With Refine One Step||2
11295287|NCT02522767|12493023|FG001|STARTED|Double-blind||114
11295288|NCT02522767|12493022|FG000|COMPLETED|Double-blind||103
11295289|NCT02522767|12493023|FG001|COMPLETED|Double-blind||90
11400621|NCT04194151|12595295|FG000|STARTED|Overall Study||32
11295290|NCT02522767|12493022|FG000|NOT COMPLETED|Double-blind||11
11295291|NCT02522767|12493023|FG001|NOT COMPLETED|Double-blind||24
11295292|NCT02522767|12493022|FG000|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|88
11295293|NCT02522767|12493023|FG001|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|82
11295294|NCT02522767|12493022|FG000|COMPLETED|Open-label||83
11295295|NCT02522767|12493023|FG001|COMPLETED|Open-label||75
11295296|NCT02522767|12493022|FG000|NOT COMPLETED|Open-label||5
11295297|NCT02522767|12493023|FG001|NOT COMPLETED|Open-label||7
11295298|NCT02522780|12493033|FG000|STARTED|Overall Study||138
11295299|NCT02522780|12493034|FG001|STARTED|Overall Study||138
11295300|NCT02522780|12493033|FG000|Treated|Overall Study||137
11295301|NCT02522780|12493034|FG001|Treated|Overall Study||135
11295302|NCT02522780|12493033|FG000|Intention-to-treat (ITT) Population|Overall Study||136
11295303|NCT02522780|12493034|FG001|Intention-to-treat (ITT) Population|Overall Study||136
11295304|NCT02522780|12493033|FG000|COMPLETED|Overall Study||121
11295305|NCT02522780|12493034|FG001|COMPLETED|Overall Study||111
11295306|NCT02522780|12493033|FG000|NOT COMPLETED|Overall Study||17
11295307|NCT02522780|12493034|FG001|NOT COMPLETED|Overall Study||27
11295308|NCT02522884|12493041|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|213
11295309|NCT02522884|12493041|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|195
11295310|NCT02522884|12493041|FG000|NOT COMPLETED|Overall Study||18
11295311|NCT02523196|12493045|FG000|STARTED|Overall Study||20
11295312|NCT02523196|12493045|FG000|Received HVPG|Overall Study||20
11295313|NCT02523196|12493045|FG000|Received HQ Shunt|Overall Study||20
11400622|NCT04194151|12595296|FG001|STARTED|Overall Study||32
11295314|NCT02523196|12493045|FG000|COMPLETED|Overall Study||20
11295315|NCT02523196|12493045|FG000|NOT COMPLETED|Overall Study||0
11295316|NCT02523235|12493056|FG000|STARTED|Overall Study||56
11295317|NCT02523235|12493057|FG001|STARTED|Overall Study||58
11295318|NCT02523235|12493056|FG000|COMPLETED|Overall Study||56
11295319|NCT02523235|12493057|FG001|COMPLETED|Overall Study||58
11295320|NCT02523235|12493056|FG000|NOT COMPLETED|Overall Study||0
11295321|NCT02523235|12493057|FG001|NOT COMPLETED|Overall Study||0
11295322|NCT02523586|12493064|FG000|STARTED|Overall Study||14
11295323|NCT02523586|12493064|FG000|COMPLETED|Overall Study||10
11295324|NCT02523586|12493064|FG000|NOT COMPLETED|Overall Study||4
11341247|NCT02930226|12538561|FG005|NOT COMPLETED|Overall Study||0
11341248|NCT02930343|12538579|FG000|STARTED|Overall Study||68
11341249|NCT02930343|12538580|FG001|STARTED|Overall Study||68
11341250|NCT02930343|12538579|FG000|COMPLETED|Overall Study||59
11341251|NCT02930343|12538580|FG001|COMPLETED|Overall Study||61
11341252|NCT02930343|12538579|FG000|NOT COMPLETED|Overall Study||9
11341253|NCT02930343|12538580|FG001|NOT COMPLETED|Overall Study||7
11341254|NCT02930824|12538590|FG000|STARTED|Overall Study||62
11341255|NCT02930824|12538591|FG001|STARTED|Overall Study||63
11341256|NCT02930824|12538592|FG002|STARTED|Overall Study||30
11341257|NCT02930824|12538593|FG003|STARTED|Overall Study||30
11341258|NCT02930824|12538590|FG000|COMPLETED|Overall Study||56
11341259|NCT02930824|12538591|FG001|COMPLETED|Overall Study||57
11341260|NCT02930824|12538592|FG002|COMPLETED|Overall Study||20
11341261|NCT02930824|12538593|FG003|COMPLETED|Overall Study||23
11341262|NCT02930824|12538590|FG000|NOT COMPLETED|Overall Study||6
11341263|NCT02930824|12538591|FG001|NOT COMPLETED|Overall Study||6
11341264|NCT02930824|12538592|FG002|NOT COMPLETED|Overall Study||10
11341265|NCT02930824|12538593|FG003|NOT COMPLETED|Overall Study||7
11341266|NCT02930837|12538609|FG000|STARTED|Overall Study|Started are treated patients|120
11341267|NCT02930837|12538609|FG000|COMPLETED|Overall Study|Completed the trial|108
11341268|NCT02930837|12538609|FG000|NOT COMPLETED|Overall Study||12
11341269|NCT02930941|12538615|FG000|STARTED|Overall Study||17
11341270|NCT02930941|12538616|FG001|STARTED|Overall Study||18
11341271|NCT02930941|12538615|FG000|COMPLETED|Overall Study||16
11341272|NCT02930941|12538616|FG001|COMPLETED|Overall Study||16
11341273|NCT02930941|12538615|FG000|NOT COMPLETED|Overall Study||1
11341274|NCT02930941|12538616|FG001|NOT COMPLETED|Overall Study||2
11341275|NCT02930980|12538626|FG000|STARTED|Overall Study||43
11341276|NCT02930980|12538626|FG000|COMPLETED|Overall Study||43
11341277|NCT02930980|12538626|FG000|NOT COMPLETED|Overall Study||0
11341278|NCT02931045|12538632|FG000|STARTED|Overall Study||30
11341279|NCT02931045|12538633|FG001|STARTED|Overall Study||30
11341280|NCT02931045|12538632|FG000|COMPLETED|Overall Study||27
11341281|NCT02931045|12538633|FG001|COMPLETED|Overall Study||28
11341282|NCT02931045|12538632|FG000|NOT COMPLETED|Overall Study||3
11341283|NCT02931045|12538633|FG001|NOT COMPLETED|Overall Study||2
11341284|NCT02931253|12538641|FG000|STARTED|Overall Study||2
11341285|NCT02931253|12538642|FG001|STARTED|Overall Study||4
11341286|NCT02931253|12538641|FG000|COMPLETED|Overall Study||2
11341287|NCT02931253|12538642|FG001|COMPLETED|Overall Study||4
11341288|NCT02931253|12538641|FG000|NOT COMPLETED|Overall Study||0
11341289|NCT02931253|12538642|FG001|NOT COMPLETED|Overall Study||0
11341290|NCT02931396|12538650|FG000|STARTED|Overall Study||10
11341291|NCT02931396|12538651|FG001|STARTED|Overall Study||10
11341292|NCT02931396|12538650|FG000|COMPLETED|Overall Study||5
11341293|NCT02931396|12538651|FG001|COMPLETED|Overall Study||10
11341294|NCT02931396|12538650|FG000|NOT COMPLETED|Overall Study||5
11341295|NCT02931396|12538651|FG001|NOT COMPLETED|Overall Study||0
11341296|NCT02931539|12538659|FG000|STARTED|Period 1: Treatment Phase||117
11341297|NCT02931539|12538660|FG001|STARTED|Period 1: Treatment Phase||235
11341298|NCT02931539|12538661|FG002|STARTED|Period 1: Treatment Phase||0
11341299|NCT02931539|12538659|FG000|Treated Participants|Period 1: Treatment Phase||116
11341300|NCT02931539|12538660|FG001|Treated Participants|Period 1: Treatment Phase||234
11341301|NCT02931539|12538661|FG002|Treated Participants|Period 1: Treatment Phase||0
11341302|NCT02931539|12538659|FG000|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||56
11341303|NCT02931539|12538660|FG001|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0
11341304|NCT02931539|12538661|FG002|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0
11341305|NCT02931539|12538659|FG000|IAT (Foscarnet)|Period 1: Treatment Phase||47
11341306|NCT02931539|12538660|FG001|IAT (Foscarnet)|Period 1: Treatment Phase||0
11341307|NCT02931539|12538661|FG002|IAT (Foscarnet)|Period 1: Treatment Phase||0
11341308|NCT02931539|12538659|FG000|IAT (Cidofovir)|Period 1: Treatment Phase||6
11341309|NCT02931539|12538660|FG001|IAT (Cidofovir)|Period 1: Treatment Phase||0
11341310|NCT02931539|12538661|FG002|IAT (Cidofovir)|Period 1: Treatment Phase||0
11341311|NCT02931539|12538659|FG000|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||7
11341312|NCT02931539|12538660|FG001|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0
11341313|NCT02931539|12538661|FG002|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0
11341314|NCT02931539|12538659|FG000|COMPLETED|Period 1: Treatment Phase||58
11341315|NCT02931539|12538660|FG001|COMPLETED|Period 1: Treatment Phase||199
11341316|NCT02931539|12538661|FG002|COMPLETED|Period 1: Treatment Phase||0
11341317|NCT02931539|12538659|FG000|NOT COMPLETED|Period 1: Treatment Phase||59
11341318|NCT02931539|12538660|FG001|NOT COMPLETED|Period 1: Treatment Phase||36
11341319|NCT02931539|12538661|FG002|NOT COMPLETED|Period 1: Treatment Phase||0
11341320|NCT02931539|12538659|FG000|STARTED|Period 2: Maribavir Rescue Therapy||0
11341321|NCT02931539|12538660|FG001|STARTED|Period 2: Maribavir Rescue Therapy||0
11341322|NCT02931539|12538661|FG002|STARTED|Period 2: Maribavir Rescue Therapy||22
11295325|NCT02523599|12493077|FG000|STARTED|Overall Study||204
11295326|NCT02523599|12493078|FG001|STARTED|Overall Study||101
11295327|NCT02523599|12493077|FG000|Randomized But Not Treated|Overall Study||1
11295328|NCT02523599|12493078|FG001|Randomized But Not Treated|Overall Study||0
11295329|NCT02523599|12493077|FG000|COMPLETED|Overall Study||196
11295330|NCT02523599|12493078|FG001|COMPLETED|Overall Study||100
11295331|NCT02523599|12493077|FG000|NOT COMPLETED|Overall Study||8
11295332|NCT02523599|12493078|FG001|NOT COMPLETED|Overall Study||1
11295333|NCT02523690|12493086|FG000|STARTED|Overall Study||3
11295334|NCT02523690|12493087|FG001|STARTED|Overall Study||2
11295335|NCT02523690|12493086|FG000|COMPLETED|Overall Study||3
11295336|NCT02523690|12493087|FG001|COMPLETED|Overall Study||2
11295337|NCT02523690|12493086|FG000|NOT COMPLETED|Overall Study||0
11295338|NCT02523690|12493087|FG001|NOT COMPLETED|Overall Study||0
11295339|NCT02523924|12493093|FG000|STARTED|Overall Study||31
11295340|NCT02523924|12493093|FG000|COMPLETED|Overall Study||31
11295341|NCT02523924|12493093|FG000|NOT COMPLETED|Overall Study||0
11295342|NCT02524054|12493099|FG000|STARTED|Overall Study||7
11295343|NCT02524054|12493100|FG001|STARTED|Overall Study||9
11295344|NCT02524054|12493101|FG002|STARTED|Overall Study||8
11295345|NCT02524054|12493099|FG000|COMPLETED|Overall Study||7
11295346|NCT02524054|12493100|FG001|COMPLETED|Overall Study||9
11295347|NCT02524054|12493101|FG002|COMPLETED|Overall Study||8
11295348|NCT02524054|12493099|FG000|NOT COMPLETED|Overall Study||0
11295349|NCT02524054|12493100|FG001|NOT COMPLETED|Overall Study||0
11295350|NCT02524054|12493101|FG002|NOT COMPLETED|Overall Study||0
11295351|NCT02524106|12493113|FG000|STARTED|Overall Study||6
11295352|NCT02524106|12493114|FG001|STARTED|Overall Study||5
11295353|NCT02524106|12493113|FG000|COMPLETED|Overall Study||6
11295354|NCT02524106|12493114|FG001|COMPLETED|Overall Study||5
11295355|NCT02524106|12493113|FG000|NOT COMPLETED|Overall Study||0
11295356|NCT02524106|12493114|FG001|NOT COMPLETED|Overall Study||0
11295357|NCT02524119|12493120|FG000|STARTED|Overall Study||5
11295358|NCT02524119|12493120|FG000|COMPLETED|Overall Study||5
11295359|NCT02524119|12493120|FG000|NOT COMPLETED|Overall Study||0
11295360|NCT02524145|12493127|FG000|STARTED|Overall Study||15
11295361|NCT02524145|12493128|FG001|STARTED|Overall Study||15
11295362|NCT02524145|12493129|FG002|STARTED|Overall Study||10
11295363|NCT02524145|12493127|FG000|COMPLETED|Overall Study||13
11295364|NCT02524145|12493128|FG001|COMPLETED|Overall Study||13
11295365|NCT02524145|12493129|FG002|COMPLETED|Overall Study||7
11295366|NCT02524145|12493127|FG000|NOT COMPLETED|Overall Study||2
11295367|NCT02524145|12493128|FG001|NOT COMPLETED|Overall Study||2
11295368|NCT02524145|12493129|FG002|NOT COMPLETED|Overall Study||3
11295369|NCT02524158|12493139|FG000|STARTED|12-weeks Assessment||76
11295370|NCT02524158|12493140|FG001|STARTED|12-weeks Assessment||76
11295371|NCT02524158|12493139|FG000|COMPLETED|12-weeks Assessment||57
11295372|NCT02524158|12493140|FG001|COMPLETED|12-weeks Assessment||63
11295373|NCT02524158|12493139|FG000|NOT COMPLETED|12-weeks Assessment||19
11295374|NCT02524158|12493140|FG001|NOT COMPLETED|12-weeks Assessment||13
11295375|NCT02524158|12493139|FG000|STARTED|6-month Assessment||76
11295376|NCT02524158|12493140|FG001|STARTED|6-month Assessment||76
11295377|NCT02524158|12493139|FG000|COMPLETED|6-month Assessment||54
11295378|NCT02524158|12493140|FG001|COMPLETED|6-month Assessment||55
11295379|NCT02524158|12493139|FG000|NOT COMPLETED|6-month Assessment||22
11295380|NCT02524158|12493140|FG001|NOT COMPLETED|6-month Assessment||21
11295381|NCT02524418|12493149|FG000|STARTED|Overall Study||88
11295382|NCT02524418|12493149|FG000|COMPLETED|Overall Study||75
11295383|NCT02524418|12493149|FG000|NOT COMPLETED|Overall Study||13
11295384|NCT02524561|12493159|FG000|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
11295385|NCT02524561|12493160|FG001|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
11295386|NCT02524561|12493161|FG002|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
11295387|NCT02524561|12493159|FG000|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
11295388|NCT02524561|12493160|FG001|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
11295389|NCT02524561|12493161|FG002|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
11295390|NCT02524561|12493159|FG000|COMPLETED|Baseline: Pre-randomization Mammogram||168
11295391|NCT02524561|12493160|FG001|COMPLETED|Baseline: Pre-randomization Mammogram||162
11295392|NCT02524561|12493161|FG002|COMPLETED|Baseline: Pre-randomization Mammogram||187
11295393|NCT02524561|12493159|FG000|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
11295394|NCT02524561|12493160|FG001|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
11295395|NCT02524561|12493161|FG002|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
11295396|NCT02524561|12493159|FG000|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
11400623|NCT04194151|12595297|FG002|STARTED|Overall Study||32
11295397|NCT02524561|12493160|FG001|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
11295398|NCT02524561|12493161|FG002|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
11295399|NCT02524561|12493159|FG000|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
11295400|NCT02524561|12493160|FG001|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
11295401|NCT02524561|12493161|FG002|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
11295402|NCT02524561|12493159|FG000|COMPLETED|Year 1: Post Randomization Mammograms||168
11295403|NCT02524561|12493160|FG001|COMPLETED|Year 1: Post Randomization Mammograms||162
11295404|NCT02524561|12493161|FG002|COMPLETED|Year 1: Post Randomization Mammograms||187
11295405|NCT02524561|12493159|FG000|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
11295406|NCT02524561|12493160|FG001|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
11295407|NCT02524561|12493161|FG002|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
11295408|NCT02524561|12493159|FG000|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
11295409|NCT02524561|12493160|FG001|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
11295410|NCT02524561|12493161|FG002|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
11295411|NCT02524561|12493159|FG000|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
11295412|NCT02524561|12493160|FG001|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
11295413|NCT02524561|12493161|FG002|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
11295414|NCT02524561|12493159|FG000|COMPLETED|Final: Year 3 or 4 Post-randomization||168
11295415|NCT02524561|12493160|FG001|COMPLETED|Final: Year 3 or 4 Post-randomization||162
11295416|NCT02524561|12493161|FG002|COMPLETED|Final: Year 3 or 4 Post-randomization||187
11295417|NCT02524561|12493159|FG000|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
11295418|NCT02524561|12493160|FG001|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
11295419|NCT02524561|12493161|FG002|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
11295420|NCT02524665|12493169|FG000|STARTED|Overall Study||20
11295421|NCT02524665|12493169|FG000|COMPLETED|Overall Study||19
11295422|NCT02524665|12493169|FG000|NOT COMPLETED|Overall Study||1
11295423|NCT02524730|12493174|FG000|STARTED|Overall Study||205
11295424|NCT02524730|12493174|FG000|COMPLETED|Overall Study||159
11295425|NCT02524730|12493174|FG000|NOT COMPLETED|Overall Study||46
11295426|NCT02524769|12493178|FG000|STARTED|Overall Study||27
11295427|NCT02524769|12493178|FG000|COMPLETED|Overall Study||17
11295428|NCT02524769|12493178|FG000|NOT COMPLETED|Overall Study||10
11295429|NCT02524847|12493182|FG000|STARTED|Overall Study||29
11295430|NCT02524847|12493182|FG000|Completed Treatment Up to Week 12|Overall Study||14
11295431|NCT02524847|12493182|FG000|Started Second Line Treatment|Overall Study||5
11295432|NCT02524847|12493182|FG000|COMPLETED|Overall Study||15
11295433|NCT02524847|12493182|FG000|NOT COMPLETED|Overall Study||14
11295434|NCT02524977|12493189|FG000|STARTED|Overall Study||738
11295435|NCT02524977|12493190|FG001|STARTED|Overall Study||846
11400624|NCT04194151|12595298|FG003|STARTED|Overall Study||32
11400625|NCT04194151|12595299|FG004|STARTED|Overall Study||32
11400626|NCT04194151|12595300|FG005|STARTED|Overall Study||32
11400627|NCT04194151|12595295|FG000|COMPLETED|Overall Study||31
11400628|NCT04194151|12595296|FG001|COMPLETED|Overall Study||30
11400629|NCT04194151|12595297|FG002|COMPLETED|Overall Study||31
11400630|NCT04194151|12595298|FG003|COMPLETED|Overall Study||31
11400631|NCT04194151|12595299|FG004|COMPLETED|Overall Study||32
11400632|NCT04194151|12595300|FG005|COMPLETED|Overall Study||31
11400633|NCT04194151|12595295|FG000|NOT COMPLETED|Overall Study||1
11400634|NCT04194151|12595296|FG001|NOT COMPLETED|Overall Study||2
11400635|NCT04194151|12595297|FG002|NOT COMPLETED|Overall Study||1
11400636|NCT04194151|12595298|FG003|NOT COMPLETED|Overall Study||1
11400637|NCT04194151|12595299|FG004|NOT COMPLETED|Overall Study||0
11400638|NCT04194151|12595300|FG005|NOT COMPLETED|Overall Study||1
11400639|NCT04194008|12595314|FG000|STARTED|Baseline (Run-in) Phase||126
11400640|NCT04194008|12595314|FG000|COMPLETED|Baseline (Run-in) Phase||99
11400641|NCT04194008|12595314|FG000|NOT COMPLETED|Baseline (Run-in) Phase||27
11400642|NCT04194008|12595314|FG000|STARTED|Treatment Phase With Nerivio||99
11400643|NCT04194008|12595314|FG000|COMPLETED|Treatment Phase With Nerivio||91
11400644|NCT04194008|12595314|FG000|NOT COMPLETED|Treatment Phase With Nerivio||8
11400645|NCT04191668|12595318|FG000|STARTED|Overall Study||106
11400646|NCT04191668|12595318|FG000|COMPLETED|Overall Study||106
11400647|NCT04191668|12595318|FG000|NOT COMPLETED|Overall Study||0
11400648|NCT04189081|12595325|FG000|STARTED|Overall Study||46
11400649|NCT04189081|12595326|FG001|STARTED|Overall Study||45
11400650|NCT04189081|12595327|FG002|STARTED|Overall Study||46
11400651|NCT04189081|12595325|FG000|COMPLETED|Overall Study||45
11400652|NCT04189081|12595326|FG001|COMPLETED|Overall Study||45
11400653|NCT04189081|12595327|FG002|COMPLETED|Overall Study||45
11400654|NCT04189081|12595325|FG000|NOT COMPLETED|Overall Study||1
11400655|NCT04189081|12595326|FG001|NOT COMPLETED|Overall Study||0
11400656|NCT04189081|12595327|FG002|NOT COMPLETED|Overall Study||1
11400657|NCT04186780|12595337|FG000|STARTED|Overall Study||36
11400658|NCT04186780|12595338|FG001|STARTED|Overall Study||32
11295436|NCT02524977|12493189|FG000|COMPLETED|Overall Study||692
11295437|NCT02524977|12493190|FG001|COMPLETED|Overall Study||801
11295438|NCT02524977|12493189|FG000|NOT COMPLETED|Overall Study||46
11295439|NCT02524977|12493190|FG001|NOT COMPLETED|Overall Study||45
11295440|NCT02525055|12493204|FG000|STARTED|Overall Study||6
11295441|NCT02525055|12493205|FG001|STARTED|Overall Study||6
11295442|NCT02525055|12493206|FG002|STARTED|Overall Study||6
11295443|NCT02525055|12493207|FG003|STARTED|Overall Study||6
11295444|NCT02525055|12493208|FG004|STARTED|Overall Study||6
11295445|NCT02525055|12493209|FG005|STARTED|Overall Study||16
11295446|NCT02525055|12493204|FG000|COMPLETED|Overall Study||6
11295447|NCT02525055|12493205|FG001|COMPLETED|Overall Study||6
11295448|NCT02525055|12493206|FG002|COMPLETED|Overall Study||6
11295449|NCT02525055|12493207|FG003|COMPLETED|Overall Study||6
11295450|NCT02525055|12493208|FG004|COMPLETED|Overall Study||6
11295451|NCT02525055|12493209|FG005|COMPLETED|Overall Study||16
11295452|NCT02525055|12493204|FG000|NOT COMPLETED|Overall Study||0
11295453|NCT02525055|12493205|FG001|NOT COMPLETED|Overall Study||0
11295454|NCT02525055|12493206|FG002|NOT COMPLETED|Overall Study||0
11295455|NCT02525055|12493207|FG003|NOT COMPLETED|Overall Study||0
11295456|NCT02525055|12493208|FG004|NOT COMPLETED|Overall Study||0
11295457|NCT02525055|12493209|FG005|NOT COMPLETED|Overall Study||0
11295458|NCT02525094|12493225|FG000|STARTED|Overall Study||57
11295459|NCT02525094|12493226|FG001|STARTED|Overall Study||56
11295460|NCT02525094|12493225|FG000|Treated|Overall Study||56
11295461|NCT02525094|12493226|FG001|Treated|Overall Study||55
11295462|NCT02525094|12493225|FG000|COMPLETED|Overall Study||49
11295463|NCT02525094|12493226|FG001|COMPLETED|Overall Study||48
11295464|NCT02525094|12493225|FG000|NOT COMPLETED|Overall Study||8
11295465|NCT02525094|12493226|FG001|NOT COMPLETED|Overall Study||8
11295466|NCT02525133|12493235|FG000|STARTED|Overall Study||213
11295467|NCT02525133|12493236|FG001|STARTED|Overall Study||106
11295468|NCT02525133|12493235|FG000|Randomized But Not Treated|Overall Study||4
11295469|NCT02525133|12493236|FG001|Randomized But Not Treated|Overall Study||0
11295470|NCT02525133|12493235|FG000|COMPLETED|Overall Study||203
11295471|NCT02525133|12493236|FG001|COMPLETED|Overall Study||103
11295472|NCT02525133|12493235|FG000|NOT COMPLETED|Overall Study||10
11295473|NCT02525133|12493236|FG001|NOT COMPLETED|Overall Study||3
11295474|NCT02525263|12493242|FG000|STARTED|Overall Study|The single patient in this trial was enrolled on 18 July 2016.|1
11295475|NCT02525263|12493242|FG000|COMPLETED|Overall Study|The trial was completed when the patient reached the specified endpoint of starting hemodialysis.|1
11295476|NCT02525263|12493242|FG000|NOT COMPLETED|Overall Study||0
11295477|NCT02525471|12493248|FG000|STARTED|Overall Study||24
11295478|NCT02525471|12493248|FG000|Randomized/Treated|Overall Study||16
11295479|NCT02525471|12493248|FG000|COMPLETED|Overall Study||13
11295480|NCT02525471|12493248|FG000|NOT COMPLETED|Overall Study||11
11295481|NCT02525523|12493255|FG000|STARTED|Overall Study||69
11295482|NCT02525523|12493256|FG001|STARTED|Overall Study||69
11295483|NCT02525523|12493255|FG000|COMPLETED|Overall Study||46
11295484|NCT02525523|12493256|FG001|COMPLETED|Overall Study||44
11295485|NCT02525523|12493255|FG000|NOT COMPLETED|Overall Study||23
11295486|NCT02525523|12493256|FG001|NOT COMPLETED|Overall Study||25
11295487|NCT02525536|12493265|FG000|STARTED|Overall Study||6
11295488|NCT02525536|12493266|FG001|STARTED|Overall Study||6
11295489|NCT02525536|12493267|FG002|STARTED|Overall Study||6
11295490|NCT02525536|12493265|FG000|COMPLETED|Overall Study||6
11295491|NCT02525536|12493266|FG001|COMPLETED|Overall Study||6
11295492|NCT02525536|12493267|FG002|COMPLETED|Overall Study||6
11295493|NCT02525536|12493265|FG000|NOT COMPLETED|Overall Study||0
11295494|NCT02525536|12493266|FG001|NOT COMPLETED|Overall Study||0
11295495|NCT02525536|12493267|FG002|NOT COMPLETED|Overall Study||0
11295496|NCT02525549|12493278|FG000|STARTED|Overall Study||365
11295497|NCT02525549|12493279|FG001|STARTED|Overall Study||360
11295498|NCT02525549|12493280|FG002|STARTED|Overall Study||178
11295499|NCT02525549|12493278|FG000|COMPLETED|Overall Study||330
11295500|NCT02525549|12493279|FG001|COMPLETED|Overall Study||307
11295501|NCT02525549|12493280|FG002|COMPLETED|Overall Study||159
11295502|NCT02525549|12493278|FG000|NOT COMPLETED|Overall Study||35
11295503|NCT02525549|12493279|FG001|NOT COMPLETED|Overall Study||53
11295504|NCT02525549|12493280|FG002|NOT COMPLETED|Overall Study||19
11295505|NCT02525575|12493288|FG000|STARTED|Overall Study||37
11295506|NCT02525575|12493288|FG000|COMPLETED|Overall Study||22
11295507|NCT02525575|12493288|FG000|NOT COMPLETED|Overall Study||15
11295508|NCT02525588|12493294|FG000|STARTED|Overall Study||48
11295509|NCT02525588|12493295|FG001|STARTED|Overall Study||48
11295510|NCT02525588|12493294|FG000|COMPLETED|Overall Study||42
11295511|NCT02525588|12493295|FG001|COMPLETED|Overall Study||45
11295512|NCT02525588|12493294|FG000|NOT COMPLETED|Overall Study||6
11295513|NCT02525588|12493295|FG001|NOT COMPLETED|Overall Study||3
11295514|NCT02525627|12493303|FG000|STARTED|Overall Study||16
11295515|NCT02525627|12493304|FG001|STARTED|Overall Study||18
11295516|NCT02525627|12493303|FG000|COMPLETED|Overall Study||2
11295517|NCT02525627|12493304|FG001|COMPLETED|Overall Study||5
11295518|NCT02525627|12493303|FG000|NOT COMPLETED|Overall Study||14
11295519|NCT02525627|12493304|FG001|NOT COMPLETED|Overall Study||13
11295520|NCT02525653|12493310|FG000|STARTED|Overall Study||40
11295521|NCT02525653|12493310|FG000|COMPLETED|Overall Study||40
11295522|NCT02525653|12493310|FG000|NOT COMPLETED|Overall Study||0
11295523|NCT02525718|12493316|FG000|STARTED|Overall Study||23
11295524|NCT02525718|12493317|FG001|STARTED|Overall Study||24
11295525|NCT02525718|12493316|FG000|COMPLETED|Overall Study||22
11295526|NCT02525718|12493317|FG001|COMPLETED|Overall Study||23
11295527|NCT02525718|12493316|FG000|NOT COMPLETED|Overall Study||1
11295528|NCT02525718|12493317|FG001|NOT COMPLETED|Overall Study||1
11295529|NCT02525744|12493323|FG000|STARTED|Period 1||6
11295530|NCT02525744|12493324|FG001|STARTED|Period 1||6
11295531|NCT02525744|12493325|FG002|STARTED|Period 1||6
11400659|NCT04186780|12595337|FG000|COMPLETED|Overall Study||22
11295532|NCT02525744|12493326|FG003|STARTED|Period 1||6
11295533|NCT02525744|12493323|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
11400660|NCT04186780|12595338|FG001|COMPLETED|Overall Study||25
11400661|NCT04186780|12595337|FG000|NOT COMPLETED|Overall Study||14
11400662|NCT04186780|12595338|FG001|NOT COMPLETED|Overall Study||7
11400663|NCT04186806|12595348|FG000|STARTED|Period 1: 7 Days||20
11295534|NCT02525744|12493324|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
11295535|NCT02525744|12493325|FG002|Received at Least 1 Dose of Study Drug|Period 1||5
11295536|NCT02525744|12493326|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
11295537|NCT02525744|12493323|FG000|COMPLETED|Period 1||6
11295538|NCT02525744|12493324|FG001|COMPLETED|Period 1||6
11295539|NCT02525744|12493325|FG002|COMPLETED|Period 1||5
11295540|NCT02525744|12493326|FG003|COMPLETED|Period 1||6
11295541|NCT02525744|12493323|FG000|NOT COMPLETED|Period 1||0
11295542|NCT02525744|12493324|FG001|NOT COMPLETED|Period 1||0
11295543|NCT02525744|12493325|FG002|NOT COMPLETED|Period 1||1
11295544|NCT02525744|12493326|FG003|NOT COMPLETED|Period 1||0
11295545|NCT02525744|12493323|FG000|STARTED|Period 2||6
11295546|NCT02525744|12493324|FG001|STARTED|Period 2||6
11295547|NCT02525744|12493325|FG002|STARTED|Period 2||5
11295548|NCT02525744|12493326|FG003|STARTED|Period 2||6
11295549|NCT02525744|12493323|FG000|Received at Least 1 Dose of Study Drug|Period 2||6
11295550|NCT02525744|12493324|FG001|Received at Least 1 Dose of Study Drug|Period 2||6
11295551|NCT02525744|12493325|FG002|Received at Least 1 Dose of Study Drug|Period 2||5
11295552|NCT02525744|12493326|FG003|Received at Least 1 Dose of Study Drug|Period 2||6
11295553|NCT02525744|12493323|FG000|COMPLETED|Period 2||6
11295554|NCT02525744|12493324|FG001|COMPLETED|Period 2||6
11295555|NCT02525744|12493325|FG002|COMPLETED|Period 2||5
11295556|NCT02525744|12493326|FG003|COMPLETED|Period 2||6
11295557|NCT02525744|12493323|FG000|NOT COMPLETED|Period 2||0
11295558|NCT02525744|12493324|FG001|NOT COMPLETED|Period 2||0
11295559|NCT02525744|12493325|FG002|NOT COMPLETED|Period 2||0
11295560|NCT02525744|12493326|FG003|NOT COMPLETED|Period 2||0
11295561|NCT02525744|12493323|FG000|STARTED|Period 3||6
11295562|NCT02525744|12493324|FG001|STARTED|Period 3||6
11295563|NCT02525744|12493325|FG002|STARTED|Period 3||5
11295564|NCT02525744|12493326|FG003|STARTED|Period 3||6
11295565|NCT02525744|12493323|FG000|Received at Least 1 Dose of Study Drug|Period 3||6
11295566|NCT02525744|12493324|FG001|Received at Least 1 Dose of Study Drug|Period 3||6
11295567|NCT02525744|12493325|FG002|Received at Least 1 Dose of Study Drug|Period 3||5
11295568|NCT02525744|12493326|FG003|Received at Least 1 Dose of Study Drug|Period 3||6
11295569|NCT02525744|12493323|FG000|COMPLETED|Period 3||6
11295570|NCT02525744|12493324|FG001|COMPLETED|Period 3||5
11295571|NCT02525744|12493325|FG002|COMPLETED|Period 3||5
11295572|NCT02525744|12493326|FG003|COMPLETED|Period 3||6
11295573|NCT02525744|12493323|FG000|NOT COMPLETED|Period 3||0
11295574|NCT02525744|12493324|FG001|NOT COMPLETED|Period 3||1
11295575|NCT02525744|12493325|FG002|NOT COMPLETED|Period 3||0
11295576|NCT02525744|12493326|FG003|NOT COMPLETED|Period 3||0
11295577|NCT02525744|12493323|FG000|STARTED|Period 4||6
11295578|NCT02525744|12493324|FG001|STARTED|Period 4||5
11295579|NCT02525744|12493325|FG002|STARTED|Period 4||5
11295580|NCT02525744|12493326|FG003|STARTED|Period 4||6
11295581|NCT02525744|12493323|FG000|Received at Least 1 Dose of Study Drug|Period 4||6
11295582|NCT02525744|12493324|FG001|Received at Least 1 Dose of Study Drug|Period 4||5
11295583|NCT02525744|12493325|FG002|Received at Least 1 Dose of Study Drug|Period 4||5
11295584|NCT02525744|12493326|FG003|Received at Least 1 Dose of Study Drug|Period 4||6
11295585|NCT02525744|12493323|FG000|COMPLETED|Period 4||5
11295586|NCT02525744|12493324|FG001|COMPLETED|Period 4||5
11295587|NCT02525744|12493325|FG002|COMPLETED|Period 4||5
11295588|NCT02525744|12493326|FG003|COMPLETED|Period 4||6
11295589|NCT02525744|12493323|FG000|NOT COMPLETED|Period 4||1
11400664|NCT04186806|12595349|FG001|STARTED|Period 1: 7 Days||20
11295590|NCT02525744|12493324|FG001|NOT COMPLETED|Period 4||0
11295591|NCT02525744|12493325|FG002|NOT COMPLETED|Period 4||0
11295592|NCT02525744|12493326|FG003|NOT COMPLETED|Period 4||0
11295593|NCT02525744|12493323|FG000|STARTED|Period 5||5
11295594|NCT02525744|12493324|FG001|STARTED|Period 5||5
11295595|NCT02525744|12493325|FG002|STARTED|Period 5||5
11295596|NCT02525744|12493326|FG003|STARTED|Period 5||6
11295597|NCT02525744|12493323|FG000|Received at Least 1 Dose of Study Drug|Period 5||4
11295598|NCT02525744|12493324|FG001|Received at Least 1 Dose of Study Drug|Period 5||5
11295599|NCT02525744|12493325|FG002|Received at Least 1 Dose of Study Drug|Period 5||5
11295600|NCT02525744|12493326|FG003|Received at Least 1 Dose of Study Drug|Period 5||6
11295601|NCT02525744|12493323|FG000|COMPLETED|Period 5||4
11295602|NCT02525744|12493324|FG001|COMPLETED|Period 5||5
11295603|NCT02525744|12493325|FG002|COMPLETED|Period 5||5
11295604|NCT02525744|12493326|FG003|COMPLETED|Period 5||6
11295605|NCT02525744|12493323|FG000|NOT COMPLETED|Period 5||1
11295606|NCT02525744|12493324|FG001|NOT COMPLETED|Period 5||0
11295607|NCT02525744|12493325|FG002|NOT COMPLETED|Period 5||0
11295608|NCT02525744|12493326|FG003|NOT COMPLETED|Period 5||0
11295609|NCT02525861|12493338|FG000|STARTED|Overall Study||18
11295610|NCT02525861|12493339|FG001|STARTED|Overall Study||16
11295611|NCT02525861|12493338|FG000|COMPLETED|Overall Study||17
11295612|NCT02525861|12493339|FG001|COMPLETED|Overall Study||14
11295613|NCT02525861|12493338|FG000|NOT COMPLETED|Overall Study||1
11295614|NCT02525861|12493339|FG001|NOT COMPLETED|Overall Study||2
11295615|NCT02525874|12493347|FG000|STARTED|Overall Study||218
11295616|NCT02525874|12493347|FG000|COMPLETED|Overall Study||158
11295617|NCT02525874|12493347|FG000|NOT COMPLETED|Overall Study||60
11295618|NCT02526160|12493353|FG000|STARTED|Double-Blind (Placebo-Controlled) Period||66
11295619|NCT02526160|12493354|FG001|STARTED|Double-Blind (Placebo-Controlled) Period||68
11295620|NCT02526160|12493353|FG000|COMPLETED|Double-Blind (Placebo-Controlled) Period||66
11295621|NCT02526160|12493354|FG001|COMPLETED|Double-Blind (Placebo-Controlled) Period||67
11295622|NCT02526160|12493353|FG000|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||0
11295623|NCT02526160|12493354|FG001|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||1
11295624|NCT02526160|12493353|FG000|STARTED|Open-label Treatment Continuation Period||66
11295625|NCT02526160|12493354|FG001|STARTED|Open-label Treatment Continuation Period||67
11295626|NCT02526160|12493353|FG000|COMPLETED|Open-label Treatment Continuation Period||63
11295627|NCT02526160|12493354|FG001|COMPLETED|Open-label Treatment Continuation Period||63
11295628|NCT02526160|12493353|FG000|NOT COMPLETED|Open-label Treatment Continuation Period||3
11295629|NCT02526160|12493354|FG001|NOT COMPLETED|Open-label Treatment Continuation Period||4
11295630|NCT02526160|12493353|FG000|STARTED|Open-Label Treatment Extension Period I||63
11295631|NCT02526160|12493354|FG001|STARTED|Open-Label Treatment Extension Period I||63
11295632|NCT02526160|12493353|FG000|COMPLETED|Open-Label Treatment Extension Period I||60
11295633|NCT02526160|12493354|FG001|COMPLETED|Open-Label Treatment Extension Period I||59
11295634|NCT02526160|12493353|FG000|NOT COMPLETED|Open-Label Treatment Extension Period I||3
11295635|NCT02526160|12493354|FG001|NOT COMPLETED|Open-Label Treatment Extension Period I||4
11295636|NCT02526160|12493353|FG000|STARTED|Open-Label Treatment Extension Period II||52
11295637|NCT02526160|12493354|FG001|STARTED|Open-Label Treatment Extension Period II||49
11295638|NCT02526160|12493353|FG000|COMPLETED|Open-Label Treatment Extension Period II||51
11295639|NCT02526160|12493354|FG001|COMPLETED|Open-Label Treatment Extension Period II||49
11295640|NCT02526160|12493353|FG000|NOT COMPLETED|Open-Label Treatment Extension Period II||1
11295641|NCT02526160|12493354|FG001|NOT COMPLETED|Open-Label Treatment Extension Period II||0
11295642|NCT02526212|12493367|FG000|STARTED|Overall Study||10
11295643|NCT02526212|12493368|FG001|STARTED|Overall Study||8
11295644|NCT02526212|12493367|FG000|COMPLETED|Overall Study||8
11295645|NCT02526212|12493368|FG001|COMPLETED|Overall Study||7
11295646|NCT02526212|12493367|FG000|NOT COMPLETED|Overall Study||2
11295647|NCT02526212|12493368|FG001|NOT COMPLETED|Overall Study||1
11295648|NCT02526277|12493378|FG000|STARTED|Overall Study||8
11295649|NCT02526277|12493379|FG001|STARTED|Overall Study||6
11295650|NCT02526277|12493380|FG002|STARTED|Overall Study||7
11295651|NCT02526277|12493381|FG003|STARTED|Overall Study||7
11295652|NCT02526277|12493378|FG000|COMPLETED|Overall Study||8
11295653|NCT02526277|12493379|FG001|COMPLETED|Overall Study||6
11295654|NCT02526277|12493380|FG002|COMPLETED|Overall Study||7
11295655|NCT02526277|12493381|FG003|COMPLETED|Overall Study||7
11295656|NCT02526277|12493378|FG000|NOT COMPLETED|Overall Study||0
11295657|NCT02526277|12493379|FG001|NOT COMPLETED|Overall Study||0
11295658|NCT02526277|12493380|FG002|NOT COMPLETED|Overall Study||0
11295659|NCT02526277|12493381|FG003|NOT COMPLETED|Overall Study||0
11295660|NCT02526290|12493394|FG000|STARTED|Overall Study||97
11295661|NCT02526290|12493394|FG000|COMPLETED|Overall Study||89
11295662|NCT02526290|12493394|FG000|NOT COMPLETED|Overall Study||8
11295663|NCT02526524|12493404|FG000|STARTED|Overall Study||94
11295664|NCT02526524|12493405|FG001|STARTED|Overall Study||95
11295665|NCT02526524|12493406|FG002|STARTED|Overall Study||96
11295666|NCT02526524|12493407|FG003|STARTED|Overall Study||96
11295667|NCT02526524|12493408|FG004|STARTED|Overall Study||96
11295668|NCT02526524|12493409|FG005|STARTED|Overall Study||94
11295669|NCT02526524|12493404|FG000|COMPLETED|Overall Study||82
11295670|NCT02526524|12493405|FG001|COMPLETED|Overall Study||86
11295671|NCT02526524|12493406|FG002|COMPLETED|Overall Study||70
11295672|NCT02526524|12493407|FG003|COMPLETED|Overall Study||89
11295673|NCT02526524|12493408|FG004|COMPLETED|Overall Study||72
11295674|NCT02526524|12493409|FG005|COMPLETED|Overall Study||73
11295675|NCT02526524|12493404|FG000|NOT COMPLETED|Overall Study||12
11295676|NCT02526524|12493405|FG001|NOT COMPLETED|Overall Study||9
11295677|NCT02526524|12493406|FG002|NOT COMPLETED|Overall Study||26
11295678|NCT02526524|12493407|FG003|NOT COMPLETED|Overall Study||7
11400665|NCT04186806|12595348|FG000|COMPLETED|Period 1: 7 Days||19
11400666|NCT04186806|12595349|FG001|COMPLETED|Period 1: 7 Days||20
11400667|NCT04186806|12595348|FG000|NOT COMPLETED|Period 1: 7 Days||1
11295679|NCT02526524|12493408|FG004|NOT COMPLETED|Overall Study||24
11295680|NCT02526524|12493409|FG005|NOT COMPLETED|Overall Study||21
11295681|NCT02526550|12493423|FG000|STARTED|Overall Study||50
11295682|NCT02526550|12493423|FG000|COMPLETED|Overall Study||49
11295683|NCT02526550|12493423|FG000|NOT COMPLETED|Overall Study||1
11295684|NCT02526654|12493429|FG000|STARTED|Overall Study||79
11295685|NCT02526654|12493430|FG001|STARTED|Overall Study||36
11295686|NCT02526654|12493429|FG000|COMPLETED|Overall Study||79
11295687|NCT02526654|12493430|FG001|COMPLETED|Overall Study||36
11295688|NCT02526654|12493429|FG000|NOT COMPLETED|Overall Study||0
11295689|NCT02526654|12493430|FG001|NOT COMPLETED|Overall Study||0
11295690|NCT02526667|12493439|FG000|STARTED|Abdomen||284
11295691|NCT02526667|12493440|FG001|STARTED|Abdomen||56
11295692|NCT02526667|12493441|FG002|STARTED|Abdomen||281
11295693|NCT02526667|12493439|FG000|COMPLETED|Abdomen||284
11295694|NCT02526667|12493440|FG001|COMPLETED|Abdomen||56
11295695|NCT02526667|12493441|FG002|COMPLETED|Abdomen||281
11295696|NCT02526667|12493439|FG000|NOT COMPLETED|Abdomen||0
11295697|NCT02526667|12493440|FG001|NOT COMPLETED|Abdomen||0
11295698|NCT02526667|12493441|FG002|NOT COMPLETED|Abdomen||0
11295699|NCT02526667|12493439|FG000|STARTED|Groin||290
11295700|NCT02526667|12493440|FG001|STARTED|Groin||56
11295701|NCT02526667|12493441|FG002|STARTED|Groin||294
11295702|NCT02526667|12493439|FG000|COMPLETED|Groin||290
11295703|NCT02526667|12493440|FG001|COMPLETED|Groin||56
11295704|NCT02526667|12493441|FG002|COMPLETED|Groin||294
11295705|NCT02526667|12493439|FG000|NOT COMPLETED|Groin||0
11400668|NCT04186806|12595349|FG001|NOT COMPLETED|Period 1: 7 Days||0
11295706|NCT02526667|12493440|FG001|NOT COMPLETED|Groin||0
11295707|NCT02526667|12493441|FG002|NOT COMPLETED|Groin||0
11295708|NCT02526680|12493455|FG000|STARTED|Overall Study||27
11295709|NCT02526680|12493455|FG000|COMPLETED|Overall Study||27
11295710|NCT02526680|12493455|FG000|NOT COMPLETED|Overall Study||0
11295711|NCT02526693|12493462|FG000|STARTED|Overall Study||53
11295712|NCT02526693|12493463|FG001|STARTED|Overall Study||51
11295713|NCT02526693|12493462|FG000|COMPLETED|Overall Study||50
11295714|NCT02526693|12493463|FG001|COMPLETED|Overall Study||50
11295715|NCT02526693|12493462|FG000|NOT COMPLETED|Overall Study||3
11295716|NCT02526693|12493463|FG001|NOT COMPLETED|Overall Study||1
11295717|NCT02527148|12493475|FG000|STARTED|Overall Study||50
11295718|NCT02527148|12493476|FG001|STARTED|Overall Study||50
11295719|NCT02527148|12493475|FG000|COMPLETED|Overall Study||49
11295720|NCT02527148|12493476|FG001|COMPLETED|Overall Study||50
11295721|NCT02527148|12493475|FG000|NOT COMPLETED|Overall Study||1
11295722|NCT02527148|12493476|FG001|NOT COMPLETED|Overall Study||0
11295723|NCT02527161|12493484|FG000|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|205
11295724|NCT02527161|12493484|FG000|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 5 year outcome interval.|73
11295725|NCT02527161|12493484|FG000|NOT COMPLETED|Overall Study||132
11295726|NCT02527265|12493491|FG000|STARTED|Overall Study||15
11295727|NCT02527265|12493492|FG001|STARTED|Overall Study||15
11295728|NCT02527265|12493491|FG000|COMPLETED|Overall Study||13
11295729|NCT02527265|12493492|FG001|COMPLETED|Overall Study||11
11295730|NCT02527265|12493491|FG000|NOT COMPLETED|Overall Study||2
11295731|NCT02527265|12493492|FG001|NOT COMPLETED|Overall Study||4
11295732|NCT02527343|12493500|FG000|STARTED|RT Period: Weeks 1 to 52||19
11295733|NCT02527343|12493501|FG001|STARTED|RT Period: Weeks 1 to 52||21
11295734|NCT02527343|12493502|FG002|STARTED|RT Period: Weeks 1 to 52||0
11295735|NCT02527343|12493503|FG003|STARTED|RT Period: Weeks 1 to 52||0
11295736|NCT02527343|12493504|FG004|STARTED|RT Period: Weeks 1 to 52||0
11295737|NCT02527343|12493505|FG005|STARTED|RT Period: Weeks 1 to 52||0
11295738|NCT02527343|12493500|FG000|COMPLETED|RT Period: Weeks 1 to 52||13
11295739|NCT02527343|12493501|FG001|COMPLETED|RT Period: Weeks 1 to 52||14
11295740|NCT02527343|12493502|FG002|COMPLETED|RT Period: Weeks 1 to 52||0
11295741|NCT02527343|12493503|FG003|COMPLETED|RT Period: Weeks 1 to 52||0
11295742|NCT02527343|12493504|FG004|COMPLETED|RT Period: Weeks 1 to 52||0
11295743|NCT02527343|12493505|FG005|COMPLETED|RT Period: Weeks 1 to 52||0
11295744|NCT02527343|12493500|FG000|NOT COMPLETED|RT Period: Weeks 1 to 52||6
11295745|NCT02527343|12493501|FG001|NOT COMPLETED|RT Period: Weeks 1 to 52||7
11295746|NCT02527343|12493502|FG002|NOT COMPLETED|RT Period: Weeks 1 to 52||0
11295747|NCT02527343|12493503|FG003|NOT COMPLETED|RT Period: Weeks 1 to 52||0
11295748|NCT02527343|12493504|FG004|NOT COMPLETED|RT Period: Weeks 1 to 52||0
11295749|NCT02527343|12493505|FG005|NOT COMPLETED|RT Period: Weeks 1 to 52||0
11295750|NCT02527343|12493500|FG000|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
11295751|NCT02527343|12493501|FG001|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
11295752|NCT02527343|12493502|FG002|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|7
11295753|NCT02527343|12493503|FG003|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|9
11295754|NCT02527343|12493504|FG004|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
11295755|NCT02527343|12493505|FG005|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
11295756|NCT02527343|12493500|FG000|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
11295757|NCT02527343|12493501|FG001|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
11295758|NCT02527343|12493502|FG002|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||6
11295759|NCT02527343|12493503|FG003|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||7
11295760|NCT02527343|12493504|FG004|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
11295761|NCT02527343|12493505|FG005|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
11295762|NCT02527343|12493500|FG000|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
11295763|NCT02527343|12493501|FG001|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
11295764|NCT02527343|12493502|FG002|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||1
11295765|NCT02527343|12493503|FG003|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||2
11295766|NCT02527343|12493504|FG004|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
11295767|NCT02527343|12493505|FG005|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
11295768|NCT02527343|12493500|FG000|STARTED|OLE Period-Year 1: Week 53 to 104||0
11295769|NCT02527343|12493501|FG001|STARTED|OLE Period-Year 1: Week 53 to 104||0
11295770|NCT02527343|12493502|FG002|STARTED|OLE Period-Year 1: Week 53 to 104||0
11295771|NCT02527343|12493503|FG003|STARTED|OLE Period-Year 1: Week 53 to 104||0
11295772|NCT02527343|12493504|FG004|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12
11295773|NCT02527343|12493505|FG005|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12
11295774|NCT02527343|12493500|FG000|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
11295775|NCT02527343|12493501|FG001|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
11295776|NCT02527343|12493502|FG002|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
11295777|NCT02527343|12493503|FG003|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
11295778|NCT02527343|12493504|FG004|COMPLETED|OLE Period-Year 1: Week 53 to 104||1
11295779|NCT02527343|12493505|FG005|COMPLETED|OLE Period-Year 1: Week 53 to 104||3
11295780|NCT02527343|12493500|FG000|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
11295781|NCT02527343|12493501|FG001|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
11295782|NCT02527343|12493502|FG002|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
11295783|NCT02527343|12493503|FG003|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
11295784|NCT02527343|12493504|FG004|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||11
11295785|NCT02527343|12493505|FG005|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||9
11295786|NCT02527343|12493500|FG000|STARTED|OLE Period-Year 2: Week 105 to 156||0
11295787|NCT02527343|12493501|FG001|STARTED|OLE Period-Year 2: Week 105 to 156||0
11295788|NCT02527343|12493502|FG002|STARTED|OLE Period-Year 2: Week 105 to 156||0
11295789|NCT02527343|12493503|FG003|STARTED|OLE Period-Year 2: Week 105 to 156||0
11295790|NCT02527343|12493504|FG004|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|1
11295791|NCT02527343|12493505|FG005|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|2
11295792|NCT02527343|12493500|FG000|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
11295793|NCT02527343|12493501|FG001|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
11295794|NCT02527343|12493502|FG002|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
11295795|NCT02527343|12493503|FG003|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
11295796|NCT02527343|12493504|FG004|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
11295797|NCT02527343|12493505|FG005|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
11295798|NCT02527343|12493500|FG000|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
11295799|NCT02527343|12493501|FG001|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
11295800|NCT02527343|12493502|FG002|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
11295801|NCT02527343|12493503|FG003|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
11295802|NCT02527343|12493504|FG004|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||1
11295803|NCT02527343|12493505|FG005|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||2
11295804|NCT02527343|12493500|FG000|STARTED|PT Follow-up: Weeks 104 to 169||0
11295805|NCT02527343|12493501|FG001|STARTED|PT Follow-up: Weeks 104 to 169||0
11295806|NCT02527343|12493502|FG002|STARTED|PT Follow-up: Weeks 104 to 169||0
11400669|NCT04186806|12595348|FG000|STARTED|Washout Period: at Least 2 Days||19
11400670|NCT04186806|12595349|FG001|STARTED|Washout Period: at Least 2 Days||20
11400671|NCT04186806|12595348|FG000|COMPLETED|Washout Period: at Least 2 Days||19
11400672|NCT04186806|12595349|FG001|COMPLETED|Washout Period: at Least 2 Days||20
11400673|NCT04186806|12595348|FG000|NOT COMPLETED|Washout Period: at Least 2 Days||0
11400674|NCT04186806|12595349|FG001|NOT COMPLETED|Washout Period: at Least 2 Days||0
11400675|NCT04186806|12595348|FG000|STARTED|Period 2: 7 Days||19
11295807|NCT02527343|12493503|FG003|STARTED|PT Follow-up: Weeks 104 to 169||0
11295808|NCT02527343|12493504|FG004|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12
11295809|NCT02527343|12493505|FG005|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12
11295810|NCT02527343|12493500|FG000|COMPLETED|PT Follow-up: Weeks 104 to 169||0
11295811|NCT02527343|12493501|FG001|COMPLETED|PT Follow-up: Weeks 104 to 169||0
11400676|NCT04186806|12595349|FG001|STARTED|Period 2: 7 Days||20
11295812|NCT02527343|12493502|FG002|COMPLETED|PT Follow-up: Weeks 104 to 169||0
11295813|NCT02527343|12493503|FG003|COMPLETED|PT Follow-up: Weeks 104 to 169||0
11295814|NCT02527343|12493504|FG004|COMPLETED|PT Follow-up: Weeks 104 to 169||11
11295815|NCT02527343|12493505|FG005|COMPLETED|PT Follow-up: Weeks 104 to 169||11
11295816|NCT02527343|12493500|FG000|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
11295817|NCT02527343|12493501|FG001|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
11295818|NCT02527343|12493502|FG002|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
11295819|NCT02527343|12493503|FG003|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
11295820|NCT02527343|12493504|FG004|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1
11295821|NCT02527343|12493505|FG005|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1
11295822|NCT02527421|12493522|FG000|STARTED|Overall Study||2
11295823|NCT02527421|12493523|FG001|STARTED|Overall Study||1
11295824|NCT02527421|12493522|FG000|COMPLETED|Overall Study||1
11295825|NCT02527421|12493523|FG001|COMPLETED|Overall Study||1
11295826|NCT02527421|12493522|FG000|NOT COMPLETED|Overall Study||1
11295827|NCT02527421|12493523|FG001|NOT COMPLETED|Overall Study||0
11295828|NCT02527512|12493531|FG000|STARTED|Overall Study||85
11295829|NCT02527512|12493532|FG001|STARTED|Overall Study||82
11295830|NCT02527512|12493531|FG000|COMPLETED|Overall Study||77
11295831|NCT02527512|12493532|FG001|COMPLETED|Overall Study||76
11295832|NCT02527512|12493531|FG000|NOT COMPLETED|Overall Study||8
11295833|NCT02527512|12493532|FG001|NOT COMPLETED|Overall Study||6
11295834|NCT02527694|12493544|FG000|STARTED|Overall Study||20
11295835|NCT02527694|12493545|FG001|STARTED|Overall Study||29
11295836|NCT02527694|12493544|FG000|COMPLETED|Overall Study||10
11295837|NCT02527694|12493545|FG001|COMPLETED|Overall Study||21
11295838|NCT02527694|12493544|FG000|NOT COMPLETED|Overall Study||10
11295839|NCT02527694|12493545|FG001|NOT COMPLETED|Overall Study||8
11295840|NCT02528188|12493556|FG000|STARTED|Overall Study||1008
11295841|NCT02528188|12493557|FG001|STARTED|Overall Study||1005
11295842|NCT02528188|12493558|FG002|STARTED|Overall Study||1008
11295843|NCT02528188|12493556|FG000|Treated|Overall Study||1002
11295844|NCT02528188|12493557|FG001|Treated|Overall Study||998
11295845|NCT02528188|12493558|FG002|Treated|Overall Study||996
11295846|NCT02528188|12493556|FG000|COMPLETED|Overall Study||741
11295847|NCT02528188|12493557|FG001|COMPLETED|Overall Study||729
11295848|NCT02528188|12493558|FG002|COMPLETED|Overall Study||757
11400677|NCT04186806|12595348|FG000|COMPLETED|Period 2: 7 Days||19
11400678|NCT04186806|12595349|FG001|COMPLETED|Period 2: 7 Days||20
11400679|NCT04186806|12595348|FG000|NOT COMPLETED|Period 2: 7 Days||0
11295849|NCT02528188|12493556|FG000|NOT COMPLETED|Overall Study||267
11295850|NCT02528188|12493557|FG001|NOT COMPLETED|Overall Study||276
11295851|NCT02528188|12493558|FG002|NOT COMPLETED|Overall Study||251
11295852|NCT02528214|12493568|FG000|STARTED|Overall Study||107
11295853|NCT02528214|12493569|FG001|STARTED|Overall Study||103
11295854|NCT02528214|12493568|FG000|Treated|Overall Study||107
11295855|NCT02528214|12493569|FG001|Treated|Overall Study||103
11295856|NCT02528214|12493568|FG000|COMPLETED|Overall Study||107
11295857|NCT02528214|12493569|FG001|COMPLETED|Overall Study||100
11295858|NCT02528214|12493568|FG000|NOT COMPLETED|Overall Study||0
11295859|NCT02528214|12493569|FG001|NOT COMPLETED|Overall Study||3
11295860|NCT02528253|12493581|FG000|STARTED|Overall Study||205
11295861|NCT02528253|12493582|FG001|STARTED|Overall Study||204
11295862|NCT02528253|12493583|FG002|STARTED|Overall Study||407
11295863|NCT02528253|12493584|FG003|STARTED|Overall Study||407
11295864|NCT02528253|12493585|FG004|STARTED|Overall Study||602
11295865|NCT02528253|12493581|FG000|Intent to Treat Population|Overall Study||202
11295866|NCT02528253|12493582|FG001|Intent to Treat Population|Overall Study||204
11295867|NCT02528253|12493583|FG002|Intent to Treat Population|Overall Study||407
11295868|NCT02528253|12493584|FG003|Intent to Treat Population|Overall Study||407
11295869|NCT02528253|12493585|FG004|Intent to Treat Population|Overall Study|3 participants randomized to placebo arm received tramadol during the course of study|605
11295870|NCT02528253|12493581|FG000|Treated at Week 16|Overall Study||99
11295871|NCT02528253|12493582|FG001|Treated at Week 16|Overall Study||95
11295872|NCT02528253|12493583|FG002|Treated at Week 16|Overall Study||236
11295873|NCT02528253|12493584|FG003|Treated at Week 16|Overall Study||242
11295874|NCT02528253|12493585|FG004|Treated at Week 16|Overall Study||307
11295875|NCT02528253|12493581|FG000|COMPLETED|Overall Study||130
11295876|NCT02528253|12493582|FG001|COMPLETED|Overall Study||134
11295877|NCT02528253|12493583|FG002|COMPLETED|Overall Study||267
11295878|NCT02528253|12493584|FG003|COMPLETED|Overall Study||271
11295879|NCT02528253|12493585|FG004|COMPLETED|Overall Study||379
11295880|NCT02528253|12493581|FG000|NOT COMPLETED|Overall Study||75
11295881|NCT02528253|12493582|FG001|NOT COMPLETED|Overall Study||70
11295882|NCT02528253|12493583|FG002|NOT COMPLETED|Overall Study||140
11295883|NCT02528253|12493584|FG003|NOT COMPLETED|Overall Study||136
11295884|NCT02528253|12493585|FG004|NOT COMPLETED|Overall Study||223
11295885|NCT02528305|12493616|FG000|STARTED|Overall Study||12
11295886|NCT02528305|12493616|FG000|End of Control Period Assessment|Overall Study||11
11295887|NCT02528305|12493616|FG000|End of Intervention Period Assessment|Overall Study||9
11295888|NCT02528305|12493616|FG000|COMPLETED|Overall Study||9
11295889|NCT02528305|12493616|FG000|NOT COMPLETED|Overall Study||3
11295890|NCT02528318|12493627|FG000|STARTED|Overall Study||8
11295891|NCT02528318|12493628|FG001|STARTED|Overall Study||8
11295892|NCT02528318|12493629|FG002|STARTED|Overall Study||8
11295893|NCT02528318|12493630|FG003|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0
11295894|NCT02528318|12493631|FG004|STARTED|Overall Study||24
11295895|NCT02528318|12493627|FG000|COMPLETED|Overall Study||8
11295896|NCT02528318|12493628|FG001|COMPLETED|Overall Study||8
11295897|NCT02528318|12493629|FG002|COMPLETED|Overall Study||8
11295898|NCT02528318|12493630|FG003|COMPLETED|Overall Study||0
11295899|NCT02528318|12493631|FG004|COMPLETED|Overall Study||24
11295900|NCT02528318|12493627|FG000|NOT COMPLETED|Overall Study||0
11295901|NCT02528318|12493628|FG001|NOT COMPLETED|Overall Study||0
11295902|NCT02528318|12493629|FG002|NOT COMPLETED|Overall Study||0
11295903|NCT02528318|12493630|FG003|NOT COMPLETED|Overall Study||0
11295904|NCT02528318|12493631|FG004|NOT COMPLETED|Overall Study||0
11295905|NCT02528331|12493643|FG000|STARTED|Overall Study||2
11295906|NCT02528331|12493643|FG000|COMPLETED|Overall Study||0
11295907|NCT02528331|12493643|FG000|NOT COMPLETED|Overall Study||2
11295908|NCT02528357|12493666|FG000|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
11295909|NCT02528357|12493667|FG001|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
11295910|NCT02528357|12493668|FG002|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||8
11295911|NCT02528357|12493669|FG003|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
11295912|NCT02528357|12493670|FG004|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
11295913|NCT02528357|12493671|FG005|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
11295914|NCT02528357|12493672|FG006|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||7
11295915|NCT02528357|12493673|FG007|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
11295916|NCT02528357|12493674|FG008|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295917|NCT02528357|12493675|FG009|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295918|NCT02528357|12493676|FG010|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295919|NCT02528357|12493677|FG011|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295920|NCT02528357|12493678|FG012|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295921|NCT02528357|12493679|FG013|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295922|NCT02528357|12493680|FG014|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295923|NCT02528357|12493681|FG015|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295924|NCT02528357|12493682|FG016|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295925|NCT02528357|12493683|FG017|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295926|NCT02528357|12493684|FG018|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295927|NCT02528357|12493666|FG000|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
11295928|NCT02528357|12493667|FG001|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295929|NCT02528357|12493668|FG002|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
11295930|NCT02528357|12493669|FG003|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||9
11295931|NCT02528357|12493670|FG004|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
11295932|NCT02528357|12493671|FG005|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
11295933|NCT02528357|12493672|FG006|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||5
11295934|NCT02528357|12493673|FG007|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
11295935|NCT02528357|12493674|FG008|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295936|NCT02528357|12493675|FG009|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295937|NCT02528357|12493676|FG010|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295938|NCT02528357|12493677|FG011|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295939|NCT02528357|12493678|FG012|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295940|NCT02528357|12493679|FG013|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295941|NCT02528357|12493680|FG014|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295942|NCT02528357|12493681|FG015|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295943|NCT02528357|12493682|FG016|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295944|NCT02528357|12493683|FG017|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295945|NCT02528357|12493684|FG018|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295946|NCT02528357|12493666|FG000|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295947|NCT02528357|12493667|FG001|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
11295948|NCT02528357|12493668|FG002|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
11295949|NCT02528357|12493669|FG003|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
11295950|NCT02528357|12493670|FG004|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||4
11295951|NCT02528357|12493671|FG005|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
11295952|NCT02528357|12493672|FG006|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
11295953|NCT02528357|12493673|FG007|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
11295954|NCT02528357|12493674|FG008|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295955|NCT02528357|12493675|FG009|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295956|NCT02528357|12493676|FG010|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295957|NCT02528357|12493677|FG011|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295958|NCT02528357|12493678|FG012|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295959|NCT02528357|12493679|FG013|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295960|NCT02528357|12493680|FG014|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295961|NCT02528357|12493681|FG015|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295962|NCT02528357|12493682|FG016|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295963|NCT02528357|12493683|FG017|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295964|NCT02528357|12493684|FG018|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
11295965|NCT02528357|12493666|FG000|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295966|NCT02528357|12493667|FG001|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295967|NCT02528357|12493668|FG002|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295968|NCT02528357|12493669|FG003|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295969|NCT02528357|12493670|FG004|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295970|NCT02528357|12493671|FG005|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295971|NCT02528357|12493672|FG006|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295972|NCT02528357|12493673|FG007|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295973|NCT02528357|12493674|FG008|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
11295974|NCT02528357|12493675|FG009|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
11295975|NCT02528357|12493676|FG010|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||10
11295976|NCT02528357|12493677|FG011|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
11400680|NCT04186806|12595349|FG001|NOT COMPLETED|Period 2: 7 Days||0
11400681|NCT04186481|12595356|FG000|STARTED|Overall Study||32
11400682|NCT04186481|12595356|FG000|Completed 6 Month Visit|Overall Study||31
11400683|NCT04186481|12595356|FG000|Completed 12 Month Visit|Overall Study||4
11400684|NCT04186481|12595356|FG000|COMPLETED|Overall Study||32
11400685|NCT04186481|12595356|FG000|NOT COMPLETED|Overall Study||0
11400686|NCT04184999|12595362|FG000|STARTED|Overall Study||40
11400687|NCT04184999|12595363|FG001|STARTED|Overall Study||40
11400688|NCT04184999|12595362|FG000|3 Week Tear Film Osmolarity Testing|Overall Study||40
11400689|NCT04184999|12595363|FG001|3 Week Tear Film Osmolarity Testing|Overall Study||40
11400690|NCT04184999|12595362|FG000|COMPLETED|Overall Study||40
11400691|NCT04184999|12595363|FG001|COMPLETED|Overall Study||40
11400692|NCT04184999|12595362|FG000|NOT COMPLETED|Overall Study||0
11400693|NCT04184999|12595363|FG001|NOT COMPLETED|Overall Study||0
11400694|NCT04184271|12595369|FG000|STARTED|Overall Study||16
11400695|NCT04184271|12595369|FG000|COMPLETED|Overall Study||16
11400696|NCT04184271|12595369|FG000|NOT COMPLETED|Overall Study||0
11400697|NCT04183231|12595373|FG000|STARTED|Overall Study||16
11400698|NCT04183231|12595373|FG000|COMPLETED|Overall Study||16
11400699|NCT04183231|12595373|FG000|NOT COMPLETED|Overall Study||0
11295977|NCT02528357|12493678|FG012|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||14
11400700|NCT04182958|12595377|FG000|STARTED|Overall Study||8
11400701|NCT04182958|12595377|FG000|COMPLETED|Overall Study||8
11400702|NCT04182958|12595377|FG000|NOT COMPLETED|Overall Study||0
11295978|NCT02528357|12493679|FG013|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
11295979|NCT02528357|12493680|FG014|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
11400703|NCT04179838|12595383|FG000|STARTED|First Intervention (1 Day)||13
11400704|NCT04179838|12595384|FG001|STARTED|First Intervention (1 Day)||16
11400705|NCT04179838|12595383|FG000|COMPLETED|First Intervention (1 Day)||13
11400706|NCT04179838|12595384|FG001|COMPLETED|First Intervention (1 Day)||13
11400707|NCT04179838|12595383|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11400708|NCT04179838|12595384|FG001|NOT COMPLETED|First Intervention (1 Day)||3
11295980|NCT02528357|12493681|FG015|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
11295981|NCT02528357|12493682|FG016|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295982|NCT02528357|12493683|FG017|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295983|NCT02528357|12493684|FG018|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295984|NCT02528357|12493666|FG000|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295985|NCT02528357|12493667|FG001|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295986|NCT02528357|12493668|FG002|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295987|NCT02528357|12493669|FG003|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295988|NCT02528357|12493670|FG004|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295989|NCT02528357|12493671|FG005|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295990|NCT02528357|12493672|FG006|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295991|NCT02528357|12493673|FG007|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11295992|NCT02528357|12493674|FG008|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
11295993|NCT02528357|12493675|FG009|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
11295994|NCT02528357|12493676|FG010|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
11295995|NCT02528357|12493677|FG011|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
11295996|NCT02528357|12493678|FG012|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
11295997|NCT02528357|12493679|FG013|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
11295998|NCT02528357|12493680|FG014|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
11295999|NCT02528357|12493681|FG015|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
11296000|NCT02528357|12493682|FG016|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296001|NCT02528357|12493683|FG017|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296002|NCT02528357|12493684|FG018|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296003|NCT02528357|12493666|FG000|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296004|NCT02528357|12493667|FG001|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296005|NCT02528357|12493668|FG002|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296006|NCT02528357|12493669|FG003|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296007|NCT02528357|12493670|FG004|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296008|NCT02528357|12493671|FG005|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296009|NCT02528357|12493672|FG006|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296010|NCT02528357|12493673|FG007|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296011|NCT02528357|12493674|FG008|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
11296012|NCT02528357|12493675|FG009|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
11296013|NCT02528357|12493676|FG010|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
11296014|NCT02528357|12493677|FG011|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
11296015|NCT02528357|12493678|FG012|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
11296016|NCT02528357|12493679|FG013|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
11296017|NCT02528357|12493680|FG014|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
11296018|NCT02528357|12493681|FG015|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296019|NCT02528357|12493682|FG016|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296020|NCT02528357|12493683|FG017|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296021|NCT02528357|12493684|FG018|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
11296022|NCT02528357|12493666|FG000|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296023|NCT02528357|12493667|FG001|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296024|NCT02528357|12493668|FG002|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296025|NCT02528357|12493669|FG003|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296026|NCT02528357|12493670|FG004|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296027|NCT02528357|12493671|FG005|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296028|NCT02528357|12493672|FG006|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296029|NCT02528357|12493673|FG007|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296030|NCT02528357|12493674|FG008|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296031|NCT02528357|12493675|FG009|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296032|NCT02528357|12493676|FG010|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296033|NCT02528357|12493677|FG011|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296034|NCT02528357|12493678|FG012|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296035|NCT02528357|12493679|FG013|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296036|NCT02528357|12493680|FG014|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296037|NCT02528357|12493681|FG015|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296038|NCT02528357|12493682|FG016|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||9
11296039|NCT02528357|12493683|FG017|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||8
11296040|NCT02528357|12493684|FG018|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||5
11296041|NCT02528357|12493666|FG000|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296042|NCT02528357|12493667|FG001|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296043|NCT02528357|12493668|FG002|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296044|NCT02528357|12493669|FG003|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296045|NCT02528357|12493670|FG004|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296046|NCT02528357|12493671|FG005|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296047|NCT02528357|12493672|FG006|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296048|NCT02528357|12493673|FG007|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296049|NCT02528357|12493674|FG008|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296050|NCT02528357|12493675|FG009|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296051|NCT02528357|12493676|FG010|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296052|NCT02528357|12493677|FG011|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296053|NCT02528357|12493678|FG012|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296054|NCT02528357|12493679|FG013|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296055|NCT02528357|12493680|FG014|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296056|NCT02528357|12493681|FG015|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296057|NCT02528357|12493682|FG016|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||6
11296058|NCT02528357|12493683|FG017|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
11296059|NCT02528357|12493684|FG018|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||2
11296060|NCT02528357|12493666|FG000|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296061|NCT02528357|12493667|FG001|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296062|NCT02528357|12493668|FG002|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296063|NCT02528357|12493669|FG003|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296064|NCT02528357|12493670|FG004|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296065|NCT02528357|12493671|FG005|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296066|NCT02528357|12493672|FG006|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296067|NCT02528357|12493673|FG007|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296068|NCT02528357|12493674|FG008|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296069|NCT02528357|12493675|FG009|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296070|NCT02528357|12493676|FG010|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296071|NCT02528357|12493677|FG011|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296072|NCT02528357|12493678|FG012|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296073|NCT02528357|12493679|FG013|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296074|NCT02528357|12493680|FG014|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296075|NCT02528357|12493681|FG015|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
11296076|NCT02528357|12493682|FG016|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
11296077|NCT02528357|12493683|FG017|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
11296078|NCT02528357|12493684|FG018|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
11296079|NCT02528370|12493726|FG000|STARTED|Overall Study||119
11296080|NCT02528370|12493727|FG001|STARTED|Overall Study||78
11296081|NCT02528370|12493726|FG000|COMPLETED|Overall Study||102
11296082|NCT02528370|12493727|FG001|COMPLETED|Overall Study||77
11296083|NCT02528370|12493726|FG000|NOT COMPLETED|Overall Study||17
11296084|NCT02528370|12493727|FG001|NOT COMPLETED|Overall Study||1
11296085|NCT02528409|12493735|FG000|STARTED|Overall Study||40
11296086|NCT02528409|12493736|FG001|STARTED|Overall Study||40
11296087|NCT02528409|12493735|FG000|COMPLETED|Overall Study||18
11296088|NCT02528409|12493736|FG001|COMPLETED|Overall Study||24
11296089|NCT02528409|12493735|FG000|NOT COMPLETED|Overall Study||22
11296090|NCT02528409|12493736|FG001|NOT COMPLETED|Overall Study||16
11296091|NCT02528721|12493744|FG000|STARTED|Overall Study||203
11296092|NCT02528721|12493745|FG001|STARTED|Overall Study||79
11296093|NCT02528721|12493744|FG000|COMPLETED|Overall Study||196
11296094|NCT02528721|12493745|FG001|COMPLETED|Overall Study||76
11296095|NCT02528721|12493744|FG000|NOT COMPLETED|Overall Study||7
11296096|NCT02528721|12493745|FG001|NOT COMPLETED|Overall Study||3
11296097|NCT02528786|12493751|FG000|STARTED|Overall Study||8
11296098|NCT02528786|12493751|FG000|COMPLETED|Overall Study||8
11296099|NCT02528786|12493751|FG000|NOT COMPLETED|Overall Study||0
11296100|NCT02528942|12493755|FG000|STARTED|Overall Study||101
11296101|NCT02528942|12493755|FG000|COMPLETED|Overall Study||67
11296102|NCT02528942|12493755|FG000|NOT COMPLETED|Overall Study||34
11296103|NCT02529072|12493761|FG000|STARTED|Overall Study||3
11296104|NCT02529072|12493762|FG001|STARTED|Overall Study||3
11296105|NCT02529072|12493761|FG000|COMPLETED|Overall Study||3
11296106|NCT02529072|12493762|FG001|COMPLETED|Overall Study||3
11296107|NCT02529072|12493761|FG000|NOT COMPLETED|Overall Study||0
11296108|NCT02529072|12493762|FG001|NOT COMPLETED|Overall Study||0
11296109|NCT02529137|12493768|FG000|STARTED|Overall Study||2000
11296110|NCT02529137|12493768|FG000|COMPLETED|Overall Study||1992
11296111|NCT02529137|12493768|FG000|NOT COMPLETED|Overall Study||8
11296112|NCT02529488|12493773|FG000|STARTED|Overall Study||149
11296113|NCT02529488|12493773|FG000|COMPLETED|Overall Study||145
11400709|NCT04179838|12595383|FG000|STARTED|Washout (4 Weeks)||13
11400710|NCT04179838|12595384|FG001|STARTED|Washout (4 Weeks)||13
11400711|NCT04179838|12595383|FG000|COMPLETED|Washout (4 Weeks)||13
11400712|NCT04179838|12595384|FG001|COMPLETED|Washout (4 Weeks)||13
11400713|NCT04179838|12595383|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11400714|NCT04179838|12595384|FG001|NOT COMPLETED|Washout (4 Weeks)||0
11400715|NCT04179838|12595383|FG000|STARTED|Second Intervention (1 Day)||13
11400716|NCT04179838|12595384|FG001|STARTED|Second Intervention (1 Day)||13
11400717|NCT04179838|12595383|FG000|COMPLETED|Second Intervention (1 Day)||13
11400718|NCT04179838|12595384|FG001|COMPLETED|Second Intervention (1 Day)||12
11400719|NCT04179838|12595383|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11400720|NCT04179838|12595384|FG001|NOT COMPLETED|Second Intervention (1 Day)||1
11296114|NCT02529488|12493773|FG000|NOT COMPLETED|Overall Study||4
11296115|NCT02529553|12493790|FG000|STARTED|Overall Study||1
11296116|NCT02529553|12493791|FG001|STARTED|Overall Study||1
11296117|NCT02529553|12493792|FG002|STARTED|Overall Study||1
11296118|NCT02529553|12493793|FG003|STARTED|Overall Study||3
11296119|NCT02529553|12493794|FG004|STARTED|Overall Study||3
11296120|NCT02529553|12493795|FG005|STARTED|Overall Study||4
11296121|NCT02529553|12493796|FG006|STARTED|Overall Study||3
11296122|NCT02529553|12493797|FG007|STARTED|Overall Study||6
11400721|NCT04179461|12595390|FG000|STARTED|Overall Study||21
11400722|NCT04179461|12595390|FG000|COMPLETED|Overall Study||17
11296123|NCT02529553|12493798|FG008|STARTED|Overall Study||3
11296124|NCT02529553|12493790|FG000|COMPLETED|Overall Study||0
11296125|NCT02529553|12493791|FG001|COMPLETED|Overall Study||0
11296126|NCT02529553|12493792|FG002|COMPLETED|Overall Study||0
11296127|NCT02529553|12493793|FG003|COMPLETED|Overall Study||0
11296128|NCT02529553|12493794|FG004|COMPLETED|Overall Study||0
11296129|NCT02529553|12493795|FG005|COMPLETED|Overall Study||0
11296130|NCT02529553|12493796|FG006|COMPLETED|Overall Study||0
11296131|NCT02529553|12493797|FG007|COMPLETED|Overall Study||0
11296132|NCT02529553|12493798|FG008|COMPLETED|Overall Study||0
11296133|NCT02529553|12493790|FG000|NOT COMPLETED|Overall Study||1
11296134|NCT02529553|12493791|FG001|NOT COMPLETED|Overall Study||1
11296135|NCT02529553|12493792|FG002|NOT COMPLETED|Overall Study||1
11296136|NCT02529553|12493793|FG003|NOT COMPLETED|Overall Study||3
11296137|NCT02529553|12493794|FG004|NOT COMPLETED|Overall Study||3
11296138|NCT02529553|12493795|FG005|NOT COMPLETED|Overall Study||4
11296139|NCT02529553|12493796|FG006|NOT COMPLETED|Overall Study||3
11296140|NCT02529553|12493797|FG007|NOT COMPLETED|Overall Study||6
11296141|NCT02529553|12493798|FG008|NOT COMPLETED|Overall Study||3
11296142|NCT02529995|12493821|FG000|STARTED|Part A||15
11296143|NCT02529995|12493822|FG001|STARTED|Part A||16
11296144|NCT02529995|12493821|FG000|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
11296145|NCT02529995|12493822|FG001|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
11296146|NCT02529995|12493821|FG000|NOT COMPLETED|Part A||15
11296147|NCT02529995|12493822|FG001|NOT COMPLETED|Part A||16
11296148|NCT02529995|12493821|FG000|STARTED|Part B||15
11296149|NCT02529995|12493822|FG001|STARTED|Part B||16
11296150|NCT02529995|12493821|FG000|COMPLETED|Part B||9
11296151|NCT02529995|12493822|FG001|COMPLETED|Part B||4
11296152|NCT02529995|12493821|FG000|NOT COMPLETED|Part B||6
11296153|NCT02529995|12493822|FG001|NOT COMPLETED|Part B||12
11296154|NCT02530125|12493828|FG000|STARTED|Completed Treatment||4
11296155|NCT02530125|12493828|FG000|COMPLETED|Completed Treatment||3
11296156|NCT02530125|12493828|FG000|NOT COMPLETED|Completed Treatment||1
11296157|NCT02530125|12493828|FG000|STARTED|Followed for Survival for 2 Years||3
11296158|NCT02530125|12493828|FG000|COMPLETED|Followed for Survival for 2 Years||0
11296159|NCT02530125|12493828|FG000|NOT COMPLETED|Followed for Survival for 2 Years||3
11296160|NCT02530151|12493834|FG000|STARTED|Overall Study||37
11296161|NCT02530151|12493835|FG001|STARTED|Overall Study||33
11296162|NCT02530151|12493834|FG000|COMPLETED|Overall Study||16
11296163|NCT02530151|12493835|FG001|COMPLETED|Overall Study||17
11296164|NCT02530151|12493834|FG000|NOT COMPLETED|Overall Study||21
11296165|NCT02530151|12493835|FG001|NOT COMPLETED|Overall Study||16
11296166|NCT02530242|12493843|FG000|STARTED|Overall Study||16
11296167|NCT02530242|12493844|FG001|STARTED|Overall Study||16
11296168|NCT02530242|12493843|FG000|COMPLETED|Overall Study||16
11296169|NCT02530242|12493844|FG001|COMPLETED|Overall Study||15
11296170|NCT02530242|12493843|FG000|NOT COMPLETED|Overall Study||0
11296171|NCT02530242|12493844|FG001|NOT COMPLETED|Overall Study||1
11296172|NCT02530281|12493852|FG000|STARTED|Overall Study||229
11296173|NCT02530281|12493853|FG001|STARTED|Overall Study||115
11296174|NCT02530281|12493852|FG000|COMPLETED|Overall Study||208
11296175|NCT02530281|12493853|FG001|COMPLETED|Overall Study||112
11296176|NCT02530281|12493852|FG000|NOT COMPLETED|Overall Study||21
11296177|NCT02530281|12493853|FG001|NOT COMPLETED|Overall Study||3
11296178|NCT02530294|12493863|FG000|STARTED|Overall Study||234
11296179|NCT02530294|12493864|FG001|STARTED|Overall Study||119
11296180|NCT02530294|12493863|FG000|COMPLETED|Overall Study||218
11296181|NCT02530294|12493864|FG001|COMPLETED|Overall Study||113
11296182|NCT02530294|12493863|FG000|NOT COMPLETED|Overall Study||16
11296183|NCT02530294|12493864|FG001|NOT COMPLETED|Overall Study||6
11296184|NCT02530385|12493872|FG000|STARTED|Overall Study||12
11296185|NCT02530385|12493873|FG001|STARTED|Overall Study||12
11296186|NCT02530385|12493872|FG000|COMPLETED|Overall Study||12
11296187|NCT02530385|12493873|FG001|COMPLETED|Overall Study||11
11296188|NCT02530385|12493872|FG000|NOT COMPLETED|Overall Study||0
11296189|NCT02530385|12493873|FG001|NOT COMPLETED|Overall Study||1
11296190|NCT02530450|12493881|FG000|STARTED|Overall Study||16
11296191|NCT02530450|12493882|FG001|STARTED|Overall Study||14
11296192|NCT02530450|12493881|FG000|COMPLETED|Overall Study||10
11296193|NCT02530450|12493882|FG001|COMPLETED|Overall Study||9
11296194|NCT02530450|12493881|FG000|NOT COMPLETED|Overall Study||6
11296195|NCT02530450|12493882|FG001|NOT COMPLETED|Overall Study||5
11296196|NCT02530476|12493892|FG000|STARTED|Overall Study||4
11296197|NCT02530476|12493893|FG001|STARTED|Overall Study||3
11296198|NCT02530476|12493894|FG002|STARTED|Overall Study||7
11296199|NCT02530476|12493895|FG003|STARTED|Overall Study||3
11296200|NCT02530476|12493892|FG000|COMPLETED|Overall Study||4
11296201|NCT02530476|12493893|FG001|COMPLETED|Overall Study||3
11296202|NCT02530476|12493894|FG002|COMPLETED|Overall Study||7
11296203|NCT02530476|12493895|FG003|COMPLETED|Overall Study||3
11296204|NCT02530476|12493892|FG000|NOT COMPLETED|Overall Study||0
11296205|NCT02530476|12493893|FG001|NOT COMPLETED|Overall Study||0
11296206|NCT02530476|12493894|FG002|NOT COMPLETED|Overall Study||0
11296207|NCT02530476|12493895|FG003|NOT COMPLETED|Overall Study||0
11296208|NCT02530515|12493908|FG000|STARTED|Overall Study||0
11296209|NCT02530515|12493909|FG001|STARTED|Overall Study||0
11296210|NCT02530515|12493910|FG002|STARTED|Overall Study||8
11296211|NCT02530515|12493908|FG000|COMPLETED|Overall Study||0
11296212|NCT02530515|12493909|FG001|COMPLETED|Overall Study||0
11296213|NCT02530515|12493910|FG002|COMPLETED|Overall Study||8
11296214|NCT02530515|12493908|FG000|NOT COMPLETED|Overall Study||0
11296215|NCT02530515|12493909|FG001|NOT COMPLETED|Overall Study||0
11296216|NCT02530515|12493910|FG002|NOT COMPLETED|Overall Study||0
11296217|NCT02530528|12493918|FG000|STARTED|Overall Study||13
11296218|NCT02530528|12493919|FG001|STARTED|Overall Study||13
11296219|NCT02530528|12493920|FG002|STARTED|Overall Study||14
11296220|NCT02530528|12493921|FG003|STARTED|Overall Study||14
11296221|NCT02530528|12493922|FG004|STARTED|Overall Study||13
11296222|NCT02530528|12493923|FG005|STARTED|Overall Study||13
11296223|NCT02530528|12493924|FG006|STARTED|Overall Study||14
11296224|NCT02530528|12493925|FG007|STARTED|Overall Study||14
11296225|NCT02530528|12493918|FG000|COMPLETED|Overall Study|13 participants received CHG Cloth|12
11296226|NCT02530528|12493919|FG001|COMPLETED|Overall Study||12
11296227|NCT02530528|12493920|FG002|COMPLETED|Overall Study|14 participants received CHG cloth|12
11296228|NCT02530528|12493921|FG003|COMPLETED|Overall Study||12
11296229|NCT02530528|12493922|FG004|COMPLETED|Overall Study|13 participants received CHG cloth|12
11296230|NCT02530528|12493923|FG005|COMPLETED|Overall Study||12
11296231|NCT02530528|12493924|FG006|COMPLETED|Overall Study|14 participants received comparator CHG.|12
11296232|NCT02530528|12493925|FG007|COMPLETED|Overall Study||12
11296233|NCT02530528|12493918|FG000|NOT COMPLETED|Overall Study||1
11296234|NCT02530528|12493919|FG001|NOT COMPLETED|Overall Study||1
11296235|NCT02530528|12493920|FG002|NOT COMPLETED|Overall Study||2
11296236|NCT02530528|12493921|FG003|NOT COMPLETED|Overall Study||2
11296237|NCT02530528|12493922|FG004|NOT COMPLETED|Overall Study||1
11296238|NCT02530528|12493923|FG005|NOT COMPLETED|Overall Study||1
11296239|NCT02530528|12493924|FG006|NOT COMPLETED|Overall Study||2
11296240|NCT02530528|12493925|FG007|NOT COMPLETED|Overall Study||2
11296241|NCT02530541|12493939|FG000|STARTED|Overall Study||21
11296242|NCT02530541|12493940|FG001|STARTED|Overall Study||23
11296243|NCT02530541|12493941|FG002|STARTED|Overall Study||22
11296244|NCT02530541|12493942|FG003|STARTED|Overall Study||21
11296245|NCT02530541|12493943|FG004|STARTED|Overall Study||20
11296246|NCT02530541|12493944|FG005|STARTED|Overall Study||19
11296247|NCT02530541|12493939|FG000|COMPLETED|Overall Study||14
11296248|NCT02530541|12493940|FG001|COMPLETED|Overall Study||15
11296249|NCT02530541|12493941|FG002|COMPLETED|Overall Study||14
11296250|NCT02530541|12493942|FG003|COMPLETED|Overall Study||15
11296251|NCT02530541|12493943|FG004|COMPLETED|Overall Study||15
11296252|NCT02530541|12493944|FG005|COMPLETED|Overall Study||14
11296253|NCT02530541|12493939|FG000|NOT COMPLETED|Overall Study||7
11296254|NCT02530541|12493940|FG001|NOT COMPLETED|Overall Study||8
11296255|NCT02530541|12493941|FG002|NOT COMPLETED|Overall Study||8
11296256|NCT02530541|12493942|FG003|NOT COMPLETED|Overall Study||6
11296257|NCT02530541|12493943|FG004|NOT COMPLETED|Overall Study||5
11296258|NCT02530541|12493944|FG005|NOT COMPLETED|Overall Study||5
11296259|NCT02530554|12493953|FG000|STARTED|Overall Study||12
11296260|NCT02530554|12493954|FG001|STARTED|Overall Study||14
11296261|NCT02530554|12493955|FG002|STARTED|Overall Study||12
11296262|NCT02530554|12493956|FG003|STARTED|Overall Study||14
11296263|NCT02530554|12493953|FG000|COMPLETED|Overall Study||12
11296264|NCT02530554|12493954|FG001|COMPLETED|Overall Study||14
11296265|NCT02530554|12493955|FG002|COMPLETED|Overall Study||12
11296266|NCT02530554|12493956|FG003|COMPLETED|Overall Study||14
11296267|NCT02530554|12493953|FG000|NOT COMPLETED|Overall Study||0
11296268|NCT02530554|12493954|FG001|NOT COMPLETED|Overall Study||0
11296269|NCT02530554|12493955|FG002|NOT COMPLETED|Overall Study||0
11296270|NCT02530554|12493956|FG003|NOT COMPLETED|Overall Study||0
11296271|NCT02530619|12493963|FG000|STARTED|Registered for Study||26
11296272|NCT02530619|12493963|FG000|Registered|Registered for Study||26
11296273|NCT02530619|12493963|FG000|Received 1st Dose of Alisertib|Registered for Study||24
11296274|NCT02530619|12493963|FG000|COMPLETED|Registered for Study||24
11296275|NCT02530619|12493963|FG000|NOT COMPLETED|Registered for Study||2
11296276|NCT02530619|12493963|FG000|STARTED|Completed 1st Cycle of Treatment||24
11296277|NCT02530619|12493963|FG000|COMPLETED|Completed 1st Cycle of Treatment||24
11296278|NCT02530619|12493963|FG000|NOT COMPLETED|Completed 1st Cycle of Treatment||0
11296279|NCT02530619|12493963|FG000|STARTED|Continued Treatment Cycles 2 Through 6||24
11296280|NCT02530619|12493963|FG000|COMPLETED|Continued Treatment Cycles 2 Through 6||14
11296281|NCT02530619|12493963|FG000|NOT COMPLETED|Continued Treatment Cycles 2 Through 6||10
11296282|NCT02530619|12493963|FG000|STARTED|Continued Treatment Cycle 7+||14
11296283|NCT02530619|12493963|FG000|COMPLETED|Continued Treatment Cycle 7+||14
11296284|NCT02530619|12493963|FG000|NOT COMPLETED|Continued Treatment Cycle 7+||0
11296285|NCT02530619|12493963|FG000|STARTED|Follow-up Period (6 Months)|Patients who received at least one dose of study drug go into follow-up.|21
11296286|NCT02530619|12493963|FG000|COMPLETED|Follow-up Period (6 Months)||10
11296287|NCT02530619|12493963|FG000|NOT COMPLETED|Follow-up Period (6 Months)||11
11296288|NCT02530671|12493969|FG000|STARTED|Overall Study||55
11296289|NCT02530671|12493970|FG001|STARTED|Overall Study||55
11296290|NCT02530671|12493969|FG000|COMPLETED|Overall Study||52
11296291|NCT02530671|12493970|FG001|COMPLETED|Overall Study||55
11296292|NCT02530671|12493969|FG000|NOT COMPLETED|Overall Study||3
11296293|NCT02530671|12493970|FG001|NOT COMPLETED|Overall Study||0
11296294|NCT02530905|12493978|FG000|STARTED|Double-Blind Period (12 Weeks)||4
11296295|NCT02530905|12493979|FG001|STARTED|Double-Blind Period (12 Weeks)||8
11296296|NCT02530905|12493980|FG002|STARTED|Double-Blind Period (12 Weeks)||0
11296297|NCT02530905|12493978|FG000|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
11296298|NCT02530905|12493979|FG001|Received 4 mg/kg|Double-Blind Period (12 Weeks)||8
11296299|NCT02530905|12493980|FG002|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
11296300|NCT02530905|12493978|FG000|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
11296301|NCT02530905|12493979|FG001|Received 10 mg/kg|Double-Blind Period (12 Weeks)||8
11296302|NCT02530905|12493980|FG002|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
11296303|NCT02530905|12493978|FG000|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
11296304|NCT02530905|12493979|FG001|Received 20 mg/kg|Double-Blind Period (12 Weeks)||8
11296305|NCT02530905|12493980|FG002|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
11296306|NCT02530905|12493978|FG000|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
11296307|NCT02530905|12493979|FG001|Received 30 mg/kg|Double-Blind Period (12 Weeks)||8
11296308|NCT02530905|12493980|FG002|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
11296309|NCT02530905|12493978|FG000|COMPLETED|Double-Blind Period (12 Weeks)||4
11296310|NCT02530905|12493979|FG001|COMPLETED|Double-Blind Period (12 Weeks)||8
11296311|NCT02530905|12493980|FG002|COMPLETED|Double-Blind Period (12 Weeks)||0
11296312|NCT02530905|12493978|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
11296313|NCT02530905|12493979|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
11296314|NCT02530905|12493980|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
11296315|NCT02530905|12493978|FG000|STARTED|Open Label Extension Period (132 Weeks)||0
11296316|NCT02530905|12493979|FG001|STARTED|Open Label Extension Period (132 Weeks)||0
11296317|NCT02530905|12493980|FG002|STARTED|Open Label Extension Period (132 Weeks)|All participants from the double-blind period amenable to exon 45 skipping were enrolled to open-label extension period.|12
11296318|NCT02530905|12493978|FG000|COMPLETED|Open Label Extension Period (132 Weeks)||0
11296319|NCT02530905|12493979|FG001|COMPLETED|Open Label Extension Period (132 Weeks)||0
11296320|NCT02530905|12493980|FG002|COMPLETED|Open Label Extension Period (132 Weeks)||11
11296321|NCT02530905|12493978|FG000|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
11296322|NCT02530905|12493979|FG001|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
11296323|NCT02530905|12493980|FG002|NOT COMPLETED|Open Label Extension Period (132 Weeks)||1
11296324|NCT02530970|12494002|FG000|STARTED|Overall Study||1025
11296325|NCT02530970|12494002|FG000|COMPLETED|Overall Study||891
11296326|NCT02530970|12494002|FG000|NOT COMPLETED|Overall Study||134
11296327|NCT02530996|12494006|FG000|STARTED|First Intervention||6
11296328|NCT02530996|12494007|FG001|STARTED|First Intervention||6
11296329|NCT02530996|12494006|FG000|COMPLETED|First Intervention||6
11296330|NCT02530996|12494007|FG001|COMPLETED|First Intervention||6
11296331|NCT02530996|12494006|FG000|NOT COMPLETED|First Intervention||0
11296332|NCT02530996|12494007|FG001|NOT COMPLETED|First Intervention||0
11296333|NCT02530996|12494006|FG000|STARTED|Washout (5 Days)||6
11296334|NCT02530996|12494007|FG001|STARTED|Washout (5 Days)||6
11296335|NCT02530996|12494006|FG000|COMPLETED|Washout (5 Days)||6
11296336|NCT02530996|12494007|FG001|COMPLETED|Washout (5 Days)||6
11296337|NCT02530996|12494006|FG000|NOT COMPLETED|Washout (5 Days)||0
11296338|NCT02530996|12494007|FG001|NOT COMPLETED|Washout (5 Days)||0
11296339|NCT02530996|12494006|FG000|STARTED|Second Intervention||6
11296340|NCT02530996|12494007|FG001|STARTED|Second Intervention||6
11296341|NCT02530996|12494006|FG000|COMPLETED|Second Intervention||6
11296342|NCT02530996|12494007|FG001|COMPLETED|Second Intervention||6
11296343|NCT02530996|12494006|FG000|NOT COMPLETED|Second Intervention||0
11296344|NCT02530996|12494007|FG001|NOT COMPLETED|Second Intervention||0
11296345|NCT02531022|12494019|FG000|STARTED|Overall Study||55
11296346|NCT02531022|12494020|FG001|STARTED|Overall Study||50
11296347|NCT02531022|12494019|FG000|COMPLETED|Overall Study||55
11296348|NCT02531022|12494020|FG001|COMPLETED|Overall Study||48
11296349|NCT02531022|12494019|FG000|NOT COMPLETED|Overall Study||0
11296350|NCT02531022|12494020|FG001|NOT COMPLETED|Overall Study||2
11296351|NCT02531035|12494028|FG000|STARTED|Overall Study||705
11296352|NCT02531035|12494029|FG001|STARTED|Overall Study||700
11296353|NCT02531035|12494028|FG000|Treated|Overall Study||703
11296354|NCT02531035|12494029|FG001|Treated|Overall Study||699
11296355|NCT02531035|12494028|FG000|COMPLETED|Overall Study||624
11296356|NCT02531035|12494029|FG001|COMPLETED|Overall Study||605
11296357|NCT02531035|12494028|FG000|NOT COMPLETED|Overall Study||81
11296358|NCT02531035|12494029|FG001|NOT COMPLETED|Overall Study||95
11296359|NCT02531113|12494035|FG000|STARTED|Induction Period: Week 0 to 12||69
11296360|NCT02531113|12494035|FG000|COMPLETED|Induction Period: Week 0 to 12||58
11296361|NCT02531113|12494035|FG000|NOT COMPLETED|Induction Period: Week 0 to 12||11
11296362|NCT02531113|12494035|FG000|STARTED|Extension Period: Week 12 up to Week 160|6 participants completed induction; did not advance to extension due to lack efficacy.|52
11296363|NCT02531113|12494035|FG000|COMPLETED|Extension Period: Week 12 up to Week 160||14
11296364|NCT02531113|12494035|FG000|NOT COMPLETED|Extension Period: Week 12 up to Week 160||38
11296365|NCT02531321|12494041|FG000|STARTED|Overall Study||7
11296366|NCT02531321|12494042|FG001|STARTED|Overall Study||10
11296367|NCT02531321|12494041|FG000|COMPLETED|Overall Study||5
11296368|NCT02531321|12494042|FG001|COMPLETED|Overall Study||10
11296369|NCT02531321|12494041|FG000|NOT COMPLETED|Overall Study||2
11296370|NCT02531321|12494042|FG001|NOT COMPLETED|Overall Study||0
11296371|NCT02531373|12494057|FG000|STARTED|Overall Study||20
11296372|NCT02531373|12494058|FG001|STARTED|Overall Study||20
11296373|NCT02531373|12494059|FG002|STARTED|Overall Study||20
11296374|NCT02531373|12494060|FG003|STARTED|Overall Study||20
11296375|NCT02531373|12494061|FG004|STARTED|Overall Study||51
11296376|NCT02531373|12494062|FG005|STARTED|Overall Study||51
11296377|NCT02531373|12494063|FG006|STARTED|Overall Study||52
11296378|NCT02531373|12494064|FG007|STARTED|Overall Study||52
11296379|NCT02531373|12494065|FG008|STARTED|Overall Study||52
11296380|NCT02531373|12494057|FG000|Vaccination 1|Overall Study||20
11296381|NCT02531373|12494058|FG001|Vaccination 1|Overall Study||20
11296382|NCT02531373|12494059|FG002|Vaccination 1|Overall Study||20
11296383|NCT02531373|12494060|FG003|Vaccination 1|Overall Study||20
11296384|NCT02531373|12494061|FG004|Vaccination 1|Overall Study||50
11296385|NCT02531373|12494062|FG005|Vaccination 1|Overall Study||50
11296386|NCT02531373|12494063|FG006|Vaccination 1|Overall Study||52
11296387|NCT02531373|12494064|FG007|Vaccination 1|Overall Study||52
11296388|NCT02531373|12494065|FG008|Vaccination 1|Overall Study||52
11296389|NCT02531373|12494057|FG000|Vaccination 2|Overall Study||0
11296390|NCT02531373|12494058|FG001|Vaccination 2|Overall Study||0
11296391|NCT02531373|12494059|FG002|Vaccination 2|Overall Study||0
11296392|NCT02531373|12494060|FG003|Vaccination 2|Overall Study||0
11296393|NCT02531373|12494061|FG004|Vaccination 2|Overall Study||49
11296394|NCT02531373|12494062|FG005|Vaccination 2|Overall Study||48
11296395|NCT02531373|12494063|FG006|Vaccination 2|Overall Study||50
11296396|NCT02531373|12494064|FG007|Vaccination 2|Overall Study||51
11296397|NCT02531373|12494065|FG008|Vaccination 2|Overall Study||51
11296398|NCT02531373|12494057|FG000|Vaccination 3|Overall Study||0
11296399|NCT02531373|12494058|FG001|Vaccination 3|Overall Study||0
11296400|NCT02531373|12494059|FG002|Vaccination 3|Overall Study||0
11296401|NCT02531373|12494060|FG003|Vaccination 3|Overall Study||0
11296402|NCT02531373|12494061|FG004|Vaccination 3|Overall Study||48
11296403|NCT02531373|12494062|FG005|Vaccination 3|Overall Study||47
11296404|NCT02531373|12494063|FG006|Vaccination 3|Overall Study||49
11296405|NCT02531373|12494064|FG007|Vaccination 3|Overall Study||51
11296406|NCT02531373|12494065|FG008|Vaccination 3|Overall Study||49
11296407|NCT02531373|12494057|FG000|Vaccination 4|Overall Study||0
11296408|NCT02531373|12494058|FG001|Vaccination 4|Overall Study||0
11296409|NCT02531373|12494059|FG002|Vaccination 4|Overall Study||0
11296410|NCT02531373|12494060|FG003|Vaccination 4|Overall Study||0
11296411|NCT02531373|12494061|FG004|Vaccination 4|Overall Study||44
11296412|NCT02531373|12494062|FG005|Vaccination 4|Overall Study||43
11400723|NCT04179461|12595390|FG000|NOT COMPLETED|Overall Study||4
11400724|NCT04179474|12595396|FG000|STARTED|Treatment Period 1 (First Intervention)||20
11400725|NCT04179474|12595397|FG001|STARTED|Treatment Period 1 (First Intervention)||20
11400726|NCT04179474|12595396|FG000|COMPLETED|Treatment Period 1 (First Intervention)||20
11400727|NCT04179474|12595397|FG001|COMPLETED|Treatment Period 1 (First Intervention)||20
11400728|NCT04179474|12595396|FG000|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
11400729|NCT04179474|12595397|FG001|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
11400730|NCT04179474|12595396|FG000|STARTED|Treatment Period 2 (Second Intervention)|1 participant did not receive Intervention B.|19
11400731|NCT04179474|12595397|FG001|STARTED|Treatment Period 2 (Second Intervention)||20
11400732|NCT04179474|12595396|FG000|COMPLETED|Treatment Period 2 (Second Intervention)||19
11400733|NCT04179474|12595397|FG001|COMPLETED|Treatment Period 2 (Second Intervention)||20
11400734|NCT04179474|12595396|FG000|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
11400735|NCT04179474|12595397|FG001|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
11400736|NCT04179474|12595396|FG000|STARTED|Treatment Period 3 (Third Intervention)||19
11400737|NCT04179474|12595397|FG001|STARTED|Treatment Period 3 (Third Intervention)|1 participant did not receive Intervention D.|19
11400738|NCT04179474|12595396|FG000|COMPLETED|Treatment Period 3 (Third Intervention)||19
11400739|NCT04179474|12595397|FG001|COMPLETED|Treatment Period 3 (Third Intervention)||19
11400740|NCT04179474|12595396|FG000|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
11400741|NCT04179474|12595397|FG001|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
11400742|NCT04178590|12595418|FG000|STARTED|Overall Study||32
11400743|NCT04178590|12595418|FG000|COMPLETED|Overall Study||30
11400744|NCT04178590|12595418|FG000|NOT COMPLETED|Overall Study||2
11400745|NCT04177862|12595446|FG000|STARTED|Overall Study||35
11400746|NCT04177862|12595447|FG001|STARTED|Overall Study||40
11400747|NCT04177862|12595446|FG000|COMPLETED|Overall Study||33
11400748|NCT04177862|12595447|FG001|COMPLETED|Overall Study||33
11400749|NCT04177862|12595446|FG000|NOT COMPLETED|Overall Study||2
11400750|NCT04177862|12595447|FG001|NOT COMPLETED|Overall Study||7
11400751|NCT04176406|12595454|FG000|STARTED|Overall Study||0
11400752|NCT04176406|12595455|FG001|STARTED|Overall Study||0
11400753|NCT04176406|12595456|FG002|STARTED|Overall Study||0
11296413|NCT02531373|12494063|FG006|Vaccination 4|Overall Study||43
11296414|NCT02531373|12494064|FG007|Vaccination 4|Overall Study||43
11296415|NCT02531373|12494065|FG008|Vaccination 4|Overall Study||43
11296416|NCT02531373|12494057|FG000|COMPLETED|Overall Study||20
11296417|NCT02531373|12494058|FG001|COMPLETED|Overall Study||20
11296418|NCT02531373|12494059|FG002|COMPLETED|Overall Study||20
11021922|NCT00806585|12200111|FG004|STARTED|Overall Study||137
11021923|NCT00806585|12200107|FG000|COMPLETED|Overall Study||105
11021924|NCT00806585|12200108|FG001|COMPLETED|Overall Study||103
11021925|NCT00806585|12200109|FG002|COMPLETED|Overall Study||109
11021926|NCT00806585|12200110|FG003|COMPLETED|Overall Study||56
11021927|NCT00806585|12200111|FG004|COMPLETED|Overall Study||106
11296419|NCT02531373|12494060|FG003|COMPLETED|Overall Study||20
11296420|NCT02531373|12494061|FG004|COMPLETED|Overall Study||43
11296421|NCT02531373|12494062|FG005|COMPLETED|Overall Study||42
11296422|NCT02531373|12494063|FG006|COMPLETED|Overall Study||41
11296423|NCT02531373|12494064|FG007|COMPLETED|Overall Study||43
11296424|NCT02531373|12494065|FG008|COMPLETED|Overall Study||43
11296425|NCT02531373|12494057|FG000|NOT COMPLETED|Overall Study||0
11296426|NCT02531373|12494058|FG001|NOT COMPLETED|Overall Study||0
11296427|NCT02531373|12494059|FG002|NOT COMPLETED|Overall Study||0
11296428|NCT02531373|12494060|FG003|NOT COMPLETED|Overall Study||0
11296429|NCT02531373|12494061|FG004|NOT COMPLETED|Overall Study||8
11296430|NCT02531373|12494062|FG005|NOT COMPLETED|Overall Study||9
11296431|NCT02531373|12494063|FG006|NOT COMPLETED|Overall Study||11
11296432|NCT02531373|12494064|FG007|NOT COMPLETED|Overall Study||9
11296433|NCT02531373|12494065|FG008|NOT COMPLETED|Overall Study||9
11296434|NCT02531438|12494088|FG000|STARTED|Overall Study||386
11296435|NCT02531438|12494089|FG001|STARTED|Overall Study||388
11296436|NCT02531438|12494088|FG000|COMPLETED|Overall Study||356
11296437|NCT02531438|12494089|FG001|COMPLETED|Overall Study||362
11296438|NCT02531438|12494088|FG000|NOT COMPLETED|Overall Study||30
11296439|NCT02531438|12494089|FG001|NOT COMPLETED|Overall Study||26
11296440|NCT02531633|12494100|FG000|STARTED|Part A (52 Weeks)||42
11296441|NCT02531633|12494101|FG001|STARTED|Part A (52 Weeks)||39
11296442|NCT02531633|12494102|FG002|STARTED|Part A (52 Weeks)||26
11296443|NCT02531633|12494103|FG003|STARTED|Part A (52 Weeks)||27
11296444|NCT02531633|12494104|FG004|STARTED|Part A (52 Weeks)||27
11296445|NCT02531633|12494105|FG005|STARTED|Part A (52 Weeks)||0
11296446|NCT02531633|12494106|FG006|STARTED|Part A (52 Weeks)||0
11296447|NCT02531633|12494107|FG007|STARTED|Part A (52 Weeks)||0
11296448|NCT02531633|12494108|FG008|STARTED|Part A (52 Weeks)||0
11296449|NCT02531633|12494109|FG009|STARTED|Part A (52 Weeks)||0
11296450|NCT02531633|12494100|FG000|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
11296451|NCT02531633|12494101|FG001|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
11296452|NCT02531633|12494102|FG002|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
11296453|NCT02531633|12494103|FG003|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
11296454|NCT02531633|12494104|FG004|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
11296455|NCT02531633|12494105|FG005|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
11296456|NCT02531633|12494106|FG006|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
11296457|NCT02531633|12494107|FG007|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
11296458|NCT02531633|12494108|FG008|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
11296459|NCT02531633|12494109|FG009|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
11296460|NCT02531633|12494100|FG000|COMPLETED|Part A (52 Weeks)||8
11296461|NCT02531633|12494101|FG001|COMPLETED|Part A (52 Weeks)||5
11296462|NCT02531633|12494102|FG002|COMPLETED|Part A (52 Weeks)||4
11296463|NCT02531633|12494103|FG003|COMPLETED|Part A (52 Weeks)||5
11296464|NCT02531633|12494104|FG004|COMPLETED|Part A (52 Weeks)||4
11296465|NCT02531633|12494105|FG005|COMPLETED|Part A (52 Weeks)||0
11296466|NCT02531633|12494106|FG006|COMPLETED|Part A (52 Weeks)||0
11296467|NCT02531633|12494107|FG007|COMPLETED|Part A (52 Weeks)||0
11296468|NCT02531633|12494108|FG008|COMPLETED|Part A (52 Weeks)||0
11296469|NCT02531633|12494109|FG009|COMPLETED|Part A (52 Weeks)||0
11296470|NCT02531633|12494100|FG000|NOT COMPLETED|Part A (52 Weeks)||34
11296471|NCT02531633|12494101|FG001|NOT COMPLETED|Part A (52 Weeks)||34
11296472|NCT02531633|12494102|FG002|NOT COMPLETED|Part A (52 Weeks)||22
11296473|NCT02531633|12494103|FG003|NOT COMPLETED|Part A (52 Weeks)||22
11296474|NCT02531633|12494104|FG004|NOT COMPLETED|Part A (52 Weeks)||23
11296475|NCT02531633|12494105|FG005|NOT COMPLETED|Part A (52 Weeks)||0
11296476|NCT02531633|12494106|FG006|NOT COMPLETED|Part A (52 Weeks)||0
11296477|NCT02531633|12494107|FG007|NOT COMPLETED|Part A (52 Weeks)||0
11296478|NCT02531633|12494108|FG008|NOT COMPLETED|Part A (52 Weeks)||0
11296479|NCT02531633|12494109|FG009|NOT COMPLETED|Part A (52 Weeks)||0
11296480|NCT02531633|12494100|FG000|STARTED|Part B (104 Weeks)||0
11296481|NCT02531633|12494101|FG001|STARTED|Part B (104 Weeks)||0
11296482|NCT02531633|12494102|FG002|STARTED|Part B (104 Weeks)||0
11296483|NCT02531633|12494103|FG003|STARTED|Part B (104 Weeks)||0
11296484|NCT02531633|12494104|FG004|STARTED|Part B (104 Weeks)||0
11296485|NCT02531633|12494105|FG005|STARTED|Part B (104 Weeks)||8
11296486|NCT02531633|12494106|FG006|STARTED|Part B (104 Weeks)||5
11296487|NCT02531633|12494107|FG007|STARTED|Part B (104 Weeks)||4
11296488|NCT02531633|12494108|FG008|STARTED|Part B (104 Weeks)||5
11296489|NCT02531633|12494109|FG009|STARTED|Part B (104 Weeks)||4
11296490|NCT02531633|12494100|FG000|COMPLETED|Part B (104 Weeks)||0
11296491|NCT02531633|12494101|FG001|COMPLETED|Part B (104 Weeks)||0
11296492|NCT02531633|12494102|FG002|COMPLETED|Part B (104 Weeks)||0
11296493|NCT02531633|12494103|FG003|COMPLETED|Part B (104 Weeks)||0
11296494|NCT02531633|12494104|FG004|COMPLETED|Part B (104 Weeks)||0
11296495|NCT02531633|12494105|FG005|COMPLETED|Part B (104 Weeks)||0
11296496|NCT02531633|12494106|FG006|COMPLETED|Part B (104 Weeks)||0
11296497|NCT02531633|12494107|FG007|COMPLETED|Part B (104 Weeks)||0
11296498|NCT02531633|12494108|FG008|COMPLETED|Part B (104 Weeks)||0
11296499|NCT02531633|12494109|FG009|COMPLETED|Part B (104 Weeks)||0
11296500|NCT02531633|12494100|FG000|NOT COMPLETED|Part B (104 Weeks)||0
11296501|NCT02531633|12494101|FG001|NOT COMPLETED|Part B (104 Weeks)||0
11296502|NCT02531633|12494102|FG002|NOT COMPLETED|Part B (104 Weeks)||0
11296503|NCT02531633|12494103|FG003|NOT COMPLETED|Part B (104 Weeks)||0
11296504|NCT02531633|12494104|FG004|NOT COMPLETED|Part B (104 Weeks)||0
11296505|NCT02531633|12494105|FG005|NOT COMPLETED|Part B (104 Weeks)||8
11296506|NCT02531633|12494106|FG006|NOT COMPLETED|Part B (104 Weeks)||5
11296507|NCT02531633|12494107|FG007|NOT COMPLETED|Part B (104 Weeks)||4
11296508|NCT02531633|12494108|FG008|NOT COMPLETED|Part B (104 Weeks)||5
11296509|NCT02531633|12494109|FG009|NOT COMPLETED|Part B (104 Weeks)||4
11296510|NCT02531646|12494152|FG000|STARTED|Overall Study||37
11296511|NCT02531646|12494153|FG001|STARTED|Overall Study||18
11296512|NCT02531646|12494154|FG002|STARTED|Overall Study||11
11296513|NCT02531646|12494152|FG000|COMPLETED|Overall Study||32
11296514|NCT02531646|12494153|FG001|COMPLETED|Overall Study||17
11296515|NCT02531646|12494154|FG002|COMPLETED|Overall Study||11
11296516|NCT02531646|12494152|FG000|NOT COMPLETED|Overall Study||5
11296517|NCT02531646|12494153|FG001|NOT COMPLETED|Overall Study||1
11296518|NCT02531646|12494154|FG002|NOT COMPLETED|Overall Study||0
11296519|NCT02531698|12494164|FG000|STARTED|Overall Study||294
11296520|NCT02531698|12494165|FG001|STARTED|Overall Study||106
11296521|NCT02531698|12494164|FG000|COMPLETED|Overall Study||283
11296522|NCT02531698|12494165|FG001|COMPLETED|Overall Study||104
11296523|NCT02531698|12494164|FG000|NOT COMPLETED|Overall Study||11
11296524|NCT02531698|12494165|FG001|NOT COMPLETED|Overall Study||2
11296525|NCT02531802|12494201|FG000|STARTED|Received Vaccination 1||15
11296526|NCT02531802|12494202|FG001|STARTED|Received Vaccination 1||15
11296527|NCT02531802|12494203|FG002|STARTED|Received Vaccination 1||15
11296528|NCT02531802|12494204|FG003|STARTED|Received Vaccination 1||15
11296529|NCT02531802|12494205|FG004|STARTED|Received Vaccination 1||15
11296530|NCT02531802|12494206|FG005|STARTED|Received Vaccination 1||3
11296531|NCT02531802|12494207|FG006|STARTED|Received Vaccination 1||15
11296532|NCT02531802|12494208|FG007|STARTED|Received Vaccination 1||15
11296533|NCT02531802|12494209|FG008|STARTED|Received Vaccination 1||15
11296534|NCT02531802|12494210|FG009|STARTED|Received Vaccination 1||52
11296535|NCT02531802|12494211|FG010|STARTED|Received Vaccination 1||15
11296536|NCT02531802|12494212|FG011|STARTED|Received Vaccination 1||15
11296537|NCT02531802|12494213|FG012|STARTED|Received Vaccination 1||15
11296538|NCT02531802|12494214|FG013|STARTED|Received Vaccination 1||15
11296539|NCT02531802|12494215|FG014|STARTED|Received Vaccination 1||40
11296540|NCT02531802|12494216|FG015|STARTED|Received Vaccination 1||30
11296541|NCT02531802|12494217|FG016|STARTED|Received Vaccination 1||30
11296542|NCT02531802|12494218|FG017|STARTED|Received Vaccination 1||30
11296543|NCT02531802|12494219|FG018|STARTED|Received Vaccination 1||30
11296544|NCT02531802|12494220|FG019|STARTED|Received Vaccination 1||30
11296545|NCT02531802|12494221|FG020|STARTED|Received Vaccination 1||50
11296546|NCT02531802|12494201|FG000|COMPLETED|Received Vaccination 1||15
11296547|NCT02531802|12494202|FG001|COMPLETED|Received Vaccination 1||15
11296548|NCT02531802|12494203|FG002|COMPLETED|Received Vaccination 1||15
11296549|NCT02531802|12494204|FG003|COMPLETED|Received Vaccination 1||15
11296550|NCT02531802|12494205|FG004|COMPLETED|Received Vaccination 1||15
11296551|NCT02531802|12494206|FG005|COMPLETED|Received Vaccination 1||3
11296552|NCT02531802|12494207|FG006|COMPLETED|Received Vaccination 1||15
11296553|NCT02531802|12494208|FG007|COMPLETED|Received Vaccination 1||15
11296554|NCT02531802|12494209|FG008|COMPLETED|Received Vaccination 1||15
11296555|NCT02531802|12494210|FG009|COMPLETED|Received Vaccination 1||52
11296556|NCT02531802|12494211|FG010|COMPLETED|Received Vaccination 1||15
11296557|NCT02531802|12494212|FG011|COMPLETED|Received Vaccination 1||15
11296558|NCT02531802|12494213|FG012|COMPLETED|Received Vaccination 1||15
11296559|NCT02531802|12494214|FG013|COMPLETED|Received Vaccination 1||15
11296560|NCT02531802|12494215|FG014|COMPLETED|Received Vaccination 1||40
11296561|NCT02531802|12494216|FG015|COMPLETED|Received Vaccination 1||30
11296562|NCT02531802|12494217|FG016|COMPLETED|Received Vaccination 1||30
11296563|NCT02531802|12494218|FG017|COMPLETED|Received Vaccination 1||30
11296564|NCT02531802|12494219|FG018|COMPLETED|Received Vaccination 1||30
11296565|NCT02531802|12494220|FG019|COMPLETED|Received Vaccination 1||30
11296566|NCT02531802|12494221|FG020|COMPLETED|Received Vaccination 1||50
11296567|NCT02531802|12494201|FG000|NOT COMPLETED|Received Vaccination 1||0
11296568|NCT02531802|12494202|FG001|NOT COMPLETED|Received Vaccination 1||0
11296569|NCT02531802|12494203|FG002|NOT COMPLETED|Received Vaccination 1||0
11296570|NCT02531802|12494204|FG003|NOT COMPLETED|Received Vaccination 1||0
11296571|NCT02531802|12494205|FG004|NOT COMPLETED|Received Vaccination 1||0
11296572|NCT02531802|12494206|FG005|NOT COMPLETED|Received Vaccination 1||0
11296573|NCT02531802|12494207|FG006|NOT COMPLETED|Received Vaccination 1||0
11296574|NCT02531802|12494208|FG007|NOT COMPLETED|Received Vaccination 1||0
11296575|NCT02531802|12494209|FG008|NOT COMPLETED|Received Vaccination 1||0
11296576|NCT02531802|12494210|FG009|NOT COMPLETED|Received Vaccination 1||0
11296577|NCT02531802|12494211|FG010|NOT COMPLETED|Received Vaccination 1||0
11296578|NCT02531802|12494212|FG011|NOT COMPLETED|Received Vaccination 1||0
11296579|NCT02531802|12494213|FG012|NOT COMPLETED|Received Vaccination 1||0
11296580|NCT02531802|12494214|FG013|NOT COMPLETED|Received Vaccination 1||0
11296581|NCT02531802|12494215|FG014|NOT COMPLETED|Received Vaccination 1||0
11296582|NCT02531802|12494216|FG015|NOT COMPLETED|Received Vaccination 1||0
11296583|NCT02531802|12494217|FG016|NOT COMPLETED|Received Vaccination 1||0
11296584|NCT02531802|12494218|FG017|NOT COMPLETED|Received Vaccination 1||0
11296585|NCT02531802|12494219|FG018|NOT COMPLETED|Received Vaccination 1||0
11296586|NCT02531802|12494220|FG019|NOT COMPLETED|Received Vaccination 1||0
11296587|NCT02531802|12494221|FG020|NOT COMPLETED|Received Vaccination 1||0
11296588|NCT02531802|12494201|FG000|STARTED|Received Vaccination 2||15
11296589|NCT02531802|12494202|FG001|STARTED|Received Vaccination 2||15
11296590|NCT02531802|12494203|FG002|STARTED|Received Vaccination 2||15
11296591|NCT02531802|12494204|FG003|STARTED|Received Vaccination 2||15
11296592|NCT02531802|12494205|FG004|STARTED|Received Vaccination 2||15
11296593|NCT02531802|12494206|FG005|STARTED|Received Vaccination 2||3
11296594|NCT02531802|12494207|FG006|STARTED|Received Vaccination 2||15
11296595|NCT02531802|12494208|FG007|STARTED|Received Vaccination 2||15
11296596|NCT02531802|12494209|FG008|STARTED|Received Vaccination 2||15
11296597|NCT02531802|12494210|FG009|STARTED|Received Vaccination 2||52
11296598|NCT02531802|12494211|FG010|STARTED|Received Vaccination 2||15
11296599|NCT02531802|12494212|FG011|STARTED|Received Vaccination 2||15
11296600|NCT02531802|12494213|FG012|STARTED|Received Vaccination 2||15
11296601|NCT02531802|12494214|FG013|STARTED|Received Vaccination 2||15
11296602|NCT02531802|12494215|FG014|STARTED|Received Vaccination 2||40
11296603|NCT02531802|12494216|FG015|STARTED|Received Vaccination 2||30
11296604|NCT02531802|12494217|FG016|STARTED|Received Vaccination 2||30
11296605|NCT02531802|12494218|FG017|STARTED|Received Vaccination 2||30
11296606|NCT02531802|12494219|FG018|STARTED|Received Vaccination 2||30
11296607|NCT02531802|12494220|FG019|STARTED|Received Vaccination 2||30
11296608|NCT02531802|12494221|FG020|STARTED|Received Vaccination 2||50
11296609|NCT02531802|12494201|FG000|COMPLETED|Received Vaccination 2||15
11296610|NCT02531802|12494202|FG001|COMPLETED|Received Vaccination 2||15
11296611|NCT02531802|12494203|FG002|COMPLETED|Received Vaccination 2||14
11296612|NCT02531802|12494204|FG003|COMPLETED|Received Vaccination 2||15
11296613|NCT02531802|12494205|FG004|COMPLETED|Received Vaccination 2||15
11296614|NCT02531802|12494206|FG005|COMPLETED|Received Vaccination 2||0
11296615|NCT02531802|12494207|FG006|COMPLETED|Received Vaccination 2||15
11296616|NCT02531802|12494208|FG007|COMPLETED|Received Vaccination 2||15
11296617|NCT02531802|12494209|FG008|COMPLETED|Received Vaccination 2||15
11296618|NCT02531802|12494210|FG009|COMPLETED|Received Vaccination 2||49
11296619|NCT02531802|12494211|FG010|COMPLETED|Received Vaccination 2||13
11296620|NCT02531802|12494212|FG011|COMPLETED|Received Vaccination 2||15
11296621|NCT02531802|12494213|FG012|COMPLETED|Received Vaccination 2||13
11296622|NCT02531802|12494214|FG013|COMPLETED|Received Vaccination 2||13
11296623|NCT02531802|12494215|FG014|COMPLETED|Received Vaccination 2||39
11296624|NCT02531802|12494216|FG015|COMPLETED|Received Vaccination 2||30
11296625|NCT02531802|12494217|FG016|COMPLETED|Received Vaccination 2||30
11296626|NCT02531802|12494218|FG017|COMPLETED|Received Vaccination 2||26
11296627|NCT02531802|12494219|FG018|COMPLETED|Received Vaccination 2||27
11296628|NCT02531802|12494220|FG019|COMPLETED|Received Vaccination 2||29
11296629|NCT02531802|12494221|FG020|COMPLETED|Received Vaccination 2||49
11296630|NCT02531802|12494201|FG000|NOT COMPLETED|Received Vaccination 2||0
11296631|NCT02531802|12494202|FG001|NOT COMPLETED|Received Vaccination 2||0
11296632|NCT02531802|12494203|FG002|NOT COMPLETED|Received Vaccination 2||1
11296633|NCT02531802|12494204|FG003|NOT COMPLETED|Received Vaccination 2||0
11296634|NCT02531802|12494205|FG004|NOT COMPLETED|Received Vaccination 2||0
11296635|NCT02531802|12494206|FG005|NOT COMPLETED|Received Vaccination 2||3
11296636|NCT02531802|12494207|FG006|NOT COMPLETED|Received Vaccination 2||0
11296637|NCT02531802|12494208|FG007|NOT COMPLETED|Received Vaccination 2||0
11296638|NCT02531802|12494209|FG008|NOT COMPLETED|Received Vaccination 2||0
11296639|NCT02531802|12494210|FG009|NOT COMPLETED|Received Vaccination 2||3
11296640|NCT02531802|12494211|FG010|NOT COMPLETED|Received Vaccination 2||2
11296641|NCT02531802|12494212|FG011|NOT COMPLETED|Received Vaccination 2||0
11296642|NCT02531802|12494213|FG012|NOT COMPLETED|Received Vaccination 2||2
11296643|NCT02531802|12494214|FG013|NOT COMPLETED|Received Vaccination 2||2
11296644|NCT02531802|12494215|FG014|NOT COMPLETED|Received Vaccination 2||1
11296645|NCT02531802|12494216|FG015|NOT COMPLETED|Received Vaccination 2||0
11296646|NCT02531802|12494217|FG016|NOT COMPLETED|Received Vaccination 2||0
11296647|NCT02531802|12494218|FG017|NOT COMPLETED|Received Vaccination 2||4
11296648|NCT02531802|12494219|FG018|NOT COMPLETED|Received Vaccination 2||3
11296649|NCT02531802|12494220|FG019|NOT COMPLETED|Received Vaccination 2||1
11296650|NCT02531802|12494221|FG020|NOT COMPLETED|Received Vaccination 2||1
11296651|NCT02531867|12494294|FG000|STARTED|Overall Study||13
11296652|NCT02531867|12494294|FG000|COMPLETED|Overall Study||13
11296653|NCT02531867|12494294|FG000|NOT COMPLETED|Overall Study||0
11296654|NCT02531971|12494300|FG000|STARTED|Overall Study||11
11296655|NCT02531971|12494301|FG001|STARTED|Overall Study||13
11296656|NCT02531971|12494300|FG000|COMPLETED|Overall Study||11
11296657|NCT02531971|12494301|FG001|COMPLETED|Overall Study||13
11296658|NCT02531971|12494300|FG000|NOT COMPLETED|Overall Study||0
11296659|NCT02531971|12494301|FG001|NOT COMPLETED|Overall Study||0
11296660|NCT02532010|12494310|FG000|STARTED|Overall Study||9
11296661|NCT02532010|12494311|FG001|STARTED|Overall Study||4
11296662|NCT02532010|12494310|FG000|COMPLETED|Overall Study||0
11296663|NCT02532010|12494311|FG001|COMPLETED|Overall Study||0
11296664|NCT02532010|12494310|FG000|NOT COMPLETED|Overall Study||9
11296665|NCT02532010|12494311|FG001|NOT COMPLETED|Overall Study||4
11296666|NCT02532036|12494317|FG000|STARTED|Overall Study||2
11296667|NCT02532036|12494318|FG001|STARTED|Overall Study||0
11296668|NCT02532036|12494317|FG000|COMPLETED|Overall Study||2
11296669|NCT02532036|12494318|FG001|COMPLETED|Overall Study||0
11296670|NCT02532036|12494317|FG000|NOT COMPLETED|Overall Study||0
11296671|NCT02532036|12494318|FG001|NOT COMPLETED|Overall Study||0
11296672|NCT02532179|12494322|FG000|STARTED|Overall Study||12
11296673|NCT02532179|12494322|FG000|COMPLETED|Overall Study||9
11296674|NCT02532179|12494322|FG000|NOT COMPLETED|Overall Study||3
11296675|NCT02532283|12494328|FG000|STARTED|Overall Study||64
11296676|NCT02532283|12494329|FG001|STARTED|Overall Study||35
11296677|NCT02532283|12494328|FG000|Full Analysis Set|Overall Study||63
11296678|NCT02532283|12494329|FG001|Full Analysis Set|Overall Study||32
11296679|NCT02532283|12494328|FG000|COMPLETED|Overall Study||55
11296680|NCT02532283|12494329|FG001|COMPLETED|Overall Study||30
11296681|NCT02532283|12494328|FG000|NOT COMPLETED|Overall Study||9
11296682|NCT02532283|12494329|FG001|NOT COMPLETED|Overall Study||5
11296683|NCT02532374|12494337|FG000|STARTED|Overall Study||16
11296684|NCT02532374|12494337|FG000|Nicorette Inhalator (Visit 3)|Overall Study||15
11296685|NCT02532374|12494337|FG000|P3L 50 μg/Puff (Visit 4)|Overall Study||15
11296686|NCT02532374|12494337|FG000|P3L 80 μg/Puff (Visit 5)|Overall Study||14
11296687|NCT02532374|12494337|FG000|P3L150 μg/Puff (Visit 6)|Overall Study||14
11296688|NCT02532374|12494337|FG000|COMPLETED|Overall Study||14
11296689|NCT02532374|12494337|FG000|NOT COMPLETED|Overall Study||2
11296690|NCT02532465|12494351|FG000|STARTED|Overall Study||25
11296691|NCT02532465|12494352|FG001|STARTED|Overall Study||25
11296692|NCT02532465|12494351|FG000|COMPLETED|Overall Study||24
11296693|NCT02532465|12494352|FG001|COMPLETED|Overall Study||24
11296694|NCT02532465|12494351|FG000|NOT COMPLETED|Overall Study||1
11296695|NCT02532465|12494352|FG001|NOT COMPLETED|Overall Study||1
11341323|NCT02931539|12538659|FG000|COMPLETED|Period 2: Maribavir Rescue Therapy||0
11341324|NCT02931539|12538660|FG001|COMPLETED|Period 2: Maribavir Rescue Therapy||0
11341325|NCT02931539|12538661|FG002|COMPLETED|Period 2: Maribavir Rescue Therapy||20
11341326|NCT02931539|12538659|FG000|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0
11341327|NCT02931539|12538660|FG001|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0
11341328|NCT02931539|12538661|FG002|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||2
11341329|NCT02931565|12538676|FG000|STARTED|Overall Study||2
11341330|NCT02931565|12538677|FG001|STARTED|Overall Study||7
11341331|NCT02931565|12538676|FG000|COMPLETED|Overall Study||2
11341332|NCT02931565|12538677|FG001|COMPLETED|Overall Study||7
11341333|NCT02931565|12538676|FG000|NOT COMPLETED|Overall Study||0
11341334|NCT02931565|12538677|FG001|NOT COMPLETED|Overall Study||0
11341335|NCT02931838|12538690|FG000|STARTED|Overall Study||45
11341336|NCT02931838|12538691|FG001|STARTED|Overall Study||44
11341337|NCT02931838|12538692|FG002|STARTED|Overall Study||44
11341338|NCT02931838|12538693|FG003|STARTED|Overall Study||45
11341339|NCT02931838|12538694|FG004|STARTED|Overall Study||45
11341340|NCT02931838|12538695|FG005|STARTED|Overall Study||44
11341341|NCT02931838|12538690|FG000|COMPLETED|Overall Study||31
11341342|NCT02931838|12538691|FG001|COMPLETED|Overall Study||34
11341343|NCT02931838|12538692|FG002|COMPLETED|Overall Study||36
11341344|NCT02931838|12538693|FG003|COMPLETED|Overall Study||42
11341345|NCT02931838|12538694|FG004|COMPLETED|Overall Study||39
11341346|NCT02931838|12538695|FG005|COMPLETED|Overall Study||42
11341347|NCT02931838|12538690|FG000|NOT COMPLETED|Overall Study||14
11341348|NCT02931838|12538691|FG001|NOT COMPLETED|Overall Study||10
11341349|NCT02931838|12538692|FG002|NOT COMPLETED|Overall Study||8
11341350|NCT02931838|12538693|FG003|NOT COMPLETED|Overall Study||3
11341351|NCT02931838|12538694|FG004|NOT COMPLETED|Overall Study||6
11341352|NCT02931838|12538695|FG005|NOT COMPLETED|Overall Study||2
11341353|NCT02932228|12538716|FG000|STARTED|Overall Study||150
11341354|NCT02932228|12538717|FG001|STARTED|Overall Study||433
11341355|NCT02932228|12538716|FG000|COMPLETED|Overall Study||140
11341356|NCT02932228|12538717|FG001|COMPLETED|Overall Study||405
11341357|NCT02932228|12538716|FG000|NOT COMPLETED|Overall Study||10
11341358|NCT02932228|12538717|FG001|NOT COMPLETED|Overall Study||28
11341359|NCT02932267|12538725|FG000|STARTED|Overall Study||50
11341360|NCT02932267|12538725|FG000|COMPLETED|Overall Study||42
11341361|NCT02932267|12538725|FG000|NOT COMPLETED|Overall Study||8
11341362|NCT02932306|12538731|FG000|STARTED|Overall Study||406
11341363|NCT02932306|12538732|FG001|STARTED|Overall Study||414
11341364|NCT02932306|12538731|FG000|Intent-to-treat (ITT) Population|Overall Study||406
11341365|NCT02932306|12538732|FG001|Intent-to-treat (ITT) Population|Overall Study||414
11341366|NCT02932306|12538731|FG000|Safety Population|Overall Study||378
11341367|NCT02932306|12538732|FG001|Safety Population|Overall Study||385
11341368|NCT02932306|12538731|FG000|COMPLETED|Overall Study||338
11341369|NCT02932306|12538732|FG001|COMPLETED|Overall Study||337
11341370|NCT02932306|12538731|FG000|NOT COMPLETED|Overall Study||68
11341371|NCT02932306|12538732|FG001|NOT COMPLETED|Overall Study||77
11341372|NCT02932462|12538740|FG000|STARTED|Overall Study||184
11341373|NCT02932462|12538741|FG001|STARTED|Overall Study||189
11341374|NCT02932462|12538740|FG000|COMPLETED|Overall Study||177
11341375|NCT02932462|12538741|FG001|COMPLETED|Overall Study||176
11341376|NCT02932462|12538740|FG000|NOT COMPLETED|Overall Study||7
11341377|NCT02932462|12538741|FG001|NOT COMPLETED|Overall Study||13
11341378|NCT02932787|12538749|FG000|STARTED|Overall Study||22
11341379|NCT02932787|12538750|FG001|STARTED|Overall Study||9
11341380|NCT02932787|12538749|FG000|COMPLETED|Overall Study||22
11341381|NCT02932787|12538750|FG001|COMPLETED|Overall Study||9
11341382|NCT02932787|12538749|FG000|NOT COMPLETED|Overall Study||0
11341383|NCT02932787|12538750|FG001|NOT COMPLETED|Overall Study||0
11343960|NCT02957942|12541278|FG001|STARTED|Overall Study|7 healthy individuals were recruited as control; 6 were recruited for practicing experiment details.|13
11343961|NCT02957942|12541277|FG000|COMPLETED|Overall Study||7
11343962|NCT02957942|12541278|FG001|COMPLETED|Overall Study||6
11343963|NCT02957942|12541277|FG000|NOT COMPLETED|Overall Study||0
11343964|NCT02957942|12541278|FG001|NOT COMPLETED|Overall Study||7
11343965|NCT02958267|12541286|FG000|STARTED|Enrollment||17
11343966|NCT02958267|12541287|FG001|STARTED|Enrollment||15
11343967|NCT02958267|12541286|FG000|COMPLETED|Enrollment||17
11343968|NCT02958267|12541287|FG001|COMPLETED|Enrollment||15
11343969|NCT02958267|12541286|FG000|NOT COMPLETED|Enrollment||0
11343970|NCT02958267|12541287|FG001|NOT COMPLETED|Enrollment||0
11343971|NCT02958267|12541286|FG000|STARTED|Enrollment to Actual Treatment Complete||17
11343972|NCT02958267|12541287|FG001|STARTED|Enrollment to Actual Treatment Complete||15
11343973|NCT02958267|12541286|FG000|COMPLETED|Enrollment to Actual Treatment Complete||15
11343974|NCT02958267|12541287|FG001|COMPLETED|Enrollment to Actual Treatment Complete||15
11343975|NCT02958267|12541286|FG000|NOT COMPLETED|Enrollment to Actual Treatment Complete||2
11343976|NCT02958267|12541287|FG001|NOT COMPLETED|Enrollment to Actual Treatment Complete||0
11343977|NCT02958267|12541286|FG000|STARTED|Follow-up Visits||15
11343978|NCT02958267|12541287|FG001|STARTED|Follow-up Visits||15
11343979|NCT02958267|12541286|FG000|3 Month Follow-up|Follow-up Visits||15
11343980|NCT02958267|12541287|FG001|3 Month Follow-up|Follow-up Visits||15
11296696|NCT02532517|12494358|FG000|STARTED|Overall Study||45
11296697|NCT02532517|12494358|FG000|mITT Analysis Set|Overall Study||44
11296698|NCT02532517|12494358|FG000|COMPLETED|Overall Study||28
11296699|NCT02532517|12494358|FG000|NOT COMPLETED|Overall Study||17
11296700|NCT02532543|12494366|FG000|STARTED|Overall Study||3
11296701|NCT02532543|12494367|FG001|STARTED|Overall Study||4
11296702|NCT02532543|12494368|FG002|STARTED|Overall Study||5
11296703|NCT02532543|12494369|FG003|STARTED|Overall Study||4
11296704|NCT02532543|12494366|FG000|COMPLETED|Overall Study||3
11296705|NCT02532543|12494367|FG001|COMPLETED|Overall Study||4
11296706|NCT02532543|12494368|FG002|COMPLETED|Overall Study||4
11296707|NCT02532543|12494369|FG003|COMPLETED|Overall Study||4
11296708|NCT02532543|12494366|FG000|NOT COMPLETED|Overall Study||0
11296709|NCT02532543|12494367|FG001|NOT COMPLETED|Overall Study||0
11296710|NCT02532543|12494368|FG002|NOT COMPLETED|Overall Study||1
11296711|NCT02532543|12494369|FG003|NOT COMPLETED|Overall Study||0
11296712|NCT02532556|12494379|FG000|STARTED|Overall Study||12
11296713|NCT02532556|12494379|FG000|COMPLETED|Overall Study||12
11296714|NCT02532556|12494379|FG000|NOT COMPLETED|Overall Study||0
11296715|NCT02532647|12494392|FG000|STARTED|Overall Study||32
11296716|NCT02532647|12494393|FG001|STARTED|Overall Study||16
11296717|NCT02532647|12494394|FG002|STARTED|Overall Study||31
11296718|NCT02532647|12494392|FG000|Safety Population|Overall Study||31
11296719|NCT02532647|12494393|FG001|Safety Population|Overall Study||16
11296720|NCT02532647|12494394|FG002|Safety Population|Overall Study||30
11296721|NCT02532647|12494392|FG000|COMPLETED|Overall Study||31
11296722|NCT02532647|12494393|FG001|COMPLETED|Overall Study||16
11296723|NCT02532647|12494394|FG002|COMPLETED|Overall Study||30
11296724|NCT02532647|12494392|FG000|NOT COMPLETED|Overall Study||1
11296725|NCT02532647|12494393|FG001|NOT COMPLETED|Overall Study||0
11296726|NCT02532647|12494394|FG002|NOT COMPLETED|Overall Study||1
11296727|NCT02532764|12494412|FG000|STARTED|Single Ascending Dose (SAD) Cohorts||6
11021928|NCT00806585|12200107|FG000|NOT COMPLETED|Overall Study||32
11021929|NCT00806585|12200108|FG001|NOT COMPLETED|Overall Study||31
11021930|NCT00806585|12200109|FG002|NOT COMPLETED|Overall Study||32
11296728|NCT02532764|12494413|FG001|STARTED|Single Ascending Dose (SAD) Cohorts||6
11296729|NCT02532764|12494414|FG002|STARTED|Single Ascending Dose (SAD) Cohorts||9
11296730|NCT02532764|12494415|FG003|STARTED|Single Ascending Dose (SAD) Cohorts||6
11296731|NCT02532764|12494416|FG004|STARTED|Single Ascending Dose (SAD) Cohorts||9
11296732|NCT02532764|12494417|FG005|STARTED|Single Ascending Dose (SAD) Cohorts||0
11296733|NCT02532764|12494418|FG006|STARTED|Single Ascending Dose (SAD) Cohorts||0
11296734|NCT02532764|12494419|FG007|STARTED|Single Ascending Dose (SAD) Cohorts||0
11400754|NCT04176406|12595457|FG003|STARTED|Overall Study||0
11400755|NCT04176406|12595454|FG000|COMPLETED|Overall Study||0
11400756|NCT04176406|12595455|FG001|COMPLETED|Overall Study||0
11400757|NCT04176406|12595456|FG002|COMPLETED|Overall Study||0
11400758|NCT04176406|12595457|FG003|COMPLETED|Overall Study||0
11400759|NCT04176406|12595454|FG000|NOT COMPLETED|Overall Study||0
11296735|NCT02532764|12494420|FG008|STARTED|Single Ascending Dose (SAD) Cohorts||0
11296736|NCT02532764|12494421|FG009|STARTED|Single Ascending Dose (SAD) Cohorts||0
11296737|NCT02532764|12494412|FG000|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
11296738|NCT02532764|12494413|FG001|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
11296739|NCT02532764|12494414|FG002|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
11296740|NCT02532764|12494415|FG003|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
11296741|NCT02532764|12494416|FG004|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
11296742|NCT02532764|12494417|FG005|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296743|NCT02532764|12494418|FG006|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296744|NCT02532764|12494419|FG007|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296745|NCT02532764|12494420|FG008|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296746|NCT02532764|12494421|FG009|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296747|NCT02532764|12494412|FG000|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296748|NCT02532764|12494413|FG001|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296749|NCT02532764|12494414|FG002|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296750|NCT02532764|12494415|FG003|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296751|NCT02532764|12494416|FG004|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296752|NCT02532764|12494417|FG005|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296753|NCT02532764|12494418|FG006|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296754|NCT02532764|12494419|FG007|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296755|NCT02532764|12494420|FG008|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296756|NCT02532764|12494421|FG009|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
11296757|NCT02532764|12494412|FG000|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
11296758|NCT02532764|12494413|FG001|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
11296759|NCT02532764|12494414|FG002|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
11296760|NCT02532764|12494415|FG003|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
11296761|NCT02532764|12494416|FG004|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
11296762|NCT02532764|12494417|FG005|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
11296763|NCT02532764|12494418|FG006|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
11296764|NCT02532764|12494419|FG007|STARTED|Multiple Ascending Dose (MAD) Cohorst||7
11296765|NCT02532764|12494420|FG008|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
11296766|NCT02532764|12494421|FG009|STARTED|Multiple Ascending Dose (MAD) Cohorst||9
11296767|NCT02532764|12494412|FG000|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
11400760|NCT04176406|12595455|FG001|NOT COMPLETED|Overall Study||0
11400761|NCT04176406|12595456|FG002|NOT COMPLETED|Overall Study||0
11021931|NCT00806585|12200110|FG003|NOT COMPLETED|Overall Study||15
11021932|NCT00806585|12200111|FG004|NOT COMPLETED|Overall Study||31
11021933|NCT00806598|12200123|FG000|STARTED|Overall Study||48
11296768|NCT02532764|12494413|FG001|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
11296769|NCT02532764|12494414|FG002|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
11296770|NCT02532764|12494415|FG003|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
11296771|NCT02532764|12494416|FG004|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
11296772|NCT02532764|12494417|FG005|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
11296773|NCT02532764|12494418|FG006|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
11296774|NCT02532764|12494419|FG007|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
11296775|NCT02532764|12494420|FG008|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5
11296776|NCT02532764|12494421|FG009|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8
11296777|NCT02532764|12494412|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
11296778|NCT02532764|12494413|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
11296779|NCT02532764|12494414|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
11296780|NCT02532764|12494415|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
11296781|NCT02532764|12494416|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
11296782|NCT02532764|12494417|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
11296783|NCT02532764|12494418|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
11296784|NCT02532764|12494419|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
11296785|NCT02532764|12494420|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
11296786|NCT02532764|12494421|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
11296787|NCT02532855|12494450|FG000|STARTED|Overall Study||307
11296788|NCT02532855|12494451|FG001|STARTED|Overall Study||307
11296789|NCT02532855|12494450|FG000|Treated|Overall Study||307
11296790|NCT02532855|12494451|FG001|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
11296791|NCT02532855|12494450|FG000|COMPLETED|Overall Study||299
11296792|NCT02532855|12494451|FG001|COMPLETED|Overall Study||296
11296793|NCT02532855|12494450|FG000|NOT COMPLETED|Overall Study||8
11296794|NCT02532855|12494451|FG001|NOT COMPLETED|Overall Study||11
11296795|NCT02532933|12494459|FG000|STARTED|Overall Study||22
11296796|NCT02532933|12494460|FG001|STARTED|Overall Study||22
11296797|NCT02532933|12494459|FG000|COMPLETED|Overall Study||16
11296798|NCT02532933|12494460|FG001|COMPLETED|Overall Study||16
11296799|NCT02532933|12494459|FG000|NOT COMPLETED|Overall Study||6
11296800|NCT02532933|12494460|FG001|NOT COMPLETED|Overall Study||6
11296801|NCT02532972|12494466|FG000|STARTED|Overall Study||11
11296802|NCT02532972|12494466|FG000|COMPLETED|Overall Study||10
11296803|NCT02532972|12494466|FG000|NOT COMPLETED|Overall Study||1
11296804|NCT02532998|12494470|FG000|STARTED|Overall Study||23
11296805|NCT02532998|12494470|FG000|COMPLETED|Overall Study||23
11296806|NCT02532998|12494470|FG000|NOT COMPLETED|Overall Study||0
11296807|NCT02533063|12494486|FG000|STARTED|Intervention 1 (8 Weeks)||16
11296808|NCT02533063|12494487|FG001|STARTED|Intervention 1 (8 Weeks)||16
11296809|NCT02533063|12494486|FG000|COMPLETED|Intervention 1 (8 Weeks)||14
11296810|NCT02533063|12494487|FG001|COMPLETED|Intervention 1 (8 Weeks)||11
11296811|NCT02533063|12494486|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||2
11296812|NCT02533063|12494487|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||5
11296813|NCT02533063|12494486|FG000|STARTED|Washout (4 Weeks)||14
11296814|NCT02533063|12494487|FG001|STARTED|Washout (4 Weeks)||11
11296815|NCT02533063|12494486|FG000|COMPLETED|Washout (4 Weeks)||14
11296816|NCT02533063|12494487|FG001|COMPLETED|Washout (4 Weeks)||11
11296817|NCT02533063|12494486|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11296818|NCT02533063|12494487|FG001|NOT COMPLETED|Washout (4 Weeks)||0
11296819|NCT02533063|12494486|FG000|STARTED|Intervention 2 (8 Weeks)||14
11296820|NCT02533063|12494487|FG001|STARTED|Intervention 2 (8 Weeks)||11
11296821|NCT02533063|12494486|FG000|COMPLETED|Intervention 2 (8 Weeks)||14
11296822|NCT02533063|12494487|FG001|COMPLETED|Intervention 2 (8 Weeks)||11
11296823|NCT02533063|12494486|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||0
11296824|NCT02533063|12494487|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||0
11296825|NCT02533089|12494496|FG000|STARTED|Overall Study||605
11296826|NCT02533089|12494497|FG001|STARTED|Overall Study||548
11296827|NCT02533089|12494496|FG000|COMPLETED|Overall Study|4 HC accrued no eligable patients 11 HC no patients with outcome data 241 cases missing outcome|364
11296828|NCT02533089|12494497|FG001|COMPLETED|Overall Study|6 HC accrued no eligible patients 8 HC no patients with outcome data 114 cases missing outcome|434
11296829|NCT02533089|12494496|FG000|NOT COMPLETED|Overall Study||241
11296830|NCT02533089|12494497|FG001|NOT COMPLETED|Overall Study||114
11296831|NCT02533167|12494503|FG000|STARTED|Overall Study||70
11296832|NCT02533167|12494503|FG000|COMPLETED|Overall Study||55
11296833|NCT02533167|12494503|FG000|NOT COMPLETED|Overall Study||15
11296834|NCT02533258|12494508|FG000|STARTED|Overall Study||13
11296835|NCT02533258|12494508|FG000|COMPLETED|Overall Study||5
11296836|NCT02533258|12494508|FG000|NOT COMPLETED|Overall Study||8
11296837|NCT02533375|12494512|FG000|STARTED|Overall Study||10
11296838|NCT02533375|12494512|FG000|COMPLETED|Overall Study||5
11296839|NCT02533375|12494512|FG000|NOT COMPLETED|Overall Study||5
11296840|NCT02533401|12494516|FG000|STARTED|Overall Study||34
11296841|NCT02533401|12494516|FG000|COMPLETED|Overall Study||23
11296842|NCT02533401|12494516|FG000|NOT COMPLETED|Overall Study||11
11296843|NCT02533427|12494520|FG000|STARTED|Overall Study||15
11296844|NCT02533427|12494520|FG000|COMPLETED|Overall Study||15
11296845|NCT02533427|12494520|FG000|NOT COMPLETED|Overall Study||0
11296846|NCT02533453|12494527|FG000|STARTED|Overall Study||110
11296847|NCT02533453|12494527|FG000|COMPLETED|Overall Study||101
11296848|NCT02533453|12494527|FG000|NOT COMPLETED|Overall Study||9
11296849|NCT02533466|12494533|FG000|STARTED|Overall Study||16
11296850|NCT02533466|12494534|FG001|STARTED|Overall Study||14
11296851|NCT02533466|12494533|FG000|COMPLETED|Overall Study||16
11296852|NCT02533466|12494534|FG001|COMPLETED|Overall Study||14
11296853|NCT02533466|12494533|FG000|NOT COMPLETED|Overall Study||0
11296854|NCT02533466|12494534|FG001|NOT COMPLETED|Overall Study||0
11296855|NCT02533505|12494542|FG000|STARTED|Overall Study||26
11296856|NCT02533505|12494543|FG001|STARTED|Overall Study||25
11296857|NCT02533505|12494542|FG000|COMPLETED|Overall Study||23
11296858|NCT02533505|12494543|FG001|COMPLETED|Overall Study||24
11296859|NCT02533505|12494542|FG000|NOT COMPLETED|Overall Study||3
11296860|NCT02533505|12494543|FG001|NOT COMPLETED|Overall Study||1
11296861|NCT02533570|12494552|FG000|STARTED|Overall Study||4
11296862|NCT02533570|12494553|FG001|STARTED|Overall Study||8
11296863|NCT02533570|12494554|FG002|STARTED|Overall Study||8
11296864|NCT02533570|12494552|FG000|COMPLETED|Overall Study||4
11296865|NCT02533570|12494553|FG001|COMPLETED|Overall Study||7
11296866|NCT02533570|12494554|FG002|COMPLETED|Overall Study||7
11296867|NCT02533570|12494552|FG000|NOT COMPLETED|Overall Study||0
11296868|NCT02533570|12494553|FG001|NOT COMPLETED|Overall Study||1
11296869|NCT02533570|12494554|FG002|NOT COMPLETED|Overall Study||1
11296870|NCT02533674|12494570|FG000|STARTED|Dose Level I||5
11296871|NCT02533674|12494571|FG001|STARTED|Dose Level I||0
11296872|NCT02533674|12494572|FG002|STARTED|Dose Level I||0
11296873|NCT02533674|12494573|FG003|STARTED|Dose Level I||0
11296874|NCT02533674|12494574|FG004|STARTED|Dose Level I||0
11296875|NCT02533674|12494575|FG005|STARTED|Dose Level I||0
11296876|NCT02533674|12494576|FG006|STARTED|Dose Level I||0
11296877|NCT02533674|12494577|FG007|STARTED|Dose Level I||0
11296878|NCT02533674|12494570|FG000|COMPLETED|Dose Level I||0
11296879|NCT02533674|12494571|FG001|COMPLETED|Dose Level I||0
11296880|NCT02533674|12494572|FG002|COMPLETED|Dose Level I||0
11296881|NCT02533674|12494573|FG003|COMPLETED|Dose Level I||0
11296882|NCT02533674|12494574|FG004|COMPLETED|Dose Level I||0
11296883|NCT02533674|12494575|FG005|COMPLETED|Dose Level I||0
11296884|NCT02533674|12494576|FG006|COMPLETED|Dose Level I||0
11296885|NCT02533674|12494577|FG007|COMPLETED|Dose Level I||0
11296886|NCT02533674|12494570|FG000|NOT COMPLETED|Dose Level I||5
11296887|NCT02533674|12494571|FG001|NOT COMPLETED|Dose Level I||0
11296888|NCT02533674|12494572|FG002|NOT COMPLETED|Dose Level I||0
11296889|NCT02533674|12494573|FG003|NOT COMPLETED|Dose Level I||0
11296890|NCT02533674|12494574|FG004|NOT COMPLETED|Dose Level I||0
11296891|NCT02533674|12494575|FG005|NOT COMPLETED|Dose Level I||0
11296892|NCT02533674|12494576|FG006|NOT COMPLETED|Dose Level I||0
11296893|NCT02533674|12494577|FG007|NOT COMPLETED|Dose Level I||0
11296894|NCT02533674|12494570|FG000|STARTED|Dose Level II||0
11296895|NCT02533674|12494571|FG001|STARTED|Dose Level II||7
11296896|NCT02533674|12494572|FG002|STARTED|Dose Level II||0
11296897|NCT02533674|12494573|FG003|STARTED|Dose Level II||0
11296898|NCT02533674|12494574|FG004|STARTED|Dose Level II||0
11296899|NCT02533674|12494575|FG005|STARTED|Dose Level II||0
11296900|NCT02533674|12494576|FG006|STARTED|Dose Level II||0
11296901|NCT02533674|12494577|FG007|STARTED|Dose Level II||0
11296902|NCT02533674|12494570|FG000|COMPLETED|Dose Level II||0
11296903|NCT02533674|12494571|FG001|COMPLETED|Dose Level II||0
11296904|NCT02533674|12494572|FG002|COMPLETED|Dose Level II||0
11296905|NCT02533674|12494573|FG003|COMPLETED|Dose Level II||0
11296906|NCT02533674|12494574|FG004|COMPLETED|Dose Level II||0
11296907|NCT02533674|12494575|FG005|COMPLETED|Dose Level II||0
11296908|NCT02533674|12494576|FG006|COMPLETED|Dose Level II||0
11296909|NCT02533674|12494577|FG007|COMPLETED|Dose Level II||0
11296910|NCT02533674|12494570|FG000|NOT COMPLETED|Dose Level II||0
11296911|NCT02533674|12494571|FG001|NOT COMPLETED|Dose Level II||7
11296912|NCT02533674|12494572|FG002|NOT COMPLETED|Dose Level II||0
11296913|NCT02533674|12494573|FG003|NOT COMPLETED|Dose Level II||0
11296914|NCT02533674|12494574|FG004|NOT COMPLETED|Dose Level II||0
11296915|NCT02533674|12494575|FG005|NOT COMPLETED|Dose Level II||0
11296916|NCT02533674|12494576|FG006|NOT COMPLETED|Dose Level II||0
11296917|NCT02533674|12494577|FG007|NOT COMPLETED|Dose Level II||0
11296918|NCT02533674|12494570|FG000|STARTED|Dose Level III||0
11296919|NCT02533674|12494571|FG001|STARTED|Dose Level III||0
11296920|NCT02533674|12494572|FG002|STARTED|Dose Level III||4
11296921|NCT02533674|12494573|FG003|STARTED|Dose Level III||0
11296922|NCT02533674|12494574|FG004|STARTED|Dose Level III||0
11296923|NCT02533674|12494575|FG005|STARTED|Dose Level III||0
11296924|NCT02533674|12494576|FG006|STARTED|Dose Level III||0
11296925|NCT02533674|12494577|FG007|STARTED|Dose Level III||0
11296926|NCT02533674|12494570|FG000|COMPLETED|Dose Level III||0
11296927|NCT02533674|12494571|FG001|COMPLETED|Dose Level III||0
11296928|NCT02533674|12494572|FG002|COMPLETED|Dose Level III||0
11296929|NCT02533674|12494573|FG003|COMPLETED|Dose Level III||0
11296930|NCT02533674|12494574|FG004|COMPLETED|Dose Level III||0
11296931|NCT02533674|12494575|FG005|COMPLETED|Dose Level III||0
11296932|NCT02533674|12494576|FG006|COMPLETED|Dose Level III||0
11296933|NCT02533674|12494577|FG007|COMPLETED|Dose Level III||0
11296934|NCT02533674|12494570|FG000|NOT COMPLETED|Dose Level III||0
11296935|NCT02533674|12494571|FG001|NOT COMPLETED|Dose Level III||0
11296936|NCT02533674|12494572|FG002|NOT COMPLETED|Dose Level III||4
11296937|NCT02533674|12494573|FG003|NOT COMPLETED|Dose Level III||0
11296938|NCT02533674|12494574|FG004|NOT COMPLETED|Dose Level III||0
11296939|NCT02533674|12494575|FG005|NOT COMPLETED|Dose Level III||0
11296940|NCT02533674|12494576|FG006|NOT COMPLETED|Dose Level III||0
11296941|NCT02533674|12494577|FG007|NOT COMPLETED|Dose Level III||0
11296942|NCT02533674|12494570|FG000|STARTED|Dose Level IV||0
11296943|NCT02533674|12494571|FG001|STARTED|Dose Level IV||0
11296944|NCT02533674|12494572|FG002|STARTED|Dose Level IV||0
11296945|NCT02533674|12494573|FG003|STARTED|Dose Level IV||5
11296946|NCT02533674|12494574|FG004|STARTED|Dose Level IV||0
11296947|NCT02533674|12494575|FG005|STARTED|Dose Level IV||0
11296948|NCT02533674|12494576|FG006|STARTED|Dose Level IV||0
11296949|NCT02533674|12494577|FG007|STARTED|Dose Level IV||0
11296950|NCT02533674|12494570|FG000|COMPLETED|Dose Level IV||0
11296951|NCT02533674|12494571|FG001|COMPLETED|Dose Level IV||0
11296952|NCT02533674|12494572|FG002|COMPLETED|Dose Level IV||0
11296953|NCT02533674|12494573|FG003|COMPLETED|Dose Level IV||0
11296954|NCT02533674|12494574|FG004|COMPLETED|Dose Level IV||0
11296955|NCT02533674|12494575|FG005|COMPLETED|Dose Level IV||0
11296956|NCT02533674|12494576|FG006|COMPLETED|Dose Level IV||0
11296957|NCT02533674|12494577|FG007|COMPLETED|Dose Level IV||0
11296958|NCT02533674|12494570|FG000|NOT COMPLETED|Dose Level IV||0
11296959|NCT02533674|12494571|FG001|NOT COMPLETED|Dose Level IV||0
11296960|NCT02533674|12494572|FG002|NOT COMPLETED|Dose Level IV||0
11296961|NCT02533674|12494573|FG003|NOT COMPLETED|Dose Level IV||5
11296962|NCT02533674|12494574|FG004|NOT COMPLETED|Dose Level IV||0
11296963|NCT02533674|12494575|FG005|NOT COMPLETED|Dose Level IV||0
11296964|NCT02533674|12494576|FG006|NOT COMPLETED|Dose Level IV||0
11296965|NCT02533674|12494577|FG007|NOT COMPLETED|Dose Level IV||0
11296966|NCT02533674|12494570|FG000|STARTED|Dose Level V||0
11296967|NCT02533674|12494571|FG001|STARTED|Dose Level V||0
11296968|NCT02533674|12494572|FG002|STARTED|Dose Level V||0
11296969|NCT02533674|12494573|FG003|STARTED|Dose Level V||0
11296970|NCT02533674|12494574|FG004|STARTED|Dose Level V||5
11296971|NCT02533674|12494575|FG005|STARTED|Dose Level V||0
11296972|NCT02533674|12494576|FG006|STARTED|Dose Level V||0
11296973|NCT02533674|12494577|FG007|STARTED|Dose Level V||0
11296974|NCT02533674|12494570|FG000|COMPLETED|Dose Level V||0
11296975|NCT02533674|12494571|FG001|COMPLETED|Dose Level V||0
11296976|NCT02533674|12494572|FG002|COMPLETED|Dose Level V||0
11296977|NCT02533674|12494573|FG003|COMPLETED|Dose Level V||0
11296978|NCT02533674|12494574|FG004|COMPLETED|Dose Level V||0
11296979|NCT02533674|12494575|FG005|COMPLETED|Dose Level V||0
11296980|NCT02533674|12494576|FG006|COMPLETED|Dose Level V||0
11296981|NCT02533674|12494577|FG007|COMPLETED|Dose Level V||0
11296982|NCT02533674|12494570|FG000|NOT COMPLETED|Dose Level V||0
11296983|NCT02533674|12494571|FG001|NOT COMPLETED|Dose Level V||0
11296984|NCT02533674|12494572|FG002|NOT COMPLETED|Dose Level V||0
11296985|NCT02533674|12494573|FG003|NOT COMPLETED|Dose Level V||0
11296986|NCT02533674|12494574|FG004|NOT COMPLETED|Dose Level V||5
11296987|NCT02533674|12494575|FG005|NOT COMPLETED|Dose Level V||0
11296988|NCT02533674|12494576|FG006|NOT COMPLETED|Dose Level V||0
11296989|NCT02533674|12494577|FG007|NOT COMPLETED|Dose Level V||0
11296990|NCT02533674|12494570|FG000|STARTED|Dose Level VI||0
11296991|NCT02533674|12494571|FG001|STARTED|Dose Level VI||0
11296992|NCT02533674|12494572|FG002|STARTED|Dose Level VI||0
11296993|NCT02533674|12494573|FG003|STARTED|Dose Level VI||0
11296994|NCT02533674|12494574|FG004|STARTED|Dose Level VI||0
11296995|NCT02533674|12494575|FG005|STARTED|Dose Level VI||9
11296996|NCT02533674|12494576|FG006|STARTED|Dose Level VI||0
11296997|NCT02533674|12494577|FG007|STARTED|Dose Level VI||0
11296998|NCT02533674|12494570|FG000|COMPLETED|Dose Level VI||0
11296999|NCT02533674|12494571|FG001|COMPLETED|Dose Level VI||0
11297000|NCT02533674|12494572|FG002|COMPLETED|Dose Level VI||0
11297001|NCT02533674|12494573|FG003|COMPLETED|Dose Level VI||0
11297002|NCT02533674|12494574|FG004|COMPLETED|Dose Level VI||0
11297003|NCT02533674|12494575|FG005|COMPLETED|Dose Level VI||0
11297004|NCT02533674|12494576|FG006|COMPLETED|Dose Level VI||0
11297005|NCT02533674|12494577|FG007|COMPLETED|Dose Level VI||0
11297006|NCT02533674|12494570|FG000|NOT COMPLETED|Dose Level VI||0
11297007|NCT02533674|12494571|FG001|NOT COMPLETED|Dose Level VI||0
11297008|NCT02533674|12494572|FG002|NOT COMPLETED|Dose Level VI||0
11297009|NCT02533674|12494573|FG003|NOT COMPLETED|Dose Level VI||0
11297010|NCT02533674|12494574|FG004|NOT COMPLETED|Dose Level VI||0
11297011|NCT02533674|12494575|FG005|NOT COMPLETED|Dose Level VI||9
11297012|NCT02533674|12494576|FG006|NOT COMPLETED|Dose Level VI||0
11297013|NCT02533674|12494577|FG007|NOT COMPLETED|Dose Level VI||0
11297014|NCT02533674|12494570|FG000|STARTED|Dose Level VII||0
11297015|NCT02533674|12494571|FG001|STARTED|Dose Level VII||0
11297016|NCT02533674|12494572|FG002|STARTED|Dose Level VII||0
11297017|NCT02533674|12494573|FG003|STARTED|Dose Level VII||0
11297018|NCT02533674|12494574|FG004|STARTED|Dose Level VII||0
11297019|NCT02533674|12494575|FG005|STARTED|Dose Level VII||0
11297020|NCT02533674|12494576|FG006|STARTED|Dose Level VII||16
11297021|NCT02533674|12494577|FG007|STARTED|Dose Level VII||0
11297022|NCT02533674|12494570|FG000|COMPLETED|Dose Level VII||0
11297023|NCT02533674|12494571|FG001|COMPLETED|Dose Level VII||0
11297024|NCT02533674|12494572|FG002|COMPLETED|Dose Level VII||0
11297025|NCT02533674|12494573|FG003|COMPLETED|Dose Level VII||0
11297026|NCT02533674|12494574|FG004|COMPLETED|Dose Level VII||0
11297027|NCT02533674|12494575|FG005|COMPLETED|Dose Level VII||0
11297028|NCT02533674|12494576|FG006|COMPLETED|Dose Level VII||0
11297029|NCT02533674|12494577|FG007|COMPLETED|Dose Level VII||0
11297030|NCT02533674|12494570|FG000|NOT COMPLETED|Dose Level VII||0
11297031|NCT02533674|12494571|FG001|NOT COMPLETED|Dose Level VII||0
11297032|NCT02533674|12494572|FG002|NOT COMPLETED|Dose Level VII||0
11297033|NCT02533674|12494573|FG003|NOT COMPLETED|Dose Level VII||0
11297034|NCT02533674|12494574|FG004|NOT COMPLETED|Dose Level VII||0
11297035|NCT02533674|12494575|FG005|NOT COMPLETED|Dose Level VII||0
11297036|NCT02533674|12494576|FG006|NOT COMPLETED|Dose Level VII||16
11297037|NCT02533674|12494577|FG007|NOT COMPLETED|Dose Level VII||0
11297038|NCT02533674|12494570|FG000|STARTED|Dose Level VIII||0
11297039|NCT02533674|12494571|FG001|STARTED|Dose Level VIII||0
11297040|NCT02533674|12494572|FG002|STARTED|Dose Level VIII||0
11297041|NCT02533674|12494573|FG003|STARTED|Dose Level VIII||0
11297042|NCT02533674|12494574|FG004|STARTED|Dose Level VIII||0
11297043|NCT02533674|12494575|FG005|STARTED|Dose Level VIII||0
11297044|NCT02533674|12494576|FG006|STARTED|Dose Level VIII||0
11297045|NCT02533674|12494577|FG007|STARTED|Dose Level VIII||6
11297046|NCT02533674|12494570|FG000|COMPLETED|Dose Level VIII||0
11297047|NCT02533674|12494571|FG001|COMPLETED|Dose Level VIII||0
11297048|NCT02533674|12494572|FG002|COMPLETED|Dose Level VIII||0
11297049|NCT02533674|12494573|FG003|COMPLETED|Dose Level VIII||0
11297050|NCT02533674|12494574|FG004|COMPLETED|Dose Level VIII||0
11297051|NCT02533674|12494575|FG005|COMPLETED|Dose Level VIII||0
11297052|NCT02533674|12494576|FG006|COMPLETED|Dose Level VIII||0
11297053|NCT02533674|12494577|FG007|COMPLETED|Dose Level VIII||0
11297054|NCT02533674|12494570|FG000|NOT COMPLETED|Dose Level VIII||0
11297055|NCT02533674|12494571|FG001|NOT COMPLETED|Dose Level VIII||0
11297056|NCT02533674|12494572|FG002|NOT COMPLETED|Dose Level VIII||0
11297057|NCT02533674|12494573|FG003|NOT COMPLETED|Dose Level VIII||0
11297058|NCT02533674|12494574|FG004|NOT COMPLETED|Dose Level VIII||0
11400762|NCT04176406|12595457|FG003|NOT COMPLETED|Overall Study||0
11400763|NCT04175262|12595468|FG000|STARTED|Overall Study||102
11400764|NCT04175262|12595468|FG000|COMPLETED|Overall Study||102
11400765|NCT04175262|12595468|FG000|NOT COMPLETED|Overall Study||0
11400766|NCT04171102|12595475|FG000|STARTED|Overall Study||4
11400767|NCT04171102|12595476|FG001|STARTED|Overall Study||5
11400768|NCT04171102|12595477|FG002|STARTED|Overall Study||6
11400769|NCT04171102|12595475|FG000|COMPLETED|Overall Study||4
11400770|NCT04171102|12595476|FG001|COMPLETED|Overall Study||5
11400771|NCT04171102|12595477|FG002|COMPLETED|Overall Study||6
11400772|NCT04171102|12595475|FG000|NOT COMPLETED|Overall Study||0
11400773|NCT04171102|12595476|FG001|NOT COMPLETED|Overall Study||0
11400774|NCT04171102|12595477|FG002|NOT COMPLETED|Overall Study||0
11400775|NCT04174638|12595487|FG000|STARTED|Overall Study||32
11297059|NCT02533674|12494575|FG005|NOT COMPLETED|Dose Level VIII||0
11297060|NCT02533674|12494576|FG006|NOT COMPLETED|Dose Level VIII||0
11297061|NCT02533674|12494577|FG007|NOT COMPLETED|Dose Level VIII||6
11297062|NCT02533726|12494597|FG000|STARTED|Initial Allocation||659
11297063|NCT02533726|12494598|FG001|STARTED|Initial Allocation||653
11297064|NCT02533726|12494597|FG000|COMPLETED|Initial Allocation||659
11297065|NCT02533726|12494598|FG001|COMPLETED|Initial Allocation||653
11297066|NCT02533726|12494597|FG000|NOT COMPLETED|Initial Allocation||0
11297067|NCT02533726|12494598|FG001|NOT COMPLETED|Initial Allocation||0
11297068|NCT02533726|12494597|FG000|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
11297069|NCT02533726|12494598|FG001|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
11297070|NCT02533726|12494597|FG000|Per Protocol Population|Treatment||671
11297071|NCT02533726|12494598|FG001|Per Protocol Population|Treatment||555
11297072|NCT02533726|12494597|FG000|COMPLETED|Treatment||709
11297073|NCT02533726|12494598|FG001|COMPLETED|Treatment||603
11297074|NCT02533726|12494597|FG000|NOT COMPLETED|Treatment||0
11297075|NCT02533726|12494598|FG001|NOT COMPLETED|Treatment||0
11297076|NCT02533921|12494606|FG000|STARTED|Overall Study||104
11297077|NCT02533921|12494607|FG001|STARTED|Overall Study||106
11297078|NCT02533921|12494606|FG000|COMPLETED|Overall Study||88
11297079|NCT02533921|12494607|FG001|COMPLETED|Overall Study||95
11297080|NCT02533921|12494606|FG000|NOT COMPLETED|Overall Study||16
11297081|NCT02533921|12494607|FG001|NOT COMPLETED|Overall Study||11
11297082|NCT02533934|12494615|FG000|STARTED|Overall Study||42
11297083|NCT02533934|12494616|FG001|STARTED|Overall Study||26
11297084|NCT02533934|12494615|FG000|COMPLETED|Overall Study||42
11297085|NCT02533934|12494616|FG001|COMPLETED|Overall Study||26
11297086|NCT02533934|12494615|FG000|NOT COMPLETED|Overall Study||0
11297087|NCT02533934|12494616|FG001|NOT COMPLETED|Overall Study||0
11297088|NCT02533999|12494624|FG000|STARTED|Overall Study||38
11400776|NCT04174638|12595488|FG001|STARTED|Overall Study||28
11400777|NCT04174638|12595487|FG000|COMPLETED|Overall Study||32
11400778|NCT04174638|12595488|FG001|COMPLETED|Overall Study||28
11400779|NCT04174638|12595487|FG000|NOT COMPLETED|Overall Study||0
11297089|NCT02533999|12494625|FG001|STARTED|Overall Study||37
11297090|NCT02533999|12494624|FG000|COMPLETED|Overall Study||32
11297091|NCT02533999|12494625|FG001|COMPLETED|Overall Study||30
11297092|NCT02533999|12494624|FG000|NOT COMPLETED|Overall Study||6
11297093|NCT02533999|12494625|FG001|NOT COMPLETED|Overall Study||7
11297094|NCT02534129|12494631|FG000|STARTED|Overall Study||13
11297095|NCT02534129|12494632|FG001|STARTED|Overall Study||13
11297096|NCT02534129|12494631|FG000|COMPLETED|Overall Study||13
11297097|NCT02534129|12494632|FG001|COMPLETED|Overall Study||13
11297098|NCT02534129|12494631|FG000|NOT COMPLETED|Overall Study||0
11297099|NCT02534129|12494632|FG001|NOT COMPLETED|Overall Study||0
11297100|NCT02534285|12494640|FG000|STARTED|Overall Study||50
11297101|NCT02534285|12494641|FG001|STARTED|Overall Study||50
11297102|NCT02534285|12494640|FG000|COMPLETED|Overall Study||50
11297103|NCT02534285|12494641|FG001|COMPLETED|Overall Study||50
11297104|NCT02534285|12494640|FG000|NOT COMPLETED|Overall Study||0
11400780|NCT04174638|12595488|FG001|NOT COMPLETED|Overall Study||0
11400781|NCT04174313|12595499|FG000|STARTED|Overall Study||15
11400782|NCT04174313|12595500|FG001|STARTED|Overall Study||50
11400783|NCT04174313|12595499|FG000|COMPLETED|Overall Study||15
11400784|NCT04174313|12595500|FG001|COMPLETED|Overall Study||50
11297105|NCT02534285|12494641|FG001|NOT COMPLETED|Overall Study||0
11297106|NCT02534324|12494649|FG000|STARTED|Overall Study||98
11297107|NCT02534324|12494650|FG001|STARTED|Overall Study||48
11297108|NCT02534324|12494649|FG000|COMPLETED|Overall Study||73
11297109|NCT02534324|12494650|FG001|COMPLETED|Overall Study||40
11297110|NCT02534324|12494649|FG000|NOT COMPLETED|Overall Study||25
11297111|NCT02534324|12494650|FG001|NOT COMPLETED|Overall Study||8
11297112|NCT02534350|12494658|FG000|STARTED|Overall Study||41
11297113|NCT02534350|12494659|FG001|STARTED|Overall Study||20
11297114|NCT02534350|12494658|FG000|COMPLETED|Overall Study||37
11297115|NCT02534350|12494659|FG001|COMPLETED|Overall Study||20
11297116|NCT02534350|12494658|FG000|NOT COMPLETED|Overall Study||4
11297117|NCT02534350|12494659|FG001|NOT COMPLETED|Overall Study||0
11297118|NCT02534493|12494665|FG000|STARTED|Overall Study||13
11297119|NCT02534493|12494665|FG000|COMPLETED|Overall Study||11
11297120|NCT02534493|12494665|FG000|NOT COMPLETED|Overall Study||2
11297121|NCT02534883|12494673|FG000|STARTED|Overall Study||8
11297122|NCT02534883|12494674|FG001|STARTED|Overall Study||3
11297123|NCT02534883|12494673|FG000|COMPLETED|Overall Study||0
11297124|NCT02534883|12494674|FG001|COMPLETED|Overall Study||0
11297125|NCT02534883|12494673|FG000|NOT COMPLETED|Overall Study||8
11297126|NCT02534883|12494674|FG001|NOT COMPLETED|Overall Study||3
11297127|NCT02534896|12494683|FG000|STARTED|Overall Study||49
11297128|NCT02534896|12494684|FG001|STARTED|Overall Study||52
11297129|NCT02534896|12494685|FG002|STARTED|Overall Study||49
11297130|NCT02534896|12494683|FG000|COMPLETED|Overall Study||45
11297131|NCT02534896|12494684|FG001|COMPLETED|Overall Study||51
11297132|NCT02534896|12494685|FG002|COMPLETED|Overall Study||48
11297133|NCT02534896|12494683|FG000|NOT COMPLETED|Overall Study||4
11297134|NCT02534896|12494684|FG001|NOT COMPLETED|Overall Study||1
11297135|NCT02534896|12494685|FG002|NOT COMPLETED|Overall Study||1
11297136|NCT02534935|12494696|FG000|STARTED|Stage 1: 24 Months||44
11297137|NCT02534935|12494697|FG001|STARTED|Stage 1: 24 Months||220
11297138|NCT02534935|12494698|FG002|STARTED|Stage 1: 24 Months||132
11297139|NCT02534935|12494696|FG000|COMPLETED|Stage 1: 24 Months||44
11297140|NCT02534935|12494697|FG001|COMPLETED|Stage 1: 24 Months||210
11297141|NCT02534935|12494698|FG002|COMPLETED|Stage 1: 24 Months||127
11297142|NCT02534935|12494696|FG000|NOT COMPLETED|Stage 1: 24 Months||0
11297143|NCT02534935|12494697|FG001|NOT COMPLETED|Stage 1: 24 Months||10
11297144|NCT02534935|12494698|FG002|NOT COMPLETED|Stage 1: 24 Months||5
11297145|NCT02534935|12494696|FG000|STARTED|Stage 2: 8 Months|Participants entered into Stage 2.|40
11297146|NCT02534935|12494697|FG001|STARTED|Stage 2: 8 Months|Participants who received all 3 doses and entered Stage 2.|174
11297147|NCT02534935|12494698|FG002|STARTED|Stage 2: 8 Months|Participants of HAV/Saline were not eligible for Stage 2.|0
11297148|NCT02534935|12494696|FG000|COMPLETED|Stage 2: 8 Months||40
11297149|NCT02534935|12494697|FG001|COMPLETED|Stage 2: 8 Months||170
11297150|NCT02534935|12494698|FG002|COMPLETED|Stage 2: 8 Months||0
11297151|NCT02534935|12494696|FG000|NOT COMPLETED|Stage 2: 8 Months||0
11297152|NCT02534935|12494697|FG001|NOT COMPLETED|Stage 2: 8 Months||4
11297153|NCT02534935|12494698|FG002|NOT COMPLETED|Stage 2: 8 Months||0
11297154|NCT02534935|12494696|FG000|STARTED|Stage 2: Booster Phase (6 Months)|Participants were not eligible for Booster vaccination in Stage 2.|0
11297155|NCT02534935|12494697|FG001|STARTED|Stage 2: Booster Phase (6 Months)|Participants who received 3 doses of bivalent rLP2086 in Stage 1 and gave consent for booster vaccination.|148
11297156|NCT02534935|12494698|FG002|STARTED|Stage 2: Booster Phase (6 Months)|Participants of HAV/Saline were not eligible for Stage 2.|0
11297157|NCT02534935|12494696|FG000|COMPLETED|Stage 2: Booster Phase (6 Months)||0
11297158|NCT02534935|12494697|FG001|COMPLETED|Stage 2: Booster Phase (6 Months)||147
11297159|NCT02534935|12494698|FG002|COMPLETED|Stage 2: Booster Phase (6 Months)||0
11297160|NCT02534935|12494696|FG000|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0
11297161|NCT02534935|12494697|FG001|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||1
11297162|NCT02534935|12494698|FG002|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0
11297163|NCT02535000|12494726|FG000|STARTED|Overall Study||30
11400785|NCT04174313|12595499|FG000|NOT COMPLETED|Overall Study||0
11297164|NCT02535000|12494727|FG001|STARTED|Overall Study||30
11297165|NCT02535000|12494726|FG000|COMPLETED|Overall Study||29
11297166|NCT02535000|12494727|FG001|COMPLETED|Overall Study||28
11297167|NCT02535000|12494726|FG000|NOT COMPLETED|Overall Study||1
11297168|NCT02535000|12494727|FG001|NOT COMPLETED|Overall Study||2
11297169|NCT02535026|12494733|FG000|STARTED|Overall Study||580
11297170|NCT02535026|12494733|FG000|COMPLETED|Overall Study||580
11297171|NCT02535026|12494733|FG000|NOT COMPLETED|Overall Study||0
11297172|NCT02535364|12494747|FG000|STARTED|Part A Screening Through Leukapheresis||82
11297173|NCT02535364|12494747|FG000|COMPLETED|Part A Screening Through Leukapheresis||57
11297174|NCT02535364|12494747|FG000|NOT COMPLETED|Part A Screening Through Leukapheresis||25
11297175|NCT02535364|12494747|FG000|STARTED|Part B Screening||57
11297176|NCT02535364|12494747|FG000|COMPLETED|Part B Screening||40
11297177|NCT02535364|12494747|FG000|NOT COMPLETED|Part B Screening||17
11297178|NCT02535364|12494747|FG000|STARTED|Study Treatment||40
11297179|NCT02535364|12494747|FG000|COMPLETED|Study Treatment||38
11297180|NCT02535364|12494747|FG000|NOT COMPLETED|Study Treatment||2
11297181|NCT02535364|12494747|FG000|STARTED|12-Month Follow-up Period||38
11297182|NCT02535364|12494747|FG000|COMPLETED|12-Month Follow-up Period||3
11297183|NCT02535364|12494747|FG000|NOT COMPLETED|12-Month Follow-up Period||35
11297184|NCT02535416|12494760|FG000|STARTED|Overall Study||4
11297185|NCT02535416|12494761|FG001|STARTED|Overall Study||2
11297186|NCT02535416|12494762|FG002|STARTED|Overall Study||4
11297187|NCT02535416|12494763|FG003|STARTED|Overall Study||4
11297188|NCT02535416|12494764|FG004|STARTED|Overall Study||4
11297189|NCT02535416|12494765|FG005|STARTED|Overall Study||4
11297190|NCT02535416|12494766|FG006|STARTED|Overall Study||6
11297191|NCT02535416|12494767|FG007|STARTED|Overall Study||6
11297192|NCT02535416|12494768|FG008|STARTED|Overall Study||6
11297193|NCT02535416|12494760|FG000|COMPLETED|Overall Study||3
11297194|NCT02535416|12494761|FG001|COMPLETED|Overall Study||2
11297195|NCT02535416|12494762|FG002|COMPLETED|Overall Study||4
11297196|NCT02535416|12494763|FG003|COMPLETED|Overall Study||4
11297197|NCT02535416|12494764|FG004|COMPLETED|Overall Study||4
11297198|NCT02535416|12494765|FG005|COMPLETED|Overall Study||4
11297199|NCT02535416|12494766|FG006|COMPLETED|Overall Study||6
11297200|NCT02535416|12494767|FG007|COMPLETED|Overall Study||6
11297201|NCT02535416|12494768|FG008|COMPLETED|Overall Study||6
11297202|NCT02535416|12494760|FG000|NOT COMPLETED|Overall Study||1
11297203|NCT02535416|12494761|FG001|NOT COMPLETED|Overall Study||0
11297204|NCT02535416|12494762|FG002|NOT COMPLETED|Overall Study||0
11297205|NCT02535416|12494763|FG003|NOT COMPLETED|Overall Study||0
11297206|NCT02535416|12494764|FG004|NOT COMPLETED|Overall Study||0
11297207|NCT02535416|12494765|FG005|NOT COMPLETED|Overall Study||0
11297208|NCT02535416|12494766|FG006|NOT COMPLETED|Overall Study||0
11297209|NCT02535416|12494767|FG007|NOT COMPLETED|Overall Study||0
11297210|NCT02535416|12494768|FG008|NOT COMPLETED|Overall Study||0
11297211|NCT02535481|12494794|FG000|STARTED|Overall Study||22
11297212|NCT02535481|12494795|FG001|STARTED|Overall Study||22
11297213|NCT02535481|12494794|FG000|COMPLETED|Overall Study||22
11297214|NCT02535481|12494795|FG001|COMPLETED|Overall Study||22
11297215|NCT02535481|12494794|FG000|NOT COMPLETED|Overall Study||0
11297216|NCT02535481|12494795|FG001|NOT COMPLETED|Overall Study||0
11297217|NCT02535572|12494803|FG000|STARTED|Overall Study||21
11297218|NCT02535572|12494804|FG001|STARTED|Overall Study||20
11297219|NCT02535572|12494803|FG000|COMPLETED|Overall Study||17
11297220|NCT02535572|12494804|FG001|COMPLETED|Overall Study||17
11297221|NCT02535572|12494803|FG000|NOT COMPLETED|Overall Study||4
11297222|NCT02535572|12494804|FG001|NOT COMPLETED|Overall Study||3
11297223|NCT02535611|12494813|FG000|STARTED|Overall Study||27
11297224|NCT02535611|12494814|FG001|STARTED|Overall Study||20
11297225|NCT02535611|12494813|FG000|COMPLETED|Overall Study||27
11297226|NCT02535611|12494814|FG001|COMPLETED|Overall Study||20
11297227|NCT02535611|12494813|FG000|NOT COMPLETED|Overall Study||0
11297228|NCT02535611|12494814|FG001|NOT COMPLETED|Overall Study||0
11297229|NCT02535715|12494820|FG000|STARTED|Overall Study||4
11297230|NCT02535715|12494821|FG001|STARTED|Overall Study||4
11297231|NCT02535715|12494822|FG002|STARTED|Overall Study||3
11297232|NCT02535715|12494820|FG000|COMPLETED|Overall Study||4
11297233|NCT02535715|12494821|FG001|COMPLETED|Overall Study||4
11297234|NCT02535715|12494822|FG002|COMPLETED|Overall Study||2
11297235|NCT02535715|12494820|FG000|NOT COMPLETED|Overall Study||0
11297236|NCT02535715|12494821|FG001|NOT COMPLETED|Overall Study||0
11297237|NCT02535715|12494822|FG002|NOT COMPLETED|Overall Study||1
11297238|NCT02535741|12494833|FG000|STARTED|Overall Study||168
11297239|NCT02535741|12494833|FG000|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
11297240|NCT02535741|12494833|FG000|NOT COMPLETED|Overall Study||32
11297241|NCT02535806|12494838|FG000|STARTED|Overall Study||2
11297242|NCT02535806|12494838|FG000|COMPLETED|Overall Study||2
11297243|NCT02535806|12494838|FG000|NOT COMPLETED|Overall Study||0
11297244|NCT02535949|12494845|FG000|STARTED|Overall Study||50
11297245|NCT02535949|12494846|FG001|STARTED|Overall Study||50
11297246|NCT02535949|12494847|FG002|STARTED|Overall Study||50
11297247|NCT02535949|12494845|FG000|COMPLETED|Overall Study||49
11297248|NCT02535949|12494846|FG001|COMPLETED|Overall Study||50
11297249|NCT02535949|12494847|FG002|COMPLETED|Overall Study||50
11297250|NCT02535949|12494845|FG000|NOT COMPLETED|Overall Study||1
11297251|NCT02535949|12494846|FG001|NOT COMPLETED|Overall Study||0
11297252|NCT02535949|12494847|FG002|NOT COMPLETED|Overall Study||0
11297253|NCT02536040|12494858|FG000|STARTED|Overall Study||30
11297254|NCT02536040|12494859|FG001|STARTED|Overall Study||36
11297255|NCT02536040|12494858|FG000|COMPLETED|Overall Study||29
11297256|NCT02536040|12494859|FG001|COMPLETED|Overall Study||35
11297257|NCT02536040|12494858|FG000|NOT COMPLETED|Overall Study||1
11297258|NCT02536040|12494859|FG001|NOT COMPLETED|Overall Study||1
11297259|NCT02536105|12494865|FG000|STARTED|Concerta Open Label||80
11297260|NCT02536105|12494865|FG000|Completion of Phase|Concerta Open Label||76
11297261|NCT02536105|12494865|FG000|COMPLETED|Concerta Open Label||72
11297262|NCT02536105|12494865|FG000|NOT COMPLETED|Concerta Open Label||8
11297263|NCT02536105|12494865|FG000|STARTED|Placebo||74
11297264|NCT02536105|12494865|FG000|Completion of Placebo Day|Placebo||74
11297265|NCT02536105|12494865|FG000|COMPLETED|Placebo||72
11297266|NCT02536105|12494865|FG000|NOT COMPLETED|Placebo||2
11297267|NCT02536105|12494865|FG000|STARTED|Methylphenidate HCl ER Tablet 1||72
11400786|NCT04174313|12595500|FG001|NOT COMPLETED|Overall Study||0
11400787|NCT04173429|12595512|FG000|STARTED|Overall Study||32
11400788|NCT04173429|12595513|FG001|STARTED|Overall Study||32
11400789|NCT04173429|12595512|FG000|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||32
11297268|NCT02536105|12494865|FG000|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72
11297269|NCT02536105|12494865|FG000|COMPLETED|Methylphenidate HCl ER Tablet 1||72
11297270|NCT02536105|12494865|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0
11297271|NCT02536105|12494865|FG000|STARTED|Methylphenidate HCl ER Tablet 2||73
11297272|NCT02536105|12494865|FG000|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73
11297273|NCT02536105|12494865|FG000|COMPLETED|Methylphenidate HCl ER Tablet 2||72
11297274|NCT02536105|12494865|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1
11297275|NCT02536105|12494865|FG000|STARTED|Methylphenidate HCl ER Suspension||74
11297276|NCT02536105|12494865|FG000|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74
11297277|NCT02536105|12494865|FG000|COMPLETED|Methylphenidate HCl ER Suspension||72
11297278|NCT02536105|12494865|FG000|NOT COMPLETED|Methylphenidate HCl ER Suspension||2
11297279|NCT02536196|12494878|FG000|STARTED|Overall Study||262
11297280|NCT02536196|12494879|FG001|STARTED|Overall Study||121
11297281|NCT02536196|12494880|FG002|STARTED|Overall Study||95
11297282|NCT02536196|12494878|FG000|COMPLETED|Overall Study||233
11297283|NCT02536196|12494879|FG001|COMPLETED|Overall Study||107
11297284|NCT02536196|12494880|FG002|COMPLETED|Overall Study||95
11297285|NCT02536196|12494878|FG000|NOT COMPLETED|Overall Study||29
11297286|NCT02536196|12494879|FG001|NOT COMPLETED|Overall Study||14
11297287|NCT02536196|12494880|FG002|NOT COMPLETED|Overall Study||0
11297288|NCT02536248|12494889|FG000|STARTED|First Intervention (6 Weeks)||10
11297289|NCT02536248|12494890|FG001|STARTED|First Intervention (6 Weeks)||10
11297290|NCT02536248|12494889|FG000|COMPLETED|First Intervention (6 Weeks)||10
11297291|NCT02536248|12494890|FG001|COMPLETED|First Intervention (6 Weeks)||10
11297292|NCT02536248|12494889|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
11297293|NCT02536248|12494890|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
11297294|NCT02536248|12494889|FG000|STARTED|Wash-out (14 Days)||10
11297295|NCT02536248|12494890|FG001|STARTED|Wash-out (14 Days)||10
11297296|NCT02536248|12494889|FG000|COMPLETED|Wash-out (14 Days)||10
11297297|NCT02536248|12494890|FG001|COMPLETED|Wash-out (14 Days)||10
11297298|NCT02536248|12494889|FG000|NOT COMPLETED|Wash-out (14 Days)||0
11297299|NCT02536248|12494890|FG001|NOT COMPLETED|Wash-out (14 Days)||0
11297300|NCT02536248|12494889|FG000|STARTED|Second Intervention (6 Weeks)||10
11297301|NCT02536248|12494890|FG001|STARTED|Second Intervention (6 Weeks)||10
11297302|NCT02536248|12494889|FG000|COMPLETED|Second Intervention (6 Weeks)||10
11297303|NCT02536248|12494890|FG001|COMPLETED|Second Intervention (6 Weeks)||10
11297304|NCT02536248|12494889|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
11297305|NCT02536248|12494890|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
11297306|NCT02536313|12494898|FG000|STARTED|Overall Study||24
11297307|NCT02536313|12494899|FG001|STARTED|Overall Study||25
11297308|NCT02536313|12494898|FG000|COMPLETED|Overall Study||24
11297309|NCT02536313|12494899|FG001|COMPLETED|Overall Study||24
11297310|NCT02536313|12494898|FG000|NOT COMPLETED|Overall Study||0
11297311|NCT02536313|12494899|FG001|NOT COMPLETED|Overall Study||1
11400790|NCT04173429|12595513|FG001|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||0
11400791|NCT04173429|12595512|FG000|COMPLETED|Overall Study||30
11400792|NCT04173429|12595513|FG001|COMPLETED|Overall Study||30
11400793|NCT04173429|12595512|FG000|NOT COMPLETED|Overall Study||2
11400794|NCT04173429|12595513|FG001|NOT COMPLETED|Overall Study||2
11400795|NCT04173741|12595522|FG000|STARTED|Overall Study||23
11400796|NCT04173741|12595523|FG001|STARTED|Overall Study||23
11400797|NCT04173741|12595522|FG000|COMPLETED|Overall Study||22
11400798|NCT04173741|12595523|FG001|COMPLETED|Overall Study||22
11400799|NCT04173741|12595522|FG000|NOT COMPLETED|Overall Study||1
11400800|NCT04173741|12595523|FG001|NOT COMPLETED|Overall Study||1
11400801|NCT04169061|12595529|FG000|STARTED|Overall Study||36
11400802|NCT04169061|12595529|FG000|Safety Population|Overall Study||36
11400803|NCT04169061|12595529|FG000|Modified Intent to Treat (mITT) Population|Overall Study||34
11400804|NCT04169061|12595529|FG000|COMPLETED|Overall Study||31
11400805|NCT04169061|12595529|FG000|NOT COMPLETED|Overall Study||5
11400806|NCT04157738|12595535|FG000|STARTED|Overall Study||12
11400807|NCT04157738|12595536|FG001|STARTED|Overall Study||12
11400808|NCT04157738|12595535|FG000|COMPLETED|Overall Study||11
11400809|NCT04157738|12595536|FG001|COMPLETED|Overall Study||10
11400810|NCT04157738|12595535|FG000|NOT COMPLETED|Overall Study||1
11400811|NCT04157738|12595536|FG001|NOT COMPLETED|Overall Study||2
11400812|NCT04156646|12595544|FG000|STARTED|Treatment Period 1 (6 Days)||8
11400813|NCT04156646|12595545|FG001|STARTED|Treatment Period 1 (6 Days)||8
11400814|NCT04156646|12595544|FG000|COMPLETED|Treatment Period 1 (6 Days)||8
11297312|NCT02536378|12494909|FG000|STARTED|Overall Study||632
11297313|NCT02536378|12494910|FG001|STARTED|Overall Study||60
11297314|NCT02536378|12494909|FG000|COMPLETED|Overall Study||625
11297315|NCT02536378|12494910|FG001|COMPLETED|Overall Study||53
11297316|NCT02536378|12494909|FG000|NOT COMPLETED|Overall Study||7
11297317|NCT02536378|12494910|FG001|NOT COMPLETED|Overall Study||7
11297318|NCT02536404|12494920|FG000|STARTED|Overall Study||112
11297319|NCT02536404|12494921|FG001|STARTED|Overall Study||6
11297320|NCT02536404|12494920|FG000|COMPLETED|Overall Study||92
11297321|NCT02536404|12494921|FG001|COMPLETED|Overall Study||5
11297322|NCT02536404|12494920|FG000|NOT COMPLETED|Overall Study||20
11297323|NCT02536404|12494921|FG001|NOT COMPLETED|Overall Study||1
11297324|NCT02536508|12494930|FG000|STARTED|Overall Study||194
11297325|NCT02536508|12494931|FG001|STARTED|Overall Study||174
11297326|NCT02536508|12494932|FG002|STARTED|Overall Study||88
11297327|NCT02536508|12494930|FG000|COMPLETED|Overall Study||142
11297328|NCT02536508|12494931|FG001|COMPLETED|Overall Study||130
11297329|NCT02536508|12494932|FG002|COMPLETED|Overall Study||65
11297330|NCT02536508|12494930|FG000|NOT COMPLETED|Overall Study||52
11297331|NCT02536508|12494931|FG001|NOT COMPLETED|Overall Study||44
11297332|NCT02536508|12494932|FG002|NOT COMPLETED|Overall Study||23
11297333|NCT02536664|12494942|FG000|STARTED|Overall Study||312
11297334|NCT02536664|12494943|FG001|STARTED|Overall Study||177
11400815|NCT04156646|12595545|FG001|COMPLETED|Treatment Period 1 (6 Days)||8
11400816|NCT04156646|12595544|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0
11400817|NCT04156646|12595545|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0
11297335|NCT02536664|12494942|FG000|COMPLETED|Overall Study||205
11297336|NCT02536664|12494943|FG001|COMPLETED|Overall Study||97
11297337|NCT02536664|12494942|FG000|NOT COMPLETED|Overall Study||107
11297338|NCT02536664|12494943|FG001|NOT COMPLETED|Overall Study||80
11297339|NCT02536781|12494951|FG000|STARTED|Overall Study||36
11297340|NCT02536781|12494952|FG001|STARTED|Overall Study||34
11297341|NCT02536781|12494951|FG000|COMPLETED|Overall Study||34
11297342|NCT02536781|12494952|FG001|COMPLETED|Overall Study||34
11297343|NCT02536781|12494951|FG000|NOT COMPLETED|Overall Study||2
11297344|NCT02536781|12494952|FG001|NOT COMPLETED|Overall Study||0
11297345|NCT02536833|12494962|FG000|STARTED|Overall Study||112
11297346|NCT02536833|12494963|FG001|STARTED|Overall Study||117
11297347|NCT02536833|12494964|FG002|STARTED|Overall Study||110
11297348|NCT02536833|12494965|FG003|STARTED|Overall Study||116
11297349|NCT02536833|12494962|FG000|COMPLETED|Overall Study||103
11297350|NCT02536833|12494963|FG001|COMPLETED|Overall Study||107
11297351|NCT02536833|12494964|FG002|COMPLETED|Overall Study||95
11297352|NCT02536833|12494965|FG003|COMPLETED|Overall Study||97
11297353|NCT02536833|12494962|FG000|NOT COMPLETED|Overall Study||9
11297354|NCT02536833|12494963|FG001|NOT COMPLETED|Overall Study||10
11297355|NCT02536833|12494964|FG002|NOT COMPLETED|Overall Study||15
11297356|NCT02536833|12494965|FG003|NOT COMPLETED|Overall Study||19
11297357|NCT02536846|12494976|FG000|STARTED|Overall Study||10
11297358|NCT02536846|12494976|FG000|COMPLETED|Overall Study||9
11297359|NCT02536846|12494976|FG000|NOT COMPLETED|Overall Study||1
11297360|NCT02536963|12494981|FG000|STARTED|Overall Study||318
11297361|NCT02536963|12494981|FG000|COMPLETED|Overall Study||300
11297362|NCT02536963|12494981|FG000|NOT COMPLETED|Overall Study||18
11297363|NCT02536976|12494987|FG000|STARTED|Overall Study|2 weeks single blind placebo run-in|3
11297364|NCT02536976|12494988|FG001|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2
11297365|NCT02536976|12494987|FG000|Randomization|Overall Study|2 weeks double blind mirabegron|3
11297366|NCT02536976|12494988|FG001|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1
11297367|NCT02536976|12494987|FG000|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3
11297368|NCT02536976|12494988|FG001|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1
11297369|NCT02536976|12494987|FG000|Washout|Overall Study||3
11297370|NCT02536976|12494988|FG001|Washout|Overall Study||1
11297371|NCT02536976|12494987|FG000|COMPLETED|Overall Study||3
11297372|NCT02536976|12494988|FG001|COMPLETED|Overall Study||1
11297373|NCT02536976|12494987|FG000|NOT COMPLETED|Overall Study||0
11297374|NCT02536976|12494988|FG001|NOT COMPLETED|Overall Study||1
11297375|NCT02537015|12494996|FG000|STARTED|Overall Study||81
11297376|NCT02537015|12494996|FG000|COMPLETED|Overall Study||75
11297377|NCT02537015|12494996|FG000|NOT COMPLETED|Overall Study||6
11297378|NCT02537431|12495000|FG000|STARTED|Open-Label Period (Week 0 to Week 48)|Screened and received at least 1 dose of study drug.|14
11297379|NCT02537431|12495000|FG000|COMPLETED|Open-Label Period (Week 0 to Week 48)|Completed Open-Label Period (Week 0 - Week 48)|13
11297380|NCT02537431|12495000|FG000|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1
11297381|NCT02537431|12495000|FG000|STARTED|Treatment Extension Period I||13
11297382|NCT02537431|12495000|FG000|COMPLETED|Treatment Extension Period I||13
11297383|NCT02537431|12495000|FG000|NOT COMPLETED|Treatment Extension Period I||0
11297384|NCT02537431|12495000|FG000|STARTED|Treatment Extension Period II|5 participants completing Treatment Extension Period I did not enter Treatment Extension Period II|8
11297385|NCT02537431|12495000|FG000|COMPLETED|Treatment Extension Period II||8
11297386|NCT02537431|12495000|FG000|NOT COMPLETED|Treatment Extension Period II||0
11297387|NCT02537444|12495006|FG000|STARTED|Overall Study||39
11297388|NCT02537444|12495007|FG001|STARTED|Overall Study||39
11297389|NCT02537444|12495006|FG000|Enrolled|Overall Study||39
11297390|NCT02537444|12495007|FG001|Enrolled|Overall Study||39
11297391|NCT02537444|12495006|FG000|Received Study Medication|Overall Study||38
11297392|NCT02537444|12495007|FG001|Received Study Medication|Overall Study||39
11297393|NCT02537444|12495006|FG000|Discontinued Study|Overall Study||39
11297394|NCT02537444|12495007|FG001|Discontinued Study|Overall Study||39
11297395|NCT02537444|12495006|FG000|COMPLETED|Overall Study||0
11297396|NCT02537444|12495007|FG001|COMPLETED|Overall Study||0
11297397|NCT02537444|12495006|FG000|NOT COMPLETED|Overall Study||39
11297398|NCT02537444|12495007|FG001|NOT COMPLETED|Overall Study||39
11297399|NCT02537522|12495013|FG000|STARTED|Phase I - Contralateral||34
11297400|NCT02537522|12495014|FG001|STARTED|Phase I - Contralateral||37
11297401|NCT02537522|12495015|FG002|STARTED|Phase I - Contralateral||0
11297402|NCT02537522|12495016|FG003|STARTED|Phase I - Contralateral||0
11297403|NCT02537522|12495013|FG000|COMPLETED|Phase I - Contralateral||19
11297404|NCT02537522|12495014|FG001|COMPLETED|Phase I - Contralateral||27
11297405|NCT02537522|12495015|FG002|COMPLETED|Phase I - Contralateral||0
11297406|NCT02537522|12495016|FG003|COMPLETED|Phase I - Contralateral||0
11297407|NCT02537522|12495013|FG000|NOT COMPLETED|Phase I - Contralateral||15
11297408|NCT02537522|12495014|FG001|NOT COMPLETED|Phase I - Contralateral||10
11297409|NCT02537522|12495015|FG002|NOT COMPLETED|Phase I - Contralateral||0
11297410|NCT02537522|12495016|FG003|NOT COMPLETED|Phase I - Contralateral||0
11297411|NCT02537522|12495013|FG000|STARTED|Phase II - Period 1 Bilateral||0
11297412|NCT02537522|12495014|FG001|STARTED|Phase II - Period 1 Bilateral||0
11297413|NCT02537522|12495015|FG002|STARTED|Phase II - Period 1 Bilateral||23
11297414|NCT02537522|12495016|FG003|STARTED|Phase II - Period 1 Bilateral||23
11297415|NCT02537522|12495013|FG000|COMPLETED|Phase II - Period 1 Bilateral||0
11297416|NCT02537522|12495014|FG001|COMPLETED|Phase II - Period 1 Bilateral||0
11297417|NCT02537522|12495015|FG002|COMPLETED|Phase II - Period 1 Bilateral||23
11297418|NCT02537522|12495016|FG003|COMPLETED|Phase II - Period 1 Bilateral||22
11297419|NCT02537522|12495013|FG000|NOT COMPLETED|Phase II - Period 1 Bilateral||0
11297420|NCT02537522|12495014|FG001|NOT COMPLETED|Phase II - Period 1 Bilateral||0
11297421|NCT02537522|12495015|FG002|NOT COMPLETED|Phase II - Period 1 Bilateral||0
11297422|NCT02537522|12495016|FG003|NOT COMPLETED|Phase II - Period 1 Bilateral||1
11297423|NCT02537522|12495013|FG000|STARTED|Phase II - Period 2 Bilateral||0
11297424|NCT02537522|12495014|FG001|STARTED|Phase II - Period 2 Bilateral||0
11297425|NCT02537522|12495015|FG002|STARTED|Phase II - Period 2 Bilateral||23
11297426|NCT02537522|12495016|FG003|STARTED|Phase II - Period 2 Bilateral||22
11297427|NCT02537522|12495013|FG000|COMPLETED|Phase II - Period 2 Bilateral||0
11297428|NCT02537522|12495014|FG001|COMPLETED|Phase II - Period 2 Bilateral||0
11297429|NCT02537522|12495015|FG002|COMPLETED|Phase II - Period 2 Bilateral||23
11297430|NCT02537522|12495016|FG003|COMPLETED|Phase II - Period 2 Bilateral||22
11297431|NCT02537522|12495013|FG000|NOT COMPLETED|Phase II - Period 2 Bilateral||0
11297432|NCT02537522|12495014|FG001|NOT COMPLETED|Phase II - Period 2 Bilateral||0
11297433|NCT02537522|12495015|FG002|NOT COMPLETED|Phase II - Period 2 Bilateral||0
11297434|NCT02537522|12495016|FG003|NOT COMPLETED|Phase II - Period 2 Bilateral||0
11297435|NCT02537574|12495025|FG000|STARTED|Overall Study||126
11297436|NCT02537574|12495026|FG001|STARTED|Overall Study||126
11297437|NCT02537574|12495027|FG002|STARTED|Overall Study||126
11297438|NCT02537574|12495025|FG000|COMPLETED|Overall Study||27
11297439|NCT02537574|12495026|FG001|COMPLETED|Overall Study||23
11297440|NCT02537574|12495027|FG002|COMPLETED|Overall Study||18
11297441|NCT02537574|12495025|FG000|NOT COMPLETED|Overall Study||99
11297442|NCT02537574|12495026|FG001|NOT COMPLETED|Overall Study||103
11297443|NCT02537574|12495027|FG002|NOT COMPLETED|Overall Study||108
11297444|NCT02537717|12495035|FG000|STARTED|Overall Study||17
11297445|NCT02537717|12495035|FG000|COMPLETED|Overall Study||17
11400818|NCT04156646|12595544|FG000|STARTED|Wash-out Period (12- to 21-days)||8
11400819|NCT04156646|12595545|FG001|STARTED|Wash-out Period (12- to 21-days)||8
11400820|NCT04156646|12595544|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8
11400821|NCT04156646|12595545|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8
11400822|NCT04156646|12595544|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
11400823|NCT04156646|12595545|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
11400824|NCT04156646|12595544|FG000|STARTED|Treatment Period 2 (6 Days)||8
11400825|NCT04156646|12595545|FG001|STARTED|Treatment Period 2 (6 Days)||8
11400826|NCT04156646|12595544|FG000|COMPLETED|Treatment Period 2 (6 Days)||8
11400827|NCT04156646|12595545|FG001|COMPLETED|Treatment Period 2 (6 Days)||8
11400828|NCT04156646|12595544|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0
11400829|NCT04156646|12595545|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0
11400830|NCT04156646|12595544|FG000|STARTED|Wash-out Period (12- to 21-days)||8
11400831|NCT04156646|12595545|FG001|STARTED|Wash-out Period (12- to 21-days)||8
11297446|NCT02537717|12495035|FG000|NOT COMPLETED|Overall Study||0
11297447|NCT02537730|12495042|FG000|STARTED|First Intervention (7 Days)||17
11297448|NCT02537730|12495043|FG001|STARTED|First Intervention (7 Days)||16
11297449|NCT02537730|12495042|FG000|COMPLETED|First Intervention (7 Days)||17
11297450|NCT02537730|12495043|FG001|COMPLETED|First Intervention (7 Days)||16
11297451|NCT02537730|12495042|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11297452|NCT02537730|12495043|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11297453|NCT02537730|12495042|FG000|STARTED|Second Intervention (7 Days)||17
11400832|NCT04156646|12595544|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8
11297454|NCT02537730|12495043|FG001|STARTED|Second Intervention (7 Days)||16
11297455|NCT02537730|12495042|FG000|COMPLETED|Second Intervention (7 Days)||17
11297456|NCT02537730|12495043|FG001|COMPLETED|Second Intervention (7 Days)||16
11297457|NCT02537730|12495042|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
11297458|NCT02537730|12495043|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11400833|NCT04156646|12595545|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8
11297459|NCT02537873|12495051|FG000|STARTED|Overall Study||17
11297460|NCT02537873|12495052|FG001|STARTED|Overall Study||8
11297461|NCT02537873|12495051|FG000|COMPLETED|Overall Study||9
11297462|NCT02537873|12495052|FG001|COMPLETED|Overall Study||4
11297463|NCT02537873|12495051|FG000|NOT COMPLETED|Overall Study||8
11297464|NCT02537873|12495052|FG001|NOT COMPLETED|Overall Study||4
11297465|NCT02537951|12495059|FG000|STARTED|Overall Study||10
11143822|NCT01474512|12330435|FG013|COMPLETED|Post-Treatment Follow-Up||0
11143823|NCT01474512|12330436|FG014|COMPLETED|Post-Treatment Follow-Up||0
11143824|NCT01474512|12330437|FG015|COMPLETED|Post-Treatment Follow-Up||17
11143825|NCT01474512|12330438|FG016|COMPLETED|Post-Treatment Follow-Up||544
11143826|NCT01474512|12330439|FG017|COMPLETED|Post-Treatment Follow-Up||239
11143827|NCT01474512|12330422|FG000|NOT COMPLETED|Post-Treatment Follow-Up||0
11297466|NCT02537951|12495059|FG000|COMPLETED|Overall Study||10
11297467|NCT02537951|12495059|FG000|NOT COMPLETED|Overall Study||0
11297468|NCT02538016|12495067|FG000|STARTED|Overall Study||4
11297469|NCT02538016|12495067|FG000|COMPLETED|Overall Study||4
11297470|NCT02538016|12495067|FG000|NOT COMPLETED|Overall Study||0
11297471|NCT02538029|12495074|FG000|STARTED|Overall Study||24
11297472|NCT02538029|12495075|FG001|STARTED|Overall Study||10
11297473|NCT02538029|12495076|FG002|STARTED|Overall Study||11
11297474|NCT02538029|12495074|FG000|COMPLETED|Overall Study||23
11297475|NCT02538029|12495075|FG001|COMPLETED|Overall Study||10
11297476|NCT02538029|12495076|FG002|COMPLETED|Overall Study||10
11297477|NCT02538029|12495074|FG000|NOT COMPLETED|Overall Study||1
11400834|NCT04156646|12595544|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
11400835|NCT04156646|12595545|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
11400836|NCT04156646|12595544|FG000|STARTED|Treatment Period 3 (6 Days)||8
11400837|NCT04156646|12595545|FG001|STARTED|Treatment Period 3 (6 Days)||8
11297478|NCT02538029|12495075|FG001|NOT COMPLETED|Overall Study||0
11297479|NCT02538029|12495076|FG002|NOT COMPLETED|Overall Study||1
11297480|NCT02538042|12495088|FG000|STARTED|Overall Study||17
11297481|NCT02538042|12495089|FG001|STARTED|Overall Study||17
11297482|NCT02538042|12495088|FG000|Completed All MCE Sessions|Overall Study||15
11297483|NCT02538042|12495089|FG001|Completed All MCE Sessions|Overall Study||15
11297484|NCT02538042|12495088|FG000|Attended Post-Quit Visit|Overall Study||15
11297485|NCT02538042|12495089|FG001|Attended Post-Quit Visit|Overall Study||14
11297486|NCT02538042|12495088|FG000|Completed All Post-Quit Visits|Overall Study||12
11297487|NCT02538042|12495089|FG001|Completed All Post-Quit Visits|Overall Study||12
11297488|NCT02538042|12495088|FG000|COMPLETED|Overall Study||6
11297489|NCT02538042|12495089|FG001|COMPLETED|Overall Study||6
11297490|NCT02538042|12495088|FG000|NOT COMPLETED|Overall Study||11
11297491|NCT02538042|12495089|FG001|NOT COMPLETED|Overall Study||11
11297492|NCT02538094|12495097|FG000|STARTED|Intervention 1 (5 Days Per Participant)||2
11297493|NCT02538094|12495098|FG001|STARTED|Intervention 1 (5 Days Per Participant)||5
11297494|NCT02538094|12495097|FG000|COMPLETED|Intervention 1 (5 Days Per Participant)||2
11297495|NCT02538094|12495098|FG001|COMPLETED|Intervention 1 (5 Days Per Participant)||4
11297496|NCT02538094|12495097|FG000|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||0
11297497|NCT02538094|12495098|FG001|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||1
11297498|NCT02538094|12495097|FG000|STARTED|Washout (4 Weeks)||2
11297499|NCT02538094|12495098|FG001|STARTED|Washout (4 Weeks)||4
11297500|NCT02538094|12495097|FG000|COMPLETED|Washout (4 Weeks)||2
11297501|NCT02538094|12495098|FG001|COMPLETED|Washout (4 Weeks)||3
11297502|NCT02538094|12495097|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11297503|NCT02538094|12495098|FG001|NOT COMPLETED|Washout (4 Weeks)||1
11297504|NCT02538094|12495097|FG000|STARTED|Intervention 2 (5 Days Per Participant)||2
11297505|NCT02538094|12495098|FG001|STARTED|Intervention 2 (5 Days Per Participant)||3
11297506|NCT02538094|12495097|FG000|COMPLETED|Intervention 2 (5 Days Per Participant)||2
11297507|NCT02538094|12495098|FG001|COMPLETED|Intervention 2 (5 Days Per Participant)||3
11297508|NCT02538094|12495097|FG000|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
11297509|NCT02538094|12495098|FG001|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
11297510|NCT02538107|12495104|FG000|STARTED|Overall Study||290
11297511|NCT02538107|12495104|FG000|COMPLETED|Overall Study||180
11297512|NCT02538107|12495104|FG000|NOT COMPLETED|Overall Study||110
11297513|NCT02538341|12495120|FG000|STARTED|Overall Study||310
11297514|NCT02538341|12495121|FG001|STARTED|Overall Study||307
11297515|NCT02538341|12495120|FG000|Week 6 (Primary Outcome)|Overall Study||303
11400838|NCT04156646|12595544|FG000|COMPLETED|Treatment Period 3 (6 Days)||8
11400839|NCT04156646|12595545|FG001|COMPLETED|Treatment Period 3 (6 Days)||7
11297516|NCT02538341|12495121|FG001|Week 6 (Primary Outcome)|Overall Study||299
11297517|NCT02538341|12495120|FG000|Month 6 (Safety Outcome)|Overall Study||276
11297518|NCT02538341|12495121|FG001|Month 6 (Safety Outcome)|Overall Study||260
11297519|NCT02538341|12495120|FG000|1 Year Visit|Overall Study||254
11297520|NCT02538341|12495121|FG001|1 Year Visit|Overall Study||0
11297521|NCT02538341|12495120|FG000|COMPLETED|Overall Study||254
11297522|NCT02538341|12495121|FG001|COMPLETED|Overall Study||260
11297523|NCT02538341|12495120|FG000|NOT COMPLETED|Overall Study||56
11297524|NCT02538341|12495121|FG001|NOT COMPLETED|Overall Study||47
11297525|NCT02538354|12495129|FG000|STARTED|Overall Study||40
11297526|NCT02538354|12495130|FG001|STARTED|Overall Study||30
11297527|NCT02538354|12495129|FG000|COMPLETED|Overall Study||40
11297528|NCT02538354|12495130|FG001|COMPLETED|Overall Study||30
11297529|NCT02538354|12495129|FG000|NOT COMPLETED|Overall Study||0
11297530|NCT02538354|12495130|FG001|NOT COMPLETED|Overall Study||0
11297531|NCT02538419|12495138|FG000|STARTED|Overall Study||20
11297532|NCT02538419|12495139|FG001|STARTED|Overall Study||20
11297533|NCT02538419|12495138|FG000|COMPLETED|Overall Study||20
11297534|NCT02538419|12495139|FG001|COMPLETED|Overall Study||20
11297535|NCT02538419|12495138|FG000|NOT COMPLETED|Overall Study||0
11297536|NCT02538419|12495139|FG001|NOT COMPLETED|Overall Study||0
11297537|NCT02538471|12495145|FG000|STARTED|Overall Study||3
11297538|NCT02538471|12495145|FG000|COMPLETED|Overall Study||1
11297539|NCT02538471|12495145|FG000|NOT COMPLETED|Overall Study||2
11297540|NCT02538523|12495151|FG000|STARTED|Overall Study||29
11297541|NCT02538523|12495152|FG001|STARTED|Overall Study||29
11297542|NCT02538523|12495151|FG000|COMPLETED|Overall Study||29
11297543|NCT02538523|12495152|FG001|COMPLETED|Overall Study||29
11297544|NCT02538523|12495151|FG000|NOT COMPLETED|Overall Study||0
11297545|NCT02538523|12495152|FG001|NOT COMPLETED|Overall Study||0
11297546|NCT02538614|12495158|FG000|STARTED|Overall Study||2
11297547|NCT02538614|12495158|FG000|COMPLETED|Overall Study||0
11297548|NCT02538614|12495158|FG000|NOT COMPLETED|Overall Study||2
11297549|NCT02538679|12495167|FG000|STARTED|Overall Study||24
11297550|NCT02538679|12495168|FG001|STARTED|Overall Study||54
11297551|NCT02538679|12495169|FG002|STARTED|Overall Study||49
11297552|NCT02538679|12495167|FG000|COMPLETED|Overall Study||21
11297553|NCT02538679|12495168|FG001|COMPLETED|Overall Study||45
11297554|NCT02538679|12495169|FG002|COMPLETED|Overall Study||41
11297555|NCT02538679|12495167|FG000|NOT COMPLETED|Overall Study||3
11297556|NCT02538679|12495168|FG001|NOT COMPLETED|Overall Study||9
11297557|NCT02538679|12495169|FG002|NOT COMPLETED|Overall Study||8
11297558|NCT02538783|12495179|FG000|STARTED|Overall Study||130
11297559|NCT02538783|12495180|FG001|STARTED|Overall Study||129
11297560|NCT02538783|12495179|FG000|COMPLETED|Overall Study||130
11297561|NCT02538783|12495180|FG001|COMPLETED|Overall Study||128
11297562|NCT02538783|12495179|FG000|NOT COMPLETED|Overall Study||0
11297563|NCT02538783|12495180|FG001|NOT COMPLETED|Overall Study||1
11297564|NCT02538900|12495189|FG000|STARTED|Overall Study||116
11297565|NCT02538900|12495190|FG001|STARTED|Overall Study||124
11297566|NCT02538900|12495191|FG002|STARTED|Overall Study||65
11297567|NCT02538900|12495189|FG000|COMPLETED|Overall Study||96
11297568|NCT02538900|12495190|FG001|COMPLETED|Overall Study||106
11297569|NCT02538900|12495191|FG002|COMPLETED|Overall Study||48
11297570|NCT02538900|12495189|FG000|NOT COMPLETED|Overall Study||20
11297571|NCT02538900|12495190|FG001|NOT COMPLETED|Overall Study||18
11297572|NCT02538900|12495191|FG002|NOT COMPLETED|Overall Study||17
11297573|NCT02538965|12495199|FG000|STARTED|Treatment Period||17
11297574|NCT02538965|12495199|FG000|COMPLETED|Treatment Period||0
11297575|NCT02538965|12495199|FG000|NOT COMPLETED|Treatment Period||17
11297576|NCT02538965|12495199|FG000|STARTED|Follow-Up Period||17
11297577|NCT02538965|12495199|FG000|COMPLETED|Follow-Up Period||0
11297578|NCT02538965|12495199|FG000|NOT COMPLETED|Follow-Up Period||17
11297579|NCT02539108|12495205|FG000|STARTED|Overall Study||30
11297580|NCT02539108|12495206|FG001|STARTED|Overall Study||30
11297581|NCT02539108|12495205|FG000|COMPLETED|Overall Study||30
11297582|NCT02539108|12495206|FG001|COMPLETED|Overall Study||30
11297583|NCT02539108|12495205|FG000|NOT COMPLETED|Overall Study||0
11297584|NCT02539108|12495206|FG001|NOT COMPLETED|Overall Study||0
11297585|NCT02539134|12495218|FG000|STARTED|Overall Study||10
11297586|NCT02539134|12495219|FG001|STARTED|Overall Study||6
11297587|NCT02539134|12495220|FG002|STARTED|Overall Study||6
11297588|NCT02539134|12495221|FG003|STARTED|Overall Study||6
11297589|NCT02539134|12495222|FG004|STARTED|Overall Study||6
11297590|NCT02539134|12495223|FG005|STARTED|Overall Study||6
11297591|NCT02539134|12495218|FG000|COMPLETED|Overall Study||9
11297592|NCT02539134|12495219|FG001|COMPLETED|Overall Study||6
11297593|NCT02539134|12495220|FG002|COMPLETED|Overall Study||6
11297594|NCT02539134|12495221|FG003|COMPLETED|Overall Study||6
11297595|NCT02539134|12495222|FG004|COMPLETED|Overall Study||6
11297596|NCT02539134|12495223|FG005|COMPLETED|Overall Study||6
11297597|NCT02539134|12495218|FG000|NOT COMPLETED|Overall Study||1
11297598|NCT02539134|12495219|FG001|NOT COMPLETED|Overall Study||0
11297599|NCT02539134|12495220|FG002|NOT COMPLETED|Overall Study||0
11297600|NCT02539134|12495221|FG003|NOT COMPLETED|Overall Study||0
11297601|NCT02539134|12495222|FG004|NOT COMPLETED|Overall Study||0
11297602|NCT02539134|12495223|FG005|NOT COMPLETED|Overall Study||0
11297603|NCT02539342|12495244|FG000|STARTED|Overall Study||1
11297604|NCT02539342|12495245|FG001|STARTED|Overall Study||0
11297605|NCT02539342|12495244|FG000|COMPLETED|Overall Study||1
11297606|NCT02539342|12495245|FG001|COMPLETED|Overall Study||0
11297607|NCT02539342|12495244|FG000|NOT COMPLETED|Overall Study||0
11297608|NCT02539342|12495245|FG001|NOT COMPLETED|Overall Study||0
11297609|NCT02539368|12495256|FG000|STARTED|Overall Study||1522
11297610|NCT02539368|12495257|FG001|STARTED|Overall Study||494
11297611|NCT02539368|12495258|FG002|STARTED|Overall Study||358
11297612|NCT02539368|12495259|FG003|STARTED|Overall Study||67
11297613|NCT02539368|12495260|FG004|STARTED|Overall Study||102
11297614|NCT02539368|12495256|FG000|COMPLETED|Overall Study||1117
11297615|NCT02539368|12495257|FG001|COMPLETED|Overall Study||393
11297616|NCT02539368|12495258|FG002|COMPLETED|Overall Study||291
11297617|NCT02539368|12495259|FG003|COMPLETED|Overall Study||60
11297618|NCT02539368|12495260|FG004|COMPLETED|Overall Study||88
11297619|NCT02539368|12495256|FG000|NOT COMPLETED|Overall Study||405
11297620|NCT02539368|12495257|FG001|NOT COMPLETED|Overall Study||101
11297621|NCT02539368|12495258|FG002|NOT COMPLETED|Overall Study||67
11297622|NCT02539368|12495259|FG003|NOT COMPLETED|Overall Study||7
11297623|NCT02539368|12495260|FG004|NOT COMPLETED|Overall Study||14
11297624|NCT02539459|12495275|FG000|STARTED|Overall Study||20
11297625|NCT02539459|12495275|FG000|COMPLETED|Overall Study||18
11297626|NCT02539459|12495275|FG000|NOT COMPLETED|Overall Study||2
11297627|NCT02539511|12495281|FG000|STARTED|Overall Study||23
11297628|NCT02539511|12495282|FG001|STARTED|Overall Study||17
11297629|NCT02539511|12495281|FG000|COMPLETED|Overall Study||17
11297630|NCT02539511|12495282|FG001|COMPLETED|Overall Study||17
11297631|NCT02539511|12495281|FG000|NOT COMPLETED|Overall Study||6
11297632|NCT02539511|12495282|FG001|NOT COMPLETED|Overall Study||0
11297633|NCT02539654|12495288|FG000|STARTED|Overall Study||14
11297634|NCT02539654|12495288|FG000|COMPLETED|Overall Study||14
11297635|NCT02539654|12495288|FG000|NOT COMPLETED|Overall Study||0
11297636|NCT02539797|12495293|FG000|STARTED|Overall Study||12
11297637|NCT02539797|12495294|FG001|STARTED|Overall Study||13
11297638|NCT02539797|12495295|FG002|STARTED|Overall Study||13
11297639|NCT02539797|12495293|FG000|COMPLETED|Overall Study||12
11297640|NCT02539797|12495294|FG001|COMPLETED|Overall Study||12
11297641|NCT02539797|12495295|FG002|COMPLETED|Overall Study||13
11297642|NCT02539797|12495293|FG000|NOT COMPLETED|Overall Study||0
11297643|NCT02539797|12495294|FG001|NOT COMPLETED|Overall Study||1
11297644|NCT02539797|12495295|FG002|NOT COMPLETED|Overall Study||0
11297645|NCT02539992|12495306|FG000|STARTED|Overall Study||15
11297646|NCT02539992|12495307|FG001|STARTED|Overall Study||11
11297647|NCT02539992|12495308|FG002|STARTED|Overall Study||18
11297648|NCT02539992|12495306|FG000|COMPLETED|Overall Study||15
11297649|NCT02539992|12495307|FG001|COMPLETED|Overall Study||7
11297650|NCT02539992|12495308|FG002|COMPLETED|Overall Study||14
11297651|NCT02539992|12495306|FG000|NOT COMPLETED|Overall Study||0
11297652|NCT02539992|12495307|FG001|NOT COMPLETED|Overall Study||4
11297653|NCT02539992|12495308|FG002|NOT COMPLETED|Overall Study||4
11297654|NCT02540083|12495318|FG000|STARTED|Overall Study||94
11297655|NCT02540083|12495318|FG000|COMPLETED|Overall Study||78
11297656|NCT02540083|12495318|FG000|NOT COMPLETED|Overall Study||16
11297657|NCT02540161|12495326|FG000|STARTED|Overall Study||20
11297658|NCT02540161|12495327|FG001|STARTED|Overall Study||7
11297659|NCT02540161|12495328|FG002|STARTED|Overall Study||5
11297660|NCT02540161|12495329|FG003|STARTED|Overall Study||7
11297661|NCT02540161|12495326|FG000|COMPLETED|Overall Study||20
11297662|NCT02540161|12495327|FG001|COMPLETED|Overall Study||7
11297663|NCT02540161|12495328|FG002|COMPLETED|Overall Study||5
11297664|NCT02540161|12495329|FG003|COMPLETED|Overall Study||7
11297665|NCT02540161|12495326|FG000|NOT COMPLETED|Overall Study||0
11297666|NCT02540161|12495327|FG001|NOT COMPLETED|Overall Study||0
11297667|NCT02540161|12495328|FG002|NOT COMPLETED|Overall Study||0
11297668|NCT02540161|12495329|FG003|NOT COMPLETED|Overall Study||0
11297669|NCT02540213|12495339|FG000|STARTED|Overall Study||240
11297670|NCT02540213|12495339|FG000|COMPLETED|Overall Study||201
11297671|NCT02540213|12495339|FG000|NOT COMPLETED|Overall Study||39
11400840|NCT04156646|12595544|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0
11400841|NCT04156646|12595545|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||1
11400842|NCT04170686|12595556|FG000|STARTED|Screening||74
11400843|NCT04170686|12595557|FG001|STARTED|Screening||72
11400844|NCT04170686|12595556|FG000|COMPLETED|Screening||62
11297672|NCT02540226|12495345|FG000|STARTED|Overall Study||33
11297673|NCT02540226|12495346|FG001|STARTED|Overall Study||33
11297674|NCT02540226|12495345|FG000|COMPLETED|Overall Study||31
11297675|NCT02540226|12495346|FG001|COMPLETED|Overall Study||32
11297676|NCT02540226|12495345|FG000|NOT COMPLETED|Overall Study||2
11297677|NCT02540226|12495346|FG001|NOT COMPLETED|Overall Study||1
11297678|NCT02540265|12495355|FG000|STARTED|Overall Study||20
11297679|NCT02540265|12495356|FG001|STARTED|Overall Study||20
11297680|NCT02540265|12495357|FG002|STARTED|Overall Study||19
11297681|NCT02540265|12495355|FG000|Treatment Completion|Overall Study||20
11297682|NCT02540265|12495356|FG001|Treatment Completion|Overall Study||19
11297683|NCT02540265|12495357|FG002|Treatment Completion|Overall Study||18
11297684|NCT02540265|12495355|FG000|COMPLETED|Overall Study||20
11297685|NCT02540265|12495356|FG001|COMPLETED|Overall Study||20
11297686|NCT02540265|12495357|FG002|COMPLETED|Overall Study||18
11400845|NCT04170686|12595557|FG001|COMPLETED|Screening||59
11400846|NCT04170686|12595556|FG000|NOT COMPLETED|Screening||12
11297687|NCT02540265|12495355|FG000|NOT COMPLETED|Overall Study||0
11297688|NCT02540265|12495356|FG001|NOT COMPLETED|Overall Study||0
11297689|NCT02540265|12495357|FG002|NOT COMPLETED|Overall Study||1
11297690|NCT02540291|12495369|FG000|STARTED|Overall Study||8
11297691|NCT02540291|12495370|FG001|STARTED|Overall Study||8
11297692|NCT02540291|12495371|FG002|STARTED|Overall Study||7
11297693|NCT02540291|12495372|FG003|STARTED|Overall Study||7
11297694|NCT02540291|12495369|FG000|COMPLETED|Overall Study||0
11297695|NCT02540291|12495370|FG001|COMPLETED|Overall Study||0
11297696|NCT02540291|12495371|FG002|COMPLETED|Overall Study||0
11297697|NCT02540291|12495372|FG003|COMPLETED|Overall Study||0
11297698|NCT02540291|12495369|FG000|NOT COMPLETED|Overall Study||8
11297699|NCT02540291|12495370|FG001|NOT COMPLETED|Overall Study||8
11297700|NCT02540291|12495371|FG002|NOT COMPLETED|Overall Study||7
11297701|NCT02540291|12495372|FG003|NOT COMPLETED|Overall Study||7
11297702|NCT02540356|12495386|FG000|STARTED|Overall Study||1
11297703|NCT02540356|12495387|FG001|STARTED|Overall Study||0
11297704|NCT02540356|12495386|FG000|COMPLETED|Overall Study||0
11297705|NCT02540356|12495387|FG001|COMPLETED|Overall Study||0
11297706|NCT02540356|12495386|FG000|NOT COMPLETED|Overall Study||1
11297707|NCT02540356|12495387|FG001|NOT COMPLETED|Overall Study||0
11297708|NCT02540447|12495394|FG000|STARTED|Overall Study||40
11297709|NCT02540447|12495395|FG001|STARTED|Overall Study||40
11297710|NCT02540447|12495394|FG000|COMPLETED|Overall Study||40
11297711|NCT02540447|12495395|FG001|COMPLETED|Overall Study||40
11297712|NCT02540447|12495394|FG000|NOT COMPLETED|Overall Study||0
11297713|NCT02540447|12495395|FG001|NOT COMPLETED|Overall Study||0
11297714|NCT02540538|12495404|FG000|STARTED|Overall Study||12
11297715|NCT02540538|12495405|FG001|STARTED|Overall Study||12
11297716|NCT02540538|12495406|FG002|STARTED|Overall Study||10
11297717|NCT02540538|12495404|FG000|COMPLETED|Overall Study||12
11297718|NCT02540538|12495405|FG001|COMPLETED|Overall Study||11
11297719|NCT02540538|12495406|FG002|COMPLETED|Overall Study||10
11297720|NCT02540538|12495404|FG000|NOT COMPLETED|Overall Study||0
11297721|NCT02540538|12495405|FG001|NOT COMPLETED|Overall Study||1
11297722|NCT02540538|12495406|FG002|NOT COMPLETED|Overall Study||0
11341384|NCT02932878|12538761|FG000|STARTED|Overall Study||15
11341385|NCT02932878|12538762|FG001|STARTED|Overall Study||1
11341386|NCT02932878|12538761|FG000|COMPLETED|Overall Study||13
11341387|NCT02932878|12538762|FG001|COMPLETED|Overall Study||0
11341388|NCT02932878|12538761|FG000|NOT COMPLETED|Overall Study||2
11341389|NCT02932878|12538762|FG001|NOT COMPLETED|Overall Study||1
11341390|NCT02932891|12538768|FG000|STARTED|Overall Study||28
11297723|NCT02540629|12495416|FG000|STARTED|Overall Study||6201
11297724|NCT02540629|12495417|FG001|STARTED|Overall Study||6469
11297725|NCT02540629|12495416|FG000|COMPLETED|Overall Study||6201
11297726|NCT02540629|12495417|FG001|COMPLETED|Overall Study||6469
11297727|NCT02540629|12495416|FG000|NOT COMPLETED|Overall Study||0
11297728|NCT02540629|12495417|FG001|NOT COMPLETED|Overall Study||0
11297729|NCT02540668|12495424|FG000|STARTED|Period 1 - Warfarin Single Dose||15
11297730|NCT02540668|12495425|FG001|STARTED|Period 1 - Warfarin Single Dose||0
11297731|NCT02540668|12495424|FG000|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15
11297732|NCT02540668|12495425|FG001|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0
11297733|NCT02540668|12495424|FG000|COMPLETED|Period 1 - Warfarin Single Dose||15
11297734|NCT02540668|12495425|FG001|COMPLETED|Period 1 - Warfarin Single Dose||0
11297735|NCT02540668|12495424|FG000|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
11297736|NCT02540668|12495425|FG001|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
11297737|NCT02540668|12495424|FG000|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0
11400847|NCT04170686|12595557|FG001|NOT COMPLETED|Screening||13
11297738|NCT02540668|12495425|FG001|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15
11297739|NCT02540668|12495424|FG000|COMPLETED|Period 2 - LY3314814 and Warfarin||0
11297740|NCT02540668|12495425|FG001|COMPLETED|Period 2 - LY3314814 and Warfarin||14
11297741|NCT02540668|12495424|FG000|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0
11297742|NCT02540668|12495425|FG001|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1
11297743|NCT02540772|12495434|FG000|STARTED|Overall Study||10
11297744|NCT02540772|12495435|FG001|STARTED|Overall Study||10
11297745|NCT02540772|12495434|FG000|COMPLETED|Overall Study||10
11297746|NCT02540772|12495435|FG001|COMPLETED|Overall Study||10
11297747|NCT02540772|12495434|FG000|NOT COMPLETED|Overall Study||0
11297748|NCT02540772|12495435|FG001|NOT COMPLETED|Overall Study||0
11297749|NCT02540850|12495444|FG000|STARTED|Overall Study||360
11297750|NCT02540850|12495445|FG001|STARTED|Overall Study||396
11297751|NCT02540850|12495446|FG002|STARTED|Overall Study||444
11297752|NCT02540850|12495444|FG000|COMPLETED|Overall Study||291
11297753|NCT02540850|12495445|FG001|COMPLETED|Overall Study||330
11297754|NCT02540850|12495446|FG002|COMPLETED|Overall Study||410
11297755|NCT02540850|12495444|FG000|NOT COMPLETED|Overall Study||69
11297756|NCT02540850|12495445|FG001|NOT COMPLETED|Overall Study||66
11297757|NCT02540850|12495446|FG002|NOT COMPLETED|Overall Study||34
11297758|NCT02540954|12495456|FG000|STARTED|Overall Study||168
11297759|NCT02540954|12495457|FG001|STARTED|Overall Study||168
11297760|NCT02540954|12495456|FG000|Treated|Overall Study||167
11297761|NCT02540954|12495457|FG001|Treated|Overall Study||168
11297762|NCT02540954|12495456|FG000|Post-baseline BCVA Assessment|Overall Study|FAS|165
11297763|NCT02540954|12495457|FG001|Post-baseline BCVA Assessment|Overall Study|FAS|167
11297764|NCT02540954|12495456|FG000|COMPLETED|Overall Study|Completed treatment|149
11297765|NCT02540954|12495457|FG001|COMPLETED|Overall Study|Completed treatment|154
11297766|NCT02540954|12495456|FG000|NOT COMPLETED|Overall Study||19
11297767|NCT02540954|12495457|FG001|NOT COMPLETED|Overall Study||14
11297768|NCT02540993|12495465|FG000|STARTED|Overall Study||2866
11297769|NCT02540993|12495466|FG001|STARTED|Overall Study||2868
11297770|NCT02540993|12495465|FG000|Included in FAS|Overall Study||2833
11297771|NCT02540993|12495466|FG001|Included in FAS|Overall Study||2841
11297772|NCT02540993|12495465|FG000|Treated|Overall Study||2827
11297773|NCT02540993|12495466|FG001|Treated|Overall Study||2831
11297774|NCT02540993|12495465|FG000|COMPLETED|Overall Study||2824
11297775|NCT02540993|12495466|FG001|COMPLETED|Overall Study||2832
11297776|NCT02540993|12495465|FG000|NOT COMPLETED|Overall Study||42
11297777|NCT02540993|12495466|FG001|NOT COMPLETED|Overall Study||36
11297778|NCT02541409|12495474|FG000|STARTED|Overall Study||25
11297779|NCT02541409|12495475|FG001|STARTED|Overall Study||25
11297780|NCT02541409|12495474|FG000|COMPLETED|Overall Study||22
11297781|NCT02541409|12495475|FG001|COMPLETED|Overall Study||22
11297782|NCT02541409|12495474|FG000|NOT COMPLETED|Overall Study||3
11297783|NCT02541409|12495475|FG001|NOT COMPLETED|Overall Study||3
11297784|NCT02541422|12495481|FG000|STARTED|First Intervention||23
11297785|NCT02541422|12495482|FG001|STARTED|First Intervention||26
11297786|NCT02541422|12495481|FG000|COMPLETED|First Intervention||23
11297787|NCT02541422|12495482|FG001|COMPLETED|First Intervention||26
11297788|NCT02541422|12495481|FG000|NOT COMPLETED|First Intervention||0
11297789|NCT02541422|12495482|FG001|NOT COMPLETED|First Intervention||0
11297790|NCT02541422|12495481|FG000|STARTED|Second Intervention||23
11297791|NCT02541422|12495482|FG001|STARTED|Second Intervention||26
11297792|NCT02541422|12495481|FG000|COMPLETED|Second Intervention||23
11297793|NCT02541422|12495482|FG001|COMPLETED|Second Intervention||26
11297794|NCT02541422|12495481|FG000|NOT COMPLETED|Second Intervention||0
11297795|NCT02541422|12495482|FG001|NOT COMPLETED|Second Intervention||0
11297796|NCT02541565|12495488|FG000|STARTED|Overall Study||30
11297797|NCT02541565|12495488|FG000|COMPLETED|Overall Study||27
11297798|NCT02541565|12495488|FG000|NOT COMPLETED|Overall Study||3
11297799|NCT02541604|12495504|FG000|STARTED|Overall Study||11
11297800|NCT02541604|12495505|FG001|STARTED|Overall Study||9
11297801|NCT02541604|12495506|FG002|STARTED|Overall Study||11
11297802|NCT02541604|12495507|FG003|STARTED|Overall Study||3
11297803|NCT02541604|12495508|FG004|STARTED|Overall Study||10
11297804|NCT02541604|12495509|FG005|STARTED|Overall Study||10
11297805|NCT02541604|12495510|FG006|STARTED|Overall Study||10
11297806|NCT02541604|12495511|FG007|STARTED|Overall Study||10
11297807|NCT02541604|12495512|FG008|STARTED|Overall Study||4
11297808|NCT02541604|12495513|FG009|STARTED|Overall Study||4
11297809|NCT02541604|12495514|FG010|STARTED|Overall Study||2
11297810|NCT02541604|12495515|FG011|STARTED|Overall Study||3
11297811|NCT02541604|12495504|FG000|COMPLETED|Overall Study||0
11297812|NCT02541604|12495505|FG001|COMPLETED|Overall Study||0
11297813|NCT02541604|12495506|FG002|COMPLETED|Overall Study||0
11297814|NCT02541604|12495507|FG003|COMPLETED|Overall Study||0
11297815|NCT02541604|12495508|FG004|COMPLETED|Overall Study||0
11400848|NCT04170686|12595556|FG000|STARTED|Randomization and Treatment||62
11400849|NCT04170686|12595557|FG001|STARTED|Randomization and Treatment||59
11400850|NCT04170686|12595556|FG000|COMPLETED|Randomization and Treatment||36
11400851|NCT04170686|12595557|FG001|COMPLETED|Randomization and Treatment||44
11400852|NCT04170686|12595556|FG000|NOT COMPLETED|Randomization and Treatment||26
11400853|NCT04170686|12595557|FG001|NOT COMPLETED|Randomization and Treatment||15
11400854|NCT04169113|12595565|FG000|STARTED|Overall Study||52
11400855|NCT04169113|12595566|FG001|STARTED|Overall Study||59
11297816|NCT02541604|12495509|FG005|COMPLETED|Overall Study||0
11297817|NCT02541604|12495510|FG006|COMPLETED|Overall Study||0
11297818|NCT02541604|12495511|FG007|COMPLETED|Overall Study||0
11297819|NCT02541604|12495512|FG008|COMPLETED|Overall Study||0
11297820|NCT02541604|12495513|FG009|COMPLETED|Overall Study||0
11297821|NCT02541604|12495514|FG010|COMPLETED|Overall Study||0
11297822|NCT02541604|12495515|FG011|COMPLETED|Overall Study||0
11297823|NCT02541604|12495504|FG000|NOT COMPLETED|Overall Study||11
11297824|NCT02541604|12495505|FG001|NOT COMPLETED|Overall Study||9
11297825|NCT02541604|12495506|FG002|NOT COMPLETED|Overall Study||11
11297826|NCT02541604|12495507|FG003|NOT COMPLETED|Overall Study||3
11297827|NCT02541604|12495508|FG004|NOT COMPLETED|Overall Study||10
11297828|NCT02541604|12495509|FG005|NOT COMPLETED|Overall Study||10
11297829|NCT02541604|12495510|FG006|NOT COMPLETED|Overall Study||10
11297830|NCT02541604|12495511|FG007|NOT COMPLETED|Overall Study||10
11297831|NCT02541604|12495512|FG008|NOT COMPLETED|Overall Study||4
11297832|NCT02541604|12495513|FG009|NOT COMPLETED|Overall Study||4
11297833|NCT02541604|12495514|FG010|NOT COMPLETED|Overall Study||2
11297834|NCT02541604|12495515|FG011|NOT COMPLETED|Overall Study||3
11297835|NCT02541669|12495569|FG000|STARTED|Open Label Treatment Period||8
11297836|NCT02541669|12495570|FG001|STARTED|Open Label Treatment Period||8
11297837|NCT02541669|12495571|FG002|STARTED|Open Label Treatment Period||0
11297838|NCT02541669|12495572|FG003|STARTED|Open Label Treatment Period||0
11297839|NCT02541669|12495573|FG004|STARTED|Open Label Treatment Period||0
11297840|NCT02541669|12495569|FG000|COMPLETED|Open Label Treatment Period||8
11297841|NCT02541669|12495570|FG001|COMPLETED|Open Label Treatment Period||8
11297842|NCT02541669|12495571|FG002|COMPLETED|Open Label Treatment Period||0
11297843|NCT02541669|12495572|FG003|COMPLETED|Open Label Treatment Period||0
11297844|NCT02541669|12495573|FG004|COMPLETED|Open Label Treatment Period||0
11297845|NCT02541669|12495569|FG000|NOT COMPLETED|Open Label Treatment Period||0
11297846|NCT02541669|12495570|FG001|NOT COMPLETED|Open Label Treatment Period||0
11297847|NCT02541669|12495571|FG002|NOT COMPLETED|Open Label Treatment Period||0
11297848|NCT02541669|12495572|FG003|NOT COMPLETED|Open Label Treatment Period||0
11297849|NCT02541669|12495573|FG004|NOT COMPLETED|Open Label Treatment Period||0
11297850|NCT02541669|12495569|FG000|STARTED|Double-Blinded Treatment Period||0
11297851|NCT02541669|12495570|FG001|STARTED|Double-Blinded Treatment Period||0
11297852|NCT02541669|12495571|FG002|STARTED|Double-Blinded Treatment Period||16
11297853|NCT02541669|12495572|FG003|STARTED|Double-Blinded Treatment Period||16
11297854|NCT02541669|12495573|FG004|STARTED|Double-Blinded Treatment Period||16
11297855|NCT02541669|12495569|FG000|COMPLETED|Double-Blinded Treatment Period||0
11297856|NCT02541669|12495570|FG001|COMPLETED|Double-Blinded Treatment Period||0
11297857|NCT02541669|12495571|FG002|COMPLETED|Double-Blinded Treatment Period||15
11297858|NCT02541669|12495572|FG003|COMPLETED|Double-Blinded Treatment Period||16
11297859|NCT02541669|12495573|FG004|COMPLETED|Double-Blinded Treatment Period||15
11297860|NCT02541669|12495569|FG000|NOT COMPLETED|Double-Blinded Treatment Period||0
11297861|NCT02541669|12495570|FG001|NOT COMPLETED|Double-Blinded Treatment Period||0
11297862|NCT02541669|12495571|FG002|NOT COMPLETED|Double-Blinded Treatment Period||1
11297863|NCT02541669|12495572|FG003|NOT COMPLETED|Double-Blinded Treatment Period||0
11297864|NCT02541669|12495573|FG004|NOT COMPLETED|Double-Blinded Treatment Period||1
11297865|NCT02541812|12495586|FG000|STARTED|Overall Study||10
11297866|NCT02541812|12495587|FG001|STARTED|Overall Study||10
11297867|NCT02541812|12495586|FG000|COMPLETED|Overall Study||10
11297868|NCT02541812|12495587|FG001|COMPLETED|Overall Study||10
11297869|NCT02541812|12495586|FG000|NOT COMPLETED|Overall Study||0
11297870|NCT02541812|12495587|FG001|NOT COMPLETED|Overall Study||0
11297871|NCT02541864|12495596|FG000|STARTED|Overall Study||164
11297872|NCT02541864|12495597|FG001|STARTED|Overall Study||166
11297873|NCT02541864|12495596|FG000|COMPLETED|Overall Study||164
11297874|NCT02541864|12495597|FG001|COMPLETED|Overall Study||166
11297875|NCT02541864|12495596|FG000|NOT COMPLETED|Overall Study||0
11297876|NCT02541864|12495597|FG001|NOT COMPLETED|Overall Study||0
11297877|NCT02541903|12495603|FG000|STARTED|Overall Study||8
11297878|NCT02541903|12495603|FG000|COMPLETED|Overall Study||7
11297879|NCT02541903|12495603|FG000|NOT COMPLETED|Overall Study||1
11297880|NCT02541942|12495607|FG000|STARTED|Overall Study||19
11297881|NCT02541942|12495607|FG000|COMPLETED|Overall Study||19
11297882|NCT02541942|12495607|FG000|NOT COMPLETED|Overall Study||0
11297883|NCT02542046|12495614|FG000|STARTED|Overall Study||300
11297884|NCT02542046|12495615|FG001|STARTED|Overall Study||300
11297885|NCT02542046|12495616|FG002|STARTED|Overall Study||300
11297886|NCT02542046|12495614|FG000|COMPLETED|Overall Study||300
11297887|NCT02542046|12495615|FG001|COMPLETED|Overall Study||300
11297888|NCT02542046|12495616|FG002|COMPLETED|Overall Study||300
11297889|NCT02542046|12495614|FG000|NOT COMPLETED|Overall Study||0
11297890|NCT02542046|12495615|FG001|NOT COMPLETED|Overall Study||0
11297891|NCT02542046|12495616|FG002|NOT COMPLETED|Overall Study||0
11297892|NCT02542072|12495626|FG000|STARTED|First Intervention (1 Month)||44
11297893|NCT02542072|12495627|FG001|STARTED|First Intervention (1 Month)||46
11297894|NCT02542072|12495626|FG000|COMPLETED|First Intervention (1 Month)||39
11297895|NCT02542072|12495627|FG001|COMPLETED|First Intervention (1 Month)||43
11297896|NCT02542072|12495626|FG000|NOT COMPLETED|First Intervention (1 Month)||5
11297897|NCT02542072|12495627|FG001|NOT COMPLETED|First Intervention (1 Month)||3
11297898|NCT02542072|12495626|FG000|STARTED|Second Intervention (1 Month)||39
11297899|NCT02542072|12495627|FG001|STARTED|Second Intervention (1 Month)||43
11297900|NCT02542072|12495626|FG000|COMPLETED|Second Intervention (1 Month)||37
11297901|NCT02542072|12495627|FG001|COMPLETED|Second Intervention (1 Month)||43
11297902|NCT02542072|12495626|FG000|NOT COMPLETED|Second Intervention (1 Month)||2
11297903|NCT02542072|12495627|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
11297904|NCT02542150|12495655|FG000|STARTED|Overall Study||12
11297905|NCT02542150|12495656|FG001|STARTED|Overall Study||12
11297906|NCT02542150|12495655|FG000|Completed Placebo|Overall Study||12
11297907|NCT02542150|12495656|FG001|Completed Placebo|Overall Study||12
11400856|NCT04169113|12595565|FG000|COMPLETED|Overall Study||47
11297908|NCT02542150|12495655|FG000|Started Intervention|Overall Study||12
11297909|NCT02542150|12495656|FG001|Started Intervention|Overall Study||12
11297910|NCT02542150|12495655|FG000|COMPLETED|Overall Study||12
11297911|NCT02542150|12495656|FG001|COMPLETED|Overall Study||12
11297912|NCT02542150|12495655|FG000|NOT COMPLETED|Overall Study||0
11297913|NCT02542150|12495656|FG001|NOT COMPLETED|Overall Study||0
11297914|NCT02542280|12495668|FG000|STARTED|Overall Study||174
11297915|NCT02542280|12495669|FG001|STARTED|Overall Study||175
11297916|NCT02542280|12495668|FG000|COMPLETED|Overall Study||162
11297917|NCT02542280|12495669|FG001|COMPLETED|Overall Study||167
11297918|NCT02542280|12495668|FG000|NOT COMPLETED|Overall Study||12
11297919|NCT02542280|12495669|FG001|NOT COMPLETED|Overall Study||8
11297920|NCT02542410|12495677|FG000|STARTED|Overall Study||5
11297921|NCT02542410|12495678|FG001|STARTED|Overall Study||5
11297922|NCT02542410|12495677|FG000|COMPLETED|Overall Study||3
11297923|NCT02542410|12495678|FG001|COMPLETED|Overall Study||4
11297924|NCT02542410|12495677|FG000|NOT COMPLETED|Overall Study||2
11297925|NCT02542410|12495678|FG001|NOT COMPLETED|Overall Study||1
11297926|NCT02542462|12495688|FG000|STARTED|Overall Study||25
11297927|NCT02542462|12495689|FG001|STARTED|Overall Study||25
11297928|NCT02542462|12495690|FG002|STARTED|Overall Study||25
11297929|NCT02542462|12495691|FG003|STARTED|Overall Study||26
11297930|NCT02542462|12495688|FG000|COMPLETED|Overall Study||25
11297931|NCT02542462|12495689|FG001|COMPLETED|Overall Study||25
11297932|NCT02542462|12495690|FG002|COMPLETED|Overall Study||25
11297933|NCT02542462|12495691|FG003|COMPLETED|Overall Study||25
11297934|NCT02542462|12495688|FG000|NOT COMPLETED|Overall Study||0
11297935|NCT02542462|12495689|FG001|NOT COMPLETED|Overall Study||0
11297936|NCT02542462|12495690|FG002|NOT COMPLETED|Overall Study||0
11297937|NCT02542462|12495691|FG003|NOT COMPLETED|Overall Study||1
11297938|NCT02542605|12495702|FG000|STARTED|Part A: PACAP-38 Dose Selection Phase||12
11297939|NCT02542605|12495703|FG001|STARTED|Part A: PACAP-38 Dose Selection Phase||0
11297940|NCT02542605|12495704|FG002|STARTED|Part A: PACAP-38 Dose Selection Phase||0
11297941|NCT02542605|12495702|FG000|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12
11297942|NCT02542605|12495703|FG001|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
11297943|NCT02542605|12495704|FG002|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
11297944|NCT02542605|12495702|FG000|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2
11297945|NCT02542605|12495703|FG001|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
11297946|NCT02542605|12495704|FG002|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
11297947|NCT02542605|12495702|FG000|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12
11297948|NCT02542605|12495703|FG001|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
11297949|NCT02542605|12495704|FG002|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
11297950|NCT02542605|12495702|FG000|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
11297951|NCT02542605|12495703|FG001|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
11297952|NCT02542605|12495704|FG002|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
11297953|NCT02542605|12495702|FG000|STARTED|Part B: Challenge Phase||23
11297954|NCT02542605|12495703|FG001|STARTED|Part B: Challenge Phase||0
11297955|NCT02542605|12495704|FG002|STARTED|Part B: Challenge Phase||0
11297956|NCT02542605|12495702|FG000|Received PACAP-38|Part B: Challenge Phase||23
11297957|NCT02542605|12495703|FG001|Received PACAP-38|Part B: Challenge Phase||0
11297958|NCT02542605|12495704|FG002|Received PACAP-38|Part B: Challenge Phase||0
11297959|NCT02542605|12495702|FG000|Proceeded to Randomization Phase|Part B: Challenge Phase||15
11297960|NCT02542605|12495703|FG001|Proceeded to Randomization Phase|Part B: Challenge Phase||0
11297961|NCT02542605|12495704|FG002|Proceeded to Randomization Phase|Part B: Challenge Phase||0
11297962|NCT02542605|12495702|FG000|COMPLETED|Part B: Challenge Phase||22
11297963|NCT02542605|12495703|FG001|COMPLETED|Part B: Challenge Phase||0
11297964|NCT02542605|12495704|FG002|COMPLETED|Part B: Challenge Phase||0
11297965|NCT02542605|12495702|FG000|NOT COMPLETED|Part B: Challenge Phase||1
11297966|NCT02542605|12495703|FG001|NOT COMPLETED|Part B: Challenge Phase||0
11297967|NCT02542605|12495704|FG002|NOT COMPLETED|Part B: Challenge Phase||0
11297968|NCT02542605|12495702|FG000|STARTED|Part B: Randomization Phase||0
11400857|NCT04169113|12595566|FG001|COMPLETED|Overall Study||53
11400858|NCT04169113|12595565|FG000|NOT COMPLETED|Overall Study||5
11297969|NCT02542605|12495703|FG001|STARTED|Part B: Randomization Phase||9
11297970|NCT02542605|12495704|FG002|STARTED|Part B: Randomization Phase||8
11297971|NCT02542605|12495702|FG000|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
11297972|NCT02542605|12495703|FG001|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2
11297973|NCT02542605|12495704|FG002|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
11297974|NCT02542605|12495702|FG000|PACAP-38 naïve Participants|Part B: Randomization Phase||0
11297975|NCT02542605|12495703|FG001|PACAP-38 naïve Participants|Part B: Randomization Phase||7
11297976|NCT02542605|12495704|FG002|PACAP-38 naïve Participants|Part B: Randomization Phase||8
11297977|NCT02542605|12495702|FG000|Received Placebo/Erenumab|Part B: Randomization Phase||0
11297978|NCT02542605|12495703|FG001|Received Placebo/Erenumab|Part B: Randomization Phase||9
11297979|NCT02542605|12495704|FG002|Received Placebo/Erenumab|Part B: Randomization Phase||7
11297980|NCT02542605|12495702|FG000|COMPLETED|Part B: Randomization Phase||0
11297981|NCT02542605|12495703|FG001|COMPLETED|Part B: Randomization Phase||9
11297982|NCT02542605|12495704|FG002|COMPLETED|Part B: Randomization Phase||7
11297983|NCT02542605|12495702|FG000|NOT COMPLETED|Part B: Randomization Phase||0
11297984|NCT02542605|12495703|FG001|NOT COMPLETED|Part B: Randomization Phase||0
11297985|NCT02542605|12495704|FG002|NOT COMPLETED|Part B: Randomization Phase||1
11297986|NCT02542631|12495715|FG000|STARTED|Overall Study||139
11297987|NCT02542631|12495716|FG001|STARTED|Overall Study||139
11297988|NCT02542631|12495715|FG000|COMPLETED|Overall Study||108
11297989|NCT02542631|12495716|FG001|COMPLETED|Overall Study||108
11297990|NCT02542631|12495715|FG000|NOT COMPLETED|Overall Study||31
11297991|NCT02542631|12495716|FG001|NOT COMPLETED|Overall Study||31
11297992|NCT02542761|12495722|FG000|STARTED|Acclimation Period 1||5
11297993|NCT02542761|12495723|FG001|STARTED|Acclimation Period 1||5
11297994|NCT02542761|12495722|FG000|COMPLETED|Acclimation Period 1||5
11297995|NCT02542761|12495723|FG001|COMPLETED|Acclimation Period 1||5
11297996|NCT02542761|12495722|FG000|NOT COMPLETED|Acclimation Period 1||0
11297997|NCT02542761|12495723|FG001|NOT COMPLETED|Acclimation Period 1||0
11297998|NCT02542761|12495722|FG000|STARTED|First Intervention||5
11297999|NCT02542761|12495723|FG001|STARTED|First Intervention||5
11298000|NCT02542761|12495722|FG000|COMPLETED|First Intervention||5
11298001|NCT02542761|12495723|FG001|COMPLETED|First Intervention||5
11298002|NCT02542761|12495722|FG000|NOT COMPLETED|First Intervention||0
11298003|NCT02542761|12495723|FG001|NOT COMPLETED|First Intervention||0
11298004|NCT02542761|12495722|FG000|STARTED|Acclimation Period 2||5
11298005|NCT02542761|12495723|FG001|STARTED|Acclimation Period 2||5
11298006|NCT02542761|12495722|FG000|COMPLETED|Acclimation Period 2||5
11298007|NCT02542761|12495723|FG001|COMPLETED|Acclimation Period 2||5
11298008|NCT02542761|12495722|FG000|NOT COMPLETED|Acclimation Period 2||0
11298009|NCT02542761|12495723|FG001|NOT COMPLETED|Acclimation Period 2||0
11298010|NCT02542761|12495722|FG000|STARTED|Second Intervention||5
11298011|NCT02542761|12495723|FG001|STARTED|Second Intervention||5
11298012|NCT02542761|12495722|FG000|COMPLETED|Second Intervention||5
11298013|NCT02542761|12495723|FG001|COMPLETED|Second Intervention||5
11298014|NCT02542761|12495722|FG000|NOT COMPLETED|Second Intervention||0
11298015|NCT02542761|12495723|FG001|NOT COMPLETED|Second Intervention||0
11298016|NCT02542865|12495731|FG000|STARTED|Overall Study||462
11298017|NCT02542865|12495732|FG001|STARTED|Overall Study||462
11298018|NCT02542865|12495731|FG000|Treated|Overall Study||460
11298019|NCT02542865|12495732|FG001|Treated|Overall Study||462
11298020|NCT02542865|12495731|FG000|COMPLETED|Overall Study||445
11298021|NCT02542865|12495732|FG001|COMPLETED|Overall Study||462
11298022|NCT02542865|12495731|FG000|NOT COMPLETED|Overall Study||17
11298023|NCT02542865|12495732|FG001|NOT COMPLETED|Overall Study||0
11298024|NCT02542943|12495741|FG000|STARTED|Overall Study||79
11298025|NCT02542943|12495742|FG001|STARTED|Overall Study||80
11298026|NCT02542943|12495743|FG002|STARTED|Overall Study||81
11298027|NCT02542943|12495741|FG000|COMPLETED|Overall Study||78
11298028|NCT02542943|12495742|FG001|COMPLETED|Overall Study||79
11298029|NCT02542943|12495743|FG002|COMPLETED|Overall Study||81
11298030|NCT02542943|12495741|FG000|NOT COMPLETED|Overall Study||1
11298031|NCT02542943|12495742|FG001|NOT COMPLETED|Overall Study||1
11298032|NCT02542943|12495743|FG002|NOT COMPLETED|Overall Study||0
11298033|NCT02543203|12495754|FG000|STARTED|Overall Study||13
11298034|NCT02543203|12495755|FG001|STARTED|Overall Study||15
11298035|NCT02543203|12495754|FG000|COMPLETED|Overall Study||7
11298036|NCT02543203|12495755|FG001|COMPLETED|Overall Study||10
11298037|NCT02543203|12495754|FG000|NOT COMPLETED|Overall Study||6
11298038|NCT02543203|12495755|FG001|NOT COMPLETED|Overall Study||5
11298039|NCT02543294|12495769|FG000|STARTED|Overall Study||20
11298040|NCT02543294|12495769|FG000|COMPLETED|Overall Study||8
11298041|NCT02543294|12495769|FG000|NOT COMPLETED|Overall Study||12
11298042|NCT02543346|12495774|FG000|STARTED|First Priming Visit||26
11298043|NCT02543346|12495775|FG001|STARTED|First Priming Visit||25
11298044|NCT02543346|12495776|FG002|STARTED|First Priming Visit||24
11298045|NCT02543346|12495777|FG003|STARTED|First Priming Visit||23
11298046|NCT02543346|12495774|FG000|COMPLETED|First Priming Visit||26
11298047|NCT02543346|12495775|FG001|COMPLETED|First Priming Visit||25
11298048|NCT02543346|12495776|FG002|COMPLETED|First Priming Visit||24
11298049|NCT02543346|12495777|FG003|COMPLETED|First Priming Visit||23
11298050|NCT02543346|12495774|FG000|NOT COMPLETED|First Priming Visit||0
11298051|NCT02543346|12495775|FG001|NOT COMPLETED|First Priming Visit||0
11298052|NCT02543346|12495776|FG002|NOT COMPLETED|First Priming Visit||0
11298053|NCT02543346|12495777|FG003|NOT COMPLETED|First Priming Visit||0
11298054|NCT02543346|12495774|FG000|STARTED|First Treatment Visit||26
11298055|NCT02543346|12495775|FG001|STARTED|First Treatment Visit||25
11298056|NCT02543346|12495776|FG002|STARTED|First Treatment Visit||24
11298057|NCT02543346|12495777|FG003|STARTED|First Treatment Visit||23
11298058|NCT02543346|12495774|FG000|COMPLETED|First Treatment Visit||26
11298059|NCT02543346|12495775|FG001|COMPLETED|First Treatment Visit||25
11298060|NCT02543346|12495776|FG002|COMPLETED|First Treatment Visit||24
11298061|NCT02543346|12495777|FG003|COMPLETED|First Treatment Visit||23
11298062|NCT02543346|12495774|FG000|NOT COMPLETED|First Treatment Visit||0
11298063|NCT02543346|12495775|FG001|NOT COMPLETED|First Treatment Visit||0
11298064|NCT02543346|12495776|FG002|NOT COMPLETED|First Treatment Visit||0
11298065|NCT02543346|12495777|FG003|NOT COMPLETED|First Treatment Visit||0
11298066|NCT02543346|12495774|FG000|STARTED|Washout (at Least 14 Days)||26
11298067|NCT02543346|12495775|FG001|STARTED|Washout (at Least 14 Days)||25
11298068|NCT02543346|12495776|FG002|STARTED|Washout (at Least 14 Days)||24
11298069|NCT02543346|12495777|FG003|STARTED|Washout (at Least 14 Days)||23
11298070|NCT02543346|12495774|FG000|COMPLETED|Washout (at Least 14 Days)||26
11298071|NCT02543346|12495775|FG001|COMPLETED|Washout (at Least 14 Days)||25
11298072|NCT02543346|12495776|FG002|COMPLETED|Washout (at Least 14 Days)||24
11298073|NCT02543346|12495777|FG003|COMPLETED|Washout (at Least 14 Days)||23
11298074|NCT02543346|12495774|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
11298075|NCT02543346|12495775|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
11298076|NCT02543346|12495776|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
11298077|NCT02543346|12495777|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0
11298078|NCT02543346|12495774|FG000|STARTED|Second Priming Visit||26
11298079|NCT02543346|12495775|FG001|STARTED|Second Priming Visit||25
11298080|NCT02543346|12495776|FG002|STARTED|Second Priming Visit||24
11298081|NCT02543346|12495777|FG003|STARTED|Second Priming Visit||23
11298082|NCT02543346|12495774|FG000|COMPLETED|Second Priming Visit||25
11298083|NCT02543346|12495775|FG001|COMPLETED|Second Priming Visit||23
11298084|NCT02543346|12495776|FG002|COMPLETED|Second Priming Visit||22
11298085|NCT02543346|12495777|FG003|COMPLETED|Second Priming Visit||21
11298086|NCT02543346|12495774|FG000|NOT COMPLETED|Second Priming Visit||1
11298087|NCT02543346|12495775|FG001|NOT COMPLETED|Second Priming Visit||2
11298088|NCT02543346|12495776|FG002|NOT COMPLETED|Second Priming Visit||2
11298089|NCT02543346|12495777|FG003|NOT COMPLETED|Second Priming Visit||2
11298090|NCT02543346|12495774|FG000|STARTED|Second Treatment Visit||25
11298091|NCT02543346|12495775|FG001|STARTED|Second Treatment Visit||23
11298092|NCT02543346|12495776|FG002|STARTED|Second Treatment Visit||22
11298093|NCT02543346|12495777|FG003|STARTED|Second Treatment Visit||21
11298094|NCT02543346|12495774|FG000|COMPLETED|Second Treatment Visit||25
11298095|NCT02543346|12495775|FG001|COMPLETED|Second Treatment Visit||23
11298096|NCT02543346|12495776|FG002|COMPLETED|Second Treatment Visit||22
11298097|NCT02543346|12495777|FG003|COMPLETED|Second Treatment Visit||21
11298098|NCT02543346|12495774|FG000|NOT COMPLETED|Second Treatment Visit||0
11298099|NCT02543346|12495775|FG001|NOT COMPLETED|Second Treatment Visit||0
11298100|NCT02543346|12495776|FG002|NOT COMPLETED|Second Treatment Visit||0
11298101|NCT02543346|12495777|FG003|NOT COMPLETED|Second Treatment Visit||0
11298102|NCT02543398|12495789|FG000|STARTED|Overall Study||20
11298103|NCT02543398|12495790|FG001|STARTED|Overall Study||20
11298104|NCT02543398|12495789|FG000|COMPLETED|Overall Study||20
11298105|NCT02543398|12495790|FG001|COMPLETED|Overall Study||20
11298106|NCT02543398|12495789|FG000|NOT COMPLETED|Overall Study||0
11298107|NCT02543398|12495790|FG001|NOT COMPLETED|Overall Study||0
11298108|NCT02543437|12495796|FG000|STARTED|Overall Study||117
11298109|NCT02543437|12495796|FG000|COMPLETED|Overall Study||117
11298110|NCT02543437|12495796|FG000|NOT COMPLETED|Overall Study||0
11298111|NCT02543528|12495800|FG000|STARTED|Adaptation Period||0
11298112|NCT02543528|12495801|FG001|STARTED|Adaptation Period||0
11298113|NCT02543528|12495802|FG002|STARTED|Adaptation Period||0
11298114|NCT02543528|12495803|FG003|STARTED|Adaptation Period||0
11298115|NCT02543528|12495804|FG004|STARTED|Adaptation Period||168
11298116|NCT02543528|12495800|FG000|COMPLETED|Adaptation Period||0
11298117|NCT02543528|12495801|FG001|COMPLETED|Adaptation Period||0
11298118|NCT02543528|12495802|FG002|COMPLETED|Adaptation Period||0
11298119|NCT02543528|12495803|FG003|COMPLETED|Adaptation Period||0
11298120|NCT02543528|12495804|FG004|COMPLETED|Adaptation Period||142
11298121|NCT02543528|12495800|FG000|NOT COMPLETED|Adaptation Period||0
11298122|NCT02543528|12495801|FG001|NOT COMPLETED|Adaptation Period||0
11298123|NCT02543528|12495802|FG002|NOT COMPLETED|Adaptation Period||0
11298124|NCT02543528|12495803|FG003|NOT COMPLETED|Adaptation Period||0
11298125|NCT02543528|12495804|FG004|NOT COMPLETED|Adaptation Period||26
11298126|NCT02543528|12495800|FG000|STARTED|Extended Wear Period||36
11298127|NCT02543528|12495801|FG001|STARTED|Extended Wear Period||35
11298128|NCT02543528|12495802|FG002|STARTED|Extended Wear Period||36
11298129|NCT02543528|12495803|FG003|STARTED|Extended Wear Period||35
11298130|NCT02543528|12495804|FG004|STARTED|Extended Wear Period||0
11298131|NCT02543528|12495800|FG000|COMPLETED|Extended Wear Period||8
11298132|NCT02543528|12495801|FG001|COMPLETED|Extended Wear Period||14
11298133|NCT02543528|12495802|FG002|COMPLETED|Extended Wear Period||13
11298134|NCT02543528|12495803|FG003|COMPLETED|Extended Wear Period||23
11298135|NCT02543528|12495804|FG004|COMPLETED|Extended Wear Period||0
11298136|NCT02543528|12495800|FG000|NOT COMPLETED|Extended Wear Period||28
11298137|NCT02543528|12495801|FG001|NOT COMPLETED|Extended Wear Period||21
11298138|NCT02543528|12495802|FG002|NOT COMPLETED|Extended Wear Period||23
11298139|NCT02543528|12495803|FG003|NOT COMPLETED|Extended Wear Period||12
11298140|NCT02543528|12495804|FG004|NOT COMPLETED|Extended Wear Period||0
11298141|NCT02543554|12495820|FG000|STARTED|Overall Study||1192
11298142|NCT02543554|12495821|FG001|STARTED|Overall Study||513
11298143|NCT02543554|12495820|FG000|COMPLETED|Overall Study||1192
11298144|NCT02543554|12495821|FG001|COMPLETED|Overall Study||513
11298145|NCT02543554|12495820|FG000|NOT COMPLETED|Overall Study||0
11298146|NCT02543554|12495821|FG001|NOT COMPLETED|Overall Study||0
11298147|NCT02543658|12495829|FG000|STARTED|Overall Study||40
11298148|NCT02543658|12495830|FG001|STARTED|Overall Study||40
11298149|NCT02543658|12495829|FG000|COMPLETED|Overall Study||40
11298150|NCT02543658|12495830|FG001|COMPLETED|Overall Study||36
11298151|NCT02543658|12495829|FG000|NOT COMPLETED|Overall Study||0
11298152|NCT02543658|12495830|FG001|NOT COMPLETED|Overall Study||4
11298153|NCT02543723|12495839|FG000|STARTED|Overall Study||65
11298154|NCT02543723|12495840|FG001|STARTED|Overall Study||63
11298155|NCT02543723|12495839|FG000|COMPLETED|Overall Study||65
11298156|NCT02543723|12495840|FG001|COMPLETED|Overall Study||63
11298157|NCT02543723|12495839|FG000|NOT COMPLETED|Overall Study||0
11298158|NCT02543723|12495840|FG001|NOT COMPLETED|Overall Study||0
11298159|NCT02543801|12495852|FG000|STARTED|Overall Study||61
11298160|NCT02543801|12495853|FG001|STARTED|Overall Study||60
11298161|NCT02543801|12495854|FG002|STARTED|Overall Study||59
11298162|NCT02543801|12495855|FG003|STARTED|Overall Study||59
11298163|NCT02543801|12495852|FG000|COMPLETED|Overall Study||60
11298164|NCT02543801|12495853|FG001|COMPLETED|Overall Study||58
11298165|NCT02543801|12495854|FG002|COMPLETED|Overall Study||59
11298166|NCT02543801|12495855|FG003|COMPLETED|Overall Study||59
11298167|NCT02543801|12495852|FG000|NOT COMPLETED|Overall Study||1
11298168|NCT02543801|12495853|FG001|NOT COMPLETED|Overall Study||2
11298169|NCT02543801|12495854|FG002|NOT COMPLETED|Overall Study||0
11298170|NCT02543801|12495855|FG003|NOT COMPLETED|Overall Study||0
11298171|NCT02543840|12495867|FG000|STARTED|Overall Study|This is a quasi-experimental design, not a RCT. 1050 veterans did 1436 interviews at 3 time points.|1050
11298172|NCT02543840|12495868|FG001|STARTED|Overall Study||62
11298173|NCT02543840|12495867|FG000|0 Month Timepoint (t0)|Overall Study||593
11298174|NCT02543840|12495868|FG001|0 Month Timepoint (t0)|Overall Study||40
11298175|NCT02543840|12495867|FG000|6 Month Timepoint (t6)|Overall Study|593 participants started at 0 months; 188 repeated and 66 participants added at 6 months timepoint.|66
11298176|NCT02543840|12495868|FG001|6 Month Timepoint (t6)|Overall Study||0
11298177|NCT02543840|12495867|FG000|12 Month Timepoint (t12)|Overall Study|91 continued from 0 months (t0), 16 from 6 months (t6), 91 from t0 & t6; 391 added at 12 months.|391
11298178|NCT02543840|12495868|FG001|12 Month Timepoint (t12)|Overall Study|22 new providers completed at 12 months; 21 completed at both 0 and 12 months. 19 completed only T0.|22
11298179|NCT02543840|12495867|FG000|COMPLETED|Overall Study||1050
11298180|NCT02543840|12495868|FG001|COMPLETED|Overall Study||62
11298181|NCT02543840|12495867|FG000|NOT COMPLETED|Overall Study||0
11298182|NCT02543840|12495868|FG001|NOT COMPLETED|Overall Study||0
11298183|NCT02543892|12495883|FG000|STARTED|Received Vaccination 1||12
11298184|NCT02543892|12495884|FG001|STARTED|Received Vaccination 1||12
11298185|NCT02543892|12495885|FG002|STARTED|Received Vaccination 1||12
11298186|NCT02543892|12495886|FG003|STARTED|Received Vaccination 1||12
11298187|NCT02543892|12495887|FG004|STARTED|Received Vaccination 1||50
11298188|NCT02543892|12495888|FG005|STARTED|Received Vaccination 1||50
11298189|NCT02543892|12495889|FG006|STARTED|Received Vaccination 1||50
11298190|NCT02543892|12495890|FG007|STARTED|Received Vaccination 1||50
11298191|NCT02543892|12495883|FG000|COMPLETED|Received Vaccination 1||12
11298192|NCT02543892|12495884|FG001|COMPLETED|Received Vaccination 1||12
11298193|NCT02543892|12495885|FG002|COMPLETED|Received Vaccination 1||12
11298194|NCT02543892|12495886|FG003|COMPLETED|Received Vaccination 1||12
11298195|NCT02543892|12495887|FG004|COMPLETED|Received Vaccination 1||50
11298196|NCT02543892|12495888|FG005|COMPLETED|Received Vaccination 1||50
11298197|NCT02543892|12495889|FG006|COMPLETED|Received Vaccination 1||50
11298198|NCT02543892|12495890|FG007|COMPLETED|Received Vaccination 1||50
11298199|NCT02543892|12495883|FG000|NOT COMPLETED|Received Vaccination 1||0
11298200|NCT02543892|12495884|FG001|NOT COMPLETED|Received Vaccination 1||0
11298201|NCT02543892|12495885|FG002|NOT COMPLETED|Received Vaccination 1||0
11298202|NCT02543892|12495886|FG003|NOT COMPLETED|Received Vaccination 1||0
11298203|NCT02543892|12495887|FG004|NOT COMPLETED|Received Vaccination 1||0
11298204|NCT02543892|12495888|FG005|NOT COMPLETED|Received Vaccination 1||0
11298205|NCT02543892|12495889|FG006|NOT COMPLETED|Received Vaccination 1||0
11298206|NCT02543892|12495890|FG007|NOT COMPLETED|Received Vaccination 1||0
11298207|NCT02543892|12495883|FG000|STARTED|Received Vaccination 2||12
11298208|NCT02543892|12495884|FG001|STARTED|Received Vaccination 2||12
11298209|NCT02543892|12495885|FG002|STARTED|Received Vaccination 2||12
11298210|NCT02543892|12495886|FG003|STARTED|Received Vaccination 2||12
11298211|NCT02543892|12495887|FG004|STARTED|Received Vaccination 2||50
11298212|NCT02543892|12495888|FG005|STARTED|Received Vaccination 2||50
11298213|NCT02543892|12495889|FG006|STARTED|Received Vaccination 2||50
11298214|NCT02543892|12495890|FG007|STARTED|Received Vaccination 2||50
11298215|NCT02543892|12495883|FG000|COMPLETED|Received Vaccination 2||11
11298216|NCT02543892|12495884|FG001|COMPLETED|Received Vaccination 2||11
11298217|NCT02543892|12495885|FG002|COMPLETED|Received Vaccination 2||12
11298218|NCT02543892|12495886|FG003|COMPLETED|Received Vaccination 2||12
11298219|NCT02543892|12495887|FG004|COMPLETED|Received Vaccination 2||50
11298220|NCT02543892|12495888|FG005|COMPLETED|Received Vaccination 2||49
11298221|NCT02543892|12495889|FG006|COMPLETED|Received Vaccination 2||50
11298222|NCT02543892|12495890|FG007|COMPLETED|Received Vaccination 2||49
11298223|NCT02543892|12495883|FG000|NOT COMPLETED|Received Vaccination 2||1
11298224|NCT02543892|12495884|FG001|NOT COMPLETED|Received Vaccination 2||1
11298225|NCT02543892|12495885|FG002|NOT COMPLETED|Received Vaccination 2||0
11298226|NCT02543892|12495886|FG003|NOT COMPLETED|Received Vaccination 2||0
11298227|NCT02543892|12495887|FG004|NOT COMPLETED|Received Vaccination 2||0
11298228|NCT02543892|12495888|FG005|NOT COMPLETED|Received Vaccination 2||1
11298229|NCT02543892|12495889|FG006|NOT COMPLETED|Received Vaccination 2||0
11298230|NCT02543892|12495890|FG007|NOT COMPLETED|Received Vaccination 2||1
11400859|NCT04169113|12595566|FG001|NOT COMPLETED|Overall Study||6
11400860|NCT04160975|12595578|FG000|STARTED|Overall Study||479
11400861|NCT04160975|12595579|FG001|STARTED|Overall Study||496
11298231|NCT02543892|12495883|FG000|STARTED|Had Immunology Data||11
11298232|NCT02543892|12495884|FG001|STARTED|Had Immunology Data||11
11298233|NCT02543892|12495885|FG002|STARTED|Had Immunology Data||12
11298234|NCT02543892|12495886|FG003|STARTED|Had Immunology Data||12
11298235|NCT02543892|12495887|FG004|STARTED|Had Immunology Data||50
11298236|NCT02543892|12495888|FG005|STARTED|Had Immunology Data||49
11298237|NCT02543892|12495889|FG006|STARTED|Had Immunology Data||50
11298238|NCT02543892|12495890|FG007|STARTED|Had Immunology Data||49
11298239|NCT02543892|12495883|FG000|COMPLETED|Had Immunology Data||11
11298240|NCT02543892|12495884|FG001|COMPLETED|Had Immunology Data||11
11298241|NCT02543892|12495885|FG002|COMPLETED|Had Immunology Data||12
11298242|NCT02543892|12495886|FG003|COMPLETED|Had Immunology Data||12
11298243|NCT02543892|12495887|FG004|COMPLETED|Had Immunology Data||50
11298244|NCT02543892|12495888|FG005|COMPLETED|Had Immunology Data||49
11298245|NCT02543892|12495889|FG006|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
11143828|NCT01474512|12330423|FG001|NOT COMPLETED|Post-Treatment Follow-Up||0
11143829|NCT01474512|12330424|FG002|NOT COMPLETED|Post-Treatment Follow-Up||0
11143830|NCT01474512|12330425|FG003|NOT COMPLETED|Post-Treatment Follow-Up||0
11143831|NCT01474512|12330426|FG004|NOT COMPLETED|Post-Treatment Follow-Up||0
11298246|NCT02543892|12495890|FG007|COMPLETED|Had Immunology Data||49
11298247|NCT02543892|12495883|FG000|NOT COMPLETED|Had Immunology Data||0
11298248|NCT02543892|12495884|FG001|NOT COMPLETED|Had Immunology Data||0
11298249|NCT02543892|12495885|FG002|NOT COMPLETED|Had Immunology Data||0
11298250|NCT02543892|12495886|FG003|NOT COMPLETED|Had Immunology Data||0
11298251|NCT02543892|12495887|FG004|NOT COMPLETED|Had Immunology Data||0
11298252|NCT02543892|12495888|FG005|NOT COMPLETED|Had Immunology Data||0
11298253|NCT02543892|12495889|FG006|NOT COMPLETED|Had Immunology Data||1
11298254|NCT02543892|12495890|FG007|NOT COMPLETED|Had Immunology Data||0
11298255|NCT02543918|12495915|FG000|STARTED|Overall Study||41
11298256|NCT02543918|12495916|FG001|STARTED|Overall Study||43
11298257|NCT02543918|12495915|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41
11298258|NCT02543918|12495916|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42
11298259|NCT02543918|12495915|FG000|COMPLETED|Overall Study||38
11298260|NCT02543918|12495916|FG001|COMPLETED|Overall Study||39
11298261|NCT02543918|12495915|FG000|NOT COMPLETED|Overall Study||3
11298262|NCT02543918|12495916|FG001|NOT COMPLETED|Overall Study||4
11298263|NCT02544113|12495924|FG000|STARTED|Overall Study||55
11298264|NCT02544113|12495925|FG001|STARTED|Overall Study||55
11298265|NCT02544113|12495924|FG000|COMPLETED|Overall Study||52
11298266|NCT02544113|12495925|FG001|COMPLETED|Overall Study||51
11400862|NCT04160975|12595580|FG002|STARTED|Overall Study||478
11400863|NCT04160975|12595581|FG003|STARTED|Overall Study||485
11400864|NCT04160975|12595582|FG004|STARTED|Overall Study||649
11400865|NCT04160975|12595583|FG005|STARTED|Overall Study||658
11400866|NCT04160975|12595578|FG000|COMPLETED|Overall Study||415
11400867|NCT04160975|12595579|FG001|COMPLETED|Overall Study||430
11400868|NCT04160975|12595580|FG002|COMPLETED|Overall Study||417
11400869|NCT04160975|12595581|FG003|COMPLETED|Overall Study||410
11298267|NCT02544113|12495924|FG000|NOT COMPLETED|Overall Study||3
11298268|NCT02544113|12495925|FG001|NOT COMPLETED|Overall Study||4
11298269|NCT02544152|12495933|FG000|STARTED|Overall Study||34
11298270|NCT02544152|12495934|FG001|STARTED|Overall Study||37
11298271|NCT02544152|12495933|FG000|Modified Intent to Treat (mITT)|Overall Study||34
11298272|NCT02544152|12495934|FG001|Modified Intent to Treat (mITT)|Overall Study||37
11400870|NCT04160975|12595582|FG004|COMPLETED|Overall Study||614
11400871|NCT04160975|12595583|FG005|COMPLETED|Overall Study||607
11298273|NCT02544152|12495933|FG000|Safety Analysis Set (SAS)|Overall Study||34
11298274|NCT02544152|12495934|FG001|Safety Analysis Set (SAS)|Overall Study||37
11298275|NCT02544152|12495933|FG000|COMPLETED|Overall Study||33
11298276|NCT02544152|12495934|FG001|COMPLETED|Overall Study||30
11298277|NCT02544152|12495933|FG000|NOT COMPLETED|Overall Study||1
11298278|NCT02544152|12495934|FG001|NOT COMPLETED|Overall Study||7
11298279|NCT02544217|12495946|FG000|STARTED|Overall Study||7
11298280|NCT02544217|12495947|FG001|STARTED|Overall Study||7
11298281|NCT02544217|12495948|FG002|STARTED|Overall Study||4
11298282|NCT02544217|12495949|FG003|STARTED|Overall Study||4
11298283|NCT02544217|12495950|FG004|STARTED|Overall Study||4
11298284|NCT02544217|12495951|FG005|STARTED|Overall Study||6
11298285|NCT02544217|12495946|FG000|COMPLETED|Overall Study||6
11298286|NCT02544217|12495947|FG001|COMPLETED|Overall Study|Two subjects prematurely withdrew from the study for non-medical reasons and were replaced.|6
11298287|NCT02544217|12495948|FG002|COMPLETED|Overall Study||4
11298288|NCT02544217|12495949|FG003|COMPLETED|Overall Study||4
11298289|NCT02544217|12495950|FG004|COMPLETED|Overall Study||4
11298290|NCT02544217|12495951|FG005|COMPLETED|Overall Study||6
11298291|NCT02544217|12495946|FG000|NOT COMPLETED|Overall Study||1
11298292|NCT02544217|12495947|FG001|NOT COMPLETED|Overall Study||1
11298293|NCT02544217|12495948|FG002|NOT COMPLETED|Overall Study||0
11298294|NCT02544217|12495949|FG003|NOT COMPLETED|Overall Study||0
11298295|NCT02544217|12495950|FG004|NOT COMPLETED|Overall Study||0
11298296|NCT02544217|12495951|FG005|NOT COMPLETED|Overall Study||0
11298297|NCT02544321|12496020|FG000|STARTED|Overall Study||43
11298298|NCT02544321|12496021|FG001|STARTED|Overall Study||43
11298299|NCT02544321|12496020|FG000|Completed First Treatment|Overall Study||43
11298300|NCT02544321|12496021|FG001|Completed First Treatment|Overall Study||41
11298301|NCT02544321|12496020|FG000|Completed Washout|Overall Study||43
11298302|NCT02544321|12496021|FG001|Completed Washout|Overall Study||41
11298303|NCT02544321|12496020|FG000|Started Second Treatment|Overall Study||42
11298304|NCT02544321|12496021|FG001|Started Second Treatment|Overall Study||40
11298305|NCT02544321|12496020|FG000|COMPLETED|Overall Study||41
11298306|NCT02544321|12496021|FG001|COMPLETED|Overall Study||39
11298307|NCT02544321|12496020|FG000|NOT COMPLETED|Overall Study||2
11298308|NCT02544321|12496021|FG001|NOT COMPLETED|Overall Study||4
11298309|NCT02544451|12496039|FG000|STARTED|Treatment Period 1 (96 Weeks)||143
11298310|NCT02544451|12496040|FG001|STARTED|Treatment Period 1 (96 Weeks)||96
11298311|NCT02544451|12496041|FG002|STARTED|Treatment Period 1 (96 Weeks)||6
11298312|NCT02544451|12496042|FG003|STARTED|Treatment Period 1 (96 Weeks)||0
11298313|NCT02544451|12496039|FG000|COMPLETED|Treatment Period 1 (96 Weeks)||129
11298314|NCT02544451|12496040|FG001|COMPLETED|Treatment Period 1 (96 Weeks)||84
11298315|NCT02544451|12496041|FG002|COMPLETED|Treatment Period 1 (96 Weeks)||5
11298316|NCT02544451|12496042|FG003|COMPLETED|Treatment Period 1 (96 Weeks)||0
11298317|NCT02544451|12496039|FG000|NOT COMPLETED|Treatment Period 1 (96 Weeks)||14
11298318|NCT02544451|12496040|FG001|NOT COMPLETED|Treatment Period 1 (96 Weeks)||12
11298319|NCT02544451|12496041|FG002|NOT COMPLETED|Treatment Period 1 (96 Weeks)||1
11298320|NCT02544451|12496042|FG003|NOT COMPLETED|Treatment Period 1 (96 Weeks)||0
11298321|NCT02544451|12496039|FG000|STARTED|Treatment Period 2 (168 Weeks)||0
11298322|NCT02544451|12496040|FG001|STARTED|Treatment Period 2 (168 Weeks)||0
11298323|NCT02544451|12496041|FG002|STARTED|Treatment Period 2 (168 Weeks)||0
11298324|NCT02544451|12496042|FG003|STARTED|Treatment Period 2 (168 Weeks)||10
11298325|NCT02544451|12496039|FG000|COMPLETED|Treatment Period 2 (168 Weeks)||0
11298326|NCT02544451|12496040|FG001|COMPLETED|Treatment Period 2 (168 Weeks)||0
11298327|NCT02544451|12496041|FG002|COMPLETED|Treatment Period 2 (168 Weeks)||0
11298328|NCT02544451|12496042|FG003|COMPLETED|Treatment Period 2 (168 Weeks)||0
11298329|NCT02544451|12496039|FG000|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
11298330|NCT02544451|12496040|FG001|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
11298331|NCT02544451|12496041|FG002|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
11298332|NCT02544451|12496042|FG003|NOT COMPLETED|Treatment Period 2 (168 Weeks)||10
11298333|NCT02544607|12496060|FG000|STARTED|Overall Study||16
11298334|NCT02544607|12496060|FG000|COMPLETED|Overall Study||16
11298335|NCT02544607|12496060|FG000|NOT COMPLETED|Overall Study||0
11298336|NCT02544633|12496069|FG000|STARTED|Treatment Period||28
11298337|NCT02544633|12496070|FG001|STARTED|Treatment Period||20
11298338|NCT02544633|12496071|FG002|STARTED|Treatment Period||8
11298339|NCT02544633|12496072|FG003|STARTED|Treatment Period||12
11298340|NCT02544633|12496069|FG000|COMPLETED|Treatment Period||0
11298341|NCT02544633|12496070|FG001|COMPLETED|Treatment Period||0
11298342|NCT02544633|12496071|FG002|COMPLETED|Treatment Period||0
11298343|NCT02544633|12496072|FG003|COMPLETED|Treatment Period||0
11298344|NCT02544633|12496069|FG000|NOT COMPLETED|Treatment Period||28
11298345|NCT02544633|12496070|FG001|NOT COMPLETED|Treatment Period||20
11298346|NCT02544633|12496071|FG002|NOT COMPLETED|Treatment Period||8
11298347|NCT02544633|12496072|FG003|NOT COMPLETED|Treatment Period||12
11298348|NCT02544633|12496069|FG000|STARTED|Survival Follow-up Period||28
11298349|NCT02544633|12496070|FG001|STARTED|Survival Follow-up Period||19
11298350|NCT02544633|12496071|FG002|STARTED|Survival Follow-up Period||7
11298351|NCT02544633|12496072|FG003|STARTED|Survival Follow-up Period||12
11298352|NCT02544633|12496069|FG000|COMPLETED|Survival Follow-up Period||0
11298353|NCT02544633|12496070|FG001|COMPLETED|Survival Follow-up Period||0
11298354|NCT02544633|12496071|FG002|COMPLETED|Survival Follow-up Period||0
11400872|NCT04160975|12595578|FG000|NOT COMPLETED|Overall Study||64
11400873|NCT04160975|12595579|FG001|NOT COMPLETED|Overall Study||66
11400874|NCT04160975|12595580|FG002|NOT COMPLETED|Overall Study||61
11400875|NCT04160975|12595581|FG003|NOT COMPLETED|Overall Study||75
11298355|NCT02544633|12496072|FG003|COMPLETED|Survival Follow-up Period||0
11298356|NCT02544633|12496069|FG000|NOT COMPLETED|Survival Follow-up Period||28
11298357|NCT02544633|12496070|FG001|NOT COMPLETED|Survival Follow-up Period||19
11298358|NCT02544633|12496071|FG002|NOT COMPLETED|Survival Follow-up Period||7
11298359|NCT02544633|12496072|FG003|NOT COMPLETED|Survival Follow-up Period||12
11298360|NCT02544984|12496096|FG000|STARTED|Overall Study||30
11298361|NCT02544984|12496097|FG001|STARTED|Overall Study||30
11298362|NCT02544984|12496096|FG000|COMPLETED|Overall Study||28
11298363|NCT02544984|12496097|FG001|COMPLETED|Overall Study||28
11298364|NCT02544984|12496096|FG000|NOT COMPLETED|Overall Study||2
11298365|NCT02544984|12496097|FG001|NOT COMPLETED|Overall Study||2
11298366|NCT02545075|12496105|FG000|STARTED|Randomization||122
11298367|NCT02545075|12496106|FG001|STARTED|Randomization||60
11298368|NCT02545075|12496105|FG000|COMPLETED|Randomization||122
11298369|NCT02545075|12496106|FG001|COMPLETED|Randomization||53
11400876|NCT04160975|12595582|FG004|NOT COMPLETED|Overall Study||35
11298370|NCT02545075|12496105|FG000|NOT COMPLETED|Randomization||0
11298371|NCT02545075|12496106|FG001|NOT COMPLETED|Randomization||7
11298372|NCT02545075|12496105|FG000|STARTED|Treatment||122
11298373|NCT02545075|12496106|FG001|STARTED|Treatment||53
11298374|NCT02545075|12496105|FG000|COMPLETED|Treatment||0
11298375|NCT02545075|12496106|FG001|COMPLETED|Treatment||0
11298376|NCT02545075|12496105|FG000|NOT COMPLETED|Treatment||122
11298377|NCT02545075|12496106|FG001|NOT COMPLETED|Treatment||53
11298378|NCT02545101|12496112|FG000|STARTED|Overall Study||100
11298379|NCT02545101|12496112|FG000|COMPLETED|Overall Study||100
11298380|NCT02545101|12496112|FG000|NOT COMPLETED|Overall Study||0
11298381|NCT02545270|12496119|FG000|STARTED|Overall Study||6
11298382|NCT02545270|12496120|FG001|STARTED|Overall Study||5
11298383|NCT02545270|12496121|FG002|STARTED|Overall Study||5
11298384|NCT02545270|12496119|FG000|COMPLETED|Overall Study||6
11298385|NCT02545270|12496120|FG001|COMPLETED|Overall Study||4
11298386|NCT02545270|12496121|FG002|COMPLETED|Overall Study||3
11298387|NCT02545270|12496119|FG000|NOT COMPLETED|Overall Study||0
11298388|NCT02545270|12496120|FG001|NOT COMPLETED|Overall Study||1
11298389|NCT02545270|12496121|FG002|NOT COMPLETED|Overall Study||2
11298390|NCT02545322|12496130|FG000|STARTED|Overall Study||18
11298391|NCT02545322|12496130|FG000|COMPLETED|Overall Study||15
11298392|NCT02545322|12496130|FG000|NOT COMPLETED|Overall Study||3
11298393|NCT02545504|12496136|FG000|STARTED|Overall Study||218
11298394|NCT02545504|12496137|FG001|STARTED|Overall Study||214
11298395|NCT02545504|12496136|FG000|COMPLETED|Overall Study||0
11298396|NCT02545504|12496137|FG001|COMPLETED|Overall Study||0
11298397|NCT02545504|12496136|FG000|NOT COMPLETED|Overall Study||218
11298398|NCT02545504|12496137|FG001|NOT COMPLETED|Overall Study||214
11400877|NCT04160975|12595583|FG005|NOT COMPLETED|Overall Study||51
11400878|NCT04153409|12595598|FG000|STARTED|Overall Study||10
11400879|NCT04153409|12595599|FG001|STARTED|Overall Study||11
11400880|NCT04153409|12595598|FG000|COMPLETED|Overall Study||8
11400881|NCT04153409|12595599|FG001|COMPLETED|Overall Study||9
11400882|NCT04153409|12595598|FG000|NOT COMPLETED|Overall Study||2
11298399|NCT02545543|12496149|FG000|STARTED|Overall Study||1709
11298400|NCT02545543|12496150|FG001|STARTED|Overall Study||569
11298401|NCT02545543|12496149|FG000|COMPLETED|Overall Study||1628
11298402|NCT02545543|12496150|FG001|COMPLETED|Overall Study||535
11298403|NCT02545543|12496149|FG000|NOT COMPLETED|Overall Study||81
11298404|NCT02545543|12496150|FG001|NOT COMPLETED|Overall Study||34
11298405|NCT02545907|12496160|FG000|STARTED|Overall Study||3
11400883|NCT04153409|12595599|FG001|NOT COMPLETED|Overall Study||2
11400884|NCT04167189|12595605|FG000|STARTED|Overall Study||28
11400885|NCT04167189|12595605|FG000|COMPLETED|Overall Study||28
11400886|NCT04167189|12595605|FG000|NOT COMPLETED|Overall Study||0
11400887|NCT04162795|12595609|FG000|STARTED|Overall Study||468
11400888|NCT04162795|12595609|FG000|COMPLETED|Overall Study||442
11298406|NCT02545907|12496161|FG001|STARTED|Overall Study||3
11298407|NCT02545907|12496162|FG002|STARTED|Overall Study||4
11400889|NCT04162795|12595609|FG000|NOT COMPLETED|Overall Study||26
11400890|NCT04161807|12595613|FG000|STARTED|Overall Study||42
11298408|NCT02545907|12496160|FG000|COMPLETED|Overall Study||3
11298409|NCT02545907|12496161|FG001|COMPLETED|Overall Study||3
11298410|NCT02545907|12496162|FG002|COMPLETED|Overall Study||4
11298411|NCT02545907|12496160|FG000|NOT COMPLETED|Overall Study||0
11298412|NCT02545907|12496161|FG001|NOT COMPLETED|Overall Study||0
11298413|NCT02545907|12496162|FG002|NOT COMPLETED|Overall Study||0
11298414|NCT02545933|12496174|FG000|STARTED|Overall Study||44
11298415|NCT02545933|12496175|FG001|STARTED|Overall Study||43
11298416|NCT02545933|12496176|FG002|STARTED|Overall Study||43
11298417|NCT02545933|12496174|FG000|COMPLETED|Overall Study||38
11298418|NCT02545933|12496175|FG001|COMPLETED|Overall Study||40
11298419|NCT02545933|12496176|FG002|COMPLETED|Overall Study||39
11298420|NCT02545933|12496174|FG000|NOT COMPLETED|Overall Study||6
11298421|NCT02545933|12496175|FG001|NOT COMPLETED|Overall Study||3
11298422|NCT02545933|12496176|FG002|NOT COMPLETED|Overall Study||4
11298423|NCT02546193|12496186|FG000|STARTED|Overall Study||10
11298424|NCT02546193|12496187|FG001|STARTED|Overall Study||10
11298425|NCT02546193|12496188|FG002|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2
11298426|NCT02546193|12496189|FG003|STARTED|Overall Study||0
11298427|NCT02546193|12496186|FG000|COMPLETED|Overall Study||4
11298428|NCT02546193|12496187|FG001|COMPLETED|Overall Study||4
11298429|NCT02546193|12496188|FG002|COMPLETED|Overall Study||0
11298430|NCT02546193|12496189|FG003|COMPLETED|Overall Study||0
11298431|NCT02546193|12496186|FG000|NOT COMPLETED|Overall Study||6
11298432|NCT02546193|12496187|FG001|NOT COMPLETED|Overall Study||6
11298433|NCT02546193|12496188|FG002|NOT COMPLETED|Overall Study||2
11298434|NCT02546193|12496189|FG003|NOT COMPLETED|Overall Study||0
11298435|NCT02546323|12496197|FG000|STARTED|Overall Study||272
11298436|NCT02546323|12496198|FG001|STARTED|Overall Study||271
11298437|NCT02546323|12496197|FG000|Received Treatment|Overall Study||272
11298438|NCT02546323|12496198|FG001|Received Treatment|Overall Study||268
11298439|NCT02546323|12496197|FG000|COMPLETED|Overall Study||212
11298440|NCT02546323|12496198|FG001|COMPLETED|Overall Study||205
11298441|NCT02546323|12496197|FG000|NOT COMPLETED|Overall Study||60
11298442|NCT02546323|12496198|FG001|NOT COMPLETED|Overall Study||66
11298443|NCT02546362|12496204|FG000|STARTED|4-week Treatment Period||50
11298444|NCT02546362|12496204|FG000|COMPLETED|4-week Treatment Period||47
11298445|NCT02546362|12496204|FG000|NOT COMPLETED|4-week Treatment Period||3
11298446|NCT02546362|12496204|FG000|STARTED|12-week Treatment Period||47
11298447|NCT02546362|12496204|FG000|COMPLETED|12-week Treatment Period||38
11298448|NCT02546362|12496204|FG000|NOT COMPLETED|12-week Treatment Period||9
11298449|NCT02546375|12496208|FG000|STARTED|Overall Study||87
11298450|NCT02546375|12496208|FG000|COMPLETED|Overall Study||87
11298451|NCT02546375|12496208|FG000|NOT COMPLETED|Overall Study||0
11298452|NCT02546388|12496214|FG000|STARTED|Overall Study||4
11298453|NCT02546388|12496215|FG001|STARTED|Overall Study||13
11298454|NCT02546388|12496214|FG000|COMPLETED|Overall Study||4
11298455|NCT02546388|12496215|FG001|COMPLETED|Overall Study||13
11298456|NCT02546388|12496214|FG000|NOT COMPLETED|Overall Study||0
11298457|NCT02546388|12496215|FG001|NOT COMPLETED|Overall Study||0
11298458|NCT02546544|12496222|FG000|STARTED|Overall Study||16
11298459|NCT02546544|12496222|FG000|Received Allocated Intervention|Overall Study||16
11298460|NCT02546544|12496222|FG000|COMPLETED|Overall Study||0
11298461|NCT02546544|12496222|FG000|NOT COMPLETED|Overall Study||16
11400891|NCT04161807|12595613|FG000|COMPLETED|Overall Study||38
11400892|NCT04161807|12595613|FG000|NOT COMPLETED|Overall Study||4
11400893|NCT04161144|12595619|FG000|STARTED|Overall Study||12
11298462|NCT02546570|12496228|FG000|STARTED|Overall Study||9
11298463|NCT02546570|12496229|FG001|STARTED|Overall Study||2
11298464|NCT02546570|12496228|FG000|Crossover Order: Oxytocin, Placebo|Overall Study||6
11298465|NCT02546570|12496229|FG001|Crossover Order: Oxytocin, Placebo|Overall Study||2
11298466|NCT02546570|12496228|FG000|Crossover Order: Placebo, Oxytocin|Overall Study||3
11298467|NCT02546570|12496229|FG001|Crossover Order: Placebo, Oxytocin|Overall Study||0
11298468|NCT02546570|12496228|FG000|COMPLETED|Overall Study||9
11298469|NCT02546570|12496229|FG001|COMPLETED|Overall Study||2
11298470|NCT02546570|12496228|FG000|NOT COMPLETED|Overall Study||0
11298471|NCT02546570|12496229|FG001|NOT COMPLETED|Overall Study||0
11298472|NCT02546609|12496242|FG000|STARTED|Overall Study||24
11298473|NCT02546609|12496243|FG001|STARTED|Overall Study||35
11298474|NCT02546609|12496244|FG002|STARTED|Overall Study||32
11298475|NCT02546609|12496242|FG000|COMPLETED|Overall Study||22
11298476|NCT02546609|12496243|FG001|COMPLETED|Overall Study||24
11298477|NCT02546609|12496244|FG002|COMPLETED|Overall Study||25
11298478|NCT02546609|12496242|FG000|NOT COMPLETED|Overall Study||2
11298479|NCT02546609|12496243|FG001|NOT COMPLETED|Overall Study||11
11298480|NCT02546609|12496244|FG002|NOT COMPLETED|Overall Study||7
11298481|NCT02546765|12496256|FG000|STARTED|Overall Study||31
11298482|NCT02546765|12496257|FG001|STARTED|Overall Study||30
11298483|NCT02546765|12496258|FG002|STARTED|Overall Study||30
11298484|NCT02546765|12496259|FG003|STARTED|Overall Study||30
11298485|NCT02546765|12496256|FG000|COMPLETED|Overall Study||31
11298486|NCT02546765|12496257|FG001|COMPLETED|Overall Study|29 Received study drug; 1 withdrew before surgery and after randomization|29
11298487|NCT02546765|12496258|FG002|COMPLETED|Overall Study||30
11298488|NCT02546765|12496259|FG003|COMPLETED|Overall Study||30
11298489|NCT02546765|12496256|FG000|NOT COMPLETED|Overall Study||0
11298490|NCT02546765|12496257|FG001|NOT COMPLETED|Overall Study||1
11298491|NCT02546765|12496258|FG002|NOT COMPLETED|Overall Study||0
11298492|NCT02546765|12496259|FG003|NOT COMPLETED|Overall Study||0
11298493|NCT02546856|12496282|FG000|STARTED|4 Months Evaluation||164
11400894|NCT04161144|12595620|FG001|STARTED|Overall Study||10
11400895|NCT04161144|12595619|FG000|COMPLETED|Overall Study||11
11298494|NCT02546856|12496283|FG001|STARTED|4 Months Evaluation||156
11298495|NCT02546856|12496282|FG000|COMPLETED|4 Months Evaluation||144
11298496|NCT02546856|12496283|FG001|COMPLETED|4 Months Evaluation||145
11298497|NCT02546856|12496282|FG000|NOT COMPLETED|4 Months Evaluation||20
11298498|NCT02546856|12496283|FG001|NOT COMPLETED|4 Months Evaluation||11
11298499|NCT02546856|12496282|FG000|STARTED|6 Months Evaluation||144
11298500|NCT02546856|12496283|FG001|STARTED|6 Months Evaluation||145
11298501|NCT02546856|12496282|FG000|COMPLETED|6 Months Evaluation||136
11298502|NCT02546856|12496283|FG001|COMPLETED|6 Months Evaluation||138
11298503|NCT02546856|12496282|FG000|NOT COMPLETED|6 Months Evaluation||8
11298504|NCT02546856|12496283|FG001|NOT COMPLETED|6 Months Evaluation||7
11298505|NCT02547012|12496303|FG000|STARTED|Overall Study||24
11298506|NCT02547012|12496304|FG001|STARTED|Overall Study||27
11298507|NCT02547012|12496303|FG000|COMPLETED|Overall Study||24
11298508|NCT02547012|12496304|FG001|COMPLETED|Overall Study||27
11298509|NCT02547012|12496303|FG000|NOT COMPLETED|Overall Study||0
11298510|NCT02547012|12496304|FG001|NOT COMPLETED|Overall Study||0
11298511|NCT02547038|12496312|FG000|STARTED|Overall Study||176
11298512|NCT02547038|12496313|FG001|STARTED|Overall Study||176
11298513|NCT02547038|12496312|FG000|COMPLETED|Overall Study||173
11298514|NCT02547038|12496313|FG001|COMPLETED|Overall Study||174
11298515|NCT02547038|12496312|FG000|NOT COMPLETED|Overall Study||3
11298516|NCT02547038|12496313|FG001|NOT COMPLETED|Overall Study||2
11298517|NCT02547064|12496321|FG000|STARTED|Overall Study||81
11298518|NCT02547064|12496322|FG001|STARTED|Overall Study||81
11298519|NCT02547064|12496321|FG000|COMPLETED|Overall Study||78
11298520|NCT02547064|12496322|FG001|COMPLETED|Overall Study||79
11298521|NCT02547064|12496321|FG000|NOT COMPLETED|Overall Study||3
11298522|NCT02547064|12496322|FG001|NOT COMPLETED|Overall Study||2
11298523|NCT02547220|12496330|FG000|STARTED|Overall Study||19
11298524|NCT02547220|12496331|FG001|STARTED|Overall Study||20
11298525|NCT02547220|12496330|FG000|COMPLETED|Overall Study||0
11298526|NCT02547220|12496331|FG001|COMPLETED|Overall Study||0
11298527|NCT02547220|12496330|FG000|NOT COMPLETED|Overall Study||19
11298528|NCT02547220|12496331|FG001|NOT COMPLETED|Overall Study||20
11298529|NCT02547233|12496339|FG000|STARTED|3-day Treatment and 8-week Follow-up||205
11298530|NCT02547233|12496340|FG001|STARTED|3-day Treatment and 8-week Follow-up||102
11298531|NCT02547233|12496339|FG000|Treated|3-day Treatment and 8-week Follow-up||205
11298532|NCT02547233|12496340|FG001|Treated|3-day Treatment and 8-week Follow-up||100
11298533|NCT02547233|12496339|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||203
11298534|NCT02547233|12496340|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||92
11298535|NCT02547233|12496339|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
11298536|NCT02547233|12496340|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
11298537|NCT02547233|12496339|FG000|STARTED|12-month Follow-up||199
11298538|NCT02547233|12496340|FG001|STARTED|12-month Follow-up||84
11298539|NCT02547233|12496339|FG000|COMPLETED|12-month Follow-up||185
11298540|NCT02547233|12496340|FG001|COMPLETED|12-month Follow-up||67
11298541|NCT02547233|12496339|FG000|NOT COMPLETED|12-month Follow-up||14
11298542|NCT02547233|12496340|FG001|NOT COMPLETED|12-month Follow-up||17
11298543|NCT02547363|12496350|FG000|STARTED|3-day Treatment and 8-week Follow-up||211
11298544|NCT02547363|12496351|FG001|STARTED|3-day Treatment and 8-week Follow-up||105
11298545|NCT02547363|12496350|FG000|Treated|3-day Treatment and 8-week Follow-up||209
11298546|NCT02547363|12496351|FG001|Treated|3-day Treatment and 8-week Follow-up||104
11298547|NCT02547363|12496350|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207
11298548|NCT02547363|12496351|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||94
11298549|NCT02547363|12496350|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
11298550|NCT02547363|12496351|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
11298551|NCT02547363|12496350|FG000|STARTED|12-month Follow-up||204
11298552|NCT02547363|12496351|FG001|STARTED|12-month Follow-up||86
11298553|NCT02547363|12496350|FG000|COMPLETED|12-month Follow-up||194
11298554|NCT02547363|12496351|FG001|COMPLETED|12-month Follow-up||81
11298555|NCT02547363|12496350|FG000|NOT COMPLETED|12-month Follow-up||10
11298556|NCT02547363|12496351|FG001|NOT COMPLETED|12-month Follow-up||5
11298557|NCT02547428|12496361|FG000|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||42
11298558|NCT02547428|12496362|FG001|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||43
11298559|NCT02547428|12496361|FG000|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||42
11298560|NCT02547428|12496362|FG001|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||43
11298561|NCT02547428|12496361|FG000|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||31
11298562|NCT02547428|12496362|FG001|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||37
11298563|NCT02547428|12496361|FG000|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||11
11298564|NCT02547428|12496362|FG001|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||6
11298565|NCT02547428|12496361|FG000|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||31
11298566|NCT02547428|12496362|FG001|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||37
11298567|NCT02547428|12496361|FG000|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30
11298568|NCT02547428|12496362|FG001|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30
11298569|NCT02547428|12496361|FG000|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||1
11298570|NCT02547428|12496362|FG001|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||7
11298571|NCT02547454|12496375|FG000|STARTED|Overall Study||393
11298572|NCT02547454|12496375|FG000|COMPLETED|Overall Study||221
11298573|NCT02547454|12496375|FG000|NOT COMPLETED|Overall Study||172
11298574|NCT02547623|12496381|FG000|STARTED|Overall Study||126
11298575|NCT02547623|12496382|FG001|STARTED|Overall Study||55
11298576|NCT02547623|12496381|FG000|COMPLETED|Overall Study||122
11298577|NCT02547623|12496382|FG001|COMPLETED|Overall Study||52
11298578|NCT02547623|12496381|FG000|NOT COMPLETED|Overall Study||4
11298579|NCT02547623|12496382|FG001|NOT COMPLETED|Overall Study||3
11298580|NCT02547649|12496391|FG000|STARTED|Overall Study||231
11298581|NCT02547649|12496392|FG001|STARTED|Overall Study||231
11298582|NCT02547649|12496393|FG002|STARTED|Overall Study||228
11298583|NCT02547649|12496391|FG000|Vaccinated|Overall Study||231
11298584|NCT02547649|12496392|FG001|Vaccinated|Overall Study||231
11298585|NCT02547649|12496393|FG002|Vaccinated|Overall Study||227
11298586|NCT02547649|12496391|FG000|COMPLETED|Overall Study||228
11298587|NCT02547649|12496392|FG001|COMPLETED|Overall Study||226
11298588|NCT02547649|12496393|FG002|COMPLETED|Overall Study||224
11298589|NCT02547649|12496391|FG000|NOT COMPLETED|Overall Study||3
11298590|NCT02547649|12496392|FG001|NOT COMPLETED|Overall Study||5
11298591|NCT02547649|12496393|FG002|NOT COMPLETED|Overall Study||4
11298592|NCT02547714|12496401|FG000|STARTED|Overall Study||34
11298593|NCT02547714|12496401|FG000|COMPLETED|Overall Study||34
11298594|NCT02547714|12496401|FG000|NOT COMPLETED|Overall Study||0
11298595|NCT02547766|12496406|FG000|STARTED|Overall Study||10
11298596|NCT02547766|12496406|FG000|COMPLETED|Overall Study||9
11298597|NCT02547766|12496406|FG000|NOT COMPLETED|Overall Study||1
11298598|NCT02547779|12496412|FG000|STARTED|Overall Study||5214
11298599|NCT02547779|12496413|FG001|STARTED|Overall Study||5207
11298600|NCT02547779|12496412|FG000|COMPLETED|Overall Study||5214
11298601|NCT02547779|12496413|FG001|COMPLETED|Overall Study||5207
11298602|NCT02547779|12496412|FG000|NOT COMPLETED|Overall Study||0
11298603|NCT02547779|12496413|FG001|NOT COMPLETED|Overall Study||0
11298604|NCT02547922|12496422|FG000|STARTED|Overall Study||46
11298605|NCT02547922|12496423|FG001|STARTED|Overall Study||52
11298606|NCT02547922|12496424|FG002|STARTED|Overall Study||49
11298607|NCT02547922|12496422|FG000|FAS (Full Analysis Set)|Overall Study||45
11298608|NCT02547922|12496423|FG001|FAS (Full Analysis Set)|Overall Study||51
11298609|NCT02547922|12496424|FG002|FAS (Full Analysis Set)|Overall Study||49
11298610|NCT02547922|12496422|FG000|COMPLETED|Overall Study||18
11298611|NCT02547922|12496423|FG001|COMPLETED|Overall Study||28
11298612|NCT02547922|12496424|FG002|COMPLETED|Overall Study||20
11298613|NCT02547922|12496422|FG000|NOT COMPLETED|Overall Study||28
11298614|NCT02547922|12496423|FG001|NOT COMPLETED|Overall Study||24
11298615|NCT02547922|12496424|FG002|NOT COMPLETED|Overall Study||29
11298616|NCT02547935|12496441|FG000|STARTED|Overall Study||155
11298617|NCT02547935|12496442|FG001|STARTED|Overall Study||145
11298618|NCT02547935|12496443|FG002|STARTED|Overall Study||148
11298619|NCT02547935|12496441|FG000|Received Treatment|Overall Study||152
11298620|NCT02547935|12496442|FG001|Received Treatment|Overall Study||145
11298621|NCT02547935|12496443|FG002|Received Treatment|Overall Study||148
11298622|NCT02547935|12496441|FG000|Full Analysis Set|Overall Study||152
11298623|NCT02547935|12496442|FG001|Full Analysis Set|Overall Study||144
11298624|NCT02547935|12496443|FG002|Full Analysis Set|Overall Study||148
11298625|NCT02547935|12496441|FG000|Safety Analysis Set|Overall Study||152
11298626|NCT02547935|12496442|FG001|Safety Analysis Set|Overall Study||145
11298627|NCT02547935|12496443|FG002|Safety Analysis Set|Overall Study||148
11298628|NCT02547935|12496441|FG000|COMPLETED|Overall Study||150
11298629|NCT02547935|12496442|FG001|COMPLETED|Overall Study||137
11298630|NCT02547935|12496443|FG002|COMPLETED|Overall Study||143
11298631|NCT02547935|12496441|FG000|NOT COMPLETED|Overall Study||5
11298632|NCT02547935|12496442|FG001|NOT COMPLETED|Overall Study||8
11298633|NCT02547935|12496443|FG002|NOT COMPLETED|Overall Study||5
11298634|NCT02547974|12496457|FG000|STARTED|Overall Study||15
11298635|NCT02547974|12496458|FG001|STARTED|Overall Study||31
11298636|NCT02547974|12496459|FG002|STARTED|Overall Study||30
11298637|NCT02547974|12496460|FG003|STARTED|Overall Study||44
11298638|NCT02547974|12496457|FG000|COMPLETED|Overall Study||14
11298639|NCT02547974|12496458|FG001|COMPLETED|Overall Study||31
11298640|NCT02547974|12496459|FG002|COMPLETED|Overall Study||30
11298641|NCT02547974|12496460|FG003|COMPLETED|Overall Study||44
11298642|NCT02547974|12496457|FG000|NOT COMPLETED|Overall Study||1
11298643|NCT02547974|12496458|FG001|NOT COMPLETED|Overall Study||0
11298644|NCT02547974|12496459|FG002|NOT COMPLETED|Overall Study||0
11298645|NCT02547974|12496460|FG003|NOT COMPLETED|Overall Study||0
11298646|NCT02547987|12496473|FG000|STARTED|Overall Study||25
11298647|NCT02547987|12496473|FG000|COMPLETED|Overall Study||22
11298648|NCT02547987|12496473|FG000|NOT COMPLETED|Overall Study||3
11298649|NCT02548078|12496479|FG000|STARTED|Overall Study||300
11298650|NCT02548078|12496480|FG001|STARTED|Overall Study||300
11298651|NCT02548078|12496479|FG000|COMPLETED|Overall Study||295
11298652|NCT02548078|12496480|FG001|COMPLETED|Overall Study||294
11298653|NCT02548078|12496479|FG000|NOT COMPLETED|Overall Study||5
11298654|NCT02548078|12496480|FG001|NOT COMPLETED|Overall Study||6
11298655|NCT02548156|12496493|FG000|STARTED|Period 1||5
11298656|NCT02548156|12496494|FG001|STARTED|Period 1||5
11298657|NCT02548156|12496495|FG002|STARTED|Period 1||4
11298658|NCT02548156|12496496|FG003|STARTED|Period 1||5
11298659|NCT02548156|12496497|FG004|STARTED|Period 1||5
11298660|NCT02548156|12496498|FG005|STARTED|Period 1||5
11400896|NCT04161144|12595620|FG001|COMPLETED|Overall Study||9
11400897|NCT04161144|12595619|FG000|NOT COMPLETED|Overall Study||1
11400898|NCT04161144|12595620|FG001|NOT COMPLETED|Overall Study||1
11400899|NCT04161079|12595626|FG000|STARTED|Clinical Investigation 2010-040||12
11400900|NCT04161079|12595626|FG000|COMPLETED|Clinical Investigation 2010-040||11
11400901|NCT04161079|12595626|FG000|NOT COMPLETED|Clinical Investigation 2010-040||1
11400902|NCT04161079|12595626|FG000|STARTED|2010-040FU5 >5 Years Follow-up|Of 11 subjects 3 refused to participate and 1 died.|7
11298661|NCT02548156|12496493|FG000|COMPLETED|Period 1||5
11298662|NCT02548156|12496494|FG001|COMPLETED|Period 1||5
11298663|NCT02548156|12496495|FG002|COMPLETED|Period 1||4
11298664|NCT02548156|12496496|FG003|COMPLETED|Period 1||5
11298665|NCT02548156|12496497|FG004|COMPLETED|Period 1||5
11298666|NCT02548156|12496498|FG005|COMPLETED|Period 1||5
11298667|NCT02548156|12496493|FG000|NOT COMPLETED|Period 1||0
11298668|NCT02548156|12496494|FG001|NOT COMPLETED|Period 1||0
11298669|NCT02548156|12496495|FG002|NOT COMPLETED|Period 1||0
11298670|NCT02548156|12496496|FG003|NOT COMPLETED|Period 1||0
11298671|NCT02548156|12496497|FG004|NOT COMPLETED|Period 1||0
11298672|NCT02548156|12496498|FG005|NOT COMPLETED|Period 1||0
11298673|NCT02548156|12496493|FG000|STARTED|Washout Period 1||5
11298674|NCT02548156|12496494|FG001|STARTED|Washout Period 1||5
11298675|NCT02548156|12496495|FG002|STARTED|Washout Period 1||4
11298676|NCT02548156|12496496|FG003|STARTED|Washout Period 1||5
11298677|NCT02548156|12496497|FG004|STARTED|Washout Period 1||5
11298678|NCT02548156|12496498|FG005|STARTED|Washout Period 1||5
11298679|NCT02548156|12496493|FG000|COMPLETED|Washout Period 1||5
11298680|NCT02548156|12496494|FG001|COMPLETED|Washout Period 1||5
11298681|NCT02548156|12496495|FG002|COMPLETED|Washout Period 1||4
11298682|NCT02548156|12496496|FG003|COMPLETED|Washout Period 1||5
11298683|NCT02548156|12496497|FG004|COMPLETED|Washout Period 1||4
11298684|NCT02548156|12496498|FG005|COMPLETED|Washout Period 1||5
11298685|NCT02548156|12496493|FG000|NOT COMPLETED|Washout Period 1||0
11298686|NCT02548156|12496494|FG001|NOT COMPLETED|Washout Period 1||0
11298687|NCT02548156|12496495|FG002|NOT COMPLETED|Washout Period 1||0
11298688|NCT02548156|12496496|FG003|NOT COMPLETED|Washout Period 1||0
11298689|NCT02548156|12496497|FG004|NOT COMPLETED|Washout Period 1||1
11298690|NCT02548156|12496498|FG005|NOT COMPLETED|Washout Period 1||0
11298691|NCT02548156|12496493|FG000|STARTED|Period 2||5
11298692|NCT02548156|12496494|FG001|STARTED|Period 2||5
11298693|NCT02548156|12496495|FG002|STARTED|Period 2||4
11298694|NCT02548156|12496496|FG003|STARTED|Period 2||5
11298695|NCT02548156|12496497|FG004|STARTED|Period 2||4
11298696|NCT02548156|12496498|FG005|STARTED|Period 2||5
11298697|NCT02548156|12496493|FG000|COMPLETED|Period 2||5
11298698|NCT02548156|12496494|FG001|COMPLETED|Period 2||5
11298699|NCT02548156|12496495|FG002|COMPLETED|Period 2||4
11298700|NCT02548156|12496496|FG003|COMPLETED|Period 2||5
11298701|NCT02548156|12496497|FG004|COMPLETED|Period 2||4
11298702|NCT02548156|12496498|FG005|COMPLETED|Period 2||5
11298703|NCT02548156|12496493|FG000|NOT COMPLETED|Period 2||0
11298704|NCT02548156|12496494|FG001|NOT COMPLETED|Period 2||0
11298705|NCT02548156|12496495|FG002|NOT COMPLETED|Period 2||0
11298706|NCT02548156|12496496|FG003|NOT COMPLETED|Period 2||0
11298707|NCT02548156|12496497|FG004|NOT COMPLETED|Period 2||0
11298708|NCT02548156|12496498|FG005|NOT COMPLETED|Period 2||0
11298709|NCT02548156|12496493|FG000|STARTED|Washout Period 2||5
11298710|NCT02548156|12496494|FG001|STARTED|Washout Period 2||5
11400903|NCT04161079|12595626|FG000|COMPLETED|2010-040FU5 >5 Years Follow-up|Timepoint distribution for individual patients ranged approximately 6-8 yrs after MAR implantation.|7
11298711|NCT02548156|12496495|FG002|STARTED|Washout Period 2||4
11298712|NCT02548156|12496496|FG003|STARTED|Washout Period 2||5
11298713|NCT02548156|12496497|FG004|STARTED|Washout Period 2||4
11298714|NCT02548156|12496498|FG005|STARTED|Washout Period 2||5
11298715|NCT02548156|12496493|FG000|COMPLETED|Washout Period 2||5
11298716|NCT02548156|12496494|FG001|COMPLETED|Washout Period 2||5
11400904|NCT04161079|12595626|FG000|NOT COMPLETED|2010-040FU5 >5 Years Follow-up||0
11400905|NCT04158466|12595636|FG000|STARTED|Overall Study||124
11298717|NCT02548156|12496495|FG002|COMPLETED|Washout Period 2||4
11298718|NCT02548156|12496496|FG003|COMPLETED|Washout Period 2||5
11298719|NCT02548156|12496497|FG004|COMPLETED|Washout Period 2||4
11298720|NCT02548156|12496498|FG005|COMPLETED|Washout Period 2||5
11400906|NCT04158466|12595637|FG001|STARTED|Overall Study||127
11400907|NCT04158466|12595636|FG000|COMPLETED|Overall Study||121
11400908|NCT04158466|12595637|FG001|COMPLETED|Overall Study||126
11298721|NCT02548156|12496493|FG000|NOT COMPLETED|Washout Period 2||0
11298722|NCT02548156|12496494|FG001|NOT COMPLETED|Washout Period 2||0
11298723|NCT02548156|12496495|FG002|NOT COMPLETED|Washout Period 2||0
11298724|NCT02548156|12496496|FG003|NOT COMPLETED|Washout Period 2||0
11298725|NCT02548156|12496497|FG004|NOT COMPLETED|Washout Period 2||0
11298726|NCT02548156|12496498|FG005|NOT COMPLETED|Washout Period 2||0
11298727|NCT02548156|12496493|FG000|STARTED|Period 3||5
11298728|NCT02548156|12496494|FG001|STARTED|Period 3||5
11298729|NCT02548156|12496495|FG002|STARTED|Period 3||4
11298730|NCT02548156|12496496|FG003|STARTED|Period 3||5
11298731|NCT02548156|12496497|FG004|STARTED|Period 3||4
11298732|NCT02548156|12496498|FG005|STARTED|Period 3||5
11298733|NCT02548156|12496493|FG000|COMPLETED|Period 3||5
11298734|NCT02548156|12496494|FG001|COMPLETED|Period 3||5
11298735|NCT02548156|12496495|FG002|COMPLETED|Period 3||4
11298736|NCT02548156|12496496|FG003|COMPLETED|Period 3||5
11298737|NCT02548156|12496497|FG004|COMPLETED|Period 3||4
11298738|NCT02548156|12496498|FG005|COMPLETED|Period 3||5
11298739|NCT02548156|12496493|FG000|NOT COMPLETED|Period 3||0
11298740|NCT02548156|12496494|FG001|NOT COMPLETED|Period 3||0
11298741|NCT02548156|12496495|FG002|NOT COMPLETED|Period 3||0
11298742|NCT02548156|12496496|FG003|NOT COMPLETED|Period 3||0
11298743|NCT02548156|12496497|FG004|NOT COMPLETED|Period 3||0
11298744|NCT02548156|12496498|FG005|NOT COMPLETED|Period 3||0
11298745|NCT02548312|12496514|FG000|STARTED|Overall Study||133
11298746|NCT02548312|12496515|FG001|STARTED|Overall Study||133
11298747|NCT02548312|12496516|FG002|STARTED|Overall Study||134
11298748|NCT02548312|12496517|FG003|STARTED|Overall Study||133
11298749|NCT02548312|12496518|FG004|STARTED|Overall Study||133
11298750|NCT02548312|12496519|FG005|STARTED|Overall Study||133
11298751|NCT02548312|12496520|FG006|STARTED|Overall Study||133
11298752|NCT02548312|12496521|FG007|STARTED|Overall Study||133
11298753|NCT02548312|12496514|FG000|COMPLETED|Overall Study||100
11298754|NCT02548312|12496515|FG001|COMPLETED|Overall Study||90
11298755|NCT02548312|12496516|FG002|COMPLETED|Overall Study||96
11298756|NCT02548312|12496517|FG003|COMPLETED|Overall Study||87
11298757|NCT02548312|12496518|FG004|COMPLETED|Overall Study||99
11298758|NCT02548312|12496519|FG005|COMPLETED|Overall Study||93
11298759|NCT02548312|12496520|FG006|COMPLETED|Overall Study||93
11298760|NCT02548312|12496521|FG007|COMPLETED|Overall Study||91
11298761|NCT02548312|12496514|FG000|NOT COMPLETED|Overall Study||33
11298762|NCT02548312|12496515|FG001|NOT COMPLETED|Overall Study||43
11298763|NCT02548312|12496516|FG002|NOT COMPLETED|Overall Study||38
11298764|NCT02548312|12496517|FG003|NOT COMPLETED|Overall Study||46
11298765|NCT02548312|12496518|FG004|NOT COMPLETED|Overall Study||34
11298766|NCT02548312|12496519|FG005|NOT COMPLETED|Overall Study||40
11298767|NCT02548312|12496520|FG006|NOT COMPLETED|Overall Study||40
11298768|NCT02548312|12496521|FG007|NOT COMPLETED|Overall Study||42
11298769|NCT02548455|12496539|FG000|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
11298770|NCT02548455|12496539|FG000|Completed Pre-Discharge|Overall Study||484
11298771|NCT02548455|12496539|FG000|Completed 6-Month Follow-up|Overall Study||259
11341391|NCT02932891|12538768|FG000|COMPLETED|Overall Study||24
11298772|NCT02548455|12496539|FG000|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
11298773|NCT02548455|12496539|FG000|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
11298774|NCT02548455|12496539|FG000|NOT COMPLETED|Overall Study||240
11298775|NCT02548585|12496550|FG000|STARTED|Overall Study||45
11298776|NCT02548585|12496551|FG001|STARTED|Overall Study||6
11298777|NCT02548585|12496552|FG002|STARTED|Overall Study||6
11298778|NCT02548585|12496553|FG003|STARTED|Overall Study||7
11298779|NCT02548585|12496554|FG004|STARTED|Overall Study||25
11298780|NCT02548585|12496555|FG005|STARTED|Overall Study||12
11298781|NCT02548585|12496556|FG006|STARTED|Overall Study||12
11298782|NCT02548585|12496550|FG000|Treated|Overall Study||45
11298783|NCT02548585|12496551|FG001|Treated|Overall Study||6
11298784|NCT02548585|12496552|FG002|Treated|Overall Study||6
11298785|NCT02548585|12496553|FG003|Treated|Overall Study||7
11298786|NCT02548585|12496554|FG004|Treated|Overall Study||25
11298787|NCT02548585|12496555|FG005|Treated|Overall Study||11
11298788|NCT02548585|12496556|FG006|Treated|Overall Study||12
11298789|NCT02548585|12496550|FG000|COMPLETED|Overall Study||43
11298790|NCT02548585|12496551|FG001|COMPLETED|Overall Study||6
11298791|NCT02548585|12496552|FG002|COMPLETED|Overall Study||6
11298792|NCT02548585|12496553|FG003|COMPLETED|Overall Study||5
11298793|NCT02548585|12496554|FG004|COMPLETED|Overall Study||22
11298794|NCT02548585|12496555|FG005|COMPLETED|Overall Study||10
11298795|NCT02548585|12496556|FG006|COMPLETED|Overall Study||11
11298796|NCT02548585|12496550|FG000|NOT COMPLETED|Overall Study||2
11298797|NCT02548585|12496551|FG001|NOT COMPLETED|Overall Study||0
11400909|NCT04158466|12595636|FG000|NOT COMPLETED|Overall Study||3
11400910|NCT04158466|12595637|FG001|NOT COMPLETED|Overall Study||1
11298798|NCT02548585|12496552|FG002|NOT COMPLETED|Overall Study||0
11298799|NCT02548585|12496553|FG003|NOT COMPLETED|Overall Study||2
11298800|NCT02548585|12496554|FG004|NOT COMPLETED|Overall Study||3
11298801|NCT02548585|12496555|FG005|NOT COMPLETED|Overall Study||2
11298802|NCT02548585|12496556|FG006|NOT COMPLETED|Overall Study||1
11298803|NCT02548650|12496599|FG000|STARTED|Triple Therapy||30
11298804|NCT02548650|12496600|FG001|STARTED|Triple Therapy||36
11298805|NCT02548650|12496599|FG000|COMPLETED|Triple Therapy||29
11400911|NCT04152083|12595645|FG000|STARTED|Overall Study||241
11298806|NCT02548650|12496600|FG001|COMPLETED|Triple Therapy||32
11298807|NCT02548650|12496599|FG000|NOT COMPLETED|Triple Therapy||1
11298808|NCT02548650|12496600|FG001|NOT COMPLETED|Triple Therapy||4
11298809|NCT02548650|12496599|FG000|STARTED|Double Therapy||29
11298810|NCT02548650|12496600|FG001|STARTED|Double Therapy||32
11298811|NCT02548650|12496599|FG000|COMPLETED|Double Therapy||28
11298812|NCT02548650|12496600|FG001|COMPLETED|Double Therapy||30
11298813|NCT02548650|12496599|FG000|NOT COMPLETED|Double Therapy||1
11298814|NCT02548650|12496600|FG001|NOT COMPLETED|Double Therapy||2
11298815|NCT02548728|12496608|FG000|STARTED|Overall Study||6
11298816|NCT02548728|12496609|FG001|STARTED|Overall Study||6
11298817|NCT02548728|12496608|FG000|COMPLETED|Overall Study||6
11298818|NCT02548728|12496609|FG001|COMPLETED|Overall Study||6
11298819|NCT02548728|12496608|FG000|NOT COMPLETED|Overall Study||0
11298820|NCT02548728|12496609|FG001|NOT COMPLETED|Overall Study||0
11298821|NCT02548845|12496615|FG000|STARTED|Overall Study||70
11298822|NCT02548845|12496615|FG000|COMPLETED|Overall Study||70
11298823|NCT02548845|12496615|FG000|NOT COMPLETED|Overall Study||0
11298824|NCT02548910|12496625|FG000|STARTED|Overall Study||31
11298825|NCT02548910|12496626|FG001|STARTED|Overall Study||31
11298826|NCT02548910|12496625|FG000|COMPLETED|Overall Study||31
11298827|NCT02548910|12496626|FG001|COMPLETED|Overall Study||31
11298828|NCT02548910|12496625|FG000|NOT COMPLETED|Overall Study||0
11298829|NCT02548910|12496626|FG001|NOT COMPLETED|Overall Study||0
11298830|NCT02548949|12496633|FG000|STARTED|Overall Study||700
11298831|NCT02548949|12496633|FG000|COMPLETED|Overall Study||700
11298832|NCT02548949|12496633|FG000|NOT COMPLETED|Overall Study||0
11298833|NCT02548962|12496639|FG000|STARTED|Overall Study||8
11298834|NCT02548962|12496640|FG001|STARTED|Overall Study||3
11298835|NCT02548962|12496639|FG000|COMPLETED|Overall Study||7
11298836|NCT02548962|12496640|FG001|COMPLETED|Overall Study||3
11298837|NCT02548962|12496639|FG000|NOT COMPLETED|Overall Study||1
11298838|NCT02548962|12496640|FG001|NOT COMPLETED|Overall Study||0
11298839|NCT02549014|12496650|FG000|STARTED|Overall Study||8
11298840|NCT02549014|12496651|FG001|STARTED|Overall Study||8
11298841|NCT02549014|12496650|FG000|COMPLETED|Overall Study||8
11298842|NCT02549014|12496651|FG001|COMPLETED|Overall Study||8
11298843|NCT02549014|12496650|FG000|NOT COMPLETED|Overall Study||0
11298844|NCT02549014|12496651|FG001|NOT COMPLETED|Overall Study||0
11298845|NCT02549027|12496675|FG000|STARTED|Period 1 - MK-1064 or Placebo||5
11298846|NCT02549027|12496676|FG001|STARTED|Period 1 - MK-1064 or Placebo||5
11298847|NCT02549027|12496677|FG002|STARTED|Period 1 - MK-1064 or Placebo||5
11298848|NCT02549027|12496678|FG003|STARTED|Period 1 - MK-1064 or Placebo||5
11298849|NCT02549027|12496679|FG004|STARTED|Period 1 - MK-1064 or Placebo||0
11298850|NCT02549027|12496680|FG005|STARTED|Period 1 - MK-1064 or Placebo||0
11298851|NCT02549027|12496675|FG000|COMPLETED|Period 1 - MK-1064 or Placebo||5
11298852|NCT02549027|12496676|FG001|COMPLETED|Period 1 - MK-1064 or Placebo||5
11298853|NCT02549027|12496677|FG002|COMPLETED|Period 1 - MK-1064 or Placebo||5
11298854|NCT02549027|12496678|FG003|COMPLETED|Period 1 - MK-1064 or Placebo||5
11298855|NCT02549027|12496679|FG004|COMPLETED|Period 1 - MK-1064 or Placebo||0
11298856|NCT02549027|12496680|FG005|COMPLETED|Period 1 - MK-1064 or Placebo||0
11298857|NCT02549027|12496675|FG000|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
11298858|NCT02549027|12496676|FG001|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
11298859|NCT02549027|12496677|FG002|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
11298860|NCT02549027|12496678|FG003|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
11298861|NCT02549027|12496679|FG004|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
11298862|NCT02549027|12496680|FG005|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
11298863|NCT02549027|12496675|FG000|STARTED|Washout After Period 1||5
11298864|NCT02549027|12496676|FG001|STARTED|Washout After Period 1||5
11298865|NCT02549027|12496677|FG002|STARTED|Washout After Period 1||5
11298866|NCT02549027|12496678|FG003|STARTED|Washout After Period 1||5
11298867|NCT02549027|12496679|FG004|STARTED|Washout After Period 1||0
11298868|NCT02549027|12496680|FG005|STARTED|Washout After Period 1||0
11298869|NCT02549027|12496675|FG000|COMPLETED|Washout After Period 1||5
11298870|NCT02549027|12496676|FG001|COMPLETED|Washout After Period 1||5
11298871|NCT02549027|12496677|FG002|COMPLETED|Washout After Period 1||5
11298872|NCT02549027|12496678|FG003|COMPLETED|Washout After Period 1||5
11298873|NCT02549027|12496679|FG004|COMPLETED|Washout After Period 1||0
11298874|NCT02549027|12496680|FG005|COMPLETED|Washout After Period 1||0
11298875|NCT02549027|12496675|FG000|NOT COMPLETED|Washout After Period 1||0
11298876|NCT02549027|12496676|FG001|NOT COMPLETED|Washout After Period 1||0
11298877|NCT02549027|12496677|FG002|NOT COMPLETED|Washout After Period 1||0
11298878|NCT02549027|12496678|FG003|NOT COMPLETED|Washout After Period 1||0
11298879|NCT02549027|12496679|FG004|NOT COMPLETED|Washout After Period 1||0
11298880|NCT02549027|12496680|FG005|NOT COMPLETED|Washout After Period 1||0
11298881|NCT02549027|12496675|FG000|STARTED|Period 2 - MK-1064 or Placebo||5
11298882|NCT02549027|12496676|FG001|STARTED|Period 2 - MK-1064 or Placebo||5
11298883|NCT02549027|12496677|FG002|STARTED|Period 2 - MK-1064 or Placebo||5
11298884|NCT02549027|12496678|FG003|STARTED|Period 2 - MK-1064 or Placebo||5
11298885|NCT02549027|12496679|FG004|STARTED|Period 2 - MK-1064 or Placebo||0
11298886|NCT02549027|12496680|FG005|STARTED|Period 2 - MK-1064 or Placebo||0
11298887|NCT02549027|12496675|FG000|COMPLETED|Period 2 - MK-1064 or Placebo||5
11298888|NCT02549027|12496676|FG001|COMPLETED|Period 2 - MK-1064 or Placebo||5
11298889|NCT02549027|12496677|FG002|COMPLETED|Period 2 - MK-1064 or Placebo||5
11400912|NCT04152083|12595646|FG001|STARTED|Overall Study||244
11400913|NCT04152083|12595645|FG000|Received at Least 1 Dose of Study Drug|Overall Study||238
11400914|NCT04152083|12595646|FG001|Received at Least 1 Dose of Study Drug|Overall Study||242
11400915|NCT04152083|12595645|FG000|COMPLETED|Overall Study||235
11400916|NCT04152083|12595646|FG001|COMPLETED|Overall Study||241
11400917|NCT04152083|12595645|FG000|NOT COMPLETED|Overall Study||6
11400918|NCT04152083|12595646|FG001|NOT COMPLETED|Overall Study||3
11298890|NCT02549027|12496678|FG003|COMPLETED|Period 2 - MK-1064 or Placebo||5
11298891|NCT02549027|12496679|FG004|COMPLETED|Period 2 - MK-1064 or Placebo||0
11298892|NCT02549027|12496680|FG005|COMPLETED|Period 2 - MK-1064 or Placebo||0
11298893|NCT02549027|12496675|FG000|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
11298894|NCT02549027|12496676|FG001|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
11298895|NCT02549027|12496677|FG002|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
11298896|NCT02549027|12496678|FG003|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
11298897|NCT02549027|12496679|FG004|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
11298898|NCT02549027|12496680|FG005|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
11298899|NCT02549027|12496675|FG000|STARTED|Washout After Period 2||5
11298900|NCT02549027|12496676|FG001|STARTED|Washout After Period 2||5
11298901|NCT02549027|12496677|FG002|STARTED|Washout After Period 2||5
11298902|NCT02549027|12496678|FG003|STARTED|Washout After Period 2||5
11298903|NCT02549027|12496679|FG004|STARTED|Washout After Period 2||0
11298904|NCT02549027|12496680|FG005|STARTED|Washout After Period 2||0
11298905|NCT02549027|12496675|FG000|COMPLETED|Washout After Period 2||5
11298906|NCT02549027|12496676|FG001|COMPLETED|Washout After Period 2||5
11298907|NCT02549027|12496677|FG002|COMPLETED|Washout After Period 2||5
11298908|NCT02549027|12496678|FG003|COMPLETED|Washout After Period 2||5
11298909|NCT02549027|12496679|FG004|COMPLETED|Washout After Period 2||0
11298910|NCT02549027|12496680|FG005|COMPLETED|Washout After Period 2||0
11298911|NCT02549027|12496675|FG000|NOT COMPLETED|Washout After Period 2||0
11298912|NCT02549027|12496676|FG001|NOT COMPLETED|Washout After Period 2||0
11298913|NCT02549027|12496677|FG002|NOT COMPLETED|Washout After Period 2||0
11298914|NCT02549027|12496678|FG003|NOT COMPLETED|Washout After Period 2||0
11298915|NCT02549027|12496679|FG004|NOT COMPLETED|Washout After Period 2||0
11298916|NCT02549027|12496680|FG005|NOT COMPLETED|Washout After Period 2||0
11298917|NCT02549027|12496675|FG000|STARTED|Period 3 - MK-1064 or Placebo||5
11298918|NCT02549027|12496676|FG001|STARTED|Period 3 - MK-1064 or Placebo||5
11298919|NCT02549027|12496677|FG002|STARTED|Period 3 - MK-1064 or Placebo||5
11298920|NCT02549027|12496678|FG003|STARTED|Period 3 - MK-1064 or Placebo||5
11298921|NCT02549027|12496679|FG004|STARTED|Period 3 - MK-1064 or Placebo||0
11298922|NCT02549027|12496680|FG005|STARTED|Period 3 - MK-1064 or Placebo||0
11298923|NCT02549027|12496675|FG000|COMPLETED|Period 3 - MK-1064 or Placebo||5
11298924|NCT02549027|12496676|FG001|COMPLETED|Period 3 - MK-1064 or Placebo||5
11298925|NCT02549027|12496677|FG002|COMPLETED|Period 3 - MK-1064 or Placebo||5
11298926|NCT02549027|12496678|FG003|COMPLETED|Period 3 - MK-1064 or Placebo||5
11298927|NCT02549027|12496679|FG004|COMPLETED|Period 3 - MK-1064 or Placebo||0
11298928|NCT02549027|12496680|FG005|COMPLETED|Period 3 - MK-1064 or Placebo||0
11298929|NCT02549027|12496675|FG000|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
11298930|NCT02549027|12496676|FG001|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
11298931|NCT02549027|12496677|FG002|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
11298932|NCT02549027|12496678|FG003|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
11400919|NCT04155567|12595652|FG000|STARTED|Overall Study||10
11298933|NCT02549027|12496679|FG004|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
11298934|NCT02549027|12496680|FG005|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
11298935|NCT02549027|12496675|FG000|STARTED|Washout After Period 3||5
11298936|NCT02549027|12496676|FG001|STARTED|Washout After Period 3||5
11298937|NCT02549027|12496677|FG002|STARTED|Washout After Period 3||5
11298938|NCT02549027|12496678|FG003|STARTED|Washout After Period 3||5
11298939|NCT02549027|12496679|FG004|STARTED|Washout After Period 3||0
11298940|NCT02549027|12496680|FG005|STARTED|Washout After Period 3||0
11298941|NCT02549027|12496675|FG000|COMPLETED|Washout After Period 3||5
11298942|NCT02549027|12496676|FG001|COMPLETED|Washout After Period 3||5
11298943|NCT02549027|12496677|FG002|COMPLETED|Washout After Period 3||5
11298944|NCT02549027|12496678|FG003|COMPLETED|Washout After Period 3||5
11298945|NCT02549027|12496679|FG004|COMPLETED|Washout After Period 3||0
11298946|NCT02549027|12496680|FG005|COMPLETED|Washout After Period 3||0
11298947|NCT02549027|12496675|FG000|NOT COMPLETED|Washout After Period 3||0
11298948|NCT02549027|12496676|FG001|NOT COMPLETED|Washout After Period 3||0
11298949|NCT02549027|12496677|FG002|NOT COMPLETED|Washout After Period 3||0
11298950|NCT02549027|12496678|FG003|NOT COMPLETED|Washout After Period 3||0
11298951|NCT02549027|12496679|FG004|NOT COMPLETED|Washout After Period 3||0
11298952|NCT02549027|12496680|FG005|NOT COMPLETED|Washout After Period 3||0
11298953|NCT02549027|12496675|FG000|STARTED|Period 4 - MK-1064 or Placebo||5
11298954|NCT02549027|12496676|FG001|STARTED|Period 4 - MK-1064 or Placebo||5
11298955|NCT02549027|12496677|FG002|STARTED|Period 4 - MK-1064 or Placebo||5
11298956|NCT02549027|12496678|FG003|STARTED|Period 4 - MK-1064 or Placebo||5
11298957|NCT02549027|12496679|FG004|STARTED|Period 4 - MK-1064 or Placebo||0
11298958|NCT02549027|12496680|FG005|STARTED|Period 4 - MK-1064 or Placebo||0
11298959|NCT02549027|12496675|FG000|COMPLETED|Period 4 - MK-1064 or Placebo||5
11298960|NCT02549027|12496676|FG001|COMPLETED|Period 4 - MK-1064 or Placebo||5
11298961|NCT02549027|12496677|FG002|COMPLETED|Period 4 - MK-1064 or Placebo||5
11298962|NCT02549027|12496678|FG003|COMPLETED|Period 4 - MK-1064 or Placebo||5
11298963|NCT02549027|12496679|FG004|COMPLETED|Period 4 - MK-1064 or Placebo||0
11298964|NCT02549027|12496680|FG005|COMPLETED|Period 4 - MK-1064 or Placebo||0
11298965|NCT02549027|12496675|FG000|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
11298966|NCT02549027|12496676|FG001|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
11298967|NCT02549027|12496677|FG002|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
11298968|NCT02549027|12496678|FG003|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
11298969|NCT02549027|12496679|FG004|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
11298970|NCT02549027|12496680|FG005|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
11298971|NCT02549027|12496675|FG000|STARTED|Washout After Period 4||5
11298972|NCT02549027|12496676|FG001|STARTED|Washout After Period 4||5
11298973|NCT02549027|12496677|FG002|STARTED|Washout After Period 4||5
11298974|NCT02549027|12496678|FG003|STARTED|Washout After Period 4||5
11298975|NCT02549027|12496679|FG004|STARTED|Washout After Period 4||0
11298976|NCT02549027|12496680|FG005|STARTED|Washout After Period 4||0
11298977|NCT02549027|12496675|FG000|COMPLETED|Washout After Period 4||5
11298978|NCT02549027|12496676|FG001|COMPLETED|Washout After Period 4||4
11298979|NCT02549027|12496677|FG002|COMPLETED|Washout After Period 4||4
11298980|NCT02549027|12496678|FG003|COMPLETED|Washout After Period 4||4
11298981|NCT02549027|12496679|FG004|COMPLETED|Washout After Period 4||0
11298982|NCT02549027|12496680|FG005|COMPLETED|Washout After Period 4||0
11298983|NCT02549027|12496675|FG000|NOT COMPLETED|Washout After Period 4||0
11298984|NCT02549027|12496676|FG001|NOT COMPLETED|Washout After Period 4||1
11298985|NCT02549027|12496677|FG002|NOT COMPLETED|Washout After Period 4||1
11298986|NCT02549027|12496678|FG003|NOT COMPLETED|Washout After Period 4||1
11298987|NCT02549027|12496679|FG004|NOT COMPLETED|Washout After Period 4||0
11298988|NCT02549027|12496680|FG005|NOT COMPLETED|Washout After Period 4||0
11298989|NCT02549027|12496675|FG000|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
11298990|NCT02549027|12496676|FG001|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
11298991|NCT02549027|12496677|FG002|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
11298992|NCT02549027|12496678|FG003|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
11298993|NCT02549027|12496679|FG004|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
11298994|NCT02549027|12496680|FG005|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
11298995|NCT02549027|12496675|FG000|COMPLETED|Period 5 - MK-6096 or Placebo||0
11298996|NCT02549027|12496676|FG001|COMPLETED|Period 5 - MK-6096 or Placebo||0
11298997|NCT02549027|12496677|FG002|COMPLETED|Period 5 - MK-6096 or Placebo||0
11298998|NCT02549027|12496678|FG003|COMPLETED|Period 5 - MK-6096 or Placebo||0
11298999|NCT02549027|12496679|FG004|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
11299000|NCT02549027|12496680|FG005|COMPLETED|Period 5 - MK-6096 or Placebo||1
11299001|NCT02549027|12496675|FG000|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
11299002|NCT02549027|12496676|FG001|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
11299003|NCT02549027|12496677|FG002|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
11400920|NCT04155567|12595652|FG000|COMPLETED|Overall Study||10
11400921|NCT04155567|12595652|FG000|NOT COMPLETED|Overall Study||0
11400922|NCT04155047|12595658|FG000|STARTED|Overall Study||11
11400923|NCT04155047|12595659|FG001|STARTED|Overall Study||11
11400924|NCT04155047|12595658|FG000|COMPLETED|Overall Study||9
11299004|NCT02549027|12496678|FG003|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
11299005|NCT02549027|12496679|FG004|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
11299006|NCT02549027|12496680|FG005|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
11299007|NCT02549040|12496695|FG000|STARTED|Period 1||16
11299008|NCT02549040|12496695|FG000|COMPLETED|Period 1||16
11299009|NCT02549040|12496695|FG000|NOT COMPLETED|Period 1||0
11299010|NCT02549040|12496695|FG000|STARTED|Period 2||16
11299011|NCT02549040|12496695|FG000|COMPLETED|Period 2||16
11299012|NCT02549040|12496695|FG000|NOT COMPLETED|Period 2||0
11299013|NCT02549040|12496695|FG000|STARTED|Period 3||16
11299014|NCT02549040|12496695|FG000|COMPLETED|Period 3||16
11299015|NCT02549040|12496695|FG000|NOT COMPLETED|Period 3||0
11299016|NCT02549040|12496695|FG000|STARTED|Period 4||16
11299017|NCT02549040|12496695|FG000|COMPLETED|Period 4||16
11299018|NCT02549040|12496695|FG000|NOT COMPLETED|Period 4||0
11299019|NCT02549040|12496695|FG000|STARTED|Period 5||16
11299020|NCT02549040|12496695|FG000|COMPLETED|Period 5||16
11299021|NCT02549040|12496695|FG000|NOT COMPLETED|Period 5||0
11299022|NCT02549196|12496711|FG000|STARTED|Overall Study||8
11400925|NCT04155047|12595659|FG001|COMPLETED|Overall Study||11
11400926|NCT04155047|12595658|FG000|NOT COMPLETED|Overall Study||2
11400927|NCT04155047|12595659|FG001|NOT COMPLETED|Overall Study||0
11400928|NCT04152642|12595665|FG000|STARTED|Overall Study||22
11400929|NCT04152642|12595665|FG000|C (Water/Negative) Control|Overall Study||20
11400930|NCT04152642|12595665|FG000|A (Marketed Rinse)|Overall Study||19
11400931|NCT04152642|12595665|FG000|B (Experimental Rinse)|Overall Study||19
11400932|NCT04152642|12595665|FG000|COMPLETED|Overall Study||15
11400933|NCT04152642|12595665|FG000|NOT COMPLETED|Overall Study||7
11299023|NCT02549196|12496712|FG001|STARTED|Overall Study||1
11299024|NCT02549196|12496713|FG002|STARTED|Overall Study||6
11299025|NCT02549196|12496714|FG003|STARTED|Overall Study||13
11299026|NCT02549196|12496711|FG000|COMPLETED|Overall Study||7
11299027|NCT02549196|12496712|FG001|COMPLETED|Overall Study||1
11299028|NCT02549196|12496713|FG002|COMPLETED|Overall Study||5
11299029|NCT02549196|12496714|FG003|COMPLETED|Overall Study||12
11299030|NCT02549196|12496711|FG000|NOT COMPLETED|Overall Study||1
11299031|NCT02549196|12496712|FG001|NOT COMPLETED|Overall Study||0
11299032|NCT02549196|12496713|FG002|NOT COMPLETED|Overall Study||1
11299033|NCT02549196|12496714|FG003|NOT COMPLETED|Overall Study||1
11299034|NCT02549287|12496726|FG000|STARTED|Overall Study||193
11299035|NCT02549287|12496727|FG001|STARTED|Overall Study||96
11299036|NCT02549287|12496726|FG000|COMPLETED|Overall Study||113
11299037|NCT02549287|12496727|FG001|COMPLETED|Overall Study||64
11299038|NCT02549287|12496726|FG000|NOT COMPLETED|Overall Study||80
11299039|NCT02549287|12496727|FG001|NOT COMPLETED|Overall Study||32
11299040|NCT02549339|12496735|FG000|STARTED|3-day Treatment and 8-week Follow-up||205
11299041|NCT02549339|12496736|FG001|STARTED|3-day Treatment and 8-week Follow-up||104
11299042|NCT02549339|12496735|FG000|Treated|3-day Treatment and 8-week Follow-up||202
11299043|NCT02549339|12496736|FG001|Treated|3-day Treatment and 8-week Follow-up||104
11299044|NCT02549339|12496735|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||201
11299045|NCT02549339|12496736|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||99
11299046|NCT02549339|12496735|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
11299047|NCT02549339|12496736|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
11299048|NCT02549339|12496735|FG000|STARTED|12-month Follow-up||201
11299049|NCT02549339|12496736|FG001|STARTED|12-month Follow-up||98
11299050|NCT02549339|12496735|FG000|COMPLETED|12-month Follow-up||192
11299051|NCT02549339|12496736|FG001|COMPLETED|12-month Follow-up||87
11299052|NCT02549339|12496735|FG000|NOT COMPLETED|12-month Follow-up||9
11299053|NCT02549339|12496736|FG001|NOT COMPLETED|12-month Follow-up||11
11299054|NCT02549352|12496746|FG000|STARTED|3-day Treatment and 8-week Follow-up||209
11299055|NCT02549352|12496747|FG001|STARTED|3-day Treatment and 8-week Follow-up||102
11299056|NCT02549352|12496746|FG000|Treated|3-day Treatment and 8-week Follow-up||209
11299057|NCT02549352|12496747|FG001|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
11299058|NCT02549352|12496746|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207
11299059|NCT02549352|12496747|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||96
11299060|NCT02549352|12496746|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
11299061|NCT02549352|12496747|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
11299062|NCT02549352|12496746|FG000|STARTED|12-month Follow-up||207
11299063|NCT02549352|12496747|FG001|STARTED|12-month Follow-up||93
11299064|NCT02549352|12496746|FG000|COMPLETED|12-month Follow-up||199
11299065|NCT02549352|12496747|FG001|COMPLETED|12-month Follow-up||81
11299066|NCT02549352|12496746|FG000|NOT COMPLETED|12-month Follow-up||8
11299067|NCT02549352|12496747|FG001|NOT COMPLETED|12-month Follow-up||12
11341392|NCT02932891|12538768|FG000|NOT COMPLETED|Overall Study||4
11341393|NCT02932904|12538776|FG000|STARTED|Overall Study||92
11341394|NCT02932904|12538777|FG001|STARTED|Overall Study||85
11341395|NCT02932904|12538778|FG002|STARTED|Overall Study||91
11341396|NCT02932904|12538779|FG003|STARTED|Overall Study||93
11341397|NCT02932904|12538776|FG000|Treated|Overall Study||91
11341398|NCT02932904|12538777|FG001|Treated|Overall Study||84
11341399|NCT02932904|12538778|FG002|Treated|Overall Study||91
11341400|NCT02932904|12538779|FG003|Treated|Overall Study||91
11341401|NCT02932904|12538776|FG000|COMPLETED|Overall Study||76
11341402|NCT02932904|12538777|FG001|COMPLETED|Overall Study||67
11341403|NCT02932904|12538778|FG002|COMPLETED|Overall Study||68
11341404|NCT02932904|12538779|FG003|COMPLETED|Overall Study||79
11341405|NCT02932904|12538776|FG000|NOT COMPLETED|Overall Study||16
11299068|NCT02549365|12496757|FG000|STARTED|Overall Study||164
11299069|NCT02549365|12496758|FG001|STARTED|Overall Study||112
11299070|NCT02549365|12496757|FG000|COMPLETED|Overall Study||164
11299071|NCT02549365|12496758|FG001|COMPLETED|Overall Study||112
11299072|NCT02549365|12496757|FG000|NOT COMPLETED|Overall Study||0
11299073|NCT02549365|12496758|FG001|NOT COMPLETED|Overall Study||0
11299074|NCT02549508|12496766|FG000|STARTED|Overall Study||47
11299075|NCT02549508|12496767|FG001|STARTED|Overall Study||38
11299076|NCT02549508|12496766|FG000|COMPLETED|Overall Study||33
11299077|NCT02549508|12496767|FG001|COMPLETED|Overall Study||21
11299078|NCT02549508|12496766|FG000|NOT COMPLETED|Overall Study||14
11299079|NCT02549508|12496767|FG001|NOT COMPLETED|Overall Study||17
11299080|NCT02549573|12496777|FG000|STARTED|Overall Study||6
11299081|NCT02549573|12496778|FG001|STARTED|Overall Study||7
11299082|NCT02549573|12496777|FG000|COMPLETED|Overall Study||6
11299083|NCT02549573|12496778|FG001|COMPLETED|Overall Study||4
11299084|NCT02549573|12496777|FG000|NOT COMPLETED|Overall Study||0
11299085|NCT02549573|12496778|FG001|NOT COMPLETED|Overall Study||3
11299086|NCT02549859|12496784|FG000|STARTED|Visit 1||11
11299087|NCT02549859|12496784|FG000|COMPLETED|Visit 1||11
11299088|NCT02549859|12496784|FG000|NOT COMPLETED|Visit 1||0
11299089|NCT02549859|12496784|FG000|STARTED|Long-term 60 Hz DBS||11
11299090|NCT02549859|12496784|FG000|COMPLETED|Long-term 60 Hz DBS||10
11299091|NCT02549859|12496784|FG000|NOT COMPLETED|Long-term 60 Hz DBS||1
11299092|NCT02549859|12496784|FG000|STARTED|Visit 2||10
11400934|NCT04150861|12595676|FG000|STARTED|Overall Study||8
11299093|NCT02549859|12496784|FG000|COMPLETED|Visit 2||10
11299094|NCT02549859|12496784|FG000|NOT COMPLETED|Visit 2||0
11400935|NCT04150861|12595677|FG001|STARTED|Overall Study||8
11299095|NCT02550106|12496792|FG000|STARTED|Overall Study||136
11299096|NCT02550106|12496792|FG000|COMPLETED|Overall Study||124
11299097|NCT02550106|12496792|FG000|NOT COMPLETED|Overall Study||12
11299098|NCT02550132|12496798|FG000|STARTED|Overall Study||25
11299099|NCT02550132|12496798|FG000|COMPLETED|Overall Study||25
11299100|NCT02550132|12496798|FG000|NOT COMPLETED|Overall Study||0
11299101|NCT02550210|12496802|FG000|STARTED|Overall Study||23
11299102|NCT02550210|12496802|FG000|COMPLETED|Overall Study||19
11299103|NCT02550210|12496802|FG000|NOT COMPLETED|Overall Study||4
11299104|NCT02550743|12496810|FG000|STARTED|Overall Study||3
11299105|NCT02550743|12496811|FG001|STARTED|Overall Study||3
11400936|NCT04150861|12595678|FG002|STARTED|Overall Study||8
11400937|NCT04150861|12595676|FG000|COMPLETED|Overall Study||8
11400938|NCT04150861|12595677|FG001|COMPLETED|Overall Study||8
11400939|NCT04150861|12595678|FG002|COMPLETED|Overall Study||8
11400940|NCT04150861|12595676|FG000|NOT COMPLETED|Overall Study||0
11400941|NCT04150861|12595677|FG001|NOT COMPLETED|Overall Study||0
11299106|NCT02550743|12496812|FG002|STARTED|Overall Study||1
11299107|NCT02550743|12496813|FG003|STARTED|Overall Study||0
11299108|NCT02550743|12496810|FG000|COMPLETED|Overall Study||3
11299109|NCT02550743|12496811|FG001|COMPLETED|Overall Study||3
11400942|NCT04150861|12595678|FG002|NOT COMPLETED|Overall Study||0
11400943|NCT04150250|12595688|FG000|STARTED|Overall Study||23
11400944|NCT04150250|12595689|FG001|STARTED|Overall Study||24
11400945|NCT04150250|12595688|FG000|COMPLETED|Overall Study||23
11400946|NCT04150250|12595689|FG001|COMPLETED|Overall Study||22
11299110|NCT02550743|12496812|FG002|COMPLETED|Overall Study||1
11299111|NCT02550743|12496813|FG003|COMPLETED|Overall Study||0
11299112|NCT02550743|12496810|FG000|NOT COMPLETED|Overall Study||0
11299113|NCT02550743|12496811|FG001|NOT COMPLETED|Overall Study||0
11299114|NCT02550743|12496812|FG002|NOT COMPLETED|Overall Study||0
11299115|NCT02550743|12496813|FG003|NOT COMPLETED|Overall Study||0
11299116|NCT02550795|12496827|FG000|STARTED|Overall Study||50
11299117|NCT02550795|12496828|FG001|STARTED|Overall Study||50
11299118|NCT02550795|12496829|FG002|STARTED|Overall Study||50
11299119|NCT02550795|12496827|FG000|COMPLETED|Overall Study||50
11299120|NCT02550795|12496828|FG001|COMPLETED|Overall Study||49
11299121|NCT02550795|12496829|FG002|COMPLETED|Overall Study||50
11299122|NCT02550795|12496827|FG000|NOT COMPLETED|Overall Study||0
11299123|NCT02550795|12496828|FG001|NOT COMPLETED|Overall Study||1
11299124|NCT02550795|12496829|FG002|NOT COMPLETED|Overall Study||0
11299125|NCT02550938|12496841|FG000|STARTED|Overall Study||44
11299126|NCT02550938|12496842|FG001|STARTED|Overall Study||85
11299127|NCT02550938|12496843|FG002|STARTED|Overall Study||43
11299128|NCT02550938|12496844|FG003|STARTED|Overall Study||81
11299129|NCT02550938|12496841|FG000|COMPLETED|Overall Study||36
11299130|NCT02550938|12496842|FG001|COMPLETED|Overall Study||78
11299131|NCT02550938|12496843|FG002|COMPLETED|Overall Study||31
11299132|NCT02550938|12496844|FG003|COMPLETED|Overall Study||70
11299133|NCT02550938|12496841|FG000|NOT COMPLETED|Overall Study||8
11299134|NCT02550938|12496842|FG001|NOT COMPLETED|Overall Study||7
11299135|NCT02550938|12496843|FG002|NOT COMPLETED|Overall Study||12
11299136|NCT02550938|12496844|FG003|NOT COMPLETED|Overall Study||11
11299137|NCT02551055|12496861|FG000|STARTED|Overall Study||4
11299138|NCT02551055|12496862|FG001|STARTED|Overall Study||6
11299139|NCT02551055|12496863|FG002|STARTED|Overall Study||3
11299140|NCT02551055|12496864|FG003|STARTED|Overall Study||6
11299141|NCT02551055|12496865|FG004|STARTED|Overall Study||7
11299142|NCT02551055|12496866|FG005|STARTED|Overall Study||2
11299143|NCT02551055|12496867|FG006|STARTED|Overall Study||4
11299144|NCT02551055|12496868|FG007|STARTED|Overall Study||0
11299145|NCT02551055|12496861|FG000|COMPLETED|Overall Study||0
11299146|NCT02551055|12496862|FG001|COMPLETED|Overall Study||0
11299147|NCT02551055|12496863|FG002|COMPLETED|Overall Study||1
11299148|NCT02551055|12496864|FG003|COMPLETED|Overall Study||1
11400947|NCT04150250|12595688|FG000|NOT COMPLETED|Overall Study||0
11299149|NCT02551055|12496865|FG004|COMPLETED|Overall Study||0
11299150|NCT02551055|12496866|FG005|COMPLETED|Overall Study||1
11299151|NCT02551055|12496867|FG006|COMPLETED|Overall Study||1
11299152|NCT02551055|12496868|FG007|COMPLETED|Overall Study||0
11299153|NCT02551055|12496861|FG000|NOT COMPLETED|Overall Study||4
11299154|NCT02551055|12496862|FG001|NOT COMPLETED|Overall Study||6
11299155|NCT02551055|12496863|FG002|NOT COMPLETED|Overall Study||2
11299156|NCT02551055|12496864|FG003|NOT COMPLETED|Overall Study||5
11299157|NCT02551055|12496865|FG004|NOT COMPLETED|Overall Study||7
11299158|NCT02551055|12496866|FG005|NOT COMPLETED|Overall Study||1
11299159|NCT02551055|12496867|FG006|NOT COMPLETED|Overall Study||3
11299160|NCT02551055|12496868|FG007|NOT COMPLETED|Overall Study||0
11299161|NCT02551094|12496888|FG000|STARTED|Overall Study||2366
11299162|NCT02551094|12496889|FG001|STARTED|Overall Study||2379
11299163|NCT02551094|12496888|FG000|COMPLETED|Overall Study||2226
11299164|NCT02551094|12496889|FG001|COMPLETED|Overall Study||2232
11299165|NCT02551094|12496888|FG000|NOT COMPLETED|Overall Study||140
11299166|NCT02551094|12496889|FG001|NOT COMPLETED|Overall Study||147
11299167|NCT02551159|12496898|FG000|STARTED|Overall Study||413
11299168|NCT02551159|12496899|FG001|STARTED|Overall Study||204
11299169|NCT02551159|12496900|FG002|STARTED|Overall Study||206
11299170|NCT02551159|12496898|FG000|Full Analysis Set|Overall Study||413
11299171|NCT02551159|12496899|FG001|Full Analysis Set|Overall Study||204
11299172|NCT02551159|12496900|FG002|Full Analysis Set|Overall Study||206
11299173|NCT02551159|12496898|FG000|Safety Analysis Set|Overall Study||408
11299174|NCT02551159|12496899|FG001|Safety Analysis Set|Overall Study||202
11299175|NCT02551159|12496900|FG002|Safety Analysis Set|Overall Study||196
11299176|NCT02551159|12496898|FG000|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||190
11299177|NCT02551159|12496899|FG001|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||99
11299178|NCT02551159|12496900|FG002|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||94
11299179|NCT02551159|12496898|FG000|COMPLETED|Overall Study||0
11299180|NCT02551159|12496899|FG001|COMPLETED|Overall Study||0
11299181|NCT02551159|12496900|FG002|COMPLETED|Overall Study||0
11299182|NCT02551159|12496898|FG000|NOT COMPLETED|Overall Study||413
11299183|NCT02551159|12496899|FG001|NOT COMPLETED|Overall Study||204
11299184|NCT02551159|12496900|FG002|NOT COMPLETED|Overall Study||206
11299185|NCT02551224|12496908|FG000|STARTED|First Intervention||50
11400948|NCT04150250|12595689|FG001|NOT COMPLETED|Overall Study||2
11400949|NCT04149925|12595697|FG000|STARTED|Overall Study||30
11400950|NCT04149925|12595698|FG001|STARTED|Overall Study||30
11299186|NCT02551224|12496909|FG001|STARTED|First Intervention||50
11299187|NCT02551224|12496908|FG000|COMPLETED|First Intervention||50
11299188|NCT02551224|12496909|FG001|COMPLETED|First Intervention||50
11299189|NCT02551224|12496908|FG000|NOT COMPLETED|First Intervention||0
11299190|NCT02551224|12496909|FG001|NOT COMPLETED|First Intervention||0
11299191|NCT02551224|12496908|FG000|STARTED|Second Intervention (5 Min After First )||50
11299192|NCT02551224|12496909|FG001|STARTED|Second Intervention (5 Min After First )||50
11299193|NCT02551224|12496908|FG000|COMPLETED|Second Intervention (5 Min After First )||50
11299194|NCT02551224|12496909|FG001|COMPLETED|Second Intervention (5 Min After First )||50
11299195|NCT02551224|12496908|FG000|NOT COMPLETED|Second Intervention (5 Min After First )||0
11299196|NCT02551224|12496909|FG001|NOT COMPLETED|Second Intervention (5 Min After First )||0
11299197|NCT02551432|12496915|FG000|STARTED|Overall Study||26
11299198|NCT02551432|12496915|FG000|COMPLETED|Overall Study||26
11299199|NCT02551432|12496915|FG000|NOT COMPLETED|Overall Study||0
11299200|NCT02551653|12496921|FG000|STARTED|Overall Study||5
11299201|NCT02551653|12496922|FG001|STARTED|Overall Study||5
11299202|NCT02551653|12496921|FG000|COMPLETED|Overall Study||5
11299203|NCT02551653|12496922|FG001|COMPLETED|Overall Study||5
11299204|NCT02551653|12496921|FG000|NOT COMPLETED|Overall Study||0
11299205|NCT02551653|12496922|FG001|NOT COMPLETED|Overall Study||0
11299206|NCT02551666|12496930|FG000|STARTED|Overall Study||16
11299207|NCT02551666|12496931|FG001|STARTED|Overall Study||19
11299208|NCT02551666|12496930|FG000|COMPLETED|Overall Study||15
11299209|NCT02551666|12496931|FG001|COMPLETED|Overall Study||16
11299210|NCT02551666|12496930|FG000|NOT COMPLETED|Overall Study||1
11299211|NCT02551666|12496931|FG001|NOT COMPLETED|Overall Study||3
11299212|NCT02551692|12496940|FG000|STARTED|Overall Study||31
11299213|NCT02551692|12496941|FG001|STARTED|Overall Study||27
11299214|NCT02551692|12496942|FG002|STARTED|Overall Study||30
11299215|NCT02551692|12496940|FG000|COMPLETED|Overall Study||30
11299216|NCT02551692|12496941|FG001|COMPLETED|Overall Study||26
11299217|NCT02551692|12496942|FG002|COMPLETED|Overall Study||25
11299218|NCT02551692|12496940|FG000|NOT COMPLETED|Overall Study||1
11299219|NCT02551692|12496941|FG001|NOT COMPLETED|Overall Study||1
11299220|NCT02551692|12496942|FG002|NOT COMPLETED|Overall Study||5
11299221|NCT02551731|12496950|FG000|STARTED|Overall Study||9
11299222|NCT02551731|12496950|FG000|COMPLETED|Overall Study||7
11299223|NCT02551731|12496950|FG000|NOT COMPLETED|Overall Study||2
11299224|NCT02551744|12496956|FG000|STARTED|Overall Study||50
11299225|NCT02551744|12496957|FG001|STARTED|Overall Study||51
11299226|NCT02551744|12496956|FG000|COMPLETED|Overall Study||50
11299227|NCT02551744|12496957|FG001|COMPLETED|Overall Study||51
11299228|NCT02551744|12496956|FG000|NOT COMPLETED|Overall Study||0
11299229|NCT02551744|12496957|FG001|NOT COMPLETED|Overall Study||0
11299230|NCT02551757|12496965|FG000|STARTED|Overall Study||20
11299231|NCT02551757|12496966|FG001|STARTED|Overall Study||20
11299232|NCT02551757|12496965|FG000|COMPLETED|Overall Study||13
11299233|NCT02551757|12496966|FG001|COMPLETED|Overall Study||17
11299234|NCT02551757|12496965|FG000|NOT COMPLETED|Overall Study||7
11299235|NCT02551757|12496966|FG001|NOT COMPLETED|Overall Study||3
11299236|NCT02551770|12496976|FG000|STARTED|Overall Study||51
11299237|NCT02551770|12496977|FG001|STARTED|Overall Study||51
11299238|NCT02551770|12496976|FG000|COMPLETED|Overall Study||48
11299239|NCT02551770|12496977|FG001|COMPLETED|Overall Study||48
11299240|NCT02551770|12496976|FG000|NOT COMPLETED|Overall Study||3
11299241|NCT02551770|12496977|FG001|NOT COMPLETED|Overall Study||3
11299242|NCT02551809|12496985|FG000|STARTED|Overall Study||14
11299243|NCT02551809|12496986|FG001|STARTED|Overall Study||15
11299244|NCT02551809|12496987|FG002|STARTED|Overall Study||14
11299245|NCT02551809|12496985|FG000|COMPLETED|Overall Study||14
11299246|NCT02551809|12496986|FG001|COMPLETED|Overall Study||14
11299247|NCT02551809|12496987|FG002|COMPLETED|Overall Study||13
11299248|NCT02551809|12496985|FG000|NOT COMPLETED|Overall Study||0
11299249|NCT02551809|12496986|FG001|NOT COMPLETED|Overall Study||1
11299250|NCT02551809|12496987|FG002|NOT COMPLETED|Overall Study||1
11299251|NCT02551822|12496997|FG000|STARTED|Overall Study||11
11299252|NCT02551822|12496998|FG001|STARTED|Overall Study||12
11299253|NCT02551822|12496997|FG000|COMPLETED|Overall Study||9
11299254|NCT02551822|12496998|FG001|COMPLETED|Overall Study||10
11299255|NCT02551822|12496997|FG000|NOT COMPLETED|Overall Study||2
11299256|NCT02551822|12496998|FG001|NOT COMPLETED|Overall Study||2
11299257|NCT02551874|12497006|FG000|STARTED|Overall Study||324
11299258|NCT02551874|12497007|FG001|STARTED|Overall Study||326
11299259|NCT02551874|12497006|FG000|Received Treatment in Short-term Study|Overall Study||324
11299260|NCT02551874|12497007|FG001|Received Treatment in Short-term Study|Overall Study||319
11299261|NCT02551874|12497006|FG000|Entered Long-term Study|Overall Study||306
11299262|NCT02551874|12497007|FG001|Entered Long-term Study|Overall Study||294
11299263|NCT02551874|12497006|FG000|Received Treatment in Long-term Study|Overall Study||295
11299264|NCT02551874|12497007|FG001|Received Treatment in Long-term Study|Overall Study||284
11299265|NCT02551874|12497006|FG000|COMPLETED|Overall Study||296
11299266|NCT02551874|12497007|FG001|COMPLETED|Overall Study||287
11299267|NCT02551874|12497006|FG000|NOT COMPLETED|Overall Study||28
11299268|NCT02551874|12497007|FG001|NOT COMPLETED|Overall Study||39
11299269|NCT02551887|12497016|FG000|STARTED|Overall Study||301
11299270|NCT02551887|12497017|FG001|STARTED|Overall Study||124
11299271|NCT02551887|12497018|FG002|STARTED|Overall Study||222
11299272|NCT02551887|12497016|FG000|COMPLETED|Overall Study||301
11299273|NCT02551887|12497017|FG001|COMPLETED|Overall Study||124
11299274|NCT02551887|12497018|FG002|COMPLETED|Overall Study||222
11299275|NCT02551887|12497016|FG000|NOT COMPLETED|Overall Study||0
11299276|NCT02551887|12497017|FG001|NOT COMPLETED|Overall Study||0
11299277|NCT02551887|12497018|FG002|NOT COMPLETED|Overall Study||0
11299278|NCT02552121|12497034|FG000|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3
11299279|NCT02552121|12497035|FG001|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299280|NCT02552121|12497036|FG002|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299281|NCT02552121|12497037|FG003|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299282|NCT02552121|12497038|FG004|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299283|NCT02552121|12497039|FG005|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299284|NCT02552121|12497040|FG006|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299285|NCT02552121|12497041|FG007|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299286|NCT02552121|12497034|FG000|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299287|NCT02552121|12497035|FG001|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299288|NCT02552121|12497036|FG002|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299289|NCT02552121|12497037|FG003|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299290|NCT02552121|12497038|FG004|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299291|NCT02552121|12497039|FG005|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299292|NCT02552121|12497040|FG006|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299293|NCT02552121|12497041|FG007|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299294|NCT02552121|12497034|FG000|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3
11299295|NCT02552121|12497035|FG001|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299296|NCT02552121|12497036|FG002|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299297|NCT02552121|12497037|FG003|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299298|NCT02552121|12497038|FG004|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299299|NCT02552121|12497039|FG005|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299300|NCT02552121|12497040|FG006|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299301|NCT02552121|12497041|FG007|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
11299302|NCT02552121|12497034|FG000|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
11299303|NCT02552121|12497035|FG001|STARTED|Part 1: Dose Level 2 (Week 17-48)||6
11299304|NCT02552121|12497036|FG002|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
11299305|NCT02552121|12497037|FG003|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
11299306|NCT02552121|12497038|FG004|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
11299307|NCT02552121|12497039|FG005|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
11299308|NCT02552121|12497040|FG006|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
11299309|NCT02552121|12497041|FG007|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
11299310|NCT02552121|12497034|FG000|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299311|NCT02552121|12497035|FG001|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299312|NCT02552121|12497036|FG002|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299313|NCT02552121|12497037|FG003|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299314|NCT02552121|12497038|FG004|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299315|NCT02552121|12497039|FG005|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299316|NCT02552121|12497040|FG006|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299317|NCT02552121|12497041|FG007|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299318|NCT02552121|12497034|FG000|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299319|NCT02552121|12497035|FG001|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6
11299320|NCT02552121|12497036|FG002|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299321|NCT02552121|12497037|FG003|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299322|NCT02552121|12497038|FG004|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299323|NCT02552121|12497039|FG005|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299324|NCT02552121|12497040|FG006|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299325|NCT02552121|12497041|FG007|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
11299326|NCT02552121|12497034|FG000|STARTED|Part 2: Cohort Expansion||0
11299327|NCT02552121|12497035|FG001|STARTED|Part 2: Cohort Expansion||0
11299328|NCT02552121|12497036|FG002|STARTED|Part 2: Cohort Expansion||11
11299329|NCT02552121|12497037|FG003|STARTED|Part 2: Cohort Expansion||3
11299330|NCT02552121|12497038|FG004|STARTED|Part 2: Cohort Expansion||1
11299331|NCT02552121|12497039|FG005|STARTED|Part 2: Cohort Expansion||5
11299332|NCT02552121|12497040|FG006|STARTED|Part 2: Cohort Expansion||1
11299333|NCT02552121|12497041|FG007|STARTED|Part 2: Cohort Expansion||3
11299334|NCT02552121|12497034|FG000|COMPLETED|Part 2: Cohort Expansion||0
11299335|NCT02552121|12497035|FG001|COMPLETED|Part 2: Cohort Expansion||0
11299336|NCT02552121|12497036|FG002|COMPLETED|Part 2: Cohort Expansion||0
11299337|NCT02552121|12497037|FG003|COMPLETED|Part 2: Cohort Expansion||0
11299338|NCT02552121|12497038|FG004|COMPLETED|Part 2: Cohort Expansion||0
11299339|NCT02552121|12497039|FG005|COMPLETED|Part 2: Cohort Expansion||1
11299340|NCT02552121|12497040|FG006|COMPLETED|Part 2: Cohort Expansion||0
11299341|NCT02552121|12497041|FG007|COMPLETED|Part 2: Cohort Expansion||0
11021934|NCT00806598|12200123|FG000|COMPLETED|Overall Study||48
11021935|NCT00806598|12200123|FG000|NOT COMPLETED|Overall Study||0
11021936|NCT00806624|12200130|FG000|STARTED|Overall Study||79
11299342|NCT02552121|12497034|FG000|NOT COMPLETED|Part 2: Cohort Expansion||0
11299343|NCT02552121|12497035|FG001|NOT COMPLETED|Part 2: Cohort Expansion||0
11299344|NCT02552121|12497036|FG002|NOT COMPLETED|Part 2: Cohort Expansion||11
11299345|NCT02552121|12497037|FG003|NOT COMPLETED|Part 2: Cohort Expansion||3
11299346|NCT02552121|12497038|FG004|NOT COMPLETED|Part 2: Cohort Expansion||1
11299347|NCT02552121|12497039|FG005|NOT COMPLETED|Part 2: Cohort Expansion||4
11299348|NCT02552121|12497040|FG006|NOT COMPLETED|Part 2: Cohort Expansion||1
11299349|NCT02552121|12497041|FG007|NOT COMPLETED|Part 2: Cohort Expansion||3
11299350|NCT02552147|12497073|FG000|STARTED|First Intervention (7 Days)||4
11299351|NCT02552147|12497074|FG001|STARTED|First Intervention (7 Days)||4
11299352|NCT02552147|12497073|FG000|COMPLETED|First Intervention (7 Days)||3
11299353|NCT02552147|12497074|FG001|COMPLETED|First Intervention (7 Days)||4
11299354|NCT02552147|12497073|FG000|NOT COMPLETED|First Intervention (7 Days)||1
11299355|NCT02552147|12497074|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11299356|NCT02552147|12497073|FG000|STARTED|Washout (7 Days)||3
11299357|NCT02552147|12497074|FG001|STARTED|Washout (7 Days)||4
11299358|NCT02552147|12497073|FG000|COMPLETED|Washout (7 Days)||3
11299359|NCT02552147|12497074|FG001|COMPLETED|Washout (7 Days)||4
11299360|NCT02552147|12497073|FG000|NOT COMPLETED|Washout (7 Days)||0
11299361|NCT02552147|12497074|FG001|NOT COMPLETED|Washout (7 Days)||0
11299362|NCT02552147|12497073|FG000|STARTED|Second Intervention (7 Days)||3
11299363|NCT02552147|12497074|FG001|STARTED|Second Intervention (7 Days)||4
11299364|NCT02552147|12497073|FG000|COMPLETED|Second Intervention (7 Days)||1
11299365|NCT02552147|12497074|FG001|COMPLETED|Second Intervention (7 Days)||4
11299366|NCT02552147|12497073|FG000|NOT COMPLETED|Second Intervention (7 Days)||2
11299367|NCT02552147|12497074|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11299368|NCT02552225|12497082|FG000|STARTED|Overall Study||3
11299369|NCT02552225|12497083|FG001|STARTED|Overall Study||3
11299370|NCT02552225|12497082|FG000|COMPLETED|Overall Study||2
11299371|NCT02552225|12497083|FG001|COMPLETED|Overall Study||3
11299372|NCT02552225|12497082|FG000|NOT COMPLETED|Overall Study||1
11299373|NCT02552225|12497083|FG001|NOT COMPLETED|Overall Study||0
11299374|NCT02552238|12497089|FG000|STARTED|Overall Study||174
11299375|NCT02552238|12497089|FG000|COMPLETED|Overall Study|Of the 174 subjects enrolled in the study, 2 withdrew consent prior to administration of investigational product and 2 discontinued due to post-dose adverse event. Therefore, 170 subjects completed the study.|170
11299376|NCT02552238|12497089|FG000|NOT COMPLETED|Overall Study||4
11341406|NCT02932904|12538777|FG001|NOT COMPLETED|Overall Study||18
11341407|NCT02932904|12538778|FG002|NOT COMPLETED|Overall Study||23
11341408|NCT02932904|12538779|FG003|NOT COMPLETED|Overall Study||14
11341409|NCT02932943|12538794|FG000|STARTED|Overall Study||227
11341410|NCT02932943|12538795|FG001|STARTED|Overall Study||231
11341411|NCT02932943|12538794|FG000|COMPLETED|Overall Study||222
11341412|NCT02932943|12538795|FG001|COMPLETED|Overall Study||224
11341413|NCT02932943|12538794|FG000|NOT COMPLETED|Overall Study||5
11341414|NCT02932943|12538795|FG001|NOT COMPLETED|Overall Study||7
11341415|NCT02933034|12538801|FG000|STARTED|Overall Study||33
11341416|NCT02933034|12538801|FG000|Received Both MEMRI and DEMRI Scans|Overall Study||24
11341417|NCT02933034|12538801|FG000|COMPLETED|Overall Study||24
11341418|NCT02933034|12538801|FG000|NOT COMPLETED|Overall Study||9
11341419|NCT02933060|12538807|FG000|STARTED|Overall Study||25
11341420|NCT02933060|12538808|FG001|STARTED|Overall Study||25
11341421|NCT02933060|12538807|FG000|COMPLETED|Overall Study||25
11341422|NCT02933060|12538808|FG001|COMPLETED|Overall Study||24
11341423|NCT02933060|12538807|FG000|NOT COMPLETED|Overall Study||0
11341424|NCT02933060|12538808|FG001|NOT COMPLETED|Overall Study||1
11341425|NCT02933320|12538818|FG000|STARTED|Overall Study||13
11341426|NCT02933320|12538819|FG001|STARTED|Overall Study||1
11341427|NCT02933320|12538820|FG002|STARTED|Overall Study|Trial terminated early|0
11299377|NCT02552303|12497104|FG000|STARTED|Allocation||10
11299378|NCT02552303|12497105|FG001|STARTED|Allocation||10
11299379|NCT02552303|12497106|FG002|STARTED|Allocation||8
11299380|NCT02552303|12497107|FG003|STARTED|Allocation||11
11299381|NCT02552303|12497104|FG000|COMPLETED|Allocation||7
11299382|NCT02552303|12497105|FG001|COMPLETED|Allocation||8
11299383|NCT02552303|12497106|FG002|COMPLETED|Allocation||7
11299384|NCT02552303|12497107|FG003|COMPLETED|Allocation||10
11299385|NCT02552303|12497104|FG000|NOT COMPLETED|Allocation||3
11299386|NCT02552303|12497105|FG001|NOT COMPLETED|Allocation||2
11299387|NCT02552303|12497106|FG002|NOT COMPLETED|Allocation||1
11299388|NCT02552303|12497107|FG003|NOT COMPLETED|Allocation||1
11299389|NCT02552303|12497104|FG000|STARTED|Follow-Up||7
11299390|NCT02552303|12497105|FG001|STARTED|Follow-Up||8
11299391|NCT02552303|12497106|FG002|STARTED|Follow-Up||7
11299392|NCT02552303|12497107|FG003|STARTED|Follow-Up||10
11299393|NCT02552303|12497104|FG000|COMPLETED|Follow-Up||7
11299394|NCT02552303|12497105|FG001|COMPLETED|Follow-Up||6
11299395|NCT02552303|12497106|FG002|COMPLETED|Follow-Up||6
11299396|NCT02552303|12497107|FG003|COMPLETED|Follow-Up||10
11299397|NCT02552303|12497104|FG000|NOT COMPLETED|Follow-Up||0
11299398|NCT02552303|12497105|FG001|NOT COMPLETED|Follow-Up||2
11299399|NCT02552303|12497106|FG002|NOT COMPLETED|Follow-Up||1
11299400|NCT02552303|12497107|FG003|NOT COMPLETED|Follow-Up||0
11299401|NCT02552316|12497117|FG000|STARTED|Overall Study||34
11299402|NCT02552316|12497117|FG000|COMPLETED|Overall Study||32
11299403|NCT02552316|12497117|FG000|NOT COMPLETED|Overall Study||2
11299404|NCT02552355|12497169|FG000|STARTED|Overall Study||14
11299405|NCT02552355|12497170|FG001|STARTED|Overall Study||13
11299406|NCT02552355|12497171|FG002|STARTED|Overall Study||14
11299407|NCT02552355|12497172|FG003|STARTED|Overall Study||15
11299408|NCT02552355|12497169|FG000|COMPLETED|Overall Study||14
11299409|NCT02552355|12497170|FG001|COMPLETED|Overall Study||11
11299410|NCT02552355|12497171|FG002|COMPLETED|Overall Study||12
11299411|NCT02552355|12497172|FG003|COMPLETED|Overall Study||14
11299412|NCT02552355|12497169|FG000|NOT COMPLETED|Overall Study||0
11299413|NCT02552355|12497170|FG001|NOT COMPLETED|Overall Study||2
11299414|NCT02552355|12497171|FG002|NOT COMPLETED|Overall Study||2
11299415|NCT02552355|12497172|FG003|NOT COMPLETED|Overall Study||1
11299416|NCT02552368|12497182|FG000|STARTED|Overall Study||23
11299417|NCT02552368|12497182|FG000|COMPLETED|Overall Study||10
11299418|NCT02552368|12497182|FG000|NOT COMPLETED|Overall Study||13
11299419|NCT02552732|12497187|FG000|STARTED|Overall Study||29
11299420|NCT02552732|12497187|FG000|Used Device|Overall Study||23
11299421|NCT02552732|12497187|FG000|Completed Week 1|Overall Study||21
11299422|NCT02552732|12497187|FG000|Completed Week 2|Overall Study||20
11299423|NCT02552732|12497187|FG000|Completed Week 3|Overall Study||19
11299424|NCT02552732|12497187|FG000|Completed Week 4|Overall Study||19
11299425|NCT02552732|12497187|FG000|Completed Day 1 and Day 31 Spirometry|Overall Study||12
11299426|NCT02552732|12497187|FG000|COMPLETED|Overall Study||19
11299427|NCT02552732|12497187|FG000|NOT COMPLETED|Overall Study||10
11299428|NCT02552810|12497194|FG000|STARTED|Overall Study||15
11299429|NCT02552810|12497195|FG001|STARTED|Overall Study||15
11299430|NCT02552810|12497194|FG000|COMPLETED|Overall Study||15
11299431|NCT02552810|12497195|FG001|COMPLETED|Overall Study||15
11299432|NCT02552810|12497194|FG000|NOT COMPLETED|Overall Study||0
11299433|NCT02552810|12497195|FG001|NOT COMPLETED|Overall Study||0
11299434|NCT02552888|12497203|FG000|STARTED|Overall Study|35 participants were enrolled.|35
11299435|NCT02552888|12497204|FG001|STARTED|Overall Study|35 participants were enrolled.|35
11299436|NCT02552888|12497203|FG000|COMPLETED|Overall Study|34 participants completed the study.|34
11299437|NCT02552888|12497204|FG001|COMPLETED|Overall Study|34 participants completed the study|34
11299438|NCT02552888|12497203|FG000|NOT COMPLETED|Overall Study||1
11299439|NCT02552888|12497204|FG001|NOT COMPLETED|Overall Study||1
11299440|NCT02552966|12497214|FG000|STARTED|Overall Study||20
11299441|NCT02552966|12497214|FG000|COMPLETED|Overall Study||15
11299442|NCT02552966|12497214|FG000|NOT COMPLETED|Overall Study||5
11299443|NCT02553135|12497218|FG000|STARTED|Overall Study||6
11299444|NCT02553135|12497218|FG000|COMPLETED|Overall Study||6
11299445|NCT02553135|12497218|FG000|NOT COMPLETED|Overall Study||0
11299446|NCT02553317|12497224|FG000|STARTED|Overall Treatment Period + Follow-up||72
11299447|NCT02553317|12497225|FG001|STARTED|Overall Treatment Period + Follow-up||73
11299448|NCT02553317|12497224|FG000|Received Study Drug|Overall Treatment Period + Follow-up||71
11299449|NCT02553317|12497225|FG001|Received Study Drug|Overall Treatment Period + Follow-up||73
11299450|NCT02553317|12497224|FG000|COMPLETED|Overall Treatment Period + Follow-up||58
11299451|NCT02553317|12497225|FG001|COMPLETED|Overall Treatment Period + Follow-up||50
11299452|NCT02553317|12497224|FG000|NOT COMPLETED|Overall Treatment Period + Follow-up||14
11299453|NCT02553317|12497225|FG001|NOT COMPLETED|Overall Treatment Period + Follow-up||23
11299454|NCT02553317|12497224|FG000|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71
11299455|NCT02553317|12497225|FG001|STARTED|Double-blind (DB) Treatment Period||73
11299456|NCT02553317|12497224|FG000|COMPLETED|Double-blind (DB) Treatment Period||68
11299457|NCT02553317|12497225|FG001|COMPLETED|Double-blind (DB) Treatment Period||65
11299458|NCT02553317|12497224|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||3
11299459|NCT02553317|12497225|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||8
11299460|NCT02553317|12497224|FG000|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2
11299461|NCT02553317|12497225|FG001|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26
11299462|NCT02553317|12497224|FG000|COMPLETED|Open-label (OL) Treatment Period||2
11299463|NCT02553317|12497225|FG001|COMPLETED|Open-label (OL) Treatment Period||22
11299464|NCT02553317|12497224|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||0
11299465|NCT02553317|12497225|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||4
11299466|NCT02553330|12497235|FG000|STARTED|Overall Study||12
11299467|NCT02553330|12497236|FG001|STARTED|Overall Study||39
11299468|NCT02553330|12497237|FG002|STARTED|Overall Study||39
11299469|NCT02553330|12497235|FG000|COMPLETED|Overall Study||7
11299470|NCT02553330|12497236|FG001|COMPLETED|Overall Study||0
11299471|NCT02553330|12497237|FG002|COMPLETED|Overall Study||2
11299472|NCT02553330|12497235|FG000|NOT COMPLETED|Overall Study||5
11299473|NCT02553330|12497236|FG001|NOT COMPLETED|Overall Study||39
11299474|NCT02553330|12497237|FG002|NOT COMPLETED|Overall Study||37
11299475|NCT02553395|12497248|FG000|STARTED|First Intervention||12
11299476|NCT02553395|12497249|FG001|STARTED|First Intervention||18
11299477|NCT02553395|12497248|FG000|COMPLETED|First Intervention||12
11299478|NCT02553395|12497249|FG001|COMPLETED|First Intervention||18
11299479|NCT02553395|12497248|FG000|NOT COMPLETED|First Intervention||0
11299480|NCT02553395|12497249|FG001|NOT COMPLETED|First Intervention||0
11299481|NCT02553395|12497248|FG000|STARTED|Second Intervention||12
11299482|NCT02553395|12497249|FG001|STARTED|Second Intervention||18
11299483|NCT02553395|12497248|FG000|COMPLETED|Second Intervention||12
11299484|NCT02553395|12497249|FG001|COMPLETED|Second Intervention||18
11299485|NCT02553395|12497248|FG000|NOT COMPLETED|Second Intervention||0
11299486|NCT02553395|12497249|FG001|NOT COMPLETED|Second Intervention||0
11299487|NCT02553421|12497258|FG000|STARTED|Overall Study||185
11299488|NCT02553421|12497259|FG001|STARTED|Overall Study||58
11299489|NCT02553421|12497258|FG000|COMPLETED|Overall Study||156
11299490|NCT02553421|12497259|FG001|COMPLETED|Overall Study||57
11299491|NCT02553421|12497258|FG000|NOT COMPLETED|Overall Study||29
11299492|NCT02553421|12497259|FG001|NOT COMPLETED|Overall Study||1
11299493|NCT02553499|12497280|FG000|STARTED|Overall Study||2
11299494|NCT02553499|12497281|FG001|STARTED|Overall Study||2
11299495|NCT02553499|12497282|FG002|STARTED|Overall Study||2
11299496|NCT02553499|12497283|FG003|STARTED|Overall Study||2
11299497|NCT02553499|12497284|FG004|STARTED|Overall Study||3
11299498|NCT02553499|12497285|FG005|STARTED|Overall Study||3
11299499|NCT02553499|12497286|FG006|STARTED|Overall Study||3
11299500|NCT02553499|12497287|FG007|STARTED|Overall Study||3
11299501|NCT02553499|12497288|FG008|STARTED|Overall Study||3
11299502|NCT02553499|12497289|FG009|STARTED|Overall Study||3
11299503|NCT02553499|12497290|FG010|STARTED|Overall Study||3
11299504|NCT02553499|12497291|FG011|STARTED|Overall Study||3
11299505|NCT02553499|12497292|FG012|STARTED|Overall Study||3
11299506|NCT02553499|12497293|FG013|STARTED|Overall Study||2
11299507|NCT02553499|12497280|FG000|COMPLETED|Overall Study||0
11299508|NCT02553499|12497281|FG001|COMPLETED|Overall Study||0
11299509|NCT02553499|12497282|FG002|COMPLETED|Overall Study||0
11299510|NCT02553499|12497283|FG003|COMPLETED|Overall Study||0
11299511|NCT02553499|12497284|FG004|COMPLETED|Overall Study||0
11299512|NCT02553499|12497285|FG005|COMPLETED|Overall Study||0
11299513|NCT02553499|12497286|FG006|COMPLETED|Overall Study||0
11299514|NCT02553499|12497287|FG007|COMPLETED|Overall Study||0
11299515|NCT02553499|12497288|FG008|COMPLETED|Overall Study||0
11299516|NCT02553499|12497289|FG009|COMPLETED|Overall Study||0
11299517|NCT02553499|12497290|FG010|COMPLETED|Overall Study||0
11299518|NCT02553499|12497291|FG011|COMPLETED|Overall Study||0
11299519|NCT02553499|12497292|FG012|COMPLETED|Overall Study||0
11299520|NCT02553499|12497293|FG013|COMPLETED|Overall Study||0
11299521|NCT02553499|12497280|FG000|NOT COMPLETED|Overall Study||2
11299522|NCT02553499|12497281|FG001|NOT COMPLETED|Overall Study||2
11299523|NCT02553499|12497282|FG002|NOT COMPLETED|Overall Study||2
11299524|NCT02553499|12497283|FG003|NOT COMPLETED|Overall Study||2
11299525|NCT02553499|12497284|FG004|NOT COMPLETED|Overall Study||3
11299526|NCT02553499|12497285|FG005|NOT COMPLETED|Overall Study||3
11299527|NCT02553499|12497286|FG006|NOT COMPLETED|Overall Study||3
11299528|NCT02553499|12497287|FG007|NOT COMPLETED|Overall Study||3
11299529|NCT02553499|12497288|FG008|NOT COMPLETED|Overall Study||3
11299530|NCT02553499|12497289|FG009|NOT COMPLETED|Overall Study||3
11299531|NCT02553499|12497290|FG010|NOT COMPLETED|Overall Study||3
11299532|NCT02553499|12497291|FG011|NOT COMPLETED|Overall Study||3
11299533|NCT02553499|12497292|FG012|NOT COMPLETED|Overall Study||3
11299534|NCT02553499|12497293|FG013|NOT COMPLETED|Overall Study||2
11299535|NCT02553512|12497324|FG000|STARTED|Overall Study||167
11299536|NCT02553512|12497324|FG000|COMPLETED|Overall Study||144
11299537|NCT02553512|12497324|FG000|NOT COMPLETED|Overall Study||23
11299538|NCT02553538|12497330|FG000|STARTED|Overall Study||792
11299539|NCT02553538|12497331|FG001|STARTED|Overall Study||820
11299540|NCT02553538|12497330|FG000|COMPLETED|Overall Study||605
11299541|NCT02553538|12497331|FG001|COMPLETED|Overall Study||764
11299542|NCT02553538|12497330|FG000|NOT COMPLETED|Overall Study||187
11299543|NCT02553538|12497331|FG001|NOT COMPLETED|Overall Study||56
11299544|NCT02553629|12497339|FG000|STARTED|Overall Study||53
11299545|NCT02553629|12497340|FG001|STARTED|Overall Study||56
11299546|NCT02553629|12497339|FG000|COMPLETED|Overall Study||50
11299547|NCT02553629|12497340|FG001|COMPLETED|Overall Study||50
11299548|NCT02553629|12497339|FG000|NOT COMPLETED|Overall Study||3
11299549|NCT02553629|12497340|FG001|NOT COMPLETED|Overall Study||6
11299550|NCT02553746|12497348|FG000|STARTED|Overall Study||80
11400951|NCT04149925|12595697|FG000|COMPLETED|Overall Study||30
11299551|NCT02553746|12497349|FG001|STARTED|Overall Study||66
11299552|NCT02553746|12497348|FG000|COMPLETED|Overall Study||77
11400952|NCT04149925|12595698|FG001|COMPLETED|Overall Study||30
11400953|NCT04149925|12595697|FG000|NOT COMPLETED|Overall Study||0
11400954|NCT04149925|12595698|FG001|NOT COMPLETED|Overall Study||0
11400955|NCT04150224|12595710|FG000|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
11400956|NCT04150224|12595711|FG001|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
11400957|NCT04150224|12595712|FG002|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
11400958|NCT04150224|12595713|FG003|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
11400959|NCT04150224|12595714|FG004|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
11400960|NCT04150224|12595715|FG005|STARTED|Overall Study|Period 2: Multple Dosing|10
11400961|NCT04150224|12595710|FG000|COMPLETED|Overall Study||10
11400962|NCT04150224|12595711|FG001|COMPLETED|Overall Study||10
11400963|NCT04150224|12595712|FG002|COMPLETED|Overall Study||10
11400964|NCT04150224|12595713|FG003|COMPLETED|Overall Study||10
11400965|NCT04150224|12595714|FG004|COMPLETED|Overall Study||10
11400966|NCT04150224|12595715|FG005|COMPLETED|Overall Study|Period 2: Multple Dosing|10
11400967|NCT04150224|12595710|FG000|NOT COMPLETED|Overall Study||0
11400968|NCT04150224|12595711|FG001|NOT COMPLETED|Overall Study||0
11400969|NCT04150224|12595712|FG002|NOT COMPLETED|Overall Study||0
11400970|NCT04150224|12595713|FG003|NOT COMPLETED|Overall Study||0
11400971|NCT04150224|12595714|FG004|NOT COMPLETED|Overall Study||0
11400972|NCT04150224|12595715|FG005|NOT COMPLETED|Overall Study||0
11400973|NCT04149405|12595742|FG000|STARTED|Overall Study||12
11400974|NCT04149405|12595743|FG001|STARTED|Overall Study||10
11400975|NCT04149405|12595744|FG002|STARTED|Overall Study||11
11400976|NCT04149405|12595745|FG003|STARTED|Overall Study||10
11400977|NCT04149405|12595742|FG000|COMPLETED|Overall Study||12
11400978|NCT04149405|12595743|FG001|COMPLETED|Overall Study||10
11400979|NCT04149405|12595744|FG002|COMPLETED|Overall Study||11
11400980|NCT04149405|12595745|FG003|COMPLETED|Overall Study||10
11400981|NCT04149405|12595742|FG000|NOT COMPLETED|Overall Study||0
11400982|NCT04149405|12595743|FG001|NOT COMPLETED|Overall Study||0
11400983|NCT04149405|12595744|FG002|NOT COMPLETED|Overall Study||0
11400984|NCT04149405|12595745|FG003|NOT COMPLETED|Overall Study||0
11400985|NCT04144088|12595764|FG000|STARTED|Overall Study||20
11400986|NCT04144088|12595765|FG001|STARTED|Overall Study||20
11400987|NCT04144088|12595766|FG002|STARTED|Overall Study||20
11400988|NCT04144088|12595764|FG000|COMPLETED|Overall Study||14
11400989|NCT04144088|12595765|FG001|COMPLETED|Overall Study||15
11400990|NCT04144088|12595766|FG002|COMPLETED|Overall Study||13
11400991|NCT04144088|12595764|FG000|NOT COMPLETED|Overall Study||6
11400992|NCT04144088|12595765|FG001|NOT COMPLETED|Overall Study||5
11400993|NCT04144088|12595766|FG002|NOT COMPLETED|Overall Study||7
11400994|NCT04149353|12595774|FG000|STARTED|Overall Study|The study was terminated for low recruitment before this subject's second imaging scan was due.|1
11400995|NCT04149353|12595774|FG000|COMPLETED|Overall Study||0
11400996|NCT04149353|12595774|FG000|NOT COMPLETED|Overall Study||1
11400997|NCT04137783|12595782|FG000|STARTED|Overall Study||7
11400998|NCT04137783|12595783|FG001|STARTED|Overall Study||10
11400999|NCT04137783|12595784|FG002|STARTED|Overall Study||22
11401000|NCT04137783|12595782|FG000|COMPLETED|Overall Study||7
11401001|NCT04137783|12595783|FG001|COMPLETED|Overall Study||10
11401002|NCT04137783|12595784|FG002|COMPLETED|Overall Study||22
11299553|NCT02553746|12497349|FG001|COMPLETED|Overall Study||64
11299554|NCT02553746|12497348|FG000|NOT COMPLETED|Overall Study||3
11299555|NCT02553746|12497349|FG001|NOT COMPLETED|Overall Study||2
11299556|NCT02553772|12497357|FG000|STARTED|Overall Study||120
11299557|NCT02553772|12497358|FG001|STARTED|Overall Study||122
11299558|NCT02553772|12497357|FG000|COMPLETED|Overall Study||114
11299559|NCT02553772|12497358|FG001|COMPLETED|Overall Study||116
11299560|NCT02553772|12497357|FG000|NOT COMPLETED|Overall Study||6
11299561|NCT02553772|12497358|FG001|NOT COMPLETED|Overall Study||6
11299562|NCT02553798|12497364|FG000|STARTED|Overall Study||564
11299563|NCT02553798|12497364|FG000|COMPLETED|Overall Study||226
11299564|NCT02553798|12497364|FG000|NOT COMPLETED|Overall Study||338
11299565|NCT02553928|12497370|FG000|STARTED|Overall Study||30
11299566|NCT02553928|12497371|FG001|STARTED|Overall Study||32
11299567|NCT02553928|12497370|FG000|COMPLETED|Overall Study||28
11299568|NCT02553928|12497371|FG001|COMPLETED|Overall Study||29
11299569|NCT02553928|12497370|FG000|NOT COMPLETED|Overall Study||2
11299570|NCT02553928|12497371|FG001|NOT COMPLETED|Overall Study||3
11299571|NCT02554019|12497381|FG000|STARTED|Overall Study||12
11299572|NCT02554019|12497382|FG001|STARTED|Overall Study||12
11299573|NCT02554019|12497383|FG002|STARTED|Overall Study||12
11299574|NCT02554019|12497381|FG000|COMPLETED|Overall Study||10
11299575|NCT02554019|12497382|FG001|COMPLETED|Overall Study||12
11299576|NCT02554019|12497383|FG002|COMPLETED|Overall Study||10
11401003|NCT04137783|12595782|FG000|NOT COMPLETED|Overall Study||0
11401004|NCT04137783|12595783|FG001|NOT COMPLETED|Overall Study||0
11401005|NCT04137783|12595784|FG002|NOT COMPLETED|Overall Study||0
11401006|NCT04136444|12595794|FG000|STARTED|Overall Study||3
11401007|NCT04136444|12595795|FG001|STARTED|Overall Study||9
11401008|NCT04136444|12595794|FG000|COMPLETED|Overall Study|The cohort was not completely recruited, as the study was stopped/terminated due to COVID-19.|3
11401009|NCT04136444|12595795|FG001|COMPLETED|Overall Study||8
11401010|NCT04136444|12595794|FG000|NOT COMPLETED|Overall Study||0
11299577|NCT02554019|12497381|FG000|NOT COMPLETED|Overall Study||2
11299578|NCT02554019|12497382|FG001|NOT COMPLETED|Overall Study||0
11299579|NCT02554019|12497383|FG002|NOT COMPLETED|Overall Study||2
11299580|NCT02554279|12497393|FG000|STARTED|Overall Study||311
11299581|NCT02554279|12497394|FG001|STARTED|Overall Study||309
11299582|NCT02554279|12497393|FG000|Treated|Overall Study||310
11299583|NCT02554279|12497394|FG001|Treated|Overall Study||309
11299584|NCT02554279|12497393|FG000|Completed Day 6 of Stimulation|Overall Study||308
11299585|NCT02554279|12497394|FG001|Completed Day 6 of Stimulation|Overall Study||309
11299586|NCT02554279|12497393|FG000|Received Trigger|Overall Study||293
11299587|NCT02554279|12497394|FG001|Received Trigger|Overall Study||307
11299588|NCT02554279|12497393|FG000|Completed Oocyte Retrieval|Overall Study||292
11299589|NCT02554279|12497394|FG001|Completed Oocyte Retrieval|Overall Study||306
11299590|NCT02554279|12497393|FG000|Completed Fresh Blastocyst Transfer|Overall Study||201
11299591|NCT02554279|12497394|FG001|Completed Fresh Blastocyst Transfer|Overall Study||191
11299592|NCT02554279|12497393|FG000|COMPLETED|Overall Study||279
11299593|NCT02554279|12497394|FG001|COMPLETED|Overall Study||291
11299594|NCT02554279|12497393|FG000|NOT COMPLETED|Overall Study||32
11299595|NCT02554279|12497394|FG001|NOT COMPLETED|Overall Study||18
11299596|NCT02554435|12497409|FG000|STARTED|Overall Study||20
11299597|NCT02554435|12497410|FG001|STARTED|Overall Study||20
11299598|NCT02554435|12497409|FG000|COMPLETED|Overall Study||14
11299599|NCT02554435|12497410|FG001|COMPLETED|Overall Study||19
11299600|NCT02554435|12497409|FG000|NOT COMPLETED|Overall Study||6
11299601|NCT02554435|12497410|FG001|NOT COMPLETED|Overall Study||1
11299602|NCT02554513|12497417|FG000|STARTED|First Treatment Phase (7 Weeks)||3
11299603|NCT02554513|12497418|FG001|STARTED|First Treatment Phase (7 Weeks)||3
11299604|NCT02554513|12497417|FG000|COMPLETED|First Treatment Phase (7 Weeks)||3
11299605|NCT02554513|12497418|FG001|COMPLETED|First Treatment Phase (7 Weeks)||2
11299606|NCT02554513|12497417|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
11299607|NCT02554513|12497418|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||1
11299608|NCT02554513|12497417|FG000|STARTED|Washout (2 Weeks)||3
11299609|NCT02554513|12497418|FG001|STARTED|Washout (2 Weeks)||2
11299610|NCT02554513|12497417|FG000|COMPLETED|Washout (2 Weeks)||3
11299611|NCT02554513|12497418|FG001|COMPLETED|Washout (2 Weeks)||2
11299612|NCT02554513|12497417|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11299613|NCT02554513|12497418|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11299614|NCT02554513|12497417|FG000|STARTED|Second Treatment Phase (7 Weeks)||3
11299615|NCT02554513|12497418|FG001|STARTED|Second Treatment Phase (7 Weeks)||2
11299616|NCT02554513|12497417|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||3
11299617|NCT02554513|12497418|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||2
11299618|NCT02554513|12497417|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
11299619|NCT02554513|12497418|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
11299620|NCT02554656|12497430|FG000|STARTED|Overall Study||89
11299621|NCT02554656|12497430|FG000|COMPLETED|Overall Study||86
11299622|NCT02554656|12497430|FG000|NOT COMPLETED|Overall Study||3
11299623|NCT02554682|12497444|FG000|STARTED|Overall Study||40
11299624|NCT02554682|12497445|FG001|STARTED|Overall Study||40
11299625|NCT02554682|12497446|FG002|STARTED|Overall Study||40
11299626|NCT02554682|12497447|FG003|STARTED|Overall Study||40
11299627|NCT02554682|12497448|FG004|STARTED|Overall Study||40
11299628|NCT02554682|12497449|FG005|STARTED|Overall Study||40
11299629|NCT02554682|12497450|FG006|STARTED|Overall Study||28
11299630|NCT02554682|12497451|FG007|STARTED|Overall Study||28
11299631|NCT02554682|12497452|FG008|STARTED|Overall Study||26
11299632|NCT02554682|12497453|FG009|STARTED|Overall Study||26
11299633|NCT02554682|12497444|FG000|COMPLETED|Overall Study||25
11299634|NCT02554682|12497445|FG001|COMPLETED|Overall Study||28
11299635|NCT02554682|12497446|FG002|COMPLETED|Overall Study||36
11299636|NCT02554682|12497447|FG003|COMPLETED|Overall Study||37
11299637|NCT02554682|12497448|FG004|COMPLETED|Overall Study||38
11299638|NCT02554682|12497449|FG005|COMPLETED|Overall Study||39
11299639|NCT02554682|12497450|FG006|COMPLETED|Overall Study||22
11299640|NCT02554682|12497451|FG007|COMPLETED|Overall Study||22
11299641|NCT02554682|12497452|FG008|COMPLETED|Overall Study||24
11299642|NCT02554682|12497453|FG009|COMPLETED|Overall Study||24
11299643|NCT02554682|12497444|FG000|NOT COMPLETED|Overall Study||15
11299644|NCT02554682|12497445|FG001|NOT COMPLETED|Overall Study||12
11299645|NCT02554682|12497446|FG002|NOT COMPLETED|Overall Study||4
11299646|NCT02554682|12497447|FG003|NOT COMPLETED|Overall Study||3
11299647|NCT02554682|12497448|FG004|NOT COMPLETED|Overall Study||2
11299648|NCT02554682|12497449|FG005|NOT COMPLETED|Overall Study||1
11299649|NCT02554682|12497450|FG006|NOT COMPLETED|Overall Study||6
11299650|NCT02554682|12497451|FG007|NOT COMPLETED|Overall Study||6
11299651|NCT02554682|12497452|FG008|NOT COMPLETED|Overall Study||2
11299652|NCT02554682|12497453|FG009|NOT COMPLETED|Overall Study||2
11299653|NCT02554721|12497483|FG000|STARTED|Overall Study||20
11299654|NCT02554721|12497484|FG001|STARTED|Overall Study||19
11299655|NCT02554721|12497485|FG002|STARTED|Overall Study||19
11299656|NCT02554721|12497486|FG003|STARTED|Overall Study||17
11299657|NCT02554721|12497487|FG004|STARTED|Overall Study||2
11299658|NCT02554721|12497483|FG000|COMPLETED|Overall Study||19
11299659|NCT02554721|12497484|FG001|COMPLETED|Overall Study||19
11299660|NCT02554721|12497485|FG002|COMPLETED|Overall Study||19
11299661|NCT02554721|12497486|FG003|COMPLETED|Overall Study||17
11299662|NCT02554721|12497487|FG004|COMPLETED|Overall Study||0
11299663|NCT02554721|12497483|FG000|NOT COMPLETED|Overall Study||1
11299664|NCT02554721|12497484|FG001|NOT COMPLETED|Overall Study||0
11299665|NCT02554721|12497485|FG002|NOT COMPLETED|Overall Study||0
11299666|NCT02554721|12497486|FG003|NOT COMPLETED|Overall Study||0
11299667|NCT02554721|12497487|FG004|NOT COMPLETED|Overall Study||2
11299668|NCT02554760|12497496|FG000|STARTED|Overall Study||9
11299669|NCT02554760|12497497|FG001|STARTED|Overall Study||10
11299670|NCT02554760|12497496|FG000|COMPLETED|Overall Study||9
11299671|NCT02554760|12497497|FG001|COMPLETED|Overall Study||10
11299672|NCT02554760|12497496|FG000|NOT COMPLETED|Overall Study||0
11299673|NCT02554760|12497497|FG001|NOT COMPLETED|Overall Study||0
11299674|NCT02554786|12497511|FG000|STARTED|Overall Study||445
11299675|NCT02554786|12497512|FG001|STARTED|Overall Study||439
11299676|NCT02554786|12497513|FG002|STARTED|Overall Study||442
11299677|NCT02554786|12497514|FG003|STARTED|Overall Study||444
11299678|NCT02554786|12497515|FG004|STARTED|Overall Study||446
11299679|NCT02554786|12497511|FG000|COMPLETED|Overall Study||410
11299680|NCT02554786|12497512|FG001|COMPLETED|Overall Study||413
11299681|NCT02554786|12497513|FG002|COMPLETED|Overall Study||412
11299682|NCT02554786|12497514|FG003|COMPLETED|Overall Study||403
11299683|NCT02554786|12497515|FG004|COMPLETED|Overall Study||416
11299684|NCT02554786|12497511|FG000|NOT COMPLETED|Overall Study||35
11299685|NCT02554786|12497512|FG001|NOT COMPLETED|Overall Study||26
11299686|NCT02554786|12497513|FG002|NOT COMPLETED|Overall Study||30
11299687|NCT02554786|12497514|FG003|NOT COMPLETED|Overall Study||41
11299688|NCT02554786|12497515|FG004|NOT COMPLETED|Overall Study||30
11299689|NCT02554799|12497533|FG000|STARTED|Overall Study||9
11299690|NCT02554799|12497534|FG001|STARTED|Overall Study||9
11299691|NCT02554799|12497533|FG000|COMPLETED|Overall Study||9
11299692|NCT02554799|12497534|FG001|COMPLETED|Overall Study||9
11299693|NCT02554799|12497533|FG000|NOT COMPLETED|Overall Study||0
11299694|NCT02554799|12497534|FG001|NOT COMPLETED|Overall Study||0
11299695|NCT02554877|12497544|FG000|STARTED|Overall Study||51
11299696|NCT02554877|12497545|FG001|STARTED|Overall Study||51
11299697|NCT02554877|12497546|FG002|STARTED|Overall Study||52
11299698|NCT02554877|12497547|FG003|STARTED|Overall Study||52
11299699|NCT02554877|12497544|FG000|COMPLETED|Overall Study||39
11299700|NCT02554877|12497545|FG001|COMPLETED|Overall Study||44
11299701|NCT02554877|12497546|FG002|COMPLETED|Overall Study||46
11299702|NCT02554877|12497547|FG003|COMPLETED|Overall Study||45
11299703|NCT02554877|12497544|FG000|NOT COMPLETED|Overall Study||12
11401011|NCT04136444|12595795|FG001|NOT COMPLETED|Overall Study||1
11401012|NCT04124536|12595812|FG000|STARTED|Overall Study||58
11401013|NCT04124536|12595813|FG001|STARTED|Overall Study||58
11401014|NCT04124536|12595814|FG002|STARTED|Overall Study||105
11401015|NCT04124536|12595815|FG003|STARTED|Overall Study||105
11401016|NCT04124536|12595816|FG004|STARTED|Overall Study||15
11401017|NCT04124536|12595812|FG000|COMPLETED|Overall Study||47
11401018|NCT04124536|12595813|FG001|COMPLETED|Overall Study||53
11401019|NCT04124536|12595814|FG002|COMPLETED|Overall Study||102
11401020|NCT04124536|12595815|FG003|COMPLETED|Overall Study||98
11401021|NCT04124536|12595816|FG004|COMPLETED|Overall Study||15
11401022|NCT04124536|12595812|FG000|NOT COMPLETED|Overall Study||11
11401023|NCT04124536|12595813|FG001|NOT COMPLETED|Overall Study||5
11401024|NCT04124536|12595814|FG002|NOT COMPLETED|Overall Study||3
11401025|NCT04124536|12595815|FG003|NOT COMPLETED|Overall Study||7
11401026|NCT04124536|12595816|FG004|NOT COMPLETED|Overall Study||0
11401027|NCT04147611|12595829|FG000|STARTED|Overall Study||9
11401028|NCT04147611|12595830|FG001|STARTED|Overall Study||13
11401029|NCT04147611|12595829|FG000|COMPLETED|Overall Study||9
11401030|NCT04147611|12595830|FG001|COMPLETED|Overall Study||12
11401031|NCT04147611|12595829|FG000|NOT COMPLETED|Overall Study||0
11401032|NCT04147611|12595830|FG001|NOT COMPLETED|Overall Study||1
11401033|NCT04147442|12595836|FG000|STARTED|Overall Study||20
11401034|NCT04147442|12595836|FG000|COMPLETED|Overall Study||20
11401035|NCT04147442|12595836|FG000|NOT COMPLETED|Overall Study||0
11401036|NCT04147455|12595850|FG000|STARTED|Overall Study||397
11401037|NCT04147455|12595851|FG001|STARTED|Overall Study||396
11401038|NCT04147455|12595850|FG000|COMPLETED|Overall Study||375
11401039|NCT04147455|12595851|FG001|COMPLETED|Overall Study||364
11401040|NCT04147455|12595850|FG000|NOT COMPLETED|Overall Study||22
11401041|NCT04147455|12595851|FG001|NOT COMPLETED|Overall Study||32
11401042|NCT04146272|12595861|FG000|STARTED|First Intervention||11
11401043|NCT04146272|12595862|FG001|STARTED|First Intervention||11
11401044|NCT04146272|12595863|FG002|STARTED|First Intervention||6
11401045|NCT04146272|12595864|FG003|STARTED|First Intervention||5
11401046|NCT04146272|12595861|FG000|COMPLETED|First Intervention||11
11401047|NCT04146272|12595862|FG001|COMPLETED|First Intervention||11
11401048|NCT04146272|12595863|FG002|COMPLETED|First Intervention||6
11401049|NCT04146272|12595864|FG003|COMPLETED|First Intervention||5
11401050|NCT04146272|12595861|FG000|NOT COMPLETED|First Intervention||0
11401051|NCT04146272|12595862|FG001|NOT COMPLETED|First Intervention||0
11401052|NCT04146272|12595863|FG002|NOT COMPLETED|First Intervention||0
11401053|NCT04146272|12595864|FG003|NOT COMPLETED|First Intervention||0
11401054|NCT04146272|12595861|FG000|STARTED|Second Intervention||11
11401055|NCT04146272|12595862|FG001|STARTED|Second Intervention||11
11401056|NCT04146272|12595863|FG002|STARTED|Second Intervention||6
11401057|NCT04146272|12595864|FG003|STARTED|Second Intervention||5
11401058|NCT04146272|12595861|FG000|COMPLETED|Second Intervention||11
11401059|NCT04146272|12595862|FG001|COMPLETED|Second Intervention||11
11401060|NCT04146272|12595863|FG002|COMPLETED|Second Intervention||6
11401061|NCT04146272|12595864|FG003|COMPLETED|Second Intervention||5
11401062|NCT04146272|12595861|FG000|NOT COMPLETED|Second Intervention||0
11299704|NCT02554877|12497545|FG001|NOT COMPLETED|Overall Study||7
11299705|NCT02554877|12497546|FG002|NOT COMPLETED|Overall Study||6
11299706|NCT02554877|12497547|FG003|NOT COMPLETED|Overall Study||7
11299707|NCT02554890|12497559|FG000|STARTED|Double-blind||444
11299708|NCT02554890|12497560|FG001|STARTED|Double-blind||443
11401063|NCT04146272|12595862|FG001|NOT COMPLETED|Second Intervention||0
11401064|NCT04146272|12595863|FG002|NOT COMPLETED|Second Intervention||0
11299709|NCT02554890|12497559|FG000|Treated Patients|Double-blind||436
11299710|NCT02554890|12497560|FG001|Treated Patients|Double-blind||439
11299711|NCT02554890|12497559|FG000|COMPLETED|Double-blind||348
11299712|NCT02554890|12497560|FG001|COMPLETED|Double-blind||352
11299713|NCT02554890|12497559|FG000|NOT COMPLETED|Double-blind||96
11299714|NCT02554890|12497560|FG001|NOT COMPLETED|Double-blind||91
11299715|NCT02554890|12497559|FG000|STARTED|Open-label||0
11299716|NCT02554890|12497560|FG001|STARTED|Open-label||887
11299717|NCT02554890|12497559|FG000|COMPLETED|Open-label||0
11299718|NCT02554890|12497560|FG001|COMPLETED|Open-label||835
11299719|NCT02554890|12497559|FG000|NOT COMPLETED|Open-label||0
11299720|NCT02554890|12497560|FG001|NOT COMPLETED|Open-label||52
11299721|NCT02554903|12497570|FG000|STARTED|Overall Study||28
11299722|NCT02554903|12497571|FG001|STARTED|Overall Study||29
11299723|NCT02554903|12497570|FG000|COMPLETED|Overall Study||24
11299724|NCT02554903|12497571|FG001|COMPLETED|Overall Study||24
11299725|NCT02554903|12497570|FG000|NOT COMPLETED|Overall Study||4
11299726|NCT02554903|12497571|FG001|NOT COMPLETED|Overall Study||5
11299727|NCT02554929|12497580|FG000|STARTED|Overall Study||46
11299728|NCT02554929|12497581|FG001|STARTED|Overall Study||44
11299729|NCT02554929|12497580|FG000|Per Protocol Received Intervention|Overall Study||44
11299730|NCT02554929|12497581|FG001|Per Protocol Received Intervention|Overall Study||36
11299731|NCT02554929|12497580|FG000|Per Protocol Post-Intervention|Overall Study||42
11299732|NCT02554929|12497581|FG001|Per Protocol Post-Intervention|Overall Study||36
11299733|NCT02554929|12497580|FG000|Per Protocol 6 Month Follow-up|Overall Study||40
11299734|NCT02554929|12497581|FG001|Per Protocol 6 Month Follow-up|Overall Study||32
11299735|NCT02554929|12497580|FG000|COMPLETED|Overall Study||40
11299736|NCT02554929|12497581|FG001|COMPLETED|Overall Study||32
11299737|NCT02554929|12497580|FG000|NOT COMPLETED|Overall Study||6
11299738|NCT02554929|12497581|FG001|NOT COMPLETED|Overall Study||12
11299739|NCT02554981|12497587|FG000|STARTED|Overall Study||51
11299740|NCT02554981|12497587|FG000|COMPLETED|Overall Study||46
11299741|NCT02554981|12497587|FG000|NOT COMPLETED|Overall Study||5
11299742|NCT02555098|12497591|FG000|STARTED|First Intervention||12
11299743|NCT02555098|12497592|FG001|STARTED|First Intervention||11
11299744|NCT02555098|12497591|FG000|COMPLETED|First Intervention||12
11299745|NCT02555098|12497592|FG001|COMPLETED|First Intervention||11
11299746|NCT02555098|12497591|FG000|NOT COMPLETED|First Intervention||0
11299747|NCT02555098|12497592|FG001|NOT COMPLETED|First Intervention||0
11299748|NCT02555098|12497591|FG000|STARTED|Second Intervention||12
11299749|NCT02555098|12497592|FG001|STARTED|Second Intervention||11
11299750|NCT02555098|12497591|FG000|COMPLETED|Second Intervention||12
11299751|NCT02555098|12497592|FG001|COMPLETED|Second Intervention||11
11299752|NCT02555098|12497591|FG000|NOT COMPLETED|Second Intervention||0
11299753|NCT02555098|12497592|FG001|NOT COMPLETED|Second Intervention||0
11299754|NCT02555215|12497602|FG000|STARTED|Overall Study||20
11299755|NCT02555215|12497602|FG000|COMPLETED|Overall Study||17
11299756|NCT02555215|12497602|FG000|NOT COMPLETED|Overall Study||3
11299757|NCT02555228|12497608|FG000|STARTED|Overall Study|20th August 2015|27
11299758|NCT02555228|12497609|FG001|STARTED|Overall Study|14th August 2015|27
11299759|NCT02555228|12497608|FG000|COMPLETED|Overall Study|19th November 2015|27
11299760|NCT02555228|12497609|FG001|COMPLETED|Overall Study|29th October 2015|27
11299761|NCT02555228|12497608|FG000|NOT COMPLETED|Overall Study||0
11299762|NCT02555228|12497609|FG001|NOT COMPLETED|Overall Study||0
11299763|NCT02555306|12497619|FG000|STARTED|Overall Study||3
11299764|NCT02555306|12497620|FG001|STARTED|Overall Study||3
11299765|NCT02555306|12497621|FG002|STARTED|Overall Study||3
11299766|NCT02555306|12497622|FG003|STARTED|Overall Study||3
11299767|NCT02555306|12497619|FG000|COMPLETED|Overall Study||3
11299768|NCT02555306|12497620|FG001|COMPLETED|Overall Study||3
11299769|NCT02555306|12497621|FG002|COMPLETED|Overall Study||3
11299770|NCT02555306|12497622|FG003|COMPLETED|Overall Study||3
11299771|NCT02555306|12497619|FG000|NOT COMPLETED|Overall Study||0
11299772|NCT02555306|12497620|FG001|NOT COMPLETED|Overall Study||0
11299773|NCT02555306|12497621|FG002|NOT COMPLETED|Overall Study||0
11299774|NCT02555306|12497622|FG003|NOT COMPLETED|Overall Study||0
11299775|NCT02555371|12497632|FG000|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306
11299776|NCT02555371|12497633|FG001|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
11299777|NCT02555371|12497634|FG002|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
11299778|NCT02555371|12497635|FG003|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
11299779|NCT02555371|12497636|FG004|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
11299780|NCT02555371|12497632|FG000|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295
11299781|NCT02555371|12497633|FG001|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
11299782|NCT02555371|12497634|FG002|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
11299783|NCT02555371|12497635|FG003|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
11299784|NCT02555371|12497636|FG004|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
11299785|NCT02555371|12497632|FG000|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11
11299786|NCT02555371|12497633|FG001|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
11299787|NCT02555371|12497634|FG002|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
11299788|NCT02555371|12497635|FG003|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
11299789|NCT02555371|12497636|FG004|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
11299790|NCT02555371|12497632|FG000|STARTED|Part C (DB Period: Up to 52W)||0
11299791|NCT02555371|12497633|FG001|STARTED|Part C (DB Period: Up to 52W)||151
11299792|NCT02555371|12497634|FG002|STARTED|Part C (DB Period: Up to 52W)||144
11299793|NCT02555371|12497635|FG003|STARTED|Part C (DB Period: Up to 52W)||0
11299794|NCT02555371|12497636|FG004|STARTED|Part C (DB Period: Up to 52W)||0
11299795|NCT02555371|12497632|FG000|COMPLETED|Part C (DB Period: Up to 52W)||0
11299796|NCT02555371|12497633|FG001|COMPLETED|Part C (DB Period: Up to 52W)||62
11299797|NCT02555371|12497634|FG002|COMPLETED|Part C (DB Period: Up to 52W)||96
11299798|NCT02555371|12497635|FG003|COMPLETED|Part C (DB Period: Up to 52W)||0
11401065|NCT04146272|12595864|FG003|NOT COMPLETED|Second Intervention||0
11401066|NCT04143945|12595883|FG000|STARTED|Treatment Period 1 (Day 1)||26
11299799|NCT02555371|12497636|FG004|COMPLETED|Part C (DB Period: Up to 52W)||0
11299800|NCT02555371|12497632|FG000|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
11299801|NCT02555371|12497633|FG001|NOT COMPLETED|Part C (DB Period: Up to 52W)||89
11299802|NCT02555371|12497634|FG002|NOT COMPLETED|Part C (DB Period: Up to 52W)||48
11299803|NCT02555371|12497635|FG003|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
11299804|NCT02555371|12497636|FG004|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
11299805|NCT02555371|12497632|FG000|STARTED|PartD(OL: 52W Post-randomization PartC)||0
11299806|NCT02555371|12497633|FG001|STARTED|PartD(OL: 52W Post-randomization PartC)||0
11299807|NCT02555371|12497634|FG002|STARTED|PartD(OL: 52W Post-randomization PartC)||0
11299808|NCT02555371|12497635|FG003|STARTED|PartD(OL: 52W Post-randomization PartC)||84
11299809|NCT02555371|12497636|FG004|STARTED|PartD(OL: 52W Post-randomization PartC)||45
11299810|NCT02555371|12497632|FG000|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
11299811|NCT02555371|12497633|FG001|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
11299812|NCT02555371|12497634|FG002|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
11299813|NCT02555371|12497635|FG003|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80
11299814|NCT02555371|12497636|FG004|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42
11299815|NCT02555371|12497632|FG000|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
11299816|NCT02555371|12497633|FG001|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
11299817|NCT02555371|12497634|FG002|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
11299818|NCT02555371|12497635|FG003|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4
11299819|NCT02555371|12497636|FG004|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3
11401067|NCT04143945|12595884|FG001|STARTED|Treatment Period 1 (Day 1)||26
11299820|NCT02555449|12497645|FG000|STARTED|Overall Study||6
11299821|NCT02555449|12497645|FG000|COMPLETED|Overall Study||6
11299822|NCT02555449|12497645|FG000|NOT COMPLETED|Overall Study||0
11299823|NCT02555618|12497651|FG000|STARTED|Overall Study||200
11299824|NCT02555618|12497652|FG001|STARTED|Overall Study||200
11299825|NCT02555618|12497651|FG000|COMPLETED|Overall Study||199
11299826|NCT02555618|12497652|FG001|COMPLETED|Overall Study||200
11299827|NCT02555618|12497651|FG000|NOT COMPLETED|Overall Study||1
11299828|NCT02555618|12497652|FG001|NOT COMPLETED|Overall Study||0
11299829|NCT02555631|12497658|FG000|STARTED|Overall Study||29
11299830|NCT02555631|12497658|FG000|COMPLETED|Overall Study||25
11299831|NCT02555631|12497658|FG000|NOT COMPLETED|Overall Study||4
11299832|NCT02555683|12497665|FG000|STARTED|Overall Study||301
11299833|NCT02555683|12497666|FG001|STARTED|Overall Study||295
11299834|NCT02555683|12497667|FG002|STARTED|Overall Study||298
11299835|NCT02555683|12497665|FG000|FAS/SAF: High Eosinophil Subpopulation|Overall Study||200
11299836|NCT02555683|12497666|FG001|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
11299837|NCT02555683|12497667|FG002|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
11299838|NCT02555683|12497665|FG000|FAS/SAF: Overall Population|Overall Study||299
11299839|NCT02555683|12497666|FG001|FAS/SAF: Overall Population|Overall Study||293
11299840|NCT02555683|12497667|FG002|FAS/SAF: Overall Population|Overall Study||298
11299841|NCT02555683|12497665|FG000|COMPLETED|Overall Study||282
11299842|NCT02555683|12497666|FG001|COMPLETED|Overall Study||278
11299843|NCT02555683|12497667|FG002|COMPLETED|Overall Study||269
11299844|NCT02555683|12497665|FG000|NOT COMPLETED|Overall Study||19
11299845|NCT02555683|12497666|FG001|NOT COMPLETED|Overall Study||17
11299846|NCT02555683|12497667|FG002|NOT COMPLETED|Overall Study||29
11299847|NCT02555722|12497677|FG000|STARTED|Lens Dispensed||60
11299848|NCT02555722|12497678|FG001|STARTED|Lens Dispensed||30
11299849|NCT02555722|12497677|FG000|COMPLETED|Lens Dispensed||60
11299850|NCT02555722|12497678|FG001|COMPLETED|Lens Dispensed||30
11299851|NCT02555722|12497677|FG000|NOT COMPLETED|Lens Dispensed||0
11299852|NCT02555722|12497678|FG001|NOT COMPLETED|Lens Dispensed||0
11299853|NCT02555722|12497677|FG000|STARTED|Week 1||60
11299854|NCT02555722|12497678|FG001|STARTED|Week 1||30
11299855|NCT02555722|12497677|FG000|COMPLETED|Week 1||60
11299856|NCT02555722|12497678|FG001|COMPLETED|Week 1||30
11299857|NCT02555722|12497677|FG000|NOT COMPLETED|Week 1||0
11299858|NCT02555722|12497678|FG001|NOT COMPLETED|Week 1||0
11299859|NCT02555722|12497677|FG000|STARTED|Week 2||60
11299860|NCT02555722|12497678|FG001|STARTED|Week 2||30
11401068|NCT04143945|12595885|FG002|STARTED|Treatment Period 1 (Day 1)||26
11299861|NCT02555722|12497677|FG000|COMPLETED|Week 2||59
11299862|NCT02555722|12497678|FG001|COMPLETED|Week 2||29
11299863|NCT02555722|12497677|FG000|NOT COMPLETED|Week 2||1
11299864|NCT02555722|12497678|FG001|NOT COMPLETED|Week 2||1
11299865|NCT02555722|12497677|FG000|STARTED|Month 1||59
11299866|NCT02555722|12497678|FG001|STARTED|Month 1||29
11299867|NCT02555722|12497677|FG000|COMPLETED|Month 1||58
11299868|NCT02555722|12497678|FG001|COMPLETED|Month 1||29
11299869|NCT02555722|12497677|FG000|NOT COMPLETED|Month 1||1
11299870|NCT02555722|12497678|FG001|NOT COMPLETED|Month 1||0
11299871|NCT02555722|12497677|FG000|STARTED|Month 2||58
11299872|NCT02555722|12497678|FG001|STARTED|Month 2||29
11299873|NCT02555722|12497677|FG000|COMPLETED|Month 2||54
11299874|NCT02555722|12497678|FG001|COMPLETED|Month 2||29
11299875|NCT02555722|12497677|FG000|NOT COMPLETED|Month 2||4
11299876|NCT02555722|12497678|FG001|NOT COMPLETED|Month 2||0
11299877|NCT02555722|12497677|FG000|STARTED|Month 3||54
11299878|NCT02555722|12497678|FG001|STARTED|Month 3||29
11299879|NCT02555722|12497677|FG000|COMPLETED|Month 3||54
11299880|NCT02555722|12497678|FG001|COMPLETED|Month 3||29
11299881|NCT02555722|12497677|FG000|NOT COMPLETED|Month 3||0
11299882|NCT02555722|12497678|FG001|NOT COMPLETED|Month 3||0
11299883|NCT02555878|12497709|FG000|STARTED|Overall Study||421
11299884|NCT02555878|12497710|FG001|STARTED|Overall Study||420
11299885|NCT02555878|12497709|FG000|Treated|Overall Study||404
11299886|NCT02555878|12497710|FG001|Treated|Overall Study||405
11299887|NCT02555878|12497709|FG000|COMPLETED|Overall Study||255
11299888|NCT02555878|12497710|FG001|COMPLETED|Overall Study||270
11299889|NCT02555878|12497709|FG000|NOT COMPLETED|Overall Study||166
11299890|NCT02555878|12497710|FG001|NOT COMPLETED|Overall Study||150
11299891|NCT02555930|12497716|FG000|STARTED|Overall Study||148
11299892|NCT02555930|12497716|FG000|COMPLETED|Overall Study||148
11299893|NCT02555930|12497716|FG000|NOT COMPLETED|Overall Study||0
11299894|NCT02556112|12497724|FG000|STARTED|Overall Study||40
11299895|NCT02556112|12497725|FG001|STARTED|Overall Study||40
11299896|NCT02556112|12497726|FG002|STARTED|Overall Study||42
11299897|NCT02556112|12497724|FG000|COMPLETED|Overall Study||30
11299898|NCT02556112|12497725|FG001|COMPLETED|Overall Study||23
11299899|NCT02556112|12497726|FG002|COMPLETED|Overall Study||30
11299900|NCT02556112|12497724|FG000|NOT COMPLETED|Overall Study||10
11299901|NCT02556112|12497725|FG001|NOT COMPLETED|Overall Study||17
11299902|NCT02556112|12497726|FG002|NOT COMPLETED|Overall Study||12
11299903|NCT02556138|12497735|FG000|STARTED|Overall Study||8
11299904|NCT02556138|12497735|FG000|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
11299905|NCT02556138|12497735|FG000|NOT COMPLETED|Overall Study||1
11299906|NCT02556177|12497741|FG000|STARTED|Overall Study||325
11299907|NCT02556177|12497742|FG001|STARTED|Overall Study||152
11299908|NCT02556177|12497741|FG000|COMPLETED|Overall Study||42
11299909|NCT02556177|12497742|FG001|COMPLETED|Overall Study||91
11299910|NCT02556177|12497741|FG000|NOT COMPLETED|Overall Study||283
11299911|NCT02556177|12497742|FG001|NOT COMPLETED|Overall Study||61
11299912|NCT02556203|12497750|FG000|STARTED|Overall Study||826
11299913|NCT02556203|12497751|FG001|STARTED|Overall Study||818
11299914|NCT02556203|12497750|FG000|Received Treatment|Overall Study||801
11299915|NCT02556203|12497751|FG001|Received Treatment|Overall Study||807
11299916|NCT02556203|12497750|FG000|COMPLETED|Overall Study||799
11299917|NCT02556203|12497751|FG001|COMPLETED|Overall Study||792
11299918|NCT02556203|12497750|FG000|NOT COMPLETED|Overall Study||27
11299919|NCT02556203|12497751|FG001|NOT COMPLETED|Overall Study||26
11299920|NCT02556255|12497757|FG000|STARTED|Overall Study||50
11299921|NCT02556255|12497757|FG000|COMPLETED|Overall Study||46
11299922|NCT02556255|12497757|FG000|NOT COMPLETED|Overall Study||4
11299923|NCT02556307|12497761|FG000|STARTED|Overall Study||270
11299924|NCT02556307|12497761|FG000|Treated|Overall Study||268
11299925|NCT02556307|12497761|FG000|COMPLETED|Overall Study||217
11299926|NCT02556307|12497761|FG000|NOT COMPLETED|Overall Study||53
11299927|NCT02556333|12497765|FG000|STARTED|Overall Study||1
11299928|NCT02556333|12497765|FG000|COMPLETED|Overall Study||1
11299929|NCT02556333|12497765|FG000|NOT COMPLETED|Overall Study||0
11299930|NCT02556554|12497772|FG000|STARTED|Overall Study||8
11299931|NCT02556554|12497773|FG001|STARTED|Overall Study||14
11299932|NCT02556554|12497774|FG002|STARTED|Overall Study||19
11299933|NCT02556554|12497775|FG003|STARTED|Overall Study||12
11299934|NCT02556554|12497776|FG004|STARTED|Overall Study||14
11299935|NCT02556554|12497772|FG000|COMPLETED|Overall Study||8
11299936|NCT02556554|12497773|FG001|COMPLETED|Overall Study||13
11299937|NCT02556554|12497774|FG002|COMPLETED|Overall Study||15
11299938|NCT02556554|12497775|FG003|COMPLETED|Overall Study||12
11299939|NCT02556554|12497776|FG004|COMPLETED|Overall Study||14
11299940|NCT02556554|12497772|FG000|NOT COMPLETED|Overall Study||0
11299941|NCT02556554|12497773|FG001|NOT COMPLETED|Overall Study||1
11299942|NCT02556554|12497774|FG002|NOT COMPLETED|Overall Study||4
11299943|NCT02556554|12497775|FG003|NOT COMPLETED|Overall Study||0
11299944|NCT02556554|12497776|FG004|NOT COMPLETED|Overall Study||0
11299945|NCT02556632|12497790|FG000|STARTED|Overall Study||64
11299946|NCT02556632|12497791|FG001|STARTED|Overall Study||65
11299947|NCT02556632|12497792|FG002|STARTED|Overall Study||62
11299948|NCT02556632|12497790|FG000|COMPLETED|Overall Study||59
11299949|NCT02556632|12497791|FG001|COMPLETED|Overall Study||59
11299950|NCT02556632|12497792|FG002|COMPLETED|Overall Study||53
11299951|NCT02556632|12497790|FG000|NOT COMPLETED|Overall Study||5
11299952|NCT02556632|12497791|FG001|NOT COMPLETED|Overall Study||6
11299953|NCT02556632|12497792|FG002|NOT COMPLETED|Overall Study||9
11299954|NCT02556775|12497804|FG000|STARTED|Overall Study||7
11299955|NCT02556775|12497805|FG001|STARTED|Overall Study||2
11299956|NCT02556775|12497806|FG002|STARTED|Overall Study||5
11299957|NCT02556775|12497807|FG003|STARTED|Overall Study||2
11299958|NCT02556775|12497804|FG000|COMPLETED|Overall Study||5
11299959|NCT02556775|12497805|FG001|COMPLETED|Overall Study||2
11299960|NCT02556775|12497806|FG002|COMPLETED|Overall Study||4
11299961|NCT02556775|12497807|FG003|COMPLETED|Overall Study||2
11299962|NCT02556775|12497804|FG000|NOT COMPLETED|Overall Study||2
11299963|NCT02556775|12497805|FG001|NOT COMPLETED|Overall Study||0
11299964|NCT02556775|12497806|FG002|NOT COMPLETED|Overall Study||1
11299965|NCT02556775|12497807|FG003|NOT COMPLETED|Overall Study||0
11299966|NCT02556788|12497821|FG000|STARTED|Overall Study||602
11299967|NCT02556788|12497822|FG001|STARTED|Overall Study||610
11299968|NCT02556788|12497821|FG000|COMPLETED|Overall Study||558
11299969|NCT02556788|12497822|FG001|COMPLETED|Overall Study||573
11299970|NCT02556788|12497821|FG000|NOT COMPLETED|Overall Study||44
11299971|NCT02556788|12497822|FG001|NOT COMPLETED|Overall Study||37
11299972|NCT02556801|12497832|FG000|STARTED|Overall Study||42
11299973|NCT02556801|12497833|FG001|STARTED|Overall Study||42
11299974|NCT02556801|12497834|FG002|STARTED|Overall Study||42
11299975|NCT02556801|12497835|FG003|STARTED|Overall Study||42
11299976|NCT02556801|12497832|FG000|COMPLETED|Overall Study||40
11299977|NCT02556801|12497833|FG001|COMPLETED|Overall Study||35
11299978|NCT02556801|12497834|FG002|COMPLETED|Overall Study||38
11299979|NCT02556801|12497835|FG003|COMPLETED|Overall Study||37
11299980|NCT02556801|12497832|FG000|NOT COMPLETED|Overall Study||2
11299981|NCT02556801|12497833|FG001|NOT COMPLETED|Overall Study||7
11299982|NCT02556801|12497834|FG002|NOT COMPLETED|Overall Study||4
11299983|NCT02556801|12497835|FG003|NOT COMPLETED|Overall Study||5
11299984|NCT02556918|12497847|FG000|STARTED|Overall Study||100
11299985|NCT02556918|12497848|FG001|STARTED|Overall Study||101
11299986|NCT02556918|12497847|FG000|COMPLETED|Overall Study||91
11299987|NCT02556918|12497848|FG001|COMPLETED|Overall Study||91
11299988|NCT02556918|12497847|FG000|NOT COMPLETED|Overall Study||9
11299989|NCT02556918|12497848|FG001|NOT COMPLETED|Overall Study||10
11299990|NCT02557035|12497857|FG000|STARTED|Overall Study||225
11299991|NCT02557035|12497858|FG001|STARTED|Overall Study||215
11299992|NCT02557035|12497857|FG000|COMPLETED|Overall Study||218
11299993|NCT02557035|12497858|FG001|COMPLETED|Overall Study||206
11299994|NCT02557035|12497857|FG000|NOT COMPLETED|Overall Study||7
11299995|NCT02557035|12497858|FG001|NOT COMPLETED|Overall Study||9
11299996|NCT02557100|12497867|FG000|STARTED|Single Blind Treatment Period||40
11299997|NCT02557100|12497868|FG001|STARTED|Single Blind Treatment Period||40
11299998|NCT02557100|12497869|FG002|STARTED|Single Blind Treatment Period||0
11299999|NCT02557100|12497867|FG000|COMPLETED|Single Blind Treatment Period||40
11300000|NCT02557100|12497868|FG001|COMPLETED|Single Blind Treatment Period||36
11300001|NCT02557100|12497869|FG002|COMPLETED|Single Blind Treatment Period||0
11300002|NCT02557100|12497867|FG000|NOT COMPLETED|Single Blind Treatment Period||0
11401069|NCT04143945|12595886|FG003|STARTED|Treatment Period 1 (Day 1)||26
11401070|NCT04143945|12595883|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
11401071|NCT04143945|12595884|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
11143832|NCT01474512|12330427|FG005|NOT COMPLETED|Post-Treatment Follow-Up||0
11300003|NCT02557100|12497868|FG001|NOT COMPLETED|Single Blind Treatment Period||4
11300004|NCT02557100|12497869|FG002|NOT COMPLETED|Single Blind Treatment Period||0
11300005|NCT02557100|12497867|FG000|STARTED|Transition to Open Label||40
11300006|NCT02557100|12497868|FG001|STARTED|Transition to Open Label||36
11300007|NCT02557100|12497869|FG002|STARTED|Transition to Open Label||0
11300008|NCT02557100|12497867|FG000|COMPLETED|Transition to Open Label||0
11300009|NCT02557100|12497868|FG001|COMPLETED|Transition to Open Label||0
11300010|NCT02557100|12497869|FG002|COMPLETED|Transition to Open Label||0
11300011|NCT02557100|12497867|FG000|NOT COMPLETED|Transition to Open Label||40
11300012|NCT02557100|12497868|FG001|NOT COMPLETED|Transition to Open Label||36
11300013|NCT02557100|12497869|FG002|NOT COMPLETED|Transition to Open Label||0
11300014|NCT02557100|12497867|FG000|STARTED|Cumulative Abatacept Period||0
11300015|NCT02557100|12497868|FG001|STARTED|Cumulative Abatacept Period||0
11300016|NCT02557100|12497869|FG002|STARTED|Cumulative Abatacept Period||76
11300017|NCT02557100|12497867|FG000|COMPLETED|Cumulative Abatacept Period||0
11300018|NCT02557100|12497868|FG001|COMPLETED|Cumulative Abatacept Period||0
11300019|NCT02557100|12497869|FG002|COMPLETED|Cumulative Abatacept Period||72
11300020|NCT02557100|12497867|FG000|NOT COMPLETED|Cumulative Abatacept Period||0
11300021|NCT02557100|12497868|FG001|NOT COMPLETED|Cumulative Abatacept Period||0
11300022|NCT02557100|12497869|FG002|NOT COMPLETED|Cumulative Abatacept Period||4
11300023|NCT02557178|12497879|FG000|STARTED|Overall Study||72
11300024|NCT02557178|12497880|FG001|STARTED|Overall Study||74
11300025|NCT02557178|12497879|FG000|COMPLETED|Overall Study||56
11300026|NCT02557178|12497880|FG001|COMPLETED|Overall Study||63
11300027|NCT02557178|12497879|FG000|NOT COMPLETED|Overall Study||16
11300028|NCT02557178|12497880|FG001|NOT COMPLETED|Overall Study||11
11300029|NCT02557399|12497888|FG000|STARTED|Overall Study||172
11300030|NCT02557399|12497889|FG001|STARTED|Overall Study||177
11300031|NCT02557399|12497888|FG000|COMPLETED|Overall Study||165
11300032|NCT02557399|12497889|FG001|COMPLETED|Overall Study||169
11300033|NCT02557399|12497888|FG000|NOT COMPLETED|Overall Study||7
11300034|NCT02557399|12497889|FG001|NOT COMPLETED|Overall Study||8
11300035|NCT02557516|12497902|FG000|STARTED|Overall Study||3
11300036|NCT02557516|12497903|FG001|STARTED|Overall Study||6
11300037|NCT02557516|12497904|FG002|STARTED|Overall Study||4
11300038|NCT02557516|12497905|FG003|STARTED|Overall Study||9
11300039|NCT02557516|12497902|FG000|COMPLETED|Overall Study||2
11300040|NCT02557516|12497903|FG001|COMPLETED|Overall Study||1
11300041|NCT02557516|12497904|FG002|COMPLETED|Overall Study||0
11300042|NCT02557516|12497905|FG003|COMPLETED|Overall Study||0
11300043|NCT02557516|12497902|FG000|NOT COMPLETED|Overall Study||1
11300044|NCT02557516|12497903|FG001|NOT COMPLETED|Overall Study||5
11300045|NCT02557516|12497904|FG002|NOT COMPLETED|Overall Study||4
11300046|NCT02557516|12497905|FG003|NOT COMPLETED|Overall Study||9
11300047|NCT02557555|12497924|FG000|STARTED|Overall Study||100
11300048|NCT02557555|12497924|FG000|COMPLETED|Overall Study||100
11300049|NCT02557555|12497924|FG000|NOT COMPLETED|Overall Study||0
11300050|NCT02557646|12497929|FG000|STARTED|Overall Study||693
11300051|NCT02557646|12497929|FG000|COMPLETED|Overall Study||417
11300052|NCT02557646|12497929|FG000|NOT COMPLETED|Overall Study||276
11300053|NCT02557698|12497935|FG000|STARTED|Overall Study||30
11300054|NCT02557698|12497936|FG001|STARTED|Overall Study||30
11300055|NCT02557698|12497935|FG000|COMPLETED|Overall Study||30
11300056|NCT02557698|12497936|FG001|COMPLETED|Overall Study||30
11300057|NCT02557698|12497935|FG000|NOT COMPLETED|Overall Study||0
11300058|NCT02557698|12497936|FG001|NOT COMPLETED|Overall Study||0
11300059|NCT02558231|12497944|FG000|STARTED|Overall Study||123
11300060|NCT02558231|12497945|FG001|STARTED|Overall Study||124
11300061|NCT02558231|12497944|FG000|Treated|Overall Study||123
11300062|NCT02558231|12497945|FG001|Treated|Overall Study||123
11300063|NCT02558231|12497944|FG000|COMPLETED|Overall Study||98
11300064|NCT02558231|12497945|FG001|COMPLETED|Overall Study||98
11300065|NCT02558231|12497944|FG000|NOT COMPLETED|Overall Study||25
11300066|NCT02558231|12497945|FG001|NOT COMPLETED|Overall Study||26
11341428|NCT02933320|12538821|FG003|STARTED|Overall Study|Trial terminated early|0
11341429|NCT02933320|12538818|FG000|COMPLETED|Overall Study||13
11341430|NCT02933320|12538819|FG001|COMPLETED|Overall Study||1
11341431|NCT02933320|12538820|FG002|COMPLETED|Overall Study||0
11341432|NCT02933320|12538821|FG003|COMPLETED|Overall Study||0
11341433|NCT02933320|12538818|FG000|NOT COMPLETED|Overall Study||0
11341434|NCT02933320|12538819|FG001|NOT COMPLETED|Overall Study||0
11341435|NCT02933320|12538820|FG002|NOT COMPLETED|Overall Study||0
11341436|NCT02933320|12538821|FG003|NOT COMPLETED|Overall Study||0
11341437|NCT02933372|12538833|FG000|STARTED|Overall Study||15
11341438|NCT02933372|12538834|FG001|STARTED|Overall Study||10
11341439|NCT02933372|12538833|FG000|COMPLETED|Overall Study||15
11341440|NCT02933372|12538834|FG001|COMPLETED|Overall Study||10
11341441|NCT02933372|12538833|FG000|NOT COMPLETED|Overall Study||0
11341442|NCT02933372|12538834|FG001|NOT COMPLETED|Overall Study||0
11341443|NCT02933450|12538842|FG000|STARTED|Overall Study||20
11341444|NCT02933450|12538843|FG001|STARTED|Overall Study||23
11341445|NCT02933450|12538842|FG000|COMPLETED|Overall Study||15
11341446|NCT02933450|12538843|FG001|COMPLETED|Overall Study||15
11341447|NCT02933450|12538842|FG000|NOT COMPLETED|Overall Study||5
11341448|NCT02933450|12538843|FG001|NOT COMPLETED|Overall Study||8
11341449|NCT02933476|12538849|FG000|STARTED|Overall Study||5
11341450|NCT02933476|12538849|FG000|COMPLETED|Overall Study||5
11341451|NCT02933476|12538849|FG000|NOT COMPLETED|Overall Study||0
11341452|NCT02933502|12538853|FG000|STARTED|Overall Study||3
11341453|NCT02933502|12538853|FG000|COMPLETED|Overall Study||3
11341454|NCT02933502|12538853|FG000|NOT COMPLETED|Overall Study||0
11341455|NCT02933528|12538857|FG000|STARTED|Overall Study||24
11341456|NCT02933528|12538857|FG000|COMPLETED|Overall Study||22
11341457|NCT02933528|12538857|FG000|NOT COMPLETED|Overall Study||2
11341458|NCT02933866|12538863|FG000|STARTED|Overall Study||186
11341459|NCT02933866|12538864|FG001|STARTED|Overall Study||185
11341460|NCT02933866|12538863|FG000|COMPLETED|Overall Study||174
11341461|NCT02933866|12538864|FG001|COMPLETED|Overall Study||176
11341462|NCT02933866|12538863|FG000|NOT COMPLETED|Overall Study||12
11341463|NCT02933866|12538864|FG001|NOT COMPLETED|Overall Study||9
11341464|NCT02933879|12538873|FG000|STARTED|Overall Study||64
11341465|NCT02933879|12538874|FG001|STARTED|Overall Study||62
11341466|NCT02933879|12538875|FG002|STARTED|Overall Study||58
11341467|NCT02933879|12538873|FG000|COMPLETED|Overall Study||48
11341468|NCT02933879|12538874|FG001|COMPLETED|Overall Study||48
11341469|NCT02933879|12538875|FG002|COMPLETED|Overall Study||41
11341470|NCT02933879|12538873|FG000|NOT COMPLETED|Overall Study||16
11341471|NCT02933879|12538874|FG001|NOT COMPLETED|Overall Study||14
11341472|NCT02933879|12538875|FG002|NOT COMPLETED|Overall Study||17
11341473|NCT02934178|12538887|FG000|STARTED|Received Vaccination 1||12
11341474|NCT02934178|12538888|FG001|STARTED|Received Vaccination 1||4
11341475|NCT02934178|12538887|FG000|COMPLETED|Received Vaccination 1||12
11341476|NCT02934178|12538888|FG001|COMPLETED|Received Vaccination 1||4
11341477|NCT02934178|12538887|FG000|NOT COMPLETED|Received Vaccination 1||0
11341478|NCT02934178|12538888|FG001|NOT COMPLETED|Received Vaccination 1||0
11341479|NCT02934178|12538887|FG000|STARTED|Received Vaccination 2||12
11341480|NCT02934178|12538888|FG001|STARTED|Received Vaccination 2||4
11341481|NCT02934178|12538887|FG000|COMPLETED|Received Vaccination 2||12
11341482|NCT02934178|12538888|FG001|COMPLETED|Received Vaccination 2||3
11341483|NCT02934178|12538887|FG000|NOT COMPLETED|Received Vaccination 2||0
11341484|NCT02934178|12538888|FG001|NOT COMPLETED|Received Vaccination 2||1
11341485|NCT02934178|12538887|FG000|STARTED|Received Vaccination 3||12
11341486|NCT02934178|12538888|FG001|STARTED|Received Vaccination 3||3
11341487|NCT02934178|12538887|FG000|COMPLETED|Received Vaccination 3||11
11341488|NCT02934178|12538888|FG001|COMPLETED|Received Vaccination 3||3
11341489|NCT02934178|12538887|FG000|NOT COMPLETED|Received Vaccination 3||1
11341490|NCT02934178|12538888|FG001|NOT COMPLETED|Received Vaccination 3||0
11341491|NCT02934191|12538897|FG000|STARTED|Overall Study||87
11341492|NCT02934191|12538898|FG001|STARTED|Overall Study||85
11341493|NCT02934191|12538897|FG000|COMPLETED|Overall Study||87
11341494|NCT02934191|12538898|FG001|COMPLETED|Overall Study||85
11341495|NCT02934191|12538897|FG000|NOT COMPLETED|Overall Study||0
11341496|NCT02934191|12538898|FG001|NOT COMPLETED|Overall Study||0
11341497|NCT02934347|12538906|FG000|STARTED|Overall Study||374
11341498|NCT02934347|12538907|FG001|STARTED|Overall Study||407
11341499|NCT02934347|12538906|FG000|COMPLETED|Overall Study||374
11341500|NCT02934347|12538907|FG001|COMPLETED|Overall Study||407
11341501|NCT02934347|12538906|FG000|NOT COMPLETED|Overall Study||0
11341502|NCT02934347|12538907|FG001|NOT COMPLETED|Overall Study||0
11341503|NCT02934555|12538915|FG000|STARTED|Overall Study||23
11341504|NCT02934555|12538916|FG001|STARTED|Overall Study||25
11341505|NCT02934555|12538915|FG000|COMPLETED|Overall Study||21
11341506|NCT02934555|12538916|FG001|COMPLETED|Overall Study||22
11341507|NCT02934555|12538915|FG000|NOT COMPLETED|Overall Study||2
11341508|NCT02934555|12538916|FG001|NOT COMPLETED|Overall Study||3
11341509|NCT02934698|12538922|FG000|STARTED|Overall Study||2
11300067|NCT02558296|12497953|FG000|STARTED|Completed the Study Through Week 24||1133
11300068|NCT02558296|12497954|FG001|STARTED|Completed the Study Through Week 24||567
11300069|NCT02558296|12497953|FG000|COMPLETED|Completed the Study Through Week 24||1089
11300070|NCT02558296|12497954|FG001|COMPLETED|Completed the Study Through Week 24||542
11300071|NCT02558296|12497953|FG000|NOT COMPLETED|Completed the Study Through Week 24||44
11300072|NCT02558296|12497954|FG001|NOT COMPLETED|Completed the Study Through Week 24||25
11300073|NCT02558296|12497953|FG000|STARTED|Completed the Study||1133
11300074|NCT02558296|12497954|FG001|STARTED|Completed the Study||567
11300075|NCT02558296|12497953|FG000|COMPLETED|Completed the Study||987
11300076|NCT02558296|12497954|FG001|COMPLETED|Completed the Study||482
11300077|NCT02558296|12497953|FG000|NOT COMPLETED|Completed the Study||146
11300078|NCT02558296|12497954|FG001|NOT COMPLETED|Completed the Study||85
11300079|NCT02558374|12497966|FG000|STARTED|Overall Study||351
11300080|NCT02558374|12497967|FG001|STARTED|Overall Study||357
11300081|NCT02558374|12497966|FG000|COMPLETED|Overall Study||243
11300082|NCT02558374|12497967|FG001|COMPLETED|Overall Study||314
11300083|NCT02558374|12497966|FG000|NOT COMPLETED|Overall Study||108
11300084|NCT02558374|12497967|FG001|NOT COMPLETED|Overall Study||43
11300085|NCT02558400|12497976|FG000|STARTED|Overall Study||238
11300086|NCT02558400|12497977|FG001|STARTED|Overall Study||244
11300087|NCT02558400|12497978|FG002|STARTED|Overall Study||236
11300088|NCT02558400|12497976|FG000|COMPLETED|Overall Study||159
11300089|NCT02558400|12497977|FG001|COMPLETED|Overall Study||148
11300090|NCT02558400|12497978|FG002|COMPLETED|Overall Study||203
11300091|NCT02558400|12497976|FG000|NOT COMPLETED|Overall Study||79
11300092|NCT02558400|12497977|FG001|NOT COMPLETED|Overall Study||96
11300093|NCT02558400|12497978|FG002|NOT COMPLETED|Overall Study||33
11300094|NCT02558790|12497989|FG000|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
11300095|NCT02558790|12497989|FG000|Treated|Overall Study||15
11300096|NCT02558790|12497989|FG000|COMPLETED|Overall Study||13
11300097|NCT02558790|12497989|FG000|NOT COMPLETED|Overall Study||7
11300098|NCT02558829|12497997|FG000|STARTED|Overall Study||21
11300099|NCT02558829|12497998|FG001|STARTED|Overall Study||21
11300100|NCT02558829|12497999|FG002|STARTED|Overall Study||24
11300101|NCT02558829|12498000|FG003|STARTED|Overall Study||18
11300102|NCT02558829|12498001|FG004|STARTED|Overall Study||18
11300103|NCT02558829|12498002|FG005|STARTED|Overall Study||26
11300104|NCT02558829|12498003|FG006|STARTED|Overall Study||18
11300105|NCT02558829|12498004|FG007|STARTED|Overall Study||11
11300106|NCT02558829|12497997|FG000|COMPLETED|Overall Study||20
11300107|NCT02558829|12497998|FG001|COMPLETED|Overall Study||18
11300108|NCT02558829|12497999|FG002|COMPLETED|Overall Study||21
11300109|NCT02558829|12498000|FG003|COMPLETED|Overall Study||16
11300110|NCT02558829|12498001|FG004|COMPLETED|Overall Study||16
11300111|NCT02558829|12498002|FG005|COMPLETED|Overall Study||24
11300112|NCT02558829|12498003|FG006|COMPLETED|Overall Study||17
11300113|NCT02558829|12498004|FG007|COMPLETED|Overall Study||8
11300114|NCT02558829|12497997|FG000|NOT COMPLETED|Overall Study||1
11300115|NCT02558829|12497998|FG001|NOT COMPLETED|Overall Study||3
11300116|NCT02558829|12497999|FG002|NOT COMPLETED|Overall Study||3
11300117|NCT02558829|12498000|FG003|NOT COMPLETED|Overall Study||2
11300118|NCT02558829|12498001|FG004|NOT COMPLETED|Overall Study||2
11300119|NCT02558829|12498002|FG005|NOT COMPLETED|Overall Study||2
11300120|NCT02558829|12498003|FG006|NOT COMPLETED|Overall Study||1
11300121|NCT02558829|12498004|FG007|NOT COMPLETED|Overall Study||3
11300122|NCT02558894|12498028|FG000|STARTED|Overall Study||32
11300123|NCT02558894|12498029|FG001|STARTED|Overall Study||33
11300124|NCT02558894|12498028|FG000|Patients Who Received IP|Overall Study||32
11300125|NCT02558894|12498029|FG001|Patients Who Received IP|Overall Study||32
11300126|NCT02558894|12498028|FG000|COMPLETED|Overall Study||0
11300127|NCT02558894|12498029|FG001|COMPLETED|Overall Study||0
11300128|NCT02558894|12498028|FG000|NOT COMPLETED|Overall Study||32
11300129|NCT02558894|12498029|FG001|NOT COMPLETED|Overall Study||33
11300130|NCT02559115|12498035|FG000|STARTED|Overall Study||19
11300131|NCT02559115|12498035|FG000|COMPLETED|Overall Study||16
11300132|NCT02559115|12498035|FG000|NOT COMPLETED|Overall Study||3
11300133|NCT02559206|12498047|FG000|STARTED|Overall Study||66
11300134|NCT02559206|12498048|FG001|STARTED|Overall Study||66
11300135|NCT02559206|12498049|FG002|STARTED|Overall Study||67
11300136|NCT02559206|12498050|FG003|STARTED|Overall Study||67
11300137|NCT02559206|12498051|FG004|STARTED|Overall Study||67
11300138|NCT02559206|12498052|FG005|STARTED|Overall Study||67
11300139|NCT02559206|12498053|FG006|STARTED|Overall Study||66
11300140|NCT02559206|12498054|FG007|STARTED|Overall Study||66
11300141|NCT02559206|12498047|FG000|COMPLETED|Overall Study||58
11300142|NCT02559206|12498048|FG001|COMPLETED|Overall Study||54
11300143|NCT02559206|12498049|FG002|COMPLETED|Overall Study||58
11300144|NCT02559206|12498050|FG003|COMPLETED|Overall Study||53
11300145|NCT02559206|12498051|FG004|COMPLETED|Overall Study||55
11300146|NCT02559206|12498052|FG005|COMPLETED|Overall Study||53
11300147|NCT02559206|12498053|FG006|COMPLETED|Overall Study||60
11300148|NCT02559206|12498054|FG007|COMPLETED|Overall Study||57
11300149|NCT02559206|12498047|FG000|NOT COMPLETED|Overall Study||8
11300150|NCT02559206|12498048|FG001|NOT COMPLETED|Overall Study||12
11300151|NCT02559206|12498049|FG002|NOT COMPLETED|Overall Study||9
11300152|NCT02559206|12498050|FG003|NOT COMPLETED|Overall Study||14
11300153|NCT02559206|12498051|FG004|NOT COMPLETED|Overall Study||12
11300154|NCT02559206|12498052|FG005|NOT COMPLETED|Overall Study||14
11300155|NCT02559206|12498053|FG006|NOT COMPLETED|Overall Study||6
11300156|NCT02559206|12498054|FG007|NOT COMPLETED|Overall Study||9
11300157|NCT02559310|12498074|FG000|STARTED|Overall Study||276
11300158|NCT02559310|12498075|FG001|STARTED|Overall Study||275
11300159|NCT02559310|12498074|FG000|COMPLETED|Overall Study||249
11300160|NCT02559310|12498075|FG001|COMPLETED|Overall Study||256
11300161|NCT02559310|12498074|FG000|NOT COMPLETED|Overall Study||27
11300162|NCT02559310|12498075|FG001|NOT COMPLETED|Overall Study||19
11401072|NCT04143945|12595885|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
11401073|NCT04143945|12595886|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
11401074|NCT04143945|12595883|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
11300163|NCT02559414|12498084|FG000|STARTED|Overall Study||11
11300164|NCT02559414|12498085|FG001|STARTED|Overall Study||22
11300165|NCT02559414|12498086|FG002|STARTED|Overall Study||22
11300166|NCT02559414|12498084|FG000|COMPLETED|Overall Study||10
11300167|NCT02559414|12498085|FG001|COMPLETED|Overall Study||20
11300168|NCT02559414|12498086|FG002|COMPLETED|Overall Study||20
11300169|NCT02559414|12498084|FG000|NOT COMPLETED|Overall Study||1
11300170|NCT02559414|12498085|FG001|NOT COMPLETED|Overall Study||2
11300171|NCT02559414|12498086|FG002|NOT COMPLETED|Overall Study||2
11300172|NCT02559505|12498111|FG000|STARTED|Overall Study||49
11300173|NCT02559505|12498112|FG001|STARTED|Overall Study||84
11300174|NCT02559505|12498111|FG000|COMPLETED|Overall Study||22
11300175|NCT02559505|12498112|FG001|COMPLETED|Overall Study||62
11300176|NCT02559505|12498111|FG000|NOT COMPLETED|Overall Study||27
11300177|NCT02559505|12498112|FG001|NOT COMPLETED|Overall Study||22
11300178|NCT02559570|12498135|FG000|STARTED|Overall Study||41
11300179|NCT02559570|12498136|FG001|STARTED|Overall Study||36
11300180|NCT02559570|12498137|FG002|STARTED|Overall Study||41
11300181|NCT02559570|12498138|FG003|STARTED|Overall Study||39
11300182|NCT02559570|12498139|FG004|STARTED|Overall Study||16
11300183|NCT02559570|12498135|FG000|COMPLETED|Overall Study||39
11300184|NCT02559570|12498136|FG001|COMPLETED|Overall Study||34
11300185|NCT02559570|12498137|FG002|COMPLETED|Overall Study||39
11300186|NCT02559570|12498138|FG003|COMPLETED|Overall Study||36
11300187|NCT02559570|12498139|FG004|COMPLETED|Overall Study||14
11300188|NCT02559570|12498135|FG000|NOT COMPLETED|Overall Study||2
11300189|NCT02559570|12498136|FG001|NOT COMPLETED|Overall Study||2
11300190|NCT02559570|12498137|FG002|NOT COMPLETED|Overall Study||2
11300191|NCT02559570|12498138|FG003|NOT COMPLETED|Overall Study||3
11300192|NCT02559570|12498139|FG004|NOT COMPLETED|Overall Study||2
11300193|NCT02559622|12498154|FG000|STARTED|Overall Study||48
11300194|NCT02559622|12498155|FG001|STARTED|Overall Study||54
11300195|NCT02559622|12498156|FG002|STARTED|Overall Study||26
11300196|NCT02559622|12498157|FG003|STARTED|Overall Study||23
11300197|NCT02559622|12498154|FG000|COMPLETED|Overall Study||47
11300198|NCT02559622|12498155|FG001|COMPLETED|Overall Study||49
11300199|NCT02559622|12498156|FG002|COMPLETED|Overall Study||24
11300200|NCT02559622|12498157|FG003|COMPLETED|Overall Study||20
11300201|NCT02559622|12498154|FG000|NOT COMPLETED|Overall Study||1
11300202|NCT02559622|12498155|FG001|NOT COMPLETED|Overall Study||5
11300203|NCT02559622|12498156|FG002|NOT COMPLETED|Overall Study||2
11300204|NCT02559622|12498157|FG003|NOT COMPLETED|Overall Study||3
11300205|NCT02559713|12498171|FG000|STARTED|Overall Study||11
11300206|NCT02559713|12498171|FG000|Safety Set|Overall Study||11
11300207|NCT02559713|12498171|FG000|Pharmacokinetic Set|Overall Study||11
11300208|NCT02559713|12498171|FG000|COMPLETED|Overall Study||10
11300209|NCT02559713|12498171|FG000|NOT COMPLETED|Overall Study||1
11300210|NCT02559817|12498180|FG000|STARTED|Treatment Period||19
11300211|NCT02559817|12498181|FG001|STARTED|Treatment Period||29
11300212|NCT02559817|12498182|FG002|STARTED|Treatment Period||21
11300213|NCT02559817|12498183|FG003|STARTED|Treatment Period||24
11300214|NCT02559817|12498184|FG004|STARTED|Treatment Period||8
11300215|NCT02559817|12498180|FG000|COMPLETED|Treatment Period||18
11300216|NCT02559817|12498181|FG001|COMPLETED|Treatment Period||27
11300217|NCT02559817|12498182|FG002|COMPLETED|Treatment Period||19
11300218|NCT02559817|12498183|FG003|COMPLETED|Treatment Period||22
11300219|NCT02559817|12498184|FG004|COMPLETED|Treatment Period||8
11300220|NCT02559817|12498180|FG000|NOT COMPLETED|Treatment Period||1
11300221|NCT02559817|12498181|FG001|NOT COMPLETED|Treatment Period||2
11300222|NCT02559817|12498182|FG002|NOT COMPLETED|Treatment Period||2
11300223|NCT02559817|12498183|FG003|NOT COMPLETED|Treatment Period||2
11300224|NCT02559817|12498184|FG004|NOT COMPLETED|Treatment Period||0
11300225|NCT02559817|12498180|FG000|STARTED|Post-treatment Period||18
11300226|NCT02559817|12498181|FG001|STARTED|Post-treatment Period||27
11300227|NCT02559817|12498182|FG002|STARTED|Post-treatment Period|1 participant who did not complete the first period, entered and completed the Post-treatment Period|20
11300228|NCT02559817|12498183|FG003|STARTED|Post-treatment Period||22
11300229|NCT02559817|12498184|FG004|STARTED|Post-treatment Period||8
11300230|NCT02559817|12498180|FG000|COMPLETED|Post-treatment Period||18
11300231|NCT02559817|12498181|FG001|COMPLETED|Post-treatment Period||27
11300232|NCT02559817|12498182|FG002|COMPLETED|Post-treatment Period||20
11300233|NCT02559817|12498183|FG003|COMPLETED|Post-treatment Period||22
11300234|NCT02559817|12498184|FG004|COMPLETED|Post-treatment Period||8
11300235|NCT02559817|12498180|FG000|NOT COMPLETED|Post-treatment Period||0
11300236|NCT02559817|12498181|FG001|NOT COMPLETED|Post-treatment Period||0
11300237|NCT02559817|12498182|FG002|NOT COMPLETED|Post-treatment Period||0
11300238|NCT02559817|12498183|FG003|NOT COMPLETED|Post-treatment Period||0
11300239|NCT02559817|12498184|FG004|NOT COMPLETED|Post-treatment Period||0
11300240|NCT02559895|12498200|FG000|STARTED|Overall Study||224
11300241|NCT02559895|12498201|FG001|STARTED|Overall Study||225
11300242|NCT02559895|12498202|FG002|STARTED|Overall Study||224
11300243|NCT02559895|12498203|FG003|STARTED|Overall Study||225
11300244|NCT02559895|12498200|FG000|Participants Treated|Overall Study||222
11300245|NCT02559895|12498201|FG001|Participants Treated|Overall Study||221
11300246|NCT02559895|12498202|FG002|Participants Treated|Overall Study||223
11300247|NCT02559895|12498203|FG003|Participants Treated|Overall Study||222
11300248|NCT02559895|12498200|FG000|COMPLETED|Overall Study||169
11300249|NCT02559895|12498201|FG001|COMPLETED|Overall Study||172
11300250|NCT02559895|12498202|FG002|COMPLETED|Overall Study||170
11300251|NCT02559895|12498203|FG003|COMPLETED|Overall Study||165
11300252|NCT02559895|12498200|FG000|NOT COMPLETED|Overall Study||55
11300253|NCT02559895|12498201|FG001|NOT COMPLETED|Overall Study||53
11300254|NCT02559895|12498202|FG002|NOT COMPLETED|Overall Study||54
11300255|NCT02559895|12498203|FG003|NOT COMPLETED|Overall Study||60
11300256|NCT02560012|12498213|FG000|STARTED|Overall Study||3
11300257|NCT02560012|12498213|FG000|COMPLETED|Overall Study||1
11300258|NCT02560012|12498213|FG000|NOT COMPLETED|Overall Study||2
11300259|NCT02560025|12498217|FG000|STARTED|Overall Study||42
11300260|NCT02560025|12498217|FG000|COMPLETED|Overall Study||39
11300261|NCT02560025|12498217|FG000|NOT COMPLETED|Overall Study||3
11300262|NCT02560038|12498221|FG000|STARTED|Overall Study||3
11300263|NCT02560038|12498221|FG000|COMPLETED|Overall Study||1
11300264|NCT02560038|12498221|FG000|NOT COMPLETED|Overall Study||2
11300265|NCT02560051|12498228|FG000|STARTED|Overall Study||6
11300266|NCT02560051|12498229|FG001|STARTED|Overall Study||8
11300267|NCT02560051|12498230|FG002|STARTED|Overall Study||5
11300268|NCT02560051|12498228|FG000|COMPLETED|Overall Study||3
11300269|NCT02560051|12498229|FG001|COMPLETED|Overall Study||4
11300270|NCT02560051|12498230|FG002|COMPLETED|Overall Study||4
11300271|NCT02560051|12498228|FG000|NOT COMPLETED|Overall Study||3
11300272|NCT02560051|12498229|FG001|NOT COMPLETED|Overall Study||4
11300273|NCT02560051|12498230|FG002|NOT COMPLETED|Overall Study||1
11300274|NCT02560324|12498240|FG000|STARTED|Period 1 (2 Weeks)||35
11300275|NCT02560324|12498241|FG001|STARTED|Period 1 (2 Weeks)||34
11300276|NCT02560324|12498240|FG000|COMPLETED|Period 1 (2 Weeks)||23
11300277|NCT02560324|12498241|FG001|COMPLETED|Period 1 (2 Weeks)||25
11300278|NCT02560324|12498240|FG000|NOT COMPLETED|Period 1 (2 Weeks)||12
11300279|NCT02560324|12498241|FG001|NOT COMPLETED|Period 1 (2 Weeks)||9
11300280|NCT02560324|12498240|FG000|STARTED|Washout (2 Weeks)||23
11300281|NCT02560324|12498241|FG001|STARTED|Washout (2 Weeks)||25
11300282|NCT02560324|12498240|FG000|COMPLETED|Washout (2 Weeks)||23
11300283|NCT02560324|12498241|FG001|COMPLETED|Washout (2 Weeks)||23
11300284|NCT02560324|12498240|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11300285|NCT02560324|12498241|FG001|NOT COMPLETED|Washout (2 Weeks)||2
11300286|NCT02560324|12498240|FG000|STARTED|Period 2 (2 Weeks)||23
11300287|NCT02560324|12498241|FG001|STARTED|Period 2 (2 Weeks)||23
11300288|NCT02560324|12498240|FG000|COMPLETED|Period 2 (2 Weeks)||22
11300289|NCT02560324|12498241|FG001|COMPLETED|Period 2 (2 Weeks)||21
11300290|NCT02560324|12498240|FG000|NOT COMPLETED|Period 2 (2 Weeks)||1
11300291|NCT02560324|12498241|FG001|NOT COMPLETED|Period 2 (2 Weeks)||2
11300292|NCT02560389|12498254|FG000|STARTED|Overall Study||34
11300293|NCT02560389|12498255|FG001|STARTED|Overall Study||28
11300294|NCT02560389|12498256|FG002|STARTED|Overall Study||29
11300295|NCT02560389|12498254|FG000|COMPLETED|Overall Study||33
11300296|NCT02560389|12498255|FG001|COMPLETED|Overall Study||25
11300297|NCT02560389|12498256|FG002|COMPLETED|Overall Study||27
11300298|NCT02560389|12498254|FG000|NOT COMPLETED|Overall Study||1
11300299|NCT02560389|12498255|FG001|NOT COMPLETED|Overall Study||3
11300300|NCT02560389|12498256|FG002|NOT COMPLETED|Overall Study||2
11300301|NCT02560493|12498266|FG000|STARTED|Overall Study||23
11300302|NCT02560493|12498267|FG001|STARTED|Overall Study||23
11300303|NCT02560493|12498266|FG000|COMPLETED|Overall Study||22
11300304|NCT02560493|12498267|FG001|COMPLETED|Overall Study||23
11300305|NCT02560493|12498266|FG000|NOT COMPLETED|Overall Study||1
11300306|NCT02560493|12498267|FG001|NOT COMPLETED|Overall Study||0
11300307|NCT02560558|12498275|FG000|STARTED|Overall Study||84
11300308|NCT02560558|12498276|FG001|STARTED|Overall Study||82
11300309|NCT02560558|12498275|FG000|COMPLETED|Overall Study||77
11300310|NCT02560558|12498276|FG001|COMPLETED|Overall Study||76
11300311|NCT02560558|12498275|FG000|NOT COMPLETED|Overall Study||7
11300312|NCT02560558|12498276|FG001|NOT COMPLETED|Overall Study||6
11300313|NCT02560584|12498282|FG000|STARTED|Overall Study||304
11300314|NCT02560584|12498282|FG000|COMPLETED|Overall Study||304
11300315|NCT02560584|12498282|FG000|NOT COMPLETED|Overall Study||0
11300316|NCT02560701|12498290|FG000|STARTED|Overall Study||8060
11300317|NCT02560701|12498291|FG001|STARTED|Overall Study||89242
11300318|NCT02560701|12498290|FG000|Carve Out|Overall Study||8060
11300319|NCT02560701|12498291|FG001|Carve Out|Overall Study||88729
11300320|NCT02560701|12498290|FG000|Restrict to Patients Between 12 and 64|Overall Study||7598
11300321|NCT02560701|12498291|FG001|Restrict to Patients Between 12 and 64|Overall Study||82367
11300322|NCT02560701|12498290|FG000|Bipolar Diagnosis Time Constraints|Overall Study||3533
11300323|NCT02560701|12498291|FG001|Bipolar Diagnosis Time Constraints|Overall Study||39427
11300324|NCT02560701|12498290|FG000|Matched Cohort|Overall Study||3517
11300325|NCT02560701|12498291|FG001|Matched Cohort|Overall Study||37776
11300326|NCT02560701|12498290|FG000|COMPLETED|Overall Study||3517
11300327|NCT02560701|12498291|FG001|COMPLETED|Overall Study||37776
11300328|NCT02560701|12498290|FG000|NOT COMPLETED|Overall Study||4543
11300329|NCT02560701|12498291|FG001|NOT COMPLETED|Overall Study||51466
11300330|NCT02560753|12498301|FG000|STARTED|Overall Study||9
11300331|NCT02560753|12498302|FG001|STARTED|Overall Study||9
11300332|NCT02560753|12498303|FG002|STARTED|Overall Study||10
11300333|NCT02560753|12498304|FG003|STARTED|Overall Study||8
11300334|NCT02560753|12498301|FG000|COMPLETED|Overall Study||8
11300335|NCT02560753|12498302|FG001|COMPLETED|Overall Study||9
11300336|NCT02560753|12498303|FG002|COMPLETED|Overall Study||9
11300337|NCT02560753|12498304|FG003|COMPLETED|Overall Study||8
11300338|NCT02560753|12498301|FG000|NOT COMPLETED|Overall Study||1
11300339|NCT02560753|12498302|FG001|NOT COMPLETED|Overall Study||0
11300340|NCT02560753|12498303|FG002|NOT COMPLETED|Overall Study||1
11300341|NCT02560753|12498304|FG003|NOT COMPLETED|Overall Study||0
11300342|NCT02560779|12498316|FG000|STARTED|Overall Study||14
11300343|NCT02560779|12498317|FG001|STARTED|Overall Study||13
11300344|NCT02560779|12498316|FG000|COMPLETED|Overall Study||14
11300345|NCT02560779|12498317|FG001|COMPLETED|Overall Study||13
11300346|NCT02560779|12498316|FG000|NOT COMPLETED|Overall Study||0
11300347|NCT02560779|12498317|FG001|NOT COMPLETED|Overall Study||0
11300348|NCT02560922|12498325|FG000|STARTED|Overall Study||124
11300349|NCT02560922|12498326|FG001|STARTED|Overall Study||124
11300350|NCT02560922|12498325|FG000|COMPLETED|Overall Study||98
11300351|NCT02560922|12498326|FG001|COMPLETED|Overall Study||112
11300352|NCT02560922|12498325|FG000|NOT COMPLETED|Overall Study||26
11300353|NCT02560922|12498326|FG001|NOT COMPLETED|Overall Study||12
11300354|NCT02561000|12498335|FG000|STARTED|Overall Study||34
11300355|NCT02561000|12498336|FG001|STARTED|Overall Study||35
11300356|NCT02561000|12498337|FG002|STARTED|Overall Study||31
11300357|NCT02561000|12498335|FG000|Safety Population|Overall Study|Includes 1 additional patient who was assigned PZ-128 0.3 mg/kg but received placebo in error (evaluated as placebo for primary safety outcome and adverse events).|35
11300358|NCT02561000|12498336|FG001|Safety Population|Overall Study|Excludes 4 patients who did not receive the study drug as allocated: 1 patient received placebo in error and was evaluated as placebo for primary safety outcome and adverse events; 2 patients withdrew full consent immediately after randomization prior to receiving any study drug; and 1 patient had an adverse event shortly after randomization prior to receiving any study drug.|31
11300359|NCT02561000|12498337|FG002|Safety Population|Overall Study||31
11300360|NCT02561000|12498335|FG000|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||34
11300361|NCT02561000|12498336|FG001|Intent-to-Treat (ITT) Population at 30 Days|Overall Study|Excludes 2 patients who withdrew full consent immediately after randomization.|33
11300362|NCT02561000|12498337|FG002|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||31
11300363|NCT02561000|12498335|FG000|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 1 patient who withdrew consent for follow-up 21 days after study drug dosing.|33
11300364|NCT02561000|12498336|FG001|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 4 patients: 2 patients withdrew full consent immediately after randomization; 1 patient followed only for 30 day ITT outcome (did not receive any study drug due to adverse event post randomization); and 1 patient withdrew consent for follow-up 7 days after study drug dosing.|31
11300365|NCT02561000|12498337|FG002|Intent-to-Treat (ITT) Population at 90 Days|Overall Study||31
11300366|NCT02561000|12498335|FG000|COMPLETED|Overall Study||32
11300367|NCT02561000|12498336|FG001|COMPLETED|Overall Study||31
11300368|NCT02561000|12498337|FG002|COMPLETED|Overall Study||31
11300369|NCT02561000|12498335|FG000|NOT COMPLETED|Overall Study||2
11300370|NCT02561000|12498336|FG001|NOT COMPLETED|Overall Study||4
11300371|NCT02561000|12498337|FG002|NOT COMPLETED|Overall Study||0
11300372|NCT02561078|12498347|FG000|STARTED|Overall Study||209
11300373|NCT02561078|12498348|FG001|STARTED|Overall Study||211
11300374|NCT02561078|12498347|FG000|Received at Least 1 Dose of Study Drug|Overall Study||208
11300375|NCT02561078|12498348|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210
11300376|NCT02561078|12498347|FG000|COMPLETED|Overall Study||179
11300377|NCT02561078|12498348|FG001|COMPLETED|Overall Study||186
11300378|NCT02561078|12498347|FG000|NOT COMPLETED|Overall Study||30
11300379|NCT02561078|12498348|FG001|NOT COMPLETED|Overall Study||25
11300380|NCT02561130|12498356|FG000|STARTED|Overall Study||77
11300381|NCT02561130|12498357|FG001|STARTED|Overall Study||77
11300382|NCT02561130|12498356|FG000|COMPLETED|Overall Study||76
11300383|NCT02561130|12498357|FG001|COMPLETED|Overall Study||76
11300384|NCT02561130|12498356|FG000|NOT COMPLETED|Overall Study||1
11300385|NCT02561130|12498357|FG001|NOT COMPLETED|Overall Study||1
11300386|NCT02561156|12498376|FG000|STARTED|Part 1||12
11300387|NCT02561156|12498377|FG001|STARTED|Part 1||6
11300388|NCT02561156|12498378|FG002|STARTED|Part 1||6
11300389|NCT02561156|12498379|FG003|STARTED|Part 1||6
11300390|NCT02561156|12498380|FG004|STARTED|Part 1||6
11300391|NCT02561156|12498381|FG005|STARTED|Part 1||6
11300392|NCT02561156|12498382|FG006|STARTED|Part 1||6
11300393|NCT02561156|12498383|FG007|STARTED|Part 1||0
11300394|NCT02561156|12498384|FG008|STARTED|Part 1||0
11300395|NCT02561156|12498385|FG009|STARTED|Part 1||0
11300396|NCT02561156|12498386|FG010|STARTED|Part 1||0
11300397|NCT02561156|12498387|FG011|STARTED|Part 1||0
11300398|NCT02561156|12498388|FG012|STARTED|Part 1||0
11300399|NCT02561156|12498376|FG000|COMPLETED|Part 1||12
11300400|NCT02561156|12498377|FG001|COMPLETED|Part 1||6
11401075|NCT04143945|12595884|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
11300401|NCT02561156|12498378|FG002|COMPLETED|Part 1||6
11300402|NCT02561156|12498379|FG003|COMPLETED|Part 1||6
11300403|NCT02561156|12498380|FG004|COMPLETED|Part 1||6
11300404|NCT02561156|12498381|FG005|COMPLETED|Part 1||6
11300405|NCT02561156|12498382|FG006|COMPLETED|Part 1||6
11300406|NCT02561156|12498383|FG007|COMPLETED|Part 1||0
11300407|NCT02561156|12498384|FG008|COMPLETED|Part 1||0
11300408|NCT02561156|12498385|FG009|COMPLETED|Part 1||0
11300409|NCT02561156|12498386|FG010|COMPLETED|Part 1||0
11300410|NCT02561156|12498387|FG011|COMPLETED|Part 1||0
11300411|NCT02561156|12498388|FG012|COMPLETED|Part 1||0
11300412|NCT02561156|12498376|FG000|NOT COMPLETED|Part 1||0
11300413|NCT02561156|12498377|FG001|NOT COMPLETED|Part 1||0
11300414|NCT02561156|12498378|FG002|NOT COMPLETED|Part 1||0
11300415|NCT02561156|12498379|FG003|NOT COMPLETED|Part 1||0
11300416|NCT02561156|12498380|FG004|NOT COMPLETED|Part 1||0
11300417|NCT02561156|12498381|FG005|NOT COMPLETED|Part 1||0
11300418|NCT02561156|12498382|FG006|NOT COMPLETED|Part 1||0
11300419|NCT02561156|12498383|FG007|NOT COMPLETED|Part 1||0
11300420|NCT02561156|12498384|FG008|NOT COMPLETED|Part 1||0
11300421|NCT02561156|12498385|FG009|NOT COMPLETED|Part 1||0
11300422|NCT02561156|12498386|FG010|NOT COMPLETED|Part 1||0
11300423|NCT02561156|12498387|FG011|NOT COMPLETED|Part 1||0
11300424|NCT02561156|12498388|FG012|NOT COMPLETED|Part 1||0
11300425|NCT02561156|12498376|FG000|STARTED|Part 2||0
11300426|NCT02561156|12498377|FG001|STARTED|Part 2||0
11300427|NCT02561156|12498378|FG002|STARTED|Part 2||0
11300428|NCT02561156|12498379|FG003|STARTED|Part 2||0
11300429|NCT02561156|12498380|FG004|STARTED|Part 2||0
11300430|NCT02561156|12498381|FG005|STARTED|Part 2||0
11300431|NCT02561156|12498382|FG006|STARTED|Part 2||0
11300432|NCT02561156|12498383|FG007|STARTED|Part 2||10
11300433|NCT02561156|12498384|FG008|STARTED|Part 2||6
11300434|NCT02561156|12498385|FG009|STARTED|Part 2||6
11300435|NCT02561156|12498386|FG010|STARTED|Part 2||6
11300436|NCT02561156|12498387|FG011|STARTED|Part 2||6
11300437|NCT02561156|12498388|FG012|STARTED|Part 2||6
11300438|NCT02561156|12498376|FG000|COMPLETED|Part 2||0
11300439|NCT02561156|12498377|FG001|COMPLETED|Part 2||0
11300440|NCT02561156|12498378|FG002|COMPLETED|Part 2||0
11300441|NCT02561156|12498379|FG003|COMPLETED|Part 2||0
11300442|NCT02561156|12498380|FG004|COMPLETED|Part 2||0
11300443|NCT02561156|12498381|FG005|COMPLETED|Part 2||0
11021937|NCT00806624|12200131|FG001|STARTED|Overall Study||80
11021938|NCT00806624|12200132|FG002|STARTED|Overall Study||75
11021939|NCT00806624|12200130|FG000|COMPLETED|Overall Study||70
11021940|NCT00806624|12200131|FG001|COMPLETED|Overall Study||68
11401076|NCT04143945|12595885|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
11021941|NCT00806624|12200132|FG002|COMPLETED|Overall Study||69
11300444|NCT02561156|12498382|FG006|COMPLETED|Part 2||0
11401077|NCT04143945|12595886|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
11021942|NCT00806624|12200130|FG000|NOT COMPLETED|Overall Study||9
11021943|NCT00806624|12200131|FG001|NOT COMPLETED|Overall Study||12
11300445|NCT02561156|12498383|FG007|COMPLETED|Part 2||10
11300446|NCT02561156|12498384|FG008|COMPLETED|Part 2||6
11300447|NCT02561156|12498385|FG009|COMPLETED|Part 2||6
11300448|NCT02561156|12498386|FG010|COMPLETED|Part 2||6
11300449|NCT02561156|12498387|FG011|COMPLETED|Part 2||5
11300450|NCT02561156|12498388|FG012|COMPLETED|Part 2||6
11300451|NCT02561156|12498376|FG000|NOT COMPLETED|Part 2||0
11300452|NCT02561156|12498377|FG001|NOT COMPLETED|Part 2||0
11300453|NCT02561156|12498378|FG002|NOT COMPLETED|Part 2||0
11300454|NCT02561156|12498379|FG003|NOT COMPLETED|Part 2||0
11401078|NCT04143945|12595883|FG000|Per Protocol Set|Treatment Period 1 (Day 1)||26
11401079|NCT04143945|12595884|FG001|Per Protocol Set|Treatment Period 1 (Day 1)||26
11401080|NCT04143945|12595885|FG002|Per Protocol Set|Treatment Period 1 (Day 1)||26
11401081|NCT04143945|12595886|FG003|Per Protocol Set|Treatment Period 1 (Day 1)||26
11401082|NCT04143945|12595883|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
11300455|NCT02561156|12498380|FG004|NOT COMPLETED|Part 2||0
11300456|NCT02561156|12498381|FG005|NOT COMPLETED|Part 2||0
11300457|NCT02561156|12498382|FG006|NOT COMPLETED|Part 2||0
11300458|NCT02561156|12498383|FG007|NOT COMPLETED|Part 2||0
11300459|NCT02561156|12498384|FG008|NOT COMPLETED|Part 2||0
11300460|NCT02561156|12498385|FG009|NOT COMPLETED|Part 2||0
11300461|NCT02561156|12498386|FG010|NOT COMPLETED|Part 2||0
11300462|NCT02561156|12498387|FG011|NOT COMPLETED|Part 2||1
11300463|NCT02561156|12498388|FG012|NOT COMPLETED|Part 2||0
11300464|NCT02561195|12498438|FG000|STARTED|Vaccination 1 to 3||183
11300465|NCT02561195|12498439|FG001|STARTED|Vaccination 1 to 3||184
11300466|NCT02561195|12498440|FG002|STARTED|Vaccination 1 to 3||61
11300467|NCT02561195|12498441|FG003|STARTED|Vaccination 1 to 3||183
11300468|NCT02561195|12498442|FG004|STARTED|Vaccination 1 to 3||183
11300469|NCT02561195|12498443|FG005|STARTED|Vaccination 1 to 3||61
11300470|NCT02561195|12498444|FG006|STARTED|Vaccination 1 to 3||0
11300471|NCT02561195|12498445|FG007|STARTED|Vaccination 1 to 3||0
11300472|NCT02561195|12498446|FG008|STARTED|Vaccination 1 to 3||0
11300473|NCT02561195|12498447|FG009|STARTED|Vaccination 1 to 3||0
11300474|NCT02561195|12498448|FG010|STARTED|Vaccination 1 to 3||0
11300475|NCT02561195|12498449|FG011|STARTED|Vaccination 1 to 3||0
11300476|NCT02561195|12498450|FG012|STARTED|Vaccination 1 to 3||0
11300477|NCT02561195|12498451|FG013|STARTED|Vaccination 1 to 3||0
11300478|NCT02561195|12498438|FG000|Treated|Vaccination 1 to 3||182
11300479|NCT02561195|12498439|FG001|Treated|Vaccination 1 to 3||184
11300480|NCT02561195|12498440|FG002|Treated|Vaccination 1 to 3||61
11300481|NCT02561195|12498441|FG003|Treated|Vaccination 1 to 3||183
11300482|NCT02561195|12498442|FG004|Treated|Vaccination 1 to 3||183
11300483|NCT02561195|12498443|FG005|Treated|Vaccination 1 to 3||61
11300484|NCT02561195|12498444|FG006|Treated|Vaccination 1 to 3||0
11300485|NCT02561195|12498445|FG007|Treated|Vaccination 1 to 3||0
11300486|NCT02561195|12498446|FG008|Treated|Vaccination 1 to 3||0
11021944|NCT00806624|12200132|FG002|NOT COMPLETED|Overall Study||6
11300487|NCT02561195|12498447|FG009|Treated|Vaccination 1 to 3||0
11300488|NCT02561195|12498448|FG010|Treated|Vaccination 1 to 3||0
11300489|NCT02561195|12498449|FG011|Treated|Vaccination 1 to 3||0
11300490|NCT02561195|12498450|FG012|Treated|Vaccination 1 to 3||0
11401083|NCT04143945|12595884|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
11401084|NCT04143945|12595885|FG002|COMPLETED|Treatment Period 1 (Day 1)||26
11401085|NCT04143945|12595886|FG003|COMPLETED|Treatment Period 1 (Day 1)||26
11300491|NCT02561195|12498451|FG013|Treated|Vaccination 1 to 3||0
11300492|NCT02561195|12498438|FG000|COMPLETED|Vaccination 1 to 3||160
11300493|NCT02561195|12498439|FG001|COMPLETED|Vaccination 1 to 3||162
11300494|NCT02561195|12498440|FG002|COMPLETED|Vaccination 1 to 3||55
11300495|NCT02561195|12498441|FG003|COMPLETED|Vaccination 1 to 3||157
11300496|NCT02561195|12498442|FG004|COMPLETED|Vaccination 1 to 3||155
11300497|NCT02561195|12498443|FG005|COMPLETED|Vaccination 1 to 3||51
11300498|NCT02561195|12498444|FG006|COMPLETED|Vaccination 1 to 3||0
11300499|NCT02561195|12498445|FG007|COMPLETED|Vaccination 1 to 3||0
11300500|NCT02561195|12498446|FG008|COMPLETED|Vaccination 1 to 3||0
11300501|NCT02561195|12498447|FG009|COMPLETED|Vaccination 1 to 3||0
11300502|NCT02561195|12498448|FG010|COMPLETED|Vaccination 1 to 3||0
11300503|NCT02561195|12498449|FG011|COMPLETED|Vaccination 1 to 3||0
11300504|NCT02561195|12498450|FG012|COMPLETED|Vaccination 1 to 3||0
11300505|NCT02561195|12498451|FG013|COMPLETED|Vaccination 1 to 3||0
11300506|NCT02561195|12498438|FG000|NOT COMPLETED|Vaccination 1 to 3||23
11300507|NCT02561195|12498439|FG001|NOT COMPLETED|Vaccination 1 to 3||22
11300508|NCT02561195|12498440|FG002|NOT COMPLETED|Vaccination 1 to 3||6
11300509|NCT02561195|12498441|FG003|NOT COMPLETED|Vaccination 1 to 3||26
11300510|NCT02561195|12498442|FG004|NOT COMPLETED|Vaccination 1 to 3||28
11300511|NCT02561195|12498443|FG005|NOT COMPLETED|Vaccination 1 to 3||10
11300512|NCT02561195|12498444|FG006|NOT COMPLETED|Vaccination 1 to 3||0
11300513|NCT02561195|12498445|FG007|NOT COMPLETED|Vaccination 1 to 3||0
11300514|NCT02561195|12498446|FG008|NOT COMPLETED|Vaccination 1 to 3||0
11300515|NCT02561195|12498447|FG009|NOT COMPLETED|Vaccination 1 to 3||0
11300516|NCT02561195|12498448|FG010|NOT COMPLETED|Vaccination 1 to 3||0
11300517|NCT02561195|12498449|FG011|NOT COMPLETED|Vaccination 1 to 3||0
11300518|NCT02561195|12498450|FG012|NOT COMPLETED|Vaccination 1 to 3||0
11300519|NCT02561195|12498451|FG013|NOT COMPLETED|Vaccination 1 to 3||0
11021945|NCT00806676|12200143|FG000|STARTED|Overall Study||29
11021946|NCT00806676|12200144|FG001|STARTED|Overall Study||9
11021947|NCT00806676|12200145|FG002|STARTED|Overall Study||29
11021948|NCT00806676|12200143|FG000|COMPLETED|Overall Study||25
11021949|NCT00806676|12200144|FG001|COMPLETED|Overall Study||9
11021950|NCT00806676|12200145|FG002|COMPLETED|Overall Study||23
11021951|NCT00806676|12200143|FG000|NOT COMPLETED|Overall Study||4
11021952|NCT00806676|12200144|FG001|NOT COMPLETED|Overall Study||0
11021953|NCT00806676|12200145|FG002|NOT COMPLETED|Overall Study||6
11021954|NCT00806819|12200156|FG000|STARTED|Overall Study|randomised patients|353
11021955|NCT00806819|12200157|FG001|STARTED|Overall Study|randomised patients|360
11021956|NCT00806819|12200156|FG000|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
11021957|NCT00806819|12200157|FG001|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
11021958|NCT00806819|12200156|FG000|NOT COMPLETED|Overall Study||346
11021959|NCT00806819|12200157|FG001|NOT COMPLETED|Overall Study||358
11021960|NCT00806988|12200166|FG000|STARTED|Overall Study||150
11021961|NCT00806988|12200167|FG001|STARTED|Overall Study||151
11021962|NCT00806988|12200166|FG000|COMPLETED|Overall Study||123
11021963|NCT00806988|12200167|FG001|COMPLETED|Overall Study||108
11021964|NCT00806988|12200166|FG000|NOT COMPLETED|Overall Study||27
11021965|NCT00806988|12200167|FG001|NOT COMPLETED|Overall Study||43
11021966|NCT00807001|12200178|FG000|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
11021967|NCT00807001|12200179|FG001|STARTED|Overall Study||8
11021968|NCT00807001|12200180|FG002|STARTED|Overall Study||8
11021969|NCT00807001|12200181|FG003|STARTED|Overall Study||8
11021970|NCT00807001|12200182|FG004|STARTED|Overall Study||9
11021971|NCT00807001|12200178|FG000|COMPLETED|Overall Study||8
11021972|NCT00807001|12200179|FG001|COMPLETED|Overall Study||7
11021973|NCT00807001|12200180|FG002|COMPLETED|Overall Study||8
11021974|NCT00807001|12200181|FG003|COMPLETED|Overall Study||8
11021975|NCT00807001|12200182|FG004|COMPLETED|Overall Study||9
11021976|NCT00807001|12200178|FG000|NOT COMPLETED|Overall Study||0
11021977|NCT00807001|12200179|FG001|NOT COMPLETED|Overall Study||1
11021978|NCT00807001|12200180|FG002|NOT COMPLETED|Overall Study||0
11021979|NCT00807001|12200181|FG003|NOT COMPLETED|Overall Study||0
11021980|NCT00807001|12200182|FG004|NOT COMPLETED|Overall Study||0
11021981|NCT00807014|12200196|FG000|STARTED|Overall Study||83
11021982|NCT00807014|12200197|FG001|STARTED|Overall Study||85
11021983|NCT00807014|12200196|FG000|COMPLETED|Overall Study||56
11021984|NCT00807014|12200197|FG001|COMPLETED|Overall Study||58
11021985|NCT00807014|12200196|FG000|NOT COMPLETED|Overall Study||27
11021986|NCT00807014|12200197|FG001|NOT COMPLETED|Overall Study||27
11021987|NCT00807040|12200205|FG000|STARTED|Overall Study||126
11021988|NCT00807040|12200206|FG001|STARTED|Overall Study||125
11021989|NCT00807040|12200205|FG000|COMPLETED|Overall Study||90
11021990|NCT00807040|12200206|FG001|COMPLETED|Overall Study||84
11021991|NCT00807040|12200205|FG000|NOT COMPLETED|Overall Study||36
11021992|NCT00807040|12200206|FG001|NOT COMPLETED|Overall Study||41
11021993|NCT00807092|12200214|FG000|STARTED|Overall Study||72
11021994|NCT00807092|12200215|FG001|STARTED|Overall Study||73
11021995|NCT00807092|12200214|FG000|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
11021996|NCT00807092|12200215|FG001|Exposed to Drug|Overall Study||73
11021997|NCT00807092|12200214|FG000|COMPLETED|Overall Study||71
11021998|NCT00807092|12200215|FG001|COMPLETED|Overall Study||69
11021999|NCT00807092|12200214|FG000|NOT COMPLETED|Overall Study||1
11022000|NCT00807092|12200215|FG001|NOT COMPLETED|Overall Study||4
11022001|NCT00807144|12200223|FG000|STARTED|Overall Study||52
11022002|NCT00807144|12200224|FG001|STARTED|Overall Study||50
11022003|NCT00807144|12200223|FG000|COMPLETED|Overall Study||52
11022004|NCT00807144|12200224|FG001|COMPLETED|Overall Study||49
11022005|NCT00807144|12200223|FG000|NOT COMPLETED|Overall Study||0
11022006|NCT00807144|12200224|FG001|NOT COMPLETED|Overall Study||1
11022007|NCT00807209|12200233|FG000|STARTED|Overall Study||1
11022008|NCT00807209|12200234|FG001|STARTED|Overall Study||1
11022009|NCT00807209|12200235|FG002|STARTED|Overall Study||1
11401086|NCT04143945|12595883|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11401087|NCT04143945|12595884|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11401088|NCT04143945|12595885|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11022010|NCT00807209|12200233|FG000|COMPLETED|Overall Study||1
11022011|NCT00807209|12200234|FG001|COMPLETED|Overall Study||1
11022012|NCT00807209|12200235|FG002|COMPLETED|Overall Study||1
11022013|NCT00807209|12200233|FG000|NOT COMPLETED|Overall Study||0
11022014|NCT00807209|12200234|FG001|NOT COMPLETED|Overall Study||0
11022015|NCT00807209|12200235|FG002|NOT COMPLETED|Overall Study||0
11022016|NCT00807235|12200245|FG000|STARTED|Overall Study||11
11022017|NCT00807235|12200246|FG001|STARTED|Overall Study||6
11022018|NCT00807235|12200245|FG000|COMPLETED|Overall Study||10
11022019|NCT00807235|12200246|FG001|COMPLETED|Overall Study||6
11022020|NCT00807235|12200245|FG000|NOT COMPLETED|Overall Study||1
11022021|NCT00807235|12200246|FG001|NOT COMPLETED|Overall Study||0
11300520|NCT02561195|12498438|FG000|STARTED|Extension Stage (Vaccination 4)||0
11300521|NCT02561195|12498439|FG001|STARTED|Extension Stage (Vaccination 4)||0
11300522|NCT02561195|12498440|FG002|STARTED|Extension Stage (Vaccination 4)||0
11300523|NCT02561195|12498441|FG003|STARTED|Extension Stage (Vaccination 4)||0
11300524|NCT02561195|12498442|FG004|STARTED|Extension Stage (Vaccination 4)||0
11300525|NCT02561195|12498443|FG005|STARTED|Extension Stage (Vaccination 4)||0
11300526|NCT02561195|12498444|FG006|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|16
11300527|NCT02561195|12498445|FG007|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|18
11300528|NCT02561195|12498446|FG008|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|24
11300529|NCT02561195|12498447|FG009|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|22
11300530|NCT02561195|12498448|FG010|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|51
11300531|NCT02561195|12498449|FG011|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|52
11300532|NCT02561195|12498450|FG012|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|58
11300533|NCT02561195|12498451|FG013|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|59
11300534|NCT02561195|12498438|FG000|COMPLETED|Extension Stage (Vaccination 4)||0
11300535|NCT02561195|12498439|FG001|COMPLETED|Extension Stage (Vaccination 4)||0
11300536|NCT02561195|12498440|FG002|COMPLETED|Extension Stage (Vaccination 4)||0
11300537|NCT02561195|12498441|FG003|COMPLETED|Extension Stage (Vaccination 4)||0
11300538|NCT02561195|12498442|FG004|COMPLETED|Extension Stage (Vaccination 4)||0
11300539|NCT02561195|12498443|FG005|COMPLETED|Extension Stage (Vaccination 4)||0
11300540|NCT02561195|12498444|FG006|COMPLETED|Extension Stage (Vaccination 4)||14
11300541|NCT02561195|12498445|FG007|COMPLETED|Extension Stage (Vaccination 4)||17
11300542|NCT02561195|12498446|FG008|COMPLETED|Extension Stage (Vaccination 4)||21
11300543|NCT02561195|12498447|FG009|COMPLETED|Extension Stage (Vaccination 4)||20
11300544|NCT02561195|12498448|FG010|COMPLETED|Extension Stage (Vaccination 4)||43
11300545|NCT02561195|12498449|FG011|COMPLETED|Extension Stage (Vaccination 4)||45
11300546|NCT02561195|12498450|FG012|COMPLETED|Extension Stage (Vaccination 4)||51
11300547|NCT02561195|12498451|FG013|COMPLETED|Extension Stage (Vaccination 4)||54
11300548|NCT02561195|12498438|FG000|NOT COMPLETED|Extension Stage (Vaccination 4)||0
11300549|NCT02561195|12498439|FG001|NOT COMPLETED|Extension Stage (Vaccination 4)||0
11300550|NCT02561195|12498440|FG002|NOT COMPLETED|Extension Stage (Vaccination 4)||0
11300551|NCT02561195|12498441|FG003|NOT COMPLETED|Extension Stage (Vaccination 4)||0
11300552|NCT02561195|12498442|FG004|NOT COMPLETED|Extension Stage (Vaccination 4)||0
11300553|NCT02561195|12498443|FG005|NOT COMPLETED|Extension Stage (Vaccination 4)||0
11300554|NCT02561195|12498444|FG006|NOT COMPLETED|Extension Stage (Vaccination 4)||2
11300555|NCT02561195|12498445|FG007|NOT COMPLETED|Extension Stage (Vaccination 4)||1
11300556|NCT02561195|12498446|FG008|NOT COMPLETED|Extension Stage (Vaccination 4)||3
11300557|NCT02561195|12498447|FG009|NOT COMPLETED|Extension Stage (Vaccination 4)||2
11401089|NCT04143945|12595886|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11300558|NCT02561195|12498448|FG010|NOT COMPLETED|Extension Stage (Vaccination 4)||8
11300559|NCT02561195|12498449|FG011|NOT COMPLETED|Extension Stage (Vaccination 4)||7
11300560|NCT02561195|12498450|FG012|NOT COMPLETED|Extension Stage (Vaccination 4)||7
11300561|NCT02561195|12498451|FG013|NOT COMPLETED|Extension Stage (Vaccination 4)||5
11300562|NCT02561247|12498483|FG000|STARTED|Overall Study||23
11300563|NCT02561247|12498483|FG000|COMPLETED|Overall Study||17
11300564|NCT02561247|12498483|FG000|NOT COMPLETED|Overall Study||6
11300565|NCT02561273|12498489|FG000|STARTED|Overall Study||40
11300566|NCT02561273|12498490|FG001|STARTED|Overall Study||4
11300567|NCT02561273|12498489|FG000|COMPLETED|Overall Study||39
11300568|NCT02561273|12498490|FG001|COMPLETED|Overall Study||4
11300569|NCT02561273|12498489|FG000|NOT COMPLETED|Overall Study||1
11300570|NCT02561273|12498490|FG001|NOT COMPLETED|Overall Study||0
11300571|NCT02561338|12498503|FG000|STARTED|Overall Study||53
11300572|NCT02561338|12498504|FG001|STARTED|Overall Study||50
11300573|NCT02561338|12498505|FG002|STARTED|Overall Study||51
11022022|NCT00807248|12200256|FG000|STARTED|Overall Study||71
11300574|NCT02561338|12498506|FG003|STARTED|Overall Study||51
11300575|NCT02561338|12498507|FG004|STARTED|Overall Study||53
11300576|NCT02561338|12498503|FG000|COMPLETED|Overall Study||45
11300577|NCT02561338|12498504|FG001|COMPLETED|Overall Study||44
11300578|NCT02561338|12498505|FG002|COMPLETED|Overall Study||42
11300579|NCT02561338|12498506|FG003|COMPLETED|Overall Study||46
11300580|NCT02561338|12498507|FG004|COMPLETED|Overall Study||51
11300581|NCT02561338|12498503|FG000|NOT COMPLETED|Overall Study||8
11300582|NCT02561338|12498504|FG001|NOT COMPLETED|Overall Study||6
11300583|NCT02561338|12498505|FG002|NOT COMPLETED|Overall Study||9
11300584|NCT02561338|12498506|FG003|NOT COMPLETED|Overall Study||5
11300585|NCT02561338|12498507|FG004|NOT COMPLETED|Overall Study||2
11300586|NCT02561455|12498525|FG000|STARTED|Overall Study||2
11300587|NCT02561455|12498526|FG001|STARTED|Overall Study||3
11300588|NCT02561455|12498527|FG002|STARTED|Overall Study||3
11300589|NCT02561455|12498528|FG003|STARTED|Overall Study||1
11300590|NCT02561455|12498525|FG000|COMPLETED|Overall Study||0
11300591|NCT02561455|12498526|FG001|COMPLETED|Overall Study||1
11300592|NCT02561455|12498527|FG002|COMPLETED|Overall Study||0
11300593|NCT02561455|12498528|FG003|COMPLETED|Overall Study||0
11300594|NCT02561455|12498525|FG000|NOT COMPLETED|Overall Study||2
11300595|NCT02561455|12498526|FG001|NOT COMPLETED|Overall Study||2
11300596|NCT02561455|12498527|FG002|NOT COMPLETED|Overall Study||3
11300597|NCT02561455|12498528|FG003|NOT COMPLETED|Overall Study||1
11300598|NCT02561481|12498540|FG000|STARTED|Pilot Trial||10
11300599|NCT02561481|12498541|FG001|STARTED|Pilot Trial||0
11300600|NCT02561481|12498540|FG000|COMPLETED|Pilot Trial||10
11300601|NCT02561481|12498541|FG001|COMPLETED|Pilot Trial||0
11300602|NCT02561481|12498540|FG000|NOT COMPLETED|Pilot Trial||0
11300603|NCT02561481|12498541|FG001|NOT COMPLETED|Pilot Trial||0
11300604|NCT02561481|12498540|FG000|STARTED|Main Trial - Double Blind Phase||25
11300605|NCT02561481|12498541|FG001|STARTED|Main Trial - Double Blind Phase||25
11300606|NCT02561481|12498540|FG000|COMPLETED|Main Trial - Double Blind Phase||22
11300607|NCT02561481|12498541|FG001|COMPLETED|Main Trial - Double Blind Phase||23
11300608|NCT02561481|12498540|FG000|NOT COMPLETED|Main Trial - Double Blind Phase||3
11300609|NCT02561481|12498541|FG001|NOT COMPLETED|Main Trial - Double Blind Phase||2
11300610|NCT02561481|12498540|FG000|STARTED|Main Trial - Open Label Phase||45
11300611|NCT02561481|12498541|FG001|STARTED|Main Trial - Open Label Phase||0
11300612|NCT02561481|12498540|FG000|COMPLETED|Main Trial - Open Label Phase||32
11300613|NCT02561481|12498541|FG001|COMPLETED|Main Trial - Open Label Phase||0
11300614|NCT02561481|12498540|FG000|NOT COMPLETED|Main Trial - Open Label Phase||13
11300615|NCT02561481|12498541|FG001|NOT COMPLETED|Main Trial - Open Label Phase||0
11300616|NCT02561572|12498552|FG000|STARTED|Overall Study||64
11300617|NCT02561572|12498553|FG001|STARTED|Overall Study||64
11300618|NCT02561572|12498552|FG000|COMPLETED|Overall Study||62
11300619|NCT02561572|12498553|FG001|COMPLETED|Overall Study||62
11300620|NCT02561572|12498552|FG000|NOT COMPLETED|Overall Study||2
11300621|NCT02561572|12498553|FG001|NOT COMPLETED|Overall Study||2
11300622|NCT02561585|12498561|FG000|STARTED|Overall Study||20
11300623|NCT02561585|12498562|FG001|STARTED|Overall Study||11
11300624|NCT02561585|12498561|FG000|COMPLETED|Overall Study||17
11300625|NCT02561585|12498562|FG001|COMPLETED|Overall Study||6
11300626|NCT02561585|12498561|FG000|NOT COMPLETED|Overall Study||3
11300627|NCT02561585|12498562|FG001|NOT COMPLETED|Overall Study||5
11300628|NCT02561702|12498572|FG000|STARTED|First Intervention||2
11300629|NCT02561702|12498573|FG001|STARTED|First Intervention||2
11300630|NCT02561702|12498572|FG000|COMPLETED|First Intervention||2
11401090|NCT04143945|12595883|FG000|STARTED|Treatment Period 2 (Day 1)||26
11300631|NCT02561702|12498573|FG001|COMPLETED|First Intervention||2
11300632|NCT02561702|12498572|FG000|NOT COMPLETED|First Intervention||0
11300633|NCT02561702|12498573|FG001|NOT COMPLETED|First Intervention||0
11300634|NCT02561702|12498572|FG000|STARTED|Washout||2
11300635|NCT02561702|12498573|FG001|STARTED|Washout||2
11300636|NCT02561702|12498572|FG000|COMPLETED|Washout||2
11300637|NCT02561702|12498573|FG001|COMPLETED|Washout||2
11300638|NCT02561702|12498572|FG000|NOT COMPLETED|Washout||0
11300639|NCT02561702|12498573|FG001|NOT COMPLETED|Washout||0
11300640|NCT02561702|12498572|FG000|STARTED|Second Intervention||2
11300641|NCT02561702|12498573|FG001|STARTED|Second Intervention||2
11300642|NCT02561702|12498572|FG000|COMPLETED|Second Intervention||2
11300643|NCT02561702|12498573|FG001|COMPLETED|Second Intervention||2
11300644|NCT02561702|12498572|FG000|NOT COMPLETED|Second Intervention||0
11300645|NCT02561702|12498573|FG001|NOT COMPLETED|Second Intervention||0
11300646|NCT02561806|12498581|FG000|STARTED|Induction Period||166
11300647|NCT02561806|12498582|FG001|STARTED|Induction Period||136
11300648|NCT02561806|12498581|FG000|Received At Least One Dose of Study Drug|Induction Period||166
11300649|NCT02561806|12498582|FG001|Received At Least One Dose of Study Drug|Induction Period||135
11300650|NCT02561806|12498581|FG000|COMPLETED|Induction Period||164
11300651|NCT02561806|12498582|FG001|COMPLETED|Induction Period||131
11300652|NCT02561806|12498581|FG000|NOT COMPLETED|Induction Period||2
11300653|NCT02561806|12498582|FG001|NOT COMPLETED|Induction Period||5
11300654|NCT02561806|12498581|FG000|STARTED|Maintenance Period||164
11300655|NCT02561806|12498582|FG001|STARTED|Maintenance Period||131
11300656|NCT02561806|12498581|FG000|COMPLETED|Maintenance Period||151
11300657|NCT02561806|12498582|FG001|COMPLETED|Maintenance Period||123
11300658|NCT02561806|12498581|FG000|NOT COMPLETED|Maintenance Period||13
11300659|NCT02561806|12498582|FG001|NOT COMPLETED|Maintenance Period||8
11300660|NCT02561806|12498581|FG000|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
11341510|NCT02934698|12538922|FG000|COMPLETED|Overall Study||2
11300661|NCT02561806|12498582|FG001|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
11300662|NCT02561806|12498581|FG000|COMPLETED|Post-Treatment Follow-up||155
11300663|NCT02561806|12498582|FG001|COMPLETED|Post-Treatment Follow-up||59
11300664|NCT02561806|12498581|FG000|NOT COMPLETED|Post-Treatment Follow-up||2
11300665|NCT02561806|12498582|FG001|NOT COMPLETED|Post-Treatment Follow-up||1
11300666|NCT02561832|12498605|FG000|STARTED|Overall Study||8
11300667|NCT02561832|12498606|FG001|STARTED|Overall Study||7
11300668|NCT02561832|12498605|FG000|INFORMED CONSENT OBTAINED|Overall Study||8
11300669|NCT02561832|12498606|FG001|INFORMED CONSENT OBTAINED|Overall Study||7
11300670|NCT02561832|12498605|FG000|COMPLETED|Overall Study||1
11300671|NCT02561832|12498606|FG001|COMPLETED|Overall Study||3
11300672|NCT02561832|12498605|FG000|NOT COMPLETED|Overall Study||7
11300673|NCT02561832|12498606|FG001|NOT COMPLETED|Overall Study||4
11300674|NCT02561897|12498614|FG000|STARTED|Overall Study||2
11300675|NCT02561897|12498615|FG001|STARTED|Overall Study||3
11300676|NCT02561897|12498614|FG000|COMPLETED|Overall Study||2
11300677|NCT02561897|12498615|FG001|COMPLETED|Overall Study||3
11300678|NCT02561897|12498614|FG000|NOT COMPLETED|Overall Study||0
11300679|NCT02561897|12498615|FG001|NOT COMPLETED|Overall Study||0
11300680|NCT02562066|12498625|FG000|STARTED|Overall Study||8
11300681|NCT02562066|12498626|FG001|STARTED|Overall Study||8
11300682|NCT02562066|12498627|FG002|STARTED|Overall Study||4
11300683|NCT02562066|12498625|FG000|COMPLETED|Overall Study||7
11300684|NCT02562066|12498626|FG001|COMPLETED|Overall Study||7
11300685|NCT02562066|12498627|FG002|COMPLETED|Overall Study||0
11300686|NCT02562066|12498625|FG000|NOT COMPLETED|Overall Study||1
11300687|NCT02562066|12498626|FG001|NOT COMPLETED|Overall Study||1
11300688|NCT02562066|12498627|FG002|NOT COMPLETED|Overall Study||4
11300689|NCT02562482|12498635|FG000|STARTED|Overall Study||201
11300690|NCT02562482|12498636|FG001|STARTED|Overall Study||199
11300691|NCT02562482|12498635|FG000|Received 1st Injection|Overall Study||197
11300692|NCT02562482|12498636|FG001|Received 1st Injection|Overall Study||199
11300693|NCT02562482|12498635|FG000|Received 2nd Injection|Overall Study||192
11300694|NCT02562482|12498636|FG001|Received 2nd Injection|Overall Study||192
11300695|NCT02562482|12498635|FG000|COMPLETED|Overall Study||180
11300696|NCT02562482|12498636|FG001|COMPLETED|Overall Study||183
11300697|NCT02562482|12498635|FG000|NOT COMPLETED|Overall Study||21
11300698|NCT02562482|12498636|FG001|NOT COMPLETED|Overall Study||16
11300699|NCT02562521|12498644|FG000|STARTED|Overall Study||18
11300700|NCT02562521|12498645|FG001|STARTED|Overall Study||7
11300701|NCT02562521|12498644|FG000|COMPLETED|Overall Study||18
11300702|NCT02562521|12498645|FG001|COMPLETED|Overall Study||7
11300703|NCT02562521|12498644|FG000|NOT COMPLETED|Overall Study||0
11300704|NCT02562521|12498645|FG001|NOT COMPLETED|Overall Study||0
11300705|NCT02562755|12498653|FG000|STARTED|Overall Study||234
11300706|NCT02562755|12498654|FG001|STARTED|Overall Study||225
11300707|NCT02562755|12498653|FG000|Safety Population|Overall Study||218
11300708|NCT02562755|12498654|FG001|Safety Population|Overall Study||217
11300709|NCT02562755|12498653|FG000|COMPLETED|Overall Study||161
11300710|NCT02562755|12498654|FG001|COMPLETED|Overall Study||153
11300711|NCT02562755|12498653|FG000|NOT COMPLETED|Overall Study||73
11300712|NCT02562755|12498654|FG001|NOT COMPLETED|Overall Study||72
11300713|NCT02562898|12498662|FG000|STARTED|Overall Study||10
11300714|NCT02562898|12498663|FG001|STARTED|Overall Study||8
11300715|NCT02562898|12498662|FG000|COMPLETED|Overall Study||10
11300716|NCT02562898|12498663|FG001|COMPLETED|Overall Study||8
11300717|NCT02562898|12498662|FG000|NOT COMPLETED|Overall Study||0
11300718|NCT02562898|12498663|FG001|NOT COMPLETED|Overall Study||0
11300719|NCT02562924|12498672|FG000|STARTED|Overall Study||13
11300720|NCT02562924|12498673|FG001|STARTED|Overall Study||12
11300721|NCT02562924|12498674|FG002|STARTED|Overall Study||12
11300722|NCT02562924|12498672|FG000|COMPLETED|Overall Study||12
11300723|NCT02562924|12498673|FG001|COMPLETED|Overall Study||1
11300724|NCT02562924|12498674|FG002|COMPLETED|Overall Study||8
11300725|NCT02562924|12498672|FG000|NOT COMPLETED|Overall Study||1
11300726|NCT02562924|12498673|FG001|NOT COMPLETED|Overall Study||11
11300727|NCT02562924|12498674|FG002|NOT COMPLETED|Overall Study||4
11300728|NCT02562989|12498688|FG000|STARTED|Overall Study||3
11300729|NCT02562989|12498689|FG001|STARTED|Overall Study||4
11300730|NCT02562989|12498690|FG002|STARTED|Overall Study||6
11300731|NCT02562989|12498688|FG000|COMPLETED|Overall Study||3
11300732|NCT02562989|12498689|FG001|COMPLETED|Overall Study||4
11300733|NCT02562989|12498690|FG002|COMPLETED|Overall Study||6
11300734|NCT02562989|12498688|FG000|NOT COMPLETED|Overall Study||0
11300735|NCT02562989|12498689|FG001|NOT COMPLETED|Overall Study||0
11300736|NCT02562989|12498690|FG002|NOT COMPLETED|Overall Study||0
11300737|NCT02563067|12498701|FG000|STARTED|Overall Study||296
11300738|NCT02563067|12498702|FG001|STARTED|Overall Study||294
11300739|NCT02563067|12498703|FG002|STARTED|Overall Study||287
11300740|NCT02563067|12498701|FG000|FAS/SAF: High Eosinophils Subpopulation|Overall Study||198
11300741|NCT02563067|12498702|FG001|FAS/SAF: High Eosinophils Subpopulation|Overall Study||196
11300742|NCT02563067|12498703|FG002|FAS/SAF: High Eosinophils Subpopulation|Overall Study||193
11300743|NCT02563067|12498701|FG000|FAS/SAF: Overall Population|Overall Study||296
11300744|NCT02563067|12498702|FG001|FAS/SAF: Overall Population|Overall Study||293
11300745|NCT02563067|12498703|FG002|FAS/SAF: Overall Population|Overall Study||287
11300746|NCT02563067|12498701|FG000|COMPLETED|Overall Study||277
11300747|NCT02563067|12498702|FG001|COMPLETED|Overall Study||268
11300748|NCT02563067|12498703|FG002|COMPLETED|Overall Study||267
11300749|NCT02563067|12498701|FG000|NOT COMPLETED|Overall Study||19
11300750|NCT02563067|12498702|FG001|NOT COMPLETED|Overall Study||26
11300751|NCT02563067|12498703|FG002|NOT COMPLETED|Overall Study||20
11300752|NCT02563093|12498715|FG000|STARTED|Overall Study||52
11300753|NCT02563093|12498716|FG001|STARTED|Overall Study||52
11300754|NCT02563093|12498717|FG002|STARTED|Overall Study||53
11300755|NCT02563093|12498718|FG003|STARTED|Overall Study||51
11300756|NCT02563093|12498715|FG000|COMPLETED|Overall Study||52
11300757|NCT02563093|12498716|FG001|COMPLETED|Overall Study||52
11300758|NCT02563093|12498717|FG002|COMPLETED|Overall Study||53
11300759|NCT02563093|12498718|FG003|COMPLETED|Overall Study||51
11300760|NCT02563093|12498715|FG000|NOT COMPLETED|Overall Study||0
11300761|NCT02563093|12498716|FG001|NOT COMPLETED|Overall Study||0
11300762|NCT02563093|12498717|FG002|NOT COMPLETED|Overall Study||0
11300763|NCT02563093|12498718|FG003|NOT COMPLETED|Overall Study||0
11300764|NCT02563106|12498731|FG000|STARTED|Overall Study||206
11300765|NCT02563106|12498732|FG001|STARTED|Overall Study||207
11300766|NCT02563106|12498731|FG000|COMPLETED|Overall Study||172
11300767|NCT02563106|12498732|FG001|COMPLETED|Overall Study||178
11300768|NCT02563106|12498731|FG000|NOT COMPLETED|Overall Study||34
11300769|NCT02563106|12498732|FG001|NOT COMPLETED|Overall Study||29
11300770|NCT02563496|12498743|FG000|STARTED|Overall Study|No participants were enrolled since they didn't meet inclusion/exclusion criteria.|0
11300771|NCT02563496|12498744|FG001|STARTED|Overall Study||14
11300772|NCT02563496|12498745|FG002|STARTED|Overall Study||5
11300773|NCT02563496|12498746|FG003|STARTED|Overall Study||22
11300774|NCT02563496|12498747|FG004|STARTED|Overall Study||19
11300775|NCT02563496|12498743|FG000|COMPLETED|Overall Study||0
11300776|NCT02563496|12498744|FG001|COMPLETED|Overall Study||14
11300777|NCT02563496|12498745|FG002|COMPLETED|Overall Study||5
11300778|NCT02563496|12498746|FG003|COMPLETED|Overall Study||22
11300779|NCT02563496|12498747|FG004|COMPLETED|Overall Study||19
11300780|NCT02563496|12498743|FG000|NOT COMPLETED|Overall Study||0
11300781|NCT02563496|12498744|FG001|NOT COMPLETED|Overall Study||0
11300782|NCT02563496|12498745|FG002|NOT COMPLETED|Overall Study||0
11300783|NCT02563496|12498746|FG003|NOT COMPLETED|Overall Study||0
11300784|NCT02563496|12498747|FG004|NOT COMPLETED|Overall Study||0
11300785|NCT02563548|12498761|FG000|STARTED|Dose Escalation (Up to 46 Weeks)||3
11300786|NCT02563548|12498762|FG001|STARTED|Dose Escalation (Up to 46 Weeks)||2
11300787|NCT02563548|12498763|FG002|STARTED|Dose Escalation (Up to 46 Weeks)||7
11300788|NCT02563548|12498764|FG003|STARTED|Dose Escalation (Up to 46 Weeks)||2
11300789|NCT02563548|12498765|FG004|STARTED|Dose Escalation (Up to 46 Weeks)||0
11300790|NCT02563548|12498766|FG005|STARTED|Dose Escalation (Up to 46 Weeks)||0
11300791|NCT02563548|12498761|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3
11300792|NCT02563548|12498762|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
11300793|NCT02563548|12498763|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7
11300794|NCT02563548|12498764|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
11300795|NCT02563548|12498765|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
11300796|NCT02563548|12498766|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
11300797|NCT02563548|12498761|FG000|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
11300798|NCT02563548|12498762|FG001|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
11300799|NCT02563548|12498763|FG002|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
11300800|NCT02563548|12498764|FG003|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
11300801|NCT02563548|12498765|FG004|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
11300802|NCT02563548|12498766|FG005|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
11300803|NCT02563548|12498761|FG000|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3
11300804|NCT02563548|12498762|FG001|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
11300805|NCT02563548|12498763|FG002|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7
11300806|NCT02563548|12498764|FG003|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
11300807|NCT02563548|12498765|FG004|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
11300808|NCT02563548|12498766|FG005|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
11300809|NCT02563548|12498761|FG000|STARTED|Dose Expansion (Up to 60 Weeks)||0
11300810|NCT02563548|12498762|FG001|STARTED|Dose Expansion (Up to 60 Weeks)||0
11300811|NCT02563548|12498763|FG002|STARTED|Dose Expansion (Up to 60 Weeks)||0
11300812|NCT02563548|12498764|FG003|STARTED|Dose Expansion (Up to 60 Weeks)||0
11300813|NCT02563548|12498765|FG004|STARTED|Dose Expansion (Up to 60 Weeks)||25
11300814|NCT02563548|12498766|FG005|STARTED|Dose Expansion (Up to 60 Weeks)||17
11300815|NCT02563548|12498761|FG000|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
11300816|NCT02563548|12498762|FG001|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
11300817|NCT02563548|12498763|FG002|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
11300818|NCT02563548|12498764|FG003|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
11300819|NCT02563548|12498765|FG004|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24
11300820|NCT02563548|12498766|FG005|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17
11300821|NCT02563548|12498761|FG000|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
11300822|NCT02563548|12498762|FG001|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
11300823|NCT02563548|12498763|FG002|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
11300824|NCT02563548|12498764|FG003|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
11300825|NCT02563548|12498765|FG004|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
11300826|NCT02563548|12498766|FG005|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
11300827|NCT02563548|12498761|FG000|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
11300828|NCT02563548|12498762|FG001|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
11300829|NCT02563548|12498763|FG002|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
11300830|NCT02563548|12498764|FG003|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
11300831|NCT02563548|12498765|FG004|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25
11300832|NCT02563548|12498766|FG005|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17
11300833|NCT02563561|12498789|FG000|STARTED|Overall Study||19
11300834|NCT02563561|12498790|FG001|STARTED|Overall Study||23
11300835|NCT02563561|12498791|FG002|STARTED|Overall Study||20
11300836|NCT02563561|12498789|FG000|Safety Population|Overall Study||19
11300837|NCT02563561|12498790|FG001|Safety Population|Overall Study||21
11300838|NCT02563561|12498791|FG002|Safety Population|Overall Study||17
11300839|NCT02563561|12498789|FG000|COMPLETED|Overall Study||1
11300840|NCT02563561|12498790|FG001|COMPLETED|Overall Study||2
11300841|NCT02563561|12498791|FG002|COMPLETED|Overall Study||3
11300842|NCT02563561|12498789|FG000|NOT COMPLETED|Overall Study||18
11300843|NCT02563561|12498790|FG001|NOT COMPLETED|Overall Study||21
11300844|NCT02563561|12498791|FG002|NOT COMPLETED|Overall Study||17
11300845|NCT02563808|12498801|FG000|STARTED|Overall Study||96
11300846|NCT02563808|12498802|FG001|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88
11300847|NCT02563808|12498801|FG000|COMPLETED|Overall Study||96
11300848|NCT02563808|12498802|FG001|COMPLETED|Overall Study||88
11300849|NCT02563808|12498801|FG000|NOT COMPLETED|Overall Study||0
11300850|NCT02563808|12498802|FG001|NOT COMPLETED|Overall Study||0
11300851|NCT02563834|12498810|FG000|STARTED|Control (Saline) Infusion (*Day 1)||10
11300852|NCT02563834|12498811|FG001|STARTED|Control (Saline) Infusion (*Day 1)||8
11300853|NCT02563834|12498810|FG000|COMPLETED|Control (Saline) Infusion (*Day 1)||10
11300854|NCT02563834|12498811|FG001|COMPLETED|Control (Saline) Infusion (*Day 1)||8
11300855|NCT02563834|12498810|FG000|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
11300856|NCT02563834|12498811|FG001|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
11300857|NCT02563834|12498810|FG000|STARTED|Insulin Infusion (*Day 2)||10
11300858|NCT02563834|12498811|FG001|STARTED|Insulin Infusion (*Day 2)||8
11300859|NCT02563834|12498810|FG000|COMPLETED|Insulin Infusion (*Day 2)||10
11300860|NCT02563834|12498811|FG001|COMPLETED|Insulin Infusion (*Day 2)||8
11300861|NCT02563834|12498810|FG000|NOT COMPLETED|Insulin Infusion (*Day 2)||0
11300862|NCT02563834|12498811|FG001|NOT COMPLETED|Insulin Infusion (*Day 2)||0
11300863|NCT02563860|12498819|FG000|STARTED|Overall Study||20
11300864|NCT02563860|12498819|FG000|COMPLETED|Overall Study||19
11300865|NCT02563860|12498819|FG000|NOT COMPLETED|Overall Study||1
11300866|NCT02563899|12498827|FG000|STARTED|Overall Study||18
11300867|NCT02563899|12498828|FG001|STARTED|Overall Study||5
11300868|NCT02563899|12498829|FG002|STARTED|Overall Study||10
11300869|NCT02563899|12498830|FG003|STARTED|Overall Study||6
11300870|NCT02563899|12498827|FG000|COMPLETED|Overall Study||17
11300871|NCT02563899|12498828|FG001|COMPLETED|Overall Study||5
11300872|NCT02563899|12498829|FG002|COMPLETED|Overall Study||9
11300873|NCT02563899|12498830|FG003|COMPLETED|Overall Study||6
11300874|NCT02563899|12498827|FG000|NOT COMPLETED|Overall Study||1
11300875|NCT02563899|12498828|FG001|NOT COMPLETED|Overall Study||0
11300876|NCT02563899|12498829|FG002|NOT COMPLETED|Overall Study||1
11300877|NCT02563899|12498830|FG003|NOT COMPLETED|Overall Study||0
11300878|NCT02563990|12498843|FG000|STARTED|Overall Study||12
11300879|NCT02563990|12498844|FG001|STARTED|Overall Study||14
11300880|NCT02563990|12498843|FG000|COMPLETED|Overall Study||12
11300881|NCT02563990|12498844|FG001|COMPLETED|Overall Study||14
11300882|NCT02563990|12498843|FG000|NOT COMPLETED|Overall Study||0
11300883|NCT02563990|12498844|FG001|NOT COMPLETED|Overall Study||0
11300884|NCT02564016|12498854|FG000|STARTED|Overall Study||22
11300885|NCT02564016|12498855|FG001|STARTED|Overall Study||14
11300886|NCT02564016|12498854|FG000|COMPLETED|Overall Study||4
11300887|NCT02564016|12498855|FG001|COMPLETED|Overall Study||4
11300888|NCT02564016|12498854|FG000|NOT COMPLETED|Overall Study||18
11300889|NCT02564016|12498855|FG001|NOT COMPLETED|Overall Study||10
11401091|NCT04143945|12595884|FG001|STARTED|Treatment Period 2 (Day 1)||26
11401092|NCT04143945|12595885|FG002|STARTED|Treatment Period 2 (Day 1)||26
11401093|NCT04143945|12595886|FG003|STARTED|Treatment Period 2 (Day 1)||26
11401094|NCT04143945|12595883|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
11401095|NCT04143945|12595884|FG001|COMPLETED|Treatment Period 2 (Day 1)||26
11401096|NCT04143945|12595885|FG002|COMPLETED|Treatment Period 2 (Day 1)||26
11401097|NCT04143945|12595886|FG003|COMPLETED|Treatment Period 2 (Day 1)||26
11401098|NCT04143945|12595883|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
11401099|NCT04143945|12595884|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
11401100|NCT04143945|12595885|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
11401101|NCT04143945|12595886|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
11401102|NCT04143373|12595891|FG000|STARTED|Overall Study||20
11401103|NCT04143373|12595892|FG001|STARTED|Overall Study||20
11401104|NCT04143373|12595891|FG000|COMPLETED|Overall Study||20
11401105|NCT04143373|12595892|FG001|COMPLETED|Overall Study||20
11401106|NCT04143373|12595891|FG000|NOT COMPLETED|Overall Study||0
11401107|NCT04143373|12595892|FG001|NOT COMPLETED|Overall Study||0
11300890|NCT02564029|12498861|FG000|STARTED|Overall Study||7
11300891|NCT02564029|12498861|FG000|COMPLETED|Overall Study||7
11300892|NCT02564029|12498861|FG000|NOT COMPLETED|Overall Study||0
11401108|NCT04142216|12595899|FG000|STARTED|Overall Study||28
11401109|NCT04142216|12595900|FG001|STARTED|Overall Study||28
11401110|NCT04142216|12595899|FG000|COMPLETED|Overall Study||22
11401111|NCT04142216|12595900|FG001|COMPLETED|Overall Study||22
11300893|NCT02564042|12498878|FG000|STARTED|Overall Study||38
11300894|NCT02564042|12498879|FG001|STARTED|Overall Study||38
11300895|NCT02564042|12498880|FG002|STARTED|Overall Study||38
11401112|NCT04142216|12595899|FG000|NOT COMPLETED|Overall Study||6
11401113|NCT04142216|12595900|FG001|NOT COMPLETED|Overall Study||6
11401114|NCT04141930|12595906|FG000|STARTED|Overall Study||302
11401115|NCT04141930|12595907|FG001|STARTED|Overall Study|The 179 individuals that were not eligible to receive the study drug, participated in an observation portion of the study where all study procedures were the same excluding telehealth visit and an antiviral delivery.|179
11401116|NCT04141930|12595906|FG000|COMPLETED|Overall Study||302
11401117|NCT04141930|12595907|FG001|COMPLETED|Overall Study||179
11401118|NCT04141930|12595906|FG000|NOT COMPLETED|Overall Study||0
11401119|NCT04141930|12595907|FG001|NOT COMPLETED|Overall Study||0
11401120|NCT04142450|12595911|FG000|STARTED|Overall Study||50
11401121|NCT04142450|12595911|FG000|Safety Population|Overall Study||49
11401122|NCT04142450|12595911|FG000|COMPLETED|Overall Study||48
11401123|NCT04142450|12595911|FG000|NOT COMPLETED|Overall Study||2
11401124|NCT04140890|12595917|FG000|STARTED|Overall Study||9
11401125|NCT04140890|12595918|FG001|STARTED|Overall Study||12
11401126|NCT04140890|12595917|FG000|COMPLETED|Overall Study||9
11401127|NCT04140890|12595918|FG001|COMPLETED|Overall Study||11
11401128|NCT04140890|12595917|FG000|NOT COMPLETED|Overall Study||0
11401129|NCT04140890|12595918|FG001|NOT COMPLETED|Overall Study||1
11401130|NCT04139018|12595929|FG000|STARTED|Overall Study||14
11401131|NCT04139018|12595930|FG001|STARTED|Overall Study||13
11401132|NCT04139018|12595929|FG000|COMPLETED|Overall Study||11
11401133|NCT04139018|12595930|FG001|COMPLETED|Overall Study||12
11401134|NCT04139018|12595929|FG000|NOT COMPLETED|Overall Study||3
11401135|NCT04139018|12595930|FG001|NOT COMPLETED|Overall Study||1
11401136|NCT04138810|12595938|FG000|STARTED|Overall Study||27
11401137|NCT04138810|12595939|FG001|STARTED|Overall Study||27
11401138|NCT04138810|12595938|FG000|COMPLETED|Overall Study||26
11401139|NCT04138810|12595939|FG001|COMPLETED|Overall Study||26
11401140|NCT04138810|12595938|FG000|NOT COMPLETED|Overall Study||1
11401141|NCT04138810|12595939|FG001|NOT COMPLETED|Overall Study||1
11401142|NCT04131556|12595945|FG000|STARTED|Overall Study||20
11300896|NCT02564042|12498881|FG003|STARTED|Overall Study||38
11300897|NCT02564042|12498882|FG004|STARTED|Overall Study||37
11300898|NCT02564042|12498883|FG005|STARTED|Overall Study||38
11300899|NCT02564042|12498878|FG000|COMPLETED|Overall Study||27
11300900|NCT02564042|12498879|FG001|COMPLETED|Overall Study||30
11300901|NCT02564042|12498880|FG002|COMPLETED|Overall Study||32
11300902|NCT02564042|12498881|FG003|COMPLETED|Overall Study||35
11300903|NCT02564042|12498882|FG004|COMPLETED|Overall Study||26
11300904|NCT02564042|12498883|FG005|COMPLETED|Overall Study||24
11300905|NCT02564042|12498878|FG000|NOT COMPLETED|Overall Study||11
11300906|NCT02564042|12498879|FG001|NOT COMPLETED|Overall Study||8
11300907|NCT02564042|12498880|FG002|NOT COMPLETED|Overall Study||6
11300908|NCT02564042|12498881|FG003|NOT COMPLETED|Overall Study||3
11300909|NCT02564042|12498882|FG004|NOT COMPLETED|Overall Study||11
11300910|NCT02564042|12498883|FG005|NOT COMPLETED|Overall Study||14
11300911|NCT02564055|12498903|FG000|STARTED|Overall Study||40
11300912|NCT02564055|12498904|FG001|STARTED|Overall Study||41
11300913|NCT02564055|12498905|FG002|STARTED|Overall Study||43
11300914|NCT02564055|12498906|FG003|STARTED|Overall Study||41
11300915|NCT02564055|12498907|FG004|STARTED|Overall Study||42
11300916|NCT02564055|12498908|FG005|STARTED|Overall Study||40
11300917|NCT02564055|12498903|FG000|COMPLETED|Overall Study||34
11300918|NCT02564055|12498904|FG001|COMPLETED|Overall Study||36
11300919|NCT02564055|12498905|FG002|COMPLETED|Overall Study||31
11300920|NCT02564055|12498906|FG003|COMPLETED|Overall Study||35
11300921|NCT02564055|12498907|FG004|COMPLETED|Overall Study||27
11300922|NCT02564055|12498908|FG005|COMPLETED|Overall Study||28
11300923|NCT02564055|12498903|FG000|NOT COMPLETED|Overall Study||6
11300924|NCT02564055|12498904|FG001|NOT COMPLETED|Overall Study||5
11300925|NCT02564055|12498905|FG002|NOT COMPLETED|Overall Study||12
11300926|NCT02564055|12498906|FG003|NOT COMPLETED|Overall Study||6
11300927|NCT02564055|12498907|FG004|NOT COMPLETED|Overall Study||15
11300928|NCT02564055|12498908|FG005|NOT COMPLETED|Overall Study||12
11300929|NCT02564120|12498927|FG000|STARTED|Overall Study||1556
11300930|NCT02564120|12498927|FG000|COMPLETED|Overall Study||1110
11300931|NCT02564120|12498927|FG000|NOT COMPLETED|Overall Study||446
11300932|NCT02564198|12498944|FG000|STARTED|Overall Study||8
11300933|NCT02564198|12498945|FG001|STARTED|Overall Study||15
11300934|NCT02564198|12498946|FG002|STARTED|Overall Study||6
11300935|NCT02564198|12498944|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
11401143|NCT04131556|12595945|FG000|COMPLETED|Overall Study||18
11022023|NCT00807248|12200257|FG001|STARTED|Overall Study||140
11022024|NCT00807248|12200258|FG002|STARTED|Overall Study||139
11022025|NCT00807248|12200259|FG003|STARTED|Overall Study||140
11022026|NCT00807248|12200256|FG000|COMPLETED|Overall Study||50
11022027|NCT00807248|12200257|FG001|COMPLETED|Overall Study||128
11022028|NCT00807248|12200258|FG002|COMPLETED|Overall Study||121
11300936|NCT02564198|12498945|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15
11300937|NCT02564198|12498946|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11300938|NCT02564198|12498944|FG000|COMPLETED|Overall Study||6
11300939|NCT02564198|12498945|FG001|COMPLETED|Overall Study||10
11300940|NCT02564198|12498946|FG002|COMPLETED|Overall Study||6
11300941|NCT02564198|12498944|FG000|NOT COMPLETED|Overall Study||2
11300942|NCT02564198|12498945|FG001|NOT COMPLETED|Overall Study||5
11300943|NCT02564198|12498946|FG002|NOT COMPLETED|Overall Study||0
11300944|NCT02564211|12498956|FG000|STARTED|Overall Study||77
11300945|NCT02564211|12498956|FG000|COMPLETED|Overall Study||73
11300946|NCT02564211|12498956|FG000|NOT COMPLETED|Overall Study||4
11300947|NCT02564354|12498962|FG000|STARTED|Overall Study||10
11300948|NCT02564354|12498963|FG001|STARTED|Overall Study||8
11300949|NCT02564354|12498962|FG000|COMPLETED|Overall Study||10
11300950|NCT02564354|12498963|FG001|COMPLETED|Overall Study||8
11300951|NCT02564354|12498962|FG000|NOT COMPLETED|Overall Study||0
11300952|NCT02564354|12498963|FG001|NOT COMPLETED|Overall Study||0
11300953|NCT02564432|12498969|FG000|STARTED|Overall Study||10
11300954|NCT02564432|12498969|FG000|COMPLETED|Overall Study|1 patient suffered periprosthetic fracture at 8 months; 1 failed to osseointegrate|8
11300955|NCT02564432|12498969|FG000|NOT COMPLETED|Overall Study||2
11300956|NCT02564471|12498979|FG000|STARTED|Overall Study||25
11300957|NCT02564471|12498980|FG001|STARTED|Overall Study||26
11300958|NCT02564471|12498981|FG002|STARTED|Overall Study||27
11300959|NCT02564471|12498982|FG003|STARTED|Overall Study||25
11300960|NCT02564471|12498979|FG000|COMPLETED|Overall Study||22
11300961|NCT02564471|12498980|FG001|COMPLETED|Overall Study||23
11300962|NCT02564471|12498981|FG002|COMPLETED|Overall Study||24
11300963|NCT02564471|12498982|FG003|COMPLETED|Overall Study||25
11300964|NCT02564471|12498979|FG000|NOT COMPLETED|Overall Study||3
11300965|NCT02564471|12498980|FG001|NOT COMPLETED|Overall Study||3
11300966|NCT02564471|12498981|FG002|NOT COMPLETED|Overall Study||3
11300967|NCT02564471|12498982|FG003|NOT COMPLETED|Overall Study||0
11300968|NCT02564497|12498994|FG000|STARTED|Overall Study||74
11300969|NCT02564497|12498995|FG001|STARTED|Overall Study||72
11300970|NCT02564497|12498994|FG000|COMPLETED|Overall Study||74
11300971|NCT02564497|12498995|FG001|COMPLETED|Overall Study||72
11300972|NCT02564497|12498994|FG000|NOT COMPLETED|Overall Study||0
11300973|NCT02564497|12498995|FG001|NOT COMPLETED|Overall Study||0
11300974|NCT02564718|12499003|FG000|STARTED|Overall Study||5
11401144|NCT04131556|12595945|FG000|NOT COMPLETED|Overall Study||2
11300975|NCT02564718|12499004|FG001|STARTED|Overall Study||5
11300976|NCT02564718|12499003|FG000|COMPLETED|Overall Study||5
11300977|NCT02564718|12499004|FG001|COMPLETED|Overall Study||4
11300978|NCT02564718|12499003|FG000|NOT COMPLETED|Overall Study||0
11300979|NCT02564718|12499004|FG001|NOT COMPLETED|Overall Study||1
11300980|NCT02564887|12499012|FG000|STARTED|Overall Study||16
11300981|NCT02564887|12499013|FG001|STARTED|Overall Study||10
11300982|NCT02564887|12499012|FG000|COMPLETED|Overall Study||10
11300983|NCT02564887|12499013|FG001|COMPLETED|Overall Study||10
11300984|NCT02564887|12499012|FG000|NOT COMPLETED|Overall Study||6
11300985|NCT02564887|12499013|FG001|NOT COMPLETED|Overall Study||0
11300986|NCT02564926|12499023|FG000|STARTED|Overall Study||60
11300987|NCT02564926|12499024|FG001|STARTED|Overall Study||61
11300988|NCT02564926|12499023|FG000|COMPLETED|Overall Study||52
11300989|NCT02564926|12499024|FG001|COMPLETED|Overall Study||54
11300990|NCT02564926|12499023|FG000|NOT COMPLETED|Overall Study||8
11300991|NCT02564926|12499024|FG001|NOT COMPLETED|Overall Study||7
11300992|NCT02565147|12499032|FG000|STARTED|Overall Study||38
11300993|NCT02565147|12499033|FG001|STARTED|Overall Study||40
11300994|NCT02565147|12499032|FG000|Received Study Drug|Overall Study||38
11300995|NCT02565147|12499033|FG001|Received Study Drug|Overall Study||40
11300996|NCT02565147|12499032|FG000|Per-Protocol Population|Overall Study||28
11300997|NCT02565147|12499033|FG001|Per-Protocol Population|Overall Study||36
11300998|NCT02565147|12499032|FG000|COMPLETED|Overall Study||32
11300999|NCT02565147|12499033|FG001|COMPLETED|Overall Study||37
11301000|NCT02565147|12499032|FG000|NOT COMPLETED|Overall Study||6
11301001|NCT02565147|12499033|FG001|NOT COMPLETED|Overall Study||3
11301002|NCT02565186|12499041|FG000|STARTED|Overall Study||1046
11301003|NCT02565186|12499042|FG001|STARTED|Overall Study||1125
11301004|NCT02565186|12499041|FG000|Received at Least One Dose of Study Drug|Overall Study||991
11301005|NCT02565186|12499042|FG001|Received at Least One Dose of Study Drug|Overall Study||1039
11301006|NCT02565186|12499041|FG000|COMPLETED|Overall Study||466
11301007|NCT02565186|12499042|FG001|COMPLETED|Overall Study||504
11301008|NCT02565186|12499041|FG000|NOT COMPLETED|Overall Study||580
11301009|NCT02565186|12499042|FG001|NOT COMPLETED|Overall Study||621
11301010|NCT02565381|12499051|FG000|STARTED|Overall Study||25
11301011|NCT02565381|12499052|FG001|STARTED|Overall Study||25
11301012|NCT02565381|12499053|FG002|STARTED|Overall Study||25
11301013|NCT02565381|12499051|FG000|COMPLETED|Overall Study||24
11301014|NCT02565381|12499052|FG001|COMPLETED|Overall Study||25
11301015|NCT02565381|12499053|FG002|COMPLETED|Overall Study||24
11301016|NCT02565381|12499051|FG000|NOT COMPLETED|Overall Study||1
11301017|NCT02565381|12499052|FG001|NOT COMPLETED|Overall Study||0
11301018|NCT02565381|12499053|FG002|NOT COMPLETED|Overall Study||1
11301019|NCT02565485|12499063|FG000|STARTED|Overall Study||139
11301020|NCT02565485|12499064|FG001|STARTED|Overall Study||137
11301021|NCT02565485|12499063|FG000|COMPLETED|Overall Study||139
11301022|NCT02565485|12499064|FG001|COMPLETED|Overall Study||137
11301023|NCT02565485|12499063|FG000|NOT COMPLETED|Overall Study||0
11301024|NCT02565485|12499064|FG001|NOT COMPLETED|Overall Study||0
11301025|NCT02565511|12499074|FG000|STARTED|Overall Study||42
11301026|NCT02565511|12499075|FG001|STARTED|Overall Study||23
11301027|NCT02565511|12499076|FG002|STARTED|Overall Study||251
11301028|NCT02565511|12499077|FG003|STARTED|Overall Study||164
11301029|NCT02565511|12499074|FG000|3 Patients Were Mis-randomized|Overall Study||0
11301030|NCT02565511|12499075|FG001|3 Patients Were Mis-randomized|Overall Study||0
11301031|NCT02565511|12499076|FG002|3 Patients Were Mis-randomized|Overall Study||2
11301032|NCT02565511|12499077|FG003|3 Patients Were Mis-randomized|Overall Study||1
11301033|NCT02565511|12499074|FG000|COMPLETED|Overall Study||0
11301034|NCT02565511|12499075|FG001|COMPLETED|Overall Study||0
11301035|NCT02565511|12499076|FG002|COMPLETED|Overall Study||0
11301036|NCT02565511|12499077|FG003|COMPLETED|Overall Study||0
11301037|NCT02565511|12499074|FG000|NOT COMPLETED|Overall Study||42
11301038|NCT02565511|12499075|FG001|NOT COMPLETED|Overall Study||23
11301039|NCT02565511|12499076|FG002|NOT COMPLETED|Overall Study||251
11301040|NCT02565511|12499077|FG003|NOT COMPLETED|Overall Study||164
11301041|NCT02565576|12499089|FG000|STARTED|Overall Study||22
11301042|NCT02565576|12499090|FG001|STARTED|Overall Study||22
11301043|NCT02565576|12499089|FG000|COMPLETED|Overall Study||17
11401145|NCT04126174|12595952|FG000|STARTED|Overall Study||41
11401146|NCT04126174|12595953|FG001|STARTED|Overall Study||41
11401147|NCT04126174|12595952|FG000|COMPLETED|Overall Study||38
11401148|NCT04126174|12595953|FG001|COMPLETED|Overall Study||38
11401149|NCT04126174|12595952|FG000|NOT COMPLETED|Overall Study||3
11401150|NCT04126174|12595953|FG001|NOT COMPLETED|Overall Study||3
11401151|NCT04134429|12595959|FG000|STARTED|Overall Study||20
11301044|NCT02565576|12499090|FG001|COMPLETED|Overall Study||17
11301045|NCT02565576|12499089|FG000|NOT COMPLETED|Overall Study||5
11301046|NCT02565576|12499090|FG001|NOT COMPLETED|Overall Study||5
11301047|NCT02565615|12499101|FG000|STARTED|Overall Study||291
11301048|NCT02565615|12499102|FG001|STARTED|Overall Study||3080
11301049|NCT02565615|12499103|FG002|STARTED|Overall Study||21
11301050|NCT02565615|12499104|FG003|STARTED|Overall Study||101
11301051|NCT02565615|12499105|FG004|STARTED|Overall Study||1622
11301052|NCT02565615|12499101|FG000|Treated|Overall Study||291
11401152|NCT04134429|12595959|FG000|COMPLETED|Overall Study||19
11401153|NCT04134429|12595959|FG000|NOT COMPLETED|Overall Study||1
11301053|NCT02565615|12499102|FG001|Treated|Overall Study||3080
11301054|NCT02565615|12499103|FG002|Treated|Overall Study||21
11301055|NCT02565615|12499104|FG003|Treated|Overall Study||101
11301056|NCT02565615|12499105|FG004|Treated|Overall Study||1055
11301057|NCT02565615|12499101|FG000|COMPLETED|Overall Study||288
11301058|NCT02565615|12499102|FG001|COMPLETED|Overall Study||3044
11301059|NCT02565615|12499103|FG002|COMPLETED|Overall Study||21
11401154|NCT04130425|12595963|FG000|STARTED|Overall Study||30
11401155|NCT04130425|12595963|FG000|COMPLETED|Overall Study||30
11401156|NCT04130425|12595963|FG000|NOT COMPLETED|Overall Study||0
11401157|NCT04138498|12595978|FG000|STARTED|Overall Study||11
11301060|NCT02565615|12499104|FG003|COMPLETED|Overall Study||98
11301061|NCT02565615|12499105|FG004|COMPLETED|Overall Study||21
11301062|NCT02565615|12499101|FG000|NOT COMPLETED|Overall Study||3
11301063|NCT02565615|12499102|FG001|NOT COMPLETED|Overall Study||36
11301064|NCT02565615|12499103|FG002|NOT COMPLETED|Overall Study||0
11301065|NCT02565615|12499104|FG003|NOT COMPLETED|Overall Study||3
11301066|NCT02565615|12499105|FG004|NOT COMPLETED|Overall Study||1601
11301067|NCT02565628|12499119|FG000|STARTED|Overall Study||10
11301068|NCT02565628|12499120|FG001|STARTED|Overall Study||9
11301069|NCT02565628|12499119|FG000|Received Treatment|Overall Study||10
11301070|NCT02565628|12499120|FG001|Received Treatment|Overall Study||9
11301071|NCT02565628|12499119|FG000|COMPLETED|Overall Study||10
11301072|NCT02565628|12499120|FG001|COMPLETED|Overall Study||9
11301073|NCT02565628|12499119|FG000|NOT COMPLETED|Overall Study||0
11301074|NCT02565628|12499120|FG001|NOT COMPLETED|Overall Study||0
11301075|NCT02565706|12499130|FG000|STARTED|Overall Study||178
11301076|NCT02565706|12499131|FG001|STARTED|Overall Study||172
11301077|NCT02565706|12499132|FG002|STARTED|Overall Study||193
11301078|NCT02565706|12499133|FG003|STARTED|Overall Study||201
11301079|NCT02565706|12499130|FG000|COMPLETED|Overall Study||101
11301080|NCT02565706|12499131|FG001|COMPLETED|Overall Study||90
11301081|NCT02565706|12499132|FG002|COMPLETED|Overall Study||104
11301082|NCT02565706|12499133|FG003|COMPLETED|Overall Study||116
11301083|NCT02565706|12499130|FG000|NOT COMPLETED|Overall Study||77
11301084|NCT02565706|12499131|FG001|NOT COMPLETED|Overall Study||82
11301085|NCT02565706|12499132|FG002|NOT COMPLETED|Overall Study||89
11301086|NCT02565706|12499133|FG003|NOT COMPLETED|Overall Study||85
11301087|NCT02565810|12499148|FG000|STARTED|Overall Study||49
11301088|NCT02565810|12499148|FG000|COMPLETED|Overall Study||48
11301089|NCT02565810|12499148|FG000|NOT COMPLETED|Overall Study||1
11301090|NCT02565901|12499160|FG000|STARTED|Overall Study||11
11301091|NCT02565901|12499161|FG001|STARTED|Overall Study||11
11301092|NCT02565901|12499162|FG002|STARTED|Overall Study||6
11301093|NCT02565901|12499160|FG000|COMPLETED|Overall Study||11
11301094|NCT02565901|12499161|FG001|COMPLETED|Overall Study||11
11301095|NCT02565901|12499162|FG002|COMPLETED|Overall Study||6
11301096|NCT02565901|12499160|FG000|NOT COMPLETED|Overall Study||0
11301097|NCT02565901|12499161|FG001|NOT COMPLETED|Overall Study||0
11301098|NCT02565901|12499162|FG002|NOT COMPLETED|Overall Study||0
11301099|NCT02566005|12499173|FG000|STARTED|Overall Study||100
11301100|NCT02566005|12499174|FG001|STARTED|Overall Study||100
11301101|NCT02566005|12499173|FG000|COMPLETED|Overall Study||92
11301102|NCT02566005|12499174|FG001|COMPLETED|Overall Study||94
11301103|NCT02566005|12499173|FG000|NOT COMPLETED|Overall Study||8
11301104|NCT02566005|12499174|FG001|NOT COMPLETED|Overall Study||6
11301105|NCT02566031|12499182|FG000|STARTED|Overall Study||189
11301106|NCT02566031|12499183|FG001|STARTED|Overall Study||190
11301107|NCT02566031|12499182|FG000|COMPLETED|Overall Study||169
11301108|NCT02566031|12499183|FG001|COMPLETED|Overall Study||178
11301109|NCT02566031|12499182|FG000|NOT COMPLETED|Overall Study||20
11301110|NCT02566031|12499183|FG001|NOT COMPLETED|Overall Study||12
11301111|NCT02566044|12499193|FG000|STARTED|Overall Study||6
11301112|NCT02566044|12499194|FG001|STARTED|Overall Study||6
11301113|NCT02566044|12499195|FG002|STARTED|Overall Study||4
11301114|NCT02566044|12499193|FG000|COMPLETED|Overall Study||6
11301115|NCT02566044|12499194|FG001|COMPLETED|Overall Study||6
11301116|NCT02566044|12499195|FG002|COMPLETED|Overall Study||4
11301117|NCT02566044|12499193|FG000|NOT COMPLETED|Overall Study||0
11301118|NCT02566044|12499194|FG001|NOT COMPLETED|Overall Study||0
11301119|NCT02566044|12499195|FG002|NOT COMPLETED|Overall Study||0
11301120|NCT02566083|12499210|FG000|STARTED|Overall Study||214
11301121|NCT02566083|12499211|FG001|STARTED|Overall Study||151
11301122|NCT02566083|12499210|FG000|COMPLETED|Overall Study||198
11301123|NCT02566083|12499211|FG001|COMPLETED|Overall Study||141
11301124|NCT02566083|12499210|FG000|NOT COMPLETED|Overall Study||16
11301125|NCT02566083|12499211|FG001|NOT COMPLETED|Overall Study||10
11301126|NCT02566109|12499217|FG000|STARTED|Overall Study||6
11301127|NCT02566109|12499217|FG000|COMPLETED|Overall Study||5
11301128|NCT02566109|12499217|FG000|NOT COMPLETED|Overall Study||1
11301129|NCT02566135|12499223|FG000|STARTED|Overall Study||29
11301130|NCT02566135|12499224|FG001|STARTED|Overall Study||29
11301131|NCT02566135|12499223|FG000|COMPLETED|Overall Study||29
11301132|NCT02566135|12499224|FG001|COMPLETED|Overall Study||29
11401158|NCT04138498|12595979|FG001|STARTED|Overall Study||10
11401159|NCT04138498|12595980|FG002|STARTED|Overall Study||12
11401160|NCT04138498|12595981|FG003|STARTED|Overall Study||12
11301133|NCT02566135|12499223|FG000|NOT COMPLETED|Overall Study||0
11301134|NCT02566135|12499224|FG001|NOT COMPLETED|Overall Study||0
11301135|NCT02566239|12499232|FG000|STARTED|Overall Study||43
11301136|NCT02566239|12499233|FG001|STARTED|Overall Study||48
11301137|NCT02566239|12499232|FG000|COMPLETED|Overall Study||39
11301138|NCT02566239|12499233|FG001|COMPLETED|Overall Study||44
11301139|NCT02566239|12499232|FG000|NOT COMPLETED|Overall Study||4
11301140|NCT02566239|12499233|FG001|NOT COMPLETED|Overall Study||4
11301141|NCT02566265|12499241|FG000|STARTED|Overall Study||81
11301142|NCT02566265|12499242|FG001|STARTED|Overall Study||41
11301143|NCT02566265|12499241|FG000|Day 7 (+/- 2 Days) (Optional)|Overall Study||19
11301144|NCT02566265|12499242|FG001|Day 7 (+/- 2 Days) (Optional)|Overall Study||12
11301145|NCT02566265|12499241|FG000|Day of Second Vaccine|Overall Study||74
11301146|NCT02566265|12499242|FG001|Day of Second Vaccine|Overall Study||41
11301147|NCT02566265|12499241|FG000|30 Days Following 2nd Vaccine|Overall Study||72
11301148|NCT02566265|12499242|FG001|30 Days Following 2nd Vaccine|Overall Study||35
11301149|NCT02566265|12499241|FG000|End of Study Visit (Optional)|Overall Study||38
11301150|NCT02566265|12499242|FG001|End of Study Visit (Optional)|Overall Study||18
11301151|NCT02566265|12499241|FG000|COMPLETED|Overall Study||72
11301152|NCT02566265|12499242|FG001|COMPLETED|Overall Study||35
11301153|NCT02566265|12499241|FG000|NOT COMPLETED|Overall Study||9
11301154|NCT02566265|12499242|FG001|NOT COMPLETED|Overall Study||6
11301155|NCT02566317|12499250|FG000|STARTED|Overall Study||276
11301156|NCT02566317|12499251|FG001|STARTED|Overall Study||354
11301157|NCT02566317|12499250|FG000|COMPLETED|Overall Study||247
11301158|NCT02566317|12499251|FG001|COMPLETED|Overall Study||292
11301159|NCT02566317|12499250|FG000|NOT COMPLETED|Overall Study||29
11301160|NCT02566317|12499251|FG001|NOT COMPLETED|Overall Study||62
11301161|NCT02566369|12499259|FG000|STARTED|Overall Study||612
11301162|NCT02566369|12499260|FG001|STARTED|Overall Study||596
11301163|NCT02566369|12499259|FG000|COMPLETED|Overall Study||540
11301164|NCT02566369|12499260|FG001|COMPLETED|Overall Study||535
11301165|NCT02566369|12499259|FG000|NOT COMPLETED|Overall Study||72
11301166|NCT02566369|12499260|FG001|NOT COMPLETED|Overall Study||61
11301167|NCT02566525|12499268|FG000|STARTED|Overall Study|FPI - CytoSorb Patient 15 Jan 2016|23
11301168|NCT02566525|12499269|FG001|STARTED|Overall Study|FPI - Control Patient 8 Dec 2015|23
11301169|NCT02566525|12499268|FG000|COMPLETED|Overall Study|LPI - CytoSorb Patient 19 Aug 2016|20
11301170|NCT02566525|12499269|FG001|COMPLETED|Overall Study|LPI - Control 16 Aug 2016|18
11301171|NCT02566525|12499268|FG000|NOT COMPLETED|Overall Study||3
11301172|NCT02566525|12499269|FG001|NOT COMPLETED|Overall Study||5
11301173|NCT02566577|12499279|FG000|STARTED|Overall Study||9
11301174|NCT02566577|12499280|FG001|STARTED|Overall Study||6
11301175|NCT02566577|12499279|FG000|COMPLETED|Overall Study||6
11301176|NCT02566577|12499280|FG001|COMPLETED|Overall Study||4
11301177|NCT02566577|12499279|FG000|NOT COMPLETED|Overall Study||3
11301178|NCT02566577|12499280|FG001|NOT COMPLETED|Overall Study||2
11341511|NCT02934698|12538922|FG000|NOT COMPLETED|Overall Study||0
11341512|NCT02935036|12538928|FG000|STARTED|Overall Study||147
11341513|NCT02935036|12538929|FG001|STARTED|Overall Study||147
11341514|NCT02935036|12538928|FG000|COMPLETED|Overall Study||137
11341515|NCT02935036|12538929|FG001|COMPLETED|Overall Study||136
11341516|NCT02935036|12538928|FG000|NOT COMPLETED|Overall Study||10
11341517|NCT02935036|12538929|FG001|NOT COMPLETED|Overall Study||11
11341518|NCT02935062|12538938|FG000|STARTED|Overall Study||8
11341519|NCT02935062|12538939|FG001|STARTED|Overall Study||8
11341520|NCT02935062|12538940|FG002|STARTED|Overall Study||8
11341521|NCT02935062|12538938|FG000|COMPLETED|Overall Study||8
11341522|NCT02935062|12538939|FG001|COMPLETED|Overall Study||8
11341523|NCT02935062|12538940|FG002|COMPLETED|Overall Study||8
11341524|NCT02935062|12538938|FG000|NOT COMPLETED|Overall Study||0
11341525|NCT02935062|12538939|FG001|NOT COMPLETED|Overall Study||0
11341526|NCT02935062|12538940|FG002|NOT COMPLETED|Overall Study||0
11341527|NCT02935088|12538948|FG000|STARTED|Overall Study||2217
11341528|NCT02935088|12538948|FG000|COMPLETED|Overall Study||2115
11341529|NCT02935088|12538948|FG000|NOT COMPLETED|Overall Study||102
11341530|NCT02935179|12538961|FG000|STARTED|Overall Study||30
11341531|NCT02935179|12538962|FG001|STARTED|Overall Study||30
11341532|NCT02935179|12538961|FG000|COMPLETED|Overall Study||29
11341533|NCT02935179|12538962|FG001|COMPLETED|Overall Study||29
11341534|NCT02935179|12538961|FG000|NOT COMPLETED|Overall Study||1
11401161|NCT04138498|12595978|FG000|COMPLETED|Overall Study||10
11301179|NCT02566590|12499290|FG000|STARTED|Overall Study||10
11301180|NCT02566590|12499291|FG001|STARTED|Overall Study||10
11301181|NCT02566590|12499290|FG000|COMPLETED|Overall Study||10
11301182|NCT02566590|12499291|FG001|COMPLETED|Overall Study||10
11301183|NCT02566590|12499290|FG000|NOT COMPLETED|Overall Study||0
11301184|NCT02566590|12499291|FG001|NOT COMPLETED|Overall Study||0
11301185|NCT02566759|12499314|FG000|STARTED|All Parts||12
11301186|NCT02566759|12499315|FG001|STARTED|All Parts||6
11301187|NCT02566759|12499316|FG002|STARTED|All Parts||6
11301188|NCT02566759|12499317|FG003|STARTED|All Parts||6
11301189|NCT02566759|12499318|FG004|STARTED|All Parts||6
11301190|NCT02566759|12499319|FG005|STARTED|All Parts||6
11301191|NCT02566759|12499320|FG006|STARTED|All Parts||6
11301192|NCT02566759|12499321|FG007|STARTED|All Parts||8
11301193|NCT02566759|12499322|FG008|STARTED|All Parts||6
11301194|NCT02566759|12499323|FG009|STARTED|All Parts||6
11301195|NCT02566759|12499324|FG010|STARTED|All Parts||6
11301196|NCT02566759|12499325|FG011|STARTED|All Parts||6
11301197|NCT02566759|12499326|FG012|STARTED|All Parts||1
11301198|NCT02566759|12499327|FG013|STARTED|All Parts||5
11301199|NCT02566759|12499328|FG014|STARTED|All Parts||8
11301200|NCT02566759|12499329|FG015|STARTED|All Parts||8
11301201|NCT02566759|12499330|FG016|STARTED|All Parts||8
11301202|NCT02566759|12499314|FG000|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
11301203|NCT02566759|12499315|FG001|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
11301204|NCT02566759|12499316|FG002|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
11301205|NCT02566759|12499317|FG003|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
11301206|NCT02566759|12499318|FG004|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
11301207|NCT02566759|12499319|FG005|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
11301208|NCT02566759|12499320|FG006|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
11301209|NCT02566759|12499321|FG007|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
11301210|NCT02566759|12499322|FG008|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
11301211|NCT02566759|12499323|FG009|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
11301212|NCT02566759|12499324|FG010|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
11301213|NCT02566759|12499325|FG011|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
11301214|NCT02566759|12499326|FG012|COMPLETED|All Parts||0
11301215|NCT02566759|12499327|FG013|COMPLETED|All Parts||0
11301216|NCT02566759|12499328|FG014|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
11301217|NCT02566759|12499329|FG015|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
11301218|NCT02566759|12499330|FG016|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
11301219|NCT02566759|12499314|FG000|NOT COMPLETED|All Parts||0
11301220|NCT02566759|12499315|FG001|NOT COMPLETED|All Parts||1
11301221|NCT02566759|12499316|FG002|NOT COMPLETED|All Parts||0
11301222|NCT02566759|12499317|FG003|NOT COMPLETED|All Parts||0
11301223|NCT02566759|12499318|FG004|NOT COMPLETED|All Parts||0
11301224|NCT02566759|12499319|FG005|NOT COMPLETED|All Parts||0
11301225|NCT02566759|12499320|FG006|NOT COMPLETED|All Parts||0
11301226|NCT02566759|12499321|FG007|NOT COMPLETED|All Parts||0
11301227|NCT02566759|12499322|FG008|NOT COMPLETED|All Parts||0
11301228|NCT02566759|12499323|FG009|NOT COMPLETED|All Parts||0
11301229|NCT02566759|12499324|FG010|NOT COMPLETED|All Parts||0
11301230|NCT02566759|12499325|FG011|NOT COMPLETED|All Parts||0
11301231|NCT02566759|12499326|FG012|NOT COMPLETED|All Parts||1
11301232|NCT02566759|12499327|FG013|NOT COMPLETED|All Parts||5
11301233|NCT02566759|12499328|FG014|NOT COMPLETED|All Parts||0
11301234|NCT02566759|12499329|FG015|NOT COMPLETED|All Parts||0
11301235|NCT02566759|12499330|FG016|NOT COMPLETED|All Parts||0
11301236|NCT02566759|12499314|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301237|NCT02566759|12499315|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301238|NCT02566759|12499316|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301239|NCT02566759|12499317|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301240|NCT02566759|12499318|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301241|NCT02566759|12499319|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301242|NCT02566759|12499320|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301243|NCT02566759|12499321|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301244|NCT02566759|12499322|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301245|NCT02566759|12499323|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301246|NCT02566759|12499324|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301247|NCT02566759|12499325|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301248|NCT02566759|12499326|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301249|NCT02566759|12499327|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301250|NCT02566759|12499328|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8
11301251|NCT02566759|12499329|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8
11301252|NCT02566759|12499330|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||8
11301253|NCT02566759|12499314|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301254|NCT02566759|12499315|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301255|NCT02566759|12499316|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301256|NCT02566759|12499317|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301257|NCT02566759|12499318|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301258|NCT02566759|12499319|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301259|NCT02566759|12499320|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301260|NCT02566759|12499321|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301261|NCT02566759|12499322|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301262|NCT02566759|12499323|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301263|NCT02566759|12499324|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301264|NCT02566759|12499325|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301265|NCT02566759|12499326|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301266|NCT02566759|12499327|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301267|NCT02566759|12499328|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
11301268|NCT02566759|12499329|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
11301269|NCT02566759|12499330|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
11301270|NCT02566759|12499314|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301271|NCT02566759|12499315|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301272|NCT02566759|12499316|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301273|NCT02566759|12499317|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301274|NCT02566759|12499318|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301275|NCT02566759|12499319|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301276|NCT02566759|12499320|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301277|NCT02566759|12499321|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301278|NCT02566759|12499322|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301279|NCT02566759|12499323|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301280|NCT02566759|12499324|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301281|NCT02566759|12499325|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301282|NCT02566759|12499326|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301283|NCT02566759|12499327|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301284|NCT02566759|12499328|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301285|NCT02566759|12499329|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301286|NCT02566759|12499330|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301287|NCT02566759|12499314|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301288|NCT02566759|12499315|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301289|NCT02566759|12499316|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301290|NCT02566759|12499317|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301291|NCT02566759|12499318|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301292|NCT02566759|12499319|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301293|NCT02566759|12499320|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301294|NCT02566759|12499321|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301295|NCT02566759|12499322|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301296|NCT02566759|12499323|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301297|NCT02566759|12499324|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301298|NCT02566759|12499325|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301299|NCT02566759|12499326|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301300|NCT02566759|12499327|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301301|NCT02566759|12499328|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8
11301302|NCT02566759|12499329|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8
11301303|NCT02566759|12499330|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||8
11301304|NCT02566759|12499314|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301305|NCT02566759|12499315|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301306|NCT02566759|12499316|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301307|NCT02566759|12499317|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301308|NCT02566759|12499318|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301309|NCT02566759|12499319|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301310|NCT02566759|12499320|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301311|NCT02566759|12499321|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301312|NCT02566759|12499322|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301313|NCT02566759|12499323|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301314|NCT02566759|12499324|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301315|NCT02566759|12499325|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301316|NCT02566759|12499326|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301317|NCT02566759|12499327|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301318|NCT02566759|12499328|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
11301319|NCT02566759|12499329|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
11301320|NCT02566759|12499330|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
11301321|NCT02566759|12499314|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301322|NCT02566759|12499315|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301323|NCT02566759|12499316|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301324|NCT02566759|12499317|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301325|NCT02566759|12499318|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301326|NCT02566759|12499319|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301327|NCT02566759|12499320|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301328|NCT02566759|12499321|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301329|NCT02566759|12499322|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301330|NCT02566759|12499323|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301331|NCT02566759|12499324|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301332|NCT02566759|12499325|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301333|NCT02566759|12499326|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301334|NCT02566759|12499327|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301335|NCT02566759|12499328|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301336|NCT02566759|12499329|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301337|NCT02566759|12499330|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
11301338|NCT02566759|12499314|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301339|NCT02566759|12499315|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301340|NCT02566759|12499316|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301341|NCT02566759|12499317|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301342|NCT02566759|12499318|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301343|NCT02566759|12499319|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301344|NCT02566759|12499320|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301345|NCT02566759|12499321|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301346|NCT02566759|12499322|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301347|NCT02566759|12499323|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301348|NCT02566759|12499324|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301349|NCT02566759|12499325|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301350|NCT02566759|12499326|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301351|NCT02566759|12499327|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0
11301352|NCT02566759|12499328|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8
11301353|NCT02566759|12499329|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8
11301354|NCT02566759|12499330|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||7
11301355|NCT02566759|12499314|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301356|NCT02566759|12499315|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301357|NCT02566759|12499316|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301358|NCT02566759|12499317|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301359|NCT02566759|12499318|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301360|NCT02566759|12499319|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301361|NCT02566759|12499320|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301362|NCT02566759|12499321|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301363|NCT02566759|12499322|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301364|NCT02566759|12499323|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301365|NCT02566759|12499324|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301366|NCT02566759|12499325|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301367|NCT02566759|12499326|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301368|NCT02566759|12499327|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301369|NCT02566759|12499328|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
11301370|NCT02566759|12499329|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
11301371|NCT02566759|12499330|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
11301372|NCT02566759|12499314|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301373|NCT02566759|12499315|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301374|NCT02566759|12499316|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301375|NCT02566759|12499317|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301376|NCT02566759|12499318|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301377|NCT02566759|12499319|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301378|NCT02566759|12499320|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301379|NCT02566759|12499321|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301380|NCT02566759|12499322|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301381|NCT02566759|12499323|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301382|NCT02566759|12499324|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301383|NCT02566759|12499325|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301384|NCT02566759|12499326|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301385|NCT02566759|12499327|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301386|NCT02566759|12499328|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301387|NCT02566759|12499329|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301388|NCT02566759|12499330|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
11301389|NCT02566759|12499314|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301390|NCT02566759|12499315|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301391|NCT02566759|12499316|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301392|NCT02566759|12499317|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301393|NCT02566759|12499318|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301394|NCT02566759|12499319|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301395|NCT02566759|12499320|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301396|NCT02566759|12499321|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301397|NCT02566759|12499322|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301398|NCT02566759|12499323|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301399|NCT02566759|12499324|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301400|NCT02566759|12499325|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301401|NCT02566759|12499326|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301402|NCT02566759|12499327|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0
11301403|NCT02566759|12499328|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8
11301404|NCT02566759|12499329|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8
11301405|NCT02566759|12499330|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||7
11301406|NCT02566759|12499314|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301407|NCT02566759|12499315|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301408|NCT02566759|12499316|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301409|NCT02566759|12499317|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301410|NCT02566759|12499318|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301411|NCT02566759|12499319|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301412|NCT02566759|12499320|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301413|NCT02566759|12499321|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301414|NCT02566759|12499322|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301415|NCT02566759|12499323|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301416|NCT02566759|12499324|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301417|NCT02566759|12499325|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301418|NCT02566759|12499326|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301419|NCT02566759|12499327|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301420|NCT02566759|12499328|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
11301421|NCT02566759|12499329|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
11301422|NCT02566759|12499330|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
11301423|NCT02566759|12499314|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301424|NCT02566759|12499315|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301425|NCT02566759|12499316|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301426|NCT02566759|12499317|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301427|NCT02566759|12499318|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301428|NCT02566759|12499319|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301429|NCT02566759|12499320|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301430|NCT02566759|12499321|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301431|NCT02566759|12499322|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301432|NCT02566759|12499323|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301433|NCT02566759|12499324|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301434|NCT02566759|12499325|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301435|NCT02566759|12499326|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301436|NCT02566759|12499327|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301437|NCT02566759|12499328|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301438|NCT02566759|12499329|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301439|NCT02566759|12499330|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
11301440|NCT02566785|12499391|FG000|STARTED|Overall Study||15
11301441|NCT02566785|12499392|FG001|STARTED|Overall Study||18
11301442|NCT02566785|12499391|FG000|COMPLETED|Overall Study||14
11301443|NCT02566785|12499392|FG001|COMPLETED|Overall Study||15
11301444|NCT02566785|12499391|FG000|NOT COMPLETED|Overall Study||1
11301445|NCT02566785|12499392|FG001|NOT COMPLETED|Overall Study||3
11301446|NCT02566889|12499400|FG000|STARTED|Overall Study||45
11301447|NCT02566889|12499401|FG001|STARTED|Overall Study||8
11301448|NCT02566889|12499400|FG000|Cross-over to Dose Escalation Group|Overall Study||1
11301449|NCT02566889|12499401|FG001|Cross-over to Dose Escalation Group|Overall Study||0
11301450|NCT02566889|12499400|FG000|COMPLETED|Overall Study||32
11301451|NCT02566889|12499401|FG001|COMPLETED|Overall Study||3
11301452|NCT02566889|12499400|FG000|NOT COMPLETED|Overall Study||13
11301453|NCT02566889|12499401|FG001|NOT COMPLETED|Overall Study||5
11301454|NCT02566902|12499408|FG000|STARTED|Overall Study||60
11301455|NCT02566902|12499409|FG001|STARTED|Overall Study||58
11301456|NCT02566902|12499408|FG000|COMPLETED|Overall Study||58
11301457|NCT02566902|12499409|FG001|COMPLETED|Overall Study||57
11301458|NCT02566902|12499408|FG000|NOT COMPLETED|Overall Study||2
11301459|NCT02566902|12499409|FG001|NOT COMPLETED|Overall Study||1
11301460|NCT02566993|12499417|FG000|STARTED|Overall Study||307
11301461|NCT02566993|12499418|FG001|STARTED|Overall Study||306
11301462|NCT02566993|12499417|FG000|COMPLETED|Overall Study||0
11301463|NCT02566993|12499418|FG001|COMPLETED|Overall Study||0
11301464|NCT02566993|12499417|FG000|NOT COMPLETED|Overall Study||307
11301465|NCT02566993|12499418|FG001|NOT COMPLETED|Overall Study||306
11301466|NCT02567188|12499426|FG000|STARTED|Overall Study||144
11301467|NCT02567188|12499426|FG000|COMPLETED|Overall Study||109
11301468|NCT02567188|12499426|FG000|NOT COMPLETED|Overall Study||35
11301469|NCT02567227|12499433|FG000|STARTED|9 Weeks||192
11301470|NCT02567227|12499434|FG001|STARTED|9 Weeks||191
11301471|NCT02567227|12499433|FG000|COMPLETED|9 Weeks||158
11301472|NCT02567227|12499434|FG001|COMPLETED|9 Weeks||167
11301473|NCT02567227|12499433|FG000|NOT COMPLETED|9 Weeks||34
11301474|NCT02567227|12499434|FG001|NOT COMPLETED|9 Weeks||24
11301475|NCT02567227|12499433|FG000|STARTED|6 Month||158
11301476|NCT02567227|12499434|FG001|STARTED|6 Month||167
11301477|NCT02567227|12499433|FG000|COMPLETED|6 Month||113
11301478|NCT02567227|12499434|FG001|COMPLETED|6 Month||127
11301479|NCT02567227|12499433|FG000|NOT COMPLETED|6 Month||45
11301480|NCT02567227|12499434|FG001|NOT COMPLETED|6 Month||40
11301481|NCT02567227|12499433|FG000|STARTED|12 Months||113
11301482|NCT02567227|12499434|FG001|STARTED|12 Months||127
11301483|NCT02567227|12499433|FG000|COMPLETED|12 Months||82
11301484|NCT02567227|12499434|FG001|COMPLETED|12 Months||93
11301485|NCT02567227|12499433|FG000|NOT COMPLETED|12 Months||31
11301486|NCT02567227|12499434|FG001|NOT COMPLETED|12 Months||34
11301487|NCT02567266|12499443|FG000|STARTED|Overall Study||68
11301488|NCT02567266|12499444|FG001|STARTED|Overall Study||60
11301489|NCT02567266|12499445|FG002|STARTED|Overall Study||68
11301490|NCT02567266|12499443|FG000|Midpoint (8 Weeks)|Overall Study||54
11301491|NCT02567266|12499444|FG001|Midpoint (8 Weeks)|Overall Study||52
11301492|NCT02567266|12499445|FG002|Midpoint (8 Weeks)|Overall Study||55
11301493|NCT02567266|12499443|FG000|Post (16 Weeks)|Overall Study||49
11301494|NCT02567266|12499444|FG001|Post (16 Weeks)|Overall Study||43
11301495|NCT02567266|12499445|FG002|Post (16 Weeks)|Overall Study||53
11301496|NCT02567266|12499443|FG000|Follow-up (28 Weeks)|Overall Study||45
11301497|NCT02567266|12499444|FG001|Follow-up (28 Weeks)|Overall Study||45
11301498|NCT02567266|12499445|FG002|Follow-up (28 Weeks)|Overall Study||52
11301499|NCT02567266|12499443|FG000|COMPLETED|Overall Study||45
11301500|NCT02567266|12499444|FG001|COMPLETED|Overall Study||45
11301501|NCT02567266|12499445|FG002|COMPLETED|Overall Study||52
11301502|NCT02567266|12499443|FG000|NOT COMPLETED|Overall Study||23
11301503|NCT02567266|12499444|FG001|NOT COMPLETED|Overall Study||15
11301504|NCT02567266|12499445|FG002|NOT COMPLETED|Overall Study||16
11301505|NCT02567552|12499455|FG000|STARTED|Overall Study||12
11301506|NCT02567552|12499456|FG001|STARTED|Overall Study||12
11301507|NCT02567552|12499455|FG000|COMPLETED|Overall Study||12
11301508|NCT02567552|12499456|FG001|COMPLETED|Overall Study|dropout by pain in the puncture site|11
11301509|NCT02567552|12499455|FG000|NOT COMPLETED|Overall Study||0
11301510|NCT02567552|12499456|FG001|NOT COMPLETED|Overall Study||1
11301511|NCT02567656|12499468|FG000|STARTED|Overall Study||4
11301512|NCT02567656|12499469|FG001|STARTED|Overall Study||4
11301513|NCT02567656|12499470|FG002|STARTED|Overall Study||5
11301514|NCT02567656|12499471|FG003|STARTED|Overall Study||6
11301515|NCT02567656|12499472|FG004|STARTED|Overall Study||19
11301516|NCT02567656|12499473|FG005|STARTED|Overall Study||20
11301517|NCT02567656|12499468|FG000|COMPLETED|Overall Study||3
11301518|NCT02567656|12499469|FG001|COMPLETED|Overall Study||3
11301519|NCT02567656|12499470|FG002|COMPLETED|Overall Study||3
11301520|NCT02567656|12499471|FG003|COMPLETED|Overall Study||6
11301521|NCT02567656|12499472|FG004|COMPLETED|Overall Study||19
11301522|NCT02567656|12499473|FG005|COMPLETED|Overall Study||20
11301523|NCT02567656|12499468|FG000|NOT COMPLETED|Overall Study||1
11301524|NCT02567656|12499469|FG001|NOT COMPLETED|Overall Study||1
11301525|NCT02567656|12499470|FG002|NOT COMPLETED|Overall Study||2
11301526|NCT02567656|12499471|FG003|NOT COMPLETED|Overall Study||0
11301527|NCT02567656|12499472|FG004|NOT COMPLETED|Overall Study||0
11301528|NCT02567656|12499473|FG005|NOT COMPLETED|Overall Study||0
11301529|NCT02567708|12499487|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
11301530|NCT02567708|12499488|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
11301531|NCT02567708|12499487|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
11301532|NCT02567708|12499488|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
11301533|NCT02567708|12499487|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
11301534|NCT02567708|12499488|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
11301535|NCT02567708|12499487|FG000|STARTED|Washout Period (Up to 4 Weeks)||22
11301536|NCT02567708|12499488|FG001|STARTED|Washout Period (Up to 4 Weeks)||23
11301537|NCT02567708|12499487|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||22
11301538|NCT02567708|12499488|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||23
11301539|NCT02567708|12499487|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
11301540|NCT02567708|12499488|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
11301541|NCT02567708|12499487|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
11301542|NCT02567708|12499488|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
11301543|NCT02567708|12499487|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
11301544|NCT02567708|12499488|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
11301545|NCT02567708|12499487|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
11301546|NCT02567708|12499488|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
11301547|NCT02567968|12499495|FG000|STARTED|First Intervention||4
11301548|NCT02567968|12499496|FG001|STARTED|First Intervention||4
11301549|NCT02567968|12499495|FG000|COMPLETED|First Intervention||4
11301550|NCT02567968|12499496|FG001|COMPLETED|First Intervention||4
11301551|NCT02567968|12499495|FG000|NOT COMPLETED|First Intervention||0
11301552|NCT02567968|12499496|FG001|NOT COMPLETED|First Intervention||0
11301553|NCT02567968|12499495|FG000|STARTED|Washout (2 Weeks)||4
11301554|NCT02567968|12499496|FG001|STARTED|Washout (2 Weeks)||4
11301555|NCT02567968|12499495|FG000|COMPLETED|Washout (2 Weeks)||4
11301556|NCT02567968|12499496|FG001|COMPLETED|Washout (2 Weeks)||4
11301557|NCT02567968|12499495|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11301558|NCT02567968|12499496|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11301559|NCT02567968|12499495|FG000|STARTED|Second Intervention||4
11301560|NCT02567968|12499496|FG001|STARTED|Second Intervention||4
11301561|NCT02567968|12499495|FG000|COMPLETED|Second Intervention||4
11301562|NCT02567968|12499496|FG001|COMPLETED|Second Intervention||4
11301563|NCT02567968|12499495|FG000|NOT COMPLETED|Second Intervention||0
11301564|NCT02567968|12499496|FG001|NOT COMPLETED|Second Intervention||0
11301565|NCT02568046|12499504|FG000|STARTED|Overall Study||5
11301566|NCT02568046|12499505|FG001|STARTED|Overall Study||5
11301567|NCT02568046|12499504|FG000|COMPLETED|Overall Study||0
11301568|NCT02568046|12499505|FG001|COMPLETED|Overall Study||2
11301569|NCT02568046|12499504|FG000|NOT COMPLETED|Overall Study||5
11301570|NCT02568046|12499505|FG001|NOT COMPLETED|Overall Study||3
11301571|NCT02568072|12499511|FG000|STARTED|Overall Study||120
11301572|NCT02568072|12499511|FG000|COMPLETED|Overall Study||68
11301573|NCT02568072|12499511|FG000|NOT COMPLETED|Overall Study||52
11301574|NCT02568254|12499516|FG000|STARTED|Period 1||13
11301575|NCT02568254|12499517|FG001|STARTED|Period 1||12
11301576|NCT02568254|12499518|FG002|STARTED|Period 1||13
11301577|NCT02568254|12499519|FG003|STARTED|Period 1||12
11301578|NCT02568254|12499520|FG004|STARTED|Period 1||12
11301579|NCT02568254|12499521|FG005|STARTED|Period 1||12
11301580|NCT02568254|12499516|FG000|COMPLETED|Period 1||13
11301581|NCT02568254|12499517|FG001|COMPLETED|Period 1||12
11301582|NCT02568254|12499518|FG002|COMPLETED|Period 1||13
11301583|NCT02568254|12499519|FG003|COMPLETED|Period 1||12
11301584|NCT02568254|12499520|FG004|COMPLETED|Period 1||12
11401162|NCT04138498|12595979|FG001|COMPLETED|Overall Study||10
11401163|NCT04138498|12595980|FG002|COMPLETED|Overall Study||10
11401164|NCT04138498|12595981|FG003|COMPLETED|Overall Study||9
11401165|NCT04138498|12595978|FG000|NOT COMPLETED|Overall Study||1
11401166|NCT04138498|12595979|FG001|NOT COMPLETED|Overall Study||0
11401167|NCT04138498|12595980|FG002|NOT COMPLETED|Overall Study||2
11401168|NCT04138498|12595981|FG003|NOT COMPLETED|Overall Study||3
11401169|NCT04138043|12595997|FG000|STARTED|Overall Study||2
11401170|NCT04138043|12595998|FG001|STARTED|Overall Study||7
11401171|NCT04138043|12595997|FG000|COMPLETED|Overall Study||2
11401172|NCT04138043|12595998|FG001|COMPLETED|Overall Study||6
11401173|NCT04138043|12595997|FG000|NOT COMPLETED|Overall Study||0
11401174|NCT04138043|12595998|FG001|NOT COMPLETED|Overall Study||1
11301585|NCT02568254|12499521|FG005|COMPLETED|Period 1||12
11301586|NCT02568254|12499516|FG000|NOT COMPLETED|Period 1||0
11301587|NCT02568254|12499517|FG001|NOT COMPLETED|Period 1||0
11301588|NCT02568254|12499518|FG002|NOT COMPLETED|Period 1||0
11301589|NCT02568254|12499519|FG003|NOT COMPLETED|Period 1||0
11301590|NCT02568254|12499520|FG004|NOT COMPLETED|Period 1||0
11301591|NCT02568254|12499521|FG005|NOT COMPLETED|Period 1||0
11301592|NCT02568254|12499516|FG000|STARTED|Period 2||13
11301593|NCT02568254|12499517|FG001|STARTED|Period 2||12
11301594|NCT02568254|12499518|FG002|STARTED|Period 2||13
11301595|NCT02568254|12499519|FG003|STARTED|Period 2||12
11301596|NCT02568254|12499520|FG004|STARTED|Period 2||12
11301597|NCT02568254|12499521|FG005|STARTED|Period 2||12
11301598|NCT02568254|12499516|FG000|COMPLETED|Period 2||13
11301599|NCT02568254|12499517|FG001|COMPLETED|Period 2||12
11301600|NCT02568254|12499518|FG002|COMPLETED|Period 2||12
11301601|NCT02568254|12499519|FG003|COMPLETED|Period 2||12
11301602|NCT02568254|12499520|FG004|COMPLETED|Period 2||12
11301603|NCT02568254|12499521|FG005|COMPLETED|Period 2||12
11301604|NCT02568254|12499516|FG000|NOT COMPLETED|Period 2||0
11301605|NCT02568254|12499517|FG001|NOT COMPLETED|Period 2||0
11301606|NCT02568254|12499518|FG002|NOT COMPLETED|Period 2||1
11301607|NCT02568254|12499519|FG003|NOT COMPLETED|Period 2||0
11301608|NCT02568254|12499520|FG004|NOT COMPLETED|Period 2||0
11301609|NCT02568254|12499521|FG005|NOT COMPLETED|Period 2||0
11301610|NCT02568254|12499516|FG000|STARTED|Period 3||13
11301611|NCT02568254|12499517|FG001|STARTED|Period 3||12
11301612|NCT02568254|12499518|FG002|STARTED|Period 3||12
11301613|NCT02568254|12499519|FG003|STARTED|Period 3||12
11301614|NCT02568254|12499520|FG004|STARTED|Period 3||12
11301615|NCT02568254|12499521|FG005|STARTED|Period 3||12
11301616|NCT02568254|12499516|FG000|COMPLETED|Period 3||13
11301617|NCT02568254|12499517|FG001|COMPLETED|Period 3||12
11301618|NCT02568254|12499518|FG002|COMPLETED|Period 3||12
11301619|NCT02568254|12499519|FG003|COMPLETED|Period 3||12
11301620|NCT02568254|12499520|FG004|COMPLETED|Period 3||11
11301621|NCT02568254|12499521|FG005|COMPLETED|Period 3||12
11301622|NCT02568254|12499516|FG000|NOT COMPLETED|Period 3||0
11301623|NCT02568254|12499517|FG001|NOT COMPLETED|Period 3||0
11301624|NCT02568254|12499518|FG002|NOT COMPLETED|Period 3||0
11301625|NCT02568254|12499519|FG003|NOT COMPLETED|Period 3||0
11301626|NCT02568254|12499520|FG004|NOT COMPLETED|Period 3||1
11301627|NCT02568254|12499521|FG005|NOT COMPLETED|Period 3||0
11301628|NCT02568345|12499529|FG000|STARTED|Overall Study||31
11301629|NCT02568345|12499529|FG000|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
11301630|NCT02568345|12499529|FG000|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
11301631|NCT02568345|12499529|FG000|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
11301632|NCT02568345|12499529|FG000|COMPLETED|Overall Study||31
11301633|NCT02568345|12499529|FG000|NOT COMPLETED|Overall Study||0
11301634|NCT02568384|12499533|FG000|STARTED|Overall Study||45
11301635|NCT02568384|12499533|FG000|COMPLETED|Overall Study||43
11301636|NCT02568384|12499533|FG000|NOT COMPLETED|Overall Study||2
11301637|NCT02568397|12499537|FG000|STARTED|Period 1||60
11301638|NCT02568397|12499538|FG001|STARTED|Period 1||0
11301639|NCT02568397|12499537|FG000|Received at Least 1 Dose of Study Drug|Period 1||60
11301640|NCT02568397|12499538|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
11301641|NCT02568397|12499537|FG000|COMPLETED|Period 1||60
11301642|NCT02568397|12499538|FG001|COMPLETED|Period 1||0
11301643|NCT02568397|12499537|FG000|NOT COMPLETED|Period 1||0
11301644|NCT02568397|12499538|FG001|NOT COMPLETED|Period 1||0
11301645|NCT02568397|12499537|FG000|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0
11301646|NCT02568397|12499538|FG001|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60
11301647|NCT02568397|12499537|FG000|COMPLETED|Period 2||0
11301648|NCT02568397|12499538|FG001|COMPLETED|Period 2||58
11301649|NCT02568397|12499537|FG000|NOT COMPLETED|Period 2||0
11301650|NCT02568397|12499538|FG001|NOT COMPLETED|Period 2||2
11301651|NCT02568475|12499555|FG000|STARTED|Overall Study||97
11401175|NCT04137627|12596007|FG000|STARTED|Overall Study||25
11301652|NCT02568475|12499556|FG001|STARTED|Overall Study||95
11301653|NCT02568475|12499555|FG000|Post-test|Overall Study||85
11301654|NCT02568475|12499556|FG001|Post-test|Overall Study||82
11301655|NCT02568475|12499555|FG000|COMPLETED|Overall Study||46
11301656|NCT02568475|12499556|FG001|COMPLETED|Overall Study||52
11301657|NCT02568475|12499555|FG000|NOT COMPLETED|Overall Study||51
11301658|NCT02568475|12499556|FG001|NOT COMPLETED|Overall Study||43
11301659|NCT02568644|12499564|FG000|STARTED|Overall Study||30
11301660|NCT02568644|12499565|FG001|STARTED|Overall Study||30
11301661|NCT02568644|12499564|FG000|COMPLETED|Overall Study||30
11301662|NCT02568644|12499565|FG001|COMPLETED|Overall Study||30
11301663|NCT02568644|12499564|FG000|NOT COMPLETED|Overall Study||0
11301664|NCT02568644|12499565|FG001|NOT COMPLETED|Overall Study||0
11301665|NCT02568683|12499575|FG000|STARTED|Overall Study||6
11301666|NCT02568683|12499576|FG001|STARTED|Overall Study||4
11301667|NCT02568683|12499575|FG000|COMPLETED|Overall Study||0
11301668|NCT02568683|12499576|FG001|COMPLETED|Overall Study||0
11301669|NCT02568683|12499575|FG000|NOT COMPLETED|Overall Study||6
11301670|NCT02568683|12499576|FG001|NOT COMPLETED|Overall Study||4
11301671|NCT02568852|12499584|FG000|STARTED|Overall Study||25
11301672|NCT02568852|12499585|FG001|STARTED|Overall Study||25
11301673|NCT02568852|12499584|FG000|COMPLETED|Overall Study||25
11301674|NCT02568852|12499585|FG001|COMPLETED|Overall Study||25
11301675|NCT02568852|12499584|FG000|NOT COMPLETED|Overall Study||0
11301676|NCT02568852|12499585|FG001|NOT COMPLETED|Overall Study||0
11301677|NCT02569086|12499591|FG000|STARTED|Overall Study||22
11301678|NCT02569086|12499591|FG000|COMPLETED|Overall Study||22
11301679|NCT02569086|12499591|FG000|NOT COMPLETED|Overall Study||0
11301680|NCT02569112|12499595|FG000|STARTED|Overall Study||10
11301681|NCT02569112|12499596|FG001|STARTED|Overall Study||10
11301682|NCT02569112|12499595|FG000|COMPLETED|Overall Study||10
11301683|NCT02569112|12499596|FG001|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
11301684|NCT02569112|12499595|FG000|NOT COMPLETED|Overall Study||0
11301685|NCT02569112|12499596|FG001|NOT COMPLETED|Overall Study||0
11301686|NCT02569398|12499604|FG000|STARTED|Overall Study||185
11301687|NCT02569398|12499605|FG001|STARTED|Overall Study||189
11301688|NCT02569398|12499606|FG002|STARTED|Overall Study||183
11301689|NCT02569398|12499604|FG000|COMPLETED|Overall Study||0
11301690|NCT02569398|12499605|FG001|COMPLETED|Overall Study||0
11301691|NCT02569398|12499606|FG002|COMPLETED|Overall Study||0
11301692|NCT02569398|12499604|FG000|NOT COMPLETED|Overall Study||185
11301693|NCT02569398|12499605|FG001|NOT COMPLETED|Overall Study||189
11301694|NCT02569398|12499606|FG002|NOT COMPLETED|Overall Study||183
11301695|NCT02569411|12499616|FG000|STARTED|Overall Study||65
11301696|NCT02569411|12499617|FG001|STARTED|Overall Study||64
11301697|NCT02569411|12499616|FG000|COMPLETED|Overall Study||0
11301698|NCT02569411|12499617|FG001|COMPLETED|Overall Study||0
11301699|NCT02569411|12499616|FG000|NOT COMPLETED|Overall Study||65
11301700|NCT02569411|12499617|FG001|NOT COMPLETED|Overall Study||64
11301701|NCT02569437|12499625|FG000|STARTED|Overall Study||24
11301702|NCT02569437|12499626|FG001|STARTED|Overall Study||25
11301703|NCT02569437|12499625|FG000|COMPLETED|Overall Study||12
11301704|NCT02569437|12499626|FG001|COMPLETED|Overall Study||11
11301705|NCT02569437|12499625|FG000|NOT COMPLETED|Overall Study||12
11301706|NCT02569437|12499626|FG001|NOT COMPLETED|Overall Study||14
11301707|NCT02569541|12499632|FG000|STARTED|Overall Study||30
11301708|NCT02569541|12499632|FG000|COMPLETED|Overall Study||9
11301709|NCT02569541|12499632|FG000|NOT COMPLETED|Overall Study||21
11301710|NCT02569632|12499636|FG000|STARTED|Overall Study||18
11301711|NCT02569632|12499636|FG000|COMPLETED|Overall Study||17
11301712|NCT02569632|12499636|FG000|NOT COMPLETED|Overall Study||1
11301713|NCT02569658|12499642|FG000|STARTED|Overall Study||53
11301714|NCT02569658|12499643|FG001|STARTED|Overall Study||57
11301715|NCT02569658|12499642|FG000|COMPLETED|Overall Study||52
11301716|NCT02569658|12499643|FG001|COMPLETED|Overall Study||56
11301717|NCT02569658|12499642|FG000|NOT COMPLETED|Overall Study||1
11301718|NCT02569658|12499643|FG001|NOT COMPLETED|Overall Study||1
11301719|NCT02569710|12499659|FG000|STARTED|Overall Study||20
11301720|NCT02569710|12499660|FG001|STARTED|Overall Study||25
11301721|NCT02569710|12499661|FG002|STARTED|Overall Study||20
11301722|NCT02569710|12499662|FG003|STARTED|Overall Study||20
11301723|NCT02569710|12499663|FG004|STARTED|Overall Study||8
11301724|NCT02569710|12499664|FG005|STARTED|Overall Study||5
11301725|NCT02569710|12499665|FG006|STARTED|Overall Study||14
11301726|NCT02569710|12499666|FG007|STARTED|Overall Study||30
11301727|NCT02569710|12499667|FG008|STARTED|Overall Study||15
11301728|NCT02569710|12499668|FG009|STARTED|Overall Study||4
11301729|NCT02569710|12499659|FG000|COMPLETED|Overall Study||19
11301730|NCT02569710|12499660|FG001|COMPLETED|Overall Study||25
11301731|NCT02569710|12499661|FG002|COMPLETED|Overall Study||20
11301732|NCT02569710|12499662|FG003|COMPLETED|Overall Study||20
11301733|NCT02569710|12499663|FG004|COMPLETED|Overall Study||7
11301734|NCT02569710|12499664|FG005|COMPLETED|Overall Study||4
11301735|NCT02569710|12499665|FG006|COMPLETED|Overall Study||12
11301736|NCT02569710|12499666|FG007|COMPLETED|Overall Study||30
11301737|NCT02569710|12499667|FG008|COMPLETED|Overall Study||14
11301738|NCT02569710|12499668|FG009|COMPLETED|Overall Study||4
11301739|NCT02569710|12499659|FG000|NOT COMPLETED|Overall Study||1
11301740|NCT02569710|12499660|FG001|NOT COMPLETED|Overall Study||0
11301741|NCT02569710|12499661|FG002|NOT COMPLETED|Overall Study||0
11301742|NCT02569710|12499662|FG003|NOT COMPLETED|Overall Study||0
11301743|NCT02569710|12499663|FG004|NOT COMPLETED|Overall Study||1
11301744|NCT02569710|12499664|FG005|NOT COMPLETED|Overall Study||1
11301745|NCT02569710|12499665|FG006|NOT COMPLETED|Overall Study||2
11301746|NCT02569710|12499666|FG007|NOT COMPLETED|Overall Study||0
11301747|NCT02569710|12499667|FG008|NOT COMPLETED|Overall Study||1
11301748|NCT02569710|12499668|FG009|NOT COMPLETED|Overall Study||0
11301749|NCT02569723|12499701|FG000|STARTED|Overall Study||6
11301750|NCT02569723|12499701|FG000|COMPLETED|Overall Study||6
11301751|NCT02569723|12499701|FG000|NOT COMPLETED|Overall Study||0
11301752|NCT02569801|12499707|FG000|STARTED|Overall Study||36
11301753|NCT02569801|12499708|FG001|STARTED|Overall Study||35
11301754|NCT02569801|12499707|FG000|Received Treatment|Overall Study||35
11301755|NCT02569801|12499708|FG001|Received Treatment|Overall Study||35
11301756|NCT02569801|12499707|FG000|COMPLETED|Overall Study||0
11301757|NCT02569801|12499708|FG001|COMPLETED|Overall Study||0
11301758|NCT02569801|12499707|FG000|NOT COMPLETED|Overall Study||36
11301759|NCT02569801|12499708|FG001|NOT COMPLETED|Overall Study||35
11301760|NCT02569853|12499716|FG000|STARTED|Overall Study||131
11301761|NCT02569853|12499717|FG001|STARTED|Overall Study||137
11301762|NCT02569853|12499716|FG000|COMPLETED|Overall Study||111
11301763|NCT02569853|12499717|FG001|COMPLETED|Overall Study||123
11301764|NCT02569853|12499716|FG000|NOT COMPLETED|Overall Study||20
11301765|NCT02569853|12499717|FG001|NOT COMPLETED|Overall Study||14
11301766|NCT02569892|12499725|FG000|STARTED|Overall Study||10
11301767|NCT02569892|12499726|FG001|STARTED|Overall Study||9
11301768|NCT02569892|12499725|FG000|COMPLETED|Overall Study||10
11301769|NCT02569892|12499726|FG001|COMPLETED|Overall Study||8
11301770|NCT02569892|12499725|FG000|NOT COMPLETED|Overall Study||0
11301771|NCT02569892|12499726|FG001|NOT COMPLETED|Overall Study||1
11301772|NCT02569996|12499732|FG000|STARTED|Overall Study||124
11301773|NCT02569996|12499732|FG000|COMPLETED|Overall Study||69
11301774|NCT02569996|12499732|FG000|NOT COMPLETED|Overall Study||55
11301775|NCT02570022|12499738|FG000|STARTED|Overall Study||26
11301776|NCT02570022|12499739|FG001|STARTED|Overall Study||31
11301777|NCT02570022|12499738|FG000|COMPLETED|Overall Study||26
11301778|NCT02570022|12499739|FG001|COMPLETED|Overall Study||31
11301779|NCT02570022|12499738|FG000|NOT COMPLETED|Overall Study||0
11301780|NCT02570022|12499739|FG001|NOT COMPLETED|Overall Study||0
11301781|NCT02570074|12499747|FG000|STARTED|Period 1 (First Dosing Regimen)||9
11301782|NCT02570074|12499748|FG001|STARTED|Period 1 (First Dosing Regimen)||10
11301783|NCT02570074|12499747|FG000|COMPLETED|Period 1 (First Dosing Regimen)||9
11301784|NCT02570074|12499748|FG001|COMPLETED|Period 1 (First Dosing Regimen)||10
11301785|NCT02570074|12499747|FG000|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
11301786|NCT02570074|12499748|FG001|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
11301787|NCT02570074|12499747|FG000|STARTED|Period 2 (Second Dosing Regimen)||9
11301788|NCT02570074|12499748|FG001|STARTED|Period 2 (Second Dosing Regimen)||10
11301789|NCT02570074|12499747|FG000|COMPLETED|Period 2 (Second Dosing Regimen)||8
11301790|NCT02570074|12499748|FG001|COMPLETED|Period 2 (Second Dosing Regimen)||10
11301791|NCT02570074|12499747|FG000|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1
11301792|NCT02570074|12499748|FG001|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0
11301793|NCT02570126|12499768|FG000|STARTED|Overall Study||615
11301794|NCT02570126|12499769|FG001|STARTED|Overall Study||616
11301795|NCT02570126|12499768|FG000|COMPLETED|Overall Study||609
11301796|NCT02570126|12499769|FG001|COMPLETED|Overall Study||607
11301797|NCT02570126|12499768|FG000|NOT COMPLETED|Overall Study||6
11301798|NCT02570126|12499769|FG001|NOT COMPLETED|Overall Study||9
11301799|NCT02570139|12499777|FG000|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
11301800|NCT02570139|12499778|FG001|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
11301801|NCT02570139|12499777|FG000|COMPLETED|Overall Study||24
11301802|NCT02570139|12499778|FG001|COMPLETED|Overall Study||21
11301803|NCT02570139|12499777|FG000|NOT COMPLETED|Overall Study||0
11301804|NCT02570139|12499778|FG001|NOT COMPLETED|Overall Study||0
11301805|NCT02570152|12499784|FG000|STARTED|Overall Study||2004
11301806|NCT02570152|12499784|FG000|COMPLETED|Overall Study||1989
11301807|NCT02570152|12499784|FG000|NOT COMPLETED|Overall Study||15
11301808|NCT02570165|12499795|FG000|STARTED|Overall Study||46
11301809|NCT02570165|12499796|FG001|STARTED|Overall Study||46
11301810|NCT02570165|12499797|FG002|STARTED|Overall Study||46
11301811|NCT02570165|12499798|FG003|STARTED|Overall Study||45
11301812|NCT02570165|12499799|FG004|STARTED|Overall Study||47
11301813|NCT02570165|12499800|FG005|STARTED|Overall Study||46
11301814|NCT02570165|12499801|FG006|STARTED|Overall Study||47
11301815|NCT02570165|12499795|FG000|COMPLETED|Overall Study||44
11301816|NCT02570165|12499796|FG001|COMPLETED|Overall Study||43
11301817|NCT02570165|12499797|FG002|COMPLETED|Overall Study||41
11301818|NCT02570165|12499798|FG003|COMPLETED|Overall Study||40
11301819|NCT02570165|12499799|FG004|COMPLETED|Overall Study||41
11301820|NCT02570165|12499800|FG005|COMPLETED|Overall Study||44
11301821|NCT02570165|12499801|FG006|COMPLETED|Overall Study||47
11301822|NCT02570165|12499795|FG000|NOT COMPLETED|Overall Study||2
11301823|NCT02570165|12499796|FG001|NOT COMPLETED|Overall Study||3
11301824|NCT02570165|12499797|FG002|NOT COMPLETED|Overall Study||5
11301825|NCT02570165|12499798|FG003|NOT COMPLETED|Overall Study||5
11301826|NCT02570165|12499799|FG004|NOT COMPLETED|Overall Study||6
11301827|NCT02570165|12499800|FG005|NOT COMPLETED|Overall Study||2
11301828|NCT02570165|12499801|FG006|NOT COMPLETED|Overall Study||0
11301829|NCT02570295|12499819|FG000|STARTED|Overall Study||375
11301830|NCT02570295|12499820|FG001|STARTED|Overall Study||347
11301831|NCT02570295|12499819|FG000|COMPLETED|Overall Study||364
11301832|NCT02570295|12499820|FG001|COMPLETED|Overall Study||289
11301833|NCT02570295|12499819|FG000|NOT COMPLETED|Overall Study||11
11301834|NCT02570295|12499820|FG001|NOT COMPLETED|Overall Study||58
11301835|NCT02570425|12499828|FG000|STARTED|Visit 1||274
11301836|NCT02570425|12499829|FG001|STARTED|Visit 1||242
11301837|NCT02570425|12499828|FG000|COMPLETED|Visit 1||274
11301838|NCT02570425|12499829|FG001|COMPLETED|Visit 1||242
11301839|NCT02570425|12499828|FG000|NOT COMPLETED|Visit 1||0
11301840|NCT02570425|12499829|FG001|NOT COMPLETED|Visit 1||0
11301841|NCT02570425|12499828|FG000|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
11301842|NCT02570425|12499829|FG001|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
11301843|NCT02570425|12499828|FG000|COMPLETED|Visit 2||251
11301844|NCT02570425|12499829|FG001|COMPLETED|Visit 2||247
11301845|NCT02570425|12499828|FG000|NOT COMPLETED|Visit 2||0
11301846|NCT02570425|12499829|FG001|NOT COMPLETED|Visit 2||0
11301847|NCT02570425|12499828|FG000|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
11301848|NCT02570425|12499829|FG001|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
11301849|NCT02570425|12499828|FG000|COMPLETED|Visit 3||229
11301850|NCT02570425|12499829|FG001|COMPLETED|Visit 3||231
11301851|NCT02570425|12499828|FG000|NOT COMPLETED|Visit 3||0
11301852|NCT02570425|12499829|FG001|NOT COMPLETED|Visit 3||0
11301853|NCT02570711|12499840|FG000|STARTED|Overall Study||1
11301854|NCT02570711|12499841|FG001|STARTED|Overall Study||2
11301855|NCT02570711|12499840|FG000|COMPLETED|Overall Study||0
11301856|NCT02570711|12499841|FG001|COMPLETED|Overall Study||0
11301857|NCT02570711|12499840|FG000|NOT COMPLETED|Overall Study||1
11301858|NCT02570711|12499841|FG001|NOT COMPLETED|Overall Study||2
11301859|NCT02570750|12499849|FG000|STARTED|Overall Study||110
11301860|NCT02570750|12499850|FG001|STARTED|Overall Study||73
11301861|NCT02570750|12499849|FG000|COMPLETED|Overall Study||96
11301862|NCT02570750|12499850|FG001|COMPLETED|Overall Study||68
11301863|NCT02570750|12499849|FG000|NOT COMPLETED|Overall Study||14
11301864|NCT02570750|12499850|FG001|NOT COMPLETED|Overall Study||5
11301865|NCT02571049|12499856|FG000|STARTED|Screening||10
11301866|NCT02571049|12499857|FG001|STARTED|Screening||14
11301867|NCT02571049|12499856|FG000|COMPLETED|Screening||8
11301868|NCT02571049|12499857|FG001|COMPLETED|Screening||12
11301869|NCT02571049|12499856|FG000|NOT COMPLETED|Screening||2
11301870|NCT02571049|12499857|FG001|NOT COMPLETED|Screening||2
11301871|NCT02571049|12499856|FG000|STARTED|Randomization||8
11301872|NCT02571049|12499857|FG001|STARTED|Randomization||12
11301873|NCT02571049|12499856|FG000|COMPLETED|Randomization||8
11301874|NCT02571049|12499857|FG001|COMPLETED|Randomization||10
11301875|NCT02571049|12499856|FG000|NOT COMPLETED|Randomization||0
11301876|NCT02571049|12499857|FG001|NOT COMPLETED|Randomization||2
11301877|NCT02571075|12499865|FG000|STARTED|Overall Study||45
11301878|NCT02571075|12499866|FG001|STARTED|Overall Study||50
11301879|NCT02571075|12499865|FG000|COMPLETED|Overall Study||25
11301880|NCT02571075|12499866|FG001|COMPLETED|Overall Study||26
11301881|NCT02571075|12499865|FG000|NOT COMPLETED|Overall Study||20
11301882|NCT02571075|12499866|FG001|NOT COMPLETED|Overall Study||24
11301883|NCT02571153|12499875|FG000|STARTED|Overall Study||45
11301884|NCT02571153|12499876|FG001|STARTED|Overall Study||45
11301885|NCT02571153|12499877|FG002|STARTED|Overall Study||45
11301886|NCT02571153|12499875|FG000|COMPLETED|Overall Study||39
11301887|NCT02571153|12499876|FG001|COMPLETED|Overall Study||37
11401176|NCT04137627|12596008|FG001|STARTED|Overall Study||25
11401177|NCT04137627|12596007|FG000|COMPLETED|Overall Study||13
11401178|NCT04137627|12596008|FG001|COMPLETED|Overall Study||12
11401179|NCT04137627|12596007|FG000|NOT COMPLETED|Overall Study||12
11401180|NCT04137627|12596008|FG001|NOT COMPLETED|Overall Study||13
11401181|NCT04136145|12596016|FG000|STARTED|Overall Study||12
11401182|NCT04136145|12596017|FG001|STARTED|Overall Study||24
11401183|NCT04136145|12596016|FG000|COMPLETED|Overall Study||12
11401184|NCT04136145|12596017|FG001|COMPLETED|Overall Study||24
11301888|NCT02571153|12499877|FG002|COMPLETED|Overall Study||43
11301889|NCT02571153|12499875|FG000|NOT COMPLETED|Overall Study||6
11301890|NCT02571153|12499876|FG001|NOT COMPLETED|Overall Study||8
11301891|NCT02571153|12499877|FG002|NOT COMPLETED|Overall Study||2
11301892|NCT02571218|12499887|FG000|STARTED|Overall Study||40
11301893|NCT02571218|12499888|FG001|STARTED|Overall Study||41
11301894|NCT02571218|12499887|FG000|COMPLETED|Overall Study||40
11301895|NCT02571218|12499888|FG001|COMPLETED|Overall Study||41
11301896|NCT02571218|12499887|FG000|NOT COMPLETED|Overall Study||0
11301897|NCT02571218|12499888|FG001|NOT COMPLETED|Overall Study||0
11301898|NCT02571244|12499896|FG000|STARTED|Overall Study||44
11301899|NCT02571244|12499897|FG001|STARTED|Overall Study||22
11301900|NCT02571244|12499896|FG000|COMPLETED|Overall Study||41
11301901|NCT02571244|12499897|FG001|COMPLETED|Overall Study||21
11301902|NCT02571244|12499896|FG000|NOT COMPLETED|Overall Study||3
11301903|NCT02571244|12499897|FG001|NOT COMPLETED|Overall Study||1
11301904|NCT02571439|12499908|FG000|STARTED|Overall Study||20
11301905|NCT02571439|12499909|FG001|STARTED|Overall Study||21
11301906|NCT02571439|12499908|FG000|COMPLETED|Overall Study||20
11301907|NCT02571439|12499909|FG001|COMPLETED|Overall Study||21
11301908|NCT02571439|12499908|FG000|NOT COMPLETED|Overall Study||0
11301909|NCT02571439|12499909|FG001|NOT COMPLETED|Overall Study||0
11301910|NCT02571452|12499917|FG000|STARTED|Overall Study Treatment||47
11301911|NCT02571452|12499918|FG001|STARTED|Overall Study Treatment||46
11301912|NCT02571452|12499917|FG000|COMPLETED|Overall Study Treatment||47
11301913|NCT02571452|12499918|FG001|COMPLETED|Overall Study Treatment||45
11301914|NCT02571452|12499917|FG000|NOT COMPLETED|Overall Study Treatment||0
11301915|NCT02571452|12499918|FG001|NOT COMPLETED|Overall Study Treatment||1
11401185|NCT04136145|12596016|FG000|NOT COMPLETED|Overall Study||0
11301916|NCT02571452|12499917|FG000|STARTED|Overall Study 6-Month Follow-up||47
11301917|NCT02571452|12499918|FG001|STARTED|Overall Study 6-Month Follow-up|Participants in the PMRT arm were not invited to complete 6-Month Follow-up.|0
11301918|NCT02571452|12499917|FG000|COMPLETED|Overall Study 6-Month Follow-up||42
11301919|NCT02571452|12499918|FG001|COMPLETED|Overall Study 6-Month Follow-up||0
11301920|NCT02571452|12499917|FG000|NOT COMPLETED|Overall Study 6-Month Follow-up||5
11301921|NCT02571452|12499918|FG001|NOT COMPLETED|Overall Study 6-Month Follow-up||0
11301922|NCT02571634|12499924|FG000|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
11301923|NCT02571634|12499924|FG000|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
11301924|NCT02571634|12499924|FG000|NOT COMPLETED|Overall Study||0
11301925|NCT02571777|12499934|FG000|STARTED|Overall Study||619
11301926|NCT02571777|12499935|FG001|STARTED|Overall Study||620
11301927|NCT02571777|12499936|FG002|STARTED|Overall Study||618
11301928|NCT02571777|12499937|FG003|STARTED|Overall Study||617
11301929|NCT02571777|12499938|FG004|STARTED|Overall Study||618
11301930|NCT02571777|12499934|FG000|Full Analysis Set (FAS)|Overall Study||615
11301931|NCT02571777|12499935|FG001|Full Analysis Set (FAS)|Overall Study||616
11301932|NCT02571777|12499936|FG002|Full Analysis Set (FAS)|Overall Study||611
11301933|NCT02571777|12499937|FG003|Full Analysis Set (FAS)|Overall Study||607
11301934|NCT02571777|12499938|FG004|Full Analysis Set (FAS)|Overall Study||612
11301935|NCT02571777|12499934|FG000|Safety Set (SAF)|Overall Study||616
11301936|NCT02571777|12499935|FG001|Safety Set (SAF)|Overall Study||617
11301937|NCT02571777|12499936|FG002|Safety Set (SAF)|Overall Study||613
11301938|NCT02571777|12499937|FG003|Safety Set (SAF)|Overall Study||608
11301939|NCT02571777|12499938|FG004|Safety Set (SAF)|Overall Study||618
11301940|NCT02571777|12499934|FG000|COMPLETED|Overall Study||580
11301941|NCT02571777|12499935|FG001|COMPLETED|Overall Study||582
11401186|NCT04136145|12596017|FG001|NOT COMPLETED|Overall Study||0
11301942|NCT02571777|12499936|FG002|COMPLETED|Overall Study||577
11401187|NCT04132336|12596031|FG000|STARTED|Overall Study||32
11401188|NCT04132336|12596032|FG001|STARTED|Overall Study||32
11301943|NCT02571777|12499937|FG003|COMPLETED|Overall Study||580
11301944|NCT02571777|12499938|FG004|COMPLETED|Overall Study||582
11301945|NCT02571777|12499934|FG000|NOT COMPLETED|Overall Study||39
11301946|NCT02571777|12499935|FG001|NOT COMPLETED|Overall Study||38
11301947|NCT02571777|12499936|FG002|NOT COMPLETED|Overall Study||41
11301948|NCT02571777|12499937|FG003|NOT COMPLETED|Overall Study||37
11301949|NCT02571777|12499938|FG004|NOT COMPLETED|Overall Study||36
11301950|NCT02571972|12499950|FG000|STARTED|Overall Study|2 patients signed consent but withdrew from the study prior to using dorzolamide-timolol drops.|14
11301951|NCT02571972|12499950|FG000|COMPLETED|Overall Study||10
11301952|NCT02571972|12499950|FG000|NOT COMPLETED|Overall Study||4
11301953|NCT02572076|12499954|FG000|STARTED|Overall Study||10
11301954|NCT02572076|12499954|FG000|COMPLETED|Overall Study||9
11301955|NCT02572076|12499954|FG000|NOT COMPLETED|Overall Study||1
11301956|NCT02572167|12499961|FG000|STARTED|Overall Study||6
11301957|NCT02572167|12499962|FG001|STARTED|Overall Study||56
11301958|NCT02572167|12499963|FG002|STARTED|Overall Study||31
11301959|NCT02572167|12499961|FG000|COMPLETED|Overall Study||0
11301960|NCT02572167|12499962|FG001|COMPLETED|Overall Study||0
11301961|NCT02572167|12499963|FG002|COMPLETED|Overall Study||0
11301962|NCT02572167|12499961|FG000|NOT COMPLETED|Overall Study||6
11301963|NCT02572167|12499962|FG001|NOT COMPLETED|Overall Study||56
11301964|NCT02572167|12499963|FG002|NOT COMPLETED|Overall Study||31
11301965|NCT02572388|12499975|FG000|STARTED|Overall Study||11
11301966|NCT02572388|12499976|FG001|STARTED|Overall Study||4
11301967|NCT02572388|12499977|FG002|STARTED|Overall Study||10
11301968|NCT02572388|12499978|FG003|STARTED|Overall Study||6
11301969|NCT02572388|12499975|FG000|COMPLETED|Overall Study||10
11301970|NCT02572388|12499976|FG001|COMPLETED|Overall Study||3
11301971|NCT02572388|12499977|FG002|COMPLETED|Overall Study||8
11301972|NCT02572388|12499978|FG003|COMPLETED|Overall Study||4
11301973|NCT02572388|12499975|FG000|NOT COMPLETED|Overall Study||1
11301974|NCT02572388|12499976|FG001|NOT COMPLETED|Overall Study||1
11301975|NCT02572388|12499977|FG002|NOT COMPLETED|Overall Study||2
11301976|NCT02572388|12499978|FG003|NOT COMPLETED|Overall Study||2
11301977|NCT02572401|12499992|FG000|STARTED|Overall Study||97
11301978|NCT02572401|12499993|FG001|STARTED|Overall Study||98
11301979|NCT02572401|12499994|FG002|STARTED|Overall Study||98
11301980|NCT02572401|12499995|FG003|STARTED|Overall Study||98
11301981|NCT02572401|12499992|FG000|COMPLETED|Overall Study||92
11301982|NCT02572401|12499993|FG001|COMPLETED|Overall Study||90
11301983|NCT02572401|12499994|FG002|COMPLETED|Overall Study||89
11301984|NCT02572401|12499995|FG003|COMPLETED|Overall Study||88
11301985|NCT02572401|12499992|FG000|NOT COMPLETED|Overall Study||5
11301986|NCT02572401|12499993|FG001|NOT COMPLETED|Overall Study||8
11301987|NCT02572401|12499994|FG002|NOT COMPLETED|Overall Study||9
11301988|NCT02572401|12499995|FG003|NOT COMPLETED|Overall Study||10
11301989|NCT02572427|12500007|FG000|STARTED|Overall Study||37
11301990|NCT02572427|12500008|FG001|STARTED|Overall Study||45
11301991|NCT02572427|12500007|FG000|COMPLETED|Overall Study||31
11301992|NCT02572427|12500008|FG001|COMPLETED|Overall Study||36
11301993|NCT02572427|12500007|FG000|NOT COMPLETED|Overall Study||6
11301994|NCT02572427|12500008|FG001|NOT COMPLETED|Overall Study||9
11301995|NCT02572570|12500014|FG000|STARTED|Overall Study||27
11301996|NCT02572570|12500014|FG000|Filtek Bulk Fill Posterior|Overall Study||27
11301997|NCT02572570|12500014|FG000|Filtek Supreme Ultra|Overall Study||27
11301998|NCT02572570|12500014|FG000|1 Year Follow-Up|Overall Study||20
11301999|NCT02572570|12500014|FG000|2 Year Follow-Up|Overall Study||13
11302000|NCT02572570|12500014|FG000|3 Year Follow-Up|Overall Study||5
11302001|NCT02572570|12500014|FG000|5 Year Follow-Up|Overall Study||0
11302002|NCT02572570|12500014|FG000|COMPLETED|Overall Study||0
11302003|NCT02572570|12500014|FG000|NOT COMPLETED|Overall Study||27
11302004|NCT02572609|12500023|FG000|STARTED|Period 1: Treatment Period 1 + Washout||18
11302005|NCT02572609|12500024|FG001|STARTED|Period 1: Treatment Period 1 + Washout||18
11302006|NCT02572609|12500023|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||18
11302007|NCT02572609|12500024|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||18
11302008|NCT02572609|12500023|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
11302009|NCT02572609|12500024|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
11302010|NCT02572609|12500023|FG000|STARTED|Period 2: Treatment Period 2||18
11302011|NCT02572609|12500024|FG001|STARTED|Period 2: Treatment Period 2||18
11302012|NCT02572609|12500023|FG000|COMPLETED|Period 2: Treatment Period 2||18
11302013|NCT02572609|12500024|FG001|COMPLETED|Period 2: Treatment Period 2||18
11302014|NCT02572609|12500023|FG000|NOT COMPLETED|Period 2: Treatment Period 2||0
11302015|NCT02572609|12500024|FG001|NOT COMPLETED|Period 2: Treatment Period 2||0
11302016|NCT02572752|12500033|FG000|STARTED|Period 1 Including Washout||23
11302017|NCT02572752|12500034|FG001|STARTED|Period 1 Including Washout||23
11302018|NCT02572752|12500035|FG002|STARTED|Period 1 Including Washout||24
11302019|NCT02572752|12500033|FG000|COMPLETED|Period 1 Including Washout||23
11302020|NCT02572752|12500034|FG001|COMPLETED|Period 1 Including Washout||23
11302021|NCT02572752|12500035|FG002|COMPLETED|Period 1 Including Washout||24
11401189|NCT04132336|12596033|FG002|STARTED|Overall Study||32
11022029|NCT00807248|12200259|FG003|COMPLETED|Overall Study||126
11022030|NCT00807248|12200256|FG000|NOT COMPLETED|Overall Study||21
11302022|NCT02572752|12500033|FG000|NOT COMPLETED|Period 1 Including Washout||0
11302023|NCT02572752|12500034|FG001|NOT COMPLETED|Period 1 Including Washout||0
11302024|NCT02572752|12500035|FG002|NOT COMPLETED|Period 1 Including Washout||0
11302025|NCT02572752|12500033|FG000|STARTED|Period 2 Including Washout||23
11302026|NCT02572752|12500034|FG001|STARTED|Period 2 Including Washout||23
11302027|NCT02572752|12500035|FG002|STARTED|Period 2 Including Washout||24
11302028|NCT02572752|12500033|FG000|COMPLETED|Period 2 Including Washout||23
11302029|NCT02572752|12500034|FG001|COMPLETED|Period 2 Including Washout||23
11302030|NCT02572752|12500035|FG002|COMPLETED|Period 2 Including Washout||24
11302031|NCT02572752|12500033|FG000|NOT COMPLETED|Period 2 Including Washout||0
11302032|NCT02572752|12500034|FG001|NOT COMPLETED|Period 2 Including Washout||0
11302033|NCT02572752|12500035|FG002|NOT COMPLETED|Period 2 Including Washout||0
11302034|NCT02572752|12500033|FG000|STARTED|Period 3 Including Washout||23
11302035|NCT02572752|12500034|FG001|STARTED|Period 3 Including Washout||23
11302036|NCT02572752|12500035|FG002|STARTED|Period 3 Including Washout||24
11302037|NCT02572752|12500033|FG000|COMPLETED|Period 3 Including Washout||23
11302038|NCT02572752|12500034|FG001|COMPLETED|Period 3 Including Washout||23
11302039|NCT02572752|12500035|FG002|COMPLETED|Period 3 Including Washout||24
11302040|NCT02572752|12500033|FG000|NOT COMPLETED|Period 3 Including Washout||0
11302041|NCT02572752|12500034|FG001|NOT COMPLETED|Period 3 Including Washout||0
11302042|NCT02572752|12500035|FG002|NOT COMPLETED|Period 3 Including Washout||0
11022031|NCT00807248|12200257|FG001|NOT COMPLETED|Overall Study||12
11022032|NCT00807248|12200258|FG002|NOT COMPLETED|Overall Study||18
11022033|NCT00807248|12200259|FG003|NOT COMPLETED|Overall Study||14
11022034|NCT00807456|12200269|FG000|STARTED|Overall Study||65
11022035|NCT00807456|12200269|FG000|COMPLETED|Overall Study||65
11022036|NCT00807456|12200269|FG000|NOT COMPLETED|Overall Study||0
11022037|NCT00807495|12200278|FG000|STARTED|Overall Study||22
11022038|NCT00807495|12200279|FG001|STARTED|Overall Study||13
11022039|NCT00807495|12200280|FG002|STARTED|Overall Study||5
11022040|NCT00807495|12200281|FG003|STARTED|Overall Study||1
11022041|NCT00807495|12200282|FG004|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
11022042|NCT00807495|12200278|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
11022043|NCT00807495|12200279|FG001|COMPLETED|Overall Study||7
11022044|NCT00807495|12200280|FG002|COMPLETED|Overall Study||1
11022045|NCT00807495|12200281|FG003|COMPLETED|Overall Study||0
11022046|NCT00807495|12200282|FG004|COMPLETED|Overall Study||2
11022047|NCT00807495|12200278|FG000|NOT COMPLETED|Overall Study||8
11022048|NCT00807495|12200279|FG001|NOT COMPLETED|Overall Study||6
11022049|NCT00807495|12200280|FG002|NOT COMPLETED|Overall Study||4
11022050|NCT00807495|12200281|FG003|NOT COMPLETED|Overall Study||1
11302043|NCT02572817|12500044|FG000|STARTED|Overall Study||91
11302044|NCT02572817|12500045|FG001|STARTED|Overall Study||47
11401190|NCT04132336|12596034|FG003|STARTED|Overall Study||32
11401191|NCT04132336|12596035|FG004|STARTED|Overall Study||32
11401192|NCT04132336|12596036|FG005|STARTED|Overall Study||16
11401193|NCT04132336|12596037|FG006|STARTED|Overall Study||17
11401194|NCT04132336|12596031|FG000|COMPLETED|Overall Study||32
11401195|NCT04132336|12596032|FG001|COMPLETED|Overall Study||31
11401196|NCT04132336|12596033|FG002|COMPLETED|Overall Study||32
11302045|NCT02572817|12500044|FG000|COMPLETED|Overall Study||82
11302046|NCT02572817|12500045|FG001|COMPLETED|Overall Study||41
11302047|NCT02572817|12500044|FG000|NOT COMPLETED|Overall Study||9
11302048|NCT02572817|12500045|FG001|NOT COMPLETED|Overall Study||6
11302049|NCT02573012|12500053|FG000|STARTED|Overall Study||131
11302050|NCT02573012|12500054|FG001|STARTED|Overall Study||128
11302051|NCT02573012|12500053|FG000|COMPLETED|Overall Study||116
11302052|NCT02573012|12500054|FG001|COMPLETED|Overall Study||113
11302053|NCT02573012|12500053|FG000|NOT COMPLETED|Overall Study||15
11302054|NCT02573012|12500054|FG001|NOT COMPLETED|Overall Study||15
11302055|NCT02573155|12500062|FG000|STARTED|Treatment Period 1||16
11302056|NCT02573155|12500063|FG001|STARTED|Treatment Period 1||38
11302057|NCT02573155|12500062|FG000|COMPLETED|Treatment Period 1||16
11302058|NCT02573155|12500063|FG001|COMPLETED|Treatment Period 1||38
11302059|NCT02573155|12500062|FG000|NOT COMPLETED|Treatment Period 1||0
11302060|NCT02573155|12500063|FG001|NOT COMPLETED|Treatment Period 1||0
11302061|NCT02573155|12500062|FG000|STARTED|Washout Between Treatment Period 1 and 2||16
11302062|NCT02573155|12500063|FG001|STARTED|Washout Between Treatment Period 1 and 2||38
11302063|NCT02573155|12500062|FG000|COMPLETED|Washout Between Treatment Period 1 and 2||16
11302064|NCT02573155|12500063|FG001|COMPLETED|Washout Between Treatment Period 1 and 2||33
11302065|NCT02573155|12500062|FG000|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
11302066|NCT02573155|12500063|FG001|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
11302067|NCT02573155|12500062|FG000|STARTED|Period 2||16
11302068|NCT02573155|12500063|FG001|STARTED|Period 2||33
11401197|NCT04132336|12596034|FG003|COMPLETED|Overall Study||32
11401198|NCT04132336|12596035|FG004|COMPLETED|Overall Study||32
11401199|NCT04132336|12596036|FG005|COMPLETED|Overall Study||16
11401200|NCT04132336|12596037|FG006|COMPLETED|Overall Study||17
11401201|NCT04132336|12596031|FG000|NOT COMPLETED|Overall Study||0
11302069|NCT02573155|12500062|FG000|COMPLETED|Period 2||16
11302070|NCT02573155|12500063|FG001|COMPLETED|Period 2||33
11401202|NCT04132336|12596032|FG001|NOT COMPLETED|Overall Study||1
11302071|NCT02573155|12500062|FG000|NOT COMPLETED|Period 2||0
11302072|NCT02573155|12500063|FG001|NOT COMPLETED|Period 2||0
11302073|NCT02573155|12500062|FG000|STARTED|Washout Between Treatment Period 2 and 3||16
11302074|NCT02573155|12500063|FG001|STARTED|Washout Between Treatment Period 2 and 3||33
11302075|NCT02573155|12500062|FG000|COMPLETED|Washout Between Treatment Period 2 and 3||15
11302076|NCT02573155|12500063|FG001|COMPLETED|Washout Between Treatment Period 2 and 3||31
11302077|NCT02573155|12500062|FG000|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
11302078|NCT02573155|12500063|FG001|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
11302079|NCT02573155|12500062|FG000|STARTED|Period 3||15
11302080|NCT02573155|12500063|FG001|STARTED|Period 3||31
11302081|NCT02573155|12500062|FG000|COMPLETED|Period 3||15
11302082|NCT02573155|12500063|FG001|COMPLETED|Period 3||31
11302083|NCT02573155|12500062|FG000|NOT COMPLETED|Period 3||0
11302084|NCT02573155|12500063|FG001|NOT COMPLETED|Period 3||0
11302085|NCT02573155|12500062|FG000|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
11302086|NCT02573155|12500063|FG001|STARTED|Washout Between Treatment Period 3 and 4||31
11302087|NCT02573155|12500062|FG000|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
11302088|NCT02573155|12500063|FG001|COMPLETED|Washout Between Treatment Period 3 and 4||29
11302089|NCT02573155|12500062|FG000|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
11302090|NCT02573155|12500063|FG001|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
11302091|NCT02573155|12500062|FG000|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
11302092|NCT02573155|12500063|FG001|STARTED|Period 4||29
11302093|NCT02573155|12500062|FG000|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
11302094|NCT02573155|12500063|FG001|COMPLETED|Period 4||29
11302095|NCT02573155|12500062|FG000|NOT COMPLETED|Period 4||0
11302096|NCT02573155|12500063|FG001|NOT COMPLETED|Period 4||0
11302097|NCT02573155|12500062|FG000|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
11302098|NCT02573155|12500063|FG001|STARTED|Washout Between Treatment Period 4 and 5||29
11302099|NCT02573155|12500062|FG000|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
11302100|NCT02573155|12500063|FG001|COMPLETED|Washout Between Treatment Period 4 and 5||28
11302101|NCT02573155|12500062|FG000|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
11302102|NCT02573155|12500063|FG001|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
11302103|NCT02573155|12500062|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
11302104|NCT02573155|12500063|FG001|STARTED|Period 5||28
11302105|NCT02573155|12500062|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
11302106|NCT02573155|12500063|FG001|COMPLETED|Period 5||28
11302107|NCT02573155|12500062|FG000|NOT COMPLETED|Period 5||0
11302108|NCT02573155|12500063|FG001|NOT COMPLETED|Period 5||0
11302109|NCT02573181|12500091|FG000|STARTED|Overall Study||127
11302110|NCT02573181|12500092|FG001|STARTED|Overall Study||126
11302111|NCT02573181|12500091|FG000|Vaccinated|Overall Study||127
11302112|NCT02573181|12500092|FG001|Vaccinated|Overall Study||126
11302113|NCT02573181|12500091|FG000|COMPLETED|Overall Study||127
11302114|NCT02573181|12500092|FG001|COMPLETED|Overall Study||126
11302115|NCT02573181|12500091|FG000|NOT COMPLETED|Overall Study||0
11302116|NCT02573181|12500092|FG001|NOT COMPLETED|Overall Study||0
11302117|NCT02573246|12500103|FG000|STARTED|Overall Study||14
11302118|NCT02573246|12500104|FG001|STARTED|Overall Study||15
11302119|NCT02573246|12500105|FG002|STARTED|Overall Study||18
11302120|NCT02573246|12500106|FG003|STARTED|Overall Study||16
11302121|NCT02573246|12500107|FG004|STARTED|Overall Study||15
11302122|NCT02573246|12500103|FG000|COMPLETED|Overall Study||11
11302123|NCT02573246|12500104|FG001|COMPLETED|Overall Study||14
11302124|NCT02573246|12500105|FG002|COMPLETED|Overall Study||15
11302125|NCT02573246|12500106|FG003|COMPLETED|Overall Study||14
11302126|NCT02573246|12500107|FG004|COMPLETED|Overall Study||11
11302127|NCT02573246|12500103|FG000|NOT COMPLETED|Overall Study||3
11302128|NCT02573246|12500104|FG001|NOT COMPLETED|Overall Study||1
11302129|NCT02573246|12500105|FG002|NOT COMPLETED|Overall Study||3
11302130|NCT02573246|12500106|FG003|NOT COMPLETED|Overall Study||2
11302131|NCT02573246|12500107|FG004|NOT COMPLETED|Overall Study||4
11302132|NCT02573311|12500126|FG000|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|1737
11302133|NCT02573311|12500127|FG001|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|364
11302134|NCT02573311|12500126|FG000|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|1730
11302135|NCT02573311|12500127|FG001|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|361
11302136|NCT02573311|12500126|FG000|NOT COMPLETED|Disposition for Part 1||7
11302137|NCT02573311|12500127|FG001|NOT COMPLETED|Disposition for Part 1||3
11302138|NCT02573311|12500126|FG000|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|964
11302139|NCT02573311|12500127|FG001|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|153
11302140|NCT02573311|12500126|FG000|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|754
11302141|NCT02573311|12500127|FG001|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|127
11302142|NCT02573311|12500126|FG000|NOT COMPLETED|Disposition for Part 2||210
11302143|NCT02573311|12500127|FG001|NOT COMPLETED|Disposition for Part 2||26
11302144|NCT02573350|12500135|FG000|STARTED|Overall Study||137
11302145|NCT02573350|12500136|FG001|STARTED|Overall Study||76
11302146|NCT02573350|12500135|FG000|Efficacy Analysis Population|Overall Study||132
11302147|NCT02573350|12500136|FG001|Efficacy Analysis Population|Overall Study||73
11302148|NCT02573350|12500135|FG000|Safety Population|Overall Study||137
11302149|NCT02573350|12500136|FG001|Safety Population|Overall Study||76
11302150|NCT02573350|12500135|FG000|COMPLETED|Overall Study||121
11302151|NCT02573350|12500136|FG001|COMPLETED|Overall Study||67
11302152|NCT02573350|12500135|FG000|NOT COMPLETED|Overall Study||16
11302153|NCT02573350|12500136|FG001|NOT COMPLETED|Overall Study||9
11302154|NCT02573402|12500147|FG000|STARTED|Overall Study||12
11302155|NCT02573402|12500148|FG001|STARTED|Overall Study||7
11302156|NCT02573402|12500147|FG000|COMPLETED|Overall Study||12
11302157|NCT02573402|12500148|FG001|COMPLETED|Overall Study||7
11302158|NCT02573402|12500147|FG000|NOT COMPLETED|Overall Study||0
11302159|NCT02573402|12500148|FG001|NOT COMPLETED|Overall Study||0
11302160|NCT02573467|12500158|FG000|STARTED|Double-blind Treatment Epoch||53
11302161|NCT02573467|12500159|FG001|STARTED|Double-blind Treatment Epoch||52
11302162|NCT02573467|12500160|FG002|STARTED|Double-blind Treatment Epoch||51
11302163|NCT02573467|12500161|FG003|STARTED|Double-blind Treatment Epoch||55
11302164|NCT02573467|12500158|FG000|Full Analysis Set|Double-blind Treatment Epoch||53
11302165|NCT02573467|12500159|FG001|Full Analysis Set|Double-blind Treatment Epoch||52
11302166|NCT02573467|12500160|FG002|Full Analysis Set|Double-blind Treatment Epoch||51
11302167|NCT02573467|12500161|FG003|Full Analysis Set|Double-blind Treatment Epoch||55
11302168|NCT02573467|12500158|FG000|COMPLETED|Double-blind Treatment Epoch||0
11302169|NCT02573467|12500159|FG001|COMPLETED|Double-blind Treatment Epoch||0
11302170|NCT02573467|12500160|FG002|COMPLETED|Double-blind Treatment Epoch||0
11302171|NCT02573467|12500161|FG003|COMPLETED|Double-blind Treatment Epoch||0
11302172|NCT02573467|12500158|FG000|NOT COMPLETED|Double-blind Treatment Epoch||53
11302173|NCT02573467|12500159|FG001|NOT COMPLETED|Double-blind Treatment Epoch||52
11302174|NCT02573467|12500160|FG002|NOT COMPLETED|Double-blind Treatment Epoch||51
11302175|NCT02573467|12500161|FG003|NOT COMPLETED|Double-blind Treatment Epoch||55
11302176|NCT02573467|12500158|FG000|STARTED|Post-treatment Follow up Epoch||41
11302177|NCT02573467|12500159|FG001|STARTED|Post-treatment Follow up Epoch||46
11302178|NCT02573467|12500160|FG002|STARTED|Post-treatment Follow up Epoch||44
11302179|NCT02573467|12500161|FG003|STARTED|Post-treatment Follow up Epoch||47
11302180|NCT02573467|12500158|FG000|COMPLETED|Post-treatment Follow up Epoch||35
11302181|NCT02573467|12500159|FG001|COMPLETED|Post-treatment Follow up Epoch||41
11302182|NCT02573467|12500160|FG002|COMPLETED|Post-treatment Follow up Epoch||34
11302183|NCT02573467|12500161|FG003|COMPLETED|Post-treatment Follow up Epoch||44
11302184|NCT02573467|12500158|FG000|NOT COMPLETED|Post-treatment Follow up Epoch||6
11302185|NCT02573467|12500159|FG001|NOT COMPLETED|Post-treatment Follow up Epoch||5
11302186|NCT02573467|12500160|FG002|NOT COMPLETED|Post-treatment Follow up Epoch||10
11302187|NCT02573467|12500161|FG003|NOT COMPLETED|Post-treatment Follow up Epoch||3
11302188|NCT02573857|12500174|FG000|STARTED|Overall Study||8
11302189|NCT02573857|12500175|FG001|STARTED|Overall Study||8
11302190|NCT02573857|12500174|FG000|COMPLETED|Overall Study||8
11302191|NCT02573857|12500175|FG001|COMPLETED|Overall Study||8
11302192|NCT02573857|12500174|FG000|NOT COMPLETED|Overall Study||0
11302193|NCT02573857|12500175|FG001|NOT COMPLETED|Overall Study||0
11302194|NCT02573870|12500183|FG000|STARTED|Overall Study||20
11302195|NCT02573870|12500184|FG001|STARTED|Overall Study||42
11302196|NCT02573870|12500183|FG000|COMPLETED|Overall Study||20
11302197|NCT02573870|12500184|FG001|COMPLETED|Overall Study||35
11302198|NCT02573870|12500183|FG000|NOT COMPLETED|Overall Study||0
11302199|NCT02573870|12500184|FG001|NOT COMPLETED|Overall Study||7
11302200|NCT02573883|12500192|FG000|STARTED|Six Month Follow Up||25
11302201|NCT02573883|12500193|FG001|STARTED|Six Month Follow Up||27
11302202|NCT02573883|12500194|FG002|STARTED|Six Month Follow Up||0
11302203|NCT02573883|12500195|FG003|STARTED|Six Month Follow Up||0
11302204|NCT02573883|12500192|FG000|COMPLETED|Six Month Follow Up||24
11302205|NCT02573883|12500193|FG001|COMPLETED|Six Month Follow Up||27
11302206|NCT02573883|12500194|FG002|COMPLETED|Six Month Follow Up||0
11302207|NCT02573883|12500195|FG003|COMPLETED|Six Month Follow Up||0
11302208|NCT02573883|12500192|FG000|NOT COMPLETED|Six Month Follow Up||1
11302209|NCT02573883|12500193|FG001|NOT COMPLETED|Six Month Follow Up||0
11302210|NCT02573883|12500194|FG002|NOT COMPLETED|Six Month Follow Up||0
11302211|NCT02573883|12500195|FG003|NOT COMPLETED|Six Month Follow Up||0
11302212|NCT02573883|12500192|FG000|STARTED|One Year Follow Up||13
11302213|NCT02573883|12500193|FG001|STARTED|One Year Follow Up||17
11302214|NCT02573883|12500194|FG002|STARTED|One Year Follow Up||11
11302215|NCT02573883|12500195|FG003|STARTED|One Year Follow Up||10
11302216|NCT02573883|12500192|FG000|COMPLETED|One Year Follow Up||11
11302217|NCT02573883|12500193|FG001|COMPLETED|One Year Follow Up||16
11302218|NCT02573883|12500194|FG002|COMPLETED|One Year Follow Up||11
11302219|NCT02573883|12500195|FG003|COMPLETED|One Year Follow Up||10
11302220|NCT02573883|12500192|FG000|NOT COMPLETED|One Year Follow Up||2
11302221|NCT02573883|12500193|FG001|NOT COMPLETED|One Year Follow Up||1
11302222|NCT02573883|12500194|FG002|NOT COMPLETED|One Year Follow Up||0
11302223|NCT02573883|12500195|FG003|NOT COMPLETED|One Year Follow Up||0
11302224|NCT02573948|12500210|FG000|STARTED|RDS||603
11302225|NCT02573948|12500210|FG000|COMPLETED|RDS||603
11302226|NCT02573948|12500210|FG000|NOT COMPLETED|RDS||0
11302227|NCT02573948|12500210|FG000|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
11302228|NCT02573948|12500210|FG000|COMPLETED|Longitudinal Cohort||194
11302229|NCT02573948|12500210|FG000|NOT COMPLETED|Longitudinal Cohort||56
11302230|NCT02574078|12500230|FG000|STARTED|Pre-Treatment Period||13
11302231|NCT02574078|12500231|FG001|STARTED|Pre-Treatment Period||6
11302232|NCT02574078|12500232|FG002|STARTED|Pre-Treatment Period||9
11302233|NCT02574078|12500233|FG003|STARTED|Pre-Treatment Period||35
11302234|NCT02574078|12500234|FG004|STARTED|Pre-Treatment Period||34
11302235|NCT02574078|12500235|FG005|STARTED|Pre-Treatment Period||35
11302236|NCT02574078|12500236|FG006|STARTED|Pre-Treatment Period||18
11302237|NCT02574078|12500237|FG007|STARTED|Pre-Treatment Period||17
11302238|NCT02574078|12500238|FG008|STARTED|Pre-Treatment Period||26
11302239|NCT02574078|12500239|FG009|STARTED|Pre-Treatment Period||26
11302240|NCT02574078|12500240|FG010|STARTED|Pre-Treatment Period||53
11302241|NCT02574078|12500241|FG011|STARTED|Pre-Treatment Period||56
11302242|NCT02574078|12500242|FG012|STARTED|Pre-Treatment Period||13
11302243|NCT02574078|12500230|FG000|COMPLETED|Pre-Treatment Period||13
11302244|NCT02574078|12500231|FG001|COMPLETED|Pre-Treatment Period||6
11302245|NCT02574078|12500232|FG002|COMPLETED|Pre-Treatment Period||9
11302246|NCT02574078|12500233|FG003|COMPLETED|Pre-Treatment Period||35
11302247|NCT02574078|12500234|FG004|COMPLETED|Pre-Treatment Period||34
11302248|NCT02574078|12500235|FG005|COMPLETED|Pre-Treatment Period||34
11302249|NCT02574078|12500236|FG006|COMPLETED|Pre-Treatment Period||14
11302250|NCT02574078|12500237|FG007|COMPLETED|Pre-Treatment Period||14
11302251|NCT02574078|12500238|FG008|COMPLETED|Pre-Treatment Period||25
11302252|NCT02574078|12500239|FG009|COMPLETED|Pre-Treatment Period||26
11302253|NCT02574078|12500240|FG010|COMPLETED|Pre-Treatment Period||49
11302254|NCT02574078|12500241|FG011|COMPLETED|Pre-Treatment Period||55
11302255|NCT02574078|12500242|FG012|COMPLETED|Pre-Treatment Period||13
11302256|NCT02574078|12500230|FG000|NOT COMPLETED|Pre-Treatment Period||0
11302257|NCT02574078|12500231|FG001|NOT COMPLETED|Pre-Treatment Period||0
11302258|NCT02574078|12500232|FG002|NOT COMPLETED|Pre-Treatment Period||0
11302259|NCT02574078|12500233|FG003|NOT COMPLETED|Pre-Treatment Period||0
11302260|NCT02574078|12500234|FG004|NOT COMPLETED|Pre-Treatment Period||0
11302261|NCT02574078|12500235|FG005|NOT COMPLETED|Pre-Treatment Period||1
11302262|NCT02574078|12500236|FG006|NOT COMPLETED|Pre-Treatment Period||4
11302263|NCT02574078|12500237|FG007|NOT COMPLETED|Pre-Treatment Period||3
11302264|NCT02574078|12500238|FG008|NOT COMPLETED|Pre-Treatment Period||1
11302265|NCT02574078|12500239|FG009|NOT COMPLETED|Pre-Treatment Period||0
11302266|NCT02574078|12500240|FG010|NOT COMPLETED|Pre-Treatment Period||4
11302267|NCT02574078|12500241|FG011|NOT COMPLETED|Pre-Treatment Period||1
11302268|NCT02574078|12500242|FG012|NOT COMPLETED|Pre-Treatment Period||0
11302269|NCT02574078|12500230|FG000|STARTED|Treatment Period||13
11302270|NCT02574078|12500231|FG001|STARTED|Treatment Period||6
11302271|NCT02574078|12500232|FG002|STARTED|Treatment Period||9
11302272|NCT02574078|12500233|FG003|STARTED|Treatment Period||35
11302273|NCT02574078|12500234|FG004|STARTED|Treatment Period||34
11302274|NCT02574078|12500235|FG005|STARTED|Treatment Period||34
11302275|NCT02574078|12500236|FG006|STARTED|Treatment Period||14
11302276|NCT02574078|12500237|FG007|STARTED|Treatment Period||14
11302277|NCT02574078|12500238|FG008|STARTED|Treatment Period||25
11302278|NCT02574078|12500239|FG009|STARTED|Treatment Period||26
11302279|NCT02574078|12500240|FG010|STARTED|Treatment Period||49
11302280|NCT02574078|12500241|FG011|STARTED|Treatment Period||55
11302281|NCT02574078|12500242|FG012|STARTED|Treatment Period||13
11302282|NCT02574078|12500230|FG000|COMPLETED|Treatment Period||3
11302283|NCT02574078|12500231|FG001|COMPLETED|Treatment Period||0
11302284|NCT02574078|12500232|FG002|COMPLETED|Treatment Period||0
11302285|NCT02574078|12500233|FG003|COMPLETED|Treatment Period||7
11302286|NCT02574078|12500234|FG004|COMPLETED|Treatment Period||3
11302287|NCT02574078|12500235|FG005|COMPLETED|Treatment Period||1
11302288|NCT02574078|12500236|FG006|COMPLETED|Treatment Period||2
11302289|NCT02574078|12500237|FG007|COMPLETED|Treatment Period||2
11302290|NCT02574078|12500238|FG008|COMPLETED|Treatment Period||1
11302291|NCT02574078|12500239|FG009|COMPLETED|Treatment Period||9
11302292|NCT02574078|12500240|FG010|COMPLETED|Treatment Period||4
11302293|NCT02574078|12500241|FG011|COMPLETED|Treatment Period||8
11302294|NCT02574078|12500242|FG012|COMPLETED|Treatment Period||0
11302295|NCT02574078|12500230|FG000|NOT COMPLETED|Treatment Period||10
11302296|NCT02574078|12500231|FG001|NOT COMPLETED|Treatment Period||6
11302297|NCT02574078|12500232|FG002|NOT COMPLETED|Treatment Period||9
11302298|NCT02574078|12500233|FG003|NOT COMPLETED|Treatment Period||28
11302299|NCT02574078|12500234|FG004|NOT COMPLETED|Treatment Period||31
11302300|NCT02574078|12500235|FG005|NOT COMPLETED|Treatment Period||33
11302301|NCT02574078|12500236|FG006|NOT COMPLETED|Treatment Period||12
11302302|NCT02574078|12500237|FG007|NOT COMPLETED|Treatment Period||12
11302303|NCT02574078|12500238|FG008|NOT COMPLETED|Treatment Period||24
11302304|NCT02574078|12500239|FG009|NOT COMPLETED|Treatment Period||17
11302305|NCT02574078|12500240|FG010|NOT COMPLETED|Treatment Period||45
11302306|NCT02574078|12500241|FG011|NOT COMPLETED|Treatment Period||47
11302307|NCT02574078|12500242|FG012|NOT COMPLETED|Treatment Period||13
11302308|NCT02574247|12500276|FG000|STARTED|Overall Study||10
11302309|NCT02574247|12500277|FG001|STARTED|Overall Study||8
11302310|NCT02574247|12500278|FG002|STARTED|Overall Study||10
11302311|NCT02574247|12500276|FG000|COMPLETED|Overall Study||5
11302312|NCT02574247|12500277|FG001|COMPLETED|Overall Study||5
11302313|NCT02574247|12500278|FG002|COMPLETED|Overall Study||5
11302314|NCT02574247|12500276|FG000|NOT COMPLETED|Overall Study||5
11302315|NCT02574247|12500277|FG001|NOT COMPLETED|Overall Study||3
11302316|NCT02574247|12500278|FG002|NOT COMPLETED|Overall Study||5
11302317|NCT02574260|12500288|FG000|STARTED|Overall Study||3
11302318|NCT02574260|12500288|FG000|COMPLETED|Overall Study||2
11302319|NCT02574260|12500288|FG000|NOT COMPLETED|Overall Study||1
11302320|NCT02574312|12500294|FG000|STARTED|Pre-Operative||44
11302321|NCT02574312|12500295|FG001|STARTED|Pre-Operative||44
11302322|NCT02574312|12500294|FG000|COMPLETED|Pre-Operative||44
11302323|NCT02574312|12500295|FG001|COMPLETED|Pre-Operative||44
11302324|NCT02574312|12500294|FG000|NOT COMPLETED|Pre-Operative||0
11302325|NCT02574312|12500295|FG001|NOT COMPLETED|Pre-Operative||0
11302326|NCT02574312|12500294|FG000|STARTED|3 Months Follow-up||44
11302327|NCT02574312|12500295|FG001|STARTED|3 Months Follow-up||44
11302328|NCT02574312|12500294|FG000|COMPLETED|3 Months Follow-up|One subject withdrew consent|43
11302329|NCT02574312|12500295|FG001|COMPLETED|3 Months Follow-up||44
11302330|NCT02574312|12500294|FG000|NOT COMPLETED|3 Months Follow-up||1
11302331|NCT02574312|12500295|FG001|NOT COMPLETED|3 Months Follow-up||0
11401203|NCT04132336|12596033|FG002|NOT COMPLETED|Overall Study||0
11401204|NCT04132336|12596034|FG003|NOT COMPLETED|Overall Study||0
11401205|NCT04132336|12596035|FG004|NOT COMPLETED|Overall Study||0
11401206|NCT04132336|12596036|FG005|NOT COMPLETED|Overall Study||0
11401207|NCT04132336|12596037|FG006|NOT COMPLETED|Overall Study||0
11022051|NCT00807495|12200282|FG004|NOT COMPLETED|Overall Study||5
11302332|NCT02574520|12500305|FG000|STARTED|Overall Study||48
11302333|NCT02574520|12500306|FG001|STARTED|Overall Study||46
11302334|NCT02574520|12500307|FG002|STARTED|Overall Study||153
11302335|NCT02574520|12500308|FG003|STARTED|Overall Study||152
11302336|NCT02574520|12500305|FG000|Dosed|Overall Study||46
11302337|NCT02574520|12500306|FG001|Dosed|Overall Study||46
11302338|NCT02574520|12500307|FG002|Dosed|Overall Study||148
11302339|NCT02574520|12500308|FG003|Dosed|Overall Study||148
11022052|NCT00807560|12200296|FG000|STARTED|Overall Study||38
11022053|NCT00807560|12200297|FG001|STARTED|Overall Study||39
11022054|NCT00807560|12200296|FG000|COMPLETED|Overall Study||38
11022055|NCT00807560|12200297|FG001|COMPLETED|Overall Study||39
11022056|NCT00807560|12200296|FG000|NOT COMPLETED|Overall Study||0
11022057|NCT00807560|12200297|FG001|NOT COMPLETED|Overall Study||0
11302340|NCT02574520|12500305|FG000|COMPLETED|Overall Study||46
11302341|NCT02574520|12500306|FG001|COMPLETED|Overall Study||46
11302342|NCT02574520|12500307|FG002|COMPLETED|Overall Study||148
11302343|NCT02574520|12500308|FG003|COMPLETED|Overall Study||144
11302344|NCT02574520|12500305|FG000|NOT COMPLETED|Overall Study||2
11302345|NCT02574520|12500306|FG001|NOT COMPLETED|Overall Study||0
11302346|NCT02574520|12500307|FG002|NOT COMPLETED|Overall Study||5
11302347|NCT02574520|12500308|FG003|NOT COMPLETED|Overall Study||8
11302348|NCT02574598|12500320|FG000|STARTED|Overall Study||40
11302349|NCT02574598|12500321|FG001|STARTED|Overall Study||38
11302350|NCT02574598|12500320|FG000|COMPLETED|Overall Study||40
11302351|NCT02574598|12500321|FG001|COMPLETED|Overall Study||38
11302352|NCT02574598|12500320|FG000|NOT COMPLETED|Overall Study||0
11302353|NCT02574598|12500321|FG001|NOT COMPLETED|Overall Study||0
11302354|NCT02574637|12500332|FG000|STARTED|Double-blind Period||5
11302355|NCT02574637|12500333|FG001|STARTED|Double-blind Period||5
11302356|NCT02574637|12500334|FG002|STARTED|Double-blind Period||9
11302357|NCT02574637|12500335|FG003|STARTED|Double-blind Period||7
11302358|NCT02574637|12500336|FG004|STARTED|Double-blind Period||3
11302359|NCT02574637|12500337|FG005|STARTED|Double-blind Period||0
11302360|NCT02574637|12500338|FG006|STARTED|Double-blind Period||0
11302361|NCT02574637|12500339|FG007|STARTED|Double-blind Period||0
11302362|NCT02574637|12500340|FG008|STARTED|Double-blind Period||0
11302363|NCT02574637|12500341|FG009|STARTED|Double-blind Period||0
11302364|NCT02574637|12500332|FG000|COMPLETED|Double-blind Period||2
11302365|NCT02574637|12500333|FG001|COMPLETED|Double-blind Period||4
11302366|NCT02574637|12500334|FG002|COMPLETED|Double-blind Period||2
11302367|NCT02574637|12500335|FG003|COMPLETED|Double-blind Period||3
11302368|NCT02574637|12500336|FG004|COMPLETED|Double-blind Period||1
11302369|NCT02574637|12500337|FG005|COMPLETED|Double-blind Period||0
11302370|NCT02574637|12500338|FG006|COMPLETED|Double-blind Period||0
11302371|NCT02574637|12500339|FG007|COMPLETED|Double-blind Period||0
11302372|NCT02574637|12500340|FG008|COMPLETED|Double-blind Period||0
11302373|NCT02574637|12500341|FG009|COMPLETED|Double-blind Period||0
11302374|NCT02574637|12500332|FG000|NOT COMPLETED|Double-blind Period||3
11302375|NCT02574637|12500333|FG001|NOT COMPLETED|Double-blind Period||1
11022058|NCT00807573|12200303|FG000|STARTED|Overall Study||44
11022059|NCT00807573|12200303|FG000|COMPLETED|Overall Study||42
11022060|NCT00807573|12200303|FG000|NOT COMPLETED|Overall Study||2
11302376|NCT02574637|12500334|FG002|NOT COMPLETED|Double-blind Period||7
11022061|NCT00807586|12200309|FG000|STARTED|Overall Study||60
11022062|NCT00807586|12200310|FG001|STARTED|Overall Study||59
11302377|NCT02574637|12500335|FG003|NOT COMPLETED|Double-blind Period||4
11302378|NCT02574637|12500336|FG004|NOT COMPLETED|Double-blind Period||2
11302379|NCT02574637|12500337|FG005|NOT COMPLETED|Double-blind Period||0
11302380|NCT02574637|12500338|FG006|NOT COMPLETED|Double-blind Period||0
11302381|NCT02574637|12500339|FG007|NOT COMPLETED|Double-blind Period||0
11302382|NCT02574637|12500340|FG008|NOT COMPLETED|Double-blind Period||0
11302383|NCT02574637|12500341|FG009|NOT COMPLETED|Double-blind Period||0
11302384|NCT02574637|12500332|FG000|STARTED|Open-label (OL) Period||0
11302385|NCT02574637|12500333|FG001|STARTED|Open-label (OL) Period||0
11302386|NCT02574637|12500334|FG002|STARTED|Open-label (OL) Period||0
11302387|NCT02574637|12500335|FG003|STARTED|Open-label (OL) Period||0
11302388|NCT02574637|12500336|FG004|STARTED|Open-label (OL) Period||0
11302389|NCT02574637|12500337|FG005|STARTED|Open-label (OL) Period||2
11302390|NCT02574637|12500338|FG006|STARTED|Open-label (OL) Period||3
11302391|NCT02574637|12500339|FG007|STARTED|Open-label (OL) Period||2
11302392|NCT02574637|12500340|FG008|STARTED|Open-label (OL) Period||3
11302393|NCT02574637|12500341|FG009|STARTED|Open-label (OL) Period||1
11302394|NCT02574637|12500332|FG000|COMPLETED|Open-label (OL) Period||0
11302395|NCT02574637|12500333|FG001|COMPLETED|Open-label (OL) Period||0
11302396|NCT02574637|12500334|FG002|COMPLETED|Open-label (OL) Period||0
11302397|NCT02574637|12500335|FG003|COMPLETED|Open-label (OL) Period||0
11302398|NCT02574637|12500336|FG004|COMPLETED|Open-label (OL) Period||0
11302399|NCT02574637|12500337|FG005|COMPLETED|Open-label (OL) Period||0
11302400|NCT02574637|12500338|FG006|COMPLETED|Open-label (OL) Period||1
11302401|NCT02574637|12500339|FG007|COMPLETED|Open-label (OL) Period||1
11302402|NCT02574637|12500340|FG008|COMPLETED|Open-label (OL) Period||1
11302403|NCT02574637|12500341|FG009|COMPLETED|Open-label (OL) Period||0
11302404|NCT02574637|12500332|FG000|NOT COMPLETED|Open-label (OL) Period||0
11302405|NCT02574637|12500333|FG001|NOT COMPLETED|Open-label (OL) Period||0
11302406|NCT02574637|12500334|FG002|NOT COMPLETED|Open-label (OL) Period||0
11302407|NCT02574637|12500335|FG003|NOT COMPLETED|Open-label (OL) Period||0
11302408|NCT02574637|12500336|FG004|NOT COMPLETED|Open-label (OL) Period||0
11302409|NCT02574637|12500337|FG005|NOT COMPLETED|Open-label (OL) Period||2
11302410|NCT02574637|12500338|FG006|NOT COMPLETED|Open-label (OL) Period||2
11302411|NCT02574637|12500339|FG007|NOT COMPLETED|Open-label (OL) Period||1
11302412|NCT02574637|12500340|FG008|NOT COMPLETED|Open-label (OL) Period||2
11302413|NCT02574637|12500341|FG009|NOT COMPLETED|Open-label (OL) Period||1
11302414|NCT02574832|12500362|FG000|STARTED|Overall Study||2
11302415|NCT02574832|12500362|FG000|COMPLETED|Overall Study||2
11302416|NCT02574832|12500362|FG000|NOT COMPLETED|Overall Study||0
11302417|NCT02574845|12500372|FG000|STARTED|Overall Study||3
11302418|NCT02574845|12500373|FG001|STARTED|Overall Study||3
11302419|NCT02574845|12500374|FG002|STARTED|Overall Study||3
11302420|NCT02574845|12500375|FG003|STARTED|Overall Study||3
11302421|NCT02574845|12500376|FG004|STARTED|Overall Study||3
11302422|NCT02574845|12500377|FG005|STARTED|Overall Study||3
11302423|NCT02574845|12500372|FG000|Received T1|Overall Study||3
11302424|NCT02574845|12500373|FG001|Received T1|Overall Study||2
11302425|NCT02574845|12500374|FG002|Received T1|Overall Study||3
11302426|NCT02574845|12500375|FG003|Received T1|Overall Study||3
11302427|NCT02574845|12500376|FG004|Received T1|Overall Study||2
11302428|NCT02574845|12500377|FG005|Received T1|Overall Study|one subject missed treatment period 2|2
11302429|NCT02574845|12500372|FG000|Received T2|Overall Study||3
11302430|NCT02574845|12500373|FG001|Received T2|Overall Study||3
11302431|NCT02574845|12500374|FG002|Received T2|Overall Study||3
11302432|NCT02574845|12500375|FG003|Received T2|Overall Study||3
11302433|NCT02574845|12500376|FG004|Received T2|Overall Study||2
11302434|NCT02574845|12500377|FG005|Received T2|Overall Study||3
11302435|NCT02574845|12500372|FG000|Received T3|Overall Study|one subject missed treatment period 2|2
11302436|NCT02574845|12500373|FG001|Received T3|Overall Study||2
11302437|NCT02574845|12500374|FG002|Received T3|Overall Study||3
11302438|NCT02574845|12500375|FG003|Received T3|Overall Study||3
11302439|NCT02574845|12500376|FG004|Received T3|Overall Study||2
11302440|NCT02574845|12500377|FG005|Received T3|Overall Study||3
11302441|NCT02574845|12500372|FG000|Received T4|Overall Study||3
11302442|NCT02574845|12500373|FG001|Received T4|Overall Study||2
11302443|NCT02574845|12500374|FG002|Received T4|Overall Study||3
11302444|NCT02574845|12500375|FG003|Received T4|Overall Study||3
11302445|NCT02574845|12500376|FG004|Received T4|Overall Study||2
11302446|NCT02574845|12500377|FG005|Received T4|Overall Study||2
11302447|NCT02574845|12500372|FG000|Received T5|Overall Study||3
11302448|NCT02574845|12500373|FG001|Received T5|Overall Study||2
11302449|NCT02574845|12500374|FG002|Received T5|Overall Study||3
11302450|NCT02574845|12500375|FG003|Received T5|Overall Study||3
11302451|NCT02574845|12500376|FG004|Received T5|Overall Study||3
11302452|NCT02574845|12500377|FG005|Received T5|Overall Study||2
11302453|NCT02574845|12500372|FG000|Received R|Overall Study||3
11302454|NCT02574845|12500373|FG001|Received R|Overall Study||2
11302455|NCT02574845|12500374|FG002|Received R|Overall Study||3
11302456|NCT02574845|12500375|FG003|Received R|Overall Study||3
11302457|NCT02574845|12500376|FG004|Received R|Overall Study||2
11302458|NCT02574845|12500377|FG005|Received R|Overall Study||3
11302459|NCT02574845|12500372|FG000|COMPLETED|Overall Study||3
11302460|NCT02574845|12500373|FG001|COMPLETED|Overall Study||2
11302461|NCT02574845|12500374|FG002|COMPLETED|Overall Study||3
11302462|NCT02574845|12500375|FG003|COMPLETED|Overall Study||3
11302463|NCT02574845|12500376|FG004|COMPLETED|Overall Study||2
11302464|NCT02574845|12500377|FG005|COMPLETED|Overall Study||2
11302465|NCT02574845|12500372|FG000|NOT COMPLETED|Overall Study||0
11302466|NCT02574845|12500373|FG001|NOT COMPLETED|Overall Study||1
11302467|NCT02574845|12500374|FG002|NOT COMPLETED|Overall Study||0
11302468|NCT02574845|12500375|FG003|NOT COMPLETED|Overall Study||0
11302469|NCT02574845|12500376|FG004|NOT COMPLETED|Overall Study||1
11302470|NCT02574845|12500377|FG005|NOT COMPLETED|Overall Study||1
11302471|NCT02574858|12500391|FG000|STARTED|Overall Study||25
11302472|NCT02574858|12500391|FG000|COMPLETED|Overall Study||25
11302473|NCT02574858|12500391|FG000|NOT COMPLETED|Overall Study||0
11302474|NCT02575079|12500397|FG000|STARTED|Overall Study||48
11302475|NCT02575079|12500398|FG001|STARTED|Overall Study||71
11302476|NCT02575079|12500397|FG000|COMPLETED|Overall Study||42
11302477|NCT02575079|12500398|FG001|COMPLETED|Overall Study||71
11302478|NCT02575079|12500397|FG000|NOT COMPLETED|Overall Study||6
11302479|NCT02575079|12500398|FG001|NOT COMPLETED|Overall Study||0
11302480|NCT02575300|12500403|FG000|STARTED|Overall Study||20
11302481|NCT02575300|12500403|FG000|COMPLETED|Overall Study||20
11302482|NCT02575300|12500403|FG000|NOT COMPLETED|Overall Study||0
11302483|NCT02575807|12500412|FG000|STARTED|Overall Study||9
11302484|NCT02575807|12500413|FG001|STARTED|Overall Study||4
11302485|NCT02575807|12500414|FG002|STARTED|Overall Study||16
11302486|NCT02575807|12500415|FG003|STARTED|Overall Study||2
11302487|NCT02575807|12500416|FG004|STARTED|Overall Study||4
11302488|NCT02575807|12500412|FG000|Treated|Overall Study||8
11302489|NCT02575807|12500413|FG001|Treated|Overall Study||4
11302490|NCT02575807|12500414|FG002|Treated|Overall Study||16
11302491|NCT02575807|12500415|FG003|Treated|Overall Study||1
11302492|NCT02575807|12500416|FG004|Treated|Overall Study||3
11302493|NCT02575807|12500412|FG000|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
11302494|NCT02575807|12500413|FG001|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
11302495|NCT02575807|12500414|FG002|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
11302496|NCT02575807|12500415|FG003|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
11302497|NCT02575807|12500416|FG004|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
11302498|NCT02575807|12500412|FG000|NOT COMPLETED|Overall Study||9
11302499|NCT02575807|12500413|FG001|NOT COMPLETED|Overall Study||4
11302500|NCT02575807|12500414|FG002|NOT COMPLETED|Overall Study||16
11302501|NCT02575807|12500415|FG003|NOT COMPLETED|Overall Study||2
11302502|NCT02575807|12500416|FG004|NOT COMPLETED|Overall Study||4
11022063|NCT00807586|12200309|FG000|COMPLETED|Overall Study||54
11022064|NCT00807586|12200310|FG001|COMPLETED|Overall Study||58
11302503|NCT02575833|12500432|FG000|STARTED|Overall Study||44
11302504|NCT02575833|12500433|FG001|STARTED|Overall Study||45
11302505|NCT02575833|12500432|FG000|Received Study Drug|Overall Study||44
11302506|NCT02575833|12500433|FG001|Received Study Drug|Overall Study||44
11302507|NCT02575833|12500432|FG000|COMPLETED|Overall Study||43
11302508|NCT02575833|12500433|FG001|COMPLETED|Overall Study||44
11302509|NCT02575833|12500432|FG000|NOT COMPLETED|Overall Study||1
11302510|NCT02575833|12500433|FG001|NOT COMPLETED|Overall Study||1
11302511|NCT02575911|12500439|FG000|STARTED|Overall Study||30
11302512|NCT02575911|12500439|FG000|COMPLETED|Overall Study||29
11302513|NCT02575911|12500439|FG000|NOT COMPLETED|Overall Study||1
11302514|NCT02575950|12500451|FG000|STARTED|Overall Study||3
11302515|NCT02575950|12500452|FG001|STARTED|Overall Study||6
11302516|NCT02575950|12500453|FG002|STARTED|Overall Study||6
11302517|NCT02575950|12500454|FG003|STARTED|Overall Study||25
11302518|NCT02575950|12500451|FG000|COMPLETED|Overall Study||3
11302519|NCT02575950|12500452|FG001|COMPLETED|Overall Study||5
11302520|NCT02575950|12500453|FG002|COMPLETED|Overall Study||6
11302521|NCT02575950|12500454|FG003|COMPLETED|Overall Study||20
11302522|NCT02575950|12500451|FG000|NOT COMPLETED|Overall Study||0
11302523|NCT02575950|12500452|FG001|NOT COMPLETED|Overall Study||1
11302524|NCT02575950|12500453|FG002|NOT COMPLETED|Overall Study||0
11302525|NCT02575950|12500454|FG003|NOT COMPLETED|Overall Study||5
11302526|NCT02576041|12500462|FG000|STARTED|Placebo (run-in)||18
11302527|NCT02576041|12500462|FG000|COMPLETED|Placebo (run-in)||18
11302528|NCT02576041|12500462|FG000|NOT COMPLETED|Placebo (run-in)||0
11302529|NCT02576041|12500462|FG000|STARTED|Bilastine (Active Treatement)||18
11302530|NCT02576041|12500462|FG000|COMPLETED|Bilastine (Active Treatement)||18
11302531|NCT02576041|12500462|FG000|NOT COMPLETED|Bilastine (Active Treatement)||0
11302532|NCT02576054|12500466|FG000|STARTED|Overall Study||101
11302533|NCT02576054|12500466|FG000|Vaccination 1|Overall Study||100
11302534|NCT02576054|12500466|FG000|Vaccination 2|Overall Study||100
11022065|NCT00807586|12200309|FG000|NOT COMPLETED|Overall Study||6
11401208|NCT04131517|12596055|FG000|STARTED|Overall Study||7
11401209|NCT04131517|12596056|FG001|STARTED|Overall Study||7
11401210|NCT04131517|12596055|FG000|COMPLETED|Overall Study||7
11401211|NCT04131517|12596056|FG001|COMPLETED|Overall Study||7
11022066|NCT00807586|12200310|FG001|NOT COMPLETED|Overall Study||1
11302535|NCT02576054|12500466|FG000|Vaccination 3|Overall Study||100
11302536|NCT02576054|12500466|FG000|COMPLETED|Overall Study||100
11302537|NCT02576054|12500466|FG000|NOT COMPLETED|Overall Study||1
11302538|NCT02576067|12500474|FG000|STARTED|Overall Study||60
11302539|NCT02576067|12500475|FG001|STARTED|Overall Study||63
11302540|NCT02576067|12500474|FG000|COMPLETED|Overall Study||26
11302541|NCT02576067|12500475|FG001|COMPLETED|Overall Study||27
11401212|NCT04131517|12596055|FG000|NOT COMPLETED|Overall Study||0
11401213|NCT04131517|12596056|FG001|NOT COMPLETED|Overall Study||0
11302542|NCT02576067|12500474|FG000|NOT COMPLETED|Overall Study||34
11302543|NCT02576067|12500475|FG001|NOT COMPLETED|Overall Study||36
11401214|NCT04128293|12596077|FG000|STARTED|Treatment Period 1 (1 Day)||4
11401215|NCT04128293|12596078|FG001|STARTED|Treatment Period 1 (1 Day)||4
11401216|NCT04128293|12596079|FG002|STARTED|Treatment Period 1 (1 Day)||4
11401217|NCT04128293|12596080|FG003|STARTED|Treatment Period 1 (1 Day)||4
11401218|NCT04128293|12596077|FG000|COMPLETED|Treatment Period 1 (1 Day)||4
11401219|NCT04128293|12596078|FG001|COMPLETED|Treatment Period 1 (1 Day)||4
11401220|NCT04128293|12596079|FG002|COMPLETED|Treatment Period 1 (1 Day)||4
11401221|NCT04128293|12596080|FG003|COMPLETED|Treatment Period 1 (1 Day)||4
11401222|NCT04128293|12596077|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11401223|NCT04128293|12596078|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11302544|NCT02576145|12500483|FG000|STARTED|Overall Study||6
11302545|NCT02576145|12500484|FG001|STARTED|Overall Study||5
11302546|NCT02576145|12500483|FG000|COMPLETED|Overall Study||3
11302547|NCT02576145|12500484|FG001|COMPLETED|Overall Study||4
11302548|NCT02576145|12500483|FG000|NOT COMPLETED|Overall Study||3
11302549|NCT02576145|12500484|FG001|NOT COMPLETED|Overall Study||1
11302550|NCT02576249|12500492|FG000|STARTED|Overall Study||15
11302551|NCT02576249|12500493|FG001|STARTED|Overall Study||14
11302552|NCT02576249|12500492|FG000|COMPLETED|Overall Study||15
11302553|NCT02576249|12500493|FG001|COMPLETED|Overall Study||14
11302554|NCT02576249|12500492|FG000|NOT COMPLETED|Overall Study||0
11302555|NCT02576249|12500493|FG001|NOT COMPLETED|Overall Study||0
11302556|NCT02576535|12500499|FG000|STARTED|Overall Study||18
11302557|NCT02576535|12500499|FG000|COMPLETED|Overall Study||16
11302558|NCT02576535|12500499|FG000|NOT COMPLETED|Overall Study||2
11341535|NCT02935179|12538962|FG001|NOT COMPLETED|Overall Study||1
11341536|NCT02935192|12538970|FG000|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320
11341537|NCT02935192|12538971|FG001|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160
11341538|NCT02935192|12538970|FG000|Received Vaccine/Placebo|Overall Study||312
11341539|NCT02935192|12538971|FG001|Received Vaccine/Placebo|Overall Study||156
11341540|NCT02935192|12538970|FG000|COMPLETED|Overall Study||312
11341541|NCT02935192|12538971|FG001|COMPLETED|Overall Study||156
11341542|NCT02935192|12538970|FG000|NOT COMPLETED|Overall Study||8
11341543|NCT02935192|12538971|FG001|NOT COMPLETED|Overall Study||4
11341544|NCT02935452|12538979|FG000|STARTED|Overall Study||30
11341545|NCT02935452|12538980|FG001|STARTED|Overall Study||30
11341546|NCT02935452|12538979|FG000|COMPLETED|Overall Study||27
11341547|NCT02935452|12538980|FG001|COMPLETED|Overall Study||29
11341548|NCT02935452|12538979|FG000|NOT COMPLETED|Overall Study||3
11341549|NCT02935452|12538980|FG001|NOT COMPLETED|Overall Study||1
11341550|NCT02935543|12538986|FG000|STARTED|Overall Study||1
11341551|NCT02935543|12538986|FG000|COMPLETED|Overall Study||1
11341552|NCT02935543|12538986|FG000|NOT COMPLETED|Overall Study||0
11341553|NCT02935673|12538993|FG000|STARTED|Overall Study||16
11341554|NCT02935673|12538994|FG001|STARTED|Overall Study||27
11341555|NCT02935673|12538995|FG002|STARTED|Overall Study||6
11341556|NCT02935673|12538993|FG000|COMPLETED|Overall Study||15
11341557|NCT02935673|12538994|FG001|COMPLETED|Overall Study||24
11341558|NCT02935673|12538995|FG002|COMPLETED|Overall Study||6
11341559|NCT02935673|12538993|FG000|NOT COMPLETED|Overall Study||1
11341560|NCT02935673|12538994|FG001|NOT COMPLETED|Overall Study||3
11341561|NCT02935673|12538995|FG002|NOT COMPLETED|Overall Study||0
11341562|NCT02935699|12539007|FG000|STARTED|Overall Study||127
11341563|NCT02935699|12539008|FG001|STARTED|Overall Study||135
11341564|NCT02935699|12539007|FG000|COMPLETED|Overall Study||127
11341565|NCT02935699|12539008|FG001|COMPLETED|Overall Study||135
11341566|NCT02935699|12539007|FG000|NOT COMPLETED|Overall Study||0
11341567|NCT02935699|12539008|FG001|NOT COMPLETED|Overall Study||0
11341568|NCT02935738|12539018|FG000|STARTED|Overall Study||67
11341569|NCT02935738|12539019|FG001|STARTED|Overall Study||74
11341570|NCT02935738|12539020|FG002|STARTED|Overall Study||47
11341571|NCT02935738|12539021|FG003|STARTED|Overall Study||53
11341572|NCT02935738|12539018|FG000|COMPLETED|Overall Study||50
11341573|NCT02935738|12539019|FG001|COMPLETED|Overall Study||53
11341574|NCT02935738|12539020|FG002|COMPLETED|Overall Study||46
11341575|NCT02935738|12539021|FG003|COMPLETED|Overall Study||48
11341576|NCT02935738|12539018|FG000|NOT COMPLETED|Overall Study||17
11341577|NCT02935738|12539019|FG001|NOT COMPLETED|Overall Study||21
11341578|NCT02935738|12539020|FG002|NOT COMPLETED|Overall Study||1
11341579|NCT02935738|12539021|FG003|NOT COMPLETED|Overall Study||5
11341580|NCT02935842|12539035|FG000|STARTED|Testing and Therapy Period 1||8
11341581|NCT02935842|12539036|FG001|STARTED|Testing and Therapy Period 1||6
11341582|NCT02935842|12539037|FG002|STARTED|Testing and Therapy Period 1||6
11341583|NCT02935842|12539038|FG003|STARTED|Testing and Therapy Period 1|Due to limited staff capacity, HC have only been included in the final tranche.|0
11341584|NCT02935842|12539035|FG000|COMPLETED|Testing and Therapy Period 1||8
11341585|NCT02935842|12539036|FG001|COMPLETED|Testing and Therapy Period 1||6
11341586|NCT02935842|12539037|FG002|COMPLETED|Testing and Therapy Period 1||6
11341587|NCT02935842|12539038|FG003|COMPLETED|Testing and Therapy Period 1||0
11341588|NCT02935842|12539035|FG000|NOT COMPLETED|Testing and Therapy Period 1||0
11341589|NCT02935842|12539036|FG001|NOT COMPLETED|Testing and Therapy Period 1||0
11341590|NCT02935842|12539037|FG002|NOT COMPLETED|Testing and Therapy Period 1||0
11343981|NCT02958267|12541286|FG000|6 Month Follow-up|Follow-up Visits||14
11302559|NCT02576587|12500505|FG000|STARTED|Baseline|Total cases baseline visit|161
11302560|NCT02576587|12500506|FG001|STARTED|Baseline|Total controls baseline visit|156
11302561|NCT02576587|12500505|FG000|COMPLETED|Baseline|Baseline visit completed|161
11302562|NCT02576587|12500506|FG001|COMPLETED|Baseline|Baseline visit completed|155
11302563|NCT02576587|12500505|FG000|NOT COMPLETED|Baseline||0
11302564|NCT02576587|12500506|FG001|NOT COMPLETED|Baseline||1
11302565|NCT02576587|12500505|FG000|STARTED|Follow up Period (Case Only)|Completed baseline.|161
11302566|NCT02576587|12500506|FG001|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
11302567|NCT02576587|12500505|FG000|Selected for Follow up|Follow up Period (Case Only)||61
11302568|NCT02576587|12500506|FG001|Selected for Follow up|Follow up Period (Case Only)||0
11302569|NCT02576587|12500505|FG000|COMPLETED|Follow up Period (Case Only)||44
11302570|NCT02576587|12500506|FG001|COMPLETED|Follow up Period (Case Only)||0
11302571|NCT02576587|12500505|FG000|NOT COMPLETED|Follow up Period (Case Only)||117
11302572|NCT02576587|12500506|FG001|NOT COMPLETED|Follow up Period (Case Only)||155
11302573|NCT02576639|12500519|FG000|STARTED|Overall Study||24
11302574|NCT02576639|12500520|FG001|STARTED|Overall Study||25
11302575|NCT02576639|12500521|FG002|STARTED|Overall Study||25
11302576|NCT02576639|12500522|FG003|STARTED|Overall Study||26
11302577|NCT02576639|12500523|FG004|STARTED|Overall Study||24
11302578|NCT02576639|12500519|FG000|Pharmacodynamic Analysis Set|Overall Study||24
11302579|NCT02576639|12500520|FG001|Pharmacodynamic Analysis Set|Overall Study||24
11302580|NCT02576639|12500521|FG002|Pharmacodynamic Analysis Set|Overall Study||25
11302581|NCT02576639|12500522|FG003|Pharmacodynamic Analysis Set|Overall Study||25
11302582|NCT02576639|12500523|FG004|Pharmacodynamic Analysis Set|Overall Study||25
11302583|NCT02576639|12500519|FG000|Pharmacokinetic Analysis Set|Overall Study||0
11302584|NCT02576639|12500520|FG001|Pharmacokinetic Analysis Set|Overall Study||25
11302585|NCT02576639|12500521|FG002|Pharmacokinetic Analysis Set|Overall Study||25
11302586|NCT02576639|12500522|FG003|Pharmacokinetic Analysis Set|Overall Study||26
11401224|NCT04128293|12596079|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11401225|NCT04128293|12596080|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11401226|NCT04128293|12596077|FG000|STARTED|Washout Period 1 (Up to 7 Days)||4
11401227|NCT04128293|12596078|FG001|STARTED|Washout Period 1 (Up to 7 Days)||4
11401228|NCT04128293|12596079|FG002|STARTED|Washout Period 1 (Up to 7 Days)||4
11302587|NCT02576639|12500523|FG004|Pharmacokinetic Analysis Set|Overall Study||24
11302588|NCT02576639|12500519|FG000|Safety Analysis Set|Overall Study||24
11302589|NCT02576639|12500520|FG001|Safety Analysis Set|Overall Study||25
11302590|NCT02576639|12500521|FG002|Safety Analysis Set|Overall Study||25
11302591|NCT02576639|12500522|FG003|Safety Analysis Set|Overall Study||26
11302592|NCT02576639|12500523|FG004|Safety Analysis Set|Overall Study||24
11302593|NCT02576639|12500519|FG000|COMPLETED|Overall Study||22
11302594|NCT02576639|12500520|FG001|COMPLETED|Overall Study||23
11302595|NCT02576639|12500521|FG002|COMPLETED|Overall Study||23
11302596|NCT02576639|12500522|FG003|COMPLETED|Overall Study||25
11302597|NCT02576639|12500523|FG004|COMPLETED|Overall Study||20
11302598|NCT02576639|12500519|FG000|NOT COMPLETED|Overall Study||2
11302599|NCT02576639|12500520|FG001|NOT COMPLETED|Overall Study||2
11302600|NCT02576639|12500521|FG002|NOT COMPLETED|Overall Study||2
11302601|NCT02576639|12500522|FG003|NOT COMPLETED|Overall Study||1
11302602|NCT02576639|12500523|FG004|NOT COMPLETED|Overall Study||4
11302603|NCT02576652|12500539|FG000|STARTED|Overall Study||6
11302604|NCT02576652|12500539|FG000|COMPLETED|Overall Study||4
11302605|NCT02576652|12500539|FG000|NOT COMPLETED|Overall Study||2
11302606|NCT02576678|12500546|FG000|STARTED|Overall Study||13
11302607|NCT02576678|12500547|FG001|STARTED|Overall Study||8
11302608|NCT02576678|12500548|FG002|STARTED|Overall Study||21
11302609|NCT02576678|12500546|FG000|Pharmacokinetic (PK) Population|Overall Study||12
11302610|NCT02576678|12500547|FG001|Pharmacokinetic (PK) Population|Overall Study||8
11302611|NCT02576678|12500548|FG002|Pharmacokinetic (PK) Population|Overall Study||18
11302612|NCT02576678|12500546|FG000|COMPLETED|Overall Study||8
11302613|NCT02576678|12500547|FG001|COMPLETED|Overall Study||7
11302614|NCT02576678|12500548|FG002|COMPLETED|Overall Study||16
11302615|NCT02576678|12500546|FG000|NOT COMPLETED|Overall Study||5
11302616|NCT02576678|12500547|FG001|NOT COMPLETED|Overall Study||1
11302617|NCT02576678|12500548|FG002|NOT COMPLETED|Overall Study||5
11302618|NCT02576899|12500558|FG000|STARTED|Overall Study||16
11302619|NCT02576899|12500559|FG001|STARTED|Overall Study||20
11302620|NCT02576899|12500558|FG000|COMPLETED|Overall Study||5
11302621|NCT02576899|12500559|FG001|COMPLETED|Overall Study||7
11302622|NCT02576899|12500558|FG000|NOT COMPLETED|Overall Study||11
11302623|NCT02576899|12500559|FG001|NOT COMPLETED|Overall Study||13
11302624|NCT02576938|12500569|FG000|STARTED|Overall Study||49
11302625|NCT02576938|12500570|FG001|STARTED|Overall Study||37
11302626|NCT02576938|12500571|FG002|STARTED|Overall Study||38
11302627|NCT02576938|12500569|FG000|Received at Least One Dose of Study Drug|Overall Study||49
11302628|NCT02576938|12500570|FG001|Received at Least One Dose of Study Drug|Overall Study||37
11302629|NCT02576938|12500571|FG002|Received at Least One Dose of Study Drug|Overall Study||38
11302630|NCT02576938|12500569|FG000|COMPLETED|Overall Study||29
11302631|NCT02576938|12500570|FG001|COMPLETED|Overall Study||25
11302632|NCT02576938|12500571|FG002|COMPLETED|Overall Study||26
11302633|NCT02576938|12500569|FG000|NOT COMPLETED|Overall Study||20
11302634|NCT02576938|12500570|FG001|NOT COMPLETED|Overall Study||12
11302635|NCT02576938|12500571|FG002|NOT COMPLETED|Overall Study||12
11302636|NCT02576951|12500585|FG000|STARTED|Overall Study||15
11302637|NCT02576951|12500586|FG001|STARTED|Overall Study||3
11302638|NCT02576951|12500587|FG002|STARTED|Overall Study||80
11302639|NCT02576951|12500588|FG003|STARTED|Overall Study||80
11302640|NCT02576951|12500585|FG000|Received at Least One Dose of Study Drug|Overall Study||15
11302641|NCT02576951|12500586|FG001|Received at Least One Dose of Study Drug|Overall Study||3
11302642|NCT02576951|12500587|FG002|Received at Least One Dose of Study Drug|Overall Study||80
11302643|NCT02576951|12500588|FG003|Received at Least One Dose of Study Drug|Overall Study||80
11302644|NCT02576951|12500585|FG000|COMPLETED|Overall Study||14
11302645|NCT02576951|12500586|FG001|COMPLETED|Overall Study||3
11302646|NCT02576951|12500587|FG002|COMPLETED|Overall Study||78
11302647|NCT02576951|12500588|FG003|COMPLETED|Overall Study||75
11302648|NCT02576951|12500585|FG000|NOT COMPLETED|Overall Study||1
11302649|NCT02576951|12500586|FG001|NOT COMPLETED|Overall Study||0
11302650|NCT02576951|12500587|FG002|NOT COMPLETED|Overall Study||2
11302651|NCT02576951|12500588|FG003|NOT COMPLETED|Overall Study||5
11302652|NCT02576977|12500602|FG000|STARTED|Overall Study||126
11302653|NCT02576977|12500603|FG001|STARTED|Overall Study||125
11302654|NCT02576977|12500602|FG000|Treated|Overall Study||122
11302655|NCT02576977|12500603|FG001|Treated|Overall Study||123
11302656|NCT02576977|12500602|FG000|COMPLETED|Overall Study||0
11302657|NCT02576977|12500603|FG001|COMPLETED|Overall Study||0
11302658|NCT02576977|12500602|FG000|NOT COMPLETED|Overall Study||126
11302659|NCT02576977|12500603|FG001|NOT COMPLETED|Overall Study||125
11302660|NCT02576990|12500611|FG000|STARTED|Overall Study||56
11302661|NCT02576990|12500612|FG001|STARTED|Overall Study||24
11302662|NCT02576990|12500611|FG000|Treated|Overall Study||53
11302663|NCT02576990|12500612|FG001|Treated|Overall Study||23
11302664|NCT02576990|12500611|FG000|COMPLETED|Overall Study||0
11302665|NCT02576990|12500612|FG001|COMPLETED|Overall Study||0
11302666|NCT02576990|12500611|FG000|NOT COMPLETED|Overall Study||56
11302667|NCT02576990|12500612|FG001|NOT COMPLETED|Overall Study||24
11302668|NCT02577003|12500620|FG000|STARTED|Overall Study||73
11302669|NCT02577003|12500621|FG001|STARTED|Overall Study||70
11302670|NCT02577003|12500620|FG000|COMPLETED|Overall Study||71
11302671|NCT02577003|12500621|FG001|COMPLETED|Overall Study||65
11302672|NCT02577003|12500620|FG000|NOT COMPLETED|Overall Study||2
11302673|NCT02577003|12500621|FG001|NOT COMPLETED|Overall Study||5
11302674|NCT02577016|12500629|FG000|STARTED|Overall Study||70
11302675|NCT02577016|12500630|FG001|STARTED|Overall Study||71
11302676|NCT02577016|12500629|FG000|COMPLETED|Overall Study||68
11302677|NCT02577016|12500630|FG001|COMPLETED|Overall Study||69
11302678|NCT02577016|12500629|FG000|NOT COMPLETED|Overall Study||2
11302679|NCT02577016|12500630|FG001|NOT COMPLETED|Overall Study||2
11302680|NCT02577029|12500644|FG000|STARTED|Overall Study||10
11302681|NCT02577029|12500645|FG001|STARTED|Overall Study||2
11302682|NCT02577029|12500646|FG002|STARTED|Overall Study||7
11302683|NCT02577029|12500647|FG003|STARTED|Overall Study||12
11302684|NCT02577029|12500648|FG004|STARTED|Overall Study||11
11302685|NCT02577029|12500649|FG005|STARTED|Overall Study||13
11302686|NCT02577029|12500650|FG006|STARTED|Overall Study||12
11302687|NCT02577029|12500651|FG007|STARTED|Overall Study||12
11302688|NCT02577029|12500644|FG000|COMPLETED|Overall Study||0
11302689|NCT02577029|12500645|FG001|COMPLETED|Overall Study||0
11302690|NCT02577029|12500646|FG002|COMPLETED|Overall Study||0
11302691|NCT02577029|12500647|FG003|COMPLETED|Overall Study||0
11302692|NCT02577029|12500648|FG004|COMPLETED|Overall Study||0
11302693|NCT02577029|12500649|FG005|COMPLETED|Overall Study||0
11302694|NCT02577029|12500650|FG006|COMPLETED|Overall Study||0
11302695|NCT02577029|12500651|FG007|COMPLETED|Overall Study||0
11302696|NCT02577029|12500644|FG000|NOT COMPLETED|Overall Study||10
11302697|NCT02577029|12500645|FG001|NOT COMPLETED|Overall Study||2
11302698|NCT02577029|12500646|FG002|NOT COMPLETED|Overall Study||7
11302699|NCT02577029|12500647|FG003|NOT COMPLETED|Overall Study||12
11302700|NCT02577029|12500648|FG004|NOT COMPLETED|Overall Study||11
11302701|NCT02577029|12500649|FG005|NOT COMPLETED|Overall Study||13
11302702|NCT02577029|12500650|FG006|NOT COMPLETED|Overall Study||12
11302703|NCT02577029|12500651|FG007|NOT COMPLETED|Overall Study||12
11302704|NCT02577042|12500671|FG000|STARTED|Overall Study||20
11302705|NCT02577042|12500672|FG001|STARTED|Overall Study||22
11302706|NCT02577042|12500671|FG000|COMPLETED|Overall Study||15
11302707|NCT02577042|12500672|FG001|COMPLETED|Overall Study||19
11302708|NCT02577042|12500671|FG000|NOT COMPLETED|Overall Study||5
11302709|NCT02577042|12500672|FG001|NOT COMPLETED|Overall Study||3
11302710|NCT02577107|12500681|FG000|STARTED|Overall Study||6
11302711|NCT02577107|12500682|FG001|STARTED|Overall Study||6
11302712|NCT02577107|12500681|FG000|COMPLETED|Overall Study||6
11302713|NCT02577107|12500682|FG001|COMPLETED|Overall Study||5
11302714|NCT02577107|12500681|FG000|NOT COMPLETED|Overall Study||0
11302715|NCT02577107|12500682|FG001|NOT COMPLETED|Overall Study||1
11302716|NCT02577146|12500688|FG000|STARTED|Overall Study||74
11302717|NCT02577146|12500688|FG000|COMPLETED|Overall Study||46
11302718|NCT02577146|12500688|FG000|NOT COMPLETED|Overall Study||28
11302719|NCT02577315|12500694|FG000|STARTED|Treatment Period 1 (4 Days)||12
11302720|NCT02577315|12500695|FG001|STARTED|Treatment Period 1 (4 Days)||13
11302721|NCT02577315|12500694|FG000|COMPLETED|Treatment Period 1 (4 Days)||12
11302722|NCT02577315|12500695|FG001|COMPLETED|Treatment Period 1 (4 Days)||12
11302723|NCT02577315|12500694|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11302724|NCT02577315|12500695|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1
11302725|NCT02577315|12500694|FG000|STARTED|Washout Period (5 Days)||12
11302726|NCT02577315|12500695|FG001|STARTED|Washout Period (5 Days)||12
11302727|NCT02577315|12500694|FG000|COMPLETED|Washout Period (5 Days)||12
11302728|NCT02577315|12500695|FG001|COMPLETED|Washout Period (5 Days)||12
11302729|NCT02577315|12500694|FG000|NOT COMPLETED|Washout Period (5 Days)||0
11302730|NCT02577315|12500695|FG001|NOT COMPLETED|Washout Period (5 Days)||0
11302731|NCT02577315|12500694|FG000|STARTED|Treatment Period 2 (4 Days)||12
11302732|NCT02577315|12500695|FG001|STARTED|Treatment Period 2 (4 Days)||12
11302733|NCT02577315|12500694|FG000|COMPLETED|Treatment Period 2 (4 Days)||12
11302734|NCT02577315|12500695|FG001|COMPLETED|Treatment Period 2 (4 Days)||12
11302735|NCT02577315|12500694|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11302736|NCT02577315|12500695|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11302737|NCT02577445|12500703|FG000|STARTED|Overall Study||14
11302738|NCT02577445|12500704|FG001|STARTED|Overall Study||17
11302739|NCT02577445|12500703|FG000|COMPLETED|Overall Study|study terminated prematurely|0
11302740|NCT02577445|12500704|FG001|COMPLETED|Overall Study|study terminated prematurely|0
11302741|NCT02577445|12500703|FG000|NOT COMPLETED|Overall Study||14
11302742|NCT02577445|12500704|FG001|NOT COMPLETED|Overall Study||17
11302743|NCT02577510|12500711|FG000|STARTED|Overall Study||21
11302744|NCT02577510|12500712|FG001|STARTED|Overall Study||21
11302745|NCT02577510|12500711|FG000|COMPLETED|Overall Study||21
11302746|NCT02577510|12500712|FG001|COMPLETED|Overall Study||21
11302747|NCT02577510|12500711|FG000|NOT COMPLETED|Overall Study||0
11302748|NCT02577510|12500712|FG001|NOT COMPLETED|Overall Study||0
11302749|NCT02577601|12500721|FG000|STARTED|UPA Only (1 Month)||36
11302750|NCT02577601|12500721|FG000|COMPLETED|UPA Only (1 Month)||36
11302751|NCT02577601|12500721|FG000|NOT COMPLETED|UPA Only (1 Month)||0
11302752|NCT02577601|12500721|FG000|STARTED|Washout (1 Month)||33
11302753|NCT02577601|12500721|FG000|COMPLETED|Washout (1 Month)||33
11302754|NCT02577601|12500721|FG000|NOT COMPLETED|Washout (1 Month)||0
11302755|NCT02577601|12500721|FG000|STARTED|UPA+COC (1 Month)||33
11302756|NCT02577601|12500721|FG000|COMPLETED|UPA+COC (1 Month)||33
11302757|NCT02577601|12500721|FG000|NOT COMPLETED|UPA+COC (1 Month)||0
11302758|NCT02577640|12500732|FG000|STARTED|Dose Escalation Group 1||4
11302759|NCT02577640|12500733|FG001|STARTED|Dose Escalation Group 1||0
11302760|NCT02577640|12500734|FG002|STARTED|Dose Escalation Group 1||0
11302761|NCT02577640|12500735|FG003|STARTED|Dose Escalation Group 1||0
11302762|NCT02577640|12500732|FG000|COMPLETED|Dose Escalation Group 1||3
11302763|NCT02577640|12500733|FG001|COMPLETED|Dose Escalation Group 1||0
11302764|NCT02577640|12500734|FG002|COMPLETED|Dose Escalation Group 1||0
11302765|NCT02577640|12500735|FG003|COMPLETED|Dose Escalation Group 1||0
11302766|NCT02577640|12500732|FG000|NOT COMPLETED|Dose Escalation Group 1||1
11302767|NCT02577640|12500733|FG001|NOT COMPLETED|Dose Escalation Group 1||0
11302768|NCT02577640|12500734|FG002|NOT COMPLETED|Dose Escalation Group 1||0
11302769|NCT02577640|12500735|FG003|NOT COMPLETED|Dose Escalation Group 1||0
11302770|NCT02577640|12500732|FG000|STARTED|Dose Escalation Group 2||0
11302771|NCT02577640|12500733|FG001|STARTED|Dose Escalation Group 2||3
11302772|NCT02577640|12500734|FG002|STARTED|Dose Escalation Group 2||0
11302773|NCT02577640|12500735|FG003|STARTED|Dose Escalation Group 2||0
11302774|NCT02577640|12500732|FG000|COMPLETED|Dose Escalation Group 2||0
11302775|NCT02577640|12500733|FG001|COMPLETED|Dose Escalation Group 2||3
11302776|NCT02577640|12500734|FG002|COMPLETED|Dose Escalation Group 2||0
11302777|NCT02577640|12500735|FG003|COMPLETED|Dose Escalation Group 2||0
11302778|NCT02577640|12500732|FG000|NOT COMPLETED|Dose Escalation Group 2||0
11302779|NCT02577640|12500733|FG001|NOT COMPLETED|Dose Escalation Group 2||0
11302780|NCT02577640|12500734|FG002|NOT COMPLETED|Dose Escalation Group 2||0
11302781|NCT02577640|12500735|FG003|NOT COMPLETED|Dose Escalation Group 2||0
11302782|NCT02577640|12500732|FG000|STARTED|Dose Escalation Group 3||0
11302783|NCT02577640|12500733|FG001|STARTED|Dose Escalation Group 3||0
11302784|NCT02577640|12500734|FG002|STARTED|Dose Escalation Group 3||3
11302785|NCT02577640|12500735|FG003|STARTED|Dose Escalation Group 3||0
11302786|NCT02577640|12500732|FG000|COMPLETED|Dose Escalation Group 3||0
11302787|NCT02577640|12500733|FG001|COMPLETED|Dose Escalation Group 3||0
11302788|NCT02577640|12500734|FG002|COMPLETED|Dose Escalation Group 3||3
11302789|NCT02577640|12500735|FG003|COMPLETED|Dose Escalation Group 3||0
11302790|NCT02577640|12500732|FG000|NOT COMPLETED|Dose Escalation Group 3||0
11302791|NCT02577640|12500733|FG001|NOT COMPLETED|Dose Escalation Group 3||0
11302792|NCT02577640|12500734|FG002|NOT COMPLETED|Dose Escalation Group 3||0
11302793|NCT02577640|12500735|FG003|NOT COMPLETED|Dose Escalation Group 3||0
11302794|NCT02577640|12500732|FG000|STARTED|Maximally Tolerated Dose||0
11302795|NCT02577640|12500733|FG001|STARTED|Maximally Tolerated Dose||0
11302796|NCT02577640|12500734|FG002|STARTED|Maximally Tolerated Dose||0
11302797|NCT02577640|12500735|FG003|STARTED|Maximally Tolerated Dose||1
11302798|NCT02577640|12500732|FG000|COMPLETED|Maximally Tolerated Dose||0
11302799|NCT02577640|12500733|FG001|COMPLETED|Maximally Tolerated Dose||0
11302800|NCT02577640|12500734|FG002|COMPLETED|Maximally Tolerated Dose||0
11302801|NCT02577640|12500735|FG003|COMPLETED|Maximally Tolerated Dose||1
11302802|NCT02577640|12500732|FG000|NOT COMPLETED|Maximally Tolerated Dose||0
11302803|NCT02577640|12500733|FG001|NOT COMPLETED|Maximally Tolerated Dose||0
11302804|NCT02577640|12500734|FG002|NOT COMPLETED|Maximally Tolerated Dose||0
11302805|NCT02577640|12500735|FG003|NOT COMPLETED|Maximally Tolerated Dose||0
11302806|NCT02577718|12500747|FG000|STARTED|Overall Study||60
11302807|NCT02577718|12500747|FG000|COMPLETED|Overall Study||52
11302808|NCT02577718|12500747|FG000|NOT COMPLETED|Overall Study||8
11302809|NCT02577822|12500755|FG000|STARTED|Overall Study||27
11302810|NCT02577822|12500756|FG001|STARTED|Overall Study||33
11302811|NCT02577822|12500755|FG000|COMPLETED|Overall Study||21
11302812|NCT02577822|12500756|FG001|COMPLETED|Overall Study||20
11302813|NCT02577822|12500755|FG000|NOT COMPLETED|Overall Study||6
11302814|NCT02577822|12500756|FG001|NOT COMPLETED|Overall Study||13
11302815|NCT02577887|12500762|FG000|STARTED|Overall Study||2101
11302816|NCT02577887|12500762|FG000|6 Month Follow-up|Overall Study||1938
11302817|NCT02577887|12500762|FG000|COMPLETED|Overall Study||1803
11302818|NCT02577887|12500762|FG000|NOT COMPLETED|Overall Study||298
11302819|NCT02577900|12500769|FG000|STARTED|Overall Study||11
11302820|NCT02577900|12500770|FG001|STARTED|Overall Study||10
11302821|NCT02577900|12500771|FG002|STARTED|Overall Study||10
11302822|NCT02577900|12500769|FG000|COMPLETED|Overall Study||11
11302823|NCT02577900|12500770|FG001|COMPLETED|Overall Study||10
11302824|NCT02577900|12500771|FG002|COMPLETED|Overall Study||10
11302825|NCT02577900|12500769|FG000|NOT COMPLETED|Overall Study||0
11302826|NCT02577900|12500770|FG001|NOT COMPLETED|Overall Study||0
11302827|NCT02577900|12500771|FG002|NOT COMPLETED|Overall Study||0
11302828|NCT02577978|12500781|FG000|STARTED|Overall Study||32
11302829|NCT02577978|12500782|FG001|STARTED|Overall Study||29
11302830|NCT02577978|12500781|FG000|COMPLETED|Overall Study||25
11302831|NCT02577978|12500782|FG001|COMPLETED|Overall Study||25
11302832|NCT02577978|12500781|FG000|NOT COMPLETED|Overall Study||7
11302833|NCT02577978|12500782|FG001|NOT COMPLETED|Overall Study||4
11302834|NCT02577991|12500791|FG000|STARTED|Overall Study||24
11302835|NCT02577991|12500792|FG001|STARTED|Overall Study||27
11302836|NCT02577991|12500793|FG002|STARTED|Overall Study||29
11302837|NCT02577991|12500791|FG000|COMPLETED|Overall Study||21
11302838|NCT02577991|12500792|FG001|COMPLETED|Overall Study||25
11302839|NCT02577991|12500793|FG002|COMPLETED|Overall Study||29
11302840|NCT02577991|12500791|FG000|NOT COMPLETED|Overall Study||3
11302841|NCT02577991|12500792|FG001|NOT COMPLETED|Overall Study||2
11302842|NCT02577991|12500793|FG002|NOT COMPLETED|Overall Study||0
11302843|NCT02578186|12500801|FG000|STARTED|Period 1 (First of Crossover)||17
11302844|NCT02578186|12500802|FG001|STARTED|Period 1 (First of Crossover)||18
11302845|NCT02578186|12500801|FG000|COMPLETED|Period 1 (First of Crossover)||12
11302846|NCT02578186|12500802|FG001|COMPLETED|Period 1 (First of Crossover)||13
11302847|NCT02578186|12500801|FG000|NOT COMPLETED|Period 1 (First of Crossover)||5
11302848|NCT02578186|12500802|FG001|NOT COMPLETED|Period 1 (First of Crossover)||5
11302849|NCT02578186|12500801|FG000|STARTED|Period 2 (Second of Crossover)||12
11302850|NCT02578186|12500802|FG001|STARTED|Period 2 (Second of Crossover)||13
11302851|NCT02578186|12500801|FG000|COMPLETED|Period 2 (Second of Crossover)||12
11302852|NCT02578186|12500802|FG001|COMPLETED|Period 2 (Second of Crossover)||13
11302853|NCT02578186|12500801|FG000|NOT COMPLETED|Period 2 (Second of Crossover)||0
11302854|NCT02578186|12500802|FG001|NOT COMPLETED|Period 2 (Second of Crossover)||0
11302855|NCT02578199|12500808|FG000|STARTED|Overall Study||31
11302856|NCT02578199|12500808|FG000|COMPLETED|Overall Study||27
11302857|NCT02578199|12500808|FG000|NOT COMPLETED|Overall Study||4
11302858|NCT02578238|12500812|FG000|STARTED|Overall Study||143
11302859|NCT02578238|12500812|FG000|COMPLETED|Overall Study||143
11302860|NCT02578238|12500812|FG000|NOT COMPLETED|Overall Study||0
11302861|NCT02578316|12500816|FG000|STARTED|Study Phase||6
11302862|NCT02578316|12500816|FG000|COMPLETED|Study Phase||6
11302863|NCT02578316|12500816|FG000|NOT COMPLETED|Study Phase||0
11302864|NCT02578316|12500816|FG000|STARTED|Extension Phase||6
11302865|NCT02578316|12500816|FG000|COMPLETED|Extension Phase||0
11302866|NCT02578316|12500816|FG000|NOT COMPLETED|Extension Phase||6
11302867|NCT02578706|12500827|FG000|STARTED|Overall Study||9
11302868|NCT02578706|12500828|FG001|STARTED|Overall Study||10
11302869|NCT02578706|12500829|FG002|STARTED|Overall Study||8
11302870|NCT02578706|12500827|FG000|COMPLETED|Overall Study||8
11302871|NCT02578706|12500828|FG001|COMPLETED|Overall Study||5
11302872|NCT02578706|12500829|FG002|COMPLETED|Overall Study||8
11302873|NCT02578706|12500827|FG000|NOT COMPLETED|Overall Study||1
11302874|NCT02578706|12500828|FG001|NOT COMPLETED|Overall Study||5
11302875|NCT02578706|12500829|FG002|NOT COMPLETED|Overall Study||0
11302876|NCT02578745|12500839|FG000|STARTED|Overall Study||60
11302877|NCT02578745|12500840|FG001|STARTED|Overall Study||60
11302878|NCT02578745|12500839|FG000|COMPLETED|Overall Study||60
11302879|NCT02578745|12500840|FG001|COMPLETED|Overall Study||60
11302880|NCT02578745|12500839|FG000|NOT COMPLETED|Overall Study||0
11302881|NCT02578745|12500840|FG001|NOT COMPLETED|Overall Study||0
11302882|NCT02578862|12500849|FG000|STARTED|Overall Study||37
11302883|NCT02578862|12500850|FG001|STARTED|Overall Study||35
11302884|NCT02578862|12500849|FG000|COMPLETED|Overall Study||37
11302885|NCT02578862|12500850|FG001|COMPLETED|Overall Study||33
11302886|NCT02578862|12500849|FG000|NOT COMPLETED|Overall Study||0
11302887|NCT02578862|12500850|FG001|NOT COMPLETED|Overall Study||2
11302888|NCT02578901|12500858|FG000|STARTED|Overall Study||165
11302889|NCT02578901|12500859|FG001|STARTED|Overall Study||165
11302890|NCT02578901|12500858|FG000|COMPLETED|Overall Study||145
11302891|NCT02578901|12500859|FG001|COMPLETED|Overall Study||144
11302892|NCT02578901|12500858|FG000|NOT COMPLETED|Overall Study||20
11302893|NCT02578901|12500859|FG001|NOT COMPLETED|Overall Study||21
11302894|NCT02578940|12500865|FG000|STARTED|Overall Study||109
11302895|NCT02578940|12500865|FG000|Received 18F-fluciclovine|Overall Study||104
11302896|NCT02578940|12500865|FG000|COMPLETED|Overall Study||103
11302897|NCT02578940|12500865|FG000|NOT COMPLETED|Overall Study||6
11302898|NCT02578992|12500873|FG000|STARTED|Overall Study|November 2014|65
11302899|NCT02578992|12500874|FG001|STARTED|Overall Study|November 2014|65
11302900|NCT02578992|12500873|FG000|COMPLETED|Overall Study|October 2015|62
11302901|NCT02578992|12500874|FG001|COMPLETED|Overall Study|October 2015|62
11302902|NCT02578992|12500873|FG000|NOT COMPLETED|Overall Study||3
11302903|NCT02578992|12500874|FG001|NOT COMPLETED|Overall Study||3
11302904|NCT02579057|12500888|FG000|STARTED|Overall Study||19
11302905|NCT02579057|12500889|FG001|STARTED|Overall Study||21
11302906|NCT02579057|12500888|FG000|COMPLETED|Overall Study||19
11302907|NCT02579057|12500889|FG001|COMPLETED|Overall Study||21
11302908|NCT02579057|12500888|FG000|NOT COMPLETED|Overall Study||0
11302909|NCT02579057|12500889|FG001|NOT COMPLETED|Overall Study||0
11302910|NCT02579135|12500897|FG000|STARTED|Overall Study||107
11302911|NCT02579135|12500898|FG001|STARTED|Overall Study||115
11302912|NCT02579135|12500897|FG000|COMPLETED|Overall Study||105
11302913|NCT02579135|12500898|FG001|COMPLETED|Overall Study||106
11302914|NCT02579135|12500897|FG000|NOT COMPLETED|Overall Study||2
11302915|NCT02579135|12500898|FG001|NOT COMPLETED|Overall Study||9
11401229|NCT04128293|12596080|FG003|STARTED|Washout Period 1 (Up to 7 Days)||4
11401230|NCT04128293|12596077|FG000|COMPLETED|Washout Period 1 (Up to 7 Days)||4
11401231|NCT04128293|12596078|FG001|COMPLETED|Washout Period 1 (Up to 7 Days)||4
11401232|NCT04128293|12596079|FG002|COMPLETED|Washout Period 1 (Up to 7 Days)||4
11302916|NCT02579343|12500906|FG000|STARTED|Overall Study||7
11302917|NCT02579343|12500907|FG001|STARTED|Overall Study||6
11302918|NCT02579343|12500906|FG000|COMPLETED|Overall Study||7
11302919|NCT02579343|12500907|FG001|COMPLETED|Overall Study||6
11302920|NCT02579343|12500906|FG000|NOT COMPLETED|Overall Study||0
11302921|NCT02579343|12500907|FG001|NOT COMPLETED|Overall Study||0
11302922|NCT02579382|12500917|FG000|STARTED|Main Study Phase||28
11302923|NCT02579382|12500918|FG001|STARTED|Main Study Phase||53
11302924|NCT02579382|12500919|FG002|STARTED|Main Study Phase||56
11302925|NCT02579382|12500920|FG003|STARTED|Main Study Phase||55
11302926|NCT02579382|12500917|FG000|COMPLETED|Main Study Phase||28
11302927|NCT02579382|12500918|FG001|COMPLETED|Main Study Phase||53
11302928|NCT02579382|12500919|FG002|COMPLETED|Main Study Phase||54
11302929|NCT02579382|12500920|FG003|COMPLETED|Main Study Phase||52
11302930|NCT02579382|12500917|FG000|NOT COMPLETED|Main Study Phase||0
11302931|NCT02579382|12500918|FG001|NOT COMPLETED|Main Study Phase||0
11302932|NCT02579382|12500919|FG002|NOT COMPLETED|Main Study Phase||2
11302933|NCT02579382|12500920|FG003|NOT COMPLETED|Main Study Phase||3
11302934|NCT02579382|12500917|FG000|STARTED|Optional Treatment Extension Phase(OTEP)|1 participant who completed the Main Study Phase did not enter the OTEP.|27
11302935|NCT02579382|12500918|FG001|STARTED|Optional Treatment Extension Phase(OTEP)|2 participants who completed the Main Study Phase did not enter the OTEP.|51
11302936|NCT02579382|12500919|FG002|STARTED|Optional Treatment Extension Phase(OTEP)||54
11302937|NCT02579382|12500920|FG003|STARTED|Optional Treatment Extension Phase(OTEP)|3 participants who completed the Main Study Phase did not enter the OTEP.|49
11302938|NCT02579382|12500917|FG000|COMPLETED|Optional Treatment Extension Phase(OTEP)||26
11302939|NCT02579382|12500918|FG001|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
11302940|NCT02579382|12500919|FG002|COMPLETED|Optional Treatment Extension Phase(OTEP)||50
11302941|NCT02579382|12500920|FG003|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
11302942|NCT02579382|12500917|FG000|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||1
11302943|NCT02579382|12500918|FG001|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||7
11302944|NCT02579382|12500919|FG002|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||4
11302945|NCT02579382|12500920|FG003|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||5
11302946|NCT02579421|12500942|FG000|STARTED|Overall Study||23
11302947|NCT02579421|12500943|FG001|STARTED|Overall Study||23
11302948|NCT02579421|12500944|FG002|STARTED|Overall Study||6
11302949|NCT02579421|12500945|FG003|STARTED|Overall Study||6
11302950|NCT02579421|12500942|FG000|COMPLETED|Overall Study||17
11302951|NCT02579421|12500943|FG001|COMPLETED|Overall Study||18
11302952|NCT02579421|12500944|FG002|COMPLETED|Overall Study||5
11302953|NCT02579421|12500945|FG003|COMPLETED|Overall Study||3
11302954|NCT02579421|12500942|FG000|NOT COMPLETED|Overall Study||6
11302955|NCT02579421|12500943|FG001|NOT COMPLETED|Overall Study||5
11302956|NCT02579421|12500944|FG002|NOT COMPLETED|Overall Study||1
11302957|NCT02579421|12500945|FG003|NOT COMPLETED|Overall Study||3
11302958|NCT02579603|12500957|FG000|STARTED|Overall Study|Started are the randomised patients|52
11302959|NCT02579603|12500958|FG001|STARTED|Overall Study|Started are the randomised patients|53
11302960|NCT02579603|12500957|FG000|Number of Patients Treated|Overall Study||51
11302961|NCT02579603|12500958|FG001|Number of Patients Treated|Overall Study||53
11302962|NCT02579603|12500957|FG000|COMPLETED|Overall Study||48
11302963|NCT02579603|12500958|FG001|COMPLETED|Overall Study||51
11302964|NCT02579603|12500957|FG000|NOT COMPLETED|Overall Study||4
11302965|NCT02579603|12500958|FG001|NOT COMPLETED|Overall Study||2
11302966|NCT02579616|12500965|FG000|STARTED|Overall Study||29
11302967|NCT02579616|12500965|FG000|Treated|Overall Study||26
11302968|NCT02579616|12500965|FG000|COMPLETED|Overall Study||26
11302969|NCT02579616|12500965|FG000|NOT COMPLETED|Overall Study||3
11302970|NCT02579629|12500972|FG000|STARTED|Overall Study||22
11302971|NCT02579629|12500973|FG001|STARTED|Overall Study||20
11302972|NCT02579629|12500974|FG002|STARTED|Overall Study||22
11302973|NCT02579629|12500972|FG000|COMPLETED|Overall Study||20
11302974|NCT02579629|12500973|FG001|COMPLETED|Overall Study||19
11302975|NCT02579629|12500974|FG002|COMPLETED|Overall Study||20
11302976|NCT02579629|12500972|FG000|NOT COMPLETED|Overall Study||2
11302977|NCT02579629|12500973|FG001|NOT COMPLETED|Overall Study||1
11302978|NCT02579629|12500974|FG002|NOT COMPLETED|Overall Study||2
11302979|NCT02579759|12500985|FG000|STARTED|Overall Study||109
11302980|NCT02579759|12500986|FG001|STARTED|Overall Study||113
11302981|NCT02579759|12500987|FG002|STARTED|Overall Study||101
11302982|NCT02579759|12500985|FG000|COMPLETED|Overall Study||85
11302983|NCT02579759|12500986|FG001|COMPLETED|Overall Study||49
11302984|NCT02579759|12500987|FG002|COMPLETED|Overall Study||80
11302985|NCT02579759|12500985|FG000|NOT COMPLETED|Overall Study||24
11302986|NCT02579759|12500986|FG001|NOT COMPLETED|Overall Study||64
11302987|NCT02579759|12500987|FG002|NOT COMPLETED|Overall Study||21
11302988|NCT02579772|12500997|FG000|STARTED|Overall Study||8
11302989|NCT02579772|12500998|FG001|STARTED|Overall Study||5
11302990|NCT02579772|12500997|FG000|COMPLETED|Overall Study||6
11302991|NCT02579772|12500998|FG001|COMPLETED|Overall Study||3
11302992|NCT02579772|12500997|FG000|NOT COMPLETED|Overall Study||2
11302993|NCT02579772|12500998|FG001|NOT COMPLETED|Overall Study||2
11302994|NCT02579863|12501006|FG000|STARTED|Overall Study||156
11302995|NCT02579863|12501007|FG001|STARTED|Overall Study||154
11302996|NCT02579863|12501006|FG000|Treated|Overall Study||154
11302997|NCT02579863|12501007|FG001|Treated|Overall Study||148
11302998|NCT02579863|12501006|FG000|COMPLETED|Overall Study||0
11302999|NCT02579863|12501007|FG001|COMPLETED|Overall Study||0
11303000|NCT02579863|12501006|FG000|NOT COMPLETED|Overall Study||156
11303001|NCT02579863|12501007|FG001|NOT COMPLETED|Overall Study||154
11303002|NCT02579876|12501015|FG000|STARTED|Overall Study||15
11303003|NCT02579876|12501016|FG001|STARTED|Overall Study||5
11303004|NCT02579876|12501015|FG000|COMPLETED|Overall Study||14
11303005|NCT02579876|12501016|FG001|COMPLETED|Overall Study||5
11303006|NCT02579876|12501015|FG000|NOT COMPLETED|Overall Study||1
11303007|NCT02579876|12501016|FG001|NOT COMPLETED|Overall Study||0
11303008|NCT02579915|12501024|FG000|STARTED|Overall Study||19
11303009|NCT02579915|12501025|FG001|STARTED|Overall Study||21
11303010|NCT02579915|12501024|FG000|COMPLETED|Overall Study||9
11303011|NCT02579915|12501025|FG001|COMPLETED|Overall Study||16
11303012|NCT02579915|12501024|FG000|NOT COMPLETED|Overall Study||10
11303013|NCT02579915|12501025|FG001|NOT COMPLETED|Overall Study||5
11303014|NCT02579928|12501033|FG000|STARTED|Overall Study||6
11303015|NCT02579928|12501034|FG001|STARTED|Overall Study||11
11303016|NCT02579928|12501033|FG000|COMPLETED|Overall Study||5
11303017|NCT02579928|12501034|FG001|COMPLETED|Overall Study||11
11303018|NCT02579928|12501033|FG000|NOT COMPLETED|Overall Study||1
11303019|NCT02579928|12501034|FG001|NOT COMPLETED|Overall Study||0
11303020|NCT02580188|12501042|FG000|STARTED|Overall Study||35
11303021|NCT02580188|12501043|FG001|STARTED|Overall Study||35
11303022|NCT02580188|12501042|FG000|COMPLETED|Overall Study||32
11303023|NCT02580188|12501043|FG001|COMPLETED|Overall Study||32
11303024|NCT02580188|12501042|FG000|NOT COMPLETED|Overall Study||3
11303025|NCT02580188|12501043|FG001|NOT COMPLETED|Overall Study||3
11303026|NCT02580201|12501052|FG000|STARTED|Overall Study||50
11303027|NCT02580201|12501053|FG001|STARTED|Overall Study||104
11303028|NCT02580201|12501052|FG000|COMPLETED|Overall Study||50
11303029|NCT02580201|12501053|FG001|COMPLETED|Overall Study||104
11303030|NCT02580201|12501052|FG000|NOT COMPLETED|Overall Study||0
11303031|NCT02580201|12501053|FG001|NOT COMPLETED|Overall Study||0
11303032|NCT02580240|12501062|FG000|STARTED|Overall Study||62
11303033|NCT02580240|12501063|FG001|STARTED|Overall Study||58
11303034|NCT02580240|12501062|FG000|COMPLETED|Overall Study||60
11303035|NCT02580240|12501063|FG001|COMPLETED|Overall Study||58
11303036|NCT02580240|12501062|FG000|NOT COMPLETED|Overall Study||2
11303037|NCT02580240|12501063|FG001|NOT COMPLETED|Overall Study||0
11303038|NCT02580318|12501069|FG000|STARTED|Overall Study||54
11303039|NCT02580318|12501069|FG000|Poor Effort|Overall Study||53
11303040|NCT02580318|12501069|FG000|Hyperventilation (Immediate)|Overall Study||54
11303041|NCT02580318|12501069|FG000|Hyperventilation (5 Minutes)|Overall Study||54
11303042|NCT02580318|12501069|FG000|Hyperventilation (10 Minutes)|Overall Study||54
11303043|NCT02580318|12501069|FG000|Drinking Water (Immediate)|Overall Study||51
11303044|NCT02580318|12501069|FG000|Drinking Water (5 Minutes)|Overall Study||54
11303045|NCT02580318|12501069|FG000|COMPLETED|Overall Study||54
11303046|NCT02580318|12501069|FG000|NOT COMPLETED|Overall Study||0
11303047|NCT02580357|12501076|FG000|STARTED|Overall Study||18
11303048|NCT02580357|12501077|FG001|STARTED|Overall Study||18
11303049|NCT02580357|12501078|FG002|STARTED|Overall Study||18
11303050|NCT02580357|12501076|FG000|COMPLETED|Overall Study||15
11303051|NCT02580357|12501077|FG001|COMPLETED|Overall Study||18
11303052|NCT02580357|12501078|FG002|COMPLETED|Overall Study||18
11303053|NCT02580357|12501076|FG000|NOT COMPLETED|Overall Study||3
11303054|NCT02580357|12501077|FG001|NOT COMPLETED|Overall Study||0
11303055|NCT02580357|12501078|FG002|NOT COMPLETED|Overall Study||0
11303056|NCT02580591|12501090|FG000|STARTED|Overall Study||242
11303057|NCT02580591|12501091|FG001|STARTED|Overall Study||242
11303058|NCT02580591|12501092|FG002|STARTED|Overall Study||248
11303059|NCT02580591|12501093|FG003|STARTED|Overall Study||245
11303060|NCT02580591|12501090|FG000|Treated|Overall Study||241
11303061|NCT02580591|12501091|FG001|Treated|Overall Study||241
11303062|NCT02580591|12501092|FG002|Treated|Overall Study||248
11303063|NCT02580591|12501093|FG003|Treated|Overall Study||245
11303064|NCT02580591|12501090|FG000|COMPLETED|Overall Study||224
11303065|NCT02580591|12501091|FG001|COMPLETED|Overall Study||232
11303066|NCT02580591|12501092|FG002|COMPLETED|Overall Study||235
11303067|NCT02580591|12501093|FG003|COMPLETED|Overall Study||233
11303068|NCT02580591|12501090|FG000|NOT COMPLETED|Overall Study||18
11303069|NCT02580591|12501091|FG001|NOT COMPLETED|Overall Study||10
11303070|NCT02580591|12501092|FG002|NOT COMPLETED|Overall Study||13
11303071|NCT02580591|12501093|FG003|NOT COMPLETED|Overall Study||12
11303072|NCT02580799|12501103|FG000|STARTED|Overall Study||30
11303073|NCT02580799|12501103|FG000|COMPLETED|Overall Study||30
11303074|NCT02580799|12501103|FG000|NOT COMPLETED|Overall Study||0
11303075|NCT02580877|12501109|FG000|STARTED|Overall Study||45
11303076|NCT02580877|12501110|FG001|STARTED|Overall Study||47
11303077|NCT02580877|12501109|FG000|COMPLETED|Overall Study||44
11303078|NCT02580877|12501110|FG001|COMPLETED|Overall Study||43
11303079|NCT02580877|12501109|FG000|NOT COMPLETED|Overall Study||1
11303080|NCT02580877|12501110|FG001|NOT COMPLETED|Overall Study||4
11303081|NCT02581111|12501119|FG000|STARTED|Overall Study||98
11303082|NCT02581111|12501120|FG001|STARTED|Overall Study||101
11303083|NCT02581111|12501119|FG000|COMPLETED|Overall Study||96
11303084|NCT02581111|12501120|FG001|COMPLETED|Overall Study||94
11303085|NCT02581111|12501119|FG000|NOT COMPLETED|Overall Study||2
11303086|NCT02581111|12501120|FG001|NOT COMPLETED|Overall Study||7
11303087|NCT02581163|12501126|FG000|STARTED|Overall Study||311
11303088|NCT02581163|12501126|FG000|COMPLETED|Overall Study||282
11303089|NCT02581163|12501126|FG000|NOT COMPLETED|Overall Study||29
11303090|NCT02581189|12501133|FG000|STARTED|Overall Study||534
11303091|NCT02581189|12501133|FG000|COMPLETED|Overall Study||481
11303092|NCT02581189|12501133|FG000|NOT COMPLETED|Overall Study||53
11303093|NCT02581202|12501140|FG000|STARTED|Overall Study||216
11303094|NCT02581202|12501140|FG000|COMPLETED|Overall Study||202
11303095|NCT02581202|12501140|FG000|NOT COMPLETED|Overall Study||14
11303096|NCT02581345|12501147|FG000|STARTED|Part 1: up to Week 16||286
11303097|NCT02581345|12501148|FG001|STARTED|Part 1: up to Week 16||286
11303098|NCT02581345|12501149|FG002|STARTED|Part 1: up to Week 16||0
11303099|NCT02581345|12501150|FG003|STARTED|Part 1: up to Week 16||0
11303100|NCT02581345|12501147|FG000|COMPLETED|Part 1: up to Week 16||271
11303101|NCT02581345|12501148|FG001|COMPLETED|Part 1: up to Week 16||263
11303102|NCT02581345|12501149|FG002|COMPLETED|Part 1: up to Week 16||0
11303103|NCT02581345|12501150|FG003|COMPLETED|Part 1: up to Week 16||0
11303104|NCT02581345|12501147|FG000|NOT COMPLETED|Part 1: up to Week 16||15
11303105|NCT02581345|12501148|FG001|NOT COMPLETED|Part 1: up to Week 16||23
11303106|NCT02581345|12501149|FG002|NOT COMPLETED|Part 1: up to Week 16||0
11303107|NCT02581345|12501150|FG003|NOT COMPLETED|Part 1: up to Week 16||0
11303108|NCT02581345|12501147|FG000|STARTED|Part 2: Week 17 to Week 47||271
11303109|NCT02581345|12501148|FG001|STARTED|Part 2: Week 17 to Week 47||0
11303110|NCT02581345|12501149|FG002|STARTED|Part 2: Week 17 to Week 47||132
11303111|NCT02581345|12501150|FG003|STARTED|Part 2: Week 17 to Week 47||131
11303112|NCT02581345|12501147|FG000|COMPLETED|Part 2: Week 17 to Week 47||242
11303113|NCT02581345|12501148|FG001|COMPLETED|Part 2: Week 17 to Week 47||0
11303114|NCT02581345|12501149|FG002|COMPLETED|Part 2: Week 17 to Week 47||117
11303115|NCT02581345|12501150|FG003|COMPLETED|Part 2: Week 17 to Week 47||119
11303116|NCT02581345|12501147|FG000|NOT COMPLETED|Part 2: Week 17 to Week 47||29
11303117|NCT02581345|12501148|FG001|NOT COMPLETED|Part 2: Week 17 to Week 47||0
11303118|NCT02581345|12501149|FG002|NOT COMPLETED|Part 2: Week 17 to Week 47||15
11303119|NCT02581345|12501150|FG003|NOT COMPLETED|Part 2: Week 17 to Week 47||12
11303120|NCT02581384|12501168|FG000|STARTED|Overall Study||3
11303121|NCT02581384|12501169|FG001|STARTED|Overall Study||2
11303122|NCT02581384|12501168|FG000|COMPLETED|Overall Study||3
11303123|NCT02581384|12501169|FG001|COMPLETED|Overall Study||2
11303124|NCT02581384|12501168|FG000|NOT COMPLETED|Overall Study||0
11303125|NCT02581384|12501169|FG001|NOT COMPLETED|Overall Study||0
11303126|NCT02581410|12501178|FG000|STARTED|Vaccination Phase||215
11303127|NCT02581410|12501179|FG001|STARTED|Vaccination Phase||215
11303128|NCT02581410|12501178|FG000|COMPLETED|Vaccination Phase||213
11303129|NCT02581410|12501179|FG001|COMPLETED|Vaccination Phase||212
11303130|NCT02581410|12501178|FG000|NOT COMPLETED|Vaccination Phase||2
11303131|NCT02581410|12501179|FG001|NOT COMPLETED|Vaccination Phase||3
11303132|NCT02581410|12501178|FG000|STARTED|End of Study Phase||215
11303133|NCT02581410|12501179|FG001|STARTED|End of Study Phase||215
11303134|NCT02581410|12501178|FG000|COMPLETED|End of Study Phase||210
11303135|NCT02581410|12501179|FG001|COMPLETED|End of Study Phase||204
11303136|NCT02581410|12501178|FG000|NOT COMPLETED|End of Study Phase||5
11303137|NCT02581410|12501179|FG001|NOT COMPLETED|End of Study Phase||11
11303138|NCT02581475|12501188|FG000|STARTED|Overall Study||193
11303139|NCT02581475|12501189|FG001|STARTED|Overall Study||193
11303140|NCT02581475|12501188|FG000|COMPLETED|Overall Study||182
11303141|NCT02581475|12501189|FG001|COMPLETED|Overall Study||178
11303142|NCT02581475|12501188|FG000|NOT COMPLETED|Overall Study||11
11401233|NCT04128293|12596080|FG003|COMPLETED|Washout Period 1 (Up to 7 Days)||4
11401234|NCT04128293|12596077|FG000|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
11401235|NCT04128293|12596078|FG001|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
11401236|NCT04128293|12596079|FG002|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
11401237|NCT04128293|12596080|FG003|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
11401238|NCT04128293|12596077|FG000|STARTED|Treatment Period 2 (1 Day)||4
11401239|NCT04128293|12596078|FG001|STARTED|Treatment Period 2 (1 Day)||4
11401240|NCT04128293|12596079|FG002|STARTED|Treatment Period 2 (1 Day)||4
11401241|NCT04128293|12596080|FG003|STARTED|Treatment Period 2 (1 Day)||4
11401242|NCT04128293|12596077|FG000|COMPLETED|Treatment Period 2 (1 Day)||4
11401243|NCT04128293|12596078|FG001|COMPLETED|Treatment Period 2 (1 Day)||4
11401244|NCT04128293|12596079|FG002|COMPLETED|Treatment Period 2 (1 Day)||4
11401245|NCT04128293|12596080|FG003|COMPLETED|Treatment Period 2 (1 Day)||4
11401246|NCT04128293|12596077|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11401247|NCT04128293|12596078|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11401248|NCT04128293|12596079|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11401249|NCT04128293|12596080|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11401250|NCT04128293|12596077|FG000|STARTED|Washout Period 2 (Up to 7 Days)||4
11401251|NCT04128293|12596078|FG001|STARTED|Washout Period 2 (Up to 7 Days)||4
11401252|NCT04128293|12596079|FG002|STARTED|Washout Period 2 (Up to 7 Days)||4
11303143|NCT02581475|12501189|FG001|NOT COMPLETED|Overall Study||15
11303144|NCT02581488|12501197|FG000|STARTED|Overall Study||51
11303145|NCT02581488|12501198|FG001|STARTED|Overall Study||51
11303146|NCT02581488|12501197|FG000|COMPLETED|Overall Study||42
11303147|NCT02581488|12501198|FG001|COMPLETED|Overall Study||40
11303148|NCT02581488|12501197|FG000|NOT COMPLETED|Overall Study||9
11401253|NCT04128293|12596080|FG003|STARTED|Washout Period 2 (Up to 7 Days)||4
11303149|NCT02581488|12501198|FG001|NOT COMPLETED|Overall Study||11
11303150|NCT02581839|12501204|FG000|STARTED|Overall Study||9
11303151|NCT02581839|12501204|FG000|COMPLETED|Overall Study||9
11303152|NCT02581839|12501204|FG000|NOT COMPLETED|Overall Study||0
11303153|NCT02581865|12501211|FG000|STARTED|Overall Study||40
11303154|NCT02581865|12501212|FG001|STARTED|Overall Study||42
11303155|NCT02581865|12501213|FG002|STARTED|Overall Study||42
11303156|NCT02581865|12501211|FG000|COMPLETED|Overall Study||36
11303157|NCT02581865|12501212|FG001|COMPLETED|Overall Study||35
11303158|NCT02581865|12501213|FG002|COMPLETED|Overall Study||26
11303159|NCT02581865|12501211|FG000|NOT COMPLETED|Overall Study||4
11303160|NCT02581865|12501212|FG001|NOT COMPLETED|Overall Study||7
11303161|NCT02581865|12501213|FG002|NOT COMPLETED|Overall Study||16
11303162|NCT02581891|12501226|FG000|STARTED|Overall Study||135
11303163|NCT02581891|12501227|FG001|STARTED|Overall Study||136
11303164|NCT02581891|12501226|FG000|Completed Treatment|Overall Study||120
11303165|NCT02581891|12501227|FG001|Completed Treatment|Overall Study||117
11303166|NCT02581891|12501226|FG000|COMPLETED|Overall Study||119
11303167|NCT02581891|12501227|FG001|COMPLETED|Overall Study||117
11303168|NCT02581891|12501226|FG000|NOT COMPLETED|Overall Study||16
11303169|NCT02581891|12501227|FG001|NOT COMPLETED|Overall Study||19
11303170|NCT02581995|12501234|FG000|STARTED|Overall Study||560
11303171|NCT02581995|12501234|FG000|Treated|Overall Study||560
11303172|NCT02581995|12501234|FG000|COMPLETED|Overall Study||529
11303173|NCT02581995|12501234|FG000|NOT COMPLETED|Overall Study||31
11303174|NCT02582151|12501240|FG000|STARTED|Overall Study||14
11303175|NCT02582151|12501241|FG001|STARTED|Overall Study||16
11303176|NCT02582151|12501240|FG000|COMPLETED|Overall Study||12
11303177|NCT02582151|12501241|FG001|COMPLETED|Overall Study||16
11303178|NCT02582151|12501240|FG000|NOT COMPLETED|Overall Study||2
11303179|NCT02582151|12501241|FG001|NOT COMPLETED|Overall Study||0
11303180|NCT02582216|12501247|FG000|STARTED|Overall Study||22
11303181|NCT02582216|12501247|FG000|COMPLETED|Overall Study||22
11303182|NCT02582216|12501247|FG000|NOT COMPLETED|Overall Study||0
11303183|NCT02582242|12501254|FG000|STARTED|Overall Study||220
11303184|NCT02582242|12501255|FG001|STARTED|Overall Study||217
11303185|NCT02582242|12501254|FG000|COMPLETED|Overall Study||200
11303186|NCT02582242|12501255|FG001|COMPLETED|Overall Study||200
11303187|NCT02582242|12501254|FG000|NOT COMPLETED|Overall Study||20
11303188|NCT02582242|12501255|FG001|NOT COMPLETED|Overall Study||17
11303189|NCT02582255|12501263|FG000|STARTED|Overall Study||50
11303190|NCT02582255|12501264|FG001|STARTED|Overall Study||50
11303191|NCT02582255|12501263|FG000|COMPLETED|Overall Study||50
11303192|NCT02582255|12501264|FG001|COMPLETED|Overall Study||47
11303193|NCT02582255|12501263|FG000|NOT COMPLETED|Overall Study||0
11303194|NCT02582255|12501264|FG001|NOT COMPLETED|Overall Study||3
11303195|NCT02582515|12501273|FG000|STARTED|Overall Study||9
11303196|NCT02582515|12501274|FG001|STARTED|Overall Study||11
11303197|NCT02582515|12501273|FG000|Received Study Intervention|Overall Study||9
11303198|NCT02582515|12501274|FG001|Received Study Intervention|Overall Study||10
11303199|NCT02582515|12501273|FG000|COMPLETED|Overall Study||9
11303200|NCT02582515|12501274|FG001|COMPLETED|Overall Study||10
11303201|NCT02582515|12501273|FG000|NOT COMPLETED|Overall Study||0
11303202|NCT02582515|12501274|FG001|NOT COMPLETED|Overall Study||1
11303203|NCT02582632|12501280|FG000|STARTED|Overall Study||166
11303204|NCT02582632|12501280|FG000|COMPLETED|Overall Study||165
11303205|NCT02582632|12501280|FG000|NOT COMPLETED|Overall Study||1
11303206|NCT02582658|12501284|FG000|STARTED|Overall Study||171
11303207|NCT02582658|12501284|FG000|COMPLETED|Overall Study||146
11303208|NCT02582658|12501284|FG000|NOT COMPLETED|Overall Study||25
11303209|NCT02582671|12501288|FG000|STARTED|Overall Study||101
11303210|NCT02582671|12501288|FG000|COMPLETED|Overall Study||99
11303211|NCT02582671|12501288|FG000|NOT COMPLETED|Overall Study||2
11303212|NCT02582684|12501293|FG000|STARTED|Overall Study||122
11303213|NCT02582684|12501293|FG000|COMPLETED|Overall Study||105
11303214|NCT02582684|12501293|FG000|NOT COMPLETED|Overall Study||17
11303215|NCT02582814|12501299|FG000|STARTED|Overall Study||76
11303216|NCT02582814|12501300|FG001|STARTED|Overall Study||75
11303217|NCT02582814|12501299|FG000|COMPLETED|Overall Study||67
11303218|NCT02582814|12501300|FG001|COMPLETED|Overall Study||68
11303219|NCT02582814|12501299|FG000|NOT COMPLETED|Overall Study||9
11303220|NCT02582814|12501300|FG001|NOT COMPLETED|Overall Study||7
11303221|NCT02582840|12501309|FG000|STARTED|Overall Study||14
11303222|NCT02582840|12501310|FG001|STARTED|Overall Study||14
11303223|NCT02582840|12501311|FG002|STARTED|Overall Study||14
11303224|NCT02582840|12501309|FG000|COMPLETED|Overall Study||14
11303225|NCT02582840|12501310|FG001|COMPLETED|Overall Study||14
11303226|NCT02582840|12501311|FG002|COMPLETED|Overall Study||14
11303227|NCT02582840|12501309|FG000|NOT COMPLETED|Overall Study||0
11303228|NCT02582840|12501310|FG001|NOT COMPLETED|Overall Study||0
11303229|NCT02582840|12501311|FG002|NOT COMPLETED|Overall Study||0
11303230|NCT02582866|12501321|FG000|STARTED|Overall Study||106
11303231|NCT02582866|12501321|FG000|COMPLETED|Overall Study||84
11303232|NCT02582866|12501321|FG000|NOT COMPLETED|Overall Study||22
11303233|NCT02582970|12501325|FG000|STARTED|Overall Study||40
11303234|NCT02582970|12501325|FG000|COMPLETED|Overall Study||40
11303235|NCT02582970|12501325|FG000|NOT COMPLETED|Overall Study||0
11303236|NCT02582983|12501329|FG000|STARTED|Overall Study||23
11303237|NCT02582983|12501329|FG000|COMPLETED|Overall Study||17
11303238|NCT02582983|12501329|FG000|NOT COMPLETED|Overall Study||6
11303239|NCT02583230|12501333|FG000|STARTED|Overall Study||11
11303240|NCT02583230|12501333|FG000|COMPLETED|Overall Study||11
11303241|NCT02583230|12501333|FG000|NOT COMPLETED|Overall Study||0
11303242|NCT02583256|12501341|FG000|STARTED|Overall Study||403
11303243|NCT02583256|12501342|FG001|STARTED|Overall Study||403
11303244|NCT02583256|12501343|FG002|STARTED|Overall Study||402
11303245|NCT02583256|12501344|FG003|STARTED|Overall Study||393
11303246|NCT02583256|12501341|FG000|Exposed|Overall Study||403
11303247|NCT02583256|12501342|FG001|Exposed|Overall Study||403
11303248|NCT02583256|12501343|FG002|Exposed|Overall Study||402
11303249|NCT02583256|12501344|FG003|Exposed|Overall Study||393
11303250|NCT02583256|12501341|FG000|COMPLETED|Overall Study||400
11303251|NCT02583256|12501342|FG001|COMPLETED|Overall Study||401
11303252|NCT02583256|12501343|FG002|COMPLETED|Overall Study||400
11303253|NCT02583256|12501344|FG003|COMPLETED|Overall Study||390
11303254|NCT02583256|12501341|FG000|NOT COMPLETED|Overall Study||3
11303255|NCT02583256|12501342|FG001|NOT COMPLETED|Overall Study||2
11303256|NCT02583256|12501343|FG002|NOT COMPLETED|Overall Study||2
11303257|NCT02583256|12501344|FG003|NOT COMPLETED|Overall Study||3
11303258|NCT02583360|12501358|FG000|STARTED|Overall Study||60
11303259|NCT02583360|12501359|FG001|STARTED|Overall Study||49
11303260|NCT02583360|12501358|FG000|COMPLETED|Overall Study||60
11303261|NCT02583360|12501359|FG001|COMPLETED|Overall Study||49
11303262|NCT02583360|12501358|FG000|NOT COMPLETED|Overall Study||0
11303263|NCT02583360|12501359|FG001|NOT COMPLETED|Overall Study||0
11303264|NCT02583399|12501365|FG000|STARTED|Overall Study||30
11303265|NCT02583399|12501365|FG000|COMPLETED|Overall Study||24
11303266|NCT02583399|12501365|FG000|NOT COMPLETED|Overall Study||6
11303267|NCT02583425|12501369|FG000|STARTED|Screening||27
11303268|NCT02583425|12501369|FG000|COMPLETED|Screening||15
11303269|NCT02583425|12501369|FG000|NOT COMPLETED|Screening||12
11303270|NCT02583425|12501369|FG000|STARTED|Baseline||15
11303271|NCT02583425|12501369|FG000|COMPLETED|Baseline||10
11303272|NCT02583425|12501369|FG000|NOT COMPLETED|Baseline||5
11303273|NCT02583425|12501369|FG000|STARTED|Treatment Period||10
11303274|NCT02583425|12501369|FG000|COMPLETED|Treatment Period||9
11303275|NCT02583425|12501369|FG000|NOT COMPLETED|Treatment Period||1
11303276|NCT02583477|12501376|FG000|STARTED|Overall Study||3
11303277|NCT02583477|12501377|FG001|STARTED|Overall Study||20
11303278|NCT02583477|12501376|FG000|Received Treatment|Overall Study||3
11303279|NCT02583477|12501377|FG001|Received Treatment|Overall Study||20
11303280|NCT02583477|12501376|FG000|Completed Treatment|Overall Study||0
11303281|NCT02583477|12501377|FG001|Completed Treatment|Overall Study||0
11303282|NCT02583477|12501376|FG000|COMPLETED|Overall Study||0
11303283|NCT02583477|12501377|FG001|COMPLETED|Overall Study||0
11303284|NCT02583477|12501376|FG000|NOT COMPLETED|Overall Study||3
11303285|NCT02583477|12501377|FG001|NOT COMPLETED|Overall Study||20
11303286|NCT02583711|12501387|FG000|STARTED|Overall Study||11
11303287|NCT02583711|12501388|FG001|STARTED|Overall Study||38
11303288|NCT02583711|12501389|FG002|STARTED|Overall Study||10
11303289|NCT02583711|12501387|FG000|COMPLETED|Overall Study||11
11303290|NCT02583711|12501388|FG001|COMPLETED|Overall Study||28
11303291|NCT02583711|12501389|FG002|COMPLETED|Overall Study||10
11303292|NCT02583711|12501387|FG000|NOT COMPLETED|Overall Study||0
11303293|NCT02583711|12501388|FG001|NOT COMPLETED|Overall Study||10
11303294|NCT02583711|12501389|FG002|NOT COMPLETED|Overall Study||0
11303295|NCT02584140|12501399|FG000|STARTED|Overall Study||136
11303296|NCT02584140|12501399|FG000|COMPLETED|Overall Study||83
11303297|NCT02584140|12501399|FG000|NOT COMPLETED|Overall Study||53
11303298|NCT02584257|12501403|FG000|STARTED|Period 1||9
11303299|NCT02584257|12501404|FG001|STARTED|Period 1||9
11303300|NCT02584257|12501405|FG002|STARTED|Period 1||9
11303301|NCT02584257|12501406|FG003|STARTED|Period 1||8
11303302|NCT02584257|12501407|FG004|STARTED|Period 1||10
11303303|NCT02584257|12501408|FG005|STARTED|Period 1||10
11303304|NCT02584257|12501409|FG006|STARTED|Period 1||18
11303305|NCT02584257|12501410|FG007|STARTED|Period 1||9
11303306|NCT02584257|12501411|FG008|STARTED|Period 1||9
11303307|NCT02584257|12501403|FG000|COMPLETED|Period 1||9
11303308|NCT02584257|12501404|FG001|COMPLETED|Period 1||9
11303309|NCT02584257|12501405|FG002|COMPLETED|Period 1||9
11303310|NCT02584257|12501406|FG003|COMPLETED|Period 1||8
11303311|NCT02584257|12501407|FG004|COMPLETED|Period 1||10
11303312|NCT02584257|12501408|FG005|COMPLETED|Period 1||10
11303313|NCT02584257|12501409|FG006|COMPLETED|Period 1||17
11303314|NCT02584257|12501410|FG007|COMPLETED|Period 1||9
11303315|NCT02584257|12501411|FG008|COMPLETED|Period 1||9
11303316|NCT02584257|12501403|FG000|NOT COMPLETED|Period 1||0
11303317|NCT02584257|12501404|FG001|NOT COMPLETED|Period 1||0
11303318|NCT02584257|12501405|FG002|NOT COMPLETED|Period 1||0
11303319|NCT02584257|12501406|FG003|NOT COMPLETED|Period 1||0
11303320|NCT02584257|12501407|FG004|NOT COMPLETED|Period 1||0
11303321|NCT02584257|12501408|FG005|NOT COMPLETED|Period 1||0
11303322|NCT02584257|12501409|FG006|NOT COMPLETED|Period 1||1
11303323|NCT02584257|12501410|FG007|NOT COMPLETED|Period 1||0
11303324|NCT02584257|12501411|FG008|NOT COMPLETED|Period 1||0
11303325|NCT02584257|12501403|FG000|STARTED|Period 2||9
11303326|NCT02584257|12501404|FG001|STARTED|Period 2||9
11303327|NCT02584257|12501405|FG002|STARTED|Period 2||9
11303328|NCT02584257|12501406|FG003|STARTED|Period 2||8
11303329|NCT02584257|12501407|FG004|STARTED|Period 2||10
11303330|NCT02584257|12501408|FG005|STARTED|Period 2||10
11303331|NCT02584257|12501409|FG006|STARTED|Period 2||17
11303332|NCT02584257|12501410|FG007|STARTED|Period 2||9
11303333|NCT02584257|12501411|FG008|STARTED|Period 2||9
11303334|NCT02584257|12501403|FG000|COMPLETED|Period 2||8
11303335|NCT02584257|12501404|FG001|COMPLETED|Period 2||8
11303336|NCT02584257|12501405|FG002|COMPLETED|Period 2||9
11303337|NCT02584257|12501406|FG003|COMPLETED|Period 2||8
11303338|NCT02584257|12501407|FG004|COMPLETED|Period 2||10
11303339|NCT02584257|12501408|FG005|COMPLETED|Period 2||10
11303340|NCT02584257|12501409|FG006|COMPLETED|Period 2||17
11303341|NCT02584257|12501410|FG007|COMPLETED|Period 2||9
11303342|NCT02584257|12501411|FG008|COMPLETED|Period 2||9
11303343|NCT02584257|12501403|FG000|NOT COMPLETED|Period 2||1
11303344|NCT02584257|12501404|FG001|NOT COMPLETED|Period 2||1
11303345|NCT02584257|12501405|FG002|NOT COMPLETED|Period 2||0
11303346|NCT02584257|12501406|FG003|NOT COMPLETED|Period 2||0
11303347|NCT02584257|12501407|FG004|NOT COMPLETED|Period 2||0
11303348|NCT02584257|12501408|FG005|NOT COMPLETED|Period 2||0
11303349|NCT02584257|12501409|FG006|NOT COMPLETED|Period 2||0
11303350|NCT02584257|12501410|FG007|NOT COMPLETED|Period 2||0
11303351|NCT02584257|12501411|FG008|NOT COMPLETED|Period 2||0
11303352|NCT02584257|12501403|FG000|STARTED|Period 3||8
11303353|NCT02584257|12501404|FG001|STARTED|Period 3||8
11303354|NCT02584257|12501405|FG002|STARTED|Period 3||9
11303355|NCT02584257|12501406|FG003|STARTED|Period 3||8
11303356|NCT02584257|12501407|FG004|STARTED|Period 3||10
11303357|NCT02584257|12501408|FG005|STARTED|Period 3||10
11303358|NCT02584257|12501409|FG006|STARTED|Period 3||17
11303359|NCT02584257|12501410|FG007|STARTED|Period 3||9
11303360|NCT02584257|12501411|FG008|STARTED|Period 3||9
11303361|NCT02584257|12501403|FG000|COMPLETED|Period 3||8
11303362|NCT02584257|12501404|FG001|COMPLETED|Period 3||8
11303363|NCT02584257|12501405|FG002|COMPLETED|Period 3||9
11303364|NCT02584257|12501406|FG003|COMPLETED|Period 3||8
11303365|NCT02584257|12501407|FG004|COMPLETED|Period 3||10
11303366|NCT02584257|12501408|FG005|COMPLETED|Period 3||10
11303367|NCT02584257|12501409|FG006|COMPLETED|Period 3||17
11303368|NCT02584257|12501410|FG007|COMPLETED|Period 3||9
11303369|NCT02584257|12501411|FG008|COMPLETED|Period 3||9
11303370|NCT02584257|12501403|FG000|NOT COMPLETED|Period 3||0
11303371|NCT02584257|12501404|FG001|NOT COMPLETED|Period 3||0
11303372|NCT02584257|12501405|FG002|NOT COMPLETED|Period 3||0
11303373|NCT02584257|12501406|FG003|NOT COMPLETED|Period 3||0
11303374|NCT02584257|12501407|FG004|NOT COMPLETED|Period 3||0
11303375|NCT02584257|12501408|FG005|NOT COMPLETED|Period 3||0
11303376|NCT02584257|12501409|FG006|NOT COMPLETED|Period 3||0
11303377|NCT02584257|12501410|FG007|NOT COMPLETED|Period 3||0
11303378|NCT02584257|12501411|FG008|NOT COMPLETED|Period 3||0
11303379|NCT02584257|12501403|FG000|STARTED|Period 4||8
11303380|NCT02584257|12501404|FG001|STARTED|Period 4||8
11303381|NCT02584257|12501405|FG002|STARTED|Period 4||9
11303382|NCT02584257|12501406|FG003|STARTED|Period 4||8
11303383|NCT02584257|12501407|FG004|STARTED|Period 4||10
11303384|NCT02584257|12501408|FG005|STARTED|Period 4||10
11303385|NCT02584257|12501409|FG006|STARTED|Period 4||17
11303386|NCT02584257|12501410|FG007|STARTED|Period 4||9
11303387|NCT02584257|12501411|FG008|STARTED|Period 4||9
11303388|NCT02584257|12501403|FG000|COMPLETED|Period 4||8
11303389|NCT02584257|12501404|FG001|COMPLETED|Period 4||8
11303390|NCT02584257|12501405|FG002|COMPLETED|Period 4||9
11303391|NCT02584257|12501406|FG003|COMPLETED|Period 4||8
11303392|NCT02584257|12501407|FG004|COMPLETED|Period 4||10
11303393|NCT02584257|12501408|FG005|COMPLETED|Period 4||10
11303394|NCT02584257|12501409|FG006|COMPLETED|Period 4||17
11303395|NCT02584257|12501410|FG007|COMPLETED|Period 4||9
11303396|NCT02584257|12501411|FG008|COMPLETED|Period 4||9
11303397|NCT02584257|12501403|FG000|NOT COMPLETED|Period 4||0
11303398|NCT02584257|12501404|FG001|NOT COMPLETED|Period 4||0
11303399|NCT02584257|12501405|FG002|NOT COMPLETED|Period 4||0
11303400|NCT02584257|12501406|FG003|NOT COMPLETED|Period 4||0
11303401|NCT02584257|12501407|FG004|NOT COMPLETED|Period 4||0
11303402|NCT02584257|12501408|FG005|NOT COMPLETED|Period 4||0
11303403|NCT02584257|12501409|FG006|NOT COMPLETED|Period 4||0
11303404|NCT02584257|12501410|FG007|NOT COMPLETED|Period 4||0
11303405|NCT02584257|12501411|FG008|NOT COMPLETED|Period 4||0
11303406|NCT02584257|12501403|FG000|STARTED|Period 5||8
11303407|NCT02584257|12501404|FG001|STARTED|Period 5||8
11303408|NCT02584257|12501405|FG002|STARTED|Period 5||9
11303409|NCT02584257|12501406|FG003|STARTED|Period 5||8
11303410|NCT02584257|12501407|FG004|STARTED|Period 5||10
11303411|NCT02584257|12501408|FG005|STARTED|Period 5||10
11303412|NCT02584257|12501409|FG006|STARTED|Period 5||17
11303413|NCT02584257|12501410|FG007|STARTED|Period 5||9
11303414|NCT02584257|12501411|FG008|STARTED|Period 5||9
11303415|NCT02584257|12501403|FG000|COMPLETED|Period 5||8
11303416|NCT02584257|12501404|FG001|COMPLETED|Period 5||8
11303417|NCT02584257|12501405|FG002|COMPLETED|Period 5||9
11303418|NCT02584257|12501406|FG003|COMPLETED|Period 5||8
11303419|NCT02584257|12501407|FG004|COMPLETED|Period 5||10
11303420|NCT02584257|12501408|FG005|COMPLETED|Period 5||10
11303421|NCT02584257|12501409|FG006|COMPLETED|Period 5||17
11303422|NCT02584257|12501410|FG007|COMPLETED|Period 5||9
11303423|NCT02584257|12501411|FG008|COMPLETED|Period 5||9
11303424|NCT02584257|12501403|FG000|NOT COMPLETED|Period 5||0
11303425|NCT02584257|12501404|FG001|NOT COMPLETED|Period 5||0
11303426|NCT02584257|12501405|FG002|NOT COMPLETED|Period 5||0
11303427|NCT02584257|12501406|FG003|NOT COMPLETED|Period 5||0
11303428|NCT02584257|12501407|FG004|NOT COMPLETED|Period 5||0
11303429|NCT02584257|12501408|FG005|NOT COMPLETED|Period 5||0
11303430|NCT02584257|12501409|FG006|NOT COMPLETED|Period 5||0
11303431|NCT02584257|12501410|FG007|NOT COMPLETED|Period 5||0
11303432|NCT02584257|12501411|FG008|NOT COMPLETED|Period 5||0
11303433|NCT02584452|12501425|FG000|STARTED|Overall Study||34
11303434|NCT02584452|12501426|FG001|STARTED|Overall Study||23
11303435|NCT02584452|12501425|FG000|COMPLETED|Overall Study||32
11303436|NCT02584452|12501426|FG001|COMPLETED|Overall Study||21
11303437|NCT02584452|12501425|FG000|NOT COMPLETED|Overall Study||2
11303438|NCT02584452|12501426|FG001|NOT COMPLETED|Overall Study||2
11303439|NCT02584504|12501436|FG000|STARTED|Double-blind Treatment|Randomized|54
11303440|NCT02584504|12501437|FG001|STARTED|Double-blind Treatment|Randomized|53
11303441|NCT02584504|12501438|FG002|STARTED|Double-blind Treatment|Randomized|56
11303442|NCT02584504|12501436|FG000|ITT Population|Double-blind Treatment||54
11303443|NCT02584504|12501437|FG001|ITT Population|Double-blind Treatment||53
11303444|NCT02584504|12501438|FG002|ITT Population|Double-blind Treatment||56
11303445|NCT02584504|12501436|FG000|mITT Population|Double-blind Treatment||54
11303446|NCT02584504|12501437|FG001|mITT Population|Double-blind Treatment||53
11303447|NCT02584504|12501438|FG002|mITT Population|Double-blind Treatment||56
11303448|NCT02584504|12501436|FG000|Safety Population|Double-blind Treatment||54
11303449|NCT02584504|12501437|FG001|Safety Population|Double-blind Treatment||53
11303450|NCT02584504|12501438|FG002|Safety Population|Double-blind Treatment||56
11303451|NCT02584504|12501436|FG000|COMPLETED|Double-blind Treatment||54
11303452|NCT02584504|12501437|FG001|COMPLETED|Double-blind Treatment||51
11303453|NCT02584504|12501438|FG002|COMPLETED|Double-blind Treatment||55
11303454|NCT02584504|12501436|FG000|NOT COMPLETED|Double-blind Treatment||0
11303455|NCT02584504|12501437|FG001|NOT COMPLETED|Double-blind Treatment||2
11303456|NCT02584504|12501438|FG002|NOT COMPLETED|Double-blind Treatment||1
11303457|NCT02584504|12501436|FG000|STARTED|Open-label Treatment||54
11303458|NCT02584504|12501437|FG001|STARTED|Open-label Treatment||51
11303459|NCT02584504|12501438|FG002|STARTED|Open-label Treatment||55
11303460|NCT02584504|12501436|FG000|Treated|Open-label Treatment||54
11303461|NCT02584504|12501437|FG001|Treated|Open-label Treatment||50
11303462|NCT02584504|12501438|FG002|Treated|Open-label Treatment||54
11303463|NCT02584504|12501436|FG000|COMPLETED|Open-label Treatment||52
11303464|NCT02584504|12501437|FG001|COMPLETED|Open-label Treatment||47
11303465|NCT02584504|12501438|FG002|COMPLETED|Open-label Treatment||47
11303466|NCT02584504|12501436|FG000|NOT COMPLETED|Open-label Treatment||2
11303467|NCT02584504|12501437|FG001|NOT COMPLETED|Open-label Treatment||4
11303468|NCT02584504|12501438|FG002|NOT COMPLETED|Open-label Treatment||8
11303469|NCT02584608|12501450|FG000|STARTED|Overall Study||12
11303470|NCT02584608|12501450|FG000|COMPLETED|Overall Study||12
11303471|NCT02584608|12501450|FG000|NOT COMPLETED|Overall Study||0
11303472|NCT02584660|12501456|FG000|STARTED|Overall Study||51
11303473|NCT02584660|12501457|FG001|STARTED|Overall Study||63
11303474|NCT02584660|12501456|FG000|Treated|Overall Study||49
11303475|NCT02584660|12501457|FG001|Treated|Overall Study||63
11303476|NCT02584660|12501456|FG000|COMPLETED|Overall Study||44
11303477|NCT02584660|12501457|FG001|COMPLETED|Overall Study||55
11303478|NCT02584660|12501456|FG000|NOT COMPLETED|Overall Study||7
11303479|NCT02584660|12501457|FG001|NOT COMPLETED|Overall Study||8
11303480|NCT02584673|12501465|FG000|STARTED|Overall Study||15
11303481|NCT02584673|12501466|FG001|STARTED|Overall Study||15
11303482|NCT02584673|12501465|FG000|COMPLETED|Overall Study||15
11303483|NCT02584673|12501466|FG001|COMPLETED|Overall Study||15
11303484|NCT02584673|12501465|FG000|NOT COMPLETED|Overall Study||0
11303485|NCT02584673|12501466|FG001|NOT COMPLETED|Overall Study||0
11303486|NCT02584686|12501474|FG000|STARTED|Overall Study||12
11303487|NCT02584686|12501475|FG001|STARTED|Overall Study||12
11303488|NCT02584686|12501474|FG000|COMPLETED|Overall Study||12
11303489|NCT02584686|12501475|FG001|COMPLETED|Overall Study||12
11303490|NCT02584686|12501474|FG000|NOT COMPLETED|Overall Study||0
11303491|NCT02584686|12501475|FG001|NOT COMPLETED|Overall Study||0
11341591|NCT02935842|12539038|FG003|NOT COMPLETED|Testing and Therapy Period 1||0
11341592|NCT02935842|12539035|FG000|STARTED|Testing and Therapy Period 2||8
11341593|NCT02935842|12539036|FG001|STARTED|Testing and Therapy Period 2||6
11341594|NCT02935842|12539037|FG002|STARTED|Testing and Therapy Period 2||6
11341595|NCT02935842|12539038|FG003|STARTED|Testing and Therapy Period 2|Due to limited staff capacity, HC have only been included in the final tranche.|0
11341596|NCT02935842|12539035|FG000|COMPLETED|Testing and Therapy Period 2||6
11341597|NCT02935842|12539036|FG001|COMPLETED|Testing and Therapy Period 2||6
11341598|NCT02935842|12539037|FG002|COMPLETED|Testing and Therapy Period 2||6
11341599|NCT02935842|12539038|FG003|COMPLETED|Testing and Therapy Period 2||0
11341600|NCT02935842|12539035|FG000|NOT COMPLETED|Testing and Therapy Period 2||2
11341601|NCT02935842|12539036|FG001|NOT COMPLETED|Testing and Therapy Period 2||0
11341602|NCT02935842|12539037|FG002|NOT COMPLETED|Testing and Therapy Period 2||0
11341603|NCT02935842|12539038|FG003|NOT COMPLETED|Testing and Therapy Period 2||0
11341604|NCT02935842|12539035|FG000|STARTED|Testing and Therapy Period 3||6
11341605|NCT02935842|12539036|FG001|STARTED|Testing and Therapy Period 3||6
11341606|NCT02935842|12539037|FG002|STARTED|Testing and Therapy Period 3||6
11341607|NCT02935842|12539038|FG003|STARTED|Testing and Therapy Period 3|HC received no interventions. They have only been tested at BL, 4 Weeks and 6 Months.|18
11341608|NCT02935842|12539035|FG000|COMPLETED|Testing and Therapy Period 3||3
11341609|NCT02935842|12539036|FG001|COMPLETED|Testing and Therapy Period 3||2
11341610|NCT02935842|12539037|FG002|COMPLETED|Testing and Therapy Period 3||1
11341611|NCT02935842|12539038|FG003|COMPLETED|Testing and Therapy Period 3||17
11341612|NCT02935842|12539035|FG000|NOT COMPLETED|Testing and Therapy Period 3||3
11341613|NCT02935842|12539036|FG001|NOT COMPLETED|Testing and Therapy Period 3||4
11341614|NCT02935842|12539037|FG002|NOT COMPLETED|Testing and Therapy Period 3||5
11341615|NCT02935842|12539038|FG003|NOT COMPLETED|Testing and Therapy Period 3||1
11341616|NCT02935894|12539055|FG000|STARTED|Overall Study||14
11341617|NCT02935894|12539055|FG000|COMPLETED|Overall Study||13
11341618|NCT02935894|12539055|FG000|NOT COMPLETED|Overall Study||1
11303492|NCT02584725|12501485|FG000|STARTED|Overall Study||28
11303493|NCT02584725|12501486|FG001|STARTED|Overall Study||28
11303494|NCT02584725|12501487|FG002|STARTED|Overall Study||28
11303495|NCT02584725|12501485|FG000|COMPLETED|Overall Study||28
11303496|NCT02584725|12501486|FG001|COMPLETED|Overall Study||28
11401254|NCT04128293|12596077|FG000|COMPLETED|Washout Period 2 (Up to 7 Days)||0
11401255|NCT04128293|12596078|FG001|COMPLETED|Washout Period 2 (Up to 7 Days)||0
11401256|NCT04128293|12596079|FG002|COMPLETED|Washout Period 2 (Up to 7 Days)||0
11401257|NCT04128293|12596080|FG003|COMPLETED|Washout Period 2 (Up to 7 Days)||0
11401258|NCT04128293|12596077|FG000|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
11401259|NCT04128293|12596078|FG001|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
11401260|NCT04128293|12596079|FG002|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
11401261|NCT04128293|12596080|FG003|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
11401262|NCT04128293|12596077|FG000|STARTED|Treatment Period 3 (1 Day)||0
11401263|NCT04128293|12596078|FG001|STARTED|Treatment Period 3 (1 Day)||0
11401264|NCT04128293|12596079|FG002|STARTED|Treatment Period 3 (1 Day)||0
11401265|NCT04128293|12596080|FG003|STARTED|Treatment Period 3 (1 Day)||0
11303497|NCT02584725|12501487|FG002|COMPLETED|Overall Study||28
11303498|NCT02584725|12501485|FG000|NOT COMPLETED|Overall Study||0
11303499|NCT02584725|12501486|FG001|NOT COMPLETED|Overall Study||0
11303500|NCT02584725|12501487|FG002|NOT COMPLETED|Overall Study||0
11303501|NCT02584790|12501495|FG000|STARTED|Overall Study||55
11303502|NCT02584790|12501495|FG000|COMPLETED|Overall Study||40
11303503|NCT02584790|12501495|FG000|NOT COMPLETED|Overall Study||15
11303504|NCT02584855|12501499|FG000|STARTED|Open-Label Treatment Period||394
11303505|NCT02584855|12501500|FG001|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0
11303506|NCT02584855|12501501|FG002|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
11303507|NCT02584855|12501502|FG003|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
11303508|NCT02584855|12501503|FG004|STARTED|Open-Label Treatment Period||0
11303509|NCT02584855|12501504|FG005|STARTED|Open-Label Treatment Period||0
11303510|NCT02584855|12501499|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394
11303511|NCT02584855|12501500|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
11303512|NCT02584855|12501501|FG002|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
11303513|NCT02584855|12501502|FG003|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
11303514|NCT02584855|12501503|FG004|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
11303515|NCT02584855|12501504|FG005|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
11303516|NCT02584855|12501499|FG000|Met Randomization Criteria|Open-Label Treatment Period||158
11401266|NCT04128293|12596077|FG000|COMPLETED|Treatment Period 3 (1 Day)||0
11401267|NCT04128293|12596078|FG001|COMPLETED|Treatment Period 3 (1 Day)||0
11303517|NCT02584855|12501500|FG001|Met Randomization Criteria|Open-Label Treatment Period||0
11303518|NCT02584855|12501501|FG002|Met Randomization Criteria|Open-Label Treatment Period||0
11303519|NCT02584855|12501502|FG003|Met Randomization Criteria|Open-Label Treatment Period||0
11303520|NCT02584855|12501503|FG004|Met Randomization Criteria|Open-Label Treatment Period||0
11303521|NCT02584855|12501504|FG005|Met Randomization Criteria|Open-Label Treatment Period||0
11303522|NCT02584855|12501499|FG000|Non-randomized|Open-Label Treatment Period||133
11303523|NCT02584855|12501500|FG001|Non-randomized|Open-Label Treatment Period||0
11303524|NCT02584855|12501501|FG002|Non-randomized|Open-Label Treatment Period||0
11303525|NCT02584855|12501502|FG003|Non-randomized|Open-Label Treatment Period||0
11303526|NCT02584855|12501503|FG004|Non-randomized|Open-Label Treatment Period||0
11303527|NCT02584855|12501504|FG005|Non-randomized|Open-Label Treatment Period||0
11303528|NCT02584855|12501499|FG000|COMPLETED|Open-Label Treatment Period||291
11303529|NCT02584855|12501500|FG001|COMPLETED|Open-Label Treatment Period||0
11303530|NCT02584855|12501501|FG002|COMPLETED|Open-Label Treatment Period||0
11303531|NCT02584855|12501502|FG003|COMPLETED|Open-Label Treatment Period||0
11303532|NCT02584855|12501503|FG004|COMPLETED|Open-Label Treatment Period||0
11303533|NCT02584855|12501504|FG005|COMPLETED|Open-Label Treatment Period||0
11303534|NCT02584855|12501499|FG000|NOT COMPLETED|Open-Label Treatment Period||103
11143833|NCT01474512|12330428|FG006|NOT COMPLETED|Post-Treatment Follow-Up||0
11143834|NCT01474512|12330429|FG007|NOT COMPLETED|Post-Treatment Follow-Up||0
11143835|NCT01474512|12330430|FG008|NOT COMPLETED|Post-Treatment Follow-Up||0
11143836|NCT01474512|12330431|FG009|NOT COMPLETED|Post-Treatment Follow-Up||0
11143837|NCT01474512|12330432|FG010|NOT COMPLETED|Post-Treatment Follow-Up||0
11143838|NCT01474512|12330433|FG011|NOT COMPLETED|Post-Treatment Follow-Up||0
11143839|NCT01474512|12330434|FG012|NOT COMPLETED|Post-Treatment Follow-Up||0
11143840|NCT01474512|12330435|FG013|NOT COMPLETED|Post-Treatment Follow-Up||0
11143841|NCT01474512|12330436|FG014|NOT COMPLETED|Post-Treatment Follow-Up||18
11143842|NCT01474512|12330437|FG015|NOT COMPLETED|Post-Treatment Follow-Up||8
11143843|NCT01474512|12330438|FG016|NOT COMPLETED|Post-Treatment Follow-Up||156
11143844|NCT01474512|12330439|FG017|NOT COMPLETED|Post-Treatment Follow-Up||46
11143845|NCT01474538|12330471|FG000|STARTED|Treatment Period 1||60
11143846|NCT01474538|12330472|FG001|STARTED|Treatment Period 1||62
11143847|NCT01474538|12330471|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
11143848|NCT01474538|12330472|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
11143849|NCT01474538|12330471|FG000|COMPLETED|Treatment Period 1||57
11143850|NCT01474538|12330472|FG001|COMPLETED|Treatment Period 1||58
11143851|NCT01474538|12330471|FG000|NOT COMPLETED|Treatment Period 1||3
11143852|NCT01474538|12330472|FG001|NOT COMPLETED|Treatment Period 1||4
11303535|NCT02584855|12501500|FG001|NOT COMPLETED|Open-Label Treatment Period||0
11303536|NCT02584855|12501501|FG002|NOT COMPLETED|Open-Label Treatment Period||0
11303537|NCT02584855|12501502|FG003|NOT COMPLETED|Open-Label Treatment Period||0
11303538|NCT02584855|12501503|FG004|NOT COMPLETED|Open-Label Treatment Period||0
11303539|NCT02584855|12501504|FG005|NOT COMPLETED|Open-Label Treatment Period||0
11303540|NCT02584855|12501499|FG000|STARTED|Double-Blind Withdrawal Period||0
11401268|NCT04128293|12596079|FG002|COMPLETED|Treatment Period 3 (1 Day)||0
11401269|NCT04128293|12596080|FG003|COMPLETED|Treatment Period 3 (1 Day)||0
11303541|NCT02584855|12501500|FG001|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133
11303542|NCT02584855|12501501|FG002|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
11303543|NCT02584855|12501502|FG003|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
11303544|NCT02584855|12501503|FG004|STARTED|Double-Blind Withdrawal Period||0
11303545|NCT02584855|12501504|FG005|STARTED|Double-Blind Withdrawal Period||0
11303546|NCT02584855|12501499|FG000|Relapsed|Double-Blind Withdrawal Period||0
11303547|NCT02584855|12501500|FG001|Relapsed|Double-Blind Withdrawal Period||0
11303548|NCT02584855|12501501|FG002|Relapsed|Double-Blind Withdrawal Period||67
11303549|NCT02584855|12501502|FG003|Relapsed|Double-Blind Withdrawal Period||30
11303550|NCT02584855|12501503|FG004|Relapsed|Double-Blind Withdrawal Period||0
11303551|NCT02584855|12501504|FG005|Relapsed|Double-Blind Withdrawal Period||0
11303552|NCT02584855|12501499|FG000|COMPLETED|Double-Blind Withdrawal Period||0
11303553|NCT02584855|12501500|FG001|COMPLETED|Double-Blind Withdrawal Period||118
11303554|NCT02584855|12501501|FG002|COMPLETED|Double-Blind Withdrawal Period||77
11303555|NCT02584855|12501502|FG003|COMPLETED|Double-Blind Withdrawal Period||78
11303556|NCT02584855|12501503|FG004|COMPLETED|Double-Blind Withdrawal Period||0
11303557|NCT02584855|12501504|FG005|COMPLETED|Double-Blind Withdrawal Period||0
11303558|NCT02584855|12501499|FG000|NOT COMPLETED|Double-Blind Withdrawal Period||0
11303559|NCT02584855|12501500|FG001|NOT COMPLETED|Double-Blind Withdrawal Period||15
11303560|NCT02584855|12501501|FG002|NOT COMPLETED|Double-Blind Withdrawal Period||2
11303561|NCT02584855|12501502|FG003|NOT COMPLETED|Double-Blind Withdrawal Period||1
11303562|NCT02584855|12501503|FG004|NOT COMPLETED|Double-Blind Withdrawal Period||0
11303563|NCT02584855|12501504|FG005|NOT COMPLETED|Double-Blind Withdrawal Period||0
11303564|NCT02584855|12501499|FG000|STARTED|Post Treatment Follow-up Period||0
11303565|NCT02584855|12501500|FG001|STARTED|Post Treatment Follow-up Period||0
11303566|NCT02584855|12501501|FG002|STARTED|Post Treatment Follow-up Period||0
11303567|NCT02584855|12501502|FG003|STARTED|Post Treatment Follow-up Period||0
11303568|NCT02584855|12501503|FG004|STARTED|Post Treatment Follow-up Period||355
11303569|NCT02584855|12501504|FG005|STARTED|Post Treatment Follow-up Period||12
11303570|NCT02584855|12501499|FG000|COMPLETED|Post Treatment Follow-up Period||0
11303571|NCT02584855|12501500|FG001|COMPLETED|Post Treatment Follow-up Period||0
11303572|NCT02584855|12501501|FG002|COMPLETED|Post Treatment Follow-up Period||0
11303573|NCT02584855|12501502|FG003|COMPLETED|Post Treatment Follow-up Period||0
11303574|NCT02584855|12501503|FG004|COMPLETED|Post Treatment Follow-up Period||347
11303575|NCT02584855|12501504|FG005|COMPLETED|Post Treatment Follow-up Period||12
11303576|NCT02584855|12501499|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0
11303577|NCT02584855|12501500|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0
11303578|NCT02584855|12501501|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0
11303579|NCT02584855|12501502|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0
11303580|NCT02584855|12501503|FG004|NOT COMPLETED|Post Treatment Follow-up Period||8
11303581|NCT02584855|12501504|FG005|NOT COMPLETED|Post Treatment Follow-up Period||0
11303582|NCT02584868|12501519|FG000|STARTED|Overall Study||44
11303583|NCT02584868|12501520|FG001|STARTED|Overall Study||44
11303584|NCT02584868|12501519|FG000|COMPLETED|Overall Study||44
11303585|NCT02584868|12501520|FG001|COMPLETED|Overall Study||44
11303586|NCT02584868|12501519|FG000|NOT COMPLETED|Overall Study||0
11303587|NCT02584868|12501520|FG001|NOT COMPLETED|Overall Study||0
11303588|NCT02584959|12501529|FG000|STARTED|Period 1||31
11303589|NCT02584959|12501530|FG001|STARTED|Period 1||29
11303590|NCT02584959|12501531|FG002|STARTED|Period 1||15
11303591|NCT02584959|12501529|FG000|COMPLETED|Period 1||28
11303592|NCT02584959|12501530|FG001|COMPLETED|Period 1||25
11303593|NCT02584959|12501531|FG002|COMPLETED|Period 1||15
11303594|NCT02584959|12501529|FG000|NOT COMPLETED|Period 1||3
11303595|NCT02584959|12501530|FG001|NOT COMPLETED|Period 1||4
11303596|NCT02584959|12501531|FG002|NOT COMPLETED|Period 1||0
11303597|NCT02584959|12501529|FG000|STARTED|Period 2||28
11303598|NCT02584959|12501530|FG001|STARTED|Period 2||25
11303599|NCT02584959|12501531|FG002|STARTED|Period 2||15
11303600|NCT02584959|12501529|FG000|COMPLETED|Period 2||22
11303601|NCT02584959|12501530|FG001|COMPLETED|Period 2||24
11303602|NCT02584959|12501531|FG002|COMPLETED|Period 2||13
11303603|NCT02584959|12501529|FG000|NOT COMPLETED|Period 2||6
11303604|NCT02584959|12501530|FG001|NOT COMPLETED|Period 2||1
11303605|NCT02584959|12501531|FG002|NOT COMPLETED|Period 2||2
11303606|NCT02584998|12501551|FG000|STARTED|Overall Study||260
11303607|NCT02584998|12501552|FG001|STARTED|Overall Study||261
11303608|NCT02584998|12501553|FG002|STARTED|Overall Study||261
11303609|NCT02584998|12501551|FG000|COMPLETED|Overall Study||260
11303610|NCT02584998|12501552|FG001|COMPLETED|Overall Study||261
11303611|NCT02584998|12501553|FG002|COMPLETED|Overall Study||261
11303612|NCT02584998|12501551|FG000|NOT COMPLETED|Overall Study||0
11303613|NCT02584998|12501552|FG001|NOT COMPLETED|Overall Study||0
11303614|NCT02584998|12501553|FG002|NOT COMPLETED|Overall Study||0
11303615|NCT02585245|12501561|FG000|STARTED|Overall Study||607
11303616|NCT02585245|12501561|FG000|COMPLETED|Overall Study||594
11303617|NCT02585245|12501561|FG000|NOT COMPLETED|Overall Study||13
11303618|NCT02585700|12501568|FG000|STARTED|Overall Study||30
11303619|NCT02585700|12501569|FG001|STARTED|Overall Study||30
11303620|NCT02585700|12501568|FG000|COMPLETED|Overall Study||30
11303621|NCT02585700|12501569|FG001|COMPLETED|Overall Study||30
11303622|NCT02585700|12501568|FG000|NOT COMPLETED|Overall Study||0
11303623|NCT02585700|12501569|FG001|NOT COMPLETED|Overall Study||0
11303624|NCT02585713|12501577|FG000|STARTED|Overall Study||150
11303625|NCT02585713|12501578|FG001|STARTED|Overall Study||150
11303626|NCT02585713|12501577|FG000|COMPLETED|Overall Study||145
11303627|NCT02585713|12501578|FG001|COMPLETED|Overall Study||142
11303628|NCT02585713|12501577|FG000|NOT COMPLETED|Overall Study||5
11303629|NCT02585713|12501578|FG001|NOT COMPLETED|Overall Study||8
11303630|NCT02585778|12501588|FG000|STARTED|Overall Study|Randomized|345
11303631|NCT02585778|12501589|FG001|STARTED|Overall Study|Randomized|172
11303632|NCT02585778|12501588|FG000|Treated (Safety Population)|Overall Study||344
11303633|NCT02585778|12501589|FG001|Treated (Safety Population)|Overall Study||170
11303634|NCT02585778|12501588|FG000|ITT Population|Overall Study||336
11303635|NCT02585778|12501589|FG001|ITT Population|Overall Study||167
11303636|NCT02585778|12501588|FG000|mITT Population|Overall Study||333
11303637|NCT02585778|12501589|FG001|mITT Population|Overall Study||164
11303638|NCT02585778|12501588|FG000|T1DM Participants|Overall Study||51
11303639|NCT02585778|12501589|FG001|T1DM Participants|Overall Study||25
11303640|NCT02585778|12501588|FG000|T2DM Participants|Overall Study||294
11303641|NCT02585778|12501589|FG001|T2DM Participants|Overall Study||147
11303642|NCT02585778|12501588|FG000|COMPLETED|Overall Study||312
11303643|NCT02585778|12501589|FG001|COMPLETED|Overall Study||157
11303644|NCT02585778|12501588|FG000|NOT COMPLETED|Overall Study||33
11303645|NCT02585778|12501589|FG001|NOT COMPLETED|Overall Study||15
11303646|NCT02585830|12501599|FG000|STARTED|Overall Study||25
11303647|NCT02585830|12501599|FG000|COMPLETED|Overall Study||22
11303648|NCT02585830|12501599|FG000|NOT COMPLETED|Overall Study||3
11303649|NCT02585843|12501605|FG000|STARTED|Overall Study||10
11303650|NCT02585843|12501606|FG001|STARTED|Overall Study||10
11303651|NCT02585843|12501605|FG000|COMPLETED|Overall Study||9
11303652|NCT02585843|12501606|FG001|COMPLETED|Overall Study||10
11303653|NCT02585843|12501605|FG000|NOT COMPLETED|Overall Study||1
11303654|NCT02585843|12501606|FG001|NOT COMPLETED|Overall Study||0
11303655|NCT02585895|12501614|FG000|STARTED|Primary Period||20
11303656|NCT02585895|12501615|FG001|STARTED|Primary Period||19
11303657|NCT02585895|12501614|FG000|COMPLETED|Primary Period||20
11303658|NCT02585895|12501615|FG001|COMPLETED|Primary Period||19
11303659|NCT02585895|12501614|FG000|NOT COMPLETED|Primary Period||0
11303660|NCT02585895|12501615|FG001|NOT COMPLETED|Primary Period||0
11303661|NCT02585895|12501614|FG000|STARTED|Post-primary Period||20
11303662|NCT02585895|12501615|FG001|STARTED|Post-primary Period||19
11303663|NCT02585895|12501614|FG000|COMPLETED|Post-primary Period||20
11303664|NCT02585895|12501615|FG001|COMPLETED|Post-primary Period||19
11303665|NCT02585895|12501614|FG000|NOT COMPLETED|Post-primary Period||0
11303666|NCT02585895|12501615|FG001|NOT COMPLETED|Post-primary Period||0
11303667|NCT02585934|12501626|FG000|STARTED|Overall Study||661
11303668|NCT02585934|12501627|FG001|STARTED|Overall Study||654
11303669|NCT02585934|12501626|FG000|Safety Population|Overall Study||656
11303670|NCT02585934|12501627|FG001|Safety Population|Overall Study||651
11303671|NCT02585934|12501626|FG000|Intent to Treat (ITT)|Overall Study||643
11303672|NCT02585934|12501627|FG001|Intent to Treat (ITT)|Overall Study||633
11303673|NCT02585934|12501626|FG000|Per Protocol (PP)|Overall Study||603
11303674|NCT02585934|12501627|FG001|Per Protocol (PP)|Overall Study||582
11303675|NCT02585934|12501626|FG000|COMPLETED|Overall Study||592
11303676|NCT02585934|12501627|FG001|COMPLETED|Overall Study||581
11303677|NCT02585934|12501626|FG000|NOT COMPLETED|Overall Study||69
11303678|NCT02585934|12501627|FG001|NOT COMPLETED|Overall Study||73
11303679|NCT02585960|12501641|FG000|STARTED|PK/Safety Assessment Period||57
11303680|NCT02585960|12501642|FG001|STARTED|PK/Safety Assessment Period||58
11303681|NCT02585960|12501643|FG002|STARTED|PK/Safety Assessment Period||6
11303682|NCT02585960|12501641|FG000|Completed 1st 6 Month Period|PK/Safety Assessment Period||57
11303683|NCT02585960|12501642|FG001|Completed 1st 6 Month Period|PK/Safety Assessment Period||53
11303684|NCT02585960|12501643|FG002|Completed 1st 6 Month Period|PK/Safety Assessment Period||0
11303685|NCT02585960|12501641|FG000|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52
11303686|NCT02585960|12501642|FG001|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48
11303687|NCT02585960|12501643|FG002|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0
11303688|NCT02585960|12501641|FG000|COMPLETED|PK/Safety Assessment Period||52
11303689|NCT02585960|12501642|FG001|COMPLETED|PK/Safety Assessment Period||48
11303690|NCT02585960|12501643|FG002|COMPLETED|PK/Safety Assessment Period||0
11303691|NCT02585960|12501641|FG000|NOT COMPLETED|PK/Safety Assessment Period||5
11303692|NCT02585960|12501642|FG001|NOT COMPLETED|PK/Safety Assessment Period||10
11303693|NCT02585960|12501643|FG002|NOT COMPLETED|PK/Safety Assessment Period||6
11303694|NCT02585960|12501641|FG000|STARTED|Prophylactic Treatment Period||52
11303695|NCT02585960|12501642|FG001|STARTED|Prophylactic Treatment Period||48
11303696|NCT02585960|12501643|FG002|STARTED|Prophylactic Treatment Period||0
11303697|NCT02585960|12501641|FG000|COMPLETED|Prophylactic Treatment Period||52
11303698|NCT02585960|12501642|FG001|COMPLETED|Prophylactic Treatment Period||43
11303699|NCT02585960|12501643|FG002|COMPLETED|Prophylactic Treatment Period||0
11303700|NCT02585960|12501641|FG000|NOT COMPLETED|Prophylactic Treatment Period||0
11303701|NCT02585960|12501642|FG001|NOT COMPLETED|Prophylactic Treatment Period||5
11303702|NCT02585960|12501643|FG002|NOT COMPLETED|Prophylactic Treatment Period||0
11303703|NCT02585999|12501654|FG000|STARTED|Overall Study||28
11303704|NCT02585999|12501654|FG000|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
11303705|NCT02585999|12501654|FG000|NOT COMPLETED|Overall Study||2
11303706|NCT02586012|12501659|FG000|STARTED|Overall Study||5
11303707|NCT02586012|12501660|FG001|STARTED|Overall Study||5
11303708|NCT02586012|12501661|FG002|STARTED|Overall Study||5
11303709|NCT02586012|12501662|FG003|STARTED|Overall Study||5
11303710|NCT02586012|12501663|FG004|STARTED|Overall Study||5
11303711|NCT02586012|12501664|FG005|STARTED|Overall Study||5
11303712|NCT02586012|12501659|FG000|COMPLETED|Overall Study||4
11303713|NCT02586012|12501660|FG001|COMPLETED|Overall Study||2
11303714|NCT02586012|12501661|FG002|COMPLETED|Overall Study||4
11303715|NCT02586012|12501662|FG003|COMPLETED|Overall Study||3
11303716|NCT02586012|12501663|FG004|COMPLETED|Overall Study||4
11303717|NCT02586012|12501664|FG005|COMPLETED|Overall Study||2
11303718|NCT02586012|12501659|FG000|NOT COMPLETED|Overall Study||1
11303719|NCT02586012|12501660|FG001|NOT COMPLETED|Overall Study||3
11303720|NCT02586012|12501661|FG002|NOT COMPLETED|Overall Study||1
11303721|NCT02586012|12501662|FG003|NOT COMPLETED|Overall Study||2
11303722|NCT02586012|12501663|FG004|NOT COMPLETED|Overall Study||1
11303723|NCT02586012|12501664|FG005|NOT COMPLETED|Overall Study||3
11303724|NCT02586064|12501675|FG000|STARTED|Overall Study||61
11303725|NCT02586064|12501676|FG001|STARTED|Overall Study||54
11303726|NCT02586064|12501675|FG000|COMPLETED|Overall Study||43
11303727|NCT02586064|12501676|FG001|COMPLETED|Overall Study||26
11303728|NCT02586064|12501675|FG000|NOT COMPLETED|Overall Study||18
11303729|NCT02586064|12501676|FG001|NOT COMPLETED|Overall Study||28
11303730|NCT02586077|12501685|FG000|STARTED|Overall Study||36
11303731|NCT02586077|12501685|FG000|COMPLETED|Overall Study||28
11303732|NCT02586077|12501685|FG000|NOT COMPLETED|Overall Study||8
11303733|NCT02586155|12501692|FG000|STARTED|Overall Study||1215
11303734|NCT02586155|12501693|FG001|STARTED|Overall Study||1210
11303735|NCT02586155|12501692|FG000|Final Number Randomized|Overall Study||1212
11303736|NCT02586155|12501693|FG001|Final Number Randomized|Overall Study||1206
11303737|NCT02586155|12501692|FG000|COMPLETED|Overall Study||1088
11303738|NCT02586155|12501693|FG001|COMPLETED|Overall Study||1083
11303739|NCT02586155|12501692|FG000|NOT COMPLETED|Overall Study||127
11303740|NCT02586155|12501693|FG001|NOT COMPLETED|Overall Study||127
11303741|NCT02586233|12501706|FG000|STARTED|Overall Study||7
11303742|NCT02586233|12501707|FG001|STARTED|Overall Study||7
11303743|NCT02586233|12501708|FG002|STARTED|Overall Study||13
11303744|NCT02586233|12501709|FG003|STARTED|Overall Study||17
11303745|NCT02586233|12501710|FG004|STARTED|Overall Study||18
11303746|NCT02586233|12501711|FG005|STARTED|Overall Study||18
11303747|NCT02586233|12501712|FG006|STARTED|Overall Study||26
11303748|NCT02586233|12501706|FG000|COMPLETED|Overall Study||7
11303749|NCT02586233|12501707|FG001|COMPLETED|Overall Study||5
11303750|NCT02586233|12501708|FG002|COMPLETED|Overall Study||13
11303751|NCT02586233|12501709|FG003|COMPLETED|Overall Study||17
11303752|NCT02586233|12501710|FG004|COMPLETED|Overall Study||16
11303753|NCT02586233|12501711|FG005|COMPLETED|Overall Study||16
11401270|NCT04128293|12596077|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11401271|NCT04128293|12596078|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11303754|NCT02586233|12501712|FG006|COMPLETED|Overall Study||24
11303755|NCT02586233|12501706|FG000|NOT COMPLETED|Overall Study||0
11303756|NCT02586233|12501707|FG001|NOT COMPLETED|Overall Study||2
11303757|NCT02586233|12501708|FG002|NOT COMPLETED|Overall Study||0
11303758|NCT02586233|12501709|FG003|NOT COMPLETED|Overall Study||0
11303759|NCT02586233|12501710|FG004|NOT COMPLETED|Overall Study||2
11303760|NCT02586233|12501711|FG005|NOT COMPLETED|Overall Study||2
11303761|NCT02586233|12501712|FG006|NOT COMPLETED|Overall Study||2
11303762|NCT02586415|12501734|FG000|STARTED|Overall Study||92
11303763|NCT02586415|12501735|FG001|STARTED|Overall Study||90
11303764|NCT02586415|12501734|FG000|24 Hour Assessment|Overall Study||91
11303765|NCT02586415|12501735|FG001|24 Hour Assessment|Overall Study||90
11303766|NCT02586415|12501734|FG000|Day 30 Assessment|Overall Study||81
11303767|NCT02586415|12501735|FG001|Day 30 Assessment|Overall Study||70
11303768|NCT02586415|12501734|FG000|Day 90 Assessment|Overall Study||78
11303769|NCT02586415|12501735|FG001|Day 90 Assessment|Overall Study||65
11303770|NCT02586415|12501734|FG000|COMPLETED|Overall Study||78
11303771|NCT02586415|12501735|FG001|COMPLETED|Overall Study||65
11303772|NCT02586415|12501734|FG000|NOT COMPLETED|Overall Study||14
11303773|NCT02586415|12501735|FG001|NOT COMPLETED|Overall Study||25
11303774|NCT02586493|12501742|FG000|STARTED|Overall Study||278
11303775|NCT02586493|12501742|FG000|COMPLETED|Overall Study||266
11303776|NCT02586493|12501742|FG000|NOT COMPLETED|Overall Study||12
11303777|NCT02586506|12501746|FG000|STARTED|Overall Study||259
11303778|NCT02586506|12501746|FG000|COMPLETED|Overall Study||250
11303779|NCT02586506|12501746|FG000|NOT COMPLETED|Overall Study||9
11303780|NCT02586727|12501752|FG000|STARTED|Overall Study||20
11303781|NCT02586727|12501753|FG001|STARTED|Overall Study||20
11303782|NCT02586727|12501752|FG000|COMPLETED|Overall Study||19
11303783|NCT02586727|12501753|FG001|COMPLETED|Overall Study||20
11303784|NCT02586727|12501752|FG000|NOT COMPLETED|Overall Study||1
11303785|NCT02586727|12501753|FG001|NOT COMPLETED|Overall Study||0
11303786|NCT02586805|12501763|FG000|STARTED|Overall Study||41
11303787|NCT02586805|12501764|FG001|STARTED|Overall Study||28
11303788|NCT02586805|12501765|FG002|STARTED|Overall Study||29
11303789|NCT02586805|12501766|FG003|STARTED|Overall Study||27
11303790|NCT02586805|12501763|FG000|COMPLETED|Overall Study||35
11303791|NCT02586805|12501764|FG001|COMPLETED|Overall Study||27
11303792|NCT02586805|12501765|FG002|COMPLETED|Overall Study||26
11303793|NCT02586805|12501766|FG003|COMPLETED|Overall Study||25
11303794|NCT02586805|12501763|FG000|NOT COMPLETED|Overall Study||6
11303795|NCT02586805|12501764|FG001|NOT COMPLETED|Overall Study||1
11303796|NCT02586805|12501765|FG002|NOT COMPLETED|Overall Study||3
11303797|NCT02586805|12501766|FG003|NOT COMPLETED|Overall Study||2
11303798|NCT02586896|12501778|FG000|STARTED|Overall Study||150
11303799|NCT02586896|12501779|FG001|STARTED|Overall Study||150
11303800|NCT02586896|12501778|FG000|3-Month Follow-up|Overall Study||126
11303801|NCT02586896|12501779|FG001|3-Month Follow-up|Overall Study||123
11303802|NCT02586896|12501778|FG000|COMPLETED|Overall Study||131
11303803|NCT02586896|12501779|FG001|COMPLETED|Overall Study||133
11303804|NCT02586896|12501778|FG000|NOT COMPLETED|Overall Study||19
11303805|NCT02586896|12501779|FG001|NOT COMPLETED|Overall Study||17
11303806|NCT02586909|12501785|FG000|STARTED|Overall Study||1099
11303807|NCT02586909|12501785|FG000|COMPLETED|Overall Study||151
11303808|NCT02586909|12501785|FG000|NOT COMPLETED|Overall Study||948
11303809|NCT02586974|12501791|FG000|STARTED|Overall Study||32
11303810|NCT02586974|12501792|FG001|STARTED|Overall Study||32
11303811|NCT02586974|12501791|FG000|COMPLETED|Overall Study||32
11303812|NCT02586974|12501792|FG001|COMPLETED|Overall Study||32
11303813|NCT02586974|12501791|FG000|NOT COMPLETED|Overall Study||0
11303814|NCT02586974|12501792|FG001|NOT COMPLETED|Overall Study||0
11303815|NCT02587065|12501800|FG000|STARTED|Overall Study||193
11303816|NCT02587065|12501800|FG000|COMPLETED|Overall Study||166
11303817|NCT02587065|12501800|FG000|NOT COMPLETED|Overall Study||27
11303818|NCT02587117|12501806|FG000|STARTED|Overall Study||13
11303819|NCT02587117|12501807|FG001|STARTED|Overall Study||15
11303820|NCT02587117|12501806|FG000|COMPLETED|Overall Study||13
11303821|NCT02587117|12501807|FG001|COMPLETED|Overall Study||15
11303822|NCT02587117|12501806|FG000|NOT COMPLETED|Overall Study||0
11303823|NCT02587117|12501807|FG001|NOT COMPLETED|Overall Study||0
11303824|NCT02587143|12501815|FG000|STARTED|Overall Study||66
11303825|NCT02587143|12501816|FG001|STARTED|Overall Study||60
11303826|NCT02587143|12501815|FG000|COMPLETED|Overall Study||65
11303827|NCT02587143|12501816|FG001|COMPLETED|Overall Study||60
11303828|NCT02587143|12501815|FG000|NOT COMPLETED|Overall Study||1
11303829|NCT02587143|12501816|FG001|NOT COMPLETED|Overall Study||0
11303830|NCT02587221|12501824|FG000|STARTED|Overall Study||3394
11303831|NCT02587221|12501825|FG001|STARTED|Overall Study||3396
11303832|NCT02587221|12501824|FG000|Treated|Overall Study||3379
11303833|NCT02587221|12501825|FG001|Treated|Overall Study||3382
11303834|NCT02587221|12501824|FG000|COMPLETED|Overall Study||3263
11303835|NCT02587221|12501825|FG001|COMPLETED|Overall Study||3273
11303836|NCT02587221|12501824|FG000|NOT COMPLETED|Overall Study||131
11303837|NCT02587221|12501825|FG001|NOT COMPLETED|Overall Study||123
11303838|NCT02587234|12501833|FG000|STARTED|Overall Study||11
11303839|NCT02587234|12501834|FG001|STARTED|Overall Study||10
11303840|NCT02587234|12501833|FG000|COMPLETED|Overall Study||10
11303841|NCT02587234|12501834|FG001|COMPLETED|Overall Study||7
11303842|NCT02587234|12501833|FG000|NOT COMPLETED|Overall Study||1
11303843|NCT02587234|12501834|FG001|NOT COMPLETED|Overall Study||3
11303844|NCT02587351|12501842|FG000|STARTED|Overall Study||268
11303845|NCT02587351|12501843|FG001|STARTED|Overall Study||264
11303846|NCT02587351|12501842|FG000|COMPLETED|Overall Study||268
11303847|NCT02587351|12501843|FG001|COMPLETED|Overall Study||264
11303848|NCT02587351|12501842|FG000|NOT COMPLETED|Overall Study||0
11303849|NCT02587351|12501843|FG001|NOT COMPLETED|Overall Study||0
11303850|NCT02587819|12501849|FG000|STARTED|Overall Study||21
11303851|NCT02587819|12501849|FG000|Exposed|Overall Study||21
11303852|NCT02587819|12501849|FG000|COMPLETED|Overall Study||19
11303853|NCT02587819|12501849|FG000|NOT COMPLETED|Overall Study||2
11303854|NCT02587962|12501859|FG000|STARTED|Overall Study||3
11303855|NCT02587962|12501860|FG001|STARTED|Overall Study||3
11303856|NCT02587962|12501861|FG002|STARTED|Overall Study||6
11303857|NCT02587962|12501862|FG003|STARTED|Overall Study||7
11303858|NCT02587962|12501863|FG004|STARTED|Overall Study||15
11303859|NCT02587962|12501859|FG000|COMPLETED|Overall Study||1
11303860|NCT02587962|12501860|FG001|COMPLETED|Overall Study||0
11303861|NCT02587962|12501861|FG002|COMPLETED|Overall Study||0
11303862|NCT02587962|12501862|FG003|COMPLETED|Overall Study||1
11303863|NCT02587962|12501863|FG004|COMPLETED|Overall Study||0
11303864|NCT02587962|12501859|FG000|NOT COMPLETED|Overall Study||2
11303865|NCT02587962|12501860|FG001|NOT COMPLETED|Overall Study||3
11303866|NCT02587962|12501861|FG002|NOT COMPLETED|Overall Study||6
11303867|NCT02587962|12501862|FG003|NOT COMPLETED|Overall Study||6
11303868|NCT02587962|12501863|FG004|NOT COMPLETED|Overall Study||15
11303869|NCT02588092|12501888|FG000|STARTED|Overall Study||4
11303870|NCT02588092|12501889|FG001|STARTED|Overall Study||3
11303871|NCT02588092|12501890|FG002|STARTED|Overall Study||3
11303872|NCT02588092|12501891|FG003|STARTED|Overall Study||3
11303873|NCT02588092|12501892|FG004|STARTED|Overall Study||3
11303874|NCT02588092|12501893|FG005|STARTED|Overall Study||3
11303875|NCT02588092|12501894|FG006|STARTED|Overall Study||3
11303876|NCT02588092|12501895|FG007|STARTED|Overall Study||4
11303877|NCT02588092|12501896|FG008|STARTED|Overall Study||6
11303878|NCT02588092|12501897|FG009|STARTED|Overall Study||3
11303879|NCT02588092|12501888|FG000|COMPLETED|Overall Study||0
11303880|NCT02588092|12501889|FG001|COMPLETED|Overall Study||0
11401272|NCT04128293|12596079|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11401273|NCT04128293|12596080|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11303881|NCT02588092|12501890|FG002|COMPLETED|Overall Study||0
11401274|NCT04128293|12596077|FG000|STARTED|Washout Period 3 (Up to 7 Days)||0
11401275|NCT04128293|12596078|FG001|STARTED|Washout Period 3 (Up to 7 Days)||0
11401276|NCT04128293|12596079|FG002|STARTED|Washout Period 3 (Up to 7 Days)||0
11401277|NCT04128293|12596080|FG003|STARTED|Washout Period 3 (Up to 7 Days)||0
11303882|NCT02588092|12501891|FG003|COMPLETED|Overall Study||0
11303883|NCT02588092|12501892|FG004|COMPLETED|Overall Study||0
11303884|NCT02588092|12501893|FG005|COMPLETED|Overall Study||0
11303885|NCT02588092|12501894|FG006|COMPLETED|Overall Study||0
11303886|NCT02588092|12501895|FG007|COMPLETED|Overall Study||0
11303887|NCT02588092|12501896|FG008|COMPLETED|Overall Study||0
11303888|NCT02588092|12501897|FG009|COMPLETED|Overall Study||0
11303889|NCT02588092|12501888|FG000|NOT COMPLETED|Overall Study||4
11303890|NCT02588092|12501889|FG001|NOT COMPLETED|Overall Study||3
11303891|NCT02588092|12501890|FG002|NOT COMPLETED|Overall Study||3
11303892|NCT02588092|12501891|FG003|NOT COMPLETED|Overall Study||3
11303893|NCT02588092|12501892|FG004|NOT COMPLETED|Overall Study||3
11303894|NCT02588092|12501893|FG005|NOT COMPLETED|Overall Study||3
11303895|NCT02588092|12501894|FG006|NOT COMPLETED|Overall Study||3
11303896|NCT02588092|12501895|FG007|NOT COMPLETED|Overall Study||4
11303897|NCT02588092|12501896|FG008|NOT COMPLETED|Overall Study||6
11303898|NCT02588092|12501897|FG009|NOT COMPLETED|Overall Study||3
11341619|NCT02936037|12539061|FG000|STARTED|Double-Blind Treatment Period||316
11341620|NCT02936037|12539062|FG001|STARTED|Double-Blind Treatment Period||326
11341621|NCT02936037|12539061|FG000|COMPLETED|Double-Blind Treatment Period||267
11341622|NCT02936037|12539062|FG001|COMPLETED|Double-Blind Treatment Period||261
11341623|NCT02936037|12539061|FG000|NOT COMPLETED|Double-Blind Treatment Period||49
11341624|NCT02936037|12539062|FG001|NOT COMPLETED|Double-Blind Treatment Period||65
11341625|NCT02936037|12539061|FG000|STARTED|Open Label Extension||0
11341626|NCT02936037|12539062|FG001|STARTED|Open Label Extension||528
11341627|NCT02936037|12539061|FG000|COMPLETED|Open Label Extension||0
11341628|NCT02936037|12539062|FG001|COMPLETED|Open Label Extension||518
11341629|NCT02936037|12539061|FG000|NOT COMPLETED|Open Label Extension||0
11341630|NCT02936037|12539062|FG001|NOT COMPLETED|Open Label Extension||10
11341631|NCT02936076|12539070|FG000|STARTED|Overall Study||25
11341632|NCT02936076|12539071|FG001|STARTED|Overall Study||24
11341633|NCT02936076|12539070|FG000|COMPLETED|Overall Study||19
11341634|NCT02936076|12539071|FG001|COMPLETED|Overall Study||20
11341635|NCT02936076|12539070|FG000|NOT COMPLETED|Overall Study||6
11341636|NCT02936076|12539071|FG001|NOT COMPLETED|Overall Study||4
11341637|NCT02936479|12539077|FG000|STARTED|Overall Study||1
11341638|NCT02936479|12539077|FG000|COMPLETED|Overall Study||1
11341639|NCT02936479|12539077|FG000|NOT COMPLETED|Overall Study||0
11341640|NCT02936635|12539083|FG000|STARTED|Overall Study||115
11341641|NCT02936635|12539084|FG001|STARTED|Overall Study||165
11341642|NCT02936635|12539083|FG000|COMPLETED|Overall Study||0
11341643|NCT02936635|12539084|FG001|COMPLETED|Overall Study||0
11341644|NCT02936635|12539083|FG000|NOT COMPLETED|Overall Study||115
11341645|NCT02936635|12539084|FG001|NOT COMPLETED|Overall Study||165
11341646|NCT02936648|12539090|FG000|STARTED|Overall Study||2209
11341647|NCT02936648|12539090|FG000|COMPLETED|Overall Study||2209
11341648|NCT02936648|12539090|FG000|NOT COMPLETED|Overall Study||0
11401278|NCT04128293|12596077|FG000|COMPLETED|Washout Period 3 (Up to 7 Days)||0
11401279|NCT04128293|12596078|FG001|COMPLETED|Washout Period 3 (Up to 7 Days)||0
11401280|NCT04128293|12596079|FG002|COMPLETED|Washout Period 3 (Up to 7 Days)||0
11401281|NCT04128293|12596080|FG003|COMPLETED|Washout Period 3 (Up to 7 Days)||0
11401282|NCT04128293|12596077|FG000|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
11401283|NCT04128293|12596078|FG001|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
11401284|NCT04128293|12596079|FG002|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
11401285|NCT04128293|12596080|FG003|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
11401286|NCT04128293|12596077|FG000|STARTED|Treatment Period 4 (1 Day)||0
11401287|NCT04128293|12596078|FG001|STARTED|Treatment Period 4 (1 Day)||0
11401288|NCT04128293|12596079|FG002|STARTED|Treatment Period 4 (1 Day)||0
11401289|NCT04128293|12596080|FG003|STARTED|Treatment Period 4 (1 Day)||0
11401290|NCT04128293|12596077|FG000|COMPLETED|Treatment Period 4 (1 Day)||0
11401291|NCT04128293|12596078|FG001|COMPLETED|Treatment Period 4 (1 Day)||0
11401292|NCT04128293|12596079|FG002|COMPLETED|Treatment Period 4 (1 Day)||0
11401293|NCT04128293|12596080|FG003|COMPLETED|Treatment Period 4 (1 Day)||0
11401294|NCT04128293|12596077|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0
11401295|NCT04128293|12596078|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0
11341649|NCT02936869|12539096|FG000|STARTED|Overall Study||104
11341650|NCT02936869|12539097|FG001|STARTED|Overall Study||103
11341651|NCT02936869|12539096|FG000|COMPLETED|Overall Study||102
11341652|NCT02936869|12539097|FG001|COMPLETED|Overall Study||98
11341653|NCT02936869|12539096|FG000|NOT COMPLETED|Overall Study||2
11341654|NCT02936869|12539097|FG001|NOT COMPLETED|Overall Study||5
11341655|NCT02937116|12539116|FG000|STARTED|Overall Study||3
11341656|NCT02937116|12539117|FG001|STARTED|Overall Study||3
11341657|NCT02937116|12539118|FG002|STARTED|Overall Study||3
11341658|NCT02937116|12539119|FG003|STARTED|Overall Study||3
11401296|NCT04128293|12596079|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0
11401297|NCT04128293|12596080|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0
11401298|NCT04126343|12596101|FG000|STARTED|Overall Study||9
11401299|NCT04126343|12596102|FG001|STARTED|Overall Study||9
11341659|NCT02937116|12539120|FG004|STARTED|Overall Study||22
11401300|NCT04126343|12596103|FG002|STARTED|Overall Study||9
11401301|NCT04126343|12596104|FG003|STARTED|Overall Study||9
11401302|NCT04126343|12596105|FG004|STARTED|Overall Study||9
11401303|NCT04126343|12596106|FG005|STARTED|Overall Study||9
11401304|NCT04126343|12596101|FG000|Completed Padsevonil Period|Overall Study||9
11401305|NCT04126343|12596102|FG001|Completed Padsevonil Period|Overall Study||9
11401306|NCT04126343|12596103|FG002|Completed Padsevonil Period|Overall Study||9
11401307|NCT04126343|12596104|FG003|Completed Padsevonil Period|Overall Study||7
11401308|NCT04126343|12596105|FG004|Completed Padsevonil Period|Overall Study||9
11401309|NCT04126343|12596106|FG005|Completed Padsevonil Period|Overall Study||8
11401310|NCT04126343|12596101|FG000|Completed Placebo Period|Overall Study||9
11401311|NCT04126343|12596102|FG001|Completed Placebo Period|Overall Study||7
11401312|NCT04126343|12596103|FG002|Completed Placebo Period|Overall Study||9
11401313|NCT04126343|12596104|FG003|Completed Placebo Period|Overall Study||9
11401314|NCT04126343|12596105|FG004|Completed Placebo Period|Overall Study||7
11401315|NCT04126343|12596106|FG005|Completed Placebo Period|Overall Study||9
11401316|NCT04126343|12596101|FG000|Completed Moxifloxacin Period|Overall Study||8
11401317|NCT04126343|12596102|FG001|Completed Moxifloxacin Period|Overall Study||9
11401318|NCT04126343|12596103|FG002|Completed Moxifloxacin Period|Overall Study||7
11401319|NCT04126343|12596104|FG003|Completed Moxifloxacin Period|Overall Study||9
11401320|NCT04126343|12596105|FG004|Completed Moxifloxacin Period|Overall Study||9
11401321|NCT04126343|12596106|FG005|Completed Moxifloxacin Period|Overall Study||9
11401322|NCT04126343|12596101|FG000|COMPLETED|Overall Study||6
11401323|NCT04126343|12596102|FG001|COMPLETED|Overall Study||5
11401324|NCT04126343|12596103|FG002|COMPLETED|Overall Study||6
11401325|NCT04126343|12596104|FG003|COMPLETED|Overall Study||5
11401326|NCT04126343|12596105|FG004|COMPLETED|Overall Study||6
11401327|NCT04126343|12596106|FG005|COMPLETED|Overall Study||5
11401328|NCT04126343|12596101|FG000|NOT COMPLETED|Overall Study||3
11401329|NCT04126343|12596102|FG001|NOT COMPLETED|Overall Study||4
11401330|NCT04126343|12596103|FG002|NOT COMPLETED|Overall Study||3
11401331|NCT04126343|12596104|FG003|NOT COMPLETED|Overall Study||4
11401332|NCT04126343|12596105|FG004|NOT COMPLETED|Overall Study||3
11401333|NCT04126343|12596106|FG005|NOT COMPLETED|Overall Study||4
11401334|NCT04126187|12596121|FG000|STARTED|Overall Study||30
11401335|NCT04126187|12596121|FG000|COMPLETED|Overall Study||30
11401336|NCT04126187|12596121|FG000|NOT COMPLETED|Overall Study||0
11401337|NCT04124952|12596125|FG000|STARTED|Overall Study||30
11401338|NCT04124952|12596125|FG000|COMPLETED|Overall Study||29
11401339|NCT04124952|12596125|FG000|NOT COMPLETED|Overall Study||1
11401340|NCT04123665|12596131|FG000|STARTED|Overall Study||50
11401341|NCT04123665|12596132|FG001|STARTED|Overall Study||48
11401342|NCT04123665|12596131|FG000|COMPLETED|Overall Study||42
11401343|NCT04123665|12596132|FG001|COMPLETED|Overall Study||48
11401344|NCT04123665|12596131|FG000|NOT COMPLETED|Overall Study||8
11401345|NCT04123665|12596132|FG001|NOT COMPLETED|Overall Study||0
11401346|NCT04122534|12596138|FG000|STARTED|Overall Study||48
11401347|NCT04122534|12596138|FG000|COMPLETED|Overall Study||44
11401348|NCT04122534|12596138|FG000|NOT COMPLETED|Overall Study||4
11401349|NCT04121078|12596144|FG000|STARTED|Study Period 1 (1 Day)||6
11401350|NCT04121078|12596145|FG001|STARTED|Study Period 1 (1 Day)||6
11401351|NCT04121078|12596144|FG000|COMPLETED|Study Period 1 (1 Day)||6
11401352|NCT04121078|12596145|FG001|COMPLETED|Study Period 1 (1 Day)||6
11401353|NCT04121078|12596144|FG000|NOT COMPLETED|Study Period 1 (1 Day)||0
11401354|NCT04121078|12596145|FG001|NOT COMPLETED|Study Period 1 (1 Day)||0
11401355|NCT04121078|12596144|FG000|STARTED|Washout Period (at Least 7 Days)||6
11401356|NCT04121078|12596145|FG001|STARTED|Washout Period (at Least 7 Days)||6
11401357|NCT04121078|12596144|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
11401358|NCT04121078|12596145|FG001|COMPLETED|Washout Period (at Least 7 Days)||6
11401359|NCT04121078|12596144|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11401360|NCT04121078|12596145|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11401361|NCT04121078|12596144|FG000|STARTED|Study Period 2 (1 Day)||6
11401362|NCT04121078|12596145|FG001|STARTED|Study Period 2 (1 Day)||6
11401363|NCT04121078|12596144|FG000|COMPLETED|Study Period 2 (1 Day)||6
11401364|NCT04121078|12596145|FG001|COMPLETED|Study Period 2 (1 Day)||6
11401365|NCT04121078|12596144|FG000|NOT COMPLETED|Study Period 2 (1 Day)||0
11401366|NCT04121078|12596145|FG001|NOT COMPLETED|Study Period 2 (1 Day)||0
11401367|NCT04117607|12596154|FG000|STARTED|Overall Study||3
11401368|NCT04117607|12596155|FG001|STARTED|Overall Study||7
11401369|NCT04117607|12596156|FG002|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
11401370|NCT04117607|12596157|FG003|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
11401371|NCT04117607|12596158|FG004|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
11401372|NCT04117607|12596159|FG005|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
11401373|NCT04117607|12596160|FG006|STARTED|Overall Study||4
11401374|NCT04117607|12596161|FG007|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
11303899|NCT04960228|12501925|FG000|STARTED|Overall Study||1098
11303900|NCT04960228|12501926|FG001|STARTED|Overall Study||999
11303901|NCT04960228|12501925|FG000|COMPLETED|Overall Study||810
11303902|NCT04960228|12501926|FG001|COMPLETED|Overall Study||813
11303903|NCT04960228|12501925|FG000|NOT COMPLETED|Overall Study||288
11303904|NCT04960228|12501926|FG001|NOT COMPLETED|Overall Study||186
11341660|NCT02937116|12539121|FG005|STARTED|Overall Study||87
11341661|NCT02937116|12539122|FG006|STARTED|Overall Study||37
11341662|NCT02937116|12539123|FG007|STARTED|Overall Study||21
11341663|NCT02937116|12539124|FG008|STARTED|Overall Study||20
11303905|NCT03922477|12501932|FG000|STARTED|Overall Study||13
11303906|NCT03922477|12501932|FG000|COMPLETED|Overall Study||0
11303907|NCT03922477|12501932|FG000|NOT COMPLETED|Overall Study||13
11303908|NCT03688074|12501938|FG000|STARTED|Overall Study||59
11303909|NCT03688074|12501939|FG001|STARTED|Overall Study||57
11303910|NCT03688074|12501938|FG000|COMPLETED|Overall Study||58
11303911|NCT03688074|12501939|FG001|COMPLETED|Overall Study||56
11303912|NCT03688074|12501938|FG000|NOT COMPLETED|Overall Study||1
11303913|NCT03688074|12501939|FG001|NOT COMPLETED|Overall Study||1
11341664|NCT02937116|12539125|FG009|STARTED|Overall Study||20
11341665|NCT02937116|12539126|FG010|STARTED|Overall Study||7
11022067|NCT00807599|12200318|FG000|STARTED|Overall Study||26
11022068|NCT00807599|12200319|FG001|STARTED|Overall Study||24
11022069|NCT00807599|12200320|FG002|STARTED|Overall Study||17
11022070|NCT00807599|12200318|FG000|COMPLETED|Overall Study||26
11022071|NCT00807599|12200319|FG001|COMPLETED|Overall Study||24
11022072|NCT00807599|12200320|FG002|COMPLETED|Overall Study||0
11341666|NCT02937116|12539127|FG011|STARTED|Overall Study||7
11341667|NCT02937116|12539116|FG000|COMPLETED|Overall Study||0
11341668|NCT02937116|12539117|FG001|COMPLETED|Overall Study||0
11341669|NCT02937116|12539118|FG002|COMPLETED|Overall Study||0
11341670|NCT02937116|12539119|FG003|COMPLETED|Overall Study||0
11341671|NCT02937116|12539120|FG004|COMPLETED|Overall Study||0
11341672|NCT02937116|12539121|FG005|COMPLETED|Overall Study||0
11341673|NCT02937116|12539122|FG006|COMPLETED|Overall Study||0
11341674|NCT02937116|12539123|FG007|COMPLETED|Overall Study||0
11341675|NCT02937116|12539124|FG008|COMPLETED|Overall Study||0
11341676|NCT02937116|12539125|FG009|COMPLETED|Overall Study||0
11341677|NCT02937116|12539126|FG010|COMPLETED|Overall Study||0
11341678|NCT02937116|12539127|FG011|COMPLETED|Overall Study||0
11341679|NCT02937116|12539116|FG000|NOT COMPLETED|Overall Study||3
11341680|NCT02937116|12539117|FG001|NOT COMPLETED|Overall Study||3
11341681|NCT02937116|12539118|FG002|NOT COMPLETED|Overall Study||3
11341682|NCT02937116|12539119|FG003|NOT COMPLETED|Overall Study||3
11341683|NCT02937116|12539120|FG004|NOT COMPLETED|Overall Study||22
11341684|NCT02937116|12539121|FG005|NOT COMPLETED|Overall Study||87
11341685|NCT02937116|12539122|FG006|NOT COMPLETED|Overall Study||37
11341686|NCT02937116|12539123|FG007|NOT COMPLETED|Overall Study||21
11341687|NCT02937116|12539124|FG008|NOT COMPLETED|Overall Study||20
11341688|NCT02937116|12539125|FG009|NOT COMPLETED|Overall Study||20
11341689|NCT02937116|12539126|FG010|NOT COMPLETED|Overall Study||7
11341690|NCT02937116|12539127|FG011|NOT COMPLETED|Overall Study||7
11341691|NCT02937168|12539153|FG000|STARTED|PET/CT Screening Period (21 Days)||5
11341692|NCT02937168|12539154|FG001|STARTED|PET/CT Screening Period (21 Days)||0
11341693|NCT02937168|12539155|FG002|STARTED|PET/CT Screening Period (21 Days)||0
11341694|NCT02937168|12539153|FG000|COMPLETED|PET/CT Screening Period (21 Days)||5
11341695|NCT02937168|12539154|FG001|COMPLETED|PET/CT Screening Period (21 Days)||0
11341696|NCT02937168|12539155|FG002|COMPLETED|PET/CT Screening Period (21 Days)||0
11341697|NCT02937168|12539153|FG000|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
11341698|NCT02937168|12539154|FG001|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
11341699|NCT02937168|12539155|FG002|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
11341700|NCT02937168|12539153|FG000|STARTED|Double-Blind Treatment Period (6 Weeks)||0
11341701|NCT02937168|12539154|FG001|STARTED|Double-Blind Treatment Period (6 Weeks)||0
11341702|NCT02937168|12539155|FG002|STARTED|Double-Blind Treatment Period (6 Weeks)||0
11341703|NCT02937168|12539153|FG000|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
11341704|NCT02937168|12539154|FG001|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
11341705|NCT02937168|12539155|FG002|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
11341706|NCT02937168|12539153|FG000|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
11341707|NCT02937168|12539154|FG001|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
11341708|NCT02937168|12539155|FG002|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
11341709|NCT02937194|12539163|FG000|STARTED|1-year Followup||294
11341710|NCT02937194|12539164|FG001|STARTED|1-year Followup||286
11341711|NCT02937194|12539163|FG000|COMPLETED|1-year Followup||223
11341712|NCT02937194|12539164|FG001|COMPLETED|1-year Followup||218
11341713|NCT02937194|12539163|FG000|NOT COMPLETED|1-year Followup||71
11341714|NCT02937194|12539164|FG001|NOT COMPLETED|1-year Followup||68
11341715|NCT02937194|12539163|FG000|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
11341716|NCT02937194|12539164|FG001|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
11341717|NCT02937194|12539163|FG000|COMPLETED|2-years Followup||216
11341718|NCT02937194|12539164|FG001|COMPLETED|2-years Followup||208
11341719|NCT02937194|12539163|FG000|NOT COMPLETED|2-years Followup||78
11341720|NCT02937194|12539164|FG001|NOT COMPLETED|2-years Followup||78
11341721|NCT02937194|12539163|FG000|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
11341722|NCT02937194|12539164|FG001|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
11303914|NCT03342001|12501945|FG000|STARTED|Overall Study||11
11303915|NCT03342001|12501945|FG000|COMPLETED|Overall Study||9
11303916|NCT03342001|12501945|FG000|NOT COMPLETED|Overall Study||2
11303917|NCT02871934|12501951|FG000|STARTED|Overall Study||193
11303918|NCT02871934|12501952|FG001|STARTED|Overall Study||215
11303919|NCT02871934|12501951|FG000|COMPLETED|Overall Study||193
11303920|NCT02871934|12501952|FG001|COMPLETED|Overall Study||215
11303921|NCT02871934|12501951|FG000|NOT COMPLETED|Overall Study||0
11303922|NCT02871934|12501952|FG001|NOT COMPLETED|Overall Study||0
11303923|NCT02859558|12501963|FG000|STARTED|Step 1||49
11303924|NCT02859558|12501964|FG001|STARTED|Step 1||79
11303925|NCT02859558|12501965|FG002|STARTED|Step 1||60
11303926|NCT02859558|12501966|FG003|STARTED|Step 1||4
11303927|NCT02859558|12501967|FG004|STARTED|Step 1||3
11303928|NCT02859558|12501963|FG000|Completed Week 48|Step 1||41
11303929|NCT02859558|12501964|FG001|Completed Week 48|Step 1||68
11303930|NCT02859558|12501965|FG002|Completed Week 48|Step 1||50
11303931|NCT02859558|12501966|FG003|Completed Week 48|Step 1||0
11303932|NCT02859558|12501967|FG004|Completed Week 48|Step 1||0
11303933|NCT02859558|12501963|FG000|COMPLETED|Step 1||37
11303934|NCT02859558|12501964|FG001|COMPLETED|Step 1||67
11303935|NCT02859558|12501965|FG002|COMPLETED|Step 1||49
11303936|NCT02859558|12501966|FG003|COMPLETED|Step 1||4
11303937|NCT02859558|12501967|FG004|COMPLETED|Step 1||0
11303938|NCT02859558|12501963|FG000|NOT COMPLETED|Step 1||12
11303939|NCT02859558|12501964|FG001|NOT COMPLETED|Step 1||12
11303940|NCT02859558|12501965|FG002|NOT COMPLETED|Step 1||11
11303941|NCT02859558|12501966|FG003|NOT COMPLETED|Step 1||0
11303942|NCT02859558|12501967|FG004|NOT COMPLETED|Step 1||3
11303943|NCT02859558|12501963|FG000|STARTED|Step 2||25
11303944|NCT02859558|12501964|FG001|STARTED|Step 2||39
11303945|NCT02859558|12501965|FG002|STARTED|Step 2||21
11303946|NCT02859558|12501966|FG003|STARTED|Step 2||0
11303947|NCT02859558|12501967|FG004|STARTED|Step 2||0
11303948|NCT02859558|12501963|FG000|COMPLETED|Step 2||0
11303949|NCT02859558|12501964|FG001|COMPLETED|Step 2||0
11303950|NCT02859558|12501965|FG002|COMPLETED|Step 2||0
11303951|NCT02859558|12501966|FG003|COMPLETED|Step 2||0
11303952|NCT02859558|12501967|FG004|COMPLETED|Step 2||0
11303953|NCT02859558|12501963|FG000|NOT COMPLETED|Step 2||25
11303954|NCT02859558|12501964|FG001|NOT COMPLETED|Step 2||39
11303955|NCT02859558|12501965|FG002|NOT COMPLETED|Step 2||21
11303956|NCT02859558|12501966|FG003|NOT COMPLETED|Step 2||0
11303957|NCT02859558|12501967|FG004|NOT COMPLETED|Step 2||0
11303958|NCT02818920|12501977|FG000|STARTED|Overall Study||30
11303959|NCT02818920|12501977|FG000|Completed Surgery|Overall Study||25
11303960|NCT02818920|12501977|FG000|Received Adjuvant Therapy|Overall Study||17
11303961|NCT02818920|12501977|FG000|COMPLETED|Overall Study||12
11303962|NCT02818920|12501977|FG000|NOT COMPLETED|Overall Study||18
11303963|NCT02481310|12501984|FG000|STARTED|Induction Treatment (6 Cycles)||1
11303964|NCT02481310|12501985|FG001|STARTED|Induction Treatment (6 Cycles)||36
11303965|NCT02481310|12501986|FG002|STARTED|Induction Treatment (6 Cycles)||1
11303966|NCT02481310|12501984|FG000|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1
11303967|NCT02481310|12501985|FG001|Reached First Evaluable Response|Induction Treatment (6 Cycles)||34
11303968|NCT02481310|12501986|FG002|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1
11303969|NCT02481310|12501984|FG000|Complete 6 Cycles|Induction Treatment (6 Cycles)||1
11303970|NCT02481310|12501985|FG001|Complete 6 Cycles|Induction Treatment (6 Cycles)||30
11303971|NCT02481310|12501986|FG002|Complete 6 Cycles|Induction Treatment (6 Cycles)||1
11303972|NCT02481310|12501984|FG000|COMPLETED|Induction Treatment (6 Cycles)||1
11303973|NCT02481310|12501985|FG001|COMPLETED|Induction Treatment (6 Cycles)||30
11303974|NCT02481310|12501986|FG002|COMPLETED|Induction Treatment (6 Cycles)||1
11303975|NCT02481310|12501984|FG000|NOT COMPLETED|Induction Treatment (6 Cycles)||0
11303976|NCT02481310|12501985|FG001|NOT COMPLETED|Induction Treatment (6 Cycles)||6
11303977|NCT02481310|12501986|FG002|NOT COMPLETED|Induction Treatment (6 Cycles)||0
11303978|NCT02481310|12501984|FG000|STARTED|Maintenance Treatment||1
11303979|NCT02481310|12501985|FG001|STARTED|Maintenance Treatment|9 patients that competed induction did not start maintenance treatment.|21
11303980|NCT02481310|12501986|FG002|STARTED|Maintenance Treatment||1
11303981|NCT02481310|12501984|FG000|Started Maintenance Treatment|Maintenance Treatment||1
11303982|NCT02481310|12501985|FG001|Started Maintenance Treatment|Maintenance Treatment||21
11303983|NCT02481310|12501986|FG002|Started Maintenance Treatment|Maintenance Treatment||1
11303984|NCT02481310|12501984|FG000|COMPLETED|Maintenance Treatment||1
11303985|NCT02481310|12501985|FG001|COMPLETED|Maintenance Treatment||21
11303986|NCT02481310|12501986|FG002|COMPLETED|Maintenance Treatment||1
11303987|NCT02481310|12501984|FG000|NOT COMPLETED|Maintenance Treatment||0
11303988|NCT02481310|12501985|FG001|NOT COMPLETED|Maintenance Treatment||0
11303989|NCT02481310|12501986|FG002|NOT COMPLETED|Maintenance Treatment||0
11303990|NCT02481310|12501984|FG000|STARTED|Follow up||1
11303991|NCT02481310|12501985|FG001|STARTED|Follow up|2 patients died prior to entering follow up, 1 patient withdrew consent and 1 patient currently on treatment.|32
11303992|NCT02481310|12501986|FG002|STARTED|Follow up||1
11303993|NCT02481310|12501984|FG000|COMPLETED|Follow up||1
11303994|NCT02481310|12501985|FG001|COMPLETED|Follow up||29
11303995|NCT02481310|12501986|FG002|COMPLETED|Follow up||1
11303996|NCT02481310|12501984|FG000|NOT COMPLETED|Follow up||0
11303997|NCT02481310|12501985|FG001|NOT COMPLETED|Follow up||3
11303998|NCT02481310|12501986|FG002|NOT COMPLETED|Follow up||0
11303999|NCT02343952|12501990|FG000|STARTED|Study Treatment||93
11304000|NCT02343952|12501990|FG000|COMPLETED|Study Treatment||40
11304001|NCT02343952|12501990|FG000|NOT COMPLETED|Study Treatment||53
11304002|NCT02343952|12501990|FG000|STARTED|Follow up||83
11304003|NCT02343952|12501990|FG000|COMPLETED|Follow up||38
11304004|NCT02343952|12501990|FG000|NOT COMPLETED|Follow up||45
11304005|NCT02326155|12501996|FG000|STARTED|Overall Study||407
11304006|NCT02326155|12501997|FG001|STARTED|Overall Study||63
11304007|NCT02326155|12501996|FG000|COMPLETED|Overall Study||13
11401375|NCT04117607|12596162|FG008|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
11401376|NCT04117607|12596163|FG009|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
11401377|NCT04117607|12596164|FG010|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
11401378|NCT04117607|12596165|FG011|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
11304008|NCT02326155|12501997|FG001|COMPLETED|Overall Study||1
11304009|NCT02326155|12501996|FG000|NOT COMPLETED|Overall Study||394
11304010|NCT02326155|12501997|FG001|NOT COMPLETED|Overall Study||62
11304011|NCT02304367|12502003|FG000|STARTED|Overall Study|14 participants with TIO; 1 participant with ENS; 2 participants with XLH|17
11304012|NCT02304367|12502003|FG000|Completed 48 Weeks of Study Drug|Overall Study||16
11304013|NCT02304367|12502003|FG000|Completed 144 Weeks of Study Drug|Overall Study||12
11304014|NCT02304367|12502003|FG000|COMPLETED|Overall Study||9
11304015|NCT02304367|12502003|FG000|NOT COMPLETED|Overall Study||8
11304016|NCT01810705|12502016|FG000|STARTED|Overall Study||83
11304017|NCT01810705|12502017|FG001|STARTED|Overall Study||40
11304018|NCT01810705|12502016|FG000|COMPLETED|Overall Study||10
11304019|NCT01810705|12502017|FG001|COMPLETED|Overall Study||5
11304020|NCT01810705|12502016|FG000|NOT COMPLETED|Overall Study||73
11304021|NCT01810705|12502017|FG001|NOT COMPLETED|Overall Study||35
11304022|NCT02588261|12502025|FG000|STARTED|Overall Study||267
11304023|NCT02588261|12502026|FG001|STARTED|Overall Study||263
11304024|NCT02588261|12502025|FG000|Treated|Overall Study||265
11304025|NCT02588261|12502026|FG001|Treated|Overall Study||262
11304026|NCT02588261|12502025|FG000|COMPLETED|Overall Study||0
11304027|NCT02588261|12502026|FG001|COMPLETED|Overall Study||0
11304028|NCT02588261|12502025|FG000|NOT COMPLETED|Overall Study||267
11304029|NCT02588261|12502026|FG001|NOT COMPLETED|Overall Study||263
11304030|NCT02588339|12502032|FG000|STARTED|Overall Study||42
11304031|NCT02588339|12502032|FG000|COMPLETED|Overall Study||39
11304032|NCT02588339|12502032|FG000|NOT COMPLETED|Overall Study||3
11304033|NCT02588573|12502038|FG000|STARTED|Overall Study||45
11304034|NCT02588573|12502039|FG001|STARTED|Overall Study||45
11304035|NCT02588573|12502038|FG000|Randomized Eye Etafilcon A|Overall Study||45
11304036|NCT02588573|12502039|FG001|Randomized Eye Etafilcon A|Overall Study||45
11304037|NCT02588573|12502038|FG000|Randomized Eye Somofilcon A|Overall Study||45
11304038|NCT02588573|12502039|FG001|Randomized Eye Somofilcon A|Overall Study||45
11304039|NCT02588573|12502038|FG000|COMPLETED|Overall Study||45
11304040|NCT02588573|12502039|FG001|COMPLETED|Overall Study||45
11304041|NCT02588573|12502038|FG000|NOT COMPLETED|Overall Study||0
11304042|NCT02588573|12502039|FG001|NOT COMPLETED|Overall Study||0
11304043|NCT02588586|12502057|FG000|STARTED|Overall Study||17
11304044|NCT02588586|12502057|FG000|COMPLETED|Overall Study||15
11304045|NCT02588586|12502057|FG000|NOT COMPLETED|Overall Study||2
11304046|NCT02588599|12502061|FG000|STARTED|Overall Study||54
11304047|NCT02588599|12502061|FG000|COMPLETED|Overall Study||54
11304048|NCT02588599|12502061|FG000|NOT COMPLETED|Overall Study||0
11304049|NCT02588612|12502065|FG000|STARTED|Overall Study||10
11304050|NCT02588612|12502065|FG000|Received T-cell Infusion|Overall Study||5
11304051|NCT02588612|12502065|FG000|COMPLETED|Overall Study||5
11304052|NCT02588612|12502065|FG000|NOT COMPLETED|Overall Study||5
11304053|NCT02588664|12502071|FG000|STARTED|Overall Study||3193
11304054|NCT02588664|12502072|FG001|STARTED|Overall Study||2689
11304055|NCT02588664|12502071|FG000|COMPLETED|Overall Study||1832
11304056|NCT02588664|12502072|FG001|COMPLETED|Overall Study||1644
11304057|NCT02588664|12502071|FG000|NOT COMPLETED|Overall Study||1361
11304058|NCT02588664|12502072|FG001|NOT COMPLETED|Overall Study||1045
11304059|NCT02588833|12502080|FG000|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|3
11304060|NCT02588833|12502081|FG001|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|20
11304061|NCT02588833|12502080|FG000|COMPLETED|Part 1||2
11304062|NCT02588833|12502081|FG001|COMPLETED|Part 1||20
11304063|NCT02588833|12502080|FG000|NOT COMPLETED|Part 1||1
11304064|NCT02588833|12502081|FG001|NOT COMPLETED|Part 1||0
11304065|NCT02588833|12502080|FG000|STARTED|Part 2A|Part 2A is not applicable since Cohort 1 subjects proceeded immediately to Part 3.|0
11304066|NCT02588833|12502081|FG001|STARTED|Part 2A||20
11304067|NCT02588833|12502080|FG000|COMPLETED|Part 2A||0
11304068|NCT02588833|12502081|FG001|COMPLETED|Part 2A||18
11304069|NCT02588833|12502080|FG000|NOT COMPLETED|Part 2A||0
11304070|NCT02588833|12502081|FG001|NOT COMPLETED|Part 2A||2
11304071|NCT02588833|12502080|FG000|STARTED|Part 2B||0
11304072|NCT02588833|12502081|FG001|STARTED|Part 2B||18
11304073|NCT02588833|12502080|FG000|COMPLETED|Part 2B||0
11304074|NCT02588833|12502081|FG001|COMPLETED|Part 2B||17
11304075|NCT02588833|12502080|FG000|NOT COMPLETED|Part 2B||0
11304076|NCT02588833|12502081|FG001|NOT COMPLETED|Part 2B||1
11304077|NCT02588833|12502080|FG000|STARTED|Part 2C||0
11304078|NCT02588833|12502081|FG001|STARTED|Part 2C|17 subjects completed Part 2B and 3 entered extension study without participating in Part 2C.|14
11304079|NCT02588833|12502080|FG000|COMPLETED|Part 2C||0
11304080|NCT02588833|12502081|FG001|COMPLETED|Part 2C||12
11304081|NCT02588833|12502080|FG000|NOT COMPLETED|Part 2C||0
11304082|NCT02588833|12502081|FG001|NOT COMPLETED|Part 2C||2
11401379|NCT04117607|12596166|FG012|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
11304083|NCT02588833|12502080|FG000|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|3
11304084|NCT02588833|12502081|FG001|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|4
11304085|NCT02588833|12502080|FG000|COMPLETED|Part 3 (Safety Follow-up)||3
11304086|NCT02588833|12502081|FG001|COMPLETED|Part 3 (Safety Follow-up)||2
11304087|NCT02588833|12502080|FG000|NOT COMPLETED|Part 3 (Safety Follow-up)||0
11304088|NCT02588833|12502081|FG001|NOT COMPLETED|Part 3 (Safety Follow-up)||2
11304089|NCT02588872|12502090|FG000|STARTED|Overall Study||59
11304090|NCT02588872|12502091|FG001|STARTED|Overall Study||52
11304091|NCT02588872|12502090|FG000|COMPLETED|Overall Study||59
11304092|NCT02588872|12502091|FG001|COMPLETED|Overall Study||52
11304093|NCT02588872|12502090|FG000|NOT COMPLETED|Overall Study||0
11304094|NCT02588872|12502091|FG001|NOT COMPLETED|Overall Study||0
11304095|NCT02588976|12502097|FG000|STARTED|Overall Study||30
11304096|NCT02588976|12502097|FG000|COMPLETED|Overall Study||30
11304097|NCT02588976|12502097|FG000|NOT COMPLETED|Overall Study||0
11304098|NCT02589067|12502104|FG000|STARTED|Overall Study||33
11304099|NCT02589067|12502105|FG001|STARTED|Overall Study||34
11304100|NCT02589067|12502104|FG000|COMPLETED|Overall Study||28
11304101|NCT02589067|12502105|FG001|COMPLETED|Overall Study||28
11304102|NCT02589067|12502104|FG000|NOT COMPLETED|Overall Study||5
11304103|NCT02589067|12502105|FG001|NOT COMPLETED|Overall Study||6
11304104|NCT02589171|12502114|FG000|STARTED|Overall Study||35
11304105|NCT02589171|12502115|FG001|STARTED|Overall Study||35
11304106|NCT02589171|12502114|FG000|Day 1 Follow up|Overall Study||35
11304107|NCT02589171|12502115|FG001|Day 1 Follow up|Overall Study||35
11304108|NCT02589171|12502114|FG000|Week 1 Follow up|Overall Study||35
11304109|NCT02589171|12502115|FG001|Week 1 Follow up|Overall Study||34
11304110|NCT02589171|12502114|FG000|Week 6 Follow up|Overall Study||28
11304111|NCT02589171|12502115|FG001|Week 6 Follow up|Overall Study||30
11304112|NCT02589171|12502114|FG000|COMPLETED|Overall Study||28
11304113|NCT02589171|12502115|FG001|COMPLETED|Overall Study||30
11304114|NCT02589171|12502114|FG000|NOT COMPLETED|Overall Study||7
11304115|NCT02589171|12502115|FG001|NOT COMPLETED|Overall Study||5
11304116|NCT02589405|12502121|FG000|STARTED|Overall Study||50
11304117|NCT02589405|12502121|FG000|COMPLETED|Overall Study||46
11304118|NCT02589405|12502121|FG000|NOT COMPLETED|Overall Study||4
11304119|NCT02589626|12502127|FG000|STARTED|Overall Study|Entered are treated patients|32
11304120|NCT02589626|12502128|FG001|STARTED|Overall Study|Entered are treated patients|33
11304121|NCT02589626|12502127|FG000|COMPLETED|Overall Study||29
11304122|NCT02589626|12502128|FG001|COMPLETED|Overall Study||31
11304123|NCT02589626|12502127|FG000|NOT COMPLETED|Overall Study||3
11304124|NCT02589626|12502128|FG001|NOT COMPLETED|Overall Study||2
11304125|NCT02589639|12502137|FG000|STARTED|Overall Study||90
11304126|NCT02589639|12502138|FG001|STARTED|Overall Study||89
11304127|NCT02589639|12502139|FG002|STARTED|Overall Study||90
11304128|NCT02589639|12502137|FG000|Treated|Overall Study||90
11304129|NCT02589639|12502138|FG001|Treated|Overall Study||86
11304130|NCT02589639|12502139|FG002|Treated|Overall Study||90
11304131|NCT02589639|12502137|FG000|COMPLETED|Overall Study||80
11304132|NCT02589639|12502138|FG001|COMPLETED|Overall Study||79
11304133|NCT02589639|12502139|FG002|COMPLETED|Overall Study||86
11304134|NCT02589639|12502137|FG000|NOT COMPLETED|Overall Study||10
11304135|NCT02589639|12502138|FG001|NOT COMPLETED|Overall Study||10
11304136|NCT02589639|12502139|FG002|NOT COMPLETED|Overall Study||4
11304137|NCT02589665|12502151|FG000|STARTED|Induction Period||63
11304138|NCT02589665|12502152|FG001|STARTED|Induction Period||63
11304139|NCT02589665|12502153|FG002|STARTED|Induction Period||62
11304140|NCT02589665|12502154|FG003|STARTED|Induction Period||61
11304141|NCT02589665|12502155|FG004|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
11304142|NCT02589665|12502156|FG005|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
11304143|NCT02589665|12502157|FG006|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
11304144|NCT02589665|12502158|FG007|STARTED|Induction Period||0
11304145|NCT02589665|12502159|FG008|STARTED|Induction Period||0
11304146|NCT02589665|12502160|FG009|STARTED|Induction Period||0
11304147|NCT02589665|12502151|FG000|Received at Least One Dose of Study Drug|Induction Period||63
11304148|NCT02589665|12502152|FG001|Received at Least One Dose of Study Drug|Induction Period||63
11304149|NCT02589665|12502153|FG002|Received at Least One Dose of Study Drug|Induction Period||62
11304150|NCT02589665|12502154|FG003|Received at Least One Dose of Study Drug|Induction Period||60
11304151|NCT02589665|12502155|FG004|Received at Least One Dose of Study Drug|Induction Period||0
11304152|NCT02589665|12502156|FG005|Received at Least One Dose of Study Drug|Induction Period||0
11304153|NCT02589665|12502157|FG006|Received at Least One Dose of Study Drug|Induction Period||0
11304154|NCT02589665|12502158|FG007|Received at Least One Dose of Study Drug|Induction Period||0
11304155|NCT02589665|12502159|FG008|Received at Least One Dose of Study Drug|Induction Period||0
11304156|NCT02589665|12502160|FG009|Received at Least One Dose of Study Drug|Induction Period||0
11304157|NCT02589665|12502151|FG000|COMPLETED|Induction Period||60
11304158|NCT02589665|12502152|FG001|COMPLETED|Induction Period||61
11304159|NCT02589665|12502153|FG002|COMPLETED|Induction Period||60
11304160|NCT02589665|12502154|FG003|COMPLETED|Induction Period||57
11304161|NCT02589665|12502155|FG004|COMPLETED|Induction Period||0
11304162|NCT02589665|12502156|FG005|COMPLETED|Induction Period||0
11304163|NCT02589665|12502157|FG006|COMPLETED|Induction Period||0
11304164|NCT02589665|12502158|FG007|COMPLETED|Induction Period||0
11304165|NCT02589665|12502159|FG008|COMPLETED|Induction Period||0
11304166|NCT02589665|12502160|FG009|COMPLETED|Induction Period||0
11304167|NCT02589665|12502151|FG000|NOT COMPLETED|Induction Period||3
11304168|NCT02589665|12502152|FG001|NOT COMPLETED|Induction Period||2
11304169|NCT02589665|12502153|FG002|NOT COMPLETED|Induction Period||2
11304170|NCT02589665|12502154|FG003|NOT COMPLETED|Induction Period||4
11304171|NCT02589665|12502155|FG004|NOT COMPLETED|Induction Period||0
11304172|NCT02589665|12502156|FG005|NOT COMPLETED|Induction Period||0
11304173|NCT02589665|12502157|FG006|NOT COMPLETED|Induction Period||0
11304174|NCT02589665|12502158|FG007|NOT COMPLETED|Induction Period||0
11304175|NCT02589665|12502159|FG008|NOT COMPLETED|Induction Period||0
11304176|NCT02589665|12502160|FG009|NOT COMPLETED|Induction Period||0
11304177|NCT02589665|12502151|FG000|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
11304178|NCT02589665|12502152|FG001|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
11304179|NCT02589665|12502153|FG002|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
11304180|NCT02589665|12502154|FG003|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
11304181|NCT02589665|12502155|FG004|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|13
11304182|NCT02589665|12502156|FG005|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|47
11304183|NCT02589665|12502157|FG006|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|46
11304184|NCT02589665|12502158|FG007|STARTED|Maintenance Period||0
11304185|NCT02589665|12502159|FG008|STARTED|Maintenance Period||0
11304186|NCT02589665|12502160|FG009|STARTED|Maintenance Period||0
11304187|NCT02589665|12502151|FG000|COMPLETED|Maintenance Period||0
11304188|NCT02589665|12502152|FG001|COMPLETED|Maintenance Period||0
11304189|NCT02589665|12502153|FG002|COMPLETED|Maintenance Period||0
11304190|NCT02589665|12502154|FG003|COMPLETED|Maintenance Period||0
11304191|NCT02589665|12502155|FG004|COMPLETED|Maintenance Period||0
11304192|NCT02589665|12502156|FG005|COMPLETED|Maintenance Period||0
11304193|NCT02589665|12502157|FG006|COMPLETED|Maintenance Period||0
11304194|NCT02589665|12502158|FG007|COMPLETED|Maintenance Period||0
11304195|NCT02589665|12502159|FG008|COMPLETED|Maintenance Period||0
11304196|NCT02589665|12502160|FG009|COMPLETED|Maintenance Period||0
11304197|NCT02589665|12502151|FG000|NOT COMPLETED|Maintenance Period||0
11304198|NCT02589665|12502152|FG001|NOT COMPLETED|Maintenance Period||0
11304199|NCT02589665|12502153|FG002|NOT COMPLETED|Maintenance Period||0
11304200|NCT02589665|12502154|FG003|NOT COMPLETED|Maintenance Period||0
11304201|NCT02589665|12502155|FG004|NOT COMPLETED|Maintenance Period||13
11304202|NCT02589665|12502156|FG005|NOT COMPLETED|Maintenance Period||47
11304203|NCT02589665|12502157|FG006|NOT COMPLETED|Maintenance Period||46
11304204|NCT02589665|12502158|FG007|NOT COMPLETED|Maintenance Period||0
11304205|NCT02589665|12502159|FG008|NOT COMPLETED|Maintenance Period||0
11304206|NCT02589665|12502160|FG009|NOT COMPLETED|Maintenance Period||0
11304207|NCT02589665|12502151|FG000|STARTED|Induction Extension Period||0
11401380|NCT04117607|12596167|FG013|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
11401381|NCT04117607|12596154|FG000|Received Study Product|Overall Study||3
11401382|NCT04117607|12596155|FG001|Received Study Product|Overall Study||6
11022073|NCT00807599|12200318|FG000|NOT COMPLETED|Overall Study||0
11022074|NCT00807599|12200319|FG001|NOT COMPLETED|Overall Study||0
11022075|NCT00807599|12200320|FG002|NOT COMPLETED|Overall Study||17
11022076|NCT00807664|12200328|FG000|STARTED|Overall Study||88
11304208|NCT02589665|12502152|FG001|STARTED|Induction Extension Period||0
11304209|NCT02589665|12502153|FG002|STARTED|Induction Extension Period||0
11304210|NCT02589665|12502154|FG003|STARTED|Induction Extension Period||0
11304211|NCT02589665|12502155|FG004|STARTED|Induction Extension Period||0
11304212|NCT02589665|12502156|FG005|STARTED|Induction Extension Period||0
11304213|NCT02589665|12502157|FG006|STARTED|Induction Extension Period||0
11304214|NCT02589665|12502158|FG007|STARTED|Induction Extension Period||32
11304215|NCT02589665|12502159|FG008|STARTED|Induction Extension Period||96
11304216|NCT02589665|12502160|FG009|STARTED|Induction Extension Period||0
11304217|NCT02589665|12502151|FG000|COMPLETED|Induction Extension Period||0
11304218|NCT02589665|12502152|FG001|COMPLETED|Induction Extension Period||0
11304219|NCT02589665|12502153|FG002|COMPLETED|Induction Extension Period||0
11304220|NCT02589665|12502154|FG003|COMPLETED|Induction Extension Period||0
11304221|NCT02589665|12502155|FG004|COMPLETED|Induction Extension Period||0
11304222|NCT02589665|12502156|FG005|COMPLETED|Induction Extension Period||0
11304223|NCT02589665|12502157|FG006|COMPLETED|Induction Extension Period||0
11304224|NCT02589665|12502158|FG007|COMPLETED|Induction Extension Period||30
11304225|NCT02589665|12502159|FG008|COMPLETED|Induction Extension Period||84
11304226|NCT02589665|12502160|FG009|COMPLETED|Induction Extension Period||0
11304227|NCT02589665|12502151|FG000|NOT COMPLETED|Induction Extension Period||0
11304228|NCT02589665|12502152|FG001|NOT COMPLETED|Induction Extension Period||0
11022077|NCT00807664|12200329|FG001|STARTED|Overall Study||94
11022078|NCT00807664|12200328|FG000|COMPLETED|Overall Study||77
11022079|NCT00807664|12200329|FG001|COMPLETED|Overall Study||75
11022080|NCT00807664|12200328|FG000|NOT COMPLETED|Overall Study||11
11022081|NCT00807664|12200329|FG001|NOT COMPLETED|Overall Study||19
11022082|NCT00807742|12200338|FG000|STARTED|Overall Study||172
11022083|NCT00807742|12200339|FG001|STARTED|Overall Study||168
11022084|NCT00807742|12200338|FG000|COMPLETED|Overall Study||126
11022085|NCT00807742|12200339|FG001|COMPLETED|Overall Study||114
11304229|NCT02589665|12502153|FG002|NOT COMPLETED|Induction Extension Period||0
11304230|NCT02589665|12502154|FG003|NOT COMPLETED|Induction Extension Period||0
11304231|NCT02589665|12502155|FG004|NOT COMPLETED|Induction Extension Period||0
11304232|NCT02589665|12502156|FG005|NOT COMPLETED|Induction Extension Period||0
11304233|NCT02589665|12502157|FG006|NOT COMPLETED|Induction Extension Period||0
11304234|NCT02589665|12502158|FG007|NOT COMPLETED|Induction Extension Period||2
11304235|NCT02589665|12502159|FG008|NOT COMPLETED|Induction Extension Period||12
11304236|NCT02589665|12502160|FG009|NOT COMPLETED|Induction Extension Period||0
11304237|NCT02589665|12502151|FG000|STARTED|Maintenance Extension Period||0
11304238|NCT02589665|12502152|FG001|STARTED|Maintenance Extension Period||0
11304239|NCT02589665|12502153|FG002|STARTED|Maintenance Extension Period||0
11304240|NCT02589665|12502154|FG003|STARTED|Maintenance Extension Period||0
11304241|NCT02589665|12502155|FG004|STARTED|Maintenance Extension Period||0
11304242|NCT02589665|12502156|FG005|STARTED|Maintenance Extension Period||0
11304243|NCT02589665|12502157|FG006|STARTED|Maintenance Extension Period||0
11304244|NCT02589665|12502158|FG007|STARTED|Maintenance Extension Period||0
11304245|NCT02589665|12502159|FG008|STARTED|Maintenance Extension Period||0
11304246|NCT02589665|12502160|FG009|STARTED|Maintenance Extension Period||68
11304247|NCT02589665|12502151|FG000|COMPLETED|Maintenance Extension Period||0
11304248|NCT02589665|12502152|FG001|COMPLETED|Maintenance Extension Period||0
11304249|NCT02589665|12502153|FG002|COMPLETED|Maintenance Extension Period||0
11304250|NCT02589665|12502154|FG003|COMPLETED|Maintenance Extension Period||0
11304251|NCT02589665|12502155|FG004|COMPLETED|Maintenance Extension Period||0
11304252|NCT02589665|12502156|FG005|COMPLETED|Maintenance Extension Period||0
11304253|NCT02589665|12502157|FG006|COMPLETED|Maintenance Extension Period||0
11304254|NCT02589665|12502158|FG007|COMPLETED|Maintenance Extension Period||0
11304255|NCT02589665|12502159|FG008|COMPLETED|Maintenance Extension Period||0
11304256|NCT02589665|12502160|FG009|COMPLETED|Maintenance Extension Period||0
11304257|NCT02589665|12502151|FG000|NOT COMPLETED|Maintenance Extension Period||0
11304258|NCT02589665|12502152|FG001|NOT COMPLETED|Maintenance Extension Period||0
11304259|NCT02589665|12502153|FG002|NOT COMPLETED|Maintenance Extension Period||0
11304260|NCT02589665|12502154|FG003|NOT COMPLETED|Maintenance Extension Period||0
11304261|NCT02589665|12502155|FG004|NOT COMPLETED|Maintenance Extension Period||0
11304262|NCT02589665|12502156|FG005|NOT COMPLETED|Maintenance Extension Period||0
11304263|NCT02589665|12502157|FG006|NOT COMPLETED|Maintenance Extension Period||0
11304264|NCT02589665|12502158|FG007|NOT COMPLETED|Maintenance Extension Period||0
11304265|NCT02589665|12502159|FG008|NOT COMPLETED|Maintenance Extension Period||0
11304266|NCT02589665|12502160|FG009|NOT COMPLETED|Maintenance Extension Period||68
11304267|NCT02589808|12502184|FG000|STARTED|Overall Study||76
11304268|NCT02589808|12502184|FG000|COMPLETED|Overall Study||76
11304269|NCT02589808|12502184|FG000|NOT COMPLETED|Overall Study||0
11304270|NCT02589847|12502190|FG000|STARTED|Overall Study||162
11304271|NCT02589847|12502191|FG001|STARTED|Overall Study||110
11304272|NCT02589847|12502190|FG000|Safety Population|Overall Study||149
11304273|NCT02589847|12502191|FG001|Safety Population|Overall Study||0
11304274|NCT02589847|12502190|FG000|Full Analysis Set (FAS)|Overall Study||149
11304275|NCT02589847|12502191|FG001|Full Analysis Set (FAS)|Overall Study||104
11304276|NCT02589847|12502190|FG000|Evaluable|Overall Study||142
11304277|NCT02589847|12502191|FG001|Evaluable|Overall Study||75
11304278|NCT02589847|12502190|FG000|COMPLETED|Overall Study||107
11304279|NCT02589847|12502191|FG001|COMPLETED|Overall Study||39
11304280|NCT02589847|12502190|FG000|NOT COMPLETED|Overall Study||55
11304281|NCT02589847|12502191|FG001|NOT COMPLETED|Overall Study||71
11304282|NCT02589977|12502201|FG000|STARTED|Overall Study||23
11304283|NCT02589977|12502202|FG001|STARTED|Overall Study||20
11304284|NCT02589977|12502203|FG002|STARTED|Overall Study||12
11304285|NCT02589977|12502201|FG000|COMPLETED|Overall Study||17
11304286|NCT02589977|12502202|FG001|COMPLETED|Overall Study||15
11304287|NCT02589977|12502203|FG002|COMPLETED|Overall Study||8
11304288|NCT02589977|12502201|FG000|NOT COMPLETED|Overall Study||6
11304289|NCT02589977|12502202|FG001|NOT COMPLETED|Overall Study||5
11304290|NCT02589977|12502203|FG002|NOT COMPLETED|Overall Study||4
11304291|NCT02590003|12502213|FG000|STARTED|Overall Study||1
11304292|NCT02590003|12502214|FG001|STARTED|Overall Study||2
11304293|NCT02590003|12502213|FG000|COMPLETED|Overall Study||0
11304294|NCT02590003|12502214|FG001|COMPLETED|Overall Study||0
11304295|NCT02590003|12502213|FG000|NOT COMPLETED|Overall Study||1
11304296|NCT02590003|12502214|FG001|NOT COMPLETED|Overall Study||2
11304297|NCT02590354|12502220|FG000|STARTED|Phase 1||114
11304298|NCT02590354|12502220|FG000|COMPLETED|Phase 1||16
11304299|NCT02590354|12502220|FG000|NOT COMPLETED|Phase 1||98
11304300|NCT02590354|12502220|FG000|STARTED|Phase 2 - Treatment Interruption||16
11304301|NCT02590354|12502220|FG000|COMPLETED|Phase 2 - Treatment Interruption||14
11304302|NCT02590354|12502220|FG000|NOT COMPLETED|Phase 2 - Treatment Interruption||2
11304303|NCT02590406|12502227|FG000|STARTED|Overall Study||25
11304304|NCT02590406|12502228|FG001|STARTED|Overall Study||25
11304305|NCT02590406|12502227|FG000|COMPLETED|Overall Study||24
11304306|NCT02590406|12502228|FG001|COMPLETED|Overall Study||24
11304307|NCT02590406|12502227|FG000|NOT COMPLETED|Overall Study||1
11304308|NCT02590406|12502228|FG001|NOT COMPLETED|Overall Study||1
11304309|NCT02590432|12502236|FG000|STARTED|Open-label Treatment Period||508
11304310|NCT02590432|12502237|FG001|STARTED|Open-label Treatment Period||318
11304311|NCT02590432|12502238|FG002|STARTED|Open-label Treatment Period||0
11304312|NCT02590432|12502239|FG003|STARTED|Open-label Treatment Period||0
11304313|NCT02590432|12502240|FG004|STARTED|Open-label Treatment Period||0
11304314|NCT02590432|12502241|FG005|STARTED|Open-label Treatment Period||0
11304315|NCT02590432|12502242|FG006|STARTED|Open-label Treatment Period||0
11304316|NCT02590432|12502243|FG007|STARTED|Open-label Treatment Period||0
11304317|NCT02590432|12502244|FG008|STARTED|Open-label Treatment Period||0
11304318|NCT02590432|12502236|FG000|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276
11304319|NCT02590432|12502237|FG001|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166
11304320|NCT02590432|12502238|FG002|COMPLETED|Open-label Treatment Period||0
11304321|NCT02590432|12502239|FG003|COMPLETED|Open-label Treatment Period||0
11304322|NCT02590432|12502240|FG004|COMPLETED|Open-label Treatment Period||0
11304323|NCT02590432|12502241|FG005|COMPLETED|Open-label Treatment Period||0
11304324|NCT02590432|12502242|FG006|COMPLETED|Open-label Treatment Period||0
11304325|NCT02590432|12502243|FG007|COMPLETED|Open-label Treatment Period||0
11304326|NCT02590432|12502244|FG008|COMPLETED|Open-label Treatment Period||0
11304327|NCT02590432|12502236|FG000|NOT COMPLETED|Open-label Treatment Period||232
11304328|NCT02590432|12502237|FG001|NOT COMPLETED|Open-label Treatment Period||152
11304329|NCT02590432|12502238|FG002|NOT COMPLETED|Open-label Treatment Period||0
11304330|NCT02590432|12502239|FG003|NOT COMPLETED|Open-label Treatment Period||0
11304331|NCT02590432|12502240|FG004|NOT COMPLETED|Open-label Treatment Period||0
11304332|NCT02590432|12502241|FG005|NOT COMPLETED|Open-label Treatment Period||0
11304333|NCT02590432|12502242|FG006|NOT COMPLETED|Open-label Treatment Period||0
11304334|NCT02590432|12502243|FG007|NOT COMPLETED|Open-label Treatment Period||0
11304335|NCT02590432|12502244|FG008|NOT COMPLETED|Open-label Treatment Period||0
11304336|NCT02590432|12502236|FG000|STARTED|Double-blind Treatment Period||0
11304337|NCT02590432|12502237|FG001|STARTED|Double-blind Treatment Period||0
11304338|NCT02590432|12502238|FG002|STARTED|Double-blind Treatment Period||18
11304339|NCT02590432|12502239|FG003|STARTED|Double-blind Treatment Period||18
11304340|NCT02590432|12502240|FG004|STARTED|Double-blind Treatment Period||16
11304341|NCT02590432|12502241|FG005|STARTED|Double-blind Treatment Period||32
11304342|NCT02590432|12502242|FG006|STARTED|Double-blind Treatment Period||30
11304343|NCT02590432|12502243|FG007|STARTED|Double-blind Treatment Period||0
11304344|NCT02590432|12502244|FG008|STARTED|Double-blind Treatment Period||0
11304345|NCT02590432|12502236|FG000|COMPLETED|Double-blind Treatment Period||0
11304346|NCT02590432|12502237|FG001|COMPLETED|Double-blind Treatment Period||0
11304347|NCT02590432|12502238|FG002|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1
11304348|NCT02590432|12502239|FG003|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3
11304349|NCT02590432|12502240|FG004|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7
11304350|NCT02590432|12502241|FG005|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6
11304351|NCT02590432|12502242|FG006|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9
11304352|NCT02590432|12502243|FG007|COMPLETED|Double-blind Treatment Period||0
11304353|NCT02590432|12502244|FG008|COMPLETED|Double-blind Treatment Period||0
11304354|NCT02590432|12502236|FG000|NOT COMPLETED|Double-blind Treatment Period||0
11304355|NCT02590432|12502237|FG001|NOT COMPLETED|Double-blind Treatment Period||0
11304356|NCT02590432|12502238|FG002|NOT COMPLETED|Double-blind Treatment Period||17
11304357|NCT02590432|12502239|FG003|NOT COMPLETED|Double-blind Treatment Period||15
11304358|NCT02590432|12502240|FG004|NOT COMPLETED|Double-blind Treatment Period||9
11304359|NCT02590432|12502241|FG005|NOT COMPLETED|Double-blind Treatment Period||26
11304360|NCT02590432|12502242|FG006|NOT COMPLETED|Double-blind Treatment Period||21
11304361|NCT02590432|12502243|FG007|NOT COMPLETED|Double-blind Treatment Period||0
11304362|NCT02590432|12502244|FG008|NOT COMPLETED|Double-blind Treatment Period||0
11304363|NCT02590432|12502236|FG000|STARTED|Dose-reduced Open Label Treatment Period||0
11304364|NCT02590432|12502237|FG001|STARTED|Dose-reduced Open Label Treatment Period||0
11304365|NCT02590432|12502238|FG002|STARTED|Dose-reduced Open Label Treatment Period||0
11304366|NCT02590432|12502239|FG003|STARTED|Dose-reduced Open Label Treatment Period||0
11304367|NCT02590432|12502240|FG004|STARTED|Dose-reduced Open Label Treatment Period||0
11304368|NCT02590432|12502241|FG005|STARTED|Dose-reduced Open Label Treatment Period||0
11304369|NCT02590432|12502242|FG006|STARTED|Dose-reduced Open Label Treatment Period||0
11304370|NCT02590432|12502243|FG007|STARTED|Dose-reduced Open Label Treatment Period||31
11304371|NCT02590432|12502244|FG008|STARTED|Dose-reduced Open Label Treatment Period||26
11304372|NCT02590432|12502236|FG000|COMPLETED|Dose-reduced Open Label Treatment Period||0
11304373|NCT02590432|12502237|FG001|COMPLETED|Dose-reduced Open Label Treatment Period||0
11304374|NCT02590432|12502238|FG002|COMPLETED|Dose-reduced Open Label Treatment Period||0
11304375|NCT02590432|12502239|FG003|COMPLETED|Dose-reduced Open Label Treatment Period||0
11304376|NCT02590432|12502240|FG004|COMPLETED|Dose-reduced Open Label Treatment Period||0
11304377|NCT02590432|12502241|FG005|COMPLETED|Dose-reduced Open Label Treatment Period||0
11304378|NCT02590432|12502242|FG006|COMPLETED|Dose-reduced Open Label Treatment Period||0
11304379|NCT02590432|12502243|FG007|COMPLETED|Dose-reduced Open Label Treatment Period||13
11304380|NCT02590432|12502244|FG008|COMPLETED|Dose-reduced Open Label Treatment Period||8
11304381|NCT02590432|12502236|FG000|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
11304382|NCT02590432|12502237|FG001|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
11304383|NCT02590432|12502238|FG002|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
11304384|NCT02590432|12502239|FG003|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
11304385|NCT02590432|12502240|FG004|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
11304386|NCT02590432|12502241|FG005|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
11304387|NCT02590432|12502242|FG006|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
11304388|NCT02590432|12502243|FG007|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
11304389|NCT02590432|12502244|FG008|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
11304390|NCT02590562|12502256|FG000|STARTED|Overall Study||808
11304391|NCT02590562|12502256|FG000|COMPLETED|Overall Study||802
11304392|NCT02590562|12502256|FG000|NOT COMPLETED|Overall Study||6
11304393|NCT02590588|12502266|FG000|STARTED|Overall Study||1
11304394|NCT02590588|12502266|FG000|COMPLETED|Overall Study||0
11304395|NCT02590588|12502266|FG000|NOT COMPLETED|Overall Study||1
11304396|NCT02590939|12502272|FG000|STARTED|Overall Study||52
11304397|NCT02590939|12502273|FG001|STARTED|Overall Study||54
11304398|NCT02590939|12502272|FG000|COMPLETED|Overall Study||47
11304399|NCT02590939|12502273|FG001|COMPLETED|Overall Study||52
11304400|NCT02590939|12502272|FG000|NOT COMPLETED|Overall Study||5
11304401|NCT02590939|12502273|FG001|NOT COMPLETED|Overall Study||2
11341723|NCT02937194|12539163|FG000|COMPLETED|3-years Followup||228
11341724|NCT02937194|12539164|FG001|COMPLETED|3-years Followup||208
11341725|NCT02937194|12539163|FG000|NOT COMPLETED|3-years Followup||66
11341726|NCT02937194|12539164|FG001|NOT COMPLETED|3-years Followup||78
11341727|NCT02937350|12539173|FG000|STARTED|Overall Study||43
11341728|NCT02937350|12539174|FG001|STARTED|Overall Study||25
11341729|NCT02937350|12539175|FG002|STARTED|Overall Study||20
11341730|NCT02937350|12539173|FG000|COMPLETED|Overall Study||43
11341731|NCT02937350|12539174|FG001|COMPLETED|Overall Study||24
11341732|NCT02937350|12539175|FG002|COMPLETED|Overall Study||20
11341733|NCT02937350|12539173|FG000|NOT COMPLETED|Overall Study||0
11341734|NCT02937350|12539174|FG001|NOT COMPLETED|Overall Study||1
11341735|NCT02937350|12539175|FG002|NOT COMPLETED|Overall Study||0
11341736|NCT02937454|12539183|FG000|STARTED|Overall Study||567
11341737|NCT02937454|12539184|FG001|STARTED|Overall Study||565
11341738|NCT02937454|12539183|FG000|Started Treatment|Overall Study||559
11341739|NCT02937454|12539184|FG001|Started Treatment|Overall Study||551
11341740|NCT02937454|12539183|FG000|COMPLETED|Overall Study||427
11341741|NCT02937454|12539184|FG001|COMPLETED|Overall Study||437
11341742|NCT02937454|12539183|FG000|NOT COMPLETED|Overall Study||140
11341743|NCT02937454|12539184|FG001|NOT COMPLETED|Overall Study||128
11341744|NCT02937506|12539193|FG000|STARTED|Overall Study||300
11341745|NCT02937506|12539194|FG001|STARTED|Overall Study||300
11341746|NCT02937506|12539193|FG000|COMPLETED|Overall Study||300
11341747|NCT02937506|12539194|FG001|COMPLETED|Overall Study||300
11341748|NCT02937506|12539193|FG000|NOT COMPLETED|Overall Study||0
11341749|NCT02937506|12539194|FG001|NOT COMPLETED|Overall Study||0
11341750|NCT02937545|12539202|FG000|STARTED|Overall Study||69
11341751|NCT02937545|12539203|FG001|STARTED|Overall Study||85
11341752|NCT02937545|12539204|FG002|STARTED|Overall Study||15
11341753|NCT02937545|12539205|FG003|STARTED|Overall Study||21
11341754|NCT02937545|12539202|FG000|COMPLETED|Overall Study||67
11341755|NCT02937545|12539203|FG001|COMPLETED|Overall Study||83
11341756|NCT02937545|12539204|FG002|COMPLETED|Overall Study||9
11022086|NCT00807742|12200338|FG000|NOT COMPLETED|Overall Study||46
11022087|NCT00807742|12200339|FG001|NOT COMPLETED|Overall Study||54
11401383|NCT04117607|12596156|FG002|Received Study Product|Overall Study||0
11401384|NCT04117607|12596157|FG003|Received Study Product|Overall Study||0
11341757|NCT02937545|12539205|FG003|COMPLETED|Overall Study||14
11341758|NCT02937545|12539202|FG000|NOT COMPLETED|Overall Study||2
11022088|NCT00807768|12200347|FG000|STARTED|Overall Study||301
11022089|NCT00807768|12200348|FG001|STARTED|Overall Study||300
11022090|NCT00807768|12200347|FG000|COMPLETED|Overall Study||301
11022091|NCT00807768|12200348|FG001|COMPLETED|Overall Study||300
11022092|NCT00807768|12200347|FG000|NOT COMPLETED|Overall Study||0
11022093|NCT00807768|12200348|FG001|NOT COMPLETED|Overall Study||0
11022094|NCT00807846|12200356|FG000|STARTED|Overall Study||100
11022095|NCT00807846|12200357|FG001|STARTED|Overall Study||98
11022096|NCT00807846|12200356|FG000|COMPLETED|Overall Study||88
11022097|NCT00807846|12200357|FG001|COMPLETED|Overall Study||94
11022098|NCT00807846|12200356|FG000|NOT COMPLETED|Overall Study||12
11022099|NCT00807846|12200357|FG001|NOT COMPLETED|Overall Study||4
11022100|NCT00807885|12200372|FG000|STARTED|Overall Study||10
11022101|NCT00807885|12200373|FG001|STARTED|Overall Study||11
11022102|NCT00807885|12200374|FG002|STARTED|Overall Study||11
11022103|NCT00807885|12200375|FG003|STARTED|Overall Study||10
11022104|NCT00807885|12200376|FG004|STARTED|Overall Study||12
11022105|NCT00807885|12200377|FG005|STARTED|Overall Study||12
11341759|NCT02937545|12539203|FG001|NOT COMPLETED|Overall Study||2
11341760|NCT02937545|12539204|FG002|NOT COMPLETED|Overall Study||6
11341761|NCT02937545|12539205|FG003|NOT COMPLETED|Overall Study||7
11341762|NCT02937558|12539218|FG000|STARTED|Double-blind Phase||3
11341763|NCT02937558|12539219|FG001|STARTED|Double-blind Phase||2
11341764|NCT02937558|12539218|FG000|COMPLETED|Double-blind Phase||3
11341765|NCT02937558|12539219|FG001|COMPLETED|Double-blind Phase||2
11341766|NCT02937558|12539218|FG000|NOT COMPLETED|Double-blind Phase||0
11341767|NCT02937558|12539219|FG001|NOT COMPLETED|Double-blind Phase||0
11341768|NCT02937558|12539218|FG000|STARTED|Open-label Phase||5
11341769|NCT02937558|12539219|FG001|STARTED|Open-label Phase||0
11341770|NCT02937558|12539218|FG000|COMPLETED|Open-label Phase||5
11022106|NCT00807885|12200378|FG006|STARTED|Overall Study||12
11022107|NCT00807885|12200379|FG007|STARTED|Overall Study||11
11022108|NCT00807885|12200380|FG008|STARTED|Overall Study||11
11341771|NCT02937558|12539219|FG001|COMPLETED|Open-label Phase||0
11341772|NCT02937558|12539218|FG000|NOT COMPLETED|Open-label Phase||0
11304402|NCT02591056|12502279|FG000|STARTED|Overall Study||27
11304403|NCT02591056|12502279|FG000|COMPLETED|Overall Study||27
11304404|NCT02591056|12502279|FG000|NOT COMPLETED|Overall Study||0
11304405|NCT02591238|12502287|FG000|STARTED|Overall Study||16
11304406|NCT02591238|12502288|FG001|STARTED|Overall Study||17
11304407|NCT02591238|12502289|FG002|STARTED|Overall Study||17
11304408|NCT02591238|12502290|FG003|STARTED|Overall Study||18
11304409|NCT02591238|12502287|FG000|COMPLETED|Overall Study||15
11304410|NCT02591238|12502288|FG001|COMPLETED|Overall Study||16
11304411|NCT02591238|12502289|FG002|COMPLETED|Overall Study||17
11304412|NCT02591238|12502290|FG003|COMPLETED|Overall Study||15
11304413|NCT02591238|12502287|FG000|NOT COMPLETED|Overall Study||1
11304414|NCT02591238|12502288|FG001|NOT COMPLETED|Overall Study||1
11304415|NCT02591238|12502289|FG002|NOT COMPLETED|Overall Study||0
11304416|NCT02591238|12502290|FG003|NOT COMPLETED|Overall Study||3
11304417|NCT02591290|12502300|FG000|STARTED|Overall Study||60
11304418|NCT02591290|12502300|FG000|Vaccinated Dose 1|Overall Study||60
11304419|NCT02591290|12502300|FG000|Vaccinated Dose 2|Overall Study||58
11304420|NCT02591290|12502300|FG000|COMPLETED|Overall Study||58
11304421|NCT02591290|12502300|FG000|NOT COMPLETED|Overall Study||2
11304422|NCT02591511|12502306|FG000|STARTED|Overall Study||30
11304423|NCT02591511|12502307|FG001|STARTED|Overall Study||33
11304424|NCT02591511|12502306|FG000|COMPLETED|Overall Study||30
11304425|NCT02591511|12502307|FG001|COMPLETED|Overall Study||33
11304426|NCT02591511|12502306|FG000|NOT COMPLETED|Overall Study||0
11304427|NCT02591511|12502307|FG001|NOT COMPLETED|Overall Study||0
11304428|NCT02591537|12502315|FG000|STARTED|Overall Study||8
11304429|NCT02591537|12502316|FG001|STARTED|Overall Study||8
11304430|NCT02591537|12502315|FG000|COMPLETED|Overall Study||8
11304431|NCT02591537|12502316|FG001|COMPLETED|Overall Study||8
11304432|NCT02591537|12502315|FG000|NOT COMPLETED|Overall Study||0
11304433|NCT02591537|12502316|FG001|NOT COMPLETED|Overall Study||0
11304434|NCT02592018|12502323|FG000|STARTED|Overall Study||15
11304435|NCT02592018|12502323|FG000|COMPLETED|Overall Study||13
11304436|NCT02592018|12502323|FG000|NOT COMPLETED|Overall Study||2
11304437|NCT02592421|12502329|FG000|STARTED|Study 1||20
11304438|NCT02592421|12502330|FG001|STARTED|Study 1||10
11304439|NCT02592421|12502329|FG000|COMPLETED|Study 1||20
11304440|NCT02592421|12502330|FG001|COMPLETED|Study 1||10
11304441|NCT02592421|12502329|FG000|NOT COMPLETED|Study 1||0
11304442|NCT02592421|12502330|FG001|NOT COMPLETED|Study 1||0
11304443|NCT02592421|12502329|FG000|STARTED|Study 2: Glucose Clamp Conditions||20
11304444|NCT02592421|12502330|FG001|STARTED|Study 2: Glucose Clamp Conditions||10
11304445|NCT02592421|12502329|FG000|COMPLETED|Study 2: Glucose Clamp Conditions||20
11304446|NCT02592421|12502330|FG001|COMPLETED|Study 2: Glucose Clamp Conditions||10
11304447|NCT02592421|12502329|FG000|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
11304448|NCT02592421|12502330|FG001|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
11304449|NCT02592421|12502329|FG000|STARTED|Study 3: Pancreatic Clamp Conditions||20
11304450|NCT02592421|12502330|FG001|STARTED|Study 3: Pancreatic Clamp Conditions||10
11304451|NCT02592421|12502329|FG000|COMPLETED|Study 3: Pancreatic Clamp Conditions||20
11304452|NCT02592421|12502330|FG001|COMPLETED|Study 3: Pancreatic Clamp Conditions||10
11304453|NCT02592421|12502329|FG000|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
11304454|NCT02592421|12502330|FG001|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
11304455|NCT02592434|12502336|FG000|STARTED|Open-Label Phase (18 Weeks)||225
11304456|NCT02592434|12502337|FG001|STARTED|Open-Label Phase (18 Weeks)||0
11304457|NCT02592434|12502338|FG002|STARTED|Open-Label Phase (18 Weeks)||0
11304458|NCT02592434|12502336|FG000|Treated|Open-Label Phase (18 Weeks)||225
11304459|NCT02592434|12502337|FG001|Treated|Open-Label Phase (18 Weeks)||0
11304460|NCT02592434|12502338|FG002|Treated|Open-Label Phase (18 Weeks)||0
11304461|NCT02592434|12502336|FG000|COMPLETED|Open-Label Phase (18 Weeks)||185
11304462|NCT02592434|12502337|FG001|COMPLETED|Open-Label Phase (18 Weeks)||0
11304463|NCT02592434|12502338|FG002|COMPLETED|Open-Label Phase (18 Weeks)||0
11304464|NCT02592434|12502336|FG000|NOT COMPLETED|Open-Label Phase (18 Weeks)||40
11304465|NCT02592434|12502337|FG001|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
11304466|NCT02592434|12502338|FG002|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
11304467|NCT02592434|12502336|FG000|STARTED|Double Blind Phase (26 Weeks)||0
11304468|NCT02592434|12502337|FG001|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase, achieved at least a JIA ACR 30 response in OL phase.|88
11304469|NCT02592434|12502338|FG002|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase,achieved at least a JIA ACR 30 response in OL phase.|85
11304470|NCT02592434|12502336|FG000|Treated|Double Blind Phase (26 Weeks)||0
11304471|NCT02592434|12502337|FG001|Treated|Double Blind Phase (26 Weeks)||88
11304472|NCT02592434|12502338|FG002|Treated|Double Blind Phase (26 Weeks)||85
11304473|NCT02592434|12502336|FG000|COMPLETED|Double Blind Phase (26 Weeks)||0
11304474|NCT02592434|12502337|FG001|COMPLETED|Double Blind Phase (26 Weeks)||61
11304475|NCT02592434|12502338|FG002|COMPLETED|Double Blind Phase (26 Weeks)||38
11304476|NCT02592434|12502336|FG000|NOT COMPLETED|Double Blind Phase (26 Weeks)||0
11304477|NCT02592434|12502337|FG001|NOT COMPLETED|Double Blind Phase (26 Weeks)||27
11304478|NCT02592434|12502338|FG002|NOT COMPLETED|Double Blind Phase (26 Weeks)||47
11304479|NCT02592447|12502348|FG000|STARTED|Overall Study||29
11304480|NCT02592447|12502349|FG001|STARTED|Overall Study||15
11304481|NCT02592447|12502348|FG000|COMPLETED|Overall Study||27
11304482|NCT02592447|12502349|FG001|COMPLETED|Overall Study||14
11304483|NCT02592447|12502348|FG000|NOT COMPLETED|Overall Study||2
11304484|NCT02592447|12502349|FG001|NOT COMPLETED|Overall Study||1
11304485|NCT02592486|12502357|FG000|STARTED|Overall Study||81
11304486|NCT02592486|12502358|FG001|STARTED|Overall Study||81
11304487|NCT02592486|12502357|FG000|COMPLETED|Overall Study||81
11304488|NCT02592486|12502358|FG001|COMPLETED|Overall Study||76
11304489|NCT02592486|12502357|FG000|NOT COMPLETED|Overall Study||0
11304490|NCT02592486|12502358|FG001|NOT COMPLETED|Overall Study||5
11304491|NCT02592629|12502367|FG000|STARTED|Overall Study||5
11304492|NCT02592629|12502368|FG001|STARTED|Overall Study||9
11304493|NCT02592629|12502369|FG002|STARTED|Overall Study||5
11304494|NCT02592629|12502367|FG000|COMPLETED|Overall Study||5
11304495|NCT02592629|12502368|FG001|COMPLETED|Overall Study||9
11304496|NCT02592629|12502369|FG002|COMPLETED|Overall Study||5
11304497|NCT02592629|12502367|FG000|NOT COMPLETED|Overall Study||0
11304498|NCT02592629|12502368|FG001|NOT COMPLETED|Overall Study||0
11304499|NCT02592629|12502369|FG002|NOT COMPLETED|Overall Study||0
11304500|NCT02592655|12502379|FG000|STARTED|First Tourniquet, Left Thigh.||19
11304501|NCT02592655|12502379|FG000|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
11304502|NCT02592655|12502379|FG000|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
11304503|NCT02592655|12502379|FG000|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
11304504|NCT02592655|12502379|FG000|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
11304505|NCT02592655|12502379|FG000|COMPLETED|First Tourniquet, Left Thigh.||19
11304506|NCT02592655|12502379|FG000|NOT COMPLETED|First Tourniquet, Left Thigh.||0
11304507|NCT02592655|12502379|FG000|STARTED|Second Tourniquet Right Thigh.||19
11304508|NCT02592655|12502379|FG000|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
11304509|NCT02592655|12502379|FG000|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
11304510|NCT02592655|12502379|FG000|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
11304511|NCT02592655|12502379|FG000|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
11304512|NCT02592655|12502379|FG000|COMPLETED|Second Tourniquet Right Thigh.||19
11304513|NCT02592655|12502379|FG000|NOT COMPLETED|Second Tourniquet Right Thigh.||0
11304514|NCT02592655|12502379|FG000|STARTED|Third Tourniquet, Left Thigh.||19
11304515|NCT02592655|12502379|FG000|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
11304516|NCT02592655|12502379|FG000|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
11304517|NCT02592655|12502379|FG000|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
11304518|NCT02592655|12502379|FG000|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
11304519|NCT02592655|12502379|FG000|COMPLETED|Third Tourniquet, Left Thigh.||19
11304520|NCT02592655|12502379|FG000|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
11304521|NCT02592655|12502379|FG000|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
11304522|NCT02592655|12502379|FG000|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
11304523|NCT02592655|12502379|FG000|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
11304524|NCT02592655|12502379|FG000|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
11304525|NCT02592655|12502379|FG000|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
11304526|NCT02592655|12502379|FG000|COMPLETED|Fourth Tourniquet Right Thigh.||4
11304527|NCT02592655|12502379|FG000|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
11304528|NCT02592798|12502396|FG000|STARTED|Double-Blind Period 1 (DB1)||17
11304529|NCT02592798|12502397|FG001|STARTED|Double-Blind Period 1 (DB1)||19
11304530|NCT02592798|12502396|FG000|COMPLETED|Double-Blind Period 1 (DB1)||14
11304531|NCT02592798|12502397|FG001|COMPLETED|Double-Blind Period 1 (DB1)||13
11304532|NCT02592798|12502396|FG000|NOT COMPLETED|Double-Blind Period 1 (DB1)||3
11304533|NCT02592798|12502397|FG001|NOT COMPLETED|Double-Blind Period 1 (DB1)||6
11304534|NCT02592798|12502396|FG000|STARTED|Transition From DB1 to DB2||14
11304535|NCT02592798|12502397|FG001|STARTED|Transition From DB1 to DB2||13
11304536|NCT02592798|12502396|FG000|COMPLETED|Transition From DB1 to DB2||11
11304537|NCT02592798|12502397|FG001|COMPLETED|Transition From DB1 to DB2||11
11304538|NCT02592798|12502396|FG000|NOT COMPLETED|Transition From DB1 to DB2||3
11401385|NCT04117607|12596158|FG004|Received Study Product|Overall Study||0
11304539|NCT02592798|12502397|FG001|NOT COMPLETED|Transition From DB1 to DB2||2
11304540|NCT02592798|12502396|FG000|STARTED|Double-Blind Period 2 (DB2)||11
11304541|NCT02592798|12502397|FG001|STARTED|Double-Blind Period 2 (DB2)||11
11304542|NCT02592798|12502396|FG000|COMPLETED|Double-Blind Period 2 (DB2)||6
11304543|NCT02592798|12502397|FG001|COMPLETED|Double-Blind Period 2 (DB2)||9
11304544|NCT02592798|12502396|FG000|NOT COMPLETED|Double-Blind Period 2 (DB2)||5
11304545|NCT02592798|12502397|FG001|NOT COMPLETED|Double-Blind Period 2 (DB2)||2
11304546|NCT02592798|12502396|FG000|STARTED|Transition From DB2 to OLE||6
11304547|NCT02592798|12502397|FG001|STARTED|Transition From DB2 to OLE||9
11304548|NCT02592798|12502396|FG000|COMPLETED|Transition From DB2 to OLE||5
11304549|NCT02592798|12502397|FG001|COMPLETED|Transition From DB2 to OLE||9
11304550|NCT02592798|12502396|FG000|NOT COMPLETED|Transition From DB2 to OLE||1
11304551|NCT02592798|12502397|FG001|NOT COMPLETED|Transition From DB2 to OLE||0
11304552|NCT02592798|12502396|FG000|STARTED|Open Label Period (OLE)||10
11304553|NCT02592798|12502397|FG001|STARTED|Open Label Period (OLE)||13
11304554|NCT02592798|12502396|FG000|COMPLETED|Open Label Period (OLE)||6
11304555|NCT02592798|12502397|FG001|COMPLETED|Open Label Period (OLE)||4
11304556|NCT02592798|12502396|FG000|NOT COMPLETED|Open Label Period (OLE)||4
11304557|NCT02592798|12502397|FG001|NOT COMPLETED|Open Label Period (OLE)||9
11304558|NCT02592876|12502412|FG000|STARTED|Overall Study||41
11304559|NCT02592876|12502413|FG001|STARTED|Overall Study||40
11304560|NCT02592876|12502412|FG000|Received Study Drug|Overall Study||40
11304561|NCT02592876|12502413|FG001|Received Study Drug|Overall Study||40
11304562|NCT02592876|12502412|FG000|Completed Treatment|Overall Study||34
11304563|NCT02592876|12502413|FG001|Completed Treatment|Overall Study||32
11304564|NCT02592876|12502412|FG000|COMPLETED|Overall Study||0
11304565|NCT02592876|12502413|FG001|COMPLETED|Overall Study||0
11304566|NCT02592876|12502412|FG000|NOT COMPLETED|Overall Study||41
11304567|NCT02592876|12502413|FG001|NOT COMPLETED|Overall Study||40
11304568|NCT02593006|12502422|FG000|STARTED|Overall Study||257
11304569|NCT02593006|12502423|FG001|STARTED|Overall Study||100
11304570|NCT02593006|12502424|FG002|STARTED|Overall Study||43
11304571|NCT02593006|12502422|FG000|COMPLETED|Overall Study||250
11304572|NCT02593006|12502423|FG001|COMPLETED|Overall Study||93
11304573|NCT02593006|12502424|FG002|COMPLETED|Overall Study||38
11304574|NCT02593006|12502422|FG000|NOT COMPLETED|Overall Study||7
11304575|NCT02593006|12502423|FG001|NOT COMPLETED|Overall Study||7
11304576|NCT02593006|12502424|FG002|NOT COMPLETED|Overall Study||5
11304577|NCT02593032|12502435|FG000|STARTED|Overall Study||17
11304578|NCT02593032|12502436|FG001|STARTED|Overall Study||33
11304579|NCT02593032|12502435|FG000|COMPLETED|Overall Study||17
11304580|NCT02593032|12502436|FG001|COMPLETED|Overall Study||33
11304581|NCT02593032|12502435|FG000|NOT COMPLETED|Overall Study||0
11304582|NCT02593032|12502436|FG001|NOT COMPLETED|Overall Study||0
11304583|NCT02593097|12502444|FG000|STARTED|First Intervention (12 Weeks)||14
11304584|NCT02593097|12502445|FG001|STARTED|First Intervention (12 Weeks)||20
11304585|NCT02593097|12502444|FG000|Received Intervention|First Intervention (12 Weeks)||14
11304586|NCT02593097|12502445|FG001|Received Intervention|First Intervention (12 Weeks)||20
11304587|NCT02593097|12502444|FG000|COMPLETED|First Intervention (12 Weeks)||12
11304588|NCT02593097|12502445|FG001|COMPLETED|First Intervention (12 Weeks)||16
11304589|NCT02593097|12502444|FG000|NOT COMPLETED|First Intervention (12 Weeks)||2
11304590|NCT02593097|12502445|FG001|NOT COMPLETED|First Intervention (12 Weeks)||4
11304591|NCT02593097|12502444|FG000|STARTED|Washout (4 Weeks)||12
11304592|NCT02593097|12502445|FG001|STARTED|Washout (4 Weeks)||16
11304593|NCT02593097|12502444|FG000|COMPLETED|Washout (4 Weeks)||12
11304594|NCT02593097|12502445|FG001|COMPLETED|Washout (4 Weeks)||16
11304595|NCT02593097|12502444|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11304596|NCT02593097|12502445|FG001|NOT COMPLETED|Washout (4 Weeks)||0
11304597|NCT02593097|12502444|FG000|STARTED|Second Intervention (12 Weeks)||12
11304598|NCT02593097|12502445|FG001|STARTED|Second Intervention (12 Weeks)||16
11304599|NCT02593097|12502444|FG000|COMPLETED|Second Intervention (12 Weeks)||9
11304600|NCT02593097|12502445|FG001|COMPLETED|Second Intervention (12 Weeks)||15
11304601|NCT02593097|12502444|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||3
11304602|NCT02593097|12502445|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||1
11304603|NCT02593149|12502453|FG000|STARTED|Run-In||340
11304604|NCT02593149|12502454|FG001|STARTED|Run-In||361
11304605|NCT02593149|12502453|FG000|COMPLETED|Run-In||304
11304606|NCT02593149|12502454|FG001|COMPLETED|Run-In||323
11304607|NCT02593149|12502453|FG000|NOT COMPLETED|Run-In||36
11304608|NCT02593149|12502454|FG001|NOT COMPLETED|Run-In||38
11304609|NCT02593149|12502453|FG000|STARTED|Intervention||942
11304610|NCT02593149|12502454|FG001|STARTED|Intervention||960
11304611|NCT02593149|12502453|FG000|COMPLETED|Intervention||826
11304612|NCT02593149|12502454|FG001|COMPLETED|Intervention||845
11304613|NCT02593149|12502453|FG000|NOT COMPLETED|Intervention||116
11304614|NCT02593149|12502454|FG001|NOT COMPLETED|Intervention||115
11304615|NCT02593305|12502463|FG000|STARTED|Baseline 1||7
11304616|NCT02593305|12502464|FG001|STARTED|Baseline 1||6
11304617|NCT02593305|12502465|FG002|STARTED|Baseline 1||10
11304618|NCT02593305|12502463|FG000|COMPLETED|Baseline 1||7
11304619|NCT02593305|12502464|FG001|COMPLETED|Baseline 1||6
11304620|NCT02593305|12502465|FG002|COMPLETED|Baseline 1||10
11304621|NCT02593305|12502463|FG000|NOT COMPLETED|Baseline 1||0
11304622|NCT02593305|12502464|FG001|NOT COMPLETED|Baseline 1||0
11304623|NCT02593305|12502465|FG002|NOT COMPLETED|Baseline 1||0
11304624|NCT02593305|12502463|FG000|STARTED|Post 1||7
11304625|NCT02593305|12502464|FG001|STARTED|Post 1||6
11304626|NCT02593305|12502465|FG002|STARTED|Post 1||10
11304627|NCT02593305|12502463|FG000|COMPLETED|Post 1||7
11304628|NCT02593305|12502464|FG001|COMPLETED|Post 1||6
11304629|NCT02593305|12502465|FG002|COMPLETED|Post 1||0
11304630|NCT02593305|12502463|FG000|NOT COMPLETED|Post 1||0
11304631|NCT02593305|12502464|FG001|NOT COMPLETED|Post 1||0
11304632|NCT02593305|12502465|FG002|NOT COMPLETED|Post 1||10
11304633|NCT02593305|12502463|FG000|STARTED|Baseline 2||7
11304634|NCT02593305|12502464|FG001|STARTED|Baseline 2||6
11304635|NCT02593305|12502465|FG002|STARTED|Baseline 2||0
11304636|NCT02593305|12502463|FG000|COMPLETED|Baseline 2||7
11304637|NCT02593305|12502464|FG001|COMPLETED|Baseline 2||6
11304638|NCT02593305|12502465|FG002|COMPLETED|Baseline 2||0
11304639|NCT02593305|12502463|FG000|NOT COMPLETED|Baseline 2||0
11304640|NCT02593305|12502464|FG001|NOT COMPLETED|Baseline 2||0
11304641|NCT02593305|12502465|FG002|NOT COMPLETED|Baseline 2||0
11304642|NCT02593305|12502463|FG000|STARTED|Post 2||7
11304643|NCT02593305|12502464|FG001|STARTED|Post 2||6
11304644|NCT02593305|12502465|FG002|STARTED|Post 2||0
11304645|NCT02593305|12502463|FG000|COMPLETED|Post 2||7
11304646|NCT02593305|12502464|FG001|COMPLETED|Post 2||6
11304647|NCT02593305|12502465|FG002|COMPLETED|Post 2||0
11304648|NCT02593305|12502463|FG000|NOT COMPLETED|Post 2||0
11304649|NCT02593305|12502464|FG001|NOT COMPLETED|Post 2||0
11304650|NCT02593305|12502465|FG002|NOT COMPLETED|Post 2||0
11304651|NCT02593318|12502476|FG000|STARTED|Overall Study||16
11304652|NCT02593318|12502477|FG001|STARTED|Overall Study||16
11304653|NCT02593318|12502476|FG000|COMPLETED|Overall Study||15
11304654|NCT02593318|12502477|FG001|COMPLETED|Overall Study||15
11304655|NCT02593318|12502476|FG000|NOT COMPLETED|Overall Study||1
11304656|NCT02593318|12502477|FG001|NOT COMPLETED|Overall Study||1
11304657|NCT02593396|12502491|FG000|STARTED|Overall Study||40
11304658|NCT02593396|12502492|FG001|STARTED|Overall Study||40
11304659|NCT02593396|12502491|FG000|At Least Done One Efficacy Assessment|Overall Study||36
11304660|NCT02593396|12502492|FG001|At Least Done One Efficacy Assessment|Overall Study||36
11304661|NCT02593396|12502491|FG000|COMPLETED|Overall Study||25
11304662|NCT02593396|12502492|FG001|COMPLETED|Overall Study||26
11304663|NCT02593396|12502491|FG000|NOT COMPLETED|Overall Study||15
11304664|NCT02593396|12502492|FG001|NOT COMPLETED|Overall Study||14
11304665|NCT02593539|12502498|FG000|STARTED|Overall Study||5
11304666|NCT02593539|12502498|FG000|COMPLETED|Overall Study||4
11304667|NCT02593539|12502498|FG000|NOT COMPLETED|Overall Study||1
11304668|NCT02593630|12502505|FG000|STARTED|Overall Study||54
11304669|NCT02593630|12502505|FG000|COMPLETED|Overall Study||53
11304670|NCT02593630|12502505|FG000|NOT COMPLETED|Overall Study||1
11304671|NCT02593773|12502510|FG000|STARTED|Overall Study||86
11304672|NCT02593773|12502510|FG000|COMPLETED|Overall Study||51
11304673|NCT02593773|12502510|FG000|NOT COMPLETED|Overall Study||35
11304674|NCT02593825|12502516|FG000|STARTED|Intervention||67
11304675|NCT02593825|12502517|FG001|STARTED|Intervention||67
11304676|NCT02593825|12502516|FG000|COMPLETED|Intervention||57
11304677|NCT02593825|12502517|FG001|COMPLETED|Intervention||55
11304678|NCT02593825|12502516|FG000|NOT COMPLETED|Intervention||10
11304679|NCT02593825|12502517|FG001|NOT COMPLETED|Intervention||12
11304680|NCT02593825|12502516|FG000|STARTED|Follow-up||57
11304681|NCT02593825|12502517|FG001|STARTED|Follow-up||55
11304682|NCT02593825|12502516|FG000|COMPLETED|Follow-up||57
11304683|NCT02593825|12502517|FG001|COMPLETED|Follow-up||55
11304684|NCT02593825|12502516|FG000|NOT COMPLETED|Follow-up||0
11304685|NCT02593825|12502517|FG001|NOT COMPLETED|Follow-up||0
11304686|NCT02593864|12502525|FG000|STARTED|Overall Study||25
11304687|NCT02593864|12502525|FG000|COMPLETED|Overall Study||19
11304688|NCT02593864|12502525|FG000|NOT COMPLETED|Overall Study||6
11341773|NCT02937558|12539219|FG001|NOT COMPLETED|Open-label Phase||0
11341774|NCT02937584|12539226|FG000|STARTED|Period 1||11
11341775|NCT02937584|12539227|FG001|STARTED|Period 1||12
11341776|NCT02937584|12539226|FG000|COMPLETED|Period 1||10
11341777|NCT02937584|12539227|FG001|COMPLETED|Period 1||10
11341778|NCT02937584|12539226|FG000|NOT COMPLETED|Period 1||1
11341779|NCT02937584|12539227|FG001|NOT COMPLETED|Period 1||2
11341780|NCT02937584|12539226|FG000|STARTED|Washout||10
11341781|NCT02937584|12539227|FG001|STARTED|Washout||10
11341782|NCT02937584|12539226|FG000|COMPLETED|Washout||10
11341783|NCT02937584|12539227|FG001|COMPLETED|Washout||9
11341784|NCT02937584|12539226|FG000|NOT COMPLETED|Washout||0
11341785|NCT02937584|12539227|FG001|NOT COMPLETED|Washout||1
11341786|NCT02937584|12539226|FG000|STARTED|Period 2||10
11341787|NCT02937584|12539227|FG001|STARTED|Period 2||9
11341788|NCT02937584|12539226|FG000|COMPLETED|Period 2||10
11341789|NCT02937584|12539227|FG001|COMPLETED|Period 2||9
11341790|NCT02937584|12539226|FG000|NOT COMPLETED|Period 2||0
11341791|NCT02937584|12539227|FG001|NOT COMPLETED|Period 2||0
11341792|NCT02937623|12539235|FG000|STARTED|Overall Study||60
11341793|NCT02937623|12539236|FG001|STARTED|Overall Study||60
11341794|NCT02937623|12539235|FG000|COMPLETED|Overall Study||60
11341795|NCT02937623|12539236|FG001|COMPLETED|Overall Study||60
11341796|NCT02937623|12539235|FG000|NOT COMPLETED|Overall Study||0
11143853|NCT01474538|12330471|FG000|STARTED|Treatment Period 2||57
11143854|NCT01474538|12330472|FG001|STARTED|Treatment Period 2||58
11341797|NCT02937623|12539236|FG001|NOT COMPLETED|Overall Study||0
11341798|NCT02937636|12539244|FG000|STARTED|Overall Study||63
11341799|NCT02937636|12539245|FG001|STARTED|Overall Study||65
11341800|NCT02937636|12539244|FG000|COMPLETED|Overall Study||60
11341801|NCT02937636|12539245|FG001|COMPLETED|Overall Study||63
11143855|NCT01474538|12330471|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
11341802|NCT02937636|12539244|FG000|NOT COMPLETED|Overall Study||3
11341803|NCT02937636|12539245|FG001|NOT COMPLETED|Overall Study||2
11341804|NCT02937701|12539254|FG000|STARTED|Day 1 to Week 22||279
11341805|NCT02937701|12539255|FG001|STARTED|Day 1 to Week 22||279
11341806|NCT02937701|12539256|FG002|STARTED|Day 1 to Week 22||0
11341807|NCT02937701|12539257|FG003|STARTED|Day 1 to Week 22||0
11341808|NCT02937701|12539258|FG004|STARTED|Day 1 to Week 22||0
11341809|NCT02937701|12539254|FG000|Received Treatment|Day 1 to Week 22||278
11341810|NCT02937701|12539255|FG001|Received Treatment|Day 1 to Week 22||278
11341811|NCT02937701|12539256|FG002|Received Treatment|Day 1 to Week 22||0
11341812|NCT02937701|12539257|FG003|Received Treatment|Day 1 to Week 22||0
11341813|NCT02937701|12539258|FG004|Received Treatment|Day 1 to Week 22||0
11341814|NCT02937701|12539254|FG000|COMPLETED|Day 1 to Week 22||244
11341815|NCT02937701|12539255|FG001|COMPLETED|Day 1 to Week 22||240
11341816|NCT02937701|12539256|FG002|COMPLETED|Day 1 to Week 22||0
11341817|NCT02937701|12539257|FG003|COMPLETED|Day 1 to Week 22||0
11341818|NCT02937701|12539258|FG004|COMPLETED|Day 1 to Week 22||0
11341819|NCT02937701|12539254|FG000|NOT COMPLETED|Day 1 to Week 22||35
11341820|NCT02937701|12539255|FG001|NOT COMPLETED|Day 1 to Week 22||39
11341821|NCT02937701|12539256|FG002|NOT COMPLETED|Day 1 to Week 22||0
11341822|NCT02937701|12539257|FG003|NOT COMPLETED|Day 1 to Week 22||0
11341823|NCT02937701|12539258|FG004|NOT COMPLETED|Day 1 to Week 22||0
11341824|NCT02937701|12539254|FG000|STARTED|Week 22 to Week 50||0
11341825|NCT02937701|12539255|FG001|STARTED|Week 22 to Week 50||0
11341826|NCT02937701|12539256|FG002|STARTED|Week 22 to Week 50||244
11341827|NCT02937701|12539257|FG003|STARTED|Week 22 to Week 50||121
11341828|NCT02937701|12539258|FG004|STARTED|Week 22 to Week 50||119
11341829|NCT02937701|12539254|FG000|COMPLETED|Week 22 to Week 50||0
11341830|NCT02937701|12539255|FG001|COMPLETED|Week 22 to Week 50||0
11341831|NCT02937701|12539256|FG002|COMPLETED|Week 22 to Week 50||212
11304689|NCT04142242|12502535|FG000|STARTED|Overall Study||139
11304690|NCT04142242|12502536|FG001|STARTED|Overall Study||176
11304691|NCT04142242|12502537|FG002|STARTED|Overall Study||31
11304692|NCT04142242|12502538|FG003|STARTED|Overall Study||39
11304693|NCT04142242|12502539|FG004|STARTED|Overall Study||26
11304694|NCT04142242|12502540|FG005|STARTED|Overall Study||60
11304695|NCT04142242|12502535|FG000|Vaccinated|Overall Study||138
11304696|NCT04142242|12502536|FG001|Vaccinated|Overall Study||175
11304697|NCT04142242|12502537|FG002|Vaccinated|Overall Study||0
11304698|NCT04142242|12502538|FG003|Vaccinated|Overall Study||0
11304699|NCT04142242|12502539|FG004|Vaccinated|Overall Study||0
11401386|NCT04117607|12596159|FG005|Received Study Product|Overall Study||0
11401387|NCT04117607|12596160|FG006|Received Study Product|Overall Study||3
11401388|NCT04117607|12596161|FG007|Received Study Product|Overall Study||0
11401389|NCT04117607|12596162|FG008|Received Study Product|Overall Study||0
11401390|NCT04117607|12596163|FG009|Received Study Product|Overall Study||0
11401391|NCT04117607|12596164|FG010|Received Study Product|Overall Study||0
11401392|NCT04117607|12596165|FG011|Received Study Product|Overall Study||0
11401393|NCT04117607|12596166|FG012|Received Study Product|Overall Study||0
11401394|NCT04117607|12596167|FG013|Received Study Product|Overall Study||0
11401395|NCT04117607|12596154|FG000|Completed All PK Blood Draws|Overall Study||0
11401396|NCT04117607|12596155|FG001|Completed All PK Blood Draws|Overall Study||6
11401397|NCT04117607|12596156|FG002|Completed All PK Blood Draws|Overall Study||0
11401398|NCT04117607|12596157|FG003|Completed All PK Blood Draws|Overall Study||0
11401399|NCT04117607|12596158|FG004|Completed All PK Blood Draws|Overall Study||0
11401400|NCT04117607|12596159|FG005|Completed All PK Blood Draws|Overall Study||0
11401401|NCT04117607|12596160|FG006|Completed All PK Blood Draws|Overall Study||1
11401402|NCT04117607|12596161|FG007|Completed All PK Blood Draws|Overall Study||0
11401403|NCT04117607|12596162|FG008|Completed All PK Blood Draws|Overall Study||0
11401404|NCT04117607|12596163|FG009|Completed All PK Blood Draws|Overall Study||0
11401405|NCT04117607|12596164|FG010|Completed All PK Blood Draws|Overall Study||0
11401406|NCT04117607|12596165|FG011|Completed All PK Blood Draws|Overall Study||0
11401407|NCT04117607|12596166|FG012|Completed All PK Blood Draws|Overall Study||0
11401408|NCT04117607|12596167|FG013|Completed All PK Blood Draws|Overall Study||0
11401409|NCT04117607|12596154|FG000|COMPLETED|Overall Study||3
11401410|NCT04117607|12596155|FG001|COMPLETED|Overall Study||6
11401411|NCT04117607|12596156|FG002|COMPLETED|Overall Study||0
11401412|NCT04117607|12596157|FG003|COMPLETED|Overall Study||0
11401413|NCT04117607|12596158|FG004|COMPLETED|Overall Study||0
11401414|NCT04117607|12596159|FG005|COMPLETED|Overall Study||0
11401415|NCT04117607|12596160|FG006|COMPLETED|Overall Study||3
11401416|NCT04117607|12596161|FG007|COMPLETED|Overall Study||0
11401417|NCT04117607|12596162|FG008|COMPLETED|Overall Study||0
11401418|NCT04117607|12596163|FG009|COMPLETED|Overall Study||0
11401419|NCT04117607|12596164|FG010|COMPLETED|Overall Study||0
11401420|NCT04117607|12596165|FG011|COMPLETED|Overall Study||0
11401421|NCT04117607|12596166|FG012|COMPLETED|Overall Study||0
11401422|NCT04117607|12596167|FG013|COMPLETED|Overall Study||0
11401423|NCT04117607|12596154|FG000|NOT COMPLETED|Overall Study||0
11401424|NCT04117607|12596155|FG001|NOT COMPLETED|Overall Study||1
11401425|NCT04117607|12596156|FG002|NOT COMPLETED|Overall Study||0
11401426|NCT04117607|12596157|FG003|NOT COMPLETED|Overall Study||0
11401427|NCT04117607|12596158|FG004|NOT COMPLETED|Overall Study||0
11401428|NCT04117607|12596159|FG005|NOT COMPLETED|Overall Study||0
11401429|NCT04117607|12596160|FG006|NOT COMPLETED|Overall Study||1
11401430|NCT04117607|12596161|FG007|NOT COMPLETED|Overall Study||0
11401431|NCT04117607|12596162|FG008|NOT COMPLETED|Overall Study||0
11401432|NCT04117607|12596163|FG009|NOT COMPLETED|Overall Study||0
11401433|NCT04117607|12596164|FG010|NOT COMPLETED|Overall Study||0
11401434|NCT04117607|12596165|FG011|NOT COMPLETED|Overall Study||0
11401435|NCT04117607|12596166|FG012|NOT COMPLETED|Overall Study||0
11401436|NCT04117607|12596167|FG013|NOT COMPLETED|Overall Study||0
11401437|NCT04116684|12596185|FG000|STARTED|Overall Study||3
11401438|NCT04116684|12596186|FG001|STARTED|Overall Study||1
11401439|NCT04116684|12596185|FG000|COMPLETED|Overall Study||1
11401440|NCT04116684|12596186|FG001|COMPLETED|Overall Study||1
11401441|NCT04116684|12596185|FG000|NOT COMPLETED|Overall Study||2
11401442|NCT04116684|12596186|FG001|NOT COMPLETED|Overall Study||0
11304700|NCT04142242|12502540|FG005|Vaccinated|Overall Study||0
11304701|NCT04142242|12502535|FG000|Full Analysis Set (FAS)|Overall Study||138
11304702|NCT04142242|12502536|FG001|Full Analysis Set (FAS)|Overall Study||175
11304703|NCT04142242|12502537|FG002|Full Analysis Set (FAS)|Overall Study||31
11304704|NCT04142242|12502538|FG003|Full Analysis Set (FAS)|Overall Study||39
11304705|NCT04142242|12502539|FG004|Full Analysis Set (FAS)|Overall Study||26
11304706|NCT04142242|12502540|FG005|Full Analysis Set (FAS)|Overall Study||59
11304707|NCT04142242|12502535|FG000|Safety Analysis Set (SAfAS)|Overall Study|1 MenACYW Conjugate vaccine-primed participant was erroneously assigned by Investigator to Group 1 but per planned analysis was counted in Group 2 for safety analysis.|151
11304708|NCT04142242|12502536|FG001|Safety Analysis Set (SAfAS)|Overall Study|14 Menomune-primed participants were erroneously assigned by Investigator to Group 2 but per planned analysis they were counted in Group 1 for safety analysis.|162
11304709|NCT04142242|12502537|FG002|Safety Analysis Set (SAfAS)|Overall Study||0
11304710|NCT04142242|12502538|FG003|Safety Analysis Set (SAfAS)|Overall Study||0
11304711|NCT04142242|12502539|FG004|Safety Analysis Set (SAfAS)|Overall Study||0
11304712|NCT04142242|12502540|FG005|Safety Analysis Set (SAfAS)|Overall Study||0
11304713|NCT04142242|12502535|FG000|COMPLETED|Overall Study||138
11304714|NCT04142242|12502536|FG001|COMPLETED|Overall Study||175
11304715|NCT04142242|12502537|FG002|COMPLETED|Overall Study||0
11304716|NCT04142242|12502538|FG003|COMPLETED|Overall Study||0
11304717|NCT04142242|12502539|FG004|COMPLETED|Overall Study||26
11304718|NCT04142242|12502540|FG005|COMPLETED|Overall Study||59
11304719|NCT04142242|12502535|FG000|NOT COMPLETED|Overall Study||1
11304720|NCT04142242|12502536|FG001|NOT COMPLETED|Overall Study||1
11304721|NCT04142242|12502537|FG002|NOT COMPLETED|Overall Study||31
11304722|NCT04142242|12502538|FG003|NOT COMPLETED|Overall Study||39
11304723|NCT04142242|12502539|FG004|NOT COMPLETED|Overall Study||0
11304724|NCT04142242|12502540|FG005|NOT COMPLETED|Overall Study||1
11304725|NCT04087122|12502553|FG000|STARTED|Overall Study||20
11304726|NCT04087122|12502553|FG000|COMPLETED|Overall Study||20
11304727|NCT04087122|12502553|FG000|NOT COMPLETED|Overall Study||0
11304728|NCT03990389|12502561|FG000|STARTED|Overall Study||15
11022109|NCT00807885|12200372|FG000|COMPLETED|Overall Study||10
11022110|NCT00807885|12200373|FG001|COMPLETED|Overall Study||11
11022111|NCT00807885|12200374|FG002|COMPLETED|Overall Study||11
11022112|NCT00807885|12200375|FG003|COMPLETED|Overall Study||10
11022113|NCT00807885|12200376|FG004|COMPLETED|Overall Study||12
11022114|NCT00807885|12200377|FG005|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
11304729|NCT03990389|12502562|FG001|STARTED|Overall Study||16
11304730|NCT03990389|12502561|FG000|COMPLETED|Overall Study||12
11304731|NCT03990389|12502562|FG001|COMPLETED|Overall Study||16
11304732|NCT03990389|12502561|FG000|NOT COMPLETED|Overall Study||3
11304733|NCT03990389|12502562|FG001|NOT COMPLETED|Overall Study||0
11304734|NCT03939312|12502568|FG000|STARTED|OL Treatment Period (40 Weeks)||685
11304735|NCT03939312|12502568|FG000|COMPLETED|OL Treatment Period (40 Weeks)||511
11304736|NCT03939312|12502568|FG000|NOT COMPLETED|OL Treatment Period (40 Weeks)||174
11304737|NCT03939312|12502568|FG000|STARTED|Safety Follow-up 4 Weeks (Up to Week 44)|Out of 685 participants, 640 participants who received treatment including 511 participants who completed the treatment entered safety follow-up period.|640
11304738|NCT03939312|12502568|FG000|COMPLETED|Safety Follow-up 4 Weeks (Up to Week 44)||624
11304739|NCT03939312|12502568|FG000|NOT COMPLETED|Safety Follow-up 4 Weeks (Up to Week 44)||16
11304740|NCT03934541|12502578|FG000|STARTED|Overall Study||5
11304741|NCT03934541|12502579|FG001|STARTED|Overall Study||15
11304742|NCT03934541|12502580|FG002|STARTED|Overall Study||1
11304743|NCT03934541|12502581|FG003|STARTED|Overall Study||3
11304744|NCT03934541|12502578|FG000|COMPLETED|Overall Study||5
11304745|NCT03934541|12502579|FG001|COMPLETED|Overall Study||14
11304746|NCT03934541|12502580|FG002|COMPLETED|Overall Study||1
11304747|NCT03934541|12502581|FG003|COMPLETED|Overall Study||3
11304748|NCT03934541|12502578|FG000|NOT COMPLETED|Overall Study||0
11304749|NCT03934541|12502579|FG001|NOT COMPLETED|Overall Study||1
11304750|NCT03934541|12502580|FG002|NOT COMPLETED|Overall Study||0
11304751|NCT03934541|12502581|FG003|NOT COMPLETED|Overall Study||0
11341832|NCT02937701|12539257|FG003|COMPLETED|Week 22 to Week 50||113
11341833|NCT02937701|12539258|FG004|COMPLETED|Week 22 to Week 50||110
11341834|NCT02937701|12539254|FG000|NOT COMPLETED|Week 22 to Week 50||0
11341835|NCT02937701|12539255|FG001|NOT COMPLETED|Week 22 to Week 50||0
11022115|NCT00807885|12200378|FG006|COMPLETED|Overall Study||12
11022116|NCT00807885|12200379|FG007|COMPLETED|Overall Study||11
11022117|NCT00807885|12200380|FG008|COMPLETED|Overall Study||11
11022118|NCT00807885|12200372|FG000|NOT COMPLETED|Overall Study||0
11022119|NCT00807885|12200373|FG001|NOT COMPLETED|Overall Study||0
11341836|NCT02937701|12539256|FG002|NOT COMPLETED|Week 22 to Week 50||32
11341837|NCT02937701|12539257|FG003|NOT COMPLETED|Week 22 to Week 50||8
11341838|NCT02937701|12539258|FG004|NOT COMPLETED|Week 22 to Week 50||9
11341839|NCT02937740|12539272|FG000|STARTED|BID for 90 Days, 22 mg/Day||24
11341840|NCT02937740|12539273|FG001|STARTED|BID for 90 Days, 22 mg/Day||93
11341841|NCT02937740|12539272|FG000|COMPLETED|BID for 90 Days, 22 mg/Day||19
11341842|NCT02937740|12539273|FG001|COMPLETED|BID for 90 Days, 22 mg/Day||62
11341843|NCT02937740|12539272|FG000|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5
11341844|NCT02937740|12539273|FG001|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31
11341845|NCT02937740|12539272|FG000|STARTED|Uptitrated to TID on Day 90 for 30 Days||13
11341846|NCT02937740|12539273|FG001|STARTED|Uptitrated to TID on Day 90 for 30 Days||17
11341847|NCT02937740|12539272|FG000|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12
11341848|NCT02937740|12539273|FG001|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15
11341849|NCT02937740|12539272|FG000|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1
11341850|NCT02937740|12539273|FG001|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2
11341851|NCT02937870|12539285|FG000|STARTED|Overall Study||23
11341852|NCT02937870|12539285|FG000|Received Test Adhesive 1|Overall Study||21
11341853|NCT02937870|12539285|FG000|Received Test Adhesive 2|Overall Study||22
11341854|NCT02937870|12539285|FG000|Received Positive Control Adhesive|Overall Study||21
11341855|NCT02937870|12539285|FG000|Received no Adhesive|Overall Study||20
11341856|NCT02937870|12539285|FG000|COMPLETED|Overall Study||20
11341857|NCT02937870|12539285|FG000|NOT COMPLETED|Overall Study||3
11341858|NCT02938052|12539299|FG000|STARTED|Overall Study||10
11341859|NCT02938052|12539299|FG000|COMPLETED|Overall Study||10
11341860|NCT02938052|12539299|FG000|NOT COMPLETED|Overall Study||0
11341861|NCT02938169|12539308|FG000|STARTED|Overall Study||15
11341862|NCT02938169|12539309|FG001|STARTED|Overall Study||15
11341863|NCT02938169|12539310|FG002|STARTED|Overall Study||15
11341864|NCT02938169|12539311|FG003|STARTED|Overall Study||15
11341865|NCT02938169|12539308|FG000|COMPLETED|Overall Study||13
11341866|NCT02938169|12539309|FG001|COMPLETED|Overall Study||13
11341867|NCT02938169|12539310|FG002|COMPLETED|Overall Study||10
11341868|NCT02938169|12539311|FG003|COMPLETED|Overall Study||12
11341869|NCT02938169|12539308|FG000|NOT COMPLETED|Overall Study||2
11304752|NCT03895034|12502591|FG000|STARTED|Overall Study||66
11304753|NCT03895034|12502591|FG000|COMPLETED|Overall Study||64
11304754|NCT03895034|12502591|FG000|NOT COMPLETED|Overall Study||2
11304755|NCT03870477|12502595|FG000|STARTED|Overall Study||1
11304756|NCT03870477|12502595|FG000|COMPLETED|Overall Study||0
11304757|NCT03870477|12502595|FG000|NOT COMPLETED|Overall Study||1
11304758|NCT03351244|12502602|FG000|STARTED|Overall Study||89
11304759|NCT03351244|12502603|FG001|STARTED|Overall Study||88
11304760|NCT03351244|12502604|FG002|STARTED|Overall Study||87
11304761|NCT03351244|12502602|FG000|COMPLETED|Overall Study||62
11304762|NCT03351244|12502603|FG001|COMPLETED|Overall Study||48
11304763|NCT03351244|12502604|FG002|COMPLETED|Overall Study||53
11304764|NCT03351244|12502602|FG000|NOT COMPLETED|Overall Study||27
11304765|NCT03351244|12502603|FG001|NOT COMPLETED|Overall Study||40
11304766|NCT03351244|12502604|FG002|NOT COMPLETED|Overall Study||34
11304767|NCT03084666|12502616|FG000|STARTED|Overall Study||20
11304768|NCT03084666|12502617|FG001|STARTED|Overall Study||20
11304769|NCT03084666|12502616|FG000|COMPLETED|Overall Study||20
11304770|NCT03084666|12502617|FG001|COMPLETED|Overall Study||20
11304771|NCT03084666|12502616|FG000|NOT COMPLETED|Overall Study||0
11304772|NCT03084666|12502617|FG001|NOT COMPLETED|Overall Study||0
11304773|NCT02982954|12502627|FG000|STARTED|Treatment Period||106
11304774|NCT02982954|12502628|FG001|STARTED|Treatment Period||52
11304775|NCT02982954|12502629|FG002|STARTED|Treatment Period||28
11304776|NCT02982954|12502630|FG003|STARTED|Treatment Period||25
11304777|NCT02982954|12502627|FG000|COMPLETED|Treatment Period||0
11304778|NCT02982954|12502628|FG001|COMPLETED|Treatment Period||0
11304779|NCT02982954|12502629|FG002|COMPLETED|Treatment Period||0
11304780|NCT02982954|12502630|FG003|COMPLETED|Treatment Period||0
11304781|NCT02982954|12502627|FG000|NOT COMPLETED|Treatment Period||106
11304782|NCT02982954|12502628|FG001|NOT COMPLETED|Treatment Period||52
11304783|NCT02982954|12502629|FG002|NOT COMPLETED|Treatment Period||28
11304784|NCT02982954|12502630|FG003|NOT COMPLETED|Treatment Period||25
11304785|NCT02982954|12502627|FG000|STARTED|Continuing in Study||106
11304786|NCT02982954|12502628|FG001|STARTED|Continuing in Study||52
11304787|NCT02982954|12502629|FG002|STARTED|Continuing in Study||28
11304788|NCT02982954|12502630|FG003|STARTED|Continuing in Study||25
11304789|NCT02982954|12502627|FG000|COMPLETED|Continuing in Study||52
11304790|NCT02982954|12502628|FG001|COMPLETED|Continuing in Study||19
11304791|NCT02982954|12502629|FG002|COMPLETED|Continuing in Study||17
11304792|NCT02982954|12502630|FG003|COMPLETED|Continuing in Study||7
11304793|NCT02982954|12502627|FG000|NOT COMPLETED|Continuing in Study||54
11304794|NCT02982954|12502628|FG001|NOT COMPLETED|Continuing in Study||33
11304795|NCT02982954|12502629|FG002|NOT COMPLETED|Continuing in Study||11
11304796|NCT02982954|12502630|FG003|NOT COMPLETED|Continuing in Study||18
11304797|NCT02727699|12502642|FG000|STARTED|Overall Study||91
11304798|NCT02727699|12502643|FG001|STARTED|Overall Study||94
11304799|NCT02727699|12502642|FG000|COMPLETED|Overall Study||82
11304800|NCT02727699|12502643|FG001|COMPLETED|Overall Study||89
11304801|NCT02727699|12502642|FG000|NOT COMPLETED|Overall Study||9
11304802|NCT02727699|12502643|FG001|NOT COMPLETED|Overall Study||5
11304803|NCT02429375|12502652|FG000|STARTED|Overall Study||3
11304804|NCT02429375|12502653|FG001|STARTED|Overall Study||3
11304805|NCT02429375|12502654|FG002|STARTED|Overall Study||1
11304806|NCT02429375|12502652|FG000|COMPLETED|Overall Study||3
11304807|NCT02429375|12502653|FG001|COMPLETED|Overall Study||3
11304808|NCT02429375|12502654|FG002|COMPLETED|Overall Study||1
11304809|NCT02429375|12502652|FG000|NOT COMPLETED|Overall Study||0
11304810|NCT02429375|12502653|FG001|NOT COMPLETED|Overall Study||0
11304811|NCT02429375|12502654|FG002|NOT COMPLETED|Overall Study||0
11341870|NCT02938169|12539309|FG001|NOT COMPLETED|Overall Study||2
11341871|NCT02938169|12539310|FG002|NOT COMPLETED|Overall Study||5
11341872|NCT02938169|12539311|FG003|NOT COMPLETED|Overall Study||3
11341873|NCT02938494|12539332|FG000|STARTED|Overall Study||69
11341874|NCT02938494|12539333|FG001|STARTED|Overall Study||72
11341875|NCT02938494|12539334|FG002|STARTED|Overall Study||34
11341876|NCT02938494|12539335|FG003|STARTED|Overall Study||35
11341877|NCT02938494|12539332|FG000|COMPLETED|Overall Study||65
11341878|NCT02938494|12539333|FG001|COMPLETED|Overall Study||63
11341879|NCT02938494|12539334|FG002|COMPLETED|Overall Study||30
11341880|NCT02938494|12539335|FG003|COMPLETED|Overall Study||31
11341881|NCT02938494|12539332|FG000|NOT COMPLETED|Overall Study||4
11341882|NCT02938494|12539333|FG001|NOT COMPLETED|Overall Study||9
11341883|NCT02938494|12539334|FG002|NOT COMPLETED|Overall Study||4
11341884|NCT02938494|12539335|FG003|NOT COMPLETED|Overall Study||4
11341885|NCT02938585|12539348|FG000|STARTED|Overall Study||9
11341886|NCT02938585|12539349|FG001|STARTED|Overall Study||33
11341887|NCT02938585|12539350|FG002|STARTED|Overall Study||11
11341888|NCT02938585|12539351|FG003|STARTED|Overall Study||15
11341889|NCT02938585|12539348|FG000|Exposed to Prophylaxis Regimen|Overall Study||9
11341890|NCT02938585|12539349|FG001|Exposed to Prophylaxis Regimen|Overall Study||31
11341891|NCT02938585|12539350|FG002|Exposed to Prophylaxis Regimen|Overall Study||11
11341892|NCT02938585|12539351|FG003|Exposed to Prophylaxis Regimen|Overall Study||12
11341893|NCT02938585|12539348|FG000|Exposed to On-demand Regimen|Overall Study||1
11341894|NCT02938585|12539349|FG001|Exposed to On-demand Regimen|Overall Study||7
11341895|NCT02938585|12539350|FG002|Exposed to On-demand Regimen|Overall Study||1
11341896|NCT02938585|12539351|FG003|Exposed to On-demand Regimen|Overall Study||8
11341897|NCT02938585|12539348|FG000|COMPLETED|Overall Study||9
11341898|NCT02938585|12539349|FG001|COMPLETED|Overall Study||32
11341899|NCT02938585|12539350|FG002|COMPLETED|Overall Study||11
11341900|NCT02938585|12539351|FG003|COMPLETED|Overall Study||10
11304812|NCT02230254|12502663|FG000|STARTED|Overall Study||101
11304813|NCT02230254|12502663|FG000|COMPLETED|Overall Study||98
11304814|NCT02230254|12502663|FG000|NOT COMPLETED|Overall Study||3
11304815|NCT01891396|12502670|FG000|STARTED|Overall Study||149
11304816|NCT01891396|12502671|FG001|STARTED|Overall Study||150
11304817|NCT01891396|12502672|FG002|STARTED|Overall Study||69
11304818|NCT01891396|12502670|FG000|Received Study Injection|Overall Study||149
11304819|NCT01891396|12502671|FG001|Received Study Injection|Overall Study||150
11304820|NCT01891396|12502672|FG002|Received Study Injection|Overall Study||69
11304821|NCT01891396|12502670|FG000|COMPLETED|Overall Study||145
11304822|NCT01891396|12502671|FG001|COMPLETED|Overall Study||145
11304823|NCT01891396|12502672|FG002|COMPLETED|Overall Study||66
11304824|NCT01891396|12502670|FG000|NOT COMPLETED|Overall Study||4
11304825|NCT01891396|12502671|FG001|NOT COMPLETED|Overall Study||5
11304826|NCT01891396|12502672|FG002|NOT COMPLETED|Overall Study||3
11304827|NCT01525901|12502688|FG000|STARTED|Period 1: 12 Weeks||5
11304828|NCT01525901|12502689|FG001|STARTED|Period 1: 12 Weeks||4
11304829|NCT01525901|12502690|FG002|STARTED|Period 1: 12 Weeks||5
11304830|NCT01525901|12502691|FG003|STARTED|Period 1: 12 Weeks||5
11304831|NCT01525901|12502688|FG000|COMPLETED|Period 1: 12 Weeks||5
11304832|NCT01525901|12502689|FG001|COMPLETED|Period 1: 12 Weeks||4
11304833|NCT01525901|12502690|FG002|COMPLETED|Period 1: 12 Weeks||5
11304834|NCT01525901|12502691|FG003|COMPLETED|Period 1: 12 Weeks||5
11304835|NCT01525901|12502688|FG000|NOT COMPLETED|Period 1: 12 Weeks||0
11304836|NCT01525901|12502689|FG001|NOT COMPLETED|Period 1: 12 Weeks||0
11304837|NCT01525901|12502690|FG002|NOT COMPLETED|Period 1: 12 Weeks||0
11304838|NCT01525901|12502691|FG003|NOT COMPLETED|Period 1: 12 Weeks||0
11304839|NCT01525901|12502688|FG000|STARTED|Washout 4 Weeks||5
11304840|NCT01525901|12502689|FG001|STARTED|Washout 4 Weeks||4
11304841|NCT01525901|12502690|FG002|STARTED|Washout 4 Weeks||5
11304842|NCT01525901|12502691|FG003|STARTED|Washout 4 Weeks||5
11304843|NCT01525901|12502688|FG000|COMPLETED|Washout 4 Weeks||5
11022120|NCT00807885|12200374|FG002|NOT COMPLETED|Overall Study||0
11022121|NCT00807885|12200375|FG003|NOT COMPLETED|Overall Study||0
11022122|NCT00807885|12200376|FG004|NOT COMPLETED|Overall Study||0
11304844|NCT01525901|12502689|FG001|COMPLETED|Washout 4 Weeks||4
11304845|NCT01525901|12502690|FG002|COMPLETED|Washout 4 Weeks||5
11304846|NCT01525901|12502691|FG003|COMPLETED|Washout 4 Weeks||5
11304847|NCT01525901|12502688|FG000|NOT COMPLETED|Washout 4 Weeks||0
11304848|NCT01525901|12502689|FG001|NOT COMPLETED|Washout 4 Weeks||0
11304849|NCT01525901|12502690|FG002|NOT COMPLETED|Washout 4 Weeks||0
11304850|NCT01525901|12502691|FG003|NOT COMPLETED|Washout 4 Weeks||0
11304851|NCT01525901|12502688|FG000|STARTED|Period 2: 12 Weeks||5
11304852|NCT01525901|12502689|FG001|STARTED|Period 2: 12 Weeks||4
11304853|NCT01525901|12502690|FG002|STARTED|Period 2: 12 Weeks||5
11304854|NCT01525901|12502691|FG003|STARTED|Period 2: 12 Weeks||5
11304855|NCT01525901|12502688|FG000|COMPLETED|Period 2: 12 Weeks||5
11304856|NCT01525901|12502689|FG001|COMPLETED|Period 2: 12 Weeks||3
11304857|NCT01525901|12502690|FG002|COMPLETED|Period 2: 12 Weeks||5
11304858|NCT01525901|12502691|FG003|COMPLETED|Period 2: 12 Weeks||5
11304859|NCT01525901|12502688|FG000|NOT COMPLETED|Period 2: 12 Weeks||0
11304860|NCT01525901|12502689|FG001|NOT COMPLETED|Period 2: 12 Weeks||1
11304861|NCT01525901|12502690|FG002|NOT COMPLETED|Period 2: 12 Weeks||0
11304862|NCT01525901|12502691|FG003|NOT COMPLETED|Period 2: 12 Weeks||0
11304863|NCT01354431|12502704|FG000|STARTED|Pre-Treatment Period||60
11304864|NCT01354431|12502705|FG001|STARTED|Pre-Treatment Period||54
11304865|NCT01354431|12502706|FG002|STARTED|Pre-Treatment Period||54
11304866|NCT01354431|12502704|FG000|COMPLETED|Pre-Treatment Period||59
11304867|NCT01354431|12502705|FG001|COMPLETED|Pre-Treatment Period||54
11304868|NCT01354431|12502706|FG002|COMPLETED|Pre-Treatment Period||54
11304869|NCT01354431|12502704|FG000|NOT COMPLETED|Pre-Treatment Period||1
11304870|NCT01354431|12502705|FG001|NOT COMPLETED|Pre-Treatment Period||0
11304871|NCT01354431|12502706|FG002|NOT COMPLETED|Pre-Treatment Period||0
11304872|NCT01354431|12502704|FG000|STARTED|Treatment Period||59
11304873|NCT01354431|12502705|FG001|STARTED|Treatment Period||54
11304874|NCT01354431|12502706|FG002|STARTED|Treatment Period||54
11304875|NCT01354431|12502704|FG000|COMPLETED|Treatment Period||0
11304876|NCT01354431|12502705|FG001|COMPLETED|Treatment Period||0
11304877|NCT01354431|12502706|FG002|COMPLETED|Treatment Period||0
11304878|NCT01354431|12502704|FG000|NOT COMPLETED|Treatment Period||59
11304879|NCT01354431|12502705|FG001|NOT COMPLETED|Treatment Period||54
11304880|NCT01354431|12502706|FG002|NOT COMPLETED|Treatment Period||54
11304881|NCT01003691|12502718|FG000|STARTED|Overall Study||6
11304882|NCT01003691|12502719|FG001|STARTED|Overall Study||6
11304883|NCT01003691|12502720|FG002|STARTED|Overall Study||6
11304884|NCT01003691|12502721|FG003|STARTED|Overall Study||6
11304885|NCT01003691|12502718|FG000|COMPLETED|Overall Study||6
11304886|NCT01003691|12502719|FG001|COMPLETED|Overall Study||6
11304887|NCT01003691|12502720|FG002|COMPLETED|Overall Study||6
11304888|NCT01003691|12502721|FG003|COMPLETED|Overall Study||5
11304889|NCT01003691|12502718|FG000|NOT COMPLETED|Overall Study||0
11304890|NCT01003691|12502719|FG001|NOT COMPLETED|Overall Study||0
11304891|NCT01003691|12502720|FG002|NOT COMPLETED|Overall Study||0
11304892|NCT01003691|12502721|FG003|NOT COMPLETED|Overall Study||1
11304893|NCT02593903|12502734|FG000|STARTED|Overall Study||35
11304894|NCT02593903|12502735|FG001|STARTED|Overall Study||32
11304895|NCT02593903|12502734|FG000|COMPLETED|Overall Study||35
11401443|NCT04096365|12596192|FG000|STARTED|Overall Study||12
11304896|NCT02593903|12502735|FG001|COMPLETED|Overall Study||31
11304897|NCT02593903|12502734|FG000|NOT COMPLETED|Overall Study||0
11401444|NCT04096365|12596192|FG000|COMPLETED|Overall Study||11
11401445|NCT04096365|12596192|FG000|NOT COMPLETED|Overall Study||1
11401446|NCT04080297|12596198|FG000|STARTED|Overall Study||10
11304898|NCT02593903|12502735|FG001|NOT COMPLETED|Overall Study||1
11304899|NCT02594098|12502743|FG000|STARTED|Overall Study||27
11304900|NCT02594098|12502744|FG001|STARTED|Overall Study||14
11304901|NCT02594098|12502743|FG000|COMPLETED|Overall Study||1
11304902|NCT02594098|12502744|FG001|COMPLETED|Overall Study||1
11304903|NCT02594098|12502743|FG000|NOT COMPLETED|Overall Study||26
11304904|NCT02594098|12502744|FG001|NOT COMPLETED|Overall Study||13
11304905|NCT02594163|12502754|FG000|STARTED|Treatment Period||12
11304906|NCT02594163|12502755|FG001|STARTED|Treatment Period||13
11304907|NCT02594163|12502754|FG000|COMPLETED|Treatment Period||5
11304908|NCT02594163|12502755|FG001|COMPLETED|Treatment Period||1
11304909|NCT02594163|12502754|FG000|NOT COMPLETED|Treatment Period||7
11304910|NCT02594163|12502755|FG001|NOT COMPLETED|Treatment Period||12
11304911|NCT02594163|12502754|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|12
11304912|NCT02594163|12502755|FG001|STARTED|Follow-up Period|All participants were to be followed after treatment|13
11304913|NCT02594163|12502754|FG000|COMPLETED|Follow-up Period||1
11304914|NCT02594163|12502755|FG001|COMPLETED|Follow-up Period||1
11304915|NCT02594163|12502754|FG000|NOT COMPLETED|Follow-up Period||11
11304916|NCT02594163|12502755|FG001|NOT COMPLETED|Follow-up Period||12
11304917|NCT02594644|12502763|FG000|STARTED|Overall Study||16
11304918|NCT02594644|12502764|FG001|STARTED|Overall Study||16
11304919|NCT02594644|12502763|FG000|COMPLETED|Overall Study||16
11304920|NCT02594644|12502764|FG001|COMPLETED|Overall Study||15
11304921|NCT02594644|12502763|FG000|NOT COMPLETED|Overall Study||0
11304922|NCT02594644|12502764|FG001|NOT COMPLETED|Overall Study||1
11304923|NCT02594826|12502782|FG000|STARTED|Overall Study||347
11304924|NCT02594826|12502783|FG001|STARTED|Overall Study||358
11304925|NCT02594826|12502782|FG000|COMPLETED|Overall Study||290
11304926|NCT02594826|12502783|FG001|COMPLETED|Overall Study||298
11304927|NCT02594826|12502782|FG000|NOT COMPLETED|Overall Study||57
11304928|NCT02594826|12502783|FG001|NOT COMPLETED|Overall Study||60
11304929|NCT02595008|12502791|FG000|STARTED|Overall Study||20
11304930|NCT02595008|12502792|FG001|STARTED|Overall Study||4
11304931|NCT02595008|12502791|FG000|COMPLETED|Overall Study||19
11304932|NCT02595008|12502792|FG001|COMPLETED|Overall Study||4
11304933|NCT02595008|12502791|FG000|NOT COMPLETED|Overall Study||1
11304934|NCT02595008|12502792|FG001|NOT COMPLETED|Overall Study||0
11304935|NCT02595073|12502800|FG000|STARTED|Overall Study||61
11304936|NCT02595073|12502801|FG001|STARTED|Overall Study||63
11304937|NCT02595073|12502800|FG000|COMPLETED|Overall Study||59
11304938|NCT02595073|12502801|FG001|COMPLETED|Overall Study||62
11304939|NCT02595073|12502800|FG000|NOT COMPLETED|Overall Study||2
11304940|NCT02595073|12502801|FG001|NOT COMPLETED|Overall Study||1
11401447|NCT04080297|12596199|FG001|STARTED|Overall Study||11
11401448|NCT04080297|12596198|FG000|COMPLETED|Overall Study||8
11401449|NCT04080297|12596199|FG001|COMPLETED|Overall Study||8
11401450|NCT04080297|12596198|FG000|NOT COMPLETED|Overall Study||2
11304941|NCT02595398|12502809|FG000|STARTED|Overall Study||96
11304942|NCT02595398|12502810|FG001|STARTED|Overall Study||64
11304943|NCT02595398|12502809|FG000|Intention-to-Treat (ITT) Population|Overall Study||96
11304944|NCT02595398|12502810|FG001|Intention-to-Treat (ITT) Population|Overall Study||64
11304945|NCT02595398|12502809|FG000|Safety Population|Overall Study||96
11304946|NCT02595398|12502810|FG001|Safety Population|Overall Study||64
11304947|NCT02595398|12502809|FG000|COMPLETED|Overall Study||92
11304948|NCT02595398|12502810|FG001|COMPLETED|Overall Study||63
11304949|NCT02595398|12502809|FG000|NOT COMPLETED|Overall Study||4
11304950|NCT02595398|12502810|FG001|NOT COMPLETED|Overall Study||1
11304951|NCT02595437|12502816|FG000|STARTED|Triferic Via IV||22
11304952|NCT02595437|12502816|FG000|COMPLETED|Triferic Via IV||21
11304953|NCT02595437|12502816|FG000|NOT COMPLETED|Triferic Via IV||1
11304954|NCT02595437|12502816|FG000|STARTED|Triferic Via Hemodialysate||21
11304955|NCT02595437|12502816|FG000|COMPLETED|Triferic Via Hemodialysate||21
11304956|NCT02595437|12502816|FG000|NOT COMPLETED|Triferic Via Hemodialysate||0
11401451|NCT04080297|12596199|FG001|NOT COMPLETED|Overall Study||3
11304957|NCT02595450|12502828|FG000|STARTED|Overall Study||299
11304958|NCT02595450|12502828|FG000|Treated|Overall Study||291
11304959|NCT02595450|12502828|FG000|COMPLETED|Overall Study||218
11304960|NCT02595450|12502828|FG000|NOT COMPLETED|Overall Study||81
11304961|NCT02595502|12502832|FG000|STARTED|Period 1||143
11304962|NCT02595502|12502833|FG001|STARTED|Period 1||142
11304963|NCT02595502|12502832|FG000|COMPLETED|Period 1||142
11304964|NCT02595502|12502833|FG001|COMPLETED|Period 1||140
11304965|NCT02595502|12502832|FG000|NOT COMPLETED|Period 1||1
11304966|NCT02595502|12502833|FG001|NOT COMPLETED|Period 1||2
11304967|NCT02595502|12502832|FG000|STARTED|Period 2||142
11304968|NCT02595502|12502833|FG001|STARTED|Period 2||140
11304969|NCT02595502|12502832|FG000|COMPLETED|Period 2||141
11304970|NCT02595502|12502833|FG001|COMPLETED|Period 2||138
11304971|NCT02595502|12502832|FG000|NOT COMPLETED|Period 2||1
11304972|NCT02595502|12502833|FG001|NOT COMPLETED|Period 2||2
11304973|NCT02595502|12502832|FG000|STARTED|Period 3||141
11304974|NCT02595502|12502833|FG001|STARTED|Period 3||138
11304975|NCT02595502|12502832|FG000|COMPLETED|Period 3||140
11304976|NCT02595502|12502833|FG001|COMPLETED|Period 3||136
11401452|NCT04115358|12596208|FG000|STARTED|Overall Study||34
11304977|NCT02595502|12502832|FG000|NOT COMPLETED|Period 3||1
11401453|NCT04115358|12596209|FG001|STARTED|Overall Study||33
11401454|NCT04115358|12596210|FG002|STARTED|Overall Study||34
11401455|NCT04115358|12596208|FG000|COMPLETED|Overall Study|34 participants 48 teeth for clinical assessment, 28 participants 35 teeth for radiographic assessment.|34
11304978|NCT02595502|12502833|FG001|NOT COMPLETED|Period 3||2
11304979|NCT02595528|12502843|FG000|STARTED|Overall Study||41
11304980|NCT02595528|12502844|FG001|STARTED|Overall Study||40
11304981|NCT02595528|12502845|FG002|STARTED|Overall Study||42
11304982|NCT02595528|12502846|FG003|STARTED|Overall Study||40
11304983|NCT02595528|12502843|FG000|COMPLETED|Overall Study||39
11304984|NCT02595528|12502844|FG001|COMPLETED|Overall Study||37
11304985|NCT02595528|12502845|FG002|COMPLETED|Overall Study||41
11304986|NCT02595528|12502846|FG003|COMPLETED|Overall Study||36
11304987|NCT02595528|12502843|FG000|NOT COMPLETED|Overall Study||2
11304988|NCT02595528|12502844|FG001|NOT COMPLETED|Overall Study||3
11304989|NCT02595528|12502845|FG002|NOT COMPLETED|Overall Study||1
11304990|NCT02595528|12502846|FG003|NOT COMPLETED|Overall Study||4
11304991|NCT02595567|12502856|FG000|STARTED|Overall Study||25
11304992|NCT02595567|12502856|FG000|COMPLETED|Overall Study||25
11304993|NCT02595567|12502856|FG000|NOT COMPLETED|Overall Study||0
11304994|NCT02595684|12502862|FG000|STARTED|Overall Study||9
11304995|NCT02595684|12502863|FG001|STARTED|Overall Study||9
11304996|NCT02595684|12502862|FG000|COMPLETED|Overall Study||9
11304997|NCT02595684|12502863|FG001|COMPLETED|Overall Study||9
11304998|NCT02595684|12502862|FG000|NOT COMPLETED|Overall Study||0
11304999|NCT02595684|12502863|FG001|NOT COMPLETED|Overall Study||0
11305000|NCT02595723|12502872|FG000|STARTED|First Intervention (4 Days)||8
11305001|NCT02595723|12502873|FG001|STARTED|First Intervention (4 Days)||6
11305002|NCT02595723|12502874|FG002|STARTED|First Intervention (4 Days)||7
11305003|NCT02595723|12502872|FG000|COMPLETED|First Intervention (4 Days)||8
11305004|NCT02595723|12502873|FG001|COMPLETED|First Intervention (4 Days)||6
11305005|NCT02595723|12502874|FG002|COMPLETED|First Intervention (4 Days)||7
11305006|NCT02595723|12502872|FG000|NOT COMPLETED|First Intervention (4 Days)||0
11305007|NCT02595723|12502873|FG001|NOT COMPLETED|First Intervention (4 Days)||0
11305008|NCT02595723|12502874|FG002|NOT COMPLETED|First Intervention (4 Days)||0
11305009|NCT02595723|12502872|FG000|STARTED|First Washout (21 Days)||8
11305010|NCT02595723|12502873|FG001|STARTED|First Washout (21 Days)||6
11305011|NCT02595723|12502874|FG002|STARTED|First Washout (21 Days)||7
11305012|NCT02595723|12502872|FG000|COMPLETED|First Washout (21 Days)||6
11305013|NCT02595723|12502873|FG001|COMPLETED|First Washout (21 Days)||6
11305014|NCT02595723|12502874|FG002|COMPLETED|First Washout (21 Days)||7
11305015|NCT02595723|12502872|FG000|NOT COMPLETED|First Washout (21 Days)||2
11305016|NCT02595723|12502873|FG001|NOT COMPLETED|First Washout (21 Days)||0
11305017|NCT02595723|12502874|FG002|NOT COMPLETED|First Washout (21 Days)||0
11305018|NCT02595723|12502872|FG000|STARTED|Second Intervention (4 Days)||6
11305019|NCT02595723|12502873|FG001|STARTED|Second Intervention (4 Days)||6
11305020|NCT02595723|12502874|FG002|STARTED|Second Intervention (4 Days)||7
11305021|NCT02595723|12502872|FG000|COMPLETED|Second Intervention (4 Days)||6
11305022|NCT02595723|12502873|FG001|COMPLETED|Second Intervention (4 Days)||6
11305023|NCT02595723|12502874|FG002|COMPLETED|Second Intervention (4 Days)||7
11305024|NCT02595723|12502872|FG000|NOT COMPLETED|Second Intervention (4 Days)||0
11305025|NCT02595723|12502873|FG001|NOT COMPLETED|Second Intervention (4 Days)||0
11305026|NCT02595723|12502874|FG002|NOT COMPLETED|Second Intervention (4 Days)||0
11305027|NCT02595723|12502872|FG000|STARTED|Second Washout (21 Days)||6
11305028|NCT02595723|12502873|FG001|STARTED|Second Washout (21 Days)||6
11305029|NCT02595723|12502874|FG002|STARTED|Second Washout (21 Days)||7
11305030|NCT02595723|12502872|FG000|COMPLETED|Second Washout (21 Days)||6
11305031|NCT02595723|12502873|FG001|COMPLETED|Second Washout (21 Days)||5
11305032|NCT02595723|12502874|FG002|COMPLETED|Second Washout (21 Days)||7
11305033|NCT02595723|12502872|FG000|NOT COMPLETED|Second Washout (21 Days)||0
11305034|NCT02595723|12502873|FG001|NOT COMPLETED|Second Washout (21 Days)||1
11305035|NCT02595723|12502874|FG002|NOT COMPLETED|Second Washout (21 Days)||0
11305036|NCT02595723|12502872|FG000|STARTED|Third Intervention (4 Days)||6
11305037|NCT02595723|12502873|FG001|STARTED|Third Intervention (4 Days)||5
11305038|NCT02595723|12502874|FG002|STARTED|Third Intervention (4 Days)||7
11305039|NCT02595723|12502872|FG000|COMPLETED|Third Intervention (4 Days)||6
11305040|NCT02595723|12502873|FG001|COMPLETED|Third Intervention (4 Days)||5
11305041|NCT02595723|12502874|FG002|COMPLETED|Third Intervention (4 Days)||7
11305042|NCT02595723|12502872|FG000|NOT COMPLETED|Third Intervention (4 Days)||0
11305043|NCT02595723|12502873|FG001|NOT COMPLETED|Third Intervention (4 Days)||0
11305044|NCT02595723|12502874|FG002|NOT COMPLETED|Third Intervention (4 Days)||0
11305045|NCT02595749|12502884|FG000|STARTED|Overall Study||45
11305046|NCT02595749|12502885|FG001|STARTED|Overall Study||38
11305047|NCT02595749|12502884|FG000|COMPLETED|Overall Study||33
11305048|NCT02595749|12502885|FG001|COMPLETED|Overall Study||31
11305049|NCT02595749|12502884|FG000|NOT COMPLETED|Overall Study||12
11305050|NCT02595749|12502885|FG001|NOT COMPLETED|Overall Study||7
11305051|NCT02595970|12502891|FG000|STARTED|Overall Study||120
11305052|NCT02595970|12502891|FG000|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100
11305053|NCT02595970|12502891|FG000|NOT COMPLETED|Overall Study||20
11305054|NCT02595983|12502895|FG000|STARTED|Overall Study||12
11305055|NCT02595983|12502895|FG000|COMPLETED|Overall Study||8
11305056|NCT02595983|12502895|FG000|NOT COMPLETED|Overall Study||4
11305057|NCT02596009|12502900|FG000|STARTED|Overall Study||14
11305058|NCT02596009|12502901|FG001|STARTED|Overall Study||16
11305059|NCT02596009|12502902|FG002|STARTED|Overall Study||16
11305060|NCT02596009|12502903|FG003|STARTED|Overall Study||16
11305061|NCT02596009|12502904|FG004|STARTED|Overall Study||18
11305062|NCT02596009|12502905|FG005|STARTED|Overall Study||17
11305063|NCT02596009|12502900|FG000|COMPLETED|Overall Study||14
11305064|NCT02596009|12502901|FG001|COMPLETED|Overall Study||15
11305065|NCT02596009|12502902|FG002|COMPLETED|Overall Study||16
11305066|NCT02596009|12502903|FG003|COMPLETED|Overall Study||16
11305067|NCT02596009|12502904|FG004|COMPLETED|Overall Study||18
11305068|NCT02596009|12502905|FG005|COMPLETED|Overall Study||17
11305069|NCT02596009|12502900|FG000|NOT COMPLETED|Overall Study||0
11305070|NCT02596009|12502901|FG001|NOT COMPLETED|Overall Study||1
11305071|NCT02596009|12502902|FG002|NOT COMPLETED|Overall Study||0
11305072|NCT02596009|12502903|FG003|NOT COMPLETED|Overall Study||0
11305073|NCT02596009|12502904|FG004|NOT COMPLETED|Overall Study||0
11305074|NCT02596009|12502905|FG005|NOT COMPLETED|Overall Study||0
11305075|NCT02596022|12502913|FG000|STARTED|Overall Study||10
11305076|NCT02596022|12502914|FG001|STARTED|Overall Study||8
11305077|NCT02596022|12502913|FG000|COMPLETED|Overall Study||10
11305078|NCT02596022|12502914|FG001|COMPLETED|Overall Study||8
11305079|NCT02596022|12502913|FG000|NOT COMPLETED|Overall Study||0
11305080|NCT02596022|12502914|FG001|NOT COMPLETED|Overall Study||0
11305081|NCT02596230|12502925|FG000|STARTED|Objective 1, One Visit During 14 Days||3714
11305082|NCT02596230|12502926|FG001|STARTED|Objective 1, One Visit During 14 Days||1006
11305083|NCT02596230|12502927|FG002|STARTED|Objective 1, One Visit During 14 Days||0
11305084|NCT02596230|12502928|FG003|STARTED|Objective 1, One Visit During 14 Days||1375
11305085|NCT02596230|12502929|FG004|STARTED|Objective 1, One Visit During 14 Days||0
11305086|NCT02596230|12502925|FG000|COMPLETED|Objective 1, One Visit During 14 Days||3714
11305087|NCT02596230|12502926|FG001|COMPLETED|Objective 1, One Visit During 14 Days||1006
11305088|NCT02596230|12502927|FG002|COMPLETED|Objective 1, One Visit During 14 Days||0
11305089|NCT02596230|12502928|FG003|COMPLETED|Objective 1, One Visit During 14 Days||1375
11305090|NCT02596230|12502929|FG004|COMPLETED|Objective 1, One Visit During 14 Days||0
11305091|NCT02596230|12502925|FG000|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
11305092|NCT02596230|12502926|FG001|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
11305093|NCT02596230|12502927|FG002|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
11305094|NCT02596230|12502928|FG003|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
11305095|NCT02596230|12502929|FG004|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
11305096|NCT02596230|12502925|FG000|STARTED|Screening Period for Objective 2||3714
11305097|NCT02596230|12502926|FG001|STARTED|Screening Period for Objective 2||1006
11305098|NCT02596230|12502927|FG002|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|910
11305099|NCT02596230|12502928|FG003|STARTED|Screening Period for Objective 2||1375
11305100|NCT02596230|12502929|FG004|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|792
11305101|NCT02596230|12502925|FG000|COMPLETED|Screening Period for Objective 2||0
11305102|NCT02596230|12502926|FG001|COMPLETED|Screening Period for Objective 2||778
11305103|NCT02596230|12502927|FG002|COMPLETED|Screening Period for Objective 2||910
11305104|NCT02596230|12502928|FG003|COMPLETED|Screening Period for Objective 2||529
11305105|NCT02596230|12502929|FG004|COMPLETED|Screening Period for Objective 2||792
11305106|NCT02596230|12502925|FG000|NOT COMPLETED|Screening Period for Objective 2||3714
11305107|NCT02596230|12502926|FG001|NOT COMPLETED|Screening Period for Objective 2||228
11305108|NCT02596230|12502927|FG002|NOT COMPLETED|Screening Period for Objective 2||0
11305109|NCT02596230|12502928|FG003|NOT COMPLETED|Screening Period for Objective 2||846
11305110|NCT02596230|12502929|FG004|NOT COMPLETED|Screening Period for Objective 2||0
11305111|NCT02596230|12502925|FG000|STARTED|Objective 2, One Year||0
11305112|NCT02596230|12502926|FG001|STARTED|Objective 2, One Year||778
11305113|NCT02596230|12502927|FG002|STARTED|Objective 2, One Year||910
11305114|NCT02596230|12502928|FG003|STARTED|Objective 2, One Year||529
11305115|NCT02596230|12502929|FG004|STARTED|Objective 2, One Year||792
11305116|NCT02596230|12502925|FG000|COMPLETED|Objective 2, One Year||0
11305117|NCT02596230|12502926|FG001|COMPLETED|Objective 2, One Year||710
11305118|NCT02596230|12502927|FG002|COMPLETED|Objective 2, One Year||812
11305119|NCT02596230|12502928|FG003|COMPLETED|Objective 2, One Year||471
11305120|NCT02596230|12502929|FG004|COMPLETED|Objective 2, One Year||714
11305121|NCT02596230|12502925|FG000|NOT COMPLETED|Objective 2, One Year||0
11305122|NCT02596230|12502926|FG001|NOT COMPLETED|Objective 2, One Year||68
11305123|NCT02596230|12502927|FG002|NOT COMPLETED|Objective 2, One Year||98
11305124|NCT02596230|12502928|FG003|NOT COMPLETED|Objective 2, One Year||58
11305125|NCT02596230|12502929|FG004|NOT COMPLETED|Objective 2, One Year||78
11305126|NCT02596321|12502941|FG000|STARTED|Overall Study||56
11305127|NCT02596321|12502942|FG001|STARTED|Overall Study||56
11305128|NCT02596321|12502941|FG000|COMPLETED|Overall Study||53
11305129|NCT02596321|12502942|FG001|COMPLETED|Overall Study||56
11305130|NCT02596321|12502941|FG000|NOT COMPLETED|Overall Study||3
11305131|NCT02596321|12502942|FG001|NOT COMPLETED|Overall Study||0
11305132|NCT02596451|12502951|FG000|STARTED|Overall Study||385
11305133|NCT02596451|12502952|FG001|STARTED|Overall Study||392
11305134|NCT02596451|12502953|FG002|STARTED|Overall Study||387
11305135|NCT02596451|12502951|FG000|COMPLETED|Overall Study||381
11305136|NCT02596451|12502952|FG001|COMPLETED|Overall Study||374
11305137|NCT02596451|12502953|FG002|COMPLETED|Overall Study||373
11305138|NCT02596451|12502951|FG000|NOT COMPLETED|Overall Study||4
11305139|NCT02596451|12502952|FG001|NOT COMPLETED|Overall Study||18
11305140|NCT02596451|12502953|FG002|NOT COMPLETED|Overall Study||14
11305141|NCT02596620|12502962|FG000|STARTED|Overall Study|Started from 1st October 2013|82
11305142|NCT02596620|12502963|FG001|STARTED|Overall Study|Started from 1st October 2013|82
11305143|NCT02596620|12502962|FG000|COMPLETED|Overall Study|Completed on 30th September 2015|81
11305144|NCT02596620|12502963|FG001|COMPLETED|Overall Study|Completed on 30th September 2015|81
11305145|NCT02596620|12502962|FG000|NOT COMPLETED|Overall Study||1
11305146|NCT02596620|12502963|FG001|NOT COMPLETED|Overall Study||1
11305147|NCT02596711|12502972|FG000|STARTED|Overall Study||9
11305148|NCT02596711|12502973|FG001|STARTED|Overall Study||8
11305149|NCT02596711|12502974|FG002|STARTED|Overall Study||8
11305150|NCT02596711|12502972|FG000|Visit 2|Overall Study||9
11305151|NCT02596711|12502973|FG001|Visit 2|Overall Study||7
11305152|NCT02596711|12502974|FG002|Visit 2|Overall Study||6
11305153|NCT02596711|12502972|FG000|Visit 3|Overall Study||7
11305154|NCT02596711|12502973|FG001|Visit 3|Overall Study||8
11305155|NCT02596711|12502974|FG002|Visit 3|Overall Study||6
11305156|NCT02596711|12502972|FG000|3 Month Follow-up|Overall Study||8
11305157|NCT02596711|12502973|FG001|3 Month Follow-up|Overall Study||6
11305158|NCT02596711|12502974|FG002|3 Month Follow-up|Overall Study||6
11305159|NCT02596711|12502972|FG000|6 Month Follow-up|Overall Study||8
11305160|NCT02596711|12502973|FG001|6 Month Follow-up|Overall Study||6
11305161|NCT02596711|12502974|FG002|6 Month Follow-up|Overall Study||5
11305162|NCT02596711|12502972|FG000|COMPLETED|Overall Study||8
11305163|NCT02596711|12502973|FG001|COMPLETED|Overall Study||6
11305164|NCT02596711|12502974|FG002|COMPLETED|Overall Study||5
11305165|NCT02596711|12502972|FG000|NOT COMPLETED|Overall Study||1
11305166|NCT02596711|12502973|FG001|NOT COMPLETED|Overall Study||2
11305167|NCT02596711|12502974|FG002|NOT COMPLETED|Overall Study||3
11305168|NCT02596750|12502984|FG000|STARTED|Baseline||21
11305169|NCT02596750|12502985|FG001|STARTED|Baseline||21
11305170|NCT02596750|12502984|FG000|COMPLETED|Baseline||21
11305171|NCT02596750|12502985|FG001|COMPLETED|Baseline||21
11305172|NCT02596750|12502984|FG000|NOT COMPLETED|Baseline||0
11305173|NCT02596750|12502985|FG001|NOT COMPLETED|Baseline||0
11305174|NCT02596750|12502984|FG000|STARTED|2 Minutes||21
11305175|NCT02596750|12502985|FG001|STARTED|2 Minutes||21
11305176|NCT02596750|12502984|FG000|COMPLETED|2 Minutes||21
11305177|NCT02596750|12502985|FG001|COMPLETED|2 Minutes||21
11305178|NCT02596750|12502984|FG000|NOT COMPLETED|2 Minutes||0
11305179|NCT02596750|12502985|FG001|NOT COMPLETED|2 Minutes||0
11305180|NCT02596750|12502984|FG000|STARTED|5 Minutes||21
11305181|NCT02596750|12502985|FG001|STARTED|5 Minutes||21
11305182|NCT02596750|12502984|FG000|COMPLETED|5 Minutes||21
11305183|NCT02596750|12502985|FG001|COMPLETED|5 Minutes||21
11305184|NCT02596750|12502984|FG000|NOT COMPLETED|5 Minutes||0
11305185|NCT02596750|12502985|FG001|NOT COMPLETED|5 Minutes||0
11305186|NCT02596750|12502984|FG000|STARTED|10 Minutes||21
11305187|NCT02596750|12502985|FG001|STARTED|10 Minutes||21
11305188|NCT02596750|12502984|FG000|COMPLETED|10 Minutes||21
11305189|NCT02596750|12502985|FG001|COMPLETED|10 Minutes||21
11305190|NCT02596750|12502984|FG000|NOT COMPLETED|10 Minutes||0
11305191|NCT02596750|12502985|FG001|NOT COMPLETED|10 Minutes||0
11305192|NCT02596750|12502984|FG000|STARTED|30 Minutes||21
11305193|NCT02596750|12502985|FG001|STARTED|30 Minutes||21
11305194|NCT02596750|12502984|FG000|COMPLETED|30 Minutes||21
11305195|NCT02596750|12502985|FG001|COMPLETED|30 Minutes||21
11305196|NCT02596750|12502984|FG000|NOT COMPLETED|30 Minutes||0
11305197|NCT02596750|12502985|FG001|NOT COMPLETED|30 Minutes||0
11305198|NCT02596854|12502992|FG000|STARTED|Overall Study||117
11305199|NCT02596854|12502992|FG000|COMPLETED|Overall Study||109
11305200|NCT02596854|12502992|FG000|NOT COMPLETED|Overall Study||8
11305201|NCT02596867|12502996|FG000|STARTED|Overall Study||2
11305202|NCT02596867|12502996|FG000|2 Patients Prospectively Recruited|Overall Study||2
11305203|NCT02596867|12502996|FG000|COMPLETED|Overall Study||2
11305204|NCT02596867|12502996|FG000|NOT COMPLETED|Overall Study||0
11305205|NCT02596893|12503005|FG000|STARTED|Overall Double-Blind Period Weeks 0-52||174
11305206|NCT02596893|12503006|FG001|STARTED|Overall Double-Blind Period Weeks 0-52||176
11305207|NCT02596893|12503007|FG002|STARTED|Overall Double-Blind Period Weeks 0-52||176
11305208|NCT02596893|12503008|FG003|STARTED|Overall Double-Blind Period Weeks 0-52||175
11305209|NCT02596893|12503005|FG000|COMPLETED|Overall Double-Blind Period Weeks 0-52||10
11305210|NCT02596893|12503006|FG001|COMPLETED|Overall Double-Blind Period Weeks 0-52||8
11305211|NCT02596893|12503007|FG002|COMPLETED|Overall Double-Blind Period Weeks 0-52||14
11305212|NCT02596893|12503008|FG003|COMPLETED|Overall Double-Blind Period Weeks 0-52||9
11305213|NCT02596893|12503005|FG000|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164
11305214|NCT02596893|12503006|FG001|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168
11305215|NCT02596893|12503007|FG002|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162
11305216|NCT02596893|12503008|FG003|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166
11305217|NCT02596893|12503005|FG000|STARTED|Follow-Up Period Weeks 0 to 52||57
11305218|NCT02596893|12503006|FG001|STARTED|Follow-Up Period Weeks 0 to 52||51
11305219|NCT02596893|12503007|FG002|STARTED|Follow-Up Period Weeks 0 to 52||56
11305220|NCT02596893|12503008|FG003|STARTED|Follow-Up Period Weeks 0 to 52||47
11305221|NCT02596893|12503005|FG000|COMPLETED|Follow-Up Period Weeks 0 to 52||57
11305222|NCT02596893|12503006|FG001|COMPLETED|Follow-Up Period Weeks 0 to 52||51
11305223|NCT02596893|12503007|FG002|COMPLETED|Follow-Up Period Weeks 0 to 52||56
11305224|NCT02596893|12503008|FG003|COMPLETED|Follow-Up Period Weeks 0 to 52||47
11305225|NCT02596893|12503005|FG000|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
11305226|NCT02596893|12503006|FG001|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
11305227|NCT02596893|12503007|FG002|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
11305228|NCT02596893|12503008|FG003|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
11305229|NCT02596906|12503020|FG000|STARTED|Overall Study||12
11305230|NCT02596906|12503021|FG001|STARTED|Overall Study||10
11305231|NCT02596906|12503020|FG000|COMPLETED|Overall Study||8
11305232|NCT02596906|12503021|FG001|COMPLETED|Overall Study||7
11305233|NCT02596906|12503020|FG000|NOT COMPLETED|Overall Study||4
11305234|NCT02596906|12503021|FG001|NOT COMPLETED|Overall Study||3
11305235|NCT02596945|12503027|FG000|STARTED|Overall Study||223
11305236|NCT02596945|12503027|FG000|Treated|Overall Study||220
11305237|NCT02596945|12503027|FG000|COMPLETED|Overall Study||167
11305238|NCT02596945|12503027|FG000|NOT COMPLETED|Overall Study||56
11305239|NCT02596958|12503031|FG000|STARTED|Overall Study||996
11305240|NCT02596958|12503031|FG000|COMPLETED|Overall Study||0
11305241|NCT02596958|12503031|FG000|NOT COMPLETED|Overall Study||996
11305242|NCT02596971|12503038|FG000|STARTED|Overall Study||42
11305243|NCT02596971|12503039|FG001|STARTED|Overall Study||7
11305244|NCT02596971|12503040|FG002|STARTED|Overall Study||42
11305245|NCT02596971|12503038|FG000|COMPLETED|Overall Study||32
11305246|NCT02596971|12503039|FG001|COMPLETED|Overall Study||5
11305247|NCT02596971|12503040|FG002|COMPLETED|Overall Study||33
11305248|NCT02596971|12503038|FG000|NOT COMPLETED|Overall Study||10
11305249|NCT02596971|12503039|FG001|NOT COMPLETED|Overall Study||2
11305250|NCT02596971|12503040|FG002|NOT COMPLETED|Overall Study||9
11305251|NCT02597049|12503054|FG000|STARTED|Overall Study||142
11305252|NCT02597049|12503055|FG001|STARTED|Overall Study||142
11305253|NCT02597049|12503056|FG002|STARTED|Overall Study||140
11305254|NCT02597049|12503054|FG000|Received at Least One Dose of Study Drug|Overall Study||142
11305255|NCT02597049|12503055|FG001|Received at Least One Dose of Study Drug|Overall Study||141
11305256|NCT02597049|12503056|FG002|Received at Least One Dose of Study Drug|Overall Study||140
11305257|NCT02597049|12503054|FG000|COMPLETED|Overall Study||135
11305258|NCT02597049|12503055|FG001|COMPLETED|Overall Study||137
11305259|NCT02597049|12503056|FG002|COMPLETED|Overall Study||137
11305260|NCT02597049|12503054|FG000|NOT COMPLETED|Overall Study||7
11305261|NCT02597049|12503055|FG001|NOT COMPLETED|Overall Study||5
11305262|NCT02597049|12503056|FG002|NOT COMPLETED|Overall Study||3
11305263|NCT02597101|12503066|FG000|STARTED|Overall Study||4
11305264|NCT02597101|12503067|FG001|STARTED|Overall Study||5
11305265|NCT02597101|12503066|FG000|COMPLETED|Overall Study||4
11305266|NCT02597101|12503067|FG001|COMPLETED|Overall Study||5
11305267|NCT02597101|12503066|FG000|NOT COMPLETED|Overall Study||0
11305268|NCT02597101|12503067|FG001|NOT COMPLETED|Overall Study||0
11305269|NCT02597127|12503081|FG000|STARTED|Overall Study||60
11305270|NCT02597127|12503082|FG001|STARTED|Overall Study||62
11305271|NCT02597127|12503083|FG002|STARTED|Overall Study||66
11305272|NCT02597127|12503084|FG003|STARTED|Overall Study||65
11305273|NCT02597127|12503085|FG004|STARTED|Overall Study||62
11305274|NCT02597127|12503086|FG005|STARTED|Overall Study||63
11305275|NCT02597127|12503087|FG006|STARTED|Overall Study||61
11305276|NCT02597127|12503088|FG007|STARTED|Overall Study||62
11305277|NCT02597127|12503081|FG000|Treated|Overall Study||60
11305278|NCT02597127|12503082|FG001|Treated|Overall Study||61
11305279|NCT02597127|12503083|FG002|Treated|Overall Study||65
11305280|NCT02597127|12503084|FG003|Treated|Overall Study||65
11305281|NCT02597127|12503085|FG004|Treated|Overall Study||61
11305282|NCT02597127|12503086|FG005|Treated|Overall Study||62
11305283|NCT02597127|12503087|FG006|Treated|Overall Study||61
11305284|NCT02597127|12503088|FG007|Treated|Overall Study||62
11305285|NCT02597127|12503081|FG000|COMPLETED|Overall Study||59
11305286|NCT02597127|12503082|FG001|COMPLETED|Overall Study||59
11305287|NCT02597127|12503083|FG002|COMPLETED|Overall Study||58
11305288|NCT02597127|12503084|FG003|COMPLETED|Overall Study||60
11305289|NCT02597127|12503085|FG004|COMPLETED|Overall Study||57
11305290|NCT02597127|12503086|FG005|COMPLETED|Overall Study||59
11305291|NCT02597127|12503087|FG006|COMPLETED|Overall Study||57
11305292|NCT02597127|12503088|FG007|COMPLETED|Overall Study||60
11305293|NCT02597127|12503081|FG000|NOT COMPLETED|Overall Study||1
11305294|NCT02597127|12503082|FG001|NOT COMPLETED|Overall Study||3
11305295|NCT02597127|12503083|FG002|NOT COMPLETED|Overall Study||8
11305296|NCT02597127|12503084|FG003|NOT COMPLETED|Overall Study||5
11305297|NCT02597127|12503085|FG004|NOT COMPLETED|Overall Study||5
11305298|NCT02597127|12503086|FG005|NOT COMPLETED|Overall Study||4
11305299|NCT02597127|12503087|FG006|NOT COMPLETED|Overall Study||4
11305300|NCT02597127|12503088|FG007|NOT COMPLETED|Overall Study||2
11305301|NCT02597452|12503127|FG000|STARTED|Overall Study||516
11305302|NCT02597452|12503127|FG000|COMPLETED|Overall Study||486
11305303|NCT02597452|12503127|FG000|NOT COMPLETED|Overall Study||30
11305304|NCT02597478|12503133|FG000|STARTED|Overall Study||16
11305305|NCT02597478|12503134|FG001|STARTED|Overall Study||18
11305306|NCT02597478|12503133|FG000|COMPLETED|Overall Study||13
11305307|NCT02597478|12503134|FG001|COMPLETED|Overall Study||17
11305308|NCT02597478|12503133|FG000|NOT COMPLETED|Overall Study||3
11305309|NCT02597478|12503134|FG001|NOT COMPLETED|Overall Study||1
11305310|NCT02597543|12503142|FG000|STARTED|Overall Study||6
11305311|NCT02597543|12503143|FG001|STARTED|Overall Study||8
11305312|NCT02597543|12503142|FG000|COMPLETED|Overall Study||6
11305313|NCT02597543|12503143|FG001|COMPLETED|Overall Study||8
11305314|NCT02597543|12503142|FG000|NOT COMPLETED|Overall Study||0
11305315|NCT02597543|12503143|FG001|NOT COMPLETED|Overall Study||0
11305316|NCT02597582|12503151|FG000|STARTED|Overall Study||21
11305317|NCT02597582|12503152|FG001|STARTED|Overall Study||20
11305318|NCT02597582|12503151|FG000|COMPLETED|Overall Study||21
11305319|NCT02597582|12503152|FG001|COMPLETED|Overall Study||20
11305320|NCT02597582|12503151|FG000|NOT COMPLETED|Overall Study||0
11305321|NCT02597582|12503152|FG001|NOT COMPLETED|Overall Study||0
11305322|NCT02597673|12503164|FG000|STARTED|Overall Study||34
11305323|NCT02597673|12503165|FG001|STARTED|Overall Study||33
11305324|NCT02597673|12503166|FG002|STARTED|Overall Study||33
11305325|NCT02597673|12503167|FG003|STARTED|Overall Study||30
11305326|NCT02597673|12503164|FG000|COMPLETED|Overall Study||31
11305327|NCT02597673|12503165|FG001|COMPLETED|Overall Study||27
11305328|NCT02597673|12503166|FG002|COMPLETED|Overall Study||28
11305329|NCT02597673|12503167|FG003|COMPLETED|Overall Study||25
11305330|NCT02597673|12503164|FG000|NOT COMPLETED|Overall Study||3
11305331|NCT02597673|12503165|FG001|NOT COMPLETED|Overall Study||6
11305332|NCT02597673|12503166|FG002|NOT COMPLETED|Overall Study||5
11305333|NCT02597673|12503167|FG003|NOT COMPLETED|Overall Study||5
11305334|NCT02597712|12503180|FG000|STARTED|Overall Study||13
11305335|NCT02597712|12503181|FG001|STARTED|Overall Study||11
11305336|NCT02597712|12503180|FG000|COMPLETED|Overall Study||10
11305337|NCT02597712|12503181|FG001|COMPLETED|Overall Study||10
11305338|NCT02597712|12503180|FG000|NOT COMPLETED|Overall Study||3
11305339|NCT02597712|12503181|FG001|NOT COMPLETED|Overall Study||1
11305340|NCT02597855|12503189|FG000|STARTED|Overall Study||18
11305341|NCT02597855|12503190|FG001|STARTED|Overall Study||14
11305342|NCT02597855|12503189|FG000|COMPLETED|Overall Study||16
11305343|NCT02597855|12503190|FG001|COMPLETED|Overall Study||13
11305344|NCT02597855|12503189|FG000|NOT COMPLETED|Overall Study||2
11305345|NCT02597855|12503190|FG001|NOT COMPLETED|Overall Study||1
11305346|NCT02597907|12503198|FG000|STARTED|Overall Study||44
11305347|NCT02597907|12503199|FG001|STARTED|Overall Study||44
11305348|NCT02597907|12503198|FG000|COMPLETED|Overall Study||44
11305349|NCT02597907|12503199|FG001|COMPLETED|Overall Study||44
11305350|NCT02597907|12503198|FG000|NOT COMPLETED|Overall Study||0
11305351|NCT02597907|12503199|FG001|NOT COMPLETED|Overall Study||0
11305352|NCT02597920|12503208|FG000|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585
11305353|NCT02597920|12503209|FG001|STARTED|Overall Study||1159
11305354|NCT02597920|12503210|FG002|STARTED|Overall Study||78
11305355|NCT02597920|12503208|FG000|COMPLETED|Overall Study||544
11305356|NCT02597920|12503209|FG001|COMPLETED|Overall Study||1075
11305357|NCT02597920|12503210|FG002|COMPLETED|Overall Study||72
11305358|NCT02597920|12503208|FG000|NOT COMPLETED|Overall Study||41
11305359|NCT02597920|12503209|FG001|NOT COMPLETED|Overall Study||84
11305360|NCT02597920|12503210|FG002|NOT COMPLETED|Overall Study||6
11305361|NCT02597933|12503222|FG000|STARTED|Overall Study|Started are randomised|290
11305362|NCT02597933|12503223|FG001|STARTED|Overall Study|Started are randomised|290
11305363|NCT02597933|12503222|FG000|Treated Patients|Overall Study||288
11305364|NCT02597933|12503223|FG001|Treated Patients|Overall Study||288
11305365|NCT02597933|12503222|FG000|COMPLETED|Overall Study||252
11305366|NCT02597933|12503223|FG001|COMPLETED|Overall Study||239
11305367|NCT02597933|12503222|FG000|NOT COMPLETED|Overall Study||38
11305368|NCT02597933|12503223|FG001|NOT COMPLETED|Overall Study||51
11305369|NCT02597946|12503229|FG000|STARTED|Overall Study||18
11305370|NCT02597946|12503229|FG000|COMPLETED|Overall Study||0
11305371|NCT02597946|12503229|FG000|NOT COMPLETED|Overall Study||18
11305372|NCT02598076|12503235|FG000|STARTED|Overall Study||31
11305373|NCT02598076|12503236|FG001|STARTED|Overall Study||29
11305374|NCT02598076|12503235|FG000|COMPLETED|Overall Study||29
11305375|NCT02598076|12503236|FG001|COMPLETED|Overall Study||26
11305376|NCT02598076|12503235|FG000|NOT COMPLETED|Overall Study||2
11305377|NCT02598076|12503236|FG001|NOT COMPLETED|Overall Study||3
11305378|NCT02598089|12503244|FG000|STARTED|Overall Study||30
11305379|NCT02598089|12503245|FG001|STARTED|Overall Study||30
11305380|NCT02598089|12503244|FG000|COMPLETED|Overall Study||30
11305381|NCT02598089|12503245|FG001|COMPLETED|Overall Study||30
11305382|NCT02598089|12503244|FG000|NOT COMPLETED|Overall Study||0
11305383|NCT02598089|12503245|FG001|NOT COMPLETED|Overall Study||0
11305384|NCT02598128|12503258|FG000|STARTED|Period A: Days -7 to -1||34
11305385|NCT02598128|12503259|FG001|STARTED|Period A: Days -7 to -1||0
11305386|NCT02598128|12503260|FG002|STARTED|Period A: Days -7 to -1||0
11305387|NCT02598128|12503261|FG003|STARTED|Period A: Days -7 to -1||0
11305388|NCT02598128|12503258|FG000|COMPLETED|Period A: Days -7 to -1||33
11305389|NCT02598128|12503259|FG001|COMPLETED|Period A: Days -7 to -1||0
11305390|NCT02598128|12503260|FG002|COMPLETED|Period A: Days -7 to -1||0
11305391|NCT02598128|12503261|FG003|COMPLETED|Period A: Days -7 to -1||0
11305392|NCT02598128|12503258|FG000|NOT COMPLETED|Period A: Days -7 to -1||1
11305393|NCT02598128|12503259|FG001|NOT COMPLETED|Period A: Days -7 to -1||0
11305394|NCT02598128|12503260|FG002|NOT COMPLETED|Period A: Days -7 to -1||0
11305395|NCT02598128|12503261|FG003|NOT COMPLETED|Period A: Days -7 to -1||0
11305396|NCT02598128|12503258|FG000|STARTED|Period B: Days 1 to 11||0
11305397|NCT02598128|12503259|FG001|STARTED|Period B: Days 1 to 11||17
11305398|NCT02598128|12503260|FG002|STARTED|Period B: Days 1 to 11||16
11305399|NCT02598128|12503261|FG003|STARTED|Period B: Days 1 to 11||0
11305400|NCT02598128|12503258|FG000|COMPLETED|Period B: Days 1 to 11||0
11305401|NCT02598128|12503259|FG001|COMPLETED|Period B: Days 1 to 11||17
11305402|NCT02598128|12503260|FG002|COMPLETED|Period B: Days 1 to 11||16
11305403|NCT02598128|12503261|FG003|COMPLETED|Period B: Days 1 to 11||0
11305404|NCT02598128|12503258|FG000|NOT COMPLETED|Period B: Days 1 to 11||0
11305405|NCT02598128|12503259|FG001|NOT COMPLETED|Period B: Days 1 to 11||0
11305406|NCT02598128|12503260|FG002|NOT COMPLETED|Period B: Days 1 to 11||0
11305407|NCT02598128|12503261|FG003|NOT COMPLETED|Period B: Days 1 to 11||0
11305408|NCT02598128|12503258|FG000|STARTED|Period C: Days 12 to 20||0
11305409|NCT02598128|12503259|FG001|STARTED|Period C: Days 12 to 20||0
11305410|NCT02598128|12503260|FG002|STARTED|Period C: Days 12 to 20||0
11305411|NCT02598128|12503261|FG003|STARTED|Period C: Days 12 to 20||33
11305412|NCT02598128|12503258|FG000|COMPLETED|Period C: Days 12 to 20||0
11305413|NCT02598128|12503259|FG001|COMPLETED|Period C: Days 12 to 20||0
11305414|NCT02598128|12503260|FG002|COMPLETED|Period C: Days 12 to 20||0
11305415|NCT02598128|12503261|FG003|COMPLETED|Period C: Days 12 to 20||33
11401456|NCT04115358|12596209|FG001|COMPLETED|Overall Study|33 participants 40 teeth for clinical assessment, 26 participants 32 teeth for radiographic assessment.|33
11401457|NCT04115358|12596210|FG002|COMPLETED|Overall Study|34 participants 38 teeth for clinical assessment, 26 participants 31 teeth for radiographic assessment.|33
11401458|NCT04115358|12596208|FG000|NOT COMPLETED|Overall Study||0
11401459|NCT04115358|12596209|FG001|NOT COMPLETED|Overall Study||0
11401460|NCT04115358|12596210|FG002|NOT COMPLETED|Overall Study||1
11401461|NCT04114058|12596221|FG000|STARTED|Overall Study||20
11401462|NCT04114058|12596222|FG001|STARTED|Overall Study||17
11401463|NCT04114058|12596221|FG000|COMPLETED|Overall Study||20
11401464|NCT04114058|12596222|FG001|COMPLETED|Overall Study||17
11401465|NCT04114058|12596221|FG000|NOT COMPLETED|Overall Study||0
11401466|NCT04114058|12596222|FG001|NOT COMPLETED|Overall Study||0
11401467|NCT04113785|12596228|FG000|STARTED|Overall Study||21
11401468|NCT04113785|12596228|FG000|COMPLETED|Overall Study||21
11401469|NCT04113785|12596228|FG000|NOT COMPLETED|Overall Study||0
11401470|NCT04113694|12596234|FG000|STARTED|Overall Study||259
11401471|NCT04113694|12596234|FG000|COMPLETED|Overall Study||248
11401472|NCT04113694|12596234|FG000|NOT COMPLETED|Overall Study||11
11401473|NCT04112160|12596243|FG000|STARTED|Overall Study||63
11401474|NCT04112160|12596244|FG001|STARTED|Overall Study||62
11401475|NCT04112160|12596243|FG000|COMPLETED|Overall Study||62
11401476|NCT04112160|12596244|FG001|COMPLETED|Overall Study||62
11401477|NCT04112160|12596243|FG000|NOT COMPLETED|Overall Study||1
11401478|NCT04112160|12596244|FG001|NOT COMPLETED|Overall Study||0
11401479|NCT04112069|12596250|FG000|STARTED|Overall Study||10
11401480|NCT04112069|12596251|FG001|STARTED|Overall Study||10
11401481|NCT04112069|12596250|FG000|COMPLETED|Overall Study||10
11401482|NCT04112069|12596251|FG001|COMPLETED|Overall Study||10
11401483|NCT04112069|12596250|FG000|NOT COMPLETED|Overall Study||0
11401484|NCT04112069|12596251|FG001|NOT COMPLETED|Overall Study||0
11305416|NCT02598128|12503258|FG000|NOT COMPLETED|Period C: Days 12 to 20||0
11305417|NCT02598128|12503259|FG001|NOT COMPLETED|Period C: Days 12 to 20||0
11305418|NCT02598128|12503260|FG002|NOT COMPLETED|Period C: Days 12 to 20||0
11305419|NCT02598128|12503261|FG003|NOT COMPLETED|Period C: Days 12 to 20||0
11305420|NCT02598193|12503273|FG000|STARTED|Overall Study||89
11305421|NCT02598193|12503273|FG000|COMPLETED|Overall Study||73
11305422|NCT02598193|12503273|FG000|NOT COMPLETED|Overall Study||16
11305423|NCT02598297|12503279|FG000|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25
11305424|NCT02598297|12503280|FG001|STARTED|Overall Study||24
11305425|NCT02598297|12503279|FG000|Not Treted Wit Study Drug|Overall Study||1
11305426|NCT02598297|12503280|FG001|Not Treted Wit Study Drug|Overall Study||0
11305427|NCT02598297|12503279|FG000|Subjects Followed for Survival|Overall Study||1
11305428|NCT02598297|12503280|FG001|Subjects Followed for Survival|Overall Study||0
11305429|NCT02598297|12503279|FG000|COMPLETED|Overall Study||0
11305430|NCT02598297|12503280|FG001|COMPLETED|Overall Study||0
11305431|NCT02598297|12503279|FG000|NOT COMPLETED|Overall Study||25
11305432|NCT02598297|12503280|FG001|NOT COMPLETED|Overall Study||24
11305433|NCT02598934|12503288|FG000|STARTED|Overall Study||154
11305434|NCT02598934|12503289|FG001|STARTED|Overall Study||154
11305435|NCT02598934|12503288|FG000|COMPLETED|Overall Study||135
11305436|NCT02598934|12503289|FG001|COMPLETED|Overall Study||132
11305437|NCT02598934|12503288|FG000|NOT COMPLETED|Overall Study||19
11305438|NCT02598934|12503289|FG001|NOT COMPLETED|Overall Study||22
11305439|NCT02599129|12503297|FG000|STARTED|Overall Study||7
11305440|NCT02599129|12503298|FG001|STARTED|Overall Study||4
11305441|NCT02599129|12503297|FG000|COMPLETED|Overall Study||2
11305442|NCT02599129|12503298|FG001|COMPLETED|Overall Study||1
11305443|NCT02599129|12503297|FG000|NOT COMPLETED|Overall Study||5
11305444|NCT02599129|12503298|FG001|NOT COMPLETED|Overall Study||3
11305445|NCT02599194|12503304|FG000|STARTED|Overall Study||7
11305446|NCT02599194|12503304|FG000|COMPLETED|Overall Study||7
11305447|NCT02599194|12503304|FG000|NOT COMPLETED|Overall Study||0
11305448|NCT02599402|12503310|FG000|STARTED|Overall Study||533
11305449|NCT02599402|12503310|FG000|COMPLETED|Overall Study||0
11305450|NCT02599402|12503310|FG000|NOT COMPLETED|Overall Study||533
11305451|NCT02599441|12503340|FG000|STARTED|Overall Study||9
11305452|NCT02599441|12503340|FG000|COMPLETED|Overall Study||9
11305453|NCT02599441|12503340|FG000|NOT COMPLETED|Overall Study||0
11305454|NCT02599649|12503348|FG000|STARTED|Overall Study||2
11305455|NCT02599649|12503349|FG001|STARTED|Overall Study||0
11305456|NCT02599649|12503350|FG002|STARTED|Overall Study||8
11305457|NCT02599649|12503351|FG003|STARTED|Overall Study||0
11305458|NCT02599649|12503348|FG000|COMPLETED|Overall Study||2
11305459|NCT02599649|12503349|FG001|COMPLETED|Overall Study||0
11305460|NCT02599649|12503350|FG002|COMPLETED|Overall Study||8
11305461|NCT02599649|12503351|FG003|COMPLETED|Overall Study||0
11305462|NCT02599649|12503348|FG000|NOT COMPLETED|Overall Study||0
11305463|NCT02599649|12503349|FG001|NOT COMPLETED|Overall Study||0
11305464|NCT02599649|12503350|FG002|NOT COMPLETED|Overall Study||0
11305465|NCT02599649|12503351|FG003|NOT COMPLETED|Overall Study||0
11305466|NCT02599688|12503361|FG000|STARTED|Overall Study||18
11305467|NCT02599688|12503361|FG000|COMPLETED|Overall Study||14
11305468|NCT02599688|12503361|FG000|NOT COMPLETED|Overall Study||4
11305469|NCT02599766|12503365|FG000|STARTED|Overall Study||22
11305470|NCT02599766|12503365|FG000|COMPLETED|Overall Study||19
11401485|NCT04109703|12596259|FG000|STARTED|Overall Study||49
11401486|NCT04109703|12596260|FG001|STARTED|Overall Study||51
11401487|NCT04109703|12596259|FG000|COMPLETED|Overall Study||49
11305471|NCT02599766|12503365|FG000|NOT COMPLETED|Overall Study||3
11305472|NCT02599961|12503373|FG000|STARTED|Overall Study||15
11305473|NCT02599961|12503373|FG000|COMPLETED|Overall Study||0
11305474|NCT02599961|12503373|FG000|NOT COMPLETED|Overall Study||15
11305475|NCT02600325|12503377|FG000|STARTED|Overall Study||80
11305476|NCT02600325|12503377|FG000|COMPLETED|Overall Study||80
11305477|NCT02600325|12503377|FG000|NOT COMPLETED|Overall Study||0
11305478|NCT02600351|12503385|FG000|STARTED|Overall Study||17
11305479|NCT02600351|12503386|FG001|STARTED|Overall Study||17
11305480|NCT02600351|12503387|FG002|STARTED|Overall Study||26
11305481|NCT02600351|12503388|FG003|STARTED|Overall Study||27
11305482|NCT02600351|12503385|FG000|COMPLETED|Overall Study||12
11305483|NCT02600351|12503386|FG001|COMPLETED|Overall Study||17
11305484|NCT02600351|12503387|FG002|COMPLETED|Overall Study||20
11305485|NCT02600351|12503388|FG003|COMPLETED|Overall Study||22
11305486|NCT02600351|12503385|FG000|NOT COMPLETED|Overall Study||5
11305487|NCT02600351|12503386|FG001|NOT COMPLETED|Overall Study||0
11305488|NCT02600351|12503387|FG002|NOT COMPLETED|Overall Study||6
11401488|NCT04109703|12596260|FG001|COMPLETED|Overall Study||51
11305489|NCT02600351|12503388|FG003|NOT COMPLETED|Overall Study||5
11305490|NCT02600403|12503403|FG000|STARTED|Overall Study||44
11305491|NCT02600403|12503404|FG001|STARTED|Overall Study||6
11305492|NCT02600403|12503405|FG002|STARTED|Overall Study||11
11305493|NCT02600403|12503403|FG000|COMPLETED|Overall Study||44
11305494|NCT02600403|12503404|FG001|COMPLETED|Overall Study||6
11305495|NCT02600403|12503405|FG002|COMPLETED|Overall Study||11
11305496|NCT02600403|12503403|FG000|NOT COMPLETED|Overall Study||0
11305497|NCT02600403|12503404|FG001|NOT COMPLETED|Overall Study||0
11305498|NCT02600403|12503405|FG002|NOT COMPLETED|Overall Study||0
11305499|NCT02600559|12503416|FG000|STARTED|Overall Study||501
11305500|NCT02600559|12503416|FG000|COMPLETED|Overall Study||478
11305501|NCT02600559|12503416|FG000|NOT COMPLETED|Overall Study||23
11305502|NCT02600611|12503422|FG000|STARTED|Overall Study||300
11305503|NCT02600611|12503423|FG001|STARTED|Overall Study||300
11305504|NCT02600611|12503422|FG000|COMPLETED|Overall Study||298
11305505|NCT02600611|12503423|FG001|COMPLETED|Overall Study||300
11305506|NCT02600611|12503422|FG000|NOT COMPLETED|Overall Study||2
11305507|NCT02600611|12503423|FG001|NOT COMPLETED|Overall Study||0
11305508|NCT02600637|12503431|FG000|STARTED|Overall Study||19
11305509|NCT02600637|12503432|FG001|STARTED|Overall Study||18
11305510|NCT02600637|12503431|FG000|COMPLETED|Overall Study||14
11305511|NCT02600637|12503432|FG001|COMPLETED|Overall Study||13
11305512|NCT02600637|12503431|FG000|NOT COMPLETED|Overall Study||5
11305513|NCT02600637|12503432|FG001|NOT COMPLETED|Overall Study||5
11305514|NCT02600715|12503440|FG000|STARTED|Overall Study||13
11305515|NCT02600715|12503441|FG001|STARTED|Overall Study||13
11305516|NCT02600715|12503440|FG000|Allocated to Randomization|Overall Study||13
11305517|NCT02600715|12503441|FG001|Allocated to Randomization|Overall Study||13
11305518|NCT02600715|12503440|FG000|Received Treatment and Suppository|Overall Study||13
11305519|NCT02600715|12503441|FG001|Received Treatment and Suppository|Overall Study||13
11305520|NCT02600715|12503440|FG000|Completed 2-week Follow-up Appointment|Overall Study||13
11305521|NCT02600715|12503441|FG001|Completed 2-week Follow-up Appointment|Overall Study||12
11305522|NCT02600715|12503440|FG000|COMPLETED|Overall Study||13
11305523|NCT02600715|12503441|FG001|COMPLETED|Overall Study||13
11305524|NCT02600715|12503440|FG000|NOT COMPLETED|Overall Study||0
11305525|NCT02600715|12503441|FG001|NOT COMPLETED|Overall Study||0
11305526|NCT02600767|12503450|FG000|STARTED|Overall Study||79
11305527|NCT02600767|12503450|FG000|COMPLETED|Overall Study||74
11305528|NCT02600767|12503450|FG000|NOT COMPLETED|Overall Study||5
11305529|NCT02600819|12503454|FG000|STARTED|GEN Phase||55
11305530|NCT02600819|12503455|FG001|STARTED|GEN Phase||0
11305531|NCT02600819|12503454|FG000|COMPLETED|GEN Phase||39
11305532|NCT02600819|12503455|FG001|COMPLETED|GEN Phase||0
11305533|NCT02600819|12503454|FG000|NOT COMPLETED|GEN Phase||16
11305534|NCT02600819|12503455|FG001|NOT COMPLETED|GEN Phase||0
11305535|NCT02600819|12503454|FG000|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0
11341901|NCT02938585|12539348|FG000|NOT COMPLETED|Overall Study||0
11305536|NCT02600819|12503455|FG001|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|10
11305537|NCT02600819|12503454|FG000|COMPLETED|BVY OL Extension Phase||0
11305538|NCT02600819|12503455|FG001|COMPLETED|BVY OL Extension Phase||10
11305539|NCT02600819|12503454|FG000|NOT COMPLETED|BVY OL Extension Phase||0
11305540|NCT02600819|12503455|FG001|NOT COMPLETED|BVY OL Extension Phase||0
11305541|NCT02600845|12503461|FG000|STARTED|Overall Study||122
11305542|NCT02600845|12503461|FG000|COMPLETED|Overall Study||104
11305543|NCT02600845|12503461|FG000|NOT COMPLETED|Overall Study||18
11305544|NCT02600871|12503467|FG000|STARTED|Overall Study||52
11305545|NCT02600871|12503468|FG001|STARTED|Overall Study||49
11305546|NCT02600871|12503467|FG000|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
11305547|NCT02600871|12503468|FG001|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
11305548|NCT02600871|12503467|FG000|NOT COMPLETED|Overall Study||13
11305549|NCT02600871|12503468|FG001|NOT COMPLETED|Overall Study||10
11305550|NCT02601001|12503478|FG000|STARTED|Dosing Period 1||10
11305551|NCT02601001|12503479|FG001|STARTED|Dosing Period 1||20
11305552|NCT02601001|12503480|FG002|STARTED|Dosing Period 1||20
11305553|NCT02601001|12503481|FG003|STARTED|Dosing Period 1||0
11305554|NCT02601001|12503482|FG004|STARTED|Dosing Period 1||0
11305555|NCT02601001|12503483|FG005|STARTED|Dosing Period 1||0
11305556|NCT02601001|12503484|FG006|STARTED|Dosing Period 1||0
11305557|NCT02601001|12503478|FG000|COMPLETED|Dosing Period 1||10
11305558|NCT02601001|12503479|FG001|COMPLETED|Dosing Period 1||20
11305559|NCT02601001|12503480|FG002|COMPLETED|Dosing Period 1||20
11305560|NCT02601001|12503481|FG003|COMPLETED|Dosing Period 1||0
11305561|NCT02601001|12503482|FG004|COMPLETED|Dosing Period 1||0
11305562|NCT02601001|12503483|FG005|COMPLETED|Dosing Period 1||0
11305563|NCT02601001|12503484|FG006|COMPLETED|Dosing Period 1||0
11305564|NCT02601001|12503478|FG000|NOT COMPLETED|Dosing Period 1||0
11305565|NCT02601001|12503479|FG001|NOT COMPLETED|Dosing Period 1||0
11305566|NCT02601001|12503480|FG002|NOT COMPLETED|Dosing Period 1||0
11305567|NCT02601001|12503481|FG003|NOT COMPLETED|Dosing Period 1||0
11305568|NCT02601001|12503482|FG004|NOT COMPLETED|Dosing Period 1||0
11305569|NCT02601001|12503483|FG005|NOT COMPLETED|Dosing Period 1||0
11305570|NCT02601001|12503484|FG006|NOT COMPLETED|Dosing Period 1||0
11305571|NCT02601001|12503478|FG000|STARTED|Dosing Period 2||10
11305572|NCT02601001|12503479|FG001|STARTED|Dosing Period 2||0
11305573|NCT02601001|12503480|FG002|STARTED|Dosing Period 2||0
11305574|NCT02601001|12503481|FG003|STARTED|Dosing Period 2||7
11305575|NCT02601001|12503482|FG004|STARTED|Dosing Period 2||13
11305576|NCT02601001|12503483|FG005|STARTED|Dosing Period 2||7
11305577|NCT02601001|12503484|FG006|STARTED|Dosing Period 2||13
11305578|NCT02601001|12503478|FG000|COMPLETED|Dosing Period 2||10
11305579|NCT02601001|12503479|FG001|COMPLETED|Dosing Period 2||0
11305580|NCT02601001|12503480|FG002|COMPLETED|Dosing Period 2||0
11305581|NCT02601001|12503481|FG003|COMPLETED|Dosing Period 2||7
11305582|NCT02601001|12503482|FG004|COMPLETED|Dosing Period 2||13
11305583|NCT02601001|12503483|FG005|COMPLETED|Dosing Period 2||7
11305584|NCT02601001|12503484|FG006|COMPLETED|Dosing Period 2||12
11305585|NCT02601001|12503478|FG000|NOT COMPLETED|Dosing Period 2||0
11305586|NCT02601001|12503479|FG001|NOT COMPLETED|Dosing Period 2||0
11305587|NCT02601001|12503480|FG002|NOT COMPLETED|Dosing Period 2||0
11305588|NCT02601001|12503481|FG003|NOT COMPLETED|Dosing Period 2||0
11305589|NCT02601001|12503482|FG004|NOT COMPLETED|Dosing Period 2||0
11305590|NCT02601001|12503483|FG005|NOT COMPLETED|Dosing Period 2||0
11305591|NCT02601001|12503484|FG006|NOT COMPLETED|Dosing Period 2||1
11305592|NCT02601027|12503507|FG000|STARTED|Registration to Surgery||64
11305593|NCT02601027|12503508|FG001|STARTED|Registration to Surgery||56
11305594|NCT02601027|12503507|FG000|COMPLETED|Registration to Surgery||44
11305595|NCT02601027|12503508|FG001|COMPLETED|Registration to Surgery||46
11305596|NCT02601027|12503507|FG000|NOT COMPLETED|Registration to Surgery||20
11305597|NCT02601027|12503508|FG001|NOT COMPLETED|Registration to Surgery||10
11305598|NCT02601027|12503507|FG000|STARTED|Surgery to Assessments||44
11305599|NCT02601027|12503508|FG001|STARTED|Surgery to Assessments||46
11305600|NCT02601027|12503507|FG000|COMPLETED|Surgery to Assessments||44
11305601|NCT02601027|12503508|FG001|COMPLETED|Surgery to Assessments||46
11305602|NCT02601027|12503507|FG000|NOT COMPLETED|Surgery to Assessments||0
11305603|NCT02601027|12503508|FG001|NOT COMPLETED|Surgery to Assessments||0
11305604|NCT02601105|12503514|FG000|STARTED|Placebo Cream; Centella Asiatica Bsln.||15
11305605|NCT02601105|12503514|FG000|COMPLETED|Placebo Cream; Centella Asiatica Bsln.||15
11305606|NCT02601105|12503514|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Bsln.||0
11305607|NCT02601105|12503514|FG000|STARTED|Placebo Cream; Centella Asiatica Week 6||15
11305608|NCT02601105|12503514|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 6||15
11305609|NCT02601105|12503514|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 6||0
11305610|NCT02601105|12503514|FG000|STARTED|Placebo Cream; Centella Asiatica Week 12||15
11305611|NCT02601105|12503514|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 12||13
11305612|NCT02601105|12503514|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 12||2
11305613|NCT02601170|12503522|FG000|STARTED|Overall Study||11
11305614|NCT02601170|12503523|FG001|STARTED|Overall Study||11
11305615|NCT02601170|12503522|FG000|COMPLETED|Overall Study||11
11305616|NCT02601170|12503523|FG001|COMPLETED|Overall Study||11
11305617|NCT02601170|12503522|FG000|NOT COMPLETED|Overall Study||0
11305618|NCT02601170|12503523|FG001|NOT COMPLETED|Overall Study||0
11305619|NCT02601300|12503529|FG000|STARTED|Induction Phase||41
11305620|NCT02601300|12503529|FG000|COMPLETED|Induction Phase||38
11305621|NCT02601300|12503529|FG000|NOT COMPLETED|Induction Phase||3
11305622|NCT02601300|12503529|FG000|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
11305623|NCT02601300|12503529|FG000|Treated With IP|Extension Phase||34
11305624|NCT02601300|12503529|FG000|COMPLETED|Extension Phase||18
11305625|NCT02601300|12503529|FG000|NOT COMPLETED|Extension Phase||17
11305626|NCT02601469|12503537|FG000|STARTED|Overall Study||25
11305627|NCT02601469|12503538|FG001|STARTED|Overall Study||1
11305628|NCT02601469|12503537|FG000|COMPLETED|Overall Study||24
11305629|NCT02601469|12503538|FG001|COMPLETED|Overall Study||1
11305630|NCT02601469|12503537|FG000|NOT COMPLETED|Overall Study||1
11305631|NCT02601469|12503538|FG001|NOT COMPLETED|Overall Study||0
11341902|NCT02938585|12539349|FG001|NOT COMPLETED|Overall Study||1
11341903|NCT02938585|12539350|FG002|NOT COMPLETED|Overall Study||0
11341904|NCT02938585|12539351|FG003|NOT COMPLETED|Overall Study||5
11341905|NCT02938949|12539377|FG000|STARTED|Overall Study||10
11341906|NCT02938949|12539378|FG001|STARTED|Overall Study||10
11341907|NCT02938949|12539377|FG000|COMPLETED|Overall Study||10
11341908|NCT02938949|12539378|FG001|COMPLETED|Overall Study||10
11341909|NCT02938949|12539377|FG000|NOT COMPLETED|Overall Study||0
11341910|NCT02938949|12539378|FG001|NOT COMPLETED|Overall Study||0
11341911|NCT02939014|12539386|FG000|STARTED|Overall Study||30
11341912|NCT02939014|12539387|FG001|STARTED|Overall Study||9
11341913|NCT02939014|12539386|FG000|COMPLETED|Overall Study||25
11341914|NCT02939014|12539387|FG001|COMPLETED|Overall Study||6
11341915|NCT02939014|12539386|FG000|NOT COMPLETED|Overall Study||5
11341916|NCT02939014|12539387|FG001|NOT COMPLETED|Overall Study||3
11341917|NCT02939079|12539396|FG000|STARTED|Overall Study||25
11341918|NCT02939079|12539397|FG001|STARTED|Overall Study||25
11341919|NCT02939079|12539396|FG000|COMPLETED|Overall Study||21
11341920|NCT02939079|12539397|FG001|COMPLETED|Overall Study||20
11341921|NCT02939079|12539396|FG000|NOT COMPLETED|Overall Study||4
11341922|NCT02939079|12539397|FG001|NOT COMPLETED|Overall Study||5
11341923|NCT02939105|12539403|FG000|STARTED|Overall Study||15
11341924|NCT02939105|12539403|FG000|COMPLETED|Overall Study||15
11341925|NCT02939105|12539403|FG000|NOT COMPLETED|Overall Study||0
11341926|NCT02939131|12539410|FG000|STARTED|Overall Study|One additional site in the COMB-R group withdrew prior to the start of participant enrollment.|81
11341927|NCT02939131|12539411|FG001|STARTED|Overall Study||75
11341928|NCT02939131|12539410|FG000|Week 24 Visit|Overall Study|These are the numbers still on study at week 24|74
11341929|NCT02939131|12539411|FG001|Week 24 Visit|Overall Study||72
11341930|NCT02939131|12539410|FG000|COMPLETED|Overall Study||70
11341931|NCT02939131|12539411|FG001|COMPLETED|Overall Study||66
11341932|NCT02939131|12539410|FG000|NOT COMPLETED|Overall Study||11
11341933|NCT02939131|12539411|FG001|NOT COMPLETED|Overall Study||9
11341934|NCT02939170|12539420|FG000|STARTED|Overall Study||40
11341935|NCT02939170|12539421|FG001|STARTED|Overall Study||40
11341936|NCT02939170|12539420|FG000|COMPLETED|Overall Study||40
11341937|NCT02939170|12539421|FG001|COMPLETED|Overall Study||40
11341938|NCT02939170|12539420|FG000|NOT COMPLETED|Overall Study||0
11341939|NCT02939170|12539421|FG001|NOT COMPLETED|Overall Study||0
11341940|NCT02939326|12539436|FG000|STARTED|Overall Study||7
11341941|NCT02939326|12539437|FG001|STARTED|Overall Study||5
11341942|NCT02939326|12539438|FG002|STARTED|Overall Study||5
11341943|NCT02939326|12539439|FG003|STARTED|Overall Study||5
11341944|NCT02939326|12539440|FG004|STARTED|Overall Study||5
11341945|NCT02939326|12539441|FG005|STARTED|Overall Study||5
11341946|NCT02939326|12539442|FG006|STARTED|Overall Study||5
11341947|NCT02939326|12539443|FG007|STARTED|Overall Study||5
11341948|NCT02939326|12539436|FG000|COMPLETED|Overall Study||7
11341949|NCT02939326|12539437|FG001|COMPLETED|Overall Study||5
11341950|NCT02939326|12539438|FG002|COMPLETED|Overall Study||5
11341951|NCT02939326|12539439|FG003|COMPLETED|Overall Study||5
11341952|NCT02939326|12539440|FG004|COMPLETED|Overall Study||5
11341953|NCT02939326|12539441|FG005|COMPLETED|Overall Study||5
11341954|NCT02939326|12539442|FG006|COMPLETED|Overall Study||5
11341955|NCT02939326|12539443|FG007|COMPLETED|Overall Study||5
11341956|NCT02939326|12539436|FG000|NOT COMPLETED|Overall Study||0
11341957|NCT02939326|12539437|FG001|NOT COMPLETED|Overall Study||0
11341958|NCT02939326|12539438|FG002|NOT COMPLETED|Overall Study||0
11341959|NCT02939326|12539439|FG003|NOT COMPLETED|Overall Study||0
11341960|NCT02939326|12539440|FG004|NOT COMPLETED|Overall Study||0
11341961|NCT02939326|12539441|FG005|NOT COMPLETED|Overall Study||0
11341962|NCT02939326|12539442|FG006|NOT COMPLETED|Overall Study||0
11341963|NCT02939326|12539443|FG007|NOT COMPLETED|Overall Study||0
11341964|NCT02939560|12539461|FG000|STARTED|Overall Study||13
11341965|NCT02939560|12539461|FG000|COMPLETED|Overall Study||10
11341966|NCT02939560|12539461|FG000|NOT COMPLETED|Overall Study||3
11341967|NCT02939599|12539467|FG000|STARTED|Overall Study||3
11341968|NCT02939599|12539468|FG001|STARTED|Overall Study||2
11341969|NCT02939599|12539467|FG000|COMPLETED|Overall Study||0
11341970|NCT02939599|12539468|FG001|COMPLETED|Overall Study||0
11341971|NCT02939599|12539467|FG000|NOT COMPLETED|Overall Study||3
11341972|NCT02939599|12539468|FG001|NOT COMPLETED|Overall Study||2
11341973|NCT02939651|12539475|FG000|STARTED|Overall Study||21
11341974|NCT02939651|12539475|FG000|COMPLETED|Overall Study||21
11341975|NCT02939651|12539475|FG000|NOT COMPLETED|Overall Study||0
11341976|NCT02939716|12539479|FG000|STARTED|Overall Study||3
11341977|NCT02939716|12539480|FG001|STARTED|Overall Study||3
11341978|NCT02939716|12539481|FG002|STARTED|Overall Study||3
11341979|NCT02939716|12539482|FG003|STARTED|Overall Study||3
11341980|NCT02939716|12539483|FG004|STARTED|Overall Study||3
11341981|NCT02939716|12539484|FG005|STARTED|Overall Study||3
11341982|NCT02939716|12539479|FG000|COMPLETED|Overall Study||3
11305632|NCT02601560|12503552|FG000|STARTED|Overall Study||8
11305633|NCT02601560|12503553|FG001|STARTED|Overall Study||6
11305634|NCT02601560|12503554|FG002|STARTED|Overall Study||6
11305635|NCT02601560|12503555|FG003|STARTED|Overall Study||6
11305636|NCT02601560|12503556|FG004|STARTED|Overall Study||6
11305637|NCT02601560|12503557|FG005|STARTED|Overall Study||4
11305638|NCT02601560|12503558|FG006|STARTED|Overall Study||6
11305639|NCT02601560|12503559|FG007|STARTED|Overall Study||6
11305640|NCT02601560|12503552|FG000|COMPLETED|Overall Study||8
11305641|NCT02601560|12503553|FG001|COMPLETED|Overall Study||6
11305642|NCT02601560|12503554|FG002|COMPLETED|Overall Study||6
11305643|NCT02601560|12503555|FG003|COMPLETED|Overall Study||6
11305644|NCT02601560|12503556|FG004|COMPLETED|Overall Study||6
11305645|NCT02601560|12503557|FG005|COMPLETED|Overall Study||4
11305646|NCT02601560|12503558|FG006|COMPLETED|Overall Study||5
11305647|NCT02601560|12503559|FG007|COMPLETED|Overall Study||6
11305648|NCT02601560|12503552|FG000|NOT COMPLETED|Overall Study||0
11305649|NCT02601560|12503553|FG001|NOT COMPLETED|Overall Study||0
11305650|NCT02601560|12503554|FG002|NOT COMPLETED|Overall Study||0
11305651|NCT02601560|12503555|FG003|NOT COMPLETED|Overall Study||0
11305652|NCT02601560|12503556|FG004|NOT COMPLETED|Overall Study||0
11305653|NCT02601560|12503557|FG005|NOT COMPLETED|Overall Study||0
11305654|NCT02601560|12503558|FG006|NOT COMPLETED|Overall Study||1
11305655|NCT02601560|12503559|FG007|NOT COMPLETED|Overall Study||0
11305656|NCT02601573|12503589|FG000|STARTED|Overall Study|Number randomized and treated.|23
11305657|NCT02601573|12503590|FG001|STARTED|Overall Study|Number randomized and treated.|24
11305658|NCT02601573|12503591|FG002|STARTED|Overall Study|Number randomized and treated.|17
11305659|NCT02601573|12503592|FG003|STARTED|Overall Study|Number randomized and treated.|18
11305660|NCT02601573|12503593|FG004|STARTED|Overall Study|Number randomized and treated.|18
11305661|NCT02601573|12503589|FG000|COMPLETED|Overall Study||23
11305662|NCT02601573|12503590|FG001|COMPLETED|Overall Study||20
11305663|NCT02601573|12503591|FG002|COMPLETED|Overall Study||16
11305664|NCT02601573|12503592|FG003|COMPLETED|Overall Study||17
11305665|NCT02601573|12503593|FG004|COMPLETED|Overall Study||16
11305666|NCT02601573|12503589|FG000|NOT COMPLETED|Overall Study||0
11305667|NCT02601573|12503590|FG001|NOT COMPLETED|Overall Study||4
11305668|NCT02601573|12503591|FG002|NOT COMPLETED|Overall Study||1
11305669|NCT02601573|12503592|FG003|NOT COMPLETED|Overall Study||1
11305670|NCT02601573|12503593|FG004|NOT COMPLETED|Overall Study||2
11305671|NCT02601625|12503609|FG000|STARTED|Overall Study||6
11305672|NCT02601625|12503610|FG001|STARTED|Overall Study||6
11305673|NCT02601625|12503611|FG002|STARTED|Overall Study||6
11305674|NCT02601625|12503612|FG003|STARTED|Overall Study||12
11305675|NCT02601625|12503609|FG000|COMPLETED|Overall Study||6
11305676|NCT02601625|12503610|FG001|COMPLETED|Overall Study||6
11305677|NCT02601625|12503611|FG002|COMPLETED|Overall Study||5
11305678|NCT02601625|12503612|FG003|COMPLETED|Overall Study||11
11305679|NCT02601625|12503609|FG000|NOT COMPLETED|Overall Study||0
11305680|NCT02601625|12503610|FG001|NOT COMPLETED|Overall Study||0
11305681|NCT02601625|12503611|FG002|NOT COMPLETED|Overall Study||1
11305682|NCT02601625|12503612|FG003|NOT COMPLETED|Overall Study||1
11305683|NCT02601820|12503636|FG000|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601
11305684|NCT02601820|12503636|FG000|COMPLETED|Pre-Treatment (T1)||1601
11305685|NCT02601820|12503636|FG000|NOT COMPLETED|Pre-Treatment (T1)||0
11305686|NCT02601820|12503636|FG000|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584
11305687|NCT02601820|12503636|FG000|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533
11305688|NCT02601820|12503636|FG000|NOT COMPLETED|Early On-Treatment (T2)||51
11305689|NCT02601820|12503636|FG000|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573
11305690|NCT02601820|12503636|FG000|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524
11305691|NCT02601820|12503636|FG000|NOT COMPLETED|Late On-Treatment (T3)||49
11305692|NCT02601820|12503636|FG000|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564
11305693|NCT02601820|12503636|FG000|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561
11305694|NCT02601820|12503636|FG000|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3
11305695|NCT02601820|12503636|FG000|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528
11305696|NCT02601820|12503636|FG000|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440
11305697|NCT02601820|12503636|FG000|NOT COMPLETED|1-Yr Post-Treatment (T5)||88
11305698|NCT02601833|12503655|FG000|STARTED|Overall Study||56
11305699|NCT02601833|12503656|FG001|STARTED|Overall Study||42
11305700|NCT02601833|12503655|FG000|COMPLETED|Overall Study||40
11305701|NCT02601833|12503656|FG001|COMPLETED|Overall Study||29
11305702|NCT02601833|12503655|FG000|NOT COMPLETED|Overall Study||16
11305703|NCT02601833|12503656|FG001|NOT COMPLETED|Overall Study||13
11305704|NCT02601976|12503665|FG000|STARTED|Overall Study||64
11305705|NCT02601976|12503665|FG000|COMPLETED|Overall Study||64
11305706|NCT02601976|12503665|FG000|NOT COMPLETED|Overall Study||0
11305707|NCT02602080|12503672|FG000|STARTED|Overall Study||21
11305708|NCT02602080|12503673|FG001|STARTED|Overall Study||16
11305709|NCT02602080|12503674|FG002|STARTED|Overall Study||18
11305710|NCT02602080|12503672|FG000|COMPLETED|Overall Study||15
11305711|NCT02602080|12503673|FG001|COMPLETED|Overall Study||15
11305712|NCT02602080|12503674|FG002|COMPLETED|Overall Study||15
11305713|NCT02602080|12503672|FG000|NOT COMPLETED|Overall Study||6
11305714|NCT02602080|12503673|FG001|NOT COMPLETED|Overall Study||1
11305715|NCT02602080|12503674|FG002|NOT COMPLETED|Overall Study||3
11305716|NCT02602223|12503682|FG000|STARTED|Overall Study||9
11305717|NCT02602223|12503682|FG000|COMPLETED|Overall Study||9
11305718|NCT02602223|12503682|FG000|NOT COMPLETED|Overall Study||0
11305719|NCT02602496|12503691|FG000|STARTED|Overall Study||15
11305720|NCT02602496|12503692|FG001|STARTED|Overall Study||20
11305721|NCT02602496|12503693|FG002|STARTED|Overall Study||17
11305722|NCT02602496|12503691|FG000|COMPLETED|Overall Study||14
11305723|NCT02602496|12503692|FG001|COMPLETED|Overall Study||18
11305724|NCT02602496|12503693|FG002|COMPLETED|Overall Study||17
11305725|NCT02602496|12503691|FG000|NOT COMPLETED|Overall Study||1
11305726|NCT02602496|12503692|FG001|NOT COMPLETED|Overall Study||2
11305727|NCT02602496|12503693|FG002|NOT COMPLETED|Overall Study||0
11305728|NCT02603107|12503703|FG000|STARTED|Randomized Phase||290
11305729|NCT02603107|12503704|FG001|STARTED|Randomized Phase||287
11305730|NCT02603107|12503703|FG000|COMPLETED|Randomized Phase||275
11305731|NCT02603107|12503704|FG001|COMPLETED|Randomized Phase||266
11305732|NCT02603107|12503703|FG000|NOT COMPLETED|Randomized Phase||15
11305733|NCT02603107|12503704|FG001|NOT COMPLETED|Randomized Phase||21
11305734|NCT02603107|12503703|FG000|STARTED|Optional Extension Phase|3 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|272
11305735|NCT02603107|12503704|FG001|STARTED|Optional Extension Phase|21 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|245
11305736|NCT02603107|12503703|FG000|COMPLETED|Optional Extension Phase||263
11305737|NCT02603107|12503704|FG001|COMPLETED|Optional Extension Phase||232
11305738|NCT02603107|12503703|FG000|NOT COMPLETED|Optional Extension Phase||9
11305739|NCT02603107|12503704|FG001|NOT COMPLETED|Optional Extension Phase||13
11305740|NCT02603120|12503714|FG000|STARTED|Double-Blind Treatment Phase||284
11305741|NCT02603120|12503715|FG001|STARTED|Double-Blind Treatment Phase||283
11305742|NCT02603120|12503714|FG000|COMPLETED|Double-Blind Treatment Phase||265
11305743|NCT02603120|12503715|FG001|COMPLETED|Double-Blind Treatment Phase||267
11305744|NCT02603120|12503714|FG000|NOT COMPLETED|Double-Blind Treatment Phase||19
11305745|NCT02603120|12503715|FG001|NOT COMPLETED|Double-Blind Treatment Phase||16
11305746|NCT02603120|12503714|FG000|STARTED|OL Extension B/F/TAF Treatment Phase||259
11305747|NCT02603120|12503715|FG001|STARTED|OL Extension B/F/TAF Treatment Phase||265
11305748|NCT02603120|12503714|FG000|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
11305749|NCT02603120|12503715|FG001|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
11305750|NCT02603120|12503714|FG000|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||5
11305751|NCT02603120|12503715|FG001|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||11
11305752|NCT02603172|12503731|FG000|STARTED|Part A (Approximately 16 Weeks)||7
11305753|NCT02603172|12503732|FG001|STARTED|Part A (Approximately 16 Weeks)||1
11305754|NCT02603172|12503733|FG002|STARTED|Part A (Approximately 16 Weeks)||8
11305755|NCT02603172|12503734|FG003|STARTED|Part A (Approximately 16 Weeks)||1
11305756|NCT02603172|12503735|FG004|STARTED|Part A (Approximately 16 Weeks)||0
11305757|NCT02603172|12503736|FG005|STARTED|Part A (Approximately 16 Weeks)||0
11305758|NCT02603172|12503737|FG006|STARTED|Part A (Approximately 16 Weeks)||0
11305759|NCT02603172|12503738|FG007|STARTED|Part A (Approximately 16 Weeks)||0
11305760|NCT02603172|12503731|FG000|COMPLETED|Part A (Approximately 16 Weeks)||7
11305761|NCT02603172|12503732|FG001|COMPLETED|Part A (Approximately 16 Weeks)||1
11305762|NCT02603172|12503733|FG002|COMPLETED|Part A (Approximately 16 Weeks)||7
11305763|NCT02603172|12503734|FG003|COMPLETED|Part A (Approximately 16 Weeks)||1
11305764|NCT02603172|12503735|FG004|COMPLETED|Part A (Approximately 16 Weeks)||0
11305765|NCT02603172|12503736|FG005|COMPLETED|Part A (Approximately 16 Weeks)||0
11305766|NCT02603172|12503737|FG006|COMPLETED|Part A (Approximately 16 Weeks)||0
11305767|NCT02603172|12503738|FG007|COMPLETED|Part A (Approximately 16 Weeks)||0
11305768|NCT02603172|12503731|FG000|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
11305769|NCT02603172|12503732|FG001|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
11305770|NCT02603172|12503733|FG002|NOT COMPLETED|Part A (Approximately 16 Weeks)||1
11305771|NCT02603172|12503734|FG003|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
11305772|NCT02603172|12503735|FG004|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
11305773|NCT02603172|12503736|FG005|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
11305774|NCT02603172|12503737|FG006|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
11305775|NCT02603172|12503738|FG007|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
11305776|NCT02603172|12503731|FG000|STARTED|Part B (Approximately 7 Weeks)||0
11305777|NCT02603172|12503732|FG001|STARTED|Part B (Approximately 7 Weeks)||1
11305778|NCT02603172|12503733|FG002|STARTED|Part B (Approximately 7 Weeks)||0
11305779|NCT02603172|12503734|FG003|STARTED|Part B (Approximately 7 Weeks)||1
11305780|NCT02603172|12503735|FG004|STARTED|Part B (Approximately 7 Weeks)||6
11305781|NCT02603172|12503736|FG005|STARTED|Part B (Approximately 7 Weeks)||0
11305782|NCT02603172|12503737|FG006|STARTED|Part B (Approximately 7 Weeks)||0
11305783|NCT02603172|12503738|FG007|STARTED|Part B (Approximately 7 Weeks)||0
11305784|NCT02603172|12503731|FG000|COMPLETED|Part B (Approximately 7 Weeks)||0
11305785|NCT02603172|12503732|FG001|COMPLETED|Part B (Approximately 7 Weeks)||1
11305786|NCT02603172|12503733|FG002|COMPLETED|Part B (Approximately 7 Weeks)||0
11305787|NCT02603172|12503734|FG003|COMPLETED|Part B (Approximately 7 Weeks)||1
11305788|NCT02603172|12503735|FG004|COMPLETED|Part B (Approximately 7 Weeks)||6
11305789|NCT02603172|12503736|FG005|COMPLETED|Part B (Approximately 7 Weeks)||0
11305790|NCT02603172|12503737|FG006|COMPLETED|Part B (Approximately 7 Weeks)||0
11305791|NCT02603172|12503738|FG007|COMPLETED|Part B (Approximately 7 Weeks)||0
11305792|NCT02603172|12503731|FG000|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
11305793|NCT02603172|12503732|FG001|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
11305794|NCT02603172|12503733|FG002|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
11305795|NCT02603172|12503734|FG003|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
11305796|NCT02603172|12503735|FG004|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
11305797|NCT02603172|12503736|FG005|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
11305798|NCT02603172|12503737|FG006|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
11305799|NCT02603172|12503738|FG007|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
11305800|NCT02603172|12503731|FG000|STARTED|Part C (Approximately 13 Weeks)||0
11305801|NCT02603172|12503732|FG001|STARTED|Part C (Approximately 13 Weeks)||0
11305802|NCT02603172|12503733|FG002|STARTED|Part C (Approximately 13 Weeks)||0
11305803|NCT02603172|12503734|FG003|STARTED|Part C (Approximately 13 Weeks)||0
11305804|NCT02603172|12503735|FG004|STARTED|Part C (Approximately 13 Weeks)||0
11305805|NCT02603172|12503736|FG005|STARTED|Part C (Approximately 13 Weeks)||0
11305806|NCT02603172|12503737|FG006|STARTED|Part C (Approximately 13 Weeks)||0
11305807|NCT02603172|12503738|FG007|STARTED|Part C (Approximately 13 Weeks)||0
11305808|NCT02603172|12503731|FG000|COMPLETED|Part C (Approximately 13 Weeks)||0
11305809|NCT02603172|12503732|FG001|COMPLETED|Part C (Approximately 13 Weeks)||0
11305810|NCT02603172|12503733|FG002|COMPLETED|Part C (Approximately 13 Weeks)||0
11305811|NCT02603172|12503734|FG003|COMPLETED|Part C (Approximately 13 Weeks)||0
11305812|NCT02603172|12503735|FG004|COMPLETED|Part C (Approximately 13 Weeks)||0
11305813|NCT02603172|12503736|FG005|COMPLETED|Part C (Approximately 13 Weeks)||0
11305814|NCT02603172|12503737|FG006|COMPLETED|Part C (Approximately 13 Weeks)||0
11305815|NCT02603172|12503738|FG007|COMPLETED|Part C (Approximately 13 Weeks)||0
11305816|NCT02603172|12503731|FG000|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
11305817|NCT02603172|12503732|FG001|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
11305818|NCT02603172|12503733|FG002|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
11305819|NCT02603172|12503734|FG003|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
11305820|NCT02603172|12503735|FG004|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
11305821|NCT02603172|12503736|FG005|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
11305822|NCT02603172|12503737|FG006|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
11305823|NCT02603172|12503738|FG007|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
11305824|NCT02603211|12503754|FG000|STARTED|Overall Study||20
11305825|NCT02603211|12503754|FG000|COMPLETED|Overall Study||20
11305826|NCT02603211|12503754|FG000|NOT COMPLETED|Overall Study||0
11305827|NCT02603393|12503761|FG000|STARTED|Overall Study||527
11305828|NCT02603393|12503762|FG001|STARTED|Overall Study||526
11305829|NCT02603393|12503761|FG000|COMPLETED|Overall Study||456
11305830|NCT02603393|12503762|FG001|COMPLETED|Overall Study||472
11305831|NCT02603393|12503761|FG000|NOT COMPLETED|Overall Study||71
11305832|NCT02603393|12503762|FG001|NOT COMPLETED|Overall Study||54
11305833|NCT02603419|12503774|FG000|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
11305834|NCT02603419|12503775|FG001|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||7
11305835|NCT02603419|12503776|FG002|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
11305836|NCT02603419|12503777|FG003|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
11305837|NCT02603419|12503778|FG004|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
11305838|NCT02603419|12503779|FG005|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||0
11305839|NCT02603419|12503774|FG000|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
11305840|NCT02603419|12503775|FG001|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
11305841|NCT02603419|12503776|FG002|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
11305842|NCT02603419|12503777|FG003|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
11305843|NCT02603419|12503778|FG004|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
11305844|NCT02603419|12503779|FG005|Treated|Lead-in Phase:Maximum Exposure:123Weeks||0
11305845|NCT02603419|12503774|FG000|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
11305846|NCT02603419|12503775|FG001|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
11305847|NCT02603419|12503776|FG002|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
11305848|NCT02603419|12503777|FG003|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
11305849|NCT02603419|12503778|FG004|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
11305850|NCT02603419|12503779|FG005|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
11305851|NCT02603419|12503774|FG000|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
11305852|NCT02603419|12503775|FG001|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||7
11305853|NCT02603419|12503776|FG002|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
11305854|NCT02603419|12503777|FG003|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
11305855|NCT02603419|12503778|FG004|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
11305856|NCT02603419|12503779|FG005|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
11305857|NCT02603419|12503774|FG000|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
11305858|NCT02603419|12503775|FG001|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
11305859|NCT02603419|12503776|FG002|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
11305860|NCT02603419|12503777|FG003|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
11305861|NCT02603419|12503778|FG004|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
11305862|NCT02603419|12503779|FG005|STARTED|Expansion Phase:Maximum Exposure:48Weeks|Participants started expansion phase while other few participants were completing lead-in phase.|3
11305863|NCT02603419|12503774|FG000|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
11305864|NCT02603419|12503775|FG001|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
11305865|NCT02603419|12503776|FG002|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
11305866|NCT02603419|12503777|FG003|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
11305867|NCT02603419|12503778|FG004|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
11305868|NCT02603419|12503779|FG005|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
11305869|NCT02603419|12503774|FG000|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
11305870|NCT02603419|12503775|FG001|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
11305871|NCT02603419|12503776|FG002|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
11305872|NCT02603419|12503777|FG003|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
11305873|NCT02603419|12503778|FG004|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
11305874|NCT02603419|12503779|FG005|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||3
11305875|NCT02603666|12503794|FG000|STARTED|Overall Study||130
11305876|NCT02603666|12503794|FG000|COMPLETED|Overall Study||130
11305877|NCT02603666|12503794|FG000|NOT COMPLETED|Overall Study||0
11305878|NCT02603809|12503804|FG000|STARTED|Overall Study||82
11305879|NCT02603809|12503805|FG001|STARTED|Overall Study||82
11305880|NCT02603809|12503806|FG002|STARTED|Overall Study||82
11305881|NCT02603809|12503807|FG003|STARTED|Overall Study||82
11305882|NCT02603809|12503808|FG004|STARTED|Overall Study||81
11305883|NCT02603809|12503809|FG005|STARTED|Overall Study||81
11305884|NCT02603809|12503804|FG000|Per-protocol Set|Overall Study||67
11305885|NCT02603809|12503805|FG001|Per-protocol Set|Overall Study||68
11305886|NCT02603809|12503806|FG002|Per-protocol Set|Overall Study||71
11305887|NCT02603809|12503807|FG003|Per-protocol Set|Overall Study||67
11305888|NCT02603809|12503808|FG004|Per-protocol Set|Overall Study||68
11305889|NCT02603809|12503809|FG005|Per-protocol Set|Overall Study||69
11305890|NCT02603809|12503804|FG000|Modified Per-Protocol Set|Overall Study|One participant had out of analysis window blood pressure measurements.|66
11305891|NCT02603809|12503805|FG001|Modified Per-Protocol Set|Overall Study||68
11305892|NCT02603809|12503806|FG002|Modified Per-Protocol Set|Overall Study||71
11305893|NCT02603809|12503807|FG003|Modified Per-Protocol Set|Overall Study||67
11305894|NCT02603809|12503808|FG004|Modified Per-Protocol Set|Overall Study||68
11305895|NCT02603809|12503809|FG005|Modified Per-Protocol Set|Overall Study||69
11305896|NCT02603809|12503804|FG000|Completed Study|Overall Study||75
11305897|NCT02603809|12503805|FG001|Completed Study|Overall Study||79
11305898|NCT02603809|12503806|FG002|Completed Study|Overall Study||79
11305899|NCT02603809|12503807|FG003|Completed Study|Overall Study||76
11305900|NCT02603809|12503808|FG004|Completed Study|Overall Study||78
11305901|NCT02603809|12503809|FG005|Completed Study|Overall Study||75
11305902|NCT02603809|12503804|FG000|COMPLETED|Overall Study||70
11305903|NCT02603809|12503805|FG001|COMPLETED|Overall Study||74
11305904|NCT02603809|12503806|FG002|COMPLETED|Overall Study||75
11305905|NCT02603809|12503807|FG003|COMPLETED|Overall Study||70
11305906|NCT02603809|12503808|FG004|COMPLETED|Overall Study||70
11305907|NCT02603809|12503809|FG005|COMPLETED|Overall Study||71
11305908|NCT02603809|12503804|FG000|NOT COMPLETED|Overall Study||12
11305909|NCT02603809|12503805|FG001|NOT COMPLETED|Overall Study||8
11305910|NCT02603809|12503806|FG002|NOT COMPLETED|Overall Study||7
11305911|NCT02603809|12503807|FG003|NOT COMPLETED|Overall Study||12
11305912|NCT02603809|12503808|FG004|NOT COMPLETED|Overall Study||11
11305913|NCT02603809|12503809|FG005|NOT COMPLETED|Overall Study||10
11305914|NCT02603926|12503825|FG000|STARTED|Overall Study||6
11305915|NCT02603926|12503825|FG000|COMPLETED|Overall Study||6
11305916|NCT02603926|12503825|FG000|NOT COMPLETED|Overall Study||0
11305917|NCT02603952|12503834|FG000|STARTED|Overall Study||32
11305918|NCT02603952|12503835|FG001|STARTED|Overall Study||31
11305919|NCT02603952|12503836|FG002|STARTED|Overall Study||31
11305920|NCT02603952|12503837|FG003|STARTED|Overall Study||32
11305921|NCT02603952|12503834|FG000|Treated|Overall Study||32
11305922|NCT02603952|12503835|FG001|Treated|Overall Study||31
11305923|NCT02603952|12503836|FG002|Treated|Overall Study||31
11305924|NCT02603952|12503837|FG003|Treated|Overall Study||31
11305925|NCT02603952|12503834|FG000|COMPLETED|Overall Study||31
11305926|NCT02603952|12503835|FG001|COMPLETED|Overall Study||31
11305927|NCT02603952|12503836|FG002|COMPLETED|Overall Study||31
11305928|NCT02603952|12503837|FG003|COMPLETED|Overall Study||31
11305929|NCT02603952|12503834|FG000|NOT COMPLETED|Overall Study||1
11305930|NCT02603952|12503835|FG001|NOT COMPLETED|Overall Study||0
11305931|NCT02603952|12503836|FG002|NOT COMPLETED|Overall Study||0
11305932|NCT02603952|12503837|FG003|NOT COMPLETED|Overall Study||1
11305933|NCT02604017|12503852|FG000|STARTED|Overall Study||352
11305934|NCT02604017|12503853|FG001|STARTED|Overall Study||351
11305935|NCT02604017|12503852|FG000|COMPLETED|Overall Study||346
11305936|NCT02604017|12503853|FG001|COMPLETED|Overall Study||343
11305937|NCT02604017|12503852|FG000|NOT COMPLETED|Overall Study||6
11305938|NCT02604017|12503853|FG001|NOT COMPLETED|Overall Study||8
11305939|NCT02604160|12503861|FG000|STARTED|Overall Study||2
11305940|NCT02604160|12503862|FG001|STARTED|Overall Study||5
11305941|NCT02604160|12503861|FG000|Received at Least One Dose of Study Drug|Overall Study||2
11305942|NCT02604160|12503862|FG001|Received at Least One Dose of Study Drug|Overall Study||5
11305943|NCT02604160|12503861|FG000|COMPLETED|Overall Study||2
11305944|NCT02604160|12503862|FG001|COMPLETED|Overall Study||3
11305945|NCT02604160|12503861|FG000|NOT COMPLETED|Overall Study||0
11305946|NCT02604160|12503862|FG001|NOT COMPLETED|Overall Study||2
11305947|NCT02604173|12503873|FG000|STARTED|Overall Study||33
11305948|NCT02604173|12503874|FG001|STARTED|Overall Study||35
11305949|NCT02604173|12503875|FG002|STARTED|Overall Study||35
11305950|NCT02604173|12503873|FG000|COMPLETED|Overall Study||33
11305951|NCT02604173|12503874|FG001|COMPLETED|Overall Study||35
11305952|NCT02604173|12503875|FG002|COMPLETED|Overall Study||35
11305953|NCT02604173|12503873|FG000|NOT COMPLETED|Overall Study||0
11305954|NCT02604173|12503874|FG001|NOT COMPLETED|Overall Study||0
11305955|NCT02604173|12503875|FG002|NOT COMPLETED|Overall Study||0
11305956|NCT02604199|12503887|FG000|STARTED|Overall Study||9
11305957|NCT02604199|12503888|FG001|STARTED|Overall Study||11
11305958|NCT02604199|12503889|FG002|STARTED|Overall Study||17
11305959|NCT02604199|12503890|FG003|STARTED|Overall Study||21
11305960|NCT02604199|12503887|FG000|COMPLETED|Overall Study||9
11305961|NCT02604199|12503888|FG001|COMPLETED|Overall Study||8
11305962|NCT02604199|12503889|FG002|COMPLETED|Overall Study||17
11305963|NCT02604199|12503890|FG003|COMPLETED|Overall Study||18
11305964|NCT02604199|12503887|FG000|NOT COMPLETED|Overall Study||0
11305965|NCT02604199|12503888|FG001|NOT COMPLETED|Overall Study||3
11305966|NCT02604199|12503889|FG002|NOT COMPLETED|Overall Study||0
11305967|NCT02604199|12503890|FG003|NOT COMPLETED|Overall Study||3
11305968|NCT02604212|12503907|FG000|STARTED|Overall Study||6
11305969|NCT02604212|12503908|FG001|STARTED|Overall Study||5
11305970|NCT02604212|12503909|FG002|STARTED|Overall Study||10
11305971|NCT02604212|12503910|FG003|STARTED|Overall Study||11
11305972|NCT02604212|12503907|FG000|COMPLETED|Overall Study||4
11305973|NCT02604212|12503908|FG001|COMPLETED|Overall Study||4
11305974|NCT02604212|12503909|FG002|COMPLETED|Overall Study||6
11305975|NCT02604212|12503910|FG003|COMPLETED|Overall Study||8
11305976|NCT02604212|12503907|FG000|NOT COMPLETED|Overall Study||2
11305977|NCT02604212|12503908|FG001|NOT COMPLETED|Overall Study||1
11305978|NCT02604212|12503909|FG002|NOT COMPLETED|Overall Study||4
11305979|NCT02604212|12503910|FG003|NOT COMPLETED|Overall Study||3
11305980|NCT02604264|12503927|FG000|STARTED|Run-In||618
11305981|NCT02604264|12503928|FG001|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
11305982|NCT02604264|12503927|FG000|COMPLETED|Run-In||618
11305983|NCT02604264|12503928|FG001|COMPLETED|Run-In||611
11305984|NCT02604264|12503927|FG000|NOT COMPLETED|Run-In||0
11305985|NCT02604264|12503928|FG001|NOT COMPLETED|Run-In||0
11305986|NCT02604264|12503927|FG000|STARTED|Intervention||1445
11305987|NCT02604264|12503928|FG001|STARTED|Intervention||1467
11305988|NCT02604264|12503927|FG000|COMPLETED|Intervention||1245
11305989|NCT02604264|12503928|FG001|COMPLETED|Intervention||1225
11305990|NCT02604264|12503927|FG000|NOT COMPLETED|Intervention||200
11305991|NCT02604264|12503928|FG001|NOT COMPLETED|Intervention||242
11305992|NCT02604342|12503936|FG000|STARTED|Overall Study||79
11305993|NCT02604342|12503937|FG001|STARTED|Overall Study||40
11305994|NCT02604342|12503936|FG000|COMPLETED|Overall Study||36
11305995|NCT02604342|12503937|FG001|COMPLETED|Overall Study||17
11305996|NCT02604342|12503936|FG000|NOT COMPLETED|Overall Study||43
11305997|NCT02604342|12503937|FG001|NOT COMPLETED|Overall Study||23
11305998|NCT02604407|12503946|FG000|STARTED|Overall Study||91
11305999|NCT02604407|12503947|FG001|STARTED|Overall Study||92
11306000|NCT02604407|12503948|FG002|STARTED|Overall Study||92
11306001|NCT02604407|12503946|FG000|TREATED|Overall Study||89
11306002|NCT02604407|12503947|FG001|TREATED|Overall Study||92
11306003|NCT02604407|12503948|FG002|TREATED|Overall Study||90
11306004|NCT02604407|12503946|FG000|COMPLETED|Overall Study||80
11306005|NCT02604407|12503947|FG001|COMPLETED|Overall Study||80
11306006|NCT02604407|12503948|FG002|COMPLETED|Overall Study||76
11306007|NCT02604407|12503946|FG000|NOT COMPLETED|Overall Study||11
11306008|NCT02604407|12503947|FG001|NOT COMPLETED|Overall Study||12
11306009|NCT02604407|12503948|FG002|NOT COMPLETED|Overall Study||16
11306010|NCT02604550|12503958|FG000|STARTED|Overall Study||56
11306011|NCT02604550|12503959|FG001|STARTED|Overall Study||59
11306012|NCT02604550|12503958|FG000|COMPLETED|Overall Study||31
11306013|NCT02604550|12503959|FG001|COMPLETED|Overall Study||33
11401489|NCT04109703|12596259|FG000|NOT COMPLETED|Overall Study||0
11401490|NCT04109703|12596260|FG001|NOT COMPLETED|Overall Study||0
11401491|NCT04109443|12596270|FG000|STARTED|Overall Study||77
11401492|NCT04109443|12596271|FG001|STARTED|Overall Study||77
11401493|NCT04109443|12596270|FG000|COMPLETED|Overall Study||67
11401494|NCT04109443|12596271|FG001|COMPLETED|Overall Study||65
11401495|NCT04109443|12596270|FG000|NOT COMPLETED|Overall Study||10
11401496|NCT04109443|12596271|FG001|NOT COMPLETED|Overall Study||12
11401497|NCT04107493|12596280|FG000|STARTED|First Intervention (1 Hour)||16
11306014|NCT02604550|12503958|FG000|NOT COMPLETED|Overall Study||25
11306015|NCT02604550|12503959|FG001|NOT COMPLETED|Overall Study||26
11306016|NCT02604589|12503968|FG000|STARTED|Overall Study||3
11306017|NCT02604589|12503969|FG001|STARTED|Overall Study||5
11306018|NCT02604589|12503970|FG002|STARTED|Overall Study||2
11306019|NCT02604589|12503968|FG000|COMPLETED|Overall Study||3
11306020|NCT02604589|12503969|FG001|COMPLETED|Overall Study||5
11306021|NCT02604589|12503970|FG002|COMPLETED|Overall Study||1
11306022|NCT02604589|12503968|FG000|NOT COMPLETED|Overall Study||0
11306023|NCT02604589|12503969|FG001|NOT COMPLETED|Overall Study||0
11306024|NCT02604589|12503970|FG002|NOT COMPLETED|Overall Study||1
11306025|NCT02604810|12503978|FG000|STARTED|IGIV-C 10%, 4-5 Weeks||52
11306026|NCT02604810|12503978|FG000|COMPLETED|IGIV-C 10%, 4-5 Weeks||49
11306027|NCT02604810|12503978|FG000|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3
11306028|NCT02604810|12503978|FG000|STARTED|IGSC 20%, 24 Weeks||49
11306029|NCT02604810|12503978|FG000|COMPLETED|IGSC 20%, 24 Weeks||42
11306030|NCT02604810|12503978|FG000|NOT COMPLETED|IGSC 20%, 24 Weeks||7
11306031|NCT02605122|12503986|FG000|STARTED|Overall Study||73
11306032|NCT02605122|12503987|FG001|STARTED|Overall Study||24
11306033|NCT02605122|12503986|FG000|Received Study Drug|Overall Study||70
11306034|NCT02605122|12503987|FG001|Received Study Drug|Overall Study||24
11306035|NCT02605122|12503986|FG000|COMPLETED|Overall Study||68
11306036|NCT02605122|12503987|FG001|COMPLETED|Overall Study||22
11306037|NCT02605122|12503986|FG000|NOT COMPLETED|Overall Study||5
11306038|NCT02605122|12503987|FG001|NOT COMPLETED|Overall Study||2
11306039|NCT02605174|12503997|FG000|STARTED|Overall Study||501
11306040|NCT02605174|12503998|FG001|STARTED|Overall Study||249
11306041|NCT02605174|12503999|FG002|STARTED|Overall Study||502
11306042|NCT02605174|12504000|FG003|STARTED|Overall Study||252
11306043|NCT02605174|12504001|FG004|STARTED|Overall Study||501
11306044|NCT02605174|12504002|FG005|STARTED|Overall Study||249
11306045|NCT02605174|12504003|FG006|STARTED|Overall Study||751
11306046|NCT02605174|12503997|FG000|Received at Least 1 Dose of Study Drug|Overall Study||429
11306047|NCT02605174|12503998|FG001|Received at Least 1 Dose of Study Drug|Overall Study||225
11306048|NCT02605174|12503999|FG002|Received at Least 1 Dose of Study Drug|Overall Study||423
11306049|NCT02605174|12504000|FG003|Received at Least 1 Dose of Study Drug|Overall Study||212
11306050|NCT02605174|12504001|FG004|Received at Least 1 Dose of Study Drug|Overall Study||434
11306051|NCT02605174|12504002|FG005|Received at Least 1 Dose of Study Drug|Overall Study||215
11306052|NCT02605174|12504003|FG006|Received at Least 1 Dose of Study Drug|Overall Study||645
11306053|NCT02605174|12503997|FG000|Received Optional 2nd Dose|Overall Study||206
11306054|NCT02605174|12503998|FG001|Received Optional 2nd Dose|Overall Study||96
11306055|NCT02605174|12503999|FG002|Received Optional 2nd Dose|Overall Study||177
11306056|NCT02605174|12504000|FG003|Received Optional 2nd Dose|Overall Study||83
11306057|NCT02605174|12504001|FG004|Received Optional 2nd Dose|Overall Study||144
11306058|NCT02605174|12504002|FG005|Received Optional 2nd Dose|Overall Study||74
11306059|NCT02605174|12504003|FG006|Received Optional 2nd Dose|Overall Study||361
11306060|NCT02605174|12503997|FG000|COMPLETED|Overall Study||437
11306061|NCT02605174|12503998|FG001|COMPLETED|Overall Study||226
11306062|NCT02605174|12503999|FG002|COMPLETED|Overall Study||426
11401498|NCT04107493|12596281|FG001|STARTED|First Intervention (1 Hour)||17
11401499|NCT04107493|12596280|FG000|COMPLETED|First Intervention (1 Hour)||16
11401500|NCT04107493|12596281|FG001|COMPLETED|First Intervention (1 Hour)||17
11306063|NCT02605174|12504000|FG003|COMPLETED|Overall Study||216
11306064|NCT02605174|12504001|FG004|COMPLETED|Overall Study||448
11306065|NCT02605174|12504002|FG005|COMPLETED|Overall Study||217
11306066|NCT02605174|12504003|FG006|COMPLETED|Overall Study||662
11306067|NCT02605174|12503997|FG000|NOT COMPLETED|Overall Study||64
11306068|NCT02605174|12503998|FG001|NOT COMPLETED|Overall Study||23
11306069|NCT02605174|12503999|FG002|NOT COMPLETED|Overall Study||76
11306070|NCT02605174|12504000|FG003|NOT COMPLETED|Overall Study||36
11306071|NCT02605174|12504001|FG004|NOT COMPLETED|Overall Study||53
11401501|NCT04107493|12596280|FG000|NOT COMPLETED|First Intervention (1 Hour)||0
11401502|NCT04107493|12596281|FG001|NOT COMPLETED|First Intervention (1 Hour)||0
11306072|NCT02605174|12504002|FG005|NOT COMPLETED|Overall Study||32
11306073|NCT02605174|12504003|FG006|NOT COMPLETED|Overall Study||89
11306074|NCT02605187|12504033|FG000|STARTED|Overall Study||40
11306075|NCT02605187|12504034|FG001|STARTED|Overall Study||21
11306076|NCT02605187|12504035|FG002|STARTED|Overall Study||83
11306077|NCT02605187|12504036|FG003|STARTED|Overall Study||16
11306078|NCT02605187|12504033|FG000|COMPLETED|Overall Study||32
11306079|NCT02605187|12504034|FG001|COMPLETED|Overall Study||19
11306080|NCT02605187|12504035|FG002|COMPLETED|Overall Study||72
11306081|NCT02605187|12504036|FG003|COMPLETED|Overall Study||15
11306082|NCT02605187|12504033|FG000|NOT COMPLETED|Overall Study||8
11306083|NCT02605187|12504034|FG001|NOT COMPLETED|Overall Study||2
11306084|NCT02605187|12504035|FG002|NOT COMPLETED|Overall Study||11
11306085|NCT02605187|12504036|FG003|NOT COMPLETED|Overall Study||1
11306086|NCT02605304|12504048|FG000|STARTED|Overall Study||4
11306087|NCT02605304|12504049|FG001|STARTED|Overall Study||3
11306088|NCT02605304|12504048|FG000|COMPLETED|Overall Study||4
11306089|NCT02605304|12504049|FG001|COMPLETED|Overall Study||3
11306090|NCT02605304|12504048|FG000|NOT COMPLETED|Overall Study||0
11306091|NCT02605304|12504049|FG001|NOT COMPLETED|Overall Study||0
11306092|NCT02605395|12504055|FG000|STARTED|Period 1, Day 1||35
11306093|NCT02605395|12504056|FG001|STARTED|Period 1, Day 1||35
11306094|NCT02605395|12504055|FG000|COMPLETED|Period 1, Day 1||35
11306095|NCT02605395|12504056|FG001|COMPLETED|Period 1, Day 1||35
11306096|NCT02605395|12504055|FG000|NOT COMPLETED|Period 1, Day 1||0
11306097|NCT02605395|12504056|FG001|NOT COMPLETED|Period 1, Day 1||0
11306098|NCT02605395|12504055|FG000|STARTED|Washout Period, Day 2 to Day 7||35
11306099|NCT02605395|12504056|FG001|STARTED|Washout Period, Day 2 to Day 7||35
11306100|NCT02605395|12504055|FG000|COMPLETED|Washout Period, Day 2 to Day 7||35
11306101|NCT02605395|12504056|FG001|COMPLETED|Washout Period, Day 2 to Day 7||35
11306102|NCT02605395|12504055|FG000|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
11306103|NCT02605395|12504056|FG001|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
11306104|NCT02605395|12504055|FG000|STARTED|Period 2, Day 8||35
11306105|NCT02605395|12504056|FG001|STARTED|Period 2, Day 8||35
11306106|NCT02605395|12504055|FG000|COMPLETED|Period 2, Day 8||35
11306107|NCT02605395|12504056|FG001|COMPLETED|Period 2, Day 8||35
11306108|NCT02605395|12504055|FG000|NOT COMPLETED|Period 2, Day 8||0
11306109|NCT02605395|12504056|FG001|NOT COMPLETED|Period 2, Day 8||0
11306110|NCT02605447|12504062|FG000|STARTED|Overall Study||1487
11306111|NCT02605447|12504062|FG000|COMPLETED|Overall Study||1385
11306112|NCT02605447|12504062|FG000|NOT COMPLETED|Overall Study||102
11306113|NCT02605642|12504069|FG000|STARTED|Overall Study||227
11306114|NCT02605642|12504070|FG001|STARTED|Overall Study||107
11306115|NCT02605642|12504069|FG000|Safety Set|Overall Study||221
11306116|NCT02605642|12504070|FG001|Safety Set|Overall Study||107
11306117|NCT02605642|12504069|FG000|COMPLETED|Overall Study||131
11306118|NCT02605642|12504070|FG001|COMPLETED|Overall Study||86
11306119|NCT02605642|12504069|FG000|NOT COMPLETED|Overall Study||96
11306120|NCT02605642|12504070|FG001|NOT COMPLETED|Overall Study||21
11306121|NCT02605837|12504078|FG000|STARTED|Overall Study||105
11306122|NCT02605837|12504079|FG001|STARTED|Overall Study||213
11306123|NCT02605837|12504078|FG000|COMPLETED|Overall Study||94
11306124|NCT02605837|12504079|FG001|COMPLETED|Overall Study||202
11306125|NCT02605837|12504078|FG000|NOT COMPLETED|Overall Study||11
11306126|NCT02605837|12504079|FG001|NOT COMPLETED|Overall Study||11
11306127|NCT02605863|12504088|FG000|STARTED|Overall Study||1
11306128|NCT02605863|12504089|FG001|STARTED|Overall Study||0
11306129|NCT02605863|12504088|FG000|COMPLETED|Overall Study||1
11306130|NCT02605863|12504089|FG001|COMPLETED|Overall Study||0
11306131|NCT02605863|12504088|FG000|NOT COMPLETED|Overall Study||0
11306132|NCT02605863|12504089|FG001|NOT COMPLETED|Overall Study||0
11306133|NCT02605876|12504098|FG000|STARTED|Overall Study||25
11306134|NCT02605876|12504099|FG001|STARTED|Overall Study||25
11306135|NCT02605876|12504100|FG002|STARTED|Overall Study||25
11306136|NCT02605876|12504098|FG000|COMPLETED|Overall Study||25
11306137|NCT02605876|12504099|FG001|COMPLETED|Overall Study||25
11306138|NCT02605876|12504100|FG002|COMPLETED|Overall Study||25
11306139|NCT02605876|12504098|FG000|NOT COMPLETED|Overall Study||0
11306140|NCT02605876|12504099|FG001|NOT COMPLETED|Overall Study||0
11306141|NCT02605876|12504100|FG002|NOT COMPLETED|Overall Study||0
11306142|NCT02605928|12504108|FG000|STARTED|Overall Study||79
11306143|NCT02605928|12504108|FG000|Pivotal Phase, Statistical Phase|Overall Study||51
11306144|NCT02605928|12504108|FG000|COMPLETED|Overall Study||46
11306145|NCT02605928|12504108|FG000|NOT COMPLETED|Overall Study||33
11306146|NCT02605954|12504114|FG000|STARTED|Overall Study||183
11306147|NCT02605954|12504115|FG001|STARTED|Overall Study||92
11306148|NCT02605954|12504114|FG000|COMPLETED|Overall Study||171
11306149|NCT02605954|12504115|FG001|COMPLETED|Overall Study||88
11022123|NCT00807885|12200377|FG005|NOT COMPLETED|Overall Study||1
11022124|NCT00807885|12200378|FG006|NOT COMPLETED|Overall Study||0
11022125|NCT00807885|12200379|FG007|NOT COMPLETED|Overall Study||0
11022126|NCT00807885|12200380|FG008|NOT COMPLETED|Overall Study||0
11022127|NCT00807937|12200404|FG000|STARTED|Overall Study||93
11022128|NCT00807937|12200405|FG001|STARTED|Overall Study||92
11306150|NCT02605954|12504114|FG000|NOT COMPLETED|Overall Study||12
11306151|NCT02605954|12504115|FG001|NOT COMPLETED|Overall Study||4
11306152|NCT02606253|12504127|FG000|STARTED|Overall Study||20
11306153|NCT02606253|12504128|FG001|STARTED|Overall Study||20
11306154|NCT02606253|12504129|FG002|STARTED|Overall Study||20
11306155|NCT02606253|12504127|FG000|COMPLETED|Overall Study||15
11306156|NCT02606253|12504128|FG001|COMPLETED|Overall Study||18
11306157|NCT02606253|12504129|FG002|COMPLETED|Overall Study||20
11306158|NCT02606253|12504127|FG000|NOT COMPLETED|Overall Study||5
11306159|NCT02606253|12504128|FG001|NOT COMPLETED|Overall Study||2
11306160|NCT02606253|12504129|FG002|NOT COMPLETED|Overall Study||0
11306161|NCT02606500|12504139|FG000|STARTED|Overall Study||35
11306162|NCT02606500|12504140|FG001|STARTED|Overall Study||35
11306163|NCT02606500|12504139|FG000|COMPLETED|Overall Study||35
11306164|NCT02606500|12504140|FG001|COMPLETED|Overall Study||35
11306165|NCT02606500|12504139|FG000|NOT COMPLETED|Overall Study||0
11306166|NCT02606500|12504140|FG001|NOT COMPLETED|Overall Study||0
11306167|NCT02606604|12504148|FG000|STARTED|Overall Study||8
11306168|NCT02606604|12504149|FG001|STARTED|Overall Study||7
11306169|NCT02606604|12504148|FG000|COMPLETED|Overall Study||7
11306170|NCT02606604|12504149|FG001|COMPLETED|Overall Study||7
11306171|NCT02606604|12504148|FG000|NOT COMPLETED|Overall Study||1
11306172|NCT02606604|12504149|FG001|NOT COMPLETED|Overall Study||0
11306173|NCT02606643|12504159|FG000|STARTED|Overall Study||68
11306174|NCT02606643|12504160|FG001|STARTED|Overall Study||76
11306175|NCT02606643|12504159|FG000|COMPLETED|Overall Study||67
11306176|NCT02606643|12504160|FG001|COMPLETED|Overall Study||73
11306177|NCT02606643|12504159|FG000|NOT COMPLETED|Overall Study||1
11306178|NCT02606643|12504160|FG001|NOT COMPLETED|Overall Study||3
11306179|NCT02606708|12504170|FG000|STARTED|Overall Study||314
11306180|NCT02606708|12504170|FG000|COMPLETED|Overall Study||314
11306181|NCT02606708|12504170|FG000|NOT COMPLETED|Overall Study||0
11306182|NCT02606734|12504174|FG000|STARTED|Overall Study||44
11306183|NCT02606734|12504174|FG000|COMPLETED|Overall Study||44
11306184|NCT02606734|12504174|FG000|NOT COMPLETED|Overall Study||0
11306185|NCT02606838|12504178|FG000|STARTED|Overall Study||119
11306186|NCT02606838|12504178|FG000|COMPLETED|Overall Study||119
11306187|NCT02606838|12504178|FG000|NOT COMPLETED|Overall Study||0
11306188|NCT02606877|12504188|FG000|STARTED|Overall Study||20
11306189|NCT02606877|12504189|FG001|STARTED|Overall Study||17
11306190|NCT02606877|12504188|FG000|COMPLETED|Overall Study||16
11306191|NCT02606877|12504189|FG001|COMPLETED|Overall Study||16
11306192|NCT02606877|12504188|FG000|NOT COMPLETED|Overall Study||4
11306193|NCT02606877|12504189|FG001|NOT COMPLETED|Overall Study||1
11306194|NCT02606903|12504199|FG000|STARTED|Overall Study||35
11306195|NCT02606903|12504200|FG001|STARTED|Overall Study||36
11306196|NCT02606903|12504199|FG000|COMPLETED|Overall Study||35
11306197|NCT02606903|12504200|FG001|COMPLETED|Overall Study||36
11306198|NCT02606903|12504199|FG000|NOT COMPLETED|Overall Study||0
11306199|NCT02606903|12504200|FG001|NOT COMPLETED|Overall Study||0
11306200|NCT02607124|12504206|FG000|STARTED|Overall Study|11 participants were enrolled however 1 participant withdrew before starting study treatment.|10
11306201|NCT02607124|12504206|FG000|COMPLETED|Overall Study||10
11306202|NCT02607124|12504206|FG000|NOT COMPLETED|Overall Study||0
11306203|NCT02607228|12504218|FG000|STARTED|Overall Study||5
11306204|NCT02607228|12504219|FG001|STARTED|Overall Study||4
11306205|NCT02607228|12504220|FG002|STARTED|Overall Study||3
11306206|NCT02607228|12504221|FG003|STARTED|Overall Study||6
11306207|NCT02607228|12504222|FG004|STARTED|Overall Study||5
11306208|NCT02607228|12504223|FG005|STARTED|Overall Study||6
11306209|NCT02607228|12504224|FG006|STARTED|Overall Study||2
11306210|NCT02607228|12504218|FG000|COMPLETED|Overall Study||0
11306211|NCT02607228|12504219|FG001|COMPLETED|Overall Study||0
11306212|NCT02607228|12504220|FG002|COMPLETED|Overall Study||0
11306213|NCT02607228|12504221|FG003|COMPLETED|Overall Study||0
11306214|NCT02607228|12504222|FG004|COMPLETED|Overall Study||0
11306215|NCT02607228|12504223|FG005|COMPLETED|Overall Study||0
11306216|NCT02607228|12504224|FG006|COMPLETED|Overall Study||0
11306217|NCT02607228|12504218|FG000|NOT COMPLETED|Overall Study||5
11306218|NCT02607228|12504219|FG001|NOT COMPLETED|Overall Study||4
11306219|NCT02607228|12504220|FG002|NOT COMPLETED|Overall Study||3
11306220|NCT02607228|12504221|FG003|NOT COMPLETED|Overall Study||6
11306221|NCT02607228|12504222|FG004|NOT COMPLETED|Overall Study||5
11306222|NCT02607228|12504223|FG005|NOT COMPLETED|Overall Study||6
11306223|NCT02607228|12504224|FG006|NOT COMPLETED|Overall Study||2
11306224|NCT02607254|12504244|FG000|STARTED|Overall Study||3
11306225|NCT02607254|12504245|FG001|STARTED|Overall Study||3
11306226|NCT02607254|12504246|FG002|STARTED|Overall Study||5
11401503|NCT04107493|12596280|FG000|STARTED|Washout (One Hour)||16
11306227|NCT02607254|12504244|FG000|COMPLETED|Overall Study||3
11306228|NCT02607254|12504245|FG001|COMPLETED|Overall Study||3
11306229|NCT02607254|12504246|FG002|COMPLETED|Overall Study||5
11306230|NCT02607254|12504244|FG000|NOT COMPLETED|Overall Study||0
11306231|NCT02607254|12504245|FG001|NOT COMPLETED|Overall Study||0
11306232|NCT02607254|12504246|FG002|NOT COMPLETED|Overall Study||0
11306233|NCT02607280|12504262|FG000|STARTED|Overall Study||30
11306234|NCT02607280|12504263|FG001|STARTED|Overall Study||5
11306235|NCT02607280|12504262|FG000|Received Study Drug|Overall Study||30
11306236|NCT02607280|12504263|FG001|Received Study Drug|Overall Study||5
11306237|NCT02607280|12504262|FG000|COMPLETED|Overall Study||26
11306238|NCT02607280|12504263|FG001|COMPLETED|Overall Study||4
11306239|NCT02607280|12504262|FG000|NOT COMPLETED|Overall Study||4
11306240|NCT02607280|12504263|FG001|NOT COMPLETED|Overall Study||1
11306241|NCT02607306|12504272|FG000|STARTED|Overall Study||275
11306242|NCT02607306|12504273|FG001|STARTED|Overall Study||271
11306243|NCT02607306|12504274|FG002|STARTED|Overall Study||273
11306244|NCT02607306|12504272|FG000|COMPLETED|Overall Study||254
11306245|NCT02607306|12504273|FG001|COMPLETED|Overall Study||248
11306246|NCT02607306|12504274|FG002|COMPLETED|Overall Study||263
11306247|NCT02607306|12504272|FG000|NOT COMPLETED|Overall Study||21
11306248|NCT02607306|12504273|FG001|NOT COMPLETED|Overall Study||23
11306249|NCT02607306|12504274|FG002|NOT COMPLETED|Overall Study||10
11306250|NCT02607618|12504285|FG000|STARTED|Overall Study||306
11306251|NCT02607618|12504286|FG001|STARTED|Overall Study||307
11306252|NCT02607618|12504285|FG000|COMPLETED|Overall Study||295
11306253|NCT02607618|12504286|FG001|COMPLETED|Overall Study||305
11306254|NCT02607618|12504285|FG000|NOT COMPLETED|Overall Study||11
11306255|NCT02607618|12504286|FG001|NOT COMPLETED|Overall Study||2
11306256|NCT02607735|12504294|FG000|STARTED|Primary Study||264
11306257|NCT02607735|12504295|FG001|STARTED|Primary Study||152
11306258|NCT02607735|12504296|FG002|STARTED|Primary Study||0
11306259|NCT02607735|12504294|FG000|COMPLETED|Primary Study||257
11306260|NCT02607735|12504295|FG001|COMPLETED|Primary Study||152
11306261|NCT02607735|12504296|FG002|COMPLETED|Primary Study||0
11306262|NCT02607735|12504294|FG000|NOT COMPLETED|Primary Study||7
11306263|NCT02607735|12504295|FG001|NOT COMPLETED|Primary Study||0
11306264|NCT02607735|12504296|FG002|NOT COMPLETED|Primary Study||0
11306265|NCT02607735|12504294|FG000|STARTED|Deferred Treatment Substudy||0
11306266|NCT02607735|12504295|FG001|STARTED|Deferred Treatment Substudy||0
11306267|NCT02607735|12504296|FG002|STARTED|Deferred Treatment Substudy||147
11306268|NCT02607735|12504294|FG000|COMPLETED|Deferred Treatment Substudy||0
11306269|NCT02607735|12504295|FG001|COMPLETED|Deferred Treatment Substudy||0
11306270|NCT02607735|12504296|FG002|COMPLETED|Deferred Treatment Substudy||142
11306271|NCT02607735|12504294|FG000|NOT COMPLETED|Deferred Treatment Substudy||0
11306272|NCT02607735|12504295|FG001|NOT COMPLETED|Deferred Treatment Substudy||0
11306273|NCT02607735|12504296|FG002|NOT COMPLETED|Deferred Treatment Substudy||5
11306274|NCT02607800|12504306|FG000|STARTED|Overall Study||502
11306275|NCT02607800|12504307|FG001|STARTED|Overall Study||441
11306276|NCT02607800|12504306|FG000|COMPLETED|Overall Study||492
11306277|NCT02607800|12504307|FG001|COMPLETED|Overall Study||430
11306278|NCT02607800|12504306|FG000|NOT COMPLETED|Overall Study||10
11306279|NCT02607800|12504307|FG001|NOT COMPLETED|Overall Study||11
11306280|NCT02608099|12504316|FG000|STARTED|Overall Study||148
11306281|NCT02608099|12504317|FG001|STARTED|Overall Study||152
11306282|NCT02608099|12504316|FG000|Safety|Overall Study||149
11306283|NCT02608099|12504317|FG001|Safety|Overall Study||151
11306284|NCT02608099|12504316|FG000|COMPLETED|Overall Study||145
11306285|NCT02608099|12504317|FG001|COMPLETED|Overall Study||150
11306286|NCT02608099|12504316|FG000|NOT COMPLETED|Overall Study||3
11306287|NCT02608099|12504317|FG001|NOT COMPLETED|Overall Study||2
11306288|NCT02608177|12504325|FG000|STARTED|Overall Study||2
11306289|NCT02608177|12504326|FG001|STARTED|Overall Study||1
11306290|NCT02608177|12504325|FG000|COMPLETED|Overall Study||2
11306291|NCT02608177|12504326|FG001|COMPLETED|Overall Study||1
11306292|NCT02608177|12504325|FG000|NOT COMPLETED|Overall Study||0
11306293|NCT02608177|12504326|FG001|NOT COMPLETED|Overall Study||0
11306294|NCT02608229|12504336|FG000|STARTED|Overall Study||10
11306295|NCT02608229|12504337|FG001|STARTED|Overall Study||8
11306296|NCT02608229|12504336|FG000|600 mg BVD-523|Overall Study||10
11306297|NCT02608229|12504337|FG001|600 mg BVD-523|Overall Study||2
11306298|NCT02608229|12504336|FG000|450 mg BVD-523|Overall Study||0
11306299|NCT02608229|12504337|FG001|450 mg BVD-523|Overall Study||6
11306300|NCT02608229|12504336|FG000|COMPLETED|Overall Study||10
11306301|NCT02608229|12504337|FG001|COMPLETED|Overall Study||8
11306302|NCT02608229|12504336|FG000|NOT COMPLETED|Overall Study||0
11306303|NCT02608229|12504337|FG001|NOT COMPLETED|Overall Study||0
11306304|NCT02608450|12504347|FG000|STARTED|Overall Study||353
11306305|NCT02608450|12504348|FG001|STARTED|Overall Study||355
11306306|NCT02608450|12504347|FG000|COMPLETED|Overall Study||287
11306307|NCT02608450|12504348|FG001|COMPLETED|Overall Study||290
11306308|NCT02608450|12504347|FG000|NOT COMPLETED|Overall Study||66
11306309|NCT02608450|12504348|FG001|NOT COMPLETED|Overall Study||65
11306310|NCT02608463|12504357|FG000|STARTED|Overall Study||10
11306311|NCT02608463|12504358|FG001|STARTED|Overall Study||5
11306312|NCT02608463|12504359|FG002|STARTED|Overall Study||0
11306313|NCT02608463|12504360|FG003|STARTED|Overall Study|No study participants were enrolled in Part B.|0
11306314|NCT02608463|12504357|FG000|COMPLETED|Overall Study||10
11306315|NCT02608463|12504358|FG001|COMPLETED|Overall Study||5
11306316|NCT02608463|12504359|FG002|COMPLETED|Overall Study||0
11306317|NCT02608463|12504360|FG003|COMPLETED|Overall Study||0
11306318|NCT02608463|12504357|FG000|NOT COMPLETED|Overall Study||0
11306319|NCT02608463|12504358|FG001|NOT COMPLETED|Overall Study||0
11306320|NCT02608463|12504359|FG002|NOT COMPLETED|Overall Study||0
11306321|NCT02608463|12504360|FG003|NOT COMPLETED|Overall Study||0
11306322|NCT02608476|12504370|FG000|STARTED|Overall Study||369
11306323|NCT02608476|12504371|FG001|STARTED|Overall Study||363
11306324|NCT02608476|12504370|FG000|COMPLETED|Overall Study||302
11306325|NCT02608476|12504371|FG001|COMPLETED|Overall Study||282
11306326|NCT02608476|12504370|FG000|NOT COMPLETED|Overall Study||67
11306327|NCT02608476|12504371|FG001|NOT COMPLETED|Overall Study||81
11306328|NCT02608489|12504379|FG000|STARTED|Overall Study||43
11306329|NCT02608489|12504380|FG001|STARTED|Overall Study||43
11306330|NCT02608489|12504379|FG000|COMPLETED|Overall Study||30
11306331|NCT02608489|12504380|FG001|COMPLETED|Overall Study||33
11306332|NCT02608489|12504379|FG000|NOT COMPLETED|Overall Study||13
11306333|NCT02608489|12504380|FG001|NOT COMPLETED|Overall Study||10
11306334|NCT02608879|12504389|FG000|STARTED|Overall Study||10
11306335|NCT02608879|12504390|FG001|STARTED|Overall Study||6
11306336|NCT02608879|12504391|FG002|STARTED|Overall Study||3
11306337|NCT02608879|12504389|FG000|COMPLETED|Overall Study||9
11306338|NCT02608879|12504390|FG001|COMPLETED|Overall Study||6
11306339|NCT02608879|12504391|FG002|COMPLETED|Overall Study||0
11306340|NCT02608879|12504389|FG000|NOT COMPLETED|Overall Study||1
11306341|NCT02608879|12504390|FG001|NOT COMPLETED|Overall Study||0
11306342|NCT02608879|12504391|FG002|NOT COMPLETED|Overall Study||3
11306343|NCT02608892|12504401|FG000|STARTED|Overall Study||51
11306344|NCT02608892|12504402|FG001|STARTED|Overall Study||49
11306345|NCT02608892|12504401|FG000|COMPLETED|Overall Study||50
11306346|NCT02608892|12504402|FG001|COMPLETED|Overall Study||49
11306347|NCT02608892|12504401|FG000|NOT COMPLETED|Overall Study||1
11306348|NCT02608892|12504402|FG001|NOT COMPLETED|Overall Study||0
11306349|NCT02609100|12504411|FG000|STARTED|Overall Study||2
11306350|NCT02609100|12504412|FG001|STARTED|Overall Study||2
11306351|NCT02609100|12504411|FG000|COMPLETED|Overall Study||2
11306352|NCT02609100|12504412|FG001|COMPLETED|Overall Study||2
11306353|NCT02609100|12504411|FG000|NOT COMPLETED|Overall Study||0
11306354|NCT02609100|12504412|FG001|NOT COMPLETED|Overall Study||0
11306355|NCT02609113|12504422|FG000|STARTED|Overall Study||11
11306356|NCT02609113|12504423|FG001|STARTED|Overall Study||11
11306357|NCT02609113|12504422|FG000|COMPLETED|Overall Study||9
11306358|NCT02609113|12504423|FG001|COMPLETED|Overall Study||9
11306359|NCT02609113|12504422|FG000|NOT COMPLETED|Overall Study||2
11306360|NCT02609113|12504423|FG001|NOT COMPLETED|Overall Study||2
11306361|NCT02609178|12504429|FG000|STARTED|First Crown||0
11306362|NCT02609178|12504430|FG001|STARTED|First Crown||1
11306363|NCT02609178|12504431|FG002|STARTED|First Crown||6
11306364|NCT02609178|12504432|FG003|STARTED|First Crown||3
11306365|NCT02609178|12504433|FG004|STARTED|First Crown||0
11306366|NCT02609178|12504434|FG005|STARTED|First Crown||2
11306367|NCT02609178|12504429|FG000|COMPLETED|First Crown||0
11306368|NCT02609178|12504430|FG001|COMPLETED|First Crown||1
11306369|NCT02609178|12504431|FG002|COMPLETED|First Crown||5
11306370|NCT02609178|12504432|FG003|COMPLETED|First Crown||2
11306371|NCT02609178|12504433|FG004|COMPLETED|First Crown||0
11306372|NCT02609178|12504434|FG005|COMPLETED|First Crown||2
11306373|NCT02609178|12504429|FG000|NOT COMPLETED|First Crown||0
11306374|NCT02609178|12504430|FG001|NOT COMPLETED|First Crown||0
11306375|NCT02609178|12504431|FG002|NOT COMPLETED|First Crown||1
11306376|NCT02609178|12504432|FG003|NOT COMPLETED|First Crown||1
11306377|NCT02609178|12504433|FG004|NOT COMPLETED|First Crown||0
11401504|NCT04107493|12596281|FG001|STARTED|Washout (One Hour)||17
11401505|NCT04107493|12596280|FG000|COMPLETED|Washout (One Hour)||16
11401506|NCT04107493|12596281|FG001|COMPLETED|Washout (One Hour)||17
11401507|NCT04107493|12596280|FG000|NOT COMPLETED|Washout (One Hour)||0
11401508|NCT04107493|12596281|FG001|NOT COMPLETED|Washout (One Hour)||0
11401509|NCT04107493|12596280|FG000|STARTED|Second Intervention||16
11401510|NCT04107493|12596281|FG001|STARTED|Second Intervention||17
11401511|NCT04107493|12596280|FG000|COMPLETED|Second Intervention||16
11401512|NCT04107493|12596281|FG001|COMPLETED|Second Intervention||17
11401513|NCT04107493|12596280|FG000|NOT COMPLETED|Second Intervention||0
11401514|NCT04107493|12596281|FG001|NOT COMPLETED|Second Intervention||0
11306378|NCT02609178|12504434|FG005|NOT COMPLETED|First Crown||0
11306379|NCT02609178|12504429|FG000|STARTED|5-minute Washout Time||0
11306380|NCT02609178|12504430|FG001|STARTED|5-minute Washout Time||1
11306381|NCT02609178|12504431|FG002|STARTED|5-minute Washout Time||5
11401515|NCT04106817|12596290|FG000|STARTED|Overall Study||12
11401516|NCT04106817|12596291|FG001|STARTED|Overall Study||11
11401517|NCT04106817|12596292|FG002|STARTED|Overall Study||12
11401518|NCT04106817|12596290|FG000|COMPLETED|Overall Study||11
11401519|NCT04106817|12596291|FG001|COMPLETED|Overall Study||11
11401520|NCT04106817|12596292|FG002|COMPLETED|Overall Study||12
11401521|NCT04106817|12596290|FG000|NOT COMPLETED|Overall Study||1
11306382|NCT02609178|12504432|FG003|STARTED|5-minute Washout Time||2
11306383|NCT02609178|12504433|FG004|STARTED|5-minute Washout Time||0
11306384|NCT02609178|12504434|FG005|STARTED|5-minute Washout Time||2
11306385|NCT02609178|12504429|FG000|COMPLETED|5-minute Washout Time||0
11401522|NCT04106817|12596291|FG001|NOT COMPLETED|Overall Study||0
11401523|NCT04106817|12596292|FG002|NOT COMPLETED|Overall Study||0
11401524|NCT04105972|12596302|FG000|STARTED|Overall Study||88
11401525|NCT04105972|12596303|FG001|STARTED|Overall Study||87
11401526|NCT04105972|12596302|FG000|COMPLETED|Overall Study||86
11306386|NCT02609178|12504430|FG001|COMPLETED|5-minute Washout Time||1
11306387|NCT02609178|12504431|FG002|COMPLETED|5-minute Washout Time||5
11306388|NCT02609178|12504432|FG003|COMPLETED|5-minute Washout Time||2
11306389|NCT02609178|12504433|FG004|COMPLETED|5-minute Washout Time||0
11306390|NCT02609178|12504434|FG005|COMPLETED|5-minute Washout Time||2
11401527|NCT04105972|12596303|FG001|COMPLETED|Overall Study||86
11401528|NCT04105972|12596302|FG000|NOT COMPLETED|Overall Study||2
11401529|NCT04105972|12596303|FG001|NOT COMPLETED|Overall Study||1
11306391|NCT02609178|12504429|FG000|NOT COMPLETED|5-minute Washout Time||0
11306392|NCT02609178|12504430|FG001|NOT COMPLETED|5-minute Washout Time||0
11306393|NCT02609178|12504431|FG002|NOT COMPLETED|5-minute Washout Time||0
11306394|NCT02609178|12504432|FG003|NOT COMPLETED|5-minute Washout Time||0
11401530|NCT04105218|12596311|FG000|STARTED|Overall Study||6
11401531|NCT04105218|12596312|FG001|STARTED|Overall Study||6
11401532|NCT04105218|12596311|FG000|Completed First Condition|Overall Study||0
11401533|NCT04105218|12596312|FG001|Completed First Condition|Overall Study||1
11401534|NCT04105218|12596311|FG000|Completed Second Condition|Overall Study||0
11401535|NCT04105218|12596312|FG001|Completed Second Condition|Overall Study||0
11401536|NCT04105218|12596311|FG000|COMPLETED|Overall Study||0
11306395|NCT02609178|12504433|FG004|NOT COMPLETED|5-minute Washout Time||0
11306396|NCT02609178|12504434|FG005|NOT COMPLETED|5-minute Washout Time||0
11306397|NCT02609178|12504429|FG000|STARTED|Second Crown||0
11306398|NCT02609178|12504430|FG001|STARTED|Second Crown||1
11306399|NCT02609178|12504431|FG002|STARTED|Second Crown||5
11306400|NCT02609178|12504432|FG003|STARTED|Second Crown||2
11306401|NCT02609178|12504433|FG004|STARTED|Second Crown||0
11306402|NCT02609178|12504434|FG005|STARTED|Second Crown||2
11306403|NCT02609178|12504429|FG000|COMPLETED|Second Crown||0
11306404|NCT02609178|12504430|FG001|COMPLETED|Second Crown||1
11306405|NCT02609178|12504431|FG002|COMPLETED|Second Crown||5
11306406|NCT02609178|12504432|FG003|COMPLETED|Second Crown||2
11401537|NCT04105218|12596312|FG001|COMPLETED|Overall Study||0
11401538|NCT04105218|12596311|FG000|NOT COMPLETED|Overall Study||6
11401539|NCT04105218|12596312|FG001|NOT COMPLETED|Overall Study||6
11401540|NCT04102956|12596320|FG000|STARTED|Overall Study||42
11401541|NCT04102956|12596321|FG001|STARTED|Overall Study||38
11401542|NCT04102956|12596320|FG000|COMPLETED|Overall Study||42
11401543|NCT04102956|12596321|FG001|COMPLETED|Overall Study||38
11401544|NCT04102956|12596320|FG000|NOT COMPLETED|Overall Study||0
11401545|NCT04102956|12596321|FG001|NOT COMPLETED|Overall Study||0
11401546|NCT04102540|12596327|FG000|STARTED|Overall Study||32
11306407|NCT02609178|12504433|FG004|COMPLETED|Second Crown||0
11306408|NCT02609178|12504434|FG005|COMPLETED|Second Crown||2
11306409|NCT02609178|12504429|FG000|NOT COMPLETED|Second Crown||0
11306410|NCT02609178|12504430|FG001|NOT COMPLETED|Second Crown||0
11306411|NCT02609178|12504431|FG002|NOT COMPLETED|Second Crown||0
11306412|NCT02609178|12504432|FG003|NOT COMPLETED|Second Crown||0
11306413|NCT02609178|12504433|FG004|NOT COMPLETED|Second Crown||0
11306414|NCT02609178|12504434|FG005|NOT COMPLETED|Second Crown||0
11306415|NCT02609178|12504429|FG000|STARTED|5-minute Washout Time||0
11306416|NCT02609178|12504430|FG001|STARTED|5-minute Washout Time||1
11306417|NCT02609178|12504431|FG002|STARTED|5-minute Washout Time||5
11306418|NCT02609178|12504432|FG003|STARTED|5-minute Washout Time||2
11306419|NCT02609178|12504433|FG004|STARTED|5-minute Washout Time||0
11306420|NCT02609178|12504434|FG005|STARTED|5-minute Washout Time||2
11306421|NCT02609178|12504429|FG000|COMPLETED|5-minute Washout Time||0
11306422|NCT02609178|12504430|FG001|COMPLETED|5-minute Washout Time||1
11306423|NCT02609178|12504431|FG002|COMPLETED|5-minute Washout Time||5
11306424|NCT02609178|12504432|FG003|COMPLETED|5-minute Washout Time||2
11306425|NCT02609178|12504433|FG004|COMPLETED|5-minute Washout Time||0
11306426|NCT02609178|12504434|FG005|COMPLETED|5-minute Washout Time||2
11306427|NCT02609178|12504429|FG000|NOT COMPLETED|5-minute Washout Time||0
11306428|NCT02609178|12504430|FG001|NOT COMPLETED|5-minute Washout Time||0
11306429|NCT02609178|12504431|FG002|NOT COMPLETED|5-minute Washout Time||0
11306430|NCT02609178|12504432|FG003|NOT COMPLETED|5-minute Washout Time||0
11306431|NCT02609178|12504433|FG004|NOT COMPLETED|5-minute Washout Time||0
11306432|NCT02609178|12504434|FG005|NOT COMPLETED|5-minute Washout Time||0
11306433|NCT02609178|12504429|FG000|STARTED|Third Crown||0
11306434|NCT02609178|12504430|FG001|STARTED|Third Crown||1
11306435|NCT02609178|12504431|FG002|STARTED|Third Crown||5
11306436|NCT02609178|12504432|FG003|STARTED|Third Crown||2
11306437|NCT02609178|12504433|FG004|STARTED|Third Crown||0
11306438|NCT02609178|12504434|FG005|STARTED|Third Crown||2
11306439|NCT02609178|12504429|FG000|COMPLETED|Third Crown||0
11306440|NCT02609178|12504430|FG001|COMPLETED|Third Crown||1
11306441|NCT02609178|12504431|FG002|COMPLETED|Third Crown||5
11306442|NCT02609178|12504432|FG003|COMPLETED|Third Crown||2
11306443|NCT02609178|12504433|FG004|COMPLETED|Third Crown||0
11306444|NCT02609178|12504434|FG005|COMPLETED|Third Crown||2
11306445|NCT02609178|12504429|FG000|NOT COMPLETED|Third Crown||0
11401547|NCT04102540|12596327|FG000|COMPLETED|Overall Study||24
11401548|NCT04102540|12596327|FG000|NOT COMPLETED|Overall Study||8
11306446|NCT02609178|12504430|FG001|NOT COMPLETED|Third Crown||0
11306447|NCT02609178|12504431|FG002|NOT COMPLETED|Third Crown||0
11306448|NCT02609178|12504432|FG003|NOT COMPLETED|Third Crown||0
11306449|NCT02609178|12504433|FG004|NOT COMPLETED|Third Crown||0
11306450|NCT02609178|12504434|FG005|NOT COMPLETED|Third Crown||0
11306451|NCT02609204|12504440|FG000|STARTED|Overall Study||51
11306452|NCT02609204|12504440|FG000|COMPLETED|Overall Study||51
11306453|NCT02609204|12504440|FG000|NOT COMPLETED|Overall Study||0
11306454|NCT02609308|12504447|FG000|STARTED|Overall Study||10
11306455|NCT02609308|12504448|FG001|STARTED|Overall Study||11
11306456|NCT02609308|12504447|FG000|COMPLETED|Overall Study||10
11306457|NCT02609308|12504448|FG001|COMPLETED|Overall Study||11
11306458|NCT02609308|12504447|FG000|NOT COMPLETED|Overall Study||0
11306459|NCT02609308|12504448|FG001|NOT COMPLETED|Overall Study||0
11306460|NCT02609399|12504456|FG000|STARTED|Influenza Season 2015-2016||27
11306461|NCT02609399|12504457|FG001|STARTED|Influenza Season 2015-2016||31
11306462|NCT02609399|12504456|FG000|COMPLETED|Influenza Season 2015-2016||24
11306463|NCT02609399|12504457|FG001|COMPLETED|Influenza Season 2015-2016||29
11306464|NCT02609399|12504456|FG000|NOT COMPLETED|Influenza Season 2015-2016||3
11306465|NCT02609399|12504457|FG001|NOT COMPLETED|Influenza Season 2015-2016||2
11306466|NCT02609399|12504456|FG000|STARTED|Influenza Season 2016-2017||58
11306467|NCT02609399|12504457|FG001|STARTED|Influenza Season 2016-2017||64
11306468|NCT02609399|12504456|FG000|COMPLETED|Influenza Season 2016-2017||49
11306469|NCT02609399|12504457|FG001|COMPLETED|Influenza Season 2016-2017||59
11306470|NCT02609399|12504456|FG000|NOT COMPLETED|Influenza Season 2016-2017||9
11306471|NCT02609399|12504457|FG001|NOT COMPLETED|Influenza Season 2016-2017||5
11306472|NCT02609607|12504467|FG000|STARTED|Overall Study||6
11306473|NCT02609607|12504468|FG001|STARTED|Overall Study||5
11306474|NCT02609607|12504467|FG000|COMPLETED|Overall Study||6
11306475|NCT02609607|12504468|FG001|COMPLETED|Overall Study||4
11306476|NCT02609607|12504467|FG000|NOT COMPLETED|Overall Study||0
11306477|NCT02609607|12504468|FG001|NOT COMPLETED|Overall Study||1
11306478|NCT02609633|12504476|FG000|STARTED|Overall Study||42
11306479|NCT02609633|12504477|FG001|STARTED|Overall Study||56
11306480|NCT02609633|12504476|FG000|Full Analysis Set (FAS)|Overall Study||32
11306481|NCT02609633|12504477|FG001|Full Analysis Set (FAS)|Overall Study||46
11306482|NCT02609633|12504476|FG000|COMPLETED|Overall Study||37
11306483|NCT02609633|12504477|FG001|COMPLETED|Overall Study||54
11306484|NCT02609633|12504476|FG000|NOT COMPLETED|Overall Study||5
11306485|NCT02609633|12504477|FG001|NOT COMPLETED|Overall Study||2
11306486|NCT02609659|12504484|FG000|STARTED|Overall Study||105
11306487|NCT02609659|12504484|FG000|COMPLETED|Overall Study||97
11306488|NCT02609659|12504484|FG000|NOT COMPLETED|Overall Study||8
11306489|NCT02609672|12504490|FG000|STARTED|Overall Study||12
11306490|NCT02609672|12504491|FG001|STARTED|Overall Study||12
11306491|NCT02609672|12504490|FG000|COMPLETED|Overall Study||9
11306492|NCT02609672|12504491|FG001|COMPLETED|Overall Study||11
11306493|NCT02609672|12504490|FG000|NOT COMPLETED|Overall Study||3
11306494|NCT02609672|12504491|FG001|NOT COMPLETED|Overall Study||1
11306495|NCT02609841|12504499|FG000|STARTED|Overall Study||240
11306496|NCT02609841|12504499|FG000|COMPLETED|Overall Study||212
11306497|NCT02609841|12504499|FG000|NOT COMPLETED|Overall Study||28
11306498|NCT02609984|12504507|FG000|STARTED|Overall Study||45
11306499|NCT02609984|12504508|FG001|STARTED|Overall Study||44
11306500|NCT02609984|12504507|FG000|Treated|Overall Study||45
11306501|NCT02609984|12504508|FG001|Treated|Overall Study||43
11306502|NCT02609984|12504507|FG000|COMPLETED|Overall Study||1
11306503|NCT02609984|12504508|FG001|COMPLETED|Overall Study||5
11306504|NCT02609984|12504507|FG000|NOT COMPLETED|Overall Study||44
11306505|NCT02609984|12504508|FG001|NOT COMPLETED|Overall Study||39
11306506|NCT02610140|12504516|FG000|STARTED|Randomization and Treatment Period||166
11306507|NCT02610140|12504517|FG001|STARTED|Randomization and Treatment Period||82
11306508|NCT02610140|12504516|FG000|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|163
11306509|NCT02610140|12504517|FG001|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|72
11306510|NCT02610140|12504516|FG000|COMPLETED|Randomization and Treatment Period||0
11306511|NCT02610140|12504517|FG001|COMPLETED|Randomization and Treatment Period||0
11306512|NCT02610140|12504516|FG000|NOT COMPLETED|Randomization and Treatment Period||166
11306513|NCT02610140|12504517|FG001|NOT COMPLETED|Randomization and Treatment Period||82
11306514|NCT02610140|12504516|FG000|STARTED|Safety Follow-up||102
11306515|NCT02610140|12504517|FG001|STARTED|Safety Follow-up||45
11306516|NCT02610140|12504516|FG000|COMPLETED|Safety Follow-up||57
11306517|NCT02610140|12504517|FG001|COMPLETED|Safety Follow-up||21
11306518|NCT02610140|12504516|FG000|NOT COMPLETED|Safety Follow-up||45
11306519|NCT02610140|12504517|FG001|NOT COMPLETED|Safety Follow-up||24
11306520|NCT02610140|12504516|FG000|STARTED|Active Follow-up||48
11306521|NCT02610140|12504517|FG001|STARTED|Active Follow-up||26
11306522|NCT02610140|12504516|FG000|COMPLETED|Active Follow-up||0
11306523|NCT02610140|12504517|FG001|COMPLETED|Active Follow-up||0
11306524|NCT02610140|12504516|FG000|NOT COMPLETED|Active Follow-up||48
11306525|NCT02610140|12504517|FG001|NOT COMPLETED|Active Follow-up||26
11306526|NCT02610140|12504516|FG000|STARTED|Long-term Follow-up||123
11306527|NCT02610140|12504517|FG001|STARTED|Long-term Follow-up||66
11306528|NCT02610140|12504516|FG000|COMPLETED|Long-term Follow-up||0
11306529|NCT02610140|12504517|FG001|COMPLETED|Long-term Follow-up||0
11306530|NCT02610140|12504516|FG000|NOT COMPLETED|Long-term Follow-up||123
11306531|NCT02610140|12504517|FG001|NOT COMPLETED|Long-term Follow-up||66
11306532|NCT02610192|12504523|FG000|STARTED|Overall Study|52 subjects had signed consent form, but 50 subjects have been treated. 2 subjects became SF.|50
11306533|NCT02610192|12504523|FG000|COMPLETED|Overall Study||41
11306534|NCT02610192|12504523|FG000|NOT COMPLETED|Overall Study||9
11306535|NCT02610231|12504527|FG000|STARTED|Overall Study||239
11306536|NCT02610231|12504527|FG000|COMPLETED|Overall Study||179
11306537|NCT02610231|12504527|FG000|NOT COMPLETED|Overall Study||60
11306538|NCT02610634|12504536|FG000|STARTED|Overall Study||60
11306539|NCT02610634|12504537|FG001|STARTED|Overall Study||40
11306540|NCT02610634|12504536|FG000|COMPLETED|Overall Study||60
11306541|NCT02610634|12504537|FG001|COMPLETED|Overall Study||40
11306542|NCT02610634|12504536|FG000|NOT COMPLETED|Overall Study||0
11306543|NCT02610634|12504537|FG001|NOT COMPLETED|Overall Study||0
11306544|NCT02610725|12504543|FG000|STARTED|Overall Study||281
11306545|NCT02610725|12504543|FG000|COMPLETED|Overall Study||75
11306546|NCT02610725|12504543|FG000|NOT COMPLETED|Overall Study||206
11306547|NCT02610816|12504549|FG000|STARTED|Phase 1||38
11306548|NCT02610816|12504550|FG001|STARTED|Phase 1||25
11306549|NCT02610816|12504551|FG002|STARTED|Phase 1||0
11306550|NCT02610816|12504552|FG003|STARTED|Phase 1||0
11306551|NCT02610816|12504549|FG000|COMPLETED|Phase 1||34
11306552|NCT02610816|12504550|FG001|COMPLETED|Phase 1||17
11306553|NCT02610816|12504551|FG002|COMPLETED|Phase 1||0
11306554|NCT02610816|12504552|FG003|COMPLETED|Phase 1||0
11306555|NCT02610816|12504549|FG000|NOT COMPLETED|Phase 1||4
11306556|NCT02610816|12504550|FG001|NOT COMPLETED|Phase 1||8
11306557|NCT02610816|12504551|FG002|NOT COMPLETED|Phase 1||0
11306558|NCT02610816|12504552|FG003|NOT COMPLETED|Phase 1||0
11306559|NCT02610816|12504549|FG000|STARTED|Phase 2||0
11306560|NCT02610816|12504550|FG001|STARTED|Phase 2||0
11306561|NCT02610816|12504551|FG002|STARTED|Phase 2||19
11306562|NCT02610816|12504552|FG003|STARTED|Phase 2||10
11306563|NCT02610816|12504549|FG000|COMPLETED|Phase 2||0
11306564|NCT02610816|12504550|FG001|COMPLETED|Phase 2||0
11306565|NCT02610816|12504551|FG002|COMPLETED|Phase 2||8
11306566|NCT02610816|12504552|FG003|COMPLETED|Phase 2||4
11306567|NCT02610816|12504549|FG000|NOT COMPLETED|Phase 2||0
11306568|NCT02610816|12504550|FG001|NOT COMPLETED|Phase 2||0
11306569|NCT02610816|12504551|FG002|NOT COMPLETED|Phase 2||11
11306570|NCT02610816|12504552|FG003|NOT COMPLETED|Phase 2||6
11306571|NCT02610842|12504562|FG000|STARTED|Overall Study||27
11306572|NCT02610842|12504562|FG000|COMPLETED|Overall Study||22
11306573|NCT02610842|12504562|FG000|NOT COMPLETED|Overall Study||5
11306574|NCT02610868|12504568|FG000|STARTED|MYOBLOC: Treatment Session 1||187
11306575|NCT02610868|12504568|FG000|COMPLETED|MYOBLOC: Treatment Session 1||180
11306576|NCT02610868|12504568|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 1||7
11306577|NCT02610868|12504568|FG000|STARTED|MYOBLOC: Treatment Session 2||177
11306578|NCT02610868|12504568|FG000|COMPLETED|MYOBLOC: Treatment Session 2||165
11306579|NCT02610868|12504568|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 2||12
11306580|NCT02610868|12504568|FG000|STARTED|MYOBLOC: Treatment Session 3||50
11306581|NCT02610868|12504568|FG000|COMPLETED|MYOBLOC: Treatment Session 3||43
11306582|NCT02610868|12504568|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 3||7
11306583|NCT02610868|12504568|FG000|STARTED|MYOBLOC: Treatment Session 4||24
11306584|NCT02610868|12504568|FG000|COMPLETED|MYOBLOC: Treatment Session 4||22
11306585|NCT02610868|12504568|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 4||2
11306586|NCT02610972|12504590|FG000|STARTED|Overall Study||100
11306587|NCT02610972|12504591|FG001|STARTED|Overall Study||50
11306588|NCT02610972|12504590|FG000|COMPLETED|Overall Study||100
11306589|NCT02610972|12504591|FG001|COMPLETED|Overall Study||50
11306590|NCT02610972|12504590|FG000|NOT COMPLETED|Overall Study||0
11306591|NCT02610972|12504591|FG001|NOT COMPLETED|Overall Study||0
11306592|NCT02611154|12504597|FG000|STARTED|Overall Study||5
11306593|NCT02611154|12504597|FG000|COMPLETED|Overall Study||5
11306594|NCT02611154|12504597|FG000|NOT COMPLETED|Overall Study||0
11306595|NCT02611362|12504618|FG000|STARTED|Overall Study||41
11306596|NCT02611362|12504619|FG001|STARTED|Overall Study||41
11306597|NCT02611362|12504618|FG000|Immediate Posttest (3 Months)|Overall Study||33
11306598|NCT02611362|12504619|FG001|Immediate Posttest (3 Months)|Overall Study||34
11306599|NCT02611362|12504618|FG000|6-month Follow-up|Overall Study||32
11306600|NCT02611362|12504619|FG001|6-month Follow-up|Overall Study||35
11306601|NCT02611362|12504618|FG000|COMPLETED|Overall Study||32
11306602|NCT02611362|12504619|FG001|COMPLETED|Overall Study||35
11306603|NCT02611362|12504618|FG000|NOT COMPLETED|Overall Study||9
11306604|NCT02611362|12504619|FG001|NOT COMPLETED|Overall Study||6
11401549|NCT04102345|12596333|FG000|STARTED|Overall Study||26
11401550|NCT04102345|12596334|FG001|STARTED|Overall Study||32
11401551|NCT04102345|12596333|FG000|COMPLETED|Overall Study||25
11401552|NCT04102345|12596334|FG001|COMPLETED|Overall Study||32
11401553|NCT04102345|12596333|FG000|NOT COMPLETED|Overall Study||1
11401554|NCT04102345|12596334|FG001|NOT COMPLETED|Overall Study||0
11401555|NCT04092907|12596342|FG000|STARTED|Overall Study||50
11401556|NCT04092907|12596343|FG001|STARTED|Overall Study||50
11401557|NCT04092907|12596342|FG000|COMPLETED|Overall Study||48
11401558|NCT04092907|12596343|FG001|COMPLETED|Overall Study||50
11401559|NCT04092907|12596342|FG000|NOT COMPLETED|Overall Study||2
11401560|NCT04092907|12596343|FG001|NOT COMPLETED|Overall Study||0
11401561|NCT04089982|12596351|FG000|STARTED|Overall Study||6
11401562|NCT04089982|12596352|FG001|STARTED|Overall Study||5
11401563|NCT04089982|12596351|FG000|COMPLETED|Overall Study||6
11401564|NCT04089982|12596352|FG001|COMPLETED|Overall Study||5
11401565|NCT04089982|12596351|FG000|NOT COMPLETED|Overall Study||0
11401566|NCT04089982|12596352|FG001|NOT COMPLETED|Overall Study||0
11401567|NCT04086433|12596360|FG000|STARTED|Overall Study||17
11401568|NCT04086433|12596361|FG001|STARTED|Overall Study||18
11401569|NCT04086433|12596360|FG000|COMPLETED|Overall Study||17
11306605|NCT02611479|12504626|FG000|STARTED|Baseline Enrollment||184
11306606|NCT02611479|12504626|FG000|COMPLETED|Baseline Enrollment||171
11306607|NCT02611479|12504626|FG000|NOT COMPLETED|Baseline Enrollment||13
11306608|NCT02611479|12504626|FG000|STARTED|Post-Surgery Follow-up at 30-90 Days||171
11306609|NCT02611479|12504626|FG000|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169
11306610|NCT02611479|12504626|FG000|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2
11306611|NCT02611479|12504626|FG000|STARTED|Post-Surgery Follow-up at 1-Year||169
11306612|NCT02611479|12504626|FG000|COMPLETED|Post-Surgery Follow-up at 1-Year||151
11306613|NCT02611479|12504626|FG000|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18
11306614|NCT02611479|12504626|FG000|STARTED|Data Cleaning||151
11306615|NCT02611479|12504626|FG000|COMPLETED|Data Cleaning||149
11306616|NCT02611479|12504626|FG000|NOT COMPLETED|Data Cleaning||2
11306617|NCT02611752|12504632|FG000|STARTED|Overall Study||22
11306618|NCT02611752|12504633|FG001|STARTED|Overall Study||25
11306619|NCT02611752|12504632|FG000|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22
11306620|NCT02611752|12504633|FG001|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25
11306621|NCT02611752|12504632|FG000|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22
11306622|NCT02611752|12504633|FG001|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24
11306623|NCT02611752|12504632|FG000|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22
11306624|NCT02611752|12504633|FG001|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24
11306625|NCT02611752|12504632|FG000|Day11-13 Hydromorphone Challenge Injs|Overall Study||22
11306626|NCT02611752|12504633|FG001|Day11-13 Hydromorphone Challenge Injs|Overall Study||24
11306627|NCT02611752|12504632|FG000|COMPLETED|Overall Study||22
11306628|NCT02611752|12504633|FG001|COMPLETED|Overall Study||24
11306629|NCT02611752|12504632|FG000|NOT COMPLETED|Overall Study||0
11306630|NCT02611752|12504633|FG001|NOT COMPLETED|Overall Study||1
11306631|NCT02611765|12504654|FG000|STARTED|Overall Study||29
11306632|NCT02611765|12504655|FG001|STARTED|Overall Study||35
11306633|NCT02611765|12504654|FG000|COMPLETED|Overall Study||27
11306634|NCT02611765|12504655|FG001|COMPLETED|Overall Study||29
11306635|NCT02611765|12504654|FG000|NOT COMPLETED|Overall Study||2
11306636|NCT02611765|12504655|FG001|NOT COMPLETED|Overall Study||6
11306637|NCT02611778|12504663|FG000|STARTED|Overall Study||238
11306638|NCT02611778|12504664|FG001|STARTED|Overall Study||239
11306639|NCT02611778|12504663|FG000|COMPLETED|Overall Study||226
11306640|NCT02611778|12504664|FG001|COMPLETED|Overall Study||226
11306641|NCT02611778|12504663|FG000|NOT COMPLETED|Overall Study||12
11306642|NCT02611778|12504664|FG001|NOT COMPLETED|Overall Study||13
11306643|NCT02611882|12504674|FG000|STARTED|Overall Study||75
11306644|NCT02611882|12504675|FG001|STARTED|Overall Study||150
11306645|NCT02611882|12504676|FG002|STARTED|Overall Study||0
11306646|NCT02611882|12504674|FG000|Completed Surgery Per Protocol|Overall Study||42
11306647|NCT02611882|12504675|FG001|Completed Surgery Per Protocol|Overall Study||0
11306648|NCT02611882|12504676|FG002|Completed Surgery Per Protocol|Overall Study||0
11306649|NCT02611882|12504674|FG000|COMPLETED|Overall Study||42
11306650|NCT02611882|12504675|FG001|COMPLETED|Overall Study||150
11306651|NCT02611882|12504676|FG002|COMPLETED|Overall Study||0
11306652|NCT02611882|12504674|FG000|NOT COMPLETED|Overall Study||33
11306653|NCT02611882|12504675|FG001|NOT COMPLETED|Overall Study||0
11306654|NCT02611882|12504676|FG002|NOT COMPLETED|Overall Study||0
11306655|NCT02612064|12504685|FG000|STARTED|Overall Study||115
11306656|NCT02612064|12504686|FG001|STARTED|Overall Study||115
11306657|NCT02612064|12504685|FG000|COMPLETED|Overall Study||114
11306658|NCT02612064|12504686|FG001|COMPLETED|Overall Study||112
11306659|NCT02612064|12504685|FG000|NOT COMPLETED|Overall Study||1
11306660|NCT02612064|12504686|FG001|NOT COMPLETED|Overall Study||3
11306661|NCT02612077|12504692|FG000|STARTED|Overall Study||765
11306662|NCT02612077|12504692|FG000|Did Not Receive Study Product|Overall Study||5
11306663|NCT02612077|12504692|FG000|Safety Analysis Set|Overall Study||760
11306664|NCT02612077|12504692|FG000|Efficacy Analysis Set|Overall Study||737
11022129|NCT00807937|12200406|FG002|STARTED|Overall Study||92
11022130|NCT00807937|12200407|FG003|STARTED|Overall Study||92
11022131|NCT00807937|12200404|FG000|COMPLETED|Overall Study||66
11022132|NCT00807937|12200405|FG001|COMPLETED|Overall Study||67
11022133|NCT00807937|12200406|FG002|COMPLETED|Overall Study||78
11022134|NCT00807937|12200407|FG003|COMPLETED|Overall Study||77
11022135|NCT00807937|12200404|FG000|NOT COMPLETED|Overall Study||27
11306665|NCT02612077|12504692|FG000|COMPLETED|Overall Study||299
11306666|NCT02612077|12504692|FG000|NOT COMPLETED|Overall Study||466
11306667|NCT02612155|12504701|FG000|STARTED|Overall Study||17
11306668|NCT02612155|12504702|FG001|STARTED|Overall Study||18
11022136|NCT00807937|12200405|FG001|NOT COMPLETED|Overall Study||25
11022137|NCT00807937|12200406|FG002|NOT COMPLETED|Overall Study||14
11306669|NCT02612155|12504701|FG000|COMPLETED|Overall Study||14
11306670|NCT02612155|12504702|FG001|COMPLETED|Overall Study||15
11306671|NCT02612155|12504701|FG000|NOT COMPLETED|Overall Study||3
11306672|NCT02612155|12504702|FG001|NOT COMPLETED|Overall Study||3
11306673|NCT02612428|12504710|FG000|STARTED|VTL-308||78
11306674|NCT02612428|12504711|FG001|STARTED|VTL-308||73
11022138|NCT00807937|12200407|FG003|NOT COMPLETED|Overall Study||15
11022139|NCT00807989|12200419|FG000|STARTED|Overall Study||107
11306675|NCT02612428|12504710|FG000|COMPLETED|VTL-308||64
11306676|NCT02612428|12504711|FG001|COMPLETED|VTL-308||56
11306677|NCT02612428|12504710|FG000|NOT COMPLETED|VTL-308||14
11306678|NCT02612428|12504711|FG001|NOT COMPLETED|VTL-308||17
11306679|NCT02612428|12504710|FG000|STARTED|VTL-308E||64
11306680|NCT02612428|12504711|FG001|STARTED|VTL-308E||56
11306681|NCT02612428|12504710|FG000|COMPLETED|VTL-308E||53
11306682|NCT02612428|12504711|FG001|COMPLETED|VTL-308E||49
11306683|NCT02612428|12504710|FG000|NOT COMPLETED|VTL-308E||11
11306684|NCT02612428|12504711|FG001|NOT COMPLETED|VTL-308E||7
11341983|NCT02939716|12539480|FG001|COMPLETED|Overall Study||3
11341984|NCT02939716|12539481|FG002|COMPLETED|Overall Study||3
11341985|NCT02939716|12539482|FG003|COMPLETED|Overall Study||2
11341986|NCT02939716|12539483|FG004|COMPLETED|Overall Study||2
11341987|NCT02939716|12539484|FG005|COMPLETED|Overall Study||2
11341988|NCT02939716|12539479|FG000|NOT COMPLETED|Overall Study||0
11341989|NCT02939716|12539480|FG001|NOT COMPLETED|Overall Study||0
11341990|NCT02939716|12539481|FG002|NOT COMPLETED|Overall Study||0
11341991|NCT02939716|12539482|FG003|NOT COMPLETED|Overall Study||1
11341992|NCT02939716|12539483|FG004|NOT COMPLETED|Overall Study||1
11341993|NCT02939716|12539484|FG005|NOT COMPLETED|Overall Study||1
11341994|NCT02939781|12539501|FG000|STARTED|Overall Study||12
11341995|NCT02939781|12539501|FG000|COMPLETED|Overall Study||3
11341996|NCT02939781|12539501|FG000|NOT COMPLETED|Overall Study||9
11341997|NCT02939937|12539508|FG000|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21
11341998|NCT02939937|12539509|FG001|STARTED|Overall Study|3 patients excluded from study|50
11341999|NCT02939937|12539508|FG000|COMPLETED|Overall Study||15
11342000|NCT02939937|12539509|FG001|COMPLETED|Overall Study||47
11342001|NCT02939937|12539508|FG000|NOT COMPLETED|Overall Study||6
11342002|NCT02939937|12539509|FG001|NOT COMPLETED|Overall Study||3
11342003|NCT02939950|12539517|FG000|STARTED|Overall Study||406
11342004|NCT02939950|12539518|FG001|STARTED|Overall Study||410
11342005|NCT02939950|12539517|FG000|Dispensed the Assigned Lenses|Overall Study||405
11342006|NCT02939950|12539518|FG001|Dispensed the Assigned Lenses|Overall Study||410
11342007|NCT02939950|12539517|FG000|Eligible at Baseline|Overall Study||403
11342008|NCT02939950|12539518|FG001|Eligible at Baseline|Overall Study||402
11342009|NCT02939950|12539517|FG000|COMPLETED|Overall Study||340
11342010|NCT02939950|12539518|FG001|COMPLETED|Overall Study||329
11342011|NCT02939950|12539517|FG000|NOT COMPLETED|Overall Study||66
11342012|NCT02939950|12539518|FG001|NOT COMPLETED|Overall Study||81
11342013|NCT02940249|12539524|FG000|STARTED|Overall Study||34
11342014|NCT02940249|12539524|FG000|COMPLETED|Overall Study||30
11342015|NCT02940249|12539524|FG000|NOT COMPLETED|Overall Study||4
11342016|NCT02940327|12539534|FG000|STARTED|Overall Study||24
11342017|NCT02940327|12539534|FG000|COMPLETED|Overall Study||24
11342018|NCT02940327|12539534|FG000|NOT COMPLETED|Overall Study||0
11342019|NCT02940392|12539539|FG000|STARTED|Overall Study||15
11342020|NCT02940392|12539539|FG000|COMPLETED|Overall Study||7
11342021|NCT02940392|12539539|FG000|NOT COMPLETED|Overall Study||8
11342022|NCT02940574|12539545|FG000|STARTED|From Study Start to 1-month Follow-up||22
11342023|NCT02940574|12539546|FG001|STARTED|From Study Start to 1-month Follow-up||18
11342024|NCT02940574|12539545|FG000|COMPLETED|From Study Start to 1-month Follow-up|Discontinued intervention (N=1): self-termination unrelated to treatment|21
11306685|NCT02612610|12504721|FG000|STARTED|Overall Study||63
11306686|NCT02612610|12504722|FG001|STARTED|Overall Study||64
11306687|NCT02612610|12504723|FG002|STARTED|Overall Study||63
11306688|NCT02612610|12504724|FG003|STARTED|Overall Study||63
11306689|NCT02612610|12504721|FG000|Treated|Overall Study||63
11306690|NCT02612610|12504722|FG001|Treated|Overall Study||63
11306691|NCT02612610|12504723|FG002|Treated|Overall Study||63
11306692|NCT02612610|12504724|FG003|Treated|Overall Study||63
11306693|NCT02612610|12504721|FG000|COMPLETED|Overall Study||58
11306694|NCT02612610|12504722|FG001|COMPLETED|Overall Study||56
11306695|NCT02612610|12504723|FG002|COMPLETED|Overall Study||58
11306696|NCT02612610|12504724|FG003|COMPLETED|Overall Study||50
11306697|NCT02612610|12504721|FG000|NOT COMPLETED|Overall Study||5
11306698|NCT02612610|12504722|FG001|NOT COMPLETED|Overall Study||8
11306699|NCT02612610|12504723|FG002|NOT COMPLETED|Overall Study||5
11306700|NCT02612610|12504724|FG003|NOT COMPLETED|Overall Study||13
11306701|NCT02612623|12504738|FG000|STARTED|Overall Study||8
11306702|NCT02612623|12504739|FG001|STARTED|Overall Study||6
11306703|NCT02612623|12504740|FG002|STARTED|Overall Study||6
11306704|NCT02612623|12504741|FG003|STARTED|Overall Study||4
11306705|NCT02612623|12504738|FG000|Treated|Overall Study||8
11306706|NCT02612623|12504739|FG001|Treated|Overall Study||5
11306707|NCT02612623|12504740|FG002|Treated|Overall Study||6
11306708|NCT02612623|12504741|FG003|Treated|Overall Study||4
11306709|NCT02612623|12504738|FG000|COMPLETED|Overall Study||7
11306710|NCT02612623|12504739|FG001|COMPLETED|Overall Study||5
11306711|NCT02612623|12504740|FG002|COMPLETED|Overall Study||5
11306712|NCT02612623|12504741|FG003|COMPLETED|Overall Study||4
11306713|NCT02612623|12504738|FG000|NOT COMPLETED|Overall Study||1
11306714|NCT02612623|12504739|FG001|NOT COMPLETED|Overall Study||1
11306715|NCT02612623|12504740|FG002|NOT COMPLETED|Overall Study||1
11306716|NCT02612623|12504741|FG003|NOT COMPLETED|Overall Study||0
11306717|NCT02612688|12504753|FG000|STARTED|Overall Study||33035
11306718|NCT02612688|12504754|FG001|STARTED|Overall Study||70013
11306719|NCT02612688|12504753|FG000|COMPLETED|Overall Study||33035
11306720|NCT02612688|12504754|FG001|COMPLETED|Overall Study||70013
11306721|NCT02612688|12504753|FG000|NOT COMPLETED|Overall Study||0
11306722|NCT02612688|12504754|FG001|NOT COMPLETED|Overall Study||0
11306723|NCT02612727|12504764|FG000|STARTED|Overall Study||87
11306724|NCT02612727|12504765|FG001|STARTED|Overall Study||87
11306725|NCT02612727|12504764|FG000|COMPLETED|Overall Study||82
11306726|NCT02612727|12504765|FG001|COMPLETED|Overall Study||83
11306727|NCT02612727|12504764|FG000|NOT COMPLETED|Overall Study||5
11306728|NCT02612727|12504765|FG001|NOT COMPLETED|Overall Study||4
11306729|NCT02612779|12504773|FG000|STARTED|Overall Study||68
11306730|NCT02612779|12504774|FG001|STARTED|Overall Study||6
11306731|NCT02612779|12504773|FG000|COMPLETED|Overall Study||0
11306732|NCT02612779|12504774|FG001|COMPLETED|Overall Study||0
11306733|NCT02612779|12504773|FG000|NOT COMPLETED|Overall Study||68
11306734|NCT02612779|12504774|FG001|NOT COMPLETED|Overall Study||6
11306735|NCT02612857|12504784|FG000|STARTED|Overall Study||11
11306736|NCT02612857|12504785|FG001|STARTED|Overall Study||9
11306737|NCT02612857|12504786|FG002|STARTED|Overall Study||10
11306738|NCT02612857|12504784|FG000|COMPLETED|Overall Study||8
11306739|NCT02612857|12504785|FG001|COMPLETED|Overall Study||5
11306740|NCT02612857|12504786|FG002|COMPLETED|Overall Study||6
11306741|NCT02612857|12504784|FG000|NOT COMPLETED|Overall Study||3
11306742|NCT02612857|12504785|FG001|NOT COMPLETED|Overall Study||4
11306743|NCT02612857|12504786|FG002|NOT COMPLETED|Overall Study||4
11306744|NCT02612909|12504799|FG000|STARTED|Phase 2||100
11306745|NCT02612909|12504800|FG001|STARTED|Phase 2||100
11306746|NCT02612909|12504801|FG002|STARTED|Phase 2||100
11306747|NCT02612909|12504802|FG003|STARTED|Phase 2||0
11306748|NCT02612909|12504803|FG004|STARTED|Phase 2||0
11306749|NCT02612909|12504799|FG000|Received Injection 1|Phase 2||100
11306750|NCT02612909|12504800|FG001|Received Injection 1|Phase 2||100
11306751|NCT02612909|12504801|FG002|Received Injection 1|Phase 2||100
11306752|NCT02612909|12504802|FG003|Received Injection 1|Phase 2||0
11306753|NCT02612909|12504803|FG004|Received Injection 1|Phase 2||0
11306754|NCT02612909|12504799|FG000|Received Injection 2|Phase 2||98
11306755|NCT02612909|12504800|FG001|Received Injection 2|Phase 2||95
11306756|NCT02612909|12504801|FG002|Received Injection 2|Phase 2||99
11306757|NCT02612909|12504802|FG003|Received Injection 2|Phase 2||0
11306758|NCT02612909|12504803|FG004|Received Injection 2|Phase 2||0
11306759|NCT02612909|12504799|FG000|Completed Day 29 Clinic Visit|Phase 2||98
11306760|NCT02612909|12504800|FG001|Completed Day 29 Clinic Visit|Phase 2||95
11306761|NCT02612909|12504801|FG002|Completed Day 29 Clinic Visit|Phase 2||99
11306762|NCT02612909|12504802|FG003|Completed Day 29 Clinic Visit|Phase 2||0
11306763|NCT02612909|12504803|FG004|Completed Day 29 Clinic Visit|Phase 2||0
11306764|NCT02612909|12504799|FG000|Completed Day 43 Clinic Visit|Phase 2||97
11306765|NCT02612909|12504800|FG001|Completed Day 43 Clinic Visit|Phase 2||94
11306766|NCT02612909|12504801|FG002|Completed Day 43 Clinic Visit|Phase 2||99
11306767|NCT02612909|12504802|FG003|Completed Day 43 Clinic Visit|Phase 2||0
11306768|NCT02612909|12504803|FG004|Completed Day 43 Clinic Visit|Phase 2||0
11306769|NCT02612909|12504799|FG000|COMPLETED|Phase 2||98
11306770|NCT02612909|12504800|FG001|COMPLETED|Phase 2||95
11306771|NCT02612909|12504801|FG002|COMPLETED|Phase 2||99
11306772|NCT02612909|12504802|FG003|COMPLETED|Phase 2||0
11306773|NCT02612909|12504803|FG004|COMPLETED|Phase 2||0
11306774|NCT02612909|12504799|FG000|NOT COMPLETED|Phase 2||2
11306775|NCT02612909|12504800|FG001|NOT COMPLETED|Phase 2||5
11306776|NCT02612909|12504801|FG002|NOT COMPLETED|Phase 2||1
11306777|NCT02612909|12504802|FG003|NOT COMPLETED|Phase 2||0
11306778|NCT02612909|12504803|FG004|NOT COMPLETED|Phase 2||0
11306779|NCT02612909|12504799|FG000|STARTED|Phase 3||0
11306780|NCT02612909|12504800|FG001|STARTED|Phase 3||0
11306781|NCT02612909|12504801|FG002|STARTED|Phase 3||0
11306782|NCT02612909|12504802|FG003|STARTED|Phase 3||105
11306783|NCT02612909|12504803|FG004|STARTED|Phase 3||525
11306784|NCT02612909|12504799|FG000|Received Injection 1|Phase 3||0
11306785|NCT02612909|12504800|FG001|Received Injection 1|Phase 3||0
11306786|NCT02612909|12504801|FG002|Received Injection 1|Phase 3||0
11306787|NCT02612909|12504802|FG003|Received Injection 1|Phase 3||105
11306788|NCT02612909|12504803|FG004|Received Injection 1|Phase 3||525
11306789|NCT02612909|12504799|FG000|Received Injection 2|Phase 3||0
11306790|NCT02612909|12504800|FG001|Received Injection 2|Phase 3||0
11306791|NCT02612909|12504801|FG002|Received Injection 2|Phase 3||0
11306792|NCT02612909|12504802|FG003|Received Injection 2|Phase 3||103
11306793|NCT02612909|12504803|FG004|Received Injection 2|Phase 3||520
11306794|NCT02612909|12504799|FG000|Completed Day 29 Clinic Visit|Phase 3||0
11306795|NCT02612909|12504800|FG001|Completed Day 29 Clinic Visit|Phase 3||0
11306796|NCT02612909|12504801|FG002|Completed Day 29 Clinic Visit|Phase 3||0
11306797|NCT02612909|12504802|FG003|Completed Day 29 Clinic Visit|Phase 3||104
11306798|NCT02612909|12504803|FG004|Completed Day 29 Clinic Visit|Phase 3||525
11306799|NCT02612909|12504799|FG000|Completed Day 43 Clinic Visit|Phase 3||0
11306800|NCT02612909|12504800|FG001|Completed Day 43 Clinic Visit|Phase 3||0
11306801|NCT02612909|12504801|FG002|Completed Day 43 Clinic Visit|Phase 3||0
11306802|NCT02612909|12504802|FG003|Completed Day 43 Clinic Visit|Phase 3||104
11306803|NCT02612909|12504803|FG004|Completed Day 43 Clinic Visit|Phase 3||524
11306804|NCT02612909|12504799|FG000|COMPLETED|Phase 3||0
11306805|NCT02612909|12504800|FG001|COMPLETED|Phase 3||0
11306806|NCT02612909|12504801|FG002|COMPLETED|Phase 3||0
11306807|NCT02612909|12504802|FG003|COMPLETED|Phase 3||104
11306808|NCT02612909|12504803|FG004|COMPLETED|Phase 3||525
11306809|NCT02612909|12504799|FG000|NOT COMPLETED|Phase 3||0
11306810|NCT02612909|12504800|FG001|NOT COMPLETED|Phase 3||0
11306811|NCT02612909|12504801|FG002|NOT COMPLETED|Phase 3||0
11306812|NCT02612909|12504802|FG003|NOT COMPLETED|Phase 3||1
11306813|NCT02612909|12504803|FG004|NOT COMPLETED|Phase 3||0
11306814|NCT02613117|12504819|FG000|STARTED|Overall Study||57
11306815|NCT02613117|12504820|FG001|STARTED|Overall Study||47
11306816|NCT02613117|12504819|FG000|COMPLETED|Overall Study||57
11306817|NCT02613117|12504820|FG001|COMPLETED|Overall Study||47
11306818|NCT02613117|12504819|FG000|NOT COMPLETED|Overall Study||0
11306819|NCT02613117|12504820|FG001|NOT COMPLETED|Overall Study||0
11306820|NCT02613169|12504828|FG000|STARTED|Overall Study||150
11306821|NCT02613169|12504829|FG001|STARTED|Overall Study||150
11306822|NCT02613169|12504828|FG000|COMPLETED|Overall Study||132
11306823|NCT02613169|12504829|FG001|COMPLETED|Overall Study||133
11306824|NCT02613169|12504828|FG000|NOT COMPLETED|Overall Study||18
11306825|NCT02613169|12504829|FG001|NOT COMPLETED|Overall Study||17
11306826|NCT02613182|12504835|FG000|STARTED|Overall Study||34
11306827|NCT02613182|12504835|FG000|Number of Patients Dosed|Overall Study||34
11306828|NCT02613182|12504835|FG000|COMPLETED|Overall Study||0
11306829|NCT02613182|12504835|FG000|NOT COMPLETED|Overall Study||34
11306830|NCT02613208|12504839|FG000|STARTED|Overall Study||111
11306831|NCT02613208|12504839|FG000|COMPLETED|Overall Study||64
11306832|NCT02613208|12504839|FG000|NOT COMPLETED|Overall Study||47
11306833|NCT02613221|12504843|FG000|STARTED|Overall Study||56
11306834|NCT02613221|12504843|FG000|Safety Population: Received Study Drug|Overall Study||55
11306835|NCT02613221|12504843|FG000|COMPLETED|Overall Study||1
11306836|NCT02613221|12504843|FG000|NOT COMPLETED|Overall Study||55
11306837|NCT02613338|12504847|FG000|STARTED|Overall Study||30
11143856|NCT01474538|12330472|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
11143857|NCT01474538|12330471|FG000|COMPLETED|Treatment Period 2||51
11143858|NCT01474538|12330472|FG001|COMPLETED|Treatment Period 2||56
11143859|NCT01474538|12330471|FG000|NOT COMPLETED|Treatment Period 2||6
11306838|NCT02613338|12504847|FG000|COMPLETED|Overall Study||30
11306839|NCT02613338|12504847|FG000|NOT COMPLETED|Overall Study||0
11306840|NCT02613364|12504854|FG000|STARTED|Overall Study||251
11306841|NCT02613364|12504855|FG001|STARTED|Overall Study||238
11306842|NCT02613364|12504856|FG002|STARTED|Overall Study||251
11306843|NCT02613364|12504854|FG000|COMPLETED|Overall Study||185
11306844|NCT02613364|12504855|FG001|COMPLETED|Overall Study||148
11401570|NCT04086433|12596361|FG001|COMPLETED|Overall Study||18
11401571|NCT04086433|12596360|FG000|NOT COMPLETED|Overall Study||0
11306845|NCT02613364|12504856|FG002|COMPLETED|Overall Study||175
11306846|NCT02613364|12504854|FG000|NOT COMPLETED|Overall Study||66
11306847|NCT02613364|12504855|FG001|NOT COMPLETED|Overall Study||90
11306848|NCT02613364|12504856|FG002|NOT COMPLETED|Overall Study||76
11306849|NCT02613403|12504868|FG000|STARTED|Overall Study||36
11306850|NCT02613403|12504869|FG001|STARTED|Overall Study||36
11401572|NCT04086433|12596361|FG001|NOT COMPLETED|Overall Study||0
11401573|NCT04086407|12596367|FG000|STARTED|Overall Study||8
11306851|NCT02613403|12504870|FG002|STARTED|Overall Study||9
11306852|NCT02613403|12504871|FG003|STARTED|Overall Study||13
11401574|NCT04086407|12596367|FG000|COMPLETED|Overall Study||8
11022140|NCT00807989|12200420|FG001|STARTED|Overall Study||100
11022141|NCT00807989|12200419|FG000|COMPLETED|Overall Study||104
11022142|NCT00807989|12200420|FG001|COMPLETED|Overall Study||98
11022143|NCT00807989|12200419|FG000|NOT COMPLETED|Overall Study||3
11022144|NCT00807989|12200420|FG001|NOT COMPLETED|Overall Study||2
11022145|NCT00808015|12200426|FG000|STARTED|Overall Study||1377
11306853|NCT02613403|12504872|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
11306854|NCT02613403|12504868|FG000|Treated|Overall Study||35
11306855|NCT02613403|12504869|FG001|Treated|Overall Study||36
11306856|NCT02613403|12504870|FG002|Treated|Overall Study||9
11306857|NCT02613403|12504871|FG003|Treated|Overall Study||13
11306858|NCT02613403|12504872|FG004|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
11306859|NCT02613403|12504868|FG000|COMPLETED|Overall Study||34
11306860|NCT02613403|12504869|FG001|COMPLETED|Overall Study||35
11306861|NCT02613403|12504870|FG002|COMPLETED|Overall Study||9
11306862|NCT02613403|12504871|FG003|COMPLETED|Overall Study||13
11022146|NCT00808015|12200426|FG000|Treated|Overall Study||1373
11022147|NCT00808015|12200426|FG000|COMPLETED|Overall Study||1033
11022148|NCT00808015|12200426|FG000|NOT COMPLETED|Overall Study||344
11022149|NCT00808028|12200434|FG000|STARTED|Stage 1 (6 Months)||121
11022150|NCT00808028|12200435|FG001|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
11022151|NCT00808028|12200436|FG002|STARTED|Stage 1 (6 Months)||198
11022152|NCT00808028|12200437|FG003|STARTED|Stage 1 (6 Months)||198
11022153|NCT00808028|12200434|FG000|COMPLETED|Stage 1 (6 Months)||116
11057005|NCT00996892|12238673|FG002|COMPLETED|Dose-Escalation Stage 1||0
11306863|NCT02613403|12504872|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
11306864|NCT02613403|12504868|FG000|NOT COMPLETED|Overall Study||2
11306865|NCT02613403|12504869|FG001|NOT COMPLETED|Overall Study||1
11306866|NCT02613403|12504870|FG002|NOT COMPLETED|Overall Study||0
11306867|NCT02613403|12504871|FG003|NOT COMPLETED|Overall Study||0
11306868|NCT02613403|12504872|FG004|NOT COMPLETED|Overall Study||0
11306869|NCT02613481|12504882|FG000|STARTED|Overall Study||50
11306870|NCT02613481|12504882|FG000|COMPLETED|Overall Study||41
11306871|NCT02613481|12504882|FG000|NOT COMPLETED|Overall Study||9
11306872|NCT02613572|12504889|FG000|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||15
11306873|NCT02613572|12504890|FG001|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
11306874|NCT02613572|12504891|FG002|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
11306875|NCT02613572|12504889|FG000|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
11306876|NCT02613572|12504890|FG001|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
11306877|NCT02613572|12504891|FG002|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
11306878|NCT02613572|12504889|FG000|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
11306879|NCT02613572|12504890|FG001|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
11306880|NCT02613572|12504891|FG002|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
11306881|NCT02613572|12504889|FG000|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||14
11306882|NCT02613572|12504890|FG001|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
11306883|NCT02613572|12504891|FG002|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
11306884|NCT02613572|12504889|FG000|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||14
11306885|NCT02613572|12504890|FG001|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
11306886|NCT02613572|12504891|FG002|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
11306887|NCT02613572|12504889|FG000|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||1
11306888|NCT02613572|12504890|FG001|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
11306889|NCT02613572|12504891|FG002|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
11306890|NCT02613572|12504889|FG000|STARTED|Phase II: Double-Blind Rand Plac Control||0
11306891|NCT02613572|12504890|FG001|STARTED|Phase II: Double-Blind Rand Plac Control||27
11306892|NCT02613572|12504891|FG002|STARTED|Phase II: Double-Blind Rand Plac Control||26
11306893|NCT02613572|12504889|FG000|COMPLETED|Phase II: Double-Blind Rand Plac Control||0
11306894|NCT02613572|12504890|FG001|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
11306895|NCT02613572|12504891|FG002|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
11306896|NCT02613572|12504889|FG000|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
11306897|NCT02613572|12504890|FG001|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||1
11306898|NCT02613572|12504891|FG002|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
11306899|NCT02613871|12504903|FG000|STARTED|Overall Study||111
11306900|NCT02613871|12504903|FG000|COMPLETED|Overall Study||108
11306901|NCT02613871|12504903|FG000|NOT COMPLETED|Overall Study||3
11306902|NCT02613884|12504907|FG000|STARTED|Overall Study||26
11306903|NCT02613884|12504907|FG000|Safety Endpoint 1|Overall Study||26
11306904|NCT02613884|12504907|FG000|Feasibility Questionnaire|Overall Study||26
11306905|NCT02613884|12504907|FG000|Safety Endpoint 2|Overall Study||26
11306906|NCT02613884|12504907|FG000|Efficacy Endpoint 1|Overall Study||25
11306907|NCT02613884|12504907|FG000|Efficacy Timepoint 2|Overall Study||25
11306908|NCT02613884|12504907|FG000|Efficacy Timepoint 3|Overall Study||24
11306909|NCT02613884|12504907|FG000|COMPLETED|Overall Study||24
11306910|NCT02613884|12504907|FG000|NOT COMPLETED|Overall Study||2
11306911|NCT02613897|12504915|FG000|STARTED|Overall Study||22
11306912|NCT02613897|12504916|FG001|STARTED|Overall Study||22
11306913|NCT02613897|12504917|FG002|STARTED|Overall Study||12
11306914|NCT02613897|12504915|FG000|COMPLETED|Overall Study||22
11306915|NCT02613897|12504916|FG001|COMPLETED|Overall Study||22
11022154|NCT00808028|12200435|FG001|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
11306916|NCT02613897|12504917|FG002|COMPLETED|Overall Study||12
11306917|NCT02613897|12504915|FG000|NOT COMPLETED|Overall Study||0
11306918|NCT02613897|12504916|FG001|NOT COMPLETED|Overall Study||0
11306919|NCT02613897|12504917|FG002|NOT COMPLETED|Overall Study||0
11306920|NCT02613910|12504926|FG000|STARTED|Overall Study||1
11306921|NCT02613910|12504926|FG000|COMPLETED|Overall Study||0
11306922|NCT02613910|12504926|FG000|NOT COMPLETED|Overall Study||1
11306923|NCT02614079|12504930|FG000|STARTED|Overall Study||6
11306924|NCT02614079|12504930|FG000|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
11306925|NCT02614079|12504930|FG000|NOT COMPLETED|Overall Study||1
11306926|NCT02614131|12504941|FG000|STARTED|Overall Study||11
11306927|NCT02614131|12504942|FG001|STARTED|Overall Study||8
11306928|NCT02614131|12504943|FG002|STARTED|Overall Study||8
11306929|NCT02614131|12504944|FG003|STARTED|Overall Study||8
11306930|NCT02614131|12504945|FG004|STARTED|Overall Study||8
11306931|NCT02614131|12504946|FG005|STARTED|Overall Study||2
11306932|NCT02614131|12504947|FG006|STARTED|Overall Study||5
11306933|NCT02614131|12504941|FG000|Received at Least One Dose of Drug|Overall Study||11
11306934|NCT02614131|12504942|FG001|Received at Least One Dose of Drug|Overall Study||8
11306935|NCT02614131|12504943|FG002|Received at Least One Dose of Drug|Overall Study||8
11306936|NCT02614131|12504944|FG003|Received at Least One Dose of Drug|Overall Study||8
11306937|NCT02614131|12504945|FG004|Received at Least One Dose of Drug|Overall Study||8
11306938|NCT02614131|12504946|FG005|Received at Least One Dose of Drug|Overall Study||2
11306939|NCT02614131|12504947|FG006|Received at Least One Dose of Drug|Overall Study||5
11306940|NCT02614131|12504941|FG000|COMPLETED|Overall Study||10
11306941|NCT02614131|12504942|FG001|COMPLETED|Overall Study||8
11306942|NCT02614131|12504943|FG002|COMPLETED|Overall Study||8
11306943|NCT02614131|12504944|FG003|COMPLETED|Overall Study||8
11306944|NCT02614131|12504945|FG004|COMPLETED|Overall Study||8
11306945|NCT02614131|12504946|FG005|COMPLETED|Overall Study||2
11306946|NCT02614131|12504947|FG006|COMPLETED|Overall Study||4
11306947|NCT02614131|12504941|FG000|NOT COMPLETED|Overall Study||1
11306948|NCT02614131|12504942|FG001|NOT COMPLETED|Overall Study||0
11306949|NCT02614131|12504943|FG002|NOT COMPLETED|Overall Study||0
11306950|NCT02614131|12504944|FG003|NOT COMPLETED|Overall Study||0
11306951|NCT02614131|12504945|FG004|NOT COMPLETED|Overall Study||0
11306952|NCT02614131|12504946|FG005|NOT COMPLETED|Overall Study||0
11306953|NCT02614131|12504947|FG006|NOT COMPLETED|Overall Study||1
11306954|NCT02614183|12504972|FG000|STARTED|Double Blind Treatment Phase||434
11306955|NCT02614183|12504973|FG001|STARTED|Double Blind Treatment Phase||214
11306956|NCT02614183|12504974|FG002|STARTED|Double Blind Treatment Phase||214
11306957|NCT02614183|12504972|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
11306958|NCT02614183|12504973|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
11306959|NCT02614183|12504974|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
11306960|NCT02614183|12504972|FG000|Safety Population|Double Blind Treatment Phase||432
11306961|NCT02614183|12504973|FG001|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
11306962|NCT02614183|12504974|FG002|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
11306963|NCT02614183|12504972|FG000|COMPLETED|Double Blind Treatment Phase||351
11306964|NCT02614183|12504973|FG001|COMPLETED|Double Blind Treatment Phase||177
11306965|NCT02614183|12504974|FG002|COMPLETED|Double Blind Treatment Phase||175
11306966|NCT02614183|12504972|FG000|NOT COMPLETED|Double Blind Treatment Phase||83
11306967|NCT02614183|12504973|FG001|NOT COMPLETED|Double Blind Treatment Phase||37
11306968|NCT02614183|12504974|FG002|NOT COMPLETED|Double Blind Treatment Phase||39
11306969|NCT02614183|12504972|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
11306970|NCT02614183|12504973|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
11306971|NCT02614183|12504974|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
11306972|NCT02614183|12504972|FG000|Safety Population|Post Treatment Follow-up Phase||372
11306973|NCT02614183|12504973|FG001|Safety Population|Post Treatment Follow-up Phase||183
11306974|NCT02614183|12504974|FG002|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
11306975|NCT02614183|12504972|FG000|COMPLETED|Post Treatment Follow-up Phase||354
11306976|NCT02614183|12504973|FG001|COMPLETED|Post Treatment Follow-up Phase||179
11306977|NCT02614183|12504974|FG002|COMPLETED|Post Treatment Follow-up Phase||171
11306978|NCT02614183|12504972|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||18
11306979|NCT02614183|12504973|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||6
11306980|NCT02614183|12504974|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||12
11306981|NCT02614196|12504994|FG000|STARTED|Double Blind Treatment Phase||463
11306982|NCT02614196|12504995|FG001|STARTED|Double Blind Treatment Phase||233
11306983|NCT02614196|12504996|FG002|STARTED|Double Blind Treatment Phase||226
11306984|NCT02614196|12504997|FG003|STARTED|Double Blind Treatment Phase||30
11306985|NCT02614196|12504998|FG004|STARTED|Double Blind Treatment Phase||15
11306986|NCT02614196|12504999|FG005|STARTED|Double Blind Treatment Phase||19
11306987|NCT02614196|12504994|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461
11306988|NCT02614196|12504995|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231
11306989|NCT02614196|12504996|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223
11306990|NCT02614196|12504997|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30
11306991|NCT02614196|12504998|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14
11306992|NCT02614196|12504999|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19
11306993|NCT02614196|12504994|FG000|COMPLETED|Double Blind Treatment Phase||387
11306994|NCT02614196|12504995|FG001|COMPLETED|Double Blind Treatment Phase||203
11306995|NCT02614196|12504996|FG002|COMPLETED|Double Blind Treatment Phase||195
11306996|NCT02614196|12504997|FG003|COMPLETED|Double Blind Treatment Phase||26
11306997|NCT02614196|12504998|FG004|COMPLETED|Double Blind Treatment Phase||14
11306998|NCT02614196|12504999|FG005|COMPLETED|Double Blind Treatment Phase||19
11306999|NCT02614196|12504994|FG000|NOT COMPLETED|Double Blind Treatment Phase||76
11307000|NCT02614196|12504995|FG001|NOT COMPLETED|Double Blind Treatment Phase||30
11307001|NCT02614196|12504996|FG002|NOT COMPLETED|Double Blind Treatment Phase||31
11307002|NCT02614196|12504997|FG003|NOT COMPLETED|Double Blind Treatment Phase||4
11307003|NCT02614196|12504998|FG004|NOT COMPLETED|Double Blind Treatment Phase||1
11307004|NCT02614196|12504999|FG005|NOT COMPLETED|Double Blind Treatment Phase||0
11307005|NCT02614196|12504994|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410
11307006|NCT02614196|12504995|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213
11307007|NCT02614196|12504996|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207
11307008|NCT02614196|12504997|FG003|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25
11307009|NCT02614196|12504998|FG004|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15
11307010|NCT02614196|12504999|FG005|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19
11307011|NCT02614196|12504994|FG000|COMPLETED|Post Treatment Follow-up Phase||390
11307012|NCT02614196|12504995|FG001|COMPLETED|Post Treatment Follow-up Phase||208
11307013|NCT02614196|12504996|FG002|COMPLETED|Post Treatment Follow-up Phase||199
11307014|NCT02614196|12504997|FG003|COMPLETED|Post Treatment Follow-up Phase||24
11307015|NCT02614196|12504998|FG004|COMPLETED|Post Treatment Follow-up Phase||13
11307016|NCT02614196|12504999|FG005|COMPLETED|Post Treatment Follow-up Phase||19
11307017|NCT02614196|12504994|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||20
11307018|NCT02614196|12504995|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5
11307019|NCT02614196|12504996|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||8
11307020|NCT02614196|12504997|FG003|NOT COMPLETED|Post Treatment Follow-up Phase||1
11307021|NCT02614196|12504998|FG004|NOT COMPLETED|Post Treatment Follow-up Phase||2
11307022|NCT02614196|12504999|FG005|NOT COMPLETED|Post Treatment Follow-up Phase||0
11307023|NCT02614222|12505029|FG000|STARTED|Overall Study||13
11307024|NCT02614222|12505030|FG001|STARTED|Overall Study||14
11307025|NCT02614222|12505029|FG000|COMPLETED|Overall Study||13
11307026|NCT02614222|12505030|FG001|COMPLETED|Overall Study||14
11307027|NCT02614222|12505029|FG000|NOT COMPLETED|Overall Study||0
11307028|NCT02614222|12505030|FG001|NOT COMPLETED|Overall Study||0
11307029|NCT02614274|12505036|FG000|STARTED|Overall Study||9
11307030|NCT02614274|12505036|FG000|COMPLETED|Overall Study||5
11307031|NCT02614274|12505036|FG000|NOT COMPLETED|Overall Study||4
11307032|NCT02614287|12505042|FG000|STARTED|Open Label (OL) Treatment Phase||135
11307033|NCT02614287|12505043|FG001|STARTED|Open Label (OL) Treatment Phase||135
11307034|NCT02614287|12505042|FG000|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
11401575|NCT04086407|12596367|FG000|NOT COMPLETED|Overall Study||0
11401576|NCT04099277|12596374|FG000|STARTED|Overall Study||2
11401577|NCT04099277|12596374|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
11401578|NCT04099277|12596374|FG000|COMPLETED|Overall Study||0
11401579|NCT04099277|12596374|FG000|NOT COMPLETED|Overall Study||2
11401580|NCT04098809|12596380|FG000|STARTED|Overall Study||27
11307035|NCT02614287|12505043|FG001|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
11307036|NCT02614287|12505042|FG000|COMPLETED|Open Label (OL) Treatment Phase||97
11307037|NCT02614287|12505043|FG001|COMPLETED|Open Label (OL) Treatment Phase||113
11307038|NCT02614287|12505042|FG000|NOT COMPLETED|Open Label (OL) Treatment Phase||38
11307039|NCT02614287|12505043|FG001|NOT COMPLETED|Open Label (OL) Treatment Phase||22
11307040|NCT02614287|12505042|FG000|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112
11307041|NCT02614287|12505043|FG001|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124
11307042|NCT02614287|12505042|FG000|COMPLETED|Post Treatment Follow-up Phase||103
11307043|NCT02614287|12505043|FG001|COMPLETED|Post Treatment Follow-up Phase||119
11307044|NCT02614287|12505042|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||9
11307045|NCT02614287|12505043|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5
11307046|NCT02614469|12505056|FG000|STARTED|Period 1||9
11307047|NCT02614469|12505057|FG001|STARTED|Period 1||9
11307048|NCT02614469|12505056|FG000|COMPLETED|Period 1||9
11307049|NCT02614469|12505057|FG001|COMPLETED|Period 1||9
11307050|NCT02614469|12505056|FG000|NOT COMPLETED|Period 1||0
11307051|NCT02614469|12505057|FG001|NOT COMPLETED|Period 1||0
11307052|NCT02614469|12505056|FG000|STARTED|Period 2||9
11307053|NCT02614469|12505057|FG001|STARTED|Period 2||9
11401581|NCT04098809|12596381|FG001|STARTED|Overall Study||25
11307054|NCT02614469|12505056|FG000|COMPLETED|Period 2||9
11307055|NCT02614469|12505057|FG001|COMPLETED|Period 2||9
11307056|NCT02614469|12505056|FG000|NOT COMPLETED|Period 2||0
11307057|NCT02614469|12505057|FG001|NOT COMPLETED|Period 2||0
11307058|NCT02614560|12505065|FG000|STARTED|Overall Study||6
11307059|NCT02614560|12505066|FG001|STARTED|Overall Study||8
11307060|NCT02614560|12505065|FG000|COMPLETED|Overall Study||0
11307061|NCT02614560|12505066|FG001|COMPLETED|Overall Study||6
11307062|NCT02614560|12505065|FG000|NOT COMPLETED|Overall Study||6
11307063|NCT02614560|12505066|FG001|NOT COMPLETED|Overall Study||2
11307064|NCT02614703|12505074|FG000|STARTED|Overall Study||31
11307065|NCT02614703|12505075|FG001|STARTED|Overall Study||29
11307066|NCT02614703|12505074|FG000|COMPLETED|Overall Study||24
11307067|NCT02614703|12505075|FG001|COMPLETED|Overall Study||28
11307068|NCT02614703|12505074|FG000|NOT COMPLETED|Overall Study||7
11401582|NCT04098809|12596380|FG000|COMPLETED|Overall Study||24
11401583|NCT04098809|12596381|FG001|COMPLETED|Overall Study||21
11401584|NCT04098809|12596380|FG000|NOT COMPLETED|Overall Study||3
11401585|NCT04098809|12596381|FG001|NOT COMPLETED|Overall Study||4
11401586|NCT04098575|12596390|FG000|STARTED|Overall Study||505
11401587|NCT04098575|12596391|FG001|STARTED|Overall Study||2961
11401588|NCT04098575|12596392|FG002|STARTED|Overall Study||6105
11401589|NCT04098575|12596390|FG000|COMPLETED|Overall Study||505
11401590|NCT04098575|12596391|FG001|COMPLETED|Overall Study||2961
11401591|NCT04098575|12596392|FG002|COMPLETED|Overall Study||6105
11401592|NCT04098575|12596390|FG000|NOT COMPLETED|Overall Study||0
11401593|NCT04098575|12596391|FG001|NOT COMPLETED|Overall Study||0
11401594|NCT04098575|12596392|FG002|NOT COMPLETED|Overall Study||0
11401595|NCT04098458|12596400|FG000|STARTED|Overall Study||18
11401596|NCT04098458|12596400|FG000|COMPLETED|Overall Study||14
11401597|NCT04098458|12596400|FG000|NOT COMPLETED|Overall Study||4
11401598|NCT04095286|12596405|FG000|STARTED|Period 1 (4 Days) + Washout (7days)||4
11401599|NCT04095286|12596406|FG001|STARTED|Period 1 (4 Days) + Washout (7days)||5
11401600|NCT04095286|12596407|FG002|STARTED|Period 1 (4 Days) + Washout (7days)||5
11401601|NCT04095286|12596408|FG003|STARTED|Period 1 (4 Days) + Washout (7days)||5
11401602|NCT04095286|12596409|FG004|STARTED|Period 1 (4 Days) + Washout (7days)||5
11401603|NCT04095286|12596410|FG005|STARTED|Period 1 (4 Days) + Washout (7days)||5
11401604|NCT04095286|12596405|FG000|COMPLETED|Period 1 (4 Days) + Washout (7days)||3
11401605|NCT04095286|12596406|FG001|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
11401606|NCT04095286|12596407|FG002|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
11401607|NCT04095286|12596408|FG003|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
11401608|NCT04095286|12596409|FG004|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
11401609|NCT04095286|12596410|FG005|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
11307069|NCT02614703|12505075|FG001|NOT COMPLETED|Overall Study||1
11307070|NCT02614729|12505083|FG000|STARTED|Overall Study||18
11307071|NCT02614729|12505084|FG001|STARTED|Overall Study||17
11307072|NCT02614729|12505083|FG000|COMPLETED|Overall Study||17
11307073|NCT02614729|12505084|FG001|COMPLETED|Overall Study||17
11307074|NCT02614729|12505083|FG000|NOT COMPLETED|Overall Study||1
11307075|NCT02614729|12505084|FG001|NOT COMPLETED|Overall Study||0
11307076|NCT02614924|12505094|FG000|STARTED|Overall Study||20
11307077|NCT02614924|12505095|FG001|STARTED|Overall Study||20
11307078|NCT02614924|12505094|FG000|COMPLETED|Overall Study||20
11307079|NCT02614924|12505095|FG001|COMPLETED|Overall Study||20
11307080|NCT02614924|12505094|FG000|NOT COMPLETED|Overall Study||0
11307081|NCT02614924|12505095|FG001|NOT COMPLETED|Overall Study||0
11307082|NCT02615145|12505105|FG000|STARTED|Overall Study||145
11307083|NCT02615145|12505106|FG001|STARTED|Overall Study||278
11307084|NCT02615145|12505107|FG002|STARTED|Overall Study||48
11307085|NCT02615145|12505108|FG003|STARTED|Overall Study||1
11307086|NCT02615145|12505105|FG000|2 DAA + Ribavirin (RBV)|Overall Study||0
11307087|NCT02615145|12505106|FG001|2 DAA + Ribavirin (RBV)|Overall Study||0
11307088|NCT02615145|12505107|FG002|2 DAA + Ribavirin (RBV)|Overall Study||45
11307089|NCT02615145|12505108|FG003|2 DAA + Ribavirin (RBV)|Overall Study||0
11307090|NCT02615145|12505105|FG000|3DAA|Overall Study||5
11307091|NCT02615145|12505106|FG001|3DAA|Overall Study||261
11307092|NCT02615145|12505107|FG002|3DAA|Overall Study||0
11307093|NCT02615145|12505108|FG003|3DAA|Overall Study||0
11307094|NCT02615145|12505105|FG000|3DAA + RBV|Overall Study||140
11307095|NCT02615145|12505106|FG001|3DAA + RBV|Overall Study||17
11307096|NCT02615145|12505107|FG002|3DAA + RBV|Overall Study||2
11307097|NCT02615145|12505108|FG003|3DAA + RBV|Overall Study||0
11307098|NCT02615145|12505105|FG000|COMPLETED|Overall Study||118
11307099|NCT02615145|12505106|FG001|COMPLETED|Overall Study||263
11307100|NCT02615145|12505107|FG002|COMPLETED|Overall Study||40
11307101|NCT02615145|12505108|FG003|COMPLETED|Overall Study||0
11307102|NCT02615145|12505105|FG000|NOT COMPLETED|Overall Study||27
11307103|NCT02615145|12505106|FG001|NOT COMPLETED|Overall Study||15
11307104|NCT02615145|12505107|FG002|NOT COMPLETED|Overall Study||8
11401610|NCT04095286|12596405|FG000|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
11307105|NCT02615145|12505108|FG003|NOT COMPLETED|Overall Study||1
11307106|NCT02615158|12505137|FG000|STARTED|Overall Study||94
11307107|NCT02615158|12505138|FG001|STARTED|Overall Study||92
11307108|NCT02615158|12505139|FG002|STARTED|Overall Study||91
11307109|NCT02615158|12505137|FG000|COMPLETED|Overall Study||73
11307110|NCT02615158|12505138|FG001|COMPLETED|Overall Study||76
11307111|NCT02615158|12505139|FG002|COMPLETED|Overall Study||75
11307112|NCT02615158|12505137|FG000|NOT COMPLETED|Overall Study||21
11307113|NCT02615158|12505138|FG001|NOT COMPLETED|Overall Study||16
11307114|NCT02615158|12505139|FG002|NOT COMPLETED|Overall Study||16
11307115|NCT02615171|12505149|FG000|STARTED|Overall Study||32
11307116|NCT02615171|12505150|FG001|STARTED|Overall Study||32
11307117|NCT02615171|12505149|FG000|COMPLETED|Overall Study||30
11307118|NCT02615171|12505150|FG001|COMPLETED|Overall Study||31
11307119|NCT02615171|12505149|FG000|NOT COMPLETED|Overall Study||2
11307120|NCT02615171|12505150|FG001|NOT COMPLETED|Overall Study||1
11307121|NCT02615249|12505156|FG000|STARTED|Overall Study||122
11307122|NCT02615249|12505156|FG000|COMPLETED|Overall Study||121
11307123|NCT02615249|12505156|FG000|NOT COMPLETED|Overall Study||1
11307124|NCT02615470|12505163|FG000|STARTED|Overall Study||58
11307125|NCT02615470|12505164|FG001|STARTED|Overall Study||62
11307126|NCT02615470|12505163|FG000|Completed the Baseline Surveys|Overall Study||46
11307127|NCT02615470|12505164|FG001|Completed the Baseline Surveys|Overall Study||47
11307128|NCT02615470|12505163|FG000|COMPLETED|Overall Study||37
11307129|NCT02615470|12505164|FG001|COMPLETED|Overall Study||30
11307130|NCT02615470|12505163|FG000|NOT COMPLETED|Overall Study||21
11307131|NCT02615470|12505164|FG001|NOT COMPLETED|Overall Study||32
11307132|NCT02615509|12505170|FG000|STARTED|Overall Study||347
11307133|NCT02615509|12505170|FG000|COMPLETED|Overall Study||201
11307134|NCT02615509|12505170|FG000|NOT COMPLETED|Overall Study||146
11307135|NCT02615535|12505176|FG000|STARTED|Overall Study||14
11307136|NCT02615535|12505177|FG001|STARTED|Overall Study||11
11307137|NCT02615535|12505176|FG000|COMPLETED|Overall Study||10
11307138|NCT02615535|12505177|FG001|COMPLETED|Overall Study||10
11307139|NCT02615535|12505176|FG000|NOT COMPLETED|Overall Study||4
11307140|NCT02615535|12505177|FG001|NOT COMPLETED|Overall Study||1
11307141|NCT02615717|12505185|FG000|STARTED|Overall Study||3
11307142|NCT02615717|12505186|FG001|STARTED|Overall Study||3
11307143|NCT02615717|12505185|FG000|COMPLETED|Overall Study||3
11307144|NCT02615717|12505186|FG001|COMPLETED|Overall Study||3
11307145|NCT02615717|12505185|FG000|NOT COMPLETED|Overall Study||0
11307146|NCT02615717|12505186|FG001|NOT COMPLETED|Overall Study||0
11307147|NCT02615743|12505194|FG000|STARTED|Overall Study||21
11307148|NCT02615743|12505195|FG001|STARTED|Overall Study||20
11307149|NCT02615743|12505194|FG000|COMPLETED|Overall Study||15
11307150|NCT02615743|12505195|FG001|COMPLETED|Overall Study||17
11307151|NCT02615743|12505194|FG000|NOT COMPLETED|Overall Study||6
11307152|NCT02615743|12505195|FG001|NOT COMPLETED|Overall Study||3
11307153|NCT02616029|12505203|FG000|STARTED|Overall Study||38
11307154|NCT02616029|12505204|FG001|STARTED|Overall Study||28
11307155|NCT02616029|12505203|FG000|COMPLETED|Overall Study||34
11307156|NCT02616029|12505204|FG001|COMPLETED|Overall Study||26
11307157|NCT02616029|12505203|FG000|NOT COMPLETED|Overall Study||4
11307158|NCT02616029|12505204|FG001|NOT COMPLETED|Overall Study||2
11307159|NCT02616250|12505212|FG000|STARTED|Overall Study||95
11307160|NCT02616250|12505213|FG001|STARTED|Overall Study||95
11307161|NCT02616250|12505212|FG000|COMPLETED|Overall Study||85
11307162|NCT02616250|12505213|FG001|COMPLETED|Overall Study||86
11307163|NCT02616250|12505212|FG000|NOT COMPLETED|Overall Study||10
11307164|NCT02616250|12505213|FG001|NOT COMPLETED|Overall Study||9
11307165|NCT02616380|12505219|FG000|STARTED|Overall Study||100
11307166|NCT02616380|12505219|FG000|COMPLETED|Overall Study||97
11307167|NCT02616380|12505219|FG000|NOT COMPLETED|Overall Study||3
11307168|NCT02616523|12505226|FG000|STARTED|Overall Study|June 2014|20
11307169|NCT02616523|12505227|FG001|STARTED|Overall Study|June 2014|20
11307170|NCT02616523|12505228|FG002|STARTED|Overall Study|June 2014|20
11307171|NCT02616523|12505226|FG000|COMPLETED|Overall Study|April 2015|19
11307172|NCT02616523|12505227|FG001|COMPLETED|Overall Study|April 2015|20
11307173|NCT02616523|12505228|FG002|COMPLETED|Overall Study|April 2015|20
11307174|NCT02616523|12505226|FG000|NOT COMPLETED|Overall Study||1
11307175|NCT02616523|12505227|FG001|NOT COMPLETED|Overall Study||0
11307176|NCT02616523|12505228|FG002|NOT COMPLETED|Overall Study||0
11307177|NCT02616601|12505242|FG000|STARTED|Overall Study||140
11307178|NCT02616601|12505243|FG001|STARTED|Overall Study||140
11307179|NCT02616601|12505244|FG002|STARTED|Overall Study||142
11307180|NCT02616601|12505242|FG000|Safety Population|Overall Study||140
11307181|NCT02616601|12505243|FG001|Safety Population|Overall Study||140
11307182|NCT02616601|12505244|FG002|Safety Population|Overall Study||142
11307183|NCT02616601|12505242|FG000|mITT Population|Overall Study||137
11307184|NCT02616601|12505243|FG001|mITT Population|Overall Study||136
11307185|NCT02616601|12505244|FG002|mITT Population|Overall Study||138
11307186|NCT02616601|12505242|FG000|PP Population|Overall Study||112
11307187|NCT02616601|12505243|FG001|PP Population|Overall Study||121
11307188|NCT02616601|12505244|FG002|PP Population|Overall Study||123
11307189|NCT02616601|12505242|FG000|COMPLETED|Overall Study||131
11307190|NCT02616601|12505243|FG001|COMPLETED|Overall Study||136
11307191|NCT02616601|12505244|FG002|COMPLETED|Overall Study||135
11307192|NCT02616601|12505242|FG000|NOT COMPLETED|Overall Study||9
11307193|NCT02616601|12505243|FG001|NOT COMPLETED|Overall Study||4
11307194|NCT02616601|12505244|FG002|NOT COMPLETED|Overall Study||7
11307195|NCT02616614|12505255|FG000|STARTED|Overall Study||347
11307196|NCT02616614|12505256|FG001|STARTED|Overall Study||345
11307197|NCT02616614|12505257|FG002|STARTED|Overall Study||170
11307198|NCT02616614|12505255|FG000|Safety Population|Overall Study||329
11307199|NCT02616614|12505256|FG001|Safety Population|Overall Study||328
11307200|NCT02616614|12505257|FG002|Safety Population|Overall Study||161
11307201|NCT02616614|12505255|FG000|mITT Population|Overall Study||325
11307202|NCT02616614|12505256|FG001|mITT Population|Overall Study||325
11307203|NCT02616614|12505257|FG002|mITT Population|Overall Study||160
11307204|NCT02616614|12505255|FG000|PP Population|Overall Study||253
11307205|NCT02616614|12505256|FG001|PP Population|Overall Study||255
11307206|NCT02616614|12505257|FG002|PP Population|Overall Study||122
11307207|NCT02616614|12505255|FG000|COMPLETED|Overall Study||282
11307208|NCT02616614|12505256|FG001|COMPLETED|Overall Study||285
11307209|NCT02616614|12505257|FG002|COMPLETED|Overall Study||141
11307210|NCT02616614|12505255|FG000|NOT COMPLETED|Overall Study||65
11307211|NCT02616614|12505256|FG001|NOT COMPLETED|Overall Study||60
11307212|NCT02616614|12505257|FG002|NOT COMPLETED|Overall Study||29
11307213|NCT02616783|12505268|FG000|STARTED|Overall Study||111
11307214|NCT02616783|12505269|FG001|STARTED|Overall Study||56
11307215|NCT02616783|12505268|FG000|COMPLETED|Overall Study||105
11307216|NCT02616783|12505269|FG001|COMPLETED|Overall Study||54
11307217|NCT02616783|12505268|FG000|NOT COMPLETED|Overall Study||6
11307218|NCT02616783|12505269|FG001|NOT COMPLETED|Overall Study||2
11307219|NCT02616900|12505275|FG000|STARTED|Overall Study||74
11307220|NCT02616900|12505275|FG000|Completed 3mo Trial|Overall Study||57
11307221|NCT02616900|12505275|FG000|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51
11307222|NCT02616900|12505275|FG000|NOT COMPLETED|Overall Study||23
11307223|NCT02617628|12505281|FG000|STARTED|Overall Study||74
11307224|NCT02617628|12505282|FG001|STARTED|Overall Study||72
11307225|NCT02617628|12505281|FG000|COMPLETED|Overall Study||12
11307226|NCT02617628|12505282|FG001|COMPLETED|Overall Study||11
11307227|NCT02617628|12505281|FG000|NOT COMPLETED|Overall Study||62
11307228|NCT02617628|12505282|FG001|NOT COMPLETED|Overall Study||61
11307229|NCT02617667|12505294|FG000|STARTED|Overall Study||51
11307230|NCT02617667|12505295|FG001|STARTED|Overall Study||51
11307231|NCT02617667|12505296|FG002|STARTED|Overall Study||52
11307232|NCT02617667|12505297|FG003|STARTED|Overall Study||53
11307233|NCT02617667|12505294|FG000|COMPLETED|Overall Study||50
11307234|NCT02617667|12505295|FG001|COMPLETED|Overall Study||50
11307235|NCT02617667|12505296|FG002|COMPLETED|Overall Study||48
11307236|NCT02617667|12505297|FG003|COMPLETED|Overall Study||52
11307237|NCT02617667|12505294|FG000|NOT COMPLETED|Overall Study||1
11307238|NCT02617667|12505295|FG001|NOT COMPLETED|Overall Study||1
11307239|NCT02617667|12505296|FG002|NOT COMPLETED|Overall Study||4
11307240|NCT02617667|12505297|FG003|NOT COMPLETED|Overall Study||1
11307241|NCT02617784|12505308|FG000|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
11307242|NCT02617784|12505309|FG001|STARTED|Overall Study||12
11307243|NCT02617784|12505308|FG000|First Dose Assessment Period|Overall Study||12
11307244|NCT02617784|12505309|FG001|First Dose Assessment Period|Overall Study||12
11307245|NCT02617784|12505308|FG000|Second Dose Assessment Period|Overall Study||11
11307246|NCT02617784|12505309|FG001|Second Dose Assessment Period|Overall Study||12
11307247|NCT02617784|12505308|FG000|COMPLETED|Overall Study||12
11307248|NCT02617784|12505309|FG001|COMPLETED|Overall Study||12
11307249|NCT02617784|12505308|FG000|NOT COMPLETED|Overall Study||0
11307250|NCT02617784|12505309|FG001|NOT COMPLETED|Overall Study||0
11307251|NCT02617888|12505318|FG000|STARTED|Overall Study||50
11307252|NCT02617888|12505319|FG001|STARTED|Overall Study||51
11307253|NCT02617888|12505320|FG002|STARTED|Overall Study||127
11307254|NCT02617888|12505318|FG000|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
11307255|NCT02617888|12505319|FG001|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
11307256|NCT02617888|12505320|FG002|COMPLETED|Overall Study||127
11307257|NCT02617888|12505318|FG000|NOT COMPLETED|Overall Study||1
11307258|NCT02617888|12505319|FG001|NOT COMPLETED|Overall Study||7
11307259|NCT02617888|12505320|FG002|NOT COMPLETED|Overall Study||0
11307260|NCT02617901|12505327|FG000|STARTED|Overall Study||20
11307261|NCT02617901|12505327|FG000|COMPLETED|Overall Study||20
11307262|NCT02617901|12505327|FG000|NOT COMPLETED|Overall Study||0
11307263|NCT02618031|12505333|FG000|STARTED|Overall Study||46
11307264|NCT02618031|12505334|FG001|STARTED|Overall Study||11
11307265|NCT02618031|12505333|FG000|COMPLETED|Overall Study||45
11307266|NCT02618031|12505334|FG001|COMPLETED|Overall Study||11
11307267|NCT02618031|12505333|FG000|NOT COMPLETED|Overall Study||1
11307268|NCT02618031|12505334|FG001|NOT COMPLETED|Overall Study||0
11401611|NCT04095286|12596406|FG001|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
11401612|NCT04095286|12596407|FG002|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
11307269|NCT02618187|12505348|FG000|STARTED|Overall Study||15
11307270|NCT02618187|12505349|FG001|STARTED|Overall Study||11
11307271|NCT02618187|12505350|FG002|STARTED|Overall Study||15
11401613|NCT04095286|12596408|FG003|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
11307272|NCT02618187|12505351|FG003|STARTED|Overall Study||17
11307273|NCT02618187|12505348|FG000|Completed|Overall Study||13
11307274|NCT02618187|12505349|FG001|Completed|Overall Study||10
11307275|NCT02618187|12505350|FG002|Completed|Overall Study||13
11307276|NCT02618187|12505351|FG003|Completed|Overall Study||13
11307277|NCT02618187|12505348|FG000|COMPLETED|Overall Study||13
11307278|NCT02618187|12505349|FG001|COMPLETED|Overall Study||9
11307279|NCT02618187|12505350|FG002|COMPLETED|Overall Study||11
11307280|NCT02618187|12505351|FG003|COMPLETED|Overall Study||12
11307281|NCT02618187|12505348|FG000|NOT COMPLETED|Overall Study||2
11307282|NCT02618187|12505349|FG001|NOT COMPLETED|Overall Study||2
11307283|NCT02618187|12505350|FG002|NOT COMPLETED|Overall Study||4
11307284|NCT02618187|12505351|FG003|NOT COMPLETED|Overall Study||5
11307285|NCT02618343|12505363|FG000|STARTED|Overall Study||28
11307286|NCT02618343|12505364|FG001|STARTED|Overall Study||23
11307287|NCT02618343|12505363|FG000|COMPLETED|Overall Study||28
11307288|NCT02618343|12505364|FG001|COMPLETED|Overall Study||23
11307289|NCT02618343|12505363|FG000|NOT COMPLETED|Overall Study||0
11307290|NCT02618343|12505364|FG001|NOT COMPLETED|Overall Study||0
11307291|NCT02618382|12505370|FG000|STARTED|Overall Study|Enrolled and consented for study treatment|32
11307292|NCT02618382|12505370|FG000|COMPLETED|Overall Study|Completed Study treatment|29
11307293|NCT02618382|12505370|FG000|NOT COMPLETED|Overall Study||3
11307294|NCT02618512|12505374|FG000|STARTED|Overall Study||3
11307295|NCT02618512|12505374|FG000|COMPLETED|Overall Study||3
11307296|NCT02618512|12505374|FG000|NOT COMPLETED|Overall Study||0
11307297|NCT02618616|12505380|FG000|STARTED|Overall Study||87
11307298|NCT02618616|12505381|FG001|STARTED|Overall Study||42
11307299|NCT02618616|12505380|FG000|COMPLETED|Overall Study||66
11307300|NCT02618616|12505381|FG001|COMPLETED|Overall Study||35
11307301|NCT02618616|12505380|FG000|NOT COMPLETED|Overall Study||21
11401614|NCT04095286|12596409|FG004|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
11401615|NCT04095286|12596410|FG005|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
11307302|NCT02618616|12505381|FG001|NOT COMPLETED|Overall Study||7
11307303|NCT02618642|12505392|FG000|STARTED|Before 10 PILER Irradiation Treatments||15
11307304|NCT02618642|12505393|FG001|STARTED|Before 10 PILER Irradiation Treatments||15
11307305|NCT02618642|12505394|FG002|STARTED|Before 10 PILER Irradiation Treatments||15
11307306|NCT02618642|12505395|FG003|STARTED|Before 10 PILER Irradiation Treatments||15
11307307|NCT02618642|12505392|FG000|COMPLETED|Before 10 PILER Irradiation Treatments||15
11307308|NCT02618642|12505393|FG001|COMPLETED|Before 10 PILER Irradiation Treatments||15
11307309|NCT02618642|12505394|FG002|COMPLETED|Before 10 PILER Irradiation Treatments||15
11307310|NCT02618642|12505395|FG003|COMPLETED|Before 10 PILER Irradiation Treatments||15
11307311|NCT02618642|12505392|FG000|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
11307312|NCT02618642|12505393|FG001|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
11307313|NCT02618642|12505394|FG002|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
11307314|NCT02618642|12505395|FG003|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
11307315|NCT02618642|12505392|FG000|STARTED|After 10 PILER Irradiation Treatments||15
11307316|NCT02618642|12505393|FG001|STARTED|After 10 PILER Irradiation Treatments||15
11307317|NCT02618642|12505394|FG002|STARTED|After 10 PILER Irradiation Treatments||15
11307318|NCT02618642|12505395|FG003|STARTED|After 10 PILER Irradiation Treatments||15
11307319|NCT02618642|12505392|FG000|COMPLETED|After 10 PILER Irradiation Treatments||15
11307320|NCT02618642|12505393|FG001|COMPLETED|After 10 PILER Irradiation Treatments||15
11307321|NCT02618642|12505394|FG002|COMPLETED|After 10 PILER Irradiation Treatments||15
11307322|NCT02618642|12505395|FG003|COMPLETED|After 10 PILER Irradiation Treatments||15
11307323|NCT02618642|12505392|FG000|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
11307324|NCT02618642|12505393|FG001|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
11307325|NCT02618642|12505394|FG002|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
11307326|NCT02618642|12505395|FG003|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
11307327|NCT02618759|12505414|FG000|STARTED|Overall Study||60
11307328|NCT02618759|12505415|FG001|STARTED|Overall Study||59
11307329|NCT02618759|12505414|FG000|COMPLETED|Overall Study||58
11307330|NCT02618759|12505415|FG001|COMPLETED|Overall Study||54
11307331|NCT02618759|12505414|FG000|NOT COMPLETED|Overall Study||2
11307332|NCT02618759|12505415|FG001|NOT COMPLETED|Overall Study||5
11307333|NCT02618772|12505423|FG000|STARTED|Overall Study||39
11307334|NCT02618772|12505424|FG001|STARTED|Overall Study||40
11307335|NCT02618772|12505423|FG000|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
11307336|NCT02618772|12505424|FG001|Withdrawal by Subject|Overall Study||0
11307337|NCT02618772|12505423|FG000|COMPLETED|Overall Study||38
11307338|NCT02618772|12505424|FG001|COMPLETED|Overall Study||40
11307339|NCT02618772|12505423|FG000|NOT COMPLETED|Overall Study||1
11307340|NCT02618772|12505424|FG001|NOT COMPLETED|Overall Study||0
11307341|NCT02618915|12505432|FG000|STARTED|Overall Study||3
11307342|NCT02618915|12505433|FG001|STARTED|Overall Study||3
11307343|NCT02618915|12505432|FG000|COMPLETED|Overall Study||3
11307344|NCT02618915|12505433|FG001|COMPLETED|Overall Study||3
11307345|NCT02618915|12505432|FG000|NOT COMPLETED|Overall Study||0
11307346|NCT02618915|12505433|FG001|NOT COMPLETED|Overall Study||0
11307347|NCT02618928|12505441|FG000|STARTED|Overall Study||735
11307348|NCT02618928|12505441|FG000|Received Treatment|Overall Study||728
11307349|NCT02618928|12505441|FG000|COMPLETED|Overall Study||677
11307350|NCT02618928|12505441|FG000|NOT COMPLETED|Overall Study||58
11307351|NCT02618967|12505456|FG000|STARTED|Overall Study||6
11307352|NCT02618967|12505457|FG001|STARTED|Overall Study||6
11307353|NCT02618967|12505458|FG002|STARTED|Overall Study||6
11307354|NCT02618967|12505459|FG003|STARTED|Overall Study||6
11401616|NCT04095286|12596405|FG000|STARTED|Period 2 (4 Days) + Washout (7days)||3
11307355|NCT02618967|12505460|FG004|STARTED|Overall Study||6
11307356|NCT02618967|12505461|FG005|STARTED|Overall Study||6
11307357|NCT02618967|12505462|FG006|STARTED|Overall Study||6
11307358|NCT02618967|12505463|FG007|STARTED|Overall Study||14
11307359|NCT02618967|12505456|FG000|Received Treatment|Overall Study||6
11307360|NCT02618967|12505457|FG001|Received Treatment|Overall Study||6
11307361|NCT02618967|12505458|FG002|Received Treatment|Overall Study||6
11307362|NCT02618967|12505459|FG003|Received Treatment|Overall Study||6
11307363|NCT02618967|12505460|FG004|Received Treatment|Overall Study||6
11307364|NCT02618967|12505461|FG005|Received Treatment|Overall Study||6
11307365|NCT02618967|12505462|FG006|Received Treatment|Overall Study||6
11307366|NCT02618967|12505463|FG007|Received Treatment|Overall Study||14
11307367|NCT02618967|12505456|FG000|COMPLETED|Overall Study||5
11307368|NCT02618967|12505457|FG001|COMPLETED|Overall Study||6
11307369|NCT02618967|12505458|FG002|COMPLETED|Overall Study||5
11307370|NCT02618967|12505459|FG003|COMPLETED|Overall Study||6
11307371|NCT02618967|12505460|FG004|COMPLETED|Overall Study||4
11307372|NCT02618967|12505461|FG005|COMPLETED|Overall Study||6
11307373|NCT02618967|12505462|FG006|COMPLETED|Overall Study||6
11307374|NCT02618967|12505463|FG007|COMPLETED|Overall Study||14
11307375|NCT02618967|12505456|FG000|NOT COMPLETED|Overall Study||1
11307376|NCT02618967|12505457|FG001|NOT COMPLETED|Overall Study||0
11307377|NCT02618967|12505458|FG002|NOT COMPLETED|Overall Study||1
11307378|NCT02618967|12505459|FG003|NOT COMPLETED|Overall Study||0
11307379|NCT02618967|12505460|FG004|NOT COMPLETED|Overall Study||2
11307380|NCT02618967|12505461|FG005|NOT COMPLETED|Overall Study||0
11307381|NCT02618967|12505462|FG006|NOT COMPLETED|Overall Study||0
11307382|NCT02618967|12505463|FG007|NOT COMPLETED|Overall Study||0
11307383|NCT02619175|12505483|FG000|STARTED|Overall Study||18
11307384|NCT02619175|12505484|FG001|STARTED|Overall Study||16
11307385|NCT02619175|12505483|FG000|COMPLETED|Overall Study||16
11307386|NCT02619175|12505484|FG001|COMPLETED|Overall Study||16
11307387|NCT02619175|12505483|FG000|NOT COMPLETED|Overall Study||2
11307388|NCT02619175|12505484|FG001|NOT COMPLETED|Overall Study||0
11307389|NCT02619396|12505498|FG000|STARTED|Overall Study||20
11307390|NCT02619396|12505499|FG001|STARTED|Overall Study||20
11307391|NCT02619396|12505500|FG002|STARTED|Overall Study||20
11307392|NCT02619396|12505501|FG003|STARTED|Overall Study||20
11307393|NCT02619396|12505498|FG000|COMPLETED|Overall Study||20
11307394|NCT02619396|12505499|FG001|COMPLETED|Overall Study||20
11307395|NCT02619396|12505500|FG002|COMPLETED|Overall Study||20
11307396|NCT02619396|12505501|FG003|COMPLETED|Overall Study||20
11307397|NCT02619396|12505498|FG000|NOT COMPLETED|Overall Study||0
11307398|NCT02619396|12505499|FG001|NOT COMPLETED|Overall Study||0
11307399|NCT02619396|12505500|FG002|NOT COMPLETED|Overall Study||0
11307400|NCT02619396|12505501|FG003|NOT COMPLETED|Overall Study||0
11307401|NCT02619409|12505517|FG000|STARTED|Overall Study||6
11307402|NCT02619409|12505518|FG001|STARTED|Overall Study||6
11307403|NCT02619409|12505519|FG002|STARTED|Overall Study||6
11307404|NCT02619409|12505520|FG003|STARTED|Overall Study||6
11307405|NCT02619409|12505521|FG004|STARTED|Overall Study||6
11307406|NCT02619409|12505517|FG000|COMPLETED|Overall Study||6
11307407|NCT02619409|12505518|FG001|COMPLETED|Overall Study||6
11307408|NCT02619409|12505519|FG002|COMPLETED|Overall Study||6
11307409|NCT02619409|12505520|FG003|COMPLETED|Overall Study||6
11307410|NCT02619409|12505521|FG004|COMPLETED|Overall Study||6
11307411|NCT02619409|12505517|FG000|NOT COMPLETED|Overall Study||0
11307412|NCT02619409|12505518|FG001|NOT COMPLETED|Overall Study||0
11307413|NCT02619409|12505519|FG002|NOT COMPLETED|Overall Study||0
11307414|NCT02619409|12505520|FG003|NOT COMPLETED|Overall Study||0
11307415|NCT02619409|12505521|FG004|NOT COMPLETED|Overall Study||0
11307416|NCT02619591|12505535|FG000|STARTED|Overall Study||139
11307417|NCT02619591|12505536|FG001|STARTED|Overall Study||121
11307418|NCT02619591|12505535|FG000|COMPLETED|Overall Study||0
11307419|NCT02619591|12505536|FG001|COMPLETED|Overall Study||0
11307420|NCT02619591|12505535|FG000|NOT COMPLETED|Overall Study||139
11307421|NCT02619591|12505536|FG001|NOT COMPLETED|Overall Study||121
11307422|NCT02619617|12505542|FG000|STARTED|Period 1 Placebo - 1st AttacK||28
11307423|NCT02619617|12505543|FG001|STARTED|Period 1 Placebo - 1st AttacK||0
11307424|NCT02619617|12505542|FG000|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20
11307425|NCT02619617|12505543|FG001|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0
11307426|NCT02619617|12505542|FG000|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28
11307427|NCT02619617|12505543|FG001|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0
11307428|NCT02619617|12505542|FG000|COMPLETED|Period 1 Placebo - 1st AttacK||28
11307429|NCT02619617|12505543|FG001|COMPLETED|Period 1 Placebo - 1st AttacK||0
11307430|NCT02619617|12505542|FG000|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
11307431|NCT02619617|12505543|FG001|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
11307432|NCT02619617|12505542|FG000|STARTED|Period 2 SOM230 - 2nd Attack||0
11307433|NCT02619617|12505543|FG001|STARTED|Period 2 SOM230 - 2nd Attack||28
11307434|NCT02619617|12505542|FG000|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0
11307435|NCT02619617|12505543|FG001|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28
11307436|NCT02619617|12505542|FG000|COMPLETED|Period 2 SOM230 - 2nd Attack||0
11307437|NCT02619617|12505543|FG001|COMPLETED|Period 2 SOM230 - 2nd Attack||24
11307438|NCT02619617|12505542|FG000|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0
11307439|NCT02619617|12505543|FG001|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4
11307440|NCT02619799|12505553|FG000|STARTED|Overall Study||25
11307441|NCT02619799|12505554|FG001|STARTED|Overall Study||25
11307442|NCT02619799|12505553|FG000|COMPLETED|Overall Study||25
11307443|NCT02619799|12505554|FG001|COMPLETED|Overall Study||25
11307444|NCT02619799|12505553|FG000|NOT COMPLETED|Overall Study||0
11307445|NCT02619799|12505554|FG001|NOT COMPLETED|Overall Study||0
11307446|NCT02620020|12505564|FG000|STARTED|Overall Study||141
11307447|NCT02620020|12505565|FG001|STARTED|Overall Study||141
11307448|NCT02620020|12505566|FG002|STARTED|Overall Study||140
11307449|NCT02620020|12505567|FG003|STARTED|Overall Study||141
11307450|NCT02620020|12505564|FG000|Modified Intent to Treat Set (mITT)|Overall Study||140
11307451|NCT02620020|12505565|FG001|Modified Intent to Treat Set (mITT)|Overall Study||139
11307452|NCT02620020|12505566|FG002|Modified Intent to Treat Set (mITT)|Overall Study||139
11307453|NCT02620020|12505567|FG003|Modified Intent to Treat Set (mITT)|Overall Study||140
11307454|NCT02620020|12505564|FG000|COMPLETED|Overall Study||97
11307455|NCT02620020|12505565|FG001|COMPLETED|Overall Study||106
11307456|NCT02620020|12505566|FG002|COMPLETED|Overall Study||115
11307457|NCT02620020|12505567|FG003|COMPLETED|Overall Study||115
11307458|NCT02620020|12505564|FG000|NOT COMPLETED|Overall Study||44
11307459|NCT02620020|12505565|FG001|NOT COMPLETED|Overall Study||35
11307460|NCT02620020|12505566|FG002|NOT COMPLETED|Overall Study||25
11307461|NCT02620020|12505567|FG003|NOT COMPLETED|Overall Study||26
11307462|NCT02620384|12505579|FG000|STARTED|Overall Study||70
11307463|NCT02620384|12505580|FG001|STARTED|Overall Study||73
11307464|NCT02620384|12505579|FG000|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
11307465|NCT02620384|12505580|FG001|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
11307466|NCT02620384|12505579|FG000|NOT COMPLETED|Overall Study||4
11307467|NCT02620384|12505580|FG001|NOT COMPLETED|Overall Study||7
11307468|NCT02620683|12505586|FG000|STARTED|First Intervention (Visit 1)||12
11307469|NCT02620683|12505587|FG001|STARTED|First Intervention (Visit 1)||11
11307470|NCT02620683|12505586|FG000|COMPLETED|First Intervention (Visit 1)||12
11307471|NCT02620683|12505587|FG001|COMPLETED|First Intervention (Visit 1)||11
11307472|NCT02620683|12505586|FG000|NOT COMPLETED|First Intervention (Visit 1)||0
11307473|NCT02620683|12505587|FG001|NOT COMPLETED|First Intervention (Visit 1)||0
11307474|NCT02620683|12505586|FG000|STARTED|Washout (2 Weeks)||12
11307475|NCT02620683|12505587|FG001|STARTED|Washout (2 Weeks)||11
11307476|NCT02620683|12505586|FG000|COMPLETED|Washout (2 Weeks)||12
11307477|NCT02620683|12505587|FG001|COMPLETED|Washout (2 Weeks)||11
11307478|NCT02620683|12505586|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11307479|NCT02620683|12505587|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11307480|NCT02620683|12505586|FG000|STARTED|Second Intervention (Visit 2)||12
11307481|NCT02620683|12505587|FG001|STARTED|Second Intervention (Visit 2)||11
11307482|NCT02620683|12505586|FG000|COMPLETED|Second Intervention (Visit 2)||12
11307483|NCT02620683|12505587|FG001|COMPLETED|Second Intervention (Visit 2)||11
11307484|NCT02620683|12505586|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0
11307485|NCT02620683|12505587|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0
11307486|NCT02620774|12505594|FG000|STARTED|Overall Study||10
11307487|NCT02620774|12505595|FG001|STARTED|Overall Study||6
11307488|NCT02620774|12505594|FG000|COMPLETED|Overall Study||10
11307489|NCT02620774|12505595|FG001|COMPLETED|Overall Study||6
11307490|NCT02620774|12505594|FG000|NOT COMPLETED|Overall Study||0
11307491|NCT02620774|12505595|FG001|NOT COMPLETED|Overall Study||0
11307492|NCT02620787|12505603|FG000|STARTED|Overall Study||12
11307493|NCT02620787|12505604|FG001|STARTED|Overall Study||6
11307494|NCT02620787|12505603|FG000|COMPLETED|Overall Study||10
11307495|NCT02620787|12505604|FG001|COMPLETED|Overall Study||6
11307496|NCT02620787|12505603|FG000|NOT COMPLETED|Overall Study||2
11307497|NCT02620787|12505604|FG001|NOT COMPLETED|Overall Study||0
11401617|NCT04095286|12596406|FG001|STARTED|Period 2 (4 Days) + Washout (7days)||4
11401618|NCT04095286|12596407|FG002|STARTED|Period 2 (4 Days) + Washout (7days)||4
11401619|NCT04095286|12596408|FG003|STARTED|Period 2 (4 Days) + Washout (7days)||5
11401620|NCT04095286|12596409|FG004|STARTED|Period 2 (4 Days) + Washout (7days)||5
11401621|NCT04095286|12596410|FG005|STARTED|Period 2 (4 Days) + Washout (7days)||5
11401622|NCT04095286|12596405|FG000|COMPLETED|Period 2 (4 Days) + Washout (7days)||3
11401623|NCT04095286|12596406|FG001|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
11401624|NCT04095286|12596407|FG002|COMPLETED|Period 2 (4 Days) + Washout (7days)||2
11401625|NCT04095286|12596408|FG003|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
11401626|NCT04095286|12596409|FG004|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
11401627|NCT04095286|12596410|FG005|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
11401628|NCT04095286|12596405|FG000|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
11401629|NCT04095286|12596406|FG001|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
11307498|NCT02620878|12505610|FG000|STARTED|Overall Study||16
11307499|NCT02620878|12505611|FG001|STARTED|Overall Study||16
11307500|NCT02620878|12505610|FG000|COMPLETED|Overall Study||16
11307501|NCT02620878|12505611|FG001|COMPLETED|Overall Study||16
11307502|NCT02620878|12505610|FG000|NOT COMPLETED|Overall Study||0
11307503|NCT02620878|12505611|FG001|NOT COMPLETED|Overall Study||0
11307504|NCT02620904|12505619|FG000|STARTED|Overall Study||4
11307505|NCT02620904|12505620|FG001|STARTED|Overall Study||5
11307506|NCT02620904|12505619|FG000|COMPLETED|Overall Study||4
11307507|NCT02620904|12505620|FG001|COMPLETED|Overall Study||5
11307508|NCT02620904|12505619|FG000|NOT COMPLETED|Overall Study||0
11307509|NCT02620904|12505620|FG001|NOT COMPLETED|Overall Study||0
11307510|NCT02620917|12505626|FG000|STARTED|Overall Study||6623
11307511|NCT02620917|12505626|FG000|COMPLETED|Overall Study||6623
11307512|NCT02620917|12505626|FG000|NOT COMPLETED|Overall Study||0
11307513|NCT02621034|12505635|FG000|STARTED|Overall Study||53
11307514|NCT02621034|12505636|FG001|STARTED|Overall Study||52
11307515|NCT02621034|12505637|FG002|STARTED|Overall Study||55
11307516|NCT02621034|12505635|FG000|COMPLETED|Overall Study||50
11307517|NCT02621034|12505636|FG001|COMPLETED|Overall Study||50
11307518|NCT02621034|12505637|FG002|COMPLETED|Overall Study||50
11307519|NCT02621034|12505635|FG000|NOT COMPLETED|Overall Study||3
11307520|NCT02621034|12505636|FG001|NOT COMPLETED|Overall Study||2
11307521|NCT02621034|12505637|FG002|NOT COMPLETED|Overall Study||5
11307522|NCT02621047|12505650|FG000|STARTED|Overall Study||8
11307523|NCT02621047|12505651|FG001|STARTED|Overall Study||8
11307524|NCT02621047|12505652|FG002|STARTED|Overall Study||12
11307525|NCT02621047|12505650|FG000|COMPLETED|Overall Study||8
11307526|NCT02621047|12505651|FG001|COMPLETED|Overall Study||8
11307527|NCT02621047|12505652|FG002|COMPLETED|Overall Study||11
11307528|NCT02621047|12505650|FG000|NOT COMPLETED|Overall Study||0
11307529|NCT02621047|12505651|FG001|NOT COMPLETED|Overall Study||0
11307530|NCT02621047|12505652|FG002|NOT COMPLETED|Overall Study||1
11307531|NCT02621060|12505663|FG000|STARTED|Overall Study||15
11307532|NCT02621060|12505664|FG001|STARTED|Overall Study||15
11307533|NCT02621060|12505663|FG000|COMPLETED|Overall Study||12
11307534|NCT02621060|12505664|FG001|COMPLETED|Overall Study||14
11307535|NCT02621060|12505663|FG000|NOT COMPLETED|Overall Study||3
11307536|NCT02621060|12505664|FG001|NOT COMPLETED|Overall Study||1
11307537|NCT02621073|12505672|FG000|STARTED|Overall Study||4
11307538|NCT02621073|12505673|FG001|STARTED|Overall Study||3
11307539|NCT02621073|12505672|FG000|COMPLETED|Overall Study||1
11307540|NCT02621073|12505673|FG001|COMPLETED|Overall Study||0
11307541|NCT02621073|12505672|FG000|NOT COMPLETED|Overall Study||3
11307542|NCT02621073|12505673|FG001|NOT COMPLETED|Overall Study||3
11307543|NCT02621463|12505679|FG000|STARTED|Overall Study||29
11307544|NCT02621463|12505679|FG000|COMPLETED|Overall Study||29
11307545|NCT02621463|12505679|FG000|NOT COMPLETED|Overall Study||0
11307546|NCT02621619|12505685|FG000|STARTED|Overall Study||80
11307547|NCT02621619|12505686|FG001|STARTED|Overall Study||79
11307548|NCT02621619|12505685|FG000|COMPLETED|Overall Study||80
11307549|NCT02621619|12505686|FG001|COMPLETED|Overall Study||79
11307550|NCT02621619|12505685|FG000|NOT COMPLETED|Overall Study||0
11307551|NCT02621619|12505686|FG001|NOT COMPLETED|Overall Study||0
11307552|NCT02621892|12505694|FG000|STARTED|Treatment Period||307
11307553|NCT02621892|12505695|FG001|STARTED|Treatment Period||299
11307554|NCT02621892|12505694|FG000|COMPLETED|Treatment Period||261
11307555|NCT02621892|12505695|FG001|COMPLETED|Treatment Period||272
11307556|NCT02621892|12505694|FG000|NOT COMPLETED|Treatment Period||46
11307557|NCT02621892|12505695|FG001|NOT COMPLETED|Treatment Period||27
11307558|NCT02621892|12505694|FG000|STARTED|Randomized Withdrawal Period||261
11307559|NCT02621892|12505695|FG001|STARTED|Randomized Withdrawal Period||272
11307560|NCT02621892|12505694|FG000|COMPLETED|Randomized Withdrawal Period||250
11307561|NCT02621892|12505695|FG001|COMPLETED|Randomized Withdrawal Period||260
11307562|NCT02621892|12505694|FG000|NOT COMPLETED|Randomized Withdrawal Period||11
11307563|NCT02621892|12505695|FG001|NOT COMPLETED|Randomized Withdrawal Period||12
11307564|NCT02621931|12505704|FG000|STARTED|Overall Study||375
11307565|NCT02621931|12505705|FG001|STARTED|Overall Study||376
11307566|NCT02621931|12505706|FG002|STARTED|Overall Study||379
11307567|NCT02621931|12505704|FG000|Safety and ITT Populations|Overall Study||375
11307568|NCT02621931|12505705|FG001|Safety and ITT Populations|Overall Study||376
11307569|NCT02621931|12505706|FG002|Safety and ITT Populations|Overall Study||379
11307570|NCT02621931|12505704|FG000|Full Analysis Set|Overall Study||371
11307571|NCT02621931|12505705|FG001|Full Analysis Set|Overall Study||375
11307572|NCT02621931|12505706|FG002|Full Analysis Set|Overall Study||375
11307573|NCT02621931|12505704|FG000|COMPLETED|Overall Study||342
11307574|NCT02621931|12505705|FG001|COMPLETED|Overall Study||349
11307575|NCT02621931|12505706|FG002|COMPLETED|Overall Study||343
11307576|NCT02621931|12505704|FG000|NOT COMPLETED|Overall Study||33
11307577|NCT02621931|12505705|FG001|NOT COMPLETED|Overall Study||27
11307578|NCT02621931|12505706|FG002|NOT COMPLETED|Overall Study||36
11307579|NCT02621983|12505718|FG000|STARTED|Overall Study||21
11307580|NCT02621983|12505719|FG001|STARTED|Overall Study||17
11307581|NCT02621983|12505718|FG000|COMPLETED|Overall Study||9
11307582|NCT02621983|12505719|FG001|COMPLETED|Overall Study||6
11307583|NCT02621983|12505718|FG000|NOT COMPLETED|Overall Study||12
11307584|NCT02621983|12505719|FG001|NOT COMPLETED|Overall Study||11
11307585|NCT02622074|12505731|FG000|STARTED|Overall Study||10
11307586|NCT02622074|12505732|FG001|STARTED|Overall Study||10
11307587|NCT02622074|12505733|FG002|STARTED|Overall Study||10
11307588|NCT02622074|12505734|FG003|STARTED|Overall Study||10
11307589|NCT02622074|12505735|FG004|STARTED|Overall Study||10
11307590|NCT02622074|12505736|FG005|STARTED|Overall Study||10
11307591|NCT02622074|12505731|FG000|COMPLETED|Overall Study||6
11307592|NCT02622074|12505732|FG001|COMPLETED|Overall Study||9
11307593|NCT02622074|12505733|FG002|COMPLETED|Overall Study||10
11307594|NCT02622074|12505734|FG003|COMPLETED|Overall Study||9
11307595|NCT02622074|12505735|FG004|COMPLETED|Overall Study||9
11307596|NCT02622074|12505736|FG005|COMPLETED|Overall Study||10
11307597|NCT02622074|12505731|FG000|NOT COMPLETED|Overall Study||4
11307598|NCT02622074|12505732|FG001|NOT COMPLETED|Overall Study||1
11307599|NCT02622074|12505733|FG002|NOT COMPLETED|Overall Study||0
11307600|NCT02622074|12505734|FG003|NOT COMPLETED|Overall Study||1
11307601|NCT02622074|12505735|FG004|NOT COMPLETED|Overall Study||1
11307602|NCT02622074|12505736|FG005|NOT COMPLETED|Overall Study||0
11307603|NCT02622113|12505752|FG000|STARTED|Overall Study||67
11307604|NCT02622113|12505753|FG001|STARTED|Overall Study||76
11307605|NCT02622113|12505752|FG000|COMPLETED|Overall Study||62
11307606|NCT02622113|12505753|FG001|COMPLETED|Overall Study||66
11307607|NCT02622113|12505752|FG000|NOT COMPLETED|Overall Study||5
11307608|NCT02622113|12505753|FG001|NOT COMPLETED|Overall Study||10
11307609|NCT02622178|12505762|FG000|STARTED|Overall Study||42
11307610|NCT02622178|12505763|FG001|STARTED|Overall Study||45
11307611|NCT02622178|12505764|FG002|STARTED|Overall Study||49
11307612|NCT02622178|12505762|FG000|COMPLETED|Overall Study||42
11307613|NCT02622178|12505763|FG001|COMPLETED|Overall Study||45
11307614|NCT02622178|12505764|FG002|COMPLETED|Overall Study||49
11307615|NCT02622178|12505762|FG000|NOT COMPLETED|Overall Study||0
11307616|NCT02622178|12505763|FG001|NOT COMPLETED|Overall Study||0
11307617|NCT02622178|12505764|FG002|NOT COMPLETED|Overall Study||0
11307618|NCT02622191|12505775|FG000|STARTED|Overall Study||19
11307619|NCT02622191|12505776|FG001|STARTED|Overall Study||14
11307620|NCT02622191|12505775|FG000|COMPLETED|Overall Study||19
11307621|NCT02622191|12505776|FG001|COMPLETED|Overall Study||14
11307622|NCT02622191|12505775|FG000|NOT COMPLETED|Overall Study||0
11307623|NCT02622191|12505776|FG001|NOT COMPLETED|Overall Study||0
11307624|NCT02622321|12505787|FG000|STARTED|Overall Study||35
11307625|NCT02622321|12505788|FG001|STARTED|Overall Study||18
11307626|NCT02622321|12505789|FG002|STARTED|Overall Study||49
11307627|NCT02622321|12505790|FG003|STARTED|Overall Study||11
11307628|NCT02622321|12505787|FG000|Received at Least One Dose of Treatment|Overall Study|1 participant withdrew prior to study Day 1.|34
11307629|NCT02622321|12505788|FG001|Received at Least One Dose of Treatment|Overall Study||18
11307630|NCT02622321|12505789|FG002|Received at Least One Dose of Treatment|Overall Study||49
11307631|NCT02622321|12505790|FG003|Received at Least One Dose of Treatment|Overall Study||11
11307632|NCT02622321|12505787|FG000|Completed 24 Weeks in the Study|Overall Study||31
11307633|NCT02622321|12505788|FG001|Completed 24 Weeks in the Study|Overall Study|After 24 weeks, all 18 participants in Arm B switched to receive emicizumab prophylaxis.|18
11307634|NCT02622321|12505789|FG002|Completed 24 Weeks in the Study|Overall Study||49
11307635|NCT02622321|12505790|FG003|Completed 24 Weeks in the Study|Overall Study||11
11307636|NCT02622321|12505787|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
11307637|NCT02622321|12505788|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
11307638|NCT02622321|12505789|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
11307639|NCT02622321|12505790|FG003|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
11307640|NCT02622321|12505787|FG000|COMPLETED|Overall Study||32
11307641|NCT02622321|12505788|FG001|COMPLETED|Overall Study||18
11307642|NCT02622321|12505789|FG002|COMPLETED|Overall Study||48
11307643|NCT02622321|12505790|FG003|COMPLETED|Overall Study||11
11307644|NCT02622321|12505787|FG000|NOT COMPLETED|Overall Study||3
11307645|NCT02622321|12505788|FG001|NOT COMPLETED|Overall Study||0
11307646|NCT02622321|12505789|FG002|NOT COMPLETED|Overall Study||1
11307647|NCT02622321|12505790|FG003|NOT COMPLETED|Overall Study||0
11307648|NCT02622568|12505816|FG000|STARTED|Overall Study||14
11307649|NCT02622568|12505817|FG001|STARTED|Overall Study||14
11307650|NCT02622568|12505816|FG000|COMPLETED|Overall Study||9
11307651|NCT02622568|12505817|FG001|COMPLETED|Overall Study||9
11307652|NCT02622568|12505816|FG000|NOT COMPLETED|Overall Study||5
11307653|NCT02622568|12505817|FG001|NOT COMPLETED|Overall Study||5
11307654|NCT02622724|12505825|FG000|STARTED|Overall Study||144
11307655|NCT02622724|12505826|FG001|STARTED|Overall Study||152
11307656|NCT02622724|12505825|FG000|Subjects Randomised|Overall Study||146
11307657|NCT02622724|12505826|FG001|Subjects Randomised|Overall Study||155
11307658|NCT02622724|12505825|FG000|Short-Term Follow-Up (Day 28)|Overall Study||105
11307659|NCT02622724|12505826|FG001|Short-Term Follow-Up (Day 28)|Overall Study||115
11307660|NCT02622724|12505825|FG000|Long-Term Follow-Up (Day 90)|Overall Study||96
11307661|NCT02622724|12505826|FG001|Long-Term Follow-Up (Day 90)|Overall Study||101
11307662|NCT02622724|12505825|FG000|Long-Term Follow-Up (Day 180)|Overall Study||73
11307663|NCT02622724|12505826|FG001|Long-Term Follow-Up (Day 180)|Overall Study||74
11307664|NCT02622724|12505825|FG000|COMPLETED|Overall Study||51
11307665|NCT02622724|12505826|FG001|COMPLETED|Overall Study||49
11307666|NCT02622724|12505825|FG000|NOT COMPLETED|Overall Study||93
11307667|NCT02622724|12505826|FG001|NOT COMPLETED|Overall Study||103
11307668|NCT02623218|12505843|FG000|STARTED|Overall Study||5
11307669|NCT02623218|12505844|FG001|STARTED|Overall Study||4
11307670|NCT02623218|12505845|FG002|STARTED|Overall Study||4
11307671|NCT02623218|12505846|FG003|STARTED|Overall Study||4
11307672|NCT02623218|12505847|FG004|STARTED|Overall Study||4
11307673|NCT02623218|12505843|FG000|COMPLETED|Overall Study||5
11307674|NCT02623218|12505844|FG001|COMPLETED|Overall Study||3
11307675|NCT02623218|12505845|FG002|COMPLETED|Overall Study||4
11307676|NCT02623218|12505846|FG003|COMPLETED|Overall Study||4
11307677|NCT02623218|12505847|FG004|COMPLETED|Overall Study||4
11307678|NCT02623218|12505843|FG000|NOT COMPLETED|Overall Study||0
11307679|NCT02623218|12505844|FG001|NOT COMPLETED|Overall Study||1
11307680|NCT02623218|12505845|FG002|NOT COMPLETED|Overall Study||0
11307681|NCT02623218|12505846|FG003|NOT COMPLETED|Overall Study||0
11307682|NCT02623218|12505847|FG004|NOT COMPLETED|Overall Study||0
11307683|NCT02623322|12505862|FG000|STARTED|Overall Study||43
11307684|NCT02623322|12505863|FG001|STARTED|Overall Study||41
11307685|NCT02623322|12505864|FG002|STARTED|Overall Study||40
11307686|NCT02623322|12505862|FG000|COMPLETED|Overall Study||41
11307687|NCT02623322|12505863|FG001|COMPLETED|Overall Study||40
11307688|NCT02623322|12505864|FG002|COMPLETED|Overall Study||40
11307689|NCT02623322|12505862|FG000|NOT COMPLETED|Overall Study||2
11307690|NCT02623322|12505863|FG001|NOT COMPLETED|Overall Study||1
11307691|NCT02623322|12505864|FG002|NOT COMPLETED|Overall Study||0
11307692|NCT02623335|12505876|FG000|STARTED|Overall Study||223
11307693|NCT02623335|12505877|FG001|STARTED|Overall Study||223
11307694|NCT02623335|12505876|FG000|T0 Audio Recording (Day of Consultation)|Overall Study||223
11307695|NCT02623335|12505877|FG001|T0 Audio Recording (Day of Consultation)|Overall Study||222
11307696|NCT02623335|12505876|FG000|T1 Survey (24-48 Hours)|Overall Study||216
11307697|NCT02623335|12505877|FG001|T1 Survey (24-48 Hours)|Overall Study||214
11307698|NCT02623335|12505876|FG000|T2 Survey (6-8 Weeks)|Overall Study||199
11307699|NCT02623335|12505877|FG001|T2 Survey (6-8 Weeks)|Overall Study||192
11307700|NCT02623335|12505876|FG000|T3 Survey (12-14 Weeks)|Overall Study||196
11307701|NCT02623335|12505877|FG001|T3 Survey (12-14 Weeks)|Overall Study||187
11307702|NCT02623335|12505876|FG000|COMPLETED|Overall Study||196
11307703|NCT02623335|12505877|FG001|COMPLETED|Overall Study||187
11307704|NCT02623335|12505876|FG000|NOT COMPLETED|Overall Study||27
11307705|NCT02623335|12505877|FG001|NOT COMPLETED|Overall Study||36
11342025|NCT02940574|12539546|FG001|COMPLETED|From Study Start to 1-month Follow-up|All participants completed, but data from 1 participant was not included in analyses.|18
11342026|NCT02940574|12539545|FG000|NOT COMPLETED|From Study Start to 1-month Follow-up||1
11342027|NCT02940574|12539546|FG001|NOT COMPLETED|From Study Start to 1-month Follow-up||0
11342028|NCT02940574|12539545|FG000|STARTED|1-year Follow-up||21
11342029|NCT02940574|12539546|FG001|STARTED|1-year Follow-up||18
11342030|NCT02940574|12539545|FG000|COMPLETED|1-year Follow-up||18
11342031|NCT02940574|12539546|FG001|COMPLETED|1-year Follow-up||14
11342032|NCT02940574|12539545|FG000|NOT COMPLETED|1-year Follow-up||3
11342033|NCT02940574|12539546|FG001|NOT COMPLETED|1-year Follow-up||4
11342034|NCT02940626|12539558|FG000|STARTED|Overall Study||77
11342035|NCT02940626|12539559|FG001|STARTED|Overall Study||78
11342036|NCT02940626|12539558|FG000|Randomized Into Primary Prevention Study|Overall Study||77
11342037|NCT02940626|12539559|FG001|Randomized Into Primary Prevention Study|Overall Study||77
11342038|NCT02940626|12539558|FG000|Randomized Into Treatment Sub-study|Overall Study||0
11342039|NCT02940626|12539559|FG001|Randomized Into Treatment Sub-study|Overall Study||1
11342040|NCT02940626|12539558|FG000|Received Study Treatment|Overall Study||77
11342041|NCT02940626|12539559|FG001|Received Study Treatment|Overall Study||77
11342042|NCT02940626|12539558|FG000|Completed Through Study Day 22|Overall Study||42
11342043|NCT02940626|12539559|FG001|Completed Through Study Day 22|Overall Study||49
11342044|NCT02940626|12539558|FG000|COMPLETED|Overall Study||30
11342045|NCT02940626|12539559|FG001|COMPLETED|Overall Study||43
11342046|NCT02940626|12539558|FG000|NOT COMPLETED|Overall Study||47
11342047|NCT02940626|12539559|FG001|NOT COMPLETED|Overall Study||35
11307706|NCT02623348|12505885|FG000|STARTED|Overall Study||30
11307707|NCT02623348|12505886|FG001|STARTED|Overall Study||30
11307708|NCT02623348|12505885|FG000|3-month Assessment|Overall Study||27
11307709|NCT02623348|12505886|FG001|3-month Assessment|Overall Study||26
11307710|NCT02623348|12505885|FG000|COMPLETED|Overall Study||27
11307711|NCT02623348|12505886|FG001|COMPLETED|Overall Study||28
11307712|NCT02623348|12505885|FG000|NOT COMPLETED|Overall Study||3
11307713|NCT02623348|12505886|FG001|NOT COMPLETED|Overall Study||2
11307714|NCT02623361|12505894|FG000|STARTED|Overall Study||40
11307715|NCT02623361|12505895|FG001|STARTED|Overall Study||40
11307716|NCT02623361|12505894|FG000|COMPLETED|Overall Study||40
11307717|NCT02623361|12505895|FG001|COMPLETED|Overall Study||38
11307718|NCT02623361|12505894|FG000|NOT COMPLETED|Overall Study||0
11307719|NCT02623361|12505895|FG001|NOT COMPLETED|Overall Study||2
11307720|NCT02623803|12505903|FG000|STARTED|Overall Study||25
11307721|NCT02623803|12505904|FG001|STARTED|Overall Study||23
11307722|NCT02623803|12505903|FG000|COMPLETED|Overall Study||25
11307723|NCT02623803|12505904|FG001|COMPLETED|Overall Study||23
11307724|NCT02623803|12505903|FG000|NOT COMPLETED|Overall Study||0
11307725|NCT02623803|12505904|FG001|NOT COMPLETED|Overall Study||0
11307726|NCT02623829|12505912|FG000|STARTED|Overall Study||21
11307727|NCT02623829|12505913|FG001|STARTED|Overall Study||21
11307728|NCT02623829|12505912|FG000|COMPLETED|Overall Study||20
11307729|NCT02623829|12505913|FG001|COMPLETED|Overall Study||20
11307730|NCT02623829|12505912|FG000|NOT COMPLETED|Overall Study||1
11307731|NCT02623829|12505913|FG001|NOT COMPLETED|Overall Study||1
11307732|NCT02623855|12505921|FG000|STARTED|Overall Study||56
11307733|NCT02623855|12505922|FG001|STARTED|Overall Study||100
11307734|NCT02623855|12505921|FG000|COMPLETED|Overall Study||46
11307735|NCT02623855|12505922|FG001|COMPLETED|Overall Study||84
11307736|NCT02623855|12505921|FG000|NOT COMPLETED|Overall Study||10
11307737|NCT02623855|12505922|FG001|NOT COMPLETED|Overall Study||16
11307738|NCT02624050|12505930|FG000|STARTED|Overall Study||26
11307739|NCT02624050|12505931|FG001|STARTED|Overall Study||25
11307740|NCT02624050|12505930|FG000|COMPLETED|Overall Study||20
11307741|NCT02624050|12505931|FG001|COMPLETED|Overall Study||25
11307742|NCT02624050|12505930|FG000|NOT COMPLETED|Overall Study||6
11307743|NCT02624050|12505931|FG001|NOT COMPLETED|Overall Study||0
11307744|NCT02624180|12505939|FG000|STARTED|Overall Study||43
11307745|NCT02624180|12505940|FG001|STARTED|Overall Study||38
11307746|NCT02624180|12505939|FG000|COMPLETED|Overall Study||37
11307747|NCT02624180|12505940|FG001|COMPLETED|Overall Study||34
11307748|NCT02624180|12505939|FG000|NOT COMPLETED|Overall Study||6
11307749|NCT02624180|12505940|FG001|NOT COMPLETED|Overall Study||4
11307750|NCT02624284|12505949|FG000|STARTED|Overall Study||49
11307751|NCT02624284|12505950|FG001|STARTED|Overall Study||53
11307752|NCT02624284|12505951|FG002|STARTED|Overall Study||47
11307753|NCT02624284|12505949|FG000|COMPLETED|Overall Study||35
11307754|NCT02624284|12505950|FG001|COMPLETED|Overall Study||35
11307755|NCT02624284|12505951|FG002|COMPLETED|Overall Study||36
11307756|NCT02624284|12505949|FG000|NOT COMPLETED|Overall Study||14
11307757|NCT02624284|12505950|FG001|NOT COMPLETED|Overall Study||18
11307758|NCT02624284|12505951|FG002|NOT COMPLETED|Overall Study||11
11307759|NCT02624375|12505959|FG000|STARTED|Overall Study||10
11307760|NCT02624375|12505959|FG000|COMPLETED|Overall Study||10
11307761|NCT02624375|12505959|FG000|NOT COMPLETED|Overall Study||0
11307762|NCT02624492|12505966|FG000|STARTED|Overall Study||5
11307763|NCT02624492|12505967|FG001|STARTED|Overall Study||8
11307764|NCT02624492|12505968|FG002|STARTED|Overall Study||8
11307765|NCT02624492|12505966|FG000|COMPLETED|Overall Study||3
11307766|NCT02624492|12505967|FG001|COMPLETED|Overall Study||4
11307767|NCT02624492|12505968|FG002|COMPLETED|Overall Study||3
11307768|NCT02624492|12505966|FG000|NOT COMPLETED|Overall Study||2
11307769|NCT02624492|12505967|FG001|NOT COMPLETED|Overall Study||4
11307770|NCT02624492|12505968|FG002|NOT COMPLETED|Overall Study||5
11307771|NCT02624687|12505978|FG000|STARTED|Overall Study||13
11307772|NCT02624687|12505979|FG001|STARTED|Overall Study||14
11307773|NCT02624687|12505978|FG000|COMPLETED|Overall Study||12
11307774|NCT02624687|12505979|FG001|COMPLETED|Overall Study||12
11307775|NCT02624687|12505978|FG000|NOT COMPLETED|Overall Study||1
11307776|NCT02624687|12505979|FG001|NOT COMPLETED|Overall Study||2
11307777|NCT02624700|12505987|FG000|STARTED|Overall Study||9
11307778|NCT02624700|12505988|FG001|STARTED|Overall Study||4
11307779|NCT02624700|12505987|FG000|COMPLETED|Overall Study||9
11307780|NCT02624700|12505988|FG001|COMPLETED|Overall Study||4
11307781|NCT02624700|12505987|FG000|NOT COMPLETED|Overall Study||0
11307782|NCT02624700|12505988|FG001|NOT COMPLETED|Overall Study||0
11307783|NCT02624713|12505998|FG000|STARTED|Overall Study||78
11307784|NCT02624713|12505999|FG001|STARTED|Overall Study||81
11307785|NCT02624713|12505998|FG000|COMPLETED|Overall Study||64
11307786|NCT02624713|12505999|FG001|COMPLETED|Overall Study||81
11307787|NCT02624713|12505998|FG000|NOT COMPLETED|Overall Study||14
11307788|NCT02624713|12505999|FG001|NOT COMPLETED|Overall Study||0
11307789|NCT02624791|12506006|FG000|STARTED|Overall Study||2
11307790|NCT02624791|12506007|FG001|STARTED|Overall Study||1
11307791|NCT02624791|12506008|FG002|STARTED|Overall Study||2
11307792|NCT02624791|12506009|FG003|STARTED|Overall Study||2
11307793|NCT02624791|12506010|FG004|STARTED|Overall Study||2
11307794|NCT02624791|12506011|FG005|STARTED|Overall Study||2
11307795|NCT02624791|12506006|FG000|COMPLETED|Overall Study||0
11307796|NCT02624791|12506007|FG001|COMPLETED|Overall Study||1
11307797|NCT02624791|12506008|FG002|COMPLETED|Overall Study||2
11307798|NCT02624791|12506009|FG003|COMPLETED|Overall Study||2
11307799|NCT02624791|12506010|FG004|COMPLETED|Overall Study||2
11307800|NCT02624791|12506011|FG005|COMPLETED|Overall Study||2
11307801|NCT02624791|12506006|FG000|NOT COMPLETED|Overall Study||2
11307802|NCT02624791|12506007|FG001|NOT COMPLETED|Overall Study||0
11307803|NCT02624791|12506008|FG002|NOT COMPLETED|Overall Study||0
11307804|NCT02624791|12506009|FG003|NOT COMPLETED|Overall Study||0
11307805|NCT02624791|12506010|FG004|NOT COMPLETED|Overall Study||0
11307806|NCT02624791|12506011|FG005|NOT COMPLETED|Overall Study||0
11307807|NCT02624843|12506018|FG000|STARTED|Overall Study||107
11307808|NCT02624843|12506019|FG001|STARTED|Overall Study||108
11307809|NCT02624843|12506020|FG002|STARTED|Overall Study||24
11307810|NCT02624843|12506018|FG000|COMPLETED|Overall Study||70
11307811|NCT02624843|12506019|FG001|COMPLETED|Overall Study||72
11307812|NCT02624843|12506020|FG002|COMPLETED|Overall Study||16
11307813|NCT02624843|12506018|FG000|NOT COMPLETED|Overall Study||37
11307814|NCT02624843|12506019|FG001|NOT COMPLETED|Overall Study||36
11307815|NCT02624843|12506020|FG002|NOT COMPLETED|Overall Study||8
11307816|NCT02624986|12506036|FG000|STARTED|Overall Study||2
11307817|NCT02624986|12506037|FG001|STARTED|Overall Study||3
11307818|NCT02624986|12506038|FG002|STARTED|Overall Study||2
11307819|NCT02624986|12506039|FG003|STARTED|Overall Study||3
11307820|NCT02624986|12506040|FG004|STARTED|Overall Study||4
11307821|NCT02624986|12506041|FG005|STARTED|Overall Study||2
11307822|NCT02624986|12506042|FG006|STARTED|Overall Study||4
11307823|NCT02624986|12506043|FG007|STARTED|Overall Study||5
11307824|NCT02624986|12506036|FG000|Received Any Study Treatment|Overall Study||1
11307825|NCT02624986|12506037|FG001|Received Any Study Treatment|Overall Study||3
11307826|NCT02624986|12506038|FG002|Received Any Study Treatment|Overall Study||2
11307827|NCT02624986|12506039|FG003|Received Any Study Treatment|Overall Study||3
11307828|NCT02624986|12506040|FG004|Received Any Study Treatment|Overall Study||4
11307829|NCT02624986|12506041|FG005|Received Any Study Treatment|Overall Study||2
11307830|NCT02624986|12506042|FG006|Received Any Study Treatment|Overall Study||4
11307831|NCT02624986|12506043|FG007|Received Any Study Treatment|Overall Study||5
11307832|NCT02624986|12506036|FG000|COMPLETED|Overall Study||0
11307833|NCT02624986|12506037|FG001|COMPLETED|Overall Study||0
11307834|NCT02624986|12506038|FG002|COMPLETED|Overall Study||0
11307835|NCT02624986|12506039|FG003|COMPLETED|Overall Study||0
11307836|NCT02624986|12506040|FG004|COMPLETED|Overall Study||0
11307837|NCT02624986|12506041|FG005|COMPLETED|Overall Study||0
11307838|NCT02624986|12506042|FG006|COMPLETED|Overall Study||0
11307839|NCT02624986|12506043|FG007|COMPLETED|Overall Study||0
11307840|NCT02624986|12506036|FG000|NOT COMPLETED|Overall Study||2
11307841|NCT02624986|12506037|FG001|NOT COMPLETED|Overall Study||3
11307842|NCT02624986|12506038|FG002|NOT COMPLETED|Overall Study||2
11307843|NCT02624986|12506039|FG003|NOT COMPLETED|Overall Study||3
11307844|NCT02624986|12506040|FG004|NOT COMPLETED|Overall Study||4
11307845|NCT02624986|12506041|FG005|NOT COMPLETED|Overall Study||2
11307846|NCT02624986|12506042|FG006|NOT COMPLETED|Overall Study||4
11307847|NCT02624986|12506043|FG007|NOT COMPLETED|Overall Study||5
11307848|NCT02625181|12506068|FG000|STARTED|Overall Study||1518
11307849|NCT02625181|12506069|FG001|STARTED|Overall Study||12809
11307850|NCT02625181|12506070|FG002|STARTED|Overall Study||12707
11307851|NCT02625181|12506068|FG000|COMPLETED|Overall Study||1518
11307852|NCT02625181|12506069|FG001|COMPLETED|Overall Study||12809
11307853|NCT02625181|12506070|FG002|COMPLETED|Overall Study||12707
11307854|NCT02625181|12506068|FG000|NOT COMPLETED|Overall Study||0
11307855|NCT02625181|12506069|FG001|NOT COMPLETED|Overall Study||0
11307856|NCT02625181|12506070|FG002|NOT COMPLETED|Overall Study||0
11307857|NCT02625207|12506080|FG000|STARTED|Part 1 (6 Days)||11
11307858|NCT02625207|12506081|FG001|STARTED|Part 1 (6 Days)||12
11307859|NCT02625207|12506082|FG002|STARTED|Part 1 (6 Days)||12
11307860|NCT02625207|12506083|FG003|STARTED|Part 1 (6 Days)||12
11307861|NCT02625207|12506080|FG000|COMPLETED|Part 1 (6 Days)||11
11307862|NCT02625207|12506081|FG001|COMPLETED|Part 1 (6 Days)||12
11307863|NCT02625207|12506082|FG002|COMPLETED|Part 1 (6 Days)||12
11307864|NCT02625207|12506083|FG003|COMPLETED|Part 1 (6 Days)||12
11307865|NCT02625207|12506080|FG000|NOT COMPLETED|Part 1 (6 Days)||0
11307866|NCT02625207|12506081|FG001|NOT COMPLETED|Part 1 (6 Days)||0
11307867|NCT02625207|12506082|FG002|NOT COMPLETED|Part 1 (6 Days)||0
11307868|NCT02625207|12506083|FG003|NOT COMPLETED|Part 1 (6 Days)||0
11307869|NCT02625207|12506080|FG000|STARTED|Part 2 (11 Days)||11
11307870|NCT02625207|12506081|FG001|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
11307871|NCT02625207|12506082|FG002|STARTED|Part 2 (11 Days)||12
11307872|NCT02625207|12506083|FG003|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
11307873|NCT02625207|12506080|FG000|COMPLETED|Part 2 (11 Days)||11
11307874|NCT02625207|12506081|FG001|COMPLETED|Part 2 (11 Days)||0
11307875|NCT02625207|12506082|FG002|COMPLETED|Part 2 (11 Days)||12
11307876|NCT02625207|12506083|FG003|COMPLETED|Part 2 (11 Days)||0
11307877|NCT02625207|12506080|FG000|NOT COMPLETED|Part 2 (11 Days)||0
11307878|NCT02625207|12506081|FG001|NOT COMPLETED|Part 2 (11 Days)||0
11307879|NCT02625207|12506082|FG002|NOT COMPLETED|Part 2 (11 Days)||0
11307880|NCT02625207|12506083|FG003|NOT COMPLETED|Part 2 (11 Days)||0
11307881|NCT02625220|12506099|FG000|STARTED|Overall Study||170
11307882|NCT02625220|12506099|FG000|COMPLETED|Overall Study||163
11307883|NCT02625220|12506099|FG000|NOT COMPLETED|Overall Study||7
11307884|NCT02625233|12506105|FG000|STARTED|Overall Study||49
11307885|NCT02625233|12506106|FG001|STARTED|Overall Study||56
11307886|NCT02625233|12506105|FG000|COMPLETED|Overall Study||47
11307887|NCT02625233|12506106|FG001|COMPLETED|Overall Study||56
11307888|NCT02625233|12506105|FG000|NOT COMPLETED|Overall Study||2
11307889|NCT02625233|12506106|FG001|NOT COMPLETED|Overall Study||0
11307890|NCT02625259|12506117|FG000|STARTED|First Intervention (Day 1)||11
11307891|NCT02625259|12506118|FG001|STARTED|First Intervention (Day 1)||9
11307892|NCT02625259|12506119|FG002|STARTED|First Intervention (Day 1)||8
11307893|NCT02625259|12506120|FG003|STARTED|First Intervention (Day 1)||10
11307894|NCT02625259|12506121|FG004|STARTED|First Intervention (Day 1)||16
11307895|NCT02625259|12506117|FG000|COMPLETED|First Intervention (Day 1)||9
11307896|NCT02625259|12506118|FG001|COMPLETED|First Intervention (Day 1)||8
11307897|NCT02625259|12506119|FG002|COMPLETED|First Intervention (Day 1)||7
11307898|NCT02625259|12506120|FG003|COMPLETED|First Intervention (Day 1)||9
11307899|NCT02625259|12506121|FG004|COMPLETED|First Intervention (Day 1)||16
11307900|NCT02625259|12506117|FG000|NOT COMPLETED|First Intervention (Day 1)||2
11307901|NCT02625259|12506118|FG001|NOT COMPLETED|First Intervention (Day 1)||1
11307902|NCT02625259|12506119|FG002|NOT COMPLETED|First Intervention (Day 1)||1
11307903|NCT02625259|12506120|FG003|NOT COMPLETED|First Intervention (Day 1)||1
11307904|NCT02625259|12506121|FG004|NOT COMPLETED|First Intervention (Day 1)||0
11307905|NCT02625259|12506117|FG000|STARTED|Washout (Day 2 to Day 14)||9
11307906|NCT02625259|12506118|FG001|STARTED|Washout (Day 2 to Day 14)||8
11307907|NCT02625259|12506119|FG002|STARTED|Washout (Day 2 to Day 14)||7
11307908|NCT02625259|12506120|FG003|STARTED|Washout (Day 2 to Day 14)||9
11307909|NCT02625259|12506121|FG004|STARTED|Washout (Day 2 to Day 14)||0
11307910|NCT02625259|12506117|FG000|COMPLETED|Washout (Day 2 to Day 14)||9
11307911|NCT02625259|12506118|FG001|COMPLETED|Washout (Day 2 to Day 14)||8
11307912|NCT02625259|12506119|FG002|COMPLETED|Washout (Day 2 to Day 14)||7
11307913|NCT02625259|12506120|FG003|COMPLETED|Washout (Day 2 to Day 14)||9
11307914|NCT02625259|12506121|FG004|COMPLETED|Washout (Day 2 to Day 14)||0
11307915|NCT02625259|12506117|FG000|NOT COMPLETED|Washout (Day 2 to Day 14)||0
11307916|NCT02625259|12506118|FG001|NOT COMPLETED|Washout (Day 2 to Day 14)||0
11307917|NCT02625259|12506119|FG002|NOT COMPLETED|Washout (Day 2 to Day 14)||0
11307918|NCT02625259|12506120|FG003|NOT COMPLETED|Washout (Day 2 to Day 14)||0
11307919|NCT02625259|12506121|FG004|NOT COMPLETED|Washout (Day 2 to Day 14)||0
11307920|NCT02625259|12506117|FG000|STARTED|Second Intervention (Day 15)||9
11307921|NCT02625259|12506118|FG001|STARTED|Second Intervention (Day 15)||8
11307922|NCT02625259|12506119|FG002|STARTED|Second Intervention (Day 15)||7
11307923|NCT02625259|12506120|FG003|STARTED|Second Intervention (Day 15)||9
11307924|NCT02625259|12506121|FG004|STARTED|Second Intervention (Day 15)||0
11307925|NCT02625259|12506117|FG000|COMPLETED|Second Intervention (Day 15)||9
11307926|NCT02625259|12506118|FG001|COMPLETED|Second Intervention (Day 15)||8
11307927|NCT02625259|12506119|FG002|COMPLETED|Second Intervention (Day 15)||7
11307928|NCT02625259|12506120|FG003|COMPLETED|Second Intervention (Day 15)||9
11307929|NCT02625259|12506121|FG004|COMPLETED|Second Intervention (Day 15)||0
11307930|NCT02625259|12506117|FG000|NOT COMPLETED|Second Intervention (Day 15)||0
11307931|NCT02625259|12506118|FG001|NOT COMPLETED|Second Intervention (Day 15)||0
11307932|NCT02625259|12506119|FG002|NOT COMPLETED|Second Intervention (Day 15)||0
11307933|NCT02625259|12506120|FG003|NOT COMPLETED|Second Intervention (Day 15)||0
11307934|NCT02625259|12506121|FG004|NOT COMPLETED|Second Intervention (Day 15)||0
11307935|NCT02625298|12506138|FG000|STARTED|Overall Study||11
11307936|NCT02625298|12506139|FG001|STARTED|Overall Study||13
11307937|NCT02625298|12506138|FG000|COMPLETED|Overall Study||10
11307938|NCT02625298|12506139|FG001|COMPLETED|Overall Study||13
11307939|NCT02625298|12506138|FG000|NOT COMPLETED|Overall Study||1
11307940|NCT02625298|12506139|FG001|NOT COMPLETED|Overall Study||0
11307941|NCT02625402|12506149|FG000|STARTED|Overall Study||42
11307942|NCT02625402|12506150|FG001|STARTED|Overall Study||37
11307943|NCT02625402|12506149|FG000|COMPLETED|Overall Study||33
11307944|NCT02625402|12506150|FG001|COMPLETED|Overall Study||25
11307945|NCT02625402|12506149|FG000|NOT COMPLETED|Overall Study||9
11307946|NCT02625402|12506150|FG001|NOT COMPLETED|Overall Study||12
11307947|NCT02625428|12506158|FG000|STARTED|Overall Study||20
11307948|NCT02625428|12506159|FG001|STARTED|Overall Study||20
11307949|NCT02625428|12506158|FG000|COMPLETED|Overall Study||20
11307950|NCT02625428|12506159|FG001|COMPLETED|Overall Study||20
11307951|NCT02625428|12506158|FG000|NOT COMPLETED|Overall Study||0
11307952|NCT02625428|12506159|FG001|NOT COMPLETED|Overall Study||0
11307953|NCT02625545|12506165|FG000|STARTED|Overall Study||45
11307954|NCT02625545|12506165|FG000|3 Month|Overall Study||45
11307955|NCT02625545|12506165|FG000|6 Month|Overall Study||45
11307956|NCT02625545|12506165|FG000|12 Month|Overall Study||45
11307957|NCT02625545|12506165|FG000|COMPLETED|Overall Study||45
11307958|NCT02625545|12506165|FG000|NOT COMPLETED|Overall Study||0
11307959|NCT02625571|12506169|FG000|STARTED|Overall Study||13
11307960|NCT02625571|12506169|FG000|COMPLETED|Overall Study||10
11307961|NCT02625571|12506169|FG000|NOT COMPLETED|Overall Study||3
11307962|NCT02625623|12506175|FG000|STARTED|Overall Study||186
11307963|NCT02625623|12506176|FG001|STARTED|Overall Study||185
11307964|NCT02625623|12506175|FG000|Treated|Overall Study||177
11307965|NCT02625623|12506176|FG001|Treated|Overall Study||184
11307966|NCT02625623|12506175|FG000|COMPLETED|Overall Study||177
11307967|NCT02625623|12506176|FG001|COMPLETED|Overall Study||184
11307968|NCT02625623|12506175|FG000|NOT COMPLETED|Overall Study||9
11307969|NCT02625623|12506176|FG001|NOT COMPLETED|Overall Study||1
11307970|NCT02625844|12506184|FG000|STARTED|Overall Study||110
11307971|NCT02625844|12506184|FG000|COMPLETED|Overall Study||110
11307972|NCT02625844|12506184|FG000|NOT COMPLETED|Overall Study||0
11307973|NCT02625909|12506190|FG000|STARTED|Overall Study||93
11307974|NCT02625909|12506191|FG001|STARTED|Overall Study||95
11307975|NCT02625909|12506190|FG000|COMPLETED|Overall Study||76
11307976|NCT02625909|12506191|FG001|COMPLETED|Overall Study||86
11307977|NCT02625909|12506190|FG000|NOT COMPLETED|Overall Study||17
11307978|NCT02625909|12506191|FG001|NOT COMPLETED|Overall Study||9
11307979|NCT02625922|12506199|FG000|STARTED|Overall Study||14
11307980|NCT02625922|12506200|FG001|STARTED|Overall Study||12
11307981|NCT02625922|12506199|FG000|Completed Treatment Period 1|Overall Study||12
11307982|NCT02625922|12506200|FG001|Completed Treatment Period 1|Overall Study||10
11307983|NCT02625922|12506199|FG000|Completed Treatment Period 2|Overall Study||11
11307984|NCT02625922|12506200|FG001|Completed Treatment Period 2|Overall Study||8
11307985|NCT02625922|12506199|FG000|COMPLETED|Overall Study||12
11307986|NCT02625922|12506200|FG001|COMPLETED|Overall Study||10
11307987|NCT02625922|12506199|FG000|NOT COMPLETED|Overall Study||2
11307988|NCT02625922|12506200|FG001|NOT COMPLETED|Overall Study||2
11307989|NCT02625974|12506211|FG000|STARTED|Overall Study||219
11307990|NCT02625974|12506212|FG001|STARTED|Overall Study||111
11307991|NCT02625974|12506211|FG000|Received Treatment|Overall Study||219
11307992|NCT02625974|12506212|FG001|Received Treatment|Overall Study||111
11307993|NCT02625974|12506211|FG000|COMPLETED|Overall Study||203
11307994|NCT02625974|12506212|FG001|COMPLETED|Overall Study||105
11307995|NCT02625974|12506211|FG000|NOT COMPLETED|Overall Study||16
11307996|NCT02625974|12506212|FG001|NOT COMPLETED|Overall Study||6
11307997|NCT02626000|12506254|FG000|STARTED|Overall Study||36
11307998|NCT02626000|12506254|FG000|COMPLETED|Overall Study||6
11307999|NCT02626000|12506254|FG000|NOT COMPLETED|Overall Study||30
11308000|NCT02626026|12506265|FG000|STARTED|Overall Study||8
11308001|NCT02626026|12506266|FG001|STARTED|Overall Study||2
11308002|NCT02626026|12506267|FG002|STARTED|Overall Study||8
11308003|NCT02626026|12506268|FG003|STARTED|Overall Study||2
11308004|NCT02626026|12506269|FG004|STARTED|Overall Study||17
11308005|NCT02626026|12506270|FG005|STARTED|Overall Study||5
11308006|NCT02626026|12506265|FG000|COMPLETED|Overall Study||8
11308007|NCT02626026|12506266|FG001|COMPLETED|Overall Study||2
11308008|NCT02626026|12506267|FG002|COMPLETED|Overall Study||8
11308009|NCT02626026|12506268|FG003|COMPLETED|Overall Study||2
11308010|NCT02626026|12506269|FG004|COMPLETED|Overall Study||16
11308011|NCT02626026|12506270|FG005|COMPLETED|Overall Study||5
11308012|NCT02626026|12506265|FG000|NOT COMPLETED|Overall Study||0
11308013|NCT02626026|12506266|FG001|NOT COMPLETED|Overall Study||0
11308014|NCT02626026|12506267|FG002|NOT COMPLETED|Overall Study||0
11308015|NCT02626026|12506268|FG003|NOT COMPLETED|Overall Study||0
11308016|NCT02626026|12506269|FG004|NOT COMPLETED|Overall Study||1
11308017|NCT02626026|12506270|FG005|NOT COMPLETED|Overall Study||0
11308018|NCT02626156|12506290|FG000|STARTED|Baseline (Visit 1 to Visit 2)||29
11308019|NCT02626156|12506291|FG001|STARTED|Baseline (Visit 1 to Visit 2)||29
11308020|NCT02626156|12506292|FG002|STARTED|Baseline (Visit 1 to Visit 2)||42
11308021|NCT02626156|12506293|FG003|STARTED|Baseline (Visit 1 to Visit 2)||40
11308022|NCT02626156|12506290|FG000|COMPLETED|Baseline (Visit 1 to Visit 2)||23
11308023|NCT02626156|12506291|FG001|COMPLETED|Baseline (Visit 1 to Visit 2)||22
11308024|NCT02626156|12506292|FG002|COMPLETED|Baseline (Visit 1 to Visit 2)||37
11308025|NCT02626156|12506293|FG003|COMPLETED|Baseline (Visit 1 to Visit 2)||35
11308026|NCT02626156|12506290|FG000|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||6
11308027|NCT02626156|12506291|FG001|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||7
11308028|NCT02626156|12506292|FG002|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
11308029|NCT02626156|12506293|FG003|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
11308030|NCT02626156|12506290|FG000|STARTED|Study Visit 3||23
11308031|NCT02626156|12506291|FG001|STARTED|Study Visit 3||22
11308032|NCT02626156|12506292|FG002|STARTED|Study Visit 3||37
11308033|NCT02626156|12506293|FG003|STARTED|Study Visit 3||35
11308034|NCT02626156|12506290|FG000|COMPLETED|Study Visit 3||15
11308035|NCT02626156|12506291|FG001|COMPLETED|Study Visit 3||17
11308036|NCT02626156|12506292|FG002|COMPLETED|Study Visit 3||33
11308037|NCT02626156|12506293|FG003|COMPLETED|Study Visit 3||33
11308038|NCT02626156|12506290|FG000|NOT COMPLETED|Study Visit 3||8
11308039|NCT02626156|12506291|FG001|NOT COMPLETED|Study Visit 3||5
11308040|NCT02626156|12506292|FG002|NOT COMPLETED|Study Visit 3||4
11308041|NCT02626156|12506293|FG003|NOT COMPLETED|Study Visit 3||2
11308042|NCT02626156|12506290|FG000|STARTED|Study Visit 4||15
11308043|NCT02626156|12506291|FG001|STARTED|Study Visit 4||17
11308044|NCT02626156|12506292|FG002|STARTED|Study Visit 4||33
11308045|NCT02626156|12506293|FG003|STARTED|Study Visit 4||33
11308046|NCT02626156|12506290|FG000|COMPLETED|Study Visit 4||12
11308047|NCT02626156|12506291|FG001|COMPLETED|Study Visit 4||15
11308048|NCT02626156|12506292|FG002|COMPLETED|Study Visit 4||24
11308049|NCT02626156|12506293|FG003|COMPLETED|Study Visit 4||28
11308050|NCT02626156|12506290|FG000|NOT COMPLETED|Study Visit 4||3
11308051|NCT02626156|12506291|FG001|NOT COMPLETED|Study Visit 4||2
11308052|NCT02626156|12506292|FG002|NOT COMPLETED|Study Visit 4||9
11308053|NCT02626156|12506293|FG003|NOT COMPLETED|Study Visit 4||5
11308054|NCT02626182|12506311|FG000|STARTED|Overall Study||11
11308055|NCT02626182|12506312|FG001|STARTED|Overall Study||3
11308056|NCT02626182|12506311|FG000|COMPLETED|Overall Study||9
11308057|NCT02626182|12506312|FG001|COMPLETED|Overall Study||3
11308058|NCT02626182|12506311|FG000|NOT COMPLETED|Overall Study||2
11308059|NCT02626182|12506312|FG001|NOT COMPLETED|Overall Study||0
11308060|NCT02626611|12506321|FG000|STARTED|Overall Study||20
11308061|NCT02626611|12506322|FG001|STARTED|Overall Study||21
11308062|NCT02626611|12506323|FG002|STARTED|Overall Study||19
11308063|NCT02626611|12506321|FG000|COMPLETED|Overall Study||16
11308064|NCT02626611|12506322|FG001|COMPLETED|Overall Study||20
11308065|NCT02626611|12506323|FG002|COMPLETED|Overall Study||16
11308066|NCT02626611|12506321|FG000|NOT COMPLETED|Overall Study||4
11308067|NCT02626611|12506322|FG001|NOT COMPLETED|Overall Study||1
11308068|NCT02626611|12506323|FG002|NOT COMPLETED|Overall Study||3
11308069|NCT02626780|12506338|FG000|STARTED|Overall Study||7
11308070|NCT02626780|12506338|FG000|Withdrew From Study|Overall Study||3
11308071|NCT02626780|12506338|FG000|COMPLETED|Overall Study||4
11308072|NCT02626780|12506338|FG000|NOT COMPLETED|Overall Study||3
11308073|NCT02626819|12506344|FG000|STARTED|Overall Study||22
11308074|NCT02626819|12506345|FG001|STARTED|Overall Study||23
11308075|NCT02626819|12506344|FG000|COMPLETED|Overall Study||18
11308076|NCT02626819|12506345|FG001|COMPLETED|Overall Study||20
11308077|NCT02626819|12506344|FG000|NOT COMPLETED|Overall Study||4
11308078|NCT02626819|12506345|FG001|NOT COMPLETED|Overall Study||3
11308079|NCT02626910|12506355|FG000|STARTED|Overall Study||23
11308080|NCT02626910|12506356|FG001|STARTED|Overall Study||10
11308081|NCT02626910|12506357|FG002|STARTED|Overall Study||6
11308082|NCT02626910|12506358|FG003|STARTED|Overall Study||10
11308083|NCT02626910|12506355|FG000|COMPLETED|Overall Study||23
11308084|NCT02626910|12506356|FG001|COMPLETED|Overall Study||10
11308085|NCT02626910|12506357|FG002|COMPLETED|Overall Study||6
11308086|NCT02626910|12506358|FG003|COMPLETED|Overall Study||10
11308087|NCT02626910|12506355|FG000|NOT COMPLETED|Overall Study||0
11308088|NCT02626910|12506356|FG001|NOT COMPLETED|Overall Study||0
11308089|NCT02626910|12506357|FG002|NOT COMPLETED|Overall Study||0
11308090|NCT02626910|12506358|FG003|NOT COMPLETED|Overall Study||0
11308091|NCT02627001|12506370|FG000|STARTED|Overall Study||13
11308092|NCT02627001|12506371|FG001|STARTED|Overall Study||14
11308093|NCT02627001|12506370|FG000|COMPLETED|Overall Study||13
11308094|NCT02627001|12506371|FG001|COMPLETED|Overall Study||14
11308095|NCT02627001|12506370|FG000|NOT COMPLETED|Overall Study||0
11308096|NCT02627001|12506371|FG001|NOT COMPLETED|Overall Study||0
11308097|NCT02627118|12506377|FG000|STARTED|Overall Study||10
11308098|NCT02627118|12506377|FG000|COMPLETED|Overall Study||10
11308099|NCT02627118|12506377|FG000|NOT COMPLETED|Overall Study||0
11308100|NCT02627144|12506382|FG000|STARTED|Overall Study||365
11308101|NCT02627144|12506382|FG000|Treated|Overall Study||359
11308102|NCT02627144|12506382|FG000|COMPLETED|Overall Study||0
11308103|NCT02627144|12506382|FG000|NOT COMPLETED|Overall Study||365
11308104|NCT02627495|12506386|FG000|STARTED|Overall Study||9
11401630|NCT04095286|12596407|FG002|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||2
11401631|NCT04095286|12596408|FG003|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
11401632|NCT04095286|12596409|FG004|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||1
11401633|NCT04095286|12596410|FG005|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
11308105|NCT02627495|12506386|FG000|COMPLETED|Overall Study||5
11308106|NCT02627495|12506386|FG000|NOT COMPLETED|Overall Study||4
11308107|NCT02627677|12506393|FG000|STARTED|Overall Study||11
11308108|NCT02627677|12506394|FG001|STARTED|Overall Study||21
11308109|NCT02627677|12506395|FG002|STARTED|Overall Study||12
11308110|NCT02627677|12506393|FG000|COMPLETED|Overall Study||0
11308111|NCT02627677|12506394|FG001|COMPLETED|Overall Study||0
11308112|NCT02627677|12506395|FG002|COMPLETED|Overall Study||0
11308113|NCT02627677|12506393|FG000|NOT COMPLETED|Overall Study||11
11308114|NCT02627677|12506394|FG001|NOT COMPLETED|Overall Study||21
11308115|NCT02627677|12506395|FG002|NOT COMPLETED|Overall Study||12
11308116|NCT02627794|12506404|FG000|STARTED|Overall Study||3
11308117|NCT02627794|12506404|FG000|COMPLETED|Overall Study||3
11308118|NCT02627794|12506404|FG000|NOT COMPLETED|Overall Study||0
11308119|NCT02627924|12506411|FG000|STARTED|Overall Study||91
11308120|NCT02627924|12506411|FG000|COMPLETED|Overall Study||79
11308121|NCT02627924|12506411|FG000|NOT COMPLETED|Overall Study||12
11308122|NCT02628028|12506426|FG000|STARTED|Dosing Period||9
11308123|NCT02628028|12506427|FG001|STARTED|Dosing Period||9
11308124|NCT02628028|12506428|FG002|STARTED|Dosing Period||10
11308125|NCT02628028|12506429|FG003|STARTED|Dosing Period||8
11308126|NCT02628028|12506430|FG004|STARTED|Dosing Period||62
11308127|NCT02628028|12506431|FG005|STARTED|Dosing Period||63
11308128|NCT02628028|12506432|FG006|STARTED|Dosing Period||62
11308129|NCT02628028|12506433|FG007|STARTED|Dosing Period||63
11308130|NCT02628028|12506426|FG000|Received at Least 1dose of Study Drug|Dosing Period||9
11308131|NCT02628028|12506427|FG001|Received at Least 1dose of Study Drug|Dosing Period||9
11308132|NCT02628028|12506428|FG002|Received at Least 1dose of Study Drug|Dosing Period||10
11308133|NCT02628028|12506429|FG003|Received at Least 1dose of Study Drug|Dosing Period||8
11308134|NCT02628028|12506430|FG004|Received at Least 1dose of Study Drug|Dosing Period||62
11308135|NCT02628028|12506431|FG005|Received at Least 1dose of Study Drug|Dosing Period||63
11308136|NCT02628028|12506432|FG006|Received at Least 1dose of Study Drug|Dosing Period||62
11308137|NCT02628028|12506433|FG007|Received at Least 1dose of Study Drug|Dosing Period||63
11308138|NCT02628028|12506426|FG000|COMPLETED|Dosing Period||9
11308139|NCT02628028|12506427|FG001|COMPLETED|Dosing Period||9
11308140|NCT02628028|12506428|FG002|COMPLETED|Dosing Period||9
11308141|NCT02628028|12506429|FG003|COMPLETED|Dosing Period||8
11308142|NCT02628028|12506430|FG004|COMPLETED|Dosing Period||46
11308143|NCT02628028|12506431|FG005|COMPLETED|Dosing Period||49
11308144|NCT02628028|12506432|FG006|COMPLETED|Dosing Period||46
11308145|NCT02628028|12506433|FG007|COMPLETED|Dosing Period||48
11308146|NCT02628028|12506426|FG000|NOT COMPLETED|Dosing Period||0
11308147|NCT02628028|12506427|FG001|NOT COMPLETED|Dosing Period||0
11308148|NCT02628028|12506428|FG002|NOT COMPLETED|Dosing Period||1
11308149|NCT02628028|12506429|FG003|NOT COMPLETED|Dosing Period||0
11308150|NCT02628028|12506430|FG004|NOT COMPLETED|Dosing Period||16
11308151|NCT02628028|12506431|FG005|NOT COMPLETED|Dosing Period||14
11308152|NCT02628028|12506432|FG006|NOT COMPLETED|Dosing Period||16
11308153|NCT02628028|12506433|FG007|NOT COMPLETED|Dosing Period||15
11308154|NCT02628028|12506426|FG000|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
11308155|NCT02628028|12506427|FG001|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
11308156|NCT02628028|12506428|FG002|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
11308157|NCT02628028|12506429|FG003|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
11308158|NCT02628028|12506430|FG004|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0
11308159|NCT02628028|12506431|FG005|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
11308160|NCT02628028|12506432|FG006|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58
11308161|NCT02628028|12506433|FG007|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
11308162|NCT02628028|12506426|FG000|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
11308163|NCT02628028|12506427|FG001|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
11308164|NCT02628028|12506428|FG002|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
11308165|NCT02628028|12506429|FG003|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
11308166|NCT02628028|12506430|FG004|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
11308167|NCT02628028|12506431|FG005|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
11308168|NCT02628028|12506432|FG006|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
11308169|NCT02628028|12506433|FG007|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
11308170|NCT02628028|12506426|FG000|COMPLETED|Long-term Extension (LTE) Period||0
11308171|NCT02628028|12506427|FG001|COMPLETED|Long-term Extension (LTE) Period||0
11308172|NCT02628028|12506428|FG002|COMPLETED|Long-term Extension (LTE) Period||0
11308173|NCT02628028|12506429|FG003|COMPLETED|Long-term Extension (LTE) Period||0
11308174|NCT02628028|12506430|FG004|COMPLETED|Long-term Extension (LTE) Period||0
11308175|NCT02628028|12506431|FG005|COMPLETED|Long-term Extension (LTE) Period||1
11308176|NCT02628028|12506432|FG006|COMPLETED|Long-term Extension (LTE) Period||0
11308177|NCT02628028|12506433|FG007|COMPLETED|Long-term Extension (LTE) Period||0
11308178|NCT02628028|12506426|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||0
11308179|NCT02628028|12506427|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||0
11401634|NCT04095286|12596405|FG000|STARTED|Period 3 (4 Days) + Follow up (14 Days)||3
11308180|NCT02628028|12506428|FG002|NOT COMPLETED|Long-term Extension (LTE) Period||0
11308181|NCT02628028|12506429|FG003|NOT COMPLETED|Long-term Extension (LTE) Period||0
11308182|NCT02628028|12506430|FG004|NOT COMPLETED|Long-term Extension (LTE) Period||0
11308183|NCT02628028|12506431|FG005|NOT COMPLETED|Long-term Extension (LTE) Period||60
11308184|NCT02628028|12506432|FG006|NOT COMPLETED|Long-term Extension (LTE) Period||58
11308185|NCT02628028|12506433|FG007|NOT COMPLETED|Long-term Extension (LTE) Period||61
11308186|NCT02628093|12506457|FG000|STARTED|Overall Study||31
11308187|NCT02628093|12506458|FG001|STARTED|Overall Study||29
11308188|NCT02628093|12506457|FG000|COMPLETED|Overall Study||31
11308189|NCT02628093|12506458|FG001|COMPLETED|Overall Study||29
11308190|NCT02628093|12506457|FG000|NOT COMPLETED|Overall Study||0
11308191|NCT02628093|12506458|FG001|NOT COMPLETED|Overall Study||0
11308192|NCT02628106|12506464|FG000|STARTED|Overall Study||21
11308193|NCT02628106|12506464|FG000|COMPLETED|Overall Study||21
11308194|NCT02628106|12506464|FG000|NOT COMPLETED|Overall Study||0
11308195|NCT02628223|12506470|FG000|STARTED|Overall Study||38
11308196|NCT02628223|12506471|FG001|STARTED|Overall Study||38
11308197|NCT02628223|12506470|FG000|COMPLETED|Overall Study||38
11308198|NCT02628223|12506471|FG001|COMPLETED|Overall Study||36
11308199|NCT02628223|12506470|FG000|NOT COMPLETED|Overall Study||0
11308200|NCT02628223|12506471|FG001|NOT COMPLETED|Overall Study||2
11308201|NCT02628236|12506477|FG000|STARTED|Overall Study||14
11308202|NCT02628236|12506477|FG000|COMPLETED|Overall Study||14
11308203|NCT02628236|12506477|FG000|NOT COMPLETED|Overall Study||0
11308204|NCT02628418|12506483|FG000|STARTED|Overall Study||15
11308205|NCT02628418|12506484|FG001|STARTED|Overall Study||15
11308206|NCT02628418|12506483|FG000|COMPLETED|Overall Study||14
11308207|NCT02628418|12506484|FG001|COMPLETED|Overall Study||13
11308208|NCT02628418|12506483|FG000|NOT COMPLETED|Overall Study||1
11308209|NCT02628418|12506484|FG001|NOT COMPLETED|Overall Study||2
11308210|NCT02628600|12506498|FG000|STARTED|Overall Study||73
11308211|NCT02628600|12506499|FG001|STARTED|Overall Study||90
11308212|NCT02628600|12506498|FG000|Participant Discontinued the Study|Overall Study||24
11308213|NCT02628600|12506499|FG001|Participant Discontinued the Study|Overall Study||32
11308214|NCT02628600|12506498|FG000|COMPLETED|Overall Study||49
11308215|NCT02628600|12506499|FG001|COMPLETED|Overall Study||58
11308216|NCT02628600|12506498|FG000|NOT COMPLETED|Overall Study||24
11308217|NCT02628600|12506499|FG001|NOT COMPLETED|Overall Study||32
11308218|NCT02628743|12506505|FG000|STARTED|Overall Study||131
11308219|NCT02628743|12506505|FG000|COMPLETED|Overall Study||0
11308220|NCT02628743|12506505|FG000|NOT COMPLETED|Overall Study||131
11308221|NCT02628769|12506509|FG000|STARTED|First Intervention||3
11308222|NCT02628769|12506510|FG001|STARTED|First Intervention||3
11308223|NCT02628769|12506509|FG000|COMPLETED|First Intervention||2
11308224|NCT02628769|12506510|FG001|COMPLETED|First Intervention||2
11308225|NCT02628769|12506509|FG000|NOT COMPLETED|First Intervention||1
11308226|NCT02628769|12506510|FG001|NOT COMPLETED|First Intervention||1
11308227|NCT02628769|12506509|FG000|STARTED|Wash Out (28 Days)||2
11308228|NCT02628769|12506510|FG001|STARTED|Wash Out (28 Days)||2
11308229|NCT02628769|12506509|FG000|COMPLETED|Wash Out (28 Days)||2
11308230|NCT02628769|12506510|FG001|COMPLETED|Wash Out (28 Days)||2
11308231|NCT02628769|12506509|FG000|NOT COMPLETED|Wash Out (28 Days)||0
11308232|NCT02628769|12506510|FG001|NOT COMPLETED|Wash Out (28 Days)||0
11308233|NCT02628769|12506509|FG000|STARTED|Second Intervention||2
11308234|NCT02628769|12506510|FG001|STARTED|Second Intervention||2
11308235|NCT02628769|12506509|FG000|COMPLETED|Second Intervention||0
11308236|NCT02628769|12506510|FG001|COMPLETED|Second Intervention||1
11308237|NCT02628769|12506509|FG000|NOT COMPLETED|Second Intervention||2
11308238|NCT02628769|12506510|FG001|NOT COMPLETED|Second Intervention||1
11308239|NCT02628873|12506518|FG000|STARTED|First Test (1 Hour)||14
11308240|NCT02628873|12506519|FG001|STARTED|First Test (1 Hour)||7
11308241|NCT02628873|12506518|FG000|COMPLETED|First Test (1 Hour)||14
11308242|NCT02628873|12506519|FG001|COMPLETED|First Test (1 Hour)||7
11308243|NCT02628873|12506518|FG000|NOT COMPLETED|First Test (1 Hour)||0
11308244|NCT02628873|12506519|FG001|NOT COMPLETED|First Test (1 Hour)||0
11308245|NCT02628873|12506518|FG000|STARTED|Break (1 Hour)||14
11308246|NCT02628873|12506519|FG001|STARTED|Break (1 Hour)||7
11401635|NCT04095286|12596406|FG001|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
11401636|NCT04095286|12596407|FG002|STARTED|Period 3 (4 Days) + Follow up (14 Days)||2
11401637|NCT04095286|12596408|FG003|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
11401638|NCT04095286|12596409|FG004|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
11401639|NCT04095286|12596410|FG005|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
11401640|NCT04095286|12596405|FG000|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||3
11308247|NCT02628873|12506518|FG000|COMPLETED|Break (1 Hour)||14
11308248|NCT02628873|12506519|FG001|COMPLETED|Break (1 Hour)||6
11308249|NCT02628873|12506518|FG000|NOT COMPLETED|Break (1 Hour)||0
11308250|NCT02628873|12506519|FG001|NOT COMPLETED|Break (1 Hour)||1
11308251|NCT02628873|12506518|FG000|STARTED|Second Test (1 Hour)||14
11308252|NCT02628873|12506519|FG001|STARTED|Second Test (1 Hour)||6
11308253|NCT02628873|12506518|FG000|COMPLETED|Second Test (1 Hour)||13
11308254|NCT02628873|12506519|FG001|COMPLETED|Second Test (1 Hour)||6
11308255|NCT02628873|12506518|FG000|NOT COMPLETED|Second Test (1 Hour)||1
11308256|NCT02628873|12506519|FG001|NOT COMPLETED|Second Test (1 Hour)||0
11308257|NCT02628938|12506528|FG000|STARTED|Overall Study||15
11308258|NCT02628938|12506529|FG001|STARTED|Overall Study||15
11308259|NCT02628938|12506530|FG002|STARTED|Overall Study||15
11308260|NCT02628938|12506528|FG000|COMPLETED|Overall Study||10
11308261|NCT02628938|12506529|FG001|COMPLETED|Overall Study||13
11308262|NCT02628938|12506530|FG002|COMPLETED|Overall Study||11
11308263|NCT02628938|12506528|FG000|NOT COMPLETED|Overall Study||5
11308264|NCT02628938|12506529|FG001|NOT COMPLETED|Overall Study||2
11308265|NCT02628938|12506530|FG002|NOT COMPLETED|Overall Study||4
11308266|NCT02628964|12506540|FG000|STARTED|Overall Study||50
11308267|NCT02628964|12506541|FG001|STARTED|Overall Study||50
11308268|NCT02628964|12506540|FG000|COMPLETED|Overall Study||50
11308269|NCT02628964|12506541|FG001|COMPLETED|Overall Study||49
11308270|NCT02628964|12506540|FG000|NOT COMPLETED|Overall Study||0
11308271|NCT02628964|12506541|FG001|NOT COMPLETED|Overall Study||1
11308272|NCT02629094|12506547|FG000|STARTED|Overall Study||5
11308273|NCT02629094|12506547|FG000|COMPLETED|Overall Study||5
11308274|NCT02629094|12506547|FG000|NOT COMPLETED|Overall Study||0
11308275|NCT02629133|12506553|FG000|STARTED|Overall Study||25
11308276|NCT02629133|12506554|FG001|STARTED|Overall Study||25
11308277|NCT02629133|12506553|FG000|COMPLETED|Overall Study||21
11308278|NCT02629133|12506554|FG001|COMPLETED|Overall Study||23
11308279|NCT02629133|12506553|FG000|NOT COMPLETED|Overall Study||4
11308280|NCT02629133|12506554|FG001|NOT COMPLETED|Overall Study||2
11308281|NCT02629354|12506562|FG000|STARTED|Period 1||18
11308282|NCT02629354|12506563|FG001|STARTED|Period 1||18
11308283|NCT02629354|12506562|FG000|COMPLETED|Period 1||18
11308284|NCT02629354|12506563|FG001|COMPLETED|Period 1||18
11308285|NCT02629354|12506562|FG000|NOT COMPLETED|Period 1||0
11308286|NCT02629354|12506563|FG001|NOT COMPLETED|Period 1||0
11308287|NCT02629354|12506562|FG000|STARTED|Washout Period||18
11308288|NCT02629354|12506563|FG001|STARTED|Washout Period||18
11308289|NCT02629354|12506562|FG000|COMPLETED|Washout Period||18
11308290|NCT02629354|12506563|FG001|COMPLETED|Washout Period||18
11308291|NCT02629354|12506562|FG000|NOT COMPLETED|Washout Period||0
11308292|NCT02629354|12506563|FG001|NOT COMPLETED|Washout Period||0
11308293|NCT02629354|12506562|FG000|STARTED|Period 2||18
11308294|NCT02629354|12506563|FG001|STARTED|Period 2||18
11308295|NCT02629354|12506562|FG000|COMPLETED|Period 2||18
11308296|NCT02629354|12506563|FG001|COMPLETED|Period 2||18
11308297|NCT02629354|12506562|FG000|NOT COMPLETED|Period 2||0
11308298|NCT02629354|12506563|FG001|NOT COMPLETED|Period 2||0
11308299|NCT02629354|12506562|FG000|STARTED|Follow-up||18
11308300|NCT02629354|12506563|FG001|STARTED|Follow-up||18
11308301|NCT02629354|12506562|FG000|COMPLETED|Follow-up||18
11308302|NCT02629354|12506563|FG001|COMPLETED|Follow-up||18
11308303|NCT02629354|12506562|FG000|NOT COMPLETED|Follow-up||0
11308304|NCT02629354|12506563|FG001|NOT COMPLETED|Follow-up||0
11308305|NCT02629822|12506569|FG000|STARTED|Base Study||10
11308306|NCT02629822|12506569|FG000|COMPLETED|Base Study||7
11308307|NCT02629822|12506569|FG000|NOT COMPLETED|Base Study||3
11308308|NCT02629822|12506569|FG000|STARTED|Extension Study|Enrollment in Extension Study was voluntary.|6
11308309|NCT02629822|12506569|FG000|COMPLETED|Extension Study||4
11308310|NCT02629822|12506569|FG000|NOT COMPLETED|Extension Study||2
11308311|NCT02629861|12506577|FG000|STARTED|Overall Study||294
11308312|NCT02629861|12506578|FG001|STARTED|Overall Study||291
11308313|NCT02629861|12506579|FG002|STARTED|Overall Study||290
11308314|NCT02629861|12506577|FG000|Intent to Treat (ITT)|Overall Study||294
11308315|NCT02629861|12506578|FG001|Intent to Treat (ITT)|Overall Study||291
11308316|NCT02629861|12506579|FG002|Intent to Treat (ITT)|Overall Study||290
11308317|NCT02629861|12506577|FG000|Safety Population|Overall Study||294
11401641|NCT04095286|12596406|FG001|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
11401642|NCT04095286|12596407|FG002|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||2
11401643|NCT04095286|12596408|FG003|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
11308318|NCT02629861|12506578|FG001|Safety Population|Overall Study||291
11308319|NCT02629861|12506579|FG002|Safety Population|Overall Study||289
11308320|NCT02629861|12506577|FG000|Full Analysis Set|Overall Study||290
11308321|NCT02629861|12506578|FG001|Full Analysis Set|Overall Study||288
11308322|NCT02629861|12506579|FG002|Full Analysis Set|Overall Study||287
11308323|NCT02629861|12506577|FG000|COMPLETED|Overall Study||265
11308324|NCT02629861|12506578|FG001|COMPLETED|Overall Study||264
11308325|NCT02629861|12506579|FG002|COMPLETED|Overall Study||262
11308326|NCT02629861|12506577|FG000|NOT COMPLETED|Overall Study||29
11401644|NCT04095286|12596409|FG004|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
11308327|NCT02629861|12506578|FG001|NOT COMPLETED|Overall Study||27
11308328|NCT02629861|12506579|FG002|NOT COMPLETED|Overall Study||28
11308329|NCT02629965|12506587|FG000|STARTED|Period 1||92
11308330|NCT02629965|12506588|FG001|STARTED|Period 1||92
11308331|NCT02629965|12506587|FG000|COMPLETED|Period 1||88
11308332|NCT02629965|12506588|FG001|COMPLETED|Period 1||90
11308333|NCT02629965|12506587|FG000|NOT COMPLETED|Period 1||4
11308334|NCT02629965|12506588|FG001|NOT COMPLETED|Period 1||2
11308335|NCT02629965|12506587|FG000|STARTED|Period 2||88
11308336|NCT02629965|12506588|FG001|STARTED|Period 2||90
11308337|NCT02629965|12506587|FG000|COMPLETED|Period 2||87
11308338|NCT02629965|12506588|FG001|COMPLETED|Period 2||90
11308339|NCT02629965|12506587|FG000|NOT COMPLETED|Period 2||1
11308340|NCT02629965|12506588|FG001|NOT COMPLETED|Period 2||0
11308341|NCT02629991|12506596|FG000|STARTED|Overall Study||11
11308342|NCT02629991|12506597|FG001|STARTED|Overall Study||12
11308343|NCT02629991|12506596|FG000|COMPLETED|Overall Study||10
11308344|NCT02629991|12506597|FG001|COMPLETED|Overall Study||11
11308345|NCT02629991|12506596|FG000|NOT COMPLETED|Overall Study||1
11308346|NCT02629991|12506597|FG001|NOT COMPLETED|Overall Study||1
11308347|NCT02630017|12506608|FG000|STARTED|Overall Study||13
11308348|NCT02630017|12506609|FG001|STARTED|Overall Study||12
11308349|NCT02630017|12506610|FG002|STARTED|Overall Study||13
11308350|NCT02630017|12506611|FG003|STARTED|Overall Study||13
11308351|NCT02630017|12506608|FG000|COMPLETED|Overall Study||12
11308352|NCT02630017|12506609|FG001|COMPLETED|Overall Study||11
11308353|NCT02630017|12506610|FG002|COMPLETED|Overall Study||11
11308354|NCT02630017|12506611|FG003|COMPLETED|Overall Study||12
11308355|NCT02630017|12506608|FG000|NOT COMPLETED|Overall Study||1
11308356|NCT02630017|12506609|FG001|NOT COMPLETED|Overall Study||1
11308357|NCT02630017|12506610|FG002|NOT COMPLETED|Overall Study||2
11308358|NCT02630017|12506611|FG003|NOT COMPLETED|Overall Study||1
11308359|NCT02630030|12506621|FG000|STARTED|Overall Study||3
11308360|NCT02630030|12506621|FG000|COMPLETED|Overall Study||3
11308361|NCT02630030|12506621|FG000|NOT COMPLETED|Overall Study||0
11308362|NCT02630186|12506625|FG000|STARTED|Overall Study||3
11308363|NCT02630186|12506625|FG000|COMPLETED|Overall Study||2
11308364|NCT02630186|12506625|FG000|NOT COMPLETED|Overall Study||1
11308365|NCT02630251|12506633|FG000|STARTED|Overall Study||2
11308366|NCT02630251|12506634|FG001|STARTED|Overall Study||1
11308367|NCT02630251|12506635|FG002|STARTED|Overall Study||1
11308368|NCT02630251|12506636|FG003|STARTED|Overall Study||1
11308369|NCT02630251|12506633|FG000|COMPLETED|Overall Study||2
11308370|NCT02630251|12506634|FG001|COMPLETED|Overall Study||1
11308371|NCT02630251|12506635|FG002|COMPLETED|Overall Study||0
11308372|NCT02630251|12506636|FG003|COMPLETED|Overall Study||1
11308373|NCT02630251|12506633|FG000|NOT COMPLETED|Overall Study||0
11308374|NCT02630251|12506634|FG001|NOT COMPLETED|Overall Study||0
11308375|NCT02630251|12506635|FG002|NOT COMPLETED|Overall Study||1
11308376|NCT02630251|12506636|FG003|NOT COMPLETED|Overall Study||0
11308377|NCT02630563|12506646|FG000|STARTED|Overall Study||9
11308378|NCT02630563|12506646|FG000|COMPLETED|Overall Study||8
11308379|NCT02630563|12506646|FG000|NOT COMPLETED|Overall Study||1
11308380|NCT02630693|12506653|FG000|STARTED|Overall Study||90
11308381|NCT02630693|12506654|FG001|STARTED|Overall Study||90
11308382|NCT02630693|12506653|FG000|COMPLETED|Overall Study||90
11308383|NCT02630693|12506654|FG001|COMPLETED|Overall Study||89
11308384|NCT02630693|12506653|FG000|NOT COMPLETED|Overall Study||0
11308385|NCT02630693|12506654|FG001|NOT COMPLETED|Overall Study||1
11308386|NCT02630706|12506663|FG000|STARTED|Overall Study||170
11308387|NCT02630706|12506664|FG001|STARTED|Overall Study||169
11308388|NCT02630706|12506665|FG002|STARTED|Overall Study||167
11308389|NCT02630706|12506663|FG000|Treated|Overall Study||170
11308390|NCT02630706|12506664|FG001|Treated|Overall Study||169
11308391|NCT02630706|12506665|FG002|Treated|Overall Study||167
11308392|NCT02630706|12506663|FG000|COMPLETED|Overall Study||163
11308393|NCT02630706|12506664|FG001|COMPLETED|Overall Study||160
11308394|NCT02630706|12506665|FG002|COMPLETED|Overall Study||157
11308395|NCT02630706|12506663|FG000|NOT COMPLETED|Overall Study||7
11308396|NCT02630706|12506664|FG001|NOT COMPLETED|Overall Study||9
11308397|NCT02630706|12506665|FG002|NOT COMPLETED|Overall Study||10
11308398|NCT02630719|12506675|FG000|STARTED|Overall Study||4
11308399|NCT02630719|12506676|FG001|STARTED|Overall Study||6
11308400|NCT02630719|12506675|FG000|COMPLETED|Overall Study||4
11308401|NCT02630719|12506676|FG001|COMPLETED|Overall Study||6
11308402|NCT02630719|12506675|FG000|NOT COMPLETED|Overall Study||0
11308403|NCT02630719|12506676|FG001|NOT COMPLETED|Overall Study||0
11308404|NCT02630953|12506684|FG000|STARTED|6 Month Assessment||97
11308405|NCT02630953|12506685|FG001|STARTED|6 Month Assessment||102
11308406|NCT02630953|12506684|FG000|COMPLETED|6 Month Assessment||83
11401645|NCT04095286|12596410|FG005|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
11401646|NCT04095286|12596405|FG000|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
11308407|NCT02630953|12506685|FG001|COMPLETED|6 Month Assessment||70
11308408|NCT02630953|12506684|FG000|NOT COMPLETED|6 Month Assessment||14
11308409|NCT02630953|12506685|FG001|NOT COMPLETED|6 Month Assessment||32
11308410|NCT02630953|12506684|FG000|STARTED|12 Month Assessment||97
11308411|NCT02630953|12506685|FG001|STARTED|12 Month Assessment||102
11308412|NCT02630953|12506684|FG000|COMPLETED|12 Month Assessment||73
11401647|NCT04095286|12596406|FG001|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
11308413|NCT02630953|12506685|FG001|COMPLETED|12 Month Assessment||64
11308414|NCT02630953|12506684|FG000|NOT COMPLETED|12 Month Assessment||24
11308415|NCT02630953|12506685|FG001|NOT COMPLETED|12 Month Assessment||38
11308416|NCT02630966|12506693|FG000|STARTED|Overall Study||16
11308417|NCT02630966|12506694|FG001|STARTED|Overall Study||18
11308418|NCT02630966|12506693|FG000|COMPLETED|Overall Study||14
11308419|NCT02630966|12506694|FG001|COMPLETED|Overall Study||10
11308420|NCT02630966|12506693|FG000|NOT COMPLETED|Overall Study||2
11308421|NCT02630966|12506694|FG001|NOT COMPLETED|Overall Study||8
11308422|NCT02630992|12506700|FG000|STARTED|Overall Study||112
11308423|NCT02630992|12506700|FG000|COMPLETED|Overall Study||99
11308424|NCT02630992|12506700|FG000|NOT COMPLETED|Overall Study||13
11308425|NCT02631057|12506706|FG000|STARTED|Overall Study||899
11308426|NCT02631057|12506707|FG001|STARTED|Overall Study||3414
11401648|NCT04095286|12596407|FG002|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
11401649|NCT04095286|12596408|FG003|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
11401650|NCT04095286|12596409|FG004|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
11401651|NCT04095286|12596410|FG005|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
11401652|NCT04094883|12596418|FG000|STARTED|Overall Study||11
11401653|NCT04094883|12596418|FG000|COMPLETED|Overall Study||10
11401654|NCT04094883|12596418|FG000|NOT COMPLETED|Overall Study||1
11401655|NCT04091659|12596424|FG000|STARTED|Overall Study||40
11401656|NCT04091659|12596425|FG001|STARTED|Overall Study||58
11401657|NCT04091659|12596424|FG000|COMPLETED|Overall Study||37
11401658|NCT04091659|12596425|FG001|COMPLETED|Overall Study||57
11401659|NCT04091659|12596424|FG000|NOT COMPLETED|Overall Study||3
11401660|NCT04091659|12596425|FG001|NOT COMPLETED|Overall Study||1
11401661|NCT04091061|12596435|FG000|STARTED|Overall Study||6
11401662|NCT04091061|12596436|FG001|STARTED|Overall Study||6
11401663|NCT04091061|12596437|FG002|STARTED|Overall Study||6
11401664|NCT04091061|12596438|FG003|STARTED|Overall Study||6
11401665|NCT04091061|12596435|FG000|COMPLETED|Overall Study||6
11308427|NCT02631057|12506706|FG000|COMPLETED|Overall Study||899
11308428|NCT02631057|12506707|FG001|COMPLETED|Overall Study||3414
11308429|NCT02631057|12506706|FG000|NOT COMPLETED|Overall Study||0
11308430|NCT02631057|12506707|FG001|NOT COMPLETED|Overall Study||0
11308431|NCT02631525|12506715|FG000|STARTED|Overall Study||20
11308432|NCT02631525|12506716|FG001|STARTED|Overall Study||20
11308433|NCT02631525|12506715|FG000|COMPLETED|Overall Study||20
11308434|NCT02631525|12506716|FG001|COMPLETED|Overall Study||20
11308435|NCT02631525|12506715|FG000|NOT COMPLETED|Overall Study||0
11308436|NCT02631525|12506716|FG001|NOT COMPLETED|Overall Study||0
11308437|NCT02631538|12506726|FG000|STARTED|Treatment Period (Up to Week 52)||13
11308438|NCT02631538|12506727|FG001|STARTED|Treatment Period (Up to Week 52)||24
11308439|NCT02631538|12506728|FG002|STARTED|Treatment Period (Up to Week 52)||24
11308440|NCT02631538|12506729|FG003|STARTED|Treatment Period (Up to Week 52)||25
11308441|NCT02631538|12506726|FG000|COMPLETED|Treatment Period (Up to Week 52)||9
11308442|NCT02631538|12506727|FG001|COMPLETED|Treatment Period (Up to Week 52)||17
11308443|NCT02631538|12506728|FG002|COMPLETED|Treatment Period (Up to Week 52)||19
11308444|NCT02631538|12506729|FG003|COMPLETED|Treatment Period (Up to Week 52)||17
11308445|NCT02631538|12506726|FG000|NOT COMPLETED|Treatment Period (Up to Week 52)||4
11308446|NCT02631538|12506727|FG001|NOT COMPLETED|Treatment Period (Up to Week 52)||7
11308447|NCT02631538|12506728|FG002|NOT COMPLETED|Treatment Period (Up to Week 52)||5
11308448|NCT02631538|12506729|FG003|NOT COMPLETED|Treatment Period (Up to Week 52)||8
11308449|NCT02631538|12506726|FG000|STARTED|General Follow-up (GFU) (Up to Week 68)||9
11308450|NCT02631538|12506727|FG001|STARTED|General Follow-up (GFU) (Up to Week 68)||17
11308451|NCT02631538|12506728|FG002|STARTED|General Follow-up (GFU) (Up to Week 68)||19
11308452|NCT02631538|12506729|FG003|STARTED|General Follow-up (GFU) (Up to Week 68)||17
11308453|NCT02631538|12506726|FG000|COMPLETED|General Follow-up (GFU) (Up to Week 68)||8
11308454|NCT02631538|12506727|FG001|COMPLETED|General Follow-up (GFU) (Up to Week 68)||17
11308455|NCT02631538|12506728|FG002|COMPLETED|General Follow-up (GFU) (Up to Week 68)||19
11308456|NCT02631538|12506729|FG003|COMPLETED|General Follow-up (GFU) (Up to Week 68)||16
11308457|NCT02631538|12506726|FG000|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
11308458|NCT02631538|12506727|FG001|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
11308459|NCT02631538|12506728|FG002|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
11308460|NCT02631538|12506729|FG003|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
11308461|NCT02631551|12506743|FG000|STARTED|Overall Study||302
11308462|NCT02631551|12506744|FG001|STARTED|Overall Study||297
11308463|NCT02631551|12506745|FG002|STARTED|Overall Study||294
11308464|NCT02631551|12506746|FG003|STARTED|Overall Study||287
11308465|NCT02631551|12506743|FG000|COMPLETED|Overall Study||289
11308466|NCT02631551|12506744|FG001|COMPLETED|Overall Study||278
11308467|NCT02631551|12506745|FG002|COMPLETED|Overall Study||283
11308468|NCT02631551|12506746|FG003|COMPLETED|Overall Study||276
11308469|NCT02631551|12506743|FG000|NOT COMPLETED|Overall Study||13
11308470|NCT02631551|12506744|FG001|NOT COMPLETED|Overall Study||19
11308471|NCT02631551|12506745|FG002|NOT COMPLETED|Overall Study||11
11308472|NCT02631551|12506746|FG003|NOT COMPLETED|Overall Study||11
11308473|NCT02631590|12506756|FG000|STARTED|Overall Study||24
11308474|NCT02631590|12506756|FG000|COMPLETED|Overall Study||24
11401666|NCT04091061|12596436|FG001|COMPLETED|Overall Study||6
11401667|NCT04091061|12596437|FG002|COMPLETED|Overall Study||6
11401668|NCT04091061|12596438|FG003|COMPLETED|Overall Study||6
11401669|NCT04091061|12596435|FG000|NOT COMPLETED|Overall Study||0
11308475|NCT02631590|12506756|FG000|NOT COMPLETED|Overall Study||0
11308476|NCT02631746|12506760|FG000|STARTED|Overall Study||3
11308477|NCT02631746|12506760|FG000|COMPLETED|Overall Study||0
11308478|NCT02631746|12506760|FG000|NOT COMPLETED|Overall Study||3
11401670|NCT04091061|12596436|FG001|NOT COMPLETED|Overall Study||0
11401671|NCT04091061|12596437|FG002|NOT COMPLETED|Overall Study||0
11308479|NCT02631772|12506766|FG000|STARTED|Overall Study||16
11308480|NCT02631772|12506767|FG001|STARTED|Overall Study||16
11308481|NCT02631772|12506766|FG000|COMPLETED|Overall Study||16
11308482|NCT02631772|12506767|FG001|COMPLETED|Overall Study||16
11308483|NCT02631772|12506766|FG000|NOT COMPLETED|Overall Study||0
11308484|NCT02631772|12506767|FG001|NOT COMPLETED|Overall Study||0
11308485|NCT02631850|12506777|FG000|STARTED|Treatment Period|One participant was withdrawn during treatment because medical records review revealed that the motor deficit was due to an old orthopedic injury and not stroke. This participant had experienced a Transient Ischemic Attack, but no stroke that resulted in lasting neurological motor deficit. 40 participants were thus analyzed for this group in the intent-to-treat analysis even though 41 began treatment.|41
11308486|NCT02631850|12506778|FG001|STARTED|Treatment Period||44
11308487|NCT02631850|12506779|FG002|STARTED|Treatment Period||45
11308488|NCT02631850|12506780|FG003|STARTED|Treatment Period||38
11308489|NCT02631850|12506777|FG000|COMPLETED|Treatment Period||38
11308490|NCT02631850|12506778|FG001|COMPLETED|Treatment Period||38
11308491|NCT02631850|12506779|FG002|COMPLETED|Treatment Period||41
11308492|NCT02631850|12506780|FG003|COMPLETED|Treatment Period||33
11308493|NCT02631850|12506777|FG000|NOT COMPLETED|Treatment Period||3
11308494|NCT02631850|12506778|FG001|NOT COMPLETED|Treatment Period||6
11308495|NCT02631850|12506779|FG002|NOT COMPLETED|Treatment Period||4
11308496|NCT02631850|12506780|FG003|NOT COMPLETED|Treatment Period||5
11308497|NCT02631850|12506777|FG000|STARTED|6 Month Follow up||38
11308498|NCT02631850|12506778|FG001|STARTED|6 Month Follow up||38
11308499|NCT02631850|12506779|FG002|STARTED|6 Month Follow up||41
11308500|NCT02631850|12506780|FG003|STARTED|6 Month Follow up||33
11022155|NCT00808028|12200436|FG002|COMPLETED|Stage 1 (6 Months)||191
11022156|NCT00808028|12200437|FG003|COMPLETED|Stage 1 (6 Months)||183
11022157|NCT00808028|12200434|FG000|NOT COMPLETED|Stage 1 (6 Months)||5
11022158|NCT00808028|12200435|FG001|NOT COMPLETED|Stage 1 (6 Months)||1
11022159|NCT00808028|12200436|FG002|NOT COMPLETED|Stage 1 (6 Months)||7
11022160|NCT00808028|12200437|FG003|NOT COMPLETED|Stage 1 (6 Months)||15
11308501|NCT02631850|12506777|FG000|COMPLETED|6 Month Follow up||31
11308502|NCT02631850|12506778|FG001|COMPLETED|6 Month Follow up||25
11308503|NCT02631850|12506779|FG002|COMPLETED|6 Month Follow up||35
11308504|NCT02631850|12506780|FG003|COMPLETED|6 Month Follow up||22
11308505|NCT02631850|12506777|FG000|NOT COMPLETED|6 Month Follow up||7
11308506|NCT02631850|12506778|FG001|NOT COMPLETED|6 Month Follow up||13
11308507|NCT02631850|12506779|FG002|NOT COMPLETED|6 Month Follow up||6
11308508|NCT02631850|12506780|FG003|NOT COMPLETED|6 Month Follow up||11
11308509|NCT02631876|12506793|FG000|STARTED|Overall Study||248
11308510|NCT02631876|12506794|FG001|STARTED|Overall Study||118
11308511|NCT02631876|12506793|FG000|Safety Population|Overall Study||243
11308512|NCT02631876|12506794|FG001|Safety Population|Overall Study||109
11308513|NCT02631876|12506793|FG000|COMPLETED|Overall Study||129
11308514|NCT02631876|12506794|FG001|COMPLETED|Overall Study||55
11308515|NCT02631876|12506793|FG000|NOT COMPLETED|Overall Study||119
11308516|NCT02631876|12506794|FG001|NOT COMPLETED|Overall Study||63
11308517|NCT02631954|12506803|FG000|STARTED|Overall Study||12
11308518|NCT02631954|12506804|FG001|STARTED|Overall Study||12
11308519|NCT02631954|12506803|FG000|COMPLETED|Overall Study||12
11308520|NCT02631954|12506804|FG001|COMPLETED|Overall Study||12
11308521|NCT02631954|12506803|FG000|NOT COMPLETED|Overall Study||0
11308522|NCT02631954|12506804|FG001|NOT COMPLETED|Overall Study||0
11308523|NCT02632110|12506815|FG000|STARTED|Overall Study||25
11308524|NCT02632110|12506816|FG001|STARTED|Overall Study||25
11308525|NCT02632110|12506817|FG002|STARTED|Overall Study||27
11308526|NCT02632110|12506818|FG003|STARTED|Overall Study||27
11308527|NCT02632110|12506819|FG004|STARTED|Overall Study||29
11308528|NCT02632110|12506820|FG005|STARTED|Overall Study||29
11308529|NCT02632110|12506821|FG006|STARTED|Overall Study||26
11308530|NCT02632110|12506822|FG007|STARTED|Overall Study||26
11308531|NCT02632110|12506823|FG008|STARTED|Overall Study||30
11308532|NCT02632110|12506824|FG009|STARTED|Overall Study||30
11308533|NCT02632110|12506815|FG000|COMPLETED|Overall Study||24
11308534|NCT02632110|12506816|FG001|COMPLETED|Overall Study||24
11308535|NCT02632110|12506817|FG002|COMPLETED|Overall Study||27
11308536|NCT02632110|12506818|FG003|COMPLETED|Overall Study||27
11401672|NCT04091061|12596438|FG003|NOT COMPLETED|Overall Study||0
11401673|NCT04090242|12596450|FG000|STARTED|Overall Study||28
11308537|NCT02632110|12506819|FG004|COMPLETED|Overall Study||28
11308538|NCT02632110|12506820|FG005|COMPLETED|Overall Study||28
11308539|NCT02632110|12506821|FG006|COMPLETED|Overall Study||23
11308540|NCT02632110|12506822|FG007|COMPLETED|Overall Study||23
11308541|NCT02632110|12506823|FG008|COMPLETED|Overall Study||29
11308542|NCT02632110|12506824|FG009|COMPLETED|Overall Study||29
11308543|NCT02632110|12506815|FG000|NOT COMPLETED|Overall Study||1
11308544|NCT02632110|12506816|FG001|NOT COMPLETED|Overall Study||1
11308545|NCT02632110|12506817|FG002|NOT COMPLETED|Overall Study||0
11308546|NCT02632110|12506818|FG003|NOT COMPLETED|Overall Study||0
11308547|NCT02632110|12506819|FG004|NOT COMPLETED|Overall Study||1
11308548|NCT02632110|12506820|FG005|NOT COMPLETED|Overall Study||1
11308549|NCT02632110|12506821|FG006|NOT COMPLETED|Overall Study||3
11308550|NCT02632110|12506822|FG007|NOT COMPLETED|Overall Study||3
11308551|NCT02632110|12506823|FG008|NOT COMPLETED|Overall Study||1
11308552|NCT02632110|12506824|FG009|NOT COMPLETED|Overall Study||1
11308553|NCT02632526|12506847|FG000|STARTED|Overall Study||36
11401674|NCT04090242|12596451|FG001|STARTED|Overall Study||30
11401675|NCT04090242|12596450|FG000|COMPLETED|Overall Study||27
11401676|NCT04090242|12596451|FG001|COMPLETED|Overall Study||30
11308554|NCT02632526|12506848|FG001|STARTED|Overall Study||12
11308555|NCT02632526|12506849|FG002|STARTED|Overall Study||24
11308556|NCT02632526|12506850|FG003|STARTED|Overall Study||12
11308557|NCT02632526|12506851|FG004|STARTED|Overall Study||4
11308558|NCT02632526|12506852|FG005|STARTED|Overall Study||8
11308559|NCT02632526|12506847|FG000|COMPLETED|Overall Study||36
11308560|NCT02632526|12506848|FG001|COMPLETED|Overall Study||12
11308561|NCT02632526|12506849|FG002|COMPLETED|Overall Study||24
11308562|NCT02632526|12506850|FG003|COMPLETED|Overall Study||12
11308563|NCT02632526|12506851|FG004|COMPLETED|Overall Study||4
11308564|NCT02632526|12506852|FG005|COMPLETED|Overall Study||8
11308565|NCT02632526|12506847|FG000|NOT COMPLETED|Overall Study||0
11308566|NCT02632526|12506848|FG001|NOT COMPLETED|Overall Study||0
11308567|NCT02632526|12506849|FG002|NOT COMPLETED|Overall Study||0
11308568|NCT02632526|12506850|FG003|NOT COMPLETED|Overall Study||0
11308569|NCT02632526|12506851|FG004|NOT COMPLETED|Overall Study||0
11308570|NCT02632526|12506852|FG005|NOT COMPLETED|Overall Study||0
11308571|NCT02632552|12506899|FG000|STARTED|Overall Study||80
11308572|NCT02632552|12506900|FG001|STARTED|Overall Study||60
11308573|NCT02632552|12506899|FG000|COMPLETED|Overall Study||57
11308574|NCT02632552|12506900|FG001|COMPLETED|Overall Study||50
11308575|NCT02632552|12506899|FG000|NOT COMPLETED|Overall Study||23
11308576|NCT02632552|12506900|FG001|NOT COMPLETED|Overall Study||10
11401677|NCT04090242|12596450|FG000|NOT COMPLETED|Overall Study||1
11401678|NCT04090242|12596451|FG001|NOT COMPLETED|Overall Study||0
11401679|NCT04089761|12596458|FG000|STARTED|"Run In Phase"||60
11308577|NCT02632747|12506909|FG000|STARTED|Treatment Period 1||16
11308578|NCT02632747|12506910|FG001|STARTED|Treatment Period 1||15
11308579|NCT02632747|12506909|FG000|COMPLETED|Treatment Period 1||16
11308580|NCT02632747|12506910|FG001|COMPLETED|Treatment Period 1||15
11308581|NCT02632747|12506909|FG000|NOT COMPLETED|Treatment Period 1||0
11308582|NCT02632747|12506910|FG001|NOT COMPLETED|Treatment Period 1||0
11308583|NCT02632747|12506909|FG000|STARTED|Wash-out Period||16
11308584|NCT02632747|12506910|FG001|STARTED|Wash-out Period||15
11308585|NCT02632747|12506909|FG000|COMPLETED|Wash-out Period||15
11308586|NCT02632747|12506910|FG001|COMPLETED|Wash-out Period||15
11308587|NCT02632747|12506909|FG000|NOT COMPLETED|Wash-out Period||1
11308588|NCT02632747|12506910|FG001|NOT COMPLETED|Wash-out Period||0
11308589|NCT02632747|12506909|FG000|STARTED|Treatment Period 2||15
11308590|NCT02632747|12506910|FG001|STARTED|Treatment Period 2||15
11308591|NCT02632747|12506909|FG000|COMPLETED|Treatment Period 2||15
11308592|NCT02632747|12506910|FG001|COMPLETED|Treatment Period 2||15
11308593|NCT02632747|12506909|FG000|NOT COMPLETED|Treatment Period 2||0
11308594|NCT02632747|12506910|FG001|NOT COMPLETED|Treatment Period 2||0
11308595|NCT02632786|12506918|FG000|STARTED|Overall Study||66
11308596|NCT02632786|12506919|FG001|STARTED|Overall Study||63
11308597|NCT02632786|12506918|FG000|Informed Consent Obtained|Overall Study||66
11308598|NCT02632786|12506919|FG001|Informed Consent Obtained|Overall Study||63
11308599|NCT02632786|12506918|FG000|Randomized and Dosed|Overall Study||66
11308600|NCT02632786|12506919|FG001|Randomized and Dosed|Overall Study||63
11308601|NCT02632786|12506918|FG000|COMPLETED|Overall Study||55
11308602|NCT02632786|12506919|FG001|COMPLETED|Overall Study||56
11308603|NCT02632786|12506918|FG000|NOT COMPLETED|Overall Study||11
11308604|NCT02632786|12506919|FG001|NOT COMPLETED|Overall Study||7
11308605|NCT02632812|12506928|FG000|STARTED|Overall Study||12
11308606|NCT02632812|12506929|FG001|STARTED|Overall Study||12
11308607|NCT02632812|12506928|FG000|COMPLETED|Overall Study||12
11308608|NCT02632812|12506929|FG001|COMPLETED|Overall Study||12
11308609|NCT02632812|12506928|FG000|NOT COMPLETED|Overall Study||0
11308610|NCT02632812|12506929|FG001|NOT COMPLETED|Overall Study||0
11308611|NCT02632838|12506937|FG000|STARTED|Overall Study||15
11308612|NCT02632838|12506938|FG001|STARTED|Overall Study||15
11308613|NCT02632838|12506937|FG000|COMPLETED|Overall Study||12
11308614|NCT02632838|12506938|FG001|COMPLETED|Overall Study||13
11308615|NCT02632838|12506937|FG000|NOT COMPLETED|Overall Study||3
11308616|NCT02632838|12506938|FG001|NOT COMPLETED|Overall Study||2
11308617|NCT02633020|12506950|FG000|STARTED|Overall Study||19
11308618|NCT02633020|12506951|FG001|STARTED|Overall Study||9
11308619|NCT02633020|12506950|FG000|COMPLETED|Overall Study||18
11401680|NCT04089761|12596458|FG000|COMPLETED|"Run In Phase"||45
11401681|NCT04089761|12596458|FG000|NOT COMPLETED|"Run In Phase"||15
11401682|NCT04089761|12596458|FG000|STARTED|"Treatment Phase"||45
11308620|NCT02633020|12506951|FG001|COMPLETED|Overall Study||9
11308621|NCT02633020|12506950|FG000|NOT COMPLETED|Overall Study||1
11308622|NCT02633020|12506951|FG001|NOT COMPLETED|Overall Study||0
11308623|NCT02633046|12506957|FG000|STARTED|Overall Study||63
11308624|NCT02633046|12506957|FG000|Safety Population|Overall Study||63
11308625|NCT02633046|12506957|FG000|COMPLETED|Overall Study||36
11308626|NCT02633046|12506957|FG000|NOT COMPLETED|Overall Study||27
11308627|NCT02633215|12506963|FG000|STARTED|Overall Study||18
11308628|NCT02633215|12506964|FG001|STARTED|Overall Study||18
11308629|NCT02633215|12506963|FG000|COMPLETED|Overall Study||16
11308630|NCT02633215|12506964|FG001|COMPLETED|Overall Study||15
11308631|NCT02633215|12506963|FG000|NOT COMPLETED|Overall Study||2
11308632|NCT02633215|12506964|FG001|NOT COMPLETED|Overall Study||3
11308633|NCT02633306|12506970|FG000|STARTED|Overall Study||9
11308634|NCT02633306|12506970|FG000|COMPLETED|Overall Study||6
11308635|NCT02633306|12506970|FG000|NOT COMPLETED|Overall Study||3
11308636|NCT02633358|12506977|FG000|STARTED|Overall Study||87
11308637|NCT02633358|12506978|FG001|STARTED|Overall Study||54
11308638|NCT02633358|12506977|FG000|COMPLETED|Overall Study||87
11308639|NCT02633358|12506978|FG001|COMPLETED|Overall Study||54
11308640|NCT02633358|12506977|FG000|NOT COMPLETED|Overall Study||0
11308641|NCT02633358|12506978|FG001|NOT COMPLETED|Overall Study||0
11308642|NCT02633371|12506985|FG000|STARTED|Overall Study||10
11308643|NCT02633371|12506985|FG000|COMPLETED|Overall Study||7
11308644|NCT02633371|12506985|FG000|NOT COMPLETED|Overall Study||3
11308645|NCT02633488|12506991|FG000|STARTED|Overall Study||6
11308646|NCT02633488|12506992|FG001|STARTED|Overall Study||5
11308647|NCT02633488|12506991|FG000|COMPLETED|Overall Study||6
11308648|NCT02633488|12506992|FG001|COMPLETED|Overall Study||5
11308649|NCT02633488|12506991|FG000|NOT COMPLETED|Overall Study||0
11308650|NCT02633488|12506992|FG001|NOT COMPLETED|Overall Study||0
11342048|NCT02940691|12539567|FG000|STARTED|Overall Study||32
11342049|NCT02940691|12539567|FG000|COMPLETED|Overall Study||26
11342050|NCT02940691|12539567|FG000|NOT COMPLETED|Overall Study||6
11342051|NCT02940730|12539574|FG000|STARTED|Intervention 1||10
11342052|NCT02940730|12539575|FG001|STARTED|Intervention 1||0
11342053|NCT02940730|12539574|FG000|Received Intervention|Intervention 1||10
11342054|NCT02940730|12539575|FG001|Received Intervention|Intervention 1||0
11342055|NCT02940730|12539574|FG000|COMPLETED|Intervention 1||10
11342056|NCT02940730|12539575|FG001|COMPLETED|Intervention 1||0
11342057|NCT02940730|12539574|FG000|NOT COMPLETED|Intervention 1||0
11342058|NCT02940730|12539575|FG001|NOT COMPLETED|Intervention 1||0
11342059|NCT02940730|12539574|FG000|STARTED|Intervention 2||10
11342060|NCT02940730|12539575|FG001|STARTED|Intervention 2||0
11342061|NCT02940730|12539574|FG000|Received Intervention|Intervention 2||3
11342062|NCT02940730|12539575|FG001|Received Intervention|Intervention 2||0
11342063|NCT02940730|12539574|FG000|COMPLETED|Intervention 2||3
11342064|NCT02940730|12539575|FG001|COMPLETED|Intervention 2||0
11342065|NCT02940730|12539574|FG000|NOT COMPLETED|Intervention 2||7
11342066|NCT02940730|12539575|FG001|NOT COMPLETED|Intervention 2||0
11342067|NCT02940860|12539583|FG000|STARTED|Overall Study||1027
11342068|NCT02940860|12539584|FG001|STARTED|Overall Study||511
11342069|NCT02940860|12539583|FG000|COMPLETED|Overall Study||971
11342070|NCT02940860|12539584|FG001|COMPLETED|Overall Study||476
11342071|NCT02940860|12539583|FG000|NOT COMPLETED|Overall Study||56
11342072|NCT02940860|12539584|FG001|NOT COMPLETED|Overall Study||35
11342073|NCT02940886|12539594|FG000|STARTED|Overall Study|Intention-to-treat analysis set included 1009 subjects, safety analysis set included 989 subjects.|1009
11342074|NCT02940886|12539595|FG001|STARTED|Overall Study|Intention-to-treat analysis set included 503 subjects, safety analysis set included 494 subjects.|503
11342075|NCT02940886|12539594|FG000|Safety Analysis Set|Overall Study||989
11342076|NCT02940886|12539595|FG001|Safety Analysis Set|Overall Study||494
11342077|NCT02940886|12539594|FG000|COMPLETED|Overall Study||907
11342078|NCT02940886|12539595|FG001|COMPLETED|Overall Study||449
11342079|NCT02940886|12539594|FG000|NOT COMPLETED|Overall Study||102
11342080|NCT02940886|12539595|FG001|NOT COMPLETED|Overall Study||54
11342081|NCT02941523|12539605|FG000|STARTED|Monotherapy|8 received NOX66 400 mg monotherapy and combination therapy with carboplatin.|8
11342082|NCT02941523|12539606|FG001|STARTED|Monotherapy||8
11342083|NCT02941523|12539605|FG000|COMPLETED|Monotherapy||8
11342084|NCT02941523|12539606|FG001|COMPLETED|Monotherapy||7
11342085|NCT02941523|12539605|FG000|NOT COMPLETED|Monotherapy||0
11342086|NCT02941523|12539606|FG001|NOT COMPLETED|Monotherapy||1
11342087|NCT02941523|12539605|FG000|STARTED|Carboplatin Combination Therapy|All continued to combination therapy|8
11342088|NCT02941523|12539606|FG001|STARTED|Carboplatin Combination Therapy|7 continued to combination therapy; 3 started combination therapy only|10
11342089|NCT02941523|12539605|FG000|COMPLETED|Carboplatin Combination Therapy||3
11342090|NCT02941523|12539606|FG001|COMPLETED|Carboplatin Combination Therapy||6
11342091|NCT02941523|12539605|FG000|NOT COMPLETED|Carboplatin Combination Therapy||5
11342092|NCT02941523|12539606|FG001|NOT COMPLETED|Carboplatin Combination Therapy||4
11342093|NCT02941614|12539622|FG000|STARTED|Overall Study||744
11342094|NCT02941614|12539623|FG001|STARTED|Overall Study||692
11342095|NCT02941614|12539622|FG000|COMPLETED|Overall Study||603
11342096|NCT02941614|12539623|FG001|COMPLETED|Overall Study||446
11401683|NCT04089761|12596458|FG000|COMPLETED|"Treatment Phase"||39
11401684|NCT04089761|12596458|FG000|NOT COMPLETED|"Treatment Phase"||6
11401685|NCT04089761|12596458|FG000|STARTED|"Follow Up Phase (Optional)"|"Due to the COVID-19 pandemic, Only 27 participants were able to continue to the folllow Up phase"|27
11401686|NCT04089761|12596458|FG000|COMPLETED|"Follow Up Phase (Optional)"||27
11401687|NCT04089761|12596458|FG000|NOT COMPLETED|"Follow Up Phase (Optional)"||0
11401688|NCT04079803|12596465|FG000|STARTED|Overall Study||22
11401689|NCT04079803|12596466|FG001|STARTED|Overall Study||21
11401690|NCT04079803|12596467|FG002|STARTED|Overall Study||21
11401691|NCT04079803|12596465|FG000|COMPLETED|Overall Study||22
11401692|NCT04079803|12596466|FG001|COMPLETED|Overall Study||21
11401693|NCT04079803|12596467|FG002|COMPLETED|Overall Study||20
11401694|NCT04079803|12596465|FG000|NOT COMPLETED|Overall Study||0
11401695|NCT04079803|12596466|FG001|NOT COMPLETED|Overall Study||0
11401696|NCT04079803|12596467|FG002|NOT COMPLETED|Overall Study||1
11401697|NCT04086576|12596491|FG000|STARTED|Overall Study||10
11401698|NCT04086576|12596492|FG001|STARTED|Overall Study||10
11401699|NCT04086576|12596491|FG000|COMPLETED|Overall Study||10
11401700|NCT04086576|12596492|FG001|COMPLETED|Overall Study||10
11401701|NCT04086576|12596491|FG000|NOT COMPLETED|Overall Study||0
11401702|NCT04086576|12596492|FG001|NOT COMPLETED|Overall Study||0
11401703|NCT04086641|12596510|FG000|STARTED|Foot 1 (Two Week Utilization)||2
11401704|NCT04086641|12596511|FG001|STARTED|Foot 1 (Two Week Utilization)||3
11401705|NCT04086641|12596510|FG000|COMPLETED|Foot 1 (Two Week Utilization)||1
11401706|NCT04086641|12596511|FG001|COMPLETED|Foot 1 (Two Week Utilization)||1
11401707|NCT04086641|12596510|FG000|NOT COMPLETED|Foot 1 (Two Week Utilization)||1
11401708|NCT04086641|12596511|FG001|NOT COMPLETED|Foot 1 (Two Week Utilization)||2
11401709|NCT04086641|12596510|FG000|STARTED|Foot 2 (Two Week Utilization)||1
11308651|NCT02633501|12507004|FG000|STARTED|Overall Study||14
11308652|NCT02633501|12507005|FG001|STARTED|Overall Study||14
11308653|NCT02633501|12507006|FG002|STARTED|Overall Study||62
11308654|NCT02633501|12507007|FG003|STARTED|Overall Study||63
11308655|NCT02633501|12507008|FG004|STARTED|Overall Study||64
11308656|NCT02633501|12507009|FG005|STARTED|Overall Study||63
11308657|NCT02633501|12507004|FG000|COMPLETED|Overall Study||12
11308658|NCT02633501|12507005|FG001|COMPLETED|Overall Study||11
11308659|NCT02633501|12507006|FG002|COMPLETED|Overall Study||55
11308660|NCT02633501|12507007|FG003|COMPLETED|Overall Study||59
11401710|NCT04086641|12596511|FG001|STARTED|Foot 2 (Two Week Utilization)||1
11401711|NCT04086641|12596510|FG000|COMPLETED|Foot 2 (Two Week Utilization)||1
11401712|NCT04086641|12596511|FG001|COMPLETED|Foot 2 (Two Week Utilization)||1
11401713|NCT04086641|12596510|FG000|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
11401714|NCT04086641|12596511|FG001|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
11401715|NCT04085289|12596520|FG000|STARTED|Overall Study||6
11401716|NCT04085289|12596521|FG001|STARTED|Overall Study||12
11401717|NCT04085289|12596522|FG002|STARTED|Overall Study||12
11401718|NCT04085289|12596520|FG000|Received at Least One Dose of Study Drug|Overall Study||6
11401719|NCT04085289|12596521|FG001|Received at Least One Dose of Study Drug|Overall Study||12
11401720|NCT04085289|12596522|FG002|Received at Least One Dose of Study Drug|Overall Study||12
11401721|NCT04085289|12596520|FG000|COMPLETED|Overall Study||6
11401722|NCT04085289|12596521|FG001|COMPLETED|Overall Study||12
11401723|NCT04085289|12596522|FG002|COMPLETED|Overall Study||11
11308661|NCT02633501|12507008|FG004|COMPLETED|Overall Study||53
11308662|NCT02633501|12507009|FG005|COMPLETED|Overall Study||48
11308663|NCT02633501|12507004|FG000|NOT COMPLETED|Overall Study||2
11308664|NCT02633501|12507005|FG001|NOT COMPLETED|Overall Study||3
11308665|NCT02633501|12507006|FG002|NOT COMPLETED|Overall Study||7
11308666|NCT02633501|12507007|FG003|NOT COMPLETED|Overall Study||4
11308667|NCT02633501|12507008|FG004|NOT COMPLETED|Overall Study||11
11308668|NCT02633501|12507009|FG005|NOT COMPLETED|Overall Study||15
11308669|NCT02633527|12507033|FG000|STARTED|Overall Study||24
11308670|NCT02633527|12507034|FG001|STARTED|Overall Study||48
11308671|NCT02633527|12507035|FG002|STARTED|Overall Study||50
11308672|NCT02633527|12507036|FG003|STARTED|Overall Study||49
11308673|NCT02633527|12507037|FG004|STARTED|Overall Study||51
11308674|NCT02633527|12507033|FG000|COMPLETED|Overall Study||21
11308675|NCT02633527|12507034|FG001|COMPLETED|Overall Study||37
11308676|NCT02633527|12507035|FG002|COMPLETED|Overall Study||33
11308677|NCT02633527|12507036|FG003|COMPLETED|Overall Study||35
11308678|NCT02633527|12507037|FG004|COMPLETED|Overall Study||34
11308679|NCT02633527|12507033|FG000|NOT COMPLETED|Overall Study||3
11308680|NCT02633527|12507034|FG001|NOT COMPLETED|Overall Study||11
11308681|NCT02633527|12507035|FG002|NOT COMPLETED|Overall Study||17
11308682|NCT02633527|12507036|FG003|NOT COMPLETED|Overall Study||14
11308683|NCT02633527|12507037|FG004|NOT COMPLETED|Overall Study||17
11308684|NCT02633735|12507051|FG000|STARTED|Pre-implementation Phase||788
11308685|NCT02633735|12507052|FG001|STARTED|Pre-implementation Phase||1011
11308686|NCT02633735|12507051|FG000|COMPLETED|Pre-implementation Phase||788
11308687|NCT02633735|12507052|FG001|COMPLETED|Pre-implementation Phase||1011
11308688|NCT02633735|12507051|FG000|NOT COMPLETED|Pre-implementation Phase||0
11308689|NCT02633735|12507052|FG001|NOT COMPLETED|Pre-implementation Phase||0
11308690|NCT02633735|12507051|FG000|STARTED|Implementation Phase||1991
11308691|NCT02633735|12507052|FG001|STARTED|Implementation Phase||2150
11308692|NCT02633735|12507051|FG000|COMPLETED|Implementation Phase||1991
11308693|NCT02633735|12507052|FG001|COMPLETED|Implementation Phase||2150
11308694|NCT02633735|12507051|FG000|NOT COMPLETED|Implementation Phase||0
11308695|NCT02633735|12507052|FG001|NOT COMPLETED|Implementation Phase||0
11308696|NCT02633787|12507058|FG000|STARTED|Overall Study||110
11308697|NCT02633787|12507058|FG000|COMPLETED|Overall Study||109
11308698|NCT02633787|12507058|FG000|NOT COMPLETED|Overall Study||1
11308699|NCT02633800|12507064|FG000|STARTED|Overall Study||44
11308700|NCT02633800|12507065|FG001|STARTED|Overall Study||43
11308701|NCT02633800|12507064|FG000|COMPLETED|Overall Study||0
11308702|NCT02633800|12507065|FG001|COMPLETED|Overall Study||0
11308703|NCT02633800|12507064|FG000|NOT COMPLETED|Overall Study||44
11401724|NCT04085289|12596520|FG000|NOT COMPLETED|Overall Study||0
11308704|NCT02633800|12507065|FG001|NOT COMPLETED|Overall Study||43
11308705|NCT02633956|12507075|FG000|STARTED|Overall Study||20
11308706|NCT02633956|12507076|FG001|STARTED|Overall Study||21
11308707|NCT02633956|12507077|FG002|STARTED|Overall Study||22
11308708|NCT02633956|12507078|FG003|STARTED|Overall Study||21
11308709|NCT02633956|12507075|FG000|COMPLETED|Overall Study||19
11308710|NCT02633956|12507076|FG001|COMPLETED|Overall Study||19
11308711|NCT02633956|12507077|FG002|COMPLETED|Overall Study||20
11308712|NCT02633956|12507078|FG003|COMPLETED|Overall Study||21
11308713|NCT02633956|12507075|FG000|NOT COMPLETED|Overall Study||1
11308714|NCT02633956|12507076|FG001|NOT COMPLETED|Overall Study||2
11308715|NCT02633956|12507077|FG002|NOT COMPLETED|Overall Study||2
11308716|NCT02633956|12507078|FG003|NOT COMPLETED|Overall Study||0
11308717|NCT02634073|12507092|FG000|STARTED|Overall Study||4
11308718|NCT02634073|12507093|FG001|STARTED|Overall Study||4
11308719|NCT02634073|12507094|FG002|STARTED|Overall Study||4
11308720|NCT02634073|12507095|FG003|STARTED|Overall Study||4
11308721|NCT02634073|12507092|FG000|COMPLETED|Overall Study||4
11308722|NCT02634073|12507093|FG001|COMPLETED|Overall Study||4
11401725|NCT04085289|12596521|FG001|NOT COMPLETED|Overall Study||0
11401726|NCT04085289|12596522|FG002|NOT COMPLETED|Overall Study||1
11401727|NCT04084015|12596529|FG000|STARTED|Overall Study||2
11308723|NCT02634073|12507094|FG002|COMPLETED|Overall Study||4
11308724|NCT02634073|12507095|FG003|COMPLETED|Overall Study||4
11308725|NCT02634073|12507092|FG000|NOT COMPLETED|Overall Study||0
11308726|NCT02634073|12507093|FG001|NOT COMPLETED|Overall Study||0
11308727|NCT02634073|12507094|FG002|NOT COMPLETED|Overall Study||0
11308728|NCT02634073|12507095|FG003|NOT COMPLETED|Overall Study||0
11308729|NCT02634151|12507107|FG000|STARTED|Overall Study||53
11308730|NCT02634151|12507108|FG001|STARTED|Overall Study||52
11308731|NCT02634151|12507107|FG000|Full Analysis Set|Overall Study||53
11308732|NCT02634151|12507108|FG001|Full Analysis Set|Overall Study||52
11308733|NCT02634151|12507107|FG000|Safety Set|Overall Study||54
11308734|NCT02634151|12507108|FG001|Safety Set|Overall Study||51
11308735|NCT02634151|12507107|FG000|COMPLETED|Overall Study||52
11308736|NCT02634151|12507108|FG001|COMPLETED|Overall Study||50
11308737|NCT02634151|12507107|FG000|NOT COMPLETED|Overall Study||1
11308738|NCT02634151|12507108|FG001|NOT COMPLETED|Overall Study||2
11308739|NCT02634177|12507116|FG000|STARTED|Overall Study||151
11308740|NCT02634177|12507117|FG001|STARTED|Overall Study||153
11308741|NCT02634177|12507116|FG000|COMPLETED|Overall Study||140
11308742|NCT02634177|12507117|FG001|COMPLETED|Overall Study||141
11308743|NCT02634177|12507116|FG000|NOT COMPLETED|Overall Study||11
11308744|NCT02634177|12507117|FG001|NOT COMPLETED|Overall Study||12
11308745|NCT02634320|12507123|FG000|STARTED|Overall Study||51
11308746|NCT02634320|12507123|FG000|COMPLETED|Overall Study||35
11308747|NCT02634320|12507123|FG000|NOT COMPLETED|Overall Study||16
11308748|NCT02634346|12507130|FG000|STARTED|Overall Study||134
11308749|NCT02634346|12507131|FG001|STARTED|Overall Study||133
11308750|NCT02634346|12507132|FG002|STARTED|Overall Study||134
11308751|NCT02634346|12507130|FG000|COMPLETED|Overall Study||122
11308752|NCT02634346|12507131|FG001|COMPLETED|Overall Study||119
11308753|NCT02634346|12507132|FG002|COMPLETED|Overall Study||111
11308754|NCT02634346|12507130|FG000|NOT COMPLETED|Overall Study||12
11308755|NCT02634346|12507131|FG001|NOT COMPLETED|Overall Study||14
11308756|NCT02634346|12507132|FG002|NOT COMPLETED|Overall Study||23
11308757|NCT02634580|12507144|FG000|STARTED|Double-blind Treatment Period||10
11308758|NCT02634580|12507145|FG001|STARTED|Double-blind Treatment Period||11
11308759|NCT02634580|12507146|FG002|STARTED|Double-blind Treatment Period||19
11308760|NCT02634580|12507147|FG003|STARTED|Double-blind Treatment Period||21
11308761|NCT02634580|12507144|FG000|COMPLETED|Double-blind Treatment Period||9
11308762|NCT02634580|12507145|FG001|COMPLETED|Double-blind Treatment Period||11
11308763|NCT02634580|12507146|FG002|COMPLETED|Double-blind Treatment Period||18
11308764|NCT02634580|12507147|FG003|COMPLETED|Double-blind Treatment Period||20
11308765|NCT02634580|12507144|FG000|NOT COMPLETED|Double-blind Treatment Period||1
11308766|NCT02634580|12507145|FG001|NOT COMPLETED|Double-blind Treatment Period||0
11308767|NCT02634580|12507146|FG002|NOT COMPLETED|Double-blind Treatment Period||1
11308768|NCT02634580|12507147|FG003|NOT COMPLETED|Double-blind Treatment Period||1
11308769|NCT02634580|12507144|FG000|STARTED|Open-label Extension Period||9
11308770|NCT02634580|12507145|FG001|STARTED|Open-label Extension Period||11
11308771|NCT02634580|12507146|FG002|STARTED|Open-label Extension Period||18
11308772|NCT02634580|12507147|FG003|STARTED|Open-label Extension Period|Includes 1 participant who did not complete the double-blind period but had study visits during OLE|21
11308773|NCT02634580|12507144|FG000|Received Open-label Treatment|Open-label Extension Period||9
11308774|NCT02634580|12507145|FG001|Received Open-label Treatment|Open-label Extension Period||11
11308775|NCT02634580|12507146|FG002|Received Open-label Treatment|Open-label Extension Period||18
11308776|NCT02634580|12507147|FG003|Received Open-label Treatment|Open-label Extension Period||20
11308777|NCT02634580|12507144|FG000|COMPLETED|Open-label Extension Period||9
11308778|NCT02634580|12507145|FG001|COMPLETED|Open-label Extension Period||10
11308779|NCT02634580|12507146|FG002|COMPLETED|Open-label Extension Period||18
11308780|NCT02634580|12507147|FG003|COMPLETED|Open-label Extension Period||20
11308781|NCT02634580|12507144|FG000|NOT COMPLETED|Open-label Extension Period||0
11308782|NCT02634580|12507145|FG001|NOT COMPLETED|Open-label Extension Period||1
11308783|NCT02634580|12507146|FG002|NOT COMPLETED|Open-label Extension Period||0
11308784|NCT02634580|12507147|FG003|NOT COMPLETED|Open-label Extension Period||1
11308785|NCT02634684|12507160|FG000|STARTED|Overall Study||19
11308786|NCT02634684|12507161|FG001|STARTED|Overall Study||19
11308787|NCT02634684|12507162|FG002|STARTED|Overall Study||21
11308788|NCT02634684|12507163|FG003|STARTED|Overall Study||23
11308789|NCT02634684|12507160|FG000|COMPLETED|Overall Study||19
11308790|NCT02634684|12507161|FG001|COMPLETED|Overall Study||19
11308791|NCT02634684|12507162|FG002|COMPLETED|Overall Study||21
11308792|NCT02634684|12507163|FG003|COMPLETED|Overall Study||23
11308793|NCT02634684|12507160|FG000|NOT COMPLETED|Overall Study||0
11308794|NCT02634684|12507161|FG001|NOT COMPLETED|Overall Study||0
11308795|NCT02634684|12507162|FG002|NOT COMPLETED|Overall Study||0
11401728|NCT04084015|12596529|FG000|COMPLETED|Overall Study||2
11308796|NCT02634684|12507163|FG003|NOT COMPLETED|Overall Study||0
11308797|NCT02634788|12507177|FG000|STARTED|Overall Study||79
11308798|NCT02634788|12507178|FG001|STARTED|Overall Study||81
11308799|NCT02634788|12507179|FG002|STARTED|Overall Study||80
11308800|NCT02634788|12507180|FG003|STARTED|Overall Study||82
11308801|NCT02634788|12507177|FG000|COMPLETED|Overall Study||75
11308802|NCT02634788|12507178|FG001|COMPLETED|Overall Study||71
11308803|NCT02634788|12507179|FG002|COMPLETED|Overall Study||75
11308804|NCT02634788|12507180|FG003|COMPLETED|Overall Study||77
11308805|NCT02634788|12507177|FG000|NOT COMPLETED|Overall Study||4
11308806|NCT02634788|12507178|FG001|NOT COMPLETED|Overall Study||10
11308807|NCT02634788|12507179|FG002|NOT COMPLETED|Overall Study||5
11308808|NCT02634788|12507180|FG003|NOT COMPLETED|Overall Study||5
11308809|NCT02634801|12507193|FG000|STARTED|Treatment Period (Weeks 0 to 24)||54
11401729|NCT04084015|12596529|FG000|NOT COMPLETED|Overall Study||0
11401730|NCT04082663|12596533|FG000|STARTED|Overall Study||20
11401731|NCT04082663|12596533|FG000|COMPLETED|Overall Study||13
11401732|NCT04082663|12596533|FG000|NOT COMPLETED|Overall Study||7
11308810|NCT02634801|12507194|FG001|STARTED|Treatment Period (Weeks 0 to 24)||54
11308811|NCT02634801|12507195|FG002|STARTED|Treatment Period (Weeks 0 to 24)||54
11308812|NCT02634801|12507193|FG000|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
11308813|NCT02634801|12507194|FG001|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
11308814|NCT02634801|12507195|FG002|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
11308815|NCT02634801|12507193|FG000|COMPLETED|Treatment Period (Weeks 0 to 24)||50
11308816|NCT02634801|12507194|FG001|COMPLETED|Treatment Period (Weeks 0 to 24)||23
11308817|NCT02634801|12507195|FG002|COMPLETED|Treatment Period (Weeks 0 to 24)||49
11308818|NCT02634801|12507193|FG000|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
11308819|NCT02634801|12507194|FG001|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
11308820|NCT02634801|12507195|FG002|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
11308821|NCT02634801|12507193|FG000|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
11308822|NCT02634801|12507194|FG001|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
11308823|NCT02634801|12507195|FG002|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
11308824|NCT02634801|12507193|FG000|COMPLETED|Extension Period (Weeks 24 to 36)||45
11308825|NCT02634801|12507194|FG001|COMPLETED|Extension Period (Weeks 24 to 36)||18
11308826|NCT02634801|12507195|FG002|COMPLETED|Extension Period (Weeks 24 to 36)||29
11308827|NCT02634801|12507193|FG000|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
11308828|NCT02634801|12507194|FG001|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
11308829|NCT02634801|12507195|FG002|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
11308830|NCT02634801|12507193|FG000|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
11308831|NCT02634801|12507194|FG001|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
11308832|NCT02634801|12507195|FG002|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
11308833|NCT02634801|12507193|FG000|COMPLETED|Follow-up Period||36
11308834|NCT02634801|12507194|FG001|COMPLETED|Follow-up Period||18
11308835|NCT02634801|12507195|FG002|COMPLETED|Follow-up Period||38
11308836|NCT02634801|12507193|FG000|NOT COMPLETED|Follow-up Period||5
11308837|NCT02634801|12507194|FG001|NOT COMPLETED|Follow-up Period||8
11308838|NCT02634801|12507195|FG002|NOT COMPLETED|Follow-up Period||8
11308839|NCT02634814|12507210|FG000|STARTED|Overall Study||32
11308840|NCT02634814|12507211|FG001|STARTED|Overall Study||29
11401733|NCT04084028|12596541|FG000|STARTED|Overall Study||18
11401734|NCT04084028|12596542|FG001|STARTED|Overall Study||16
11401735|NCT04084028|12596543|FG002|STARTED|Overall Study||9
11308841|NCT02634814|12507212|FG002|STARTED|Overall Study||29
11308842|NCT02634814|12507210|FG000|COMPLETED|Overall Study||30
11308843|NCT02634814|12507211|FG001|COMPLETED|Overall Study||23
11308844|NCT02634814|12507212|FG002|COMPLETED|Overall Study||29
11308845|NCT02634814|12507210|FG000|NOT COMPLETED|Overall Study||2
11308846|NCT02634814|12507211|FG001|NOT COMPLETED|Overall Study||6
11308847|NCT02634814|12507212|FG002|NOT COMPLETED|Overall Study||0
11308848|NCT02634983|12507220|FG000|STARTED|Period One (First Treatment, 8-10 Days)||16
11308849|NCT02634983|12507221|FG001|STARTED|Period One (First Treatment, 8-10 Days)||15
11308850|NCT02634983|12507220|FG000|COMPLETED|Period One (First Treatment, 8-10 Days)||16
11308851|NCT02634983|12507221|FG001|COMPLETED|Period One (First Treatment, 8-10 Days)||15
11308852|NCT02634983|12507220|FG000|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
11308853|NCT02634983|12507221|FG001|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
11308854|NCT02634983|12507220|FG000|STARTED|Washout (Approximately 7-14 Days)||16
11308855|NCT02634983|12507221|FG001|STARTED|Washout (Approximately 7-14 Days)||15
11308856|NCT02634983|12507220|FG000|COMPLETED|Washout (Approximately 7-14 Days)||16
11401736|NCT04084028|12596544|FG003|STARTED|Overall Study||10
11308857|NCT02634983|12507221|FG001|COMPLETED|Washout (Approximately 7-14 Days)||15
11308858|NCT02634983|12507220|FG000|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
11308859|NCT02634983|12507221|FG001|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
11308860|NCT02634983|12507220|FG000|STARTED|Period 2 (Second Treatment, 8-10 Days)||16
11308861|NCT02634983|12507221|FG001|STARTED|Period 2 (Second Treatment, 8-10 Days)||15
11308862|NCT02634983|12507220|FG000|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14
11308863|NCT02634983|12507221|FG001|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15
11401737|NCT04084028|12596541|FG000|COMPLETED|Overall Study||18
11308864|NCT02634983|12507220|FG000|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2
11308865|NCT02634983|12507221|FG001|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0
11308866|NCT02635035|12507229|FG000|STARTED|Overall Study||17
11308867|NCT02635035|12507230|FG001|STARTED|Overall Study||21
11308868|NCT02635035|12507229|FG000|COMPLETED|Overall Study||17
11308869|NCT02635035|12507230|FG001|COMPLETED|Overall Study||21
11308870|NCT02635035|12507229|FG000|NOT COMPLETED|Overall Study||0
11308871|NCT02635035|12507230|FG001|NOT COMPLETED|Overall Study||0
11308872|NCT02635204|12507238|FG000|STARTED|Overall Study||178
11308873|NCT02635204|12507239|FG001|STARTED|Overall Study||89
11308874|NCT02635204|12507238|FG000|COMPLETED|Overall Study||176
11308875|NCT02635204|12507239|FG001|COMPLETED|Overall Study||88
11401738|NCT04084028|12596542|FG001|COMPLETED|Overall Study||16
11401739|NCT04084028|12596543|FG002|COMPLETED|Overall Study||9
11308876|NCT02635204|12507238|FG000|NOT COMPLETED|Overall Study||2
11308877|NCT02635204|12507239|FG001|NOT COMPLETED|Overall Study||1
11308878|NCT02635347|12507247|FG000|STARTED|Overall Study||51
11308879|NCT02635347|12507248|FG001|STARTED|Overall Study||70
11308880|NCT02635347|12507247|FG000|Screening|Overall Study||51
11308881|NCT02635347|12507248|FG001|Screening|Overall Study||70
11308882|NCT02635347|12507247|FG000|Enrollment|Overall Study||31
11308883|NCT02635347|12507248|FG001|Enrollment|Overall Study||63
11308884|NCT02635347|12507247|FG000|Protocol Completion|Overall Study||22
11308885|NCT02635347|12507248|FG001|Protocol Completion|Overall Study||63
11308886|NCT02635347|12507247|FG000|Follow up|Overall Study||31
11308887|NCT02635347|12507248|FG001|Follow up|Overall Study||63
11308888|NCT02635347|12507247|FG000|Analyses|Overall Study||30
11308889|NCT02635347|12507248|FG001|Analyses|Overall Study||63
11308890|NCT02635347|12507247|FG000|COMPLETED|Overall Study||31
11308891|NCT02635347|12507248|FG001|COMPLETED|Overall Study||63
11308892|NCT02635347|12507247|FG000|NOT COMPLETED|Overall Study||20
11308893|NCT02635347|12507248|FG001|NOT COMPLETED|Overall Study||7
11308894|NCT02635386|12507260|FG000|STARTED|Overall Study||23
11308895|NCT02635386|12507261|FG001|STARTED|Overall Study||23
11308896|NCT02635386|12507262|FG002|STARTED|Overall Study||22
11308897|NCT02635386|12507263|FG003|STARTED|Overall Study||26
11308898|NCT02635386|12507264|FG004|STARTED|Overall Study||25
11308899|NCT02635386|12507260|FG000|COMPLETED|Overall Study||20
11308900|NCT02635386|12507261|FG001|COMPLETED|Overall Study||17
11308901|NCT02635386|12507262|FG002|COMPLETED|Overall Study||20
11308902|NCT02635386|12507263|FG003|COMPLETED|Overall Study||19
11308903|NCT02635386|12507264|FG004|COMPLETED|Overall Study||16
11308904|NCT02635386|12507260|FG000|NOT COMPLETED|Overall Study||3
11308905|NCT02635386|12507261|FG001|NOT COMPLETED|Overall Study||6
11308906|NCT02635386|12507262|FG002|NOT COMPLETED|Overall Study||2
11308907|NCT02635386|12507263|FG003|NOT COMPLETED|Overall Study||7
11308908|NCT02635386|12507264|FG004|NOT COMPLETED|Overall Study||9
11308909|NCT02635425|12507283|FG000|STARTED|Overall Study||15
11308910|NCT02635425|12507284|FG001|STARTED|Overall Study||15
11308911|NCT02635425|12507283|FG000|COMPLETED|Overall Study||15
11308912|NCT02635425|12507284|FG001|COMPLETED|Overall Study||15
11308913|NCT02635425|12507283|FG000|NOT COMPLETED|Overall Study||0
11308914|NCT02635425|12507284|FG001|NOT COMPLETED|Overall Study||0
11308915|NCT02635542|12507292|FG000|STARTED|Overall Study||50
11308916|NCT02635542|12507293|FG001|STARTED|Overall Study||50
11308917|NCT02635542|12507292|FG000|COMPLETED|Overall Study||50
11308918|NCT02635542|12507293|FG001|COMPLETED|Overall Study||50
11308919|NCT02635542|12507292|FG000|NOT COMPLETED|Overall Study||0
11308920|NCT02635542|12507293|FG001|NOT COMPLETED|Overall Study||0
11308921|NCT02635646|12507301|FG000|STARTED|Overall Study||57
11308922|NCT02635646|12507302|FG001|STARTED|Overall Study||65
11308923|NCT02635646|12507301|FG000|COMPLETED|Overall Study||32
11308924|NCT02635646|12507302|FG001|COMPLETED|Overall Study||39
11308925|NCT02635646|12507301|FG000|NOT COMPLETED|Overall Study||25
11308926|NCT02635646|12507302|FG001|NOT COMPLETED|Overall Study||26
11308927|NCT02635724|12507317|FG000|STARTED|Overall Study||41
11308928|NCT02635724|12507318|FG001|STARTED|Overall Study||26
11308929|NCT02635724|12507319|FG002|STARTED|Overall Study||7
11308930|NCT02635724|12507317|FG000|ITT Population|Overall Study||41
11308931|NCT02635724|12507318|FG001|ITT Population|Overall Study||26
11308932|NCT02635724|12507319|FG002|ITT Population|Overall Study||7
11308933|NCT02635724|12507317|FG000|Safety Population|Overall Study||41
11308934|NCT02635724|12507318|FG001|Safety Population|Overall Study||25
11308935|NCT02635724|12507319|FG002|Safety Population|Overall Study||7
11308936|NCT02635724|12507317|FG000|ITTI Population|Overall Study||28
11308937|NCT02635724|12507318|FG001|ITTI Population|Overall Study||19
11308938|NCT02635724|12507319|FG002|ITTI Population|Overall Study||5
11308939|NCT02635724|12507317|FG000|E-R Population|Overall Study||28
11308940|NCT02635724|12507318|FG001|E-R Population|Overall Study||19
11308941|NCT02635724|12507319|FG002|E-R Population|Overall Study||5
11308942|NCT02635724|12507317|FG000|COMPLETED|Overall Study||41
11308943|NCT02635724|12507318|FG001|COMPLETED|Overall Study||25
11308944|NCT02635724|12507319|FG002|COMPLETED|Overall Study||7
11308945|NCT02635724|12507317|FG000|NOT COMPLETED|Overall Study||0
11308946|NCT02635724|12507318|FG001|NOT COMPLETED|Overall Study||1
11308947|NCT02635724|12507319|FG002|NOT COMPLETED|Overall Study||0
11308948|NCT02635737|12507327|FG000|STARTED|Overall Study||29
11308949|NCT02635737|12507327|FG000|COMPLETED|Overall Study||28
11308950|NCT02635737|12507327|FG000|NOT COMPLETED|Overall Study||1
11308951|NCT02635828|12507331|FG000|STARTED|Overall Study||54
11308952|NCT02635828|12507331|FG000|COMPLETED|Overall Study||40
11308953|NCT02635828|12507331|FG000|NOT COMPLETED|Overall Study||14
11308954|NCT02635880|12507335|FG000|STARTED|Overall Study||32
11308955|NCT02635880|12507335|FG000|COMPLETED|Overall Study||32
11308956|NCT02635880|12507335|FG000|NOT COMPLETED|Overall Study||0
11308957|NCT02635984|12507341|FG000|STARTED|Overall Study||53
11308958|NCT02635984|12507342|FG001|STARTED|Overall Study||55
11308959|NCT02635984|12507341|FG000|COMPLETED|Overall Study||50
11308960|NCT02635984|12507342|FG001|COMPLETED|Overall Study||51
11308961|NCT02635984|12507341|FG000|NOT COMPLETED|Overall Study||3
11308962|NCT02635984|12507342|FG001|NOT COMPLETED|Overall Study||4
11308963|NCT02636049|12507348|FG000|STARTED|Overall Study||12
11308964|NCT02636049|12507348|FG000|Triferic 6 mg IV Over 3 Hours|Overall Study||12
11308965|NCT02636049|12507348|FG000|Triferic 35 Micrograms/kg IV Push|Overall Study||12
11308966|NCT02636049|12507348|FG000|COMPLETED|Overall Study||12
11308967|NCT02636049|12507348|FG000|NOT COMPLETED|Overall Study||0
11308968|NCT02636361|12507354|FG000|STARTED|Period 1||5
11308969|NCT02636361|12507355|FG001|STARTED|Period 1||6
11308970|NCT02636361|12507356|FG002|STARTED|Period 1||5
11308971|NCT02636361|12507357|FG003|STARTED|Period 1||5
11308972|NCT02636361|12507358|FG004|STARTED|Period 1||5
11308973|NCT02636361|12507354|FG000|Received at Least One Dose of Study Drug|Period 1||5
11308974|NCT02636361|12507355|FG001|Received at Least One Dose of Study Drug|Period 1||5
11308975|NCT02636361|12507356|FG002|Received at Least One Dose of Study Drug|Period 1||5
11308976|NCT02636361|12507357|FG003|Received at Least One Dose of Study Drug|Period 1||5
11308977|NCT02636361|12507358|FG004|Received at Least One Dose of Study Drug|Period 1||4
11308978|NCT02636361|12507354|FG000|COMPLETED|Period 1||5
11308979|NCT02636361|12507355|FG001|COMPLETED|Period 1||5
11308980|NCT02636361|12507356|FG002|COMPLETED|Period 1||5
11308981|NCT02636361|12507357|FG003|COMPLETED|Period 1||5
11308982|NCT02636361|12507358|FG004|COMPLETED|Period 1||4
11308983|NCT02636361|12507354|FG000|NOT COMPLETED|Period 1||0
11308984|NCT02636361|12507355|FG001|NOT COMPLETED|Period 1||1
11308985|NCT02636361|12507356|FG002|NOT COMPLETED|Period 1||0
11308986|NCT02636361|12507357|FG003|NOT COMPLETED|Period 1||0
11308987|NCT02636361|12507358|FG004|NOT COMPLETED|Period 1||1
11308988|NCT02636361|12507354|FG000|STARTED|Period 2||5
11308989|NCT02636361|12507355|FG001|STARTED|Period 2||5
11308990|NCT02636361|12507356|FG002|STARTED|Period 2||5
11308991|NCT02636361|12507357|FG003|STARTED|Period 2||5
11308992|NCT02636361|12507358|FG004|STARTED|Period 2||4
11308993|NCT02636361|12507354|FG000|COMPLETED|Period 2||5
11308994|NCT02636361|12507355|FG001|COMPLETED|Period 2||5
11308995|NCT02636361|12507356|FG002|COMPLETED|Period 2||5
11308996|NCT02636361|12507357|FG003|COMPLETED|Period 2||5
11308997|NCT02636361|12507358|FG004|COMPLETED|Period 2||4
11308998|NCT02636361|12507354|FG000|NOT COMPLETED|Period 2||0
11308999|NCT02636361|12507355|FG001|NOT COMPLETED|Period 2||0
11309000|NCT02636361|12507356|FG002|NOT COMPLETED|Period 2||0
11309001|NCT02636361|12507357|FG003|NOT COMPLETED|Period 2||0
11309002|NCT02636361|12507358|FG004|NOT COMPLETED|Period 2||0
11309003|NCT02636361|12507354|FG000|STARTED|Period 3||5
11309004|NCT02636361|12507355|FG001|STARTED|Period 3||5
11309005|NCT02636361|12507356|FG002|STARTED|Period 3||5
11309006|NCT02636361|12507357|FG003|STARTED|Period 3||5
11309007|NCT02636361|12507358|FG004|STARTED|Period 3||4
11309008|NCT02636361|12507354|FG000|COMPLETED|Period 3||5
11309009|NCT02636361|12507355|FG001|COMPLETED|Period 3||5
11309010|NCT02636361|12507356|FG002|COMPLETED|Period 3||5
11309011|NCT02636361|12507357|FG003|COMPLETED|Period 3||5
11309012|NCT02636361|12507358|FG004|COMPLETED|Period 3||4
11309013|NCT02636361|12507354|FG000|NOT COMPLETED|Period 3||0
11309014|NCT02636361|12507355|FG001|NOT COMPLETED|Period 3||0
11309015|NCT02636361|12507356|FG002|NOT COMPLETED|Period 3||0
11309016|NCT02636361|12507357|FG003|NOT COMPLETED|Period 3||0
11309017|NCT02636361|12507358|FG004|NOT COMPLETED|Period 3||0
11309018|NCT02636361|12507354|FG000|STARTED|Period 4||5
11309019|NCT02636361|12507355|FG001|STARTED|Period 4||5
11309020|NCT02636361|12507356|FG002|STARTED|Period 4||5
11309021|NCT02636361|12507357|FG003|STARTED|Period 4||5
11309022|NCT02636361|12507358|FG004|STARTED|Period 4||4
11309023|NCT02636361|12507354|FG000|COMPLETED|Period 4||5
11309024|NCT02636361|12507355|FG001|COMPLETED|Period 4||5
11309025|NCT02636361|12507356|FG002|COMPLETED|Period 4||5
11309026|NCT02636361|12507357|FG003|COMPLETED|Period 4||4
11309027|NCT02636361|12507358|FG004|COMPLETED|Period 4||4
11309028|NCT02636361|12507354|FG000|NOT COMPLETED|Period 4||0
11309029|NCT02636361|12507355|FG001|NOT COMPLETED|Period 4||0
11309030|NCT02636361|12507356|FG002|NOT COMPLETED|Period 4||0
11309031|NCT02636361|12507357|FG003|NOT COMPLETED|Period 4||1
11309032|NCT02636361|12507358|FG004|NOT COMPLETED|Period 4||0
11309033|NCT02636361|12507354|FG000|STARTED|Period 5||5
11309034|NCT02636361|12507355|FG001|STARTED|Period 5||5
11309035|NCT02636361|12507356|FG002|STARTED|Period 5||5
11309036|NCT02636361|12507357|FG003|STARTED|Period 5||4
11309037|NCT02636361|12507358|FG004|STARTED|Period 5||4
11309038|NCT02636361|12507354|FG000|COMPLETED|Period 5||5
11309039|NCT02636361|12507355|FG001|COMPLETED|Period 5||5
11309040|NCT02636361|12507356|FG002|COMPLETED|Period 5||5
11309041|NCT02636361|12507357|FG003|COMPLETED|Period 5||4
11309042|NCT02636361|12507358|FG004|COMPLETED|Period 5||4
11309043|NCT02636361|12507354|FG000|NOT COMPLETED|Period 5||0
11309044|NCT02636361|12507355|FG001|NOT COMPLETED|Period 5||0
11309045|NCT02636361|12507356|FG002|NOT COMPLETED|Period 5||0
11309046|NCT02636361|12507357|FG003|NOT COMPLETED|Period 5||0
11309047|NCT02636361|12507358|FG004|NOT COMPLETED|Period 5||0
11309048|NCT02636595|12507372|FG000|STARTED|Overall Study||121
11309049|NCT02636595|12507372|FG000|COMPLETED|Overall Study||119
11309050|NCT02636595|12507372|FG000|NOT COMPLETED|Overall Study||2
11309051|NCT02636608|12507376|FG000|STARTED|Overall Study||244
11309052|NCT02636608|12507376|FG000|Received Treatment|Overall Study||243
11309053|NCT02636608|12507376|FG000|COMPLETED|Overall Study||233
11309054|NCT02636608|12507376|FG000|NOT COMPLETED|Overall Study||11
11309055|NCT02636699|12507385|FG000|STARTED|Overall Study||238
11309056|NCT02636699|12507386|FG001|STARTED|Overall Study||118
11309057|NCT02636699|12507385|FG000|COMPLETED|Overall Study||213
11309058|NCT02636699|12507386|FG001|COMPLETED|Overall Study||107
11309059|NCT02636699|12507385|FG000|NOT COMPLETED|Overall Study||25
11309060|NCT02636699|12507386|FG001|NOT COMPLETED|Overall Study||11
11309061|NCT02636712|12507392|FG000|STARTED|Overall Study||10
11309062|NCT02636712|12507392|FG000|COMPLETED|Overall Study||10
11309063|NCT02636712|12507392|FG000|NOT COMPLETED|Overall Study||0
11309064|NCT02636725|12507397|FG000|STARTED|Baseline||33
11309065|NCT02636725|12507397|FG000|COMPLETED|Baseline||30
11309066|NCT02636725|12507397|FG000|NOT COMPLETED|Baseline||3
11309067|NCT02636725|12507397|FG000|STARTED|Post-Baseline Imaging Assessment||30
11309068|NCT02636725|12507397|FG000|COMPLETED|Post-Baseline Imaging Assessment||30
11309069|NCT02636725|12507397|FG000|NOT COMPLETED|Post-Baseline Imaging Assessment||0
11309070|NCT02636868|12507404|FG000|STARTED|Overall Study||73
11309071|NCT02636868|12507405|FG001|STARTED|Overall Study||76
11309072|NCT02636868|12507406|FG002|STARTED|Overall Study||72
11309073|NCT02636868|12507404|FG000|COMPLETED|Overall Study||73
11309074|NCT02636868|12507405|FG001|COMPLETED|Overall Study||75
11309075|NCT02636868|12507406|FG002|COMPLETED|Overall Study||70
11309076|NCT02636868|12507404|FG000|NOT COMPLETED|Overall Study||0
11309077|NCT02636868|12507405|FG001|NOT COMPLETED|Overall Study||1
11309078|NCT02636868|12507406|FG002|NOT COMPLETED|Overall Study||2
11309079|NCT02636907|12507414|FG000|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
11309080|NCT02636907|12507414|FG000|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
11309081|NCT02636907|12507414|FG000|NOT COMPLETED|Autoinjector Assessment Period||4
11309082|NCT02636907|12507414|FG000|STARTED|Extension Phase||72
11309083|NCT02636907|12507414|FG000|COMPLETED|Extension Phase||62
11309084|NCT02636907|12507414|FG000|NOT COMPLETED|Extension Phase||10
11309085|NCT02637037|12507420|FG000|STARTED|Overall Study||40
11309086|NCT02637037|12507421|FG001|STARTED|Overall Study||40
11309087|NCT02637037|12507420|FG000|COMPLETED|Overall Study||36
11309088|NCT02637037|12507421|FG001|COMPLETED|Overall Study||39
11309089|NCT02637037|12507420|FG000|NOT COMPLETED|Overall Study||4
11309090|NCT02637037|12507421|FG001|NOT COMPLETED|Overall Study||1
11309091|NCT02637063|12507442|FG000|STARTED|Overall Study||67
11309092|NCT02637063|12507443|FG001|STARTED|Overall Study||68
11309093|NCT02637063|12507444|FG002|STARTED|Overall Study||68
11309094|NCT02637063|12507442|FG000|COMPLETED|Overall Study||62
11309095|NCT02637063|12507443|FG001|COMPLETED|Overall Study||64
11309096|NCT02637063|12507444|FG002|COMPLETED|Overall Study||62
11309097|NCT02637063|12507442|FG000|NOT COMPLETED|Overall Study||5
11309098|NCT02637063|12507443|FG001|NOT COMPLETED|Overall Study||4
11309099|NCT02637063|12507444|FG002|NOT COMPLETED|Overall Study||6
11309100|NCT02637076|12507454|FG000|STARTED|Overall Study||2
11309101|NCT02637076|12507455|FG001|STARTED|Overall Study||15
11309102|NCT02637076|12507454|FG000|COMPLETED|Overall Study||1
11309103|NCT02637076|12507455|FG001|COMPLETED|Overall Study||10
11309104|NCT02637076|12507454|FG000|NOT COMPLETED|Overall Study||1
11309105|NCT02637076|12507455|FG001|NOT COMPLETED|Overall Study||5
11309106|NCT02637141|12507464|FG000|STARTED|Overall Study||22
11309107|NCT02637141|12507465|FG001|STARTED|Overall Study||22
11309108|NCT02637141|12507466|FG002|STARTED|Overall Study||20
11309109|NCT02637141|12507464|FG000|Received Study Drug|Overall Study||22
11309110|NCT02637141|12507465|FG001|Received Study Drug|Overall Study||21
11309111|NCT02637141|12507466|FG002|Received Study Drug|Overall Study||19
11309112|NCT02637141|12507464|FG000|COMPLETED|Overall Study||20
11309113|NCT02637141|12507465|FG001|COMPLETED|Overall Study||20
11309114|NCT02637141|12507466|FG002|COMPLETED|Overall Study||19
11309115|NCT02637141|12507464|FG000|NOT COMPLETED|Overall Study||2
11309116|NCT02637141|12507465|FG001|NOT COMPLETED|Overall Study||2
11309117|NCT02637141|12507466|FG002|NOT COMPLETED|Overall Study||1
11309118|NCT02637232|12507474|FG000|STARTED|Overall Study||301
11309119|NCT02637232|12507474|FG000|COMPLETED|Overall Study||246
11309120|NCT02637232|12507474|FG000|NOT COMPLETED|Overall Study||55
11309121|NCT02637323|12507480|FG000|STARTED|Overall Study||63
11309122|NCT02637323|12507481|FG001|STARTED|Overall Study||18
11309123|NCT02637323|12507480|FG000|COMPLETED|Overall Study||61
11309124|NCT02637323|12507481|FG001|COMPLETED|Overall Study||17
11309125|NCT02637323|12507480|FG000|NOT COMPLETED|Overall Study||2
11309126|NCT02637323|12507481|FG001|NOT COMPLETED|Overall Study||1
11309127|NCT02637427|12507490|FG000|STARTED|Overall Study||27
11309128|NCT02637427|12507491|FG001|STARTED|Overall Study||30
11309129|NCT02637427|12507490|FG000|COMPLETED|Overall Study||27
11309130|NCT02637427|12507491|FG001|COMPLETED|Overall Study||30
11309131|NCT02637427|12507490|FG000|NOT COMPLETED|Overall Study||0
11309132|NCT02637427|12507491|FG001|NOT COMPLETED|Overall Study||0
11309133|NCT02637557|12507501|FG000|STARTED|Overall Study||71
11309134|NCT02637557|12507502|FG001|STARTED|Overall Study||71
11309135|NCT02637557|12507503|FG002|STARTED|Overall Study||71
11309136|NCT02637557|12507504|FG003|STARTED|Overall Study||69
11309137|NCT02637557|12507501|FG000|COMPLETED|Overall Study||63
11309138|NCT02637557|12507502|FG001|COMPLETED|Overall Study||66
11309139|NCT02637557|12507503|FG002|COMPLETED|Overall Study||62
11309140|NCT02637557|12507504|FG003|COMPLETED|Overall Study||62
11309141|NCT02637557|12507501|FG000|NOT COMPLETED|Overall Study||8
11309142|NCT02637557|12507502|FG001|NOT COMPLETED|Overall Study||5
11309143|NCT02637557|12507503|FG002|NOT COMPLETED|Overall Study||9
11309144|NCT02637557|12507504|FG003|NOT COMPLETED|Overall Study||7
11309145|NCT02637804|12507516|FG000|STARTED|First Intervention (1 Week)||27
11309146|NCT02637804|12507517|FG001|STARTED|First Intervention (1 Week)||28
11309147|NCT02637804|12507518|FG002|STARTED|First Intervention (1 Week)||25
11309148|NCT02637804|12507519|FG003|STARTED|First Intervention (1 Week)||26
11309149|NCT02637804|12507516|FG000|COMPLETED|First Intervention (1 Week)||27
11309150|NCT02637804|12507517|FG001|COMPLETED|First Intervention (1 Week)||28
11309151|NCT02637804|12507518|FG002|COMPLETED|First Intervention (1 Week)||25
11309152|NCT02637804|12507519|FG003|COMPLETED|First Intervention (1 Week)||26
11309153|NCT02637804|12507516|FG000|NOT COMPLETED|First Intervention (1 Week)||0
11309154|NCT02637804|12507517|FG001|NOT COMPLETED|First Intervention (1 Week)||0
11309155|NCT02637804|12507518|FG002|NOT COMPLETED|First Intervention (1 Week)||0
11309156|NCT02637804|12507519|FG003|NOT COMPLETED|First Intervention (1 Week)||0
11309157|NCT02637804|12507516|FG000|STARTED|Second Intervention (1 Week)||27
11309158|NCT02637804|12507517|FG001|STARTED|Second Intervention (1 Week)||28
11143860|NCT01474538|12330472|FG001|NOT COMPLETED|Treatment Period 2||2
11143861|NCT01474551|12330478|FG000|STARTED|Overall Study||2
11143862|NCT01474551|12330478|FG000|COMPLETED|Overall Study||1
11143863|NCT01474551|12330478|FG000|NOT COMPLETED|Overall Study||1
11143864|NCT01474590|12330484|FG000|STARTED|Overall Study||133
11143865|NCT01474590|12330485|FG001|STARTED|Overall Study||133
11143866|NCT01474590|12330484|FG000|COMPLETED|Overall Study||105
11143867|NCT01474590|12330485|FG001|COMPLETED|Overall Study||116
11143868|NCT01474590|12330484|FG000|NOT COMPLETED|Overall Study||28
11143869|NCT01474590|12330485|FG001|NOT COMPLETED|Overall Study||17
11143870|NCT01474681|12330493|FG000|STARTED|Overall Study||1
11143871|NCT01474681|12330494|FG001|STARTED|Overall Study||8
11143872|NCT01474681|12330495|FG002|STARTED|Overall Study||3
11143873|NCT01474681|12330496|FG003|STARTED|Overall Study||15
11143874|NCT01474681|12330493|FG000|COMPLETED|Overall Study||1
11143875|NCT01474681|12330494|FG001|COMPLETED|Overall Study||5
11143876|NCT01474681|12330495|FG002|COMPLETED|Overall Study||1
11143877|NCT01474681|12330496|FG003|COMPLETED|Overall Study||9
11143878|NCT01474681|12330493|FG000|NOT COMPLETED|Overall Study||0
11143879|NCT01474681|12330494|FG001|NOT COMPLETED|Overall Study||3
11143880|NCT01474681|12330495|FG002|NOT COMPLETED|Overall Study||2
11143881|NCT01474681|12330496|FG003|NOT COMPLETED|Overall Study||6
11143882|NCT01474746|12330512|FG000|STARTED|Overall Study||30
11143883|NCT01474746|12330513|FG001|STARTED|Overall Study||27
11143884|NCT01474746|12330512|FG000|COMPLETED|Overall Study||27
11143885|NCT01474746|12330513|FG001|COMPLETED|Overall Study||25
11143886|NCT01474746|12330512|FG000|NOT COMPLETED|Overall Study||3
11143887|NCT01474746|12330513|FG001|NOT COMPLETED|Overall Study||2
11143888|NCT01474772|12330521|FG000|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
11143889|NCT01474772|12330522|FG001|STARTED|Period 1|STARTED=treated|102
11143890|NCT01474772|12330521|FG000|COMPLETED|Period 1||89
11143891|NCT01474772|12330522|FG001|COMPLETED|Period 1||99
11143892|NCT01474772|12330521|FG000|NOT COMPLETED|Period 1||12
11143893|NCT01474772|12330522|FG001|NOT COMPLETED|Period 1||3
11143894|NCT01474772|12330521|FG000|STARTED|Washout||89
11143895|NCT01474772|12330522|FG001|STARTED|Washout||99
11143896|NCT01474772|12330521|FG000|COMPLETED|Washout||86
11143897|NCT01474772|12330522|FG001|COMPLETED|Washout||97
11143898|NCT01474772|12330521|FG000|NOT COMPLETED|Washout||3
11143899|NCT01474772|12330522|FG001|NOT COMPLETED|Washout||2
11143900|NCT01474772|12330521|FG000|STARTED|Period 2||86
11143901|NCT01474772|12330522|FG001|STARTED|Period 2||97
11143902|NCT01474772|12330521|FG000|COMPLETED|Period 2||77
11143903|NCT01474772|12330522|FG001|COMPLETED|Period 2||87
11143904|NCT01474772|12330521|FG000|NOT COMPLETED|Period 2||9
11143905|NCT01474772|12330522|FG001|NOT COMPLETED|Period 2||10
11143906|NCT01474772|12330521|FG000|STARTED|Follow-up||77
11143907|NCT01474772|12330522|FG001|STARTED|Follow-up||87
11143908|NCT01474772|12330521|FG000|COMPLETED|Follow-up||77
11143909|NCT01474772|12330522|FG001|COMPLETED|Follow-up||86
11143910|NCT01474772|12330521|FG000|NOT COMPLETED|Follow-up||0
11143911|NCT01474772|12330522|FG001|NOT COMPLETED|Follow-up||1
11143912|NCT01474863|12330531|FG000|STARTED|Overall Study||26
11143913|NCT01474863|12330532|FG001|STARTED|Overall Study||22
11143914|NCT01474863|12330533|FG002|STARTED|Overall Study||24
11143915|NCT01474863|12330531|FG000|COMPLETED|Overall Study||26
11143916|NCT01474863|12330532|FG001|COMPLETED|Overall Study||22
11143917|NCT01474863|12330533|FG002|COMPLETED|Overall Study||24
11143918|NCT01474863|12330531|FG000|NOT COMPLETED|Overall Study||0
11143919|NCT01474863|12330532|FG001|NOT COMPLETED|Overall Study||0
11143920|NCT01474863|12330533|FG002|NOT COMPLETED|Overall Study||0
11143921|NCT01474876|12330544|FG000|STARTED|Overall Study||403
11143922|NCT01474876|12330545|FG001|STARTED|Overall Study||151
11143923|NCT01474876|12330546|FG002|STARTED|Overall Study||1
11143924|NCT01474876|12330544|FG000|COMPLETED|Overall Study||337
11143925|NCT01474876|12330545|FG001|COMPLETED|Overall Study||128
11143926|NCT01474876|12330546|FG002|COMPLETED|Overall Study||1
11143927|NCT01474876|12330544|FG000|NOT COMPLETED|Overall Study||66
11143928|NCT01474876|12330545|FG001|NOT COMPLETED|Overall Study||23
11143929|NCT01474876|12330546|FG002|NOT COMPLETED|Overall Study||0
11143930|NCT01474915|12330554|FG000|STARTED|Overall Study||60
11143931|NCT01474915|12330555|FG001|STARTED|Overall Study||61
11143932|NCT01474915|12330554|FG000|COMPLETED|Overall Study||50
11143933|NCT01474915|12330555|FG001|COMPLETED|Overall Study||51
11143934|NCT01474915|12330554|FG000|NOT COMPLETED|Overall Study||10
11143935|NCT01474915|12330555|FG001|NOT COMPLETED|Overall Study||10
11143936|NCT01474993|12330564|FG000|STARTED|Overall Study||15
11143937|NCT01474993|12330565|FG001|STARTED|Overall Study||29
11309159|NCT02637804|12507518|FG002|STARTED|Second Intervention (1 Week)||25
11309160|NCT02637804|12507519|FG003|STARTED|Second Intervention (1 Week)||26
11309161|NCT02637804|12507516|FG000|COMPLETED|Second Intervention (1 Week)||27
11309162|NCT02637804|12507517|FG001|COMPLETED|Second Intervention (1 Week)||28
11309163|NCT02637804|12507518|FG002|COMPLETED|Second Intervention (1 Week)||25
11309164|NCT02637804|12507519|FG003|COMPLETED|Second Intervention (1 Week)||26
11309165|NCT02637804|12507516|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
11309166|NCT02637804|12507517|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
11309167|NCT02637804|12507518|FG002|NOT COMPLETED|Second Intervention (1 Week)||0
11309168|NCT02637804|12507519|FG003|NOT COMPLETED|Second Intervention (1 Week)||0
11309169|NCT02637856|12507536|FG000|STARTED|Main Study (Baseline to Week 100)||608
11309170|NCT02637856|12507537|FG001|STARTED|Main Study (Baseline to Week 100)||0
11309171|NCT02637856|12507536|FG000|COMPLETED|Main Study (Baseline to Week 100)||389
11309172|NCT02637856|12507537|FG001|COMPLETED|Main Study (Baseline to Week 100)||0
11309173|NCT02637856|12507536|FG000|NOT COMPLETED|Main Study (Baseline to Week 100)||219
11309174|NCT02637856|12507537|FG001|NOT COMPLETED|Main Study (Baseline to Week 100)||0
11309175|NCT02637856|12507536|FG000|STARTED|Sub-Study (Week 72 to Week 100)||0
11309176|NCT02637856|12507537|FG001|STARTED|Sub-Study (Week 72 to Week 100)||129
11309177|NCT02637856|12507536|FG000|COMPLETED|Sub-Study (Week 72 to Week 100)||0
11309178|NCT02637856|12507537|FG001|COMPLETED|Sub-Study (Week 72 to Week 100)||125
11309179|NCT02637856|12507536|FG000|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||0
11309180|NCT02637856|12507537|FG001|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||4
11309181|NCT02637895|12507545|FG000|STARTED|Overall Study||21
11309182|NCT02637895|12507546|FG001|STARTED|Overall Study||20
11309183|NCT02637895|12507545|FG000|COMPLETED|Overall Study||15
11309184|NCT02637895|12507546|FG001|COMPLETED|Overall Study||17
11309185|NCT02637895|12507545|FG000|NOT COMPLETED|Overall Study||6
11309186|NCT02637895|12507546|FG001|NOT COMPLETED|Overall Study||3
11309187|NCT02637999|12507556|FG000|STARTED|Overall Study||8
11309188|NCT02637999|12507557|FG001|STARTED|Overall Study||8
11309189|NCT02637999|12507558|FG002|STARTED|Overall Study||8
11309190|NCT02637999|12507556|FG000|COMPLETED|Overall Study||7
11309191|NCT02637999|12507557|FG001|COMPLETED|Overall Study||6
11401740|NCT04084028|12596544|FG003|COMPLETED|Overall Study||10
11401741|NCT04084028|12596541|FG000|NOT COMPLETED|Overall Study||0
11401742|NCT04084028|12596542|FG001|NOT COMPLETED|Overall Study||0
11401743|NCT04084028|12596543|FG002|NOT COMPLETED|Overall Study||0
11401744|NCT04084028|12596544|FG003|NOT COMPLETED|Overall Study||0
11401745|NCT04082819|12596559|FG000|STARTED|Overall Study||37
11309192|NCT02637999|12507558|FG002|COMPLETED|Overall Study||6
11309193|NCT02637999|12507556|FG000|NOT COMPLETED|Overall Study||1
11309194|NCT02637999|12507557|FG001|NOT COMPLETED|Overall Study||2
11309195|NCT02637999|12507558|FG002|NOT COMPLETED|Overall Study||2
11309196|NCT02638012|12507566|FG000|STARTED|Overall Study||8
11309197|NCT02638012|12507566|FG000|COMPLETED|Overall Study||7
11309198|NCT02638012|12507566|FG000|NOT COMPLETED|Overall Study||1
11309199|NCT02638051|12507572|FG000|STARTED|Overall Study||130
11309200|NCT02638051|12507573|FG001|STARTED|Overall Study||130
11309201|NCT02638051|12507572|FG000|COMPLETED|Overall Study||130
11309202|NCT02638051|12507573|FG001|COMPLETED|Overall Study||130
11401746|NCT04082819|12596560|FG001|STARTED|Overall Study||54
11401747|NCT04082819|12596561|FG002|STARTED|Overall Study||3
11401748|NCT04082819|12596559|FG000|COMPLETED|Overall Study||37
11401749|NCT04082819|12596560|FG001|COMPLETED|Overall Study||54
11401750|NCT04082819|12596561|FG002|COMPLETED|Overall Study||3
11401751|NCT04082819|12596559|FG000|NOT COMPLETED|Overall Study||0
11401752|NCT04082819|12596560|FG001|NOT COMPLETED|Overall Study||0
11401753|NCT04082819|12596561|FG002|NOT COMPLETED|Overall Study||0
11401754|NCT04081961|12596575|FG000|STARTED|Overall Study||9
11309203|NCT02638051|12507572|FG000|NOT COMPLETED|Overall Study||0
11309204|NCT02638051|12507573|FG001|NOT COMPLETED|Overall Study||0
11309205|NCT02638103|12507583|FG000|STARTED|Overall Study||419
11309206|NCT02638103|12507584|FG001|STARTED|Overall Study||526
11309207|NCT02638103|12507585|FG002|STARTED|Overall Study||420
11309208|NCT02638103|12507586|FG003|STARTED|Overall Study||525
11309209|NCT02638103|12507583|FG000|Safety Analysis Set|Overall Study||418
11309210|NCT02638103|12507584|FG001|Safety Analysis Set|Overall Study||526
11309211|NCT02638103|12507585|FG002|Safety Analysis Set|Overall Study||419
11309212|NCT02638103|12507586|FG003|Safety Analysis Set|Overall Study||525
11309213|NCT02638103|12507583|FG000|Full Analysis Set (FAS)|Overall Study||416
11309214|NCT02638103|12507584|FG001|Full Analysis Set (FAS)|Overall Study||520
11309215|NCT02638103|12507585|FG002|Full Analysis Set (FAS)|Overall Study||419
11401755|NCT04081961|12596576|FG001|STARTED|Overall Study||9
11401756|NCT04081961|12596577|FG002|STARTED|Overall Study||9
11401757|NCT04081961|12596575|FG000|COMPLETED|Overall Study||9
11401758|NCT04081961|12596576|FG001|COMPLETED|Overall Study||9
11401759|NCT04081961|12596577|FG002|COMPLETED|Overall Study||9
11401760|NCT04081961|12596575|FG000|NOT COMPLETED|Overall Study||0
11401761|NCT04081961|12596576|FG001|NOT COMPLETED|Overall Study||0
11401762|NCT04081961|12596577|FG002|NOT COMPLETED|Overall Study||0
11401763|NCT04081610|12596587|FG000|STARTED|Overall Study||16
11309216|NCT02638103|12507586|FG003|Full Analysis Set (FAS)|Overall Study||523
11309217|NCT02638103|12507583|FG000|COMPLETED|Overall Study||313
11309218|NCT02638103|12507584|FG001|COMPLETED|Overall Study||408
11309219|NCT02638103|12507585|FG002|COMPLETED|Overall Study||335
11309220|NCT02638103|12507586|FG003|COMPLETED|Overall Study||383
11309221|NCT02638103|12507583|FG000|NOT COMPLETED|Overall Study||106
11309222|NCT02638103|12507584|FG001|NOT COMPLETED|Overall Study||118
11309223|NCT02638103|12507585|FG002|NOT COMPLETED|Overall Study||85
11309224|NCT02638103|12507586|FG003|NOT COMPLETED|Overall Study||142
11309225|NCT02638168|12507604|FG000|STARTED|Overall Study||3
11309226|NCT02638168|12507605|FG001|STARTED|Overall Study||0
11401764|NCT04081610|12596588|FG001|STARTED|Overall Study||18
11401765|NCT04081610|12596587|FG000|COMPLETED|Overall Study||16
11401766|NCT04081610|12596588|FG001|COMPLETED|Overall Study||18
11401767|NCT04081610|12596587|FG000|NOT COMPLETED|Overall Study||0
11309227|NCT02638168|12507604|FG000|COMPLETED|Overall Study||3
11309228|NCT02638168|12507605|FG001|COMPLETED|Overall Study||0
11309229|NCT02638168|12507604|FG000|NOT COMPLETED|Overall Study||0
11309230|NCT02638168|12507605|FG001|NOT COMPLETED|Overall Study||0
11309231|NCT02638207|12507612|FG000|STARTED|Overall Study||35
11309232|NCT02638207|12507613|FG001|STARTED|Overall Study||69
11309233|NCT02638207|12507614|FG002|STARTED|Overall Study||38
11309234|NCT02638207|12507612|FG000|COMPLETED|Overall Study||28
11309235|NCT02638207|12507613|FG001|COMPLETED|Overall Study||61
11309236|NCT02638207|12507614|FG002|COMPLETED|Overall Study||34
11309237|NCT02638207|12507612|FG000|NOT COMPLETED|Overall Study||7
11309238|NCT02638207|12507613|FG001|NOT COMPLETED|Overall Study||8
11309239|NCT02638207|12507614|FG002|NOT COMPLETED|Overall Study||4
11309240|NCT02638259|12507626|FG000|STARTED|Treatment Period 1||186
11309241|NCT02638259|12507627|FG001|STARTED|Treatment Period 1||190
11309242|NCT02638259|12507626|FG000|COMPLETED|Treatment Period 1||181
11309243|NCT02638259|12507627|FG001|COMPLETED|Treatment Period 1||172
11309244|NCT02638259|12507626|FG000|NOT COMPLETED|Treatment Period 1||5
11309245|NCT02638259|12507627|FG001|NOT COMPLETED|Treatment Period 1||18
11309246|NCT02638259|12507626|FG000|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
11309247|NCT02638259|12507627|FG001|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
11309248|NCT02638259|12507626|FG000|COMPLETED|Treatment Period 2||169
11309249|NCT02638259|12507627|FG001|COMPLETED|Treatment Period 2||155
11309250|NCT02638259|12507626|FG000|NOT COMPLETED|Treatment Period 2||6
11309251|NCT02638259|12507627|FG001|NOT COMPLETED|Treatment Period 2||11
11309252|NCT02638337|12507639|FG000|STARTED|Overall Study||316
11309253|NCT02638337|12507640|FG001|STARTED|Overall Study||315
11309254|NCT02638337|12507639|FG000|Received Treatment|Overall Study||313
11309255|NCT02638337|12507640|FG001|Received Treatment|Overall Study||315
11309256|NCT02638337|12507639|FG000|COMPLETED|Overall Study||283
11309257|NCT02638337|12507640|FG001|COMPLETED|Overall Study||279
11309258|NCT02638337|12507639|FG000|NOT COMPLETED|Overall Study||33
11309259|NCT02638337|12507640|FG001|NOT COMPLETED|Overall Study||36
11309260|NCT02638493|12507649|FG000|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
11309261|NCT02638493|12507650|FG001|STARTED|Overall Study||8
11309262|NCT02638493|12507651|FG002|STARTED|Overall Study||8
11309263|NCT02638493|12507649|FG000|COMPLETED|Overall Study||8
11309264|NCT02638493|12507650|FG001|COMPLETED|Overall Study||8
11309265|NCT02638493|12507651|FG002|COMPLETED|Overall Study||8
11309266|NCT02638493|12507649|FG000|NOT COMPLETED|Overall Study||2
11309267|NCT02638493|12507650|FG001|NOT COMPLETED|Overall Study||0
11309268|NCT02638493|12507651|FG002|NOT COMPLETED|Overall Study||0
11309269|NCT02638597|12507661|FG000|STARTED|Overall Study||8
11309270|NCT02638597|12507662|FG001|STARTED|Overall Study||8
11309271|NCT02638597|12507661|FG000|COMPLETED|Overall Study||4
11309272|NCT02638597|12507662|FG001|COMPLETED|Overall Study||3
11309273|NCT02638597|12507661|FG000|NOT COMPLETED|Overall Study||4
11309274|NCT02638597|12507662|FG001|NOT COMPLETED|Overall Study||5
11309275|NCT02638623|12507672|FG000|STARTED|Overall Study||27
11309276|NCT02638623|12507673|FG001|STARTED|Overall Study||25
11309277|NCT02638623|12507672|FG000|COMPLETED|Overall Study||20
11309278|NCT02638623|12507673|FG001|COMPLETED|Overall Study||19
11309279|NCT02638623|12507672|FG000|NOT COMPLETED|Overall Study||7
11309280|NCT02638623|12507673|FG001|NOT COMPLETED|Overall Study||6
11309281|NCT02638948|12507683|FG000|STARTED|Overall Study||75
11309282|NCT02638948|12507684|FG001|STARTED|Overall Study||73
11309283|NCT02638948|12507685|FG002|STARTED|Overall Study||73
11309284|NCT02638948|12507686|FG003|STARTED|Overall Study||26
11309285|NCT02638948|12507683|FG000|COMPLETED|Overall Study||66
11309286|NCT02638948|12507684|FG001|COMPLETED|Overall Study||62
11309287|NCT02638948|12507685|FG002|COMPLETED|Overall Study||66
11309288|NCT02638948|12507686|FG003|COMPLETED|Overall Study||18
11309289|NCT02638948|12507683|FG000|NOT COMPLETED|Overall Study||9
11309290|NCT02638948|12507684|FG001|NOT COMPLETED|Overall Study||11
11309291|NCT02638948|12507685|FG002|NOT COMPLETED|Overall Study||7
11309292|NCT02638948|12507686|FG003|NOT COMPLETED|Overall Study||8
11309293|NCT02638974|12507701|FG000|STARTED|Overall Study||26
11309294|NCT02638974|12507702|FG001|STARTED|Overall Study||25
11309295|NCT02638974|12507701|FG000|COMPLETED|Overall Study||23
11309296|NCT02638974|12507702|FG001|COMPLETED|Overall Study||22
11309297|NCT02638974|12507701|FG000|NOT COMPLETED|Overall Study||3
11309298|NCT02638974|12507702|FG001|NOT COMPLETED|Overall Study||3
11309299|NCT02639052|12507708|FG000|STARTED|Overall Study||35
11309300|NCT02639052|12507708|FG000|Visit 1 (Baseline)|Overall Study||35
11309301|NCT02639052|12507708|FG000|Visit 2 (1-week Follow-up)|Overall Study||35
11309302|NCT02639052|12507708|FG000|Visit 3 (1-month Follow-up)|Overall Study||35
11309303|NCT02639052|12507708|FG000|Visit 4 (3-month Follow-up)|Overall Study||34
11309304|NCT02639052|12507708|FG000|COMPLETED|Overall Study||34
11309305|NCT02639052|12507708|FG000|NOT COMPLETED|Overall Study||1
11309306|NCT02639182|12507716|FG000|STARTED|Overall Study||67
11309307|NCT02639182|12507717|FG001|STARTED|Overall Study||66
11309308|NCT02639182|12507716|FG000|Treated|Overall Study||66
11309309|NCT02639182|12507717|FG001|Treated|Overall Study||65
11309310|NCT02639182|12507716|FG000|COMPLETED|Overall Study||0
11309311|NCT02639182|12507717|FG001|COMPLETED|Overall Study||0
11309312|NCT02639182|12507716|FG000|NOT COMPLETED|Overall Study||67
11309313|NCT02639182|12507717|FG001|NOT COMPLETED|Overall Study||66
11309314|NCT02639247|12507725|FG000|STARTED|Overall Study||182
11309315|NCT02639247|12507726|FG001|STARTED|Overall Study||151
11309316|NCT02639247|12507725|FG000|COMPLETED|Overall Study||177
11309317|NCT02639247|12507726|FG001|COMPLETED|Overall Study||149
11309318|NCT02639247|12507725|FG000|NOT COMPLETED|Overall Study||5
11309319|NCT02639247|12507726|FG001|NOT COMPLETED|Overall Study||2
11309320|NCT02639286|12507734|FG000|STARTED|Overall Study||3
11309321|NCT02639286|12507735|FG001|STARTED|Overall Study||2
11309322|NCT02639286|12507734|FG000|COMPLETED|Overall Study||3
11309323|NCT02639286|12507735|FG001|COMPLETED|Overall Study||2
11309324|NCT02639286|12507734|FG000|NOT COMPLETED|Overall Study||0
11309325|NCT02639286|12507735|FG001|NOT COMPLETED|Overall Study||0
11309326|NCT02639338|12507743|FG000|STARTED|Overall Study||110
11309327|NCT02639338|12507744|FG001|STARTED|Overall Study||110
11309328|NCT02639338|12507743|FG000|COMPLETED|Overall Study||106
11309329|NCT02639338|12507744|FG001|COMPLETED|Overall Study||105
11309330|NCT02639338|12507743|FG000|NOT COMPLETED|Overall Study||4
11309331|NCT02639338|12507744|FG001|NOT COMPLETED|Overall Study||5
11309332|NCT02639351|12507755|FG000|STARTED|Overall Study||16
11309333|NCT02639351|12507756|FG001|STARTED|Overall Study||16
11309334|NCT02639351|12507757|FG002|STARTED|Overall Study||16
11309335|NCT02639351|12507758|FG003|STARTED|Overall Study||16
11309336|NCT02639351|12507759|FG004|STARTED|Overall Study||16
11309337|NCT02639351|12507755|FG000|COMPLETED|Overall Study||16
11309338|NCT02639351|12507756|FG001|COMPLETED|Overall Study||16
11309339|NCT02639351|12507757|FG002|COMPLETED|Overall Study||16
11309340|NCT02639351|12507758|FG003|COMPLETED|Overall Study||16
11309341|NCT02639351|12507759|FG004|COMPLETED|Overall Study||16
11309342|NCT02639351|12507755|FG000|NOT COMPLETED|Overall Study||0
11309343|NCT02639351|12507756|FG001|NOT COMPLETED|Overall Study||0
11309344|NCT02639351|12507757|FG002|NOT COMPLETED|Overall Study||0
11309345|NCT02639351|12507758|FG003|NOT COMPLETED|Overall Study||0
11309346|NCT02639351|12507759|FG004|NOT COMPLETED|Overall Study||0
11309347|NCT02639429|12507775|FG000|STARTED|Overall Study||113
11309348|NCT02639429|12507776|FG001|STARTED|Overall Study||123
11309349|NCT02639429|12507775|FG000|COMPLETED|Overall Study||113
11309350|NCT02639429|12507776|FG001|COMPLETED|Overall Study||123
11309351|NCT02639429|12507775|FG000|NOT COMPLETED|Overall Study||0
11309352|NCT02639429|12507776|FG001|NOT COMPLETED|Overall Study||0
11309353|NCT02639494|12507782|FG000|STARTED|Overall Study||20
11309354|NCT02639494|12507782|FG000|COMPLETED|Overall Study||20
11309355|NCT02639494|12507782|FG000|NOT COMPLETED|Overall Study||0
11309356|NCT02639637|12507789|FG000|STARTED|Overall Study||7
11309357|NCT02639637|12507790|FG001|STARTED|Overall Study||6
11309358|NCT02639637|12507791|FG002|STARTED|Overall Study||2
11309359|NCT02639637|12507792|FG003|STARTED|Overall Study||3
11309360|NCT02639637|12507789|FG000|COMPLETED|Overall Study||7
11309361|NCT02639637|12507790|FG001|COMPLETED|Overall Study||6
11309362|NCT02639637|12507791|FG002|COMPLETED|Overall Study||2
11309363|NCT02639637|12507792|FG003|COMPLETED|Overall Study||3
11309364|NCT02639637|12507789|FG000|NOT COMPLETED|Overall Study||0
11309365|NCT02639637|12507790|FG001|NOT COMPLETED|Overall Study||0
11309366|NCT02639637|12507791|FG002|NOT COMPLETED|Overall Study||0
11309367|NCT02639637|12507792|FG003|NOT COMPLETED|Overall Study||0
11309368|NCT02639884|12507808|FG000|STARTED|Overall Study||51
11309369|NCT02639884|12507808|FG000|COMPLETED|Overall Study||47
11309370|NCT02639884|12507808|FG000|NOT COMPLETED|Overall Study||4
11309371|NCT02640053|12507815|FG000|STARTED|Overall Study||21
11309372|NCT02640053|12507816|FG001|STARTED|Overall Study||21
11309373|NCT02640053|12507815|FG000|COMPLETED|Overall Study||17
11309374|NCT02640053|12507816|FG001|COMPLETED|Overall Study||17
11309375|NCT02640053|12507815|FG000|NOT COMPLETED|Overall Study||4
11309376|NCT02640053|12507816|FG001|NOT COMPLETED|Overall Study||4
11309377|NCT02640157|12507825|FG000|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
11401768|NCT04081610|12596588|FG001|NOT COMPLETED|Overall Study||0
11401769|NCT04081324|12596598|FG000|STARTED|Overall Study||6
11401770|NCT04081324|12596599|FG001|STARTED|Overall Study||10
11309378|NCT02640157|12507826|FG001|STARTED|Overall Study||116
11309379|NCT02640157|12507827|FG002|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
11309380|NCT02640157|12507825|FG000|Received Study Drug|Overall Study||233
11309381|NCT02640157|12507826|FG001|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
11309382|NCT02640157|12507827|FG002|Received Study Drug|Overall Study||157
11309383|NCT02640157|12507825|FG000|Completed Study Drug|Overall Study||225
11309384|NCT02640157|12507826|FG001|Completed Study Drug|Overall Study||112
11309385|NCT02640157|12507827|FG002|Completed Study Drug|Overall Study||154
11309386|NCT02640157|12507825|FG000|Discontinued Study Drug|Overall Study||8
11309387|NCT02640157|12507826|FG001|Discontinued Study Drug|Overall Study||3
11309388|NCT02640157|12507827|FG002|Discontinued Study Drug|Overall Study||3
11309389|NCT02640157|12507825|FG000|COMPLETED|Overall Study||220
11309390|NCT02640157|12507826|FG001|COMPLETED|Overall Study||111
11309391|NCT02640157|12507827|FG002|COMPLETED|Overall Study||147
11309392|NCT02640157|12507825|FG000|NOT COMPLETED|Overall Study||13
11309393|NCT02640157|12507826|FG001|NOT COMPLETED|Overall Study||5
11309394|NCT02640157|12507827|FG002|NOT COMPLETED|Overall Study||10
11309395|NCT02640235|12507838|FG000|STARTED|Overall Study||131
11309396|NCT02640235|12507839|FG001|STARTED|Overall Study||129
11309397|NCT02640235|12507838|FG000|COMPLETED|Overall Study||117
11401771|NCT04081324|12596600|FG002|STARTED|Overall Study||10
11309398|NCT02640235|12507839|FG001|COMPLETED|Overall Study||115
11309399|NCT02640235|12507838|FG000|NOT COMPLETED|Overall Study||14
11309400|NCT02640235|12507839|FG001|NOT COMPLETED|Overall Study||14
11401772|NCT04081324|12596601|FG003|STARTED|Overall Study||10
11309401|NCT02640404|12507847|FG000|STARTED|Overall Study||112
11309402|NCT02640404|12507848|FG001|STARTED|Overall Study||112
11309403|NCT02640404|12507847|FG000|COMPLETED|Overall Study||110
11309404|NCT02640404|12507848|FG001|COMPLETED|Overall Study||112
11309405|NCT02640404|12507847|FG000|NOT COMPLETED|Overall Study||2
11309406|NCT02640404|12507848|FG001|NOT COMPLETED|Overall Study||0
11309407|NCT02640482|12507856|FG000|STARTED|Overall Study||202
11309408|NCT02640482|12507857|FG001|STARTED|Overall Study||100
11309409|NCT02640482|12507856|FG000|COMPLETED|Overall Study||199
11309410|NCT02640482|12507857|FG001|COMPLETED|Overall Study||100
11309411|NCT02640482|12507856|FG000|NOT COMPLETED|Overall Study||3
11309412|NCT02640482|12507857|FG001|NOT COMPLETED|Overall Study||0
11309413|NCT02640547|12507863|FG000|STARTED|Overall Study||394
11309414|NCT02640547|12507863|FG000|COMPLETED|Overall Study||383
11309415|NCT02640547|12507863|FG000|NOT COMPLETED|Overall Study||11
11309416|NCT02640612|12507878|FG000|STARTED|Overall Study||225
11309417|NCT02640612|12507879|FG001|STARTED|Overall Study||103
11309418|NCT02640612|12507880|FG002|STARTED|Overall Study||102
11309419|NCT02640612|12507878|FG000|COMPLETED|Overall Study||203
11309420|NCT02640612|12507879|FG001|COMPLETED|Overall Study||89
11309421|NCT02640612|12507880|FG002|COMPLETED|Overall Study||96
11309422|NCT02640612|12507878|FG000|NOT COMPLETED|Overall Study||22
11309423|NCT02640612|12507879|FG001|NOT COMPLETED|Overall Study||14
11309424|NCT02640612|12507880|FG002|NOT COMPLETED|Overall Study||6
11309425|NCT02640716|12507890|FG000|STARTED|Overall Study||30
11309426|NCT02640716|12507891|FG001|STARTED|Overall Study||30
11309427|NCT02640716|12507890|FG000|Training Completion|Overall Study||27
11309428|NCT02640716|12507891|FG001|Training Completion|Overall Study||27
11309429|NCT02640716|12507890|FG000|COMPLETED|Overall Study||23
11309430|NCT02640716|12507891|FG001|COMPLETED|Overall Study||21
11309431|NCT02640716|12507890|FG000|NOT COMPLETED|Overall Study||7
11309432|NCT02640716|12507891|FG001|NOT COMPLETED|Overall Study||9
11309433|NCT02640755|12507899|FG000|STARTED|Single Dose Period (Day 1 - 8)||3
11309434|NCT02640755|12507900|FG001|STARTED|Single Dose Period (Day 1 - 8)||1
11309435|NCT02640755|12507899|FG000|COMPLETED|Single Dose Period (Day 1 - 8)||3
11309436|NCT02640755|12507900|FG001|COMPLETED|Single Dose Period (Day 1 - 8)||1
11309437|NCT02640755|12507899|FG000|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
11309438|NCT02640755|12507900|FG001|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
11309439|NCT02640755|12507899|FG000|STARTED|Multiple Dose Period (Day 8 - EoS)||3
11309440|NCT02640755|12507900|FG001|STARTED|Multiple Dose Period (Day 8 - EoS)||1
11309441|NCT02640755|12507899|FG000|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
11309442|NCT02640755|12507900|FG001|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0
11309443|NCT02640755|12507899|FG000|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2
11309444|NCT02640755|12507900|FG001|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
11309445|NCT02640807|12507910|FG000|STARTED|Overall Study||9
11309446|NCT02640807|12507911|FG001|STARTED|Overall Study||8
11309447|NCT02640807|12507912|FG002|STARTED|Overall Study||10
11309448|NCT02640807|12507910|FG000|COMPLETED|Overall Study||9
11309449|NCT02640807|12507911|FG001|COMPLETED|Overall Study||8
11309450|NCT02640807|12507912|FG002|COMPLETED|Overall Study||10
11309451|NCT02640807|12507910|FG000|NOT COMPLETED|Overall Study||0
11309452|NCT02640807|12507911|FG001|NOT COMPLETED|Overall Study||0
11309453|NCT02640807|12507912|FG002|NOT COMPLETED|Overall Study||0
11309454|NCT02641067|12507922|FG000|STARTED|Overall Study||8
11309455|NCT02641067|12507923|FG001|STARTED|Overall Study||8
11309456|NCT02641067|12507922|FG000|COMPLETED|Overall Study||8
11309457|NCT02641067|12507923|FG001|COMPLETED|Overall Study||8
11309458|NCT02641067|12507922|FG000|NOT COMPLETED|Overall Study||0
11309459|NCT02641067|12507923|FG001|NOT COMPLETED|Overall Study||0
11309460|NCT02641080|12507931|FG000|STARTED|Overall Study||40
11309461|NCT02641080|12507932|FG001|STARTED|Overall Study||40
11309462|NCT02641080|12507931|FG000|COMPLETED|Overall Study||38
11309463|NCT02641080|12507932|FG001|COMPLETED|Overall Study||33
11309464|NCT02641080|12507931|FG000|NOT COMPLETED|Overall Study||2
11309465|NCT02641080|12507932|FG001|NOT COMPLETED|Overall Study||7
11309466|NCT02641249|12507938|FG000|STARTED|Overall Study||19
11309467|NCT02641249|12507938|FG000|COMPLETED|Overall Study||15
11309468|NCT02641249|12507938|FG000|NOT COMPLETED|Overall Study||4
11309469|NCT02641353|12507943|FG000|STARTED|Overall Study||5
11309470|NCT02641353|12507944|FG001|STARTED|Overall Study||5
11309471|NCT02641353|12507945|FG002|STARTED|Overall Study||6
11309472|NCT02641353|12507946|FG003|STARTED|Overall Study||6
11309473|NCT02641353|12507947|FG004|STARTED|Overall Study||6
11309474|NCT02641353|12507948|FG005|STARTED|Overall Study||6
11309475|NCT02641353|12507943|FG000|COMPLETED|Overall Study||5
11309476|NCT02641353|12507944|FG001|COMPLETED|Overall Study||5
11309477|NCT02641353|12507945|FG002|COMPLETED|Overall Study||6
11309478|NCT02641353|12507946|FG003|COMPLETED|Overall Study||6
11309479|NCT02641353|12507947|FG004|COMPLETED|Overall Study||6
11309480|NCT02641353|12507948|FG005|COMPLETED|Overall Study||6
11309481|NCT02641353|12507943|FG000|NOT COMPLETED|Overall Study||0
11309482|NCT02641353|12507944|FG001|NOT COMPLETED|Overall Study||0
11309483|NCT02641353|12507945|FG002|NOT COMPLETED|Overall Study||0
11309484|NCT02641353|12507946|FG003|NOT COMPLETED|Overall Study||0
11309485|NCT02641353|12507947|FG004|NOT COMPLETED|Overall Study||0
11309486|NCT02641353|12507948|FG005|NOT COMPLETED|Overall Study||0
11309487|NCT02641379|12507970|FG000|STARTED|Overall Study||142
11309488|NCT02641379|12507971|FG001|STARTED|Overall Study||152
11309489|NCT02641379|12507972|FG002|STARTED|Overall Study||78
11309490|NCT02641379|12507973|FG003|STARTED|Overall Study||156
11309491|NCT02641379|12507974|FG004|STARTED|Overall Study||17
11309492|NCT02641379|12507975|FG005|STARTED|Overall Study||36
11309493|NCT02641379|12507976|FG006|STARTED|Overall Study||25
11309494|NCT02641379|12507977|FG007|STARTED|Overall Study||20
11309495|NCT02641379|12507978|FG008|STARTED|Overall Study||42
11309496|NCT02641379|12507979|FG009|STARTED|Overall Study||45
11309497|NCT02641379|12507980|FG010|STARTED|Overall Study||8
11309498|NCT02641379|12507970|FG000|COMPLETED|Overall Study||107
11309499|NCT02641379|12507971|FG001|COMPLETED|Overall Study||101
11309500|NCT02641379|12507972|FG002|COMPLETED|Overall Study||7
11309501|NCT02641379|12507973|FG003|COMPLETED|Overall Study||139
11309502|NCT02641379|12507974|FG004|COMPLETED|Overall Study||0
11309503|NCT02641379|12507975|FG005|COMPLETED|Overall Study||20
11309504|NCT02641379|12507976|FG006|COMPLETED|Overall Study||12
11309505|NCT02641379|12507977|FG007|COMPLETED|Overall Study||1
11309506|NCT02641379|12507978|FG008|COMPLETED|Overall Study||36
11309507|NCT02641379|12507979|FG009|COMPLETED|Overall Study||36
11309508|NCT02641379|12507980|FG010|COMPLETED|Overall Study||0
11309509|NCT02641379|12507970|FG000|NOT COMPLETED|Overall Study||35
11309510|NCT02641379|12507971|FG001|NOT COMPLETED|Overall Study||51
11309511|NCT02641379|12507972|FG002|NOT COMPLETED|Overall Study||71
11309512|NCT02641379|12507973|FG003|NOT COMPLETED|Overall Study||17
11309513|NCT02641379|12507974|FG004|NOT COMPLETED|Overall Study||17
11309514|NCT02641379|12507975|FG005|NOT COMPLETED|Overall Study||16
11309515|NCT02641379|12507976|FG006|NOT COMPLETED|Overall Study||13
11309516|NCT02641379|12507977|FG007|NOT COMPLETED|Overall Study||19
11309517|NCT02641379|12507978|FG008|NOT COMPLETED|Overall Study||6
11309518|NCT02641379|12507979|FG009|NOT COMPLETED|Overall Study||9
11309519|NCT02641379|12507980|FG010|NOT COMPLETED|Overall Study||8
11309520|NCT02641392|12508012|FG000|STARTED|Overall Study||4
11309521|NCT02641392|12508013|FG001|STARTED|Overall Study||13
11309522|NCT02641392|12508014|FG002|STARTED|Overall Study||293
11309523|NCT02641392|12508012|FG000|COMPLETED|Overall Study||0
11309524|NCT02641392|12508013|FG001|COMPLETED|Overall Study||0
11309525|NCT02641392|12508014|FG002|COMPLETED|Overall Study||0
11309526|NCT02641392|12508012|FG000|NOT COMPLETED|Overall Study||4
11309527|NCT02641392|12508013|FG001|NOT COMPLETED|Overall Study||13
11309528|NCT02641392|12508014|FG002|NOT COMPLETED|Overall Study||293
11309529|NCT02641522|12508022|FG000|STARTED|Overall Study||10
11309530|NCT02641522|12508022|FG000|COMPLETED|Overall Study||10
11309531|NCT02641522|12508022|FG000|NOT COMPLETED|Overall Study||0
11309532|NCT02641561|12508030|FG000|STARTED|Overall Study||48
11309533|NCT02641561|12508031|FG001|STARTED|Overall Study||48
11309534|NCT02641561|12508032|FG002|STARTED|Overall Study||48
11309535|NCT02641561|12508033|FG003|STARTED|Overall Study||48
11309536|NCT02641561|12508030|FG000|COMPLETED|Overall Study||48
11309537|NCT02641561|12508031|FG001|COMPLETED|Overall Study||48
11309538|NCT02641561|12508032|FG002|COMPLETED|Overall Study||48
11309539|NCT02641561|12508033|FG003|COMPLETED|Overall Study||48
11309540|NCT02641561|12508030|FG000|NOT COMPLETED|Overall Study||0
11309541|NCT02641561|12508031|FG001|NOT COMPLETED|Overall Study||0
11309542|NCT02641561|12508032|FG002|NOT COMPLETED|Overall Study||0
11309543|NCT02641561|12508033|FG003|NOT COMPLETED|Overall Study||0
11309544|NCT02641587|12508046|FG000|STARTED|Confinement Period||80
11309545|NCT02641587|12508047|FG001|STARTED|Confinement Period||40
11309546|NCT02641587|12508046|FG000|COMPLETED|Confinement Period||77
11309547|NCT02641587|12508047|FG001|COMPLETED|Confinement Period||39
11309548|NCT02641587|12508046|FG000|NOT COMPLETED|Confinement Period||3
11309549|NCT02641587|12508047|FG001|NOT COMPLETED|Confinement Period||1
11309550|NCT02641587|12508046|FG000|STARTED|Ambulatory Period||77
11022161|NCT00808028|12200434|FG000|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
11022162|NCT00808028|12200435|FG001|STARTED|Stage 2 (Followed up to 48 Months )||0
11022163|NCT00808028|12200436|FG002|STARTED|Stage 2 (Followed up to 48 Months )||170
11022164|NCT00808028|12200437|FG003|STARTED|Stage 2 (Followed up to 48 Months )||151
11022165|NCT00808028|12200434|FG000|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
11309551|NCT02641587|12508047|FG001|STARTED|Ambulatory Period||39
11309552|NCT02641587|12508046|FG000|COMPLETED|Ambulatory Period||76
11309553|NCT02641587|12508047|FG001|COMPLETED|Ambulatory Period||39
11309554|NCT02641587|12508046|FG000|NOT COMPLETED|Ambulatory Period||1
11309555|NCT02641587|12508047|FG001|NOT COMPLETED|Ambulatory Period||0
11309556|NCT02641691|12508060|FG000|STARTED|Overall Study||20
11309557|NCT02641691|12508060|FG000|COMPLETED|Overall Study||20
11309558|NCT02641691|12508060|FG000|NOT COMPLETED|Overall Study||0
11309559|NCT02641730|12508073|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||53
11309560|NCT02641730|12508074|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||0
11309561|NCT02641730|12508075|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||0
11309562|NCT02641730|12508076|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||54
11309563|NCT02641730|12508077|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||52
11309564|NCT02641730|12508073|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51
11309565|NCT02641730|12508074|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
11309566|NCT02641730|12508075|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
11309567|NCT02641730|12508076|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53
11309568|NCT02641730|12508077|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50
11309569|NCT02641730|12508073|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
11309570|NCT02641730|12508074|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
11309571|NCT02641730|12508075|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
11309572|NCT02641730|12508076|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1
11309573|NCT02641730|12508077|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
11309574|NCT02641730|12508073|FG000|STARTED|After Controlled Period (Week 16 - 52)||0
11309575|NCT02641730|12508074|FG001|STARTED|After Controlled Period (Week 16 - 52)||25
11309576|NCT02641730|12508075|FG002|STARTED|After Controlled Period (Week 16 - 52)||26
11309577|NCT02641730|12508076|FG003|STARTED|After Controlled Period (Week 16 - 52)||53
11401773|NCT04081324|12596598|FG000|Received At Least One Dose of Study Drug|Overall Study||6
11401774|NCT04081324|12596599|FG001|Received At Least One Dose of Study Drug|Overall Study||10
11401775|NCT04081324|12596600|FG002|Received At Least One Dose of Study Drug|Overall Study||10
11401776|NCT04081324|12596601|FG003|Received At Least One Dose of Study Drug|Overall Study||10
11401777|NCT04081324|12596598|FG000|COMPLETED|Overall Study||6
11401778|NCT04081324|12596599|FG001|COMPLETED|Overall Study||10
11401779|NCT04081324|12596600|FG002|COMPLETED|Overall Study||10
11401780|NCT04081324|12596601|FG003|COMPLETED|Overall Study||10
11401781|NCT04081324|12596598|FG000|NOT COMPLETED|Overall Study||0
11022166|NCT00808028|12200435|FG001|COMPLETED|Stage 2 (Followed up to 48 Months )||0
11022167|NCT00808028|12200436|FG002|COMPLETED|Stage 2 (Followed up to 48 Months )||141
11401782|NCT04081324|12596599|FG001|NOT COMPLETED|Overall Study||0
11309578|NCT02641730|12508077|FG004|STARTED|After Controlled Period (Week 16 - 52)||50
11309579|NCT02641730|12508073|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0
11309580|NCT02641730|12508074|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||21
11309581|NCT02641730|12508075|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||24
11309582|NCT02641730|12508076|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||45
11309583|NCT02641730|12508077|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||44
11309584|NCT02641730|12508073|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
11309585|NCT02641730|12508074|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||4
11309586|NCT02641730|12508075|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||2
11309587|NCT02641730|12508076|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||8
11309588|NCT02641730|12508077|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||6
11309589|NCT02641730|12508073|FG000|STARTED|Observational Period (Week 60 - Week 84)||0
11309590|NCT02641730|12508074|FG001|STARTED|Observational Period (Week 60 - Week 84)||21
11309591|NCT02641730|12508075|FG002|STARTED|Observational Period (Week 60 - Week 84)||24
11309592|NCT02641730|12508076|FG003|STARTED|Observational Period (Week 60 - Week 84)||45
11309593|NCT02641730|12508077|FG004|STARTED|Observational Period (Week 60 - Week 84)||44
11309594|NCT02641730|12508073|FG000|COMPLETED|Observational Period (Week 60 - Week 84)||0
11309595|NCT02641730|12508074|FG001|COMPLETED|Observational Period (Week 60 - Week 84)||21
11309596|NCT02641730|12508075|FG002|COMPLETED|Observational Period (Week 60 - Week 84)||24
11309597|NCT02641730|12508076|FG003|COMPLETED|Observational Period (Week 60 - Week 84)||45
11309598|NCT02641730|12508077|FG004|COMPLETED|Observational Period (Week 60 - Week 84)||43
11309599|NCT02641730|12508073|FG000|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
11309600|NCT02641730|12508074|FG001|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
11309601|NCT02641730|12508075|FG002|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
11309602|NCT02641730|12508076|FG003|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
11309603|NCT02641730|12508077|FG004|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1
11309604|NCT02641834|12508093|FG000|STARTED|Overall Study||60
11309605|NCT02641834|12508094|FG001|STARTED|Overall Study||58
11309606|NCT02641834|12508093|FG000|COMPLETED|Overall Study||50
11309607|NCT02641834|12508094|FG001|COMPLETED|Overall Study||50
11309608|NCT02641834|12508093|FG000|NOT COMPLETED|Overall Study||10
11309609|NCT02641834|12508094|FG001|NOT COMPLETED|Overall Study||8
11309610|NCT02641912|12508103|FG000|STARTED|Overall Study||53
11309611|NCT02641912|12508104|FG001|STARTED|Overall Study||47
11309612|NCT02641912|12508103|FG000|COMPLETED|Overall Study||53
11309613|NCT02641912|12508104|FG001|COMPLETED|Overall Study||47
11309614|NCT02641912|12508103|FG000|NOT COMPLETED|Overall Study||0
11309615|NCT02641912|12508104|FG001|NOT COMPLETED|Overall Study||0
11309616|NCT02642159|12508116|FG000|STARTED|Overall Study|Randomized|276
11309617|NCT02642159|12508117|FG001|STARTED|Overall Study|Randomized|137
11309618|NCT02642159|12508116|FG000|Treated (Safety Population)|Overall Study||275
11309619|NCT02642159|12508117|FG001|Treated (Safety Population)|Overall Study||137
11309620|NCT02642159|12508116|FG000|ITT Population|Overall Study||273
11309621|NCT02642159|12508117|FG001|ITT Population|Overall Study||136
11309622|NCT02642159|12508116|FG000|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only 'intended to prescribe' in the Alirocumab arm but not actually administered.|47
11309623|NCT02642159|12508117|FG001|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
11309624|NCT02642159|12508116|FG000|COMPLETED|Overall Study||245
11309625|NCT02642159|12508117|FG001|COMPLETED|Overall Study||129
11309626|NCT02642159|12508116|FG000|NOT COMPLETED|Overall Study||31
11309627|NCT02642159|12508117|FG001|NOT COMPLETED|Overall Study||8
11309628|NCT02642237|12508126|FG000|STARTED|Overall Study||15
11309629|NCT02642237|12508127|FG001|STARTED|Overall Study||15
11309630|NCT02642237|12508126|FG000|COMPLETED|Overall Study||15
11309631|NCT02642237|12508127|FG001|COMPLETED|Overall Study||15
11309632|NCT02642237|12508126|FG000|NOT COMPLETED|Overall Study||0
11309633|NCT02642237|12508127|FG001|NOT COMPLETED|Overall Study||0
11309634|NCT02642393|12508135|FG000|STARTED|Overall Study||149
11309635|NCT02642393|12508136|FG001|STARTED|Overall Study||149
11309636|NCT02642393|12508135|FG000|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 31; In-person off-drug:13; By telephone off-drug: 6"|50
11309637|NCT02642393|12508136|FG001|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 40; In-person off-drug: 16; By telephone off-drug: 1"|57
11309638|NCT02642393|12508135|FG000|NOT COMPLETED|Overall Study||99
11309639|NCT02642393|12508136|FG001|NOT COMPLETED|Overall Study||92
11309640|NCT02642432|12508142|FG000|STARTED|Overall Study||146
11309641|NCT02642432|12508142|FG000|COMPLETED|Overall Study||138
11309642|NCT02642432|12508142|FG000|NOT COMPLETED|Overall Study||8
11309643|NCT02642536|12508148|FG000|STARTED|Overall Study||21
11309644|NCT02642536|12508149|FG001|STARTED|Overall Study||23
11309645|NCT02642536|12508148|FG000|COMPLETED|Overall Study||19
11309646|NCT02642536|12508149|FG001|COMPLETED|Overall Study||18
11309647|NCT02642536|12508148|FG000|NOT COMPLETED|Overall Study||2
11309648|NCT02642536|12508149|FG001|NOT COMPLETED|Overall Study||5
11342097|NCT02941614|12539622|FG000|NOT COMPLETED|Overall Study||141
11342098|NCT02941614|12539623|FG001|NOT COMPLETED|Overall Study||246
11342099|NCT02941627|12539631|FG000|STARTED|Overall Study|Among 53 patients enrolled: 1 passed away after the informed consent completion, 1 was not implanted for surgical failure, and 1 for cholesteatoma discovered during surgical procedure. This last patient was included in safety analysis as defined in the protocol. Therefore, among 53 patients enrolled 51 were evaluated for safety outcomes, and 50 were successfully implanted and complete the study.|53
11342100|NCT02941627|12539631|FG000|Clinical Safety on Overall Participants|Overall Study||51
11342101|NCT02941627|12539631|FG000|Clinical Efficiency on English Speaking Participants|Overall Study|Among the 50 patients successfully implanted 33 English speaking participant complete speech performance measure.|33
11342102|NCT02941627|12539631|FG000|COMPLETED|Overall Study||50
11342103|NCT02941627|12539631|FG000|NOT COMPLETED|Overall Study||3
11342104|NCT02941640|12539645|FG000|STARTED|Overall Study||30
11342105|NCT02941640|12539646|FG001|STARTED|Overall Study||30
11342106|NCT02941640|12539647|FG002|STARTED|Overall Study||30
11342107|NCT02941640|12539648|FG003|STARTED|Overall Study||30
11342108|NCT02941640|12539645|FG000|COMPLETED|Overall Study||30
11342109|NCT02941640|12539646|FG001|COMPLETED|Overall Study||30
11342110|NCT02941640|12539647|FG002|COMPLETED|Overall Study||30
11342111|NCT02941640|12539648|FG003|COMPLETED|Overall Study||30
11342112|NCT02941640|12539645|FG000|NOT COMPLETED|Overall Study||0
11342113|NCT02941640|12539646|FG001|NOT COMPLETED|Overall Study||0
11342114|NCT02941640|12539647|FG002|NOT COMPLETED|Overall Study||0
11342115|NCT02941640|12539648|FG003|NOT COMPLETED|Overall Study||0
11342116|NCT02941692|12539660|FG000|STARTED|Overall Study||32
11342117|NCT02941692|12539661|FG001|STARTED|Overall Study||34
11342118|NCT02941692|12539660|FG000|COMPLETED|Overall Study||32
11342119|NCT02941692|12539661|FG001|COMPLETED|Overall Study||34
11342120|NCT02941692|12539660|FG000|NOT COMPLETED|Overall Study||0
11342121|NCT02941692|12539661|FG001|NOT COMPLETED|Overall Study||0
11342122|NCT02942160|12539667|FG000|STARTED|Overall Study|Observation Phase prior to open-label treatment phase|259
11342123|NCT02942160|12539667|FG000|EN3835-202 Participants|Overall Study|Observation Phase Completed|222
11342124|NCT02942160|12539667|FG000|EN3835 Treated Subjects in EN3835-202|Overall Study|EN3835 Treated Participants in EN3835-202 Started|200
11342125|NCT02942160|12539667|FG000|COMPLETED|Overall Study|EN3835 Treated Participants in EN3835-202 Completed|156
11342126|NCT02942160|12539667|FG000|NOT COMPLETED|Overall Study||103
11342127|NCT02942264|12539684|FG000|STARTED|Phase 1 MTD Finding Stage||6
11342128|NCT02942264|12539685|FG001|STARTED|Phase 1 MTD Finding Stage||13
11342129|NCT02942264|12539686|FG002|STARTED|Phase 1 MTD Finding Stage||3
11342130|NCT02942264|12539687|FG003|STARTED|Phase 1 MTD Finding Stage||6
11342131|NCT02942264|12539688|FG004|STARTED|Phase 1 MTD Finding Stage||3
11342132|NCT02942264|12539689|FG005|STARTED|Phase 1 MTD Finding Stage||2
11342133|NCT02942264|12539690|FG006|STARTED|Phase 1 MTD Finding Stage||7
11342134|NCT02942264|12539691|FG007|STARTED|Phase 1 MTD Finding Stage||0
11342135|NCT02942264|12539692|FG008|STARTED|Phase 1 MTD Finding Stage||0
11342136|NCT02942264|12539684|FG000|COMPLETED|Phase 1 MTD Finding Stage||6
11342137|NCT02942264|12539685|FG001|COMPLETED|Phase 1 MTD Finding Stage||12
11342138|NCT02942264|12539686|FG002|COMPLETED|Phase 1 MTD Finding Stage||3
11342139|NCT02942264|12539687|FG003|COMPLETED|Phase 1 MTD Finding Stage||6
11342140|NCT02942264|12539688|FG004|COMPLETED|Phase 1 MTD Finding Stage||3
11342141|NCT02942264|12539689|FG005|COMPLETED|Phase 1 MTD Finding Stage||2
11342142|NCT02942264|12539690|FG006|COMPLETED|Phase 1 MTD Finding Stage||6
11342143|NCT02942264|12539691|FG007|COMPLETED|Phase 1 MTD Finding Stage||0
11342144|NCT02942264|12539692|FG008|COMPLETED|Phase 1 MTD Finding Stage||0
11342145|NCT02942264|12539684|FG000|NOT COMPLETED|Phase 1 MTD Finding Stage||0
11342146|NCT02942264|12539685|FG001|NOT COMPLETED|Phase 1 MTD Finding Stage||1
11342147|NCT02942264|12539686|FG002|NOT COMPLETED|Phase 1 MTD Finding Stage||0
11342148|NCT02942264|12539687|FG003|NOT COMPLETED|Phase 1 MTD Finding Stage||0
11342149|NCT02942264|12539688|FG004|NOT COMPLETED|Phase 1 MTD Finding Stage||0
11342150|NCT02942264|12539689|FG005|NOT COMPLETED|Phase 1 MTD Finding Stage||0
11342151|NCT02942264|12539690|FG006|NOT COMPLETED|Phase 1 MTD Finding Stage||1
11342152|NCT02942264|12539691|FG007|NOT COMPLETED|Phase 1 MTD Finding Stage||0
11342153|NCT02942264|12539692|FG008|NOT COMPLETED|Phase 1 MTD Finding Stage||0
11342154|NCT02942264|12539684|FG000|STARTED|Phase 1 Cohort Expansion Stage||0
11342155|NCT02942264|12539685|FG001|STARTED|Phase 1 Cohort Expansion Stage||0
11342156|NCT02942264|12539686|FG002|STARTED|Phase 1 Cohort Expansion Stage||0
11342157|NCT02942264|12539687|FG003|STARTED|Phase 1 Cohort Expansion Stage||0
11342158|NCT02942264|12539688|FG004|STARTED|Phase 1 Cohort Expansion Stage||0
11342159|NCT02942264|12539689|FG005|STARTED|Phase 1 Cohort Expansion Stage||0
11342160|NCT02942264|12539690|FG006|STARTED|Phase 1 Cohort Expansion Stage||0
11342161|NCT02942264|12539691|FG007|STARTED|Phase 1 Cohort Expansion Stage||6
11342162|NCT02942264|12539692|FG008|STARTED|Phase 1 Cohort Expansion Stage||7
11342163|NCT02942264|12539684|FG000|COMPLETED|Phase 1 Cohort Expansion Stage||0
11342164|NCT02942264|12539685|FG001|COMPLETED|Phase 1 Cohort Expansion Stage||0
11342165|NCT02942264|12539686|FG002|COMPLETED|Phase 1 Cohort Expansion Stage||0
11401783|NCT04081324|12596600|FG002|NOT COMPLETED|Overall Study||0
11309649|NCT02642575|12508155|FG000|STARTED|Overall Study||67
11309650|NCT02642575|12508155|FG000|COMPLETED|Overall Study||67
11309651|NCT02642575|12508155|FG000|NOT COMPLETED|Overall Study||0
11309652|NCT02642614|12508163|FG000|STARTED|Overall Study||30
11309653|NCT02642614|12508164|FG001|STARTED|Overall Study||30
11309654|NCT02642614|12508165|FG002|STARTED|Overall Study||30
11309655|NCT02642614|12508166|FG003|STARTED|Overall Study||30
11309656|NCT02642614|12508163|FG000|COMPLETED|Overall Study||27
11309657|NCT02642614|12508164|FG001|COMPLETED|Overall Study||28
11309658|NCT02642614|12508165|FG002|COMPLETED|Overall Study||28
11309659|NCT02642614|12508166|FG003|COMPLETED|Overall Study||28
11309660|NCT02642614|12508163|FG000|NOT COMPLETED|Overall Study||3
11309661|NCT02642614|12508164|FG001|NOT COMPLETED|Overall Study||2
11309662|NCT02642614|12508165|FG002|NOT COMPLETED|Overall Study||2
11309663|NCT02642614|12508166|FG003|NOT COMPLETED|Overall Study||2
11309664|NCT02642627|12508179|FG000|STARTED|Overall Study||42
11309665|NCT02642627|12508179|FG000|COMPLETED|Overall Study||39
11309666|NCT02642627|12508179|FG000|NOT COMPLETED|Overall Study||3
11309667|NCT02642653|12508186|FG000|STARTED|Overall Study||14
11309668|NCT02642653|12508187|FG001|STARTED|Overall Study||16
11309669|NCT02642653|12508186|FG000|COMPLETED|Overall Study||12
11309670|NCT02642653|12508187|FG001|COMPLETED|Overall Study||16
11309671|NCT02642653|12508186|FG000|NOT COMPLETED|Overall Study||2
11309672|NCT02642653|12508187|FG001|NOT COMPLETED|Overall Study||0
11309673|NCT02642679|12508193|FG000|STARTED|Overall Study||19
11309674|NCT02642679|12508193|FG000|COMPLETED|Overall Study||16
11309675|NCT02642679|12508193|FG000|NOT COMPLETED|Overall Study||3
11309676|NCT02642835|12508197|FG000|STARTED|Overall Study||48
11309677|NCT02642835|12508197|FG000|COMPLETED|Overall Study||48
11309678|NCT02642835|12508197|FG000|NOT COMPLETED|Overall Study||0
11309679|NCT02642952|12508203|FG000|STARTED|Overall Study||21
11309680|NCT02642952|12508204|FG001|STARTED|Overall Study||30
11309681|NCT02642952|12508203|FG000|COMPLETED|Overall Study||19
11309682|NCT02642952|12508204|FG001|COMPLETED|Overall Study||25
11309683|NCT02642952|12508203|FG000|NOT COMPLETED|Overall Study||2
11309684|NCT02642952|12508204|FG001|NOT COMPLETED|Overall Study||5
11309685|NCT02642991|12508210|FG000|STARTED|First Intervention||22
11309686|NCT02642991|12508211|FG001|STARTED|First Intervention||22
11309687|NCT02642991|12508210|FG000|COMPLETED|First Intervention||22
11309688|NCT02642991|12508211|FG001|COMPLETED|First Intervention||22
11309689|NCT02642991|12508210|FG000|NOT COMPLETED|First Intervention||0
11309690|NCT02642991|12508211|FG001|NOT COMPLETED|First Intervention||0
11309691|NCT02642991|12508210|FG000|STARTED|Second Intervention||22
11309692|NCT02642991|12508211|FG001|STARTED|Second Intervention||22
11309693|NCT02642991|12508210|FG000|COMPLETED|Second Intervention||22
11309694|NCT02642991|12508211|FG001|COMPLETED|Second Intervention||22
11309695|NCT02642991|12508210|FG000|NOT COMPLETED|Second Intervention||0
11309696|NCT02642991|12508211|FG001|NOT COMPLETED|Second Intervention||0
11309697|NCT02643004|12508220|FG000|STARTED|First Intervention (One Week)||35
11309698|NCT02643004|12508221|FG001|STARTED|First Intervention (One Week)||35
11309699|NCT02643004|12508220|FG000|COMPLETED|First Intervention (One Week)||35
11309700|NCT02643004|12508221|FG001|COMPLETED|First Intervention (One Week)||35
11309701|NCT02643004|12508220|FG000|NOT COMPLETED|First Intervention (One Week)||0
11309702|NCT02643004|12508221|FG001|NOT COMPLETED|First Intervention (One Week)||0
11309703|NCT02643004|12508220|FG000|STARTED|Second Intervention (One Week)||35
11309704|NCT02643004|12508221|FG001|STARTED|Second Intervention (One Week)||35
11309705|NCT02643004|12508220|FG000|COMPLETED|Second Intervention (One Week)||35
11309706|NCT02643004|12508221|FG001|COMPLETED|Second Intervention (One Week)||35
11309707|NCT02643004|12508220|FG000|NOT COMPLETED|Second Intervention (One Week)||0
11309708|NCT02643004|12508221|FG001|NOT COMPLETED|Second Intervention (One Week)||0
11309709|NCT02643082|12508227|FG000|STARTED|Period 1||10
11309710|NCT02643082|12508228|FG001|STARTED|Period 1||10
11309711|NCT02643082|12508227|FG000|COMPLETED|Period 1||9
11309712|NCT02643082|12508228|FG001|COMPLETED|Period 1||10
11309713|NCT02643082|12508227|FG000|NOT COMPLETED|Period 1||1
11309714|NCT02643082|12508228|FG001|NOT COMPLETED|Period 1||0
11309715|NCT02643082|12508227|FG000|STARTED|Washout||9
11309716|NCT02643082|12508228|FG001|STARTED|Washout||10
11309717|NCT02643082|12508227|FG000|COMPLETED|Washout||9
11309718|NCT02643082|12508228|FG001|COMPLETED|Washout||10
11309719|NCT02643082|12508227|FG000|NOT COMPLETED|Washout||0
11309720|NCT02643082|12508228|FG001|NOT COMPLETED|Washout||0
11309721|NCT02643082|12508227|FG000|STARTED|Period 2||9
11309722|NCT02643082|12508228|FG001|STARTED|Period 2||10
11309723|NCT02643082|12508227|FG000|COMPLETED|Period 2||9
11309724|NCT02643082|12508228|FG001|COMPLETED|Period 2||10
11309725|NCT02643082|12508227|FG000|NOT COMPLETED|Period 2||0
11309726|NCT02643082|12508228|FG001|NOT COMPLETED|Period 2||0
11309727|NCT02643095|12508235|FG000|STARTED|Overall Study||22
11309728|NCT02643095|12508235|FG000|COMPLETED|Overall Study||21
11309729|NCT02643095|12508235|FG000|NOT COMPLETED|Overall Study||1
11309730|NCT02643199|12508239|FG000|STARTED|Overall Study||90
11309731|NCT02643199|12508239|FG000|COMPLETED|Overall Study||90
11309732|NCT02643199|12508239|FG000|NOT COMPLETED|Overall Study||0
11309733|NCT02643225|12508245|FG000|STARTED|Overall Study||40
11309734|NCT02643225|12508246|FG001|STARTED|Overall Study||40
11309735|NCT02643225|12508245|FG000|COMPLETED|Overall Study||40
11309736|NCT02643225|12508246|FG001|COMPLETED|Overall Study||40
11309737|NCT02643225|12508245|FG000|NOT COMPLETED|Overall Study||0
11309738|NCT02643225|12508246|FG001|NOT COMPLETED|Overall Study||0
11309739|NCT02643251|12508255|FG000|STARTED|Overall Study||69
11309740|NCT02643251|12508256|FG001|STARTED|Overall Study||69
11309741|NCT02643251|12508255|FG000|COMPLETED|Overall Study||58
11309742|NCT02643251|12508256|FG001|COMPLETED|Overall Study||67
11309743|NCT02643251|12508255|FG000|NOT COMPLETED|Overall Study||11
11309744|NCT02643251|12508256|FG001|NOT COMPLETED|Overall Study||2
11309745|NCT02643355|12508264|FG000|STARTED|Overall Study||34
11309746|NCT02643355|12508265|FG001|STARTED|Overall Study||35
11309747|NCT02643355|12508264|FG000|COMPLETED|Overall Study||33
11309748|NCT02643355|12508265|FG001|COMPLETED|Overall Study||30
11309749|NCT02643355|12508264|FG000|NOT COMPLETED|Overall Study||1
11309750|NCT02643355|12508265|FG001|NOT COMPLETED|Overall Study||5
11309751|NCT02643394|12508273|FG000|STARTED|Overall Study||55
11309752|NCT02643394|12508274|FG001|STARTED|Overall Study||55
11309753|NCT02643394|12508273|FG000|COMPLETED|Overall Study||51
11309754|NCT02643394|12508274|FG001|COMPLETED|Overall Study||50
11309755|NCT02643394|12508273|FG000|NOT COMPLETED|Overall Study||4
11309756|NCT02643394|12508274|FG001|NOT COMPLETED|Overall Study||5
11309757|NCT02643459|12508282|FG000|STARTED|Overall Study||7901
11022168|NCT00808028|12200437|FG003|COMPLETED|Stage 2 (Followed up to 48 Months )||128
11022169|NCT00808028|12200434|FG000|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
11022170|NCT00808028|12200435|FG001|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
11022171|NCT00808028|12200436|FG002|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
11022172|NCT00808028|12200437|FG003|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
11022173|NCT00808067|12200459|FG000|STARTED|Overall Study|Number of patients which are treated.|2927
11022174|NCT00808067|12200460|FG001|STARTED|Overall Study|Number of patients which are treated.|2956
11022175|NCT00808067|12200459|FG000|COMPLETED|Overall Study||2446
11022176|NCT00808067|12200460|FG001|COMPLETED|Overall Study||2438
11022177|NCT00808067|12200459|FG000|NOT COMPLETED|Overall Study||481
11022178|NCT00808067|12200460|FG001|NOT COMPLETED|Overall Study||518
11022179|NCT00808132|12200471|FG000|STARTED|Overall Study||455
11022180|NCT00808132|12200472|FG001|STARTED|Overall Study||481
11022181|NCT00808132|12200473|FG002|STARTED|Overall Study||239
11022182|NCT00808132|12200474|FG003|STARTED|Overall Study||228
11022183|NCT00808132|12200475|FG004|STARTED|Overall Study||483
11022184|NCT00808132|12200471|FG000|Treated|Overall Study||445
11022185|NCT00808132|12200472|FG001|Treated|Overall Study||474
11309758|NCT02643459|12508283|FG001|STARTED|Overall Study||8900
11309759|NCT02643459|12508282|FG000|COMPLETED|Overall Study||7901
11309760|NCT02643459|12508283|FG001|COMPLETED|Overall Study||8900
11309761|NCT02643459|12508282|FG000|NOT COMPLETED|Overall Study||0
11309762|NCT02643459|12508283|FG001|NOT COMPLETED|Overall Study||0
11309763|NCT02643472|12508292|FG000|STARTED|Overall Study||150
11309764|NCT02643472|12508293|FG001|STARTED|Overall Study||150
11309765|NCT02643472|12508292|FG000|COMPLETED|Overall Study||123
11309766|NCT02643472|12508293|FG001|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116
11309767|NCT02643472|12508292|FG000|NOT COMPLETED|Overall Study||27
11309768|NCT02643472|12508293|FG001|NOT COMPLETED|Overall Study||34
11309769|NCT02643615|12508303|FG000|STARTED|Overall Study||9
11309770|NCT02643615|12508304|FG001|STARTED|Overall Study||11
11309771|NCT02643615|12508303|FG000|COMPLETED|Overall Study||9
11309772|NCT02643615|12508304|FG001|COMPLETED|Overall Study||11
11309773|NCT02643615|12508303|FG000|NOT COMPLETED|Overall Study||0
11309774|NCT02643615|12508304|FG001|NOT COMPLETED|Overall Study||0
11309775|NCT02643628|12508313|FG000|STARTED|Overall Study||21
11309776|NCT02643628|12508314|FG001|STARTED|Overall Study||23
11309777|NCT02643628|12508313|FG000|COMPLETED|Overall Study||20
11309778|NCT02643628|12508314|FG001|COMPLETED|Overall Study||17
11309779|NCT02643628|12508313|FG000|NOT COMPLETED|Overall Study||1
11309780|NCT02643628|12508314|FG001|NOT COMPLETED|Overall Study||6
11309781|NCT02643693|12508322|FG000|STARTED|Overall Study||4
11309782|NCT02643693|12508323|FG001|STARTED|Overall Study||4
11309783|NCT02643693|12508324|FG002|STARTED|Overall Study||4
11309784|NCT02643693|12508325|FG003|STARTED|Overall Study||4
11309785|NCT02643693|12508326|FG004|STARTED|Overall Study||4
11309786|NCT02643693|12508327|FG005|STARTED|Overall Study||4
11309787|NCT02643693|12508322|FG000|COMPLETED|Overall Study||2
11309788|NCT02643693|12508323|FG001|COMPLETED|Overall Study||2
11309789|NCT02643693|12508324|FG002|COMPLETED|Overall Study||3
11309790|NCT02643693|12508325|FG003|COMPLETED|Overall Study||4
11309791|NCT02643693|12508326|FG004|COMPLETED|Overall Study||4
11309792|NCT02643693|12508327|FG005|COMPLETED|Overall Study||3
11309793|NCT02643693|12508322|FG000|NOT COMPLETED|Overall Study||2
11309794|NCT02643693|12508323|FG001|NOT COMPLETED|Overall Study||2
11309795|NCT02643693|12508324|FG002|NOT COMPLETED|Overall Study||1
11309796|NCT02643693|12508325|FG003|NOT COMPLETED|Overall Study||0
11309797|NCT02643693|12508326|FG004|NOT COMPLETED|Overall Study||0
11309798|NCT02643693|12508327|FG005|NOT COMPLETED|Overall Study||1
11309799|NCT02643849|12508335|FG000|STARTED|Overall Study||107
11309800|NCT02643849|12508335|FG000|COMPLETED|Overall Study||82
11309801|NCT02643849|12508335|FG000|NOT COMPLETED|Overall Study||25
11309802|NCT02643862|12508341|FG000|STARTED|Overall Study||36
11309803|NCT02643862|12508342|FG001|STARTED|Overall Study||12
11309804|NCT02643862|12508341|FG000|COMPLETED|Overall Study||36
11309805|NCT02643862|12508342|FG001|COMPLETED|Overall Study||12
11309806|NCT02643862|12508341|FG000|NOT COMPLETED|Overall Study||0
11309807|NCT02643862|12508342|FG001|NOT COMPLETED|Overall Study||0
11309808|NCT02643875|12508348|FG000|STARTED|Overall Study||36
11309809|NCT02643875|12508348|FG000|Received 0.75|Overall Study||36
11309810|NCT02643875|12508348|FG000|Received 1.75 D|Overall Study||36
11309811|NCT02643875|12508348|FG000|COMPLETED|Overall Study||28
11309812|NCT02643875|12508348|FG000|NOT COMPLETED|Overall Study||8
11309813|NCT02643979|12508355|FG000|STARTED|Overall Study||11
11309814|NCT02643979|12508356|FG001|STARTED|Overall Study||11
11309815|NCT02643979|12508355|FG000|COMPLETED|Overall Study||11
11309816|NCT02643979|12508356|FG001|COMPLETED|Overall Study||11
11309817|NCT02643979|12508355|FG000|NOT COMPLETED|Overall Study||0
11309818|NCT02643979|12508356|FG001|NOT COMPLETED|Overall Study||0
11309819|NCT02644096|12508364|FG000|STARTED|Overall Study||93
11309820|NCT02644096|12508365|FG001|STARTED|Overall Study||82
11309821|NCT02644096|12508364|FG000|2 Week Interview|Overall Study|Not done in control group|0
11309822|NCT02644096|12508365|FG001|2 Week Interview|Overall Study||68
11309823|NCT02644096|12508364|FG000|10 Week Interview|Overall Study|Not done in control group|0
11309824|NCT02644096|12508365|FG001|10 Week Interview|Overall Study||59
11309825|NCT02644096|12508364|FG000|12 Week SF-36 Questionnaire|Overall Study||68
11309826|NCT02644096|12508365|FG001|12 Week SF-36 Questionnaire|Overall Study||59
11309827|NCT02644096|12508364|FG000|9 Month SF-36 Questionnaire|Overall Study||65
11309828|NCT02644096|12508365|FG001|9 Month SF-36 Questionnaire|Overall Study||57
11309829|NCT02644096|12508364|FG000|COMPLETED|Overall Study||65
11309830|NCT02644096|12508365|FG001|COMPLETED|Overall Study||57
11309831|NCT02644096|12508364|FG000|NOT COMPLETED|Overall Study||28
11309832|NCT02644096|12508365|FG001|NOT COMPLETED|Overall Study||25
11309833|NCT02644109|12508373|FG000|STARTED|Overall Study||24
11309834|NCT02644109|12508374|FG001|STARTED|Overall Study||28
11309835|NCT02644109|12508373|FG000|COMPLETED|Overall Study||24
11309836|NCT02644109|12508374|FG001|COMPLETED|Overall Study||24
11309837|NCT02644109|12508373|FG000|NOT COMPLETED|Overall Study||0
11309838|NCT02644109|12508374|FG001|NOT COMPLETED|Overall Study||4
11309839|NCT02644122|12508380|FG000|STARTED|Overall Study||1
11309840|NCT02644122|12508380|FG000|COMPLETED|Overall Study||0
11309841|NCT02644122|12508380|FG000|NOT COMPLETED|Overall Study||1
11309842|NCT02644278|12508389|FG000|STARTED|Overall Study||3
11309843|NCT02644278|12508390|FG001|STARTED|Overall Study||3
11309844|NCT02644278|12508391|FG002|STARTED|Overall Study||6
11309845|NCT02644278|12508392|FG003|STARTED|Overall Study||3
11309846|NCT02644278|12508389|FG000|COMPLETED|Overall Study||3
11309847|NCT02644278|12508390|FG001|COMPLETED|Overall Study||3
11309848|NCT02644278|12508391|FG002|COMPLETED|Overall Study||6
11309849|NCT02644278|12508392|FG003|COMPLETED|Overall Study||3
11309850|NCT02644278|12508389|FG000|NOT COMPLETED|Overall Study||0
11309851|NCT02644278|12508390|FG001|NOT COMPLETED|Overall Study||0
11309852|NCT02644278|12508391|FG002|NOT COMPLETED|Overall Study||0
11309853|NCT02644278|12508392|FG003|NOT COMPLETED|Overall Study||0
11309854|NCT02644343|12508402|FG000|STARTED|Overall Study||40
11309855|NCT02644343|12508402|FG000|COMPLETED|Overall Study||39
11309856|NCT02644343|12508402|FG000|NOT COMPLETED|Overall Study||1
11309857|NCT02644356|12508406|FG000|STARTED|Overall Study||51
11309858|NCT02644356|12508406|FG000|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
11309859|NCT02644356|12508406|FG000|NOT COMPLETED|Overall Study||2
11309860|NCT02644668|12508413|FG000|STARTED|Overall Study||26
11309861|NCT02644668|12508414|FG001|STARTED|Overall Study||24
11309862|NCT02644668|12508415|FG002|STARTED|Overall Study||20
11309863|NCT02644668|12508413|FG000|COMPLETED|Overall Study||24
11309864|NCT02644668|12508414|FG001|COMPLETED|Overall Study||24
11309865|NCT02644668|12508415|FG002|COMPLETED|Overall Study||17
11309866|NCT02644668|12508413|FG000|NOT COMPLETED|Overall Study||2
11309867|NCT02644668|12508414|FG001|NOT COMPLETED|Overall Study||0
11309868|NCT02644668|12508415|FG002|NOT COMPLETED|Overall Study||3
11309869|NCT02645019|12508430|FG000|STARTED|Overall Study||13
11309870|NCT02645019|12508431|FG001|STARTED|Overall Study||15
11309871|NCT02645019|12508432|FG002|STARTED|Overall Study||15
11309872|NCT02645019|12508433|FG003|STARTED|Overall Study||33
11309873|NCT02645019|12508434|FG004|STARTED|Overall Study||24
11309874|NCT02645019|12508430|FG000|COMPLETED|Overall Study||13
11309875|NCT02645019|12508431|FG001|COMPLETED|Overall Study||15
11309876|NCT02645019|12508432|FG002|COMPLETED|Overall Study||15
11309877|NCT02645019|12508433|FG003|COMPLETED|Overall Study||33
11309878|NCT02645019|12508434|FG004|COMPLETED|Overall Study||24
11309879|NCT02645019|12508430|FG000|NOT COMPLETED|Overall Study||0
11309880|NCT02645019|12508431|FG001|NOT COMPLETED|Overall Study||0
11309881|NCT02645019|12508432|FG002|NOT COMPLETED|Overall Study||0
11309882|NCT02645019|12508433|FG003|NOT COMPLETED|Overall Study||0
11309883|NCT02645019|12508434|FG004|NOT COMPLETED|Overall Study||0
11309884|NCT02645123|12508449|FG000|STARTED|Overall Study||25
11309885|NCT02645123|12508450|FG001|STARTED|Overall Study||25
11309886|NCT02645123|12508451|FG002|STARTED|Overall Study||25
11309887|NCT02645123|12508449|FG000|COMPLETED|Overall Study||25
11309888|NCT02645123|12508450|FG001|COMPLETED|Overall Study||25
11309889|NCT02645123|12508451|FG002|COMPLETED|Overall Study||25
11309890|NCT02645123|12508449|FG000|NOT COMPLETED|Overall Study||0
11309891|NCT02645123|12508450|FG001|NOT COMPLETED|Overall Study||0
11309892|NCT02645123|12508451|FG002|NOT COMPLETED|Overall Study||0
11309893|NCT02645253|12508463|FG000|STARTED|Overall Study||7
11309894|NCT02645253|12508464|FG001|STARTED|Overall Study||7
11309895|NCT02645253|12508465|FG002|STARTED|Overall Study||7
11309896|NCT02645253|12508466|FG003|STARTED|Overall Study||6
11309897|NCT02645253|12508463|FG000|COMPLETED|Overall Study||7
11309898|NCT02645253|12508464|FG001|COMPLETED|Overall Study||7
11309899|NCT02645253|12508465|FG002|COMPLETED|Overall Study||7
11309900|NCT02645253|12508466|FG003|COMPLETED|Overall Study||6
11309901|NCT02645253|12508463|FG000|NOT COMPLETED|Overall Study||0
11309902|NCT02645253|12508464|FG001|NOT COMPLETED|Overall Study||0
11309903|NCT02645253|12508465|FG002|NOT COMPLETED|Overall Study||0
11309904|NCT02645253|12508466|FG003|NOT COMPLETED|Overall Study||0
11309905|NCT02645409|12508483|FG000|STARTED|Overall Study||14
11309906|NCT02645409|12508484|FG001|STARTED|Overall Study|It was decided to not continue with the Radical Nephrectomy arm of the study.|0
11309907|NCT02645409|12508483|FG000|COMPLETED|Overall Study||10
11309908|NCT02645409|12508484|FG001|COMPLETED|Overall Study||0
11309909|NCT02645409|12508483|FG000|NOT COMPLETED|Overall Study||4
11309910|NCT02645409|12508484|FG001|NOT COMPLETED|Overall Study||0
11309911|NCT02645617|12508489|FG000|STARTED|Overall Study||12
11309912|NCT02645617|12508489|FG000|COMPLETED|Overall Study||12
11309913|NCT02645617|12508489|FG000|NOT COMPLETED|Overall Study||0
11309914|NCT02645760|12508495|FG000|STARTED|Overall Study||19
11309915|NCT02645760|12508496|FG001|STARTED|Overall Study||19
11309916|NCT02645760|12508495|FG000|COMPLETED|Overall Study||19
11309917|NCT02645760|12508496|FG001|COMPLETED|Overall Study||19
11309918|NCT02645760|12508495|FG000|NOT COMPLETED|Overall Study||0
11309919|NCT02645760|12508496|FG001|NOT COMPLETED|Overall Study||0
11309920|NCT02646124|12508505|FG000|STARTED|Overall Study||57
11309921|NCT02646124|12508506|FG001|STARTED|Overall Study||57
11309922|NCT02646124|12508505|FG000|COMPLETED|Overall Study||57
11309923|NCT02646124|12508506|FG001|COMPLETED|Overall Study||55
11309924|NCT02646124|12508505|FG000|NOT COMPLETED|Overall Study||0
11309925|NCT02646124|12508506|FG001|NOT COMPLETED|Overall Study||2
11309926|NCT02646332|12508514|FG000|STARTED|Overall Study||124
11309927|NCT02646332|12508515|FG001|STARTED|Overall Study||124
11309928|NCT02646332|12508514|FG000|COMPLETED|Overall Study||124
11309929|NCT02646332|12508515|FG001|COMPLETED|Overall Study||121
11309930|NCT02646332|12508514|FG000|NOT COMPLETED|Overall Study||0
11309931|NCT02646332|12508515|FG001|NOT COMPLETED|Overall Study||3
11309932|NCT02646371|12508523|FG000|STARTED|Overall Study||34
11309933|NCT02646371|12508524|FG001|STARTED|Overall Study||33
11309934|NCT02646371|12508523|FG000|COMPLETED|Overall Study||34
11309935|NCT02646371|12508524|FG001|COMPLETED|Overall Study||33
11309936|NCT02646371|12508523|FG000|NOT COMPLETED|Overall Study||0
11309937|NCT02646371|12508524|FG001|NOT COMPLETED|Overall Study||0
11309938|NCT02646423|12508532|FG000|STARTED|Overall Study||742
11309939|NCT02646423|12508533|FG001|STARTED|Overall Study||743
11401784|NCT04081324|12596601|FG003|NOT COMPLETED|Overall Study||0
11309940|NCT02646423|12508532|FG000|COMPLETED|Overall Study||735
11309941|NCT02646423|12508533|FG001|COMPLETED|Overall Study||735
11309942|NCT02646423|12508532|FG000|NOT COMPLETED|Overall Study||7
11309943|NCT02646423|12508533|FG001|NOT COMPLETED|Overall Study||8
11309944|NCT02646449|12508541|FG000|STARTED|Overall Study||4
11309945|NCT02646449|12508542|FG001|STARTED|Overall Study||3
11309946|NCT02646449|12508541|FG000|COMPLETED|Overall Study||4
11309947|NCT02646449|12508542|FG001|COMPLETED|Overall Study||3
11309948|NCT02646449|12508541|FG000|NOT COMPLETED|Overall Study||0
11309949|NCT02646449|12508542|FG001|NOT COMPLETED|Overall Study||0
11309950|NCT02646566|12508551|FG000|STARTED|Overall Study||237
11309951|NCT02646566|12508552|FG001|STARTED|Overall Study||230
11309952|NCT02646566|12508553|FG002|STARTED|Overall Study||235
11309953|NCT02646566|12508551|FG000|COMPLETED|Overall Study||231
11309954|NCT02646566|12508552|FG001|COMPLETED|Overall Study||226
11309955|NCT02646566|12508553|FG002|COMPLETED|Overall Study||230
11309956|NCT02646566|12508551|FG000|NOT COMPLETED|Overall Study||6
11309957|NCT02646566|12508552|FG001|NOT COMPLETED|Overall Study||4
11309958|NCT02646566|12508553|FG002|NOT COMPLETED|Overall Study||5
11309959|NCT02646618|12508563|FG000|STARTED|Overall Study||167
11309960|NCT02646618|12508564|FG001|STARTED|Overall Study||162
11309961|NCT02646618|12508563|FG000|6 Month Follow-up|Overall Study||152
11309962|NCT02646618|12508564|FG001|6 Month Follow-up|Overall Study||150
11309963|NCT02646618|12508563|FG000|COMPLETED|Overall Study||157
11309964|NCT02646618|12508564|FG001|COMPLETED|Overall Study||148
11309965|NCT02646618|12508563|FG000|NOT COMPLETED|Overall Study||10
11309966|NCT02646618|12508564|FG001|NOT COMPLETED|Overall Study||14
11309967|NCT02646761|12508574|FG000|STARTED|Overall Study||18
11309968|NCT02646761|12508575|FG001|STARTED|Overall Study||20
11309969|NCT02646761|12508574|FG000|Subject Withdrew Before Baseline|Overall Study||5
11309970|NCT02646761|12508575|FG001|Subject Withdrew Before Baseline|Overall Study||8
11309971|NCT02646761|12508574|FG000|Baseline Assessment|Overall Study||13
11309972|NCT02646761|12508575|FG001|Baseline Assessment|Overall Study||12
11309973|NCT02646761|12508574|FG000|5-week Assessment|Overall Study||12
11309974|NCT02646761|12508575|FG001|5-week Assessment|Overall Study||10
11309975|NCT02646761|12508574|FG000|COMPLETED|Overall Study||10
11309976|NCT02646761|12508575|FG001|COMPLETED|Overall Study||10
11309977|NCT02646761|12508574|FG000|NOT COMPLETED|Overall Study||8
11309978|NCT02646761|12508575|FG001|NOT COMPLETED|Overall Study||10
11309979|NCT02646826|12508585|FG000|STARTED|Overall Study||21
11309980|NCT02646826|12508586|FG001|STARTED|Overall Study||22
11309981|NCT02646826|12508587|FG002|STARTED|Overall Study||21
11309982|NCT02646826|12508588|FG003|STARTED|Overall Study||22
11309983|NCT02646826|12508585|FG000|COMPLETED|Overall Study||19
11309984|NCT02646826|12508586|FG001|COMPLETED|Overall Study||22
11309985|NCT02646826|12508587|FG002|COMPLETED|Overall Study||20
11309986|NCT02646826|12508588|FG003|COMPLETED|Overall Study||21
11309987|NCT02646826|12508585|FG000|NOT COMPLETED|Overall Study||2
11309988|NCT02646826|12508586|FG001|NOT COMPLETED|Overall Study||0
11309989|NCT02646826|12508587|FG002|NOT COMPLETED|Overall Study||1
11309990|NCT02646826|12508588|FG003|NOT COMPLETED|Overall Study||1
11309991|NCT02646891|12508608|FG000|STARTED|Overall Study||6
11309992|NCT02646891|12508609|FG001|STARTED|Overall Study||12
11309993|NCT02646891|12508610|FG002|STARTED|Overall Study||12
11309994|NCT02646891|12508611|FG003|STARTED|Overall Study||6
11309995|NCT02646891|12508612|FG004|STARTED|Overall Study||12
11309996|NCT02646891|12508613|FG005|STARTED|Overall Study||12
11309997|NCT02646891|12508614|FG006|STARTED|Overall Study||139
11309998|NCT02646891|12508615|FG007|STARTED|Overall Study||140
11309999|NCT02646891|12508616|FG008|STARTED|Overall Study||140
11310000|NCT02646891|12508617|FG009|STARTED|Overall Study||139
11310001|NCT02646891|12508608|FG000|Received at Least 1 Dose|Overall Study||6
11401785|NCT04079790|12596614|FG000|STARTED|Part 1, Period 1(Day 1 to Day 4)||14
11310002|NCT02646891|12508609|FG001|Received at Least 1 Dose|Overall Study||12
11310003|NCT02646891|12508610|FG002|Received at Least 1 Dose|Overall Study||12
11310004|NCT02646891|12508611|FG003|Received at Least 1 Dose|Overall Study||6
11310005|NCT02646891|12508612|FG004|Received at Least 1 Dose|Overall Study||12
11310006|NCT02646891|12508613|FG005|Received at Least 1 Dose|Overall Study||12
11401786|NCT04079790|12596615|FG001|STARTED|Part 1, Period 1(Day 1 to Day 4)||2
11401787|NCT04079790|12596616|FG002|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
11401788|NCT04079790|12596617|FG003|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
11310007|NCT02646891|12508614|FG006|Received at Least 1 Dose|Overall Study||139
11310008|NCT02646891|12508615|FG007|Received at Least 1 Dose|Overall Study|One participant was randomized but determined to be ineligible pre-vaccination.|139
11310009|NCT02646891|12508616|FG008|Received at Least 1 Dose|Overall Study||140
11310010|NCT02646891|12508617|FG009|Received at Least 1 Dose|Overall Study||139
11310011|NCT02646891|12508608|FG000|COMPLETED|Overall Study||4
11310012|NCT02646891|12508609|FG001|COMPLETED|Overall Study||11
11310013|NCT02646891|12508610|FG002|COMPLETED|Overall Study||11
11310014|NCT02646891|12508611|FG003|COMPLETED|Overall Study||6
11310015|NCT02646891|12508612|FG004|COMPLETED|Overall Study||12
11310016|NCT02646891|12508613|FG005|COMPLETED|Overall Study||12
11310017|NCT02646891|12508614|FG006|COMPLETED|Overall Study||130
11310018|NCT02646891|12508615|FG007|COMPLETED|Overall Study||127
11310019|NCT02646891|12508616|FG008|COMPLETED|Overall Study||130
11310020|NCT02646891|12508617|FG009|COMPLETED|Overall Study||134
11310021|NCT02646891|12508608|FG000|NOT COMPLETED|Overall Study||2
11310022|NCT02646891|12508609|FG001|NOT COMPLETED|Overall Study||1
11310023|NCT02646891|12508610|FG002|NOT COMPLETED|Overall Study||1
11401789|NCT04079790|12596614|FG000|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||13
11401790|NCT04079790|12596615|FG001|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||2
11401791|NCT04079790|12596616|FG002|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
11401792|NCT04079790|12596617|FG003|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
11401793|NCT04079790|12596614|FG000|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||1
11310024|NCT02646891|12508611|FG003|NOT COMPLETED|Overall Study||0
11310025|NCT02646891|12508612|FG004|NOT COMPLETED|Overall Study||0
11310026|NCT02646891|12508613|FG005|NOT COMPLETED|Overall Study||0
11310027|NCT02646891|12508614|FG006|NOT COMPLETED|Overall Study||9
11310028|NCT02646891|12508615|FG007|NOT COMPLETED|Overall Study||13
11310029|NCT02646891|12508616|FG008|NOT COMPLETED|Overall Study||10
11310030|NCT02646891|12508617|FG009|NOT COMPLETED|Overall Study||5
11310031|NCT02646917|12508653|FG000|STARTED|Overall Study||21
11310032|NCT02646917|12508654|FG001|STARTED|Overall Study||20
11310033|NCT02646917|12508653|FG000|COMPLETED|Overall Study||21
11310034|NCT02646917|12508654|FG001|COMPLETED|Overall Study||20
11310035|NCT02646917|12508653|FG000|NOT COMPLETED|Overall Study||0
11310036|NCT02646917|12508654|FG001|NOT COMPLETED|Overall Study||0
11310037|NCT02647203|12508667|FG000|STARTED|12 Month Follow-up||173
11310038|NCT02647203|12508668|FG001|STARTED|12 Month Follow-up||172
11310039|NCT02647203|12508667|FG000|COMPLETED|12 Month Follow-up||148
11310040|NCT02647203|12508668|FG001|COMPLETED|12 Month Follow-up||149
11310041|NCT02647203|12508667|FG000|NOT COMPLETED|12 Month Follow-up||25
11310042|NCT02647203|12508668|FG001|NOT COMPLETED|12 Month Follow-up||23
11310043|NCT02647203|12508667|FG000|STARTED|24 Month Follow-up||148
11310044|NCT02647203|12508668|FG001|STARTED|24 Month Follow-up||149
11310045|NCT02647203|12508667|FG000|COMPLETED|24 Month Follow-up||142
11310046|NCT02647203|12508668|FG001|COMPLETED|24 Month Follow-up||138
11310047|NCT02647203|12508667|FG000|NOT COMPLETED|24 Month Follow-up||6
11310048|NCT02647203|12508668|FG001|NOT COMPLETED|24 Month Follow-up||11
11310049|NCT02647281|12508683|FG000|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
11310050|NCT02647281|12508684|FG001|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
11310051|NCT02647281|12508685|FG002|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
11310052|NCT02647281|12508686|FG003|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
11310053|NCT02647281|12508687|FG004|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
11310054|NCT02647281|12508688|FG005|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
11310055|NCT02647281|12508689|FG006|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
11310056|NCT02647281|12508690|FG007|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
11310057|NCT02647281|12508691|FG008|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
11310058|NCT02647281|12508683|FG000|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
11310059|NCT02647281|12508684|FG001|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
11310060|NCT02647281|12508685|FG002|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
11310061|NCT02647281|12508686|FG003|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
11310062|NCT02647281|12508687|FG004|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
11310063|NCT02647281|12508688|FG005|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
11310064|NCT02647281|12508689|FG006|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
11310065|NCT02647281|12508690|FG007|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
11310066|NCT02647281|12508691|FG008|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
11310067|NCT02647281|12508683|FG000|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
11310068|NCT02647281|12508684|FG001|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
11310069|NCT02647281|12508685|FG002|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
11310070|NCT02647281|12508686|FG003|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
11310071|NCT02647281|12508687|FG004|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
11401794|NCT04079790|12596615|FG001|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
11401795|NCT04079790|12596616|FG002|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
11401796|NCT04079790|12596617|FG003|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
11310072|NCT02647281|12508688|FG005|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
11310073|NCT02647281|12508689|FG006|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
11310074|NCT02647281|12508690|FG007|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
11310075|NCT02647281|12508691|FG008|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
11310076|NCT02647281|12508683|FG000|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310077|NCT02647281|12508684|FG001|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310078|NCT02647281|12508685|FG002|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310079|NCT02647281|12508686|FG003|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310080|NCT02647281|12508687|FG004|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310081|NCT02647281|12508688|FG005|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
11310082|NCT02647281|12508689|FG006|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
11310083|NCT02647281|12508690|FG007|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
11310084|NCT02647281|12508691|FG008|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
11310085|NCT02647281|12508683|FG000|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310086|NCT02647281|12508684|FG001|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310087|NCT02647281|12508685|FG002|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310088|NCT02647281|12508686|FG003|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310089|NCT02647281|12508687|FG004|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310090|NCT02647281|12508688|FG005|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
11310091|NCT02647281|12508689|FG006|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
11310092|NCT02647281|12508690|FG007|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
11310093|NCT02647281|12508691|FG008|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
11310094|NCT02647281|12508683|FG000|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310095|NCT02647281|12508684|FG001|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310096|NCT02647281|12508685|FG002|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310097|NCT02647281|12508686|FG003|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310098|NCT02647281|12508687|FG004|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310099|NCT02647281|12508688|FG005|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310100|NCT02647281|12508689|FG006|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310101|NCT02647281|12508690|FG007|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
11310102|NCT02647281|12508691|FG008|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
11310103|NCT02647320|12508725|FG000|STARTED|Overall Study||46
11310104|NCT02647320|12508726|FG001|STARTED|Overall Study||46
11310105|NCT02647320|12508727|FG002|STARTED|Overall Study||69
11310106|NCT02647320|12508728|FG003|STARTED|Overall Study||68
11310107|NCT02647320|12508729|FG004|STARTED|Overall Study||69
11310108|NCT02647320|12508725|FG000|Inadvertently Randomized|Overall Study||0
11310109|NCT02647320|12508726|FG001|Inadvertently Randomized|Overall Study||0
11310110|NCT02647320|12508727|FG002|Inadvertently Randomized|Overall Study||0
11310111|NCT02647320|12508728|FG003|Inadvertently Randomized|Overall Study||1
11310112|NCT02647320|12508729|FG004|Inadvertently Randomized|Overall Study||0
11310113|NCT02647320|12508725|FG000|Safety Set|Overall Study||43
11310114|NCT02647320|12508726|FG001|Safety Set|Overall Study||44
11310115|NCT02647320|12508727|FG002|Safety Set|Overall Study||68
11310116|NCT02647320|12508728|FG003|Safety Set|Overall Study||68
11310117|NCT02647320|12508729|FG004|Safety Set|Overall Study||69
11310118|NCT02647320|12508725|FG000|Modified Intent-to-Treat Set (mITT)|Overall Study||40
11310119|NCT02647320|12508726|FG001|Modified Intent-to-Treat Set (mITT)|Overall Study||38
11310120|NCT02647320|12508727|FG002|Modified Intent-to-Treat Set (mITT)|Overall Study||61
11310121|NCT02647320|12508728|FG003|Modified Intent-to-Treat Set (mITT)|Overall Study||62
11310122|NCT02647320|12508729|FG004|Modified Intent-to-Treat Set (mITT)|Overall Study||62
11310123|NCT02647320|12508725|FG000|COMPLETED|Overall Study||34
11310124|NCT02647320|12508726|FG001|COMPLETED|Overall Study||35
11310125|NCT02647320|12508727|FG002|COMPLETED|Overall Study||54
11310126|NCT02647320|12508728|FG003|COMPLETED|Overall Study||58
11310127|NCT02647320|12508729|FG004|COMPLETED|Overall Study||52
11310128|NCT02647320|12508725|FG000|NOT COMPLETED|Overall Study||12
11310129|NCT02647320|12508726|FG001|NOT COMPLETED|Overall Study||11
11310130|NCT02647320|12508727|FG002|NOT COMPLETED|Overall Study||15
11310131|NCT02647320|12508728|FG003|NOT COMPLETED|Overall Study||10
11310132|NCT02647320|12508729|FG004|NOT COMPLETED|Overall Study||17
11310133|NCT02647346|12508743|FG000|STARTED|Overall Study||132
11310134|NCT02647346|12508743|FG000|COMPLETED|Overall Study||129
11310135|NCT02647346|12508743|FG000|NOT COMPLETED|Overall Study||3
11310136|NCT02647645|12508749|FG000|STARTED|Overall Study||11
11310137|NCT02647645|12508750|FG001|STARTED|Overall Study||10
11310138|NCT02647645|12508749|FG000|COMPLETED|Overall Study||9
11310139|NCT02647645|12508750|FG001|COMPLETED|Overall Study||9
11310140|NCT02647645|12508749|FG000|NOT COMPLETED|Overall Study||2
11310141|NCT02647645|12508750|FG001|NOT COMPLETED|Overall Study||1
11310142|NCT02647658|12508758|FG000|STARTED|Overall Study||1207
11310143|NCT02647658|12508759|FG001|STARTED|Overall Study||1093
11310144|NCT02647658|12508758|FG000|6 Month Assessment|Overall Study||658
11310145|NCT02647658|12508759|FG001|6 Month Assessment|Overall Study||635
11310146|NCT02647658|12508758|FG000|COMPLETED|Overall Study||1192
11310147|NCT02647658|12508759|FG001|COMPLETED|Overall Study||1069
11310148|NCT02647658|12508758|FG000|NOT COMPLETED|Overall Study||15
11310149|NCT02647658|12508759|FG001|NOT COMPLETED|Overall Study||24
11310150|NCT02647788|12508767|FG000|STARTED|Overall Study||70
11310151|NCT02647788|12508768|FG001|STARTED|Overall Study||70
11310152|NCT02647788|12508767|FG000|COMPLETED|Overall Study||54
11310153|NCT02647788|12508768|FG001|COMPLETED|Overall Study||57
11310154|NCT02647788|12508767|FG000|NOT COMPLETED|Overall Study||16
11310155|NCT02647788|12508768|FG001|NOT COMPLETED|Overall Study||13
11310156|NCT02647866|12508779|FG000|STARTED|Overall Study||9
11310157|NCT02647866|12508780|FG001|STARTED|Overall Study||10
11310158|NCT02647866|12508781|FG002|STARTED|Overall Study||9
11310159|NCT02647866|12508782|FG003|STARTED|Overall Study||21
11310160|NCT02647866|12508783|FG004|STARTED|Overall Study||17
11310161|NCT02647866|12508779|FG000|Completed Induction Therapy|Overall Study|Subjects received KHK4083 1.0 mg/kg for 12 weeks|8
11310162|NCT02647866|12508780|FG001|Completed Induction Therapy|Overall Study|Subjects received KHK4083 3.0 mg/kg for 12 weeks|9
11310163|NCT02647866|12508781|FG002|Completed Induction Therapy|Overall Study|Subjects received KHK4083 10.0 mg/kg for 12 weeks|8
11310164|NCT02647866|12508782|FG003|Completed Induction Therapy|Overall Study|Subjects received the maximum tolerated dose of KHK4083 10.0 mg/kg for 12 weeks|19
11310165|NCT02647866|12508783|FG004|Completed Induction Therapy|Overall Study|Subjects received Placebo for 12 weeks|17
11310166|NCT02647866|12508779|FG000|Completed Induction Therapy Follow-Up|Overall Study||5
11310167|NCT02647866|12508780|FG001|Completed Induction Therapy Follow-Up|Overall Study||1
11310168|NCT02647866|12508781|FG002|Completed Induction Therapy Follow-Up|Overall Study||2
11310169|NCT02647866|12508782|FG003|Completed Induction Therapy Follow-Up|Overall Study||0
11310170|NCT02647866|12508783|FG004|Completed Induction Therapy Follow-Up|Overall Study||2
11310171|NCT02647866|12508779|FG000|Completed Long-Term Extension Therapy|Overall Study|10 add'l treatments of KHK4083 (same dose as Induction Therapy) as maintenance therapy.|3
11310172|NCT02647866|12508780|FG001|Completed Long-Term Extension Therapy|Overall Study||0
11310173|NCT02647866|12508781|FG002|Completed Long-Term Extension Therapy|Overall Study||0
11310174|NCT02647866|12508782|FG003|Completed Long-Term Extension Therapy|Overall Study||0
11310175|NCT02647866|12508783|FG004|Completed Long-Term Extension Therapy|Overall Study||0
11310176|NCT02647866|12508779|FG000|Completed LTE Follow-up|Overall Study||2
11310177|NCT02647866|12508780|FG001|Completed LTE Follow-up|Overall Study||0
11310178|NCT02647866|12508781|FG002|Completed LTE Follow-up|Overall Study||0
11310179|NCT02647866|12508782|FG003|Completed LTE Follow-up|Overall Study||0
11310180|NCT02647866|12508783|FG004|Completed LTE Follow-up|Overall Study||0
11310181|NCT02647866|12508779|FG000|Completed Open-Label Extension Therapy|Overall Study||0
11310182|NCT02647866|12508780|FG001|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy.|7
11310183|NCT02647866|12508781|FG002|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|4
11310184|NCT02647866|12508782|FG003|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|17
11310185|NCT02647866|12508783|FG004|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|13
11310186|NCT02647866|12508779|FG000|Completed OLE Follow-up|Overall Study||0
11310187|NCT02647866|12508780|FG001|Completed OLE Follow-up|Overall Study||6
11310188|NCT02647866|12508781|FG002|Completed OLE Follow-up|Overall Study||4
11310189|NCT02647866|12508782|FG003|Completed OLE Follow-up|Overall Study||14
11310190|NCT02647866|12508783|FG004|Completed OLE Follow-up|Overall Study||10
11310191|NCT02647866|12508779|FG000|Moved From LTE to OLE Therapy|Overall Study||0
11310192|NCT02647866|12508780|FG001|Moved From LTE to OLE Therapy|Overall Study||5
11310193|NCT02647866|12508781|FG002|Moved From LTE to OLE Therapy|Overall Study||0
11310194|NCT02647866|12508782|FG003|Moved From LTE to OLE Therapy|Overall Study||0
11310195|NCT02647866|12508783|FG004|Moved From LTE to OLE Therapy|Overall Study||2
11310196|NCT02647866|12508779|FG000|Discontinued the Treatment|Overall Study||4
11310197|NCT02647866|12508780|FG001|Discontinued the Treatment|Overall Study||5
11310198|NCT02647866|12508781|FG002|Discontinued the Treatment|Overall Study||5
11310199|NCT02647866|12508782|FG003|Discontinued the Treatment|Overall Study||5
11310200|NCT02647866|12508783|FG004|Discontinued the Treatment|Overall Study||8
11310201|NCT02647866|12508779|FG000|Discontinued the Study|Overall Study||5
11310202|NCT02647866|12508780|FG001|Discontinued the Study|Overall Study||4
11310203|NCT02647866|12508781|FG002|Discontinued the Study|Overall Study||5
11310204|NCT02647866|12508782|FG003|Discontinued the Study|Overall Study||6
11310205|NCT02647866|12508783|FG004|Discontinued the Study|Overall Study||8
11310206|NCT02647866|12508779|FG000|COMPLETED|Overall Study||4
11310207|NCT02647866|12508780|FG001|COMPLETED|Overall Study||6
11310208|NCT02647866|12508781|FG002|COMPLETED|Overall Study||4
11310209|NCT02647866|12508782|FG003|COMPLETED|Overall Study||15
11310210|NCT02647866|12508783|FG004|COMPLETED|Overall Study||9
11401797|NCT04079790|12596614|FG000|STARTED|Part 1, Period 2 (Day 5 to Day 8)||13
11401798|NCT04079790|12596615|FG001|STARTED|Part 1, Period 2 (Day 5 to Day 8)||2
11401799|NCT04079790|12596616|FG002|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
11310211|NCT02647866|12508779|FG000|NOT COMPLETED|Overall Study||5
11310212|NCT02647866|12508780|FG001|NOT COMPLETED|Overall Study||4
11401800|NCT04079790|12596617|FG003|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
11401801|NCT04079790|12596614|FG000|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||13
11401802|NCT04079790|12596615|FG001|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||2
11401803|NCT04079790|12596616|FG002|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
11310213|NCT02647866|12508781|FG002|NOT COMPLETED|Overall Study||5
11310214|NCT02647866|12508782|FG003|NOT COMPLETED|Overall Study||6
11401804|NCT04079790|12596617|FG003|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
11401805|NCT04079790|12596614|FG000|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
11401806|NCT04079790|12596615|FG001|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
11401807|NCT04079790|12596616|FG002|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
11401808|NCT04079790|12596617|FG003|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
11401809|NCT04079790|12596614|FG000|STARTED|Part 1, Period 3 (Day 9 to Day 11)||13
11310215|NCT02647866|12508783|FG004|NOT COMPLETED|Overall Study||8
11310216|NCT02647905|12508803|FG000|STARTED|Overall Study||90
11310217|NCT02647905|12508803|FG000|COMPLETED|Overall Study||87
11310218|NCT02647905|12508803|FG000|NOT COMPLETED|Overall Study||3
11310219|NCT02647944|12508809|FG000|STARTED|Overall Study||19
11310220|NCT02647944|12508810|FG001|STARTED|Overall Study||21
11310221|NCT02647944|12508809|FG000|COMPLETED|Overall Study||17
11310222|NCT02647944|12508810|FG001|COMPLETED|Overall Study||18
11310223|NCT02647944|12508809|FG000|NOT COMPLETED|Overall Study||2
11310224|NCT02647944|12508810|FG001|NOT COMPLETED|Overall Study||3
11310225|NCT02648022|12508818|FG000|STARTED|Overall Study||40
11310226|NCT02648022|12508819|FG001|STARTED|Overall Study||39
11310227|NCT02648022|12508818|FG000|COMPLETED|Overall Study||40
11310228|NCT02648022|12508819|FG001|COMPLETED|Overall Study||39
11310229|NCT02648022|12508818|FG000|NOT COMPLETED|Overall Study||0
11310230|NCT02648022|12508819|FG001|NOT COMPLETED|Overall Study||0
11310231|NCT02648178|12508825|FG000|STARTED|Overall Study||19
11310232|NCT02648178|12508825|FG000|COMPLETED|Overall Study||10
11310233|NCT02648178|12508825|FG000|NOT COMPLETED|Overall Study||9
11310234|NCT02648204|12508833|FG000|STARTED|Overall Study||301
11310235|NCT02648204|12508834|FG001|STARTED|Overall Study||300
11310236|NCT02648204|12508835|FG002|STARTED|Overall Study||300
11310237|NCT02648204|12508836|FG003|STARTED|Overall Study||300
11310238|NCT02648204|12508833|FG000|Exposed|Overall Study||301
11310239|NCT02648204|12508834|FG001|Exposed|Overall Study||300
11310240|NCT02648204|12508835|FG002|Exposed|Overall Study||299
11310241|NCT02648204|12508836|FG003|Exposed|Overall Study||299
11310242|NCT02648204|12508833|FG000|COMPLETED|Overall Study||279
11310243|NCT02648204|12508834|FG001|COMPLETED|Overall Study||279
11310244|NCT02648204|12508835|FG002|COMPLETED|Overall Study||287
11310245|NCT02648204|12508836|FG003|COMPLETED|Overall Study||284
11310246|NCT02648204|12508833|FG000|NOT COMPLETED|Overall Study||22
11310247|NCT02648204|12508834|FG001|NOT COMPLETED|Overall Study||21
11310248|NCT02648204|12508835|FG002|NOT COMPLETED|Overall Study||13
11310249|NCT02648204|12508836|FG003|NOT COMPLETED|Overall Study||16
11310250|NCT02648217|12508848|FG000|STARTED|Overall Study||131
11310251|NCT02648217|12508849|FG001|STARTED|Overall Study||132
11310252|NCT02648217|12508848|FG000|Exposed|Overall Study||130
11310253|NCT02648217|12508849|FG001|Exposed|Overall Study||132
11310254|NCT02648217|12508848|FG000|COMPLETED|Overall Study||121
11310255|NCT02648217|12508849|FG001|COMPLETED|Overall Study||127
11310256|NCT02648217|12508848|FG000|NOT COMPLETED|Overall Study||10
11310257|NCT02648217|12508849|FG001|NOT COMPLETED|Overall Study||5
11310258|NCT02648230|12508855|FG000|STARTED|Overall Study||74
11310259|NCT02648230|12508855|FG000|COMPLETED|Overall Study||74
11310260|NCT02648230|12508855|FG000|NOT COMPLETED|Overall Study||0
11310261|NCT02648438|12508862|FG000|STARTED|Overall Study||12
11310262|NCT02648438|12508863|FG001|STARTED|Overall Study||12
11310263|NCT02648438|12508864|FG002|STARTED|Overall Study||6
11310264|NCT02648438|12508862|FG000|COMPLETED|Overall Study||9
11310265|NCT02648438|12508863|FG001|COMPLETED|Overall Study||9
11310266|NCT02648438|12508864|FG002|COMPLETED|Overall Study||6
11310267|NCT02648438|12508862|FG000|NOT COMPLETED|Overall Study||3
11310268|NCT02648438|12508863|FG001|NOT COMPLETED|Overall Study||3
11310269|NCT02648438|12508864|FG002|NOT COMPLETED|Overall Study||0
11310270|NCT02648646|12508880|FG000|STARTED|Overall Study||10
11310271|NCT02648646|12508880|FG000|COMPLETED|Overall Study||8
11310272|NCT02648646|12508880|FG000|NOT COMPLETED|Overall Study||2
11310273|NCT02648880|12508884|FG000|STARTED|Overall Study|Recruitment was significantly limited, only 3 participants were eligible, all enrolled. All three were assigned to the exercise arm, per protocol. No participants were recruited into the control arm and it was eliminated.|3
11310274|NCT02648880|12508884|FG000|COMPLETED|Overall Study||3
11310275|NCT02648880|12508884|FG000|NOT COMPLETED|Overall Study||0
11310276|NCT02648919|12508888|FG000|STARTED|Overall Study||6
11310277|NCT02648919|12508888|FG000|COMPLETED|Overall Study||6
11310278|NCT02648919|12508888|FG000|NOT COMPLETED|Overall Study||0
11310279|NCT02648932|12508895|FG000|STARTED|Overall Study||5
11310280|NCT02648932|12508896|FG001|STARTED|Overall Study||4
11310281|NCT02648932|12508895|FG000|COMPLETED|Overall Study||2
11310282|NCT02648932|12508896|FG001|COMPLETED|Overall Study||3
11310283|NCT02648932|12508895|FG000|NOT COMPLETED|Overall Study||3
11310284|NCT02648932|12508896|FG001|NOT COMPLETED|Overall Study||1
11310285|NCT02648971|12508904|FG000|STARTED|Overall Study||18
11310286|NCT02648971|12508905|FG001|STARTED|Overall Study||18
11310287|NCT02648971|12508904|FG000|COMPLETED|Overall Study||18
11310288|NCT02648971|12508905|FG001|COMPLETED|Overall Study||18
11310289|NCT02648971|12508904|FG000|NOT COMPLETED|Overall Study||0
11310290|NCT02648971|12508905|FG001|NOT COMPLETED|Overall Study||0
11310291|NCT02649192|12508917|FG000|STARTED|Overall Study||5
11310292|NCT02649192|12508918|FG001|STARTED|Overall Study||4
11310293|NCT02649192|12508919|FG002|STARTED|Overall Study||22
11310294|NCT02649192|12508920|FG003|STARTED|Overall Study||22
11310295|NCT02649192|12508921|FG004|STARTED|Overall Study||12
11310296|NCT02649192|12508922|FG005|STARTED|Overall Study||14
11310297|NCT02649192|12508917|FG000|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
11310298|NCT02649192|12508918|FG001|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
11310299|NCT02649192|12508919|FG002|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11
11310300|NCT02649192|12508920|FG003|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12
11310301|NCT02649192|12508921|FG004|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7
11310302|NCT02649192|12508922|FG005|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8
11310303|NCT02649192|12508917|FG000|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3
11310304|NCT02649192|12508918|FG001|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2
11310305|NCT02649192|12508919|FG002|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11
11310306|NCT02649192|12508920|FG003|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10
11310307|NCT02649192|12508921|FG004|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5
11310308|NCT02649192|12508922|FG005|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6
11310309|NCT02649192|12508917|FG000|COMPLETED|Overall Study||5
11022186|NCT00808132|12200473|FG002|Treated|Overall Study||230
11022187|NCT00808132|12200474|FG003|Treated|Overall Study||220
11022188|NCT00808132|12200475|FG004|Treated|Overall Study||474
11022189|NCT00808132|12200471|FG000|COMPLETED|Overall Study||357
11022190|NCT00808132|12200472|FG001|COMPLETED|Overall Study||393
11022191|NCT00808132|12200473|FG002|COMPLETED|Overall Study||185
11022192|NCT00808132|12200474|FG003|COMPLETED|Overall Study||159
11022193|NCT00808132|12200475|FG004|COMPLETED|Overall Study||383
11022194|NCT00808132|12200471|FG000|NOT COMPLETED|Overall Study||98
11022195|NCT00808132|12200472|FG001|NOT COMPLETED|Overall Study||88
11022196|NCT00808132|12200473|FG002|NOT COMPLETED|Overall Study||54
11022197|NCT00808132|12200474|FG003|NOT COMPLETED|Overall Study||69
11022198|NCT00808132|12200475|FG004|NOT COMPLETED|Overall Study||100
11022199|NCT00808210|12200489|FG000|STARTED|Study Period + 48 Weeks of Follow-up||15
11022200|NCT00808210|12200490|FG001|STARTED|Study Period + 48 Weeks of Follow-up||13
11022201|NCT00808210|12200489|FG000|COMPLETED|Study Period + 48 Weeks of Follow-up||6
11022202|NCT00808210|12200490|FG001|COMPLETED|Study Period + 48 Weeks of Follow-up||4
11022203|NCT00808210|12200489|FG000|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
11022204|NCT00808210|12200490|FG001|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
11022205|NCT00808210|12200489|FG000|STARTED|Double-Blind TX Period||15
11022206|NCT00808210|12200490|FG001|STARTED|Double-Blind TX Period||13
11310310|NCT02649192|12508918|FG001|COMPLETED|Overall Study||4
11310311|NCT02649192|12508919|FG002|COMPLETED|Overall Study||21
11310312|NCT02649192|12508920|FG003|COMPLETED|Overall Study||20
11310313|NCT02649192|12508921|FG004|COMPLETED|Overall Study||11
11310314|NCT02649192|12508922|FG005|COMPLETED|Overall Study||14
11310315|NCT02649192|12508917|FG000|NOT COMPLETED|Overall Study||0
11310316|NCT02649192|12508918|FG001|NOT COMPLETED|Overall Study||0
11310317|NCT02649192|12508919|FG002|NOT COMPLETED|Overall Study||1
11310318|NCT02649192|12508920|FG003|NOT COMPLETED|Overall Study||2
11310319|NCT02649192|12508921|FG004|NOT COMPLETED|Overall Study||1
11310320|NCT02649192|12508922|FG005|NOT COMPLETED|Overall Study||0
11310321|NCT02649218|12508949|FG000|STARTED|Overall Study||226
11310322|NCT02649218|12508949|FG000|COMPLETED|Overall Study||201
11310323|NCT02649218|12508949|FG000|NOT COMPLETED|Overall Study||25
11310324|NCT02649231|12508958|FG000|STARTED|Overall Study||24
11310325|NCT02649231|12508959|FG001|STARTED|Overall Study||24
11310326|NCT02649231|12508960|FG002|STARTED|Overall Study||23
11310327|NCT02649231|12508961|FG003|STARTED|Overall Study||25
11310328|NCT02649231|12508958|FG000|COMPLETED|Overall Study||20
11310329|NCT02649231|12508959|FG001|COMPLETED|Overall Study||21
11310330|NCT02649231|12508960|FG002|COMPLETED|Overall Study||21
11310331|NCT02649231|12508961|FG003|COMPLETED|Overall Study||23
11310332|NCT02649231|12508958|FG000|NOT COMPLETED|Overall Study||4
11310333|NCT02649231|12508959|FG001|NOT COMPLETED|Overall Study||3
11310334|NCT02649231|12508960|FG002|NOT COMPLETED|Overall Study||2
11310335|NCT02649231|12508961|FG003|NOT COMPLETED|Overall Study||2
11310336|NCT02649322|12508973|FG000|STARTED|Overall Study||58
11310337|NCT02649322|12508974|FG001|STARTED|Overall Study||57
11310338|NCT02649322|12508973|FG000|COMPLETED|Overall Study||58
11310339|NCT02649322|12508974|FG001|COMPLETED|Overall Study||57
11310340|NCT02649322|12508973|FG000|NOT COMPLETED|Overall Study||0
11310341|NCT02649322|12508974|FG001|NOT COMPLETED|Overall Study||0
11310342|NCT02649556|12508984|FG000|STARTED|Overall Study||230
11310343|NCT02649556|12508985|FG001|STARTED|Overall Study||424
11310344|NCT02649556|12508986|FG002|STARTED|Overall Study||152
11310345|NCT02649556|12508987|FG003|STARTED|Overall Study||51
11310346|NCT02649556|12508984|FG000|COMPLETED|Overall Study||167
11310347|NCT02649556|12508985|FG001|COMPLETED|Overall Study||312
11310348|NCT02649556|12508986|FG002|COMPLETED|Overall Study||102
11310349|NCT02649556|12508987|FG003|COMPLETED|Overall Study||28
11310350|NCT02649556|12508984|FG000|NOT COMPLETED|Overall Study||63
11310351|NCT02649556|12508985|FG001|NOT COMPLETED|Overall Study||112
11310352|NCT02649556|12508986|FG002|NOT COMPLETED|Overall Study||50
11310353|NCT02649556|12508987|FG003|NOT COMPLETED|Overall Study||23
11310354|NCT02649608|12508997|FG000|STARTED|Overall Study||2
11310355|NCT02649608|12508998|FG001|STARTED|Overall Study||1
11310356|NCT02649608|12508999|FG002|STARTED|Overall Study||3
11310357|NCT02649608|12509000|FG003|STARTED|Overall Study||3
11022207|NCT00808210|12200489|FG000|COMPLETED|Double-Blind TX Period||13
11022208|NCT00808210|12200490|FG001|COMPLETED|Double-Blind TX Period||10
11022209|NCT00808210|12200489|FG000|NOT COMPLETED|Double-Blind TX Period||2
11022210|NCT00808210|12200490|FG001|NOT COMPLETED|Double-Blind TX Period||3
11310358|NCT02649608|12509001|FG004|STARTED|Overall Study||3
11310359|NCT02649608|12509002|FG005|STARTED|Overall Study||2
11310360|NCT02649608|12509003|FG006|STARTED|Overall Study||1
11310361|NCT02649608|12508997|FG000|COMPLETED|Overall Study||2
11310362|NCT02649608|12508998|FG001|COMPLETED|Overall Study||1
11310363|NCT02649608|12508999|FG002|COMPLETED|Overall Study||3
11310364|NCT02649608|12509000|FG003|COMPLETED|Overall Study||3
11310365|NCT02649608|12509001|FG004|COMPLETED|Overall Study||3
11310366|NCT02649608|12509002|FG005|COMPLETED|Overall Study||2
11310367|NCT02649608|12509003|FG006|COMPLETED|Overall Study||1
11310368|NCT02649608|12508997|FG000|NOT COMPLETED|Overall Study||0
11310369|NCT02649608|12508998|FG001|NOT COMPLETED|Overall Study||0
11310370|NCT02649608|12508999|FG002|NOT COMPLETED|Overall Study||0
11310371|NCT02649608|12509000|FG003|NOT COMPLETED|Overall Study||0
11310372|NCT02649608|12509001|FG004|NOT COMPLETED|Overall Study||0
11310373|NCT02649608|12509002|FG005|NOT COMPLETED|Overall Study||0
11310374|NCT02649608|12509003|FG006|NOT COMPLETED|Overall Study||0
11310375|NCT02649634|12509034|FG000|STARTED|Overall Study||69
11310376|NCT02649634|12509035|FG001|STARTED|Overall Study||66
11310377|NCT02649634|12509034|FG000|COMPLETED|Overall Study||66
11310378|NCT02649634|12509035|FG001|COMPLETED|Overall Study||60
11310379|NCT02649634|12509034|FG000|NOT COMPLETED|Overall Study||3
11310380|NCT02649634|12509035|FG001|NOT COMPLETED|Overall Study||6
11310381|NCT02649842|12509041|FG000|STARTED|Overall Study||101
11310382|NCT02649842|12509041|FG000|COMPLETED|Overall Study||101
11310383|NCT02649842|12509041|FG000|NOT COMPLETED|Overall Study||0
11310384|NCT02649894|12509049|FG000|STARTED|Overall Study||81
11310385|NCT02649894|12509050|FG001|STARTED|Overall Study||38
11310386|NCT02649894|12509049|FG000|Device Inserted|Overall Study||77
11310387|NCT02649894|12509050|FG001|Device Inserted|Overall Study||37
11310388|NCT02649894|12509049|FG000|Completed Day 30|Overall Study||56
11310389|NCT02649894|12509050|FG001|Completed Day 30|Overall Study||35
11310390|NCT02649894|12509049|FG000|COMPLETED|Overall Study||37
11310391|NCT02649894|12509050|FG001|COMPLETED|Overall Study||27
11310392|NCT02649894|12509049|FG000|NOT COMPLETED|Overall Study||44
11310393|NCT02649894|12509050|FG001|NOT COMPLETED|Overall Study||11
11310394|NCT02650128|12509056|FG000|STARTED|Overall Study||60
11310395|NCT02650128|12509056|FG000|30 Day Primary and Safety Endpoint|Overall Study||60
11310396|NCT02650128|12509056|FG000|COMPLETED|Overall Study||58
11310397|NCT02650128|12509056|FG000|NOT COMPLETED|Overall Study||2
11310398|NCT02650193|12509064|FG000|STARTED|Overall Study||6
11310399|NCT02650193|12509065|FG001|STARTED|Overall Study||6
11310400|NCT02650193|12509066|FG002|STARTED|Overall Study||13
11310401|NCT02650193|12509064|FG000|COMPLETED|Overall Study||6
11310402|NCT02650193|12509065|FG001|COMPLETED|Overall Study||6
11310403|NCT02650193|12509066|FG002|COMPLETED|Overall Study||13
11310404|NCT02650193|12509064|FG000|NOT COMPLETED|Overall Study||0
11310405|NCT02650193|12509065|FG001|NOT COMPLETED|Overall Study||0
11310406|NCT02650193|12509066|FG002|NOT COMPLETED|Overall Study||0
11310407|NCT02650219|12509077|FG000|STARTED|Overall Study||40
11310408|NCT02650219|12509078|FG001|STARTED|Overall Study||20
11310409|NCT02650219|12509077|FG000|COMPLETED|Overall Study||40
11310410|NCT02650219|12509078|FG001|COMPLETED|Overall Study||20
11310411|NCT02650219|12509077|FG000|NOT COMPLETED|Overall Study||0
11310412|NCT02650219|12509078|FG001|NOT COMPLETED|Overall Study||0
11310413|NCT02650440|12509086|FG000|STARTED|Overall Study||10
11310414|NCT02650440|12509087|FG001|STARTED|Overall Study||10
11310415|NCT02650440|12509086|FG000|COMPLETED|Overall Study||10
11310416|NCT02650440|12509087|FG001|COMPLETED|Overall Study||8
11310417|NCT02650440|12509086|FG000|NOT COMPLETED|Overall Study||0
11310418|NCT02650440|12509087|FG001|NOT COMPLETED|Overall Study||2
11310419|NCT02650466|12509093|FG000|STARTED|Overall Study||24
11310420|NCT02650466|12509093|FG000|COMPLETED|Overall Study||17
11310421|NCT02650466|12509093|FG000|NOT COMPLETED|Overall Study||7
11310422|NCT02650856|12509101|FG000|STARTED|Overall Study||19
11310423|NCT02650856|12509102|FG001|STARTED|Overall Study||21
11310424|NCT02650856|12509101|FG000|Baseline|Overall Study||19
11310425|NCT02650856|12509102|FG001|Baseline|Overall Study||21
11310426|NCT02650856|12509101|FG000|24 Hours|Overall Study||19
11310427|NCT02650856|12509102|FG001|24 Hours|Overall Study||21
11310428|NCT02650856|12509101|FG000|48 Hours|Overall Study||19
11401810|NCT04079790|12596615|FG001|STARTED|Part 1, Period 3 (Day 9 to Day 11)||2
11401811|NCT04079790|12596616|FG002|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
11401812|NCT04079790|12596617|FG003|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
11310429|NCT02650856|12509102|FG001|48 Hours|Overall Study||21
11310430|NCT02650856|12509101|FG000|72 Hours|Overall Study||19
11310431|NCT02650856|12509102|FG001|72 Hours|Overall Study||21
11310432|NCT02650856|12509101|FG000|COMPLETED|Overall Study||19
11310433|NCT02650856|12509102|FG001|COMPLETED|Overall Study||21
11310434|NCT02650856|12509101|FG000|NOT COMPLETED|Overall Study||0
11310435|NCT02650856|12509102|FG001|NOT COMPLETED|Overall Study||0
11310436|NCT02650895|12509114|FG000|STARTED|Overall Study||10
11310437|NCT02650895|12509115|FG001|STARTED|Overall Study||6
11310438|NCT02650895|12509116|FG002|STARTED|Overall Study||6
11310439|NCT02650895|12509117|FG003|STARTED|Overall Study||6
11310440|NCT02650895|12509118|FG004|STARTED|Overall Study||6
11310441|NCT02650895|12509119|FG005|STARTED|Overall Study||6
11310442|NCT02650895|12509114|FG000|COMPLETED|Overall Study||10
11310443|NCT02650895|12509115|FG001|COMPLETED|Overall Study||5
11310444|NCT02650895|12509116|FG002|COMPLETED|Overall Study||6
11310445|NCT02650895|12509117|FG003|COMPLETED|Overall Study||6
11310446|NCT02650895|12509118|FG004|COMPLETED|Overall Study||6
11310447|NCT02650895|12509119|FG005|COMPLETED|Overall Study||6
11310448|NCT02650895|12509114|FG000|NOT COMPLETED|Overall Study||0
11310449|NCT02650895|12509115|FG001|NOT COMPLETED|Overall Study||1
11310450|NCT02650895|12509116|FG002|NOT COMPLETED|Overall Study||0
11401813|NCT04079790|12596614|FG000|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||13
11401814|NCT04079790|12596615|FG001|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||2
11310451|NCT02650895|12509117|FG003|NOT COMPLETED|Overall Study||0
11310452|NCT02650895|12509118|FG004|NOT COMPLETED|Overall Study||0
11310453|NCT02650895|12509119|FG005|NOT COMPLETED|Overall Study||0
11310454|NCT02650999|12509138|FG000|STARTED|Overall Study||12
11310455|NCT02650999|12509138|FG000|COMPLETED|Overall Study||12
11310456|NCT02650999|12509138|FG000|NOT COMPLETED|Overall Study||0
11310457|NCT02651103|12509142|FG000|STARTED|Overall Study||30
11310458|NCT02651103|12509142|FG000|COMPLETED|Overall Study||30
11310459|NCT02651103|12509142|FG000|NOT COMPLETED|Overall Study||0
11310460|NCT02651116|12509148|FG000|STARTED|Overall Study||68
11310461|NCT02651116|12509149|FG001|STARTED|Overall Study||63
11310462|NCT02651116|12509148|FG000|Treated|Overall Study||68
11310463|NCT02651116|12509149|FG001|Treated|Overall Study||63
11310464|NCT02651116|12509148|FG000|COMPLETED|Overall Study||67
11401815|NCT04079790|12596616|FG002|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
11401816|NCT04079790|12596617|FG003|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
11401817|NCT04079790|12596614|FG000|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
11401818|NCT04079790|12596615|FG001|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
11401819|NCT04079790|12596616|FG002|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
11401820|NCT04079790|12596617|FG003|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
11401821|NCT04079790|12596614|FG000|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
11401822|NCT04079790|12596615|FG001|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
11401823|NCT04079790|12596616|FG002|STARTED|Part 2, Period 1 (Day 1 to Day 3)||15
11401824|NCT04079790|12596617|FG003|STARTED|Part 2, Period 1 (Day 1 to Day 3)||3
11401825|NCT04079790|12596614|FG000|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
11401826|NCT04079790|12596615|FG001|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
11401827|NCT04079790|12596616|FG002|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||12
11401828|NCT04079790|12596617|FG003|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
11401829|NCT04079790|12596614|FG000|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
11401830|NCT04079790|12596615|FG001|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
11401831|NCT04079790|12596616|FG002|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
11401832|NCT04079790|12596617|FG003|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
11401833|NCT04079790|12596614|FG000|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
11401834|NCT04079790|12596615|FG001|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
11401835|NCT04079790|12596616|FG002|STARTED|Part 2, Period 2 (Day 1 to Day 3)||12
11401836|NCT04079790|12596617|FG003|STARTED|Part 2, Period 2 (Day 1 to Day 3)||3
11401837|NCT04079790|12596614|FG000|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
11401838|NCT04079790|12596615|FG001|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
11401839|NCT04079790|12596616|FG002|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||12
11401840|NCT04079790|12596617|FG003|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||3
11401841|NCT04079790|12596614|FG000|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
11401842|NCT04079790|12596615|FG001|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
11401843|NCT04079790|12596616|FG002|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
11401844|NCT04079790|12596617|FG003|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
11401845|NCT04079127|12596643|FG000|STARTED|Overall Study|hips (in 141 patients)|150
11401846|NCT04079127|12596643|FG000|COMPLETED|Overall Study|89 hips have completed the study, and all 10 year data of 81 were available for analysis.|89
11401847|NCT04079127|12596643|FG000|NOT COMPLETED|Overall Study||61
11401848|NCT04076787|12596650|FG000|STARTED|Overall Study||318
11401849|NCT04076787|12596651|FG001|STARTED|Overall Study||1031
11401850|NCT04076787|12596652|FG002|STARTED|Overall Study||420
11401851|NCT04076787|12596650|FG000|COMPLETED|Overall Study||318
11401852|NCT04076787|12596651|FG001|COMPLETED|Overall Study||1031
11401853|NCT04076787|12596652|FG002|COMPLETED|Overall Study||420
11401854|NCT04076787|12596650|FG000|NOT COMPLETED|Overall Study||0
11401855|NCT04076787|12596651|FG001|NOT COMPLETED|Overall Study||0
11401856|NCT04076787|12596652|FG002|NOT COMPLETED|Overall Study||0
11401857|NCT04075812|12596660|FG000|STARTED|Overall Study||2
11401858|NCT04075812|12596660|FG000|COMPLETED|Overall Study||2
11401859|NCT04075812|12596660|FG000|NOT COMPLETED|Overall Study||0
11401860|NCT04075409|12596667|FG000|STARTED|Overall Study||13
11401861|NCT04075409|12596668|FG001|STARTED|Overall Study||13
11401862|NCT04075409|12596669|FG002|STARTED|Overall Study||13
11401863|NCT04075409|12596667|FG000|COMPLETED|Overall Study||13
11401864|NCT04075409|12596668|FG001|COMPLETED|Overall Study||13
11401865|NCT04075409|12596669|FG002|COMPLETED|Overall Study||13
11401866|NCT04075409|12596667|FG000|NOT COMPLETED|Overall Study||0
11401867|NCT04075409|12596668|FG001|NOT COMPLETED|Overall Study||0
11401868|NCT04075409|12596669|FG002|NOT COMPLETED|Overall Study||0
11401869|NCT04074941|12596690|FG000|STARTED|Overall Study||11
11401870|NCT04074941|12596691|FG001|STARTED|Overall Study||9
11401871|NCT04074941|12596690|FG000|COMPLETED|Overall Study||11
11401872|NCT04074941|12596691|FG001|COMPLETED|Overall Study||9
11401873|NCT04074941|12596690|FG000|NOT COMPLETED|Overall Study||0
11401874|NCT04074941|12596691|FG001|NOT COMPLETED|Overall Study||0
11401875|NCT04073823|12596699|FG000|STARTED|Overall Study||1
11401876|NCT04073823|12596700|FG001|STARTED|Overall Study||1
11401877|NCT04073823|12596699|FG000|COMPLETED|Overall Study||1
11401878|NCT04073823|12596700|FG001|COMPLETED|Overall Study||1
11401879|NCT04073823|12596699|FG000|NOT COMPLETED|Overall Study||0
11401880|NCT04073823|12596700|FG001|NOT COMPLETED|Overall Study||0
11401881|NCT04073407|12596708|FG000|STARTED|Part 1||6
11401882|NCT04073407|12596709|FG001|STARTED|Part 1||3
11401883|NCT04073407|12596708|FG000|COMPLETED|Part 1||1
11401884|NCT04073407|12596709|FG001|COMPLETED|Part 1||2
11401885|NCT04073407|12596708|FG000|NOT COMPLETED|Part 1||5
11310465|NCT02651116|12509149|FG001|COMPLETED|Overall Study||62
11310466|NCT02651116|12509148|FG000|NOT COMPLETED|Overall Study||1
11310467|NCT02651116|12509149|FG001|NOT COMPLETED|Overall Study||1
11310468|NCT02651155|12509157|FG000|STARTED|Overall Study||99
11310469|NCT02651155|12509158|FG001|STARTED|Overall Study||105
11310470|NCT02651155|12509157|FG000|COMPLETED|Overall Study||93
11310471|NCT02651155|12509158|FG001|COMPLETED|Overall Study||103
11310472|NCT02651155|12509157|FG000|NOT COMPLETED|Overall Study||6
11310473|NCT02651155|12509158|FG001|NOT COMPLETED|Overall Study||2
11310474|NCT02651194|12509164|FG000|STARTED|Overall Study||104
11310475|NCT02651194|12509164|FG000|COMPLETED|Overall Study||99
11310476|NCT02651194|12509164|FG000|NOT COMPLETED|Overall Study||5
11310477|NCT02651220|12509171|FG000|STARTED|Overall Study||337
11310478|NCT02651220|12509172|FG001|STARTED|Overall Study||335
11310479|NCT02651220|12509173|FG002|STARTED|Overall Study||329
11310480|NCT02651220|12509171|FG000|COMPLETED|Overall Study||314
11310481|NCT02651220|12509172|FG001|COMPLETED|Overall Study||308
11310482|NCT02651220|12509173|FG002|COMPLETED|Overall Study||300
11310483|NCT02651220|12509171|FG000|NOT COMPLETED|Overall Study||23
11310484|NCT02651220|12509172|FG001|NOT COMPLETED|Overall Study||27
11310485|NCT02651220|12509173|FG002|NOT COMPLETED|Overall Study||29
11310486|NCT02651259|12509183|FG000|STARTED|Overall Study||25
11310487|NCT02651259|12509184|FG001|STARTED|Overall Study||25
11310488|NCT02651259|12509183|FG000|COMPLETED|Overall Study||25
11310489|NCT02651259|12509184|FG001|COMPLETED|Overall Study||25
11310490|NCT02651259|12509183|FG000|NOT COMPLETED|Overall Study||0
11310491|NCT02651259|12509184|FG001|NOT COMPLETED|Overall Study||0
11310492|NCT02651272|12509198|FG000|STARTED|Overall Study||4
11310493|NCT02651272|12509198|FG000|COMPLETED|Overall Study||1
11310494|NCT02651272|12509198|FG000|NOT COMPLETED|Overall Study||3
11310495|NCT02651337|12509202|FG000|STARTED|Overall Study||5
11310496|NCT02651337|12509202|FG000|COMPLETED|Overall Study||4
11310497|NCT02651337|12509202|FG000|NOT COMPLETED|Overall Study||1
11310498|NCT02651415|12509206|FG000|STARTED|Overall Study|12 patients were enrolled.|12
11310499|NCT02651415|12509206|FG000|COMPLETED|Overall Study|10 patients were evaluable.|10
11310500|NCT02651415|12509206|FG000|NOT COMPLETED|Overall Study||2
11310501|NCT02651428|12509212|FG000|STARTED|Overall Study||403
11310502|NCT02651428|12509213|FG001|STARTED|Overall Study||403
11310503|NCT02651428|12509212|FG000|COMPLETED|Overall Study||359
11310504|NCT02651428|12509213|FG001|COMPLETED|Overall Study||359
11310505|NCT02651428|12509212|FG000|NOT COMPLETED|Overall Study||44
11310506|NCT02651428|12509213|FG001|NOT COMPLETED|Overall Study||44
11310507|NCT02651467|12509222|FG000|STARTED|Overall Study||74
11310508|NCT02651467|12509223|FG001|STARTED|Overall Study||74
11310509|NCT02651467|12509224|FG002|STARTED|Overall Study||73
11310510|NCT02651467|12509222|FG000|COMPLETED|Overall Study||73
11310511|NCT02651467|12509223|FG001|COMPLETED|Overall Study||74
11310512|NCT02651467|12509224|FG002|COMPLETED|Overall Study||69
11310513|NCT02651467|12509222|FG000|NOT COMPLETED|Overall Study||1
11310514|NCT02651467|12509223|FG001|NOT COMPLETED|Overall Study||0
11310515|NCT02651467|12509224|FG002|NOT COMPLETED|Overall Study||4
11310516|NCT02651545|12509235|FG000|STARTED|Overall Study||30
11310517|NCT02651545|12509236|FG001|STARTED|Overall Study||30
11310518|NCT02651545|12509235|FG000|COMPLETED|Overall Study||7
11310519|NCT02651545|12509236|FG001|COMPLETED|Overall Study||17
11310520|NCT02651545|12509235|FG000|NOT COMPLETED|Overall Study||23
11310521|NCT02651545|12509236|FG001|NOT COMPLETED|Overall Study||13
11310522|NCT02651584|12509244|FG000|STARTED|Overall Study||215
11310523|NCT02651584|12509245|FG001|STARTED|Overall Study||213
11310524|NCT02651584|12509244|FG000|COMPLETED|Overall Study||126
11310525|NCT02651584|12509245|FG001|COMPLETED|Overall Study||121
11310526|NCT02651584|12509244|FG000|NOT COMPLETED|Overall Study||89
11310527|NCT02651584|12509245|FG001|NOT COMPLETED|Overall Study||92
11342166|NCT02942264|12539687|FG003|COMPLETED|Phase 1 Cohort Expansion Stage||0
11342167|NCT02942264|12539688|FG004|COMPLETED|Phase 1 Cohort Expansion Stage||0
11342168|NCT02942264|12539689|FG005|COMPLETED|Phase 1 Cohort Expansion Stage||0
11342169|NCT02942264|12539690|FG006|COMPLETED|Phase 1 Cohort Expansion Stage||0
11342170|NCT02942264|12539691|FG007|COMPLETED|Phase 1 Cohort Expansion Stage||6
11342171|NCT02942264|12539692|FG008|COMPLETED|Phase 1 Cohort Expansion Stage||6
11342172|NCT02942264|12539684|FG000|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
11342173|NCT02942264|12539685|FG001|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
11342174|NCT02942264|12539686|FG002|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
11342175|NCT02942264|12539687|FG003|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
11342176|NCT02942264|12539688|FG004|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
11342177|NCT02942264|12539689|FG005|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
11342178|NCT02942264|12539690|FG006|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
11342179|NCT02942264|12539691|FG007|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
11342180|NCT02942264|12539692|FG008|NOT COMPLETED|Phase 1 Cohort Expansion Stage||1
11342181|NCT02942407|12539719|FG000|STARTED|Overall Study||82
11342182|NCT02942407|12539720|FG001|STARTED|Overall Study||72
11342183|NCT02942407|12539719|FG000|COMPLETED|Overall Study||56
11342184|NCT02942407|12539720|FG001|COMPLETED|Overall Study||48
11342185|NCT02942407|12539719|FG000|NOT COMPLETED|Overall Study||26
11342186|NCT02942407|12539720|FG001|NOT COMPLETED|Overall Study||24
11342187|NCT02942485|12539736|FG000|STARTED|Overall Study||7
11310528|NCT02651688|12509257|FG000|STARTED|Overall Study||18
11310529|NCT02651688|12509258|FG001|STARTED|Overall Study||17
11310530|NCT02651688|12509259|FG002|STARTED|Overall Study||15
11310531|NCT02651688|12509257|FG000|COMPLETED|Overall Study||16
11310532|NCT02651688|12509258|FG001|COMPLETED|Overall Study||12
11310533|NCT02651688|12509259|FG002|COMPLETED|Overall Study||12
11310534|NCT02651688|12509257|FG000|NOT COMPLETED|Overall Study||2
11310535|NCT02651688|12509258|FG001|NOT COMPLETED|Overall Study||5
11310536|NCT02651688|12509259|FG002|NOT COMPLETED|Overall Study||3
11310537|NCT02651922|12509267|FG000|STARTED|Overall Study||156
11310538|NCT02651922|12509267|FG000|COMPLETED|Overall Study||154
11310539|NCT02651922|12509267|FG000|NOT COMPLETED|Overall Study||2
11310540|NCT02651987|12509273|FG000|STARTED|Overall Study||48
11310541|NCT02651987|12509274|FG001|STARTED|Overall Study||51
11310542|NCT02651987|12509273|FG000|COMPLETED|Overall Study||43
11310543|NCT02651987|12509274|FG001|COMPLETED|Overall Study||46
11310544|NCT02651987|12509273|FG000|NOT COMPLETED|Overall Study||5
11310545|NCT02651987|12509274|FG001|NOT COMPLETED|Overall Study||5
11310546|NCT02652156|12509286|FG000|STARTED|Overall Study||4
11310547|NCT02652156|12509287|FG001|STARTED|Overall Study||6
11310548|NCT02652156|12509288|FG002|STARTED|Overall Study||4
11310549|NCT02652156|12509286|FG000|COMPLETED|Overall Study||3
11310550|NCT02652156|12509287|FG001|COMPLETED|Overall Study||6
11310551|NCT02652156|12509288|FG002|COMPLETED|Overall Study||4
11310552|NCT02652156|12509286|FG000|NOT COMPLETED|Overall Study||1
11310553|NCT02652156|12509287|FG001|NOT COMPLETED|Overall Study||0
11310554|NCT02652156|12509288|FG002|NOT COMPLETED|Overall Study||0
11310555|NCT02652208|12509298|FG000|STARTED|Overall Study||17
11310556|NCT02652208|12509299|FG001|STARTED|Overall Study||17
11310557|NCT02652208|12509298|FG000|COMPLETED|Overall Study||13
11310558|NCT02652208|12509299|FG001|COMPLETED|Overall Study||15
11310559|NCT02652208|12509298|FG000|NOT COMPLETED|Overall Study||4
11310560|NCT02652208|12509299|FG001|NOT COMPLETED|Overall Study||2
11310561|NCT02652221|12509305|FG000|STARTED|Overall Study||55
11310562|NCT02652221|12509305|FG000|COMPLETED|Overall Study||55
11310563|NCT02652221|12509305|FG000|NOT COMPLETED|Overall Study||0
11310564|NCT02652390|12509313|FG000|STARTED|Overall Study||37
11310565|NCT02652390|12509314|FG001|STARTED|Overall Study||37
11310566|NCT02652390|12509315|FG002|STARTED|Overall Study||37
11310567|NCT02652390|12509313|FG000|COMPLETED|Overall Study||37
11310568|NCT02652390|12509314|FG001|COMPLETED|Overall Study||37
11310569|NCT02652390|12509315|FG002|COMPLETED|Overall Study||37
11310570|NCT02652390|12509313|FG000|NOT COMPLETED|Overall Study||0
11310571|NCT02652390|12509314|FG001|NOT COMPLETED|Overall Study||0
11310572|NCT02652390|12509315|FG002|NOT COMPLETED|Overall Study||0
11310573|NCT02652416|12509329|FG000|STARTED|Overall Study||18
11310574|NCT02652416|12509330|FG001|STARTED|Overall Study||18
11310575|NCT02652416|12509331|FG002|STARTED|Overall Study||18
11310576|NCT02652416|12509332|FG003|STARTED|Overall Study||18
11310577|NCT02652416|12509329|FG000|Subjects Who Participated in MD Part|Overall Study||6
11310578|NCT02652416|12509330|FG001|Subjects Who Participated in MD Part|Overall Study||0
11310579|NCT02652416|12509331|FG002|Subjects Who Participated in MD Part|Overall Study||0
11310580|NCT02652416|12509332|FG003|Subjects Who Participated in MD Part|Overall Study||18
11310581|NCT02652416|12509329|FG000|COMPLETED|Overall Study||18
11310582|NCT02652416|12509330|FG001|COMPLETED|Overall Study||18
11310583|NCT02652416|12509331|FG002|COMPLETED|Overall Study||18
11310584|NCT02652416|12509332|FG003|COMPLETED|Overall Study||18
11310585|NCT02652416|12509329|FG000|NOT COMPLETED|Overall Study||0
11310586|NCT02652416|12509330|FG001|NOT COMPLETED|Overall Study||0
11310587|NCT02652416|12509331|FG002|NOT COMPLETED|Overall Study||0
11310588|NCT02652416|12509332|FG003|NOT COMPLETED|Overall Study||0
11310589|NCT02652442|12509346|FG000|STARTED|Centrifugation - Distance||6
11310590|NCT02652442|12509346|FG000|COMPLETED|Centrifugation - Distance||5
11310591|NCT02652442|12509346|FG000|NOT COMPLETED|Centrifugation - Distance||1
11310592|NCT02652442|12509346|FG000|STARTED|Centrifugation - Duration||5
11310593|NCT02652442|12509346|FG000|COMPLETED|Centrifugation - Duration||5
11310594|NCT02652442|12509346|FG000|NOT COMPLETED|Centrifugation - Duration||0
11310595|NCT02652442|12509346|FG000|STARTED|Centrifugation - Schedule||5
11310596|NCT02652442|12509346|FG000|COMPLETED|Centrifugation - Schedule||5
11310597|NCT02652442|12509346|FG000|NOT COMPLETED|Centrifugation - Schedule||0
11310598|NCT02652481|12509358|FG000|STARTED|Phase 1||239
11310599|NCT02652481|12509358|FG000|COMPLETED|Phase 1||141
11310600|NCT02652481|12509358|FG000|NOT COMPLETED|Phase 1||98
11310601|NCT02652481|12509358|FG000|STARTED|Phase 2||261
11310602|NCT02652481|12509358|FG000|COMPLETED|Phase 2||243
11310603|NCT02652481|12509358|FG000|NOT COMPLETED|Phase 2||18
11310604|NCT02652624|12509364|FG000|STARTED|Randomized Phase||234
11310605|NCT02652624|12509365|FG001|STARTED|Randomized Phase||236
11310606|NCT02652624|12509364|FG000|COMPLETED|Randomized Phase||231
11310607|NCT02652624|12509365|FG001|COMPLETED|Randomized Phase||231
11310608|NCT02652624|12509364|FG000|NOT COMPLETED|Randomized Phase||3
11310609|NCT02652624|12509365|FG001|NOT COMPLETED|Randomized Phase||5
11310610|NCT02652624|12509364|FG000|STARTED|Extension Phase||231
11310611|NCT02652624|12509365|FG001|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228
11310612|NCT02652624|12509364|FG000|COMPLETED|Extension Phase||227
11310613|NCT02652624|12509365|FG001|COMPLETED|Extension Phase||224
11310614|NCT02652624|12509364|FG000|NOT COMPLETED|Extension Phase||4
11310615|NCT02652624|12509365|FG001|NOT COMPLETED|Extension Phase||4
11310616|NCT02652780|12509373|FG000|STARTED|Overall Study||37
11310617|NCT02652780|12509373|FG000|COMPLETED|Overall Study||37
11310618|NCT02652780|12509373|FG000|NOT COMPLETED|Overall Study||0
11310619|NCT02653144|12509383|FG000|STARTED|Overall Study||30
11310620|NCT02653144|12509384|FG001|STARTED|Overall Study||28
11310621|NCT02653144|12509385|FG002|STARTED|Overall Study||31
11310622|NCT02653144|12509383|FG000|COMPLETED|Overall Study||30
11310623|NCT02653144|12509384|FG001|COMPLETED|Overall Study||28
11310624|NCT02653144|12509385|FG002|COMPLETED|Overall Study||31
11310625|NCT02653144|12509383|FG000|NOT COMPLETED|Overall Study||0
11310626|NCT02653144|12509384|FG001|NOT COMPLETED|Overall Study||0
11310627|NCT02653144|12509385|FG002|NOT COMPLETED|Overall Study||0
11310628|NCT02653170|12509396|FG000|STARTED|Overall Study||87
11310629|NCT02653170|12509397|FG001|STARTED|Overall Study||88
11310630|NCT02653170|12509398|FG002|STARTED|Overall Study||90
11310631|NCT02653170|12509396|FG000|COMPLETED|Overall Study||70
11310632|NCT02653170|12509397|FG001|COMPLETED|Overall Study||72
11310633|NCT02653170|12509398|FG002|COMPLETED|Overall Study||72
11310634|NCT02653170|12509396|FG000|NOT COMPLETED|Overall Study||17
11310635|NCT02653170|12509397|FG001|NOT COMPLETED|Overall Study||16
11310636|NCT02653170|12509398|FG002|NOT COMPLETED|Overall Study||18
11310637|NCT02653183|12509408|FG000|STARTED|Overall Study||53
11310638|NCT02653183|12509409|FG001|STARTED|Overall Study||50
11310639|NCT02653183|12509408|FG000|COMPLETED|Overall Study||49
11310640|NCT02653183|12509409|FG001|COMPLETED|Overall Study||46
11310641|NCT02653183|12509408|FG000|NOT COMPLETED|Overall Study||4
11310642|NCT02653183|12509409|FG001|NOT COMPLETED|Overall Study||4
11310643|NCT02653300|12509415|FG000|STARTED|Overall Study||10
11310644|NCT02653300|12509415|FG000|COMPLETED|Overall Study||8
11310645|NCT02653300|12509415|FG000|NOT COMPLETED|Overall Study||2
11310646|NCT02653326|12509421|FG000|STARTED|Overall Study||32
11310647|NCT02653326|12509422|FG001|STARTED|Overall Study||34
11310648|NCT02653326|12509421|FG000|COMPLETED|Overall Study||22
11310649|NCT02653326|12509422|FG001|COMPLETED|Overall Study||27
11310650|NCT02653326|12509421|FG000|NOT COMPLETED|Overall Study||10
11310651|NCT02653326|12509422|FG001|NOT COMPLETED|Overall Study||7
11310652|NCT02653391|12509431|FG000|STARTED|Overall Study||18
11310653|NCT02653391|12509432|FG001|STARTED|Overall Study||3
11310654|NCT02653391|12509433|FG002|STARTED|Overall Study||1
11310655|NCT02653391|12509431|FG000|COMPLETED|Overall Study||16
11310656|NCT02653391|12509432|FG001|COMPLETED|Overall Study||1
11310657|NCT02653391|12509433|FG002|COMPLETED|Overall Study||1
11310658|NCT02653391|12509431|FG000|NOT COMPLETED|Overall Study||2
11310659|NCT02653391|12509432|FG001|NOT COMPLETED|Overall Study||2
11310660|NCT02653391|12509433|FG002|NOT COMPLETED|Overall Study||0
11310661|NCT02653417|12509481|FG000|STARTED|Overall Study||38
11310662|NCT02653417|12509482|FG001|STARTED|Overall Study||34
11310663|NCT02653417|12509483|FG002|STARTED|Overall Study||29
11310664|NCT02653417|12509484|FG003|STARTED|Overall Study||38
11310665|NCT02653417|12509481|FG000|COMPLETED|Overall Study||37
11310666|NCT02653417|12509482|FG001|COMPLETED|Overall Study||32
11310667|NCT02653417|12509483|FG002|COMPLETED|Overall Study||26
11310668|NCT02653417|12509484|FG003|COMPLETED|Overall Study||33
11310669|NCT02653417|12509481|FG000|NOT COMPLETED|Overall Study||1
11310670|NCT02653417|12509482|FG001|NOT COMPLETED|Overall Study||2
11310671|NCT02653417|12509483|FG002|NOT COMPLETED|Overall Study||3
11310672|NCT02653417|12509484|FG003|NOT COMPLETED|Overall Study||5
11310673|NCT02653456|12509498|FG000|STARTED|Overall Study||64
11310674|NCT02653456|12509498|FG000|COMPLETED|Overall Study||59
11310675|NCT02653456|12509498|FG000|NOT COMPLETED|Overall Study||5
11310676|NCT02653560|12509503|FG000|STARTED|KMgCit Phase||30
11310677|NCT02653560|12509504|FG001|STARTED|KMgCit Phase||0
11310678|NCT02653560|12509505|FG002|STARTED|KMgCit Phase||0
11310679|NCT02653560|12509506|FG003|STARTED|KMgCit Phase||0
11310680|NCT02653560|12509503|FG000|COMPLETED|KMgCit Phase||30
11310681|NCT02653560|12509504|FG001|COMPLETED|KMgCit Phase||0
11310682|NCT02653560|12509505|FG002|COMPLETED|KMgCit Phase||0
11310683|NCT02653560|12509506|FG003|COMPLETED|KMgCit Phase||0
11310684|NCT02653560|12509503|FG000|NOT COMPLETED|KMgCit Phase||0
11310685|NCT02653560|12509504|FG001|NOT COMPLETED|KMgCit Phase||0
11310686|NCT02653560|12509505|FG002|NOT COMPLETED|KMgCit Phase||0
11310687|NCT02653560|12509506|FG003|NOT COMPLETED|KMgCit Phase||0
11310688|NCT02653560|12509503|FG000|STARTED|K Citrate Phase||0
11310689|NCT02653560|12509504|FG001|STARTED|K Citrate Phase||30
11310690|NCT02653560|12509505|FG002|STARTED|K Citrate Phase||0
11310691|NCT02653560|12509506|FG003|STARTED|K Citrate Phase||0
11310692|NCT02653560|12509503|FG000|COMPLETED|K Citrate Phase||0
11310693|NCT02653560|12509504|FG001|COMPLETED|K Citrate Phase||30
11310694|NCT02653560|12509505|FG002|COMPLETED|K Citrate Phase||0
11310695|NCT02653560|12509506|FG003|COMPLETED|K Citrate Phase||0
11310696|NCT02653560|12509503|FG000|NOT COMPLETED|K Citrate Phase||0
11310697|NCT02653560|12509504|FG001|NOT COMPLETED|K Citrate Phase||0
11310698|NCT02653560|12509505|FG002|NOT COMPLETED|K Citrate Phase||0
11310699|NCT02653560|12509506|FG003|NOT COMPLETED|K Citrate Phase||0
11310700|NCT02653560|12509503|FG000|STARTED|KCl Phase||0
11310701|NCT02653560|12509504|FG001|STARTED|KCl Phase||0
11310702|NCT02653560|12509505|FG002|STARTED|KCl Phase||30
11310703|NCT02653560|12509506|FG003|STARTED|KCl Phase||0
11310704|NCT02653560|12509503|FG000|COMPLETED|KCl Phase||0
11310705|NCT02653560|12509504|FG001|COMPLETED|KCl Phase||0
11310706|NCT02653560|12509505|FG002|COMPLETED|KCl Phase||30
11310707|NCT02653560|12509506|FG003|COMPLETED|KCl Phase||0
11310708|NCT02653560|12509503|FG000|NOT COMPLETED|KCl Phase||0
11310709|NCT02653560|12509504|FG001|NOT COMPLETED|KCl Phase||0
11310710|NCT02653560|12509505|FG002|NOT COMPLETED|KCl Phase||0
11310711|NCT02653560|12509506|FG003|NOT COMPLETED|KCl Phase||0
11310712|NCT02653560|12509503|FG000|STARTED|Placebo Phase||0
11310713|NCT02653560|12509504|FG001|STARTED|Placebo Phase||0
11310714|NCT02653560|12509505|FG002|STARTED|Placebo Phase||0
11310715|NCT02653560|12509506|FG003|STARTED|Placebo Phase||30
11310716|NCT02653560|12509503|FG000|COMPLETED|Placebo Phase||0
11310717|NCT02653560|12509504|FG001|COMPLETED|Placebo Phase||0
11310718|NCT02653560|12509505|FG002|COMPLETED|Placebo Phase||0
11310719|NCT02653560|12509506|FG003|COMPLETED|Placebo Phase||30
11310720|NCT02653560|12509503|FG000|NOT COMPLETED|Placebo Phase||0
11310721|NCT02653560|12509504|FG001|NOT COMPLETED|Placebo Phase||0
11310722|NCT02653560|12509505|FG002|NOT COMPLETED|Placebo Phase||0
11310723|NCT02653560|12509506|FG003|NOT COMPLETED|Placebo Phase||0
11310724|NCT02653625|12509516|FG000|STARTED|Overall Study||24
11310725|NCT02653625|12509516|FG000|COMPLETED|Overall Study||20
11310726|NCT02653625|12509516|FG000|NOT COMPLETED|Overall Study||4
11310727|NCT02653664|12509523|FG000|STARTED|Post-Treatment||110
11310728|NCT02653664|12509524|FG001|STARTED|Post-Treatment||110
11310729|NCT02653664|12509525|FG002|STARTED|Post-Treatment||108
11310730|NCT02653664|12509523|FG000|Primary and Secondary Data|Post-Treatment||93
11310731|NCT02653664|12509524|FG001|Primary and Secondary Data|Post-Treatment||104
11310732|NCT02653664|12509525|FG002|Primary and Secondary Data|Post-Treatment||91
11310733|NCT02653664|12509523|FG000|Primary Outcome Data Only|Post-Treatment||3
11310734|NCT02653664|12509524|FG001|Primary Outcome Data Only|Post-Treatment||0
11310735|NCT02653664|12509525|FG002|Primary Outcome Data Only|Post-Treatment||3
11310736|NCT02653664|12509523|FG000|COMPLETED|Post-Treatment||96
11310737|NCT02653664|12509524|FG001|COMPLETED|Post-Treatment||104
11310738|NCT02653664|12509525|FG002|COMPLETED|Post-Treatment||94
11310739|NCT02653664|12509523|FG000|NOT COMPLETED|Post-Treatment||14
11310740|NCT02653664|12509524|FG001|NOT COMPLETED|Post-Treatment||6
11310741|NCT02653664|12509525|FG002|NOT COMPLETED|Post-Treatment||14
11310742|NCT02653664|12509523|FG000|STARTED|3 Month Follow-Up||110
11310743|NCT02653664|12509524|FG001|STARTED|3 Month Follow-Up||110
11310744|NCT02653664|12509525|FG002|STARTED|3 Month Follow-Up||108
11310745|NCT02653664|12509523|FG000|Primary and Secondary Data|3 Month Follow-Up||83
11310746|NCT02653664|12509524|FG001|Primary and Secondary Data|3 Month Follow-Up||95
11310747|NCT02653664|12509525|FG002|Primary and Secondary Data|3 Month Follow-Up||82
11310748|NCT02653664|12509523|FG000|Primary Outcome Data Only|3 Month Follow-Up||6
11310749|NCT02653664|12509524|FG001|Primary Outcome Data Only|3 Month Follow-Up||0
11310750|NCT02653664|12509525|FG002|Primary Outcome Data Only|3 Month Follow-Up||1
11310751|NCT02653664|12509523|FG000|COMPLETED|3 Month Follow-Up||89
11310752|NCT02653664|12509524|FG001|COMPLETED|3 Month Follow-Up||95
11310753|NCT02653664|12509525|FG002|COMPLETED|3 Month Follow-Up||83
11310754|NCT02653664|12509523|FG000|NOT COMPLETED|3 Month Follow-Up||21
11310755|NCT02653664|12509524|FG001|NOT COMPLETED|3 Month Follow-Up||15
11310756|NCT02653664|12509525|FG002|NOT COMPLETED|3 Month Follow-Up||25
11310757|NCT02653664|12509523|FG000|STARTED|6 Month Follow-Up||110
11310758|NCT02653664|12509524|FG001|STARTED|6 Month Follow-Up||110
11310759|NCT02653664|12509525|FG002|STARTED|6 Month Follow-Up||108
11310760|NCT02653664|12509523|FG000|Primary and Secondary Outcome Data|6 Month Follow-Up||85
11310761|NCT02653664|12509524|FG001|Primary and Secondary Outcome Data|6 Month Follow-Up||87
11310762|NCT02653664|12509525|FG002|Primary and Secondary Outcome Data|6 Month Follow-Up||83
11310763|NCT02653664|12509523|FG000|Primary Outcome Data Only|6 Month Follow-Up||2
11310764|NCT02653664|12509524|FG001|Primary Outcome Data Only|6 Month Follow-Up||2
11310765|NCT02653664|12509525|FG002|Primary Outcome Data Only|6 Month Follow-Up||2
11310766|NCT02653664|12509523|FG000|COMPLETED|6 Month Follow-Up||87
11310767|NCT02653664|12509524|FG001|COMPLETED|6 Month Follow-Up||89
11310768|NCT02653664|12509525|FG002|COMPLETED|6 Month Follow-Up||85
11310769|NCT02653664|12509523|FG000|NOT COMPLETED|6 Month Follow-Up||23
11310770|NCT02653664|12509524|FG001|NOT COMPLETED|6 Month Follow-Up||21
11310771|NCT02653664|12509525|FG002|NOT COMPLETED|6 Month Follow-Up||23
11310772|NCT02653768|12509538|FG000|STARTED|3-Month Follow-Up||230
11310773|NCT02653768|12509539|FG001|STARTED|3-Month Follow-Up||115
11310774|NCT02653768|12509538|FG000|COMPLETED|3-Month Follow-Up||164
11310775|NCT02653768|12509539|FG001|COMPLETED|3-Month Follow-Up||100
11310776|NCT02653768|12509538|FG000|NOT COMPLETED|3-Month Follow-Up||66
11310777|NCT02653768|12509539|FG001|NOT COMPLETED|3-Month Follow-Up||15
11310778|NCT02653768|12509538|FG000|STARTED|6-Month Follow-Up|21 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|209
11310779|NCT02653768|12509539|FG001|STARTED|6-Month Follow-Up|2 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|113
11310780|NCT02653768|12509538|FG000|COMPLETED|6-Month Follow-Up||164
11310781|NCT02653768|12509539|FG001|COMPLETED|6-Month Follow-Up||100
11310782|NCT02653768|12509538|FG000|NOT COMPLETED|6-Month Follow-Up||45
11310783|NCT02653768|12509539|FG001|NOT COMPLETED|6-Month Follow-Up||13
11310784|NCT02653768|12509538|FG000|STARTED|9-Month Follow-Up (Primary)|34 withdrew/excluded before 9 months; others missed prior assessments but remained in study|196
11310785|NCT02653768|12509539|FG001|STARTED|9-Month Follow-Up (Primary)|4 withdrew/excluded before 9 months; others missed prior assessments but remained in study|111
11310786|NCT02653768|12509538|FG000|COMPLETED|9-Month Follow-Up (Primary)|13 withdrew/refused before 9 months; others missed prior assessments but remained in study|163
11310787|NCT02653768|12509539|FG001|COMPLETED|9-Month Follow-Up (Primary)||95
11310788|NCT02653768|12509538|FG000|NOT COMPLETED|9-Month Follow-Up (Primary)||33
11310789|NCT02653768|12509539|FG001|NOT COMPLETED|9-Month Follow-Up (Primary)||16
11310790|NCT02653872|12509545|FG000|STARTED|Overall Study||15
11310791|NCT02653872|12509545|FG000|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
11310792|NCT02653872|12509545|FG000|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
11342188|NCT02942485|12539737|FG001|STARTED|Overall Study||1
11310793|NCT02653872|12509545|FG000|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
11310794|NCT02653872|12509545|FG000|COMPLETED|Overall Study||15
11310795|NCT02653872|12509545|FG000|NOT COMPLETED|Overall Study||0
11310796|NCT02654002|12509568|FG000|STARTED|Overall Study||12
11310797|NCT02654002|12509569|FG001|STARTED|Overall Study||12
11310798|NCT02654002|12509570|FG002|STARTED|Overall Study||12
11310799|NCT02654002|12509571|FG003|STARTED|Overall Study||12
11310800|NCT02654002|12509572|FG004|STARTED|Overall Study||12
11310801|NCT02654002|12509573|FG005|STARTED|Overall Study||12
11310802|NCT02654002|12509574|FG006|STARTED|Overall Study||12
11310803|NCT02654002|12509575|FG007|STARTED|Overall Study||12
11310804|NCT02654002|12509576|FG008|STARTED|Overall Study||24
11310805|NCT02654002|12509568|FG000|COMPLETED|Overall Study||12
11310806|NCT02654002|12509569|FG001|COMPLETED|Overall Study||12
11310807|NCT02654002|12509570|FG002|COMPLETED|Overall Study||12
11310808|NCT02654002|12509571|FG003|COMPLETED|Overall Study||12
11310809|NCT02654002|12509572|FG004|COMPLETED|Overall Study||12
11310810|NCT02654002|12509573|FG005|COMPLETED|Overall Study||11
11310811|NCT02654002|12509574|FG006|COMPLETED|Overall Study||11
11310812|NCT02654002|12509575|FG007|COMPLETED|Overall Study||11
11310813|NCT02654002|12509576|FG008|COMPLETED|Overall Study||24
11310814|NCT02654002|12509568|FG000|NOT COMPLETED|Overall Study||0
11310815|NCT02654002|12509569|FG001|NOT COMPLETED|Overall Study||0
11310816|NCT02654002|12509570|FG002|NOT COMPLETED|Overall Study||0
11310817|NCT02654002|12509571|FG003|NOT COMPLETED|Overall Study||0
11310818|NCT02654002|12509572|FG004|NOT COMPLETED|Overall Study||0
11310819|NCT02654002|12509573|FG005|NOT COMPLETED|Overall Study||1
11310820|NCT02654002|12509574|FG006|NOT COMPLETED|Overall Study||1
11310821|NCT02654002|12509575|FG007|NOT COMPLETED|Overall Study||1
11310822|NCT02654002|12509576|FG008|NOT COMPLETED|Overall Study||0
11310823|NCT02654054|12509614|FG000|STARTED|Treatment Period||102
11310824|NCT02654054|12509615|FG001|STARTED|Treatment Period||104
11310825|NCT02654054|12509616|FG002|STARTED|Treatment Period||207
11310826|NCT02654054|12509614|FG000|Randomized and Treated|Treatment Period||102
11310827|NCT02654054|12509615|FG001|Randomized and Treated|Treatment Period||104
11310828|NCT02654054|12509616|FG002|Randomized and Treated|Treatment Period||206
11310829|NCT02654054|12509614|FG000|COMPLETED|Treatment Period||83
11310830|NCT02654054|12509615|FG001|COMPLETED|Treatment Period||81
11310831|NCT02654054|12509616|FG002|COMPLETED|Treatment Period||164
11310832|NCT02654054|12509614|FG000|NOT COMPLETED|Treatment Period||19
11310833|NCT02654054|12509615|FG001|NOT COMPLETED|Treatment Period||23
11310834|NCT02654054|12509616|FG002|NOT COMPLETED|Treatment Period||43
11310835|NCT02654054|12509614|FG000|STARTED|Post-Treatment Follow-Up Period||25
11310836|NCT02654054|12509615|FG001|STARTED|Post-Treatment Follow-Up Period||32
11310837|NCT02654054|12509616|FG002|STARTED|Post-Treatment Follow-Up Period||59
11310838|NCT02654054|12509614|FG000|COMPLETED|Post-Treatment Follow-Up Period||17
11310839|NCT02654054|12509615|FG001|COMPLETED|Post-Treatment Follow-Up Period||24
11310840|NCT02654054|12509616|FG002|COMPLETED|Post-Treatment Follow-Up Period||29
11310841|NCT02654054|12509614|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||8
11310842|NCT02654054|12509615|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||8
11310843|NCT02654054|12509616|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||30
11310844|NCT02654145|12509625|FG000|STARTED|Overall Study||145
11310845|NCT02654145|12509625|FG000|COMPLETED|Overall Study||138
11310846|NCT02654145|12509625|FG000|NOT COMPLETED|Overall Study||7
11310847|NCT02654483|12509631|FG000|STARTED|Double-blind||7
11310848|NCT02654483|12509632|FG001|STARTED|Double-blind||7
11310849|NCT02654483|12509631|FG000|COMPLETED|Double-blind||7
11310850|NCT02654483|12509632|FG001|COMPLETED|Double-blind||7
11310851|NCT02654483|12509631|FG000|NOT COMPLETED|Double-blind||0
11310852|NCT02654483|12509632|FG001|NOT COMPLETED|Double-blind||0
11310853|NCT02654483|12509631|FG000|STARTED|Open-label|2 participants did not proceed to open-label arm|5
11310854|NCT02654483|12509632|FG001|STARTED|Open-label|4 participants did not continue to open-label arm|3
11310855|NCT02654483|12509631|FG000|COMPLETED|Open-label||5
11310856|NCT02654483|12509632|FG001|COMPLETED|Open-label||3
11310857|NCT02654483|12509631|FG000|NOT COMPLETED|Open-label||0
11310858|NCT02654483|12509632|FG001|NOT COMPLETED|Open-label||0
11310859|NCT02654652|12509646|FG000|STARTED|Overall Study||19
11310860|NCT02654652|12509647|FG001|STARTED|Overall Study||21
11310861|NCT02654652|12509646|FG000|COMPLETED|Overall Study||18
11310862|NCT02654652|12509647|FG001|COMPLETED|Overall Study||18
11310863|NCT02654652|12509646|FG000|NOT COMPLETED|Overall Study||1
11310864|NCT02654652|12509647|FG001|NOT COMPLETED|Overall Study||3
11310865|NCT02654691|12509653|FG000|STARTED|Overall Study||63
11310866|NCT02654691|12509653|FG000|COMPLETED|Overall Study||63
11310867|NCT02654691|12509653|FG000|NOT COMPLETED|Overall Study||0
11310868|NCT02654717|12509659|FG000|STARTED|Overall Study||56
11310869|NCT02654717|12509660|FG001|STARTED|Overall Study||55
11310870|NCT02654717|12509659|FG000|COMPLETED|Overall Study||50
11310871|NCT02654717|12509660|FG001|COMPLETED|Overall Study||50
11310872|NCT02654717|12509659|FG000|NOT COMPLETED|Overall Study||6
11310873|NCT02654717|12509660|FG001|NOT COMPLETED|Overall Study||5
11310874|NCT02654769|12509669|FG000|STARTED|Overall Study||149
11310875|NCT02654769|12509670|FG001|STARTED|Overall Study||149
11310876|NCT02654769|12509671|FG002|STARTED|Overall Study||143
11310877|NCT02654769|12509669|FG000|COMPLETED|Overall Study||145
11310878|NCT02654769|12509670|FG001|COMPLETED|Overall Study||148
11310879|NCT02654769|12509671|FG002|COMPLETED|Overall Study||142
11310880|NCT02654769|12509669|FG000|NOT COMPLETED|Overall Study||4
11310881|NCT02654769|12509670|FG001|NOT COMPLETED|Overall Study||1
11310882|NCT02654769|12509671|FG002|NOT COMPLETED|Overall Study||1
11310883|NCT02654808|12509683|FG000|STARTED|Overall Study||33
11310884|NCT02654808|12509684|FG001|STARTED|Overall Study||33
11310885|NCT02654808|12509685|FG002|STARTED|Overall Study||33
11310886|NCT02654808|12509686|FG003|STARTED|Overall Study||33
11310887|NCT02654808|12509683|FG000|COMPLETED|Overall Study||33
11310888|NCT02654808|12509684|FG001|COMPLETED|Overall Study||33
11310889|NCT02654808|12509685|FG002|COMPLETED|Overall Study||33
11310890|NCT02654808|12509686|FG003|COMPLETED|Overall Study||33
11310891|NCT02654808|12509683|FG000|NOT COMPLETED|Overall Study||0
11310892|NCT02654808|12509684|FG001|NOT COMPLETED|Overall Study||0
11310893|NCT02654808|12509685|FG002|NOT COMPLETED|Overall Study||0
11310894|NCT02654808|12509686|FG003|NOT COMPLETED|Overall Study||0
11310895|NCT02654860|12509704|FG000|STARTED|First Part||3
11310896|NCT02654860|12509705|FG001|STARTED|First Part||3
11310897|NCT02654860|12509706|FG002|STARTED|First Part||3
11310898|NCT02654860|12509707|FG003|STARTED|First Part||0
11310899|NCT02654860|12509704|FG000|COMPLETED|First Part||3
11310900|NCT02654860|12509705|FG001|COMPLETED|First Part||3
11310901|NCT02654860|12509706|FG002|COMPLETED|First Part||3
11310902|NCT02654860|12509707|FG003|COMPLETED|First Part||0
11310903|NCT02654860|12509704|FG000|NOT COMPLETED|First Part||0
11310904|NCT02654860|12509705|FG001|NOT COMPLETED|First Part||0
11310905|NCT02654860|12509706|FG002|NOT COMPLETED|First Part||0
11310906|NCT02654860|12509707|FG003|NOT COMPLETED|First Part||0
11310907|NCT02654860|12509704|FG000|STARTED|Second Part||15
11310908|NCT02654860|12509705|FG001|STARTED|Second Part||15
11310909|NCT02654860|12509706|FG002|STARTED|Second Part||15
11310910|NCT02654860|12509707|FG003|STARTED|Second Part||15
11310911|NCT02654860|12509704|FG000|COMPLETED|Second Part||15
11310912|NCT02654860|12509705|FG001|COMPLETED|Second Part||15
11310913|NCT02654860|12509706|FG002|COMPLETED|Second Part||15
11310914|NCT02654860|12509707|FG003|COMPLETED|Second Part||15
11310915|NCT02654860|12509704|FG000|NOT COMPLETED|Second Part||0
11310916|NCT02654860|12509705|FG001|NOT COMPLETED|Second Part||0
11310917|NCT02654860|12509706|FG002|NOT COMPLETED|Second Part||0
11310918|NCT02654860|12509707|FG003|NOT COMPLETED|Second Part||0
11310919|NCT02654977|12509717|FG000|STARTED|Overall Study||11
11310920|NCT02654977|12509717|FG000|COMPLETED|Overall Study||4
11310921|NCT02654977|12509717|FG000|NOT COMPLETED|Overall Study||7
11310922|NCT02655224|12509723|FG000|STARTED|Overall Study||33
11310923|NCT02655224|12509724|FG001|STARTED|Overall Study||32
11310924|NCT02655224|12509723|FG000|COMPLETED|Overall Study||32
11310925|NCT02655224|12509724|FG001|COMPLETED|Overall Study||31
11310926|NCT02655224|12509723|FG000|NOT COMPLETED|Overall Study||1
11310927|NCT02655224|12509724|FG001|NOT COMPLETED|Overall Study||1
11310928|NCT02655237|12509732|FG000|STARTED|Overall Study||139
11310929|NCT02655237|12509733|FG001|STARTED|Overall Study||142
11310930|NCT02655237|12509732|FG000|COMPLETED|Overall Study||122
11310931|NCT02655237|12509733|FG001|COMPLETED|Overall Study||131
11310932|NCT02655237|12509732|FG000|NOT COMPLETED|Overall Study||17
11310933|NCT02655237|12509733|FG001|NOT COMPLETED|Overall Study||11
11310934|NCT02655354|12509741|FG000|STARTED|Overall Study||265
11310935|NCT02655354|12509742|FG001|STARTED|Overall Study||370
11310936|NCT02655354|12509741|FG000|COMPLETED|Overall Study||188
11310937|NCT02655354|12509742|FG001|COMPLETED|Overall Study||289
11310938|NCT02655354|12509741|FG000|NOT COMPLETED|Overall Study||77
11310939|NCT02655354|12509742|FG001|NOT COMPLETED|Overall Study||81
11310940|NCT02655419|12509750|FG000|STARTED|Overall Study||17
11310941|NCT02655419|12509751|FG001|STARTED|Overall Study||23
11310942|NCT02655419|12509750|FG000|Treated|Overall Study||16
11310943|NCT02655419|12509751|FG001|Treated|Overall Study||18
11310944|NCT02655419|12509750|FG000|COMPLETED|Overall Study||12
11310945|NCT02655419|12509751|FG001|COMPLETED|Overall Study||16
11310946|NCT02655419|12509750|FG000|NOT COMPLETED|Overall Study||5
11310947|NCT02655419|12509751|FG001|NOT COMPLETED|Overall Study||7
11310948|NCT02655510|12509764|FG000|STARTED|Overall Study||6
11310949|NCT02655510|12509765|FG001|STARTED|Overall Study||6
11310950|NCT02655510|12509766|FG002|STARTED|Overall Study||6
11310951|NCT02655510|12509764|FG000|COMPLETED|Overall Study||6
11310952|NCT02655510|12509765|FG001|COMPLETED|Overall Study||6
11310953|NCT02655510|12509766|FG002|COMPLETED|Overall Study||6
11310954|NCT02655510|12509764|FG000|NOT COMPLETED|Overall Study||0
11310955|NCT02655510|12509765|FG001|NOT COMPLETED|Overall Study||0
11310956|NCT02655510|12509766|FG002|NOT COMPLETED|Overall Study||0
11310957|NCT02655653|12509776|FG000|STARTED|Overall Study||56
11310958|NCT02655653|12509777|FG001|STARTED|Overall Study||58
11310959|NCT02655653|12509776|FG000|COMPLETED|Overall Study||56
11310960|NCT02655653|12509777|FG001|COMPLETED|Overall Study||58
11310961|NCT02655653|12509776|FG000|NOT COMPLETED|Overall Study||0
11310962|NCT02655653|12509777|FG001|NOT COMPLETED|Overall Study||0
11310963|NCT02655666|12509789|FG000|STARTED|Overall Study||16
11310964|NCT02655666|12509789|FG000|COMPLETED|Overall Study||4
11310965|NCT02655666|12509789|FG000|NOT COMPLETED|Overall Study||12
11310966|NCT02655679|12509798|FG000|STARTED|Overall Study||21
11310967|NCT02655679|12509799|FG001|STARTED|Overall Study||19
11310968|NCT02655679|12509800|FG002|STARTED|Overall Study||20
11310969|NCT02655679|12509801|FG003|STARTED|Overall Study||24
11310970|NCT02655679|12509802|FG004|STARTED|Overall Study||20
11310971|NCT02655679|12509798|FG000|Received Study Drug (Safety Population)|Overall Study||20
11310972|NCT02655679|12509799|FG001|Received Study Drug (Safety Population)|Overall Study||19
11310973|NCT02655679|12509800|FG002|Received Study Drug (Safety Population)|Overall Study||20
11310974|NCT02655679|12509801|FG003|Received Study Drug (Safety Population)|Overall Study||24
11310975|NCT02655679|12509802|FG004|Received Study Drug (Safety Population)|Overall Study||20
11310976|NCT02655679|12509798|FG000|COMPLETED|Overall Study||18
11310977|NCT02655679|12509799|FG001|COMPLETED|Overall Study||16
11310978|NCT02655679|12509800|FG002|COMPLETED|Overall Study||19
11310979|NCT02655679|12509801|FG003|COMPLETED|Overall Study||20
11310980|NCT02655679|12509802|FG004|COMPLETED|Overall Study||19
11310981|NCT02655679|12509798|FG000|NOT COMPLETED|Overall Study||3
11310982|NCT02655679|12509799|FG001|NOT COMPLETED|Overall Study||3
11310983|NCT02655679|12509800|FG002|NOT COMPLETED|Overall Study||1
11310984|NCT02655679|12509801|FG003|NOT COMPLETED|Overall Study||4
11310985|NCT02655679|12509802|FG004|NOT COMPLETED|Overall Study||1
11310986|NCT02655887|12509815|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|170
11310987|NCT02655887|12509815|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|156
11310988|NCT02655887|12509815|FG000|NOT COMPLETED|Overall Study||14
11310989|NCT02656069|12509821|FG000|STARTED|First Intervention||44
11310990|NCT02656069|12509822|FG001|STARTED|First Intervention||36
11310991|NCT02656069|12509821|FG000|COMPLETED|First Intervention||44
11310992|NCT02656069|12509822|FG001|COMPLETED|First Intervention||36
11310993|NCT02656069|12509821|FG000|NOT COMPLETED|First Intervention||0
11310994|NCT02656069|12509822|FG001|NOT COMPLETED|First Intervention||0
11310995|NCT02656069|12509821|FG000|STARTED|Second Intervention||44
11310996|NCT02656069|12509822|FG001|STARTED|Second Intervention||36
11310997|NCT02656069|12509821|FG000|COMPLETED|Second Intervention||43
11310998|NCT02656069|12509822|FG001|COMPLETED|Second Intervention||35
11310999|NCT02656069|12509821|FG000|NOT COMPLETED|Second Intervention||1
11311000|NCT02656069|12509822|FG001|NOT COMPLETED|Second Intervention||1
11311001|NCT02656160|12509828|FG000|STARTED|First Study Night||7
11311002|NCT02656160|12509829|FG001|STARTED|First Study Night||6
11311003|NCT02656160|12509828|FG000|COMPLETED|First Study Night||7
11311004|NCT02656160|12509829|FG001|COMPLETED|First Study Night||6
11311005|NCT02656160|12509828|FG000|NOT COMPLETED|First Study Night||0
11311006|NCT02656160|12509829|FG001|NOT COMPLETED|First Study Night||0
11311007|NCT02656160|12509828|FG000|STARTED|Second Study Night|3 subjects did not return for the second study night|4
11311008|NCT02656160|12509829|FG001|STARTED|Second Study Night||6
11311009|NCT02656160|12509828|FG000|COMPLETED|Second Study Night||4
11311010|NCT02656160|12509829|FG001|COMPLETED|Second Study Night||6
11311011|NCT02656160|12509828|FG000|NOT COMPLETED|Second Study Night||0
11311012|NCT02656160|12509829|FG001|NOT COMPLETED|Second Study Night||0
11311013|NCT02656173|12509837|FG000|STARTED|Overall Study||285
11311014|NCT02656173|12509838|FG001|STARTED|Overall Study||283
11311015|NCT02656173|12509837|FG000|Received Treatment|Overall Study||284
11311016|NCT02656173|12509838|FG001|Received Treatment|Overall Study||282
11311017|NCT02656173|12509837|FG000|COMPLETED|Overall Study||272
11311018|NCT02656173|12509838|FG001|COMPLETED|Overall Study||272
11311019|NCT02656173|12509837|FG000|NOT COMPLETED|Overall Study||13
11311020|NCT02656173|12509838|FG001|NOT COMPLETED|Overall Study||11
11311021|NCT02656329|12509848|FG000|STARTED|Overall Study||164
11311022|NCT02656329|12509849|FG001|STARTED|Overall Study||157
11311023|NCT02656329|12509848|FG000|COMPLETED|Overall Study||0
11311024|NCT02656329|12509849|FG001|COMPLETED|Overall Study||0
11311025|NCT02656329|12509848|FG000|NOT COMPLETED|Overall Study||164
11311026|NCT02656329|12509849|FG001|NOT COMPLETED|Overall Study||157
11311027|NCT02656420|12509860|FG000|STARTED|Overall Study||55
11311028|NCT02656420|12509861|FG001|STARTED|Overall Study||25
11311029|NCT02656420|12509862|FG002|STARTED|Overall Study||35
11311030|NCT02656420|12509863|FG003|STARTED|Overall Study||55
11311031|NCT02656420|12509860|FG000|COMPLETED|Overall Study||55
11311032|NCT02656420|12509861|FG001|COMPLETED|Overall Study||24
11311033|NCT02656420|12509862|FG002|COMPLETED|Overall Study||35
11311034|NCT02656420|12509863|FG003|COMPLETED|Overall Study||55
11311035|NCT02656420|12509860|FG000|NOT COMPLETED|Overall Study||0
11311036|NCT02656420|12509861|FG001|NOT COMPLETED|Overall Study||1
11311037|NCT02656420|12509862|FG002|NOT COMPLETED|Overall Study||0
11311038|NCT02656420|12509863|FG003|NOT COMPLETED|Overall Study||0
11311039|NCT02656485|12509879|FG000|STARTED|Overall Study||9
11311040|NCT02656485|12509880|FG001|STARTED|Overall Study||9
11311041|NCT02656485|12509881|FG002|STARTED|Overall Study||9
11311042|NCT02656485|12509882|FG003|STARTED|Overall Study||9
11311043|NCT02656485|12509879|FG000|COMPLETED|Overall Study||7
11311044|NCT02656485|12509880|FG001|COMPLETED|Overall Study||6
11311045|NCT02656485|12509881|FG002|COMPLETED|Overall Study||7
11311046|NCT02656485|12509882|FG003|COMPLETED|Overall Study||7
11311047|NCT02656485|12509879|FG000|NOT COMPLETED|Overall Study||2
11311048|NCT02656485|12509880|FG001|NOT COMPLETED|Overall Study||3
11311049|NCT02656485|12509881|FG002|NOT COMPLETED|Overall Study||2
11311050|NCT02656485|12509882|FG003|NOT COMPLETED|Overall Study||2
11311051|NCT02656680|12509896|FG000|STARTED|Overall Study||40
11311052|NCT02656680|12509897|FG001|STARTED|Overall Study||40
11311053|NCT02656680|12509896|FG000|COMPLETED|Overall Study||40
11311054|NCT02656680|12509897|FG001|COMPLETED|Overall Study||39
11311055|NCT02656680|12509896|FG000|NOT COMPLETED|Overall Study||0
11311056|NCT02656680|12509897|FG001|NOT COMPLETED|Overall Study||1
11311057|NCT02656693|12509908|FG000|STARTED|Overall Study||326
11311058|NCT02656693|12509909|FG001|STARTED|Overall Study||216
11311059|NCT02656693|12509910|FG002|STARTED|Overall Study||298
11311060|NCT02656693|12509908|FG000|COMPLETED|Overall Study||325
11311061|NCT02656693|12509909|FG001|COMPLETED|Overall Study||214
11311062|NCT02656693|12509910|FG002|COMPLETED|Overall Study||295
11311063|NCT02656693|12509908|FG000|NOT COMPLETED|Overall Study||1
11311064|NCT02656693|12509909|FG001|NOT COMPLETED|Overall Study||2
11311065|NCT02656693|12509910|FG002|NOT COMPLETED|Overall Study||3
11311066|NCT02656745|12509918|FG000|STARTED|Overall Study||416
11311067|NCT02656745|12509918|FG000|COMPLETED|Overall Study||416
11311068|NCT02656745|12509918|FG000|NOT COMPLETED|Overall Study||0
11311069|NCT02656836|12509925|FG000|STARTED|Overall Study||9
11311070|NCT02656836|12509925|FG000|COMPLETED|Overall Study||6
11311071|NCT02656836|12509925|FG000|NOT COMPLETED|Overall Study||3
11311072|NCT02656875|12509929|FG000|STARTED|Overall Study||768
11311073|NCT02656875|12509929|FG000|COMPLETED|Overall Study||698
11311074|NCT02656875|12509929|FG000|NOT COMPLETED|Overall Study||70
11311075|NCT02657031|12509935|FG000|STARTED|Overall Study||29
11311076|NCT02657031|12509936|FG001|STARTED|Overall Study||25
11311077|NCT02657031|12509935|FG000|COMPLETED|Overall Study||28
11311078|NCT02657031|12509936|FG001|COMPLETED|Overall Study||23
11311079|NCT02657031|12509935|FG000|NOT COMPLETED|Overall Study||1
11311080|NCT02657031|12509936|FG001|NOT COMPLETED|Overall Study||2
11311081|NCT02657226|12509942|FG000|STARTED|Overall Study||15724
11311082|NCT02657226|12509942|FG000|COMPLETED|Overall Study||15724
11311083|NCT02657226|12509942|FG000|NOT COMPLETED|Overall Study||0
11311084|NCT02657252|12509951|FG000|STARTED|Overall Study||57
11311085|NCT02657252|12509952|FG001|STARTED|Overall Study||58
11311086|NCT02657252|12509951|FG000|COMPLETED|Overall Study||47
11311087|NCT02657252|12509952|FG001|COMPLETED|Overall Study||51
11311088|NCT02657252|12509951|FG000|NOT COMPLETED|Overall Study||10
11311089|NCT02657252|12509952|FG001|NOT COMPLETED|Overall Study||7
11401886|NCT04073407|12596709|FG001|NOT COMPLETED|Part 1||1
11311090|NCT02657369|12509958|FG000|STARTED|Overall Study||34
11311091|NCT02657369|12509958|FG000|COMPLETED|Overall Study||0
11311092|NCT02657369|12509958|FG000|NOT COMPLETED|Overall Study||34
11311093|NCT02657408|12509964|FG000|STARTED|Overall Study||28
11311094|NCT02657408|12509965|FG001|STARTED|Overall Study||29
11311095|NCT02657408|12509964|FG000|COMPLETED|Overall Study||25
11311096|NCT02657408|12509965|FG001|COMPLETED|Overall Study||22
11311097|NCT02657408|12509964|FG000|NOT COMPLETED|Overall Study||3
11311098|NCT02657408|12509965|FG001|NOT COMPLETED|Overall Study||7
11311099|NCT02657538|12509971|FG000|STARTED|Overall Study||35
11311100|NCT02657538|12509971|FG000|Received Near Infrared Transillumination|Overall Study||35
11311101|NCT02657538|12509971|FG000|Received Visual Caries Detection + Bite|Overall Study||35
11311102|NCT02657538|12509971|FG000|COMPLETED|Overall Study||31
11311103|NCT02657538|12509971|FG000|NOT COMPLETED|Overall Study||4
11311104|NCT02657564|12509978|FG000|STARTED|Overall Study||1237
11311105|NCT02657564|12509978|FG000|COMPLETED|Overall Study||1163
11311106|NCT02657564|12509978|FG000|NOT COMPLETED|Overall Study||74
11311107|NCT02657629|12509985|FG000|STARTED|Overall Study||14
11311108|NCT02657629|12509986|FG001|STARTED|Overall Study||14
11311109|NCT02657629|12509985|FG000|COMPLETED|Overall Study||12
11311110|NCT02657629|12509986|FG001|COMPLETED|Overall Study||14
11311111|NCT02657629|12509985|FG000|NOT COMPLETED|Overall Study||2
11311112|NCT02657629|12509986|FG001|NOT COMPLETED|Overall Study||0
11311113|NCT02657889|12509996|FG000|STARTED|Overall Study||7
11311114|NCT02657889|12509997|FG001|STARTED|Overall Study||7
11311115|NCT02657889|12509998|FG002|STARTED|Overall Study||53
11311116|NCT02657889|12509999|FG003|STARTED|Overall Study||55
11311117|NCT02657889|12509996|FG000|COMPLETED|Overall Study||0
11311118|NCT02657889|12509997|FG001|COMPLETED|Overall Study||0
11311119|NCT02657889|12509998|FG002|COMPLETED|Overall Study||0
11311120|NCT02657889|12509999|FG003|COMPLETED|Overall Study||0
11311121|NCT02657889|12509996|FG000|NOT COMPLETED|Overall Study||7
11311122|NCT02657889|12509997|FG001|NOT COMPLETED|Overall Study||7
11311123|NCT02657889|12509998|FG002|NOT COMPLETED|Overall Study||53
11311124|NCT02657889|12509999|FG003|NOT COMPLETED|Overall Study||55
11311125|NCT02657915|12510013|FG000|STARTED|Overall Study||24
11311126|NCT02657915|12510014|FG001|STARTED|Overall Study||28
11311127|NCT02657915|12510013|FG000|Intent-to Treat (ITT) Population|Overall Study||24
11311128|NCT02657915|12510014|FG001|Intent-to Treat (ITT) Population|Overall Study||28
11311129|NCT02657915|12510013|FG000|Per-protocol Population|Overall Study||23
11311130|NCT02657915|12510014|FG001|Per-protocol Population|Overall Study||24
11311131|NCT02657915|12510013|FG000|COMPLETED|Overall Study||24
11311132|NCT02657915|12510014|FG001|COMPLETED|Overall Study||28
11311133|NCT02657915|12510013|FG000|NOT COMPLETED|Overall Study||0
11311134|NCT02657915|12510014|FG001|NOT COMPLETED|Overall Study||0
11311135|NCT02657928|12510022|FG000|STARTED|Overall Study||20
11311136|NCT02657928|12510023|FG001|STARTED|Overall Study||20
11311137|NCT02657928|12510022|FG000|COMPLETED|Overall Study||20
11311138|NCT02657928|12510023|FG001|COMPLETED|Overall Study||20
11311139|NCT02657928|12510022|FG000|NOT COMPLETED|Overall Study||0
11311140|NCT02657928|12510023|FG001|NOT COMPLETED|Overall Study||0
11311141|NCT02658019|12510030|FG000|STARTED|Overall Study||29
11311142|NCT02658019|12510030|FG000|COMPLETED|Overall Study||28
11311143|NCT02658019|12510030|FG000|NOT COMPLETED|Overall Study||1
11311144|NCT02658084|12510036|FG000|STARTED|Overall Study||2
11311145|NCT02658084|12510037|FG001|STARTED|Overall Study||0
11311146|NCT02658084|12510036|FG000|COMPLETED|Overall Study||0
11311147|NCT02658084|12510037|FG001|COMPLETED|Overall Study||0
11311148|NCT02658084|12510036|FG000|NOT COMPLETED|Overall Study||2
11311149|NCT02658084|12510037|FG001|NOT COMPLETED|Overall Study||0
11311150|NCT02658149|12510044|FG000|STARTED|Overall Study||50
11311151|NCT02658149|12510045|FG001|STARTED|Overall Study||50
11311152|NCT02658149|12510044|FG000|COMPLETED|Overall Study||49
11311153|NCT02658149|12510045|FG001|COMPLETED|Overall Study||50
11311154|NCT02658149|12510044|FG000|NOT COMPLETED|Overall Study||1
11311155|NCT02658149|12510045|FG001|NOT COMPLETED|Overall Study||0
11311156|NCT02658175|12510054|FG000|STARTED|Treatment Period: Weeks 1 to 52||51
11311157|NCT02658175|12510055|FG001|STARTED|Treatment Period: Weeks 1 to 52||14
11311158|NCT02658175|12510056|FG002|STARTED|Treatment Period: Weeks 1 to 52||3
11311159|NCT02658175|12510054|FG000|COMPLETED|Treatment Period: Weeks 1 to 52||36
11311160|NCT02658175|12510055|FG001|COMPLETED|Treatment Period: Weeks 1 to 52||7
11311161|NCT02658175|12510056|FG002|COMPLETED|Treatment Period: Weeks 1 to 52||3
11311162|NCT02658175|12510054|FG000|NOT COMPLETED|Treatment Period: Weeks 1 to 52||15
11311163|NCT02658175|12510055|FG001|NOT COMPLETED|Treatment Period: Weeks 1 to 52||7
11311164|NCT02658175|12510056|FG002|NOT COMPLETED|Treatment Period: Weeks 1 to 52||0
11311165|NCT02658175|12510054|FG000|STARTED|1st Extended Treatment: Weeks 53 to 104||36
11311166|NCT02658175|12510055|FG001|STARTED|1st Extended Treatment: Weeks 53 to 104||7
11311167|NCT02658175|12510056|FG002|STARTED|1st Extended Treatment: Weeks 53 to 104||3
11311168|NCT02658175|12510054|FG000|COMPLETED|1st Extended Treatment: Weeks 53 to 104||15
11311169|NCT02658175|12510055|FG001|COMPLETED|1st Extended Treatment: Weeks 53 to 104||5
11311170|NCT02658175|12510056|FG002|COMPLETED|1st Extended Treatment: Weeks 53 to 104||1
11311171|NCT02658175|12510054|FG000|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||21
11311172|NCT02658175|12510055|FG001|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
11311173|NCT02658175|12510056|FG002|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
11311174|NCT02658175|12510054|FG000|STARTED|2nd Extended Treatment: Weeks 105 to156||1
11311175|NCT02658175|12510055|FG001|STARTED|2nd Extended Treatment: Weeks 105 to156||0
11311176|NCT02658175|12510056|FG002|STARTED|2nd Extended Treatment: Weeks 105 to156||1
11311177|NCT02658175|12510054|FG000|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
11311178|NCT02658175|12510055|FG001|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
11311179|NCT02658175|12510056|FG002|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
11311180|NCT02658175|12510054|FG000|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
11311181|NCT02658175|12510055|FG001|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
11311182|NCT02658175|12510056|FG002|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
11311183|NCT02658240|12510066|FG000|STARTED|Overall Study||30
11311184|NCT02658240|12510067|FG001|STARTED|Overall Study||30
11311185|NCT02658240|12510066|FG000|COMPLETED|Overall Study||30
11311186|NCT02658240|12510067|FG001|COMPLETED|Overall Study||30
11311187|NCT02658240|12510066|FG000|NOT COMPLETED|Overall Study||0
11311188|NCT02658240|12510067|FG001|NOT COMPLETED|Overall Study||0
11311189|NCT02658448|12510073|FG000|STARTED|Overall Study||19
11311190|NCT02658448|12510073|FG000|COMPLETED|Overall Study|One patient was lost to follow-up after enrollment and prior to visit 1|18
11311191|NCT02658448|12510073|FG000|NOT COMPLETED|Overall Study||1
11311192|NCT02658461|12510080|FG000|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
11311193|NCT02658461|12510081|FG001|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
11311194|NCT02658461|12510082|FG002|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
11311195|NCT02658461|12510080|FG000|COMPLETED|Overall Study||12
11311196|NCT02658461|12510081|FG001|COMPLETED|Overall Study||12
11311197|NCT02658461|12510082|FG002|COMPLETED|Overall Study||12
11311198|NCT02658461|12510080|FG000|NOT COMPLETED|Overall Study||0
11311199|NCT02658461|12510081|FG001|NOT COMPLETED|Overall Study||0
11311200|NCT02658461|12510082|FG002|NOT COMPLETED|Overall Study||0
11311201|NCT02658487|12510092|FG000|STARTED|Overall Study||42
11311202|NCT02658487|12510092|FG000|COMPLETED|Overall Study||26
11311203|NCT02658487|12510092|FG000|NOT COMPLETED|Overall Study||16
11311204|NCT02658630|12510097|FG000|STARTED|Overall Study||46
11311205|NCT02658630|12510097|FG000|COMPLETED|Overall Study||42
11311206|NCT02658630|12510097|FG000|NOT COMPLETED|Overall Study||4
11311207|NCT02658734|12510101|FG000|STARTED|Overall Study||70
11311208|NCT02658734|12510101|FG000|COMPLETED|Overall Study||13
11311209|NCT02658734|12510101|FG000|NOT COMPLETED|Overall Study||57
11311210|NCT02658851|12510105|FG000|STARTED|Overall Study||100
11311211|NCT02658851|12510105|FG000|COMPLETED|Overall Study||100
11401887|NCT04073407|12596708|FG000|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|0
11401888|NCT04073407|12596709|FG001|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|1
11401889|NCT04073407|12596708|FG000|COMPLETED|Part 2||0
11311212|NCT02658851|12510105|FG000|NOT COMPLETED|Overall Study||0
11311213|NCT02658994|12510112|FG000|STARTED|Enrollment||287
11311214|NCT02658994|12510113|FG001|STARTED|Enrollment||283
11311215|NCT02658994|12510114|FG002|STARTED|Enrollment||584
11401890|NCT04073407|12596709|FG001|COMPLETED|Part 2||0
11401891|NCT04073407|12596708|FG000|NOT COMPLETED|Part 2||0
11401892|NCT04073407|12596709|FG001|NOT COMPLETED|Part 2||1
11401893|NCT04073368|12596719|FG000|STARTED|Overall Study||32
11401894|NCT04073368|12596720|FG001|STARTED|Overall Study||26
11401895|NCT04073368|12596721|FG002|STARTED|Overall Study||29
11401896|NCT04073368|12596722|FG003|STARTED|Overall Study||15
11401897|NCT04073368|12596719|FG000|COMPLETED|Overall Study||20
11401898|NCT04073368|12596720|FG001|COMPLETED|Overall Study||18
11401899|NCT04073368|12596721|FG002|COMPLETED|Overall Study||26
11401900|NCT04073368|12596722|FG003|COMPLETED|Overall Study||13
11401901|NCT04073368|12596719|FG000|NOT COMPLETED|Overall Study||12
11401902|NCT04073368|12596720|FG001|NOT COMPLETED|Overall Study||8
11401903|NCT04073368|12596721|FG002|NOT COMPLETED|Overall Study||3
11401904|NCT04073368|12596722|FG003|NOT COMPLETED|Overall Study||2
11401905|NCT04072237|12596732|FG000|STARTED|Stage I: MarzAA 18 µg/kg IV||11
11401906|NCT04072237|12596732|FG000|COMPLETED|Stage I: MarzAA 18 µg/kg IV||10
11401907|NCT04072237|12596732|FG000|NOT COMPLETED|Stage I: MarzAA 18 µg/kg IV||1
11401908|NCT04072237|12596732|FG000|STARTED|Stage 2: MarzAA 30 µg/kg SC||8
11401909|NCT04072237|12596732|FG000|COMPLETED|Stage 2: MarzAA 30 µg/kg SC||8
11401910|NCT04072237|12596732|FG000|NOT COMPLETED|Stage 2: MarzAA 30 µg/kg SC||0
11401911|NCT04072237|12596732|FG000|STARTED|Stage 3: MarzAA 45 µg/kg SC||8
11401912|NCT04072237|12596732|FG000|COMPLETED|Stage 3: MarzAA 45 µg/kg SC||8
11401913|NCT04072237|12596732|FG000|NOT COMPLETED|Stage 3: MarzAA 45 µg/kg SC||0
11401914|NCT04072237|12596732|FG000|STARTED|Stage 4: MarzAA 60 µg/kg SC||8
11401915|NCT04072237|12596732|FG000|COMPLETED|Stage 4: MarzAA 60 µg/kg SC||8
11401916|NCT04072237|12596732|FG000|NOT COMPLETED|Stage 4: MarzAA 60 µg/kg SC||0
11401917|NCT04072237|12596732|FG000|STARTED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
11401918|NCT04072237|12596732|FG000|COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
11401919|NCT04072237|12596732|FG000|NOT COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||0
11401920|NCT04072237|12596732|FG000|STARTED|Stage 6: MarzAA 90 µg/kg SC||8
11401921|NCT04072237|12596732|FG000|COMPLETED|Stage 6: MarzAA 90 µg/kg SC||8
11401922|NCT04072237|12596732|FG000|NOT COMPLETED|Stage 6: MarzAA 90 µg/kg SC||0
11401923|NCT04072237|12596732|FG000|STARTED|Stage 7: MarzAA 120 µg/kg SC||8
11401924|NCT04072237|12596732|FG000|COMPLETED|Stage 7: MarzAA 120 µg/kg SC||8
11401925|NCT04072237|12596732|FG000|NOT COMPLETED|Stage 7: MarzAA 120 µg/kg SC||0
11311216|NCT02658994|12510112|FG000|COMPLETED|Enrollment||287
11311217|NCT02658994|12510113|FG001|COMPLETED|Enrollment||283
11311218|NCT02658994|12510114|FG002|COMPLETED|Enrollment||584
11311219|NCT02658994|12510112|FG000|NOT COMPLETED|Enrollment||0
11311220|NCT02658994|12510113|FG001|NOT COMPLETED|Enrollment||0
11311221|NCT02658994|12510114|FG002|NOT COMPLETED|Enrollment||0
11311222|NCT02658994|12510112|FG000|STARTED|3 Month Follow up||287
11311223|NCT02658994|12510113|FG001|STARTED|3 Month Follow up||283
11311224|NCT02658994|12510114|FG002|STARTED|3 Month Follow up||584
11311225|NCT02658994|12510112|FG000|COMPLETED|3 Month Follow up||221
11311226|NCT02658994|12510113|FG001|COMPLETED|3 Month Follow up||223
11311227|NCT02658994|12510114|FG002|COMPLETED|3 Month Follow up||451
11311228|NCT02658994|12510112|FG000|NOT COMPLETED|3 Month Follow up||66
11311229|NCT02658994|12510113|FG001|NOT COMPLETED|3 Month Follow up||60
11311230|NCT02658994|12510114|FG002|NOT COMPLETED|3 Month Follow up||133
11311231|NCT02658994|12510112|FG000|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|287
11311232|NCT02658994|12510113|FG001|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|283
11311233|NCT02658994|12510114|FG002|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|584
11311234|NCT02658994|12510112|FG000|COMPLETED|6 Month Follow up||228
11311235|NCT02658994|12510113|FG001|COMPLETED|6 Month Follow up||230
11311236|NCT02658994|12510114|FG002|COMPLETED|6 Month Follow up||471
11311237|NCT02658994|12510112|FG000|NOT COMPLETED|6 Month Follow up||59
11311238|NCT02658994|12510113|FG001|NOT COMPLETED|6 Month Follow up||53
11311239|NCT02658994|12510114|FG002|NOT COMPLETED|6 Month Follow up||113
11311240|NCT02658994|12510112|FG000|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|287
11311241|NCT02658994|12510113|FG001|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|283
11311242|NCT02658994|12510114|FG002|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|584
11311243|NCT02658994|12510112|FG000|COMPLETED|12 Month Follow up||228
11311244|NCT02658994|12510113|FG001|COMPLETED|12 Month Follow up||223
11311245|NCT02658994|12510114|FG002|COMPLETED|12 Month Follow up||489
11311246|NCT02658994|12510112|FG000|NOT COMPLETED|12 Month Follow up||59
11311247|NCT02658994|12510113|FG001|NOT COMPLETED|12 Month Follow up||60
11311248|NCT02658994|12510114|FG002|NOT COMPLETED|12 Month Follow up||95
11311249|NCT02658994|12510112|FG000|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|287
11311250|NCT02658994|12510113|FG001|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|283
11342189|NCT02942485|12539736|FG000|COMPLETED|Overall Study||6
11311251|NCT02658994|12510114|FG002|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|584
11311252|NCT02658994|12510112|FG000|COMPLETED|24 Month Follow up||220
11311253|NCT02658994|12510113|FG001|COMPLETED|24 Month Follow up||210
11311254|NCT02658994|12510114|FG002|COMPLETED|24 Month Follow up||473
11311255|NCT02658994|12510112|FG000|NOT COMPLETED|24 Month Follow up||67
11311256|NCT02658994|12510113|FG001|NOT COMPLETED|24 Month Follow up||73
11311257|NCT02658994|12510114|FG002|NOT COMPLETED|24 Month Follow up||111
11311258|NCT02658994|12510112|FG000|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|287
11311259|NCT02658994|12510113|FG001|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|283
11311260|NCT02658994|12510114|FG002|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|584
11311261|NCT02658994|12510112|FG000|COMPLETED|36 Month Follow up||216
11311262|NCT02658994|12510113|FG001|COMPLETED|36 Month Follow up||206
11311263|NCT02658994|12510114|FG002|COMPLETED|36 Month Follow up||467
11311264|NCT02658994|12510112|FG000|NOT COMPLETED|36 Month Follow up||71
11311265|NCT02658994|12510113|FG001|NOT COMPLETED|36 Month Follow up||77
11311266|NCT02658994|12510114|FG002|NOT COMPLETED|36 Month Follow up||117
11311267|NCT02659098|12510123|FG000|STARTED|Overall Study||21
11311268|NCT02659098|12510123|FG000|COMPLETED|Overall Study||14
11311269|NCT02659098|12510123|FG000|NOT COMPLETED|Overall Study||7
11311270|NCT02659150|12510127|FG000|STARTED|Subject Enrollment||16
11311271|NCT02659150|12510127|FG000|COMPLETED|Subject Enrollment||11
11311272|NCT02659150|12510127|FG000|NOT COMPLETED|Subject Enrollment||5
11311273|NCT02659150|12510127|FG000|STARTED|Baseline Imaging||11
11311274|NCT02659150|12510127|FG000|COMPLETED|Baseline Imaging||9
11311275|NCT02659150|12510127|FG000|NOT COMPLETED|Baseline Imaging||2
11311276|NCT02659150|12510127|FG000|STARTED|Study Drug Dosing||9
11311277|NCT02659150|12510127|FG000|COMPLETED|Study Drug Dosing||8
11311278|NCT02659150|12510127|FG000|NOT COMPLETED|Study Drug Dosing||1
11311279|NCT02659150|12510127|FG000|STARTED|Follow-up Imaging||8
11311280|NCT02659150|12510127|FG000|COMPLETED|Follow-up Imaging||8
11311281|NCT02659150|12510127|FG000|NOT COMPLETED|Follow-up Imaging||0
11311282|NCT02659501|12510134|FG000|STARTED|Overall Study||12
11311283|NCT02659501|12510135|FG001|STARTED|Overall Study||12
11311284|NCT02659501|12510134|FG000|COMPLETED|Overall Study||12
11311285|NCT02659501|12510135|FG001|COMPLETED|Overall Study||12
11311286|NCT02659501|12510134|FG000|NOT COMPLETED|Overall Study||0
11311287|NCT02659501|12510135|FG001|NOT COMPLETED|Overall Study||0
11311288|NCT02659540|12510143|FG000|STARTED|Overall Study||10
11311289|NCT02659540|12510144|FG001|STARTED|Overall Study||10
11311290|NCT02659540|12510143|FG000|COMPLETED|Overall Study||4
11311291|NCT02659540|12510144|FG001|COMPLETED|Overall Study||2
11311292|NCT02659540|12510143|FG000|NOT COMPLETED|Overall Study||6
11311293|NCT02659540|12510144|FG001|NOT COMPLETED|Overall Study||8
11311294|NCT02659631|12510160|FG000|STARTED|Overall Study||1
11311295|NCT02659631|12510161|FG001|STARTED|Overall Study||2
11311296|NCT02659631|12510162|FG002|STARTED|Overall Study||3
11311297|NCT02659631|12510163|FG003|STARTED|Overall Study||2
11311298|NCT02659631|12510164|FG004|STARTED|Overall Study||5
11311299|NCT02659631|12510165|FG005|STARTED|Overall Study||5
11311300|NCT02659631|12510166|FG006|STARTED|Overall Study||4
11311301|NCT02659631|12510167|FG007|STARTED|Overall Study||3
11311302|NCT02659631|12510168|FG008|STARTED|Overall Study||2
11311303|NCT02659631|12510169|FG009|STARTED|Overall Study||1
11311304|NCT02659631|12510160|FG000|COMPLETED|Overall Study||0
11311305|NCT02659631|12510161|FG001|COMPLETED|Overall Study||0
11311306|NCT02659631|12510162|FG002|COMPLETED|Overall Study||0
11311307|NCT02659631|12510163|FG003|COMPLETED|Overall Study||0
11311308|NCT02659631|12510164|FG004|COMPLETED|Overall Study||0
11311309|NCT02659631|12510165|FG005|COMPLETED|Overall Study||2
11311310|NCT02659631|12510166|FG006|COMPLETED|Overall Study||3
11311311|NCT02659631|12510167|FG007|COMPLETED|Overall Study||0
11311312|NCT02659631|12510168|FG008|COMPLETED|Overall Study||0
11311313|NCT02659631|12510169|FG009|COMPLETED|Overall Study||1
11311314|NCT02659631|12510160|FG000|NOT COMPLETED|Overall Study||1
11311315|NCT02659631|12510161|FG001|NOT COMPLETED|Overall Study||2
11311316|NCT02659631|12510162|FG002|NOT COMPLETED|Overall Study||3
11311317|NCT02659631|12510163|FG003|NOT COMPLETED|Overall Study||2
11311318|NCT02659631|12510164|FG004|NOT COMPLETED|Overall Study||5
11311319|NCT02659631|12510165|FG005|NOT COMPLETED|Overall Study||3
11311320|NCT02659631|12510166|FG006|NOT COMPLETED|Overall Study||1
11311321|NCT02659631|12510167|FG007|NOT COMPLETED|Overall Study||3
11311322|NCT02659631|12510168|FG008|NOT COMPLETED|Overall Study||2
11311323|NCT02659631|12510169|FG009|NOT COMPLETED|Overall Study||0
11311324|NCT02659709|12510193|FG000|STARTED|Overall Study||50
11311325|NCT02659709|12510193|FG000|COMPLETED|Overall Study||50
11311326|NCT02659709|12510193|FG000|NOT COMPLETED|Overall Study||0
11311327|NCT02659787|12510197|FG000|STARTED|First Intervention (1 Day)||19
11311328|NCT02659787|12510198|FG001|STARTED|First Intervention (1 Day)||19
11311329|NCT02659787|12510197|FG000|COMPLETED|First Intervention (1 Day)||19
11311330|NCT02659787|12510198|FG001|COMPLETED|First Intervention (1 Day)||19
11311331|NCT02659787|12510197|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11311332|NCT02659787|12510198|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11311333|NCT02659787|12510197|FG000|STARTED|Washout (3 Days)||19
11311334|NCT02659787|12510198|FG001|STARTED|Washout (3 Days)||19
11311335|NCT02659787|12510197|FG000|COMPLETED|Washout (3 Days)||19
11311336|NCT02659787|12510198|FG001|COMPLETED|Washout (3 Days)||19
11311337|NCT02659787|12510197|FG000|NOT COMPLETED|Washout (3 Days)||0
11311338|NCT02659787|12510198|FG001|NOT COMPLETED|Washout (3 Days)||0
11311339|NCT02659787|12510197|FG000|STARTED|Second Intervention (1 Day)||19
11311340|NCT02659787|12510198|FG001|STARTED|Second Intervention (1 Day)||19
11311341|NCT02659787|12510197|FG000|COMPLETED|Second Intervention (1 Day)||19
11311342|NCT02659787|12510198|FG001|COMPLETED|Second Intervention (1 Day)||19
11311343|NCT02659787|12510197|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11311344|NCT02659787|12510198|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11311345|NCT02659943|12510211|FG000|STARTED|Overall Study||3
11311346|NCT02659943|12510212|FG001|STARTED|Overall Study||2
11311347|NCT02659943|12510213|FG002|STARTED|Overall Study||1
11311348|NCT02659943|12510214|FG003|STARTED|Overall Study||4
11311349|NCT02659943|12510215|FG004|STARTED|Overall Study||2
11311350|NCT02659943|12510216|FG005|STARTED|Overall Study||9
11311351|NCT02659943|12510217|FG006|STARTED|Overall Study||6
11311352|NCT02659943|12510211|FG000|COMPLETED|Overall Study||2
11311353|NCT02659943|12510212|FG001|COMPLETED|Overall Study||0
11311354|NCT02659943|12510213|FG002|COMPLETED|Overall Study||0
11311355|NCT02659943|12510214|FG003|COMPLETED|Overall Study||1
11311356|NCT02659943|12510215|FG004|COMPLETED|Overall Study||0
11311357|NCT02659943|12510216|FG005|COMPLETED|Overall Study||4
11311358|NCT02659943|12510217|FG006|COMPLETED|Overall Study||0
11311359|NCT02659943|12510211|FG000|NOT COMPLETED|Overall Study||1
11311360|NCT02659943|12510212|FG001|NOT COMPLETED|Overall Study||2
11311361|NCT02659943|12510213|FG002|NOT COMPLETED|Overall Study||1
11311362|NCT02659943|12510214|FG003|NOT COMPLETED|Overall Study||3
11311363|NCT02659943|12510215|FG004|NOT COMPLETED|Overall Study||2
11311364|NCT02659943|12510216|FG005|NOT COMPLETED|Overall Study||5
11311365|NCT02659943|12510217|FG006|NOT COMPLETED|Overall Study||6
11311366|NCT02660112|12510238|FG000|STARTED|Overall Study||10
11311367|NCT02660112|12510238|FG000|COMPLETED|Overall Study||10
11311368|NCT02660112|12510238|FG000|NOT COMPLETED|Overall Study||0
11311369|NCT02660229|12510244|FG000|STARTED|Overall Study|Randomization|34
11311370|NCT02660229|12510245|FG001|STARTED|Overall Study|Randomization|32
11311371|NCT02660229|12510244|FG000|Safety Analysis Set|Overall Study||34
11311372|NCT02660229|12510245|FG001|Safety Analysis Set|Overall Study||32
11311373|NCT02660229|12510244|FG000|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
11311374|NCT02660229|12510245|FG001|FAS Set|Overall Study||32
11311375|NCT02660229|12510244|FG000|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
11311376|NCT02660229|12510245|FG001|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
11311377|NCT02660229|12510244|FG000|COMPLETED|Overall Study||32
11311378|NCT02660229|12510245|FG001|COMPLETED|Overall Study||31
11311379|NCT02660229|12510244|FG000|NOT COMPLETED|Overall Study||2
11311380|NCT02660229|12510245|FG001|NOT COMPLETED|Overall Study||1
11311381|NCT02660242|12510251|FG000|STARTED|Control||16
11311382|NCT02660242|12510251|FG000|COMPLETED|Control||16
11311383|NCT02660242|12510251|FG000|NOT COMPLETED|Control||0
11311384|NCT02660242|12510251|FG000|STARTED|Basal Insulin Reduction||16
11311385|NCT02660242|12510251|FG000|COMPLETED|Basal Insulin Reduction||16
11311386|NCT02660242|12510251|FG000|NOT COMPLETED|Basal Insulin Reduction||0
11311387|NCT02660242|12510251|FG000|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
11311388|NCT02660242|12510251|FG000|COMPLETED|Glucose Tabs||15
11311389|NCT02660242|12510251|FG000|NOT COMPLETED|Glucose Tabs||1
11311390|NCT02660242|12510251|FG000|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
11311391|NCT02660242|12510251|FG000|COMPLETED|Glucagon Injection||15
11311392|NCT02660242|12510251|FG000|NOT COMPLETED|Glucagon Injection||1
11311393|NCT02660489|12510266|FG000|STARTED|Overall Study||22
11311394|NCT02660489|12510267|FG001|STARTED|Overall Study||22
11311395|NCT02660489|12510266|FG000|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|16
11311396|NCT02660489|12510267|FG001|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|14
11311397|NCT02660489|12510266|FG000|NOT COMPLETED|Overall Study||6
11311398|NCT02660489|12510267|FG001|NOT COMPLETED|Overall Study||8
11311399|NCT02660580|12510275|FG000|STARTED|Core Treatment Period (Week 1 to 16)||222
11311400|NCT02660580|12510276|FG001|STARTED|Core Treatment Period (Week 1 to 16)||221
11401926|NCT04072237|12596732|FG000|STARTED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
11401927|NCT04072237|12596732|FG000|COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
11401928|NCT04072237|12596732|FG000|NOT COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||0
11401929|NCT04072237|12596732|FG000|STARTED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
11401930|NCT04072237|12596732|FG000|COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
11401931|NCT04072237|12596732|FG000|NOT COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||0
11401932|NCT04063371|12596762|FG000|STARTED|Overall Study||100
11401933|NCT04063371|12596763|FG001|STARTED|Overall Study||100
11401934|NCT04063371|12596764|FG002|STARTED|Overall Study||100
11401935|NCT04063371|12596762|FG000|COMPLETED|Overall Study||100
11401936|NCT04063371|12596763|FG001|COMPLETED|Overall Study||100
11401937|NCT04063371|12596764|FG002|COMPLETED|Overall Study||100
11401938|NCT04063371|12596762|FG000|NOT COMPLETED|Overall Study||0
11401939|NCT04063371|12596763|FG001|NOT COMPLETED|Overall Study||0
11401940|NCT04063371|12596764|FG002|NOT COMPLETED|Overall Study||0
11401941|NCT04042324|12596774|FG000|STARTED|UFH and Triferic Admixture (Day 1)||12
11401942|NCT04042324|12596775|FG001|STARTED|UFH and Triferic Admixture (Day 1)||0
11401943|NCT04042324|12596776|FG002|STARTED|UFH and Triferic Admixture (Day 1)||0
11401944|NCT04042324|12596774|FG000|COMPLETED|UFH and Triferic Admixture (Day 1)||12
11401945|NCT04042324|12596775|FG001|COMPLETED|UFH and Triferic Admixture (Day 1)||0
11401946|NCT04042324|12596776|FG002|COMPLETED|UFH and Triferic Admixture (Day 1)||0
11401947|NCT04042324|12596774|FG000|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
11401948|NCT04042324|12596775|FG001|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
11401949|NCT04042324|12596776|FG002|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
11401950|NCT04042324|12596774|FG000|STARTED|Triferic Post-dialyzer (Day 3)||0
11401951|NCT04042324|12596775|FG001|STARTED|Triferic Post-dialyzer (Day 3)||12
11401952|NCT04042324|12596776|FG002|STARTED|Triferic Post-dialyzer (Day 3)||0
11401953|NCT04042324|12596774|FG000|COMPLETED|Triferic Post-dialyzer (Day 3)||0
11401954|NCT04042324|12596775|FG001|COMPLETED|Triferic Post-dialyzer (Day 3)||12
11401955|NCT04042324|12596776|FG002|COMPLETED|Triferic Post-dialyzer (Day 3)||0
11401956|NCT04042324|12596774|FG000|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
11401957|NCT04042324|12596775|FG001|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
11401958|NCT04042324|12596776|FG002|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
11401959|NCT04042324|12596774|FG000|STARTED|Triferic Pre-dialyzer (Day 5)||0
11401960|NCT04042324|12596775|FG001|STARTED|Triferic Pre-dialyzer (Day 5)||0
11401961|NCT04042324|12596776|FG002|STARTED|Triferic Pre-dialyzer (Day 5)||12
11401962|NCT04042324|12596774|FG000|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
11401963|NCT04042324|12596775|FG001|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
11401964|NCT04042324|12596776|FG002|COMPLETED|Triferic Pre-dialyzer (Day 5)||12
11401965|NCT04042324|12596774|FG000|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
11401966|NCT04042324|12596775|FG001|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
11401967|NCT04042324|12596776|FG002|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
11401968|NCT04071392|12596788|FG000|STARTED|Overall Study||12
11401969|NCT04071392|12596789|FG001|STARTED|Overall Study||12
11401970|NCT04071392|12596788|FG000|COMPLETED|Overall Study||10
11401971|NCT04071392|12596789|FG001|COMPLETED|Overall Study||10
11401972|NCT04071392|12596788|FG000|NOT COMPLETED|Overall Study||2
11401973|NCT04071392|12596789|FG001|NOT COMPLETED|Overall Study||2
11401974|NCT04071301|12596795|FG000|STARTED|Overall Study||15
11401975|NCT04071301|12596795|FG000|COMPLETED|Overall Study||8
11401976|NCT04071301|12596795|FG000|NOT COMPLETED|Overall Study||7
11401977|NCT04071158|12596804|FG000|STARTED|Overall Study||143
11401978|NCT04071158|12596805|FG001|STARTED|Overall Study||143
11401979|NCT04071158|12596806|FG002|STARTED|Overall Study||143
11401980|NCT04071158|12596807|FG003|STARTED|Overall Study||143
11401981|NCT04071158|12596808|FG004|STARTED|Overall Study||141
11401982|NCT04071158|12596804|FG000|Treated|Overall Study||141
11401983|NCT04071158|12596805|FG001|Treated|Overall Study||141
11311401|NCT02660580|12510277|FG002|STARTED|Core Treatment Period (Week 1 to 16)||0
11311402|NCT02660580|12510278|FG003|STARTED|Core Treatment Period (Week 1 to 16)||0
11311403|NCT02660580|12510279|FG004|STARTED|Core Treatment Period (Week 1 to 16)||0
11311404|NCT02660580|12510275|FG000|Treated|Core Treatment Period (Week 1 to 16)||221
11311405|NCT02660580|12510276|FG001|Treated|Core Treatment Period (Week 1 to 16)||220
11311406|NCT02660580|12510277|FG002|Treated|Core Treatment Period (Week 1 to 16)||0
11311407|NCT02660580|12510278|FG003|Treated|Core Treatment Period (Week 1 to 16)||0
11311408|NCT02660580|12510279|FG004|Treated|Core Treatment Period (Week 1 to 16)||0
11311409|NCT02660580|12510275|FG000|COMPLETED|Core Treatment Period (Week 1 to 16)||213
11311410|NCT02660580|12510276|FG001|COMPLETED|Core Treatment Period (Week 1 to 16)||202
11311411|NCT02660580|12510277|FG002|COMPLETED|Core Treatment Period (Week 1 to 16)||0
11311412|NCT02660580|12510278|FG003|COMPLETED|Core Treatment Period (Week 1 to 16)||0
11311413|NCT02660580|12510279|FG004|COMPLETED|Core Treatment Period (Week 1 to 16)||0
11311414|NCT02660580|12510275|FG000|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9
11311415|NCT02660580|12510276|FG001|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19
11311416|NCT02660580|12510277|FG002|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
11311417|NCT02660580|12510278|FG003|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
11311418|NCT02660580|12510279|FG004|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
11311419|NCT02660580|12510275|FG000|STARTED|Extended Treatment Period(Week 16 to 52)||0
11311420|NCT02660580|12510276|FG001|STARTED|Extended Treatment Period(Week 16 to 52)||0
11311421|NCT02660580|12510277|FG002|STARTED|Extended Treatment Period(Week 16 to 52)||213
11311422|NCT02660580|12510278|FG003|STARTED|Extended Treatment Period(Week 16 to 52)||101
11311423|NCT02660580|12510279|FG004|STARTED|Extended Treatment Period(Week 16 to 52)||101
11311424|NCT02660580|12510275|FG000|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
11311425|NCT02660580|12510276|FG001|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
11311426|NCT02660580|12510277|FG002|COMPLETED|Extended Treatment Period(Week 16 to 52)||195
11311427|NCT02660580|12510278|FG003|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
11311428|NCT02660580|12510279|FG004|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
11311429|NCT02660580|12510275|FG000|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
11311430|NCT02660580|12510276|FG001|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
11311431|NCT02660580|12510277|FG002|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18
11311432|NCT02660580|12510278|FG003|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
11311433|NCT02660580|12510279|FG004|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
11311434|NCT02660788|12510300|FG000|STARTED|Overall Study||2749
11311435|NCT02660788|12510301|FG001|STARTED|Overall Study||2749
11311436|NCT02660788|12510300|FG000|COMPLETED|Overall Study||2749
11311437|NCT02660788|12510301|FG001|COMPLETED|Overall Study||2749
11311438|NCT02660788|12510300|FG000|NOT COMPLETED|Overall Study||0
11311439|NCT02660788|12510301|FG001|NOT COMPLETED|Overall Study||0
11311440|NCT02660801|12510307|FG000|STARTED|Overall Study||11
11311441|NCT02660801|12510308|FG001|STARTED|Overall Study||15
11311442|NCT02660801|12510307|FG000|COMPLETED|Overall Study||11
11311443|NCT02660801|12510308|FG001|COMPLETED|Overall Study||15
11311444|NCT02660801|12510307|FG000|NOT COMPLETED|Overall Study||0
11311445|NCT02660801|12510308|FG001|NOT COMPLETED|Overall Study||0
11311446|NCT02660853|12510314|FG000|STARTED|Overall Study||25
11311447|NCT02660853|12510314|FG000|COMPLETED|Overall Study||25
11311448|NCT02660853|12510314|FG000|NOT COMPLETED|Overall Study||0
11311449|NCT02660918|12510320|FG000|STARTED|Overall Study||42
11311450|NCT02660918|12510321|FG001|STARTED|Overall Study||42
11311451|NCT02660918|12510320|FG000|COMPLETED|Overall Study|Age ineligible|41
11401984|NCT04071158|12596806|FG002|Treated|Overall Study||143
11401985|NCT04071158|12596807|FG003|Treated|Overall Study||143
11401986|NCT04071158|12596808|FG004|Treated|Overall Study||141
11401987|NCT04071158|12596804|FG000|Safety Population|Overall Study||141
11401988|NCT04071158|12596805|FG001|Safety Population|Overall Study||141
11401989|NCT04071158|12596806|FG002|Safety Population|Overall Study|1 participant randomized to this arm received RSV vaccine 240 mcg with aluminum hydroxide withTdap|142
11401990|NCT04071158|12596807|FG003|Safety Population|Overall Study|1 participant of this arm actually received RSV vaccine 240 mcg with aluminum hydroxide with Tdap|144
11401991|NCT04071158|12596808|FG004|Safety Population|Overall Study||141
11401992|NCT04071158|12596804|FG000|COMPLETED|Overall Study||140
11401993|NCT04071158|12596805|FG001|COMPLETED|Overall Study||139
11401994|NCT04071158|12596806|FG002|COMPLETED|Overall Study||140
11311452|NCT02660918|12510321|FG001|COMPLETED|Overall Study|Age ineligible|41
11311453|NCT02660918|12510320|FG000|NOT COMPLETED|Overall Study||1
11311454|NCT02660918|12510321|FG001|NOT COMPLETED|Overall Study||1
11311455|NCT02660944|12510330|FG000|STARTED|Overall Study||42
11311456|NCT02660944|12510331|FG001|STARTED|Overall Study||22
11311457|NCT02660944|12510330|FG000|COMPLETED|Overall Study||25
11311458|NCT02660944|12510331|FG001|COMPLETED|Overall Study||12
11311459|NCT02660944|12510330|FG000|NOT COMPLETED|Overall Study||17
11311460|NCT02660944|12510331|FG001|NOT COMPLETED|Overall Study||10
11311461|NCT02660983|12510339|FG000|STARTED|Double-blind (DB) Phase (24 Weeks)||154
11311462|NCT02660983|12510340|FG001|STARTED|Double-blind (DB) Phase (24 Weeks)||148
11311463|NCT02660983|12510339|FG000|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153
11311464|NCT02660983|12510340|FG001|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147
11311465|NCT02660983|12510339|FG000|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130
11311466|NCT02660983|12510340|FG001|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122
11311467|NCT02660983|12510339|FG000|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24
11311468|NCT02660983|12510340|FG001|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26
11311469|NCT02660983|12510339|FG000|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|86
11311470|NCT02660983|12510340|FG001|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|75
11311471|NCT02660983|12510339|FG000|Safety Set|Open Label Extension Phase (24 Weeks)||86
11311472|NCT02660983|12510340|FG001|Safety Set|Open Label Extension Phase (24 Weeks)||75
11311473|NCT02660983|12510339|FG000|COMPLETED|Open Label Extension Phase (24 Weeks)||83
11311474|NCT02660983|12510340|FG001|COMPLETED|Open Label Extension Phase (24 Weeks)||66
11311475|NCT02660983|12510339|FG000|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3
11311476|NCT02660983|12510340|FG001|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9
11311477|NCT02661061|12510349|FG000|STARTED|Overall Study||5
11311478|NCT02661061|12510350|FG001|STARTED|Overall Study||4
11311479|NCT02661061|12510349|FG000|COMPLETED|Overall Study||3
11311480|NCT02661061|12510350|FG001|COMPLETED|Overall Study||2
11311481|NCT02661061|12510349|FG000|NOT COMPLETED|Overall Study||2
11311482|NCT02661061|12510350|FG001|NOT COMPLETED|Overall Study||2
11311483|NCT02661126|12510358|FG000|STARTED|Overall Study||8
11311484|NCT02661126|12510359|FG001|STARTED|Overall Study||8
11311485|NCT02661126|12510358|FG000|COMPLETED|Overall Study||8
11311486|NCT02661126|12510359|FG001|COMPLETED|Overall Study||8
11311487|NCT02661126|12510358|FG000|NOT COMPLETED|Overall Study||0
11311488|NCT02661126|12510359|FG001|NOT COMPLETED|Overall Study||0
11342190|NCT02942485|12539737|FG001|COMPLETED|Overall Study||1
11342191|NCT02942485|12539736|FG000|NOT COMPLETED|Overall Study||1
11342192|NCT02942485|12539737|FG001|NOT COMPLETED|Overall Study||0
11342193|NCT02942576|12539745|FG000|STARTED|Overall Study||405
11342194|NCT02942576|12539746|FG001|STARTED|Overall Study||197
11342195|NCT02942576|12539745|FG000|COMPLETED|Overall Study||359
11342196|NCT02942576|12539746|FG001|COMPLETED|Overall Study||174
11342197|NCT02942576|12539745|FG000|NOT COMPLETED|Overall Study||46
11342198|NCT02942576|12539746|FG001|NOT COMPLETED|Overall Study||23
11342199|NCT02942654|12539752|FG000|STARTED|Period 1||16
11342200|NCT02942654|12539753|FG001|STARTED|Period 1||16
11342201|NCT02942654|12539752|FG000|Received at Least 1 Dose of Study Drug|Period 1||16
11342202|NCT02942654|12539753|FG001|Received at Least 1 Dose of Study Drug|Period 1||16
11342203|NCT02942654|12539752|FG000|COMPLETED|Period 1||16
11342204|NCT02942654|12539753|FG001|COMPLETED|Period 1||16
11342205|NCT02942654|12539752|FG000|NOT COMPLETED|Period 1||0
11342206|NCT02942654|12539753|FG001|NOT COMPLETED|Period 1||0
11342207|NCT02942654|12539752|FG000|STARTED|Washout||16
11342208|NCT02942654|12539753|FG001|STARTED|Washout||16
11342209|NCT02942654|12539752|FG000|COMPLETED|Washout||16
11342210|NCT02942654|12539753|FG001|COMPLETED|Washout||16
11342211|NCT02942654|12539752|FG000|NOT COMPLETED|Washout||0
11342212|NCT02942654|12539753|FG001|NOT COMPLETED|Washout||0
11342213|NCT02942654|12539752|FG000|STARTED|Period 2||16
11342214|NCT02942654|12539753|FG001|STARTED|Period 2||16
11342215|NCT02942654|12539752|FG000|COMPLETED|Period 2||16
11342216|NCT02942654|12539753|FG001|COMPLETED|Period 2||16
11311489|NCT02661178|12510380|FG000|STARTED|Part 1||1
11311490|NCT02661178|12510381|FG001|STARTED|Part 1||5
11311491|NCT02661178|12510382|FG002|STARTED|Part 1||6
11311492|NCT02661178|12510383|FG003|STARTED|Part 1||6
11311493|NCT02661178|12510384|FG004|STARTED|Part 1||5
11311494|NCT02661178|12510385|FG005|STARTED|Part 1||6
11311495|NCT02661178|12510386|FG006|STARTED|Part 1||6
11311496|NCT02661178|12510387|FG007|STARTED|Part 1||6
11311497|NCT02661178|12510388|FG008|STARTED|Part 1||6
11311498|NCT02661178|12510389|FG009|STARTED|Part 1||12
11022211|NCT00808210|12200489|FG000|STARTED|Open Label Ocrelizumab Treatment Period||9
11022212|NCT00808210|12200490|FG001|STARTED|Open Label Ocrelizumab Treatment Period||4
11022213|NCT00808210|12200489|FG000|COMPLETED|Open Label Ocrelizumab Treatment Period||0
11022214|NCT00808210|12200490|FG001|COMPLETED|Open Label Ocrelizumab Treatment Period||0
11022215|NCT00808210|12200489|FG000|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||9
11311499|NCT02661178|12510390|FG010|STARTED|Part 1||4
11311500|NCT02661178|12510391|FG011|STARTED|Part 1||0
11311501|NCT02661178|12510392|FG012|STARTED|Part 1||0
11311502|NCT02661178|12510393|FG013|STARTED|Part 1||0
11311503|NCT02661178|12510394|FG014|STARTED|Part 1||0
11311504|NCT02661178|12510380|FG000|COMPLETED|Part 1||0
11311505|NCT02661178|12510381|FG001|COMPLETED|Part 1||5
11311506|NCT02661178|12510382|FG002|COMPLETED|Part 1||6
11311507|NCT02661178|12510383|FG003|COMPLETED|Part 1||6
11311508|NCT02661178|12510384|FG004|COMPLETED|Part 1||5
11311509|NCT02661178|12510385|FG005|COMPLETED|Part 1||6
11311510|NCT02661178|12510386|FG006|COMPLETED|Part 1||6
11311511|NCT02661178|12510387|FG007|COMPLETED|Part 1||6
11311512|NCT02661178|12510388|FG008|COMPLETED|Part 1||6
11311513|NCT02661178|12510389|FG009|COMPLETED|Part 1||12
11311514|NCT02661178|12510390|FG010|COMPLETED|Part 1||4
11311515|NCT02661178|12510391|FG011|COMPLETED|Part 1||0
11311516|NCT02661178|12510392|FG012|COMPLETED|Part 1||0
11311517|NCT02661178|12510393|FG013|COMPLETED|Part 1||0
11311518|NCT02661178|12510394|FG014|COMPLETED|Part 1||0
11311519|NCT02661178|12510380|FG000|NOT COMPLETED|Part 1||1
11311520|NCT02661178|12510381|FG001|NOT COMPLETED|Part 1||0
11311521|NCT02661178|12510382|FG002|NOT COMPLETED|Part 1||0
11311522|NCT02661178|12510383|FG003|NOT COMPLETED|Part 1||0
11311523|NCT02661178|12510384|FG004|NOT COMPLETED|Part 1||0
11311524|NCT02661178|12510385|FG005|NOT COMPLETED|Part 1||0
11311525|NCT02661178|12510386|FG006|NOT COMPLETED|Part 1||0
11311526|NCT02661178|12510387|FG007|NOT COMPLETED|Part 1||0
11311527|NCT02661178|12510388|FG008|NOT COMPLETED|Part 1||0
11311528|NCT02661178|12510389|FG009|NOT COMPLETED|Part 1||0
11311529|NCT02661178|12510390|FG010|NOT COMPLETED|Part 1||0
11311530|NCT02661178|12510391|FG011|NOT COMPLETED|Part 1||0
11311531|NCT02661178|12510392|FG012|NOT COMPLETED|Part 1||0
11311532|NCT02661178|12510393|FG013|NOT COMPLETED|Part 1||0
11311533|NCT02661178|12510394|FG014|NOT COMPLETED|Part 1||0
11311534|NCT02661178|12510380|FG000|STARTED|Part 2||0
11311535|NCT02661178|12510381|FG001|STARTED|Part 2||0
11401995|NCT04071158|12596807|FG003|COMPLETED|Overall Study||140
11401996|NCT04071158|12596808|FG004|COMPLETED|Overall Study||136
11401997|NCT04071158|12596804|FG000|NOT COMPLETED|Overall Study||3
11401998|NCT04071158|12596805|FG001|NOT COMPLETED|Overall Study||4
11401999|NCT04071158|12596806|FG002|NOT COMPLETED|Overall Study||3
11311536|NCT02661178|12510382|FG002|STARTED|Part 2||0
11311537|NCT02661178|12510383|FG003|STARTED|Part 2||0
11311538|NCT02661178|12510384|FG004|STARTED|Part 2||0
11311539|NCT02661178|12510385|FG005|STARTED|Part 2||0
11311540|NCT02661178|12510386|FG006|STARTED|Part 2||0
11311541|NCT02661178|12510387|FG007|STARTED|Part 2||0
11311542|NCT02661178|12510388|FG008|STARTED|Part 2||0
11311543|NCT02661178|12510389|FG009|STARTED|Part 2||0
11311544|NCT02661178|12510390|FG010|STARTED|Part 2||0
11311545|NCT02661178|12510391|FG011|STARTED|Part 2||6
11311546|NCT02661178|12510392|FG012|STARTED|Part 2||6
11311547|NCT02661178|12510393|FG013|STARTED|Part 2||2
11311548|NCT02661178|12510394|FG014|STARTED|Part 2||2
11311549|NCT02661178|12510380|FG000|COMPLETED|Part 2||0
11311550|NCT02661178|12510381|FG001|COMPLETED|Part 2||0
11311551|NCT02661178|12510382|FG002|COMPLETED|Part 2||0
11311552|NCT02661178|12510383|FG003|COMPLETED|Part 2||0
11402000|NCT04071158|12596807|FG003|NOT COMPLETED|Overall Study||3
11402001|NCT04071158|12596808|FG004|NOT COMPLETED|Overall Study||5
11311553|NCT02661178|12510384|FG004|COMPLETED|Part 2||0
11311554|NCT02661178|12510385|FG005|COMPLETED|Part 2||0
11311555|NCT02661178|12510386|FG006|COMPLETED|Part 2||0
11311556|NCT02661178|12510387|FG007|COMPLETED|Part 2||0
11311557|NCT02661178|12510388|FG008|COMPLETED|Part 2||0
11311558|NCT02661178|12510389|FG009|COMPLETED|Part 2||0
11311559|NCT02661178|12510390|FG010|COMPLETED|Part 2||0
11311560|NCT02661178|12510391|FG011|COMPLETED|Part 2||6
11311561|NCT02661178|12510392|FG012|COMPLETED|Part 2||6
11311562|NCT02661178|12510393|FG013|COMPLETED|Part 2||2
11311563|NCT02661178|12510394|FG014|COMPLETED|Part 2||2
11311564|NCT02661178|12510380|FG000|NOT COMPLETED|Part 2||0
11311565|NCT02661178|12510381|FG001|NOT COMPLETED|Part 2||0
11311566|NCT02661178|12510382|FG002|NOT COMPLETED|Part 2||0
11311567|NCT02661178|12510383|FG003|NOT COMPLETED|Part 2||0
11311568|NCT02661178|12510384|FG004|NOT COMPLETED|Part 2||0
11311569|NCT02661178|12510385|FG005|NOT COMPLETED|Part 2||0
11311570|NCT02661178|12510386|FG006|NOT COMPLETED|Part 2||0
11311571|NCT02661178|12510387|FG007|NOT COMPLETED|Part 2||0
11311572|NCT02661178|12510388|FG008|NOT COMPLETED|Part 2||0
11311573|NCT02661178|12510389|FG009|NOT COMPLETED|Part 2||0
11311574|NCT02661178|12510390|FG010|NOT COMPLETED|Part 2||0
11311575|NCT02661178|12510391|FG011|NOT COMPLETED|Part 2||0
11311576|NCT02661178|12510392|FG012|NOT COMPLETED|Part 2||0
11311577|NCT02661178|12510393|FG013|NOT COMPLETED|Part 2||0
11311578|NCT02661178|12510394|FG014|NOT COMPLETED|Part 2||0
11311579|NCT02661217|12510446|FG000|STARTED|Overall Study||500
11311580|NCT02661217|12510447|FG001|STARTED|Overall Study||502
11311581|NCT02661217|12510446|FG000|Started 10 Weeks Treatment Epoch|Overall Study||497
11311582|NCT02661217|12510447|FG001|Started 10 Weeks Treatment Epoch|Overall Study||501
11311583|NCT02661217|12510446|FG000|Completed 10 Weeks Treatment Epoch|Overall Study||460
11311584|NCT02661217|12510447|FG001|Completed 10 Weeks Treatment Epoch|Overall Study||455
11311585|NCT02661217|12510446|FG000|COMPLETED|Overall Study||425
11311586|NCT02661217|12510447|FG001|COMPLETED|Overall Study||419
11311587|NCT02661217|12510446|FG000|NOT COMPLETED|Overall Study||75
11311588|NCT02661217|12510447|FG001|NOT COMPLETED|Overall Study||83
11311589|NCT02661256|12510454|FG000|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7
11311590|NCT02661256|12510454|FG000|COMPLETED|Overall Study||7
11311591|NCT02661256|12510454|FG000|NOT COMPLETED|Overall Study||0
11311592|NCT02661490|12510465|FG000|STARTED|Overall Study||76
11311593|NCT02661490|12510466|FG001|STARTED|Overall Study||74
11311594|NCT02661490|12510467|FG002|STARTED|Overall Study||72
11311595|NCT02661490|12510468|FG003|STARTED|Overall Study||72
11311596|NCT02661490|12510469|FG004|STARTED|Overall Study||26
11311597|NCT02661490|12510465|FG000|COMPLETED|Overall Study||73
11311598|NCT02661490|12510466|FG001|COMPLETED|Overall Study||72
11311599|NCT02661490|12510467|FG002|COMPLETED|Overall Study||70
11311600|NCT02661490|12510468|FG003|COMPLETED|Overall Study||71
11311601|NCT02661490|12510469|FG004|COMPLETED|Overall Study||23
11311602|NCT02661490|12510465|FG000|NOT COMPLETED|Overall Study||3
11311603|NCT02661490|12510466|FG001|NOT COMPLETED|Overall Study||2
11311604|NCT02661490|12510467|FG002|NOT COMPLETED|Overall Study||2
11311605|NCT02661490|12510468|FG003|NOT COMPLETED|Overall Study||1
11311606|NCT02661490|12510469|FG004|NOT COMPLETED|Overall Study||3
11311607|NCT02661594|12510485|FG000|STARTED|Overall Study||10
11311608|NCT02661594|12510486|FG001|STARTED|Overall Study||11
11311609|NCT02661594|12510487|FG002|STARTED|Overall Study||10
11311610|NCT02661594|12510488|FG003|STARTED|Overall Study||9
11311611|NCT02661594|12510485|FG000|COMPLETED|Overall Study||9
11311612|NCT02661594|12510486|FG001|COMPLETED|Overall Study||11
11311613|NCT02661594|12510487|FG002|COMPLETED|Overall Study||9
11311614|NCT02661594|12510488|FG003|COMPLETED|Overall Study||9
11311615|NCT02661594|12510485|FG000|NOT COMPLETED|Overall Study||1
11311616|NCT02661594|12510486|FG001|NOT COMPLETED|Overall Study||0
11311617|NCT02661594|12510487|FG002|NOT COMPLETED|Overall Study||1
11311618|NCT02661594|12510488|FG003|NOT COMPLETED|Overall Study||0
11311619|NCT02661737|12510498|FG000|STARTED|Overall Study||503
11311620|NCT02661737|12510498|FG000|COMPLETED|Overall Study||469
11311621|NCT02661737|12510498|FG000|NOT COMPLETED|Overall Study||34
11311622|NCT02661815|12510506|FG000|STARTED|Overall Study||6
11311623|NCT02661815|12510507|FG001|STARTED|Overall Study||0
11311624|NCT02661815|12510508|FG002|STARTED|Overall Study||0
11311625|NCT02661815|12510509|FG003|STARTED|Overall Study||0
11311626|NCT02661815|12510506|FG000|COMPLETED|Overall Study||5
11311627|NCT02661815|12510507|FG001|COMPLETED|Overall Study||0
11311628|NCT02661815|12510508|FG002|COMPLETED|Overall Study||0
11311629|NCT02661815|12510509|FG003|COMPLETED|Overall Study||0
11311630|NCT02661815|12510506|FG000|NOT COMPLETED|Overall Study||1
11311631|NCT02661815|12510507|FG001|NOT COMPLETED|Overall Study||0
11311632|NCT02661815|12510508|FG002|NOT COMPLETED|Overall Study||0
11311633|NCT02661815|12510509|FG003|NOT COMPLETED|Overall Study||0
11311634|NCT02661828|12510525|FG000|STARTED|Overall Study||1
11311635|NCT02661828|12510526|FG001|STARTED|Overall Study||0
11311636|NCT02661828|12510525|FG000|COMPLETED|Overall Study||1
11311637|NCT02661828|12510526|FG001|COMPLETED|Overall Study||0
11311638|NCT02661828|12510525|FG000|NOT COMPLETED|Overall Study||0
11311639|NCT02661828|12510526|FG001|NOT COMPLETED|Overall Study||0
11311640|NCT02662023|12510533|FG000|STARTED|Overall Study||12
11311641|NCT02662023|12510534|FG001|STARTED|Overall Study||12
11311642|NCT02662023|12510533|FG000|COMPLETED|Overall Study||12
11311643|NCT02662023|12510534|FG001|COMPLETED|Overall Study||12
11311644|NCT02662023|12510533|FG000|NOT COMPLETED|Overall Study||0
11311645|NCT02662023|12510534|FG001|NOT COMPLETED|Overall Study||0
11311646|NCT02662036|12510542|FG000|STARTED|Overall Study||35
11311647|NCT02662036|12510543|FG001|STARTED|Overall Study||35
11311648|NCT02662036|12510542|FG000|COMPLETED|Overall Study||22
11311649|NCT02662036|12510543|FG001|COMPLETED|Overall Study||22
11311650|NCT02662036|12510542|FG000|NOT COMPLETED|Overall Study||13
11311651|NCT02662036|12510543|FG001|NOT COMPLETED|Overall Study||13
11311652|NCT02662244|12510549|FG000|STARTED|Overall Study||33
11402002|NCT04070287|12596831|FG000|STARTED|Overall Study||114
11402003|NCT04070287|12596832|FG001|STARTED|Overall Study||86
11402004|NCT04070287|12596833|FG002|STARTED|Overall Study||81
11311653|NCT02662244|12510549|FG000|COMPLETED|Overall Study||31
11311654|NCT02662244|12510549|FG000|NOT COMPLETED|Overall Study||2
11311655|NCT02662387|12510557|FG000|STARTED|Overall Study||27
11311656|NCT02662387|12510558|FG001|STARTED|Overall Study||28
11311657|NCT02662387|12510557|FG000|COMPLETED|Overall Study||27
11311658|NCT02662387|12510558|FG001|COMPLETED|Overall Study||28
11311659|NCT02662387|12510557|FG000|NOT COMPLETED|Overall Study||0
11311660|NCT02662387|12510558|FG001|NOT COMPLETED|Overall Study||0
11311661|NCT02662556|12510566|FG000|STARTED|Overall Study||140
11311662|NCT02662556|12510566|FG000|COMPLETED|Overall Study||132
11311663|NCT02662556|12510566|FG000|NOT COMPLETED|Overall Study||8
11311664|NCT02662569|12510575|FG000|STARTED|Overall Study||166
11311665|NCT02662569|12510576|FG001|STARTED|Overall Study||161
11311666|NCT02662569|12510577|FG002|STARTED|Overall Study||327
11311667|NCT02662569|12510578|FG003|STARTED|Overall Study||332
11311668|NCT02662569|12510575|FG000|Received Study Drug|Overall Study||164
11311669|NCT02662569|12510576|FG001|Received Study Drug|Overall Study||160
11311670|NCT02662569|12510577|FG002|Received Study Drug|Overall Study||325
11311671|NCT02662569|12510578|FG003|Received Study Drug|Overall Study||332
11311672|NCT02662569|12510575|FG000|COMPLETED|Overall Study||159
11311673|NCT02662569|12510576|FG001|COMPLETED|Overall Study||160
11311674|NCT02662569|12510577|FG002|COMPLETED|Overall Study||321
11311675|NCT02662569|12510578|FG003|COMPLETED|Overall Study||328
11311676|NCT02662569|12510575|FG000|NOT COMPLETED|Overall Study||7
11311677|NCT02662569|12510576|FG001|NOT COMPLETED|Overall Study||1
11311678|NCT02662569|12510577|FG002|NOT COMPLETED|Overall Study||6
11311679|NCT02662569|12510578|FG003|NOT COMPLETED|Overall Study||4
11311680|NCT02662582|12510590|FG000|STARTED|Treatment Period 1 (14 Days)||23
11311681|NCT02662582|12510591|FG001|STARTED|Treatment Period 1 (14 Days)||23
11311682|NCT02662582|12510590|FG000|COMPLETED|Treatment Period 1 (14 Days)||18
11311683|NCT02662582|12510591|FG001|COMPLETED|Treatment Period 1 (14 Days)||19
11311684|NCT02662582|12510590|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||5
11311685|NCT02662582|12510591|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||4
11311686|NCT02662582|12510590|FG000|STARTED|Washout Period (14 Days)||18
11311687|NCT02662582|12510591|FG001|STARTED|Washout Period (14 Days)||19
11311688|NCT02662582|12510590|FG000|COMPLETED|Washout Period (14 Days)||18
11311689|NCT02662582|12510591|FG001|COMPLETED|Washout Period (14 Days)||19
11402005|NCT04070287|12596834|FG003|STARTED|Overall Study||11
11402006|NCT04070287|12596835|FG004|STARTED|Overall Study||96
11402007|NCT04070287|12596831|FG000|COMPLETED|Overall Study||103
11402008|NCT04070287|12596832|FG001|COMPLETED|Overall Study||44
11402009|NCT04070287|12596833|FG002|COMPLETED|Overall Study||75
11402010|NCT04070287|12596834|FG003|COMPLETED|Overall Study||7
11311690|NCT02662582|12510590|FG000|NOT COMPLETED|Washout Period (14 Days)||0
11311691|NCT02662582|12510591|FG001|NOT COMPLETED|Washout Period (14 Days)||0
11311692|NCT02662582|12510590|FG000|STARTED|Treatment Period 2 (14 Days)||18
11311693|NCT02662582|12510591|FG001|STARTED|Treatment Period 2 (14 Days)||19
11311694|NCT02662582|12510590|FG000|COMPLETED|Treatment Period 2 (14 Days)||18
11311695|NCT02662582|12510591|FG001|COMPLETED|Treatment Period 2 (14 Days)||19
11311696|NCT02662582|12510590|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11311697|NCT02662582|12510591|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11311698|NCT02662608|12510598|FG000|STARTED|Overall Study||1
11311699|NCT02662608|12510598|FG000|COMPLETED|Overall Study||1
11311700|NCT02662608|12510598|FG000|NOT COMPLETED|Overall Study||0
11311701|NCT02662764|12510602|FG000|STARTED|Overall Study||320
11311702|NCT02662764|12510602|FG000|COMPLETED|Overall Study|First 24-hours of study treatment|290
11311703|NCT02662764|12510602|FG000|NOT COMPLETED|Overall Study||30
11311704|NCT02663128|12510613|FG000|STARTED|Period 1||3
11311705|NCT02663128|12510614|FG001|STARTED|Period 1||3
11311706|NCT02663128|12510615|FG002|STARTED|Period 1||3
11311707|NCT02663128|12510616|FG003|STARTED|Period 1||3
11311708|NCT02663128|12510617|FG004|STARTED|Period 1||3
11311709|NCT02663128|12510618|FG005|STARTED|Period 1||3
11311710|NCT02663128|12510613|FG000|Received at Least One Dose of Study Drug|Period 1||3
11311711|NCT02663128|12510614|FG001|Received at Least One Dose of Study Drug|Period 1||3
11402011|NCT04070287|12596835|FG004|COMPLETED|Overall Study||95
11402012|NCT04070287|12596831|FG000|NOT COMPLETED|Overall Study||11
11402013|NCT04070287|12596832|FG001|NOT COMPLETED|Overall Study||42
11402014|NCT04070287|12596833|FG002|NOT COMPLETED|Overall Study||6
11311712|NCT02663128|12510615|FG002|Received at Least One Dose of Study Drug|Period 1||3
11311713|NCT02663128|12510616|FG003|Received at Least One Dose of Study Drug|Period 1||3
11311714|NCT02663128|12510617|FG004|Received at Least One Dose of Study Drug|Period 1||3
11311715|NCT02663128|12510618|FG005|Received at Least One Dose of Study Drug|Period 1||3
11311716|NCT02663128|12510613|FG000|COMPLETED|Period 1||3
11311717|NCT02663128|12510614|FG001|COMPLETED|Period 1||3
11311718|NCT02663128|12510615|FG002|COMPLETED|Period 1||3
11311719|NCT02663128|12510616|FG003|COMPLETED|Period 1||3
11402015|NCT04070287|12596834|FG003|NOT COMPLETED|Overall Study||4
11402016|NCT04070287|12596835|FG004|NOT COMPLETED|Overall Study||1
11311720|NCT02663128|12510617|FG004|COMPLETED|Period 1||3
11311721|NCT02663128|12510618|FG005|COMPLETED|Period 1||3
11311722|NCT02663128|12510613|FG000|NOT COMPLETED|Period 1||0
11311723|NCT02663128|12510614|FG001|NOT COMPLETED|Period 1||0
11311724|NCT02663128|12510615|FG002|NOT COMPLETED|Period 1||0
11311725|NCT02663128|12510616|FG003|NOT COMPLETED|Period 1||0
11311726|NCT02663128|12510617|FG004|NOT COMPLETED|Period 1||0
11311727|NCT02663128|12510618|FG005|NOT COMPLETED|Period 1||0
11402017|NCT04069715|12596849|FG000|STARTED|Overall Study||47
11311728|NCT02663128|12510613|FG000|STARTED|Period 2||3
11311729|NCT02663128|12510614|FG001|STARTED|Period 2||3
11311730|NCT02663128|12510615|FG002|STARTED|Period 2||3
11311731|NCT02663128|12510616|FG003|STARTED|Period 2||3
11311732|NCT02663128|12510617|FG004|STARTED|Period 2||3
11311733|NCT02663128|12510618|FG005|STARTED|Period 2||3
11311734|NCT02663128|12510613|FG000|COMPLETED|Period 2||3
11311735|NCT02663128|12510614|FG001|COMPLETED|Period 2||3
11311736|NCT02663128|12510615|FG002|COMPLETED|Period 2||3
11311737|NCT02663128|12510616|FG003|COMPLETED|Period 2||3
11311738|NCT02663128|12510617|FG004|COMPLETED|Period 2||2
11311739|NCT02663128|12510618|FG005|COMPLETED|Period 2||3
11311740|NCT02663128|12510613|FG000|NOT COMPLETED|Period 2||0
11311741|NCT02663128|12510614|FG001|NOT COMPLETED|Period 2||0
11311742|NCT02663128|12510615|FG002|NOT COMPLETED|Period 2||0
11311743|NCT02663128|12510616|FG003|NOT COMPLETED|Period 2||0
11311744|NCT02663128|12510617|FG004|NOT COMPLETED|Period 2||1
11311745|NCT02663128|12510618|FG005|NOT COMPLETED|Period 2||0
11311746|NCT02663128|12510613|FG000|STARTED|Period 3||3
11311747|NCT02663128|12510614|FG001|STARTED|Period 3||3
11311748|NCT02663128|12510615|FG002|STARTED|Period 3||3
11311749|NCT02663128|12510616|FG003|STARTED|Period 3||3
11311750|NCT02663128|12510617|FG004|STARTED|Period 3||2
11311751|NCT02663128|12510618|FG005|STARTED|Period 3||3
11311752|NCT02663128|12510613|FG000|COMPLETED|Period 3||3
11311753|NCT02663128|12510614|FG001|COMPLETED|Period 3||3
11311754|NCT02663128|12510615|FG002|COMPLETED|Period 3||3
11311755|NCT02663128|12510616|FG003|COMPLETED|Period 3||3
11311756|NCT02663128|12510617|FG004|COMPLETED|Period 3||2
11311757|NCT02663128|12510618|FG005|COMPLETED|Period 3||3
11311758|NCT02663128|12510613|FG000|NOT COMPLETED|Period 3||0
11311759|NCT02663128|12510614|FG001|NOT COMPLETED|Period 3||0
11402018|NCT04069715|12596850|FG001|STARTED|Overall Study||48
11402019|NCT04069715|12596849|FG000|COMPLETED|Overall Study||42
11402020|NCT04069715|12596850|FG001|COMPLETED|Overall Study||43
11402021|NCT04069715|12596849|FG000|NOT COMPLETED|Overall Study||5
11402022|NCT04069715|12596850|FG001|NOT COMPLETED|Overall Study||5
11402023|NCT04050722|12596858|FG000|STARTED|Overall Study||65
11311760|NCT02663128|12510615|FG002|NOT COMPLETED|Period 3||0
11311761|NCT02663128|12510616|FG003|NOT COMPLETED|Period 3||0
11311762|NCT02663128|12510617|FG004|NOT COMPLETED|Period 3||0
11311763|NCT02663128|12510618|FG005|NOT COMPLETED|Period 3||0
11311764|NCT02663232|12510627|FG000|STARTED|Overall Study||264
11311765|NCT02663232|12510627|FG000|COMPLETED|Overall Study||264
11311766|NCT02663232|12510627|FG000|NOT COMPLETED|Overall Study||0
11311767|NCT02663453|12510633|FG000|STARTED|Overall Study||22
11311768|NCT02663453|12510634|FG001|STARTED|Overall Study||22
11311769|NCT02663453|12510633|FG000|COMPLETED|Overall Study||17
11311770|NCT02663453|12510634|FG001|COMPLETED|Overall Study||18
11311771|NCT02663453|12510633|FG000|NOT COMPLETED|Overall Study||5
11311772|NCT02663453|12510634|FG001|NOT COMPLETED|Overall Study||4
11311773|NCT02663674|12510642|FG000|STARTED|Overall Study||33
11311774|NCT02663674|12510643|FG001|STARTED|Overall Study||39
11311775|NCT02663674|12510642|FG000|COMPLETED|Overall Study||26
11311776|NCT02663674|12510643|FG001|COMPLETED|Overall Study||29
11311777|NCT02663674|12510642|FG000|NOT COMPLETED|Overall Study||7
11311778|NCT02663674|12510643|FG001|NOT COMPLETED|Overall Study||10
11311779|NCT02663687|12510654|FG000|STARTED|Overall Study||12
11311780|NCT02663687|12510655|FG001|STARTED|Overall Study||9
11402024|NCT04050722|12596859|FG001|STARTED|Overall Study||65
11402025|NCT04050722|12596858|FG000|COMPLETED|Overall Study||64
11402026|NCT04050722|12596859|FG001|COMPLETED|Overall Study||65
11311781|NCT02663687|12510656|FG002|STARTED|Overall Study||9
11311782|NCT02663687|12510657|FG003|STARTED|Overall Study||9
11311783|NCT02663687|12510658|FG004|STARTED|Overall Study||9
11311784|NCT02663687|12510654|FG000|Treatment Period 1 (IV)|Overall Study||12
11311785|NCT02663687|12510655|FG001|Treatment Period 1 (IV)|Overall Study||9
11311786|NCT02663687|12510656|FG002|Treatment Period 1 (IV)|Overall Study||9
11311787|NCT02663687|12510657|FG003|Treatment Period 1 (IV)|Overall Study||9
11311788|NCT02663687|12510658|FG004|Treatment Period 1 (IV)|Overall Study||9
11311789|NCT02663687|12510654|FG000|Treatment Period 2 (SC)|Overall Study||10
11311790|NCT02663687|12510655|FG001|Treatment Period 2 (SC)|Overall Study||9
11311791|NCT02663687|12510656|FG002|Treatment Period 2 (SC)|Overall Study||8
11311792|NCT02663687|12510657|FG003|Treatment Period 2 (SC)|Overall Study||9
11311793|NCT02663687|12510658|FG004|Treatment Period 2 (SC)|Overall Study||9
11311794|NCT02663687|12510654|FG000|COMPLETED|Overall Study||10
11311795|NCT02663687|12510655|FG001|COMPLETED|Overall Study||9
11311796|NCT02663687|12510656|FG002|COMPLETED|Overall Study||8
11311797|NCT02663687|12510657|FG003|COMPLETED|Overall Study||9
11311798|NCT02663687|12510658|FG004|COMPLETED|Overall Study||9
11402027|NCT04050722|12596858|FG000|NOT COMPLETED|Overall Study||1
11402028|NCT04050722|12596859|FG001|NOT COMPLETED|Overall Study||0
11402029|NCT04069221|12596867|FG000|STARTED|Overall Study||8
11402030|NCT04069221|12596868|FG001|STARTED|Overall Study||6
11402031|NCT04069221|12596869|FG002|STARTED|Overall Study||6
11402032|NCT04069221|12596870|FG003|STARTED|Overall Study||6
11402033|NCT04069221|12596867|FG000|COMPLETED|Overall Study||8
11402034|NCT04069221|12596868|FG001|COMPLETED|Overall Study||6
11402035|NCT04069221|12596869|FG002|COMPLETED|Overall Study||6
11311799|NCT02663687|12510654|FG000|NOT COMPLETED|Overall Study||2
11311800|NCT02663687|12510655|FG001|NOT COMPLETED|Overall Study||0
11311801|NCT02663687|12510656|FG002|NOT COMPLETED|Overall Study||1
11311802|NCT02663687|12510657|FG003|NOT COMPLETED|Overall Study||0
11311803|NCT02663687|12510658|FG004|NOT COMPLETED|Overall Study||0
11311804|NCT02663817|12510683|FG000|STARTED|Overall Study||52
11311805|NCT02663817|12510683|FG000|COMPLETED|Overall Study||50
11311806|NCT02663817|12510683|FG000|NOT COMPLETED|Overall Study||2
11311807|NCT02663882|12510691|FG000|STARTED|Overall Study||39
11311808|NCT02663882|12510692|FG001|STARTED|Overall Study||36
11311809|NCT02663882|12510691|FG000|COMPLETED|Overall Study||35
11311810|NCT02663882|12510692|FG001|COMPLETED|Overall Study||34
11311811|NCT02663882|12510691|FG000|NOT COMPLETED|Overall Study||4
11311812|NCT02663882|12510692|FG001|NOT COMPLETED|Overall Study||2
11311813|NCT02663895|12510698|FG000|STARTED|Overall Study||12
11311814|NCT02663895|12510698|FG000|COMPLETED|Overall Study||5
11311815|NCT02663895|12510698|FG000|NOT COMPLETED|Overall Study||7
11311816|NCT02664220|12510705|FG000|STARTED|Overall Study||50
11402036|NCT04069221|12596870|FG003|COMPLETED|Overall Study||6
11311817|NCT02664220|12510706|FG001|STARTED|Overall Study||50
11311818|NCT02664220|12510705|FG000|COMPLETED|Overall Study||50
11311819|NCT02664220|12510706|FG001|COMPLETED|Overall Study||50
11311820|NCT02664220|12510705|FG000|NOT COMPLETED|Overall Study||0
11311821|NCT02664220|12510706|FG001|NOT COMPLETED|Overall Study||0
11311822|NCT02664272|12510712|FG000|STARTED|Overall Study||40
11311823|NCT02664272|12510712|FG000|COMPLETED|Overall Study||38
11311824|NCT02664272|12510712|FG000|NOT COMPLETED|Overall Study||2
11311825|NCT02664311|12510718|FG000|STARTED|Overall Study||6
11311826|NCT02664311|12510719|FG001|STARTED|Overall Study||3
11311827|NCT02664311|12510718|FG000|COMPLETED|Overall Study||6
11311828|NCT02664311|12510719|FG001|COMPLETED|Overall Study||3
11311829|NCT02664311|12510718|FG000|NOT COMPLETED|Overall Study||0
11311830|NCT02664311|12510719|FG001|NOT COMPLETED|Overall Study||0
11311831|NCT02664363|12510725|FG000|STARTED|Overall Study||3
11311832|NCT02664363|12510725|FG000|COMPLETED|Overall Study||3
11311833|NCT02664363|12510725|FG000|NOT COMPLETED|Overall Study||0
11311834|NCT02664415|12510731|FG000|STARTED|Overall Study||14
11311835|NCT02664415|12510732|FG001|STARTED|Overall Study||5
11311836|NCT02664415|12510731|FG000|COMPLETED|Overall Study||13
11311837|NCT02664415|12510732|FG001|COMPLETED|Overall Study||5
11311838|NCT02664415|12510731|FG000|NOT COMPLETED|Overall Study||1
11311839|NCT02664415|12510732|FG001|NOT COMPLETED|Overall Study||0
11311840|NCT02664532|12510740|FG000|STARTED|Overall Study||75
11311841|NCT02664532|12510741|FG001|STARTED|Overall Study||75
11311842|NCT02664532|12510740|FG000|COMPLETED|Overall Study||75
11311843|NCT02664532|12510741|FG001|COMPLETED|Overall Study||75
11311844|NCT02664532|12510740|FG000|NOT COMPLETED|Overall Study||0
11311845|NCT02664532|12510741|FG001|NOT COMPLETED|Overall Study||0
11311846|NCT02664610|12510749|FG000|STARTED|Overall Study||46
11311847|NCT02664610|12510750|FG001|STARTED|Overall Study||48
11311848|NCT02664610|12510749|FG000|COMPLETED|Overall Study||32
11311849|NCT02664610|12510750|FG001|COMPLETED|Overall Study||41
11311850|NCT02664610|12510749|FG000|NOT COMPLETED|Overall Study||14
11311851|NCT02664610|12510750|FG001|NOT COMPLETED|Overall Study||7
11311852|NCT02664909|12510758|FG000|STARTED|Overall Study||17
11311853|NCT02664909|12510759|FG001|STARTED|Overall Study||19
11311854|NCT02664909|12510758|FG000|COMPLETED|Overall Study||15
11311855|NCT02664909|12510759|FG001|COMPLETED|Overall Study||16
11311856|NCT02664909|12510758|FG000|NOT COMPLETED|Overall Study||2
11311857|NCT02664909|12510759|FG001|NOT COMPLETED|Overall Study||3
11311858|NCT02664922|12510769|FG000|STARTED|Overall Study||11
11311859|NCT02664922|12510770|FG001|STARTED|Overall Study||12
11311860|NCT02664922|12510771|FG002|STARTED|Overall Study||7
11311861|NCT02664922|12510772|FG003|STARTED|Overall Study||5
11311862|NCT02664922|12510769|FG000|COMPLETED|Overall Study||10
11311863|NCT02664922|12510770|FG001|COMPLETED|Overall Study||12
11311864|NCT02664922|12510771|FG002|COMPLETED|Overall Study||7
11311865|NCT02664922|12510772|FG003|COMPLETED|Overall Study||5
11311866|NCT02664922|12510769|FG000|NOT COMPLETED|Overall Study||1
11311867|NCT02664922|12510770|FG001|NOT COMPLETED|Overall Study||0
11311868|NCT02664922|12510771|FG002|NOT COMPLETED|Overall Study||0
11311869|NCT02664922|12510772|FG003|NOT COMPLETED|Overall Study||0
11311870|NCT02664961|12510782|FG000|STARTED|Overall Study||3
11311871|NCT02664961|12510782|FG000|COMPLETED|Overall Study||3
11311872|NCT02664961|12510782|FG000|NOT COMPLETED|Overall Study||0
11311873|NCT02664987|12510786|FG000|STARTED|Overall Study||462
11311874|NCT02664987|12510786|FG000|COMPLETED|Overall Study||462
11311875|NCT02664987|12510786|FG000|NOT COMPLETED|Overall Study||0
11311876|NCT02665052|12510794|FG000|STARTED|Overall Study||11
11311877|NCT02665052|12510795|FG001|STARTED|Overall Study||9
11311878|NCT02665052|12510796|FG002|STARTED|Overall Study||9
11311879|NCT02665052|12510797|FG003|STARTED|Overall Study||19
11402037|NCT04069221|12596867|FG000|NOT COMPLETED|Overall Study||0
11311880|NCT02665052|12510794|FG000|COMPLETED|Overall Study||8
11311881|NCT02665052|12510795|FG001|COMPLETED|Overall Study||7
11311882|NCT02665052|12510796|FG002|COMPLETED|Overall Study||9
11311883|NCT02665052|12510797|FG003|COMPLETED|Overall Study||14
11311884|NCT02665052|12510794|FG000|NOT COMPLETED|Overall Study||3
11311885|NCT02665052|12510795|FG001|NOT COMPLETED|Overall Study||2
11311886|NCT02665052|12510796|FG002|NOT COMPLETED|Overall Study||0
11402038|NCT04069221|12596868|FG001|NOT COMPLETED|Overall Study||0
11311887|NCT02665052|12510797|FG003|NOT COMPLETED|Overall Study||5
11311888|NCT02665260|12510812|FG000|STARTED|Overall Study||24
11311889|NCT02665260|12510813|FG001|STARTED|Overall Study||23
11311890|NCT02665260|12510814|FG002|STARTED|Overall Study||25
11311891|NCT02665260|12510815|FG003|STARTED|Overall Study||22
11311892|NCT02665260|12510812|FG000|COMPLETED|Overall Study||22
11311893|NCT02665260|12510813|FG001|COMPLETED|Overall Study||22
11311894|NCT02665260|12510814|FG002|COMPLETED|Overall Study||21
11311895|NCT02665260|12510815|FG003|COMPLETED|Overall Study||21
11311896|NCT02665260|12510812|FG000|NOT COMPLETED|Overall Study||2
11311897|NCT02665260|12510813|FG001|NOT COMPLETED|Overall Study||1
11311898|NCT02665260|12510814|FG002|NOT COMPLETED|Overall Study||4
11311899|NCT02665260|12510815|FG003|NOT COMPLETED|Overall Study||1
11311900|NCT02665273|12510831|FG000|STARTED|Overall Study||13
11311901|NCT02665273|12510832|FG001|STARTED|Overall Study||15
11311902|NCT02665273|12510831|FG000|COMPLETED|Overall Study||13
11311903|NCT02665273|12510832|FG001|COMPLETED|Overall Study||15
11311904|NCT02665273|12510831|FG000|NOT COMPLETED|Overall Study||0
11311905|NCT02665273|12510832|FG001|NOT COMPLETED|Overall Study||0
11311906|NCT02665286|12510841|FG000|STARTED|Overall Study||79
11311907|NCT02665286|12510842|FG001|STARTED|Overall Study||80
11311908|NCT02665286|12510843|FG002|STARTED|Overall Study||81
11311909|NCT02665286|12510841|FG000|COMPLETED|Overall Study||76
11311910|NCT02665286|12510842|FG001|COMPLETED|Overall Study||78
11311911|NCT02665286|12510843|FG002|COMPLETED|Overall Study||80
11311912|NCT02665286|12510841|FG000|NOT COMPLETED|Overall Study||3
11311913|NCT02665286|12510842|FG001|NOT COMPLETED|Overall Study||2
11311914|NCT02665286|12510843|FG002|NOT COMPLETED|Overall Study||1
11311915|NCT02665364|12510853|FG000|STARTED|Overall Study||91
11311916|NCT02665364|12510854|FG001|STARTED|Overall Study||93
11311917|NCT02665364|12510853|FG000|COMPLETED|Overall Study||85
11311918|NCT02665364|12510854|FG001|COMPLETED|Overall Study||84
11311919|NCT02665364|12510853|FG000|NOT COMPLETED|Overall Study||6
11311920|NCT02665364|12510854|FG001|NOT COMPLETED|Overall Study||9
11311921|NCT02665455|12510860|FG000|STARTED|Overall Study||83
11311922|NCT02665455|12510860|FG000|COMPLETED|Overall Study||74
11311923|NCT02665455|12510860|FG000|NOT COMPLETED|Overall Study||9
11311924|NCT02665468|12510866|FG000|STARTED|Overall Study||595
11311925|NCT02665468|12510867|FG001|STARTED|Overall Study||601
11311926|NCT02665468|12510866|FG000|COMPLETED|Overall Study||595
11311927|NCT02665468|12510867|FG001|COMPLETED|Overall Study||601
11311928|NCT02665468|12510866|FG000|NOT COMPLETED|Overall Study||0
11311929|NCT02665468|12510867|FG001|NOT COMPLETED|Overall Study||0
11311930|NCT02665689|12510875|FG000|STARTED|Overall Study||2
11311931|NCT02665689|12510876|FG001|STARTED|Overall Study||2
11311932|NCT02665689|12510875|FG000|COMPLETED|Overall Study||0
11311933|NCT02665689|12510876|FG001|COMPLETED|Overall Study||0
11311934|NCT02665689|12510875|FG000|NOT COMPLETED|Overall Study||2
11311935|NCT02665689|12510876|FG001|NOT COMPLETED|Overall Study||2
11311936|NCT02665728|12510882|FG000|STARTED|Overall Study||33
11311937|NCT02665728|12510882|FG000|COMPLETED|Overall Study||33
11311938|NCT02665728|12510882|FG000|NOT COMPLETED|Overall Study||0
11311939|NCT02665741|12510889|FG000|STARTED|Overall Study||42
11311940|NCT02665741|12510890|FG001|STARTED|Overall Study||42
11311941|NCT02665741|12510891|FG002|STARTED|Overall Study||42
11311942|NCT02665741|12510889|FG000|COMPLETED|Overall Study||42
11311943|NCT02665741|12510890|FG001|COMPLETED|Overall Study||42
11311944|NCT02665741|12510891|FG002|COMPLETED|Overall Study||42
11311945|NCT02665741|12510889|FG000|NOT COMPLETED|Overall Study||0
11311946|NCT02665741|12510890|FG001|NOT COMPLETED|Overall Study||0
11311947|NCT02665741|12510891|FG002|NOT COMPLETED|Overall Study||0
11311948|NCT02665975|12510901|FG000|STARTED|Overall Study||46
11311949|NCT02665975|12510902|FG001|STARTED|Overall Study||46
11311950|NCT02665975|12510901|FG000|COMPLETED|Overall Study||37
11311951|NCT02665975|12510902|FG001|COMPLETED|Overall Study||37
11311952|NCT02665975|12510901|FG000|NOT COMPLETED|Overall Study||9
11311953|NCT02665975|12510902|FG001|NOT COMPLETED|Overall Study||9
11311954|NCT02666222|12510908|FG000|STARTED|Overall Study||51
11311955|NCT02666222|12510908|FG000|COMPLETED|Overall Study||49
11311956|NCT02666222|12510908|FG000|NOT COMPLETED|Overall Study||2
11311957|NCT02666352|12510915|FG000|STARTED|Overall Study||8
11311958|NCT02666352|12510916|FG001|STARTED|Overall Study||8
11311959|NCT02666352|12510917|FG002|STARTED|Overall Study||8
11311960|NCT02666352|12510915|FG000|COMPLETED|Overall Study||8
11311961|NCT02666352|12510916|FG001|COMPLETED|Overall Study||8
11311962|NCT02666352|12510917|FG002|COMPLETED|Overall Study||8
11311963|NCT02666352|12510915|FG000|NOT COMPLETED|Overall Study||0
11311964|NCT02666352|12510916|FG001|NOT COMPLETED|Overall Study||0
11311965|NCT02666352|12510917|FG002|NOT COMPLETED|Overall Study||0
11311966|NCT02666508|12510927|FG000|STARTED|Overall Study||31
11311967|NCT02666508|12510928|FG001|STARTED|Overall Study||30
11311968|NCT02666508|12510927|FG000|COMPLETED|Overall Study||31
11311969|NCT02666508|12510928|FG001|COMPLETED|Overall Study||30
11311970|NCT02666508|12510927|FG000|NOT COMPLETED|Overall Study||0
11311971|NCT02666508|12510928|FG001|NOT COMPLETED|Overall Study||0
11311972|NCT02666560|12510938|FG000|STARTED|Condition 1 (1 Day)||8
11311973|NCT02666560|12510939|FG001|STARTED|Condition 1 (1 Day)||11
11311974|NCT02666560|12510938|FG000|COMPLETED|Condition 1 (1 Day)||8
11311975|NCT02666560|12510939|FG001|COMPLETED|Condition 1 (1 Day)||11
11311976|NCT02666560|12510938|FG000|NOT COMPLETED|Condition 1 (1 Day)||0
11311977|NCT02666560|12510939|FG001|NOT COMPLETED|Condition 1 (1 Day)||0
11311978|NCT02666560|12510938|FG000|STARTED|Condition 2 (1 Day)||8
11311979|NCT02666560|12510939|FG001|STARTED|Condition 2 (1 Day)||11
11311980|NCT02666560|12510938|FG000|COMPLETED|Condition 2 (1 Day)||8
11311981|NCT02666560|12510939|FG001|COMPLETED|Condition 2 (1 Day)||11
11311982|NCT02666560|12510938|FG000|NOT COMPLETED|Condition 2 (1 Day)||0
11311983|NCT02666560|12510939|FG001|NOT COMPLETED|Condition 2 (1 Day)||0
11311984|NCT02666664|12510948|FG000|STARTED|Overall Study||742
11311985|NCT02666664|12510949|FG001|STARTED|Overall Study||1488
11311986|NCT02666664|12510948|FG000|COMPLETED|Overall Study||706
11311987|NCT02666664|12510949|FG001|COMPLETED|Overall Study||1404
11311988|NCT02666664|12510948|FG000|NOT COMPLETED|Overall Study||36
11311989|NCT02666664|12510949|FG001|NOT COMPLETED|Overall Study||84
11311990|NCT02666846|12510958|FG000|STARTED|Overall Study||20
11311991|NCT02666846|12510959|FG001|STARTED|Overall Study||20
11311992|NCT02666846|12510960|FG002|STARTED|Overall Study||20
11311993|NCT02666846|12510958|FG000|COMPLETED|Overall Study||20
11311994|NCT02666846|12510959|FG001|COMPLETED|Overall Study||20
11311995|NCT02666846|12510960|FG002|COMPLETED|Overall Study||20
11311996|NCT02666846|12510958|FG000|NOT COMPLETED|Overall Study||0
11311997|NCT02666846|12510959|FG001|NOT COMPLETED|Overall Study||0
11311998|NCT02666846|12510960|FG002|NOT COMPLETED|Overall Study||0
11311999|NCT02666950|12510990|FG000|STARTED|Overall Study||3
11312000|NCT02666950|12510990|FG000|COMPLETED|Overall Study||3
11312001|NCT02666950|12510990|FG000|NOT COMPLETED|Overall Study||0
11312002|NCT02667236|12510996|FG000|STARTED|Overall Study||223
11312003|NCT02667236|12510997|FG001|STARTED|Overall Study||227
11312004|NCT02667236|12510996|FG000|COMPLETED|Overall Study||220
11312005|NCT02667236|12510997|FG001|COMPLETED|Overall Study||226
11312006|NCT02667236|12510996|FG000|NOT COMPLETED|Overall Study||3
11312007|NCT02667236|12510997|FG001|NOT COMPLETED|Overall Study||1
11312008|NCT02667275|12511005|FG000|STARTED|Overall Study||244
11312009|NCT02667275|12511006|FG001|STARTED|Overall Study||243
11312010|NCT02667275|12511005|FG000|COMPLETED|Overall Study||233
11312011|NCT02667275|12511006|FG001|COMPLETED|Overall Study||228
11312012|NCT02667275|12511005|FG000|NOT COMPLETED|Overall Study||11
11312013|NCT02667275|12511006|FG001|NOT COMPLETED|Overall Study||15
11312014|NCT02667288|12511012|FG000|STARTED|Overall Study||147
11312015|NCT02667288|12511012|FG000|COMPLETED|Overall Study||134
11312016|NCT02667288|12511012|FG000|NOT COMPLETED|Overall Study||13
11312017|NCT02667301|12511016|FG000|STARTED|Overall Study||16
11312018|NCT02667301|12511016|FG000|COMPLETED|Overall Study||14
11312019|NCT02667301|12511016|FG000|NOT COMPLETED|Overall Study||2
11312020|NCT02667392|12511022|FG000|STARTED|Overall Study||11
11312021|NCT02667392|12511022|FG000|COMPLETED|Overall Study||11
11312022|NCT02667392|12511022|FG000|NOT COMPLETED|Overall Study||0
11312023|NCT02667457|12511028|FG000|STARTED|Overall Study||27
11312024|NCT02667457|12511029|FG001|STARTED|Overall Study||12
11312025|NCT02667457|12511028|FG000|Dosed Participants|Overall Study||26
11312026|NCT02667457|12511029|FG001|Dosed Participants|Overall Study||10
11312027|NCT02667457|12511028|FG000|Full Analysis Set Population (FAS)|Overall Study||25
11312028|NCT02667457|12511029|FG001|Full Analysis Set Population (FAS)|Overall Study||10
11312029|NCT02667457|12511028|FG000|COMPLETED|Overall Study||26
11312030|NCT02667457|12511029|FG001|COMPLETED|Overall Study||10
11312031|NCT02667457|12511028|FG000|NOT COMPLETED|Overall Study||1
11312032|NCT02667457|12511029|FG001|NOT COMPLETED|Overall Study||2
11312033|NCT02667626|12511038|FG000|STARTED|Overall Study||86
11312034|NCT02667626|12511039|FG001|STARTED|Overall Study||96
11312035|NCT02667626|12511038|FG000|COMPLETED|Overall Study||86
11312036|NCT02667626|12511039|FG001|COMPLETED|Overall Study||95
11312037|NCT02667626|12511038|FG000|NOT COMPLETED|Overall Study||0
11312038|NCT02667626|12511039|FG001|NOT COMPLETED|Overall Study||1
11312039|NCT02667704|12511048|FG000|STARTED|Treatment Period 1||13
11312040|NCT02667704|12511048|FG000|COMPLETED|Treatment Period 1||13
11312041|NCT02667704|12511048|FG000|NOT COMPLETED|Treatment Period 1||0
11312042|NCT02667704|12511048|FG000|STARTED|Treatment Period 2||13
11312043|NCT02667704|12511048|FG000|COMPLETED|Treatment Period 2||13
11312044|NCT02667704|12511048|FG000|NOT COMPLETED|Treatment Period 2||0
11312045|NCT02667821|12511055|FG000|STARTED|Overall Study||20
11312046|NCT02667821|12511055|FG000|COMPLETED|Overall Study||20
11312047|NCT02667821|12511055|FG000|NOT COMPLETED|Overall Study||0
11312048|NCT02667912|12511062|FG000|STARTED|Overall Study||28
11312049|NCT02667912|12511063|FG001|STARTED|Overall Study||27
11312050|NCT02667912|12511062|FG000|Six Months|Overall Study||27
11312051|NCT02667912|12511063|FG001|Six Months|Overall Study||24
11312052|NCT02667912|12511062|FG000|COMPLETED|Overall Study||23
11312053|NCT02667912|12511063|FG001|COMPLETED|Overall Study||24
11312054|NCT02667912|12511062|FG000|NOT COMPLETED|Overall Study||5
11312055|NCT02667912|12511063|FG001|NOT COMPLETED|Overall Study||3
11312056|NCT02667951|12511071|FG000|STARTED|Overall Study||66
11312057|NCT02667951|12511072|FG001|STARTED|Overall Study||63
11312058|NCT02667951|12511071|FG000|COMPLETED|Overall Study||45
11312059|NCT02667951|12511072|FG001|COMPLETED|Overall Study||40
11312060|NCT02667951|12511071|FG000|NOT COMPLETED|Overall Study||21
11312061|NCT02667951|12511072|FG001|NOT COMPLETED|Overall Study||23
11312062|NCT02668003|12511080|FG000|STARTED|Overall Study||501
11312063|NCT02668003|12511081|FG001|STARTED|Overall Study||501
11312064|NCT02668003|12511080|FG000|COMPLETED|Overall Study||500
11312065|NCT02668003|12511081|FG001|COMPLETED|Overall Study||496
11312066|NCT02668003|12511080|FG000|NOT COMPLETED|Overall Study||1
11312067|NCT02668003|12511081|FG001|NOT COMPLETED|Overall Study||5
11312068|NCT02668185|12511087|FG000|STARTED|Baseline Period (2 Weeks)||20
11312069|NCT02668185|12511088|FG001|STARTED|Baseline Period (2 Weeks)||17
11312070|NCT02668185|12511087|FG000|COMPLETED|Baseline Period (2 Weeks)||20
11312071|NCT02668185|12511088|FG001|COMPLETED|Baseline Period (2 Weeks)||17
11312072|NCT02668185|12511087|FG000|NOT COMPLETED|Baseline Period (2 Weeks)||0
11312073|NCT02668185|12511088|FG001|NOT COMPLETED|Baseline Period (2 Weeks)||0
11312074|NCT02668185|12511087|FG000|STARTED|First Intervention (4 Weeks)||20
11312075|NCT02668185|12511088|FG001|STARTED|First Intervention (4 Weeks)||17
11312076|NCT02668185|12511087|FG000|COMPLETED|First Intervention (4 Weeks)||18
11312077|NCT02668185|12511088|FG001|COMPLETED|First Intervention (4 Weeks)||17
11312078|NCT02668185|12511087|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
11312079|NCT02668185|12511088|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
11312080|NCT02668185|12511087|FG000|STARTED|Washout Period (2 Weeks)||18
11312081|NCT02668185|12511088|FG001|STARTED|Washout Period (2 Weeks)||17
11312082|NCT02668185|12511087|FG000|COMPLETED|Washout Period (2 Weeks)||17
11312083|NCT02668185|12511088|FG001|COMPLETED|Washout Period (2 Weeks)||15
11312084|NCT02668185|12511087|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
11312085|NCT02668185|12511088|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2
11312086|NCT02668185|12511087|FG000|STARTED|Second Intervention (4 Weeks)||17
11312087|NCT02668185|12511088|FG001|STARTED|Second Intervention (4 Weeks)||15
11312088|NCT02668185|12511087|FG000|COMPLETED|Second Intervention (4 Weeks)||16
11312089|NCT02668185|12511088|FG001|COMPLETED|Second Intervention (4 Weeks)||12
11312090|NCT02668185|12511087|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
11312091|NCT02668185|12511088|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3
11312092|NCT02668185|12511087|FG000|STARTED|Moitoring Period (2 Weeks)||16
11312093|NCT02668185|12511088|FG001|STARTED|Moitoring Period (2 Weeks)||12
11312094|NCT02668185|12511087|FG000|COMPLETED|Moitoring Period (2 Weeks)||16
11312095|NCT02668185|12511088|FG001|COMPLETED|Moitoring Period (2 Weeks)||12
11312096|NCT02668185|12511087|FG000|NOT COMPLETED|Moitoring Period (2 Weeks)||0
11312097|NCT02668185|12511088|FG001|NOT COMPLETED|Moitoring Period (2 Weeks)||0
11312098|NCT02668198|12511094|FG000|STARTED|Overall Study||230
11312099|NCT02668198|12511094|FG000|COMPLETED|Overall Study||230
11312100|NCT02668198|12511094|FG000|NOT COMPLETED|Overall Study||0
11312101|NCT02668302|12511101|FG000|STARTED|Overall Study||20
11312102|NCT02668302|12511102|FG001|STARTED|Overall Study||20
11312103|NCT02668302|12511101|FG000|COMPLETED|Overall Study||19
11312104|NCT02668302|12511102|FG001|COMPLETED|Overall Study||20
11312105|NCT02668302|12511101|FG000|NOT COMPLETED|Overall Study||1
11312106|NCT02668302|12511102|FG001|NOT COMPLETED|Overall Study||0
11312107|NCT02668393|12511110|FG000|STARTED|Overall Study||7
11312108|NCT02668393|12511111|FG001|STARTED|Overall Study||7
11312109|NCT02668393|12511110|FG000|COMPLETED|Overall Study||0
11312110|NCT02668393|12511111|FG001|COMPLETED|Overall Study||1
11312111|NCT02668393|12511110|FG000|NOT COMPLETED|Overall Study||7
11312112|NCT02668393|12511111|FG001|NOT COMPLETED|Overall Study||6
11312113|NCT02668432|12511120|FG000|STARTED|Overall Study||5
11312114|NCT02668432|12511121|FG001|STARTED|Overall Study||4
11312115|NCT02668432|12511120|FG000|COMPLETED|Overall Study||5
11312116|NCT02668432|12511121|FG001|COMPLETED|Overall Study||4
11312117|NCT02668432|12511120|FG000|NOT COMPLETED|Overall Study||0
11312118|NCT02668432|12511121|FG001|NOT COMPLETED|Overall Study||0
11312119|NCT02668640|12511127|FG000|STARTED|Overall Study||55
11312120|NCT02668640|12511127|FG000|COMPLETED|Overall Study||41
11312121|NCT02668640|12511127|FG000|NOT COMPLETED|Overall Study||14
11312122|NCT02668692|12511133|FG000|STARTED|Overall Study||101
11312123|NCT02668692|12511134|FG001|STARTED|Overall Study||105
11312124|NCT02668692|12511133|FG000|COMPLETED|Overall Study||100
11312125|NCT02668692|12511134|FG001|COMPLETED|Overall Study||105
11312126|NCT02668692|12511133|FG000|NOT COMPLETED|Overall Study||1
11312127|NCT02668692|12511134|FG001|NOT COMPLETED|Overall Study||0
11312128|NCT02668952|12511142|FG000|STARTED|Overall Study||16
11312129|NCT02668952|12511143|FG001|STARTED|Overall Study||14
11312130|NCT02668952|12511142|FG000|COMPLETED|Overall Study||16
11312131|NCT02668952|12511143|FG001|COMPLETED|Overall Study||14
11312132|NCT02668952|12511142|FG000|NOT COMPLETED|Overall Study||0
11312133|NCT02668952|12511143|FG001|NOT COMPLETED|Overall Study||0
11312134|NCT02669017|12511158|FG000|STARTED|Overall Study||4
11312135|NCT02669017|12511159|FG001|STARTED|Overall Study||4
11312136|NCT02669017|12511160|FG002|STARTED|Overall Study||4
11312137|NCT02669017|12511161|FG003|STARTED|Overall Study||5
11312138|NCT02669017|12511162|FG004|STARTED|Overall Study||16
11312139|NCT02669017|12511163|FG005|STARTED|Overall Study||26
11312140|NCT02669017|12511164|FG006|STARTED|Overall Study||19
11312141|NCT02669017|12511165|FG007|STARTED|Overall Study||69
11312142|NCT02669017|12511166|FG008|STARTED|Overall Study||36
11312143|NCT02669017|12511158|FG000|COMPLETED|Overall Study||3
11312144|NCT02669017|12511159|FG001|COMPLETED|Overall Study||2
11312145|NCT02669017|12511160|FG002|COMPLETED|Overall Study||2
11312146|NCT02669017|12511161|FG003|COMPLETED|Overall Study||1
11312147|NCT02669017|12511162|FG004|COMPLETED|Overall Study||4
11312148|NCT02669017|12511163|FG005|COMPLETED|Overall Study||7
11312149|NCT02669017|12511164|FG006|COMPLETED|Overall Study||8
11312150|NCT02669017|12511165|FG007|COMPLETED|Overall Study||7
11312151|NCT02669017|12511166|FG008|COMPLETED|Overall Study||11
11312152|NCT02669017|12511158|FG000|NOT COMPLETED|Overall Study||1
11312153|NCT02669017|12511159|FG001|NOT COMPLETED|Overall Study||2
11312154|NCT02669017|12511160|FG002|NOT COMPLETED|Overall Study||2
11312155|NCT02669017|12511161|FG003|NOT COMPLETED|Overall Study||4
11312156|NCT02669017|12511162|FG004|NOT COMPLETED|Overall Study||12
11312157|NCT02669017|12511163|FG005|NOT COMPLETED|Overall Study||19
11312158|NCT02669017|12511164|FG006|NOT COMPLETED|Overall Study||11
11312159|NCT02669017|12511165|FG007|NOT COMPLETED|Overall Study||62
11312160|NCT02669017|12511166|FG008|NOT COMPLETED|Overall Study||25
11312161|NCT02669043|12511194|FG000|STARTED|Overall Study||8
11312162|NCT02669043|12511194|FG000|COMPLETED|Overall Study||4
11312163|NCT02669043|12511194|FG000|NOT COMPLETED|Overall Study||4
11312164|NCT02669082|12511198|FG000|STARTED|Overall Study||26
11312165|NCT02669082|12511198|FG000|COMPLETED|Overall Study||25
11312166|NCT02669082|12511198|FG000|NOT COMPLETED|Overall Study||1
11312167|NCT02669095|12511204|FG000|STARTED|Overall Study||75
11312168|NCT02669095|12511205|FG001|STARTED|Overall Study||75
11312169|NCT02669095|12511204|FG000|COMPLETED|Overall Study||74
11312170|NCT02669095|12511205|FG001|COMPLETED|Overall Study||72
11312171|NCT02669095|12511204|FG000|NOT COMPLETED|Overall Study||1
11312172|NCT02669095|12511205|FG001|NOT COMPLETED|Overall Study||3
11312173|NCT02669121|12511213|FG000|STARTED|Overall Study||2377
11312174|NCT02669121|12511214|FG001|STARTED|Overall Study||2371
11312175|NCT02669121|12511213|FG000|Treated (Safety Analysis Set)|Overall Study||2357
11312176|NCT02669121|12511214|FG001|Treated (Safety Analysis Set)|Overall Study||2355
11312177|NCT02669121|12511213|FG000|COMPLETED|Overall Study||2087
11312178|NCT02669121|12511214|FG001|COMPLETED|Overall Study||2089
11312179|NCT02669121|12511213|FG000|NOT COMPLETED|Overall Study||290
11312180|NCT02669121|12511214|FG001|NOT COMPLETED|Overall Study||282
11312181|NCT02669264|12511227|FG000|STARTED|Overall Study||5
11312182|NCT02669264|12511228|FG001|STARTED|Overall Study||7
11312183|NCT02669264|12511229|FG002|STARTED|Overall Study||3
11312184|NCT02669264|12511230|FG003|STARTED|Overall Study||4
11312185|NCT02669264|12511231|FG004|STARTED|Overall Study||5
11312186|NCT02669264|12511232|FG005|STARTED|Overall Study||6
11312187|NCT02669264|12511233|FG006|STARTED|Overall Study||5
11312188|NCT02669264|12511227|FG000|COMPLETED|Overall Study||0
11312189|NCT02669264|12511228|FG001|COMPLETED|Overall Study||1
11312190|NCT02669264|12511229|FG002|COMPLETED|Overall Study||0
11312191|NCT02669264|12511230|FG003|COMPLETED|Overall Study||1
11312192|NCT02669264|12511231|FG004|COMPLETED|Overall Study||0
11312193|NCT02669264|12511232|FG005|COMPLETED|Overall Study||0
11312194|NCT02669264|12511233|FG006|COMPLETED|Overall Study||0
11312195|NCT02669264|12511227|FG000|NOT COMPLETED|Overall Study||5
11312196|NCT02669264|12511228|FG001|NOT COMPLETED|Overall Study||6
11312197|NCT02669264|12511229|FG002|NOT COMPLETED|Overall Study||3
11312198|NCT02669264|12511230|FG003|NOT COMPLETED|Overall Study||3
11312199|NCT02669264|12511231|FG004|NOT COMPLETED|Overall Study||5
11312200|NCT02669264|12511232|FG005|NOT COMPLETED|Overall Study||6
11312201|NCT02669264|12511233|FG006|NOT COMPLETED|Overall Study||5
11312202|NCT02669329|12511251|FG000|STARTED|Overall Study||30
11312203|NCT02669329|12511251|FG000|COMPLETED|Overall Study||30
11312204|NCT02669329|12511251|FG000|NOT COMPLETED|Overall Study||0
11312205|NCT02669407|12511255|FG000|STARTED|Overall Study||14
11312206|NCT02669407|12511255|FG000|COMPLETED|Overall Study||11
11312207|NCT02669407|12511255|FG000|NOT COMPLETED|Overall Study||3
11312208|NCT02669433|12511262|FG000|STARTED|Overall Study||91
11312209|NCT02669433|12511263|FG001|STARTED|Overall Study||89
11312210|NCT02669433|12511264|FG002|STARTED|Overall Study||89
11312211|NCT02669433|12511262|FG000|Safety Population|Overall Study||91
11312212|NCT02669433|12511263|FG001|Safety Population|Overall Study||89
11312213|NCT02669433|12511264|FG002|Safety Population|Overall Study||88
11312214|NCT02669433|12511262|FG000|Intent to Treat (ITT) Population|Overall Study||89
11312215|NCT02669433|12511263|FG001|Intent to Treat (ITT) Population|Overall Study||89
11312216|NCT02669433|12511264|FG002|Intent to Treat (ITT) Population|Overall Study||87
11312217|NCT02669433|12511262|FG000|Per-Protocol Population|Overall Study||78
11312218|NCT02669433|12511263|FG001|Per-Protocol Population|Overall Study||79
11312219|NCT02669433|12511264|FG002|Per-Protocol Population|Overall Study||82
11312220|NCT02669433|12511262|FG000|Completers Population|Overall Study||73
11312221|NCT02669433|12511263|FG001|Completers Population|Overall Study||72
11312222|NCT02669433|12511264|FG002|Completers Population|Overall Study||69
11312223|NCT02669433|12511262|FG000|UPDRS Primary Population|Overall Study||87
11312224|NCT02669433|12511263|FG001|UPDRS Primary Population|Overall Study||87
11312225|NCT02669433|12511264|FG002|UPDRS Primary Population|Overall Study||84
11312226|NCT02669433|12511262|FG000|COMPLETED|Overall Study||76
11312227|NCT02669433|12511263|FG001|COMPLETED|Overall Study||75
11312228|NCT02669433|12511264|FG002|COMPLETED|Overall Study||74
11312229|NCT02669433|12511262|FG000|NOT COMPLETED|Overall Study||15
11312230|NCT02669433|12511263|FG001|NOT COMPLETED|Overall Study||14
11312231|NCT02669433|12511264|FG002|NOT COMPLETED|Overall Study||15
11312232|NCT02669615|12511272|FG000|STARTED|Overall Study||24
11312233|NCT02669615|12511272|FG000|COMPLETED|Overall Study||24
11312234|NCT02669615|12511272|FG000|NOT COMPLETED|Overall Study||0
11312235|NCT02669667|12511283|FG000|STARTED|Overall Study||12
11312236|NCT02669667|12511284|FG001|STARTED|Overall Study||4
11312237|NCT02669667|12511285|FG002|STARTED|Overall Study||4
11312238|NCT02669667|12511286|FG003|STARTED|Overall Study||6
11312239|NCT02669667|12511287|FG004|STARTED|Overall Study||6
11312240|NCT02669667|12511288|FG005|STARTED|Overall Study||6
11312241|NCT02669667|12511289|FG006|STARTED|Overall Study||6
11312242|NCT02669667|12511283|FG000|COMPLETED|Overall Study||12
11312243|NCT02669667|12511284|FG001|COMPLETED|Overall Study||4
11312244|NCT02669667|12511285|FG002|COMPLETED|Overall Study||4
11312245|NCT02669667|12511286|FG003|COMPLETED|Overall Study||6
11312246|NCT02669667|12511287|FG004|COMPLETED|Overall Study||6
11312247|NCT02669667|12511288|FG005|COMPLETED|Overall Study||5
11312248|NCT02669667|12511289|FG006|COMPLETED|Overall Study||6
11312249|NCT02669667|12511283|FG000|NOT COMPLETED|Overall Study||0
11312250|NCT02669667|12511284|FG001|NOT COMPLETED|Overall Study||0
11312251|NCT02669667|12511285|FG002|NOT COMPLETED|Overall Study||0
11312252|NCT02669667|12511286|FG003|NOT COMPLETED|Overall Study||0
11312253|NCT02669667|12511287|FG004|NOT COMPLETED|Overall Study||0
11312254|NCT02669667|12511288|FG005|NOT COMPLETED|Overall Study||1
11312255|NCT02669667|12511289|FG006|NOT COMPLETED|Overall Study||0
11312256|NCT02669758|12511311|FG000|STARTED|Overall Study||277
11312257|NCT02669758|12511311|FG000|COMPLETED|Overall Study||183
11312258|NCT02669758|12511311|FG000|NOT COMPLETED|Overall Study||94
11312259|NCT02669784|12511317|FG000|STARTED|Overall Study||18
11312260|NCT02669784|12511318|FG001|STARTED|Overall Study||16
11312261|NCT02669784|12511317|FG000|COMPLETED|Overall Study||18
11312262|NCT02669784|12511318|FG001|COMPLETED|Overall Study||16
11312263|NCT02669784|12511317|FG000|NOT COMPLETED|Overall Study||0
11312264|NCT02669784|12511318|FG001|NOT COMPLETED|Overall Study||0
11312265|NCT02669849|12511327|FG000|STARTED|Overall Study||29
11312266|NCT02669849|12511328|FG001|STARTED|Overall Study||6
11312267|NCT02669849|12511329|FG002|STARTED|Overall Study||32
11312268|NCT02669849|12511327|FG000|COMPLETED|Overall Study||11
11312269|NCT02669849|12511328|FG001|COMPLETED|Overall Study||4
11312270|NCT02669849|12511329|FG002|COMPLETED|Overall Study||8
11312271|NCT02669849|12511327|FG000|NOT COMPLETED|Overall Study||18
11312272|NCT02669849|12511328|FG001|NOT COMPLETED|Overall Study||2
11312273|NCT02669849|12511329|FG002|NOT COMPLETED|Overall Study||24
11312274|NCT02669862|12511340|FG000|STARTED|Overall Study||33
11312275|NCT02669862|12511341|FG001|STARTED|Overall Study||34
11312276|NCT02669862|12511342|FG002|STARTED|Overall Study||31
11312277|NCT02669862|12511340|FG000|COMPLETED|Overall Study||31
11312278|NCT02669862|12511341|FG001|COMPLETED|Overall Study||29
11312279|NCT02669862|12511342|FG002|COMPLETED|Overall Study||26
11312280|NCT02669862|12511340|FG000|NOT COMPLETED|Overall Study||2
11312281|NCT02669862|12511341|FG001|NOT COMPLETED|Overall Study||5
11312282|NCT02669862|12511342|FG002|NOT COMPLETED|Overall Study||5
11312283|NCT02669914|12511356|FG000|STARTED|Overall Study||4
11312284|NCT02669914|12511357|FG001|STARTED|Overall Study||0
11312285|NCT02669914|12511358|FG002|STARTED|Overall Study||0
11312286|NCT02669914|12511356|FG000|COMPLETED|Overall Study||4
11312287|NCT02669914|12511357|FG001|COMPLETED|Overall Study||0
11312288|NCT02669914|12511358|FG002|COMPLETED|Overall Study||0
11312289|NCT02669914|12511356|FG000|NOT COMPLETED|Overall Study||0
11312290|NCT02669914|12511357|FG001|NOT COMPLETED|Overall Study||0
11312291|NCT02669914|12511358|FG002|NOT COMPLETED|Overall Study||0
11312292|NCT02669940|12511368|FG000|STARTED|Overall Study||63
11312293|NCT02669940|12511369|FG001|STARTED|Overall Study||95
11312294|NCT02669940|12511368|FG000|COMPLETED|Overall Study||62
11312295|NCT02669940|12511369|FG001|COMPLETED|Overall Study||92
11312296|NCT02669940|12511368|FG000|NOT COMPLETED|Overall Study||1
11312297|NCT02669940|12511369|FG001|NOT COMPLETED|Overall Study||3
11312298|NCT02670083|12511384|FG000|STARTED|Overall Study||409
11312299|NCT02670083|12511385|FG001|STARTED|Overall Study||404
11312300|NCT02670083|12511384|FG000|COMPLETED|Overall Study||88
11312301|NCT02670083|12511385|FG001|COMPLETED|Overall Study||85
11312302|NCT02670083|12511384|FG000|NOT COMPLETED|Overall Study||321
11312303|NCT02670083|12511385|FG001|NOT COMPLETED|Overall Study||319
11312304|NCT02670122|12511392|FG000|STARTED|Overall Study||131
11312305|NCT02670122|12511392|FG000|COMPLETED|Overall Study|18 patients recieved liver transplantation|127
11312306|NCT02670122|12511392|FG000|NOT COMPLETED|Overall Study||4
11312307|NCT02670330|12511405|FG000|STARTED|Overall Study||75
11312308|NCT02670330|12511406|FG001|STARTED|Overall Study||77
11312309|NCT02670330|12511405|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||75
11312310|NCT02670330|12511406|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||77
11312311|NCT02670330|12511405|FG000|COMPLETED|Overall Study||0
11312312|NCT02670330|12511406|FG001|COMPLETED|Overall Study||0
11312313|NCT02670330|12511405|FG000|NOT COMPLETED|Overall Study||75
11312314|NCT02670330|12511406|FG001|NOT COMPLETED|Overall Study||77
11312315|NCT02670343|12511412|FG000|STARTED|Overall Study||8
11312316|NCT02670343|12511412|FG000|COMPLETED|Overall Study||8
11312317|NCT02670343|12511412|FG000|NOT COMPLETED|Overall Study||0
11312318|NCT02670382|12511416|FG000|STARTED|Placebo lead-in Phase||12
11312319|NCT02670382|12511417|FG001|STARTED|Placebo lead-in Phase||12
11312320|NCT02670382|12511416|FG000|COMPLETED|Placebo lead-in Phase|Two enrolled subjects randomized to receive EPA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 10 subjects continued to the EPA and then DHA supplementation phases. No data were collected from these two subjects.|10
11312321|NCT02670382|12511417|FG001|COMPLETED|Placebo lead-in Phase|One enrolled subjects randomized to receive EDHA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 11 subjects continued to the DHA and then EPA supplementation phases. No data were collected from this subject.|11
11312322|NCT02670382|12511416|FG000|NOT COMPLETED|Placebo lead-in Phase||2
11312323|NCT02670382|12511417|FG001|NOT COMPLETED|Placebo lead-in Phase||1
11312324|NCT02670382|12511416|FG000|STARTED|First Active Intervention|Only 10 of the 12 enrolled subjects randomized to receive EPA as the first supplementation completed the lead-in placebo phase and then entered the EPA supplementation phase.|10
11312325|NCT02670382|12511417|FG001|STARTED|First Active Intervention|Only 11 of the 12 enrolled subjects randomized to receive DHA as the first supplementation completed the lead-in placebo phase and then entered the EDHA supplementation phase.|11
11312326|NCT02670382|12511416|FG000|COMPLETED|First Active Intervention||10
11312327|NCT02670382|12511417|FG001|COMPLETED|First Active Intervention||11
11312328|NCT02670382|12511416|FG000|NOT COMPLETED|First Active Intervention||0
11312329|NCT02670382|12511417|FG001|NOT COMPLETED|First Active Intervention||0
11312330|NCT02670382|12511416|FG000|STARTED|Second Active Intervention||10
11312331|NCT02670382|12511417|FG001|STARTED|Second Active Intervention||11
11312332|NCT02670382|12511416|FG000|COMPLETED|Second Active Intervention||10
11312333|NCT02670382|12511417|FG001|COMPLETED|Second Active Intervention||11
11312334|NCT02670382|12511416|FG000|NOT COMPLETED|Second Active Intervention||0
11312335|NCT02670382|12511417|FG001|NOT COMPLETED|Second Active Intervention||0
11312336|NCT02670473|12511425|FG000|STARTED|Overall Study||35
11312337|NCT02670473|12511425|FG000|COMPLETED|Overall Study||34
11312338|NCT02670473|12511425|FG000|NOT COMPLETED|Overall Study||1
11312339|NCT02670538|12511441|FG000|STARTED|Overall Study||167
11312340|NCT02670538|12511442|FG001|STARTED|Overall Study||168
11312341|NCT02670538|12511443|FG002|STARTED|Overall Study||158
11312342|NCT02670538|12511441|FG000|Safety Population : Received Study Drug|Overall Study||165
11312343|NCT02670538|12511442|FG001|Safety Population : Received Study Drug|Overall Study||167
11312344|NCT02670538|12511443|FG002|Safety Population : Received Study Drug|Overall Study||158
11312345|NCT02670538|12511441|FG000|Intent-to-Treat Population|Overall Study||163
11312346|NCT02670538|12511442|FG001|Intent-to-Treat Population|Overall Study||162
11312347|NCT02670538|12511443|FG002|Intent-to-Treat Population|Overall Study||153
11312348|NCT02670538|12511441|FG000|COMPLETED|Overall Study||135
11312349|NCT02670538|12511442|FG001|COMPLETED|Overall Study||136
11312350|NCT02670538|12511443|FG002|COMPLETED|Overall Study||128
11312351|NCT02670538|12511441|FG000|NOT COMPLETED|Overall Study||32
11312352|NCT02670538|12511442|FG001|NOT COMPLETED|Overall Study||32
11312353|NCT02670538|12511443|FG002|NOT COMPLETED|Overall Study||30
11312354|NCT02670551|12511454|FG000|STARTED|Overall Study||163
11312355|NCT02670551|12511455|FG001|STARTED|Overall Study||160
11312356|NCT02670551|12511456|FG002|STARTED|Overall Study||165
11312357|NCT02670551|12511454|FG000|Received Treatment (Safety Population)|Overall Study||158
11312358|NCT02670551|12511455|FG001|Received Treatment (Safety Population)|Overall Study||157
11312359|NCT02670551|12511456|FG002|Received Treatment (Safety Population)|Overall Study||165
11312360|NCT02670551|12511454|FG000|COMPLETED|Overall Study||135
11312361|NCT02670551|12511455|FG001|COMPLETED|Overall Study||134
11312362|NCT02670551|12511456|FG002|COMPLETED|Overall Study||134
11312363|NCT02670551|12511454|FG000|NOT COMPLETED|Overall Study||28
11312364|NCT02670551|12511455|FG001|NOT COMPLETED|Overall Study||26
11312365|NCT02670551|12511456|FG002|NOT COMPLETED|Overall Study||31
11312366|NCT02670629|12511466|FG000|STARTED|Overall Study||29
11312367|NCT02670629|12511467|FG001|STARTED|Overall Study||29
11312368|NCT02670629|12511466|FG000|COMPLETED|Overall Study||29
11312369|NCT02670629|12511467|FG001|COMPLETED|Overall Study||29
11312370|NCT02670629|12511466|FG000|NOT COMPLETED|Overall Study||0
11312371|NCT02670629|12511467|FG001|NOT COMPLETED|Overall Study||0
11342217|NCT02942654|12539752|FG000|NOT COMPLETED|Period 2||0
11342218|NCT02942654|12539753|FG001|NOT COMPLETED|Period 2||0
11342219|NCT02942771|12539764|FG000|STARTED|Overall Study||9
11342220|NCT02942771|12539765|FG001|STARTED|Overall Study||6
11342221|NCT02942771|12539766|FG002|STARTED|Overall Study||6
11342222|NCT02942771|12539767|FG003|STARTED|Overall Study||6
11342223|NCT02942771|12539768|FG004|STARTED|Overall Study||8
11342224|NCT02942771|12539764|FG000|COMPLETED|Overall Study||6
11342225|NCT02942771|12539765|FG001|COMPLETED|Overall Study||6
11342226|NCT02942771|12539766|FG002|COMPLETED|Overall Study||6
11342227|NCT02942771|12539767|FG003|COMPLETED|Overall Study||6
11342228|NCT02942771|12539768|FG004|COMPLETED|Overall Study||4
11342229|NCT02942771|12539764|FG000|NOT COMPLETED|Overall Study||3
11342230|NCT02942771|12539765|FG001|NOT COMPLETED|Overall Study||0
11342231|NCT02942771|12539766|FG002|NOT COMPLETED|Overall Study||0
11342232|NCT02942771|12539767|FG003|NOT COMPLETED|Overall Study||0
11342233|NCT02942771|12539768|FG004|NOT COMPLETED|Overall Study||4
11342234|NCT02942979|12539782|FG000|STARTED|Step 0||108
11342235|NCT02942979|12539783|FG001|STARTED|Step 0||0
11342236|NCT02942979|12539782|FG000|COMPLETED|Step 0||108
11342237|NCT02942979|12539783|FG001|COMPLETED|Step 0|This is a stepped wedge design - all participants received both MISSION Implementation as Usual and Facilitation|0
11342238|NCT02942979|12539782|FG000|NOT COMPLETED|Step 0||0
11342239|NCT02942979|12539783|FG001|NOT COMPLETED|Step 0||0
11342240|NCT02942979|12539782|FG000|STARTED|Step 1||15
11342241|NCT02942979|12539783|FG001|STARTED|Step 1||93
11342242|NCT02942979|12539782|FG000|COMPLETED|Step 1||15
11342243|NCT02942979|12539783|FG001|COMPLETED|Step 1||93
11342244|NCT02942979|12539782|FG000|NOT COMPLETED|Step 1||0
11342245|NCT02942979|12539783|FG001|NOT COMPLETED|Step 1||0
11342246|NCT02942979|12539782|FG000|STARTED|Step 2||0
11342247|NCT02942979|12539783|FG001|STARTED|Step 2||108
11342248|NCT02942979|12539782|FG000|COMPLETED|Step 2||0
11342249|NCT02942979|12539783|FG001|COMPLETED|Step 2||108
11342250|NCT02942979|12539782|FG000|NOT COMPLETED|Step 2||0
11342251|NCT02942979|12539783|FG001|NOT COMPLETED|Step 2||0
11342252|NCT02943070|12539789|FG000|STARTED|Overall Study||50
11342253|NCT02943070|12539789|FG000|COMPLETED|Overall Study||7
11342254|NCT02943070|12539789|FG000|NOT COMPLETED|Overall Study||43
11342255|NCT02943096|12539802|FG000|STARTED|Overall Study||3
11342256|NCT02943096|12539803|FG001|STARTED|Overall Study||3
11342257|NCT02943096|12539802|FG000|COMPLETED|Overall Study||3
11342258|NCT02943096|12539803|FG001|COMPLETED|Overall Study||2
11342259|NCT02943096|12539802|FG000|NOT COMPLETED|Overall Study||0
11342260|NCT02943096|12539803|FG001|NOT COMPLETED|Overall Study||1
11342261|NCT02943213|12539809|FG000|STARTED|Treatment Period 1||20
11342262|NCT02943213|12539809|FG000|COMPLETED|Treatment Period 1||20
11342263|NCT02943213|12539809|FG000|NOT COMPLETED|Treatment Period 1||0
11342264|NCT02943213|12539809|FG000|STARTED|Treatment Period 2||20
11342265|NCT02943213|12539809|FG000|COMPLETED|Treatment Period 2||20
11342266|NCT02943213|12539809|FG000|NOT COMPLETED|Treatment Period 2||0
11342267|NCT02943226|12539817|FG000|STARTED|Overall Study||31
11342268|NCT02943226|12539818|FG001|STARTED|Overall Study||30
11342269|NCT02943226|12539817|FG000|COMPLETED|Overall Study||31
11342270|NCT02943226|12539818|FG001|COMPLETED|Overall Study||30
11342271|NCT02943226|12539817|FG000|NOT COMPLETED|Overall Study||0
11342272|NCT02943226|12539818|FG001|NOT COMPLETED|Overall Study||0
11342273|NCT02943447|12539827|FG000|STARTED|Blinded Study Phase||28
11342274|NCT02943447|12539828|FG001|STARTED|Blinded Study Phase||30
11342275|NCT02943447|12539829|FG002|STARTED|Blinded Study Phase||13
11342276|NCT02943447|12539827|FG000|COMPLETED|Blinded Study Phase||23
11342277|NCT02943447|12539828|FG001|COMPLETED|Blinded Study Phase||28
11342278|NCT02943447|12539829|FG002|COMPLETED|Blinded Study Phase||12
11342279|NCT02943447|12539827|FG000|NOT COMPLETED|Blinded Study Phase||5
11342280|NCT02943447|12539828|FG001|NOT COMPLETED|Blinded Study Phase||2
11342281|NCT02943447|12539829|FG002|NOT COMPLETED|Blinded Study Phase||1
11342282|NCT02943447|12539827|FG000|STARTED|Open-Label Extension Phase||23
11342283|NCT02943447|12539828|FG001|STARTED|Open-Label Extension Phase||28
11342284|NCT02943447|12539829|FG002|STARTED|Open-Label Extension Phase||12
11342285|NCT02943447|12539827|FG000|COMPLETED|Open-Label Extension Phase||5
11342286|NCT02943447|12539828|FG001|COMPLETED|Open-Label Extension Phase||3
11342287|NCT02943447|12539829|FG002|COMPLETED|Open-Label Extension Phase||2
11312372|NCT02670811|12511475|FG000|STARTED|Overall Study||18
11312373|NCT02670811|12511476|FG001|STARTED|Overall Study||18
11312374|NCT02670811|12511475|FG000|COMPLETED|Overall Study||17
11312375|NCT02670811|12511476|FG001|COMPLETED|Overall Study||18
11312376|NCT02670811|12511475|FG000|NOT COMPLETED|Overall Study||1
11312377|NCT02670811|12511476|FG001|NOT COMPLETED|Overall Study||0
11312378|NCT02670915|12511485|FG000|STARTED|Overall Study||260
11402039|NCT04069221|12596869|FG002|NOT COMPLETED|Overall Study||0
11312379|NCT02670915|12511486|FG001|STARTED|Overall Study||259
11312380|NCT02670915|12511487|FG002|STARTED|Overall Study||258
11312381|NCT02670915|12511485|FG000|COMPLETED|Overall Study||256
11312382|NCT02670915|12511486|FG001|COMPLETED|Overall Study||251
11312383|NCT02670915|12511487|FG002|COMPLETED|Overall Study||253
11312384|NCT02670915|12511485|FG000|NOT COMPLETED|Overall Study||4
11312385|NCT02670915|12511486|FG001|NOT COMPLETED|Overall Study||8
11312386|NCT02670915|12511487|FG002|NOT COMPLETED|Overall Study||5
11312387|NCT02670928|12511497|FG000|STARTED|Overall Study||100
11312388|NCT02670928|12511498|FG001|STARTED|Overall Study||30
11312389|NCT02670928|12511497|FG000|COMPLETED|Overall Study||90
11312390|NCT02670928|12511498|FG001|COMPLETED|Overall Study||29
11312391|NCT02670928|12511497|FG000|NOT COMPLETED|Overall Study||10
11312392|NCT02670928|12511498|FG001|NOT COMPLETED|Overall Study||1
11312393|NCT02671032|12511504|FG000|STARTED|Overall Study||12
11312394|NCT02671032|12511504|FG000|COMPLETED|Overall Study||12
11312395|NCT02671032|12511504|FG000|NOT COMPLETED|Overall Study||0
11312396|NCT02671266|12511510|FG000|STARTED|Overall Study||20
11312397|NCT02671266|12511511|FG001|STARTED|Overall Study||21
11312398|NCT02671266|12511510|FG000|BDD Participants|Overall Study||9
11312399|NCT02671266|12511511|FG001|BDD Participants|Overall Study||9
11312400|NCT02671266|12511510|FG000|OCD Participants|Overall Study||2
11312401|NCT02671266|12511511|FG001|OCD Participants|Overall Study||3
11312402|NCT02671266|12511510|FG000|Healthy Participants|Overall Study||8
11312403|NCT02671266|12511511|FG001|Healthy Participants|Overall Study||8
11312404|NCT02671266|12511510|FG000|COMPLETED|Overall Study||19
11312405|NCT02671266|12511511|FG001|COMPLETED|Overall Study||20
11312406|NCT02671266|12511510|FG000|NOT COMPLETED|Overall Study||1
11312407|NCT02671266|12511511|FG001|NOT COMPLETED|Overall Study||1
11312408|NCT02671422|12511517|FG000|STARTED|Overall Study||260
11312409|NCT02671422|12511517|FG000|Not Treated With Vargatef®|Overall Study||3
11312410|NCT02671422|12511517|FG000|COMPLETED|Overall Study||0
11312411|NCT02671422|12511517|FG000|NOT COMPLETED|Overall Study||260
11312412|NCT02671500|12511521|FG000|STARTED|Overall Study||375
11312413|NCT02671500|12511521|FG000|COMPLETED|Overall Study||361
11312414|NCT02671500|12511521|FG000|NOT COMPLETED|Overall Study||14
11312415|NCT02671760|12511529|FG000|STARTED|Overall Study||13
11312416|NCT02671760|12511530|FG001|STARTED|Overall Study||13
11312417|NCT02671760|12511531|FG002|STARTED|Overall Study||13
11312418|NCT02671760|12511529|FG000|COMPLETED|Overall Study||13
11312419|NCT02671760|12511530|FG001|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
11312420|NCT02671760|12511531|FG002|COMPLETED|Overall Study||13
11312421|NCT02671760|12511529|FG000|NOT COMPLETED|Overall Study||0
11312422|NCT02671760|12511530|FG001|NOT COMPLETED|Overall Study||1
11312423|NCT02671760|12511531|FG002|NOT COMPLETED|Overall Study||0
11312424|NCT02672111|12511541|FG000|STARTED|Overall Study||190
11312425|NCT02672111|12511542|FG001|STARTED|Overall Study||37
11312426|NCT02672111|12511541|FG000|Completed Treatment|Overall Study||138
11312427|NCT02672111|12511542|FG001|Completed Treatment|Overall Study||29
11312428|NCT02672111|12511541|FG000|COMPLETED|Overall Study||132
11312429|NCT02672111|12511542|FG001|COMPLETED|Overall Study||25
11312430|NCT02672111|12511541|FG000|NOT COMPLETED|Overall Study||58
11312431|NCT02672111|12511542|FG001|NOT COMPLETED|Overall Study||12
11312432|NCT02672176|12511551|FG000|STARTED|Overall Study||161
11312433|NCT02672176|12511552|FG001|STARTED|Overall Study||158
11312434|NCT02672176|12511551|FG000|COMPLETED|Overall Study||155
11312435|NCT02672176|12511552|FG001|COMPLETED|Overall Study||132
11312436|NCT02672176|12511551|FG000|NOT COMPLETED|Overall Study||6
11312437|NCT02672176|12511552|FG001|NOT COMPLETED|Overall Study||26
11312438|NCT02672423|12511564|FG000|STARTED|Period 1||7
11312439|NCT02672423|12511565|FG001|STARTED|Period 1||7
11312440|NCT02672423|12511566|FG002|STARTED|Period 1||14
11312441|NCT02672423|12511567|FG003|STARTED|Period 1||15
11312442|NCT02672423|12511568|FG004|STARTED|Period 1||15
11312443|NCT02672423|12511569|FG005|STARTED|Period 1||15
11312444|NCT02672423|12511570|FG006|STARTED|Period 1||15
11312445|NCT02672423|12511571|FG007|STARTED|Period 1||15
11312446|NCT02672423|12511572|FG008|STARTED|Period 1||12
11312447|NCT02672423|12511573|FG009|STARTED|Period 1||12
11312448|NCT02672423|12511564|FG000|Received at Least One Dose of Study Drug|Period 1||7
11312449|NCT02672423|12511565|FG001|Received at Least One Dose of Study Drug|Period 1||7
11312450|NCT02672423|12511566|FG002|Received at Least One Dose of Study Drug|Period 1||14
11312451|NCT02672423|12511567|FG003|Received at Least One Dose of Study Drug|Period 1||15
11312452|NCT02672423|12511568|FG004|Received at Least One Dose of Study Drug|Period 1||15
11312453|NCT02672423|12511569|FG005|Received at Least One Dose of Study Drug|Period 1||15
11312454|NCT02672423|12511570|FG006|Received at Least One Dose of Study Drug|Period 1||15
11312455|NCT02672423|12511571|FG007|Received at Least One Dose of Study Drug|Period 1||15
11312456|NCT02672423|12511572|FG008|Received at Least One Dose of Study Drug|Period 1||12
11312457|NCT02672423|12511573|FG009|Received at Least One Dose of Study Drug|Period 1||12
11312458|NCT02672423|12511564|FG000|COMPLETED|Period 1||7
11312459|NCT02672423|12511565|FG001|COMPLETED|Period 1||7
11312460|NCT02672423|12511566|FG002|COMPLETED|Period 1||14
11312461|NCT02672423|12511567|FG003|COMPLETED|Period 1||15
11312462|NCT02672423|12511568|FG004|COMPLETED|Period 1||14
11312463|NCT02672423|12511569|FG005|COMPLETED|Period 1||15
11312464|NCT02672423|12511570|FG006|COMPLETED|Period 1||15
11312465|NCT02672423|12511571|FG007|COMPLETED|Period 1||15
11312466|NCT02672423|12511572|FG008|COMPLETED|Period 1||12
11312467|NCT02672423|12511573|FG009|COMPLETED|Period 1||12
11312468|NCT02672423|12511564|FG000|NOT COMPLETED|Period 1||0
11312469|NCT02672423|12511565|FG001|NOT COMPLETED|Period 1||0
11312470|NCT02672423|12511566|FG002|NOT COMPLETED|Period 1||0
11312471|NCT02672423|12511567|FG003|NOT COMPLETED|Period 1||0
11312472|NCT02672423|12511568|FG004|NOT COMPLETED|Period 1||1
11312473|NCT02672423|12511569|FG005|NOT COMPLETED|Period 1||0
11312474|NCT02672423|12511570|FG006|NOT COMPLETED|Period 1||0
11312475|NCT02672423|12511571|FG007|NOT COMPLETED|Period 1||0
11312476|NCT02672423|12511572|FG008|NOT COMPLETED|Period 1||0
11312477|NCT02672423|12511573|FG009|NOT COMPLETED|Period 1||0
11312478|NCT02672423|12511564|FG000|STARTED|Washout 1||7
11312479|NCT02672423|12511565|FG001|STARTED|Washout 1||7
11312480|NCT02672423|12511566|FG002|STARTED|Washout 1||14
11312481|NCT02672423|12511567|FG003|STARTED|Washout 1||15
11312482|NCT02672423|12511568|FG004|STARTED|Washout 1||14
11312483|NCT02672423|12511569|FG005|STARTED|Washout 1||15
11312484|NCT02672423|12511570|FG006|STARTED|Washout 1||15
11312485|NCT02672423|12511571|FG007|STARTED|Washout 1||15
11312486|NCT02672423|12511572|FG008|STARTED|Washout 1||12
11312487|NCT02672423|12511573|FG009|STARTED|Washout 1||12
11312488|NCT02672423|12511564|FG000|COMPLETED|Washout 1||7
11312489|NCT02672423|12511565|FG001|COMPLETED|Washout 1||7
11312490|NCT02672423|12511566|FG002|COMPLETED|Washout 1||14
11312491|NCT02672423|12511567|FG003|COMPLETED|Washout 1||15
11312492|NCT02672423|12511568|FG004|COMPLETED|Washout 1||14
11312493|NCT02672423|12511569|FG005|COMPLETED|Washout 1||15
11312494|NCT02672423|12511570|FG006|COMPLETED|Washout 1||15
11312495|NCT02672423|12511571|FG007|COMPLETED|Washout 1||15
11312496|NCT02672423|12511572|FG008|COMPLETED|Washout 1||12
11312497|NCT02672423|12511573|FG009|COMPLETED|Washout 1||12
11312498|NCT02672423|12511564|FG000|NOT COMPLETED|Washout 1||0
11312499|NCT02672423|12511565|FG001|NOT COMPLETED|Washout 1||0
11312500|NCT02672423|12511566|FG002|NOT COMPLETED|Washout 1||0
11312501|NCT02672423|12511567|FG003|NOT COMPLETED|Washout 1||0
11312502|NCT02672423|12511568|FG004|NOT COMPLETED|Washout 1||0
11312503|NCT02672423|12511569|FG005|NOT COMPLETED|Washout 1||0
11312504|NCT02672423|12511570|FG006|NOT COMPLETED|Washout 1||0
11312505|NCT02672423|12511571|FG007|NOT COMPLETED|Washout 1||0
11312506|NCT02672423|12511572|FG008|NOT COMPLETED|Washout 1||0
11312507|NCT02672423|12511573|FG009|NOT COMPLETED|Washout 1||0
11312508|NCT02672423|12511564|FG000|STARTED|Period 2||7
11312509|NCT02672423|12511565|FG001|STARTED|Period 2||7
11312510|NCT02672423|12511566|FG002|STARTED|Period 2||14
11312511|NCT02672423|12511567|FG003|STARTED|Period 2||15
11312512|NCT02672423|12511568|FG004|STARTED|Period 2||14
11312513|NCT02672423|12511569|FG005|STARTED|Period 2||15
11312514|NCT02672423|12511570|FG006|STARTED|Period 2||15
11312515|NCT02672423|12511571|FG007|STARTED|Period 2||15
11312516|NCT02672423|12511572|FG008|STARTED|Period 2||12
11312517|NCT02672423|12511573|FG009|STARTED|Period 2||12
11312518|NCT02672423|12511564|FG000|COMPLETED|Period 2||7
11312519|NCT02672423|12511565|FG001|COMPLETED|Period 2||7
11312520|NCT02672423|12511566|FG002|COMPLETED|Period 2||13
11312521|NCT02672423|12511567|FG003|COMPLETED|Period 2||15
11312522|NCT02672423|12511568|FG004|COMPLETED|Period 2||14
11312523|NCT02672423|12511569|FG005|COMPLETED|Period 2||15
11312524|NCT02672423|12511570|FG006|COMPLETED|Period 2||15
11312525|NCT02672423|12511571|FG007|COMPLETED|Period 2||15
11312526|NCT02672423|12511572|FG008|COMPLETED|Period 2||12
11312527|NCT02672423|12511573|FG009|COMPLETED|Period 2||12
11312528|NCT02672423|12511564|FG000|NOT COMPLETED|Period 2||0
11312529|NCT02672423|12511565|FG001|NOT COMPLETED|Period 2||0
11312530|NCT02672423|12511566|FG002|NOT COMPLETED|Period 2||1
11312531|NCT02672423|12511567|FG003|NOT COMPLETED|Period 2||0
11312532|NCT02672423|12511568|FG004|NOT COMPLETED|Period 2||0
11312533|NCT02672423|12511569|FG005|NOT COMPLETED|Period 2||0
11312534|NCT02672423|12511570|FG006|NOT COMPLETED|Period 2||0
11312535|NCT02672423|12511571|FG007|NOT COMPLETED|Period 2||0
11312536|NCT02672423|12511572|FG008|NOT COMPLETED|Period 2||0
11312537|NCT02672423|12511573|FG009|NOT COMPLETED|Period 2||0
11312538|NCT02672423|12511564|FG000|STARTED|Washout 2||7
11312539|NCT02672423|12511565|FG001|STARTED|Washout 2||7
11312540|NCT02672423|12511566|FG002|STARTED|Washout 2||13
11312541|NCT02672423|12511567|FG003|STARTED|Washout 2||15
11312542|NCT02672423|12511568|FG004|STARTED|Washout 2||14
11312543|NCT02672423|12511569|FG005|STARTED|Washout 2||15
11312544|NCT02672423|12511570|FG006|STARTED|Washout 2||15
11312545|NCT02672423|12511571|FG007|STARTED|Washout 2||15
11312546|NCT02672423|12511572|FG008|STARTED|Washout 2||12
11312547|NCT02672423|12511573|FG009|STARTED|Washout 2||12
11312548|NCT02672423|12511564|FG000|COMPLETED|Washout 2||7
11312549|NCT02672423|12511565|FG001|COMPLETED|Washout 2||7
11312550|NCT02672423|12511566|FG002|COMPLETED|Washout 2||13
11312551|NCT02672423|12511567|FG003|COMPLETED|Washout 2||15
11312552|NCT02672423|12511568|FG004|COMPLETED|Washout 2||14
11312553|NCT02672423|12511569|FG005|COMPLETED|Washout 2||15
11312554|NCT02672423|12511570|FG006|COMPLETED|Washout 2||15
11312555|NCT02672423|12511571|FG007|COMPLETED|Washout 2||15
11312556|NCT02672423|12511572|FG008|COMPLETED|Washout 2||12
11312557|NCT02672423|12511573|FG009|COMPLETED|Washout 2||12
11312558|NCT02672423|12511564|FG000|NOT COMPLETED|Washout 2||0
11312559|NCT02672423|12511565|FG001|NOT COMPLETED|Washout 2||0
11312560|NCT02672423|12511566|FG002|NOT COMPLETED|Washout 2||0
11312561|NCT02672423|12511567|FG003|NOT COMPLETED|Washout 2||0
11312562|NCT02672423|12511568|FG004|NOT COMPLETED|Washout 2||0
11312563|NCT02672423|12511569|FG005|NOT COMPLETED|Washout 2||0
11312564|NCT02672423|12511570|FG006|NOT COMPLETED|Washout 2||0
11312565|NCT02672423|12511571|FG007|NOT COMPLETED|Washout 2||0
11312566|NCT02672423|12511572|FG008|NOT COMPLETED|Washout 2||0
11312567|NCT02672423|12511573|FG009|NOT COMPLETED|Washout 2||0
11312568|NCT02672423|12511564|FG000|STARTED|Period 3|Part A was a 2-period study design.|0
11312569|NCT02672423|12511565|FG001|STARTED|Period 3|Part A was a 2-period study design.|0
11312570|NCT02672423|12511566|FG002|STARTED|Period 3||13
11312571|NCT02672423|12511567|FG003|STARTED|Period 3||15
11312572|NCT02672423|12511568|FG004|STARTED|Period 3||14
11312573|NCT02672423|12511569|FG005|STARTED|Period 3||15
11312574|NCT02672423|12511570|FG006|STARTED|Period 3||15
11312575|NCT02672423|12511571|FG007|STARTED|Period 3||15
11312576|NCT02672423|12511572|FG008|STARTED|Period 3|Part C was a 2-period study design.|0
11312577|NCT02672423|12511573|FG009|STARTED|Period 3|Part C was a 2-period study design.|0
11312578|NCT02672423|12511564|FG000|COMPLETED|Period 3||0
11312579|NCT02672423|12511565|FG001|COMPLETED|Period 3||0
11312580|NCT02672423|12511566|FG002|COMPLETED|Period 3||13
11312581|NCT02672423|12511567|FG003|COMPLETED|Period 3||15
11312582|NCT02672423|12511568|FG004|COMPLETED|Period 3||14
11312583|NCT02672423|12511569|FG005|COMPLETED|Period 3||14
11312584|NCT02672423|12511570|FG006|COMPLETED|Period 3||15
11312585|NCT02672423|12511571|FG007|COMPLETED|Period 3||14
11312586|NCT02672423|12511572|FG008|COMPLETED|Period 3||0
11312587|NCT02672423|12511573|FG009|COMPLETED|Period 3||0
11312588|NCT02672423|12511564|FG000|NOT COMPLETED|Period 3||0
11312589|NCT02672423|12511565|FG001|NOT COMPLETED|Period 3||0
11312590|NCT02672423|12511566|FG002|NOT COMPLETED|Period 3||0
11312591|NCT02672423|12511567|FG003|NOT COMPLETED|Period 3||0
11312592|NCT02672423|12511568|FG004|NOT COMPLETED|Period 3||0
11312593|NCT02672423|12511569|FG005|NOT COMPLETED|Period 3||1
11312594|NCT02672423|12511570|FG006|NOT COMPLETED|Period 3||0
11312595|NCT02672423|12511571|FG007|NOT COMPLETED|Period 3||1
11312596|NCT02672423|12511572|FG008|NOT COMPLETED|Period 3||0
11312597|NCT02672423|12511573|FG009|NOT COMPLETED|Period 3||0
11312598|NCT02672514|12511596|FG000|STARTED|Overall Study||53
11312599|NCT02672514|12511597|FG001|STARTED|Overall Study||51
11312600|NCT02672514|12511596|FG000|COMPLETED|Overall Study||53
11312601|NCT02672514|12511597|FG001|COMPLETED|Overall Study||51
11312602|NCT02672514|12511596|FG000|NOT COMPLETED|Overall Study||0
11312603|NCT02672514|12511597|FG001|NOT COMPLETED|Overall Study||0
11312604|NCT02672553|12511605|FG000|STARTED|Overall Study||51
11312605|NCT02672553|12511606|FG001|STARTED|Overall Study||49
11312606|NCT02672553|12511605|FG000|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49
11312607|NCT02672553|12511606|FG001|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48
11312608|NCT02672553|12511605|FG000|As Treated (AT) Randomized Arm/Group|Overall Study||46
11312609|NCT02672553|12511606|FG001|As Treated (AT) Randomized Arm/Group|Overall Study||51
11312610|NCT02672553|12511605|FG000|As Intended (AI) Randomized Arm/Group|Overall Study||46
11312611|NCT02672553|12511606|FG001|As Intended (AI) Randomized Arm/Group|Overall Study||48
11312612|NCT02672553|12511605|FG000|COMPLETED|Overall Study||39
11312613|NCT02672553|12511606|FG001|COMPLETED|Overall Study||41
11312614|NCT02672553|12511605|FG000|NOT COMPLETED|Overall Study||12
11312615|NCT02672553|12511606|FG001|NOT COMPLETED|Overall Study||8
11312616|NCT02672852|12511615|FG000|STARTED|Part A1||100
11312617|NCT02672852|12511616|FG001|STARTED|Part A1||407
11312618|NCT02672852|12511617|FG002|STARTED|Part A1||0
11312619|NCT02672852|12511618|FG003|STARTED|Part A1||0
11312620|NCT02672852|12511619|FG004|STARTED|Part A1||0
11312621|NCT02672852|12511620|FG005|STARTED|Part A1||0
11312622|NCT02672852|12511621|FG006|STARTED|Part A1||0
11312623|NCT02672852|12511615|FG000|COMPLETED|Part A1||97
11312624|NCT02672852|12511616|FG001|COMPLETED|Part A1||403
11312625|NCT02672852|12511617|FG002|COMPLETED|Part A1||0
11312626|NCT02672852|12511618|FG003|COMPLETED|Part A1||0
11312627|NCT02672852|12511619|FG004|COMPLETED|Part A1||0
11312628|NCT02672852|12511620|FG005|COMPLETED|Part A1||0
11312629|NCT02672852|12511621|FG006|COMPLETED|Part A1||0
11312630|NCT02672852|12511615|FG000|NOT COMPLETED|Part A1||3
11312631|NCT02672852|12511616|FG001|NOT COMPLETED|Part A1||4
11312632|NCT02672852|12511617|FG002|NOT COMPLETED|Part A1||0
11312633|NCT02672852|12511618|FG003|NOT COMPLETED|Part A1||0
11312634|NCT02672852|12511619|FG004|NOT COMPLETED|Part A1||0
11312635|NCT02672852|12511620|FG005|NOT COMPLETED|Part A1||0
11312636|NCT02672852|12511621|FG006|NOT COMPLETED|Part A1||0
11312637|NCT02672852|12511615|FG000|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
11312638|NCT02672852|12511616|FG001|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
11312639|NCT02672852|12511617|FG002|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93
11312640|NCT02672852|12511618|FG003|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403
11312641|NCT02672852|12511619|FG004|STARTED|Part A2||0
11312642|NCT02672852|12511620|FG005|STARTED|Part A2||0
11312643|NCT02672852|12511621|FG006|STARTED|Part A2||0
11312644|NCT02672852|12511615|FG000|COMPLETED|Part A2||0
11312645|NCT02672852|12511616|FG001|COMPLETED|Part A2||0
11312646|NCT02672852|12511617|FG002|COMPLETED|Part A2||83
11312647|NCT02672852|12511618|FG003|COMPLETED|Part A2||399
11312648|NCT02672852|12511619|FG004|COMPLETED|Part A2||0
11312649|NCT02672852|12511620|FG005|COMPLETED|Part A2||0
11312650|NCT02672852|12511621|FG006|COMPLETED|Part A2||0
11312651|NCT02672852|12511615|FG000|NOT COMPLETED|Part A2||0
11312652|NCT02672852|12511616|FG001|NOT COMPLETED|Part A2||0
11312653|NCT02672852|12511617|FG002|NOT COMPLETED|Part A2||10
11312654|NCT02672852|12511618|FG003|NOT COMPLETED|Part A2||4
11312655|NCT02672852|12511619|FG004|NOT COMPLETED|Part A2||0
11312656|NCT02672852|12511620|FG005|NOT COMPLETED|Part A2||0
11312657|NCT02672852|12511621|FG006|NOT COMPLETED|Part A2||0
11312658|NCT02672852|12511615|FG000|STARTED|Part B||0
11312659|NCT02672852|12511616|FG001|STARTED|Part B||0
11312660|NCT02672852|12511617|FG002|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
11312661|NCT02672852|12511618|FG003|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
11312662|NCT02672852|12511619|FG004|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225
11312663|NCT02672852|12511620|FG005|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111
11312664|NCT02672852|12511621|FG006|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63
11312665|NCT02672852|12511615|FG000|COMPLETED|Part B||0
11312666|NCT02672852|12511616|FG001|COMPLETED|Part B||0
11312667|NCT02672852|12511617|FG002|COMPLETED|Part B||0
11312668|NCT02672852|12511618|FG003|COMPLETED|Part B||0
11312669|NCT02672852|12511619|FG004|COMPLETED|Part B||209
11312670|NCT02672852|12511620|FG005|COMPLETED|Part B||100
11312671|NCT02672852|12511621|FG006|COMPLETED|Part B||51
11312672|NCT02672852|12511615|FG000|NOT COMPLETED|Part B||0
11312673|NCT02672852|12511616|FG001|NOT COMPLETED|Part B||0
11312674|NCT02672852|12511617|FG002|NOT COMPLETED|Part B||0
11312675|NCT02672852|12511618|FG003|NOT COMPLETED|Part B||0
11312676|NCT02672852|12511619|FG004|NOT COMPLETED|Part B||16
11312677|NCT02672852|12511620|FG005|NOT COMPLETED|Part B||11
11312678|NCT02672852|12511621|FG006|NOT COMPLETED|Part B||12
11312679|NCT02673138|12511632|FG000|STARTED|Overall Study||10
11312680|NCT02673138|12511632|FG000|Started Day 1|Overall Study||10
11312681|NCT02673138|12511632|FG000|Ended Day 1|Overall Study||10
11312682|NCT02673138|12511632|FG000|Started Day 2|Overall Study||10
11312683|NCT02673138|12511632|FG000|Ended Day 2|Overall Study||10
11312684|NCT02673138|12511632|FG000|COMPLETED|Overall Study||10
11312685|NCT02673138|12511632|FG000|NOT COMPLETED|Overall Study||0
11402040|NCT04069221|12596870|FG003|NOT COMPLETED|Overall Study||0
11402041|NCT04067141|12596880|FG000|STARTED|First Intervention||35
11402042|NCT04067141|12596881|FG001|STARTED|First Intervention||35
11312686|NCT02673372|12511640|FG000|STARTED|Overall Study||30
11312687|NCT02673372|12511641|FG001|STARTED|Overall Study||30
11312688|NCT02673372|12511640|FG000|COMPLETED|Overall Study||30
11312689|NCT02673372|12511641|FG001|COMPLETED|Overall Study||30
11312690|NCT02673372|12511640|FG000|NOT COMPLETED|Overall Study||0
11312691|NCT02673372|12511641|FG001|NOT COMPLETED|Overall Study||0
11312692|NCT02673489|12511649|FG000|STARTED|Treatment Period||54
11312693|NCT02673489|12511650|FG001|STARTED|Treatment Period||24
11312694|NCT02673489|12511649|FG000|COMPLETED|Treatment Period||49
11312695|NCT02673489|12511650|FG001|COMPLETED|Treatment Period||21
11312696|NCT02673489|12511649|FG000|NOT COMPLETED|Treatment Period||5
11312697|NCT02673489|12511650|FG001|NOT COMPLETED|Treatment Period||3
11312698|NCT02673489|12511649|FG000|STARTED|Follow Up Period||50
11312699|NCT02673489|12511650|FG001|STARTED|Follow Up Period||23
11312700|NCT02673489|12511649|FG000|COMPLETED|Follow Up Period||50
11312701|NCT02673489|12511650|FG001|COMPLETED|Follow Up Period||21
11312702|NCT02673489|12511649|FG000|NOT COMPLETED|Follow Up Period||0
11312703|NCT02673489|12511650|FG001|NOT COMPLETED|Follow Up Period||2
11312704|NCT02673515|12511659|FG000|STARTED|Overall Study||30
11312705|NCT02673515|12511660|FG001|STARTED|Overall Study||30
11312706|NCT02673515|12511659|FG000|COMPLETED|Overall Study||28
11312707|NCT02673515|12511660|FG001|COMPLETED|Overall Study||29
11312708|NCT02673515|12511659|FG000|NOT COMPLETED|Overall Study||2
11312709|NCT02673515|12511660|FG001|NOT COMPLETED|Overall Study||1
11312710|NCT02673541|12511668|FG000|STARTED|Overall Study||3
11312711|NCT02673541|12511669|FG001|STARTED|Overall Study||2
11312712|NCT02673541|12511668|FG000|COMPLETED|Overall Study||3
11312713|NCT02673541|12511669|FG001|COMPLETED|Overall Study||2
11312714|NCT02673541|12511668|FG000|NOT COMPLETED|Overall Study||0
11312715|NCT02673541|12511669|FG001|NOT COMPLETED|Overall Study||0
11312716|NCT02673619|12511679|FG000|STARTED|Overall Study||20
11312717|NCT02673619|12511680|FG001|STARTED|Overall Study||5
11312718|NCT02673619|12511681|FG002|STARTED|Overall Study||26
11312719|NCT02673619|12511682|FG003|STARTED|Overall Study||7
11312720|NCT02673619|12511679|FG000|COMPLETED|Overall Study||18
11312721|NCT02673619|12511680|FG001|COMPLETED|Overall Study||4
11312722|NCT02673619|12511681|FG002|COMPLETED|Overall Study||23
11312723|NCT02673619|12511682|FG003|COMPLETED|Overall Study||7
11312724|NCT02673619|12511679|FG000|NOT COMPLETED|Overall Study||2
11312725|NCT02673619|12511680|FG001|NOT COMPLETED|Overall Study||1
11312726|NCT02673619|12511681|FG002|NOT COMPLETED|Overall Study||3
11312727|NCT02673619|12511682|FG003|NOT COMPLETED|Overall Study||0
11312728|NCT02673918|12511695|FG000|STARTED|Overall Study||35
11312729|NCT02673918|12511696|FG001|STARTED|Overall Study||24
11312730|NCT02673918|12511695|FG000|COMPLETED|Overall Study||29
11312731|NCT02673918|12511696|FG001|COMPLETED|Overall Study||20
11312732|NCT02673918|12511695|FG000|NOT COMPLETED|Overall Study||6
11312733|NCT02673918|12511696|FG001|NOT COMPLETED|Overall Study||4
11312734|NCT02673944|12511704|FG000|STARTED|Overall Study||10
11312735|NCT02673944|12511704|FG000|COMPLETED|Overall Study||10
11312736|NCT02673944|12511704|FG000|NOT COMPLETED|Overall Study||0
11312737|NCT02674334|12511711|FG000|STARTED|Overall Study||47
11312738|NCT02674334|12511712|FG001|STARTED|Overall Study||43
11312739|NCT02674334|12511711|FG000|COMPLETED|Overall Study||40
11312740|NCT02674334|12511712|FG001|COMPLETED|Overall Study||40
11312741|NCT02674334|12511711|FG000|NOT COMPLETED|Overall Study||7
11312742|NCT02674334|12511712|FG001|NOT COMPLETED|Overall Study||3
11312743|NCT02674386|12511721|FG000|STARTED|Overall Study||20
11312744|NCT02674386|12511722|FG001|STARTED|Overall Study||117
11312745|NCT02674386|12511723|FG002|STARTED|Overall Study||17
11312746|NCT02674386|12511721|FG000|Safety Analysis Set|Overall Study||20
11312747|NCT02674386|12511722|FG001|Safety Analysis Set|Overall Study||113
11312748|NCT02674386|12511723|FG002|Safety Analysis Set|Overall Study||17
11312749|NCT02674386|12511721|FG000|COMPLETED|Overall Study||20
11312750|NCT02674386|12511722|FG001|COMPLETED|Overall Study||107
11312751|NCT02674386|12511723|FG002|COMPLETED|Overall Study||16
11312752|NCT02674386|12511721|FG000|NOT COMPLETED|Overall Study||0
11312753|NCT02674386|12511722|FG001|NOT COMPLETED|Overall Study||10
11312754|NCT02674386|12511723|FG002|NOT COMPLETED|Overall Study||1
11312755|NCT02674399|12511738|FG000|STARTED|Overall Study||19
11312756|NCT02674399|12511739|FG001|STARTED|Overall Study||9
11312757|NCT02674399|12511738|FG000|COMPLETED|Overall Study||17
11312758|NCT02674399|12511739|FG001|COMPLETED|Overall Study||9
11312759|NCT02674399|12511738|FG000|NOT COMPLETED|Overall Study||2
11312760|NCT02674399|12511739|FG001|NOT COMPLETED|Overall Study||0
11312761|NCT02674412|12511745|FG000|STARTED|Overall Study||5
11312762|NCT02674412|12511746|FG001|STARTED|Overall Study||5
11312763|NCT02674412|12511745|FG000|COMPLETED|Overall Study||5
11312764|NCT02674412|12511746|FG001|COMPLETED|Overall Study||5
11312765|NCT02674412|12511745|FG000|NOT COMPLETED|Overall Study||0
11312766|NCT02674412|12511746|FG001|NOT COMPLETED|Overall Study||0
11312767|NCT02674477|12511755|FG000|STARTED|Overall Study||48
11312768|NCT02674477|12511756|FG001|STARTED|Overall Study||47
11312769|NCT02674477|12511755|FG000|COMPLETED|Overall Study||40
11312770|NCT02674477|12511756|FG001|COMPLETED|Overall Study||45
11312771|NCT02674477|12511755|FG000|NOT COMPLETED|Overall Study||8
11312772|NCT02674477|12511756|FG001|NOT COMPLETED|Overall Study||2
11312773|NCT02674568|12511762|FG000|STARTED|Overall Study|Enrolled and dosed.|339
11312774|NCT02674568|12511762|FG000|Delta-like Protein 3 (DLL3) High|Overall Study||238
11312775|NCT02674568|12511762|FG000|DLL3 Positive|Overall Study||287
11312776|NCT02674568|12511762|FG000|COMPLETED|Overall Study||0
11312777|NCT02674568|12511762|FG000|NOT COMPLETED|Overall Study||339
11312778|NCT02674633|12511773|FG000|STARTED|Overall Study||180
11312779|NCT02674633|12511774|FG001|STARTED|Overall Study||168
11312780|NCT02674633|12511773|FG000|COMPLETED|Overall Study||175
11312781|NCT02674633|12511774|FG001|COMPLETED|Overall Study||164
11312782|NCT02674633|12511773|FG000|NOT COMPLETED|Overall Study||5
11312783|NCT02674633|12511774|FG001|NOT COMPLETED|Overall Study||4
11312784|NCT02674659|12511782|FG000|STARTED|Overall Study||43
11312785|NCT02674659|12511783|FG001|STARTED|Overall Study||44
11312786|NCT02674659|12511782|FG000|COMPLETED|Overall Study||39
11312787|NCT02674659|12511783|FG001|COMPLETED|Overall Study||40
11312788|NCT02674659|12511782|FG000|NOT COMPLETED|Overall Study||4
11312789|NCT02674659|12511783|FG001|NOT COMPLETED|Overall Study||4
11312790|NCT02674685|12511789|FG000|STARTED|Overall Study||237
11312791|NCT02674685|12511789|FG000|COMPLETED|Overall Study||233
11312792|NCT02674685|12511789|FG000|NOT COMPLETED|Overall Study||4
11312793|NCT02674854|12511796|FG000|STARTED|Overall Study||245
11312794|NCT02674854|12511797|FG001|STARTED|Overall Study||255
11312795|NCT02674854|12511798|FG002|STARTED|Overall Study||250
11312796|NCT02674854|12511796|FG000|COMPLETED|Overall Study||221
11312797|NCT02674854|12511797|FG001|COMPLETED|Overall Study||228
11312798|NCT02674854|12511798|FG002|COMPLETED|Overall Study||236
11312799|NCT02674854|12511796|FG000|NOT COMPLETED|Overall Study||24
11312800|NCT02674854|12511797|FG001|NOT COMPLETED|Overall Study||27
11312801|NCT02674854|12511798|FG002|NOT COMPLETED|Overall Study||14
11312802|NCT02675075|12511808|FG000|STARTED|Overall Study||15
11312803|NCT02675075|12511809|FG001|STARTED|Overall Study||19
11312804|NCT02675075|12511808|FG000|COMPLETED|Overall Study||12
11312805|NCT02675075|12511809|FG001|COMPLETED|Overall Study||19
11312806|NCT02675075|12511808|FG000|NOT COMPLETED|Overall Study||3
11312807|NCT02675075|12511809|FG001|NOT COMPLETED|Overall Study||0
11312808|NCT02675517|12511817|FG000|STARTED|Overall Study||1737
11312809|NCT02675517|12511817|FG000|COMPLETED|Overall Study||1578
11312810|NCT02675517|12511817|FG000|NOT COMPLETED|Overall Study||159
11312811|NCT02675543|12511823|FG000|STARTED|Overall Study||15
11312812|NCT02675543|12511824|FG001|STARTED|Overall Study||20
11312813|NCT02675543|12511823|FG000|COMPLETED|Overall Study||15
11312814|NCT02675543|12511824|FG001|COMPLETED|Overall Study||20
11312815|NCT02675543|12511823|FG000|NOT COMPLETED|Overall Study||0
11312816|NCT02675543|12511824|FG001|NOT COMPLETED|Overall Study||0
11312817|NCT02675634|12511830|FG000|STARTED|Test Period 1||10
11312818|NCT02675634|12511831|FG001|STARTED|Test Period 1||8
11312819|NCT02675634|12511832|FG002|STARTED|Test Period 1||9
11312820|NCT02675634|12511833|FG003|STARTED|Test Period 1||9
11312821|NCT02675634|12511834|FG004|STARTED|Test Period 1||10
11312822|NCT02675634|12511835|FG005|STARTED|Test Period 1||9
11312823|NCT02675634|12511830|FG000|COMPLETED|Test Period 1||10
11312824|NCT02675634|12511831|FG001|COMPLETED|Test Period 1||7
11312825|NCT02675634|12511832|FG002|COMPLETED|Test Period 1||8
11312826|NCT02675634|12511833|FG003|COMPLETED|Test Period 1||8
11312827|NCT02675634|12511834|FG004|COMPLETED|Test Period 1||10
11312828|NCT02675634|12511835|FG005|COMPLETED|Test Period 1||9
11312829|NCT02675634|12511830|FG000|NOT COMPLETED|Test Period 1||0
11312830|NCT02675634|12511831|FG001|NOT COMPLETED|Test Period 1||1
11312831|NCT02675634|12511832|FG002|NOT COMPLETED|Test Period 1||1
11312832|NCT02675634|12511833|FG003|NOT COMPLETED|Test Period 1||1
11312833|NCT02675634|12511834|FG004|NOT COMPLETED|Test Period 1||0
11312834|NCT02675634|12511835|FG005|NOT COMPLETED|Test Period 1||0
11312835|NCT02675634|12511830|FG000|STARTED|Test Period 2||10
11312836|NCT02675634|12511831|FG001|STARTED|Test Period 2||7
11312837|NCT02675634|12511832|FG002|STARTED|Test Period 2||8
11312838|NCT02675634|12511833|FG003|STARTED|Test Period 2||8
11312839|NCT02675634|12511834|FG004|STARTED|Test Period 2||10
11312840|NCT02675634|12511835|FG005|STARTED|Test Period 2||9
11312841|NCT02675634|12511830|FG000|COMPLETED|Test Period 2||9
11312842|NCT02675634|12511831|FG001|COMPLETED|Test Period 2||7
11312843|NCT02675634|12511832|FG002|COMPLETED|Test Period 2||8
11312844|NCT02675634|12511833|FG003|COMPLETED|Test Period 2||8
11312845|NCT02675634|12511834|FG004|COMPLETED|Test Period 2||10
11312846|NCT02675634|12511835|FG005|COMPLETED|Test Period 2||8
11312847|NCT02675634|12511830|FG000|NOT COMPLETED|Test Period 2||1
11312848|NCT02675634|12511831|FG001|NOT COMPLETED|Test Period 2||0
11312849|NCT02675634|12511832|FG002|NOT COMPLETED|Test Period 2||0
11312850|NCT02675634|12511833|FG003|NOT COMPLETED|Test Period 2||0
11312851|NCT02675634|12511834|FG004|NOT COMPLETED|Test Period 2||0
11312852|NCT02675634|12511835|FG005|NOT COMPLETED|Test Period 2||1
11312853|NCT02675634|12511830|FG000|STARTED|Test Period 3||9
11312854|NCT02675634|12511831|FG001|STARTED|Test Period 3||7
11312855|NCT02675634|12511832|FG002|STARTED|Test Period 3||8
11312856|NCT02675634|12511833|FG003|STARTED|Test Period 3||8
11312857|NCT02675634|12511834|FG004|STARTED|Test Period 3||10
11312858|NCT02675634|12511835|FG005|STARTED|Test Period 3||8
11312859|NCT02675634|12511830|FG000|COMPLETED|Test Period 3||9
11312860|NCT02675634|12511831|FG001|COMPLETED|Test Period 3||7
11312861|NCT02675634|12511832|FG002|COMPLETED|Test Period 3||8
11312862|NCT02675634|12511833|FG003|COMPLETED|Test Period 3||8
11312863|NCT02675634|12511834|FG004|COMPLETED|Test Period 3||10
11312864|NCT02675634|12511835|FG005|COMPLETED|Test Period 3||8
11312865|NCT02675634|12511830|FG000|NOT COMPLETED|Test Period 3||0
11312866|NCT02675634|12511831|FG001|NOT COMPLETED|Test Period 3||0
11312867|NCT02675634|12511832|FG002|NOT COMPLETED|Test Period 3||0
11312868|NCT02675634|12511833|FG003|NOT COMPLETED|Test Period 3||0
11312869|NCT02675634|12511834|FG004|NOT COMPLETED|Test Period 3||0
11312870|NCT02675634|12511835|FG005|NOT COMPLETED|Test Period 3||0
11312871|NCT02675764|12511845|FG000|STARTED|Overall Study||6
11312872|NCT02675764|12511846|FG001|STARTED|Overall Study||6
11312873|NCT02675764|12511845|FG000|COMPLETED|Overall Study||6
11312874|NCT02675764|12511846|FG001|COMPLETED|Overall Study||6
11312875|NCT02675764|12511845|FG000|NOT COMPLETED|Overall Study||0
11312876|NCT02675764|12511846|FG001|NOT COMPLETED|Overall Study||0
11312877|NCT02675907|12511854|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
11312878|NCT02675907|12511855|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
11312879|NCT02675907|12511854|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
11312880|NCT02675907|12511855|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
11312881|NCT02675907|12511854|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
11312882|NCT02675907|12511855|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
11312883|NCT02675907|12511854|FG000|STARTED|Study Overall||100
11312884|NCT02675907|12511855|FG001|STARTED|Study Overall||101
11312885|NCT02675907|12511854|FG000|COMPLETED|Study Overall||97
11312886|NCT02675907|12511855|FG001|COMPLETED|Study Overall||97
11312887|NCT02675907|12511854|FG000|NOT COMPLETED|Study Overall||3
11312888|NCT02675907|12511855|FG001|NOT COMPLETED|Study Overall||4
11312889|NCT02675998|12511865|FG000|STARTED|8-Week Treatment Period||74
11312890|NCT02675998|12511866|FG001|STARTED|8-Week Treatment Period||73
11312891|NCT02675998|12511867|FG002|STARTED|8-Week Treatment Period||72
11312892|NCT02675998|12511868|FG003|STARTED|8-Week Treatment Period||0
11312893|NCT02675998|12511865|FG000|COMPLETED|8-Week Treatment Period||57
11312894|NCT02675998|12511866|FG001|COMPLETED|8-Week Treatment Period||54
11312895|NCT02675998|12511867|FG002|COMPLETED|8-Week Treatment Period||53
11312896|NCT02675998|12511868|FG003|COMPLETED|8-Week Treatment Period||0
11312897|NCT02675998|12511865|FG000|NOT COMPLETED|8-Week Treatment Period||17
11312898|NCT02675998|12511866|FG001|NOT COMPLETED|8-Week Treatment Period||19
11312899|NCT02675998|12511867|FG002|NOT COMPLETED|8-Week Treatment Period||19
11312900|NCT02675998|12511868|FG003|NOT COMPLETED|8-Week Treatment Period||0
11312901|NCT02675998|12511865|FG000|STARTED|4-Week Randomized Withdrawal Period||25
11312902|NCT02675998|12511866|FG001|STARTED|4-Week Randomized Withdrawal Period||23
11312903|NCT02675998|12511867|FG002|STARTED|4-Week Randomized Withdrawal Period||34
11312904|NCT02675998|12511868|FG003|STARTED|4-Week Randomized Withdrawal Period||82
11312905|NCT02675998|12511865|FG000|COMPLETED|4-Week Randomized Withdrawal Period||24
11312906|NCT02675998|12511866|FG001|COMPLETED|4-Week Randomized Withdrawal Period||22
11312907|NCT02675998|12511867|FG002|COMPLETED|4-Week Randomized Withdrawal Period||32
11312908|NCT02675998|12511868|FG003|COMPLETED|4-Week Randomized Withdrawal Period||74
11312909|NCT02675998|12511865|FG000|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
11312910|NCT02675998|12511866|FG001|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
11312911|NCT02675998|12511867|FG002|NOT COMPLETED|4-Week Randomized Withdrawal Period||2
11312912|NCT02675998|12511868|FG003|NOT COMPLETED|4-Week Randomized Withdrawal Period||8
11312913|NCT02676375|12511881|FG000|STARTED|Overall Study||14
11312914|NCT02676375|12511882|FG001|STARTED|Overall Study||14
11312915|NCT02676375|12511883|FG002|STARTED|Overall Study||14
11312916|NCT02676375|12511881|FG000|COMPLETED|Overall Study||13
11312917|NCT02676375|12511882|FG001|COMPLETED|Overall Study||10
11312918|NCT02676375|12511883|FG002|COMPLETED|Overall Study||11
11312919|NCT02676375|12511881|FG000|NOT COMPLETED|Overall Study||1
11312920|NCT02676375|12511882|FG001|NOT COMPLETED|Overall Study||4
11312921|NCT02676375|12511883|FG002|NOT COMPLETED|Overall Study||3
11312922|NCT02676466|12511899|FG000|STARTED|Overall Study||109
11312923|NCT02676466|12511900|FG001|STARTED|Overall Study||71
11312924|NCT02676466|12511901|FG002|STARTED|Overall Study||26
11312925|NCT02676466|12511902|FG003|STARTED|Overall Study||17
11312926|NCT02676466|12511903|FG004|STARTED|Overall Study||26
11312927|NCT02676466|12511904|FG005|STARTED|Overall Study||13
11312928|NCT02676466|12511905|FG006|STARTED|Overall Study||13
11312929|NCT02676466|12511906|FG007|STARTED|Overall Study||14
11312930|NCT02676466|12511899|FG000|COMPLETED|Overall Study||105
11312931|NCT02676466|12511900|FG001|COMPLETED|Overall Study||66
11312932|NCT02676466|12511901|FG002|COMPLETED|Overall Study||24
11312933|NCT02676466|12511902|FG003|COMPLETED|Overall Study||17
11312934|NCT02676466|12511903|FG004|COMPLETED|Overall Study||23
11312935|NCT02676466|12511904|FG005|COMPLETED|Overall Study||12
11312936|NCT02676466|12511905|FG006|COMPLETED|Overall Study||12
11312937|NCT02676466|12511906|FG007|COMPLETED|Overall Study||13
11312938|NCT02676466|12511899|FG000|NOT COMPLETED|Overall Study||4
11312939|NCT02676466|12511900|FG001|NOT COMPLETED|Overall Study||5
11312940|NCT02676466|12511901|FG002|NOT COMPLETED|Overall Study||2
11312941|NCT02676466|12511902|FG003|NOT COMPLETED|Overall Study||0
11312942|NCT02676466|12511903|FG004|NOT COMPLETED|Overall Study||3
11312943|NCT02676466|12511904|FG005|NOT COMPLETED|Overall Study||1
11312944|NCT02676466|12511905|FG006|NOT COMPLETED|Overall Study||1
11312945|NCT02676466|12511906|FG007|NOT COMPLETED|Overall Study||1
11312946|NCT02676778|12511931|FG000|STARTED|Overall Study||17
11312947|NCT02676778|12511932|FG001|STARTED|Overall Study||19
11312948|NCT02676778|12511933|FG002|STARTED|Overall Study||1
11312949|NCT02676778|12511931|FG000|COMPLETED|Overall Study||0
11312950|NCT02676778|12511932|FG001|COMPLETED|Overall Study||7
11312951|NCT02676778|12511933|FG002|COMPLETED|Overall Study||0
11312952|NCT02676778|12511931|FG000|NOT COMPLETED|Overall Study||17
11312953|NCT02676778|12511932|FG001|NOT COMPLETED|Overall Study||12
11312954|NCT02676778|12511933|FG002|NOT COMPLETED|Overall Study||1
11312955|NCT02676843|12511942|FG000|STARTED|Overall Study||7
11312956|NCT02676843|12511942|FG000|COMPLETED|Overall Study||7
11312957|NCT02676843|12511942|FG000|NOT COMPLETED|Overall Study||0
11312958|NCT02676882|12511949|FG000|STARTED|Overall Study||13
11312959|NCT02676882|12511950|FG001|STARTED|Overall Study||7
11312960|NCT02676882|12511949|FG000|Evaluable|Overall Study||11
11312961|NCT02676882|12511950|FG001|Evaluable|Overall Study||6
11402043|NCT04067141|12596880|FG000|COMPLETED|First Intervention||35
11402044|NCT04067141|12596881|FG001|COMPLETED|First Intervention||34
11402045|NCT04067141|12596880|FG000|NOT COMPLETED|First Intervention||0
11402046|NCT04067141|12596881|FG001|NOT COMPLETED|First Intervention||1
11402047|NCT04067141|12596880|FG000|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject.|34
11402048|NCT04067141|12596881|FG001|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject|33
11402049|NCT04067141|12596880|FG000|COMPLETED|Second Intervention||34
11402050|NCT04067141|12596881|FG001|COMPLETED|Second Intervention||31
11402051|NCT04067141|12596880|FG000|NOT COMPLETED|Second Intervention||0
11402052|NCT04067141|12596881|FG001|NOT COMPLETED|Second Intervention||2
11402053|NCT04049578|12596887|FG000|STARTED|Overall Study||2
11402054|NCT04049578|12596887|FG000|COMPLETED|Overall Study||1
11402055|NCT04049578|12596887|FG000|NOT COMPLETED|Overall Study||1
11402056|NCT04067401|12596893|FG000|STARTED|Overall Study||748
11402057|NCT04067401|12596894|FG001|STARTED|Overall Study||737
11402058|NCT04067401|12596893|FG000|Baseline Survey Completion|Overall Study||746
11402059|NCT04067401|12596894|FG001|Baseline Survey Completion|Overall Study||735
11402060|NCT04067401|12596893|FG000|1 Month Survey Completion|Overall Study||697
11402061|NCT04067401|12596894|FG001|1 Month Survey Completion|Overall Study||694
11402062|NCT04067401|12596893|FG000|6 Month Survey Completion|Overall Study||629
11402063|NCT04067401|12596894|FG001|6 Month Survey Completion|Overall Study||618
11402064|NCT04067401|12596893|FG000|COMPLETED|Overall Study||740
11402065|NCT04067401|12596894|FG001|COMPLETED|Overall Study||737
11402066|NCT04067401|12596893|FG000|NOT COMPLETED|Overall Study||8
11402067|NCT04067401|12596894|FG001|NOT COMPLETED|Overall Study||0
11402068|NCT04067050|12596902|FG000|STARTED|One Month||32
11402069|NCT04067050|12596903|FG001|STARTED|One Month||29
11402070|NCT04067050|12596902|FG000|COMPLETED|One Month||28
11402071|NCT04067050|12596903|FG001|COMPLETED|One Month||29
11402072|NCT04067050|12596902|FG000|NOT COMPLETED|One Month||4
11402073|NCT04067050|12596903|FG001|NOT COMPLETED|One Month||0
11402074|NCT04067050|12596902|FG000|STARTED|Two Month|6 subjects discontinued after 1 month visit. 22 Subjects continued the study.|22
11402075|NCT04067050|12596903|FG001|STARTED|Two Month||29
11402076|NCT04067050|12596902|FG000|COMPLETED|Two Month||20
11402077|NCT04067050|12596903|FG001|COMPLETED|Two Month||29
11312962|NCT02676882|12511949|FG000|COMPLETED|Overall Study||10
11402078|NCT04067050|12596902|FG000|NOT COMPLETED|Two Month||2
11402079|NCT04067050|12596903|FG001|NOT COMPLETED|Two Month||0
11402080|NCT04066647|12596909|FG000|STARTED|Overall Study||7
11402081|NCT04066647|12596909|FG000|COMPLETED|Overall Study||7
11402082|NCT04066647|12596909|FG000|NOT COMPLETED|Overall Study||0
11402083|NCT04066426|12596917|FG000|STARTED|Overall Study||50
11402084|NCT04066426|12596918|FG001|STARTED|Overall Study||50
11402085|NCT04066426|12596919|FG002|STARTED|Overall Study||50
11402086|NCT04066426|12596920|FG003|STARTED|Overall Study||50
11402087|NCT04066426|12596917|FG000|COMPLETED|Overall Study||40
11402088|NCT04066426|12596918|FG001|COMPLETED|Overall Study||40
11402089|NCT04066426|12596919|FG002|COMPLETED|Overall Study||42
11402090|NCT04066426|12596920|FG003|COMPLETED|Overall Study||47
11402091|NCT04066426|12596917|FG000|NOT COMPLETED|Overall Study||10
11402092|NCT04066426|12596918|FG001|NOT COMPLETED|Overall Study||10
11402093|NCT04066426|12596919|FG002|NOT COMPLETED|Overall Study||8
11402094|NCT04066426|12596920|FG003|NOT COMPLETED|Overall Study||3
11402095|NCT04061694|12596932|FG000|STARTED|Overall Study||21
11402096|NCT04061694|12596933|FG001|STARTED|Overall Study||25
11402097|NCT04061694|12596932|FG000|COMPLETED|Overall Study||19
11402098|NCT04061694|12596933|FG001|COMPLETED|Overall Study||25
11402099|NCT04061694|12596932|FG000|NOT COMPLETED|Overall Study||2
11402100|NCT04061694|12596933|FG001|NOT COMPLETED|Overall Study||0
11402101|NCT04060654|12596939|FG000|STARTED|Overall Study||17
11402102|NCT04060654|12596939|FG000|COMPLETED|Overall Study||11
11402103|NCT04060654|12596939|FG000|NOT COMPLETED|Overall Study||6
11402104|NCT04059250|12596943|FG000|STARTED|Overall Study||25
11402105|NCT04059250|12596944|FG001|STARTED|Overall Study||25
11402106|NCT04059250|12596943|FG000|COMPLETED|Overall Study||25
11402107|NCT04059250|12596944|FG001|COMPLETED|Overall Study||25
11402108|NCT04059250|12596943|FG000|NOT COMPLETED|Overall Study||0
11402109|NCT04059250|12596944|FG001|NOT COMPLETED|Overall Study||0
11402110|NCT04058353|12596952|FG000|STARTED|Overall Study||126
11402111|NCT04058353|12596953|FG001|STARTED|Overall Study||132
11312963|NCT02676882|12511950|FG001|COMPLETED|Overall Study||5
11312964|NCT02676882|12511949|FG000|NOT COMPLETED|Overall Study||3
11312965|NCT02676882|12511950|FG001|NOT COMPLETED|Overall Study||2
11312966|NCT02676895|12511959|FG000|STARTED|Overall Study||22
11312967|NCT02676895|12511960|FG001|STARTED|Overall Study||26
11312968|NCT02676895|12511961|FG002|STARTED|Overall Study||24
11312969|NCT02676895|12511959|FG000|COMPLETED|Overall Study||20
11312970|NCT02676895|12511960|FG001|COMPLETED|Overall Study||23
11312971|NCT02676895|12511961|FG002|COMPLETED|Overall Study||21
11312972|NCT02676895|12511959|FG000|NOT COMPLETED|Overall Study||2
11312973|NCT02676895|12511960|FG001|NOT COMPLETED|Overall Study||3
11312974|NCT02676895|12511961|FG002|NOT COMPLETED|Overall Study||3
11312975|NCT02677116|12511979|FG000|STARTED|Overall Study||10
11312976|NCT02677116|12511980|FG001|STARTED|Overall Study||11
11312977|NCT02677116|12511981|FG002|STARTED|Overall Study||9
11312978|NCT02677116|12511982|FG003|STARTED|Overall Study||10
11312979|NCT02677116|12511983|FG004|STARTED|Overall Study||1
11312980|NCT02677116|12511984|FG005|STARTED|Overall Study||13
11312981|NCT02677116|12511985|FG006|STARTED|Overall Study||6
11312982|NCT02677116|12511986|FG007|STARTED|Overall Study||4
11312983|NCT02677116|12511987|FG008|STARTED|Overall Study||4
11312984|NCT02677116|12511979|FG000|Cycle 1 Olaratumab Alone|Overall Study||10
11312985|NCT02677116|12511980|FG001|Cycle 1 Olaratumab Alone|Overall Study||11
11312986|NCT02677116|12511981|FG002|Cycle 1 Olaratumab Alone|Overall Study||9
11312987|NCT02677116|12511982|FG003|Cycle 1 Olaratumab Alone|Overall Study||10
11312988|NCT02677116|12511983|FG004|Cycle 1 Olaratumab Alone|Overall Study||1
11312989|NCT02677116|12511984|FG005|Cycle 1 Olaratumab Alone|Overall Study||13
11312990|NCT02677116|12511985|FG006|Cycle 1 Olaratumab Alone|Overall Study||6
11312991|NCT02677116|12511986|FG007|Cycle 1 Olaratumab Alone|Overall Study||4
11312992|NCT02677116|12511987|FG008|Cycle 1 Olaratumab Alone|Overall Study||4
11312993|NCT02677116|12511979|FG000|Progressive Disease|Overall Study||7
11312994|NCT02677116|12511980|FG001|Progressive Disease|Overall Study||7
11312995|NCT02677116|12511981|FG002|Progressive Disease|Overall Study||6
11312996|NCT02677116|12511982|FG003|Progressive Disease|Overall Study||7
11312997|NCT02677116|12511983|FG004|Progressive Disease|Overall Study||0
11312998|NCT02677116|12511984|FG005|Progressive Disease|Overall Study||9
11312999|NCT02677116|12511985|FG006|Progressive Disease|Overall Study||2
11313000|NCT02677116|12511986|FG007|Progressive Disease|Overall Study||2
11313001|NCT02677116|12511987|FG008|Progressive Disease|Overall Study||2
11313002|NCT02677116|12511979|FG000|COMPLETED|Overall Study||7
11313003|NCT02677116|12511980|FG001|COMPLETED|Overall Study||7
11313004|NCT02677116|12511981|FG002|COMPLETED|Overall Study||6
11313005|NCT02677116|12511982|FG003|COMPLETED|Overall Study||7
11313006|NCT02677116|12511983|FG004|COMPLETED|Overall Study||0
11313007|NCT02677116|12511984|FG005|COMPLETED|Overall Study||9
11313008|NCT02677116|12511985|FG006|COMPLETED|Overall Study||2
11313009|NCT02677116|12511986|FG007|COMPLETED|Overall Study||2
11313010|NCT02677116|12511987|FG008|COMPLETED|Overall Study||2
11313011|NCT02677116|12511979|FG000|NOT COMPLETED|Overall Study||3
11313012|NCT02677116|12511980|FG001|NOT COMPLETED|Overall Study||4
11313013|NCT02677116|12511981|FG002|NOT COMPLETED|Overall Study||3
11313014|NCT02677116|12511982|FG003|NOT COMPLETED|Overall Study||3
11313015|NCT02677116|12511983|FG004|NOT COMPLETED|Overall Study||1
11402112|NCT04058353|12596952|FG000|COMPLETED|Overall Study||122
11402113|NCT04058353|12596953|FG001|COMPLETED|Overall Study||131
11313016|NCT02677116|12511984|FG005|NOT COMPLETED|Overall Study||4
11313017|NCT02677116|12511985|FG006|NOT COMPLETED|Overall Study||4
11313018|NCT02677116|12511986|FG007|NOT COMPLETED|Overall Study||2
11313019|NCT02677116|12511987|FG008|NOT COMPLETED|Overall Study||2
11313020|NCT02677220|12512030|FG000|STARTED|Overall Study||1
11313021|NCT02677220|12512030|FG000|COMPLETED|Overall Study||0
11313022|NCT02677220|12512030|FG000|NOT COMPLETED|Overall Study||1
11313023|NCT02677428|12512037|FG000|STARTED|Overall Study||63
11313024|NCT02677428|12512038|FG001|STARTED|Overall Study||55
11313025|NCT02677428|12512037|FG000|COMPLETED|Overall Study||63
11313026|NCT02677428|12512038|FG001|COMPLETED|Overall Study||55
11313027|NCT02677428|12512037|FG000|NOT COMPLETED|Overall Study||0
11313028|NCT02677428|12512038|FG001|NOT COMPLETED|Overall Study||0
11313029|NCT02677493|12512047|FG000|STARTED|Overall Study||1197
11313030|NCT02677493|12512048|FG001|STARTED|Overall Study||298
11313031|NCT02677493|12512049|FG002|STARTED|Overall Study||299
11313032|NCT02677493|12512047|FG000|COMPLETED|Overall Study||1186
11313033|NCT02677493|12512048|FG001|COMPLETED|Overall Study||296
11313034|NCT02677493|12512049|FG002|COMPLETED|Overall Study||296
11313035|NCT02677493|12512047|FG000|NOT COMPLETED|Overall Study||11
11313036|NCT02677493|12512048|FG001|NOT COMPLETED|Overall Study||2
11313037|NCT02677493|12512049|FG002|NOT COMPLETED|Overall Study||3
11313038|NCT02677623|12512064|FG000|STARTED|Overall Study||33
11313039|NCT02677623|12512065|FG001|STARTED|Overall Study||32
11313040|NCT02677623|12512066|FG002|STARTED|Overall Study||32
11313041|NCT02677623|12512067|FG003|STARTED|Overall Study||33
11313042|NCT02677623|12512064|FG000|COMPLETED|Overall Study||33
11313043|NCT02677623|12512065|FG001|COMPLETED|Overall Study||32
11313044|NCT02677623|12512066|FG002|COMPLETED|Overall Study||32
11313045|NCT02677623|12512067|FG003|COMPLETED|Overall Study||33
11313046|NCT02677623|12512064|FG000|NOT COMPLETED|Overall Study||0
11313047|NCT02677623|12512065|FG001|NOT COMPLETED|Overall Study||0
11313048|NCT02677623|12512066|FG002|NOT COMPLETED|Overall Study||0
11313049|NCT02677623|12512067|FG003|NOT COMPLETED|Overall Study||0
11313050|NCT02677701|12512079|FG000|STARTED|Overall Study||62
11313051|NCT02677701|12512080|FG001|STARTED|Overall Study||57
11313052|NCT02677701|12512079|FG000|Treated|Overall Study||61
11313053|NCT02677701|12512080|FG001|Treated|Overall Study||54
11313054|NCT02677701|12512079|FG000|COMPLETED|Overall Study||56
11313055|NCT02677701|12512080|FG001|COMPLETED|Overall Study||52
11313056|NCT02677701|12512079|FG000|NOT COMPLETED|Overall Study||6
11313057|NCT02677701|12512080|FG001|NOT COMPLETED|Overall Study||5
11313058|NCT02677714|12512088|FG000|STARTED|Overall Study||12
11313059|NCT02677714|12512089|FG001|STARTED|Overall Study||2
11313060|NCT02677714|12512088|FG000|COMPLETED|Overall Study||10
11313061|NCT02677714|12512089|FG001|COMPLETED|Overall Study||2
11313062|NCT02677714|12512088|FG000|NOT COMPLETED|Overall Study||2
11313063|NCT02677714|12512089|FG001|NOT COMPLETED|Overall Study||0
11313064|NCT02677740|12512097|FG000|STARTED|Overall Study||7
11313065|NCT02677740|12512098|FG001|STARTED|Overall Study||1
11313066|NCT02677740|12512097|FG000|COMPLETED|Overall Study||7
11313067|NCT02677740|12512098|FG001|COMPLETED|Overall Study||1
11313068|NCT02677740|12512097|FG000|NOT COMPLETED|Overall Study||0
11313069|NCT02677740|12512098|FG001|NOT COMPLETED|Overall Study||0
11313070|NCT02677753|12512106|FG000|STARTED|Overall Study||37
11313071|NCT02677753|12512107|FG001|STARTED|Overall Study||38
11313072|NCT02677753|12512106|FG000|COMPLETED|Overall Study||36
11313073|NCT02677753|12512107|FG001|COMPLETED|Overall Study||38
11313074|NCT02677753|12512106|FG000|NOT COMPLETED|Overall Study||1
11313075|NCT02677753|12512107|FG001|NOT COMPLETED|Overall Study||0
11313076|NCT02677766|12512115|FG000|STARTED|Overall Study||20
11313077|NCT02677766|12512116|FG001|STARTED|Overall Study||20
11313078|NCT02677766|12512115|FG000|COMPLETED|Overall Study||15
11313079|NCT02677766|12512116|FG001|COMPLETED|Overall Study||17
11313080|NCT02677766|12512115|FG000|NOT COMPLETED|Overall Study||5
11313081|NCT02677766|12512116|FG001|NOT COMPLETED|Overall Study||3
11313082|NCT02677779|12512124|FG000|STARTED|Overall Study||10
11313083|NCT02677779|12512125|FG001|STARTED|Overall Study||10
11313084|NCT02677779|12512124|FG000|COMPLETED|Overall Study||10
11313085|NCT02677779|12512125|FG001|COMPLETED|Overall Study||10
11313086|NCT02677779|12512124|FG000|NOT COMPLETED|Overall Study||0
11313087|NCT02677779|12512125|FG001|NOT COMPLETED|Overall Study||0
11313088|NCT02677844|12512133|FG000|STARTED|Period 1||5
11313089|NCT02677844|12512134|FG001|STARTED|Period 1||5
11313090|NCT02677844|12512135|FG002|STARTED|Period 1||5
11313091|NCT02677844|12512136|FG003|STARTED|Period 1||5
11313092|NCT02677844|12512137|FG004|STARTED|Period 1||0
11313093|NCT02677844|12512138|FG005|STARTED|Period 1||0
11313094|NCT02677844|12512139|FG006|STARTED|Period 1||0
11313095|NCT02677844|12512133|FG000|COMPLETED|Period 1||5
11313096|NCT02677844|12512134|FG001|COMPLETED|Period 1||5
11313097|NCT02677844|12512135|FG002|COMPLETED|Period 1||5
11402114|NCT04058353|12596952|FG000|NOT COMPLETED|Overall Study||4
11402115|NCT04058353|12596953|FG001|NOT COMPLETED|Overall Study||1
11402116|NCT04057248|12596960|FG000|STARTED|Overall Study||14
11313098|NCT02677844|12512136|FG003|COMPLETED|Period 1||5
11313099|NCT02677844|12512137|FG004|COMPLETED|Period 1||0
11313100|NCT02677844|12512138|FG005|COMPLETED|Period 1||0
11313101|NCT02677844|12512139|FG006|COMPLETED|Period 1||0
11313102|NCT02677844|12512133|FG000|NOT COMPLETED|Period 1||0
11313103|NCT02677844|12512134|FG001|NOT COMPLETED|Period 1||0
11313104|NCT02677844|12512135|FG002|NOT COMPLETED|Period 1||0
11313105|NCT02677844|12512136|FG003|NOT COMPLETED|Period 1||0
11313106|NCT02677844|12512137|FG004|NOT COMPLETED|Period 1||0
11313107|NCT02677844|12512138|FG005|NOT COMPLETED|Period 1||0
11022216|NCT00808210|12200490|FG001|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||4
11022217|NCT00808236|12200498|FG000|STARTED|Overall Study||96
11022218|NCT00808236|12200499|FG001|STARTED|Overall Study||104
11022219|NCT00808236|12200498|FG000|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
11022220|NCT00808236|12200499|FG001|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
11022221|NCT00808236|12200498|FG000|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
11022222|NCT00808236|12200499|FG001|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
11022223|NCT00808236|12200498|FG000|Achieved ROSC|Overall Study||33
11022224|NCT00808236|12200499|FG001|Achieved ROSC|Overall Study||43
11022225|NCT00808236|12200498|FG000|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
11057006|NCT00996892|12238674|FG003|COMPLETED|Dose-Escalation Stage 1||0
11313108|NCT02677844|12512139|FG006|NOT COMPLETED|Period 1||0
11402117|NCT04057248|12596960|FG000|COMPLETED|Overall Study||12
11402118|NCT04057248|12596960|FG000|NOT COMPLETED|Overall Study||2
11313109|NCT02677844|12512133|FG000|STARTED|Period 2||5
11313110|NCT02677844|12512134|FG001|STARTED|Period 2||5
11313111|NCT02677844|12512135|FG002|STARTED|Period 2||5
11313112|NCT02677844|12512136|FG003|STARTED|Period 2||5
11313113|NCT02677844|12512137|FG004|STARTED|Period 2||0
11313114|NCT02677844|12512138|FG005|STARTED|Period 2||0
11313115|NCT02677844|12512139|FG006|STARTED|Period 2||0
11313116|NCT02677844|12512133|FG000|COMPLETED|Period 2||5
11313117|NCT02677844|12512134|FG001|COMPLETED|Period 2||5
11313118|NCT02677844|12512135|FG002|COMPLETED|Period 2||5
11313119|NCT02677844|12512136|FG003|COMPLETED|Period 2||5
11313120|NCT02677844|12512137|FG004|COMPLETED|Period 2||0
11313121|NCT02677844|12512138|FG005|COMPLETED|Period 2||0
11313122|NCT02677844|12512139|FG006|COMPLETED|Period 2||0
11402119|NCT04055519|12596964|FG000|STARTED|First Wear Period (30 Days)||16
11313123|NCT02677844|12512133|FG000|NOT COMPLETED|Period 2||0
11313124|NCT02677844|12512134|FG001|NOT COMPLETED|Period 2||0
11313125|NCT02677844|12512135|FG002|NOT COMPLETED|Period 2||0
11313126|NCT02677844|12512136|FG003|NOT COMPLETED|Period 2||0
11313127|NCT02677844|12512137|FG004|NOT COMPLETED|Period 2||0
11313128|NCT02677844|12512138|FG005|NOT COMPLETED|Period 2||0
11313129|NCT02677844|12512139|FG006|NOT COMPLETED|Period 2||0
11313130|NCT02677844|12512133|FG000|STARTED|Period 3||5
11313131|NCT02677844|12512134|FG001|STARTED|Period 3||5
11313132|NCT02677844|12512135|FG002|STARTED|Period 3||5
11313133|NCT02677844|12512136|FG003|STARTED|Period 3||5
11313134|NCT02677844|12512137|FG004|STARTED|Period 3||0
11313135|NCT02677844|12512138|FG005|STARTED|Period 3||0
11313136|NCT02677844|12512139|FG006|STARTED|Period 3||0
11313137|NCT02677844|12512133|FG000|COMPLETED|Period 3||5
11313138|NCT02677844|12512134|FG001|COMPLETED|Period 3||5
11313139|NCT02677844|12512135|FG002|COMPLETED|Period 3||5
11313140|NCT02677844|12512136|FG003|COMPLETED|Period 3||4
11313141|NCT02677844|12512137|FG004|COMPLETED|Period 3||0
11313142|NCT02677844|12512138|FG005|COMPLETED|Period 3||0
11313143|NCT02677844|12512139|FG006|COMPLETED|Period 3||0
11313144|NCT02677844|12512133|FG000|NOT COMPLETED|Period 3||0
11313145|NCT02677844|12512134|FG001|NOT COMPLETED|Period 3||0
11313146|NCT02677844|12512135|FG002|NOT COMPLETED|Period 3||0
11313147|NCT02677844|12512136|FG003|NOT COMPLETED|Period 3||1
11313148|NCT02677844|12512137|FG004|NOT COMPLETED|Period 3||0
11313149|NCT02677844|12512138|FG005|NOT COMPLETED|Period 3||0
11313150|NCT02677844|12512139|FG006|NOT COMPLETED|Period 3||0
11313151|NCT02677844|12512133|FG000|STARTED|Period 4||5
11313152|NCT02677844|12512134|FG001|STARTED|Period 4||5
11313153|NCT02677844|12512135|FG002|STARTED|Period 4||5
11313154|NCT02677844|12512136|FG003|STARTED|Period 4||4
11313155|NCT02677844|12512137|FG004|STARTED|Period 4||0
11313156|NCT02677844|12512138|FG005|STARTED|Period 4||0
11313157|NCT02677844|12512139|FG006|STARTED|Period 4||0
11313158|NCT02677844|12512133|FG000|COMPLETED|Period 4||5
11313159|NCT02677844|12512134|FG001|COMPLETED|Period 4||5
11313160|NCT02677844|12512135|FG002|COMPLETED|Period 4||5
11313161|NCT02677844|12512136|FG003|COMPLETED|Period 4||4
11313162|NCT02677844|12512137|FG004|COMPLETED|Period 4||0
11313163|NCT02677844|12512138|FG005|COMPLETED|Period 4||0
11313164|NCT02677844|12512139|FG006|COMPLETED|Period 4||0
11313165|NCT02677844|12512133|FG000|NOT COMPLETED|Period 4||0
11313166|NCT02677844|12512134|FG001|NOT COMPLETED|Period 4||0
11313167|NCT02677844|12512135|FG002|NOT COMPLETED|Period 4||0
11313168|NCT02677844|12512136|FG003|NOT COMPLETED|Period 4||0
11313169|NCT02677844|12512137|FG004|NOT COMPLETED|Period 4||0
11313170|NCT02677844|12512138|FG005|NOT COMPLETED|Period 4||0
11313171|NCT02677844|12512139|FG006|NOT COMPLETED|Period 4||0
11313172|NCT02677844|12512133|FG000|STARTED|Period 4 (DDI)||0
11313173|NCT02677844|12512134|FG001|STARTED|Period 4 (DDI)||0
11313174|NCT02677844|12512135|FG002|STARTED|Period 4 (DDI)||0
11313175|NCT02677844|12512136|FG003|STARTED|Period 4 (DDI)||0
11313176|NCT02677844|12512137|FG004|STARTED|Period 4 (DDI)||7
11313177|NCT02677844|12512138|FG005|STARTED|Period 4 (DDI)||4
11313178|NCT02677844|12512139|FG006|STARTED|Period 4 (DDI)||4
11313179|NCT02677844|12512133|FG000|COMPLETED|Period 4 (DDI)||0
11313180|NCT02677844|12512134|FG001|COMPLETED|Period 4 (DDI)||0
11313181|NCT02677844|12512135|FG002|COMPLETED|Period 4 (DDI)||0
11313182|NCT02677844|12512136|FG003|COMPLETED|Period 4 (DDI)||0
11313183|NCT02677844|12512137|FG004|COMPLETED|Period 4 (DDI)||7
11313184|NCT02677844|12512138|FG005|COMPLETED|Period 4 (DDI)||4
11313185|NCT02677844|12512139|FG006|COMPLETED|Period 4 (DDI)||4
11313186|NCT02677844|12512133|FG000|NOT COMPLETED|Period 4 (DDI)||0
11313187|NCT02677844|12512134|FG001|NOT COMPLETED|Period 4 (DDI)||0
11313188|NCT02677844|12512135|FG002|NOT COMPLETED|Period 4 (DDI)||0
11313189|NCT02677844|12512136|FG003|NOT COMPLETED|Period 4 (DDI)||0
11313190|NCT02677844|12512137|FG004|NOT COMPLETED|Period 4 (DDI)||0
11313191|NCT02677844|12512138|FG005|NOT COMPLETED|Period 4 (DDI)||0
11313192|NCT02677844|12512139|FG006|NOT COMPLETED|Period 4 (DDI)||0
11313193|NCT02677844|12512133|FG000|STARTED|Period 5||0
11313194|NCT02677844|12512134|FG001|STARTED|Period 5||0
11313195|NCT02677844|12512135|FG002|STARTED|Period 5||0
11313196|NCT02677844|12512136|FG003|STARTED|Period 5||0
11313197|NCT02677844|12512137|FG004|STARTED|Period 5||7
11313198|NCT02677844|12512138|FG005|STARTED|Period 5||4
11313199|NCT02677844|12512139|FG006|STARTED|Period 5||4
11313200|NCT02677844|12512133|FG000|COMPLETED|Period 5||0
11313201|NCT02677844|12512134|FG001|COMPLETED|Period 5||0
11313202|NCT02677844|12512135|FG002|COMPLETED|Period 5||0
11313203|NCT02677844|12512136|FG003|COMPLETED|Period 5||0
11313204|NCT02677844|12512137|FG004|COMPLETED|Period 5||7
11313205|NCT02677844|12512138|FG005|COMPLETED|Period 5||4
11313206|NCT02677844|12512139|FG006|COMPLETED|Period 5||4
11313207|NCT02677844|12512133|FG000|NOT COMPLETED|Period 5||0
11313208|NCT02677844|12512134|FG001|NOT COMPLETED|Period 5||0
11313209|NCT02677844|12512135|FG002|NOT COMPLETED|Period 5||0
11313210|NCT02677844|12512136|FG003|NOT COMPLETED|Period 5||0
11313211|NCT02677844|12512137|FG004|NOT COMPLETED|Period 5||0
11313212|NCT02677844|12512138|FG005|NOT COMPLETED|Period 5||0
11313213|NCT02677844|12512139|FG006|NOT COMPLETED|Period 5||0
11313214|NCT02677844|12512133|FG000|STARTED|Period 6||0
11313215|NCT02677844|12512134|FG001|STARTED|Period 6||0
11313216|NCT02677844|12512135|FG002|STARTED|Period 6||0
11313217|NCT02677844|12512136|FG003|STARTED|Period 6||0
11313218|NCT02677844|12512137|FG004|STARTED|Period 6||7
11313219|NCT02677844|12512138|FG005|STARTED|Period 6||4
11313220|NCT02677844|12512139|FG006|STARTED|Period 6||4
11313221|NCT02677844|12512133|FG000|COMPLETED|Period 6||0
11313222|NCT02677844|12512134|FG001|COMPLETED|Period 6||0
11313223|NCT02677844|12512135|FG002|COMPLETED|Period 6||0
11313224|NCT02677844|12512136|FG003|COMPLETED|Period 6||0
11313225|NCT02677844|12512137|FG004|COMPLETED|Period 6||7
11313226|NCT02677844|12512138|FG005|COMPLETED|Period 6||4
11313227|NCT02677844|12512139|FG006|COMPLETED|Period 6||4
11313228|NCT02677844|12512133|FG000|NOT COMPLETED|Period 6||0
11313229|NCT02677844|12512134|FG001|NOT COMPLETED|Period 6||0
11313230|NCT02677844|12512135|FG002|NOT COMPLETED|Period 6||0
11313231|NCT02677844|12512136|FG003|NOT COMPLETED|Period 6||0
11313232|NCT02677844|12512137|FG004|NOT COMPLETED|Period 6||0
11313233|NCT02677844|12512138|FG005|NOT COMPLETED|Period 6||0
11313234|NCT02677844|12512139|FG006|NOT COMPLETED|Period 6||0
11313235|NCT02677844|12512133|FG000|STARTED|Period 7||0
11313236|NCT02677844|12512134|FG001|STARTED|Period 7||0
11313237|NCT02677844|12512135|FG002|STARTED|Period 7||0
11313238|NCT02677844|12512136|FG003|STARTED|Period 7||0
11313239|NCT02677844|12512137|FG004|STARTED|Period 7||7
11313240|NCT02677844|12512138|FG005|STARTED|Period 7||4
11313241|NCT02677844|12512139|FG006|STARTED|Period 7||4
11313242|NCT02677844|12512133|FG000|COMPLETED|Period 7||0
11313243|NCT02677844|12512134|FG001|COMPLETED|Period 7||0
11313244|NCT02677844|12512135|FG002|COMPLETED|Period 7||0
11313245|NCT02677844|12512136|FG003|COMPLETED|Period 7||0
11313246|NCT02677844|12512137|FG004|COMPLETED|Period 7||7
11313247|NCT02677844|12512138|FG005|COMPLETED|Period 7||4
11313248|NCT02677844|12512139|FG006|COMPLETED|Period 7||4
11313249|NCT02677844|12512133|FG000|NOT COMPLETED|Period 7||0
11313250|NCT02677844|12512134|FG001|NOT COMPLETED|Period 7||0
11313251|NCT02677844|12512135|FG002|NOT COMPLETED|Period 7||0
11313252|NCT02677844|12512136|FG003|NOT COMPLETED|Period 7||0
11313253|NCT02677844|12512137|FG004|NOT COMPLETED|Period 7||0
11313254|NCT02677844|12512138|FG005|NOT COMPLETED|Period 7||0
11313255|NCT02677844|12512139|FG006|NOT COMPLETED|Period 7||0
11313256|NCT02678000|12512163|FG000|STARTED|PART 1||7
11313257|NCT02678000|12512164|FG001|STARTED|PART 1||4
11313258|NCT02678000|12512165|FG002|STARTED|PART 1||0
11313259|NCT02678000|12512166|FG003|STARTED|PART 1||0
11313260|NCT02678000|12512167|FG004|STARTED|PART 1||0
11313261|NCT02678000|12512163|FG000|COMPLETED|PART 1||7
11313262|NCT02678000|12512164|FG001|COMPLETED|PART 1||4
11313263|NCT02678000|12512165|FG002|COMPLETED|PART 1||0
11313264|NCT02678000|12512166|FG003|COMPLETED|PART 1||0
11313265|NCT02678000|12512167|FG004|COMPLETED|PART 1||0
11313266|NCT02678000|12512163|FG000|NOT COMPLETED|PART 1||0
11313267|NCT02678000|12512164|FG001|NOT COMPLETED|PART 1||0
11313268|NCT02678000|12512165|FG002|NOT COMPLETED|PART 1||0
11313269|NCT02678000|12512166|FG003|NOT COMPLETED|PART 1||0
11313270|NCT02678000|12512167|FG004|NOT COMPLETED|PART 1||0
11313271|NCT02678000|12512163|FG000|STARTED|PART 2||0
11313272|NCT02678000|12512164|FG001|STARTED|PART 2||0
11313273|NCT02678000|12512165|FG002|STARTED|PART 2||28
11313274|NCT02678000|12512166|FG003|STARTED|PART 2||27
11313275|NCT02678000|12512167|FG004|STARTED|PART 2||18
11313276|NCT02678000|12512163|FG000|COMPLETED|PART 2||0
11313277|NCT02678000|12512164|FG001|COMPLETED|PART 2||0
11313278|NCT02678000|12512165|FG002|COMPLETED|PART 2||25
11313279|NCT02678000|12512166|FG003|COMPLETED|PART 2||26
11313280|NCT02678000|12512167|FG004|COMPLETED|PART 2||18
11313281|NCT02678000|12512163|FG000|NOT COMPLETED|PART 2||0
11313282|NCT02678000|12512164|FG001|NOT COMPLETED|PART 2||0
11313283|NCT02678000|12512165|FG002|NOT COMPLETED|PART 2||3
11313284|NCT02678000|12512166|FG003|NOT COMPLETED|PART 2||1
11313285|NCT02678000|12512167|FG004|NOT COMPLETED|PART 2||0
11313286|NCT02678039|12512194|FG000|STARTED|Overall Study||53
11313287|NCT02678039|12512195|FG001|STARTED|Overall Study||47
11313288|NCT02678039|12512194|FG000|COMPLETED|Overall Study||53
11313289|NCT02678039|12512195|FG001|COMPLETED|Overall Study||47
11313290|NCT02678039|12512194|FG000|NOT COMPLETED|Overall Study||0
11313291|NCT02678039|12512195|FG001|NOT COMPLETED|Overall Study||0
11313292|NCT02678247|12512203|FG000|STARTED|First Intervention (7 Weeks)||15
11313293|NCT02678247|12512204|FG001|STARTED|First Intervention (7 Weeks)||15
11313294|NCT02678247|12512203|FG000|COMPLETED|First Intervention (7 Weeks)||13
11313295|NCT02678247|12512204|FG001|COMPLETED|First Intervention (7 Weeks)||11
11313296|NCT02678247|12512203|FG000|NOT COMPLETED|First Intervention (7 Weeks)||2
11313297|NCT02678247|12512204|FG001|NOT COMPLETED|First Intervention (7 Weeks)||4
11313298|NCT02678247|12512203|FG000|STARTED|Second Intervention (7 Weeks)|One subject crossed over despite not completing all data collection time points for the preceding socket.|14
11313299|NCT02678247|12512204|FG001|STARTED|Second Intervention (7 Weeks)||11
11313300|NCT02678247|12512203|FG000|COMPLETED|Second Intervention (7 Weeks)||10
11313301|NCT02678247|12512204|FG001|COMPLETED|Second Intervention (7 Weeks)||9
11313302|NCT02678247|12512203|FG000|NOT COMPLETED|Second Intervention (7 Weeks)||4
11313303|NCT02678247|12512204|FG001|NOT COMPLETED|Second Intervention (7 Weeks)||2
11313304|NCT02678286|12512217|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
11313305|NCT02678286|12512218|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
11313306|NCT02678286|12512217|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
11313307|NCT02678286|12512218|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
11313308|NCT02678286|12512217|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
11313309|NCT02678286|12512218|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
11313310|NCT02678286|12512217|FG000|STARTED|Study Overall (28 Day Follow-Up)||110
11313311|NCT02678286|12512218|FG001|STARTED|Study Overall (28 Day Follow-Up)||109
11313312|NCT02678286|12512217|FG000|COMPLETED|Study Overall (28 Day Follow-Up)||104
11313313|NCT02678286|12512218|FG001|COMPLETED|Study Overall (28 Day Follow-Up)||105
11313314|NCT02678286|12512217|FG000|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
11313315|NCT02678286|12512218|FG001|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
11313316|NCT02678390|12512226|FG000|STARTED|Control (5 Days)||10
11313317|NCT02678390|12512227|FG001|STARTED|Control (5 Days)||10
11313318|NCT02678390|12512226|FG000|COMPLETED|Control (5 Days)||10
11313319|NCT02678390|12512227|FG001|COMPLETED|Control (5 Days)||10
11313320|NCT02678390|12512226|FG000|NOT COMPLETED|Control (5 Days)||0
11313321|NCT02678390|12512227|FG001|NOT COMPLETED|Control (5 Days)||0
11313322|NCT02678390|12512226|FG000|STARTED|MCT (5 Days)||10
11313323|NCT02678390|12512227|FG001|STARTED|MCT (5 Days)||10
11313324|NCT02678390|12512226|FG000|COMPLETED|MCT (5 Days)||10
11313325|NCT02678390|12512227|FG001|COMPLETED|MCT (5 Days)||10
11313326|NCT02678390|12512226|FG000|NOT COMPLETED|MCT (5 Days)||0
11313327|NCT02678390|12512227|FG001|NOT COMPLETED|MCT (5 Days)||0
11313328|NCT02678390|12512226|FG000|STARTED|AE (1 Day)||10
11313329|NCT02678390|12512227|FG001|STARTED|AE (1 Day)||10
11313330|NCT02678390|12512226|FG000|COMPLETED|AE (1 Day)||10
11313331|NCT02678390|12512227|FG001|COMPLETED|AE (1 Day)||9
11313332|NCT02678390|12512226|FG000|NOT COMPLETED|AE (1 Day)||0
11313333|NCT02678390|12512227|FG001|NOT COMPLETED|AE (1 Day)||1
11313334|NCT02678390|12512226|FG000|STARTED|MCT + AE (5 Days)||10
11313335|NCT02678390|12512227|FG001|STARTED|MCT + AE (5 Days)||9
11313336|NCT02678390|12512226|FG000|COMPLETED|MCT + AE (5 Days)||10
11313337|NCT02678390|12512227|FG001|COMPLETED|MCT + AE (5 Days)||9
11313338|NCT02678390|12512226|FG000|NOT COMPLETED|MCT + AE (5 Days)||0
11313339|NCT02678390|12512227|FG001|NOT COMPLETED|MCT + AE (5 Days)||0
11313340|NCT02678416|12512235|FG000|STARTED|Part 1||12
11313341|NCT02678416|12512235|FG000|Safety Population|Part 1||12
11313342|NCT02678416|12512235|FG000|Modified Intent to Treat (mITT)|Part 1||12
11313343|NCT02678416|12512235|FG000|Per Protocol Population|Part 1||8
11313344|NCT02678416|12512235|FG000|COMPLETED|Part 1||11
11313345|NCT02678416|12512235|FG000|NOT COMPLETED|Part 1||1
11313346|NCT02678416|12512235|FG000|STARTED|Part 2|Part 2 enrolled all new participants|67
11313347|NCT02678416|12512235|FG000|Treated (Safety Population)|Part 2||66
11313348|NCT02678416|12512235|FG000|Modified Intent to Treat Population|Part 2||66
11313349|NCT02678416|12512235|FG000|Pharmacokinetic Population|Part 2||65
11313350|NCT02678416|12512235|FG000|Per Protocol Population|Part 2||64
11313351|NCT02678416|12512235|FG000|COMPLETED|Part 2||64
11313352|NCT02678416|12512235|FG000|NOT COMPLETED|Part 2||3
11313353|NCT02678442|12512255|FG000|STARTED|First Intervention||25
11313354|NCT02678442|12512256|FG001|STARTED|First Intervention||25
11313355|NCT02678442|12512255|FG000|COMPLETED|First Intervention||25
11313356|NCT02678442|12512256|FG001|COMPLETED|First Intervention||25
11313357|NCT02678442|12512255|FG000|NOT COMPLETED|First Intervention||0
11313358|NCT02678442|12512256|FG001|NOT COMPLETED|First Intervention||0
11313359|NCT02678442|12512255|FG000|STARTED|Second Intervention||25
11313360|NCT02678442|12512256|FG001|STARTED|Second Intervention||25
11313361|NCT02678442|12512255|FG000|COMPLETED|Second Intervention||23
11313362|NCT02678442|12512256|FG001|COMPLETED|Second Intervention||23
11313363|NCT02678442|12512255|FG000|NOT COMPLETED|Second Intervention||2
11313364|NCT02678442|12512256|FG001|NOT COMPLETED|Second Intervention||2
11313365|NCT02678676|12512264|FG000|STARTED|Overall Study||1820
11313366|NCT02678676|12512265|FG001|STARTED|Overall Study||1779
11313367|NCT02678676|12512264|FG000|COMPLETED|Overall Study||932
11313368|NCT02678676|12512265|FG001|COMPLETED|Overall Study||907
11313369|NCT02678676|12512264|FG000|NOT COMPLETED|Overall Study||888
11313370|NCT02678676|12512265|FG001|NOT COMPLETED|Overall Study||872
11313371|NCT02678923|12512273|FG000|STARTED|Overall Study||59
11313372|NCT02678923|12512274|FG001|STARTED|Overall Study||67
11313373|NCT02678923|12512273|FG000|Received at Least 1 Dose of Study Drug|Overall Study||58
11313374|NCT02678923|12512274|FG001|Received at Least 1 Dose of Study Drug|Overall Study||64
11313375|NCT02678923|12512273|FG000|mITT Population|Overall Study||52
11313376|NCT02678923|12512274|FG001|mITT Population|Overall Study||61
11313377|NCT02678923|12512273|FG000|COMPLETED|Overall Study||53
11402120|NCT04055519|12596965|FG001|STARTED|First Wear Period (30 Days)||20
11402121|NCT04055519|12596964|FG000|COMPLETED|First Wear Period (30 Days)||16
11402122|NCT04055519|12596965|FG001|COMPLETED|First Wear Period (30 Days)||20
11402123|NCT04055519|12596964|FG000|NOT COMPLETED|First Wear Period (30 Days)||0
11402124|NCT04055519|12596965|FG001|NOT COMPLETED|First Wear Period (30 Days)||0
11402125|NCT04055519|12596964|FG000|STARTED|Second Wear Period (30 Days)||16
11402126|NCT04055519|12596965|FG001|STARTED|Second Wear Period (30 Days)||20
11402127|NCT04055519|12596964|FG000|COMPLETED|Second Wear Period (30 Days)||16
11402128|NCT04055519|12596965|FG001|COMPLETED|Second Wear Period (30 Days)||20
11402129|NCT04055519|12596964|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0
11313378|NCT02678923|12512274|FG001|COMPLETED|Overall Study||62
11313379|NCT02678923|12512273|FG000|NOT COMPLETED|Overall Study||6
11313380|NCT02678923|12512274|FG001|NOT COMPLETED|Overall Study||5
11313381|NCT02679079|12512283|FG000|STARTED|Overall Study||33
11313382|NCT02679079|12512284|FG001|STARTED|Overall Study||32
11313383|NCT02679079|12512285|FG002|STARTED|Overall Study||33
11313384|NCT02679079|12512283|FG000|ITT Analysis Set|Overall Study||31
11313385|NCT02679079|12512284|FG001|ITT Analysis Set|Overall Study||32
11313386|NCT02679079|12512285|FG002|ITT Analysis Set|Overall Study||32
11313387|NCT02679079|12512283|FG000|COMPLETED|Overall Study||29
11313388|NCT02679079|12512284|FG001|COMPLETED|Overall Study||30
11313389|NCT02679079|12512285|FG002|COMPLETED|Overall Study||31
11313390|NCT02679079|12512283|FG000|NOT COMPLETED|Overall Study||4
11313391|NCT02679079|12512284|FG001|NOT COMPLETED|Overall Study||2
11313392|NCT02679079|12512285|FG002|NOT COMPLETED|Overall Study||2
11313393|NCT02679222|12512293|FG000|STARTED|Overall Study||10
11313394|NCT02679222|12512293|FG000|COMPLETED|Overall Study||9
11313395|NCT02679222|12512293|FG000|NOT COMPLETED|Overall Study||1
11313396|NCT02679235|12512305|FG000|STARTED|Overall Study||15
11313397|NCT02679235|12512305|FG000|COMPLETED|Overall Study||11
11313398|NCT02679235|12512305|FG000|NOT COMPLETED|Overall Study||4
11313399|NCT02679274|12512311|FG000|STARTED|Overall Study||2
11313400|NCT02679274|12512312|FG001|STARTED|Overall Study||1
11313401|NCT02679274|12512311|FG000|COMPLETED|Overall Study||1
11313402|NCT02679274|12512312|FG001|COMPLETED|Overall Study||1
11313403|NCT02679274|12512311|FG000|NOT COMPLETED|Overall Study||1
11402130|NCT04055519|12596965|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0
11402131|NCT04055675|12596976|FG000|STARTED|Overall Study||96
11402132|NCT04055675|12596977|FG001|STARTED|Overall Study||104
11313404|NCT02679274|12512312|FG001|NOT COMPLETED|Overall Study||0
11313405|NCT02679287|12512320|FG000|STARTED|Period 1: Randomization-Study Session 1||47
11313406|NCT02679287|12512321|FG001|STARTED|Period 1: Randomization-Study Session 1||46
11313407|NCT02679287|12512320|FG000|COMPLETED|Period 1: Randomization-Study Session 1||43
11313408|NCT02679287|12512321|FG001|COMPLETED|Period 1: Randomization-Study Session 1||40
11313409|NCT02679287|12512320|FG000|NOT COMPLETED|Period 1: Randomization-Study Session 1||4
11313410|NCT02679287|12512321|FG001|NOT COMPLETED|Period 1: Randomization-Study Session 1||6
11313411|NCT02679287|12512320|FG000|STARTED|Period 2||43
11313412|NCT02679287|12512321|FG001|STARTED|Period 2||40
11313413|NCT02679287|12512320|FG000|COMPLETED|Period 2||40
11313414|NCT02679287|12512321|FG001|COMPLETED|Period 2||40
11313415|NCT02679287|12512320|FG000|NOT COMPLETED|Period 2||3
11313416|NCT02679287|12512321|FG001|NOT COMPLETED|Period 2||0
11313417|NCT02679287|12512320|FG000|STARTED|Period 3||40
11313418|NCT02679287|12512321|FG001|STARTED|Period 3||40
11313419|NCT02679287|12512320|FG000|COMPLETED|Period 3||40
11313420|NCT02679287|12512321|FG001|COMPLETED|Period 3||39
11313421|NCT02679287|12512320|FG000|NOT COMPLETED|Period 3||0
11313422|NCT02679287|12512321|FG001|NOT COMPLETED|Period 3||1
11313423|NCT02679287|12512320|FG000|STARTED|Phase 4||40
11313424|NCT02679287|12512321|FG001|STARTED|Phase 4||39
11313425|NCT02679287|12512320|FG000|COMPLETED|Phase 4||40
11313426|NCT02679287|12512321|FG001|COMPLETED|Phase 4||39
11313427|NCT02679287|12512320|FG000|NOT COMPLETED|Phase 4||0
11313428|NCT02679287|12512321|FG001|NOT COMPLETED|Phase 4||0
11313429|NCT02679469|12512333|FG000|STARTED|Overall Study||7
11313430|NCT02679469|12512333|FG000|COMPLETED|Overall Study||7
11313431|NCT02679469|12512333|FG000|NOT COMPLETED|Overall Study||0
11313432|NCT02679573|12512339|FG000|STARTED|Overall Study||431
11313433|NCT02679573|12512340|FG001|STARTED|Overall Study||428
11313434|NCT02679573|12512339|FG000|COMPLETED|Overall Study||394
11313435|NCT02679573|12512340|FG001|COMPLETED|Overall Study||389
11313436|NCT02679573|12512339|FG000|NOT COMPLETED|Overall Study||37
11313437|NCT02679573|12512340|FG001|NOT COMPLETED|Overall Study||39
11313438|NCT02679690|12512346|FG000|STARTED|Overall Study||10
11313439|NCT02679690|12512346|FG000|COMPLETED|Overall Study||9
11313440|NCT02679690|12512346|FG000|NOT COMPLETED|Overall Study||1
11313441|NCT02679729|12512361|FG000|STARTED|Overall Study||6
11313442|NCT02679729|12512362|FG001|STARTED|Overall Study||7
11313443|NCT02679729|12512363|FG002|STARTED|Overall Study||6
11313444|NCT02679729|12512364|FG003|STARTED|Overall Study||6
11313445|NCT02679729|12512365|FG004|STARTED|Overall Study||6
11313446|NCT02679729|12512366|FG005|STARTED|Overall Study||6
11313447|NCT02679729|12512367|FG006|STARTED|Overall Study||6
11313448|NCT02679729|12512368|FG007|STARTED|Overall Study||14
11313449|NCT02679729|12512369|FG008|STARTED|Overall Study||6
11313450|NCT02679729|12512361|FG000|COMPLETED|Overall Study||6
11313451|NCT02679729|12512362|FG001|COMPLETED|Overall Study||5
11313452|NCT02679729|12512363|FG002|COMPLETED|Overall Study||6
11313453|NCT02679729|12512364|FG003|COMPLETED|Overall Study||6
11313454|NCT02679729|12512365|FG004|COMPLETED|Overall Study||5
11313455|NCT02679729|12512366|FG005|COMPLETED|Overall Study||6
11313456|NCT02679729|12512367|FG006|COMPLETED|Overall Study||5
11313457|NCT02679729|12512368|FG007|COMPLETED|Overall Study||14
11313458|NCT02679729|12512369|FG008|COMPLETED|Overall Study||6
11313459|NCT02679729|12512361|FG000|NOT COMPLETED|Overall Study||0
11313460|NCT02679729|12512362|FG001|NOT COMPLETED|Overall Study||2
11313461|NCT02679729|12512363|FG002|NOT COMPLETED|Overall Study||0
11313462|NCT02679729|12512364|FG003|NOT COMPLETED|Overall Study||0
11313463|NCT02679729|12512365|FG004|NOT COMPLETED|Overall Study||1
11313464|NCT02679729|12512366|FG005|NOT COMPLETED|Overall Study||0
11313465|NCT02679729|12512367|FG006|NOT COMPLETED|Overall Study||1
11313466|NCT02679729|12512368|FG007|NOT COMPLETED|Overall Study||0
11313467|NCT02679729|12512369|FG008|NOT COMPLETED|Overall Study||0
11313468|NCT02679807|12512403|FG000|STARTED|Overall Study||165
11313469|NCT02679807|12512404|FG001|STARTED|Overall Study||169
11313470|NCT02679807|12512403|FG000|COMPLETED|Overall Study||143
11313471|NCT02679807|12512404|FG001|COMPLETED|Overall Study||153
11313472|NCT02679807|12512403|FG000|NOT COMPLETED|Overall Study||22
11402133|NCT04055675|12596976|FG000|COMPLETED|Overall Study||96
11402134|NCT04055675|12596977|FG001|COMPLETED|Overall Study||104
11402135|NCT04055675|12596976|FG000|NOT COMPLETED|Overall Study||0
11402136|NCT04055675|12596977|FG001|NOT COMPLETED|Overall Study||0
11402137|NCT04054765|12596985|FG000|STARTED|Baseline||155
11313473|NCT02679807|12512404|FG001|NOT COMPLETED|Overall Study||16
11313474|NCT02679911|12512410|FG000|STARTED|Overall Study|Intra-individual study|20
11313475|NCT02679911|12512410|FG000|COMPLETED|Overall Study||20
11313476|NCT02679911|12512410|FG000|NOT COMPLETED|Overall Study||0
11313477|NCT02679976|12512415|FG000|STARTED|Overall Study||30
11313478|NCT02679976|12512415|FG000|Hyperopes|Overall Study||16
11313479|NCT02679976|12512415|FG000|Myopes|Overall Study||14
11313480|NCT02679976|12512415|FG000|COMPLETED|Overall Study||30
11313481|NCT02679976|12512415|FG000|NOT COMPLETED|Overall Study||0
11313482|NCT02680002|12512426|FG000|STARTED|Overall Study||71
11313483|NCT02680002|12512427|FG001|STARTED|Overall Study||70
11313484|NCT02680002|12512428|FG002|STARTED|Overall Study||70
11313485|NCT02680002|12512429|FG003|STARTED|Overall Study||71
11313486|NCT02680002|12512430|FG004|STARTED|Overall Study||70
11313487|NCT02680002|12512431|FG005|STARTED|Overall Study||70
11402138|NCT04054765|12596986|FG001|STARTED|Baseline||132
11402139|NCT04054765|12596985|FG000|COMPLETED|Baseline||150
11402140|NCT04054765|12596986|FG001|COMPLETED|Baseline||129
11313488|NCT02680002|12512426|FG000|Day 0 (Dose 1)|Overall Study||70
11313489|NCT02680002|12512427|FG001|Day 0 (Dose 1)|Overall Study||70
11313490|NCT02680002|12512428|FG002|Day 0 (Dose 1)|Overall Study||70
11313491|NCT02680002|12512429|FG003|Day 0 (Dose 1)|Overall Study||71
11313492|NCT02680002|12512430|FG004|Day 0 (Dose 1)|Overall Study||70
11313493|NCT02680002|12512431|FG005|Day 0 (Dose 1)|Overall Study||68
11313494|NCT02680002|12512426|FG000|Day 21 (Dose 2)|Overall Study||63
11313495|NCT02680002|12512427|FG001|Day 21 (Dose 2)|Overall Study||68
11313496|NCT02680002|12512428|FG002|Day 21 (Dose 2)|Overall Study||65
11313497|NCT02680002|12512429|FG003|Day 21 (Dose 2)|Overall Study||69
11313498|NCT02680002|12512430|FG004|Day 21 (Dose 2)|Overall Study||65
11313499|NCT02680002|12512431|FG005|Day 21 (Dose 2)|Overall Study||63
11313500|NCT02680002|12512426|FG000|Day 201|Overall Study||58
11313501|NCT02680002|12512427|FG001|Day 201|Overall Study||66
11313502|NCT02680002|12512428|FG002|Day 201|Overall Study||60
11313503|NCT02680002|12512429|FG003|Day 201|Overall Study||67
11313504|NCT02680002|12512430|FG004|Day 201|Overall Study||59
11313505|NCT02680002|12512431|FG005|Day 201|Overall Study||61
11313506|NCT02680002|12512426|FG000|COMPLETED|Overall Study||58
11313507|NCT02680002|12512427|FG001|COMPLETED|Overall Study||66
11313508|NCT02680002|12512428|FG002|COMPLETED|Overall Study||60
11313509|NCT02680002|12512429|FG003|COMPLETED|Overall Study||67
11313510|NCT02680002|12512430|FG004|COMPLETED|Overall Study||59
11313511|NCT02680002|12512431|FG005|COMPLETED|Overall Study||61
11313512|NCT02680002|12512426|FG000|NOT COMPLETED|Overall Study||13
11313513|NCT02680002|12512427|FG001|NOT COMPLETED|Overall Study||4
11313514|NCT02680002|12512428|FG002|NOT COMPLETED|Overall Study||10
11313515|NCT02680002|12512429|FG003|NOT COMPLETED|Overall Study||4
11313516|NCT02680002|12512430|FG004|NOT COMPLETED|Overall Study||11
11313517|NCT02680002|12512431|FG005|NOT COMPLETED|Overall Study||9
11313518|NCT02680041|12512448|FG000|STARTED|Overall Study||221
11313519|NCT02680041|12512448|FG000|Received 18F-fluciclovine|Overall Study||213
11313520|NCT02680041|12512448|FG000|COMPLETED|Overall Study||211
11313521|NCT02680041|12512448|FG000|NOT COMPLETED|Overall Study||10
11313522|NCT02680054|12512453|FG000|STARTED|Overall Study||38
11313523|NCT02680054|12512453|FG000|COMPLETED|Overall Study||27
11313524|NCT02680054|12512453|FG000|NOT COMPLETED|Overall Study||11
11313525|NCT02680145|12512462|FG000|STARTED|Overall Study||58
11313526|NCT02680145|12512462|FG000|COMPLETED|Overall Study||47
11313527|NCT02680145|12512462|FG000|NOT COMPLETED|Overall Study||11
11313528|NCT02680158|12512466|FG000|STARTED|Overall Study||8
11313529|NCT02680158|12512467|FG001|STARTED|Overall Study||8
11313530|NCT02680158|12512468|FG002|STARTED|Overall Study||8
11313531|NCT02680158|12512469|FG003|STARTED|Overall Study||8
11313532|NCT02680158|12512470|FG004|STARTED|Overall Study||8
11313533|NCT02680158|12512471|FG005|STARTED|Overall Study||8
11313534|NCT02680158|12512466|FG000|COMPLETED|Overall Study||8
11313535|NCT02680158|12512467|FG001|COMPLETED|Overall Study||8
11313536|NCT02680158|12512468|FG002|COMPLETED|Overall Study||8
11313537|NCT02680158|12512469|FG003|COMPLETED|Overall Study||8
11313538|NCT02680158|12512470|FG004|COMPLETED|Overall Study||8
11313539|NCT02680158|12512471|FG005|COMPLETED|Overall Study||8
11313540|NCT02680158|12512466|FG000|NOT COMPLETED|Overall Study||0
11313541|NCT02680158|12512467|FG001|NOT COMPLETED|Overall Study||0
11313542|NCT02680158|12512468|FG002|NOT COMPLETED|Overall Study||0
11313543|NCT02680158|12512469|FG003|NOT COMPLETED|Overall Study||0
11313544|NCT02680158|12512470|FG004|NOT COMPLETED|Overall Study||0
11313545|NCT02680158|12512471|FG005|NOT COMPLETED|Overall Study||0
11313546|NCT02680301|12512481|FG000|STARTED|Overall Study||22
11313547|NCT02680301|12512482|FG001|STARTED|Overall Study||18
11313548|NCT02680301|12512481|FG000|COMPLETED|Overall Study||22
11313549|NCT02680301|12512482|FG001|COMPLETED|Overall Study||17
11313550|NCT02680301|12512481|FG000|NOT COMPLETED|Overall Study||0
11313551|NCT02680301|12512482|FG001|NOT COMPLETED|Overall Study||1
11313552|NCT02680457|12512489|FG000|STARTED|Initial Intervention||6
11313553|NCT02680457|12512490|FG001|STARTED|Initial Intervention||6
11313554|NCT02680457|12512489|FG000|COMPLETED|Initial Intervention||6
11313555|NCT02680457|12512490|FG001|COMPLETED|Initial Intervention||6
11313556|NCT02680457|12512489|FG000|NOT COMPLETED|Initial Intervention||0
11313557|NCT02680457|12512490|FG001|NOT COMPLETED|Initial Intervention||0
11313558|NCT02680457|12512489|FG000|STARTED|Washout Period||6
11313559|NCT02680457|12512490|FG001|STARTED|Washout Period||6
11313560|NCT02680457|12512489|FG000|COMPLETED|Washout Period||6
11313561|NCT02680457|12512490|FG001|COMPLETED|Washout Period||6
11313562|NCT02680457|12512489|FG000|NOT COMPLETED|Washout Period||0
11313563|NCT02680457|12512490|FG001|NOT COMPLETED|Washout Period||0
11313564|NCT02680457|12512489|FG000|STARTED|Cross-over Intervention||6
11313565|NCT02680457|12512490|FG001|STARTED|Cross-over Intervention||6
11313566|NCT02680457|12512489|FG000|COMPLETED|Cross-over Intervention||6
11313567|NCT02680457|12512490|FG001|COMPLETED|Cross-over Intervention||6
11313568|NCT02680457|12512489|FG000|NOT COMPLETED|Cross-over Intervention||0
11313569|NCT02680457|12512490|FG001|NOT COMPLETED|Cross-over Intervention||0
11313570|NCT02680639|12512496|FG000|STARTED|Screening Period||10
11313571|NCT02680639|12512497|FG001|STARTED|Screening Period||0
11313572|NCT02680639|12512498|FG002|STARTED|Screening Period||0
11313573|NCT02680639|12512496|FG000|COMPLETED|Screening Period||3
11313574|NCT02680639|12512497|FG001|COMPLETED|Screening Period||0
11313575|NCT02680639|12512498|FG002|COMPLETED|Screening Period||0
11313576|NCT02680639|12512496|FG000|NOT COMPLETED|Screening Period||7
11313577|NCT02680639|12512497|FG001|NOT COMPLETED|Screening Period||0
11313578|NCT02680639|12512498|FG002|NOT COMPLETED|Screening Period||0
11313579|NCT02680639|12512496|FG000|STARTED|High Frequency Oscillation (HFO) Therapy||0
11313580|NCT02680639|12512497|FG001|STARTED|High Frequency Oscillation (HFO) Therapy||2
11313581|NCT02680639|12512498|FG002|STARTED|High Frequency Oscillation (HFO) Therapy||1
11313582|NCT02680639|12512496|FG000|COMPLETED|High Frequency Oscillation (HFO) Therapy||0
11313583|NCT02680639|12512497|FG001|COMPLETED|High Frequency Oscillation (HFO) Therapy||2
11313584|NCT02680639|12512498|FG002|COMPLETED|High Frequency Oscillation (HFO) Therapy||1
11313585|NCT02680639|12512496|FG000|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
11313586|NCT02680639|12512497|FG001|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
11313587|NCT02680639|12512498|FG002|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
11313588|NCT02680665|12512508|FG000|STARTED|Overall Study||120
11313589|NCT02680665|12512508|FG000|COMPLETED|Overall Study||115
11313590|NCT02680665|12512508|FG000|NOT COMPLETED|Overall Study||5
11313591|NCT02680756|12512514|FG000|STARTED|Overall Study||125
11313592|NCT02680756|12512515|FG001|STARTED|Overall Study||125
11313593|NCT02680756|12512514|FG000|Received Treatment|Overall Study||127
11313594|NCT02680756|12512515|FG001|Received Treatment|Overall Study||120
11313595|NCT02680756|12512514|FG000|COMPLETED|Overall Study||93
11313596|NCT02680756|12512515|FG001|COMPLETED|Overall Study||106
11313597|NCT02680756|12512514|FG000|NOT COMPLETED|Overall Study||32
11313598|NCT02680756|12512515|FG001|NOT COMPLETED|Overall Study||19
11313599|NCT02680834|12512523|FG000|STARTED|Overall Study||26
11313600|NCT02680834|12512524|FG001|STARTED|Overall Study||30
11313601|NCT02680834|12512523|FG000|COMPLETED|Overall Study||15
11313602|NCT02680834|12512524|FG001|COMPLETED|Overall Study||27
11313603|NCT02680834|12512523|FG000|NOT COMPLETED|Overall Study||11
11313604|NCT02680834|12512524|FG001|NOT COMPLETED|Overall Study||3
11313605|NCT02680847|12512533|FG000|STARTED|Overall Study||16
11313606|NCT02680847|12512534|FG001|STARTED|Overall Study||9
11313607|NCT02680847|12512535|FG002|STARTED|Overall Study||7
11313608|NCT02680847|12512533|FG000|COMPLETED|Overall Study||11
11313609|NCT02680847|12512534|FG001|COMPLETED|Overall Study||6
11313610|NCT02680847|12512535|FG002|COMPLETED|Overall Study||4
11313611|NCT02680847|12512533|FG000|NOT COMPLETED|Overall Study||5
11313612|NCT02680847|12512534|FG001|NOT COMPLETED|Overall Study||3
11313613|NCT02680847|12512535|FG002|NOT COMPLETED|Overall Study||3
11313614|NCT02681094|12512546|FG000|STARTED|1 -Modified Enrolled Participants Set||293
11313615|NCT02681094|12512547|FG001|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
11313616|NCT02681094|12512548|FG002|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
11313617|NCT02681094|12512546|FG000|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
11313618|NCT02681094|12512547|FG001|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
11313619|NCT02681094|12512548|FG002|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
11313620|NCT02681094|12512546|FG000|COMPLETED|1 -Modified Enrolled Participants Set||256
11313621|NCT02681094|12512547|FG001|COMPLETED|1 -Modified Enrolled Participants Set||255
11313622|NCT02681094|12512548|FG002|COMPLETED|1 -Modified Enrolled Participants Set||243
11313623|NCT02681094|12512546|FG000|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
11313624|NCT02681094|12512547|FG001|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
11313625|NCT02681094|12512548|FG002|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
11313626|NCT02681094|12512546|FG000|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
11313627|NCT02681094|12512547|FG001|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
11313628|NCT02681094|12512548|FG002|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
11313629|NCT02681094|12512546|FG000|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
11313630|NCT02681094|12512547|FG001|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
11313631|NCT02681094|12512548|FG002|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
11313632|NCT02681094|12512546|FG000|COMPLETED|2 - Enrolled Participants Set||261
11313633|NCT02681094|12512547|FG001|COMPLETED|2 - Enrolled Participants Set||261
11313634|NCT02681094|12512548|FG002|COMPLETED|2 - Enrolled Participants Set||248
11313635|NCT02681094|12512546|FG000|NOT COMPLETED|2 - Enrolled Participants Set||40
11313636|NCT02681094|12512547|FG001|NOT COMPLETED|2 - Enrolled Participants Set||41
11313637|NCT02681094|12512548|FG002|NOT COMPLETED|2 - Enrolled Participants Set||54
11313638|NCT02681172|12512557|FG000|STARTED|Overall Study||218
11313639|NCT02681172|12512557|FG000|Safety Analysis Set|Overall Study||205
11313640|NCT02681172|12512557|FG000|Full Analysis Set|Overall Study||205
11313641|NCT02681172|12512557|FG000|Per Protocol Set|Overall Study||205
11313642|NCT02681172|12512557|FG000|COMPLETED|Overall Study||205
11313643|NCT02681172|12512557|FG000|NOT COMPLETED|Overall Study||13
11313644|NCT02681458|12512563|FG000|STARTED|Overall Study||718
11313645|NCT02681458|12512564|FG001|STARTED|Overall Study||718
11313646|NCT02681458|12512563|FG000|COMPLETED|Overall Study||73
11313647|NCT02681458|12512564|FG001|COMPLETED|Overall Study||62
11313648|NCT02681458|12512563|FG000|NOT COMPLETED|Overall Study||645
11313649|NCT02681458|12512564|FG001|NOT COMPLETED|Overall Study||656
11313650|NCT02681510|12512570|FG000|STARTED|Overall Study||36
11313651|NCT02681510|12512570|FG000|COMPLETED|Overall Study||26
11313652|NCT02681510|12512570|FG000|NOT COMPLETED|Overall Study||10
11313653|NCT02681523|12512574|FG000|STARTED|Overall Study||8
11313654|NCT02681523|12512574|FG000|COMPLETED|Overall Study||6
11313655|NCT02681523|12512574|FG000|NOT COMPLETED|Overall Study||2
11313656|NCT02681757|12512580|FG000|STARTED|Overall Study||47
11313657|NCT02681757|12512581|FG001|STARTED|Overall Study||49
11313658|NCT02681757|12512580|FG000|COMPLETED|Overall Study||47
11313659|NCT02681757|12512581|FG001|COMPLETED|Overall Study||49
11313660|NCT02681757|12512580|FG000|NOT COMPLETED|Overall Study||0
11313661|NCT02681757|12512581|FG001|NOT COMPLETED|Overall Study||0
11313662|NCT02681809|12512590|FG000|STARTED|Overall Study||20
11313663|NCT02681809|12512591|FG001|STARTED|Overall Study||19
11313664|NCT02681809|12512592|FG002|STARTED|Overall Study||9
11313665|NCT02681809|12512590|FG000|COMPLETED|Overall Study||15
11313666|NCT02681809|12512591|FG001|COMPLETED|Overall Study||15
11313667|NCT02681809|12512592|FG002|COMPLETED|Overall Study||8
11313668|NCT02681809|12512590|FG000|NOT COMPLETED|Overall Study||5
11313669|NCT02681809|12512591|FG001|NOT COMPLETED|Overall Study||4
11313670|NCT02681809|12512592|FG002|NOT COMPLETED|Overall Study||1
11313671|NCT02682030|12512602|FG000|STARTED|Overall Study||1
11313672|NCT02682030|12512603|FG001|STARTED|Overall Study||4
11313673|NCT02682030|12512602|FG000|COMPLETED|Overall Study||0
11313674|NCT02682030|12512603|FG001|COMPLETED|Overall Study||2
11313675|NCT02682030|12512602|FG000|NOT COMPLETED|Overall Study||1
11313676|NCT02682030|12512603|FG001|NOT COMPLETED|Overall Study||2
11313677|NCT02682056|12512610|FG000|STARTED|Overall Study||15
11313678|NCT02682056|12512610|FG000|COMPLETED|Overall Study||15
11313679|NCT02682056|12512610|FG000|NOT COMPLETED|Overall Study||0
11313680|NCT02682069|12512618|FG000|STARTED|Overall Study||30
11313681|NCT02682069|12512618|FG000|COMPLETED|Overall Study||30
11313682|NCT02682069|12512618|FG000|NOT COMPLETED|Overall Study||0
11342288|NCT02943447|12539827|FG000|NOT COMPLETED|Open-Label Extension Phase||18
11342289|NCT02943447|12539828|FG001|NOT COMPLETED|Open-Label Extension Phase||25
11342290|NCT02943447|12539829|FG002|NOT COMPLETED|Open-Label Extension Phase||10
11342291|NCT02943460|12539849|FG000|STARTED|Blinded Study Phase||22
11342292|NCT02943460|12539850|FG001|STARTED|Blinded Study Phase||20
11342293|NCT02943460|12539851|FG002|STARTED|Blinded Study Phase||10
11342294|NCT02943460|12539849|FG000|COMPLETED|Blinded Study Phase||19
11342295|NCT02943460|12539850|FG001|COMPLETED|Blinded Study Phase||19
11342296|NCT02943460|12539851|FG002|COMPLETED|Blinded Study Phase||10
11342297|NCT02943460|12539849|FG000|NOT COMPLETED|Blinded Study Phase||3
11342298|NCT02943460|12539850|FG001|NOT COMPLETED|Blinded Study Phase||1
11342299|NCT02943460|12539851|FG002|NOT COMPLETED|Blinded Study Phase||0
11342300|NCT02943460|12539849|FG000|STARTED|Open Label Extension (OLE) Phase||19
11342301|NCT02943460|12539850|FG001|STARTED|Open Label Extension (OLE) Phase|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18
11342302|NCT02943460|12539851|FG002|STARTED|Open Label Extension (OLE) Phase||10
11022226|NCT00808236|12200499|FG001|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
11022227|NCT00808236|12200498|FG000|COMPLETED|Overall Study||14
11022228|NCT00808236|12200499|FG001|COMPLETED|Overall Study||13
11022229|NCT00808236|12200498|FG000|NOT COMPLETED|Overall Study||82
11022230|NCT00808236|12200499|FG001|NOT COMPLETED|Overall Study||91
11022231|NCT00808249|12200509|FG000|STARTED|Overall Study||107
11022232|NCT00808249|12200510|FG001|STARTED|Overall Study||106
11022233|NCT00808249|12200511|FG002|STARTED|Overall Study||105
11022234|NCT00808249|12200512|FG003|STARTED|Overall Study||106
11022235|NCT00808249|12200509|FG000|COMPLETED|Overall Study||90
11342303|NCT02943460|12539849|FG000|COMPLETED|Open Label Extension (OLE) Phase||14
11342304|NCT02943460|12539850|FG001|COMPLETED|Open Label Extension (OLE) Phase||11
11342305|NCT02943460|12539851|FG002|COMPLETED|Open Label Extension (OLE) Phase||8
11342306|NCT02943460|12539849|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||5
11342307|NCT02943460|12539850|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||7
11342308|NCT02943460|12539851|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||2
11342309|NCT02943473|12539860|FG000|STARTED|Overall Study||9
11342310|NCT02943473|12539860|FG000|COMPLETED|Overall Study||3
11342311|NCT02943473|12539860|FG000|NOT COMPLETED|Overall Study||6
11342312|NCT02943499|12539866|FG000|STARTED|Overall Study||41
11342313|NCT02943499|12539867|FG001|STARTED|Overall Study||39
11342314|NCT02943499|12539866|FG000|COMPLETED|Overall Study||34
11342315|NCT02943499|12539867|FG001|COMPLETED|Overall Study||34
11342316|NCT02943499|12539866|FG000|NOT COMPLETED|Overall Study||7
11342317|NCT02943499|12539867|FG001|NOT COMPLETED|Overall Study||5
11342318|NCT02943564|12539876|FG000|STARTED|Overall Study||217
11342319|NCT02943564|12539877|FG001|STARTED|Overall Study||211
11342320|NCT02943564|12539878|FG002|STARTED|Overall Study||210
11342321|NCT02943564|12539876|FG000|Responder|Overall Study||83
11342322|NCT02943564|12539877|FG001|Responder|Overall Study||77
11342323|NCT02943564|12539878|FG002|Responder|Overall Study||77
11342324|NCT02943564|12539876|FG000|Non-Responder|Overall Study||134
11342325|NCT02943564|12539877|FG001|Non-Responder|Overall Study||134
11342326|NCT02943564|12539878|FG002|Non-Responder|Overall Study||133
11342327|NCT02943564|12539876|FG000|COMPLETED|Overall Study||207
11342328|NCT02943564|12539877|FG001|COMPLETED|Overall Study||198
11342329|NCT02943564|12539878|FG002|COMPLETED|Overall Study||201
11342330|NCT02943564|12539876|FG000|NOT COMPLETED|Overall Study||10
11342331|NCT02943564|12539877|FG001|NOT COMPLETED|Overall Study||13
11342332|NCT02943564|12539878|FG002|NOT COMPLETED|Overall Study||9
11343982|NCT02958267|12541287|FG001|6 Month Follow-up|Follow-up Visits||14
11343983|NCT02958267|12541286|FG000|12 Month Follow-up|Follow-up Visits||13
11343984|NCT02958267|12541287|FG001|12 Month Follow-up|Follow-up Visits||14
11343985|NCT02958267|12541286|FG000|COMPLETED|Follow-up Visits||13
11343986|NCT02958267|12541287|FG001|COMPLETED|Follow-up Visits||14
11343987|NCT02958267|12541286|FG000|NOT COMPLETED|Follow-up Visits||2
11343988|NCT02958267|12541287|FG001|NOT COMPLETED|Follow-up Visits||1
11343989|NCT02958345|12541295|FG000|STARTED|Overall Study||14
11343990|NCT02958345|12541296|FG001|STARTED|Overall Study||14
11343991|NCT02958345|12541295|FG000|COMPLETED|Overall Study||13
11343992|NCT02958345|12541296|FG001|COMPLETED|Overall Study||13
11343993|NCT02958345|12541295|FG000|NOT COMPLETED|Overall Study||1
11022236|NCT00808249|12200510|FG001|COMPLETED|Overall Study||91
11313683|NCT02682264|12512624|FG000|STARTED|Overall Study||317
11313684|NCT02682264|12512625|FG001|STARTED|Overall Study||290
11313685|NCT02682264|12512624|FG000|COMPLETED|Overall Study||179
11313686|NCT02682264|12512625|FG001|COMPLETED|Overall Study||168
11313687|NCT02682264|12512624|FG000|NOT COMPLETED|Overall Study||138
11313688|NCT02682264|12512625|FG001|NOT COMPLETED|Overall Study||122
11313689|NCT02682381|12512634|FG000|STARTED|Overall Study||24
11313690|NCT02682381|12512635|FG001|STARTED|Overall Study||26
11313691|NCT02682381|12512636|FG002|STARTED|Overall Study||9
11313692|NCT02682381|12512634|FG000|COMPLETED|Overall Study||24
11313693|NCT02682381|12512635|FG001|COMPLETED|Overall Study||26
11313694|NCT02682381|12512636|FG002|COMPLETED|Overall Study||9
11313695|NCT02682381|12512634|FG000|NOT COMPLETED|Overall Study||0
11313696|NCT02682381|12512635|FG001|NOT COMPLETED|Overall Study||0
11313697|NCT02682381|12512636|FG002|NOT COMPLETED|Overall Study||0
11313698|NCT02682420|12512644|FG000|STARTED|Overall Study||100
11313699|NCT02682420|12512644|FG000|COMPLETED|Overall Study|Note: 63 participants completed the 6-month visit. The study was discontinued prematurely due to company acquisition and therefore, many participants did not complete their 12-month visit.|63
11313700|NCT02682420|12512644|FG000|NOT COMPLETED|Overall Study||37
11313701|NCT02682498|12512657|FG000|STARTED|Overall Study||18
11313702|NCT02682498|12512658|FG001|STARTED|Overall Study||20
11313703|NCT02682498|12512657|FG000|COMPLETED|Overall Study||18
11313704|NCT02682498|12512658|FG001|COMPLETED|Overall Study||20
11313705|NCT02682498|12512657|FG000|NOT COMPLETED|Overall Study||0
11313706|NCT02682498|12512658|FG001|NOT COMPLETED|Overall Study||0
11313707|NCT02682563|12512667|FG000|STARTED|Overall Study||24
11313708|NCT02682563|12512668|FG001|STARTED|Overall Study||20
11313709|NCT02682563|12512667|FG000|COMPLETED|Overall Study||24
11313710|NCT02682563|12512668|FG001|COMPLETED|Overall Study||20
11313711|NCT02682563|12512667|FG000|NOT COMPLETED|Overall Study||0
11313712|NCT02682563|12512668|FG001|NOT COMPLETED|Overall Study||0
11313713|NCT02682602|12512676|FG000|STARTED|Pre-operative Diseased & Normal Hips||11
11313714|NCT02682602|12512677|FG001|STARTED|Pre-operative Diseased & Normal Hips||10
11313715|NCT02682602|12512676|FG000|COMPLETED|Pre-operative Diseased & Normal Hips||10
11313716|NCT02682602|12512677|FG001|COMPLETED|Pre-operative Diseased & Normal Hips||10
11313717|NCT02682602|12512676|FG000|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1
11313718|NCT02682602|12512677|FG001|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0
11313719|NCT02682602|12512676|FG000|STARTED|Post-operative Fluoroscopy for Implanted||10
11313720|NCT02682602|12512677|FG001|STARTED|Post-operative Fluoroscopy for Implanted||0
11313721|NCT02682602|12512676|FG000|COMPLETED|Post-operative Fluoroscopy for Implanted||7
11313722|NCT02682602|12512677|FG001|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0
11313723|NCT02682602|12512676|FG000|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3
11313724|NCT02682602|12512677|FG001|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0
11313725|NCT02682784|12512691|FG000|STARTED|Overall Study||40
11313726|NCT02682784|12512692|FG001|STARTED|Overall Study||37
11313727|NCT02682784|12512693|FG002|STARTED|Overall Study||29
11313728|NCT02682784|12512694|FG003|STARTED|Overall Study||32
11313729|NCT02682784|12512691|FG000|COMPLETED|Overall Study||39
11313730|NCT02682784|12512692|FG001|COMPLETED|Overall Study||35
11313731|NCT02682784|12512693|FG002|COMPLETED|Overall Study||27
11313732|NCT02682784|12512694|FG003|COMPLETED|Overall Study||29
11313733|NCT02682784|12512691|FG000|NOT COMPLETED|Overall Study||1
11313734|NCT02682784|12512692|FG001|NOT COMPLETED|Overall Study||2
11313735|NCT02682784|12512693|FG002|NOT COMPLETED|Overall Study||2
11313736|NCT02682784|12512694|FG003|NOT COMPLETED|Overall Study||3
11313737|NCT02682823|12512709|FG000|STARTED|Overall Study||17
11313738|NCT02682823|12512710|FG001|STARTED|Overall Study||19
11313739|NCT02682823|12512711|FG002|STARTED|Overall Study||19
11313740|NCT02682823|12512712|FG003|STARTED|Overall Study||17
11313741|NCT02682823|12512713|FG004|STARTED|Overall Study||19
11313742|NCT02682823|12512709|FG000|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17
11313743|NCT02682823|12512710|FG001|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19
11313744|NCT02682823|12512711|FG002|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18
11313745|NCT02682823|12512712|FG003|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17
11313746|NCT02682823|12512713|FG004|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19
11313747|NCT02682823|12512709|FG000|COMPLETED|Overall Study||17
11313748|NCT02682823|12512710|FG001|COMPLETED|Overall Study||18
11313749|NCT02682823|12512711|FG002|COMPLETED|Overall Study||18
11313750|NCT02682823|12512712|FG003|COMPLETED|Overall Study||16
11313751|NCT02682823|12512713|FG004|COMPLETED|Overall Study||18
11313752|NCT02682823|12512709|FG000|NOT COMPLETED|Overall Study||0
11313753|NCT02682823|12512710|FG001|NOT COMPLETED|Overall Study||1
11313754|NCT02682823|12512711|FG002|NOT COMPLETED|Overall Study||1
11313755|NCT02682823|12512712|FG003|NOT COMPLETED|Overall Study||1
11313756|NCT02682823|12512713|FG004|NOT COMPLETED|Overall Study||1
11313757|NCT02683083|12512725|FG000|STARTED|Overall Study||9
11313758|NCT02683083|12512725|FG000|COMPLETED|Overall Study||9
11313759|NCT02683083|12512725|FG000|NOT COMPLETED|Overall Study||0
11313760|NCT02683109|12512731|FG000|STARTED|Overall Study||110
11313761|NCT02683109|12512732|FG001|STARTED|Overall Study||111
11313762|NCT02683109|12512731|FG000|COMPLETED|Overall Study||109
11313763|NCT02683109|12512732|FG001|COMPLETED|Overall Study||111
11313764|NCT02683109|12512731|FG000|NOT COMPLETED|Overall Study||1
11313765|NCT02683109|12512732|FG001|NOT COMPLETED|Overall Study||0
11313766|NCT02683161|12512739|FG000|STARTED|Overall Study||5
11313767|NCT02683161|12512739|FG000|COMPLETED|Overall Study||5
11313768|NCT02683161|12512739|FG000|NOT COMPLETED|Overall Study||0
11313769|NCT02683174|12512743|FG000|STARTED|Overall Study||86
11313770|NCT02683174|12512743|FG000|COMPLETED|Overall Study||86
11313771|NCT02683174|12512743|FG000|NOT COMPLETED|Overall Study||0
11313772|NCT02683187|12512748|FG000|STARTED|Overall Study||40
11313773|NCT02683187|12512748|FG000|COMPLETED|Overall Study||32
11313774|NCT02683187|12512748|FG000|NOT COMPLETED|Overall Study||8
11313775|NCT02683421|12512760|FG000|STARTED|Overall Study||5
11313776|NCT02683421|12512761|FG001|STARTED|Overall Study||4
11313777|NCT02683421|12512762|FG002|STARTED|Overall Study||4
11313778|NCT02683421|12512763|FG003|STARTED|Overall Study||5
11313779|NCT02683421|12512760|FG000|COMPLETED|Overall Study||5
11313780|NCT02683421|12512761|FG001|COMPLETED|Overall Study||4
11313781|NCT02683421|12512762|FG002|COMPLETED|Overall Study||4
11313782|NCT02683421|12512763|FG003|COMPLETED|Overall Study||5
11313783|NCT02683421|12512760|FG000|NOT COMPLETED|Overall Study||0
11313784|NCT02683421|12512761|FG001|NOT COMPLETED|Overall Study||0
11313785|NCT02683421|12512762|FG002|NOT COMPLETED|Overall Study||0
11313786|NCT02683421|12512763|FG003|NOT COMPLETED|Overall Study||0
11313787|NCT02683525|12512773|FG000|STARTED|Overall Study||37
11313788|NCT02683525|12512773|FG000|COMPLETED|Overall Study||29
11313789|NCT02683525|12512773|FG000|NOT COMPLETED|Overall Study||8
11313790|NCT02683577|12512780|FG000|STARTED|Overall Study||8
11313791|NCT02683577|12512781|FG001|STARTED|Overall Study||8
11313792|NCT02683577|12512782|FG002|STARTED|Overall Study||8
11313793|NCT02683577|12512780|FG000|COMPLETED|Overall Study||8
11313794|NCT02683577|12512781|FG001|COMPLETED|Overall Study||8
11313795|NCT02683577|12512782|FG002|COMPLETED|Overall Study||8
11313796|NCT02683577|12512780|FG000|NOT COMPLETED|Overall Study||0
11313797|NCT02683577|12512781|FG001|NOT COMPLETED|Overall Study||0
11313798|NCT02683577|12512782|FG002|NOT COMPLETED|Overall Study||0
11313799|NCT02683668|12512792|FG000|STARTED|Period 1||44
11313800|NCT02683668|12512793|FG001|STARTED|Period 1||0
11313801|NCT02683668|12512794|FG002|STARTED|Period 1||0
11313802|NCT02683668|12512792|FG000|COMPLETED|Period 1||44
11313803|NCT02683668|12512793|FG001|COMPLETED|Period 1||0
11313804|NCT02683668|12512794|FG002|COMPLETED|Period 1||0
11313805|NCT02683668|12512792|FG000|NOT COMPLETED|Period 1||0
11313806|NCT02683668|12512793|FG001|NOT COMPLETED|Period 1||0
11313807|NCT02683668|12512794|FG002|NOT COMPLETED|Period 1||0
11313808|NCT02683668|12512792|FG000|STARTED|Period 2||0
11313809|NCT02683668|12512793|FG001|STARTED|Period 2||44
11313810|NCT02683668|12512794|FG002|STARTED|Period 2||0
11313811|NCT02683668|12512792|FG000|COMPLETED|Period 2||0
11313812|NCT02683668|12512793|FG001|COMPLETED|Period 2||43
11313813|NCT02683668|12512794|FG002|COMPLETED|Period 2||0
11313814|NCT02683668|12512792|FG000|NOT COMPLETED|Period 2||0
11313815|NCT02683668|12512793|FG001|NOT COMPLETED|Period 2||1
11313816|NCT02683668|12512794|FG002|NOT COMPLETED|Period 2||0
11313817|NCT02683668|12512792|FG000|STARTED|Period 3||0
11313818|NCT02683668|12512793|FG001|STARTED|Period 3||0
11313819|NCT02683668|12512794|FG002|STARTED|Period 3||43
11313820|NCT02683668|12512792|FG000|COMPLETED|Period 3||0
11313821|NCT02683668|12512793|FG001|COMPLETED|Period 3||0
11313822|NCT02683668|12512794|FG002|COMPLETED|Period 3||43
11313823|NCT02683668|12512792|FG000|NOT COMPLETED|Period 3||0
11313824|NCT02683668|12512793|FG001|NOT COMPLETED|Period 3||0
11313825|NCT02683668|12512794|FG002|NOT COMPLETED|Period 3||0
11402141|NCT04054765|12596985|FG000|NOT COMPLETED|Baseline||5
11402142|NCT04054765|12596986|FG001|NOT COMPLETED|Baseline||3
11402143|NCT04054765|12596985|FG000|STARTED|Post-Gameplay / 1-week Follow up||150
11313826|NCT02683707|12512802|FG000|STARTED|Overall Study||105
11313827|NCT02683707|12512803|FG001|STARTED|Overall Study||107
11313828|NCT02683707|12512802|FG000|COMPLETED|Overall Study||105
11313829|NCT02683707|12512803|FG001|COMPLETED|Overall Study||107
11313830|NCT02683707|12512802|FG000|NOT COMPLETED|Overall Study||0
11313831|NCT02683707|12512803|FG001|NOT COMPLETED|Overall Study||0
11313832|NCT02683746|12512811|FG000|STARTED|Overall Study||154
11313833|NCT02683746|12512812|FG001|STARTED|Overall Study||154
11313834|NCT02683746|12512811|FG000|COMPLETED|Overall Study||138
11313835|NCT02683746|12512812|FG001|COMPLETED|Overall Study||140
11313836|NCT02683746|12512811|FG000|NOT COMPLETED|Overall Study||16
11313837|NCT02683746|12512812|FG001|NOT COMPLETED|Overall Study||14
11313838|NCT02683772|12512818|FG000|STARTED|Overall Study||15
11313839|NCT02683772|12512819|FG001|STARTED|Overall Study||23
11313840|NCT02683772|12512818|FG000|COMPLETED|Overall Study||15
11313841|NCT02683772|12512819|FG001|COMPLETED|Overall Study||23
11313842|NCT02683772|12512818|FG000|NOT COMPLETED|Overall Study||0
11313843|NCT02683772|12512819|FG001|NOT COMPLETED|Overall Study||0
11313844|NCT02683785|12512831|FG000|STARTED|Overall Study||22
11313845|NCT02683785|12512832|FG001|STARTED|Overall Study||22
11313846|NCT02683785|12512831|FG000|COMPLETED|Overall Study||21
11313847|NCT02683785|12512832|FG001|COMPLETED|Overall Study||18
11313848|NCT02683785|12512831|FG000|NOT COMPLETED|Overall Study||1
11313849|NCT02683785|12512832|FG001|NOT COMPLETED|Overall Study||4
11313850|NCT02683876|12512842|FG000|STARTED|Overall Study||17
11313851|NCT02683876|12512843|FG001|STARTED|Overall Study||22
11313852|NCT02683876|12512842|FG000|COMPLETED|Overall Study||15
11313853|NCT02683876|12512843|FG001|COMPLETED|Overall Study||22
11313854|NCT02683876|12512842|FG000|NOT COMPLETED|Overall Study||2
11313855|NCT02683876|12512843|FG001|NOT COMPLETED|Overall Study||0
11313856|NCT02683928|12512853|FG000|STARTED|Overall Study||48
11313857|NCT02683928|12512854|FG001|STARTED|Overall Study||16
11313858|NCT02683928|12512853|FG000|COMPLETED|Overall Study||26
11313859|NCT02683928|12512854|FG001|COMPLETED|Overall Study||8
11313860|NCT02683928|12512853|FG000|NOT COMPLETED|Overall Study||22
11313861|NCT02683928|12512854|FG001|NOT COMPLETED|Overall Study||8
11313862|NCT02683941|12512862|FG000|STARTED|Double-blind Phase||51
11313863|NCT02683941|12512863|FG001|STARTED|Double-blind Phase||26
11313864|NCT02683941|12512862|FG000|COMPLETED|Double-blind Phase||41
11313865|NCT02683941|12512863|FG001|COMPLETED|Double-blind Phase||21
11313866|NCT02683941|12512862|FG000|NOT COMPLETED|Double-blind Phase||10
11313867|NCT02683941|12512863|FG001|NOT COMPLETED|Double-blind Phase||5
11313868|NCT02683941|12512862|FG000|STARTED|Open-label Treatment Phase||21
11313869|NCT02683941|12512863|FG001|STARTED|Open-label Treatment Phase||19
11313870|NCT02683941|12512862|FG000|COMPLETED|Open-label Treatment Phase||1
11313871|NCT02683941|12512863|FG001|COMPLETED|Open-label Treatment Phase||6
11402144|NCT04054765|12596986|FG001|STARTED|Post-Gameplay / 1-week Follow up||129
11402145|NCT04054765|12596985|FG000|COMPLETED|Post-Gameplay / 1-week Follow up||142
11313872|NCT02683941|12512862|FG000|NOT COMPLETED|Open-label Treatment Phase||20
11313873|NCT02683941|12512863|FG001|NOT COMPLETED|Open-label Treatment Phase||13
11313874|NCT02683941|12512862|FG000|STARTED|Open-label Follow-up Phase||18
11313875|NCT02683941|12512863|FG001|STARTED|Open-label Follow-up Phase||8
11313876|NCT02683941|12512862|FG000|COMPLETED|Open-label Follow-up Phase||0
11313877|NCT02683941|12512863|FG001|COMPLETED|Open-label Follow-up Phase||0
11313878|NCT02683941|12512862|FG000|NOT COMPLETED|Open-label Follow-up Phase||18
11313879|NCT02683941|12512863|FG001|NOT COMPLETED|Open-label Follow-up Phase||8
11313880|NCT02683954|12512875|FG000|STARTED|Overall Study||30
11313881|NCT02683954|12512876|FG001|STARTED|Overall Study||30
11313882|NCT02683954|12512875|FG000|COMPLETED|Overall Study||30
11313883|NCT02683954|12512876|FG001|COMPLETED|Overall Study||30
11313884|NCT02683954|12512875|FG000|NOT COMPLETED|Overall Study||0
11313885|NCT02683954|12512876|FG001|NOT COMPLETED|Overall Study||0
11313886|NCT02684097|12512884|FG000|STARTED|Overall Study||15
11313887|NCT02684097|12512885|FG001|STARTED|Overall Study||7
11313888|NCT02684097|12512884|FG000|COMPLETED|Overall Study||2
11313889|NCT02684097|12512885|FG001|COMPLETED|Overall Study||1
11313890|NCT02684097|12512884|FG000|NOT COMPLETED|Overall Study||13
11313891|NCT02684097|12512885|FG001|NOT COMPLETED|Overall Study||6
11313892|NCT02684136|12512891|FG000|STARTED|First Intervention (9 Nights)||5
11313893|NCT02684136|12512892|FG001|STARTED|First Intervention (9 Nights)||5
11313894|NCT02684136|12512891|FG000|COMPLETED|First Intervention (9 Nights)||5
11313895|NCT02684136|12512892|FG001|COMPLETED|First Intervention (9 Nights)||5
11313896|NCT02684136|12512891|FG000|NOT COMPLETED|First Intervention (9 Nights)||0
11313897|NCT02684136|12512892|FG001|NOT COMPLETED|First Intervention (9 Nights)||0
11313898|NCT02684136|12512891|FG000|STARTED|Washout (7 Days)||5
11313899|NCT02684136|12512892|FG001|STARTED|Washout (7 Days)||5
11313900|NCT02684136|12512891|FG000|COMPLETED|Washout (7 Days)||5
11313901|NCT02684136|12512892|FG001|COMPLETED|Washout (7 Days)||5
11313902|NCT02684136|12512891|FG000|NOT COMPLETED|Washout (7 Days)||0
11313903|NCT02684136|12512892|FG001|NOT COMPLETED|Washout (7 Days)||0
11313904|NCT02684136|12512891|FG000|STARTED|Second Intervention (9 Nights)||5
11313905|NCT02684136|12512892|FG001|STARTED|Second Intervention (9 Nights)||5
11313906|NCT02684136|12512891|FG000|COMPLETED|Second Intervention (9 Nights)||5
11313907|NCT02684136|12512892|FG001|COMPLETED|Second Intervention (9 Nights)||5
11313908|NCT02684136|12512891|FG000|NOT COMPLETED|Second Intervention (9 Nights)||0
11313909|NCT02684136|12512892|FG001|NOT COMPLETED|Second Intervention (9 Nights)||0
11313910|NCT02684188|12512900|FG000|STARTED|Overall Study||77
11313911|NCT02684188|12512901|FG001|STARTED|Overall Study||50
11313912|NCT02684188|12512900|FG000|COMPLETED|Overall Study||75
11313913|NCT02684188|12512901|FG001|COMPLETED|Overall Study||47
11313914|NCT02684188|12512900|FG000|NOT COMPLETED|Overall Study||2
11313915|NCT02684188|12512901|FG001|NOT COMPLETED|Overall Study||3
11313916|NCT02684279|12512910|FG000|STARTED|Overall Study||528
11313917|NCT02684279|12512910|FG000|COMPLETED|Overall Study||249
11313918|NCT02684279|12512910|FG000|NOT COMPLETED|Overall Study||279
11313919|NCT02684344|12512916|FG000|STARTED|Overall Study||1
11313920|NCT02684344|12512917|FG001|STARTED|Overall Study||4
11313921|NCT02684344|12512916|FG000|COMPLETED|Overall Study||1
11313922|NCT02684344|12512917|FG001|COMPLETED|Overall Study||3
11313923|NCT02684344|12512916|FG000|NOT COMPLETED|Overall Study||0
11313924|NCT02684344|12512917|FG001|NOT COMPLETED|Overall Study||1
11313925|NCT02684357|12512926|FG000|STARTED|Part A||98
11313926|NCT02684357|12512927|FG001|STARTED|Part A||99
11313927|NCT02684357|12512928|FG002|STARTED|Part A||294
11313928|NCT02684357|12512929|FG003|STARTED|Part A||0
11313929|NCT02684357|12512930|FG004|STARTED|Part A||0
11313930|NCT02684357|12512931|FG005|STARTED|Part A||0
11313931|NCT02684357|12512926|FG000|COMPLETED|Part A||94
11313932|NCT02684357|12512927|FG001|COMPLETED|Part A||96
11313933|NCT02684357|12512928|FG002|COMPLETED|Part A||292
11313934|NCT02684357|12512929|FG003|COMPLETED|Part A||0
11313935|NCT02684357|12512930|FG004|COMPLETED|Part A||0
11313936|NCT02684357|12512931|FG005|COMPLETED|Part A||0
11313937|NCT02684357|12512926|FG000|NOT COMPLETED|Part A||4
11313938|NCT02684357|12512927|FG001|NOT COMPLETED|Part A||3
11313939|NCT02684357|12512928|FG002|NOT COMPLETED|Part A||2
11313940|NCT02684357|12512929|FG003|NOT COMPLETED|Part A||0
11313941|NCT02684357|12512930|FG004|NOT COMPLETED|Part A||0
11313942|NCT02684357|12512931|FG005|NOT COMPLETED|Part A||0
11313943|NCT02684357|12512926|FG000|STARTED|Part B||0
11313944|NCT02684357|12512927|FG001|STARTED|Part B||0
11313945|NCT02684357|12512928|FG002|STARTED|Part B||0
11313946|NCT02684357|12512929|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94
11313947|NCT02684357|12512930|FG004|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94
11313948|NCT02684357|12512931|FG005|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291
11313949|NCT02684357|12512926|FG000|COMPLETED|Part B||0
11313950|NCT02684357|12512927|FG001|COMPLETED|Part B||0
11313951|NCT02684357|12512928|FG002|COMPLETED|Part B||0
11313952|NCT02684357|12512929|FG003|COMPLETED|Part B||91
11313953|NCT02684357|12512930|FG004|COMPLETED|Part B||90
11313954|NCT02684357|12512931|FG005|COMPLETED|Part B||278
11313955|NCT02684357|12512926|FG000|NOT COMPLETED|Part B||0
11313956|NCT02684357|12512927|FG001|NOT COMPLETED|Part B||0
11313957|NCT02684357|12512928|FG002|NOT COMPLETED|Part B||0
11313958|NCT02684357|12512929|FG003|NOT COMPLETED|Part B||3
11313959|NCT02684357|12512930|FG004|NOT COMPLETED|Part B||4
11313960|NCT02684357|12512931|FG005|NOT COMPLETED|Part B||13
11313961|NCT02684370|12512947|FG000|STARTED|Part A||102
11313962|NCT02684370|12512948|FG001|STARTED|Part A||100
11313963|NCT02684370|12512949|FG002|STARTED|Part A||304
11402146|NCT04054765|12596986|FG001|COMPLETED|Post-Gameplay / 1-week Follow up||126
11402147|NCT04054765|12596985|FG000|NOT COMPLETED|Post-Gameplay / 1-week Follow up||8
11402148|NCT04054765|12596986|FG001|NOT COMPLETED|Post-Gameplay / 1-week Follow up||3
11402149|NCT04054765|12596985|FG000|STARTED|3-month Follow up||142
11402150|NCT04054765|12596986|FG001|STARTED|3-month Follow up||126
11402151|NCT04054765|12596985|FG000|COMPLETED|3-month Follow up||142
11402152|NCT04054765|12596986|FG001|COMPLETED|3-month Follow up||123
11402153|NCT04054765|12596985|FG000|NOT COMPLETED|3-month Follow up||0
11402154|NCT04054765|12596986|FG001|NOT COMPLETED|3-month Follow up||3
11402155|NCT04054765|12596985|FG000|STARTED|6-month Follow up||142
11402156|NCT04054765|12596986|FG001|STARTED|6-month Follow up||123
11402157|NCT04054765|12596985|FG000|COMPLETED|6-month Follow up||110
11402158|NCT04054765|12596986|FG001|COMPLETED|6-month Follow up||91
11402159|NCT04054765|12596985|FG000|NOT COMPLETED|6-month Follow up||32
11402160|NCT04054765|12596986|FG001|NOT COMPLETED|6-month Follow up||32
11402161|NCT04054011|12596992|FG000|STARTED|Overall Study||15
11402162|NCT04054011|12596992|FG000|COMPLETED|Overall Study||12
11402163|NCT04054011|12596992|FG000|NOT COMPLETED|Overall Study||3
11402164|NCT04059094|12597003|FG000|STARTED|Overall Study||18
11402165|NCT04059094|12597004|FG001|STARTED|Overall Study||6
11313964|NCT02684370|12512950|FG003|STARTED|Part A||0
11313965|NCT02684370|12512951|FG004|STARTED|Part A||0
11313966|NCT02684370|12512952|FG005|STARTED|Part A||0
11313967|NCT02684370|12512947|FG000|COMPLETED|Part A||98
11313968|NCT02684370|12512948|FG001|COMPLETED|Part A||99
11313969|NCT02684370|12512949|FG002|COMPLETED|Part A||299
11313970|NCT02684370|12512950|FG003|COMPLETED|Part A||0
11313971|NCT02684370|12512951|FG004|COMPLETED|Part A||0
11313972|NCT02684370|12512952|FG005|COMPLETED|Part A||0
11313973|NCT02684370|12512947|FG000|NOT COMPLETED|Part A||4
11313974|NCT02684370|12512948|FG001|NOT COMPLETED|Part A||1
11313975|NCT02684370|12512949|FG002|NOT COMPLETED|Part A||5
11313976|NCT02684370|12512950|FG003|NOT COMPLETED|Part A||0
11313977|NCT02684370|12512951|FG004|NOT COMPLETED|Part A||0
11313978|NCT02684370|12512952|FG005|NOT COMPLETED|Part A||0
11313979|NCT02684370|12512947|FG000|STARTED|Part B||0
11313980|NCT02684370|12512948|FG001|STARTED|Part B||0
11313981|NCT02684370|12512949|FG002|STARTED|Part B||0
11313982|NCT02684370|12512950|FG003|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97
11313983|NCT02684370|12512951|FG004|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99
11313984|NCT02684370|12512952|FG005|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297
11313985|NCT02684370|12512947|FG000|COMPLETED|Part B||0
11313986|NCT02684370|12512948|FG001|COMPLETED|Part B||0
11313987|NCT02684370|12512949|FG002|COMPLETED|Part B||0
11313988|NCT02684370|12512950|FG003|COMPLETED|Part B||95
11313989|NCT02684370|12512951|FG004|COMPLETED|Part B||94
11313990|NCT02684370|12512952|FG005|COMPLETED|Part B||289
11313991|NCT02684370|12512947|FG000|NOT COMPLETED|Part B||0
11313992|NCT02684370|12512948|FG001|NOT COMPLETED|Part B||0
11313993|NCT02684370|12512949|FG002|NOT COMPLETED|Part B||0
11313994|NCT02684370|12512950|FG003|NOT COMPLETED|Part B||2
11313995|NCT02684370|12512951|FG004|NOT COMPLETED|Part B||5
11313996|NCT02684370|12512952|FG005|NOT COMPLETED|Part B||8
11313997|NCT02684396|12512972|FG000|STARTED|Overall Study||6
11313998|NCT02684396|12512973|FG001|STARTED|Overall Study||6
11313999|NCT02684396|12512974|FG002|STARTED|Overall Study||6
11402166|NCT04059094|12597005|FG002|STARTED|Overall Study||5
11402167|NCT04059094|12597006|FG003|STARTED|Overall Study||5
11314000|NCT02684396|12512975|FG003|STARTED|Overall Study||6
11314001|NCT02684396|12512976|FG004|STARTED|Overall Study||5
11314002|NCT02684396|12512977|FG005|STARTED|Overall Study||10
11314003|NCT02684396|12512972|FG000|COMPLETED|Overall Study||6
11402168|NCT04059094|12597007|FG004|STARTED|Overall Study||18
11314004|NCT02684396|12512973|FG001|COMPLETED|Overall Study||6
11314005|NCT02684396|12512974|FG002|COMPLETED|Overall Study||6
11314006|NCT02684396|12512975|FG003|COMPLETED|Overall Study||6
11314007|NCT02684396|12512976|FG004|COMPLETED|Overall Study||5
11314008|NCT02684396|12512977|FG005|COMPLETED|Overall Study||10
11314009|NCT02684396|12512972|FG000|NOT COMPLETED|Overall Study||0
11314010|NCT02684396|12512973|FG001|NOT COMPLETED|Overall Study||0
11314011|NCT02684396|12512974|FG002|NOT COMPLETED|Overall Study||0
11314012|NCT02684396|12512975|FG003|NOT COMPLETED|Overall Study||0
11314013|NCT02684396|12512976|FG004|NOT COMPLETED|Overall Study||0
11314014|NCT02684396|12512977|FG005|NOT COMPLETED|Overall Study||0
11314015|NCT02684435|12512991|FG000|STARTED|Overall Study||63
11314016|NCT02684435|12512991|FG000|COMPLETED|Overall Study||63
11314017|NCT02684435|12512991|FG000|NOT COMPLETED|Overall Study||0
11314018|NCT02684591|12512997|FG000|STARTED|Overall Study||25
11314019|NCT02684591|12512998|FG001|STARTED|Overall Study||25
11314020|NCT02684591|12512997|FG000|COMPLETED|Overall Study||24
11314021|NCT02684591|12512998|FG001|COMPLETED|Overall Study||22
11314022|NCT02684591|12512997|FG000|NOT COMPLETED|Overall Study||1
11314023|NCT02684591|12512998|FG001|NOT COMPLETED|Overall Study||3
11314024|NCT02684604|12513006|FG000|STARTED|Overall Study||44
11314025|NCT02684604|12513007|FG001|STARTED|Overall Study||44
11314026|NCT02684604|12513006|FG000|COMPLETED|Overall Study||44
11314027|NCT02684604|12513007|FG001|COMPLETED|Overall Study||44
11314028|NCT02684604|12513006|FG000|NOT COMPLETED|Overall Study||0
11314029|NCT02684604|12513007|FG001|NOT COMPLETED|Overall Study||0
11314030|NCT02684617|12513016|FG000|STARTED|Overall Study||18
11314031|NCT02684617|12513017|FG001|STARTED|Overall Study||17
11314032|NCT02684617|12513018|FG002|STARTED|Overall Study||40
11314033|NCT02684617|12513016|FG000|Treated|Overall Study||17
11314034|NCT02684617|12513017|FG001|Treated|Overall Study||17
11314035|NCT02684617|12513018|FG002|Treated|Overall Study||38
11314036|NCT02684617|12513016|FG000|COMPLETED|Overall Study||0
11314037|NCT02684617|12513017|FG001|COMPLETED|Overall Study||0
11314038|NCT02684617|12513018|FG002|COMPLETED|Overall Study||0
11314039|NCT02684617|12513016|FG000|NOT COMPLETED|Overall Study||18
11314040|NCT02684617|12513017|FG001|NOT COMPLETED|Overall Study||17
11314041|NCT02684617|12513018|FG002|NOT COMPLETED|Overall Study||40
11314042|NCT02684630|12513028|FG000|STARTED|Overall Study||65
11314043|NCT02684630|12513029|FG001|STARTED|Overall Study||63
11314044|NCT02684630|12513028|FG000|COMPLETED|Overall Study||60
11314045|NCT02684630|12513029|FG001|COMPLETED|Overall Study||60
11314046|NCT02684630|12513028|FG000|NOT COMPLETED|Overall Study||5
11314047|NCT02684630|12513029|FG001|NOT COMPLETED|Overall Study||3
11314048|NCT02684942|12513037|FG000|STARTED|Overall Study||7
11314049|NCT02684942|12513038|FG001|STARTED|Overall Study||7
11314050|NCT02684942|12513039|FG002|STARTED|Overall Study||7
11314051|NCT02684942|12513040|FG003|STARTED|Overall Study||7
11314052|NCT02684942|12513041|FG004|STARTED|Overall Study||6
11314053|NCT02684942|12513042|FG005|STARTED|Overall Study||6
11314054|NCT02684942|12513037|FG000|COMPLETED|Overall Study||7
11314055|NCT02684942|12513038|FG001|COMPLETED|Overall Study||7
11314056|NCT02684942|12513039|FG002|COMPLETED|Overall Study||7
11314057|NCT02684942|12513040|FG003|COMPLETED|Overall Study||7
11314058|NCT02684942|12513041|FG004|COMPLETED|Overall Study||6
11314059|NCT02684942|12513042|FG005|COMPLETED|Overall Study||6
11314060|NCT02684942|12513037|FG000|NOT COMPLETED|Overall Study||0
11314061|NCT02684942|12513038|FG001|NOT COMPLETED|Overall Study||0
11314062|NCT02684942|12513039|FG002|NOT COMPLETED|Overall Study||0
11314063|NCT02684942|12513040|FG003|NOT COMPLETED|Overall Study||0
11314064|NCT02684942|12513041|FG004|NOT COMPLETED|Overall Study||0
11314065|NCT02684942|12513042|FG005|NOT COMPLETED|Overall Study||0
11314066|NCT02684981|12513056|FG000|STARTED|Overall Study||4100
11314067|NCT02684981|12513057|FG001|STARTED|Overall Study||3179
11314068|NCT02684981|12513058|FG002|STARTED|Overall Study||2186
11314069|NCT02684981|12513056|FG000|COMPLETED|Overall Study||3860
11314070|NCT02684981|12513057|FG001|COMPLETED|Overall Study||2969
11314071|NCT02684981|12513058|FG002|COMPLETED|Overall Study||2059
11314072|NCT02684981|12513056|FG000|NOT COMPLETED|Overall Study||240
11314073|NCT02684981|12513057|FG001|NOT COMPLETED|Overall Study||210
11314074|NCT02684981|12513058|FG002|NOT COMPLETED|Overall Study||127
11314075|NCT02685007|12513072|FG000|STARTED|Overall Study||131
11314076|NCT02685007|12513072|FG000|COMPLETED|Overall Study||131
11314077|NCT02685007|12513072|FG000|NOT COMPLETED|Overall Study||0
11314078|NCT02685033|12513078|FG000|STARTED|Overall Study||70
11314079|NCT02685033|12513079|FG001|STARTED|Overall Study||10
11314080|NCT02685033|12513078|FG000|COMPLETED|Overall Study||67
11314081|NCT02685033|12513079|FG001|COMPLETED|Overall Study||8
11314082|NCT02685033|12513078|FG000|NOT COMPLETED|Overall Study||3
11314083|NCT02685033|12513079|FG001|NOT COMPLETED|Overall Study||2
11314084|NCT02685072|12513087|FG000|STARTED|Treatment Period||33
11314085|NCT02685072|12513088|FG001|STARTED|Treatment Period||31
11314086|NCT02685072|12513087|FG000|Completed Week 2 Visit|Treatment Period||23
11314087|NCT02685072|12513088|FG001|Completed Week 2 Visit|Treatment Period||26
11314088|NCT02685072|12513087|FG000|Completed Week 3 Visit|Treatment Period||20
11314089|NCT02685072|12513088|FG001|Completed Week 3 Visit|Treatment Period||23
11314090|NCT02685072|12513087|FG000|Completed Week 4 Visit|Treatment Period||19
11314091|NCT02685072|12513088|FG001|Completed Week 4 Visit|Treatment Period||23
11314092|NCT02685072|12513087|FG000|Completed Week 5 Visit|Treatment Period||19
11314093|NCT02685072|12513088|FG001|Completed Week 5 Visit|Treatment Period||22
11314094|NCT02685072|12513087|FG000|Completed Week 6 Visit|Treatment Period||18
11314095|NCT02685072|12513088|FG001|Completed Week 6 Visit|Treatment Period||19
11314096|NCT02685072|12513087|FG000|Completed Week 7 Visit|Treatment Period||17
11314097|NCT02685072|12513088|FG001|Completed Week 7 Visit|Treatment Period||18
11314098|NCT02685072|12513087|FG000|Completed Week 8 Visit|Treatment Period||20
11314099|NCT02685072|12513088|FG001|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22
11314100|NCT02685072|12513087|FG000|COMPLETED|Treatment Period||20
11314101|NCT02685072|12513088|FG001|COMPLETED|Treatment Period||22
11314102|NCT02685072|12513087|FG000|NOT COMPLETED|Treatment Period||13
11314103|NCT02685072|12513088|FG001|NOT COMPLETED|Treatment Period||9
11314104|NCT02685072|12513087|FG000|STARTED|1-Month Follow-Up||20
11314105|NCT02685072|12513088|FG001|STARTED|1-Month Follow-Up||22
11314106|NCT02685072|12513087|FG000|COMPLETED|1-Month Follow-Up||19
11314107|NCT02685072|12513088|FG001|COMPLETED|1-Month Follow-Up||22
11314108|NCT02685072|12513087|FG000|NOT COMPLETED|1-Month Follow-Up||1
11314109|NCT02685072|12513088|FG001|NOT COMPLETED|1-Month Follow-Up||0
11314110|NCT02685072|12513087|FG000|STARTED|3-Month Follow-Up||19
11314111|NCT02685072|12513088|FG001|STARTED|3-Month Follow-Up||22
11314112|NCT02685072|12513087|FG000|COMPLETED|3-Month Follow-Up||19
11314113|NCT02685072|12513088|FG001|COMPLETED|3-Month Follow-Up||22
11314114|NCT02685072|12513087|FG000|NOT COMPLETED|3-Month Follow-Up||0
11314115|NCT02685072|12513088|FG001|NOT COMPLETED|3-Month Follow-Up||0
11314116|NCT02685267|12513097|FG000|STARTED|Overall Study||5
11314117|NCT02685267|12513098|FG001|STARTED|Overall Study||4
11314118|NCT02685267|12513097|FG000|COMPLETED|Overall Study||5
11314119|NCT02685267|12513098|FG001|COMPLETED|Overall Study||4
11314120|NCT02685267|12513097|FG000|NOT COMPLETED|Overall Study||0
11314121|NCT02685267|12513098|FG001|NOT COMPLETED|Overall Study||0
11314122|NCT02685293|12513104|FG000|STARTED|Treatment Period 1||1
11314123|NCT02685293|12513105|FG001|STARTED|Treatment Period 1||3
11314124|NCT02685293|12513104|FG000|COMPLETED|Treatment Period 1||1
11314125|NCT02685293|12513105|FG001|COMPLETED|Treatment Period 1||3
11314126|NCT02685293|12513104|FG000|NOT COMPLETED|Treatment Period 1||0
11314127|NCT02685293|12513105|FG001|NOT COMPLETED|Treatment Period 1||0
11314128|NCT02685293|12513104|FG000|STARTED|Washout Period||1
11314129|NCT02685293|12513105|FG001|STARTED|Washout Period||3
11314130|NCT02685293|12513104|FG000|COMPLETED|Washout Period||1
11314131|NCT02685293|12513105|FG001|COMPLETED|Washout Period||3
11314132|NCT02685293|12513104|FG000|NOT COMPLETED|Washout Period||0
11314133|NCT02685293|12513105|FG001|NOT COMPLETED|Washout Period||0
11314134|NCT02685293|12513104|FG000|STARTED|Treatment Period 2||1
11314135|NCT02685293|12513105|FG001|STARTED|Treatment Period 2||3
11314136|NCT02685293|12513104|FG000|COMPLETED|Treatment Period 2||1
11314137|NCT02685293|12513105|FG001|COMPLETED|Treatment Period 2||3
11314138|NCT02685293|12513104|FG000|NOT COMPLETED|Treatment Period 2||0
11314139|NCT02685293|12513105|FG001|NOT COMPLETED|Treatment Period 2||0
11314140|NCT02685436|12513111|FG000|STARTED|Overall Study|the overall studied group|52
11314141|NCT02685436|12513111|FG000|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38
11314142|NCT02685436|12513111|FG000|NOT COMPLETED|Overall Study||14
11314143|NCT02685488|12513117|FG000|STARTED|Overall Study||12
11314144|NCT02685488|12513118|FG001|STARTED|Overall Study||14
11314145|NCT02685488|12513117|FG000|COMPLETED|Overall Study||12
11314146|NCT02685488|12513118|FG001|COMPLETED|Overall Study||13
11314147|NCT02685488|12513117|FG000|NOT COMPLETED|Overall Study||0
11314148|NCT02685488|12513118|FG001|NOT COMPLETED|Overall Study||1
11314149|NCT02685566|12513124|FG000|STARTED|First Reading Session||50
11314150|NCT02685566|12513125|FG001|STARTED|First Reading Session||50
11314151|NCT02685566|12513124|FG000|COMPLETED|First Reading Session||50
11314152|NCT02685566|12513125|FG001|COMPLETED|First Reading Session||50
11314153|NCT02685566|12513124|FG000|NOT COMPLETED|First Reading Session||0
11314154|NCT02685566|12513125|FG001|NOT COMPLETED|First Reading Session||0
11402169|NCT04059094|12597003|FG000|COMPLETED|Overall Study||18
11402170|NCT04059094|12597004|FG001|COMPLETED|Overall Study||4
11402171|NCT04059094|12597005|FG002|COMPLETED|Overall Study||5
11402172|NCT04059094|12597006|FG003|COMPLETED|Overall Study||5
11314155|NCT02685566|12513124|FG000|STARTED|4 Week Memory Washout Period||50
11314156|NCT02685566|12513125|FG001|STARTED|4 Week Memory Washout Period||50
11314157|NCT02685566|12513124|FG000|COMPLETED|4 Week Memory Washout Period||50
11314158|NCT02685566|12513125|FG001|COMPLETED|4 Week Memory Washout Period||50
11314159|NCT02685566|12513124|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
11314160|NCT02685566|12513125|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
11314161|NCT02685566|12513124|FG000|STARTED|Second Reading Session||50
11314162|NCT02685566|12513125|FG001|STARTED|Second Reading Session||50
11314163|NCT02685566|12513124|FG000|COMPLETED|Second Reading Session||50
11314164|NCT02685566|12513125|FG001|COMPLETED|Second Reading Session||50
11314165|NCT02685566|12513124|FG000|NOT COMPLETED|Second Reading Session||0
11314166|NCT02685566|12513125|FG001|NOT COMPLETED|Second Reading Session||0
11314167|NCT02685956|12513135|FG000|STARTED|Overall Study||317
11314168|NCT02685956|12513136|FG001|STARTED|Overall Study||1978
11314169|NCT02685956|12513135|FG000|COMPLETED|Overall Study||317
11314170|NCT02685956|12513136|FG001|COMPLETED|Overall Study||1978
11314171|NCT02685956|12513135|FG000|NOT COMPLETED|Overall Study||0
11314172|NCT02685956|12513136|FG001|NOT COMPLETED|Overall Study||0
11314173|NCT02685995|12513146|FG000|STARTED|Overall Study||50
11314174|NCT02685995|12513147|FG001|STARTED|Overall Study||50
11314175|NCT02685995|12513146|FG000|COMPLETED|Overall Study||49
11314176|NCT02685995|12513147|FG001|COMPLETED|Overall Study||49
11314177|NCT02685995|12513146|FG000|NOT COMPLETED|Overall Study||1
11314178|NCT02685995|12513147|FG001|NOT COMPLETED|Overall Study||1
11314179|NCT02686034|12513155|FG000|STARTED|Run-In Period 1||142
11314180|NCT02686034|12513156|FG001|STARTED|Run-In Period 1||143
11314181|NCT02686034|12513155|FG000|COMPLETED|Run-In Period 1||122
11314182|NCT02686034|12513156|FG001|COMPLETED|Run-In Period 1||126
11314183|NCT02686034|12513155|FG000|NOT COMPLETED|Run-In Period 1||20
11314184|NCT02686034|12513156|FG001|NOT COMPLETED|Run-In Period 1||17
11314185|NCT02686034|12513155|FG000|STARTED|Randomized Controlled Period 2||122
11402173|NCT04059094|12597007|FG004|COMPLETED|Overall Study||17
11314186|NCT02686034|12513156|FG001|STARTED|Randomized Controlled Period 2||126
11314187|NCT02686034|12513155|FG000|COMPLETED|Randomized Controlled Period 2||117
11314188|NCT02686034|12513156|FG001|COMPLETED|Randomized Controlled Period 2||122
11402174|NCT04059094|12597003|FG000|NOT COMPLETED|Overall Study||0
11402175|NCT04059094|12597004|FG001|NOT COMPLETED|Overall Study||2
11402176|NCT04059094|12597005|FG002|NOT COMPLETED|Overall Study||0
11314189|NCT02686034|12513155|FG000|NOT COMPLETED|Randomized Controlled Period 2||5
11314190|NCT02686034|12513156|FG001|NOT COMPLETED|Randomized Controlled Period 2||4
11314191|NCT02686034|12513155|FG000|STARTED|Open Label Period 3||117
11314192|NCT02686034|12513156|FG001|STARTED|Open Label Period 3||122
11314193|NCT02686034|12513155|FG000|COMPLETED|Open Label Period 3||117
11402177|NCT04059094|12597006|FG003|NOT COMPLETED|Overall Study||0
11402178|NCT04059094|12597007|FG004|NOT COMPLETED|Overall Study||1
11314194|NCT02686034|12513156|FG001|COMPLETED|Open Label Period 3||121
11314195|NCT02686034|12513155|FG000|NOT COMPLETED|Open Label Period 3||0
11314196|NCT02686034|12513156|FG001|NOT COMPLETED|Open Label Period 3||1
11314197|NCT02686138|12513164|FG000|STARTED|Overall Study||293
11314198|NCT02686138|12513165|FG001|STARTED|Overall Study||300
11314199|NCT02686138|12513164|FG000|COMPLETED|Overall Study||219
11314200|NCT02686138|12513165|FG001|COMPLETED|Overall Study||235
11314201|NCT02686138|12513164|FG000|NOT COMPLETED|Overall Study||74
11314202|NCT02686138|12513165|FG001|NOT COMPLETED|Overall Study||65
11314203|NCT02686164|12513171|FG000|STARTED|Overall Study||30
11314204|NCT02686164|12513171|FG000|COMPLETED|Overall Study||27
11314205|NCT02686164|12513171|FG000|NOT COMPLETED|Overall Study||3
11314206|NCT02686437|12513180|FG000|STARTED|Overall Study||16
11314207|NCT02686437|12513181|FG001|STARTED|Overall Study||20
11314208|NCT02686437|12513180|FG000|COMPLETED|Overall Study||13
11314209|NCT02686437|12513181|FG001|COMPLETED|Overall Study||12
11314210|NCT02686437|12513180|FG000|NOT COMPLETED|Overall Study||3
11314211|NCT02686437|12513181|FG001|NOT COMPLETED|Overall Study||8
11314212|NCT02687035|12513187|FG000|STARTED|Overall Study||1822
11314213|NCT02687035|12513187|FG000|COMPLETED|Overall Study||1638
11314214|NCT02687035|12513187|FG000|NOT COMPLETED|Overall Study||184
11314215|NCT02687126|12513191|FG000|STARTED|Data Collection||106
11314216|NCT02687126|12513191|FG000|COMPLETED|Data Collection||106
11314217|NCT02687126|12513191|FG000|NOT COMPLETED|Data Collection||0
11314218|NCT02687126|12513191|FG000|STARTED|Data Analysis||106
11314219|NCT02687126|12513191|FG000|COMPLETED|Data Analysis||106
11314220|NCT02687126|12513191|FG000|NOT COMPLETED|Data Analysis||0
11314221|NCT02687139|12513198|FG000|STARTED|Overall Study||34
11314222|NCT02687139|12513198|FG000|COMPLETED|Overall Study||34
11314223|NCT02687139|12513198|FG000|NOT COMPLETED|Overall Study||0
11314224|NCT02687191|12513208|FG000|STARTED|Overall Study||3
11314225|NCT02687191|12513209|FG001|STARTED|Overall Study||3
11314226|NCT02687191|12513210|FG002|STARTED|Overall Study||3
11314227|NCT02687191|12513211|FG003|STARTED|Overall Study||6
11314228|NCT02687191|12513212|FG004|STARTED|Overall Study||3
11314229|NCT02687191|12513213|FG005|STARTED|Overall Study||3
11314230|NCT02687191|12513208|FG000|COMPLETED|Overall Study||3
11314231|NCT02687191|12513209|FG001|COMPLETED|Overall Study||2
11314232|NCT02687191|12513210|FG002|COMPLETED|Overall Study||2
11314233|NCT02687191|12513211|FG003|COMPLETED|Overall Study||5
11314234|NCT02687191|12513212|FG004|COMPLETED|Overall Study||2
11314235|NCT02687191|12513213|FG005|COMPLETED|Overall Study||2
11314236|NCT02687191|12513208|FG000|NOT COMPLETED|Overall Study||0
11314237|NCT02687191|12513209|FG001|NOT COMPLETED|Overall Study||1
11314238|NCT02687191|12513210|FG002|NOT COMPLETED|Overall Study||1
11314239|NCT02687191|12513211|FG003|NOT COMPLETED|Overall Study||1
11314240|NCT02687191|12513212|FG004|NOT COMPLETED|Overall Study||1
11314241|NCT02687191|12513213|FG005|NOT COMPLETED|Overall Study||1
11314242|NCT02687217|12513229|FG000|STARTED|Overall Study||30
11314243|NCT02687217|12513230|FG001|STARTED|Overall Study||30
11314244|NCT02687217|12513229|FG000|COMPLETED|Overall Study||30
11314245|NCT02687217|12513230|FG001|COMPLETED|Overall Study||30
11314246|NCT02687217|12513229|FG000|NOT COMPLETED|Overall Study||0
11314247|NCT02687217|12513230|FG001|NOT COMPLETED|Overall Study||0
11314248|NCT02687412|12513238|FG000|STARTED|Overall Study||50
11314249|NCT02687412|12513239|FG001|STARTED|Overall Study||57
11314250|NCT02687412|12513238|FG000|COMPLETED|Overall Study||50
11314251|NCT02687412|12513239|FG001|COMPLETED|Overall Study||57
11314252|NCT02687412|12513238|FG000|NOT COMPLETED|Overall Study||0
11314253|NCT02687412|12513239|FG001|NOT COMPLETED|Overall Study||0
11314254|NCT02687451|12513251|FG000|STARTED|Overall Study||6
11402179|NCT04051684|12597025|FG000|STARTED|Overall Study||12
11402180|NCT04051684|12597026|FG001|STARTED|Overall Study||11
11402181|NCT04051684|12597025|FG000|COMPLETED|Overall Study||12
11402182|NCT04051684|12597026|FG001|COMPLETED|Overall Study||11
11314255|NCT02687451|12513252|FG001|STARTED|Overall Study||5
11314256|NCT02687451|12513253|FG002|STARTED|Overall Study||5
11314257|NCT02687451|12513254|FG003|STARTED|Overall Study||5
11314258|NCT02687451|12513255|FG004|STARTED|Overall Study||4
11314259|NCT02687451|12513256|FG005|STARTED|Overall Study||3
11314260|NCT02687451|12513251|FG000|COMPLETED|Overall Study||5
11314261|NCT02687451|12513252|FG001|COMPLETED|Overall Study||5
11314262|NCT02687451|12513253|FG002|COMPLETED|Overall Study||5
11314263|NCT02687451|12513254|FG003|COMPLETED|Overall Study||5
11314264|NCT02687451|12513255|FG004|COMPLETED|Overall Study||4
11314265|NCT02687451|12513256|FG005|COMPLETED|Overall Study||2
11314266|NCT02687451|12513251|FG000|NOT COMPLETED|Overall Study||1
11314267|NCT02687451|12513252|FG001|NOT COMPLETED|Overall Study||0
11314268|NCT02687451|12513253|FG002|NOT COMPLETED|Overall Study||0
11314269|NCT02687451|12513254|FG003|NOT COMPLETED|Overall Study||0
11402183|NCT04051684|12597025|FG000|NOT COMPLETED|Overall Study||0
11314270|NCT02687451|12513255|FG004|NOT COMPLETED|Overall Study||0
11314271|NCT02687451|12513256|FG005|NOT COMPLETED|Overall Study||1
11314272|NCT02687529|12513274|FG000|STARTED|Overall Study||34
11314273|NCT02687529|12513275|FG001|STARTED|Overall Study||32
11402184|NCT04051684|12597026|FG001|NOT COMPLETED|Overall Study||0
11314274|NCT02687529|12513274|FG000|COMPLETED|Overall Study||34
11314275|NCT02687529|12513275|FG001|COMPLETED|Overall Study||32
11314276|NCT02687529|12513274|FG000|NOT COMPLETED|Overall Study||0
11314277|NCT02687529|12513275|FG001|NOT COMPLETED|Overall Study||0
11402185|NCT04046341|12597032|FG000|STARTED|Overall Study||15
11314278|NCT02687542|12513286|FG000|STARTED|Overall Study||23
11314279|NCT02687542|12513287|FG001|STARTED|Overall Study||13
11314280|NCT02687542|12513288|FG002|STARTED|Overall Study||15
11314281|NCT02687542|12513289|FG003|STARTED|Overall Study||13
11314282|NCT02687542|12513290|FG004|STARTED|Overall Study||44
11314283|NCT02687542|12513286|FG000|COMPLETED|Overall Study||15
11314284|NCT02687542|12513287|FG001|COMPLETED|Overall Study||1
11314285|NCT02687542|12513288|FG002|COMPLETED|Overall Study||1
11314286|NCT02687542|12513289|FG003|COMPLETED|Overall Study||3
11314287|NCT02687542|12513290|FG004|COMPLETED|Overall Study||24
11314288|NCT02687542|12513286|FG000|NOT COMPLETED|Overall Study||8
11314289|NCT02687542|12513287|FG001|NOT COMPLETED|Overall Study||12
11314290|NCT02687542|12513288|FG002|NOT COMPLETED|Overall Study||14
11314291|NCT02687542|12513289|FG003|NOT COMPLETED|Overall Study||10
11314292|NCT02687542|12513290|FG004|NOT COMPLETED|Overall Study||20
11314293|NCT02687711|12513302|FG000|STARTED|Overall Study||544
11314294|NCT02687711|12513302|FG000|COMPLETED|Overall Study||332
11314295|NCT02687711|12513302|FG000|NOT COMPLETED|Overall Study||212
11314296|NCT02687815|12513308|FG000|STARTED|Overall Study||96
11314297|NCT02687815|12513309|FG001|STARTED|Overall Study||96
11314298|NCT02687815|12513308|FG000|COMPLETED|Overall Study||92
11314299|NCT02687815|12513309|FG001|COMPLETED|Overall Study||88
11314300|NCT02687815|12513308|FG000|NOT COMPLETED|Overall Study||4
11314301|NCT02687815|12513309|FG001|NOT COMPLETED|Overall Study||8
11314302|NCT02687919|12513317|FG000|STARTED|Overall Study||16
11314303|NCT02687919|12513318|FG001|STARTED|Overall Study||15
11314304|NCT02687919|12513317|FG000|COMPLETED|Overall Study||8
11314305|NCT02687919|12513318|FG001|COMPLETED|Overall Study||9
11314306|NCT02687919|12513317|FG000|NOT COMPLETED|Overall Study||8
11314307|NCT02687919|12513318|FG001|NOT COMPLETED|Overall Study||6
11314308|NCT02688153|12513326|FG000|STARTED|Overall Study||62
11314309|NCT02688153|12513327|FG001|STARTED|Overall Study||58
11314310|NCT02688153|12513326|FG000|Final Randomized Arm/Group|Overall Study||59
11314311|NCT02688153|12513327|FG001|Final Randomized Arm/Group|Overall Study||61
11314312|NCT02688153|12513326|FG000|COMPLETED|Overall Study||47
11314313|NCT02688153|12513327|FG001|COMPLETED|Overall Study||51
11314314|NCT02688153|12513326|FG000|NOT COMPLETED|Overall Study||15
11314315|NCT02688153|12513327|FG001|NOT COMPLETED|Overall Study||7
11314316|NCT02688192|12513336|FG000|STARTED|Overall Study||25
11314317|NCT02688192|12513337|FG001|STARTED|Overall Study||24
11314318|NCT02688192|12513336|FG000|COMPLETED|Overall Study||13
11314319|NCT02688192|12513337|FG001|COMPLETED|Overall Study||19
11314320|NCT02688192|12513336|FG000|NOT COMPLETED|Overall Study||12
11314321|NCT02688192|12513337|FG001|NOT COMPLETED|Overall Study||5
11314322|NCT02688218|12513346|FG000|STARTED|First Exercise Intervention (2 Hours)||24
11314323|NCT02688218|12513347|FG001|STARTED|First Exercise Intervention (2 Hours)||6
11314324|NCT02688218|12513346|FG000|COMPLETED|First Exercise Intervention (2 Hours)||24
11314325|NCT02688218|12513347|FG001|COMPLETED|First Exercise Intervention (2 Hours)||6
11314326|NCT02688218|12513346|FG000|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
11314327|NCT02688218|12513347|FG001|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
11314328|NCT02688218|12513346|FG000|STARTED|Washout (30 Minutes)||24
11314329|NCT02688218|12513347|FG001|STARTED|Washout (30 Minutes)||6
11314330|NCT02688218|12513346|FG000|COMPLETED|Washout (30 Minutes)||24
11314331|NCT02688218|12513347|FG001|COMPLETED|Washout (30 Minutes)||6
11314332|NCT02688218|12513346|FG000|NOT COMPLETED|Washout (30 Minutes)||0
11314333|NCT02688218|12513347|FG001|NOT COMPLETED|Washout (30 Minutes)||0
11314334|NCT02688218|12513346|FG000|STARTED|Second Exercise Intervention (2 Hours)||24
11314335|NCT02688218|12513347|FG001|STARTED|Second Exercise Intervention (2 Hours)||6
11314336|NCT02688218|12513346|FG000|COMPLETED|Second Exercise Intervention (2 Hours)||24
11314337|NCT02688218|12513347|FG001|COMPLETED|Second Exercise Intervention (2 Hours)||6
11314338|NCT02688218|12513346|FG000|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
11314339|NCT02688218|12513347|FG001|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
11314340|NCT02688387|12513357|FG000|STARTED|Part 1, Period 1 (up to 6 Days)||3
11314341|NCT02688387|12513358|FG001|STARTED|Part 1, Period 1 (up to 6 Days)||3
11314342|NCT02688387|12513359|FG002|STARTED|Part 1, Period 1 (up to 6 Days)||4
11314343|NCT02688387|12513360|FG003|STARTED|Part 1, Period 1 (up to 6 Days)||3
11314344|NCT02688387|12513361|FG004|STARTED|Part 1, Period 1 (up to 6 Days)||3
11314345|NCT02688387|12513362|FG005|STARTED|Part 1, Period 1 (up to 6 Days)||2
11314346|NCT02688387|12513363|FG006|STARTED|Part 1, Period 1 (up to 6 Days)||2
11314347|NCT02688387|12513364|FG007|STARTED|Part 1, Period 1 (up to 6 Days)||2
11314348|NCT02688387|12513365|FG008|STARTED|Part 1, Period 1 (up to 6 Days)||2
11314349|NCT02688387|12513366|FG009|STARTED|Part 1, Period 1 (up to 6 Days)||2
11314350|NCT02688387|12513367|FG010|STARTED|Part 1, Period 1 (up to 6 Days)||0
11314351|NCT02688387|12513368|FG011|STARTED|Part 1, Period 1 (up to 6 Days)||0
11314352|NCT02688387|12513369|FG012|STARTED|Part 1, Period 1 (up to 6 Days)||0
11314353|NCT02688387|12513370|FG013|STARTED|Part 1, Period 1 (up to 6 Days)||0
11314354|NCT02688387|12513371|FG014|STARTED|Part 1, Period 1 (up to 6 Days)||0
11314355|NCT02688387|12513372|FG015|STARTED|Part 1, Period 1 (up to 6 Days)||0
11314356|NCT02688387|12513373|FG016|STARTED|Part 1, Period 1 (up to 6 Days)||0
11314357|NCT02688387|12513374|FG017|STARTED|Part 1, Period 1 (up to 6 Days)||0
11314358|NCT02688387|12513375|FG018|STARTED|Part 1, Period 1 (up to 6 Days)||0
11314359|NCT02688387|12513376|FG019|STARTED|Part 1, Period 1 (up to 6 Days)||0
11314360|NCT02688387|12513377|FG020|STARTED|Part 1, Period 1 (up to 6 Days)||0
11314361|NCT02688387|12513378|FG021|STARTED|Part 1, Period 1 (up to 6 Days)||0
11314362|NCT02688387|12513357|FG000|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
11314363|NCT02688387|12513358|FG001|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
11314364|NCT02688387|12513359|FG002|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
11314365|NCT02688387|12513360|FG003|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
11314366|NCT02688387|12513361|FG004|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
11314367|NCT02688387|12513362|FG005|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
11314368|NCT02688387|12513363|FG006|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
11314369|NCT02688387|12513364|FG007|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
11314370|NCT02688387|12513365|FG008|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
11314371|NCT02688387|12513366|FG009|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
11314372|NCT02688387|12513367|FG010|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314373|NCT02688387|12513368|FG011|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314374|NCT02688387|12513369|FG012|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314375|NCT02688387|12513370|FG013|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314376|NCT02688387|12513371|FG014|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314377|NCT02688387|12513372|FG015|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314378|NCT02688387|12513373|FG016|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314379|NCT02688387|12513374|FG017|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314380|NCT02688387|12513375|FG018|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314381|NCT02688387|12513376|FG019|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314382|NCT02688387|12513377|FG020|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314383|NCT02688387|12513378|FG021|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314384|NCT02688387|12513357|FG000|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314385|NCT02688387|12513358|FG001|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314386|NCT02688387|12513359|FG002|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
11314387|NCT02688387|12513360|FG003|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
11314388|NCT02688387|12513361|FG004|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314389|NCT02688387|12513362|FG005|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314390|NCT02688387|12513363|FG006|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314391|NCT02688387|12513364|FG007|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314392|NCT02688387|12513365|FG008|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314393|NCT02688387|12513366|FG009|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314394|NCT02688387|12513367|FG010|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314395|NCT02688387|12513368|FG011|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314396|NCT02688387|12513369|FG012|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314397|NCT02688387|12513370|FG013|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314398|NCT02688387|12513371|FG014|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314399|NCT02688387|12513372|FG015|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314400|NCT02688387|12513373|FG016|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314401|NCT02688387|12513374|FG017|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314402|NCT02688387|12513375|FG018|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314403|NCT02688387|12513376|FG019|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314404|NCT02688387|12513377|FG020|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314405|NCT02688387|12513378|FG021|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
11314406|NCT02688387|12513357|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||3
11314407|NCT02688387|12513358|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||3
11314408|NCT02688387|12513359|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||3
11314409|NCT02688387|12513360|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||2
11314410|NCT02688387|12513361|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||3
11314411|NCT02688387|12513362|FG005|STARTED|Part 1, Washout Period 1 (7 Days)||2
11314412|NCT02688387|12513363|FG006|STARTED|Part 1, Washout Period 1 (7 Days)||2
11314413|NCT02688387|12513364|FG007|STARTED|Part 1, Washout Period 1 (7 Days)||2
11314414|NCT02688387|12513365|FG008|STARTED|Part 1, Washout Period 1 (7 Days)||2
11314415|NCT02688387|12513366|FG009|STARTED|Part 1, Washout Period 1 (7 Days)||2
11314416|NCT02688387|12513367|FG010|STARTED|Part 1, Washout Period 1 (7 Days)||0
11314417|NCT02688387|12513368|FG011|STARTED|Part 1, Washout Period 1 (7 Days)||0
11314418|NCT02688387|12513369|FG012|STARTED|Part 1, Washout Period 1 (7 Days)||0
11314419|NCT02688387|12513370|FG013|STARTED|Part 1, Washout Period 1 (7 Days)||0
11314420|NCT02688387|12513371|FG014|STARTED|Part 1, Washout Period 1 (7 Days)||0
11314421|NCT02688387|12513372|FG015|STARTED|Part 1, Washout Period 1 (7 Days)||0
11314422|NCT02688387|12513373|FG016|STARTED|Part 1, Washout Period 1 (7 Days)||0
11314423|NCT02688387|12513374|FG017|STARTED|Part 1, Washout Period 1 (7 Days)||0
11314424|NCT02688387|12513375|FG018|STARTED|Part 1, Washout Period 1 (7 Days)||0
11314425|NCT02688387|12513376|FG019|STARTED|Part 1, Washout Period 1 (7 Days)||0
11314426|NCT02688387|12513377|FG020|STARTED|Part 1, Washout Period 1 (7 Days)||0
11314427|NCT02688387|12513378|FG021|STARTED|Part 1, Washout Period 1 (7 Days)||0
11314428|NCT02688387|12513357|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
11314429|NCT02688387|12513358|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
11314430|NCT02688387|12513359|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
11314431|NCT02688387|12513360|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
11314432|NCT02688387|12513361|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
11314433|NCT02688387|12513362|FG005|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
11314434|NCT02688387|12513363|FG006|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
11314435|NCT02688387|12513364|FG007|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
11314436|NCT02688387|12513365|FG008|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
11314437|NCT02688387|12513366|FG009|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
11314438|NCT02688387|12513367|FG010|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314439|NCT02688387|12513368|FG011|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314440|NCT02688387|12513369|FG012|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314441|NCT02688387|12513370|FG013|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314442|NCT02688387|12513371|FG014|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314443|NCT02688387|12513372|FG015|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314444|NCT02688387|12513373|FG016|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314445|NCT02688387|12513374|FG017|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314446|NCT02688387|12513375|FG018|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314447|NCT02688387|12513376|FG019|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314448|NCT02688387|12513377|FG020|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314449|NCT02688387|12513378|FG021|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314450|NCT02688387|12513357|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314451|NCT02688387|12513358|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1
11314452|NCT02688387|12513359|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314453|NCT02688387|12513360|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314454|NCT02688387|12513361|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314455|NCT02688387|12513362|FG005|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314456|NCT02688387|12513363|FG006|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314457|NCT02688387|12513364|FG007|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314458|NCT02688387|12513365|FG008|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314459|NCT02688387|12513366|FG009|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314460|NCT02688387|12513367|FG010|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314461|NCT02688387|12513368|FG011|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314462|NCT02688387|12513369|FG012|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314463|NCT02688387|12513370|FG013|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314464|NCT02688387|12513371|FG014|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314465|NCT02688387|12513372|FG015|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314466|NCT02688387|12513373|FG016|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314467|NCT02688387|12513374|FG017|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314468|NCT02688387|12513375|FG018|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314469|NCT02688387|12513376|FG019|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314470|NCT02688387|12513377|FG020|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314471|NCT02688387|12513378|FG021|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
11314472|NCT02688387|12513357|FG000|STARTED|Part 1, Period 2 (up to 6 Days)||3
11314473|NCT02688387|12513358|FG001|STARTED|Part 1, Period 2 (up to 6 Days)||2
11314474|NCT02688387|12513359|FG002|STARTED|Part 1, Period 2 (up to 6 Days)||3
11314475|NCT02688387|12513360|FG003|STARTED|Part 1, Period 2 (up to 6 Days)||2
11314476|NCT02688387|12513361|FG004|STARTED|Part 1, Period 2 (up to 6 Days)||3
11314477|NCT02688387|12513362|FG005|STARTED|Part 1, Period 2 (up to 6 Days)||2
11314478|NCT02688387|12513363|FG006|STARTED|Part 1, Period 2 (up to 6 Days)||2
11314479|NCT02688387|12513364|FG007|STARTED|Part 1, Period 2 (up to 6 Days)||2
11314480|NCT02688387|12513365|FG008|STARTED|Part 1, Period 2 (up to 6 Days)||2
11314481|NCT02688387|12513366|FG009|STARTED|Part 1, Period 2 (up to 6 Days)||2
11314482|NCT02688387|12513367|FG010|STARTED|Part 1, Period 2 (up to 6 Days)||0
11314483|NCT02688387|12513368|FG011|STARTED|Part 1, Period 2 (up to 6 Days)||0
11314484|NCT02688387|12513369|FG012|STARTED|Part 1, Period 2 (up to 6 Days)||0
11314485|NCT02688387|12513370|FG013|STARTED|Part 1, Period 2 (up to 6 Days)||0
11314486|NCT02688387|12513371|FG014|STARTED|Part 1, Period 2 (up to 6 Days)||0
11314487|NCT02688387|12513372|FG015|STARTED|Part 1, Period 2 (up to 6 Days)||0
11314488|NCT02688387|12513373|FG016|STARTED|Part 1, Period 2 (up to 6 Days)||0
11314489|NCT02688387|12513374|FG017|STARTED|Part 1, Period 2 (up to 6 Days)||0
11314490|NCT02688387|12513375|FG018|STARTED|Part 1, Period 2 (up to 6 Days)||0
11314491|NCT02688387|12513376|FG019|STARTED|Part 1, Period 2 (up to 6 Days)||0
11314492|NCT02688387|12513377|FG020|STARTED|Part 1, Period 2 (up to 6 Days)||0
11314493|NCT02688387|12513378|FG021|STARTED|Part 1, Period 2 (up to 6 Days)||0
11314494|NCT02688387|12513357|FG000|COMPLETED|Part 1, Period 2 (up to 6 Days)||3
11314495|NCT02688387|12513358|FG001|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
11314496|NCT02688387|12513359|FG002|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
11314497|NCT02688387|12513360|FG003|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
11314498|NCT02688387|12513361|FG004|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
11314499|NCT02688387|12513362|FG005|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
11314500|NCT02688387|12513363|FG006|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
11314501|NCT02688387|12513364|FG007|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
11314502|NCT02688387|12513365|FG008|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
11314503|NCT02688387|12513366|FG009|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
11314504|NCT02688387|12513367|FG010|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314505|NCT02688387|12513368|FG011|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314506|NCT02688387|12513369|FG012|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314507|NCT02688387|12513370|FG013|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314508|NCT02688387|12513371|FG014|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314509|NCT02688387|12513372|FG015|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314510|NCT02688387|12513373|FG016|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314511|NCT02688387|12513374|FG017|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314512|NCT02688387|12513375|FG018|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314513|NCT02688387|12513376|FG019|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314514|NCT02688387|12513377|FG020|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314515|NCT02688387|12513378|FG021|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314516|NCT02688387|12513357|FG000|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314517|NCT02688387|12513358|FG001|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314518|NCT02688387|12513359|FG002|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
11314519|NCT02688387|12513360|FG003|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314520|NCT02688387|12513361|FG004|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
11314521|NCT02688387|12513362|FG005|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314522|NCT02688387|12513363|FG006|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314523|NCT02688387|12513364|FG007|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314524|NCT02688387|12513365|FG008|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314525|NCT02688387|12513366|FG009|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314526|NCT02688387|12513367|FG010|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314527|NCT02688387|12513368|FG011|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314528|NCT02688387|12513369|FG012|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314529|NCT02688387|12513370|FG013|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314530|NCT02688387|12513371|FG014|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314531|NCT02688387|12513372|FG015|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314532|NCT02688387|12513373|FG016|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314533|NCT02688387|12513374|FG017|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314534|NCT02688387|12513375|FG018|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314535|NCT02688387|12513376|FG019|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314536|NCT02688387|12513377|FG020|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314537|NCT02688387|12513378|FG021|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
11314538|NCT02688387|12513357|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||3
11314539|NCT02688387|12513358|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||2
11314540|NCT02688387|12513359|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||2
11314541|NCT02688387|12513360|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||2
11314542|NCT02688387|12513361|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||2
11314543|NCT02688387|12513362|FG005|STARTED|Part 1, Washout Period 2 (7 Days)||2
11314544|NCT02688387|12513363|FG006|STARTED|Part 1, Washout Period 2 (7 Days)||2
11314545|NCT02688387|12513364|FG007|STARTED|Part 1, Washout Period 2 (7 Days)||2
11314546|NCT02688387|12513365|FG008|STARTED|Part 1, Washout Period 2 (7 Days)||2
11314547|NCT02688387|12513366|FG009|STARTED|Part 1, Washout Period 2 (7 Days)||2
11314548|NCT02688387|12513367|FG010|STARTED|Part 1, Washout Period 2 (7 Days)||0
11314549|NCT02688387|12513368|FG011|STARTED|Part 1, Washout Period 2 (7 Days)||0
11314550|NCT02688387|12513369|FG012|STARTED|Part 1, Washout Period 2 (7 Days)||0
11314551|NCT02688387|12513370|FG013|STARTED|Part 1, Washout Period 2 (7 Days)||0
11314552|NCT02688387|12513371|FG014|STARTED|Part 1, Washout Period 2 (7 Days)||0
11314553|NCT02688387|12513372|FG015|STARTED|Part 1, Washout Period 2 (7 Days)||0
11314554|NCT02688387|12513373|FG016|STARTED|Part 1, Washout Period 2 (7 Days)||0
11314555|NCT02688387|12513374|FG017|STARTED|Part 1, Washout Period 2 (7 Days)||0
11314556|NCT02688387|12513375|FG018|STARTED|Part 1, Washout Period 2 (7 Days)||0
11314557|NCT02688387|12513376|FG019|STARTED|Part 1, Washout Period 2 (7 Days)||0
11314558|NCT02688387|12513377|FG020|STARTED|Part 1, Washout Period 2 (7 Days)||0
11314559|NCT02688387|12513378|FG021|STARTED|Part 1, Washout Period 2 (7 Days)||0
11314560|NCT02688387|12513357|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||3
11314561|NCT02688387|12513358|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
11314562|NCT02688387|12513359|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
11314563|NCT02688387|12513360|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
11314564|NCT02688387|12513361|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
11314565|NCT02688387|12513362|FG005|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
11314566|NCT02688387|12513363|FG006|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
11314567|NCT02688387|12513364|FG007|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
11314568|NCT02688387|12513365|FG008|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
11314569|NCT02688387|12513366|FG009|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
11314570|NCT02688387|12513367|FG010|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314571|NCT02688387|12513368|FG011|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314572|NCT02688387|12513369|FG012|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314573|NCT02688387|12513370|FG013|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314574|NCT02688387|12513371|FG014|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314575|NCT02688387|12513372|FG015|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314576|NCT02688387|12513373|FG016|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314577|NCT02688387|12513374|FG017|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314578|NCT02688387|12513375|FG018|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314579|NCT02688387|12513376|FG019|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314580|NCT02688387|12513377|FG020|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314581|NCT02688387|12513378|FG021|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314582|NCT02688387|12513357|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314583|NCT02688387|12513358|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314584|NCT02688387|12513359|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314585|NCT02688387|12513360|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314586|NCT02688387|12513361|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314587|NCT02688387|12513362|FG005|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314588|NCT02688387|12513363|FG006|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314589|NCT02688387|12513364|FG007|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314590|NCT02688387|12513365|FG008|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314591|NCT02688387|12513366|FG009|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314592|NCT02688387|12513367|FG010|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314593|NCT02688387|12513368|FG011|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314594|NCT02688387|12513369|FG012|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314595|NCT02688387|12513370|FG013|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314596|NCT02688387|12513371|FG014|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314597|NCT02688387|12513372|FG015|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314598|NCT02688387|12513373|FG016|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314599|NCT02688387|12513374|FG017|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314600|NCT02688387|12513375|FG018|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314601|NCT02688387|12513376|FG019|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314602|NCT02688387|12513377|FG020|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314603|NCT02688387|12513378|FG021|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
11314604|NCT02688387|12513357|FG000|STARTED|Part 1, Period 3 (up to 6 Days)||3
11314605|NCT02688387|12513358|FG001|STARTED|Part 1, Period 3 (up to 6 Days)||2
11314606|NCT02688387|12513359|FG002|STARTED|Part 1, Period 3 (up to 6 Days)||2
11314607|NCT02688387|12513360|FG003|STARTED|Part 1, Period 3 (up to 6 Days)||2
11314608|NCT02688387|12513361|FG004|STARTED|Part 1, Period 3 (up to 6 Days)||2
11314609|NCT02688387|12513362|FG005|STARTED|Part 1, Period 3 (up to 6 Days)||2
11314610|NCT02688387|12513363|FG006|STARTED|Part 1, Period 3 (up to 6 Days)||2
11314611|NCT02688387|12513364|FG007|STARTED|Part 1, Period 3 (up to 6 Days)||2
11314612|NCT02688387|12513365|FG008|STARTED|Part 1, Period 3 (up to 6 Days)||2
11314613|NCT02688387|12513366|FG009|STARTED|Part 1, Period 3 (up to 6 Days)||2
11314614|NCT02688387|12513367|FG010|STARTED|Part 1, Period 3 (up to 6 Days)||0
11314615|NCT02688387|12513368|FG011|STARTED|Part 1, Period 3 (up to 6 Days)||0
11314616|NCT02688387|12513369|FG012|STARTED|Part 1, Period 3 (up to 6 Days)||0
11314617|NCT02688387|12513370|FG013|STARTED|Part 1, Period 3 (up to 6 Days)||0
11314618|NCT02688387|12513371|FG014|STARTED|Part 1, Period 3 (up to 6 Days)||0
11314619|NCT02688387|12513372|FG015|STARTED|Part 1, Period 3 (up to 6 Days)||0
11314620|NCT02688387|12513373|FG016|STARTED|Part 1, Period 3 (up to 6 Days)||0
11314621|NCT02688387|12513374|FG017|STARTED|Part 1, Period 3 (up to 6 Days)||0
11314622|NCT02688387|12513375|FG018|STARTED|Part 1, Period 3 (up to 6 Days)||0
11314623|NCT02688387|12513376|FG019|STARTED|Part 1, Period 3 (up to 6 Days)||0
11314624|NCT02688387|12513377|FG020|STARTED|Part 1, Period 3 (up to 6 Days)||0
11314625|NCT02688387|12513378|FG021|STARTED|Part 1, Period 3 (up to 6 Days)||0
11314626|NCT02688387|12513357|FG000|COMPLETED|Part 1, Period 3 (up to 6 Days)||3
11314627|NCT02688387|12513358|FG001|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
11314628|NCT02688387|12513359|FG002|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
11314629|NCT02688387|12513360|FG003|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
11314630|NCT02688387|12513361|FG004|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
11314631|NCT02688387|12513362|FG005|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
11314632|NCT02688387|12513363|FG006|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
11314633|NCT02688387|12513364|FG007|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
11314634|NCT02688387|12513365|FG008|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
11314635|NCT02688387|12513366|FG009|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
11314636|NCT02688387|12513367|FG010|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314637|NCT02688387|12513368|FG011|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314638|NCT02688387|12513369|FG012|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314639|NCT02688387|12513370|FG013|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314640|NCT02688387|12513371|FG014|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314641|NCT02688387|12513372|FG015|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314642|NCT02688387|12513373|FG016|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314643|NCT02688387|12513374|FG017|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314644|NCT02688387|12513375|FG018|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314645|NCT02688387|12513376|FG019|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314646|NCT02688387|12513377|FG020|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314647|NCT02688387|12513378|FG021|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314648|NCT02688387|12513357|FG000|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314649|NCT02688387|12513358|FG001|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314650|NCT02688387|12513359|FG002|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314651|NCT02688387|12513360|FG003|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314652|NCT02688387|12513361|FG004|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314653|NCT02688387|12513362|FG005|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314654|NCT02688387|12513363|FG006|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314655|NCT02688387|12513364|FG007|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314656|NCT02688387|12513365|FG008|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314657|NCT02688387|12513366|FG009|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314658|NCT02688387|12513367|FG010|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314659|NCT02688387|12513368|FG011|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314660|NCT02688387|12513369|FG012|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314661|NCT02688387|12513370|FG013|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314662|NCT02688387|12513371|FG014|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314663|NCT02688387|12513372|FG015|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314664|NCT02688387|12513373|FG016|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314665|NCT02688387|12513374|FG017|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314666|NCT02688387|12513375|FG018|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314667|NCT02688387|12513376|FG019|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314668|NCT02688387|12513377|FG020|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314669|NCT02688387|12513378|FG021|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
11314670|NCT02688387|12513357|FG000|STARTED|Part 1, Washout Period 3 (7 Days)||3
11314671|NCT02688387|12513358|FG001|STARTED|Part 1, Washout Period 3 (7 Days)||2
11314672|NCT02688387|12513359|FG002|STARTED|Part 1, Washout Period 3 (7 Days)||2
11314673|NCT02688387|12513360|FG003|STARTED|Part 1, Washout Period 3 (7 Days)||2
11314674|NCT02688387|12513361|FG004|STARTED|Part 1, Washout Period 3 (7 Days)||2
11314675|NCT02688387|12513362|FG005|STARTED|Part 1, Washout Period 3 (7 Days)||2
11314676|NCT02688387|12513363|FG006|STARTED|Part 1, Washout Period 3 (7 Days)||2
11314677|NCT02688387|12513364|FG007|STARTED|Part 1, Washout Period 3 (7 Days)||2
11314678|NCT02688387|12513365|FG008|STARTED|Part 1, Washout Period 3 (7 Days)||2
11314679|NCT02688387|12513366|FG009|STARTED|Part 1, Washout Period 3 (7 Days)||2
11314680|NCT02688387|12513367|FG010|STARTED|Part 1, Washout Period 3 (7 Days)||0
11314681|NCT02688387|12513368|FG011|STARTED|Part 1, Washout Period 3 (7 Days)||0
11314682|NCT02688387|12513369|FG012|STARTED|Part 1, Washout Period 3 (7 Days)||0
11314683|NCT02688387|12513370|FG013|STARTED|Part 1, Washout Period 3 (7 Days)||0
11314684|NCT02688387|12513371|FG014|STARTED|Part 1, Washout Period 3 (7 Days)||0
11314685|NCT02688387|12513372|FG015|STARTED|Part 1, Washout Period 3 (7 Days)||0
11314686|NCT02688387|12513373|FG016|STARTED|Part 1, Washout Period 3 (7 Days)||0
11314687|NCT02688387|12513374|FG017|STARTED|Part 1, Washout Period 3 (7 Days)||0
11314688|NCT02688387|12513375|FG018|STARTED|Part 1, Washout Period 3 (7 Days)||0
11314689|NCT02688387|12513376|FG019|STARTED|Part 1, Washout Period 3 (7 Days)||0
11314690|NCT02688387|12513377|FG020|STARTED|Part 1, Washout Period 3 (7 Days)||0
11314691|NCT02688387|12513378|FG021|STARTED|Part 1, Washout Period 3 (7 Days)||0
11314692|NCT02688387|12513357|FG000|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
11314693|NCT02688387|12513358|FG001|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
11314694|NCT02688387|12513359|FG002|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
11314695|NCT02688387|12513360|FG003|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
11314696|NCT02688387|12513361|FG004|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
11314697|NCT02688387|12513362|FG005|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
11314698|NCT02688387|12513363|FG006|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
11314699|NCT02688387|12513364|FG007|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
11314700|NCT02688387|12513365|FG008|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
11314701|NCT02688387|12513366|FG009|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
11314702|NCT02688387|12513367|FG010|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314703|NCT02688387|12513368|FG011|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314704|NCT02688387|12513369|FG012|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314705|NCT02688387|12513370|FG013|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314706|NCT02688387|12513371|FG014|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314707|NCT02688387|12513372|FG015|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314708|NCT02688387|12513373|FG016|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314709|NCT02688387|12513374|FG017|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314710|NCT02688387|12513375|FG018|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314711|NCT02688387|12513376|FG019|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314712|NCT02688387|12513377|FG020|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314713|NCT02688387|12513378|FG021|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314714|NCT02688387|12513357|FG000|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1
11314715|NCT02688387|12513358|FG001|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314716|NCT02688387|12513359|FG002|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314717|NCT02688387|12513360|FG003|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314718|NCT02688387|12513361|FG004|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314719|NCT02688387|12513362|FG005|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314720|NCT02688387|12513363|FG006|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314721|NCT02688387|12513364|FG007|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314722|NCT02688387|12513365|FG008|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314723|NCT02688387|12513366|FG009|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314724|NCT02688387|12513367|FG010|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314725|NCT02688387|12513368|FG011|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314726|NCT02688387|12513369|FG012|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314727|NCT02688387|12513370|FG013|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314728|NCT02688387|12513371|FG014|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314729|NCT02688387|12513372|FG015|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314730|NCT02688387|12513373|FG016|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314731|NCT02688387|12513374|FG017|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314732|NCT02688387|12513375|FG018|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314733|NCT02688387|12513376|FG019|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314734|NCT02688387|12513377|FG020|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314735|NCT02688387|12513378|FG021|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
11314736|NCT02688387|12513357|FG000|STARTED|Part 1, Period 4 (up to 6 Days)||2
11314737|NCT02688387|12513358|FG001|STARTED|Part 1, Period 4 (up to 6 Days)||2
11314738|NCT02688387|12513359|FG002|STARTED|Part 1, Period 4 (up to 6 Days)||2
11314739|NCT02688387|12513360|FG003|STARTED|Part 1, Period 4 (up to 6 Days)||2
11314740|NCT02688387|12513361|FG004|STARTED|Part 1, Period 4 (up to 6 Days)||2
11314741|NCT02688387|12513362|FG005|STARTED|Part 1, Period 4 (up to 6 Days)||2
11314742|NCT02688387|12513363|FG006|STARTED|Part 1, Period 4 (up to 6 Days)||2
11314743|NCT02688387|12513364|FG007|STARTED|Part 1, Period 4 (up to 6 Days)||2
11314744|NCT02688387|12513365|FG008|STARTED|Part 1, Period 4 (up to 6 Days)||2
11314745|NCT02688387|12513366|FG009|STARTED|Part 1, Period 4 (up to 6 Days)||2
11314746|NCT02688387|12513367|FG010|STARTED|Part 1, Period 4 (up to 6 Days)||0
11314747|NCT02688387|12513368|FG011|STARTED|Part 1, Period 4 (up to 6 Days)||0
11314748|NCT02688387|12513369|FG012|STARTED|Part 1, Period 4 (up to 6 Days)||0
11314749|NCT02688387|12513370|FG013|STARTED|Part 1, Period 4 (up to 6 Days)||0
11314750|NCT02688387|12513371|FG014|STARTED|Part 1, Period 4 (up to 6 Days)||0
11314751|NCT02688387|12513372|FG015|STARTED|Part 1, Period 4 (up to 6 Days)||0
11314752|NCT02688387|12513373|FG016|STARTED|Part 1, Period 4 (up to 6 Days)||0
11314753|NCT02688387|12513374|FG017|STARTED|Part 1, Period 4 (up to 6 Days)||0
11314754|NCT02688387|12513375|FG018|STARTED|Part 1, Period 4 (up to 6 Days)||0
11314755|NCT02688387|12513376|FG019|STARTED|Part 1, Period 4 (up to 6 Days)||0
11314756|NCT02688387|12513377|FG020|STARTED|Part 1, Period 4 (up to 6 Days)||0
11314757|NCT02688387|12513378|FG021|STARTED|Part 1, Period 4 (up to 6 Days)||0
11314758|NCT02688387|12513357|FG000|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
11314759|NCT02688387|12513358|FG001|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
11314760|NCT02688387|12513359|FG002|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
11314761|NCT02688387|12513360|FG003|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
11314762|NCT02688387|12513361|FG004|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
11314763|NCT02688387|12513362|FG005|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
11314764|NCT02688387|12513363|FG006|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
11314765|NCT02688387|12513364|FG007|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
11314766|NCT02688387|12513365|FG008|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
11314767|NCT02688387|12513366|FG009|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
11314768|NCT02688387|12513367|FG010|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314769|NCT02688387|12513368|FG011|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314770|NCT02688387|12513369|FG012|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314771|NCT02688387|12513370|FG013|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314772|NCT02688387|12513371|FG014|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314773|NCT02688387|12513372|FG015|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314774|NCT02688387|12513373|FG016|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314775|NCT02688387|12513374|FG017|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314776|NCT02688387|12513375|FG018|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314777|NCT02688387|12513376|FG019|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314778|NCT02688387|12513377|FG020|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314779|NCT02688387|12513378|FG021|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314780|NCT02688387|12513357|FG000|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314781|NCT02688387|12513358|FG001|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314782|NCT02688387|12513359|FG002|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314783|NCT02688387|12513360|FG003|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314784|NCT02688387|12513361|FG004|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314785|NCT02688387|12513362|FG005|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314786|NCT02688387|12513363|FG006|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314787|NCT02688387|12513364|FG007|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314788|NCT02688387|12513365|FG008|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314789|NCT02688387|12513366|FG009|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314790|NCT02688387|12513367|FG010|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314791|NCT02688387|12513368|FG011|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314792|NCT02688387|12513369|FG012|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314793|NCT02688387|12513370|FG013|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314794|NCT02688387|12513371|FG014|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314795|NCT02688387|12513372|FG015|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314796|NCT02688387|12513373|FG016|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314797|NCT02688387|12513374|FG017|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314798|NCT02688387|12513375|FG018|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314799|NCT02688387|12513376|FG019|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314800|NCT02688387|12513377|FG020|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314801|NCT02688387|12513378|FG021|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
11314802|NCT02688387|12513357|FG000|STARTED|Part 1, Washout Period 4 (7 Days)||2
11314803|NCT02688387|12513358|FG001|STARTED|Part 1, Washout Period 4 (7 Days)||2
11314804|NCT02688387|12513359|FG002|STARTED|Part 1, Washout Period 4 (7 Days)||2
11314805|NCT02688387|12513360|FG003|STARTED|Part 1, Washout Period 4 (7 Days)||2
11314806|NCT02688387|12513361|FG004|STARTED|Part 1, Washout Period 4 (7 Days)||2
11314807|NCT02688387|12513362|FG005|STARTED|Part 1, Washout Period 4 (7 Days)||2
11314808|NCT02688387|12513363|FG006|STARTED|Part 1, Washout Period 4 (7 Days)||2
11314809|NCT02688387|12513364|FG007|STARTED|Part 1, Washout Period 4 (7 Days)||2
11314810|NCT02688387|12513365|FG008|STARTED|Part 1, Washout Period 4 (7 Days)||2
11314811|NCT02688387|12513366|FG009|STARTED|Part 1, Washout Period 4 (7 Days)||2
11314812|NCT02688387|12513367|FG010|STARTED|Part 1, Washout Period 4 (7 Days)||0
11314813|NCT02688387|12513368|FG011|STARTED|Part 1, Washout Period 4 (7 Days)||0
11314814|NCT02688387|12513369|FG012|STARTED|Part 1, Washout Period 4 (7 Days)||0
11314815|NCT02688387|12513370|FG013|STARTED|Part 1, Washout Period 4 (7 Days)||0
11314816|NCT02688387|12513371|FG014|STARTED|Part 1, Washout Period 4 (7 Days)||0
11314817|NCT02688387|12513372|FG015|STARTED|Part 1, Washout Period 4 (7 Days)||0
11314818|NCT02688387|12513373|FG016|STARTED|Part 1, Washout Period 4 (7 Days)||0
11314819|NCT02688387|12513374|FG017|STARTED|Part 1, Washout Period 4 (7 Days)||0
11314820|NCT02688387|12513375|FG018|STARTED|Part 1, Washout Period 4 (7 Days)||0
11314821|NCT02688387|12513376|FG019|STARTED|Part 1, Washout Period 4 (7 Days)||0
11314822|NCT02688387|12513377|FG020|STARTED|Part 1, Washout Period 4 (7 Days)||0
11314823|NCT02688387|12513378|FG021|STARTED|Part 1, Washout Period 4 (7 Days)||0
11314824|NCT02688387|12513357|FG000|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
11314825|NCT02688387|12513358|FG001|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
11314826|NCT02688387|12513359|FG002|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
11314827|NCT02688387|12513360|FG003|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
11314828|NCT02688387|12513361|FG004|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
11314829|NCT02688387|12513362|FG005|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
11314830|NCT02688387|12513363|FG006|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
11314831|NCT02688387|12513364|FG007|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
11314832|NCT02688387|12513365|FG008|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
11314833|NCT02688387|12513366|FG009|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
11314834|NCT02688387|12513367|FG010|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314835|NCT02688387|12513368|FG011|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314836|NCT02688387|12513369|FG012|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314837|NCT02688387|12513370|FG013|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314838|NCT02688387|12513371|FG014|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314839|NCT02688387|12513372|FG015|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314840|NCT02688387|12513373|FG016|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314841|NCT02688387|12513374|FG017|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314842|NCT02688387|12513375|FG018|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314843|NCT02688387|12513376|FG019|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314844|NCT02688387|12513377|FG020|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314845|NCT02688387|12513378|FG021|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314846|NCT02688387|12513357|FG000|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314847|NCT02688387|12513358|FG001|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314848|NCT02688387|12513359|FG002|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314849|NCT02688387|12513360|FG003|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314850|NCT02688387|12513361|FG004|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314851|NCT02688387|12513362|FG005|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314852|NCT02688387|12513363|FG006|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314853|NCT02688387|12513364|FG007|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314854|NCT02688387|12513365|FG008|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314855|NCT02688387|12513366|FG009|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314856|NCT02688387|12513367|FG010|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314857|NCT02688387|12513368|FG011|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314858|NCT02688387|12513369|FG012|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314859|NCT02688387|12513370|FG013|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314860|NCT02688387|12513371|FG014|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314861|NCT02688387|12513372|FG015|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314862|NCT02688387|12513373|FG016|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314863|NCT02688387|12513374|FG017|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314864|NCT02688387|12513375|FG018|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314865|NCT02688387|12513376|FG019|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314866|NCT02688387|12513377|FG020|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314867|NCT02688387|12513378|FG021|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
11314868|NCT02688387|12513357|FG000|STARTED|Part 1, Period 5 (up to 6 Days)||2
11314869|NCT02688387|12513358|FG001|STARTED|Part 1, Period 5 (up to 6 Days)||2
11314870|NCT02688387|12513359|FG002|STARTED|Part 1, Period 5 (up to 6 Days)||2
11314871|NCT02688387|12513360|FG003|STARTED|Part 1, Period 5 (up to 6 Days)||2
11314872|NCT02688387|12513361|FG004|STARTED|Part 1, Period 5 (up to 6 Days)||2
11314873|NCT02688387|12513362|FG005|STARTED|Part 1, Period 5 (up to 6 Days)||2
11314874|NCT02688387|12513363|FG006|STARTED|Part 1, Period 5 (up to 6 Days)||2
11314875|NCT02688387|12513364|FG007|STARTED|Part 1, Period 5 (up to 6 Days)||2
11314876|NCT02688387|12513365|FG008|STARTED|Part 1, Period 5 (up to 6 Days)||2
11314877|NCT02688387|12513366|FG009|STARTED|Part 1, Period 5 (up to 6 Days)||2
11314878|NCT02688387|12513367|FG010|STARTED|Part 1, Period 5 (up to 6 Days)||0
11314879|NCT02688387|12513368|FG011|STARTED|Part 1, Period 5 (up to 6 Days)||0
11314880|NCT02688387|12513369|FG012|STARTED|Part 1, Period 5 (up to 6 Days)||0
11314881|NCT02688387|12513370|FG013|STARTED|Part 1, Period 5 (up to 6 Days)||0
11314882|NCT02688387|12513371|FG014|STARTED|Part 1, Period 5 (up to 6 Days)||0
11314883|NCT02688387|12513372|FG015|STARTED|Part 1, Period 5 (up to 6 Days)||0
11314884|NCT02688387|12513373|FG016|STARTED|Part 1, Period 5 (up to 6 Days)||0
11314885|NCT02688387|12513374|FG017|STARTED|Part 1, Period 5 (up to 6 Days)||0
11314886|NCT02688387|12513375|FG018|STARTED|Part 1, Period 5 (up to 6 Days)||0
11314887|NCT02688387|12513376|FG019|STARTED|Part 1, Period 5 (up to 6 Days)||0
11314888|NCT02688387|12513377|FG020|STARTED|Part 1, Period 5 (up to 6 Days)||0
11314889|NCT02688387|12513378|FG021|STARTED|Part 1, Period 5 (up to 6 Days)||0
11314890|NCT02688387|12513357|FG000|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
11314891|NCT02688387|12513358|FG001|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
11314892|NCT02688387|12513359|FG002|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
11314893|NCT02688387|12513360|FG003|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
11314894|NCT02688387|12513361|FG004|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
11314895|NCT02688387|12513362|FG005|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
11314896|NCT02688387|12513363|FG006|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
11314897|NCT02688387|12513364|FG007|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
11314898|NCT02688387|12513365|FG008|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
11314899|NCT02688387|12513366|FG009|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
11314900|NCT02688387|12513367|FG010|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314901|NCT02688387|12513368|FG011|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314902|NCT02688387|12513369|FG012|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314903|NCT02688387|12513370|FG013|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314904|NCT02688387|12513371|FG014|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314905|NCT02688387|12513372|FG015|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314906|NCT02688387|12513373|FG016|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314907|NCT02688387|12513374|FG017|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314908|NCT02688387|12513375|FG018|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314909|NCT02688387|12513376|FG019|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314910|NCT02688387|12513377|FG020|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314911|NCT02688387|12513378|FG021|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314912|NCT02688387|12513357|FG000|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314913|NCT02688387|12513358|FG001|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314914|NCT02688387|12513359|FG002|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314915|NCT02688387|12513360|FG003|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314916|NCT02688387|12513361|FG004|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314917|NCT02688387|12513362|FG005|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314918|NCT02688387|12513363|FG006|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314919|NCT02688387|12513364|FG007|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314920|NCT02688387|12513365|FG008|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314921|NCT02688387|12513366|FG009|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314922|NCT02688387|12513367|FG010|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314923|NCT02688387|12513368|FG011|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314924|NCT02688387|12513369|FG012|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314925|NCT02688387|12513370|FG013|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314926|NCT02688387|12513371|FG014|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314927|NCT02688387|12513372|FG015|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314928|NCT02688387|12513373|FG016|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314929|NCT02688387|12513374|FG017|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314930|NCT02688387|12513375|FG018|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314931|NCT02688387|12513376|FG019|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314932|NCT02688387|12513377|FG020|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314933|NCT02688387|12513378|FG021|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
11314934|NCT02688387|12513357|FG000|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314935|NCT02688387|12513358|FG001|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314936|NCT02688387|12513359|FG002|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314937|NCT02688387|12513360|FG003|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314938|NCT02688387|12513361|FG004|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314939|NCT02688387|12513362|FG005|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314940|NCT02688387|12513363|FG006|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314941|NCT02688387|12513364|FG007|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314942|NCT02688387|12513365|FG008|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314943|NCT02688387|12513366|FG009|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314944|NCT02688387|12513367|FG010|STARTED|Part 2, Period 1 (up to 6 Days)||6
11314945|NCT02688387|12513368|FG011|STARTED|Part 2, Period 1 (up to 6 Days)||5
11314946|NCT02688387|12513369|FG012|STARTED|Part 2, Period 1 (up to 6 Days)||5
11314947|NCT02688387|12513370|FG013|STARTED|Part 2, Period 1 (up to 6 Days)||5
11314948|NCT02688387|12513371|FG014|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314949|NCT02688387|12513372|FG015|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314950|NCT02688387|12513373|FG016|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314951|NCT02688387|12513374|FG017|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314952|NCT02688387|12513375|FG018|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314953|NCT02688387|12513376|FG019|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314954|NCT02688387|12513377|FG020|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314955|NCT02688387|12513378|FG021|STARTED|Part 2, Period 1 (up to 6 Days)||0
11314956|NCT02688387|12513357|FG000|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314957|NCT02688387|12513358|FG001|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314958|NCT02688387|12513359|FG002|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314959|NCT02688387|12513360|FG003|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314960|NCT02688387|12513361|FG004|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314961|NCT02688387|12513362|FG005|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314962|NCT02688387|12513363|FG006|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314963|NCT02688387|12513364|FG007|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314964|NCT02688387|12513365|FG008|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314965|NCT02688387|12513366|FG009|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314966|NCT02688387|12513367|FG010|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
11314967|NCT02688387|12513368|FG011|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
11314968|NCT02688387|12513369|FG012|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
11314969|NCT02688387|12513370|FG013|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
11314970|NCT02688387|12513371|FG014|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314971|NCT02688387|12513372|FG015|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314972|NCT02688387|12513373|FG016|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314973|NCT02688387|12513374|FG017|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314974|NCT02688387|12513375|FG018|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314975|NCT02688387|12513376|FG019|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314976|NCT02688387|12513377|FG020|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314977|NCT02688387|12513378|FG021|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314978|NCT02688387|12513357|FG000|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314979|NCT02688387|12513358|FG001|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314980|NCT02688387|12513359|FG002|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314981|NCT02688387|12513360|FG003|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314982|NCT02688387|12513361|FG004|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314983|NCT02688387|12513362|FG005|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314984|NCT02688387|12513363|FG006|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314985|NCT02688387|12513364|FG007|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314986|NCT02688387|12513365|FG008|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314987|NCT02688387|12513366|FG009|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314988|NCT02688387|12513367|FG010|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1
11314989|NCT02688387|12513368|FG011|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314990|NCT02688387|12513369|FG012|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314991|NCT02688387|12513370|FG013|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314992|NCT02688387|12513371|FG014|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314993|NCT02688387|12513372|FG015|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314994|NCT02688387|12513373|FG016|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314995|NCT02688387|12513374|FG017|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314996|NCT02688387|12513375|FG018|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314997|NCT02688387|12513376|FG019|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314998|NCT02688387|12513377|FG020|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11314999|NCT02688387|12513378|FG021|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
11315000|NCT02688387|12513357|FG000|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315001|NCT02688387|12513358|FG001|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315002|NCT02688387|12513359|FG002|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315003|NCT02688387|12513360|FG003|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315004|NCT02688387|12513361|FG004|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315005|NCT02688387|12513362|FG005|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315006|NCT02688387|12513363|FG006|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315007|NCT02688387|12513364|FG007|STARTED|Part 2, Washout Period 1 (10 Days)||0
11402186|NCT04046341|12597032|FG000|COMPLETED|Overall Study||12
11402187|NCT04046341|12597032|FG000|NOT COMPLETED|Overall Study||3
11402188|NCT04045964|12597038|FG000|STARTED|Overall Study||16
11402189|NCT04045964|12597039|FG001|STARTED|Overall Study||16
11402190|NCT04045964|12597038|FG000|Intervention Visit(s)|Overall Study||15
11402191|NCT04045964|12597039|FG001|Intervention Visit(s)|Overall Study||16
11402192|NCT04045964|12597038|FG000|Follow up Visit 1|Overall Study||15
11402193|NCT04045964|12597039|FG001|Follow up Visit 1|Overall Study||15
11402194|NCT04045964|12597038|FG000|Follow up Visit 2|Overall Study||15
11402195|NCT04045964|12597039|FG001|Follow up Visit 2|Overall Study||15
11402196|NCT04045964|12597038|FG000|COMPLETED|Overall Study||15
11402197|NCT04045964|12597039|FG001|COMPLETED|Overall Study||15
11402198|NCT04045964|12597038|FG000|NOT COMPLETED|Overall Study||1
11402199|NCT04045964|12597039|FG001|NOT COMPLETED|Overall Study||1
11402200|NCT04043416|12597047|FG000|STARTED|Campaign 1||14
11402201|NCT04043416|12597048|FG001|STARTED|Campaign 1||14
11402202|NCT04043416|12597047|FG000|COMPLETED|Campaign 1||14
11402203|NCT04043416|12597048|FG001|COMPLETED|Campaign 1||14
11402204|NCT04043416|12597047|FG000|NOT COMPLETED|Campaign 1||0
11402205|NCT04043416|12597048|FG001|NOT COMPLETED|Campaign 1||0
11402206|NCT04043416|12597047|FG000|STARTED|Washout||14
11402207|NCT04043416|12597048|FG001|STARTED|Washout||14
11402208|NCT04043416|12597047|FG000|COMPLETED|Washout||14
11402209|NCT04043416|12597048|FG001|COMPLETED|Washout||13
11402210|NCT04043416|12597047|FG000|NOT COMPLETED|Washout||0
11402211|NCT04043416|12597048|FG001|NOT COMPLETED|Washout||1
11402212|NCT04043416|12597047|FG000|STARTED|Campaign 2||14
11402213|NCT04043416|12597048|FG001|STARTED|Campaign 2||13
11402214|NCT04043416|12597047|FG000|COMPLETED|Campaign 2||14
11402215|NCT04043416|12597048|FG001|COMPLETED|Campaign 2||13
11402216|NCT04043416|12597047|FG000|NOT COMPLETED|Campaign 2||0
11402217|NCT04043416|12597048|FG001|NOT COMPLETED|Campaign 2||0
11402218|NCT04057768|12597057|FG000|STARTED|Overall Study||10
11402219|NCT04057768|12597057|FG000|COMPLETED|Overall Study||10
11402220|NCT04057768|12597057|FG000|NOT COMPLETED|Overall Study||0
11402221|NCT04052542|12597073|FG000|STARTED|Overall Study||116
11402222|NCT04052542|12597074|FG001|STARTED|Overall Study||28
11402223|NCT04052542|12597075|FG002|STARTED|Overall Study||146
11402224|NCT04052542|12597076|FG003|STARTED|Overall Study||188
11402225|NCT04052542|12597077|FG004|STARTED|Overall Study||24
11402226|NCT04052542|12597078|FG005|STARTED|Overall Study||183
11402227|NCT04052542|12597079|FG006|STARTED|Overall Study||275
11402228|NCT04052542|12597080|FG007|STARTED|Overall Study||27
11402229|NCT04052542|12597081|FG008|STARTED|Overall Study||276
11402230|NCT04052542|12597082|FG009|STARTED|Overall Study||22
11402231|NCT04052542|12597083|FG010|STARTED|Overall Study||31
11402232|NCT04052542|12597084|FG011|STARTED|Overall Study||12
11402233|NCT04052542|12597073|FG000|COMPLETED|Overall Study||116
11402234|NCT04052542|12597074|FG001|COMPLETED|Overall Study||28
11402235|NCT04052542|12597075|FG002|COMPLETED|Overall Study||146
11402236|NCT04052542|12597076|FG003|COMPLETED|Overall Study||188
11402237|NCT04052542|12597077|FG004|COMPLETED|Overall Study||24
11402238|NCT04052542|12597078|FG005|COMPLETED|Overall Study||183
11402239|NCT04052542|12597079|FG006|COMPLETED|Overall Study||275
11402240|NCT04052542|12597080|FG007|COMPLETED|Overall Study||27
11402241|NCT04052542|12597081|FG008|COMPLETED|Overall Study||276
11402242|NCT04052542|12597082|FG009|COMPLETED|Overall Study||22
11402243|NCT04052542|12597083|FG010|COMPLETED|Overall Study||31
11402244|NCT04052542|12597084|FG011|COMPLETED|Overall Study||12
11402245|NCT04052542|12597073|FG000|NOT COMPLETED|Overall Study||0
11402246|NCT04052542|12597074|FG001|NOT COMPLETED|Overall Study||0
11402247|NCT04052542|12597075|FG002|NOT COMPLETED|Overall Study||0
11402248|NCT04052542|12597076|FG003|NOT COMPLETED|Overall Study||0
11402249|NCT04052542|12597077|FG004|NOT COMPLETED|Overall Study||0
11402250|NCT04052542|12597078|FG005|NOT COMPLETED|Overall Study||0
11402251|NCT04052542|12597079|FG006|NOT COMPLETED|Overall Study||0
11402252|NCT04052542|12597080|FG007|NOT COMPLETED|Overall Study||0
11402253|NCT04052542|12597081|FG008|NOT COMPLETED|Overall Study||0
11402254|NCT04052542|12597082|FG009|NOT COMPLETED|Overall Study||0
11402255|NCT04052542|12597083|FG010|NOT COMPLETED|Overall Study||0
11402256|NCT04052542|12597084|FG011|NOT COMPLETED|Overall Study||0
11402257|NCT04054193|12597110|FG000|STARTED|Cycle 1||103
11402258|NCT04054193|12597110|FG000|Treated (≥1 Dose)|Cycle 1||100
11402259|NCT04054193|12597110|FG000|COMPLETED|Cycle 1||98
11402260|NCT04054193|12597110|FG000|NOT COMPLETED|Cycle 1||5
11402261|NCT04054193|12597110|FG000|STARTED|Cycles 2-3|Participation in Cycles 2-3 was optional after completing Cycle 1.|69
11402262|NCT04054193|12597110|FG000|COMPLETED|Cycles 2-3||48
11402263|NCT04054193|12597110|FG000|NOT COMPLETED|Cycles 2-3||21
11402264|NCT04050618|12597117|FG000|STARTED|First Intervention||58
11315008|NCT02688387|12513365|FG008|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315009|NCT02688387|12513366|FG009|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315010|NCT02688387|12513367|FG010|STARTED|Part 2, Washout Period 1 (10 Days)||5
11315011|NCT02688387|12513368|FG011|STARTED|Part 2, Washout Period 1 (10 Days)||5
11315012|NCT02688387|12513369|FG012|STARTED|Part 2, Washout Period 1 (10 Days)||5
11315013|NCT02688387|12513370|FG013|STARTED|Part 2, Washout Period 1 (10 Days)||5
11315014|NCT02688387|12513371|FG014|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315015|NCT02688387|12513372|FG015|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315016|NCT02688387|12513373|FG016|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315017|NCT02688387|12513374|FG017|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315018|NCT02688387|12513375|FG018|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315019|NCT02688387|12513376|FG019|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315020|NCT02688387|12513377|FG020|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315021|NCT02688387|12513378|FG021|STARTED|Part 2, Washout Period 1 (10 Days)||0
11315022|NCT02688387|12513357|FG000|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315023|NCT02688387|12513358|FG001|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315024|NCT02688387|12513359|FG002|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315025|NCT02688387|12513360|FG003|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315026|NCT02688387|12513361|FG004|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315027|NCT02688387|12513362|FG005|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315028|NCT02688387|12513363|FG006|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315029|NCT02688387|12513364|FG007|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315030|NCT02688387|12513365|FG008|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315031|NCT02688387|12513366|FG009|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315032|NCT02688387|12513367|FG010|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
11315033|NCT02688387|12513368|FG011|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
11315034|NCT02688387|12513369|FG012|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
11315035|NCT02688387|12513370|FG013|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
11315036|NCT02688387|12513371|FG014|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315037|NCT02688387|12513372|FG015|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315038|NCT02688387|12513373|FG016|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315039|NCT02688387|12513374|FG017|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315040|NCT02688387|12513375|FG018|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315041|NCT02688387|12513376|FG019|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315042|NCT02688387|12513377|FG020|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315043|NCT02688387|12513378|FG021|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315044|NCT02688387|12513357|FG000|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315045|NCT02688387|12513358|FG001|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315046|NCT02688387|12513359|FG002|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315047|NCT02688387|12513360|FG003|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315048|NCT02688387|12513361|FG004|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315049|NCT02688387|12513362|FG005|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315050|NCT02688387|12513363|FG006|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315051|NCT02688387|12513364|FG007|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315052|NCT02688387|12513365|FG008|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315053|NCT02688387|12513366|FG009|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315054|NCT02688387|12513367|FG010|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315055|NCT02688387|12513368|FG011|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315056|NCT02688387|12513369|FG012|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315057|NCT02688387|12513370|FG013|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315058|NCT02688387|12513371|FG014|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315059|NCT02688387|12513372|FG015|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315060|NCT02688387|12513373|FG016|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315061|NCT02688387|12513374|FG017|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315062|NCT02688387|12513375|FG018|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11402265|NCT04050618|12597118|FG001|STARTED|First Intervention||56
11402266|NCT04050618|12597117|FG000|COMPLETED|First Intervention||56
11402267|NCT04050618|12597118|FG001|COMPLETED|First Intervention||56
11402268|NCT04050618|12597117|FG000|NOT COMPLETED|First Intervention||2
11315063|NCT02688387|12513376|FG019|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315064|NCT02688387|12513377|FG020|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315065|NCT02688387|12513378|FG021|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
11315066|NCT02688387|12513357|FG000|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315067|NCT02688387|12513358|FG001|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315068|NCT02688387|12513359|FG002|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315069|NCT02688387|12513360|FG003|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315070|NCT02688387|12513361|FG004|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315071|NCT02688387|12513362|FG005|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315072|NCT02688387|12513363|FG006|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315073|NCT02688387|12513364|FG007|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315074|NCT02688387|12513365|FG008|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315075|NCT02688387|12513366|FG009|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315076|NCT02688387|12513367|FG010|STARTED|Part 2, Period 2 (up to 6 Days)||5
11315077|NCT02688387|12513368|FG011|STARTED|Part 2, Period 2 (up to 6 Days)||5
11315078|NCT02688387|12513369|FG012|STARTED|Part 2, Period 2 (up to 6 Days)||5
11315079|NCT02688387|12513370|FG013|STARTED|Part 2, Period 2 (up to 6 Days)||5
11315080|NCT02688387|12513371|FG014|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315081|NCT02688387|12513372|FG015|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315082|NCT02688387|12513373|FG016|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315083|NCT02688387|12513374|FG017|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315084|NCT02688387|12513375|FG018|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315085|NCT02688387|12513376|FG019|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315086|NCT02688387|12513377|FG020|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315087|NCT02688387|12513378|FG021|STARTED|Part 2, Period 2 (up to 6 Days)||0
11315088|NCT02688387|12513357|FG000|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315089|NCT02688387|12513358|FG001|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315090|NCT02688387|12513359|FG002|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315091|NCT02688387|12513360|FG003|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315092|NCT02688387|12513361|FG004|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315093|NCT02688387|12513362|FG005|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315094|NCT02688387|12513363|FG006|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315095|NCT02688387|12513364|FG007|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315096|NCT02688387|12513365|FG008|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315097|NCT02688387|12513366|FG009|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315098|NCT02688387|12513367|FG010|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
11315099|NCT02688387|12513368|FG011|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
11315100|NCT02688387|12513369|FG012|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
11315101|NCT02688387|12513370|FG013|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
11315102|NCT02688387|12513371|FG014|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315103|NCT02688387|12513372|FG015|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315104|NCT02688387|12513373|FG016|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315105|NCT02688387|12513374|FG017|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315106|NCT02688387|12513375|FG018|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315107|NCT02688387|12513376|FG019|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315108|NCT02688387|12513377|FG020|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315109|NCT02688387|12513378|FG021|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315110|NCT02688387|12513357|FG000|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315111|NCT02688387|12513358|FG001|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315112|NCT02688387|12513359|FG002|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315113|NCT02688387|12513360|FG003|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315114|NCT02688387|12513361|FG004|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315115|NCT02688387|12513362|FG005|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315116|NCT02688387|12513363|FG006|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315117|NCT02688387|12513364|FG007|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315118|NCT02688387|12513365|FG008|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315119|NCT02688387|12513366|FG009|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315120|NCT02688387|12513367|FG010|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315121|NCT02688387|12513368|FG011|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315122|NCT02688387|12513369|FG012|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315123|NCT02688387|12513370|FG013|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315124|NCT02688387|12513371|FG014|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315125|NCT02688387|12513372|FG015|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315126|NCT02688387|12513373|FG016|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315127|NCT02688387|12513374|FG017|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315128|NCT02688387|12513375|FG018|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315129|NCT02688387|12513376|FG019|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315130|NCT02688387|12513377|FG020|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315131|NCT02688387|12513378|FG021|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
11315132|NCT02688387|12513357|FG000|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315133|NCT02688387|12513358|FG001|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315134|NCT02688387|12513359|FG002|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315135|NCT02688387|12513360|FG003|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315136|NCT02688387|12513361|FG004|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315137|NCT02688387|12513362|FG005|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315138|NCT02688387|12513363|FG006|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315139|NCT02688387|12513364|FG007|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315140|NCT02688387|12513365|FG008|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315141|NCT02688387|12513366|FG009|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315142|NCT02688387|12513367|FG010|STARTED|Part 2, Washout Period 2 (10 Days)||5
11315143|NCT02688387|12513368|FG011|STARTED|Part 2, Washout Period 2 (10 Days)||5
11315144|NCT02688387|12513369|FG012|STARTED|Part 2, Washout Period 2 (10 Days)||5
11315145|NCT02688387|12513370|FG013|STARTED|Part 2, Washout Period 2 (10 Days)||5
11315146|NCT02688387|12513371|FG014|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315147|NCT02688387|12513372|FG015|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315148|NCT02688387|12513373|FG016|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315149|NCT02688387|12513374|FG017|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315150|NCT02688387|12513375|FG018|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315151|NCT02688387|12513376|FG019|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315152|NCT02688387|12513377|FG020|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315153|NCT02688387|12513378|FG021|STARTED|Part 2, Washout Period 2 (10 Days)||0
11315154|NCT02688387|12513357|FG000|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315155|NCT02688387|12513358|FG001|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315156|NCT02688387|12513359|FG002|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315157|NCT02688387|12513360|FG003|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315158|NCT02688387|12513361|FG004|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315159|NCT02688387|12513362|FG005|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315160|NCT02688387|12513363|FG006|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315161|NCT02688387|12513364|FG007|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315162|NCT02688387|12513365|FG008|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315163|NCT02688387|12513366|FG009|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315164|NCT02688387|12513367|FG010|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
11315165|NCT02688387|12513368|FG011|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
11315166|NCT02688387|12513369|FG012|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
11315167|NCT02688387|12513370|FG013|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
11315168|NCT02688387|12513371|FG014|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315169|NCT02688387|12513372|FG015|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315170|NCT02688387|12513373|FG016|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315171|NCT02688387|12513374|FG017|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315172|NCT02688387|12513375|FG018|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315173|NCT02688387|12513376|FG019|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315174|NCT02688387|12513377|FG020|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315175|NCT02688387|12513378|FG021|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315176|NCT02688387|12513357|FG000|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315177|NCT02688387|12513358|FG001|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315178|NCT02688387|12513359|FG002|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315179|NCT02688387|12513360|FG003|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315180|NCT02688387|12513361|FG004|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315181|NCT02688387|12513362|FG005|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315182|NCT02688387|12513363|FG006|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315183|NCT02688387|12513364|FG007|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315184|NCT02688387|12513365|FG008|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315185|NCT02688387|12513366|FG009|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315186|NCT02688387|12513367|FG010|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315187|NCT02688387|12513368|FG011|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315188|NCT02688387|12513369|FG012|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315189|NCT02688387|12513370|FG013|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315190|NCT02688387|12513371|FG014|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315191|NCT02688387|12513372|FG015|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315192|NCT02688387|12513373|FG016|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315193|NCT02688387|12513374|FG017|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315194|NCT02688387|12513375|FG018|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315195|NCT02688387|12513376|FG019|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315196|NCT02688387|12513377|FG020|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315197|NCT02688387|12513378|FG021|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
11315198|NCT02688387|12513357|FG000|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315199|NCT02688387|12513358|FG001|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315200|NCT02688387|12513359|FG002|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315201|NCT02688387|12513360|FG003|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315202|NCT02688387|12513361|FG004|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315203|NCT02688387|12513362|FG005|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315204|NCT02688387|12513363|FG006|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315205|NCT02688387|12513364|FG007|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315206|NCT02688387|12513365|FG008|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315207|NCT02688387|12513366|FG009|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315208|NCT02688387|12513367|FG010|STARTED|Part 2, Period 3 (up to 6 Days)||5
11315209|NCT02688387|12513368|FG011|STARTED|Part 2, Period 3 (up to 6 Days)||5
11315210|NCT02688387|12513369|FG012|STARTED|Part 2, Period 3 (up to 6 Days)||5
11315211|NCT02688387|12513370|FG013|STARTED|Part 2, Period 3 (up to 6 Days)||5
11315212|NCT02688387|12513371|FG014|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315213|NCT02688387|12513372|FG015|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315214|NCT02688387|12513373|FG016|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315215|NCT02688387|12513374|FG017|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315216|NCT02688387|12513375|FG018|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315217|NCT02688387|12513376|FG019|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315218|NCT02688387|12513377|FG020|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315219|NCT02688387|12513378|FG021|STARTED|Part 2, Period 3 (up to 6 Days)||0
11315220|NCT02688387|12513357|FG000|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315221|NCT02688387|12513358|FG001|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315222|NCT02688387|12513359|FG002|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315223|NCT02688387|12513360|FG003|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315224|NCT02688387|12513361|FG004|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315225|NCT02688387|12513362|FG005|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315226|NCT02688387|12513363|FG006|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315227|NCT02688387|12513364|FG007|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315228|NCT02688387|12513365|FG008|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315229|NCT02688387|12513366|FG009|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315230|NCT02688387|12513367|FG010|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
11315231|NCT02688387|12513368|FG011|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
11315232|NCT02688387|12513369|FG012|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
11315233|NCT02688387|12513370|FG013|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
11315234|NCT02688387|12513371|FG014|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315235|NCT02688387|12513372|FG015|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315236|NCT02688387|12513373|FG016|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315237|NCT02688387|12513374|FG017|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315238|NCT02688387|12513375|FG018|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315239|NCT02688387|12513376|FG019|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315240|NCT02688387|12513377|FG020|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315241|NCT02688387|12513378|FG021|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315242|NCT02688387|12513357|FG000|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315243|NCT02688387|12513358|FG001|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315244|NCT02688387|12513359|FG002|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315245|NCT02688387|12513360|FG003|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315246|NCT02688387|12513361|FG004|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315247|NCT02688387|12513362|FG005|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315248|NCT02688387|12513363|FG006|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315249|NCT02688387|12513364|FG007|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315250|NCT02688387|12513365|FG008|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315251|NCT02688387|12513366|FG009|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315252|NCT02688387|12513367|FG010|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315253|NCT02688387|12513368|FG011|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315254|NCT02688387|12513369|FG012|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315255|NCT02688387|12513370|FG013|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315256|NCT02688387|12513371|FG014|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315257|NCT02688387|12513372|FG015|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315258|NCT02688387|12513373|FG016|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315259|NCT02688387|12513374|FG017|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315260|NCT02688387|12513375|FG018|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315261|NCT02688387|12513376|FG019|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315262|NCT02688387|12513377|FG020|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315263|NCT02688387|12513378|FG021|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
11315264|NCT02688387|12513357|FG000|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315265|NCT02688387|12513358|FG001|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315266|NCT02688387|12513359|FG002|STARTED|Part 2, Washout Period 3 (10 Days)||0
11022237|NCT00808249|12200511|FG002|COMPLETED|Overall Study||83
11022238|NCT00808249|12200512|FG003|COMPLETED|Overall Study||90
11022239|NCT00808249|12200509|FG000|NOT COMPLETED|Overall Study||17
11022240|NCT00808249|12200510|FG001|NOT COMPLETED|Overall Study||15
11022241|NCT00808249|12200511|FG002|NOT COMPLETED|Overall Study||22
11315267|NCT02688387|12513360|FG003|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315268|NCT02688387|12513361|FG004|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315269|NCT02688387|12513362|FG005|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315270|NCT02688387|12513363|FG006|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315271|NCT02688387|12513364|FG007|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315272|NCT02688387|12513365|FG008|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315273|NCT02688387|12513366|FG009|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315274|NCT02688387|12513367|FG010|STARTED|Part 2, Washout Period 3 (10 Days)||5
11315275|NCT02688387|12513368|FG011|STARTED|Part 2, Washout Period 3 (10 Days)||5
11315276|NCT02688387|12513369|FG012|STARTED|Part 2, Washout Period 3 (10 Days)||5
11315277|NCT02688387|12513370|FG013|STARTED|Part 2, Washout Period 3 (10 Days)||5
11315278|NCT02688387|12513371|FG014|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315279|NCT02688387|12513372|FG015|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315280|NCT02688387|12513373|FG016|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315281|NCT02688387|12513374|FG017|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315282|NCT02688387|12513375|FG018|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315283|NCT02688387|12513376|FG019|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315284|NCT02688387|12513377|FG020|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315285|NCT02688387|12513378|FG021|STARTED|Part 2, Washout Period 3 (10 Days)||0
11315286|NCT02688387|12513357|FG000|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315287|NCT02688387|12513358|FG001|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315288|NCT02688387|12513359|FG002|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11342333|NCT02943577|12539888|FG000|STARTED|Overall Study||209
11315289|NCT02688387|12513360|FG003|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315290|NCT02688387|12513361|FG004|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315291|NCT02688387|12513362|FG005|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315292|NCT02688387|12513363|FG006|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315293|NCT02688387|12513364|FG007|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315294|NCT02688387|12513365|FG008|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315295|NCT02688387|12513366|FG009|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315296|NCT02688387|12513367|FG010|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
11315297|NCT02688387|12513368|FG011|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
11315298|NCT02688387|12513369|FG012|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
11315299|NCT02688387|12513370|FG013|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
11315300|NCT02688387|12513371|FG014|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315301|NCT02688387|12513372|FG015|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315302|NCT02688387|12513373|FG016|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315303|NCT02688387|12513374|FG017|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315304|NCT02688387|12513375|FG018|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315305|NCT02688387|12513376|FG019|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315306|NCT02688387|12513377|FG020|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315307|NCT02688387|12513378|FG021|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315308|NCT02688387|12513357|FG000|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315309|NCT02688387|12513358|FG001|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315310|NCT02688387|12513359|FG002|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315311|NCT02688387|12513360|FG003|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315312|NCT02688387|12513361|FG004|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315313|NCT02688387|12513362|FG005|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315314|NCT02688387|12513363|FG006|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315315|NCT02688387|12513364|FG007|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315316|NCT02688387|12513365|FG008|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315317|NCT02688387|12513366|FG009|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315318|NCT02688387|12513367|FG010|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315319|NCT02688387|12513368|FG011|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315320|NCT02688387|12513369|FG012|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315321|NCT02688387|12513370|FG013|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315322|NCT02688387|12513371|FG014|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315323|NCT02688387|12513372|FG015|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315324|NCT02688387|12513373|FG016|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315325|NCT02688387|12513374|FG017|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315326|NCT02688387|12513375|FG018|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315327|NCT02688387|12513376|FG019|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315328|NCT02688387|12513377|FG020|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315329|NCT02688387|12513378|FG021|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
11315330|NCT02688387|12513357|FG000|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315331|NCT02688387|12513358|FG001|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315332|NCT02688387|12513359|FG002|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315333|NCT02688387|12513360|FG003|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315334|NCT02688387|12513361|FG004|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315335|NCT02688387|12513362|FG005|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315336|NCT02688387|12513363|FG006|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315337|NCT02688387|12513364|FG007|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315338|NCT02688387|12513365|FG008|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315339|NCT02688387|12513366|FG009|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315340|NCT02688387|12513367|FG010|STARTED|Part 2, Period 4 (up to 6 Days)||5
11315341|NCT02688387|12513368|FG011|STARTED|Part 2, Period 4 (up to 6 Days)||5
11315342|NCT02688387|12513369|FG012|STARTED|Part 2, Period 4 (up to 6 Days)||5
11315343|NCT02688387|12513370|FG013|STARTED|Part 2, Period 4 (up to 6 Days)||5
11315344|NCT02688387|12513371|FG014|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315345|NCT02688387|12513372|FG015|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315346|NCT02688387|12513373|FG016|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315347|NCT02688387|12513374|FG017|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315348|NCT02688387|12513375|FG018|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315349|NCT02688387|12513376|FG019|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315350|NCT02688387|12513377|FG020|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315351|NCT02688387|12513378|FG021|STARTED|Part 2, Period 4 (up to 6 Days)||0
11315352|NCT02688387|12513357|FG000|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315353|NCT02688387|12513358|FG001|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315354|NCT02688387|12513359|FG002|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315355|NCT02688387|12513360|FG003|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315356|NCT02688387|12513361|FG004|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315357|NCT02688387|12513362|FG005|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315358|NCT02688387|12513363|FG006|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315359|NCT02688387|12513364|FG007|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315360|NCT02688387|12513365|FG008|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315361|NCT02688387|12513366|FG009|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315362|NCT02688387|12513367|FG010|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
11315363|NCT02688387|12513368|FG011|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
11315364|NCT02688387|12513369|FG012|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
11315365|NCT02688387|12513370|FG013|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
11315366|NCT02688387|12513371|FG014|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315367|NCT02688387|12513372|FG015|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315368|NCT02688387|12513373|FG016|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315369|NCT02688387|12513374|FG017|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315370|NCT02688387|12513375|FG018|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315371|NCT02688387|12513376|FG019|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315372|NCT02688387|12513377|FG020|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315373|NCT02688387|12513378|FG021|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315374|NCT02688387|12513357|FG000|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315375|NCT02688387|12513358|FG001|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315376|NCT02688387|12513359|FG002|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315377|NCT02688387|12513360|FG003|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315378|NCT02688387|12513361|FG004|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315379|NCT02688387|12513362|FG005|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315380|NCT02688387|12513363|FG006|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315381|NCT02688387|12513364|FG007|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315382|NCT02688387|12513365|FG008|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315383|NCT02688387|12513366|FG009|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315384|NCT02688387|12513367|FG010|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315385|NCT02688387|12513368|FG011|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315386|NCT02688387|12513369|FG012|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315387|NCT02688387|12513370|FG013|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315388|NCT02688387|12513371|FG014|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315389|NCT02688387|12513372|FG015|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315390|NCT02688387|12513373|FG016|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315391|NCT02688387|12513374|FG017|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315392|NCT02688387|12513375|FG018|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315393|NCT02688387|12513376|FG019|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315394|NCT02688387|12513377|FG020|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315395|NCT02688387|12513378|FG021|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
11315396|NCT02688387|12513357|FG000|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315397|NCT02688387|12513358|FG001|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315398|NCT02688387|12513359|FG002|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315399|NCT02688387|12513360|FG003|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315400|NCT02688387|12513361|FG004|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315401|NCT02688387|12513362|FG005|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315402|NCT02688387|12513363|FG006|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315403|NCT02688387|12513364|FG007|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315404|NCT02688387|12513365|FG008|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315405|NCT02688387|12513366|FG009|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315406|NCT02688387|12513367|FG010|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315407|NCT02688387|12513368|FG011|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315408|NCT02688387|12513369|FG012|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315409|NCT02688387|12513370|FG013|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315410|NCT02688387|12513371|FG014|STARTED|Part 3A, Period 1 (up to 6 Days)||9
11315411|NCT02688387|12513372|FG015|STARTED|Part 3A, Period 1 (up to 6 Days)||8
11315412|NCT02688387|12513373|FG016|STARTED|Part 3A, Period 1 (up to 6 Days)||8
11315413|NCT02688387|12513374|FG017|STARTED|Part 3A, Period 1 (up to 6 Days)||8
11315414|NCT02688387|12513375|FG018|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315415|NCT02688387|12513376|FG019|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315416|NCT02688387|12513377|FG020|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315417|NCT02688387|12513378|FG021|STARTED|Part 3A, Period 1 (up to 6 Days)||0
11315418|NCT02688387|12513357|FG000|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315419|NCT02688387|12513358|FG001|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315420|NCT02688387|12513359|FG002|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315421|NCT02688387|12513360|FG003|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315422|NCT02688387|12513361|FG004|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315423|NCT02688387|12513362|FG005|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315424|NCT02688387|12513363|FG006|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315425|NCT02688387|12513364|FG007|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315426|NCT02688387|12513365|FG008|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315427|NCT02688387|12513366|FG009|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315428|NCT02688387|12513367|FG010|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315429|NCT02688387|12513368|FG011|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315430|NCT02688387|12513369|FG012|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315431|NCT02688387|12513370|FG013|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315432|NCT02688387|12513371|FG014|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
11315433|NCT02688387|12513372|FG015|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
11315434|NCT02688387|12513373|FG016|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
11315435|NCT02688387|12513374|FG017|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
11315436|NCT02688387|12513375|FG018|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315437|NCT02688387|12513376|FG019|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315438|NCT02688387|12513377|FG020|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315439|NCT02688387|12513378|FG021|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315440|NCT02688387|12513357|FG000|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315441|NCT02688387|12513358|FG001|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315442|NCT02688387|12513359|FG002|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315443|NCT02688387|12513360|FG003|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315444|NCT02688387|12513361|FG004|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315445|NCT02688387|12513362|FG005|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315446|NCT02688387|12513363|FG006|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315447|NCT02688387|12513364|FG007|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315448|NCT02688387|12513365|FG008|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315449|NCT02688387|12513366|FG009|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315450|NCT02688387|12513367|FG010|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315451|NCT02688387|12513368|FG011|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315452|NCT02688387|12513369|FG012|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315453|NCT02688387|12513370|FG013|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315454|NCT02688387|12513371|FG014|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1
11315455|NCT02688387|12513372|FG015|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315456|NCT02688387|12513373|FG016|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315457|NCT02688387|12513374|FG017|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315458|NCT02688387|12513375|FG018|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315459|NCT02688387|12513376|FG019|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315460|NCT02688387|12513377|FG020|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315461|NCT02688387|12513378|FG021|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
11315462|NCT02688387|12513357|FG000|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315463|NCT02688387|12513358|FG001|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315464|NCT02688387|12513359|FG002|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315465|NCT02688387|12513360|FG003|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315466|NCT02688387|12513361|FG004|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315467|NCT02688387|12513362|FG005|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315468|NCT02688387|12513363|FG006|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315469|NCT02688387|12513364|FG007|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315470|NCT02688387|12513365|FG008|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315471|NCT02688387|12513366|FG009|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315472|NCT02688387|12513367|FG010|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315473|NCT02688387|12513368|FG011|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315474|NCT02688387|12513369|FG012|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315475|NCT02688387|12513370|FG013|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315476|NCT02688387|12513371|FG014|STARTED|Part 3A, Washout Period 1 (10 Days)||8
11315477|NCT02688387|12513372|FG015|STARTED|Part 3A, Washout Period 1 (10 Days)||8
11315478|NCT02688387|12513373|FG016|STARTED|Part 3A, Washout Period 1 (10 Days)||8
11315479|NCT02688387|12513374|FG017|STARTED|Part 3A, Washout Period 1 (10 Days)||8
11315480|NCT02688387|12513375|FG018|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315481|NCT02688387|12513376|FG019|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315482|NCT02688387|12513377|FG020|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315483|NCT02688387|12513378|FG021|STARTED|Part 3A, Washout Period 1 (10 Days)||0
11315484|NCT02688387|12513357|FG000|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11402269|NCT04050618|12597118|FG001|NOT COMPLETED|First Intervention||0
11315485|NCT02688387|12513358|FG001|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315486|NCT02688387|12513359|FG002|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315487|NCT02688387|12513360|FG003|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315488|NCT02688387|12513361|FG004|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315489|NCT02688387|12513362|FG005|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315490|NCT02688387|12513363|FG006|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315491|NCT02688387|12513364|FG007|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315492|NCT02688387|12513365|FG008|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315493|NCT02688387|12513366|FG009|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315494|NCT02688387|12513367|FG010|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315495|NCT02688387|12513368|FG011|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315496|NCT02688387|12513369|FG012|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315497|NCT02688387|12513370|FG013|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315498|NCT02688387|12513371|FG014|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
11315499|NCT02688387|12513372|FG015|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
11315500|NCT02688387|12513373|FG016|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
11315501|NCT02688387|12513374|FG017|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
11315502|NCT02688387|12513375|FG018|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315503|NCT02688387|12513376|FG019|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315504|NCT02688387|12513377|FG020|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315505|NCT02688387|12513378|FG021|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315506|NCT02688387|12513357|FG000|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315507|NCT02688387|12513358|FG001|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315508|NCT02688387|12513359|FG002|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315509|NCT02688387|12513360|FG003|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315510|NCT02688387|12513361|FG004|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315511|NCT02688387|12513362|FG005|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315512|NCT02688387|12513363|FG006|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315513|NCT02688387|12513364|FG007|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315514|NCT02688387|12513365|FG008|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315515|NCT02688387|12513366|FG009|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315516|NCT02688387|12513367|FG010|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315517|NCT02688387|12513368|FG011|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315518|NCT02688387|12513369|FG012|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315519|NCT02688387|12513370|FG013|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315520|NCT02688387|12513371|FG014|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315521|NCT02688387|12513372|FG015|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315522|NCT02688387|12513373|FG016|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315523|NCT02688387|12513374|FG017|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315524|NCT02688387|12513375|FG018|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315525|NCT02688387|12513376|FG019|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315526|NCT02688387|12513377|FG020|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315527|NCT02688387|12513378|FG021|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
11315528|NCT02688387|12513357|FG000|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315529|NCT02688387|12513358|FG001|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315530|NCT02688387|12513359|FG002|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315531|NCT02688387|12513360|FG003|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315532|NCT02688387|12513361|FG004|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315533|NCT02688387|12513362|FG005|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315534|NCT02688387|12513363|FG006|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315535|NCT02688387|12513364|FG007|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315536|NCT02688387|12513365|FG008|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315537|NCT02688387|12513366|FG009|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315538|NCT02688387|12513367|FG010|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315539|NCT02688387|12513368|FG011|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315540|NCT02688387|12513369|FG012|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315541|NCT02688387|12513370|FG013|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315542|NCT02688387|12513371|FG014|STARTED|Part 3A, Period 2 (up to 6 Days)||8
11315543|NCT02688387|12513372|FG015|STARTED|Part 3A, Period 2 (up to 6 Days)||8
11315544|NCT02688387|12513373|FG016|STARTED|Part 3A, Period 2 (up to 6 Days)||8
11315545|NCT02688387|12513374|FG017|STARTED|Part 3A, Period 2 (up to 6 Days)||8
11315546|NCT02688387|12513375|FG018|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315547|NCT02688387|12513376|FG019|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315548|NCT02688387|12513377|FG020|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315549|NCT02688387|12513378|FG021|STARTED|Part 3A, Period 2 (up to 6 Days)||0
11315550|NCT02688387|12513357|FG000|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315551|NCT02688387|12513358|FG001|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315552|NCT02688387|12513359|FG002|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315553|NCT02688387|12513360|FG003|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315554|NCT02688387|12513361|FG004|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315555|NCT02688387|12513362|FG005|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315556|NCT02688387|12513363|FG006|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315557|NCT02688387|12513364|FG007|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315558|NCT02688387|12513365|FG008|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11402270|NCT04050618|12597117|FG000|STARTED|Second Intervention||56
11402271|NCT04050618|12597118|FG001|STARTED|Second Intervention||56
11315559|NCT02688387|12513366|FG009|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315560|NCT02688387|12513367|FG010|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315561|NCT02688387|12513368|FG011|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315562|NCT02688387|12513369|FG012|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315563|NCT02688387|12513370|FG013|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315564|NCT02688387|12513371|FG014|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
11315565|NCT02688387|12513372|FG015|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
11315566|NCT02688387|12513373|FG016|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
11315567|NCT02688387|12513374|FG017|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
11315568|NCT02688387|12513375|FG018|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315569|NCT02688387|12513376|FG019|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315570|NCT02688387|12513377|FG020|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315571|NCT02688387|12513378|FG021|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315572|NCT02688387|12513357|FG000|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315573|NCT02688387|12513358|FG001|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315574|NCT02688387|12513359|FG002|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315575|NCT02688387|12513360|FG003|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315576|NCT02688387|12513361|FG004|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315577|NCT02688387|12513362|FG005|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315578|NCT02688387|12513363|FG006|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315579|NCT02688387|12513364|FG007|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315580|NCT02688387|12513365|FG008|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315581|NCT02688387|12513366|FG009|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315582|NCT02688387|12513367|FG010|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315583|NCT02688387|12513368|FG011|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315584|NCT02688387|12513369|FG012|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315585|NCT02688387|12513370|FG013|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315586|NCT02688387|12513371|FG014|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315587|NCT02688387|12513372|FG015|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315588|NCT02688387|12513373|FG016|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315589|NCT02688387|12513374|FG017|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315590|NCT02688387|12513375|FG018|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315591|NCT02688387|12513376|FG019|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315592|NCT02688387|12513377|FG020|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315593|NCT02688387|12513378|FG021|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
11315594|NCT02688387|12513357|FG000|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315595|NCT02688387|12513358|FG001|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315596|NCT02688387|12513359|FG002|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315597|NCT02688387|12513360|FG003|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315598|NCT02688387|12513361|FG004|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315599|NCT02688387|12513362|FG005|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315600|NCT02688387|12513363|FG006|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315601|NCT02688387|12513364|FG007|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315602|NCT02688387|12513365|FG008|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315603|NCT02688387|12513366|FG009|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315604|NCT02688387|12513367|FG010|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315605|NCT02688387|12513368|FG011|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315606|NCT02688387|12513369|FG012|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315607|NCT02688387|12513370|FG013|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315608|NCT02688387|12513371|FG014|STARTED|Part 3A, Washout Period 2 (10 Days)||8
11315609|NCT02688387|12513372|FG015|STARTED|Part 3A, Washout Period 2 (10 Days)||8
11315610|NCT02688387|12513373|FG016|STARTED|Part 3A, Washout Period 2 (10 Days)||8
11315611|NCT02688387|12513374|FG017|STARTED|Part 3A, Washout Period 2 (10 Days)||8
11315612|NCT02688387|12513375|FG018|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315613|NCT02688387|12513376|FG019|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315614|NCT02688387|12513377|FG020|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315615|NCT02688387|12513378|FG021|STARTED|Part 3A, Washout Period 2 (10 Days)||0
11315616|NCT02688387|12513357|FG000|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315617|NCT02688387|12513358|FG001|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315618|NCT02688387|12513359|FG002|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315619|NCT02688387|12513360|FG003|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315620|NCT02688387|12513361|FG004|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315621|NCT02688387|12513362|FG005|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315622|NCT02688387|12513363|FG006|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315623|NCT02688387|12513364|FG007|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315624|NCT02688387|12513365|FG008|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315625|NCT02688387|12513366|FG009|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315626|NCT02688387|12513367|FG010|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315627|NCT02688387|12513368|FG011|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315628|NCT02688387|12513369|FG012|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315629|NCT02688387|12513370|FG013|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315630|NCT02688387|12513371|FG014|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
11315631|NCT02688387|12513372|FG015|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
11315632|NCT02688387|12513373|FG016|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
11315633|NCT02688387|12513374|FG017|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
11315634|NCT02688387|12513375|FG018|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315635|NCT02688387|12513376|FG019|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315636|NCT02688387|12513377|FG020|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315637|NCT02688387|12513378|FG021|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11402272|NCT04050618|12597117|FG000|COMPLETED|Second Intervention||55
11315638|NCT02688387|12513357|FG000|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315639|NCT02688387|12513358|FG001|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315640|NCT02688387|12513359|FG002|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315641|NCT02688387|12513360|FG003|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315642|NCT02688387|12513361|FG004|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315643|NCT02688387|12513362|FG005|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315644|NCT02688387|12513363|FG006|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315645|NCT02688387|12513364|FG007|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315646|NCT02688387|12513365|FG008|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315647|NCT02688387|12513366|FG009|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315648|NCT02688387|12513367|FG010|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315649|NCT02688387|12513368|FG011|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315650|NCT02688387|12513369|FG012|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315651|NCT02688387|12513370|FG013|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315652|NCT02688387|12513371|FG014|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315653|NCT02688387|12513372|FG015|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315654|NCT02688387|12513373|FG016|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315655|NCT02688387|12513374|FG017|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315656|NCT02688387|12513375|FG018|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315657|NCT02688387|12513376|FG019|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315658|NCT02688387|12513377|FG020|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315659|NCT02688387|12513378|FG021|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
11315660|NCT02688387|12513357|FG000|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315661|NCT02688387|12513358|FG001|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315662|NCT02688387|12513359|FG002|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315663|NCT02688387|12513360|FG003|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315664|NCT02688387|12513361|FG004|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315665|NCT02688387|12513362|FG005|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11402273|NCT04050618|12597118|FG001|COMPLETED|Second Intervention||56
11315666|NCT02688387|12513363|FG006|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315667|NCT02688387|12513364|FG007|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315668|NCT02688387|12513365|FG008|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315669|NCT02688387|12513366|FG009|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315670|NCT02688387|12513367|FG010|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315671|NCT02688387|12513368|FG011|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315672|NCT02688387|12513369|FG012|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315673|NCT02688387|12513370|FG013|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315674|NCT02688387|12513371|FG014|STARTED|Part 3A, Period 3 (up to 6 Days)||8
11315675|NCT02688387|12513372|FG015|STARTED|Part 3A, Period 3 (up to 6 Days)||8
11315676|NCT02688387|12513373|FG016|STARTED|Part 3A, Period 3 (up to 6 Days)||8
11315677|NCT02688387|12513374|FG017|STARTED|Part 3A, Period 3 (up to 6 Days)||8
11315678|NCT02688387|12513375|FG018|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315679|NCT02688387|12513376|FG019|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315680|NCT02688387|12513377|FG020|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315681|NCT02688387|12513378|FG021|STARTED|Part 3A, Period 3 (up to 6 Days)||0
11315682|NCT02688387|12513357|FG000|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315683|NCT02688387|12513358|FG001|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11402274|NCT04050618|12597117|FG000|NOT COMPLETED|Second Intervention||1
11402275|NCT04050618|12597118|FG001|NOT COMPLETED|Second Intervention||0
11315684|NCT02688387|12513359|FG002|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315685|NCT02688387|12513360|FG003|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315686|NCT02688387|12513361|FG004|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315687|NCT02688387|12513362|FG005|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315688|NCT02688387|12513363|FG006|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315689|NCT02688387|12513364|FG007|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315690|NCT02688387|12513365|FG008|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315691|NCT02688387|12513366|FG009|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315692|NCT02688387|12513367|FG010|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315693|NCT02688387|12513368|FG011|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315694|NCT02688387|12513369|FG012|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315695|NCT02688387|12513370|FG013|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315696|NCT02688387|12513371|FG014|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
11315697|NCT02688387|12513372|FG015|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
11315698|NCT02688387|12513373|FG016|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
11315699|NCT02688387|12513374|FG017|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
11315700|NCT02688387|12513375|FG018|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315701|NCT02688387|12513376|FG019|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315702|NCT02688387|12513377|FG020|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315703|NCT02688387|12513378|FG021|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315704|NCT02688387|12513357|FG000|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315705|NCT02688387|12513358|FG001|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315706|NCT02688387|12513359|FG002|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315707|NCT02688387|12513360|FG003|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315708|NCT02688387|12513361|FG004|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315709|NCT02688387|12513362|FG005|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315710|NCT02688387|12513363|FG006|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315711|NCT02688387|12513364|FG007|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315712|NCT02688387|12513365|FG008|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315713|NCT02688387|12513366|FG009|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315714|NCT02688387|12513367|FG010|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315715|NCT02688387|12513368|FG011|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315716|NCT02688387|12513369|FG012|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315717|NCT02688387|12513370|FG013|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315718|NCT02688387|12513371|FG014|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315719|NCT02688387|12513372|FG015|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315720|NCT02688387|12513373|FG016|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315721|NCT02688387|12513374|FG017|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315722|NCT02688387|12513375|FG018|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315723|NCT02688387|12513376|FG019|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315724|NCT02688387|12513377|FG020|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315725|NCT02688387|12513378|FG021|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
11315726|NCT02688387|12513357|FG000|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315727|NCT02688387|12513358|FG001|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315728|NCT02688387|12513359|FG002|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315729|NCT02688387|12513360|FG003|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315730|NCT02688387|12513361|FG004|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315731|NCT02688387|12513362|FG005|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315732|NCT02688387|12513363|FG006|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315733|NCT02688387|12513364|FG007|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315734|NCT02688387|12513365|FG008|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315735|NCT02688387|12513366|FG009|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315736|NCT02688387|12513367|FG010|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315737|NCT02688387|12513368|FG011|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315738|NCT02688387|12513369|FG012|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315739|NCT02688387|12513370|FG013|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11402276|NCT04053465|12597131|FG000|STARTED|Overall Study||22
11315740|NCT02688387|12513371|FG014|STARTED|Part 3A, Washout Period 3 (10 Days)||8
11315741|NCT02688387|12513372|FG015|STARTED|Part 3A, Washout Period 3 (10 Days)||8
11315742|NCT02688387|12513373|FG016|STARTED|Part 3A, Washout Period 3 (10 Days)||8
11315743|NCT02688387|12513374|FG017|STARTED|Part 3A, Washout Period 3 (10 Days)||8
11315744|NCT02688387|12513375|FG018|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315745|NCT02688387|12513376|FG019|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315746|NCT02688387|12513377|FG020|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315747|NCT02688387|12513378|FG021|STARTED|Part 3A, Washout Period 3 (10 Days)||0
11315748|NCT02688387|12513357|FG000|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315749|NCT02688387|12513358|FG001|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315750|NCT02688387|12513359|FG002|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315751|NCT02688387|12513360|FG003|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315752|NCT02688387|12513361|FG004|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315753|NCT02688387|12513362|FG005|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315754|NCT02688387|12513363|FG006|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315755|NCT02688387|12513364|FG007|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315756|NCT02688387|12513365|FG008|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315757|NCT02688387|12513366|FG009|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315758|NCT02688387|12513367|FG010|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315759|NCT02688387|12513368|FG011|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315760|NCT02688387|12513369|FG012|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315761|NCT02688387|12513370|FG013|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315762|NCT02688387|12513371|FG014|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
11315763|NCT02688387|12513372|FG015|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
11315764|NCT02688387|12513373|FG016|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
11315765|NCT02688387|12513374|FG017|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
11315766|NCT02688387|12513375|FG018|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315767|NCT02688387|12513376|FG019|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315768|NCT02688387|12513377|FG020|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315769|NCT02688387|12513378|FG021|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315770|NCT02688387|12513357|FG000|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315771|NCT02688387|12513358|FG001|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315772|NCT02688387|12513359|FG002|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11402277|NCT04053465|12597132|FG001|STARTED|Overall Study||12
11402278|NCT04053465|12597131|FG000|COMPLETED|Overall Study||18
11402279|NCT04053465|12597132|FG001|COMPLETED|Overall Study||8
11315773|NCT02688387|12513360|FG003|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315774|NCT02688387|12513361|FG004|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315775|NCT02688387|12513362|FG005|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315776|NCT02688387|12513363|FG006|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315777|NCT02688387|12513364|FG007|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315778|NCT02688387|12513365|FG008|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315779|NCT02688387|12513366|FG009|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315780|NCT02688387|12513367|FG010|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315781|NCT02688387|12513368|FG011|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315782|NCT02688387|12513369|FG012|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315783|NCT02688387|12513370|FG013|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315784|NCT02688387|12513371|FG014|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315785|NCT02688387|12513372|FG015|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315786|NCT02688387|12513373|FG016|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315787|NCT02688387|12513374|FG017|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315788|NCT02688387|12513375|FG018|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315789|NCT02688387|12513376|FG019|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315790|NCT02688387|12513377|FG020|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315791|NCT02688387|12513378|FG021|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
11315792|NCT02688387|12513357|FG000|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315793|NCT02688387|12513358|FG001|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315794|NCT02688387|12513359|FG002|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315795|NCT02688387|12513360|FG003|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315796|NCT02688387|12513361|FG004|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315797|NCT02688387|12513362|FG005|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315798|NCT02688387|12513363|FG006|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315799|NCT02688387|12513364|FG007|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315800|NCT02688387|12513365|FG008|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315801|NCT02688387|12513366|FG009|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315802|NCT02688387|12513367|FG010|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11402280|NCT04053465|12597131|FG000|NOT COMPLETED|Overall Study||4
11402281|NCT04053465|12597132|FG001|NOT COMPLETED|Overall Study||4
11402282|NCT04053270|12597140|FG000|STARTED|Overall Study||49
11402283|NCT04053270|12597141|FG001|STARTED|Overall Study||51
11402284|NCT04053270|12597140|FG000|COMPLETED|Overall Study||47
11402285|NCT04053270|12597141|FG001|COMPLETED|Overall Study||46
11402286|NCT04053270|12597140|FG000|NOT COMPLETED|Overall Study||2
11402287|NCT04053270|12597141|FG001|NOT COMPLETED|Overall Study||5
11402288|NCT04049552|12597151|FG000|STARTED|Overall Study||4
11402289|NCT04049552|12597151|FG000|COMPLETED|Overall Study||3
11402290|NCT04049552|12597151|FG000|NOT COMPLETED|Overall Study||1
11402291|NCT04053023|12597159|FG000|STARTED|Part A: Period 1 (Day 1 to Day 19)||19
11315803|NCT02688387|12513368|FG011|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315804|NCT02688387|12513369|FG012|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11402292|NCT04053023|12597160|FG001|STARTED|Part A: Period 1 (Day 1 to Day 19)||0
11315805|NCT02688387|12513370|FG013|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315806|NCT02688387|12513371|FG014|STARTED|Part 3A, Period 4 (up to 6 Days)||8
11315807|NCT02688387|12513372|FG015|STARTED|Part 3A, Period 4 (up to 6 Days)||8
11315808|NCT02688387|12513373|FG016|STARTED|Part 3A, Period 4 (up to 6 Days)||8
11315809|NCT02688387|12513374|FG017|STARTED|Part 3A, Period 4 (up to 6 Days)||8
11315810|NCT02688387|12513375|FG018|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315811|NCT02688387|12513376|FG019|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315812|NCT02688387|12513377|FG020|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315813|NCT02688387|12513378|FG021|STARTED|Part 3A, Period 4 (up to 6 Days)||0
11315814|NCT02688387|12513357|FG000|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315815|NCT02688387|12513358|FG001|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315816|NCT02688387|12513359|FG002|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315817|NCT02688387|12513360|FG003|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315818|NCT02688387|12513361|FG004|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315819|NCT02688387|12513362|FG005|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315820|NCT02688387|12513363|FG006|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315821|NCT02688387|12513364|FG007|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315822|NCT02688387|12513365|FG008|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315823|NCT02688387|12513366|FG009|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315824|NCT02688387|12513367|FG010|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315825|NCT02688387|12513368|FG011|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315826|NCT02688387|12513369|FG012|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315827|NCT02688387|12513370|FG013|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315828|NCT02688387|12513371|FG014|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
11315829|NCT02688387|12513372|FG015|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
11315830|NCT02688387|12513373|FG016|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
11315831|NCT02688387|12513374|FG017|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
11315832|NCT02688387|12513375|FG018|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315833|NCT02688387|12513376|FG019|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315834|NCT02688387|12513377|FG020|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315835|NCT02688387|12513378|FG021|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315836|NCT02688387|12513357|FG000|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315837|NCT02688387|12513358|FG001|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315838|NCT02688387|12513359|FG002|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315839|NCT02688387|12513360|FG003|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315840|NCT02688387|12513361|FG004|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315841|NCT02688387|12513362|FG005|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315842|NCT02688387|12513363|FG006|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315843|NCT02688387|12513364|FG007|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315844|NCT02688387|12513365|FG008|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315845|NCT02688387|12513366|FG009|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315846|NCT02688387|12513367|FG010|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315847|NCT02688387|12513368|FG011|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315848|NCT02688387|12513369|FG012|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315849|NCT02688387|12513370|FG013|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315850|NCT02688387|12513371|FG014|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315851|NCT02688387|12513372|FG015|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315852|NCT02688387|12513373|FG016|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315853|NCT02688387|12513374|FG017|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315854|NCT02688387|12513375|FG018|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315855|NCT02688387|12513376|FG019|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315856|NCT02688387|12513377|FG020|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315857|NCT02688387|12513378|FG021|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
11315858|NCT02688387|12513357|FG000|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315859|NCT02688387|12513358|FG001|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315860|NCT02688387|12513359|FG002|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315861|NCT02688387|12513360|FG003|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315862|NCT02688387|12513361|FG004|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315863|NCT02688387|12513362|FG005|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315864|NCT02688387|12513363|FG006|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315865|NCT02688387|12513364|FG007|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315866|NCT02688387|12513365|FG008|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315867|NCT02688387|12513366|FG009|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315868|NCT02688387|12513367|FG010|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315869|NCT02688387|12513368|FG011|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315870|NCT02688387|12513369|FG012|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315871|NCT02688387|12513370|FG013|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315872|NCT02688387|12513371|FG014|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315873|NCT02688387|12513372|FG015|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315874|NCT02688387|12513373|FG016|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315875|NCT02688387|12513374|FG017|STARTED|Part 3B, Period 1 (up to 6 Days)||0
11315876|NCT02688387|12513375|FG018|STARTED|Part 3B, Period 1 (up to 6 Days)||8
11315877|NCT02688387|12513376|FG019|STARTED|Part 3B, Period 1 (up to 6 Days)||8
11315878|NCT02688387|12513377|FG020|STARTED|Part 3B, Period 1 (up to 6 Days)||8
11315879|NCT02688387|12513378|FG021|STARTED|Part 3B, Period 1 (up to 6 Days)||8
11315880|NCT02688387|12513357|FG000|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315881|NCT02688387|12513358|FG001|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315882|NCT02688387|12513359|FG002|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315883|NCT02688387|12513360|FG003|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315884|NCT02688387|12513361|FG004|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315885|NCT02688387|12513362|FG005|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315886|NCT02688387|12513363|FG006|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315887|NCT02688387|12513364|FG007|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315888|NCT02688387|12513365|FG008|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315889|NCT02688387|12513366|FG009|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315890|NCT02688387|12513367|FG010|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315891|NCT02688387|12513368|FG011|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315892|NCT02688387|12513369|FG012|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315893|NCT02688387|12513370|FG013|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315894|NCT02688387|12513371|FG014|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315895|NCT02688387|12513372|FG015|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315896|NCT02688387|12513373|FG016|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315897|NCT02688387|12513374|FG017|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315898|NCT02688387|12513375|FG018|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
11315899|NCT02688387|12513376|FG019|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
11315900|NCT02688387|12513377|FG020|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
11315901|NCT02688387|12513378|FG021|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
11315902|NCT02688387|12513357|FG000|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315903|NCT02688387|12513358|FG001|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315904|NCT02688387|12513359|FG002|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315905|NCT02688387|12513360|FG003|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315906|NCT02688387|12513361|FG004|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315907|NCT02688387|12513362|FG005|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315908|NCT02688387|12513363|FG006|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315909|NCT02688387|12513364|FG007|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315910|NCT02688387|12513365|FG008|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315911|NCT02688387|12513366|FG009|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315912|NCT02688387|12513367|FG010|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315913|NCT02688387|12513368|FG011|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315914|NCT02688387|12513369|FG012|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315915|NCT02688387|12513370|FG013|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315916|NCT02688387|12513371|FG014|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315917|NCT02688387|12513372|FG015|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315918|NCT02688387|12513373|FG016|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315919|NCT02688387|12513374|FG017|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315920|NCT02688387|12513375|FG018|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315921|NCT02688387|12513376|FG019|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315922|NCT02688387|12513377|FG020|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315923|NCT02688387|12513378|FG021|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
11315924|NCT02688387|12513357|FG000|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315925|NCT02688387|12513358|FG001|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315926|NCT02688387|12513359|FG002|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315927|NCT02688387|12513360|FG003|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315928|NCT02688387|12513361|FG004|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315929|NCT02688387|12513362|FG005|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315930|NCT02688387|12513363|FG006|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315931|NCT02688387|12513364|FG007|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315932|NCT02688387|12513365|FG008|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315933|NCT02688387|12513366|FG009|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315934|NCT02688387|12513367|FG010|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315935|NCT02688387|12513368|FG011|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315936|NCT02688387|12513369|FG012|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315937|NCT02688387|12513370|FG013|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315938|NCT02688387|12513371|FG014|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315939|NCT02688387|12513372|FG015|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315940|NCT02688387|12513373|FG016|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315941|NCT02688387|12513374|FG017|STARTED|Part 3B, Washout Period 1 (10 Days)||0
11315942|NCT02688387|12513375|FG018|STARTED|Part 3B, Washout Period 1 (10 Days)||8
11315943|NCT02688387|12513376|FG019|STARTED|Part 3B, Washout Period 1 (10 Days)||8
11315944|NCT02688387|12513377|FG020|STARTED|Part 3B, Washout Period 1 (10 Days)||8
11315945|NCT02688387|12513378|FG021|STARTED|Part 3B, Washout Period 1 (10 Days)||8
11315946|NCT02688387|12513357|FG000|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315947|NCT02688387|12513358|FG001|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315948|NCT02688387|12513359|FG002|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315949|NCT02688387|12513360|FG003|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315950|NCT02688387|12513361|FG004|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315951|NCT02688387|12513362|FG005|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315952|NCT02688387|12513363|FG006|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11402293|NCT04053023|12597159|FG000|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||19
11315953|NCT02688387|12513364|FG007|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315954|NCT02688387|12513365|FG008|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315955|NCT02688387|12513366|FG009|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315956|NCT02688387|12513367|FG010|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315957|NCT02688387|12513368|FG011|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315958|NCT02688387|12513369|FG012|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315959|NCT02688387|12513370|FG013|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315960|NCT02688387|12513371|FG014|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315961|NCT02688387|12513372|FG015|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315962|NCT02688387|12513373|FG016|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315963|NCT02688387|12513374|FG017|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315964|NCT02688387|12513375|FG018|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
11315965|NCT02688387|12513376|FG019|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
11315966|NCT02688387|12513377|FG020|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
11315967|NCT02688387|12513378|FG021|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
11315968|NCT02688387|12513357|FG000|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315969|NCT02688387|12513358|FG001|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315970|NCT02688387|12513359|FG002|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315971|NCT02688387|12513360|FG003|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315972|NCT02688387|12513361|FG004|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315973|NCT02688387|12513362|FG005|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315974|NCT02688387|12513363|FG006|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315975|NCT02688387|12513364|FG007|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315976|NCT02688387|12513365|FG008|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315977|NCT02688387|12513366|FG009|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315978|NCT02688387|12513367|FG010|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315979|NCT02688387|12513368|FG011|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315980|NCT02688387|12513369|FG012|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315981|NCT02688387|12513370|FG013|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315982|NCT02688387|12513371|FG014|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315983|NCT02688387|12513372|FG015|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315984|NCT02688387|12513373|FG016|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315985|NCT02688387|12513374|FG017|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315986|NCT02688387|12513375|FG018|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315987|NCT02688387|12513376|FG019|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315988|NCT02688387|12513377|FG020|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315989|NCT02688387|12513378|FG021|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
11315990|NCT02688387|12513357|FG000|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11315991|NCT02688387|12513358|FG001|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11315992|NCT02688387|12513359|FG002|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11315993|NCT02688387|12513360|FG003|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11315994|NCT02688387|12513361|FG004|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11315995|NCT02688387|12513362|FG005|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11315996|NCT02688387|12513363|FG006|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11315997|NCT02688387|12513364|FG007|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11315998|NCT02688387|12513365|FG008|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11315999|NCT02688387|12513366|FG009|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11316000|NCT02688387|12513367|FG010|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11316001|NCT02688387|12513368|FG011|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11316002|NCT02688387|12513369|FG012|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11316003|NCT02688387|12513370|FG013|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11316004|NCT02688387|12513371|FG014|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11316005|NCT02688387|12513372|FG015|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11316006|NCT02688387|12513373|FG016|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11316007|NCT02688387|12513374|FG017|STARTED|Part 3B, Period 2 (up to 6 Days)||0
11316008|NCT02688387|12513375|FG018|STARTED|Part 3B, Period 2 (up to 6 Days)||8
11316009|NCT02688387|12513376|FG019|STARTED|Part 3B, Period 2 (up to 6 Days)||8
11316010|NCT02688387|12513377|FG020|STARTED|Part 3B, Period 2 (up to 6 Days)||8
11316011|NCT02688387|12513378|FG021|STARTED|Part 3B, Period 2 (up to 6 Days)||8
11316012|NCT02688387|12513357|FG000|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316013|NCT02688387|12513358|FG001|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316014|NCT02688387|12513359|FG002|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316015|NCT02688387|12513360|FG003|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316016|NCT02688387|12513361|FG004|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316017|NCT02688387|12513362|FG005|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316018|NCT02688387|12513363|FG006|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316019|NCT02688387|12513364|FG007|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316020|NCT02688387|12513365|FG008|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316021|NCT02688387|12513366|FG009|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316022|NCT02688387|12513367|FG010|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316023|NCT02688387|12513368|FG011|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316024|NCT02688387|12513369|FG012|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316025|NCT02688387|12513370|FG013|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316026|NCT02688387|12513371|FG014|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316027|NCT02688387|12513372|FG015|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316028|NCT02688387|12513373|FG016|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316029|NCT02688387|12513374|FG017|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316030|NCT02688387|12513375|FG018|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
11316031|NCT02688387|12513376|FG019|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
11316032|NCT02688387|12513377|FG020|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
11316033|NCT02688387|12513378|FG021|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
11316034|NCT02688387|12513357|FG000|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316035|NCT02688387|12513358|FG001|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316036|NCT02688387|12513359|FG002|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316037|NCT02688387|12513360|FG003|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316038|NCT02688387|12513361|FG004|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316039|NCT02688387|12513362|FG005|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316040|NCT02688387|12513363|FG006|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316041|NCT02688387|12513364|FG007|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316042|NCT02688387|12513365|FG008|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316043|NCT02688387|12513366|FG009|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316044|NCT02688387|12513367|FG010|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316045|NCT02688387|12513368|FG011|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316046|NCT02688387|12513369|FG012|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316047|NCT02688387|12513370|FG013|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316048|NCT02688387|12513371|FG014|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316049|NCT02688387|12513372|FG015|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316050|NCT02688387|12513373|FG016|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316051|NCT02688387|12513374|FG017|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316052|NCT02688387|12513375|FG018|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316053|NCT02688387|12513376|FG019|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316054|NCT02688387|12513377|FG020|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316055|NCT02688387|12513378|FG021|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
11316056|NCT02688387|12513357|FG000|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316057|NCT02688387|12513358|FG001|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316058|NCT02688387|12513359|FG002|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316059|NCT02688387|12513360|FG003|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316060|NCT02688387|12513361|FG004|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316061|NCT02688387|12513362|FG005|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316062|NCT02688387|12513363|FG006|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316063|NCT02688387|12513364|FG007|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316064|NCT02688387|12513365|FG008|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316065|NCT02688387|12513366|FG009|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316066|NCT02688387|12513367|FG010|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316067|NCT02688387|12513368|FG011|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316068|NCT02688387|12513369|FG012|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316069|NCT02688387|12513370|FG013|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316070|NCT02688387|12513371|FG014|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316071|NCT02688387|12513372|FG015|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316072|NCT02688387|12513373|FG016|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316073|NCT02688387|12513374|FG017|STARTED|Part 3B, Washout Period 2 (10 Days)||0
11316074|NCT02688387|12513375|FG018|STARTED|Part 3B, Washout Period 2 (10 Days)||8
11316075|NCT02688387|12513376|FG019|STARTED|Part 3B, Washout Period 2 (10 Days)||8
11316076|NCT02688387|12513377|FG020|STARTED|Part 3B, Washout Period 2 (10 Days)||8
11316077|NCT02688387|12513378|FG021|STARTED|Part 3B, Washout Period 2 (10 Days)||8
11316078|NCT02688387|12513357|FG000|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316079|NCT02688387|12513358|FG001|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316080|NCT02688387|12513359|FG002|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316081|NCT02688387|12513360|FG003|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316082|NCT02688387|12513361|FG004|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316083|NCT02688387|12513362|FG005|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316084|NCT02688387|12513363|FG006|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316085|NCT02688387|12513364|FG007|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316086|NCT02688387|12513365|FG008|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316087|NCT02688387|12513366|FG009|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316088|NCT02688387|12513367|FG010|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316089|NCT02688387|12513368|FG011|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316090|NCT02688387|12513369|FG012|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316091|NCT02688387|12513370|FG013|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316092|NCT02688387|12513371|FG014|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316093|NCT02688387|12513372|FG015|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316094|NCT02688387|12513373|FG016|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316095|NCT02688387|12513374|FG017|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316096|NCT02688387|12513375|FG018|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
11316097|NCT02688387|12513376|FG019|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
11316098|NCT02688387|12513377|FG020|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
11316099|NCT02688387|12513378|FG021|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
11316100|NCT02688387|12513357|FG000|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316101|NCT02688387|12513358|FG001|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316102|NCT02688387|12513359|FG002|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316103|NCT02688387|12513360|FG003|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316104|NCT02688387|12513361|FG004|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316105|NCT02688387|12513362|FG005|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316106|NCT02688387|12513363|FG006|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316107|NCT02688387|12513364|FG007|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316108|NCT02688387|12513365|FG008|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316109|NCT02688387|12513366|FG009|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316110|NCT02688387|12513367|FG010|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316111|NCT02688387|12513368|FG011|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316112|NCT02688387|12513369|FG012|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11402294|NCT04053023|12597160|FG001|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
11402295|NCT04053023|12597159|FG000|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
11402296|NCT04053023|12597160|FG001|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
11402297|NCT04053023|12597159|FG000|STARTED|Part A: Period 2 (Day 20 to Day 38)||19
11402298|NCT04053023|12597160|FG001|STARTED|Part A: Period 2 (Day 20 to Day 38)||0
11316113|NCT02688387|12513370|FG013|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316114|NCT02688387|12513371|FG014|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316115|NCT02688387|12513372|FG015|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316116|NCT02688387|12513373|FG016|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316117|NCT02688387|12513374|FG017|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316118|NCT02688387|12513375|FG018|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316119|NCT02688387|12513376|FG019|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316120|NCT02688387|12513377|FG020|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316121|NCT02688387|12513378|FG021|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
11316122|NCT02688387|12513357|FG000|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316123|NCT02688387|12513358|FG001|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316124|NCT02688387|12513359|FG002|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316125|NCT02688387|12513360|FG003|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316126|NCT02688387|12513361|FG004|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316127|NCT02688387|12513362|FG005|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316128|NCT02688387|12513363|FG006|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316129|NCT02688387|12513364|FG007|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316130|NCT02688387|12513365|FG008|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316131|NCT02688387|12513366|FG009|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316132|NCT02688387|12513367|FG010|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316133|NCT02688387|12513368|FG011|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316134|NCT02688387|12513369|FG012|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316135|NCT02688387|12513370|FG013|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316136|NCT02688387|12513371|FG014|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316137|NCT02688387|12513372|FG015|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316138|NCT02688387|12513373|FG016|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316139|NCT02688387|12513374|FG017|STARTED|Part 3B, Period 3 (up to 6 Days)||0
11316140|NCT02688387|12513375|FG018|STARTED|Part 3B, Period 3 (up to 6 Days)||8
11316141|NCT02688387|12513376|FG019|STARTED|Part 3B, Period 3 (up to 6 Days)||8
11402299|NCT04053023|12597159|FG000|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||18
11402300|NCT04053023|12597160|FG001|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
11402301|NCT04053023|12597159|FG000|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||1
11402302|NCT04053023|12597160|FG001|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
11402303|NCT04053023|12597159|FG000|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
11402304|NCT04053023|12597160|FG001|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
11402305|NCT04053023|12597159|FG000|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
11402306|NCT04053023|12597160|FG001|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
11402307|NCT04053023|12597159|FG000|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
11402308|NCT04053023|12597160|FG001|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
11402309|NCT04053023|12597159|FG000|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
11402310|NCT04053023|12597160|FG001|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
11402311|NCT04053023|12597159|FG000|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
11402312|NCT04053023|12597160|FG001|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
11402313|NCT04053023|12597159|FG000|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
11402314|NCT04053023|12597160|FG001|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
11402315|NCT04051710|12597173|FG000|STARTED|Overall Study||620
11402316|NCT04051710|12597174|FG001|STARTED|Overall Study||620
11402317|NCT04051710|12597175|FG002|STARTED|Overall Study||310
11402318|NCT04051710|12597173|FG000|COMPLETED|Overall Study||616
11402319|NCT04051710|12597174|FG001|COMPLETED|Overall Study||612
11402320|NCT04051710|12597175|FG002|COMPLETED|Overall Study||306
11402321|NCT04051710|12597173|FG000|NOT COMPLETED|Overall Study||4
11402322|NCT04051710|12597174|FG001|NOT COMPLETED|Overall Study||8
11402323|NCT04051710|12597175|FG002|NOT COMPLETED|Overall Study||4
11402324|NCT04050865|12597185|FG000|STARTED|Overall Study||48
11402325|NCT04050865|12597186|FG001|STARTED|Overall Study||48
11402326|NCT04050865|12597185|FG000|COMPLETED|Overall Study||44
11402327|NCT04050865|12597186|FG001|COMPLETED|Overall Study||43
11402328|NCT04050865|12597185|FG000|NOT COMPLETED|Overall Study||4
11402329|NCT04050865|12597186|FG001|NOT COMPLETED|Overall Study||5
11316142|NCT02688387|12513377|FG020|STARTED|Part 3B, Period 3 (up to 6 Days)||8
11316143|NCT02688387|12513378|FG021|STARTED|Part 3B, Period 3 (up to 6 Days)||8
11316144|NCT02688387|12513357|FG000|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316145|NCT02688387|12513358|FG001|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316146|NCT02688387|12513359|FG002|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316147|NCT02688387|12513360|FG003|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316148|NCT02688387|12513361|FG004|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316149|NCT02688387|12513362|FG005|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316150|NCT02688387|12513363|FG006|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316151|NCT02688387|12513364|FG007|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316152|NCT02688387|12513365|FG008|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316153|NCT02688387|12513366|FG009|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316154|NCT02688387|12513367|FG010|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316155|NCT02688387|12513368|FG011|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316156|NCT02688387|12513369|FG012|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316157|NCT02688387|12513370|FG013|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316158|NCT02688387|12513371|FG014|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316159|NCT02688387|12513372|FG015|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316160|NCT02688387|12513373|FG016|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316161|NCT02688387|12513374|FG017|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316162|NCT02688387|12513375|FG018|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
11316163|NCT02688387|12513376|FG019|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
11316164|NCT02688387|12513377|FG020|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7
11316165|NCT02688387|12513378|FG021|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
11316166|NCT02688387|12513357|FG000|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316167|NCT02688387|12513358|FG001|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316168|NCT02688387|12513359|FG002|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316169|NCT02688387|12513360|FG003|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316170|NCT02688387|12513361|FG004|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316171|NCT02688387|12513362|FG005|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316172|NCT02688387|12513363|FG006|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316173|NCT02688387|12513364|FG007|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316174|NCT02688387|12513365|FG008|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316175|NCT02688387|12513366|FG009|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316176|NCT02688387|12513367|FG010|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316177|NCT02688387|12513368|FG011|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316178|NCT02688387|12513369|FG012|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316179|NCT02688387|12513370|FG013|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316180|NCT02688387|12513371|FG014|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316181|NCT02688387|12513372|FG015|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316182|NCT02688387|12513373|FG016|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316183|NCT02688387|12513374|FG017|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316184|NCT02688387|12513375|FG018|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316185|NCT02688387|12513376|FG019|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316186|NCT02688387|12513377|FG020|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1
11316187|NCT02688387|12513378|FG021|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
11316188|NCT02688387|12513357|FG000|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316189|NCT02688387|12513358|FG001|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316190|NCT02688387|12513359|FG002|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316191|NCT02688387|12513360|FG003|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316192|NCT02688387|12513361|FG004|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316193|NCT02688387|12513362|FG005|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316194|NCT02688387|12513363|FG006|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316195|NCT02688387|12513364|FG007|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316196|NCT02688387|12513365|FG008|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316197|NCT02688387|12513366|FG009|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316198|NCT02688387|12513367|FG010|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316199|NCT02688387|12513368|FG011|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316200|NCT02688387|12513369|FG012|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316201|NCT02688387|12513370|FG013|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316202|NCT02688387|12513371|FG014|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316203|NCT02688387|12513372|FG015|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316204|NCT02688387|12513373|FG016|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316205|NCT02688387|12513374|FG017|STARTED|Part 3B, Washout Period 3 (10 Days)||0
11316206|NCT02688387|12513375|FG018|STARTED|Part 3B, Washout Period 3 (10 Days)||8
11316207|NCT02688387|12513376|FG019|STARTED|Part 3B, Washout Period 3 (10 Days)||8
11316208|NCT02688387|12513377|FG020|STARTED|Part 3B, Washout Period 3 (10 Days)||7
11316209|NCT02688387|12513378|FG021|STARTED|Part 3B, Washout Period 3 (10 Days)||8
11316210|NCT02688387|12513357|FG000|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316211|NCT02688387|12513358|FG001|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316212|NCT02688387|12513359|FG002|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316213|NCT02688387|12513360|FG003|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316214|NCT02688387|12513361|FG004|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316215|NCT02688387|12513362|FG005|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316216|NCT02688387|12513363|FG006|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316217|NCT02688387|12513364|FG007|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316218|NCT02688387|12513365|FG008|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316219|NCT02688387|12513366|FG009|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316220|NCT02688387|12513367|FG010|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316221|NCT02688387|12513368|FG011|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316222|NCT02688387|12513369|FG012|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316223|NCT02688387|12513370|FG013|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316224|NCT02688387|12513371|FG014|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316225|NCT02688387|12513372|FG015|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316226|NCT02688387|12513373|FG016|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316227|NCT02688387|12513374|FG017|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316228|NCT02688387|12513375|FG018|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
11316229|NCT02688387|12513376|FG019|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
11316230|NCT02688387|12513377|FG020|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6
11316231|NCT02688387|12513378|FG021|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8
11316232|NCT02688387|12513357|FG000|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316233|NCT02688387|12513358|FG001|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316234|NCT02688387|12513359|FG002|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316235|NCT02688387|12513360|FG003|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316236|NCT02688387|12513361|FG004|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316237|NCT02688387|12513362|FG005|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316238|NCT02688387|12513363|FG006|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316239|NCT02688387|12513364|FG007|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316240|NCT02688387|12513365|FG008|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316241|NCT02688387|12513366|FG009|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316242|NCT02688387|12513367|FG010|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316243|NCT02688387|12513368|FG011|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316244|NCT02688387|12513369|FG012|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316245|NCT02688387|12513370|FG013|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316246|NCT02688387|12513371|FG014|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316247|NCT02688387|12513372|FG015|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316248|NCT02688387|12513373|FG016|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316249|NCT02688387|12513374|FG017|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316250|NCT02688387|12513375|FG018|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
11316251|NCT02688387|12513376|FG019|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
11316252|NCT02688387|12513377|FG020|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
11316253|NCT02688387|12513378|FG021|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
11316254|NCT02688387|12513357|FG000|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316255|NCT02688387|12513358|FG001|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316256|NCT02688387|12513359|FG002|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316257|NCT02688387|12513360|FG003|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316258|NCT02688387|12513361|FG004|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316259|NCT02688387|12513362|FG005|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316260|NCT02688387|12513363|FG006|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316261|NCT02688387|12513364|FG007|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316262|NCT02688387|12513365|FG008|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11022242|NCT00808249|12200512|FG003|NOT COMPLETED|Overall Study||16
11022243|NCT00808340|12200522|FG000|STARTED|First Intervention||4
11022244|NCT00808340|12200523|FG001|STARTED|First Intervention||9
11022245|NCT00808340|12200524|FG002|STARTED|First Intervention||7
11022246|NCT00808340|12200525|FG003|STARTED|First Intervention||3
11022247|NCT00808340|12200526|FG004|STARTED|First Intervention||5
11316263|NCT02688387|12513366|FG009|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316264|NCT02688387|12513367|FG010|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316265|NCT02688387|12513368|FG011|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316266|NCT02688387|12513369|FG012|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316267|NCT02688387|12513370|FG013|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316268|NCT02688387|12513371|FG014|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316269|NCT02688387|12513372|FG015|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316270|NCT02688387|12513373|FG016|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316271|NCT02688387|12513374|FG017|STARTED|Part 3B, Period 4 (up to 6 Days)||0
11316272|NCT02688387|12513375|FG018|STARTED|Part 3B, Period 4 (up to 6 Days)||7
11316273|NCT02688387|12513376|FG019|STARTED|Part 3B, Period 4 (up to 6 Days)||7
11316274|NCT02688387|12513377|FG020|STARTED|Part 3B, Period 4 (up to 6 Days)||6
11316275|NCT02688387|12513378|FG021|STARTED|Part 3B, Period 4 (up to 6 Days)||8
11316276|NCT02688387|12513357|FG000|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316277|NCT02688387|12513358|FG001|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316278|NCT02688387|12513359|FG002|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316279|NCT02688387|12513360|FG003|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316280|NCT02688387|12513361|FG004|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316281|NCT02688387|12513362|FG005|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316282|NCT02688387|12513363|FG006|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316283|NCT02688387|12513364|FG007|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316284|NCT02688387|12513365|FG008|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316285|NCT02688387|12513366|FG009|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316286|NCT02688387|12513367|FG010|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316287|NCT02688387|12513368|FG011|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316288|NCT02688387|12513369|FG012|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316289|NCT02688387|12513370|FG013|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316290|NCT02688387|12513371|FG014|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316291|NCT02688387|12513372|FG015|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316292|NCT02688387|12513373|FG016|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11022248|NCT00808340|12200527|FG005|STARTED|First Intervention||6
11316293|NCT02688387|12513374|FG017|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316294|NCT02688387|12513375|FG018|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
11316295|NCT02688387|12513376|FG019|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
11316296|NCT02688387|12513377|FG020|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6
11316297|NCT02688387|12513378|FG021|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8
11316298|NCT02688387|12513357|FG000|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316299|NCT02688387|12513358|FG001|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316300|NCT02688387|12513359|FG002|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316301|NCT02688387|12513360|FG003|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316302|NCT02688387|12513361|FG004|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316303|NCT02688387|12513362|FG005|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316304|NCT02688387|12513363|FG006|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316305|NCT02688387|12513364|FG007|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316306|NCT02688387|12513365|FG008|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316307|NCT02688387|12513366|FG009|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316308|NCT02688387|12513367|FG010|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316309|NCT02688387|12513368|FG011|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316310|NCT02688387|12513369|FG012|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316311|NCT02688387|12513370|FG013|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316312|NCT02688387|12513371|FG014|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316313|NCT02688387|12513372|FG015|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316314|NCT02688387|12513373|FG016|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316315|NCT02688387|12513374|FG017|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316316|NCT02688387|12513375|FG018|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316317|NCT02688387|12513376|FG019|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316318|NCT02688387|12513377|FG020|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316319|NCT02688387|12513378|FG021|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
11316320|NCT02688621|12513426|FG000|STARTED|Overall Study||212
11316321|NCT02688621|12513427|FG001|STARTED|Overall Study||206
11316322|NCT02688621|12513426|FG000|COMPLETED|Overall Study||172
11316323|NCT02688621|12513427|FG001|COMPLETED|Overall Study||188
11316324|NCT02688621|12513426|FG000|NOT COMPLETED|Overall Study||40
11316325|NCT02688621|12513427|FG001|NOT COMPLETED|Overall Study||18
11316326|NCT02688764|12513438|FG000|STARTED|Overall Study||66
11316327|NCT02688764|12513439|FG001|STARTED|Overall Study||19
11316328|NCT02688764|12513438|FG000|Treated in Stage 1|Overall Study||66
11316329|NCT02688764|12513439|FG001|Treated in Stage 1|Overall Study||19
11316330|NCT02688764|12513438|FG000|Treated in Stage 2|Overall Study||43
11316331|NCT02688764|12513439|FG001|Treated in Stage 2|Overall Study||8
11316332|NCT02688764|12513438|FG000|COMPLETED|Overall Study||26
11316333|NCT02688764|12513439|FG001|COMPLETED|Overall Study||2
11316334|NCT02688764|12513438|FG000|NOT COMPLETED|Overall Study||40
11316335|NCT02688764|12513439|FG001|NOT COMPLETED|Overall Study||17
11316336|NCT02688829|12513448|FG000|STARTED|Overall Study||21
11316337|NCT02688829|12513448|FG000|COMPLETED|Overall Study||19
11316338|NCT02688829|12513448|FG000|NOT COMPLETED|Overall Study||2
11316339|NCT02688842|12513452|FG000|STARTED|Overall Study||38
11316340|NCT02688842|12513452|FG000|COMPLETED|Overall Study||38
11316341|NCT02688842|12513452|FG000|NOT COMPLETED|Overall Study||0
11316342|NCT02688868|12513456|FG000|STARTED|Overall Study||38
11316343|NCT02688868|12513456|FG000|COMPLETED|Overall Study||34
11316344|NCT02688868|12513456|FG000|NOT COMPLETED|Overall Study||4
11316345|NCT02689063|12513464|FG000|STARTED|Overall Study||75
11316346|NCT02689063|12513465|FG001|STARTED|Overall Study||75
11316347|NCT02689063|12513466|FG002|STARTED|Overall Study||76
11316348|NCT02689063|12513467|FG003|STARTED|Overall Study||50
11316349|NCT02689063|12513464|FG000|COMPLETED|Overall Study||75
11316350|NCT02689063|12513465|FG001|COMPLETED|Overall Study||73
11316351|NCT02689063|12513466|FG002|COMPLETED|Overall Study||73
11316352|NCT02689063|12513467|FG003|COMPLETED|Overall Study||50
11316353|NCT02689063|12513464|FG000|NOT COMPLETED|Overall Study||0
11316354|NCT02689063|12513465|FG001|NOT COMPLETED|Overall Study||2
11316355|NCT02689063|12513466|FG002|NOT COMPLETED|Overall Study||3
11316356|NCT02689063|12513467|FG003|NOT COMPLETED|Overall Study||0
11316357|NCT02689076|12513480|FG000|STARTED|Overall Study||268
11316358|NCT02689076|12513481|FG001|STARTED|Overall Study||337
11316359|NCT02689076|12513482|FG002|STARTED|Overall Study||191
11316360|NCT02689076|12513480|FG000|COMPLETED|Overall Study||87
11316361|NCT02689076|12513481|FG001|COMPLETED|Overall Study||115
11316362|NCT02689076|12513482|FG002|COMPLETED|Overall Study||191
11316363|NCT02689076|12513480|FG000|NOT COMPLETED|Overall Study||181
11316364|NCT02689076|12513481|FG001|NOT COMPLETED|Overall Study||222
11316365|NCT02689076|12513482|FG002|NOT COMPLETED|Overall Study||0
11402330|NCT04050605|12597192|FG000|STARTED|Overall Study||40
11316366|NCT02689154|12513490|FG000|STARTED|Overall Study||18
11316367|NCT02689154|12513490|FG000|COMPLETED|Overall Study||18
11316368|NCT02689154|12513490|FG000|NOT COMPLETED|Overall Study||0
11316369|NCT02689206|12513499|FG000|STARTED|Overall Study||20
11316370|NCT02689206|12513500|FG001|STARTED|Overall Study||20
11316371|NCT02689206|12513501|FG002|STARTED|Overall Study||20
11316372|NCT02689206|12513502|FG003|STARTED|Overall Study||21
11316373|NCT02689206|12513503|FG004|STARTED|Overall Study||22
11316374|NCT02689206|12513499|FG000|COMPLETED|Overall Study||17
11316375|NCT02689206|12513500|FG001|COMPLETED|Overall Study||19
11316376|NCT02689206|12513501|FG002|COMPLETED|Overall Study||16
11316377|NCT02689206|12513502|FG003|COMPLETED|Overall Study||17
11316378|NCT02689206|12513503|FG004|COMPLETED|Overall Study||14
11316379|NCT02689206|12513499|FG000|NOT COMPLETED|Overall Study||3
11316380|NCT02689206|12513500|FG001|NOT COMPLETED|Overall Study||1
11316381|NCT02689206|12513501|FG002|NOT COMPLETED|Overall Study||4
11316382|NCT02689206|12513502|FG003|NOT COMPLETED|Overall Study||4
11316383|NCT02689206|12513503|FG004|NOT COMPLETED|Overall Study||8
11316384|NCT02689219|12513521|FG000|STARTED|Overall Study||11
11316385|NCT02689219|12513522|FG001|STARTED|Overall Study||7
11316386|NCT02689219|12513521|FG000|COMPLETED|Overall Study||0
11316387|NCT02689219|12513522|FG001|COMPLETED|Overall Study||0
11316388|NCT02689219|12513521|FG000|NOT COMPLETED|Overall Study||11
11316389|NCT02689219|12513522|FG001|NOT COMPLETED|Overall Study||7
11316390|NCT02689492|12513528|FG000|STARTED|Overall Study||401
11316391|NCT02689492|12513528|FG000|COMPLETED|Overall Study||315
11316392|NCT02689492|12513528|FG000|NOT COMPLETED|Overall Study||86
11316393|NCT02689804|12513537|FG000|STARTED|Overall Study||18
11316394|NCT02689804|12513538|FG001|STARTED|Overall Study||16
11316395|NCT02689804|12513537|FG000|COMPLETED|Overall Study||16
11316396|NCT02689804|12513538|FG001|COMPLETED|Overall Study||16
11316397|NCT02689804|12513537|FG000|NOT COMPLETED|Overall Study||2
11316398|NCT02689804|12513538|FG001|NOT COMPLETED|Overall Study||0
11316399|NCT02689973|12513551|FG000|STARTED|Overall Study||311
11316400|NCT02689973|12513552|FG001|STARTED|Overall Study||270
11316401|NCT02689973|12513553|FG002|STARTED|Overall Study||351
11316402|NCT02689973|12513554|FG003|STARTED|Overall Study||285
11316403|NCT02689973|12513551|FG000|COMPLETED|Overall Study||257
11316404|NCT02689973|12513552|FG001|COMPLETED|Overall Study||221
11316405|NCT02689973|12513553|FG002|COMPLETED|Overall Study||279
11316406|NCT02689973|12513554|FG003|COMPLETED|Overall Study||232
11316407|NCT02689973|12513551|FG000|NOT COMPLETED|Overall Study||54
11316408|NCT02689973|12513552|FG001|NOT COMPLETED|Overall Study||49
11316409|NCT02689973|12513553|FG002|NOT COMPLETED|Overall Study||72
11316410|NCT02689973|12513554|FG003|NOT COMPLETED|Overall Study||53
11316411|NCT02690168|12513565|FG000|STARTED|Overall Study||6
11316412|NCT02690168|12513565|FG000|COMPLETED|Overall Study||6
11316413|NCT02690168|12513565|FG000|NOT COMPLETED|Overall Study||0
11316414|NCT02690181|12513576|FG000|STARTED|Overall Study||14
11316415|NCT02690181|12513577|FG001|STARTED|Overall Study||14
11316416|NCT02690181|12513578|FG002|STARTED|Overall Study||15
11316417|NCT02690181|12513579|FG003|STARTED|Overall Study||10
11316418|NCT02690181|12513580|FG004|STARTED|Overall Study||6
11316419|NCT02690181|12513581|FG005|STARTED|Overall Study||21
11316420|NCT02690181|12513576|FG000|COMPLETED|Overall Study||14
11316421|NCT02690181|12513577|FG001|COMPLETED|Overall Study||14
11316422|NCT02690181|12513578|FG002|COMPLETED|Overall Study||15
11316423|NCT02690181|12513579|FG003|COMPLETED|Overall Study||10
11316424|NCT02690181|12513580|FG004|COMPLETED|Overall Study||6
11316425|NCT02690181|12513581|FG005|COMPLETED|Overall Study||21
11316426|NCT02690181|12513576|FG000|NOT COMPLETED|Overall Study||0
11316427|NCT02690181|12513577|FG001|NOT COMPLETED|Overall Study||0
11316428|NCT02690181|12513578|FG002|NOT COMPLETED|Overall Study||0
11316429|NCT02690181|12513579|FG003|NOT COMPLETED|Overall Study||0
11316430|NCT02690181|12513580|FG004|NOT COMPLETED|Overall Study||0
11316431|NCT02690181|12513581|FG005|NOT COMPLETED|Overall Study||0
11316432|NCT02690194|12513598|FG000|STARTED|Overall Study||17
11316433|NCT02690194|12513599|FG001|STARTED|Overall Study||18
11316434|NCT02690194|12513600|FG002|STARTED|Overall Study||19
11316435|NCT02690194|12513598|FG000|COMPLETED|Overall Study||16
11316436|NCT02690194|12513599|FG001|COMPLETED|Overall Study||14
11316437|NCT02690194|12513600|FG002|COMPLETED|Overall Study||19
11316438|NCT02690194|12513598|FG000|NOT COMPLETED|Overall Study||1
11316439|NCT02690194|12513599|FG001|NOT COMPLETED|Overall Study||4
11316440|NCT02690194|12513600|FG002|NOT COMPLETED|Overall Study||0
11316441|NCT02690207|12513608|FG000|STARTED|Overall Study||8687
11316442|NCT02690207|12513608|FG000|COMPLETED|Overall Study||8434
11316443|NCT02690207|12513608|FG000|NOT COMPLETED|Overall Study||253
11316444|NCT02690558|12513612|FG000|STARTED|Overall Study||39
11316445|NCT02690558|12513612|FG000|COMPLETED|Overall Study||39
11316446|NCT02690558|12513612|FG000|NOT COMPLETED|Overall Study||0
11316447|NCT02690649|12513618|FG000|STARTED|Overall Study||80
11316448|NCT02690649|12513619|FG001|STARTED|Overall Study||80
11316449|NCT02690649|12513618|FG000|COMPLETED|Overall Study||79
11316450|NCT02690649|12513619|FG001|COMPLETED|Overall Study||76
11316451|NCT02690649|12513618|FG000|NOT COMPLETED|Overall Study||1
11316452|NCT02690649|12513619|FG001|NOT COMPLETED|Overall Study||4
11316453|NCT02690701|12513629|FG000|STARTED|Treatment Period 1||46
11316454|NCT02690701|12513630|FG001|STARTED|Treatment Period 1||45
11316455|NCT02690701|12513629|FG000|COMPLETED|Treatment Period 1||44
11316456|NCT02690701|12513630|FG001|COMPLETED|Treatment Period 1||42
11316457|NCT02690701|12513629|FG000|NOT COMPLETED|Treatment Period 1||2
11316458|NCT02690701|12513630|FG001|NOT COMPLETED|Treatment Period 1||3
11316459|NCT02690701|12513629|FG000|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44
11316460|NCT02690701|12513630|FG001|STARTED|Treatment Period 2||42
11316461|NCT02690701|12513629|FG000|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41
11316462|NCT02690701|12513630|FG001|COMPLETED|Treatment Period 2||37
11316463|NCT02690701|12513629|FG000|NOT COMPLETED|Treatment Period 2||3
11316464|NCT02690701|12513630|FG001|NOT COMPLETED|Treatment Period 2||5
11316465|NCT02690714|12513637|FG000|STARTED|Segment 1: Single-dose Day -4 to Day 0||9
11316466|NCT02690714|12513637|FG000|COMPLETED|Segment 1: Single-dose Day -4 to Day 0|Six participants skipped Segment 1 as they had PK data from Phase 1 study 2002C005G.|9
11316467|NCT02690714|12513637|FG000|NOT COMPLETED|Segment 1: Single-dose Day -4 to Day 0||0
11316468|NCT02690714|12513637|FG000|STARTED|Segment 2: Multi-dose Day 0 to Week 12||15
11316469|NCT02690714|12513637|FG000|COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||15
11316470|NCT02690714|12513637|FG000|NOT COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||0
11316471|NCT02690714|12513637|FG000|STARTED|Segment 3: Extended Treatment Wks 12-48||15
11316472|NCT02690714|12513637|FG000|COMPLETED|Segment 3: Extended Treatment Wks 12-48||15
11316473|NCT02690714|12513637|FG000|NOT COMPLETED|Segment 3: Extended Treatment Wks 12-48||0
11316474|NCT02690714|12513637|FG000|STARTED|Post-Wk 48: Safety Week 48 to EoS Visit|3 subjects from Norway did not go past 48 weeks|12
11316475|NCT02690714|12513637|FG000|COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||10
11316476|NCT02690714|12513637|FG000|NOT COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||2
11316477|NCT02690727|12513645|FG000|STARTED|Overall Study||9
11316478|NCT02690727|12513646|FG001|STARTED|Overall Study||9
11316479|NCT02690727|12513645|FG000|COMPLETED|Overall Study||7
11316480|NCT02690727|12513646|FG001|COMPLETED|Overall Study||7
11316481|NCT02690727|12513645|FG000|NOT COMPLETED|Overall Study||2
11316482|NCT02690727|12513646|FG001|NOT COMPLETED|Overall Study||2
11316483|NCT02690935|12513656|FG000|STARTED|Overall Study|Count of participants|51
11316484|NCT02690935|12513657|FG001|STARTED|Overall Study|Count of participants|51
11316485|NCT02690935|12513656|FG000|COMPLETED|Overall Study|Count of participants|51
11316486|NCT02690935|12513657|FG001|COMPLETED|Overall Study|Count of participants|51
11316487|NCT02690935|12513656|FG000|NOT COMPLETED|Overall Study||0
11316488|NCT02690935|12513657|FG001|NOT COMPLETED|Overall Study||0
11316489|NCT02690948|12513665|FG000|STARTED|Overall Study||9
11316490|NCT02690948|12513666|FG001|STARTED|Overall Study||7
11316491|NCT02690948|12513665|FG000|COMPLETED|Overall Study||9
11316492|NCT02690948|12513666|FG001|COMPLETED|Overall Study||7
11316493|NCT02690948|12513665|FG000|NOT COMPLETED|Overall Study||0
11316494|NCT02690948|12513666|FG001|NOT COMPLETED|Overall Study||0
11316495|NCT02690974|12513672|FG000|STARTED|Overall Study||302
11316496|NCT02690974|12513672|FG000|COMPLETED|Overall Study||262
11316497|NCT02690974|12513672|FG000|NOT COMPLETED|Overall Study||40
11316498|NCT02691143|12513678|FG000|STARTED|Overall Study||27
11316499|NCT02691143|12513679|FG001|STARTED|Overall Study||23
11316500|NCT02691143|12513678|FG000|COMPLETED|Overall Study||27
11316501|NCT02691143|12513679|FG001|COMPLETED|Overall Study||23
11316502|NCT02691143|12513678|FG000|NOT COMPLETED|Overall Study||0
11316503|NCT02691143|12513679|FG001|NOT COMPLETED|Overall Study||0
11316504|NCT02691247|12513688|FG000|STARTED|Overall Study||40
11316505|NCT02691247|12513689|FG001|STARTED|Overall Study||24
11316506|NCT02691247|12513690|FG002|STARTED|Overall Study||46
11316507|NCT02691247|12513688|FG000|COMPLETED|Overall Study||37
11316508|NCT02691247|12513689|FG001|COMPLETED|Overall Study||22
11316509|NCT02691247|12513690|FG002|COMPLETED|Overall Study||43
11316510|NCT02691247|12513688|FG000|NOT COMPLETED|Overall Study||3
11316511|NCT02691247|12513689|FG001|NOT COMPLETED|Overall Study||2
11316512|NCT02691247|12513690|FG002|NOT COMPLETED|Overall Study||3
11316513|NCT02691260|12513702|FG000|STARTED|Overall Study||26
11316514|NCT02691260|12513703|FG001|STARTED|Overall Study||26
11316515|NCT02691260|12513704|FG002|STARTED|Overall Study||27
11316516|NCT02691260|12513705|FG003|STARTED|Overall Study||26
11316517|NCT02691260|12513702|FG000|COMPLETED|Overall Study||24
11316518|NCT02691260|12513703|FG001|COMPLETED|Overall Study||24
11316519|NCT02691260|12513704|FG002|COMPLETED|Overall Study||25
11316520|NCT02691260|12513705|FG003|COMPLETED|Overall Study||23
11316521|NCT02691260|12513702|FG000|NOT COMPLETED|Overall Study||2
11316522|NCT02691260|12513703|FG001|NOT COMPLETED|Overall Study||2
11316523|NCT02691260|12513704|FG002|NOT COMPLETED|Overall Study||2
11316524|NCT02691260|12513705|FG003|NOT COMPLETED|Overall Study||3
11316525|NCT02691416|12513717|FG000|STARTED|Overall Study||30
11316526|NCT02691416|12513718|FG001|STARTED|Overall Study||30
11316527|NCT02691416|12513717|FG000|COMPLETED|Overall Study||30
11316528|NCT02691416|12513718|FG001|COMPLETED|Overall Study||30
11316529|NCT02691416|12513717|FG000|NOT COMPLETED|Overall Study||0
11316530|NCT02691416|12513718|FG001|NOT COMPLETED|Overall Study||0
11316531|NCT02691455|12513730|FG000|STARTED|Overall Study||23
11316532|NCT02691455|12513731|FG001|STARTED|Overall Study||22
11316533|NCT02691455|12513730|FG000|Randomized|Overall Study||23
11316534|NCT02691455|12513731|FG001|Randomized|Overall Study||22
11316535|NCT02691455|12513730|FG000|Received Assigned Intervention|Overall Study||22
11316536|NCT02691455|12513731|FG001|Received Assigned Intervention|Overall Study||20
11316537|NCT02691455|12513730|FG000|Week 1 Follow up|Overall Study||22
11316538|NCT02691455|12513731|FG001|Week 1 Follow up|Overall Study||19
11316539|NCT02691455|12513730|FG000|Month 1 Follow up|Overall Study||22
11316540|NCT02691455|12513731|FG001|Month 1 Follow up|Overall Study||18
11316541|NCT02691455|12513730|FG000|Month 3 Follow up|Overall Study||21
11316542|NCT02691455|12513731|FG001|Month 3 Follow up|Overall Study||18
11316543|NCT02691455|12513730|FG000|Month 6 Follow up|Overall Study||19
11316544|NCT02691455|12513731|FG001|Month 6 Follow up|Overall Study||19
11316545|NCT02691455|12513730|FG000|Month 12 Follow up|Overall Study||16
11316546|NCT02691455|12513731|FG001|Month 12 Follow up|Overall Study||16
11316547|NCT02691455|12513730|FG000|Year 2 Follow up|Overall Study||6
11316548|NCT02691455|12513731|FG001|Year 2 Follow up|Overall Study||9
11316549|NCT02691455|12513730|FG000|Year 3 Follow up|Overall Study||7
11316550|NCT02691455|12513731|FG001|Year 3 Follow up|Overall Study||5
11316551|NCT02691455|12513730|FG000|COMPLETED|Overall Study||7
11316552|NCT02691455|12513731|FG001|COMPLETED|Overall Study||5
11316553|NCT02691455|12513730|FG000|NOT COMPLETED|Overall Study||16
11316554|NCT02691455|12513731|FG001|NOT COMPLETED|Overall Study||17
11342334|NCT02943577|12539889|FG001|STARTED|Overall Study||206
11342335|NCT02943577|12539888|FG000|COMPLETED|Overall Study||204
11342336|NCT02943577|12539889|FG001|COMPLETED|Overall Study||201
11402331|NCT04050605|12597192|FG000|COMPLETED|Overall Study||40
11402332|NCT04050605|12597192|FG000|NOT COMPLETED|Overall Study||0
11402333|NCT04050371|12597204|FG000|STARTED|Overall Study||24
11402334|NCT04050371|12597205|FG001|STARTED|Overall Study||24
11402335|NCT04050371|12597204|FG000|COMPLETED|Overall Study||23
11402336|NCT04050371|12597205|FG001|COMPLETED|Overall Study||24
11342337|NCT02943577|12539888|FG000|NOT COMPLETED|Overall Study||5
11342338|NCT02943577|12539889|FG001|NOT COMPLETED|Overall Study||5
11342339|NCT02943668|12539895|FG000|STARTED|Overall Study||2
11342340|NCT02943668|12539895|FG000|COMPLETED|Overall Study||1
11342341|NCT02943668|12539895|FG000|NOT COMPLETED|Overall Study||1
11342342|NCT02943941|12539902|FG000|STARTED|Overall Study||16
11342343|NCT02943941|12539902|FG000|COMPLETED|Overall Study||16
11342344|NCT02943941|12539902|FG000|NOT COMPLETED|Overall Study||0
11402337|NCT04050371|12597204|FG000|NOT COMPLETED|Overall Study||1
11402338|NCT04050371|12597205|FG001|NOT COMPLETED|Overall Study||0
11402339|NCT04048460|12597211|FG000|STARTED|Overall Study||10
11402340|NCT04048460|12597211|FG000|COMPLETED|Overall Study||10
11402341|NCT04048460|12597211|FG000|NOT COMPLETED|Overall Study||0
11402342|NCT04048681|12597215|FG000|STARTED|Overall Study||1
11402343|NCT04048681|12597216|FG001|STARTED|Overall Study||1
11402344|NCT04048681|12597217|FG002|STARTED|Overall Study||1
11342345|NCT02944383|12539910|FG000|STARTED|Overall Study||30
11342346|NCT02944383|12539911|FG001|STARTED|Overall Study||30
11342347|NCT02944383|12539912|FG002|STARTED|Overall Study||31
11342348|NCT02944383|12539910|FG000|COMPLETED|Overall Study||29
11342349|NCT02944383|12539911|FG001|COMPLETED|Overall Study||30
11342350|NCT02944383|12539912|FG002|COMPLETED|Overall Study||30
11342351|NCT02944383|12539910|FG000|NOT COMPLETED|Overall Study||1
11342352|NCT02944383|12539911|FG001|NOT COMPLETED|Overall Study||0
11342353|NCT02944383|12539912|FG002|NOT COMPLETED|Overall Study||1
11402345|NCT04048681|12597218|FG003|STARTED|Overall Study||1
11402346|NCT04048681|12597219|FG004|STARTED|Overall Study||1
11402347|NCT04048681|12597215|FG000|COMPLETED|Overall Study||1
11402348|NCT04048681|12597216|FG001|COMPLETED|Overall Study||1
11402349|NCT04048681|12597217|FG002|COMPLETED|Overall Study||1
11402350|NCT04048681|12597218|FG003|COMPLETED|Overall Study||0
11402351|NCT04048681|12597219|FG004|COMPLETED|Overall Study||1
11402352|NCT04048681|12597215|FG000|NOT COMPLETED|Overall Study||0
11342354|NCT02944448|12539924|FG000|STARTED|Overall Study||316
11342355|NCT02944448|12539925|FG001|STARTED|Overall Study||160
11342356|NCT02944448|12539924|FG000|COMPLETED|Overall Study||227
11342357|NCT02944448|12539925|FG001|COMPLETED|Overall Study||136
11342358|NCT02944448|12539924|FG000|NOT COMPLETED|Overall Study||89
11342359|NCT02944448|12539925|FG001|NOT COMPLETED|Overall Study||24
11342360|NCT02944461|12539932|FG000|STARTED|Overall Study||20
11342361|NCT02944461|12539932|FG000|COMPLETED|Overall Study||15
11342362|NCT02944461|12539932|FG000|NOT COMPLETED|Overall Study||5
11342363|NCT02944565|12539936|FG000|STARTED|Overall Study||28
11342364|NCT02944565|12539936|FG000|COMPLETED|Overall Study||28
11342365|NCT02944565|12539936|FG000|NOT COMPLETED|Overall Study||0
11402353|NCT04048681|12597216|FG001|NOT COMPLETED|Overall Study||0
11402354|NCT04048681|12597217|FG002|NOT COMPLETED|Overall Study||0
11402355|NCT04048681|12597218|FG003|NOT COMPLETED|Overall Study||1
11342366|NCT02944656|12539943|FG000|STARTED|Overall Study||57
11342367|NCT02944656|12539944|FG001|STARTED|Overall Study||57
11342368|NCT02944656|12539943|FG000|Completed Procedure Day|Overall Study||54
11342369|NCT02944656|12539944|FG001|Completed Procedure Day|Overall Study||57
11342370|NCT02944656|12539943|FG000|Completed Day 1 Follow up|Overall Study||47
11342371|NCT02944656|12539944|FG001|Completed Day 1 Follow up|Overall Study||47
11342372|NCT02944656|12539943|FG000|COMPLETED|Overall Study||47
11342373|NCT02944656|12539944|FG001|COMPLETED|Overall Study||47
11342374|NCT02944656|12539943|FG000|NOT COMPLETED|Overall Study||10
11342375|NCT02944656|12539944|FG001|NOT COMPLETED|Overall Study||10
11342376|NCT02944968|12539950|FG000|STARTED|Overall Study||51
11342377|NCT02944968|12539950|FG000|COMPLETED|Overall Study||48
11342378|NCT02944968|12539950|FG000|NOT COMPLETED|Overall Study||3
11342379|NCT02945046|12539957|FG000|STARTED|Overall Study||59
11342380|NCT02945046|12539958|FG001|STARTED|Overall Study||55
11342381|NCT02945046|12539959|FG002|STARTED|Overall Study||55
11342382|NCT02945046|12539957|FG000|Safety Analysis Set|Overall Study||59
11342383|NCT02945046|12539958|FG001|Safety Analysis Set|Overall Study||55
11342384|NCT02945046|12539959|FG002|Safety Analysis Set|Overall Study||55
11342385|NCT02945046|12539957|FG000|Full Analysis Set|Overall Study||57
11342386|NCT02945046|12539958|FG001|Full Analysis Set|Overall Study||53
11342387|NCT02945046|12539959|FG002|Full Analysis Set|Overall Study||55
11342388|NCT02945046|12539957|FG000|COMPLETED|Overall Study||46
11316555|NCT02691468|12513739|FG000|STARTED|Overall Study||54
11316556|NCT02691468|12513740|FG001|STARTED|Overall Study||54
11316557|NCT02691468|12513739|FG000|COMPLETED|Overall Study||48
11316558|NCT02691468|12513740|FG001|COMPLETED|Overall Study||52
11316559|NCT02691468|12513739|FG000|NOT COMPLETED|Overall Study||6
11316560|NCT02691468|12513740|FG001|NOT COMPLETED|Overall Study||2
11316561|NCT02691494|12513749|FG000|STARTED|Treatment Period||94
11316562|NCT02691494|12513750|FG001|STARTED|Treatment Period||95
11316563|NCT02691494|12513751|FG002|STARTED|Treatment Period||189
11316564|NCT02691494|12513749|FG000|COMPLETED|Treatment Period|completed treatment period|72
11316565|NCT02691494|12513750|FG001|COMPLETED|Treatment Period|completed treatment period|69
11316566|NCT02691494|12513751|FG002|COMPLETED|Treatment Period|completed treatment period|148
11316567|NCT02691494|12513749|FG000|NOT COMPLETED|Treatment Period||22
11316568|NCT02691494|12513750|FG001|NOT COMPLETED|Treatment Period||26
11316569|NCT02691494|12513751|FG002|NOT COMPLETED|Treatment Period||41
11316570|NCT02691494|12513749|FG000|STARTED|Post-Treatment Follow-Up Period||14
11316571|NCT02691494|12513750|FG001|STARTED|Post-Treatment Follow-Up Period||25
11316572|NCT02691494|12513751|FG002|STARTED|Post-Treatment Follow-Up Period||59
11316573|NCT02691494|12513749|FG000|COMPLETED|Post-Treatment Follow-Up Period||9
11316574|NCT02691494|12513750|FG001|COMPLETED|Post-Treatment Follow-Up Period||18
11316575|NCT02691494|12513751|FG002|COMPLETED|Post-Treatment Follow-Up Period||42
11316576|NCT02691494|12513749|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||5
11316577|NCT02691494|12513750|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||7
11316578|NCT02691494|12513751|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||17
11316579|NCT02691507|12513761|FG000|STARTED|Overall Study||40
11316580|NCT02691507|12513762|FG001|STARTED|Overall Study||13
11402356|NCT04048681|12597219|FG004|NOT COMPLETED|Overall Study||0
11402357|NCT04046250|12597229|FG000|STARTED|Overall Study||11
11022249|NCT00808340|12200522|FG000|COMPLETED|First Intervention||4
11022250|NCT00808340|12200523|FG001|COMPLETED|First Intervention||9
11022251|NCT00808340|12200524|FG002|COMPLETED|First Intervention||7
11402358|NCT04046250|12597230|FG001|STARTED|Overall Study||11
11402359|NCT04046250|12597229|FG000|COMPLETED|Overall Study|Four Methotrexate + TK-112690 Treatments|8
11402360|NCT04046250|12597230|FG001|COMPLETED|Overall Study|Four Methotrexate + TK-12260 Placebo Treatments|7
11022252|NCT00808340|12200525|FG003|COMPLETED|First Intervention||3
11022253|NCT00808340|12200526|FG004|COMPLETED|First Intervention||5
11022254|NCT00808340|12200527|FG005|COMPLETED|First Intervention||6
11022255|NCT00808340|12200522|FG000|NOT COMPLETED|First Intervention||0
11022256|NCT00808340|12200523|FG001|NOT COMPLETED|First Intervention||0
11022257|NCT00808340|12200524|FG002|NOT COMPLETED|First Intervention||0
11022258|NCT00808340|12200525|FG003|NOT COMPLETED|First Intervention||0
11022259|NCT00808340|12200526|FG004|NOT COMPLETED|First Intervention||0
11022260|NCT00808340|12200527|FG005|NOT COMPLETED|First Intervention||0
11022261|NCT00808340|12200522|FG000|STARTED|Second Intervention||4
11022262|NCT00808340|12200523|FG001|STARTED|Second Intervention||9
11022263|NCT00808340|12200524|FG002|STARTED|Second Intervention||7
11022264|NCT00808340|12200525|FG003|STARTED|Second Intervention||3
11022265|NCT00808340|12200526|FG004|STARTED|Second Intervention||5
11022266|NCT00808340|12200527|FG005|STARTED|Second Intervention||6
11022267|NCT00808340|12200522|FG000|COMPLETED|Second Intervention||4
11022268|NCT00808340|12200523|FG001|COMPLETED|Second Intervention||9
11022269|NCT00808340|12200524|FG002|COMPLETED|Second Intervention||7
11022270|NCT00808340|12200525|FG003|COMPLETED|Second Intervention||3
11022271|NCT00808340|12200526|FG004|COMPLETED|Second Intervention||5
11022272|NCT00808340|12200527|FG005|COMPLETED|Second Intervention||6
11022273|NCT00808340|12200522|FG000|NOT COMPLETED|Second Intervention||0
11022274|NCT00808340|12200523|FG001|NOT COMPLETED|Second Intervention||0
11402361|NCT04046250|12597229|FG000|NOT COMPLETED|Overall Study||3
11402362|NCT04046250|12597230|FG001|NOT COMPLETED|Overall Study||4
11402363|NCT04047342|12597238|FG000|STARTED|Overall Study||409
11402364|NCT04047342|12597239|FG001|STARTED|Overall Study||415
11402365|NCT04047342|12597238|FG000|COMPLETED|Overall Study||409
11402366|NCT04047342|12597239|FG001|COMPLETED|Overall Study||415
11022275|NCT00808340|12200524|FG002|NOT COMPLETED|Second Intervention||0
11022276|NCT00808340|12200525|FG003|NOT COMPLETED|Second Intervention||0
11022277|NCT00808340|12200526|FG004|NOT COMPLETED|Second Intervention||0
11022278|NCT00808340|12200527|FG005|NOT COMPLETED|Second Intervention||0
11022279|NCT00808340|12200522|FG000|STARTED|Third Intervention||4
11402367|NCT04047342|12597238|FG000|NOT COMPLETED|Overall Study||0
11316581|NCT02691507|12513761|FG000|COMPLETED|Overall Study||40
11316582|NCT02691507|12513762|FG001|COMPLETED|Overall Study||12
11316583|NCT02691507|12513761|FG000|NOT COMPLETED|Overall Study||0
11316584|NCT02691507|12513762|FG001|NOT COMPLETED|Overall Study||1
11316585|NCT02691572|12513770|FG000|STARTED|Overall Study||40
11316586|NCT02691572|12513771|FG001|STARTED|Overall Study||40
11316587|NCT02691572|12513770|FG000|COMPLETED|Overall Study||39
11316588|NCT02691572|12513771|FG001|COMPLETED|Overall Study||39
11316589|NCT02691572|12513770|FG000|NOT COMPLETED|Overall Study||1
11316590|NCT02691572|12513771|FG001|NOT COMPLETED|Overall Study||1
11316591|NCT02691702|12513788|FG000|STARTED|Overall Study||10
11316592|NCT02691702|12513789|FG001|STARTED|Overall Study||11
11316593|NCT02691702|12513790|FG002|STARTED|Overall Study||8
11316594|NCT02691702|12513791|FG003|STARTED|Overall Study||8
11316595|NCT02691702|12513792|FG004|STARTED|Overall Study||8
11022280|NCT00808340|12200523|FG001|STARTED|Third Intervention||9
11022281|NCT00808340|12200524|FG002|STARTED|Third Intervention||7
11022282|NCT00808340|12200525|FG003|STARTED|Third Intervention||3
11022283|NCT00808340|12200526|FG004|STARTED|Third Intervention||5
11316596|NCT02691702|12513793|FG005|STARTED|Overall Study||8
11316597|NCT02691702|12513794|FG006|STARTED|Overall Study||8
11316598|NCT02691702|12513795|FG007|STARTED|Overall Study||12
11316599|NCT02691702|12513796|FG008|STARTED|Overall Study||8
11316600|NCT02691702|12513797|FG009|STARTED|Overall Study||8
11316601|NCT02691702|12513798|FG010|STARTED|Overall Study||8
11316602|NCT02691702|12513788|FG000|COMPLETED|Overall Study||8
11316603|NCT02691702|12513789|FG001|COMPLETED|Overall Study||10
11316604|NCT02691702|12513790|FG002|COMPLETED|Overall Study||7
11316605|NCT02691702|12513791|FG003|COMPLETED|Overall Study||8
11316606|NCT02691702|12513792|FG004|COMPLETED|Overall Study||8
11316607|NCT02691702|12513793|FG005|COMPLETED|Overall Study||5
11316608|NCT02691702|12513794|FG006|COMPLETED|Overall Study||5
11316609|NCT02691702|12513795|FG007|COMPLETED|Overall Study||12
11316610|NCT02691702|12513796|FG008|COMPLETED|Overall Study||6
11316611|NCT02691702|12513797|FG009|COMPLETED|Overall Study||6
11316612|NCT02691702|12513798|FG010|COMPLETED|Overall Study||6
11316613|NCT02691702|12513788|FG000|NOT COMPLETED|Overall Study||2
11316614|NCT02691702|12513789|FG001|NOT COMPLETED|Overall Study||1
11316615|NCT02691702|12513790|FG002|NOT COMPLETED|Overall Study||1
11316616|NCT02691702|12513791|FG003|NOT COMPLETED|Overall Study||0
11316617|NCT02691702|12513792|FG004|NOT COMPLETED|Overall Study||0
11316618|NCT02691702|12513793|FG005|NOT COMPLETED|Overall Study||3
11316619|NCT02691702|12513794|FG006|NOT COMPLETED|Overall Study||3
11316620|NCT02691702|12513795|FG007|NOT COMPLETED|Overall Study||0
11316621|NCT02691702|12513796|FG008|NOT COMPLETED|Overall Study||2
11316622|NCT02691702|12513797|FG009|NOT COMPLETED|Overall Study||2
11316623|NCT02691702|12513798|FG010|NOT COMPLETED|Overall Study||2
11316624|NCT02691741|12513832|FG000|STARTED|Overall Study||94
11316625|NCT02691741|12513833|FG001|STARTED|Overall Study||94
11316626|NCT02691741|12513832|FG000|All-Implanted Analysis Set|Overall Study||93
11316627|NCT02691741|12513833|FG001|All-Implanted Analysis Set|Overall Study||89
11316628|NCT02691741|12513832|FG000|Best-Case Analysis Set|Overall Study||86
11316629|NCT02691741|12513833|FG001|Best-Case Analysis Set|Overall Study||85
11316630|NCT02691741|12513832|FG000|Safety Analysis Set|Overall Study||93
11316631|NCT02691741|12513833|FG001|Safety Analysis Set|Overall Study||89
11316632|NCT02691741|12513832|FG000|COMPLETED|Overall Study||93
11402368|NCT04047342|12597239|FG001|NOT COMPLETED|Overall Study||0
11402369|NCT04044352|12597245|FG000|STARTED|Overall Study||76
11402370|NCT04044352|12597245|FG000|COMPLETED|Overall Study||65
11402371|NCT04044352|12597245|FG000|NOT COMPLETED|Overall Study||11
11402372|NCT04043728|12597253|FG000|STARTED|Overall Study||6
11402373|NCT04043728|12597254|FG001|STARTED|Overall Study||6
11402374|NCT04043728|12597255|FG002|STARTED|Overall Study||6
11402375|NCT04043728|12597253|FG000|COMPLETED|Overall Study||5
11402376|NCT04043728|12597254|FG001|COMPLETED|Overall Study||4
11402377|NCT04043728|12597255|FG002|COMPLETED|Overall Study||6
11402378|NCT04043728|12597253|FG000|NOT COMPLETED|Overall Study||1
11402379|NCT04043728|12597254|FG001|NOT COMPLETED|Overall Study||2
11402380|NCT04043728|12597255|FG002|NOT COMPLETED|Overall Study||0
11402381|NCT04041453|12597267|FG000|STARTED|Overall Study||38
11402382|NCT04041453|12597268|FG001|STARTED|Overall Study||57
11402383|NCT04041453|12597269|FG002|STARTED|Overall Study||23
11402384|NCT04041453|12597270|FG003|STARTED|Overall Study||58
11402385|NCT04041453|12597267|FG000|Safety Population|Overall Study||38
11402386|NCT04041453|12597268|FG001|Safety Population|Overall Study||56
11402387|NCT04041453|12597269|FG002|Safety Population|Overall Study||23
11402388|NCT04041453|12597270|FG003|Safety Population|Overall Study||58
11402389|NCT04041453|12597267|FG000|COMPLETED|Overall Study||24
11402390|NCT04041453|12597268|FG001|COMPLETED|Overall Study||35
11402391|NCT04041453|12597269|FG002|COMPLETED|Overall Study||18
11402392|NCT04041453|12597270|FG003|COMPLETED|Overall Study||40
11402393|NCT04041453|12597267|FG000|NOT COMPLETED|Overall Study||14
11402394|NCT04041453|12597268|FG001|NOT COMPLETED|Overall Study||22
11402395|NCT04041453|12597269|FG002|NOT COMPLETED|Overall Study||5
11316633|NCT02691741|12513833|FG001|COMPLETED|Overall Study||87
11316634|NCT02691741|12513832|FG000|NOT COMPLETED|Overall Study||1
11316635|NCT02691741|12513833|FG001|NOT COMPLETED|Overall Study||7
11316636|NCT02691936|12513846|FG000|STARTED|Overall Study||35
11316637|NCT02691936|12513847|FG001|STARTED|Overall Study||34
11316638|NCT02691936|12513846|FG000|COMPLETED|Overall Study||33
11316639|NCT02691936|12513847|FG001|COMPLETED|Overall Study||29
11316640|NCT02691936|12513846|FG000|NOT COMPLETED|Overall Study||2
11316641|NCT02691936|12513847|FG001|NOT COMPLETED|Overall Study||5
11316642|NCT02691962|12513853|FG000|STARTED|Overall Study||75
11316643|NCT02691962|12513853|FG000|COMPLETED|Overall Study||59
11316644|NCT02691962|12513853|FG000|NOT COMPLETED|Overall Study||16
11316645|NCT02692040|12513875|FG000|STARTED|Overall Study||10
11316646|NCT02692040|12513876|FG001|STARTED|Overall Study||4
11316647|NCT02692040|12513877|FG002|STARTED|Overall Study||5
11316648|NCT02692040|12513878|FG003|STARTED|Overall Study||5
11316649|NCT02692040|12513879|FG004|STARTED|Overall Study||4
11316650|NCT02692040|12513880|FG005|STARTED|Overall Study||5
11316651|NCT02692040|12513881|FG006|STARTED|Overall Study||5
11316652|NCT02692040|12513882|FG007|STARTED|Overall Study||5
11316653|NCT02692040|12513883|FG008|STARTED|Overall Study||5
11316654|NCT02692040|12513884|FG009|STARTED|Overall Study||4
11316655|NCT02692040|12513885|FG010|STARTED|Overall Study||5
11316656|NCT02692040|12513886|FG011|STARTED|Overall Study||5
11316657|NCT02692040|12513887|FG012|STARTED|Overall Study||6
11316658|NCT02692040|12513888|FG013|STARTED|Overall Study||6
11316659|NCT02692040|12513889|FG014|STARTED|Overall Study||6
11316660|NCT02692040|12513890|FG015|STARTED|Overall Study||6
11316661|NCT02692040|12513891|FG016|STARTED|Overall Study||4
11316662|NCT02692040|12513875|FG000|COMPLETED|Overall Study||10
11316663|NCT02692040|12513876|FG001|COMPLETED|Overall Study||4
11316664|NCT02692040|12513877|FG002|COMPLETED|Overall Study||5
11316665|NCT02692040|12513878|FG003|COMPLETED|Overall Study||5
11316666|NCT02692040|12513879|FG004|COMPLETED|Overall Study||4
11316667|NCT02692040|12513880|FG005|COMPLETED|Overall Study||5
11316668|NCT02692040|12513881|FG006|COMPLETED|Overall Study||5
11316669|NCT02692040|12513882|FG007|COMPLETED|Overall Study||5
11316670|NCT02692040|12513883|FG008|COMPLETED|Overall Study||5
11316671|NCT02692040|12513884|FG009|COMPLETED|Overall Study||4
11316672|NCT02692040|12513885|FG010|COMPLETED|Overall Study||5
11316673|NCT02692040|12513886|FG011|COMPLETED|Overall Study||5
11316674|NCT02692040|12513887|FG012|COMPLETED|Overall Study||5
11316675|NCT02692040|12513888|FG013|COMPLETED|Overall Study||3
11316676|NCT02692040|12513889|FG014|COMPLETED|Overall Study||5
11316677|NCT02692040|12513890|FG015|COMPLETED|Overall Study||5
11316678|NCT02692040|12513891|FG016|COMPLETED|Overall Study||4
11316679|NCT02692040|12513875|FG000|NOT COMPLETED|Overall Study||0
11316680|NCT02692040|12513876|FG001|NOT COMPLETED|Overall Study||0
11316681|NCT02692040|12513877|FG002|NOT COMPLETED|Overall Study||0
11316682|NCT02692040|12513878|FG003|NOT COMPLETED|Overall Study||0
11316683|NCT02692040|12513879|FG004|NOT COMPLETED|Overall Study||0
11316684|NCT02692040|12513880|FG005|NOT COMPLETED|Overall Study||0
11316685|NCT02692040|12513881|FG006|NOT COMPLETED|Overall Study||0
11316686|NCT02692040|12513882|FG007|NOT COMPLETED|Overall Study||0
11316687|NCT02692040|12513883|FG008|NOT COMPLETED|Overall Study||0
11316688|NCT02692040|12513884|FG009|NOT COMPLETED|Overall Study||0
11316689|NCT02692040|12513885|FG010|NOT COMPLETED|Overall Study||0
11316690|NCT02692040|12513886|FG011|NOT COMPLETED|Overall Study||0
11316691|NCT02692040|12513887|FG012|NOT COMPLETED|Overall Study||1
11316692|NCT02692040|12513888|FG013|NOT COMPLETED|Overall Study||3
11316693|NCT02692040|12513889|FG014|NOT COMPLETED|Overall Study||1
11316694|NCT02692040|12513890|FG015|NOT COMPLETED|Overall Study||1
11316695|NCT02692040|12513891|FG016|NOT COMPLETED|Overall Study||0
11316696|NCT02692209|12513968|FG000|STARTED|Overall Study||298
11316697|NCT02692209|12513968|FG000|COMPLETED|Overall Study||298
11316698|NCT02692209|12513968|FG000|NOT COMPLETED|Overall Study||0
11316699|NCT02692235|12513976|FG000|STARTED|Overall Study||14
11316700|NCT02692235|12513977|FG001|STARTED|Overall Study||14
11316701|NCT02692235|12513976|FG000|COMPLETED|Overall Study||11
11316702|NCT02692235|12513977|FG001|COMPLETED|Overall Study||11
11316703|NCT02692235|12513976|FG000|NOT COMPLETED|Overall Study||3
11316704|NCT02692235|12513977|FG001|NOT COMPLETED|Overall Study||3
11316705|NCT02692391|12513985|FG000|STARTED|Overall Study||24
11316706|NCT02692391|12513986|FG001|STARTED|Overall Study||18
11316707|NCT02692391|12513985|FG000|COMPLETED|Overall Study||24
11316708|NCT02692391|12513986|FG001|COMPLETED|Overall Study||18
11316709|NCT02692391|12513985|FG000|NOT COMPLETED|Overall Study||0
11316710|NCT02692391|12513986|FG001|NOT COMPLETED|Overall Study||0
11316711|NCT02692417|12513994|FG000|STARTED|Overall Study||9
11316712|NCT02692417|12513995|FG001|STARTED|Overall Study||7
11316713|NCT02692417|12513994|FG000|COMPLETED|Overall Study||3
11316714|NCT02692417|12513995|FG001|COMPLETED|Overall Study||6
11316715|NCT02692417|12513994|FG000|NOT COMPLETED|Overall Study||6
11316716|NCT02692417|12513995|FG001|NOT COMPLETED|Overall Study||1
11316717|NCT02692482|12514003|FG000|STARTED|Overall Study||177
11316718|NCT02692482|12514004|FG001|STARTED|Overall Study||182
11316719|NCT02692482|12514003|FG000|COMPLETED|Overall Study||174
11316720|NCT02692482|12514004|FG001|COMPLETED|Overall Study||178
11316721|NCT02692482|12514003|FG000|NOT COMPLETED|Overall Study||3
11316722|NCT02692482|12514004|FG001|NOT COMPLETED|Overall Study||4
11316723|NCT02692495|12514013|FG000|STARTED|Overall Study||12
11316724|NCT02692495|12514014|FG001|STARTED|Overall Study||4
11316725|NCT02692495|12514013|FG000|COMPLETED|Overall Study||12
11316726|NCT02692495|12514014|FG001|COMPLETED|Overall Study||4
11316727|NCT02692495|12514013|FG000|NOT COMPLETED|Overall Study||0
11316728|NCT02692495|12514014|FG001|NOT COMPLETED|Overall Study||0
11316729|NCT02692560|12514026|FG000|STARTED|Overall Study||29
11316730|NCT02692560|12514027|FG001|STARTED|Overall Study||31
11316731|NCT02692560|12514026|FG000|COMPLETED|Overall Study||29
11316732|NCT02692560|12514027|FG001|COMPLETED|Overall Study||25
11316733|NCT02692560|12514026|FG000|NOT COMPLETED|Overall Study||0
11316734|NCT02692560|12514027|FG001|NOT COMPLETED|Overall Study||6
11316735|NCT02692586|12514033|FG000|STARTED|Overall Study||106
11316736|NCT02692586|12514033|FG000|COMPLETED|Overall Study||103
11316737|NCT02692586|12514033|FG000|NOT COMPLETED|Overall Study||3
11316738|NCT02692703|12514037|FG000|STARTED|Overall Study||100
11316739|NCT02692703|12514037|FG000|COMPLETED|Overall Study||98
11316740|NCT02692703|12514037|FG000|NOT COMPLETED|Overall Study||2
11316741|NCT02692755|12514041|FG000|STARTED|Overall Study||35
11316742|NCT02692755|12514041|FG000|COMPLETED|Overall Study||35
11316743|NCT02692755|12514041|FG000|NOT COMPLETED|Overall Study||0
11316744|NCT02692859|12514048|FG000|STARTED|Overall Study||996
11316745|NCT02692859|12514049|FG001|STARTED|Overall Study||996
11316746|NCT02692859|12514048|FG000|COMPLETED|Overall Study||912
11316747|NCT02692859|12514049|FG001|COMPLETED|Overall Study||901
11316748|NCT02692859|12514048|FG000|NOT COMPLETED|Overall Study||84
11316749|NCT02692859|12514049|FG001|NOT COMPLETED|Overall Study||95
11316750|NCT02693106|12514055|FG000|STARTED|Overall Study||13
11316751|NCT02693106|12514055|FG000|COMPLETED|Overall Study||10
11316752|NCT02693106|12514055|FG000|NOT COMPLETED|Overall Study||3
11316753|NCT02693119|12514067|FG000|STARTED|Double-Blind Period||8
11316754|NCT02693119|12514068|FG001|STARTED|Double-Blind Period||4
11316755|NCT02693119|12514067|FG000|COMPLETED|Double-Blind Period||8
11316756|NCT02693119|12514068|FG001|COMPLETED|Double-Blind Period||4
11316757|NCT02693119|12514067|FG000|NOT COMPLETED|Double-Blind Period||0
11316758|NCT02693119|12514068|FG001|NOT COMPLETED|Double-Blind Period||0
11316759|NCT02693119|12514067|FG000|STARTED|Open-Label Period||8
11316760|NCT02693119|12514068|FG001|STARTED|Open-Label Period||4
11316761|NCT02693119|12514067|FG000|COMPLETED|Open-Label Period||8
11316762|NCT02693119|12514068|FG001|COMPLETED|Open-Label Period||3
11316763|NCT02693119|12514067|FG000|NOT COMPLETED|Open-Label Period||0
11316764|NCT02693119|12514068|FG001|NOT COMPLETED|Open-Label Period||1
11316765|NCT02693132|12514107|FG000|STARTED|Overall Study||17
11316766|NCT02693132|12514108|FG001|STARTED|Overall Study||17
11316767|NCT02693132|12514109|FG002|STARTED|Overall Study||18
11316768|NCT02693132|12514107|FG000|COMPLETED|Overall Study||16
11316769|NCT02693132|12514108|FG001|COMPLETED|Overall Study||16
11316770|NCT02693132|12514109|FG002|COMPLETED|Overall Study||17
11316771|NCT02693132|12514107|FG000|NOT COMPLETED|Overall Study||1
11316772|NCT02693132|12514108|FG001|NOT COMPLETED|Overall Study||1
11316773|NCT02693132|12514109|FG002|NOT COMPLETED|Overall Study||1
11316774|NCT02693262|12514117|FG000|STARTED|Overall Study||4
11316775|NCT02693262|12514118|FG001|STARTED|Overall Study||5
11316776|NCT02693262|12514117|FG000|COMPLETED|Overall Study||4
11316777|NCT02693262|12514118|FG001|COMPLETED|Overall Study||5
11316778|NCT02693262|12514117|FG000|NOT COMPLETED|Overall Study||0
11316779|NCT02693262|12514118|FG001|NOT COMPLETED|Overall Study||0
11316780|NCT02693418|12514129|FG000|STARTED|Overall Study||22
11316781|NCT02693418|12514130|FG001|STARTED|Overall Study||21
11316782|NCT02693418|12514131|FG002|STARTED|Overall Study||21
11316783|NCT02693418|12514132|FG003|STARTED|Overall Study||20
11316784|NCT02693418|12514133|FG004|STARTED|Overall Study||21
11316785|NCT02693418|12514129|FG000|COMPLETED|Overall Study||21
11316786|NCT02693418|12514130|FG001|COMPLETED|Overall Study||19
11316787|NCT02693418|12514131|FG002|COMPLETED|Overall Study||19
11316788|NCT02693418|12514132|FG003|COMPLETED|Overall Study||20
11316789|NCT02693418|12514133|FG004|COMPLETED|Overall Study||21
11316790|NCT02693418|12514129|FG000|NOT COMPLETED|Overall Study||1
11316791|NCT02693418|12514130|FG001|NOT COMPLETED|Overall Study||2
11316792|NCT02693418|12514131|FG002|NOT COMPLETED|Overall Study||2
11316793|NCT02693418|12514132|FG003|NOT COMPLETED|Overall Study||0
11316794|NCT02693418|12514133|FG004|NOT COMPLETED|Overall Study||0
11316795|NCT02693704|12514149|FG000|STARTED|Overall Study||10
11316796|NCT02693704|12514150|FG001|STARTED|Overall Study||10
11316797|NCT02693704|12514151|FG002|STARTED|Overall Study||10
11316798|NCT02693704|12514152|FG003|STARTED|Overall Study||10
11316799|NCT02693704|12514149|FG000|COMPLETED|Overall Study||10
11316800|NCT02693704|12514150|FG001|COMPLETED|Overall Study||10
11316801|NCT02693704|12514151|FG002|COMPLETED|Overall Study||10
11316802|NCT02693704|12514152|FG003|COMPLETED|Overall Study||10
11316803|NCT02693704|12514149|FG000|NOT COMPLETED|Overall Study||0
11316804|NCT02693704|12514150|FG001|NOT COMPLETED|Overall Study||0
11316805|NCT02693704|12514151|FG002|NOT COMPLETED|Overall Study||0
11316806|NCT02693704|12514152|FG003|NOT COMPLETED|Overall Study||0
11316807|NCT02693834|12514162|FG000|STARTED|Baseline Measurement|10 were randomized to PLS AFO first week group (2 dropped out at baseline)|12
11316808|NCT02693834|12514163|FG001|STARTED|Baseline Measurement|11 participants were assigned to DA AFO first group|11
11316809|NCT02693834|12514162|FG000|COMPLETED|Baseline Measurement|10 particiapnts completed wearing PLS AFO during the first week and 10 during the second week|10
11316810|NCT02693834|12514163|FG001|COMPLETED|Baseline Measurement|10 particiapnts completed wearing DA AFO during the first week and 10 the second week (1 was lost)|11
11316811|NCT02693834|12514162|FG000|NOT COMPLETED|Baseline Measurement||2
11316812|NCT02693834|12514163|FG001|NOT COMPLETED|Baseline Measurement||0
11316813|NCT02693834|12514162|FG000|STARTED|Week 1 Practice|During the first week of practice, 10 participants were assigned to PLS AFO group|10
11316814|NCT02693834|12514163|FG001|STARTED|Week 1 Practice|During the first week of practice, 11 participants were assigned to DAAFO group|11
11316815|NCT02693834|12514162|FG000|COMPLETED|Week 1 Practice||10
11316816|NCT02693834|12514163|FG001|COMPLETED|Week 1 Practice||11
11316817|NCT02693834|12514162|FG000|NOT COMPLETED|Week 1 Practice||0
11316818|NCT02693834|12514163|FG001|NOT COMPLETED|Week 1 Practice||0
11316819|NCT02693834|12514162|FG000|STARTED|Week 2 Practice||10
11316820|NCT02693834|12514163|FG001|STARTED|Week 2 Practice||11
11316821|NCT02693834|12514162|FG000|COMPLETED|Week 2 Practice||10
11316822|NCT02693834|12514163|FG001|COMPLETED|Week 2 Practice||10
11316823|NCT02693834|12514162|FG000|NOT COMPLETED|Week 2 Practice||0
11316824|NCT02693834|12514163|FG001|NOT COMPLETED|Week 2 Practice||1
11316825|NCT02694029|12514171|FG000|STARTED|Overall Study||5
11316826|NCT02694029|12514172|FG001|STARTED|Overall Study||5
11316827|NCT02694029|12514171|FG000|First Intervention|Overall Study||5
11316828|NCT02694029|12514172|FG001|First Intervention|Overall Study||5
11316829|NCT02694029|12514171|FG000|Second Intervention|Overall Study||5
11316830|NCT02694029|12514172|FG001|Second Intervention|Overall Study||5
11316831|NCT02694029|12514171|FG000|COMPLETED|Overall Study||5
11316832|NCT02694029|12514172|FG001|COMPLETED|Overall Study||5
11316833|NCT02694029|12514171|FG000|NOT COMPLETED|Overall Study||0
11316834|NCT02694029|12514172|FG001|NOT COMPLETED|Overall Study||0
11316835|NCT02694198|12514182|FG000|STARTED|Overall Study||135
11316836|NCT02694198|12514182|FG000|COMPLETED|Overall Study||135
11316837|NCT02694198|12514182|FG000|NOT COMPLETED|Overall Study||0
11316838|NCT02694315|12514186|FG000|STARTED|Overall Study||200
11316839|NCT02694315|12514186|FG000|COMPLETED|Overall Study||200
11316840|NCT02694315|12514186|FG000|NOT COMPLETED|Overall Study||0
11316841|NCT02694328|12514192|FG000|STARTED|Overall Study||276
11316842|NCT02694328|12514193|FG001|STARTED|Overall Study||274
11316843|NCT02694328|12514192|FG000|COMPLETED|Overall Study||176
11316844|NCT02694328|12514193|FG001|COMPLETED|Overall Study||176
11316845|NCT02694328|12514192|FG000|NOT COMPLETED|Overall Study||100
11316846|NCT02694328|12514193|FG001|NOT COMPLETED|Overall Study||98
11316847|NCT02694445|12514199|FG000|STARTED|Overall Study||3098
11316848|NCT02694445|12514199|FG000|COMPLETED|Overall Study||3046
11316849|NCT02694445|12514199|FG000|NOT COMPLETED|Overall Study||52
11316850|NCT02694523|12514205|FG000|STARTED|Part A||304
11316851|NCT02694523|12514206|FG001|STARTED|Part A||301
11316852|NCT02694523|12514207|FG002|STARTED|Part A||0
11316853|NCT02694523|12514208|FG003|STARTED|Part A||0
11316854|NCT02694523|12514209|FG004|STARTED|Part A||0
11316855|NCT02694523|12514210|FG005|STARTED|Part A||0
11316856|NCT02694523|12514211|FG006|STARTED|Part A||0
11316857|NCT02694523|12514205|FG000|COMPLETED|Part A||291
11316858|NCT02694523|12514206|FG001|COMPLETED|Part A||294
11316859|NCT02694523|12514207|FG002|COMPLETED|Part A||0
11316860|NCT02694523|12514208|FG003|COMPLETED|Part A||0
11316861|NCT02694523|12514209|FG004|COMPLETED|Part A||0
11316862|NCT02694523|12514210|FG005|COMPLETED|Part A||0
11316863|NCT02694523|12514211|FG006|COMPLETED|Part A||0
11316864|NCT02694523|12514205|FG000|NOT COMPLETED|Part A||13
11316865|NCT02694523|12514206|FG001|NOT COMPLETED|Part A||7
11316866|NCT02694523|12514207|FG002|NOT COMPLETED|Part A||0
11316867|NCT02694523|12514208|FG003|NOT COMPLETED|Part A||0
11316868|NCT02694523|12514209|FG004|NOT COMPLETED|Part A||0
11316869|NCT02694523|12514210|FG005|NOT COMPLETED|Part A||0
11316870|NCT02694523|12514211|FG006|NOT COMPLETED|Part A||0
11316871|NCT02694523|12514205|FG000|STARTED|Part B||0
11316872|NCT02694523|12514206|FG001|STARTED|Part B||0
11316873|NCT02694523|12514207|FG002|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294
11316874|NCT02694523|12514208|FG003|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144
11316875|NCT02694523|12514209|FG004|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38
11316876|NCT02694523|12514210|FG005|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56
11316877|NCT02694523|12514211|FG006|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53
11316878|NCT02694523|12514205|FG000|COMPLETED|Part B||0
11316879|NCT02694523|12514206|FG001|COMPLETED|Part B||0
11316880|NCT02694523|12514207|FG002|COMPLETED|Part B||274
11316881|NCT02694523|12514208|FG003|COMPLETED|Part B||140
11316882|NCT02694523|12514209|FG004|COMPLETED|Part B||34
11316883|NCT02694523|12514210|FG005|COMPLETED|Part B||51
11316884|NCT02694523|12514211|FG006|COMPLETED|Part B||51
11316885|NCT02694523|12514205|FG000|NOT COMPLETED|Part B||0
11316886|NCT02694523|12514206|FG001|NOT COMPLETED|Part B||0
11316887|NCT02694523|12514207|FG002|NOT COMPLETED|Part B||20
11316888|NCT02694523|12514208|FG003|NOT COMPLETED|Part B||4
11316889|NCT02694523|12514209|FG004|NOT COMPLETED|Part B||4
11316890|NCT02694523|12514210|FG005|NOT COMPLETED|Part B||5
11316891|NCT02694523|12514211|FG006|NOT COMPLETED|Part B||2
11316892|NCT02694536|12514223|FG000|STARTED|Overall Study||80
11316893|NCT02694536|12514223|FG000|COMPLETED|Overall Study||0
11316894|NCT02694536|12514223|FG000|NOT COMPLETED|Overall Study||80
11316895|NCT02694549|12514227|FG000|STARTED|Overall Study||12
11316896|NCT02694549|12514227|FG000|COMPLETED|Overall Study||10
11316897|NCT02694549|12514227|FG000|NOT COMPLETED|Overall Study||2
11316898|NCT02694562|12514231|FG000|STARTED|Overall Study||20
11316899|NCT02694562|12514231|FG000|COMPLETED|Overall Study||2
11316900|NCT02694562|12514231|FG000|NOT COMPLETED|Overall Study||18
11316901|NCT02694601|12514235|FG000|STARTED|Overall Study||10
11316902|NCT02694601|12514235|FG000|COMPLETED|Overall Study||10
11316903|NCT02694601|12514235|FG000|NOT COMPLETED|Overall Study||0
11316904|NCT02694718|12514239|FG000|STARTED|Overall Study||60
11316905|NCT02694718|12514239|FG000|COMPLETED|Overall Study||58
11316906|NCT02694718|12514239|FG000|NOT COMPLETED|Overall Study||2
11316907|NCT02694744|12514245|FG000|STARTED|Overall Study||57
11316908|NCT02694744|12514246|FG001|STARTED|Overall Study||57
11316909|NCT02694744|12514245|FG000|Safety Population|Overall Study||57
11316910|NCT02694744|12514246|FG001|Safety Population|Overall Study||56
11316911|NCT02694744|12514245|FG000|ITT|Overall Study||57
11316912|NCT02694744|12514246|FG001|ITT|Overall Study||55
11316913|NCT02694744|12514245|FG000|COMPLETED|Overall Study||51
11316914|NCT02694744|12514246|FG001|COMPLETED|Overall Study||52
11316915|NCT02694744|12514245|FG000|NOT COMPLETED|Overall Study||6
11316916|NCT02694744|12514246|FG001|NOT COMPLETED|Overall Study||5
11316917|NCT02694835|12514256|FG000|STARTED|Overall Study||41
11316918|NCT02694835|12514257|FG001|STARTED|Overall Study||39
11316919|NCT02694835|12514256|FG000|COMPLETED|Overall Study||41
11316920|NCT02694835|12514257|FG001|COMPLETED|Overall Study||39
11316921|NCT02694835|12514256|FG000|NOT COMPLETED|Overall Study||0
11316922|NCT02694835|12514257|FG001|NOT COMPLETED|Overall Study||0
11316923|NCT02694978|12514265|FG000|STARTED|Overall Study||1006
11316924|NCT02694978|12514266|FG001|STARTED|Overall Study||1008
11316925|NCT02694978|12514265|FG000|Received at Least 1 Dose of Study Drug|Overall Study||997
11316926|NCT02694978|12514266|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1000
11316927|NCT02694978|12514265|FG000|COMPLETED|Overall Study||935
11316928|NCT02694978|12514266|FG001|COMPLETED|Overall Study||948
11316929|NCT02694978|12514265|FG000|NOT COMPLETED|Overall Study||71
11316930|NCT02694978|12514266|FG001|NOT COMPLETED|Overall Study||60
11316931|NCT02695290|12514272|FG000|STARTED|Overall Study||1
11316932|NCT02695290|12514272|FG000|COMPLETED|Overall Study||1
11316933|NCT02695290|12514272|FG000|NOT COMPLETED|Overall Study||0
11316934|NCT02695329|12514278|FG000|STARTED|Overall Study||50
11316935|NCT02695329|12514279|FG001|STARTED|Overall Study||50
11316936|NCT02695329|12514278|FG000|COMPLETED|Overall Study||45
11316937|NCT02695329|12514279|FG001|COMPLETED|Overall Study||45
11316938|NCT02695329|12514278|FG000|NOT COMPLETED|Overall Study||5
11316939|NCT02695329|12514279|FG001|NOT COMPLETED|Overall Study||5
11316940|NCT02695420|12514289|FG000|STARTED|Overall Study||21
11316941|NCT02695420|12514290|FG001|STARTED|Overall Study||21
11316942|NCT02695420|12514291|FG002|STARTED|Overall Study||19
11316943|NCT02695420|12514292|FG003|STARTED|Overall Study||20
11316944|NCT02695420|12514289|FG000|COMPLETED|Overall Study||21
11316945|NCT02695420|12514290|FG001|COMPLETED|Overall Study||20
11316946|NCT02695420|12514291|FG002|COMPLETED|Overall Study||19
11316947|NCT02695420|12514292|FG003|COMPLETED|Overall Study||20
11316948|NCT02695420|12514289|FG000|NOT COMPLETED|Overall Study||0
11316949|NCT02695420|12514290|FG001|NOT COMPLETED|Overall Study||1
11316950|NCT02695420|12514291|FG002|NOT COMPLETED|Overall Study||0
11316951|NCT02695420|12514292|FG003|NOT COMPLETED|Overall Study||0
11316952|NCT02695446|12514305|FG000|STARTED|Overall Study||12
11316953|NCT02695446|12514305|FG000|COMPLETED|Overall Study||12
11316954|NCT02695446|12514305|FG000|NOT COMPLETED|Overall Study||0
11316955|NCT02695524|12514311|FG000|STARTED|Overall Study||30
11316956|NCT02695524|12514312|FG001|STARTED|Overall Study||30
11316957|NCT02695524|12514311|FG000|COMPLETED|Overall Study||27
11316958|NCT02695524|12514312|FG001|COMPLETED|Overall Study||27
11316959|NCT02695524|12514311|FG000|NOT COMPLETED|Overall Study||3
11316960|NCT02695524|12514312|FG001|NOT COMPLETED|Overall Study||3
11316961|NCT02695537|12514318|FG000|STARTED|Overall Study||89
11316962|NCT02695537|12514318|FG000|COMPLETED|Overall Study||51
11316963|NCT02695537|12514318|FG000|NOT COMPLETED|Overall Study||38
11316964|NCT02695628|12514322|FG000|STARTED|Overall Study||5
11316965|NCT02695628|12514322|FG000|COMPLETED|Overall Study||4
11316966|NCT02695628|12514322|FG000|NOT COMPLETED|Overall Study||1
11316967|NCT02695719|12514328|FG000|STARTED|Overall Study||74
11316968|NCT02695719|12514329|FG001|STARTED|Overall Study||82
11316969|NCT02695719|12514328|FG000|COMPLETED|Overall Study||71
11316970|NCT02695719|12514329|FG001|COMPLETED|Overall Study||72
11316971|NCT02695719|12514328|FG000|NOT COMPLETED|Overall Study||3
11316972|NCT02695719|12514329|FG001|NOT COMPLETED|Overall Study||10
11316973|NCT02696070|12514337|FG000|STARTED|Overall Study||8
11316974|NCT02696070|12514338|FG001|STARTED|Overall Study||14
11316975|NCT02696070|12514337|FG000|COMPLETED|Overall Study||7
11316976|NCT02696070|12514338|FG001|COMPLETED|Overall Study||12
11316977|NCT02696070|12514337|FG000|NOT COMPLETED|Overall Study||1
11316978|NCT02696070|12514338|FG001|NOT COMPLETED|Overall Study||2
11316979|NCT02696083|12514344|FG000|STARTED|Overall Study||19
11316980|NCT02696083|12514344|FG000|COMPLETED|Overall Study||13
11316981|NCT02696083|12514344|FG000|NOT COMPLETED|Overall Study||6
11316982|NCT02696200|12514355|FG000|STARTED|Overall Study||32
11316983|NCT02696200|12514356|FG001|STARTED|Overall Study||30
11316984|NCT02696200|12514355|FG000|COMPLETED|Overall Study||32
11316985|NCT02696200|12514356|FG001|COMPLETED|Overall Study||30
11316986|NCT02696200|12514355|FG000|NOT COMPLETED|Overall Study||0
11316987|NCT02696200|12514356|FG001|NOT COMPLETED|Overall Study||0
11316988|NCT02696291|12514364|FG000|STARTED|Overall Study||5
11316989|NCT02696291|12514365|FG001|STARTED|Overall Study||2
11316990|NCT02696291|12514364|FG000|COMPLETED|Overall Study||5
11316991|NCT02696291|12514365|FG001|COMPLETED|Overall Study||2
11316992|NCT02696291|12514364|FG000|NOT COMPLETED|Overall Study||0
11316993|NCT02696291|12514365|FG001|NOT COMPLETED|Overall Study||0
11316994|NCT02696317|12514371|FG000|STARTED|Habitual, 10 Days of Wear||42
11316995|NCT02696317|12514372|FG001|STARTED|Habitual, 10 Days of Wear||40
11316996|NCT02696317|12514371|FG000|COMPLETED|Habitual, 10 Days of Wear||40
11316997|NCT02696317|12514372|FG001|COMPLETED|Habitual, 10 Days of Wear||36
11316998|NCT02696317|12514371|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||2
11316999|NCT02696317|12514372|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||4
11317000|NCT02696317|12514371|FG000|STARTED|Period 1, 10 Days of Wear||40
11317001|NCT02696317|12514372|FG001|STARTED|Period 1, 10 Days of Wear||36
11317002|NCT02696317|12514371|FG000|COMPLETED|Period 1, 10 Days of Wear||40
11317003|NCT02696317|12514372|FG001|COMPLETED|Period 1, 10 Days of Wear||36
11317004|NCT02696317|12514371|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||0
11317005|NCT02696317|12514372|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||0
11317006|NCT02696317|12514371|FG000|STARTED|Period 2, 10 Days of Wear||40
11317007|NCT02696317|12514372|FG001|STARTED|Period 2, 10 Days of Wear||36
11317008|NCT02696317|12514371|FG000|COMPLETED|Period 2, 10 Days of Wear||39
11317009|NCT02696317|12514372|FG001|COMPLETED|Period 2, 10 Days of Wear||36
11317010|NCT02696317|12514371|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||1
11317011|NCT02696317|12514372|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0
11317012|NCT02696434|12514382|FG000|STARTED|Overall Study||50
11317013|NCT02696434|12514383|FG001|STARTED|Overall Study||51
11317014|NCT02696434|12514382|FG000|COMPLETED|Overall Study||28
11317015|NCT02696434|12514383|FG001|COMPLETED|Overall Study||33
11317016|NCT02696434|12514382|FG000|NOT COMPLETED|Overall Study||22
11317017|NCT02696434|12514383|FG001|NOT COMPLETED|Overall Study||18
11317018|NCT02696785|12514393|FG000|STARTED|Blinded Treatment Period||87
11317019|NCT02696785|12514394|FG001|STARTED|Blinded Treatment Period||90
11317020|NCT02696785|12514395|FG002|STARTED|Blinded Treatment Period||83
11317021|NCT02696785|12514396|FG003|STARTED|Blinded Treatment Period||81
11317022|NCT02696785|12514393|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period||86
11317023|NCT02696785|12514394|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period||90
11317024|NCT02696785|12514395|FG002|Received at Least One Dose of Study Drug|Blinded Treatment Period||83
11317025|NCT02696785|12514396|FG003|Received at Least One Dose of Study Drug|Blinded Treatment Period||81
11317026|NCT02696785|12514393|FG000|COMPLETED|Blinded Treatment Period||86
11317027|NCT02696785|12514394|FG001|COMPLETED|Blinded Treatment Period||88
11317028|NCT02696785|12514395|FG002|COMPLETED|Blinded Treatment Period||79
11317029|NCT02696785|12514396|FG003|COMPLETED|Blinded Treatment Period||78
11317030|NCT02696785|12514393|FG000|NOT COMPLETED|Blinded Treatment Period||1
11317031|NCT02696785|12514394|FG001|NOT COMPLETED|Blinded Treatment Period||2
11317032|NCT02696785|12514395|FG002|NOT COMPLETED|Blinded Treatment Period||4
11317033|NCT02696785|12514396|FG003|NOT COMPLETED|Blinded Treatment Period||3
11317034|NCT02696785|12514393|FG000|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
11317035|NCT02696785|12514394|FG001|STARTED|Washout Period||88
11317036|NCT02696785|12514395|FG002|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
11317037|NCT02696785|12514396|FG003|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
11317038|NCT02696785|12514393|FG000|COMPLETED|Washout Period||0
11317039|NCT02696785|12514394|FG001|COMPLETED|Washout Period||86
11317040|NCT02696785|12514395|FG002|COMPLETED|Washout Period||0
11317041|NCT02696785|12514396|FG003|COMPLETED|Washout Period||0
11317042|NCT02696785|12514393|FG000|NOT COMPLETED|Washout Period||0
11317043|NCT02696785|12514394|FG001|NOT COMPLETED|Washout Period||2
11317044|NCT02696785|12514395|FG002|NOT COMPLETED|Washout Period||0
11317045|NCT02696785|12514396|FG003|NOT COMPLETED|Washout Period||0
11317046|NCT02696785|12514393|FG000|STARTED|Extended Treatment Period||86
11317047|NCT02696785|12514394|FG001|STARTED|Extended Treatment Period||86
11317048|NCT02696785|12514395|FG002|STARTED|Extended Treatment Period||79
11317049|NCT02696785|12514396|FG003|STARTED|Extended Treatment Period||78
11317050|NCT02696785|12514393|FG000|COMPLETED|Extended Treatment Period||83
11317051|NCT02696785|12514394|FG001|COMPLETED|Extended Treatment Period||80
11317052|NCT02696785|12514395|FG002|COMPLETED|Extended Treatment Period||74
11317053|NCT02696785|12514396|FG003|COMPLETED|Extended Treatment Period||72
11317054|NCT02696785|12514393|FG000|NOT COMPLETED|Extended Treatment Period||3
11317055|NCT02696785|12514394|FG001|NOT COMPLETED|Extended Treatment Period||6
11317056|NCT02696785|12514395|FG002|NOT COMPLETED|Extended Treatment Period||5
11317057|NCT02696785|12514396|FG003|NOT COMPLETED|Extended Treatment Period||6
11317058|NCT02696785|12514393|FG000|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1
11317059|NCT02696785|12514394|FG001|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0
11317060|NCT02696785|12514395|FG002|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24
11317061|NCT02696785|12514396|FG003|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16
11317062|NCT02696785|12514393|FG000|COMPLETED|Follow-up Period||0
11317063|NCT02696785|12514394|FG001|COMPLETED|Follow-up Period||0
11317064|NCT02696785|12514395|FG002|COMPLETED|Follow-up Period||11
11317065|NCT02696785|12514396|FG003|COMPLETED|Follow-up Period||8
11317066|NCT02696785|12514393|FG000|NOT COMPLETED|Follow-up Period||1
11317067|NCT02696785|12514394|FG001|NOT COMPLETED|Follow-up Period||0
11317068|NCT02696785|12514395|FG002|NOT COMPLETED|Follow-up Period||13
11317069|NCT02696785|12514396|FG003|NOT COMPLETED|Follow-up Period||8
11317070|NCT02696798|12514427|FG000|STARTED|Blinded Treatment Dosing Period||104
11317071|NCT02696798|12514428|FG001|STARTED|Blinded Treatment Dosing Period||114
11317072|NCT02696798|12514429|FG002|STARTED|Blinded Treatment Dosing Period||98
11317073|NCT02696798|12514427|FG000|COMPLETED|Blinded Treatment Dosing Period||93
11317074|NCT02696798|12514428|FG001|COMPLETED|Blinded Treatment Dosing Period||99
11317075|NCT02696798|12514429|FG002|COMPLETED|Blinded Treatment Dosing Period||90
11317076|NCT02696798|12514427|FG000|NOT COMPLETED|Blinded Treatment Dosing Period||11
11317077|NCT02696798|12514428|FG001|NOT COMPLETED|Blinded Treatment Dosing Period||15
11317078|NCT02696798|12514429|FG002|NOT COMPLETED|Blinded Treatment Dosing Period||8
11317079|NCT02696798|12514427|FG000|STARTED|Extended Treatment Period||93
11317080|NCT02696798|12514428|FG001|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98
11317081|NCT02696798|12514429|FG002|STARTED|Extended Treatment Period||90
11317082|NCT02696798|12514427|FG000|COMPLETED|Extended Treatment Period||81
11317083|NCT02696798|12514428|FG001|COMPLETED|Extended Treatment Period||89
11317084|NCT02696798|12514429|FG002|COMPLETED|Extended Treatment Period||80
11317085|NCT02696798|12514427|FG000|NOT COMPLETED|Extended Treatment Period||12
11317086|NCT02696798|12514428|FG001|NOT COMPLETED|Extended Treatment Period||9
11317087|NCT02696798|12514429|FG002|NOT COMPLETED|Extended Treatment Period||10
11317088|NCT02696798|12514427|FG000|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5
11317089|NCT02696798|12514428|FG001|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34
11342389|NCT02945046|12539958|FG001|COMPLETED|Overall Study||42
11402396|NCT04041453|12597270|FG003|NOT COMPLETED|Overall Study||18
11402397|NCT04041414|12597284|FG000|STARTED|Overall Study||27
11402398|NCT04041414|12597285|FG001|STARTED|Overall Study||20
11317090|NCT02696798|12514429|FG002|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22
11402399|NCT04041414|12597284|FG000|COMPLETED|Overall Study||26
11402400|NCT04041414|12597285|FG001|COMPLETED|Overall Study||18
11402401|NCT04041414|12597284|FG000|NOT COMPLETED|Overall Study||1
11402402|NCT04041414|12597285|FG001|NOT COMPLETED|Overall Study||2
11402403|NCT04041219|12597294|FG000|STARTED|Overall Study||10
11402404|NCT04041219|12597294|FG000|COMPLETED|Overall Study||10
11402405|NCT04041219|12597294|FG000|NOT COMPLETED|Overall Study||0
11402406|NCT04041700|12597298|FG000|STARTED|Overall Study||29
11402407|NCT04041700|12597298|FG000|COMPLETED|Overall Study||27
11402408|NCT04041700|12597298|FG000|NOT COMPLETED|Overall Study||2
11402409|NCT04039867|12597302|FG000|STARTED|Overall Study||17
11402410|NCT04039867|12597302|FG000|COMPLETED|Overall Study||17
11402411|NCT04039867|12597302|FG000|NOT COMPLETED|Overall Study||0
11402412|NCT04039412|12597309|FG000|STARTED|Overall Study||110
11402413|NCT04039412|12597310|FG001|STARTED|Overall Study||110
11402414|NCT04039412|12597311|FG002|STARTED|Overall Study||110
11402415|NCT04039412|12597309|FG000|COMPLETED|Overall Study||109
11402416|NCT04039412|12597310|FG001|COMPLETED|Overall Study||107
11402417|NCT04039412|12597311|FG002|COMPLETED|Overall Study||108
11402418|NCT04039412|12597309|FG000|NOT COMPLETED|Overall Study||1
11402419|NCT04039412|12597310|FG001|NOT COMPLETED|Overall Study||3
11402420|NCT04039412|12597311|FG002|NOT COMPLETED|Overall Study||2
11402421|NCT04035161|12597322|FG000|STARTED|Overall Study||1121
11402422|NCT04035161|12597322|FG000|Treated With Investigational Product|Overall Study||609
11402423|NCT04035161|12597322|FG000|Treated With Reference Standard|Overall Study||419
11402424|NCT04035161|12597322|FG000|Treated With Active Control|Overall Study||609
11402425|NCT04035161|12597322|FG000|Treated With Negative Control|Overall Study||605
11402426|NCT04035161|12597322|FG000|COMPLETED|Overall Study||1121
11402427|NCT04035161|12597322|FG000|NOT COMPLETED|Overall Study||0
11402428|NCT04029519|12597332|FG000|STARTED|Overall Study||84
11402429|NCT04029519|12597332|FG000|COMPLETED|Overall Study||79
11402430|NCT04029519|12597332|FG000|NOT COMPLETED|Overall Study||5
11402431|NCT04039919|12597341|FG000|STARTED|Treatment Period 1||7
11402432|NCT04039919|12597342|FG001|STARTED|Treatment Period 1||6
11402433|NCT04039919|12597343|FG002|STARTED|Treatment Period 1||5
11402434|NCT04039919|12597344|FG003|STARTED|Treatment Period 1||6
11402435|NCT04039919|12597345|FG004|STARTED|Treatment Period 1||16
11402436|NCT04039919|12597341|FG000|COMPLETED|Treatment Period 1||6
11402437|NCT04039919|12597342|FG001|COMPLETED|Treatment Period 1||6
11402438|NCT04039919|12597343|FG002|COMPLETED|Treatment Period 1||5
11402439|NCT04039919|12597344|FG003|COMPLETED|Treatment Period 1||6
11402440|NCT04039919|12597345|FG004|COMPLETED|Treatment Period 1||0
11402441|NCT04039919|12597341|FG000|NOT COMPLETED|Treatment Period 1||1
11402442|NCT04039919|12597342|FG001|NOT COMPLETED|Treatment Period 1||0
11402443|NCT04039919|12597343|FG002|NOT COMPLETED|Treatment Period 1||0
11402444|NCT04039919|12597344|FG003|NOT COMPLETED|Treatment Period 1||0
11402445|NCT04039919|12597345|FG004|NOT COMPLETED|Treatment Period 1||16
11402446|NCT04039919|12597341|FG000|STARTED|Treatment Period 2||6
11402447|NCT04039919|12597342|FG001|STARTED|Treatment Period 2||6
11402448|NCT04039919|12597343|FG002|STARTED|Treatment Period 2||5
11402449|NCT04039919|12597344|FG003|STARTED|Treatment Period 2||6
11402450|NCT04039919|12597345|FG004|STARTED|Treatment Period 2||0
11402451|NCT04039919|12597341|FG000|COMPLETED|Treatment Period 2||6
11402452|NCT04039919|12597342|FG001|COMPLETED|Treatment Period 2||6
11402453|NCT04039919|12597343|FG002|COMPLETED|Treatment Period 2||5
11402454|NCT04039919|12597344|FG003|COMPLETED|Treatment Period 2||6
11402455|NCT04039919|12597345|FG004|COMPLETED|Treatment Period 2||0
11402456|NCT04039919|12597341|FG000|NOT COMPLETED|Treatment Period 2||0
11402457|NCT04039919|12597342|FG001|NOT COMPLETED|Treatment Period 2||0
11402458|NCT04039919|12597343|FG002|NOT COMPLETED|Treatment Period 2||0
11402459|NCT04039919|12597344|FG003|NOT COMPLETED|Treatment Period 2||0
11402460|NCT04039919|12597345|FG004|NOT COMPLETED|Treatment Period 2||0
11402461|NCT04039919|12597341|FG000|STARTED|Treatment Period 3||6
11402462|NCT04039919|12597342|FG001|STARTED|Treatment Period 3||6
11402463|NCT04039919|12597343|FG002|STARTED|Treatment Period 3||5
11402464|NCT04039919|12597344|FG003|STARTED|Treatment Period 3||6
11317091|NCT02696798|12514427|FG000|COMPLETED|Post-treatment Follow-up Period||0
11317092|NCT02696798|12514428|FG001|COMPLETED|Post-treatment Follow-up Period||8
11317093|NCT02696798|12514429|FG002|COMPLETED|Post-treatment Follow-up Period||3
11317094|NCT02696798|12514427|FG000|NOT COMPLETED|Post-treatment Follow-up Period||5
11317095|NCT02696798|12514428|FG001|NOT COMPLETED|Post-treatment Follow-up Period||26
11317096|NCT02696798|12514429|FG002|NOT COMPLETED|Post-treatment Follow-up Period||19
11317097|NCT02696850|12514453|FG000|STARTED|Overall Study||40
11317098|NCT02696850|12514454|FG001|STARTED|Overall Study||40
11317099|NCT02696850|12514453|FG000|COMPLETED|Overall Study||29
11317100|NCT02696850|12514454|FG001|COMPLETED|Overall Study||32
11317101|NCT02696850|12514453|FG000|NOT COMPLETED|Overall Study||11
11317102|NCT02696850|12514454|FG001|NOT COMPLETED|Overall Study||8
11317103|NCT02696902|12514463|FG000|STARTED|Overall Study||85
11317104|NCT02696902|12514464|FG001|STARTED|Overall Study||16
11317105|NCT02696902|12514465|FG002|STARTED|Overall Study||87
11317106|NCT02696902|12514463|FG000|Treated|Overall Study||83
11317107|NCT02696902|12514464|FG001|Treated|Overall Study||16
11317108|NCT02696902|12514465|FG002|Treated|Overall Study||85
11317109|NCT02696902|12514463|FG000|Intent-to-treat (ITT) Population|Overall Study||85
11317110|NCT02696902|12514464|FG001|Intent-to-treat (ITT) Population|Overall Study||16
11317111|NCT02696902|12514465|FG002|Intent-to-treat (ITT) Population|Overall Study||87
11317112|NCT02696902|12514463|FG000|As-treated Population|Overall Study||83
11317113|NCT02696902|12514464|FG001|As-treated Population|Overall Study||16
11317114|NCT02696902|12514465|FG002|As-treated Population|Overall Study||85
11317115|NCT02696902|12514463|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||83
11317116|NCT02696902|12514464|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||16
11317117|NCT02696902|12514465|FG002|Modified Intent-to-treat (mITT) Population|Overall Study||85
11317118|NCT02696902|12514463|FG000|COMPLETED|Overall Study||63
11317119|NCT02696902|12514464|FG001|COMPLETED|Overall Study||12
11317120|NCT02696902|12514465|FG002|COMPLETED|Overall Study||59
11317121|NCT02696902|12514463|FG000|NOT COMPLETED|Overall Study||22
11317122|NCT02696902|12514464|FG001|NOT COMPLETED|Overall Study||4
11317123|NCT02696902|12514465|FG002|NOT COMPLETED|Overall Study||28
11317124|NCT02696967|12514479|FG000|STARTED|Overall Study||4
11317125|NCT02696967|12514480|FG001|STARTED|Overall Study||6
11317126|NCT02696967|12514481|FG002|STARTED|Overall Study||6
11317127|NCT02696967|12514482|FG003|STARTED|Overall Study||10
11317128|NCT02696967|12514479|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4
11317129|NCT02696967|12514480|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||6
11317130|NCT02696967|12514481|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||4
11317131|NCT02696967|12514482|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||0
11317132|NCT02696967|12514479|FG000|COMPLETED|Overall Study||4
11317133|NCT02696967|12514480|FG001|COMPLETED|Overall Study||6
11317134|NCT02696967|12514481|FG002|COMPLETED|Overall Study||6
11317135|NCT02696967|12514482|FG003|COMPLETED|Overall Study||10
11317136|NCT02696967|12514479|FG000|NOT COMPLETED|Overall Study||0
11317137|NCT02696967|12514480|FG001|NOT COMPLETED|Overall Study||0
11317138|NCT02696967|12514481|FG002|NOT COMPLETED|Overall Study||0
11317139|NCT02696967|12514482|FG003|NOT COMPLETED|Overall Study||0
11317140|NCT02697071|12514494|FG000|STARTED|Overall Study||18
11317141|NCT02697071|12514495|FG001|STARTED|Overall Study||16
11317142|NCT02697071|12514494|FG000|COMPLETED|Overall Study||18
11317143|NCT02697071|12514495|FG001|COMPLETED|Overall Study||16
11317144|NCT02697071|12514494|FG000|NOT COMPLETED|Overall Study||0
11317145|NCT02697071|12514495|FG001|NOT COMPLETED|Overall Study||0
11317146|NCT02697188|12514501|FG000|STARTED|TE Period 1 - 400 mg QD||12
11317147|NCT02697188|12514501|FG000|COMPLETED|TE Period 1 - 400 mg QD||12
11317148|NCT02697188|12514501|FG000|NOT COMPLETED|TE Period 1 - 400 mg QD||0
11317149|NCT02697188|12514501|FG000|STARTED|TU Period 2 - 200 mg QD||12
11317150|NCT02697188|12514501|FG000|COMPLETED|TU Period 2 - 200 mg QD||12
11317151|NCT02697188|12514501|FG000|NOT COMPLETED|TU Period 2 - 200 mg QD||0
11317152|NCT02697188|12514501|FG000|STARTED|TU Period 3 - 200 mg BID||12
11317153|NCT02697188|12514501|FG000|COMPLETED|TU Period 3 - 200 mg BID||12
11317154|NCT02697188|12514501|FG000|NOT COMPLETED|TU Period 3 - 200 mg BID||0
11317155|NCT02697188|12514501|FG000|STARTED|TU Period 4 - 400 BID||12
11317156|NCT02697188|12514501|FG000|COMPLETED|TU Period 4 - 400 BID||12
11317157|NCT02697188|12514501|FG000|NOT COMPLETED|TU Period 4 - 400 BID||0
11317158|NCT02697188|12514501|FG000|STARTED|TE Period 5 - 800 mg BID||12
11317159|NCT02697188|12514501|FG000|COMPLETED|TE Period 5 - 800 mg BID||12
11317160|NCT02697188|12514501|FG000|NOT COMPLETED|TE Period 5 - 800 mg BID||0
11317161|NCT02697214|12514513|FG000|STARTED|Overall Study||26
11317162|NCT02697214|12514514|FG001|STARTED|Overall Study||25
11317163|NCT02697214|12514515|FG002|STARTED|Overall Study||25
11317164|NCT02697214|12514516|FG003|STARTED|Overall Study||24
11317165|NCT02697214|12514517|FG004|STARTED|Overall Study||50
11317166|NCT02697214|12514518|FG005|STARTED|Overall Study||50
11317167|NCT02697214|12514513|FG000|Heart Rate at 2mph|Overall Study||26
11317168|NCT02697214|12514514|FG001|Heart Rate at 2mph|Overall Study||25
11317169|NCT02697214|12514515|FG002|Heart Rate at 2mph|Overall Study||25
11317170|NCT02697214|12514516|FG003|Heart Rate at 2mph|Overall Study||24
11317171|NCT02697214|12514517|FG004|Heart Rate at 2mph|Overall Study||50
11317172|NCT02697214|12514518|FG005|Heart Rate at 2mph|Overall Study||50
11317173|NCT02697214|12514513|FG000|Heart Rate at 3mph|Overall Study||26
11317174|NCT02697214|12514514|FG001|Heart Rate at 3mph|Overall Study||25
11317175|NCT02697214|12514515|FG002|Heart Rate at 3mph|Overall Study||25
11317176|NCT02697214|12514516|FG003|Heart Rate at 3mph|Overall Study||24
11317177|NCT02697214|12514517|FG004|Heart Rate at 3mph|Overall Study||50
11317178|NCT02697214|12514518|FG005|Heart Rate at 3mph|Overall Study||50
11317179|NCT02697214|12514513|FG000|Heart Rate at 4mph|Overall Study||26
11317180|NCT02697214|12514514|FG001|Heart Rate at 4mph|Overall Study||25
11317181|NCT02697214|12514515|FG002|Heart Rate at 4mph|Overall Study||25
11317182|NCT02697214|12514516|FG003|Heart Rate at 4mph|Overall Study||24
11317183|NCT02697214|12514517|FG004|Heart Rate at 4mph|Overall Study||50
11402465|NCT04039919|12597345|FG004|STARTED|Treatment Period 3||0
11402466|NCT04039919|12597341|FG000|COMPLETED|Treatment Period 3||6
11402467|NCT04039919|12597342|FG001|COMPLETED|Treatment Period 3||6
11317184|NCT02697214|12514518|FG005|Heart Rate at 4mph|Overall Study||50
11317185|NCT02697214|12514513|FG000|Heart Rate at 6mph|Overall Study||26
11317186|NCT02697214|12514514|FG001|Heart Rate at 6mph|Overall Study||25
11317187|NCT02697214|12514515|FG002|Heart Rate at 6mph|Overall Study||25
11317188|NCT02697214|12514516|FG003|Heart Rate at 6mph|Overall Study||24
11317189|NCT02697214|12514517|FG004|Heart Rate at 6mph|Overall Study||50
11317190|NCT02697214|12514518|FG005|Heart Rate at 6mph|Overall Study||50
11317191|NCT02697214|12514513|FG000|COMPLETED|Overall Study||26
11317192|NCT02697214|12514514|FG001|COMPLETED|Overall Study||25
11317193|NCT02697214|12514515|FG002|COMPLETED|Overall Study||25
11317194|NCT02697214|12514516|FG003|COMPLETED|Overall Study||24
11317195|NCT02697214|12514517|FG004|COMPLETED|Overall Study||50
11317196|NCT02697214|12514518|FG005|COMPLETED|Overall Study||50
11317197|NCT02697214|12514513|FG000|NOT COMPLETED|Overall Study||0
11317198|NCT02697214|12514514|FG001|NOT COMPLETED|Overall Study||0
11317199|NCT02697214|12514515|FG002|NOT COMPLETED|Overall Study||0
11317200|NCT02697214|12514516|FG003|NOT COMPLETED|Overall Study||0
11317201|NCT02697214|12514517|FG004|NOT COMPLETED|Overall Study||0
11317202|NCT02697214|12514518|FG005|NOT COMPLETED|Overall Study||0
11317203|NCT02697240|12514528|FG000|STARTED|Overall Study||4
11317204|NCT02697240|12514528|FG000|COMPLETED|Overall Study||4
11317205|NCT02697240|12514528|FG000|NOT COMPLETED|Overall Study||0
11317206|NCT02697292|12514534|FG000|STARTED|Overall Study||9
11317207|NCT02697292|12514535|FG001|STARTED|Overall Study||8
11317208|NCT02697292|12514534|FG000|COMPLETED|Overall Study||9
11317209|NCT02697292|12514535|FG001|COMPLETED|Overall Study||8
11317210|NCT02697292|12514534|FG000|NOT COMPLETED|Overall Study||0
11317211|NCT02697292|12514535|FG001|NOT COMPLETED|Overall Study||0
11317212|NCT02697435|12514544|FG000|STARTED|Overall Study||25
11317213|NCT02697435|12514545|FG001|STARTED|Overall Study||30
11317214|NCT02697435|12514544|FG000|COMPLETED|Overall Study||24
11317215|NCT02697435|12514545|FG001|COMPLETED|Overall Study||26
11317216|NCT02697435|12514544|FG000|NOT COMPLETED|Overall Study||1
11317217|NCT02697435|12514545|FG001|NOT COMPLETED|Overall Study||4
11317218|NCT02697591|12514562|FG000|STARTED|Overall Study||4
11317219|NCT02697591|12514563|FG001|STARTED|Overall Study||4
11317220|NCT02697591|12514564|FG002|STARTED|Overall Study||4
11317221|NCT02697591|12514565|FG003|STARTED|Overall Study||3
11317222|NCT02697591|12514566|FG004|STARTED|Overall Study||15
11317223|NCT02697591|12514567|FG005|STARTED|Overall Study||18
11317224|NCT02697591|12514568|FG006|STARTED|Overall Study||16
11317225|NCT02697591|12514569|FG007|STARTED|Overall Study||4
11317226|NCT02697591|12514570|FG008|STARTED|Overall Study||10
11317227|NCT02697591|12514571|FG009|STARTED|Overall Study||22
11317228|NCT02697591|12514562|FG000|COMPLETED|Overall Study||0
11317229|NCT02697591|12514563|FG001|COMPLETED|Overall Study||0
11317230|NCT02697591|12514564|FG002|COMPLETED|Overall Study||1
11317231|NCT02697591|12514565|FG003|COMPLETED|Overall Study||0
11317232|NCT02697591|12514566|FG004|COMPLETED|Overall Study||2
11317233|NCT02697591|12514567|FG005|COMPLETED|Overall Study||2
11317234|NCT02697591|12514568|FG006|COMPLETED|Overall Study||0
11317235|NCT02697591|12514569|FG007|COMPLETED|Overall Study||1
11317236|NCT02697591|12514570|FG008|COMPLETED|Overall Study||1
11317237|NCT02697591|12514571|FG009|COMPLETED|Overall Study||2
11317238|NCT02697591|12514562|FG000|NOT COMPLETED|Overall Study||4
11317239|NCT02697591|12514563|FG001|NOT COMPLETED|Overall Study||4
11317240|NCT02697591|12514564|FG002|NOT COMPLETED|Overall Study||3
11317241|NCT02697591|12514565|FG003|NOT COMPLETED|Overall Study||3
11317242|NCT02697591|12514566|FG004|NOT COMPLETED|Overall Study||13
11317243|NCT02697591|12514567|FG005|NOT COMPLETED|Overall Study||16
11317244|NCT02697591|12514568|FG006|NOT COMPLETED|Overall Study||16
11317245|NCT02697591|12514569|FG007|NOT COMPLETED|Overall Study||3
11317246|NCT02697591|12514570|FG008|NOT COMPLETED|Overall Study||9
11317247|NCT02697591|12514571|FG009|NOT COMPLETED|Overall Study||20
11317248|NCT02697617|12514594|FG000|STARTED|Overall Study||9
11317249|NCT02697617|12514595|FG001|STARTED|Overall Study||9
11317250|NCT02697617|12514594|FG000|COMPLETED|Overall Study|15 completed both arms|8
11317251|NCT02697617|12514595|FG001|COMPLETED|Overall Study||7
11317252|NCT02697617|12514594|FG000|NOT COMPLETED|Overall Study||1
11317253|NCT02697617|12514595|FG001|NOT COMPLETED|Overall Study||2
11317254|NCT02697734|12514607|FG000|STARTED|Core Phase - up to Week 48||48
11317255|NCT02697734|12514608|FG001|STARTED|Core Phase - up to Week 48||25
11317256|NCT02697734|12514607|FG000|COMPLETED|Core Phase - up to Week 48||42
11317257|NCT02697734|12514608|FG001|COMPLETED|Core Phase - up to Week 48||23
11317258|NCT02697734|12514607|FG000|NOT COMPLETED|Core Phase - up to Week 48||6
11317259|NCT02697734|12514608|FG001|NOT COMPLETED|Core Phase - up to Week 48||2
11317260|NCT02697734|12514607|FG000|STARTED|Optional Extension Phase||38
11317261|NCT02697734|12514608|FG001|STARTED|Optional Extension Phase||22
11317262|NCT02697734|12514607|FG000|COMPLETED|Optional Extension Phase||33
11317263|NCT02697734|12514608|FG001|COMPLETED|Optional Extension Phase||20
11317264|NCT02697734|12514607|FG000|NOT COMPLETED|Optional Extension Phase||5
11317265|NCT02697734|12514608|FG001|NOT COMPLETED|Optional Extension Phase||2
11317266|NCT02697773|12514625|FG000|STARTED|Overall Study||233
11317267|NCT02697773|12514626|FG001|STARTED|Overall Study||232
11317268|NCT02697773|12514627|FG002|STARTED|Overall Study||233
11317269|NCT02697773|12514625|FG000|Treated|Overall Study||232
11317270|NCT02697773|12514626|FG001|Treated|Overall Study||231
11317271|NCT02697773|12514627|FG002|Treated|Overall Study||233
11317272|NCT02697773|12514625|FG000|COMPLETED|Overall Study||195
11317273|NCT02697773|12514626|FG001|COMPLETED|Overall Study||194
11317274|NCT02697773|12514627|FG002|COMPLETED|Overall Study||193
11317275|NCT02697773|12514625|FG000|NOT COMPLETED|Overall Study||38
11317276|NCT02697773|12514626|FG001|NOT COMPLETED|Overall Study||38
11317277|NCT02697773|12514627|FG002|NOT COMPLETED|Overall Study||40
11317278|NCT02697890|12514637|FG000|STARTED|Overall Study||14
11317279|NCT02697890|12514638|FG001|STARTED|Overall Study||14
11317280|NCT02697890|12514637|FG000|COMPLETED|Overall Study||14
11317281|NCT02697890|12514638|FG001|COMPLETED|Overall Study||14
11317282|NCT02697890|12514637|FG000|NOT COMPLETED|Overall Study||0
11317283|NCT02697890|12514638|FG001|NOT COMPLETED|Overall Study||0
11317284|NCT02697916|12514646|FG000|STARTED|Overall Study||7540
11317285|NCT02697916|12514647|FG001|STARTED|Overall Study||7536
11317286|NCT02697916|12514646|FG000|COMPLETED|Overall Study||6962
11317287|NCT02697916|12514647|FG001|COMPLETED|Overall Study||6828
11317288|NCT02697916|12514646|FG000|NOT COMPLETED|Overall Study||578
11317289|NCT02697916|12514647|FG001|NOT COMPLETED|Overall Study||708
11317290|NCT02698033|12514653|FG000|STARTED|Overall Study||7
11317291|NCT02698033|12514653|FG000|COMPLETED|Overall Study||6
11317292|NCT02698033|12514653|FG000|NOT COMPLETED|Overall Study||1
11317293|NCT02698176|12514660|FG000|STARTED|Overall Study||9
11317294|NCT02698176|12514661|FG001|STARTED|Overall Study||3
11317295|NCT02698176|12514662|FG002|STARTED|Overall Study||1
11317296|NCT02698176|12514663|FG003|STARTED|Overall Study|No participants were enrolled in Part B.|0
11317297|NCT02698176|12514660|FG000|COMPLETED|Overall Study||0
11317298|NCT02698176|12514661|FG001|COMPLETED|Overall Study||0
11317299|NCT02698176|12514662|FG002|COMPLETED|Overall Study||0
11317300|NCT02698176|12514663|FG003|COMPLETED|Overall Study||0
11317301|NCT02698176|12514660|FG000|NOT COMPLETED|Overall Study||9
11317302|NCT02698176|12514661|FG001|NOT COMPLETED|Overall Study||3
11317303|NCT02698176|12514662|FG002|NOT COMPLETED|Overall Study||1
11317304|NCT02698176|12514663|FG003|NOT COMPLETED|Overall Study||0
11317305|NCT02698215|12514676|FG000|STARTED|Overall Study||83
11317306|NCT02698215|12514677|FG001|STARTED|Overall Study||82
11317307|NCT02698215|12514676|FG000|COMPLETED|Overall Study||55
11317308|NCT02698215|12514677|FG001|COMPLETED|Overall Study||64
11317309|NCT02698215|12514676|FG000|NOT COMPLETED|Overall Study||28
11317310|NCT02698215|12514677|FG001|NOT COMPLETED|Overall Study||18
11317311|NCT02698241|12514683|FG000|STARTED|Overall Study|Number of subjects enrolled the study|79
11317312|NCT02698241|12514683|FG000|Baseline & Programming|Overall Study|Number of subjects that passed screening and completed baseline and programming visit|66
11317313|NCT02698241|12514683|FG000|COMPLETED|Overall Study|Number of subjects completed the study (no early exit or death)|45
11317314|NCT02698241|12514683|FG000|NOT COMPLETED|Overall Study||34
11317315|NCT02698371|12514687|FG000|STARTED|All Participants Flow||38
11317316|NCT02698371|12514687|FG000|COMPLETED|All Participants Flow||35
11317317|NCT02698371|12514687|FG000|NOT COMPLETED|All Participants Flow||3
11317318|NCT02698371|12514687|FG000|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35
11317319|NCT02698371|12514687|FG000|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32
11317320|NCT02698371|12514687|FG000|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3
11317321|NCT02698371|12514687|FG000|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35
11317322|NCT02698371|12514687|FG000|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32
11317323|NCT02698371|12514687|FG000|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3
11317324|NCT02698371|12514687|FG000|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35
11317325|NCT02698371|12514687|FG000|COMPLETED|FBU-ER (G3) Arm/Group Flow||32
11317326|NCT02698371|12514687|FG000|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3
11317327|NCT02698371|12514687|FG000|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35
11317328|NCT02698371|12514687|FG000|COMPLETED|FBU-SE (G4) Arm/Group Flow||32
11317329|NCT02698371|12514687|FG000|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3
11317330|NCT02698371|12514687|FG000|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35
11317331|NCT02698371|12514687|FG000|COMPLETED|ADU-ER (G5) Arm/Group Flow||32
11317332|NCT02698371|12514687|FG000|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3
11317333|NCT02698371|12514687|FG000|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35
11317334|NCT02698371|12514687|FG000|COMPLETED|ADU-SE (G6) Arm/Group Flow||33
11317335|NCT02698371|12514687|FG000|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2
11317336|NCT02698410|12514703|FG000|STARTED|Overall Study||40
11317337|NCT02698410|12514703|FG000|COMPLETED|Overall Study||36
11317338|NCT02698410|12514703|FG000|NOT COMPLETED|Overall Study||4
11317339|NCT02698423|12514709|FG000|STARTED|Overall Study||336
11317340|NCT02698423|12514710|FG001|STARTED|Overall Study||331
11317341|NCT02698423|12514709|FG000|COMPLETED|Overall Study||317
11317342|NCT02698423|12514710|FG001|COMPLETED|Overall Study||307
11317343|NCT02698423|12514709|FG000|NOT COMPLETED|Overall Study||19
11317344|NCT02698423|12514710|FG001|NOT COMPLETED|Overall Study||24
11317345|NCT02698436|12514720|FG000|STARTED|Overall Study||59
11317346|NCT02698436|12514721|FG001|STARTED|Overall Study||58
11317347|NCT02698436|12514720|FG000|COMPLETED|Overall Study||52
11317348|NCT02698436|12514721|FG001|COMPLETED|Overall Study||51
11317349|NCT02698436|12514720|FG000|NOT COMPLETED|Overall Study||7
11317350|NCT02698436|12514721|FG001|NOT COMPLETED|Overall Study||7
11317351|NCT02698475|12514727|FG000|STARTED|Main Study Period||44
11317352|NCT02698475|12514727|FG000|COMPLETED|Main Study Period||41
11317353|NCT02698475|12514727|FG000|NOT COMPLETED|Main Study Period||3
11317354|NCT02698475|12514727|FG000|STARTED|Long-Term Extension Period|13 participants did not enter the long-term extension period.|28
11317355|NCT02698475|12514727|FG000|COMPLETED|Long-Term Extension Period||0
11317356|NCT02698475|12514727|FG000|NOT COMPLETED|Long-Term Extension Period||28
11317357|NCT02698566|12514734|FG000|STARTED|Overall Study||35
11317358|NCT02698566|12514735|FG001|STARTED|Overall Study||3
11317359|NCT02698566|12514734|FG000|COMPLETED|Overall Study||35
11317360|NCT02698566|12514735|FG001|COMPLETED|Overall Study||3
11317361|NCT02698566|12514734|FG000|NOT COMPLETED|Overall Study||0
11317362|NCT02698566|12514735|FG001|NOT COMPLETED|Overall Study||0
11317363|NCT02698735|12514739|FG000|STARTED|Overall Study||5
11317364|NCT02698735|12514739|FG000|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5
11317365|NCT02698735|12514739|FG000|NOT COMPLETED|Overall Study||0
11317366|NCT02698787|12514751|FG000|STARTED|First Intervention (3 Months)||6
11317367|NCT02698787|12514752|FG001|STARTED|First Intervention (3 Months)||5
11317368|NCT02698787|12514751|FG000|COMPLETED|First Intervention (3 Months)||6
11317369|NCT02698787|12514752|FG001|COMPLETED|First Intervention (3 Months)||5
11317370|NCT02698787|12514751|FG000|NOT COMPLETED|First Intervention (3 Months)||0
11317371|NCT02698787|12514752|FG001|NOT COMPLETED|First Intervention (3 Months)||0
11317372|NCT02698787|12514751|FG000|STARTED|Second Intervention (3 Months)||6
11317373|NCT02698787|12514752|FG001|STARTED|Second Intervention (3 Months)||5
11317374|NCT02698787|12514751|FG000|COMPLETED|Second Intervention (3 Months)||6
11317375|NCT02698787|12514752|FG001|COMPLETED|Second Intervention (3 Months)||4
11317376|NCT02698787|12514751|FG000|NOT COMPLETED|Second Intervention (3 Months)||0
11317377|NCT02698787|12514752|FG001|NOT COMPLETED|Second Intervention (3 Months)||1
11317378|NCT02698800|12514759|FG000|STARTED|Overall Study||7
11317379|NCT02698800|12514760|FG001|STARTED|Overall Study||8
11317380|NCT02698800|12514759|FG000|COMPLETED|Overall Study||6
11317381|NCT02698800|12514760|FG001|COMPLETED|Overall Study||8
11317382|NCT02698800|12514759|FG000|NOT COMPLETED|Overall Study||1
11317383|NCT02698800|12514760|FG001|NOT COMPLETED|Overall Study||0
11317384|NCT02699099|12514769|FG000|STARTED|Overall Study||231
11317385|NCT02699099|12514770|FG001|STARTED|Overall Study||236
11317386|NCT02699099|12514771|FG002|STARTED|Overall Study||232
11317387|NCT02699099|12514769|FG000|COMPLETED|Overall Study||223
11317388|NCT02699099|12514770|FG001|COMPLETED|Overall Study||233
11317389|NCT02699099|12514771|FG002|COMPLETED|Overall Study||226
11317390|NCT02699099|12514769|FG000|NOT COMPLETED|Overall Study||8
11317391|NCT02699099|12514770|FG001|NOT COMPLETED|Overall Study||3
11317392|NCT02699099|12514771|FG002|NOT COMPLETED|Overall Study||6
11317393|NCT02699125|12514781|FG000|STARTED|Placebo||21
11317394|NCT02699125|12514782|FG001|STARTED|Placebo||20
11317395|NCT02699125|12514781|FG000|COMPLETED|Placebo||18
11317396|NCT02699125|12514782|FG001|COMPLETED|Placebo||16
11317397|NCT02699125|12514781|FG000|NOT COMPLETED|Placebo||3
11317398|NCT02699125|12514782|FG001|NOT COMPLETED|Placebo||4
11317399|NCT02699125|12514781|FG000|STARTED|First Intervention (6 Weeks).||18
11317400|NCT02699125|12514782|FG001|STARTED|First Intervention (6 Weeks).||16
11317401|NCT02699125|12514781|FG000|COMPLETED|First Intervention (6 Weeks).||18
11317402|NCT02699125|12514782|FG001|COMPLETED|First Intervention (6 Weeks).||16
11317403|NCT02699125|12514781|FG000|NOT COMPLETED|First Intervention (6 Weeks).||0
11317404|NCT02699125|12514782|FG001|NOT COMPLETED|First Intervention (6 Weeks).||0
11317405|NCT02699125|12514781|FG000|STARTED|Second Intervention (6 Weeks).||18
11317406|NCT02699125|12514782|FG001|STARTED|Second Intervention (6 Weeks).||16
11317407|NCT02699125|12514781|FG000|COMPLETED|Second Intervention (6 Weeks).||11
11317408|NCT02699125|12514782|FG001|COMPLETED|Second Intervention (6 Weeks).||14
11317409|NCT02699125|12514781|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||7
11317410|NCT02699125|12514782|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2
11317411|NCT02699450|12514795|FG000|STARTED|Overall Study||90
11317412|NCT02699450|12514796|FG001|STARTED|Overall Study||55
11317413|NCT02699450|12514797|FG002|STARTED|Overall Study||82
11317414|NCT02699450|12514795|FG000|Received at Least One Dose of Study Drug|Overall Study||89
11317415|NCT02699450|12514796|FG001|Received at Least One Dose of Study Drug|Overall Study||55
11317416|NCT02699450|12514797|FG002|Received at Least One Dose of Study Drug|Overall Study||80
11317417|NCT02699450|12514795|FG000|Completed up to Week 24|Overall Study||81
11317418|NCT02699450|12514796|FG001|Completed up to Week 24|Overall Study||53
11317419|NCT02699450|12514797|FG002|Completed up to Week 24|Overall Study||73
11317420|NCT02699450|12514795|FG000|COMPLETED|Overall Study||75
11317421|NCT02699450|12514796|FG001|COMPLETED|Overall Study||50
11317422|NCT02699450|12514797|FG002|COMPLETED|Overall Study||67
11317423|NCT02699450|12514795|FG000|NOT COMPLETED|Overall Study||15
11317424|NCT02699450|12514796|FG001|NOT COMPLETED|Overall Study||5
11317425|NCT02699450|12514797|FG002|NOT COMPLETED|Overall Study||15
11317426|NCT02699463|12514808|FG000|STARTED|Overall Study||115
11317427|NCT02699463|12514809|FG001|STARTED|Overall Study||118
11317428|NCT02699463|12514808|FG000|COMPLETED|Overall Study||100
11317429|NCT02699463|12514809|FG001|COMPLETED|Overall Study||109
11317430|NCT02699463|12514808|FG000|NOT COMPLETED|Overall Study||15
11317431|NCT02699463|12514809|FG001|NOT COMPLETED|Overall Study||9
11317432|NCT02699593|12514815|FG000|STARTED|Period 1||72
11317433|NCT02699593|12514816|FG001|STARTED|Period 1||69
11317434|NCT02699593|12514815|FG000|COMPLETED|Period 1||67
11317435|NCT02699593|12514816|FG001|COMPLETED|Period 1||62
11317436|NCT02699593|12514815|FG000|NOT COMPLETED|Period 1||5
11317437|NCT02699593|12514816|FG001|NOT COMPLETED|Period 1||7
11317438|NCT02699593|12514815|FG000|STARTED|Period 2||67
11317439|NCT02699593|12514816|FG001|STARTED|Period 2||62
11317440|NCT02699593|12514815|FG000|COMPLETED|Period 2||65
11317441|NCT02699593|12514816|FG001|COMPLETED|Period 2||60
11317442|NCT02699593|12514815|FG000|NOT COMPLETED|Period 2||2
11317443|NCT02699593|12514816|FG001|NOT COMPLETED|Period 2||2
11317444|NCT02699632|12514822|FG000|STARTED|Overall Study||360
11317445|NCT02699632|12514822|FG000|COMPLETED|Overall Study||358
11317446|NCT02699632|12514822|FG000|NOT COMPLETED|Overall Study||2
11317447|NCT02699684|12514829|FG000|STARTED|Period 1, First 30 Days of Wear||37
11317448|NCT02699684|12514830|FG001|STARTED|Period 1, First 30 Days of Wear||38
11317449|NCT02699684|12514829|FG000|COMPLETED|Period 1, First 30 Days of Wear||37
11317450|NCT02699684|12514830|FG001|COMPLETED|Period 1, First 30 Days of Wear||38
11317451|NCT02699684|12514829|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
11317452|NCT02699684|12514830|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||0
11317453|NCT02699684|12514829|FG000|STARTED|Period 2, Second 30 Days of Wear||37
11317454|NCT02699684|12514830|FG001|STARTED|Period 2, Second 30 Days of Wear||38
11317455|NCT02699684|12514829|FG000|COMPLETED|Period 2, Second 30 Days of Wear||36
11317456|NCT02699684|12514830|FG001|COMPLETED|Period 2, Second 30 Days of Wear||38
11317457|NCT02699684|12514829|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
11317458|NCT02699684|12514830|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
11317459|NCT02699749|12514851|FG000|STARTED|Overall Study||3
11317460|NCT02699749|12514852|FG001|STARTED|Overall Study||3
11317461|NCT02699749|12514853|FG002|STARTED|Overall Study||16
11317462|NCT02699749|12514854|FG003|STARTED|Overall Study||3
11317463|NCT02699749|12514855|FG004|STARTED|Overall Study||3
11317464|NCT02699749|12514856|FG005|STARTED|Overall Study||9
11317465|NCT02699749|12514857|FG006|STARTED|Overall Study||6
11317466|NCT02699749|12514858|FG007|STARTED|Overall Study||6
11317467|NCT02699749|12514859|FG008|STARTED|Overall Study||6
11317468|NCT02699749|12514860|FG009|STARTED|Overall Study||6
11317469|NCT02699749|12514861|FG010|STARTED|Overall Study||6
11317470|NCT02699749|12514862|FG011|STARTED|Overall Study||4
11317471|NCT02699749|12514863|FG012|STARTED|Overall Study||3
11317472|NCT02699749|12514864|FG013|STARTED|Overall Study||6
11317473|NCT02699749|12514851|FG000|COMPLETED|Overall Study||0
11317474|NCT02699749|12514852|FG001|COMPLETED|Overall Study||0
11317475|NCT02699749|12514853|FG002|COMPLETED|Overall Study||0
11317476|NCT02699749|12514854|FG003|COMPLETED|Overall Study||0
11317477|NCT02699749|12514855|FG004|COMPLETED|Overall Study||0
11317478|NCT02699749|12514856|FG005|COMPLETED|Overall Study||0
11402468|NCT04039919|12597343|FG002|COMPLETED|Treatment Period 3||5
11402469|NCT04039919|12597344|FG003|COMPLETED|Treatment Period 3||6
11317479|NCT02699749|12514857|FG006|COMPLETED|Overall Study||0
11317480|NCT02699749|12514858|FG007|COMPLETED|Overall Study||0
11317481|NCT02699749|12514859|FG008|COMPLETED|Overall Study||0
11317482|NCT02699749|12514860|FG009|COMPLETED|Overall Study||0
11317483|NCT02699749|12514861|FG010|COMPLETED|Overall Study||0
11317484|NCT02699749|12514862|FG011|COMPLETED|Overall Study||0
11317485|NCT02699749|12514863|FG012|COMPLETED|Overall Study||0
11317486|NCT02699749|12514864|FG013|COMPLETED|Overall Study||0
11317487|NCT02699749|12514851|FG000|NOT COMPLETED|Overall Study||3
11317488|NCT02699749|12514852|FG001|NOT COMPLETED|Overall Study||3
11317489|NCT02699749|12514853|FG002|NOT COMPLETED|Overall Study||16
11317490|NCT02699749|12514854|FG003|NOT COMPLETED|Overall Study||3
11317491|NCT02699749|12514855|FG004|NOT COMPLETED|Overall Study||3
11317492|NCT02699749|12514856|FG005|NOT COMPLETED|Overall Study||9
11317493|NCT02699749|12514857|FG006|NOT COMPLETED|Overall Study||6
11317494|NCT02699749|12514858|FG007|NOT COMPLETED|Overall Study||6
11317495|NCT02699749|12514859|FG008|NOT COMPLETED|Overall Study||6
11317496|NCT02699749|12514860|FG009|NOT COMPLETED|Overall Study||6
11317497|NCT02699749|12514861|FG010|NOT COMPLETED|Overall Study||6
11317498|NCT02699749|12514862|FG011|NOT COMPLETED|Overall Study||4
11317499|NCT02699749|12514863|FG012|NOT COMPLETED|Overall Study||3
11317500|NCT02699749|12514864|FG013|NOT COMPLETED|Overall Study||6
11317501|NCT02699866|12514894|FG000|STARTED|Overall Study|First study centre initiation.|46
11317502|NCT02699866|12514894|FG000|Included|Overall Study||41
11317503|NCT02699866|12514894|FG000|COMPLETED|Overall Study|Last study centre close-out.|38
11317504|NCT02699866|12514894|FG000|NOT COMPLETED|Overall Study||8
11317505|NCT02699892|12514898|FG000|STARTED|Overall Study||130
11317506|NCT02699892|12514898|FG000|COMPLETED|Overall Study||94
11317507|NCT02699892|12514898|FG000|NOT COMPLETED|Overall Study||36
11317508|NCT02699970|12514902|FG000|STARTED|Overall Study||399
11317509|NCT02699970|12514902|FG000|Intra-system|Overall Study||399
11317510|NCT02699970|12514902|FG000|Inter-system|Overall Study||399
11317511|NCT02699970|12514902|FG000|COMPLETED|Overall Study||399
11317512|NCT02699970|12514902|FG000|NOT COMPLETED|Overall Study||0
11317513|NCT02699983|12514909|FG000|STARTED|Overall Study||18
11317514|NCT02699983|12514910|FG001|STARTED|Overall Study||17
11317515|NCT02699983|12514909|FG000|COMPLETED|Overall Study||17
11317516|NCT02699983|12514910|FG001|COMPLETED|Overall Study||17
11317517|NCT02699983|12514909|FG000|NOT COMPLETED|Overall Study||1
11317518|NCT02699983|12514910|FG001|NOT COMPLETED|Overall Study||0
11317519|NCT02699996|12514922|FG000|STARTED|Overall Study||20
11317520|NCT02699996|12514923|FG001|STARTED|Overall Study||11
11317521|NCT02699996|12514922|FG000|COMPLETED|Overall Study||15
11317522|NCT02699996|12514923|FG001|COMPLETED|Overall Study||9
11317523|NCT02699996|12514922|FG000|NOT COMPLETED|Overall Study||5
11317524|NCT02699996|12514923|FG001|NOT COMPLETED|Overall Study||2
11317525|NCT02700165|12514930|FG000|STARTED|Overall Study||14
11317526|NCT02700165|12514930|FG000|COMPLETED|Overall Study||14
11317527|NCT02700165|12514930|FG000|NOT COMPLETED|Overall Study||0
11317528|NCT02700334|12514937|FG000|STARTED|Overall Study||12
11317529|NCT02700334|12514938|FG001|STARTED|Overall Study||12
11317530|NCT02700334|12514937|FG000|COMPLETED|Overall Study||12
11317531|NCT02700334|12514938|FG001|COMPLETED|Overall Study||12
11317532|NCT02700334|12514937|FG000|NOT COMPLETED|Overall Study||0
11317533|NCT02700334|12514938|FG001|NOT COMPLETED|Overall Study||0
11342390|NCT02945046|12539959|FG002|COMPLETED|Overall Study||40
11342391|NCT02945046|12539957|FG000|NOT COMPLETED|Overall Study||13
11342392|NCT02945046|12539958|FG001|NOT COMPLETED|Overall Study||13
11342393|NCT02945046|12539959|FG002|NOT COMPLETED|Overall Study||15
11342394|NCT02945150|12539967|FG000|STARTED|Overall Study||8
11342395|NCT02945150|12539967|FG000|SVR12|Overall Study||8
11342396|NCT02945150|12539967|FG000|COMPLETED|Overall Study||8
11342397|NCT02945150|12539967|FG000|NOT COMPLETED|Overall Study||0
11342398|NCT02945254|12539973|FG000|STARTED|Overall Study||10
11317534|NCT02700412|12514944|FG000|STARTED|Overall Study||80
11317535|NCT02700412|12514944|FG000|COMPLETED|Overall Study||47
11317536|NCT02700412|12514944|FG000|NOT COMPLETED|Overall Study||33
11317537|NCT02700425|12514950|FG000|STARTED|Overall Study||21
11317538|NCT02700425|12514951|FG001|STARTED|Overall Study||20
11317539|NCT02700425|12514950|FG000|COMPLETED|Overall Study||21
11317540|NCT02700425|12514951|FG001|COMPLETED|Overall Study|1 patient withdrew after randomization|19
11317541|NCT02700425|12514950|FG000|NOT COMPLETED|Overall Study||0
11317542|NCT02700425|12514951|FG001|NOT COMPLETED|Overall Study||1
11317543|NCT02700815|12514961|FG000|STARTED|Overall Study||75
11317544|NCT02700815|12514962|FG001|STARTED|Overall Study||223
11317545|NCT02700815|12514963|FG002|STARTED|Overall Study||223
11317546|NCT02700815|12514964|FG003|STARTED|Overall Study||225
11317547|NCT02700815|12514961|FG000|COMPLETED|Overall Study||74
11317548|NCT02700815|12514962|FG001|COMPLETED|Overall Study||216
11317549|NCT02700815|12514963|FG002|COMPLETED|Overall Study||219
11317550|NCT02700815|12514964|FG003|COMPLETED|Overall Study||218
11317551|NCT02700815|12514961|FG000|NOT COMPLETED|Overall Study||1
11317552|NCT02700815|12514962|FG001|NOT COMPLETED|Overall Study||7
11317553|NCT02700815|12514963|FG002|NOT COMPLETED|Overall Study||4
11317554|NCT02700815|12514964|FG003|NOT COMPLETED|Overall Study||7
11317555|NCT02700919|12514977|FG000|STARTED|Overall Study||94
11317556|NCT02700919|12514978|FG001|STARTED|Overall Study||97
11317557|NCT02700919|12514979|FG002|STARTED|Overall Study||91
11317558|NCT02700919|12514977|FG000|COMPLETED|Overall Study||82
11317559|NCT02700919|12514978|FG001|COMPLETED|Overall Study||85
11317560|NCT02700919|12514979|FG002|COMPLETED|Overall Study||87
11317561|NCT02700919|12514977|FG000|NOT COMPLETED|Overall Study||12
11317562|NCT02700919|12514978|FG001|NOT COMPLETED|Overall Study||12
11317563|NCT02700919|12514979|FG002|NOT COMPLETED|Overall Study||4
11317564|NCT02700984|12514989|FG000|STARTED|Overall Study||215
11317565|NCT02700984|12514990|FG001|STARTED|Overall Study||67
11317566|NCT02700984|12514989|FG000|COMPLETED|Overall Study||200
11317567|NCT02700984|12514990|FG001|COMPLETED|Overall Study||53
11317568|NCT02700984|12514989|FG000|NOT COMPLETED|Overall Study||15
11317569|NCT02700984|12514990|FG001|NOT COMPLETED|Overall Study||14
11317570|NCT02700997|12515006|FG000|STARTED|Overall Study||17
11317571|NCT02700997|12515006|FG000|COMPLETED|Overall Study||15
11317572|NCT02700997|12515006|FG000|NOT COMPLETED|Overall Study||2
11317573|NCT02701049|12515013|FG000|STARTED|Overall Study|Patients who completed a follow-up survey|209
11317574|NCT02701049|12515014|FG001|STARTED|Overall Study|Patients who completed a follow-up survey|342
11317575|NCT02701049|12515015|FG002|STARTED|Overall Study|Patients who completed a follow-up survey|198
11317576|NCT02701049|12515013|FG000|COMPLETED|Overall Study|Total patients included in analysis|209
11317577|NCT02701049|12515014|FG001|COMPLETED|Overall Study|Total patients included in analysis|342
11317578|NCT02701049|12515015|FG002|COMPLETED|Overall Study|Total patients included in analysis|198
11317579|NCT02701049|12515013|FG000|NOT COMPLETED|Overall Study||0
11317580|NCT02701049|12515014|FG001|NOT COMPLETED|Overall Study||0
11317581|NCT02701049|12515015|FG002|NOT COMPLETED|Overall Study||0
11317582|NCT02701062|12515029|FG000|STARTED|Baseline||376
11317583|NCT02701062|12515030|FG001|STARTED|Baseline||186
11317584|NCT02701062|12515029|FG000|COMPLETED|Baseline||376
11317585|NCT02701062|12515030|FG001|COMPLETED|Baseline||186
11317586|NCT02701062|12515029|FG000|NOT COMPLETED|Baseline||0
11317587|NCT02701062|12515030|FG001|NOT COMPLETED|Baseline||0
11317588|NCT02701062|12515029|FG000|STARTED|Index Procedure||376
11317589|NCT02701062|12515030|FG001|STARTED|Index Procedure||186
11317590|NCT02701062|12515029|FG000|COMPLETED|Index Procedure||376
11317591|NCT02701062|12515030|FG001|COMPLETED|Index Procedure||186
11317592|NCT02701062|12515029|FG000|NOT COMPLETED|Index Procedure||0
11317593|NCT02701062|12515030|FG001|NOT COMPLETED|Index Procedure||0
11317594|NCT02701062|12515029|FG000|STARTED|Discharge||376
11317595|NCT02701062|12515030|FG001|STARTED|Discharge||186
11317596|NCT02701062|12515029|FG000|COMPLETED|Discharge||376
11317597|NCT02701062|12515030|FG001|COMPLETED|Discharge||186
11317598|NCT02701062|12515029|FG000|NOT COMPLETED|Discharge||0
11317599|NCT02701062|12515030|FG001|NOT COMPLETED|Discharge||0
11317600|NCT02701062|12515029|FG000|STARTED|30 Day Follow-up||376
11317601|NCT02701062|12515030|FG001|STARTED|30 Day Follow-up||186
11317602|NCT02701062|12515029|FG000|COMPLETED|30 Day Follow-up||366
11317603|NCT02701062|12515030|FG001|COMPLETED|30 Day Follow-up||183
11317604|NCT02701062|12515029|FG000|NOT COMPLETED|30 Day Follow-up||10
11317605|NCT02701062|12515030|FG001|NOT COMPLETED|30 Day Follow-up||3
11402470|NCT04039919|12597345|FG004|COMPLETED|Treatment Period 3||0
11317606|NCT02701062|12515029|FG000|STARTED|90 Day Follow-up||366
11317607|NCT02701062|12515030|FG001|STARTED|90 Day Follow-up||183
11317608|NCT02701062|12515029|FG000|COMPLETED|90 Day Follow-up||308
11317609|NCT02701062|12515030|FG001|COMPLETED|90 Day Follow-up||72
11317610|NCT02701062|12515029|FG000|NOT COMPLETED|90 Day Follow-up||58
11317611|NCT02701062|12515030|FG001|NOT COMPLETED|90 Day Follow-up||111
11317612|NCT02701062|12515029|FG000|STARTED|365 Day Follow-up||308
11317613|NCT02701062|12515030|FG001|STARTED|365 Day Follow-up||72
11317614|NCT02701062|12515029|FG000|COMPLETED|365 Day Follow-up||294
11317615|NCT02701062|12515030|FG001|COMPLETED|365 Day Follow-up||69
11317616|NCT02701062|12515029|FG000|NOT COMPLETED|365 Day Follow-up||14
11317617|NCT02701062|12515030|FG001|NOT COMPLETED|365 Day Follow-up||3
11317618|NCT02701101|12515044|FG000|STARTED|Overall Study||189
11317619|NCT02701101|12515044|FG000|COMPLETED|Overall Study||189
11317620|NCT02701101|12515044|FG000|NOT COMPLETED|Overall Study||0
11317621|NCT02701257|12515054|FG000|STARTED|Overall Study||6
11317622|NCT02701257|12515055|FG001|STARTED|Overall Study||6
11317623|NCT02701257|12515056|FG002|STARTED|Overall Study||0
11317624|NCT02701257|12515057|FG003|STARTED|Overall Study||4
11317625|NCT02701257|12515058|FG004|STARTED|Overall Study||4
11317626|NCT02701257|12515054|FG000|COMPLETED|Overall Study||6
11317627|NCT02701257|12515055|FG001|COMPLETED|Overall Study||3
11317628|NCT02701257|12515056|FG002|COMPLETED|Overall Study||0
11317629|NCT02701257|12515057|FG003|COMPLETED|Overall Study||3
11317630|NCT02701257|12515058|FG004|COMPLETED|Overall Study||1
11317631|NCT02701257|12515054|FG000|NOT COMPLETED|Overall Study||0
11317632|NCT02701257|12515055|FG001|NOT COMPLETED|Overall Study||3
11317633|NCT02701257|12515056|FG002|NOT COMPLETED|Overall Study||0
11317634|NCT02701257|12515057|FG003|NOT COMPLETED|Overall Study||1
11317635|NCT02701257|12515058|FG004|NOT COMPLETED|Overall Study||3
11317636|NCT02701270|12515074|FG000|STARTED|First Intervention at Visit 1||2
11317637|NCT02701270|12515075|FG001|STARTED|First Intervention at Visit 1||3
11317638|NCT02701270|12515076|FG002|STARTED|First Intervention at Visit 1||3
11317639|NCT02701270|12515077|FG003|STARTED|First Intervention at Visit 1||3
11317640|NCT02701270|12515074|FG000|COMPLETED|First Intervention at Visit 1||2
11317641|NCT02701270|12515075|FG001|COMPLETED|First Intervention at Visit 1||3
11317642|NCT02701270|12515076|FG002|COMPLETED|First Intervention at Visit 1||3
11317643|NCT02701270|12515077|FG003|COMPLETED|First Intervention at Visit 1||3
11317644|NCT02701270|12515074|FG000|NOT COMPLETED|First Intervention at Visit 1||0
11317645|NCT02701270|12515075|FG001|NOT COMPLETED|First Intervention at Visit 1||0
11317646|NCT02701270|12515076|FG002|NOT COMPLETED|First Intervention at Visit 1||0
11317647|NCT02701270|12515077|FG003|NOT COMPLETED|First Intervention at Visit 1||0
11317648|NCT02701270|12515074|FG000|STARTED|Second Intervention at Visit 2||2
11317649|NCT02701270|12515075|FG001|STARTED|Second Intervention at Visit 2||3
11317650|NCT02701270|12515076|FG002|STARTED|Second Intervention at Visit 2||3
11317651|NCT02701270|12515077|FG003|STARTED|Second Intervention at Visit 2||3
11317652|NCT02701270|12515074|FG000|COMPLETED|Second Intervention at Visit 2||2
11317653|NCT02701270|12515075|FG001|COMPLETED|Second Intervention at Visit 2||3
11317654|NCT02701270|12515076|FG002|COMPLETED|Second Intervention at Visit 2||3
11317655|NCT02701270|12515077|FG003|COMPLETED|Second Intervention at Visit 2||3
11317656|NCT02701270|12515074|FG000|NOT COMPLETED|Second Intervention at Visit 2||0
11317657|NCT02701270|12515075|FG001|NOT COMPLETED|Second Intervention at Visit 2||0
11317658|NCT02701270|12515076|FG002|NOT COMPLETED|Second Intervention at Visit 2||0
11317659|NCT02701270|12515077|FG003|NOT COMPLETED|Second Intervention at Visit 2||0
11317660|NCT02701270|12515074|FG000|STARTED|Third Intervention at Visit 3||2
11317661|NCT02701270|12515075|FG001|STARTED|Third Intervention at Visit 3||3
11317662|NCT02701270|12515076|FG002|STARTED|Third Intervention at Visit 3||3
11317663|NCT02701270|12515077|FG003|STARTED|Third Intervention at Visit 3||3
11317664|NCT02701270|12515074|FG000|COMPLETED|Third Intervention at Visit 3||2
11317665|NCT02701270|12515075|FG001|COMPLETED|Third Intervention at Visit 3||3
11317666|NCT02701270|12515076|FG002|COMPLETED|Third Intervention at Visit 3||3
11317667|NCT02701270|12515077|FG003|COMPLETED|Third Intervention at Visit 3||3
11317668|NCT02701270|12515074|FG000|NOT COMPLETED|Third Intervention at Visit 3||0
11317669|NCT02701270|12515075|FG001|NOT COMPLETED|Third Intervention at Visit 3||0
11317670|NCT02701270|12515076|FG002|NOT COMPLETED|Third Intervention at Visit 3||0
11317671|NCT02701270|12515077|FG003|NOT COMPLETED|Third Intervention at Visit 3||0
11317672|NCT02701270|12515074|FG000|STARTED|Fourth Intervention at Visit 4||2
11317673|NCT02701270|12515075|FG001|STARTED|Fourth Intervention at Visit 4||3
11317674|NCT02701270|12515076|FG002|STARTED|Fourth Intervention at Visit 4||3
11317675|NCT02701270|12515077|FG003|STARTED|Fourth Intervention at Visit 4||3
11317676|NCT02701270|12515074|FG000|COMPLETED|Fourth Intervention at Visit 4||2
11317677|NCT02701270|12515075|FG001|COMPLETED|Fourth Intervention at Visit 4||3
11317678|NCT02701270|12515076|FG002|COMPLETED|Fourth Intervention at Visit 4||3
11317679|NCT02701270|12515077|FG003|COMPLETED|Fourth Intervention at Visit 4||3
11317680|NCT02701270|12515074|FG000|NOT COMPLETED|Fourth Intervention at Visit 4||0
11317681|NCT02701270|12515075|FG001|NOT COMPLETED|Fourth Intervention at Visit 4||0
11317682|NCT02701270|12515076|FG002|NOT COMPLETED|Fourth Intervention at Visit 4||0
11317683|NCT02701270|12515077|FG003|NOT COMPLETED|Fourth Intervention at Visit 4||0
11317684|NCT02701296|12515090|FG000|STARTED|Overall Study||42
11317685|NCT02701296|12515091|FG001|STARTED|Overall Study||38
11317686|NCT02701296|12515090|FG000|COMPLETED|Overall Study||42
11317687|NCT02701296|12515091|FG001|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
11317688|NCT02701296|12515090|FG000|NOT COMPLETED|Overall Study||0
11317689|NCT02701296|12515091|FG001|NOT COMPLETED|Overall Study||2
11317690|NCT02701361|12515100|FG000|STARTED|Overall Study||31
11317691|NCT02701361|12515101|FG001|STARTED|Overall Study||31
11317692|NCT02701361|12515102|FG002|STARTED|Overall Study||18
11317693|NCT02701361|12515100|FG000|COMPLETED|Overall Study||22
11317694|NCT02701361|12515101|FG001|COMPLETED|Overall Study||28
11317695|NCT02701361|12515102|FG002|COMPLETED|Overall Study||16
11317696|NCT02701361|12515100|FG000|NOT COMPLETED|Overall Study||9
11317697|NCT02701361|12515101|FG001|NOT COMPLETED|Overall Study||3
11317698|NCT02701361|12515102|FG002|NOT COMPLETED|Overall Study||2
11317699|NCT02701387|12515112|FG000|STARTED|Overall Study||7
11317700|NCT02701387|12515112|FG000|COMPLETED|Overall Study||7
11317701|NCT02701387|12515112|FG000|NOT COMPLETED|Overall Study||0
11317702|NCT02701400|12515119|FG000|STARTED|Overall Study||9
11317703|NCT02701400|12515120|FG001|STARTED|Overall Study||9
11317704|NCT02701400|12515119|FG000|COMPLETED|Overall Study||9
11317705|NCT02701400|12515120|FG001|COMPLETED|Overall Study||9
11317706|NCT02701400|12515119|FG000|NOT COMPLETED|Overall Study||0
11317707|NCT02701400|12515120|FG001|NOT COMPLETED|Overall Study||0
11317708|NCT02701413|12515129|FG000|STARTED|Overall Study||33
11317709|NCT02701413|12515130|FG001|STARTED|Overall Study||33
11317710|NCT02701413|12515129|FG000|COMPLETED|Overall Study||26
11317711|NCT02701413|12515130|FG001|COMPLETED|Overall Study||22
11317712|NCT02701413|12515129|FG000|NOT COMPLETED|Overall Study||7
11317713|NCT02701413|12515130|FG001|NOT COMPLETED|Overall Study||11
11317714|NCT02701582|12515138|FG000|STARTED|Overall Study||35
11317715|NCT02701582|12515139|FG001|STARTED|Overall Study||33
11317716|NCT02701582|12515138|FG000|COMPLETED|Overall Study||33
11317717|NCT02701582|12515139|FG001|COMPLETED|Overall Study||33
11317718|NCT02701582|12515138|FG000|NOT COMPLETED|Overall Study||2
11317719|NCT02701582|12515139|FG001|NOT COMPLETED|Overall Study||0
11317720|NCT02701634|12515149|FG000|STARTED|Overall Study||33
11317721|NCT02701634|12515150|FG001|STARTED|Overall Study||33
11317722|NCT02701634|12515149|FG000|COMPLETED|Overall Study||1
11317723|NCT02701634|12515150|FG001|COMPLETED|Overall Study||2
11317724|NCT02701634|12515149|FG000|NOT COMPLETED|Overall Study||32
11317725|NCT02701634|12515150|FG001|NOT COMPLETED|Overall Study||31
11317726|NCT02701647|12515160|FG000|STARTED|Overall Study||17
11317727|NCT02701647|12515161|FG001|STARTED|Overall Study||17
11317728|NCT02701647|12515162|FG002|STARTED|Overall Study||17
11317729|NCT02701647|12515160|FG000|COMPLETED|Overall Study||17
11317730|NCT02701647|12515161|FG001|COMPLETED|Overall Study||17
11317731|NCT02701647|12515162|FG002|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16
11317732|NCT02701647|12515160|FG000|NOT COMPLETED|Overall Study||0
11317733|NCT02701647|12515161|FG001|NOT COMPLETED|Overall Study||0
11317734|NCT02701647|12515162|FG002|NOT COMPLETED|Overall Study||1
11317735|NCT02701764|12515178|FG000|STARTED|Overall Study||21
11317736|NCT02701764|12515179|FG001|STARTED|Overall Study||22
11317737|NCT02701764|12515178|FG000|COMPLETED|Overall Study||21
11317738|NCT02701764|12515179|FG001|COMPLETED|Overall Study||21
11317739|NCT02701764|12515178|FG000|NOT COMPLETED|Overall Study||0
11317740|NCT02701764|12515179|FG001|NOT COMPLETED|Overall Study||1
11317741|NCT02701868|12515188|FG000|STARTED|Overall Study||21
11317742|NCT02701868|12515189|FG001|STARTED|Overall Study||75
11317743|NCT02701868|12515190|FG002|STARTED|Overall Study||75
11317744|NCT02701868|12515188|FG000|COMPLETED|Overall Study||21
11317745|NCT02701868|12515189|FG001|COMPLETED|Overall Study||75
11317746|NCT02701868|12515190|FG002|COMPLETED|Overall Study||75
11317747|NCT02701868|12515188|FG000|NOT COMPLETED|Overall Study||0
11317748|NCT02701868|12515189|FG001|NOT COMPLETED|Overall Study||0
11317749|NCT02701868|12515190|FG002|NOT COMPLETED|Overall Study||0
11317750|NCT02701985|12515201|FG000|STARTED|Overall Study||37
11317751|NCT02701985|12515202|FG001|STARTED|Overall Study||38
11317752|NCT02701985|12515201|FG000|COMPLETED|Overall Study||34
11317753|NCT02701985|12515202|FG001|COMPLETED|Overall Study||32
11317754|NCT02701985|12515201|FG000|NOT COMPLETED|Overall Study||3
11317755|NCT02701985|12515202|FG001|NOT COMPLETED|Overall Study||6
11317756|NCT02702011|12515213|FG000|STARTED|Overall Study|Started are the treated patients.|11
11317757|NCT02702011|12515214|FG001|STARTED|Overall Study|Started are the treated patients.|13
11317758|NCT02702011|12515215|FG002|STARTED|Overall Study|Started are the treated patients.|12
11317759|NCT02702011|12515216|FG003|STARTED|Overall Study|Started are the treated patients.|12
11317760|NCT02702011|12515213|FG000|COMPLETED|Overall Study||11
11317761|NCT02702011|12515214|FG001|COMPLETED|Overall Study||12
11317762|NCT02702011|12515215|FG002|COMPLETED|Overall Study||12
11317763|NCT02702011|12515216|FG003|COMPLETED|Overall Study||12
11317764|NCT02702011|12515213|FG000|NOT COMPLETED|Overall Study||0
11317765|NCT02702011|12515214|FG001|NOT COMPLETED|Overall Study||1
11317766|NCT02702011|12515215|FG002|NOT COMPLETED|Overall Study||0
11317767|NCT02702011|12515216|FG003|NOT COMPLETED|Overall Study||0
11317768|NCT02702193|12515228|FG000|STARTED|Baseline Assessment/Randomization||86
11317769|NCT02702193|12515229|FG001|STARTED|Baseline Assessment/Randomization||87
11317770|NCT02702193|12515228|FG000|COMPLETED|Baseline Assessment/Randomization||85
11317771|NCT02702193|12515229|FG001|COMPLETED|Baseline Assessment/Randomization||87
11317772|NCT02702193|12515228|FG000|NOT COMPLETED|Baseline Assessment/Randomization||1
11317773|NCT02702193|12515229|FG001|NOT COMPLETED|Baseline Assessment/Randomization||0
11317774|NCT02702193|12515228|FG000|STARTED|4 Month Follow up||86
11317775|NCT02702193|12515229|FG001|STARTED|4 Month Follow up||87
11317776|NCT02702193|12515228|FG000|COMPLETED|4 Month Follow up||68
11317777|NCT02702193|12515229|FG001|COMPLETED|4 Month Follow up||69
11317778|NCT02702193|12515228|FG000|NOT COMPLETED|4 Month Follow up||18
11317779|NCT02702193|12515229|FG001|NOT COMPLETED|4 Month Follow up||18
11317780|NCT02702193|12515228|FG000|STARTED|8 Month Follow up||86
11317781|NCT02702193|12515229|FG001|STARTED|8 Month Follow up||87
11317782|NCT02702193|12515228|FG000|COMPLETED|8 Month Follow up||71
11317783|NCT02702193|12515229|FG001|COMPLETED|8 Month Follow up||69
11317784|NCT02702193|12515228|FG000|NOT COMPLETED|8 Month Follow up||15
11317785|NCT02702193|12515229|FG001|NOT COMPLETED|8 Month Follow up||18
11317786|NCT02702193|12515228|FG000|STARTED|12 Month Follow up||86
11317787|NCT02702193|12515229|FG001|STARTED|12 Month Follow up||87
11317788|NCT02702193|12515228|FG000|COMPLETED|12 Month Follow up||69
11317789|NCT02702193|12515229|FG001|COMPLETED|12 Month Follow up||69
11317790|NCT02702193|12515228|FG000|NOT COMPLETED|12 Month Follow up||17
11317791|NCT02702193|12515229|FG001|NOT COMPLETED|12 Month Follow up||18
11317792|NCT02702388|12515237|FG000|STARTED|Overall Study||75
11317793|NCT02702388|12515238|FG001|STARTED|Overall Study||77
11317794|NCT02702388|12515237|FG000|COMPLETED|Overall Study||35
11317795|NCT02702388|12515238|FG001|COMPLETED|Overall Study||26
11317796|NCT02702388|12515237|FG000|NOT COMPLETED|Overall Study||40
11317797|NCT02702388|12515238|FG001|NOT COMPLETED|Overall Study||51
11317798|NCT02702518|12515255|FG000|STARTED|Overall Study||29
11317799|NCT02702518|12515256|FG001|STARTED|Overall Study||29
11317800|NCT02702518|12515255|FG000|COMPLETED|Overall Study||26
11317801|NCT02702518|12515256|FG001|COMPLETED|Overall Study||25
11317802|NCT02702518|12515255|FG000|NOT COMPLETED|Overall Study||3
11317803|NCT02702518|12515256|FG001|NOT COMPLETED|Overall Study||4
11317804|NCT02702609|12515264|FG000|STARTED|Overall Study||24
11317805|NCT02702609|12515265|FG001|STARTED|Overall Study||21
11317806|NCT02702609|12515264|FG000|Implant Placement|Overall Study||23
11317807|NCT02702609|12515265|FG001|Implant Placement|Overall Study||21
11317808|NCT02702609|12515264|FG000|Crown Delivery|Overall Study||16
11317809|NCT02702609|12515265|FG001|Crown Delivery|Overall Study||18
11317810|NCT02702609|12515264|FG000|COMPLETED|Overall Study||15
11317811|NCT02702609|12515265|FG001|COMPLETED|Overall Study||17
11317812|NCT02702609|12515264|FG000|NOT COMPLETED|Overall Study||9
11317813|NCT02702609|12515265|FG001|NOT COMPLETED|Overall Study||4
11317814|NCT02702921|12515273|FG000|STARTED|Overall Study||98
11317815|NCT02702921|12515274|FG001|STARTED|Overall Study||103
11317816|NCT02702921|12515273|FG000|COMPLETED|Overall Study||84
11317817|NCT02702921|12515274|FG001|COMPLETED|Overall Study||95
11317818|NCT02702921|12515273|FG000|NOT COMPLETED|Overall Study||14
11317819|NCT02702921|12515274|FG001|NOT COMPLETED|Overall Study||8
11317820|NCT02702999|12515282|FG000|STARTED|Overall Study||102
11317821|NCT02702999|12515283|FG001|STARTED|Overall Study||104
11317822|NCT02702999|12515282|FG000|COMPLETED|Overall Study||102
11317823|NCT02702999|12515283|FG001|COMPLETED|Overall Study||104
11317824|NCT02702999|12515282|FG000|NOT COMPLETED|Overall Study||0
11317825|NCT02702999|12515283|FG001|NOT COMPLETED|Overall Study||0
11317826|NCT02703259|12515291|FG000|STARTED|24 Hours Postoperative Assessment||70
11317827|NCT02703259|12515292|FG001|STARTED|24 Hours Postoperative Assessment||67
11317828|NCT02703259|12515291|FG000|COMPLETED|24 Hours Postoperative Assessment||68
11317829|NCT02703259|12515292|FG001|COMPLETED|24 Hours Postoperative Assessment||61
11317830|NCT02703259|12515291|FG000|NOT COMPLETED|24 Hours Postoperative Assessment||2
11317831|NCT02703259|12515292|FG001|NOT COMPLETED|24 Hours Postoperative Assessment||6
11317832|NCT02703259|12515291|FG000|STARTED|2 Weeks Postoperative Assessment||68
11317833|NCT02703259|12515292|FG001|STARTED|2 Weeks Postoperative Assessment||61
11317834|NCT02703259|12515291|FG000|COMPLETED|2 Weeks Postoperative Assessment||58
11317835|NCT02703259|12515292|FG001|COMPLETED|2 Weeks Postoperative Assessment||51
11317836|NCT02703259|12515291|FG000|NOT COMPLETED|2 Weeks Postoperative Assessment||10
11317837|NCT02703259|12515292|FG001|NOT COMPLETED|2 Weeks Postoperative Assessment||10
11317838|NCT02703311|12515298|FG000|STARTED|Overall Study||11
11317839|NCT02703311|12515298|FG000|Implanted|Overall Study||11
11317840|NCT02703311|12515298|FG000|30 Day Follow-Up Completed|Overall Study||9
11317841|NCT02703311|12515298|FG000|COMPLETED|Overall Study||3
11317842|NCT02703311|12515298|FG000|NOT COMPLETED|Overall Study||8
11317843|NCT02703324|12515302|FG000|STARTED|Period One||5
11317844|NCT02703324|12515303|FG001|STARTED|Period One||5
11317845|NCT02703324|12515304|FG002|STARTED|Period One||5
11317846|NCT02703324|12515305|FG003|STARTED|Period One||5
11317847|NCT02703324|12515306|FG004|STARTED|Period One||5
11317848|NCT02703324|12515307|FG005|STARTED|Period One||5
11317849|NCT02703324|12515302|FG000|Received Study Drug|Period One||5
11317850|NCT02703324|12515303|FG001|Received Study Drug|Period One||5
11317851|NCT02703324|12515304|FG002|Received Study Drug|Period One||5
11317852|NCT02703324|12515305|FG003|Received Study Drug|Period One||5
11317853|NCT02703324|12515306|FG004|Received Study Drug|Period One||5
11317854|NCT02703324|12515307|FG005|Received Study Drug|Period One||5
11317855|NCT02703324|12515302|FG000|COMPLETED|Period One||5
11317856|NCT02703324|12515303|FG001|COMPLETED|Period One||5
11317857|NCT02703324|12515304|FG002|COMPLETED|Period One||5
11317858|NCT02703324|12515305|FG003|COMPLETED|Period One||5
11317859|NCT02703324|12515306|FG004|COMPLETED|Period One||5
11317860|NCT02703324|12515307|FG005|COMPLETED|Period One||5
11317861|NCT02703324|12515302|FG000|NOT COMPLETED|Period One||0
11317862|NCT02703324|12515303|FG001|NOT COMPLETED|Period One||0
11317863|NCT02703324|12515304|FG002|NOT COMPLETED|Period One||0
11317864|NCT02703324|12515305|FG003|NOT COMPLETED|Period One||0
11317865|NCT02703324|12515306|FG004|NOT COMPLETED|Period One||0
11317866|NCT02703324|12515307|FG005|NOT COMPLETED|Period One||0
11317867|NCT02703324|12515302|FG000|STARTED|Period Two||5
11317868|NCT02703324|12515303|FG001|STARTED|Period Two||5
11317869|NCT02703324|12515304|FG002|STARTED|Period Two||5
11317870|NCT02703324|12515305|FG003|STARTED|Period Two||5
11402471|NCT04039919|12597341|FG000|NOT COMPLETED|Treatment Period 3||0
11402472|NCT04039919|12597342|FG001|NOT COMPLETED|Treatment Period 3||0
11402473|NCT04039919|12597343|FG002|NOT COMPLETED|Treatment Period 3||0
11402474|NCT04039919|12597344|FG003|NOT COMPLETED|Treatment Period 3||0
11402475|NCT04039919|12597345|FG004|NOT COMPLETED|Treatment Period 3||0
11402476|NCT04039919|12597341|FG000|STARTED|Treatment Period 4||6
11402477|NCT04039919|12597342|FG001|STARTED|Treatment Period 4||6
11402478|NCT04039919|12597343|FG002|STARTED|Treatment Period 4||5
11402479|NCT04039919|12597344|FG003|STARTED|Treatment Period 4||6
11402480|NCT04039919|12597345|FG004|STARTED|Treatment Period 4||0
11317871|NCT02703324|12515306|FG004|STARTED|Period Two||5
11317872|NCT02703324|12515307|FG005|STARTED|Period Two||5
11317873|NCT02703324|12515302|FG000|Received Study Drug|Period Two||5
11317874|NCT02703324|12515303|FG001|Received Study Drug|Period Two||5
11317875|NCT02703324|12515304|FG002|Received Study Drug|Period Two||5
11402481|NCT04039919|12597341|FG000|COMPLETED|Treatment Period 4||6
11402482|NCT04039919|12597342|FG001|COMPLETED|Treatment Period 4||6
11402483|NCT04039919|12597343|FG002|COMPLETED|Treatment Period 4||5
11402484|NCT04039919|12597344|FG003|COMPLETED|Treatment Period 4||6
11402485|NCT04039919|12597345|FG004|COMPLETED|Treatment Period 4||0
11402486|NCT04039919|12597341|FG000|NOT COMPLETED|Treatment Period 4||0
11402487|NCT04039919|12597342|FG001|NOT COMPLETED|Treatment Period 4||0
11402488|NCT04039919|12597343|FG002|NOT COMPLETED|Treatment Period 4||0
11402489|NCT04039919|12597344|FG003|NOT COMPLETED|Treatment Period 4||0
11402490|NCT04039919|12597345|FG004|NOT COMPLETED|Treatment Period 4||0
11402491|NCT04039919|12597341|FG000|STARTED|Treatment Period 5||6
11402492|NCT04039919|12597342|FG001|STARTED|Treatment Period 5||6
11317876|NCT02703324|12515305|FG003|Received Study Drug|Period Two||5
11317877|NCT02703324|12515306|FG004|Received Study Drug|Period Two||5
11317878|NCT02703324|12515307|FG005|Received Study Drug|Period Two||5
11317879|NCT02703324|12515302|FG000|COMPLETED|Period Two||5
11317880|NCT02703324|12515303|FG001|COMPLETED|Period Two||5
11317881|NCT02703324|12515304|FG002|COMPLETED|Period Two||4
11317882|NCT02703324|12515305|FG003|COMPLETED|Period Two||5
11317883|NCT02703324|12515306|FG004|COMPLETED|Period Two||5
11317884|NCT02703324|12515307|FG005|COMPLETED|Period Two||5
11317885|NCT02703324|12515302|FG000|NOT COMPLETED|Period Two||0
11317886|NCT02703324|12515303|FG001|NOT COMPLETED|Period Two||0
11317887|NCT02703324|12515304|FG002|NOT COMPLETED|Period Two||1
11317888|NCT02703324|12515305|FG003|NOT COMPLETED|Period Two||0
11402493|NCT04039919|12597343|FG002|STARTED|Treatment Period 5||5
11402494|NCT04039919|12597344|FG003|STARTED|Treatment Period 5||6
11402495|NCT04039919|12597345|FG004|STARTED|Treatment Period 5||0
11317889|NCT02703324|12515306|FG004|NOT COMPLETED|Period Two||0
11317890|NCT02703324|12515307|FG005|NOT COMPLETED|Period Two||0
11317891|NCT02703324|12515302|FG000|STARTED|Period Three||5
11402496|NCT04039919|12597341|FG000|COMPLETED|Treatment Period 5||5
11402497|NCT04039919|12597342|FG001|COMPLETED|Treatment Period 5||6
11402498|NCT04039919|12597343|FG002|COMPLETED|Treatment Period 5||5
11402499|NCT04039919|12597344|FG003|COMPLETED|Treatment Period 5||6
11402500|NCT04039919|12597345|FG004|COMPLETED|Treatment Period 5||0
11317892|NCT02703324|12515303|FG001|STARTED|Period Three||5
11317893|NCT02703324|12515304|FG002|STARTED|Period Three||4
11317894|NCT02703324|12515305|FG003|STARTED|Period Three||5
11317895|NCT02703324|12515306|FG004|STARTED|Period Three||5
11317896|NCT02703324|12515307|FG005|STARTED|Period Three||5
11317897|NCT02703324|12515302|FG000|Received Study Drug|Period Three||5
11402501|NCT04039919|12597341|FG000|NOT COMPLETED|Treatment Period 5||1
11402502|NCT04039919|12597342|FG001|NOT COMPLETED|Treatment Period 5||0
11402503|NCT04039919|12597343|FG002|NOT COMPLETED|Treatment Period 5||0
11317898|NCT02703324|12515303|FG001|Received Study Drug|Period Three||5
11317899|NCT02703324|12515304|FG002|Received Study Drug|Period Three||4
11317900|NCT02703324|12515305|FG003|Received Study Drug|Period Three||5
11317901|NCT02703324|12515306|FG004|Received Study Drug|Period Three||5
11317902|NCT02703324|12515307|FG005|Received Study Drug|Period Three||5
11317903|NCT02703324|12515302|FG000|COMPLETED|Period Three||5
11317904|NCT02703324|12515303|FG001|COMPLETED|Period Three|One participant discontinued after Period 3. Did not enter Period 4.|5
11317905|NCT02703324|12515304|FG002|COMPLETED|Period Three||4
11317906|NCT02703324|12515305|FG003|COMPLETED|Period Three||5
11317907|NCT02703324|12515306|FG004|COMPLETED|Period Three||5
11317908|NCT02703324|12515307|FG005|COMPLETED|Period Three||5
11317909|NCT02703324|12515302|FG000|NOT COMPLETED|Period Three||0
11317910|NCT02703324|12515303|FG001|NOT COMPLETED|Period Three||0
11317911|NCT02703324|12515304|FG002|NOT COMPLETED|Period Three||0
11317912|NCT02703324|12515305|FG003|NOT COMPLETED|Period Three||0
11317913|NCT02703324|12515306|FG004|NOT COMPLETED|Period Three||0
11317914|NCT02703324|12515307|FG005|NOT COMPLETED|Period Three||0
11317915|NCT02703324|12515302|FG000|STARTED|Period Four||5
11317916|NCT02703324|12515303|FG001|STARTED|Period Four|One participant discontinued after Period 3. Did not enter Period 4.|4
11317917|NCT02703324|12515304|FG002|STARTED|Period Four||4
11317918|NCT02703324|12515305|FG003|STARTED|Period Four||5
11317919|NCT02703324|12515306|FG004|STARTED|Period Four||5
11317920|NCT02703324|12515307|FG005|STARTED|Period Four||5
11317921|NCT02703324|12515302|FG000|Received Study Drug|Period Four||5
11317922|NCT02703324|12515303|FG001|Received Study Drug|Period Four||4
11317923|NCT02703324|12515304|FG002|Received Study Drug|Period Four||4
11317924|NCT02703324|12515305|FG003|Received Study Drug|Period Four||5
11317925|NCT02703324|12515306|FG004|Received Study Drug|Period Four||5
11317926|NCT02703324|12515307|FG005|Received Study Drug|Period Four||5
11317927|NCT02703324|12515302|FG000|COMPLETED|Period Four||5
11317928|NCT02703324|12515303|FG001|COMPLETED|Period Four||4
11317929|NCT02703324|12515304|FG002|COMPLETED|Period Four||4
11317930|NCT02703324|12515305|FG003|COMPLETED|Period Four||5
11317931|NCT02703324|12515306|FG004|COMPLETED|Period Four||5
11317932|NCT02703324|12515307|FG005|COMPLETED|Period Four||5
11317933|NCT02703324|12515302|FG000|NOT COMPLETED|Period Four||0
11317934|NCT02703324|12515303|FG001|NOT COMPLETED|Period Four||0
11317935|NCT02703324|12515304|FG002|NOT COMPLETED|Period Four||0
11317936|NCT02703324|12515305|FG003|NOT COMPLETED|Period Four||0
11317937|NCT02703324|12515306|FG004|NOT COMPLETED|Period Four||0
11317938|NCT02703324|12515307|FG005|NOT COMPLETED|Period Four||0
11317939|NCT02703337|12515316|FG000|STARTED|Period One (Part A)||5
11317940|NCT02703337|12515317|FG001|STARTED|Period One (Part A)||5
11317941|NCT02703337|12515318|FG002|STARTED|Period One (Part A)||5
11402504|NCT04039919|12597344|FG003|NOT COMPLETED|Treatment Period 5||0
11317942|NCT02703337|12515319|FG003|STARTED|Period One (Part A)||5
11317943|NCT02703337|12515320|FG004|STARTED|Period One (Part A)||5
11317944|NCT02703337|12515321|FG005|STARTED|Period One (Part A)||5
11317945|NCT02703337|12515322|FG006|STARTED|Period One (Part A)||0
11317946|NCT02703337|12515323|FG007|STARTED|Period One (Part A)||0
11317947|NCT02703337|12515316|FG000|Received Study Drug|Period One (Part A)||5
11317948|NCT02703337|12515317|FG001|Received Study Drug|Period One (Part A)||5
11317949|NCT02703337|12515318|FG002|Received Study Drug|Period One (Part A)||5
11317950|NCT02703337|12515319|FG003|Received Study Drug|Period One (Part A)||5
11317951|NCT02703337|12515320|FG004|Received Study Drug|Period One (Part A)||5
11317952|NCT02703337|12515321|FG005|Received Study Drug|Period One (Part A)||5
11317953|NCT02703337|12515322|FG006|Received Study Drug|Period One (Part A)||0
11317954|NCT02703337|12515323|FG007|Received Study Drug|Period One (Part A)||0
11317955|NCT02703337|12515316|FG000|COMPLETED|Period One (Part A)||5
11317956|NCT02703337|12515317|FG001|COMPLETED|Period One (Part A)||5
11317957|NCT02703337|12515318|FG002|COMPLETED|Period One (Part A)||5
11317958|NCT02703337|12515319|FG003|COMPLETED|Period One (Part A)||5
11317959|NCT02703337|12515320|FG004|COMPLETED|Period One (Part A)||4
11317960|NCT02703337|12515321|FG005|COMPLETED|Period One (Part A)||5
11317961|NCT02703337|12515322|FG006|COMPLETED|Period One (Part A)||0
11317962|NCT02703337|12515323|FG007|COMPLETED|Period One (Part A)||0
11317963|NCT02703337|12515316|FG000|NOT COMPLETED|Period One (Part A)||0
11317964|NCT02703337|12515317|FG001|NOT COMPLETED|Period One (Part A)||0
11317965|NCT02703337|12515318|FG002|NOT COMPLETED|Period One (Part A)||0
11317966|NCT02703337|12515319|FG003|NOT COMPLETED|Period One (Part A)||0
11402505|NCT04039919|12597345|FG004|NOT COMPLETED|Treatment Period 5||0
11402506|NCT04039919|12597341|FG000|STARTED|Treatment Period 6||5
11402507|NCT04039919|12597342|FG001|STARTED|Treatment Period 6||6
11402508|NCT04039919|12597343|FG002|STARTED|Treatment Period 6||5
11402509|NCT04039919|12597344|FG003|STARTED|Treatment Period 6||6
11402510|NCT04039919|12597345|FG004|STARTED|Treatment Period 6||0
11317967|NCT02703337|12515320|FG004|NOT COMPLETED|Period One (Part A)||1
11317968|NCT02703337|12515321|FG005|NOT COMPLETED|Period One (Part A)||0
11317969|NCT02703337|12515322|FG006|NOT COMPLETED|Period One (Part A)||0
11317970|NCT02703337|12515323|FG007|NOT COMPLETED|Period One (Part A)||0
11317971|NCT02703337|12515316|FG000|STARTED|Period Two (Part A)||5
11317972|NCT02703337|12515317|FG001|STARTED|Period Two (Part A)||5
11317973|NCT02703337|12515318|FG002|STARTED|Period Two (Part A)||5
11317974|NCT02703337|12515319|FG003|STARTED|Period Two (Part A)||5
11317975|NCT02703337|12515320|FG004|STARTED|Period Two (Part A)||4
11317976|NCT02703337|12515321|FG005|STARTED|Period Two (Part A)||5
11317977|NCT02703337|12515322|FG006|STARTED|Period Two (Part A)||0
11317978|NCT02703337|12515323|FG007|STARTED|Period Two (Part A)||0
11317979|NCT02703337|12515316|FG000|Received Study Drug|Period Two (Part A)||5
11317980|NCT02703337|12515317|FG001|Received Study Drug|Period Two (Part A)||5
11317981|NCT02703337|12515318|FG002|Received Study Drug|Period Two (Part A)||5
11317982|NCT02703337|12515319|FG003|Received Study Drug|Period Two (Part A)||5
11317983|NCT02703337|12515320|FG004|Received Study Drug|Period Two (Part A)||4
11317984|NCT02703337|12515321|FG005|Received Study Drug|Period Two (Part A)||5
11317985|NCT02703337|12515322|FG006|Received Study Drug|Period Two (Part A)||0
11317986|NCT02703337|12515323|FG007|Received Study Drug|Period Two (Part A)||0
11317987|NCT02703337|12515316|FG000|COMPLETED|Period Two (Part A)||5
11317988|NCT02703337|12515317|FG001|COMPLETED|Period Two (Part A)||5
11317989|NCT02703337|12515318|FG002|COMPLETED|Period Two (Part A)||5
11317990|NCT02703337|12515319|FG003|COMPLETED|Period Two (Part A)||5
11317991|NCT02703337|12515320|FG004|COMPLETED|Period Two (Part A)||4
11317992|NCT02703337|12515321|FG005|COMPLETED|Period Two (Part A)||5
11317993|NCT02703337|12515322|FG006|COMPLETED|Period Two (Part A)||0
11317994|NCT02703337|12515323|FG007|COMPLETED|Period Two (Part A)||0
11317995|NCT02703337|12515316|FG000|NOT COMPLETED|Period Two (Part A)||0
11317996|NCT02703337|12515317|FG001|NOT COMPLETED|Period Two (Part A)||0
11317997|NCT02703337|12515318|FG002|NOT COMPLETED|Period Two (Part A)||0
11317998|NCT02703337|12515319|FG003|NOT COMPLETED|Period Two (Part A)||0
11317999|NCT02703337|12515320|FG004|NOT COMPLETED|Period Two (Part A)||0
11318000|NCT02703337|12515321|FG005|NOT COMPLETED|Period Two (Part A)||0
11318001|NCT02703337|12515322|FG006|NOT COMPLETED|Period Two (Part A)||0
11318002|NCT02703337|12515323|FG007|NOT COMPLETED|Period Two (Part A)||0
11318003|NCT02703337|12515316|FG000|STARTED|Period Three (Part A)||5
11318004|NCT02703337|12515317|FG001|STARTED|Period Three (Part A)||5
11318005|NCT02703337|12515318|FG002|STARTED|Period Three (Part A)||5
11318006|NCT02703337|12515319|FG003|STARTED|Period Three (Part A)||5
11318007|NCT02703337|12515320|FG004|STARTED|Period Three (Part A)||4
11318008|NCT02703337|12515321|FG005|STARTED|Period Three (Part A)||5
11318009|NCT02703337|12515322|FG006|STARTED|Period Three (Part A)||0
11318010|NCT02703337|12515323|FG007|STARTED|Period Three (Part A)||0
11318011|NCT02703337|12515316|FG000|Received Study Drug|Period Three (Part A)||5
11318012|NCT02703337|12515317|FG001|Received Study Drug|Period Three (Part A)||5
11318013|NCT02703337|12515318|FG002|Received Study Drug|Period Three (Part A)||5
11318014|NCT02703337|12515319|FG003|Received Study Drug|Period Three (Part A)||5
11318015|NCT02703337|12515320|FG004|Received Study Drug|Period Three (Part A)||4
11318016|NCT02703337|12515321|FG005|Received Study Drug|Period Three (Part A)||5
11318017|NCT02703337|12515322|FG006|Received Study Drug|Period Three (Part A)||0
11318018|NCT02703337|12515323|FG007|Received Study Drug|Period Three (Part A)||0
11402511|NCT04039919|12597341|FG000|COMPLETED|Treatment Period 6||5
11402512|NCT04039919|12597342|FG001|COMPLETED|Treatment Period 6||6
11318019|NCT02703337|12515316|FG000|COMPLETED|Period Three (Part A)||5
11318020|NCT02703337|12515317|FG001|COMPLETED|Period Three (Part A)||5
11318021|NCT02703337|12515318|FG002|COMPLETED|Period Three (Part A)||5
11318022|NCT02703337|12515319|FG003|COMPLETED|Period Three (Part A)||5
11318023|NCT02703337|12515320|FG004|COMPLETED|Period Three (Part A)||4
11318024|NCT02703337|12515321|FG005|COMPLETED|Period Three (Part A)||5
11318025|NCT02703337|12515322|FG006|COMPLETED|Period Three (Part A)||0
11318026|NCT02703337|12515323|FG007|COMPLETED|Period Three (Part A)||0
11318027|NCT02703337|12515316|FG000|NOT COMPLETED|Period Three (Part A)||0
11318028|NCT02703337|12515317|FG001|NOT COMPLETED|Period Three (Part A)||0
11318029|NCT02703337|12515318|FG002|NOT COMPLETED|Period Three (Part A)||0
11318030|NCT02703337|12515319|FG003|NOT COMPLETED|Period Three (Part A)||0
11318031|NCT02703337|12515320|FG004|NOT COMPLETED|Period Three (Part A)||0
11318032|NCT02703337|12515321|FG005|NOT COMPLETED|Period Three (Part A)||0
11318033|NCT02703337|12515322|FG006|NOT COMPLETED|Period Three (Part A)||0
11318034|NCT02703337|12515323|FG007|NOT COMPLETED|Period Three (Part A)||0
11318035|NCT02703337|12515316|FG000|STARTED|Period Four (Part A)||5
11318036|NCT02703337|12515317|FG001|STARTED|Period Four (Part A)||5
11318037|NCT02703337|12515318|FG002|STARTED|Period Four (Part A)||5
11318038|NCT02703337|12515319|FG003|STARTED|Period Four (Part A)||5
11318039|NCT02703337|12515320|FG004|STARTED|Period Four (Part A)||4
11318040|NCT02703337|12515321|FG005|STARTED|Period Four (Part A)||5
11318041|NCT02703337|12515322|FG006|STARTED|Period Four (Part A)||0
11318042|NCT02703337|12515323|FG007|STARTED|Period Four (Part A)||0
11318043|NCT02703337|12515316|FG000|Received Study Drug|Period Four (Part A)||5
11318044|NCT02703337|12515317|FG001|Received Study Drug|Period Four (Part A)||5
11318045|NCT02703337|12515318|FG002|Received Study Drug|Period Four (Part A)||5
11318046|NCT02703337|12515319|FG003|Received Study Drug|Period Four (Part A)||5
11318047|NCT02703337|12515320|FG004|Received Study Drug|Period Four (Part A)||4
11318048|NCT02703337|12515321|FG005|Received Study Drug|Period Four (Part A)||5
11318049|NCT02703337|12515322|FG006|Received Study Drug|Period Four (Part A)||0
11318050|NCT02703337|12515323|FG007|Received Study Drug|Period Four (Part A)||0
11318051|NCT02703337|12515316|FG000|COMPLETED|Period Four (Part A)||5
11318052|NCT02703337|12515317|FG001|COMPLETED|Period Four (Part A)||5
11318053|NCT02703337|12515318|FG002|COMPLETED|Period Four (Part A)||5
11318054|NCT02703337|12515319|FG003|COMPLETED|Period Four (Part A)||5
11318055|NCT02703337|12515320|FG004|COMPLETED|Period Four (Part A)||4
11318056|NCT02703337|12515321|FG005|COMPLETED|Period Four (Part A)||5
11318057|NCT02703337|12515322|FG006|COMPLETED|Period Four (Part A)||0
11318058|NCT02703337|12515323|FG007|COMPLETED|Period Four (Part A)||0
11318059|NCT02703337|12515316|FG000|NOT COMPLETED|Period Four (Part A)||0
11318060|NCT02703337|12515317|FG001|NOT COMPLETED|Period Four (Part A)||0
11318061|NCT02703337|12515318|FG002|NOT COMPLETED|Period Four (Part A)||0
11318062|NCT02703337|12515319|FG003|NOT COMPLETED|Period Four (Part A)||0
11318063|NCT02703337|12515320|FG004|NOT COMPLETED|Period Four (Part A)||0
11318064|NCT02703337|12515321|FG005|NOT COMPLETED|Period Four (Part A)||0
11318065|NCT02703337|12515322|FG006|NOT COMPLETED|Period Four (Part A)||0
11318066|NCT02703337|12515323|FG007|NOT COMPLETED|Period Four (Part A)||0
11318067|NCT02703337|12515316|FG000|STARTED|Period Five (Part A)||5
11318068|NCT02703337|12515317|FG001|STARTED|Period Five (Part A)||5
11318069|NCT02703337|12515318|FG002|STARTED|Period Five (Part A)||5
11318070|NCT02703337|12515319|FG003|STARTED|Period Five (Part A)||5
11318071|NCT02703337|12515320|FG004|STARTED|Period Five (Part A)||4
11318072|NCT02703337|12515321|FG005|STARTED|Period Five (Part A)||5
11318073|NCT02703337|12515322|FG006|STARTED|Period Five (Part A)||0
11318074|NCT02703337|12515323|FG007|STARTED|Period Five (Part A)||0
11318075|NCT02703337|12515316|FG000|Received Study Drug|Period Five (Part A)||5
11318076|NCT02703337|12515317|FG001|Received Study Drug|Period Five (Part A)||5
11318077|NCT02703337|12515318|FG002|Received Study Drug|Period Five (Part A)||5
11318078|NCT02703337|12515319|FG003|Received Study Drug|Period Five (Part A)||5
11318079|NCT02703337|12515320|FG004|Received Study Drug|Period Five (Part A)||4
11318080|NCT02703337|12515321|FG005|Received Study Drug|Period Five (Part A)||5
11318081|NCT02703337|12515322|FG006|Received Study Drug|Period Five (Part A)||0
11318082|NCT02703337|12515323|FG007|Received Study Drug|Period Five (Part A)||0
11318083|NCT02703337|12515316|FG000|COMPLETED|Period Five (Part A)||5
11318084|NCT02703337|12515317|FG001|COMPLETED|Period Five (Part A)||5
11318085|NCT02703337|12515318|FG002|COMPLETED|Period Five (Part A)||5
11318086|NCT02703337|12515319|FG003|COMPLETED|Period Five (Part A)||5
11318087|NCT02703337|12515320|FG004|COMPLETED|Period Five (Part A)||4
11318088|NCT02703337|12515321|FG005|COMPLETED|Period Five (Part A)||5
11318089|NCT02703337|12515322|FG006|COMPLETED|Period Five (Part A)||0
11318090|NCT02703337|12515323|FG007|COMPLETED|Period Five (Part A)||0
11318091|NCT02703337|12515316|FG000|NOT COMPLETED|Period Five (Part A)||0
11318092|NCT02703337|12515317|FG001|NOT COMPLETED|Period Five (Part A)||0
11318093|NCT02703337|12515318|FG002|NOT COMPLETED|Period Five (Part A)||0
11318094|NCT02703337|12515319|FG003|NOT COMPLETED|Period Five (Part A)||0
11318095|NCT02703337|12515320|FG004|NOT COMPLETED|Period Five (Part A)||0
11318096|NCT02703337|12515321|FG005|NOT COMPLETED|Period Five (Part A)||0
11318097|NCT02703337|12515322|FG006|NOT COMPLETED|Period Five (Part A)||0
11318098|NCT02703337|12515323|FG007|NOT COMPLETED|Period Five (Part A)||0
11318099|NCT02703337|12515316|FG000|STARTED|Period Six (Part A)||5
11318100|NCT02703337|12515317|FG001|STARTED|Period Six (Part A)||5
11318101|NCT02703337|12515318|FG002|STARTED|Period Six (Part A)||5
11318102|NCT02703337|12515319|FG003|STARTED|Period Six (Part A)||5
11318103|NCT02703337|12515320|FG004|STARTED|Period Six (Part A)||4
11318104|NCT02703337|12515321|FG005|STARTED|Period Six (Part A)||5
11318105|NCT02703337|12515322|FG006|STARTED|Period Six (Part A)||0
11318106|NCT02703337|12515323|FG007|STARTED|Period Six (Part A)||0
11318107|NCT02703337|12515316|FG000|Received Study Drug|Period Six (Part A)||5
11318108|NCT02703337|12515317|FG001|Received Study Drug|Period Six (Part A)||5
11318109|NCT02703337|12515318|FG002|Received Study Drug|Period Six (Part A)||5
11318110|NCT02703337|12515319|FG003|Received Study Drug|Period Six (Part A)||5
11318111|NCT02703337|12515320|FG004|Received Study Drug|Period Six (Part A)||4
11318112|NCT02703337|12515321|FG005|Received Study Drug|Period Six (Part A)||5
11318113|NCT02703337|12515322|FG006|Received Study Drug|Period Six (Part A)||0
11318114|NCT02703337|12515323|FG007|Received Study Drug|Period Six (Part A)||0
11318115|NCT02703337|12515316|FG000|COMPLETED|Period Six (Part A)||5
11318116|NCT02703337|12515317|FG001|COMPLETED|Period Six (Part A)||5
11318117|NCT02703337|12515318|FG002|COMPLETED|Period Six (Part A)||5
11318118|NCT02703337|12515319|FG003|COMPLETED|Period Six (Part A)||5
11318119|NCT02703337|12515320|FG004|COMPLETED|Period Six (Part A)||4
11318120|NCT02703337|12515321|FG005|COMPLETED|Period Six (Part A)||5
11318121|NCT02703337|12515322|FG006|COMPLETED|Period Six (Part A)||0
11318122|NCT02703337|12515323|FG007|COMPLETED|Period Six (Part A)||0
11318123|NCT02703337|12515316|FG000|NOT COMPLETED|Period Six (Part A)||0
11318124|NCT02703337|12515317|FG001|NOT COMPLETED|Period Six (Part A)||0
11318125|NCT02703337|12515318|FG002|NOT COMPLETED|Period Six (Part A)||0
11318126|NCT02703337|12515319|FG003|NOT COMPLETED|Period Six (Part A)||0
11318127|NCT02703337|12515320|FG004|NOT COMPLETED|Period Six (Part A)||0
11318128|NCT02703337|12515321|FG005|NOT COMPLETED|Period Six (Part A)||0
11318129|NCT02703337|12515322|FG006|NOT COMPLETED|Period Six (Part A)||0
11318130|NCT02703337|12515323|FG007|NOT COMPLETED|Period Six (Part A)||0
11318131|NCT02703337|12515316|FG000|STARTED|Part B||0
11318132|NCT02703337|12515317|FG001|STARTED|Part B||0
11318133|NCT02703337|12515318|FG002|STARTED|Part B||0
11318134|NCT02703337|12515319|FG003|STARTED|Part B||0
11318135|NCT02703337|12515320|FG004|STARTED|Part B||0
11318136|NCT02703337|12515321|FG005|STARTED|Part B||0
11318137|NCT02703337|12515322|FG006|STARTED|Part B||15
11318138|NCT02703337|12515323|FG007|STARTED|Part B||14
11318139|NCT02703337|12515316|FG000|Received Study Drug|Part B||0
11318140|NCT02703337|12515317|FG001|Received Study Drug|Part B||0
11318141|NCT02703337|12515318|FG002|Received Study Drug|Part B||0
11402513|NCT04039919|12597343|FG002|COMPLETED|Treatment Period 6||5
11402514|NCT04039919|12597344|FG003|COMPLETED|Treatment Period 6||6
11402515|NCT04039919|12597345|FG004|COMPLETED|Treatment Period 6||0
11402516|NCT04039919|12597341|FG000|NOT COMPLETED|Treatment Period 6||0
11402517|NCT04039919|12597342|FG001|NOT COMPLETED|Treatment Period 6||0
11402518|NCT04039919|12597343|FG002|NOT COMPLETED|Treatment Period 6||0
11402519|NCT04039919|12597344|FG003|NOT COMPLETED|Treatment Period 6||0
11402520|NCT04039919|12597345|FG004|NOT COMPLETED|Treatment Period 6||0
11318142|NCT02703337|12515319|FG003|Received Study Drug|Part B||0
11318143|NCT02703337|12515320|FG004|Received Study Drug|Part B||0
11318144|NCT02703337|12515321|FG005|Received Study Drug|Part B||0
11318145|NCT02703337|12515322|FG006|Received Study Drug|Part B||15
11318146|NCT02703337|12515323|FG007|Received Study Drug|Part B||14
11318147|NCT02703337|12515316|FG000|COMPLETED|Part B||0
11318148|NCT02703337|12515317|FG001|COMPLETED|Part B||0
11318149|NCT02703337|12515318|FG002|COMPLETED|Part B||0
11318150|NCT02703337|12515319|FG003|COMPLETED|Part B||0
11318151|NCT02703337|12515320|FG004|COMPLETED|Part B||0
11318152|NCT02703337|12515321|FG005|COMPLETED|Part B||0
11318153|NCT02703337|12515322|FG006|COMPLETED|Part B||15
11318154|NCT02703337|12515323|FG007|COMPLETED|Part B||14
11318155|NCT02703337|12515316|FG000|NOT COMPLETED|Part B||0
11318156|NCT02703337|12515317|FG001|NOT COMPLETED|Part B||0
11318157|NCT02703337|12515318|FG002|NOT COMPLETED|Part B||0
11318158|NCT02703337|12515319|FG003|NOT COMPLETED|Part B||0
11318159|NCT02703337|12515320|FG004|NOT COMPLETED|Part B||0
11318160|NCT02703337|12515321|FG005|NOT COMPLETED|Part B||0
11318161|NCT02703337|12515322|FG006|NOT COMPLETED|Part B||0
11318162|NCT02703337|12515323|FG007|NOT COMPLETED|Part B||0
11318163|NCT02703350|12515341|FG000|STARTED|Period One (Part A)||5
11318164|NCT02703350|12515342|FG001|STARTED|Period One (Part A)||5
11318165|NCT02703350|12515343|FG002|STARTED|Period One (Part A)||5
11318166|NCT02703350|12515344|FG003|STARTED|Period One (Part A)||5
11318167|NCT02703350|12515345|FG004|STARTED|Period One (Part A)||5
11318168|NCT02703350|12515346|FG005|STARTED|Period One (Part A)||5
11318169|NCT02703350|12515347|FG006|STARTED|Period One (Part A)||0
11318170|NCT02703350|12515348|FG007|STARTED|Period One (Part A)||0
11318171|NCT02703350|12515341|FG000|Received Study Drug|Period One (Part A)||5
11318172|NCT02703350|12515342|FG001|Received Study Drug|Period One (Part A)||5
11318173|NCT02703350|12515343|FG002|Received Study Drug|Period One (Part A)||5
11318174|NCT02703350|12515344|FG003|Received Study Drug|Period One (Part A)||5
11318175|NCT02703350|12515345|FG004|Received Study Drug|Period One (Part A)||5
11318176|NCT02703350|12515346|FG005|Received Study Drug|Period One (Part A)||5
11318177|NCT02703350|12515347|FG006|Received Study Drug|Period One (Part A)||0
11318178|NCT02703350|12515348|FG007|Received Study Drug|Period One (Part A)||0
11318179|NCT02703350|12515341|FG000|COMPLETED|Period One (Part A)||5
11318180|NCT02703350|12515342|FG001|COMPLETED|Period One (Part A)||5
11318181|NCT02703350|12515343|FG002|COMPLETED|Period One (Part A)||5
11318182|NCT02703350|12515344|FG003|COMPLETED|Period One (Part A)||5
11318183|NCT02703350|12515345|FG004|COMPLETED|Period One (Part A)||5
11318184|NCT02703350|12515346|FG005|COMPLETED|Period One (Part A)||5
11318185|NCT02703350|12515347|FG006|COMPLETED|Period One (Part A)||0
11318186|NCT02703350|12515348|FG007|COMPLETED|Period One (Part A)||0
11318187|NCT02703350|12515341|FG000|NOT COMPLETED|Period One (Part A)||0
11318188|NCT02703350|12515342|FG001|NOT COMPLETED|Period One (Part A)||0
11318189|NCT02703350|12515343|FG002|NOT COMPLETED|Period One (Part A)||0
11318190|NCT02703350|12515344|FG003|NOT COMPLETED|Period One (Part A)||0
11318191|NCT02703350|12515345|FG004|NOT COMPLETED|Period One (Part A)||0
11318192|NCT02703350|12515346|FG005|NOT COMPLETED|Period One (Part A)||0
11318193|NCT02703350|12515347|FG006|NOT COMPLETED|Period One (Part A)||0
11318194|NCT02703350|12515348|FG007|NOT COMPLETED|Period One (Part A)||0
11318195|NCT02703350|12515341|FG000|STARTED|Period Two (Part A)||5
11318196|NCT02703350|12515342|FG001|STARTED|Period Two (Part A)||5
11318197|NCT02703350|12515343|FG002|STARTED|Period Two (Part A)||5
11318198|NCT02703350|12515344|FG003|STARTED|Period Two (Part A)||5
11318199|NCT02703350|12515345|FG004|STARTED|Period Two (Part A)||5
11318200|NCT02703350|12515346|FG005|STARTED|Period Two (Part A)||5
11402521|NCT04037969|12597381|FG000|STARTED|Overall Study||10
11402522|NCT04037969|12597382|FG001|STARTED|Overall Study||10
11318201|NCT02703350|12515347|FG006|STARTED|Period Two (Part A)||0
11402523|NCT04037969|12597381|FG000|COMPLETED|Overall Study||10
11318202|NCT02703350|12515348|FG007|STARTED|Period Two (Part A)||0
11318203|NCT02703350|12515341|FG000|Received Study Drug|Period Two (Part A)||5
11318204|NCT02703350|12515342|FG001|Received Study Drug|Period Two (Part A)||5
11318205|NCT02703350|12515343|FG002|Received Study Drug|Period Two (Part A)||5
11402524|NCT04037969|12597382|FG001|COMPLETED|Overall Study||10
11402525|NCT04037969|12597381|FG000|NOT COMPLETED|Overall Study||0
11318206|NCT02703350|12515344|FG003|Received Study Drug|Period Two (Part A)||5
11318207|NCT02703350|12515345|FG004|Received Study Drug|Period Two (Part A)||5
11318208|NCT02703350|12515346|FG005|Received Study Drug|Period Two (Part A)||5
11318209|NCT02703350|12515347|FG006|Received Study Drug|Period Two (Part A)||0
11318210|NCT02703350|12515348|FG007|Received Study Drug|Period Two (Part A)||0
11318211|NCT02703350|12515341|FG000|COMPLETED|Period Two (Part A)||5
11318212|NCT02703350|12515342|FG001|COMPLETED|Period Two (Part A)||5
11318213|NCT02703350|12515343|FG002|COMPLETED|Period Two (Part A)||5
11318214|NCT02703350|12515344|FG003|COMPLETED|Period Two (Part A)||5
11318215|NCT02703350|12515345|FG004|COMPLETED|Period Two (Part A)||5
11318216|NCT02703350|12515346|FG005|COMPLETED|Period Two (Part A)||5
11318217|NCT02703350|12515347|FG006|COMPLETED|Period Two (Part A)||0
11318218|NCT02703350|12515348|FG007|COMPLETED|Period Two (Part A)||0
11318219|NCT02703350|12515341|FG000|NOT COMPLETED|Period Two (Part A)||0
11318220|NCT02703350|12515342|FG001|NOT COMPLETED|Period Two (Part A)||0
11318221|NCT02703350|12515343|FG002|NOT COMPLETED|Period Two (Part A)||0
11318222|NCT02703350|12515344|FG003|NOT COMPLETED|Period Two (Part A)||0
11318223|NCT02703350|12515345|FG004|NOT COMPLETED|Period Two (Part A)||0
11318224|NCT02703350|12515346|FG005|NOT COMPLETED|Period Two (Part A)||0
11318225|NCT02703350|12515347|FG006|NOT COMPLETED|Period Two (Part A)||0
11318226|NCT02703350|12515348|FG007|NOT COMPLETED|Period Two (Part A)||0
11318227|NCT02703350|12515341|FG000|STARTED|Period Three (Part A)||5
11318228|NCT02703350|12515342|FG001|STARTED|Period Three (Part A)||5
11318229|NCT02703350|12515343|FG002|STARTED|Period Three (Part A)||5
11318230|NCT02703350|12515344|FG003|STARTED|Period Three (Part A)||5
11318231|NCT02703350|12515345|FG004|STARTED|Period Three (Part A)||5
11318232|NCT02703350|12515346|FG005|STARTED|Period Three (Part A)||5
11318233|NCT02703350|12515347|FG006|STARTED|Period Three (Part A)||0
11318234|NCT02703350|12515348|FG007|STARTED|Period Three (Part A)||0
11318235|NCT02703350|12515341|FG000|Received Study Drug|Period Three (Part A)||5
11318236|NCT02703350|12515342|FG001|Received Study Drug|Period Three (Part A)||5
11318237|NCT02703350|12515343|FG002|Received Study Drug|Period Three (Part A)||5
11318238|NCT02703350|12515344|FG003|Received Study Drug|Period Three (Part A)||5
11318239|NCT02703350|12515345|FG004|Received Study Drug|Period Three (Part A)||5
11318240|NCT02703350|12515346|FG005|Received Study Drug|Period Three (Part A)||5
11318241|NCT02703350|12515347|FG006|Received Study Drug|Period Three (Part A)||0
11318242|NCT02703350|12515348|FG007|Received Study Drug|Period Three (Part A)||0
11318243|NCT02703350|12515341|FG000|COMPLETED|Period Three (Part A)||5
11318244|NCT02703350|12515342|FG001|COMPLETED|Period Three (Part A)||5
11318245|NCT02703350|12515343|FG002|COMPLETED|Period Three (Part A)||5
11318246|NCT02703350|12515344|FG003|COMPLETED|Period Three (Part A)||5
11318247|NCT02703350|12515345|FG004|COMPLETED|Period Three (Part A)||5
11318248|NCT02703350|12515346|FG005|COMPLETED|Period Three (Part A)||5
11318249|NCT02703350|12515347|FG006|COMPLETED|Period Three (Part A)||0
11318250|NCT02703350|12515348|FG007|COMPLETED|Period Three (Part A)||0
11318251|NCT02703350|12515341|FG000|NOT COMPLETED|Period Three (Part A)||0
11318252|NCT02703350|12515342|FG001|NOT COMPLETED|Period Three (Part A)||0
11318253|NCT02703350|12515343|FG002|NOT COMPLETED|Period Three (Part A)||0
11318254|NCT02703350|12515344|FG003|NOT COMPLETED|Period Three (Part A)||0
11318255|NCT02703350|12515345|FG004|NOT COMPLETED|Period Three (Part A)||0
11318256|NCT02703350|12515346|FG005|NOT COMPLETED|Period Three (Part A)||0
11318257|NCT02703350|12515347|FG006|NOT COMPLETED|Period Three (Part A)||0
11318258|NCT02703350|12515348|FG007|NOT COMPLETED|Period Three (Part A)||0
11318259|NCT02703350|12515341|FG000|STARTED|Period Four (Part A)||5
11318260|NCT02703350|12515342|FG001|STARTED|Period Four (Part A)||5
11318261|NCT02703350|12515343|FG002|STARTED|Period Four (Part A)||5
11402526|NCT04037969|12597382|FG001|NOT COMPLETED|Overall Study||0
11318262|NCT02703350|12515344|FG003|STARTED|Period Four (Part A)||5
11318263|NCT02703350|12515345|FG004|STARTED|Period Four (Part A)||5
11318264|NCT02703350|12515346|FG005|STARTED|Period Four (Part A)||5
11318265|NCT02703350|12515347|FG006|STARTED|Period Four (Part A)||0
11318266|NCT02703350|12515348|FG007|STARTED|Period Four (Part A)||0
11318267|NCT02703350|12515341|FG000|Received Study Drug|Period Four (Part A)||5
11318268|NCT02703350|12515342|FG001|Received Study Drug|Period Four (Part A)||5
11318269|NCT02703350|12515343|FG002|Received Study Drug|Period Four (Part A)||5
11318270|NCT02703350|12515344|FG003|Received Study Drug|Period Four (Part A)||5
11318271|NCT02703350|12515345|FG004|Received Study Drug|Period Four (Part A)||5
11318272|NCT02703350|12515346|FG005|Received Study Drug|Period Four (Part A)||5
11318273|NCT02703350|12515347|FG006|Received Study Drug|Period Four (Part A)||0
11318274|NCT02703350|12515348|FG007|Received Study Drug|Period Four (Part A)||0
11318275|NCT02703350|12515341|FG000|COMPLETED|Period Four (Part A)||5
11318276|NCT02703350|12515342|FG001|COMPLETED|Period Four (Part A)||5
11318277|NCT02703350|12515343|FG002|COMPLETED|Period Four (Part A)||5
11318278|NCT02703350|12515344|FG003|COMPLETED|Period Four (Part A)||5
11318279|NCT02703350|12515345|FG004|COMPLETED|Period Four (Part A)||5
11318280|NCT02703350|12515346|FG005|COMPLETED|Period Four (Part A)||5
11318281|NCT02703350|12515347|FG006|COMPLETED|Period Four (Part A)||0
11318282|NCT02703350|12515348|FG007|COMPLETED|Period Four (Part A)||0
11318283|NCT02703350|12515341|FG000|NOT COMPLETED|Period Four (Part A)||0
11318284|NCT02703350|12515342|FG001|NOT COMPLETED|Period Four (Part A)||0
11318285|NCT02703350|12515343|FG002|NOT COMPLETED|Period Four (Part A)||0
11318286|NCT02703350|12515344|FG003|NOT COMPLETED|Period Four (Part A)||0
11318287|NCT02703350|12515345|FG004|NOT COMPLETED|Period Four (Part A)||0
11318288|NCT02703350|12515346|FG005|NOT COMPLETED|Period Four (Part A)||0
11318289|NCT02703350|12515347|FG006|NOT COMPLETED|Period Four (Part A)||0
11318290|NCT02703350|12515348|FG007|NOT COMPLETED|Period Four (Part A)||0
11318291|NCT02703350|12515341|FG000|STARTED|Period Five (Part A)||5
11318292|NCT02703350|12515342|FG001|STARTED|Period Five (Part A)||5
11318293|NCT02703350|12515343|FG002|STARTED|Period Five (Part A)||5
11318294|NCT02703350|12515344|FG003|STARTED|Period Five (Part A)||5
11318295|NCT02703350|12515345|FG004|STARTED|Period Five (Part A)||5
11318296|NCT02703350|12515346|FG005|STARTED|Period Five (Part A)||5
11318297|NCT02703350|12515347|FG006|STARTED|Period Five (Part A)||0
11318298|NCT02703350|12515348|FG007|STARTED|Period Five (Part A)||0
11318299|NCT02703350|12515341|FG000|Received Study Drug|Period Five (Part A)||5
11318300|NCT02703350|12515342|FG001|Received Study Drug|Period Five (Part A)||5
11318301|NCT02703350|12515343|FG002|Received Study Drug|Period Five (Part A)||5
11318302|NCT02703350|12515344|FG003|Received Study Drug|Period Five (Part A)||5
11318303|NCT02703350|12515345|FG004|Received Study Drug|Period Five (Part A)||5
11318304|NCT02703350|12515346|FG005|Received Study Drug|Period Five (Part A)||5
11318305|NCT02703350|12515347|FG006|Received Study Drug|Period Five (Part A)||0
11318306|NCT02703350|12515348|FG007|Received Study Drug|Period Five (Part A)||0
11318307|NCT02703350|12515341|FG000|COMPLETED|Period Five (Part A)||5
11318308|NCT02703350|12515342|FG001|COMPLETED|Period Five (Part A)||5
11318309|NCT02703350|12515343|FG002|COMPLETED|Period Five (Part A)||5
11318310|NCT02703350|12515344|FG003|COMPLETED|Period Five (Part A)||5
11318311|NCT02703350|12515345|FG004|COMPLETED|Period Five (Part A)||5
11318312|NCT02703350|12515346|FG005|COMPLETED|Period Five (Part A)||5
11318313|NCT02703350|12515347|FG006|COMPLETED|Period Five (Part A)||0
11318314|NCT02703350|12515348|FG007|COMPLETED|Period Five (Part A)||0
11318315|NCT02703350|12515341|FG000|NOT COMPLETED|Period Five (Part A)||0
11318316|NCT02703350|12515342|FG001|NOT COMPLETED|Period Five (Part A)||0
11318317|NCT02703350|12515343|FG002|NOT COMPLETED|Period Five (Part A)||0
11318318|NCT02703350|12515344|FG003|NOT COMPLETED|Period Five (Part A)||0
11318319|NCT02703350|12515345|FG004|NOT COMPLETED|Period Five (Part A)||0
11318320|NCT02703350|12515346|FG005|NOT COMPLETED|Period Five (Part A)||0
11318321|NCT02703350|12515347|FG006|NOT COMPLETED|Period Five (Part A)||0
11318322|NCT02703350|12515348|FG007|NOT COMPLETED|Period Five (Part A)||0
11318323|NCT02703350|12515341|FG000|STARTED|Period Six (Part A)||5
11318324|NCT02703350|12515342|FG001|STARTED|Period Six (Part A)||5
11318325|NCT02703350|12515343|FG002|STARTED|Period Six (Part A)||5
11318326|NCT02703350|12515344|FG003|STARTED|Period Six (Part A)||5
11318327|NCT02703350|12515345|FG004|STARTED|Period Six (Part A)||5
11318328|NCT02703350|12515346|FG005|STARTED|Period Six (Part A)||5
11318329|NCT02703350|12515347|FG006|STARTED|Period Six (Part A)||0
11318330|NCT02703350|12515348|FG007|STARTED|Period Six (Part A)||0
11318331|NCT02703350|12515341|FG000|Received Study Drug|Period Six (Part A)||5
11318332|NCT02703350|12515342|FG001|Received Study Drug|Period Six (Part A)||5
11318333|NCT02703350|12515343|FG002|Received Study Drug|Period Six (Part A)||5
11318334|NCT02703350|12515344|FG003|Received Study Drug|Period Six (Part A)||5
11318335|NCT02703350|12515345|FG004|Received Study Drug|Period Six (Part A)||5
11318336|NCT02703350|12515346|FG005|Received Study Drug|Period Six (Part A)||5
11318337|NCT02703350|12515347|FG006|Received Study Drug|Period Six (Part A)||0
11318338|NCT02703350|12515348|FG007|Received Study Drug|Period Six (Part A)||0
11318339|NCT02703350|12515341|FG000|COMPLETED|Period Six (Part A)||5
11318340|NCT02703350|12515342|FG001|COMPLETED|Period Six (Part A)||5
11318341|NCT02703350|12515343|FG002|COMPLETED|Period Six (Part A)||5
11318342|NCT02703350|12515344|FG003|COMPLETED|Period Six (Part A)||5
11318343|NCT02703350|12515345|FG004|COMPLETED|Period Six (Part A)||5
11318344|NCT02703350|12515346|FG005|COMPLETED|Period Six (Part A)||5
11318345|NCT02703350|12515347|FG006|COMPLETED|Period Six (Part A)||0
11318346|NCT02703350|12515348|FG007|COMPLETED|Period Six (Part A)||0
11318347|NCT02703350|12515341|FG000|NOT COMPLETED|Period Six (Part A)||0
11318348|NCT02703350|12515342|FG001|NOT COMPLETED|Period Six (Part A)||0
11318349|NCT02703350|12515343|FG002|NOT COMPLETED|Period Six (Part A)||0
11318350|NCT02703350|12515344|FG003|NOT COMPLETED|Period Six (Part A)||0
11318351|NCT02703350|12515345|FG004|NOT COMPLETED|Period Six (Part A)||0
11318352|NCT02703350|12515346|FG005|NOT COMPLETED|Period Six (Part A)||0
11318353|NCT02703350|12515347|FG006|NOT COMPLETED|Period Six (Part A)||0
11318354|NCT02703350|12515348|FG007|NOT COMPLETED|Period Six (Part A)||0
11318355|NCT02703350|12515341|FG000|STARTED|Part B||0
11318356|NCT02703350|12515342|FG001|STARTED|Part B||0
11318357|NCT02703350|12515343|FG002|STARTED|Part B||0
11318358|NCT02703350|12515344|FG003|STARTED|Part B||0
11318359|NCT02703350|12515345|FG004|STARTED|Part B||0
11318360|NCT02703350|12515346|FG005|STARTED|Part B||0
11318361|NCT02703350|12515347|FG006|STARTED|Part B||15
11318362|NCT02703350|12515348|FG007|STARTED|Part B||15
11318363|NCT02703350|12515341|FG000|Received Study Drug|Part B||0
11318364|NCT02703350|12515342|FG001|Received Study Drug|Part B||0
11318365|NCT02703350|12515343|FG002|Received Study Drug|Part B||0
11402527|NCT04037865|12597387|FG000|STARTED|Overall Study||8
11402528|NCT04037865|12597387|FG000|COMPLETED|Overall Study||8
11402529|NCT04037865|12597387|FG000|NOT COMPLETED|Overall Study||0
11318366|NCT02703350|12515344|FG003|Received Study Drug|Part B||0
11318367|NCT02703350|12515345|FG004|Received Study Drug|Part B||0
11318368|NCT02703350|12515346|FG005|Received Study Drug|Part B||0
11318369|NCT02703350|12515347|FG006|Received Study Drug|Part B||15
11402530|NCT04037748|12597394|FG000|STARTED|Treatment Period 1||36
11318370|NCT02703350|12515348|FG007|Received Study Drug|Part B||15
11318371|NCT02703350|12515341|FG000|COMPLETED|Part B||0
11318372|NCT02703350|12515342|FG001|COMPLETED|Part B||0
11318373|NCT02703350|12515343|FG002|COMPLETED|Part B||0
11318374|NCT02703350|12515344|FG003|COMPLETED|Part B||0
11318375|NCT02703350|12515345|FG004|COMPLETED|Part B||0
11318376|NCT02703350|12515346|FG005|COMPLETED|Part B||0
11318377|NCT02703350|12515347|FG006|COMPLETED|Part B||15
11318378|NCT02703350|12515348|FG007|COMPLETED|Part B||15
11318379|NCT02703350|12515341|FG000|NOT COMPLETED|Part B||0
11318380|NCT02703350|12515342|FG001|NOT COMPLETED|Part B||0
11318381|NCT02703350|12515343|FG002|NOT COMPLETED|Part B||0
11318382|NCT02703350|12515344|FG003|NOT COMPLETED|Part B||0
11318383|NCT02703350|12515345|FG004|NOT COMPLETED|Part B||0
11318384|NCT02703350|12515346|FG005|NOT COMPLETED|Part B||0
11318385|NCT02703350|12515347|FG006|NOT COMPLETED|Part B||0
11318386|NCT02703350|12515348|FG007|NOT COMPLETED|Part B||0
11318387|NCT02703454|12515368|FG000|STARTED|Overall Study||24
11318388|NCT02703454|12515369|FG001|STARTED|Overall Study||27
11318389|NCT02703454|12515368|FG000|Treated|Overall Study||23
11318390|NCT02703454|12515369|FG001|Treated|Overall Study||24
11318391|NCT02703454|12515368|FG000|COMPLETED|Overall Study||13
11318392|NCT02703454|12515369|FG001|COMPLETED|Overall Study||11
11318393|NCT02703454|12515368|FG000|NOT COMPLETED|Overall Study||11
11318394|NCT02703454|12515369|FG001|NOT COMPLETED|Overall Study||16
11318395|NCT02703467|12515378|FG000|STARTED|Overall Study||20
11318396|NCT02703467|12515379|FG001|STARTED|Overall Study||5
11318397|NCT02703467|12515380|FG002|STARTED|Overall Study||45
11318398|NCT02703467|12515378|FG000|COMPLETED|Overall Study||20
11318399|NCT02703467|12515379|FG001|COMPLETED|Overall Study||5
11318400|NCT02703467|12515380|FG002|COMPLETED|Overall Study||45
11318401|NCT02703467|12515378|FG000|NOT COMPLETED|Overall Study||0
11318402|NCT02703467|12515379|FG001|NOT COMPLETED|Overall Study||0
11318403|NCT02703467|12515380|FG002|NOT COMPLETED|Overall Study||0
11318404|NCT02703532|12515396|FG000|STARTED|Overall Study||21
11318405|NCT02703532|12515397|FG001|STARTED|Overall Study||11
11318406|NCT02703532|12515398|FG002|STARTED|Overall Study||21
11318407|NCT02703532|12515399|FG003|STARTED|Overall Study||11
11402531|NCT04037748|12597395|FG001|STARTED|Treatment Period 1||36
11402532|NCT04037748|12597394|FG000|COMPLETED|Treatment Period 1||28
11402533|NCT04037748|12597395|FG001|COMPLETED|Treatment Period 1||30
11402534|NCT04037748|12597394|FG000|NOT COMPLETED|Treatment Period 1||8
11402535|NCT04037748|12597395|FG001|NOT COMPLETED|Treatment Period 1||6
11402536|NCT04037748|12597394|FG000|STARTED|Treatment Period 2||28
11402537|NCT04037748|12597395|FG001|STARTED|Treatment Period 2||30
11402538|NCT04037748|12597394|FG000|COMPLETED|Treatment Period 2||26
11402539|NCT04037748|12597395|FG001|COMPLETED|Treatment Period 2||29
11402540|NCT04037748|12597394|FG000|NOT COMPLETED|Treatment Period 2||2
11402541|NCT04037748|12597395|FG001|NOT COMPLETED|Treatment Period 2||1
11402542|NCT04036838|12597401|FG000|STARTED|Overall Study||415
11402543|NCT04036838|12597401|FG000|COMPLETED|Overall Study||324
11402544|NCT04036838|12597401|FG000|NOT COMPLETED|Overall Study||91
11402545|NCT04034121|12597405|FG000|STARTED|European Cohort|The European Cohort enrolled 30 patients|30
11402546|NCT04034121|12597405|FG000|COMPLETED|European Cohort||30
11402547|NCT04034121|12597405|FG000|NOT COMPLETED|European Cohort||0
11402548|NCT04034121|12597405|FG000|STARTED|Brazil Cohort|The Brazil Cohort enrolled 20 patients|20
11402549|NCT04034121|12597405|FG000|COMPLETED|Brazil Cohort||20
11402550|NCT04034121|12597405|FG000|NOT COMPLETED|Brazil Cohort||0
11402551|NCT04027686|12597412|FG000|STARTED|Overall Study||17
11318408|NCT02703532|12515396|FG000|COMPLETED|Overall Study||19
11318409|NCT02703532|12515397|FG001|COMPLETED|Overall Study||10
11318410|NCT02703532|12515398|FG002|COMPLETED|Overall Study||19
11318411|NCT02703532|12515399|FG003|COMPLETED|Overall Study||10
11318412|NCT02703532|12515396|FG000|NOT COMPLETED|Overall Study||2
11318413|NCT02703532|12515397|FG001|NOT COMPLETED|Overall Study||1
11318414|NCT02703532|12515398|FG002|NOT COMPLETED|Overall Study||2
11402552|NCT04027686|12597413|FG001|STARTED|Overall Study||6
11402553|NCT04027686|12597412|FG000|COMPLETED|Overall Study||15
11402554|NCT04027686|12597413|FG001|COMPLETED|Overall Study||5
11402555|NCT04027686|12597412|FG000|NOT COMPLETED|Overall Study||2
11402556|NCT04027686|12597413|FG001|NOT COMPLETED|Overall Study||1
11402557|NCT04022694|12597425|FG000|STARTED|Overall Study||167
11402558|NCT04022694|12597426|FG001|STARTED|Overall Study||145
11402559|NCT04022694|12597427|FG002|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|143
11402560|NCT04022694|12597428|FG003|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|173
11402561|NCT04022694|12597425|FG000|COMPLETED|Overall Study||167
11402562|NCT04022694|12597426|FG001|COMPLETED|Overall Study||145
11402563|NCT04022694|12597427|FG002|COMPLETED|Overall Study||143
11402564|NCT04022694|12597428|FG003|COMPLETED|Overall Study||173
11402565|NCT04022694|12597425|FG000|NOT COMPLETED|Overall Study||0
11402566|NCT04022694|12597426|FG001|NOT COMPLETED|Overall Study||0
11402567|NCT04022694|12597427|FG002|NOT COMPLETED|Overall Study||0
11402568|NCT04022694|12597428|FG003|NOT COMPLETED|Overall Study||0
11402569|NCT04036110|12597443|FG000|STARTED|Overall Study||12
11402570|NCT04036110|12597444|FG001|STARTED|Overall Study||12
11402571|NCT04036110|12597445|FG002|STARTED|Overall Study||12
11402572|NCT04036110|12597443|FG000|COMPLETED|Overall Study||5
11402573|NCT04036110|12597444|FG001|COMPLETED|Overall Study||5
11402574|NCT04036110|12597445|FG002|COMPLETED|Overall Study||10
11402575|NCT04036110|12597443|FG000|NOT COMPLETED|Overall Study||7
11402576|NCT04036110|12597444|FG001|NOT COMPLETED|Overall Study||7
11402577|NCT04036110|12597445|FG002|NOT COMPLETED|Overall Study||2
11318415|NCT02703532|12515399|FG003|NOT COMPLETED|Overall Study||1
11318416|NCT02703636|12515409|FG000|STARTED|Overall Study||118
11318417|NCT02703636|12515409|FG000|COMPLETED|Overall Study||102
11318418|NCT02703636|12515409|FG000|NOT COMPLETED|Overall Study||16
11318419|NCT02703779|12515415|FG000|STARTED|Overall Study||51
11318420|NCT02703779|12515416|FG001|STARTED|Overall Study||50
11318421|NCT02703779|12515415|FG000|COMPLETED|Overall Study||51
11318422|NCT02703779|12515416|FG001|COMPLETED|Overall Study||50
11318423|NCT02703779|12515415|FG000|NOT COMPLETED|Overall Study||0
11318424|NCT02703779|12515416|FG001|NOT COMPLETED|Overall Study||0
11318425|NCT02703909|12515426|FG000|STARTED|Overall Study||36
11318426|NCT02703909|12515427|FG001|STARTED|Overall Study||37
11318427|NCT02703909|12515428|FG002|STARTED|Overall Study||36
11318428|NCT02703909|12515429|FG003|STARTED|Overall Study||35
11318429|NCT02703909|12515426|FG000|COMPLETED|Overall Study||36
11318430|NCT02703909|12515427|FG001|COMPLETED|Overall Study||37
11318431|NCT02703909|12515428|FG002|COMPLETED|Overall Study||36
11318432|NCT02703909|12515429|FG003|COMPLETED|Overall Study||35
11318433|NCT02703909|12515426|FG000|NOT COMPLETED|Overall Study||0
11318434|NCT02703909|12515427|FG001|NOT COMPLETED|Overall Study||0
11318435|NCT02703909|12515428|FG002|NOT COMPLETED|Overall Study||0
11318436|NCT02703909|12515429|FG003|NOT COMPLETED|Overall Study||0
11318437|NCT02703987|12515443|FG000|STARTED|Visit 3 Intervention (1 Day)||14
11318438|NCT02703987|12515444|FG001|STARTED|Visit 3 Intervention (1 Day)||14
11318439|NCT02703987|12515443|FG000|COMPLETED|Visit 3 Intervention (1 Day)||13
11318440|NCT02703987|12515444|FG001|COMPLETED|Visit 3 Intervention (1 Day)||11
11318441|NCT02703987|12515443|FG000|NOT COMPLETED|Visit 3 Intervention (1 Day)||1
11318442|NCT02703987|12515444|FG001|NOT COMPLETED|Visit 3 Intervention (1 Day)||3
11318443|NCT02703987|12515443|FG000|STARTED|Washout (Minimum 5 Days)||13
11318444|NCT02703987|12515444|FG001|STARTED|Washout (Minimum 5 Days)||11
11318445|NCT02703987|12515443|FG000|COMPLETED|Washout (Minimum 5 Days)||13
11318446|NCT02703987|12515444|FG001|COMPLETED|Washout (Minimum 5 Days)||11
11318447|NCT02703987|12515443|FG000|NOT COMPLETED|Washout (Minimum 5 Days)||0
11318448|NCT02703987|12515444|FG001|NOT COMPLETED|Washout (Minimum 5 Days)||0
11318449|NCT02703987|12515443|FG000|STARTED|Visit 4 Intervention (1 Day)||13
11318450|NCT02703987|12515444|FG001|STARTED|Visit 4 Intervention (1 Day)||11
11318451|NCT02703987|12515443|FG000|COMPLETED|Visit 4 Intervention (1 Day)||12
11318452|NCT02703987|12515444|FG001|COMPLETED|Visit 4 Intervention (1 Day)||10
11318453|NCT02703987|12515443|FG000|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
11318454|NCT02703987|12515444|FG001|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
11318455|NCT02704091|12515452|FG000|STARTED|Overall Study||430
11318456|NCT02704091|12515453|FG001|STARTED|Overall Study||423
11318457|NCT02704091|12515452|FG000|COMPLETED|Overall Study||402
11318458|NCT02704091|12515453|FG001|COMPLETED|Overall Study||400
11318459|NCT02704091|12515452|FG000|NOT COMPLETED|Overall Study||28
11318460|NCT02704091|12515453|FG001|NOT COMPLETED|Overall Study||23
11318461|NCT02704104|12515459|FG000|STARTED|Overall Study||46
11318462|NCT02704104|12515459|FG000|COMPLETED|Overall Study||46
11318463|NCT02704104|12515459|FG000|NOT COMPLETED|Overall Study||0
11318464|NCT02704143|12515467|FG000|STARTED|Overall Study||63
11318465|NCT02704143|12515467|FG000|COMPLETED|Overall Study||53
11318466|NCT02704143|12515467|FG000|NOT COMPLETED|Overall Study||10
11318467|NCT02704689|12515471|FG000|STARTED|Overall Study||9
11318468|NCT02704689|12515471|FG000|COMPLETED|Overall Study||6
11318469|NCT02704689|12515471|FG000|NOT COMPLETED|Overall Study||3
11318470|NCT02704702|12515481|FG000|STARTED|Overall Study||6
11318471|NCT02704702|12515482|FG001|STARTED|Overall Study||6
11318472|NCT02704702|12515483|FG002|STARTED|Overall Study||6
11318473|NCT02704702|12515484|FG003|STARTED|Overall Study||6
11402578|NCT04035694|12597455|FG000|STARTED|Overall Study||374
11402579|NCT04035694|12597456|FG001|STARTED|Overall Study||216
11402580|NCT04035694|12597455|FG000|COMPLETED|Overall Study||374
11402581|NCT04035694|12597456|FG001|COMPLETED|Overall Study||216
11318474|NCT02704702|12515485|FG004|STARTED|Overall Study||6
11318475|NCT02704702|12515486|FG005|STARTED|Overall Study||6
11318476|NCT02704702|12515481|FG000|COMPLETED|Overall Study||5
11318477|NCT02704702|12515482|FG001|COMPLETED|Overall Study||6
11318478|NCT02704702|12515483|FG002|COMPLETED|Overall Study||6
11318479|NCT02704702|12515484|FG003|COMPLETED|Overall Study||5
11318480|NCT02704702|12515485|FG004|COMPLETED|Overall Study||4
11318481|NCT02704702|12515486|FG005|COMPLETED|Overall Study||4
11318482|NCT02704702|12515481|FG000|NOT COMPLETED|Overall Study||1
11318483|NCT02704702|12515482|FG001|NOT COMPLETED|Overall Study||0
11318484|NCT02704702|12515483|FG002|NOT COMPLETED|Overall Study||0
11318485|NCT02704702|12515484|FG003|NOT COMPLETED|Overall Study||1
11318486|NCT02704702|12515485|FG004|NOT COMPLETED|Overall Study||2
11318487|NCT02704702|12515486|FG005|NOT COMPLETED|Overall Study||2
11318488|NCT02705352|12515506|FG000|STARTED|Overall Study||1
11318489|NCT02705352|12515507|FG001|STARTED|Overall Study||0
11318490|NCT02705352|12515506|FG000|COMPLETED|Overall Study||1
11318491|NCT02705352|12515507|FG001|COMPLETED|Overall Study||0
11318492|NCT02705352|12515506|FG000|NOT COMPLETED|Overall Study||0
11318493|NCT02705352|12515507|FG001|NOT COMPLETED|Overall Study||0
11318494|NCT02705365|12515515|FG000|STARTED|Overall Study||400
11318495|NCT02705365|12515516|FG001|STARTED|Overall Study||800
11318496|NCT02705365|12515515|FG000|COMPLETED|Overall Study||400
11318497|NCT02705365|12515516|FG001|COMPLETED|Overall Study||800
11318498|NCT02705365|12515515|FG000|NOT COMPLETED|Overall Study||0
11318499|NCT02705365|12515516|FG001|NOT COMPLETED|Overall Study||0
11318500|NCT02705586|12515522|FG000|STARTED|Overall Study||13
11318501|NCT02705586|12515522|FG000|COMPLETED|Overall Study||5
11318502|NCT02705586|12515522|FG000|NOT COMPLETED|Overall Study||8
11318503|NCT02705625|12515529|FG000|STARTED|Overall Study||82
11318504|NCT02705625|12515530|FG001|STARTED|Overall Study||82
11318505|NCT02705625|12515531|FG002|STARTED|Overall Study||80
11318506|NCT02705625|12515529|FG000|COMPLETED|Overall Study||74
11318507|NCT02705625|12515530|FG001|COMPLETED|Overall Study||72
11318508|NCT02705625|12515531|FG002|COMPLETED|Overall Study||69
11318509|NCT02705625|12515529|FG000|NOT COMPLETED|Overall Study||8
11318510|NCT02705625|12515530|FG001|NOT COMPLETED|Overall Study||10
11318511|NCT02705625|12515531|FG002|NOT COMPLETED|Overall Study||11
11318512|NCT02705716|12515541|FG000|STARTED|Overall Study||72
11318513|NCT02705716|12515542|FG001|STARTED|Overall Study||70
11318514|NCT02705716|12515541|FG000|COMPLETED|Overall Study||68
11318515|NCT02705716|12515542|FG001|COMPLETED|Overall Study||68
11318516|NCT02705716|12515541|FG000|NOT COMPLETED|Overall Study||4
11318517|NCT02705716|12515542|FG001|NOT COMPLETED|Overall Study||2
11318518|NCT02705807|12515548|FG000|STARTED|Overall Study||10
11318519|NCT02705807|12515548|FG000|COMPLETED|Overall Study||10
11318520|NCT02705807|12515548|FG000|NOT COMPLETED|Overall Study||0
11318521|NCT02706041|12515554|FG000|STARTED|Overall Study||18
11318522|NCT02706041|12515555|FG001|STARTED|Overall Study||21
11318523|NCT02706041|12515554|FG000|Received Allocated Intervention|Overall Study||18
11318524|NCT02706041|12515555|FG001|Received Allocated Intervention|Overall Study||18
11318525|NCT02706041|12515554|FG000|COMPLETED|Overall Study||18
11318526|NCT02706041|12515555|FG001|COMPLETED|Overall Study||18
11318527|NCT02706041|12515554|FG000|NOT COMPLETED|Overall Study||0
11318528|NCT02706041|12515555|FG001|NOT COMPLETED|Overall Study||3
11318529|NCT02706249|12515563|FG000|STARTED|Overall Study||25
11318530|NCT02706249|12515564|FG001|STARTED|Overall Study||25
11318531|NCT02706249|12515563|FG000|COMPLETED|Overall Study||23
11318532|NCT02706249|12515564|FG001|COMPLETED|Overall Study||24
11318533|NCT02706249|12515563|FG000|NOT COMPLETED|Overall Study||2
11318534|NCT02706249|12515564|FG001|NOT COMPLETED|Overall Study||1
11318535|NCT02706327|12515575|FG000|STARTED|Overall Study||22
11318536|NCT02706327|12515576|FG001|STARTED|Overall Study||22
11318537|NCT02706327|12515577|FG002|STARTED|Overall Study||23
11318538|NCT02706327|12515575|FG000|COMPLETED|Overall Study||21
11318539|NCT02706327|12515576|FG001|COMPLETED|Overall Study||21
11318540|NCT02706327|12515577|FG002|COMPLETED|Overall Study||21
11318541|NCT02706327|12515575|FG000|NOT COMPLETED|Overall Study||1
11318542|NCT02706327|12515576|FG001|NOT COMPLETED|Overall Study||1
11318543|NCT02706327|12515577|FG002|NOT COMPLETED|Overall Study||2
11318544|NCT02706483|12515585|FG000|STARTED|Overall Study||2272
11318545|NCT02706483|12515585|FG000|COMPLETED|Overall Study||1842
11318546|NCT02706483|12515585|FG000|NOT COMPLETED|Overall Study||430
11318547|NCT02706717|12515591|FG000|STARTED|Overall Study||47
11318548|NCT02706717|12515592|FG001|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
11318549|NCT02706717|12515591|FG000|COMPLETED|Overall Study||46
11318550|NCT02706717|12515592|FG001|COMPLETED|Overall Study||35
11318551|NCT02706717|12515591|FG000|NOT COMPLETED|Overall Study||1
11318552|NCT02706717|12515592|FG001|NOT COMPLETED|Overall Study||11
11318553|NCT02706834|12515609|FG000|STARTED|Overall Study||3
11318554|NCT02706834|12515610|FG001|STARTED|Overall Study||3
11318555|NCT02706834|12515611|FG002|STARTED|Overall Study||3
11318556|NCT02706834|12515612|FG003|STARTED|Overall Study||3
11318557|NCT02706834|12515613|FG004|STARTED|Overall Study||3
11318558|NCT02706834|12515614|FG005|STARTED|Overall Study||3
11318559|NCT02706834|12515615|FG006|STARTED|Overall Study||3
11318560|NCT02706834|12515616|FG007|STARTED|Overall Study||3
11318561|NCT02706834|12515617|FG008|STARTED|Overall Study||4
11318562|NCT02706834|12515618|FG009|STARTED|Overall Study||4
11318563|NCT02706834|12515619|FG010|STARTED|Overall Study||4
11318564|NCT02706834|12515609|FG000|COMPLETED|Overall Study|Completed = completed study drug|1
11318565|NCT02706834|12515610|FG001|COMPLETED|Overall Study||2
11318566|NCT02706834|12515611|FG002|COMPLETED|Overall Study||2
11318567|NCT02706834|12515612|FG003|COMPLETED|Overall Study||3
11318568|NCT02706834|12515613|FG004|COMPLETED|Overall Study||2
11318569|NCT02706834|12515614|FG005|COMPLETED|Overall Study||3
11318570|NCT02706834|12515615|FG006|COMPLETED|Overall Study||3
11318571|NCT02706834|12515616|FG007|COMPLETED|Overall Study||3
11318572|NCT02706834|12515617|FG008|COMPLETED|Overall Study||4
11318573|NCT02706834|12515618|FG009|COMPLETED|Overall Study||3
11318574|NCT02706834|12515619|FG010|COMPLETED|Overall Study||3
11318575|NCT02706834|12515609|FG000|NOT COMPLETED|Overall Study||2
11318576|NCT02706834|12515610|FG001|NOT COMPLETED|Overall Study||1
11318577|NCT02706834|12515611|FG002|NOT COMPLETED|Overall Study||1
11318578|NCT02706834|12515612|FG003|NOT COMPLETED|Overall Study||0
11318579|NCT02706834|12515613|FG004|NOT COMPLETED|Overall Study||1
11318580|NCT02706834|12515614|FG005|NOT COMPLETED|Overall Study||0
11318581|NCT02706834|12515615|FG006|NOT COMPLETED|Overall Study||0
11318582|NCT02706834|12515616|FG007|NOT COMPLETED|Overall Study||0
11318583|NCT02706834|12515617|FG008|NOT COMPLETED|Overall Study||0
11318584|NCT02706834|12515618|FG009|NOT COMPLETED|Overall Study||1
11318585|NCT02706834|12515619|FG010|NOT COMPLETED|Overall Study||1
11318586|NCT02706886|12515673|FG000|STARTED|Part A: SAD Period||8
11318587|NCT02706886|12515674|FG001|STARTED|Part A: SAD Period||6
11318588|NCT02706886|12515675|FG002|STARTED|Part A: SAD Period||6
11318589|NCT02706886|12515676|FG003|STARTED|Part A: SAD Period||6
11318590|NCT02706886|12515677|FG004|STARTED|Part A: SAD Period||6
11318591|NCT02706886|12515678|FG005|STARTED|Part A: SAD Period||0
11318592|NCT02706886|12515679|FG006|STARTED|Part A: SAD Period||0
11318593|NCT02706886|12515680|FG007|STARTED|Part A: SAD Period||0
11318594|NCT02706886|12515681|FG008|STARTED|Part A: SAD Period||0
11318595|NCT02706886|12515673|FG000|COMPLETED|Part A: SAD Period||8
11318596|NCT02706886|12515674|FG001|COMPLETED|Part A: SAD Period||6
11318597|NCT02706886|12515675|FG002|COMPLETED|Part A: SAD Period||6
11318598|NCT02706886|12515676|FG003|COMPLETED|Part A: SAD Period||4
11318599|NCT02706886|12515677|FG004|COMPLETED|Part A: SAD Period||6
11318600|NCT02706886|12515678|FG005|COMPLETED|Part A: SAD Period||0
11318601|NCT02706886|12515679|FG006|COMPLETED|Part A: SAD Period||0
11318602|NCT02706886|12515680|FG007|COMPLETED|Part A: SAD Period||0
11318603|NCT02706886|12515681|FG008|COMPLETED|Part A: SAD Period||0
11318604|NCT02706886|12515673|FG000|NOT COMPLETED|Part A: SAD Period||0
11318605|NCT02706886|12515674|FG001|NOT COMPLETED|Part A: SAD Period||0
11318606|NCT02706886|12515675|FG002|NOT COMPLETED|Part A: SAD Period||0
11318607|NCT02706886|12515676|FG003|NOT COMPLETED|Part A: SAD Period||2
11318608|NCT02706886|12515677|FG004|NOT COMPLETED|Part A: SAD Period||0
11318609|NCT02706886|12515678|FG005|NOT COMPLETED|Part A: SAD Period||0
11318610|NCT02706886|12515679|FG006|NOT COMPLETED|Part A: SAD Period||0
11318611|NCT02706886|12515680|FG007|NOT COMPLETED|Part A: SAD Period||0
11318612|NCT02706886|12515681|FG008|NOT COMPLETED|Part A: SAD Period||0
11318613|NCT02706886|12515673|FG000|STARTED|Part B: MAD Study Days 1-85||0
11318614|NCT02706886|12515674|FG001|STARTED|Part B: MAD Study Days 1-85||0
11318615|NCT02706886|12515675|FG002|STARTED|Part B: MAD Study Days 1-85||0
11318616|NCT02706886|12515676|FG003|STARTED|Part B: MAD Study Days 1-85||0
11318617|NCT02706886|12515677|FG004|STARTED|Part B: MAD Study Days 1-85||0
11318618|NCT02706886|12515678|FG005|STARTED|Part B: MAD Study Days 1-85||3
11318619|NCT02706886|12515679|FG006|STARTED|Part B: MAD Study Days 1-85||7
11318620|NCT02706886|12515680|FG007|STARTED|Part B: MAD Study Days 1-85||7
11318621|NCT02706886|12515681|FG008|STARTED|Part B: MAD Study Days 1-85||3
11318622|NCT02706886|12515673|FG000|COMPLETED|Part B: MAD Study Days 1-85||0
11318623|NCT02706886|12515674|FG001|COMPLETED|Part B: MAD Study Days 1-85||0
11318624|NCT02706886|12515675|FG002|COMPLETED|Part B: MAD Study Days 1-85||0
11318625|NCT02706886|12515676|FG003|COMPLETED|Part B: MAD Study Days 1-85||0
11318626|NCT02706886|12515677|FG004|COMPLETED|Part B: MAD Study Days 1-85||0
11318627|NCT02706886|12515678|FG005|COMPLETED|Part B: MAD Study Days 1-85||3
11318628|NCT02706886|12515679|FG006|COMPLETED|Part B: MAD Study Days 1-85||7
11318629|NCT02706886|12515680|FG007|COMPLETED|Part B: MAD Study Days 1-85||7
11318630|NCT02706886|12515681|FG008|COMPLETED|Part B: MAD Study Days 1-85||3
11318631|NCT02706886|12515673|FG000|NOT COMPLETED|Part B: MAD Study Days 1-85||0
11318632|NCT02706886|12515674|FG001|NOT COMPLETED|Part B: MAD Study Days 1-85||0
11318633|NCT02706886|12515675|FG002|NOT COMPLETED|Part B: MAD Study Days 1-85||0
11318634|NCT02706886|12515676|FG003|NOT COMPLETED|Part B: MAD Study Days 1-85||0
11318635|NCT02706886|12515677|FG004|NOT COMPLETED|Part B: MAD Study Days 1-85||0
11318636|NCT02706886|12515678|FG005|NOT COMPLETED|Part B: MAD Study Days 1-85||0
11318637|NCT02706886|12515679|FG006|NOT COMPLETED|Part B: MAD Study Days 1-85||0
11318638|NCT02706886|12515680|FG007|NOT COMPLETED|Part B: MAD Study Days 1-85||0
11318639|NCT02706886|12515681|FG008|NOT COMPLETED|Part B: MAD Study Days 1-85||0
11318640|NCT02706886|12515673|FG000|STARTED|Part B: MAD Study Day 85-End of Study||0
11318641|NCT02706886|12515674|FG001|STARTED|Part B: MAD Study Day 85-End of Study||0
11318642|NCT02706886|12515675|FG002|STARTED|Part B: MAD Study Day 85-End of Study||0
11318643|NCT02706886|12515676|FG003|STARTED|Part B: MAD Study Day 85-End of Study||0
11318644|NCT02706886|12515677|FG004|STARTED|Part B: MAD Study Day 85-End of Study||0
11318645|NCT02706886|12515678|FG005|STARTED|Part B: MAD Study Day 85-End of Study||0
11318646|NCT02706886|12515679|FG006|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
11318647|NCT02706886|12515680|FG007|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
11318648|NCT02706886|12515681|FG008|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|4
11318649|NCT02706886|12515673|FG000|COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318650|NCT02706886|12515674|FG001|COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318651|NCT02706886|12515675|FG002|COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318652|NCT02706886|12515676|FG003|COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318653|NCT02706886|12515677|FG004|COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318654|NCT02706886|12515678|FG005|COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318655|NCT02706886|12515679|FG006|COMPLETED|Part B: MAD Study Day 85-End of Study||8
11318656|NCT02706886|12515680|FG007|COMPLETED|Part B: MAD Study Day 85-End of Study||8
11318657|NCT02706886|12515681|FG008|COMPLETED|Part B: MAD Study Day 85-End of Study||4
11318658|NCT02706886|12515673|FG000|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318659|NCT02706886|12515674|FG001|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318660|NCT02706886|12515675|FG002|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318661|NCT02706886|12515676|FG003|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318662|NCT02706886|12515677|FG004|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318663|NCT02706886|12515678|FG005|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318664|NCT02706886|12515679|FG006|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318665|NCT02706886|12515680|FG007|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318666|NCT02706886|12515681|FG008|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
11318667|NCT02706899|12515726|FG000|STARTED|Overall Study||13
11318668|NCT02706899|12515727|FG001|STARTED|Overall Study||6
11318669|NCT02706899|12515726|FG000|COMPLETED|Overall Study||0
11318670|NCT02706899|12515727|FG001|COMPLETED|Overall Study||0
11318671|NCT02706899|12515726|FG000|NOT COMPLETED|Overall Study||13
11318672|NCT02706899|12515727|FG001|NOT COMPLETED|Overall Study||6
11318673|NCT02706925|12515742|FG000|STARTED|Overall Study||16
11318674|NCT02706925|12515743|FG001|STARTED|Overall Study||6
11318675|NCT02706925|12515744|FG002|STARTED|Overall Study||6
11318676|NCT02706925|12515745|FG003|STARTED|Overall Study||6
11318677|NCT02706925|12515746|FG004|STARTED|Overall Study||6
11318678|NCT02706925|12515747|FG005|STARTED|Overall Study||5
11318679|NCT02706925|12515748|FG006|STARTED|Overall Study||6
11318680|NCT02706925|12515749|FG007|STARTED|Overall Study||6
11318681|NCT02706925|12515750|FG008|STARTED|Overall Study||6
11318682|NCT02706925|12515742|FG000|COMPLETED|Overall Study||16
11318683|NCT02706925|12515743|FG001|COMPLETED|Overall Study||6
11318684|NCT02706925|12515744|FG002|COMPLETED|Overall Study||6
11318685|NCT02706925|12515745|FG003|COMPLETED|Overall Study||6
11318686|NCT02706925|12515746|FG004|COMPLETED|Overall Study||6
11318687|NCT02706925|12515747|FG005|COMPLETED|Overall Study||5
11318688|NCT02706925|12515748|FG006|COMPLETED|Overall Study||6
11318689|NCT02706925|12515749|FG007|COMPLETED|Overall Study||6
11318690|NCT02706925|12515750|FG008|COMPLETED|Overall Study||6
11318691|NCT02706925|12515742|FG000|NOT COMPLETED|Overall Study||0
11318692|NCT02706925|12515743|FG001|NOT COMPLETED|Overall Study||0
11318693|NCT02706925|12515744|FG002|NOT COMPLETED|Overall Study||0
11318694|NCT02706925|12515745|FG003|NOT COMPLETED|Overall Study||0
11318695|NCT02706925|12515746|FG004|NOT COMPLETED|Overall Study||0
11318696|NCT02706925|12515747|FG005|NOT COMPLETED|Overall Study||0
11318697|NCT02706925|12515748|FG006|NOT COMPLETED|Overall Study||0
11318698|NCT02706925|12515749|FG007|NOT COMPLETED|Overall Study||0
11318699|NCT02706925|12515750|FG008|NOT COMPLETED|Overall Study||0
11318700|NCT02706938|12515780|FG000|STARTED|First Period, 6 Weeks||32
11318701|NCT02706938|12515781|FG001|STARTED|First Period, 6 Weeks||33
11318702|NCT02706938|12515780|FG000|COMPLETED|First Period, 6 Weeks||21
11318703|NCT02706938|12515781|FG001|COMPLETED|First Period, 6 Weeks||31
11318704|NCT02706938|12515780|FG000|NOT COMPLETED|First Period, 6 Weeks||11
11318705|NCT02706938|12515781|FG001|NOT COMPLETED|First Period, 6 Weeks||2
11318706|NCT02706938|12515780|FG000|STARTED|Second Period, 6 Weeks||21
11318707|NCT02706938|12515781|FG001|STARTED|Second Period, 6 Weeks||31
11318708|NCT02706938|12515780|FG000|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21
11318709|NCT02706938|12515781|FG001|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21
11318710|NCT02706938|12515780|FG000|NOT COMPLETED|Second Period, 6 Weeks||0
11318711|NCT02706938|12515781|FG001|NOT COMPLETED|Second Period, 6 Weeks||10
11318712|NCT02707146|12515790|FG000|STARTED|Overall Study||359
11318713|NCT02707146|12515791|FG001|STARTED|Overall Study||391
11318714|NCT02707146|12515790|FG000|COMPLETED|Overall Study||359
11318715|NCT02707146|12515791|FG001|COMPLETED|Overall Study||388
11318716|NCT02707146|12515790|FG000|NOT COMPLETED|Overall Study||0
11318717|NCT02707146|12515791|FG001|NOT COMPLETED|Overall Study||3
11318718|NCT02707172|12515797|FG000|STARTED|1st Set of Experiment||28
11318719|NCT02707172|12515797|FG000|COMPLETED|1st Set of Experiment||28
11318720|NCT02707172|12515797|FG000|NOT COMPLETED|1st Set of Experiment||0
11318721|NCT02707172|12515797|FG000|STARTED|Wash Out||28
11318722|NCT02707172|12515797|FG000|COMPLETED|Wash Out||28
11318723|NCT02707172|12515797|FG000|NOT COMPLETED|Wash Out||0
11318724|NCT02707172|12515797|FG000|STARTED|2nd Set of Experiment||28
11318725|NCT02707172|12515797|FG000|COMPLETED|2nd Set of Experiment||28
11318726|NCT02707172|12515797|FG000|NOT COMPLETED|2nd Set of Experiment||0
11318727|NCT02707432|12515804|FG000|STARTED|Overall Study||72
11318728|NCT02707432|12515805|FG001|STARTED|Overall Study||71
11318729|NCT02707432|12515804|FG000|COMPLETED|Overall Study||57
11318730|NCT02707432|12515805|FG001|COMPLETED|Overall Study||51
11318731|NCT02707432|12515804|FG000|NOT COMPLETED|Overall Study||15
11318732|NCT02707432|12515805|FG001|NOT COMPLETED|Overall Study||20
11318733|NCT02707523|12515814|FG000|STARTED|Overall Study||16
11318734|NCT02707523|12515815|FG001|STARTED|Overall Study||16
11318735|NCT02707523|12515816|FG002|STARTED|Overall Study||16
11318736|NCT02707523|12515814|FG000|COMPLETED|Overall Study||16
11318737|NCT02707523|12515815|FG001|COMPLETED|Overall Study||16
11318738|NCT02707523|12515816|FG002|COMPLETED|Overall Study||16
11318739|NCT02707523|12515814|FG000|NOT COMPLETED|Overall Study||0
11318740|NCT02707523|12515815|FG001|NOT COMPLETED|Overall Study||0
11318741|NCT02707523|12515816|FG002|NOT COMPLETED|Overall Study||0
11318742|NCT02707601|12515826|FG000|STARTED|Overall Study||76
11318743|NCT02707601|12515827|FG001|STARTED|Overall Study||74
11318744|NCT02707601|12515826|FG000|COMPLETED|Overall Study||72
11318745|NCT02707601|12515827|FG001|COMPLETED|Overall Study||70
11318746|NCT02707601|12515826|FG000|NOT COMPLETED|Overall Study||4
11318747|NCT02707601|12515827|FG001|NOT COMPLETED|Overall Study||4
11318748|NCT02707640|12515839|FG000|STARTED|Overall Study||61
11318749|NCT02707640|12515840|FG001|STARTED|Overall Study||62
11318750|NCT02707640|12515839|FG000|COMPLETED|Overall Study||52
11318751|NCT02707640|12515840|FG001|COMPLETED|Overall Study||55
11318752|NCT02707640|12515839|FG000|NOT COMPLETED|Overall Study||9
11318753|NCT02707640|12515840|FG001|NOT COMPLETED|Overall Study||7
11318754|NCT02707757|12515848|FG000|STARTED|Overall Study||88
11318755|NCT02707757|12515849|FG001|STARTED|Overall Study||96
11318756|NCT02707757|12515848|FG000|COMPLETED|Overall Study||76
11318757|NCT02707757|12515849|FG001|COMPLETED|Overall Study||84
11318758|NCT02707757|12515848|FG000|NOT COMPLETED|Overall Study||12
11318759|NCT02707757|12515849|FG001|NOT COMPLETED|Overall Study||12
11318760|NCT02707770|12515857|FG000|STARTED|Overall Study||10
11318761|NCT02707770|12515858|FG001|STARTED|Overall Study||10
11318762|NCT02707770|12515857|FG000|COMPLETED|Overall Study|One patient withdrew from the study following consent, initial assessment and randomisation|9
11318763|NCT02707770|12515858|FG001|COMPLETED|Overall Study||10
11318764|NCT02707770|12515857|FG000|NOT COMPLETED|Overall Study||1
11318765|NCT02707770|12515858|FG001|NOT COMPLETED|Overall Study||0
11318766|NCT02707861|12515868|FG000|STARTED|Overall Study||41
11318767|NCT02707861|12515869|FG001|STARTED|Overall Study||38
11318768|NCT02707861|12515868|FG000|COMPLETED|Overall Study||0
11318769|NCT02707861|12515869|FG001|COMPLETED|Overall Study||0
11318770|NCT02707861|12515868|FG000|NOT COMPLETED|Overall Study||41
11318771|NCT02707861|12515869|FG001|NOT COMPLETED|Overall Study||38
11318772|NCT02707952|12515879|FG000|STARTED|Overall Study||129
11318773|NCT02707952|12515880|FG001|STARTED|Overall Study||53
11318774|NCT02707952|12515881|FG002|STARTED|Overall Study||103
11318775|NCT02707952|12515882|FG003|STARTED|Overall Study||10
11318776|NCT02707952|12515879|FG000|Participants Who Received Study Drug|Overall Study||129
11318777|NCT02707952|12515880|FG001|Participants Who Received Study Drug|Overall Study||52
11318778|NCT02707952|12515881|FG002|Participants Who Received Study Drug|Overall Study||103
11318779|NCT02707952|12515882|FG003|Participants Who Received Study Drug|Overall Study||10
11318780|NCT02707952|12515879|FG000|COMPLETED|Overall Study||127
11318781|NCT02707952|12515880|FG001|COMPLETED|Overall Study||52
11318782|NCT02707952|12515881|FG002|COMPLETED|Overall Study||101
11318783|NCT02707952|12515882|FG003|COMPLETED|Overall Study||10
11318784|NCT02707952|12515879|FG000|NOT COMPLETED|Overall Study||2
11318785|NCT02707952|12515880|FG001|NOT COMPLETED|Overall Study||1
11318786|NCT02707952|12515881|FG002|NOT COMPLETED|Overall Study||2
11318787|NCT02707952|12515882|FG003|NOT COMPLETED|Overall Study||0
11318788|NCT02707965|12515903|FG000|STARTED|Overall Study||3
11318789|NCT02707965|12515904|FG001|STARTED|Overall Study||2
11318790|NCT02707965|12515905|FG002|STARTED|Overall Study||4
11318791|NCT02707965|12515906|FG003|STARTED|Overall Study||0
11318792|NCT02707965|12515907|FG004|STARTED|Overall Study||2
11318793|NCT02707965|12515908|FG005|STARTED|Overall Study||1
11318794|NCT02707965|12515909|FG006|STARTED|Overall Study||0
11318795|NCT02707965|12515910|FG007|STARTED|Overall Study||3
11318796|NCT02707965|12515911|FG008|STARTED|Overall Study||1
11318797|NCT02707965|12515912|FG009|STARTED|Overall Study||0
11318798|NCT02707965|12515913|FG010|STARTED|Overall Study||1
11318799|NCT02707965|12515914|FG011|STARTED|Overall Study||0
11318800|NCT02707965|12515915|FG012|STARTED|Overall Study||0
11318801|NCT02707965|12515916|FG013|STARTED|Overall Study||2
11318802|NCT02707965|12515917|FG014|STARTED|Overall Study||2
11318803|NCT02707965|12515918|FG015|STARTED|Overall Study||0
11318804|NCT02707965|12515903|FG000|COMPLETED|Overall Study||2
11318805|NCT02707965|12515904|FG001|COMPLETED|Overall Study||1
11318806|NCT02707965|12515905|FG002|COMPLETED|Overall Study||3
11318807|NCT02707965|12515906|FG003|COMPLETED|Overall Study||0
11318808|NCT02707965|12515907|FG004|COMPLETED|Overall Study||2
11318809|NCT02707965|12515908|FG005|COMPLETED|Overall Study||1
11318810|NCT02707965|12515909|FG006|COMPLETED|Overall Study||0
11318811|NCT02707965|12515910|FG007|COMPLETED|Overall Study||0
11318812|NCT02707965|12515911|FG008|COMPLETED|Overall Study||1
11318813|NCT02707965|12515912|FG009|COMPLETED|Overall Study||0
11318814|NCT02707965|12515913|FG010|COMPLETED|Overall Study||1
11318815|NCT02707965|12515914|FG011|COMPLETED|Overall Study||0
11318816|NCT02707965|12515915|FG012|COMPLETED|Overall Study||0
11318817|NCT02707965|12515916|FG013|COMPLETED|Overall Study||2
11318818|NCT02707965|12515917|FG014|COMPLETED|Overall Study||0
11318819|NCT02707965|12515918|FG015|COMPLETED|Overall Study||0
11402582|NCT04035694|12597455|FG000|NOT COMPLETED|Overall Study||0
11402583|NCT04035694|12597456|FG001|NOT COMPLETED|Overall Study||0
11318820|NCT02707965|12515903|FG000|NOT COMPLETED|Overall Study||1
11318821|NCT02707965|12515904|FG001|NOT COMPLETED|Overall Study||1
11318822|NCT02707965|12515905|FG002|NOT COMPLETED|Overall Study||1
11318823|NCT02707965|12515906|FG003|NOT COMPLETED|Overall Study||0
11318824|NCT02707965|12515907|FG004|NOT COMPLETED|Overall Study||0
11318825|NCT02707965|12515908|FG005|NOT COMPLETED|Overall Study||0
11318826|NCT02707965|12515909|FG006|NOT COMPLETED|Overall Study||0
11318827|NCT02707965|12515910|FG007|NOT COMPLETED|Overall Study||3
11318828|NCT02707965|12515911|FG008|NOT COMPLETED|Overall Study||0
11318829|NCT02707965|12515912|FG009|NOT COMPLETED|Overall Study||0
11318830|NCT02707965|12515913|FG010|NOT COMPLETED|Overall Study||0
11318831|NCT02707965|12515914|FG011|NOT COMPLETED|Overall Study||0
11318832|NCT02707965|12515915|FG012|NOT COMPLETED|Overall Study||0
11318833|NCT02707965|12515916|FG013|NOT COMPLETED|Overall Study||0
11318834|NCT02707965|12515917|FG014|NOT COMPLETED|Overall Study||2
11318835|NCT02707965|12515918|FG015|NOT COMPLETED|Overall Study||0
11318836|NCT02707991|12515953|FG000|STARTED|Overall Study||33
11318837|NCT02707991|12515954|FG001|STARTED|Overall Study||35
11318838|NCT02707991|12515953|FG000|Day 60 Data Collectio|Overall Study||32
11318839|NCT02707991|12515954|FG001|Day 60 Data Collectio|Overall Study||34
11318840|NCT02707991|12515953|FG000|Month 6 Data Collection|Overall Study||32
11318841|NCT02707991|12515954|FG001|Month 6 Data Collection|Overall Study||34
11318842|NCT02707991|12515953|FG000|COMPLETED|Overall Study||32
11318843|NCT02707991|12515954|FG001|COMPLETED|Overall Study||34
11318844|NCT02707991|12515953|FG000|NOT COMPLETED|Overall Study||1
11318845|NCT02707991|12515954|FG001|NOT COMPLETED|Overall Study||1
11318846|NCT02708095|12515963|FG000|STARTED|Overall Study||105
11318847|NCT02708095|12515964|FG001|STARTED|Overall Study||105
11318848|NCT02708095|12515965|FG002|STARTED|Overall Study||104
11318849|NCT02708095|12515963|FG000|Received at Least 1 Dose of Study Drug|Overall Study||105
11318850|NCT02708095|12515964|FG001|Received at Least 1 Dose of Study Drug|Overall Study||105
11318851|NCT02708095|12515965|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104
11318852|NCT02708095|12515963|FG000|COMPLETED|Overall Study||83
11318853|NCT02708095|12515964|FG001|COMPLETED|Overall Study||86
11318854|NCT02708095|12515965|FG002|COMPLETED|Overall Study||86
11318855|NCT02708095|12515963|FG000|NOT COMPLETED|Overall Study||22
11318856|NCT02708095|12515964|FG001|NOT COMPLETED|Overall Study||19
11318857|NCT02708095|12515965|FG002|NOT COMPLETED|Overall Study||18
11318858|NCT02708121|12515977|FG000|STARTED|Overall Study||35
11318859|NCT02708121|12515978|FG001|STARTED|Overall Study||31
11318860|NCT02708121|12515977|FG000|Provided Acceptability Data|Overall Study||20
11318861|NCT02708121|12515978|FG001|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0
11318862|NCT02708121|12515977|FG000|Treatment Program Use Data Available|Overall Study||34
11318863|NCT02708121|12515978|FG001|Treatment Program Use Data Available|Overall Study||24
11318864|NCT02708121|12515977|FG000|6 Month In-Person Follow Up Data|Overall Study||22
11318865|NCT02708121|12515978|FG001|6 Month In-Person Follow Up Data|Overall Study||19
11318866|NCT02708121|12515977|FG000|6 Month Weight Data Via EHR|Overall Study||14
11318867|NCT02708121|12515978|FG001|6 Month Weight Data Via EHR|Overall Study||13
11318868|NCT02708121|12515977|FG000|COMPLETED|Overall Study||34
11318869|NCT02708121|12515978|FG001|COMPLETED|Overall Study||26
11318870|NCT02708121|12515977|FG000|NOT COMPLETED|Overall Study||1
11318871|NCT02708121|12515978|FG001|NOT COMPLETED|Overall Study||5
11318872|NCT02708186|12515986|FG000|STARTED|Overall Study||16
11318873|NCT02708186|12515987|FG001|STARTED|Overall Study||18
11318874|NCT02708186|12515986|FG000|COMPLETED|Overall Study||14
11318875|NCT02708186|12515987|FG001|COMPLETED|Overall Study||16
11318876|NCT02708186|12515986|FG000|NOT COMPLETED|Overall Study||2
11318877|NCT02708186|12515987|FG001|NOT COMPLETED|Overall Study||2
11318878|NCT02708212|12515995|FG000|STARTED|Overall Study||60
11318879|NCT02708212|12515996|FG001|STARTED|Overall Study||60
11318880|NCT02708212|12515995|FG000|COMPLETED|Overall Study||60
11318881|NCT02708212|12515996|FG001|COMPLETED|Overall Study||60
11318882|NCT02708212|12515995|FG000|NOT COMPLETED|Overall Study||0
11318883|NCT02708212|12515996|FG001|NOT COMPLETED|Overall Study||0
11318884|NCT02708238|12516009|FG000|STARTED|Overall Study||60
11318885|NCT02708238|12516010|FG001|STARTED|Overall Study||60
11318886|NCT02708238|12516011|FG002|STARTED|Overall Study||60
11318887|NCT02708238|12516009|FG000|COMPLETED|Overall Study||60
11318888|NCT02708238|12516010|FG001|COMPLETED|Overall Study||59
11318889|NCT02708238|12516011|FG002|COMPLETED|Overall Study||57
11318890|NCT02708238|12516009|FG000|NOT COMPLETED|Overall Study||0
11318891|NCT02708238|12516010|FG001|NOT COMPLETED|Overall Study||1
11318892|NCT02708238|12516011|FG002|NOT COMPLETED|Overall Study||3
11318893|NCT02708277|12516021|FG000|STARTED|Overall Study||50
11318894|NCT02708277|12516022|FG001|STARTED|Overall Study||43
11318895|NCT02708277|12516021|FG000|COMPLETED|Overall Study||43
11318896|NCT02708277|12516022|FG001|COMPLETED|Overall Study||39
11318897|NCT02708277|12516021|FG000|NOT COMPLETED|Overall Study||7
11318898|NCT02708277|12516022|FG001|NOT COMPLETED|Overall Study||4
11318899|NCT02708290|12516030|FG000|STARTED|Overall Study||1009
11318900|NCT02708290|12516031|FG001|STARTED|Overall Study||1009
11318901|NCT02708290|12516030|FG000|COMPLETED|Overall Study||1009
11318902|NCT02708290|12516031|FG001|COMPLETED|Overall Study||1009
11318903|NCT02708290|12516030|FG000|NOT COMPLETED|Overall Study||0
11318904|NCT02708290|12516031|FG001|NOT COMPLETED|Overall Study||0
11318905|NCT02708355|12516040|FG000|STARTED|Overall Study||21
11318906|NCT02708355|12516041|FG001|STARTED|Overall Study||22
11318907|NCT02708355|12516042|FG002|STARTED|Overall Study||12
11318908|NCT02708355|12516040|FG000|COMPLETED|Overall Study||20
11318909|NCT02708355|12516041|FG001|COMPLETED|Overall Study||22
11318910|NCT02708355|12516042|FG002|COMPLETED|Overall Study||12
11318911|NCT02708355|12516040|FG000|NOT COMPLETED|Overall Study||1
11318912|NCT02708355|12516041|FG001|NOT COMPLETED|Overall Study||0
11318913|NCT02708355|12516042|FG002|NOT COMPLETED|Overall Study||0
11318914|NCT02708433|12516050|FG000|STARTED|First Intervention (Visit 1)||12
11318915|NCT02708433|12516051|FG001|STARTED|First Intervention (Visit 1)||11
11318916|NCT02708433|12516050|FG000|COMPLETED|First Intervention (Visit 1)||12
11318917|NCT02708433|12516051|FG001|COMPLETED|First Intervention (Visit 1)||11
11318918|NCT02708433|12516050|FG000|NOT COMPLETED|First Intervention (Visit 1)||0
11318919|NCT02708433|12516051|FG001|NOT COMPLETED|First Intervention (Visit 1)||0
11318920|NCT02708433|12516050|FG000|STARTED|Washout (at Least 1 Week)||12
11318921|NCT02708433|12516051|FG001|STARTED|Washout (at Least 1 Week)||11
11318922|NCT02708433|12516050|FG000|COMPLETED|Washout (at Least 1 Week)||12
11318923|NCT02708433|12516051|FG001|COMPLETED|Washout (at Least 1 Week)||11
11318924|NCT02708433|12516050|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
11318925|NCT02708433|12516051|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
11318926|NCT02708433|12516050|FG000|STARTED|Second Intervention (Visit 2)||12
11318927|NCT02708433|12516051|FG001|STARTED|Second Intervention (Visit 2)||11
11318928|NCT02708433|12516050|FG000|COMPLETED|Second Intervention (Visit 2)||12
11318929|NCT02708433|12516051|FG001|COMPLETED|Second Intervention (Visit 2)||11
11318930|NCT02708433|12516050|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0
11318931|NCT02708433|12516051|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0
11318932|NCT02708485|12516059|FG000|STARTED|Overall Study||3
11318933|NCT02708485|12516060|FG001|STARTED|Overall Study||12
11318934|NCT02708485|12516059|FG000|COMPLETED|Overall Study||0
11318935|NCT02708485|12516060|FG001|COMPLETED|Overall Study||10
11318936|NCT02708485|12516059|FG000|NOT COMPLETED|Overall Study||3
11318937|NCT02708485|12516060|FG001|NOT COMPLETED|Overall Study||2
11318938|NCT02708498|12516074|FG000|STARTED|Overall Study||42
11318939|NCT02708498|12516075|FG001|STARTED|Overall Study||40
11318940|NCT02708498|12516076|FG002|STARTED|Overall Study||152
11318941|NCT02708498|12516077|FG003|STARTED|Overall Study||156
11318942|NCT02708498|12516078|FG004|STARTED|Overall Study||363
11318943|NCT02708498|12516079|FG005|STARTED|Overall Study||330
11318944|NCT02708498|12516080|FG006|STARTED|Overall Study||20
11402584|NCT04035577|12597462|FG000|STARTED|Overall Study|One participant withdrew after signing the consent but before initiating any study activities.|21
11402585|NCT04035577|12597462|FG000|COMPLETED|Overall Study||19
11402586|NCT04035577|12597462|FG000|NOT COMPLETED|Overall Study||2
11402587|NCT04035564|12597470|FG000|STARTED|Overall Study||27
11402588|NCT04035564|12597471|FG001|STARTED|Overall Study||25
11402589|NCT04035564|12597470|FG000|COMPLETED|Overall Study||23
11402590|NCT04035564|12597471|FG001|COMPLETED|Overall Study||19
11402591|NCT04035564|12597470|FG000|NOT COMPLETED|Overall Study||4
11402592|NCT04035564|12597471|FG001|NOT COMPLETED|Overall Study||6
11402593|NCT04032977|12597479|FG000|STARTED|Overall Study||80
11402594|NCT04032977|12597480|FG001|STARTED|Overall Study||78
11402595|NCT04032977|12597479|FG000|COMPLETED|Overall Study||71
11402596|NCT04032977|12597480|FG001|COMPLETED|Overall Study||70
11402597|NCT04032977|12597479|FG000|NOT COMPLETED|Overall Study||9
11402598|NCT04032977|12597480|FG001|NOT COMPLETED|Overall Study||8
11402599|NCT04032652|12597488|FG000|STARTED|Overall Study||1
11402600|NCT04032652|12597489|FG001|STARTED|Overall Study||1
11318945|NCT02708498|12516081|FG007|STARTED|Overall Study||48
11318946|NCT02708498|12516074|FG000|COMPLETED|Overall Study||22
11318947|NCT02708498|12516075|FG001|COMPLETED|Overall Study||21
11318948|NCT02708498|12516076|FG002|COMPLETED|Overall Study||90
11318949|NCT02708498|12516077|FG003|COMPLETED|Overall Study||105
11318950|NCT02708498|12516078|FG004|COMPLETED|Overall Study||167
11318951|NCT02708498|12516079|FG005|COMPLETED|Overall Study||198
11318952|NCT02708498|12516080|FG006|COMPLETED|Overall Study||20
11318953|NCT02708498|12516081|FG007|COMPLETED|Overall Study||48
11318954|NCT02708498|12516074|FG000|NOT COMPLETED|Overall Study||20
11318955|NCT02708498|12516075|FG001|NOT COMPLETED|Overall Study||19
11318956|NCT02708498|12516076|FG002|NOT COMPLETED|Overall Study||62
11318957|NCT02708498|12516077|FG003|NOT COMPLETED|Overall Study||51
11318958|NCT02708498|12516078|FG004|NOT COMPLETED|Overall Study||196
11318959|NCT02708498|12516079|FG005|NOT COMPLETED|Overall Study||132
11402601|NCT04032652|12597488|FG000|COMPLETED|Overall Study||0
11318960|NCT02708498|12516080|FG006|NOT COMPLETED|Overall Study||0
11318961|NCT02708498|12516081|FG007|NOT COMPLETED|Overall Study||0
11318962|NCT02708524|12516101|FG000|STARTED|Overall Study||139
11318963|NCT02708524|12516102|FG001|STARTED|Overall Study||136
11318964|NCT02708524|12516103|FG002|STARTED|Overall Study||137
11318965|NCT02708524|12516104|FG003|STARTED|Overall Study||136
11318966|NCT02708524|12516101|FG000|COMPLETED|Overall Study||135
11318967|NCT02708524|12516102|FG001|COMPLETED|Overall Study||130
11318968|NCT02708524|12516103|FG002|COMPLETED|Overall Study||134
11318969|NCT02708524|12516104|FG003|COMPLETED|Overall Study||136
11318970|NCT02708524|12516101|FG000|NOT COMPLETED|Overall Study||4
11318971|NCT02708524|12516102|FG001|NOT COMPLETED|Overall Study||6
11318972|NCT02708524|12516103|FG002|NOT COMPLETED|Overall Study||3
11318973|NCT02708524|12516104|FG003|NOT COMPLETED|Overall Study||0
11318974|NCT02708641|12516114|FG000|STARTED|Overall Study||12
11318975|NCT02708641|12516114|FG000|COMPLETED|Overall Study||12
11318976|NCT02708641|12516114|FG000|NOT COMPLETED|Overall Study||0
11318977|NCT02708745|12516122|FG000|STARTED|Overall Study||91
11318978|NCT02708745|12516123|FG001|STARTED|Overall Study||69
11318979|NCT02708745|12516124|FG002|STARTED|Overall Study||204
11318980|NCT02708745|12516125|FG003|STARTED|Overall Study||198
11318981|NCT02708745|12516122|FG000|COMPLETED|Overall Study||91
11318982|NCT02708745|12516123|FG001|COMPLETED|Overall Study||65
11402602|NCT04032652|12597489|FG001|COMPLETED|Overall Study||0
11318983|NCT02708745|12516124|FG002|COMPLETED|Overall Study||121
11318984|NCT02708745|12516125|FG003|COMPLETED|Overall Study||116
11318985|NCT02708745|12516122|FG000|NOT COMPLETED|Overall Study||0
11318986|NCT02708745|12516123|FG001|NOT COMPLETED|Overall Study||4
11318987|NCT02708745|12516124|FG002|NOT COMPLETED|Overall Study||83
11318988|NCT02708745|12516125|FG003|NOT COMPLETED|Overall Study||82
11318989|NCT02708862|12516137|FG000|STARTED|Overall Study||26
11318990|NCT02708862|12516137|FG000|COMPLETED|Overall Study||26
11318991|NCT02708862|12516137|FG000|NOT COMPLETED|Overall Study||0
11318992|NCT02708966|12516146|FG000|STARTED|Overall Study||15
11318993|NCT02708966|12516147|FG001|STARTED|Overall Study||15
11318994|NCT02708966|12516146|FG000|COMPLETED|Overall Study||13
11318995|NCT02708966|12516147|FG001|COMPLETED|Overall Study||13
11318996|NCT02708966|12516146|FG000|NOT COMPLETED|Overall Study||2
11318997|NCT02708966|12516147|FG001|NOT COMPLETED|Overall Study||2
11318998|NCT02709005|12516155|FG000|STARTED|Overall Study||73
11318999|NCT02709005|12516156|FG001|STARTED|Overall Study||36
11319000|NCT02709005|12516155|FG000|COMPLETED|Overall Study||69
11319001|NCT02709005|12516156|FG001|COMPLETED|Overall Study||35
11319002|NCT02709005|12516155|FG000|NOT COMPLETED|Overall Study||4
11319003|NCT02709005|12516156|FG001|NOT COMPLETED|Overall Study||1
11319004|NCT02709018|12516164|FG000|STARTED|Overall Study||75
11319005|NCT02709018|12516165|FG001|STARTED|Overall Study||74
11319006|NCT02709018|12516164|FG000|COMPLETED|Overall Study||59
11319007|NCT02709018|12516165|FG001|COMPLETED|Overall Study||58
11319008|NCT02709018|12516164|FG000|NOT COMPLETED|Overall Study||16
11319009|NCT02709018|12516165|FG001|NOT COMPLETED|Overall Study||16
11319010|NCT02709096|12516175|FG000|STARTED|Overall Study||22
11319011|NCT02709096|12516176|FG001|STARTED|Overall Study||11
11319012|NCT02709096|12516175|FG000|COMPLETED|Overall Study||21
11319013|NCT02709096|12516176|FG001|COMPLETED|Overall Study||10
11319014|NCT02709096|12516175|FG000|NOT COMPLETED|Overall Study||1
11319015|NCT02709096|12516176|FG001|NOT COMPLETED|Overall Study||1
11319016|NCT02709109|12516186|FG000|STARTED|Treatment Period 1 (28 Days)||49
11319017|NCT02709109|12516187|FG001|STARTED|Treatment Period 1 (28 Days)||47
11319018|NCT02709109|12516188|FG002|STARTED|Treatment Period 1 (28 Days)||22
11319019|NCT02709109|12516189|FG003|STARTED|Treatment Period 1 (28 Days)||24
11319020|NCT02709109|12516186|FG000|COMPLETED|Treatment Period 1 (28 Days)||45
11319021|NCT02709109|12516187|FG001|COMPLETED|Treatment Period 1 (28 Days)||42
11319022|NCT02709109|12516188|FG002|COMPLETED|Treatment Period 1 (28 Days)||21
11319023|NCT02709109|12516189|FG003|COMPLETED|Treatment Period 1 (28 Days)||24
11319024|NCT02709109|12516186|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||4
11319025|NCT02709109|12516187|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||5
11319026|NCT02709109|12516188|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1
11319027|NCT02709109|12516189|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11319028|NCT02709109|12516186|FG000|STARTED|Washout Period (28 Days)||45
11319029|NCT02709109|12516187|FG001|STARTED|Washout Period (28 Days)||42
11319030|NCT02709109|12516188|FG002|STARTED|Washout Period (28 Days)||21
11319031|NCT02709109|12516189|FG003|STARTED|Washout Period (28 Days)||24
11319032|NCT02709109|12516186|FG000|COMPLETED|Washout Period (28 Days)||43
11319033|NCT02709109|12516187|FG001|COMPLETED|Washout Period (28 Days)||40
11319034|NCT02709109|12516188|FG002|COMPLETED|Washout Period (28 Days)||18
11319035|NCT02709109|12516189|FG003|COMPLETED|Washout Period (28 Days)||24
11319036|NCT02709109|12516186|FG000|NOT COMPLETED|Washout Period (28 Days)||2
11319037|NCT02709109|12516187|FG001|NOT COMPLETED|Washout Period (28 Days)||2
11319038|NCT02709109|12516188|FG002|NOT COMPLETED|Washout Period (28 Days)||3
11319039|NCT02709109|12516189|FG003|NOT COMPLETED|Washout Period (28 Days)||0
11319040|NCT02709109|12516186|FG000|STARTED|Treatment Period 2 (28 Days)||43
11319041|NCT02709109|12516187|FG001|STARTED|Treatment Period 2 (28 Days)||40
11319042|NCT02709109|12516188|FG002|STARTED|Treatment Period 2 (28 Days)||18
11319043|NCT02709109|12516189|FG003|STARTED|Treatment Period 2 (28 Days)||24
11319044|NCT02709109|12516186|FG000|COMPLETED|Treatment Period 2 (28 Days)||41
11319045|NCT02709109|12516187|FG001|COMPLETED|Treatment Period 2 (28 Days)||36
11319046|NCT02709109|12516188|FG002|COMPLETED|Treatment Period 2 (28 Days)||15
11319047|NCT02709109|12516189|FG003|COMPLETED|Treatment Period 2 (28 Days)||24
11319048|NCT02709109|12516186|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||2
11319049|NCT02709109|12516187|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||4
11319050|NCT02709109|12516188|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||3
11319051|NCT02709109|12516189|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11319052|NCT02709330|12516200|FG000|STARTED|Overall Study||50
11319053|NCT02709330|12516201|FG001|STARTED|Overall Study||10
11319054|NCT02709330|12516200|FG000|COMPLETED|Overall Study||37
11319055|NCT02709330|12516201|FG001|COMPLETED|Overall Study||10
11319056|NCT02709330|12516200|FG000|NOT COMPLETED|Overall Study||13
11319057|NCT02709330|12516201|FG001|NOT COMPLETED|Overall Study||0
11319058|NCT02709369|12516207|FG000|STARTED|Overall Study||300
11319059|NCT02709369|12516207|FG000|COMPLETED|Overall Study||273
11319060|NCT02709369|12516207|FG000|NOT COMPLETED|Overall Study||27
11319061|NCT02709486|12516214|FG000|STARTED|Overall Study||282
11319062|NCT02709486|12516215|FG001|STARTED|Overall Study||283
11319063|NCT02709486|12516216|FG002|STARTED|Overall Study||284
11319064|NCT02709486|12516214|FG000|COMPLETED|Overall Study||238
11319065|NCT02709486|12516215|FG001|COMPLETED|Overall Study||249
11319066|NCT02709486|12516216|FG002|COMPLETED|Overall Study||239
11319067|NCT02709486|12516214|FG000|NOT COMPLETED|Overall Study||44
11319068|NCT02709486|12516215|FG001|NOT COMPLETED|Overall Study||34
11319069|NCT02709486|12516216|FG002|NOT COMPLETED|Overall Study||45
11319070|NCT02709538|12516227|FG000|STARTED|Overall Study||400
11319071|NCT02709538|12516228|FG001|STARTED|Overall Study||100
11319072|NCT02709538|12516229|FG002|STARTED|Overall Study||101
11319073|NCT02709538|12516227|FG000|COMPLETED|Overall Study||287
11319074|NCT02709538|12516228|FG001|COMPLETED|Overall Study||72
11319075|NCT02709538|12516229|FG002|COMPLETED|Overall Study||81
11319076|NCT02709538|12516227|FG000|NOT COMPLETED|Overall Study||113
11319077|NCT02709538|12516228|FG001|NOT COMPLETED|Overall Study||28
11319078|NCT02709538|12516229|FG002|NOT COMPLETED|Overall Study||20
11319079|NCT02709577|12516239|FG000|STARTED|Overall Study||12
11319080|NCT02709577|12516240|FG001|STARTED|Overall Study||13
11319081|NCT02709577|12516241|FG002|STARTED|Overall Study||6
11319082|NCT02709577|12516242|FG003|STARTED|Overall Study||5
11319083|NCT02709577|12516239|FG000|COMPLETED|Overall Study||10
11319084|NCT02709577|12516240|FG001|COMPLETED|Overall Study||8
11319085|NCT02709577|12516241|FG002|COMPLETED|Overall Study||4
11319086|NCT02709577|12516242|FG003|COMPLETED|Overall Study||5
11319087|NCT02709577|12516239|FG000|NOT COMPLETED|Overall Study||2
11319088|NCT02709577|12516240|FG001|NOT COMPLETED|Overall Study||5
11319089|NCT02709577|12516241|FG002|NOT COMPLETED|Overall Study||2
11319090|NCT02709577|12516242|FG003|NOT COMPLETED|Overall Study||0
11319091|NCT02709694|12516253|FG000|STARTED|Overall Study||33
11319092|NCT02709694|12516253|FG000|Any Back Pain|Overall Study||19
11319093|NCT02709694|12516253|FG000|No Back Pain|Overall Study||14
11319094|NCT02709694|12516253|FG000|MRI Showing Presence of Sacroiliitis|Overall Study||4
11319095|NCT02709694|12516253|FG000|MRI Not Showing Sacroiliitis|Overall Study||29
11319096|NCT02709694|12516253|FG000|Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||6
11319097|NCT02709694|12516253|FG000|Not Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||25
11319098|NCT02709694|12516253|FG000|Having Bone Marrow Edema Seen in MRI|Overall Study||33
11319099|NCT02709694|12516253|FG000|Having Erosion (a Structural Lesion) Seen in MRI|Overall Study||33
11319100|NCT02709694|12516253|FG000|Having Fat Metaplasia Seen in MRI|Overall Study||33
11319101|NCT02709694|12516253|FG000|Having Backfill (Type of Structural Lesion) Seen in MRI|Overall Study||33
11319102|NCT02709694|12516253|FG000|Having Ankylosis Seen in MRI|Overall Study||33
11319103|NCT02709694|12516253|FG000|COMPLETED|Overall Study||33
11319104|NCT02709694|12516253|FG000|NOT COMPLETED|Overall Study||0
11342399|NCT02945254|12539974|FG001|STARTED|Overall Study||10
11342400|NCT02945254|12539973|FG000|COMPLETED|Overall Study||8
11342401|NCT02945254|12539974|FG001|COMPLETED|Overall Study||10
11342402|NCT02945254|12539973|FG000|NOT COMPLETED|Overall Study||2
11342403|NCT02945254|12539974|FG001|NOT COMPLETED|Overall Study||0
11342404|NCT02945410|12539986|FG000|STARTED|Intervention 1 (5 Days)||3
11342405|NCT02945410|12539987|FG001|STARTED|Intervention 1 (5 Days)||4
11342406|NCT02945410|12539988|FG002|STARTED|Intervention 1 (5 Days)||2
11342407|NCT02945410|12539989|FG003|STARTED|Intervention 1 (5 Days)||3
11342408|NCT02945410|12539990|FG004|STARTED|Intervention 1 (5 Days)||2
11342409|NCT02945410|12539991|FG005|STARTED|Intervention 1 (5 Days)||1
11342410|NCT02945410|12539986|FG000|COMPLETED|Intervention 1 (5 Days)||2
11342411|NCT02945410|12539987|FG001|COMPLETED|Intervention 1 (5 Days)||1
11342412|NCT02945410|12539988|FG002|COMPLETED|Intervention 1 (5 Days)||2
11342413|NCT02945410|12539989|FG003|COMPLETED|Intervention 1 (5 Days)||3
11342414|NCT02945410|12539990|FG004|COMPLETED|Intervention 1 (5 Days)||2
11342415|NCT02945410|12539991|FG005|COMPLETED|Intervention 1 (5 Days)||0
11342416|NCT02945410|12539986|FG000|NOT COMPLETED|Intervention 1 (5 Days)||1
11342417|NCT02945410|12539987|FG001|NOT COMPLETED|Intervention 1 (5 Days)||3
11342418|NCT02945410|12539988|FG002|NOT COMPLETED|Intervention 1 (5 Days)||0
11342419|NCT02945410|12539989|FG003|NOT COMPLETED|Intervention 1 (5 Days)||0
11342420|NCT02945410|12539990|FG004|NOT COMPLETED|Intervention 1 (5 Days)||0
11342421|NCT02945410|12539991|FG005|NOT COMPLETED|Intervention 1 (5 Days)||1
11342422|NCT02945410|12539986|FG000|STARTED|Washout 1 (14 Days)||2
11342423|NCT02945410|12539987|FG001|STARTED|Washout 1 (14 Days)||1
11342424|NCT02945410|12539988|FG002|STARTED|Washout 1 (14 Days)||2
11342425|NCT02945410|12539989|FG003|STARTED|Washout 1 (14 Days)||3
11342426|NCT02945410|12539990|FG004|STARTED|Washout 1 (14 Days)||2
11342427|NCT02945410|12539991|FG005|STARTED|Washout 1 (14 Days)||0
11342428|NCT02945410|12539986|FG000|COMPLETED|Washout 1 (14 Days)||2
11342429|NCT02945410|12539987|FG001|COMPLETED|Washout 1 (14 Days)||1
11342430|NCT02945410|12539988|FG002|COMPLETED|Washout 1 (14 Days)||0
11342431|NCT02945410|12539989|FG003|COMPLETED|Washout 1 (14 Days)||3
11342432|NCT02945410|12539990|FG004|COMPLETED|Washout 1 (14 Days)||1
11342433|NCT02945410|12539991|FG005|COMPLETED|Washout 1 (14 Days)||0
11342434|NCT02945410|12539986|FG000|NOT COMPLETED|Washout 1 (14 Days)||0
11342435|NCT02945410|12539987|FG001|NOT COMPLETED|Washout 1 (14 Days)||0
11342436|NCT02945410|12539988|FG002|NOT COMPLETED|Washout 1 (14 Days)||2
11342437|NCT02945410|12539989|FG003|NOT COMPLETED|Washout 1 (14 Days)||0
11342438|NCT02945410|12539990|FG004|NOT COMPLETED|Washout 1 (14 Days)||1
11342439|NCT02945410|12539991|FG005|NOT COMPLETED|Washout 1 (14 Days)||0
11342440|NCT02945410|12539986|FG000|STARTED|Intervention 2 (5 Days)||2
11342441|NCT02945410|12539987|FG001|STARTED|Intervention 2 (5 Days)||1
11342442|NCT02945410|12539988|FG002|STARTED|Intervention 2 (5 Days)||0
11342443|NCT02945410|12539989|FG003|STARTED|Intervention 2 (5 Days)||3
11342444|NCT02945410|12539990|FG004|STARTED|Intervention 2 (5 Days)||1
11342445|NCT02945410|12539991|FG005|STARTED|Intervention 2 (5 Days)||0
11342446|NCT02945410|12539986|FG000|COMPLETED|Intervention 2 (5 Days)||2
11342447|NCT02945410|12539987|FG001|COMPLETED|Intervention 2 (5 Days)||1
11342448|NCT02945410|12539988|FG002|COMPLETED|Intervention 2 (5 Days)||0
11342449|NCT02945410|12539989|FG003|COMPLETED|Intervention 2 (5 Days)||3
11342450|NCT02945410|12539990|FG004|COMPLETED|Intervention 2 (5 Days)||1
11319105|NCT02709746|12516272|FG000|STARTED|Phase A (Single-blind Treatment Period)||784
11319106|NCT02709746|12516273|FG001|STARTED|Phase A (Single-blind Treatment Period)||0
11319107|NCT02709746|12516274|FG002|STARTED|Phase A (Single-blind Treatment Period)||0
11319108|NCT02709746|12516275|FG003|STARTED|Phase A (Single-blind Treatment Period)||0
11319109|NCT02709746|12516276|FG004|STARTED|Phase A (Single-blind Treatment Period)||0
11319110|NCT02709746|12516272|FG000|COMPLETED|Phase A (Single-blind Treatment Period)||616
11319111|NCT02709746|12516273|FG001|COMPLETED|Phase A (Single-blind Treatment Period)||0
11319112|NCT02709746|12516274|FG002|COMPLETED|Phase A (Single-blind Treatment Period)||0
11319113|NCT02709746|12516275|FG003|COMPLETED|Phase A (Single-blind Treatment Period)||0
11319114|NCT02709746|12516276|FG004|COMPLETED|Phase A (Single-blind Treatment Period)||0
11319115|NCT02709746|12516272|FG000|NOT COMPLETED|Phase A (Single-blind Treatment Period)||168
11319116|NCT02709746|12516273|FG001|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
11319117|NCT02709746|12516274|FG002|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
11319118|NCT02709746|12516275|FG003|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
11319119|NCT02709746|12516276|FG004|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
11319120|NCT02709746|12516272|FG000|STARTED|Phase B (Double-blind Treatment Period)||0
11319121|NCT02709746|12516273|FG001|STARTED|Phase B (Double-blind Treatment Period)||147
11319122|NCT02709746|12516274|FG002|STARTED|Phase B (Double-blind Treatment Period)||162
11319123|NCT02709746|12516275|FG003|STARTED|Phase B (Double-blind Treatment Period)||153
11319124|NCT02709746|12516276|FG004|STARTED|Phase B (Double-blind Treatment Period)||154
11319125|NCT02709746|12516272|FG000|COMPLETED|Phase B (Double-blind Treatment Period)||0
11319126|NCT02709746|12516273|FG001|COMPLETED|Phase B (Double-blind Treatment Period)||126
11319127|NCT02709746|12516274|FG002|COMPLETED|Phase B (Double-blind Treatment Period)||140
11319128|NCT02709746|12516275|FG003|COMPLETED|Phase B (Double-blind Treatment Period)||138
11319129|NCT02709746|12516276|FG004|COMPLETED|Phase B (Double-blind Treatment Period)||138
11319130|NCT02709746|12516272|FG000|NOT COMPLETED|Phase B (Double-blind Treatment Period)||0
11319131|NCT02709746|12516273|FG001|NOT COMPLETED|Phase B (Double-blind Treatment Period)||21
11319132|NCT02709746|12516274|FG002|NOT COMPLETED|Phase B (Double-blind Treatment Period)||22
11319133|NCT02709746|12516275|FG003|NOT COMPLETED|Phase B (Double-blind Treatment Period)||15
11319134|NCT02709746|12516276|FG004|NOT COMPLETED|Phase B (Double-blind Treatment Period)||16
11319135|NCT02709785|12516291|FG000|STARTED|Overall Study||24
11319136|NCT02709785|12516292|FG001|STARTED|Overall Study||28
11319137|NCT02709785|12516293|FG002|STARTED|Overall Study||28
11319138|NCT02709785|12516291|FG000|3 Weeks|Overall Study||23
11319139|NCT02709785|12516292|FG001|3 Weeks|Overall Study||27
11319140|NCT02709785|12516293|FG002|3 Weeks|Overall Study||27
11319141|NCT02709785|12516291|FG000|6 Weeks|Overall Study||23
11319142|NCT02709785|12516292|FG001|6 Weeks|Overall Study||26
11319143|NCT02709785|12516293|FG002|6 Weeks|Overall Study||27
11319144|NCT02709785|12516291|FG000|COMPLETED|Overall Study||23
11319145|NCT02709785|12516292|FG001|COMPLETED|Overall Study||26
11319146|NCT02709785|12516293|FG002|COMPLETED|Overall Study||27
11319147|NCT02709785|12516291|FG000|NOT COMPLETED|Overall Study||1
11319148|NCT02709785|12516292|FG001|NOT COMPLETED|Overall Study||2
11319149|NCT02709785|12516293|FG002|NOT COMPLETED|Overall Study||1
11319150|NCT02709889|12516309|FG000|STARTED|Overall Study||43
11319151|NCT02709889|12516310|FG001|STARTED|Overall Study||57
11319152|NCT02709889|12516311|FG002|STARTED|Overall Study||12
11319153|NCT02709889|12516312|FG003|STARTED|Overall Study||88
11319154|NCT02709889|12516309|FG000|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||3
11319155|NCT02709889|12516310|FG001|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
11319156|NCT02709889|12516311|FG002|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||2
11319157|NCT02709889|12516312|FG003|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
11319158|NCT02709889|12516309|FG000|Neuroendocrine Prostate Cancer|Overall Study||4
11319159|NCT02709889|12516310|FG001|Neuroendocrine Prostate Cancer|Overall Study||7
11319160|NCT02709889|12516311|FG002|Neuroendocrine Prostate Cancer|Overall Study||3
11319161|NCT02709889|12516312|FG003|Neuroendocrine Prostate Cancer|Overall Study||7
11319162|NCT02709889|12516309|FG000|Gastroenteropancreatic NEC|Overall Study||6
11319163|NCT02709889|12516310|FG001|Gastroenteropancreatic NEC|Overall Study||5
11319164|NCT02709889|12516311|FG002|Gastroenteropancreatic NEC|Overall Study||2
11319165|NCT02709889|12516312|FG003|Gastroenteropancreatic NEC|Overall Study||23
11319166|NCT02709889|12516309|FG000|Other NEC|Overall Study||11
11319167|NCT02709889|12516310|FG001|Other NEC|Overall Study||12
11319168|NCT02709889|12516311|FG002|Other NEC|Overall Study||1
11319169|NCT02709889|12516312|FG003|Other NEC|Overall Study||7
11319170|NCT02709889|12516309|FG000|Malignant Melanoma|Overall Study||3
11319171|NCT02709889|12516310|FG001|Malignant Melanoma|Overall Study||6
11319172|NCT02709889|12516311|FG002|Malignant Melanoma|Overall Study||0
11319173|NCT02709889|12516312|FG003|Malignant Melanoma|Overall Study||11
11319174|NCT02709889|12516309|FG000|Medullary Thyroid Cancer|Overall Study||3
11319175|NCT02709889|12516310|FG001|Medullary Thyroid Cancer|Overall Study||3
11319176|NCT02709889|12516311|FG002|Medullary Thyroid Cancer|Overall Study||0
11319177|NCT02709889|12516312|FG003|Medullary Thyroid Cancer|Overall Study||7
11319178|NCT02709889|12516309|FG000|Glioblastoma|Overall Study||4
11319179|NCT02709889|12516310|FG001|Glioblastoma|Overall Study||4
11319180|NCT02709889|12516311|FG002|Glioblastoma|Overall Study||1
11319181|NCT02709889|12516312|FG003|Glioblastoma|Overall Study||14
11319182|NCT02709889|12516309|FG000|Other Solid Tumors|Overall Study||9
11319183|NCT02709889|12516310|FG001|Other Solid Tumors|Overall Study||16
11319184|NCT02709889|12516311|FG002|Other Solid Tumors|Overall Study||3
11319185|NCT02709889|12516312|FG003|Other Solid Tumors|Overall Study||15
11319186|NCT02709889|12516309|FG000|COMPLETED|Overall Study||0
11319187|NCT02709889|12516310|FG001|COMPLETED|Overall Study||0
11319188|NCT02709889|12516311|FG002|COMPLETED|Overall Study||0
11319189|NCT02709889|12516312|FG003|COMPLETED|Overall Study||0
11319190|NCT02709889|12516309|FG000|NOT COMPLETED|Overall Study||43
11319191|NCT02709889|12516310|FG001|NOT COMPLETED|Overall Study||57
11319192|NCT02709889|12516311|FG002|NOT COMPLETED|Overall Study||12
11319193|NCT02709889|12516312|FG003|NOT COMPLETED|Overall Study||88
11319194|NCT02710045|12516360|FG000|STARTED|Overall Study||106
11319195|NCT02710045|12516361|FG001|STARTED|Overall Study||115
11319196|NCT02710045|12516362|FG002|STARTED|Overall Study||81
11319197|NCT02710045|12516360|FG000|COMPLETED|Overall Study||95
11319198|NCT02710045|12516361|FG001|COMPLETED|Overall Study||98
11319199|NCT02710045|12516362|FG002|COMPLETED|Overall Study||68
11319200|NCT02710045|12516360|FG000|NOT COMPLETED|Overall Study||11
11319201|NCT02710045|12516361|FG001|NOT COMPLETED|Overall Study||17
11319202|NCT02710045|12516362|FG002|NOT COMPLETED|Overall Study||13
11319203|NCT02710071|12516372|FG000|STARTED|Placebo (2 Weeks).||21
11319204|NCT02710071|12516373|FG001|STARTED|Placebo (2 Weeks).||20
11319205|NCT02710071|12516372|FG000|COMPLETED|Placebo (2 Weeks).||21
11319206|NCT02710071|12516373|FG001|COMPLETED|Placebo (2 Weeks).||20
11319207|NCT02710071|12516372|FG000|NOT COMPLETED|Placebo (2 Weeks).||0
11319208|NCT02710071|12516373|FG001|NOT COMPLETED|Placebo (2 Weeks).||0
11319209|NCT02710071|12516372|FG000|STARTED|First Intervention (6 Weeks).||21
11319210|NCT02710071|12516373|FG001|STARTED|First Intervention (6 Weeks).||20
11319211|NCT02710071|12516372|FG000|COMPLETED|First Intervention (6 Weeks).||18
11319212|NCT02710071|12516373|FG001|COMPLETED|First Intervention (6 Weeks).||16
11319213|NCT02710071|12516372|FG000|NOT COMPLETED|First Intervention (6 Weeks).||3
11319214|NCT02710071|12516373|FG001|NOT COMPLETED|First Intervention (6 Weeks).||4
11319215|NCT02710071|12516372|FG000|STARTED|Second Intervention (6 Weeks).||18
11319216|NCT02710071|12516373|FG001|STARTED|Second Intervention (6 Weeks).||16
11319217|NCT02710071|12516372|FG000|COMPLETED|Second Intervention (6 Weeks).||17
11319218|NCT02710071|12516373|FG001|COMPLETED|Second Intervention (6 Weeks).||14
11319219|NCT02710071|12516372|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||1
11319220|NCT02710071|12516373|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2
11319221|NCT02710136|12516382|FG000|STARTED|Study Enrollment||10
11319222|NCT02710136|12516383|FG001|STARTED|Study Enrollment||25
11319223|NCT02710136|12516382|FG000|COMPLETED|Study Enrollment||10
11319224|NCT02710136|12516383|FG001|COMPLETED|Study Enrollment||25
11319225|NCT02710136|12516382|FG000|NOT COMPLETED|Study Enrollment||0
11319226|NCT02710136|12516383|FG001|NOT COMPLETED|Study Enrollment||0
11319227|NCT02710136|12516382|FG000|STARTED|Phase 1a[Refer to Arm/Group Description]||10
11319228|NCT02710136|12516383|FG001|STARTED|Phase 1a[Refer to Arm/Group Description]||0
11319229|NCT02710136|12516382|FG000|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
11319230|NCT02710136|12516383|FG001|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
11319231|NCT02710136|12516382|FG000|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
11319232|NCT02710136|12516383|FG001|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
11319233|NCT02710136|12516382|FG000|STARTED|Phase 1b[Refer to Arm/Group Description]||4
11319234|NCT02710136|12516383|FG001|STARTED|Phase 1b[Refer to Arm/Group Description]||0
11319235|NCT02710136|12516382|FG000|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
11319236|NCT02710136|12516383|FG001|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
11319237|NCT02710136|12516382|FG000|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
11319238|NCT02710136|12516383|FG001|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
11319239|NCT02710136|12516382|FG000|STARTED|Phase 2 [Refer to Arm/Group Description]||0
11319240|NCT02710136|12516383|FG001|STARTED|Phase 2 [Refer to Arm/Group Description]||25
11319241|NCT02710136|12516382|FG000|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
11319242|NCT02710136|12516383|FG001|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
11319243|NCT02710136|12516382|FG000|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
11319244|NCT02710136|12516383|FG001|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
11319245|NCT02710214|12516392|FG000|STARTED|Overall Study||12
11319246|NCT02710214|12516393|FG001|STARTED|Overall Study||12
11319247|NCT02710214|12516392|FG000|COMPLETED|Overall Study||11
11319248|NCT02710214|12516393|FG001|COMPLETED|Overall Study||10
11319249|NCT02710214|12516392|FG000|NOT COMPLETED|Overall Study||1
11319250|NCT02710214|12516393|FG001|NOT COMPLETED|Overall Study||2
11319251|NCT02710240|12516399|FG000|STARTED|Overall Study||336
11319252|NCT02710240|12516399|FG000|COMPLETED|Overall Study||336
11319253|NCT02710240|12516399|FG000|NOT COMPLETED|Overall Study||0
11319254|NCT02710292|12516403|FG000|STARTED|Period 1, First 10 Days of Wear||47
11319255|NCT02710292|12516404|FG001|STARTED|Period 1, First 10 Days of Wear||52
11319256|NCT02710292|12516403|FG000|COMPLETED|Period 1, First 10 Days of Wear||46
11319257|NCT02710292|12516404|FG001|COMPLETED|Period 1, First 10 Days of Wear||49
11319258|NCT02710292|12516403|FG000|NOT COMPLETED|Period 1, First 10 Days of Wear||1
11319259|NCT02710292|12516404|FG001|NOT COMPLETED|Period 1, First 10 Days of Wear||3
11319260|NCT02710292|12516403|FG000|STARTED|Period 2, Second 10 Days of Wear||46
11319261|NCT02710292|12516404|FG001|STARTED|Period 2, Second 10 Days of Wear||49
11319262|NCT02710292|12516403|FG000|COMPLETED|Period 2, Second 10 Days of Wear||46
11319263|NCT02710292|12516404|FG001|COMPLETED|Period 2, Second 10 Days of Wear||49
11319264|NCT02710292|12516403|FG000|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
11319265|NCT02710292|12516404|FG001|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
11319266|NCT02710422|12516413|FG000|STARTED|Overall Study||12
11319267|NCT02710422|12516414|FG001|STARTED|Overall Study||12
11319268|NCT02710422|12516413|FG000|3 Month Visit|Overall Study||9
11319269|NCT02710422|12516414|FG001|3 Month Visit|Overall Study||11
11319270|NCT02710422|12516413|FG000|6 Month Visit|Overall Study||7
11319271|NCT02710422|12516414|FG001|6 Month Visit|Overall Study||8
11319272|NCT02710422|12516413|FG000|9 Month Visit|Overall Study||5
11319273|NCT02710422|12516414|FG001|9 Month Visit|Overall Study||5
11319274|NCT02710422|12516413|FG000|12 Month Visit|Overall Study||3
11319275|NCT02710422|12516414|FG001|12 Month Visit|Overall Study||3
11319276|NCT02710422|12516413|FG000|COMPLETED|Overall Study||3
11319277|NCT02710422|12516414|FG001|COMPLETED|Overall Study||3
11319278|NCT02710422|12516413|FG000|NOT COMPLETED|Overall Study||9
11319279|NCT02710422|12516414|FG001|NOT COMPLETED|Overall Study||9
11319280|NCT02710526|12516425|FG000|STARTED|Treatment Phase||28
11319281|NCT02710526|12516426|FG001|STARTED|Treatment Phase||20
11319282|NCT02710526|12516427|FG002|STARTED|Treatment Phase||18
11319283|NCT02710526|12516425|FG000|COMPLETED|Treatment Phase||22
11319284|NCT02710526|12516426|FG001|COMPLETED|Treatment Phase||16
11319285|NCT02710526|12516427|FG002|COMPLETED|Treatment Phase||12
11319286|NCT02710526|12516425|FG000|NOT COMPLETED|Treatment Phase||6
11319287|NCT02710526|12516426|FG001|NOT COMPLETED|Treatment Phase||4
11319288|NCT02710526|12516427|FG002|NOT COMPLETED|Treatment Phase||6
11319289|NCT02710526|12516425|FG000|STARTED|Safety Extension||15
11319290|NCT02710526|12516426|FG001|STARTED|Safety Extension||12
11319291|NCT02710526|12516427|FG002|STARTED|Safety Extension||0
11319292|NCT02710526|12516425|FG000|COMPLETED|Safety Extension||14
11319293|NCT02710526|12516426|FG001|COMPLETED|Safety Extension||12
11319294|NCT02710526|12516427|FG002|COMPLETED|Safety Extension||0
11319295|NCT02710526|12516425|FG000|NOT COMPLETED|Safety Extension||1
11319296|NCT02710526|12516426|FG001|NOT COMPLETED|Safety Extension||0
11319297|NCT02710526|12516427|FG002|NOT COMPLETED|Safety Extension||0
11319298|NCT02710591|12516449|FG000|STARTED|Overall Study||5
11319299|NCT02710591|12516450|FG001|STARTED|Overall Study||5
11319300|NCT02710591|12516451|FG002|STARTED|Overall Study||5
11319301|NCT02710591|12516452|FG003|STARTED|Overall Study||5
11319302|NCT02710591|12516449|FG000|COMPLETED|Overall Study||5
11319303|NCT02710591|12516450|FG001|COMPLETED|Overall Study||5
11319304|NCT02710591|12516451|FG002|COMPLETED|Overall Study||5
11319305|NCT02710591|12516452|FG003|COMPLETED|Overall Study||5
11319306|NCT02710591|12516449|FG000|NOT COMPLETED|Overall Study||0
11319307|NCT02710591|12516450|FG001|NOT COMPLETED|Overall Study||0
11319308|NCT02710591|12516451|FG002|NOT COMPLETED|Overall Study||0
11319309|NCT02710591|12516452|FG003|NOT COMPLETED|Overall Study||0
11319310|NCT02710630|12516467|FG000|STARTED|Period 1||7
11319311|NCT02710630|12516468|FG001|STARTED|Period 1||7
11319312|NCT02710630|12516469|FG002|STARTED|Period 1||7
11319313|NCT02710630|12516470|FG003|STARTED|Period 1||7
11319314|NCT02710630|12516471|FG004|STARTED|Period 1||7
11319315|NCT02710630|12516467|FG000|COMPLETED|Period 1||7
11319316|NCT02710630|12516468|FG001|COMPLETED|Period 1||7
11319317|NCT02710630|12516469|FG002|COMPLETED|Period 1||7
11319318|NCT02710630|12516470|FG003|COMPLETED|Period 1||7
11319319|NCT02710630|12516471|FG004|COMPLETED|Period 1||7
11319320|NCT02710630|12516467|FG000|NOT COMPLETED|Period 1||0
11319321|NCT02710630|12516468|FG001|NOT COMPLETED|Period 1||0
11319322|NCT02710630|12516469|FG002|NOT COMPLETED|Period 1||0
11319323|NCT02710630|12516470|FG003|NOT COMPLETED|Period 1||0
11319324|NCT02710630|12516471|FG004|NOT COMPLETED|Period 1||0
11319325|NCT02710630|12516467|FG000|STARTED|Period 2||7
11319326|NCT02710630|12516468|FG001|STARTED|Period 2||7
11319327|NCT02710630|12516469|FG002|STARTED|Period 2||7
11319328|NCT02710630|12516470|FG003|STARTED|Period 2||7
11319329|NCT02710630|12516471|FG004|STARTED|Period 2||7
11319330|NCT02710630|12516467|FG000|Not Treated|Period 2||1
11319331|NCT02710630|12516468|FG001|Not Treated|Period 2||0
11319332|NCT02710630|12516469|FG002|Not Treated|Period 2||0
11319333|NCT02710630|12516470|FG003|Not Treated|Period 2||0
11319334|NCT02710630|12516471|FG004|Not Treated|Period 2||0
11319335|NCT02710630|12516467|FG000|COMPLETED|Period 2||7
11319336|NCT02710630|12516468|FG001|COMPLETED|Period 2||7
11319337|NCT02710630|12516469|FG002|COMPLETED|Period 2||7
11319338|NCT02710630|12516470|FG003|COMPLETED|Period 2||7
11319339|NCT02710630|12516471|FG004|COMPLETED|Period 2||7
11319340|NCT02710630|12516467|FG000|NOT COMPLETED|Period 2||0
11319341|NCT02710630|12516468|FG001|NOT COMPLETED|Period 2||0
11319342|NCT02710630|12516469|FG002|NOT COMPLETED|Period 2||0
11319343|NCT02710630|12516470|FG003|NOT COMPLETED|Period 2||0
11319344|NCT02710630|12516471|FG004|NOT COMPLETED|Period 2||0
11319345|NCT02710630|12516467|FG000|STARTED|Period 3||7
11319346|NCT02710630|12516468|FG001|STARTED|Period 3||7
11319347|NCT02710630|12516469|FG002|STARTED|Period 3||7
11319348|NCT02710630|12516470|FG003|STARTED|Period 3||7
11319349|NCT02710630|12516471|FG004|STARTED|Period 3||7
11319350|NCT02710630|12516467|FG000|COMPLETED|Period 3||7
11319351|NCT02710630|12516468|FG001|COMPLETED|Period 3||7
11319352|NCT02710630|12516469|FG002|COMPLETED|Period 3||7
11319353|NCT02710630|12516470|FG003|COMPLETED|Period 3||7
11319354|NCT02710630|12516471|FG004|COMPLETED|Period 3||7
11319355|NCT02710630|12516467|FG000|NOT COMPLETED|Period 3||0
11319356|NCT02710630|12516468|FG001|NOT COMPLETED|Period 3||0
11319357|NCT02710630|12516469|FG002|NOT COMPLETED|Period 3||0
11319358|NCT02710630|12516470|FG003|NOT COMPLETED|Period 3||0
11319359|NCT02710630|12516471|FG004|NOT COMPLETED|Period 3||0
11319360|NCT02710630|12516467|FG000|STARTED|Period 4||7
11319361|NCT02710630|12516468|FG001|STARTED|Period 4||7
11319362|NCT02710630|12516469|FG002|STARTED|Period 4||7
11319363|NCT02710630|12516470|FG003|STARTED|Period 4||7
11319364|NCT02710630|12516471|FG004|STARTED|Period 4||7
11319365|NCT02710630|12516467|FG000|COMPLETED|Period 4||7
11319366|NCT02710630|12516468|FG001|COMPLETED|Period 4||7
11319367|NCT02710630|12516469|FG002|COMPLETED|Period 4||7
11319368|NCT02710630|12516470|FG003|COMPLETED|Period 4||7
11319369|NCT02710630|12516471|FG004|COMPLETED|Period 4||7
11402603|NCT04032652|12597488|FG000|NOT COMPLETED|Overall Study||1
11402604|NCT04032652|12597489|FG001|NOT COMPLETED|Overall Study||1
11402605|NCT04024501|12597495|FG000|STARTED|Overall Study||25
11319370|NCT02710630|12516467|FG000|NOT COMPLETED|Period 4||0
11319371|NCT02710630|12516468|FG001|NOT COMPLETED|Period 4||0
11319372|NCT02710630|12516469|FG002|NOT COMPLETED|Period 4||0
11319373|NCT02710630|12516470|FG003|NOT COMPLETED|Period 4||0
11319374|NCT02710630|12516471|FG004|NOT COMPLETED|Period 4||0
11319375|NCT02710630|12516467|FG000|STARTED|Period 5||7
11319376|NCT02710630|12516468|FG001|STARTED|Period 5||7
11319377|NCT02710630|12516469|FG002|STARTED|Period 5||7
11319378|NCT02710630|12516470|FG003|STARTED|Period 5||7
11319379|NCT02710630|12516471|FG004|STARTED|Period 5||7
11319380|NCT02710630|12516467|FG000|COMPLETED|Period 5||7
11319381|NCT02710630|12516468|FG001|COMPLETED|Period 5||7
11319382|NCT02710630|12516469|FG002|COMPLETED|Period 5||7
11319383|NCT02710630|12516470|FG003|COMPLETED|Period 5||7
11319384|NCT02710630|12516471|FG004|COMPLETED|Period 5||7
11319385|NCT02710630|12516467|FG000|NOT COMPLETED|Period 5||0
11319386|NCT02710630|12516468|FG001|NOT COMPLETED|Period 5||0
11319387|NCT02710630|12516469|FG002|NOT COMPLETED|Period 5||0
11319388|NCT02710630|12516470|FG003|NOT COMPLETED|Period 5||0
11319389|NCT02710630|12516471|FG004|NOT COMPLETED|Period 5||0
11319390|NCT02710630|12516467|FG000|STARTED|Period 6||7
11319391|NCT02710630|12516468|FG001|STARTED|Period 6||7
11402606|NCT04024501|12597495|FG000|COMPLETED|Overall Study||25
11402607|NCT04024501|12597495|FG000|NOT COMPLETED|Overall Study||0
11402608|NCT04032613|12597509|FG000|STARTED|Overall Study||21
11402609|NCT04032613|12597510|FG001|STARTED|Overall Study||25
11402610|NCT04032613|12597509|FG000|COMPLETED|Overall Study||16
11319392|NCT02710630|12516469|FG002|STARTED|Period 6||7
11319393|NCT02710630|12516470|FG003|STARTED|Period 6||7
11319394|NCT02710630|12516471|FG004|STARTED|Period 6||7
11319395|NCT02710630|12516467|FG000|COMPLETED|Period 6||7
11319396|NCT02710630|12516468|FG001|COMPLETED|Period 6||7
11319397|NCT02710630|12516469|FG002|COMPLETED|Period 6||7
11319398|NCT02710630|12516470|FG003|COMPLETED|Period 6||7
11319399|NCT02710630|12516471|FG004|COMPLETED|Period 6||7
11319400|NCT02710630|12516467|FG000|NOT COMPLETED|Period 6||0
11319401|NCT02710630|12516468|FG001|NOT COMPLETED|Period 6||0
11319402|NCT02710630|12516469|FG002|NOT COMPLETED|Period 6||0
11319403|NCT02710630|12516470|FG003|NOT COMPLETED|Period 6||0
11319404|NCT02710630|12516471|FG004|NOT COMPLETED|Period 6||0
11319405|NCT02710890|12516487|FG000|STARTED|Overall Study||48
11319406|NCT02710890|12516488|FG001|STARTED|Overall Study||55
11319407|NCT02710890|12516487|FG000|COMPLETED|Overall Study||48
11319408|NCT02710890|12516488|FG001|COMPLETED|Overall Study||55
11319409|NCT02710890|12516487|FG000|NOT COMPLETED|Overall Study||0
11319410|NCT02710890|12516488|FG001|NOT COMPLETED|Overall Study||0
11319411|NCT02710981|12516494|FG000|STARTED|6th Ovulation Induction Cycle (5 Days)||42
11319412|NCT02710981|12516495|FG001|STARTED|6th Ovulation Induction Cycle (5 Days)||0
11319413|NCT02710981|12516494|FG000|COMPLETED|6th Ovulation Induction Cycle (5 Days)||41
11319414|NCT02710981|12516495|FG001|COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
11319415|NCT02710981|12516494|FG000|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||1
11319416|NCT02710981|12516495|FG001|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
11319417|NCT02710981|12516494|FG000|STARTED|7th Ovulation Induction Cycle (5 Days)||0
11319418|NCT02710981|12516495|FG001|STARTED|7th Ovulation Induction Cycle (5 Days)||41
11319419|NCT02710981|12516494|FG000|COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
11319420|NCT02710981|12516495|FG001|COMPLETED|7th Ovulation Induction Cycle (5 Days)||36
11319421|NCT02710981|12516494|FG000|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
11319422|NCT02710981|12516495|FG001|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||5
11319423|NCT02711306|12516505|FG000|STARTED|Overall Study||18
11319424|NCT02711306|12516506|FG001|STARTED|Overall Study||18
11319425|NCT02711306|12516505|FG000|COMPLETED|Overall Study||16
11319426|NCT02711306|12516506|FG001|COMPLETED|Overall Study||16
11319427|NCT02711306|12516505|FG000|NOT COMPLETED|Overall Study||2
11319428|NCT02711306|12516506|FG001|NOT COMPLETED|Overall Study||2
11319429|NCT02711345|12516522|FG000|STARTED|Overall Study||2
11319430|NCT02711345|12516523|FG001|STARTED|Overall Study||3
11319431|NCT02711345|12516524|FG002|STARTED|Overall Study||6
11319432|NCT02711345|12516525|FG003|STARTED|Overall Study||4
11319433|NCT02711345|12516526|FG004|STARTED|Overall Study||8
11319434|NCT02711345|12516527|FG005|STARTED|Overall Study||6
11319435|NCT02711345|12516528|FG006|STARTED|Overall Study||12
11319436|NCT02711345|12516529|FG007|STARTED|Overall Study||6
11319437|NCT02711345|12516530|FG008|STARTED|Overall Study||6
11319438|NCT02711345|12516531|FG009|STARTED|Overall Study||12
11319439|NCT02711345|12516522|FG000|COMPLETED|Overall Study||0
11319440|NCT02711345|12516523|FG001|COMPLETED|Overall Study||0
11319441|NCT02711345|12516524|FG002|COMPLETED|Overall Study||0
11319442|NCT02711345|12516525|FG003|COMPLETED|Overall Study||0
11319443|NCT02711345|12516526|FG004|COMPLETED|Overall Study||0
11319444|NCT02711345|12516527|FG005|COMPLETED|Overall Study||0
11319445|NCT02711345|12516528|FG006|COMPLETED|Overall Study||0
11319446|NCT02711345|12516529|FG007|COMPLETED|Overall Study||0
11319447|NCT02711345|12516530|FG008|COMPLETED|Overall Study||0
11319448|NCT02711345|12516531|FG009|COMPLETED|Overall Study||0
11402611|NCT04032613|12597510|FG001|COMPLETED|Overall Study||23
11402612|NCT04032613|12597509|FG000|NOT COMPLETED|Overall Study||5
11319449|NCT02711345|12516522|FG000|NOT COMPLETED|Overall Study||2
11319450|NCT02711345|12516523|FG001|NOT COMPLETED|Overall Study||3
11319451|NCT02711345|12516524|FG002|NOT COMPLETED|Overall Study||6
11319452|NCT02711345|12516525|FG003|NOT COMPLETED|Overall Study||4
11319453|NCT02711345|12516526|FG004|NOT COMPLETED|Overall Study||8
11319454|NCT02711345|12516527|FG005|NOT COMPLETED|Overall Study||6
11319455|NCT02711345|12516528|FG006|NOT COMPLETED|Overall Study||12
11319456|NCT02711345|12516529|FG007|NOT COMPLETED|Overall Study||6
11319457|NCT02711345|12516530|FG008|NOT COMPLETED|Overall Study||6
11319458|NCT02711345|12516531|FG009|NOT COMPLETED|Overall Study||12
11319459|NCT02711553|12516562|FG000|STARTED|Overall Study||106
11319460|NCT02711553|12516563|FG001|STARTED|Overall Study||52
11319461|NCT02711553|12516564|FG002|STARTED|Overall Study||102
11319462|NCT02711553|12516565|FG003|STARTED|Overall Study||49
11319463|NCT02711553|12516562|FG000|Received at Least 1 Dose of Study Drug|Overall Study||104
11319464|NCT02711553|12516563|FG001|Received at Least 1 Dose of Study Drug|Overall Study||52
11319465|NCT02711553|12516564|FG002|Received at Least 1 Dose of Study Drug|Overall Study||102
11319466|NCT02711553|12516565|FG003|Received at Least 1 Dose of Study Drug|Overall Study||48
11319467|NCT02711553|12516562|FG000|COMPLETED|Overall Study||100
11319468|NCT02711553|12516563|FG001|COMPLETED|Overall Study||47
11319469|NCT02711553|12516564|FG002|COMPLETED|Overall Study||92
11319470|NCT02711553|12516565|FG003|COMPLETED|Overall Study||45
11319471|NCT02711553|12516562|FG000|NOT COMPLETED|Overall Study||6
11319472|NCT02711553|12516563|FG001|NOT COMPLETED|Overall Study||5
11319473|NCT02711553|12516564|FG002|NOT COMPLETED|Overall Study||10
11319474|NCT02711553|12516565|FG003|NOT COMPLETED|Overall Study||4
11319475|NCT02711800|12516577|FG000|STARTED|Overall Study||9
11319476|NCT02711800|12516577|FG000|COMPLETED|Overall Study||7
11319477|NCT02711800|12516577|FG000|NOT COMPLETED|Overall Study||2
11319478|NCT02711839|12516583|FG000|STARTED|Overall Study||20
11319479|NCT02711839|12516584|FG001|STARTED|Overall Study||34
11319480|NCT02711839|12516583|FG000|COMPLETED|Overall Study||16
11319481|NCT02711839|12516584|FG001|COMPLETED|Overall Study||24
11319482|NCT02711839|12516583|FG000|NOT COMPLETED|Overall Study||4
11319483|NCT02711839|12516584|FG001|NOT COMPLETED|Overall Study||10
11319484|NCT02711956|12516605|FG000|STARTED|Overall Study||2
11319485|NCT02711956|12516606|FG001|STARTED|Overall Study||2
11319486|NCT02711956|12516607|FG002|STARTED|Overall Study||3
11319487|NCT02711956|12516608|FG003|STARTED|Overall Study||5
11319488|NCT02711956|12516609|FG004|STARTED|Overall Study||4
11319489|NCT02711956|12516610|FG005|STARTED|Overall Study||3
11319490|NCT02711956|12516611|FG006|STARTED|Overall Study||4
11319491|NCT02711956|12516612|FG007|STARTED|Overall Study||4
11319492|NCT02711956|12516613|FG008|STARTED|Overall Study||4
11319493|NCT02711956|12516614|FG009|STARTED|Overall Study||3
11319494|NCT02711956|12516615|FG010|STARTED|Overall Study||1
11319495|NCT02711956|12516616|FG011|STARTED|Overall Study||9
11319496|NCT02711956|12516617|FG012|STARTED|Overall Study||17
11319497|NCT02711956|12516618|FG013|STARTED|Overall Study||6
11319498|NCT02711956|12516619|FG014|STARTED|Overall Study||8
11319499|NCT02711956|12516605|FG000|COMPLETED|Overall Study||0
11319500|NCT02711956|12516606|FG001|COMPLETED|Overall Study||0
11319501|NCT02711956|12516607|FG002|COMPLETED|Overall Study||1
11319502|NCT02711956|12516608|FG003|COMPLETED|Overall Study||2
11319503|NCT02711956|12516609|FG004|COMPLETED|Overall Study||0
11319504|NCT02711956|12516610|FG005|COMPLETED|Overall Study||1
11319505|NCT02711956|12516611|FG006|COMPLETED|Overall Study||0
11319506|NCT02711956|12516612|FG007|COMPLETED|Overall Study||2
11319507|NCT02711956|12516613|FG008|COMPLETED|Overall Study||0
11319508|NCT02711956|12516614|FG009|COMPLETED|Overall Study||0
11319509|NCT02711956|12516615|FG010|COMPLETED|Overall Study||0
11402613|NCT04032613|12597510|FG001|NOT COMPLETED|Overall Study||2
11402614|NCT04032171|12597518|FG000|STARTED|Overall Study||1
11402615|NCT04032171|12597519|FG001|STARTED|Overall Study||0
11402616|NCT04032171|12597518|FG000|COMPLETED|Overall Study||0
11402617|NCT04032171|12597519|FG001|COMPLETED|Overall Study||0
11319510|NCT02711956|12516616|FG011|COMPLETED|Overall Study||0
11319511|NCT02711956|12516617|FG012|COMPLETED|Overall Study||1
11319512|NCT02711956|12516618|FG013|COMPLETED|Overall Study||1
11319513|NCT02711956|12516619|FG014|COMPLETED|Overall Study||0
11319514|NCT02711956|12516605|FG000|NOT COMPLETED|Overall Study||2
11319515|NCT02711956|12516606|FG001|NOT COMPLETED|Overall Study||2
11319516|NCT02711956|12516607|FG002|NOT COMPLETED|Overall Study||2
11319517|NCT02711956|12516608|FG003|NOT COMPLETED|Overall Study||3
11319518|NCT02711956|12516609|FG004|NOT COMPLETED|Overall Study||4
11319519|NCT02711956|12516610|FG005|NOT COMPLETED|Overall Study||2
11319520|NCT02711956|12516611|FG006|NOT COMPLETED|Overall Study||4
11319521|NCT02711956|12516612|FG007|NOT COMPLETED|Overall Study||2
11319522|NCT02711956|12516613|FG008|NOT COMPLETED|Overall Study||4
11319523|NCT02711956|12516614|FG009|NOT COMPLETED|Overall Study||3
11319524|NCT02711956|12516615|FG010|NOT COMPLETED|Overall Study||1
11319525|NCT02711956|12516616|FG011|NOT COMPLETED|Overall Study||9
11319526|NCT02711956|12516617|FG012|NOT COMPLETED|Overall Study||16
11319527|NCT02711956|12516618|FG013|NOT COMPLETED|Overall Study||5
11319528|NCT02711956|12516619|FG014|NOT COMPLETED|Overall Study||8
11319529|NCT02711995|12516660|FG000|STARTED|First Intervention (30 Days)||8
11319530|NCT02711995|12516660|FG000|COMPLETED|First Intervention (30 Days)||8
11319531|NCT02711995|12516660|FG000|NOT COMPLETED|First Intervention (30 Days)||0
11319532|NCT02711995|12516660|FG000|STARTED|Washout (90 Days)||8
11319533|NCT02711995|12516660|FG000|COMPLETED|Washout (90 Days)||7
11319534|NCT02711995|12516660|FG000|NOT COMPLETED|Washout (90 Days)||1
11319535|NCT02711995|12516660|FG000|STARTED|Second Intervention (30 Days)||7
11319536|NCT02711995|12516660|FG000|COMPLETED|Second Intervention (30 Days)||7
11319537|NCT02711995|12516660|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
11319538|NCT02712008|12516669|FG000|STARTED|Baseline (Day 1) up to Week 12||50
11319539|NCT02712008|12516670|FG001|STARTED|Baseline (Day 1) up to Week 12||100
11319540|NCT02712008|12516671|FG002|STARTED|Baseline (Day 1) up to Week 12||152
11319541|NCT02712008|12516672|FG003|STARTED|Baseline (Day 1) up to Week 12||0
11319542|NCT02712008|12516673|FG004|STARTED|Baseline (Day 1) up to Week 12||0
11319543|NCT02712008|12516674|FG005|STARTED|Baseline (Day 1) up to Week 12||0
11319544|NCT02712008|12516675|FG006|STARTED|Baseline (Day 1) up to Week 12||0
11319545|NCT02712008|12516676|FG007|STARTED|Baseline (Day 1) up to Week 12||0
11319546|NCT02712008|12516669|FG000|COMPLETED|Baseline (Day 1) up to Week 12||46
11319547|NCT02712008|12516670|FG001|COMPLETED|Baseline (Day 1) up to Week 12||97
11319548|NCT02712008|12516671|FG002|COMPLETED|Baseline (Day 1) up to Week 12||148
11319549|NCT02712008|12516672|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0
11319550|NCT02712008|12516673|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0
11319551|NCT02712008|12516674|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0
11319552|NCT02712008|12516675|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0
11319553|NCT02712008|12516676|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0
11319554|NCT02712008|12516669|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
11319555|NCT02712008|12516670|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
11319556|NCT02712008|12516671|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
11319557|NCT02712008|12516672|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
11319558|NCT02712008|12516673|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
11319559|NCT02712008|12516674|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
11319560|NCT02712008|12516675|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
11319561|NCT02712008|12516676|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
11402618|NCT04032171|12597518|FG000|NOT COMPLETED|Overall Study||1
11402619|NCT04032171|12597519|FG001|NOT COMPLETED|Overall Study||0
11402620|NCT04032158|12597527|FG000|STARTED|Overall Study||2
11402621|NCT04032158|12597528|FG001|STARTED|Overall Study||1
11319562|NCT02712008|12516669|FG000|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
11319563|NCT02712008|12516670|FG001|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
11319564|NCT02712008|12516671|FG002|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
11319565|NCT02712008|12516672|FG003|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
11319566|NCT02712008|12516673|FG004|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
11319567|NCT02712008|12516674|FG005|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
11319568|NCT02712008|12516675|FG006|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
11319569|NCT02712008|12516676|FG007|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
11319570|NCT02712008|12516669|FG000|COMPLETED|From Week 12 up to Week 36||44
11319571|NCT02712008|12516670|FG001|COMPLETED|From Week 12 up to Week 36||0
11319572|NCT02712008|12516671|FG002|COMPLETED|From Week 12 up to Week 36||0
11319573|NCT02712008|12516672|FG003|COMPLETED|From Week 12 up to Week 36||42
11319574|NCT02712008|12516673|FG004|COMPLETED|From Week 12 up to Week 36||50
11319575|NCT02712008|12516674|FG005|COMPLETED|From Week 12 up to Week 36||46
11319576|NCT02712008|12516675|FG006|COMPLETED|From Week 12 up to Week 36||43
11319577|NCT02712008|12516676|FG007|COMPLETED|From Week 12 up to Week 36||45
11402622|NCT04032158|12597527|FG000|COMPLETED|Overall Study||0
11319578|NCT02712008|12516669|FG000|NOT COMPLETED|From Week 12 up to Week 36||1
11319579|NCT02712008|12516670|FG001|NOT COMPLETED|From Week 12 up to Week 36||0
11319580|NCT02712008|12516671|FG002|NOT COMPLETED|From Week 12 up to Week 36||0
11319581|NCT02712008|12516672|FG003|NOT COMPLETED|From Week 12 up to Week 36||2
11319582|NCT02712008|12516673|FG004|NOT COMPLETED|From Week 12 up to Week 36||2
11319583|NCT02712008|12516674|FG005|NOT COMPLETED|From Week 12 up to Week 36||0
11319584|NCT02712008|12516675|FG006|NOT COMPLETED|From Week 12 up to Week 36||5
11319585|NCT02712008|12516676|FG007|NOT COMPLETED|From Week 12 up to Week 36||4
11319586|NCT02712047|12516690|FG000|STARTED|Treatment Period 1 (35 Days)||14
11319587|NCT02712047|12516691|FG001|STARTED|Treatment Period 1 (35 Days)||13
11319588|NCT02712047|12516690|FG000|COMPLETED|Treatment Period 1 (35 Days)||14
11319589|NCT02712047|12516691|FG001|COMPLETED|Treatment Period 1 (35 Days)||13
11319590|NCT02712047|12516690|FG000|NOT COMPLETED|Treatment Period 1 (35 Days)||0
11319591|NCT02712047|12516691|FG001|NOT COMPLETED|Treatment Period 1 (35 Days)||0
11319592|NCT02712047|12516690|FG000|STARTED|Washout Period (21 Days)||14
11319593|NCT02712047|12516691|FG001|STARTED|Washout Period (21 Days)||13
11319594|NCT02712047|12516690|FG000|COMPLETED|Washout Period (21 Days)||14
11319595|NCT02712047|12516691|FG001|COMPLETED|Washout Period (21 Days)||13
11402623|NCT04032158|12597528|FG001|COMPLETED|Overall Study||0
11319596|NCT02712047|12516690|FG000|NOT COMPLETED|Washout Period (21 Days)||0
11319597|NCT02712047|12516691|FG001|NOT COMPLETED|Washout Period (21 Days)||0
11319598|NCT02712047|12516690|FG000|STARTED|Treatment Period 2 (35 Days)||14
11319599|NCT02712047|12516691|FG001|STARTED|Treatment Period 2 (35 Days)||13
11319600|NCT02712047|12516690|FG000|COMPLETED|Treatment Period 2 (35 Days)||14
11319601|NCT02712047|12516691|FG001|COMPLETED|Treatment Period 2 (35 Days)||13
11319602|NCT02712047|12516690|FG000|NOT COMPLETED|Treatment Period 2 (35 Days)||0
11319603|NCT02712047|12516691|FG001|NOT COMPLETED|Treatment Period 2 (35 Days)||0
11319604|NCT02712099|12516699|FG000|STARTED|Overall Study||30
11319605|NCT02712099|12516700|FG001|STARTED|Overall Study||20
11319606|NCT02712099|12516699|FG000|COMPLETED|Overall Study||30
11319607|NCT02712099|12516700|FG001|COMPLETED|Overall Study||20
11319608|NCT02712099|12516699|FG000|NOT COMPLETED|Overall Study||0
11319609|NCT02712099|12516700|FG001|NOT COMPLETED|Overall Study||0
11319610|NCT02712320|12516706|FG000|STARTED|Overall Study||30
11319611|NCT02712320|12516706|FG000|COMPLETED|Overall Study||25
11319612|NCT02712320|12516706|FG000|NOT COMPLETED|Overall Study||5
11319613|NCT02712333|12516712|FG000|STARTED|First Period||34
11319614|NCT02712333|12516713|FG001|STARTED|First Period||26
11319615|NCT02712333|12516712|FG000|COMPLETED|First Period||31
11319616|NCT02712333|12516713|FG001|COMPLETED|First Period||24
11319617|NCT02712333|12516712|FG000|NOT COMPLETED|First Period||3
11319618|NCT02712333|12516713|FG001|NOT COMPLETED|First Period||2
11319619|NCT02712333|12516712|FG000|STARTED|Second Period||31
11319620|NCT02712333|12516713|FG001|STARTED|Second Period||24
11319621|NCT02712333|12516712|FG000|COMPLETED|Second Period||31
11319622|NCT02712333|12516713|FG001|COMPLETED|Second Period||24
11319623|NCT02712333|12516712|FG000|NOT COMPLETED|Second Period||0
11319624|NCT02712333|12516713|FG001|NOT COMPLETED|Second Period||0
11319625|NCT02712359|12516728|FG000|STARTED|Epoch 001: Persistence at Year 8||300
11319626|NCT02712359|12516729|FG001|STARTED|Epoch 001: Persistence at Year 8||300
11319627|NCT02712359|12516730|FG002|STARTED|Epoch 001: Persistence at Year 8||0
11319628|NCT02712359|12516731|FG003|STARTED|Epoch 001: Persistence at Year 8||0
11319629|NCT02712359|12516728|FG000|COMPLETED|Epoch 001: Persistence at Year 8||300
11319630|NCT02712359|12516729|FG001|COMPLETED|Epoch 001: Persistence at Year 8||300
11319631|NCT02712359|12516730|FG002|COMPLETED|Epoch 001: Persistence at Year 8||0
11319632|NCT02712359|12516731|FG003|COMPLETED|Epoch 001: Persistence at Year 8||0
11319633|NCT02712359|12516728|FG000|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
11319634|NCT02712359|12516729|FG001|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
11319635|NCT02712359|12516730|FG002|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
11319636|NCT02712359|12516731|FG003|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
11319637|NCT02712359|12516728|FG000|STARTED|Epoch 002: Persistence at Year 10||0
11319638|NCT02712359|12516729|FG001|STARTED|Epoch 002: Persistence at Year 10||0
11319639|NCT02712359|12516730|FG002|STARTED|Epoch 002: Persistence at Year 10||299
11319640|NCT02712359|12516731|FG003|STARTED|Epoch 002: Persistence at Year 10||300
11319641|NCT02712359|12516728|FG000|COMPLETED|Epoch 002: Persistence at Year 10||0
11319642|NCT02712359|12516729|FG001|COMPLETED|Epoch 002: Persistence at Year 10||0
11319643|NCT02712359|12516730|FG002|COMPLETED|Epoch 002: Persistence at Year 10||299
11319644|NCT02712359|12516731|FG003|COMPLETED|Epoch 002: Persistence at Year 10||300
11319645|NCT02712359|12516728|FG000|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
11319646|NCT02712359|12516729|FG001|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
11319647|NCT02712359|12516730|FG002|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
11319648|NCT02712359|12516731|FG003|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
11319649|NCT02712398|12516741|FG000|STARTED|Overall Study||120
11319650|NCT02712398|12516741|FG000|COMPLETED|Overall Study||83
11319651|NCT02712398|12516741|FG000|NOT COMPLETED|Overall Study||37
11319652|NCT02712424|12516747|FG000|STARTED|Overall Study||315
11319653|NCT02712424|12516748|FG001|STARTED|Overall Study||310
11319654|NCT02712424|12516747|FG000|COMPLETED|Overall Study||281
11319655|NCT02712424|12516748|FG001|COMPLETED|Overall Study||278
11319656|NCT02712424|12516747|FG000|NOT COMPLETED|Overall Study||34
11319657|NCT02712424|12516748|FG001|NOT COMPLETED|Overall Study||32
11319658|NCT02712554|12516756|FG000|STARTED|Part A: Dose Selection Phase||12
11319659|NCT02712554|12516757|FG001|STARTED|Part A: Dose Selection Phase||0
11319660|NCT02712554|12516756|FG000|COMPLETED|Part A: Dose Selection Phase||12
11319661|NCT02712554|12516757|FG001|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0
11319662|NCT02712554|12516756|FG000|NOT COMPLETED|Part A: Dose Selection Phase||0
11319663|NCT02712554|12516757|FG001|NOT COMPLETED|Part A: Dose Selection Phase||0
11319664|NCT02712554|12516756|FG000|STARTED|Part B: Qualification Phase||0
11319665|NCT02712554|12516757|FG001|STARTED|Part B: Qualification Phase||61
11319666|NCT02712554|12516756|FG000|COMPLETED|Part B: Qualification Phase||0
11319667|NCT02712554|12516757|FG001|COMPLETED|Part B: Qualification Phase||40
11319668|NCT02712554|12516756|FG000|NOT COMPLETED|Part B: Qualification Phase||0
11319669|NCT02712554|12516757|FG001|NOT COMPLETED|Part B: Qualification Phase||21
11319670|NCT02712554|12516756|FG000|STARTED|Part B: Treatment Phase||0
11319671|NCT02712554|12516757|FG001|STARTED|Part B: Treatment Phase||40
11319672|NCT02712554|12516756|FG000|COMPLETED|Part B: Treatment Phase||0
11319673|NCT02712554|12516757|FG001|COMPLETED|Part B: Treatment Phase||37
11319674|NCT02712554|12516756|FG000|NOT COMPLETED|Part B: Treatment Phase||0
11319675|NCT02712554|12516757|FG001|NOT COMPLETED|Part B: Treatment Phase||3
11319676|NCT02712788|12516782|FG000|STARTED|Overall Study||2
11319677|NCT02712788|12516783|FG001|STARTED|Overall Study||2
11319678|NCT02712788|12516782|FG000|COMPLETED|Overall Study||0
11319679|NCT02712788|12516783|FG001|COMPLETED|Overall Study||2
11319680|NCT02712788|12516782|FG000|NOT COMPLETED|Overall Study||2
11319681|NCT02712788|12516783|FG001|NOT COMPLETED|Overall Study||0
11319682|NCT02712983|12516798|FG000|STARTED|Treatment Phase||14
11319683|NCT02712983|12516799|FG001|STARTED|Treatment Phase||13
11319684|NCT02712983|12516800|FG002|STARTED|Treatment Phase||7
11319685|NCT02712983|12516801|FG003|STARTED|Treatment Phase||15
11319686|NCT02712983|12516802|FG004|STARTED|Treatment Phase||14
11319687|NCT02712983|12516803|FG005|STARTED|Treatment Phase||7
11319688|NCT02712983|12516804|FG006|STARTED|Treatment Phase||15
11319689|NCT02712983|12516805|FG007|STARTED|Treatment Phase||15
11319690|NCT02712983|12516806|FG008|STARTED|Treatment Phase||7
11319691|NCT02712983|12516798|FG000|Pharmacokinetic Analysis Set|Treatment Phase||14
11319692|NCT02712983|12516799|FG001|Pharmacokinetic Analysis Set|Treatment Phase||13
11319693|NCT02712983|12516800|FG002|Pharmacokinetic Analysis Set|Treatment Phase||0
11319694|NCT02712983|12516801|FG003|Pharmacokinetic Analysis Set|Treatment Phase||15
11319695|NCT02712983|12516802|FG004|Pharmacokinetic Analysis Set|Treatment Phase||14
11319696|NCT02712983|12516803|FG005|Pharmacokinetic Analysis Set|Treatment Phase||0
11319697|NCT02712983|12516804|FG006|Pharmacokinetic Analysis Set|Treatment Phase||15
11319698|NCT02712983|12516805|FG007|Pharmacokinetic Analysis Set|Treatment Phase||14
11319699|NCT02712983|12516806|FG008|Pharmacokinetic Analysis Set|Treatment Phase||0
11319700|NCT02712983|12516798|FG000|COMPLETED|Treatment Phase||9
11319701|NCT02712983|12516799|FG001|COMPLETED|Treatment Phase||12
11319702|NCT02712983|12516800|FG002|COMPLETED|Treatment Phase||6
11319703|NCT02712983|12516801|FG003|COMPLETED|Treatment Phase||7
11319704|NCT02712983|12516802|FG004|COMPLETED|Treatment Phase||10
11319705|NCT02712983|12516803|FG005|COMPLETED|Treatment Phase||7
11319706|NCT02712983|12516804|FG006|COMPLETED|Treatment Phase||6
11319707|NCT02712983|12516805|FG007|COMPLETED|Treatment Phase||6
11319708|NCT02712983|12516806|FG008|COMPLETED|Treatment Phase||5
11319709|NCT02712983|12516798|FG000|NOT COMPLETED|Treatment Phase||5
11319710|NCT02712983|12516799|FG001|NOT COMPLETED|Treatment Phase||1
11319711|NCT02712983|12516800|FG002|NOT COMPLETED|Treatment Phase||1
11319712|NCT02712983|12516801|FG003|NOT COMPLETED|Treatment Phase||8
11319713|NCT02712983|12516802|FG004|NOT COMPLETED|Treatment Phase||4
11319714|NCT02712983|12516803|FG005|NOT COMPLETED|Treatment Phase||0
11319715|NCT02712983|12516804|FG006|NOT COMPLETED|Treatment Phase||9
11319716|NCT02712983|12516805|FG007|NOT COMPLETED|Treatment Phase||9
11319717|NCT02712983|12516806|FG008|NOT COMPLETED|Treatment Phase||2
11319718|NCT02712983|12516798|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
11319719|NCT02712983|12516799|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
11319720|NCT02712983|12516800|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
11319721|NCT02712983|12516801|FG003|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
11319722|NCT02712983|12516802|FG004|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
11319723|NCT02712983|12516803|FG005|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
11319724|NCT02712983|12516804|FG006|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
11319725|NCT02712983|12516805|FG007|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|3
11319726|NCT02712983|12516806|FG008|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
11319727|NCT02712983|12516798|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11319728|NCT02712983|12516799|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11319729|NCT02712983|12516800|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11319730|NCT02712983|12516801|FG003|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11319731|NCT02712983|12516802|FG004|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11319732|NCT02712983|12516803|FG005|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11319733|NCT02712983|12516804|FG006|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11319734|NCT02712983|12516805|FG007|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11319735|NCT02712983|12516806|FG008|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11319736|NCT02712983|12516798|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11319737|NCT02712983|12516799|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
11319738|NCT02712983|12516800|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11319739|NCT02712983|12516801|FG003|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
11319740|NCT02712983|12516802|FG004|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
11319741|NCT02712983|12516803|FG005|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
11319742|NCT02712983|12516804|FG006|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
11319743|NCT02712983|12516805|FG007|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||3
11319744|NCT02712983|12516806|FG008|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11319745|NCT02712996|12516828|FG000|STARTED|First Intervention (Study Days 1-42)||8
11319746|NCT02712996|12516829|FG001|STARTED|First Intervention (Study Days 1-42)||9
11319747|NCT02712996|12516828|FG000|COMPLETED|First Intervention (Study Days 1-42)||8
11319748|NCT02712996|12516829|FG001|COMPLETED|First Intervention (Study Days 1-42)||9
11319749|NCT02712996|12516828|FG000|NOT COMPLETED|First Intervention (Study Days 1-42)||0
11319750|NCT02712996|12516829|FG001|NOT COMPLETED|First Intervention (Study Days 1-42)||0
11319751|NCT02712996|12516828|FG000|STARTED|Second Intervention (Study Days 43-84)||8
11319752|NCT02712996|12516829|FG001|STARTED|Second Intervention (Study Days 43-84)||9
11319753|NCT02712996|12516828|FG000|COMPLETED|Second Intervention (Study Days 43-84)||8
11319754|NCT02712996|12516829|FG001|COMPLETED|Second Intervention (Study Days 43-84)||8
11319755|NCT02712996|12516828|FG000|NOT COMPLETED|Second Intervention (Study Days 43-84)||0
11319756|NCT02712996|12516829|FG001|NOT COMPLETED|Second Intervention (Study Days 43-84)||1
11319757|NCT02713178|12516840|FG000|STARTED|Overall Study||76
11319758|NCT02713178|12516841|FG001|STARTED|Overall Study||77
11319759|NCT02713178|12516842|FG002|STARTED|Overall Study||79
11319760|NCT02713178|12516840|FG000|COMPLETED|Overall Study||75
11319761|NCT02713178|12516841|FG001|COMPLETED|Overall Study||73
11319762|NCT02713178|12516842|FG002|COMPLETED|Overall Study||74
11319763|NCT02713178|12516840|FG000|NOT COMPLETED|Overall Study||1
11319764|NCT02713178|12516841|FG001|NOT COMPLETED|Overall Study||4
11319765|NCT02713178|12516842|FG002|NOT COMPLETED|Overall Study||5
11319766|NCT02713204|12516853|FG000|STARTED|Baseline (Day 1) up to Week 12||60
11319767|NCT02713204|12516854|FG001|STARTED|Baseline (Day 1) up to Week 12||122
11319768|NCT02713204|12516855|FG002|STARTED|Baseline (Day 1) up to Week 12||183
11319769|NCT02713204|12516856|FG003|STARTED|Baseline (Day 1) up to Week 12||0
11319770|NCT02713204|12516857|FG004|STARTED|Baseline (Day 1) up to Week 12||0
11319771|NCT02713204|12516858|FG005|STARTED|Baseline (Day 1) up to Week 12||0
11319772|NCT02713204|12516859|FG006|STARTED|Baseline (Day 1) up to Week 12||0
11319773|NCT02713204|12516860|FG007|STARTED|Baseline (Day 1) up to Week 12||0
11319774|NCT02713204|12516853|FG000|COMPLETED|Baseline (Day 1) up to Week 12||59
11319775|NCT02713204|12516854|FG001|COMPLETED|Baseline (Day 1) up to Week 12||121
11319776|NCT02713204|12516855|FG002|COMPLETED|Baseline (Day 1) up to Week 12||181
11319777|NCT02713204|12516856|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0
11319778|NCT02713204|12516857|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0
11319779|NCT02713204|12516858|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0
11319780|NCT02713204|12516859|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0
11319781|NCT02713204|12516860|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0
11319782|NCT02713204|12516853|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
11319783|NCT02713204|12516854|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
11319784|NCT02713204|12516855|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||2
11319785|NCT02713204|12516856|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
11319786|NCT02713204|12516857|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
11319787|NCT02713204|12516858|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
11319788|NCT02713204|12516859|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
11319789|NCT02713204|12516860|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
11319790|NCT02713204|12516853|FG000|STARTED|From Week 12 up to Week 36||58
11319791|NCT02713204|12516854|FG001|STARTED|From Week 12 up to Week 36||0
11319792|NCT02713204|12516855|FG002|STARTED|From Week 12 up to Week 36||0
11319793|NCT02713204|12516856|FG003|STARTED|From Week 12 up to Week 36||57
11319794|NCT02713204|12516857|FG004|STARTED|From Week 12 up to Week 36||62
11319795|NCT02713204|12516858|FG005|STARTED|From Week 12 up to Week 36||60
11319796|NCT02713204|12516859|FG006|STARTED|From Week 12 up to Week 36||62
11319797|NCT02713204|12516860|FG007|STARTED|From Week 12 up to Week 36||58
11319798|NCT02713204|12516853|FG000|COMPLETED|From Week 12 up to Week 36||57
11319799|NCT02713204|12516854|FG001|COMPLETED|From Week 12 up to Week 36||0
11319800|NCT02713204|12516855|FG002|COMPLETED|From Week 12 up to Week 36||0
11319801|NCT02713204|12516856|FG003|COMPLETED|From Week 12 up to Week 36||53
11319802|NCT02713204|12516857|FG004|COMPLETED|From Week 12 up to Week 36||60
11319803|NCT02713204|12516858|FG005|COMPLETED|From Week 12 up to Week 36||59
11319804|NCT02713204|12516859|FG006|COMPLETED|From Week 12 up to Week 36||60
11319805|NCT02713204|12516860|FG007|COMPLETED|From Week 12 up to Week 36||54
11319806|NCT02713204|12516853|FG000|NOT COMPLETED|From Week 12 up to Week 36||1
11319807|NCT02713204|12516854|FG001|NOT COMPLETED|From Week 12 up to Week 36||0
11319808|NCT02713204|12516855|FG002|NOT COMPLETED|From Week 12 up to Week 36||0
11319809|NCT02713204|12516856|FG003|NOT COMPLETED|From Week 12 up to Week 36||4
11319810|NCT02713204|12516857|FG004|NOT COMPLETED|From Week 12 up to Week 36||2
11319811|NCT02713204|12516858|FG005|NOT COMPLETED|From Week 12 up to Week 36||1
11319812|NCT02713204|12516859|FG006|NOT COMPLETED|From Week 12 up to Week 36||2
11319813|NCT02713204|12516860|FG007|NOT COMPLETED|From Week 12 up to Week 36||4
11319814|NCT02713230|12516880|FG000|STARTED|Overall Study||69
11319815|NCT02713230|12516881|FG001|STARTED|Overall Study||15
11319816|NCT02713230|12516882|FG002|STARTED|Overall Study||71
11319817|NCT02713230|12516880|FG000|COMPLETED|Overall Study||68
11319818|NCT02713230|12516881|FG001|COMPLETED|Overall Study||15
11319819|NCT02713230|12516882|FG002|COMPLETED|Overall Study||71
11402624|NCT04032158|12597527|FG000|NOT COMPLETED|Overall Study||2
11402625|NCT04032158|12597528|FG001|NOT COMPLETED|Overall Study||1
11402626|NCT04031404|12597534|FG000|STARTED|Baseline||10
11402627|NCT04031404|12597535|FG001|STARTED|Baseline||13
11402628|NCT04031404|12597534|FG000|COMPLETED|Baseline||8
11402629|NCT04031404|12597535|FG001|COMPLETED|Baseline||8
11402630|NCT04031404|12597534|FG000|NOT COMPLETED|Baseline||2
11402631|NCT04031404|12597535|FG001|NOT COMPLETED|Baseline||5
11402632|NCT04031404|12597534|FG000|STARTED|Pre-randomization||8
11402633|NCT04031404|12597535|FG001|STARTED|Pre-randomization||8
11402634|NCT04031404|12597534|FG000|COMPLETED|Pre-randomization||6
11402635|NCT04031404|12597535|FG001|COMPLETED|Pre-randomization||5
11402636|NCT04031404|12597534|FG000|NOT COMPLETED|Pre-randomization||2
11402637|NCT04031404|12597535|FG001|NOT COMPLETED|Pre-randomization||3
11402638|NCT04031404|12597534|FG000|STARTED|First Drink Visit||6
11402639|NCT04031404|12597535|FG001|STARTED|First Drink Visit||5
11402640|NCT04031404|12597534|FG000|COMPLETED|First Drink Visit||6
11402641|NCT04031404|12597535|FG001|COMPLETED|First Drink Visit||5
11402642|NCT04031404|12597534|FG000|NOT COMPLETED|First Drink Visit||0
11402643|NCT04031404|12597535|FG001|NOT COMPLETED|First Drink Visit||0
11402644|NCT04031404|12597534|FG000|STARTED|Washout (5 Day Min)||6
11402645|NCT04031404|12597535|FG001|STARTED|Washout (5 Day Min)||5
11402646|NCT04031404|12597534|FG000|COMPLETED|Washout (5 Day Min)||5
11402647|NCT04031404|12597535|FG001|COMPLETED|Washout (5 Day Min)||5
11402648|NCT04031404|12597534|FG000|NOT COMPLETED|Washout (5 Day Min)||1
11402649|NCT04031404|12597535|FG001|NOT COMPLETED|Washout (5 Day Min)||0
11402650|NCT04031404|12597534|FG000|STARTED|Second Drink Visit||5
11402651|NCT04031404|12597535|FG001|STARTED|Second Drink Visit||5
11402652|NCT04031404|12597534|FG000|COMPLETED|Second Drink Visit||5
11402653|NCT04031404|12597535|FG001|COMPLETED|Second Drink Visit||5
11402654|NCT04031404|12597534|FG000|NOT COMPLETED|Second Drink Visit||0
11402655|NCT04031404|12597535|FG001|NOT COMPLETED|Second Drink Visit||0
11402656|NCT04031885|12597551|FG000|STARTED|Overall Study||1
11402657|NCT04031885|12597552|FG001|STARTED|Overall Study||3
11402658|NCT04031885|12597551|FG000|Received Any Quantity of Study Treatment|Overall Study||1
11402659|NCT04031885|12597552|FG001|Received Any Quantity of Study Treatment|Overall Study||1
11402660|NCT04031885|12597551|FG000|COMPLETED|Overall Study||1
11402661|NCT04031885|12597552|FG001|COMPLETED|Overall Study||3
11402662|NCT04031885|12597551|FG000|NOT COMPLETED|Overall Study||0
11402663|NCT04031885|12597552|FG001|NOT COMPLETED|Overall Study||0
11402664|NCT04018924|12597558|FG000|STARTED|Overall Study|The total number of participants is 90 and the patient is control of themselves.|90
11402665|NCT04018924|12597558|FG000|Standard Of Care Intervention|Overall Study||90
11402666|NCT04018924|12597558|FG000|EmoLED Intervention|Overall Study||90
11402667|NCT04018924|12597558|FG000|COMPLETED|Overall Study||84
11402668|NCT04018924|12597558|FG000|NOT COMPLETED|Overall Study||6
11402669|NCT04015440|12597564|FG000|STARTED|Overall Study||117
11402670|NCT04015440|12597565|FG001|STARTED|Overall Study||112
11402671|NCT04015440|12597564|FG000|COMPLETED|Overall Study||109
11402672|NCT04015440|12597565|FG001|COMPLETED|Overall Study||108
11402673|NCT04015440|12597564|FG000|NOT COMPLETED|Overall Study||8
11402674|NCT04015440|12597565|FG001|NOT COMPLETED|Overall Study||4
11402675|NCT04030104|12597571|FG000|STARTED|Overall Study||480
11402676|NCT04030104|12597571|FG000|COMPLETED|Overall Study||480
11402677|NCT04030104|12597571|FG000|NOT COMPLETED|Overall Study||0
11402678|NCT04029961|12597580|FG000|STARTED|Overall Study||13
11402679|NCT04029961|12597581|FG001|STARTED|Overall Study||13
11402680|NCT04029961|12597580|FG000|COMPLETED|Overall Study||12
11402681|NCT04029961|12597581|FG001|COMPLETED|Overall Study||12
11402682|NCT04029961|12597580|FG000|NOT COMPLETED|Overall Study||1
11402683|NCT04029961|12597581|FG001|NOT COMPLETED|Overall Study||1
11402684|NCT04025684|12597591|FG000|STARTED|Overall Study||20
11402685|NCT04025684|12597592|FG001|STARTED|Overall Study||19
11402686|NCT04025684|12597593|FG002|STARTED|Overall Study||20
11402687|NCT04025684|12597594|FG003|STARTED|Overall Study||21
11402688|NCT04025684|12597591|FG000|COMPLETED|Overall Study||18
11402689|NCT04025684|12597592|FG001|COMPLETED|Overall Study||15
11402690|NCT04025684|12597593|FG002|COMPLETED|Overall Study||20
11402691|NCT04025684|12597594|FG003|COMPLETED|Overall Study||20
11402692|NCT04025684|12597591|FG000|NOT COMPLETED|Overall Study||2
11402693|NCT04025684|12597592|FG001|NOT COMPLETED|Overall Study||4
11402694|NCT04025684|12597593|FG002|NOT COMPLETED|Overall Study||0
11402695|NCT04025684|12597594|FG003|NOT COMPLETED|Overall Study||1
11402696|NCT04019054|12597606|FG000|STARTED|Overall Study||11
11402697|NCT04019054|12597607|FG001|STARTED|Overall Study||11
11402698|NCT04019054|12597606|FG000|COMPLETED|Overall Study||8
11402699|NCT04019054|12597607|FG001|COMPLETED|Overall Study||9
11402700|NCT04019054|12597606|FG000|NOT COMPLETED|Overall Study||3
11402701|NCT04019054|12597607|FG001|NOT COMPLETED|Overall Study||2
11402702|NCT04029545|12597616|FG000|STARTED|Overall Study||2
11402703|NCT04029545|12597617|FG001|STARTED|Overall Study||1
11402704|NCT04029545|12597618|FG002|STARTED|Overall Study||2
11402705|NCT04029545|12597616|FG000|COMPLETED|Overall Study||2
11402706|NCT04029545|12597617|FG001|COMPLETED|Overall Study||1
11402707|NCT04029545|12597618|FG002|COMPLETED|Overall Study||2
11402708|NCT04029545|12597616|FG000|NOT COMPLETED|Overall Study||0
11402709|NCT04029545|12597617|FG001|NOT COMPLETED|Overall Study||0
11319820|NCT02713230|12516880|FG000|NOT COMPLETED|Overall Study||1
11402710|NCT04029545|12597618|FG002|NOT COMPLETED|Overall Study||0
11402711|NCT04029584|12597626|FG000|STARTED|Uninduced Study 1st Intervention (1 Day)||4
11402712|NCT04029584|12597627|FG001|STARTED|Uninduced Study 1st Intervention (1 Day)||6
11402713|NCT04029584|12597626|FG000|COMPLETED|Uninduced Study 1st Intervention (1 Day)||4
11402714|NCT04029584|12597627|FG001|COMPLETED|Uninduced Study 1st Intervention (1 Day)||6
11402715|NCT04029584|12597626|FG000|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0
11319821|NCT02713230|12516881|FG001|NOT COMPLETED|Overall Study||0
11319822|NCT02713230|12516882|FG002|NOT COMPLETED|Overall Study||0
11319823|NCT02713243|12516891|FG000|STARTED|Overall Study||10
11319824|NCT02713243|12516892|FG001|STARTED|Overall Study||10
11319825|NCT02713243|12516891|FG000|PD Analysis Set|Overall Study||9
11319826|NCT02713243|12516892|FG001|PD Analysis Set|Overall Study||10
11319827|NCT02713243|12516891|FG000|PK Analysis Set|Overall Study||8
11319828|NCT02713243|12516892|FG001|PK Analysis Set|Overall Study||9
11319829|NCT02713243|12516891|FG000|COMPLETED|Overall Study||9
11319830|NCT02713243|12516892|FG001|COMPLETED|Overall Study||8
11319831|NCT02713243|12516891|FG000|NOT COMPLETED|Overall Study||1
11319832|NCT02713243|12516892|FG001|NOT COMPLETED|Overall Study||2
11319833|NCT02713256|12516898|FG000|STARTED|Overall Study||15
11319834|NCT02713256|12516898|FG000|COMPLETED|Overall Study||15
11319835|NCT02713256|12516898|FG000|NOT COMPLETED|Overall Study||0
11319836|NCT02713425|12516902|FG000|STARTED|Overall Study||20
11319837|NCT02713425|12516902|FG000|COMPLETED|Overall Study||20
11319838|NCT02713425|12516902|FG000|NOT COMPLETED|Overall Study||0
11319839|NCT02713490|12516908|FG000|STARTED|Overall Study||71
11319840|NCT02713490|12516909|FG001|STARTED|Overall Study||69
11319841|NCT02713490|12516908|FG000|COMPLETED|Overall Study||68
11319842|NCT02713490|12516909|FG001|COMPLETED|Overall Study||67
11319843|NCT02713490|12516908|FG000|NOT COMPLETED|Overall Study||3
11319844|NCT02713490|12516909|FG001|NOT COMPLETED|Overall Study||2
11319845|NCT02713529|12516922|FG000|STARTED|Overall Study||8
11402716|NCT04029584|12597627|FG001|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0
11402717|NCT04029584|12597626|FG000|STARTED|Uninduced Washout (1 Day)||4
11402718|NCT04029584|12597627|FG001|STARTED|Uninduced Washout (1 Day)||6
11402719|NCT04029584|12597626|FG000|COMPLETED|Uninduced Washout (1 Day)||4
11402720|NCT04029584|12597627|FG001|COMPLETED|Uninduced Washout (1 Day)||6
11402721|NCT04029584|12597626|FG000|NOT COMPLETED|Uninduced Washout (1 Day)||0
11402722|NCT04029584|12597627|FG001|NOT COMPLETED|Uninduced Washout (1 Day)||0
11402723|NCT04029584|12597626|FG000|STARTED|Uninduced Study 2nd Intervention (1 Day)||4
11402724|NCT04029584|12597627|FG001|STARTED|Uninduced Study 2nd Intervention (1 Day)||6
11402725|NCT04029584|12597626|FG000|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||4
11402726|NCT04029584|12597627|FG001|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||6
11402727|NCT04029584|12597626|FG000|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0
11402728|NCT04029584|12597627|FG001|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0
11402729|NCT04029584|12597626|FG000|STARTED|Washout Between (>1 Week)||4
11319846|NCT02713529|12516923|FG001|STARTED|Overall Study||7
11319847|NCT02713529|12516924|FG002|STARTED|Overall Study||42
11319848|NCT02713529|12516925|FG003|STARTED|Overall Study||31
11319849|NCT02713529|12516926|FG004|STARTED|Overall Study||4
11319850|NCT02713529|12516927|FG005|STARTED|Overall Study||19
11319851|NCT02713529|12516928|FG006|STARTED|Overall Study||6
11319852|NCT02713529|12516922|FG000|COMPLETED|Overall Study||1
11319853|NCT02713529|12516923|FG001|COMPLETED|Overall Study||3
11319854|NCT02713529|12516924|FG002|COMPLETED|Overall Study||11
11319855|NCT02713529|12516925|FG003|COMPLETED|Overall Study||2
11319856|NCT02713529|12516926|FG004|COMPLETED|Overall Study||1
11319857|NCT02713529|12516927|FG005|COMPLETED|Overall Study||5
11319858|NCT02713529|12516928|FG006|COMPLETED|Overall Study||2
11319859|NCT02713529|12516922|FG000|NOT COMPLETED|Overall Study||7
11319860|NCT02713529|12516923|FG001|NOT COMPLETED|Overall Study||4
11319861|NCT02713529|12516924|FG002|NOT COMPLETED|Overall Study||31
11319862|NCT02713529|12516925|FG003|NOT COMPLETED|Overall Study||29
11319863|NCT02713529|12516926|FG004|NOT COMPLETED|Overall Study||3
11319864|NCT02713529|12516927|FG005|NOT COMPLETED|Overall Study||14
11319865|NCT02713529|12516928|FG006|NOT COMPLETED|Overall Study||4
11319866|NCT02713542|12516950|FG000|STARTED|Overall Study||60
11402730|NCT04029584|12597627|FG001|STARTED|Washout Between (>1 Week)||6
11319867|NCT02713542|12516951|FG001|STARTED|Overall Study||30
11319868|NCT02713542|12516950|FG000|COMPLETED|Overall Study||42
11319869|NCT02713542|12516951|FG001|COMPLETED|Overall Study||24
11319870|NCT02713542|12516950|FG000|NOT COMPLETED|Overall Study||18
11319871|NCT02713542|12516951|FG001|NOT COMPLETED|Overall Study||6
11319872|NCT02713594|12516959|FG000|STARTED|Overall Study||952
11319873|NCT02713594|12516960|FG001|STARTED|Overall Study||948
11319874|NCT02713594|12516959|FG000|COMPLETED|Overall Study||562
11319875|NCT02713594|12516960|FG001|COMPLETED|Overall Study||552
11319876|NCT02713594|12516959|FG000|NOT COMPLETED|Overall Study||390
11319877|NCT02713594|12516960|FG001|NOT COMPLETED|Overall Study||396
11319878|NCT02713659|12516970|FG000|STARTED|Baseline||60
11319879|NCT02713659|12516971|FG001|STARTED|Baseline||60
11319880|NCT02713659|12516970|FG000|COMPLETED|Baseline||60
11319881|NCT02713659|12516971|FG001|COMPLETED|Baseline||60
11402731|NCT04029584|12597626|FG000|COMPLETED|Washout Between (>1 Week)||4
11402732|NCT04029584|12597627|FG001|COMPLETED|Washout Between (>1 Week)||6
11402733|NCT04029584|12597626|FG000|NOT COMPLETED|Washout Between (>1 Week)||0
11402734|NCT04029584|12597627|FG001|NOT COMPLETED|Washout Between (>1 Week)||0
11402735|NCT04029584|12597626|FG000|STARTED|Induced Study 1st Intervention (1 Day)||2
11319882|NCT02713659|12516970|FG000|NOT COMPLETED|Baseline||0
11319883|NCT02713659|12516971|FG001|NOT COMPLETED|Baseline||0
11319884|NCT02713659|12516970|FG000|STARTED|6 Month Study Visit||60
11319885|NCT02713659|12516971|FG001|STARTED|6 Month Study Visit||60
11319886|NCT02713659|12516970|FG000|COMPLETED|6 Month Study Visit||53
11319887|NCT02713659|12516971|FG001|COMPLETED|6 Month Study Visit||47
11319888|NCT02713659|12516970|FG000|NOT COMPLETED|6 Month Study Visit||7
11319889|NCT02713659|12516971|FG001|NOT COMPLETED|6 Month Study Visit||13
11319890|NCT02713659|12516970|FG000|STARTED|12 Month Study Visit||57
11319891|NCT02713659|12516971|FG001|STARTED|12 Month Study Visit||55
11319892|NCT02713659|12516970|FG000|COMPLETED|12 Month Study Visit||54
11319893|NCT02713659|12516971|FG001|COMPLETED|12 Month Study Visit||52
11319894|NCT02713659|12516970|FG000|NOT COMPLETED|12 Month Study Visit||3
11319895|NCT02713659|12516971|FG001|NOT COMPLETED|12 Month Study Visit||3
11319896|NCT02713659|12516970|FG000|STARTED|18 Month Study Visit||58
11319897|NCT02713659|12516971|FG001|STARTED|18 Month Study Visit||53
11319898|NCT02713659|12516970|FG000|COMPLETED|18 Month Study Visit||50
11319899|NCT02713659|12516971|FG001|COMPLETED|18 Month Study Visit||50
11319900|NCT02713659|12516970|FG000|NOT COMPLETED|18 Month Study Visit||8
11319901|NCT02713659|12516971|FG001|NOT COMPLETED|18 Month Study Visit||3
11319902|NCT02713659|12516970|FG000|STARTED|24 Month Study Visit||57
11319903|NCT02713659|12516971|FG001|STARTED|24 Month Study Visit||52
11319904|NCT02713659|12516970|FG000|COMPLETED|24 Month Study Visit||49
11319905|NCT02713659|12516971|FG001|COMPLETED|24 Month Study Visit||44
11319906|NCT02713659|12516970|FG000|NOT COMPLETED|24 Month Study Visit||8
11319907|NCT02713659|12516971|FG001|NOT COMPLETED|24 Month Study Visit||8
11319908|NCT02713698|12516980|FG000|STARTED|Overall Study||20
11402736|NCT04029584|12597627|FG001|STARTED|Induced Study 1st Intervention (1 Day)||8
11319909|NCT02713698|12516981|FG001|STARTED|Overall Study||20
11319910|NCT02713698|12516982|FG002|STARTED|Overall Study||20
11319911|NCT02713698|12516980|FG000|COMPLETED|Overall Study||20
11319912|NCT02713698|12516981|FG001|COMPLETED|Overall Study||20
11319913|NCT02713698|12516982|FG002|COMPLETED|Overall Study||20
11319914|NCT02713698|12516980|FG000|NOT COMPLETED|Overall Study||0
11319915|NCT02713698|12516981|FG001|NOT COMPLETED|Overall Study||0
11319916|NCT02713698|12516982|FG002|NOT COMPLETED|Overall Study||0
11319917|NCT02713711|12516990|FG000|STARTED|Overall Study||9
11319918|NCT02713711|12516991|FG001|STARTED|Overall Study||6
11319919|NCT02713711|12516992|FG002|STARTED|Overall Study||6
11319920|NCT02713711|12516993|FG003|STARTED|Overall Study||10
11319921|NCT02713711|12516990|FG000|COMPLETED|Overall Study||9
11319922|NCT02713711|12516991|FG001|COMPLETED|Overall Study||6
11319923|NCT02713711|12516992|FG002|COMPLETED|Overall Study||6
11319924|NCT02713711|12516993|FG003|COMPLETED|Overall Study||10
11319925|NCT02713711|12516990|FG000|NOT COMPLETED|Overall Study||0
11319926|NCT02713711|12516991|FG001|NOT COMPLETED|Overall Study||0
11319927|NCT02713711|12516992|FG002|NOT COMPLETED|Overall Study||0
11319928|NCT02713711|12516993|FG003|NOT COMPLETED|Overall Study||0
11319929|NCT02713789|12517009|FG000|STARTED|Overall Study||8
11319930|NCT02713789|12517010|FG001|STARTED|Overall Study||10
11319931|NCT02713789|12517011|FG002|STARTED|Overall Study||8
11319932|NCT02713789|12517009|FG000|COMPLETED|Overall Study||8
11319933|NCT02713789|12517010|FG001|COMPLETED|Overall Study||9
11319934|NCT02713789|12517011|FG002|COMPLETED|Overall Study||7
11319935|NCT02713789|12517009|FG000|NOT COMPLETED|Overall Study||0
11319936|NCT02713789|12517010|FG001|NOT COMPLETED|Overall Study||1
11319937|NCT02713789|12517011|FG002|NOT COMPLETED|Overall Study||1
11319938|NCT02713828|12517021|FG000|STARTED|Overall Study||13
11319939|NCT02713828|12517022|FG001|STARTED|Overall Study||0
11319940|NCT02713828|12517021|FG000|COMPLETED|Overall Study||8
11319941|NCT02713828|12517022|FG001|COMPLETED|Overall Study||0
11319942|NCT02713828|12517021|FG000|NOT COMPLETED|Overall Study||5
11319943|NCT02713828|12517022|FG001|NOT COMPLETED|Overall Study||0
11319944|NCT02714153|12517027|FG000|STARTED|Overall Study||23
11319945|NCT02714153|12517027|FG000|COMPLETED|Overall Study||22
11319946|NCT02714153|12517027|FG000|NOT COMPLETED|Overall Study||1
11319947|NCT02714283|12517033|FG000|STARTED|Overall Study||83589
11319948|NCT02714283|12517034|FG001|STARTED|Overall Study||6500
11319949|NCT02714283|12517033|FG000|COMPLETED|Overall Study||83589
11319950|NCT02714283|12517034|FG001|COMPLETED|Overall Study||6500
11319951|NCT02714283|12517033|FG000|NOT COMPLETED|Overall Study||0
11319952|NCT02714283|12517034|FG001|NOT COMPLETED|Overall Study||0
11319953|NCT02714400|12517044|FG000|STARTED|First Intervention (1 Day)||12
11319954|NCT02714400|12517045|FG001|STARTED|First Intervention (1 Day)||8
11402737|NCT04029584|12597626|FG000|COMPLETED|Induced Study 1st Intervention (1 Day)||2
11319955|NCT02714400|12517044|FG000|COMPLETED|First Intervention (1 Day)||12
11319956|NCT02714400|12517045|FG001|COMPLETED|First Intervention (1 Day)||8
11319957|NCT02714400|12517044|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11319958|NCT02714400|12517045|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11319959|NCT02714400|12517044|FG000|STARTED|Washout (>4 Days)||12
11319960|NCT02714400|12517045|FG001|STARTED|Washout (>4 Days)||8
11319961|NCT02714400|12517044|FG000|COMPLETED|Washout (>4 Days)||12
11319962|NCT02714400|12517045|FG001|COMPLETED|Washout (>4 Days)||8
11319963|NCT02714400|12517044|FG000|NOT COMPLETED|Washout (>4 Days)||0
11319964|NCT02714400|12517045|FG001|NOT COMPLETED|Washout (>4 Days)||0
11319965|NCT02714400|12517044|FG000|STARTED|Second Intervention (1 Day)||12
11319966|NCT02714400|12517045|FG001|STARTED|Second Intervention (1 Day)||8
11319967|NCT02714400|12517044|FG000|COMPLETED|Second Intervention (1 Day)||12
11319968|NCT02714400|12517045|FG001|COMPLETED|Second Intervention (1 Day)||8
11319969|NCT02714400|12517044|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11319970|NCT02714400|12517045|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11319971|NCT02714426|12517053|FG000|STARTED|Overall Study||21
11319972|NCT02714426|12517054|FG001|STARTED|Overall Study||21
11319973|NCT02714426|12517053|FG000|COMPLETED|Overall Study||19
11319974|NCT02714426|12517054|FG001|COMPLETED|Overall Study||19
11319975|NCT02714426|12517053|FG000|NOT COMPLETED|Overall Study||2
11319976|NCT02714426|12517054|FG001|NOT COMPLETED|Overall Study||2
11319977|NCT02714504|12517062|FG000|STARTED|Overall Study||61
11319978|NCT02714504|12517063|FG001|STARTED|Overall Study||178
11319979|NCT02714504|12517062|FG000|COMPLETED|Overall Study||61
11319980|NCT02714504|12517063|FG001|COMPLETED|Overall Study||178
11319981|NCT02714504|12517062|FG000|NOT COMPLETED|Overall Study||0
11319982|NCT02714504|12517063|FG001|NOT COMPLETED|Overall Study||0
11319983|NCT02714569|12517080|FG000|STARTED|Part A First Intervention||3
11319984|NCT02714569|12517081|FG001|STARTED|Part A First Intervention||3
11319985|NCT02714569|12517082|FG002|STARTED|Part A First Intervention||3
11319986|NCT02714569|12517083|FG003|STARTED|Part A First Intervention||3
11319987|NCT02714569|12517084|FG004|STARTED|Part A First Intervention||3
11319988|NCT02714569|12517085|FG005|STARTED|Part A First Intervention||3
11319989|NCT02714569|12517086|FG006|STARTED|Part A First Intervention||0
11319990|NCT02714569|12517087|FG007|STARTED|Part A First Intervention||0
11319991|NCT02714569|12517088|FG008|STARTED|Part A First Intervention||0
11319992|NCT02714569|12517089|FG009|STARTED|Part A First Intervention||0
11319993|NCT02714569|12517090|FG010|STARTED|Part A First Intervention||0
11319994|NCT02714569|12517080|FG000|Received at Least One Dose of Study Drug|Part A First Intervention||3
11319995|NCT02714569|12517081|FG001|Received at Least One Dose of Study Drug|Part A First Intervention||3
11319996|NCT02714569|12517082|FG002|Received at Least One Dose of Study Drug|Part A First Intervention||3
11319997|NCT02714569|12517083|FG003|Received at Least One Dose of Study Drug|Part A First Intervention||3
11319998|NCT02714569|12517084|FG004|Received at Least One Dose of Study Drug|Part A First Intervention||3
11319999|NCT02714569|12517085|FG005|Received at Least One Dose of Study Drug|Part A First Intervention||3
11320000|NCT02714569|12517086|FG006|Received at Least One Dose of Study Drug|Part A First Intervention||0
11320001|NCT02714569|12517087|FG007|Received at Least One Dose of Study Drug|Part A First Intervention||0
11320002|NCT02714569|12517088|FG008|Received at Least One Dose of Study Drug|Part A First Intervention||0
11320003|NCT02714569|12517089|FG009|Received at Least One Dose of Study Drug|Part A First Intervention||0
11320004|NCT02714569|12517090|FG010|Received at Least One Dose of Study Drug|Part A First Intervention||0
11320005|NCT02714569|12517080|FG000|COMPLETED|Part A First Intervention||3
11320006|NCT02714569|12517081|FG001|COMPLETED|Part A First Intervention||3
11320007|NCT02714569|12517082|FG002|COMPLETED|Part A First Intervention||3
11320008|NCT02714569|12517083|FG003|COMPLETED|Part A First Intervention||3
11320009|NCT02714569|12517084|FG004|COMPLETED|Part A First Intervention||3
11320010|NCT02714569|12517085|FG005|COMPLETED|Part A First Intervention||3
11320011|NCT02714569|12517086|FG006|COMPLETED|Part A First Intervention||0
11320012|NCT02714569|12517087|FG007|COMPLETED|Part A First Intervention||0
11320013|NCT02714569|12517088|FG008|COMPLETED|Part A First Intervention||0
11320014|NCT02714569|12517089|FG009|COMPLETED|Part A First Intervention||0
11320015|NCT02714569|12517090|FG010|COMPLETED|Part A First Intervention||0
11320016|NCT02714569|12517080|FG000|NOT COMPLETED|Part A First Intervention||0
11320017|NCT02714569|12517081|FG001|NOT COMPLETED|Part A First Intervention||0
11320018|NCT02714569|12517082|FG002|NOT COMPLETED|Part A First Intervention||0
11320019|NCT02714569|12517083|FG003|NOT COMPLETED|Part A First Intervention||0
11320020|NCT02714569|12517084|FG004|NOT COMPLETED|Part A First Intervention||0
11320021|NCT02714569|12517085|FG005|NOT COMPLETED|Part A First Intervention||0
11320022|NCT02714569|12517086|FG006|NOT COMPLETED|Part A First Intervention||0
11320023|NCT02714569|12517087|FG007|NOT COMPLETED|Part A First Intervention||0
11320024|NCT02714569|12517088|FG008|NOT COMPLETED|Part A First Intervention||0
11320025|NCT02714569|12517089|FG009|NOT COMPLETED|Part A First Intervention||0
11320026|NCT02714569|12517090|FG010|NOT COMPLETED|Part A First Intervention||0
11320027|NCT02714569|12517080|FG000|STARTED|Part A Second Intervention||3
11320028|NCT02714569|12517081|FG001|STARTED|Part A Second Intervention||3
11320029|NCT02714569|12517082|FG002|STARTED|Part A Second Intervention||3
11320030|NCT02714569|12517083|FG003|STARTED|Part A Second Intervention||3
11320031|NCT02714569|12517084|FG004|STARTED|Part A Second Intervention||3
11320032|NCT02714569|12517085|FG005|STARTED|Part A Second Intervention||3
11320033|NCT02714569|12517086|FG006|STARTED|Part A Second Intervention||0
11320034|NCT02714569|12517087|FG007|STARTED|Part A Second Intervention||0
11320035|NCT02714569|12517088|FG008|STARTED|Part A Second Intervention||0
11320036|NCT02714569|12517089|FG009|STARTED|Part A Second Intervention||0
11320037|NCT02714569|12517090|FG010|STARTED|Part A Second Intervention||0
11320038|NCT02714569|12517080|FG000|Received at Least One Dose of Study Drug|Part A Second Intervention||3
11320039|NCT02714569|12517081|FG001|Received at Least One Dose of Study Drug|Part A Second Intervention||2
11320040|NCT02714569|12517082|FG002|Received at Least One Dose of Study Drug|Part A Second Intervention||3
11320041|NCT02714569|12517083|FG003|Received at Least One Dose of Study Drug|Part A Second Intervention||3
11320042|NCT02714569|12517084|FG004|Received at Least One Dose of Study Drug|Part A Second Intervention||3
11320043|NCT02714569|12517085|FG005|Received at Least One Dose of Study Drug|Part A Second Intervention||3
11320044|NCT02714569|12517086|FG006|Received at Least One Dose of Study Drug|Part A Second Intervention||0
11320045|NCT02714569|12517087|FG007|Received at Least One Dose of Study Drug|Part A Second Intervention||0
11320046|NCT02714569|12517088|FG008|Received at Least One Dose of Study Drug|Part A Second Intervention||0
11320047|NCT02714569|12517089|FG009|Received at Least One Dose of Study Drug|Part A Second Intervention||0
11320048|NCT02714569|12517090|FG010|Received at Least One Dose of Study Drug|Part A Second Intervention||0
11320049|NCT02714569|12517080|FG000|COMPLETED|Part A Second Intervention||3
11320050|NCT02714569|12517081|FG001|COMPLETED|Part A Second Intervention||2
11320051|NCT02714569|12517082|FG002|COMPLETED|Part A Second Intervention||3
11320052|NCT02714569|12517083|FG003|COMPLETED|Part A Second Intervention||3
11320053|NCT02714569|12517084|FG004|COMPLETED|Part A Second Intervention||3
11320054|NCT02714569|12517085|FG005|COMPLETED|Part A Second Intervention||3
11320055|NCT02714569|12517086|FG006|COMPLETED|Part A Second Intervention||0
11320056|NCT02714569|12517087|FG007|COMPLETED|Part A Second Intervention||0
11402738|NCT04029584|12597627|FG001|COMPLETED|Induced Study 1st Intervention (1 Day)||8
11402739|NCT04029584|12597626|FG000|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0
11320057|NCT02714569|12517088|FG008|COMPLETED|Part A Second Intervention||0
11320058|NCT02714569|12517089|FG009|COMPLETED|Part A Second Intervention||0
11320059|NCT02714569|12517090|FG010|COMPLETED|Part A Second Intervention||0
11320060|NCT02714569|12517080|FG000|NOT COMPLETED|Part A Second Intervention||0
11320061|NCT02714569|12517081|FG001|NOT COMPLETED|Part A Second Intervention||1
11320062|NCT02714569|12517082|FG002|NOT COMPLETED|Part A Second Intervention||0
11320063|NCT02714569|12517083|FG003|NOT COMPLETED|Part A Second Intervention||0
11320064|NCT02714569|12517084|FG004|NOT COMPLETED|Part A Second Intervention||0
11320065|NCT02714569|12517085|FG005|NOT COMPLETED|Part A Second Intervention||0
11320066|NCT02714569|12517086|FG006|NOT COMPLETED|Part A Second Intervention||0
11320067|NCT02714569|12517087|FG007|NOT COMPLETED|Part A Second Intervention||0
11320068|NCT02714569|12517088|FG008|NOT COMPLETED|Part A Second Intervention||0
11320069|NCT02714569|12517089|FG009|NOT COMPLETED|Part A Second Intervention||0
11320070|NCT02714569|12517090|FG010|NOT COMPLETED|Part A Second Intervention||0
11320071|NCT02714569|12517080|FG000|STARTED|Part A Third Intervention||3
11320072|NCT02714569|12517081|FG001|STARTED|Part A Third Intervention||2
11320073|NCT02714569|12517082|FG002|STARTED|Part A Third Intervention||3
11320074|NCT02714569|12517083|FG003|STARTED|Part A Third Intervention||3
11320075|NCT02714569|12517084|FG004|STARTED|Part A Third Intervention||3
11320076|NCT02714569|12517085|FG005|STARTED|Part A Third Intervention||3
11320077|NCT02714569|12517086|FG006|STARTED|Part A Third Intervention||0
11320078|NCT02714569|12517087|FG007|STARTED|Part A Third Intervention||0
11320079|NCT02714569|12517088|FG008|STARTED|Part A Third Intervention||0
11320080|NCT02714569|12517089|FG009|STARTED|Part A Third Intervention||0
11320081|NCT02714569|12517090|FG010|STARTED|Part A Third Intervention||0
11320082|NCT02714569|12517080|FG000|Received at Least One Dose of Study Drug|Part A Third Intervention||3
11320083|NCT02714569|12517081|FG001|Received at Least One Dose of Study Drug|Part A Third Intervention||2
11320084|NCT02714569|12517082|FG002|Received at Least One Dose of Study Drug|Part A Third Intervention||2
11320085|NCT02714569|12517083|FG003|Received at Least One Dose of Study Drug|Part A Third Intervention||2
11320086|NCT02714569|12517084|FG004|Received at Least One Dose of Study Drug|Part A Third Intervention||3
11320087|NCT02714569|12517085|FG005|Received at Least One Dose of Study Drug|Part A Third Intervention||3
11320088|NCT02714569|12517086|FG006|Received at Least One Dose of Study Drug|Part A Third Intervention||0
11320089|NCT02714569|12517087|FG007|Received at Least One Dose of Study Drug|Part A Third Intervention||0
11320090|NCT02714569|12517088|FG008|Received at Least One Dose of Study Drug|Part A Third Intervention||0
11320091|NCT02714569|12517089|FG009|Received at Least One Dose of Study Drug|Part A Third Intervention||0
11320092|NCT02714569|12517090|FG010|Received at Least One Dose of Study Drug|Part A Third Intervention||0
11320093|NCT02714569|12517080|FG000|COMPLETED|Part A Third Intervention||3
11320094|NCT02714569|12517081|FG001|COMPLETED|Part A Third Intervention||2
11320095|NCT02714569|12517082|FG002|COMPLETED|Part A Third Intervention||2
11320096|NCT02714569|12517083|FG003|COMPLETED|Part A Third Intervention||2
11320097|NCT02714569|12517084|FG004|COMPLETED|Part A Third Intervention||3
11320098|NCT02714569|12517085|FG005|COMPLETED|Part A Third Intervention||3
11320099|NCT02714569|12517086|FG006|COMPLETED|Part A Third Intervention||0
11320100|NCT02714569|12517087|FG007|COMPLETED|Part A Third Intervention||0
11320101|NCT02714569|12517088|FG008|COMPLETED|Part A Third Intervention||0
11320102|NCT02714569|12517089|FG009|COMPLETED|Part A Third Intervention||0
11320103|NCT02714569|12517090|FG010|COMPLETED|Part A Third Intervention||0
11320104|NCT02714569|12517080|FG000|NOT COMPLETED|Part A Third Intervention||0
11320105|NCT02714569|12517081|FG001|NOT COMPLETED|Part A Third Intervention||0
11320106|NCT02714569|12517082|FG002|NOT COMPLETED|Part A Third Intervention||1
11320107|NCT02714569|12517083|FG003|NOT COMPLETED|Part A Third Intervention||1
11320108|NCT02714569|12517084|FG004|NOT COMPLETED|Part A Third Intervention||0
11320109|NCT02714569|12517085|FG005|NOT COMPLETED|Part A Third Intervention||0
11320110|NCT02714569|12517086|FG006|NOT COMPLETED|Part A Third Intervention||0
11320111|NCT02714569|12517087|FG007|NOT COMPLETED|Part A Third Intervention||0
11320112|NCT02714569|12517088|FG008|NOT COMPLETED|Part A Third Intervention||0
11320113|NCT02714569|12517089|FG009|NOT COMPLETED|Part A Third Intervention||0
11320114|NCT02714569|12517090|FG010|NOT COMPLETED|Part A Third Intervention||0
11320115|NCT02714569|12517080|FG000|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|4
11320116|NCT02714569|12517081|FG001|STARTED|Part A Fourth Intervention||2
11320117|NCT02714569|12517082|FG002|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|3
11320118|NCT02714569|12517083|FG003|STARTED|Part A Fourth Intervention||2
11320119|NCT02714569|12517084|FG004|STARTED|Part A Fourth Intervention||3
11320120|NCT02714569|12517085|FG005|STARTED|Part A Fourth Intervention||3
11320121|NCT02714569|12517086|FG006|STARTED|Part A Fourth Intervention||0
11320122|NCT02714569|12517087|FG007|STARTED|Part A Fourth Intervention||0
11320123|NCT02714569|12517088|FG008|STARTED|Part A Fourth Intervention||0
11320124|NCT02714569|12517089|FG009|STARTED|Part A Fourth Intervention||0
11320125|NCT02714569|12517090|FG010|STARTED|Part A Fourth Intervention||0
11320126|NCT02714569|12517080|FG000|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
11320127|NCT02714569|12517081|FG001|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
11320128|NCT02714569|12517082|FG002|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
11320129|NCT02714569|12517083|FG003|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
11320130|NCT02714569|12517084|FG004|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
11320131|NCT02714569|12517085|FG005|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
11320132|NCT02714569|12517086|FG006|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
11320133|NCT02714569|12517087|FG007|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
11320134|NCT02714569|12517088|FG008|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
11320135|NCT02714569|12517089|FG009|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
11320136|NCT02714569|12517090|FG010|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
11320137|NCT02714569|12517080|FG000|COMPLETED|Part A Fourth Intervention||3
11320138|NCT02714569|12517081|FG001|COMPLETED|Part A Fourth Intervention||2
11320139|NCT02714569|12517082|FG002|COMPLETED|Part A Fourth Intervention||3
11320140|NCT02714569|12517083|FG003|COMPLETED|Part A Fourth Intervention||2
11320141|NCT02714569|12517084|FG004|COMPLETED|Part A Fourth Intervention||3
11320142|NCT02714569|12517085|FG005|COMPLETED|Part A Fourth Intervention||2
11320143|NCT02714569|12517086|FG006|COMPLETED|Part A Fourth Intervention||0
11320144|NCT02714569|12517087|FG007|COMPLETED|Part A Fourth Intervention||0
11320145|NCT02714569|12517088|FG008|COMPLETED|Part A Fourth Intervention||0
11320146|NCT02714569|12517089|FG009|COMPLETED|Part A Fourth Intervention||0
11320147|NCT02714569|12517090|FG010|COMPLETED|Part A Fourth Intervention||0
11320148|NCT02714569|12517080|FG000|NOT COMPLETED|Part A Fourth Intervention||1
11320149|NCT02714569|12517081|FG001|NOT COMPLETED|Part A Fourth Intervention||0
11320150|NCT02714569|12517082|FG002|NOT COMPLETED|Part A Fourth Intervention||0
11320151|NCT02714569|12517083|FG003|NOT COMPLETED|Part A Fourth Intervention||0
11320152|NCT02714569|12517084|FG004|NOT COMPLETED|Part A Fourth Intervention||0
11320153|NCT02714569|12517085|FG005|NOT COMPLETED|Part A Fourth Intervention||1
11320154|NCT02714569|12517086|FG006|NOT COMPLETED|Part A Fourth Intervention||0
11320155|NCT02714569|12517087|FG007|NOT COMPLETED|Part A Fourth Intervention||0
11320156|NCT02714569|12517088|FG008|NOT COMPLETED|Part A Fourth Intervention||0
11320157|NCT02714569|12517089|FG009|NOT COMPLETED|Part A Fourth Intervention||0
11320158|NCT02714569|12517090|FG010|NOT COMPLETED|Part A Fourth Intervention||0
11320159|NCT02714569|12517080|FG000|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
11320160|NCT02714569|12517081|FG001|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
11320161|NCT02714569|12517082|FG002|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
11320162|NCT02714569|12517083|FG003|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
11320163|NCT02714569|12517084|FG004|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
11320164|NCT02714569|12517085|FG005|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
11320165|NCT02714569|12517086|FG006|STARTED|Part B (Overall)|Part B participants randomized to receive 5 mg of LY3202328 + atorvastatin/simvastatin.|8
11320166|NCT02714569|12517087|FG007|STARTED|Part B (Overall)|Part B participants randomized to receive 20 mg of LY3202328 + atorvastatin/simvastatin.|8
11320167|NCT02714569|12517088|FG008|STARTED|Part B (Overall)|Part B participants randomized to receive 100 mg of LY3202328 + atorvastatin/simvastatin.|8
11320168|NCT02714569|12517089|FG009|STARTED|Part B (Overall)|Part B participants randomized to receive 300 mg of LY3202328 + atorvastatin/simvastatin.|8
11320169|NCT02714569|12517090|FG010|STARTED|Part B (Overall)|Part B participants randomized to receive placebo instead of LY3202328 + atorvastatin/simvastatin.|8
11320170|NCT02714569|12517080|FG000|COMPLETED|Part B (Overall)||0
11320171|NCT02714569|12517081|FG001|COMPLETED|Part B (Overall)||0
11320172|NCT02714569|12517082|FG002|COMPLETED|Part B (Overall)||0
11320173|NCT02714569|12517083|FG003|COMPLETED|Part B (Overall)||0
11320174|NCT02714569|12517084|FG004|COMPLETED|Part B (Overall)||0
11320175|NCT02714569|12517085|FG005|COMPLETED|Part B (Overall)||0
11320176|NCT02714569|12517086|FG006|COMPLETED|Part B (Overall)||7
11320177|NCT02714569|12517087|FG007|COMPLETED|Part B (Overall)||7
11402740|NCT04029584|12597627|FG001|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0
11402741|NCT04029584|12597626|FG000|STARTED|Induced Washout (1 Day)||2
11320178|NCT02714569|12517088|FG008|COMPLETED|Part B (Overall)||8
11320179|NCT02714569|12517089|FG009|COMPLETED|Part B (Overall)||6
11402742|NCT04029584|12597627|FG001|STARTED|Induced Washout (1 Day)||8
11320180|NCT02714569|12517090|FG010|COMPLETED|Part B (Overall)||8
11320181|NCT02714569|12517080|FG000|NOT COMPLETED|Part B (Overall)||0
11320182|NCT02714569|12517081|FG001|NOT COMPLETED|Part B (Overall)||0
11320183|NCT02714569|12517082|FG002|NOT COMPLETED|Part B (Overall)||0
11320184|NCT02714569|12517083|FG003|NOT COMPLETED|Part B (Overall)||0
11320185|NCT02714569|12517084|FG004|NOT COMPLETED|Part B (Overall)||0
11320186|NCT02714569|12517085|FG005|NOT COMPLETED|Part B (Overall)||0
11320187|NCT02714569|12517086|FG006|NOT COMPLETED|Part B (Overall)||1
11320188|NCT02714569|12517087|FG007|NOT COMPLETED|Part B (Overall)||1
11320189|NCT02714569|12517088|FG008|NOT COMPLETED|Part B (Overall)||0
11320190|NCT02714569|12517089|FG009|NOT COMPLETED|Part B (Overall)||2
11320191|NCT02714569|12517090|FG010|NOT COMPLETED|Part B (Overall)||0
11320192|NCT02714595|12517152|FG000|STARTED|Overall Study||101
11320193|NCT02714595|12517153|FG001|STARTED|Overall Study||51
11402743|NCT04029584|12597626|FG000|COMPLETED|Induced Washout (1 Day)||2
11320194|NCT02714595|12517152|FG000|Received Treatment|Overall Study||101
11320195|NCT02714595|12517153|FG001|Received Treatment|Overall Study||49
11320196|NCT02714595|12517152|FG000|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||80
11320197|NCT02714595|12517153|FG001|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||38
11320198|NCT02714595|12517152|FG000|COMPLETED|Overall Study||69
11402744|NCT04029584|12597627|FG001|COMPLETED|Induced Washout (1 Day)||8
11402745|NCT04029584|12597626|FG000|NOT COMPLETED|Induced Washout (1 Day)||0
11320199|NCT02714595|12517153|FG001|COMPLETED|Overall Study||38
11320200|NCT02714595|12517152|FG000|NOT COMPLETED|Overall Study||32
11320201|NCT02714595|12517153|FG001|NOT COMPLETED|Overall Study||13
11320202|NCT02714868|12517179|FG000|STARTED|Overall Study||47
11320203|NCT02714868|12517180|FG001|STARTED|Overall Study||35
11320204|NCT02714868|12517179|FG000|COMPLETED|Overall Study||42
11320205|NCT02714868|12517180|FG001|COMPLETED|Overall Study||35
11320206|NCT02714868|12517179|FG000|NOT COMPLETED|Overall Study||5
11320207|NCT02714868|12517180|FG001|NOT COMPLETED|Overall Study||0
11320208|NCT02715076|12517193|FG000|STARTED|Overall Study||48
11320209|NCT02715076|12517194|FG001|STARTED|Overall Study||50
11320210|NCT02715076|12517195|FG002|STARTED|Overall Study||49
11320211|NCT02715076|12517196|FG003|STARTED|Overall Study||50
11320212|NCT02715076|12517197|FG004|STARTED|Overall Study||47
11320213|NCT02715076|12517198|FG005|STARTED|Overall Study||48
11320214|NCT02715076|12517193|FG000|COMPLETED|Overall Study||48
11320215|NCT02715076|12517194|FG001|COMPLETED|Overall Study||50
11320216|NCT02715076|12517195|FG002|COMPLETED|Overall Study||49
11320217|NCT02715076|12517196|FG003|COMPLETED|Overall Study||50
11320218|NCT02715076|12517197|FG004|COMPLETED|Overall Study||47
11320219|NCT02715076|12517198|FG005|COMPLETED|Overall Study||48
11320220|NCT02715076|12517193|FG000|NOT COMPLETED|Overall Study||0
11320221|NCT02715076|12517194|FG001|NOT COMPLETED|Overall Study||0
11320222|NCT02715076|12517195|FG002|NOT COMPLETED|Overall Study||0
11320223|NCT02715076|12517196|FG003|NOT COMPLETED|Overall Study||0
11320224|NCT02715076|12517197|FG004|NOT COMPLETED|Overall Study||0
11320225|NCT02715076|12517198|FG005|NOT COMPLETED|Overall Study||0
11320226|NCT02715258|12517214|FG000|STARTED|Overall Study||140
11320227|NCT02715258|12517215|FG001|STARTED|Overall Study||70
11320228|NCT02715258|12517214|FG000|Intent to Treat/Safety Analysis|Overall Study||138
11320229|NCT02715258|12517215|FG001|Intent to Treat/Safety Analysis|Overall Study||69
11320230|NCT02715258|12517214|FG000|COMPLETED|Overall Study||124
11320231|NCT02715258|12517215|FG001|COMPLETED|Overall Study||64
11320232|NCT02715258|12517214|FG000|NOT COMPLETED|Overall Study||16
11320233|NCT02715258|12517215|FG001|NOT COMPLETED|Overall Study||6
11320234|NCT02715700|12517221|FG000|STARTED|Overall Study||14
11320235|NCT02715700|12517221|FG000|COMPLETED|Overall Study||14
11320236|NCT02715700|12517221|FG000|NOT COMPLETED|Overall Study||0
11402746|NCT04029584|12597627|FG001|NOT COMPLETED|Induced Washout (1 Day)||0
11402747|NCT04029584|12597626|FG000|STARTED|Induced Study 2nd Intervention (1 Day)||2
11402748|NCT04029584|12597627|FG001|STARTED|Induced Study 2nd Intervention (1 Day)||8
11402749|NCT04029584|12597626|FG000|COMPLETED|Induced Study 2nd Intervention (1 Day)||2
11320237|NCT02715726|12517231|FG000|STARTED|Overall Study|Randomized|208
11320238|NCT02715726|12517232|FG001|STARTED|Overall Study|Randomized|407
11320239|NCT02715726|12517231|FG000|Treated|Overall Study||207
11320240|NCT02715726|12517232|FG001|Treated|Overall Study||405
11320241|NCT02715726|12517231|FG000|Safety Population|Overall Study||206
11320242|NCT02715726|12517232|FG001|Safety Population|Overall Study||406
11320243|NCT02715726|12517231|FG000|COMPLETED|Overall Study||190
11320244|NCT02715726|12517232|FG001|COMPLETED|Overall Study||380
11320245|NCT02715726|12517231|FG000|NOT COMPLETED|Overall Study||18
11320246|NCT02715726|12517232|FG001|NOT COMPLETED|Overall Study||27
11320247|NCT02715804|12517240|FG000|STARTED|Overall Study||327
11320248|NCT02715804|12517241|FG001|STARTED|Overall Study||165
11320249|NCT02715804|12517240|FG000|Received at Least 1 Dose of Study Drug|Overall Study||323
11320250|NCT02715804|12517241|FG001|Received at Least 1 Dose of Study Drug|Overall Study||158
11320251|NCT02715804|12517240|FG000|Safety Population|Overall Study|3 participants randomized to AG but received PAG|325
11320252|NCT02715804|12517241|FG001|Safety Population|Overall Study|1 participant randomized to PAG but received AG|156
11320253|NCT02715804|12517240|FG000|COMPLETED|Overall Study||98
11320254|NCT02715804|12517241|FG001|COMPLETED|Overall Study||52
11320255|NCT02715804|12517240|FG000|NOT COMPLETED|Overall Study||229
11320256|NCT02715804|12517241|FG001|NOT COMPLETED|Overall Study||113
11320257|NCT02716194|12517250|FG000|STARTED|Period 1 - ADVATE||11
11320258|NCT02716194|12517251|FG001|STARTED|Period 1 - ADVATE||16
11320259|NCT02716194|12517252|FG002|STARTED|Period 1 - ADVATE||13
11320260|NCT02716194|12517250|FG000|COMPLETED|Period 1 - ADVATE||10
11320261|NCT02716194|12517251|FG001|COMPLETED|Period 1 - ADVATE||15
11320262|NCT02716194|12517252|FG002|COMPLETED|Period 1 - ADVATE||13
11320263|NCT02716194|12517250|FG000|NOT COMPLETED|Period 1 - ADVATE||1
11320264|NCT02716194|12517251|FG001|NOT COMPLETED|Period 1 - ADVATE||1
11320265|NCT02716194|12517252|FG002|NOT COMPLETED|Period 1 - ADVATE||0
11320266|NCT02716194|12517250|FG000|STARTED|Period 2 - BAX 826||10
11320267|NCT02716194|12517251|FG001|STARTED|Period 2 - BAX 826||15
11320268|NCT02716194|12517252|FG002|STARTED|Period 2 - BAX 826||13
11320269|NCT02716194|12517250|FG000|COMPLETED|Period 2 - BAX 826||10
11320270|NCT02716194|12517251|FG001|COMPLETED|Period 2 - BAX 826||15
11320271|NCT02716194|12517252|FG002|COMPLETED|Period 2 - BAX 826||13
11320272|NCT02716194|12517250|FG000|NOT COMPLETED|Period 2 - BAX 826||0
11320273|NCT02716194|12517251|FG001|NOT COMPLETED|Period 2 - BAX 826||0
11320274|NCT02716194|12517252|FG002|NOT COMPLETED|Period 2 - BAX 826||0
11320275|NCT02716298|12517273|FG000|STARTED|First Intervention (1 Month)||25
11320276|NCT02716298|12517274|FG001|STARTED|First Intervention (1 Month)||24
11320277|NCT02716298|12517273|FG000|COMPLETED|First Intervention (1 Month)||24
11320278|NCT02716298|12517274|FG001|COMPLETED|First Intervention (1 Month)||23
11320279|NCT02716298|12517273|FG000|NOT COMPLETED|First Intervention (1 Month)||1
11320280|NCT02716298|12517274|FG001|NOT COMPLETED|First Intervention (1 Month)||1
11320281|NCT02716298|12517273|FG000|STARTED|Second Intervention (1 Month)||24
11320282|NCT02716298|12517274|FG001|STARTED|Second Intervention (1 Month)||23
11320283|NCT02716298|12517273|FG000|COMPLETED|Second Intervention (1 Month)||24
11320284|NCT02716298|12517274|FG001|COMPLETED|Second Intervention (1 Month)||23
11320285|NCT02716298|12517273|FG000|NOT COMPLETED|Second Intervention (1 Month)||0
11320286|NCT02716298|12517274|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
11320287|NCT02716324|12517287|FG000|STARTED|Overall Study||149
11320288|NCT02716324|12517288|FG001|STARTED|Overall Study||154
11402750|NCT04029584|12597627|FG001|COMPLETED|Induced Study 2nd Intervention (1 Day)||8
11402751|NCT04029584|12597626|FG000|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0
11402752|NCT04029584|12597627|FG001|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0
11402753|NCT04029311|12597639|FG000|STARTED|Overall Study||15
11402754|NCT04029311|12597640|FG001|STARTED|Overall Study||13
11402755|NCT04029311|12597639|FG000|COMPLETED|Overall Study||12
11402756|NCT04029311|12597640|FG001|COMPLETED|Overall Study||13
11402757|NCT04029311|12597639|FG000|NOT COMPLETED|Overall Study||3
11402758|NCT04029311|12597640|FG001|NOT COMPLETED|Overall Study||0
11402759|NCT04028960|12597648|FG000|STARTED|Overall Study||2
11402760|NCT04028960|12597649|FG001|STARTED|Overall Study||2
11402761|NCT04028960|12597648|FG000|COMPLETED|Overall Study||2
11402762|NCT04028960|12597649|FG001|COMPLETED|Overall Study||2
11402763|NCT04028960|12597648|FG000|NOT COMPLETED|Overall Study||0
11402764|NCT04028960|12597649|FG001|NOT COMPLETED|Overall Study||0
11402765|NCT04026399|12597657|FG000|STARTED|Overall Study||6
11402766|NCT04026399|12597658|FG001|STARTED|Overall Study||6
11402767|NCT04026399|12597657|FG000|COMPLETED|Overall Study||1
11402768|NCT04026399|12597658|FG001|COMPLETED|Overall Study||3
11402769|NCT04026399|12597657|FG000|NOT COMPLETED|Overall Study||5
11402770|NCT04026399|12597658|FG001|NOT COMPLETED|Overall Study||3
11402771|NCT04023578|12597664|FG000|STARTED|Overall Study||15
11402772|NCT04023578|12597664|FG000|COMPLETED|Overall Study||13
11402773|NCT04023578|12597664|FG000|NOT COMPLETED|Overall Study||2
11402774|NCT04023695|12597671|FG000|STARTED|Overall Study||57
11402775|NCT04023695|12597672|FG001|STARTED|Overall Study||53
11402776|NCT04023695|12597671|FG000|COMPLETED|Overall Study||57
11402777|NCT04023695|12597672|FG001|COMPLETED|Overall Study||53
11320289|NCT02716324|12517287|FG000|COMPLETED|Overall Study||130
11320290|NCT02716324|12517288|FG001|COMPLETED|Overall Study||143
11320291|NCT02716324|12517287|FG000|NOT COMPLETED|Overall Study||19
11320292|NCT02716324|12517288|FG001|NOT COMPLETED|Overall Study||11
11320293|NCT02716506|12517294|FG000|STARTED|Overall Study||3515
11320294|NCT02716506|12517294|FG000|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528
11320295|NCT02716506|12517294|FG000|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351
11320296|NCT02716506|12517294|FG000|COMPLETED|Overall Study||2351
11320297|NCT02716506|12517294|FG000|NOT COMPLETED|Overall Study||1164
11320298|NCT02716584|12517300|FG000|STARTED|Overall Study||35
11143938|NCT01474993|12330564|FG000|COMPLETED|Overall Study||14
11320299|NCT02716584|12517301|FG001|STARTED|Overall Study||18
11320300|NCT02716584|12517300|FG000|COMPLETED|Overall Study||27
11320301|NCT02716584|12517301|FG001|COMPLETED|Overall Study||13
11320302|NCT02716584|12517300|FG000|NOT COMPLETED|Overall Study||8
11320303|NCT02716584|12517301|FG001|NOT COMPLETED|Overall Study||5
11320304|NCT02716714|12517309|FG000|STARTED|Overall Study||67
11320305|NCT02716714|12517310|FG001|STARTED|Overall Study||10
11320306|NCT02716714|12517309|FG000|COMPLETED|Overall Study||55
11320307|NCT02716714|12517310|FG001|COMPLETED|Overall Study||8
11320308|NCT02716714|12517309|FG000|NOT COMPLETED|Overall Study||12
11320309|NCT02716714|12517310|FG001|NOT COMPLETED|Overall Study||2
11320310|NCT02716727|12517322|FG000|STARTED|Overall Study||7
11320311|NCT02716727|12517323|FG001|STARTED|Overall Study||9
11320312|NCT02716727|12517322|FG000|COMPLETED|Overall Study||7
11320313|NCT02716727|12517323|FG001|COMPLETED|Overall Study||9
11320314|NCT02716727|12517322|FG000|NOT COMPLETED|Overall Study||0
11320315|NCT02716727|12517323|FG001|NOT COMPLETED|Overall Study||0
11320316|NCT02716779|12517332|FG000|STARTED|Monotherapy||14
11320317|NCT02716779|12517333|FG001|STARTED|Monotherapy||26
11320318|NCT02716779|12517334|FG002|STARTED|Monotherapy||27
11320319|NCT02716779|12517332|FG000|COMPLETED|Monotherapy||14
11320320|NCT02716779|12517333|FG001|COMPLETED|Monotherapy||25
11402778|NCT04023695|12597671|FG000|NOT COMPLETED|Overall Study||0
11402779|NCT04023695|12597672|FG001|NOT COMPLETED|Overall Study||0
11402780|NCT04018664|12597686|FG000|STARTED|Overall Study||14
11143939|NCT01474993|12330565|FG001|COMPLETED|Overall Study||26
11143940|NCT01474993|12330564|FG000|NOT COMPLETED|Overall Study||1
11143941|NCT01474993|12330565|FG001|NOT COMPLETED|Overall Study||3
11143942|NCT01475071|12330573|FG000|STARTED|Overall Study||100
11143943|NCT01475071|12330573|FG000|COMPLETED|Overall Study||92
11143944|NCT01475071|12330573|FG000|NOT COMPLETED|Overall Study||8
11143945|NCT01475097|12330581|FG000|STARTED|Overall Study||128
11143946|NCT01475097|12330582|FG001|STARTED|Overall Study||127
11143947|NCT01475097|12330581|FG000|COMPLETED|Overall Study||127
11143948|NCT01475097|12330582|FG001|COMPLETED|Overall Study||126
11143949|NCT01475097|12330581|FG000|NOT COMPLETED|Overall Study||1
11143950|NCT01475097|12330582|FG001|NOT COMPLETED|Overall Study||1
11143951|NCT01475136|12330592|FG000|STARTED|Overall Study||7
11143952|NCT01475136|12330593|FG001|STARTED|Overall Study||9
11143953|NCT01475136|12330594|FG002|STARTED|Overall Study||9
11143954|NCT01475136|12330595|FG003|STARTED|Overall Study||12
11143955|NCT01475136|12330592|FG000|Received 1 Dose of Study Drug|Overall Study||7
11143956|NCT01475136|12330593|FG001|Received 1 Dose of Study Drug|Overall Study||6
11143957|NCT01475136|12330594|FG002|Received 1 Dose of Study Drug|Overall Study||6
11143958|NCT01475136|12330595|FG003|Received 1 Dose of Study Drug|Overall Study||7
11143959|NCT01475136|12330592|FG000|COMPLETED|Overall Study||6
11143960|NCT01475136|12330593|FG001|COMPLETED|Overall Study||6
11143961|NCT01475136|12330594|FG002|COMPLETED|Overall Study||6
11402781|NCT04018664|12597687|FG001|STARTED|Overall Study||6
11402782|NCT04018664|12597688|FG002|STARTED|Overall Study||6
11402783|NCT04018664|12597689|FG003|STARTED|Overall Study||6
11402784|NCT04018664|12597690|FG004|STARTED|Overall Study||6
11402785|NCT04018664|12597691|FG005|STARTED|Overall Study||6
11402786|NCT04018664|12597692|FG006|STARTED|Overall Study||6
11402787|NCT04018664|12597693|FG007|STARTED|Overall Study||6
11402788|NCT04018664|12597686|FG000|COMPLETED|Overall Study||14
11402789|NCT04018664|12597687|FG001|COMPLETED|Overall Study||6
11402790|NCT04018664|12597688|FG002|COMPLETED|Overall Study||6
11143962|NCT01475136|12330595|FG003|COMPLETED|Overall Study||7
11143963|NCT01475136|12330592|FG000|NOT COMPLETED|Overall Study||1
11143964|NCT01475136|12330593|FG001|NOT COMPLETED|Overall Study||3
11143965|NCT01475136|12330594|FG002|NOT COMPLETED|Overall Study||3
11320321|NCT02716779|12517334|FG002|COMPLETED|Monotherapy||26
11320322|NCT02716779|12517332|FG000|NOT COMPLETED|Monotherapy||0
11320323|NCT02716779|12517333|FG001|NOT COMPLETED|Monotherapy||1
11320324|NCT02716779|12517334|FG002|NOT COMPLETED|Monotherapy||1
11320325|NCT02716779|12517332|FG000|STARTED|Combination Therapy||14
11320326|NCT02716779|12517333|FG001|STARTED|Combination Therapy||25
11320327|NCT02716779|12517334|FG002|STARTED|Combination Therapy||26
11320328|NCT02716779|12517332|FG000|COMPLETED|Combination Therapy||14
11320329|NCT02716779|12517333|FG001|COMPLETED|Combination Therapy||23
11143966|NCT01475136|12330595|FG003|NOT COMPLETED|Overall Study||5
11143967|NCT01475162|12330605|FG000|STARTED|Overall Study||14
11143968|NCT01475162|12330605|FG000|COMPLETED|Overall Study||0
11143969|NCT01475162|12330605|FG000|NOT COMPLETED|Overall Study||14
11143970|NCT01475175|12330610|FG000|STARTED|Overall Study||12
11143971|NCT01475175|12330610|FG000|COMPLETED|Overall Study||12
11143972|NCT01475175|12330610|FG000|NOT COMPLETED|Overall Study||0
11143973|NCT01475214|12330617|FG000|STARTED|Overall Study||84
11143974|NCT01475214|12330618|FG001|STARTED|Overall Study||79
11143975|NCT01475214|12330619|FG002|STARTED|Overall Study||81
11143976|NCT01475214|12330617|FG000|COMPLETED|Overall Study||79
11143977|NCT01475214|12330618|FG001|COMPLETED|Overall Study||75
11143978|NCT01475214|12330619|FG002|COMPLETED|Overall Study||79
11143979|NCT01475214|12330617|FG000|NOT COMPLETED|Overall Study||5
11143980|NCT01475214|12330618|FG001|NOT COMPLETED|Overall Study||4
11320330|NCT02716779|12517334|FG002|COMPLETED|Combination Therapy||25
11320331|NCT02716779|12517332|FG000|NOT COMPLETED|Combination Therapy||0
11320332|NCT02716779|12517333|FG001|NOT COMPLETED|Combination Therapy||2
11320333|NCT02716779|12517334|FG002|NOT COMPLETED|Combination Therapy||1
11320334|NCT02716805|12517348|FG000|STARTED|Overall Study||6
11320335|NCT02716805|12517349|FG001|STARTED|Overall Study||0
11320336|NCT02716805|12517350|FG002|STARTED|Overall Study||0
11320337|NCT02716805|12517351|FG003|STARTED|Overall Study||0
11320338|NCT02716805|12517348|FG000|COMPLETED|Overall Study||4
11320339|NCT02716805|12517349|FG001|COMPLETED|Overall Study||0
11320340|NCT02716805|12517350|FG002|COMPLETED|Overall Study||0
11320341|NCT02716805|12517351|FG003|COMPLETED|Overall Study||0
11320342|NCT02716805|12517348|FG000|NOT COMPLETED|Overall Study||2
11320343|NCT02716805|12517349|FG001|NOT COMPLETED|Overall Study||0
11320344|NCT02716805|12517350|FG002|NOT COMPLETED|Overall Study||0
11320345|NCT02716805|12517351|FG003|NOT COMPLETED|Overall Study||0
11320346|NCT02716818|12517357|FG000|STARTED|Overall Study||61
11320347|NCT02716818|12517358|FG001|STARTED|Overall Study||61
11320348|NCT02716818|12517357|FG000|COMPLETED|Overall Study||58
11320349|NCT02716818|12517358|FG001|COMPLETED|Overall Study||59
11320350|NCT02716818|12517357|FG000|NOT COMPLETED|Overall Study||3
11320351|NCT02716818|12517358|FG001|NOT COMPLETED|Overall Study||2
11320352|NCT02716896|12517388|FG000|STARTED|Overall Study||1
11320353|NCT02716896|12517389|FG001|STARTED|Overall Study||1
11320354|NCT02716896|12517388|FG000|COMPLETED|Overall Study||1
11320355|NCT02716896|12517389|FG001|COMPLETED|Overall Study||0
11320356|NCT02716896|12517388|FG000|NOT COMPLETED|Overall Study||0
11320357|NCT02716896|12517389|FG001|NOT COMPLETED|Overall Study||1
11320358|NCT02716987|12517401|FG000|STARTED|Overall Study||4
11320359|NCT02716987|12517402|FG001|STARTED|Overall Study||2
11320360|NCT02716987|12517403|FG002|STARTED|Overall Study||5
11320361|NCT02716987|12517404|FG003|STARTED|Overall Study||2
11320362|NCT02716987|12517405|FG004|STARTED|Overall Study||6
11320363|NCT02716987|12517406|FG005|STARTED|Overall Study||1
11320364|NCT02716987|12517401|FG000|COMPLETED|Overall Study||4
11320365|NCT02716987|12517402|FG001|COMPLETED|Overall Study||2
11320366|NCT02716987|12517403|FG002|COMPLETED|Overall Study||4
11320367|NCT02716987|12517404|FG003|COMPLETED|Overall Study||2
11320368|NCT02716987|12517405|FG004|COMPLETED|Overall Study||5
11320369|NCT02716987|12517406|FG005|COMPLETED|Overall Study||0
11320370|NCT02716987|12517401|FG000|NOT COMPLETED|Overall Study||0
11320371|NCT02716987|12517402|FG001|NOT COMPLETED|Overall Study||0
11320372|NCT02716987|12517403|FG002|NOT COMPLETED|Overall Study||1
11320373|NCT02716987|12517404|FG003|NOT COMPLETED|Overall Study||0
11320374|NCT02716987|12517405|FG004|NOT COMPLETED|Overall Study||1
11320375|NCT02716987|12517406|FG005|NOT COMPLETED|Overall Study||1
11320376|NCT02717195|12517435|FG000|STARTED|Prospective Confirmation (PC) Period||711
11320377|NCT02717195|12517436|FG001|STARTED|Prospective Confirmation (PC) Period||387
11320378|NCT02717195|12517437|FG002|STARTED|Prospective Confirmation (PC) Period||0
11143981|NCT01475214|12330619|FG002|NOT COMPLETED|Overall Study||2
11143982|NCT01475253|12330631|FG000|STARTED|Randomized, Blinded Study||47
11143983|NCT01475253|12330632|FG001|STARTED|Randomized, Blinded Study||46
11143984|NCT01475253|12330633|FG002|STARTED|Randomized, Blinded Study||11
11143985|NCT01475253|12330634|FG003|STARTED|Randomized, Blinded Study||0
11143986|NCT01475253|12330631|FG000|COMPLETED|Randomized, Blinded Study||45
11143987|NCT01475253|12330632|FG001|COMPLETED|Randomized, Blinded Study||45
11143988|NCT01475253|12330633|FG002|COMPLETED|Randomized, Blinded Study||11
11143989|NCT01475253|12330634|FG003|COMPLETED|Randomized, Blinded Study||0
11143990|NCT01475253|12330631|FG000|NOT COMPLETED|Randomized, Blinded Study||2
11143991|NCT01475253|12330632|FG001|NOT COMPLETED|Randomized, Blinded Study||1
11143992|NCT01475253|12330633|FG002|NOT COMPLETED|Randomized, Blinded Study||0
11143993|NCT01475253|12330634|FG003|NOT COMPLETED|Randomized, Blinded Study||0
11320379|NCT02717195|12517438|FG003|STARTED|Prospective Confirmation (PC) Period||0
11320380|NCT02717195|12517439|FG004|STARTED|Prospective Confirmation (PC) Period||0
11320381|NCT02717195|12517435|FG000|COMPLETED|Prospective Confirmation (PC) Period||421
11320382|NCT02717195|12517436|FG001|COMPLETED|Prospective Confirmation (PC) Period||276
11320383|NCT02717195|12517437|FG002|COMPLETED|Prospective Confirmation (PC) Period||0
11320384|NCT02717195|12517438|FG003|COMPLETED|Prospective Confirmation (PC) Period||0
11320385|NCT02717195|12517439|FG004|COMPLETED|Prospective Confirmation (PC) Period||0
11320386|NCT02717195|12517435|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||290
11320387|NCT02717195|12517436|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||111
11320388|NCT02717195|12517437|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0
11320389|NCT02717195|12517438|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0
11320390|NCT02717195|12517439|FG004|NOT COMPLETED|Prospective Confirmation (PC) Period||0
11320391|NCT02717195|12517435|FG000|STARTED|Double-blind Treatment (DBT) Period||0
11320392|NCT02717195|12517436|FG001|STARTED|Double-blind Treatment (DBT) Period||0
11320393|NCT02717195|12517437|FG002|STARTED|Double-blind Treatment (DBT) Period||235
11320394|NCT02717195|12517438|FG003|STARTED|Double-blind Treatment (DBT) Period||232
11320395|NCT02717195|12517439|FG004|STARTED|Double-blind Treatment (DBT) Period||230
11320396|NCT02717195|12517435|FG000|COMPLETED|Double-blind Treatment (DBT) Period||0
11320397|NCT02717195|12517436|FG001|COMPLETED|Double-blind Treatment (DBT) Period||0
11320398|NCT02717195|12517437|FG002|COMPLETED|Double-blind Treatment (DBT) Period||198
11320399|NCT02717195|12517438|FG003|COMPLETED|Double-blind Treatment (DBT) Period||188
11320400|NCT02717195|12517439|FG004|COMPLETED|Double-blind Treatment (DBT) Period||200
11320401|NCT02717195|12517435|FG000|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
11320402|NCT02717195|12517436|FG001|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
11320403|NCT02717195|12517437|FG002|NOT COMPLETED|Double-blind Treatment (DBT) Period||37
11320404|NCT02717195|12517438|FG003|NOT COMPLETED|Double-blind Treatment (DBT) Period||44
11320405|NCT02717195|12517439|FG004|NOT COMPLETED|Double-blind Treatment (DBT) Period||30
11320406|NCT02717273|12517454|FG000|STARTED|Overall Study||52
11320407|NCT02717273|12517455|FG001|STARTED|Overall Study||50
11320408|NCT02717273|12517454|FG000|COMPLETED|Overall Study||49
11320409|NCT02717273|12517455|FG001|COMPLETED|Overall Study||48
11320410|NCT02717273|12517454|FG000|NOT COMPLETED|Overall Study||3
11320411|NCT02717273|12517455|FG001|NOT COMPLETED|Overall Study||2
11320412|NCT02717494|12517464|FG000|STARTED|First Intervention (Step 1)||115
11320413|NCT02717494|12517465|FG001|STARTED|First Intervention (Step 1)||115
11320414|NCT02717494|12517466|FG002|STARTED|First Intervention (Step 1)||116
11320415|NCT02717494|12517464|FG000|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
11320416|NCT02717494|12517465|FG001|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
11320417|NCT02717494|12517466|FG002|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53
11320418|NCT02717494|12517464|FG000|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
11320419|NCT02717494|12517465|FG001|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
11320420|NCT02717494|12517466|FG002|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53
11320421|NCT02717494|12517464|FG000|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
11320422|NCT02717494|12517465|FG001|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
11320423|NCT02717494|12517466|FG002|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4
11320424|NCT02717494|12517464|FG000|COMPLETED|First Intervention (Step 1)||109
11320425|NCT02717494|12517465|FG001|COMPLETED|First Intervention (Step 1)||108
11320426|NCT02717494|12517466|FG002|COMPLETED|First Intervention (Step 1)||111
11320427|NCT02717494|12517464|FG000|NOT COMPLETED|First Intervention (Step 1)||6
11320428|NCT02717494|12517465|FG001|NOT COMPLETED|First Intervention (Step 1)||7
11320429|NCT02717494|12517466|FG002|NOT COMPLETED|First Intervention (Step 1)||5
11320430|NCT02717494|12517464|FG000|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
11320431|NCT02717494|12517465|FG001|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
11320432|NCT02717494|12517466|FG002|STARTED|Second Intervention (Step 2 or Step 3)|One participant who completed Step 1 did not enroll in Step 2.|110
11320433|NCT02717494|12517464|FG000|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
11320434|NCT02717494|12517465|FG001|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
11320435|NCT02717494|12517466|FG002|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52
11320436|NCT02717494|12517464|FG000|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
11320437|NCT02717494|12517465|FG001|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
11402791|NCT04018664|12597689|FG003|COMPLETED|Overall Study||6
11402792|NCT04018664|12597690|FG004|COMPLETED|Overall Study||6
11402793|NCT04018664|12597691|FG005|COMPLETED|Overall Study||6
11022284|NCT00808340|12200527|FG005|STARTED|Third Intervention||6
11022285|NCT00808340|12200522|FG000|COMPLETED|Third Intervention||4
11022286|NCT00808340|12200523|FG001|COMPLETED|Third Intervention||9
11022287|NCT00808340|12200524|FG002|COMPLETED|Third Intervention||7
11320438|NCT02717494|12517466|FG002|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50
11320439|NCT02717494|12517464|FG000|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
11320440|NCT02717494|12517465|FG001|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
11320441|NCT02717494|12517466|FG002|Completed Step 3|Second Intervention (Step 2 or Step 3)||4
11320442|NCT02717494|12517464|FG000|COMPLETED|Second Intervention (Step 2 or Step 3)||0
11320443|NCT02717494|12517465|FG001|COMPLETED|Second Intervention (Step 2 or Step 3)||0
11320444|NCT02717494|12517466|FG002|COMPLETED|Second Intervention (Step 2 or Step 3)||106
11320445|NCT02717494|12517464|FG000|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
11342451|NCT02945410|12539991|FG005|COMPLETED|Intervention 2 (5 Days)||0
11320446|NCT02717494|12517465|FG001|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
11320447|NCT02717494|12517466|FG002|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4
11320448|NCT02717546|12517492|FG000|STARTED|Overall Study||32
11320449|NCT02717546|12517492|FG000|COMPLETED|Overall Study||20
11320450|NCT02717546|12517492|FG000|NOT COMPLETED|Overall Study||12
11320451|NCT02717754|12517502|FG000|STARTED|Overall Study||10
11320452|NCT02717754|12517503|FG001|STARTED|Overall Study||19
11320453|NCT02717754|12517504|FG002|STARTED|Overall Study||20
11320454|NCT02717754|12517505|FG003|STARTED|Overall Study||10
11320455|NCT02717754|12517506|FG004|STARTED|Overall Study||20
11320456|NCT02717754|12517507|FG005|STARTED|Overall Study||20
11320457|NCT02717754|12517502|FG000|COMPLETED|Overall Study||10
11320458|NCT02717754|12517503|FG001|COMPLETED|Overall Study||19
11320459|NCT02717754|12517504|FG002|COMPLETED|Overall Study||20
11320460|NCT02717754|12517505|FG003|COMPLETED|Overall Study||0
11320461|NCT02717754|12517506|FG004|COMPLETED|Overall Study||0
11320462|NCT02717754|12517507|FG005|COMPLETED|Overall Study||0
11320463|NCT02717754|12517502|FG000|NOT COMPLETED|Overall Study||0
11320464|NCT02717754|12517503|FG001|NOT COMPLETED|Overall Study||0
11320465|NCT02717754|12517504|FG002|NOT COMPLETED|Overall Study||0
11320466|NCT02717754|12517505|FG003|NOT COMPLETED|Overall Study||10
11320467|NCT02717754|12517506|FG004|NOT COMPLETED|Overall Study||20
11320468|NCT02717754|12517507|FG005|NOT COMPLETED|Overall Study||20
11320469|NCT02718131|12517519|FG000|STARTED|Overall Study||5
11320470|NCT02718131|12517520|FG001|STARTED|Overall Study||0
11320471|NCT02718131|12517519|FG000|Completed 12 Months|Overall Study||2
11320472|NCT02718131|12517520|FG001|Completed 12 Months|Overall Study||0
11320473|NCT02718131|12517519|FG000|COMPLETED|Overall Study||2
11320474|NCT02718131|12517520|FG001|COMPLETED|Overall Study||0
11320475|NCT02718131|12517519|FG000|NOT COMPLETED|Overall Study||3
11320476|NCT02718131|12517520|FG001|NOT COMPLETED|Overall Study||0
11320477|NCT02718157|12517528|FG000|STARTED|Overall Study||771
11022288|NCT00808340|12200525|FG003|COMPLETED|Third Intervention||3
11022289|NCT00808340|12200526|FG004|COMPLETED|Third Intervention||5
11022290|NCT00808340|12200527|FG005|COMPLETED|Third Intervention||6
11320478|NCT02718157|12517528|FG000|COMPLETED|Overall Study||609
11320479|NCT02718157|12517528|FG000|NOT COMPLETED|Overall Study||162
11320480|NCT02718248|12517532|FG000|STARTED|Overall Study||7
11320481|NCT02718248|12517532|FG000|COMPLETED|Overall Study||7
11320482|NCT02718248|12517532|FG000|NOT COMPLETED|Overall Study||0
11320483|NCT02718326|12517539|FG000|STARTED|Overall Study||133
11320484|NCT02718326|12517540|FG001|STARTED|Overall Study||135
11402794|NCT04018664|12597692|FG006|COMPLETED|Overall Study||6
11402795|NCT04018664|12597693|FG007|COMPLETED|Overall Study||6
11402796|NCT04018664|12597686|FG000|NOT COMPLETED|Overall Study||0
11402797|NCT04018664|12597687|FG001|NOT COMPLETED|Overall Study||0
11402798|NCT04018664|12597688|FG002|NOT COMPLETED|Overall Study||0
11402799|NCT04018664|12597689|FG003|NOT COMPLETED|Overall Study||0
11402800|NCT04018664|12597690|FG004|NOT COMPLETED|Overall Study||0
11402801|NCT04018664|12597691|FG005|NOT COMPLETED|Overall Study||0
11402802|NCT04018664|12597692|FG006|NOT COMPLETED|Overall Study||0
11402803|NCT04018664|12597693|FG007|NOT COMPLETED|Overall Study||0
11402804|NCT04016259|12597713|FG000|STARTED|Overall Study||15
11402805|NCT04016259|12597714|FG001|STARTED|Overall Study||15
11402806|NCT04016259|12597713|FG000|COMPLETED|Overall Study||15
11402807|NCT04016259|12597714|FG001|COMPLETED|Overall Study||15
11402808|NCT04016259|12597713|FG000|NOT COMPLETED|Overall Study||0
11402809|NCT04016259|12597714|FG001|NOT COMPLETED|Overall Study||0
11402810|NCT04016077|12597722|FG000|STARTED|Overall Study||10
11402811|NCT04016077|12597723|FG001|STARTED|Overall Study||8
11402812|NCT04016077|12597722|FG000|COMPLETED|Overall Study||10
11402813|NCT04016077|12597723|FG001|COMPLETED|Overall Study||8
11402814|NCT04016077|12597722|FG000|NOT COMPLETED|Overall Study||0
11320485|NCT02718326|12517541|FG002|STARTED|Overall Study||134
11320486|NCT02718326|12517539|FG000|Completed Week 52|Overall Study||109
11320487|NCT02718326|12517540|FG001|Completed Week 52|Overall Study||122
11320488|NCT02718326|12517541|FG002|Completed Week 52|Overall Study||124
11320489|NCT02718326|12517539|FG000|COMPLETED|Overall Study||97
11320490|NCT02718326|12517540|FG001|COMPLETED|Overall Study||111
11320491|NCT02718326|12517541|FG002|COMPLETED|Overall Study||112
11320492|NCT02718326|12517539|FG000|NOT COMPLETED|Overall Study||36
11320493|NCT02718326|12517540|FG001|NOT COMPLETED|Overall Study||24
11320494|NCT02718326|12517541|FG002|NOT COMPLETED|Overall Study||22
11320495|NCT02718417|12517554|FG000|STARTED|Chemotherapy Phase (CP)||332
11320496|NCT02718417|12517555|FG001|STARTED|Chemotherapy Phase (CP)||331
11320497|NCT02718417|12517556|FG002|STARTED|Chemotherapy Phase (CP)||335
11320498|NCT02718417|12517554|FG000|Safety Population|Chemotherapy Phase (CP)||328
11320499|NCT02718417|12517555|FG001|Safety Population|Chemotherapy Phase (CP)||329
11320500|NCT02718417|12517556|FG002|Safety Population|Chemotherapy Phase (CP)||334
11320501|NCT02718417|12517554|FG000|COMPLETED|Chemotherapy Phase (CP)||280
11320502|NCT02718417|12517555|FG001|COMPLETED|Chemotherapy Phase (CP)||294
11320503|NCT02718417|12517556|FG002|COMPLETED|Chemotherapy Phase (CP)||289
11320504|NCT02718417|12517554|FG000|NOT COMPLETED|Chemotherapy Phase (CP)||52
11320505|NCT02718417|12517555|FG001|NOT COMPLETED|Chemotherapy Phase (CP)||37
11320506|NCT02718417|12517556|FG002|NOT COMPLETED|Chemotherapy Phase (CP)||46
11320507|NCT02718417|12517554|FG000|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|267
11320508|NCT02718417|12517555|FG001|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|288
11342452|NCT02945410|12539986|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0
11320509|NCT02718417|12517556|FG002|STARTED|Maintenance Phase (MP)|After completing CP, participants moved to observation phase. MP was not applicable for this arm.|0
11320510|NCT02718417|12517554|FG000|COMPLETED|Maintenance Phase (MP)||1
11320511|NCT02718417|12517555|FG001|COMPLETED|Maintenance Phase (MP)||1
11320512|NCT02718417|12517556|FG002|COMPLETED|Maintenance Phase (MP)||0
11320513|NCT02718417|12517554|FG000|NOT COMPLETED|Maintenance Phase (MP)||266
11320514|NCT02718417|12517555|FG001|NOT COMPLETED|Maintenance Phase (MP)||287
11320515|NCT02718417|12517556|FG002|NOT COMPLETED|Maintenance Phase (MP)||0
11320516|NCT02718417|12517554|FG000|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
11320517|NCT02718417|12517555|FG001|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
11320518|NCT02718417|12517556|FG002|STARTED|Observation Phase (OP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|284
11320519|NCT02718417|12517554|FG000|COMPLETED|Observation Phase (OP)||0
11320520|NCT02718417|12517555|FG001|COMPLETED|Observation Phase (OP)||0
11320521|NCT02718417|12517556|FG002|COMPLETED|Observation Phase (OP)||2
11320522|NCT02718417|12517554|FG000|NOT COMPLETED|Observation Phase (OP)||0
11320523|NCT02718417|12517555|FG001|NOT COMPLETED|Observation Phase (OP)||0
11320524|NCT02718417|12517556|FG002|NOT COMPLETED|Observation Phase (OP)||282
11320525|NCT02718417|12517554|FG000|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|238
11320526|NCT02718417|12517555|FG001|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|263
11320527|NCT02718417|12517556|FG002|STARTED|Follow-up Phase|Participants not completing OP could also start this phase.|39
11320528|NCT02718417|12517554|FG000|COMPLETED|Follow-up Phase||103
11320529|NCT02718417|12517555|FG001|COMPLETED|Follow-up Phase||91
11320530|NCT02718417|12517556|FG002|COMPLETED|Follow-up Phase||20
11320531|NCT02718417|12517554|FG000|NOT COMPLETED|Follow-up Phase||135
11320532|NCT02718417|12517555|FG001|NOT COMPLETED|Follow-up Phase||172
11320533|NCT02718417|12517556|FG002|NOT COMPLETED|Follow-up Phase||19
11320534|NCT02718417|12517554|FG000|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|139
11320535|NCT02718417|12517555|FG001|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|112
11320536|NCT02718417|12517556|FG002|STARTED|Long-term Follow-up Phase|Participants not completing follow-up could also start this phase.|135
11320537|NCT02718417|12517554|FG000|COMPLETED|Long-term Follow-up Phase||0
11320538|NCT02718417|12517555|FG001|COMPLETED|Long-term Follow-up Phase||0
11320539|NCT02718417|12517556|FG002|COMPLETED|Long-term Follow-up Phase||0
11320540|NCT02718417|12517554|FG000|NOT COMPLETED|Long-term Follow-up Phase||139
11320541|NCT02718417|12517555|FG001|NOT COMPLETED|Long-term Follow-up Phase||112
11320542|NCT02718417|12517556|FG002|NOT COMPLETED|Long-term Follow-up Phase||135
11320543|NCT02718625|12517573|FG000|STARTED|Overall Study||1
11320544|NCT02718625|12517574|FG001|STARTED|Overall Study||2
11320545|NCT02718625|12517573|FG000|COMPLETED|Overall Study||1
11320546|NCT02718625|12517574|FG001|COMPLETED|Overall Study||0
11402815|NCT04016077|12597723|FG001|NOT COMPLETED|Overall Study||0
11402816|NCT04027803|12597731|FG000|STARTED|Overall Study||39
11402817|NCT04027803|12597732|FG001|STARTED|Overall Study||39
11402818|NCT04027803|12597731|FG000|COMPLETED|Overall Study||39
11402819|NCT04027803|12597732|FG001|COMPLETED|Overall Study||39
11320547|NCT02718625|12517573|FG000|NOT COMPLETED|Overall Study||0
11320548|NCT02718625|12517574|FG001|NOT COMPLETED|Overall Study||2
11320549|NCT02718898|12517582|FG000|STARTED|Blinded Treatment Period||74
11320550|NCT02718898|12517583|FG001|STARTED|Blinded Treatment Period||75
11320551|NCT02718898|12517584|FG002|STARTED|Blinded Treatment Period||0
11320552|NCT02718898|12517585|FG003|STARTED|Blinded Treatment Period||0
11320553|NCT02718898|12517586|FG004|STARTED|Blinded Treatment Period||0
11320554|NCT02718898|12517587|FG005|STARTED|Blinded Treatment Period||0
11320555|NCT02718898|12517588|FG006|STARTED|Blinded Treatment Period||0
11320556|NCT02718898|12517582|FG000|COMPLETED|Blinded Treatment Period||65
11320557|NCT02718898|12517583|FG001|COMPLETED|Blinded Treatment Period||74
11320558|NCT02718898|12517584|FG002|COMPLETED|Blinded Treatment Period||0
11320559|NCT02718898|12517585|FG003|COMPLETED|Blinded Treatment Period||0
11320560|NCT02718898|12517586|FG004|COMPLETED|Blinded Treatment Period||0
11320561|NCT02718898|12517587|FG005|COMPLETED|Blinded Treatment Period||0
11320562|NCT02718898|12517588|FG006|COMPLETED|Blinded Treatment Period||0
11320563|NCT02718898|12517582|FG000|NOT COMPLETED|Blinded Treatment Period||9
11320564|NCT02718898|12517583|FG001|NOT COMPLETED|Blinded Treatment Period||1
11320565|NCT02718898|12517584|FG002|NOT COMPLETED|Blinded Treatment Period||0
11320566|NCT02718898|12517585|FG003|NOT COMPLETED|Blinded Treatment Period||0
11320567|NCT02718898|12517586|FG004|NOT COMPLETED|Blinded Treatment Period||0
11320568|NCT02718898|12517587|FG005|NOT COMPLETED|Blinded Treatment Period||0
11320569|NCT02718898|12517588|FG006|NOT COMPLETED|Blinded Treatment Period||0
11320570|NCT02718898|12517582|FG000|STARTED|Open Label Treatment Period (OLTP)||0
11320571|NCT02718898|12517583|FG001|STARTED|Open Label Treatment Period (OLTP)||0
11320572|NCT02718898|12517584|FG002|STARTED|Open Label Treatment Period (OLTP)||65
11320573|NCT02718898|12517585|FG003|STARTED|Open Label Treatment Period (OLTP)||74
11320574|NCT02718898|12517586|FG004|STARTED|Open Label Treatment Period (OLTP)||0
11320575|NCT02718898|12517587|FG005|STARTED|Open Label Treatment Period (OLTP)||0
11320576|NCT02718898|12517588|FG006|STARTED|Open Label Treatment Period (OLTP)||0
11402820|NCT04027803|12597731|FG000|NOT COMPLETED|Overall Study||0
11402821|NCT04027803|12597732|FG001|NOT COMPLETED|Overall Study||0
11402822|NCT04016311|12597740|FG000|STARTED|Overall Study||18
11402823|NCT04016311|12597741|FG001|STARTED|Overall Study||20
11402824|NCT04016311|12597740|FG000|COMPLETED|Overall Study||17
11402825|NCT04016311|12597741|FG001|COMPLETED|Overall Study||20
11402826|NCT04016311|12597740|FG000|NOT COMPLETED|Overall Study||1
11402827|NCT04016311|12597741|FG001|NOT COMPLETED|Overall Study||0
11402828|NCT04027218|12597755|FG000|STARTED|Overall Study||10
11402829|NCT04027218|12597756|FG001|STARTED|Overall Study||11
11402830|NCT04027218|12597757|FG002|STARTED|Overall Study||9
11402831|NCT04027218|12597758|FG003|STARTED|Overall Study||11
11402832|NCT04027218|12597759|FG004|STARTED|Overall Study||10
11402833|NCT04027218|12597760|FG005|STARTED|Overall Study||11
11402834|NCT04027218|12597755|FG000|COMPLETED|Overall Study||10
11402835|NCT04027218|12597756|FG001|COMPLETED|Overall Study||8
11402836|NCT04027218|12597757|FG002|COMPLETED|Overall Study||9
11402837|NCT04027218|12597758|FG003|COMPLETED|Overall Study||11
11402838|NCT04027218|12597759|FG004|COMPLETED|Overall Study||10
11402839|NCT04027218|12597760|FG005|COMPLETED|Overall Study||11
11402840|NCT04027218|12597755|FG000|NOT COMPLETED|Overall Study||0
11402841|NCT04027218|12597756|FG001|NOT COMPLETED|Overall Study||3
11402842|NCT04027218|12597757|FG002|NOT COMPLETED|Overall Study||0
11402843|NCT04027218|12597758|FG003|NOT COMPLETED|Overall Study||0
11402844|NCT04027218|12597759|FG004|NOT COMPLETED|Overall Study||0
11402845|NCT04027218|12597760|FG005|NOT COMPLETED|Overall Study||0
11402846|NCT04026750|12597772|FG000|STARTED|Overall Study||3
11402847|NCT04026750|12597773|FG001|STARTED|Overall Study||2
11402848|NCT04026750|12597772|FG000|COMPLETED|Overall Study||3
11402849|NCT04026750|12597773|FG001|COMPLETED|Overall Study||2
11402850|NCT04026750|12597772|FG000|NOT COMPLETED|Overall Study||0
11402851|NCT04026750|12597773|FG001|NOT COMPLETED|Overall Study||0
11402852|NCT04026308|12597782|FG000|STARTED|Overall Study||14
11402853|NCT04026308|12597783|FG001|STARTED|Overall Study||16
11402854|NCT04026308|12597782|FG000|COMPLETED|Overall Study||14
11402855|NCT04026308|12597783|FG001|COMPLETED|Overall Study||16
11402856|NCT04026308|12597782|FG000|NOT COMPLETED|Overall Study||0
11402857|NCT04026308|12597783|FG001|NOT COMPLETED|Overall Study||0
11402858|NCT04023682|12597789|FG000|STARTED|Overall Study||31
11402859|NCT04023682|12597789|FG000|COMPLETED|Overall Study||25
11402860|NCT04023682|12597789|FG000|NOT COMPLETED|Overall Study||6
11402861|NCT04021771|12597799|FG000|STARTED|Overall Study||55
11402862|NCT04021771|12597800|FG001|STARTED|Overall Study||54
11320577|NCT02718898|12517582|FG000|COMPLETED|Open Label Treatment Period (OLTP)||0
11320578|NCT02718898|12517583|FG001|COMPLETED|Open Label Treatment Period (OLTP)||0
11320579|NCT02718898|12517584|FG002|COMPLETED|Open Label Treatment Period (OLTP)||62
11320580|NCT02718898|12517585|FG003|COMPLETED|Open Label Treatment Period (OLTP)||64
11320581|NCT02718898|12517586|FG004|COMPLETED|Open Label Treatment Period (OLTP)||0
11320582|NCT02718898|12517587|FG005|COMPLETED|Open Label Treatment Period (OLTP)||0
11320583|NCT02718898|12517588|FG006|COMPLETED|Open Label Treatment Period (OLTP)||0
11320584|NCT02718898|12517582|FG000|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
11320585|NCT02718898|12517583|FG001|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
11320586|NCT02718898|12517584|FG002|NOT COMPLETED|Open Label Treatment Period (OLTP)||3
11320587|NCT02718898|12517585|FG003|NOT COMPLETED|Open Label Treatment Period (OLTP)||10
11320588|NCT02718898|12517586|FG004|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
11320589|NCT02718898|12517587|FG005|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
11320590|NCT02718898|12517588|FG006|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
11320591|NCT02718898|12517582|FG000|STARTED|Post Treatment Follow-up Period||0
11320592|NCT02718898|12517583|FG001|STARTED|Post Treatment Follow-up Period||0
11320593|NCT02718898|12517584|FG002|STARTED|Post Treatment Follow-up Period||0
11320594|NCT02718898|12517585|FG003|STARTED|Post Treatment Follow-up Period||0
11320595|NCT02718898|12517586|FG004|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1
11320596|NCT02718898|12517587|FG005|STARTED|Post Treatment Follow-up Period||78
11320597|NCT02718898|12517588|FG006|STARTED|Post Treatment Follow-up Period||49
11320598|NCT02718898|12517582|FG000|COMPLETED|Post Treatment Follow-up Period||0
11320599|NCT02718898|12517583|FG001|COMPLETED|Post Treatment Follow-up Period||0
11320600|NCT02718898|12517584|FG002|COMPLETED|Post Treatment Follow-up Period||0
11320601|NCT02718898|12517585|FG003|COMPLETED|Post Treatment Follow-up Period||0
11320602|NCT02718898|12517586|FG004|COMPLETED|Post Treatment Follow-up Period||0
11320603|NCT02718898|12517587|FG005|COMPLETED|Post Treatment Follow-up Period||67
11320604|NCT02718898|12517588|FG006|COMPLETED|Post Treatment Follow-up Period||44
11320605|NCT02718898|12517582|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0
11320606|NCT02718898|12517583|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0
11320607|NCT02718898|12517584|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0
11320608|NCT02718898|12517585|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0
11320609|NCT02718898|12517586|FG004|NOT COMPLETED|Post Treatment Follow-up Period||1
11320610|NCT02718898|12517587|FG005|NOT COMPLETED|Post Treatment Follow-up Period||11
11320611|NCT02718898|12517588|FG006|NOT COMPLETED|Post Treatment Follow-up Period||5
11320612|NCT02718963|12517603|FG000|STARTED|Overall Study||10
11320613|NCT02718963|12517604|FG001|STARTED|Overall Study||10
11320614|NCT02718963|12517603|FG000|COMPLETED|Overall Study||9
11320615|NCT02718963|12517604|FG001|COMPLETED|Overall Study||9
11320616|NCT02718963|12517603|FG000|NOT COMPLETED|Overall Study||1
11320617|NCT02718963|12517604|FG001|NOT COMPLETED|Overall Study||1
11402863|NCT04021771|12597799|FG000|COMPLETED|Overall Study||55
11402864|NCT04021771|12597800|FG001|COMPLETED|Overall Study||54
11402865|NCT04021771|12597799|FG000|NOT COMPLETED|Overall Study||0
11402866|NCT04021771|12597800|FG001|NOT COMPLETED|Overall Study||0
11402867|NCT04019626|12597811|FG000|STARTED|Overall Study||42
11320618|NCT02719028|12517614|FG000|STARTED|Overall Study||30
11320619|NCT02719028|12517615|FG001|STARTED|Overall Study||30
11320620|NCT02719028|12517616|FG002|STARTED|Overall Study||30
11320621|NCT02719028|12517617|FG003|STARTED|Overall Study||30
11320622|NCT02719028|12517614|FG000|COMPLETED|Overall Study||28
11320623|NCT02719028|12517615|FG001|COMPLETED|Overall Study||28
11320624|NCT02719028|12517616|FG002|COMPLETED|Overall Study||24
11320625|NCT02719028|12517617|FG003|COMPLETED|Overall Study||20
11320626|NCT02719028|12517614|FG000|NOT COMPLETED|Overall Study||2
11320627|NCT02719028|12517615|FG001|NOT COMPLETED|Overall Study||2
11320628|NCT02719028|12517616|FG002|NOT COMPLETED|Overall Study||6
11320629|NCT02719028|12517617|FG003|NOT COMPLETED|Overall Study||10
11320630|NCT02719158|12517630|FG000|STARTED|Overall Study||38
11320631|NCT02719158|12517631|FG001|STARTED|Overall Study||38
11320632|NCT02719158|12517632|FG002|STARTED|Overall Study||19
11320633|NCT02719158|12517630|FG000|COMPLETED|Overall Study||38
11320634|NCT02719158|12517631|FG001|COMPLETED|Overall Study||38
11320635|NCT02719158|12517632|FG002|COMPLETED|Overall Study||18
11320636|NCT02719158|12517630|FG000|NOT COMPLETED|Overall Study||0
11320637|NCT02719158|12517631|FG001|NOT COMPLETED|Overall Study||0
11320638|NCT02719158|12517632|FG002|NOT COMPLETED|Overall Study||1
11320639|NCT02719171|12517645|FG000|STARTED|Overall Study||42
11320640|NCT02719171|12517646|FG001|STARTED|Overall Study||42
11320641|NCT02719171|12517647|FG002|STARTED|Overall Study||42
11320642|NCT02719171|12517648|FG003|STARTED|Overall Study||39
11320643|NCT02719171|12517649|FG004|STARTED|Overall Study||20
11320644|NCT02719171|12517645|FG000|COMPLETED|Overall Study||41
11320645|NCT02719171|12517646|FG001|COMPLETED|Overall Study||38
11320646|NCT02719171|12517647|FG002|COMPLETED|Overall Study||39
11320647|NCT02719171|12517648|FG003|COMPLETED|Overall Study||37
11320648|NCT02719171|12517649|FG004|COMPLETED|Overall Study||18
11320649|NCT02719171|12517645|FG000|NOT COMPLETED|Overall Study||1
11320650|NCT02719171|12517646|FG001|NOT COMPLETED|Overall Study||4
11320651|NCT02719171|12517647|FG002|NOT COMPLETED|Overall Study||3
11320652|NCT02719171|12517648|FG003|NOT COMPLETED|Overall Study||2
11320653|NCT02719171|12517649|FG004|NOT COMPLETED|Overall Study||2
11320654|NCT02719353|12517664|FG000|STARTED|First Intervention||7
11320655|NCT02719353|12517665|FG001|STARTED|First Intervention||7
11320656|NCT02719353|12517664|FG000|COMPLETED|First Intervention||7
11320657|NCT02719353|12517665|FG001|COMPLETED|First Intervention||6
11320658|NCT02719353|12517664|FG000|NOT COMPLETED|First Intervention||0
11320659|NCT02719353|12517665|FG001|NOT COMPLETED|First Intervention||1
11320660|NCT02719353|12517664|FG000|STARTED|Second Intervention||7
11320661|NCT02719353|12517665|FG001|STARTED|Second Intervention||6
11320662|NCT02719353|12517664|FG000|COMPLETED|Second Intervention||7
11320663|NCT02719353|12517665|FG001|COMPLETED|Second Intervention||6
11320664|NCT02719353|12517664|FG000|NOT COMPLETED|Second Intervention||0
11320665|NCT02719353|12517665|FG001|NOT COMPLETED|Second Intervention||0
11320666|NCT02719366|12517672|FG000|STARTED|First Intervention||6
11320667|NCT02719366|12517673|FG001|STARTED|First Intervention||6
11320668|NCT02719366|12517672|FG000|COMPLETED|First Intervention||6
11320669|NCT02719366|12517673|FG001|COMPLETED|First Intervention||6
11320670|NCT02719366|12517672|FG000|NOT COMPLETED|First Intervention||0
11320671|NCT02719366|12517673|FG001|NOT COMPLETED|First Intervention||0
11320672|NCT02719366|12517672|FG000|STARTED|Second Intervention||6
11320673|NCT02719366|12517673|FG001|STARTED|Second Intervention||6
11320674|NCT02719366|12517672|FG000|COMPLETED|Second Intervention||6
11320675|NCT02719366|12517673|FG001|COMPLETED|Second Intervention||6
11320676|NCT02719366|12517672|FG000|NOT COMPLETED|Second Intervention||0
11320677|NCT02719366|12517673|FG001|NOT COMPLETED|Second Intervention||0
11320678|NCT02719535|12517680|FG000|STARTED|Overall Study||59
11320679|NCT02719535|12517680|FG000|COMPLETED|Overall Study||37
11320680|NCT02719535|12517680|FG000|NOT COMPLETED|Overall Study||22
11320681|NCT02719639|12517684|FG000|STARTED|Overall Study||7443
11320682|NCT02719639|12517684|FG000|COMPLETED|Overall Study||7443
11320683|NCT02719639|12517684|FG000|NOT COMPLETED|Overall Study||0
11320684|NCT02719743|12517693|FG000|STARTED|Overall Study||38
11320685|NCT02719743|12517694|FG001|STARTED|Overall Study||37
11320686|NCT02719743|12517695|FG002|STARTED|Overall Study||38
11320687|NCT02719743|12517696|FG003|STARTED|Overall Study||37
11320688|NCT02719743|12517697|FG004|STARTED|Overall Study||35
11320689|NCT02719743|12517693|FG000|COMPLETED|Overall Study||37
11402868|NCT04019626|12597812|FG001|STARTED|Overall Study||42
11402869|NCT04019626|12597813|FG002|STARTED|Overall Study||45
11320690|NCT02719743|12517694|FG001|COMPLETED|Overall Study||34
11320691|NCT02719743|12517695|FG002|COMPLETED|Overall Study||38
11320692|NCT02719743|12517696|FG003|COMPLETED|Overall Study||36
11320693|NCT02719743|12517697|FG004|COMPLETED|Overall Study||33
11320694|NCT02719743|12517693|FG000|NOT COMPLETED|Overall Study||1
11320695|NCT02719743|12517694|FG001|NOT COMPLETED|Overall Study||3
11320696|NCT02719743|12517695|FG002|NOT COMPLETED|Overall Study||0
11320697|NCT02719743|12517696|FG003|NOT COMPLETED|Overall Study||1
11320698|NCT02719743|12517697|FG004|NOT COMPLETED|Overall Study||2
11320699|NCT02719938|12517711|FG000|STARTED|Overall Study||30
11320700|NCT02719938|12517712|FG001|STARTED|Overall Study||32
11320701|NCT02719938|12517711|FG000|COMPLETED|Overall Study||26
11320702|NCT02719938|12517712|FG001|COMPLETED|Overall Study||31
11320703|NCT02719938|12517711|FG000|NOT COMPLETED|Overall Study||4
11320704|NCT02719938|12517712|FG001|NOT COMPLETED|Overall Study||1
11320705|NCT02720042|12517718|FG000|STARTED|Overall Study||84
11320706|NCT02720042|12517718|FG000|COMPLETED|Overall Study||69
11320707|NCT02720042|12517718|FG000|NOT COMPLETED|Overall Study||15
11320708|NCT02720081|12517724|FG000|STARTED|Overall Study||72
11320709|NCT02720081|12517725|FG001|STARTED|Overall Study||70
11320710|NCT02720081|12517724|FG000|Treated|Overall Study||70
11320711|NCT02720081|12517725|FG001|Treated|Overall Study||69
11320712|NCT02720081|12517724|FG000|COMPLETED|Overall Study||68
11320713|NCT02720081|12517725|FG001|COMPLETED|Overall Study||66
11320714|NCT02720081|12517724|FG000|NOT COMPLETED|Overall Study||4
11320715|NCT02720081|12517725|FG001|NOT COMPLETED|Overall Study||4
11320716|NCT02720107|12517731|FG000|STARTED|Overall Study||130
11320717|NCT02720107|12517731|FG000|COMPLETED|Overall Study||130
11320718|NCT02720107|12517731|FG000|NOT COMPLETED|Overall Study||0
11320719|NCT02720198|12517737|FG000|STARTED|Overall Study||29
11320720|NCT02720198|12517738|FG001|STARTED|Overall Study||31
11320721|NCT02720198|12517737|FG000|COMPLETED|Overall Study||29
11320722|NCT02720198|12517738|FG001|COMPLETED|Overall Study||30
11320723|NCT02720198|12517737|FG000|NOT COMPLETED|Overall Study||0
11320724|NCT02720198|12517738|FG001|NOT COMPLETED|Overall Study||1
11342453|NCT02945410|12539987|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0
11342454|NCT02945410|12539988|FG002|NOT COMPLETED|Intervention 2 (5 Days)||0
11342455|NCT02945410|12539989|FG003|NOT COMPLETED|Intervention 2 (5 Days)||0
11342456|NCT02945410|12539990|FG004|NOT COMPLETED|Intervention 2 (5 Days)||0
11342457|NCT02945410|12539991|FG005|NOT COMPLETED|Intervention 2 (5 Days)||0
11342458|NCT02945410|12539986|FG000|STARTED|Washout 2 (14 Days)||2
11342459|NCT02945410|12539987|FG001|STARTED|Washout 2 (14 Days)||1
11342460|NCT02945410|12539988|FG002|STARTED|Washout 2 (14 Days)||0
11342461|NCT02945410|12539989|FG003|STARTED|Washout 2 (14 Days)||3
11342462|NCT02945410|12539990|FG004|STARTED|Washout 2 (14 Days)||1
11342463|NCT02945410|12539991|FG005|STARTED|Washout 2 (14 Days)||0
11342464|NCT02945410|12539986|FG000|COMPLETED|Washout 2 (14 Days)||2
11342465|NCT02945410|12539987|FG001|COMPLETED|Washout 2 (14 Days)||1
11342466|NCT02945410|12539988|FG002|COMPLETED|Washout 2 (14 Days)||0
11342467|NCT02945410|12539989|FG003|COMPLETED|Washout 2 (14 Days)||3
11342468|NCT02945410|12539990|FG004|COMPLETED|Washout 2 (14 Days)||1
11342469|NCT02945410|12539991|FG005|COMPLETED|Washout 2 (14 Days)||0
11342470|NCT02945410|12539986|FG000|NOT COMPLETED|Washout 2 (14 Days)||0
11342471|NCT02945410|12539987|FG001|NOT COMPLETED|Washout 2 (14 Days)||0
11342472|NCT02945410|12539988|FG002|NOT COMPLETED|Washout 2 (14 Days)||0
11342473|NCT02945410|12539989|FG003|NOT COMPLETED|Washout 2 (14 Days)||0
11342474|NCT02945410|12539990|FG004|NOT COMPLETED|Washout 2 (14 Days)||0
11342475|NCT02945410|12539991|FG005|NOT COMPLETED|Washout 2 (14 Days)||0
11342476|NCT02945410|12539986|FG000|STARTED|Intervention 3 (5 Days)||2
11342477|NCT02945410|12539987|FG001|STARTED|Intervention 3 (5 Days)||1
11342478|NCT02945410|12539988|FG002|STARTED|Intervention 3 (5 Days)||0
11342479|NCT02945410|12539989|FG003|STARTED|Intervention 3 (5 Days)||3
11342480|NCT02945410|12539990|FG004|STARTED|Intervention 3 (5 Days)||1
11342481|NCT02945410|12539991|FG005|STARTED|Intervention 3 (5 Days)||0
11342482|NCT02945410|12539986|FG000|COMPLETED|Intervention 3 (5 Days)||2
11342483|NCT02945410|12539987|FG001|COMPLETED|Intervention 3 (5 Days)||1
11342484|NCT02945410|12539988|FG002|COMPLETED|Intervention 3 (5 Days)||0
11342485|NCT02945410|12539989|FG003|COMPLETED|Intervention 3 (5 Days)||3
11342486|NCT02945410|12539990|FG004|COMPLETED|Intervention 3 (5 Days)||1
11342487|NCT02945410|12539991|FG005|COMPLETED|Intervention 3 (5 Days)||0
11342488|NCT02945410|12539986|FG000|NOT COMPLETED|Intervention 3 (5 Days)||0
11342489|NCT02945410|12539987|FG001|NOT COMPLETED|Intervention 3 (5 Days)||0
11342490|NCT02945410|12539988|FG002|NOT COMPLETED|Intervention 3 (5 Days)||0
11342491|NCT02945410|12539989|FG003|NOT COMPLETED|Intervention 3 (5 Days)||0
11342492|NCT02945410|12539990|FG004|NOT COMPLETED|Intervention 3 (5 Days)||0
11342493|NCT02945410|12539991|FG005|NOT COMPLETED|Intervention 3 (5 Days)||0
11342494|NCT02945553|12540001|FG000|STARTED|Overall Study||14
11342495|NCT02945553|12540002|FG001|STARTED|Overall Study||11
11342496|NCT02945553|12540001|FG000|COMPLETED|Overall Study|Included in analysis for primary aim.|11
11342497|NCT02945553|12540002|FG001|COMPLETED|Overall Study|Included in analysis for primary aim.|9
11342498|NCT02945553|12540001|FG000|NOT COMPLETED|Overall Study||3
11342499|NCT02945553|12540002|FG001|NOT COMPLETED|Overall Study||2
11342500|NCT02945657|12540012|FG000|STARTED|Overall Study||32
11342501|NCT02945657|12540012|FG000|COMPLETED|Overall Study||28
11342502|NCT02945657|12540012|FG000|NOT COMPLETED|Overall Study||4
11342503|NCT02946021|12540019|FG000|STARTED|Overall Study||6
11342504|NCT02946021|12540020|FG001|STARTED|Overall Study||5
11342505|NCT02946021|12540019|FG000|COMPLETED|Overall Study||6
11342506|NCT02946021|12540020|FG001|COMPLETED|Overall Study||5
11342507|NCT02946021|12540019|FG000|NOT COMPLETED|Overall Study||0
11342508|NCT02946021|12540020|FG001|NOT COMPLETED|Overall Study||0
11342509|NCT02946034|12540026|FG000|STARTED|Overall Study||10
11342510|NCT02946034|12540026|FG000|COMPLETED|Overall Study||10
11342511|NCT02946034|12540026|FG000|NOT COMPLETED|Overall Study||0
11342512|NCT02946073|12540036|FG000|STARTED|Titration Phase||811
11342513|NCT02946073|12540037|FG001|STARTED|Titration Phase||0
11342514|NCT02946073|12540038|FG002|STARTED|Titration Phase||98
11342515|NCT02946073|12540039|FG003|STARTED|Titration Phase||0
11342516|NCT02946073|12540036|FG000|COMPLETED|Titration Phase||222
11342517|NCT02946073|12540037|FG001|COMPLETED|Titration Phase||0
11342518|NCT02946073|12540038|FG002|COMPLETED|Titration Phase||75
11342519|NCT02946073|12540039|FG003|COMPLETED|Titration Phase||0
11342520|NCT02946073|12540036|FG000|NOT COMPLETED|Titration Phase||589
11342521|NCT02946073|12540037|FG001|NOT COMPLETED|Titration Phase||0
11342522|NCT02946073|12540038|FG002|NOT COMPLETED|Titration Phase||23
11342523|NCT02946073|12540039|FG003|NOT COMPLETED|Titration Phase||0
11342524|NCT02946073|12540036|FG000|STARTED|Double Blind Phase||112
11320725|NCT02720224|12517744|FG000|STARTED|Overall Study||6
11320726|NCT02720224|12517744|FG000|COMPLETED|Overall Study||6
11320727|NCT02720224|12517744|FG000|NOT COMPLETED|Overall Study||0
11320728|NCT02720484|12517748|FG000|STARTED|Treatment on Study||10
11320729|NCT02720484|12517748|FG000|Reached 1st Response/2 Cycles|Treatment on Study||7
11320730|NCT02720484|12517748|FG000|Treated Cycle 3|Treatment on Study||4
11320731|NCT02720484|12517748|FG000|COMPLETED|Treatment on Study||4
11320732|NCT02720484|12517748|FG000|NOT COMPLETED|Treatment on Study||6
11320733|NCT02720484|12517748|FG000|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7
11320734|NCT02720484|12517748|FG000|COMPLETED|Follow Up for 2 Years||1
11320735|NCT02720484|12517748|FG000|NOT COMPLETED|Follow Up for 2 Years||6
11320736|NCT02720536|12517752|FG000|STARTED|Overall Study||53
11320737|NCT02720536|12517752|FG000|COMPLETED|Overall Study||34
11320738|NCT02720536|12517752|FG000|NOT COMPLETED|Overall Study||19
11320739|NCT02720627|12517762|FG000|STARTED|Overall Study||27
11320740|NCT02720627|12517762|FG000|COMPLETED|Overall Study||27
11320741|NCT02720627|12517762|FG000|NOT COMPLETED|Overall Study||0
11320742|NCT02720757|12517766|FG000|STARTED|Overall Study||132
11320743|NCT02720757|12517766|FG000|COMPLETED|Overall Study||114
11320744|NCT02720757|12517766|FG000|NOT COMPLETED|Overall Study||18
11320745|NCT02721017|12517772|FG000|STARTED|Hospital Stay|Intraoperative Application of Cryoanalgesia started on Date of Surgery (DOS).|10
11320746|NCT02721017|12517773|FG001|STARTED|Hospital Stay|Thoracic Epidural placed on Date of Surgery (DOS).|10
11320747|NCT02721017|12517772|FG000|COMPLETED|Hospital Stay|Completed during the course of surgery.|10
11320748|NCT02721017|12517773|FG001|COMPLETED|Hospital Stay|Removal occurs prior to Hospital Discharge.|10
11320749|NCT02721017|12517772|FG000|NOT COMPLETED|Hospital Stay||0
11320750|NCT02721017|12517773|FG001|NOT COMPLETED|Hospital Stay||0
11320751|NCT02721017|12517772|FG000|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
11320752|NCT02721017|12517773|FG001|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
11320753|NCT02721017|12517772|FG000|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
11320754|NCT02721017|12517773|FG001|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
11320755|NCT02721017|12517772|FG000|NOT COMPLETED|Participant Follow Up||0
11320756|NCT02721017|12517773|FG001|NOT COMPLETED|Participant Follow Up||0
11320757|NCT02721147|12517784|FG000|STARTED|Overall Study||40
11320758|NCT02721147|12517785|FG001|STARTED|Overall Study||18
11320759|NCT02721147|12517786|FG002|STARTED|Overall Study||31
11320760|NCT02721147|12517784|FG000|COMPLETED|Overall Study||38
11320761|NCT02721147|12517785|FG001|COMPLETED|Overall Study||18
11320762|NCT02721147|12517786|FG002|COMPLETED|Overall Study||31
11320763|NCT02721147|12517784|FG000|NOT COMPLETED|Overall Study||2
11320764|NCT02721147|12517785|FG001|NOT COMPLETED|Overall Study||0
11320765|NCT02721147|12517786|FG002|NOT COMPLETED|Overall Study||0
11320766|NCT02721251|12517797|FG000|STARTED|Overall Study||14
11320767|NCT02721251|12517798|FG001|STARTED|Overall Study||16
11320768|NCT02721251|12517799|FG002|STARTED|Overall Study||17
11320769|NCT02721251|12517797|FG000|COMPLETED|Overall Study||4
11320770|NCT02721251|12517798|FG001|COMPLETED|Overall Study||7
11320771|NCT02721251|12517799|FG002|COMPLETED|Overall Study||6
11320772|NCT02721251|12517797|FG000|NOT COMPLETED|Overall Study||10
11320773|NCT02721251|12517798|FG001|NOT COMPLETED|Overall Study||9
11320774|NCT02721251|12517799|FG002|NOT COMPLETED|Overall Study||11
11320775|NCT02721355|12517810|FG000|STARTED|Overall Study||42
11320776|NCT02721355|12517811|FG001|STARTED|Overall Study||42
11320777|NCT02721355|12517810|FG000|COMPLETED|Overall Study||36
11320778|NCT02721355|12517811|FG001|COMPLETED|Overall Study||41
11320779|NCT02721355|12517810|FG000|NOT COMPLETED|Overall Study||6
11320780|NCT02721355|12517811|FG001|NOT COMPLETED|Overall Study||1
11320781|NCT02721641|12517817|FG000|STARTED|Overall Study||69
11320782|NCT02721641|12517817|FG000|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
11320783|NCT02721641|12517817|FG000|NOT COMPLETED|Overall Study||0
11320784|NCT02721875|12517823|FG000|STARTED|Overall Study||1
11320785|NCT02721875|12517824|FG001|STARTED|Overall Study||0
11320786|NCT02721875|12517823|FG000|COMPLETED|Overall Study||0
11320787|NCT02721875|12517824|FG001|COMPLETED|Overall Study||0
11320788|NCT02721875|12517823|FG000|NOT COMPLETED|Overall Study||1
11320789|NCT02721875|12517824|FG001|NOT COMPLETED|Overall Study||0
11320790|NCT02721966|12517833|FG000|STARTED|Overall Study||167
11320791|NCT02721966|12517834|FG001|STARTED|Overall Study||165
11320792|NCT02721966|12517835|FG002|STARTED|Overall Study||81
11320793|NCT02721966|12517836|FG003|STARTED|Overall Study||80
11320794|NCT02721966|12517837|FG004|STARTED|Overall Study||5
11320795|NCT02721966|12517833|FG000|Completed Period 1 & Went to Period 2|Overall Study||162
11320796|NCT02721966|12517834|FG001|Completed Period 1 & Went to Period 2|Overall Study||153
11320797|NCT02721966|12517835|FG002|Completed Period 1 & Went to Period 2|Overall Study||81
11320798|NCT02721966|12517836|FG003|Completed Period 1 & Went to Period 2|Overall Study||80
11320799|NCT02721966|12517837|FG004|Completed Period 1 & Went to Period 2|Overall Study||0
11320800|NCT02721966|12517833|FG000|COMPLETED|Overall Study||138
11320801|NCT02721966|12517834|FG001|COMPLETED|Overall Study||142
11320802|NCT02721966|12517835|FG002|COMPLETED|Overall Study||72
11320803|NCT02721966|12517836|FG003|COMPLETED|Overall Study||73
11320804|NCT02721966|12517837|FG004|COMPLETED|Overall Study||0
11320805|NCT02721966|12517833|FG000|NOT COMPLETED|Overall Study||29
11320806|NCT02721966|12517834|FG001|NOT COMPLETED|Overall Study||23
11320807|NCT02721966|12517835|FG002|NOT COMPLETED|Overall Study||9
11320808|NCT02721966|12517836|FG003|NOT COMPLETED|Overall Study||7
11320809|NCT02721966|12517837|FG004|NOT COMPLETED|Overall Study||5
11320810|NCT02722044|12517845|FG000|STARTED|Overall Study||33
11320811|NCT02722044|12517845|FG000|COMPLETED|Overall Study||28
11320812|NCT02722044|12517845|FG000|NOT COMPLETED|Overall Study||5
11320813|NCT02722148|12517850|FG000|STARTED|Overall Study||24
11320814|NCT02722148|12517850|FG000|COMPLETED|Overall Study||19
11320815|NCT02722148|12517850|FG000|NOT COMPLETED|Overall Study||5
11320816|NCT02722239|12517856|FG000|STARTED|Overall Study||20
11320817|NCT02722239|12517857|FG001|STARTED|Overall Study||20
11320818|NCT02722239|12517856|FG000|First Intervention (1 Day)|Overall Study||20
11320819|NCT02722239|12517857|FG001|First Intervention (1 Day)|Overall Study||20
11320820|NCT02722239|12517856|FG000|Washout (7 Days)|Overall Study||20
11320821|NCT02722239|12517857|FG001|Washout (7 Days)|Overall Study||20
11320822|NCT02722239|12517856|FG000|Second Intervention (1 Day)|Overall Study||20
11320823|NCT02722239|12517857|FG001|Second Intervention (1 Day)|Overall Study||20
11320824|NCT02722239|12517856|FG000|COMPLETED|Overall Study||20
11320825|NCT02722239|12517857|FG001|COMPLETED|Overall Study||20
11320826|NCT02722239|12517856|FG000|NOT COMPLETED|Overall Study||0
11320827|NCT02722239|12517857|FG001|NOT COMPLETED|Overall Study||0
11320828|NCT02722278|12517866|FG000|STARTED|Overall Study||166
11320829|NCT02722278|12517867|FG001|STARTED|Overall Study||56
11320830|NCT02722278|12517866|FG000|COMPLETED|Overall Study||154
11320831|NCT02722278|12517867|FG001|COMPLETED|Overall Study||49
11320832|NCT02722278|12517866|FG000|NOT COMPLETED|Overall Study||12
11320833|NCT02722278|12517867|FG001|NOT COMPLETED|Overall Study||7
11320834|NCT02722304|12517880|FG000|STARTED|Overall Study||1
11320835|NCT02722304|12517881|FG001|STARTED|Overall Study||0
11320836|NCT02722304|12517882|FG002|STARTED|Overall Study||2
11320837|NCT02722304|12517883|FG003|STARTED|Overall Study||2
11320838|NCT02722304|12517884|FG004|STARTED|Overall Study||2
11320839|NCT02722304|12517880|FG000|Treated|Overall Study||1
11320840|NCT02722304|12517881|FG001|Treated|Overall Study||0
11320841|NCT02722304|12517882|FG002|Treated|Overall Study||1
11320842|NCT02722304|12517883|FG003|Treated|Overall Study||1
11320843|NCT02722304|12517884|FG004|Treated|Overall Study||2
11320844|NCT02722304|12517880|FG000|COMPLETED|Overall Study||0
11320845|NCT02722304|12517881|FG001|COMPLETED|Overall Study||0
11320846|NCT02722304|12517882|FG002|COMPLETED|Overall Study||0
11320847|NCT02722304|12517883|FG003|COMPLETED|Overall Study||0
11320848|NCT02722304|12517884|FG004|COMPLETED|Overall Study||0
11320849|NCT02722304|12517880|FG000|NOT COMPLETED|Overall Study||1
11320850|NCT02722304|12517881|FG001|NOT COMPLETED|Overall Study||0
11320851|NCT02722304|12517882|FG002|NOT COMPLETED|Overall Study||2
11320852|NCT02722304|12517883|FG003|NOT COMPLETED|Overall Study||2
11320853|NCT02722304|12517884|FG004|NOT COMPLETED|Overall Study||2
11320854|NCT02722330|12517898|FG000|STARTED|Overall Study||23
11320855|NCT02722330|12517898|FG000|COMPLETED|Overall Study||23
11320856|NCT02722330|12517898|FG000|NOT COMPLETED|Overall Study||0
11320857|NCT02722408|12517902|FG000|STARTED|Overall Study||8
11320858|NCT02722408|12517902|FG000|COMPLETED|Overall Study||8
11320859|NCT02722408|12517902|FG000|NOT COMPLETED|Overall Study||0
11320860|NCT02722499|12517911|FG000|STARTED|Overall Study||20
11320861|NCT02722499|12517912|FG001|STARTED|Overall Study||20
11320862|NCT02722499|12517913|FG002|STARTED|Overall Study||20
11320863|NCT02722499|12517911|FG000|COMPLETED|Overall Study||18
11320864|NCT02722499|12517912|FG001|COMPLETED|Overall Study||20
11320865|NCT02722499|12517913|FG002|COMPLETED|Overall Study||19
11320866|NCT02722499|12517911|FG000|NOT COMPLETED|Overall Study||2
11320867|NCT02722499|12517912|FG001|NOT COMPLETED|Overall Study||0
11320868|NCT02722499|12517913|FG002|NOT COMPLETED|Overall Study||1
11320869|NCT02722564|12517921|FG000|STARTED|Overall Study||55
11320870|NCT02722564|12517921|FG000|COMPLETED|Overall Study||55
11402870|NCT04019626|12597814|FG003|STARTED|Overall Study||46
11402871|NCT04019626|12597815|FG004|STARTED|Overall Study||44
11402872|NCT04019626|12597816|FG005|STARTED|Overall Study||21
11402873|NCT04019626|12597811|FG000|COMPLETED|Overall Study||36
11402874|NCT04019626|12597812|FG001|COMPLETED|Overall Study||32
11320871|NCT02722564|12517921|FG000|NOT COMPLETED|Overall Study||0
11320872|NCT02722577|12517925|FG000|STARTED|Overall Study||20
11320873|NCT02722577|12517925|FG000|COMPLETED|Overall Study||20
11320874|NCT02722577|12517925|FG000|NOT COMPLETED|Overall Study||0
11320875|NCT02722837|12517929|FG000|STARTED|Overall Study||119
11320876|NCT02722837|12517929|FG000|COMPLETED|Overall Study||119
11320877|NCT02722837|12517929|FG000|NOT COMPLETED|Overall Study||0
11320878|NCT02722863|12517933|FG000|STARTED|Overall Study||908
11320879|NCT02722863|12517933|FG000|COMPLETED|Overall Study||908
11320880|NCT02722863|12517933|FG000|NOT COMPLETED|Overall Study||0
11320881|NCT02722928|12517940|FG000|STARTED|Overall Study||49
11320882|NCT02722928|12517941|FG001|STARTED|Overall Study||51
11320883|NCT02722928|12517940|FG000|COMPLETED|Overall Study||39
11320884|NCT02722928|12517941|FG001|COMPLETED|Overall Study||31
11320885|NCT02722928|12517940|FG000|NOT COMPLETED|Overall Study||10
11320886|NCT02722928|12517941|FG001|NOT COMPLETED|Overall Study||20
11320887|NCT02722967|12517954|FG000|STARTED|Overall Study||22
11320888|NCT02722967|12517955|FG001|STARTED|Overall Study||12
11320889|NCT02722967|12517956|FG002|STARTED|Overall Study||15
11320890|NCT02722967|12517954|FG000|COMPLETED|Overall Study||17
11320891|NCT02722967|12517955|FG001|COMPLETED|Overall Study||10
11320892|NCT02722967|12517956|FG002|COMPLETED|Overall Study||11
11320893|NCT02722967|12517954|FG000|NOT COMPLETED|Overall Study||5
11320894|NCT02722967|12517955|FG001|NOT COMPLETED|Overall Study||2
11402875|NCT04019626|12597813|FG002|COMPLETED|Overall Study||37
11320895|NCT02722967|12517956|FG002|NOT COMPLETED|Overall Study||4
11320896|NCT02723006|12517967|FG000|STARTED|Overall Study||1
11320897|NCT02723006|12517968|FG001|STARTED|Overall Study||9
11320898|NCT02723006|12517969|FG002|STARTED|Overall Study||12
11320899|NCT02723006|12517967|FG000|COMPLETED|Overall Study||0
11320900|NCT02723006|12517968|FG001|COMPLETED|Overall Study||2
11320901|NCT02723006|12517969|FG002|COMPLETED|Overall Study||5
11320902|NCT02723006|12517967|FG000|NOT COMPLETED|Overall Study||1
11320903|NCT02723006|12517968|FG001|NOT COMPLETED|Overall Study||7
11320904|NCT02723006|12517969|FG002|NOT COMPLETED|Overall Study||7
11320905|NCT02723084|12517979|FG000|STARTED|Overall Study||90
11320906|NCT02723084|12517980|FG001|STARTED|Overall Study||46
11320907|NCT02723084|12517979|FG000|COMPLETED|Overall Study||86
11320908|NCT02723084|12517980|FG001|COMPLETED|Overall Study||45
11320909|NCT02723084|12517979|FG000|NOT COMPLETED|Overall Study||4
11320910|NCT02723084|12517980|FG001|NOT COMPLETED|Overall Study||1
11320911|NCT02723175|12517988|FG000|STARTED|Overall Study||8
11320912|NCT02723175|12517989|FG001|STARTED|Overall Study||7
11320913|NCT02723175|12517988|FG000|COMPLETED|Overall Study||4
11320914|NCT02723175|12517989|FG001|COMPLETED|Overall Study||4
11320915|NCT02723175|12517988|FG000|NOT COMPLETED|Overall Study||4
11320916|NCT02723175|12517989|FG001|NOT COMPLETED|Overall Study||3
11320917|NCT02723188|12517998|FG000|STARTED|Overall Study||15
11320918|NCT02723188|12517999|FG001|STARTED|Overall Study||15
11320919|NCT02723188|12518000|FG002|STARTED|Overall Study||15
11320920|NCT02723188|12517998|FG000|COMPLETED|Overall Study||14
11320921|NCT02723188|12517999|FG001|COMPLETED|Overall Study||15
11320922|NCT02723188|12518000|FG002|COMPLETED|Overall Study||15
11320923|NCT02723188|12517998|FG000|NOT COMPLETED|Overall Study||1
11320924|NCT02723188|12517999|FG001|NOT COMPLETED|Overall Study||0
11320925|NCT02723188|12518000|FG002|NOT COMPLETED|Overall Study||0
11320926|NCT02723201|12518011|FG000|STARTED|First Intervention Period||11
11320927|NCT02723201|12518012|FG001|STARTED|First Intervention Period||7
11320928|NCT02723201|12518013|FG002|STARTED|First Intervention Period||7
11320929|NCT02723201|12518011|FG000|COMPLETED|First Intervention Period||11
11320930|NCT02723201|12518012|FG001|COMPLETED|First Intervention Period||7
11320931|NCT02723201|12518013|FG002|COMPLETED|First Intervention Period||7
11320932|NCT02723201|12518011|FG000|NOT COMPLETED|First Intervention Period||0
11320933|NCT02723201|12518012|FG001|NOT COMPLETED|First Intervention Period||0
11320934|NCT02723201|12518013|FG002|NOT COMPLETED|First Intervention Period||0
11320935|NCT02723201|12518011|FG000|STARTED|Washout Period 1||11
11320936|NCT02723201|12518012|FG001|STARTED|Washout Period 1||7
11320937|NCT02723201|12518013|FG002|STARTED|Washout Period 1||7
11320938|NCT02723201|12518011|FG000|COMPLETED|Washout Period 1||11
11320939|NCT02723201|12518012|FG001|COMPLETED|Washout Period 1||7
11320940|NCT02723201|12518013|FG002|COMPLETED|Washout Period 1||7
11320941|NCT02723201|12518011|FG000|NOT COMPLETED|Washout Period 1||0
11320942|NCT02723201|12518012|FG001|NOT COMPLETED|Washout Period 1||0
11320943|NCT02723201|12518013|FG002|NOT COMPLETED|Washout Period 1||0
11320944|NCT02723201|12518011|FG000|STARTED|Second Intervention Period||11
11320945|NCT02723201|12518012|FG001|STARTED|Second Intervention Period||7
11320946|NCT02723201|12518013|FG002|STARTED|Second Intervention Period||7
11320947|NCT02723201|12518011|FG000|COMPLETED|Second Intervention Period||9
11320948|NCT02723201|12518012|FG001|COMPLETED|Second Intervention Period||7
11320949|NCT02723201|12518013|FG002|COMPLETED|Second Intervention Period||7
11320950|NCT02723201|12518011|FG000|NOT COMPLETED|Second Intervention Period||2
11320951|NCT02723201|12518012|FG001|NOT COMPLETED|Second Intervention Period||0
11320952|NCT02723201|12518013|FG002|NOT COMPLETED|Second Intervention Period||0
11320953|NCT02723201|12518011|FG000|STARTED|Washout Period 2||9
11320954|NCT02723201|12518012|FG001|STARTED|Washout Period 2||0
11320955|NCT02723201|12518013|FG002|STARTED|Washout Period 2||0
11320956|NCT02723201|12518011|FG000|COMPLETED|Washout Period 2||9
11320957|NCT02723201|12518012|FG001|COMPLETED|Washout Period 2||0
11320958|NCT02723201|12518013|FG002|COMPLETED|Washout Period 2||0
11320959|NCT02723201|12518011|FG000|NOT COMPLETED|Washout Period 2||0
11320960|NCT02723201|12518012|FG001|NOT COMPLETED|Washout Period 2||0
11320961|NCT02723201|12518013|FG002|NOT COMPLETED|Washout Period 2||0
11320962|NCT02723201|12518011|FG000|STARTED|Third Intervention Period||9
11320963|NCT02723201|12518012|FG001|STARTED|Third Intervention Period||0
11320964|NCT02723201|12518013|FG002|STARTED|Third Intervention Period||0
11320965|NCT02723201|12518011|FG000|COMPLETED|Third Intervention Period||9
11320966|NCT02723201|12518012|FG001|COMPLETED|Third Intervention Period||0
11320967|NCT02723201|12518013|FG002|COMPLETED|Third Intervention Period||0
11320968|NCT02723201|12518011|FG000|NOT COMPLETED|Third Intervention Period||0
11320969|NCT02723201|12518012|FG001|NOT COMPLETED|Third Intervention Period||0
11320970|NCT02723201|12518013|FG002|NOT COMPLETED|Third Intervention Period||0
11320971|NCT02723201|12518011|FG000|STARTED|Washout Period 3||9
11320972|NCT02723201|12518012|FG001|STARTED|Washout Period 3||0
11320973|NCT02723201|12518013|FG002|STARTED|Washout Period 3||0
11320974|NCT02723201|12518011|FG000|COMPLETED|Washout Period 3||9
11320975|NCT02723201|12518012|FG001|COMPLETED|Washout Period 3||0
11320976|NCT02723201|12518013|FG002|COMPLETED|Washout Period 3||0
11320977|NCT02723201|12518011|FG000|NOT COMPLETED|Washout Period 3||0
11320978|NCT02723201|12518012|FG001|NOT COMPLETED|Washout Period 3||0
11320979|NCT02723201|12518013|FG002|NOT COMPLETED|Washout Period 3||0
11320980|NCT02723201|12518011|FG000|STARTED|Fourth Intervention Period||9
11320981|NCT02723201|12518012|FG001|STARTED|Fourth Intervention Period||0
11320982|NCT02723201|12518013|FG002|STARTED|Fourth Intervention Period||0
11320983|NCT02723201|12518011|FG000|COMPLETED|Fourth Intervention Period||9
11320984|NCT02723201|12518012|FG001|COMPLETED|Fourth Intervention Period||0
11320985|NCT02723201|12518013|FG002|COMPLETED|Fourth Intervention Period||0
11320986|NCT02723201|12518011|FG000|NOT COMPLETED|Fourth Intervention Period||0
11320987|NCT02723201|12518012|FG001|NOT COMPLETED|Fourth Intervention Period||0
11320988|NCT02723201|12518013|FG002|NOT COMPLETED|Fourth Intervention Period||0
11320989|NCT02723344|12518029|FG000|STARTED|Overall Study||15
11320990|NCT02723344|12518030|FG001|STARTED|Overall Study||16
11320991|NCT02723344|12518029|FG000|COMPLETED|Overall Study||15
11320992|NCT02723344|12518030|FG001|COMPLETED|Overall Study||12
11320993|NCT02723344|12518029|FG000|NOT COMPLETED|Overall Study||0
11320994|NCT02723344|12518030|FG001|NOT COMPLETED|Overall Study||4
11320995|NCT02723591|12518038|FG000|STARTED|Overall Study||300
11320996|NCT02723591|12518039|FG001|STARTED|Overall Study||299
11320997|NCT02723591|12518038|FG000|COMPLETED|Overall Study||204
11320998|NCT02723591|12518039|FG001|COMPLETED|Overall Study||198
11320999|NCT02723591|12518038|FG000|NOT COMPLETED|Overall Study||96
11321000|NCT02723591|12518039|FG001|NOT COMPLETED|Overall Study||101
11321001|NCT02723630|12518051|FG000|STARTED|Intervention Period 1||10
11321002|NCT02723630|12518052|FG001|STARTED|Intervention Period 1||10
11321003|NCT02723630|12518053|FG002|STARTED|Intervention Period 1||10
11321004|NCT02723630|12518054|FG003|STARTED|Intervention Period 1||10
11321005|NCT02723630|12518055|FG004|STARTED|Intervention Period 1||10
11321006|NCT02723630|12518056|FG005|STARTED|Intervention Period 1||10
11321007|NCT02723630|12518051|FG000|COMPLETED|Intervention Period 1||9
11321008|NCT02723630|12518052|FG001|COMPLETED|Intervention Period 1||10
11321009|NCT02723630|12518053|FG002|COMPLETED|Intervention Period 1||10
11321010|NCT02723630|12518054|FG003|COMPLETED|Intervention Period 1||10
11321011|NCT02723630|12518055|FG004|COMPLETED|Intervention Period 1||10
11321012|NCT02723630|12518056|FG005|COMPLETED|Intervention Period 1||10
11321013|NCT02723630|12518051|FG000|NOT COMPLETED|Intervention Period 1||1
11321014|NCT02723630|12518052|FG001|NOT COMPLETED|Intervention Period 1||0
11321015|NCT02723630|12518053|FG002|NOT COMPLETED|Intervention Period 1||0
11321016|NCT02723630|12518054|FG003|NOT COMPLETED|Intervention Period 1||0
11321017|NCT02723630|12518055|FG004|NOT COMPLETED|Intervention Period 1||0
11321018|NCT02723630|12518056|FG005|NOT COMPLETED|Intervention Period 1||0
11321019|NCT02723630|12518051|FG000|STARTED|Intervention Period 2||9
11402876|NCT04019626|12597814|FG003|COMPLETED|Overall Study||39
11402877|NCT04019626|12597815|FG004|COMPLETED|Overall Study||38
11321020|NCT02723630|12518052|FG001|STARTED|Intervention Period 2||10
11321021|NCT02723630|12518053|FG002|STARTED|Intervention Period 2||10
11321022|NCT02723630|12518054|FG003|STARTED|Intervention Period 2||10
11321023|NCT02723630|12518055|FG004|STARTED|Intervention Period 2||10
11321024|NCT02723630|12518056|FG005|STARTED|Intervention Period 2||10
11321025|NCT02723630|12518051|FG000|COMPLETED|Intervention Period 2||9
11321026|NCT02723630|12518052|FG001|COMPLETED|Intervention Period 2||10
11321027|NCT02723630|12518053|FG002|COMPLETED|Intervention Period 2||10
11321028|NCT02723630|12518054|FG003|COMPLETED|Intervention Period 2||10
11321029|NCT02723630|12518055|FG004|COMPLETED|Intervention Period 2||10
11321030|NCT02723630|12518056|FG005|COMPLETED|Intervention Period 2||10
11321031|NCT02723630|12518051|FG000|NOT COMPLETED|Intervention Period 2||0
11321032|NCT02723630|12518052|FG001|NOT COMPLETED|Intervention Period 2||0
11321033|NCT02723630|12518053|FG002|NOT COMPLETED|Intervention Period 2||0
11321034|NCT02723630|12518054|FG003|NOT COMPLETED|Intervention Period 2||0
11321035|NCT02723630|12518055|FG004|NOT COMPLETED|Intervention Period 2||0
11321036|NCT02723630|12518056|FG005|NOT COMPLETED|Intervention Period 2||0
11321037|NCT02723630|12518051|FG000|STARTED|Intervention Period 3||9
11321038|NCT02723630|12518052|FG001|STARTED|Intervention Period 3||10
11321039|NCT02723630|12518053|FG002|STARTED|Intervention Period 3||10
11321040|NCT02723630|12518054|FG003|STARTED|Intervention Period 3||10
11321041|NCT02723630|12518055|FG004|STARTED|Intervention Period 3||10
11321042|NCT02723630|12518056|FG005|STARTED|Intervention Period 3||10
11321043|NCT02723630|12518051|FG000|COMPLETED|Intervention Period 3||9
11321044|NCT02723630|12518052|FG001|COMPLETED|Intervention Period 3||9
11321045|NCT02723630|12518053|FG002|COMPLETED|Intervention Period 3||10
11321046|NCT02723630|12518054|FG003|COMPLETED|Intervention Period 3||10
11321047|NCT02723630|12518055|FG004|COMPLETED|Intervention Period 3||10
11321048|NCT02723630|12518056|FG005|COMPLETED|Intervention Period 3||10
11321049|NCT02723630|12518051|FG000|NOT COMPLETED|Intervention Period 3||0
11321050|NCT02723630|12518052|FG001|NOT COMPLETED|Intervention Period 3||1
11321051|NCT02723630|12518053|FG002|NOT COMPLETED|Intervention Period 3||0
11321052|NCT02723630|12518054|FG003|NOT COMPLETED|Intervention Period 3||0
11321053|NCT02723630|12518055|FG004|NOT COMPLETED|Intervention Period 3||0
11321054|NCT02723630|12518056|FG005|NOT COMPLETED|Intervention Period 3||0
11321055|NCT02723786|12518069|FG000|STARTED|Overall Study||7
11402878|NCT04019626|12597816|FG005|COMPLETED|Overall Study||20
11402879|NCT04019626|12597811|FG000|NOT COMPLETED|Overall Study||6
11143994|NCT01475253|12330631|FG000|STARTED|Open Label Extension||0
11143995|NCT01475253|12330632|FG001|STARTED|Open Label Extension||0
11143996|NCT01475253|12330633|FG002|STARTED|Open Label Extension||0
11143997|NCT01475253|12330634|FG003|STARTED|Open Label Extension||56
11143998|NCT01475253|12330631|FG000|COMPLETED|Open Label Extension||0
11143999|NCT01475253|12330632|FG001|COMPLETED|Open Label Extension||0
11144000|NCT01475253|12330633|FG002|COMPLETED|Open Label Extension||0
11144001|NCT01475253|12330634|FG003|COMPLETED|Open Label Extension||56
11144002|NCT01475253|12330631|FG000|NOT COMPLETED|Open Label Extension||0
11321056|NCT02723786|12518069|FG000|COMPLETED|Overall Study||6
11402880|NCT04019626|12597812|FG001|NOT COMPLETED|Overall Study||10
11144003|NCT01475253|12330632|FG001|NOT COMPLETED|Open Label Extension||0
11144004|NCT01475253|12330633|FG002|NOT COMPLETED|Open Label Extension||0
11144005|NCT01475253|12330634|FG003|NOT COMPLETED|Open Label Extension||0
11144006|NCT01475305|12330644|FG000|STARTED|Overall Study||4
11144007|NCT01475305|12330645|FG001|STARTED|Overall Study||3
11144008|NCT01475305|12330644|FG000|End of Quarantine, Day 15|Overall Study||4
11144009|NCT01475305|12330645|FG001|End of Quarantine, Day 15|Overall Study||3
11144010|NCT01475305|12330644|FG000|COMPLETED|Overall Study||4
11144011|NCT01475305|12330645|FG001|COMPLETED|Overall Study||3
11144012|NCT01475305|12330644|FG000|NOT COMPLETED|Overall Study||0
11144013|NCT01475305|12330645|FG001|NOT COMPLETED|Overall Study||0
11144014|NCT01475331|12330654|FG000|STARTED|Overall Study||23
11144015|NCT01475331|12330655|FG001|STARTED|Overall Study||23
11144016|NCT01475331|12330654|FG000|COMPLETED|Overall Study||18
11144017|NCT01475331|12330655|FG001|COMPLETED|Overall Study||21
11144018|NCT01475331|12330654|FG000|NOT COMPLETED|Overall Study||5
11144019|NCT01475331|12330655|FG001|NOT COMPLETED|Overall Study||2
11144020|NCT01475370|12330664|FG000|STARTED|Overall Study||3
11144021|NCT01475370|12330665|FG001|STARTED|Overall Study||3
11144022|NCT01475370|12330666|FG002|STARTED|Overall Study||3
11144023|NCT01475370|12330664|FG000|COMPLETED|Overall Study||0
11144024|NCT01475370|12330665|FG001|COMPLETED|Overall Study||0
11144025|NCT01475370|12330666|FG002|COMPLETED|Overall Study||0
11144026|NCT01475370|12330664|FG000|NOT COMPLETED|Overall Study||3
11144027|NCT01475370|12330665|FG001|NOT COMPLETED|Overall Study||3
11321057|NCT02723786|12518069|FG000|NOT COMPLETED|Overall Study||1
11321058|NCT02723916|12518075|FG000|STARTED|Overall Study||144
11321059|NCT02723916|12518076|FG001|STARTED|Overall Study||143
11402881|NCT04019626|12597813|FG002|NOT COMPLETED|Overall Study||8
11402882|NCT04019626|12597814|FG003|NOT COMPLETED|Overall Study||7
11402883|NCT04019626|12597815|FG004|NOT COMPLETED|Overall Study||6
11321060|NCT02723916|12518075|FG000|COMPLETED|Overall Study||135
11144028|NCT01475370|12330666|FG002|NOT COMPLETED|Overall Study||3
11321061|NCT02723916|12518076|FG001|COMPLETED|Overall Study||137
11402884|NCT04019626|12597816|FG005|NOT COMPLETED|Overall Study||1
11402885|NCT04023994|12597836|FG000|STARTED|Overall Study||10
11402886|NCT04023994|12597837|FG001|STARTED|Overall Study||4
11402887|NCT04023994|12597838|FG002|STARTED|Overall Study||4
11402888|NCT04023994|12597839|FG003|STARTED|Overall Study||6
11402889|NCT04023994|12597840|FG004|STARTED|Overall Study||6
11402890|NCT04023994|12597841|FG005|STARTED|Overall Study||6
11402891|NCT04023994|12597836|FG000|COMPLETED|Overall Study||10
11402892|NCT04023994|12597837|FG001|COMPLETED|Overall Study||3
11402893|NCT04023994|12597838|FG002|COMPLETED|Overall Study||2
11402894|NCT04023994|12597839|FG003|COMPLETED|Overall Study||5
11402895|NCT04023994|12597840|FG004|COMPLETED|Overall Study||6
11402896|NCT04023994|12597841|FG005|COMPLETED|Overall Study||6
11402897|NCT04023994|12597836|FG000|NOT COMPLETED|Overall Study||0
11402898|NCT04023994|12597837|FG001|NOT COMPLETED|Overall Study||1
11402899|NCT04023994|12597838|FG002|NOT COMPLETED|Overall Study||2
11144029|NCT01475461|12330680|FG000|STARTED|Run-in Period||376
11144030|NCT01475461|12330681|FG001|STARTED|Run-in Period||0
11144031|NCT01475461|12330682|FG002|STARTED|Run-in Period||0
11144032|NCT01475461|12330683|FG003|STARTED|Run-in Period||0
11144033|NCT01475461|12330684|FG004|STARTED|Run-in Period||0
11144034|NCT01475461|12330685|FG005|STARTED|Run-in Period||0
11321062|NCT02723916|12518075|FG000|NOT COMPLETED|Overall Study||9
11321063|NCT02723916|12518076|FG001|NOT COMPLETED|Overall Study||6
11321064|NCT02724020|12518085|FG000|STARTED|Overall Study||32
11321065|NCT02724020|12518086|FG001|STARTED|Overall Study||32
11321066|NCT02724020|12518087|FG002|STARTED|Overall Study||32
11321067|NCT02724020|12518085|FG000|Treated (Safety Analysis Set)|Overall Study||32
11321068|NCT02724020|12518086|FG001|Treated (Safety Analysis Set)|Overall Study||32
11321069|NCT02724020|12518087|FG002|Treated (Safety Analysis Set)|Overall Study||31
11321070|NCT02724020|12518085|FG000|COMPLETED|Overall Study||0
11321071|NCT02724020|12518086|FG001|COMPLETED|Overall Study||0
11321072|NCT02724020|12518087|FG002|COMPLETED|Overall Study||0
11321073|NCT02724020|12518085|FG000|NOT COMPLETED|Overall Study||32
11321074|NCT02724020|12518086|FG001|NOT COMPLETED|Overall Study||32
11321075|NCT02724020|12518087|FG002|NOT COMPLETED|Overall Study||32
11321076|NCT02724033|12518098|FG000|STARTED|Overall Study||11
11321077|NCT02724033|12518099|FG001|STARTED|Overall Study||14
11321078|NCT02724033|12518100|FG002|STARTED|Overall Study||12
11321079|NCT02724033|12518098|FG000|COMPLETED|Overall Study||11
11321080|NCT02724033|12518099|FG001|COMPLETED|Overall Study||14
11321081|NCT02724033|12518100|FG002|COMPLETED|Overall Study||12
11321082|NCT02724033|12518098|FG000|NOT COMPLETED|Overall Study||0
11144035|NCT01475461|12330686|FG006|STARTED|Run-in Period||0
11144036|NCT01475461|12330680|FG000|COMPLETED|Run-in Period||335
11144037|NCT01475461|12330681|FG001|COMPLETED|Run-in Period||0
11144038|NCT01475461|12330682|FG002|COMPLETED|Run-in Period||0
11144039|NCT01475461|12330683|FG003|COMPLETED|Run-in Period||0
11144040|NCT01475461|12330684|FG004|COMPLETED|Run-in Period||0
11144041|NCT01475461|12330685|FG005|COMPLETED|Run-in Period||0
11144042|NCT01475461|12330686|FG006|COMPLETED|Run-in Period||0
11321083|NCT02724033|12518099|FG001|NOT COMPLETED|Overall Study||0
11144043|NCT01475461|12330680|FG000|NOT COMPLETED|Run-in Period||41
11144044|NCT01475461|12330681|FG001|NOT COMPLETED|Run-in Period||0
11144045|NCT01475461|12330682|FG002|NOT COMPLETED|Run-in Period||0
11402900|NCT04023994|12597839|FG003|NOT COMPLETED|Overall Study||1
11402901|NCT04023994|12597840|FG004|NOT COMPLETED|Overall Study||0
11402902|NCT04023994|12597841|FG005|NOT COMPLETED|Overall Study||0
11321084|NCT02724033|12518100|FG002|NOT COMPLETED|Overall Study||0
11321085|NCT02724111|12518110|FG000|STARTED|Overall Study||45
11321086|NCT02724111|12518111|FG001|STARTED|Overall Study||45
11321087|NCT02724111|12518110|FG000|COMPLETED|Overall Study||43
11321088|NCT02724111|12518111|FG001|COMPLETED|Overall Study||40
11321089|NCT02724111|12518110|FG000|NOT COMPLETED|Overall Study||2
11321090|NCT02724111|12518111|FG001|NOT COMPLETED|Overall Study||5
11321091|NCT02724423|12518117|FG000|STARTED|Overall Study||57
11321092|NCT02724423|12518117|FG000|COMPLETED|Overall Study||54
11321093|NCT02724423|12518117|FG000|NOT COMPLETED|Overall Study||3
11402903|NCT04022668|12597863|FG000|STARTED|Overall Study||1000
11144046|NCT01475461|12330683|FG003|NOT COMPLETED|Run-in Period||0
11144047|NCT01475461|12330684|FG004|NOT COMPLETED|Run-in Period||0
11144048|NCT01475461|12330685|FG005|NOT COMPLETED|Run-in Period||0
11144049|NCT01475461|12330686|FG006|NOT COMPLETED|Run-in Period||0
11144050|NCT01475461|12330680|FG000|STARTED|Treatment Period||0
11144051|NCT01475461|12330681|FG001|STARTED|Treatment Period||57
11144052|NCT01475461|12330682|FG002|STARTED|Treatment Period||57
11144053|NCT01475461|12330683|FG003|STARTED|Treatment Period||54
11144054|NCT01475461|12330684|FG004|STARTED|Treatment Period||56
11144055|NCT01475461|12330685|FG005|STARTED|Treatment Period||56
11144056|NCT01475461|12330686|FG006|STARTED|Treatment Period||55
11144057|NCT01475461|12330680|FG000|COMPLETED|Treatment Period||0
11144058|NCT01475461|12330681|FG001|COMPLETED|Treatment Period||48
11144059|NCT01475461|12330682|FG002|COMPLETED|Treatment Period||53
11144060|NCT01475461|12330683|FG003|COMPLETED|Treatment Period||46
11144061|NCT01475461|12330684|FG004|COMPLETED|Treatment Period||52
11144062|NCT01475461|12330685|FG005|COMPLETED|Treatment Period||51
11321094|NCT02724449|12518122|FG000|STARTED|Overall Study||16
11321095|NCT02724449|12518122|FG000|COMPLETED|Overall Study||16
11321096|NCT02724449|12518122|FG000|NOT COMPLETED|Overall Study||0
11321097|NCT02724462|12518128|FG000|STARTED|3 Month Follow-up Survey||1254
11321098|NCT02724462|12518129|FG001|STARTED|3 Month Follow-up Survey||1249
11321099|NCT02724462|12518128|FG000|COMPLETED|3 Month Follow-up Survey||1043
11321100|NCT02724462|12518129|FG001|COMPLETED|3 Month Follow-up Survey||1050
11321101|NCT02724462|12518128|FG000|NOT COMPLETED|3 Month Follow-up Survey||211
11321102|NCT02724462|12518129|FG001|NOT COMPLETED|3 Month Follow-up Survey||199
11321103|NCT02724462|12518128|FG000|STARTED|6 Month Follow-up Survey||1254
11321104|NCT02724462|12518129|FG001|STARTED|6 Month Follow-up Survey||1249
11321105|NCT02724462|12518128|FG000|COMPLETED|6 Month Follow-up Survey||1058
11321106|NCT02724462|12518129|FG001|COMPLETED|6 Month Follow-up Survey||1078
11321107|NCT02724462|12518128|FG000|NOT COMPLETED|6 Month Follow-up Survey||196
11321108|NCT02724462|12518129|FG001|NOT COMPLETED|6 Month Follow-up Survey||171
11321109|NCT02724462|12518128|FG000|STARTED|12 Month Follow-up Survey||1254
11321110|NCT02724462|12518129|FG001|STARTED|12 Month Follow-up Survey||1249
11321111|NCT02724462|12518128|FG000|COMPLETED|12 Month Follow-up Survey||1040
11321112|NCT02724462|12518129|FG001|COMPLETED|12 Month Follow-up Survey||1067
11321113|NCT02724462|12518128|FG000|NOT COMPLETED|12 Month Follow-up Survey||214
11321114|NCT02724462|12518129|FG001|NOT COMPLETED|12 Month Follow-up Survey||182
11321115|NCT02724592|12518137|FG000|STARTED|Overall Study||35
11321116|NCT02724592|12518138|FG001|STARTED|Overall Study||35
11321117|NCT02724592|12518137|FG000|COMPLETED|Overall Study||31
11321118|NCT02724592|12518138|FG001|COMPLETED|Overall Study||34
11321119|NCT02724592|12518137|FG000|NOT COMPLETED|Overall Study||4
11321120|NCT02724592|12518138|FG001|NOT COMPLETED|Overall Study||1
11321121|NCT02724644|12518146|FG000|STARTED|Overall Study||189
11321122|NCT02724644|12518147|FG001|STARTED|Overall Study||186
11321123|NCT02724644|12518146|FG000|COMPLETED|Overall Study||168
11321124|NCT02724644|12518147|FG001|COMPLETED|Overall Study||182
11321125|NCT02724644|12518146|FG000|NOT COMPLETED|Overall Study||21
11321126|NCT02724644|12518147|FG001|NOT COMPLETED|Overall Study||4
11321127|NCT02724787|12518153|FG000|STARTED|Overall Study||24
11321128|NCT02724787|12518153|FG000|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22
11321129|NCT02724787|12518153|FG000|NOT COMPLETED|Overall Study||2
11321130|NCT02724800|12518159|FG000|STARTED|Overall Study||32
11321131|NCT02724800|12518160|FG001|STARTED|Overall Study||31
11321132|NCT02724800|12518159|FG000|COMPLETED|Overall Study||15
11321133|NCT02724800|12518160|FG001|COMPLETED|Overall Study||22
11321134|NCT02724800|12518159|FG000|NOT COMPLETED|Overall Study||17
11321135|NCT02724800|12518160|FG001|NOT COMPLETED|Overall Study||9
11321136|NCT02724839|12518169|FG000|STARTED|Overall Study||13
11321137|NCT02724839|12518170|FG001|STARTED|Overall Study||12
11321138|NCT02724839|12518171|FG002|STARTED|Overall Study||11
11321139|NCT02724839|12518169|FG000|COMPLETED|Overall Study||12
11321140|NCT02724839|12518170|FG001|COMPLETED|Overall Study||8
11321141|NCT02724839|12518171|FG002|COMPLETED|Overall Study||6
11321142|NCT02724839|12518169|FG000|NOT COMPLETED|Overall Study||1
11321143|NCT02724839|12518170|FG001|NOT COMPLETED|Overall Study||4
11321144|NCT02724839|12518171|FG002|NOT COMPLETED|Overall Study||5
11321145|NCT02724956|12518188|FG000|STARTED|Overall Study||27
11321146|NCT02724956|12518189|FG001|STARTED|Overall Study||26
11321147|NCT02724956|12518188|FG000|COMPLETED|Overall Study||26
11321148|NCT02724956|12518189|FG001|COMPLETED|Overall Study||24
11321149|NCT02724956|12518188|FG000|NOT COMPLETED|Overall Study||1
11321150|NCT02724956|12518189|FG001|NOT COMPLETED|Overall Study||2
11321151|NCT02725008|12518197|FG000|STARTED|Overall Study||46
11321152|NCT02725008|12518198|FG001|STARTED|Overall Study||51
11321153|NCT02725008|12518197|FG000|COMPLETED|Overall Study||37
11402904|NCT04022668|12597864|FG001|STARTED|Overall Study||1000
11402905|NCT04022668|12597865|FG002|STARTED|Overall Study||1000
11402906|NCT04022668|12597863|FG000|COMPLETED|Overall Study||986
11321154|NCT02725008|12518198|FG001|COMPLETED|Overall Study||39
11321155|NCT02725008|12518197|FG000|NOT COMPLETED|Overall Study||9
11321156|NCT02725008|12518198|FG001|NOT COMPLETED|Overall Study||12
11321157|NCT02725268|12518208|FG000|STARTED|Overall Study||90
11321158|NCT02725268|12518209|FG001|STARTED|Overall Study||90
11321159|NCT02725268|12518210|FG002|STARTED|Overall Study||41
11321160|NCT02725268|12518211|FG003|STARTED|Overall Study||20
11321161|NCT02725268|12518208|FG000|Started|Overall Study||90
11321162|NCT02725268|12518209|FG001|Started|Overall Study||90
11321163|NCT02725268|12518210|FG002|Started|Overall Study||41
11321164|NCT02725268|12518211|FG003|Started|Overall Study||20
11321165|NCT02725268|12518208|FG000|Completed|Overall Study||18
11321166|NCT02725268|12518209|FG001|Completed|Overall Study||20
11321167|NCT02725268|12518210|FG002|Completed|Overall Study||3
11321168|NCT02725268|12518211|FG003|Completed|Overall Study||2
11321169|NCT02725268|12518208|FG000|COMPLETED|Overall Study||18
11321170|NCT02725268|12518209|FG001|COMPLETED|Overall Study||20
11321171|NCT02725268|12518210|FG002|COMPLETED|Overall Study||3
11321172|NCT02725268|12518211|FG003|COMPLETED|Overall Study||2
11321173|NCT02725268|12518208|FG000|NOT COMPLETED|Overall Study||72
11321174|NCT02725268|12518209|FG001|NOT COMPLETED|Overall Study||70
11321175|NCT02725268|12518210|FG002|NOT COMPLETED|Overall Study||38
11321176|NCT02725268|12518211|FG003|NOT COMPLETED|Overall Study||18
11321177|NCT02725411|12518224|FG000|STARTED|Treatment Period (56 Weeks)||92
11321178|NCT02725411|12518225|FG001|STARTED|Treatment Period (56 Weeks)||93
11321179|NCT02725411|12518226|FG002|STARTED|Treatment Period (56 Weeks)||92
11321180|NCT02725411|12518224|FG000|Treated|Treatment Period (56 Weeks)||92
11321181|NCT02725411|12518225|FG001|Treated|Treatment Period (56 Weeks)||93
11321182|NCT02725411|12518226|FG002|Treated|Treatment Period (56 Weeks)||92
11321183|NCT02725411|12518224|FG000|COMPLETED|Treatment Period (56 Weeks)||62
11321184|NCT02725411|12518225|FG001|COMPLETED|Treatment Period (56 Weeks)||43
11321185|NCT02725411|12518226|FG002|COMPLETED|Treatment Period (56 Weeks)||43
11321186|NCT02725411|12518224|FG000|NOT COMPLETED|Treatment Period (56 Weeks)||30
11321187|NCT02725411|12518225|FG001|NOT COMPLETED|Treatment Period (56 Weeks)||50
11321188|NCT02725411|12518226|FG002|NOT COMPLETED|Treatment Period (56 Weeks)||49
11321189|NCT02725411|12518224|FG000|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
11321190|NCT02725411|12518225|FG001|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|93
11321191|NCT02725411|12518226|FG002|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
11321192|NCT02725411|12518224|FG000|COMPLETED|Follow-up Period (24 Weeks)||88
11321193|NCT02725411|12518225|FG001|COMPLETED|Follow-up Period (24 Weeks)||82
11402907|NCT04022668|12597864|FG001|COMPLETED|Overall Study||973
11321194|NCT02725411|12518226|FG002|COMPLETED|Follow-up Period (24 Weeks)||87
11321195|NCT02725411|12518224|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||4
11321196|NCT02725411|12518225|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||11
11321197|NCT02725411|12518226|FG002|NOT COMPLETED|Follow-up Period (24 Weeks)||5
11321198|NCT02725476|12518236|FG000|STARTED|Overall Study||15
11321199|NCT02725476|12518237|FG001|STARTED|Overall Study||5
11321200|NCT02725476|12518236|FG000|COMPLETED|Overall Study||12
11321201|NCT02725476|12518237|FG001|COMPLETED|Overall Study||4
11321202|NCT02725476|12518236|FG000|NOT COMPLETED|Overall Study||3
11321203|NCT02725476|12518237|FG001|NOT COMPLETED|Overall Study||1
11321204|NCT02725515|12518245|FG000|STARTED|Overall Study||53
11321205|NCT02725515|12518246|FG001|STARTED|Overall Study||52
11321206|NCT02725515|12518245|FG000|COMPLETED|Overall Study||28
11321207|NCT02725515|12518246|FG001|COMPLETED|Overall Study||17
11321208|NCT02725515|12518245|FG000|NOT COMPLETED|Overall Study||25
11321209|NCT02725515|12518246|FG001|NOT COMPLETED|Overall Study||35
11321210|NCT02725645|12518252|FG000|STARTED|Overall Study||14
11321211|NCT02725645|12518252|FG000|COMPLETED|Overall Study||14
11321212|NCT02725645|12518252|FG000|NOT COMPLETED|Overall Study||0
11321213|NCT02725710|12518258|FG000|STARTED|Overall Study||48
11321214|NCT02725710|12518259|FG001|STARTED|Overall Study||47
11321215|NCT02725710|12518258|FG000|COMPLETED|Overall Study||47
11321216|NCT02725710|12518259|FG001|COMPLETED|Overall Study||47
11321217|NCT02725710|12518258|FG000|NOT COMPLETED|Overall Study||1
11321218|NCT02725710|12518259|FG001|NOT COMPLETED|Overall Study||0
11321219|NCT02725788|12518267|FG000|STARTED|Overall Study||123
11321220|NCT02725788|12518268|FG001|STARTED|Overall Study||124
11321221|NCT02725788|12518267|FG000|COMPLETED|Overall Study||122
11321222|NCT02725788|12518268|FG001|COMPLETED|Overall Study||122
11321223|NCT02725788|12518267|FG000|NOT COMPLETED|Overall Study||1
11321224|NCT02725788|12518268|FG001|NOT COMPLETED|Overall Study||2
11321225|NCT02725801|12518276|FG000|STARTED|Overall Study||8
11321226|NCT02725801|12518277|FG001|STARTED|Overall Study||12
11321227|NCT02725801|12518276|FG000|COMPLETED|Overall Study||8
11321228|NCT02725801|12518277|FG001|COMPLETED|Overall Study||12
11321229|NCT02725801|12518276|FG000|NOT COMPLETED|Overall Study||0
11321230|NCT02725801|12518277|FG001|NOT COMPLETED|Overall Study||0
11321231|NCT02725866|12518283|FG000|STARTED|Overall Study||216
11321232|NCT02725866|12518283|FG000|COMPLETED|Overall Study||202
11321233|NCT02725866|12518283|FG000|NOT COMPLETED|Overall Study||14
11321234|NCT02726022|12518287|FG000|STARTED|Overall Study||114
11321235|NCT02726022|12518287|FG000|COMPLETED|Overall Study||78
11321236|NCT02726022|12518287|FG000|NOT COMPLETED|Overall Study||36
11321237|NCT02726074|12518291|FG000|STARTED|Overall Study||106
11321238|NCT02726074|12518291|FG000|Treated|Overall Study||102
11402908|NCT04022668|12597865|FG002|COMPLETED|Overall Study||1000
11321239|NCT02726074|12518291|FG000|COMPLETED|Overall Study||80
11321240|NCT02726074|12518291|FG000|NOT COMPLETED|Overall Study||26
11321241|NCT02726113|12518297|FG000|STARTED|Total Enrollment||28
11321242|NCT02726113|12518298|FG001|STARTED|Total Enrollment||22
11321243|NCT02726113|12518297|FG000|COMPLETED|Total Enrollment||24
11321244|NCT02726113|12518298|FG001|COMPLETED|Total Enrollment||19
11321245|NCT02726113|12518297|FG000|NOT COMPLETED|Total Enrollment||4
11321246|NCT02726113|12518298|FG001|NOT COMPLETED|Total Enrollment||3
11321247|NCT02726113|12518297|FG000|STARTED|Genomic Analysis||19
11321248|NCT02726113|12518298|FG001|STARTED|Genomic Analysis||14
11321249|NCT02726113|12518297|FG000|COMPLETED|Genomic Analysis||15
11321250|NCT02726113|12518298|FG001|COMPLETED|Genomic Analysis||12
11321251|NCT02726113|12518297|FG000|NOT COMPLETED|Genomic Analysis||4
11321252|NCT02726113|12518298|FG001|NOT COMPLETED|Genomic Analysis||2
11321253|NCT02726178|12518307|FG000|STARTED|Overall Study||28
11321254|NCT02726178|12518308|FG001|STARTED|Overall Study||28
11321255|NCT02726178|12518307|FG000|COMPLETED|Overall Study||28
11321256|NCT02726178|12518308|FG001|COMPLETED|Overall Study||28
11321257|NCT02726178|12518307|FG000|NOT COMPLETED|Overall Study||0
11321258|NCT02726178|12518308|FG001|NOT COMPLETED|Overall Study||0
11321259|NCT02726451|12518318|FG000|STARTED|Overall Study||10
11321260|NCT02726451|12518319|FG001|STARTED|Overall Study||10
11321261|NCT02726451|12518318|FG000|COMPLETED|Overall Study||10
11321262|NCT02726451|12518319|FG001|COMPLETED|Overall Study||10
11321263|NCT02726451|12518318|FG000|NOT COMPLETED|Overall Study||0
11321264|NCT02726451|12518319|FG001|NOT COMPLETED|Overall Study||0
11321265|NCT02726620|12518327|FG000|STARTED|Historic Cohort - Three Years||17463
11321266|NCT02726620|12518328|FG001|STARTED|Historic Cohort - Three Years||0
11321267|NCT02726620|12518327|FG000|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624
11321268|NCT02726620|12518328|FG001|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0
11321269|NCT02726620|12518327|FG000|COMPLETED|Historic Cohort - Three Years||17463
11321270|NCT02726620|12518328|FG001|COMPLETED|Historic Cohort - Three Years||0
11321271|NCT02726620|12518327|FG000|NOT COMPLETED|Historic Cohort - Three Years||0
11321272|NCT02726620|12518328|FG001|NOT COMPLETED|Historic Cohort - Three Years||0
11321273|NCT02726620|12518327|FG000|STARTED|Month 1: Attending Randomization||0
11321274|NCT02726620|12518328|FG001|STARTED|Month 1: Attending Randomization||485
11321275|NCT02726620|12518327|FG000|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0
11321276|NCT02726620|12518328|FG001|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432
11321277|NCT02726620|12518327|FG000|Correct IOH Notifications|Month 1: Attending Randomization||0
11321278|NCT02726620|12518328|FG001|Correct IOH Notifications|Month 1: Attending Randomization||313
11321279|NCT02726620|12518327|FG000|COMPLETED|Month 1: Attending Randomization||0
11321280|NCT02726620|12518328|FG001|COMPLETED|Month 1: Attending Randomization||485
11321281|NCT02726620|12518327|FG000|NOT COMPLETED|Month 1: Attending Randomization||0
11321282|NCT02726620|12518328|FG001|NOT COMPLETED|Month 1: Attending Randomization||0
11321283|NCT02726620|12518327|FG000|STARTED|Months 2-3: In-room Providers Randomized||0
11321284|NCT02726620|12518328|FG001|STARTED|Months 2-3: In-room Providers Randomized||1253
11321285|NCT02726620|12518327|FG000|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0
11321286|NCT02726620|12518328|FG001|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103
11321287|NCT02726620|12518327|FG000|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0
11321288|NCT02726620|12518328|FG001|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825
11321289|NCT02726620|12518327|FG000|COMPLETED|Months 2-3: In-room Providers Randomized||0
11321290|NCT02726620|12518328|FG001|COMPLETED|Months 2-3: In-room Providers Randomized||1253
11321291|NCT02726620|12518327|FG000|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
11321292|NCT02726620|12518328|FG001|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
11321293|NCT02726620|12518327|FG000|STARTED|Through End of Study: All Interventions||0
11321294|NCT02726620|12518328|FG001|STARTED|Through End of Study: All Interventions||3234
11321295|NCT02726620|12518327|FG000|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0
11321296|NCT02726620|12518328|FG001|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793
11321297|NCT02726620|12518327|FG000|Correct IOH Notifications|Through End of Study: All Interventions||0
11321298|NCT02726620|12518328|FG001|Correct IOH Notifications|Through End of Study: All Interventions||2072
11321299|NCT02726620|12518327|FG000|COMPLETED|Through End of Study: All Interventions||0
11321300|NCT02726620|12518328|FG001|COMPLETED|Through End of Study: All Interventions||3234
11321301|NCT02726620|12518327|FG000|NOT COMPLETED|Through End of Study: All Interventions||0
11321302|NCT02726620|12518328|FG001|NOT COMPLETED|Through End of Study: All Interventions||0
11321303|NCT02726789|12518334|FG000|STARTED|Overall Study||5
11321304|NCT02726789|12518334|FG000|COMPLETED|Overall Study||5
11321305|NCT02726789|12518334|FG000|NOT COMPLETED|Overall Study||0
11321306|NCT02726945|12518342|FG000|STARTED|Overall Study||13
11321307|NCT02726945|12518343|FG001|STARTED|Overall Study||13
11321308|NCT02726945|12518344|FG002|STARTED|Overall Study||13
11321309|NCT02726945|12518342|FG000|COMPLETED|Overall Study||13
11321310|NCT02726945|12518343|FG001|COMPLETED|Overall Study||12
11321311|NCT02726945|12518344|FG002|COMPLETED|Overall Study||12
11321312|NCT02726945|12518342|FG000|NOT COMPLETED|Overall Study||0
11321313|NCT02726945|12518343|FG001|NOT COMPLETED|Overall Study||1
11321314|NCT02726945|12518344|FG002|NOT COMPLETED|Overall Study||1
11321315|NCT02726971|12518354|FG000|STARTED|Overall Study||70
11321316|NCT02726971|12518355|FG001|STARTED|Overall Study||71
11321317|NCT02726971|12518354|FG000|COMPLETED|Overall Study||59
11321318|NCT02726971|12518355|FG001|COMPLETED|Overall Study||62
11321319|NCT02726971|12518354|FG000|NOT COMPLETED|Overall Study||11
11321320|NCT02726971|12518355|FG001|NOT COMPLETED|Overall Study||9
11321321|NCT02727192|12518363|FG000|STARTED|Overall Study||54
11321322|NCT02727192|12518364|FG001|STARTED|Overall Study||54
11321323|NCT02727192|12518365|FG002|STARTED|Overall Study||1
11321324|NCT02727192|12518363|FG000|COMPLETED|Overall Study||53
11321325|NCT02727192|12518364|FG001|COMPLETED|Overall Study||54
11321326|NCT02727192|12518365|FG002|COMPLETED|Overall Study||1
11321327|NCT02727192|12518363|FG000|NOT COMPLETED|Overall Study||1
11321328|NCT02727192|12518364|FG001|NOT COMPLETED|Overall Study||0
11321329|NCT02727192|12518365|FG002|NOT COMPLETED|Overall Study||0
11321330|NCT02727322|12518374|FG000|STARTED|Overall Study||77
11321331|NCT02727322|12518375|FG001|STARTED|Overall Study||77
11321332|NCT02727322|12518374|FG000|COMPLETED|Overall Study||75
11321333|NCT02727322|12518375|FG001|COMPLETED|Overall Study||76
11321334|NCT02727322|12518374|FG000|NOT COMPLETED|Overall Study||2
11321335|NCT02727322|12518375|FG001|NOT COMPLETED|Overall Study||1
11321336|NCT02727660|12518388|FG000|STARTED|Overall Study||619
11321337|NCT02727660|12518389|FG001|STARTED|Overall Study||617
11321338|NCT02727660|12518390|FG002|STARTED|Overall Study||607
11321339|NCT02727660|12518388|FG000|COMPLETED|Overall Study||503
11321340|NCT02727660|12518389|FG001|COMPLETED|Overall Study||501
11321341|NCT02727660|12518390|FG002|COMPLETED|Overall Study||442
11321342|NCT02727660|12518388|FG000|NOT COMPLETED|Overall Study||116
11321343|NCT02727660|12518389|FG001|NOT COMPLETED|Overall Study||116
11321344|NCT02727660|12518390|FG002|NOT COMPLETED|Overall Study||165
11321345|NCT02727751|12518398|FG000|STARTED|Overall Study||312
11321346|NCT02727751|12518398|FG000|COMPLETED|Overall Study||262
11321347|NCT02727751|12518398|FG000|NOT COMPLETED|Overall Study||50
11321348|NCT02727777|12518405|FG000|STARTED|Overall Study||4
11321349|NCT02727777|12518406|FG001|STARTED|Overall Study||0
11321350|NCT02727777|12518407|FG002|STARTED|Overall Study||0
11321351|NCT02727777|12518405|FG000|COMPLETED|Overall Study||0
11321352|NCT02727777|12518406|FG001|COMPLETED|Overall Study||0
11321353|NCT02727777|12518407|FG002|COMPLETED|Overall Study||0
11321354|NCT02727777|12518405|FG000|NOT COMPLETED|Overall Study||4
11321355|NCT02727777|12518406|FG001|NOT COMPLETED|Overall Study||0
11321356|NCT02727777|12518407|FG002|NOT COMPLETED|Overall Study||0
11321357|NCT02727816|12518415|FG000|STARTED|Overall Study||35
11321358|NCT02727816|12518415|FG000|COMPLETED|Overall Study||35
11321359|NCT02727816|12518415|FG000|NOT COMPLETED|Overall Study||0
11321360|NCT02727842|12518435|FG000|STARTED|Overall Study||30
11321361|NCT02727842|12518435|FG000|COMPLETED|Overall Study||30
11321362|NCT02727842|12518435|FG000|NOT COMPLETED|Overall Study||0
11321363|NCT02727894|12518441|FG000|STARTED|Overall Study|March 2013|73
11321364|NCT02727894|12518442|FG001|STARTED|Overall Study|March 2013|192
11321365|NCT02727894|12518441|FG000|COMPLETED|Overall Study|September 2015|73
11321366|NCT02727894|12518442|FG001|COMPLETED|Overall Study|September 2015|192
11321367|NCT02727894|12518441|FG000|NOT COMPLETED|Overall Study||0
11321368|NCT02727894|12518442|FG001|NOT COMPLETED|Overall Study||0
11321369|NCT02728089|12518451|FG000|STARTED|Overall Study||115
11321370|NCT02728089|12518451|FG000|Treated|Overall Study||114
11321371|NCT02728089|12518451|FG000|COMPLETED|Overall Study||112
11321372|NCT02728089|12518451|FG000|NOT COMPLETED|Overall Study||3
11321373|NCT02728206|12518455|FG000|STARTED|Overall Study||9
11321374|NCT02728206|12518455|FG000|COMPLETED|Overall Study||8
11321375|NCT02728206|12518455|FG000|NOT COMPLETED|Overall Study||1
11321376|NCT02728830|12518459|FG000|STARTED|Overall Study||39
11321377|NCT02728830|12518459|FG000|COMPLETED|Overall Study||15
11321378|NCT02728830|12518459|FG000|NOT COMPLETED|Overall Study||24
11321379|NCT02728895|12518465|FG000|STARTED|Overall Study||3
11321380|NCT02728895|12518466|FG001|STARTED|Overall Study||21
11321381|NCT02728895|12518465|FG000|COMPLETED|Overall Study||2
11321382|NCT02728895|12518466|FG001|COMPLETED|Overall Study||16
11321383|NCT02728895|12518465|FG000|NOT COMPLETED|Overall Study||1
11321384|NCT02728895|12518466|FG001|NOT COMPLETED|Overall Study||5
11321385|NCT02729038|12518476|FG000|STARTED|Part 1 (Up to 44 Days)||8
11321386|NCT02729038|12518477|FG001|STARTED|Part 1 (Up to 44 Days)||8
11321387|NCT02729038|12518478|FG002|STARTED|Part 1 (Up to 44 Days)||8
11321388|NCT02729038|12518479|FG003|STARTED|Part 1 (Up to 44 Days)||0
11321389|NCT02729038|12518476|FG000|COMPLETED|Part 1 (Up to 44 Days)||8
11321390|NCT02729038|12518477|FG001|COMPLETED|Part 1 (Up to 44 Days)||8
11321391|NCT02729038|12518478|FG002|COMPLETED|Part 1 (Up to 44 Days)||8
11321392|NCT02729038|12518479|FG003|COMPLETED|Part 1 (Up to 44 Days)||0
11321393|NCT02729038|12518476|FG000|NOT COMPLETED|Part 1 (Up to 44 Days)||0
11321394|NCT02729038|12518477|FG001|NOT COMPLETED|Part 1 (Up to 44 Days)||0
11321395|NCT02729038|12518478|FG002|NOT COMPLETED|Part 1 (Up to 44 Days)||0
11321396|NCT02729038|12518479|FG003|NOT COMPLETED|Part 1 (Up to 44 Days)||0
11321397|NCT02729038|12518476|FG000|STARTED|Part 2 (Up to 50 Days)||0
11321398|NCT02729038|12518477|FG001|STARTED|Part 2 (Up to 50 Days)||0
11321399|NCT02729038|12518478|FG002|STARTED|Part 2 (Up to 50 Days)||0
11321400|NCT02729038|12518479|FG003|STARTED|Part 2 (Up to 50 Days)||8
11321401|NCT02729038|12518476|FG000|COMPLETED|Part 2 (Up to 50 Days)||0
11321402|NCT02729038|12518477|FG001|COMPLETED|Part 2 (Up to 50 Days)||0
11321403|NCT02729038|12518478|FG002|COMPLETED|Part 2 (Up to 50 Days)||0
11321404|NCT02729038|12518479|FG003|COMPLETED|Part 2 (Up to 50 Days)||8
11321405|NCT02729038|12518476|FG000|NOT COMPLETED|Part 2 (Up to 50 Days)||0
11321406|NCT02729038|12518477|FG001|NOT COMPLETED|Part 2 (Up to 50 Days)||0
11321407|NCT02729038|12518478|FG002|NOT COMPLETED|Part 2 (Up to 50 Days)||0
11321408|NCT02729038|12518479|FG003|NOT COMPLETED|Part 2 (Up to 50 Days)||0
11321409|NCT02729051|12518498|FG000|STARTED|Overall Study||527
11321410|NCT02729051|12518499|FG001|STARTED|Overall Study||528
11321411|NCT02729051|12518498|FG000|COMPLETED|Overall Study||497
11321412|NCT02729051|12518499|FG001|COMPLETED|Overall Study||496
11321413|NCT02729051|12518498|FG000|NOT COMPLETED|Overall Study||30
11321414|NCT02729051|12518499|FG001|NOT COMPLETED|Overall Study||32
11321415|NCT02729194|12518505|FG000|STARTED|Overall Study||16
11321416|NCT02729194|12518505|FG000|COMPLETED|Overall Study||13
11321417|NCT02729194|12518505|FG000|NOT COMPLETED|Overall Study||3
11321418|NCT02729545|12518511|FG000|STARTED|Overall Study||30
11321419|NCT02729545|12518512|FG001|STARTED|Overall Study||30
11321420|NCT02729545|12518511|FG000|COMPLETED|Overall Study||27
11321421|NCT02729545|12518512|FG001|COMPLETED|Overall Study||25
11321422|NCT02729545|12518511|FG000|NOT COMPLETED|Overall Study||3
11321423|NCT02729545|12518512|FG001|NOT COMPLETED|Overall Study||5
11321424|NCT02729740|12518518|FG000|STARTED|Overall Study||995
11321425|NCT02729740|12518518|FG000|COMPLETED|Overall Study||864
11321426|NCT02729740|12518518|FG000|NOT COMPLETED|Overall Study||131
11321427|NCT02729831|12518526|FG000|STARTED|Baseline (Post Decision Aid, Pre-visit)||320
11321428|NCT02729831|12518527|FG001|STARTED|Baseline (Post Decision Aid, Pre-visit)||315
11321429|NCT02729831|12518528|FG002|STARTED|Baseline (Post Decision Aid, Pre-visit)||293
11321430|NCT02729831|12518529|FG003|STARTED|Baseline (Post Decision Aid, Pre-visit)||292
11321431|NCT02729831|12518526|FG000|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282
11321432|NCT02729831|12518527|FG001|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292
11321433|NCT02729831|12518528|FG002|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
11321434|NCT02729831|12518529|FG003|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
11321435|NCT02729831|12518526|FG000|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38
11321436|NCT02729831|12518527|FG001|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23
11321437|NCT02729831|12518528|FG002|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18
11321438|NCT02729831|12518529|FG003|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17
11321439|NCT02729831|12518526|FG000|STARTED|1 Week Post-visit||282
11321440|NCT02729831|12518527|FG001|STARTED|1 Week Post-visit||292
11321441|NCT02729831|12518528|FG002|STARTED|1 Week Post-visit||275
11321442|NCT02729831|12518529|FG003|STARTED|1 Week Post-visit||275
11321443|NCT02729831|12518526|FG000|COMPLETED|1 Week Post-visit||239
11321444|NCT02729831|12518527|FG001|COMPLETED|1 Week Post-visit||252
11321445|NCT02729831|12518528|FG002|COMPLETED|1 Week Post-visit||237
11321446|NCT02729831|12518529|FG003|COMPLETED|1 Week Post-visit||239
11321447|NCT02729831|12518526|FG000|NOT COMPLETED|1 Week Post-visit||43
11321448|NCT02729831|12518527|FG001|NOT COMPLETED|1 Week Post-visit||40
11321449|NCT02729831|12518528|FG002|NOT COMPLETED|1 Week Post-visit||38
11321450|NCT02729831|12518529|FG003|NOT COMPLETED|1 Week Post-visit||36
11321451|NCT02729831|12518526|FG000|STARTED|6 Month Follow-up||282
11321452|NCT02729831|12518527|FG001|STARTED|6 Month Follow-up||292
11321453|NCT02729831|12518528|FG002|STARTED|6 Month Follow-up||275
11321454|NCT02729831|12518529|FG003|STARTED|6 Month Follow-up||275
11321455|NCT02729831|12518526|FG000|COMPLETED|6 Month Follow-up||227
11321456|NCT02729831|12518527|FG001|COMPLETED|6 Month Follow-up||238
11321457|NCT02729831|12518528|FG002|COMPLETED|6 Month Follow-up||227
11321458|NCT02729831|12518529|FG003|COMPLETED|6 Month Follow-up||232
11321459|NCT02729831|12518526|FG000|NOT COMPLETED|6 Month Follow-up||55
11321460|NCT02729831|12518527|FG001|NOT COMPLETED|6 Month Follow-up||54
11321461|NCT02729831|12518528|FG002|NOT COMPLETED|6 Month Follow-up||48
11321462|NCT02729831|12518529|FG003|NOT COMPLETED|6 Month Follow-up||43
11321463|NCT02729896|12518542|FG000|STARTED|Overall Study||3
11321464|NCT02729896|12518543|FG001|STARTED|Overall Study||10
11321465|NCT02729896|12518544|FG002|STARTED|Overall Study||23
11321466|NCT02729896|12518542|FG000|COMPLETED|Overall Study||1
11321467|NCT02729896|12518543|FG001|COMPLETED|Overall Study||1
11321468|NCT02729896|12518544|FG002|COMPLETED|Overall Study||1
11321469|NCT02729896|12518542|FG000|NOT COMPLETED|Overall Study||2
11321470|NCT02729896|12518543|FG001|NOT COMPLETED|Overall Study||9
11321471|NCT02729896|12518544|FG002|NOT COMPLETED|Overall Study||22
11321472|NCT02729909|12518555|FG000|STARTED|Overall Study||105
11321473|NCT02729909|12518556|FG001|STARTED|Overall Study||106
11321474|NCT02729909|12518555|FG000|COMPLETED|Overall Study||104
11321475|NCT02729909|12518556|FG001|COMPLETED|Overall Study||101
11321476|NCT02729909|12518555|FG000|NOT COMPLETED|Overall Study||1
11321477|NCT02729909|12518556|FG001|NOT COMPLETED|Overall Study||5
11321478|NCT02730195|12518562|FG000|STARTED|Overall Study||9
11321479|NCT02730195|12518562|FG000|COMPLETED|Overall Study||8
11321480|NCT02730195|12518562|FG000|NOT COMPLETED|Overall Study||1
11321481|NCT02730208|12518568|FG000|STARTED|Overall Study||20
11321482|NCT02730208|12518569|FG001|STARTED|Overall Study||21
11321483|NCT02730208|12518568|FG000|COMPLETED|Overall Study||20
11321484|NCT02730208|12518569|FG001|COMPLETED|Overall Study||20
11321485|NCT02730208|12518568|FG000|NOT COMPLETED|Overall Study||0
11321486|NCT02730208|12518569|FG001|NOT COMPLETED|Overall Study||1
11321487|NCT02730234|12518575|FG000|STARTED|Overall Study||60
11321488|NCT02730234|12518575|FG000|COMPLETED|Overall Study|8 Deaths|52
11321489|NCT02730234|12518575|FG000|NOT COMPLETED|Overall Study||8
11321490|NCT02730247|12518579|FG000|STARTED|Overall Study||7
11321491|NCT02730247|12518579|FG000|COMPLETED|Overall Study||7
11321492|NCT02730247|12518579|FG000|NOT COMPLETED|Overall Study||0
11321493|NCT02730260|12518585|FG000|STARTED|Overall Study||258
11321494|NCT02730260|12518586|FG001|STARTED|Overall Study||260
11321495|NCT02730260|12518585|FG000|COMPLETED|Overall Study||176
11321496|NCT02730260|12518586|FG001|COMPLETED|Overall Study||185
11321497|NCT02730260|12518585|FG000|NOT COMPLETED|Overall Study||82
11321498|NCT02730260|12518586|FG001|NOT COMPLETED|Overall Study||75
11321499|NCT02730351|12518592|FG000|STARTED|Treatment Period 1 (2 Weeks)||37
11321500|NCT02730351|12518593|FG001|STARTED|Treatment Period 1 (2 Weeks)||37
11321501|NCT02730351|12518592|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||36
11321502|NCT02730351|12518593|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||37
11321503|NCT02730351|12518592|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
11321504|NCT02730351|12518593|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
11321505|NCT02730351|12518592|FG000|STARTED|Wash-out Period (2 Weeks)||36
11321506|NCT02730351|12518593|FG001|STARTED|Wash-out Period (2 Weeks)||37
11321507|NCT02730351|12518592|FG000|COMPLETED|Wash-out Period (2 Weeks)||35
11321508|NCT02730351|12518593|FG001|COMPLETED|Wash-out Period (2 Weeks)||36
11321509|NCT02730351|12518592|FG000|NOT COMPLETED|Wash-out Period (2 Weeks)||1
11321510|NCT02730351|12518593|FG001|NOT COMPLETED|Wash-out Period (2 Weeks)||1
11321511|NCT02730351|12518592|FG000|STARTED|Treatment Period 2 (2 Weeks)||35
11321512|NCT02730351|12518593|FG001|STARTED|Treatment Period 2 (2 Weeks)||36
11321513|NCT02730351|12518592|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||33
11321514|NCT02730351|12518593|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||36
11321515|NCT02730351|12518592|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
11321516|NCT02730351|12518593|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
11321517|NCT02730377|12518601|FG000|STARTED|Overall Study||996
11321518|NCT02730377|12518602|FG001|STARTED|Overall Study||995
11321519|NCT02730377|12518601|FG000|Treated|Overall Study||980
11321520|NCT02730377|12518602|FG001|Treated|Overall Study||984
11321521|NCT02730377|12518601|FG000|Full Analysis Set (FAS)|Overall Study||996
11321522|NCT02730377|12518602|FG001|Full Analysis Set (FAS)|Overall Study||995
11321523|NCT02730377|12518601|FG000|Safety Analysis Set (SAS)|Overall Study||980
11321524|NCT02730377|12518602|FG001|Safety Analysis Set (SAS)|Overall Study||984
11321525|NCT02730377|12518601|FG000|COMPLETED|Overall Study||446
11321526|NCT02730377|12518602|FG001|COMPLETED|Overall Study||362
11321527|NCT02730377|12518601|FG000|NOT COMPLETED|Overall Study||550
11321528|NCT02730377|12518602|FG001|NOT COMPLETED|Overall Study||633
11321529|NCT02730403|12518608|FG000|STARTED|Overall Study||211
11321530|NCT02730403|12518608|FG000|COMPLETED|Overall Study||157
11321531|NCT02730403|12518608|FG000|NOT COMPLETED|Overall Study||54
11321532|NCT02730455|12518616|FG000|STARTED|Overall Study||94
11321533|NCT02730455|12518617|FG001|STARTED|Overall Study||91
11321534|NCT02730455|12518618|FG002|STARTED|Overall Study||92
11321535|NCT02730455|12518616|FG000|Safety Population|Overall Study||91
11321536|NCT02730455|12518617|FG001|Safety Population|Overall Study||90
11321537|NCT02730455|12518618|FG002|Safety Population|Overall Study||89
11321538|NCT02730455|12518616|FG000|Participants Dosed|Overall Study||91
11321539|NCT02730455|12518617|FG001|Participants Dosed|Overall Study||88
11321540|NCT02730455|12518618|FG002|Participants Dosed|Overall Study||91
11321541|NCT02730455|12518616|FG000|Who Received Total Volume of Study Drug|Overall Study||90
11321542|NCT02730455|12518617|FG001|Who Received Total Volume of Study Drug|Overall Study||88
11321543|NCT02730455|12518618|FG002|Who Received Total Volume of Study Drug|Overall Study||89
11321544|NCT02730455|12518616|FG000|COMPLETED|Overall Study||81
11321545|NCT02730455|12518617|FG001|COMPLETED|Overall Study||77
11321546|NCT02730455|12518618|FG002|COMPLETED|Overall Study||81
11321547|NCT02730455|12518616|FG000|NOT COMPLETED|Overall Study||13
11321548|NCT02730455|12518617|FG001|NOT COMPLETED|Overall Study||14
11321549|NCT02730455|12518618|FG002|NOT COMPLETED|Overall Study||11
11321550|NCT02730598|12518628|FG000|STARTED|Overall Study||14
11321551|NCT02730598|12518629|FG001|STARTED|Overall Study||14
11321552|NCT02730598|12518628|FG000|COMPLETED|Overall Study||10
11321553|NCT02730598|12518629|FG001|COMPLETED|Overall Study||10
11321554|NCT02730598|12518628|FG000|NOT COMPLETED|Overall Study||4
11321555|NCT02730598|12518629|FG001|NOT COMPLETED|Overall Study||4
11321556|NCT02730663|12518635|FG000|STARTED|Overall Study||36
11321557|NCT02730663|12518635|FG000|COMPLETED|Overall Study||35
11321558|NCT02730663|12518635|FG000|NOT COMPLETED|Overall Study||1
11321559|NCT02730728|12518642|FG000|STARTED|Overall Study||53
11321560|NCT02730728|12518643|FG001|STARTED|Overall Study||53
11321561|NCT02730728|12518644|FG002|STARTED|Overall Study||53
11321562|NCT02730728|12518642|FG000|COMPLETED|Overall Study||53
11321563|NCT02730728|12518643|FG001|COMPLETED|Overall Study||51
11321564|NCT02730728|12518644|FG002|COMPLETED|Overall Study||52
11321565|NCT02730728|12518642|FG000|NOT COMPLETED|Overall Study||0
11321566|NCT02730728|12518643|FG001|NOT COMPLETED|Overall Study||2
11321567|NCT02730728|12518644|FG002|NOT COMPLETED|Overall Study||1
11321568|NCT02730819|12518652|FG000|STARTED|Overall Study||19
11321569|NCT02730819|12518652|FG000|Follow-up Week 2|Overall Study||15
11321570|NCT02730819|12518652|FG000|Follow-up Week 4|Overall Study||16
11321571|NCT02730819|12518652|FG000|Follow-up Week 8|Overall Study||14
11321572|NCT02730819|12518652|FG000|Follow-up Week 12|Overall Study||11
11321573|NCT02730819|12518652|FG000|Follow-up Week 16|Overall Study||11
11321574|NCT02730819|12518652|FG000|Follow-up Week 20|Overall Study||10
11321575|NCT02730819|12518652|FG000|COMPLETED|Overall Study||10
11321576|NCT02730819|12518652|FG000|NOT COMPLETED|Overall Study||9
11321577|NCT02730871|12518658|FG000|STARTED|Overall Study||67
11321578|NCT02730871|12518659|FG001|STARTED|Overall Study||67
11321579|NCT02730871|12518658|FG000|Full Analysis Set (FAS)|Overall Study||67
11321580|NCT02730871|12518659|FG001|Full Analysis Set (FAS)|Overall Study||67
11321581|NCT02730871|12518658|FG000|Safety Analysis Set|Overall Study||67
11321582|NCT02730871|12518659|FG001|Safety Analysis Set|Overall Study||67
11321583|NCT02730871|12518658|FG000|COMPLETED|Overall Study||61
11321584|NCT02730871|12518659|FG001|COMPLETED|Overall Study||67
11321585|NCT02730871|12518658|FG000|NOT COMPLETED|Overall Study||6
11321586|NCT02730871|12518659|FG001|NOT COMPLETED|Overall Study||0
11321587|NCT02730884|12518665|FG000|STARTED|Overall Study||3
11321588|NCT02730884|12518665|FG000|COMPLETED|Overall Study||3
11321589|NCT02730884|12518665|FG000|NOT COMPLETED|Overall Study||0
11321590|NCT02730962|12518671|FG000|STARTED|Overall Study||7
11321591|NCT02730962|12518672|FG001|STARTED|Overall Study||5
11321592|NCT02730962|12518671|FG000|COMPLETED|Overall Study||7
11321593|NCT02730962|12518672|FG001|COMPLETED|Overall Study||5
11321594|NCT02730962|12518671|FG000|NOT COMPLETED|Overall Study||0
11321595|NCT02730962|12518672|FG001|NOT COMPLETED|Overall Study||0
11321596|NCT02730988|12518680|FG000|STARTED|Overall Study||47
11321597|NCT02730988|12518681|FG001|STARTED|Overall Study||49
11321598|NCT02730988|12518680|FG000|COMPLETED|Overall Study||43
11321599|NCT02730988|12518681|FG001|COMPLETED|Overall Study||39
11321600|NCT02730988|12518680|FG000|NOT COMPLETED|Overall Study||4
11321601|NCT02730988|12518681|FG001|NOT COMPLETED|Overall Study||10
11321602|NCT02731131|12518689|FG000|STARTED|Overall Study||6
11321603|NCT02731131|12518690|FG001|STARTED|Overall Study||6
11321604|NCT02731131|12518689|FG000|COMPLETED|Overall Study||6
11321605|NCT02731131|12518690|FG001|COMPLETED|Overall Study||4
11321606|NCT02731131|12518689|FG000|NOT COMPLETED|Overall Study||0
11321607|NCT02731131|12518690|FG001|NOT COMPLETED|Overall Study||2
11402909|NCT04022668|12597863|FG000|NOT COMPLETED|Overall Study||14
11402910|NCT04022668|12597864|FG001|NOT COMPLETED|Overall Study||27
11402911|NCT04022668|12597865|FG002|NOT COMPLETED|Overall Study||0
11402912|NCT04020822|12597873|FG000|STARTED|Overall Study||19
11402913|NCT04020822|12597873|FG000|COMPLETED|Overall Study||19
11402914|NCT04020822|12597873|FG000|NOT COMPLETED|Overall Study||0
11402915|NCT04019990|12597877|FG000|STARTED|Overall Study||13
11402916|NCT04019990|12597878|FG001|STARTED|Overall Study||15
11402917|NCT04019990|12597877|FG000|COMPLETED|Overall Study||12
11402918|NCT04019990|12597878|FG001|COMPLETED|Overall Study||12
11402919|NCT04019990|12597877|FG000|NOT COMPLETED|Overall Study||1
11402920|NCT04019990|12597878|FG001|NOT COMPLETED|Overall Study||3
11321608|NCT02731157|12518696|FG000|STARTED|First Standard RCE||4
11321609|NCT02731157|12518696|FG000|COMPLETED|First Standard RCE||4
11321610|NCT02731157|12518696|FG000|NOT COMPLETED|First Standard RCE||0
11321611|NCT02731157|12518696|FG000|STARTED|First Rejuvenated RCE||4
11321612|NCT02731157|12518696|FG000|COMPLETED|First Rejuvenated RCE||3
11321613|NCT02731157|12518696|FG000|NOT COMPLETED|First Rejuvenated RCE||1
11321614|NCT02731157|12518696|FG000|STARTED|Second Rejuvenated RCE||3
11321615|NCT02731157|12518696|FG000|COMPLETED|Second Rejuvenated RCE||3
11321616|NCT02731157|12518696|FG000|NOT COMPLETED|Second Rejuvenated RCE||0
11321617|NCT02731157|12518696|FG000|STARTED|Third Rejuvenated RCE||3
11321618|NCT02731157|12518696|FG000|COMPLETED|Third Rejuvenated RCE||3
11321619|NCT02731157|12518696|FG000|NOT COMPLETED|Third Rejuvenated RCE||0
11321620|NCT02731157|12518696|FG000|STARTED|Second Standard RCE||3
11321621|NCT02731157|12518696|FG000|COMPLETED|Second Standard RCE||3
11321622|NCT02731157|12518696|FG000|NOT COMPLETED|Second Standard RCE||0
11321623|NCT02731157|12518696|FG000|STARTED|Third Standard RCE||3
11321624|NCT02731157|12518696|FG000|COMPLETED|Third Standard RCE||3
11321625|NCT02731157|12518696|FG000|NOT COMPLETED|Third Standard RCE||0
11321626|NCT02731300|12518704|FG000|STARTED|Overall Study||15
11321627|NCT02731300|12518705|FG001|STARTED|Overall Study||7
11321628|NCT02731300|12518704|FG000|COMPLETED|Overall Study||15
11321629|NCT02731300|12518705|FG001|COMPLETED|Overall Study||7
11321630|NCT02731300|12518704|FG000|NOT COMPLETED|Overall Study||0
11321631|NCT02731300|12518705|FG001|NOT COMPLETED|Overall Study||0
11321632|NCT02731313|12518711|FG000|STARTED|Overall Study||367
11321633|NCT02731313|12518711|FG000|COMPLETED|Overall Study||367
11321634|NCT02731313|12518711|FG000|NOT COMPLETED|Overall Study||0
11321635|NCT02731469|12518726|FG000|STARTED|Overall Study||3
11321636|NCT02731469|12518727|FG001|STARTED|Overall Study||3
11321637|NCT02731469|12518728|FG002|STARTED|Overall Study||3
11321638|NCT02731469|12518729|FG003|STARTED|Overall Study||3
11321639|NCT02731469|12518730|FG004|STARTED|Overall Study||3
11321640|NCT02731469|12518731|FG005|STARTED|Overall Study||3
11321641|NCT02731469|12518732|FG006|STARTED|Overall Study||3
11321642|NCT02731469|12518733|FG007|STARTED|Overall Study||6
11321643|NCT02731469|12518734|FG008|STARTED|Overall Study||6
11321644|NCT02731469|12518735|FG009|STARTED|Overall Study||6
11321645|NCT02731469|12518736|FG010|STARTED|Overall Study||6
11321646|NCT02731469|12518726|FG000|COMPLETED|Overall Study||3
11321647|NCT02731469|12518727|FG001|COMPLETED|Overall Study||3
11321648|NCT02731469|12518728|FG002|COMPLETED|Overall Study||3
11321649|NCT02731469|12518729|FG003|COMPLETED|Overall Study||3
11321650|NCT02731469|12518730|FG004|COMPLETED|Overall Study||3
11321651|NCT02731469|12518731|FG005|COMPLETED|Overall Study||3
11321652|NCT02731469|12518732|FG006|COMPLETED|Overall Study||3
11321653|NCT02731469|12518733|FG007|COMPLETED|Overall Study||6
11321654|NCT02731469|12518734|FG008|COMPLETED|Overall Study||6
11402921|NCT04017611|12597884|FG000|STARTED|Overall Study||13
11402922|NCT04017611|12597884|FG000|COMPLETED|Overall Study||12
11321655|NCT02731469|12518735|FG009|COMPLETED|Overall Study||6
11321656|NCT02731469|12518736|FG010|COMPLETED|Overall Study||6
11321657|NCT02731469|12518726|FG000|NOT COMPLETED|Overall Study||0
11321658|NCT02731469|12518727|FG001|NOT COMPLETED|Overall Study||0
11321659|NCT02731469|12518728|FG002|NOT COMPLETED|Overall Study||0
11321660|NCT02731469|12518729|FG003|NOT COMPLETED|Overall Study||0
11321661|NCT02731469|12518730|FG004|NOT COMPLETED|Overall Study||0
11321662|NCT02731469|12518731|FG005|NOT COMPLETED|Overall Study||0
11321663|NCT02731469|12518732|FG006|NOT COMPLETED|Overall Study||0
11321664|NCT02731469|12518733|FG007|NOT COMPLETED|Overall Study||0
11321665|NCT02731469|12518734|FG008|NOT COMPLETED|Overall Study||0
11321666|NCT02731469|12518735|FG009|NOT COMPLETED|Overall Study||0
11321667|NCT02731469|12518736|FG010|NOT COMPLETED|Overall Study||0
11321668|NCT02731638|12518762|FG000|STARTED|Overall Study||35
11321669|NCT02731638|12518763|FG001|STARTED|Overall Study||35
11321670|NCT02731638|12518762|FG000|COMPLETED|Overall Study||29
11321671|NCT02731638|12518763|FG001|COMPLETED|Overall Study||26
11321672|NCT02731638|12518762|FG000|NOT COMPLETED|Overall Study||6
11321673|NCT02731638|12518763|FG001|NOT COMPLETED|Overall Study||9
11321674|NCT02731690|12518769|FG000|STARTED|Overall Study||42
11321675|NCT02731690|12518769|FG000|COMPLETED|Overall Study||12
11321676|NCT02731690|12518769|FG000|NOT COMPLETED|Overall Study||30
11321677|NCT02731729|12518775|FG000|STARTED|Overall Study||10
11321678|NCT02731729|12518776|FG001|STARTED|Overall Study||10
11321679|NCT02731729|12518775|FG000|COMPLETED|Overall Study||1
11321680|NCT02731729|12518776|FG001|COMPLETED|Overall Study||2
11321681|NCT02731729|12518775|FG000|NOT COMPLETED|Overall Study||9
11321682|NCT02731729|12518776|FG001|NOT COMPLETED|Overall Study||8
11321683|NCT02731742|12518786|FG000|STARTED|Overall Study||3
11321684|NCT02731742|12518787|FG001|STARTED|Overall Study||3
11321685|NCT02731742|12518788|FG002|STARTED|Overall Study||6
11321686|NCT02731742|12518789|FG003|STARTED|Overall Study||2
11321687|NCT02731742|12518786|FG000|COMPLETED|Overall Study||0
11321688|NCT02731742|12518787|FG001|COMPLETED|Overall Study||0
11321689|NCT02731742|12518788|FG002|COMPLETED|Overall Study||0
11321690|NCT02731742|12518789|FG003|COMPLETED|Overall Study||0
11321691|NCT02731742|12518786|FG000|NOT COMPLETED|Overall Study||3
11321692|NCT02731742|12518787|FG001|NOT COMPLETED|Overall Study||3
11321693|NCT02731742|12518788|FG002|NOT COMPLETED|Overall Study||6
11321694|NCT02731742|12518789|FG003|NOT COMPLETED|Overall Study||2
11321695|NCT02731755|12518799|FG000|STARTED|First Intervention||8
11321696|NCT02731755|12518800|FG001|STARTED|First Intervention||10
11321697|NCT02731755|12518799|FG000|COMPLETED|First Intervention||8
11321698|NCT02731755|12518800|FG001|COMPLETED|First Intervention||8
11321699|NCT02731755|12518799|FG000|NOT COMPLETED|First Intervention||0
11321700|NCT02731755|12518800|FG001|NOT COMPLETED|First Intervention||2
11321701|NCT02731755|12518799|FG000|STARTED|Second Intervention||8
11321702|NCT02731755|12518800|FG001|STARTED|Second Intervention||8
11321703|NCT02731755|12518799|FG000|COMPLETED|Second Intervention||8
11321704|NCT02731755|12518800|FG001|COMPLETED|Second Intervention||8
11321705|NCT02731755|12518799|FG000|NOT COMPLETED|Second Intervention||0
11321706|NCT02731755|12518800|FG001|NOT COMPLETED|Second Intervention||0
11321707|NCT02731820|12518808|FG000|STARTED|Overall Study||20
11321708|NCT02731820|12518809|FG001|STARTED|Overall Study||20
11321709|NCT02731820|12518808|FG000|COMPLETED|Overall Study||17
11321710|NCT02731820|12518809|FG001|COMPLETED|Overall Study||18
11321711|NCT02731820|12518808|FG000|NOT COMPLETED|Overall Study||3
11321712|NCT02731820|12518809|FG001|NOT COMPLETED|Overall Study||2
11321713|NCT02731833|12518817|FG000|STARTED|Overall Study||111
11321714|NCT02731833|12518818|FG001|STARTED|Overall Study||111
11321715|NCT02731833|12518817|FG000|COMPLETED|Overall Study||111
11321716|NCT02731833|12518818|FG001|COMPLETED|Overall Study||111
11321717|NCT02731833|12518817|FG000|NOT COMPLETED|Overall Study||0
11321718|NCT02731833|12518818|FG001|NOT COMPLETED|Overall Study||0
11321719|NCT02732015|12518826|FG000|STARTED|Overall Study||9
11321720|NCT02732015|12518827|FG001|STARTED|Overall Study||27
11321721|NCT02732015|12518826|FG000|COMPLETED|Overall Study||9
11321722|NCT02732015|12518827|FG001|COMPLETED|Overall Study||26
11321723|NCT02732015|12518826|FG000|NOT COMPLETED|Overall Study||0
11321724|NCT02732015|12518827|FG001|NOT COMPLETED|Overall Study||1
11321725|NCT02732119|12518838|FG000|STARTED|Phase I||8
11321726|NCT02732119|12518839|FG001|STARTED|Phase I||10
11321727|NCT02732119|12518840|FG002|STARTED|Phase I||7
11321728|NCT02732119|12518841|FG003|STARTED|Phase I||0
11321729|NCT02732119|12518842|FG004|STARTED|Phase I||0
11321730|NCT02732119|12518838|FG000|COMPLETED|Phase I||0
11321731|NCT02732119|12518839|FG001|COMPLETED|Phase I||0
11321732|NCT02732119|12518840|FG002|COMPLETED|Phase I||0
11321733|NCT02732119|12518841|FG003|COMPLETED|Phase I||0
11321734|NCT02732119|12518842|FG004|COMPLETED|Phase I||0
11321735|NCT02732119|12518838|FG000|NOT COMPLETED|Phase I||8
11321736|NCT02732119|12518839|FG001|NOT COMPLETED|Phase I||10
11321737|NCT02732119|12518840|FG002|NOT COMPLETED|Phase I||7
11321738|NCT02732119|12518841|FG003|NOT COMPLETED|Phase I||0
11321739|NCT02732119|12518842|FG004|NOT COMPLETED|Phase I||0
11321740|NCT02732119|12518838|FG000|STARTED|Phase II||0
11321741|NCT02732119|12518839|FG001|STARTED|Phase II||0
11321742|NCT02732119|12518840|FG002|STARTED|Phase II||0
11321743|NCT02732119|12518841|FG003|STARTED|Phase II||46
11321744|NCT02732119|12518842|FG004|STARTED|Phase II||33
11321745|NCT02732119|12518838|FG000|Protocol Analysis Set|Phase II||0
11321746|NCT02732119|12518839|FG001|Protocol Analysis Set|Phase II||0
11321747|NCT02732119|12518840|FG002|Protocol Analysis Set|Phase II||0
11321748|NCT02732119|12518841|FG003|Protocol Analysis Set|Phase II||46
11321749|NCT02732119|12518842|FG004|Protocol Analysis Set|Phase II||32
11321750|NCT02732119|12518838|FG000|COMPLETED|Phase II||0
11321751|NCT02732119|12518839|FG001|COMPLETED|Phase II||0
11321752|NCT02732119|12518840|FG002|COMPLETED|Phase II||0
11321753|NCT02732119|12518841|FG003|COMPLETED|Phase II||0
11321754|NCT02732119|12518842|FG004|COMPLETED|Phase II||0
11321755|NCT02732119|12518838|FG000|NOT COMPLETED|Phase II||0
11321756|NCT02732119|12518839|FG001|NOT COMPLETED|Phase II||0
11321757|NCT02732119|12518840|FG002|NOT COMPLETED|Phase II||0
11321758|NCT02732119|12518841|FG003|NOT COMPLETED|Phase II||46
11321759|NCT02732119|12518842|FG004|NOT COMPLETED|Phase II||33
11321760|NCT02732145|12518858|FG000|STARTED|Overall Study||82
11321761|NCT02732145|12518859|FG001|STARTED|Overall Study||82
11321762|NCT02732145|12518860|FG002|STARTED|Overall Study||82
11321763|NCT02732145|12518861|FG003|STARTED|Overall Study||82
11321764|NCT02732145|12518858|FG000|COMPLETED|Overall Study||82
11321765|NCT02732145|12518859|FG001|COMPLETED|Overall Study||82
11321766|NCT02732145|12518860|FG002|COMPLETED|Overall Study||82
11321767|NCT02732145|12518861|FG003|COMPLETED|Overall Study||82
11321768|NCT02732145|12518858|FG000|NOT COMPLETED|Overall Study||0
11321769|NCT02732145|12518859|FG001|NOT COMPLETED|Overall Study||0
11321770|NCT02732145|12518860|FG002|NOT COMPLETED|Overall Study||0
11321771|NCT02732145|12518861|FG003|NOT COMPLETED|Overall Study||0
11321772|NCT02732210|12518893|FG000|STARTED|Overall Study||303
11321773|NCT02732210|12518894|FG001|STARTED|Overall Study||632
11321774|NCT02732210|12518893|FG000|COMPLETED|Overall Study||218
11321775|NCT02732210|12518894|FG001|COMPLETED|Overall Study||338
11321776|NCT02732210|12518893|FG000|NOT COMPLETED|Overall Study||85
11321777|NCT02732210|12518894|FG001|NOT COMPLETED|Overall Study||294
11321778|NCT02732366|12518902|FG000|STARTED|Overall Study||23
11321779|NCT02732366|12518903|FG001|STARTED|Overall Study||23
11321780|NCT02732366|12518902|FG000|Withdrawal by Participant|Overall Study||5
11321781|NCT02732366|12518903|FG001|Withdrawal by Participant|Overall Study||2
11321782|NCT02732366|12518902|FG000|COMPLETED|Overall Study||18
11321783|NCT02732366|12518903|FG001|COMPLETED|Overall Study||21
11321784|NCT02732366|12518902|FG000|NOT COMPLETED|Overall Study||5
11321785|NCT02732366|12518903|FG001|NOT COMPLETED|Overall Study||2
11321786|NCT02732561|12518914|FG000|STARTED|Overall Study||5
11321787|NCT02732561|12518915|FG001|STARTED|Overall Study||5
11321788|NCT02732561|12518914|FG000|COMPLETED|Overall Study||3
11321789|NCT02732561|12518915|FG001|COMPLETED|Overall Study||4
11321790|NCT02732561|12518914|FG000|NOT COMPLETED|Overall Study||2
11321791|NCT02732561|12518915|FG001|NOT COMPLETED|Overall Study||1
11321792|NCT02732587|12518921|FG000|STARTED|Overall Study||5
11321793|NCT02732587|12518921|FG000|COMPLETED|Overall Study||5
11321794|NCT02732587|12518921|FG000|NOT COMPLETED|Overall Study||0
11321795|NCT02732600|12518927|FG000|STARTED|Overall Study||3525
11321796|NCT02732600|12518928|FG001|STARTED|Overall Study||2091
11321797|NCT02732600|12518927|FG000|Sub-set of Sites Newly Delivering PS Services|Overall Study||899
11321798|NCT02732600|12518928|FG001|Sub-set of Sites Newly Delivering PS Services|Overall Study||1484
11321799|NCT02732600|12518927|FG000|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||118
11321800|NCT02732600|12518928|FG001|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||145
11321801|NCT02732600|12518927|FG000|Veteran 6-months (Sub-set 23 Sites)|Overall Study||70
11321802|NCT02732600|12518928|FG001|Veteran 6-months (Sub-set 23 Sites)|Overall Study||84
11321803|NCT02732600|12518927|FG000|Veteran 1-year (Sub-set 23 Sites)|Overall Study||54
11321804|NCT02732600|12518928|FG001|Veteran 1-year (Sub-set 23 Sites)|Overall Study||71
11321805|NCT02732600|12518927|FG000|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||12
11321806|NCT02732600|12518928|FG001|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||14
11321807|NCT02732600|12518927|FG000|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||5
11321808|NCT02732600|12518928|FG001|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||12
11321809|NCT02732600|12518927|FG000|Supervisor Responses 6-months (All 25 Sites)|Overall Study||10
11321810|NCT02732600|12518928|FG001|Supervisor Responses 6-months (All 25 Sites)|Overall Study||21
11321811|NCT02732600|12518927|FG000|Supervisor 1-year (All 25 Sites)|Overall Study||6
11321812|NCT02732600|12518928|FG001|Supervisor 1-year (All 25 Sites)|Overall Study||10
11321813|NCT02732600|12518927|FG000|COMPLETED|Overall Study||100
11321814|NCT02732600|12518928|FG001|COMPLETED|Overall Study||113
11321815|NCT02732600|12518927|FG000|NOT COMPLETED|Overall Study||3425
11321816|NCT02732600|12518928|FG001|NOT COMPLETED|Overall Study||1978
11321817|NCT02732639|12518935|FG000|STARTED|Overall Study||31
11321818|NCT02732639|12518935|FG000|COMPLETED|Overall Study||30
11321819|NCT02732639|12518935|FG000|NOT COMPLETED|Overall Study||1
11321820|NCT02732847|12518941|FG000|STARTED|Overall Study||75
11321821|NCT02732847|12518942|FG001|STARTED|Overall Study||74
11321822|NCT02732847|12518941|FG000|COMPLETED|Overall Study||33
11321823|NCT02732847|12518942|FG001|COMPLETED|Overall Study||32
11321824|NCT02732847|12518941|FG000|NOT COMPLETED|Overall Study||42
11321825|NCT02732847|12518942|FG001|NOT COMPLETED|Overall Study||42
11321826|NCT02732899|12518950|FG000|STARTED|Overall Study||10
11321827|NCT02732899|12518951|FG001|STARTED|Overall Study||10
11321828|NCT02732899|12518950|FG000|COMPLETED|Overall Study||10
11321829|NCT02732899|12518951|FG001|COMPLETED|Overall Study||10
11321830|NCT02732899|12518950|FG000|NOT COMPLETED|Overall Study||0
11321831|NCT02732899|12518951|FG001|NOT COMPLETED|Overall Study||0
11321832|NCT02732912|12518959|FG000|STARTED|Overall Study||97
11321833|NCT02732912|12518960|FG001|STARTED|Overall Study||109
11321834|NCT02732912|12518959|FG000|COMPLETED|Overall Study||87
11321835|NCT02732912|12518960|FG001|COMPLETED|Overall Study||91
11321836|NCT02732912|12518959|FG000|NOT COMPLETED|Overall Study||10
11321837|NCT02732912|12518960|FG001|NOT COMPLETED|Overall Study||18
11321838|NCT02732938|12518968|FG000|STARTED|Overall Study||4
11321839|NCT02732938|12518969|FG001|STARTED|Overall Study||18
11321840|NCT02732938|12518970|FG002|STARTED|Overall Study||0
11321841|NCT02732938|12518968|FG000|Received Treatment|Overall Study||4
11321842|NCT02732938|12518969|FG001|Received Treatment|Overall Study||17
11321843|NCT02732938|12518970|FG002|Received Treatment|Overall Study||0
11321844|NCT02732938|12518968|FG000|COMPLETED|Overall Study||0
11321845|NCT02732938|12518969|FG001|COMPLETED|Overall Study||0
11321846|NCT02732938|12518970|FG002|COMPLETED|Overall Study||0
11321847|NCT02732938|12518968|FG000|NOT COMPLETED|Overall Study||4
11321848|NCT02732938|12518969|FG001|NOT COMPLETED|Overall Study||18
11321849|NCT02732938|12518970|FG002|NOT COMPLETED|Overall Study||0
11321850|NCT02732951|12518980|FG000|STARTED|Overall Study||53
11321851|NCT02732951|12518981|FG001|STARTED|Overall Study||52
11321852|NCT02732951|12518980|FG000|COMPLETED|Overall Study||48
11321853|NCT02732951|12518981|FG001|COMPLETED|Overall Study||46
11321854|NCT02732951|12518980|FG000|NOT COMPLETED|Overall Study||5
11321855|NCT02732951|12518981|FG001|NOT COMPLETED|Overall Study||6
11321856|NCT02733367|12518987|FG000|STARTED|Overall Study||18
11321857|NCT02733367|12518987|FG000|COMPLETED|Overall Study||12
11321858|NCT02733367|12518987|FG000|NOT COMPLETED|Overall Study||6
11321859|NCT02733588|12518992|FG000|STARTED|Overall Study||7
11321860|NCT02733588|12518992|FG000|COMPLETED|Overall Study||7
11321861|NCT02733588|12518992|FG000|NOT COMPLETED|Overall Study||0
11321862|NCT02733627|12519000|FG000|STARTED|Overall Study||9
11321863|NCT02733627|12519001|FG001|STARTED|Overall Study||9
11321864|NCT02733627|12519002|FG002|STARTED|Overall Study||9
11321865|NCT02733627|12519003|FG003|STARTED|Overall Study||9
11321866|NCT02733627|12519000|FG000|COMPLETED|Overall Study||9
11321867|NCT02733627|12519001|FG001|COMPLETED|Overall Study||8
11321868|NCT02733627|12519002|FG002|COMPLETED|Overall Study||7
11321869|NCT02733627|12519003|FG003|COMPLETED|Overall Study||9
11321870|NCT02733627|12519000|FG000|NOT COMPLETED|Overall Study||0
11321871|NCT02733627|12519001|FG001|NOT COMPLETED|Overall Study||1
11321872|NCT02733627|12519002|FG002|NOT COMPLETED|Overall Study||2
11321873|NCT02733627|12519003|FG003|NOT COMPLETED|Overall Study||0
11321874|NCT02733653|12519013|FG000|STARTED|Overall Study||50
11321875|NCT02733653|12519013|FG000|COMPLETED|Overall Study||49
11321876|NCT02733653|12519013|FG000|NOT COMPLETED|Overall Study||1
11321877|NCT02733757|12519021|FG000|STARTED|Overall Study||20
11321878|NCT02733757|12519022|FG001|STARTED|Overall Study||20
11321879|NCT02733757|12519023|FG002|STARTED|Overall Study||20
11321880|NCT02733757|12519024|FG003|STARTED|Overall Study||20
11321881|NCT02733757|12519021|FG000|COMPLETED|Overall Study||20
11321882|NCT02733757|12519022|FG001|COMPLETED|Overall Study||20
11321883|NCT02733757|12519023|FG002|COMPLETED|Overall Study||20
11321884|NCT02733757|12519024|FG003|COMPLETED|Overall Study||20
11321885|NCT02733757|12519021|FG000|NOT COMPLETED|Overall Study||0
11321886|NCT02733757|12519022|FG001|NOT COMPLETED|Overall Study||0
11321887|NCT02733757|12519023|FG002|NOT COMPLETED|Overall Study||0
11321888|NCT02733757|12519024|FG003|NOT COMPLETED|Overall Study||0
11321889|NCT02733991|12519036|FG000|STARTED|Overall Study||76
11321890|NCT02733991|12519037|FG001|STARTED|Overall Study||77
11321891|NCT02733991|12519036|FG000|COMPLETED|Overall Study||75
11321892|NCT02733991|12519037|FG001|COMPLETED|Overall Study||72
11321893|NCT02733991|12519036|FG000|NOT COMPLETED|Overall Study||1
11321894|NCT02733991|12519037|FG001|NOT COMPLETED|Overall Study||5
11321895|NCT02734056|12519045|FG000|STARTED|Overall Study||50
11321896|NCT02734056|12519046|FG001|STARTED|Overall Study||50
11321897|NCT02734056|12519045|FG000|COMPLETED|Overall Study||50
11321898|NCT02734056|12519046|FG001|COMPLETED|Overall Study||49
11321899|NCT02734056|12519045|FG000|NOT COMPLETED|Overall Study||0
11321900|NCT02734056|12519046|FG001|NOT COMPLETED|Overall Study||1
11321901|NCT02734147|12519054|FG000|STARTED|Overall Study||12
11321902|NCT02734147|12519055|FG001|STARTED|Overall Study||12
11321903|NCT02734147|12519054|FG000|COMPLETED|Overall Study||9
11321904|NCT02734147|12519055|FG001|COMPLETED|Overall Study||11
11321905|NCT02734147|12519054|FG000|NOT COMPLETED|Overall Study||3
11321906|NCT02734147|12519055|FG001|NOT COMPLETED|Overall Study||1
11321907|NCT02734212|12519063|FG000|STARTED|Overall Study||29
11321908|NCT02734212|12519064|FG001|STARTED|Overall Study||28
11321909|NCT02734212|12519063|FG000|COMPLETED|Overall Study||24
11321910|NCT02734212|12519064|FG001|COMPLETED|Overall Study||18
11321911|NCT02734212|12519063|FG000|NOT COMPLETED|Overall Study||5
11321912|NCT02734212|12519064|FG001|NOT COMPLETED|Overall Study||10
11321913|NCT02734238|12519073|FG000|STARTED|Overall Study||26
11321914|NCT02734238|12519074|FG001|STARTED|Overall Study||24
11321915|NCT02734238|12519073|FG000|COMPLETED|Overall Study||26
11321916|NCT02734238|12519074|FG001|COMPLETED|Overall Study||24
11321917|NCT02734238|12519073|FG000|NOT COMPLETED|Overall Study||0
11321918|NCT02734238|12519074|FG001|NOT COMPLETED|Overall Study||0
11321919|NCT02734355|12519082|FG000|STARTED|Overall Study||34
11321920|NCT02734355|12519083|FG001|STARTED|Overall Study||30
11321921|NCT02734355|12519082|FG000|COMPLETED|Overall Study||34
11321922|NCT02734355|12519083|FG001|COMPLETED|Overall Study||30
11321923|NCT02734355|12519082|FG000|NOT COMPLETED|Overall Study||0
11321924|NCT02734355|12519083|FG001|NOT COMPLETED|Overall Study||0
11321925|NCT02734498|12519092|FG000|STARTED|Overall Study||2
11321926|NCT02734498|12519093|FG001|STARTED|Overall Study||0
11321927|NCT02734498|12519094|FG002|STARTED|Overall Study||0
11321928|NCT02734498|12519092|FG000|COMPLETED|Overall Study||2
11321929|NCT02734498|12519093|FG001|COMPLETED|Overall Study||0
11321930|NCT02734498|12519094|FG002|COMPLETED|Overall Study||0
11321931|NCT02734498|12519092|FG000|NOT COMPLETED|Overall Study||0
11321932|NCT02734498|12519093|FG001|NOT COMPLETED|Overall Study||0
11321933|NCT02734498|12519094|FG002|NOT COMPLETED|Overall Study||0
11321934|NCT02734576|12519102|FG000|STARTED|Overall Study||10
11321935|NCT02734576|12519102|FG000|COMPLETED|Overall Study||10
11321936|NCT02734576|12519102|FG000|NOT COMPLETED|Overall Study||0
11321937|NCT02734693|12519109|FG000|STARTED|Overall Study||56
11321938|NCT02734693|12519110|FG001|STARTED|Overall Study||56
11321939|NCT02734693|12519111|FG002|STARTED|Overall Study||20
11321940|NCT02734693|12519109|FG000|COMPLETED|Overall Study||50
11321941|NCT02734693|12519110|FG001|COMPLETED|Overall Study||53
11321942|NCT02734693|12519111|FG002|COMPLETED|Overall Study||17
11321943|NCT02734693|12519109|FG000|NOT COMPLETED|Overall Study||6
11321944|NCT02734693|12519110|FG001|NOT COMPLETED|Overall Study||3
11321945|NCT02734693|12519111|FG002|NOT COMPLETED|Overall Study||3
11321946|NCT02734810|12519121|FG000|STARTED|Overall Study||15
11321947|NCT02734810|12519122|FG001|STARTED|Overall Study||0
11321948|NCT02734810|12519121|FG000|COMPLETED|Overall Study||13
11321949|NCT02734810|12519122|FG001|COMPLETED|Overall Study||0
11402923|NCT04017611|12597884|FG000|NOT COMPLETED|Overall Study||1
11321950|NCT02734810|12519121|FG000|NOT COMPLETED|Overall Study||2
11321951|NCT02734810|12519122|FG001|NOT COMPLETED|Overall Study||0
11321952|NCT02734849|12519131|FG000|STARTED|Overall Study|One patient was randomized but never received study treatment and excluded from all analysis sets.|16
11321953|NCT02734849|12519132|FG001|STARTED|Overall Study||14
11321954|NCT02734849|12519133|FG002|STARTED|Overall Study||10
11321955|NCT02734849|12519131|FG000|COMPLETED|Overall Study||12
11321956|NCT02734849|12519132|FG001|COMPLETED|Overall Study||14
11321957|NCT02734849|12519133|FG002|COMPLETED|Overall Study||9
11321958|NCT02734849|12519131|FG000|NOT COMPLETED|Overall Study||4
11321959|NCT02734849|12519132|FG001|NOT COMPLETED|Overall Study||0
11321960|NCT02734849|12519133|FG002|NOT COMPLETED|Overall Study||1
11321961|NCT02734862|12519144|FG000|STARTED|Part A||35
11321962|NCT02734862|12519145|FG001|STARTED|Part A||36
11321963|NCT02734862|12519146|FG002|STARTED|Part A||36
11321964|NCT02734862|12519144|FG000|COMPLETED|Part A||23
11321965|NCT02734862|12519145|FG001|COMPLETED|Part A||28
11321966|NCT02734862|12519146|FG002|COMPLETED|Part A||22
11321967|NCT02734862|12519144|FG000|NOT COMPLETED|Part A||12
11321968|NCT02734862|12519145|FG001|NOT COMPLETED|Part A||8
11321969|NCT02734862|12519146|FG002|NOT COMPLETED|Part A||14
11321970|NCT02734862|12519144|FG000|STARTED|Part B||46
11321971|NCT02734862|12519145|FG001|STARTED|Part B||21
11321972|NCT02734862|12519146|FG002|STARTED|Part B||33
11321973|NCT02734862|12519144|FG000|COMPLETED|Part B||33
11321974|NCT02734862|12519145|FG001|COMPLETED|Part B||14
11321975|NCT02734862|12519146|FG002|COMPLETED|Part B||28
11321976|NCT02734862|12519144|FG000|NOT COMPLETED|Part B||13
11321977|NCT02734862|12519145|FG001|NOT COMPLETED|Part B||7
11321978|NCT02734862|12519146|FG002|NOT COMPLETED|Part B||5
11321979|NCT02734953|12519155|FG000|STARTED|Overall Study||10
11321980|NCT02734953|12519155|FG000|COMPLETED|Overall Study||10
11321981|NCT02734953|12519155|FG000|NOT COMPLETED|Overall Study||0
11321982|NCT02734979|12519159|FG000|STARTED|Overall Study||1
11321983|NCT02734979|12519159|FG000|COMPLETED|Overall Study||1
11321984|NCT02734979|12519159|FG000|NOT COMPLETED|Overall Study||0
11321985|NCT02735096|12519171|FG000|STARTED|Overall Study||4
11321986|NCT02735096|12519171|FG000|COMPLETED|Overall Study||3
11321987|NCT02735096|12519171|FG000|NOT COMPLETED|Overall Study||1
11321988|NCT02735174|12519175|FG000|STARTED|Overall Study||21
11321989|NCT02735174|12519175|FG000|COMPLETED|Overall Study||21
11321990|NCT02735174|12519175|FG000|NOT COMPLETED|Overall Study||0
11321991|NCT02735187|12519181|FG000|STARTED|Overall Study||25
11321992|NCT02735187|12519182|FG001|STARTED|Overall Study||26
11321993|NCT02735187|12519181|FG000|COMPLETED|Overall Study||21
11321994|NCT02735187|12519182|FG001|COMPLETED|Overall Study||25
11321995|NCT02735187|12519181|FG000|NOT COMPLETED|Overall Study||4
11321996|NCT02735187|12519182|FG001|NOT COMPLETED|Overall Study||1
11321997|NCT02735200|12519196|FG000|STARTED|Overall Study||200
11321998|NCT02735200|12519197|FG001|STARTED|Overall Study||350
11321999|NCT02735200|12519196|FG000|COMPLETED|Overall Study||192
11322000|NCT02735200|12519197|FG001|COMPLETED|Overall Study||345
11322001|NCT02735200|12519196|FG000|NOT COMPLETED|Overall Study||8
11322002|NCT02735200|12519197|FG001|NOT COMPLETED|Overall Study||5
11322003|NCT02735382|12519207|FG000|STARTED|Overall Study||7481
11322004|NCT02735382|12519208|FG001|STARTED|Overall Study||7155
11322005|NCT02735382|12519209|FG002|STARTED|Overall Study||184
11322006|NCT02735382|12519210|FG003|STARTED|Overall Study||110
11322007|NCT02735382|12519207|FG000|COMPLETED|Overall Study||7481
11322008|NCT02735382|12519208|FG001|COMPLETED|Overall Study||7155
11322009|NCT02735382|12519209|FG002|COMPLETED|Overall Study||184
11322010|NCT02735382|12519210|FG003|COMPLETED|Overall Study||110
11322011|NCT02735382|12519207|FG000|NOT COMPLETED|Overall Study||0
11322012|NCT02735382|12519208|FG001|NOT COMPLETED|Overall Study||0
11322013|NCT02735382|12519209|FG002|NOT COMPLETED|Overall Study||0
11322014|NCT02735382|12519210|FG003|NOT COMPLETED|Overall Study||0
11322015|NCT02735551|12519223|FG000|STARTED|Overall Study||3
11322016|NCT02735551|12519224|FG001|STARTED|Overall Study||0
11322017|NCT02735551|12519225|FG002|STARTED|Overall Study||0
11322018|NCT02735551|12519223|FG000|COMPLETED|Overall Study||3
11322019|NCT02735551|12519224|FG001|COMPLETED|Overall Study||0
11322020|NCT02735551|12519225|FG002|COMPLETED|Overall Study||0
11322021|NCT02735551|12519223|FG000|NOT COMPLETED|Overall Study||0
11322022|NCT02735551|12519224|FG001|NOT COMPLETED|Overall Study||0
11322023|NCT02735551|12519225|FG002|NOT COMPLETED|Overall Study||0
11322024|NCT02735577|12519233|FG000|STARTED|Disulfiram Treatment||7
11322025|NCT02735577|12519233|FG000|COMPLETED|Disulfiram Treatment||6
11322026|NCT02735577|12519233|FG000|NOT COMPLETED|Disulfiram Treatment||1
11322027|NCT02735577|12519233|FG000|STARTED|Optional 28 Days of Disulfiram Treatment||6
11322028|NCT02735577|12519233|FG000|COMPLETED|Optional 28 Days of Disulfiram Treatment||4
11322029|NCT02735577|12519233|FG000|NOT COMPLETED|Optional 28 Days of Disulfiram Treatment||2
11322030|NCT02735642|12519239|FG000|STARTED|Overall Study||1046
11322031|NCT02735642|12519240|FG001|STARTED|Overall Study||152
11322032|NCT02735642|12519239|FG000|COMPLETED|Overall Study||1046
11322033|NCT02735642|12519240|FG001|COMPLETED|Overall Study||152
11322034|NCT02735642|12519239|FG000|NOT COMPLETED|Overall Study||0
11322035|NCT02735642|12519240|FG001|NOT COMPLETED|Overall Study||0
11322036|NCT02735915|12519250|FG000|STARTED|Overall Study||70
11322037|NCT02735915|12519250|FG000|Vaccinated|Overall Study||62
11322038|NCT02735915|12519250|FG000|COMPLETED|Overall Study||59
11322039|NCT02735915|12519250|FG000|NOT COMPLETED|Overall Study||11
11322040|NCT02735980|12519259|FG000|STARTED|Overall Study||58
11322041|NCT02735980|12519260|FG001|STARTED|Overall Study||60
11322042|NCT02735980|12519261|FG002|STARTED|Overall Study||15
11322043|NCT02735980|12519259|FG000|Received at Least 1 Dose of Study Drug|Overall Study||56
11322044|NCT02735980|12519260|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
11322045|NCT02735980|12519261|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
11322046|NCT02735980|12519259|FG000|COMPLETED|Overall Study||48
11322047|NCT02735980|12519260|FG001|COMPLETED|Overall Study||49
11322048|NCT02735980|12519261|FG002|COMPLETED|Overall Study||14
11322049|NCT02735980|12519259|FG000|NOT COMPLETED|Overall Study||10
11322050|NCT02735980|12519260|FG001|NOT COMPLETED|Overall Study||11
11322051|NCT02735980|12519261|FG002|NOT COMPLETED|Overall Study||1
11322052|NCT02736175|12519276|FG000|STARTED|Overall Study||216
11322053|NCT02736175|12519277|FG001|STARTED|Overall Study||222
11322054|NCT02736175|12519276|FG000|COMPLETED|Overall Study||214
11322055|NCT02736175|12519277|FG001|COMPLETED|Overall Study||221
11322056|NCT02736175|12519276|FG000|NOT COMPLETED|Overall Study||2
11322057|NCT02736175|12519277|FG001|NOT COMPLETED|Overall Study||1
11322058|NCT02736188|12519283|FG000|STARTED|Overall Study||142
11322059|NCT02736188|12519283|FG000|COMPLETED|Overall Study||0
11322060|NCT02736188|12519283|FG000|NOT COMPLETED|Overall Study||142
11322061|NCT02736409|12519293|FG000|STARTED|Overall Study||23
11322062|NCT02736409|12519294|FG001|STARTED|Overall Study||25
11322063|NCT02736409|12519295|FG002|STARTED|Overall Study||106
11322064|NCT02736409|12519296|FG003|STARTED|Overall Study||65
11322065|NCT02736409|12519293|FG000|COMPLETED|Overall Study||19
11322066|NCT02736409|12519294|FG001|COMPLETED|Overall Study||22
11322067|NCT02736409|12519295|FG002|COMPLETED|Overall Study||80
11322068|NCT02736409|12519296|FG003|COMPLETED|Overall Study||53
11322069|NCT02736409|12519293|FG000|NOT COMPLETED|Overall Study||4
11322070|NCT02736409|12519294|FG001|NOT COMPLETED|Overall Study||3
11322071|NCT02736409|12519295|FG002|NOT COMPLETED|Overall Study||26
11322072|NCT02736409|12519296|FG003|NOT COMPLETED|Overall Study||12
11322073|NCT02736474|12519309|FG000|STARTED|Overall Study||11
11322074|NCT02736474|12519310|FG001|STARTED|Overall Study||11
11322075|NCT02736474|12519309|FG000|COMPLETED|Overall Study||11
11322076|NCT02736474|12519310|FG001|COMPLETED|Overall Study||10
11322077|NCT02736474|12519309|FG000|NOT COMPLETED|Overall Study||0
11322078|NCT02736474|12519310|FG001|NOT COMPLETED|Overall Study||1
11322079|NCT02736578|12519318|FG000|STARTED|Overall Study||6
11322080|NCT02736578|12519319|FG001|STARTED|Overall Study||2
11322081|NCT02736578|12519318|FG000|COMPLETED|Overall Study||5
11322082|NCT02736578|12519319|FG001|COMPLETED|Overall Study||2
11322083|NCT02736578|12519318|FG000|NOT COMPLETED|Overall Study||1
11322084|NCT02736578|12519319|FG001|NOT COMPLETED|Overall Study||0
11322085|NCT02736721|12519329|FG000|STARTED|Overall Study||41
11322086|NCT02736721|12519329|FG000|COMPLETED|Overall Study||25
11322087|NCT02736721|12519329|FG000|NOT COMPLETED|Overall Study||16
11322088|NCT02736825|12519335|FG000|STARTED|Overall Study||127
11322089|NCT02736825|12519336|FG001|STARTED|Overall Study||135
11322090|NCT02736825|12519335|FG000|COMPLETED|Overall Study||117
11322091|NCT02736825|12519336|FG001|COMPLETED|Overall Study||123
11322092|NCT02736825|12519335|FG000|NOT COMPLETED|Overall Study||10
11322093|NCT02736825|12519336|FG001|NOT COMPLETED|Overall Study||12
11322094|NCT02736890|12519345|FG000|STARTED|First 12 Weeks||5
11322095|NCT02736890|12519346|FG001|STARTED|First 12 Weeks||3
11322096|NCT02736890|12519345|FG000|COMPLETED|First 12 Weeks||5
11322097|NCT02736890|12519346|FG001|COMPLETED|First 12 Weeks||3
11322098|NCT02736890|12519345|FG000|NOT COMPLETED|First 12 Weeks||0
11322099|NCT02736890|12519346|FG001|NOT COMPLETED|First 12 Weeks||0
11322100|NCT02736890|12519345|FG000|STARTED|Crossover Next 12 Weeks||5
11322101|NCT02736890|12519346|FG001|STARTED|Crossover Next 12 Weeks||3
11322102|NCT02736890|12519345|FG000|COMPLETED|Crossover Next 12 Weeks||3
11322103|NCT02736890|12519346|FG001|COMPLETED|Crossover Next 12 Weeks||1
11322104|NCT02736890|12519345|FG000|NOT COMPLETED|Crossover Next 12 Weeks||2
11322105|NCT02736890|12519346|FG001|NOT COMPLETED|Crossover Next 12 Weeks||2
11322106|NCT02736955|12519355|FG000|STARTED|Overall Study||36
11322107|NCT02736955|12519356|FG001|STARTED|Overall Study||117
11322108|NCT02736955|12519357|FG002|STARTED|Overall Study||8
11322109|NCT02736955|12519355|FG000|COMPLETED|Overall Study||29
11322110|NCT02736955|12519356|FG001|COMPLETED|Overall Study||103
11322111|NCT02736955|12519357|FG002|COMPLETED|Overall Study||6
11322112|NCT02736955|12519355|FG000|NOT COMPLETED|Overall Study||7
11322113|NCT02736955|12519356|FG001|NOT COMPLETED|Overall Study||14
11322114|NCT02736955|12519357|FG002|NOT COMPLETED|Overall Study||2
11322115|NCT02737072|12519369|FG000|STARTED|Overall Study||3
11322116|NCT02737072|12519370|FG001|STARTED|Overall Study||3
11322117|NCT02737072|12519371|FG002|STARTED|Overall Study||3
11322118|NCT02737072|12519369|FG000|Received at Least One Dose of Drug|Overall Study||3
11322119|NCT02737072|12519370|FG001|Received at Least One Dose of Drug|Overall Study||3
11322120|NCT02737072|12519371|FG002|Received at Least One Dose of Drug|Overall Study||3
11322121|NCT02737072|12519369|FG000|COMPLETED|Overall Study||3
11322122|NCT02737072|12519370|FG001|COMPLETED|Overall Study||3
11322123|NCT02737072|12519371|FG002|COMPLETED|Overall Study||3
11322124|NCT02737072|12519369|FG000|NOT COMPLETED|Overall Study||0
11322125|NCT02737072|12519370|FG001|NOT COMPLETED|Overall Study||0
11322126|NCT02737072|12519371|FG002|NOT COMPLETED|Overall Study||0
11322127|NCT02737163|12519383|FG000|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95
11322128|NCT02737163|12519383|FG000|COMPLETED|Overall Study||95
11322129|NCT02737163|12519383|FG000|NOT COMPLETED|Overall Study||0
11322130|NCT02737332|12519389|FG000|STARTED|Overall Study||29
11322131|NCT02737332|12519390|FG001|STARTED|Overall Study||24
11322132|NCT02737332|12519389|FG000|COMPLETED|Overall Study||28
11322133|NCT02737332|12519390|FG001|COMPLETED|Overall Study||23
11322134|NCT02737332|12519389|FG000|NOT COMPLETED|Overall Study||1
11322135|NCT02737332|12519390|FG001|NOT COMPLETED|Overall Study||1
11322136|NCT02737358|12519400|FG000|STARTED|Overall Study||55
11322137|NCT02737358|12519401|FG001|STARTED|Overall Study||59
11322138|NCT02737358|12519400|FG000|COMPLETED|Overall Study||46
11322139|NCT02737358|12519401|FG001|COMPLETED|Overall Study||44
11322140|NCT02737358|12519400|FG000|NOT COMPLETED|Overall Study||9
11322141|NCT02737358|12519401|FG001|NOT COMPLETED|Overall Study||15
11322142|NCT02737397|12519407|FG000|STARTED|Overall Study||13
11322143|NCT02737397|12519407|FG000|JMI-001|Overall Study||13
11322144|NCT02737397|12519407|FG000|SJP-304|Overall Study||12
11322145|NCT02737397|12519407|FG000|SJP-223|Overall Study||13
11322146|NCT02737397|12519407|FG000|Placebo|Overall Study||13
11322147|NCT02737397|12519407|FG000|COMPLETED|Overall Study||13
11322148|NCT02737397|12519407|FG000|NOT COMPLETED|Overall Study||0
11022291|NCT00808340|12200522|FG000|NOT COMPLETED|Third Intervention||0
11022292|NCT00808340|12200523|FG001|NOT COMPLETED|Third Intervention||0
11022293|NCT00808340|12200524|FG002|NOT COMPLETED|Third Intervention||0
11022294|NCT00808340|12200525|FG003|NOT COMPLETED|Third Intervention||0
11022295|NCT00808340|12200526|FG004|NOT COMPLETED|Third Intervention||0
11022296|NCT00808340|12200527|FG005|NOT COMPLETED|Third Intervention||0
11022297|NCT00808405|12200537|FG000|STARTED|Overall Study||61
11022298|NCT00808405|12200538|FG001|STARTED|Overall Study||27
11022299|NCT00808405|12200537|FG000|COMPLETED|Overall Study||61
11022300|NCT00808405|12200538|FG001|COMPLETED|Overall Study||27
11022301|NCT00808405|12200537|FG000|NOT COMPLETED|Overall Study||0
11022302|NCT00808405|12200538|FG001|NOT COMPLETED|Overall Study||0
11022303|NCT00808444|12200546|FG000|STARTED|Overall Study||233
11022304|NCT00808444|12200547|FG001|STARTED|Overall Study||233
11022305|NCT00808444|12200546|FG000|COMPLETED|Overall Study||232
11022306|NCT00808444|12200547|FG001|COMPLETED|Overall Study||232
11022307|NCT00808444|12200546|FG000|NOT COMPLETED|Overall Study||1
11022308|NCT00808444|12200547|FG001|NOT COMPLETED|Overall Study||1
11022309|NCT00808470|12200555|FG000|STARTED|Overall Study||37
11022310|NCT00808470|12200556|FG001|STARTED|Overall Study||35
11022311|NCT00808470|12200555|FG000|COMPLETED|Overall Study||35
11022312|NCT00808470|12200556|FG001|COMPLETED|Overall Study||35
11022313|NCT00808470|12200555|FG000|NOT COMPLETED|Overall Study||2
11022314|NCT00808470|12200556|FG001|NOT COMPLETED|Overall Study||0
11022315|NCT00808483|12200568|FG000|STARTED|From 3 to 5 Months After Surgery||35
11022316|NCT00808483|12200569|FG001|STARTED|From 3 to 5 Months After Surgery||33
11322149|NCT02737501|12519419|FG000|STARTED|Randomized Phase||137
11322150|NCT02737501|12519420|FG001|STARTED|Randomized Phase||138
11322151|NCT02737501|12519421|FG002|STARTED|Randomized Phase||0
11322152|NCT02737501|12519419|FG000|Safety Analysis Set|Randomized Phase||136
11322153|NCT02737501|12519420|FG001|Safety Analysis Set|Randomized Phase||137
11322154|NCT02737501|12519421|FG002|Safety Analysis Set|Randomized Phase||0
11322155|NCT02737501|12519419|FG000|COMPLETED|Randomized Phase||20
11322156|NCT02737501|12519420|FG001|COMPLETED|Randomized Phase||84
11322157|NCT02737501|12519421|FG002|COMPLETED|Randomized Phase||0
11322158|NCT02737501|12519419|FG000|NOT COMPLETED|Randomized Phase||117
11322159|NCT02737501|12519420|FG001|NOT COMPLETED|Randomized Phase||54
11322160|NCT02737501|12519421|FG002|NOT COMPLETED|Randomized Phase||0
11322161|NCT02737501|12519419|FG000|STARTED|Crossover Phase||0
11322162|NCT02737501|12519420|FG001|STARTED|Crossover Phase||0
11322163|NCT02737501|12519421|FG002|STARTED|Crossover Phase||65
11322164|NCT02737501|12519419|FG000|COMPLETED|Crossover Phase||0
11322165|NCT02737501|12519420|FG001|COMPLETED|Crossover Phase||0
11322166|NCT02737501|12519421|FG002|COMPLETED|Crossover Phase||10
11322167|NCT02737501|12519419|FG000|NOT COMPLETED|Crossover Phase||0
11322168|NCT02737501|12519420|FG001|NOT COMPLETED|Crossover Phase||0
11322169|NCT02737501|12519421|FG002|NOT COMPLETED|Crossover Phase||55
11322170|NCT02737592|12519429|FG000|STARTED|Overall Study||34
11322171|NCT02737592|12519429|FG000|COMPLETED|Overall Study||33
11322172|NCT02737592|12519429|FG000|NOT COMPLETED|Overall Study||1
11322173|NCT02737618|12519433|FG000|STARTED|Overall Study||43
11322174|NCT02737618|12519433|FG000|COMPLETED|Overall Study||34
11322175|NCT02737618|12519433|FG000|NOT COMPLETED|Overall Study||9
11322176|NCT02737631|12519437|FG000|STARTED|Overall Study||222
11322177|NCT02737631|12519437|FG000|COMPLETED|Overall Study||222
11322178|NCT02737631|12519437|FG000|NOT COMPLETED|Overall Study||0
11342525|NCT02946073|12540037|FG001|STARTED|Double Blind Phase||110
11342526|NCT02946073|12540038|FG002|STARTED|Double Blind Phase||0
11342527|NCT02946073|12540039|FG003|STARTED|Double Blind Phase||0
11342528|NCT02946073|12540036|FG000|COMPLETED|Double Blind Phase||88
11342529|NCT02946073|12540037|FG001|COMPLETED|Double Blind Phase||70
11342530|NCT02946073|12540038|FG002|COMPLETED|Double Blind Phase||0
11342531|NCT02946073|12540039|FG003|COMPLETED|Double Blind Phase||0
11402924|NCT04015232|12597890|FG000|STARTED|Overall Study||100
11402925|NCT04015232|12597891|FG001|STARTED|Overall Study||100
11402926|NCT04015232|12597890|FG000|COMPLETED|Overall Study||89
11402927|NCT04015232|12597891|FG001|COMPLETED|Overall Study||93
11402928|NCT04015232|12597890|FG000|NOT COMPLETED|Overall Study||11
11402929|NCT04015232|12597891|FG001|NOT COMPLETED|Overall Study||7
11402930|NCT04016623|12597901|FG000|STARTED|Pair 1 Test / Control Dispense||10
11402931|NCT04016623|12597901|FG000|COMPLETED|Pair 1 Test / Control Dispense||10
11402932|NCT04016623|12597901|FG000|NOT COMPLETED|Pair 1 Test / Control Dispense||0
11402933|NCT04016623|12597901|FG000|STARTED|Pair 1 Test /Control Follow up||10
11402934|NCT04016623|12597901|FG000|COMPLETED|Pair 1 Test /Control Follow up||10
11402935|NCT04016623|12597901|FG000|NOT COMPLETED|Pair 1 Test /Control Follow up||0
11402936|NCT04016623|12597901|FG000|STARTED|Pair 2 Test / Control Dispense||10
11402937|NCT04016623|12597901|FG000|COMPLETED|Pair 2 Test / Control Dispense||10
11402938|NCT04016623|12597901|FG000|NOT COMPLETED|Pair 2 Test / Control Dispense||0
11402939|NCT04016623|12597901|FG000|STARTED|Pair 2 Test /Control Follow up||10
11402940|NCT04016623|12597901|FG000|COMPLETED|Pair 2 Test /Control Follow up||10
11402941|NCT04016623|12597901|FG000|NOT COMPLETED|Pair 2 Test /Control Follow up||0
11342532|NCT02946073|12540036|FG000|NOT COMPLETED|Double Blind Phase||24
11342533|NCT02946073|12540037|FG001|NOT COMPLETED|Double Blind Phase||40
11342534|NCT02946073|12540038|FG002|NOT COMPLETED|Double Blind Phase||0
11342535|NCT02946073|12540039|FG003|NOT COMPLETED|Double Blind Phase||0
11342536|NCT02946073|12540036|FG000|STARTED|Open Label Phase||0
11342537|NCT02946073|12540037|FG001|STARTED|Open Label Phase||0
11342538|NCT02946073|12540038|FG002|STARTED|Open Label Phase||75
11342539|NCT02946073|12540039|FG003|STARTED|Open Label Phase||57
11342540|NCT02946073|12540036|FG000|COMPLETED|Open Label Phase||0
11342541|NCT02946073|12540037|FG001|COMPLETED|Open Label Phase||0
11342542|NCT02946073|12540038|FG002|COMPLETED|Open Label Phase||54
11342543|NCT02946073|12540039|FG003|COMPLETED|Open Label Phase||44
11342544|NCT02946073|12540036|FG000|NOT COMPLETED|Open Label Phase||0
11342545|NCT02946073|12540037|FG001|NOT COMPLETED|Open Label Phase||0
11342546|NCT02946073|12540038|FG002|NOT COMPLETED|Open Label Phase||21
11342547|NCT02946073|12540039|FG003|NOT COMPLETED|Open Label Phase||13
11342548|NCT02946229|12540058|FG000|STARTED|Overall Study||142
11342549|NCT02946229|12540058|FG000|COMPLETED|Overall Study||142
11342550|NCT02946229|12540058|FG000|NOT COMPLETED|Overall Study||0
11342551|NCT02946385|12540068|FG000|STARTED|Overall Study||126
11342552|NCT02946385|12540069|FG001|STARTED|Overall Study||127
11342553|NCT02946385|12540070|FG002|STARTED|Overall Study||99
11342554|NCT02946385|12540071|FG003|STARTED|Overall Study||74
11342555|NCT02946385|12540072|FG004|STARTED|Overall Study||101
11342556|NCT02946385|12540073|FG005|STARTED|Overall Study||77
11342557|NCT02946385|12540068|FG000|COMPLETED|Overall Study||126
11342558|NCT02946385|12540069|FG001|COMPLETED|Overall Study||127
11342559|NCT02946385|12540070|FG002|COMPLETED|Overall Study||96
11342560|NCT02946385|12540071|FG003|COMPLETED|Overall Study||74
11342561|NCT02946385|12540072|FG004|COMPLETED|Overall Study||99
11342562|NCT02946385|12540073|FG005|COMPLETED|Overall Study||76
11342563|NCT02946385|12540068|FG000|NOT COMPLETED|Overall Study||0
11342564|NCT02946385|12540069|FG001|NOT COMPLETED|Overall Study||0
11342565|NCT02946385|12540070|FG002|NOT COMPLETED|Overall Study||3
11342566|NCT02946385|12540071|FG003|NOT COMPLETED|Overall Study||0
11342567|NCT02946385|12540072|FG004|NOT COMPLETED|Overall Study||2
11342568|NCT02946385|12540073|FG005|NOT COMPLETED|Overall Study||1
11342569|NCT02946489|12540093|FG000|STARTED|Overall Study||8
11342570|NCT02946489|12540093|FG000|COMPLETED|Overall Study||8
11342571|NCT02946489|12540093|FG000|NOT COMPLETED|Overall Study||0
11342572|NCT02946515|12540099|FG000|STARTED|Overall Study||22
11342573|NCT02946515|12540100|FG001|STARTED|Overall Study||22
11342574|NCT02946515|12540099|FG000|COMPLETED|Overall Study||20
11342575|NCT02946515|12540100|FG001|COMPLETED|Overall Study||21
11342576|NCT02946515|12540099|FG000|NOT COMPLETED|Overall Study||2
11342577|NCT02946515|12540100|FG001|NOT COMPLETED|Overall Study||1
11342578|NCT02946580|12540108|FG000|STARTED|Overall Study||28
11342579|NCT02946580|12540109|FG001|STARTED|Overall Study||25
11342580|NCT02946580|12540108|FG000|COMPLETED|Overall Study||27
11342581|NCT02946580|12540109|FG001|COMPLETED|Overall Study||20
11342582|NCT02946580|12540108|FG000|NOT COMPLETED|Overall Study||1
11342583|NCT02946580|12540109|FG001|NOT COMPLETED|Overall Study||5
11342584|NCT02946892|12540115|FG000|STARTED|First Intervention (12 Weeks)||11
11342585|NCT02946892|12540116|FG001|STARTED|First Intervention (12 Weeks)||15
11342586|NCT02946892|12540115|FG000|COMPLETED|First Intervention (12 Weeks)||11
11342587|NCT02946892|12540116|FG001|COMPLETED|First Intervention (12 Weeks)||14
11402942|NCT04016623|12597901|FG000|STARTED|Pair 3 Test / Control Dispense||10
11322179|NCT04865354|12519443|FG000|STARTED|First Wear Period (8 Days)||83
11322180|NCT04865354|12519444|FG001|STARTED|First Wear Period (8 Days)||84
11322181|NCT04865354|12519443|FG000|COMPLETED|First Wear Period (8 Days)||82
11322182|NCT04865354|12519444|FG001|COMPLETED|First Wear Period (8 Days)||83
11322183|NCT04865354|12519443|FG000|NOT COMPLETED|First Wear Period (8 Days)||1
11322184|NCT04865354|12519444|FG001|NOT COMPLETED|First Wear Period (8 Days)||1
11322185|NCT04865354|12519443|FG000|STARTED|Second Wear Period (8 Days)||82
11322186|NCT04865354|12519444|FG001|STARTED|Second Wear Period (8 Days)||83
11322187|NCT04865354|12519443|FG000|COMPLETED|Second Wear Period (8 Days)||81
11322188|NCT04865354|12519444|FG001|COMPLETED|Second Wear Period (8 Days)||83
11322189|NCT04865354|12519443|FG000|NOT COMPLETED|Second Wear Period (8 Days)||1
11322190|NCT04865354|12519444|FG001|NOT COMPLETED|Second Wear Period (8 Days)||0
11402943|NCT04016623|12597901|FG000|COMPLETED|Pair 3 Test / Control Dispense||10
11322191|NCT04658888|12519455|FG000|STARTED|Overall Study||333
11322192|NCT04658888|12519456|FG001|STARTED|Overall Study||631
11322193|NCT04658888|12519455|FG000|COMPLETED|Overall Study||333
11322194|NCT04658888|12519456|FG001|COMPLETED|Overall Study||631
11322195|NCT04658888|12519455|FG000|NOT COMPLETED|Overall Study||0
11322196|NCT04658888|12519456|FG001|NOT COMPLETED|Overall Study||0
11342588|NCT02946892|12540115|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
11342589|NCT02946892|12540116|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
11342590|NCT02946892|12540115|FG000|STARTED|Washout (6 Weeks)||11
11342591|NCT02946892|12540116|FG001|STARTED|Washout (6 Weeks)||14
11342592|NCT02946892|12540115|FG000|COMPLETED|Washout (6 Weeks)||9
11342593|NCT02946892|12540116|FG001|COMPLETED|Washout (6 Weeks)||14
11342594|NCT02946892|12540115|FG000|NOT COMPLETED|Washout (6 Weeks)||2
11342595|NCT02946892|12540116|FG001|NOT COMPLETED|Washout (6 Weeks)||0
11342596|NCT02946892|12540115|FG000|STARTED|Second Intervention||9
11342597|NCT02946892|12540116|FG001|STARTED|Second Intervention||14
11342598|NCT02946892|12540115|FG000|COMPLETED|Second Intervention||9
11342599|NCT02946892|12540116|FG001|COMPLETED|Second Intervention||14
11342600|NCT02946892|12540115|FG000|NOT COMPLETED|Second Intervention||0
11342601|NCT02946892|12540116|FG001|NOT COMPLETED|Second Intervention||0
11342602|NCT02946918|12540124|FG000|STARTED|Overall Study||6
11342603|NCT02946918|12540125|FG001|STARTED|Overall Study||8
11342604|NCT02946918|12540124|FG000|COMPLETED|Overall Study||5
11342605|NCT02946918|12540125|FG001|COMPLETED|Overall Study||5
11342606|NCT02946918|12540124|FG000|NOT COMPLETED|Overall Study||1
11342607|NCT02946918|12540125|FG001|NOT COMPLETED|Overall Study||3
11342608|NCT02947984|12540133|FG000|STARTED|Overall Study||22
11342609|NCT02947984|12540134|FG001|STARTED|Overall Study||22
11342610|NCT02947984|12540133|FG000|COMPLETED|Overall Study||22
11342611|NCT02947984|12540134|FG001|COMPLETED|Overall Study||22
11342612|NCT02947984|12540133|FG000|NOT COMPLETED|Overall Study||0
11342613|NCT02947984|12540134|FG001|NOT COMPLETED|Overall Study||0
11342614|NCT02947997|12540140|FG000|STARTED|Overall Study||4
11342615|NCT02947997|12540140|FG000|COMPLETED|Overall Study||4
11342616|NCT02947997|12540140|FG000|NOT COMPLETED|Overall Study||0
11342617|NCT02948257|12540144|FG000|STARTED|Overall Study||52
11342618|NCT02948257|12540144|FG000|COMPLETED|Overall Study||52
11342619|NCT02948257|12540144|FG000|NOT COMPLETED|Overall Study||0
11342620|NCT02948426|12540152|FG000|STARTED|Overall Study||3
11342621|NCT02948426|12540153|FG001|STARTED|Overall Study||6
11342622|NCT02948426|12540154|FG002|STARTED|Overall Study||3
11342623|NCT02948426|12540155|FG003|STARTED|Overall Study||6
11342624|NCT02948426|12540152|FG000|COMPLETED|Overall Study||3
11342625|NCT02948426|12540153|FG001|COMPLETED|Overall Study||6
11342626|NCT02948426|12540154|FG002|COMPLETED|Overall Study||3
11342627|NCT02948426|12540155|FG003|COMPLETED|Overall Study||6
11342628|NCT02948426|12540152|FG000|NOT COMPLETED|Overall Study||0
11342629|NCT02948426|12540153|FG001|NOT COMPLETED|Overall Study||0
11342630|NCT02948426|12540154|FG002|NOT COMPLETED|Overall Study||0
11342631|NCT02948426|12540155|FG003|NOT COMPLETED|Overall Study||0
11342632|NCT02948582|12540167|FG000|STARTED|Treatment Period 1||7
11342633|NCT02948582|12540168|FG001|STARTED|Treatment Period 1||7
11342634|NCT02948582|12540169|FG002|STARTED|Treatment Period 1||7
11342635|NCT02948582|12540170|FG003|STARTED|Treatment Period 1||7
11342636|NCT02948582|12540171|FG004|STARTED|Treatment Period 1||7
11342637|NCT02948582|12540172|FG005|STARTED|Treatment Period 1||7
11342638|NCT02948582|12540167|FG000|COMPLETED|Treatment Period 1||7
11342639|NCT02948582|12540168|FG001|COMPLETED|Treatment Period 1||7
11342640|NCT02948582|12540169|FG002|COMPLETED|Treatment Period 1||7
11342641|NCT02948582|12540170|FG003|COMPLETED|Treatment Period 1||7
11342642|NCT02948582|12540171|FG004|COMPLETED|Treatment Period 1||7
11342643|NCT02948582|12540172|FG005|COMPLETED|Treatment Period 1||7
11342644|NCT02948582|12540167|FG000|NOT COMPLETED|Treatment Period 1||0
11342645|NCT02948582|12540168|FG001|NOT COMPLETED|Treatment Period 1||0
11342646|NCT02948582|12540169|FG002|NOT COMPLETED|Treatment Period 1||0
11342647|NCT02948582|12540170|FG003|NOT COMPLETED|Treatment Period 1||0
11342648|NCT02948582|12540171|FG004|NOT COMPLETED|Treatment Period 1||0
11342649|NCT02948582|12540172|FG005|NOT COMPLETED|Treatment Period 1||0
11342650|NCT02948582|12540167|FG000|STARTED|Washout Period 1||7
11342651|NCT02948582|12540168|FG001|STARTED|Washout Period 1||7
11342652|NCT02948582|12540169|FG002|STARTED|Washout Period 1||7
11342653|NCT02948582|12540170|FG003|STARTED|Washout Period 1||7
11342654|NCT02948582|12540171|FG004|STARTED|Washout Period 1||7
11342655|NCT02948582|12540172|FG005|STARTED|Washout Period 1||7
11342656|NCT02948582|12540167|FG000|COMPLETED|Washout Period 1||7
11342657|NCT02948582|12540168|FG001|COMPLETED|Washout Period 1||5
11342658|NCT02948582|12540169|FG002|COMPLETED|Washout Period 1||7
11322197|NCT04097925|12519464|FG000|STARTED|Overall Study||30
11322198|NCT04097925|12519464|FG000|COMPLETED|Overall Study||29
11322199|NCT04097925|12519464|FG000|NOT COMPLETED|Overall Study||1
11322200|NCT04043312|12519470|FG000|STARTED|Overall Study||12
11322201|NCT04043312|12519471|FG001|STARTED|Overall Study||14
11322202|NCT04043312|12519470|FG000|COMPLETED|Overall Study||12
11322203|NCT04043312|12519471|FG001|COMPLETED|Overall Study||14
11322204|NCT04043312|12519470|FG000|NOT COMPLETED|Overall Study||0
11322205|NCT04043312|12519471|FG001|NOT COMPLETED|Overall Study||0
11322206|NCT04003987|12519479|FG000|STARTED|Overall Study||39
11322207|NCT04003987|12519480|FG001|STARTED|Overall Study||39
11322208|NCT04003987|12519479|FG000|COMPLETED|Overall Study||39
11322209|NCT04003987|12519480|FG001|COMPLETED|Overall Study||39
11322210|NCT04003987|12519479|FG000|NOT COMPLETED|Overall Study||0
11322211|NCT04003987|12519480|FG001|NOT COMPLETED|Overall Study||0
11322212|NCT03994120|12519488|FG000|STARTED|Overall Study||7
11322213|NCT03994120|12519489|FG001|STARTED|Overall Study||6
11322214|NCT03994120|12519488|FG000|COMPLETED|Overall Study||4
11322215|NCT03994120|12519489|FG001|COMPLETED|Overall Study||5
11322216|NCT03994120|12519488|FG000|NOT COMPLETED|Overall Study||3
11322217|NCT03994120|12519489|FG001|NOT COMPLETED|Overall Study||1
11322218|NCT03934216|12519497|FG000|STARTED|Randomization||88
11322219|NCT03934216|12519498|FG001|STARTED|Randomization||43
11322220|NCT03934216|12519497|FG000|COMPLETED|Randomization||87
11322221|NCT03934216|12519498|FG001|COMPLETED|Randomization||42
11322222|NCT03934216|12519497|FG000|NOT COMPLETED|Randomization||1
11322223|NCT03934216|12519498|FG001|NOT COMPLETED|Randomization||1
11322224|NCT03934216|12519497|FG000|STARTED|Treatment Period||87
11322225|NCT03934216|12519498|FG001|STARTED|Treatment Period||42
11322226|NCT03934216|12519497|FG000|COMPLETED|Treatment Period||69
11322227|NCT03934216|12519498|FG001|COMPLETED|Treatment Period||35
11322228|NCT03934216|12519497|FG000|NOT COMPLETED|Treatment Period||18
11322229|NCT03934216|12519498|FG001|NOT COMPLETED|Treatment Period||7
11342659|NCT02948582|12540170|FG003|COMPLETED|Washout Period 1||7
11342660|NCT02948582|12540171|FG004|COMPLETED|Washout Period 1||7
11342661|NCT02948582|12540172|FG005|COMPLETED|Washout Period 1||6
11342662|NCT02948582|12540167|FG000|NOT COMPLETED|Washout Period 1||0
11342663|NCT02948582|12540168|FG001|NOT COMPLETED|Washout Period 1||2
11342664|NCT02948582|12540169|FG002|NOT COMPLETED|Washout Period 1||0
11342665|NCT02948582|12540170|FG003|NOT COMPLETED|Washout Period 1||0
11342666|NCT02948582|12540171|FG004|NOT COMPLETED|Washout Period 1||0
11342667|NCT02948582|12540172|FG005|NOT COMPLETED|Washout Period 1||1
11342668|NCT02948582|12540167|FG000|STARTED|Treatment Period 2||7
11342669|NCT02948582|12540168|FG001|STARTED|Treatment Period 2||5
11342670|NCT02948582|12540169|FG002|STARTED|Treatment Period 2||7
11342671|NCT02948582|12540170|FG003|STARTED|Treatment Period 2||7
11342672|NCT02948582|12540171|FG004|STARTED|Treatment Period 2||7
11342673|NCT02948582|12540172|FG005|STARTED|Treatment Period 2||6
11342674|NCT02948582|12540167|FG000|COMPLETED|Treatment Period 2||7
11342675|NCT02948582|12540168|FG001|COMPLETED|Treatment Period 2||5
11342676|NCT02948582|12540169|FG002|COMPLETED|Treatment Period 2||7
11342677|NCT02948582|12540170|FG003|COMPLETED|Treatment Period 2||7
11342678|NCT02948582|12540171|FG004|COMPLETED|Treatment Period 2||7
11342679|NCT02948582|12540172|FG005|COMPLETED|Treatment Period 2||6
11342680|NCT02948582|12540167|FG000|NOT COMPLETED|Treatment Period 2||0
11342681|NCT02948582|12540168|FG001|NOT COMPLETED|Treatment Period 2||0
11342682|NCT02948582|12540169|FG002|NOT COMPLETED|Treatment Period 2||0
11342683|NCT02948582|12540170|FG003|NOT COMPLETED|Treatment Period 2||0
11342684|NCT02948582|12540171|FG004|NOT COMPLETED|Treatment Period 2||0
11342685|NCT02948582|12540172|FG005|NOT COMPLETED|Treatment Period 2||0
11342686|NCT02948582|12540167|FG000|STARTED|Washout Period 2||7
11342687|NCT02948582|12540168|FG001|STARTED|Washout Period 2||5
11342688|NCT02948582|12540169|FG002|STARTED|Washout Period 2||7
11342689|NCT02948582|12540170|FG003|STARTED|Washout Period 2||7
11342690|NCT02948582|12540171|FG004|STARTED|Washout Period 2||7
11342691|NCT02948582|12540172|FG005|STARTED|Washout Period 2||6
11342692|NCT02948582|12540167|FG000|COMPLETED|Washout Period 2||7
11342693|NCT02948582|12540168|FG001|COMPLETED|Washout Period 2||4
11342694|NCT02948582|12540169|FG002|COMPLETED|Washout Period 2||7
11342695|NCT02948582|12540170|FG003|COMPLETED|Washout Period 2||6
11342696|NCT02948582|12540171|FG004|COMPLETED|Washout Period 2||7
11342697|NCT02948582|12540172|FG005|COMPLETED|Washout Period 2||6
11342698|NCT02948582|12540167|FG000|NOT COMPLETED|Washout Period 2||0
11342699|NCT02948582|12540168|FG001|NOT COMPLETED|Washout Period 2||1
11342700|NCT02948582|12540169|FG002|NOT COMPLETED|Washout Period 2||0
11342701|NCT02948582|12540170|FG003|NOT COMPLETED|Washout Period 2||1
11342702|NCT02948582|12540171|FG004|NOT COMPLETED|Washout Period 2||0
11342703|NCT02948582|12540172|FG005|NOT COMPLETED|Washout Period 2||0
11342704|NCT02948582|12540167|FG000|STARTED|Treatment Period 3||7
11342705|NCT02948582|12540168|FG001|STARTED|Treatment Period 3||4
11342706|NCT02948582|12540169|FG002|STARTED|Treatment Period 3||7
11342707|NCT02948582|12540170|FG003|STARTED|Treatment Period 3||6
11342708|NCT02948582|12540171|FG004|STARTED|Treatment Period 3||7
11342709|NCT02948582|12540172|FG005|STARTED|Treatment Period 3||6
11342710|NCT02948582|12540167|FG000|COMPLETED|Treatment Period 3||7
11342711|NCT02948582|12540168|FG001|COMPLETED|Treatment Period 3||4
11342712|NCT02948582|12540169|FG002|COMPLETED|Treatment Period 3||7
11342713|NCT02948582|12540170|FG003|COMPLETED|Treatment Period 3||6
11342714|NCT02948582|12540171|FG004|COMPLETED|Treatment Period 3||7
11342715|NCT02948582|12540172|FG005|COMPLETED|Treatment Period 3||6
11342716|NCT02948582|12540167|FG000|NOT COMPLETED|Treatment Period 3||0
11322230|NCT03907280|12519507|FG000|STARTED|Treatment Period 1 + Washout Period 1||4
11322231|NCT03907280|12519508|FG001|STARTED|Treatment Period 1 + Washout Period 1||4
11322232|NCT03907280|12519509|FG002|STARTED|Treatment Period 1 + Washout Period 1||4
11322233|NCT03907280|12519507|FG000|Treated With BI 1265162|Treatment Period 1 + Washout Period 1||4
11322234|NCT03907280|12519508|FG001|Treated With BI 1265162|Treatment Period 1 + Washout Period 1||4
11322235|NCT03907280|12519509|FG002|Treated With BI 1265162|Treatment Period 1 + Washout Period 1||4
11322236|NCT03907280|12519507|FG000|COMPLETED|Treatment Period 1 + Washout Period 1||4
11322237|NCT03907280|12519508|FG001|COMPLETED|Treatment Period 1 + Washout Period 1||4
11322238|NCT03907280|12519509|FG002|COMPLETED|Treatment Period 1 + Washout Period 1||4
11322239|NCT03907280|12519507|FG000|NOT COMPLETED|Treatment Period 1 + Washout Period 1||0
11322240|NCT03907280|12519508|FG001|NOT COMPLETED|Treatment Period 1 + Washout Period 1||0
11322241|NCT03907280|12519509|FG002|NOT COMPLETED|Treatment Period 1 + Washout Period 1||0
11322242|NCT03907280|12519507|FG000|STARTED|Treatment Period 2 + Washout Period 2||4
11322243|NCT03907280|12519508|FG001|STARTED|Treatment Period 2 + Washout Period 2||4
11322244|NCT03907280|12519509|FG002|STARTED|Treatment Period 2 + Washout Period 2||4
11322245|NCT03907280|12519507|FG000|Treated With BI 1265162|Treatment Period 2 + Washout Period 2||4
11322246|NCT03907280|12519508|FG001|Treated With BI 1265162|Treatment Period 2 + Washout Period 2||4
11322247|NCT03907280|12519509|FG002|Treated With BI 1265162|Treatment Period 2 + Washout Period 2||4
11322248|NCT03907280|12519507|FG000|COMPLETED|Treatment Period 2 + Washout Period 2||4
11322249|NCT03907280|12519508|FG001|COMPLETED|Treatment Period 2 + Washout Period 2||4
11322250|NCT03907280|12519509|FG002|COMPLETED|Treatment Period 2 + Washout Period 2||4
11322251|NCT03907280|12519507|FG000|NOT COMPLETED|Treatment Period 2 + Washout Period 2||0
11322252|NCT03907280|12519508|FG001|NOT COMPLETED|Treatment Period 2 + Washout Period 2||0
11322253|NCT03907280|12519509|FG002|NOT COMPLETED|Treatment Period 2 + Washout Period 2||0
11322254|NCT03907280|12519507|FG000|STARTED|Treatment Period 3 + Washout Period 3||4
11322255|NCT03907280|12519508|FG001|STARTED|Treatment Period 3 + Washout Period 3||4
11322256|NCT03907280|12519509|FG002|STARTED|Treatment Period 3 + Washout Period 3||4
11322257|NCT03907280|12519507|FG000|Treated With BI 1265162|Treatment Period 3 + Washout Period 3||4
11322258|NCT03907280|12519508|FG001|Treated With BI 1265162|Treatment Period 3 + Washout Period 3||3
11322259|NCT03907280|12519509|FG002|Treated With BI 1265162|Treatment Period 3 + Washout Period 3||4
11322260|NCT03907280|12519507|FG000|COMPLETED|Treatment Period 3 + Washout Period 3||4
11322261|NCT03907280|12519508|FG001|COMPLETED|Treatment Period 3 + Washout Period 3||3
11322262|NCT03907280|12519509|FG002|COMPLETED|Treatment Period 3 + Washout Period 3||4
11322263|NCT03907280|12519507|FG000|NOT COMPLETED|Treatment Period 3 + Washout Period 3||0
11322264|NCT03907280|12519508|FG001|NOT COMPLETED|Treatment Period 3 + Washout Period 3||1
11322265|NCT03907280|12519509|FG002|NOT COMPLETED|Treatment Period 3 + Washout Period 3||0
11322266|NCT03907280|12519507|FG000|STARTED|Treatment Period 4: Fixed Treatment T3||4
11322267|NCT03907280|12519508|FG001|STARTED|Treatment Period 4: Fixed Treatment T3||4
11322268|NCT03907280|12519509|FG002|STARTED|Treatment Period 4: Fixed Treatment T3||4
11322269|NCT03907280|12519507|FG000|Treated With BI 1265162|Treatment Period 4: Fixed Treatment T3||4
11322270|NCT03907280|12519508|FG001|Treated With BI 1265162|Treatment Period 4: Fixed Treatment T3||4
11322271|NCT03907280|12519509|FG002|Treated With BI 1265162|Treatment Period 4: Fixed Treatment T3||4
11322272|NCT03907280|12519507|FG000|COMPLETED|Treatment Period 4: Fixed Treatment T3||4
11322273|NCT03907280|12519508|FG001|COMPLETED|Treatment Period 4: Fixed Treatment T3||4
11322274|NCT03907280|12519509|FG002|COMPLETED|Treatment Period 4: Fixed Treatment T3||4
11322275|NCT03907280|12519507|FG000|NOT COMPLETED|Treatment Period 4: Fixed Treatment T3||0
11322276|NCT03907280|12519508|FG001|NOT COMPLETED|Treatment Period 4: Fixed Treatment T3||0
11322277|NCT03907280|12519509|FG002|NOT COMPLETED|Treatment Period 4: Fixed Treatment T3||0
11322278|NCT03745768|12519521|FG000|STARTED|Overall Study||10
11322279|NCT03745768|12519522|FG001|STARTED|Overall Study||9
11322280|NCT03745768|12519521|FG000|COMPLETED|Overall Study||8
11322281|NCT03745768|12519522|FG001|COMPLETED|Overall Study||9
11322282|NCT03745768|12519521|FG000|NOT COMPLETED|Overall Study||2
11322283|NCT03745768|12519522|FG001|NOT COMPLETED|Overall Study||0
11322284|NCT03694522|12519530|FG000|STARTED|Overall Study||77
11322285|NCT03694522|12519531|FG001|STARTED|Overall Study||78
11322286|NCT03694522|12519530|FG000|Received Any Study Treatment|Overall Study||76
11322287|NCT03694522|12519531|FG001|Received Any Study Treatment|Overall Study||77
11322288|NCT03694522|12519530|FG000|COMPLETED|Overall Study||0
11322289|NCT03694522|12519531|FG001|COMPLETED|Overall Study||0
11322290|NCT03694522|12519530|FG000|NOT COMPLETED|Overall Study||77
11322291|NCT03694522|12519531|FG001|NOT COMPLETED|Overall Study||78
11322292|NCT03689374|12519539|FG000|STARTED|Run-in Period (12 Weeks)||2274
11322293|NCT03689374|12519540|FG001|STARTED|Run-in Period (12 Weeks)||0
11322294|NCT03689374|12519541|FG002|STARTED|Run-in Period (12 Weeks)||0
11322295|NCT03689374|12519539|FG000|COMPLETED|Run-in Period (12 Weeks)||1748
11322296|NCT03689374|12519540|FG001|COMPLETED|Run-in Period (12 Weeks)||0
11322297|NCT03689374|12519541|FG002|COMPLETED|Run-in Period (12 Weeks)||0
11322298|NCT03689374|12519539|FG000|NOT COMPLETED|Run-in Period (12 Weeks)||526
11322299|NCT03689374|12519540|FG001|NOT COMPLETED|Run-in Period (12 Weeks)||0
11322300|NCT03689374|12519541|FG002|NOT COMPLETED|Run-in Period (12 Weeks)||0
11402944|NCT04016623|12597901|FG000|NOT COMPLETED|Pair 3 Test / Control Dispense||0
11402945|NCT04016623|12597901|FG000|STARTED|Pair 3 Test /Control Follow up||10
11402946|NCT04016623|12597901|FG000|COMPLETED|Pair 3 Test /Control Follow up||10
11402947|NCT04016623|12597901|FG000|NOT COMPLETED|Pair 3 Test /Control Follow up||0
11322301|NCT03689374|12519539|FG000|STARTED|Treatment Period (Week 0 to 52)||0
11322302|NCT03689374|12519540|FG001|STARTED|Treatment Period (Week 0 to 52)||874
11322303|NCT03689374|12519541|FG002|STARTED|Treatment Period (Week 0 to 52)||874
11322304|NCT03689374|12519539|FG000|Treated|Treatment Period (Week 0 to 52)||0
11322305|NCT03689374|12519540|FG001|Treated|Treatment Period (Week 0 to 52)||874
11322306|NCT03689374|12519541|FG002|Treated|Treatment Period (Week 0 to 52)||864
11322307|NCT03689374|12519539|FG000|Full Analysis Set|Treatment Period (Week 0 to 52)||0
11322308|NCT03689374|12519540|FG001|Full Analysis Set|Treatment Period (Week 0 to 52)||874
11322309|NCT03689374|12519541|FG002|Full Analysis Set|Treatment Period (Week 0 to 52)||874
11322310|NCT03689374|12519539|FG000|Safety Analysis Set|Treatment Period (Week 0 to 52)||0
11322311|NCT03689374|12519540|FG001|Safety Analysis Set|Treatment Period (Week 0 to 52)||874
11322312|NCT03689374|12519541|FG002|Safety Analysis Set|Treatment Period (Week 0 to 52)||864
11322313|NCT03689374|12519539|FG000|COMPLETED|Treatment Period (Week 0 to 52)||0
11322314|NCT03689374|12519540|FG001|COMPLETED|Treatment Period (Week 0 to 52)||850
11322315|NCT03689374|12519541|FG002|COMPLETED|Treatment Period (Week 0 to 52)||831
11322316|NCT03689374|12519539|FG000|NOT COMPLETED|Treatment Period (Week 0 to 52)||0
11322317|NCT03689374|12519540|FG001|NOT COMPLETED|Treatment Period (Week 0 to 52)||24
11402948|NCT04016623|12597901|FG000|STARTED|Pair 4 Test / Control Dispense||10
11402949|NCT04016623|12597901|FG000|COMPLETED|Pair 4 Test / Control Dispense||10
11322318|NCT03689374|12519541|FG002|NOT COMPLETED|Treatment Period (Week 0 to 52)||43
11322319|NCT03639311|12519549|FG000|STARTED|Overall Study||90
11322320|NCT03639311|12519550|FG001|STARTED|Overall Study||7
11322321|NCT03639311|12519549|FG000|COMPLETED|Overall Study||0
11322322|NCT03639311|12519550|FG001|COMPLETED|Overall Study||7
11322323|NCT03639311|12519549|FG000|NOT COMPLETED|Overall Study||90
11322324|NCT03639311|12519550|FG001|NOT COMPLETED|Overall Study||0
11322325|NCT03617926|12519561|FG000|STARTED|Overall Study||35
11322326|NCT03617926|12519562|FG001|STARTED|Overall Study||35
11322327|NCT03617926|12519561|FG000|COMPLETED|Overall Study||35
11322328|NCT03617926|12519562|FG001|COMPLETED|Overall Study||35
11322329|NCT03617926|12519561|FG000|NOT COMPLETED|Overall Study||0
11322330|NCT03617926|12519562|FG001|NOT COMPLETED|Overall Study||0
11322331|NCT03614663|12519575|FG000|STARTED|Overall Study||110
11322332|NCT03614663|12519576|FG001|STARTED|Overall Study||102
11322333|NCT03614663|12519575|FG000|COMPLETED|Overall Study||106
11322334|NCT03614663|12519576|FG001|COMPLETED|Overall Study||99
11322335|NCT03614663|12519575|FG000|NOT COMPLETED|Overall Study||4
11322336|NCT03614663|12519576|FG001|NOT COMPLETED|Overall Study||3
11322337|NCT03591874|12519586|FG000|STARTED|Overall Study||40
11322338|NCT03591874|12519587|FG001|STARTED|Overall Study||19
11322339|NCT03591874|12519586|FG000|Received at Least 1 Study Treatment|Overall Study||29
11322340|NCT03591874|12519587|FG001|Received at Least 1 Study Treatment|Overall Study||16
11322341|NCT03591874|12519586|FG000|COMPLETED|Overall Study||21
11322342|NCT03591874|12519587|FG001|COMPLETED|Overall Study||12
11322343|NCT03591874|12519586|FG000|NOT COMPLETED|Overall Study||19
11322344|NCT03591874|12519587|FG001|NOT COMPLETED|Overall Study||7
11342717|NCT02948582|12540168|FG001|NOT COMPLETED|Treatment Period 3||0
11342718|NCT02948582|12540169|FG002|NOT COMPLETED|Treatment Period 3||0
11342719|NCT02948582|12540170|FG003|NOT COMPLETED|Treatment Period 3||0
11342720|NCT02948582|12540171|FG004|NOT COMPLETED|Treatment Period 3||0
11342721|NCT02948582|12540172|FG005|NOT COMPLETED|Treatment Period 3||0
11342722|NCT02948582|12540167|FG000|STARTED|Washout Period 3||7
11342723|NCT02948582|12540168|FG001|STARTED|Washout Period 3||4
11342724|NCT02948582|12540169|FG002|STARTED|Washout Period 3||7
11342725|NCT02948582|12540170|FG003|STARTED|Washout Period 3||6
11342726|NCT02948582|12540171|FG004|STARTED|Washout Period 3||7
11342727|NCT02948582|12540172|FG005|STARTED|Washout Period 3||6
11342728|NCT02948582|12540167|FG000|COMPLETED|Washout Period 3||7
11342729|NCT02948582|12540168|FG001|COMPLETED|Washout Period 3||4
11342730|NCT02948582|12540169|FG002|COMPLETED|Washout Period 3||7
11342731|NCT02948582|12540170|FG003|COMPLETED|Washout Period 3||6
11342732|NCT02948582|12540171|FG004|COMPLETED|Washout Period 3||7
11342733|NCT02948582|12540172|FG005|COMPLETED|Washout Period 3||6
11342734|NCT02948582|12540167|FG000|NOT COMPLETED|Washout Period 3||0
11342735|NCT02948582|12540168|FG001|NOT COMPLETED|Washout Period 3||0
11342736|NCT02948582|12540169|FG002|NOT COMPLETED|Washout Period 3||0
11342737|NCT02948582|12540170|FG003|NOT COMPLETED|Washout Period 3||0
11342738|NCT02948582|12540171|FG004|NOT COMPLETED|Washout Period 3||0
11342739|NCT02948582|12540172|FG005|NOT COMPLETED|Washout Period 3||0
11342740|NCT02948582|12540167|FG000|STARTED|Treatment Period 4||7
11342741|NCT02948582|12540168|FG001|STARTED|Treatment Period 4||4
11342742|NCT02948582|12540169|FG002|STARTED|Treatment Period 4||7
11342743|NCT02948582|12540170|FG003|STARTED|Treatment Period 4||6
11342744|NCT02948582|12540171|FG004|STARTED|Treatment Period 4||7
11342745|NCT02948582|12540172|FG005|STARTED|Treatment Period 4||6
11342746|NCT02948582|12540167|FG000|COMPLETED|Treatment Period 4||7
11342747|NCT02948582|12540168|FG001|COMPLETED|Treatment Period 4||4
11342748|NCT02948582|12540169|FG002|COMPLETED|Treatment Period 4||7
11342749|NCT02948582|12540170|FG003|COMPLETED|Treatment Period 4||6
11342750|NCT02948582|12540171|FG004|COMPLETED|Treatment Period 4||7
11342751|NCT02948582|12540172|FG005|COMPLETED|Treatment Period 4||6
11342752|NCT02948582|12540167|FG000|NOT COMPLETED|Treatment Period 4||0
11342753|NCT02948582|12540168|FG001|NOT COMPLETED|Treatment Period 4||0
11342754|NCT02948582|12540169|FG002|NOT COMPLETED|Treatment Period 4||0
11342755|NCT02948582|12540170|FG003|NOT COMPLETED|Treatment Period 4||0
11342756|NCT02948582|12540171|FG004|NOT COMPLETED|Treatment Period 4||0
11342757|NCT02948582|12540172|FG005|NOT COMPLETED|Treatment Period 4||0
11322345|NCT03418727|12519596|FG000|STARTED|Overall Study||29
11322346|NCT03418727|12519597|FG001|STARTED|Overall Study||28
11322347|NCT03418727|12519598|FG002|STARTED|Overall Study||27
11322348|NCT03418727|12519596|FG000|Received at Least 1 Study Treatment|Overall Study||29
11322349|NCT03418727|12519597|FG001|Received at Least 1 Study Treatment|Overall Study||28
11322350|NCT03418727|12519598|FG002|Received at Least 1 Study Treatment|Overall Study||27
11322351|NCT03418727|12519596|FG000|COMPLETED|Overall Study||28
11322352|NCT03418727|12519597|FG001|COMPLETED|Overall Study||26
11322353|NCT03418727|12519598|FG002|COMPLETED|Overall Study||25
11322354|NCT03418727|12519596|FG000|NOT COMPLETED|Overall Study||1
11322355|NCT03418727|12519597|FG001|NOT COMPLETED|Overall Study||2
11322356|NCT03418727|12519598|FG002|NOT COMPLETED|Overall Study||2
11322357|NCT03410108|12519606|FG000|STARTED|Overall Study||104
11322358|NCT03410108|12519606|FG000|Safety Evaluation Lead-in Part|Overall Study||9
11322359|NCT03410108|12519606|FG000|Refractory Expansion Part: Main Cohort|Overall Study||47
11322360|NCT03410108|12519606|FG000|Refractory Expansion Part: Sub-Cohort|Overall Study||16
11322361|NCT03410108|12519606|FG000|Refractory Expansion Part|Overall Study||63
11322362|NCT03410108|12519606|FG000|All Refractory Participants|Overall Study||72
11322363|NCT03410108|12519606|FG000|TKI-Naive Expansion Cohort|Overall Study||32
11322364|NCT03410108|12519606|FG000|Completed|Overall Study||0
11322365|NCT03410108|12519606|FG000|COMPLETED|Overall Study||0
11322366|NCT03410108|12519606|FG000|NOT COMPLETED|Overall Study||104
11322367|NCT03242824|12519613|FG000|STARTED|Overall Study||20
11322368|NCT03242824|12519613|FG000|COMPLETED|Overall Study||20
11322369|NCT03242824|12519613|FG000|NOT COMPLETED|Overall Study||0
11322370|NCT03123185|12519631|FG000|STARTED|Overall Study||12
11322371|NCT03123185|12519632|FG001|STARTED|Overall Study||8
11402950|NCT04016623|12597901|FG000|NOT COMPLETED|Pair 4 Test / Control Dispense||0
11402951|NCT04016623|12597901|FG000|STARTED|Pair 4 Test /Control Follow up||10
11402952|NCT04016623|12597901|FG000|COMPLETED|Pair 4 Test /Control Follow up||10
11402953|NCT04016623|12597901|FG000|NOT COMPLETED|Pair 4 Test /Control Follow up||0
11402954|NCT04013737|12597923|FG000|STARTED|Overall Study||18
11402955|NCT04013737|12597924|FG001|STARTED|Overall Study||15
11402956|NCT04013737|12597923|FG000|COMPLETED|Overall Study|12 participants declined to participate in the study|18
11402957|NCT04013737|12597924|FG001|COMPLETED|Overall Study||15
11402958|NCT04013737|12597923|FG000|NOT COMPLETED|Overall Study||0
11322372|NCT03123185|12519633|FG002|STARTED|Overall Study||6
11322373|NCT03123185|12519634|FG003|STARTED|Overall Study||5
11322374|NCT03123185|12519635|FG004|STARTED|Overall Study||6
11322375|NCT03123185|12519636|FG005|STARTED|Overall Study||6
11322376|NCT03123185|12519637|FG006|STARTED|Overall Study||6
11322377|NCT03123185|12519638|FG007|STARTED|Overall Study||6
11322378|NCT03123185|12519639|FG008|STARTED|Overall Study||6
11322379|NCT03123185|12519640|FG009|STARTED|Overall Study||6
11322380|NCT03123185|12519641|FG010|STARTED|Overall Study||6
11322381|NCT03123185|12519642|FG011|STARTED|Overall Study||6
11322382|NCT03123185|12519643|FG012|STARTED|Overall Study||6
11322383|NCT03123185|12519644|FG013|STARTED|Overall Study||6
11322384|NCT03123185|12519631|FG000|COMPLETED|Overall Study||12
11322385|NCT03123185|12519632|FG001|COMPLETED|Overall Study||8
11322386|NCT03123185|12519633|FG002|COMPLETED|Overall Study||6
11322387|NCT03123185|12519634|FG003|COMPLETED|Overall Study||5
11322388|NCT03123185|12519635|FG004|COMPLETED|Overall Study||6
11322389|NCT03123185|12519636|FG005|COMPLETED|Overall Study||6
11322390|NCT03123185|12519637|FG006|COMPLETED|Overall Study||6
11322391|NCT03123185|12519638|FG007|COMPLETED|Overall Study||6
11322392|NCT03123185|12519639|FG008|COMPLETED|Overall Study||6
11322393|NCT03123185|12519640|FG009|COMPLETED|Overall Study||6
11322394|NCT03123185|12519641|FG010|COMPLETED|Overall Study||6
11322395|NCT03123185|12519642|FG011|COMPLETED|Overall Study||6
11322396|NCT03123185|12519643|FG012|COMPLETED|Overall Study||5
11322397|NCT03123185|12519644|FG013|COMPLETED|Overall Study||6
11322398|NCT03123185|12519631|FG000|NOT COMPLETED|Overall Study||0
11322399|NCT03123185|12519632|FG001|NOT COMPLETED|Overall Study||0
11322400|NCT03123185|12519633|FG002|NOT COMPLETED|Overall Study||0
11322401|NCT03123185|12519634|FG003|NOT COMPLETED|Overall Study||0
11322402|NCT03123185|12519635|FG004|NOT COMPLETED|Overall Study||0
11322403|NCT03123185|12519636|FG005|NOT COMPLETED|Overall Study||0
11322404|NCT03123185|12519637|FG006|NOT COMPLETED|Overall Study||0
11322405|NCT03123185|12519638|FG007|NOT COMPLETED|Overall Study||0
11322406|NCT03123185|12519639|FG008|NOT COMPLETED|Overall Study||0
11322407|NCT03123185|12519640|FG009|NOT COMPLETED|Overall Study||0
11322408|NCT03123185|12519641|FG010|NOT COMPLETED|Overall Study||0
11322409|NCT03123185|12519642|FG011|NOT COMPLETED|Overall Study||0
11322410|NCT03123185|12519643|FG012|NOT COMPLETED|Overall Study||1
11322411|NCT03123185|12519644|FG013|NOT COMPLETED|Overall Study||0
11322412|NCT03122509|12519694|FG000|STARTED|Overall Study||25
11322413|NCT03122509|12519695|FG001|STARTED|Overall Study||0
11322414|NCT03122509|12519694|FG000|COMPLETED|Overall Study||25
11322415|NCT03122509|12519695|FG001|COMPLETED|Overall Study||0
11322416|NCT03122509|12519694|FG000|NOT COMPLETED|Overall Study||0
11322417|NCT03122509|12519695|FG001|NOT COMPLETED|Overall Study||0
11322418|NCT03110133|12519702|FG000|STARTED|Week 8||106
11322419|NCT03110133|12519703|FG001|STARTED|Week 8||100
11322420|NCT03110133|12519702|FG000|COMPLETED|Week 8||101
11322421|NCT03110133|12519703|FG001|COMPLETED|Week 8||96
11322422|NCT03110133|12519702|FG000|NOT COMPLETED|Week 8||5
11322423|NCT03110133|12519703|FG001|NOT COMPLETED|Week 8||4
11322424|NCT03110133|12519702|FG000|STARTED|Week 24||101
11322425|NCT03110133|12519703|FG001|STARTED|Week 24||96
11322426|NCT03110133|12519702|FG000|COMPLETED|Week 24||99
11322427|NCT03110133|12519703|FG001|COMPLETED|Week 24||95
11322428|NCT03110133|12519702|FG000|NOT COMPLETED|Week 24||2
11322429|NCT03110133|12519703|FG001|NOT COMPLETED|Week 24||1
11322430|NCT03105128|12519712|FG000|STARTED|Period 1||373
11322431|NCT03105128|12519713|FG001|STARTED|Period 1||372
11322432|NCT03105128|12519714|FG002|STARTED|Period 1||186
11322433|NCT03105128|12519715|FG003|STARTED|Period 1||0
11322434|NCT03105128|12519716|FG004|STARTED|Period 1||0
11322435|NCT03105128|12519717|FG005|STARTED|Period 1||0
11322436|NCT03105128|12519718|FG006|STARTED|Period 1||0
11322437|NCT03105128|12519712|FG000|COMPLETED|Period 1||365
11322438|NCT03105128|12519713|FG001|COMPLETED|Period 1||366
11322439|NCT03105128|12519714|FG002|COMPLETED|Period 1||163
11322440|NCT03105128|12519715|FG003|COMPLETED|Period 1||0
11322441|NCT03105128|12519716|FG004|COMPLETED|Period 1||0
11322442|NCT03105128|12519717|FG005|COMPLETED|Period 1||0
11322443|NCT03105128|12519718|FG006|COMPLETED|Period 1||0
11322444|NCT03105128|12519712|FG000|NOT COMPLETED|Period 1||8
11322445|NCT03105128|12519713|FG001|NOT COMPLETED|Period 1||6
11322446|NCT03105128|12519714|FG002|NOT COMPLETED|Period 1||23
11322447|NCT03105128|12519715|FG003|NOT COMPLETED|Period 1||0
11322448|NCT03105128|12519716|FG004|NOT COMPLETED|Period 1||0
11322449|NCT03105128|12519717|FG005|NOT COMPLETED|Period 1||0
11322450|NCT03105128|12519718|FG006|NOT COMPLETED|Period 1||0
11322451|NCT03105128|12519712|FG000|STARTED|Period 2||0
11322452|NCT03105128|12519713|FG001|STARTED|Period 2||0
11402959|NCT04013737|12597924|FG001|NOT COMPLETED|Overall Study||0
11322453|NCT03105128|12519714|FG002|STARTED|Period 2||0
11322454|NCT03105128|12519715|FG003|STARTED|Period 2||67
11322455|NCT03105128|12519716|FG004|STARTED|Period 2||68
11322456|NCT03105128|12519717|FG005|STARTED|Period 2||67
11322457|NCT03105128|12519718|FG006|STARTED|Period 2||76
11322458|NCT03105128|12519712|FG000|COMPLETED|Period 2||0
11322459|NCT03105128|12519713|FG001|COMPLETED|Period 2||0
11322460|NCT03105128|12519714|FG002|COMPLETED|Period 2||0
11322461|NCT03105128|12519715|FG003|COMPLETED|Period 2||62
11322462|NCT03105128|12519716|FG004|COMPLETED|Period 2||65
11322463|NCT03105128|12519717|FG005|COMPLETED|Period 2||64
11322464|NCT03105128|12519718|FG006|COMPLETED|Period 2||74
11322465|NCT03105128|12519712|FG000|NOT COMPLETED|Period 2||0
11322466|NCT03105128|12519713|FG001|NOT COMPLETED|Period 2||0
11322467|NCT03105128|12519714|FG002|NOT COMPLETED|Period 2||0
11322468|NCT03105128|12519715|FG003|NOT COMPLETED|Period 2||5
11322469|NCT03105128|12519716|FG004|NOT COMPLETED|Period 2||3
11322470|NCT03105128|12519717|FG005|NOT COMPLETED|Period 2||3
11322471|NCT03105128|12519718|FG006|NOT COMPLETED|Period 2||2
11322472|NCT02952534|12519737|FG000|STARTED|Overall Study||172
11322473|NCT02952534|12519738|FG001|STARTED|Overall Study||59
11322474|NCT02952534|12519739|FG002|STARTED|Overall Study||14
11322475|NCT02952534|12519740|FG003|STARTED|Overall Study||7
11322476|NCT02952534|12519741|FG004|STARTED|Overall Study||25
11322477|NCT02952534|12519737|FG000|COMPLETED|Overall Study||172
11322478|NCT02952534|12519738|FG001|COMPLETED|Overall Study||59
11322479|NCT02952534|12519739|FG002|COMPLETED|Overall Study||14
11322480|NCT02952534|12519740|FG003|COMPLETED|Overall Study||7
11322481|NCT02952534|12519741|FG004|COMPLETED|Overall Study||25
11322482|NCT02952534|12519737|FG000|NOT COMPLETED|Overall Study||0
11322483|NCT02952534|12519738|FG001|NOT COMPLETED|Overall Study||0
11322484|NCT02952534|12519739|FG002|NOT COMPLETED|Overall Study||0
11322485|NCT02952534|12519740|FG003|NOT COMPLETED|Overall Study||0
11322486|NCT02952534|12519741|FG004|NOT COMPLETED|Overall Study||0
11322487|NCT02949219|12519752|FG000|STARTED|Overall Study||41
11322488|NCT02949219|12519752|FG000|COMPLETED|Overall Study||40
11322489|NCT02949219|12519752|FG000|NOT COMPLETED|Overall Study||1
11322490|NCT02921763|12519756|FG000|STARTED|Overall Study||60
11322491|NCT02921763|12519756|FG000|COMPLETED|Overall Study||42
11322492|NCT02921763|12519756|FG000|NOT COMPLETED|Overall Study||18
11322493|NCT02876172|12519776|FG000|STARTED|Overall Study||6
11322494|NCT02876172|12519777|FG001|STARTED|Overall Study||6
11322495|NCT02876172|12519776|FG000|COMPLETED|Overall Study||6
11322496|NCT02876172|12519777|FG001|COMPLETED|Overall Study||6
11322497|NCT02876172|12519776|FG000|NOT COMPLETED|Overall Study||0
11322498|NCT02876172|12519777|FG001|NOT COMPLETED|Overall Study||0
11322499|NCT02836236|12519786|FG000|STARTED|Overall Study||105
11322500|NCT02836236|12519787|FG001|STARTED|Overall Study||50
11322501|NCT02836236|12519786|FG000|COMPLETED|Overall Study||0
11322502|NCT02836236|12519787|FG001|COMPLETED|Overall Study||0
11322503|NCT02836236|12519786|FG000|NOT COMPLETED|Overall Study||105
11322504|NCT02836236|12519787|FG001|NOT COMPLETED|Overall Study||50
11322505|NCT02811861|12519796|FG000|STARTED|Overall Study||357
11322506|NCT02811861|12519797|FG001|STARTED|Overall Study||355
11322507|NCT02811861|12519798|FG002|STARTED|Overall Study||357
11322508|NCT02811861|12519796|FG000|Treated|Overall Study||355
11322509|NCT02811861|12519797|FG001|Treated|Overall Study||352
11322510|NCT02811861|12519798|FG002|Treated|Overall Study||340
11322511|NCT02811861|12519796|FG000|COMPLETED|Overall Study||0
11322512|NCT02811861|12519797|FG001|COMPLETED|Overall Study||0
11322513|NCT02811861|12519798|FG002|COMPLETED|Overall Study||0
11322514|NCT02811861|12519796|FG000|NOT COMPLETED|Overall Study||357
11322515|NCT02811861|12519797|FG001|NOT COMPLETED|Overall Study||355
11322516|NCT02811861|12519798|FG002|NOT COMPLETED|Overall Study||357
11322517|NCT02759185|12519810|FG000|STARTED|Stage 1||20
11322518|NCT02759185|12519811|FG001|STARTED|Stage 1||20
11322519|NCT02759185|12519812|FG002|STARTED|Stage 1||20
11322520|NCT02759185|12519813|FG003|STARTED|Stage 1||20
11322521|NCT02759185|12519814|FG004|STARTED|Stage 1||0
11322522|NCT02759185|12519815|FG005|STARTED|Stage 1||0
11322523|NCT02759185|12519816|FG006|STARTED|Stage 1||0
11322524|NCT02759185|12519810|FG000|COMPLETED|Stage 1||19
11322525|NCT02759185|12519811|FG001|COMPLETED|Stage 1||19
11322526|NCT02759185|12519812|FG002|COMPLETED|Stage 1||17
11322527|NCT02759185|12519813|FG003|COMPLETED|Stage 1||20
11322528|NCT02759185|12519814|FG004|COMPLETED|Stage 1||0
11322529|NCT02759185|12519815|FG005|COMPLETED|Stage 1||0
11322530|NCT02759185|12519816|FG006|COMPLETED|Stage 1||0
11322531|NCT02759185|12519810|FG000|NOT COMPLETED|Stage 1||1
11322532|NCT02759185|12519811|FG001|NOT COMPLETED|Stage 1||1
11322533|NCT02759185|12519812|FG002|NOT COMPLETED|Stage 1||3
11322534|NCT02759185|12519813|FG003|NOT COMPLETED|Stage 1||0
11402960|NCT04014062|12597931|FG000|STARTED|Period I: Dosing||71
11322535|NCT02759185|12519814|FG004|NOT COMPLETED|Stage 1||0
11322536|NCT02759185|12519815|FG005|NOT COMPLETED|Stage 1||0
11322537|NCT02759185|12519816|FG006|NOT COMPLETED|Stage 1||0
11322538|NCT02759185|12519810|FG000|STARTED|Stage 2||0
11322539|NCT02759185|12519811|FG001|STARTED|Stage 2||0
11322540|NCT02759185|12519812|FG002|STARTED|Stage 2||0
11322541|NCT02759185|12519813|FG003|STARTED|Stage 2||0
11322542|NCT02759185|12519814|FG004|STARTED|Stage 2||29
11322543|NCT02759185|12519815|FG005|STARTED|Stage 2||27
11322544|NCT02759185|12519816|FG006|STARTED|Stage 2||18
11322545|NCT02759185|12519810|FG000|COMPLETED|Stage 2||0
11322546|NCT02759185|12519811|FG001|COMPLETED|Stage 2||0
11322547|NCT02759185|12519812|FG002|COMPLETED|Stage 2||0
11322548|NCT02759185|12519813|FG003|COMPLETED|Stage 2||0
11322549|NCT02759185|12519814|FG004|COMPLETED|Stage 2||27
11322550|NCT02759185|12519815|FG005|COMPLETED|Stage 2||24
11322551|NCT02759185|12519816|FG006|COMPLETED|Stage 2||17
11322552|NCT02759185|12519810|FG000|NOT COMPLETED|Stage 2||0
11322553|NCT02759185|12519811|FG001|NOT COMPLETED|Stage 2||0
11322554|NCT02759185|12519812|FG002|NOT COMPLETED|Stage 2||0
11322555|NCT02759185|12519813|FG003|NOT COMPLETED|Stage 2||0
11322556|NCT02759185|12519814|FG004|NOT COMPLETED|Stage 2||2
11322557|NCT02759185|12519815|FG005|NOT COMPLETED|Stage 2||3
11322558|NCT02759185|12519816|FG006|NOT COMPLETED|Stage 2||1
11342758|NCT02948582|12540167|FG000|STARTED|Washout Period 4||7
11342759|NCT02948582|12540168|FG001|STARTED|Washout Period 4||4
11342760|NCT02948582|12540169|FG002|STARTED|Washout Period 4||7
11342761|NCT02948582|12540170|FG003|STARTED|Washout Period 4||6
11342762|NCT02948582|12540171|FG004|STARTED|Washout Period 4||7
11342763|NCT02948582|12540172|FG005|STARTED|Washout Period 4||6
11342764|NCT02948582|12540167|FG000|COMPLETED|Washout Period 4||6
11342765|NCT02948582|12540168|FG001|COMPLETED|Washout Period 4||4
11342766|NCT02948582|12540169|FG002|COMPLETED|Washout Period 4||6
11342767|NCT02948582|12540170|FG003|COMPLETED|Washout Period 4||6
11342768|NCT02948582|12540171|FG004|COMPLETED|Washout Period 4||7
11342769|NCT02948582|12540172|FG005|COMPLETED|Washout Period 4||6
11342770|NCT02948582|12540167|FG000|NOT COMPLETED|Washout Period 4||1
11342771|NCT02948582|12540168|FG001|NOT COMPLETED|Washout Period 4||0
11342772|NCT02948582|12540169|FG002|NOT COMPLETED|Washout Period 4||1
11342773|NCT02948582|12540170|FG003|NOT COMPLETED|Washout Period 4||0
11342774|NCT02948582|12540171|FG004|NOT COMPLETED|Washout Period 4||0
11342775|NCT02948582|12540172|FG005|NOT COMPLETED|Washout Period 4||0
11342776|NCT02948582|12540167|FG000|STARTED|Treatment Period 5||6
11342777|NCT02948582|12540168|FG001|STARTED|Treatment Period 5||4
11342778|NCT02948582|12540169|FG002|STARTED|Treatment Period 5||6
11342779|NCT02948582|12540170|FG003|STARTED|Treatment Period 5||6
11342780|NCT02948582|12540171|FG004|STARTED|Treatment Period 5||7
11342781|NCT02948582|12540172|FG005|STARTED|Treatment Period 5||6
11342782|NCT02948582|12540167|FG000|COMPLETED|Treatment Period 5||6
11342783|NCT02948582|12540168|FG001|COMPLETED|Treatment Period 5||4
11342784|NCT02948582|12540169|FG002|COMPLETED|Treatment Period 5||6
11342785|NCT02948582|12540170|FG003|COMPLETED|Treatment Period 5||6
11342786|NCT02948582|12540171|FG004|COMPLETED|Treatment Period 5||7
11342787|NCT02948582|12540172|FG005|COMPLETED|Treatment Period 5||6
11342788|NCT02948582|12540167|FG000|NOT COMPLETED|Treatment Period 5||0
11342789|NCT02948582|12540168|FG001|NOT COMPLETED|Treatment Period 5||0
11342790|NCT02948582|12540169|FG002|NOT COMPLETED|Treatment Period 5||0
11342791|NCT02948582|12540170|FG003|NOT COMPLETED|Treatment Period 5||0
11342792|NCT02948582|12540171|FG004|NOT COMPLETED|Treatment Period 5||0
11342793|NCT02948582|12540172|FG005|NOT COMPLETED|Treatment Period 5||0
11342794|NCT02948582|12540167|FG000|STARTED|Washout Period 5||6
11342795|NCT02948582|12540168|FG001|STARTED|Washout Period 5||4
11342796|NCT02948582|12540169|FG002|STARTED|Washout Period 5||6
11342797|NCT02948582|12540170|FG003|STARTED|Washout Period 5||6
11342798|NCT02948582|12540171|FG004|STARTED|Washout Period 5||7
11342799|NCT02948582|12540172|FG005|STARTED|Washout Period 5||6
11342800|NCT02948582|12540167|FG000|COMPLETED|Washout Period 5||6
11342801|NCT02948582|12540168|FG001|COMPLETED|Washout Period 5||4
11342802|NCT02948582|12540169|FG002|COMPLETED|Washout Period 5||6
11342803|NCT02948582|12540170|FG003|COMPLETED|Washout Period 5||6
11342804|NCT02948582|12540171|FG004|COMPLETED|Washout Period 5||7
11342805|NCT02948582|12540172|FG005|COMPLETED|Washout Period 5||6
11342806|NCT02948582|12540167|FG000|NOT COMPLETED|Washout Period 5||0
11342807|NCT02948582|12540168|FG001|NOT COMPLETED|Washout Period 5||0
11342808|NCT02948582|12540169|FG002|NOT COMPLETED|Washout Period 5||0
11342809|NCT02948582|12540170|FG003|NOT COMPLETED|Washout Period 5||0
11342810|NCT02948582|12540171|FG004|NOT COMPLETED|Washout Period 5||0
11342811|NCT02948582|12540172|FG005|NOT COMPLETED|Washout Period 5||0
11342812|NCT02948582|12540167|FG000|STARTED|Treatment Period 6||6
11342813|NCT02948582|12540168|FG001|STARTED|Treatment Period 6||4
11342814|NCT02948582|12540169|FG002|STARTED|Treatment Period 6||6
11402961|NCT04014062|12597932|FG001|STARTED|Period I: Dosing||71
11322559|NCT02629159|12519841|FG000|STARTED|Overall Study||651
11322560|NCT02629159|12519842|FG001|STARTED|Overall Study||327
11322561|NCT02629159|12519843|FG002|STARTED|Overall Study||651
11322562|NCT02629159|12519841|FG000|Received Assigned Study Drug|Overall Study||651
11322563|NCT02629159|12519842|FG001|Received Assigned Study Drug|Overall Study||327
11322564|NCT02629159|12519843|FG002|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650
11322565|NCT02629159|12519841|FG000|Completed Week 14 on Study Drug|Overall Study||620
11322566|NCT02629159|12519842|FG001|Completed Week 14 on Study Drug|Overall Study||300
11322567|NCT02629159|12519843|FG002|Completed Week 14 on Study Drug|Overall Study||620
11322568|NCT02629159|12519841|FG000|Rescued at Week 14|Overall Study||231
11322569|NCT02629159|12519842|FG001|Rescued at Week 14|Overall Study||56
11322570|NCT02629159|12519843|FG002|Rescued at Week 14|Overall Study||78
11322571|NCT02629159|12519841|FG000|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48
11322572|NCT02629159|12519842|FG001|Rescued at Week 18|Overall Study||14
11322573|NCT02629159|12519843|FG002|Rescued at Week 18|Overall Study||29
11322574|NCT02629159|12519841|FG000|Rescued at Week 22|Overall Study||26
11322575|NCT02629159|12519842|FG001|Rescued at Week 22|Overall Study||7
11322576|NCT02629159|12519843|FG002|Rescued at Week 22|Overall Study||18
11322577|NCT02629159|12519841|FG000|COMPLETED|Overall Study||595
11322578|NCT02629159|12519842|FG001|COMPLETED|Overall Study||288
11402962|NCT04014062|12597931|FG000|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64
11402963|NCT04014062|12597932|FG001|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65
11402964|NCT04014062|12597931|FG000|NOT COMPLETED|Period I: Dosing||7
11402965|NCT04014062|12597932|FG001|NOT COMPLETED|Period I: Dosing||6
11402966|NCT04014062|12597931|FG000|STARTED|Period II: Crossover Dosing||64
11402967|NCT04014062|12597932|FG001|STARTED|Period II: Crossover Dosing||65
11402968|NCT04014062|12597931|FG000|COMPLETED|Period II: Crossover Dosing||64
11402969|NCT04014062|12597932|FG001|COMPLETED|Period II: Crossover Dosing||65
11402970|NCT04014062|12597931|FG000|NOT COMPLETED|Period II: Crossover Dosing||0
11402971|NCT04014062|12597932|FG001|NOT COMPLETED|Period II: Crossover Dosing||0
11402972|NCT04013789|12597943|FG000|STARTED|First Wear Period (1 Week)||33
11402973|NCT04013789|12597944|FG001|STARTED|First Wear Period (1 Week)||34
11402974|NCT04013789|12597943|FG000|COMPLETED|First Wear Period (1 Week)||33
11402975|NCT04013789|12597944|FG001|COMPLETED|First Wear Period (1 Week)||34
11402976|NCT04013789|12597943|FG000|NOT COMPLETED|First Wear Period (1 Week)||0
11402977|NCT04013789|12597944|FG001|NOT COMPLETED|First Wear Period (1 Week)||0
11402978|NCT04013789|12597943|FG000|STARTED|Second Wear Period (1 Week)|One subject withdrew from the study between the first wear period and the second wear period.|32
11402979|NCT04013789|12597944|FG001|STARTED|Second Wear Period (1 Week)||34
11402980|NCT04013789|12597943|FG000|COMPLETED|Second Wear Period (1 Week)||32
11402981|NCT04013789|12597944|FG001|COMPLETED|Second Wear Period (1 Week)||34
11402982|NCT04013789|12597943|FG000|NOT COMPLETED|Second Wear Period (1 Week)||0
11402983|NCT04013789|12597944|FG001|NOT COMPLETED|Second Wear Period (1 Week)||0
11402984|NCT04012970|12597954|FG000|STARTED|Intervention Session, 30 Minutes||26
11402985|NCT04012970|12597955|FG001|STARTED|Intervention Session, 30 Minutes||14
11402986|NCT04012970|12597954|FG000|COMPLETED|Intervention Session, 30 Minutes||26
11402987|NCT04012970|12597955|FG001|COMPLETED|Intervention Session, 30 Minutes||14
11402988|NCT04012970|12597954|FG000|NOT COMPLETED|Intervention Session, 30 Minutes||0
11402989|NCT04012970|12597955|FG001|NOT COMPLETED|Intervention Session, 30 Minutes||0
11402990|NCT04012970|12597954|FG000|STARTED|Control Session, 30 Minutes||26
11402991|NCT04012970|12597955|FG001|STARTED|Control Session, 30 Minutes||14
11402992|NCT04012970|12597954|FG000|COMPLETED|Control Session, 30 Minutes||26
11402993|NCT04012970|12597955|FG001|COMPLETED|Control Session, 30 Minutes||14
11402994|NCT04012970|12597954|FG000|NOT COMPLETED|Control Session, 30 Minutes||0
11402995|NCT04012970|12597955|FG001|NOT COMPLETED|Control Session, 30 Minutes||0
11402996|NCT04013191|12597969|FG000|STARTED|Overall Study||10
11402997|NCT04013191|12597970|FG001|STARTED|Overall Study||18
11402998|NCT04013191|12597969|FG000|Completed Period 1A (Single Dose)|Overall Study||10
11402999|NCT04013191|12597970|FG001|Completed Period 1A (Single Dose)|Overall Study||18
11403000|NCT04013191|12597969|FG000|Completed Period 1B (Multiple Dose)|Overall Study||9
11403001|NCT04013191|12597970|FG001|Completed Period 1B (Multiple Dose)|Overall Study||18
11403002|NCT04013191|12597969|FG000|COMPLETED|Overall Study||9
11403003|NCT04013191|12597970|FG001|COMPLETED|Overall Study||18
11403004|NCT04013191|12597969|FG000|NOT COMPLETED|Overall Study||1
11403005|NCT04013191|12597970|FG001|NOT COMPLETED|Overall Study||0
11403006|NCT04011631|12597980|FG000|STARTED|Overall Study||100
11403007|NCT04011631|12597980|FG000|COMPLETED|Overall Study||100
11403008|NCT04011631|12597980|FG000|NOT COMPLETED|Overall Study||0
11403009|NCT04011735|12597987|FG000|STARTED|Overall Study||133
11403010|NCT04011735|12597988|FG001|STARTED|Overall Study||71
11403011|NCT04011735|12597989|FG002|STARTED|Overall Study||56
11403012|NCT04011735|12597987|FG000|COMPLETED|Overall Study||132
11403013|NCT04011735|12597988|FG001|COMPLETED|Overall Study||70
11403014|NCT04011735|12597989|FG002|COMPLETED|Overall Study||55
11403015|NCT04011735|12597987|FG000|NOT COMPLETED|Overall Study||1
11403016|NCT04011735|12597988|FG001|NOT COMPLETED|Overall Study||1
11403017|NCT04011735|12597989|FG002|NOT COMPLETED|Overall Study||1
11403018|NCT04009577|12598003|FG000|STARTED|Core Study||7
11403019|NCT04009577|12598004|FG001|STARTED|Core Study||3
11403020|NCT04009577|12598005|FG002|STARTED|Core Study||21
11403021|NCT04009577|12598006|FG003|STARTED|Core Study||22
11403022|NCT04009577|12598003|FG000|LEM5|Core Study||7
11403023|NCT04009577|12598004|FG001|LEM5|Core Study||3
11403024|NCT04009577|12598005|FG002|LEM5|Core Study||21
11403025|NCT04009577|12598006|FG003|LEM5|Core Study||5
11403026|NCT04009577|12598003|FG000|LEM10|Core Study||3
11403027|NCT04009577|12598004|FG001|LEM10|Core Study||2
11403028|NCT04009577|12598005|FG002|LEM10|Core Study||10
11403029|NCT04009577|12598006|FG003|LEM10|Core Study||22
11403030|NCT04009577|12598003|FG000|COMPLETED|Core Study||6
11403031|NCT04009577|12598004|FG001|COMPLETED|Core Study||3
11403032|NCT04009577|12598005|FG002|COMPLETED|Core Study||17
11403033|NCT04009577|12598006|FG003|COMPLETED|Core Study||17
11403034|NCT04009577|12598003|FG000|NOT COMPLETED|Core Study||1
11403035|NCT04009577|12598004|FG001|NOT COMPLETED|Core Study||0
11403036|NCT04009577|12598005|FG002|NOT COMPLETED|Core Study||4
11403037|NCT04009577|12598006|FG003|NOT COMPLETED|Core Study||5
11403038|NCT04009577|12598003|FG000|STARTED|Extension Phase||6
11403039|NCT04009577|12598004|FG001|STARTED|Extension Phase||3
11403040|NCT04009577|12598005|FG002|STARTED|Extension Phase||17
11403041|NCT04009577|12598006|FG003|STARTED|Extension Phase||17
11403042|NCT04009577|12598003|FG000|Treated|Extension Phase||6
11403043|NCT04009577|12598004|FG001|Treated|Extension Phase||3
11403044|NCT04009577|12598005|FG002|Treated|Extension Phase||15
11403045|NCT04009577|12598006|FG003|Treated|Extension Phase||17
11403046|NCT04009577|12598003|FG000|LEM5|Extension Phase||6
11403047|NCT04009577|12598004|FG001|LEM5|Extension Phase||3
11403048|NCT04009577|12598005|FG002|LEM5|Extension Phase||15
11403049|NCT04009577|12598006|FG003|LEM5|Extension Phase||8
11403050|NCT04009577|12598003|FG000|LEM10|Extension Phase||5
11403051|NCT04009577|12598004|FG001|LEM10|Extension Phase||3
11403052|NCT04009577|12598005|FG002|LEM10|Extension Phase||12
11403053|NCT04009577|12598006|FG003|LEM10|Extension Phase||17
11403054|NCT04009577|12598003|FG000|COMPLETED|Extension Phase||6
11403055|NCT04009577|12598004|FG001|COMPLETED|Extension Phase||3
11403056|NCT04009577|12598005|FG002|COMPLETED|Extension Phase||13
11403057|NCT04009577|12598006|FG003|COMPLETED|Extension Phase||16
11403058|NCT04009577|12598003|FG000|NOT COMPLETED|Extension Phase||0
11403059|NCT04009577|12598004|FG001|NOT COMPLETED|Extension Phase||0
11403060|NCT04009577|12598005|FG002|NOT COMPLETED|Extension Phase||4
11403061|NCT04009577|12598006|FG003|NOT COMPLETED|Extension Phase||1
11403062|NCT04007159|12598032|FG000|STARTED|Induction Phase||280
11403063|NCT04007159|12598032|FG000|COMPLETED|Induction Phase||258
11403064|NCT04007159|12598032|FG000|NOT COMPLETED|Induction Phase||22
11403065|NCT04007159|12598032|FG000|STARTED|Rest Phase||258
11403066|NCT04007159|12598032|FG000|COMPLETED|Rest Phase||258
11403067|NCT04007159|12598032|FG000|NOT COMPLETED|Rest Phase||0
11403068|NCT04007159|12598032|FG000|STARTED|Challenge Phase||258
11403069|NCT04007159|12598032|FG000|COMPLETED|Challenge Phase||255
11403070|NCT04007159|12598032|FG000|NOT COMPLETED|Challenge Phase||3
11403071|NCT04007107|12598043|FG000|STARTED|Treatment Period 1 (Day 1)||26
11403072|NCT04007107|12598044|FG001|STARTED|Treatment Period 1 (Day 1)||26
11403073|NCT04007107|12598045|FG002|STARTED|Treatment Period 1 (Day 1)||25
11403074|NCT04007107|12598046|FG003|STARTED|Treatment Period 1 (Day 1)||26
11403075|NCT04007107|12598043|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
11403076|NCT04007107|12598044|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
11403077|NCT04007107|12598045|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||25
11403078|NCT04007107|12598046|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
11403079|NCT04007107|12598043|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
11403080|NCT04007107|12598044|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
11403081|NCT04007107|12598045|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||25
11403082|NCT04007107|12598046|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
11403083|NCT04007107|12598043|FG000|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
11403084|NCT04007107|12598044|FG001|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
11403085|NCT04007107|12598045|FG002|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
11403086|NCT04007107|12598046|FG003|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
11403087|NCT04007107|12598043|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
11403088|NCT04007107|12598044|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
11403089|NCT04007107|12598045|FG002|COMPLETED|Treatment Period 1 (Day 1)||25
11403090|NCT04007107|12598046|FG003|COMPLETED|Treatment Period 1 (Day 1)||26
11403091|NCT04007107|12598043|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11403092|NCT04007107|12598044|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11403093|NCT04007107|12598045|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11403094|NCT04007107|12598046|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11403095|NCT04007107|12598043|FG000|STARTED|Treatment Period 2 (Day 1)||26
11403096|NCT04007107|12598044|FG001|STARTED|Treatment Period 2 (Day 1)||26
11403097|NCT04007107|12598045|FG002|STARTED|Treatment Period 2 (Day 1)||25
11403098|NCT04007107|12598046|FG003|STARTED|Treatment Period 2 (Day 1)||26
11403099|NCT04007107|12598043|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
11403100|NCT04007107|12598044|FG001|COMPLETED|Treatment Period 2 (Day 1)||25
11403101|NCT04007107|12598045|FG002|COMPLETED|Treatment Period 2 (Day 1)||25
11403102|NCT04007107|12598046|FG003|COMPLETED|Treatment Period 2 (Day 1)||26
11403103|NCT04007107|12598043|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
11403104|NCT04007107|12598044|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||1
11403105|NCT04007107|12598045|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
11403106|NCT04007107|12598046|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
11403107|NCT04006795|12598051|FG000|STARTED|Induction Phase||37
11403108|NCT04006795|12598051|FG000|COMPLETED|Induction Phase||37
11403109|NCT04006795|12598051|FG000|NOT COMPLETED|Induction Phase||0
11403110|NCT04006795|12598051|FG000|STARTED|Rest Phase||37
11403111|NCT04006795|12598051|FG000|COMPLETED|Rest Phase||37
11403112|NCT04006795|12598051|FG000|NOT COMPLETED|Rest Phase||0
11403113|NCT04006795|12598051|FG000|STARTED|Challenge Phase||37
11403114|NCT04006795|12598051|FG000|COMPLETED|Challenge Phase||37
11403115|NCT04006795|12598051|FG000|NOT COMPLETED|Challenge Phase||0
11403116|NCT04005885|12598062|FG000|STARTED|First Intervention||26
11403117|NCT04005885|12598063|FG001|STARTED|First Intervention||29
11403118|NCT04005885|12598062|FG000|COMPLETED|First Intervention||25
11403119|NCT04005885|12598063|FG001|COMPLETED|First Intervention||28
11403120|NCT04005885|12598062|FG000|NOT COMPLETED|First Intervention||1
11403121|NCT04005885|12598063|FG001|NOT COMPLETED|First Intervention||1
11403122|NCT04005885|12598062|FG000|STARTED|Second Intervention||25
11403123|NCT04005885|12598063|FG001|STARTED|Second Intervention||28
11403124|NCT04005885|12598062|FG000|COMPLETED|Second Intervention||25
11403125|NCT04005885|12598063|FG001|COMPLETED|Second Intervention||26
11403126|NCT04005885|12598062|FG000|NOT COMPLETED|Second Intervention||0
11403127|NCT04005885|12598063|FG001|NOT COMPLETED|Second Intervention||2
11403128|NCT04005885|12598062|FG000|STARTED|Third Intervention||25
11403129|NCT04005885|12598063|FG001|STARTED|Third Intervention||26
11403130|NCT04005885|12598062|FG000|COMPLETED|Third Intervention||25
11403131|NCT04005885|12598063|FG001|COMPLETED|Third Intervention||26
11403132|NCT04005885|12598062|FG000|NOT COMPLETED|Third Intervention||0
11403133|NCT04005885|12598063|FG001|NOT COMPLETED|Third Intervention||0
11403134|NCT04000815|12598077|FG000|STARTED|Overall Study||29
11403135|NCT04000815|12598078|FG001|STARTED|Overall Study||20
11403136|NCT04000815|12598079|FG002|STARTED|Overall Study||22
11403137|NCT04000815|12598077|FG000|COMPLETED|Overall Study||15
11403138|NCT04000815|12598078|FG001|COMPLETED|Overall Study||15
11403139|NCT04000815|12598079|FG002|COMPLETED|Overall Study||15
11403140|NCT04000815|12598077|FG000|NOT COMPLETED|Overall Study||14
11403141|NCT04000815|12598078|FG001|NOT COMPLETED|Overall Study||5
11403142|NCT04000815|12598079|FG002|NOT COMPLETED|Overall Study||7
11403143|NCT03999944|12598087|FG000|STARTED|First Sleep Night||26
11403144|NCT03999944|12598088|FG001|STARTED|First Sleep Night||26
11403145|NCT03999944|12598087|FG000|COMPLETED|First Sleep Night||22
11403146|NCT03999944|12598088|FG001|COMPLETED|First Sleep Night||24
11403147|NCT03999944|12598087|FG000|NOT COMPLETED|First Sleep Night||4
11403148|NCT03999944|12598088|FG001|NOT COMPLETED|First Sleep Night||2
11403149|NCT03999944|12598087|FG000|STARTED|Second Sleep Night||22
11403150|NCT03999944|12598088|FG001|STARTED|Second Sleep Night||24
11403151|NCT03999944|12598087|FG000|COMPLETED|Second Sleep Night||22
11403152|NCT03999944|12598088|FG001|COMPLETED|Second Sleep Night||20
11403153|NCT03999944|12598087|FG000|NOT COMPLETED|Second Sleep Night||0
11403154|NCT03999944|12598088|FG001|NOT COMPLETED|Second Sleep Night||4
11403155|NCT03995680|12598097|FG000|STARTED|Overall Study||199
11403156|NCT03995680|12598098|FG001|STARTED|Overall Study||198
11403157|NCT03995680|12598097|FG000|COMPLETED|Overall Study||197
11403158|NCT03995680|12598098|FG001|COMPLETED|Overall Study||196
11403159|NCT03995680|12598097|FG000|NOT COMPLETED|Overall Study||2
11403160|NCT03995680|12598098|FG001|NOT COMPLETED|Overall Study||2
11403161|NCT04006366|12598104|FG000|STARTED|Overall Study||6
11403162|NCT04006366|12598104|FG000|COMPLETED|Overall Study||5
11403163|NCT04006366|12598104|FG000|NOT COMPLETED|Overall Study||1
11403164|NCT04006145|12598110|FG000|STARTED|Overall Study||23
11403165|NCT04006145|12598111|FG001|STARTED|Overall Study||24
11403166|NCT04006145|12598110|FG000|Received Treatment|Overall Study||23
11403167|NCT04006145|12598111|FG001|Received Treatment|Overall Study||24
11403168|NCT04006145|12598110|FG000|COMPLETED|Overall Study||22
11403169|NCT04006145|12598111|FG001|COMPLETED|Overall Study||21
11403170|NCT04006145|12598110|FG000|NOT COMPLETED|Overall Study||1
11403171|NCT04006145|12598111|FG001|NOT COMPLETED|Overall Study||3
11403172|NCT04005755|12598117|FG000|STARTED|Overall Study||232
11403173|NCT04005755|12598117|FG000|COMPLETED|Overall Study||215
11403174|NCT04005755|12598117|FG000|NOT COMPLETED|Overall Study||17
11403175|NCT04005586|12598121|FG000|STARTED|Overall Study||25
11403176|NCT04005586|12598121|FG000|COMPLETED|Overall Study||25
11403177|NCT04005586|12598121|FG000|NOT COMPLETED|Overall Study||0
11403178|NCT04005404|12598128|FG000|STARTED|Overall Study||43
11403179|NCT04005404|12598129|FG001|STARTED|Overall Study||34
11403180|NCT04005404|12598130|FG002|STARTED|Overall Study||3
11403181|NCT04005404|12598128|FG000|COMPLETED|Overall Study||42
11403182|NCT04005404|12598129|FG001|COMPLETED|Overall Study||33
11403183|NCT04005404|12598130|FG002|COMPLETED|Overall Study||3
11403184|NCT04005404|12598128|FG000|NOT COMPLETED|Overall Study||1
11403185|NCT04005404|12598129|FG001|NOT COMPLETED|Overall Study||1
11403186|NCT04005404|12598130|FG002|NOT COMPLETED|Overall Study||0
11403187|NCT03993288|12598140|FG000|STARTED|Overall Study||133
11403188|NCT03993288|12598141|FG001|STARTED|Overall Study||134
11403189|NCT03993288|12598140|FG000|Intention-to-treat (ITT) Population|Overall Study||123
11403190|NCT03993288|12598141|FG001|Intention-to-treat (ITT) Population|Overall Study||129
11403191|NCT03993288|12598140|FG000|Safety Analysis Set|Overall Study||133
11403192|NCT03993288|12598141|FG001|Safety Analysis Set|Overall Study||134
11403193|NCT03993288|12598140|FG000|COMPLETED|Overall Study||123
11403194|NCT03993288|12598141|FG001|COMPLETED|Overall Study||129
11403195|NCT03993288|12598140|FG000|NOT COMPLETED|Overall Study||10
11403196|NCT03993288|12598141|FG001|NOT COMPLETED|Overall Study||5
11403197|NCT03990298|12598147|FG000|STARTED|Overall Study||16
11403198|NCT03990298|12598147|FG000|COMPLETED|Overall Study||16
11403199|NCT03990298|12598147|FG000|NOT COMPLETED|Overall Study||0
11403200|NCT03988647|12598151|FG000|STARTED|Overall Study||1
11403201|NCT03988647|12598151|FG000|COMPLETED|Overall Study||1
11403202|NCT03988647|12598151|FG000|NOT COMPLETED|Overall Study||0
11403203|NCT03979872|12598159|FG000|STARTED|Overall Study||22
11403204|NCT03979872|12598160|FG001|STARTED|Overall Study||23
11403205|NCT03979872|12598161|FG002|STARTED|Overall Study||24
11403206|NCT03979872|12598162|FG003|STARTED|Overall Study||23
11403207|NCT03979872|12598159|FG000|COMPLETED|Overall Study||19
11403208|NCT03979872|12598160|FG001|COMPLETED|Overall Study||15
11403209|NCT03979872|12598161|FG002|COMPLETED|Overall Study||18
11403210|NCT03979872|12598162|FG003|COMPLETED|Overall Study||19
11403211|NCT03979872|12598159|FG000|NOT COMPLETED|Overall Study||3
11403212|NCT03979872|12598160|FG001|NOT COMPLETED|Overall Study||8
11403213|NCT03979872|12598161|FG002|NOT COMPLETED|Overall Study||6
11403214|NCT03979872|12598162|FG003|NOT COMPLETED|Overall Study||4
11403215|NCT03978832|12598172|FG000|STARTED|Overall Study|69 participants signed the ICF and entered screening; 25 met eligibility criteria and were enrolled.|69
11403216|NCT03978832|12598172|FG000|Stabilization Period|Overall Study||25
11403217|NCT03978832|12598172|FG000|Treatment Period|Overall Study||23
11403218|NCT03978832|12598172|FG000|COMPLETED|Overall Study||15
11403219|NCT03978832|12598172|FG000|NOT COMPLETED|Overall Study||54
11403220|NCT04005391|12598178|FG000|STARTED|Overall Study|10/23/18|108
11403221|NCT04005391|12598179|FG001|STARTED|Overall Study|10/23/18|100
11403222|NCT04005391|12598178|FG000|COMPLETED|Overall Study||101
11403223|NCT04005391|12598179|FG001|COMPLETED|Overall Study||100
11403224|NCT04005391|12598178|FG000|NOT COMPLETED|Overall Study||7
11403225|NCT04005391|12598179|FG001|NOT COMPLETED|Overall Study||0
11403226|NCT04004481|12598189|FG000|STARTED|Overall Study||50
11403227|NCT04004481|12598189|FG000|COMPLETED|Overall Study||47
11403228|NCT04004481|12598189|FG000|NOT COMPLETED|Overall Study||3
11403229|NCT04004260|12598213|FG000|STARTED|Overall Study||79
11403230|NCT04004260|12598214|FG001|STARTED|Overall Study||79
11403231|NCT04004260|12598213|FG000|COMPLETED|Overall Study||37
11403232|NCT04004260|12598214|FG001|COMPLETED|Overall Study||47
11403233|NCT04004260|12598213|FG000|NOT COMPLETED|Overall Study||42
11403234|NCT04004260|12598214|FG001|NOT COMPLETED|Overall Study||32
11403235|NCT03997851|12598220|FG000|STARTED|Overall Study||17
11403236|NCT03997851|12598220|FG000|COMPLETED|Overall Study||17
11403237|NCT03997851|12598220|FG000|NOT COMPLETED|Overall Study||0
11403238|NCT03991715|12598230|FG000|STARTED|Overall Study||5
11403239|NCT03991715|12598230|FG000|COMPLETED|Overall Study||5
11403240|NCT03991715|12598230|FG000|NOT COMPLETED|Overall Study||0
11403241|NCT03990415|12598237|FG000|STARTED|Overall Study||19
11403242|NCT03990415|12598238|FG001|STARTED|Overall Study||19
11403243|NCT03990415|12598239|FG002|STARTED|Overall Study||14
11403244|NCT03990415|12598237|FG000|COMPLETED|Overall Study||15
11403245|NCT03990415|12598238|FG001|COMPLETED|Overall Study||17
11403246|NCT03990415|12598239|FG002|COMPLETED|Overall Study||14
11403247|NCT03990415|12598237|FG000|NOT COMPLETED|Overall Study||4
11403248|NCT03990415|12598238|FG001|NOT COMPLETED|Overall Study||2
11403249|NCT03990415|12598239|FG002|NOT COMPLETED|Overall Study||0
11403250|NCT04002960|12598247|FG000|STARTED|Overall Study||23
11403251|NCT04002960|12598247|FG000|COMPLETED|Overall Study||21
11403252|NCT04002960|12598247|FG000|NOT COMPLETED|Overall Study||2
11403253|NCT04002973|12598251|FG000|STARTED|Overall Study||11
11403254|NCT04002973|12598251|FG000|COMPLETED|Overall Study||11
11403255|NCT04002973|12598251|FG000|NOT COMPLETED|Overall Study||0
11403256|NCT04002648|12598257|FG000|STARTED|Overall Study||104
11403257|NCT04002648|12598258|FG001|STARTED|Overall Study||104
11403258|NCT04002648|12598257|FG000|COMPLETED|Overall Study||102
11403259|NCT04002648|12598258|FG001|COMPLETED|Overall Study||104
11403260|NCT04002648|12598257|FG000|NOT COMPLETED|Overall Study||2
11403261|NCT04002648|12598258|FG001|NOT COMPLETED|Overall Study||0
11403262|NCT03993210|12598266|FG000|STARTED|Overall Study||1
11403263|NCT03993210|12598267|FG001|STARTED|Overall Study||0
11403264|NCT03993210|12598266|FG000|COMPLETED|Overall Study||1
11403265|NCT03993210|12598267|FG001|COMPLETED|Overall Study||0
11403266|NCT03993210|12598266|FG000|NOT COMPLETED|Overall Study||0
11403267|NCT03993210|12598267|FG001|NOT COMPLETED|Overall Study||0
11403268|NCT03992014|12598277|FG000|STARTED|Treatment Period 1 (8 Days)||6
11403269|NCT03992014|12598277|FG000|COMPLETED|Treatment Period 1 (8 Days)||6
11403270|NCT03992014|12598277|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11403271|NCT03992014|12598277|FG000|STARTED|Washout Period (7 Days)||6
11403272|NCT03992014|12598277|FG000|COMPLETED|Washout Period (7 Days)||6
11403273|NCT03992014|12598277|FG000|NOT COMPLETED|Washout Period (7 Days)||0
11403274|NCT03992014|12598277|FG000|STARTED|Treatment Period 2 (8 Days)||6
11403275|NCT03992014|12598277|FG000|COMPLETED|Treatment Period 2 (8 Days)||6
11403276|NCT03992014|12598277|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11403277|NCT03990649|12598287|FG000|STARTED|Part A: DB Treatment Period (15 Weeks)||9
11403278|NCT03990649|12598288|FG001|STARTED|Part A: DB Treatment Period (15 Weeks)||15
11403279|NCT03990649|12598289|FG002|STARTED|Part A: DB Treatment Period (15 Weeks)||0
11403280|NCT03990649|12598287|FG000|COMPLETED|Part A: DB Treatment Period (15 Weeks)||6
11403281|NCT03990649|12598288|FG001|COMPLETED|Part A: DB Treatment Period (15 Weeks)||12
11403282|NCT03990649|12598289|FG002|COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
11403283|NCT03990649|12598287|FG000|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
11403284|NCT03990649|12598288|FG001|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
11403285|NCT03990649|12598289|FG002|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
11403286|NCT03990649|12598287|FG000|STARTED|Part B: OL Extension Period (14 Weeks)||0
11403287|NCT03990649|12598288|FG001|STARTED|Part B: OL Extension Period (14 Weeks)||0
11403288|NCT03990649|12598289|FG002|STARTED|Part B: OL Extension Period (14 Weeks)||18
11403289|NCT03990649|12598287|FG000|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
11403290|NCT03990649|12598288|FG001|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
11403291|NCT03990649|12598289|FG002|COMPLETED|Part B: OL Extension Period (14 Weeks)||14
11403292|NCT03990649|12598287|FG000|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
11403293|NCT03990649|12598288|FG001|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
11403294|NCT03990649|12598289|FG002|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||4
11403295|NCT04002791|12598298|FG000|STARTED|Overall Study||127
11403296|NCT04002791|12598299|FG001|STARTED|Overall Study||126
11403297|NCT04002791|12598298|FG000|COMPLETED|Overall Study||127
11403298|NCT04002791|12598299|FG001|COMPLETED|Overall Study||126
11403299|NCT04002791|12598298|FG000|NOT COMPLETED|Overall Study||0
11403300|NCT04002791|12598299|FG001|NOT COMPLETED|Overall Study||0
11403301|NCT03996694|12598305|FG000|STARTED|First Intervention (1 Day)||3
11403302|NCT03996694|12598306|FG001|STARTED|First Intervention (1 Day)||3
11403303|NCT03996694|12598307|FG002|STARTED|First Intervention (1 Day)||4
11403304|NCT03996694|12598308|FG003|STARTED|First Intervention (1 Day)||3
11403305|NCT03996694|12598309|FG004|STARTED|First Intervention (1 Day)||3
11403306|NCT03996694|12598310|FG005|STARTED|First Intervention (1 Day)||3
11403307|NCT03996694|12598305|FG000|COMPLETED|First Intervention (1 Day)||3
11403308|NCT03996694|12598306|FG001|COMPLETED|First Intervention (1 Day)||3
11403309|NCT03996694|12598307|FG002|COMPLETED|First Intervention (1 Day)||4
11403310|NCT03996694|12598308|FG003|COMPLETED|First Intervention (1 Day)||3
11403311|NCT03996694|12598309|FG004|COMPLETED|First Intervention (1 Day)||3
11403312|NCT03996694|12598310|FG005|COMPLETED|First Intervention (1 Day)||3
11403313|NCT03996694|12598305|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11403314|NCT03996694|12598306|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11403315|NCT03996694|12598307|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11403316|NCT03996694|12598308|FG003|NOT COMPLETED|First Intervention (1 Day)||0
11403317|NCT03996694|12598309|FG004|NOT COMPLETED|First Intervention (1 Day)||0
11403318|NCT03996694|12598310|FG005|NOT COMPLETED|First Intervention (1 Day)||0
11403319|NCT03996694|12598305|FG000|STARTED|First Washout (7 Days)||3
11403320|NCT03996694|12598306|FG001|STARTED|First Washout (7 Days)||3
11403321|NCT03996694|12598307|FG002|STARTED|First Washout (7 Days)||4
11403322|NCT03996694|12598308|FG003|STARTED|First Washout (7 Days)||3
11403323|NCT03996694|12598309|FG004|STARTED|First Washout (7 Days)||3
11403324|NCT03996694|12598310|FG005|STARTED|First Washout (7 Days)||3
11403325|NCT03996694|12598305|FG000|COMPLETED|First Washout (7 Days)||3
11403326|NCT03996694|12598306|FG001|COMPLETED|First Washout (7 Days)||2
11403327|NCT03996694|12598307|FG002|COMPLETED|First Washout (7 Days)||2
11403328|NCT03996694|12598308|FG003|COMPLETED|First Washout (7 Days)||3
11403329|NCT03996694|12598309|FG004|COMPLETED|First Washout (7 Days)||3
11403330|NCT03996694|12598310|FG005|COMPLETED|First Washout (7 Days)||3
11403331|NCT03996694|12598305|FG000|NOT COMPLETED|First Washout (7 Days)||0
11403332|NCT03996694|12598306|FG001|NOT COMPLETED|First Washout (7 Days)||1
11403333|NCT03996694|12598307|FG002|NOT COMPLETED|First Washout (7 Days)||2
11403334|NCT03996694|12598308|FG003|NOT COMPLETED|First Washout (7 Days)||0
11403335|NCT03996694|12598309|FG004|NOT COMPLETED|First Washout (7 Days)||0
11403336|NCT03996694|12598310|FG005|NOT COMPLETED|First Washout (7 Days)||0
11403337|NCT03996694|12598305|FG000|STARTED|Second Intervention (1 Day)||3
11403338|NCT03996694|12598306|FG001|STARTED|Second Intervention (1 Day)||2
11403339|NCT03996694|12598307|FG002|STARTED|Second Intervention (1 Day)||2
11403340|NCT03996694|12598308|FG003|STARTED|Second Intervention (1 Day)||3
11403341|NCT03996694|12598309|FG004|STARTED|Second Intervention (1 Day)||3
11403342|NCT03996694|12598310|FG005|STARTED|Second Intervention (1 Day)||3
11403343|NCT03996694|12598305|FG000|COMPLETED|Second Intervention (1 Day)||3
11403344|NCT03996694|12598306|FG001|COMPLETED|Second Intervention (1 Day)||2
11403345|NCT03996694|12598307|FG002|COMPLETED|Second Intervention (1 Day)||2
11403346|NCT03996694|12598308|FG003|COMPLETED|Second Intervention (1 Day)||3
11403347|NCT03996694|12598309|FG004|COMPLETED|Second Intervention (1 Day)||3
11403348|NCT03996694|12598310|FG005|COMPLETED|Second Intervention (1 Day)||3
11403349|NCT03996694|12598305|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11403350|NCT03996694|12598306|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11403351|NCT03996694|12598307|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11403352|NCT03996694|12598308|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
11403353|NCT03996694|12598309|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
11403354|NCT03996694|12598310|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
11403355|NCT03996694|12598305|FG000|STARTED|Second Washout (7 Days)||3
11403356|NCT03996694|12598306|FG001|STARTED|Second Washout (7 Days)||2
11403357|NCT03996694|12598307|FG002|STARTED|Second Washout (7 Days)||2
11403358|NCT03996694|12598308|FG003|STARTED|Second Washout (7 Days)||3
11403359|NCT03996694|12598309|FG004|STARTED|Second Washout (7 Days)||3
11403360|NCT03996694|12598310|FG005|STARTED|Second Washout (7 Days)||3
11403361|NCT03996694|12598305|FG000|COMPLETED|Second Washout (7 Days)||3
11403362|NCT03996694|12598306|FG001|COMPLETED|Second Washout (7 Days)||2
11403363|NCT03996694|12598307|FG002|COMPLETED|Second Washout (7 Days)||2
11403364|NCT03996694|12598308|FG003|COMPLETED|Second Washout (7 Days)||3
11403365|NCT03996694|12598309|FG004|COMPLETED|Second Washout (7 Days)||3
11403366|NCT03996694|12598310|FG005|COMPLETED|Second Washout (7 Days)||3
11403367|NCT03996694|12598305|FG000|NOT COMPLETED|Second Washout (7 Days)||0
11403368|NCT03996694|12598306|FG001|NOT COMPLETED|Second Washout (7 Days)||0
11403369|NCT03996694|12598307|FG002|NOT COMPLETED|Second Washout (7 Days)||0
11403370|NCT03996694|12598308|FG003|NOT COMPLETED|Second Washout (7 Days)||0
11403371|NCT03996694|12598309|FG004|NOT COMPLETED|Second Washout (7 Days)||0
11403372|NCT03996694|12598310|FG005|NOT COMPLETED|Second Washout (7 Days)||0
11403373|NCT03996694|12598305|FG000|STARTED|Third Intervention (1 Day)||3
11403374|NCT03996694|12598306|FG001|STARTED|Third Intervention (1 Day)||2
11403375|NCT03996694|12598307|FG002|STARTED|Third Intervention (1 Day)||2
11403376|NCT03996694|12598308|FG003|STARTED|Third Intervention (1 Day)||3
11403377|NCT03996694|12598309|FG004|STARTED|Third Intervention (1 Day)||3
11403378|NCT03996694|12598310|FG005|STARTED|Third Intervention (1 Day)||3
11403379|NCT03996694|12598305|FG000|COMPLETED|Third Intervention (1 Day)||3
11403380|NCT03996694|12598306|FG001|COMPLETED|Third Intervention (1 Day)||2
11403381|NCT03996694|12598307|FG002|COMPLETED|Third Intervention (1 Day)||2
11403382|NCT03996694|12598308|FG003|COMPLETED|Third Intervention (1 Day)||3
11403383|NCT03996694|12598309|FG004|COMPLETED|Third Intervention (1 Day)||3
11403384|NCT03996694|12598310|FG005|COMPLETED|Third Intervention (1 Day)||3
11403385|NCT03996694|12598305|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11403386|NCT03996694|12598306|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11403387|NCT03996694|12598307|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
11403388|NCT03996694|12598308|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
11403389|NCT03996694|12598309|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
11403390|NCT03996694|12598310|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
11403391|NCT03996694|12598305|FG000|STARTED|Third Washout (7 Days)||3
11403392|NCT03996694|12598306|FG001|STARTED|Third Washout (7 Days)||2
11403393|NCT03996694|12598307|FG002|STARTED|Third Washout (7 Days)||2
11403394|NCT03996694|12598308|FG003|STARTED|Third Washout (7 Days)||3
11403395|NCT03996694|12598309|FG004|STARTED|Third Washout (7 Days)||3
11403396|NCT03996694|12598310|FG005|STARTED|Third Washout (7 Days)||3
11403397|NCT03996694|12598305|FG000|COMPLETED|Third Washout (7 Days)||3
11403398|NCT03996694|12598306|FG001|COMPLETED|Third Washout (7 Days)||2
11403399|NCT03996694|12598307|FG002|COMPLETED|Third Washout (7 Days)||2
11403400|NCT03996694|12598308|FG003|COMPLETED|Third Washout (7 Days)||3
11403401|NCT03996694|12598309|FG004|COMPLETED|Third Washout (7 Days)||2
11403402|NCT03996694|12598310|FG005|COMPLETED|Third Washout (7 Days)||3
11403403|NCT03996694|12598305|FG000|NOT COMPLETED|Third Washout (7 Days)||0
11403404|NCT03996694|12598306|FG001|NOT COMPLETED|Third Washout (7 Days)||0
11403405|NCT03996694|12598307|FG002|NOT COMPLETED|Third Washout (7 Days)||0
11403406|NCT03996694|12598308|FG003|NOT COMPLETED|Third Washout (7 Days)||0
11403407|NCT03996694|12598309|FG004|NOT COMPLETED|Third Washout (7 Days)||1
11403408|NCT03996694|12598310|FG005|NOT COMPLETED|Third Washout (7 Days)||0
11403409|NCT03996694|12598305|FG000|STARTED|Fourth Intervention (1 Day)||3
11403410|NCT03996694|12598306|FG001|STARTED|Fourth Intervention (1 Day)||2
11403411|NCT03996694|12598307|FG002|STARTED|Fourth Intervention (1 Day)||2
11403412|NCT03996694|12598308|FG003|STARTED|Fourth Intervention (1 Day)||3
11403413|NCT03996694|12598309|FG004|STARTED|Fourth Intervention (1 Day)||2
11403414|NCT03996694|12598310|FG005|STARTED|Fourth Intervention (1 Day)||3
11403415|NCT03996694|12598305|FG000|COMPLETED|Fourth Intervention (1 Day)||3
11403416|NCT03996694|12598306|FG001|COMPLETED|Fourth Intervention (1 Day)||2
11403417|NCT03996694|12598307|FG002|COMPLETED|Fourth Intervention (1 Day)||2
11403418|NCT03996694|12598308|FG003|COMPLETED|Fourth Intervention (1 Day)||3
11403419|NCT03996694|12598309|FG004|COMPLETED|Fourth Intervention (1 Day)||2
11403420|NCT03996694|12598310|FG005|COMPLETED|Fourth Intervention (1 Day)||3
11403421|NCT03996694|12598305|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
11403422|NCT03996694|12598306|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
11403423|NCT03996694|12598307|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
11403424|NCT03996694|12598308|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
11403425|NCT03996694|12598309|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0
11403426|NCT03996694|12598310|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0
11403427|NCT03996694|12598305|FG000|STARTED|Fourth Washout (7 Days)||3
11403428|NCT03996694|12598306|FG001|STARTED|Fourth Washout (7 Days)||2
11403429|NCT03996694|12598307|FG002|STARTED|Fourth Washout (7 Days)||2
11403430|NCT03996694|12598308|FG003|STARTED|Fourth Washout (7 Days)||3
11403431|NCT03996694|12598309|FG004|STARTED|Fourth Washout (7 Days)||2
11403432|NCT03996694|12598310|FG005|STARTED|Fourth Washout (7 Days)||3
11403433|NCT03996694|12598305|FG000|COMPLETED|Fourth Washout (7 Days)||3
11403434|NCT03996694|12598306|FG001|COMPLETED|Fourth Washout (7 Days)||2
11022317|NCT00808483|12200568|FG000|COMPLETED|From 3 to 5 Months After Surgery||33
11022318|NCT00808483|12200569|FG001|COMPLETED|From 3 to 5 Months After Surgery||32
11022319|NCT00808483|12200568|FG000|NOT COMPLETED|From 3 to 5 Months After Surgery||2
11022320|NCT00808483|12200569|FG001|NOT COMPLETED|From 3 to 5 Months After Surgery||1
11022321|NCT00808483|12200568|FG000|STARTED|From 5 Months to 12 Months||33
11022322|NCT00808483|12200569|FG001|STARTED|From 5 Months to 12 Months||32
11022323|NCT00808483|12200568|FG000|COMPLETED|From 5 Months to 12 Months||32
11022324|NCT00808483|12200569|FG001|COMPLETED|From 5 Months to 12 Months||32
11022325|NCT00808483|12200568|FG000|NOT COMPLETED|From 5 Months to 12 Months||1
11022326|NCT00808483|12200569|FG001|NOT COMPLETED|From 5 Months to 12 Months||0
11022327|NCT00808509|12200584|FG000|STARTED|Randomized Phase||17
11022328|NCT00808509|12200585|FG001|STARTED|Randomized Phase||16
11022329|NCT00808509|12200584|FG000|Received Rescue Therapy|Randomized Phase||0
11022330|NCT00808509|12200585|FG001|Received Rescue Therapy|Randomized Phase||9
11022331|NCT00808509|12200584|FG000|COMPLETED|Randomized Phase||15
11022332|NCT00808509|12200585|FG001|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
11022333|NCT00808509|12200584|FG000|NOT COMPLETED|Randomized Phase||2
11403435|NCT03996694|12598307|FG002|COMPLETED|Fourth Washout (7 Days)||2
11403436|NCT03996694|12598308|FG003|COMPLETED|Fourth Washout (7 Days)||3
11403437|NCT03996694|12598309|FG004|COMPLETED|Fourth Washout (7 Days)||2
11403438|NCT03996694|12598310|FG005|COMPLETED|Fourth Washout (7 Days)||3
11403439|NCT03996694|12598305|FG000|NOT COMPLETED|Fourth Washout (7 Days)||0
11403440|NCT03996694|12598306|FG001|NOT COMPLETED|Fourth Washout (7 Days)||0
11403441|NCT03996694|12598307|FG002|NOT COMPLETED|Fourth Washout (7 Days)||0
11403442|NCT03996694|12598308|FG003|NOT COMPLETED|Fourth Washout (7 Days)||0
11403443|NCT03996694|12598309|FG004|NOT COMPLETED|Fourth Washout (7 Days)||0
11403444|NCT03996694|12598310|FG005|NOT COMPLETED|Fourth Washout (7 Days)||0
11403445|NCT03996694|12598305|FG000|STARTED|Fifth Intervention (1 Day)||3
11403446|NCT03996694|12598306|FG001|STARTED|Fifth Intervention (1 Day)||2
11403447|NCT03996694|12598307|FG002|STARTED|Fifth Intervention (1 Day)||2
11403448|NCT03996694|12598308|FG003|STARTED|Fifth Intervention (1 Day)||3
11403449|NCT03996694|12598309|FG004|STARTED|Fifth Intervention (1 Day)||2
11403450|NCT03996694|12598310|FG005|STARTED|Fifth Intervention (1 Day)||3
11403451|NCT03996694|12598305|FG000|COMPLETED|Fifth Intervention (1 Day)||3
11403452|NCT03996694|12598306|FG001|COMPLETED|Fifth Intervention (1 Day)||2
11403453|NCT03996694|12598307|FG002|COMPLETED|Fifth Intervention (1 Day)||2
11403454|NCT03996694|12598308|FG003|COMPLETED|Fifth Intervention (1 Day)||3
11403455|NCT03996694|12598309|FG004|COMPLETED|Fifth Intervention (1 Day)||2
11403456|NCT03996694|12598310|FG005|COMPLETED|Fifth Intervention (1 Day)||3
11403457|NCT03996694|12598305|FG000|NOT COMPLETED|Fifth Intervention (1 Day)||0
11403458|NCT03996694|12598306|FG001|NOT COMPLETED|Fifth Intervention (1 Day)||0
11403459|NCT03996694|12598307|FG002|NOT COMPLETED|Fifth Intervention (1 Day)||0
11403460|NCT03996694|12598308|FG003|NOT COMPLETED|Fifth Intervention (1 Day)||0
11403461|NCT03996694|12598309|FG004|NOT COMPLETED|Fifth Intervention (1 Day)||0
11403462|NCT03996694|12598310|FG005|NOT COMPLETED|Fifth Intervention (1 Day)||0
11403463|NCT03996694|12598305|FG000|STARTED|Fifth Washout (7 Days)||3
11403464|NCT03996694|12598306|FG001|STARTED|Fifth Washout (7 Days)||2
11403465|NCT03996694|12598307|FG002|STARTED|Fifth Washout (7 Days)||2
11403466|NCT03996694|12598308|FG003|STARTED|Fifth Washout (7 Days)||3
11403467|NCT03996694|12598309|FG004|STARTED|Fifth Washout (7 Days)||2
11403468|NCT03996694|12598310|FG005|STARTED|Fifth Washout (7 Days)||3
11403469|NCT03996694|12598305|FG000|COMPLETED|Fifth Washout (7 Days)||3
11403470|NCT03996694|12598306|FG001|COMPLETED|Fifth Washout (7 Days)||2
11403471|NCT03996694|12598307|FG002|COMPLETED|Fifth Washout (7 Days)||2
11403472|NCT03996694|12598308|FG003|COMPLETED|Fifth Washout (7 Days)||3
11403473|NCT03996694|12598309|FG004|COMPLETED|Fifth Washout (7 Days)||2
11403474|NCT03996694|12598310|FG005|COMPLETED|Fifth Washout (7 Days)||3
11403475|NCT03996694|12598305|FG000|NOT COMPLETED|Fifth Washout (7 Days)||0
11403476|NCT03996694|12598306|FG001|NOT COMPLETED|Fifth Washout (7 Days)||0
11403477|NCT03996694|12598307|FG002|NOT COMPLETED|Fifth Washout (7 Days)||0
11403478|NCT03996694|12598308|FG003|NOT COMPLETED|Fifth Washout (7 Days)||0
11403479|NCT03996694|12598309|FG004|NOT COMPLETED|Fifth Washout (7 Days)||0
11403480|NCT03996694|12598310|FG005|NOT COMPLETED|Fifth Washout (7 Days)||0
11403481|NCT03996694|12598305|FG000|STARTED|Sixth Intervention (1 Day)||3
11403482|NCT03996694|12598306|FG001|STARTED|Sixth Intervention (1 Day)||2
11403483|NCT03996694|12598307|FG002|STARTED|Sixth Intervention (1 Day)||2
11403484|NCT03996694|12598308|FG003|STARTED|Sixth Intervention (1 Day)||3
11403485|NCT03996694|12598309|FG004|STARTED|Sixth Intervention (1 Day)||2
11403486|NCT03996694|12598310|FG005|STARTED|Sixth Intervention (1 Day)||3
11403487|NCT03996694|12598305|FG000|COMPLETED|Sixth Intervention (1 Day)||3
11403488|NCT03996694|12598306|FG001|COMPLETED|Sixth Intervention (1 Day)||2
11403489|NCT03996694|12598307|FG002|COMPLETED|Sixth Intervention (1 Day)||2
11403490|NCT03996694|12598308|FG003|COMPLETED|Sixth Intervention (1 Day)||3
11403491|NCT03996694|12598309|FG004|COMPLETED|Sixth Intervention (1 Day)||2
11403492|NCT03996694|12598310|FG005|COMPLETED|Sixth Intervention (1 Day)||3
11403493|NCT03996694|12598305|FG000|NOT COMPLETED|Sixth Intervention (1 Day)||0
11403494|NCT03996694|12598306|FG001|NOT COMPLETED|Sixth Intervention (1 Day)||0
11403495|NCT03996694|12598307|FG002|NOT COMPLETED|Sixth Intervention (1 Day)||0
11403496|NCT03996694|12598308|FG003|NOT COMPLETED|Sixth Intervention (1 Day)||0
11403497|NCT03996694|12598309|FG004|NOT COMPLETED|Sixth Intervention (1 Day)||0
11403498|NCT03996694|12598310|FG005|NOT COMPLETED|Sixth Intervention (1 Day)||0
11403499|NCT03988907|12598326|FG000|STARTED|Overall Study||8
11403500|NCT03988907|12598327|FG001|STARTED|Overall Study||27
11403501|NCT03988907|12598326|FG000|COMPLETED|Overall Study||8
11403502|NCT03988907|12598327|FG001|COMPLETED|Overall Study||26
11403503|NCT03988907|12598326|FG000|NOT COMPLETED|Overall Study||0
11403504|NCT03988907|12598327|FG001|NOT COMPLETED|Overall Study||1
11403505|NCT03988088|12598341|FG000|STARTED|Single-Dose Pharmacokinetic Study||11
11403506|NCT03988088|12598342|FG001|STARTED|Single-Dose Pharmacokinetic Study||7
11403507|NCT03988088|12598343|FG002|STARTED|Single-Dose Pharmacokinetic Study||0
11403508|NCT03988088|12598344|FG003|STARTED|Single-Dose Pharmacokinetic Study||0
11403509|NCT03988088|12598341|FG000|COMPLETED|Single-Dose Pharmacokinetic Study||11
11403510|NCT03988088|12598342|FG001|COMPLETED|Single-Dose Pharmacokinetic Study||6
11403511|NCT03988088|12598343|FG002|COMPLETED|Single-Dose Pharmacokinetic Study||0
11403512|NCT03988088|12598344|FG003|COMPLETED|Single-Dose Pharmacokinetic Study||0
11403513|NCT03988088|12598341|FG000|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
11403514|NCT03988088|12598342|FG001|NOT COMPLETED|Single-Dose Pharmacokinetic Study||1
11403515|NCT03988088|12598343|FG002|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
11403516|NCT03988088|12598344|FG003|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
11403517|NCT03988088|12598341|FG000|STARTED|Open-Label Addendum||0
11403518|NCT03988088|12598342|FG001|STARTED|Open-Label Addendum||0
11403519|NCT03988088|12598343|FG002|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
11403520|NCT03988088|12598344|FG003|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
11403521|NCT03988088|12598341|FG000|COMPLETED|Open-Label Addendum||0
11403522|NCT03988088|12598342|FG001|COMPLETED|Open-Label Addendum||0
11403523|NCT03988088|12598343|FG002|COMPLETED|Open-Label Addendum||1
11403524|NCT03988088|12598344|FG003|COMPLETED|Open-Label Addendum||2
11403525|NCT03988088|12598341|FG000|NOT COMPLETED|Open-Label Addendum||0
11403526|NCT03988088|12598342|FG001|NOT COMPLETED|Open-Label Addendum||0
11403527|NCT03988088|12598343|FG002|NOT COMPLETED|Open-Label Addendum||1
11403528|NCT03988088|12598344|FG003|NOT COMPLETED|Open-Label Addendum||0
11403529|NCT03980522|12598357|FG000|STARTED|Treatment Period||13
11403530|NCT03980522|12598358|FG001|STARTED|Treatment Period||3
11403531|NCT03980522|12598359|FG002|STARTED|Treatment Period||6
11403532|NCT03980522|12598360|FG003|STARTED|Treatment Period||1
11403533|NCT03980522|12598361|FG004|STARTED|Treatment Period||3
11403534|NCT03980522|12598357|FG000|COMPLETED|Treatment Period||12
11403535|NCT03980522|12598358|FG001|COMPLETED|Treatment Period||3
11403536|NCT03980522|12598359|FG002|COMPLETED|Treatment Period||6
11403537|NCT03980522|12598360|FG003|COMPLETED|Treatment Period||1
11403538|NCT03980522|12598361|FG004|COMPLETED|Treatment Period||3
11403539|NCT03980522|12598357|FG000|NOT COMPLETED|Treatment Period||1
11403540|NCT03980522|12598358|FG001|NOT COMPLETED|Treatment Period||0
11403541|NCT03980522|12598359|FG002|NOT COMPLETED|Treatment Period||0
11403542|NCT03980522|12598360|FG003|NOT COMPLETED|Treatment Period||0
11403543|NCT03980522|12598361|FG004|NOT COMPLETED|Treatment Period||0
11403544|NCT03980522|12598357|FG000|STARTED|Extension Period||12
11403545|NCT03980522|12598358|FG001|STARTED|Extension Period||3
11403546|NCT03980522|12598359|FG002|STARTED|Extension Period|1 participant did not sign the optional Extension Period consent form.|5
11403547|NCT03980522|12598360|FG003|STARTED|Extension Period||1
11403548|NCT03980522|12598361|FG004|STARTED|Extension Period||3
11403549|NCT03980522|12598357|FG000|COMPLETED|Extension Period||12
11403550|NCT03980522|12598358|FG001|COMPLETED|Extension Period||3
11403551|NCT03980522|12598359|FG002|COMPLETED|Extension Period||5
11403552|NCT03980522|12598360|FG003|COMPLETED|Extension Period||1
11403553|NCT03980522|12598361|FG004|COMPLETED|Extension Period||3
11403554|NCT03980522|12598357|FG000|NOT COMPLETED|Extension Period||0
11403555|NCT03980522|12598358|FG001|NOT COMPLETED|Extension Period||0
11403556|NCT03980522|12598359|FG002|NOT COMPLETED|Extension Period||0
11403557|NCT03980522|12598360|FG003|NOT COMPLETED|Extension Period||0
11403558|NCT03980522|12598361|FG004|NOT COMPLETED|Extension Period||0
11403559|NCT03999684|12598373|FG000|STARTED|Overall Study||18
11403560|NCT03999684|12598373|FG000|COMPLETED|Overall Study||18
11403561|NCT03999684|12598373|FG000|NOT COMPLETED|Overall Study||0
11403562|NCT03995784|12598377|FG000|STARTED|Overall Study||6
11403563|NCT03995784|12598377|FG000|COMPLETED|Overall Study||5
11403564|NCT03995784|12598377|FG000|NOT COMPLETED|Overall Study||1
11403565|NCT03993392|12598388|FG000|STARTED|Overall Study||26
11403566|NCT03993392|12598388|FG000|Treated With SUBLOCADE|Overall Study||24
11403567|NCT03993392|12598388|FG000|COMPLETED|Overall Study||20
11403568|NCT03993392|12598388|FG000|NOT COMPLETED|Overall Study||6
11403569|NCT03989427|12598395|FG000|STARTED|First Intervention (2 Weeks)||15
11403570|NCT03989427|12598396|FG001|STARTED|First Intervention (2 Weeks)||15
11403571|NCT03989427|12598395|FG000|COMPLETED|First Intervention (2 Weeks)||15
11403572|NCT03989427|12598396|FG001|COMPLETED|First Intervention (2 Weeks)||15
11403573|NCT03989427|12598395|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
11403574|NCT03989427|12598396|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
11403575|NCT03989427|12598395|FG000|STARTED|Washout (1 Week)||15
11403576|NCT03989427|12598396|FG001|STARTED|Washout (1 Week)||15
11403577|NCT03989427|12598395|FG000|COMPLETED|Washout (1 Week)||15
11403578|NCT03989427|12598396|FG001|COMPLETED|Washout (1 Week)||15
11403579|NCT03989427|12598395|FG000|NOT COMPLETED|Washout (1 Week)||0
11403580|NCT03989427|12598396|FG001|NOT COMPLETED|Washout (1 Week)||0
11403581|NCT03989427|12598395|FG000|STARTED|Second Intervention (2 Weeks)||15
11403582|NCT03989427|12598396|FG001|STARTED|Second Intervention (2 Weeks)||15
11403583|NCT03989427|12598395|FG000|COMPLETED|Second Intervention (2 Weeks)||15
11403584|NCT03989427|12598396|FG001|COMPLETED|Second Intervention (2 Weeks)||15
11403585|NCT03989427|12598395|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
11403586|NCT03989427|12598396|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
11403587|NCT03981822|12598411|FG000|STARTED|Overall Study||5
11403588|NCT03981822|12598412|FG001|STARTED|Overall Study||5
11403589|NCT03981822|12598413|FG002|STARTED|Overall Study||5
11403590|NCT03981822|12598414|FG003|STARTED|Overall Study||3
11403591|NCT03981822|12598415|FG004|STARTED|Overall Study||25
11403592|NCT03981822|12598416|FG005|STARTED|Overall Study||23
11403593|NCT03981822|12598417|FG006|STARTED|Overall Study||22
11403594|NCT03981822|12598418|FG007|STARTED|Overall Study||17
11403595|NCT03981822|12598411|FG000|COMPLETED|Overall Study||5
11403596|NCT03981822|12598412|FG001|COMPLETED|Overall Study||3
11403597|NCT03981822|12598413|FG002|COMPLETED|Overall Study||4
11403598|NCT03981822|12598414|FG003|COMPLETED|Overall Study||3
11403599|NCT03981822|12598415|FG004|COMPLETED|Overall Study||17
11403600|NCT03981822|12598416|FG005|COMPLETED|Overall Study||17
11403601|NCT03981822|12598417|FG006|COMPLETED|Overall Study||16
11403602|NCT03981822|12598418|FG007|COMPLETED|Overall Study||12
11403603|NCT03981822|12598411|FG000|NOT COMPLETED|Overall Study||0
11403604|NCT03981822|12598412|FG001|NOT COMPLETED|Overall Study||2
11403605|NCT03981822|12598413|FG002|NOT COMPLETED|Overall Study||1
11403606|NCT03981822|12598414|FG003|NOT COMPLETED|Overall Study||0
11403607|NCT03981822|12598415|FG004|NOT COMPLETED|Overall Study||8
11403608|NCT03981822|12598416|FG005|NOT COMPLETED|Overall Study||6
11403609|NCT03981822|12598417|FG006|NOT COMPLETED|Overall Study||6
11403610|NCT03981822|12598418|FG007|NOT COMPLETED|Overall Study||5
11403611|NCT03992482|12598432|FG000|STARTED|Overall Study||13
11403612|NCT03992482|12598433|FG001|STARTED|Overall Study||14
11403613|NCT03992482|12598432|FG000|COMPLETED|Overall Study||13
11403614|NCT03992482|12598433|FG001|COMPLETED|Overall Study||14
11403615|NCT03992482|12598432|FG000|NOT COMPLETED|Overall Study||0
11403616|NCT03992482|12598433|FG001|NOT COMPLETED|Overall Study||0
11403617|NCT03993119|12598443|FG000|STARTED|Overall Study||192
11403618|NCT03993119|12598444|FG001|STARTED|Overall Study||76
11403619|NCT03993119|12598445|FG002|STARTED|Overall Study||166
11403620|NCT03993119|12598446|FG003|STARTED|Overall Study||66
11403621|NCT03993119|12598443|FG000|COMPLETED|Overall Study||192
11403622|NCT03993119|12598444|FG001|COMPLETED|Overall Study||76
11403623|NCT03993119|12598445|FG002|COMPLETED|Overall Study||166
11403624|NCT03993119|12598446|FG003|COMPLETED|Overall Study||66
11403625|NCT03993119|12598443|FG000|NOT COMPLETED|Overall Study||0
11403626|NCT03993119|12598444|FG001|NOT COMPLETED|Overall Study||0
11403627|NCT03993119|12598445|FG002|NOT COMPLETED|Overall Study||0
11403628|NCT03993119|12598446|FG003|NOT COMPLETED|Overall Study||0
11403629|NCT03991494|12598471|FG000|STARTED|Overall Study||4
11403630|NCT03991494|12598471|FG000|COMPLETED|Overall Study||0
11403631|NCT03991494|12598471|FG000|NOT COMPLETED|Overall Study||4
11403632|NCT03989570|12598480|FG000|STARTED|Overall Study||31
11403633|NCT03989570|12598481|FG001|STARTED|Overall Study||31
11403634|NCT03989570|12598482|FG002|STARTED|Overall Study||31
11403635|NCT03989570|12598480|FG000|COMPLETED|Overall Study||31
11403636|NCT03989570|12598481|FG001|COMPLETED|Overall Study||31
11403637|NCT03989570|12598482|FG002|COMPLETED|Overall Study||31
11403638|NCT03989570|12598480|FG000|NOT COMPLETED|Overall Study||0
11403639|NCT03989570|12598481|FG001|NOT COMPLETED|Overall Study||0
11403640|NCT03989570|12598482|FG002|NOT COMPLETED|Overall Study||0
11403641|NCT03988803|12598490|FG000|STARTED|Screening||16
11403642|NCT03988803|12598490|FG000|COMPLETED|Screening||16
11403643|NCT03988803|12598490|FG000|NOT COMPLETED|Screening||0
11403644|NCT03988803|12598490|FG000|STARTED|Period 1||16
11403645|NCT03988803|12598490|FG000|COMPLETED|Period 1||16
11403646|NCT03988803|12598490|FG000|NOT COMPLETED|Period 1||0
11403647|NCT03988803|12598490|FG000|STARTED|Period 2||16
11403648|NCT03988803|12598490|FG000|Treated|Period 2||15
11403649|NCT03988803|12598490|FG000|Started Days 1 - 7: Multiple Doses of 5 mg Memantine qd|Period 2||15
11403650|NCT03988803|12598490|FG000|Started Days 8 - 14: Multiple Doses of 10 mg Memantine qd|Period 2||14
11403651|NCT03988803|12598490|FG000|Started Days 15 - 21: Multiple Doses of 15 mg Memantine qd|Period 2||13
11403652|NCT03988803|12598490|FG000|Started Days 22 - 35: Multiple Doses of 20 mg Memantine qd|Period 2||13
11403653|NCT03988803|12598490|FG000|COMPLETED|Period 2||13
11403654|NCT03988803|12598490|FG000|NOT COMPLETED|Period 2||3
11403655|NCT03988803|12598490|FG000|STARTED|Period 3||13
11403656|NCT03988803|12598490|FG000|COMPLETED|Period 3||13
11403657|NCT03988803|12598490|FG000|NOT COMPLETED|Period 3||0
11403658|NCT03987932|12598501|FG000|STARTED|Overall Study||4
11403659|NCT03987932|12598502|FG001|STARTED|Overall Study||3
11403660|NCT03987932|12598503|FG002|STARTED|Overall Study||4
11403661|NCT03987932|12598501|FG000|1 Month|Overall Study||4
11403662|NCT03987932|12598502|FG001|1 Month|Overall Study||2
11403663|NCT03987932|12598503|FG002|1 Month|Overall Study||3
11403664|NCT03987932|12598501|FG000|3 Months|Overall Study||4
11403665|NCT03987932|12598502|FG001|3 Months|Overall Study||2
11403666|NCT03987932|12598503|FG002|3 Months|Overall Study||3
11403667|NCT03987932|12598501|FG000|6 Months|Overall Study||2
11403668|NCT03987932|12598502|FG001|6 Months|Overall Study||2
11403669|NCT03987932|12598503|FG002|6 Months|Overall Study||2
11403670|NCT03987932|12598501|FG000|COMPLETED|Overall Study||2
11403671|NCT03987932|12598502|FG001|COMPLETED|Overall Study||2
11403672|NCT03987932|12598503|FG002|COMPLETED|Overall Study||2
11403673|NCT03987932|12598501|FG000|NOT COMPLETED|Overall Study||2
11403674|NCT03987932|12598502|FG001|NOT COMPLETED|Overall Study||1
11403675|NCT03987932|12598503|FG002|NOT COMPLETED|Overall Study||2
11403676|NCT03987191|12598513|FG000|STARTED|Overall Study||17
11403677|NCT03987191|12598514|FG001|STARTED|Overall Study||15
11403678|NCT03987191|12598513|FG000|Data Collected|Overall Study||17
11403679|NCT03987191|12598514|FG001|Data Collected|Overall Study||13
11403680|NCT03987191|12598513|FG000|COMPLETED|Overall Study||17
11403681|NCT03987191|12598514|FG001|COMPLETED|Overall Study||13
11403682|NCT03987191|12598513|FG000|NOT COMPLETED|Overall Study||0
11403683|NCT03987191|12598514|FG001|NOT COMPLETED|Overall Study||2
11403684|NCT03988842|12598520|FG000|STARTED|Overall Study||4
11403685|NCT03988842|12598520|FG000|COMPLETED|Overall Study||3
11403686|NCT03988842|12598520|FG000|NOT COMPLETED|Overall Study||1
11403687|NCT03981861|12598525|FG000|STARTED|Overall Study||12
11403688|NCT03981861|12598525|FG000|COMPLETED|Overall Study||9
11403689|NCT03981861|12598525|FG000|NOT COMPLETED|Overall Study||3
11403690|NCT03974334|12598529|FG000|STARTED|Overall Study||25
11403691|NCT03974334|12598529|FG000|COMPLETED|Overall Study||24
11403692|NCT03974334|12598529|FG000|NOT COMPLETED|Overall Study||1
11403693|NCT03988426|12598533|FG000|STARTED|Overall Study||25
11403694|NCT03988426|12598533|FG000|COMPLETED|Overall Study||24
11403695|NCT03988426|12598533|FG000|NOT COMPLETED|Overall Study||1
11403696|NCT03988374|12598542|FG000|STARTED|Overall Study||104
11403697|NCT03988374|12598543|FG001|STARTED|Overall Study||107
11403698|NCT03988374|12598544|FG002|STARTED|Overall Study||108
11403699|NCT03988374|12598542|FG000|COMPLETED|Overall Study||103
11403700|NCT03988374|12598543|FG001|COMPLETED|Overall Study||105
11403701|NCT03988374|12598544|FG002|COMPLETED|Overall Study||107
11403702|NCT03988374|12598542|FG000|NOT COMPLETED|Overall Study||1
11403703|NCT03988374|12598543|FG001|NOT COMPLETED|Overall Study||2
11403704|NCT03988374|12598544|FG002|NOT COMPLETED|Overall Study||1
11403705|NCT03987074|12598557|FG000|STARTED|Overall Study||21
11403706|NCT03987074|12598558|FG001|STARTED|Overall Study||22
11403707|NCT03987074|12598559|FG002|STARTED|Overall Study||22
11403708|NCT03987074|12598560|FG003|STARTED|Overall Study||22
11403709|NCT03987074|12598561|FG004|STARTED|Overall Study||21
11403710|NCT03987074|12598557|FG000|COMPLETED|Overall Study||18
11403711|NCT03987074|12598558|FG001|COMPLETED|Overall Study||20
11403712|NCT03987074|12598559|FG002|COMPLETED|Overall Study||21
11403713|NCT03987074|12598560|FG003|COMPLETED|Overall Study||18
11403714|NCT03987074|12598561|FG004|COMPLETED|Overall Study||19
11403715|NCT03987074|12598557|FG000|NOT COMPLETED|Overall Study||3
11403716|NCT03987074|12598558|FG001|NOT COMPLETED|Overall Study||2
11403717|NCT03987074|12598559|FG002|NOT COMPLETED|Overall Study||1
11403718|NCT03987074|12598560|FG003|NOT COMPLETED|Overall Study||4
11403719|NCT03987074|12598561|FG004|NOT COMPLETED|Overall Study||2
11403720|NCT03977935|12598575|FG000|STARTED|Overall Study||40
11403721|NCT03977935|12598576|FG001|STARTED|Overall Study||40
11403722|NCT03977935|12598575|FG000|COMPLETED|Overall Study||40
11403723|NCT03977935|12598576|FG001|COMPLETED|Overall Study||40
11403724|NCT03977935|12598575|FG000|NOT COMPLETED|Overall Study||0
11403725|NCT03977935|12598576|FG001|NOT COMPLETED|Overall Study||0
11403726|NCT03988049|12598584|FG000|STARTED|Overall Study||22
11403727|NCT03988049|12598585|FG001|STARTED|Overall Study||22
11403728|NCT03988049|12598584|FG000|COMPLETED|Overall Study||22
11403729|NCT03988049|12598585|FG001|COMPLETED|Overall Study||22
11403730|NCT03988049|12598584|FG000|NOT COMPLETED|Overall Study||0
11403731|NCT03988049|12598585|FG001|NOT COMPLETED|Overall Study||0
11403732|NCT03979820|12598595|FG000|STARTED|Overall Study||13
11403733|NCT03979820|12598596|FG001|STARTED|Overall Study||14
11403734|NCT03979820|12598597|FG002|STARTED|Overall Study||16
11403735|NCT03979820|12598598|FG003|STARTED|Overall Study||10
11403736|NCT03979820|12598595|FG000|COMPLETED|Overall Study||7
11403737|NCT03979820|12598596|FG001|COMPLETED|Overall Study||14
11403738|NCT03979820|12598597|FG002|COMPLETED|Overall Study||15
11403739|NCT03979820|12598598|FG003|COMPLETED|Overall Study||0
11403740|NCT03979820|12598595|FG000|NOT COMPLETED|Overall Study||6
11403741|NCT03979820|12598596|FG001|NOT COMPLETED|Overall Study||0
11403742|NCT03979820|12598597|FG002|NOT COMPLETED|Overall Study||1
11403743|NCT03979820|12598598|FG003|NOT COMPLETED|Overall Study||10
11403744|NCT03972137|12598612|FG000|STARTED|Overall Study||10
11403745|NCT03972137|12598612|FG000|Enrolled|Overall Study||10
11403746|NCT03972137|12598612|FG000|Treatment Completed|Overall Study||6
11403747|NCT03972137|12598612|FG000|Follow-up Completed|Overall Study||4
11403748|NCT03972137|12598612|FG000|COMPLETED|Overall Study||4
11403749|NCT03972137|12598612|FG000|NOT COMPLETED|Overall Study||6
11403750|NCT03970395|12598630|FG000|STARTED|Overall Study||48
11403751|NCT03970395|12598631|FG001|STARTED|Overall Study||48
11403752|NCT03970395|12598630|FG000|COMPLETED|Overall Study||41
11403753|NCT03970395|12598631|FG001|COMPLETED|Overall Study||36
11403754|NCT03970395|12598630|FG000|NOT COMPLETED|Overall Study||7
11403755|NCT03970395|12598631|FG001|NOT COMPLETED|Overall Study||12
11403756|NCT03987620|12598643|FG000|STARTED|Overall Study||303
11403757|NCT03987620|12598644|FG001|STARTED|Overall Study||152
11403758|NCT03987620|12598643|FG000|Withdrawn Before Treatment|Overall Study||5
11403759|NCT03987620|12598644|FG001|Withdrawn Before Treatment|Overall Study||1
11403760|NCT03987620|12598643|FG000|Withdrawn Before TOC|Overall Study||48
11403761|NCT03987620|12598644|FG001|Withdrawn Before TOC|Overall Study||45
11403762|NCT03987620|12598643|FG000|Completed the TOC Visit|Overall Study||250
11403763|NCT03987620|12598644|FG001|Completed the TOC Visit|Overall Study||106
11403764|NCT03987620|12598643|FG000|Withdrawn At or After the TOC Visit|Overall Study||4
11403765|NCT03987620|12598644|FG001|Withdrawn At or After the TOC Visit|Overall Study||4
11403766|NCT03987620|12598643|FG000|COMPLETED|Overall Study||246
11403767|NCT03987620|12598644|FG001|COMPLETED|Overall Study||102
11403768|NCT03987620|12598643|FG000|NOT COMPLETED|Overall Study||57
11403769|NCT03987620|12598644|FG001|NOT COMPLETED|Overall Study||50
11403770|NCT03983317|12598650|FG000|STARTED|Overall Study||25
11403771|NCT03983317|12598650|FG000|COMPLETED|Overall Study||20
11403772|NCT03983317|12598650|FG000|NOT COMPLETED|Overall Study||5
11403773|NCT03985657|12598654|FG000|STARTED|Intervention 1 (One Night)||20
11403774|NCT03985657|12598655|FG001|STARTED|Intervention 1 (One Night)||11
11403775|NCT03985657|12598654|FG000|COMPLETED|Intervention 1 (One Night)||20
11403776|NCT03985657|12598655|FG001|COMPLETED|Intervention 1 (One Night)||10
11403777|NCT03985657|12598654|FG000|NOT COMPLETED|Intervention 1 (One Night)||0
11403778|NCT03985657|12598655|FG001|NOT COMPLETED|Intervention 1 (One Night)||1
11403779|NCT03985657|12598654|FG000|STARTED|Washout (Up to 1 Week)||20
11403780|NCT03985657|12598655|FG001|STARTED|Washout (Up to 1 Week)||10
11403781|NCT03985657|12598654|FG000|COMPLETED|Washout (Up to 1 Week)||20
11403782|NCT03985657|12598655|FG001|COMPLETED|Washout (Up to 1 Week)||10
11403783|NCT03985657|12598654|FG000|NOT COMPLETED|Washout (Up to 1 Week)||0
11403784|NCT03985657|12598655|FG001|NOT COMPLETED|Washout (Up to 1 Week)||0
11403785|NCT03985657|12598654|FG000|STARTED|Intervention 2 (One Night)||20
11403786|NCT03985657|12598655|FG001|STARTED|Intervention 2 (One Night)||10
11403787|NCT03985657|12598654|FG000|COMPLETED|Intervention 2 (One Night)||20
11403788|NCT03985657|12598655|FG001|COMPLETED|Intervention 2 (One Night)||10
11403789|NCT03985657|12598654|FG000|NOT COMPLETED|Intervention 2 (One Night)||0
11403790|NCT03985657|12598655|FG001|NOT COMPLETED|Intervention 2 (One Night)||0
11403791|NCT03981939|12598664|FG000|STARTED|Overall Study||549
11403792|NCT03981939|12598665|FG001|STARTED|Overall Study||1902
11403793|NCT03981939|12598666|FG002|STARTED|Overall Study||581
11403794|NCT03981939|12598664|FG000|COMPLETED|Overall Study||549
11403795|NCT03981939|12598665|FG001|COMPLETED|Overall Study||1902
11403796|NCT03981939|12598666|FG002|COMPLETED|Overall Study||581
11403797|NCT03981939|12598664|FG000|NOT COMPLETED|Overall Study||0
11403798|NCT03981939|12598665|FG001|NOT COMPLETED|Overall Study||0
11403799|NCT03981939|12598666|FG002|NOT COMPLETED|Overall Study||0
11403800|NCT03973905|12598679|FG000|STARTED|Overall Study||107
11403801|NCT03973905|12598680|FG001|STARTED|Overall Study||183
11403802|NCT03973905|12598679|FG000|COMPLETED|Overall Study||107
11403803|NCT03973905|12598680|FG001|COMPLETED|Overall Study||183
11403804|NCT03973905|12598679|FG000|NOT COMPLETED|Overall Study||0
11403805|NCT03973905|12598680|FG001|NOT COMPLETED|Overall Study||0
11403806|NCT03984838|12598686|FG000|STARTED|Overall Study||16
11403807|NCT03984838|12598686|FG000|COMPLETED|Overall Study||16
11403808|NCT03984838|12598686|FG000|NOT COMPLETED|Overall Study||0
11403809|NCT03983941|12598692|FG000|STARTED|Overall Study||2
11403810|NCT03983941|12598693|FG001|STARTED|Overall Study||5
11403811|NCT03983941|12598692|FG000|COMPLETED|Overall Study||2
11403812|NCT03983941|12598693|FG001|COMPLETED|Overall Study||5
11403813|NCT03983941|12598692|FG000|NOT COMPLETED|Overall Study||0
11403814|NCT03983941|12598693|FG001|NOT COMPLETED|Overall Study||0
11403815|NCT03976752|12598701|FG000|STARTED|Overall Study||4
11403816|NCT03976752|12598702|FG001|STARTED|Overall Study||37
11403817|NCT03976752|12598701|FG000|Started Study Arm A|Overall Study||0
11403818|NCT03976752|12598702|FG001|Started Study Arm A|Overall Study||14
11403819|NCT03976752|12598701|FG000|Completed Study Arm A|Overall Study||0
11403820|NCT03976752|12598702|FG001|Completed Study Arm A|Overall Study||8
11403821|NCT03976752|12598701|FG000|Started Study Arm B|Overall Study||0
11403822|NCT03976752|12598702|FG001|Started Study Arm B|Overall Study||8
11403823|NCT03976752|12598701|FG000|Completed Study Arm B|Overall Study||0
11403824|NCT03976752|12598702|FG001|Completed Study Arm B|Overall Study||8
11403825|NCT03976752|12598701|FG000|Started Study Arm C|Overall Study||0
11403826|NCT03976752|12598702|FG001|Started Study Arm C|Overall Study||11
11403827|NCT03976752|12598701|FG000|Completed Study Arm C|Overall Study||0
11403828|NCT03976752|12598702|FG001|Completed Study Arm C|Overall Study||8
11403829|NCT03976752|12598701|FG000|Started Study Arm D|Overall Study||0
11403830|NCT03976752|12598702|FG001|Started Study Arm D|Overall Study||6
11403831|NCT03976752|12598701|FG000|Completed Study Arm D|Overall Study||0
11403832|NCT03976752|12598702|FG001|Completed Study Arm D|Overall Study||4
11403833|NCT03976752|12598701|FG000|COMPLETED|Overall Study||3
11403834|NCT03976752|12598702|FG001|COMPLETED|Overall Study||28
11403835|NCT03976752|12598701|FG000|NOT COMPLETED|Overall Study||1
11403836|NCT03976752|12598702|FG001|NOT COMPLETED|Overall Study||9
11403837|NCT03984825|12598713|FG000|STARTED|Run-in Period (Day -3 to -1)||23
11403838|NCT03984825|12598713|FG000|COMPLETED|Run-in Period (Day -3 to -1)||23
11403839|NCT03984825|12598713|FG000|NOT COMPLETED|Run-in Period (Day -3 to -1)||0
11403840|NCT03984825|12598713|FG000|STARTED|Treatment Period 1 (Day 1 to 10)||23
11403841|NCT03984825|12598713|FG000|COMPLETED|Treatment Period 1 (Day 1 to 10)||21
11403842|NCT03984825|12598713|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 10)||2
11403843|NCT03984825|12598713|FG000|STARTED|Treatment Period 2 (Day 11 to 21)||21
11403844|NCT03984825|12598713|FG000|COMPLETED|Treatment Period 2 (Day 11 to 21)||17
11403845|NCT03984825|12598713|FG000|NOT COMPLETED|Treatment Period 2 (Day 11 to 21)||4
11403846|NCT03971721|12598722|FG000|STARTED|Overall Study||3
11403847|NCT03971721|12598722|FG000|COMPLETED|Overall Study||3
11403848|NCT03971721|12598722|FG000|NOT COMPLETED|Overall Study||0
11403849|NCT03982433|12598726|FG000|STARTED|Overall Study||8
11403850|NCT03982433|12598726|FG000|COMPLETED|Overall Study||7
11403851|NCT03982433|12598726|FG000|NOT COMPLETED|Overall Study||1
11403852|NCT03979677|12598730|FG000|STARTED|Overall Study|Participants enrolled|41
11403853|NCT03979677|12598730|FG000|COMPLETED|Overall Study|participants completed|28
11403854|NCT03979677|12598730|FG000|NOT COMPLETED|Overall Study||13
11403855|NCT03976466|12598736|FG000|STARTED|Overall Study||44
11403856|NCT03976466|12598737|FG001|STARTED|Overall Study||43
11403857|NCT03976466|12598736|FG000|COMPLETED|Overall Study||43
11403858|NCT03976466|12598737|FG001|COMPLETED|Overall Study||40
11403859|NCT03976466|12598736|FG000|NOT COMPLETED|Overall Study||1
11403860|NCT03976466|12598737|FG001|NOT COMPLETED|Overall Study||3
11403861|NCT03979638|12598747|FG000|STARTED|Period 1||33
11403862|NCT03979638|12598748|FG001|STARTED|Period 1||35
11403863|NCT03979638|12598747|FG000|COMPLETED|Period 1||26
11403864|NCT03979638|12598748|FG001|COMPLETED|Period 1||28
11403865|NCT03979638|12598747|FG000|NOT COMPLETED|Period 1||7
11403866|NCT03979638|12598748|FG001|NOT COMPLETED|Period 1||7
11403867|NCT03979638|12598747|FG000|STARTED|Period 2||26
11403868|NCT03979638|12598748|FG001|STARTED|Period 2||28
11403869|NCT03979638|12598747|FG000|COMPLETED|Period 2||25
11403870|NCT03979638|12598748|FG001|COMPLETED|Period 2||27
11403871|NCT03979638|12598747|FG000|NOT COMPLETED|Period 2||1
11403872|NCT03979638|12598748|FG001|NOT COMPLETED|Period 2||1
11403873|NCT03979274|12598763|FG000|STARTED|Treatment Period 1||22
11403874|NCT03979274|12598764|FG001|STARTED|Treatment Period 1||22
11403875|NCT03979274|12598763|FG000|COMPLETED|Treatment Period 1||22
11403876|NCT03979274|12598764|FG001|COMPLETED|Treatment Period 1||22
11403877|NCT03979274|12598763|FG000|NOT COMPLETED|Treatment Period 1||0
11403878|NCT03979274|12598764|FG001|NOT COMPLETED|Treatment Period 1||0
11403879|NCT03979274|12598763|FG000|STARTED|Treatment Period 2||22
11403880|NCT03979274|12598764|FG001|STARTED|Treatment Period 2||22
11403881|NCT03979274|12598763|FG000|COMPLETED|Treatment Period 2||22
11403882|NCT03979274|12598764|FG001|COMPLETED|Treatment Period 2||21
11403883|NCT03979274|12598763|FG000|NOT COMPLETED|Treatment Period 2||0
11403884|NCT03979274|12598764|FG001|NOT COMPLETED|Treatment Period 2||1
11403885|NCT03979066|12598772|FG000|STARTED|Overall Study||0
11403886|NCT03979066|12598773|FG001|STARTED|Overall Study||0
11403887|NCT03979066|12598772|FG000|COMPLETED|Overall Study||0
11403888|NCT03979066|12598773|FG001|COMPLETED|Overall Study||0
11403889|NCT03979066|12598772|FG000|NOT COMPLETED|Overall Study||0
11403890|NCT03979066|12598773|FG001|NOT COMPLETED|Overall Study||0
11403891|NCT03977727|12598781|FG000|STARTED|First Treatment||20
11403892|NCT03977727|12598782|FG001|STARTED|First Treatment||20
11403893|NCT03977727|12598781|FG000|Received Treatment|First Treatment||20
11403894|NCT03977727|12598782|FG001|Received Treatment|First Treatment||20
11403895|NCT03977727|12598781|FG000|COMPLETED|First Treatment||20
11403896|NCT03977727|12598782|FG001|COMPLETED|First Treatment||20
11403897|NCT03977727|12598781|FG000|NOT COMPLETED|First Treatment||0
11403898|NCT03977727|12598782|FG001|NOT COMPLETED|First Treatment||0
11403899|NCT03977727|12598781|FG000|STARTED|Second Treatment||20
11403900|NCT03977727|12598782|FG001|STARTED|Second Treatment||20
11403901|NCT03977727|12598781|FG000|COMPLETED|Second Treatment||20
11403902|NCT03977727|12598782|FG001|COMPLETED|Second Treatment||17
11403903|NCT03977727|12598781|FG000|NOT COMPLETED|Second Treatment||0
11403904|NCT03977727|12598782|FG001|NOT COMPLETED|Second Treatment||3
11403905|NCT03977155|12598791|FG000|STARTED|Overall Study||43
11403906|NCT03977155|12598792|FG001|STARTED|Overall Study||48
11403907|NCT03977155|12598793|FG002|STARTED|Overall Study||42
11403908|NCT03977155|12598791|FG000|COMPLETED|Overall Study||38
11403909|NCT03977155|12598792|FG001|COMPLETED|Overall Study||46
11403910|NCT03977155|12598793|FG002|COMPLETED|Overall Study||40
11403911|NCT03977155|12598791|FG000|NOT COMPLETED|Overall Study||5
11403912|NCT03977155|12598792|FG001|NOT COMPLETED|Overall Study||2
11403913|NCT03977155|12598793|FG002|NOT COMPLETED|Overall Study||2
11403914|NCT03974802|12598803|FG000|STARTED|Overall Study||41
11403915|NCT03974802|12598803|FG000|COMPLETED|Overall Study||41
11403916|NCT03974802|12598803|FG000|NOT COMPLETED|Overall Study||0
11403917|NCT03970733|12598815|FG000|STARTED|Overall Study||97
11403918|NCT03970733|12598816|FG001|STARTED|Overall Study||98
11403919|NCT03970733|12598817|FG002|STARTED|Overall Study||51
11403920|NCT03970733|12598815|FG000|COMPLETED|Overall Study||93
11403921|NCT03970733|12598816|FG001|COMPLETED|Overall Study||92
11403922|NCT03970733|12598817|FG002|COMPLETED|Overall Study||49
11403923|NCT03970733|12598815|FG000|NOT COMPLETED|Overall Study||4
11403924|NCT03970733|12598816|FG001|NOT COMPLETED|Overall Study||6
11403925|NCT03970733|12598817|FG002|NOT COMPLETED|Overall Study||2
11403926|NCT03968978|12598827|FG000|STARTED|Overall Study||111
11403927|NCT03968978|12598828|FG001|STARTED|Overall Study||105
11403928|NCT03968978|12598827|FG000|COMPLETED|Overall Study||110
11403929|NCT03968978|12598828|FG001|COMPLETED|Overall Study||105
11403930|NCT03968978|12598827|FG000|NOT COMPLETED|Overall Study||1
11403931|NCT03968978|12598828|FG001|NOT COMPLETED|Overall Study||0
11403932|NCT03968848|12598836|FG000|STARTED|Overall Study||8
11403933|NCT03968848|12598837|FG001|STARTED|Overall Study||8
11403934|NCT03968848|12598836|FG000|COMPLETED|Overall Study||8
11403935|NCT03968848|12598837|FG001|COMPLETED|Overall Study||8
11403936|NCT03968848|12598836|FG000|NOT COMPLETED|Overall Study||0
11403937|NCT03968848|12598837|FG001|NOT COMPLETED|Overall Study||0
11403938|NCT03966924|12598843|FG000|STARTED|Overall Study||2
11403939|NCT03966924|12598843|FG000|COMPLETED|Overall Study||2
11403940|NCT03966924|12598843|FG000|NOT COMPLETED|Overall Study||0
11403941|NCT03966911|12598849|FG000|STARTED|Overall Study||169
11403942|NCT03966911|12598850|FG001|STARTED|Overall Study||142
11403943|NCT03966911|12598849|FG000|COMPLETED|Overall Study||160
11403944|NCT03966911|12598850|FG001|COMPLETED|Overall Study||126
11403945|NCT03966911|12598849|FG000|NOT COMPLETED|Overall Study||9
11403946|NCT03966911|12598850|FG001|NOT COMPLETED|Overall Study||16
11403947|NCT03966365|12598860|FG000|STARTED|Overall Study||12
11403948|NCT03966365|12598861|FG001|STARTED|Overall Study||12
11403949|NCT03966365|12598860|FG000|COMPLETED|Overall Study||11
11403950|NCT03966365|12598861|FG001|COMPLETED|Overall Study||12
11403951|NCT03966365|12598860|FG000|NOT COMPLETED|Overall Study||1
11403952|NCT03966365|12598861|FG001|NOT COMPLETED|Overall Study||0
11403953|NCT03965403|12598867|FG000|STARTED|Overall Study||7
11403954|NCT03965403|12598867|FG000|COMPLETED|Overall Study||6
11403955|NCT03965403|12598867|FG000|NOT COMPLETED|Overall Study||1
11403956|NCT03965754|12598875|FG000|STARTED|Overall Study||1422
11403957|NCT03965754|12598876|FG001|STARTED|Overall Study||1425
11403958|NCT03965754|12598877|FG002|STARTED|Overall Study||1425
11403959|NCT03965754|12598878|FG003|STARTED|Overall Study||1425
11403960|NCT03965754|12598875|FG000|COMPLETED|Overall Study||1422
11403961|NCT03965754|12598876|FG001|COMPLETED|Overall Study||1425
11403962|NCT03965754|12598877|FG002|COMPLETED|Overall Study||1425
11403963|NCT03965754|12598878|FG003|COMPLETED|Overall Study||1425
11403964|NCT03965754|12598875|FG000|NOT COMPLETED|Overall Study||0
11403965|NCT03965754|12598876|FG001|NOT COMPLETED|Overall Study||0
11403966|NCT03965754|12598877|FG002|NOT COMPLETED|Overall Study||0
11403967|NCT03965754|12598878|FG003|NOT COMPLETED|Overall Study||0
11403968|NCT03965533|12598895|FG000|STARTED|Part A (112 Days)||2
11403969|NCT03965533|12598896|FG001|STARTED|Part A (112 Days)||6
11403970|NCT03965533|12598897|FG002|STARTED|Part A (112 Days)||2
11403971|NCT03965533|12598898|FG003|STARTED|Part A (112 Days)||6
11403972|NCT03965533|12598899|FG004|STARTED|Part A (112 Days)||0
11403973|NCT03965533|12598900|FG005|STARTED|Part A (112 Days)||0
11403974|NCT03965533|12598901|FG006|STARTED|Part A (112 Days)||0
11403975|NCT03965533|12598895|FG000|COMPLETED|Part A (112 Days)||2
11403976|NCT03965533|12598896|FG001|COMPLETED|Part A (112 Days)||6
11403977|NCT03965533|12598897|FG002|COMPLETED|Part A (112 Days)||2
11403978|NCT03965533|12598898|FG003|COMPLETED|Part A (112 Days)||6
11403979|NCT03965533|12598899|FG004|COMPLETED|Part A (112 Days)||0
11403980|NCT03965533|12598900|FG005|COMPLETED|Part A (112 Days)||0
11403981|NCT03965533|12598901|FG006|COMPLETED|Part A (112 Days)||0
11403982|NCT03965533|12598895|FG000|NOT COMPLETED|Part A (112 Days)||0
11403983|NCT03965533|12598896|FG001|NOT COMPLETED|Part A (112 Days)||0
11403984|NCT03965533|12598897|FG002|NOT COMPLETED|Part A (112 Days)||0
11403985|NCT03965533|12598898|FG003|NOT COMPLETED|Part A (112 Days)||0
11403986|NCT03965533|12598899|FG004|NOT COMPLETED|Part A (112 Days)||0
11403987|NCT03965533|12598900|FG005|NOT COMPLETED|Part A (112 Days)||0
11403988|NCT03965533|12598901|FG006|NOT COMPLETED|Part A (112 Days)||0
11403989|NCT03965533|12598895|FG000|STARTED|Part B (112 Days)||0
11403990|NCT03965533|12598896|FG001|STARTED|Part B (112 Days)||0
11403991|NCT03965533|12598897|FG002|STARTED|Part B (112 Days)||0
11403992|NCT03965533|12598898|FG003|STARTED|Part B (112 Days)||0
11403993|NCT03965533|12598899|FG004|STARTED|Part B (112 Days)||4
11403994|NCT03965533|12598900|FG005|STARTED|Part B (112 Days)||8
11403995|NCT03965533|12598901|FG006|STARTED|Part B (112 Days)||8
11403996|NCT03965533|12598895|FG000|COMPLETED|Part B (112 Days)||0
11403997|NCT03965533|12598896|FG001|COMPLETED|Part B (112 Days)||0
11403998|NCT03965533|12598897|FG002|COMPLETED|Part B (112 Days)||0
11403999|NCT03965533|12598898|FG003|COMPLETED|Part B (112 Days)||0
11404000|NCT03965533|12598899|FG004|COMPLETED|Part B (112 Days)||4
11404001|NCT03965533|12598900|FG005|COMPLETED|Part B (112 Days)||8
11404002|NCT03965533|12598901|FG006|COMPLETED|Part B (112 Days)||8
11404003|NCT03965533|12598895|FG000|NOT COMPLETED|Part B (112 Days)||0
11404004|NCT03965533|12598896|FG001|NOT COMPLETED|Part B (112 Days)||0
11404005|NCT03965533|12598897|FG002|NOT COMPLETED|Part B (112 Days)||0
11404006|NCT03965533|12598898|FG003|NOT COMPLETED|Part B (112 Days)||0
11404007|NCT03965533|12598899|FG004|NOT COMPLETED|Part B (112 Days)||0
11404008|NCT03965533|12598900|FG005|NOT COMPLETED|Part B (112 Days)||0
11404009|NCT03965533|12598901|FG006|NOT COMPLETED|Part B (112 Days)||0
11404010|NCT03965351|12598924|FG000|STARTED|First Intervention (4 Weeks)||3
11404011|NCT03965351|12598925|FG001|STARTED|First Intervention (4 Weeks)||5
11404012|NCT03965351|12598924|FG000|COMPLETED|First Intervention (4 Weeks)||3
11404013|NCT03965351|12598925|FG001|COMPLETED|First Intervention (4 Weeks)||4
11404014|NCT03965351|12598924|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
11404015|NCT03965351|12598925|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
11404016|NCT03965351|12598924|FG000|STARTED|Wash Out Period (4 Weeks)||3
11404017|NCT03965351|12598925|FG001|STARTED|Wash Out Period (4 Weeks)||4
11404018|NCT03965351|12598924|FG000|COMPLETED|Wash Out Period (4 Weeks)||3
11404019|NCT03965351|12598925|FG001|COMPLETED|Wash Out Period (4 Weeks)||4
11404020|NCT03965351|12598924|FG000|NOT COMPLETED|Wash Out Period (4 Weeks)||0
11404021|NCT03965351|12598925|FG001|NOT COMPLETED|Wash Out Period (4 Weeks)||0
11404022|NCT03965351|12598924|FG000|STARTED|Second Intervention (4 Weeks)||3
11404023|NCT03965351|12598925|FG001|STARTED|Second Intervention (4 Weeks)||4
11404024|NCT03965351|12598924|FG000|COMPLETED|Second Intervention (4 Weeks)||3
11404025|NCT03965351|12598925|FG001|COMPLETED|Second Intervention (4 Weeks)||3
11404026|NCT03965351|12598924|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
11404027|NCT03965351|12598925|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
11404028|NCT03964220|12598933|FG000|STARTED|Overall Study||2619
11404029|NCT03964220|12598934|FG001|STARTED|Overall Study||5238
11404030|NCT03964220|12598933|FG000|COMPLETED|Overall Study||2619
11404031|NCT03964220|12598934|FG001|COMPLETED|Overall Study||5238
11404032|NCT03964220|12598933|FG000|NOT COMPLETED|Overall Study||0
11404033|NCT03964220|12598934|FG001|NOT COMPLETED|Overall Study||0
11404034|NCT03958955|12598940|FG000|STARTED|Overall Study||27
11404035|NCT03958955|12598940|FG000|Lesions Treated With Delgocitinib Cream|Overall Study||27
11404036|NCT03958955|12598940|FG000|Lesions Treated With Delgocitinib Cream Vehicle|Overall Study||27
11404037|NCT03958955|12598940|FG000|COMPLETED|Overall Study||26
11404038|NCT03958955|12598940|FG000|NOT COMPLETED|Overall Study||1
11404039|NCT03965052|12598948|FG000|STARTED|Overall Study||12
11404040|NCT03965052|12598949|FG001|STARTED|Overall Study||12
11404041|NCT03965052|12598948|FG000|COMPLETED|Overall Study||11
11404042|NCT03965052|12598949|FG001|COMPLETED|Overall Study||12
11404043|NCT03965052|12598948|FG000|NOT COMPLETED|Overall Study||1
11404044|NCT03965052|12598949|FG001|NOT COMPLETED|Overall Study||0
11404045|NCT03965039|12598959|FG000|STARTED|Overall Study||30
11404046|NCT03965039|12598960|FG001|STARTED|Overall Study||30
11404047|NCT03965039|12598961|FG002|STARTED|Overall Study||30
11404048|NCT03965039|12598962|FG003|STARTED|Overall Study||30
11404049|NCT03965039|12598959|FG000|COMPLETED|Overall Study||30
11404050|NCT03965039|12598960|FG001|COMPLETED|Overall Study||29
11404051|NCT03965039|12598961|FG002|COMPLETED|Overall Study||30
11404052|NCT03965039|12598962|FG003|COMPLETED|Overall Study||29
11404053|NCT03965039|12598959|FG000|NOT COMPLETED|Overall Study||0
11404054|NCT03965039|12598960|FG001|NOT COMPLETED|Overall Study||1
11404055|NCT03965039|12598961|FG002|NOT COMPLETED|Overall Study||0
11404056|NCT03965039|12598962|FG003|NOT COMPLETED|Overall Study||1
11404057|NCT03963401|12598978|FG000|STARTED|Initial Period (Day 1 - Week 16)||60
11404058|NCT03963401|12598979|FG001|STARTED|Initial Period (Day 1 - Week 16)||61
11404059|NCT03963401|12598980|FG002|STARTED|Initial Period (Day 1 - Week 16)||16
11404060|NCT03963401|12598981|FG003|STARTED|Initial Period (Day 1 - Week 16)||15
11404061|NCT03963401|12598982|FG004|STARTED|Initial Period (Day 1 - Week 16)||34
11404062|NCT03963401|12598983|FG005|STARTED|Initial Period (Day 1 - Week 16)||33
11404063|NCT03963401|12598978|FG000|Treated|Initial Period (Day 1 - Week 16)||60
11404064|NCT03963401|12598979|FG001|Treated|Initial Period (Day 1 - Week 16)||60
11404065|NCT03963401|12598980|FG002|Treated|Initial Period (Day 1 - Week 16)||16
11404066|NCT03963401|12598981|FG003|Treated|Initial Period (Day 1 - Week 16)||15
11404067|NCT03963401|12598982|FG004|Treated|Initial Period (Day 1 - Week 16)||34
11404068|NCT03963401|12598983|FG005|Treated|Initial Period (Day 1 - Week 16)||33
11404069|NCT03963401|12598978|FG000|COMPLETED|Initial Period (Day 1 - Week 16)||57
11404070|NCT03963401|12598979|FG001|COMPLETED|Initial Period (Day 1 - Week 16)||57
11404071|NCT03963401|12598980|FG002|COMPLETED|Initial Period (Day 1 - Week 16)||14
11404072|NCT03963401|12598981|FG003|COMPLETED|Initial Period (Day 1 - Week 16)||13
11404073|NCT03963401|12598982|FG004|COMPLETED|Initial Period (Day 1 - Week 16)||31
11404074|NCT03963401|12598983|FG005|COMPLETED|Initial Period (Day 1 - Week 16)||31
11404075|NCT03963401|12598978|FG000|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
11404076|NCT03963401|12598979|FG001|NOT COMPLETED|Initial Period (Day 1 - Week 16)||4
11404077|NCT03963401|12598980|FG002|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
11404078|NCT03963401|12598981|FG003|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
11404079|NCT03963401|12598982|FG004|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
11404080|NCT03963401|12598983|FG005|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
11404081|NCT03963401|12598978|FG000|STARTED|Extension Period (Week 17 - Week 52)||57
11404082|NCT03963401|12598979|FG001|STARTED|Extension Period (Week 17 - Week 52)||57
11404083|NCT03963401|12598980|FG002|STARTED|Extension Period (Week 17 - Week 52)||14
11404084|NCT03963401|12598981|FG003|STARTED|Extension Period (Week 17 - Week 52)||13
11404085|NCT03963401|12598982|FG004|STARTED|Extension Period (Week 17 - Week 52)||31
11404086|NCT03963401|12598983|FG005|STARTED|Extension Period (Week 17 - Week 52)||31
11404087|NCT03963401|12598978|FG000|COMPLETED|Extension Period (Week 17 - Week 52)||43
11404088|NCT03963401|12598979|FG001|COMPLETED|Extension Period (Week 17 - Week 52)||52
11404089|NCT03963401|12598980|FG002|COMPLETED|Extension Period (Week 17 - Week 52)||10
11404090|NCT03963401|12598981|FG003|COMPLETED|Extension Period (Week 17 - Week 52)||12
11404091|NCT03963401|12598982|FG004|COMPLETED|Extension Period (Week 17 - Week 52)||25
11404092|NCT03963401|12598983|FG005|COMPLETED|Extension Period (Week 17 - Week 52)||26
11404093|NCT03963401|12598978|FG000|NOT COMPLETED|Extension Period (Week 17 - Week 52)||14
11404094|NCT03963401|12598979|FG001|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
11404095|NCT03963401|12598980|FG002|NOT COMPLETED|Extension Period (Week 17 - Week 52)||4
11404096|NCT03963401|12598981|FG003|NOT COMPLETED|Extension Period (Week 17 - Week 52)||1
11404097|NCT03963401|12598982|FG004|NOT COMPLETED|Extension Period (Week 17 - Week 52)||6
11404098|NCT03963401|12598983|FG005|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
11404099|NCT03962634|12599003|FG000|STARTED|Overall Study||1
11404100|NCT03962634|12599004|FG001|STARTED|Overall Study||2
11404101|NCT03962634|12599003|FG000|COMPLETED|Overall Study||1
11404102|NCT03962634|12599004|FG001|COMPLETED|Overall Study||2
11404103|NCT03962634|12599003|FG000|NOT COMPLETED|Overall Study||0
11404104|NCT03962634|12599004|FG001|NOT COMPLETED|Overall Study||0
11404105|NCT03962790|12599010|FG000|STARTED|Period 1||48
11404106|NCT03962790|12599011|FG001|STARTED|Period 1||46
11404107|NCT03962790|12599010|FG000|COMPLETED|Period 1||45
11404108|NCT03962790|12599011|FG001|COMPLETED|Period 1||44
11404109|NCT03962790|12599010|FG000|NOT COMPLETED|Period 1||3
11404110|NCT03962790|12599011|FG001|NOT COMPLETED|Period 1||2
11404111|NCT03962790|12599010|FG000|STARTED|Period 2||45
11404112|NCT03962790|12599011|FG001|STARTED|Period 2||44
11404113|NCT03962790|12599010|FG000|COMPLETED|Period 2||45
11404114|NCT03962790|12599011|FG001|COMPLETED|Period 2||44
11404115|NCT03962790|12599010|FG000|NOT COMPLETED|Period 2||0
11404116|NCT03962790|12599011|FG001|NOT COMPLETED|Period 2||0
11404117|NCT03956225|12599019|FG000|STARTED|Overall Study||119
11404118|NCT03956225|12599020|FG001|STARTED|Overall Study||117
11404119|NCT03956225|12599019|FG000|COMPLETED|Overall Study||114
11404120|NCT03956225|12599020|FG001|COMPLETED|Overall Study||113
11404121|NCT03956225|12599019|FG000|NOT COMPLETED|Overall Study||5
11404122|NCT03956225|12599020|FG001|NOT COMPLETED|Overall Study||4
11404123|NCT03951610|12599029|FG000|STARTED|First Intervention||27
11404124|NCT03951610|12599030|FG001|STARTED|First Intervention||25
11404125|NCT03951610|12599029|FG000|COMPLETED|First Intervention||27
11404126|NCT03951610|12599030|FG001|COMPLETED|First Intervention||25
11404127|NCT03951610|12599029|FG000|NOT COMPLETED|First Intervention||0
11404128|NCT03951610|12599030|FG001|NOT COMPLETED|First Intervention||0
11404129|NCT03951610|12599029|FG000|STARTED|Second Intervention||27
11404130|NCT03951610|12599030|FG001|STARTED|Second Intervention||25
11404131|NCT03951610|12599029|FG000|COMPLETED|Second Intervention||27
11404132|NCT03951610|12599030|FG001|COMPLETED|Second Intervention||25
11404133|NCT03951610|12599029|FG000|NOT COMPLETED|Second Intervention||0
11404134|NCT03951610|12599030|FG001|NOT COMPLETED|Second Intervention||0
11404135|NCT03958149|12599038|FG000|STARTED|Overall Study||20
11404136|NCT03958149|12599039|FG001|STARTED|Overall Study||18
11404137|NCT03958149|12599038|FG000|COMPLETED|Overall Study||20
11404138|NCT03958149|12599039|FG001|COMPLETED|Overall Study||17
11404139|NCT03958149|12599038|FG000|NOT COMPLETED|Overall Study||0
11404140|NCT03958149|12599039|FG001|NOT COMPLETED|Overall Study||1
11404141|NCT03953183|12599051|FG000|STARTED|Overall Study||30
11404142|NCT03953183|12599052|FG001|STARTED|Overall Study||30
11404143|NCT03953183|12599051|FG000|COMPLETED|Overall Study||30
11404144|NCT03953183|12599052|FG001|COMPLETED|Overall Study||28
11404145|NCT03953183|12599051|FG000|NOT COMPLETED|Overall Study||0
11404146|NCT03953183|12599052|FG001|NOT COMPLETED|Overall Study||2
11404147|NCT03949335|12599060|FG000|STARTED|Overall Study||135
11404148|NCT03949335|12599061|FG001|STARTED|Overall Study||137
11404149|NCT03949335|12599060|FG000|COMPLETED|Overall Study||132
11404150|NCT03949335|12599061|FG001|COMPLETED|Overall Study||131
11404151|NCT03949335|12599060|FG000|NOT COMPLETED|Overall Study||3
11404152|NCT03949335|12599061|FG001|NOT COMPLETED|Overall Study||6
11404153|NCT03962738|12599073|FG000|STARTED|Overall Study||258
11404154|NCT03962738|12599074|FG001|STARTED|Overall Study||109
11404155|NCT03962738|12599075|FG002|STARTED|Overall Study||261
11404156|NCT03962738|12599076|FG003|STARTED|Overall Study||218
11404157|NCT03962738|12599073|FG000|Received At Least One Dose of Study Drug|Overall Study||214
11404158|NCT03962738|12599074|FG001|Received At Least One Dose of Study Drug|Overall Study||87
11404159|NCT03962738|12599075|FG002|Received At Least One Dose of Study Drug|Overall Study||208
11404160|NCT03962738|12599076|FG003|Received At Least One Dose of Study Drug|Overall Study||182
11404161|NCT03962738|12599073|FG000|COMPLETED|Overall Study||251
11404162|NCT03962738|12599074|FG001|COMPLETED|Overall Study||109
11404163|NCT03962738|12599075|FG002|COMPLETED|Overall Study||259
11404164|NCT03962738|12599076|FG003|COMPLETED|Overall Study||217
11404165|NCT03962738|12599073|FG000|NOT COMPLETED|Overall Study||7
11404166|NCT03962738|12599074|FG001|NOT COMPLETED|Overall Study||0
11404167|NCT03962738|12599075|FG002|NOT COMPLETED|Overall Study||2
11404168|NCT03962738|12599076|FG003|NOT COMPLETED|Overall Study||1
11404169|NCT03962101|12599094|FG000|STARTED|Overall Study||45
11404170|NCT03962101|12599094|FG000|COMPLETED|Overall Study||41
11404171|NCT03962101|12599094|FG000|NOT COMPLETED|Overall Study||4
11404172|NCT03959137|12599099|FG000|STARTED|Overall Study||215
11404173|NCT03959137|12599099|FG000|COMPLETED|Overall Study||209
11404174|NCT03959137|12599099|FG000|NOT COMPLETED|Overall Study||6
11404175|NCT03946124|12599103|FG000|STARTED|Overall Study||74
11404176|NCT03946124|12599103|FG000|COMPLETED|Overall Study||55
11404177|NCT03946124|12599103|FG000|NOT COMPLETED|Overall Study||19
11404178|NCT03961308|12599109|FG000|STARTED|Overall Study||102
11404179|NCT03961308|12599110|FG001|STARTED|Overall Study||102
11404180|NCT03961308|12599109|FG000|COMPLETED|Overall Study||100
11404181|NCT03961308|12599110|FG001|COMPLETED|Overall Study||100
11404182|NCT03961308|12599109|FG000|NOT COMPLETED|Overall Study||2
11404183|NCT03961308|12599110|FG001|NOT COMPLETED|Overall Study||2
11404184|NCT03961295|12599118|FG000|STARTED|Overall Study||12
11404185|NCT03961295|12599119|FG001|STARTED|Overall Study||12
11404186|NCT03961295|12599118|FG000|COMPLETED|Overall Study||12
11404187|NCT03961295|12599119|FG001|COMPLETED|Overall Study||12
11404188|NCT03961295|12599118|FG000|NOT COMPLETED|Overall Study||0
11404189|NCT03961295|12599119|FG001|NOT COMPLETED|Overall Study||0
11404190|NCT03956862|12599127|FG000|STARTED|Overall Study||50
11404191|NCT03956862|12599128|FG001|STARTED|Overall Study||47
11404192|NCT03956862|12599127|FG000|COMPLETED|Overall Study||48
11404193|NCT03956862|12599128|FG001|COMPLETED|Overall Study||45
11404194|NCT03956862|12599127|FG000|NOT COMPLETED|Overall Study||2
11404195|NCT03956862|12599128|FG001|NOT COMPLETED|Overall Study||2
11404196|NCT03954444|12599137|FG000|STARTED|Overall Study||379
11404197|NCT03954444|12599138|FG001|STARTED|Overall Study||382
11404198|NCT03954444|12599139|FG002|STARTED|Overall Study||344
11404199|NCT03954444|12599137|FG000|COMPLETED|Overall Study||366
11404200|NCT03954444|12599138|FG001|COMPLETED|Overall Study||366
11404201|NCT03954444|12599139|FG002|COMPLETED|Overall Study||327
11404202|NCT03954444|12599137|FG000|NOT COMPLETED|Overall Study||13
11404203|NCT03954444|12599138|FG001|NOT COMPLETED|Overall Study||16
11404204|NCT03954444|12599139|FG002|NOT COMPLETED|Overall Study||17
11404205|NCT03953820|12599147|FG000|STARTED|Two-Sequence, Two-Way Crossover||15
11404206|NCT03953820|12599148|FG001|STARTED|Two-Sequence, Two-Way Crossover||16
11404207|NCT03953820|12599149|FG002|STARTED|Two-Sequence, Two-Way Crossover||0
11404208|NCT03953820|12599147|FG000|COMPLETED|Two-Sequence, Two-Way Crossover||13
11404209|NCT03953820|12599148|FG001|COMPLETED|Two-Sequence, Two-Way Crossover||16
11404210|NCT03953820|12599149|FG002|COMPLETED|Two-Sequence, Two-Way Crossover||0
11404211|NCT03953820|12599147|FG000|NOT COMPLETED|Two-Sequence, Two-Way Crossover||2
11404212|NCT03953820|12599148|FG001|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
11404213|NCT03953820|12599149|FG002|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
11404214|NCT03953820|12599147|FG000|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
11404215|NCT03953820|12599148|FG001|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
11404216|NCT03953820|12599149|FG002|STARTED|DBF Following High-Fat Meal|Participants in Period 2 completed 1 of the 2 arms in Period 1 and volunteered to continue.|10
11404217|NCT03953820|12599147|FG000|COMPLETED|DBF Following High-Fat Meal||0
11404218|NCT03953820|12599148|FG001|COMPLETED|DBF Following High-Fat Meal||0
11404219|NCT03953820|12599149|FG002|COMPLETED|DBF Following High-Fat Meal||10
11404220|NCT03953820|12599147|FG000|NOT COMPLETED|DBF Following High-Fat Meal||0
11404221|NCT03953820|12599148|FG001|NOT COMPLETED|DBF Following High-Fat Meal||0
11404222|NCT03953820|12599149|FG002|NOT COMPLETED|DBF Following High-Fat Meal||0
11404223|NCT03961100|12599167|FG000|STARTED|Part 1||5
11404224|NCT03961100|12599168|FG001|STARTED|Part 1||5
11404225|NCT03961100|12599169|FG002|STARTED|Part 1||5
11404226|NCT03961100|12599170|FG003|STARTED|Part 1||0
11404227|NCT03961100|12599171|FG004|STARTED|Part 1||0
11404228|NCT03961100|12599167|FG000|COMPLETED|Part 1||5
11404229|NCT03961100|12599168|FG001|COMPLETED|Part 1||5
11404230|NCT03961100|12599169|FG002|COMPLETED|Part 1||5
11404231|NCT03961100|12599170|FG003|COMPLETED|Part 1||0
11404232|NCT03961100|12599171|FG004|COMPLETED|Part 1||0
11404233|NCT03961100|12599167|FG000|NOT COMPLETED|Part 1||0
11404234|NCT03961100|12599168|FG001|NOT COMPLETED|Part 1||0
11404235|NCT03961100|12599169|FG002|NOT COMPLETED|Part 1||0
11404236|NCT03961100|12599170|FG003|NOT COMPLETED|Part 1||0
11404237|NCT03961100|12599171|FG004|NOT COMPLETED|Part 1||0
11404238|NCT03961100|12599167|FG000|STARTED|Part 2||0
11404239|NCT03961100|12599168|FG001|STARTED|Part 2||0
11404240|NCT03961100|12599169|FG002|STARTED|Part 2||0
11404241|NCT03961100|12599170|FG003|STARTED|Part 2||8
11404242|NCT03961100|12599171|FG004|STARTED|Part 2||8
11404243|NCT03961100|12599167|FG000|COMPLETED|Part 2||0
11404244|NCT03961100|12599168|FG001|COMPLETED|Part 2||0
11404245|NCT03961100|12599169|FG002|COMPLETED|Part 2||0
11404246|NCT03961100|12599170|FG003|COMPLETED|Part 2||8
11404247|NCT03961100|12599171|FG004|COMPLETED|Part 2||8
11404248|NCT03961100|12599167|FG000|NOT COMPLETED|Part 2||0
11404249|NCT03961100|12599168|FG001|NOT COMPLETED|Part 2||0
11022334|NCT00808509|12200585|FG001|NOT COMPLETED|Randomized Phase||5
11022335|NCT00808509|12200584|FG000|STARTED|Observation Phase|The observation phase was open to all participants|16
11022336|NCT00808509|12200585|FG001|STARTED|Observation Phase|The observation phase was open to all participants|15
11022337|NCT00808509|12200584|FG000|COMPLETED|Observation Phase||16
11022338|NCT00808509|12200585|FG001|COMPLETED|Observation Phase||15
11022339|NCT00808509|12200584|FG000|NOT COMPLETED|Observation Phase||0
11022340|NCT00808509|12200585|FG001|NOT COMPLETED|Observation Phase||0
11022341|NCT00808639|12200593|FG000|STARTED|Overall Study||39
11022342|NCT00808639|12200593|FG000|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
11022343|NCT00808639|12200593|FG000|NOT COMPLETED|Overall Study||1
11022344|NCT00808665|12200599|FG000|STARTED|Overall Study||31
11022345|NCT00808665|12200600|FG001|STARTED|Overall Study||32
11022346|NCT00808665|12200599|FG000|Medication Started|Overall Study||30
11022347|NCT00808665|12200600|FG001|Medication Started|Overall Study||32
11022348|NCT00808665|12200599|FG000|Completed Intra-operative Dose|Overall Study||26
11022349|NCT00808665|12200600|FG001|Completed Intra-operative Dose|Overall Study||32
11022350|NCT00808665|12200599|FG000|Completed Post Operative Doses|Overall Study||25
11022351|NCT00808665|12200600|FG001|Completed Post Operative Doses|Overall Study||29
11404250|NCT03961100|12599169|FG002|NOT COMPLETED|Part 2||0
11404251|NCT03961100|12599170|FG003|NOT COMPLETED|Part 2||0
11404252|NCT03961100|12599171|FG004|NOT COMPLETED|Part 2||0
11404253|NCT03950856|12599187|FG000|STARTED|Overall Study||702
11404254|NCT03950856|12599188|FG001|STARTED|Overall Study||704
11404255|NCT03950856|12599189|FG002|STARTED|Overall Study||701
11404256|NCT03950856|12599190|FG003|STARTED|Overall Study||233
11404257|NCT03950856|12599187|FG000|Vaccinated|Overall Study||698
11404258|NCT03950856|12599188|FG001|Vaccinated|Overall Study||704
11404259|NCT03950856|12599189|FG002|Vaccinated|Overall Study||700
11404260|NCT03950856|12599190|FG003|Vaccinated|Overall Study||231
11404261|NCT03950856|12599187|FG000|COMPLETED|Overall Study||683
11404262|NCT03950856|12599188|FG001|COMPLETED|Overall Study||689
11404263|NCT03950856|12599189|FG002|COMPLETED|Overall Study||683
11404264|NCT03950856|12599190|FG003|COMPLETED|Overall Study||227
11404265|NCT03950856|12599187|FG000|NOT COMPLETED|Overall Study||19
11404266|NCT03950856|12599188|FG001|NOT COMPLETED|Overall Study||15
11404267|NCT03950856|12599189|FG002|NOT COMPLETED|Overall Study||18
11404268|NCT03950856|12599190|FG003|NOT COMPLETED|Overall Study||6
11404269|NCT03947983|12599204|FG000|STARTED|Overall Study||19
11404270|NCT03947983|12599205|FG001|STARTED|Overall Study||19
11404271|NCT03947983|12599204|FG000|12 Weeks|Overall Study||15
11404272|NCT03947983|12599205|FG001|12 Weeks|Overall Study||17
11404273|NCT03947983|12599204|FG000|COMPLETED|Overall Study||14
11404274|NCT03947983|12599205|FG001|COMPLETED|Overall Study||13
11404275|NCT03947983|12599204|FG000|NOT COMPLETED|Overall Study||5
11404276|NCT03947983|12599205|FG001|NOT COMPLETED|Overall Study||6
11404277|NCT03960658|12599211|FG000|STARTED|Overall Study||12
11404278|NCT03960658|12599211|FG000|COMPLETED|Overall Study||10
11404279|NCT03960658|12599211|FG000|NOT COMPLETED|Overall Study||2
11404280|NCT03959332|12599217|FG000|STARTED|Overall Study||16
11404281|NCT03959332|12599218|FG001|STARTED|Overall Study||16
11404282|NCT03959332|12599217|FG000|COMPLETED|Overall Study||16
11404283|NCT03959332|12599218|FG001|COMPLETED|Overall Study||16
11404284|NCT03959332|12599217|FG000|NOT COMPLETED|Overall Study||0
11404285|NCT03959332|12599218|FG001|NOT COMPLETED|Overall Study||0
11404286|NCT03959189|12599226|FG000|STARTED|Overall Study||7
11404287|NCT03959189|12599227|FG001|STARTED|Overall Study||5
11404288|NCT03959189|12599226|FG000|COMPLETED|Overall Study||7
11404289|NCT03959189|12599227|FG001|COMPLETED|Overall Study||5
11404290|NCT03959189|12599226|FG000|NOT COMPLETED|Overall Study||0
11404291|NCT03959189|12599227|FG001|NOT COMPLETED|Overall Study||0
11404292|NCT03956550|12599243|FG000|STARTED|Overall Study||88
11404293|NCT03956550|12599244|FG001|STARTED|Overall Study||86
11404294|NCT03956550|12599245|FG002|STARTED|Overall Study||85
11404295|NCT03956550|12599243|FG000|COMPLETED|Overall Study||18
11404296|NCT03956550|12599244|FG001|COMPLETED|Overall Study||14
11404297|NCT03956550|12599245|FG002|COMPLETED|Overall Study||15
11404298|NCT03956550|12599243|FG000|NOT COMPLETED|Overall Study||70
11404299|NCT03956550|12599244|FG001|NOT COMPLETED|Overall Study||72
11404300|NCT03956550|12599245|FG002|NOT COMPLETED|Overall Study||70
11404301|NCT03954158|12599257|FG000|STARTED|Overall Study||20
11404302|NCT03954158|12599258|FG001|STARTED|Overall Study||21
11404303|NCT03954158|12599259|FG002|STARTED|Overall Study||20
11404304|NCT03954158|12599260|FG003|STARTED|Overall Study||20
11404305|NCT03954158|12599257|FG000|COMPLETED|Overall Study||20
11404306|NCT03954158|12599258|FG001|COMPLETED|Overall Study||21
11404307|NCT03954158|12599259|FG002|COMPLETED|Overall Study||20
11404308|NCT03954158|12599260|FG003|COMPLETED|Overall Study||20
11404309|NCT03954158|12599257|FG000|NOT COMPLETED|Overall Study||0
11404310|NCT03954158|12599258|FG001|NOT COMPLETED|Overall Study||0
11404311|NCT03954158|12599259|FG002|NOT COMPLETED|Overall Study||0
11404312|NCT03954158|12599260|FG003|NOT COMPLETED|Overall Study||0
11404313|NCT03958656|12599297|FG000|STARTED|Overall Study||3
11404314|NCT03958656|12599298|FG001|STARTED|Overall Study||4
11404315|NCT03958656|12599299|FG002|STARTED|Overall Study||5
11404316|NCT03958656|12599300|FG003|STARTED|Overall Study||1
11404317|NCT03958656|12599297|FG000|COMPLETED|Overall Study||3
11404318|NCT03958656|12599298|FG001|COMPLETED|Overall Study||3
11404319|NCT03958656|12599299|FG002|COMPLETED|Overall Study||3
11404320|NCT03958656|12599300|FG003|COMPLETED|Overall Study||1
11404321|NCT03958656|12599297|FG000|NOT COMPLETED|Overall Study||0
11404322|NCT03958656|12599298|FG001|NOT COMPLETED|Overall Study||1
11404323|NCT03958656|12599299|FG002|NOT COMPLETED|Overall Study||2
11404324|NCT03958656|12599300|FG003|NOT COMPLETED|Overall Study||0
11404325|NCT03955133|12599310|FG000|STARTED|Overall Study|participants recruited from 3 care homes|19
11404326|NCT03955133|12599310|FG000|COMPLETED|Overall Study|End of study funding|19
11404327|NCT03955133|12599310|FG000|NOT COMPLETED|Overall Study||0
11022352|NCT00808665|12200599|FG000|COMPLETED|Overall Study||25
11022353|NCT00808665|12200600|FG001|COMPLETED|Overall Study||29
11022354|NCT00808665|12200599|FG000|NOT COMPLETED|Overall Study||6
11404328|NCT03954626|12599315|FG000|STARTED|Overall Study||14
11404329|NCT03954626|12599315|FG000|COMPLETED|Overall Study||14
11404330|NCT03954626|12599315|FG000|NOT COMPLETED|Overall Study||0
11404331|NCT03951805|12599323|FG000|STARTED|Overall Study||51
11404332|NCT03951805|12599324|FG001|STARTED|Overall Study||51
11404333|NCT03951805|12599325|FG002|STARTED|Overall Study||52
11404334|NCT03951805|12599326|FG003|STARTED|Overall Study||51
11404335|NCT03951805|12599323|FG000|Full Analysis Set (FAS)|Overall Study||51
11404336|NCT03951805|12599324|FG001|Full Analysis Set (FAS)|Overall Study||51
11404337|NCT03951805|12599325|FG002|Full Analysis Set (FAS)|Overall Study||52
11404338|NCT03951805|12599326|FG003|Full Analysis Set (FAS)|Overall Study||51
11404339|NCT03951805|12599323|FG000|Safety Analysis Set (SAS)|Overall Study||51
11404340|NCT03951805|12599324|FG001|Safety Analysis Set (SAS)|Overall Study||51
11404341|NCT03951805|12599325|FG002|Safety Analysis Set (SAS)|Overall Study||52
11404342|NCT03951805|12599326|FG003|Safety Analysis Set (SAS)|Overall Study||51
11404343|NCT03951805|12599323|FG000|COMPLETED|Overall Study||50
11404344|NCT03951805|12599324|FG001|COMPLETED|Overall Study||51
11404345|NCT03951805|12599325|FG002|COMPLETED|Overall Study||52
11404346|NCT03951805|12599326|FG003|COMPLETED|Overall Study||51
11404347|NCT03951805|12599323|FG000|NOT COMPLETED|Overall Study||1
11404348|NCT03951805|12599324|FG001|NOT COMPLETED|Overall Study||0
11404349|NCT03951805|12599325|FG002|NOT COMPLETED|Overall Study||0
11404350|NCT03951805|12599326|FG003|NOT COMPLETED|Overall Study||0
11404351|NCT03944785|12599339|FG000|STARTED|2 Month Study Completion||2
11404352|NCT03944785|12599340|FG001|STARTED|2 Month Study Completion||34
11404353|NCT03944785|12599341|FG002|STARTED|2 Month Study Completion||128
11404354|NCT03944785|12599339|FG000|COMPLETED|2 Month Study Completion||2
11404355|NCT03944785|12599340|FG001|COMPLETED|2 Month Study Completion||30
11404356|NCT03944785|12599341|FG002|COMPLETED|2 Month Study Completion||123
11404357|NCT03944785|12599339|FG000|NOT COMPLETED|2 Month Study Completion||0
11404358|NCT03944785|12599340|FG001|NOT COMPLETED|2 Month Study Completion||4
11404359|NCT03944785|12599341|FG002|NOT COMPLETED|2 Month Study Completion||5
11404360|NCT03944785|12599339|FG000|STARTED|4 Month Study Optional Extension||1
11404361|NCT03944785|12599340|FG001|STARTED|4 Month Study Optional Extension||10
11404362|NCT03944785|12599341|FG002|STARTED|4 Month Study Optional Extension||64
11404363|NCT03944785|12599339|FG000|COMPLETED|4 Month Study Optional Extension||0
11404364|NCT03944785|12599340|FG001|COMPLETED|4 Month Study Optional Extension||8
11404365|NCT03944785|12599341|FG002|COMPLETED|4 Month Study Optional Extension||41
11404366|NCT03944785|12599339|FG000|NOT COMPLETED|4 Month Study Optional Extension||1
11404367|NCT03944785|12599340|FG001|NOT COMPLETED|4 Month Study Optional Extension||2
11404368|NCT03944785|12599341|FG002|NOT COMPLETED|4 Month Study Optional Extension||23
11404369|NCT03950622|12599351|FG000|STARTED|Overall Study||604
11404370|NCT03950622|12599352|FG001|STARTED|Overall Study||601
11404371|NCT03950622|12599351|FG000|Vaccinated|Overall Study||602
11404372|NCT03950622|12599352|FG001|Vaccinated|Overall Study||600
11404373|NCT03950622|12599351|FG000|COMPLETED|Overall Study||596
11404374|NCT03950622|12599352|FG001|COMPLETED|Overall Study||594
11404375|NCT03950622|12599351|FG000|NOT COMPLETED|Overall Study||8
11404376|NCT03950622|12599352|FG001|NOT COMPLETED|Overall Study||7
11404377|NCT03949621|12599360|FG000|STARTED|Overall Study||12
11404378|NCT03949621|12599361|FG001|STARTED|Overall Study||12
11404379|NCT03949621|12599360|FG000|COMPLETED|Overall Study||12
11404380|NCT03949621|12599361|FG001|COMPLETED|Overall Study||12
11404381|NCT03949621|12599360|FG000|NOT COMPLETED|Overall Study||0
11404382|NCT03949621|12599361|FG001|NOT COMPLETED|Overall Study||0
11404383|NCT03949244|12599370|FG000|STARTED|Overall Study||12
11404384|NCT03949244|12599371|FG001|STARTED|Overall Study||21
11404385|NCT03949244|12599372|FG002|STARTED|Overall Study||14
11404386|NCT03949244|12599370|FG000|COMPLETED|Overall Study||12
11404387|NCT03949244|12599371|FG001|COMPLETED|Overall Study||21
11404388|NCT03949244|12599372|FG002|COMPLETED|Overall Study||14
11404389|NCT03949244|12599370|FG000|NOT COMPLETED|Overall Study||0
11404390|NCT03949244|12599371|FG001|NOT COMPLETED|Overall Study||0
11404391|NCT03949244|12599372|FG002|NOT COMPLETED|Overall Study||0
11404392|NCT03948386|12599383|FG000|STARTED|Overall Study||52
11404393|NCT03948386|12599384|FG001|STARTED|Overall Study||54
11404394|NCT03948386|12599385|FG002|STARTED|Overall Study||53
11404395|NCT03948386|12599383|FG000|COMPLETED|Overall Study||51
11404396|NCT03948386|12599384|FG001|COMPLETED|Overall Study||53
11404397|NCT03948386|12599385|FG002|COMPLETED|Overall Study||50
11404398|NCT03948386|12599383|FG000|NOT COMPLETED|Overall Study||1
11404399|NCT03948386|12599384|FG001|NOT COMPLETED|Overall Study||1
11404400|NCT03948386|12599385|FG002|NOT COMPLETED|Overall Study||3
11404401|NCT03948334|12599395|FG000|STARTED|Overall Study||60
11404402|NCT03948334|12599396|FG001|STARTED|Overall Study||63
11404403|NCT03948334|12599395|FG000|COMPLETED|Overall Study||0
11404404|NCT03948334|12599396|FG001|COMPLETED|Overall Study||0
11404405|NCT03948334|12599395|FG000|NOT COMPLETED|Overall Study||60
11404406|NCT03948334|12599396|FG001|NOT COMPLETED|Overall Study||63
11404407|NCT03946059|12599412|FG000|STARTED|Overall Study||13
11404408|NCT03946059|12599413|FG001|STARTED|Overall Study||12
11404409|NCT03946059|12599412|FG000|COMPLETED|Overall Study||13
11404410|NCT03946059|12599413|FG001|COMPLETED|Overall Study||11
11404411|NCT03946059|12599412|FG000|NOT COMPLETED|Overall Study||0
11404412|NCT03946059|12599413|FG001|NOT COMPLETED|Overall Study||1
11404413|NCT03944707|12599423|FG000|STARTED|Overall Study||47
11404414|NCT03944707|12599424|FG001|STARTED|Overall Study||29
11404415|NCT03944707|12599423|FG000|PK Analysis Set|Overall Study||33
11404416|NCT03944707|12599424|FG001|PK Analysis Set|Overall Study||0
11404417|NCT03944707|12599423|FG000|PD Analysis Set|Overall Study||47
11404418|NCT03944707|12599424|FG001|PD Analysis Set|Overall Study||29
11404419|NCT03944707|12599423|FG000|COMPLETED|Overall Study||35
11404420|NCT03944707|12599424|FG001|COMPLETED|Overall Study||19
11404421|NCT03944707|12599423|FG000|NOT COMPLETED|Overall Study||12
11404422|NCT03944707|12599424|FG001|NOT COMPLETED|Overall Study||10
11404423|NCT03944668|12599430|FG000|STARTED|Overall Study|Enrolled in Study|17
11404424|NCT03944668|12599430|FG000|Able to Use Patient Data|Overall Study|3 Patient's Data Unusable|14
11404425|NCT03944668|12599430|FG000|Participated in Intervention|Overall Study|Started Cardiac Rehabilitation|10
11404426|NCT03944668|12599430|FG000|COMPLETED|Overall Study|Completed 75% of Comprehensive Cardiac Rehabilitation Sessions|8
11404427|NCT03944668|12599430|FG000|NOT COMPLETED|Overall Study||9
11404428|NCT03943160|12599435|FG000|STARTED|Overall Study||50
11404429|NCT03943160|12599435|FG000|COMPLETED|Overall Study||50
11404430|NCT03943160|12599435|FG000|NOT COMPLETED|Overall Study||0
11404431|NCT03943095|12599441|FG000|STARTED|Overall Study||52
11404432|NCT03943095|12599442|FG001|STARTED|Overall Study||52
11404433|NCT03943095|12599441|FG000|COMPLETED|Overall Study||51
11404434|NCT03943095|12599442|FG001|COMPLETED|Overall Study||51
11404435|NCT03943095|12599441|FG000|NOT COMPLETED|Overall Study||1
11404436|NCT03943095|12599442|FG001|NOT COMPLETED|Overall Study||1
11404437|NCT03942042|12599451|FG000|STARTED|Induction Dosing Period (12 Weeks)||7
11404438|NCT03942042|12599452|FG001|STARTED|Induction Dosing Period (12 Weeks)||5
11404439|NCT03942042|12599451|FG000|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||7
11404440|NCT03942042|12599452|FG001|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||5
11404441|NCT03942042|12599451|FG000|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||4
11404442|NCT03942042|12599452|FG001|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||0
11404443|NCT03942042|12599451|FG000|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||2
11404444|NCT03942042|12599452|FG001|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||4
11404445|NCT03942042|12599451|FG000|COMPLETED|Induction Dosing Period (12 Weeks)||6
11404446|NCT03942042|12599452|FG001|COMPLETED|Induction Dosing Period (12 Weeks)||4
11404447|NCT03942042|12599451|FG000|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
11404448|NCT03942042|12599452|FG001|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
11404449|NCT03942042|12599451|FG000|STARTED|Maintenance Dosing Period (8 Weeks)|Only participants with GIS ≥2 at Week 12 and based on investigators' discretion continued to maintenance dosing period.|2
11404450|NCT03942042|12599452|FG001|STARTED|Maintenance Dosing Period (8 Weeks)||4
11404451|NCT03942042|12599451|FG000|COMPLETED|Maintenance Dosing Period (8 Weeks)||2
11404452|NCT03942042|12599452|FG001|COMPLETED|Maintenance Dosing Period (8 Weeks)||4
11404453|NCT03942042|12599451|FG000|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
11404454|NCT03942042|12599452|FG001|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
11404455|NCT03938337|12599464|FG000|STARTED|Overall Study||1
11404456|NCT03938337|12599465|FG001|STARTED|Overall Study||0
11404457|NCT03938337|12599464|FG000|COMPLETED|Overall Study||1
11404458|NCT03938337|12599465|FG001|COMPLETED|Overall Study||0
11404459|NCT03938337|12599464|FG000|NOT COMPLETED|Overall Study||0
11404460|NCT03938337|12599465|FG001|NOT COMPLETED|Overall Study||0
11404461|NCT03923530|12599471|FG000|STARTED|Overall Study||12
11404462|NCT03923530|12599471|FG000|COMPLETED|Overall Study||8
11404463|NCT03923530|12599471|FG000|NOT COMPLETED|Overall Study||4
11404464|NCT03914417|12599475|FG000|STARTED|Overall Study||21
11404465|NCT03914417|12599475|FG000|COMPLETED|Overall Study||19
11404466|NCT03914417|12599475|FG000|NOT COMPLETED|Overall Study||2
11404467|NCT03913377|12599481|FG000|STARTED|Period 1||21
11404468|NCT03913377|12599482|FG001|STARTED|Period 1||22
11404469|NCT03913377|12599483|FG002|STARTED|Period 1||22
11404470|NCT03913377|12599481|FG000|COMPLETED|Period 1||21
11404471|NCT03913377|12599482|FG001|COMPLETED|Period 1||21
11404472|NCT03913377|12599483|FG002|COMPLETED|Period 1||21
11404473|NCT03913377|12599481|FG000|NOT COMPLETED|Period 1||0
11404474|NCT03913377|12599482|FG001|NOT COMPLETED|Period 1||1
11404475|NCT03913377|12599483|FG002|NOT COMPLETED|Period 1||1
11404476|NCT03913377|12599481|FG000|STARTED|Period 2||0
11404477|NCT03913377|12599482|FG001|STARTED|Period 2||21
11404478|NCT03913377|12599483|FG002|STARTED|Period 2||21
11404479|NCT03913377|12599481|FG000|COMPLETED|Period 2||0
11404480|NCT03913377|12599482|FG001|COMPLETED|Period 2||21
11404481|NCT03913377|12599483|FG002|COMPLETED|Period 2||21
11404482|NCT03913377|12599481|FG000|NOT COMPLETED|Period 2||0
11404483|NCT03913377|12599482|FG001|NOT COMPLETED|Period 2||0
11404484|NCT03913377|12599483|FG002|NOT COMPLETED|Period 2||0
11404485|NCT03937791|12599490|FG000|STARTED|Overall Study||1
11404486|NCT03937791|12599490|FG000|COMPLETED|Overall Study||1
11404487|NCT03937791|12599490|FG000|NOT COMPLETED|Overall Study||0
11404488|NCT03937778|12599494|FG000|STARTED|Overall Study||7
11404489|NCT03937778|12599494|FG000|COMPLETED|Overall Study||5
11404490|NCT03937778|12599494|FG000|NOT COMPLETED|Overall Study||2
11404491|NCT03937479|12599503|FG000|STARTED|Overall Study||83
11404492|NCT03937479|12599504|FG001|STARTED|Overall Study||85
11404493|NCT03937479|12599505|FG002|STARTED|Overall Study||82
11404494|NCT03937479|12599506|FG003|STARTED|Overall Study||82
11404495|NCT03937479|12599507|FG004|STARTED|Overall Study||84
11404496|NCT03937479|12599503|FG000|Received Treatment|Overall Study||83
11404497|NCT03937479|12599504|FG001|Received Treatment|Overall Study||83
11404498|NCT03937479|12599505|FG002|Received Treatment|Overall Study||81
11404499|NCT03937479|12599506|FG003|Received Treatment|Overall Study||82
11404500|NCT03937479|12599507|FG004|Received Treatment|Overall Study||84
11404501|NCT03937479|12599503|FG000|COMPLETED|Overall Study||73
11404502|NCT03937479|12599504|FG001|COMPLETED|Overall Study||70
11404503|NCT03937479|12599505|FG002|COMPLETED|Overall Study||75
11404504|NCT03937479|12599506|FG003|COMPLETED|Overall Study||76
11404505|NCT03937479|12599507|FG004|COMPLETED|Overall Study||79
11404506|NCT03937479|12599503|FG000|NOT COMPLETED|Overall Study||10
11404507|NCT03937479|12599504|FG001|NOT COMPLETED|Overall Study||15
11404508|NCT03937479|12599505|FG002|NOT COMPLETED|Overall Study||7
11404509|NCT03937479|12599506|FG003|NOT COMPLETED|Overall Study||6
11404510|NCT03937479|12599507|FG004|NOT COMPLETED|Overall Study||5
11404511|NCT03936387|12599519|FG000|STARTED|Overall Study||10
11404512|NCT03936387|12599519|FG000|COMPLETED|Overall Study||10
11404513|NCT03936387|12599519|FG000|NOT COMPLETED|Overall Study||0
11404514|NCT03935399|12599525|FG000|STARTED|First Study Day||5
11404515|NCT03935399|12599526|FG001|STARTED|First Study Day||5
11404516|NCT03935399|12599525|FG000|COMPLETED|First Study Day||5
11404517|NCT03935399|12599526|FG001|COMPLETED|First Study Day||5
11404518|NCT03935399|12599525|FG000|NOT COMPLETED|First Study Day||0
11404519|NCT03935399|12599526|FG001|NOT COMPLETED|First Study Day||0
11404520|NCT03935399|12599525|FG000|STARTED|Second Study Day||5
11404521|NCT03935399|12599526|FG001|STARTED|Second Study Day||5
11404522|NCT03935399|12599525|FG000|COMPLETED|Second Study Day||5
11404523|NCT03935399|12599526|FG001|COMPLETED|Second Study Day||5
11404524|NCT03935399|12599525|FG000|NOT COMPLETED|Second Study Day||0
11404525|NCT03935399|12599526|FG001|NOT COMPLETED|Second Study Day||0
11404526|NCT03936608|12599534|FG000|STARTED|Overall Study||2
11404527|NCT03936608|12599535|FG001|STARTED|Overall Study||2
11404528|NCT03936608|12599534|FG000|COMPLETED|Overall Study||0
11404529|NCT03936608|12599535|FG001|COMPLETED|Overall Study||0
11404530|NCT03936608|12599534|FG000|NOT COMPLETED|Overall Study||2
11404531|NCT03936608|12599535|FG001|NOT COMPLETED|Overall Study||2
11404532|NCT03936244|12599543|FG000|STARTED|Overall Study||57
11404533|NCT03936244|12599544|FG001|STARTED|Overall Study||43
11404534|NCT03936244|12599543|FG000|COMPLETED|Overall Study||45
11404535|NCT03936244|12599544|FG001|COMPLETED|Overall Study||39
11404536|NCT03936244|12599543|FG000|NOT COMPLETED|Overall Study||12
11404537|NCT03936244|12599544|FG001|NOT COMPLETED|Overall Study||4
11404538|NCT03935126|12599551|FG000|STARTED|Overall Study||3
11404539|NCT03935126|12599551|FG000|COMPLETED|Overall Study||0
11404540|NCT03935126|12599551|FG000|NOT COMPLETED|Overall Study||3
11404541|NCT03928327|12599557|FG000|STARTED|Period 1||12
11404542|NCT03928327|12599558|FG001|STARTED|Period 1||12
11404543|NCT03928327|12599557|FG000|COMPLETED|Period 1||12
11404544|NCT03928327|12599558|FG001|COMPLETED|Period 1||12
11404545|NCT03928327|12599557|FG000|NOT COMPLETED|Period 1||0
11404546|NCT03928327|12599558|FG001|NOT COMPLETED|Period 1||0
11404547|NCT03928327|12599557|FG000|STARTED|Washout Period||12
11404548|NCT03928327|12599558|FG001|STARTED|Washout Period||12
11404549|NCT03928327|12599557|FG000|COMPLETED|Washout Period||12
11404550|NCT03928327|12599558|FG001|COMPLETED|Washout Period||12
11404551|NCT03928327|12599557|FG000|NOT COMPLETED|Washout Period||0
11404552|NCT03928327|12599558|FG001|NOT COMPLETED|Washout Period||0
11404553|NCT03928327|12599557|FG000|STARTED|Period 2||12
11404554|NCT03928327|12599558|FG001|STARTED|Period 2||12
11404555|NCT03928327|12599557|FG000|COMPLETED|Period 2||12
11404556|NCT03928327|12599558|FG001|COMPLETED|Period 2||12
11404557|NCT03928327|12599557|FG000|NOT COMPLETED|Period 2||0
11404558|NCT03928327|12599558|FG001|NOT COMPLETED|Period 2||0
11404559|NCT03933462|12599570|FG000|STARTED|Overall Study||10
11404560|NCT03933462|12599571|FG001|STARTED|Overall Study||10
11404561|NCT03933462|12599570|FG000|Crossover|Overall Study||8
11404562|NCT03933462|12599571|FG001|Crossover|Overall Study||10
11404563|NCT03933462|12599570|FG000|COMPLETED|Overall Study||8
11404564|NCT03933462|12599571|FG001|COMPLETED|Overall Study||10
11404565|NCT03933462|12599570|FG000|NOT COMPLETED|Overall Study||2
11404566|NCT03933462|12599571|FG001|NOT COMPLETED|Overall Study||0
11404567|NCT03933774|12599579|FG000|STARTED|Overall Study||12
11404568|NCT03933774|12599580|FG001|STARTED|Overall Study||13
11404569|NCT03933774|12599579|FG000|COMPLETED|Overall Study||10
11404570|NCT03933774|12599580|FG001|COMPLETED|Overall Study||11
11404571|NCT03933774|12599579|FG000|NOT COMPLETED|Overall Study||2
11404572|NCT03933774|12599580|FG001|NOT COMPLETED|Overall Study||2
11404573|NCT03931330|12599586|FG000|STARTED|Overall Study||8
11404574|NCT03931330|12599586|FG000|4 Weeks of Neuromodulation|Overall Study|at 4 weeks of neuromodulation|7
11404575|NCT03931330|12599586|FG000|COMPLETED|Overall Study||7
11404576|NCT03931330|12599586|FG000|NOT COMPLETED|Overall Study||1
11404577|NCT03918811|12599593|FG000|STARTED|Overall Study||367
11404578|NCT03918811|12599594|FG001|STARTED|Overall Study||358
11404579|NCT03918811|12599593|FG000|COMPLETED|Overall Study||363
11404580|NCT03918811|12599594|FG001|COMPLETED|Overall Study||345
11404581|NCT03918811|12599593|FG000|NOT COMPLETED|Overall Study||4
11404582|NCT03918811|12599594|FG001|NOT COMPLETED|Overall Study||13
11404583|NCT03933618|12599606|FG000|STARTED|Baseline||4
11404584|NCT03933618|12599607|FG001|STARTED|Baseline||4
11404585|NCT03933618|12599608|FG002|STARTED|Baseline||4
11404586|NCT03933618|12599609|FG003|STARTED|Baseline||4
11404587|NCT03933618|12599610|FG004|STARTED|Baseline||4
11404588|NCT03933618|12599611|FG005|STARTED|Baseline||4
11404589|NCT03933618|12599606|FG000|COMPLETED|Baseline||4
11404590|NCT03933618|12599607|FG001|COMPLETED|Baseline||4
11404591|NCT03933618|12599608|FG002|COMPLETED|Baseline||4
11404592|NCT03933618|12599609|FG003|COMPLETED|Baseline||4
11404593|NCT03933618|12599610|FG004|COMPLETED|Baseline||4
11404594|NCT03933618|12599611|FG005|COMPLETED|Baseline||4
11404595|NCT03933618|12599606|FG000|NOT COMPLETED|Baseline||0
11404596|NCT03933618|12599607|FG001|NOT COMPLETED|Baseline||0
11404597|NCT03933618|12599608|FG002|NOT COMPLETED|Baseline||0
11404598|NCT03933618|12599609|FG003|NOT COMPLETED|Baseline||0
11404599|NCT03933618|12599610|FG004|NOT COMPLETED|Baseline||0
11404600|NCT03933618|12599611|FG005|NOT COMPLETED|Baseline||0
11404601|NCT03933618|12599606|FG000|STARTED|Baseline to Week 8||4
11404602|NCT03933618|12599607|FG001|STARTED|Baseline to Week 8||4
11404603|NCT03933618|12599608|FG002|STARTED|Baseline to Week 8||4
11404604|NCT03933618|12599609|FG003|STARTED|Baseline to Week 8||4
11404605|NCT03933618|12599610|FG004|STARTED|Baseline to Week 8||4
11404606|NCT03933618|12599611|FG005|STARTED|Baseline to Week 8||4
11404607|NCT03933618|12599606|FG000|COMPLETED|Baseline to Week 8||4
11404608|NCT03933618|12599607|FG001|COMPLETED|Baseline to Week 8||4
11404609|NCT03933618|12599608|FG002|COMPLETED|Baseline to Week 8||4
11404610|NCT03933618|12599609|FG003|COMPLETED|Baseline to Week 8||4
11404611|NCT03933618|12599610|FG004|COMPLETED|Baseline to Week 8||4
11404612|NCT03933618|12599611|FG005|COMPLETED|Baseline to Week 8||4
11404613|NCT03933618|12599606|FG000|NOT COMPLETED|Baseline to Week 8||0
11404614|NCT03933618|12599607|FG001|NOT COMPLETED|Baseline to Week 8||0
11404615|NCT03933618|12599608|FG002|NOT COMPLETED|Baseline to Week 8||0
11404616|NCT03933618|12599609|FG003|NOT COMPLETED|Baseline to Week 8||0
11404617|NCT03933618|12599610|FG004|NOT COMPLETED|Baseline to Week 8||0
11404618|NCT03933618|12599611|FG005|NOT COMPLETED|Baseline to Week 8||0
11404619|NCT03933618|12599606|FG000|STARTED|Week 8 to Week 16||4
11404620|NCT03933618|12599607|FG001|STARTED|Week 8 to Week 16||4
11404621|NCT03933618|12599608|FG002|STARTED|Week 8 to Week 16||4
11404622|NCT03933618|12599609|FG003|STARTED|Week 8 to Week 16||4
11404623|NCT03933618|12599610|FG004|STARTED|Week 8 to Week 16||4
11404624|NCT03933618|12599611|FG005|STARTED|Week 8 to Week 16||4
11404625|NCT03933618|12599606|FG000|COMPLETED|Week 8 to Week 16||4
11404626|NCT03933618|12599607|FG001|COMPLETED|Week 8 to Week 16||4
11404627|NCT03933618|12599608|FG002|COMPLETED|Week 8 to Week 16||4
11404628|NCT03933618|12599609|FG003|COMPLETED|Week 8 to Week 16||4
11404629|NCT03933618|12599610|FG004|COMPLETED|Week 8 to Week 16||4
11404630|NCT03933618|12599611|FG005|COMPLETED|Week 8 to Week 16||4
11404631|NCT03933618|12599606|FG000|NOT COMPLETED|Week 8 to Week 16||0
11404632|NCT03933618|12599607|FG001|NOT COMPLETED|Week 8 to Week 16||0
11404633|NCT03933618|12599608|FG002|NOT COMPLETED|Week 8 to Week 16||0
11404634|NCT03933618|12599609|FG003|NOT COMPLETED|Week 8 to Week 16||0
11404635|NCT03933618|12599610|FG004|NOT COMPLETED|Week 8 to Week 16||0
11404636|NCT03933618|12599611|FG005|NOT COMPLETED|Week 8 to Week 16||0
11404637|NCT03933618|12599606|FG000|STARTED|Week 16 to Week 24||4
11404638|NCT03933618|12599607|FG001|STARTED|Week 16 to Week 24||4
11404639|NCT03933618|12599608|FG002|STARTED|Week 16 to Week 24||4
11404640|NCT03933618|12599609|FG003|STARTED|Week 16 to Week 24||4
11404641|NCT03933618|12599610|FG004|STARTED|Week 16 to Week 24||4
11404642|NCT03933618|12599611|FG005|STARTED|Week 16 to Week 24||4
11022355|NCT00808665|12200600|FG001|NOT COMPLETED|Overall Study||3
11022356|NCT00808808|12200609|FG000|STARTED|Overall Study|Started includes all employees at participating sites.|4078
11022357|NCT00808808|12200610|FG001|STARTED|Overall Study|Started includes all employees at participating sites|3757
11404643|NCT03933618|12599606|FG000|COMPLETED|Week 16 to Week 24||4
11404644|NCT03933618|12599607|FG001|COMPLETED|Week 16 to Week 24||4
11404645|NCT03933618|12599608|FG002|COMPLETED|Week 16 to Week 24||4
11404646|NCT03933618|12599609|FG003|COMPLETED|Week 16 to Week 24||4
11404647|NCT03933618|12599610|FG004|COMPLETED|Week 16 to Week 24||4
11404648|NCT03933618|12599611|FG005|COMPLETED|Week 16 to Week 24||4
11404649|NCT03933618|12599606|FG000|NOT COMPLETED|Week 16 to Week 24||0
11404650|NCT03933618|12599607|FG001|NOT COMPLETED|Week 16 to Week 24||0
11404651|NCT03933618|12599608|FG002|NOT COMPLETED|Week 16 to Week 24||0
11404652|NCT03933618|12599609|FG003|NOT COMPLETED|Week 16 to Week 24||0
11404653|NCT03933618|12599610|FG004|NOT COMPLETED|Week 16 to Week 24||0
11404654|NCT03933618|12599611|FG005|NOT COMPLETED|Week 16 to Week 24||0
11404655|NCT03931785|12599629|FG000|STARTED|Overall Study||97
11404656|NCT03931785|12599630|FG001|STARTED|Overall Study||97
11404657|NCT03931785|12599631|FG002|STARTED|Overall Study||97
11404658|NCT03931785|12599632|FG003|STARTED|Overall Study||97
11404659|NCT03931785|12599629|FG000|COMPLETED|Overall Study||92
11404660|NCT03931785|12599630|FG001|COMPLETED|Overall Study||90
11404661|NCT03931785|12599631|FG002|COMPLETED|Overall Study||84
11404662|NCT03931785|12599632|FG003|COMPLETED|Overall Study||86
11404663|NCT03931785|12599629|FG000|NOT COMPLETED|Overall Study||5
11404664|NCT03931785|12599630|FG001|NOT COMPLETED|Overall Study||7
11404665|NCT03931785|12599631|FG002|NOT COMPLETED|Overall Study||13
11404666|NCT03931785|12599632|FG003|NOT COMPLETED|Overall Study||11
11404667|NCT03930641|12599642|FG000|STARTED|Overall Study||34
11404668|NCT03930641|12599642|FG000|COMPLETED|Overall Study||34
11404669|NCT03930641|12599642|FG000|NOT COMPLETED|Overall Study||0
11404670|NCT03927846|12599648|FG000|STARTED|Overall Study||30
11404671|NCT03927846|12599649|FG001|STARTED|Overall Study||30
11404672|NCT03927846|12599648|FG000|COMPLETED|Overall Study||20
11404673|NCT03927846|12599649|FG001|COMPLETED|Overall Study||19
11404674|NCT03927846|12599648|FG000|NOT COMPLETED|Overall Study||10
11404675|NCT03927846|12599649|FG001|NOT COMPLETED|Overall Study||11
11404676|NCT03927105|12599655|FG000|STARTED|Overall Study||4
11404677|NCT03927105|12599655|FG000|Began Treatment|Overall Study||3
11404678|NCT03927105|12599655|FG000|Follow-up|Overall Study||3
11022358|NCT00808808|12200611|FG002|STARTED|Overall Study|Started includes all employees at participating sites.|4387
11022359|NCT00808808|12200609|FG000|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
11057007|NCT00996892|12238675|FG004|COMPLETED|Dose-Escalation Stage 1||0
11404679|NCT03927105|12599655|FG000|COMPLETED|Overall Study||0
11404680|NCT03927105|12599655|FG000|NOT COMPLETED|Overall Study||4
11404681|NCT03923933|12599661|FG000|STARTED|Overall Study||17
11404682|NCT03923933|12599662|FG001|STARTED|Overall Study||17
11404683|NCT03923933|12599661|FG000|COMPLETED|Overall Study||16
11404684|NCT03923933|12599662|FG001|COMPLETED|Overall Study||16
11404685|NCT03923933|12599661|FG000|NOT COMPLETED|Overall Study||1
11404686|NCT03923933|12599662|FG001|NOT COMPLETED|Overall Study||1
11404687|NCT03909295|12599668|FG000|STARTED|Overall Study||52
11404688|NCT03909295|12599668|FG000|Safety Set (SAF)|Overall Study||52
11404689|NCT03909295|12599668|FG000|COMPLETED|Overall Study||0
11404690|NCT03909295|12599668|FG000|NOT COMPLETED|Overall Study||52
11404691|NCT03908970|12599674|FG000|STARTED|Overall Study||182
11404692|NCT03908970|12599675|FG001|STARTED|Overall Study||182
11404693|NCT03908970|12599674|FG000|COMPLETED|Overall Study||165
11404694|NCT03908970|12599675|FG001|COMPLETED|Overall Study||135
11404695|NCT03908970|12599674|FG000|NOT COMPLETED|Overall Study||17
11404696|NCT03908970|12599675|FG001|NOT COMPLETED|Overall Study||47
11404697|NCT03897179|12599681|FG000|STARTED|Overall Study||27
11404698|NCT03897179|12599681|FG000|COMPLETED|Overall Study||26
11404699|NCT03897179|12599681|FG000|NOT COMPLETED|Overall Study||1
11404700|NCT03930264|12599687|FG000|STARTED|Overall Study||15
11404701|NCT03930264|12599688|FG001|STARTED|Overall Study||15
11404702|NCT03930264|12599687|FG000|COMPLETED|Overall Study||15
11404703|NCT03930264|12599688|FG001|COMPLETED|Overall Study||14
11404704|NCT03930264|12599687|FG000|NOT COMPLETED|Overall Study||0
11404705|NCT03930264|12599688|FG001|NOT COMPLETED|Overall Study||1
11404706|NCT03929367|12599694|FG000|STARTED|Overall Study||11
11404707|NCT03929367|12599694|FG000|COMPLETED|Overall Study||11
11404708|NCT03929367|12599694|FG000|NOT COMPLETED|Overall Study||0
11404709|NCT03928522|12599703|FG000|STARTED|Overall Study||12
11404710|NCT03928522|12599704|FG001|STARTED|Overall Study||12
11404711|NCT03928522|12599705|FG002|STARTED|Overall Study||12
11404712|NCT03928522|12599706|FG003|STARTED|Overall Study||12
11404713|NCT03928522|12599707|FG004|STARTED|Overall Study||12
11404714|NCT03928522|12599703|FG000|COMPLETED|Overall Study||12
11404715|NCT03928522|12599704|FG001|COMPLETED|Overall Study||12
11404716|NCT03928522|12599705|FG002|COMPLETED|Overall Study||12
11404717|NCT03928522|12599706|FG003|COMPLETED|Overall Study||12
11404718|NCT03928522|12599707|FG004|COMPLETED|Overall Study||12
11404719|NCT03928522|12599703|FG000|NOT COMPLETED|Overall Study||0
11404720|NCT03928522|12599704|FG001|NOT COMPLETED|Overall Study||0
11404721|NCT03928522|12599705|FG002|NOT COMPLETED|Overall Study||0
11404722|NCT03928522|12599706|FG003|NOT COMPLETED|Overall Study||0
11404723|NCT03928522|12599707|FG004|NOT COMPLETED|Overall Study||0
11404724|NCT03910439|12599719|FG000|STARTED|Overall Study||4
11404725|NCT03910439|12599719|FG000|COMPLETED|Overall Study||4
11404726|NCT03910439|12599719|FG000|NOT COMPLETED|Overall Study||0
11404727|NCT03907241|12599730|FG000|STARTED|Overall Study||27
11404728|NCT03907241|12599730|FG000|COMPLETED|Overall Study||23
11404729|NCT03907241|12599730|FG000|NOT COMPLETED|Overall Study||4
11404730|NCT03927950|12599745|FG000|STARTED|Overall Study||135
11404731|NCT03927950|12599745|FG000|COMPLETED|Overall Study||126
11404732|NCT03927950|12599745|FG000|NOT COMPLETED|Overall Study||9
11404733|NCT03927781|12599750|FG000|STARTED|Overall Study||10
11404734|NCT03927781|12599750|FG000|COMPLETED|Overall Study||10
11404735|NCT03927781|12599750|FG000|NOT COMPLETED|Overall Study||0
11404736|NCT03927209|12599756|FG000|STARTED|Overall Study||5
11404737|NCT03927209|12599757|FG001|STARTED|Overall Study||5
11404738|NCT03927209|12599756|FG000|COMPLETED|Overall Study||5
11404739|NCT03927209|12599757|FG001|COMPLETED|Overall Study||5
11404740|NCT03927209|12599756|FG000|NOT COMPLETED|Overall Study||0
11404741|NCT03927209|12599757|FG001|NOT COMPLETED|Overall Study||0
11404742|NCT03920670|12599767|FG000|STARTED|Overall Study||60
11404743|NCT03920670|12599768|FG001|STARTED|Overall Study||60
11404744|NCT03920670|12599767|FG000|COMPLETED|Overall Study||57
11404745|NCT03920670|12599768|FG001|COMPLETED|Overall Study||58
11404746|NCT03920670|12599767|FG000|NOT COMPLETED|Overall Study||3
11404747|NCT03920670|12599768|FG001|NOT COMPLETED|Overall Study||2
11404748|NCT03919422|12599776|FG000|STARTED|Overall Study||40
11404749|NCT03919422|12599777|FG001|STARTED|Overall Study||40
11404750|NCT03919422|12599776|FG000|COMPLETED|Overall Study||40
11404751|NCT03919422|12599777|FG001|COMPLETED|Overall Study||40
11404752|NCT03919422|12599776|FG000|NOT COMPLETED|Overall Study||0
11404753|NCT03919422|12599777|FG001|NOT COMPLETED|Overall Study||0
11404754|NCT03907579|12599783|FG000|STARTED|Overall Study||100
11404755|NCT03907579|12599783|FG000|COMPLETED|Overall Study||100
11404756|NCT03907579|12599783|FG000|NOT COMPLETED|Overall Study||0
11404757|NCT03898063|12599789|FG000|STARTED|Overall Study||74
11404758|NCT03898063|12599790|FG001|STARTED|Overall Study||74
11404759|NCT03898063|12599789|FG000|COMPLETED|Overall Study||64
11404760|NCT03898063|12599790|FG001|COMPLETED|Overall Study||66
11404761|NCT03898063|12599789|FG000|NOT COMPLETED|Overall Study||10
11404762|NCT03898063|12599790|FG001|NOT COMPLETED|Overall Study||8
11404763|NCT03895307|12599800|FG000|STARTED|Overall Study||21
11404764|NCT03895307|12599801|FG001|STARTED|Overall Study||20
11404765|NCT03895307|12599802|FG002|STARTED|Overall Study||22
11404766|NCT03895307|12599803|FG003|STARTED|Overall Study||21
11404767|NCT03895307|12599800|FG000|COMPLETED|Overall Study||19
11404768|NCT03895307|12599801|FG001|COMPLETED|Overall Study||20
11404769|NCT03895307|12599802|FG002|COMPLETED|Overall Study||20
11404770|NCT03895307|12599803|FG003|COMPLETED|Overall Study||21
11404771|NCT03895307|12599800|FG000|NOT COMPLETED|Overall Study||2
11404772|NCT03895307|12599801|FG001|NOT COMPLETED|Overall Study||0
11404773|NCT03895307|12599802|FG002|NOT COMPLETED|Overall Study||2
11404774|NCT03895307|12599803|FG003|NOT COMPLETED|Overall Study||0
11404775|NCT03926208|12599815|FG000|STARTED|Overall Study||119
11404776|NCT03926208|12599816|FG001|STARTED|Overall Study||123
11404777|NCT03926208|12599815|FG000|COMPLETED|Overall Study||119
11404778|NCT03926208|12599816|FG001|COMPLETED|Overall Study||123
11404779|NCT03926208|12599815|FG000|NOT COMPLETED|Overall Study||0
11404780|NCT03926208|12599816|FG001|NOT COMPLETED|Overall Study||0
11404781|NCT03926065|12599822|FG000|STARTED|Study Week 1||11
11404782|NCT03926065|12599823|FG001|STARTED|Study Week 1||9
11404783|NCT03926065|12599824|FG002|STARTED|Study Week 1||14
11404784|NCT03926065|12599825|FG003|STARTED|Study Week 1||18
11404785|NCT03926065|12599826|FG004|STARTED|Study Week 1||15
11404786|NCT03926065|12599822|FG000|COMPLETED|Study Week 1||11
11404787|NCT03926065|12599823|FG001|COMPLETED|Study Week 1||9
11404788|NCT03926065|12599824|FG002|COMPLETED|Study Week 1||14
11404789|NCT03926065|12599825|FG003|COMPLETED|Study Week 1||18
11404790|NCT03926065|12599826|FG004|COMPLETED|Study Week 1||15
11404791|NCT03926065|12599822|FG000|NOT COMPLETED|Study Week 1||0
11404792|NCT03926065|12599823|FG001|NOT COMPLETED|Study Week 1||0
11404793|NCT03926065|12599824|FG002|NOT COMPLETED|Study Week 1||0
11404794|NCT03926065|12599825|FG003|NOT COMPLETED|Study Week 1||0
11404795|NCT03926065|12599826|FG004|NOT COMPLETED|Study Week 1||0
11404796|NCT03926065|12599822|FG000|STARTED|Study Week 2||11
11404797|NCT03926065|12599823|FG001|STARTED|Study Week 2||9
11404798|NCT03926065|12599824|FG002|STARTED|Study Week 2||14
11404799|NCT03926065|12599825|FG003|STARTED|Study Week 2||18
11404800|NCT03926065|12599826|FG004|STARTED|Study Week 2||15
11404801|NCT03926065|12599822|FG000|COMPLETED|Study Week 2||11
11404802|NCT03926065|12599823|FG001|COMPLETED|Study Week 2||9
11404803|NCT03926065|12599824|FG002|COMPLETED|Study Week 2||14
11404804|NCT03926065|12599825|FG003|COMPLETED|Study Week 2||18
11404805|NCT03926065|12599826|FG004|COMPLETED|Study Week 2||15
11404806|NCT03926065|12599822|FG000|NOT COMPLETED|Study Week 2||0
11404807|NCT03926065|12599823|FG001|NOT COMPLETED|Study Week 2||0
11404808|NCT03926065|12599824|FG002|NOT COMPLETED|Study Week 2||0
11404809|NCT03926065|12599825|FG003|NOT COMPLETED|Study Week 2||0
11404810|NCT03926065|12599826|FG004|NOT COMPLETED|Study Week 2||0
11404811|NCT03926065|12599822|FG000|STARTED|Study Week 3||11
11404812|NCT03926065|12599823|FG001|STARTED|Study Week 3||9
11404813|NCT03926065|12599824|FG002|STARTED|Study Week 3||14
11404814|NCT03926065|12599825|FG003|STARTED|Study Week 3||18
11404815|NCT03926065|12599826|FG004|STARTED|Study Week 3||15
11404816|NCT03926065|12599822|FG000|COMPLETED|Study Week 3||11
11404817|NCT03926065|12599823|FG001|COMPLETED|Study Week 3||9
11404818|NCT03926065|12599824|FG002|COMPLETED|Study Week 3||14
11404819|NCT03926065|12599825|FG003|COMPLETED|Study Week 3||18
11404820|NCT03926065|12599826|FG004|COMPLETED|Study Week 3||15
11404821|NCT03926065|12599822|FG000|NOT COMPLETED|Study Week 3||0
11404822|NCT03926065|12599823|FG001|NOT COMPLETED|Study Week 3||0
11404823|NCT03926065|12599824|FG002|NOT COMPLETED|Study Week 3||0
11404824|NCT03926065|12599825|FG003|NOT COMPLETED|Study Week 3||0
11404825|NCT03926065|12599826|FG004|NOT COMPLETED|Study Week 3||0
11404826|NCT03926065|12599822|FG000|STARTED|Study Week 4||11
11404827|NCT03926065|12599823|FG001|STARTED|Study Week 4||9
11404828|NCT03926065|12599824|FG002|STARTED|Study Week 4||14
11404829|NCT03926065|12599825|FG003|STARTED|Study Week 4||18
11404830|NCT03926065|12599826|FG004|STARTED|Study Week 4||15
11404831|NCT03926065|12599822|FG000|COMPLETED|Study Week 4||11
11404832|NCT03926065|12599823|FG001|COMPLETED|Study Week 4||9
11404833|NCT03926065|12599824|FG002|COMPLETED|Study Week 4||14
11404834|NCT03926065|12599825|FG003|COMPLETED|Study Week 4||18
11404835|NCT03926065|12599826|FG004|COMPLETED|Study Week 4||15
11404836|NCT03926065|12599822|FG000|NOT COMPLETED|Study Week 4||0
11404837|NCT03926065|12599823|FG001|NOT COMPLETED|Study Week 4||0
11404838|NCT03926065|12599824|FG002|NOT COMPLETED|Study Week 4||0
11404839|NCT03926065|12599825|FG003|NOT COMPLETED|Study Week 4||0
11404840|NCT03926065|12599826|FG004|NOT COMPLETED|Study Week 4||0
11404841|NCT03909100|12599836|FG000|STARTED|Overall Study||120
11404842|NCT03909100|12599836|FG000|Safety Population|Overall Study||112
11404843|NCT03909100|12599836|FG000|Received Treatment in Session 2|Overall Study||107
11404844|NCT03909100|12599836|FG000|Evaluable Population|Overall Study||106
11404845|NCT03909100|12599836|FG000|COMPLETED|Overall Study||105
11404846|NCT03909100|12599836|FG000|NOT COMPLETED|Overall Study||15
11404847|NCT03905642|12599843|FG000|STARTED|Overall Study||49
11404848|NCT03905642|12599843|FG000|COMPLETED|Overall Study||41
11404849|NCT03905642|12599843|FG000|NOT COMPLETED|Overall Study||8
11404850|NCT03892889|12599847|FG000|STARTED|Overall Study||277
11404851|NCT03892889|12599847|FG000|COMPLETED|Overall Study||73
11404852|NCT03892889|12599847|FG000|NOT COMPLETED|Overall Study||204
11404853|NCT03921723|12599851|FG000|STARTED|Period 1 (4 Days)||22
11404854|NCT03921723|12599851|FG000|COMPLETED|Period 1 (4 Days)||22
11404855|NCT03921723|12599851|FG000|NOT COMPLETED|Period 1 (4 Days)||0
11404856|NCT03921723|12599851|FG000|STARTED|Period 2 (4 Days)||22
11404857|NCT03921723|12599851|FG000|COMPLETED|Period 2 (4 Days)||19
11404858|NCT03921723|12599851|FG000|NOT COMPLETED|Period 2 (4 Days)||3
11404859|NCT03921723|12599851|FG000|STARTED|Period 3 (4 Days)||19
11404860|NCT03921723|12599851|FG000|COMPLETED|Period 3 (4 Days)||18
11404861|NCT03921723|12599851|FG000|NOT COMPLETED|Period 3 (4 Days)||1
11404862|NCT03921190|12599861|FG000|STARTED|Overall Study||56
11404863|NCT03921190|12599862|FG001|STARTED|Overall Study||64
11404864|NCT03921190|12599861|FG000|COMPLETED|Overall Study||56
11404865|NCT03921190|12599862|FG001|COMPLETED|Overall Study||64
11404866|NCT03921190|12599861|FG000|NOT COMPLETED|Overall Study||0
11404867|NCT03921190|12599862|FG001|NOT COMPLETED|Overall Study||0
11404868|NCT03920865|12599873|FG000|STARTED|Overall Study||8
11404869|NCT03920865|12599874|FG001|STARTED|Overall Study||8
11404870|NCT03920865|12599875|FG002|STARTED|Overall Study||10
11404871|NCT03920865|12599873|FG000|COMPLETED|Overall Study||8
11404872|NCT03920865|12599874|FG001|COMPLETED|Overall Study||8
11404873|NCT03920865|12599875|FG002|COMPLETED|Overall Study||10
11404874|NCT03920865|12599873|FG000|NOT COMPLETED|Overall Study||0
11404875|NCT03920865|12599874|FG001|NOT COMPLETED|Overall Study||0
11404876|NCT03920865|12599875|FG002|NOT COMPLETED|Overall Study||0
11404877|NCT03918239|12599895|FG000|STARTED|Overall Study||94
11404878|NCT03918239|12599896|FG001|STARTED|Overall Study||96
11404879|NCT03918239|12599895|FG000|COMPLETED|Overall Study||84
11404880|NCT03918239|12599896|FG001|COMPLETED|Overall Study||89
11404881|NCT03918239|12599895|FG000|NOT COMPLETED|Overall Study||10
11404882|NCT03918239|12599896|FG001|NOT COMPLETED|Overall Study||7
11404883|NCT03917823|12599904|FG000|STARTED|Overall Study||2
11404884|NCT03917823|12599905|FG001|STARTED|Overall Study||2
11404885|NCT03917823|12599904|FG000|COMPLETED|Overall Study||1
11404886|NCT03917823|12599905|FG001|COMPLETED|Overall Study||0
11404887|NCT03917823|12599904|FG000|NOT COMPLETED|Overall Study||1
11404888|NCT03917823|12599905|FG001|NOT COMPLETED|Overall Study||2
11404889|NCT03911752|12599914|FG000|STARTED|Overall Study||8
11404890|NCT03911752|12599915|FG001|STARTED|Overall Study||2
11404891|NCT03911752|12599916|FG002|STARTED|Overall Study||2
11404892|NCT03911752|12599914|FG000|COMPLETED|Overall Study||8
11404893|NCT03911752|12599915|FG001|COMPLETED|Overall Study||2
11404894|NCT03911752|12599916|FG002|COMPLETED|Overall Study||2
11404895|NCT03911752|12599914|FG000|NOT COMPLETED|Overall Study||0
11404896|NCT03911752|12599915|FG001|NOT COMPLETED|Overall Study||0
11404897|NCT03911752|12599916|FG002|NOT COMPLETED|Overall Study||0
11404898|NCT03902613|12599926|FG000|STARTED|Overall Study||1
11404899|NCT03902613|12599926|FG000|COMPLETED|Overall Study||0
11404900|NCT03902613|12599926|FG000|NOT COMPLETED|Overall Study||1
11404901|NCT03902574|12599933|FG000|STARTED|Overall Study||7
11404902|NCT03902574|12599934|FG001|STARTED|Overall Study||7
11404903|NCT03902574|12599935|FG002|STARTED|Overall Study||7
11404904|NCT03902574|12599933|FG000|COMPLETED|Overall Study||7
11404905|NCT03902574|12599934|FG001|COMPLETED|Overall Study||7
11404906|NCT03902574|12599935|FG002|COMPLETED|Overall Study||6
11404907|NCT03902574|12599933|FG000|NOT COMPLETED|Overall Study||0
11404908|NCT03902574|12599934|FG001|NOT COMPLETED|Overall Study||0
11404909|NCT03902574|12599935|FG002|NOT COMPLETED|Overall Study||1
11404910|NCT03914950|12599943|FG000|STARTED|Overall Study||174
11404911|NCT03914950|12599943|FG000|COMPLETED|Overall Study||120
11404912|NCT03914950|12599943|FG000|NOT COMPLETED|Overall Study||54
11404913|NCT03911843|12599955|FG000|STARTED|Overall Study||26
11404914|NCT03911843|12599956|FG001|STARTED|Overall Study||38
11404915|NCT03911843|12599955|FG000|COMPLETED|Overall Study||22
11404916|NCT03911843|12599956|FG001|COMPLETED|Overall Study||37
11404917|NCT03911843|12599955|FG000|NOT COMPLETED|Overall Study||4
11404918|NCT03911843|12599956|FG001|NOT COMPLETED|Overall Study||1
11404919|NCT03896633|12599964|FG000|STARTED|Overall Study||321
11404920|NCT03896633|12599965|FG001|STARTED|Overall Study||316
11404921|NCT03896633|12599964|FG000|COMPLETED|Overall Study||312
11404922|NCT03896633|12599965|FG001|COMPLETED|Overall Study||306
11404923|NCT03896633|12599964|FG000|NOT COMPLETED|Overall Study||9
11404924|NCT03896633|12599965|FG001|NOT COMPLETED|Overall Study||10
11404925|NCT03894813|12599973|FG000|STARTED|Overall Study||63
11404926|NCT03894813|12599974|FG001|STARTED|Overall Study||63
11404927|NCT03894813|12599973|FG000|COMPLETED|Overall Study||52
11404928|NCT03894813|12599974|FG001|COMPLETED|Overall Study||47
11404929|NCT03894813|12599973|FG000|NOT COMPLETED|Overall Study||11
11404930|NCT03894813|12599974|FG001|NOT COMPLETED|Overall Study||16
11404931|NCT03911960|12599982|FG000|STARTED|Overall Study||9
11404932|NCT03911960|12599983|FG001|STARTED|Overall Study||5
11404933|NCT03911960|12599982|FG000|COMPLETED|Overall Study||4
11404934|NCT03911960|12599983|FG001|COMPLETED|Overall Study||2
11404935|NCT03911960|12599982|FG000|NOT COMPLETED|Overall Study||5
11404936|NCT03911960|12599983|FG001|NOT COMPLETED|Overall Study||3
11404937|NCT03907072|12599993|FG000|STARTED|Overall Study||2
11404938|NCT03907072|12599994|FG001|STARTED|Overall Study||2
11404939|NCT03907072|12599995|FG002|STARTED|Overall Study||2
11404940|NCT03907072|12599993|FG000|COMPLETED|Overall Study||0
11404941|NCT03907072|12599994|FG001|COMPLETED|Overall Study||0
11404942|NCT03907072|12599995|FG002|COMPLETED|Overall Study||0
11404943|NCT03907072|12599993|FG000|NOT COMPLETED|Overall Study||2
11404944|NCT03907072|12599994|FG001|NOT COMPLETED|Overall Study||2
11404945|NCT03907072|12599995|FG002|NOT COMPLETED|Overall Study||2
11404946|NCT03906448|12600005|FG000|STARTED|Overall Study||1
11404947|NCT03906448|12600006|FG001|STARTED|Overall Study||0
11404948|NCT03906448|12600005|FG000|COMPLETED|Overall Study||1
11404949|NCT03906448|12600006|FG001|COMPLETED|Overall Study||0
11404950|NCT03906448|12600005|FG000|NOT COMPLETED|Overall Study||0
11404951|NCT03906448|12600006|FG001|NOT COMPLETED|Overall Study||0
11404952|NCT03911401|12600015|FG000|STARTED|Overall Study||83
11404953|NCT03911401|12600016|FG001|STARTED|Overall Study||85
11404954|NCT03911401|12600017|FG002|STARTED|Overall Study||83
11404955|NCT03911401|12600015|FG000|COMPLETED|Overall Study||76
11404956|NCT03911401|12600016|FG001|COMPLETED|Overall Study||76
11404957|NCT03911401|12600017|FG002|COMPLETED|Overall Study||58
11404958|NCT03911401|12600015|FG000|NOT COMPLETED|Overall Study||7
11404959|NCT03911401|12600016|FG001|NOT COMPLETED|Overall Study||9
11404960|NCT03911401|12600017|FG002|NOT COMPLETED|Overall Study||25
11404961|NCT03909763|12600025|FG000|STARTED|Overall Study||55
11404962|NCT03909763|12600025|FG000|COMPLETED|Overall Study||45
11404963|NCT03909763|12600025|FG000|NOT COMPLETED|Overall Study||10
11404964|NCT03909009|12600031|FG000|STARTED|Overall Study||10
11404965|NCT03909009|12600032|FG001|STARTED|Overall Study||10
11404966|NCT03909009|12600031|FG000|COMPLETED|Overall Study||10
11404967|NCT03909009|12600032|FG001|COMPLETED|Overall Study||10
11404968|NCT03909009|12600031|FG000|NOT COMPLETED|Overall Study||0
11404969|NCT03909009|12600032|FG001|NOT COMPLETED|Overall Study||0
11404970|NCT03906968|12600038|FG000|STARTED|Overall Study||40
11404971|NCT03906968|12600038|FG000|COMPLETED|Overall Study||40
11404972|NCT03906968|12600038|FG000|NOT COMPLETED|Overall Study||0
11404973|NCT03904420|12600044|FG000|STARTED|Overall Study||2
11404974|NCT03904420|12600045|FG001|STARTED|Overall Study||2
11404975|NCT03904420|12600044|FG000|COMPLETED|Overall Study||0
11404976|NCT03904420|12600045|FG001|COMPLETED|Overall Study||0
11404977|NCT03904420|12600044|FG000|NOT COMPLETED|Overall Study||2
11404978|NCT03904420|12600045|FG001|NOT COMPLETED|Overall Study||2
11404979|NCT03903822|12600059|FG000|STARTED|Treatment Phase (6 Weeks)||37
11404980|NCT03903822|12600060|FG001|STARTED|Treatment Phase (6 Weeks)||37
11404981|NCT03903822|12600061|FG002|STARTED|Treatment Phase (6 Weeks)||36
11404982|NCT03903822|12600062|FG003|STARTED|Treatment Phase (6 Weeks)||37
11404983|NCT03903822|12600063|FG004|STARTED|Treatment Phase (6 Weeks)||36
11404984|NCT03903822|12600064|FG005|STARTED|Treatment Phase (6 Weeks)||36
11404985|NCT03903822|12600065|FG006|STARTED|Treatment Phase (6 Weeks)||36
11404986|NCT03903822|12600066|FG007|STARTED|Treatment Phase (6 Weeks)||37
11404987|NCT03903822|12600059|FG000|COMPLETED|Treatment Phase (6 Weeks)||28
11404988|NCT03903822|12600060|FG001|COMPLETED|Treatment Phase (6 Weeks)||27
11404989|NCT03903822|12600061|FG002|COMPLETED|Treatment Phase (6 Weeks)||33
11404990|NCT03903822|12600062|FG003|COMPLETED|Treatment Phase (6 Weeks)||32
11404991|NCT03903822|12600063|FG004|COMPLETED|Treatment Phase (6 Weeks)||31
11404992|NCT03903822|12600064|FG005|COMPLETED|Treatment Phase (6 Weeks)||25
11404993|NCT03903822|12600065|FG006|COMPLETED|Treatment Phase (6 Weeks)||31
11404994|NCT03903822|12600066|FG007|COMPLETED|Treatment Phase (6 Weeks)||33
11404995|NCT03903822|12600059|FG000|NOT COMPLETED|Treatment Phase (6 Weeks)||9
11404996|NCT03903822|12600060|FG001|NOT COMPLETED|Treatment Phase (6 Weeks)||10
11404997|NCT03903822|12600061|FG002|NOT COMPLETED|Treatment Phase (6 Weeks)||3
11404998|NCT03903822|12600062|FG003|NOT COMPLETED|Treatment Phase (6 Weeks)||5
11404999|NCT03903822|12600063|FG004|NOT COMPLETED|Treatment Phase (6 Weeks)||5
11405000|NCT03903822|12600064|FG005|NOT COMPLETED|Treatment Phase (6 Weeks)||11
11405001|NCT03903822|12600065|FG006|NOT COMPLETED|Treatment Phase (6 Weeks)||5
11405002|NCT03903822|12600066|FG007|NOT COMPLETED|Treatment Phase (6 Weeks)||4
11405003|NCT03903822|12600059|FG000|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
11405004|NCT03903822|12600060|FG001|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
11405005|NCT03903822|12600061|FG002|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
11405006|NCT03903822|12600062|FG003|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
11405007|NCT03903822|12600063|FG004|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
11405008|NCT03903822|12600064|FG005|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
11405009|NCT03903822|12600065|FG006|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
11405010|NCT03903822|12600066|FG007|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
11405011|NCT03903822|12600059|FG000|COMPLETED|Follow up Phase (4 Weeks)||29
11405012|NCT03903822|12600060|FG001|COMPLETED|Follow up Phase (4 Weeks)||29
11405013|NCT03903822|12600061|FG002|COMPLETED|Follow up Phase (4 Weeks)||32
11405014|NCT03903822|12600062|FG003|COMPLETED|Follow up Phase (4 Weeks)||33
11405015|NCT03903822|12600063|FG004|COMPLETED|Follow up Phase (4 Weeks)||32
11405016|NCT03903822|12600064|FG005|COMPLETED|Follow up Phase (4 Weeks)||28
11405017|NCT03903822|12600065|FG006|COMPLETED|Follow up Phase (4 Weeks)||31
11405018|NCT03903822|12600066|FG007|COMPLETED|Follow up Phase (4 Weeks)||31
11405019|NCT03903822|12600059|FG000|NOT COMPLETED|Follow up Phase (4 Weeks)||8
11405020|NCT03903822|12600060|FG001|NOT COMPLETED|Follow up Phase (4 Weeks)||8
11405021|NCT03903822|12600061|FG002|NOT COMPLETED|Follow up Phase (4 Weeks)||4
11405022|NCT03903822|12600062|FG003|NOT COMPLETED|Follow up Phase (4 Weeks)||4
11405023|NCT03903822|12600063|FG004|NOT COMPLETED|Follow up Phase (4 Weeks)||4
11405024|NCT03903822|12600064|FG005|NOT COMPLETED|Follow up Phase (4 Weeks)||8
11405025|NCT03903822|12600065|FG006|NOT COMPLETED|Follow up Phase (4 Weeks)||5
11405026|NCT03903822|12600066|FG007|NOT COMPLETED|Follow up Phase (4 Weeks)||6
11405027|NCT03905096|12600086|FG000|STARTED|Period 1 for Trial Part 1 and 2||18
11405028|NCT03905096|12600087|FG001|STARTED|Period 1 for Trial Part 1 and 2||14
11405029|NCT03905096|12600086|FG000|COMPLETED|Period 1 for Trial Part 1 and 2||18
11405030|NCT03905096|12600087|FG001|COMPLETED|Period 1 for Trial Part 1 and 2||14
11405031|NCT03905096|12600086|FG000|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
11405032|NCT03905096|12600087|FG001|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
11405033|NCT03905096|12600086|FG000|STARTED|Period 2 for Trial Part 1 and 2||18
11405034|NCT03905096|12600087|FG001|STARTED|Period 2 for Trial Part 1 and 2||14
11405035|NCT03905096|12600086|FG000|COMPLETED|Period 2 for Trial Part 1 and 2||17
11405036|NCT03905096|12600087|FG001|COMPLETED|Period 2 for Trial Part 1 and 2||14
11405037|NCT03905096|12600086|FG000|NOT COMPLETED|Period 2 for Trial Part 1 and 2||1
11405038|NCT03905096|12600087|FG001|NOT COMPLETED|Period 2 for Trial Part 1 and 2||0
11405039|NCT03899064|12600100|FG000|STARTED|Overall Study||58
11405040|NCT03899064|12600100|FG000|MC2-01 Cream, Irradiation|Overall Study||58
11405041|NCT03899064|12600100|FG000|MC2-01 Cream, No Irradiation|Overall Study||58
11405042|NCT03899064|12600100|FG000|MC2-01 Vehicle, Irradiation|Overall Study||58
11405043|NCT03899064|12600100|FG000|MC2-01 Vehicle, no Irradiation|Overall Study||58
11405044|NCT03899064|12600100|FG000|Control, Irradiation|Overall Study||58
11405045|NCT03899064|12600100|FG000|COMPLETED|Overall Study||51
11405046|NCT03899064|12600100|FG000|NOT COMPLETED|Overall Study||7
11405047|NCT03903159|12600104|FG000|STARTED|Overall Study||15
11405048|NCT03903159|12600104|FG000|COMPLETED|Overall Study||10
11405049|NCT03903159|12600104|FG000|NOT COMPLETED|Overall Study||5
11405050|NCT03902392|12600110|FG000|STARTED|Overall Study||25
11405051|NCT03902392|12600111|FG001|STARTED|Overall Study||25
11405052|NCT03902392|12600110|FG000|COMPLETED|Overall Study||18
11405053|NCT03902392|12600111|FG001|COMPLETED|Overall Study||18
11405054|NCT03902392|12600110|FG000|NOT COMPLETED|Overall Study||7
11405055|NCT03902392|12600111|FG001|NOT COMPLETED|Overall Study||7
11405056|NCT03901105|12600117|FG000|STARTED|Overall Study||205
11405057|NCT03901105|12600117|FG000|COMPLETED|Overall Study||205
11405058|NCT03901105|12600117|FG000|NOT COMPLETED|Overall Study||0
11405059|NCT03895853|12600129|FG000|STARTED|Overall Study||0
11405060|NCT03895853|12600130|FG001|STARTED|Overall Study||2
11405061|NCT03895853|12600129|FG000|COMPLETED|Overall Study||0
11405062|NCT03895853|12600130|FG001|COMPLETED|Overall Study||2
11405063|NCT03895853|12600129|FG000|NOT COMPLETED|Overall Study||0
11405064|NCT03895853|12600130|FG001|NOT COMPLETED|Overall Study||0
11405065|NCT03901313|12600136|FG000|STARTED|Overall Study||4
11405066|NCT03901313|12600137|FG001|STARTED|Overall Study||4
11405067|NCT03901313|12600138|FG002|STARTED|Overall Study||4
11405068|NCT03901313|12600139|FG003|STARTED|Overall Study||4
11405069|NCT03901313|12600140|FG004|STARTED|Overall Study||4
11405070|NCT03901313|12600141|FG005|STARTED|Overall Study||4
11405071|NCT03901313|12600136|FG000|COMPLETED|Overall Study||4
11405072|NCT03901313|12600137|FG001|COMPLETED|Overall Study||4
11405073|NCT03901313|12600138|FG002|COMPLETED|Overall Study||4
11405074|NCT03901313|12600139|FG003|COMPLETED|Overall Study||4
11405075|NCT03901313|12600140|FG004|COMPLETED|Overall Study||4
11405076|NCT03901313|12600141|FG005|COMPLETED|Overall Study||4
11405077|NCT03901313|12600136|FG000|NOT COMPLETED|Overall Study||0
11405078|NCT03901313|12600137|FG001|NOT COMPLETED|Overall Study||0
11405079|NCT03901313|12600138|FG002|NOT COMPLETED|Overall Study||0
11405080|NCT03901313|12600139|FG003|NOT COMPLETED|Overall Study||0
11405081|NCT03901313|12600140|FG004|NOT COMPLETED|Overall Study||0
11405082|NCT03901313|12600141|FG005|NOT COMPLETED|Overall Study||0
11405083|NCT03901092|12600149|FG000|STARTED|Overall Study||83
11405084|NCT03901092|12600150|FG001|STARTED|Overall Study||159
11405085|NCT03901092|12600149|FG000|COMPLETED|Overall Study||83
11405086|NCT03901092|12600150|FG001|COMPLETED|Overall Study||159
11405087|NCT03901092|12600149|FG000|NOT COMPLETED|Overall Study||0
11405088|NCT03901092|12600150|FG001|NOT COMPLETED|Overall Study||0
11405089|NCT03900728|12600167|FG000|STARTED|Overall Study||40
11405090|NCT03900728|12600168|FG001|STARTED|Overall Study||57
11405091|NCT03900728|12600169|FG002|STARTED|Overall Study||39
11405092|NCT03900728|12600167|FG000|COMPLETED|Overall Study||40
11405093|NCT03900728|12600168|FG001|COMPLETED|Overall Study||57
11405094|NCT03900728|12600169|FG002|COMPLETED|Overall Study||35
11405095|NCT03900728|12600167|FG000|NOT COMPLETED|Overall Study||0
11405096|NCT03900728|12600168|FG001|NOT COMPLETED|Overall Study||0
11405097|NCT03900728|12600169|FG002|NOT COMPLETED|Overall Study||4
11405098|NCT03900299|12600179|FG000|STARTED|Overall Study||56
11405099|NCT03900299|12600180|FG001|STARTED|Overall Study||58
11405100|NCT03900299|12600179|FG000|COMPLETED|Overall Study||56
11405101|NCT03900299|12600180|FG001|COMPLETED|Overall Study||58
11405102|NCT03900299|12600179|FG000|NOT COMPLETED|Overall Study||0
11405103|NCT03900299|12600180|FG001|NOT COMPLETED|Overall Study||0
11405104|NCT03898349|12600189|FG000|STARTED|Overall Study||125
11405105|NCT03898349|12600190|FG001|STARTED|Overall Study||625
11405106|NCT03898349|12600189|FG000|COMPLETED|Overall Study||15
11405107|NCT03898349|12600190|FG001|COMPLETED|Overall Study||15
11405108|NCT03898349|12600189|FG000|NOT COMPLETED|Overall Study||110
11405109|NCT03898349|12600190|FG001|NOT COMPLETED|Overall Study||610
11405110|NCT03897634|12600196|FG000|STARTED|Overall Study||22
11405111|NCT03897634|12600196|FG000|COMPLETED|Overall Study||22
11405112|NCT03897634|12600196|FG000|NOT COMPLETED|Overall Study||0
11405113|NCT03895372|12600208|FG000|STARTED|Investigational Treatment Period||23
11405114|NCT03895372|12600209|FG001|STARTED|Investigational Treatment Period||22
11405115|NCT03895372|12600210|FG002|STARTED|Investigational Treatment Period||11
11405116|NCT03895372|12600211|FG003|STARTED|Investigational Treatment Period||11
11405117|NCT03895372|12600212|FG004|STARTED|Investigational Treatment Period||12
11405118|NCT03895372|12600213|FG005|STARTED|Investigational Treatment Period||11
11405119|NCT03895372|12600214|FG006|STARTED|Investigational Treatment Period||45
11405120|NCT03895372|12600215|FG007|STARTED|Investigational Treatment Period||43
11405121|NCT03895372|12600208|FG000|COMPLETED|Investigational Treatment Period||19
11405122|NCT03895372|12600209|FG001|COMPLETED|Investigational Treatment Period||19
11405123|NCT03895372|12600210|FG002|COMPLETED|Investigational Treatment Period||10
11405124|NCT03895372|12600211|FG003|COMPLETED|Investigational Treatment Period||9
11405125|NCT03895372|12600212|FG004|COMPLETED|Investigational Treatment Period||12
11405126|NCT03895372|12600213|FG005|COMPLETED|Investigational Treatment Period||9
11405127|NCT03895372|12600214|FG006|COMPLETED|Investigational Treatment Period||37
11405128|NCT03895372|12600215|FG007|COMPLETED|Investigational Treatment Period||38
11405129|NCT03895372|12600208|FG000|NOT COMPLETED|Investigational Treatment Period||4
11405130|NCT03895372|12600209|FG001|NOT COMPLETED|Investigational Treatment Period||3
11405131|NCT03895372|12600210|FG002|NOT COMPLETED|Investigational Treatment Period||1
11405132|NCT03895372|12600211|FG003|NOT COMPLETED|Investigational Treatment Period||2
11405133|NCT03895372|12600212|FG004|NOT COMPLETED|Investigational Treatment Period||0
11405134|NCT03895372|12600213|FG005|NOT COMPLETED|Investigational Treatment Period||2
11405135|NCT03895372|12600214|FG006|NOT COMPLETED|Investigational Treatment Period||8
11405136|NCT03895372|12600215|FG007|NOT COMPLETED|Investigational Treatment Period||5
11405137|NCT03895372|12600208|FG000|STARTED|Extension Treatment Period||19
11405138|NCT03895372|12600209|FG001|STARTED|Extension Treatment Period||19
11405139|NCT03895372|12600210|FG002|STARTED|Extension Treatment Period||10
11405140|NCT03895372|12600211|FG003|STARTED|Extension Treatment Period||9
11405141|NCT03895372|12600212|FG004|STARTED|Extension Treatment Period||12
11405142|NCT03895372|12600213|FG005|STARTED|Extension Treatment Period||9
11405143|NCT03895372|12600214|FG006|STARTED|Extension Treatment Period||37
11405144|NCT03895372|12600215|FG007|STARTED|Extension Treatment Period||38
11405145|NCT03895372|12600208|FG000|COMPLETED|Extension Treatment Period||16
11405146|NCT03895372|12600209|FG001|COMPLETED|Extension Treatment Period||14
11405147|NCT03895372|12600210|FG002|COMPLETED|Extension Treatment Period||10
11405148|NCT03895372|12600211|FG003|COMPLETED|Extension Treatment Period||8
11405149|NCT03895372|12600212|FG004|COMPLETED|Extension Treatment Period||9
11405150|NCT03895372|12600213|FG005|COMPLETED|Extension Treatment Period||8
11405151|NCT03895372|12600214|FG006|COMPLETED|Extension Treatment Period||33
11405152|NCT03895372|12600215|FG007|COMPLETED|Extension Treatment Period||32
11405153|NCT03895372|12600208|FG000|NOT COMPLETED|Extension Treatment Period||3
11405154|NCT03895372|12600209|FG001|NOT COMPLETED|Extension Treatment Period||5
11405155|NCT03895372|12600210|FG002|NOT COMPLETED|Extension Treatment Period||0
11405156|NCT03895372|12600211|FG003|NOT COMPLETED|Extension Treatment Period||1
11405157|NCT03895372|12600212|FG004|NOT COMPLETED|Extension Treatment Period||3
11405158|NCT03895372|12600213|FG005|NOT COMPLETED|Extension Treatment Period||1
11405159|NCT03895372|12600214|FG006|NOT COMPLETED|Extension Treatment Period||4
11405160|NCT03895372|12600215|FG007|NOT COMPLETED|Extension Treatment Period||6
11405161|NCT03896022|12600241|FG000|STARTED|Overall Study||74
11405162|NCT03896022|12600242|FG001|STARTED|Overall Study||51
11405163|NCT03896022|12600243|FG002|STARTED|Overall Study||52
11405164|NCT03896022|12600241|FG000|COMPLETED|Overall Study||70
11405165|NCT03896022|12600242|FG001|COMPLETED|Overall Study||51
11405166|NCT03896022|12600243|FG002|COMPLETED|Overall Study||52
11405167|NCT03896022|12600241|FG000|NOT COMPLETED|Overall Study||4
11405168|NCT03896022|12600242|FG001|NOT COMPLETED|Overall Study||0
11405169|NCT03896022|12600243|FG002|NOT COMPLETED|Overall Study||0
11405170|NCT03891862|12600255|FG000|STARTED|Open-label Period||135
11405171|NCT03891862|12600256|FG001|STARTED|Open-label Period||0
11405172|NCT03891862|12600257|FG002|STARTED|Open-label Period||0
11405173|NCT03891862|12600255|FG000|Safety Analysis Set|Open-label Period||132
11405174|NCT03891862|12600256|FG001|Safety Analysis Set|Open-label Period||0
11405175|NCT03891862|12600257|FG002|Safety Analysis Set|Open-label Period||0
11405176|NCT03891862|12600255|FG000|COMPLETED|Open-label Period||119
11405177|NCT03891862|12600256|FG001|COMPLETED|Open-label Period||0
11405178|NCT03891862|12600257|FG002|COMPLETED|Open-label Period||0
11405179|NCT03891862|12600255|FG000|NOT COMPLETED|Open-label Period||16
11405180|NCT03891862|12600256|FG001|NOT COMPLETED|Open-label Period||0
11405181|NCT03891862|12600257|FG002|NOT COMPLETED|Open-label Period||0
11405182|NCT03891862|12600255|FG000|STARTED|Placebo-controlled Period and Follow-up||0
11405183|NCT03891862|12600256|FG001|STARTED|Placebo-controlled Period and Follow-up||59
11405184|NCT03891862|12600257|FG002|STARTED|Placebo-controlled Period and Follow-up||59
11405185|NCT03891862|12600255|FG000|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||0
11405186|NCT03891862|12600256|FG001|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||58
11405187|NCT03891862|12600257|FG002|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||59
11405188|NCT03891862|12600255|FG000|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||0
11405189|NCT03891862|12600256|FG001|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||53
11405190|NCT03891862|12600257|FG002|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||56
11405191|NCT03891862|12600255|FG000|COMPLETED|Placebo-controlled Period and Follow-up||0
11405192|NCT03891862|12600256|FG001|COMPLETED|Placebo-controlled Period and Follow-up||53
11405193|NCT03891862|12600257|FG002|COMPLETED|Placebo-controlled Period and Follow-up||55
11405194|NCT03891862|12600255|FG000|NOT COMPLETED|Placebo-controlled Period and Follow-up||0
11405195|NCT03891862|12600256|FG001|NOT COMPLETED|Placebo-controlled Period and Follow-up||6
11405196|NCT03891862|12600257|FG002|NOT COMPLETED|Placebo-controlled Period and Follow-up||4
11405197|NCT03894449|12600269|FG000|STARTED|Overall Study||15
11405198|NCT03894449|12600270|FG001|STARTED|Overall Study||15
11405199|NCT03894449|12600271|FG002|STARTED|Overall Study||15
11405200|NCT03894449|12600272|FG003|STARTED|Overall Study||15
11405201|NCT03894449|12600273|FG004|STARTED|Overall Study||15
11405202|NCT03894449|12600269|FG000|COMPLETED|Overall Study||15
11405203|NCT03894449|12600270|FG001|COMPLETED|Overall Study||15
11405204|NCT03894449|12600271|FG002|COMPLETED|Overall Study||15
11405205|NCT03894449|12600272|FG003|COMPLETED|Overall Study||15
11405206|NCT03894449|12600273|FG004|COMPLETED|Overall Study||15
11405207|NCT03894449|12600269|FG000|NOT COMPLETED|Overall Study||0
11405208|NCT03894449|12600270|FG001|NOT COMPLETED|Overall Study||0
11405209|NCT03894449|12600271|FG002|NOT COMPLETED|Overall Study||0
11405210|NCT03894449|12600272|FG003|NOT COMPLETED|Overall Study||0
11405211|NCT03894449|12600273|FG004|NOT COMPLETED|Overall Study||0
11405212|NCT03892564|12600285|FG000|STARTED|Overall Study||35
11405213|NCT03892564|12600285|FG000|MC2-01 Cream + Irridiation|Overall Study||35
11405214|NCT03892564|12600285|FG000|MC2-01 Cream + Non-irridiation|Overall Study||35
11405215|NCT03892564|12600285|FG000|MC2-01 Vehicle + Irridiation|Overall Study||35
11405216|NCT03892564|12600285|FG000|MC2-01 Vehicle + Non-irridiation|Overall Study||35
11405217|NCT03892564|12600285|FG000|Control Site|Overall Study||35
11405218|NCT03892564|12600285|FG000|COMPLETED|Overall Study||33
11405219|NCT03892564|12600285|FG000|NOT COMPLETED|Overall Study||2
11405220|NCT03892707|12600292|FG000|STARTED|Overall Study||250
11405221|NCT03892707|12600293|FG001|STARTED|Overall Study||250
11405222|NCT03892707|12600292|FG000|Started Study Treatment at Baseline|Overall Study||244
11405223|NCT03892707|12600293|FG001|Started Study Treatment at Baseline|Overall Study||250
11405224|NCT03892707|12600292|FG000|COMPLETED|Overall Study||244
11405225|NCT03892707|12600293|FG001|COMPLETED|Overall Study||244
11405226|NCT03892707|12600292|FG000|NOT COMPLETED|Overall Study||6
11405227|NCT03892707|12600293|FG001|NOT COMPLETED|Overall Study||6
11405228|NCT03892460|12600302|FG000|STARTED|Overall Study||30
11405229|NCT03892460|12600303|FG001|STARTED|Overall Study||24
11405230|NCT03892460|12600302|FG000|Randomization|Overall Study||25
11405231|NCT03892460|12600303|FG001|Randomization|Overall Study||20
11405232|NCT03892460|12600302|FG000|COMPLETED|Overall Study||18
11405233|NCT03892460|12600303|FG001|COMPLETED|Overall Study||19
11405234|NCT03892460|12600302|FG000|NOT COMPLETED|Overall Study||12
11405235|NCT03892460|12600303|FG001|NOT COMPLETED|Overall Study||5
11405236|NCT03891641|12600312|FG000|STARTED|Overall Study||10
11405237|NCT03891641|12600313|FG001|STARTED|Overall Study||7
11405238|NCT03891641|12600312|FG000|COMPLETED|Overall Study||8
11405239|NCT03891641|12600313|FG001|COMPLETED|Overall Study||5
11405240|NCT03891641|12600312|FG000|NOT COMPLETED|Overall Study||2
11405241|NCT03891641|12600313|FG001|NOT COMPLETED|Overall Study||2
11405242|NCT03889704|12600319|FG000|STARTED|Overall Study||2
11405243|NCT03889704|12600319|FG000|COMPLETED|Overall Study||1
11405244|NCT03889704|12600319|FG000|NOT COMPLETED|Overall Study||1
11405245|NCT03889444|12600323|FG000|STARTED|Overall Study||141
11405246|NCT03889444|12600323|FG000|COMPLETED|Overall Study||141
11405247|NCT03889444|12600323|FG000|NOT COMPLETED|Overall Study||0
11405248|NCT03888755|12600327|FG000|STARTED|Overall Study||8
11405249|NCT03888755|12600327|FG000|COMPLETED|Overall Study||8
11405250|NCT03888755|12600327|FG000|NOT COMPLETED|Overall Study||0
11405251|NCT03888391|12600333|FG000|STARTED|Overall Study||18
11405252|NCT03888391|12600333|FG000|COMPLETED|Overall Study||3
11405253|NCT03888391|12600333|FG000|NOT COMPLETED|Overall Study||15
11405254|NCT03888482|12600339|FG000|STARTED|First Wear Period (8 -1/+2 Days)||76
11405255|NCT03888482|12600340|FG001|STARTED|First Wear Period (8 -1/+2 Days)||75
11405256|NCT03888482|12600339|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||76
11405257|NCT03888482|12600340|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||75
11405258|NCT03888482|12600339|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
11405259|NCT03888482|12600340|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
11405260|NCT03888482|12600339|FG000|STARTED|Second Wear (8 -1/+2 Days)|2 subjects were discontinued between Treatment 1 and Treatment 2.|74
11405261|NCT03888482|12600340|FG001|STARTED|Second Wear (8 -1/+2 Days)||75
11405262|NCT03888482|12600339|FG000|COMPLETED|Second Wear (8 -1/+2 Days)||73
11405263|NCT03888482|12600340|FG001|COMPLETED|Second Wear (8 -1/+2 Days)||74
11405264|NCT03888482|12600339|FG000|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
11405265|NCT03888482|12600340|FG001|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
11405266|NCT03888274|12600348|FG000|STARTED|Overall Study||30
11405267|NCT03888274|12600348|FG000|COMPLETED|Overall Study||30
11405268|NCT03888274|12600348|FG000|NOT COMPLETED|Overall Study||0
11405269|NCT03888365|12600354|FG000|STARTED|Cohort A Peak Level/Cohort B Period 1||20
11405270|NCT03888365|12600355|FG001|STARTED|Cohort A Peak Level/Cohort B Period 1||23
11405271|NCT03888365|12600354|FG000|Safety Population|Cohort A Peak Level/Cohort B Period 1||20
11405272|NCT03888365|12600355|FG001|Safety Population|Cohort A Peak Level/Cohort B Period 1||23
11405273|NCT03888365|12600354|FG000|COMPLETED|Cohort A Peak Level/Cohort B Period 1||20
11405274|NCT03888365|12600355|FG001|COMPLETED|Cohort A Peak Level/Cohort B Period 1||23
11405275|NCT03888365|12600354|FG000|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
11405276|NCT03888365|12600355|FG001|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
11405277|NCT03888365|12600354|FG000|STARTED|Rest - At Least 1 h||20
11405278|NCT03888365|12600355|FG001|STARTED|Rest - At Least 1 h||23
11405279|NCT03888365|12600354|FG000|COMPLETED|Rest - At Least 1 h||20
11405280|NCT03888365|12600355|FG001|COMPLETED|Rest - At Least 1 h||23
11405281|NCT03888365|12600354|FG000|NOT COMPLETED|Rest - At Least 1 h||0
11405282|NCT03888365|12600355|FG001|NOT COMPLETED|Rest - At Least 1 h||0
11405283|NCT03888365|12600354|FG000|STARTED|Cohort A Trough Level/Cohort B Period 2||20
11405284|NCT03888365|12600355|FG001|STARTED|Cohort A Trough Level/Cohort B Period 2||23
11405285|NCT03888365|12600354|FG000|COMPLETED|Cohort A Trough Level/Cohort B Period 2||20
11405286|NCT03888365|12600355|FG001|COMPLETED|Cohort A Trough Level/Cohort B Period 2||23
11405287|NCT03888365|12600354|FG000|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
11405288|NCT03888365|12600355|FG001|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
11405289|NCT03888469|12600364|FG000|STARTED|First Wear Period (8 -1/+2 Days)||46
11405290|NCT03888469|12600365|FG001|STARTED|First Wear Period (8 -1/+2 Days)||46
11405291|NCT03888469|12600364|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||46
11405292|NCT03888469|12600365|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||46
11405293|NCT03888469|12600364|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
11405294|NCT03888469|12600365|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
11405295|NCT03888469|12600364|FG000|STARTED|Second Wear Period (8 -1/+2 Days)||46
11405296|NCT03888469|12600365|FG001|STARTED|Second Wear Period (8 -1/+2 Days)||46
11405297|NCT03888469|12600364|FG000|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
11405298|NCT03888469|12600365|FG001|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
11405299|NCT03888469|12600364|FG000|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
11405300|NCT03888469|12600365|FG001|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
11405301|NCT03887442|12600375|FG000|STARTED|Overall Study||9
11405302|NCT03887442|12600376|FG001|STARTED|Overall Study||8
11405303|NCT03887442|12600375|FG000|COMPLETED|Overall Study||8
11405304|NCT03887442|12600376|FG001|COMPLETED|Overall Study||8
11405305|NCT03887442|12600375|FG000|NOT COMPLETED|Overall Study||1
11405306|NCT03887442|12600376|FG001|NOT COMPLETED|Overall Study||0
11405307|NCT03887286|12600384|FG000|STARTED|Overall Study||47
11405308|NCT03887286|12600384|FG000|COMPLETED|Overall Study||47
11405309|NCT03887286|12600384|FG000|NOT COMPLETED|Overall Study||0
11405310|NCT03881007|12600391|FG000|STARTED|First 3 Months||172
11405311|NCT03881007|12600392|FG001|STARTED|First 3 Months||171
11405312|NCT03881007|12600391|FG000|COMPLETED|First 3 Months||121
11405313|NCT03881007|12600392|FG001|COMPLETED|First 3 Months||119
11405314|NCT03881007|12600391|FG000|NOT COMPLETED|First 3 Months||51
11405315|NCT03881007|12600392|FG001|NOT COMPLETED|First 3 Months||52
11405316|NCT03881007|12600391|FG000|STARTED|Last 3 Months||121
11405317|NCT03881007|12600392|FG001|STARTED|Last 3 Months||119
11405318|NCT03881007|12600391|FG000|COMPLETED|Last 3 Months||77
11405319|NCT03881007|12600392|FG001|COMPLETED|Last 3 Months||74
11405320|NCT03881007|12600391|FG000|NOT COMPLETED|Last 3 Months||44
11405321|NCT03881007|12600392|FG001|NOT COMPLETED|Last 3 Months||45
11405322|NCT03878602|12600400|FG000|STARTED|Overall Study||75
11405323|NCT03878602|12600401|FG001|STARTED|Overall Study||67
11405324|NCT03878602|12600400|FG000|COMPLETED|Overall Study||66
11405325|NCT03878602|12600401|FG001|COMPLETED|Overall Study||66
11405326|NCT03878602|12600400|FG000|NOT COMPLETED|Overall Study||9
11405327|NCT03878602|12600401|FG001|NOT COMPLETED|Overall Study||1
11405328|NCT03875118|12600411|FG000|STARTED|Overall Study||34
11405329|NCT03875118|12600412|FG001|STARTED|Overall Study||34
11405330|NCT03875118|12600411|FG000|COMPLETED|Overall Study||30
11405331|NCT03875118|12600412|FG001|COMPLETED|Overall Study||30
11405332|NCT03875118|12600411|FG000|NOT COMPLETED|Overall Study||4
11405333|NCT03875118|12600412|FG001|NOT COMPLETED|Overall Study||4
11405334|NCT03873987|12600420|FG000|STARTED|Overall Study||52
11405335|NCT03873987|12600421|FG001|STARTED|Overall Study||50
11405336|NCT03873987|12600420|FG000|COMPLETED|Overall Study||50
11405337|NCT03873987|12600421|FG001|COMPLETED|Overall Study||49
11405338|NCT03873987|12600420|FG000|NOT COMPLETED|Overall Study||2
11405339|NCT03873987|12600421|FG001|NOT COMPLETED|Overall Study||1
11405340|NCT03870893|12600430|FG000|STARTED|Overall Study||23
11405341|NCT03870893|12600431|FG001|STARTED|Overall Study||24
11405342|NCT03870893|12600430|FG000|COMPLETED|Overall Study||23
11405343|NCT03870893|12600431|FG001|COMPLETED|Overall Study||23
11405344|NCT03870893|12600430|FG000|NOT COMPLETED|Overall Study||0
11405345|NCT03870893|12600431|FG001|NOT COMPLETED|Overall Study||1
11405346|NCT03887299|12600440|FG000|STARTED|Overall Study||77
11405347|NCT03887299|12600441|FG001|STARTED|Overall Study||77
11405348|NCT03887299|12600440|FG000|COMPLETED|Overall Study||77
11405349|NCT03887299|12600441|FG001|COMPLETED|Overall Study||77
11405350|NCT03887299|12600440|FG000|NOT COMPLETED|Overall Study||0
11405351|NCT03887299|12600441|FG001|NOT COMPLETED|Overall Study||0
11405352|NCT03878758|12600447|FG000|STARTED|Overall Study||158
11405353|NCT03878758|12600447|FG000|COMPLETED|Overall Study||154
11405354|NCT03878758|12600447|FG000|NOT COMPLETED|Overall Study||4
11405355|NCT03849300|12600464|FG000|STARTED|Overall Study||42
11405356|NCT03849300|12600465|FG001|STARTED|Overall Study||42
11405357|NCT03849300|12600466|FG002|STARTED|Overall Study||32
11405358|NCT03849300|12600467|FG003|STARTED|Overall Study||31
11405359|NCT03849300|12600464|FG000|COMPLETED|Overall Study||37
11405360|NCT03849300|12600465|FG001|COMPLETED|Overall Study||35
11405361|NCT03849300|12600466|FG002|COMPLETED|Overall Study||28
11405362|NCT03849300|12600467|FG003|COMPLETED|Overall Study||25
11405363|NCT03849300|12600464|FG000|NOT COMPLETED|Overall Study||5
11405364|NCT03849300|12600465|FG001|NOT COMPLETED|Overall Study||7
11405365|NCT03849300|12600466|FG002|NOT COMPLETED|Overall Study||4
11405366|NCT03849300|12600467|FG003|NOT COMPLETED|Overall Study||6
11405367|NCT03887429|12600483|FG000|STARTED|Overall Study||8
11405368|NCT03887429|12600484|FG001|STARTED|Overall Study||9
11405369|NCT03887429|12600485|FG002|STARTED|Overall Study||9
11405370|NCT03887429|12600486|FG003|STARTED|Overall Study||8
11405371|NCT03887429|12600483|FG000|Completed First Intervention (5 Days)|Overall Study||7
11405372|NCT03887429|12600484|FG001|Completed First Intervention (5 Days)|Overall Study||8
11405373|NCT03887429|12600485|FG002|Completed First Intervention (5 Days)|Overall Study||7
11405374|NCT03887429|12600486|FG003|Completed First Intervention (5 Days)|Overall Study||7
11405375|NCT03887429|12600483|FG000|Completed Washout (9 Days)|Overall Study||7
11405376|NCT03887429|12600484|FG001|Completed Washout (9 Days)|Overall Study||8
11405377|NCT03887429|12600485|FG002|Completed Washout (9 Days)|Overall Study||7
11405378|NCT03887429|12600486|FG003|Completed Washout (9 Days)|Overall Study||7
11405379|NCT03887429|12600483|FG000|Completed Second Intervention (5 Days)|Overall Study||7
11405380|NCT03887429|12600484|FG001|Completed Second Intervention (5 Days)|Overall Study||8
11405381|NCT03887429|12600485|FG002|Completed Second Intervention (5 Days)|Overall Study||7
11405382|NCT03887429|12600486|FG003|Completed Second Intervention (5 Days)|Overall Study||7
11405383|NCT03887429|12600483|FG000|COMPLETED|Overall Study||7
11405384|NCT03887429|12600484|FG001|COMPLETED|Overall Study||8
11405385|NCT03887429|12600485|FG002|COMPLETED|Overall Study||7
11405386|NCT03887429|12600486|FG003|COMPLETED|Overall Study||7
11405387|NCT03887429|12600483|FG000|NOT COMPLETED|Overall Study||1
11405388|NCT03887429|12600484|FG001|NOT COMPLETED|Overall Study||1
11405389|NCT03887429|12600485|FG002|NOT COMPLETED|Overall Study||2
11405390|NCT03887429|12600486|FG003|NOT COMPLETED|Overall Study||1
11405391|NCT03886701|12600501|FG000|STARTED|Period 1: Study Days 1-4||11
11405392|NCT03886701|12600501|FG000|COMPLETED|Period 1: Study Days 1-4||11
11405393|NCT03886701|12600501|FG000|NOT COMPLETED|Period 1: Study Days 1-4||0
11405394|NCT03886701|12600501|FG000|STARTED|Period 2: Study Days 7-21||11
11405395|NCT03886701|12600501|FG000|COMPLETED|Period 2: Study Days 7-21||11
11405396|NCT03886701|12600501|FG000|NOT COMPLETED|Period 2: Study Days 7-21||0
11405397|NCT03883113|12600509|FG000|STARTED|Overall Study||87
11405398|NCT03883113|12600510|FG001|STARTED|Overall Study||58
11405399|NCT03883113|12600509|FG000|COMPLETED|Overall Study||71
11405400|NCT03883113|12600510|FG001|COMPLETED|Overall Study||46
11405401|NCT03883113|12600509|FG000|NOT COMPLETED|Overall Study||16
11405402|NCT03883113|12600510|FG001|NOT COMPLETED|Overall Study||12
11405403|NCT03880227|12600532|FG000|STARTED|First Visit||20
11405404|NCT03880227|12600533|FG001|STARTED|First Visit||21
11405405|NCT03880227|12600534|FG002|STARTED|First Visit||22
11405406|NCT03880227|12600535|FG003|STARTED|First Visit||18
11405407|NCT03880227|12600532|FG000|COMPLETED|First Visit||19
11405408|NCT03880227|12600533|FG001|COMPLETED|First Visit||21
11405409|NCT03880227|12600534|FG002|COMPLETED|First Visit||22
11405410|NCT03880227|12600535|FG003|COMPLETED|First Visit||18
11405411|NCT03880227|12600532|FG000|NOT COMPLETED|First Visit||1
11405412|NCT03880227|12600533|FG001|NOT COMPLETED|First Visit||0
11405413|NCT03880227|12600534|FG002|NOT COMPLETED|First Visit||0
11405414|NCT03880227|12600535|FG003|NOT COMPLETED|First Visit||0
11405415|NCT03880227|12600532|FG000|STARTED|1 Week Washout/ Delay||19
11405416|NCT03880227|12600533|FG001|STARTED|1 Week Washout/ Delay||21
11405417|NCT03880227|12600534|FG002|STARTED|1 Week Washout/ Delay||22
11405418|NCT03880227|12600535|FG003|STARTED|1 Week Washout/ Delay||18
11405419|NCT03880227|12600532|FG000|COMPLETED|1 Week Washout/ Delay||19
11405420|NCT03880227|12600533|FG001|COMPLETED|1 Week Washout/ Delay||20
11405421|NCT03880227|12600534|FG002|COMPLETED|1 Week Washout/ Delay||19
11405422|NCT03880227|12600535|FG003|COMPLETED|1 Week Washout/ Delay||18
11405423|NCT03880227|12600532|FG000|NOT COMPLETED|1 Week Washout/ Delay||0
11405424|NCT03880227|12600533|FG001|NOT COMPLETED|1 Week Washout/ Delay||1
11405425|NCT03880227|12600534|FG002|NOT COMPLETED|1 Week Washout/ Delay||3
11405426|NCT03880227|12600535|FG003|NOT COMPLETED|1 Week Washout/ Delay||0
11405427|NCT03880227|12600532|FG000|STARTED|Second Visit||19
11405428|NCT03880227|12600533|FG001|STARTED|Second Visit||20
11405429|NCT03880227|12600534|FG002|STARTED|Second Visit||19
11405430|NCT03880227|12600535|FG003|STARTED|Second Visit||18
11405431|NCT03880227|12600532|FG000|COMPLETED|Second Visit||19
11405432|NCT03880227|12600533|FG001|COMPLETED|Second Visit||20
11405433|NCT03880227|12600534|FG002|COMPLETED|Second Visit||19
11405434|NCT03880227|12600535|FG003|COMPLETED|Second Visit||18
11405435|NCT03880227|12600532|FG000|NOT COMPLETED|Second Visit||0
11405436|NCT03880227|12600533|FG001|NOT COMPLETED|Second Visit||0
11405437|NCT03880227|12600534|FG002|NOT COMPLETED|Second Visit||0
11405438|NCT03880227|12600535|FG003|NOT COMPLETED|Second Visit||0
11405439|NCT03876743|12600549|FG000|STARTED|Overall Study||54
11405440|NCT03876743|12600550|FG001|STARTED|Overall Study||51
11405441|NCT03876743|12600551|FG002|STARTED|Overall Study||46
11405442|NCT03876743|12600552|FG003|STARTED|Overall Study||50
11405443|NCT03876743|12600549|FG000|COMPLETED|Overall Study||48
11405444|NCT03876743|12600550|FG001|COMPLETED|Overall Study||47
11405445|NCT03876743|12600551|FG002|COMPLETED|Overall Study||42
11405446|NCT03876743|12600552|FG003|COMPLETED|Overall Study||43
11405447|NCT03876743|12600549|FG000|NOT COMPLETED|Overall Study||6
11405448|NCT03876743|12600550|FG001|NOT COMPLETED|Overall Study||4
11405449|NCT03876743|12600551|FG002|NOT COMPLETED|Overall Study||4
11405450|NCT03876743|12600552|FG003|NOT COMPLETED|Overall Study||7
11405451|NCT03885934|12600572|FG000|STARTED|Overall Study||64
11405452|NCT03885934|12600573|FG001|STARTED|Overall Study||64
11405453|NCT03885934|12600574|FG002|STARTED|Overall Study||62
11405454|NCT03885934|12600575|FG003|STARTED|Overall Study||64
11405455|NCT03885934|12600576|FG004|STARTED|Overall Study||177
11405456|NCT03885934|12600577|FG005|STARTED|Overall Study||175
11405457|NCT03885934|12600572|FG000|PCV Dose 1|Overall Study||64
11405458|NCT03885934|12600573|FG001|PCV Dose 1|Overall Study||64
11405459|NCT03885934|12600574|FG002|PCV Dose 1|Overall Study||62
11405460|NCT03885934|12600575|FG003|PCV Dose 1|Overall Study||64
11405461|NCT03885934|12600576|FG004|PCV Dose 1|Overall Study||177
11405462|NCT03885934|12600577|FG005|PCV Dose 1|Overall Study||175
11405463|NCT03885934|12600572|FG000|PCV Dose 2|Overall Study||63
11405464|NCT03885934|12600573|FG001|PCV Dose 2|Overall Study||64
11405465|NCT03885934|12600574|FG002|PCV Dose 2|Overall Study||62
11405466|NCT03885934|12600575|FG003|PCV Dose 2|Overall Study||64
11405467|NCT03885934|12600576|FG004|PCV Dose 2|Overall Study||0
11405468|NCT03885934|12600577|FG005|PCV Dose 2|Overall Study||0
11405469|NCT03885934|12600572|FG000|PCV Dose 3|Overall Study||63
11405470|NCT03885934|12600573|FG001|PCV Dose 3|Overall Study||64
11405471|NCT03885934|12600574|FG002|PCV Dose 3|Overall Study||0
11405472|NCT03885934|12600575|FG003|PCV Dose 3|Overall Study||0
11405473|NCT03885934|12600576|FG004|PCV Dose 3|Overall Study||0
11405474|NCT03885934|12600577|FG005|PCV Dose 3|Overall Study||0
11405475|NCT03885934|12600572|FG000|COMPLETED|Overall Study||63
11405476|NCT03885934|12600573|FG001|COMPLETED|Overall Study||64
11405477|NCT03885934|12600574|FG002|COMPLETED|Overall Study||62
11405478|NCT03885934|12600575|FG003|COMPLETED|Overall Study||64
11405479|NCT03885934|12600576|FG004|COMPLETED|Overall Study||177
11405480|NCT03885934|12600577|FG005|COMPLETED|Overall Study||175
11405481|NCT03885934|12600572|FG000|NOT COMPLETED|Overall Study||1
11405482|NCT03885934|12600573|FG001|NOT COMPLETED|Overall Study||0
11405483|NCT03885934|12600574|FG002|NOT COMPLETED|Overall Study||0
11405484|NCT03885934|12600575|FG003|NOT COMPLETED|Overall Study||0
11405485|NCT03885934|12600576|FG004|NOT COMPLETED|Overall Study||0
11405486|NCT03885934|12600577|FG005|NOT COMPLETED|Overall Study||0
11405487|NCT03885726|12600591|FG000|STARTED|Overall Study||32
11405488|NCT03885726|12600591|FG000|COMPLETED|Overall Study||28
11405489|NCT03885726|12600591|FG000|NOT COMPLETED|Overall Study||4
11405490|NCT03885154|12600603|FG000|STARTED|Overall Study||12
11405491|NCT03885154|12600604|FG001|STARTED|Overall Study||10
11405492|NCT03885154|12600605|FG002|STARTED|Overall Study||0
11405493|NCT03885154|12600606|FG003|STARTED|Overall Study||2
11405494|NCT03885154|12600603|FG000|COMPLETED|Overall Study||12
11405495|NCT03885154|12600604|FG001|COMPLETED|Overall Study||10
11405496|NCT03885154|12600605|FG002|COMPLETED|Overall Study||0
11405497|NCT03885154|12600606|FG003|COMPLETED|Overall Study||2
11405498|NCT03885154|12600603|FG000|NOT COMPLETED|Overall Study||0
11405499|NCT03885154|12600604|FG001|NOT COMPLETED|Overall Study||0
11405500|NCT03885154|12600605|FG002|NOT COMPLETED|Overall Study||0
11405501|NCT03885154|12600606|FG003|NOT COMPLETED|Overall Study||0
11405502|NCT03883386|12600616|FG000|STARTED|First Assignment||2
11405503|NCT03883386|12600617|FG001|STARTED|First Assignment||1
11405504|NCT03883386|12600616|FG000|Surveys Begun|First Assignment||1
11405505|NCT03883386|12600617|FG001|Surveys Begun|First Assignment||1
11405506|NCT03883386|12600616|FG000|COMPLETED|First Assignment||0
11405507|NCT03883386|12600617|FG001|COMPLETED|First Assignment||0
11405508|NCT03883386|12600616|FG000|NOT COMPLETED|First Assignment||2
11405509|NCT03883386|12600617|FG001|NOT COMPLETED|First Assignment||1
11405510|NCT03883386|12600616|FG000|STARTED|Washout and Second Assignment||0
11405511|NCT03883386|12600617|FG001|STARTED|Washout and Second Assignment||0
11405512|NCT03883386|12600616|FG000|COMPLETED|Washout and Second Assignment||0
11405513|NCT03883386|12600617|FG001|COMPLETED|Washout and Second Assignment||0
11405514|NCT03883386|12600616|FG000|NOT COMPLETED|Washout and Second Assignment||0
11405515|NCT03883386|12600617|FG001|NOT COMPLETED|Washout and Second Assignment||0
11405516|NCT03882528|12600623|FG000|STARTED|Overall Study||12
11405517|NCT03882528|12600623|FG000|COMPLETED|Overall Study||12
11405518|NCT03882528|12600623|FG000|NOT COMPLETED|Overall Study||0
11405519|NCT03882801|12600629|FG000|STARTED|Period 1||12
11405520|NCT03882801|12600630|FG001|STARTED|Period 1||12
11405521|NCT03882801|12600629|FG000|Treated|Period 1|1 participant did not receive any dose of study drug|11
11405522|NCT03882801|12600630|FG001|Treated|Period 1||12
11405523|NCT03882801|12600629|FG000|COMPLETED|Period 1||10
11405524|NCT03882801|12600630|FG001|COMPLETED|Period 1||10
11405525|NCT03882801|12600629|FG000|NOT COMPLETED|Period 1||2
11405526|NCT03882801|12600630|FG001|NOT COMPLETED|Period 1||2
11405527|NCT03882801|12600629|FG000|STARTED|Washout Period||10
11405528|NCT03882801|12600630|FG001|STARTED|Washout Period||10
11405529|NCT03882801|12600629|FG000|COMPLETED|Washout Period||10
11405530|NCT03882801|12600630|FG001|COMPLETED|Washout Period||9
11405531|NCT03882801|12600629|FG000|NOT COMPLETED|Washout Period||0
11405532|NCT03882801|12600630|FG001|NOT COMPLETED|Washout Period||1
11405533|NCT03882801|12600629|FG000|STARTED|Period 2||10
11405534|NCT03882801|12600630|FG001|STARTED|Period 2||9
11405535|NCT03882801|12600629|FG000|COMPLETED|Period 2||10
11405536|NCT03882801|12600630|FG001|COMPLETED|Period 2||8
11405537|NCT03882801|12600629|FG000|NOT COMPLETED|Period 2||0
11405538|NCT03882801|12600630|FG001|NOT COMPLETED|Period 2||1
11405539|NCT03882424|12600641|FG000|STARTED|Overall Study||38
11405540|NCT03882424|12600642|FG001|STARTED|Overall Study||38
11405541|NCT03882424|12600643|FG002|STARTED|Overall Study||38
11405542|NCT03882424|12600641|FG000|COMPLETED|Overall Study||34
11405543|NCT03882424|12600642|FG001|COMPLETED|Overall Study||38
11405544|NCT03882424|12600643|FG002|COMPLETED|Overall Study||38
11405545|NCT03882424|12600641|FG000|NOT COMPLETED|Overall Study||4
11405546|NCT03882424|12600642|FG001|NOT COMPLETED|Overall Study||0
11405547|NCT03882424|12600643|FG002|NOT COMPLETED|Overall Study||0
11405548|NCT03881163|12600651|FG000|STARTED|Overall Study||24
11405549|NCT03881163|12600651|FG000|COMPLETED|Overall Study||24
11405550|NCT03881163|12600651|FG000|NOT COMPLETED|Overall Study||0
11405551|NCT03881670|12600659|FG000|STARTED|Overall Study||12
11405552|NCT03881670|12600660|FG001|STARTED|Overall Study||12
11405553|NCT03881670|12600659|FG000|Completed First Intervention|Overall Study||12
11405554|NCT03881670|12600660|FG001|Completed First Intervention|Overall Study||12
11405555|NCT03881670|12600659|FG000|Completed Second Intervetion|Overall Study||12
11405556|NCT03881670|12600660|FG001|Completed Second Intervetion|Overall Study||12
11405557|NCT03881670|12600659|FG000|COMPLETED|Overall Study||12
11405558|NCT03881670|12600660|FG001|COMPLETED|Overall Study||12
11405559|NCT03881670|12600659|FG000|NOT COMPLETED|Overall Study||0
11405560|NCT03881670|12600660|FG001|NOT COMPLETED|Overall Study||0
11405561|NCT03880266|12600676|FG000|STARTED|Overall Study||12
11405562|NCT03880266|12600677|FG001|STARTED|Overall Study||6
11405563|NCT03880266|12600678|FG002|STARTED|Overall Study||12
11405564|NCT03880266|12600679|FG003|STARTED|Overall Study||4
11405565|NCT03880266|12600680|FG004|STARTED|Overall Study||12
11405566|NCT03880266|12600681|FG005|STARTED|Overall Study||6
11405567|NCT03880266|12600682|FG006|STARTED|Overall Study||13
11405568|NCT03880266|12600683|FG007|STARTED|Overall Study||7
11405569|NCT03880266|12600676|FG000|COMPLETED|Overall Study||12
11405570|NCT03880266|12600677|FG001|COMPLETED|Overall Study||5
11405571|NCT03880266|12600678|FG002|COMPLETED|Overall Study||11
11405572|NCT03880266|12600679|FG003|COMPLETED|Overall Study||4
11405573|NCT03880266|12600680|FG004|COMPLETED|Overall Study||12
11405574|NCT03880266|12600681|FG005|COMPLETED|Overall Study||6
11405575|NCT03880266|12600682|FG006|COMPLETED|Overall Study||13
11405576|NCT03880266|12600683|FG007|COMPLETED|Overall Study||7
11405577|NCT03880266|12600676|FG000|NOT COMPLETED|Overall Study||0
11405578|NCT03880266|12600677|FG001|NOT COMPLETED|Overall Study||1
11405579|NCT03880266|12600678|FG002|NOT COMPLETED|Overall Study||1
11405580|NCT03880266|12600679|FG003|NOT COMPLETED|Overall Study||0
11405581|NCT03880266|12600680|FG004|NOT COMPLETED|Overall Study||0
11405582|NCT03880266|12600681|FG005|NOT COMPLETED|Overall Study||0
11405583|NCT03880266|12600682|FG006|NOT COMPLETED|Overall Study||0
11405584|NCT03880266|12600683|FG007|NOT COMPLETED|Overall Study||0
11405585|NCT03856320|12600703|FG000|STARTED|Overall Study||20
11405586|NCT03856320|12600704|FG001|STARTED|Overall Study||22
11405587|NCT03856320|12600703|FG000|COMPLETED|Overall Study||20
11405588|NCT03856320|12600704|FG001|COMPLETED|Overall Study||20
11405589|NCT03856320|12600703|FG000|NOT COMPLETED|Overall Study||0
11405590|NCT03856320|12600704|FG001|NOT COMPLETED|Overall Study||2
11405591|NCT03848871|12600710|FG000|STARTED|Overall Study||20
11405592|NCT03848871|12600710|FG000|COMPLETED|Overall Study||20
11405593|NCT03848871|12600710|FG000|NOT COMPLETED|Overall Study||0
11405594|NCT03880474|12600716|FG000|STARTED|Overall Study||1077
11405595|NCT03880474|12600717|FG001|STARTED|Overall Study||1075
11405596|NCT03880474|12600716|FG000|COMPLETED|Overall Study||1054
11405597|NCT03880474|12600717|FG001|COMPLETED|Overall Study||1055
11405598|NCT03880474|12600716|FG000|NOT COMPLETED|Overall Study||23
11405599|NCT03880474|12600717|FG001|NOT COMPLETED|Overall Study||20
11405600|NCT03878160|12600726|FG000|STARTED|Overall Study||7
11405601|NCT03878160|12600727|FG001|STARTED|Overall Study||9
11405602|NCT03878160|12600728|FG002|STARTED|Overall Study||11
11405603|NCT03878160|12600726|FG000|COMPLETED|Overall Study||5
11405604|NCT03878160|12600727|FG001|COMPLETED|Overall Study||8
11405605|NCT03878160|12600728|FG002|COMPLETED|Overall Study||10
11405606|NCT03878160|12600726|FG000|NOT COMPLETED|Overall Study||2
11405607|NCT03878160|12600727|FG001|NOT COMPLETED|Overall Study||1
11405608|NCT03878160|12600728|FG002|NOT COMPLETED|Overall Study||1
11405609|NCT03864627|12600738|FG000|STARTED|Overall Study||11
11405610|NCT03864627|12600739|FG001|STARTED|Overall Study||22
11405611|NCT03864627|12600738|FG000|COMPLETED|Overall Study||7
11405612|NCT03864627|12600739|FG001|COMPLETED|Overall Study||10
11405613|NCT03864627|12600738|FG000|NOT COMPLETED|Overall Study||4
11405614|NCT03864627|12600739|FG001|NOT COMPLETED|Overall Study||12
11405615|NCT03861000|12600748|FG000|STARTED|Overall Study||2
11405616|NCT03861000|12600749|FG001|STARTED|Overall Study||1
11405617|NCT03861000|12600748|FG000|COMPLETED|Overall Study||2
11405618|NCT03861000|12600749|FG001|COMPLETED|Overall Study||1
11405619|NCT03861000|12600748|FG000|NOT COMPLETED|Overall Study||0
11405620|NCT03861000|12600749|FG001|NOT COMPLETED|Overall Study||0
11405621|NCT03848403|12600754|FG000|STARTED|Period 1 (Day 1)||24
11405622|NCT03848403|12600755|FG001|STARTED|Period 1 (Day 1)||24
11405623|NCT03848403|12600756|FG002|STARTED|Period 1 (Day 1)||22
11405624|NCT03848403|12600754|FG000|Received Intervention|Period 1 (Day 1)||24
11405625|NCT03848403|12600755|FG001|Received Intervention|Period 1 (Day 1)||24
11405626|NCT03848403|12600756|FG002|Received Intervention|Period 1 (Day 1)||22
11405627|NCT03848403|12600754|FG000|COMPLETED|Period 1 (Day 1)||24
11405628|NCT03848403|12600755|FG001|COMPLETED|Period 1 (Day 1)||24
11405629|NCT03848403|12600756|FG002|COMPLETED|Period 1 (Day 1)||22
11405630|NCT03848403|12600754|FG000|NOT COMPLETED|Period 1 (Day 1)||0
11405631|NCT03848403|12600755|FG001|NOT COMPLETED|Period 1 (Day 1)||0
11405632|NCT03848403|12600756|FG002|NOT COMPLETED|Period 1 (Day 1)||0
11405633|NCT03848403|12600754|FG000|STARTED|Period 2 (Day 8)||24
11405634|NCT03848403|12600755|FG001|STARTED|Period 2 (Day 8)||24
11405635|NCT03848403|12600756|FG002|STARTED|Period 2 (Day 8)||22
11405636|NCT03848403|12600754|FG000|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
11405637|NCT03848403|12600755|FG001|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
11405638|NCT03848403|12600756|FG002|Received at Least One Dose of Study Drug|Period 2 (Day 8)||22
11405639|NCT03848403|12600754|FG000|COMPLETED|Period 2 (Day 8)||15
11405640|NCT03848403|12600755|FG001|COMPLETED|Period 2 (Day 8)||15
11405641|NCT03848403|12600756|FG002|COMPLETED|Period 2 (Day 8)||15
11405642|NCT03848403|12600754|FG000|NOT COMPLETED|Period 2 (Day 8)||9
11405643|NCT03848403|12600755|FG001|NOT COMPLETED|Period 2 (Day 8)||9
11405644|NCT03848403|12600756|FG002|NOT COMPLETED|Period 2 (Day 8)||7
11405645|NCT03848403|12600754|FG000|STARTED|Period 3 (Day 15)||15
11405646|NCT03848403|12600755|FG001|STARTED|Period 3 (Day 15)||15
11405647|NCT03848403|12600756|FG002|STARTED|Period 3 (Day 15)||15
11405648|NCT03848403|12600754|FG000|COMPLETED|Period 3 (Day 15)||15
11405649|NCT03848403|12600755|FG001|COMPLETED|Period 3 (Day 15)||15
11405650|NCT03848403|12600756|FG002|COMPLETED|Period 3 (Day 15)||15
11405651|NCT03848403|12600754|FG000|NOT COMPLETED|Period 3 (Day 15)||0
11405652|NCT03848403|12600755|FG001|NOT COMPLETED|Period 3 (Day 15)||0
11405653|NCT03848403|12600756|FG002|NOT COMPLETED|Period 3 (Day 15)||0
11405654|NCT03847233|12600764|FG000|STARTED|Index Procedure||31
11405655|NCT03847233|12600764|FG000|COMPLETED|Index Procedure||31
11405656|NCT03847233|12600764|FG000|NOT COMPLETED|Index Procedure||0
11405657|NCT03847233|12600764|FG000|STARTED|6 Month After Index Procedure||31
11405658|NCT03847233|12600764|FG000|COMPLETED|6 Month After Index Procedure||30
11405659|NCT03847233|12600764|FG000|NOT COMPLETED|6 Month After Index Procedure||1
11405660|NCT03879603|12600775|FG000|STARTED|Overall Study||5
11405661|NCT03879603|12600776|FG001|STARTED|Overall Study||5
11405662|NCT03879603|12600777|FG002|STARTED|Overall Study||5
11405663|NCT03879603|12600778|FG003|STARTED|Overall Study||5
11405664|NCT03879603|12600779|FG004|STARTED|Overall Study||5
11405665|NCT03879603|12600780|FG005|STARTED|Overall Study||5
11405666|NCT03879603|12600775|FG000|Received First Product Administration|Overall Study||5
11405667|NCT03879603|12600776|FG001|Received First Product Administration|Overall Study||5
11405668|NCT03879603|12600777|FG002|Received First Product Administration|Overall Study||5
11405669|NCT03879603|12600778|FG003|Received First Product Administration|Overall Study||5
11405670|NCT03879603|12600779|FG004|Received First Product Administration|Overall Study||5
11405671|NCT03879603|12600780|FG005|Received First Product Administration|Overall Study||5
11405672|NCT03879603|12600775|FG000|Received All Product Administrations|Overall Study|Second administration not completed due to a grade 3 neutropenia not related to study product.|4
11405673|NCT03879603|12600776|FG001|Received All Product Administrations|Overall Study||5
11405674|NCT03879603|12600777|FG002|Received All Product Administrations|Overall Study||5
11405675|NCT03879603|12600778|FG003|Received All Product Administrations|Overall Study||5
11405676|NCT03879603|12600779|FG004|Received All Product Administrations|Overall Study||5
11405677|NCT03879603|12600780|FG005|Received All Product Administrations|Overall Study||5
11405678|NCT03879603|12600775|FG000|COMPLETED|Overall Study||5
11405679|NCT03879603|12600776|FG001|COMPLETED|Overall Study||5
11405680|NCT03879603|12600777|FG002|COMPLETED|Overall Study||5
11405681|NCT03879603|12600778|FG003|COMPLETED|Overall Study||5
11405682|NCT03879603|12600779|FG004|COMPLETED|Overall Study||5
11405683|NCT03879603|12600780|FG005|COMPLETED|Overall Study||5
11405684|NCT03879603|12600775|FG000|NOT COMPLETED|Overall Study||0
11405685|NCT03879603|12600776|FG001|NOT COMPLETED|Overall Study||0
11405686|NCT03879603|12600777|FG002|NOT COMPLETED|Overall Study||0
11405687|NCT03879603|12600778|FG003|NOT COMPLETED|Overall Study||0
11405688|NCT03879603|12600779|FG004|NOT COMPLETED|Overall Study||0
11405689|NCT03879603|12600780|FG005|NOT COMPLETED|Overall Study||0
11405690|NCT03878745|12600796|FG000|STARTED|Overall Study||55
11405691|NCT03878745|12600796|FG000|COMPLETED|Overall Study||55
11405692|NCT03878745|12600796|FG000|NOT COMPLETED|Overall Study||0
11405693|NCT03848221|12600811|FG000|STARTED|Overall Study||25
11405694|NCT03848221|12600812|FG001|STARTED|Overall Study||24
11405695|NCT03848221|12600813|FG002|STARTED|Overall Study||24
11405696|NCT03848221|12600811|FG000|COMPLETED|Overall Study||25
11405697|NCT03848221|12600812|FG001|COMPLETED|Overall Study||24
11405698|NCT03848221|12600813|FG002|COMPLETED|Overall Study||24
11405699|NCT03848221|12600811|FG000|NOT COMPLETED|Overall Study||0
11405700|NCT03848221|12600812|FG001|NOT COMPLETED|Overall Study||0
11405701|NCT03848221|12600813|FG002|NOT COMPLETED|Overall Study||0
11405702|NCT03878108|12600823|FG000|STARTED|Overall Study||11
11405703|NCT03878108|12600824|FG001|STARTED|Overall Study||10
11405704|NCT03878108|12600823|FG000|Completed First Phase|Overall Study||10
11405705|NCT03878108|12600824|FG001|Completed First Phase|Overall Study||10
11405706|NCT03878108|12600823|FG000|COMPLETED|Overall Study||10
11405707|NCT03878108|12600824|FG001|COMPLETED|Overall Study||10
11405708|NCT03878108|12600823|FG000|NOT COMPLETED|Overall Study||1
11405709|NCT03878108|12600824|FG001|NOT COMPLETED|Overall Study||0
11405710|NCT03877432|12600830|FG000|STARTED|Overall Study||10
11405711|NCT03877432|12600830|FG000|COMPLETED|Overall Study||10
11405712|NCT03877432|12600830|FG000|NOT COMPLETED|Overall Study||0
11405713|NCT03877237|12600840|FG000|STARTED|Overall Study||156
11405714|NCT03877237|12600841|FG001|STARTED|Overall Study||157
11405715|NCT03877237|12600840|FG000|Treated|Overall Study||156
11405716|NCT03877237|12600841|FG001|Treated|Overall Study||157
11405717|NCT03877237|12600840|FG000|COMPLETED|Overall Study||151
11405718|NCT03877237|12600841|FG001|COMPLETED|Overall Study||151
11405719|NCT03877237|12600840|FG000|NOT COMPLETED|Overall Study||5
11405720|NCT03877237|12600841|FG001|NOT COMPLETED|Overall Study||6
11405721|NCT03866434|12600847|FG000|STARTED|Overall Study||20
11405722|NCT03866434|12600847|FG000|COMPLETED|Overall Study||20
11405723|NCT03866434|12600847|FG000|NOT COMPLETED|Overall Study||0
11405724|NCT03863210|12600853|FG000|STARTED|Overall Study|March 1st, 2014.|104
11405725|NCT03863210|12600853|FG000|COMPLETED|Overall Study|September 1st, 2014.|102
11405726|NCT03863210|12600853|FG000|NOT COMPLETED|Overall Study||2
11405727|NCT03859323|12600870|FG000|STARTED|Overall Study||5
11405728|NCT03859323|12600871|FG001|STARTED|Overall Study||5
11405729|NCT03859323|12600872|FG002|STARTED|Overall Study||5
11405730|NCT03859323|12600873|FG003|STARTED|Overall Study||5
11405731|NCT03859323|12600874|FG004|STARTED|Overall Study||5
11405732|NCT03859323|12600875|FG005|STARTED|Overall Study||5
11405733|NCT03859323|12600876|FG006|STARTED|Overall Study||12
11405734|NCT03859323|12600877|FG007|STARTED|Overall Study||10
11405735|NCT03859323|12600878|FG008|STARTED|Overall Study||10
11405736|NCT03859323|12600879|FG009|STARTED|Overall Study||10
11405737|NCT03859323|12600880|FG010|STARTED|Overall Study||10
11405738|NCT03859323|12600881|FG011|STARTED|Overall Study||12
11405739|NCT03859323|12600882|FG012|STARTED|Overall Study||10
11405740|NCT03859323|12600870|FG000|COMPLETED|Overall Study||5
11405741|NCT03859323|12600871|FG001|COMPLETED|Overall Study||5
11405742|NCT03859323|12600872|FG002|COMPLETED|Overall Study||4
11405743|NCT03859323|12600873|FG003|COMPLETED|Overall Study||5
11405744|NCT03859323|12600874|FG004|COMPLETED|Overall Study||5
11405745|NCT03859323|12600875|FG005|COMPLETED|Overall Study||4
11405746|NCT03859323|12600876|FG006|COMPLETED|Overall Study||11
11405747|NCT03859323|12600877|FG007|COMPLETED|Overall Study||10
11405748|NCT03859323|12600878|FG008|COMPLETED|Overall Study||10
11405749|NCT03859323|12600879|FG009|COMPLETED|Overall Study||8
11405750|NCT03859323|12600880|FG010|COMPLETED|Overall Study||9
11405751|NCT03859323|12600881|FG011|COMPLETED|Overall Study||10
11405752|NCT03859323|12600882|FG012|COMPLETED|Overall Study||9
11405753|NCT03859323|12600870|FG000|NOT COMPLETED|Overall Study||0
11405754|NCT03859323|12600871|FG001|NOT COMPLETED|Overall Study||0
11405755|NCT03859323|12600872|FG002|NOT COMPLETED|Overall Study||1
11405756|NCT03859323|12600873|FG003|NOT COMPLETED|Overall Study||0
11405757|NCT03859323|12600874|FG004|NOT COMPLETED|Overall Study||0
11405758|NCT03859323|12600875|FG005|NOT COMPLETED|Overall Study||1
11405759|NCT03859323|12600876|FG006|NOT COMPLETED|Overall Study||1
11405760|NCT03859323|12600877|FG007|NOT COMPLETED|Overall Study||0
11405761|NCT03859323|12600878|FG008|NOT COMPLETED|Overall Study||0
11405762|NCT03859323|12600879|FG009|NOT COMPLETED|Overall Study||2
11405763|NCT03859323|12600880|FG010|NOT COMPLETED|Overall Study||1
11405764|NCT03859323|12600881|FG011|NOT COMPLETED|Overall Study||2
11405765|NCT03859323|12600882|FG012|NOT COMPLETED|Overall Study||1
11405766|NCT03867838|12600921|FG000|STARTED|Overall Study||6
11405767|NCT03867838|12600921|FG000|COMPLETED|Overall Study||6
11405768|NCT03867838|12600921|FG000|NOT COMPLETED|Overall Study||0
11405769|NCT03855059|12600927|FG000|STARTED|Overall Study||25
11405770|NCT03855059|12600928|FG001|STARTED|Overall Study||25
11405771|NCT03855059|12600927|FG000|COMPLETED|Overall Study||23
11405772|NCT03855059|12600928|FG001|COMPLETED|Overall Study||25
11405773|NCT03855059|12600927|FG000|NOT COMPLETED|Overall Study||2
11405774|NCT03855059|12600928|FG001|NOT COMPLETED|Overall Study||0
11405775|NCT03852537|12600936|FG000|STARTED|Overall Study||23
11405776|NCT03852537|12600937|FG001|STARTED|Overall Study||21
11405777|NCT03852537|12600936|FG000|COMPLETED|Overall Study||23
11405778|NCT03852537|12600937|FG001|COMPLETED|Overall Study||21
11405779|NCT03852537|12600936|FG000|NOT COMPLETED|Overall Study||0
11405780|NCT03852537|12600937|FG001|NOT COMPLETED|Overall Study||0
11405781|NCT03875859|12600943|FG000|STARTED|Overall Study||4
11405782|NCT03875859|12600943|FG000|COMPLETED|Overall Study||4
11405783|NCT03875859|12600943|FG000|NOT COMPLETED|Overall Study||0
11405784|NCT03875508|12600947|FG000|STARTED|Overall Study||108
11405785|NCT03875508|12600947|FG000|COMPLETED|Overall Study||96
11405786|NCT03875508|12600947|FG000|NOT COMPLETED|Overall Study||12
11405787|NCT03869333|12600955|FG000|STARTED|Overall Study||14
11405788|NCT03869333|12600956|FG001|STARTED|Overall Study||16
11405789|NCT03869333|12600957|FG002|STARTED|Overall Study||16
11405790|NCT03869333|12600958|FG003|STARTED|Overall Study||12
11405791|NCT03869333|12600955|FG000|Received First Dose|Overall Study||14
11405792|NCT03869333|12600956|FG001|Received First Dose|Overall Study||16
11405793|NCT03869333|12600957|FG002|Received First Dose|Overall Study||16
11405794|NCT03869333|12600958|FG003|Received First Dose|Overall Study||12
11405795|NCT03869333|12600955|FG000|Received Second Dose|Overall Study||13
11405796|NCT03869333|12600956|FG001|Received Second Dose|Overall Study||15
11405797|NCT03869333|12600957|FG002|Received Second Dose|Overall Study||16
11405798|NCT03869333|12600958|FG003|Received Second Dose|Overall Study||12
11405799|NCT03869333|12600955|FG000|Received Third Dose|Overall Study||13
11405800|NCT03869333|12600956|FG001|Received Third Dose|Overall Study||15
11405801|NCT03869333|12600957|FG002|Received Third Dose|Overall Study||16
11405802|NCT03869333|12600958|FG003|Received Third Dose|Overall Study||11
11405803|NCT03869333|12600955|FG000|COMPLETED|Overall Study||12
11405804|NCT03869333|12600956|FG001|COMPLETED|Overall Study||15
11405805|NCT03869333|12600957|FG002|COMPLETED|Overall Study||16
11405806|NCT03869333|12600958|FG003|COMPLETED|Overall Study||12
11405807|NCT03869333|12600955|FG000|NOT COMPLETED|Overall Study||2
11405808|NCT03869333|12600956|FG001|NOT COMPLETED|Overall Study||1
11405809|NCT03869333|12600957|FG002|NOT COMPLETED|Overall Study||0
11405810|NCT03869333|12600958|FG003|NOT COMPLETED|Overall Study||0
11405811|NCT03864900|12600970|FG000|STARTED|Overall Study||36
11405812|NCT03864900|12600971|FG001|STARTED|Overall Study||36
11405813|NCT03864900|12600970|FG000|COMPLETED|Overall Study||33
11405814|NCT03864900|12600971|FG001|COMPLETED|Overall Study||30
11405815|NCT03864900|12600970|FG000|NOT COMPLETED|Overall Study||3
11405816|NCT03864900|12600971|FG001|NOT COMPLETED|Overall Study||6
11405817|NCT03863795|12600981|FG000|STARTED|Overall Study||306
11405818|NCT03863795|12600982|FG001|STARTED|Overall Study||269
11405819|NCT03863795|12600983|FG002|STARTED|Overall Study||244
11405820|NCT03863795|12600984|FG003|STARTED|Overall Study||281
11405821|NCT03863795|12600981|FG000|COMPLETED|Overall Study||306
11405822|NCT03863795|12600982|FG001|COMPLETED|Overall Study||269
11405823|NCT03863795|12600983|FG002|COMPLETED|Overall Study||244
11405824|NCT03863795|12600984|FG003|COMPLETED|Overall Study||281
11405825|NCT03863795|12600981|FG000|NOT COMPLETED|Overall Study||0
11405826|NCT03863795|12600982|FG001|NOT COMPLETED|Overall Study||0
11405827|NCT03863795|12600983|FG002|NOT COMPLETED|Overall Study||0
11405828|NCT03863795|12600984|FG003|NOT COMPLETED|Overall Study||0
11405829|NCT03875482|12600996|FG000|STARTED|Overall Study||105
11405830|NCT03875482|12600997|FG001|STARTED|Overall Study||52
11405831|NCT03875482|12600996|FG000|COMPLETED|Overall Study||92
11405832|NCT03875482|12600997|FG001|COMPLETED|Overall Study||32
11405833|NCT03875482|12600996|FG000|NOT COMPLETED|Overall Study||13
11405834|NCT03875482|12600997|FG001|NOT COMPLETED|Overall Study||20
11405835|NCT03874377|12601003|FG000|STARTED|Overall Study||11
11405836|NCT03874377|12601003|FG000|COMPLETED|Overall Study||8
11405837|NCT03874377|12601003|FG000|NOT COMPLETED|Overall Study||3
11405838|NCT03863496|12601007|FG000|STARTED|Overall Study||71
11405839|NCT03863496|12601007|FG000|COMPLETED|Overall Study||71
11405840|NCT03863496|12601007|FG000|NOT COMPLETED|Overall Study||0
11405841|NCT03874013|12601015|FG000|STARTED|Overall Study||22
11405842|NCT03874013|12601016|FG001|STARTED|Overall Study||22
11405843|NCT03874013|12601015|FG000|COMPLETED|Overall Study||22
11405844|NCT03874013|12601016|FG001|COMPLETED|Overall Study||21
11405845|NCT03874013|12601015|FG000|NOT COMPLETED|Overall Study||0
11405846|NCT03874013|12601016|FG001|NOT COMPLETED|Overall Study||1
11405847|NCT03873116|12601025|FG000|STARTED|Overall Study||6
11405848|NCT03873116|12601026|FG001|STARTED|Overall Study||7
11405849|NCT03873116|12601027|FG002|STARTED|Overall Study||6
11405850|NCT03873116|12601025|FG000|COMPLETED|Overall Study||6
11405851|NCT03873116|12601026|FG001|COMPLETED|Overall Study||7
11405852|NCT03873116|12601027|FG002|COMPLETED|Overall Study||5
11405853|NCT03873116|12601025|FG000|NOT COMPLETED|Overall Study||0
11405854|NCT03873116|12601026|FG001|NOT COMPLETED|Overall Study||0
11405855|NCT03873116|12601027|FG002|NOT COMPLETED|Overall Study||1
11405856|NCT03872843|12601037|FG000|STARTED|Overall Study||12
11405857|NCT03872843|12601038|FG001|STARTED|Overall Study||10
11405858|NCT03872843|12601037|FG000|COMPLETED|Overall Study||7
11405859|NCT03872843|12601038|FG001|COMPLETED|Overall Study||3
11405860|NCT03872843|12601037|FG000|NOT COMPLETED|Overall Study||5
11405861|NCT03872843|12601038|FG001|NOT COMPLETED|Overall Study||7
11405862|NCT03870997|12601050|FG000|STARTED|Overall Study||15702
11405863|NCT03870997|12601051|FG001|STARTED|Overall Study||15702
11405864|NCT03870997|12601052|FG002|STARTED|Overall Study||15756
11405865|NCT03870997|12601053|FG003|STARTED|Overall Study||15757
11405866|NCT03870997|12601054|FG004|STARTED|Overall Study||15702
11405867|NCT03870997|12601055|FG005|STARTED|Overall Study||15702
11405868|NCT03870997|12601050|FG000|COMPLETED|Overall Study||5158
11405869|NCT03870997|12601051|FG001|COMPLETED|Overall Study||5271
11405870|NCT03870997|12601052|FG002|COMPLETED|Overall Study||4778
11405871|NCT03870997|12601053|FG003|COMPLETED|Overall Study||4810
11405872|NCT03870997|12601054|FG004|COMPLETED|Overall Study||5114
11405873|NCT03870997|12601055|FG005|COMPLETED|Overall Study||5171
11405874|NCT03870997|12601050|FG000|NOT COMPLETED|Overall Study||10544
11405875|NCT03870997|12601051|FG001|NOT COMPLETED|Overall Study||10431
11405876|NCT03870997|12601052|FG002|NOT COMPLETED|Overall Study||10978
11405877|NCT03870997|12601053|FG003|NOT COMPLETED|Overall Study||10947
11405878|NCT03870997|12601054|FG004|NOT COMPLETED|Overall Study||10588
11405879|NCT03870997|12601055|FG005|NOT COMPLETED|Overall Study||10531
11405880|NCT03869684|12601067|FG000|STARTED|Overall Study||3
11405881|NCT03869684|12601068|FG001|STARTED|Overall Study||5
11405882|NCT03869684|12601069|FG002|STARTED|Overall Study||5
11405883|NCT03869684|12601067|FG000|COMPLETED|Overall Study||1
11405884|NCT03869684|12601068|FG001|COMPLETED|Overall Study||2
11405885|NCT03869684|12601069|FG002|COMPLETED|Overall Study||2
11405886|NCT03869684|12601067|FG000|NOT COMPLETED|Overall Study||2
11405887|NCT03869684|12601068|FG001|NOT COMPLETED|Overall Study||3
11405888|NCT03869684|12601069|FG002|NOT COMPLETED|Overall Study||3
11405889|NCT03861338|12601077|FG000|STARTED|Overall Study||10
11405890|NCT03861338|12601077|FG000|COMPLETED|Overall Study||8
11405891|NCT03861338|12601077|FG000|NOT COMPLETED|Overall Study||2
11405892|NCT03858335|12601083|FG000|STARTED|Overall Study||16
11405893|NCT03858335|12601084|FG001|STARTED|Overall Study||16
11405894|NCT03858335|12601083|FG000|COMPLETED|Overall Study||12
11405895|NCT03858335|12601084|FG001|COMPLETED|Overall Study||12
11405896|NCT03858335|12601083|FG000|NOT COMPLETED|Overall Study||4
11405897|NCT03858335|12601084|FG001|NOT COMPLETED|Overall Study||4
11405898|NCT03857243|12601092|FG000|STARTED|Overall Study||1
11405899|NCT03857243|12601093|FG001|STARTED|Overall Study||1
11405900|NCT03857243|12601092|FG000|COMPLETED|Overall Study||1
11405901|NCT03857243|12601093|FG001|COMPLETED|Overall Study||1
11405902|NCT03857243|12601092|FG000|NOT COMPLETED|Overall Study||0
11405903|NCT03857243|12601093|FG001|NOT COMPLETED|Overall Study||0
11405904|NCT03851744|12601101|FG000|STARTED|Overall Study||4
11405905|NCT03851744|12601102|FG001|STARTED|Overall Study||6
11405906|NCT03851744|12601101|FG000|COMPLETED|Overall Study||4
11405907|NCT03851744|12601102|FG001|COMPLETED|Overall Study||4
11405908|NCT03851744|12601101|FG000|NOT COMPLETED|Overall Study||0
11405909|NCT03851744|12601102|FG001|NOT COMPLETED|Overall Study||2
11405910|NCT03849937|12601108|FG000|STARTED|Overall Study||147
11405911|NCT03849937|12601109|FG001|STARTED|Overall Study||72
11405912|NCT03849937|12601108|FG000|COMPLETED|Overall Study||94
11405913|NCT03849937|12601109|FG001|COMPLETED|Overall Study||35
11405914|NCT03849937|12601108|FG000|NOT COMPLETED|Overall Study||53
11405915|NCT03849937|12601109|FG001|NOT COMPLETED|Overall Study||37
11405916|NCT03848416|12601123|FG000|STARTED|Overall Study||33
11405917|NCT03848416|12601124|FG001|STARTED|Overall Study||33
11405918|NCT03848416|12601125|FG002|STARTED|Overall Study||33
11405919|NCT03848416|12601123|FG000|Received at Least One Dose of Study Drug|Overall Study||33
11405920|NCT03848416|12601124|FG001|Received at Least One Dose of Study Drug|Overall Study||33
11405921|NCT03848416|12601125|FG002|Received at Least One Dose of Study Drug|Overall Study||33
11405922|NCT03848416|12601123|FG000|COMPLETED|Overall Study||32
11405923|NCT03848416|12601124|FG001|COMPLETED|Overall Study||33
11405924|NCT03848416|12601125|FG002|COMPLETED|Overall Study||32
11405925|NCT03848416|12601123|FG000|NOT COMPLETED|Overall Study||1
11405926|NCT03848416|12601124|FG001|NOT COMPLETED|Overall Study||0
11405927|NCT03848416|12601125|FG002|NOT COMPLETED|Overall Study||1
11405928|NCT03847987|12601135|FG000|STARTED|Overall Study||16
11405929|NCT03847987|12601136|FG001|STARTED|Overall Study||8
11405930|NCT03847987|12601135|FG000|COMPLETED|Overall Study||13
11405931|NCT03847987|12601136|FG001|COMPLETED|Overall Study||8
11405932|NCT03847987|12601135|FG000|NOT COMPLETED|Overall Study||3
11405933|NCT03847987|12601136|FG001|NOT COMPLETED|Overall Study||0
11405934|NCT03854253|12601155|FG000|STARTED|Overall Study||50
11405935|NCT03854253|12601156|FG001|STARTED|Overall Study||50
11405936|NCT03854253|12601155|FG000|COMPLETED|Overall Study||49
11405937|NCT03854253|12601156|FG001|COMPLETED|Overall Study||50
11405938|NCT03854253|12601155|FG000|NOT COMPLETED|Overall Study||1
11405939|NCT03854253|12601156|FG001|NOT COMPLETED|Overall Study||0
11405940|NCT03870737|12601162|FG000|STARTED|Overall Study||22
11405941|NCT03870737|12601162|FG000|COMPLETED|Overall Study||20
11405942|NCT03870737|12601162|FG000|NOT COMPLETED|Overall Study||2
11405943|NCT03860181|12601170|FG000|STARTED|Overall Study||21
11405944|NCT03860181|12601171|FG001|STARTED|Overall Study||22
11405945|NCT03860181|12601172|FG002|STARTED|Overall Study||25
11405946|NCT03860181|12601173|FG003|STARTED|Overall Study||21
11405947|NCT03860181|12601170|FG000|COMPLETED|Overall Study||21
11405948|NCT03860181|12601171|FG001|COMPLETED|Overall Study||22
11405949|NCT03860181|12601172|FG002|COMPLETED|Overall Study||25
11405950|NCT03860181|12601173|FG003|COMPLETED|Overall Study||21
11405951|NCT03860181|12601170|FG000|NOT COMPLETED|Overall Study||0
11405952|NCT03860181|12601171|FG001|NOT COMPLETED|Overall Study||0
11405953|NCT03860181|12601172|FG002|NOT COMPLETED|Overall Study||0
11405954|NCT03860181|12601173|FG003|NOT COMPLETED|Overall Study||0
11405955|NCT03856944|12601194|FG000|STARTED|Overall Study||29
11405956|NCT03856944|12601194|FG000|COMPLETED|Overall Study||29
11405957|NCT03856944|12601194|FG000|NOT COMPLETED|Overall Study||0
11405958|NCT03853551|12601198|FG000|STARTED|Overall Study||60
11405959|NCT03853551|12601198|FG000|COMPLETED|Overall Study||51
11405960|NCT03853551|12601198|FG000|NOT COMPLETED|Overall Study||9
11405961|NCT03870555|12601205|FG000|STARTED|Period 1 (2 Days)||2
11405962|NCT03870555|12601206|FG001|STARTED|Period 1 (2 Days)||2
11405963|NCT03870555|12601207|FG002|STARTED|Period 1 (2 Days)||2
11405964|NCT03870555|12601205|FG000|COMPLETED|Period 1 (2 Days)||2
11405965|NCT03870555|12601206|FG001|COMPLETED|Period 1 (2 Days)||2
11405966|NCT03870555|12601207|FG002|COMPLETED|Period 1 (2 Days)||2
11405967|NCT03870555|12601205|FG000|NOT COMPLETED|Period 1 (2 Days)||0
11405968|NCT03870555|12601206|FG001|NOT COMPLETED|Period 1 (2 Days)||0
11405969|NCT03870555|12601207|FG002|NOT COMPLETED|Period 1 (2 Days)||0
11405970|NCT03870555|12601205|FG000|STARTED|Washout Period (at Least 16 Days)||2
11405971|NCT03870555|12601206|FG001|STARTED|Washout Period (at Least 16 Days)||2
11405972|NCT03870555|12601207|FG002|STARTED|Washout Period (at Least 16 Days)||2
11405973|NCT03870555|12601205|FG000|COMPLETED|Washout Period (at Least 16 Days)||2
11405974|NCT03870555|12601206|FG001|COMPLETED|Washout Period (at Least 16 Days)||2
11405975|NCT03870555|12601207|FG002|COMPLETED|Washout Period (at Least 16 Days)||2
11405976|NCT03870555|12601205|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0
11405977|NCT03870555|12601206|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0
11405978|NCT03870555|12601207|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0
11405979|NCT03870555|12601205|FG000|STARTED|Period 2 (2 Days)||2
11405980|NCT03870555|12601206|FG001|STARTED|Period 2 (2 Days)||2
11405981|NCT03870555|12601207|FG002|STARTED|Period 2 (2 Days)||2
11405982|NCT03870555|12601205|FG000|COMPLETED|Period 2 (2 Days)||2
11405983|NCT03870555|12601206|FG001|COMPLETED|Period 2 (2 Days)||2
11405984|NCT03870555|12601207|FG002|COMPLETED|Period 2 (2 Days)||2
11405985|NCT03870555|12601205|FG000|NOT COMPLETED|Period 2 (2 Days)||0
11405986|NCT03870555|12601206|FG001|NOT COMPLETED|Period 2 (2 Days)||0
11405987|NCT03870555|12601207|FG002|NOT COMPLETED|Period 2 (2 Days)||0
11405988|NCT03870555|12601205|FG000|STARTED|Washout Period (at Least 16 Days)||2
11405989|NCT03870555|12601206|FG001|STARTED|Washout Period (at Least 16 Days)||2
11405990|NCT03870555|12601207|FG002|STARTED|Washout Period (at Least 16 Days)||2
11405991|NCT03870555|12601205|FG000|COMPLETED|Washout Period (at Least 16 Days)||2
11405992|NCT03870555|12601206|FG001|COMPLETED|Washout Period (at Least 16 Days)||2
11405993|NCT03870555|12601207|FG002|COMPLETED|Washout Period (at Least 16 Days)||2
11405994|NCT03870555|12601205|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0
11022360|NCT00808808|12200610|FG001|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
11022361|NCT00808808|12200611|FG002|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
11022362|NCT00808808|12200609|FG000|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
11022363|NCT00808808|12200610|FG001|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
11022364|NCT00808808|12200611|FG002|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
11022365|NCT00808808|12200609|FG000|NOT COMPLETED|Overall Study||2817
11022366|NCT00808808|12200610|FG001|NOT COMPLETED|Overall Study||2437
11022367|NCT00808808|12200611|FG002|NOT COMPLETED|Overall Study||2557
11022368|NCT00808834|12200625|FG000|STARTED|Period 1||97
11022369|NCT00808834|12200626|FG001|STARTED|Period 1||99
11022370|NCT00808834|12200625|FG000|COMPLETED|Period 1||97
11022371|NCT00808834|12200626|FG001|COMPLETED|Period 1||99
11022372|NCT00808834|12200625|FG000|NOT COMPLETED|Period 1||0
11022373|NCT00808834|12200626|FG001|NOT COMPLETED|Period 1||0
11022374|NCT00808834|12200625|FG000|STARTED|Period 2||97
11022375|NCT00808834|12200626|FG001|STARTED|Period 2||99
11022376|NCT00808834|12200625|FG000|COMPLETED|Period 2||97
11022377|NCT00808834|12200626|FG001|COMPLETED|Period 2||99
11022378|NCT00808834|12200625|FG000|NOT COMPLETED|Period 2||0
11022379|NCT00808834|12200626|FG001|NOT COMPLETED|Period 2||0
11022380|NCT00809055|12200634|FG000|STARTED|Overall Study||37
11022381|NCT00809055|12200635|FG001|STARTED|Overall Study||37
11022382|NCT00809055|12200634|FG000|COMPLETED|Overall Study||28
11022383|NCT00809055|12200635|FG001|COMPLETED|Overall Study||30
11022384|NCT00809055|12200634|FG000|NOT COMPLETED|Overall Study||9
11405995|NCT03870555|12601206|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0
11405996|NCT03870555|12601207|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0
11405997|NCT03870555|12601205|FG000|STARTED|Period 3 (2 Days)||2
11405998|NCT03870555|12601206|FG001|STARTED|Period 3 (2 Days)||2
11405999|NCT03870555|12601207|FG002|STARTED|Period 3 (2 Days)||2
11406000|NCT03870555|12601205|FG000|COMPLETED|Period 3 (2 Days)||1
11406001|NCT03870555|12601206|FG001|COMPLETED|Period 3 (2 Days)||2
11406002|NCT03870555|12601207|FG002|COMPLETED|Period 3 (2 Days)||2
11406003|NCT03870555|12601205|FG000|NOT COMPLETED|Period 3 (2 Days)||1
11406004|NCT03870555|12601206|FG001|NOT COMPLETED|Period 3 (2 Days)||0
11406005|NCT03870555|12601207|FG002|NOT COMPLETED|Period 3 (2 Days)||0
11406006|NCT03861845|12601221|FG000|STARTED|Overall Study||6
11406007|NCT03861845|12601222|FG001|STARTED|Overall Study||5
11406008|NCT03861845|12601223|FG002|STARTED|Overall Study||4
11406009|NCT03861845|12601221|FG000|COMPLETED|Overall Study||6
11406010|NCT03861845|12601222|FG001|COMPLETED|Overall Study||5
11406011|NCT03861845|12601223|FG002|COMPLETED|Overall Study||4
11406012|NCT03861845|12601221|FG000|NOT COMPLETED|Overall Study||0
11406013|NCT03861845|12601222|FG001|NOT COMPLETED|Overall Study||0
11406014|NCT03861845|12601223|FG002|NOT COMPLETED|Overall Study||0
11022385|NCT00809055|12200635|FG001|NOT COMPLETED|Overall Study||7
11022386|NCT00809094|12200643|FG000|STARTED|Overall Study||36
11022387|NCT00809094|12200644|FG001|STARTED|Overall Study||34
11022388|NCT00809094|12200643|FG000|COMPLETED|Overall Study||36
11022389|NCT00809094|12200644|FG001|COMPLETED|Overall Study||33
11022390|NCT00809094|12200643|FG000|NOT COMPLETED|Overall Study||0
11022391|NCT00809094|12200644|FG001|NOT COMPLETED|Overall Study||1
11022392|NCT00809133|12200664|FG000|STARTED|Overall Study||3
11022393|NCT00809133|12200665|FG001|STARTED|Overall Study||7
11022394|NCT00809133|12200666|FG002|STARTED|Overall Study||6
11406015|NCT03851094|12601233|FG000|STARTED|Overall Study||111
11406016|NCT03851094|12601234|FG001|STARTED|Overall Study||55
11406017|NCT03851094|12601233|FG000|COMPLETED|Overall Study||111
11406018|NCT03851094|12601234|FG001|COMPLETED|Overall Study||51
11406019|NCT03851094|12601233|FG000|NOT COMPLETED|Overall Study||0
11406020|NCT03851094|12601234|FG001|NOT COMPLETED|Overall Study||4
11406021|NCT03868631|12601244|FG000|STARTED|Baseline to Week 6||30
11406022|NCT03868631|12601245|FG001|STARTED|Baseline to Week 6||31
11406023|NCT03868631|12601244|FG000|COMPLETED|Baseline to Week 6||26
11406024|NCT03868631|12601245|FG001|COMPLETED|Baseline to Week 6||27
11406025|NCT03868631|12601244|FG000|NOT COMPLETED|Baseline to Week 6||4
11406026|NCT03868631|12601245|FG001|NOT COMPLETED|Baseline to Week 6||4
11406027|NCT03868631|12601244|FG000|STARTED|Week 6 to Week 12 (Study Completion)||26
11406028|NCT03868631|12601245|FG001|STARTED|Week 6 to Week 12 (Study Completion)||27
11406029|NCT03868631|12601244|FG000|COMPLETED|Week 6 to Week 12 (Study Completion)||22
11406030|NCT03868631|12601245|FG001|COMPLETED|Week 6 to Week 12 (Study Completion)||26
11406031|NCT03868631|12601244|FG000|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4
11406032|NCT03868631|12601245|FG001|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1
11406033|NCT03865953|12601253|FG000|STARTED|First Intervention (4 Weeks)||25
11406034|NCT03865953|12601254|FG001|STARTED|First Intervention (4 Weeks)||28
11406035|NCT03865953|12601253|FG000|COMPLETED|First Intervention (4 Weeks)||23
11406036|NCT03865953|12601254|FG001|COMPLETED|First Intervention (4 Weeks)||27
11406037|NCT03865953|12601253|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
11406038|NCT03865953|12601254|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
11406039|NCT03865953|12601253|FG000|STARTED|Washout/Baseline Period (3 Weeks)||23
11406040|NCT03865953|12601254|FG001|STARTED|Washout/Baseline Period (3 Weeks)||27
11406041|NCT03865953|12601253|FG000|COMPLETED|Washout/Baseline Period (3 Weeks)||23
11406042|NCT03865953|12601254|FG001|COMPLETED|Washout/Baseline Period (3 Weeks)||27
11406043|NCT03865953|12601253|FG000|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
11406044|NCT03865953|12601254|FG001|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
11406045|NCT03865953|12601253|FG000|STARTED|Second Intervention (4 Weeks)||23
11406046|NCT03865953|12601254|FG001|STARTED|Second Intervention (4 Weeks)||27
11406047|NCT03865953|12601253|FG000|COMPLETED|Second Intervention (4 Weeks)||23
11406048|NCT03865953|12601254|FG001|COMPLETED|Second Intervention (4 Weeks)||25
11406049|NCT03865953|12601253|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
11406050|NCT03865953|12601254|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2
11406051|NCT03865381|12601260|FG000|STARTED|Overall Study||60
11406052|NCT03865381|12601260|FG000|COMPLETED|Overall Study||55
11406053|NCT03865381|12601260|FG000|NOT COMPLETED|Overall Study||5
11406054|NCT03865446|12601266|FG000|STARTED|Overall Study||8
11406055|NCT03865446|12601267|FG001|STARTED|Overall Study||8
11406056|NCT03865446|12601266|FG000|COMPLETED|Overall Study||8
11406057|NCT03865446|12601267|FG001|COMPLETED|Overall Study||8
11406058|NCT03865446|12601266|FG000|NOT COMPLETED|Overall Study||0
11406059|NCT03865446|12601267|FG001|NOT COMPLETED|Overall Study||0
11406060|NCT03862027|12601273|FG000|STARTED|Overall Study||1
11406061|NCT03862027|12601273|FG000|COMPLETED|Overall Study||1
11406062|NCT03862027|12601273|FG000|NOT COMPLETED|Overall Study||0
11406063|NCT03859960|12601279|FG000|STARTED|Overall Study||14
11406064|NCT03859960|12601280|FG001|STARTED|Overall Study||19
11406065|NCT03859960|12601279|FG000|COMPLETED|Overall Study||14
11406066|NCT03859960|12601280|FG001|COMPLETED|Overall Study||19
11406067|NCT03859960|12601279|FG000|NOT COMPLETED|Overall Study||0
11406068|NCT03859960|12601280|FG001|NOT COMPLETED|Overall Study||0
11406069|NCT03868059|12601288|FG000|STARTED|Overall Study||138
11406070|NCT03868059|12601288|FG000|COMPLETED|Overall Study||126
11406071|NCT03868059|12601288|FG000|NOT COMPLETED|Overall Study||12
11406072|NCT03868254|12601294|FG000|STARTED|Overall Study||98
11406073|NCT03868254|12601295|FG001|STARTED|Overall Study||76
11406074|NCT03868254|12601294|FG000|COMPLETED|Overall Study||98
11406075|NCT03868254|12601295|FG001|COMPLETED|Overall Study||76
11406076|NCT03868254|12601294|FG000|NOT COMPLETED|Overall Study||0
11406077|NCT03868254|12601295|FG001|NOT COMPLETED|Overall Study||0
11406078|NCT03865407|12601303|FG000|STARTED|Overall Study||10
11406079|NCT03865407|12601304|FG001|STARTED|Overall Study||7
11406080|NCT03865407|12601303|FG000|COMPLETED|Overall Study||7
11406081|NCT03865407|12601304|FG001|COMPLETED|Overall Study||7
11406082|NCT03865407|12601303|FG000|NOT COMPLETED|Overall Study||3
11406083|NCT03865407|12601304|FG001|NOT COMPLETED|Overall Study||0
11406084|NCT03857230|12601312|FG000|STARTED|Period 1 (Primapur-Gonal-F)||12
11406085|NCT03857230|12601313|FG001|STARTED|Period 1 (Primapur-Gonal-F)||12
11406086|NCT03857230|12601312|FG000|COMPLETED|Period 1 (Primapur-Gonal-F)||12
11406087|NCT03857230|12601313|FG001|COMPLETED|Period 1 (Primapur-Gonal-F)||12
11406088|NCT03857230|12601312|FG000|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
11022395|NCT00809133|12200667|FG003|STARTED|Overall Study||3
11406089|NCT03857230|12601313|FG001|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
11406090|NCT03857230|12601312|FG000|STARTED|Period 2 (Gonal-F-Primapur)||12
11406091|NCT03857230|12601313|FG001|STARTED|Period 2 (Gonal-F-Primapur)||12
11406092|NCT03857230|12601312|FG000|COMPLETED|Period 2 (Gonal-F-Primapur)||12
11406093|NCT03857230|12601313|FG001|COMPLETED|Period 2 (Gonal-F-Primapur)||12
11406094|NCT03857230|12601312|FG000|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
11406095|NCT03857230|12601313|FG001|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
11406096|NCT03865329|12601319|FG000|STARTED|Overall Study||9
11406097|NCT03865329|12601319|FG000|COMPLETED|Overall Study||9
11406098|NCT03865329|12601319|FG000|NOT COMPLETED|Overall Study||0
11406099|NCT03864653|12601323|FG000|STARTED|Overall Study||39
11406100|NCT03864653|12601323|FG000|COMPLETED|Overall Study||38
11406101|NCT03864653|12601323|FG000|NOT COMPLETED|Overall Study||1
11406102|NCT03862482|12601330|FG000|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 1 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
11406103|NCT03862482|12601331|FG001|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 2 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
11406104|NCT03862482|12601332|FG002|STARTED|Overall Study|Six participants (thirty implant units) were randomly allocated to Configuration 3 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|6
11406105|NCT03862482|12601330|FG000|COMPLETED|Overall Study|Sixteen B, 16 SW, and eight SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, one implant unit (SW) had fractured and was subsequently excluded from all future analyses|8
11406106|NCT03862482|12601331|FG001|COMPLETED|Overall Study|Eight B, 16 SW, and 16 SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, two implant units (one B, one SW) were removed from all future analyses due to technical issues with radiographs|8
11406107|NCT03862482|12601332|FG002|COMPLETED|Overall Study|Twelve B, six SW, and 12 SC implant units were placed on a rotating basis at the five sites for a total of 30 implant units|6
11406108|NCT03862482|12601330|FG000|NOT COMPLETED|Overall Study||0
11406109|NCT03862482|12601331|FG001|NOT COMPLETED|Overall Study||0
11406110|NCT03862482|12601332|FG002|NOT COMPLETED|Overall Study||0
11406111|NCT03853213|12601340|FG000|STARTED|Overall Study||11
11406112|NCT03853213|12601341|FG001|STARTED|Overall Study||9
11406113|NCT03853213|12601340|FG000|COMPLETED|Overall Study||10
11406114|NCT03853213|12601341|FG001|COMPLETED|Overall Study||7
11406115|NCT03853213|12601340|FG000|NOT COMPLETED|Overall Study||1
11406116|NCT03853213|12601341|FG001|NOT COMPLETED|Overall Study||2
11406117|NCT03847610|12601347|FG000|STARTED|Overall Study||11
11406118|NCT03847610|12601347|FG000|COMPLETED|Overall Study||10
11406119|NCT03847610|12601347|FG000|NOT COMPLETED|Overall Study||1
11406120|NCT03850093|12601354|FG000|STARTED|Overall Study||22
11406121|NCT03850093|12601355|FG001|STARTED|Overall Study||22
11406122|NCT03850093|12601356|FG002|STARTED|Overall Study||19
11406123|NCT03850093|12601354|FG000|COMPLETED|Overall Study||21
11406124|NCT03850093|12601355|FG001|COMPLETED|Overall Study||22
11406125|NCT03850093|12601356|FG002|COMPLETED|Overall Study||17
11406126|NCT03850093|12601354|FG000|NOT COMPLETED|Overall Study||1
11406127|NCT03850093|12601355|FG001|NOT COMPLETED|Overall Study||0
11406128|NCT03850093|12601356|FG002|NOT COMPLETED|Overall Study||2
11406129|NCT03848208|12601374|FG000|STARTED|Overall Study||18
11406130|NCT03848208|12601375|FG001|STARTED|Overall Study||6
11406131|NCT03848208|12601376|FG002|STARTED|Overall Study||6
11406132|NCT03848208|12601377|FG003|STARTED|Overall Study||6
11406133|NCT03848208|12601378|FG004|STARTED|Overall Study||6
11406134|NCT03848208|12601379|FG005|STARTED|Overall Study||6
11406135|NCT03848208|12601380|FG006|STARTED|Overall Study||6
11406136|NCT03848208|12601381|FG007|STARTED|Overall Study||6
11406137|NCT03848208|12601382|FG008|STARTED|Overall Study||6
11406138|NCT03848208|12601383|FG009|STARTED|Overall Study||6
11406139|NCT03848208|12601374|FG000|COMPLETED|Overall Study||18
11406140|NCT03848208|12601375|FG001|COMPLETED|Overall Study||6
11406141|NCT03848208|12601376|FG002|COMPLETED|Overall Study||6
11406142|NCT03848208|12601377|FG003|COMPLETED|Overall Study||6
11406143|NCT03848208|12601378|FG004|COMPLETED|Overall Study||6
11406144|NCT03848208|12601379|FG005|COMPLETED|Overall Study||6
11406145|NCT03848208|12601380|FG006|COMPLETED|Overall Study||6
11406146|NCT03848208|12601381|FG007|COMPLETED|Overall Study||6
11406147|NCT03848208|12601382|FG008|COMPLETED|Overall Study||6
11406148|NCT03848208|12601383|FG009|COMPLETED|Overall Study||6
11406149|NCT03848208|12601374|FG000|NOT COMPLETED|Overall Study||0
11406150|NCT03848208|12601375|FG001|NOT COMPLETED|Overall Study||0
11406151|NCT03848208|12601376|FG002|NOT COMPLETED|Overall Study||0
11406152|NCT03848208|12601377|FG003|NOT COMPLETED|Overall Study||0
11406153|NCT03848208|12601378|FG004|NOT COMPLETED|Overall Study||0
11406154|NCT03848208|12601379|FG005|NOT COMPLETED|Overall Study||0
11406155|NCT03848208|12601380|FG006|NOT COMPLETED|Overall Study||0
11406156|NCT03848208|12601381|FG007|NOT COMPLETED|Overall Study||0
11406157|NCT03848208|12601382|FG008|NOT COMPLETED|Overall Study||0
11406158|NCT03848208|12601383|FG009|NOT COMPLETED|Overall Study||0
11406159|NCT03847389|12601417|FG000|STARTED|Overall Study||8
11406160|NCT03847389|12601418|FG001|STARTED|Overall Study|Start of Cohort 2 can only happen if less than or equal to 40% of subjects in Cohort 1 had HPA axis suppression.|0
11406161|NCT03847389|12601419|FG002|STARTED|Overall Study|Start of Cohort 3 can only happen if less than or equal to 40% of subjects in Cohort 2 had HPA axis suppression.|0
11406162|NCT03847389|12601417|FG000|COMPLETED|Overall Study||8
11406163|NCT03847389|12601418|FG001|COMPLETED|Overall Study||0
11406164|NCT03847389|12601419|FG002|COMPLETED|Overall Study||0
11406165|NCT03847389|12601417|FG000|NOT COMPLETED|Overall Study||0
11406166|NCT03847389|12601418|FG001|NOT COMPLETED|Overall Study||0
11406167|NCT03847389|12601419|FG002|NOT COMPLETED|Overall Study||0
11406168|NCT03862040|12601430|FG000|STARTED|Overall Study||7
11406169|NCT03862040|12601430|FG000|COMPLETED|Overall Study||7
11406170|NCT03862040|12601430|FG000|NOT COMPLETED|Overall Study||0
11406171|NCT03861936|12601437|FG000|STARTED|Overall Study||48
11406172|NCT03861936|12601438|FG001|STARTED|Overall Study||53
11406173|NCT03861936|12601439|FG002|STARTED|Overall Study||49
11406174|NCT03861936|12601437|FG000|COMPLETED|Overall Study||34
11406175|NCT03861936|12601438|FG001|COMPLETED|Overall Study||43
11406176|NCT03861936|12601439|FG002|COMPLETED|Overall Study||39
11406177|NCT03861936|12601437|FG000|NOT COMPLETED|Overall Study||14
11406178|NCT03861936|12601438|FG001|NOT COMPLETED|Overall Study||10
11406179|NCT03861936|12601439|FG002|NOT COMPLETED|Overall Study||10
11406180|NCT03859739|12601451|FG000|STARTED|Overall Study||5
11406181|NCT03859739|12601452|FG001|STARTED|Overall Study||6
11406182|NCT03859739|12601453|FG002|STARTED|Overall Study||6
11406183|NCT03859739|12601454|FG003|STARTED|Overall Study||4
11406184|NCT03859739|12601451|FG000|COMPLETED|Overall Study||5
11406185|NCT03859739|12601452|FG001|COMPLETED|Overall Study||6
11406186|NCT03859739|12601453|FG002|COMPLETED|Overall Study||6
11406187|NCT03859739|12601454|FG003|COMPLETED|Overall Study||4
11406188|NCT03859739|12601451|FG000|NOT COMPLETED|Overall Study||0
11406189|NCT03859739|12601452|FG001|NOT COMPLETED|Overall Study||0
11406190|NCT03859739|12601453|FG002|NOT COMPLETED|Overall Study||0
11406191|NCT03859739|12601454|FG003|NOT COMPLETED|Overall Study||0
11406192|NCT03857750|12601466|FG000|STARTED|Overall Study||16
11406193|NCT03857750|12601467|FG001|STARTED|Overall Study||16
11406194|NCT03857750|12601466|FG000|COMPLETED|Overall Study||16
11406195|NCT03857750|12601467|FG001|COMPLETED|Overall Study||16
11406196|NCT03857750|12601466|FG000|NOT COMPLETED|Overall Study||0
11406197|NCT03857750|12601467|FG001|NOT COMPLETED|Overall Study||0
11406198|NCT03856255|12601473|FG000|STARTED|Overall Study||23
11406199|NCT03856255|12601473|FG000|COMPLETED|Overall Study||23
11406200|NCT03856255|12601473|FG000|NOT COMPLETED|Overall Study||0
11406201|NCT03850509|12601479|FG000|STARTED|Overall Study||2
11406202|NCT03850509|12601480|FG001|STARTED|Overall Study||1
11406203|NCT03850509|12601479|FG000|COMPLETED|Overall Study||0
11406204|NCT03850509|12601480|FG001|COMPLETED|Overall Study||0
11406205|NCT03850509|12601479|FG000|NOT COMPLETED|Overall Study||2
11406206|NCT03850509|12601480|FG001|NOT COMPLETED|Overall Study||1
11406207|NCT03860753|12601488|FG000|STARTED|Overall Study||4
11406208|NCT03860753|12601489|FG001|STARTED|Overall Study||0
11406209|NCT03860753|12601488|FG000|COMPLETED|Overall Study||4
11406210|NCT03860753|12601489|FG001|COMPLETED|Overall Study||0
11406211|NCT03860753|12601488|FG000|NOT COMPLETED|Overall Study||0
11406212|NCT03860753|12601489|FG001|NOT COMPLETED|Overall Study||0
11406213|NCT03848455|12601498|FG000|STARTED|Overall Study||90
11406214|NCT03848455|12601499|FG001|STARTED|Overall Study||125
11406215|NCT03848455|12601500|FG002|STARTED|Overall Study||23
11406216|NCT03848455|12601498|FG000|COMPLETED|Overall Study||90
11406217|NCT03848455|12601499|FG001|COMPLETED|Overall Study||125
11406218|NCT03848455|12601500|FG002|COMPLETED|Overall Study||23
11406219|NCT03848455|12601498|FG000|NOT COMPLETED|Overall Study||0
11406220|NCT03848455|12601499|FG001|NOT COMPLETED|Overall Study||0
11406221|NCT03848455|12601500|FG002|NOT COMPLETED|Overall Study||0
11406222|NCT03858894|12601511|FG000|STARTED|Overall Study||48
11406223|NCT03858894|12601512|FG001|STARTED|Overall Study||50
11406224|NCT03858894|12601511|FG000|COMPLETED|Overall Study||44
11406225|NCT03858894|12601512|FG001|COMPLETED|Overall Study||50
11406226|NCT03858894|12601511|FG000|NOT COMPLETED|Overall Study||4
11406227|NCT03858894|12601512|FG001|NOT COMPLETED|Overall Study||0
11406228|NCT03856164|12601520|FG000|STARTED|Overall Study||55
11406229|NCT03856164|12601521|FG001|STARTED|Overall Study||55
11406230|NCT03856164|12601520|FG000|COMPLETED|Overall Study||55
11406231|NCT03856164|12601521|FG001|COMPLETED|Overall Study||55
11406232|NCT03856164|12601520|FG000|NOT COMPLETED|Overall Study||0
11406233|NCT03856164|12601521|FG001|NOT COMPLETED|Overall Study||0
11406234|NCT03850275|12601535|FG000|STARTED|Overall Study||5
11406235|NCT03850275|12601536|FG001|STARTED|Overall Study||5
11406236|NCT03850275|12601537|FG002|STARTED|Overall Study||5
11406237|NCT03850275|12601538|FG003|STARTED|Overall Study||5
11406238|NCT03850275|12601539|FG004|STARTED|Overall Study||5
11406239|NCT03850275|12601540|FG005|STARTED|Overall Study||5
11406240|NCT03850275|12601535|FG000|COMPLETED|Overall Study||5
11406241|NCT03850275|12601536|FG001|COMPLETED|Overall Study||5
11406242|NCT03850275|12601537|FG002|COMPLETED|Overall Study||5
11406243|NCT03850275|12601538|FG003|COMPLETED|Overall Study||5
11406244|NCT03850275|12601539|FG004|COMPLETED|Overall Study||5
11406245|NCT03850275|12601540|FG005|COMPLETED|Overall Study||5
11406246|NCT03850275|12601535|FG000|NOT COMPLETED|Overall Study||0
11406247|NCT03850275|12601536|FG001|NOT COMPLETED|Overall Study||0
11406248|NCT03850275|12601537|FG002|NOT COMPLETED|Overall Study||0
11406249|NCT03850275|12601538|FG003|NOT COMPLETED|Overall Study||0
11406250|NCT03850275|12601539|FG004|NOT COMPLETED|Overall Study||0
11406251|NCT03850275|12601540|FG005|NOT COMPLETED|Overall Study||0
11406252|NCT03851016|12601565|FG000|STARTED|First Intervention (3 Weeks)||12
11406253|NCT03851016|12601566|FG001|STARTED|First Intervention (3 Weeks)||12
11406254|NCT03851016|12601565|FG000|COMPLETED|First Intervention (3 Weeks)||11
11406255|NCT03851016|12601566|FG001|COMPLETED|First Intervention (3 Weeks)||10
11406256|NCT03851016|12601565|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
11406257|NCT03851016|12601566|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2
11406258|NCT03851016|12601565|FG000|STARTED|Washout (1 Week)||11
11406259|NCT03851016|12601566|FG001|STARTED|Washout (1 Week)||10
11406260|NCT03851016|12601565|FG000|COMPLETED|Washout (1 Week)||11
11406261|NCT03851016|12601566|FG001|COMPLETED|Washout (1 Week)||10
11406262|NCT03851016|12601565|FG000|NOT COMPLETED|Washout (1 Week)||0
11406263|NCT03851016|12601566|FG001|NOT COMPLETED|Washout (1 Week)||0
11406264|NCT03851016|12601565|FG000|STARTED|Second Intervention (3 Weeks)||11
11406265|NCT03851016|12601566|FG001|STARTED|Second Intervention (3 Weeks)||10
11406266|NCT03851016|12601565|FG000|COMPLETED|Second Intervention (3 Weeks)||11
11406267|NCT03851016|12601566|FG001|COMPLETED|Second Intervention (3 Weeks)||10
11406268|NCT03851016|12601565|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
11406269|NCT03851016|12601566|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
11406270|NCT03850496|12601575|FG000|STARTED|Overall Study||26
11406271|NCT03850496|12601576|FG001|STARTED|Overall Study||25
11406272|NCT03850496|12601577|FG002|STARTED|Overall Study||25
11406273|NCT03850496|12601575|FG000|COMPLETED|Overall Study||25
11406274|NCT03850496|12601576|FG001|COMPLETED|Overall Study||24
11406275|NCT03850496|12601577|FG002|COMPLETED|Overall Study||21
11406276|NCT03850496|12601575|FG000|NOT COMPLETED|Overall Study||1
11406277|NCT03850496|12601576|FG001|NOT COMPLETED|Overall Study||1
11406278|NCT03850496|12601577|FG002|NOT COMPLETED|Overall Study||4
11406279|NCT03848949|12601587|FG000|STARTED|Overall Study||54
11406280|NCT03848949|12601588|FG001|STARTED|Overall Study||53
11406281|NCT03848949|12601587|FG000|COMPLETED|Overall Study||49
11406282|NCT03848949|12601588|FG001|COMPLETED|Overall Study||46
11406283|NCT03848949|12601587|FG000|NOT COMPLETED|Overall Study||5
11406284|NCT03848949|12601588|FG001|NOT COMPLETED|Overall Study||7
11406285|NCT03849690|12601594|FG000|STARTED|Period 1 (3 Days)||12
11406286|NCT03849690|12601594|FG000|COMPLETED|Period 1 (3 Days)||12
11406287|NCT03849690|12601594|FG000|NOT COMPLETED|Period 1 (3 Days)||0
11406288|NCT03849690|12601594|FG000|STARTED|Washout Period (at Least 4 Days)||12
11406289|NCT03849690|12601594|FG000|COMPLETED|Washout Period (at Least 4 Days)||12
11406290|NCT03849690|12601594|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0
11406291|NCT03849690|12601594|FG000|STARTED|Period 2 (6 Days)||12
11406292|NCT03849690|12601594|FG000|COMPLETED|Period 2 (6 Days)||12
11406293|NCT03849690|12601594|FG000|NOT COMPLETED|Period 2 (6 Days)||0
11406294|NCT03845933|12601605|FG000|STARTED|Overall Study||131
11406295|NCT03845933|12601606|FG001|STARTED|Overall Study||131
11406296|NCT03845933|12601605|FG000|COMPLETED|Overall Study||131
11406297|NCT03845933|12601606|FG001|COMPLETED|Overall Study||131
11406298|NCT03845933|12601605|FG000|NOT COMPLETED|Overall Study||0
11406299|NCT03845933|12601606|FG001|NOT COMPLETED|Overall Study||0
11406300|NCT03844945|12601616|FG000|STARTED|Overall Study||55
11406301|NCT03844945|12601617|FG001|STARTED|Overall Study||54
11406302|NCT03844945|12601618|FG002|STARTED|Overall Study||51
11406303|NCT03844945|12601619|FG003|STARTED|Overall Study||55
11406304|NCT03844945|12601616|FG000|COMPLETED|Overall Study||54
11406305|NCT03844945|12601617|FG001|COMPLETED|Overall Study||53
11406306|NCT03844945|12601618|FG002|COMPLETED|Overall Study||46
11406307|NCT03844945|12601619|FG003|COMPLETED|Overall Study||54
11406308|NCT03844945|12601616|FG000|NOT COMPLETED|Overall Study||1
11406309|NCT03844945|12601617|FG001|NOT COMPLETED|Overall Study||1
11406310|NCT03844945|12601618|FG002|NOT COMPLETED|Overall Study||5
11406311|NCT03844945|12601619|FG003|NOT COMPLETED|Overall Study||1
11406312|NCT03844321|12601631|FG000|STARTED|Overall Study||2220
11406313|NCT03844321|12601632|FG001|STARTED|Overall Study||2192
11406314|NCT03844321|12601631|FG000|COMPLETED|Overall Study||579
11406315|NCT03844321|12601632|FG001|COMPLETED|Overall Study||533
11406316|NCT03844321|12601631|FG000|NOT COMPLETED|Overall Study||1641
11406317|NCT03844321|12601632|FG001|NOT COMPLETED|Overall Study||1659
11406318|NCT03843632|12601642|FG000|STARTED|Overall Study||50
11406319|NCT03843632|12601643|FG001|STARTED|Overall Study||30
11406320|NCT03843632|12601644|FG002|STARTED|Overall Study||33
11406321|NCT03843632|12601645|FG003|STARTED|Overall Study||37
11406322|NCT03843632|12601642|FG000|Vaccination 1|Overall Study||50
11406323|NCT03843632|12601643|FG001|Vaccination 1|Overall Study||30
11406324|NCT03843632|12601644|FG002|Vaccination 1|Overall Study||33
11406325|NCT03843632|12601645|FG003|Vaccination 1|Overall Study||37
11406326|NCT03843632|12601642|FG000|Vaccination 2|Overall Study||49
11406327|NCT03843632|12601643|FG001|Vaccination 2|Overall Study||30
11406328|NCT03843632|12601644|FG002|Vaccination 2|Overall Study||0
11406329|NCT03843632|12601645|FG003|Vaccination 2|Overall Study||0
11406330|NCT03843632|12601642|FG000|COMPLETED|Overall Study||49
11406331|NCT03843632|12601643|FG001|COMPLETED|Overall Study||30
11406332|NCT03843632|12601644|FG002|COMPLETED|Overall Study||33
11406333|NCT03843632|12601645|FG003|COMPLETED|Overall Study||37
11406334|NCT03843632|12601642|FG000|NOT COMPLETED|Overall Study||1
11406335|NCT03843632|12601643|FG001|NOT COMPLETED|Overall Study||0
11406336|NCT03843632|12601644|FG002|NOT COMPLETED|Overall Study||0
11406337|NCT03843632|12601645|FG003|NOT COMPLETED|Overall Study||0
11406338|NCT03840811|12601658|FG000|STARTED|Overall Study||9
11406339|NCT03840811|12601659|FG001|STARTED|Overall Study||6
11406340|NCT03840811|12601660|FG002|STARTED|Overall Study||12
11406341|NCT03840811|12601658|FG000|COMPLETED|Overall Study||9
11406342|NCT03840811|12601659|FG001|COMPLETED|Overall Study||6
11406343|NCT03840811|12601660|FG002|COMPLETED|Overall Study||11
11406344|NCT03840811|12601658|FG000|NOT COMPLETED|Overall Study||0
11406345|NCT03840811|12601659|FG001|NOT COMPLETED|Overall Study||0
11144063|NCT01475461|12330686|FG006|COMPLETED|Treatment Period||53
11144064|NCT01475461|12330680|FG000|NOT COMPLETED|Treatment Period||0
11144065|NCT01475461|12330681|FG001|NOT COMPLETED|Treatment Period||9
11144066|NCT01475461|12330682|FG002|NOT COMPLETED|Treatment Period||4
11144067|NCT01475461|12330683|FG003|NOT COMPLETED|Treatment Period||8
11144068|NCT01475461|12330684|FG004|NOT COMPLETED|Treatment Period||4
11144069|NCT01475461|12330685|FG005|NOT COMPLETED|Treatment Period||5
11144070|NCT01475461|12330686|FG006|NOT COMPLETED|Treatment Period||2
11144071|NCT01475474|12330719|FG000|STARTED|Baseline Period - 4 Weeks||97
11144072|NCT01475474|12330719|FG000|COMPLETED|Baseline Period - 4 Weeks||91
11144073|NCT01475474|12330719|FG000|NOT COMPLETED|Baseline Period - 4 Weeks||6
11144074|NCT01475474|12330719|FG000|STARTED|Treatment Period - 12 Weeks||91
11144075|NCT01475474|12330719|FG000|COMPLETED|Treatment Period - 12 Weeks||73
11144076|NCT01475474|12330719|FG000|NOT COMPLETED|Treatment Period - 12 Weeks||18
11406346|NCT03840811|12601660|FG002|NOT COMPLETED|Overall Study||1
11406347|NCT03837028|12601672|FG000|STARTED|Overall Study||35
11406348|NCT03837028|12601673|FG001|STARTED|Overall Study||34
11406349|NCT03837028|12601674|FG002|STARTED|Overall Study||33
11406350|NCT03837028|12601675|FG003|STARTED|Overall Study||25
11406351|NCT03837028|12601672|FG000|COMPLETED|Overall Study||19
11406352|NCT03837028|12601673|FG001|COMPLETED|Overall Study||23
11406353|NCT03837028|12601674|FG002|COMPLETED|Overall Study||20
11406354|NCT03837028|12601675|FG003|COMPLETED|Overall Study||18
11406355|NCT03837028|12601672|FG000|NOT COMPLETED|Overall Study||16
11406356|NCT03837028|12601673|FG001|NOT COMPLETED|Overall Study||11
11406357|NCT03837028|12601674|FG002|NOT COMPLETED|Overall Study||13
11406358|NCT03837028|12601675|FG003|NOT COMPLETED|Overall Study||7
11406359|NCT03825939|12601688|FG000|STARTED|Overall Study||18
11406360|NCT03825939|12601689|FG001|STARTED|Overall Study||20
11406361|NCT03825939|12601690|FG002|STARTED|Overall Study||14
11406362|NCT03825939|12601688|FG000|COMPLETED|Overall Study||18
11406363|NCT03825939|12601689|FG001|COMPLETED|Overall Study||20
11406364|NCT03825939|12601690|FG002|COMPLETED|Overall Study||14
11406365|NCT03825939|12601688|FG000|NOT COMPLETED|Overall Study||0
11406366|NCT03825939|12601689|FG001|NOT COMPLETED|Overall Study||0
11406367|NCT03825939|12601690|FG002|NOT COMPLETED|Overall Study||0
11406368|NCT03817775|12601700|FG000|STARTED|Overall Study||22
11406369|NCT03817775|12601701|FG001|STARTED|Overall Study||54
11406370|NCT03817775|12601700|FG000|COMPLETED|Overall Study||22
11406371|NCT03817775|12601701|FG001|COMPLETED|Overall Study||54
11406372|NCT03817775|12601700|FG000|NOT COMPLETED|Overall Study||0
11406373|NCT03817775|12601701|FG001|NOT COMPLETED|Overall Study||0
11406374|NCT03843372|12601709|FG000|STARTED|Overall Study||14
11406375|NCT03843372|12601710|FG001|STARTED|Overall Study||18
11406376|NCT03843372|12601709|FG000|COMPLETED|Overall Study||12
11406377|NCT03843372|12601710|FG001|COMPLETED|Overall Study||16
11406378|NCT03843372|12601709|FG000|NOT COMPLETED|Overall Study||2
11406379|NCT03843372|12601710|FG001|NOT COMPLETED|Overall Study||2
11406380|NCT03841331|12601718|FG000|STARTED|Overall Study||117
11406381|NCT03841331|12601719|FG001|STARTED|Overall Study||116
11406382|NCT03841331|12601718|FG000|COMPLETED|Overall Study||108
11406383|NCT03841331|12601719|FG001|COMPLETED|Overall Study||106
11406384|NCT03841331|12601718|FG000|NOT COMPLETED|Overall Study||9
11406385|NCT03841331|12601719|FG001|NOT COMPLETED|Overall Study||10
11406386|NCT03840278|12601725|FG000|STARTED|Overall Study||5
11406387|NCT03840278|12601726|FG001|STARTED|Overall Study||5
11406388|NCT03840278|12601725|FG000|COMPLETED|Overall Study||5
11406389|NCT03840278|12601726|FG001|COMPLETED|Overall Study||5
11406390|NCT03840278|12601725|FG000|NOT COMPLETED|Overall Study||0
11406391|NCT03840278|12601726|FG001|NOT COMPLETED|Overall Study||0
11406392|NCT03840135|12601734|FG000|STARTED|Overall Study||86
11406393|NCT03840135|12601735|FG001|STARTED|Overall Study||86
11406394|NCT03840135|12601734|FG000|COMPLETED|Overall Study||79
11406395|NCT03840135|12601735|FG001|COMPLETED|Overall Study||85
11406396|NCT03840135|12601734|FG000|NOT COMPLETED|Overall Study||7
11406397|NCT03840135|12601735|FG001|NOT COMPLETED|Overall Study||1
11406398|NCT03839641|12601747|FG000|STARTED|Overall Study||5
11406399|NCT03839641|12601748|FG001|STARTED|Overall Study||5
11406400|NCT03839641|12601747|FG000|COMPLETED|Overall Study||4
11406401|NCT03839641|12601748|FG001|COMPLETED|Overall Study||4
11406402|NCT03839641|12601747|FG000|NOT COMPLETED|Overall Study||1
11406403|NCT03839641|12601748|FG001|NOT COMPLETED|Overall Study||1
11406404|NCT03839212|12601756|FG000|STARTED|Overall Study||18
11406405|NCT03839212|12601756|FG000|COMPLETED|Overall Study||14
11406406|NCT03839212|12601756|FG000|NOT COMPLETED|Overall Study||4
11406407|NCT03839355|12601762|FG000|STARTED|Overall Study||18
11406408|NCT03839355|12601763|FG001|STARTED|Overall Study||16
11406409|NCT03839355|12601762|FG000|COMPLETED|Overall Study||17
11406410|NCT03839355|12601763|FG001|COMPLETED|Overall Study||16
11406411|NCT03839355|12601762|FG000|NOT COMPLETED|Overall Study||1
11406412|NCT03839355|12601763|FG001|NOT COMPLETED|Overall Study||0
11406413|NCT03838874|12601771|FG000|STARTED|Overall Study||80
11406414|NCT03838874|12601772|FG001|STARTED|Overall Study||74
11406415|NCT03838874|12601771|FG000|COMPLETED|Overall Study||80
11406416|NCT03838874|12601772|FG001|COMPLETED|Overall Study||74
11406417|NCT03838874|12601771|FG000|NOT COMPLETED|Overall Study||0
11406418|NCT03838874|12601772|FG001|NOT COMPLETED|Overall Study||0
11406419|NCT03838731|12601780|FG000|STARTED|Overall Study||27
11406420|NCT03838731|12601781|FG001|STARTED|Overall Study||29
11406421|NCT03838731|12601780|FG000|COMPLETED|Overall Study||26
11406422|NCT03838731|12601781|FG001|COMPLETED|Overall Study||28
11406423|NCT03838731|12601780|FG000|NOT COMPLETED|Overall Study||1
11406424|NCT03838731|12601781|FG001|NOT COMPLETED|Overall Study||1
11406425|NCT03838198|12601789|FG000|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
11406426|NCT03838198|12601790|FG001|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
11406427|NCT03838198|12601791|FG002|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
11406428|NCT03838198|12601792|FG003|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
11406429|NCT03838198|12601789|FG000|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
11406430|NCT03838198|12601790|FG001|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
11406431|NCT03838198|12601791|FG002|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
11406432|NCT03838198|12601792|FG003|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
11406433|NCT03838198|12601789|FG000|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
11406434|NCT03838198|12601790|FG001|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
11406435|NCT03838198|12601791|FG002|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
11406436|NCT03838198|12601792|FG003|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
11406437|NCT03838198|12601789|FG000|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with added booster call.|18
11406438|NCT03838198|12601790|FG001|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with no added booster call.|22
11406439|NCT03838198|12601791|FG002|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with added booster call.|18
11406440|NCT03838198|12601792|FG003|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with no added booster call in Phase 2|22
11406441|NCT03838198|12601789|FG000|COMPLETED|Phase 2: Added Booster Call or Not|All 18 completed the safety plan; but only 14 had both parent and adolescent completing the call; 1 had parent only; 1 had adolescent only; 2 were unable to be reached.|18
11406442|NCT03838198|12601790|FG001|COMPLETED|Phase 2: Added Booster Call or Not||0
11406443|NCT03838198|12601791|FG002|COMPLETED|Phase 2: Added Booster Call or Not|Of the 17 who completed the safety plan, only 15 had both parent and adolescent completing the call; 1 had parent only; 1 was unable to be reached.|17
11406444|NCT03838198|12601792|FG003|COMPLETED|Phase 2: Added Booster Call or Not||0
11406445|NCT03838198|12601789|FG000|NOT COMPLETED|Phase 2: Added Booster Call or Not||0
11406446|NCT03838198|12601790|FG001|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
11406447|NCT03838198|12601791|FG002|NOT COMPLETED|Phase 2: Added Booster Call or Not||1
11406448|NCT03838198|12601792|FG003|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
11406449|NCT03838198|12601789|FG000|STARTED|1 Month Follow up Period||18
11406450|NCT03838198|12601790|FG001|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
11406451|NCT03838198|12601791|FG002|STARTED|1 Month Follow up Period||17
11406452|NCT03838198|12601792|FG003|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
11406453|NCT03838198|12601789|FG000|Adolescent Surveys Completed|1 Month Follow up Period||16
11406454|NCT03838198|12601790|FG001|Adolescent Surveys Completed|1 Month Follow up Period||22
11406455|NCT03838198|12601791|FG002|Adolescent Surveys Completed|1 Month Follow up Period||16
11406456|NCT03838198|12601792|FG003|Adolescent Surveys Completed|1 Month Follow up Period||22
11406457|NCT03838198|12601789|FG000|COMPLETED|1 Month Follow up Period||16
11406458|NCT03838198|12601790|FG001|COMPLETED|1 Month Follow up Period||22
11406459|NCT03838198|12601791|FG002|COMPLETED|1 Month Follow up Period||16
11406460|NCT03838198|12601792|FG003|COMPLETED|1 Month Follow up Period||21
11406461|NCT03838198|12601789|FG000|NOT COMPLETED|1 Month Follow up Period||2
11406462|NCT03838198|12601790|FG001|NOT COMPLETED|1 Month Follow up Period||0
11406463|NCT03838198|12601791|FG002|NOT COMPLETED|1 Month Follow up Period||1
11406464|NCT03838198|12601792|FG003|NOT COMPLETED|1 Month Follow up Period||1
11406465|NCT03838198|12601789|FG000|STARTED|3 Month Follow up Period||18
11406466|NCT03838198|12601790|FG001|STARTED|3 Month Follow up Period||22
11406467|NCT03838198|12601791|FG002|STARTED|3 Month Follow up Period||17
11406468|NCT03838198|12601792|FG003|STARTED|3 Month Follow up Period||22
11406469|NCT03838198|12601789|FG000|Adolescent Survey Completed|3 Month Follow up Period||16
11406470|NCT03838198|12601790|FG001|Adolescent Survey Completed|3 Month Follow up Period||21
11406471|NCT03838198|12601791|FG002|Adolescent Survey Completed|3 Month Follow up Period||15
11406472|NCT03838198|12601792|FG003|Adolescent Survey Completed|3 Month Follow up Period||21
11406473|NCT03838198|12601789|FG000|COMPLETED|3 Month Follow up Period||15
11406474|NCT03838198|12601790|FG001|COMPLETED|3 Month Follow up Period||19
11406475|NCT03838198|12601791|FG002|COMPLETED|3 Month Follow up Period||14
11406476|NCT03838198|12601792|FG003|COMPLETED|3 Month Follow up Period||18
11406477|NCT03838198|12601789|FG000|NOT COMPLETED|3 Month Follow up Period||3
11406478|NCT03838198|12601790|FG001|NOT COMPLETED|3 Month Follow up Period||3
11406479|NCT03838198|12601791|FG002|NOT COMPLETED|3 Month Follow up Period||3
11406480|NCT03838198|12601792|FG003|NOT COMPLETED|3 Month Follow up Period||4
11406481|NCT03831451|12601805|FG000|STARTED|Overall Study||74
11406482|NCT03831451|12601806|FG001|STARTED|Overall Study||55
11406483|NCT03831451|12601805|FG000|COMPLETED|Overall Study||74
11406484|NCT03831451|12601806|FG001|COMPLETED|Overall Study||55
11406485|NCT03831451|12601805|FG000|NOT COMPLETED|Overall Study||0
11406486|NCT03831451|12601806|FG001|NOT COMPLETED|Overall Study||0
11406487|NCT03822078|12601818|FG000|STARTED|Overall Study||12
11406488|NCT03822078|12601819|FG001|STARTED|Overall Study||6
11406489|NCT03822078|12601820|FG002|STARTED|Overall Study||6
11406490|NCT03822078|12601821|FG003|STARTED|Overall Study||8
11406491|NCT03822078|12601822|FG004|STARTED|Overall Study||7
11406492|NCT03822078|12601823|FG005|STARTED|Overall Study||6
11406493|NCT03822078|12601818|FG000|Received Study Drug|Overall Study||10
11406494|NCT03822078|12601819|FG001|Received Study Drug|Overall Study||6
11406495|NCT03822078|12601820|FG002|Received Study Drug|Overall Study||6
11406496|NCT03822078|12601821|FG003|Received Study Drug|Overall Study||6
11406497|NCT03822078|12601822|FG004|Received Study Drug|Overall Study||6
11406498|NCT03822078|12601823|FG005|Received Study Drug|Overall Study||6
11406499|NCT03822078|12601818|FG000|COMPLETED|Overall Study||10
11406500|NCT03822078|12601819|FG001|COMPLETED|Overall Study||6
11406501|NCT03822078|12601820|FG002|COMPLETED|Overall Study||6
11406502|NCT03822078|12601821|FG003|COMPLETED|Overall Study||6
11406503|NCT03822078|12601822|FG004|COMPLETED|Overall Study||6
11406504|NCT03822078|12601823|FG005|COMPLETED|Overall Study||6
11406505|NCT03822078|12601818|FG000|NOT COMPLETED|Overall Study||2
11406506|NCT03822078|12601819|FG001|NOT COMPLETED|Overall Study||0
11406507|NCT03822078|12601820|FG002|NOT COMPLETED|Overall Study||0
11406508|NCT03822078|12601821|FG003|NOT COMPLETED|Overall Study||2
11406509|NCT03822078|12601822|FG004|NOT COMPLETED|Overall Study||1
11406510|NCT03822078|12601823|FG005|NOT COMPLETED|Overall Study||0
11406511|NCT03815240|12601843|FG000|STARTED|Intervention no Dressing||2
11406512|NCT03815240|12601844|FG001|STARTED|Intervention no Dressing||1
11406513|NCT03815240|12601845|FG002|STARTED|Intervention no Dressing||1
11406514|NCT03815240|12601846|FG003|STARTED|Intervention no Dressing||2
11406515|NCT03815240|12601847|FG004|STARTED|Intervention no Dressing||1
11406516|NCT03815240|12601848|FG005|STARTED|Intervention no Dressing||2
11406517|NCT03815240|12601849|FG006|STARTED|Intervention no Dressing||1
11406518|NCT03815240|12601850|FG007|STARTED|Intervention no Dressing||1
11406519|NCT03815240|12601851|FG008|STARTED|Intervention no Dressing||1
11406520|NCT03815240|12601843|FG000|COMPLETED|Intervention no Dressing||2
11406521|NCT03815240|12601844|FG001|COMPLETED|Intervention no Dressing||1
11406522|NCT03815240|12601845|FG002|COMPLETED|Intervention no Dressing||1
11406523|NCT03815240|12601846|FG003|COMPLETED|Intervention no Dressing||2
11406524|NCT03815240|12601847|FG004|COMPLETED|Intervention no Dressing||1
11406525|NCT03815240|12601848|FG005|COMPLETED|Intervention no Dressing||2
11406526|NCT03815240|12601849|FG006|COMPLETED|Intervention no Dressing||1
11406527|NCT03815240|12601850|FG007|COMPLETED|Intervention no Dressing||1
11406528|NCT03815240|12601851|FG008|COMPLETED|Intervention no Dressing||1
11406529|NCT03815240|12601843|FG000|NOT COMPLETED|Intervention no Dressing||0
11406530|NCT03815240|12601844|FG001|NOT COMPLETED|Intervention no Dressing||0
11406531|NCT03815240|12601845|FG002|NOT COMPLETED|Intervention no Dressing||0
11406532|NCT03815240|12601846|FG003|NOT COMPLETED|Intervention no Dressing||0
11406533|NCT03815240|12601847|FG004|NOT COMPLETED|Intervention no Dressing||0
11406534|NCT03815240|12601848|FG005|NOT COMPLETED|Intervention no Dressing||0
11406535|NCT03815240|12601849|FG006|NOT COMPLETED|Intervention no Dressing||0
11406536|NCT03815240|12601850|FG007|NOT COMPLETED|Intervention no Dressing||0
11406537|NCT03815240|12601851|FG008|NOT COMPLETED|Intervention no Dressing||0
11406538|NCT03815240|12601843|FG000|STARTED|Intervention Mepilex Dressing||2
11406539|NCT03815240|12601844|FG001|STARTED|Intervention Mepilex Dressing||1
11406540|NCT03815240|12601845|FG002|STARTED|Intervention Mepilex Dressing||1
11406541|NCT03815240|12601846|FG003|STARTED|Intervention Mepilex Dressing||2
11406542|NCT03815240|12601847|FG004|STARTED|Intervention Mepilex Dressing||1
11406543|NCT03815240|12601848|FG005|STARTED|Intervention Mepilex Dressing||2
11406544|NCT03815240|12601849|FG006|STARTED|Intervention Mepilex Dressing||1
11406545|NCT03815240|12601850|FG007|STARTED|Intervention Mepilex Dressing||1
11406546|NCT03815240|12601851|FG008|STARTED|Intervention Mepilex Dressing||1
11406547|NCT03815240|12601843|FG000|COMPLETED|Intervention Mepilex Dressing||2
11406548|NCT03815240|12601844|FG001|COMPLETED|Intervention Mepilex Dressing||1
11406549|NCT03815240|12601845|FG002|COMPLETED|Intervention Mepilex Dressing||1
11406550|NCT03815240|12601846|FG003|COMPLETED|Intervention Mepilex Dressing||2
11406551|NCT03815240|12601847|FG004|COMPLETED|Intervention Mepilex Dressing||1
11406552|NCT03815240|12601848|FG005|COMPLETED|Intervention Mepilex Dressing||2
11406553|NCT03815240|12601849|FG006|COMPLETED|Intervention Mepilex Dressing||1
11406554|NCT03815240|12601850|FG007|COMPLETED|Intervention Mepilex Dressing||1
11406555|NCT03815240|12601851|FG008|COMPLETED|Intervention Mepilex Dressing||1
11406556|NCT03815240|12601843|FG000|NOT COMPLETED|Intervention Mepilex Dressing||0
11406557|NCT03815240|12601844|FG001|NOT COMPLETED|Intervention Mepilex Dressing||0
11406558|NCT03815240|12601845|FG002|NOT COMPLETED|Intervention Mepilex Dressing||0
11406559|NCT03815240|12601846|FG003|NOT COMPLETED|Intervention Mepilex Dressing||0
11406560|NCT03815240|12601847|FG004|NOT COMPLETED|Intervention Mepilex Dressing||0
11406561|NCT03815240|12601848|FG005|NOT COMPLETED|Intervention Mepilex Dressing||0
11406562|NCT03815240|12601849|FG006|NOT COMPLETED|Intervention Mepilex Dressing||0
11406563|NCT03815240|12601850|FG007|NOT COMPLETED|Intervention Mepilex Dressing||0
11406564|NCT03815240|12601851|FG008|NOT COMPLETED|Intervention Mepilex Dressing||0
11406565|NCT03815240|12601843|FG000|STARTED|Intervention Allevyn Dressing||2
11406566|NCT03815240|12601844|FG001|STARTED|Intervention Allevyn Dressing||1
11406567|NCT03815240|12601845|FG002|STARTED|Intervention Allevyn Dressing||1
11406568|NCT03815240|12601846|FG003|STARTED|Intervention Allevyn Dressing||2
11406569|NCT03815240|12601847|FG004|STARTED|Intervention Allevyn Dressing||1
11406570|NCT03815240|12601848|FG005|STARTED|Intervention Allevyn Dressing||2
11406571|NCT03815240|12601849|FG006|STARTED|Intervention Allevyn Dressing||1
11406572|NCT03815240|12601850|FG007|STARTED|Intervention Allevyn Dressing||1
11406573|NCT03815240|12601851|FG008|STARTED|Intervention Allevyn Dressing||1
11406574|NCT03815240|12601843|FG000|COMPLETED|Intervention Allevyn Dressing||2
11406575|NCT03815240|12601844|FG001|COMPLETED|Intervention Allevyn Dressing||1
11406576|NCT03815240|12601845|FG002|COMPLETED|Intervention Allevyn Dressing||1
11406577|NCT03815240|12601846|FG003|COMPLETED|Intervention Allevyn Dressing||2
11406578|NCT03815240|12601847|FG004|COMPLETED|Intervention Allevyn Dressing||1
11406579|NCT03815240|12601848|FG005|COMPLETED|Intervention Allevyn Dressing||2
11406580|NCT03815240|12601849|FG006|COMPLETED|Intervention Allevyn Dressing||1
11406581|NCT03815240|12601850|FG007|COMPLETED|Intervention Allevyn Dressing||1
11406582|NCT03815240|12601851|FG008|COMPLETED|Intervention Allevyn Dressing||1
11406583|NCT03815240|12601843|FG000|NOT COMPLETED|Intervention Allevyn Dressing||0
11406584|NCT03815240|12601844|FG001|NOT COMPLETED|Intervention Allevyn Dressing||0
11406585|NCT03815240|12601845|FG002|NOT COMPLETED|Intervention Allevyn Dressing||0
11406586|NCT03815240|12601846|FG003|NOT COMPLETED|Intervention Allevyn Dressing||0
11406587|NCT03815240|12601847|FG004|NOT COMPLETED|Intervention Allevyn Dressing||0
11406588|NCT03815240|12601848|FG005|NOT COMPLETED|Intervention Allevyn Dressing||0
11406589|NCT03815240|12601849|FG006|NOT COMPLETED|Intervention Allevyn Dressing||0
11406590|NCT03815240|12601850|FG007|NOT COMPLETED|Intervention Allevyn Dressing||0
11406591|NCT03815240|12601851|FG008|NOT COMPLETED|Intervention Allevyn Dressing||0
11406592|NCT03815240|12601843|FG000|STARTED|Intervention Optifoam Dressing||2
11406593|NCT03815240|12601844|FG001|STARTED|Intervention Optifoam Dressing||1
11406594|NCT03815240|12601845|FG002|STARTED|Intervention Optifoam Dressing||1
11406595|NCT03815240|12601846|FG003|STARTED|Intervention Optifoam Dressing||2
11406596|NCT03815240|12601847|FG004|STARTED|Intervention Optifoam Dressing||1
11406597|NCT03815240|12601848|FG005|STARTED|Intervention Optifoam Dressing||2
11406598|NCT03815240|12601849|FG006|STARTED|Intervention Optifoam Dressing||1
11406599|NCT03815240|12601850|FG007|STARTED|Intervention Optifoam Dressing||1
11406600|NCT03815240|12601851|FG008|STARTED|Intervention Optifoam Dressing||1
11406601|NCT03815240|12601843|FG000|COMPLETED|Intervention Optifoam Dressing||2
11406602|NCT03815240|12601844|FG001|COMPLETED|Intervention Optifoam Dressing||1
11406603|NCT03815240|12601845|FG002|COMPLETED|Intervention Optifoam Dressing||1
11406604|NCT03815240|12601846|FG003|COMPLETED|Intervention Optifoam Dressing||2
11406605|NCT03815240|12601847|FG004|COMPLETED|Intervention Optifoam Dressing||1
11406606|NCT03815240|12601848|FG005|COMPLETED|Intervention Optifoam Dressing||2
11406607|NCT03815240|12601849|FG006|COMPLETED|Intervention Optifoam Dressing||1
11406608|NCT03815240|12601850|FG007|COMPLETED|Intervention Optifoam Dressing||1
11406609|NCT03815240|12601851|FG008|COMPLETED|Intervention Optifoam Dressing||1
11406610|NCT03815240|12601843|FG000|NOT COMPLETED|Intervention Optifoam Dressing||0
11406611|NCT03815240|12601844|FG001|NOT COMPLETED|Intervention Optifoam Dressing||0
11406612|NCT03815240|12601845|FG002|NOT COMPLETED|Intervention Optifoam Dressing||0
11406613|NCT03815240|12601846|FG003|NOT COMPLETED|Intervention Optifoam Dressing||0
11406614|NCT03815240|12601847|FG004|NOT COMPLETED|Intervention Optifoam Dressing||0
11406615|NCT03815240|12601848|FG005|NOT COMPLETED|Intervention Optifoam Dressing||0
11406616|NCT03815240|12601849|FG006|NOT COMPLETED|Intervention Optifoam Dressing||0
11406617|NCT03815240|12601850|FG007|NOT COMPLETED|Intervention Optifoam Dressing||0
11406618|NCT03815240|12601851|FG008|NOT COMPLETED|Intervention Optifoam Dressing||0
11406619|NCT03836859|12601869|FG000|STARTED|Overall Study||20
11406620|NCT03836859|12601870|FG001|STARTED|Overall Study||10
11406621|NCT03836859|12601869|FG000|COMPLETED|Overall Study||20
11406622|NCT03836859|12601870|FG001|COMPLETED|Overall Study||10
11406623|NCT03836859|12601869|FG000|NOT COMPLETED|Overall Study||0
11406624|NCT03836859|12601870|FG001|NOT COMPLETED|Overall Study||0
11406625|NCT03835078|12601876|FG000|STARTED|Overall Study||39
11406626|NCT03835078|12601876|FG000|COMPLETED|Overall Study||39
11406627|NCT03835078|12601876|FG000|NOT COMPLETED|Overall Study||0
11406628|NCT03834025|12601889|FG000|STARTED|Sent Recruitment Letter (Phase 1)||4150
11406629|NCT03834025|12601890|FG001|STARTED|Sent Recruitment Letter (Phase 1)||3871
11406630|NCT03834025|12601891|FG002|STARTED|Sent Recruitment Letter (Phase 1)||4121
11406631|NCT03834025|12601892|FG003|STARTED|Sent Recruitment Letter (Phase 1)||3693
11406632|NCT03834025|12601893|FG004|STARTED|Sent Recruitment Letter (Phase 1)||0
11406633|NCT03834025|12601894|FG005|STARTED|Sent Recruitment Letter (Phase 1)||0
11406634|NCT03834025|12601895|FG006|STARTED|Sent Recruitment Letter (Phase 1)||0
11406635|NCT03834025|12601889|FG000|Sent Letter|Sent Recruitment Letter (Phase 1)||4150
11406636|NCT03834025|12601890|FG001|Sent Letter|Sent Recruitment Letter (Phase 1)||3871
11406637|NCT03834025|12601891|FG002|Sent Letter|Sent Recruitment Letter (Phase 1)||4121
11406638|NCT03834025|12601892|FG003|Sent Letter|Sent Recruitment Letter (Phase 1)||3693
11406639|NCT03834025|12601893|FG004|Sent Letter|Sent Recruitment Letter (Phase 1)||0
11406640|NCT03834025|12601894|FG005|Sent Letter|Sent Recruitment Letter (Phase 1)||0
11406641|NCT03834025|12601895|FG006|Sent Letter|Sent Recruitment Letter (Phase 1)||0
11406642|NCT03834025|12601889|FG000|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
11406643|NCT03834025|12601890|FG001|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
11406644|NCT03834025|12601891|FG002|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
11406645|NCT03834025|12601892|FG003|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
11406646|NCT03834025|12601893|FG004|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
11406647|NCT03834025|12601894|FG005|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
11406648|NCT03834025|12601895|FG006|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
11406649|NCT03834025|12601889|FG000|COMPLETED|Sent Recruitment Letter (Phase 1)||36
11406650|NCT03834025|12601890|FG001|COMPLETED|Sent Recruitment Letter (Phase 1)||36
11406651|NCT03834025|12601891|FG002|COMPLETED|Sent Recruitment Letter (Phase 1)||44
11406652|NCT03834025|12601892|FG003|COMPLETED|Sent Recruitment Letter (Phase 1)||44
11406653|NCT03834025|12601893|FG004|COMPLETED|Sent Recruitment Letter (Phase 1)||0
11406654|NCT03834025|12601894|FG005|COMPLETED|Sent Recruitment Letter (Phase 1)||0
11406655|NCT03834025|12601895|FG006|COMPLETED|Sent Recruitment Letter (Phase 1)||0
11406656|NCT03834025|12601889|FG000|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4114
11406657|NCT03834025|12601890|FG001|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3835
11406658|NCT03834025|12601891|FG002|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4077
11406659|NCT03834025|12601892|FG003|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3649
11406660|NCT03834025|12601893|FG004|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
11406661|NCT03834025|12601894|FG005|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
11406662|NCT03834025|12601895|FG006|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
11406663|NCT03834025|12601889|FG000|STARTED|Randomized to Payment Condition(Phase 2)||0
11406664|NCT03834025|12601890|FG001|STARTED|Randomized to Payment Condition(Phase 2)||0
11406665|NCT03834025|12601891|FG002|STARTED|Randomized to Payment Condition(Phase 2)||0
11406666|NCT03834025|12601892|FG003|STARTED|Randomized to Payment Condition(Phase 2)||0
11406667|NCT03834025|12601893|FG004|STARTED|Randomized to Payment Condition(Phase 2)||24
11406668|NCT03834025|12601894|FG005|STARTED|Randomized to Payment Condition(Phase 2)||21
11406669|NCT03834025|12601895|FG006|STARTED|Randomized to Payment Condition(Phase 2)||28
11406670|NCT03834025|12601889|FG000|COMPLETED|Randomized to Payment Condition(Phase 2)||0
11406671|NCT03834025|12601890|FG001|COMPLETED|Randomized to Payment Condition(Phase 2)||0
11406672|NCT03834025|12601891|FG002|COMPLETED|Randomized to Payment Condition(Phase 2)||0
11406673|NCT03834025|12601892|FG003|COMPLETED|Randomized to Payment Condition(Phase 2)||0
11406674|NCT03834025|12601893|FG004|COMPLETED|Randomized to Payment Condition(Phase 2)||24
11406675|NCT03834025|12601894|FG005|COMPLETED|Randomized to Payment Condition(Phase 2)||21
11406676|NCT03834025|12601895|FG006|COMPLETED|Randomized to Payment Condition(Phase 2)||27
11406677|NCT03834025|12601889|FG000|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
11406678|NCT03834025|12601890|FG001|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
11406679|NCT03834025|12601891|FG002|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
11406680|NCT03834025|12601892|FG003|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
11406681|NCT03834025|12601893|FG004|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
11406682|NCT03834025|12601894|FG005|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
11406683|NCT03834025|12601895|FG006|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||1
11406684|NCT03836677|12601911|FG000|STARTED|Period 1||13
11406685|NCT03836677|12601912|FG001|STARTED|Period 1||10
11406686|NCT03836677|12601911|FG000|COMPLETED|Period 1||13
11406687|NCT03836677|12601912|FG001|COMPLETED|Period 1||9
11406688|NCT03836677|12601911|FG000|NOT COMPLETED|Period 1||0
11406689|NCT03836677|12601912|FG001|NOT COMPLETED|Period 1||1
11406690|NCT03836677|12601911|FG000|STARTED|Washout||13
11406691|NCT03836677|12601912|FG001|STARTED|Washout||9
11406692|NCT03836677|12601911|FG000|COMPLETED|Washout||13
11406693|NCT03836677|12601912|FG001|COMPLETED|Washout||9
11406694|NCT03836677|12601911|FG000|NOT COMPLETED|Washout||0
11406695|NCT03836677|12601912|FG001|NOT COMPLETED|Washout||0
11406696|NCT03836677|12601911|FG000|STARTED|Period 2||13
11406697|NCT03836677|12601912|FG001|STARTED|Period 2||9
11406698|NCT03836677|12601911|FG000|COMPLETED|Period 2||12
11406699|NCT03836677|12601912|FG001|COMPLETED|Period 2||9
11406700|NCT03836677|12601911|FG000|NOT COMPLETED|Period 2||1
11406701|NCT03836677|12601912|FG001|NOT COMPLETED|Period 2||0
11406702|NCT03836989|12601920|FG000|STARTED|Overall Study||4
11406703|NCT03836989|12601921|FG001|STARTED|Overall Study||0
11406704|NCT03836989|12601920|FG000|Subjects > 60 Years Old With Complete Paralysis|Overall Study||1
11406705|NCT03836989|12601921|FG001|Subjects > 60 Years Old With Complete Paralysis|Overall Study||0
11406706|NCT03836989|12601920|FG000|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||1
11406707|NCT03836989|12601921|FG001|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||0
11406708|NCT03836989|12601920|FG000|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||1
11406709|NCT03836989|12601921|FG001|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||0
11406710|NCT03836989|12601920|FG000|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||1
11406711|NCT03836989|12601921|FG001|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||0
11406712|NCT03836989|12601920|FG000|COMPLETED|Overall Study||4
11406713|NCT03836989|12601921|FG001|COMPLETED|Overall Study||0
11406714|NCT03836989|12601920|FG000|NOT COMPLETED|Overall Study||0
11406715|NCT03836989|12601921|FG001|NOT COMPLETED|Overall Study||0
11406716|NCT03827564|12601932|FG000|STARTED|Overall Study||9
11406717|NCT03827564|12601933|FG001|STARTED|Overall Study||5
11406718|NCT03827564|12601932|FG000|COMPLETED|Overall Study||8
11406719|NCT03827564|12601933|FG001|COMPLETED|Overall Study||5
11406720|NCT03827564|12601932|FG000|NOT COMPLETED|Overall Study||1
11406721|NCT03827564|12601933|FG001|NOT COMPLETED|Overall Study||0
11406722|NCT03824236|12601942|FG000|STARTED|Overall Study||25
11406723|NCT03824236|12601943|FG001|STARTED|Overall Study||24
11406724|NCT03824236|12601944|FG002|STARTED|Overall Study||12
11406725|NCT03824236|12601942|FG000|COMPLETED|Overall Study||25
11406726|NCT03824236|12601943|FG001|COMPLETED|Overall Study||24
11406727|NCT03824236|12601944|FG002|COMPLETED|Overall Study||11
11406728|NCT03824236|12601942|FG000|NOT COMPLETED|Overall Study||0
11406729|NCT03824236|12601943|FG001|NOT COMPLETED|Overall Study||0
11406730|NCT03824236|12601944|FG002|NOT COMPLETED|Overall Study||1
11406731|NCT03811951|12601954|FG000|STARTED|First Intervention (1 Day)||2
11406732|NCT03811951|12601955|FG001|STARTED|First Intervention (1 Day)||2
11406733|NCT03811951|12601954|FG000|COMPLETED|First Intervention (1 Day)||2
11406734|NCT03811951|12601955|FG001|COMPLETED|First Intervention (1 Day)||2
11406735|NCT03811951|12601954|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11406736|NCT03811951|12601955|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11406737|NCT03811951|12601954|FG000|STARTED|Washout (1 Week)||2
11406738|NCT03811951|12601955|FG001|STARTED|Washout (1 Week)||2
11406739|NCT03811951|12601954|FG000|COMPLETED|Washout (1 Week)||2
11406740|NCT03811951|12601955|FG001|COMPLETED|Washout (1 Week)||2
11406741|NCT03811951|12601954|FG000|NOT COMPLETED|Washout (1 Week)||0
11406742|NCT03811951|12601955|FG001|NOT COMPLETED|Washout (1 Week)||0
11406743|NCT03811951|12601954|FG000|STARTED|Second Intervention (1 Day)||2
11406744|NCT03811951|12601955|FG001|STARTED|Second Intervention (1 Day)||2
11406745|NCT03811951|12601954|FG000|COMPLETED|Second Intervention (1 Day)||2
11406746|NCT03811951|12601955|FG001|COMPLETED|Second Intervention (1 Day)||2
11406747|NCT03811951|12601954|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11406748|NCT03811951|12601955|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11406749|NCT03810235|12601965|FG000|STARTED|Overall Study||32
11406750|NCT03810235|12601966|FG001|STARTED|Overall Study||31
11406751|NCT03810235|12601965|FG000|Participant Data Analyzed|Overall Study||30
11406752|NCT03810235|12601966|FG001|Participant Data Analyzed|Overall Study||31
11406753|NCT03810235|12601965|FG000|COMPLETED|Overall Study||30
11406754|NCT03810235|12601966|FG001|COMPLETED|Overall Study||31
11406755|NCT03810235|12601965|FG000|NOT COMPLETED|Overall Study||2
11406756|NCT03810235|12601966|FG001|NOT COMPLETED|Overall Study||0
11406757|NCT03806556|12601975|FG000|STARTED|Overall Study||6
11406758|NCT03806556|12601976|FG001|STARTED|Overall Study||5
11406759|NCT03806556|12601975|FG000|COMPLETED|Overall Study||6
11406760|NCT03806556|12601976|FG001|COMPLETED|Overall Study||5
11406761|NCT03806556|12601975|FG000|NOT COMPLETED|Overall Study||0
11406762|NCT03806556|12601976|FG001|NOT COMPLETED|Overall Study||0
11406763|NCT03836664|12601985|FG000|STARTED|Overall Study||14
11406764|NCT03836664|12601986|FG001|STARTED|Overall Study||11
11406765|NCT03836664|12601985|FG000|COMPLETED|Overall Study||11
11406766|NCT03836664|12601986|FG001|COMPLETED|Overall Study||8
11406767|NCT03836664|12601985|FG000|NOT COMPLETED|Overall Study||3
11406768|NCT03836664|12601986|FG001|NOT COMPLETED|Overall Study||3
11406769|NCT03832738|12601999|FG000|STARTED|Overall Study||51
11406770|NCT03832738|12602000|FG001|STARTED|Overall Study||50
11406771|NCT03832738|12602001|FG002|STARTED|Overall Study||51
11406772|NCT03832738|12601999|FG000|COMPLETED|Overall Study||43
11406773|NCT03832738|12602000|FG001|COMPLETED|Overall Study||38
11406774|NCT03832738|12602001|FG002|COMPLETED|Overall Study||32
11406775|NCT03832738|12601999|FG000|NOT COMPLETED|Overall Study||8
11406776|NCT03832738|12602000|FG001|NOT COMPLETED|Overall Study||12
11406777|NCT03832738|12602001|FG002|NOT COMPLETED|Overall Study||19
11406778|NCT03823391|12602011|FG000|STARTED|Period 1: Week 1 to Week 12||17
11406779|NCT03823391|12602012|FG001|STARTED|Period 1: Week 1 to Week 12||31
11406780|NCT03823391|12602011|FG000|COMPLETED|Period 1: Week 1 to Week 12||17
11406781|NCT03823391|12602012|FG001|COMPLETED|Period 1: Week 1 to Week 12||31
11406782|NCT03823391|12602011|FG000|NOT COMPLETED|Period 1: Week 1 to Week 12||0
11406783|NCT03823391|12602012|FG001|NOT COMPLETED|Period 1: Week 1 to Week 12||0
11406784|NCT03823391|12602011|FG000|STARTED|Period 2: Weeks 12 to Week 24||17
11406785|NCT03823391|12602012|FG001|STARTED|Period 2: Weeks 12 to Week 24||31
11406786|NCT03823391|12602011|FG000|COMPLETED|Period 2: Weeks 12 to Week 24||15
11406787|NCT03823391|12602012|FG001|COMPLETED|Period 2: Weeks 12 to Week 24||30
11406788|NCT03823391|12602011|FG000|NOT COMPLETED|Period 2: Weeks 12 to Week 24||2
11406789|NCT03823391|12602012|FG001|NOT COMPLETED|Period 2: Weeks 12 to Week 24||1
11406790|NCT03820258|12602020|FG000|STARTED|Overall Study||21
11406791|NCT03820258|12602020|FG000|COMPLETED|Overall Study||21
11406792|NCT03820258|12602020|FG000|NOT COMPLETED|Overall Study||0
11406793|NCT03819491|12602026|FG000|STARTED|Before Randomization||24
11406794|NCT03819491|12602027|FG001|STARTED|Before Randomization||0
11406795|NCT03819491|12602026|FG000|COMPLETED|Before Randomization||24
11406796|NCT03819491|12602027|FG001|COMPLETED|Before Randomization||0
11406797|NCT03819491|12602026|FG000|NOT COMPLETED|Before Randomization||0
11406798|NCT03819491|12602027|FG001|NOT COMPLETED|Before Randomization||0
11406799|NCT03819491|12602026|FG000|STARTED|After Randomization||12
11406800|NCT03819491|12602027|FG001|STARTED|After Randomization||12
11406801|NCT03819491|12602026|FG000|COMPLETED|After Randomization||12
11406802|NCT03819491|12602027|FG001|COMPLETED|After Randomization||12
11406803|NCT03819491|12602026|FG000|NOT COMPLETED|After Randomization||0
11406804|NCT03819491|12602027|FG001|NOT COMPLETED|After Randomization||0
11406805|NCT03808298|12602034|FG000|STARTED|Overall Study||57
11406806|NCT03808298|12602034|FG000|COMPLETED|Overall Study||49
11406807|NCT03808298|12602034|FG000|NOT COMPLETED|Overall Study||8
11406808|NCT03836729|12602063|FG000|STARTED|Treatment Period 1 (Up to Day 14)||16
11406809|NCT03836729|12602063|FG000|COMPLETED|Treatment Period 1 (Up to Day 14)||16
11406810|NCT03836729|12602063|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 14)||0
11406811|NCT03836729|12602063|FG000|STARTED|Treatment Period 2 (Up to Day 7)||16
11406812|NCT03836729|12602063|FG000|COMPLETED|Treatment Period 2 (Up to Day 7)||15
11406813|NCT03836729|12602063|FG000|NOT COMPLETED|Treatment Period 2 (Up to Day 7)||1
11406814|NCT03835975|12602076|FG000|STARTED|Overall Study||253
11406815|NCT03835975|12602077|FG001|STARTED|Overall Study||122
11406816|NCT03835975|12602078|FG002|STARTED|Overall Study||248
11406817|NCT03835975|12602079|FG003|STARTED|Overall Study||127
11406818|NCT03835975|12602080|FG004|STARTED|Overall Study||125
11406819|NCT03835975|12602076|FG000|Vaccinated|Overall Study||253
11406820|NCT03835975|12602077|FG001|Vaccinated|Overall Study||122
11406821|NCT03835975|12602078|FG002|Vaccinated|Overall Study||246
11406822|NCT03835975|12602079|FG003|Vaccinated|Overall Study||127
11406823|NCT03835975|12602080|FG004|Vaccinated|Overall Study||125
11406824|NCT03835975|12602076|FG000|Safety Population|Overall Study||253
11406825|NCT03835975|12602077|FG001|Safety Population|Overall Study||122
11406826|NCT03835975|12602078|FG002|Safety Population|Overall Study||246
11406827|NCT03835975|12602079|FG003|Safety Population|Overall Study||127
11406828|NCT03835975|12602080|FG004|Safety Population|Overall Study||125
11406829|NCT03835975|12602076|FG000|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||247
11406830|NCT03835975|12602077|FG001|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
11406831|NCT03835975|12602078|FG002|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||243
11406832|NCT03835975|12602079|FG003|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
11406833|NCT03835975|12602080|FG004|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||121
11406834|NCT03835975|12602076|FG000|COMPLETED|Overall Study||250
11406835|NCT03835975|12602077|FG001|COMPLETED|Overall Study||119
11406836|NCT03835975|12602078|FG002|COMPLETED|Overall Study||245
11406837|NCT03835975|12602079|FG003|COMPLETED|Overall Study||126
11406838|NCT03835975|12602080|FG004|COMPLETED|Overall Study||125
11406839|NCT03835975|12602076|FG000|NOT COMPLETED|Overall Study||3
11406840|NCT03835975|12602077|FG001|NOT COMPLETED|Overall Study||3
11406841|NCT03835975|12602078|FG002|NOT COMPLETED|Overall Study||3
11406842|NCT03835975|12602079|FG003|NOT COMPLETED|Overall Study||1
11406843|NCT03835975|12602080|FG004|NOT COMPLETED|Overall Study||0
11406844|NCT03821259|12602094|FG000|STARTED|Overall Study||88
11406845|NCT03821259|12602094|FG000|COMPLETED|Overall Study||88
11406846|NCT03821259|12602094|FG000|NOT COMPLETED|Overall Study||0
11406847|NCT03803085|12602100|FG000|STARTED|Overall Study||30
11406848|NCT03803085|12602101|FG001|STARTED|Overall Study||30
11406849|NCT03803085|12602100|FG000|COMPLETED|Overall Study||28
11406850|NCT03803085|12602101|FG001|COMPLETED|Overall Study||28
11406851|NCT03803085|12602100|FG000|NOT COMPLETED|Overall Study||2
11406852|NCT03803085|12602101|FG001|NOT COMPLETED|Overall Study||2
11406853|NCT03801473|12602110|FG000|STARTED|Overall Study||21
11406854|NCT03801473|12602111|FG001|STARTED|Overall Study||21
11406855|NCT03801473|12602110|FG000|COMPLETED|Overall Study||18
11406856|NCT03801473|12602111|FG001|COMPLETED|Overall Study||19
11406857|NCT03801473|12602110|FG000|NOT COMPLETED|Overall Study||3
11406858|NCT03801473|12602111|FG001|NOT COMPLETED|Overall Study||2
11406859|NCT03828149|12602119|FG000|STARTED|First Intervention (Single Dose)||9
11406860|NCT03828149|12602120|FG001|STARTED|First Intervention (Single Dose)||8
11406861|NCT03828149|12602119|FG000|COMPLETED|First Intervention (Single Dose)||9
11406862|NCT03828149|12602120|FG001|COMPLETED|First Intervention (Single Dose)||8
11406863|NCT03828149|12602119|FG000|NOT COMPLETED|First Intervention (Single Dose)||0
11406864|NCT03828149|12602120|FG001|NOT COMPLETED|First Intervention (Single Dose)||0
11406865|NCT03828149|12602119|FG000|STARTED|Washout (6 Days)||9
11406866|NCT03828149|12602120|FG001|STARTED|Washout (6 Days)||8
11406867|NCT03828149|12602119|FG000|COMPLETED|Washout (6 Days)||9
11406868|NCT03828149|12602120|FG001|COMPLETED|Washout (6 Days)||8
11406869|NCT03828149|12602119|FG000|NOT COMPLETED|Washout (6 Days)||0
11406870|NCT03828149|12602120|FG001|NOT COMPLETED|Washout (6 Days)||0
11406871|NCT03828149|12602119|FG000|STARTED|Second Intervention (Single Dose)||9
11406872|NCT03828149|12602120|FG001|STARTED|Second Intervention (Single Dose)||8
11406873|NCT03828149|12602119|FG000|COMPLETED|Second Intervention (Single Dose)||9
11406874|NCT03828149|12602120|FG001|COMPLETED|Second Intervention (Single Dose)||8
11406875|NCT03828149|12602119|FG000|NOT COMPLETED|Second Intervention (Single Dose)||0
11406876|NCT03828149|12602120|FG001|NOT COMPLETED|Second Intervention (Single Dose)||0
11406877|NCT03835221|12602126|FG000|STARTED|Methafilcon A||43
11406878|NCT03835221|12602126|FG000|COMPLETED|Methafilcon A||42
11406879|NCT03835221|12602126|FG000|NOT COMPLETED|Methafilcon A||1
11406880|NCT03835221|12602126|FG000|STARTED|Fanfilcon A||42
11406881|NCT03835221|12602126|FG000|COMPLETED|Fanfilcon A||42
11406882|NCT03835221|12602126|FG000|NOT COMPLETED|Fanfilcon A||0
11406883|NCT03819634|12602132|FG000|STARTED|Overall Study||24
11406884|NCT03819634|12602132|FG000|COMPLETED|Overall Study||22
11406885|NCT03819634|12602132|FG000|NOT COMPLETED|Overall Study||2
11406886|NCT03812679|12602136|FG000|STARTED|Overall Study||22
11406887|NCT03812679|12602136|FG000|COMPLETED|Overall Study||14
11406888|NCT03812679|12602136|FG000|NOT COMPLETED|Overall Study||8
11406889|NCT03809052|12602151|FG000|STARTED|Overall Study||6
11406890|NCT03809052|12602152|FG001|STARTED|Overall Study||6
11406891|NCT03809052|12602153|FG002|STARTED|Overall Study||6
11406892|NCT03809052|12602154|FG003|STARTED|Overall Study||6
11406893|NCT03809052|12602155|FG004|STARTED|Overall Study||6
11406894|NCT03809052|12602156|FG005|STARTED|Overall Study||6
11406895|NCT03809052|12602157|FG006|STARTED|Overall Study||6
11406896|NCT03809052|12602158|FG007|STARTED|Overall Study||14
11406897|NCT03809052|12602159|FG008|STARTED|Overall Study||8
11406898|NCT03809052|12602160|FG009|STARTED|Overall Study||8
11406899|NCT03809052|12602161|FG010|STARTED|Overall Study||6
11406900|NCT03809052|12602151|FG000|COMPLETED|Overall Study||6
11406901|NCT03809052|12602152|FG001|COMPLETED|Overall Study||6
11406902|NCT03809052|12602153|FG002|COMPLETED|Overall Study||6
11406903|NCT03809052|12602154|FG003|COMPLETED|Overall Study||6
11406904|NCT03809052|12602155|FG004|COMPLETED|Overall Study||6
11406905|NCT03809052|12602156|FG005|COMPLETED|Overall Study||6
11406906|NCT03809052|12602157|FG006|COMPLETED|Overall Study||6
11406907|NCT03809052|12602158|FG007|COMPLETED|Overall Study||14
11406908|NCT03809052|12602159|FG008|COMPLETED|Overall Study||8
11406909|NCT03809052|12602160|FG009|COMPLETED|Overall Study||8
11406910|NCT03809052|12602161|FG010|COMPLETED|Overall Study||6
11406911|NCT03809052|12602151|FG000|NOT COMPLETED|Overall Study||0
11406912|NCT03809052|12602152|FG001|NOT COMPLETED|Overall Study||0
11406913|NCT03809052|12602153|FG002|NOT COMPLETED|Overall Study||0
11406914|NCT03809052|12602154|FG003|NOT COMPLETED|Overall Study||0
11406915|NCT03809052|12602155|FG004|NOT COMPLETED|Overall Study||0
11406916|NCT03809052|12602156|FG005|NOT COMPLETED|Overall Study||0
11406917|NCT03809052|12602157|FG006|NOT COMPLETED|Overall Study||0
11406918|NCT03809052|12602158|FG007|NOT COMPLETED|Overall Study||0
11406919|NCT03809052|12602159|FG008|NOT COMPLETED|Overall Study||0
11406920|NCT03809052|12602160|FG009|NOT COMPLETED|Overall Study||0
11406921|NCT03809052|12602161|FG010|NOT COMPLETED|Overall Study||0
11406922|NCT03801148|12602191|FG000|STARTED|Period 1 (2 Days)||31
11406923|NCT03801148|12602192|FG001|STARTED|Period 1 (2 Days)||31
11406924|NCT03801148|12602193|FG002|STARTED|Period 1 (2 Days)||30
11406925|NCT03801148|12602194|FG003|STARTED|Period 1 (2 Days)||30
11406926|NCT03801148|12602191|FG000|COMPLETED|Period 1 (2 Days)||30
11406927|NCT03801148|12602192|FG001|COMPLETED|Period 1 (2 Days)||30
11406928|NCT03801148|12602193|FG002|COMPLETED|Period 1 (2 Days)||30
11406929|NCT03801148|12602194|FG003|COMPLETED|Period 1 (2 Days)||30
11406930|NCT03801148|12602191|FG000|NOT COMPLETED|Period 1 (2 Days)||1
11406931|NCT03801148|12602192|FG001|NOT COMPLETED|Period 1 (2 Days)||1
11406932|NCT03801148|12602193|FG002|NOT COMPLETED|Period 1 (2 Days)||0
11406933|NCT03801148|12602194|FG003|NOT COMPLETED|Period 1 (2 Days)||0
11406934|NCT03801148|12602191|FG000|STARTED|Washout Period (at Least 5 Days)||30
11406935|NCT03801148|12602192|FG001|STARTED|Washout Period (at Least 5 Days)||30
11406936|NCT03801148|12602193|FG002|STARTED|Washout Period (at Least 5 Days)||30
11406937|NCT03801148|12602194|FG003|STARTED|Washout Period (at Least 5 Days)||30
11406938|NCT03801148|12602191|FG000|COMPLETED|Washout Period (at Least 5 Days)||30
11406939|NCT03801148|12602192|FG001|COMPLETED|Washout Period (at Least 5 Days)||30
11406940|NCT03801148|12602193|FG002|COMPLETED|Washout Period (at Least 5 Days)||29
11406941|NCT03801148|12602194|FG003|COMPLETED|Washout Period (at Least 5 Days)||29
11406942|NCT03801148|12602191|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||0
11406943|NCT03801148|12602192|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||0
11406944|NCT03801148|12602193|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||1
11406945|NCT03801148|12602194|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||1
11406946|NCT03801148|12602191|FG000|STARTED|Period 2 (2 Days)||30
11406947|NCT03801148|12602192|FG001|STARTED|Period 2 (2 Days)||30
11406948|NCT03801148|12602193|FG002|STARTED|Period 2 (2 Days)||29
11406949|NCT03801148|12602194|FG003|STARTED|Period 2 (2 Days)||29
11406950|NCT03801148|12602191|FG000|COMPLETED|Period 2 (2 Days)||30
11406951|NCT03801148|12602192|FG001|COMPLETED|Period 2 (2 Days)||30
11406952|NCT03801148|12602193|FG002|COMPLETED|Period 2 (2 Days)||29
11406953|NCT03801148|12602194|FG003|COMPLETED|Period 2 (2 Days)||29
11406954|NCT03801148|12602191|FG000|NOT COMPLETED|Period 2 (2 Days)||0
11406955|NCT03801148|12602192|FG001|NOT COMPLETED|Period 2 (2 Days)||0
11406956|NCT03801148|12602193|FG002|NOT COMPLETED|Period 2 (2 Days)||0
11406957|NCT03801148|12602194|FG003|NOT COMPLETED|Period 2 (2 Days)||0
11406958|NCT03801148|12602191|FG000|STARTED|Follow-Up (12 Days)||30
11406959|NCT03801148|12602192|FG001|STARTED|Follow-Up (12 Days)||30
11406960|NCT03801148|12602193|FG002|STARTED|Follow-Up (12 Days)||29
11406961|NCT03801148|12602194|FG003|STARTED|Follow-Up (12 Days)||29
11406962|NCT03801148|12602191|FG000|COMPLETED|Follow-Up (12 Days)||30
11406963|NCT03801148|12602192|FG001|COMPLETED|Follow-Up (12 Days)||29
11406964|NCT03801148|12602193|FG002|COMPLETED|Follow-Up (12 Days)||28
11406965|NCT03801148|12602194|FG003|COMPLETED|Follow-Up (12 Days)||29
11406966|NCT03801148|12602191|FG000|NOT COMPLETED|Follow-Up (12 Days)||0
11406967|NCT03801148|12602192|FG001|NOT COMPLETED|Follow-Up (12 Days)||1
11406968|NCT03801148|12602193|FG002|NOT COMPLETED|Follow-Up (12 Days)||1
11406969|NCT03801148|12602194|FG003|NOT COMPLETED|Follow-Up (12 Days)||0
11406970|NCT03832907|12602204|FG000|STARTED|Overall Study||101
11406971|NCT03832907|12602204|FG000|COMPLETED|Overall Study||91
11406972|NCT03832907|12602204|FG000|NOT COMPLETED|Overall Study||10
11406973|NCT03832322|12602210|FG000|STARTED|Overall Study||89
11406974|NCT03832322|12602211|FG001|STARTED|Overall Study||87
11406975|NCT03832322|12602210|FG000|COMPLETED|Overall Study||86
11406976|NCT03832322|12602211|FG001|COMPLETED|Overall Study||86
11406977|NCT03832322|12602210|FG000|NOT COMPLETED|Overall Study||3
11406978|NCT03832322|12602211|FG001|NOT COMPLETED|Overall Study||1
11406979|NCT03832387|12602221|FG000|STARTED|Overall Study||38
11406980|NCT03832387|12602222|FG001|STARTED|Overall Study||39
11406981|NCT03832387|12602221|FG000|COMPLETED|Overall Study||33
11406982|NCT03832387|12602222|FG001|COMPLETED|Overall Study||32
11406983|NCT03832387|12602221|FG000|NOT COMPLETED|Overall Study||5
11406984|NCT03832387|12602222|FG001|NOT COMPLETED|Overall Study||7
11406985|NCT03831971|12602228|FG000|STARTED|Overall Study||12
11406986|NCT03831971|12602228|FG000|COMPLETED|Overall Study||12
11406987|NCT03831971|12602228|FG000|NOT COMPLETED|Overall Study||0
11406988|NCT03831854|12602234|FG000|STARTED|Overall Study||23
11406989|NCT03831854|12602235|FG001|STARTED|Overall Study||23
11406990|NCT03831854|12602234|FG000|COMPLETED|Overall Study||23
11406991|NCT03831854|12602235|FG001|COMPLETED|Overall Study||23
11406992|NCT03831854|12602234|FG000|NOT COMPLETED|Overall Study||0
11406993|NCT03831854|12602235|FG001|NOT COMPLETED|Overall Study||0
11406994|NCT03807739|12602245|FG000|STARTED|Overall Study||9
11406995|NCT03807739|12602246|FG001|STARTED|Overall Study||10
11406996|NCT03807739|12602247|FG002|STARTED|Overall Study||9
11406997|NCT03807739|12602248|FG003|STARTED|Overall Study||10
11406998|NCT03807739|12602245|FG000|COMPLETED|Overall Study||7
11406999|NCT03807739|12602246|FG001|COMPLETED|Overall Study||10
11407000|NCT03807739|12602247|FG002|COMPLETED|Overall Study||9
11407001|NCT03807739|12602248|FG003|COMPLETED|Overall Study||10
11407002|NCT03807739|12602245|FG000|NOT COMPLETED|Overall Study||2
11407003|NCT03807739|12602246|FG001|NOT COMPLETED|Overall Study||0
11407004|NCT03807739|12602247|FG002|NOT COMPLETED|Overall Study||0
11407005|NCT03807739|12602248|FG003|NOT COMPLETED|Overall Study||0
11407006|NCT03831282|12602258|FG000|STARTED|Overall Study||12
11407007|NCT03831282|12602258|FG000|COMPLETED|Overall Study||11
11407008|NCT03831282|12602258|FG000|NOT COMPLETED|Overall Study||1
11407009|NCT03824912|12602265|FG000|STARTED|Overall Study||332
11407010|NCT03824912|12602266|FG001|STARTED|Overall Study||335
11407011|NCT03824912|12602267|FG002|STARTED|Overall Study||164
11407012|NCT03824912|12602265|FG000|COMPLETED|Overall Study||192
11407013|NCT03824912|12602266|FG001|COMPLETED|Overall Study||201
11407014|NCT03824912|12602267|FG002|COMPLETED|Overall Study||96
11407015|NCT03824912|12602265|FG000|NOT COMPLETED|Overall Study||140
11407016|NCT03824912|12602266|FG001|NOT COMPLETED|Overall Study||134
11407017|NCT03824912|12602267|FG002|NOT COMPLETED|Overall Study||68
11407018|NCT03822884|12602281|FG000|STARTED|Overall Study||4
11407019|NCT03822884|12602282|FG001|STARTED|Overall Study||4
11407020|NCT03822884|12602283|FG002|STARTED|Overall Study||4
11407021|NCT03822884|12602284|FG003|STARTED|Overall Study||4
11407022|NCT03822884|12602285|FG004|STARTED|Overall Study||4
11407023|NCT03822884|12602286|FG005|STARTED|Overall Study||4
11407024|NCT03822884|12602281|FG000|COMPLETED|Overall Study||4
11407025|NCT03822884|12602282|FG001|COMPLETED|Overall Study||4
11407026|NCT03822884|12602283|FG002|COMPLETED|Overall Study||4
11407027|NCT03822884|12602284|FG003|COMPLETED|Overall Study||4
11407028|NCT03822884|12602285|FG004|COMPLETED|Overall Study||3
11407029|NCT03822884|12602286|FG005|COMPLETED|Overall Study||4
11407030|NCT03822884|12602281|FG000|NOT COMPLETED|Overall Study||0
11407031|NCT03822884|12602282|FG001|NOT COMPLETED|Overall Study||0
11407032|NCT03822884|12602283|FG002|NOT COMPLETED|Overall Study||0
11407033|NCT03822884|12602284|FG003|NOT COMPLETED|Overall Study||0
11407034|NCT03822884|12602285|FG004|NOT COMPLETED|Overall Study||1
11407035|NCT03822884|12602286|FG005|NOT COMPLETED|Overall Study||0
11407036|NCT03816709|12602294|FG000|STARTED|Overall Study||25
11407037|NCT03816709|12602294|FG000|COMPLETED|Overall Study||25
11407038|NCT03816709|12602294|FG000|NOT COMPLETED|Overall Study||0
11407039|NCT03810014|12602302|FG000|STARTED|Overall Study||215
11407040|NCT03810014|12602303|FG001|STARTED|Overall Study||204
11407041|NCT03810014|12602304|FG002|STARTED|Overall Study||210
11407042|NCT03810014|12602305|FG003|STARTED|Overall Study||213
11407043|NCT03810014|12602302|FG000|COMPLETED|Overall Study||213
11407044|NCT03810014|12602303|FG001|COMPLETED|Overall Study||202
11407045|NCT03810014|12602304|FG002|COMPLETED|Overall Study||210
11407046|NCT03810014|12602305|FG003|COMPLETED|Overall Study||211
11407047|NCT03810014|12602302|FG000|NOT COMPLETED|Overall Study||2
11407048|NCT03810014|12602303|FG001|NOT COMPLETED|Overall Study||2
11407049|NCT03810014|12602304|FG002|NOT COMPLETED|Overall Study||0
11407050|NCT03810014|12602305|FG003|NOT COMPLETED|Overall Study||2
11407051|NCT03806270|12602318|FG000|STARTED|Overall Study||15
11407052|NCT03806270|12602319|FG001|STARTED|Overall Study||15
11407053|NCT03806270|12602320|FG002|STARTED|Overall Study||15
11407054|NCT03806270|12602318|FG000|COMPLETED|Overall Study||15
11407055|NCT03806270|12602319|FG001|COMPLETED|Overall Study||15
11407056|NCT03806270|12602320|FG002|COMPLETED|Overall Study||15
11407057|NCT03806270|12602318|FG000|NOT COMPLETED|Overall Study||0
11407058|NCT03806270|12602319|FG001|NOT COMPLETED|Overall Study||0
11407059|NCT03806270|12602320|FG002|NOT COMPLETED|Overall Study||0
11407060|NCT03830892|12602330|FG000|STARTED|Overall Study||25
11407061|NCT03830892|12602331|FG001|STARTED|Overall Study||23
11407062|NCT03830892|12602330|FG000|15 Watts, 10 mg Nicotine|Overall Study||19
11407063|NCT03830892|12602331|FG001|15 Watts, 10 mg Nicotine|Overall Study||17
11407064|NCT03830892|12602330|FG000|15 Watts, 30 mg Nicotine|Overall Study||19
11407065|NCT03830892|12602331|FG001|15 Watts, 30 mg Nicotine|Overall Study||17
11407066|NCT03830892|12602330|FG000|30 Watts, 10 mg Nicotine|Overall Study||19
11407067|NCT03830892|12602331|FG001|30 Watts, 10 mg Nicotine|Overall Study||17
11407068|NCT03830892|12602330|FG000|30 Watts, 30 mg Nicotine|Overall Study||19
11407069|NCT03830892|12602331|FG001|30 Watts, 30 mg Nicotine|Overall Study||17
11407070|NCT03830892|12602330|FG000|Own Brand|Overall Study||19
11407071|NCT03830892|12602331|FG001|Own Brand|Overall Study||17
11407072|NCT03830892|12602330|FG000|COMPLETED|Overall Study||19
11407073|NCT03830892|12602331|FG001|COMPLETED|Overall Study||17
11407074|NCT03830892|12602330|FG000|NOT COMPLETED|Overall Study||6
11407075|NCT03830892|12602331|FG001|NOT COMPLETED|Overall Study||6
11407076|NCT03830307|12602337|FG000|STARTED|Overall Study||5
11407077|NCT03830307|12602337|FG000|COMPLETED|Overall Study||5
11407078|NCT03830307|12602337|FG000|NOT COMPLETED|Overall Study||0
11407079|NCT03825042|12602343|FG000|STARTED|Overall Study||40
11407080|NCT03825042|12602344|FG001|STARTED|Overall Study||40
11407081|NCT03825042|12602343|FG000|COMPLETED|Overall Study||38
11407082|NCT03825042|12602344|FG001|COMPLETED|Overall Study||40
11407083|NCT03825042|12602343|FG000|NOT COMPLETED|Overall Study||2
11407084|NCT03825042|12602344|FG001|NOT COMPLETED|Overall Study||0
11407085|NCT03823378|12602356|FG000|STARTED|Overall Study||28
11407086|NCT03823378|12602357|FG001|STARTED|Overall Study||16
11407087|NCT03823378|12602358|FG002|STARTED|Overall Study||12
11407088|NCT03823378|12602359|FG003|STARTED|Overall Study||12
11407089|NCT03823378|12602360|FG004|STARTED|Overall Study||20
11407090|NCT03823378|12602361|FG005|STARTED|Overall Study||9
11407091|NCT03823378|12602356|FG000|COMPLETED|Overall Study||7
11407092|NCT03823378|12602357|FG001|COMPLETED|Overall Study||0
11407093|NCT03823378|12602358|FG002|COMPLETED|Overall Study||2
11407094|NCT03823378|12602359|FG003|COMPLETED|Overall Study||2
11407095|NCT03823378|12602360|FG004|COMPLETED|Overall Study||2
11407096|NCT03823378|12602361|FG005|COMPLETED|Overall Study||1
11407097|NCT03823378|12602356|FG000|NOT COMPLETED|Overall Study||21
11407098|NCT03823378|12602357|FG001|NOT COMPLETED|Overall Study||16
11407099|NCT03823378|12602358|FG002|NOT COMPLETED|Overall Study||10
11407100|NCT03823378|12602359|FG003|NOT COMPLETED|Overall Study||10
11407101|NCT03823378|12602360|FG004|NOT COMPLETED|Overall Study||18
11407102|NCT03823378|12602361|FG005|NOT COMPLETED|Overall Study||8
11407103|NCT03831191|12602379|FG000|STARTED|Induction Period (16 Weeks)||33
11407104|NCT03831191|12602380|FG001|STARTED|Induction Period (16 Weeks)||35
11407105|NCT03831191|12602381|FG002|STARTED|Induction Period (16 Weeks)||34
11407106|NCT03831191|12602382|FG003|STARTED|Induction Period (16 Weeks)||34
11407107|NCT03831191|12602383|FG004|STARTED|Induction Period (16 Weeks)||0
11407108|NCT03831191|12602384|FG005|STARTED|Induction Period (16 Weeks)||0
11407109|NCT03831191|12602385|FG006|STARTED|Induction Period (16 Weeks)||0
11407110|NCT03831191|12602386|FG007|STARTED|Induction Period (16 Weeks)||0
11407111|NCT03831191|12602387|FG008|STARTED|Induction Period (16 Weeks)||0
11407112|NCT03831191|12602388|FG009|STARTED|Induction Period (16 Weeks)||0
11407113|NCT03831191|12602389|FG010|STARTED|Induction Period (16 Weeks)||0
11407114|NCT03831191|12602390|FG011|STARTED|Induction Period (16 Weeks)||0
11407115|NCT03831191|12602391|FG012|STARTED|Induction Period (16 Weeks)||0
11407116|NCT03831191|12602392|FG013|STARTED|Induction Period (16 Weeks)||0
11407117|NCT03831191|12602393|FG014|STARTED|Induction Period (16 Weeks)||0
11407118|NCT03831191|12602379|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
11407119|NCT03831191|12602380|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||35
11407120|NCT03831191|12602381|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||34
11407121|NCT03831191|12602382|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
11407122|NCT03831191|12602383|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11407123|NCT03831191|12602384|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11407124|NCT03831191|12602385|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11407125|NCT03831191|12602386|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11407126|NCT03831191|12602387|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11407127|NCT03831191|12602388|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11407128|NCT03831191|12602389|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11407129|NCT03831191|12602390|FG011|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11407130|NCT03831191|12602391|FG012|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11407131|NCT03831191|12602392|FG013|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11407132|NCT03831191|12602393|FG014|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11407133|NCT03831191|12602379|FG000|COMPLETED|Induction Period (16 Weeks)||10
11407134|NCT03831191|12602380|FG001|COMPLETED|Induction Period (16 Weeks)||14
11407135|NCT03831191|12602381|FG002|COMPLETED|Induction Period (16 Weeks)||13
11407136|NCT03831191|12602382|FG003|COMPLETED|Induction Period (16 Weeks)||11
11407137|NCT03831191|12602383|FG004|COMPLETED|Induction Period (16 Weeks)||0
11407138|NCT03831191|12602384|FG005|COMPLETED|Induction Period (16 Weeks)||0
11407139|NCT03831191|12602385|FG006|COMPLETED|Induction Period (16 Weeks)||0
11407140|NCT03831191|12602386|FG007|COMPLETED|Induction Period (16 Weeks)||0
11407141|NCT03831191|12602387|FG008|COMPLETED|Induction Period (16 Weeks)||0
11407142|NCT03831191|12602388|FG009|COMPLETED|Induction Period (16 Weeks)||0
11407143|NCT03831191|12602389|FG010|COMPLETED|Induction Period (16 Weeks)||0
11407144|NCT03831191|12602390|FG011|COMPLETED|Induction Period (16 Weeks)||0
11407145|NCT03831191|12602391|FG012|COMPLETED|Induction Period (16 Weeks)||0
11407146|NCT03831191|12602392|FG013|COMPLETED|Induction Period (16 Weeks)||0
11407147|NCT03831191|12602393|FG014|COMPLETED|Induction Period (16 Weeks)||0
11407148|NCT03831191|12602379|FG000|NOT COMPLETED|Induction Period (16 Weeks)||23
11407149|NCT03831191|12602380|FG001|NOT COMPLETED|Induction Period (16 Weeks)||21
11407150|NCT03831191|12602381|FG002|NOT COMPLETED|Induction Period (16 Weeks)||21
11407151|NCT03831191|12602382|FG003|NOT COMPLETED|Induction Period (16 Weeks)||23
11407152|NCT03831191|12602383|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
11407153|NCT03831191|12602384|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
11407154|NCT03831191|12602385|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
11407155|NCT03831191|12602386|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
11407156|NCT03831191|12602387|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0
11407157|NCT03831191|12602388|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0
11407158|NCT03831191|12602389|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0
11407159|NCT03831191|12602390|FG011|NOT COMPLETED|Induction Period (16 Weeks)||0
11407160|NCT03831191|12602391|FG012|NOT COMPLETED|Induction Period (16 Weeks)||0
11407161|NCT03831191|12602392|FG013|NOT COMPLETED|Induction Period (16 Weeks)||0
11407162|NCT03831191|12602393|FG014|NOT COMPLETED|Induction Period (16 Weeks)||0
11407163|NCT03831191|12602379|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
11407164|NCT03831191|12602380|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
11407165|NCT03831191|12602381|FG002|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
11407166|NCT03831191|12602382|FG003|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
11407167|NCT03831191|12602383|FG004|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
11407168|NCT03831191|12602384|FG005|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|5
11407169|NCT03831191|12602385|FG006|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|2
11407170|NCT03831191|12602386|FG007|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
11407171|NCT03831191|12602387|FG008|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
11407172|NCT03831191|12602388|FG009|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
11407173|NCT03831191|12602389|FG010|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
11407174|NCT03831191|12602390|FG011|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
11407175|NCT03831191|12602391|FG012|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
11407176|NCT03831191|12602392|FG013|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
11407177|NCT03831191|12602393|FG014|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|9
11407178|NCT03831191|12602379|FG000|COMPLETED|Maintenance Period (36 Weeks)||0
11407179|NCT03831191|12602380|FG001|COMPLETED|Maintenance Period (36 Weeks)||0
11407180|NCT03831191|12602381|FG002|COMPLETED|Maintenance Period (36 Weeks)||0
11407181|NCT03831191|12602382|FG003|COMPLETED|Maintenance Period (36 Weeks)||0
11407182|NCT03831191|12602383|FG004|COMPLETED|Maintenance Period (36 Weeks)||0
11407183|NCT03831191|12602384|FG005|COMPLETED|Maintenance Period (36 Weeks)||0
11407184|NCT03831191|12602385|FG006|COMPLETED|Maintenance Period (36 Weeks)||0
11407185|NCT03831191|12602386|FG007|COMPLETED|Maintenance Period (36 Weeks)||0
11407186|NCT03831191|12602387|FG008|COMPLETED|Maintenance Period (36 Weeks)||0
11407187|NCT03831191|12602388|FG009|COMPLETED|Maintenance Period (36 Weeks)||0
11407188|NCT03831191|12602389|FG010|COMPLETED|Maintenance Period (36 Weeks)||0
11407189|NCT03831191|12602390|FG011|COMPLETED|Maintenance Period (36 Weeks)||1
11407190|NCT03831191|12602391|FG012|COMPLETED|Maintenance Period (36 Weeks)||0
11407191|NCT03831191|12602392|FG013|COMPLETED|Maintenance Period (36 Weeks)||0
11407192|NCT03831191|12602393|FG014|COMPLETED|Maintenance Period (36 Weeks)||0
11407193|NCT03831191|12602379|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0
11407194|NCT03831191|12602380|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0
11407195|NCT03831191|12602381|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||0
11407196|NCT03831191|12602382|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||0
11407197|NCT03831191|12602383|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||4
11407198|NCT03831191|12602384|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||5
11407199|NCT03831191|12602385|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||2
11407200|NCT03831191|12602386|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||4
11407201|NCT03831191|12602387|FG008|NOT COMPLETED|Maintenance Period (36 Weeks)||8
11407202|NCT03831191|12602388|FG009|NOT COMPLETED|Maintenance Period (36 Weeks)||1
11407203|NCT03831191|12602389|FG010|NOT COMPLETED|Maintenance Period (36 Weeks)||4
11407204|NCT03831191|12602390|FG011|NOT COMPLETED|Maintenance Period (36 Weeks)||7
11407205|NCT03831191|12602391|FG012|NOT COMPLETED|Maintenance Period (36 Weeks)||1
11407206|NCT03831191|12602392|FG013|NOT COMPLETED|Maintenance Period (36 Weeks)||1
11407207|NCT03831191|12602393|FG014|NOT COMPLETED|Maintenance Period (36 Weeks)||9
11407208|NCT03831191|12602379|FG000|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407209|NCT03831191|12602380|FG001|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407210|NCT03831191|12602381|FG002|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407211|NCT03831191|12602382|FG003|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407212|NCT03831191|12602383|FG004|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407213|NCT03831191|12602384|FG005|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407214|NCT03831191|12602385|FG006|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407215|NCT03831191|12602386|FG007|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407216|NCT03831191|12602387|FG008|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407217|NCT03831191|12602388|FG009|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407218|NCT03831191|12602389|FG010|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407219|NCT03831191|12602390|FG011|STARTED|Post-Treatment Follow-Up Period(8 Weeks)|No participant entered the post follow-up period.|0
11407220|NCT03831191|12602391|FG012|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407221|NCT03831191|12602392|FG013|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407222|NCT03831191|12602393|FG014|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407223|NCT03831191|12602379|FG000|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407224|NCT03831191|12602380|FG001|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407225|NCT03831191|12602381|FG002|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407226|NCT03831191|12602382|FG003|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407227|NCT03831191|12602383|FG004|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407228|NCT03831191|12602384|FG005|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407229|NCT03831191|12602385|FG006|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407230|NCT03831191|12602386|FG007|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407231|NCT03831191|12602387|FG008|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407232|NCT03831191|12602388|FG009|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407233|NCT03831191|12602389|FG010|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407234|NCT03831191|12602390|FG011|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407235|NCT03831191|12602391|FG012|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407236|NCT03831191|12602392|FG013|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407237|NCT03831191|12602393|FG014|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407238|NCT03831191|12602379|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407239|NCT03831191|12602380|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407240|NCT03831191|12602381|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407241|NCT03831191|12602382|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407242|NCT03831191|12602383|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407243|NCT03831191|12602384|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407244|NCT03831191|12602385|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407245|NCT03831191|12602386|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407246|NCT03831191|12602387|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407247|NCT03831191|12602388|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407248|NCT03831191|12602389|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407249|NCT03831191|12602390|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407250|NCT03831191|12602391|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407251|NCT03831191|12602392|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407252|NCT03831191|12602393|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
11407253|NCT03830281|12602428|FG000|STARTED|Lead-in Period (2 Weeks)||471
11407254|NCT03830281|12602429|FG001|STARTED|Lead-in Period (2 Weeks)||0
11407255|NCT03830281|12602428|FG000|COMPLETED|Lead-in Period (2 Weeks)||432
11407256|NCT03830281|12602429|FG001|COMPLETED|Lead-in Period (2 Weeks)||0
11407257|NCT03830281|12602428|FG000|NOT COMPLETED|Lead-in Period (2 Weeks)||39
11407258|NCT03830281|12602429|FG001|NOT COMPLETED|Lead-in Period (2 Weeks)||0
11407259|NCT03830281|12602428|FG000|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|217
11407260|NCT03830281|12602429|FG001|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|215
11407261|NCT03830281|12602428|FG000|COMPLETED|Treatment Period (16 Weeks)||205
11407262|NCT03830281|12602429|FG001|COMPLETED|Treatment Period (16 Weeks)||198
11407263|NCT03830281|12602428|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||12
11407264|NCT03830281|12602429|FG001|NOT COMPLETED|Treatment Period (16 Weeks)||17
11407265|NCT03828734|12602436|FG000|STARTED|Baseline||32
11407266|NCT03828734|12602437|FG001|STARTED|Baseline||26
11407267|NCT03828734|12602436|FG000|COMPLETED|Baseline||32
11407268|NCT03828734|12602437|FG001|COMPLETED|Baseline||26
11407269|NCT03828734|12602436|FG000|NOT COMPLETED|Baseline||0
11407270|NCT03828734|12602437|FG001|NOT COMPLETED|Baseline||0
11407271|NCT03828734|12602436|FG000|STARTED|Pre-Randomization (1 Week)||32
11407272|NCT03828734|12602437|FG001|STARTED|Pre-Randomization (1 Week)||26
11407273|NCT03828734|12602436|FG000|COMPLETED|Pre-Randomization (1 Week)||29
11407274|NCT03828734|12602437|FG001|COMPLETED|Pre-Randomization (1 Week)||25
11407275|NCT03828734|12602436|FG000|NOT COMPLETED|Pre-Randomization (1 Week)||3
11407276|NCT03828734|12602437|FG001|NOT COMPLETED|Pre-Randomization (1 Week)||1
11407277|NCT03828734|12602436|FG000|STARTED|First Intervention||29
11407278|NCT03828734|12602437|FG001|STARTED|First Intervention||25
11407279|NCT03828734|12602436|FG000|COMPLETED|First Intervention||25
11407280|NCT03828734|12602437|FG001|COMPLETED|First Intervention||25
11407281|NCT03828734|12602436|FG000|NOT COMPLETED|First Intervention||4
11407282|NCT03828734|12602437|FG001|NOT COMPLETED|First Intervention||0
11407283|NCT03828734|12602436|FG000|STARTED|First Washout (1 Week)||25
11407284|NCT03828734|12602437|FG001|STARTED|First Washout (1 Week)||25
11407285|NCT03828734|12602436|FG000|COMPLETED|First Washout (1 Week)||25
11407286|NCT03828734|12602437|FG001|COMPLETED|First Washout (1 Week)||24
11407287|NCT03828734|12602436|FG000|NOT COMPLETED|First Washout (1 Week)||0
11407288|NCT03828734|12602437|FG001|NOT COMPLETED|First Washout (1 Week)||1
11407289|NCT03828734|12602436|FG000|STARTED|Second Intervention||25
11407290|NCT03828734|12602437|FG001|STARTED|Second Intervention||24
11407291|NCT03828734|12602436|FG000|COMPLETED|Second Intervention||25
11407292|NCT03828734|12602437|FG001|COMPLETED|Second Intervention||24
11407293|NCT03828734|12602436|FG000|NOT COMPLETED|Second Intervention||0
11407294|NCT03828734|12602437|FG001|NOT COMPLETED|Second Intervention||0
11407295|NCT03827395|12602445|FG000|STARTED|Overall Study||20
11407296|NCT03827395|12602446|FG001|STARTED|Overall Study||5
11407297|NCT03827395|12602445|FG000|COMPLETED|Overall Study||17
11407298|NCT03827395|12602446|FG001|COMPLETED|Overall Study||3
11407299|NCT03827395|12602445|FG000|NOT COMPLETED|Overall Study||3
11407300|NCT03827395|12602446|FG001|NOT COMPLETED|Overall Study||2
11407301|NCT03819218|12602452|FG000|STARTED|Overall Study||7
11407302|NCT03819218|12602452|FG000|COMPLETED|Overall Study||6
11407303|NCT03819218|12602452|FG000|NOT COMPLETED|Overall Study||1
11407304|NCT03818815|12602458|FG000|STARTED|Overall Study||56
11407305|NCT03818815|12602459|FG001|STARTED|Overall Study||47
11407306|NCT03818815|12602458|FG000|COMPLETED|Overall Study||48
11407307|NCT03818815|12602459|FG001|COMPLETED|Overall Study||42
11407308|NCT03818815|12602458|FG000|NOT COMPLETED|Overall Study||8
11407309|NCT03818815|12602459|FG001|NOT COMPLETED|Overall Study||5
11407310|NCT03828487|12602465|FG000|STARTED|Overall Study||8
11407311|NCT03828487|12602465|FG000|COMPLETED|Overall Study||7
11407312|NCT03828487|12602465|FG000|NOT COMPLETED|Overall Study||1
11407313|NCT03828617|12602473|FG000|STARTED|Overall Study||489
11407314|NCT03828617|12602474|FG001|STARTED|Overall Study||490
11407315|NCT03828617|12602475|FG002|STARTED|Overall Study||486
11407316|NCT03828617|12602476|FG003|STARTED|Overall Study||245
11407317|NCT03828617|12602473|FG000|Vaccinated|Overall Study||488
11407318|NCT03828617|12602474|FG001|Vaccinated|Overall Study||489
11407319|NCT03828617|12602475|FG002|Vaccinated|Overall Study||486
11407320|NCT03828617|12602476|FG003|Vaccinated|Overall Study||245
11407321|NCT03828617|12602473|FG000|Safety Population|Overall Study||488
11407322|NCT03828617|12602474|FG001|Safety Population|Overall Study||489
11407323|NCT03828617|12602475|FG002|Safety Population|Overall Study||486
11407324|NCT03828617|12602476|FG003|Safety Population|Overall Study||245
11407325|NCT03828617|12602473|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||463
11407326|NCT03828617|12602474|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||473
11407327|NCT03828617|12602475|FG002|Evaluable Immunogenicity Population(EIP)|Overall Study||456
11407328|NCT03828617|12602476|FG003|Evaluable Immunogenicity Population(EIP)|Overall Study||232
11407329|NCT03828617|12602473|FG000|COMPLETED|Overall Study||465
11407330|NCT03828617|12602474|FG001|COMPLETED|Overall Study||475
11407331|NCT03828617|12602475|FG002|COMPLETED|Overall Study||460
11407332|NCT03828617|12602476|FG003|COMPLETED|Overall Study||235
11407333|NCT03828617|12602473|FG000|NOT COMPLETED|Overall Study||24
11407334|NCT03828617|12602474|FG001|NOT COMPLETED|Overall Study||15
11407335|NCT03828617|12602475|FG002|NOT COMPLETED|Overall Study||26
11407336|NCT03828617|12602476|FG003|NOT COMPLETED|Overall Study||10
11407337|NCT03828539|12602487|FG000|STARTED|Overall Study||389
11407338|NCT03828539|12602488|FG001|STARTED|Overall Study||388
11407339|NCT03828539|12602487|FG000|Full Analysis Set (FAS)|Overall Study||388
11407340|NCT03828539|12602488|FG001|Full Analysis Set (FAS)|Overall Study||388
11407341|NCT03828539|12602487|FG000|Safety Analysis Set (SAF)|Overall Study||388
11407342|NCT03828539|12602488|FG001|Safety Analysis Set (SAF)|Overall Study||388
11407343|NCT03828539|12602487|FG000|COMPLETED|Overall Study||373
11407344|NCT03828539|12602488|FG001|COMPLETED|Overall Study||366
11407345|NCT03828539|12602487|FG000|NOT COMPLETED|Overall Study||16
11407346|NCT03828539|12602488|FG001|NOT COMPLETED|Overall Study||22
11407347|NCT03824704|12602494|FG000|STARTED|Overall Study||1
11407348|NCT03824704|12602494|FG000|COMPLETED|Overall Study||0
11407349|NCT03824704|12602494|FG000|NOT COMPLETED|Overall Study||1
11407350|NCT03823937|12602500|FG000|STARTED|Overall Study||30
11407351|NCT03823937|12602501|FG001|STARTED|Overall Study||20
11407352|NCT03823937|12602500|FG000|COMPLETED|Overall Study||30
11407353|NCT03823937|12602501|FG001|COMPLETED|Overall Study||20
11407354|NCT03823937|12602500|FG000|NOT COMPLETED|Overall Study||0
11407355|NCT03823937|12602501|FG001|NOT COMPLETED|Overall Study||0
11407356|NCT03817879|12602509|FG000|STARTED|Overall Study||35
11407357|NCT03817879|12602510|FG001|STARTED|Overall Study||35
11407358|NCT03817879|12602509|FG000|COMPLETED|Overall Study||30
11407359|NCT03817879|12602510|FG001|COMPLETED|Overall Study||22
11407360|NCT03817879|12602509|FG000|NOT COMPLETED|Overall Study||5
11407361|NCT03817879|12602510|FG001|NOT COMPLETED|Overall Study||13
11407362|NCT03811834|12602516|FG000|STARTED|Period 1 ( 7 Days)||7
11407363|NCT03811834|12602516|FG000|COMPLETED|Period 1 ( 7 Days)||6
11407364|NCT03811834|12602516|FG000|NOT COMPLETED|Period 1 ( 7 Days)||1
11407365|NCT03811834|12602516|FG000|STARTED|Washout Period (9 Days)||6
11407366|NCT03811834|12602516|FG000|COMPLETED|Washout Period (9 Days)||6
11407367|NCT03811834|12602516|FG000|NOT COMPLETED|Washout Period (9 Days)||0
11407368|NCT03811834|12602516|FG000|STARTED|Period 2 (10 Days)||6
11407369|NCT03811834|12602516|FG000|COMPLETED|Period 2 (10 Days)||6
11407370|NCT03811834|12602516|FG000|NOT COMPLETED|Period 2 (10 Days)||0
11407371|NCT03806127|12602531|FG000|STARTED|Overall Study||111
11407372|NCT03806127|12602532|FG001|STARTED|Overall Study||111
11407373|NCT03806127|12602531|FG000|COMPLETED|Overall Study||90
11407374|NCT03806127|12602532|FG001|COMPLETED|Overall Study||99
11407375|NCT03806127|12602531|FG000|NOT COMPLETED|Overall Study||21
11407376|NCT03806127|12602532|FG001|NOT COMPLETED|Overall Study||12
11407377|NCT03827473|12602540|FG000|STARTED|Overall Study||1
11407378|NCT03827473|12602541|FG001|STARTED|Overall Study||0
11407379|NCT03827473|12602540|FG000|COMPLETED|Overall Study||0
11407380|NCT03827473|12602541|FG001|COMPLETED|Overall Study||0
11407381|NCT03827473|12602540|FG000|NOT COMPLETED|Overall Study||1
11407382|NCT03827473|12602541|FG001|NOT COMPLETED|Overall Study||0
11407383|NCT03826914|12602549|FG000|STARTED|Overall Study||35
11407384|NCT03826914|12602550|FG001|STARTED|Overall Study||34
11407385|NCT03826914|12602549|FG000|COMPLETED|Overall Study||34
11407386|NCT03826914|12602550|FG001|COMPLETED|Overall Study||33
11407387|NCT03826914|12602549|FG000|NOT COMPLETED|Overall Study||1
11407388|NCT03826914|12602550|FG001|NOT COMPLETED|Overall Study||1
11407389|NCT03812328|12602561|FG000|STARTED|Overall Study||55
11407390|NCT03812328|12602562|FG001|STARTED|Overall Study||63
11407391|NCT03812328|12602563|FG002|STARTED|Overall Study||89
11407392|NCT03812328|12602561|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||48
11407393|NCT03812328|12602562|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||61
11407394|NCT03812328|12602563|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||84
11407395|NCT03812328|12602561|FG000|Safety Population|Overall Study||55
11407396|NCT03812328|12602562|FG001|Safety Population|Overall Study||63
11407397|NCT03812328|12602563|FG002|Safety Population|Overall Study||88
11407398|NCT03812328|12602561|FG000|COMPLETED|Overall Study||55
11407399|NCT03812328|12602562|FG001|COMPLETED|Overall Study||60
11407400|NCT03812328|12602563|FG002|COMPLETED|Overall Study||88
11407401|NCT03812328|12602561|FG000|NOT COMPLETED|Overall Study||0
11407402|NCT03812328|12602562|FG001|NOT COMPLETED|Overall Study||3
11407403|NCT03812328|12602563|FG002|NOT COMPLETED|Overall Study||1
11407404|NCT03808688|12602573|FG000|STARTED|Overall Study||99
11407405|NCT03808688|12602574|FG001|STARTED|Overall Study||161
11407406|NCT03808688|12602573|FG000|COMPLETED|Overall Study||81
11407407|NCT03808688|12602574|FG001|COMPLETED|Overall Study||138
11407408|NCT03808688|12602573|FG000|NOT COMPLETED|Overall Study||18
11407409|NCT03808688|12602574|FG001|NOT COMPLETED|Overall Study||23
11407410|NCT03822182|12602585|FG000|STARTED|Overall Study||26
11407411|NCT03822182|12602586|FG001|STARTED|Overall Study||25
11407412|NCT03822182|12602587|FG002|STARTED|Overall Study||27
11407413|NCT03822182|12602585|FG000|COMPLETED|Overall Study||26
11407414|NCT03822182|12602586|FG001|COMPLETED|Overall Study||24
11407415|NCT03822182|12602587|FG002|COMPLETED|Overall Study||26
11407416|NCT03822182|12602585|FG000|NOT COMPLETED|Overall Study||0
11407417|NCT03822182|12602586|FG001|NOT COMPLETED|Overall Study||1
11407418|NCT03822182|12602587|FG002|NOT COMPLETED|Overall Study||1
11407419|NCT03822416|12602598|FG000|STARTED|Overall Study||19
11407420|NCT03822416|12602599|FG001|STARTED|Overall Study||19
11407421|NCT03822416|12602598|FG000|COMPLETED|Overall Study||18
11407422|NCT03822416|12602599|FG001|COMPLETED|Overall Study||18
11407423|NCT03822416|12602598|FG000|NOT COMPLETED|Overall Study||1
11407424|NCT03822416|12602599|FG001|NOT COMPLETED|Overall Study||1
11407425|NCT03809104|12602605|FG000|STARTED|Overall Study||43
11407426|NCT03809104|12602605|FG000|COMPLETED|Overall Study||40
11407427|NCT03809104|12602605|FG000|NOT COMPLETED|Overall Study||3
11407428|NCT03807089|12602611|FG000|STARTED|Overall Study||101
11407429|NCT03807089|12602612|FG001|STARTED|Overall Study||93
11407430|NCT03807089|12602611|FG000|COMPLETED|Overall Study||101
11407431|NCT03807089|12602612|FG001|COMPLETED|Overall Study||93
11407432|NCT03807089|12602611|FG000|NOT COMPLETED|Overall Study||0
11407433|NCT03807089|12602612|FG001|NOT COMPLETED|Overall Study||0
11407434|NCT03806231|12602620|FG000|STARTED|Overall Study||4
11407435|NCT03806231|12602621|FG001|STARTED|Overall Study||4
11407436|NCT03806231|12602620|FG000|COMPLETED|Overall Study||2
11407437|NCT03806231|12602621|FG001|COMPLETED|Overall Study||4
11407438|NCT03806231|12602620|FG000|NOT COMPLETED|Overall Study||2
11407439|NCT03806231|12602621|FG001|NOT COMPLETED|Overall Study||0
11407440|NCT03804710|12602629|FG000|STARTED|Overall Study||75
11407441|NCT03804710|12602630|FG001|STARTED|Overall Study||74
11407442|NCT03804710|12602629|FG000|COMPLETED|Overall Study||73
11407443|NCT03804710|12602630|FG001|COMPLETED|Overall Study||69
11407444|NCT03804710|12602629|FG000|NOT COMPLETED|Overall Study||2
11407445|NCT03804710|12602630|FG001|NOT COMPLETED|Overall Study||5
11407446|NCT03822377|12602642|FG000|STARTED|Overall Study||65
11407447|NCT03822377|12602643|FG001|STARTED|Overall Study||65
11407448|NCT03822377|12602642|FG000|COMPLETED|Overall Study||65
11407449|NCT03822377|12602643|FG001|COMPLETED|Overall Study||65
11407450|NCT03822377|12602642|FG000|NOT COMPLETED|Overall Study||0
11407451|NCT03822377|12602643|FG001|NOT COMPLETED|Overall Study||0
11407452|NCT03820388|12602654|FG000|STARTED|Overall Study||25
11407453|NCT03820388|12602655|FG001|STARTED|Overall Study||25
11407454|NCT03820388|12602656|FG002|STARTED|Overall Study||25
11407455|NCT03820388|12602654|FG000|COMPLETED|Overall Study||25
11407456|NCT03820388|12602655|FG001|COMPLETED|Overall Study||25
11407457|NCT03820388|12602656|FG002|COMPLETED|Overall Study||25
11407458|NCT03820388|12602654|FG000|NOT COMPLETED|Overall Study||0
11407459|NCT03820388|12602655|FG001|NOT COMPLETED|Overall Study||0
11407460|NCT03820388|12602656|FG002|NOT COMPLETED|Overall Study||0
11407461|NCT03816696|12602664|FG000|STARTED|Period 1 (Up to Day 5)||16
11407462|NCT03816696|12602664|FG000|COMPLETED|Period 1 (Up to Day 5)||16
11407463|NCT03816696|12602664|FG000|NOT COMPLETED|Period 1 (Up to Day 5)||0
11407464|NCT03816696|12602664|FG000|STARTED|Wash Out Period (Days 6 to 9)||16
11407465|NCT03816696|12602664|FG000|COMPLETED|Wash Out Period (Days 6 to 9)||16
11407466|NCT03816696|12602664|FG000|NOT COMPLETED|Wash Out Period (Days 6 to 9)||0
11407467|NCT03816696|12602664|FG000|STARTED|Period 2 (Up to Day 7)||16
11407468|NCT03816696|12602664|FG000|COMPLETED|Period 2 (Up to Day 7)||16
11407469|NCT03816696|12602664|FG000|NOT COMPLETED|Period 2 (Up to Day 7)||0
11407470|NCT03816696|12602664|FG000|STARTED|Period 3 (Up to Day 11)||16
11407471|NCT03816696|12602664|FG000|COMPLETED|Period 3 (Up to Day 11)||16
11407472|NCT03816696|12602664|FG000|NOT COMPLETED|Period 3 (Up to Day 11)||0
11407473|NCT03821064|12602674|FG000|STARTED|Overall Study||11
11407474|NCT03821064|12602674|FG000|COMPLETED|Overall Study||10
11407475|NCT03821064|12602674|FG000|NOT COMPLETED|Overall Study||1
11407476|NCT03820544|12602680|FG000|STARTED|Overall Study||2
11407477|NCT03820544|12602681|FG001|STARTED|Overall Study||2
11407478|NCT03820544|12602680|FG000|COMPLETED|Overall Study||2
11407479|NCT03820544|12602681|FG001|COMPLETED|Overall Study||2
11407480|NCT03820544|12602680|FG000|NOT COMPLETED|Overall Study||0
11407481|NCT03820544|12602681|FG001|NOT COMPLETED|Overall Study||0
11407482|NCT03820024|12602689|FG000|STARTED|Overall Study||19
11407483|NCT03820024|12602690|FG001|STARTED|Overall Study||20
11407484|NCT03820024|12602689|FG000|COMPLETED|Overall Study||18
11407485|NCT03820024|12602690|FG001|COMPLETED|Overall Study||18
11407486|NCT03820024|12602689|FG000|NOT COMPLETED|Overall Study||1
11407487|NCT03820024|12602690|FG001|NOT COMPLETED|Overall Study||2
11407488|NCT03807544|12602696|FG000|STARTED|Overall Study||17
11407489|NCT03807544|12602696|FG000|COMPLETED|Overall Study||17
11407490|NCT03807544|12602696|FG000|NOT COMPLETED|Overall Study||0
11407491|NCT03809182|12602703|FG000|STARTED|Overall Study||20
11407492|NCT03809182|12602704|FG001|STARTED|Overall Study||20
11407493|NCT03809182|12602703|FG000|COMPLETED|Overall Study||20
11407494|NCT03809182|12602704|FG001|COMPLETED|Overall Study||20
11407495|NCT03809182|12602703|FG000|NOT COMPLETED|Overall Study||0
11407496|NCT03809182|12602704|FG001|NOT COMPLETED|Overall Study||0
11407497|NCT03816761|12602715|FG000|STARTED|First Treatment Period (7 Days)||4
11407498|NCT03816761|12602716|FG001|STARTED|First Treatment Period (7 Days)||4
11407499|NCT03816761|12602717|FG002|STARTED|First Treatment Period (7 Days)||4
11407500|NCT03816761|12602718|FG003|STARTED|First Treatment Period (7 Days)||4
11407501|NCT03816761|12602719|FG004|STARTED|First Treatment Period (7 Days)||4
11407502|NCT03816761|12602720|FG005|STARTED|First Treatment Period (7 Days)||4
11407503|NCT03816761|12602715|FG000|COMPLETED|First Treatment Period (7 Days)||4
11407504|NCT03816761|12602716|FG001|COMPLETED|First Treatment Period (7 Days)||4
11407505|NCT03816761|12602717|FG002|COMPLETED|First Treatment Period (7 Days)||4
11407506|NCT03816761|12602718|FG003|COMPLETED|First Treatment Period (7 Days)||4
11407507|NCT03816761|12602719|FG004|COMPLETED|First Treatment Period (7 Days)||4
11407508|NCT03816761|12602720|FG005|COMPLETED|First Treatment Period (7 Days)||3
11407509|NCT03816761|12602715|FG000|NOT COMPLETED|First Treatment Period (7 Days)||0
11407510|NCT03816761|12602716|FG001|NOT COMPLETED|First Treatment Period (7 Days)||0
11407511|NCT03816761|12602717|FG002|NOT COMPLETED|First Treatment Period (7 Days)||0
11407512|NCT03816761|12602718|FG003|NOT COMPLETED|First Treatment Period (7 Days)||0
11407513|NCT03816761|12602719|FG004|NOT COMPLETED|First Treatment Period (7 Days)||0
11407514|NCT03816761|12602720|FG005|NOT COMPLETED|First Treatment Period (7 Days)||1
11407515|NCT03816761|12602715|FG000|STARTED|Second Treatment Period (7 Days)||4
11407516|NCT03816761|12602716|FG001|STARTED|Second Treatment Period (7 Days)||4
11407517|NCT03816761|12602717|FG002|STARTED|Second Treatment Period (7 Days)||4
11407518|NCT03816761|12602718|FG003|STARTED|Second Treatment Period (7 Days)||4
11407519|NCT03816761|12602719|FG004|STARTED|Second Treatment Period (7 Days)||4
11407520|NCT03816761|12602720|FG005|STARTED|Second Treatment Period (7 Days)||3
11407521|NCT03816761|12602715|FG000|COMPLETED|Second Treatment Period (7 Days)||4
11407522|NCT03816761|12602716|FG001|COMPLETED|Second Treatment Period (7 Days)||4
11407523|NCT03816761|12602717|FG002|COMPLETED|Second Treatment Period (7 Days)||4
11407524|NCT03816761|12602718|FG003|COMPLETED|Second Treatment Period (7 Days)||3
11407525|NCT03816761|12602719|FG004|COMPLETED|Second Treatment Period (7 Days)||4
11407526|NCT03816761|12602720|FG005|COMPLETED|Second Treatment Period (7 Days)||3
11407527|NCT03816761|12602715|FG000|NOT COMPLETED|Second Treatment Period (7 Days)||0
11407528|NCT03816761|12602716|FG001|NOT COMPLETED|Second Treatment Period (7 Days)||0
11407529|NCT03816761|12602717|FG002|NOT COMPLETED|Second Treatment Period (7 Days)||0
11407530|NCT03816761|12602718|FG003|NOT COMPLETED|Second Treatment Period (7 Days)||1
11407531|NCT03816761|12602719|FG004|NOT COMPLETED|Second Treatment Period (7 Days)||0
11407532|NCT03816761|12602720|FG005|NOT COMPLETED|Second Treatment Period (7 Days)||0
11407533|NCT03801044|12602742|FG000|STARTED|Overall Study||21
11407534|NCT03801044|12602742|FG000|COMPLETED|Overall Study||21
11407535|NCT03801044|12602742|FG000|NOT COMPLETED|Overall Study||0
11407536|NCT03805672|12602752|FG000|STARTED|Overall Study||2
11407537|NCT03805672|12602753|FG001|STARTED|Overall Study||2
11407538|NCT03805672|12602752|FG000|COMPLETED|Overall Study||2
11407539|NCT03805672|12602753|FG001|COMPLETED|Overall Study||2
11407540|NCT03805672|12602752|FG000|NOT COMPLETED|Overall Study||0
11407541|NCT03805672|12602753|FG001|NOT COMPLETED|Overall Study||0
11407542|NCT03808493|12602763|FG000|STARTED|Overall Study||12
11407543|NCT03808493|12602764|FG001|STARTED|Overall Study||12
11407544|NCT03808493|12602765|FG002|STARTED|Overall Study||12
11407545|NCT03808493|12602766|FG003|STARTED|Overall Study||12
11407546|NCT03808493|12602763|FG000|COMPLETED|Overall Study||12
11407547|NCT03808493|12602764|FG001|COMPLETED|Overall Study||12
11407548|NCT03808493|12602765|FG002|COMPLETED|Overall Study||12
11407549|NCT03808493|12602766|FG003|COMPLETED|Overall Study||12
11407550|NCT03808493|12602763|FG000|NOT COMPLETED|Overall Study||0
11407551|NCT03808493|12602764|FG001|NOT COMPLETED|Overall Study||0
11407552|NCT03808493|12602765|FG002|NOT COMPLETED|Overall Study||0
11407553|NCT03808493|12602766|FG003|NOT COMPLETED|Overall Study||0
11407554|NCT03815292|12602778|FG000|STARTED|Overall Study||135
11407555|NCT03815292|12602779|FG001|STARTED|Overall Study||140
11407556|NCT03815292|12602778|FG000|COMPLETED|Overall Study||135
11407557|NCT03815292|12602779|FG001|COMPLETED|Overall Study||140
11407558|NCT03815292|12602778|FG000|NOT COMPLETED|Overall Study||0
11407559|NCT03815292|12602779|FG001|NOT COMPLETED|Overall Study||0
11407560|NCT03812510|12602785|FG000|STARTED|Overall Study||426
11407561|NCT03812510|12602785|FG000|COMPLETED|Overall Study||274
11407562|NCT03812510|12602785|FG000|NOT COMPLETED|Overall Study||152
11407563|NCT03802994|12602795|FG000|STARTED|Overall Study||9
11407564|NCT03802994|12602796|FG001|STARTED|Overall Study||12
11407565|NCT03802994|12602797|FG002|STARTED|Overall Study||15
11407566|NCT03802994|12602798|FG003|STARTED|Overall Study||11
11407567|NCT03802994|12602799|FG004|STARTED|Overall Study||10
11407568|NCT03802994|12602795|FG000|COMPLETED|Overall Study||9
11407569|NCT03802994|12602796|FG001|COMPLETED|Overall Study||10
11407570|NCT03802994|12602797|FG002|COMPLETED|Overall Study||12
11407571|NCT03802994|12602798|FG003|COMPLETED|Overall Study||9
11407572|NCT03802994|12602799|FG004|COMPLETED|Overall Study||8
11407573|NCT03802994|12602795|FG000|NOT COMPLETED|Overall Study||0
11407574|NCT03802994|12602796|FG001|NOT COMPLETED|Overall Study||2
11407575|NCT03802994|12602797|FG002|NOT COMPLETED|Overall Study||3
11407576|NCT03802994|12602798|FG003|NOT COMPLETED|Overall Study||2
11407577|NCT03802994|12602799|FG004|NOT COMPLETED|Overall Study||2
11407578|NCT03810183|12602824|FG000|STARTED|Overall Study||6
11407579|NCT03810183|12602825|FG001|STARTED|Overall Study||3
11407580|NCT03810183|12602824|FG000|COMPLETED|Overall Study||4
11407581|NCT03810183|12602825|FG001|COMPLETED|Overall Study||2
11407582|NCT03810183|12602824|FG000|NOT COMPLETED|Overall Study||2
11407583|NCT03810183|12602825|FG001|NOT COMPLETED|Overall Study||1
11407584|NCT03809910|12602832|FG000|STARTED|Period 1 (Visit 2)||20
11407585|NCT03809910|12602833|FG001|STARTED|Period 1 (Visit 2)||19
11407586|NCT03809910|12602832|FG000|COMPLETED|Period 1 (Visit 2)||20
11407587|NCT03809910|12602833|FG001|COMPLETED|Period 1 (Visit 2)||19
11407588|NCT03809910|12602832|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
11407589|NCT03809910|12602833|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
11407590|NCT03809910|12602832|FG000|STARTED|Washout Period 1 (3 Days)||20
11407591|NCT03809910|12602833|FG001|STARTED|Washout Period 1 (3 Days)||19
11407592|NCT03809910|12602832|FG000|COMPLETED|Washout Period 1 (3 Days)||20
11407593|NCT03809910|12602833|FG001|COMPLETED|Washout Period 1 (3 Days)||19
11407594|NCT03809910|12602832|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0
11407595|NCT03809910|12602833|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0
11407596|NCT03809910|12602832|FG000|STARTED|Period 2 (Visit 3)||20
11407597|NCT03809910|12602833|FG001|STARTED|Period 2 (Visit 3)||19
11407598|NCT03809910|12602832|FG000|COMPLETED|Period 2 (Visit 3)||20
11407599|NCT03809910|12602833|FG001|COMPLETED|Period 2 (Visit 3)||19
11407600|NCT03809910|12602832|FG000|NOT COMPLETED|Period 2 (Visit 3)||0
11407601|NCT03809910|12602833|FG001|NOT COMPLETED|Period 2 (Visit 3)||0
11407602|NCT03809910|12602832|FG000|STARTED|Washout Period 2 (3 Days)||20
11407603|NCT03809910|12602833|FG001|STARTED|Washout Period 2 (3 Days)||19
11407604|NCT03809910|12602832|FG000|COMPLETED|Washout Period 2 (3 Days)||20
11407605|NCT03809910|12602833|FG001|COMPLETED|Washout Period 2 (3 Days)||19
11407606|NCT03809910|12602832|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
11407607|NCT03809910|12602833|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
11407608|NCT03809910|12602832|FG000|STARTED|Period 3 (Visit 4)||20
11407609|NCT03809910|12602833|FG001|STARTED|Period 3 (Visit 4)||19
11407610|NCT03809910|12602832|FG000|COMPLETED|Period 3 (Visit 4)||20
11407611|NCT03809910|12602833|FG001|COMPLETED|Period 3 (Visit 4)||19
11407612|NCT03809910|12602832|FG000|NOT COMPLETED|Period 3 (Visit 4)||0
11407613|NCT03809910|12602833|FG001|NOT COMPLETED|Period 3 (Visit 4)||0
11407614|NCT03806790|12602845|FG000|STARTED|Overall Study||87
11407615|NCT03806790|12602846|FG001|STARTED|Overall Study||95
11407616|NCT03806790|12602845|FG000|COMPLETED|Overall Study||87
11407617|NCT03806790|12602846|FG001|COMPLETED|Overall Study||95
11407618|NCT03806790|12602845|FG000|NOT COMPLETED|Overall Study||0
11407619|NCT03806790|12602846|FG001|NOT COMPLETED|Overall Study||0
11407620|NCT03807245|12602855|FG000|STARTED|Overall Study||24
11407621|NCT03807245|12602856|FG001|STARTED|Overall Study||24
11407622|NCT03807245|12602857|FG002|STARTED|Overall Study||12
11407623|NCT03807245|12602855|FG000|COMPLETED|Overall Study||23
11407624|NCT03807245|12602856|FG001|COMPLETED|Overall Study||24
11407625|NCT03807245|12602857|FG002|COMPLETED|Overall Study||12
11407626|NCT03807245|12602855|FG000|NOT COMPLETED|Overall Study||1
11407627|NCT03807245|12602856|FG001|NOT COMPLETED|Overall Study||0
11407628|NCT03807245|12602857|FG002|NOT COMPLETED|Overall Study||0
11407629|NCT03805971|12602865|FG000|STARTED|Overall Study||65
11407630|NCT03805971|12602865|FG000|COMPLETED|Overall Study||62
11407631|NCT03805971|12602865|FG000|NOT COMPLETED|Overall Study||3
11407632|NCT03802916|12602872|FG000|STARTED|Overall Study||15
11407633|NCT03802916|12602873|FG001|STARTED|Overall Study||15
11407634|NCT03802916|12602872|FG000|COMPLETED|Overall Study||15
11407635|NCT03802916|12602873|FG001|COMPLETED|Overall Study||13
11407636|NCT03802916|12602872|FG000|NOT COMPLETED|Overall Study||0
11407637|NCT03802916|12602873|FG001|NOT COMPLETED|Overall Study||2
11407638|NCT03809039|12602890|FG000|STARTED|Part 1|11 subjects (2 subjects in each of Part 1 MT-6345 1 mg, 5 mg, 20 mg, 60 mg, 240 mg, and 1 subject in Part 1 MT-6345 120 mg) received a matching placebo per their respective dose. The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 Placebo.|11
11407639|NCT03809039|12602891|FG001|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
11407640|NCT03809039|12602892|FG002|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
11407641|NCT03809039|12602893|FG003|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 MT-6345 20mg.|6
11407642|NCT03809039|12602894|FG004|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
11407643|NCT03809039|12602895|FG005|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|4
11407644|NCT03809039|12602896|FG006|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|5
11407645|NCT03809039|12602897|FG007|STARTED|Part 1||0
11407646|NCT03809039|12602898|FG008|STARTED|Part 1||0
11407647|NCT03809039|12602890|FG000|COMPLETED|Part 1||10
11407648|NCT03809039|12602891|FG001|COMPLETED|Part 1||6
11407649|NCT03809039|12602892|FG002|COMPLETED|Part 1||6
11407650|NCT03809039|12602893|FG003|COMPLETED|Part 1||5
11407651|NCT03809039|12602894|FG004|COMPLETED|Part 1||6
11407652|NCT03809039|12602895|FG005|COMPLETED|Part 1||4
11407653|NCT03809039|12602896|FG006|COMPLETED|Part 1||5
11407654|NCT03809039|12602897|FG007|COMPLETED|Part 1||0
11407655|NCT03809039|12602898|FG008|COMPLETED|Part 1||0
11407656|NCT03809039|12602890|FG000|NOT COMPLETED|Part 1||1
11407657|NCT03809039|12602891|FG001|NOT COMPLETED|Part 1||0
11407658|NCT03809039|12602892|FG002|NOT COMPLETED|Part 1||0
11407659|NCT03809039|12602893|FG003|NOT COMPLETED|Part 1||1
11407660|NCT03809039|12602894|FG004|NOT COMPLETED|Part 1||0
11407661|NCT03809039|12602895|FG005|NOT COMPLETED|Part 1||0
11407662|NCT03809039|12602896|FG006|NOT COMPLETED|Part 1||0
11407663|NCT03809039|12602897|FG007|NOT COMPLETED|Part 1||0
11407664|NCT03809039|12602898|FG008|NOT COMPLETED|Part 1||0
11407665|NCT03809039|12602890|FG000|STARTED|Part 2|2 subjects who received a matching placebo per Part 1 MT-6345 20mg were selected to return for Part 2. Out of 2 subjects, only 1 subject received the placebo, and another subject withdrew the consent after Part 1. Therefore, this 1 subject is not a unique subject and was not counted again in the total number of exposed subjects.|1
11407666|NCT03809039|12602891|FG001|STARTED|Part 2||0
11407667|NCT03809039|12602892|FG002|STARTED|Part 2||0
11407668|NCT03809039|12602893|FG003|STARTED|Part 2|6 subjects in Part 1 MT-6345 20mg were selected to return for Part 2. Out of 6 subjects, only 5 subjects received MT-6345, and 1 subject withdrew the consent after Part 1. Therefore, these 5 subjects are not a unique subject and were not counted again in the total number of exposed subjects.|5
11407669|NCT03809039|12602894|FG004|STARTED|Part 2||0
11407670|NCT03809039|12602895|FG005|STARTED|Part 2||0
11407671|NCT03809039|12602896|FG006|STARTED|Part 2||0
11407672|NCT03809039|12602897|FG007|STARTED|Part 2||0
11407673|NCT03809039|12602898|FG008|STARTED|Part 2||0
11407674|NCT03809039|12602890|FG000|COMPLETED|Part 2||1
11407675|NCT03809039|12602891|FG001|COMPLETED|Part 2||0
11407676|NCT03809039|12602892|FG002|COMPLETED|Part 2||0
11407677|NCT03809039|12602893|FG003|COMPLETED|Part 2||5
11407678|NCT03809039|12602894|FG004|COMPLETED|Part 2||0
11407679|NCT03809039|12602895|FG005|COMPLETED|Part 2||0
11407680|NCT03809039|12602896|FG006|COMPLETED|Part 2||0
11407681|NCT03809039|12602897|FG007|COMPLETED|Part 2||0
11407682|NCT03809039|12602898|FG008|COMPLETED|Part 2||0
11407683|NCT03809039|12602890|FG000|NOT COMPLETED|Part 2||0
11407684|NCT03809039|12602891|FG001|NOT COMPLETED|Part 2||0
11407685|NCT03809039|12602892|FG002|NOT COMPLETED|Part 2||0
11407686|NCT03809039|12602893|FG003|NOT COMPLETED|Part 2||0
11407687|NCT03809039|12602894|FG004|NOT COMPLETED|Part 2||0
11407688|NCT03809039|12602895|FG005|NOT COMPLETED|Part 2||0
11407689|NCT03809039|12602896|FG006|NOT COMPLETED|Part 2||0
11407690|NCT03809039|12602897|FG007|NOT COMPLETED|Part 2||0
11407691|NCT03809039|12602898|FG008|NOT COMPLETED|Part 2||0
11407692|NCT03809039|12602890|FG000|STARTED|Part 3||0
11407693|NCT03809039|12602891|FG001|STARTED|Part 3||0
11407694|NCT03809039|12602892|FG002|STARTED|Part 3||0
11407695|NCT03809039|12602893|FG003|STARTED|Part 3||0
11407696|NCT03809039|12602894|FG004|STARTED|Part 3||0
11407697|NCT03809039|12602895|FG005|STARTED|Part 3||0
11407698|NCT03809039|12602896|FG006|STARTED|Part 3||0
11407699|NCT03809039|12602897|FG007|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|2
11407700|NCT03809039|12602898|FG008|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|6
11407701|NCT03809039|12602890|FG000|COMPLETED|Part 3||0
11407702|NCT03809039|12602891|FG001|COMPLETED|Part 3||0
11407703|NCT03809039|12602892|FG002|COMPLETED|Part 3||0
11407704|NCT03809039|12602893|FG003|COMPLETED|Part 3||0
11407705|NCT03809039|12602894|FG004|COMPLETED|Part 3||0
11407706|NCT03809039|12602895|FG005|COMPLETED|Part 3||0
11407707|NCT03809039|12602896|FG006|COMPLETED|Part 3||0
11407708|NCT03809039|12602897|FG007|COMPLETED|Part 3||0
11407709|NCT03809039|12602898|FG008|COMPLETED|Part 3||0
11407710|NCT03809039|12602890|FG000|NOT COMPLETED|Part 3||0
11407711|NCT03809039|12602891|FG001|NOT COMPLETED|Part 3||0
11407712|NCT03809039|12602892|FG002|NOT COMPLETED|Part 3||0
11407713|NCT03809039|12602893|FG003|NOT COMPLETED|Part 3||0
11407714|NCT03809039|12602894|FG004|NOT COMPLETED|Part 3||0
11407715|NCT03809039|12602895|FG005|NOT COMPLETED|Part 3||0
11407716|NCT03809039|12602896|FG006|NOT COMPLETED|Part 3||0
11407717|NCT03809039|12602897|FG007|NOT COMPLETED|Part 3||2
11407718|NCT03809039|12602898|FG008|NOT COMPLETED|Part 3||6
11407719|NCT03807700|12602933|FG000|STARTED|Overall Study||60
11407720|NCT03807700|12602934|FG001|STARTED|Overall Study||59
11407721|NCT03807700|12602933|FG000|COMPLETED|Overall Study||58
11407722|NCT03807700|12602934|FG001|COMPLETED|Overall Study||58
11407723|NCT03807700|12602933|FG000|NOT COMPLETED|Overall Study||2
11407724|NCT03807700|12602934|FG001|NOT COMPLETED|Overall Study||1
11407725|NCT03804918|12602941|FG000|STARTED|Overall Study||17
11407726|NCT03804918|12602941|FG000|COMPLETED|Overall Study||16
11407727|NCT03804918|12602941|FG000|NOT COMPLETED|Overall Study||1
11144077|NCT01475474|12330719|FG000|STARTED|Return to Baseline Period - 4 Weeks||73
11144078|NCT01475474|12330719|FG000|COMPLETED|Return to Baseline Period - 4 Weeks||71
11322579|NCT02629159|12519843|FG002|COMPLETED|Overall Study||600
11322580|NCT02629159|12519841|FG000|NOT COMPLETED|Overall Study||56
11322581|NCT02629159|12519842|FG001|NOT COMPLETED|Overall Study||39
11322582|NCT02629159|12519843|FG002|NOT COMPLETED|Overall Study||51
11322583|NCT02586025|12519856|FG000|STARTED|Neoadjuvant Treatment||219
11322584|NCT02586025|12519857|FG001|STARTED|Neoadjuvant Treatment||110
11322585|NCT02586025|12519856|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||218
11322586|NCT02586025|12519857|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||110
11322587|NCT02586025|12519856|FG000|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214
11322588|NCT02586025|12519857|FG001|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108
11322589|NCT02586025|12519856|FG000|Underwent Surgery|Neoadjuvant Treatment||210
11322590|NCT02586025|12519857|FG001|Underwent Surgery|Neoadjuvant Treatment||105
11322591|NCT02586025|12519856|FG000|COMPLETED|Neoadjuvant Treatment||208
11322592|NCT02586025|12519857|FG001|COMPLETED|Neoadjuvant Treatment||103
11322593|NCT02586025|12519856|FG000|NOT COMPLETED|Neoadjuvant Treatment||11
11322594|NCT02586025|12519857|FG001|NOT COMPLETED|Neoadjuvant Treatment||7
11322595|NCT02586025|12519856|FG000|STARTED|Adjuvant Treatment||208
11322596|NCT02586025|12519857|FG001|STARTED|Adjuvant Treatment||103
11322597|NCT02586025|12519856|FG000|Started Adjuvant FEC Treatment|Adjuvant Treatment||208
11322598|NCT02586025|12519857|FG001|Started Adjuvant FEC Treatment|Adjuvant Treatment||103
11322599|NCT02586025|12519856|FG000|Started Adjuvant HER2 Treatment|Adjuvant Treatment||204
11322600|NCT02586025|12519857|FG001|Started Adjuvant HER2 Treatment|Adjuvant Treatment||99
11322601|NCT02586025|12519856|FG000|COMPLETED|Adjuvant Treatment||69
11322602|NCT02586025|12519857|FG001|COMPLETED|Adjuvant Treatment||34
11322603|NCT02586025|12519856|FG000|NOT COMPLETED|Adjuvant Treatment||139
11322604|NCT02586025|12519857|FG001|NOT COMPLETED|Adjuvant Treatment||69
11322605|NCT02586025|12519856|FG000|STARTED|Treatment-Free Follow-Up||59
11322606|NCT02586025|12519857|FG001|STARTED|Treatment-Free Follow-Up||38
11322607|NCT02586025|12519856|FG000|COMPLETED|Treatment-Free Follow-Up||3
11322608|NCT02586025|12519857|FG001|COMPLETED|Treatment-Free Follow-Up||3
11322609|NCT02586025|12519856|FG000|NOT COMPLETED|Treatment-Free Follow-Up||56
11322610|NCT02586025|12519857|FG001|NOT COMPLETED|Treatment-Free Follow-Up||35
11322611|NCT02569242|12519865|FG000|STARTED|Overall Study|Included in intention-to-treat analysis for overall survival and progression-free survival|210
11322612|NCT02569242|12519866|FG001|STARTED|Overall Study|Included in intention-to-treat analysis for overall survival and progression-free survival|209
11322613|NCT02569242|12519865|FG000|COMPLETED|Overall Study|Analysed for safety|209
11322614|NCT02569242|12519866|FG001|COMPLETED|Overall Study|Analysed for safety|208
11322615|NCT02569242|12519865|FG000|NOT COMPLETED|Overall Study||1
11322616|NCT02569242|12519866|FG001|NOT COMPLETED|Overall Study||1
11322617|NCT02524379|12519872|FG000|STARTED|Overall Study||3
11322618|NCT02524379|12519872|FG000|COMPLETED|Overall Study||2
11322619|NCT02524379|12519872|FG000|NOT COMPLETED|Overall Study||1
11322620|NCT02445456|12519878|FG000|STARTED|Overall Study||13
11322621|NCT02445456|12519879|FG001|STARTED|Overall Study||2
11322622|NCT02445456|12519878|FG000|COMPLETED|Overall Study||13
11322623|NCT02445456|12519879|FG001|COMPLETED|Overall Study||2
11322624|NCT02445456|12519878|FG000|NOT COMPLETED|Overall Study||0
11322625|NCT02445456|12519879|FG001|NOT COMPLETED|Overall Study||0
11322626|NCT02427568|12519887|FG000|STARTED|Overall Study||5
11322627|NCT02427568|12519888|FG001|STARTED|Overall Study||13
11322628|NCT02427568|12519887|FG000|COMPLETED|Overall Study||5
11322629|NCT02427568|12519888|FG001|COMPLETED|Overall Study||13
11322630|NCT02427568|12519887|FG000|NOT COMPLETED|Overall Study||0
11407728|NCT03805386|12602947|FG000|STARTED|Overall Study||32
11407729|NCT03805386|12602948|FG001|STARTED|Overall Study||33
11407730|NCT03805386|12602947|FG000|COMPLETED|Overall Study||32
11407731|NCT03805386|12602948|FG001|COMPLETED|Overall Study||33
11407732|NCT03805386|12602947|FG000|NOT COMPLETED|Overall Study||0
11407733|NCT03805386|12602948|FG001|NOT COMPLETED|Overall Study||0
11407734|NCT03803475|12602957|FG000|STARTED|Overall Study||485
11407735|NCT03803475|12602957|FG000|COMPLETED|Overall Study||484
11407736|NCT03803475|12602957|FG000|NOT COMPLETED|Overall Study||1
11407737|NCT03802227|12602963|FG000|STARTED|Overall Study||4
11407738|NCT03802227|12602964|FG001|STARTED|Overall Study||4
11407739|NCT03802227|12602963|FG000|COMPLETED|Overall Study||4
11407740|NCT03802227|12602964|FG001|COMPLETED|Overall Study||4
11407741|NCT03802227|12602963|FG000|NOT COMPLETED|Overall Study||0
11407742|NCT03802227|12602964|FG001|NOT COMPLETED|Overall Study||0
11407743|NCT03802864|12602974|FG000|STARTED|Overall Study||25
11407744|NCT03802864|12602975|FG001|STARTED|Overall Study||25
11407745|NCT03802864|12602974|FG000|COMPLETED|Overall Study||25
11407746|NCT03802864|12602975|FG001|COMPLETED|Overall Study||25
11407747|NCT03802864|12602974|FG000|NOT COMPLETED|Overall Study||0
11407748|NCT03802864|12602975|FG001|NOT COMPLETED|Overall Study||0
11407749|NCT03801265|12602983|FG000|STARTED|Overall Study||23
11407750|NCT03801265|12602984|FG001|STARTED|Overall Study||23
11407751|NCT03801265|12602983|FG000|COMPLETED|Overall Study||23
11407752|NCT03801265|12602984|FG001|COMPLETED|Overall Study||23
11407753|NCT03801265|12602983|FG000|NOT COMPLETED|Overall Study||0
11407754|NCT03801265|12602984|FG001|NOT COMPLETED|Overall Study||0
11407755|NCT03802344|12602993|FG000|STARTED|Overall Study||213
11407756|NCT03802344|12602994|FG001|STARTED|Overall Study||209
11407757|NCT03802344|12602995|FG002|STARTED|Overall Study||68
11407758|NCT03802344|12602993|FG000|COMPLETED|Overall Study||205
11407759|NCT03802344|12602994|FG001|COMPLETED|Overall Study||203
11407760|NCT03802344|12602995|FG002|COMPLETED|Overall Study||55
11407761|NCT03802344|12602993|FG000|NOT COMPLETED|Overall Study||8
11407762|NCT03802344|12602994|FG001|NOT COMPLETED|Overall Study||6
11407763|NCT03802344|12602995|FG002|NOT COMPLETED|Overall Study||13
11407764|NCT03801928|12603010|FG000|STARTED|Overall Study||18
11407765|NCT03801928|12603011|FG001|STARTED|Overall Study||21
11407766|NCT03801928|12603012|FG002|STARTED|Overall Study||9
11407767|NCT03801928|12603013|FG003|STARTED|Overall Study||21
11407768|NCT03801928|12603014|FG004|STARTED|Overall Study||36
11407769|NCT03801928|12603015|FG005|STARTED|Overall Study||10
11407770|NCT03801928|12603010|FG000|COMPLETED|Overall Study||12
11407771|NCT03801928|12603011|FG001|COMPLETED|Overall Study||18
11407772|NCT03801928|12603012|FG002|COMPLETED|Overall Study||4
11407773|NCT03801928|12603013|FG003|COMPLETED|Overall Study||13
11407774|NCT03801928|12603014|FG004|COMPLETED|Overall Study||32
11407775|NCT03801928|12603015|FG005|COMPLETED|Overall Study||5
11407776|NCT03801928|12603010|FG000|NOT COMPLETED|Overall Study||6
11407777|NCT03801928|12603011|FG001|NOT COMPLETED|Overall Study||3
11407778|NCT03801928|12603012|FG002|NOT COMPLETED|Overall Study||5
11407779|NCT03801928|12603013|FG003|NOT COMPLETED|Overall Study||8
11407780|NCT03801928|12603014|FG004|NOT COMPLETED|Overall Study||4
11407781|NCT03801928|12603015|FG005|NOT COMPLETED|Overall Study||5
11407782|NCT03800173|12603037|FG000|STARTED|Overall Study||8
11407783|NCT03800173|12603038|FG001|STARTED|Overall Study||6
11407784|NCT03800173|12603039|FG002|STARTED|Overall Study||6
11407785|NCT03800173|12603040|FG003|STARTED|Overall Study||6
11407786|NCT03800173|12603041|FG004|STARTED|Overall Study||6
11407787|NCT03800173|12603037|FG000|Safety Population|Overall Study||8
11407788|NCT03800173|12603038|FG001|Safety Population|Overall Study||6
11407789|NCT03800173|12603039|FG002|Safety Population|Overall Study||6
11407790|NCT03800173|12603040|FG003|Safety Population|Overall Study||6
11407791|NCT03800173|12603041|FG004|Safety Population|Overall Study||6
11407792|NCT03800173|12603037|FG000|PK Population|Overall Study||0
11407793|NCT03800173|12603038|FG001|PK Population|Overall Study||6
11407794|NCT03800173|12603039|FG002|PK Population|Overall Study||6
11407795|NCT03800173|12603040|FG003|PK Population|Overall Study||6
11407796|NCT03800173|12603041|FG004|PK Population|Overall Study||6
11407797|NCT03800173|12603037|FG000|COMPLETED|Overall Study||8
11407798|NCT03800173|12603038|FG001|COMPLETED|Overall Study||6
11407799|NCT03800173|12603039|FG002|COMPLETED|Overall Study||6
11407800|NCT03800173|12603040|FG003|COMPLETED|Overall Study||6
11407801|NCT03800173|12603041|FG004|COMPLETED|Overall Study||5
11407802|NCT03800173|12603037|FG000|NOT COMPLETED|Overall Study||0
11407803|NCT03800173|12603038|FG001|NOT COMPLETED|Overall Study||0
11407804|NCT03800173|12603039|FG002|NOT COMPLETED|Overall Study||0
11407805|NCT03800173|12603040|FG003|NOT COMPLETED|Overall Study||0
11407806|NCT03800173|12603041|FG004|NOT COMPLETED|Overall Study||1
11407807|NCT03799783|12603057|FG000|STARTED|Overall Study||19
11407808|NCT03799783|12603057|FG000|COMPLETED|Overall Study||19
11407809|NCT03799783|12603057|FG000|NOT COMPLETED|Overall Study||0
11407810|NCT03800030|12603061|FG000|STARTED|Baseline||4
11407811|NCT03800030|12603062|FG001|STARTED|Baseline||4
11407812|NCT03800030|12603063|FG002|STARTED|Baseline||4
11407813|NCT03800030|12603064|FG003|STARTED|Baseline||6
11407814|NCT03800030|12603065|FG004|STARTED|Baseline||4
11407815|NCT03800030|12603066|FG005|STARTED|Baseline||4
11407816|NCT03800030|12603061|FG000|COMPLETED|Baseline||4
11407817|NCT03800030|12603062|FG001|COMPLETED|Baseline||4
11407818|NCT03800030|12603063|FG002|COMPLETED|Baseline||4
11407819|NCT03800030|12603064|FG003|COMPLETED|Baseline||6
11407820|NCT03800030|12603065|FG004|COMPLETED|Baseline||4
11407821|NCT03800030|12603066|FG005|COMPLETED|Baseline||4
11407822|NCT03800030|12603061|FG000|NOT COMPLETED|Baseline||0
11407823|NCT03800030|12603062|FG001|NOT COMPLETED|Baseline||0
11407824|NCT03800030|12603063|FG002|NOT COMPLETED|Baseline||0
11407825|NCT03800030|12603064|FG003|NOT COMPLETED|Baseline||0
11407826|NCT03800030|12603065|FG004|NOT COMPLETED|Baseline||0
11407827|NCT03800030|12603066|FG005|NOT COMPLETED|Baseline||0
11407828|NCT03800030|12603061|FG000|STARTED|Pre-Randomization Period (1 Week)||4
11407829|NCT03800030|12603062|FG001|STARTED|Pre-Randomization Period (1 Week)||4
11407830|NCT03800030|12603063|FG002|STARTED|Pre-Randomization Period (1 Week)||4
11407831|NCT03800030|12603064|FG003|STARTED|Pre-Randomization Period (1 Week)||6
11407832|NCT03800030|12603065|FG004|STARTED|Pre-Randomization Period (1 Week)||4
11407833|NCT03800030|12603066|FG005|STARTED|Pre-Randomization Period (1 Week)||4
11407834|NCT03800030|12603061|FG000|COMPLETED|Pre-Randomization Period (1 Week)||4
11407835|NCT03800030|12603062|FG001|COMPLETED|Pre-Randomization Period (1 Week)||4
11407836|NCT03800030|12603063|FG002|COMPLETED|Pre-Randomization Period (1 Week)||4
11407837|NCT03800030|12603064|FG003|COMPLETED|Pre-Randomization Period (1 Week)||6
11407838|NCT03800030|12603065|FG004|COMPLETED|Pre-Randomization Period (1 Week)||4
11407839|NCT03800030|12603066|FG005|COMPLETED|Pre-Randomization Period (1 Week)||4
11407840|NCT03800030|12603061|FG000|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
11407841|NCT03800030|12603062|FG001|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
11407842|NCT03800030|12603063|FG002|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
11407843|NCT03800030|12603064|FG003|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
11407844|NCT03800030|12603065|FG004|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
11407845|NCT03800030|12603066|FG005|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
11407846|NCT03800030|12603061|FG000|STARTED|First Intervention||4
11407847|NCT03800030|12603062|FG001|STARTED|First Intervention||4
11407848|NCT03800030|12603063|FG002|STARTED|First Intervention||4
11407849|NCT03800030|12603064|FG003|STARTED|First Intervention||6
11407850|NCT03800030|12603065|FG004|STARTED|First Intervention||4
11407851|NCT03800030|12603066|FG005|STARTED|First Intervention||4
11407852|NCT03800030|12603061|FG000|COMPLETED|First Intervention||4
11407853|NCT03800030|12603062|FG001|COMPLETED|First Intervention||4
11407854|NCT03800030|12603063|FG002|COMPLETED|First Intervention||4
11407855|NCT03800030|12603064|FG003|COMPLETED|First Intervention||6
11407856|NCT03800030|12603065|FG004|COMPLETED|First Intervention||4
11407857|NCT03800030|12603066|FG005|COMPLETED|First Intervention||4
11407858|NCT03800030|12603061|FG000|NOT COMPLETED|First Intervention||0
11407859|NCT03800030|12603062|FG001|NOT COMPLETED|First Intervention||0
11407860|NCT03800030|12603063|FG002|NOT COMPLETED|First Intervention||0
11407861|NCT03800030|12603064|FG003|NOT COMPLETED|First Intervention||0
11407862|NCT03800030|12603065|FG004|NOT COMPLETED|First Intervention||0
11407863|NCT03800030|12603066|FG005|NOT COMPLETED|First Intervention||0
11407864|NCT03800030|12603061|FG000|STARTED|First Washout (1 Week)||4
11407865|NCT03800030|12603062|FG001|STARTED|First Washout (1 Week)||4
11407866|NCT03800030|12603063|FG002|STARTED|First Washout (1 Week)||4
11407867|NCT03800030|12603064|FG003|STARTED|First Washout (1 Week)||6
11407868|NCT03800030|12603065|FG004|STARTED|First Washout (1 Week)||4
11407869|NCT03800030|12603066|FG005|STARTED|First Washout (1 Week)||4
11407870|NCT03800030|12603061|FG000|COMPLETED|First Washout (1 Week)||4
11407871|NCT03800030|12603062|FG001|COMPLETED|First Washout (1 Week)||4
11407872|NCT03800030|12603063|FG002|COMPLETED|First Washout (1 Week)||4
11407873|NCT03800030|12603064|FG003|COMPLETED|First Washout (1 Week)||6
11407874|NCT03800030|12603065|FG004|COMPLETED|First Washout (1 Week)||4
11407875|NCT03800030|12603066|FG005|COMPLETED|First Washout (1 Week)||4
11407876|NCT03800030|12603061|FG000|NOT COMPLETED|First Washout (1 Week)||0
11407877|NCT03800030|12603062|FG001|NOT COMPLETED|First Washout (1 Week)||0
11407878|NCT03800030|12603063|FG002|NOT COMPLETED|First Washout (1 Week)||0
11407879|NCT03800030|12603064|FG003|NOT COMPLETED|First Washout (1 Week)||0
11407880|NCT03800030|12603065|FG004|NOT COMPLETED|First Washout (1 Week)||0
11407881|NCT03800030|12603066|FG005|NOT COMPLETED|First Washout (1 Week)||0
11407882|NCT03800030|12603061|FG000|STARTED|Second Intervention||4
11407883|NCT03800030|12603062|FG001|STARTED|Second Intervention||4
11407884|NCT03800030|12603063|FG002|STARTED|Second Intervention||4
11407885|NCT03800030|12603064|FG003|STARTED|Second Intervention||6
11407886|NCT03800030|12603065|FG004|STARTED|Second Intervention||4
11407887|NCT03800030|12603066|FG005|STARTED|Second Intervention||4
11407888|NCT03800030|12603061|FG000|COMPLETED|Second Intervention||4
11407889|NCT03800030|12603062|FG001|COMPLETED|Second Intervention||4
11407890|NCT03800030|12603063|FG002|COMPLETED|Second Intervention||4
11407891|NCT03800030|12603064|FG003|COMPLETED|Second Intervention||5
11407892|NCT03800030|12603065|FG004|COMPLETED|Second Intervention||4
11407893|NCT03800030|12603066|FG005|COMPLETED|Second Intervention||4
11407894|NCT03800030|12603061|FG000|NOT COMPLETED|Second Intervention||0
11407895|NCT03800030|12603062|FG001|NOT COMPLETED|Second Intervention||0
11407896|NCT03800030|12603063|FG002|NOT COMPLETED|Second Intervention||0
11407897|NCT03800030|12603064|FG003|NOT COMPLETED|Second Intervention||1
11407898|NCT03800030|12603065|FG004|NOT COMPLETED|Second Intervention||0
11407899|NCT03800030|12603066|FG005|NOT COMPLETED|Second Intervention||0
11407900|NCT03800030|12603061|FG000|STARTED|Second Washout (1 Week)||4
11407901|NCT03800030|12603062|FG001|STARTED|Second Washout (1 Week)||4
11407902|NCT03800030|12603063|FG002|STARTED|Second Washout (1 Week)||4
11407903|NCT03800030|12603064|FG003|STARTED|Second Washout (1 Week)||5
11407904|NCT03800030|12603065|FG004|STARTED|Second Washout (1 Week)||4
11407905|NCT03800030|12603066|FG005|STARTED|Second Washout (1 Week)||4
11407906|NCT03800030|12603061|FG000|COMPLETED|Second Washout (1 Week)||4
11407907|NCT03800030|12603062|FG001|COMPLETED|Second Washout (1 Week)||4
11407908|NCT03800030|12603063|FG002|COMPLETED|Second Washout (1 Week)||4
11407909|NCT03800030|12603064|FG003|COMPLETED|Second Washout (1 Week)||4
11407910|NCT03800030|12603065|FG004|COMPLETED|Second Washout (1 Week)||4
11407911|NCT03800030|12603066|FG005|COMPLETED|Second Washout (1 Week)||4
11407912|NCT03800030|12603061|FG000|NOT COMPLETED|Second Washout (1 Week)||0
11407913|NCT03800030|12603062|FG001|NOT COMPLETED|Second Washout (1 Week)||0
11407914|NCT03800030|12603063|FG002|NOT COMPLETED|Second Washout (1 Week)||0
11407915|NCT03800030|12603064|FG003|NOT COMPLETED|Second Washout (1 Week)||1
11407916|NCT03800030|12603065|FG004|NOT COMPLETED|Second Washout (1 Week)||0
11407917|NCT03800030|12603066|FG005|NOT COMPLETED|Second Washout (1 Week)||0
11407918|NCT03800030|12603061|FG000|STARTED|Third Intervention||4
11407919|NCT03800030|12603062|FG001|STARTED|Third Intervention||4
11407920|NCT03800030|12603063|FG002|STARTED|Third Intervention||4
11407921|NCT03800030|12603064|FG003|STARTED|Third Intervention||4
11407922|NCT03800030|12603065|FG004|STARTED|Third Intervention||4
11407923|NCT03800030|12603066|FG005|STARTED|Third Intervention||4
11407924|NCT03800030|12603061|FG000|COMPLETED|Third Intervention||4
11407925|NCT03800030|12603062|FG001|COMPLETED|Third Intervention||4
11407926|NCT03800030|12603063|FG002|COMPLETED|Third Intervention||4
11407927|NCT03800030|12603064|FG003|COMPLETED|Third Intervention||4
11407928|NCT03800030|12603065|FG004|COMPLETED|Third Intervention||4
11407929|NCT03800030|12603066|FG005|COMPLETED|Third Intervention||4
11407930|NCT03800030|12603061|FG000|NOT COMPLETED|Third Intervention||0
11407931|NCT03800030|12603062|FG001|NOT COMPLETED|Third Intervention||0
11407932|NCT03800030|12603063|FG002|NOT COMPLETED|Third Intervention||0
11407933|NCT03800030|12603064|FG003|NOT COMPLETED|Third Intervention||0
11407934|NCT03800030|12603065|FG004|NOT COMPLETED|Third Intervention||0
11407935|NCT03800030|12603066|FG005|NOT COMPLETED|Third Intervention||0
11407936|NCT03799211|12603076|FG000|STARTED|Overall Study||36
11407937|NCT03799211|12603077|FG001|STARTED|Overall Study||40
11407938|NCT03799211|12603076|FG000|COMPLETED|Overall Study||32
11407939|NCT03799211|12603077|FG001|COMPLETED|Overall Study||27
11407940|NCT03799211|12603076|FG000|NOT COMPLETED|Overall Study||4
11407941|NCT03799211|12603077|FG001|NOT COMPLETED|Overall Study||13
11407942|NCT03798717|12603091|FG000|STARTED|Overall Study||4
11407943|NCT03798717|12603092|FG001|STARTED|Overall Study||3
11407944|NCT03798717|12603093|FG002|STARTED|Overall Study||3
11407945|NCT03798717|12603094|FG003|STARTED|Overall Study||4
11407946|NCT03798717|12603095|FG004|STARTED|Overall Study||3
11407947|NCT03798717|12603096|FG005|STARTED|Overall Study||3
11407948|NCT03798717|12603091|FG000|COMPLETED|Overall Study||2
11407949|NCT03798717|12603092|FG001|COMPLETED|Overall Study||2
11407950|NCT03798717|12603093|FG002|COMPLETED|Overall Study||2
11407951|NCT03798717|12603094|FG003|COMPLETED|Overall Study||2
11407952|NCT03798717|12603095|FG004|COMPLETED|Overall Study||2
11407953|NCT03798717|12603096|FG005|COMPLETED|Overall Study||2
11407954|NCT03798717|12603091|FG000|NOT COMPLETED|Overall Study||2
11407955|NCT03798717|12603092|FG001|NOT COMPLETED|Overall Study||1
11407956|NCT03798717|12603093|FG002|NOT COMPLETED|Overall Study||1
11407957|NCT03798717|12603094|FG003|NOT COMPLETED|Overall Study||2
11407958|NCT03798717|12603095|FG004|NOT COMPLETED|Overall Study||1
11407959|NCT03798717|12603096|FG005|NOT COMPLETED|Overall Study||1
11407960|NCT03798483|12603105|FG000|STARTED|Overall Study||15
11407961|NCT03798483|12603105|FG000|Returned All Follow-up Outcome Data|Overall Study||11
11407962|NCT03798483|12603105|FG000|COMPLETED|Overall Study||13
11407963|NCT03798483|12603105|FG000|NOT COMPLETED|Overall Study||2
11407964|NCT03798366|12603115|FG000|STARTED|Overall Study||21
11407965|NCT03798366|12603116|FG001|STARTED|Overall Study||12
11407966|NCT03798366|12603115|FG000|COMPLETED|Overall Study||21
11407967|NCT03798366|12603116|FG001|COMPLETED|Overall Study||11
11407968|NCT03798366|12603115|FG000|NOT COMPLETED|Overall Study||0
11407969|NCT03798366|12603116|FG001|NOT COMPLETED|Overall Study||1
11407970|NCT03799952|12603124|FG000|STARTED|Overall Study||31
11407971|NCT03799952|12603125|FG001|STARTED|Overall Study||31
11407972|NCT03799952|12603124|FG000|COMPLETED|Overall Study||30
11407973|NCT03799952|12603125|FG001|COMPLETED|Overall Study||29
11407974|NCT03799952|12603124|FG000|NOT COMPLETED|Overall Study||1
11407975|NCT03799952|12603125|FG001|NOT COMPLETED|Overall Study||2
11407976|NCT03797872|12603133|FG000|STARTED|Overall Study||1
11407977|NCT03797872|12603134|FG001|STARTED|Overall Study||0
11407978|NCT03797872|12603133|FG000|COMPLETED|Overall Study||0
11407979|NCT03797872|12603134|FG001|COMPLETED|Overall Study||0
11407980|NCT03797872|12603133|FG000|NOT COMPLETED|Overall Study||1
11407981|NCT03797872|12603134|FG001|NOT COMPLETED|Overall Study||0
11407982|NCT03799614|12603142|FG000|STARTED|Overall Study||15
11407983|NCT03799614|12603143|FG001|STARTED|Overall Study||15
11407984|NCT03799614|12603142|FG000|COMPLETED|Overall Study||15
11407985|NCT03799614|12603143|FG001|COMPLETED|Overall Study||15
11407986|NCT03799614|12603142|FG000|NOT COMPLETED|Overall Study||0
11407987|NCT03799614|12603143|FG001|NOT COMPLETED|Overall Study||0
11407988|NCT03799484|12603152|FG000|STARTED|Overall Study||14
11407989|NCT03799484|12603152|FG000|COMPLETED|Overall Study||14
11407990|NCT03799484|12603152|FG000|NOT COMPLETED|Overall Study||0
11407991|NCT03796728|12603159|FG000|STARTED|Overall Study||60
11407992|NCT03796728|12603159|FG000|COMPLETED|Overall Study||36
11407993|NCT03796728|12603159|FG000|NOT COMPLETED|Overall Study||24
11407994|NCT03797144|12603165|FG000|STARTED|Enrollment||16
11407995|NCT03797144|12603166|FG001|STARTED|Enrollment||11
11407996|NCT03797144|12603165|FG000|COMPLETED|Enrollment||12
11407997|NCT03797144|12603166|FG001|COMPLETED|Enrollment||10
11407998|NCT03797144|12603165|FG000|NOT COMPLETED|Enrollment||4
11407999|NCT03797144|12603166|FG001|NOT COMPLETED|Enrollment||1
11408000|NCT03797144|12603165|FG000|STARTED|Surgery||12
11408001|NCT03797144|12603166|FG001|STARTED|Surgery||10
11408002|NCT03797144|12603165|FG000|COMPLETED|Surgery||11
11408003|NCT03797144|12603166|FG001|COMPLETED|Surgery||10
11408004|NCT03797144|12603165|FG000|NOT COMPLETED|Surgery||1
11408005|NCT03797144|12603166|FG001|NOT COMPLETED|Surgery||0
11408006|NCT03797144|12603165|FG000|STARTED|3 Month||11
11408007|NCT03797144|12603166|FG001|STARTED|3 Month||10
11408008|NCT03797144|12603165|FG000|COMPLETED|3 Month||9
11408009|NCT03797144|12603166|FG001|COMPLETED|3 Month||10
11408010|NCT03797144|12603165|FG000|NOT COMPLETED|3 Month||2
11408011|NCT03797144|12603166|FG001|NOT COMPLETED|3 Month||0
11408012|NCT03797144|12603165|FG000|STARTED|12 Month||9
11408013|NCT03797144|12603166|FG001|STARTED|12 Month||10
11408014|NCT03797144|12603165|FG000|COMPLETED|12 Month||1
11408015|NCT03797144|12603166|FG001|COMPLETED|12 Month||1
11408016|NCT03797144|12603165|FG000|NOT COMPLETED|12 Month||8
11408017|NCT03797144|12603166|FG001|NOT COMPLETED|12 Month||9
11408018|NCT03797144|12603165|FG000|STARTED|24 Month||1
11408019|NCT03797144|12603166|FG001|STARTED|24 Month||1
11408020|NCT03797144|12603165|FG000|COMPLETED|24 Month||0
11408021|NCT03797144|12603166|FG001|COMPLETED|24 Month||0
11408022|NCT03797144|12603165|FG000|NOT COMPLETED|24 Month||1
11408023|NCT03797144|12603166|FG001|NOT COMPLETED|24 Month||1
11408024|NCT03782571|12603173|FG000|STARTED|Period 1||6
11408025|NCT03782571|12603174|FG001|STARTED|Period 1||6
11408026|NCT03782571|12603175|FG002|STARTED|Period 1||6
11408027|NCT03782571|12603176|FG003|STARTED|Period 1||7
11408028|NCT03782571|12603173|FG000|COMPLETED|Period 1||5
11408029|NCT03782571|12603174|FG001|COMPLETED|Period 1||6
11408030|NCT03782571|12603175|FG002|COMPLETED|Period 1||6
11408031|NCT03782571|12603176|FG003|COMPLETED|Period 1||7
11408032|NCT03782571|12603173|FG000|NOT COMPLETED|Period 1||1
11408033|NCT03782571|12603174|FG001|NOT COMPLETED|Period 1||0
11408034|NCT03782571|12603175|FG002|NOT COMPLETED|Period 1||0
11408035|NCT03782571|12603176|FG003|NOT COMPLETED|Period 1||0
11408036|NCT03782571|12603173|FG000|STARTED|Period 2||5
11408037|NCT03782571|12603174|FG001|STARTED|Period 2||6
11408038|NCT03782571|12603175|FG002|STARTED|Period 2||6
11408039|NCT03782571|12603176|FG003|STARTED|Period 2||7
11408040|NCT03782571|12603173|FG000|COMPLETED|Period 2||5
11408041|NCT03782571|12603174|FG001|COMPLETED|Period 2||6
11408042|NCT03782571|12603175|FG002|COMPLETED|Period 2||6
11408043|NCT03782571|12603176|FG003|COMPLETED|Period 2||7
11408044|NCT03782571|12603173|FG000|NOT COMPLETED|Period 2||0
11408045|NCT03782571|12603174|FG001|NOT COMPLETED|Period 2||0
11408046|NCT03782571|12603175|FG002|NOT COMPLETED|Period 2||0
11408047|NCT03782571|12603176|FG003|NOT COMPLETED|Period 2||0
11408048|NCT03782571|12603173|FG000|STARTED|Period 3||5
11408049|NCT03782571|12603174|FG001|STARTED|Period 3||6
11408050|NCT03782571|12603175|FG002|STARTED|Period 3||6
11408051|NCT03782571|12603176|FG003|STARTED|Period 3||7
11408052|NCT03782571|12603173|FG000|COMPLETED|Period 3||3
11408053|NCT03782571|12603174|FG001|COMPLETED|Period 3||6
11408054|NCT03782571|12603175|FG002|COMPLETED|Period 3||6
11408055|NCT03782571|12603176|FG003|COMPLETED|Period 3||7
11408056|NCT03782571|12603173|FG000|NOT COMPLETED|Period 3||2
11408057|NCT03782571|12603174|FG001|NOT COMPLETED|Period 3||0
11408058|NCT03782571|12603175|FG002|NOT COMPLETED|Period 3||0
11408059|NCT03782571|12603176|FG003|NOT COMPLETED|Period 3||0
11408060|NCT03782571|12603173|FG000|STARTED|Period 4||3
11408061|NCT03782571|12603174|FG001|STARTED|Period 4||6
11408062|NCT03782571|12603175|FG002|STARTED|Period 4||6
11408063|NCT03782571|12603176|FG003|STARTED|Period 4||7
11408064|NCT03782571|12603173|FG000|COMPLETED|Period 4||3
11408065|NCT03782571|12603174|FG001|COMPLETED|Period 4||6
11408066|NCT03782571|12603175|FG002|COMPLETED|Period 4||6
11408067|NCT03782571|12603176|FG003|COMPLETED|Period 4||7
11408068|NCT03782571|12603173|FG000|NOT COMPLETED|Period 4||0
11408069|NCT03782571|12603174|FG001|NOT COMPLETED|Period 4||0
11408070|NCT03782571|12603175|FG002|NOT COMPLETED|Period 4||0
11408071|NCT03782571|12603176|FG003|NOT COMPLETED|Period 4||0
11408072|NCT03796260|12603190|FG000|STARTED|Period 1||7
11408073|NCT03796260|12603191|FG001|STARTED|Period 1||7
11408074|NCT03796260|12603190|FG000|COMPLETED|Period 1||7
11408075|NCT03796260|12603191|FG001|COMPLETED|Period 1||7
11408076|NCT03796260|12603190|FG000|NOT COMPLETED|Period 1||0
11408077|NCT03796260|12603191|FG001|NOT COMPLETED|Period 1||0
11408078|NCT03796260|12603190|FG000|STARTED|Period 2||7
11408079|NCT03796260|12603191|FG001|STARTED|Period 2||7
11408080|NCT03796260|12603190|FG000|COMPLETED|Period 2||7
11408081|NCT03796260|12603191|FG001|COMPLETED|Period 2||7
11408082|NCT03796260|12603190|FG000|NOT COMPLETED|Period 2||0
11408083|NCT03796260|12603191|FG001|NOT COMPLETED|Period 2||0
11408084|NCT03796039|12603199|FG000|STARTED|Overall Study||50
11408085|NCT03796039|12603200|FG001|STARTED|Overall Study||47
11408086|NCT03796039|12603199|FG000|COMPLETED|Overall Study||41
11408087|NCT03796039|12603200|FG001|COMPLETED|Overall Study||42
11408088|NCT03796039|12603199|FG000|NOT COMPLETED|Overall Study||9
11408089|NCT03796039|12603200|FG001|NOT COMPLETED|Overall Study||5
11408090|NCT03783780|12603206|FG000|STARTED|Overall Study||21
11408091|NCT03783780|12603206|FG000|COMPLETED|Overall Study||20
11408092|NCT03783780|12603206|FG000|NOT COMPLETED|Overall Study||1
11408093|NCT03780959|12603214|FG000|STARTED|Part 1||69
11408094|NCT03780959|12603215|FG001|STARTED|Part 1||0
11408095|NCT03780959|12603216|FG002|STARTED|Part 1||0
11408096|NCT03780959|12603214|FG000|COMPLETED|Part 1||64
11408097|NCT03780959|12603215|FG001|COMPLETED|Part 1||0
11408098|NCT03780959|12603216|FG002|COMPLETED|Part 1||0
11408099|NCT03780959|12603214|FG000|NOT COMPLETED|Part 1||5
11408100|NCT03780959|12603215|FG001|NOT COMPLETED|Part 1||0
11408101|NCT03780959|12603216|FG002|NOT COMPLETED|Part 1||0
11408102|NCT03780959|12603214|FG000|STARTED|Part 2||0
11408103|NCT03780959|12603215|FG001|STARTED|Part 2||26
11408104|NCT03780959|12603216|FG002|STARTED|Part 2||25
11408105|NCT03780959|12603214|FG000|COMPLETED|Part 2||0
11408106|NCT03780959|12603215|FG001|COMPLETED|Part 2||7
11408107|NCT03780959|12603216|FG002|COMPLETED|Part 2||19
11408108|NCT03780959|12603214|FG000|NOT COMPLETED|Part 2||0
11408109|NCT03780959|12603215|FG001|NOT COMPLETED|Part 2||19
11408110|NCT03780959|12603216|FG002|NOT COMPLETED|Part 2||6
11408111|NCT03796182|12603226|FG000|STARTED|Period 1||6
11408112|NCT03796182|12603227|FG001|STARTED|Period 1||6
11408113|NCT03796182|12603226|FG000|COMPLETED|Period 1||6
11408114|NCT03796182|12603227|FG001|COMPLETED|Period 1||6
11408115|NCT03796182|12603226|FG000|NOT COMPLETED|Period 1||0
11408116|NCT03796182|12603227|FG001|NOT COMPLETED|Period 1||0
11408117|NCT03796182|12603226|FG000|STARTED|Washout Period||6
11408118|NCT03796182|12603227|FG001|STARTED|Washout Period||6
11408119|NCT03796182|12603226|FG000|COMPLETED|Washout Period||6
11408120|NCT03796182|12603227|FG001|COMPLETED|Washout Period||6
11408121|NCT03796182|12603226|FG000|NOT COMPLETED|Washout Period||0
11408122|NCT03796182|12603227|FG001|NOT COMPLETED|Washout Period||0
11408123|NCT03796182|12603226|FG000|STARTED|Period 2||6
11408124|NCT03796182|12603227|FG001|STARTED|Period 2||6
11408125|NCT03796182|12603226|FG000|COMPLETED|Period 2||6
11408126|NCT03796182|12603227|FG001|COMPLETED|Period 2||6
11408127|NCT03796182|12603226|FG000|NOT COMPLETED|Period 2||0
11408128|NCT03796182|12603227|FG001|NOT COMPLETED|Period 2||0
11408129|NCT03796013|12603235|FG000|STARTED|Period 1||14
11408130|NCT03796013|12603236|FG001|STARTED|Period 1||14
11408131|NCT03796013|12603235|FG000|COMPLETED|Period 1||14
11408132|NCT03796013|12603236|FG001|COMPLETED|Period 1||14
11408133|NCT03796013|12603235|FG000|NOT COMPLETED|Period 1||0
11408134|NCT03796013|12603236|FG001|NOT COMPLETED|Period 1||0
11408135|NCT03796013|12603235|FG000|STARTED|Period 2||14
11408136|NCT03796013|12603236|FG001|STARTED|Period 2||14
11408137|NCT03796013|12603235|FG000|COMPLETED|Period 2||14
11408138|NCT03796013|12603236|FG001|COMPLETED|Period 2||14
11408139|NCT03796013|12603235|FG000|NOT COMPLETED|Period 2||0
11408140|NCT03796013|12603236|FG001|NOT COMPLETED|Period 2||0
11408141|NCT03795753|12603244|FG000|STARTED|Overall Study||23
11408142|NCT03795753|12603245|FG001|STARTED|Overall Study||13
11408143|NCT03795753|12603244|FG000|COMPLETED|Overall Study||23
11408144|NCT03795753|12603245|FG001|COMPLETED|Overall Study||13
11408145|NCT03795753|12603244|FG000|NOT COMPLETED|Overall Study||0
11408146|NCT03795753|12603245|FG001|NOT COMPLETED|Overall Study||0
11408147|NCT03792477|12603256|FG000|STARTED|Overall Study||6
11408148|NCT03792477|12603257|FG001|STARTED|Overall Study||6
11408149|NCT03792477|12603258|FG002|STARTED|Overall Study||21
11408150|NCT03792477|12603259|FG003|STARTED|Overall Study||21
11408151|NCT03792477|12603260|FG004|STARTED|Overall Study||20
11408152|NCT03792477|12603256|FG000|COMPLETED|Overall Study||6
11408153|NCT03792477|12603257|FG001|COMPLETED|Overall Study||6
11408154|NCT03792477|12603258|FG002|COMPLETED|Overall Study||19
11408155|NCT03792477|12603259|FG003|COMPLETED|Overall Study||20
11408156|NCT03792477|12603260|FG004|COMPLETED|Overall Study||19
11408157|NCT03792477|12603256|FG000|NOT COMPLETED|Overall Study||0
11408158|NCT03792477|12603257|FG001|NOT COMPLETED|Overall Study||0
11408159|NCT03792477|12603258|FG002|NOT COMPLETED|Overall Study||2
11408160|NCT03792477|12603259|FG003|NOT COMPLETED|Overall Study||1
11408161|NCT03792477|12603260|FG004|NOT COMPLETED|Overall Study||1
11408162|NCT03783962|12603268|FG000|STARTED|Overall Study||28
11408163|NCT03783962|12603269|FG001|STARTED|Overall Study||28
11408164|NCT03783962|12603268|FG000|COMPLETED|Overall Study||25
11408165|NCT03783962|12603269|FG001|COMPLETED|Overall Study||21
11408166|NCT03783962|12603268|FG000|NOT COMPLETED|Overall Study||3
11408167|NCT03783962|12603269|FG001|NOT COMPLETED|Overall Study||7
11408168|NCT03782272|12603277|FG000|STARTED|Overall Study||6
11408169|NCT03782272|12603278|FG001|STARTED|Overall Study||6
11408170|NCT03782272|12603277|FG000|COMPLETED|Overall Study||6
11408171|NCT03782272|12603278|FG001|COMPLETED|Overall Study||6
11408172|NCT03782272|12603277|FG000|NOT COMPLETED|Overall Study||0
11408173|NCT03782272|12603278|FG001|NOT COMPLETED|Overall Study||0
11408174|NCT03779724|12603287|FG000|STARTED|Overall Study||25
11408175|NCT03779724|12603288|FG001|STARTED|Overall Study||25
11408176|NCT03779724|12603287|FG000|COMPLETED|Overall Study||19
11408177|NCT03779724|12603288|FG001|COMPLETED|Overall Study||21
11408178|NCT03779724|12603287|FG000|NOT COMPLETED|Overall Study||6
11408179|NCT03779724|12603288|FG001|NOT COMPLETED|Overall Study||4
11408180|NCT03775915|12603298|FG000|STARTED|Overall Study||12
11408181|NCT03775915|12603299|FG001|STARTED|Overall Study||12
11408182|NCT03775915|12603298|FG000|COMPLETED|Overall Study||12
11408183|NCT03775915|12603299|FG001|COMPLETED|Overall Study||12
11408184|NCT03775915|12603298|FG000|NOT COMPLETED|Overall Study||0
11408185|NCT03775915|12603299|FG001|NOT COMPLETED|Overall Study||0
11408186|NCT03794752|12603305|FG000|STARTED|Overall Study||8
11408187|NCT03794752|12603305|FG000|COMPLETED|Overall Study||8
11408188|NCT03794752|12603305|FG000|NOT COMPLETED|Overall Study||0
11408189|NCT03793751|12603315|FG000|STARTED|Overall Study||60
11408190|NCT03793751|12603316|FG001|STARTED|Overall Study||60
11408191|NCT03793751|12603315|FG000|COMPLETED|Overall Study||60
11408192|NCT03793751|12603316|FG001|COMPLETED|Overall Study||60
11408193|NCT03793751|12603315|FG000|NOT COMPLETED|Overall Study||0
11408194|NCT03793751|12603316|FG001|NOT COMPLETED|Overall Study||0
11408195|NCT03793556|12603324|FG000|STARTED|Overall Study||35
11408196|NCT03793556|12603325|FG001|STARTED|Overall Study||36
11408197|NCT03793556|12603324|FG000|COMPLETED|Overall Study||22
11408198|NCT03793556|12603325|FG001|COMPLETED|Overall Study||34
11408199|NCT03793556|12603324|FG000|NOT COMPLETED|Overall Study||13
11408200|NCT03793556|12603325|FG001|NOT COMPLETED|Overall Study||2
11408201|NCT03785548|12603336|FG000|STARTED|Overall Study||73
11408202|NCT03785548|12603337|FG001|STARTED|Overall Study||74
11408203|NCT03785548|12603336|FG000|COMPLETED|Overall Study||71
11408204|NCT03785548|12603337|FG001|COMPLETED|Overall Study||74
11408205|NCT03785548|12603336|FG000|NOT COMPLETED|Overall Study||2
11408206|NCT03785548|12603337|FG001|NOT COMPLETED|Overall Study||0
11408207|NCT03782701|12603343|FG000|STARTED|Overall Study||43
11408208|NCT03782701|12603343|FG000|Lumify|Overall Study||43
11408209|NCT03782701|12603343|FG000|Saline Solution|Overall Study||43
11408210|NCT03782701|12603343|FG000|COMPLETED|Overall Study||43
11408211|NCT03782701|12603343|FG000|NOT COMPLETED|Overall Study||0
11408212|NCT03792672|12603349|FG000|STARTED|Treatment Period 1 (1 Day)||4
11408213|NCT03792672|12603350|FG001|STARTED|Treatment Period 1 (1 Day)||4
11408214|NCT03792672|12603351|FG002|STARTED|Treatment Period 1 (1 Day)||4
11408215|NCT03792672|12603352|FG003|STARTED|Treatment Period 1 (1 Day)||4
11408216|NCT03792672|12603353|FG004|STARTED|Treatment Period 1 (1 Day)||4
11408217|NCT03792672|12603354|FG005|STARTED|Treatment Period 1 (1 Day)||4
11408218|NCT03792672|12603349|FG000|COMPLETED|Treatment Period 1 (1 Day)||4
11408219|NCT03792672|12603350|FG001|COMPLETED|Treatment Period 1 (1 Day)||4
11408220|NCT03792672|12603351|FG002|COMPLETED|Treatment Period 1 (1 Day)||4
11408221|NCT03792672|12603352|FG003|COMPLETED|Treatment Period 1 (1 Day)||4
11408222|NCT03792672|12603353|FG004|COMPLETED|Treatment Period 1 (1 Day)||4
11408223|NCT03792672|12603354|FG005|COMPLETED|Treatment Period 1 (1 Day)||4
11408224|NCT03792672|12603349|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11408225|NCT03792672|12603350|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11408226|NCT03792672|12603351|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11408227|NCT03792672|12603352|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11408228|NCT03792672|12603353|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11408229|NCT03792672|12603354|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11408230|NCT03792672|12603349|FG000|STARTED|Washout Period 1 (10 Days)||4
11408231|NCT03792672|12603350|FG001|STARTED|Washout Period 1 (10 Days)||4
11408232|NCT03792672|12603351|FG002|STARTED|Washout Period 1 (10 Days)||4
11408233|NCT03792672|12603352|FG003|STARTED|Washout Period 1 (10 Days)||4
11408234|NCT03792672|12603353|FG004|STARTED|Washout Period 1 (10 Days)||4
11408235|NCT03792672|12603354|FG005|STARTED|Washout Period 1 (10 Days)||4
11408236|NCT03792672|12603349|FG000|COMPLETED|Washout Period 1 (10 Days)||4
11408237|NCT03792672|12603350|FG001|COMPLETED|Washout Period 1 (10 Days)||4
11408238|NCT03792672|12603351|FG002|COMPLETED|Washout Period 1 (10 Days)||4
11408239|NCT03792672|12603352|FG003|COMPLETED|Washout Period 1 (10 Days)||4
11408240|NCT03792672|12603353|FG004|COMPLETED|Washout Period 1 (10 Days)||4
11408241|NCT03792672|12603354|FG005|COMPLETED|Washout Period 1 (10 Days)||4
11408242|NCT03792672|12603349|FG000|NOT COMPLETED|Washout Period 1 (10 Days)||0
11408243|NCT03792672|12603350|FG001|NOT COMPLETED|Washout Period 1 (10 Days)||0
11408244|NCT03792672|12603351|FG002|NOT COMPLETED|Washout Period 1 (10 Days)||0
11408245|NCT03792672|12603352|FG003|NOT COMPLETED|Washout Period 1 (10 Days)||0
11408246|NCT03792672|12603353|FG004|NOT COMPLETED|Washout Period 1 (10 Days)||0
11408247|NCT03792672|12603354|FG005|NOT COMPLETED|Washout Period 1 (10 Days)||0
11408248|NCT03792672|12603349|FG000|STARTED|Treatment Period 2 (1 Day)||4
11408249|NCT03792672|12603350|FG001|STARTED|Treatment Period 2 (1 Day)||4
11408250|NCT03792672|12603351|FG002|STARTED|Treatment Period 2 (1 Day)||4
11408251|NCT03792672|12603352|FG003|STARTED|Treatment Period 2 (1 Day)||4
11408252|NCT03792672|12603353|FG004|STARTED|Treatment Period 2 (1 Day)||4
11408253|NCT03792672|12603354|FG005|STARTED|Treatment Period 2 (1 Day)||4
11408254|NCT03792672|12603349|FG000|COMPLETED|Treatment Period 2 (1 Day)||4
11408255|NCT03792672|12603350|FG001|COMPLETED|Treatment Period 2 (1 Day)||4
11408256|NCT03792672|12603351|FG002|COMPLETED|Treatment Period 2 (1 Day)||4
11408257|NCT03792672|12603352|FG003|COMPLETED|Treatment Period 2 (1 Day)||4
11408258|NCT03792672|12603353|FG004|COMPLETED|Treatment Period 2 (1 Day)||4
11408259|NCT03792672|12603354|FG005|COMPLETED|Treatment Period 2 (1 Day)||4
11408260|NCT03792672|12603349|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11408261|NCT03792672|12603350|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11408262|NCT03792672|12603351|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11408263|NCT03792672|12603352|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11408264|NCT03792672|12603353|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11408265|NCT03792672|12603354|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11408266|NCT03792672|12603349|FG000|STARTED|Washout Period 2 (10 Days)||4
11408267|NCT03792672|12603350|FG001|STARTED|Washout Period 2 (10 Days)||4
11408268|NCT03792672|12603351|FG002|STARTED|Washout Period 2 (10 Days)||4
11408269|NCT03792672|12603352|FG003|STARTED|Washout Period 2 (10 Days)||4
11408270|NCT03792672|12603353|FG004|STARTED|Washout Period 2 (10 Days)||4
11408271|NCT03792672|12603354|FG005|STARTED|Washout Period 2 (10 Days)||4
11408272|NCT03792672|12603349|FG000|COMPLETED|Washout Period 2 (10 Days)||4
11408273|NCT03792672|12603350|FG001|COMPLETED|Washout Period 2 (10 Days)||4
11408274|NCT03792672|12603351|FG002|COMPLETED|Washout Period 2 (10 Days)||4
11408275|NCT03792672|12603352|FG003|COMPLETED|Washout Period 2 (10 Days)||4
11408276|NCT03792672|12603353|FG004|COMPLETED|Washout Period 2 (10 Days)||4
11408277|NCT03792672|12603354|FG005|COMPLETED|Washout Period 2 (10 Days)||4
11408278|NCT03792672|12603349|FG000|NOT COMPLETED|Washout Period 2 (10 Days)||0
11408279|NCT03792672|12603350|FG001|NOT COMPLETED|Washout Period 2 (10 Days)||0
11408280|NCT03792672|12603351|FG002|NOT COMPLETED|Washout Period 2 (10 Days)||0
11408281|NCT03792672|12603352|FG003|NOT COMPLETED|Washout Period 2 (10 Days)||0
11408282|NCT03792672|12603353|FG004|NOT COMPLETED|Washout Period 2 (10 Days)||0
11408283|NCT03792672|12603354|FG005|NOT COMPLETED|Washout Period 2 (10 Days)||0
11408284|NCT03792672|12603349|FG000|STARTED|Treatment Period 3 (1 Day)||4
11408285|NCT03792672|12603350|FG001|STARTED|Treatment Period 3 (1 Day)||4
11408286|NCT03792672|12603351|FG002|STARTED|Treatment Period 3 (1 Day)||4
11408287|NCT03792672|12603352|FG003|STARTED|Treatment Period 3 (1 Day)||4
11408288|NCT03792672|12603353|FG004|STARTED|Treatment Period 3 (1 Day)||4
11408289|NCT03792672|12603354|FG005|STARTED|Treatment Period 3 (1 Day)||4
11408290|NCT03792672|12603349|FG000|COMPLETED|Treatment Period 3 (1 Day)||4
11408291|NCT03792672|12603350|FG001|COMPLETED|Treatment Period 3 (1 Day)||4
11408292|NCT03792672|12603351|FG002|COMPLETED|Treatment Period 3 (1 Day)||4
11408293|NCT03792672|12603352|FG003|COMPLETED|Treatment Period 3 (1 Day)||4
11408294|NCT03792672|12603353|FG004|COMPLETED|Treatment Period 3 (1 Day)||4
11408295|NCT03792672|12603354|FG005|COMPLETED|Treatment Period 3 (1 Day)||4
11408296|NCT03792672|12603349|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11408297|NCT03792672|12603350|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11408298|NCT03792672|12603351|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11408299|NCT03792672|12603352|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11408300|NCT03792672|12603353|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11408301|NCT03792672|12603354|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11408302|NCT03792672|12603349|FG000|STARTED|Washout Period 3 (10 Days)||4
11408303|NCT03792672|12603350|FG001|STARTED|Washout Period 3 (10 Days)||4
11408304|NCT03792672|12603351|FG002|STARTED|Washout Period 3 (10 Days)||4
11408305|NCT03792672|12603352|FG003|STARTED|Washout Period 3 (10 Days)||4
11408306|NCT03792672|12603353|FG004|STARTED|Washout Period 3 (10 Days)||4
11408307|NCT03792672|12603354|FG005|STARTED|Washout Period 3 (10 Days)||4
11408308|NCT03792672|12603349|FG000|COMPLETED|Washout Period 3 (10 Days)||3
11408309|NCT03792672|12603350|FG001|COMPLETED|Washout Period 3 (10 Days)||4
11408310|NCT03792672|12603351|FG002|COMPLETED|Washout Period 3 (10 Days)||3
11408311|NCT03792672|12603352|FG003|COMPLETED|Washout Period 3 (10 Days)||2
11408312|NCT03792672|12603353|FG004|COMPLETED|Washout Period 3 (10 Days)||4
11408313|NCT03792672|12603354|FG005|COMPLETED|Washout Period 3 (10 Days)||4
11408314|NCT03792672|12603349|FG000|NOT COMPLETED|Washout Period 3 (10 Days)||1
11408315|NCT03792672|12603350|FG001|NOT COMPLETED|Washout Period 3 (10 Days)||0
11408316|NCT03792672|12603351|FG002|NOT COMPLETED|Washout Period 3 (10 Days)||1
11408317|NCT03792672|12603352|FG003|NOT COMPLETED|Washout Period 3 (10 Days)||2
11408318|NCT03792672|12603353|FG004|NOT COMPLETED|Washout Period 3 (10 Days)||0
11408319|NCT03792672|12603354|FG005|NOT COMPLETED|Washout Period 3 (10 Days)||0
11408320|NCT03792672|12603349|FG000|STARTED|Treatment Period 4 (2 Days)||3
11408321|NCT03792672|12603350|FG001|STARTED|Treatment Period 4 (2 Days)||4
11408322|NCT03792672|12603351|FG002|STARTED|Treatment Period 4 (2 Days)||3
11408323|NCT03792672|12603352|FG003|STARTED|Treatment Period 4 (2 Days)||2
11408324|NCT03792672|12603353|FG004|STARTED|Treatment Period 4 (2 Days)||4
11408325|NCT03792672|12603354|FG005|STARTED|Treatment Period 4 (2 Days)||4
11408326|NCT03792672|12603349|FG000|COMPLETED|Treatment Period 4 (2 Days)||2
11408327|NCT03792672|12603350|FG001|COMPLETED|Treatment Period 4 (2 Days)||4
11408328|NCT03792672|12603351|FG002|COMPLETED|Treatment Period 4 (2 Days)||3
11408329|NCT03792672|12603352|FG003|COMPLETED|Treatment Period 4 (2 Days)||2
11408330|NCT03792672|12603353|FG004|COMPLETED|Treatment Period 4 (2 Days)||4
11408331|NCT03792672|12603354|FG005|COMPLETED|Treatment Period 4 (2 Days)||4
11408332|NCT03792672|12603349|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||1
11408333|NCT03792672|12603350|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
11408334|NCT03792672|12603351|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
11408335|NCT03792672|12603352|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
11408336|NCT03792672|12603353|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0
11408337|NCT03792672|12603354|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||0
11408338|NCT03786744|12603366|FG000|STARTED|Overall Study||10
11408339|NCT03786744|12603367|FG001|STARTED|Overall Study||10
11408340|NCT03786744|12603366|FG000|COMPLETED|Overall Study||10
11408341|NCT03786744|12603367|FG001|COMPLETED|Overall Study||10
11408342|NCT03786744|12603366|FG000|NOT COMPLETED|Overall Study||0
11408343|NCT03786744|12603367|FG001|NOT COMPLETED|Overall Study||0
11408344|NCT03782181|12603376|FG000|STARTED|Overall Study||20
11408345|NCT03782181|12603377|FG001|STARTED|Overall Study||20
11408346|NCT03782181|12603376|FG000|COMPLETED|Overall Study||20
11408347|NCT03782181|12603377|FG001|COMPLETED|Overall Study||20
11408348|NCT03782181|12603376|FG000|NOT COMPLETED|Overall Study||0
11408349|NCT03782181|12603377|FG001|NOT COMPLETED|Overall Study||0
11408350|NCT03792191|12603386|FG000|STARTED|Overall Study||140
11408351|NCT03792191|12603387|FG001|STARTED|Overall Study||140
11408352|NCT03792191|12603386|FG000|COMPLETED|Overall Study||140
11408353|NCT03792191|12603387|FG001|COMPLETED|Overall Study||140
11408354|NCT03792191|12603386|FG000|NOT COMPLETED|Overall Study||0
11408355|NCT03792191|12603387|FG001|NOT COMPLETED|Overall Study||0
11408356|NCT03791489|12603393|FG000|STARTED|30 Days||30
11408357|NCT03791489|12603393|FG000|COMPLETED|30 Days||30
11408358|NCT03791489|12603393|FG000|NOT COMPLETED|30 Days||0
11408359|NCT03791489|12603393|FG000|STARTED|90 Days (Primary Endpoint)||30
11408360|NCT03791489|12603393|FG000|COMPLETED|90 Days (Primary Endpoint)||30
11408361|NCT03791489|12603393|FG000|NOT COMPLETED|90 Days (Primary Endpoint)||0
11408362|NCT03790865|12603400|FG000|STARTED|Overall Study||52
11408363|NCT03790865|12603401|FG001|STARTED|Overall Study||52
11408364|NCT03790865|12603402|FG002|STARTED|Overall Study||54
11408365|NCT03790865|12603400|FG000|COMPLETED|Overall Study||52
11408366|NCT03790865|12603401|FG001|COMPLETED|Overall Study||50
11408367|NCT03790865|12603402|FG002|COMPLETED|Overall Study||54
11408368|NCT03790865|12603400|FG000|NOT COMPLETED|Overall Study||0
11408369|NCT03790865|12603401|FG001|NOT COMPLETED|Overall Study||2
11408370|NCT03790865|12603402|FG002|NOT COMPLETED|Overall Study||0
11408371|NCT03784300|12603416|FG000|STARTED|Overall Study||6
11408372|NCT03784300|12603417|FG001|STARTED|Overall Study||2
11408373|NCT03784300|12603418|FG002|STARTED|Overall Study||6
11408374|NCT03784300|12603419|FG003|STARTED|Overall Study||2
11408375|NCT03784300|12603420|FG004|STARTED|Overall Study||6
11408376|NCT03784300|12603421|FG005|STARTED|Overall Study||2
11408377|NCT03784300|12603416|FG000|COMPLETED|Overall Study||6
11408378|NCT03784300|12603417|FG001|COMPLETED|Overall Study||2
11408379|NCT03784300|12603418|FG002|COMPLETED|Overall Study||6
11408380|NCT03784300|12603419|FG003|COMPLETED|Overall Study||2
11408381|NCT03784300|12603420|FG004|COMPLETED|Overall Study||6
11408382|NCT03784300|12603421|FG005|COMPLETED|Overall Study||2
11408383|NCT03784300|12603416|FG000|NOT COMPLETED|Overall Study||0
11408384|NCT03784300|12603417|FG001|NOT COMPLETED|Overall Study||0
11408385|NCT03784300|12603418|FG002|NOT COMPLETED|Overall Study||0
11408386|NCT03784300|12603419|FG003|NOT COMPLETED|Overall Study||0
11408387|NCT03784300|12603420|FG004|NOT COMPLETED|Overall Study||0
11408388|NCT03784300|12603421|FG005|NOT COMPLETED|Overall Study||0
11408389|NCT03790878|12603438|FG000|STARTED|Overall Study||26
11408390|NCT03790878|12603439|FG001|STARTED|Overall Study||27
11408391|NCT03790878|12603440|FG002|STARTED|Overall Study||27
11408392|NCT03790878|12603438|FG000|COMPLETED|Overall Study||26
11408393|NCT03790878|12603439|FG001|COMPLETED|Overall Study||27
11408394|NCT03790878|12603440|FG002|COMPLETED|Overall Study||27
11408395|NCT03790878|12603438|FG000|NOT COMPLETED|Overall Study||0
11408396|NCT03790878|12603439|FG001|NOT COMPLETED|Overall Study||0
11408397|NCT03790878|12603440|FG002|NOT COMPLETED|Overall Study||0
11408398|NCT03789474|12603450|FG000|STARTED|Overall Study||30
11408399|NCT03789474|12603451|FG001|STARTED|Overall Study||30
11408400|NCT03789474|12603450|FG000|COMPLETED|Overall Study||30
11408401|NCT03789474|12603451|FG001|COMPLETED|Overall Study||30
11022396|NCT00809133|12200668|FG004|STARTED|Overall Study||5
11022397|NCT00809133|12200669|FG005|STARTED|Overall Study||7
11022398|NCT00809133|12200670|FG006|STARTED|Overall Study||6
11022399|NCT00809133|12200671|FG007|STARTED|Overall Study||8
11022400|NCT00809133|12200672|FG008|STARTED|Overall Study||3
11022401|NCT00809133|12200673|FG009|STARTED|Overall Study||9
11022402|NCT00809133|12200674|FG010|STARTED|Overall Study||6
11022403|NCT00809133|12200675|FG011|STARTED|Overall Study||8
11022404|NCT00809133|12200676|FG012|STARTED|Overall Study||5
11408402|NCT03789474|12603450|FG000|NOT COMPLETED|Overall Study||0
11408403|NCT03789474|12603451|FG001|NOT COMPLETED|Overall Study||0
11408404|NCT03789175|12603457|FG000|STARTED|Week 0 to Week 12 of NR||1
11408405|NCT03789175|12603457|FG000|COMPLETED|Week 0 to Week 12 of NR||1
11408406|NCT03789175|12603457|FG000|NOT COMPLETED|Week 0 to Week 12 of NR||0
11408407|NCT03789175|12603457|FG000|STARTED|Week 12 to Week 24 of NR||1
11408408|NCT03789175|12603457|FG000|COMPLETED|Week 12 to Week 24 of NR|Participant did not meet primary endpoint and completed study at week 24|1
11408409|NCT03789175|12603457|FG000|NOT COMPLETED|Week 12 to Week 24 of NR||0
11144079|NCT01475474|12330719|FG000|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
11144080|NCT01475487|12330726|FG000|STARTED|Overall Study||25
11408410|NCT03787615|12603463|FG000|STARTED|Overall Study||31
11408411|NCT03787615|12603463|FG000|COMPLETED|Overall Study||27
11408412|NCT03787615|12603463|FG000|NOT COMPLETED|Overall Study||4
11408413|NCT03786718|12603468|FG000|STARTED|Overall Study||67
11408414|NCT03786718|12603468|FG000|COMPLETED|Overall Study||60
11408415|NCT03786718|12603468|FG000|NOT COMPLETED|Overall Study||7
11408416|NCT03784963|12603477|FG000|STARTED|Overall Study||12
11408417|NCT03784963|12603478|FG001|STARTED|Overall Study||10
11408418|NCT03784963|12603479|FG002|STARTED|Overall Study||1
11408419|NCT03784963|12603480|FG003|STARTED|Overall Study||0
11408420|NCT03784963|12603477|FG000|COMPLETED|Overall Study||0
11408421|NCT03784963|12603478|FG001|COMPLETED|Overall Study||0
11408422|NCT03784963|12603479|FG002|COMPLETED|Overall Study||0
11408423|NCT03784963|12603480|FG003|COMPLETED|Overall Study||0
11408424|NCT03784963|12603477|FG000|NOT COMPLETED|Overall Study||12
11408425|NCT03784963|12603478|FG001|NOT COMPLETED|Overall Study||10
11408426|NCT03784963|12603479|FG002|NOT COMPLETED|Overall Study||1
11408427|NCT03784963|12603480|FG003|NOT COMPLETED|Overall Study||0
11408428|NCT03771274|12603490|FG000|STARTED|Overall Study||39
11408429|NCT03771274|12603490|FG000|COMPLETED|Overall Study||39
11022405|NCT00809133|12200677|FG013|STARTED|Overall Study||7
11408430|NCT03771274|12603490|FG000|NOT COMPLETED|Overall Study||0
11408431|NCT03787472|12603494|FG000|STARTED|Period 1||23
11408432|NCT03787472|12603495|FG001|STARTED|Period 1||22
11408433|NCT03787472|12603494|FG000|COMPLETED|Period 1||23
11408434|NCT03787472|12603495|FG001|COMPLETED|Period 1||22
11408435|NCT03787472|12603494|FG000|NOT COMPLETED|Period 1||0
11408436|NCT03787472|12603495|FG001|NOT COMPLETED|Period 1||0
11408437|NCT03787472|12603494|FG000|STARTED|Period 2||23
11408438|NCT03787472|12603495|FG001|STARTED|Period 2||22
11408439|NCT03787472|12603494|FG000|COMPLETED|Period 2||23
11408440|NCT03787472|12603495|FG001|COMPLETED|Period 2||22
11408441|NCT03787472|12603494|FG000|NOT COMPLETED|Period 2||0
11408442|NCT03787472|12603495|FG001|NOT COMPLETED|Period 2||0
11408443|NCT03787212|12603501|FG000|STARTED|Period 1||2
11408444|NCT03787212|12603502|FG001|STARTED|Period 1||2
11408445|NCT03787212|12603501|FG000|COMPLETED|Period 1||2
11408446|NCT03787212|12603502|FG001|COMPLETED|Period 1||2
11408447|NCT03787212|12603501|FG000|NOT COMPLETED|Period 1||0
11408448|NCT03787212|12603502|FG001|NOT COMPLETED|Period 1||0
11408449|NCT03787212|12603501|FG000|STARTED|Period 1||2
11408450|NCT03787212|12603502|FG001|STARTED|Period 1||2
11408451|NCT03787212|12603501|FG000|COMPLETED|Period 1||0
11408452|NCT03787212|12603502|FG001|COMPLETED|Period 1||0
11408453|NCT03787212|12603501|FG000|NOT COMPLETED|Period 1||2
11144081|NCT01475487|12330727|FG001|STARTED|Overall Study||25
11408454|NCT03787212|12603502|FG001|NOT COMPLETED|Period 1||2
11408455|NCT03784001|12603511|FG000|STARTED|Overall Study||46
11408456|NCT03784001|12603512|FG001|STARTED|Overall Study||38
11408457|NCT03784001|12603513|FG002|STARTED|Overall Study||41
11408458|NCT03784001|12603511|FG000|COMPLETED|Overall Study||44
11408459|NCT03784001|12603512|FG001|COMPLETED|Overall Study||38
11408460|NCT03784001|12603513|FG002|COMPLETED|Overall Study||40
11408461|NCT03784001|12603511|FG000|NOT COMPLETED|Overall Study||2
11408462|NCT03784001|12603512|FG001|NOT COMPLETED|Overall Study||0
11408463|NCT03784001|12603513|FG002|NOT COMPLETED|Overall Study||1
11408464|NCT03783702|12603523|FG000|STARTED|Overall Study||56
11408465|NCT03783702|12603524|FG001|STARTED|Overall Study||62
11408466|NCT03783702|12603523|FG000|COMPLETED|Overall Study||49
11408467|NCT03783702|12603524|FG001|COMPLETED|Overall Study||51
11408468|NCT03783702|12603523|FG000|NOT COMPLETED|Overall Study||7
11408469|NCT03783702|12603524|FG001|NOT COMPLETED|Overall Study||11
11408470|NCT03781479|12603533|FG000|STARTED|Overall Study||6
11408471|NCT03781479|12603534|FG001|STARTED|Overall Study||6
11408472|NCT03781479|12603535|FG002|STARTED|Overall Study||1
11408473|NCT03781479|12603533|FG000|COMPLETED|Overall Study||6
11408474|NCT03781479|12603534|FG001|COMPLETED|Overall Study||6
11408475|NCT03781479|12603535|FG002|COMPLETED|Overall Study||0
11408476|NCT03781479|12603533|FG000|NOT COMPLETED|Overall Study||0
11408477|NCT03781479|12603534|FG001|NOT COMPLETED|Overall Study||0
11408478|NCT03781479|12603535|FG002|NOT COMPLETED|Overall Study||1
11408479|NCT03781037|12603541|FG000|STARTED|Overall Study||18
11408480|NCT03781037|12603541|FG000|COMPLETED|Overall Study||18
11408481|NCT03781037|12603541|FG000|NOT COMPLETED|Overall Study||0
11408482|NCT03784079|12603553|FG000|STARTED|Part 1: Up to Day 24||6
11408483|NCT03784079|12603554|FG001|STARTED|Part 1: Up to Day 24||6
11408484|NCT03784079|12603555|FG002|STARTED|Part 1: Up to Day 24||2
11408485|NCT03784079|12603556|FG003|STARTED|Part 1: Up to Day 24||0
11408486|NCT03784079|12603557|FG004|STARTED|Part 1: Up to Day 24||0
11408487|NCT03784079|12603558|FG005|STARTED|Part 1: Up to Day 24||0
11408488|NCT03784079|12603559|FG006|STARTED|Part 1: Up to Day 24||0
11408489|NCT03784079|12603553|FG000|COMPLETED|Part 1: Up to Day 24||6
11408490|NCT03784079|12603554|FG001|COMPLETED|Part 1: Up to Day 24||6
11408491|NCT03784079|12603555|FG002|COMPLETED|Part 1: Up to Day 24||2
11408492|NCT03784079|12603556|FG003|COMPLETED|Part 1: Up to Day 24||0
11408493|NCT03784079|12603557|FG004|COMPLETED|Part 1: Up to Day 24||0
11408494|NCT03784079|12603558|FG005|COMPLETED|Part 1: Up to Day 24||0
11408495|NCT03784079|12603559|FG006|COMPLETED|Part 1: Up to Day 24||0
11408496|NCT03784079|12603553|FG000|NOT COMPLETED|Part 1: Up to Day 24||0
11408497|NCT03784079|12603554|FG001|NOT COMPLETED|Part 1: Up to Day 24||0
11408498|NCT03784079|12603555|FG002|NOT COMPLETED|Part 1: Up to Day 24||0
11408499|NCT03784079|12603556|FG003|NOT COMPLETED|Part 1: Up to Day 24||0
11408500|NCT03784079|12603557|FG004|NOT COMPLETED|Part 1: Up to Day 24||0
11408501|NCT03784079|12603558|FG005|NOT COMPLETED|Part 1: Up to Day 24||0
11408502|NCT03784079|12603559|FG006|NOT COMPLETED|Part 1: Up to Day 24||0
11408503|NCT03784079|12603553|FG000|STARTED|Part 2: Up to Day 12||0
11408504|NCT03784079|12603554|FG001|STARTED|Part 2: Up to Day 12||0
11408505|NCT03784079|12603555|FG002|STARTED|Part 2: Up to Day 12||0
11408506|NCT03784079|12603556|FG003|STARTED|Part 2: Up to Day 12||6
11408507|NCT03784079|12603557|FG004|STARTED|Part 2: Up to Day 12||6
11408508|NCT03784079|12603558|FG005|STARTED|Part 2: Up to Day 12||6
11408509|NCT03784079|12603559|FG006|STARTED|Part 2: Up to Day 12||2
11408510|NCT03784079|12603553|FG000|COMPLETED|Part 2: Up to Day 12||0
11408511|NCT03784079|12603554|FG001|COMPLETED|Part 2: Up to Day 12||0
11408512|NCT03784079|12603555|FG002|COMPLETED|Part 2: Up to Day 12||0
11408513|NCT03784079|12603556|FG003|COMPLETED|Part 2: Up to Day 12||6
11408514|NCT03784079|12603557|FG004|COMPLETED|Part 2: Up to Day 12||6
11408515|NCT03784079|12603558|FG005|COMPLETED|Part 2: Up to Day 12||6
11408516|NCT03784079|12603559|FG006|COMPLETED|Part 2: Up to Day 12||2
11408517|NCT03784079|12603553|FG000|NOT COMPLETED|Part 2: Up to Day 12||0
11408518|NCT03784079|12603554|FG001|NOT COMPLETED|Part 2: Up to Day 12||0
11408519|NCT03784079|12603555|FG002|NOT COMPLETED|Part 2: Up to Day 12||0
11408520|NCT03784079|12603556|FG003|NOT COMPLETED|Part 2: Up to Day 12||0
11408521|NCT03784079|12603557|FG004|NOT COMPLETED|Part 2: Up to Day 12||0
11408522|NCT03784079|12603558|FG005|NOT COMPLETED|Part 2: Up to Day 12||0
11408523|NCT03784079|12603559|FG006|NOT COMPLETED|Part 2: Up to Day 12||0
11408524|NCT03783039|12603582|FG000|STARTED|Overall Study||119
11408525|NCT03783039|12603583|FG001|STARTED|Overall Study||115
11408526|NCT03783039|12603582|FG000|COMPLETED|Overall Study||117
11408527|NCT03783039|12603583|FG001|COMPLETED|Overall Study||114
11408528|NCT03783039|12603582|FG000|NOT COMPLETED|Overall Study||2
11408529|NCT03783039|12603583|FG001|NOT COMPLETED|Overall Study||1
11408530|NCT03783130|12603593|FG000|STARTED|Overall Study||3
11408531|NCT03783130|12603594|FG001|STARTED|Overall Study||3
11408532|NCT03783130|12603595|FG002|STARTED|Overall Study||5
11408533|NCT03783130|12603596|FG003|STARTED|Overall Study||5
11408534|NCT03783130|12603593|FG000|Received All Product Administrations|Overall Study||3
11408535|NCT03783130|12603594|FG001|Received All Product Administrations|Overall Study||3
11408536|NCT03783130|12603595|FG002|Received All Product Administrations|Overall Study||5
11408537|NCT03783130|12603596|FG003|Received All Product Administrations|Overall Study||5
11408538|NCT03783130|12603593|FG000|COMPLETED|Overall Study||3
11408539|NCT03783130|12603594|FG001|COMPLETED|Overall Study||3
11408540|NCT03783130|12603595|FG002|COMPLETED|Overall Study||5
11408541|NCT03783130|12603596|FG003|COMPLETED|Overall Study||5
11408542|NCT03783130|12603593|FG000|NOT COMPLETED|Overall Study||0
11408543|NCT03783130|12603594|FG001|NOT COMPLETED|Overall Study||0
11408544|NCT03783130|12603595|FG002|NOT COMPLETED|Overall Study||0
11408545|NCT03783130|12603596|FG003|NOT COMPLETED|Overall Study||0
11408546|NCT03776175|12603611|FG000|STARTED|Treatment Period (42 Days)||14
11408547|NCT03776175|12603612|FG001|STARTED|Treatment Period (42 Days)||29
11408548|NCT03776175|12603613|FG002|STARTED|Treatment Period (42 Days)||28
11408549|NCT03776175|12603614|FG003|STARTED|Treatment Period (42 Days)||28
11408550|NCT03776175|12603611|FG000|Treated|Treatment Period (42 Days)||14
11408551|NCT03776175|12603612|FG001|Treated|Treatment Period (42 Days)||29
11408552|NCT03776175|12603613|FG002|Treated|Treatment Period (42 Days)||28
11408553|NCT03776175|12603614|FG003|Treated|Treatment Period (42 Days)||28
11408554|NCT03776175|12603611|FG000|COMPLETED|Treatment Period (42 Days)||13
11022406|NCT00809133|12200664|FG000|COMPLETED|Overall Study||0
11022407|NCT00809133|12200665|FG001|COMPLETED|Overall Study||0
11022408|NCT00809133|12200666|FG002|COMPLETED|Overall Study||0
11022409|NCT00809133|12200667|FG003|COMPLETED|Overall Study||0
11022410|NCT00809133|12200668|FG004|COMPLETED|Overall Study||0
11022411|NCT00809133|12200669|FG005|COMPLETED|Overall Study||0
11022412|NCT00809133|12200670|FG006|COMPLETED|Overall Study||0
11022413|NCT00809133|12200671|FG007|COMPLETED|Overall Study||0
11022414|NCT00809133|12200672|FG008|COMPLETED|Overall Study||0
11022415|NCT00809133|12200673|FG009|COMPLETED|Overall Study||0
11022416|NCT00809133|12200674|FG010|COMPLETED|Overall Study||0
11022417|NCT00809133|12200675|FG011|COMPLETED|Overall Study||0
11022418|NCT00809133|12200676|FG012|COMPLETED|Overall Study||0
11022419|NCT00809133|12200677|FG013|COMPLETED|Overall Study||0
11022420|NCT00809133|12200664|FG000|NOT COMPLETED|Overall Study||3
11022421|NCT00809133|12200665|FG001|NOT COMPLETED|Overall Study||7
11022422|NCT00809133|12200666|FG002|NOT COMPLETED|Overall Study||6
11022423|NCT00809133|12200667|FG003|NOT COMPLETED|Overall Study||3
11022424|NCT00809133|12200668|FG004|NOT COMPLETED|Overall Study||5
11022425|NCT00809133|12200669|FG005|NOT COMPLETED|Overall Study||7
11022426|NCT00809133|12200670|FG006|NOT COMPLETED|Overall Study||6
11022427|NCT00809133|12200671|FG007|NOT COMPLETED|Overall Study||8
11022428|NCT00809133|12200672|FG008|NOT COMPLETED|Overall Study||3
11022429|NCT00809133|12200673|FG009|NOT COMPLETED|Overall Study||9
11022430|NCT00809133|12200674|FG010|NOT COMPLETED|Overall Study||6
11022431|NCT00809133|12200675|FG011|NOT COMPLETED|Overall Study||8
11022432|NCT00809133|12200676|FG012|NOT COMPLETED|Overall Study||5
11022433|NCT00809133|12200677|FG013|NOT COMPLETED|Overall Study||7
11022434|NCT00809146|12200722|FG000|STARTED|Overall Study||448
11022435|NCT00809146|12200723|FG001|STARTED|Overall Study||445
11022436|NCT00809146|12200722|FG000|COMPLETED|Overall Study||448
11022437|NCT00809146|12200723|FG001|COMPLETED|Overall Study||445
11408555|NCT03776175|12603612|FG001|COMPLETED|Treatment Period (42 Days)||22
11408556|NCT03776175|12603613|FG002|COMPLETED|Treatment Period (42 Days)||24
11408557|NCT03776175|12603614|FG003|COMPLETED|Treatment Period (42 Days)||26
11408558|NCT03776175|12603611|FG000|NOT COMPLETED|Treatment Period (42 Days)||1
11408559|NCT03776175|12603612|FG001|NOT COMPLETED|Treatment Period (42 Days)||7
11408560|NCT03776175|12603613|FG002|NOT COMPLETED|Treatment Period (42 Days)||4
11408561|NCT03776175|12603614|FG003|NOT COMPLETED|Treatment Period (42 Days)||2
11408562|NCT03776175|12603611|FG000|STARTED|Follow-Up Period (35 Days)||13
11408563|NCT03776175|12603612|FG001|STARTED|Follow-Up Period (35 Days)||22
11408564|NCT03776175|12603613|FG002|STARTED|Follow-Up Period (35 Days)||24
11408565|NCT03776175|12603614|FG003|STARTED|Follow-Up Period (35 Days)||26
11408566|NCT03776175|12603611|FG000|COMPLETED|Follow-Up Period (35 Days)||13
11408567|NCT03776175|12603612|FG001|COMPLETED|Follow-Up Period (35 Days)||22
11022438|NCT00809146|12200722|FG000|NOT COMPLETED|Overall Study||0
11022439|NCT00809146|12200723|FG001|NOT COMPLETED|Overall Study||0
11022440|NCT00809159|12200733|FG000|STARTED|Part 1||24
11022441|NCT00809159|12200734|FG001|STARTED|Part 1||6
11408568|NCT03776175|12603613|FG002|COMPLETED|Follow-Up Period (35 Days)||24
11408569|NCT03776175|12603614|FG003|COMPLETED|Follow-Up Period (35 Days)||24
11022442|NCT00809159|12200735|FG002|STARTED|Part 1||0
11022443|NCT00809159|12200736|FG003|STARTED|Part 1||0
11022444|NCT00809159|12200737|FG004|STARTED|Part 1||0
11408570|NCT03776175|12603611|FG000|NOT COMPLETED|Follow-Up Period (35 Days)||0
11408571|NCT03776175|12603612|FG001|NOT COMPLETED|Follow-Up Period (35 Days)||0
11408572|NCT03776175|12603613|FG002|NOT COMPLETED|Follow-Up Period (35 Days)||0
11022445|NCT00809159|12200738|FG005|STARTED|Part 1||0
11022446|NCT00809159|12200733|FG000|PK Analysis Set|Part 1||24
11022447|NCT00809159|12200734|FG001|PK Analysis Set|Part 1||6
11022448|NCT00809159|12200735|FG002|PK Analysis Set|Part 1||0
11022449|NCT00809159|12200736|FG003|PK Analysis Set|Part 1||0
11022450|NCT00809159|12200737|FG004|PK Analysis Set|Part 1||0
11022451|NCT00809159|12200738|FG005|PK Analysis Set|Part 1||0
11022452|NCT00809159|12200733|FG000|PD Analysis Set|Part 1||23
11022453|NCT00809159|12200734|FG001|PD Analysis Set|Part 1||6
11408573|NCT03776175|12603614|FG003|NOT COMPLETED|Follow-Up Period (35 Days)||2
11408574|NCT03771963|12603624|FG000|STARTED|Overall Study||200
11408575|NCT03771963|12603624|FG000|COMPLETED|Overall Study||168
11408576|NCT03771963|12603624|FG000|NOT COMPLETED|Overall Study||32
11408577|NCT03771352|12603628|FG000|STARTED|Overall Study||55
11408578|NCT03771352|12603628|FG000|COMPLETED|Overall Study|The fellow eye of one subject was not implanted per the discretion of the investigator.|51
11408579|NCT03771352|12603628|FG000|NOT COMPLETED|Overall Study||4
11408580|NCT03773796|12603632|FG000|STARTED|Overall Study||22
11408581|NCT03773796|12603632|FG000|COMPLETED|Overall Study||19
11408582|NCT03773796|12603632|FG000|NOT COMPLETED|Overall Study||3
11408583|NCT03782233|12603638|FG000|STARTED|Overall Study||50
11408584|NCT03782233|12603639|FG001|STARTED|Overall Study||33
11408585|NCT03782233|12603638|FG000|COMPLETED|Overall Study||46
11408586|NCT03782233|12603639|FG001|COMPLETED|Overall Study||31
11408587|NCT03782233|12603638|FG000|NOT COMPLETED|Overall Study||4
11408588|NCT03782233|12603639|FG001|NOT COMPLETED|Overall Study||2
11408589|NCT03781375|12603649|FG000|STARTED|Double-blind Phase||12
11408590|NCT03781375|12603650|FG001|STARTED|Double-blind Phase||13
11408591|NCT03781375|12603649|FG000|Received Study Drug|Double-blind Phase||12
11408592|NCT03781375|12603650|FG001|Received Study Drug|Double-blind Phase||13
11408593|NCT03781375|12603649|FG000|COMPLETED|Double-blind Phase||5
11408594|NCT03781375|12603650|FG001|COMPLETED|Double-blind Phase||7
11408595|NCT03781375|12603649|FG000|NOT COMPLETED|Double-blind Phase||7
11408596|NCT03781375|12603650|FG001|NOT COMPLETED|Double-blind Phase||6
11408597|NCT03781375|12603649|FG000|STARTED|Open-label Phase||11
11408598|NCT03781375|12603650|FG001|STARTED|Open-label Phase||9
11408599|NCT03781375|12603649|FG000|Received Study Drug|Open-label Phase||10
11408600|NCT03781375|12603650|FG001|Received Study Drug|Open-label Phase||9
11408601|NCT03781375|12603649|FG000|COMPLETED|Open-label Phase||8
11408602|NCT03781375|12603650|FG001|COMPLETED|Open-label Phase||6
11408603|NCT03781375|12603649|FG000|NOT COMPLETED|Open-label Phase||3
11408604|NCT03781375|12603650|FG001|NOT COMPLETED|Open-label Phase||3
11408605|NCT03781336|12603659|FG000|STARTED|Overall Study||45
11408606|NCT03781336|12603660|FG001|STARTED|Overall Study||37
11408607|NCT03781336|12603659|FG000|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|43
11408608|NCT03781336|12603660|FG001|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|35
11408609|NCT03781336|12603659|FG000|NOT COMPLETED|Overall Study||2
11408610|NCT03781336|12603660|FG001|NOT COMPLETED|Overall Study||2
11408611|NCT03780400|12603666|FG000|STARTED|Overall Study||60
11408612|NCT03780400|12603666|FG000|COMPLETED|Overall Study||53
11408613|NCT03780400|12603666|FG000|NOT COMPLETED|Overall Study||7
11408614|NCT03779997|12603672|FG000|STARTED|Overall Study||39
11408615|NCT03779997|12603673|FG001|STARTED|Overall Study||39
11408616|NCT03779997|12603672|FG000|Completed at Least One Visit|Overall Study||39
11408617|NCT03779997|12603673|FG001|Completed at Least One Visit|Overall Study||39
11408618|NCT03779997|12603672|FG000|COMPLETED|Overall Study||39
11408619|NCT03779997|12603673|FG001|COMPLETED|Overall Study||39
11408620|NCT03779997|12603672|FG000|NOT COMPLETED|Overall Study||0
11408621|NCT03779997|12603673|FG001|NOT COMPLETED|Overall Study||0
11408622|NCT03779503|12603679|FG000|STARTED|First Intervention||28
11408623|NCT03779503|12603680|FG001|STARTED|First Intervention||27
11408624|NCT03779503|12603679|FG000|COMPLETED|First Intervention||27
11408625|NCT03779503|12603680|FG001|COMPLETED|First Intervention||26
11408626|NCT03779503|12603679|FG000|NOT COMPLETED|First Intervention||1
11408627|NCT03779503|12603680|FG001|NOT COMPLETED|First Intervention||1
11408628|NCT03779503|12603679|FG000|STARTED|Second Intervention||27
11408629|NCT03779503|12603680|FG001|STARTED|Second Intervention||26
11408630|NCT03779503|12603679|FG000|COMPLETED|Second Intervention||27
11408631|NCT03779503|12603680|FG001|COMPLETED|Second Intervention||26
11408632|NCT03779503|12603679|FG000|NOT COMPLETED|Second Intervention||0
11408633|NCT03779503|12603680|FG001|NOT COMPLETED|Second Intervention||0
11408634|NCT03780010|12603688|FG000|STARTED|Overall Study||3
11408635|NCT03780010|12603689|FG001|STARTED|Overall Study||12
11408636|NCT03780010|12603688|FG000|COMPLETED|Overall Study||3
11408637|NCT03780010|12603689|FG001|COMPLETED|Overall Study||12
11408638|NCT03780010|12603688|FG000|NOT COMPLETED|Overall Study||0
11408639|NCT03780010|12603689|FG001|NOT COMPLETED|Overall Study||0
11408640|NCT03778190|12603706|FG000|STARTED|Overall Study||10
11408641|NCT03778190|12603706|FG000|COMPLETED|Overall Study||10
11408642|NCT03778190|12603706|FG000|NOT COMPLETED|Overall Study||0
11408643|NCT03777059|12603714|FG000|STARTED|DB Treatment Period (Up to Week 12)||223
11408644|NCT03777059|12603715|FG001|STARTED|DB Treatment Period (Up to Week 12)||222
11408645|NCT03777059|12603716|FG002|STARTED|DB Treatment Period (Up to Week 12)||230
11408646|NCT03777059|12603717|FG003|STARTED|DB Treatment Period (Up to Week 12)||235
11408647|NCT03777059|12603714|FG000|Treated: Safety Population|DB Treatment Period (Up to Week 12)||222
11408648|NCT03777059|12603715|FG001|Treated: Safety Population|DB Treatment Period (Up to Week 12)||221
11408649|NCT03777059|12603716|FG002|Treated: Safety Population|DB Treatment Period (Up to Week 12)||228
11408650|NCT03777059|12603717|FG003|Treated: Safety Population|DB Treatment Period (Up to Week 12)||231
11408651|NCT03777059|12603714|FG000|COMPLETED|DB Treatment Period (Up to Week 12)||201
11408652|NCT03777059|12603715|FG001|COMPLETED|DB Treatment Period (Up to Week 12)||193
11408653|NCT03777059|12603716|FG002|COMPLETED|DB Treatment Period (Up to Week 12)||207
11408654|NCT03777059|12603717|FG003|COMPLETED|DB Treatment Period (Up to Week 12)||204
11408655|NCT03777059|12603714|FG000|NOT COMPLETED|DB Treatment Period (Up to Week 12)||22
11408656|NCT03777059|12603715|FG001|NOT COMPLETED|DB Treatment Period (Up to Week 12)||29
11408657|NCT03777059|12603716|FG002|NOT COMPLETED|DB Treatment Period (Up to Week 12)||23
11408658|NCT03777059|12603717|FG003|NOT COMPLETED|DB Treatment Period (Up to Week 12)||31
11408659|NCT03777059|12603714|FG000|STARTED|Follow-Up Period (Weeks 12 to 16)||46
11408660|NCT03777059|12603715|FG001|STARTED|Follow-Up Period (Weeks 12 to 16)||54
11408661|NCT03777059|12603716|FG002|STARTED|Follow-Up Period (Weeks 12 to 16)||38
11408662|NCT03777059|12603717|FG003|STARTED|Follow-Up Period (Weeks 12 to 16)||45
11408663|NCT03777059|12603714|FG000|COMPLETED|Follow-Up Period (Weeks 12 to 16)||41
11408664|NCT03777059|12603715|FG001|COMPLETED|Follow-Up Period (Weeks 12 to 16)||49
11408665|NCT03777059|12603716|FG002|COMPLETED|Follow-Up Period (Weeks 12 to 16)||32
11408666|NCT03777059|12603717|FG003|COMPLETED|Follow-Up Period (Weeks 12 to 16)||36
11408667|NCT03777059|12603714|FG000|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
11408668|NCT03777059|12603715|FG001|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
11408669|NCT03777059|12603716|FG002|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||6
11408670|NCT03777059|12603717|FG003|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||9
11408671|NCT03772522|12603729|FG000|STARTED|Pre-intervention||12
11408672|NCT03772522|12603730|FG001|STARTED|Pre-intervention||15
11408673|NCT03772522|12603729|FG000|COMPLETED|Pre-intervention||9
11408674|NCT03772522|12603730|FG001|COMPLETED|Pre-intervention||11
11408675|NCT03772522|12603729|FG000|NOT COMPLETED|Pre-intervention||3
11408676|NCT03772522|12603730|FG001|NOT COMPLETED|Pre-intervention||4
11408677|NCT03772522|12603729|FG000|STARTED|Intervention||9
11408678|NCT03772522|12603730|FG001|STARTED|Intervention||11
11408679|NCT03772522|12603729|FG000|COMPLETED|Intervention||8
11408680|NCT03772522|12603730|FG001|COMPLETED|Intervention||11
11408681|NCT03772522|12603729|FG000|NOT COMPLETED|Intervention||1
11408682|NCT03772522|12603730|FG001|NOT COMPLETED|Intervention||0
11408683|NCT03772522|12603729|FG000|STARTED|Post-intervention Follow-up||8
11408684|NCT03772522|12603730|FG001|STARTED|Post-intervention Follow-up||11
11408685|NCT03772522|12603729|FG000|COMPLETED|Post-intervention Follow-up||7
11408686|NCT03772522|12603730|FG001|COMPLETED|Post-intervention Follow-up||11
11408687|NCT03772522|12603729|FG000|NOT COMPLETED|Post-intervention Follow-up||1
11408688|NCT03772522|12603730|FG001|NOT COMPLETED|Post-intervention Follow-up||0
11408689|NCT03772327|12603742|FG000|STARTED|Overall Study||30
11408690|NCT03772327|12603743|FG001|STARTED|Overall Study||33
11408691|NCT03772327|12603742|FG000|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28
11408692|NCT03772327|12603743|FG001|Week 0 Visit|Overall Study||33
11408693|NCT03772327|12603742|FG000|COMPLETED|Overall Study||25
11408694|NCT03772327|12603743|FG001|COMPLETED|Overall Study||26
11408695|NCT03772327|12603742|FG000|NOT COMPLETED|Overall Study||5
11408696|NCT03772327|12603743|FG001|NOT COMPLETED|Overall Study||7
11408697|NCT03777865|12603749|FG000|STARTED|Overall Study||100
11408698|NCT03777865|12603749|FG000|COMPLETED|Overall Study||100
11408699|NCT03777865|12603749|FG000|NOT COMPLETED|Overall Study||0
11408700|NCT03774576|12603753|FG000|STARTED|Period 1||14
11408701|NCT03774576|12603753|FG000|COMPLETED|Period 1||14
11408702|NCT03774576|12603753|FG000|NOT COMPLETED|Period 1||0
11408703|NCT03774576|12603753|FG000|STARTED|Period 2||14
11408704|NCT03774576|12603753|FG000|COMPLETED|Period 2||13
11408705|NCT03774576|12603753|FG000|NOT COMPLETED|Period 2||1
11408706|NCT03776539|12603766|FG000|STARTED|Overall Study||6
11408707|NCT03776539|12603767|FG001|STARTED|Overall Study||6
11408708|NCT03776539|12603768|FG002|STARTED|Overall Study||6
11408709|NCT03776539|12603769|FG003|STARTED|Overall Study||6
11408710|NCT03776539|12603766|FG000|COMPLETED|Overall Study||6
11408711|NCT03776539|12603767|FG001|COMPLETED|Overall Study||6
11408712|NCT03776539|12603768|FG002|COMPLETED|Overall Study||6
11408713|NCT03776539|12603769|FG003|COMPLETED|Overall Study||6
11408714|NCT03776539|12603766|FG000|NOT COMPLETED|Overall Study||0
11408715|NCT03776539|12603767|FG001|NOT COMPLETED|Overall Study||0
11408716|NCT03776539|12603768|FG002|NOT COMPLETED|Overall Study||0
11408717|NCT03776539|12603769|FG003|NOT COMPLETED|Overall Study||0
11408718|NCT03772041|12603781|FG000|STARTED|Overall Study||149
11408719|NCT03772041|12603782|FG001|STARTED|Overall Study||145
11408720|NCT03772041|12603781|FG000|COMPLETED|Overall Study||135
11408721|NCT03772041|12603782|FG001|COMPLETED|Overall Study||135
11408722|NCT03772041|12603781|FG000|NOT COMPLETED|Overall Study||14
11408723|NCT03772041|12603782|FG001|NOT COMPLETED|Overall Study||10
11408724|NCT03775681|12603788|FG000|STARTED|Overall Study||33
11408725|NCT03775681|12603788|FG000|COMPLETED|Overall Study||30
11408726|NCT03775681|12603788|FG000|NOT COMPLETED|Overall Study||3
11408727|NCT03774823|12603794|FG000|STARTED|Overall Study||5
11408728|NCT03774823|12603795|FG001|STARTED|Overall Study||5
11408729|NCT03774823|12603794|FG000|COMPLETED|Overall Study||4
11408730|NCT03774823|12603795|FG001|COMPLETED|Overall Study||4
11408731|NCT03774823|12603794|FG000|NOT COMPLETED|Overall Study||1
11408732|NCT03774823|12603795|FG001|NOT COMPLETED|Overall Study||1
11408733|NCT03774745|12603803|FG000|STARTED|Overall Study||6
11408734|NCT03774745|12603804|FG001|STARTED|Overall Study||6
11408735|NCT03774745|12603803|FG000|Follow-Up 1|Overall Study||5
11408736|NCT03774745|12603804|FG001|Follow-Up 1|Overall Study||6
11408737|NCT03774745|12603803|FG000|Follow-up 2|Overall Study||4
11408738|NCT03774745|12603804|FG001|Follow-up 2|Overall Study||2
11408739|NCT03774745|12603803|FG000|COMPLETED|Overall Study||4
11408740|NCT03774745|12603804|FG001|COMPLETED|Overall Study||2
11408741|NCT03774745|12603803|FG000|NOT COMPLETED|Overall Study||2
11408742|NCT03774745|12603804|FG001|NOT COMPLETED|Overall Study||4
11408743|NCT03774433|12603810|FG000|STARTED|Overall Study||114
11408744|NCT03774433|12603810|FG000|COMPLETED|Overall Study|Participants who completed at least 12 EMAs for inclusion in data analysis|100
11408745|NCT03774433|12603810|FG000|NOT COMPLETED|Overall Study||14
11408746|NCT03771560|12603814|FG000|STARTED|Overall Study||18
11408747|NCT03771560|12603814|FG000|COMPLETED|Overall Study||12
11408748|NCT03771560|12603814|FG000|NOT COMPLETED|Overall Study||6
11408749|NCT03770091|12603821|FG000|STARTED|Overall Study||15
11408750|NCT03770091|12603822|FG001|STARTED|Overall Study||13
11408751|NCT03770091|12603823|FG002|STARTED|Overall Study||12
11408752|NCT03770091|12603821|FG000|COMPLETED|Overall Study||15
11408753|NCT03770091|12603822|FG001|COMPLETED|Overall Study||13
11408754|NCT03770091|12603823|FG002|COMPLETED|Overall Study||12
11408755|NCT03770091|12603821|FG000|NOT COMPLETED|Overall Study||0
11408756|NCT03770091|12603822|FG001|NOT COMPLETED|Overall Study||0
11408757|NCT03770091|12603823|FG002|NOT COMPLETED|Overall Study||0
11408758|NCT03769896|12603833|FG000|STARTED|Open-label Phase||47
11408759|NCT03769896|12603834|FG001|STARTED|Open-label Phase||0
11408760|NCT03769896|12603833|FG000|COMPLETED|Open-label Phase||38
11408761|NCT03769896|12603834|FG001|COMPLETED|Open-label Phase||0
11408762|NCT03769896|12603833|FG000|NOT COMPLETED|Open-label Phase||9
11408763|NCT03769896|12603834|FG001|NOT COMPLETED|Open-label Phase||0
11408764|NCT03769896|12603833|FG000|STARTED|Double-blind Treatment Phase||19
11408765|NCT03769896|12603834|FG001|STARTED|Double-blind Treatment Phase||19
11408766|NCT03769896|12603833|FG000|COMPLETED|Double-blind Treatment Phase||19
11408767|NCT03769896|12603834|FG001|COMPLETED|Double-blind Treatment Phase||19
11408768|NCT03769896|12603833|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
11408769|NCT03769896|12603834|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
11408770|NCT03769207|12603841|FG000|STARTED|Overall Study||17
11408771|NCT03769207|12603841|FG000|Attended First Study Visit|Overall Study||11
11408772|NCT03769207|12603841|FG000|ECG Patch Shipped|Overall Study||11
11408773|NCT03769207|12603841|FG000|ECG Patch Returned and Readable|Overall Study||9
11408774|NCT03769207|12603841|FG000|Attended Second Study Visit|Overall Study||6
11408775|NCT03769207|12603841|FG000|COMPLETED|Overall Study||6
11408776|NCT03769207|12603841|FG000|NOT COMPLETED|Overall Study||11
11408777|NCT03768856|12603845|FG000|STARTED|Overall Study||5
11408778|NCT03768856|12603845|FG000|COMPLETED|Overall Study||5
11408779|NCT03768856|12603845|FG000|NOT COMPLETED|Overall Study||0
11408780|NCT03768726|12603851|FG000|STARTED|Treatment Phase||10
11408781|NCT03768726|12603852|FG001|STARTED|Treatment Phase||13
11408782|NCT03768726|12603851|FG000|COMPLETED|Treatment Phase||2
11408783|NCT03768726|12603852|FG001|COMPLETED|Treatment Phase||10
11408784|NCT03768726|12603851|FG000|NOT COMPLETED|Treatment Phase||8
11408785|NCT03768726|12603852|FG001|NOT COMPLETED|Treatment Phase||3
11408786|NCT03768726|12603851|FG000|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|8
11408787|NCT03768726|12603852|FG001|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|12
11408788|NCT03768726|12603851|FG000|Received Treatment|Follow-Up||8
11408789|NCT03768726|12603852|FG001|Received Treatment|Follow-Up||12
11408790|NCT03768726|12603851|FG000|COMPLETED|Follow-Up||2
11408791|NCT03768726|12603852|FG001|COMPLETED|Follow-Up||9
11408792|NCT03768726|12603851|FG000|NOT COMPLETED|Follow-Up||6
11408793|NCT03768726|12603852|FG001|NOT COMPLETED|Follow-Up||3
11408794|NCT03768206|12603860|FG000|STARTED|Overall Study||24
11408795|NCT03768206|12603861|FG001|STARTED|Overall Study||21
11408796|NCT03768206|12603860|FG000|COMPLETED|Overall Study||22
11408797|NCT03768206|12603861|FG001|COMPLETED|Overall Study||19
11408798|NCT03768206|12603860|FG000|NOT COMPLETED|Overall Study||2
11408799|NCT03768206|12603861|FG001|NOT COMPLETED|Overall Study||2
11408800|NCT03767894|12603868|FG000|STARTED|Overall Study||12
11408801|NCT03767894|12603868|FG000|COMPLETED|Overall Study||11
11408802|NCT03767894|12603868|FG000|NOT COMPLETED|Overall Study||1
11408803|NCT03767738|12603874|FG000|STARTED|Overall Study||35
11408804|NCT03767738|12603875|FG001|STARTED|Overall Study||30
11408805|NCT03767738|12603874|FG000|COMPLETED|Overall Study||35
11408806|NCT03767738|12603875|FG001|COMPLETED|Overall Study||30
11408807|NCT03767738|12603874|FG000|NOT COMPLETED|Overall Study||0
11408808|NCT03767738|12603875|FG001|NOT COMPLETED|Overall Study||0
11408809|NCT03767153|12603883|FG000|STARTED|Overall Study||14
11408810|NCT03767153|12603884|FG001|STARTED|Overall Study||11
11408811|NCT03767153|12603883|FG000|COMPLETED|Overall Study||14
11408812|NCT03767153|12603884|FG001|COMPLETED|Overall Study||11
11408813|NCT03767153|12603883|FG000|NOT COMPLETED|Overall Study||0
11408814|NCT03767153|12603884|FG001|NOT COMPLETED|Overall Study||0
11408815|NCT03767062|12603892|FG000|STARTED|Overall Study||45
11408816|NCT03767062|12603893|FG001|STARTED|Overall Study||45
11408817|NCT03767062|12603892|FG000|COMPLETED|Overall Study||37
11408818|NCT03767062|12603893|FG001|COMPLETED|Overall Study||41
11408819|NCT03767062|12603892|FG000|NOT COMPLETED|Overall Study||8
11408820|NCT03767062|12603893|FG001|NOT COMPLETED|Overall Study||4
11408821|NCT03766646|12603901|FG000|STARTED|Overall Study||19
11408822|NCT03766646|12603902|FG001|STARTED|Overall Study||15
11408823|NCT03766646|12603901|FG000|COMPLETED|Overall Study||18
11408824|NCT03766646|12603902|FG001|COMPLETED|Overall Study||12
11408825|NCT03766646|12603901|FG000|NOT COMPLETED|Overall Study||1
11408826|NCT03766646|12603902|FG001|NOT COMPLETED|Overall Study||3
11408827|NCT03766373|12603910|FG000|STARTED|Overall Study||12
11408828|NCT03766373|12603911|FG001|STARTED|Overall Study||12
11408829|NCT03766373|12603910|FG000|COMPLETED|Overall Study||12
11408830|NCT03766373|12603911|FG001|COMPLETED|Overall Study||12
11408831|NCT03766373|12603910|FG000|NOT COMPLETED|Overall Study||0
11408832|NCT03766373|12603911|FG001|NOT COMPLETED|Overall Study||0
11408833|NCT03766165|12603919|FG000|STARTED|Overall Study||19
11408834|NCT03766165|12603920|FG001|STARTED|Overall Study||19
11408835|NCT03766165|12603919|FG000|COMPLETED|Overall Study||19
11408836|NCT03766165|12603920|FG001|COMPLETED|Overall Study||19
11408837|NCT03766165|12603919|FG000|NOT COMPLETED|Overall Study||0
11408838|NCT03766165|12603920|FG001|NOT COMPLETED|Overall Study||0
11408839|NCT03765996|12603929|FG000|STARTED|Overall Study||18
11408840|NCT03765996|12603930|FG001|STARTED|Overall Study||18
11408841|NCT03765996|12603929|FG000|COMPLETED|Overall Study||14
11408842|NCT03765996|12603930|FG001|COMPLETED|Overall Study||18
11408843|NCT03765996|12603929|FG000|NOT COMPLETED|Overall Study||4
11408844|NCT03765996|12603930|FG001|NOT COMPLETED|Overall Study||0
11408845|NCT03765762|12603938|FG000|STARTED|Overall Study||18
11408846|NCT03765762|12603939|FG001|STARTED|Overall Study||8
11408847|NCT03765762|12603938|FG000|COMPLETED|Overall Study||18
11408848|NCT03765762|12603939|FG001|COMPLETED|Overall Study||8
11408849|NCT03765762|12603938|FG000|NOT COMPLETED|Overall Study||0
11408850|NCT03765762|12603939|FG001|NOT COMPLETED|Overall Study||0
11408851|NCT03765502|12603948|FG000|STARTED|Simulation 1||20
11408852|NCT03765502|12603949|FG001|STARTED|Simulation 1||13
11408853|NCT03765502|12603950|FG002|STARTED|Simulation 1||33
11408854|NCT03765502|12603951|FG003|STARTED|Simulation 1||16
11408855|NCT03765502|12603952|FG004|STARTED|Simulation 1||17
11408856|NCT03765502|12603948|FG000|COMPLETED|Simulation 1||20
11408857|NCT03765502|12603949|FG001|COMPLETED|Simulation 1||13
11408858|NCT03765502|12603950|FG002|COMPLETED|Simulation 1||33
11408859|NCT03765502|12603951|FG003|COMPLETED|Simulation 1||16
11408860|NCT03765502|12603952|FG004|COMPLETED|Simulation 1||17
11408861|NCT03765502|12603948|FG000|NOT COMPLETED|Simulation 1||0
11408862|NCT03765502|12603949|FG001|NOT COMPLETED|Simulation 1||0
11408863|NCT03765502|12603950|FG002|NOT COMPLETED|Simulation 1||0
11408864|NCT03765502|12603951|FG003|NOT COMPLETED|Simulation 1||0
11408865|NCT03765502|12603952|FG004|NOT COMPLETED|Simulation 1||0
11408866|NCT03765502|12603948|FG000|STARTED|Simulation 2||20
11408867|NCT03765502|12603949|FG001|STARTED|Simulation 2|Participant completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|12
11408868|NCT03765502|12603950|FG002|STARTED|Simulation 2|PWD completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|32
11408869|NCT03765502|12603951|FG003|STARTED|Simulation 2||16
11408870|NCT03765502|12603952|FG004|STARTED|Simulation 2||17
11408871|NCT03765502|12603948|FG000|COMPLETED|Simulation 2||20
11408872|NCT03765502|12603949|FG001|COMPLETED|Simulation 2||12
11408873|NCT03765502|12603950|FG002|COMPLETED|Simulation 2||32
11408874|NCT03765502|12603951|FG003|COMPLETED|Simulation 2||16
11408875|NCT03765502|12603952|FG004|COMPLETED|Simulation 2||17
11408876|NCT03765502|12603948|FG000|NOT COMPLETED|Simulation 2||0
11408877|NCT03765502|12603949|FG001|NOT COMPLETED|Simulation 2||0
11408878|NCT03765502|12603950|FG002|NOT COMPLETED|Simulation 2||0
11408879|NCT03765502|12603951|FG003|NOT COMPLETED|Simulation 2||0
11408880|NCT03765502|12603952|FG004|NOT COMPLETED|Simulation 2||0
11408881|NCT03765164|12603974|FG000|STARTED|Pre-intervention||78
11408882|NCT03765164|12603975|FG001|STARTED|Pre-intervention||78
11408883|NCT03765164|12603974|FG000|COMPLETED|Pre-intervention||73
11408884|NCT03765164|12603975|FG001|COMPLETED|Pre-intervention||72
11408885|NCT03765164|12603974|FG000|NOT COMPLETED|Pre-intervention||5
11408886|NCT03765164|12603975|FG001|NOT COMPLETED|Pre-intervention||6
11408887|NCT03765164|12603974|FG000|STARTED|Post-intervention||73
11408888|NCT03765164|12603975|FG001|STARTED|Post-intervention||72
11408889|NCT03765164|12603974|FG000|COMPLETED|Post-intervention||0
11408890|NCT03765164|12603975|FG001|COMPLETED|Post-intervention||0
11408891|NCT03765164|12603974|FG000|NOT COMPLETED|Post-intervention||73
11408892|NCT03765164|12603975|FG001|NOT COMPLETED|Post-intervention||72
11408893|NCT03765138|12603981|FG000|STARTED|Overall Study||1
11408894|NCT03765138|12603981|FG000|COMPLETED|Overall Study||0
11408895|NCT03765138|12603981|FG000|NOT COMPLETED|Overall Study||1
11408896|NCT03764449|12603988|FG000|STARTED|Overall Study||8
11408897|NCT03764449|12603989|FG001|STARTED|Overall Study||8
11408898|NCT03764449|12603988|FG000|COMPLETED|Overall Study||8
11408899|NCT03764449|12603989|FG001|COMPLETED|Overall Study||8
11408900|NCT03764449|12603988|FG000|NOT COMPLETED|Overall Study||0
11408901|NCT03764449|12603989|FG001|NOT COMPLETED|Overall Study||0
11408902|NCT03763929|12604004|FG000|STARTED|Overall Study||2
11408903|NCT03763929|12604005|FG001|STARTED|Overall Study||4
11408904|NCT03763929|12604004|FG000|COMPLETED|Overall Study||2
11408905|NCT03763929|12604005|FG001|COMPLETED|Overall Study||4
11408906|NCT03763929|12604004|FG000|NOT COMPLETED|Overall Study||0
11408907|NCT03763929|12604005|FG001|NOT COMPLETED|Overall Study||0
11408908|NCT03763747|12604011|FG000|STARTED|Overall Study||200
11408909|NCT03763747|12604011|FG000|COMPLETED|Overall Study||200
11408910|NCT03763747|12604011|FG000|NOT COMPLETED|Overall Study||0
11408911|NCT03763058|12604015|FG000|STARTED|Overall Study||20
11408912|NCT03763058|12604015|FG000|COMPLETED|Overall Study||18
11408913|NCT03763058|12604015|FG000|NOT COMPLETED|Overall Study||2
11408914|NCT03762993|12604021|FG000|STARTED|Overall Study||21
11408915|NCT03762993|12604022|FG001|STARTED|Overall Study||10
11408916|NCT03762993|12604021|FG000|COMPLETED|Overall Study||21
11408917|NCT03762993|12604022|FG001|COMPLETED|Overall Study||10
11408918|NCT03762993|12604021|FG000|NOT COMPLETED|Overall Study||0
11408919|NCT03762993|12604022|FG001|NOT COMPLETED|Overall Study||0
11408920|NCT03762681|12604036|FG000|STARTED|Part 1||8
11408921|NCT03762681|12604037|FG001|STARTED|Part 1||8
11408922|NCT03762681|12604038|FG002|STARTED|Part 1||8
11408923|NCT03762681|12604039|FG003|STARTED|Part 1||8
11408924|NCT03762681|12604040|FG004|STARTED|Part 1||8
11408925|NCT03762681|12604041|FG005|STARTED|Part 1||0
11408926|NCT03762681|12604042|FG006|STARTED|Part 1||0
11408927|NCT03762681|12604043|FG007|STARTED|Part 1||0
11408928|NCT03762681|12604036|FG000|COMPLETED|Part 1||8
11408929|NCT03762681|12604037|FG001|COMPLETED|Part 1||8
11408930|NCT03762681|12604038|FG002|COMPLETED|Part 1||8
11408931|NCT03762681|12604039|FG003|COMPLETED|Part 1||7
11408932|NCT03762681|12604040|FG004|COMPLETED|Part 1||8
11408933|NCT03762681|12604041|FG005|COMPLETED|Part 1||0
11408934|NCT03762681|12604042|FG006|COMPLETED|Part 1||0
11408935|NCT03762681|12604043|FG007|COMPLETED|Part 1||0
11408936|NCT03762681|12604036|FG000|NOT COMPLETED|Part 1||0
11408937|NCT03762681|12604037|FG001|NOT COMPLETED|Part 1||0
11408938|NCT03762681|12604038|FG002|NOT COMPLETED|Part 1||0
11408939|NCT03762681|12604039|FG003|NOT COMPLETED|Part 1||1
11408940|NCT03762681|12604040|FG004|NOT COMPLETED|Part 1||0
11408941|NCT03762681|12604041|FG005|NOT COMPLETED|Part 1||0
11408942|NCT03762681|12604042|FG006|NOT COMPLETED|Part 1||0
11408943|NCT03762681|12604043|FG007|NOT COMPLETED|Part 1||0
11408944|NCT03762681|12604036|FG000|STARTED|Part 2a||0
11408945|NCT03762681|12604037|FG001|STARTED|Part 2a||0
11408946|NCT03762681|12604038|FG002|STARTED|Part 2a||0
11408947|NCT03762681|12604039|FG003|STARTED|Part 2a||0
11408948|NCT03762681|12604040|FG004|STARTED|Part 2a||0
11408949|NCT03762681|12604041|FG005|STARTED|Part 2a||2
11408950|NCT03762681|12604042|FG006|STARTED|Part 2a||8
11408951|NCT03762681|12604043|FG007|STARTED|Part 2a||5
11408952|NCT03762681|12604036|FG000|COMPLETED|Part 2a||0
11408953|NCT03762681|12604037|FG001|COMPLETED|Part 2a||0
11408954|NCT03762681|12604038|FG002|COMPLETED|Part 2a||0
11408955|NCT03762681|12604039|FG003|COMPLETED|Part 2a||0
11408956|NCT03762681|12604040|FG004|COMPLETED|Part 2a||0
11408957|NCT03762681|12604041|FG005|COMPLETED|Part 2a||2
11408958|NCT03762681|12604042|FG006|COMPLETED|Part 2a||8
11408959|NCT03762681|12604043|FG007|COMPLETED|Part 2a||4
11408960|NCT03762681|12604036|FG000|NOT COMPLETED|Part 2a||0
11408961|NCT03762681|12604037|FG001|NOT COMPLETED|Part 2a||0
11408962|NCT03762681|12604038|FG002|NOT COMPLETED|Part 2a||0
11408963|NCT03762681|12604039|FG003|NOT COMPLETED|Part 2a||0
11408964|NCT03762681|12604040|FG004|NOT COMPLETED|Part 2a||0
11408965|NCT03762681|12604041|FG005|NOT COMPLETED|Part 2a||0
11408966|NCT03762681|12604042|FG006|NOT COMPLETED|Part 2a||0
11408967|NCT03762681|12604043|FG007|NOT COMPLETED|Part 2a||1
11408968|NCT03762668|12604072|FG000|STARTED|Period 1, First Week of Wear||30
11408969|NCT03762668|12604073|FG001|STARTED|Period 1, First Week of Wear||30
11408970|NCT03762668|12604072|FG000|COMPLETED|Period 1, First Week of Wear||30
11408971|NCT03762668|12604073|FG001|COMPLETED|Period 1, First Week of Wear||29
11408972|NCT03762668|12604072|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
11408973|NCT03762668|12604073|FG001|NOT COMPLETED|Period 1, First Week of Wear||1
11408974|NCT03762668|12604072|FG000|STARTED|Period 2, Second Week of Wear||30
11408975|NCT03762668|12604073|FG001|STARTED|Period 2, Second Week of Wear||29
11408976|NCT03762668|12604072|FG000|COMPLETED|Period 2, Second Week of Wear||30
11408977|NCT03762668|12604073|FG001|COMPLETED|Period 2, Second Week of Wear||29
11408978|NCT03762668|12604072|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
11408979|NCT03762668|12604073|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
11408980|NCT03762616|12604079|FG000|STARTED|Overall Study||120
11408981|NCT03762616|12604079|FG000|COMPLETED|Overall Study||118
11408982|NCT03762616|12604079|FG000|NOT COMPLETED|Overall Study||2
11408983|NCT03762213|12604087|FG000|STARTED|Overall Study||16
11408984|NCT03762213|12604088|FG001|STARTED|Overall Study||14
11408985|NCT03762213|12604087|FG000|COMPLETED|Overall Study||16
11408986|NCT03762213|12604088|FG001|COMPLETED|Overall Study||14
11408987|NCT03762213|12604087|FG000|NOT COMPLETED|Overall Study||0
11408988|NCT03762213|12604088|FG001|NOT COMPLETED|Overall Study||0
11408989|NCT03762200|12604094|FG000|STARTED|Overall Study||103
11408990|NCT03762200|12604094|FG000|COMPLETED|Overall Study||101
11408991|NCT03762200|12604094|FG000|NOT COMPLETED|Overall Study||2
11408992|NCT03761368|12604100|FG000|STARTED|Overall Study||50
11408993|NCT03761368|12604101|FG001|STARTED|Overall Study||51
11408994|NCT03761368|12604100|FG000|COMPLETED|Overall Study||50
11408995|NCT03761368|12604101|FG001|COMPLETED|Overall Study||51
11408996|NCT03761368|12604100|FG000|NOT COMPLETED|Overall Study||0
11408997|NCT03761368|12604101|FG001|NOT COMPLETED|Overall Study||0
11408998|NCT03761147|12604109|FG000|STARTED|Overall Study||32
11408999|NCT03761147|12604110|FG001|STARTED|Overall Study||32
11409000|NCT03761147|12604109|FG000|COMPLETED|Overall Study||25
11409001|NCT03761147|12604110|FG001|COMPLETED|Overall Study||28
11409002|NCT03761147|12604109|FG000|NOT COMPLETED|Overall Study||7
11409003|NCT03761147|12604110|FG001|NOT COMPLETED|Overall Study||4
11409004|NCT03760913|12604135|FG000|STARTED|Overall Study||17
11409005|NCT03760913|12604136|FG001|STARTED|Overall Study||3
11409006|NCT03760913|12604137|FG002|STARTED|Overall Study||6
11409007|NCT03760913|12604138|FG003|STARTED|Overall Study||3
11409008|NCT03760913|12604139|FG004|STARTED|Overall Study||6
11409009|NCT03760913|12604140|FG005|STARTED|Overall Study||3
11409010|NCT03760913|12604141|FG006|STARTED|Overall Study||6
11409011|NCT03760913|12604142|FG007|STARTED|Overall Study||3
11409012|NCT03760913|12604143|FG008|STARTED|Overall Study||3
11409013|NCT03760913|12604144|FG009|STARTED|Overall Study||6
11409014|NCT03760913|12604145|FG010|STARTED|Overall Study||6
11409015|NCT03760913|12604146|FG011|STARTED|Overall Study||6
11409016|NCT03760913|12604147|FG012|STARTED|Overall Study||12
11409017|NCT03760913|12604148|FG013|STARTED|Overall Study||6
11409018|NCT03760913|12604149|FG014|STARTED|Overall Study||6
11409019|NCT03760913|12604150|FG015|STARTED|Overall Study||6
11409020|NCT03760913|12604151|FG016|STARTED|Overall Study||6
11409021|NCT03760913|12604152|FG017|STARTED|Overall Study||6
11409022|NCT03760913|12604153|FG018|STARTED|Overall Study||6
11409023|NCT03760913|12604135|FG000|COMPLETED|Overall Study||17
11409024|NCT03760913|12604136|FG001|COMPLETED|Overall Study||3
11409025|NCT03760913|12604137|FG002|COMPLETED|Overall Study||6
11409026|NCT03760913|12604138|FG003|COMPLETED|Overall Study||3
11409027|NCT03760913|12604139|FG004|COMPLETED|Overall Study||6
11409028|NCT03760913|12604140|FG005|COMPLETED|Overall Study||3
11409029|NCT03760913|12604141|FG006|COMPLETED|Overall Study||6
11409030|NCT03760913|12604142|FG007|COMPLETED|Overall Study||3
11409031|NCT03760913|12604143|FG008|COMPLETED|Overall Study||3
11409032|NCT03760913|12604144|FG009|COMPLETED|Overall Study||6
11409033|NCT03760913|12604145|FG010|COMPLETED|Overall Study||6
11409034|NCT03760913|12604146|FG011|COMPLETED|Overall Study||6
11409035|NCT03760913|12604147|FG012|COMPLETED|Overall Study||12
11409036|NCT03760913|12604148|FG013|COMPLETED|Overall Study||6
11409037|NCT03760913|12604149|FG014|COMPLETED|Overall Study||6
11409038|NCT03760913|12604150|FG015|COMPLETED|Overall Study||6
11409039|NCT03760913|12604151|FG016|COMPLETED|Overall Study||6
11409040|NCT03760913|12604152|FG017|COMPLETED|Overall Study||6
11409041|NCT03760913|12604153|FG018|COMPLETED|Overall Study||6
11409042|NCT03760913|12604135|FG000|NOT COMPLETED|Overall Study||0
11409043|NCT03760913|12604136|FG001|NOT COMPLETED|Overall Study||0
11409044|NCT03760913|12604137|FG002|NOT COMPLETED|Overall Study||0
11409045|NCT03760913|12604138|FG003|NOT COMPLETED|Overall Study||0
11409046|NCT03760913|12604139|FG004|NOT COMPLETED|Overall Study||0
11409047|NCT03760913|12604140|FG005|NOT COMPLETED|Overall Study||0
11409048|NCT03760913|12604141|FG006|NOT COMPLETED|Overall Study||0
11409049|NCT03760913|12604142|FG007|NOT COMPLETED|Overall Study||0
11409050|NCT03760913|12604143|FG008|NOT COMPLETED|Overall Study||0
11409051|NCT03760913|12604144|FG009|NOT COMPLETED|Overall Study||0
11409052|NCT03760913|12604145|FG010|NOT COMPLETED|Overall Study||0
11409053|NCT03760913|12604146|FG011|NOT COMPLETED|Overall Study||0
11409054|NCT03760913|12604147|FG012|NOT COMPLETED|Overall Study||0
11409055|NCT03760913|12604148|FG013|NOT COMPLETED|Overall Study||0
11409056|NCT03760913|12604149|FG014|NOT COMPLETED|Overall Study||0
11409057|NCT03760913|12604150|FG015|NOT COMPLETED|Overall Study||0
11409058|NCT03760913|12604151|FG016|NOT COMPLETED|Overall Study||0
11409059|NCT03760913|12604152|FG017|NOT COMPLETED|Overall Study||0
11409060|NCT03760913|12604153|FG018|NOT COMPLETED|Overall Study||0
11409061|NCT03760796|12604206|FG000|STARTED|Overall Study||200
11409062|NCT03760796|12604207|FG001|STARTED|Overall Study||864
11409063|NCT03760796|12604206|FG000|COMPLETED|Overall Study||200
11409064|NCT03760796|12604207|FG001|COMPLETED|Overall Study||864
11409065|NCT03760796|12604206|FG000|NOT COMPLETED|Overall Study||0
11409066|NCT03760796|12604207|FG001|NOT COMPLETED|Overall Study||0
11409067|NCT03760640|12604215|FG000|STARTED|Period 1||20
11409068|NCT03760640|12604216|FG001|STARTED|Period 1||22
11409069|NCT03760640|12604215|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
11409070|NCT03760640|12604216|FG001|Received at Least 1 Dose of Study Drug|Period 1||22
11409071|NCT03760640|12604215|FG000|COMPLETED|Period 1||20
11409072|NCT03760640|12604216|FG001|COMPLETED|Period 1||22
11409073|NCT03760640|12604215|FG000|NOT COMPLETED|Period 1||0
11409074|NCT03760640|12604216|FG001|NOT COMPLETED|Period 1||0
11409075|NCT03760640|12604215|FG000|STARTED|Period 2||20
11409076|NCT03760640|12604216|FG001|STARTED|Period 2||22
11409077|NCT03760640|12604215|FG000|COMPLETED|Period 2||20
11409078|NCT03760640|12604216|FG001|COMPLETED|Period 2||22
11409079|NCT03760640|12604215|FG000|NOT COMPLETED|Period 2||0
11409080|NCT03760640|12604216|FG001|NOT COMPLETED|Period 2||0
11409081|NCT03760510|12604224|FG000|STARTED|Overall Study||250
11409082|NCT03760510|12604225|FG001|STARTED|Overall Study||250
11409083|NCT03760510|12604224|FG000|COMPLETED|Overall Study||145
11409084|NCT03760510|12604225|FG001|COMPLETED|Overall Study||153
11409085|NCT03760510|12604224|FG000|NOT COMPLETED|Overall Study||105
11409086|NCT03760510|12604225|FG001|NOT COMPLETED|Overall Study||97
11409087|NCT03760250|12604231|FG000|STARTED|Overall Study||6
11409088|NCT03760250|12604231|FG000|COMPLETED|Overall Study||4
11409089|NCT03760250|12604231|FG000|NOT COMPLETED|Overall Study||2
11409090|NCT03759600|12604235|FG000|STARTED|Overall Study||20
11409091|NCT03759600|12604235|FG000|COMPLETED|Overall Study||0
11409092|NCT03759600|12604235|FG000|NOT COMPLETED|Overall Study||20
11409093|NCT03759340|12604239|FG000|STARTED|Overall Study||56
11409094|NCT03759340|12604239|FG000|COMPLETED|Overall Study||0
11409095|NCT03759340|12604239|FG000|NOT COMPLETED|Overall Study||56
11409096|NCT03758716|12604243|FG000|STARTED|Overall Study||12
11409097|NCT03758716|12604243|FG000|COMPLETED|Overall Study||12
11409098|NCT03758716|12604243|FG000|NOT COMPLETED|Overall Study||0
11409099|NCT03758365|12604247|FG000|STARTED|Overall Study||36
11409100|NCT03758365|12604247|FG000|MC2-01 Cream|Overall Study||36
11409101|NCT03758365|12604247|FG000|Clobetasol Propionate 0.05% Lotion|Overall Study||36
11409102|NCT03758365|12604247|FG000|Betamethasone Dipropionate 0.05% Cream|Overall Study||36
11409103|NCT03758365|12604247|FG000|Triamcinolone Acetonide 0,1% Cream|Overall Study||36
11409104|NCT03758365|12604247|FG000|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36
11409105|NCT03758365|12604247|FG000|Desonide 0.05% Cream|Overall Study||36
11409106|NCT03758365|12604247|FG000|Vehicle Cream|Overall Study||36
11409107|NCT03758365|12604247|FG000|COMPLETED|Overall Study||36
11409108|NCT03758365|12604247|FG000|NOT COMPLETED|Overall Study||0
11409109|NCT03758157|12604258|FG000|STARTED|Overall Study||110
11409110|NCT03758157|12604258|FG000|COMPLETED|Overall Study||110
11409111|NCT03758157|12604258|FG000|NOT COMPLETED|Overall Study||0
11409112|NCT03757988|12604262|FG000|STARTED|Overall Study||17
11409113|NCT03757988|12604262|FG000|COMPLETED|Overall Study||16
11409114|NCT03757988|12604262|FG000|NOT COMPLETED|Overall Study||1
11409115|NCT03757312|12604269|FG000|STARTED|Overall Study||5
11409116|NCT03757312|12604270|FG001|STARTED|Overall Study||9
11409117|NCT03757312|12604269|FG000|COMPLETED|Overall Study||5
11409118|NCT03757312|12604270|FG001|COMPLETED|Overall Study||9
11409119|NCT03757312|12604269|FG000|NOT COMPLETED|Overall Study||0
11409120|NCT03757312|12604270|FG001|NOT COMPLETED|Overall Study||0
11409121|NCT03757234|12604283|FG000|STARTED|Overall Study||75
11409122|NCT03757234|12604284|FG001|STARTED|Overall Study||18
11409123|NCT03757234|12604285|FG002|STARTED|Overall Study||17
11409124|NCT03757234|12604286|FG003|STARTED|Overall Study||17
11409125|NCT03757234|12604287|FG004|STARTED|Overall Study||74
11409126|NCT03757234|12604283|FG000|Completed PTE Visit|Overall Study||72
11409127|NCT03757234|12604284|FG001|Completed PTE Visit|Overall Study||16
11409128|NCT03757234|12604285|FG002|Completed PTE Visit|Overall Study||17
11409129|NCT03757234|12604286|FG003|Completed PTE Visit|Overall Study||16
11409130|NCT03757234|12604287|FG004|Completed PTE Visit|Overall Study||71
11409131|NCT03757234|12604283|FG000|COMPLETED|Overall Study||72
11409132|NCT03757234|12604284|FG001|COMPLETED|Overall Study||16
11409133|NCT03757234|12604285|FG002|COMPLETED|Overall Study||17
11409134|NCT03757234|12604286|FG003|COMPLETED|Overall Study||16
11409135|NCT03757234|12604287|FG004|COMPLETED|Overall Study||70
11409136|NCT03757234|12604283|FG000|NOT COMPLETED|Overall Study||3
11409137|NCT03757234|12604284|FG001|NOT COMPLETED|Overall Study||2
11409138|NCT03757234|12604285|FG002|NOT COMPLETED|Overall Study||0
11409139|NCT03757234|12604286|FG003|NOT COMPLETED|Overall Study||1
11409140|NCT03757234|12604287|FG004|NOT COMPLETED|Overall Study||4
11409141|NCT03757039|12604303|FG000|STARTED|Overall Study||32
11409142|NCT03757039|12604304|FG001|STARTED|Overall Study||9
11409143|NCT03757039|12604303|FG000|AOHG MF|Overall Study||11
11409144|NCT03757039|12604304|FG001|AOHG MF|Overall Study||0
11409145|NCT03757039|12604303|FG000|DT1 MF|Overall Study||11
11409146|NCT03757039|12604304|FG001|DT1 MF|Overall Study||0
11409147|NCT03757039|12604303|FG000|DACP MF|Overall Study||10
11409148|NCT03757039|12604304|FG001|DACP MF|Overall Study||0
11409149|NCT03757039|12604303|FG000|COMPLETED|Overall Study||32
11409150|NCT03757039|12604304|FG001|COMPLETED|Overall Study||9
11409151|NCT03757039|12604303|FG000|NOT COMPLETED|Overall Study||0
11409152|NCT03757039|12604304|FG001|NOT COMPLETED|Overall Study||0
11409153|NCT03756883|12604315|FG000|STARTED|Overall Study||485
11409154|NCT03756883|12604316|FG001|STARTED|Overall Study||413
11409155|NCT03756883|12604317|FG002|STARTED|Overall Study||101
11409156|NCT03756883|12604315|FG000|COMPLETED|Overall Study||472
11409157|NCT03756883|12604316|FG001|COMPLETED|Overall Study||402
11409158|NCT03756883|12604317|FG002|COMPLETED|Overall Study||94
11409159|NCT03756883|12604315|FG000|NOT COMPLETED|Overall Study||13
11409160|NCT03756883|12604316|FG001|NOT COMPLETED|Overall Study||11
11409161|NCT03756883|12604317|FG002|NOT COMPLETED|Overall Study||7
11409162|NCT03756506|12604327|FG000|STARTED|Overall Study||7
11409163|NCT03756506|12604328|FG001|STARTED|Overall Study||6
11409164|NCT03756506|12604327|FG000|COMPLETED|Overall Study||6
11409165|NCT03756506|12604328|FG001|COMPLETED|Overall Study||6
11409166|NCT03756506|12604327|FG000|NOT COMPLETED|Overall Study||1
11409167|NCT03756506|12604328|FG001|NOT COMPLETED|Overall Study||0
11409168|NCT03756285|12604336|FG000|STARTED|Overall Study||27
11409169|NCT03756285|12604337|FG001|STARTED|Overall Study||14
11409170|NCT03756285|12604336|FG000|COMPLETED|Overall Study||24
11409171|NCT03756285|12604337|FG001|COMPLETED|Overall Study||9
11409172|NCT03756285|12604336|FG000|NOT COMPLETED|Overall Study||3
11409173|NCT03756285|12604337|FG001|NOT COMPLETED|Overall Study||5
11409174|NCT03756129|12604350|FG000|STARTED|Overall Study||11
11409175|NCT03756129|12604351|FG001|STARTED|Overall Study||10
11409176|NCT03756129|12604352|FG002|STARTED|Overall Study||10
11409177|NCT03756129|12604353|FG003|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|9
11409178|NCT03756129|12604354|FG004|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|10
11409179|NCT03756129|12604355|FG005|STARTED|Overall Study||20
11409180|NCT03756129|12604350|FG000|COMPLETED|Overall Study||8
11409181|NCT03756129|12604351|FG001|COMPLETED|Overall Study||8
11409182|NCT03756129|12604352|FG002|COMPLETED|Overall Study||7
11409183|NCT03756129|12604353|FG003|COMPLETED|Overall Study||6
11409184|NCT03756129|12604354|FG004|COMPLETED|Overall Study||9
11409185|NCT03756129|12604355|FG005|COMPLETED|Overall Study||15
11409186|NCT03756129|12604350|FG000|NOT COMPLETED|Overall Study||3
11409187|NCT03756129|12604351|FG001|NOT COMPLETED|Overall Study||2
11409188|NCT03756129|12604352|FG002|NOT COMPLETED|Overall Study||3
11409189|NCT03756129|12604353|FG003|NOT COMPLETED|Overall Study||3
11409190|NCT03756129|12604354|FG004|NOT COMPLETED|Overall Study||1
11409191|NCT03756129|12604355|FG005|NOT COMPLETED|Overall Study||5
11409192|NCT03756038|12604379|FG000|STARTED|Overall Study||1
11409193|NCT03756038|12604380|FG001|STARTED|Overall Study||0
11409194|NCT03756038|12604379|FG000|COMPLETED|Overall Study||1
11409195|NCT03756038|12604380|FG001|COMPLETED|Overall Study||0
11409196|NCT03756038|12604379|FG000|NOT COMPLETED|Overall Study||0
11409197|NCT03756038|12604380|FG001|NOT COMPLETED|Overall Study||0
11409198|NCT03756012|12604386|FG000|STARTED|Overall Study||15
11409199|NCT03756012|12604386|FG000|COMPLETED|Overall Study||15
11409200|NCT03756012|12604386|FG000|NOT COMPLETED|Overall Study||0
11409201|NCT03755882|12604391|FG000|STARTED|Period 1||23
11409202|NCT03755882|12604392|FG001|STARTED|Period 1||22
11409203|NCT03755882|12604391|FG000|COMPLETED|Period 1||19
11409204|NCT03755882|12604392|FG001|COMPLETED|Period 1||22
11409205|NCT03755882|12604391|FG000|NOT COMPLETED|Period 1||4
11409206|NCT03755882|12604392|FG001|NOT COMPLETED|Period 1||0
11409207|NCT03755882|12604391|FG000|STARTED|Period 2||19
11409208|NCT03755882|12604392|FG001|STARTED|Period 2||22
11409209|NCT03755882|12604391|FG000|COMPLETED|Period 2||19
11409210|NCT03755882|12604392|FG001|COMPLETED|Period 2||22
11409211|NCT03755882|12604391|FG000|NOT COMPLETED|Period 2||0
11409212|NCT03755882|12604392|FG001|NOT COMPLETED|Period 2||0
11409213|NCT03755661|12604400|FG000|STARTED|Overall Study||12
11409214|NCT03755661|12604401|FG001|STARTED|Overall Study||12
11409215|NCT03755661|12604400|FG000|COMPLETED|Overall Study||11
11409216|NCT03755661|12604401|FG001|COMPLETED|Overall Study||12
11409217|NCT03755661|12604400|FG000|NOT COMPLETED|Overall Study||1
11409218|NCT03755661|12604401|FG001|NOT COMPLETED|Overall Study||0
11409219|NCT03754582|12604407|FG000|STARTED|Pretreatment Phase||21
11409220|NCT03754582|12604408|FG001|STARTED|Pretreatment Phase||0
11409221|NCT03754582|12604409|FG002|STARTED|Pretreatment Phase||0
11409222|NCT03754582|12604407|FG000|COMPLETED|Pretreatment Phase||21
11409223|NCT03754582|12604408|FG001|COMPLETED|Pretreatment Phase||0
11409224|NCT03754582|12604409|FG002|COMPLETED|Pretreatment Phase||0
11409225|NCT03754582|12604407|FG000|NOT COMPLETED|Pretreatment Phase||0
11409226|NCT03754582|12604408|FG001|NOT COMPLETED|Pretreatment Phase||0
11409227|NCT03754582|12604409|FG002|NOT COMPLETED|Pretreatment Phase||0
11409228|NCT03754582|12604407|FG000|STARTED|Treatment Phase||0
11409229|NCT03754582|12604408|FG001|STARTED|Treatment Phase||21
11409230|NCT03754582|12604409|FG002|STARTED|Treatment Phase||0
11409231|NCT03754582|12604407|FG000|COMPLETED|Treatment Phase||0
11409232|NCT03754582|12604408|FG001|COMPLETED|Treatment Phase||20
11409233|NCT03754582|12604409|FG002|COMPLETED|Treatment Phase||0
11409234|NCT03754582|12604407|FG000|NOT COMPLETED|Treatment Phase||0
11409235|NCT03754582|12604408|FG001|NOT COMPLETED|Treatment Phase||1
11409236|NCT03754582|12604409|FG002|NOT COMPLETED|Treatment Phase||0
11409237|NCT03754582|12604407|FG000|STARTED|Follow-up Phase||0
11409238|NCT03754582|12604408|FG001|STARTED|Follow-up Phase||0
11409239|NCT03754582|12604409|FG002|STARTED|Follow-up Phase|1 participant who discontinued in Treatment Phase was assessed at Follow-up Visit.|21
11409240|NCT03754582|12604407|FG000|COMPLETED|Follow-up Phase||0
11409241|NCT03754582|12604408|FG001|COMPLETED|Follow-up Phase||0
11409242|NCT03754582|12604409|FG002|COMPLETED|Follow-up Phase||20
11409243|NCT03754582|12604407|FG000|NOT COMPLETED|Follow-up Phase||0
11409244|NCT03754582|12604408|FG001|NOT COMPLETED|Follow-up Phase||0
11409245|NCT03754582|12604409|FG002|NOT COMPLETED|Follow-up Phase||1
11409246|NCT03754556|12604425|FG000|STARTED|Overall Study||326658
11409247|NCT03754556|12604425|FG000|COMPLETED|Overall Study||326658
11409248|NCT03754556|12604425|FG000|NOT COMPLETED|Overall Study||0
11409249|NCT03753113|12604431|FG000|STARTED|Overall Study||12
11409250|NCT03753113|12604432|FG001|STARTED|Overall Study||12
11409251|NCT03753113|12604431|FG000|COMPLETED|Overall Study||12
11409252|NCT03753113|12604432|FG001|COMPLETED|Overall Study||12
11409253|NCT03753113|12604431|FG000|NOT COMPLETED|Overall Study||0
11409254|NCT03753113|12604432|FG001|NOT COMPLETED|Overall Study||0
11409255|NCT03752567|12604438|FG000|STARTED|Overall Study||40
11409256|NCT03752567|12604438|FG000|COMPLETED|Overall Study||40
11409257|NCT03752567|12604438|FG000|NOT COMPLETED|Overall Study||0
11409258|NCT03752528|12604442|FG000|STARTED|Part A||53
11409259|NCT03752528|12604442|FG000|COMPLETED|Part A||51
11409260|NCT03752528|12604442|FG000|NOT COMPLETED|Part A||2
11409261|NCT03752528|12604442|FG000|STARTED|Part B||24
11409262|NCT03752528|12604442|FG000|COMPLETED|Part B||20
11409263|NCT03752528|12604442|FG000|NOT COMPLETED|Part B||4
11409264|NCT03752151|12604449|FG000|STARTED|Overall Study||77
11409265|NCT03752151|12604449|FG000|COMPLETED|Overall Study||75
11409266|NCT03752151|12604449|FG000|NOT COMPLETED|Overall Study||2
11409267|NCT03751657|12604456|FG000|STARTED|Overall Study||125
11409268|NCT03751657|12604457|FG001|STARTED|Overall Study||122
11409269|NCT03751657|12604456|FG000|COMPLETED|Overall Study||122
11409270|NCT03751657|12604457|FG001|COMPLETED|Overall Study||119
11409271|NCT03751657|12604456|FG000|NOT COMPLETED|Overall Study||3
11409272|NCT03751657|12604457|FG001|NOT COMPLETED|Overall Study||3
11409273|NCT03751280|12604465|FG000|STARTED|Overall Study||56
11409274|NCT03751280|12604466|FG001|STARTED|Overall Study||56
11409275|NCT03751280|12604465|FG000|Full Analysis Set (FAS)|Overall Study||54
11409276|NCT03751280|12604466|FG001|Full Analysis Set (FAS)|Overall Study||55
11409277|NCT03751280|12604465|FG000|Safety Set (SAF)|Overall Study||55
11409278|NCT03751280|12604466|FG001|Safety Set (SAF)|Overall Study||55
11409279|NCT03751280|12604465|FG000|COMPLETED|Overall Study||48
11409280|NCT03751280|12604466|FG001|COMPLETED|Overall Study||44
11409281|NCT03751280|12604465|FG000|NOT COMPLETED|Overall Study||8
11409282|NCT03751280|12604466|FG001|NOT COMPLETED|Overall Study||12
11409283|NCT03751020|12604476|FG000|STARTED|Overall Study||36
11409284|NCT03751020|12604477|FG001|STARTED|Overall Study||36
11409285|NCT03751020|12604478|FG002|STARTED|Overall Study||36
11409286|NCT03751020|12604476|FG000|Post Intervention|Overall Study||33
11409287|NCT03751020|12604477|FG001|Post Intervention|Overall Study||33
11409288|NCT03751020|12604478|FG002|Post Intervention|Overall Study||30
11409289|NCT03751020|12604476|FG000|3 Month Follow Up|Overall Study||27
11409290|NCT03751020|12604477|FG001|3 Month Follow Up|Overall Study||32
11409291|NCT03751020|12604478|FG002|3 Month Follow Up|Overall Study||26
11409292|NCT03751020|12604476|FG000|COMPLETED|Overall Study||27
11409293|NCT03751020|12604477|FG001|COMPLETED|Overall Study||32
11409294|NCT03751020|12604478|FG002|COMPLETED|Overall Study||26
11409295|NCT03751020|12604476|FG000|NOT COMPLETED|Overall Study||9
11409296|NCT03751020|12604477|FG001|NOT COMPLETED|Overall Study||4
11409297|NCT03751020|12604478|FG002|NOT COMPLETED|Overall Study||10
11409298|NCT03750955|12604488|FG000|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
11409299|NCT03750955|12604489|FG001|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
11409300|NCT03750955|12604488|FG000|COMPLETED|Hygiene Phase of 2 Weeks||13
11409301|NCT03750955|12604489|FG001|COMPLETED|Hygiene Phase of 2 Weeks||13
11409302|NCT03750955|12604488|FG000|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
11409303|NCT03750955|12604489|FG001|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
11409304|NCT03750955|12604488|FG000|STARTED|Gingivitis Induction Phase of 2 Weeks||13
11409305|NCT03750955|12604489|FG001|STARTED|Gingivitis Induction Phase of 2 Weeks||13
11409306|NCT03750955|12604488|FG000|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 participants randomized to L maxillary sextant SIBO; 7 randomized to R maxillary sextant SIBO.|13
11409307|NCT03750955|12604489|FG001|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 randomized to R max. sextant oral hygiene maintenance (OHM); 7 randomized to L max. sextant OHM.|13
11409308|NCT03750955|12604488|FG000|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
11409309|NCT03750955|12604489|FG001|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
11409310|NCT03750955|12604488|FG000|STARTED|Resolution Phase of 2 Weeks|No stent in use; oral hygiene resumed.|13
11409311|NCT03750955|12604489|FG001|STARTED|Resolution Phase of 2 Weeks|Oral hygiene maintenance continued.|13
11409312|NCT03750955|12604488|FG000|COMPLETED|Resolution Phase of 2 Weeks||13
11409313|NCT03750955|12604489|FG001|COMPLETED|Resolution Phase of 2 Weeks||13
11409314|NCT03750955|12604488|FG000|NOT COMPLETED|Resolution Phase of 2 Weeks||0
11409315|NCT03750955|12604489|FG001|NOT COMPLETED|Resolution Phase of 2 Weeks||0
11409316|NCT03750695|12604497|FG000|STARTED|Overall Study||8
11409317|NCT03750695|12604498|FG001|STARTED|Overall Study||8
11409318|NCT03750695|12604497|FG000|COMPLETED|Overall Study||8
11409319|NCT03750695|12604498|FG001|COMPLETED|Overall Study||7
11409320|NCT03750695|12604497|FG000|NOT COMPLETED|Overall Study||0
11409321|NCT03750695|12604498|FG001|NOT COMPLETED|Overall Study||1
11409322|NCT03748992|12604509|FG000|STARTED|Overall Study||10
11409323|NCT03748992|12604509|FG000|COMPLETED|Overall Study||10
11409324|NCT03748992|12604509|FG000|NOT COMPLETED|Overall Study||0
11409325|NCT03748979|12604524|FG000|STARTED|Overall Study||6
11409326|NCT03748979|12604525|FG001|STARTED|Overall Study||6
11409327|NCT03748979|12604526|FG002|STARTED|Overall Study||6
11409328|NCT03748979|12604527|FG003|STARTED|Overall Study||6
11409329|NCT03748979|12604528|FG004|STARTED|Overall Study||4
11409330|NCT03748979|12604529|FG005|STARTED|Overall Study||4
11409331|NCT03748979|12604530|FG006|STARTED|Overall Study||5
11409332|NCT03748979|12604531|FG007|STARTED|Overall Study||5
11409333|NCT03748979|12604532|FG008|STARTED|Overall Study||4
11409334|NCT03748979|12604533|FG009|STARTED|Overall Study||5
11409335|NCT03748979|12604534|FG010|STARTED|Overall Study||6
11409336|NCT03748979|12604524|FG000|COMPLETED|Overall Study||6
11409337|NCT03748979|12604525|FG001|COMPLETED|Overall Study||6
11409338|NCT03748979|12604526|FG002|COMPLETED|Overall Study||6
11409339|NCT03748979|12604527|FG003|COMPLETED|Overall Study||6
11409340|NCT03748979|12604528|FG004|COMPLETED|Overall Study||4
11409341|NCT03748979|12604529|FG005|COMPLETED|Overall Study||4
11409342|NCT03748979|12604530|FG006|COMPLETED|Overall Study||5
11409343|NCT03748979|12604531|FG007|COMPLETED|Overall Study||5
11409344|NCT03748979|12604532|FG008|COMPLETED|Overall Study||4
11409345|NCT03748979|12604533|FG009|COMPLETED|Overall Study||5
11409346|NCT03748979|12604534|FG010|COMPLETED|Overall Study||6
11409347|NCT03748979|12604524|FG000|NOT COMPLETED|Overall Study||0
11409348|NCT03748979|12604525|FG001|NOT COMPLETED|Overall Study||0
11409349|NCT03748979|12604526|FG002|NOT COMPLETED|Overall Study||0
11409350|NCT03748979|12604527|FG003|NOT COMPLETED|Overall Study||0
11409351|NCT03748979|12604528|FG004|NOT COMPLETED|Overall Study||0
11409352|NCT03748979|12604529|FG005|NOT COMPLETED|Overall Study||0
11409353|NCT03748979|12604530|FG006|NOT COMPLETED|Overall Study||0
11409354|NCT03748979|12604531|FG007|NOT COMPLETED|Overall Study||0
11409355|NCT03748979|12604532|FG008|NOT COMPLETED|Overall Study||0
11409356|NCT03748979|12604533|FG009|NOT COMPLETED|Overall Study||0
11409357|NCT03748979|12604534|FG010|NOT COMPLETED|Overall Study||0
11409358|NCT03748758|12604574|FG000|STARTED|Overall Study||12
11409359|NCT03748758|12604575|FG001|STARTED|Overall Study||12
11409360|NCT03748758|12604576|FG002|STARTED|Overall Study||6
11409361|NCT03748758|12604574|FG000|COMPLETED|Overall Study||12
11409362|NCT03748758|12604575|FG001|COMPLETED|Overall Study||12
11409363|NCT03748758|12604576|FG002|COMPLETED|Overall Study||5
11409364|NCT03748758|12604574|FG000|NOT COMPLETED|Overall Study||0
11409365|NCT03748758|12604575|FG001|NOT COMPLETED|Overall Study||0
11409366|NCT03748758|12604576|FG002|NOT COMPLETED|Overall Study||1
11409367|NCT03748706|12604606|FG000|STARTED|Overall Study||13
11409368|NCT03748706|12604606|FG000|COMPLETED|Overall Study||12
11409369|NCT03748706|12604606|FG000|NOT COMPLETED|Overall Study||1
11409370|NCT03748264|12604613|FG000|STARTED|Overall Study||21
11409371|NCT03748264|12604614|FG001|STARTED|Overall Study||21
11409372|NCT03748264|12604615|FG002|STARTED|Overall Study||20
11409373|NCT03748264|12604613|FG000|COMPLETED|Overall Study||21
11409374|NCT03748264|12604614|FG001|COMPLETED|Overall Study||21
11409375|NCT03748264|12604615|FG002|COMPLETED|Overall Study||20
11409376|NCT03748264|12604613|FG000|NOT COMPLETED|Overall Study||0
11409377|NCT03748264|12604614|FG001|NOT COMPLETED|Overall Study||0
11409378|NCT03748264|12604615|FG002|NOT COMPLETED|Overall Study||0
11409379|NCT03747497|12604625|FG000|STARTED|Overall Study||131
11409380|NCT03747497|12604626|FG001|STARTED|Overall Study||65
11409381|NCT03747497|12604625|FG000|COMPLETED|Overall Study||106
11409382|NCT03747497|12604626|FG001|COMPLETED|Overall Study||55
11409383|NCT03747497|12604625|FG000|NOT COMPLETED|Overall Study||25
11409384|NCT03747497|12604626|FG001|NOT COMPLETED|Overall Study||10
11409385|NCT03746405|12604634|FG000|STARTED|Overall Study||10
11409386|NCT03746405|12604635|FG001|STARTED|Overall Study||8
11409387|NCT03746405|12604634|FG000|COMPLETED|Overall Study||7
11409388|NCT03746405|12604635|FG001|COMPLETED|Overall Study||6
11409389|NCT03746405|12604634|FG000|NOT COMPLETED|Overall Study||3
11409390|NCT03746405|12604635|FG001|NOT COMPLETED|Overall Study||2
11409391|NCT03745937|12604645|FG000|STARTED|Overall Study||2
11409392|NCT03745937|12604646|FG001|STARTED|Overall Study||6
11409393|NCT03745937|12604647|FG002|STARTED|Overall Study||3
11409394|NCT03745937|12604648|FG003|STARTED|Overall Study||9
11409395|NCT03745937|12604645|FG000|COMPLETED|Overall Study||2
11409396|NCT03745937|12604646|FG001|COMPLETED|Overall Study||5
11409397|NCT03745937|12604647|FG002|COMPLETED|Overall Study||3
11409398|NCT03745937|12604648|FG003|COMPLETED|Overall Study||7
11409399|NCT03745937|12604645|FG000|NOT COMPLETED|Overall Study||0
11409400|NCT03745937|12604646|FG001|NOT COMPLETED|Overall Study||1
11409401|NCT03745937|12604647|FG002|NOT COMPLETED|Overall Study||0
11409402|NCT03745937|12604648|FG003|NOT COMPLETED|Overall Study||2
11409403|NCT03745222|12604662|FG000|STARTED|Overall Study||0
11409404|NCT03745222|12604663|FG001|STARTED|Overall Study||1
11409405|NCT03745222|12604664|FG002|STARTED|Overall Study||0
11409406|NCT03745222|12604662|FG000|COMPLETED|Overall Study||0
11409407|NCT03745222|12604663|FG001|COMPLETED|Overall Study||0
11409408|NCT03745222|12604664|FG002|COMPLETED|Overall Study||0
11409409|NCT03745222|12604662|FG000|NOT COMPLETED|Overall Study||0
11409410|NCT03745222|12604663|FG001|NOT COMPLETED|Overall Study||1
11409411|NCT03745222|12604664|FG002|NOT COMPLETED|Overall Study||0
11409412|NCT03745092|12604674|FG000|STARTED|Overall Study||26
11409413|NCT03745092|12604675|FG001|STARTED|Overall Study||23
11409414|NCT03745092|12604674|FG000|COMPLETED|Overall Study||26
11409415|NCT03745092|12604675|FG001|COMPLETED|Overall Study||23
11409416|NCT03745092|12604674|FG000|NOT COMPLETED|Overall Study||0
11409417|NCT03745092|12604675|FG001|NOT COMPLETED|Overall Study||0
11409418|NCT03744780|12604681|FG000|STARTED|Overall Study||32
11409419|NCT03744780|12604681|FG000|COMPLETED|Overall Study||32
11409420|NCT03744780|12604681|FG000|NOT COMPLETED|Overall Study||0
11409421|NCT03743311|12604688|FG000|STARTED|Overall Study||311
11409422|NCT03743311|12604689|FG001|STARTED|Overall Study||298
11409423|NCT03743311|12604690|FG002|STARTED|Overall Study||423
11409424|NCT03743311|12604688|FG000|COMPLETED|Overall Study||311
11409425|NCT03743311|12604689|FG001|COMPLETED|Overall Study||298
11409426|NCT03743311|12604690|FG002|COMPLETED|Overall Study||423
11409427|NCT03743311|12604688|FG000|NOT COMPLETED|Overall Study||0
11409428|NCT03743311|12604689|FG001|NOT COMPLETED|Overall Study||0
11409429|NCT03743311|12604690|FG002|NOT COMPLETED|Overall Study||0
11409430|NCT03743038|12604699|FG000|STARTED|Overall Study||12
11409431|NCT03743038|12604699|FG000|Test Article A|Overall Study||12
11409432|NCT03743038|12604699|FG000|Test Article B|Overall Study||12
11409433|NCT03743038|12604699|FG000|COMPLETED|Overall Study||11
11409434|NCT03743038|12604699|FG000|NOT COMPLETED|Overall Study||1
11409435|NCT03742973|12604707|FG000|STARTED|Overall Study||0
11409436|NCT03742973|12604708|FG001|STARTED|Overall Study||0
11409437|NCT03742973|12604707|FG000|COMPLETED|Overall Study||0
11409438|NCT03742973|12604708|FG001|COMPLETED|Overall Study||0
11409439|NCT03742973|12604707|FG000|NOT COMPLETED|Overall Study||0
11409440|NCT03742973|12604708|FG001|NOT COMPLETED|Overall Study||0
11409441|NCT03742440|12604714|FG000|STARTED|Overall Study||40
11409442|NCT03742440|12604714|FG000|COMPLETED|Overall Study||40
11409443|NCT03742440|12604714|FG000|NOT COMPLETED|Overall Study||0
11409444|NCT03742427|12604718|FG000|STARTED|Overall Study||50
11409445|NCT03742427|12604718|FG000|COMPLETED|Overall Study||50
11409446|NCT03742427|12604718|FG000|NOT COMPLETED|Overall Study||0
11409447|NCT03742271|12604722|FG000|STARTED|Overall Study||127
11409448|NCT03742271|12604722|FG000|COMPLETED|Overall Study||115
11409449|NCT03742271|12604722|FG000|NOT COMPLETED|Overall Study||12
11409450|NCT03742154|12604728|FG000|STARTED|Overall Study||50
11409451|NCT03742154|12604729|FG001|STARTED|Overall Study||49
11409452|NCT03742154|12604728|FG000|COMPLETED|Overall Study||50
11409453|NCT03742154|12604729|FG001|COMPLETED|Overall Study||49
11409454|NCT03742154|12604728|FG000|NOT COMPLETED|Overall Study||0
11409455|NCT03742154|12604729|FG001|NOT COMPLETED|Overall Study||0
11409456|NCT03741725|12604738|FG000|STARTED|Overall Study||101
11409457|NCT03741725|12604739|FG001|STARTED|Overall Study||100
11409458|NCT03741725|12604740|FG002|STARTED|Overall Study||100
11409459|NCT03741725|12604738|FG000|COMPLETED|Overall Study||101
11409460|NCT03741725|12604739|FG001|COMPLETED|Overall Study||100
11409461|NCT03741725|12604740|FG002|COMPLETED|Overall Study||100
11409462|NCT03741725|12604738|FG000|NOT COMPLETED|Overall Study||0
11409463|NCT03741725|12604739|FG001|NOT COMPLETED|Overall Study||0
11409464|NCT03741725|12604740|FG002|NOT COMPLETED|Overall Study||0
11409465|NCT03741088|12604751|FG000|STARTED|Overall Study||8
11409466|NCT03741088|12604751|FG000|COMPLETED|Overall Study||5
11409467|NCT03741088|12604751|FG000|NOT COMPLETED|Overall Study||3
11409468|NCT03741062|12604757|FG000|STARTED|Overall Study||5
11409469|NCT03741062|12604758|FG001|STARTED|Overall Study||6
11409470|NCT03741062|12604757|FG000|COMPLETED|Overall Study||4
11409471|NCT03741062|12604758|FG001|COMPLETED|Overall Study||6
11409472|NCT03741062|12604757|FG000|NOT COMPLETED|Overall Study||1
11409473|NCT03741062|12604758|FG001|NOT COMPLETED|Overall Study||0
11409474|NCT03740659|12604767|FG000|STARTED|Overall Study||42
11409475|NCT03740659|12604768|FG001|STARTED|Overall Study||42
11409476|NCT03740659|12604769|FG002|STARTED|Overall Study||41
11409477|NCT03740659|12604767|FG000|COMPLETED|Overall Study||42
11409478|NCT03740659|12604768|FG001|COMPLETED|Overall Study||42
11409479|NCT03740659|12604769|FG002|COMPLETED|Overall Study||41
11409480|NCT03740659|12604767|FG000|NOT COMPLETED|Overall Study||0
11409481|NCT03740659|12604768|FG001|NOT COMPLETED|Overall Study||0
11409482|NCT03740659|12604769|FG002|NOT COMPLETED|Overall Study||0
11409483|NCT03740152|12604777|FG000|STARTED|Overall Study||10
11409484|NCT03740152|12604777|FG000|COMPLETED|Overall Study||10
11409485|NCT03740152|12604777|FG000|NOT COMPLETED|Overall Study||0
11409486|NCT03739866|12604789|FG000|STARTED|Overall Study||6
11409487|NCT03739866|12604790|FG001|STARTED|Overall Study||6
11409488|NCT03739866|12604791|FG002|STARTED|Overall Study||7
11409489|NCT03739866|12604792|FG003|STARTED|Overall Study||6
11409490|NCT03739866|12604793|FG004|STARTED|Overall Study||6
11409491|NCT03739866|12604794|FG005|STARTED|Overall Study||10
11409492|NCT03739866|12604795|FG006|STARTED|Overall Study||7
11409493|NCT03739866|12604796|FG007|STARTED|Overall Study||5
11409494|NCT03739866|12604789|FG000|COMPLETED|Overall Study||6
11409495|NCT03739866|12604790|FG001|COMPLETED|Overall Study||6
11409496|NCT03739866|12604791|FG002|COMPLETED|Overall Study||6
11409497|NCT03739866|12604792|FG003|COMPLETED|Overall Study||5
11409498|NCT03739866|12604793|FG004|COMPLETED|Overall Study||5
11409499|NCT03739866|12604794|FG005|COMPLETED|Overall Study||10
11409500|NCT03739866|12604795|FG006|COMPLETED|Overall Study||7
11409501|NCT03739866|12604796|FG007|COMPLETED|Overall Study||5
11409502|NCT03739866|12604789|FG000|NOT COMPLETED|Overall Study||0
11409503|NCT03739866|12604790|FG001|NOT COMPLETED|Overall Study||0
11409504|NCT03739866|12604791|FG002|NOT COMPLETED|Overall Study||1
11409505|NCT03739866|12604792|FG003|NOT COMPLETED|Overall Study||1
11409506|NCT03739866|12604793|FG004|NOT COMPLETED|Overall Study||1
11409507|NCT03739866|12604794|FG005|NOT COMPLETED|Overall Study||0
11409508|NCT03739866|12604795|FG006|NOT COMPLETED|Overall Study||0
11409509|NCT03739866|12604796|FG007|NOT COMPLETED|Overall Study||0
11409510|NCT03739684|12604818|FG000|STARTED|Overall Study||208
11409511|NCT03739684|12604818|FG000|COMPLETED|Overall Study||195
11409512|NCT03739684|12604818|FG000|NOT COMPLETED|Overall Study||13
11409513|NCT03739528|12604824|FG000|STARTED|Overall Study||403
11409514|NCT03739528|12604825|FG001|STARTED|Overall Study||405
11409515|NCT03739528|12604824|FG000|Received at Least One Treatment|Overall Study||395
11409516|NCT03739528|12604825|FG001|Received at Least One Treatment|Overall Study||393
11409517|NCT03739528|12604824|FG000|COMPLETED|Overall Study||388
11409518|NCT03739528|12604825|FG001|COMPLETED|Overall Study||388
11409519|NCT03739528|12604824|FG000|NOT COMPLETED|Overall Study||15
11409520|NCT03739528|12604825|FG001|NOT COMPLETED|Overall Study||17
11409521|NCT03739242|12604836|FG000|STARTED|Overall Study||44
11409522|NCT03739242|12604837|FG001|STARTED|Overall Study||44
11409523|NCT03739242|12604836|FG000|COMPLETED|Overall Study||43
11409524|NCT03739242|12604837|FG001|COMPLETED|Overall Study||42
11409525|NCT03739242|12604836|FG000|NOT COMPLETED|Overall Study||1
11409526|NCT03739242|12604837|FG001|NOT COMPLETED|Overall Study||2
11409527|NCT03738865|12604845|FG000|STARTED|Overall Study||66
11409528|NCT03738865|12604846|FG001|STARTED|Overall Study||66
11409529|NCT03738865|12604845|FG000|COMPLETED|Overall Study||61
11409530|NCT03738865|12604846|FG001|COMPLETED|Overall Study||62
11409531|NCT03738865|12604845|FG000|NOT COMPLETED|Overall Study||5
11409532|NCT03738865|12604846|FG001|NOT COMPLETED|Overall Study||4
11409533|NCT03738826|12604854|FG000|STARTED|Overall Study||130
11409534|NCT03738826|12604855|FG001|STARTED|Overall Study||5
11409535|NCT03738826|12604854|FG000|COMPLETED|Overall Study||130
11409536|NCT03738826|12604855|FG001|COMPLETED|Overall Study||5
11409537|NCT03738826|12604854|FG000|NOT COMPLETED|Overall Study||0
11409538|NCT03738826|12604855|FG001|NOT COMPLETED|Overall Study||0
11409539|NCT03738475|12604863|FG000|STARTED|Overall Study||16
11409540|NCT03738475|12604864|FG001|STARTED|Overall Study||18
11409541|NCT03738475|12604863|FG000|COMPLETED|Overall Study||15
11409542|NCT03738475|12604864|FG001|COMPLETED|Overall Study||18
11409543|NCT03738475|12604863|FG000|NOT COMPLETED|Overall Study||1
11409544|NCT03738475|12604864|FG001|NOT COMPLETED|Overall Study||0
11409545|NCT03738241|12604880|FG000|STARTED|Overall Study||38
11409546|NCT03738241|12604881|FG001|STARTED|Overall Study||40
11409547|NCT03738241|12604882|FG002|STARTED|Overall Study||24
11409548|NCT03738241|12604883|FG003|STARTED|Overall Study||18
11409549|NCT03738241|12604884|FG004|STARTED|Overall Study||40
11409550|NCT03738241|12604885|FG005|STARTED|Overall Study||44
11409551|NCT03738241|12604886|FG006|STARTED|Overall Study||20
11409552|NCT03738241|12604887|FG007|STARTED|Overall Study||16
11409553|NCT03738241|12604888|FG008|STARTED|Overall Study||29
11409554|NCT03738241|12604889|FG009|STARTED|Overall Study||35
11409555|NCT03738241|12604880|FG000|COMPLETED|Overall Study||37
11409556|NCT03738241|12604881|FG001|COMPLETED|Overall Study||40
11409557|NCT03738241|12604882|FG002|COMPLETED|Overall Study||24
11409558|NCT03738241|12604883|FG003|COMPLETED|Overall Study||18
11409559|NCT03738241|12604884|FG004|COMPLETED|Overall Study||40
11409560|NCT03738241|12604885|FG005|COMPLETED|Overall Study||44
11409561|NCT03738241|12604886|FG006|COMPLETED|Overall Study||20
11409562|NCT03738241|12604887|FG007|COMPLETED|Overall Study||16
11409563|NCT03738241|12604888|FG008|COMPLETED|Overall Study||28
11409564|NCT03738241|12604889|FG009|COMPLETED|Overall Study||34
11409565|NCT03738241|12604880|FG000|NOT COMPLETED|Overall Study||1
11409566|NCT03738241|12604881|FG001|NOT COMPLETED|Overall Study||0
11409567|NCT03738241|12604882|FG002|NOT COMPLETED|Overall Study||0
11409568|NCT03738241|12604883|FG003|NOT COMPLETED|Overall Study||0
11409569|NCT03738241|12604884|FG004|NOT COMPLETED|Overall Study||0
11409570|NCT03738241|12604885|FG005|NOT COMPLETED|Overall Study||0
11409571|NCT03738241|12604886|FG006|NOT COMPLETED|Overall Study||0
11409572|NCT03738241|12604887|FG007|NOT COMPLETED|Overall Study||0
11409573|NCT03738241|12604888|FG008|NOT COMPLETED|Overall Study||1
11409574|NCT03738241|12604889|FG009|NOT COMPLETED|Overall Study||1
11409575|NCT03738163|12604911|FG000|STARTED|Overall Study||121
11409576|NCT03738163|12604911|FG000|COMPLETED|Overall Study||114
11409577|NCT03738163|12604911|FG000|NOT COMPLETED|Overall Study||7
11409578|NCT03738020|12604915|FG000|STARTED|Overall Study||58
11409579|NCT03738020|12604915|FG000|COMPLETED|Overall Study||57
11409580|NCT03738020|12604915|FG000|NOT COMPLETED|Overall Study||1
11409581|NCT03736785|12604925|FG000|STARTED|Overall Study||135
11409582|NCT03736785|12604926|FG001|STARTED|Overall Study||132
11409583|NCT03736785|12604927|FG002|STARTED|Overall Study||132
11409584|NCT03736785|12604925|FG000|COMPLETED|Overall Study||118
11409585|NCT03736785|12604926|FG001|COMPLETED|Overall Study||115
11409586|NCT03736785|12604927|FG002|COMPLETED|Overall Study||118
11409587|NCT03736785|12604925|FG000|NOT COMPLETED|Overall Study||17
11409588|NCT03736785|12604926|FG001|NOT COMPLETED|Overall Study||17
11409589|NCT03736785|12604927|FG002|NOT COMPLETED|Overall Study||14
11409590|NCT03736031|12604938|FG000|STARTED|Overall Study||56
11409591|NCT03736031|12604939|FG001|STARTED|Overall Study||46
11409592|NCT03736031|12604938|FG000|COMPLETED|Overall Study||24
11409593|NCT03736031|12604939|FG001|COMPLETED|Overall Study||40
11409594|NCT03736031|12604938|FG000|NOT COMPLETED|Overall Study||32
11409595|NCT03736031|12604939|FG001|NOT COMPLETED|Overall Study||6
11409596|NCT03735862|12604945|FG000|STARTED|Overall Study||73
11409597|NCT03735862|12604945|FG000|COMPLETED|Overall Study||73
11409598|NCT03735862|12604945|FG000|NOT COMPLETED|Overall Study||0
11409599|NCT03734991|12604951|FG000|STARTED|Overall Study||249
11409600|NCT03734991|12604952|FG001|STARTED|Overall Study||127
11409601|NCT03734991|12604951|FG000|Withdrawn Before Treatment|Overall Study||2
11409602|NCT03734991|12604952|FG001|Withdrawn Before Treatment|Overall Study||3
11409603|NCT03734991|12604951|FG000|Withdrawn Before TOC|Overall Study||59
11409604|NCT03734991|12604952|FG001|Withdrawn Before TOC|Overall Study||41
11409605|NCT03734991|12604951|FG000|Completed the TOC Visit|Overall Study||188
11409606|NCT03734991|12604952|FG001|Completed the TOC Visit|Overall Study||83
11409607|NCT03734991|12604951|FG000|Withdrawn At or After the TOC Visit|Overall Study||5
11409608|NCT03734991|12604952|FG001|Withdrawn At or After the TOC Visit|Overall Study||3
11409609|NCT03734991|12604951|FG000|COMPLETED|Overall Study||183
11409610|NCT03734991|12604952|FG001|COMPLETED|Overall Study||80
11409611|NCT03734991|12604951|FG000|NOT COMPLETED|Overall Study||66
11409612|NCT03734991|12604952|FG001|NOT COMPLETED|Overall Study||47
11409613|NCT03734822|12604958|FG000|STARTED|Overall Study||47
11409614|NCT03734822|12604958|FG000|COMPLETED|Overall Study||47
11409615|NCT03734822|12604958|FG000|NOT COMPLETED|Overall Study||0
11409616|NCT03734601|12604962|FG000|STARTED|Overall Study||22
11409617|NCT03734601|12604962|FG000|COMPLETED|Overall Study||22
11409618|NCT03734601|12604962|FG000|NOT COMPLETED|Overall Study||0
11409619|NCT03733899|12604966|FG000|STARTED|Period 1||3
11409620|NCT03733899|12604967|FG001|STARTED|Period 1||3
11409621|NCT03733899|12604968|FG002|STARTED|Period 1||3
11409622|NCT03733899|12604969|FG003|STARTED|Period 1||4
11409623|NCT03733899|12604970|FG004|STARTED|Period 1||4
11409624|NCT03733899|12604971|FG005|STARTED|Period 1||3
11409625|NCT03733899|12604966|FG000|COMPLETED|Period 1||3
11409626|NCT03733899|12604967|FG001|COMPLETED|Period 1||3
11409627|NCT03733899|12604968|FG002|COMPLETED|Period 1||3
11409628|NCT03733899|12604969|FG003|COMPLETED|Period 1||4
11409629|NCT03733899|12604970|FG004|COMPLETED|Period 1||4
11409630|NCT03733899|12604971|FG005|COMPLETED|Period 1||2
11409631|NCT03733899|12604966|FG000|NOT COMPLETED|Period 1||0
11409632|NCT03733899|12604967|FG001|NOT COMPLETED|Period 1||0
11409633|NCT03733899|12604968|FG002|NOT COMPLETED|Period 1||0
11409634|NCT03733899|12604969|FG003|NOT COMPLETED|Period 1||0
11409635|NCT03733899|12604970|FG004|NOT COMPLETED|Period 1||0
11409636|NCT03733899|12604971|FG005|NOT COMPLETED|Period 1||1
11409637|NCT03733899|12604966|FG000|STARTED|Period 2||3
11409638|NCT03733899|12604967|FG001|STARTED|Period 2||3
11409639|NCT03733899|12604968|FG002|STARTED|Period 2||3
11409640|NCT03733899|12604969|FG003|STARTED|Period 2||4
11409641|NCT03733899|12604970|FG004|STARTED|Period 2||4
11409642|NCT03733899|12604971|FG005|STARTED|Period 2||2
11409643|NCT03733899|12604966|FG000|COMPLETED|Period 2||3
11409644|NCT03733899|12604967|FG001|COMPLETED|Period 2||2
11409645|NCT03733899|12604968|FG002|COMPLETED|Period 2||3
11409646|NCT03733899|12604969|FG003|COMPLETED|Period 2||4
11409647|NCT03733899|12604970|FG004|COMPLETED|Period 2||4
11409648|NCT03733899|12604971|FG005|COMPLETED|Period 2||2
11409649|NCT03733899|12604966|FG000|NOT COMPLETED|Period 2||0
11409650|NCT03733899|12604967|FG001|NOT COMPLETED|Period 2||1
11409651|NCT03733899|12604968|FG002|NOT COMPLETED|Period 2||0
11409652|NCT03733899|12604969|FG003|NOT COMPLETED|Period 2||0
11409653|NCT03733899|12604970|FG004|NOT COMPLETED|Period 2||0
11409654|NCT03733899|12604971|FG005|NOT COMPLETED|Period 2||0
11409655|NCT03733899|12604966|FG000|STARTED|Period 3||3
11409656|NCT03733899|12604967|FG001|STARTED|Period 3||2
11409657|NCT03733899|12604968|FG002|STARTED|Period 3||3
11409658|NCT03733899|12604969|FG003|STARTED|Period 3||4
11409659|NCT03733899|12604970|FG004|STARTED|Period 3||4
11409660|NCT03733899|12604971|FG005|STARTED|Period 3||2
11409661|NCT03733899|12604966|FG000|COMPLETED|Period 3||2
11409662|NCT03733899|12604967|FG001|COMPLETED|Period 3||2
11409663|NCT03733899|12604968|FG002|COMPLETED|Period 3||3
11409664|NCT03733899|12604969|FG003|COMPLETED|Period 3||4
11409665|NCT03733899|12604970|FG004|COMPLETED|Period 3||4
11409666|NCT03733899|12604971|FG005|COMPLETED|Period 3||2
11409667|NCT03733899|12604966|FG000|NOT COMPLETED|Period 3||1
11409668|NCT03733899|12604967|FG001|NOT COMPLETED|Period 3||0
11409669|NCT03733899|12604968|FG002|NOT COMPLETED|Period 3||0
11409670|NCT03733899|12604969|FG003|NOT COMPLETED|Period 3||0
11409671|NCT03733899|12604970|FG004|NOT COMPLETED|Period 3||0
11409672|NCT03733899|12604971|FG005|NOT COMPLETED|Period 3||0
11409673|NCT03733483|12604984|FG000|STARTED|Overall Study||12
11409674|NCT03733483|12604984|FG000|COMPLETED|Overall Study||12
11409675|NCT03733483|12604984|FG000|NOT COMPLETED|Overall Study||0
11409676|NCT03733470|12604990|FG000|STARTED|Overall Study||8
11409677|NCT03733470|12604991|FG001|STARTED|Overall Study||11
11409678|NCT03733470|12604990|FG000|COMPLETED|Overall Study||7
11409679|NCT03733470|12604991|FG001|COMPLETED|Overall Study||10
11409680|NCT03733470|12604990|FG000|NOT COMPLETED|Overall Study||1
11409681|NCT03733470|12604991|FG001|NOT COMPLETED|Overall Study||1
11409682|NCT03733301|12605000|FG000|STARTED|Overall Study||109
11409683|NCT03733301|12605001|FG001|STARTED|Overall Study||109
11409684|NCT03733301|12605002|FG002|STARTED|Overall Study||111
11409685|NCT03733301|12605000|FG000|Received One Dose of Study Drug|Overall Study||108
11409686|NCT03733301|12605001|FG001|Received One Dose of Study Drug|Overall Study||109
11409687|NCT03733301|12605002|FG002|Received One Dose of Study Drug|Overall Study||111
11409688|NCT03733301|12605000|FG000|COMPLETED|Overall Study||102
11409689|NCT03733301|12605001|FG001|COMPLETED|Overall Study||100
11409690|NCT03733301|12605002|FG002|COMPLETED|Overall Study||107
11409691|NCT03733301|12605000|FG000|NOT COMPLETED|Overall Study||7
11409692|NCT03733301|12605001|FG001|NOT COMPLETED|Overall Study||9
11409693|NCT03733301|12605002|FG002|NOT COMPLETED|Overall Study||4
11409694|NCT03732638|12605013|FG000|STARTED|Overall Study||370
11409695|NCT03732638|12605014|FG001|STARTED|Overall Study||371
11409696|NCT03732638|12605013|FG000|COMPLETED|Overall Study||316
11409697|NCT03732638|12605014|FG001|COMPLETED|Overall Study||310
11409698|NCT03732638|12605013|FG000|NOT COMPLETED|Overall Study||54
11409699|NCT03732638|12605014|FG001|NOT COMPLETED|Overall Study||61
11409700|NCT03732248|12605023|FG000|STARTED|Overall Study||11
11409701|NCT03732248|12605024|FG001|STARTED|Overall Study||10
11409702|NCT03732248|12605023|FG000|COMPLETED|Overall Study||10
11409703|NCT03732248|12605024|FG001|COMPLETED|Overall Study||10
11409704|NCT03732248|12605023|FG000|NOT COMPLETED|Overall Study||1
11409705|NCT03732248|12605024|FG001|NOT COMPLETED|Overall Study||0
11409706|NCT03731182|12605032|FG000|STARTED|Overall Study||70
11409707|NCT03731182|12605033|FG001|STARTED|Overall Study||34
11409708|NCT03731182|12605032|FG000|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||69
11409709|NCT03731182|12605033|FG001|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||34
11409710|NCT03731182|12605032|FG000|COMPLETED|Overall Study||65
11409711|NCT03731182|12605033|FG001|COMPLETED|Overall Study||34
11409712|NCT03731182|12605032|FG000|NOT COMPLETED|Overall Study||5
11409713|NCT03731182|12605033|FG001|NOT COMPLETED|Overall Study||0
11409714|NCT03730961|12605042|FG000|STARTED|Overall Study||12
11409715|NCT03730961|12605043|FG001|STARTED|Overall Study||11
11409716|NCT03730961|12605042|FG000|Period 1 Completion|Overall Study||12
11409717|NCT03730961|12605043|FG001|Period 1 Completion|Overall Study||11
11409718|NCT03730961|12605042|FG000|Period 2 Completion|Overall Study|1 participant did not complete Period 2 due to hypotension but remained in the study|11
11409719|NCT03730961|12605043|FG001|Period 2 Completion|Overall Study|1 participant discontinued study due to AE|10
11409720|NCT03730961|12605042|FG000|COMPLETED|Overall Study||12
11409721|NCT03730961|12605043|FG001|COMPLETED|Overall Study||10
11409722|NCT03730961|12605042|FG000|NOT COMPLETED|Overall Study||0
11409723|NCT03730961|12605043|FG001|NOT COMPLETED|Overall Study||1
11409724|NCT03730116|12605049|FG000|STARTED|Inclusion|Planned to include 1920 pts, included 1909|1909
11409725|NCT03730116|12605049|FG000|FVFP|Inclusion||1909
11409726|NCT03730116|12605049|FG000|COMPLETED|Inclusion||1909
11409727|NCT03730116|12605049|FG000|NOT COMPLETED|Inclusion||0
11409728|NCT03730116|12605049|FG000|STARTED|1 Month After Inclusion||1909
11409729|NCT03730116|12605049|FG000|1 Month After Inclusion|1 Month After Inclusion||1909
11409730|NCT03730116|12605049|FG000|COMPLETED|1 Month After Inclusion||1909
11409731|NCT03730116|12605049|FG000|NOT COMPLETED|1 Month After Inclusion||0
11409732|NCT03730116|12605049|FG000|STARTED|3 Month After Inclusion||1909
11409733|NCT03730116|12605049|FG000|3 Month After Inclusion|3 Month After Inclusion||1909
11409734|NCT03730116|12605049|FG000|COMPLETED|3 Month After Inclusion||1892
11409735|NCT03730116|12605049|FG000|NOT COMPLETED|3 Month After Inclusion||17
11409736|NCT03730103|12605059|FG000|STARTED|Overall Study||61
11409737|NCT03730103|12605060|FG001|STARTED|Overall Study||52
11409738|NCT03730103|12605059|FG000|COMPLETED|Overall Study||61
11409739|NCT03730103|12605060|FG001|COMPLETED|Overall Study||47
11409740|NCT03730103|12605059|FG000|NOT COMPLETED|Overall Study||0
11409741|NCT03730103|12605060|FG001|NOT COMPLETED|Overall Study||5
11409742|NCT03729960|12605066|FG000|STARTED|Overall Study||20
11409743|NCT03729960|12605066|FG000|COMPLETED|Overall Study||20
11409744|NCT03729960|12605066|FG000|NOT COMPLETED|Overall Study||0
11409745|NCT03729024|12605071|FG000|STARTED|Overall Study||21
11409746|NCT03729024|12605071|FG000|COMPLETED|Overall Study||21
11409747|NCT03729024|12605071|FG000|NOT COMPLETED|Overall Study||0
11409748|NCT03728790|12605077|FG000|STARTED|Overall Study||112
11409749|NCT03728790|12605078|FG001|STARTED|Overall Study||101
11409750|NCT03728790|12605077|FG000|COMPLETED|Overall Study||112
11409751|NCT03728790|12605078|FG001|COMPLETED|Overall Study||101
11409752|NCT03728790|12605077|FG000|NOT COMPLETED|Overall Study||0
11409753|NCT03728790|12605078|FG001|NOT COMPLETED|Overall Study||0
11022454|NCT00809159|12200735|FG002|PD Analysis Set|Part 1||0
11022455|NCT00809159|12200736|FG003|PD Analysis Set|Part 1||0
11022456|NCT00809159|12200737|FG004|PD Analysis Set|Part 1||0
11022457|NCT00809159|12200738|FG005|PD Analysis Set|Part 1||0
11022458|NCT00809159|12200733|FG000|COMPLETED|Part 1||16
11022459|NCT00809159|12200734|FG001|COMPLETED|Part 1||3
11022460|NCT00809159|12200735|FG002|COMPLETED|Part 1||0
11022461|NCT00809159|12200736|FG003|COMPLETED|Part 1||0
11022462|NCT00809159|12200737|FG004|COMPLETED|Part 1||0
11409754|NCT03728348|12605084|FG000|STARTED|Overall Study||983
11409755|NCT03728348|12605084|FG000|Did Not Complete Study Procedures|Overall Study||107
11409756|NCT03728348|12605084|FG000|Multi-target DNA Test Excluded|Overall Study||15
11409757|NCT03728348|12605084|FG000|Colonoscopy Excluded|Overall Study||19
11409758|NCT03728348|12605084|FG000|COMPLETED|Overall Study||842
11409759|NCT03728348|12605084|FG000|NOT COMPLETED|Overall Study||141
11409760|NCT03728140|12605090|FG000|STARTED|Overall Study|embryo transfer with self-spent culture medium|160
11409761|NCT03728140|12605091|FG001|STARTED|Overall Study|embryo transfer with new culture medium|175
11409762|NCT03728140|12605090|FG000|COMPLETED|Overall Study||150
11409763|NCT03728140|12605091|FG001|COMPLETED|Overall Study||168
11409764|NCT03728140|12605090|FG000|NOT COMPLETED|Overall Study||10
11409765|NCT03728140|12605091|FG001|NOT COMPLETED|Overall Study||7
11409766|NCT03727854|12605099|FG000|STARTED|Overall Study||20
11409767|NCT03727854|12605100|FG001|STARTED|Overall Study||20
11409768|NCT03727854|12605099|FG000|COMPLETED|Overall Study||20
11409769|NCT03727854|12605100|FG001|COMPLETED|Overall Study||20
11409770|NCT03727854|12605099|FG000|NOT COMPLETED|Overall Study||0
11409771|NCT03727854|12605100|FG001|NOT COMPLETED|Overall Study||0
11409772|NCT03727425|12605106|FG000|STARTED|Overall Study||55
11409773|NCT03727425|12605106|FG000|COMPLETED|Overall Study||55
11409774|NCT03727425|12605106|FG000|NOT COMPLETED|Overall Study||0
11409775|NCT03727347|12605110|FG000|STARTED|Overall Study||50
11409776|NCT03727347|12605110|FG000|2-week Evaluation|Overall Study||50
11409777|NCT03727347|12605110|FG000|4-week Evaluation|Overall Study||50
11409778|NCT03727347|12605110|FG000|12-week Primary Endpoint Evaluation|Overall Study||50
11409779|NCT03727347|12605110|FG000|26-week Evaluation|Overall Study||48
11409780|NCT03727347|12605110|FG000|52-week Evaluation|Overall Study||47
11409781|NCT03727347|12605110|FG000|COMPLETED|Overall Study||47
11409782|NCT03727347|12605110|FG000|NOT COMPLETED|Overall Study||3
11409783|NCT03726996|12605123|FG000|STARTED|Overall Study||4
11409784|NCT03726996|12605123|FG000|COMPLETED|Overall Study||0
11409785|NCT03726996|12605123|FG000|NOT COMPLETED|Overall Study||4
11409786|NCT03726164|12605129|FG000|STARTED|Overall Study||310
11409787|NCT03726164|12605130|FG001|STARTED|Overall Study||316
11409788|NCT03726164|12605129|FG000|COMPLETED|Overall Study||99
11409789|NCT03726164|12605130|FG001|COMPLETED|Overall Study||119
11409790|NCT03726164|12605129|FG000|NOT COMPLETED|Overall Study||211
11409791|NCT03726164|12605130|FG001|NOT COMPLETED|Overall Study||197
11409792|NCT03725852|12605138|FG000|STARTED|Overall Study||45
11409793|NCT03725852|12605139|FG001|STARTED|Overall Study||23
11409794|NCT03725852|12605138|FG000|COMPLETED|Overall Study||41
11409795|NCT03725852|12605139|FG001|COMPLETED|Overall Study||23
11409796|NCT03725852|12605138|FG000|NOT COMPLETED|Overall Study||4
11409797|NCT03725852|12605139|FG001|NOT COMPLETED|Overall Study||0
11409798|NCT03725722|12605150|FG000|STARTED|Overall Study||49
11409799|NCT03725722|12605151|FG001|STARTED|Overall Study||50
11409800|NCT03725722|12605152|FG002|STARTED|Overall Study||50
11409801|NCT03725722|12605153|FG003|STARTED|Overall Study||52
11409802|NCT03725722|12605154|FG004|STARTED|Overall Study||50
11409803|NCT03725722|12605150|FG000|COMPLETED|Overall Study||38
11409804|NCT03725722|12605151|FG001|COMPLETED|Overall Study||44
11409805|NCT03725722|12605152|FG002|COMPLETED|Overall Study||44
11409806|NCT03725722|12605153|FG003|COMPLETED|Overall Study||46
11409807|NCT03725722|12605154|FG004|COMPLETED|Overall Study||36
11409808|NCT03725722|12605150|FG000|NOT COMPLETED|Overall Study||11
11409809|NCT03725722|12605151|FG001|NOT COMPLETED|Overall Study||6
11409810|NCT03725722|12605152|FG002|NOT COMPLETED|Overall Study||6
11409811|NCT03725722|12605153|FG003|NOT COMPLETED|Overall Study||6
11409812|NCT03725722|12605154|FG004|NOT COMPLETED|Overall Study||14
11409813|NCT03725098|12605168|FG000|STARTED|Overall Study||53
11409814|NCT03725098|12605169|FG001|STARTED|Overall Study||52
11409815|NCT03725098|12605168|FG000|COMPLETED|Overall Study||53
11409816|NCT03725098|12605169|FG001|COMPLETED|Overall Study||52
11409817|NCT03725098|12605168|FG000|NOT COMPLETED|Overall Study||0
11409818|NCT03725098|12605169|FG001|NOT COMPLETED|Overall Study||0
11409819|NCT03725085|12605175|FG000|STARTED|Overall Study||552
11409820|NCT03725085|12605175|FG000|COMPLETED|Overall Study||550
11409821|NCT03725085|12605175|FG000|NOT COMPLETED|Overall Study||2
11409822|NCT03725033|12605182|FG000|STARTED|Overall Study||105
11409823|NCT03725033|12605183|FG001|STARTED|Overall Study||97
11409824|NCT03725033|12605182|FG000|COMPLETED|Overall Study||105
11409825|NCT03725033|12605183|FG001|COMPLETED|Overall Study||97
11409826|NCT03725033|12605182|FG000|NOT COMPLETED|Overall Study||0
11409827|NCT03725033|12605183|FG001|NOT COMPLETED|Overall Study||0
11409828|NCT03724981|12605191|FG000|STARTED|First Device||156
11409829|NCT03724981|12605192|FG001|STARTED|First Device||156
11409830|NCT03724981|12605191|FG000|COMPLETED|First Device||155
11409831|NCT03724981|12605192|FG001|COMPLETED|First Device||155
11409832|NCT03724981|12605191|FG000|NOT COMPLETED|First Device||1
11409833|NCT03724981|12605192|FG001|NOT COMPLETED|First Device||1
11409834|NCT03724981|12605191|FG000|STARTED|Second Device||155
11409835|NCT03724981|12605192|FG001|STARTED|Second Device||155
11022463|NCT00809159|12200738|FG005|COMPLETED|Part 1||0
11409836|NCT03724981|12605191|FG000|COMPLETED|Second Device||155
11409837|NCT03724981|12605192|FG001|COMPLETED|Second Device||155
11409838|NCT03724981|12605191|FG000|NOT COMPLETED|Second Device||0
11409839|NCT03724981|12605192|FG001|NOT COMPLETED|Second Device||0
11409840|NCT03724968|12605202|FG000|STARTED|Overall Study||0
11409841|NCT03724968|12605203|FG001|STARTED|Overall Study||2
11409842|NCT03724968|12605202|FG000|COMPLETED|Overall Study||0
11409843|NCT03724968|12605203|FG001|COMPLETED|Overall Study||0
11409844|NCT03724968|12605202|FG000|NOT COMPLETED|Overall Study||0
11409845|NCT03724968|12605203|FG001|NOT COMPLETED|Overall Study||2
11409846|NCT03724877|12605211|FG000|STARTED|Overall Study||6921
11409847|NCT03724877|12605212|FG001|STARTED|Overall Study||1932
11409848|NCT03724877|12605211|FG000|COMPLETED|Overall Study||6921
11409849|NCT03724877|12605212|FG001|COMPLETED|Overall Study||1932
11409850|NCT03724877|12605211|FG000|NOT COMPLETED|Overall Study||0
11409851|NCT03724877|12605212|FG001|NOT COMPLETED|Overall Study||0
11409852|NCT03724253|12605223|FG000|STARTED|Overall Study||5
11409853|NCT03724253|12605224|FG001|STARTED|Overall Study||5
11409854|NCT03724253|12605225|FG002|STARTED|Overall Study||5
11409855|NCT03724253|12605226|FG003|STARTED|Overall Study||3
11409856|NCT03724253|12605227|FG004|STARTED|Overall Study||1
11409857|NCT03724253|12605223|FG000|COMPLETED|Overall Study||5
11409858|NCT03724253|12605224|FG001|COMPLETED|Overall Study||5
11409859|NCT03724253|12605225|FG002|COMPLETED|Overall Study||5
11409860|NCT03724253|12605226|FG003|COMPLETED|Overall Study||3
11409861|NCT03724253|12605227|FG004|COMPLETED|Overall Study||1
11409862|NCT03724253|12605223|FG000|NOT COMPLETED|Overall Study||0
11409863|NCT03724253|12605224|FG001|NOT COMPLETED|Overall Study||0
11409864|NCT03724253|12605225|FG002|NOT COMPLETED|Overall Study||0
11409865|NCT03724253|12605226|FG003|NOT COMPLETED|Overall Study||0
11409866|NCT03724253|12605227|FG004|NOT COMPLETED|Overall Study||0
11409867|NCT03723980|12605241|FG000|STARTED|Overall Study||40
11409868|NCT03723980|12605242|FG001|STARTED|Overall Study||40
11409869|NCT03723980|12605241|FG000|COMPLETED|Overall Study||33
11409870|NCT03723980|12605242|FG001|COMPLETED|Overall Study||35
11409871|NCT03723980|12605241|FG000|NOT COMPLETED|Overall Study||7
11409872|NCT03723980|12605242|FG001|NOT COMPLETED|Overall Study||5
11409873|NCT03723603|12605254|FG000|STARTED|Overall Study||8
11409874|NCT03723603|12605254|FG000|COMPLETED|Overall Study||5
11409875|NCT03723603|12605254|FG000|NOT COMPLETED|Overall Study||3
11409876|NCT03723447|12605260|FG000|STARTED|Overall Study||50
11409877|NCT03723447|12605261|FG001|STARTED|Overall Study||51
11409878|NCT03723447|12605260|FG000|COMPLETED|Overall Study||50
11409879|NCT03723447|12605261|FG001|COMPLETED|Overall Study||51
11409880|NCT03723447|12605260|FG000|NOT COMPLETED|Overall Study||0
11409881|NCT03723447|12605261|FG001|NOT COMPLETED|Overall Study||0
11409882|NCT03723070|12605267|FG000|STARTED|Overall Study||88
11409883|NCT03723070|12605267|FG000|COMPLETED|Overall Study||79
11409884|NCT03723070|12605267|FG000|NOT COMPLETED|Overall Study||9
11409885|NCT03720210|12605271|FG000|STARTED|Overall Study||1
11409886|NCT03720210|12605271|FG000|COMPLETED|Overall Study||0
11409887|NCT03720210|12605271|FG000|NOT COMPLETED|Overall Study||1
11409888|NCT03718455|12605275|FG000|STARTED|Overall Study||1
11409889|NCT03718455|12605275|FG000|COMPLETED|Overall Study||1
11409890|NCT03718455|12605275|FG000|NOT COMPLETED|Overall Study||0
11409891|NCT03718143|12605279|FG000|STARTED|Overall Study||3
11409892|NCT03718143|12605280|FG001|STARTED|Overall Study||2
11409893|NCT03718143|12605281|FG002|STARTED|Overall Study||1
11409894|NCT03718143|12605279|FG000|COMPLETED|Overall Study||0
11409895|NCT03718143|12605280|FG001|COMPLETED|Overall Study||0
11409896|NCT03718143|12605281|FG002|COMPLETED|Overall Study||0
11409897|NCT03718143|12605279|FG000|NOT COMPLETED|Overall Study||3
11409898|NCT03718143|12605280|FG001|NOT COMPLETED|Overall Study||2
11409899|NCT03718143|12605281|FG002|NOT COMPLETED|Overall Study||1
11409900|NCT03709576|12605289|FG000|STARTED|Overall Study||3
11409901|NCT03709576|12605289|FG000|COMPLETED|Overall Study||2
11409902|NCT03709576|12605289|FG000|NOT COMPLETED|Overall Study||1
11409903|NCT03704636|12605294|FG000|STARTED|Overall Study||23
11409904|NCT03704636|12605294|FG000|COMPLETED|Overall Study||20
11409905|NCT03704636|12605294|FG000|NOT COMPLETED|Overall Study||3
11409906|NCT03703791|12605300|FG000|STARTED|Overall Study||0
11409907|NCT03703791|12605301|FG001|STARTED|Overall Study||1
11409908|NCT03703791|12605300|FG000|COMPLETED|Overall Study||0
11409909|NCT03703791|12605301|FG001|COMPLETED|Overall Study||0
11409910|NCT03703791|12605300|FG000|NOT COMPLETED|Overall Study||0
11409911|NCT03703791|12605301|FG001|NOT COMPLETED|Overall Study||1
11409912|NCT03701295|12605307|FG000|STARTED|Overall Study||1
11409913|NCT03701295|12605307|FG000|COMPLETED|Overall Study||1
11409914|NCT03701295|12605307|FG000|NOT COMPLETED|Overall Study||0
11409915|NCT03697551|12605311|FG000|STARTED|Overall Study||4
11409916|NCT03697551|12605311|FG000|COMPLETED|Overall Study||4
11409917|NCT03697551|12605311|FG000|NOT COMPLETED|Overall Study||0
11409918|NCT03694821|12605318|FG000|STARTED|Overall Study||4
11409919|NCT03694821|12605319|FG001|STARTED|Overall Study||8
11409920|NCT03694821|12605320|FG002|STARTED|Overall Study||6
11409921|NCT03694821|12605318|FG000|COMPLETED|Overall Study||0
11409922|NCT03694821|12605319|FG001|COMPLETED|Overall Study||0
11409923|NCT03694821|12605320|FG002|COMPLETED|Overall Study||2
11409924|NCT03694821|12605318|FG000|NOT COMPLETED|Overall Study||4
11409925|NCT03694821|12605319|FG001|NOT COMPLETED|Overall Study||8
11409926|NCT03694821|12605320|FG002|NOT COMPLETED|Overall Study||4
11409927|NCT03686969|12605330|FG000|STARTED|Overall Study||1
11409928|NCT03686969|12605331|FG001|STARTED|Overall Study||0
11409929|NCT03686969|12605330|FG000|COMPLETED|Overall Study||0
11409930|NCT03686969|12605331|FG001|COMPLETED|Overall Study||0
11409931|NCT03686969|12605330|FG000|NOT COMPLETED|Overall Study||1
11409932|NCT03686969|12605331|FG001|NOT COMPLETED|Overall Study||0
11409933|NCT03682367|12605339|FG000|STARTED|Overall Study||4
11409934|NCT03682367|12605340|FG001|STARTED|Overall Study||4
11409935|NCT03682367|12605339|FG000|COMPLETED|Overall Study|Withdrawn due to non-compliance|2
11409936|NCT03682367|12605340|FG001|COMPLETED|Overall Study|Patients withdrawn due to confounding neuropathic pain or exited early from study.|0
11409937|NCT03682367|12605339|FG000|NOT COMPLETED|Overall Study||2
11409938|NCT03682367|12605340|FG001|NOT COMPLETED|Overall Study||4
11409939|NCT03680911|12605348|FG000|STARTED|Visit 1 (Baseline)||3
11409940|NCT03680911|12605349|FG001|STARTED|Visit 1 (Baseline)||4
11409941|NCT03680911|12605348|FG000|COMPLETED|Visit 1 (Baseline)||3
11409942|NCT03680911|12605349|FG001|COMPLETED|Visit 1 (Baseline)||4
11409943|NCT03680911|12605348|FG000|NOT COMPLETED|Visit 1 (Baseline)||0
11409944|NCT03680911|12605349|FG001|NOT COMPLETED|Visit 1 (Baseline)||0
11409945|NCT03680911|12605348|FG000|STARTED|At Home Treatment||3
11409946|NCT03680911|12605349|FG001|STARTED|At Home Treatment||4
11409947|NCT03680911|12605348|FG000|COMPLETED|At Home Treatment||0
11409948|NCT03680911|12605349|FG001|COMPLETED|At Home Treatment||1
11409949|NCT03680911|12605348|FG000|NOT COMPLETED|At Home Treatment||3
11409950|NCT03680911|12605349|FG001|NOT COMPLETED|At Home Treatment||3
11409951|NCT03680911|12605348|FG000|STARTED|Visit 2 (1 Month Follow up)||0
11409952|NCT03680911|12605349|FG001|STARTED|Visit 2 (1 Month Follow up)||1
11409953|NCT03680911|12605348|FG000|COMPLETED|Visit 2 (1 Month Follow up)||0
11409954|NCT03680911|12605349|FG001|COMPLETED|Visit 2 (1 Month Follow up)||1
11409955|NCT03680911|12605348|FG000|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
11409956|NCT03680911|12605349|FG001|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
11409957|NCT03680911|12605348|FG000|STARTED|Visit 3 (4 Month Follow up)||0
11409958|NCT03680911|12605349|FG001|STARTED|Visit 3 (4 Month Follow up)||1
11409959|NCT03680911|12605348|FG000|COMPLETED|Visit 3 (4 Month Follow up)||0
11409960|NCT03680911|12605349|FG001|COMPLETED|Visit 3 (4 Month Follow up)||0
11409961|NCT03680911|12605348|FG000|NOT COMPLETED|Visit 3 (4 Month Follow up)||0
11409962|NCT03680911|12605349|FG001|NOT COMPLETED|Visit 3 (4 Month Follow up)||1
11409963|NCT03656692|12605355|FG000|STARTED|Overall Study||5
11409964|NCT03656692|12605355|FG000|COMPLETED|Overall Study||2
11409965|NCT03656692|12605355|FG000|NOT COMPLETED|Overall Study||3
11409966|NCT03648983|12605359|FG000|STARTED|Overall Study||95
11409967|NCT03648983|12605359|FG000|COMPLETED|Overall Study||0
11409968|NCT03648983|12605359|FG000|NOT COMPLETED|Overall Study||95
11409969|NCT03643159|12605366|FG000|STARTED|Overall Study||2
11409970|NCT03643159|12605366|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||2
11409971|NCT03643159|12605366|FG000|COMPLETED|Overall Study||0
11409972|NCT03643159|12605366|FG000|NOT COMPLETED|Overall Study||2
11409973|NCT03632655|12605373|FG000|STARTED|Overall Study||22
11409974|NCT03632655|12605374|FG001|STARTED|Overall Study||16
11409975|NCT03632655|12605373|FG000|COMPLETED|Overall Study||0
11409976|NCT03632655|12605374|FG001|COMPLETED|Overall Study||0
11409977|NCT03632655|12605373|FG000|NOT COMPLETED|Overall Study||22
11409978|NCT03632655|12605374|FG001|NOT COMPLETED|Overall Study||16
11409979|NCT03630120|12605384|FG000|STARTED|Overall Study||2
11409980|NCT03630120|12605385|FG001|STARTED|Overall Study||2
11409981|NCT03630120|12605386|FG002|STARTED|Overall Study||1
11409982|NCT03630120|12605387|FG003|STARTED|Overall Study||1
11409983|NCT03630120|12605384|FG000|COMPLETED|Overall Study||2
11409984|NCT03630120|12605385|FG001|COMPLETED|Overall Study||1
11409985|NCT03630120|12605386|FG002|COMPLETED|Overall Study||0
11409986|NCT03630120|12605387|FG003|COMPLETED|Overall Study||0
11409987|NCT03630120|12605384|FG000|NOT COMPLETED|Overall Study||0
11409988|NCT03630120|12605385|FG001|NOT COMPLETED|Overall Study||1
11409989|NCT03630120|12605386|FG002|NOT COMPLETED|Overall Study||1
11409990|NCT03630120|12605387|FG003|NOT COMPLETED|Overall Study||1
11409991|NCT03621657|12605400|FG000|STARTED|Overall Study||0
11409992|NCT03621657|12605401|FG001|STARTED|Overall Study||0
11409993|NCT03621657|12605402|FG002|STARTED|Overall Study||1
11409994|NCT03621657|12605400|FG000|COMPLETED|Overall Study||0
11409995|NCT03621657|12605401|FG001|COMPLETED|Overall Study||0
11409996|NCT03621657|12605402|FG002|COMPLETED|Overall Study||1
11409997|NCT03621657|12605400|FG000|NOT COMPLETED|Overall Study||0
11409998|NCT03621657|12605401|FG001|NOT COMPLETED|Overall Study||0
11409999|NCT03621657|12605402|FG002|NOT COMPLETED|Overall Study||0
11410000|NCT03615144|12605414|FG000|STARTED|Overall Study||1
11410001|NCT03615144|12605415|FG001|STARTED|Overall Study||0
11410002|NCT03615144|12605414|FG000|COMPLETED|Overall Study||0
11410003|NCT03615144|12605415|FG001|COMPLETED|Overall Study||0
11410004|NCT03615144|12605414|FG000|NOT COMPLETED|Overall Study||1
11410005|NCT03615144|12605415|FG001|NOT COMPLETED|Overall Study||0
11410006|NCT03605303|12605421|FG000|STARTED|Period 1||2
11410007|NCT03605303|12605422|FG001|STARTED|Period 1||1
11410008|NCT03605303|12605421|FG000|COMPLETED|Period 1||0
11410009|NCT03605303|12605422|FG001|COMPLETED|Period 1||0
11410010|NCT03605303|12605421|FG000|NOT COMPLETED|Period 1||2
11410011|NCT03605303|12605422|FG001|NOT COMPLETED|Period 1||1
11410012|NCT03605303|12605421|FG000|STARTED|Period 2||0
11410013|NCT03605303|12605422|FG001|STARTED|Period 2||0
11410014|NCT03605303|12605421|FG000|COMPLETED|Period 2||0
11410015|NCT03605303|12605422|FG001|COMPLETED|Period 2||0
11410016|NCT03605303|12605421|FG000|NOT COMPLETED|Period 2||0
11410017|NCT03605303|12605422|FG001|NOT COMPLETED|Period 2||0
11410018|NCT03600740|12605428|FG000|STARTED|Overall Study||1
11410019|NCT03600740|12605428|FG000|COMPLETED|Overall Study||0
11410020|NCT03600740|12605428|FG000|NOT COMPLETED|Overall Study||1
11410021|NCT03598140|12605434|FG000|STARTED|Overall Study||10
11410022|NCT03598140|12605435|FG001|STARTED|Overall Study||11
11410023|NCT03598140|12605434|FG000|COMPLETED|Overall Study||9
11410024|NCT03598140|12605435|FG001|COMPLETED|Overall Study||11
11410025|NCT03598140|12605434|FG000|NOT COMPLETED|Overall Study||1
11410026|NCT03598140|12605435|FG001|NOT COMPLETED|Overall Study||0
11410027|NCT03598036|12605443|FG000|STARTED|Overall Study||5
11410028|NCT03598036|12605444|FG001|STARTED|Overall Study|Trial ended prematurely before any patients were enrolled into Cohort 2|0
11410029|NCT03598036|12605443|FG000|Week 1: 7.9 mg Twice Daily|Overall Study||5
11410030|NCT03598036|12605444|FG001|Week 1: 7.9 mg Twice Daily|Overall Study||0
11410031|NCT03598036|12605443|FG000|Week 2: 15.9 mg Twice Daily|Overall Study||5
11410032|NCT03598036|12605444|FG001|Week 2: 15.9 mg Twice Daily|Overall Study||0
11410033|NCT03598036|12605443|FG000|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study|1 subject withdrew at Week 12|5
11410034|NCT03598036|12605444|FG001|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study||0
11410035|NCT03598036|12605443|FG000|COMPLETED|Overall Study||4
11410036|NCT03598036|12605444|FG001|COMPLETED|Overall Study||0
11410037|NCT03598036|12605443|FG000|NOT COMPLETED|Overall Study||1
11410038|NCT03598036|12605444|FG001|NOT COMPLETED|Overall Study||0
11410039|NCT03591458|12605454|FG000|STARTED|Overall Study||1
11410040|NCT03591458|12605455|FG001|STARTED|Overall Study||1
11410041|NCT03591458|12605454|FG000|COMPLETED|Overall Study||1
11410042|NCT03591458|12605455|FG001|COMPLETED|Overall Study||1
11410043|NCT03591458|12605454|FG000|NOT COMPLETED|Overall Study||0
11410044|NCT03591458|12605455|FG001|NOT COMPLETED|Overall Study||0
11410045|NCT03590743|12605463|FG000|STARTED|Overall Study||2
11410046|NCT03590743|12605464|FG001|STARTED|Overall Study||3
11410047|NCT03590743|12605463|FG000|COMPLETED|Overall Study||2
11410048|NCT03590743|12605464|FG001|COMPLETED|Overall Study||2
11410049|NCT03590743|12605463|FG000|NOT COMPLETED|Overall Study||0
11410050|NCT03590743|12605464|FG001|NOT COMPLETED|Overall Study||1
11410051|NCT03580382|12605472|FG000|STARTED|Overall Study||0
11410052|NCT03580382|12605473|FG001|STARTED|Overall Study||3
11410053|NCT03580382|12605472|FG000|COMPLETED|Overall Study||0
11410054|NCT03580382|12605473|FG001|COMPLETED|Overall Study||0
11410055|NCT03580382|12605472|FG000|NOT COMPLETED|Overall Study||0
11410056|NCT03580382|12605473|FG001|NOT COMPLETED|Overall Study||3
11410057|NCT03571646|12605480|FG000|STARTED|Overall Study||3
11410058|NCT03571646|12605481|FG001|STARTED|Overall Study||3
11410059|NCT03571646|12605480|FG000|COMPLETED|Overall Study||1
11410060|NCT03571646|12605481|FG001|COMPLETED|Overall Study||2
11410061|NCT03571646|12605480|FG000|NOT COMPLETED|Overall Study||2
11410062|NCT03571646|12605481|FG001|NOT COMPLETED|Overall Study||1
11410063|NCT03565328|12605487|FG000|STARTED|Overall Study||1
11410064|NCT03565328|12605487|FG000|COMPLETED|Overall Study||1
11410065|NCT03565328|12605487|FG000|NOT COMPLETED|Overall Study||0
11410066|NCT03544242|12605494|FG000|STARTED|Overall Study||1
11410067|NCT03544242|12605495|FG001|STARTED|Overall Study||1
11410068|NCT03544242|12605496|FG002|STARTED|Overall Study||2
11410069|NCT03544242|12605494|FG000|COMPLETED|Overall Study||1
11410070|NCT03544242|12605495|FG001|COMPLETED|Overall Study||1
11410071|NCT03544242|12605496|FG002|COMPLETED|Overall Study||2
11410072|NCT03544242|12605494|FG000|NOT COMPLETED|Overall Study||0
11410073|NCT03544242|12605495|FG001|NOT COMPLETED|Overall Study||0
11410074|NCT03544242|12605496|FG002|NOT COMPLETED|Overall Study||0
11410075|NCT03543358|12605504|FG000|STARTED|Overall Study||3
11410076|NCT03543358|12605505|FG001|STARTED|Overall Study||0
11410077|NCT03543358|12605504|FG000|Received Treatment or Retreatment|Overall Study||0
11410078|NCT03543358|12605505|FG001|Received Treatment or Retreatment|Overall Study||0
11410079|NCT03543358|12605504|FG000|COMPLETED|Overall Study||0
11410080|NCT03543358|12605505|FG001|COMPLETED|Overall Study||0
11410081|NCT03543358|12605504|FG000|NOT COMPLETED|Overall Study||3
11410082|NCT03543358|12605505|FG001|NOT COMPLETED|Overall Study||0
11410083|NCT03538015|12605512|FG000|STARTED|Overall Study||0
11410084|NCT03538015|12605513|FG001|STARTED|Overall Study||0
11410085|NCT03538015|12605514|FG002|STARTED|Overall Study||1
11410086|NCT03538015|12605512|FG000|COMPLETED|Overall Study||0
11410087|NCT03538015|12605513|FG001|COMPLETED|Overall Study||0
11410088|NCT03538015|12605514|FG002|COMPLETED|Overall Study||0
11410089|NCT03538015|12605512|FG000|NOT COMPLETED|Overall Study||0
11410090|NCT03538015|12605513|FG001|NOT COMPLETED|Overall Study||0
11410091|NCT03538015|12605514|FG002|NOT COMPLETED|Overall Study||1
11410092|NCT03534362|12605524|FG000|STARTED|Overall Study||0
11410093|NCT03534362|12605525|FG001|STARTED|Overall Study||1
11410094|NCT03534362|12605524|FG000|COMPLETED|Overall Study||0
11410095|NCT03534362|12605525|FG001|COMPLETED|Overall Study||1
11410096|NCT03534362|12605524|FG000|NOT COMPLETED|Overall Study||0
11410097|NCT03534362|12605525|FG001|NOT COMPLETED|Overall Study||0
11410098|NCT03509207|12605533|FG000|STARTED|Overall Study||3
11410099|NCT03509207|12605533|FG000|COMPLETED|Overall Study||1
11410100|NCT03509207|12605533|FG000|NOT COMPLETED|Overall Study||2
11410101|NCT03505372|12605537|FG000|STARTED|Overall Study||5
11410102|NCT03505372|12605537|FG000|COMPLETED|Overall Study||5
11410103|NCT03505372|12605537|FG000|NOT COMPLETED|Overall Study||0
11410104|NCT03500406|12605543|FG000|STARTED|Overall Study||4
11410105|NCT03500406|12605544|FG001|STARTED|Overall Study||20
11410106|NCT03500406|12605543|FG000|COMPLETED|Overall Study||4
11410107|NCT03500406|12605544|FG001|COMPLETED|Overall Study||20
11410108|NCT03500406|12605543|FG000|NOT COMPLETED|Overall Study||0
11410109|NCT03500406|12605544|FG001|NOT COMPLETED|Overall Study||0
11410110|NCT03500341|12605550|FG000|STARTED|Overall Study||16
11410111|NCT03500341|12605550|FG000|COMPLETED|Overall Study||14
11410112|NCT03500341|12605550|FG000|NOT COMPLETED|Overall Study||2
11410113|NCT03500159|12605556|FG000|STARTED|Overall Study||2
11410114|NCT03500159|12605557|FG001|STARTED|Overall Study||1
11410115|NCT03500159|12605556|FG000|COMPLETED|Overall Study||0
11410116|NCT03500159|12605557|FG001|COMPLETED|Overall Study||0
11410117|NCT03500159|12605556|FG000|NOT COMPLETED|Overall Study||2
11410118|NCT03500159|12605557|FG001|NOT COMPLETED|Overall Study||1
11410119|NCT03490916|12605565|FG000|STARTED|Overall Study||0
11410120|NCT03490916|12605566|FG001|STARTED|Overall Study||0
11410121|NCT03490916|12605565|FG000|COMPLETED|Overall Study||0
11410122|NCT03490916|12605566|FG001|COMPLETED|Overall Study||0
11410123|NCT03490916|12605565|FG000|NOT COMPLETED|Overall Study||0
11410124|NCT03490916|12605566|FG001|NOT COMPLETED|Overall Study||0
11410125|NCT03483051|12605574|FG000|STARTED|First Treatment, Pre Crossover||2
11410126|NCT03483051|12605575|FG001|STARTED|First Treatment, Pre Crossover||1
11410127|NCT03483051|12605574|FG000|COMPLETED|First Treatment, Pre Crossover||2
11410128|NCT03483051|12605575|FG001|COMPLETED|First Treatment, Pre Crossover||1
11410129|NCT03483051|12605574|FG000|NOT COMPLETED|First Treatment, Pre Crossover||0
11410130|NCT03483051|12605575|FG001|NOT COMPLETED|First Treatment, Pre Crossover||0
11410131|NCT03483051|12605574|FG000|STARTED|Second Treatment, After Crossover||2
11410132|NCT03483051|12605575|FG001|STARTED|Second Treatment, After Crossover||1
11410133|NCT03483051|12605574|FG000|COMPLETED|Second Treatment, After Crossover||2
11410134|NCT03483051|12605575|FG001|COMPLETED|Second Treatment, After Crossover||1
11410135|NCT03483051|12605574|FG000|NOT COMPLETED|Second Treatment, After Crossover||0
11410136|NCT03483051|12605575|FG001|NOT COMPLETED|Second Treatment, After Crossover||0
11410137|NCT03477903|12605583|FG000|STARTED|Overall Study||1
11410138|NCT03477903|12605583|FG000|COMPLETED|Overall Study||0
11410139|NCT03477903|12605583|FG000|NOT COMPLETED|Overall Study||1
11410140|NCT03469258|12605587|FG000|STARTED|Overall Study||4
11410141|NCT03469258|12605587|FG000|COMPLETED|Overall Study||0
11410142|NCT03469258|12605587|FG000|NOT COMPLETED|Overall Study||4
11410143|NCT03466658|12605591|FG000|STARTED|Overall Study||17
11410144|NCT03466658|12605591|FG000|COMPLETED|Overall Study||14
11410145|NCT03466658|12605591|FG000|NOT COMPLETED|Overall Study||3
11410146|NCT03465891|12605599|FG000|STARTED|Overall Study||1
11410147|NCT03465891|12605600|FG001|STARTED|Overall Study||1
11410148|NCT03465891|12605599|FG000|COMPLETED|Overall Study||0
11410149|NCT03465891|12605600|FG001|COMPLETED|Overall Study||0
11410150|NCT03465891|12605599|FG000|NOT COMPLETED|Overall Study||1
11410151|NCT03465891|12605600|FG001|NOT COMPLETED|Overall Study||1
11410152|NCT03465735|12605608|FG000|STARTED|Overall Study||8
11410153|NCT03465735|12605609|FG001|STARTED|Overall Study||7
11410154|NCT03465735|12605608|FG000|COMPLETED|Overall Study||7
11410155|NCT03465735|12605609|FG001|COMPLETED|Overall Study||5
11410156|NCT03465735|12605608|FG000|NOT COMPLETED|Overall Study||1
11410157|NCT03465735|12605609|FG001|NOT COMPLETED|Overall Study||2
11410158|NCT03461705|12605615|FG000|STARTED|Overall Study||5
11410159|NCT03461705|12605615|FG000|COMPLETED|Overall Study||5
11410160|NCT03461705|12605615|FG000|NOT COMPLETED|Overall Study||0
11410161|NCT03455556|12605619|FG000|STARTED|Overall Study||1
11410162|NCT03455556|12605619|FG000|COMPLETED|Overall Study||1
11410163|NCT03455556|12605619|FG000|NOT COMPLETED|Overall Study||0
11410164|NCT03447639|12605625|FG000|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
11410165|NCT03447639|12605626|FG001|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3
11410166|NCT03447639|12605625|FG000|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
11410167|NCT03447639|12605626|FG001|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1
11410168|NCT03447639|12605625|FG000|NOT COMPLETED|Overall Study||0
11410169|NCT03447639|12605626|FG001|NOT COMPLETED|Overall Study||2
11410170|NCT03429712|12605632|FG000|STARTED|Overall Study||19
11410171|NCT03429712|12605632|FG000|COMPLETED|Overall Study||10
11410172|NCT03429712|12605632|FG000|NOT COMPLETED|Overall Study||9
11410173|NCT03426137|12605639|FG000|STARTED|Overall Study||0
11410174|NCT03426137|12605640|FG001|STARTED|Overall Study||0
11410175|NCT03426137|12605641|FG002|STARTED|Overall Study||0
11410176|NCT03426137|12605639|FG000|COMPLETED|Overall Study||0
11410177|NCT03426137|12605640|FG001|COMPLETED|Overall Study||0
11410178|NCT03426137|12605641|FG002|COMPLETED|Overall Study||0
11410179|NCT03426137|12605639|FG000|NOT COMPLETED|Overall Study||0
11410180|NCT03426137|12605640|FG001|NOT COMPLETED|Overall Study||0
11410181|NCT03426137|12605641|FG002|NOT COMPLETED|Overall Study||0
11410182|NCT03425799|12605651|FG000|STARTED|Overall Study|Study terminated due to low recruitment|0
11410183|NCT03425799|12605652|FG001|STARTED|Overall Study|Study terminated due to low recruitment|0
11410184|NCT03425799|12605651|FG000|COMPLETED|Overall Study|Study terminated due to low recruitment|0
11410185|NCT03425799|12605652|FG001|COMPLETED|Overall Study|Study terminated due to low recruitment|0
11410186|NCT03425799|12605651|FG000|NOT COMPLETED|Overall Study||0
11410187|NCT03425799|12605652|FG001|NOT COMPLETED|Overall Study||0
11410188|NCT03423654|12605660|FG000|STARTED|Overall Study||3
11410189|NCT03423654|12605661|FG001|STARTED|Overall Study||3
11410190|NCT03423654|12605660|FG000|COMPLETED|Overall Study||3
11410191|NCT03423654|12605661|FG001|COMPLETED|Overall Study||3
11410192|NCT03423654|12605660|FG000|NOT COMPLETED|Overall Study||0
11410193|NCT03423654|12605661|FG001|NOT COMPLETED|Overall Study||0
11410194|NCT03387059|12605669|FG000|STARTED|Overall Study||5
11410195|NCT03387059|12605670|FG001|STARTED|Overall Study||4
11410196|NCT03387059|12605669|FG000|COMPLETED|Overall Study||0
11410197|NCT03387059|12605670|FG001|COMPLETED|Overall Study||0
11410198|NCT03387059|12605669|FG000|NOT COMPLETED|Overall Study||5
11410199|NCT03387059|12605670|FG001|NOT COMPLETED|Overall Study||4
11410200|NCT03382925|12605678|FG000|STARTED|Overall Study||10
11410201|NCT03382925|12605679|FG001|STARTED|Overall Study||6
11410202|NCT03382925|12605678|FG000|COMPLETED|Overall Study||10
11410203|NCT03382925|12605679|FG001|COMPLETED|Overall Study||6
11410204|NCT03382925|12605678|FG000|NOT COMPLETED|Overall Study||0
11410205|NCT03382925|12605679|FG001|NOT COMPLETED|Overall Study||0
11410206|NCT03379233|12605687|FG000|STARTED|Overall Study||1
11410207|NCT03379233|12605688|FG001|STARTED|Overall Study||6
11410208|NCT03379233|12605687|FG000|COMPLETED|Overall Study||0
11410209|NCT03379233|12605688|FG001|COMPLETED|Overall Study||0
11410210|NCT03379233|12605687|FG000|NOT COMPLETED|Overall Study||1
11410211|NCT03379233|12605688|FG001|NOT COMPLETED|Overall Study||6
11410212|NCT03370536|12605694|FG000|STARTED|Overall Study||1
11410213|NCT03370536|12605694|FG000|COMPLETED|Overall Study||0
11410214|NCT03370536|12605694|FG000|NOT COMPLETED|Overall Study||1
11410215|NCT03363633|12605698|FG000|STARTED|Overall Study||12
11410216|NCT03363633|12605698|FG000|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
11410217|NCT03363633|12605698|FG000|NOT COMPLETED|Overall Study||12
11410218|NCT03361228|12605704|FG000|STARTED|Overall Study||4
11410219|NCT03361228|12605705|FG001|STARTED|Overall Study||1
11410220|NCT03361228|12605704|FG000|COMPLETED|Overall Study||0
11410221|NCT03361228|12605705|FG001|COMPLETED|Overall Study||0
11410222|NCT03361228|12605704|FG000|NOT COMPLETED|Overall Study||4
11410223|NCT03361228|12605705|FG001|NOT COMPLETED|Overall Study||1
11410224|NCT03360903|12605713|FG000|STARTED|First Intervention||4
11410225|NCT03360903|12605714|FG001|STARTED|First Intervention||4
11410226|NCT03360903|12605713|FG000|COMPLETED|First Intervention||4
11410227|NCT03360903|12605714|FG001|COMPLETED|First Intervention||4
11410228|NCT03360903|12605713|FG000|NOT COMPLETED|First Intervention||0
11410229|NCT03360903|12605714|FG001|NOT COMPLETED|First Intervention||0
11410230|NCT03360903|12605713|FG000|STARTED|Washout (2 Weeks)||4
11410231|NCT03360903|12605714|FG001|STARTED|Washout (2 Weeks)||4
11410232|NCT03360903|12605713|FG000|COMPLETED|Washout (2 Weeks)||4
11410233|NCT03360903|12605714|FG001|COMPLETED|Washout (2 Weeks)||4
11410234|NCT03360903|12605713|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11410235|NCT03360903|12605714|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11410236|NCT03360903|12605713|FG000|STARTED|Second Intervention||4
11410237|NCT03360903|12605714|FG001|STARTED|Second Intervention||4
11410238|NCT03360903|12605713|FG000|COMPLETED|Second Intervention||4
11410239|NCT03360903|12605714|FG001|COMPLETED|Second Intervention||4
11410240|NCT03360903|12605713|FG000|NOT COMPLETED|Second Intervention||0
11410241|NCT03360903|12605714|FG001|NOT COMPLETED|Second Intervention||0
11410242|NCT03359174|12605720|FG000|STARTED|Overall Study||2
11410243|NCT03359174|12605720|FG000|COMPLETED|Overall Study||1
11410244|NCT03359174|12605720|FG000|NOT COMPLETED|Overall Study||1
11410245|NCT03352882|12605724|FG000|STARTED|Overall Study||1
11410246|NCT03352882|12605724|FG000|COMPLETED|Overall Study||1
11410247|NCT03352882|12605724|FG000|NOT COMPLETED|Overall Study||0
11410248|NCT03348904|12605731|FG000|STARTED|Overall Study||0
11410249|NCT03348904|12605732|FG001|STARTED|Overall Study||2
11410250|NCT03348904|12605733|FG002|STARTED|Overall Study||0
11410251|NCT03348904|12605731|FG000|COMPLETED|Overall Study||0
11410252|NCT03348904|12605732|FG001|COMPLETED|Overall Study||1
11410253|NCT03348904|12605733|FG002|COMPLETED|Overall Study||0
11410254|NCT03348904|12605731|FG000|NOT COMPLETED|Overall Study||0
11410255|NCT03348904|12605732|FG001|NOT COMPLETED|Overall Study||1
11410256|NCT03348904|12605733|FG002|NOT COMPLETED|Overall Study||0
11410257|NCT03345901|12605741|FG000|STARTED|Overall Study||18
11410258|NCT03345901|12605741|FG000|COMPLETED|Overall Study||0
11410259|NCT03345901|12605741|FG000|NOT COMPLETED|Overall Study||18
11410260|NCT03344562|12605748|FG000|STARTED|Overall Study||10
11410261|NCT03344562|12605749|FG001|STARTED|Overall Study||9
11410262|NCT03344562|12605748|FG000|COMPLETED|Overall Study||8
11410263|NCT03344562|12605749|FG001|COMPLETED|Overall Study||9
11410264|NCT03344562|12605748|FG000|NOT COMPLETED|Overall Study||2
11410265|NCT03344562|12605749|FG001|NOT COMPLETED|Overall Study||0
11410266|NCT03342638|12605757|FG000|STARTED|Overall Study||34
11410267|NCT03342638|12605758|FG001|STARTED|Overall Study||32
11410268|NCT03342638|12605757|FG000|COMPLETED|Overall Study||33
11410269|NCT03342638|12605758|FG001|COMPLETED|Overall Study||31
11410270|NCT03342638|12605757|FG000|NOT COMPLETED|Overall Study||1
11410271|NCT03342638|12605758|FG001|NOT COMPLETED|Overall Study||1
11410272|NCT03342157|12605766|FG000|STARTED|Overall Study||1
11410273|NCT03342157|12605767|FG001|STARTED|Overall Study||1
11410274|NCT03342157|12605766|FG000|COMPLETED|Overall Study||1
11410275|NCT03342157|12605767|FG001|COMPLETED|Overall Study||1
11410276|NCT03342157|12605766|FG000|NOT COMPLETED|Overall Study||0
11410277|NCT03342157|12605767|FG001|NOT COMPLETED|Overall Study||0
11410278|NCT03339401|12605775|FG000|STARTED|Overall Study||20
11410279|NCT03339401|12605776|FG001|STARTED|Overall Study||9
11410280|NCT03339401|12605775|FG000|COMPLETED|Overall Study||11
11410281|NCT03339401|12605776|FG001|COMPLETED|Overall Study||5
11410282|NCT03339401|12605775|FG000|NOT COMPLETED|Overall Study||9
11410283|NCT03339401|12605776|FG001|NOT COMPLETED|Overall Study||4
11410284|NCT03339245|12605784|FG000|STARTED|Overall Study||6
11410285|NCT03339245|12605785|FG001|STARTED|Overall Study||7
11410286|NCT03339245|12605784|FG000|COMPLETED|Overall Study|"1 withdrawn due to elevated glucose during pre-intervention testing~1 withdrawn for personal reason"|4
11410287|NCT03339245|12605785|FG001|COMPLETED|Overall Study|1 withdrawn due to elevated glucose on baseline testing|6
11410288|NCT03339245|12605784|FG000|NOT COMPLETED|Overall Study||2
11410289|NCT03339245|12605785|FG001|NOT COMPLETED|Overall Study||1
11410290|NCT03333746|12605791|FG000|STARTED|Overall Study||1
11410291|NCT03333746|12605791|FG000|COMPLETED|Overall Study||0
11410292|NCT03333746|12605791|FG000|NOT COMPLETED|Overall Study||1
11410293|NCT03329404|12605797|FG000|STARTED|Overall Study||4
11410294|NCT03329404|12605798|FG001|STARTED|Overall Study||5
11410295|NCT03329404|12605797|FG000|COMPLETED|Overall Study||3
11410296|NCT03329404|12605798|FG001|COMPLETED|Overall Study||1
11410297|NCT03329404|12605797|FG000|NOT COMPLETED|Overall Study||1
11410298|NCT03329404|12605798|FG001|NOT COMPLETED|Overall Study||4
11410299|NCT03326869|12605806|FG000|STARTED|Overall Study||1
11410300|NCT03326869|12605807|FG001|STARTED|Overall Study||1
11410301|NCT03326869|12605806|FG000|COMPLETED|Overall Study||0
11410302|NCT03326869|12605807|FG001|COMPLETED|Overall Study||0
11410303|NCT03326869|12605806|FG000|NOT COMPLETED|Overall Study||1
11410304|NCT03326869|12605807|FG001|NOT COMPLETED|Overall Study||1
11410305|NCT03325114|12605813|FG000|STARTED|Overall Study||1
11410306|NCT03325114|12605813|FG000|COMPLETED|Overall Study||0
11410307|NCT03325114|12605813|FG000|NOT COMPLETED|Overall Study||1
11410308|NCT03319407|12605817|FG000|STARTED|Overall Study||21
11410309|NCT03319407|12605817|FG000|COMPLETED|Overall Study||0
11410310|NCT03319407|12605817|FG000|NOT COMPLETED|Overall Study||21
11410311|NCT03316105|12605823|FG000|STARTED|Overall Study||9
11410312|NCT03316105|12605824|FG001|STARTED|Overall Study||7
11410313|NCT03316105|12605823|FG000|COMPLETED|Overall Study||9
11410314|NCT03316105|12605824|FG001|COMPLETED|Overall Study||7
11410315|NCT03316105|12605823|FG000|NOT COMPLETED|Overall Study||0
11410316|NCT03316105|12605824|FG001|NOT COMPLETED|Overall Study||0
11410317|NCT03305055|12605832|FG000|STARTED|Overall Study||2
11410318|NCT03305055|12605833|FG001|STARTED|Overall Study||2
11410319|NCT03305055|12605832|FG000|COMPLETED|Overall Study||1
11410320|NCT03305055|12605833|FG001|COMPLETED|Overall Study||0
11410321|NCT03305055|12605832|FG000|NOT COMPLETED|Overall Study||1
11410322|NCT03305055|12605833|FG001|NOT COMPLETED|Overall Study||2
11410323|NCT03303469|12605839|FG000|STARTED|Overall Study||3
11410324|NCT03303469|12605839|FG000|COMPLETED|Overall Study||1
11410325|NCT03303469|12605839|FG000|NOT COMPLETED|Overall Study||2
11410326|NCT03302247|12605843|FG000|STARTED|Overall Study||3
11410327|NCT03302247|12605843|FG000|COMPLETED|Overall Study||0
11410328|NCT03302247|12605843|FG000|NOT COMPLETED|Overall Study||3
11410329|NCT03300024|12605849|FG000|STARTED|Overall Study||4
11410330|NCT03300024|12605850|FG001|STARTED|Overall Study||6
11410331|NCT03300024|12605849|FG000|COMPLETED|Overall Study||0
11410332|NCT03300024|12605850|FG001|COMPLETED|Overall Study||0
11410333|NCT03300024|12605849|FG000|NOT COMPLETED|Overall Study||4
11410334|NCT03300024|12605850|FG001|NOT COMPLETED|Overall Study||6
11410335|NCT03283709|12605860|FG000|STARTED|Overall Study||0
11410336|NCT03283709|12605861|FG001|STARTED|Overall Study||1
11410337|NCT03283709|12605860|FG000|COMPLETED|Overall Study||0
11410338|NCT03283709|12605861|FG001|COMPLETED|Overall Study||0
11410339|NCT03283709|12605860|FG000|NOT COMPLETED|Overall Study||0
11410340|NCT03283709|12605861|FG001|NOT COMPLETED|Overall Study||1
11410341|NCT03277183|12605869|FG000|STARTED|Overall Study||3
11410342|NCT03277183|12605870|FG001|STARTED|Overall Study||2
11410343|NCT03277183|12605869|FG000|COMPLETED|Overall Study||0
11410344|NCT03277183|12605870|FG001|COMPLETED|Overall Study||0
11410345|NCT03277183|12605869|FG000|NOT COMPLETED|Overall Study||3
11410346|NCT03277183|12605870|FG001|NOT COMPLETED|Overall Study||2
11410347|NCT03269968|12605878|FG000|STARTED|Overall Study||0
11410348|NCT03269968|12605879|FG001|STARTED|Overall Study||0
11410349|NCT03269968|12605878|FG000|COMPLETED|Overall Study||0
11410350|NCT03269968|12605879|FG001|COMPLETED|Overall Study||0
11410351|NCT03269968|12605878|FG000|NOT COMPLETED|Overall Study||0
11410352|NCT03269968|12605879|FG001|NOT COMPLETED|Overall Study||0
11410353|NCT03248141|12605887|FG000|STARTED|Overall Study||11
11410354|NCT03248141|12605888|FG001|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0
11410355|NCT03248141|12605887|FG000|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11
11410356|NCT03248141|12605888|FG001|COMPLETED|Overall Study||0
11410357|NCT03248141|12605887|FG000|NOT COMPLETED|Overall Study||0
11410358|NCT03248141|12605888|FG001|NOT COMPLETED|Overall Study||0
11410359|NCT03263806|12605896|FG000|STARTED|Overall Study||6
11410360|NCT03263806|12605897|FG001|STARTED|Overall Study||7
11410361|NCT03263806|12605896|FG000|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
11410362|NCT03263806|12605897|FG001|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
11410363|NCT03263806|12605896|FG000|NOT COMPLETED|Overall Study||6
11410364|NCT03263806|12605897|FG001|NOT COMPLETED|Overall Study||7
11410365|NCT03261531|12605903|FG000|STARTED|Overall Study||7
11410366|NCT03261531|12605903|FG000|COMPLETED|Overall Study||3
11410367|NCT03261531|12605903|FG000|NOT COMPLETED|Overall Study||4
11410368|NCT03219372|12605909|FG000|STARTED|Overall Study||1
11410369|NCT03219372|12605910|FG001|STARTED|Overall Study||0
11410370|NCT03219372|12605909|FG000|COMPLETED|Overall Study||0
11410371|NCT03219372|12605910|FG001|COMPLETED|Overall Study||0
11410372|NCT03219372|12605909|FG000|NOT COMPLETED|Overall Study||1
11410373|NCT03219372|12605910|FG001|NOT COMPLETED|Overall Study||0
11410374|NCT03217175|12605916|FG000|STARTED|Overall Study||4
11410375|NCT03217175|12605917|FG001|STARTED|Overall Study||1
11410376|NCT03217175|12605916|FG000|COMPLETED|Overall Study||0
11410377|NCT03217175|12605917|FG001|COMPLETED|Overall Study||0
11410378|NCT03217175|12605916|FG000|NOT COMPLETED|Overall Study||4
11410379|NCT03217175|12605917|FG001|NOT COMPLETED|Overall Study||1
11410380|NCT03231397|12605927|FG000|STARTED|Overall Study||0
11410381|NCT03231397|12605928|FG001|STARTED|Overall Study||1
11410382|NCT03231397|12605929|FG002|STARTED|Overall Study||1
11410383|NCT03231397|12605930|FG003|STARTED|Overall Study||0
11410384|NCT03231397|12605927|FG000|COMPLETED|Overall Study||0
11410385|NCT03231397|12605928|FG001|COMPLETED|Overall Study||1
11410386|NCT03231397|12605929|FG002|COMPLETED|Overall Study||1
11410387|NCT03231397|12605930|FG003|COMPLETED|Overall Study||0
11410388|NCT03231397|12605927|FG000|NOT COMPLETED|Overall Study||0
11410389|NCT03231397|12605928|FG001|NOT COMPLETED|Overall Study||0
11410390|NCT03231397|12605929|FG002|NOT COMPLETED|Overall Study||0
11410391|NCT03231397|12605930|FG003|NOT COMPLETED|Overall Study||0
11410392|NCT03232892|12605940|FG000|STARTED|Overall Study||1
11410393|NCT03232892|12605940|FG000|COMPLETED|Overall Study||1
11410394|NCT03232892|12605940|FG000|NOT COMPLETED|Overall Study||0
11410395|NCT03223662|12605944|FG000|STARTED|Overall Study||2
11410396|NCT03223662|12605944|FG000|COMPLETED|Overall Study||0
11410397|NCT03223662|12605944|FG000|NOT COMPLETED|Overall Study||2
11410398|NCT03212144|12605950|FG000|STARTED|First Sequence (4 Weeks)||2
11410399|NCT03212144|12605951|FG001|STARTED|First Sequence (4 Weeks)||1
11410400|NCT03212144|12605950|FG000|COMPLETED|First Sequence (4 Weeks)||1
11410401|NCT03212144|12605951|FG001|COMPLETED|First Sequence (4 Weeks)||1
11410402|NCT03212144|12605950|FG000|NOT COMPLETED|First Sequence (4 Weeks)||1
11410403|NCT03212144|12605951|FG001|NOT COMPLETED|First Sequence (4 Weeks)||0
11410404|NCT03212144|12605950|FG000|STARTED|Washout (4 Weeks)||1
11410405|NCT03212144|12605951|FG001|STARTED|Washout (4 Weeks)||1
11410406|NCT03212144|12605950|FG000|COMPLETED|Washout (4 Weeks)||1
11410407|NCT03212144|12605951|FG001|COMPLETED|Washout (4 Weeks)||1
11410408|NCT03212144|12605950|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11410409|NCT03212144|12605951|FG001|NOT COMPLETED|Washout (4 Weeks)||0
11410410|NCT03212144|12605950|FG000|STARTED|Second Sequence (4 Weeks)||1
11410411|NCT03212144|12605951|FG001|STARTED|Second Sequence (4 Weeks)||1
11410412|NCT03212144|12605950|FG000|COMPLETED|Second Sequence (4 Weeks)||0
11410413|NCT03212144|12605951|FG001|COMPLETED|Second Sequence (4 Weeks)||0
11410414|NCT03212144|12605950|FG000|NOT COMPLETED|Second Sequence (4 Weeks)||1
11410415|NCT03212144|12605951|FG001|NOT COMPLETED|Second Sequence (4 Weeks)||1
11410416|NCT03218163|12605957|FG000|STARTED|Overall Study||0
11410417|NCT03218163|12605957|FG000|COMPLETED|Overall Study||0
11410418|NCT03218163|12605957|FG000|NOT COMPLETED|Overall Study||0
11410419|NCT03172520|12605961|FG000|STARTED|Overall Study||10
11410420|NCT03172520|12605961|FG000|COMPLETED|Overall Study||0
11410421|NCT03172520|12605961|FG000|NOT COMPLETED|Overall Study||10
11410422|NCT03204539|12605967|FG000|STARTED|Overall Study||0
11410423|NCT03204539|12605968|FG001|STARTED|Overall Study||1
11410424|NCT03204539|12605967|FG000|COMPLETED|Overall Study||0
11410425|NCT03204539|12605968|FG001|COMPLETED|Overall Study||0
11410426|NCT03204539|12605967|FG000|NOT COMPLETED|Overall Study||0
11410427|NCT03204539|12605968|FG001|NOT COMPLETED|Overall Study||1
11410428|NCT03206216|12605976|FG000|STARTED|Overall Study||0
11410429|NCT03206216|12605977|FG001|STARTED|Overall Study||1
11410430|NCT03206216|12605976|FG000|COMPLETED|Overall Study||0
11410431|NCT03206216|12605977|FG001|COMPLETED|Overall Study||0
11410432|NCT03206216|12605976|FG000|NOT COMPLETED|Overall Study||0
11410433|NCT03206216|12605977|FG001|NOT COMPLETED|Overall Study||1
11410434|NCT03195660|12605983|FG000|STARTED|Overall Study||2
11410435|NCT03195660|12605983|FG000|COMPLETED|Overall Study||0
11410436|NCT03195660|12605983|FG000|NOT COMPLETED|Overall Study||2
11410437|NCT03195465|12605987|FG000|STARTED|Overall Study||0
11410438|NCT03195465|12605987|FG000|COMPLETED|Overall Study||0
11410439|NCT03195465|12605987|FG000|NOT COMPLETED|Overall Study||0
11410440|NCT03166618|12605993|FG000|STARTED|Overall Study||0
11410441|NCT03166618|12605994|FG001|STARTED|Overall Study||1
11410442|NCT03166618|12605993|FG000|COMPLETED|Overall Study||0
11410443|NCT03166618|12605994|FG001|COMPLETED|Overall Study||0
11410444|NCT03166618|12605993|FG000|NOT COMPLETED|Overall Study||0
11410445|NCT03166618|12605994|FG001|NOT COMPLETED|Overall Study||1
11410446|NCT03169530|12606002|FG000|STARTED|Overall Study||15
11410447|NCT03169530|12606003|FG001|STARTED|Overall Study||17
11410448|NCT03169530|12606002|FG000|COMPLETED|Overall Study||0
11410449|NCT03169530|12606003|FG001|COMPLETED|Overall Study||0
11410450|NCT03169530|12606002|FG000|NOT COMPLETED|Overall Study||15
11410451|NCT03169530|12606003|FG001|NOT COMPLETED|Overall Study||17
11410452|NCT03189433|12606011|FG000|STARTED|Overall Study||2
11410453|NCT03189433|12606012|FG001|STARTED|Overall Study||0
11410454|NCT03189433|12606011|FG000|COMPLETED|Overall Study||0
11410455|NCT03189433|12606012|FG001|COMPLETED|Overall Study||0
11410456|NCT03189433|12606011|FG000|NOT COMPLETED|Overall Study||2
11410457|NCT03189433|12606012|FG001|NOT COMPLETED|Overall Study||0
11410458|NCT03151226|12606018|FG000|STARTED|Overall Study||3
11410459|NCT03151226|12606018|FG000|COMPLETED|Overall Study||0
11410460|NCT03151226|12606018|FG000|NOT COMPLETED|Overall Study||3
11410461|NCT03165747|12606024|FG000|STARTED|Overall Study||0
11410462|NCT03165747|12606025|FG001|STARTED|Overall Study||0
11410463|NCT03165747|12606024|FG000|COMPLETED|Overall Study||0
11410464|NCT03165747|12606025|FG001|COMPLETED|Overall Study||0
11410465|NCT03165747|12606024|FG000|NOT COMPLETED|Overall Study||0
11410466|NCT03165747|12606025|FG001|NOT COMPLETED|Overall Study||0
11410467|NCT03168906|12606033|FG000|STARTED|Overall Study||6
11410468|NCT03168906|12606034|FG001|STARTED|Overall Study||6
11410469|NCT03168906|12606033|FG000|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
11410470|NCT03168906|12606034|FG001|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
11410471|NCT03168906|12606033|FG000|NOT COMPLETED|Overall Study||6
11410472|NCT03168906|12606034|FG001|NOT COMPLETED|Overall Study||6
11410473|NCT03178201|12606041|FG000|STARTED|Overall Study||5
11410474|NCT03178201|12606041|FG000|COMPLETED|Overall Study||0
11410475|NCT03178201|12606041|FG000|NOT COMPLETED|Overall Study||5
11410476|NCT03172026|12606047|FG000|STARTED|Overall Study||2
11410477|NCT03172026|12606048|FG001|STARTED|Overall Study||0
11410478|NCT03172026|12606047|FG000|8 Week Assessment|Overall Study||0
11410479|NCT03172026|12606048|FG001|8 Week Assessment|Overall Study||0
11410480|NCT03172026|12606047|FG000|6 Month Assessment|Overall Study||0
11410481|NCT03172026|12606048|FG001|6 Month Assessment|Overall Study||0
11410482|NCT03172026|12606047|FG000|COMPLETED|Overall Study||0
11410483|NCT03172026|12606048|FG001|COMPLETED|Overall Study||0
11410484|NCT03172026|12606047|FG000|NOT COMPLETED|Overall Study||2
11410485|NCT03172026|12606048|FG001|NOT COMPLETED|Overall Study||0
11410486|NCT03152526|12606057|FG000|STARTED|Overall Study|No participants were enrolled on this arm.|0
11410487|NCT03152526|12606058|FG001|STARTED|Overall Study|One participant was enrolled on this arm.|1
11410488|NCT03152526|12606057|FG000|COMPLETED|Overall Study|No participants were enrolled on this arm.|0
11410489|NCT03152526|12606058|FG001|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0
11410490|NCT03152526|12606057|FG000|NOT COMPLETED|Overall Study||0
11410491|NCT03152526|12606058|FG001|NOT COMPLETED|Overall Study||1
11410492|NCT03161964|12606066|FG000|STARTED|Overall Study||1
11410493|NCT03161964|12606067|FG001|STARTED|Overall Study||1
11410494|NCT03161964|12606066|FG000|COMPLETED|Overall Study||1
11410495|NCT03161964|12606067|FG001|COMPLETED|Overall Study||0
11410496|NCT03161964|12606066|FG000|NOT COMPLETED|Overall Study||0
11410497|NCT03161964|12606067|FG001|NOT COMPLETED|Overall Study||1
11410498|NCT03150160|12606075|FG000|STARTED|Overall Study||0
11410499|NCT03150160|12606076|FG001|STARTED|Overall Study||1
11410500|NCT03150160|12606075|FG000|COMPLETED|Overall Study||0
11410501|NCT03150160|12606076|FG001|COMPLETED|Overall Study||1
11410502|NCT03150160|12606075|FG000|NOT COMPLETED|Overall Study||0
11410503|NCT03150160|12606076|FG001|NOT COMPLETED|Overall Study||0
11410504|NCT03137225|12606084|FG000|STARTED|First 4 Hour Measurement Period||1
11410505|NCT03137225|12606085|FG001|STARTED|First 4 Hour Measurement Period||0
11410506|NCT03137225|12606084|FG000|COMPLETED|First 4 Hour Measurement Period||1
11410507|NCT03137225|12606085|FG001|COMPLETED|First 4 Hour Measurement Period||0
11410508|NCT03137225|12606084|FG000|NOT COMPLETED|First 4 Hour Measurement Period||0
11410509|NCT03137225|12606085|FG001|NOT COMPLETED|First 4 Hour Measurement Period||0
11410510|NCT03137225|12606084|FG000|STARTED|Second 4 Hour Measurement Period||1
11410511|NCT03137225|12606085|FG001|STARTED|Second 4 Hour Measurement Period||0
11410512|NCT03137225|12606084|FG000|COMPLETED|Second 4 Hour Measurement Period||1
11410513|NCT03137225|12606085|FG001|COMPLETED|Second 4 Hour Measurement Period||0
11410514|NCT03137225|12606084|FG000|NOT COMPLETED|Second 4 Hour Measurement Period||0
11410515|NCT03137225|12606085|FG001|NOT COMPLETED|Second 4 Hour Measurement Period||0
11410516|NCT03123393|12606093|FG000|STARTED|Overall Study||24
11410517|NCT03123393|12606094|FG001|STARTED|Overall Study||25
11410518|NCT03123393|12606093|FG000|COMPLETED|Overall Study||3
11410519|NCT03123393|12606094|FG001|COMPLETED|Overall Study||2
11410520|NCT03123393|12606093|FG000|NOT COMPLETED|Overall Study||21
11410521|NCT03123393|12606094|FG001|NOT COMPLETED|Overall Study||23
11410522|NCT03123328|12606100|FG000|STARTED|Overall Study||380
11410523|NCT03123328|12606100|FG000|COMPLETED|Overall Study||351
11410524|NCT03123328|12606100|FG000|NOT COMPLETED|Overall Study||29
11410525|NCT03119662|12606106|FG000|STARTED|Overall Study||2
11410526|NCT03119662|12606107|FG001|STARTED|Overall Study||2
11410527|NCT03119662|12606106|FG000|COMPLETED|Overall Study||2
11410528|NCT03119662|12606107|FG001|COMPLETED|Overall Study||1
11410529|NCT03119662|12606106|FG000|NOT COMPLETED|Overall Study||0
11410530|NCT03119662|12606107|FG001|NOT COMPLETED|Overall Study||1
11410531|NCT03109418|12606115|FG000|STARTED|Overall Study||2
11410532|NCT03109418|12606116|FG001|STARTED|Overall Study||4
11410533|NCT03109418|12606115|FG000|COMPLETED|Overall Study||2
11410534|NCT03109418|12606116|FG001|COMPLETED|Overall Study||3
11410535|NCT03109418|12606115|FG000|NOT COMPLETED|Overall Study||0
11410536|NCT03109418|12606116|FG001|NOT COMPLETED|Overall Study||1
11410537|NCT03120676|12606122|FG000|STARTED|Overall Study||3
11410538|NCT03120676|12606122|FG000|COMPLETED|Overall Study||2
11410539|NCT03120676|12606122|FG000|NOT COMPLETED|Overall Study||1
11410540|NCT03109873|12606128|FG000|STARTED|Overall Study||5
11410541|NCT03109873|12606129|FG001|STARTED|Overall Study||4
11410542|NCT03109873|12606128|FG000|COMPLETED|Overall Study||5
11410543|NCT03109873|12606129|FG001|COMPLETED|Overall Study||4
11410544|NCT03109873|12606128|FG000|NOT COMPLETED|Overall Study||0
11410545|NCT03109873|12606129|FG001|NOT COMPLETED|Overall Study||0
11410546|NCT03100617|12606135|FG000|STARTED|Overall Study||6
11410547|NCT03100617|12606135|FG000|COMPLETED|Overall Study||6
11410548|NCT03100617|12606135|FG000|NOT COMPLETED|Overall Study||0
11410549|NCT03115853|12606139|FG000|STARTED|Overall Study||31
11410550|NCT03115853|12606139|FG000|COMPLETED|Overall Study||31
11410551|NCT03115853|12606139|FG000|NOT COMPLETED|Overall Study||0
11410552|NCT03113071|12606147|FG000|STARTED|Overall Study||1
11410553|NCT03113071|12606148|FG001|STARTED|Overall Study||0
11410554|NCT03113071|12606147|FG000|COMPLETED|Overall Study||0
11410555|NCT03113071|12606148|FG001|COMPLETED|Overall Study||0
11410556|NCT03113071|12606147|FG000|NOT COMPLETED|Overall Study||1
11410557|NCT03113071|12606148|FG001|NOT COMPLETED|Overall Study||0
11410558|NCT03110900|12606156|FG000|STARTED|Overall Study||1
11410559|NCT03110900|12606157|FG001|STARTED|Overall Study||1
11410560|NCT03110900|12606156|FG000|COMPLETED|Overall Study||0
11410561|NCT03110900|12606157|FG001|COMPLETED|Overall Study||0
11410562|NCT03110900|12606156|FG000|NOT COMPLETED|Overall Study||1
11410563|NCT03110900|12606157|FG001|NOT COMPLETED|Overall Study||1
11410564|NCT03078868|12606163|FG000|STARTED|Overall Study||3
11410565|NCT03078868|12606163|FG000|COMPLETED|Overall Study||0
11410566|NCT03078868|12606163|FG000|NOT COMPLETED|Overall Study||3
11410567|NCT03078270|12606169|FG000|STARTED|Overall Study||4
11410568|NCT03078270|12606170|FG001|STARTED|Overall Study||0
11410569|NCT03078270|12606169|FG000|COMPLETED|Overall Study||0
11410570|NCT03078270|12606170|FG001|COMPLETED|Overall Study||0
11410571|NCT03078270|12606169|FG000|NOT COMPLETED|Overall Study||4
11410572|NCT03078270|12606170|FG001|NOT COMPLETED|Overall Study||0
11410573|NCT03065933|12606176|FG000|STARTED|Overall Study||5
11410574|NCT03065933|12606176|FG000|COMPLETED|Overall Study||0
11410575|NCT03065933|12606176|FG000|NOT COMPLETED|Overall Study||5
11410576|NCT03070002|12606180|FG000|STARTED|3 Cycles of Treatment||1
11410577|NCT03070002|12606180|FG000|COMPLETED|3 Cycles of Treatment||1
11410578|NCT03070002|12606180|FG000|NOT COMPLETED|3 Cycles of Treatment||0
11410579|NCT03070002|12606180|FG000|STARTED|Follow up for 2 Years||1
11410580|NCT03070002|12606180|FG000|COMPLETED|Follow up for 2 Years||0
11410581|NCT03070002|12606180|FG000|NOT COMPLETED|Follow up for 2 Years||1
11410582|NCT03058705|12606184|FG000|STARTED|Overall Study||10
11410583|NCT03058705|12606184|FG000|COMPLETED|Overall Study||6
11410584|NCT03058705|12606184|FG000|NOT COMPLETED|Overall Study||4
11410585|NCT03061279|12606190|FG000|STARTED|Overall Study||0
11410586|NCT03061279|12606191|FG001|STARTED|Overall Study||1
11410587|NCT03061279|12606190|FG000|COMPLETED|Overall Study||0
11410588|NCT03061279|12606191|FG001|COMPLETED|Overall Study||0
11410589|NCT03061279|12606190|FG000|NOT COMPLETED|Overall Study||0
11410590|NCT03061279|12606191|FG001|NOT COMPLETED|Overall Study||1
11410591|NCT03040323|12606199|FG000|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
11410592|NCT03040323|12606200|FG001|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
11410593|NCT03040323|12606199|FG000|COMPLETED|Overall Study||0
11410594|NCT03040323|12606200|FG001|COMPLETED|Overall Study||0
11410595|NCT03040323|12606199|FG000|NOT COMPLETED|Overall Study||0
11410596|NCT03040323|12606200|FG001|NOT COMPLETED|Overall Study||0
11410597|NCT03053518|12606206|FG000|STARTED|Overall Study||22
11410598|NCT03053518|12606206|FG000|COMPLETED|Overall Study||12
11410599|NCT03053518|12606206|FG000|NOT COMPLETED|Overall Study||10
11410600|NCT03050398|12606210|FG000|STARTED|Overall Study||8
11410601|NCT03050398|12606210|FG000|COMPLETED|Overall Study||0
11410602|NCT03050398|12606210|FG000|NOT COMPLETED|Overall Study||8
11410603|NCT03042780|12606214|FG000|STARTED|Overall Study||2
11410604|NCT03042780|12606214|FG000|COMPLETED|Overall Study||2
11410605|NCT03042780|12606214|FG000|NOT COMPLETED|Overall Study||0
11410606|NCT03053960|12606218|FG000|STARTED|Overall Study||8
11410607|NCT03053960|12606218|FG000|COMPLETED|Overall Study||8
11410608|NCT03053960|12606218|FG000|NOT COMPLETED|Overall Study||0
11410609|NCT03036735|12606222|FG000|STARTED|Overall Study||10
11410610|NCT03036735|12606222|FG000|COMPLETED|Overall Study||0
11410611|NCT03036735|12606222|FG000|NOT COMPLETED|Overall Study||10
11410612|NCT03029832|12606228|FG000|STARTED|Overall Study||4
11410613|NCT03029832|12606229|FG001|STARTED|Overall Study||1
11410614|NCT03029832|12606228|FG000|COMPLETED|Overall Study||0
11410615|NCT03029832|12606229|FG001|COMPLETED|Overall Study||0
11410616|NCT03029832|12606228|FG000|NOT COMPLETED|Overall Study||4
11410617|NCT03029832|12606229|FG001|NOT COMPLETED|Overall Study||1
11410618|NCT03020446|12606235|FG000|STARTED|Overall Study||3
11410619|NCT03020446|12606235|FG000|COMPLETED|Overall Study||0
11410620|NCT03020446|12606235|FG000|NOT COMPLETED|Overall Study||3
11410621|NCT03031340|12606241|FG000|STARTED|Overall Study||2
11410622|NCT03031340|12606242|FG001|STARTED|Overall Study||1
11410623|NCT03031340|12606241|FG000|COMPLETED|Overall Study||0
11410624|NCT03031340|12606242|FG001|COMPLETED|Overall Study||0
11410625|NCT03031340|12606241|FG000|NOT COMPLETED|Overall Study||2
11410626|NCT03031340|12606242|FG001|NOT COMPLETED|Overall Study||1
11410627|NCT03017040|12606248|FG000|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
11410628|NCT03017040|12606249|FG001|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
11410629|NCT03017040|12606248|FG000|COMPLETED|Overall Study||0
11410630|NCT03017040|12606249|FG001|COMPLETED|Overall Study||0
11410631|NCT03017040|12606248|FG000|NOT COMPLETED|Overall Study||1
11410632|NCT03017040|12606249|FG001|NOT COMPLETED|Overall Study||1
11410633|NCT03007719|12606257|FG000|STARTED|Overall Study||0
11410634|NCT03007719|12606258|FG001|STARTED|Overall Study||4
11410635|NCT03007719|12606257|FG000|COMPLETED|Overall Study||0
11410636|NCT03007719|12606258|FG001|COMPLETED|Overall Study||4
11410637|NCT03007719|12606257|FG000|NOT COMPLETED|Overall Study||0
11410638|NCT03007719|12606258|FG001|NOT COMPLETED|Overall Study||0
11410639|NCT03010423|12606264|FG000|STARTED|Overall Study||8
11410640|NCT03010423|12606264|FG000|COMPLETED|Overall Study||0
11410641|NCT03010423|12606264|FG000|NOT COMPLETED|Overall Study||8
11410642|NCT02985801|12606270|FG000|STARTED|Overall Study||8
11410643|NCT02985801|12606271|FG001|STARTED|Overall Study||8
11410644|NCT02985801|12606270|FG000|COMPLETED|Overall Study||8
11410645|NCT02985801|12606271|FG001|COMPLETED|Overall Study||8
11410646|NCT02985801|12606270|FG000|NOT COMPLETED|Overall Study||0
11410647|NCT02985801|12606271|FG001|NOT COMPLETED|Overall Study||0
11410648|NCT02991430|12606280|FG000|STARTED|Treatment Period 1||14
11410649|NCT02991430|12606281|FG001|STARTED|Treatment Period 1||15
11410650|NCT02991430|12606282|FG002|STARTED|Treatment Period 1||16
11410651|NCT02991430|12606280|FG000|COMPLETED|Treatment Period 1||13
11410652|NCT02991430|12606281|FG001|COMPLETED|Treatment Period 1||11
11410653|NCT02991430|12606282|FG002|COMPLETED|Treatment Period 1||14
11410654|NCT02991430|12606280|FG000|NOT COMPLETED|Treatment Period 1||1
11410655|NCT02991430|12606281|FG001|NOT COMPLETED|Treatment Period 1||4
11410656|NCT02991430|12606282|FG002|NOT COMPLETED|Treatment Period 1||2
11410657|NCT02991430|12606280|FG000|STARTED|Treatment Period 2||13
11410658|NCT02991430|12606281|FG001|STARTED|Treatment Period 2||11
11410659|NCT02991430|12606282|FG002|STARTED|Treatment Period 2||14
11410660|NCT02991430|12606280|FG000|COMPLETED|Treatment Period 2||7
11410661|NCT02991430|12606281|FG001|COMPLETED|Treatment Period 2||8
11410662|NCT02991430|12606282|FG002|COMPLETED|Treatment Period 2||10
11410663|NCT02991430|12606280|FG000|NOT COMPLETED|Treatment Period 2||6
11410664|NCT02991430|12606281|FG001|NOT COMPLETED|Treatment Period 2||3
11410665|NCT02991430|12606282|FG002|NOT COMPLETED|Treatment Period 2||4
11410666|NCT02991430|12606280|FG000|STARTED|Post-treatment Observation Period||7
11410667|NCT02991430|12606281|FG001|STARTED|Post-treatment Observation Period||8
11410668|NCT02991430|12606282|FG002|STARTED|Post-treatment Observation Period||10
11410669|NCT02991430|12606280|FG000|COMPLETED|Post-treatment Observation Period||4
11410670|NCT02991430|12606281|FG001|COMPLETED|Post-treatment Observation Period||2
11410671|NCT02991430|12606282|FG002|COMPLETED|Post-treatment Observation Period||5
11410672|NCT02991430|12606280|FG000|NOT COMPLETED|Post-treatment Observation Period||3
11410673|NCT02991430|12606281|FG001|NOT COMPLETED|Post-treatment Observation Period||6
11410674|NCT02991430|12606282|FG002|NOT COMPLETED|Post-treatment Observation Period||5
11410675|NCT02995967|12606292|FG000|STARTED|Overall Study||1
11410676|NCT02995967|12606293|FG001|STARTED|Overall Study||2
11410677|NCT02995967|12606292|FG000|COMPLETED|Overall Study||1
11410678|NCT02995967|12606293|FG001|COMPLETED|Overall Study||2
11410679|NCT02995967|12606292|FG000|NOT COMPLETED|Overall Study||0
11410680|NCT02995967|12606293|FG001|NOT COMPLETED|Overall Study||0
11410681|NCT02994251|12606300|FG000|STARTED|Overall Study||0
11410682|NCT02994251|12606300|FG000|COMPLETED|Overall Study||0
11410683|NCT02994251|12606300|FG000|NOT COMPLETED|Overall Study||0
11410684|NCT02978885|12606306|FG000|STARTED|Overall Study||0
11410685|NCT02978885|12606307|FG001|STARTED|Overall Study||1
11410686|NCT02978885|12606306|FG000|COMPLETED|Overall Study||0
11410687|NCT02978885|12606307|FG001|COMPLETED|Overall Study||1
11410688|NCT02978885|12606306|FG000|NOT COMPLETED|Overall Study||0
11410689|NCT02978885|12606307|FG001|NOT COMPLETED|Overall Study||0
11410690|NCT02978833|12606315|FG000|STARTED|Overall Study||1
11410691|NCT02978833|12606316|FG001|STARTED|Overall Study||1
11410692|NCT02978833|12606315|FG000|COMPLETED|Overall Study||0
11410693|NCT02978833|12606316|FG001|COMPLETED|Overall Study||0
11410694|NCT02978833|12606315|FG000|NOT COMPLETED|Overall Study||1
11410695|NCT02978833|12606316|FG001|NOT COMPLETED|Overall Study||1
11410696|NCT02971839|12606328|FG000|STARTED|Overall Study||2
11410697|NCT02971839|12606329|FG001|STARTED|Overall Study||2
11410698|NCT02971839|12606330|FG002|STARTED|Overall Study||2
11410699|NCT02971839|12606331|FG003|STARTED|Overall Study||2
11410700|NCT02971839|12606332|FG004|STARTED|Overall Study||3
11410701|NCT02971839|12606328|FG000|COMPLETED|Overall Study||2
11410702|NCT02971839|12606329|FG001|COMPLETED|Overall Study||2
11410703|NCT02971839|12606330|FG002|COMPLETED|Overall Study||2
11410704|NCT02971839|12606331|FG003|COMPLETED|Overall Study||2
11410705|NCT02971839|12606332|FG004|COMPLETED|Overall Study||3
11410706|NCT02971839|12606328|FG000|NOT COMPLETED|Overall Study||0
11410707|NCT02971839|12606329|FG001|NOT COMPLETED|Overall Study||0
11410708|NCT02971839|12606330|FG002|NOT COMPLETED|Overall Study||0
11410709|NCT02971839|12606331|FG003|NOT COMPLETED|Overall Study||0
11410710|NCT02971839|12606332|FG004|NOT COMPLETED|Overall Study||0
11410711|NCT02985840|12606346|FG000|STARTED|Overall Study||64
11410712|NCT02985840|12606347|FG001|STARTED|Overall Study||63
11410713|NCT02985840|12606346|FG000|COMPLETED|Overall Study||64
11410714|NCT02985840|12606347|FG001|COMPLETED|Overall Study||63
11410715|NCT02985840|12606346|FG000|NOT COMPLETED|Overall Study||0
11410716|NCT02985840|12606347|FG001|NOT COMPLETED|Overall Study||0
11410717|NCT02966223|12606353|FG000|STARTED|Overall Study||20
11410718|NCT02966223|12606353|FG000|COMPLETED|Overall Study||5
11410719|NCT02966223|12606353|FG000|NOT COMPLETED|Overall Study||15
11410720|NCT02965846|12606360|FG000|STARTED|Overall Study||5
11410721|NCT02965846|12606361|FG001|STARTED|Overall Study||5
11410722|NCT02965846|12606362|FG002|STARTED|Overall Study||33
11410723|NCT02965846|12606360|FG000|COMPLETED|Overall Study||0
11410724|NCT02965846|12606361|FG001|COMPLETED|Overall Study||0
11410725|NCT02965846|12606362|FG002|COMPLETED|Overall Study||0
11410726|NCT02965846|12606360|FG000|NOT COMPLETED|Overall Study||5
11410727|NCT02965846|12606361|FG001|NOT COMPLETED|Overall Study||5
11410728|NCT02965846|12606362|FG002|NOT COMPLETED|Overall Study||33
11410729|NCT02974803|12606368|FG000|STARTED|Overall Study||6
11410730|NCT02974803|12606368|FG000|COMPLETED|Overall Study||6
11410731|NCT02974803|12606368|FG000|NOT COMPLETED|Overall Study||0
11410732|NCT02974686|12606374|FG000|STARTED|Overall Study||0
11410733|NCT02974686|12606375|FG001|STARTED|Overall Study||0
11410734|NCT02974686|12606374|FG000|COMPLETED|Overall Study||0
11410735|NCT02974686|12606375|FG001|COMPLETED|Overall Study||0
11410736|NCT02974686|12606374|FG000|NOT COMPLETED|Overall Study||0
11410737|NCT02974686|12606375|FG001|NOT COMPLETED|Overall Study||0
11410738|NCT02956005|12606383|FG000|STARTED|Overall Study||18
11410739|NCT02956005|12606383|FG000|COMPLETED|Overall Study||2
11410740|NCT02956005|12606383|FG000|NOT COMPLETED|Overall Study||16
11410741|NCT02966184|12606389|FG000|STARTED|Overall Study||0
11410742|NCT02966184|12606390|FG001|STARTED|Overall Study||8
11410743|NCT02966184|12606389|FG000|COMPLETED|Overall Study||0
11410744|NCT02966184|12606390|FG001|COMPLETED|Overall Study||0
11410745|NCT02966184|12606389|FG000|NOT COMPLETED|Overall Study||0
11410746|NCT02966184|12606390|FG001|NOT COMPLETED|Overall Study||8
11410747|NCT02940223|12606398|FG000|STARTED|Overall Study||2
11410748|NCT02940223|12606399|FG001|STARTED|Overall Study||0
11410749|NCT02940223|12606398|FG000|COMPLETED|Overall Study||0
11410750|NCT02940223|12606399|FG001|COMPLETED|Overall Study||0
11410751|NCT02940223|12606398|FG000|NOT COMPLETED|Overall Study||2
11410752|NCT02940223|12606399|FG001|NOT COMPLETED|Overall Study||0
11410753|NCT02954159|12606407|FG000|STARTED|Overall Study||2
11410754|NCT02954159|12606408|FG001|STARTED|Overall Study||2
11410755|NCT02954159|12606407|FG000|COMPLETED|Overall Study||1
11410756|NCT02954159|12606408|FG001|COMPLETED|Overall Study||1
11410757|NCT02954159|12606407|FG000|NOT COMPLETED|Overall Study||1
11410758|NCT02954159|12606408|FG001|NOT COMPLETED|Overall Study||1
11410759|NCT02954952|12606417|FG000|STARTED|Overall Study||36
11410760|NCT02954952|12606418|FG001|STARTED|Overall Study||5
11410761|NCT02954952|12606419|FG002|STARTED|Overall Study||3
11410762|NCT02954952|12606417|FG000|COMPLETED|Overall Study||35
11410763|NCT02954952|12606418|FG001|COMPLETED|Overall Study||4
11410764|NCT02954952|12606419|FG002|COMPLETED|Overall Study||3
11410765|NCT02954952|12606417|FG000|NOT COMPLETED|Overall Study||1
11410766|NCT02954952|12606418|FG001|NOT COMPLETED|Overall Study||1
11410767|NCT02954952|12606419|FG002|NOT COMPLETED|Overall Study||0
11410768|NCT02950896|12606427|FG000|STARTED|Overall Study||4
11410769|NCT02950896|12606427|FG000|COMPLETED|Overall Study||4
11410770|NCT02950896|12606427|FG000|NOT COMPLETED|Overall Study||0
11410771|NCT02947022|12606431|FG000|STARTED|Overall Study||1
11410772|NCT02947022|12606431|FG000|COMPLETED|Overall Study||0
11410773|NCT02947022|12606431|FG000|NOT COMPLETED|Overall Study||1
11410774|NCT02936999|12606438|FG000|STARTED|Overall Study||8
11410775|NCT02936999|12606438|FG000|COMPLETED|Overall Study||8
11410776|NCT02936999|12606438|FG000|NOT COMPLETED|Overall Study||0
11410777|NCT02950480|12606446|FG000|STARTED|Overall Study||2
11410778|NCT02950480|12606447|FG001|STARTED|Overall Study||2
11410779|NCT02950480|12606446|FG000|COMPLETED|Overall Study||1
11410780|NCT02950480|12606447|FG001|COMPLETED|Overall Study||2
11410781|NCT02950480|12606446|FG000|NOT COMPLETED|Overall Study||1
11410782|NCT02950480|12606447|FG001|NOT COMPLETED|Overall Study||0
11410783|NCT02949947|12606455|FG000|STARTED|Overall Study||1
11410784|NCT02949947|12606456|FG001|STARTED|Overall Study||2
11410785|NCT02949947|12606455|FG000|COMPLETED|Overall Study||0
11410786|NCT02949947|12606456|FG001|COMPLETED|Overall Study||1
11410787|NCT02949947|12606455|FG000|NOT COMPLETED|Overall Study||1
11410788|NCT02949947|12606456|FG001|NOT COMPLETED|Overall Study||1
11410789|NCT02947100|12606462|FG000|STARTED|Overall Study||4
11410790|NCT02947100|12606462|FG000|COMPLETED|Overall Study||0
11410791|NCT02947100|12606462|FG000|NOT COMPLETED|Overall Study||4
11410792|NCT02936206|12606468|FG000|STARTED|Overall Study||0
11410793|NCT02936206|12606469|FG001|STARTED|Overall Study||2
11410794|NCT02936206|12606468|FG000|COMPLETED|Overall Study||0
11410795|NCT02936206|12606469|FG001|COMPLETED|Overall Study||2
11410796|NCT02936206|12606468|FG000|NOT COMPLETED|Overall Study||0
11410797|NCT02936206|12606469|FG001|NOT COMPLETED|Overall Study||0
11410798|NCT02934932|12606475|FG000|STARTED|Overall Study||9
11410799|NCT02934932|12606475|FG000|COMPLETED|Overall Study||6
11410800|NCT02934932|12606475|FG000|NOT COMPLETED|Overall Study||3
11410801|NCT02908516|12606483|FG000|STARTED|Overall Study||3
11410802|NCT02908516|12606484|FG001|STARTED|Overall Study||3
11410803|NCT02908516|12606483|FG000|COMPLETED|Overall Study||0
11410804|NCT02908516|12606484|FG001|COMPLETED|Overall Study||0
11410805|NCT02908516|12606483|FG000|NOT COMPLETED|Overall Study||3
11410806|NCT02908516|12606484|FG001|NOT COMPLETED|Overall Study||3
11410807|NCT02923830|12606492|FG000|STARTED|Overall Study||13
11410808|NCT02923830|12606493|FG001|STARTED|Overall Study||15
11410809|NCT02923830|12606492|FG000|COMPLETED|Overall Study|Study terminated|0
11410810|NCT02923830|12606493|FG001|COMPLETED|Overall Study|Study terminated|0
11410811|NCT02923830|12606492|FG000|NOT COMPLETED|Overall Study||13
11410812|NCT02923830|12606493|FG001|NOT COMPLETED|Overall Study||15
11410813|NCT02920450|12606499|FG000|STARTED|Overall Study||3
11410814|NCT02920450|12606500|FG001|STARTED|Overall Study||0
11410815|NCT02920450|12606501|FG002|STARTED|Overall Study||0
11410816|NCT02920450|12606502|FG003|STARTED|Overall Study||0
11410817|NCT02920450|12606499|FG000|COMPLETED|Overall Study||1
11410818|NCT02920450|12606500|FG001|COMPLETED|Overall Study||0
11410819|NCT02920450|12606501|FG002|COMPLETED|Overall Study||0
11410820|NCT02920450|12606502|FG003|COMPLETED|Overall Study||0
11410821|NCT02920450|12606499|FG000|NOT COMPLETED|Overall Study||2
11410822|NCT02920450|12606500|FG001|NOT COMPLETED|Overall Study||0
11410823|NCT02920450|12606501|FG002|NOT COMPLETED|Overall Study||0
11410824|NCT02920450|12606502|FG003|NOT COMPLETED|Overall Study||0
11410825|NCT02920177|12606511|FG000|STARTED|Overall Study||2
11410826|NCT02920177|12606512|FG001|STARTED|Overall Study||2
11410827|NCT02920177|12606511|FG000|COMPLETED|Overall Study||0
11410828|NCT02920177|12606512|FG001|COMPLETED|Overall Study||0
11410829|NCT02920177|12606511|FG000|NOT COMPLETED|Overall Study||2
11410830|NCT02920177|12606512|FG001|NOT COMPLETED|Overall Study||2
11410831|NCT02926638|12606520|FG000|STARTED|Overall Study||4
11410832|NCT02926638|12606521|FG001|STARTED|Overall Study||5
11410833|NCT02926638|12606520|FG000|Eligible|Overall Study||3
11410834|NCT02926638|12606521|FG001|Eligible|Overall Study||5
11410835|NCT02926638|12606520|FG000|COMPLETED|Overall Study||0
11410836|NCT02926638|12606521|FG001|COMPLETED|Overall Study||0
11410837|NCT02926638|12606520|FG000|NOT COMPLETED|Overall Study||4
11410838|NCT02926638|12606521|FG001|NOT COMPLETED|Overall Study||5
11410839|NCT02920242|12606530|FG000|STARTED|Overall Study||13
11410840|NCT02920242|12606531|FG001|STARTED|Overall Study||11
11410841|NCT02920242|12606532|FG002|STARTED|Overall Study||4
11410842|NCT02920242|12606530|FG000|Safety Set|Overall Study||12
11410843|NCT02920242|12606531|FG001|Safety Set|Overall Study||11
11410844|NCT02920242|12606532|FG002|Safety Set|Overall Study||4
11410845|NCT02920242|12606530|FG000|COMPLETED|Overall Study||11
11410846|NCT02920242|12606531|FG001|COMPLETED|Overall Study||11
11410847|NCT02920242|12606532|FG002|COMPLETED|Overall Study||3
11410848|NCT02920242|12606530|FG000|NOT COMPLETED|Overall Study||2
11410849|NCT02920242|12606531|FG001|NOT COMPLETED|Overall Study||0
11410850|NCT02920242|12606532|FG002|NOT COMPLETED|Overall Study||1
11410851|NCT02900781|12606542|FG000|STARTED|Overall Study||4
11410852|NCT02900781|12606543|FG001|STARTED|Overall Study||5
11410853|NCT02900781|12606542|FG000|COMPLETED|Overall Study||0
11410854|NCT02900781|12606543|FG001|COMPLETED|Overall Study||0
11410855|NCT02900781|12606542|FG000|NOT COMPLETED|Overall Study||4
11410856|NCT02900781|12606543|FG001|NOT COMPLETED|Overall Study||5
11410857|NCT02892500|12606551|FG000|STARTED|Overall Study||0
11410858|NCT02892500|12606552|FG001|STARTED|Overall Study||0
11410859|NCT02892500|12606551|FG000|COMPLETED|Overall Study||0
11410860|NCT02892500|12606552|FG001|COMPLETED|Overall Study||0
11410861|NCT02892500|12606551|FG000|NOT COMPLETED|Overall Study||0
11410862|NCT02892500|12606552|FG001|NOT COMPLETED|Overall Study||0
11410863|NCT02904356|12606558|FG000|STARTED|Overall Study||2
11410864|NCT02904356|12606558|FG000|COMPLETED|Overall Study||2
11410865|NCT02904356|12606558|FG000|NOT COMPLETED|Overall Study||0
11410866|NCT02899728|12606564|FG000|STARTED|Overall Study|0|5
11410867|NCT02899728|12606565|FG001|STARTED|Overall Study||3
11410868|NCT02899728|12606564|FG000|COMPLETED|Overall Study||4
11410869|NCT02899728|12606565|FG001|COMPLETED|Overall Study||2
11410870|NCT02899728|12606564|FG000|NOT COMPLETED|Overall Study||1
11410871|NCT02899728|12606565|FG001|NOT COMPLETED|Overall Study||1
11410872|NCT02875067|12606571|FG000|STARTED|Overall Study||6
11410873|NCT02875067|12606571|FG000|COMPLETED|Overall Study||0
11410874|NCT02875067|12606571|FG000|NOT COMPLETED|Overall Study||6
11410875|NCT02877732|12606577|FG000|STARTED|Overall Study||6
11410876|NCT02877732|12606578|FG001|STARTED|Overall Study||6
11410877|NCT02877732|12606577|FG000|COMPLETED|Overall Study||0
11410878|NCT02877732|12606578|FG001|COMPLETED|Overall Study||0
11410879|NCT02877732|12606577|FG000|NOT COMPLETED|Overall Study||6
11410880|NCT02877732|12606578|FG001|NOT COMPLETED|Overall Study||6
11410881|NCT02860169|12606586|FG000|STARTED|Part A||46
11410882|NCT02860169|12606586|FG000|Healthy Participants|Part A||46
11410883|NCT02860169|12606586|FG000|Participants With Cold and Flu|Part A||0
11410884|NCT02860169|12606586|FG000|COMPLETED|Part A||35
11410885|NCT02860169|12606586|FG000|NOT COMPLETED|Part A||11
11410886|NCT02860169|12606586|FG000|STARTED|Part B||20
11410887|NCT02860169|12606586|FG000|Healthy Participants|Part B||10
11410888|NCT02860169|12606586|FG000|Participants With Cold and Flu|Part B||10
11410889|NCT02860169|12606586|FG000|COMPLETED|Part B||9
11410890|NCT02860169|12606586|FG000|NOT COMPLETED|Part B||11
11410891|NCT02860169|12606586|FG000|STARTED|Part C||48
11410892|NCT02860169|12606586|FG000|Healthy Participants|Part C||6
11410893|NCT02860169|12606586|FG000|Participants With Cold and Flu|Part C||42
11410894|NCT02860169|12606586|FG000|COMPLETED|Part C||47
11410895|NCT02860169|12606586|FG000|NOT COMPLETED|Part C||1
11410896|NCT02865395|12606595|FG000|STARTED|Overall Study||6
11410897|NCT02865395|12606596|FG001|STARTED|Overall Study||10
11410898|NCT02865395|12606597|FG002|STARTED|Overall Study||7
11410899|NCT02865395|12606595|FG000|COMPLETED|Overall Study|Data Not Collected|0
11410900|NCT02865395|12606596|FG001|COMPLETED|Overall Study|Data Not Collected|0
11410901|NCT02865395|12606597|FG002|COMPLETED|Overall Study|Data Not Collected|0
11410902|NCT02865395|12606595|FG000|NOT COMPLETED|Overall Study||6
11410903|NCT02865395|12606596|FG001|NOT COMPLETED|Overall Study||10
11410904|NCT02865395|12606597|FG002|NOT COMPLETED|Overall Study||7
11410905|NCT02868892|12606605|FG000|STARTED|Overall Study||6
11410906|NCT02868892|12606605|FG000|COMPLETED|Overall Study||0
11410907|NCT02868892|12606605|FG000|NOT COMPLETED|Overall Study||6
11410908|NCT02865083|12606611|FG000|STARTED|Overall Study||3
11410909|NCT02865083|12606612|FG001|STARTED|Overall Study||1
11410910|NCT02865083|12606611|FG000|COMPLETED|Overall Study||0
11410911|NCT02865083|12606612|FG001|COMPLETED|Overall Study||0
11410912|NCT02865083|12606611|FG000|NOT COMPLETED|Overall Study||3
11410913|NCT02865083|12606612|FG001|NOT COMPLETED|Overall Study||1
11410914|NCT02865122|12606621|FG000|STARTED|Overall Study||1
11410915|NCT02865122|12606622|FG001|STARTED|Overall Study||1
11410916|NCT02865122|12606623|FG002|STARTED|Overall Study||0
11410917|NCT02865122|12606621|FG000|COMPLETED|Overall Study||0
11410918|NCT02865122|12606622|FG001|COMPLETED|Overall Study||1
11410919|NCT02865122|12606623|FG002|COMPLETED|Overall Study||0
11410920|NCT02865122|12606621|FG000|NOT COMPLETED|Overall Study||1
11410921|NCT02865122|12606622|FG001|NOT COMPLETED|Overall Study||0
11410922|NCT02865122|12606623|FG002|NOT COMPLETED|Overall Study||0
11410923|NCT02865915|12606633|FG000|STARTED|Overall Study||25
11410924|NCT02865915|12606634|FG001|STARTED|Overall Study||30
11410925|NCT02865915|12606633|FG000|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
11410926|NCT02865915|12606634|FG001|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
11410927|NCT02865915|12606633|FG000|NOT COMPLETED|Overall Study||25
11410928|NCT02865915|12606634|FG001|NOT COMPLETED|Overall Study||30
11410929|NCT02855411|12606640|FG000|STARTED|Overall Study||35
11410930|NCT02855411|12606640|FG000|Assigned to Study Treatment|Overall Study||0
11410931|NCT02855411|12606640|FG000|COMPLETED|Overall Study||0
11410932|NCT02855411|12606640|FG000|NOT COMPLETED|Overall Study||35
11410933|NCT02828124|12606648|FG000|STARTED|Overall Study||1
11410934|NCT02828124|12606649|FG001|STARTED|Overall Study||2
11410935|NCT02828124|12606650|FG002|STARTED|Overall Study||1
11410936|NCT02828124|12606651|FG003|STARTED|Overall Study||6
11410937|NCT02828124|12606648|FG000|COMPLETED|Overall Study||0
11410938|NCT02828124|12606649|FG001|COMPLETED|Overall Study||0
11410939|NCT02828124|12606650|FG002|COMPLETED|Overall Study||0
11410940|NCT02828124|12606651|FG003|COMPLETED|Overall Study||0
11410941|NCT02828124|12606648|FG000|NOT COMPLETED|Overall Study||1
11410942|NCT02828124|12606649|FG001|NOT COMPLETED|Overall Study||2
11410943|NCT02828124|12606650|FG002|NOT COMPLETED|Overall Study||1
11410944|NCT02828124|12606651|FG003|NOT COMPLETED|Overall Study||6
11410945|NCT02826551|12606663|FG000|STARTED|Overall Study||11
11410946|NCT02826551|12606664|FG001|STARTED|Overall Study||12
11410947|NCT02826551|12606663|FG000|COMPLETED|Overall Study||11
11410948|NCT02826551|12606664|FG001|COMPLETED|Overall Study||12
11410949|NCT02826551|12606663|FG000|NOT COMPLETED|Overall Study||0
11410950|NCT02826551|12606664|FG001|NOT COMPLETED|Overall Study||0
11410951|NCT02825043|12606670|FG000|STARTED|Overall Study||6
11410952|NCT02825043|12606670|FG000|COMPLETED|Overall Study||2
11410953|NCT02825043|12606670|FG000|NOT COMPLETED|Overall Study||4
11410954|NCT02819804|12606674|FG000|STARTED|Complete Cycle 1 (28 Days)||1
11410955|NCT02819804|12606674|FG000|COMPLETED|Complete Cycle 1 (28 Days)||0
11410956|NCT02819804|12606674|FG000|NOT COMPLETED|Complete Cycle 1 (28 Days)||1
11410957|NCT02819804|12606674|FG000|STARTED|Start Cycle 2 and Beyond||0
11410958|NCT02819804|12606674|FG000|COMPLETED|Start Cycle 2 and Beyond||0
11410959|NCT02819804|12606674|FG000|NOT COMPLETED|Start Cycle 2 and Beyond||0
11410960|NCT02819804|12606674|FG000|STARTED|Follow-up for 1 Year||1
11410961|NCT02819804|12606674|FG000|COMPLETED|Follow-up for 1 Year||1
11410962|NCT02819804|12606674|FG000|NOT COMPLETED|Follow-up for 1 Year||0
11410963|NCT02809118|12606681|FG000|STARTED|Overall Study||18
11410964|NCT02809118|12606682|FG001|STARTED|Overall Study||19
11410965|NCT02809118|12606683|FG002|STARTED|Overall Study||19
11410966|NCT02809118|12606681|FG000|COMPLETED|Overall Study||18
11410967|NCT02809118|12606682|FG001|COMPLETED|Overall Study||18
11410968|NCT02809118|12606683|FG002|COMPLETED|Overall Study||18
11410969|NCT02809118|12606681|FG000|NOT COMPLETED|Overall Study||0
11410970|NCT02809118|12606682|FG001|NOT COMPLETED|Overall Study||1
11410971|NCT02809118|12606683|FG002|NOT COMPLETED|Overall Study||1
11410972|NCT02818946|12606691|FG000|STARTED|Overall Study||30
11410973|NCT02818946|12606691|FG000|COMPLETED|Overall Study||30
11410974|NCT02818946|12606691|FG000|NOT COMPLETED|Overall Study||0
11410975|NCT02819908|12606697|FG000|STARTED|Overall Study||12
11410976|NCT02819908|12606698|FG001|STARTED|Overall Study||13
11410977|NCT02819908|12606697|FG000|COMPLETED|Overall Study||12
11410978|NCT02819908|12606698|FG001|COMPLETED|Overall Study||13
11410979|NCT02819908|12606697|FG000|NOT COMPLETED|Overall Study||0
11410980|NCT02819908|12606698|FG001|NOT COMPLETED|Overall Study||0
11410981|NCT02808390|12606709|FG000|STARTED|Overall Study||4
11410982|NCT02808390|12606710|FG001|STARTED|Overall Study||8
11410983|NCT02808390|12606711|FG002|STARTED|Overall Study||7
11410984|NCT02808390|12606709|FG000|COMPLETED|Overall Study||2
11410985|NCT02808390|12606710|FG001|COMPLETED|Overall Study||2
11410986|NCT02808390|12606711|FG002|COMPLETED|Overall Study||4
11410987|NCT02808390|12606709|FG000|NOT COMPLETED|Overall Study||2
11410988|NCT02808390|12606710|FG001|NOT COMPLETED|Overall Study||6
11410989|NCT02808390|12606711|FG002|NOT COMPLETED|Overall Study||3
11410990|NCT02806960|12606719|FG000|STARTED|Period 1||3
11410991|NCT02806960|12606720|FG001|STARTED|Period 1||3
11410992|NCT02806960|12606721|FG002|STARTED|Period 1||3
11410993|NCT02806960|12606722|FG003|STARTED|Period 1||3
11410994|NCT02806960|12606719|FG000|COMPLETED|Period 1||0
11410995|NCT02806960|12606720|FG001|COMPLETED|Period 1||0
11410996|NCT02806960|12606721|FG002|COMPLETED|Period 1||0
11410997|NCT02806960|12606722|FG003|COMPLETED|Period 1||0
11410998|NCT02806960|12606719|FG000|NOT COMPLETED|Period 1||3
11410999|NCT02806960|12606720|FG001|NOT COMPLETED|Period 1||3
11411000|NCT02806960|12606721|FG002|NOT COMPLETED|Period 1||3
11411001|NCT02806960|12606722|FG003|NOT COMPLETED|Period 1||3
11411002|NCT02806960|12606719|FG000|STARTED|Period 2||0
11411003|NCT02806960|12606720|FG001|STARTED|Period 2||0
11411004|NCT02806960|12606721|FG002|STARTED|Period 2||0
11411005|NCT02806960|12606722|FG003|STARTED|Period 2||0
11411006|NCT02806960|12606719|FG000|COMPLETED|Period 2||0
11411007|NCT02806960|12606720|FG001|COMPLETED|Period 2||0
11411008|NCT02806960|12606721|FG002|COMPLETED|Period 2||0
11411009|NCT02806960|12606722|FG003|COMPLETED|Period 2||0
11411010|NCT02806960|12606719|FG000|NOT COMPLETED|Period 2||0
11411011|NCT02806960|12606720|FG001|NOT COMPLETED|Period 2||0
11411012|NCT02806960|12606721|FG002|NOT COMPLETED|Period 2||0
11411013|NCT02806960|12606722|FG003|NOT COMPLETED|Period 2||0
11411014|NCT02806960|12606719|FG000|STARTED|Period 3||0
11411015|NCT02806960|12606720|FG001|STARTED|Period 3||0
11411016|NCT02806960|12606721|FG002|STARTED|Period 3||0
11411017|NCT02806960|12606722|FG003|STARTED|Period 3||0
11411018|NCT02806960|12606719|FG000|COMPLETED|Period 3||0
11411019|NCT02806960|12606720|FG001|COMPLETED|Period 3||0
11411020|NCT02806960|12606721|FG002|COMPLETED|Period 3||0
11411021|NCT02806960|12606722|FG003|COMPLETED|Period 3||0
11411022|NCT02806960|12606719|FG000|NOT COMPLETED|Period 3||0
11411023|NCT02806960|12606720|FG001|NOT COMPLETED|Period 3||0
11411024|NCT02806960|12606721|FG002|NOT COMPLETED|Period 3||0
11411025|NCT02806960|12606722|FG003|NOT COMPLETED|Period 3||0
11411026|NCT02806960|12606719|FG000|STARTED|Period 4||0
11411027|NCT02806960|12606720|FG001|STARTED|Period 4||0
11411028|NCT02806960|12606721|FG002|STARTED|Period 4||0
11411029|NCT02806960|12606722|FG003|STARTED|Period 4||0
11411030|NCT02806960|12606719|FG000|COMPLETED|Period 4||0
11411031|NCT02806960|12606720|FG001|COMPLETED|Period 4||0
11411032|NCT02806960|12606721|FG002|COMPLETED|Period 4||0
11411033|NCT02806960|12606722|FG003|COMPLETED|Period 4||0
11411034|NCT02806960|12606719|FG000|NOT COMPLETED|Period 4||0
11411035|NCT02806960|12606720|FG001|NOT COMPLETED|Period 4||0
11411036|NCT02806960|12606721|FG002|NOT COMPLETED|Period 4||0
11411037|NCT02806960|12606722|FG003|NOT COMPLETED|Period 4||0
11411038|NCT02815397|12606732|FG000|STARTED|Overall Study||2
11411039|NCT02815397|12606732|FG000|COMPLETED|Overall Study||0
11411040|NCT02815397|12606732|FG000|NOT COMPLETED|Overall Study||2
11411041|NCT02802592|12606736|FG000|STARTED|Overall Study||4
11411042|NCT02802592|12606736|FG000|COMPLETED|Overall Study||0
11411043|NCT02802592|12606736|FG000|NOT COMPLETED|Overall Study||4
11411044|NCT02774148|12606743|FG000|STARTED|Overall Study||0
11411045|NCT02774148|12606744|FG001|STARTED|Overall Study||0
11411046|NCT02774148|12606743|FG000|COMPLETED|Overall Study||0
11411047|NCT02774148|12606744|FG001|COMPLETED|Overall Study||0
11411048|NCT02774148|12606743|FG000|NOT COMPLETED|Overall Study||0
11411049|NCT02774148|12606744|FG001|NOT COMPLETED|Overall Study||0
11411050|NCT02773576|12606752|FG000|STARTED|Overall Study||0
11411051|NCT02773576|12606753|FG001|STARTED|Overall Study||0
11411052|NCT02773576|12606752|FG000|COMPLETED|Overall Study||0
11411053|NCT02773576|12606753|FG001|COMPLETED|Overall Study||0
11411054|NCT02773576|12606752|FG000|NOT COMPLETED|Overall Study||0
11411055|NCT02773576|12606753|FG001|NOT COMPLETED|Overall Study||0
11411056|NCT02730793|12606761|FG000|STARTED|Overall Study||2
11411057|NCT02730793|12606762|FG001|STARTED|Overall Study||3
11411058|NCT02730793|12606761|FG000|COMPLETED|Overall Study||2
11411059|NCT02730793|12606762|FG001|COMPLETED|Overall Study||1
11411060|NCT02730793|12606761|FG000|NOT COMPLETED|Overall Study||0
11411061|NCT02730793|12606762|FG001|NOT COMPLETED|Overall Study||2
11411062|NCT02744352|12606770|FG000|STARTED|Overall Study||4
11411063|NCT02744352|12606771|FG001|STARTED|Overall Study||4
11411064|NCT02744352|12606770|FG000|COMPLETED|Overall Study||4
11411065|NCT02744352|12606771|FG001|COMPLETED|Overall Study||4
11022464|NCT00809159|12200733|FG000|NOT COMPLETED|Part 1||8
11022465|NCT00809159|12200734|FG001|NOT COMPLETED|Part 1||3
11022466|NCT00809159|12200735|FG002|NOT COMPLETED|Part 1||0
11022467|NCT00809159|12200736|FG003|NOT COMPLETED|Part 1||0
11022468|NCT00809159|12200737|FG004|NOT COMPLETED|Part 1||0
11022469|NCT00809159|12200738|FG005|NOT COMPLETED|Part 1||0
11411066|NCT02744352|12606770|FG000|NOT COMPLETED|Overall Study||0
11411067|NCT02744352|12606771|FG001|NOT COMPLETED|Overall Study||0
11411068|NCT02760602|12606779|FG000|STARTED|Overall Study||13
11411069|NCT02760602|12606780|FG001|STARTED|Overall Study||13
11411070|NCT02760602|12606779|FG000|COMPLETED|Overall Study||0
11411071|NCT02760602|12606780|FG001|COMPLETED|Overall Study||0
11411072|NCT02760602|12606779|FG000|NOT COMPLETED|Overall Study||13
11411073|NCT02760602|12606780|FG001|NOT COMPLETED|Overall Study||13
11411074|NCT02757521|12606788|FG000|STARTED|Overall Study||1
11411075|NCT02757521|12606789|FG001|STARTED|Overall Study||0
11411076|NCT02757521|12606788|FG000|COMPLETED|Overall Study||0
11411077|NCT02757521|12606789|FG001|COMPLETED|Overall Study||0
11411078|NCT02757521|12606788|FG000|NOT COMPLETED|Overall Study||1
11411079|NCT02757521|12606789|FG001|NOT COMPLETED|Overall Study||0
11411080|NCT02758132|12606797|FG000|STARTED|Overall Study||0
11411081|NCT02758132|12606798|FG001|STARTED|Overall Study||1
11411082|NCT02758132|12606797|FG000|COMPLETED|Overall Study||0
11411083|NCT02758132|12606798|FG001|COMPLETED|Overall Study||0
11411084|NCT02758132|12606797|FG000|NOT COMPLETED|Overall Study||0
11411085|NCT02758132|12606798|FG001|NOT COMPLETED|Overall Study||1
11411086|NCT02757547|12606804|FG000|STARTED|Overall Study||2
11411087|NCT02757547|12606804|FG000|COMPLETED|Overall Study||2
11411088|NCT02757547|12606804|FG000|NOT COMPLETED|Overall Study||0
11411089|NCT02757053|12606811|FG000|STARTED|Overall Study||3
11411090|NCT02757053|12606812|FG001|STARTED|Overall Study||5
11411091|NCT02757053|12606811|FG000|COMPLETED|Overall Study||0
11411092|NCT02757053|12606812|FG001|COMPLETED|Overall Study||0
11411093|NCT02757053|12606811|FG000|NOT COMPLETED|Overall Study||3
11411094|NCT02757053|12606812|FG001|NOT COMPLETED|Overall Study||5
11411095|NCT02734940|12606820|FG000|STARTED|Overall Study||0
11411096|NCT02734940|12606821|FG001|STARTED|Overall Study||0
11411097|NCT02734940|12606820|FG000|COMPLETED|Overall Study||0
11411098|NCT02734940|12606821|FG001|COMPLETED|Overall Study||0
11411099|NCT02734940|12606820|FG000|NOT COMPLETED|Overall Study||0
11411100|NCT02734940|12606821|FG001|NOT COMPLETED|Overall Study||0
11411101|NCT02749617|12606827|FG000|STARTED|Overall Study||2
11411102|NCT02749617|12606827|FG000|COMPLETED|Overall Study||2
11411103|NCT02749617|12606827|FG000|NOT COMPLETED|Overall Study||0
11411104|NCT02749227|12606831|FG000|STARTED|Overall Study||4
11411105|NCT02749227|12606831|FG000|COMPLETED|Overall Study||4
11411106|NCT02749227|12606831|FG000|NOT COMPLETED|Overall Study||0
11411107|NCT02745210|12606837|FG000|STARTED|Overall Study||0
11411108|NCT02745210|12606838|FG001|STARTED|Overall Study||9
11411109|NCT02745210|12606837|FG000|COMPLETED|Overall Study||0
11411110|NCT02745210|12606838|FG001|COMPLETED|Overall Study||9
11411111|NCT02745210|12606837|FG000|NOT COMPLETED|Overall Study||0
11411112|NCT02745210|12606838|FG001|NOT COMPLETED|Overall Study||0
11411113|NCT02725671|12606842|FG000|STARTED|Overall Study||2
11411114|NCT02725671|12606842|FG000|COMPLETED|Overall Study||1
11411115|NCT02725671|12606842|FG000|NOT COMPLETED|Overall Study||1
11411116|NCT02746263|12606850|FG000|STARTED|Overall Study||0
11411117|NCT02746263|12606851|FG001|STARTED|Overall Study||1
11411118|NCT02746263|12606850|FG000|Per Protocol Analysis Set|Overall Study||0
11411119|NCT02746263|12606851|FG001|Per Protocol Analysis Set|Overall Study||0
11411120|NCT02746263|12606850|FG000|COMPLETED|Overall Study||0
11411121|NCT02746263|12606851|FG001|COMPLETED|Overall Study||1
11411122|NCT02746263|12606850|FG000|NOT COMPLETED|Overall Study||0
11411123|NCT02746263|12606851|FG001|NOT COMPLETED|Overall Study||0
11411124|NCT02721277|12606857|FG000|STARTED|Overall Study||2
11411125|NCT02721277|12606857|FG000|COMPLETED|Overall Study||2
11411126|NCT02721277|12606857|FG000|NOT COMPLETED|Overall Study||0
11411127|NCT02732327|12606863|FG000|STARTED|Overall Study||0
11411128|NCT02732327|12606864|FG001|STARTED|Overall Study||2
11411129|NCT02732327|12606863|FG000|COMPLETED|Overall Study||0
11411130|NCT02732327|12606864|FG001|COMPLETED|Overall Study||1
11411131|NCT02732327|12606863|FG000|NOT COMPLETED|Overall Study||0
11411132|NCT02732327|12606864|FG001|NOT COMPLETED|Overall Study||1
11411133|NCT02726399|12606870|FG000|STARTED|Overall Study||7
11411134|NCT02726399|12606870|FG000|COMPLETED|Overall Study||0
11411135|NCT02726399|12606870|FG000|NOT COMPLETED|Overall Study||7
11411136|NCT02720510|12606876|FG000|STARTED|Overall Study||3
11411137|NCT02720510|12606877|FG001|STARTED|Overall Study||3
11411138|NCT02720510|12606876|FG000|COMPLETED|Overall Study||0
11411139|NCT02720510|12606877|FG001|COMPLETED|Overall Study||0
11411140|NCT02720510|12606876|FG000|NOT COMPLETED|Overall Study||3
11411141|NCT02720510|12606877|FG001|NOT COMPLETED|Overall Study||3
11411142|NCT02715765|12606886|FG000|STARTED|Overall Study||3
11411143|NCT02715765|12606887|FG001|STARTED|Overall Study||0
11411144|NCT02715765|12606888|FG002|STARTED|Overall Study||0
11411145|NCT02715765|12606886|FG000|COMPLETED|Overall Study||0
11411146|NCT02715765|12606887|FG001|COMPLETED|Overall Study||0
11411147|NCT02715765|12606888|FG002|COMPLETED|Overall Study||0
11411148|NCT02715765|12606886|FG000|NOT COMPLETED|Overall Study||3
11411149|NCT02715765|12606887|FG001|NOT COMPLETED|Overall Study||0
11411150|NCT02715765|12606888|FG002|NOT COMPLETED|Overall Study||0
11411151|NCT02717949|12606898|FG000|STARTED|Overall Study||0
11411152|NCT02717949|12606899|FG001|STARTED|Overall Study||0
11411153|NCT02717949|12606898|FG000|COMPLETED|Overall Study||0
11411154|NCT02717949|12606899|FG001|COMPLETED|Overall Study||0
11411155|NCT02717949|12606898|FG000|NOT COMPLETED|Overall Study||0
11411156|NCT02717949|12606899|FG001|NOT COMPLETED|Overall Study||0
11411157|NCT02717130|12606907|FG000|STARTED|Overall Study|Of the nine enrolled subjects, eight received study drug.|8
11411158|NCT02717130|12606907|FG000|COMPLETED|Overall Study||1
11411159|NCT02717130|12606907|FG000|NOT COMPLETED|Overall Study||7
11411160|NCT02685202|12606911|FG000|STARTED|Overall Study||9
11411161|NCT02685202|12606911|FG000|COMPLETED|Overall Study||0
11411162|NCT02685202|12606911|FG000|NOT COMPLETED|Overall Study||9
11411163|NCT02709083|12606915|FG000|STARTED|Overall Study||7
11411164|NCT02709083|12606915|FG000|COMPLETED|Overall Study||0
11411165|NCT02709083|12606915|FG000|NOT COMPLETED|Overall Study||7
11411166|NCT02693171|12606919|FG000|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12
11411167|NCT02693171|12606919|FG000|COMPLETED|Overall Study||3
11411168|NCT02693171|12606919|FG000|NOT COMPLETED|Overall Study||9
11411169|NCT02696226|12606927|FG000|STARTED|Overall Study||1
11411170|NCT02696226|12606928|FG001|STARTED|Overall Study||0
11411171|NCT02696226|12606929|FG002|STARTED|Overall Study||2
11411172|NCT02696226|12606930|FG003|STARTED|Overall Study||0
11411173|NCT02696226|12606927|FG000|COMPLETED|Overall Study||0
11411174|NCT02696226|12606928|FG001|COMPLETED|Overall Study||0
11411175|NCT02696226|12606929|FG002|COMPLETED|Overall Study||0
11411176|NCT02696226|12606930|FG003|COMPLETED|Overall Study||0
11411177|NCT02696226|12606927|FG000|NOT COMPLETED|Overall Study||1
11411178|NCT02696226|12606928|FG001|NOT COMPLETED|Overall Study||0
11411179|NCT02696226|12606929|FG002|NOT COMPLETED|Overall Study||2
11411180|NCT02696226|12606930|FG003|NOT COMPLETED|Overall Study||0
11411181|NCT02693743|12606942|FG000|STARTED|Overall Study||1
11411182|NCT02693743|12606943|FG001|STARTED|Overall Study||0
11411183|NCT02693743|12606942|FG000|COMPLETED|Overall Study||0
11411184|NCT02693743|12606943|FG001|COMPLETED|Overall Study||0
11411185|NCT02693743|12606942|FG000|NOT COMPLETED|Overall Study||1
11411186|NCT02693743|12606943|FG001|NOT COMPLETED|Overall Study||0
11411187|NCT02706691|12606949|FG000|STARTED|Overall Study||1
11411188|NCT02706691|12606949|FG000|COMPLETED|Overall Study||0
11411189|NCT02706691|12606949|FG000|NOT COMPLETED|Overall Study||1
11411190|NCT02708849|12606956|FG000|STARTED|Overall Study||2
11411191|NCT02708849|12606957|FG001|STARTED|Overall Study||1
11411192|NCT02708849|12606956|FG000|COMPLETED|Overall Study||1
11411193|NCT02708849|12606957|FG001|COMPLETED|Overall Study||1
11411194|NCT02708849|12606956|FG000|NOT COMPLETED|Overall Study||1
11411195|NCT02708849|12606957|FG001|NOT COMPLETED|Overall Study||0
11411196|NCT02693717|12606963|FG000|STARTED|Overall Study||7
11411197|NCT02693717|12606963|FG000|COMPLETED|Overall Study||7
11411198|NCT02693717|12606963|FG000|NOT COMPLETED|Overall Study||0
11411199|NCT02694757|12606967|FG000|STARTED|Overall Study||3
11411200|NCT02694757|12606967|FG000|COMPLETED|Overall Study||0
11411201|NCT02694757|12606967|FG000|NOT COMPLETED|Overall Study||3
11411202|NCT02693002|12606973|FG000|STARTED|Overall Study||2
11411203|NCT02693002|12606974|FG001|STARTED|Overall Study||2
11411204|NCT02693002|12606973|FG000|COMPLETED|Overall Study||1
11411205|NCT02693002|12606974|FG001|COMPLETED|Overall Study||2
11411206|NCT02693002|12606973|FG000|NOT COMPLETED|Overall Study||1
11411207|NCT02693002|12606974|FG001|NOT COMPLETED|Overall Study||0
11411208|NCT02689518|12606980|FG000|STARTED|Overall Study||49
11411209|NCT02689518|12606980|FG000|COMPLETED|Overall Study||46
11411210|NCT02689518|12606980|FG000|NOT COMPLETED|Overall Study||3
11411211|NCT02687165|12606984|FG000|STARTED|Overall Study||0
11411212|NCT02687165|12606985|FG001|STARTED|Overall Study||0
11411213|NCT02687165|12606984|FG000|COMPLETED|Overall Study||0
11411214|NCT02687165|12606985|FG001|COMPLETED|Overall Study||0
11411215|NCT02687165|12606984|FG000|NOT COMPLETED|Overall Study||0
11411216|NCT02687165|12606985|FG001|NOT COMPLETED|Overall Study||0
11411217|NCT02679560|12606993|FG000|STARTED|Overall Study||1
11411218|NCT02679560|12606994|FG001|STARTED|Overall Study||2
11411219|NCT02679560|12606993|FG000|COMPLETED|Overall Study||1
11411220|NCT02679560|12606994|FG001|COMPLETED|Overall Study||2
11411221|NCT02679560|12606993|FG000|NOT COMPLETED|Overall Study||0
11411222|NCT02679560|12606994|FG001|NOT COMPLETED|Overall Study||0
11411223|NCT02679066|12607002|FG000|STARTED|Overall Study||100
11411224|NCT02679066|12607003|FG001|STARTED|Overall Study||100
11411225|NCT02679066|12607002|FG000|COMPLETED|Overall Study||100
11411226|NCT02679066|12607003|FG001|COMPLETED|Overall Study||100
11411227|NCT02679066|12607002|FG000|NOT COMPLETED|Overall Study||0
11411228|NCT02679066|12607003|FG001|NOT COMPLETED|Overall Study||0
11411229|NCT02673684|12607011|FG000|STARTED|Overall Study||9
11411230|NCT02673684|12607012|FG001|STARTED|Overall Study||8
11411231|NCT02673684|12607011|FG000|COMPLETED|Overall Study||0
11411232|NCT02673684|12607012|FG001|COMPLETED|Overall Study||0
11411233|NCT02673684|12607011|FG000|NOT COMPLETED|Overall Study||9
11411234|NCT02673684|12607012|FG001|NOT COMPLETED|Overall Study||8
11411235|NCT02674204|12607022|FG000|STARTED|Overall Study||1
11411236|NCT02674204|12607023|FG001|STARTED|Overall Study||1
11411237|NCT02674204|12607022|FG000|COMPLETED|Overall Study||0
11411238|NCT02674204|12607023|FG001|COMPLETED|Overall Study||1
11411239|NCT02674204|12607022|FG000|NOT COMPLETED|Overall Study||1
11411240|NCT02674204|12607023|FG001|NOT COMPLETED|Overall Study||0
11411241|NCT02665221|12607031|FG000|STARTED|Overall Study||15
11411242|NCT02665221|12607032|FG001|STARTED|Overall Study||15
11411243|NCT02665221|12607031|FG000|COMPLETED|Overall Study||0
11411244|NCT02665221|12607032|FG001|COMPLETED|Overall Study||0
11411245|NCT02665221|12607031|FG000|NOT COMPLETED|Overall Study||15
11411246|NCT02665221|12607032|FG001|NOT COMPLETED|Overall Study||15
11411247|NCT02672033|12607038|FG000|STARTED|Overall Study||2
11411248|NCT02672033|12607038|FG000|COMPLETED|Overall Study||2
11411249|NCT02672033|12607038|FG000|NOT COMPLETED|Overall Study||0
11411250|NCT02671461|12607045|FG000|STARTED|Treatment||3
11411251|NCT02671461|12607046|FG001|STARTED|Treatment||5
11411252|NCT02671461|12607047|FG002|STARTED|Treatment||7
11411253|NCT02671461|12607045|FG000|COMPLETED|Treatment||1
11411254|NCT02671461|12607046|FG001|COMPLETED|Treatment||2
11411255|NCT02671461|12607047|FG002|COMPLETED|Treatment||2
11411256|NCT02671461|12607045|FG000|NOT COMPLETED|Treatment||2
11411257|NCT02671461|12607046|FG001|NOT COMPLETED|Treatment||3
11411258|NCT02671461|12607047|FG002|NOT COMPLETED|Treatment||5
11411259|NCT02671461|12607045|FG000|STARTED|Follow-up||2
11411260|NCT02671461|12607046|FG001|STARTED|Follow-up||5
11411261|NCT02671461|12607047|FG002|STARTED|Follow-up||7
11411262|NCT02671461|12607045|FG000|COMPLETED|Follow-up||1
11411263|NCT02671461|12607046|FG001|COMPLETED|Follow-up||4
11411264|NCT02671461|12607047|FG002|COMPLETED|Follow-up||6
11411265|NCT02671461|12607045|FG000|NOT COMPLETED|Follow-up||1
11411266|NCT02671461|12607046|FG001|NOT COMPLETED|Follow-up||1
11411267|NCT02671461|12607047|FG002|NOT COMPLETED|Follow-up||1
11411268|NCT02671136|12607057|FG000|STARTED|Overall Study||3
11411269|NCT02671136|12607058|FG001|STARTED|Overall Study||0
11411270|NCT02671136|12607057|FG000|COMPLETED|Overall Study||3
11411271|NCT02671136|12607058|FG001|COMPLETED|Overall Study||0
11411272|NCT02671136|12607057|FG000|NOT COMPLETED|Overall Study||0
11411273|NCT02671136|12607058|FG001|NOT COMPLETED|Overall Study||0
11411274|NCT02663752|12607064|FG000|STARTED|Overall Study||1
11411275|NCT02663752|12607064|FG000|COMPLETED|Overall Study||1
11411276|NCT02663752|12607064|FG000|NOT COMPLETED|Overall Study||0
11411277|NCT02658357|12607070|FG000|STARTED|Overall Study||0
11411278|NCT02658357|12607071|FG001|STARTED|Overall Study||0
11411279|NCT02658357|12607070|FG000|COMPLETED|Overall Study||0
11411280|NCT02658357|12607071|FG001|COMPLETED|Overall Study||0
11411281|NCT02658357|12607070|FG000|NOT COMPLETED|Overall Study||0
11411282|NCT02658357|12607071|FG001|NOT COMPLETED|Overall Study||0
11411283|NCT02665988|12607079|FG000|STARTED|Overall Study||2
11411284|NCT02665988|12607080|FG001|STARTED|Overall Study||2
11411285|NCT02665988|12607079|FG000|COMPLETED|Overall Study||2
11411286|NCT02665988|12607080|FG001|COMPLETED|Overall Study||2
11411287|NCT02665988|12607079|FG000|NOT COMPLETED|Overall Study||0
11411288|NCT02665988|12607080|FG001|NOT COMPLETED|Overall Study||0
11411289|NCT02660528|12607086|FG000|STARTED|Overall Study||0
11411290|NCT02660528|12607086|FG000|COMPLETED|Overall Study||0
11411291|NCT02660528|12607086|FG000|NOT COMPLETED|Overall Study||0
11411292|NCT02658877|12607092|FG000|STARTED|Overall Study||3
11411293|NCT02658877|12607093|FG001|STARTED|Overall Study||0
11411294|NCT02658877|12607092|FG000|COMPLETED|Overall Study||3
11411295|NCT02658877|12607093|FG001|COMPLETED|Overall Study||0
11411296|NCT02658877|12607092|FG000|NOT COMPLETED|Overall Study||0
11411297|NCT02658877|12607093|FG001|NOT COMPLETED|Overall Study||0
11411298|NCT02654782|12607101|FG000|STARTED|Overall Study||5
11411299|NCT02654782|12607102|FG001|STARTED|Overall Study||5
11411300|NCT02654782|12607101|FG000|COMPLETED|Overall Study||5
11411301|NCT02654782|12607102|FG001|COMPLETED|Overall Study||5
11411302|NCT02654782|12607101|FG000|NOT COMPLETED|Overall Study||0
11411303|NCT02654782|12607102|FG001|NOT COMPLETED|Overall Study||0
11411304|NCT02656199|12607108|FG000|STARTED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
11411305|NCT02656199|12607108|FG000|COMPLETED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
11411306|NCT02656199|12607108|FG000|NOT COMPLETED|Overall Study||0
11411307|NCT02654639|12607112|FG000|STARTED|Overall Study||4
11411308|NCT02654639|12607112|FG000|COMPLETED|Overall Study||4
11411309|NCT02654639|12607112|FG000|NOT COMPLETED|Overall Study||0
11411310|NCT02653495|12607118|FG000|STARTED|Overall Study||15
11411311|NCT02653495|12607119|FG001|STARTED|Overall Study||2
11411312|NCT02653495|12607118|FG000|COMPLETED|Overall Study||3
11411313|NCT02653495|12607119|FG001|COMPLETED|Overall Study||2
11411314|NCT02653495|12607118|FG000|NOT COMPLETED|Overall Study||12
11411315|NCT02653495|12607119|FG001|NOT COMPLETED|Overall Study||0
11411316|NCT02640573|12607125|FG000|STARTED|Overall Study||1
11411317|NCT02640573|12607125|FG000|COMPLETED|Overall Study||0
11411318|NCT02640573|12607125|FG000|NOT COMPLETED|Overall Study||1
11411319|NCT02639390|12607131|FG000|STARTED|Overall Study||0
11411320|NCT02639390|12607132|FG001|STARTED|Overall Study||5
11411321|NCT02639390|12607131|FG000|COMPLETED|Overall Study||0
11411322|NCT02639390|12607132|FG001|COMPLETED|Overall Study||3
11411323|NCT02639390|12607131|FG000|NOT COMPLETED|Overall Study||0
11411324|NCT02639390|12607132|FG001|NOT COMPLETED|Overall Study||2
11411325|NCT02634606|12607138|FG000|STARTED|Overall Study||13
11411326|NCT02634606|12607138|FG000|COMPLETED|Overall Study||0
11411327|NCT02634606|12607138|FG000|NOT COMPLETED|Overall Study||13
11411328|NCT02634827|12607146|FG000|STARTED|Overall Study||1
11411329|NCT02634827|12607146|FG000|COMPLETED|Overall Study||1
11411330|NCT02634827|12607146|FG000|NOT COMPLETED|Overall Study||0
11411331|NCT02636283|12607152|FG000|STARTED|Overall Study||3
11411332|NCT02636283|12607153|FG001|STARTED|Overall Study||3
11411333|NCT02636283|12607152|FG000|COMPLETED|Overall Study||1
11411334|NCT02636283|12607153|FG001|COMPLETED|Overall Study||0
11411335|NCT02636283|12607152|FG000|NOT COMPLETED|Overall Study||2
11411336|NCT02636283|12607153|FG001|NOT COMPLETED|Overall Study||3
11411337|NCT02638129|12607161|FG000|STARTED|Overall Study||28
11411338|NCT02638129|12607162|FG001|STARTED|Overall Study||30
11411339|NCT02638129|12607161|FG000|COMPLETED|Overall Study||0
11411340|NCT02638129|12607162|FG001|COMPLETED|Overall Study||0
11411341|NCT02638129|12607161|FG000|NOT COMPLETED|Overall Study||28
11411342|NCT02638129|12607162|FG001|NOT COMPLETED|Overall Study||30
11411343|NCT02615990|12607170|FG000|STARTED|Overall Study||1
11411344|NCT02615990|12607171|FG001|STARTED|Overall Study||1
11411345|NCT02615990|12607170|FG000|COMPLETED|Overall Study||0
11411346|NCT02615990|12607171|FG001|COMPLETED|Overall Study||0
11411347|NCT02615990|12607170|FG000|NOT COMPLETED|Overall Study||1
11411348|NCT02615990|12607171|FG001|NOT COMPLETED|Overall Study||1
11411349|NCT02640677|12607177|FG000|STARTED|Overall Study||2
11411350|NCT02640677|12607177|FG000|COMPLETED|Overall Study||0
11411351|NCT02640677|12607177|FG000|NOT COMPLETED|Overall Study||2
11411352|NCT02633540|12607181|FG000|STARTED|Overall Study||2
11411353|NCT02633540|12607181|FG000|COMPLETED|Overall Study||2
11411354|NCT02633540|12607181|FG000|NOT COMPLETED|Overall Study||0
11411355|NCT02623959|12607187|FG000|STARTED|Overall Study||0
11411356|NCT02623959|12607188|FG001|STARTED|Overall Study||1
11411357|NCT02623959|12607187|FG000|COMPLETED|Overall Study||0
11411358|NCT02623959|12607188|FG001|COMPLETED|Overall Study|due to progression|0
11411359|NCT02623959|12607187|FG000|NOT COMPLETED|Overall Study||0
11411360|NCT02623959|12607188|FG001|NOT COMPLETED|Overall Study||1
11411361|NCT02631148|12607198|FG000|STARTED|Overall Study||12
11411362|NCT02631148|12607199|FG001|STARTED|Overall Study||0
11411363|NCT02631148|12607198|FG000|COMPLETED|Overall Study||2
11411364|NCT02631148|12607199|FG001|COMPLETED|Overall Study||0
11411365|NCT02631148|12607198|FG000|NOT COMPLETED|Overall Study||10
11411366|NCT02631148|12607199|FG001|NOT COMPLETED|Overall Study||0
11411367|NCT02630472|12607207|FG000|STARTED|Overall Study||10
11411368|NCT02630472|12607208|FG001|STARTED|Overall Study||0
11411369|NCT02630472|12607207|FG000|COMPLETED|Overall Study||0
11411370|NCT02630472|12607208|FG001|COMPLETED|Overall Study||0
11411371|NCT02630472|12607207|FG000|NOT COMPLETED|Overall Study||10
11411372|NCT02630472|12607208|FG001|NOT COMPLETED|Overall Study||0
11411373|NCT02626520|12607217|FG000|STARTED|Overall Study||1
11411374|NCT02626520|12607218|FG001|STARTED|Overall Study||10
11411375|NCT02626520|12607217|FG000|COMPLETED|Overall Study||0
11411376|NCT02626520|12607218|FG001|COMPLETED|Overall Study||0
11411377|NCT02626520|12607217|FG000|NOT COMPLETED|Overall Study||1
11411378|NCT02626520|12607218|FG001|NOT COMPLETED|Overall Study||10
11411379|NCT02614898|12607226|FG000|STARTED|Overall Study||15
11411380|NCT02614898|12607227|FG001|STARTED|Overall Study||52
11411381|NCT02614898|12607226|FG000|Safety Population|Overall Study||15
11411382|NCT02614898|12607227|FG001|Safety Population|Overall Study||52
11411383|NCT02614898|12607226|FG000|COMPLETED|Overall Study||0
11411384|NCT02614898|12607227|FG001|COMPLETED|Overall Study||1
11411385|NCT02614898|12607226|FG000|NOT COMPLETED|Overall Study||15
11411386|NCT02614898|12607227|FG001|NOT COMPLETED|Overall Study||51
11411387|NCT02622828|12607234|FG000|STARTED|Overall Study||4
11411388|NCT02622828|12607234|FG000|COMPLETED|Overall Study||1
11411389|NCT02622828|12607234|FG000|NOT COMPLETED|Overall Study||3
11411390|NCT02624739|12607240|FG000|STARTED|Overall Study||0
11411391|NCT02624739|12607241|FG001|STARTED|Overall Study||0
11411392|NCT02624739|12607240|FG000|COMPLETED|Overall Study||0
11411393|NCT02624739|12607241|FG001|COMPLETED|Overall Study||0
11411394|NCT02624739|12607240|FG000|NOT COMPLETED|Overall Study||0
11411395|NCT02624739|12607241|FG001|NOT COMPLETED|Overall Study||0
11411396|NCT02608905|12607249|FG000|STARTED|Overall Study||7
11411397|NCT02608905|12607250|FG001|STARTED|Overall Study||10
11411398|NCT02608905|12607249|FG000|COMPLETED|Overall Study||5
11411399|NCT02608905|12607250|FG001|COMPLETED|Overall Study||10
11411400|NCT02608905|12607249|FG000|NOT COMPLETED|Overall Study||2
11411401|NCT02608905|12607250|FG001|NOT COMPLETED|Overall Study||0
11411402|NCT02619812|12607260|FG000|STARTED|Overall Study||0
11411403|NCT02619812|12607261|FG001|STARTED|Overall Study||0
11411404|NCT02619812|12607262|FG002|STARTED|Overall Study||1
11411405|NCT02619812|12607263|FG003|STARTED|Overall Study||2
11411406|NCT02619812|12607260|FG000|COMPLETED|Overall Study||0
11411407|NCT02619812|12607261|FG001|COMPLETED|Overall Study||0
11411408|NCT02619812|12607262|FG002|COMPLETED|Overall Study||0
11411409|NCT02619812|12607263|FG003|COMPLETED|Overall Study||0
11411410|NCT02619812|12607260|FG000|NOT COMPLETED|Overall Study||0
11411411|NCT02619812|12607261|FG001|NOT COMPLETED|Overall Study||0
11411412|NCT02619812|12607262|FG002|NOT COMPLETED|Overall Study||1
11411413|NCT02619812|12607263|FG003|NOT COMPLETED|Overall Study||2
11411414|NCT02612285|12607273|FG000|STARTED|Overall Study||1
11411415|NCT02612285|12607273|FG000|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
11411416|NCT02612285|12607273|FG000|NOT COMPLETED|Overall Study||1
11411417|NCT02614586|12607277|FG000|STARTED|Overall Study||11
11411418|NCT02614586|12607277|FG000|COMPLETED|Overall Study||11
11411419|NCT02614586|12607277|FG000|NOT COMPLETED|Overall Study||0
11411420|NCT02606279|12607283|FG000|STARTED|Overall Study||0
11411421|NCT02606279|12607284|FG001|STARTED|Overall Study||1
11411422|NCT02606279|12607283|FG000|COMPLETED|Overall Study||0
11411423|NCT02606279|12607284|FG001|COMPLETED|Overall Study||0
11411424|NCT02606279|12607283|FG000|NOT COMPLETED|Overall Study||0
11411425|NCT02606279|12607284|FG001|NOT COMPLETED|Overall Study||1
11411426|NCT02605824|12607292|FG000|STARTED|Overall Study||1
11411427|NCT02605824|12607293|FG001|STARTED|Overall Study||0
11411428|NCT02605824|12607292|FG000|COMPLETED|Overall Study||0
11411429|NCT02605824|12607293|FG001|COMPLETED|Overall Study||0
11411430|NCT02605824|12607292|FG000|NOT COMPLETED|Overall Study||1
11411431|NCT02605824|12607293|FG001|NOT COMPLETED|Overall Study||0
11411432|NCT02598622|12607301|FG000|STARTED|Overall Study||8
11411433|NCT02598622|12607302|FG001|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
11411434|NCT02598622|12607301|FG000|COMPLETED|Overall Study||2
11411435|NCT02598622|12607302|FG001|COMPLETED|Overall Study||0
11411436|NCT02598622|12607301|FG000|NOT COMPLETED|Overall Study||6
11411437|NCT02598622|12607302|FG001|NOT COMPLETED|Overall Study||0
11411438|NCT02589145|12607311|FG000|STARTED|Overall Study||4
11411439|NCT02589145|12607312|FG001|STARTED|Overall Study||2
11411440|NCT02589145|12607313|FG002|STARTED|Overall Study||2
11411441|NCT02589145|12607311|FG000|COMPLETED|Overall Study||4
11411442|NCT02589145|12607312|FG001|COMPLETED|Overall Study||2
11411443|NCT02589145|12607313|FG002|COMPLETED|Overall Study||2
11411444|NCT02589145|12607311|FG000|NOT COMPLETED|Overall Study||0
11411445|NCT02589145|12607312|FG001|NOT COMPLETED|Overall Study||0
11411446|NCT02589145|12607313|FG002|NOT COMPLETED|Overall Study||0
11411447|NCT02590068|12607323|FG000|STARTED|Overall Study||0
11411448|NCT02590068|12607324|FG001|STARTED|Overall Study||14
11411449|NCT02590068|12607323|FG000|COMPLETED|Overall Study||0
11411450|NCT02590068|12607324|FG001|COMPLETED|Overall Study||14
11411451|NCT02590068|12607323|FG000|NOT COMPLETED|Overall Study||0
11411452|NCT02590068|12607324|FG001|NOT COMPLETED|Overall Study||0
11411453|NCT02593682|12607332|FG000|STARTED|Overall Study||0
11411454|NCT02593682|12607333|FG001|STARTED|Overall Study||0
11411455|NCT02593682|12607332|FG000|COMPLETED|Overall Study||0
11411456|NCT02593682|12607333|FG001|COMPLETED|Overall Study||0
11411457|NCT02593682|12607332|FG000|NOT COMPLETED|Overall Study||0
11411458|NCT02593682|12607333|FG001|NOT COMPLETED|Overall Study||0
11411459|NCT02587650|12607339|FG000|STARTED|Overall Study||0
11411460|NCT02587650|12607340|FG001|STARTED|Overall Study||0
11411461|NCT02587650|12607341|FG002|STARTED|Overall Study||1
11411462|NCT02587650|12607342|FG003|STARTED|Overall Study||0
11411463|NCT02587650|12607339|FG000|COMPLETED|Overall Study||0
11411464|NCT02587650|12607340|FG001|COMPLETED|Overall Study||0
11411465|NCT02587650|12607341|FG002|COMPLETED|Overall Study||1
11411466|NCT02587650|12607342|FG003|COMPLETED|Overall Study||0
11411467|NCT02587650|12607339|FG000|NOT COMPLETED|Overall Study||0
11411468|NCT02587650|12607340|FG001|NOT COMPLETED|Overall Study||0
11411469|NCT02587650|12607341|FG002|NOT COMPLETED|Overall Study||0
11411470|NCT02587650|12607342|FG003|NOT COMPLETED|Overall Study||0
11411471|NCT02569957|12607348|FG000|STARTED|Overall Study||0
11411472|NCT02569957|12607349|FG001|STARTED|Overall Study||1
11411473|NCT02569957|12607348|FG000|COMPLETED|Overall Study||0
11411474|NCT02569957|12607349|FG001|COMPLETED|Overall Study||0
11411475|NCT02569957|12607348|FG000|NOT COMPLETED|Overall Study||0
11411476|NCT02569957|12607349|FG001|NOT COMPLETED|Overall Study||1
11411477|NCT02568007|12607358|FG000|STARTED|Overall Study||2
11411478|NCT02568007|12607359|FG001|STARTED|Overall Study||2
11411479|NCT02568007|12607360|FG002|STARTED|Overall Study||0
11411480|NCT02568007|12607358|FG000|COMPLETED|Overall Study||2
11411481|NCT02568007|12607359|FG001|COMPLETED|Overall Study||2
11411482|NCT02568007|12607360|FG002|COMPLETED|Overall Study||0
11411483|NCT02568007|12607358|FG000|NOT COMPLETED|Overall Study||0
11411484|NCT02568007|12607359|FG001|NOT COMPLETED|Overall Study||0
11411485|NCT02568007|12607360|FG002|NOT COMPLETED|Overall Study||0
11411486|NCT02575365|12607368|FG000|STARTED|Overall Study||4
11411487|NCT02575365|12607368|FG000|COMPLETED|Overall Study||0
11411488|NCT02575365|12607368|FG000|NOT COMPLETED|Overall Study||4
11411489|NCT02549755|12607372|FG000|STARTED|Overall Study||1
11411490|NCT02549755|12607372|FG000|COMPLETED|Overall Study||0
11411491|NCT02549755|12607372|FG000|NOT COMPLETED|Overall Study||1
11411492|NCT02547129|12607378|FG000|STARTED|Overall Study||2
11411493|NCT02547129|12607379|FG001|STARTED|Overall Study||2
11411494|NCT02547129|12607378|FG000|COMPLETED|Overall Study||1
11411495|NCT02547129|12607379|FG001|COMPLETED|Overall Study||2
11411496|NCT02547129|12607378|FG000|NOT COMPLETED|Overall Study||1
11411497|NCT02547129|12607379|FG001|NOT COMPLETED|Overall Study||0
11411498|NCT02528097|12607387|FG000|STARTED|Overall Study||1
11411499|NCT02528097|12607388|FG001|STARTED|Overall Study||1
11411500|NCT02528097|12607387|FG000|COMPLETED|Overall Study||1
11411501|NCT02528097|12607388|FG001|COMPLETED|Overall Study||1
11411502|NCT02528097|12607387|FG000|NOT COMPLETED|Overall Study||0
11411503|NCT02528097|12607388|FG001|NOT COMPLETED|Overall Study||0
11411504|NCT02549716|12607396|FG000|STARTED|Overall Study||1
11411505|NCT02549716|12607397|FG001|STARTED|Overall Study||2
11411506|NCT02549716|12607396|FG000|COMPLETED|Overall Study||1
11411507|NCT02549716|12607397|FG001|COMPLETED|Overall Study||2
11411508|NCT02549716|12607396|FG000|NOT COMPLETED|Overall Study||0
11411509|NCT02549716|12607397|FG001|NOT COMPLETED|Overall Study||0
11411510|NCT02540434|12607405|FG000|STARTED|Overall Study||1
11411511|NCT02540434|12607406|FG001|STARTED|Overall Study||1
11411512|NCT02540434|12607405|FG000|COMPLETED|Overall Study||1
11411513|NCT02540434|12607406|FG001|COMPLETED|Overall Study||1
11411514|NCT02540434|12607405|FG000|NOT COMPLETED|Overall Study||0
11411515|NCT02540434|12607406|FG001|NOT COMPLETED|Overall Study||0
11411516|NCT02533531|12607414|FG000|STARTED|Overall Study||1
11411517|NCT02533531|12607414|FG000|COMPLETED|Overall Study||0
11411518|NCT02533531|12607414|FG000|NOT COMPLETED|Overall Study||1
11411519|NCT02534038|12607420|FG000|STARTED|Period 1 (6 Weeks)||1
11411520|NCT02534038|12607421|FG001|STARTED|Period 1 (6 Weeks)||0
11411521|NCT02534038|12607420|FG000|COMPLETED|Period 1 (6 Weeks)||1
11411522|NCT02534038|12607421|FG001|COMPLETED|Period 1 (6 Weeks)||0
11411523|NCT02534038|12607420|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
11411524|NCT02534038|12607421|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
11411525|NCT02534038|12607420|FG000|STARTED|Period 2 (6 Weeks)||1
11411526|NCT02534038|12607421|FG001|STARTED|Period 2 (6 Weeks)||0
11411527|NCT02534038|12607420|FG000|COMPLETED|Period 2 (6 Weeks)||1
11411528|NCT02534038|12607421|FG001|COMPLETED|Period 2 (6 Weeks)||0
11411529|NCT02534038|12607420|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0
11411530|NCT02534038|12607421|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
11411531|NCT02520726|12607430|FG000|STARTED|Overall Study||3
11411532|NCT02520726|12607431|FG001|STARTED|Overall Study||2
11411533|NCT02520726|12607430|FG000|COMPLETED|Overall Study||0
11411534|NCT02520726|12607431|FG001|COMPLETED|Overall Study||0
11411535|NCT02520726|12607430|FG000|NOT COMPLETED|Overall Study||3
11411536|NCT02520726|12607431|FG001|NOT COMPLETED|Overall Study||2
11411537|NCT02520297|12607437|FG000|STARTED|Overall Study||1
11411538|NCT02520297|12607437|FG000|COMPLETED|Overall Study||1
11411539|NCT02520297|12607437|FG000|NOT COMPLETED|Overall Study||0
11411540|NCT02519712|12607441|FG000|STARTED|Overall Study||4
11411541|NCT02519712|12607441|FG000|COMPLETED|Overall Study||0
11411542|NCT02519712|12607441|FG000|NOT COMPLETED|Overall Study||4
11411543|NCT02518750|12607445|FG000|STARTED|Overall Study||3
11411544|NCT02518750|12607445|FG000|COMPLETED|Overall Study||1
11411545|NCT02518750|12607445|FG000|NOT COMPLETED|Overall Study||2
11411546|NCT02516228|12607449|FG000|STARTED|Overall Study||6
11411547|NCT02516228|12607449|FG000|COMPLETED|Overall Study||3
11411548|NCT02516228|12607449|FG000|NOT COMPLETED|Overall Study||3
11411549|NCT02515851|12607455|FG000|STARTED|Overall Study||15
11411550|NCT02515851|12607456|FG001|STARTED|Overall Study||15
11411551|NCT02515851|12607455|FG000|COMPLETED|Overall Study||15
11411552|NCT02515851|12607456|FG001|COMPLETED|Overall Study||15
11411553|NCT02515851|12607455|FG000|NOT COMPLETED|Overall Study||0
11411554|NCT02515851|12607456|FG001|NOT COMPLETED|Overall Study||0
11411555|NCT02506985|12607464|FG000|STARTED|Overall Study||4
11411556|NCT02506985|12607465|FG001|STARTED|Overall Study||6
11411557|NCT02506985|12607464|FG000|COMPLETED|Overall Study||4
11411558|NCT02506985|12607465|FG001|COMPLETED|Overall Study||6
11411559|NCT02506985|12607464|FG000|NOT COMPLETED|Overall Study||0
11411560|NCT02506985|12607465|FG001|NOT COMPLETED|Overall Study||0
11411561|NCT02514252|12607471|FG000|STARTED|Overall Study||6
11411562|NCT02514252|12607471|FG000|COMPLETED|Overall Study||6
11411563|NCT02514252|12607471|FG000|NOT COMPLETED|Overall Study||0
11411564|NCT02501759|12607475|FG000|STARTED|Overall Study||2
11411565|NCT02501759|12607475|FG000|COMPLETED|Overall Study||1
11411566|NCT02501759|12607475|FG000|NOT COMPLETED|Overall Study||1
11411567|NCT02487277|12607481|FG000|STARTED|Overall Study||3
11411568|NCT02487277|12607482|FG001|STARTED|Overall Study||0
11411569|NCT02487277|12607481|FG000|COMPLETED|Overall Study||3
11411570|NCT02487277|12607482|FG001|COMPLETED|Overall Study||0
11411571|NCT02487277|12607481|FG000|NOT COMPLETED|Overall Study||0
11411572|NCT02487277|12607482|FG001|NOT COMPLETED|Overall Study||0
11411573|NCT02506101|12607489|FG000|STARTED|Overall Study||2
11411574|NCT02506101|12607490|FG001|STARTED|Overall Study||0
11411575|NCT02506101|12607489|FG000|COMPLETED|Overall Study||0
11411576|NCT02506101|12607490|FG001|COMPLETED|Overall Study||0
11411577|NCT02506101|12607489|FG000|NOT COMPLETED|Overall Study||2
11411578|NCT02506101|12607490|FG001|NOT COMPLETED|Overall Study||0
11411579|NCT02499887|12607498|FG000|STARTED|Overall Study||3
11411580|NCT02499887|12607499|FG001|STARTED|Overall Study||3
11411581|NCT02499887|12607498|FG000|COMPLETED|Overall Study||3
11411582|NCT02499887|12607499|FG001|COMPLETED|Overall Study||3
11411583|NCT02499887|12607498|FG000|NOT COMPLETED|Overall Study||0
11411584|NCT02499887|12607499|FG001|NOT COMPLETED|Overall Study||0
11411585|NCT02504099|12607505|FG000|STARTED|Overall Study||3
11411586|NCT02504099|12607505|FG000|COMPLETED|Overall Study||3
11411587|NCT02504099|12607505|FG000|NOT COMPLETED|Overall Study||0
11411588|NCT02500901|12607509|FG000|STARTED|Overall Study||2
11411589|NCT02500901|12607509|FG000|COMPLETED|Overall Study||0
11411590|NCT02500901|12607509|FG000|NOT COMPLETED|Overall Study||2
11411591|NCT02483533|12607515|FG000|STARTED|Overall Study||50
11411592|NCT02483533|12607516|FG001|STARTED|Overall Study||50
11411593|NCT02483533|12607515|FG000|COMPLETED|Overall Study||0
11411594|NCT02483533|12607516|FG001|COMPLETED|Overall Study||0
11411595|NCT02483533|12607515|FG000|NOT COMPLETED|Overall Study||50
11411596|NCT02483533|12607516|FG001|NOT COMPLETED|Overall Study||50
11411597|NCT02496039|12607522|FG000|STARTED|Overall Study||5
11411598|NCT02496039|12607522|FG000|COMPLETED|Overall Study||1
11411599|NCT02496039|12607522|FG000|NOT COMPLETED|Overall Study||4
11411600|NCT02492295|12607526|FG000|STARTED|Overall Study||0
11411601|NCT02492295|12607526|FG000|COMPLETED|Overall Study||0
11411602|NCT02492295|12607526|FG000|NOT COMPLETED|Overall Study||0
11411603|NCT02494206|12607531|FG000|STARTED|Overall Study||9
11411604|NCT02494206|12607531|FG000|COMPLETED|Overall Study||7
11411605|NCT02494206|12607531|FG000|NOT COMPLETED|Overall Study||2
11022470|NCT00809159|12200733|FG000|STARTED|Part 1 and 2||0
11022471|NCT00809159|12200734|FG001|STARTED|Part 1 and 2||0
11022472|NCT00809159|12200735|FG002|STARTED|Part 1 and 2||30
11022473|NCT00809159|12200736|FG003|STARTED|Part 1 and 2||12
11022474|NCT00809159|12200737|FG004|STARTED|Part 1 and 2||12
11022475|NCT00809159|12200738|FG005|STARTED|Part 1 and 2||6
11411606|NCT02473445|12607535|FG000|STARTED|Overall Study||22
11411607|NCT02473445|12607535|FG000|COMPLETED|Overall Study||0
11411608|NCT02473445|12607535|FG000|NOT COMPLETED|Overall Study||22
11411609|NCT02491411|12607539|FG000|STARTED|Overall Study||4
11411610|NCT02491411|12607539|FG000|COMPLETED|Overall Study||0
11411611|NCT02491411|12607539|FG000|NOT COMPLETED|Overall Study||4
11411612|NCT02476994|12607545|FG000|STARTED|Overall Study||1
11411613|NCT02476994|12607546|FG001|STARTED|Overall Study||0
11411614|NCT02476994|12607545|FG000|COMPLETED|Overall Study||0
11411615|NCT02476994|12607546|FG001|COMPLETED|Overall Study||0
11411616|NCT02476994|12607545|FG000|NOT COMPLETED|Overall Study||1
11411617|NCT02476994|12607546|FG001|NOT COMPLETED|Overall Study||0
11411618|NCT02473523|12607552|FG000|STARTED|Overall Study||2
11411619|NCT02473523|12607552|FG000|COMPLETED|Overall Study||0
11411620|NCT02473523|12607552|FG000|NOT COMPLETED|Overall Study||2
11411621|NCT02468583|12607558|FG000|STARTED|Overall Study||3
11411622|NCT02468583|12607559|FG001|STARTED|Overall Study||3
11411623|NCT02468583|12607558|FG000|COMPLETED|Overall Study||3
11411624|NCT02468583|12607559|FG001|COMPLETED|Overall Study||3
11411625|NCT02468583|12607558|FG000|NOT COMPLETED|Overall Study||0
11411626|NCT02468583|12607559|FG001|NOT COMPLETED|Overall Study||0
11411627|NCT02450591|12607565|FG000|STARTED|Overall Study||4
11411628|NCT02450591|12607565|FG000|COMPLETED|Overall Study||4
11411629|NCT02450591|12607565|FG000|NOT COMPLETED|Overall Study||0
11411630|NCT02472639|12607571|FG000|STARTED|Overall Study||4
11411631|NCT02472639|12607572|FG001|STARTED|Overall Study||3
11411632|NCT02472639|12607571|FG000|COMPLETED|Overall Study||0
11411633|NCT02472639|12607572|FG001|COMPLETED|Overall Study||0
11411634|NCT02472639|12607571|FG000|NOT COMPLETED|Overall Study||4
11411635|NCT02472639|12607572|FG001|NOT COMPLETED|Overall Study||3
11411636|NCT02469415|12607578|FG000|STARTED|Overall Study||3
11411637|NCT02469415|12607578|FG000|COMPLETED|Overall Study||0
11411638|NCT02469415|12607578|FG000|NOT COMPLETED|Overall Study||3
11411639|NCT02461550|12607582|FG000|STARTED|Overall Study||2
11411640|NCT02461550|12607582|FG000|COMPLETED|Overall Study||2
11411641|NCT02461550|12607582|FG000|NOT COMPLETED|Overall Study||0
11411642|NCT02461355|12607586|FG000|STARTED|Overall Study||2
11411643|NCT02461355|12607586|FG000|COMPLETED|Overall Study||2
11411644|NCT02461355|12607586|FG000|NOT COMPLETED|Overall Study||0
11411645|NCT02452359|12607590|FG000|STARTED|Overall Study||54
11411646|NCT02452359|12607590|FG000|COMPLETED|Overall Study||33
11411647|NCT02452359|12607590|FG000|NOT COMPLETED|Overall Study||21
11411648|NCT02434146|12607594|FG000|STARTED|Overall Study||3
11411649|NCT02434146|12607594|FG000|COMPLETED|Overall Study||3
11411650|NCT02434146|12607594|FG000|NOT COMPLETED|Overall Study||0
11411651|NCT02452398|12607598|FG000|STARTED|Overall Study|Study was halted prematurely. No results analysis completed.|79
11411652|NCT02452398|12607598|FG000|COMPLETED|Overall Study|Study was halted prematurely. No results analysis completed.|38
11411653|NCT02452398|12607598|FG000|NOT COMPLETED|Overall Study||41
11411654|NCT02447887|12607602|FG000|STARTED|Overall Study||3
11411655|NCT02447887|12607602|FG000|COMPLETED|Overall Study||0
11411656|NCT02447887|12607602|FG000|NOT COMPLETED|Overall Study||3
11411657|NCT02431494|12607609|FG000|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
11411658|NCT02431494|12607610|FG001|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
11411659|NCT02431494|12607611|FG002|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
11411660|NCT02431494|12607609|FG000|COMPLETED|Overall Study||0
11411661|NCT02431494|12607610|FG001|COMPLETED|Overall Study||0
11411662|NCT02431494|12607611|FG002|COMPLETED|Overall Study||0
11411663|NCT02431494|12607609|FG000|NOT COMPLETED|Overall Study||0
11411664|NCT02431494|12607610|FG001|NOT COMPLETED|Overall Study||0
11411665|NCT02431494|12607611|FG002|NOT COMPLETED|Overall Study||0
11411666|NCT02439970|12607623|FG000|STARTED|Overall Study||2
11411667|NCT02439970|12607624|FG001|STARTED|Overall Study||3
11022476|NCT00809159|12200733|FG000|PK Analysis Set|Part 1 and 2||0
11022477|NCT00809159|12200734|FG001|PK Analysis Set|Part 1 and 2||0
11411668|NCT02439970|12607623|FG000|COMPLETED|Overall Study||0
11411669|NCT02439970|12607624|FG001|COMPLETED|Overall Study||0
11411670|NCT02439970|12607623|FG000|NOT COMPLETED|Overall Study||2
11411671|NCT02439970|12607624|FG001|NOT COMPLETED|Overall Study||3
11411672|NCT02439957|12607632|FG000|STARTED|Overall Study||3
11411673|NCT02439957|12607633|FG001|STARTED|Overall Study||3
11411674|NCT02439957|12607632|FG000|Blinded Treatment Period|Overall Study||1
11411675|NCT02439957|12607633|FG001|Blinded Treatment Period|Overall Study||2
11411676|NCT02439957|12607632|FG000|COMPLETED|Overall Study||0
11411677|NCT02439957|12607633|FG001|COMPLETED|Overall Study||0
11411678|NCT02439957|12607632|FG000|NOT COMPLETED|Overall Study||3
11411679|NCT02439957|12607633|FG001|NOT COMPLETED|Overall Study||3
11411680|NCT02441036|12607644|FG000|STARTED|Overall Study||3
11411681|NCT02441036|12607645|FG001|STARTED|Overall Study||5
11411682|NCT02441036|12607646|FG002|STARTED|Overall Study||3
11411683|NCT02441036|12607647|FG003|STARTED|Overall Study||4
11411684|NCT02441036|12607648|FG004|STARTED|Overall Study||1
11411685|NCT02441036|12607644|FG000|Treated|Overall Study||3
11411686|NCT02441036|12607645|FG001|Treated|Overall Study||5
11411687|NCT02441036|12607646|FG002|Treated|Overall Study||3
11411688|NCT02441036|12607647|FG003|Treated|Overall Study||4
11411689|NCT02441036|12607648|FG004|Treated|Overall Study||1
11411690|NCT02441036|12607644|FG000|Tissue Resected|Overall Study||3
11411691|NCT02441036|12607645|FG001|Tissue Resected|Overall Study||4
11411692|NCT02441036|12607646|FG002|Tissue Resected|Overall Study||3
11411693|NCT02441036|12607647|FG003|Tissue Resected|Overall Study||3
11411694|NCT02441036|12607648|FG004|Tissue Resected|Overall Study||1
11411695|NCT02441036|12607644|FG000|COMPLETED|Overall Study||3
11411696|NCT02441036|12607645|FG001|COMPLETED|Overall Study||4
11411697|NCT02441036|12607646|FG002|COMPLETED|Overall Study||3
11411698|NCT02441036|12607647|FG003|COMPLETED|Overall Study||3
11411699|NCT02441036|12607648|FG004|COMPLETED|Overall Study||1
11411700|NCT02441036|12607644|FG000|NOT COMPLETED|Overall Study||0
11411701|NCT02441036|12607645|FG001|NOT COMPLETED|Overall Study||1
11411702|NCT02441036|12607646|FG002|NOT COMPLETED|Overall Study||0
11411703|NCT02441036|12607647|FG003|NOT COMPLETED|Overall Study||1
11411704|NCT02441036|12607648|FG004|NOT COMPLETED|Overall Study||0
11411705|NCT02436265|12607663|FG000|STARTED|Overall Study||3
11411706|NCT02436265|12607664|FG001|STARTED|Overall Study||4
11411707|NCT02436265|12607663|FG000|COMPLETED|Overall Study||3
11411708|NCT02436265|12607664|FG001|COMPLETED|Overall Study||4
11411709|NCT02436265|12607663|FG000|NOT COMPLETED|Overall Study||0
11411710|NCT02436265|12607664|FG001|NOT COMPLETED|Overall Study||0
11411711|NCT02429583|12607672|FG000|STARTED|Overall Study||1
11411712|NCT02429583|12607673|FG001|STARTED|Overall Study||23
11411713|NCT02429583|12607672|FG000|COMPLETED|Overall Study||1
11411714|NCT02429583|12607673|FG001|COMPLETED|Overall Study||3
11411715|NCT02429583|12607672|FG000|NOT COMPLETED|Overall Study||0
11411716|NCT02429583|12607673|FG001|NOT COMPLETED|Overall Study||20
11411717|NCT02417870|12607679|FG000|STARTED|Overall Study||2
11411718|NCT02417870|12607679|FG000|COMPLETED|Overall Study||0
11411719|NCT02417870|12607679|FG000|NOT COMPLETED|Overall Study||2
11411720|NCT02430532|12607685|FG000|STARTED|Overall Study||30
11411721|NCT02430532|12607686|FG001|STARTED|Overall Study||28
11411722|NCT02430532|12607685|FG000|COMPLETED|Overall Study||0
11411723|NCT02430532|12607686|FG001|COMPLETED|Overall Study||0
11411724|NCT02430532|12607685|FG000|NOT COMPLETED|Overall Study||30
11411725|NCT02430532|12607686|FG001|NOT COMPLETED|Overall Study||28
11411726|NCT02428231|12607696|FG000|STARTED|Overall Study||30
11411727|NCT02428231|12607697|FG001|STARTED|Overall Study||32
11411728|NCT02428231|12607696|FG000|COMPLETED|Overall Study||17
11411729|NCT02428231|12607697|FG001|COMPLETED|Overall Study||15
11411730|NCT02428231|12607696|FG000|NOT COMPLETED|Overall Study||13
11411731|NCT02428231|12607697|FG001|NOT COMPLETED|Overall Study||17
11411732|NCT02424565|12607703|FG000|STARTED|Period 1 (D0)||8
11411733|NCT02424565|12607704|FG001|STARTED|Period 1 (D0)||7
11411734|NCT02424565|12607703|FG000|COMPLETED|Period 1 (D0)||8
11411735|NCT02424565|12607704|FG001|COMPLETED|Period 1 (D0)||6
11411736|NCT02424565|12607703|FG000|NOT COMPLETED|Period 1 (D0)||0
11411737|NCT02424565|12607704|FG001|NOT COMPLETED|Period 1 (D0)||1
11411738|NCT02424565|12607703|FG000|STARTED|Washout Period||8
11411739|NCT02424565|12607704|FG001|STARTED|Washout Period||6
11411740|NCT02424565|12607703|FG000|COMPLETED|Washout Period||8
11411741|NCT02424565|12607704|FG001|COMPLETED|Washout Period||6
11411742|NCT02424565|12607703|FG000|NOT COMPLETED|Washout Period||0
11411743|NCT02424565|12607704|FG001|NOT COMPLETED|Washout Period||0
11411744|NCT02424565|12607703|FG000|STARTED|Period 2 (D3)||8
11411745|NCT02424565|12607704|FG001|STARTED|Period 2 (D3)||6
11411746|NCT02424565|12607703|FG000|COMPLETED|Period 2 (D3)||8
11411747|NCT02424565|12607704|FG001|COMPLETED|Period 2 (D3)||6
11411748|NCT02424565|12607703|FG000|NOT COMPLETED|Period 2 (D3)||0
11411749|NCT02424565|12607704|FG001|NOT COMPLETED|Period 2 (D3)||0
11411750|NCT02413047|12607710|FG000|STARTED|Overall Study||3
11411751|NCT02413047|12607710|FG000|Participants on Infliximab|Overall Study||2
11411752|NCT02413047|12607710|FG000|Participants on Adalimumab|Overall Study||1
11411753|NCT02413047|12607710|FG000|COMPLETED|Overall Study||3
11411754|NCT02413047|12607710|FG000|NOT COMPLETED|Overall Study||0
11411755|NCT02414698|12607716|FG000|STARTED|Overall Study||3
11411756|NCT02414698|12607717|FG001|STARTED|Overall Study||1
11411757|NCT02414698|12607716|FG000|COMPLETED|Overall Study||3
11411758|NCT02414698|12607717|FG001|COMPLETED|Overall Study||1
11411759|NCT02414698|12607716|FG000|NOT COMPLETED|Overall Study||0
11411760|NCT02414698|12607717|FG001|NOT COMPLETED|Overall Study||0
11411761|NCT02422303|12607725|FG000|STARTED|Overall Study||6
11411762|NCT02422303|12607726|FG001|STARTED|Overall Study||6
11411763|NCT02422303|12607725|FG000|COMPLETED|Overall Study||5
11411764|NCT02422303|12607726|FG001|COMPLETED|Overall Study||5
11411765|NCT02422303|12607725|FG000|NOT COMPLETED|Overall Study||1
11411766|NCT02422303|12607726|FG001|NOT COMPLETED|Overall Study||1
11411767|NCT02415166|12607736|FG000|STARTED|Overall Study||6
11411768|NCT02415166|12607737|FG001|STARTED|Overall Study||0
11411769|NCT02415166|12607738|FG002|STARTED|Overall Study||0
11411770|NCT02415166|12607739|FG003|STARTED|Overall Study||0
11411771|NCT02415166|12607736|FG000|COMPLETED|Overall Study||6
11411772|NCT02415166|12607737|FG001|COMPLETED|Overall Study||0
11411773|NCT02415166|12607738|FG002|COMPLETED|Overall Study||0
11411774|NCT02415166|12607739|FG003|COMPLETED|Overall Study||0
11411775|NCT02415166|12607736|FG000|NOT COMPLETED|Overall Study||0
11411776|NCT02415166|12607737|FG001|NOT COMPLETED|Overall Study||0
11411777|NCT02415166|12607738|FG002|NOT COMPLETED|Overall Study||0
11411778|NCT02415166|12607739|FG003|NOT COMPLETED|Overall Study||0
11411779|NCT02414152|12607749|FG000|STARTED|Overall Study||2
11411780|NCT02414152|12607749|FG000|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
11411781|NCT02414152|12607749|FG000|NOT COMPLETED|Overall Study||2
11411782|NCT02410551|12607753|FG000|STARTED|Overall Study||4
11411783|NCT02410551|12607753|FG000|COMPLETED|Overall Study||0
11411784|NCT02410551|12607753|FG000|NOT COMPLETED|Overall Study||4
11411785|NCT02411643|12607758|FG000|STARTED|Overall Study||2
11411786|NCT02411643|12607758|FG000|COMPLETED|Overall Study||2
11411787|NCT02411643|12607758|FG000|NOT COMPLETED|Overall Study||0
11411788|NCT02410954|12607764|FG000|STARTED|Overall Study||14
11411789|NCT02410954|12607765|FG001|STARTED|Overall Study||0
11411790|NCT02410954|12607764|FG000|COMPLETED|Overall Study||0
11411791|NCT02410954|12607765|FG001|COMPLETED|Overall Study||0
11411792|NCT02410954|12607764|FG000|NOT COMPLETED|Overall Study||14
11411793|NCT02410954|12607765|FG001|NOT COMPLETED|Overall Study||0
11411794|NCT02410577|12607771|FG000|STARTED|Overall Study||2
11411795|NCT02410577|12607771|FG000|COMPLETED|Overall Study||2
11411796|NCT02410577|12607771|FG000|NOT COMPLETED|Overall Study||0
11411797|NCT02409355|12607777|FG000|STARTED|Overall Study||4
11411798|NCT02409355|12607778|FG001|STARTED|Overall Study||4
11411799|NCT02409355|12607777|FG000|COMPLETED|Overall Study||0
11411800|NCT02409355|12607778|FG001|COMPLETED|Overall Study||0
11411801|NCT02409355|12607777|FG000|NOT COMPLETED|Overall Study||4
11411802|NCT02409355|12607778|FG001|NOT COMPLETED|Overall Study||4
11411803|NCT02403154|12607788|FG000|STARTED|Overall Study||2
11411804|NCT02403154|12607789|FG001|STARTED|Overall Study||0
11411805|NCT02403154|12607790|FG002|STARTED|Overall Study||1
11411806|NCT02403154|12607791|FG003|STARTED|Overall Study||1
11411807|NCT02403154|12607788|FG000|COMPLETED|Overall Study||0
11411808|NCT02403154|12607789|FG001|COMPLETED|Overall Study||0
11411809|NCT02403154|12607790|FG002|COMPLETED|Overall Study||0
11411810|NCT02403154|12607791|FG003|COMPLETED|Overall Study||0
11411811|NCT02403154|12607788|FG000|NOT COMPLETED|Overall Study||2
11411812|NCT02403154|12607789|FG001|NOT COMPLETED|Overall Study||0
11411813|NCT02403154|12607790|FG002|NOT COMPLETED|Overall Study||1
11411814|NCT02403154|12607791|FG003|NOT COMPLETED|Overall Study||1
11411815|NCT02404545|12607803|FG000|STARTED|Overall Study||6
11411816|NCT02404545|12607804|FG001|STARTED|Overall Study||6
11411817|NCT02404545|12607803|FG000|COMPLETED|Overall Study||0
11411818|NCT02404545|12607804|FG001|COMPLETED|Overall Study||0
11411819|NCT02404545|12607803|FG000|NOT COMPLETED|Overall Study||6
11411820|NCT02404545|12607804|FG001|NOT COMPLETED|Overall Study||6
11411821|NCT02392377|12607813|FG000|STARTED|Overall Study||0
11411822|NCT02392377|12607814|FG001|STARTED|Overall Study||1
11411823|NCT02392377|12607813|FG000|COMPLETED|Overall Study||0
11411824|NCT02392377|12607814|FG001|COMPLETED|Overall Study||0
11411825|NCT02392377|12607813|FG000|NOT COMPLETED|Overall Study||0
11411826|NCT02392377|12607814|FG001|NOT COMPLETED|Overall Study||1
11411827|NCT02399111|12607826|FG000|STARTED|Overall Study||4
11411828|NCT02399111|12607827|FG001|STARTED|Overall Study||1
11411829|NCT02399111|12607828|FG002|STARTED|Overall Study||4
11411830|NCT02399111|12607829|FG003|STARTED|Overall Study||0
11411831|NCT02399111|12607826|FG000|COMPLETED|Overall Study||4
11411832|NCT02399111|12607827|FG001|COMPLETED|Overall Study||1
11411833|NCT02399111|12607828|FG002|COMPLETED|Overall Study||4
11411834|NCT02399111|12607829|FG003|COMPLETED|Overall Study||0
11411835|NCT02399111|12607826|FG000|NOT COMPLETED|Overall Study||0
11411836|NCT02399111|12607827|FG001|NOT COMPLETED|Overall Study||0
11411837|NCT02399111|12607828|FG002|NOT COMPLETED|Overall Study||0
11411838|NCT02399111|12607829|FG003|NOT COMPLETED|Overall Study||0
11411839|NCT02402036|12607841|FG000|STARTED|Overall Study||10
11411840|NCT02402036|12607841|FG000|COMPLETED|Overall Study||10
11411841|NCT02402036|12607841|FG000|NOT COMPLETED|Overall Study||0
11411842|NCT02394665|12607848|FG000|STARTED|Overall Study||1
11411843|NCT02394665|12607849|FG001|STARTED|Overall Study||0
11411844|NCT02394665|12607850|FG002|STARTED|Overall Study||0
11411845|NCT02394665|12607848|FG000|COMPLETED|Overall Study||0
11411846|NCT02394665|12607849|FG001|COMPLETED|Overall Study||0
11411847|NCT02394665|12607850|FG002|COMPLETED|Overall Study||0
11411848|NCT02394665|12607848|FG000|NOT COMPLETED|Overall Study||1
11411849|NCT02394665|12607849|FG001|NOT COMPLETED|Overall Study||0
11411850|NCT02394665|12607850|FG002|NOT COMPLETED|Overall Study||0
11411851|NCT02389712|12607860|FG000|STARTED|Overall Study||1
11411852|NCT02389712|12607861|FG001|STARTED|Overall Study||1
11411853|NCT02389712|12607860|FG000|COMPLETED|Overall Study||1
11411854|NCT02389712|12607861|FG001|COMPLETED|Overall Study||1
11411855|NCT02389712|12607860|FG000|NOT COMPLETED|Overall Study||0
11411856|NCT02389712|12607861|FG001|NOT COMPLETED|Overall Study||0
11411857|NCT02390362|12607869|FG000|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1
11411858|NCT02390362|12607870|FG001|STARTED|Overall Study||2
11411859|NCT02390362|12607869|FG000|COMPLETED|Overall Study||1
11411860|NCT02390362|12607870|FG001|COMPLETED|Overall Study||1
11411861|NCT02390362|12607869|FG000|NOT COMPLETED|Overall Study||0
11411862|NCT02390362|12607870|FG001|NOT COMPLETED|Overall Study||1
11411863|NCT02388776|12607876|FG000|STARTED|Overall Study||2
11411864|NCT02388776|12607876|FG000|COMPLETED|Overall Study||0
11411865|NCT02388776|12607876|FG000|NOT COMPLETED|Overall Study||2
11411866|NCT02383433|12607881|FG000|STARTED|Overall Study||2
11411867|NCT02383433|12607881|FG000|COMPLETED|Overall Study||0
11411868|NCT02383433|12607881|FG000|NOT COMPLETED|Overall Study||2
11411869|NCT02382588|12607887|FG000|STARTED|Overall Study||4
11411870|NCT02382588|12607888|FG001|STARTED|Overall Study||4
11411871|NCT02382588|12607887|FG000|COMPLETED|Overall Study||4
11411872|NCT02382588|12607888|FG001|COMPLETED|Overall Study||4
11411873|NCT02382588|12607887|FG000|NOT COMPLETED|Overall Study||0
11411874|NCT02382588|12607888|FG001|NOT COMPLETED|Overall Study||0
11411875|NCT02381626|12607897|FG000|STARTED|Overall Study||17
11411876|NCT02381626|12607898|FG001|STARTED|Overall Study||16
11411877|NCT02381626|12607899|FG002|STARTED|Overall Study||6
11411878|NCT02381626|12607897|FG000|COMPLETED|Overall Study||17
11411879|NCT02381626|12607898|FG001|COMPLETED|Overall Study||16
11411880|NCT02381626|12607899|FG002|COMPLETED|Overall Study||6
11411881|NCT02381626|12607897|FG000|NOT COMPLETED|Overall Study||0
11411882|NCT02381626|12607898|FG001|NOT COMPLETED|Overall Study||0
11411883|NCT02381626|12607899|FG002|NOT COMPLETED|Overall Study||0
11411884|NCT02379390|12607909|FG000|STARTED|Overall Study||4
11411885|NCT02379390|12607910|FG001|STARTED|Overall Study||4
11411886|NCT02379390|12607909|FG000|COMPLETED|Overall Study||2
11411887|NCT02379390|12607910|FG001|COMPLETED|Overall Study||2
11411888|NCT02379390|12607909|FG000|NOT COMPLETED|Overall Study||2
11411889|NCT02379390|12607910|FG001|NOT COMPLETED|Overall Study||2
11411890|NCT02373865|12607921|FG000|STARTED|Overall Study||2
11411891|NCT02373865|12607922|FG001|STARTED|Overall Study||2
11411892|NCT02373865|12607921|FG000|COMPLETED|Overall Study||2
11411893|NCT02373865|12607922|FG001|COMPLETED|Overall Study||2
11411894|NCT02373865|12607921|FG000|NOT COMPLETED|Overall Study||0
11411895|NCT02373865|12607922|FG001|NOT COMPLETED|Overall Study||0
11411896|NCT02365688|12607928|FG000|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
11411897|NCT02365688|12607928|FG000|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
11411898|NCT02365688|12607928|FG000|NOT COMPLETED|Overall Study||0
11411899|NCT02361580|12607934|FG000|STARTED|Overall Study||6
11411900|NCT02361580|12607935|FG001|STARTED|Overall Study||3
11411901|NCT02361580|12607934|FG000|COMPLETED|Overall Study||0
11411902|NCT02361580|12607935|FG001|COMPLETED|Overall Study||0
11411903|NCT02361580|12607934|FG000|NOT COMPLETED|Overall Study||6
11411904|NCT02361580|12607935|FG001|NOT COMPLETED|Overall Study||3
11411905|NCT02369744|12607943|FG000|STARTED|Overall Study||0
11411906|NCT02369744|12607944|FG001|STARTED|Overall Study||0
11411907|NCT02369744|12607943|FG000|COMPLETED|Overall Study||0
11411908|NCT02369744|12607944|FG001|COMPLETED|Overall Study||0
11411909|NCT02369744|12607943|FG000|NOT COMPLETED|Overall Study||0
11411910|NCT02369744|12607944|FG001|NOT COMPLETED|Overall Study||0
11411911|NCT02379585|12607952|FG000|STARTED|Overall Study||3
11411912|NCT02379585|12607953|FG001|STARTED|Overall Study||5
11411913|NCT02379585|12607952|FG000|COMPLETED|Overall Study||0
11411914|NCT02379585|12607953|FG001|COMPLETED|Overall Study||0
11411915|NCT02379585|12607952|FG000|NOT COMPLETED|Overall Study||3
11411916|NCT02379585|12607953|FG001|NOT COMPLETED|Overall Study||5
11411917|NCT02370888|12607966|FG000|STARTED|Overall Study||9
11411918|NCT02370888|12607966|FG000|Proceed to Treatment|Overall Study||3
11411919|NCT02370888|12607966|FG000|COMPLETED|Overall Study||1
11411920|NCT02370888|12607966|FG000|NOT COMPLETED|Overall Study||8
11411921|NCT02367170|12607976|FG000|STARTED|Overall Study||1
11411922|NCT02367170|12607977|FG001|STARTED|Overall Study||0
11411923|NCT02367170|12607976|FG000|COMPLETED|Overall Study||1
11411924|NCT02367170|12607977|FG001|COMPLETED|Overall Study||0
11411925|NCT02367170|12607976|FG000|NOT COMPLETED|Overall Study||0
11411926|NCT02367170|12607977|FG001|NOT COMPLETED|Overall Study||0
11411927|NCT02376933|12607983|FG000|STARTED|Overall Study||10
11411928|NCT02376933|12607983|FG000|COMPLETED|Overall Study||8
11411929|NCT02376933|12607983|FG000|NOT COMPLETED|Overall Study||2
11411930|NCT02365233|12607990|FG000|STARTED|Overall Study||1
11411931|NCT02365233|12607991|FG001|STARTED|Overall Study||2
11411932|NCT02365233|12607992|FG002|STARTED|Overall Study||2
11411933|NCT02365233|12607990|FG000|COMPLETED|Overall Study||0
11411934|NCT02365233|12607991|FG001|COMPLETED|Overall Study||0
11411935|NCT02365233|12607992|FG002|COMPLETED|Overall Study||0
11411936|NCT02365233|12607990|FG000|NOT COMPLETED|Overall Study||1
11411937|NCT02365233|12607991|FG001|NOT COMPLETED|Overall Study||2
11411938|NCT02365233|12607992|FG002|NOT COMPLETED|Overall Study||2
11411939|NCT02347943|12608003|FG000|STARTED|Overall Study||140
11411940|NCT02347943|12608004|FG001|STARTED|Overall Study||67
11411941|NCT02347943|12608005|FG002|STARTED|Overall Study||45
11411942|NCT02347943|12608003|FG000|COMPLETED|Overall Study||0
11411943|NCT02347943|12608004|FG001|COMPLETED|Overall Study||0
11411944|NCT02347943|12608005|FG002|COMPLETED|Overall Study||0
11411945|NCT02347943|12608003|FG000|NOT COMPLETED|Overall Study||140
11411946|NCT02347943|12608004|FG001|NOT COMPLETED|Overall Study||67
11411947|NCT02347943|12608005|FG002|NOT COMPLETED|Overall Study||45
11411948|NCT02365207|12608013|FG000|STARTED|Overall Study||6
11411949|NCT02365207|12608013|FG000|COMPLETED|Overall Study||4
11411950|NCT02365207|12608013|FG000|NOT COMPLETED|Overall Study||2
11411951|NCT02360111|12608017|FG000|STARTED|Overall Study||3
11411952|NCT02360111|12608017|FG000|COMPLETED|Overall Study||1
11411953|NCT02360111|12608017|FG000|NOT COMPLETED|Overall Study||2
11411954|NCT02353468|12608021|FG000|STARTED|Overall Study||3
11411955|NCT02353468|12608021|FG000|COMPLETED|Overall Study||0
11411956|NCT02353468|12608021|FG000|NOT COMPLETED|Overall Study||3
11411957|NCT02360059|12608027|FG000|STARTED|Overall Study||1
11411958|NCT02360059|12608028|FG001|STARTED|Overall Study||0
11411959|NCT02360059|12608027|FG000|COMPLETED|Overall Study||1
11411960|NCT02360059|12608028|FG001|COMPLETED|Overall Study||0
11411961|NCT02360059|12608027|FG000|NOT COMPLETED|Overall Study||0
11411962|NCT02360059|12608028|FG001|NOT COMPLETED|Overall Study||0
11411963|NCT02350777|12608036|FG000|STARTED|Overall Study||2
11411964|NCT02350777|12608037|FG001|STARTED|Overall Study||2
11411965|NCT02350777|12608036|FG000|COMPLETED|Overall Study||2
11411966|NCT02350777|12608037|FG001|COMPLETED|Overall Study||2
11411967|NCT02350777|12608036|FG000|NOT COMPLETED|Overall Study||0
11411968|NCT02350777|12608037|FG001|NOT COMPLETED|Overall Study||0
11411969|NCT02345460|12608043|FG000|STARTED|Overall Study||1
11411970|NCT02345460|12608043|FG000|COMPLETED|Overall Study||1
11411971|NCT02345460|12608043|FG000|NOT COMPLETED|Overall Study||0
11411972|NCT02346877|12608049|FG000|STARTED|Overall Study||19
11411973|NCT02346877|12608050|FG001|STARTED|Overall Study||0
11411974|NCT02346877|12608049|FG000|COMPLETED|Overall Study||0
11411975|NCT02346877|12608050|FG001|COMPLETED|Overall Study||0
11411976|NCT02346877|12608049|FG000|NOT COMPLETED|Overall Study||19
11411977|NCT02346877|12608050|FG001|NOT COMPLETED|Overall Study||0
11411978|NCT02351063|12608056|FG000|STARTED|Overall Study||1
11411979|NCT02351063|12608056|FG000|COMPLETED|Overall Study|Study terminated. No study data collected.|1
11411980|NCT02351063|12608056|FG000|NOT COMPLETED|Overall Study||0
11411981|NCT02345772|12608060|FG000|STARTED|Overall Study||4
11411982|NCT02345772|12608060|FG000|COMPLETED|Overall Study||0
11411983|NCT02345772|12608060|FG000|NOT COMPLETED|Overall Study||4
11411984|NCT02340728|12608066|FG000|STARTED|Overall Study||13
11411985|NCT02340728|12608067|FG001|STARTED|Overall Study||11
11411986|NCT02340728|12608066|FG000|COMPLETED|Overall Study||13
11411987|NCT02340728|12608067|FG001|COMPLETED|Overall Study||11
11411988|NCT02340728|12608066|FG000|NOT COMPLETED|Overall Study||0
11411989|NCT02340728|12608067|FG001|NOT COMPLETED|Overall Study||0
11411990|NCT02353572|12608073|FG000|STARTED|Overall Study||3
11411991|NCT02353572|12608073|FG000|COMPLETED|Overall Study||0
11411992|NCT02353572|12608073|FG000|NOT COMPLETED|Overall Study||3
11411993|NCT02345369|12608079|FG000|STARTED|Overall Study||0
11411994|NCT02345369|12608080|FG001|STARTED|Overall Study||0
11411995|NCT02345369|12608079|FG000|COMPLETED|Overall Study||0
11411996|NCT02345369|12608080|FG001|COMPLETED|Overall Study||0
11411997|NCT02345369|12608079|FG000|NOT COMPLETED|Overall Study||0
11411998|NCT02345369|12608080|FG001|NOT COMPLETED|Overall Study||0
11411999|NCT02343263|12608089|FG000|STARTED|Overall Study|Study closed due for administrative reasons|5
11412000|NCT02343263|12608090|FG001|STARTED|Overall Study||3
11412001|NCT02343263|12608091|FG002|STARTED|Overall Study||1
11412002|NCT02343263|12608089|FG000|COMPLETED|Overall Study|Study closed due for administrative reasons|0
11412003|NCT02343263|12608090|FG001|COMPLETED|Overall Study||0
11412004|NCT02343263|12608091|FG002|COMPLETED|Overall Study||0
11412005|NCT02343263|12608089|FG000|NOT COMPLETED|Overall Study||5
11412006|NCT02343263|12608090|FG001|NOT COMPLETED|Overall Study||3
11412007|NCT02343263|12608091|FG002|NOT COMPLETED|Overall Study||1
11412008|NCT02343159|12608106|FG000|STARTED|Overall Study||27
11412009|NCT02343159|12608107|FG001|STARTED|Overall Study||27
11412010|NCT02343159|12608108|FG002|STARTED|Overall Study||30
11412011|NCT02343159|12608106|FG000|COMPLETED|Overall Study||1
11412012|NCT02343159|12608107|FG001|COMPLETED|Overall Study||1
11412013|NCT02343159|12608108|FG002|COMPLETED|Overall Study||0
11412014|NCT02343159|12608106|FG000|NOT COMPLETED|Overall Study||26
11412015|NCT02343159|12608107|FG001|NOT COMPLETED|Overall Study||26
11412016|NCT02343159|12608108|FG002|NOT COMPLETED|Overall Study||30
11412017|NCT02341495|12608117|FG000|STARTED|Overall Study||4
11412018|NCT02341495|12608117|FG000|COMPLETED|Overall Study||4
11412019|NCT02341495|12608117|FG000|NOT COMPLETED|Overall Study||0
11412020|NCT02336425|12608125|FG000|STARTED|Overall Study||2
11412021|NCT02336425|12608126|FG001|STARTED|Overall Study||2
11412022|NCT02336425|12608127|FG002|STARTED|Overall Study||3
11412023|NCT02336425|12608128|FG003|STARTED|Overall Study||3
11412024|NCT02336425|12608125|FG000|COMPLETED|Overall Study||0
11412025|NCT02336425|12608126|FG001|COMPLETED|Overall Study||0
11412026|NCT02336425|12608127|FG002|COMPLETED|Overall Study||0
11412027|NCT02336425|12608128|FG003|COMPLETED|Overall Study||0
11412028|NCT02336425|12608125|FG000|NOT COMPLETED|Overall Study||2
11412029|NCT02336425|12608126|FG001|NOT COMPLETED|Overall Study||2
11412030|NCT02336425|12608127|FG002|NOT COMPLETED|Overall Study||3
11412031|NCT02336425|12608128|FG003|NOT COMPLETED|Overall Study||3
11412032|NCT02336763|12608138|FG000|STARTED|Overall Study||2
11412033|NCT02336763|12608138|FG000|COMPLETED|Overall Study||2
11412034|NCT02336763|12608138|FG000|NOT COMPLETED|Overall Study||0
11412035|NCT02320825|12608144|FG000|STARTED|Overall Study||8
11412036|NCT02320825|12608145|FG001|STARTED|Overall Study||8
11412037|NCT02320825|12608144|FG000|COMPLETED|Overall Study||8
11412038|NCT02320825|12608145|FG001|COMPLETED|Overall Study||8
11412039|NCT02320825|12608144|FG000|NOT COMPLETED|Overall Study||0
11412040|NCT02320825|12608145|FG001|NOT COMPLETED|Overall Study||0
11412041|NCT02319005|12608153|FG000|STARTED|Overall Study||140
11412042|NCT02319005|12608154|FG001|STARTED|Overall Study||66
11412043|NCT02319005|12608153|FG000|COMPLETED|Overall Study||92
11412044|NCT02319005|12608154|FG001|COMPLETED|Overall Study||51
11412045|NCT02319005|12608153|FG000|NOT COMPLETED|Overall Study||48
11412046|NCT02319005|12608154|FG001|NOT COMPLETED|Overall Study||15
11412047|NCT02318901|12608163|FG000|STARTED|Overall Study||5
11412048|NCT02318901|12608164|FG001|STARTED|Overall Study||1
11412049|NCT02318901|12608165|FG002|STARTED|Overall Study||10
11412050|NCT02318901|12608163|FG000|COMPLETED|Overall Study||0
11412051|NCT02318901|12608164|FG001|COMPLETED|Overall Study||0
11412052|NCT02318901|12608165|FG002|COMPLETED|Overall Study||0
11412053|NCT02318901|12608163|FG000|NOT COMPLETED|Overall Study||5
11412054|NCT02318901|12608164|FG001|NOT COMPLETED|Overall Study||1
11412055|NCT02318901|12608165|FG002|NOT COMPLETED|Overall Study||10
11412056|NCT02317276|12608173|FG000|STARTED|Overall Study||11
11412057|NCT02317276|12608173|FG000|COMPLETED|Overall Study||5
11412058|NCT02317276|12608173|FG000|NOT COMPLETED|Overall Study||6
11412059|NCT02307188|12608177|FG000|STARTED|Overall Study||5
11412060|NCT02307188|12608177|FG000|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
11412061|NCT02307188|12608177|FG000|NOT COMPLETED|Overall Study||4
11412062|NCT02308475|12608181|FG000|STARTED|Overall Study||2
11412063|NCT02308475|12608181|FG000|COMPLETED|Overall Study||2
11412064|NCT02308475|12608181|FG000|NOT COMPLETED|Overall Study||0
11412065|NCT02308735|12608189|FG000|STARTED|Overall Study||2
11412066|NCT02308735|12608190|FG001|STARTED|Overall Study||0
11412067|NCT02308735|12608191|FG002|STARTED|Overall Study||0
11412068|NCT02308735|12608192|FG003|STARTED|Overall Study||2
11412069|NCT02308735|12608189|FG000|COMPLETED|Overall Study||0
11412070|NCT02308735|12608190|FG001|COMPLETED|Overall Study||0
11412071|NCT02308735|12608191|FG002|COMPLETED|Overall Study||0
11412072|NCT02308735|12608192|FG003|COMPLETED|Overall Study||0
11412073|NCT02308735|12608189|FG000|NOT COMPLETED|Overall Study||2
11412074|NCT02308735|12608190|FG001|NOT COMPLETED|Overall Study||0
11412075|NCT02308735|12608191|FG002|NOT COMPLETED|Overall Study||0
11412076|NCT02308735|12608192|FG003|NOT COMPLETED|Overall Study||2
11412077|NCT02299206|12608202|FG000|STARTED|Overall Study||4
11412078|NCT02299206|12608202|FG000|COMPLETED|Overall Study||2
11412079|NCT02299206|12608202|FG000|NOT COMPLETED|Overall Study||2
11412080|NCT02302859|12608208|FG000|STARTED|Overall Study||2
11412081|NCT02302859|12608209|FG001|STARTED|Overall Study||6
11412082|NCT02302859|12608208|FG000|COMPLETED|Overall Study||1
11412083|NCT02302859|12608209|FG001|COMPLETED|Overall Study||4
11412084|NCT02302859|12608208|FG000|NOT COMPLETED|Overall Study||1
11412085|NCT02302859|12608209|FG001|NOT COMPLETED|Overall Study||2
11412086|NCT02299934|12608215|FG000|STARTED|Overall Study||13
11412087|NCT02299934|12608215|FG000|COMPLETED|Overall Study||0
11412088|NCT02299934|12608215|FG000|NOT COMPLETED|Overall Study||13
11144082|NCT01475487|12330726|FG000|COMPLETED|Overall Study||23
11144083|NCT01475487|12330727|FG001|COMPLETED|Overall Study||24
11144084|NCT01475487|12330726|FG000|NOT COMPLETED|Overall Study||2
11144085|NCT01475487|12330727|FG001|NOT COMPLETED|Overall Study||1
11144086|NCT01475513|12330735|FG000|STARTED|Overall Study||20
11144087|NCT01475513|12330736|FG001|STARTED|Overall Study||26
11144088|NCT01475513|12330735|FG000|COMPLETED|Overall Study||17
11144089|NCT01475513|12330736|FG001|COMPLETED|Overall Study||16
11144090|NCT01475513|12330735|FG000|NOT COMPLETED|Overall Study||3
11412089|NCT02297230|12608223|FG000|STARTED|Overall Study||11
11412090|NCT02297230|12608224|FG001|STARTED|Overall Study||11
11412091|NCT02297230|12608225|FG002|STARTED|Overall Study||11
11412092|NCT02297230|12608226|FG003|STARTED|Overall Study||11
11412093|NCT02297230|12608223|FG000|COMPLETED|Overall Study||11
11412094|NCT02297230|12608224|FG001|COMPLETED|Overall Study||11
11412095|NCT02297230|12608225|FG002|COMPLETED|Overall Study||11
11412096|NCT02297230|12608226|FG003|COMPLETED|Overall Study||11
11412097|NCT02297230|12608223|FG000|NOT COMPLETED|Overall Study||0
11412098|NCT02297230|12608224|FG001|NOT COMPLETED|Overall Study||0
11412099|NCT02297230|12608225|FG002|NOT COMPLETED|Overall Study||0
11412100|NCT02297230|12608226|FG003|NOT COMPLETED|Overall Study||0
11412101|NCT02294981|12608242|FG000|STARTED|Overall Study||4
11412102|NCT02294981|12608242|FG000|COMPLETED|Overall Study||3
11412103|NCT02294981|12608242|FG000|NOT COMPLETED|Overall Study||1
11412104|NCT02284906|12608249|FG000|STARTED|Overall Study||3
11412105|NCT02284906|12608250|FG001|STARTED|Overall Study||18
11412106|NCT02284906|12608251|FG002|STARTED|Overall Study||19
11412107|NCT02284906|12608249|FG000|COMPLETED|Overall Study||0
11412108|NCT02284906|12608250|FG001|COMPLETED|Overall Study||0
11412109|NCT02284906|12608251|FG002|COMPLETED|Overall Study||0
11412110|NCT02284906|12608249|FG000|NOT COMPLETED|Overall Study||3
11412111|NCT02284906|12608250|FG001|NOT COMPLETED|Overall Study||18
11412112|NCT02284906|12608251|FG002|NOT COMPLETED|Overall Study||19
11412113|NCT02287025|12608261|FG000|STARTED|Overall Study||12
11412114|NCT02287025|12608262|FG001|STARTED|Overall Study||11
11412115|NCT02287025|12608261|FG000|COMPLETED|Overall Study||2
11412116|NCT02287025|12608262|FG001|COMPLETED|Overall Study||2
11412117|NCT02287025|12608261|FG000|NOT COMPLETED|Overall Study||10
11412118|NCT02287025|12608262|FG001|NOT COMPLETED|Overall Study||9
11412119|NCT02282332|12608266|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
11412120|NCT02282332|12608266|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
11412121|NCT02282332|12608266|FG000|NOT COMPLETED|Overall Study||0
11412122|NCT02287636|12608270|FG000|STARTED|Overall Study||13
11412123|NCT02287636|12608270|FG000|COMPLETED|Overall Study||13
11412124|NCT02287636|12608270|FG000|NOT COMPLETED|Overall Study||0
11412125|NCT02276560|12608277|FG000|STARTED|Overall Study||1
11412126|NCT02276560|12608278|FG001|STARTED|Overall Study||0
11412127|NCT02276560|12608279|FG002|STARTED|Overall Study||0
11412128|NCT02276560|12608277|FG000|COMPLETED|Overall Study||0
11412129|NCT02276560|12608278|FG001|COMPLETED|Overall Study||0
11412130|NCT02276560|12608279|FG002|COMPLETED|Overall Study||0
11412131|NCT02276560|12608277|FG000|NOT COMPLETED|Overall Study||1
11412132|NCT02276560|12608278|FG001|NOT COMPLETED|Overall Study||0
11412133|NCT02276560|12608279|FG002|NOT COMPLETED|Overall Study||0
11412134|NCT02280252|12608287|FG000|STARTED|Overall Study||0
11412135|NCT02280252|12608287|FG000|COMPLETED|Overall Study||0
11412136|NCT02280252|12608287|FG000|NOT COMPLETED|Overall Study||0
11412137|NCT02284373|12608294|FG000|STARTED|Overall Study||5
11412138|NCT02284373|12608295|FG001|STARTED|Overall Study||5
11412139|NCT02284373|12608296|FG002|STARTED|Overall Study||29
11412140|NCT02284373|12608294|FG000|COMPLETED|Overall Study||5
11412141|NCT02284373|12608295|FG001|COMPLETED|Overall Study||2
11412142|NCT02284373|12608296|FG002|COMPLETED|Overall Study||29
11412143|NCT02284373|12608294|FG000|NOT COMPLETED|Overall Study||0
11412144|NCT02284373|12608295|FG001|NOT COMPLETED|Overall Study||3
11412145|NCT02284373|12608296|FG002|NOT COMPLETED|Overall Study||0
11412146|NCT02285270|12608304|FG000|STARTED|Overall Study||10
11412147|NCT02285270|12608304|FG000|COMPLETED|Overall Study||5
11412148|NCT02285270|12608304|FG000|NOT COMPLETED|Overall Study||5
11412149|NCT02275481|12608310|FG000|STARTED|Overall Study||32
11412150|NCT02275481|12608311|FG001|STARTED|Overall Study||34
11412151|NCT02275481|12608310|FG000|COMPLETED|Overall Study||23
11412152|NCT02275481|12608311|FG001|COMPLETED|Overall Study||31
11412153|NCT02275481|12608310|FG000|NOT COMPLETED|Overall Study||9
11412154|NCT02275481|12608311|FG001|NOT COMPLETED|Overall Study||3
11412155|NCT02266914|12608317|FG000|STARTED|Overall Study||9
11412156|NCT02266914|12608317|FG000|COMPLETED|Overall Study||0
11412157|NCT02266914|12608317|FG000|NOT COMPLETED|Overall Study||9
11412158|NCT02273752|12608321|FG000|STARTED|Overall Study||2
11412159|NCT02273752|12608321|FG000|COMPLETED|Overall Study||0
11412160|NCT02273752|12608321|FG000|NOT COMPLETED|Overall Study||2
11412161|NCT02270684|12608327|FG000|STARTED|Overall Study||1
11412162|NCT02270684|12608328|FG001|STARTED|Overall Study||3
11412163|NCT02270684|12608327|FG000|COMPLETED|Overall Study||0
11412164|NCT02270684|12608328|FG001|COMPLETED|Overall Study||0
11412165|NCT02270684|12608327|FG000|NOT COMPLETED|Overall Study||1
11412166|NCT02270684|12608328|FG001|NOT COMPLETED|Overall Study||3
11412167|NCT02262000|12608336|FG000|STARTED|Overall Study||3
11412168|NCT02262000|12608337|FG001|STARTED|Overall Study||0
11412169|NCT02262000|12608336|FG000|COMPLETED|Overall Study||3
11412170|NCT02262000|12608337|FG001|COMPLETED|Overall Study||0
11412171|NCT02262000|12608336|FG000|NOT COMPLETED|Overall Study||0
11412172|NCT02262000|12608337|FG001|NOT COMPLETED|Overall Study||0
11412173|NCT02271594|12608345|FG000|STARTED|Overall Study||19
11412174|NCT02271594|12608346|FG001|STARTED|Overall Study||12
11412175|NCT02271594|12608345|FG000|COMPLETED|Overall Study|Study closed down|0
11412176|NCT02271594|12608346|FG001|COMPLETED|Overall Study|Study closed down|0
11412177|NCT02271594|12608345|FG000|NOT COMPLETED|Overall Study||19
11412178|NCT02271594|12608346|FG001|NOT COMPLETED|Overall Study||12
11412179|NCT02263365|12608356|FG000|STARTED|Overall Study||22
11412180|NCT02263365|12608357|FG001|STARTED|Overall Study||18
11412181|NCT02263365|12608356|FG000|COMPLETED|Overall Study||0
11412182|NCT02263365|12608357|FG001|COMPLETED|Overall Study||0
11412183|NCT02263365|12608356|FG000|NOT COMPLETED|Overall Study||22
11412184|NCT02263365|12608357|FG001|NOT COMPLETED|Overall Study||18
11412185|NCT02266797|12608366|FG000|STARTED|Overall Study||1
11412186|NCT02266797|12608367|FG001|STARTED|Overall Study||3
11412187|NCT02266797|12608366|FG000|COMPLETED|Overall Study||1
11412188|NCT02266797|12608367|FG001|COMPLETED|Overall Study||2
11412189|NCT02266797|12608366|FG000|NOT COMPLETED|Overall Study||0
11412190|NCT02266797|12608367|FG001|NOT COMPLETED|Overall Study||1
11412191|NCT02249377|12608375|FG000|STARTED|Overall Study||25
11412192|NCT02249377|12608376|FG001|STARTED|Overall Study||25
11412193|NCT02249377|12608375|FG000|COMPLETED|Overall Study||0
11412194|NCT02249377|12608376|FG001|COMPLETED|Overall Study||1
11412195|NCT02249377|12608375|FG000|NOT COMPLETED|Overall Study||25
11412196|NCT02249377|12608376|FG001|NOT COMPLETED|Overall Study||24
11412197|NCT02253394|12608382|FG000|STARTED|Overall Study||0
11412198|NCT02253394|12608383|FG001|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2
11412199|NCT02253394|12608382|FG000|COMPLETED|Overall Study||0
11412200|NCT02253394|12608383|FG001|COMPLETED|Overall Study||2
11412201|NCT02253394|12608382|FG000|NOT COMPLETED|Overall Study||0
11412202|NCT02253394|12608383|FG001|NOT COMPLETED|Overall Study||0
11412203|NCT02241551|12608391|FG000|STARTED|Overall Study||1
11412204|NCT02241551|12608392|FG001|STARTED|Overall Study||0
11412205|NCT02241551|12608391|FG000|COMPLETED|Overall Study||0
11412206|NCT02241551|12608392|FG001|COMPLETED|Overall Study||0
11412207|NCT02241551|12608391|FG000|NOT COMPLETED|Overall Study||1
11412208|NCT02241551|12608392|FG001|NOT COMPLETED|Overall Study||0
11412209|NCT02246114|12608402|FG000|STARTED|Overall Study||1
11412210|NCT02246114|12608403|FG001|STARTED|Overall Study||0
11412211|NCT02246114|12608402|FG000|COMPLETED|Overall Study||0
11412212|NCT02246114|12608403|FG001|COMPLETED|Overall Study||0
11412213|NCT02246114|12608402|FG000|NOT COMPLETED|Overall Study||1
11412214|NCT02246114|12608403|FG001|NOT COMPLETED|Overall Study||0
11412215|NCT02232880|12608409|FG000|STARTED|Overall Study||1
11412216|NCT02232880|12608409|FG000|COMPLETED|Overall Study||0
11412217|NCT02232880|12608409|FG000|NOT COMPLETED|Overall Study||1
11412218|NCT02248740|12608415|FG000|STARTED|Overall Study||18
11412219|NCT02248740|12608416|FG001|STARTED|Overall Study||18
11412220|NCT02248740|12608415|FG000|COMPLETED|Overall Study||0
11412221|NCT02248740|12608416|FG001|COMPLETED|Overall Study||0
11412222|NCT02248740|12608415|FG000|NOT COMPLETED|Overall Study||18
11412223|NCT02248740|12608416|FG001|NOT COMPLETED|Overall Study||18
11412224|NCT02239627|12608424|FG000|STARTED|Overall Study||0
11412225|NCT02239627|12608425|FG001|STARTED|Overall Study||0
11412226|NCT02239627|12608424|FG000|COMPLETED|Overall Study||0
11412227|NCT02239627|12608425|FG001|COMPLETED|Overall Study||0
11412228|NCT02239627|12608424|FG000|NOT COMPLETED|Overall Study||0
11412229|NCT02239627|12608425|FG001|NOT COMPLETED|Overall Study||0
11412230|NCT02244944|12608431|FG000|STARTED|Overall Study||2
11412231|NCT02244944|12608431|FG000|COMPLETED|Overall Study||0
11412232|NCT02244944|12608431|FG000|NOT COMPLETED|Overall Study||2
11412233|NCT02241187|12608435|FG000|STARTED|Overall Study||2
11412234|NCT02241187|12608435|FG000|COMPLETED|Overall Study||0
11412235|NCT02241187|12608435|FG000|NOT COMPLETED|Overall Study||2
11412236|NCT02239926|12608441|FG000|STARTED|Overall Study||0
11412237|NCT02239926|12608442|FG001|STARTED|Overall Study||2
11412238|NCT02239926|12608441|FG000|COMPLETED|Overall Study||0
11412239|NCT02239926|12608442|FG001|COMPLETED|Overall Study||1
11412240|NCT02239926|12608441|FG000|NOT COMPLETED|Overall Study||0
11412241|NCT02239926|12608442|FG001|NOT COMPLETED|Overall Study||1
11412242|NCT02231892|12608451|FG000|STARTED|Overall Study||17
11412243|NCT02231892|12608452|FG001|STARTED|Overall Study||17
11412244|NCT02231892|12608453|FG002|STARTED|Overall Study||70
11412245|NCT02231892|12608451|FG000|Sham|Overall Study||8
11412246|NCT02231892|12608452|FG001|Sham|Overall Study||5
11412247|NCT02231892|12608453|FG002|Sham|Overall Study||26
11412248|NCT02231892|12608451|FG000|100% MT|Overall Study||7
11412249|NCT02231892|12608452|FG001|100% MT|Overall Study||6
11412250|NCT02231892|12608453|FG002|100% MT|Overall Study||25
11412251|NCT02231892|12608451|FG000|110% MT|Overall Study||7
11412252|NCT02231892|12608452|FG001|110% MT|Overall Study||5
11412253|NCT02231892|12608453|FG002|110% MT|Overall Study||27
11412254|NCT02231892|12608451|FG000|COMPLETED|Overall Study||6
11412255|NCT02231892|12608452|FG001|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency MRI phase, but are only counted in Hi Freq MRI.|5
11412256|NCT02231892|12608453|FG002|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency Beh phase, but are only counted in Hi Freq MRI.|25
11412257|NCT02231892|12608451|FG000|NOT COMPLETED|Overall Study||11
11412258|NCT02231892|12608452|FG001|NOT COMPLETED|Overall Study||12
11412259|NCT02231892|12608453|FG002|NOT COMPLETED|Overall Study||45
11412260|NCT02241343|12608467|FG000|STARTED|Overall Study||1
11412261|NCT02241343|12608467|FG000|COMPLETED|Overall Study||0
11412262|NCT02241343|12608467|FG000|NOT COMPLETED|Overall Study||1
11412263|NCT02242578|12608474|FG000|STARTED|Overall Study||0
11412264|NCT02242578|12608475|FG001|STARTED|Overall Study||0
11412265|NCT02242578|12608474|FG000|COMPLETED|Overall Study||0
11412266|NCT02242578|12608475|FG001|COMPLETED|Overall Study||0
11412267|NCT02242578|12608474|FG000|NOT COMPLETED|Overall Study||0
11412268|NCT02242578|12608475|FG001|NOT COMPLETED|Overall Study||0
11412269|NCT02234011|12608481|FG000|STARTED|Overall Study||0
11412270|NCT02234011|12608481|FG000|COMPLETED|Overall Study||0
11412271|NCT02234011|12608481|FG000|NOT COMPLETED|Overall Study||0
11412272|NCT02236546|12608485|FG000|STARTED|Overall Study||3
11412273|NCT02236546|12608485|FG000|COMPLETED|Overall Study||3
11412274|NCT02236546|12608485|FG000|NOT COMPLETED|Overall Study||0
11412275|NCT02234687|12608492|FG000|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
11412276|NCT02234687|12608493|FG001|STARTED|Overall Study||4
11412277|NCT02234687|12608494|FG002|STARTED|Overall Study||4
11412278|NCT02234687|12608492|FG000|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
11412279|NCT02234687|12608493|FG001|COMPLETED|Overall Study||0
11412280|NCT02234687|12608494|FG002|COMPLETED|Overall Study||0
11412281|NCT02234687|12608492|FG000|NOT COMPLETED|Overall Study||6
11412282|NCT02234687|12608493|FG001|NOT COMPLETED|Overall Study||4
11412283|NCT02234687|12608494|FG002|NOT COMPLETED|Overall Study||4
11412284|NCT02224599|12608502|FG000|STARTED|Overall Study||3
11412285|NCT02224599|12608502|FG000|COMPLETED|Overall Study||1
11412286|NCT02224599|12608502|FG000|NOT COMPLETED|Overall Study||2
11412287|NCT02201472|12608506|FG000|STARTED|Overall Study||2
11412288|NCT02201472|12608506|FG000|COMPLETED|Overall Study||0
11412289|NCT02201472|12608506|FG000|NOT COMPLETED|Overall Study||2
11412290|NCT02202044|12608510|FG000|STARTED|Overall Study||0
11412291|NCT02202044|12608510|FG000|COMPLETED|Overall Study||0
11412292|NCT02202044|12608510|FG000|NOT COMPLETED|Overall Study||0
11412293|NCT02192775|12608514|FG000|STARTED|Overall Study||2
11144091|NCT01475513|12330736|FG001|NOT COMPLETED|Overall Study||10
11144092|NCT01475643|12330746|FG000|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54
11144093|NCT01475643|12330747|FG001|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53
11144094|NCT01475643|12330746|FG000|COMPLETED|Overall Study||40
11144095|NCT01475643|12330747|FG001|COMPLETED|Overall Study||43
11144096|NCT01475643|12330746|FG000|NOT COMPLETED|Overall Study||14
11144097|NCT01475643|12330747|FG001|NOT COMPLETED|Overall Study||10
11144098|NCT01475721|12330755|FG000|STARTED|Overall Study||5834
11144099|NCT01475721|12330756|FG001|STARTED|Overall Study||5845
11144100|NCT01475721|12330755|FG000|COMPLETED|Overall Study||5823
11144101|NCT01475721|12330756|FG001|COMPLETED|Overall Study||5831
11144102|NCT01475721|12330755|FG000|NOT COMPLETED|Overall Study||11
11144103|NCT01475721|12330756|FG001|NOT COMPLETED|Overall Study||14
11144104|NCT01475734|12330764|FG000|STARTED|Overall Study||22
11144105|NCT01475734|12330765|FG001|STARTED|Overall Study||22
11144106|NCT01475734|12330764|FG000|COMPLETED|Overall Study||20
11144107|NCT01475734|12330765|FG001|COMPLETED|Overall Study||21
11144108|NCT01475734|12330764|FG000|NOT COMPLETED|Overall Study||2
11144109|NCT01475734|12330765|FG001|NOT COMPLETED|Overall Study||1
11144110|NCT01475825|12330775|FG000|STARTED|Overall Study||104
11144111|NCT01475825|12330776|FG001|STARTED|Overall Study||51
11144112|NCT01475825|12330777|FG002|STARTED|Overall Study||102
11144113|NCT01475825|12330778|FG003|STARTED|Overall Study||52
11144114|NCT01475825|12330775|FG000|Randomized and Treated|Overall Study||104
11144115|NCT01475825|12330776|FG001|Randomized and Treated|Overall Study||51
11144116|NCT01475825|12330777|FG002|Randomized and Treated|Overall Study||102
11144117|NCT01475825|12330778|FG003|Randomized and Treated|Overall Study||52
11144118|NCT01475825|12330775|FG000|Completed Blinded Treatment Period|Overall Study||60
11144119|NCT01475825|12330776|FG001|Completed Blinded Treatment Period|Overall Study||42
11412294|NCT02192775|12608514|FG000|COMPLETED|Overall Study||0
11412295|NCT02192775|12608514|FG000|NOT COMPLETED|Overall Study||2
11412296|NCT02200328|12608520|FG000|STARTED|Overall Study||43
11412297|NCT02200328|12608521|FG001|STARTED|Overall Study||33
11412298|NCT02200328|12608520|FG000|COMPLETED|Overall Study||0
11412299|NCT02200328|12608521|FG001|COMPLETED|Overall Study||0
11412300|NCT02200328|12608520|FG000|NOT COMPLETED|Overall Study||43
11412301|NCT02200328|12608521|FG001|NOT COMPLETED|Overall Study||33
11412302|NCT02200042|12608529|FG000|STARTED|Overall Study||0
11412303|NCT02200042|12608530|FG001|STARTED|Overall Study||1
11412304|NCT02200042|12608529|FG000|COMPLETED|Overall Study||0
11412305|NCT02200042|12608530|FG001|COMPLETED|Overall Study||0
11412306|NCT02200042|12608529|FG000|NOT COMPLETED|Overall Study||0
11412307|NCT02200042|12608530|FG001|NOT COMPLETED|Overall Study||1
11412308|NCT02181790|12608538|FG000|STARTED|Overall Study||2
11412309|NCT02181790|12608539|FG001|STARTED|Overall Study||0
11412310|NCT02181790|12608538|FG000|COMPLETED|Overall Study||0
11412311|NCT02181790|12608539|FG001|COMPLETED|Overall Study||0
11412312|NCT02181790|12608538|FG000|NOT COMPLETED|Overall Study||2
11412313|NCT02181790|12608539|FG001|NOT COMPLETED|Overall Study||0
11412314|NCT02198833|12608549|FG000|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
11412315|NCT02198833|12608550|FG001|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
11412316|NCT02198833|12608549|FG000|COMPLETED|Overall Study||1
11412317|NCT02198833|12608550|FG001|COMPLETED|Overall Study||1
11412318|NCT02198833|12608549|FG000|NOT COMPLETED|Overall Study||0
11412319|NCT02198833|12608550|FG001|NOT COMPLETED|Overall Study||0
11412320|NCT02175628|12608558|FG000|STARTED|Overall Study||6
11412321|NCT02175628|12608559|FG001|STARTED|Overall Study||17
11412322|NCT02175628|12608558|FG000|COMPLETED|Overall Study||6
11412323|NCT02175628|12608559|FG001|COMPLETED|Overall Study||17
11412324|NCT02175628|12608558|FG000|NOT COMPLETED|Overall Study||0
11412325|NCT02175628|12608559|FG001|NOT COMPLETED|Overall Study||0
11412326|NCT02177266|12608567|FG000|STARTED|Overall Study||1
11412327|NCT02177266|12608568|FG001|STARTED|Overall Study||1
11412328|NCT02177266|12608567|FG000|COMPLETED|Overall Study||0
11412329|NCT02177266|12608568|FG001|COMPLETED|Overall Study||0
11412330|NCT02177266|12608567|FG000|NOT COMPLETED|Overall Study||1
11412331|NCT02177266|12608568|FG001|NOT COMPLETED|Overall Study||1
11412332|NCT02184520|12608576|FG000|STARTED|Overall Study||0
11412333|NCT02184520|12608577|FG001|STARTED|Overall Study||0
11412334|NCT02184520|12608576|FG000|COMPLETED|Overall Study||0
11412335|NCT02184520|12608577|FG001|COMPLETED|Overall Study||0
11412336|NCT02184520|12608576|FG000|NOT COMPLETED|Overall Study||0
11412337|NCT02184520|12608577|FG001|NOT COMPLETED|Overall Study||0
11412338|NCT02170298|12608585|FG000|STARTED|Overall Study||1
11412339|NCT02170298|12608586|FG001|STARTED|Overall Study||5
11412340|NCT02170298|12608585|FG000|COMPLETED|Overall Study||0
11412341|NCT02170298|12608586|FG001|COMPLETED|Overall Study||4
11412342|NCT02170298|12608585|FG000|NOT COMPLETED|Overall Study||1
11412343|NCT02170298|12608586|FG001|NOT COMPLETED|Overall Study||1
11412344|NCT02177773|12608592|FG000|STARTED|Overall Study||300
11412345|NCT02177773|12608592|FG000|COMPLETED|Overall Study||300
11412346|NCT02177773|12608592|FG000|NOT COMPLETED|Overall Study||0
11412347|NCT02162979|12608598|FG000|STARTED|Overall Study||0
11412348|NCT02162979|12608599|FG001|STARTED|Overall Study||0
11412349|NCT02162979|12608598|FG000|COMPLETED|Overall Study||0
11412350|NCT02162979|12608599|FG001|COMPLETED|Overall Study||0
11412351|NCT02162979|12608598|FG000|NOT COMPLETED|Overall Study||0
11412352|NCT02162979|12608599|FG001|NOT COMPLETED|Overall Study||0
11412353|NCT02169830|12608608|FG000|STARTED|Diet Intervention (4 Weeks)||0
11412354|NCT02169830|12608609|FG001|STARTED|Diet Intervention (4 Weeks)||0
11412355|NCT02169830|12608610|FG002|STARTED|Diet Intervention (4 Weeks)||33
11412356|NCT02169830|12608608|FG000|COMPLETED|Diet Intervention (4 Weeks)||0
11412357|NCT02169830|12608609|FG001|COMPLETED|Diet Intervention (4 Weeks)||0
11412358|NCT02169830|12608610|FG002|COMPLETED|Diet Intervention (4 Weeks)||32
11412359|NCT02169830|12608608|FG000|NOT COMPLETED|Diet Intervention (4 Weeks)||0
11412360|NCT02169830|12608609|FG001|NOT COMPLETED|Diet Intervention (4 Weeks)||0
11412361|NCT02169830|12608610|FG002|NOT COMPLETED|Diet Intervention (4 Weeks)||1
11412362|NCT02169830|12608608|FG000|STARTED|Second Intervention (8 Weeks)||12
11412363|NCT02169830|12608609|FG001|STARTED|Second Intervention (8 Weeks)||5
11412364|NCT02169830|12608610|FG002|STARTED|Second Intervention (8 Weeks)||0
11412365|NCT02169830|12608608|FG000|COMPLETED|Second Intervention (8 Weeks)||9
11412366|NCT02169830|12608609|FG001|COMPLETED|Second Intervention (8 Weeks)||0
11412367|NCT02169830|12608610|FG002|COMPLETED|Second Intervention (8 Weeks)||0
11412368|NCT02169830|12608608|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||3
11412369|NCT02169830|12608609|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||5
11412370|NCT02169830|12608610|FG002|NOT COMPLETED|Second Intervention (8 Weeks)||0
11412371|NCT02169830|12608608|FG000|STARTED|Third Intervention (8 Weeks)||0
11412372|NCT02169830|12608609|FG001|STARTED|Third Intervention (8 Weeks)|These four subjects were randomized to Diet first Topiramate second, and Nortriptyline third. No subjects from this group were weaned and moved to Nortriptyline.|4
11412373|NCT02169830|12608610|FG002|STARTED|Third Intervention (8 Weeks)||0
11412374|NCT02169830|12608608|FG000|COMPLETED|Third Intervention (8 Weeks)||0
11412375|NCT02169830|12608609|FG001|COMPLETED|Third Intervention (8 Weeks)||2
11412376|NCT02169830|12608610|FG002|COMPLETED|Third Intervention (8 Weeks)||0
11412377|NCT02169830|12608608|FG000|NOT COMPLETED|Third Intervention (8 Weeks)||0
11412378|NCT02169830|12608609|FG001|NOT COMPLETED|Third Intervention (8 Weeks)||2
11412379|NCT02169830|12608610|FG002|NOT COMPLETED|Third Intervention (8 Weeks)||0
11412380|NCT02163187|12608620|FG000|STARTED|Overall Study||4
11412381|NCT02163187|12608621|FG001|STARTED|Overall Study||0
11412382|NCT02163187|12608620|FG000|Treatment|Overall Study||2
11412383|NCT02163187|12608621|FG001|Treatment|Overall Study||0
11412384|NCT02163187|12608620|FG000|COMPLETED|Overall Study||2
11412385|NCT02163187|12608621|FG001|COMPLETED|Overall Study||0
11412386|NCT02163187|12608620|FG000|NOT COMPLETED|Overall Study||2
11412387|NCT02163187|12608621|FG001|NOT COMPLETED|Overall Study||0
11412388|NCT02161016|12608627|FG000|STARTED|Overall Study||1
11412389|NCT02161016|12608627|FG000|COMPLETED|Overall Study||0
11412390|NCT02161016|12608627|FG000|NOT COMPLETED|Overall Study||1
11412391|NCT02159040|12608631|FG000|STARTED|Overall Study||1
11412392|NCT02159040|12608631|FG000|COMPLETED|Overall Study||0
11412393|NCT02159040|12608631|FG000|NOT COMPLETED|Overall Study||1
11412394|NCT02168270|12608635|FG000|STARTED|Overall Study||4
11412395|NCT02168270|12608635|FG000|COMPLETED|Overall Study||0
11412396|NCT02168270|12608635|FG000|NOT COMPLETED|Overall Study||4
11412397|NCT02157116|12608639|FG000|STARTED|Overall Study|signed consent form|13
11412398|NCT02157116|12608639|FG000|COMPLETED|Overall Study||4
11412399|NCT02157116|12608639|FG000|NOT COMPLETED|Overall Study||9
11412400|NCT02154087|12608643|FG000|STARTED|Overall Study||1
11412401|NCT02154087|12608643|FG000|COMPLETED|Overall Study||0
11412402|NCT02154087|12608643|FG000|NOT COMPLETED|Overall Study||1
11412403|NCT02152670|12608647|FG000|STARTED|Overall Study||1
11412404|NCT02152670|12608647|FG000|COMPLETED|Overall Study||1
11412405|NCT02152670|12608647|FG000|NOT COMPLETED|Overall Study||0
11412406|NCT02152566|12608651|FG000|STARTED|Overall Study||6
11412407|NCT02152566|12608651|FG000|COMPLETED|Overall Study||3
11412408|NCT02152566|12608651|FG000|NOT COMPLETED|Overall Study||3
11412409|NCT02137096|12608655|FG000|STARTED|Overall Study||1
11412410|NCT02137096|12608655|FG000|COMPLETED|Overall Study||1
11412411|NCT02137096|12608655|FG000|NOT COMPLETED|Overall Study||0
11412412|NCT02147834|12608661|FG000|STARTED|Overall Study||3
11412413|NCT02147834|12608662|FG001|STARTED|Overall Study||2
11412414|NCT02147834|12608661|FG000|COMPLETED|Overall Study||3
11412415|NCT02147834|12608662|FG001|COMPLETED|Overall Study||2
11412416|NCT02147834|12608661|FG000|NOT COMPLETED|Overall Study||0
11412417|NCT02147834|12608662|FG001|NOT COMPLETED|Overall Study||0
11412418|NCT02145390|12608668|FG000|STARTED|Overall Study||1
11412419|NCT02145390|12608668|FG000|COMPLETED|Overall Study||0
11412420|NCT02145390|12608668|FG000|NOT COMPLETED|Overall Study||1
11412421|NCT02132884|12608674|FG000|STARTED|Overall Study||0
11412422|NCT02132884|12608675|FG001|STARTED|Overall Study||0
11412423|NCT02132884|12608674|FG000|COMPLETED|Overall Study||0
11412424|NCT02132884|12608675|FG001|COMPLETED|Overall Study||0
11412425|NCT02132884|12608674|FG000|NOT COMPLETED|Overall Study||0
11412426|NCT02132884|12608675|FG001|NOT COMPLETED|Overall Study||0
11412427|NCT02144155|12608681|FG000|STARTED|Overall Study||14
11412428|NCT02144155|12608681|FG000|COMPLETED|Overall Study||14
11412429|NCT02144155|12608681|FG000|NOT COMPLETED|Overall Study||0
11412430|NCT02140788|12608685|FG000|STARTED|Overall Study||0
11412431|NCT02140788|12608686|FG001|STARTED|Overall Study||0
11412432|NCT02140788|12608687|FG002|STARTED|Overall Study||0
11412433|NCT02140788|12608688|FG003|STARTED|Overall Study||0
11412434|NCT02140788|12608685|FG000|COMPLETED|Overall Study||0
11412435|NCT02140788|12608686|FG001|COMPLETED|Overall Study||0
11412436|NCT02140788|12608687|FG002|COMPLETED|Overall Study||0
11412437|NCT02140788|12608688|FG003|COMPLETED|Overall Study||0
11412438|NCT02140788|12608685|FG000|NOT COMPLETED|Overall Study||0
11412439|NCT02140788|12608686|FG001|NOT COMPLETED|Overall Study||0
11412440|NCT02140788|12608687|FG002|NOT COMPLETED|Overall Study||0
11412441|NCT02140788|12608688|FG003|NOT COMPLETED|Overall Study||0
11412442|NCT02150863|12608701|FG000|STARTED|Overall Study||0
11412443|NCT02150863|12608702|FG001|STARTED|Overall Study||1
11412444|NCT02150863|12608703|FG002|STARTED|Overall Study||0
11412445|NCT02150863|12608701|FG000|COMPLETED|Overall Study||0
11412446|NCT02150863|12608702|FG001|COMPLETED|Overall Study||0
11412447|NCT02150863|12608703|FG002|COMPLETED|Overall Study||0
11412448|NCT02150863|12608701|FG000|NOT COMPLETED|Overall Study||0
11412449|NCT02150863|12608702|FG001|NOT COMPLETED|Overall Study||1
11412450|NCT02150863|12608703|FG002|NOT COMPLETED|Overall Study||0
11412451|NCT02145169|12608711|FG000|STARTED|Overall Study||0
11412452|NCT02145169|12608711|FG000|COMPLETED|Overall Study||0
11412453|NCT02145169|12608711|FG000|NOT COMPLETED|Overall Study||0
11412454|NCT02130622|12608717|FG000|STARTED|Overall Study||2
11412455|NCT02130622|12608718|FG001|STARTED|Overall Study||1
11412456|NCT02130622|12608717|FG000|COMPLETED|Overall Study||2
11412457|NCT02130622|12608718|FG001|COMPLETED|Overall Study||1
11412458|NCT02130622|12608717|FG000|NOT COMPLETED|Overall Study||0
11412459|NCT02130622|12608718|FG001|NOT COMPLETED|Overall Study||0
11412460|NCT02133534|12608724|FG000|STARTED|Overall Study||1
11412461|NCT02133534|12608724|FG000|COMPLETED|Overall Study||1
11412462|NCT02133534|12608724|FG000|NOT COMPLETED|Overall Study||0
11412463|NCT02134912|12608730|FG000|STARTED|Overall Study||0
11412464|NCT02134912|12608731|FG001|STARTED|Overall Study||0
11412465|NCT02134912|12608730|FG000|COMPLETED|Overall Study||0
11412466|NCT02134912|12608731|FG001|COMPLETED|Overall Study||0
11412467|NCT02134912|12608730|FG000|NOT COMPLETED|Overall Study||0
11412468|NCT02134912|12608731|FG001|NOT COMPLETED|Overall Study||0
11412469|NCT02131155|12608739|FG000|STARTED|Overall Study|Started are treated patients.|25
11412470|NCT02131155|12608740|FG001|STARTED|Overall Study|Started are treated patients.|11
11412471|NCT02131155|12608739|FG000|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
11412472|NCT02131155|12608740|FG001|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
11412473|NCT02131155|12608739|FG000|NOT COMPLETED|Overall Study||25
11412474|NCT02131155|12608740|FG001|NOT COMPLETED|Overall Study||11
11412475|NCT02117050|12608746|FG000|STARTED|Overall Study||1
11412476|NCT02117050|12608746|FG000|COMPLETED|Overall Study||0
11412477|NCT02117050|12608746|FG000|NOT COMPLETED|Overall Study||1
11412478|NCT02110069|12608753|FG000|STARTED|Overall Study||2
11412479|NCT02110069|12608754|FG001|STARTED|Overall Study||2
11412480|NCT02110069|12608753|FG000|COMPLETED|Overall Study|subject was switched to sirolimus at maintenance course 7 for failure on Vincristine|0
11412481|NCT02110069|12608754|FG001|COMPLETED|Overall Study|1 subject was takend off protocol treatment at 10 months of maintenance for disease response.|2
11412482|NCT02110069|12608753|FG000|NOT COMPLETED|Overall Study||2
11412483|NCT02110069|12608754|FG001|NOT COMPLETED|Overall Study||0
11412484|NCT02110277|12608760|FG000|STARTED|Overall Study||2
11412485|NCT02110277|12608760|FG000|COMPLETED|Overall Study||0
11412486|NCT02110277|12608760|FG000|NOT COMPLETED|Overall Study||2
11412487|NCT02109809|12608764|FG000|STARTED|Overall Study||4
11412488|NCT02109809|12608764|FG000|COMPLETED|Overall Study||1
11412489|NCT02109809|12608764|FG000|NOT COMPLETED|Overall Study||3
11412490|NCT02105116|12608768|FG000|STARTED|Overall Study||6
11412491|NCT02105116|12608768|FG000|COMPLETED|Overall Study||0
11412492|NCT02105116|12608768|FG000|NOT COMPLETED|Overall Study||6
11412493|NCT02099318|12608774|FG000|STARTED|Overall Study||20
11412494|NCT02099318|12608775|FG001|STARTED|Overall Study||20
11412495|NCT02099318|12608774|FG000|COMPLETED|Overall Study||20
11412496|NCT02099318|12608775|FG001|COMPLETED|Overall Study||20
11412497|NCT02099318|12608774|FG000|NOT COMPLETED|Overall Study||0
11412498|NCT02099318|12608775|FG001|NOT COMPLETED|Overall Study||0
11412499|NCT02099344|12608785|FG000|STARTED|Overall Study||1
11412500|NCT02099344|12608786|FG001|STARTED|Overall Study||0
11412501|NCT02099344|12608785|FG000|COMPLETED|Overall Study||0
11412502|NCT02099344|12608786|FG001|COMPLETED|Overall Study||0
11412503|NCT02099344|12608785|FG000|NOT COMPLETED|Overall Study||1
11412504|NCT02099344|12608786|FG001|NOT COMPLETED|Overall Study||0
11412505|NCT02094352|12608796|FG000|STARTED|Overall Study||2
11412506|NCT02094352|12608797|FG001|STARTED|Overall Study||1
11412507|NCT02094352|12608796|FG000|COMPLETED|Overall Study||2
11412508|NCT02094352|12608797|FG001|COMPLETED|Overall Study||1
11412509|NCT02094352|12608796|FG000|NOT COMPLETED|Overall Study||0
11412510|NCT02094352|12608797|FG001|NOT COMPLETED|Overall Study||0
11412511|NCT02096042|12608803|FG000|STARTED|Overall Study||1
11412512|NCT02096042|12608804|FG001|STARTED|Overall Study||0
11412513|NCT02096042|12608805|FG002|STARTED|Overall Study||0
11412514|NCT02096042|12608803|FG000|COMPLETED|Overall Study||0
11412515|NCT02096042|12608804|FG001|COMPLETED|Overall Study||0
11412516|NCT02096042|12608805|FG002|COMPLETED|Overall Study||0
11412517|NCT02096042|12608803|FG000|NOT COMPLETED|Overall Study||1
11412518|NCT02096042|12608804|FG001|NOT COMPLETED|Overall Study||0
11412519|NCT02096042|12608805|FG002|NOT COMPLETED|Overall Study||0
11412520|NCT02088957|12608812|FG000|STARTED|Overall Study||1
11412521|NCT02088957|12608813|FG001|STARTED|Overall Study||0
11412522|NCT02088957|12608812|FG000|COMPLETED|Overall Study||0
11412523|NCT02088957|12608813|FG001|COMPLETED|Overall Study||0
11412524|NCT02088957|12608812|FG000|NOT COMPLETED|Overall Study||1
11412525|NCT02088957|12608813|FG001|NOT COMPLETED|Overall Study||0
11412526|NCT02093689|12608822|FG000|STARTED|Overall Study||18
11412527|NCT02093689|12608823|FG001|STARTED|Overall Study||0
11412528|NCT02093689|12608824|FG002|STARTED|Overall Study||0
11412529|NCT02093689|12608822|FG000|COMPLETED|Overall Study||14
11412530|NCT02093689|12608823|FG001|COMPLETED|Overall Study||0
11412531|NCT02093689|12608824|FG002|COMPLETED|Overall Study||0
11412532|NCT02093689|12608822|FG000|NOT COMPLETED|Overall Study||4
11412533|NCT02093689|12608823|FG001|NOT COMPLETED|Overall Study||0
11412534|NCT02093689|12608824|FG002|NOT COMPLETED|Overall Study||0
11412535|NCT02091752|12608830|FG000|STARTED|Overall Study||3
11412536|NCT02091752|12608830|FG000|COMPLETED|Overall Study||0
11412537|NCT02091752|12608830|FG000|NOT COMPLETED|Overall Study||3
11412538|NCT02068547|12608836|FG000|STARTED|Overall Study||4
11412539|NCT02068547|12608837|FG001|STARTED|Overall Study||4
11412540|NCT02068547|12608836|FG000|COMPLETED|Overall Study||0
11412541|NCT02068547|12608837|FG001|COMPLETED|Overall Study||1
11412542|NCT02068547|12608836|FG000|NOT COMPLETED|Overall Study||4
11412543|NCT02068547|12608837|FG001|NOT COMPLETED|Overall Study||3
11412544|NCT02075411|12608847|FG000|STARTED|Overall Study||0
11412545|NCT02075411|12608848|FG001|STARTED|Overall Study||0
11412546|NCT02075411|12608849|FG002|STARTED|Overall Study||0
11412547|NCT02075411|12608850|FG003|STARTED|Overall Study||1
11412548|NCT02075411|12608847|FG000|COMPLETED|Overall Study||0
11412549|NCT02075411|12608848|FG001|COMPLETED|Overall Study||0
11412550|NCT02075411|12608849|FG002|COMPLETED|Overall Study||0
11412551|NCT02075411|12608850|FG003|COMPLETED|Overall Study||1
11412552|NCT02075411|12608847|FG000|NOT COMPLETED|Overall Study||0
11412553|NCT02075411|12608848|FG001|NOT COMPLETED|Overall Study||0
11412554|NCT02075411|12608849|FG002|NOT COMPLETED|Overall Study||0
11412555|NCT02075411|12608850|FG003|NOT COMPLETED|Overall Study||0
11412556|NCT02074904|12608862|FG000|STARTED|Overall Study||1
11412557|NCT02074904|12608863|FG001|STARTED|Overall Study||0
11412558|NCT02074904|12608862|FG000|COMPLETED|Overall Study||1
11412559|NCT02074904|12608863|FG001|COMPLETED|Overall Study||0
11412560|NCT02074904|12608862|FG000|NOT COMPLETED|Overall Study||0
11412561|NCT02074904|12608863|FG001|NOT COMPLETED|Overall Study||0
11412562|NCT02084147|12608869|FG000|STARTED|Overall Study||72
11412563|NCT02084147|12608869|FG000|COMPLETED|Overall Study||72
11412564|NCT02084147|12608869|FG000|NOT COMPLETED|Overall Study||0
11412565|NCT02081183|12608875|FG000|STARTED|Overall Study||5
11412566|NCT02081183|12608876|FG001|STARTED|Overall Study||6
11412567|NCT02081183|12608875|FG000|COMPLETED|Overall Study||1
11412568|NCT02081183|12608876|FG001|COMPLETED|Overall Study||2
11412569|NCT02081183|12608875|FG000|NOT COMPLETED|Overall Study||4
11412570|NCT02081183|12608876|FG001|NOT COMPLETED|Overall Study||4
11412571|NCT02067611|12608882|FG000|STARTED|Overall Study||72
11412572|NCT02067611|12608883|FG001|STARTED|Overall Study||72
11412573|NCT02067611|12608884|FG002|STARTED|Overall Study||72
11412574|NCT02067611|12608882|FG000|COMPLETED|Overall Study||66
11412575|NCT02067611|12608883|FG001|COMPLETED|Overall Study||66
11412576|NCT02067611|12608884|FG002|COMPLETED|Overall Study||68
11412577|NCT02067611|12608882|FG000|NOT COMPLETED|Overall Study||6
11412578|NCT02067611|12608883|FG001|NOT COMPLETED|Overall Study||6
11412579|NCT02067611|12608884|FG002|NOT COMPLETED|Overall Study||4
11412580|NCT02067104|12608896|FG000|STARTED|Overall Study||4
11412581|NCT02067104|12608897|FG001|STARTED|Overall Study||5
11412582|NCT02067104|12608896|FG000|COMPLETED|Overall Study||0
11412583|NCT02067104|12608897|FG001|COMPLETED|Overall Study||0
11412584|NCT02067104|12608896|FG000|NOT COMPLETED|Overall Study||4
11412585|NCT02067104|12608897|FG001|NOT COMPLETED|Overall Study||5
11412586|NCT02075021|12608903|FG000|STARTED|Overall Study||3
11412587|NCT02075021|12608903|FG000|COMPLETED|Overall Study||3
11412588|NCT02075021|12608903|FG000|NOT COMPLETED|Overall Study||0
11412589|NCT02057874|12608907|FG000|STARTED|Overall Study||2
11412590|NCT02057874|12608907|FG000|COMPLETED|Overall Study||1
11412591|NCT02057874|12608907|FG000|NOT COMPLETED|Overall Study||1
11412592|NCT02057237|12608912|FG000|STARTED|Overall Study||1
11412593|NCT02057237|12608912|FG000|COMPLETED|Overall Study||1
11412594|NCT02057237|12608912|FG000|NOT COMPLETED|Overall Study||0
11412595|NCT02047747|12608917|FG000|STARTED|Overall Study||4
11412596|NCT02047747|12608917|FG000|COMPLETED|Overall Study||1
11412597|NCT02047747|12608917|FG000|NOT COMPLETED|Overall Study||3
11412598|NCT02058537|12608921|FG000|STARTED|Overall Study||3
11412599|NCT02058537|12608921|FG000|COMPLETED|Overall Study||2
11412600|NCT02058537|12608921|FG000|NOT COMPLETED|Overall Study||1
11412601|NCT02057276|12608927|FG000|STARTED|Overall Study||0
11412602|NCT02057276|12608928|FG001|STARTED|Overall Study||0
11412603|NCT02057276|12608927|FG000|COMPLETED|Overall Study||0
11412604|NCT02057276|12608928|FG001|COMPLETED|Overall Study||0
11412605|NCT02057276|12608927|FG000|NOT COMPLETED|Overall Study||0
11412606|NCT02057276|12608928|FG001|NOT COMPLETED|Overall Study||0
11412607|NCT02038153|12608934|FG000|STARTED|Overall Study||3
11412608|NCT02038153|12608934|FG000|COMPLETED|Overall Study||2
11412609|NCT02038153|12608934|FG000|NOT COMPLETED|Overall Study||1
11412610|NCT02054910|12608940|FG000|STARTED|Overall Study||4
11412611|NCT02054910|12608941|FG001|STARTED|Overall Study||1
11412612|NCT02054910|12608940|FG000|COMPLETED|Overall Study||0
11412613|NCT02054910|12608941|FG001|COMPLETED|Overall Study||0
11412614|NCT02054910|12608940|FG000|NOT COMPLETED|Overall Study||4
11412615|NCT02054910|12608941|FG001|NOT COMPLETED|Overall Study||1
11412616|NCT02044302|12608951|FG000|STARTED|Overall Study||2
11412617|NCT02044302|12608952|FG001|STARTED|Overall Study||0
11412618|NCT02044302|12608951|FG000|COMPLETED|Overall Study||0
11412619|NCT02044302|12608952|FG001|COMPLETED|Overall Study||0
11412620|NCT02044302|12608951|FG000|NOT COMPLETED|Overall Study||2
11412621|NCT02044302|12608952|FG001|NOT COMPLETED|Overall Study||0
11412622|NCT02046226|12608956|FG000|STARTED|Overall Study||7
11412623|NCT02046226|12608956|FG000|COMPLETED|Overall Study||0
11412624|NCT02046226|12608956|FG000|NOT COMPLETED|Overall Study||7
11412625|NCT02044848|12608963|FG000|STARTED|Overall Study||2
11412626|NCT02044848|12608964|FG001|STARTED|Overall Study||3
11412627|NCT02044848|12608963|FG000|COMPLETED|Overall Study||0
11412628|NCT02044848|12608964|FG001|COMPLETED|Overall Study||0
11412629|NCT02044848|12608963|FG000|NOT COMPLETED|Overall Study||2
11412630|NCT02044848|12608964|FG001|NOT COMPLETED|Overall Study||3
11412631|NCT02042950|12608970|FG000|STARTED|Overall Study||4
11412632|NCT02042950|12608970|FG000|COMPLETED|Overall Study||0
11412633|NCT02042950|12608970|FG000|NOT COMPLETED|Overall Study||4
11412634|NCT02048904|12608974|FG000|STARTED|Overall Study||142
11412635|NCT02048904|12608974|FG000|COMPLETED|Overall Study||65
11412636|NCT02048904|12608974|FG000|NOT COMPLETED|Overall Study||77
11412637|NCT02044822|12608978|FG000|STARTED|Overall Study||102
11412638|NCT02044822|12608978|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
11412639|NCT02044822|12608978|FG000|NOT COMPLETED|Overall Study||93
11412640|NCT02042924|12608982|FG000|STARTED|Overall Study||2
11412641|NCT02042924|12608982|FG000|COMPLETED|Overall Study||1
11412642|NCT02042924|12608982|FG000|NOT COMPLETED|Overall Study||1
11412643|NCT02043860|12608986|FG000|STARTED|Overall Study||2
11412644|NCT02043860|12608986|FG000|COMPLETED|Overall Study||2
11412645|NCT02043860|12608986|FG000|NOT COMPLETED|Overall Study||0
11412646|NCT02017522|12608990|FG000|STARTED|Overall Study||3
11412647|NCT02017522|12608990|FG000|Scan|Overall Study||2
11412648|NCT02017522|12608990|FG000|COMPLETED|Overall Study||2
11412649|NCT02017522|12608990|FG000|NOT COMPLETED|Overall Study||1
11412650|NCT02030015|12608995|FG000|STARTED|Overall Study||16
11412651|NCT02030015|12608995|FG000|COMPLETED|Overall Study||0
11412652|NCT02030015|12608995|FG000|NOT COMPLETED|Overall Study||16
11412653|NCT02015663|12609001|FG000|STARTED|Overall Study||16
11412654|NCT02015663|12609002|FG001|STARTED|Overall Study||16
11412655|NCT02015663|12609001|FG000|COMPLETED|Overall Study||1
11412656|NCT02015663|12609002|FG001|COMPLETED|Overall Study||4
11412657|NCT02015663|12609001|FG000|NOT COMPLETED|Overall Study||15
11412658|NCT02015663|12609002|FG001|NOT COMPLETED|Overall Study||12
11412659|NCT02029846|12609011|FG000|STARTED|Overall Study||1
11412660|NCT02029846|12609012|FG001|STARTED|Overall Study||1
11412661|NCT02029846|12609011|FG000|COMPLETED|Overall Study||0
11412662|NCT02029846|12609012|FG001|COMPLETED|Overall Study||0
11412663|NCT02029846|12609011|FG000|NOT COMPLETED|Overall Study||1
11412664|NCT02029846|12609012|FG001|NOT COMPLETED|Overall Study||1
11412665|NCT02027272|12609020|FG000|STARTED|Overall Study||0
11412666|NCT02027272|12609021|FG001|STARTED|Overall Study||1
11412667|NCT02027272|12609020|FG000|COMPLETED|Overall Study||0
11412668|NCT02027272|12609021|FG001|COMPLETED|Overall Study||0
11412669|NCT02027272|12609020|FG000|NOT COMPLETED|Overall Study||0
11412670|NCT02027272|12609021|FG001|NOT COMPLETED|Overall Study||1
11412671|NCT02012608|12609029|FG000|STARTED|Overall Study||7
11412672|NCT02012608|12609030|FG001|STARTED|Overall Study||7
11412673|NCT02012608|12609029|FG000|COMPLETED|Overall Study||4
11412674|NCT02012608|12609030|FG001|COMPLETED|Overall Study||7
11412675|NCT02012608|12609029|FG000|NOT COMPLETED|Overall Study||3
11412676|NCT02012608|12609030|FG001|NOT COMPLETED|Overall Study||0
11412677|NCT02017379|12609039|FG000|STARTED|Overall Study||0
11412678|NCT02017379|12609040|FG001|STARTED|Overall Study||0
11412679|NCT02017379|12609041|FG002|STARTED|Overall Study||0
11412680|NCT02017379|12609039|FG000|COMPLETED|Overall Study||0
11412681|NCT02017379|12609040|FG001|COMPLETED|Overall Study||0
11412682|NCT02017379|12609041|FG002|COMPLETED|Overall Study||0
11412683|NCT02017379|12609039|FG000|NOT COMPLETED|Overall Study||0
11412684|NCT02017379|12609040|FG001|NOT COMPLETED|Overall Study||0
11412685|NCT02017379|12609041|FG002|NOT COMPLETED|Overall Study||0
11412686|NCT02011542|12609049|FG000|STARTED|Overall Study||30
11412687|NCT02011542|12609049|FG000|COMPLETED|Overall Study||29
11412688|NCT02011542|12609049|FG000|NOT COMPLETED|Overall Study||1
11412689|NCT02008370|12609053|FG000|STARTED|Overall Study||7
11412690|NCT02008370|12609053|FG000|COMPLETED|Overall Study||0
11412691|NCT02008370|12609053|FG000|NOT COMPLETED|Overall Study||7
11412692|NCT02009982|12609059|FG000|STARTED|Overall Study||1
11412693|NCT02009982|12609060|FG001|STARTED|Overall Study||2
11412694|NCT02009982|12609059|FG000|COMPLETED|Overall Study||1
11412695|NCT02009982|12609060|FG001|COMPLETED|Overall Study||2
11412696|NCT02009982|12609059|FG000|NOT COMPLETED|Overall Study||0
11412697|NCT02009982|12609060|FG001|NOT COMPLETED|Overall Study||0
11412698|NCT02013414|12609066|FG000|STARTED|Overall Study||9
11412699|NCT02013414|12609066|FG000|COMPLETED|Overall Study||9
11412700|NCT02013414|12609066|FG000|NOT COMPLETED|Overall Study||0
11412701|NCT02005445|12609074|FG000|STARTED|Overall Study||2
11412702|NCT02005445|12609075|FG001|STARTED|Overall Study||2
11412703|NCT02005445|12609074|FG000|COMPLETED|Overall Study||2
11412704|NCT02005445|12609075|FG001|COMPLETED|Overall Study||1
11412705|NCT02005445|12609074|FG000|NOT COMPLETED|Overall Study||0
11412706|NCT02005445|12609075|FG001|NOT COMPLETED|Overall Study||1
11412707|NCT02020837|12609081|FG000|STARTED|Overall Study||2
11412708|NCT02020837|12609081|FG000|COMPLETED|Overall Study||2
11412709|NCT02020837|12609081|FG000|NOT COMPLETED|Overall Study||0
11412710|NCT02015910|12609087|FG000|STARTED|Overall Study||0
11412711|NCT02015910|12609088|FG001|STARTED|Overall Study||1
11412712|NCT02015910|12609087|FG000|COMPLETED|Overall Study||0
11412713|NCT02015910|12609088|FG001|COMPLETED|Overall Study||1
11412714|NCT02015910|12609087|FG000|NOT COMPLETED|Overall Study||0
11412715|NCT02015910|12609088|FG001|NOT COMPLETED|Overall Study||0
11412716|NCT02006927|12609094|FG000|STARTED|Overall Study||3
11412717|NCT02006927|12609094|FG000|COMPLETED|Overall Study||0
11412718|NCT02006927|12609094|FG000|NOT COMPLETED|Overall Study||3
11412719|NCT01996982|12609098|FG000|STARTED|Overall Study||7
11412720|NCT01996982|12609098|FG000|COMPLETED|Overall Study||0
11412721|NCT01996982|12609098|FG000|NOT COMPLETED|Overall Study||7
11412722|NCT02006407|12609102|FG000|STARTED|Overall Study||5
11412723|NCT02006407|12609102|FG000|COMPLETED|Overall Study||5
11412724|NCT02006407|12609102|FG000|NOT COMPLETED|Overall Study||0
11412725|NCT01986751|12609108|FG000|STARTED|Overall Study||10
11412726|NCT01986751|12609109|FG001|STARTED|Overall Study||4
11412727|NCT01986751|12609108|FG000|COMPLETED|Overall Study||0
11412728|NCT01986751|12609109|FG001|COMPLETED|Overall Study||2
11412729|NCT01986751|12609108|FG000|NOT COMPLETED|Overall Study||10
11412730|NCT01986751|12609109|FG001|NOT COMPLETED|Overall Study||2
11412731|NCT01996410|12609127|FG000|STARTED|Overall Study||3
11412732|NCT01996410|12609128|FG001|STARTED|Overall Study||3
11412733|NCT01996410|12609129|FG002|STARTED|Overall Study||0
11412734|NCT01996410|12609130|FG003|STARTED|Overall Study||0
11412735|NCT01996410|12609131|FG004|STARTED|Overall Study||2
11412736|NCT01996410|12609132|FG005|STARTED|Overall Study||2
11412737|NCT01996410|12609133|FG006|STARTED|Overall Study||0
11412738|NCT01996410|12609134|FG007|STARTED|Overall Study||0
11412739|NCT01996410|12609127|FG000|COMPLETED|Overall Study||3
11412740|NCT01996410|12609128|FG001|COMPLETED|Overall Study||3
11412741|NCT01996410|12609129|FG002|COMPLETED|Overall Study||0
11412742|NCT01996410|12609130|FG003|COMPLETED|Overall Study||0
11412743|NCT01996410|12609131|FG004|COMPLETED|Overall Study||2
11412744|NCT01996410|12609132|FG005|COMPLETED|Overall Study||2
11412745|NCT01996410|12609133|FG006|COMPLETED|Overall Study||0
11412746|NCT01996410|12609134|FG007|COMPLETED|Overall Study||0
11412747|NCT01996410|12609127|FG000|NOT COMPLETED|Overall Study||0
11412748|NCT01996410|12609128|FG001|NOT COMPLETED|Overall Study||0
11412749|NCT01996410|12609129|FG002|NOT COMPLETED|Overall Study||0
11412750|NCT01996410|12609130|FG003|NOT COMPLETED|Overall Study||0
11412751|NCT01996410|12609131|FG004|NOT COMPLETED|Overall Study||0
11412752|NCT01996410|12609132|FG005|NOT COMPLETED|Overall Study||0
11412753|NCT01996410|12609133|FG006|NOT COMPLETED|Overall Study||0
11412754|NCT01996410|12609134|FG007|NOT COMPLETED|Overall Study||0
11412755|NCT01996852|12609149|FG000|STARTED|Overall Study||0
11412756|NCT01996852|12609150|FG001|STARTED|Overall Study||0
11412757|NCT01996852|12609151|FG002|STARTED|Overall Study||0
11412758|NCT01996852|12609149|FG000|COMPLETED|Overall Study||0
11412759|NCT01996852|12609150|FG001|COMPLETED|Overall Study||0
11412760|NCT01996852|12609151|FG002|COMPLETED|Overall Study||0
11412761|NCT01996852|12609149|FG000|NOT COMPLETED|Overall Study||0
11412762|NCT01996852|12609150|FG001|NOT COMPLETED|Overall Study||0
11412763|NCT01996852|12609151|FG002|NOT COMPLETED|Overall Study||0
11412764|NCT01997567|12609161|FG000|STARTED|Overall Study||0
11412765|NCT01997567|12609162|FG001|STARTED|Overall Study||0
11412766|NCT01997567|12609161|FG000|COMPLETED|Overall Study||0
11412767|NCT01997567|12609162|FG001|COMPLETED|Overall Study||0
11412768|NCT01997567|12609161|FG000|NOT COMPLETED|Overall Study||0
11412769|NCT01997567|12609162|FG001|NOT COMPLETED|Overall Study||0
11412770|NCT01977729|12609168|FG000|STARTED|Overall Study||1
11412771|NCT01977729|12609168|FG000|COMPLETED|Overall Study||0
11412772|NCT01977729|12609168|FG000|NOT COMPLETED|Overall Study||1
11412773|NCT01973062|12609174|FG000|STARTED|Overall Study||1
11412774|NCT01973062|12609174|FG000|COMPLETED|Overall Study||1
11412775|NCT01973062|12609174|FG000|NOT COMPLETED|Overall Study||0
11412776|NCT01982253|12609181|FG000|STARTED|Overall Study||2
11412777|NCT01982253|12609182|FG001|STARTED|Overall Study||4
11412778|NCT01982253|12609183|FG002|STARTED|Overall Study||4
11412779|NCT01982253|12609181|FG000|COMPLETED|Overall Study||0
11412780|NCT01982253|12609182|FG001|COMPLETED|Overall Study||0
11412781|NCT01982253|12609183|FG002|COMPLETED|Overall Study||0
11412782|NCT01982253|12609181|FG000|NOT COMPLETED|Overall Study||2
11412783|NCT01982253|12609182|FG001|NOT COMPLETED|Overall Study||4
11412784|NCT01982253|12609183|FG002|NOT COMPLETED|Overall Study||4
11412785|NCT01984268|12609191|FG000|STARTED|Overall Study||15
11412786|NCT01984268|12609191|FG000|COMPLETED|Overall Study||0
11412787|NCT01984268|12609191|FG000|NOT COMPLETED|Overall Study||15
11412788|NCT01974284|12609195|FG000|STARTED|Overall Study||7
11412789|NCT01974284|12609195|FG000|COMPLETED|Overall Study||0
11412790|NCT01974284|12609195|FG000|NOT COMPLETED|Overall Study||7
11412791|NCT01971853|12609201|FG000|STARTED|Overall Study||0
11412792|NCT01971853|12609202|FG001|STARTED|Overall Study||0
11412793|NCT01971853|12609201|FG000|COMPLETED|Overall Study||0
11412794|NCT01971853|12609202|FG001|COMPLETED|Overall Study||0
11412795|NCT01971853|12609201|FG000|NOT COMPLETED|Overall Study||0
11412796|NCT01971853|12609202|FG001|NOT COMPLETED|Overall Study||0
11412797|NCT01980875|12609211|FG000|STARTED|Overall Study||8
11412798|NCT01980875|12609212|FG001|STARTED|Overall Study||25
11412799|NCT01980875|12609213|FG002|STARTED|Overall Study||24
11412800|NCT01980875|12609211|FG000|COMPLETED|Overall Study||0
11412801|NCT01980875|12609212|FG001|COMPLETED|Overall Study||0
11412802|NCT01980875|12609213|FG002|COMPLETED|Overall Study||0
11412803|NCT01980875|12609211|FG000|NOT COMPLETED|Overall Study||8
11412804|NCT01980875|12609212|FG001|NOT COMPLETED|Overall Study||25
11412805|NCT01980875|12609213|FG002|NOT COMPLETED|Overall Study||24
11412806|NCT01982383|12609223|FG000|STARTED|Overall Study||2
11412807|NCT01982383|12609224|FG001|STARTED|Overall Study||0
11412808|NCT01982383|12609223|FG000|COMPLETED|Overall Study||2
11412809|NCT01982383|12609224|FG001|COMPLETED|Overall Study||0
11412810|NCT01982383|12609223|FG000|NOT COMPLETED|Overall Study||0
11412811|NCT01982383|12609224|FG001|NOT COMPLETED|Overall Study||0
11412812|NCT01980342|12609230|FG000|STARTED|Overall Study||1
11412813|NCT01980342|12609230|FG000|COMPLETED|Overall Study||0
11412814|NCT01980342|12609230|FG000|NOT COMPLETED|Overall Study||1
11412815|NCT01978535|12609236|FG000|STARTED|Overall Study||1
11412816|NCT01978535|12609237|FG001|STARTED|Overall Study||2
11412817|NCT01978535|12609236|FG000|COMPLETED|Overall Study||1
11412818|NCT01978535|12609237|FG001|COMPLETED|Overall Study||2
11412819|NCT01978535|12609236|FG000|NOT COMPLETED|Overall Study||0
11412820|NCT01978535|12609237|FG001|NOT COMPLETED|Overall Study||0
11412821|NCT01974635|12609243|FG000|STARTED|Overall Study||2
11412822|NCT01974635|12609243|FG000|COMPLETED|Overall Study||2
11412823|NCT01974635|12609243|FG000|NOT COMPLETED|Overall Study||0
11412824|NCT01975467|12609250|FG000|STARTED|Overall Study|Study terminated before enrollment|0
11412825|NCT01975467|12609251|FG001|STARTED|Overall Study|Study terminated before enrollment|0
11412826|NCT01975467|12609250|FG000|COMPLETED|Overall Study||0
11412827|NCT01975467|12609251|FG001|COMPLETED|Overall Study||0
11412828|NCT01975467|12609250|FG000|NOT COMPLETED|Overall Study||0
11412829|NCT01975467|12609251|FG001|NOT COMPLETED|Overall Study||0
11412830|NCT01970462|12609259|FG000|STARTED|Overall Study||1
11412831|NCT01970462|12609260|FG001|STARTED|Overall Study||4
11412832|NCT01970462|12609259|FG000|COMPLETED|Overall Study||1
11412833|NCT01970462|12609260|FG001|COMPLETED|Overall Study||2
11412834|NCT01970462|12609259|FG000|NOT COMPLETED|Overall Study||0
11412835|NCT01970462|12609260|FG001|NOT COMPLETED|Overall Study||2
11412836|NCT01969565|12609266|FG000|STARTED|Overall Study||1
11412837|NCT01969565|12609266|FG000|COMPLETED|Overall Study||0
11412838|NCT01969565|12609266|FG000|NOT COMPLETED|Overall Study||1
11412839|NCT01968226|12609271|FG000|STARTED|Overall Study||3
11412840|NCT01968226|12609271|FG000|COMPLETED|Overall Study||1
11412841|NCT01968226|12609271|FG000|NOT COMPLETED|Overall Study||2
11412842|NCT01965782|12609275|FG000|STARTED|Overall Study||0
11412843|NCT01965782|12609275|FG000|COMPLETED|Overall Study||0
11412844|NCT01965782|12609275|FG000|NOT COMPLETED|Overall Study||0
11412845|NCT01962675|12609281|FG000|STARTED|Overall Study||7
11412846|NCT01962675|12609282|FG001|STARTED|Overall Study||7
11412847|NCT01962675|12609281|FG000|COMPLETED|Overall Study||7
11412848|NCT01962675|12609282|FG001|COMPLETED|Overall Study||7
11412849|NCT01962675|12609281|FG000|NOT COMPLETED|Overall Study||0
11412850|NCT01962675|12609282|FG001|NOT COMPLETED|Overall Study||0
11412851|NCT01962974|12609290|FG000|STARTED|Overall Study||7
11412852|NCT01962974|12609290|FG000|COMPLETED|Overall Study||0
11412853|NCT01962974|12609290|FG000|NOT COMPLETED|Overall Study||7
11412854|NCT01954160|12609296|FG000|STARTED|Overall Study||5
11412855|NCT01954160|12609297|FG001|STARTED|Overall Study|Not started|0
11412856|NCT01954160|12609296|FG000|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
11412857|NCT01954160|12609297|FG001|COMPLETED|Overall Study||0
11412858|NCT01954160|12609296|FG000|NOT COMPLETED|Overall Study||5
11412859|NCT01954160|12609297|FG001|NOT COMPLETED|Overall Study||0
11412860|NCT01951378|12609307|FG000|STARTED|Overall Study||23
11412861|NCT01951378|12609308|FG001|STARTED|Overall Study||17
11412862|NCT01951378|12609307|FG000|COMPLETED|Overall Study||0
11412863|NCT01951378|12609308|FG001|COMPLETED|Overall Study||0
11412864|NCT01951378|12609307|FG000|NOT COMPLETED|Overall Study||23
11412865|NCT01951378|12609308|FG001|NOT COMPLETED|Overall Study||17
11412866|NCT01941615|12609314|FG000|STARTED|Run in Treatment: Microgynon®||16
11412867|NCT01941615|12609314|FG000|COMPLETED|Run in Treatment: Microgynon®||16
11412868|NCT01941615|12609314|FG000|NOT COMPLETED|Run in Treatment: Microgynon®||0
11412869|NCT01941615|12609314|FG000|STARTED|Reference Treatment: Microgynon®||0
11412870|NCT01941615|12609314|FG000|COMPLETED|Reference Treatment: Microgynon®||0
11412871|NCT01941615|12609314|FG000|NOT COMPLETED|Reference Treatment: Microgynon®||0
11412872|NCT01941615|12609314|FG000|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
11412873|NCT01941615|12609314|FG000|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
11412874|NCT01941615|12609314|FG000|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
11412875|NCT01946542|12609320|FG000|STARTED|Testing Visit 1||1
11412876|NCT01946542|12609321|FG001|STARTED|Testing Visit 1||1
11412877|NCT01946542|12609320|FG000|COMPLETED|Testing Visit 1||1
11412878|NCT01946542|12609321|FG001|COMPLETED|Testing Visit 1||1
11412879|NCT01946542|12609320|FG000|NOT COMPLETED|Testing Visit 1||0
11412880|NCT01946542|12609321|FG001|NOT COMPLETED|Testing Visit 1||0
11412881|NCT01946542|12609320|FG000|STARTED|Testing Visit 2||1
11412882|NCT01946542|12609321|FG001|STARTED|Testing Visit 2||1
11412883|NCT01946542|12609320|FG000|COMPLETED|Testing Visit 2||1
11412884|NCT01946542|12609321|FG001|COMPLETED|Testing Visit 2||1
11412885|NCT01946542|12609320|FG000|NOT COMPLETED|Testing Visit 2||0
11412886|NCT01946542|12609321|FG001|NOT COMPLETED|Testing Visit 2||0
11412887|NCT01937507|12609327|FG000|STARTED|Overall Study||2
11412888|NCT01937507|12609327|FG000|COMPLETED|Overall Study||0
11412889|NCT01937507|12609327|FG000|NOT COMPLETED|Overall Study||2
11412890|NCT01944059|12609331|FG000|STARTED|Overall Study||31
11412891|NCT01944059|12609331|FG000|COMPLETED|Overall Study||24
11412892|NCT01944059|12609331|FG000|NOT COMPLETED|Overall Study||7
11412893|NCT01935947|12609339|FG000|STARTED|Overall Study||4
11412894|NCT01935947|12609340|FG001|STARTED|Overall Study||4
11412895|NCT01935947|12609341|FG002|STARTED|Overall Study||2
11412896|NCT01935947|12609339|FG000|Epigenetic Therapy|Overall Study||4
11412897|NCT01935947|12609340|FG001|Epigenetic Therapy|Overall Study||4
11412898|NCT01935947|12609341|FG002|Epigenetic Therapy|Overall Study||0
11412899|NCT01935947|12609339|FG000|Cytotoxic Therapy|Overall Study||3
11412900|NCT01935947|12609340|FG001|Cytotoxic Therapy|Overall Study||3
11412901|NCT01935947|12609341|FG002|Cytotoxic Therapy|Overall Study||2
11412902|NCT01935947|12609339|FG000|COMPLETED|Overall Study||1
11412903|NCT01935947|12609340|FG001|COMPLETED|Overall Study||0
11412904|NCT01935947|12609341|FG002|COMPLETED|Overall Study||0
11412905|NCT01935947|12609339|FG000|NOT COMPLETED|Overall Study||3
11412906|NCT01935947|12609340|FG001|NOT COMPLETED|Overall Study||4
11412907|NCT01935947|12609341|FG002|NOT COMPLETED|Overall Study||2
11412908|NCT01939223|12609354|FG000|STARTED|Overall Study||14
11412909|NCT01939223|12609355|FG001|STARTED|Overall Study||11
11412910|NCT01939223|12609354|FG000|Participants Received Treatment|Overall Study||14
11412911|NCT01939223|12609355|FG001|Participants Received Treatment|Overall Study||11
11412912|NCT01939223|12609354|FG000|COMPLETED|Overall Study||1
11412913|NCT01939223|12609355|FG001|COMPLETED|Overall Study||0
11412914|NCT01939223|12609354|FG000|NOT COMPLETED|Overall Study||13
11412915|NCT01939223|12609355|FG001|NOT COMPLETED|Overall Study||11
11412916|NCT01938716|12609361|FG000|STARTED|Overall Study||12
11412917|NCT01938716|12609361|FG000|COMPLETED|Overall Study||8
11412918|NCT01938716|12609361|FG000|NOT COMPLETED|Overall Study||4
11412919|NCT01936974|12609367|FG000|STARTED|Overall Study||2
11412920|NCT01936974|12609368|FG001|STARTED|Overall Study||5
11412921|NCT01936974|12609367|FG000|COMPLETED|Overall Study||0
11412922|NCT01936974|12609368|FG001|COMPLETED|Overall Study||0
11412923|NCT01936974|12609367|FG000|NOT COMPLETED|Overall Study||2
11412924|NCT01936974|12609368|FG001|NOT COMPLETED|Overall Study||5
11412925|NCT01938833|12609374|FG000|STARTED|Overall Study||9
11412926|NCT01938833|12609374|FG000|COMPLETED|Overall Study||9
11412927|NCT01938833|12609374|FG000|NOT COMPLETED|Overall Study||0
11412928|NCT01934647|12609381|FG000|STARTED|Overall Study||2
11412929|NCT01934647|12609382|FG001|STARTED|Overall Study||2
11412930|NCT01934647|12609383|FG002|STARTED|Overall Study||3
11412931|NCT01934647|12609381|FG000|COMPLETED|Overall Study||2
11412932|NCT01934647|12609382|FG001|COMPLETED|Overall Study||2
11412933|NCT01934647|12609383|FG002|COMPLETED|Overall Study||3
11412934|NCT01934647|12609381|FG000|NOT COMPLETED|Overall Study||0
11412935|NCT01934647|12609382|FG001|NOT COMPLETED|Overall Study||0
11412936|NCT01934647|12609383|FG002|NOT COMPLETED|Overall Study||0
11412937|NCT01934504|12609395|FG000|STARTED|Overall Study||6
11412938|NCT01934504|12609396|FG001|STARTED|Overall Study||3
11412939|NCT01934504|12609397|FG002|STARTED|Overall Study||16
11412940|NCT01934504|12609398|FG003|STARTED|Overall Study||8
11412941|NCT01934504|12609395|FG000|COMPLETED|Overall Study||5
11412942|NCT01934504|12609396|FG001|COMPLETED|Overall Study||3
11412943|NCT01934504|12609397|FG002|COMPLETED|Overall Study||11
11412944|NCT01934504|12609398|FG003|COMPLETED|Overall Study||1
11412945|NCT01934504|12609395|FG000|NOT COMPLETED|Overall Study||1
11412946|NCT01934504|12609396|FG001|NOT COMPLETED|Overall Study||0
11412947|NCT01934504|12609397|FG002|NOT COMPLETED|Overall Study||5
11412948|NCT01934504|12609398|FG003|NOT COMPLETED|Overall Study||7
11412949|NCT01928082|12609408|FG000|STARTED|Overall Study||1
11412950|NCT01928082|12609408|FG000|COMPLETED|Overall Study||0
11412951|NCT01928082|12609408|FG000|NOT COMPLETED|Overall Study||1
11412952|NCT01928615|12609412|FG000|STARTED|Overall Study||2
11412953|NCT01928615|12609412|FG000|COMPLETED|Overall Study||0
11412954|NCT01928615|12609412|FG000|NOT COMPLETED|Overall Study||2
11412955|NCT01911793|12609419|FG000|STARTED|Overall Study||1
11412956|NCT01911793|12609420|FG001|STARTED|Overall Study||5
11412957|NCT01911793|12609419|FG000|COMPLETED|Overall Study||0
11412958|NCT01911793|12609420|FG001|COMPLETED|Overall Study||0
11412959|NCT01911793|12609419|FG000|NOT COMPLETED|Overall Study||1
11412960|NCT01911793|12609420|FG001|NOT COMPLETED|Overall Study||5
11412961|NCT01912404|12609428|FG000|STARTED|Overall Study||3
11412962|NCT01912404|12609429|FG001|STARTED|Overall Study||2
11412963|NCT01912404|12609428|FG000|COMPLETED|Overall Study||2
11412964|NCT01912404|12609429|FG001|COMPLETED|Overall Study||2
11412965|NCT01912404|12609428|FG000|NOT COMPLETED|Overall Study||1
11412966|NCT01912404|12609429|FG001|NOT COMPLETED|Overall Study||0
11412967|NCT01910389|12609437|FG000|STARTED|Overall Study||15
11412968|NCT01910389|12609438|FG001|STARTED|Overall Study||8
11412969|NCT01910389|12609437|FG000|COMPLETED|Overall Study||0
11412970|NCT01910389|12609438|FG001|COMPLETED|Overall Study||0
11412971|NCT01910389|12609437|FG000|NOT COMPLETED|Overall Study||15
11412972|NCT01910389|12609438|FG001|NOT COMPLETED|Overall Study||8
11412973|NCT01921114|12609446|FG000|STARTED|Overall Study||0
11412974|NCT01921114|12609447|FG001|STARTED|Overall Study||0
11412975|NCT01921114|12609446|FG000|COMPLETED|Overall Study||0
11412976|NCT01921114|12609447|FG001|COMPLETED|Overall Study||0
11412977|NCT01921114|12609446|FG000|NOT COMPLETED|Overall Study||0
11412978|NCT01921114|12609447|FG001|NOT COMPLETED|Overall Study||0
11412979|NCT01916590|12609455|FG000|STARTED|Overall Study||4
11412980|NCT01916590|12609456|FG001|STARTED|Overall Study||3
11412981|NCT01916590|12609455|FG000|COMPLETED|Overall Study||4
11412982|NCT01916590|12609456|FG001|COMPLETED|Overall Study||3
11412983|NCT01916590|12609455|FG000|NOT COMPLETED|Overall Study||0
11412984|NCT01916590|12609456|FG001|NOT COMPLETED|Overall Study||0
11412985|NCT01913327|12609464|FG000|STARTED|Overall Study||1
11412986|NCT01913327|12609465|FG001|STARTED|Overall Study||2
11412987|NCT01913327|12609464|FG000|COMPLETED|Overall Study||1
11412988|NCT01913327|12609465|FG001|COMPLETED|Overall Study||1
11412989|NCT01913327|12609464|FG000|NOT COMPLETED|Overall Study||0
11412990|NCT01913327|12609465|FG001|NOT COMPLETED|Overall Study||1
11412991|NCT01902888|12609471|FG000|STARTED|Overall Study||3
11412992|NCT01902888|12609471|FG000|COMPLETED|Overall Study||0
11412993|NCT01902888|12609471|FG000|NOT COMPLETED|Overall Study||3
11412994|NCT01901224|12609475|FG000|STARTED|Overall Study||2
11412995|NCT01901224|12609475|FG000|COMPLETED|Overall Study||0
11412996|NCT01901224|12609475|FG000|NOT COMPLETED|Overall Study||2
11412997|NCT01910441|12609481|FG000|STARTED|Overall Study||48
11412998|NCT01910441|12609482|FG001|STARTED|Overall Study||47
11412999|NCT01910441|12609481|FG000|COMPLETED|Overall Study||41
11413000|NCT01910441|12609482|FG001|COMPLETED|Overall Study||37
11413001|NCT01910441|12609481|FG000|NOT COMPLETED|Overall Study||7
11413002|NCT01910441|12609482|FG001|NOT COMPLETED|Overall Study||10
11413003|NCT01902966|12609488|FG000|STARTED|Overall Study||5
11413004|NCT01902966|12609488|FG000|COMPLETED|Overall Study||2
11413005|NCT01902966|12609488|FG000|NOT COMPLETED|Overall Study||3
11413006|NCT01901679|12609494|FG000|STARTED|Overall Study||5
11413007|NCT01901679|12609495|FG001|STARTED|Overall Study||5
11413008|NCT01901679|12609494|FG000|COMPLETED|Overall Study||5
11413009|NCT01901679|12609495|FG001|COMPLETED|Overall Study||5
11413010|NCT01901679|12609494|FG000|NOT COMPLETED|Overall Study||0
11413011|NCT01901679|12609495|FG001|NOT COMPLETED|Overall Study||0
11413012|NCT01900730|12609503|FG000|STARTED|Overall Study||3
11413013|NCT01900730|12609504|FG001|STARTED|Overall Study||0
11413014|NCT01900730|12609503|FG000|COMPLETED|Overall Study||1
11413015|NCT01900730|12609504|FG001|COMPLETED|Overall Study||0
11413016|NCT01900730|12609503|FG000|NOT COMPLETED|Overall Study||2
11413017|NCT01900730|12609504|FG001|NOT COMPLETED|Overall Study||0
11413018|NCT01877564|12609512|FG000|STARTED|Overall Study||6
11413019|NCT01877564|12609513|FG001|STARTED|Overall Study||4
11413020|NCT01877564|12609512|FG000|COMPLETED|Overall Study||6
11413021|NCT01877564|12609513|FG001|COMPLETED|Overall Study||4
11413022|NCT01877564|12609512|FG000|NOT COMPLETED|Overall Study||0
11413023|NCT01877564|12609513|FG001|NOT COMPLETED|Overall Study||0
11413024|NCT01890694|12609521|FG000|STARTED|Overall Study||1
11413025|NCT01890694|12609522|FG001|STARTED|Overall Study||1
11413026|NCT01890694|12609521|FG000|COMPLETED|Overall Study||0
11413027|NCT01890694|12609522|FG001|COMPLETED|Overall Study||0
11413028|NCT01890694|12609521|FG000|NOT COMPLETED|Overall Study||1
11413029|NCT01890694|12609522|FG001|NOT COMPLETED|Overall Study||1
11413030|NCT01900626|12609532|FG000|STARTED|Overall Study||1
11413031|NCT01900626|12609533|FG001|STARTED|Overall Study||1
11413032|NCT01900626|12609532|FG000|COMPLETED|Overall Study||0
11413033|NCT01900626|12609533|FG001|COMPLETED|Overall Study||0
11413034|NCT01900626|12609532|FG000|NOT COMPLETED|Overall Study||1
11413035|NCT01900626|12609533|FG001|NOT COMPLETED|Overall Study||1
11413036|NCT01890577|12609541|FG000|STARTED|Overall Study||28
11413037|NCT01890577|12609541|FG000|COMPLETED|Overall Study||0
11413038|NCT01890577|12609541|FG000|NOT COMPLETED|Overall Study||28
11413039|NCT01895959|12609545|FG000|STARTED|Overall Study||12
11413040|NCT01895959|12609545|FG000|COMPLETED|Overall Study||10
11413041|NCT01895959|12609545|FG000|NOT COMPLETED|Overall Study||2
11413042|NCT01889420|12609549|FG000|STARTED|Overall Study||1
11413043|NCT01889420|12609549|FG000|COMPLETED|Overall Study||1
11413044|NCT01889420|12609549|FG000|NOT COMPLETED|Overall Study||0
11413045|NCT01884077|12609555|FG000|STARTED|Overall Study||8
11413046|NCT01884077|12609556|FG001|STARTED|Overall Study||11
11413047|NCT01884077|12609555|FG000|COMPLETED|Overall Study||0
11413048|NCT01884077|12609556|FG001|COMPLETED|Overall Study||1
11413049|NCT01884077|12609555|FG000|NOT COMPLETED|Overall Study||8
11413050|NCT01884077|12609556|FG001|NOT COMPLETED|Overall Study||10
11413051|NCT01881984|12609562|FG000|STARTED|Overall Study||4
11413052|NCT01881984|12609562|FG000|COMPLETED|Overall Study||4
11413053|NCT01881984|12609562|FG000|NOT COMPLETED|Overall Study||0
11413054|NCT01893359|12609569|FG000|STARTED|Overall Study||0
11413055|NCT01893359|12609570|FG001|STARTED|Overall Study||2
11413056|NCT01893359|12609571|FG002|STARTED|Overall Study||0
11413057|NCT01893359|12609569|FG000|COMPLETED|Overall Study||0
11413058|NCT01893359|12609570|FG001|COMPLETED|Overall Study||2
11413059|NCT01893359|12609571|FG002|COMPLETED|Overall Study||0
11413060|NCT01893359|12609569|FG000|NOT COMPLETED|Overall Study||0
11413061|NCT01893359|12609570|FG001|NOT COMPLETED|Overall Study||0
11413062|NCT01893359|12609571|FG002|NOT COMPLETED|Overall Study||0
11413063|NCT01883908|12609581|FG000|STARTED|Overall Study||3
11413064|NCT01883908|12609582|FG001|STARTED|Overall Study||1
11413065|NCT01883908|12609581|FG000|COMPLETED|Overall Study||3
11413066|NCT01883908|12609582|FG001|COMPLETED|Overall Study||1
11413067|NCT01883908|12609581|FG000|NOT COMPLETED|Overall Study||0
11413068|NCT01883908|12609582|FG001|NOT COMPLETED|Overall Study||0
11413069|NCT01887288|12609588|FG000|STARTED|Overall Study||16
11413070|NCT01887288|12609588|FG000|COMPLETED|Overall Study||0
11413071|NCT01887288|12609588|FG000|NOT COMPLETED|Overall Study||16
11413072|NCT01881932|12609595|FG000|STARTED|Overall Study||2
11413073|NCT01881932|12609596|FG001|STARTED|Overall Study||4
11413074|NCT01881932|12609597|FG002|STARTED|Overall Study||13
11413075|NCT01881932|12609595|FG000|COMPLETED|Overall Study||2
11413076|NCT01881932|12609596|FG001|COMPLETED|Overall Study||4
11413077|NCT01881932|12609597|FG002|COMPLETED|Overall Study||13
11413078|NCT01881932|12609595|FG000|NOT COMPLETED|Overall Study||0
11413079|NCT01881932|12609596|FG001|NOT COMPLETED|Overall Study||0
11413080|NCT01881932|12609597|FG002|NOT COMPLETED|Overall Study||0
11413081|NCT01878786|12609608|FG000|STARTED|Overall Study||9
11413082|NCT01878786|12609609|FG001|STARTED|Overall Study||9
11413083|NCT01878786|12609610|FG002|STARTED|Overall Study||7
11413084|NCT01878786|12609608|FG000|COMPLETED|Overall Study|Study closed prematurely|0
11413085|NCT01878786|12609609|FG001|COMPLETED|Overall Study|Study closed prematurely|0
11413086|NCT01878786|12609610|FG002|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0
11413087|NCT01878786|12609608|FG000|NOT COMPLETED|Overall Study||9
11413088|NCT01878786|12609609|FG001|NOT COMPLETED|Overall Study||9
11413089|NCT01878786|12609610|FG002|NOT COMPLETED|Overall Study||7
11413090|NCT01877343|12609621|FG000|STARTED|Overall Study||2
11413091|NCT01877343|12609622|FG001|STARTED|Overall Study||3
11413092|NCT01877343|12609623|FG002|STARTED|Overall Study||0
11413093|NCT01877343|12609624|FG003|STARTED|Overall Study||0
11413094|NCT01877343|12609625|FG004|STARTED|Overall Study||0
11413095|NCT01877343|12609626|FG005|STARTED|Overall Study||5
11413096|NCT01877343|12609627|FG006|STARTED|Overall Study||0
11413097|NCT01877343|12609621|FG000|COMPLETED|Overall Study||2
11413098|NCT01877343|12609622|FG001|COMPLETED|Overall Study||3
11413099|NCT01877343|12609623|FG002|COMPLETED|Overall Study||0
11413100|NCT01877343|12609624|FG003|COMPLETED|Overall Study||0
11413101|NCT01877343|12609625|FG004|COMPLETED|Overall Study||0
11413102|NCT01877343|12609626|FG005|COMPLETED|Overall Study||5
11413103|NCT01877343|12609627|FG006|COMPLETED|Overall Study||0
11413104|NCT01877343|12609621|FG000|NOT COMPLETED|Overall Study||0
11413105|NCT01877343|12609622|FG001|NOT COMPLETED|Overall Study||0
11413106|NCT01877343|12609623|FG002|NOT COMPLETED|Overall Study||0
11413107|NCT01877343|12609624|FG003|NOT COMPLETED|Overall Study||0
11413108|NCT01877343|12609625|FG004|NOT COMPLETED|Overall Study||0
11413109|NCT01877343|12609626|FG005|NOT COMPLETED|Overall Study||0
11413110|NCT01877343|12609627|FG006|NOT COMPLETED|Overall Study||0
11413111|NCT01861717|12609631|FG000|STARTED|Overall Study||4
11413112|NCT01861717|12609631|FG000|COMPLETED|Overall Study||2
11413113|NCT01861717|12609631|FG000|NOT COMPLETED|Overall Study||2
11413114|NCT01866709|12609638|FG000|STARTED|Overall Study||15
11413115|NCT01866709|12609639|FG001|STARTED|Overall Study||17
11413116|NCT01866709|12609638|FG000|COMPLETED|Overall Study||14
11413117|NCT01866709|12609639|FG001|COMPLETED|Overall Study||17
11413118|NCT01866709|12609638|FG000|NOT COMPLETED|Overall Study||1
11413119|NCT01866709|12609639|FG001|NOT COMPLETED|Overall Study||0
11413120|NCT01860040|12609647|FG000|STARTED|Overall Study|did not meet recruitment goal|1
11413121|NCT01860040|12609648|FG001|STARTED|Overall Study|did not meet recruitment goal|0
11413122|NCT01860040|12609647|FG000|COMPLETED|Overall Study|did not meet recruitment goal|0
11413123|NCT01860040|12609648|FG001|COMPLETED|Overall Study|did not meet recruitment goal|0
11413124|NCT01860040|12609647|FG000|NOT COMPLETED|Overall Study||1
11413125|NCT01860040|12609648|FG001|NOT COMPLETED|Overall Study||0
11413126|NCT01869478|12609655|FG000|STARTED|Overall Study||0
11413127|NCT01869478|12609656|FG001|STARTED|Overall Study||1
11413128|NCT01869478|12609655|FG000|COMPLETED|Overall Study||0
11413129|NCT01869478|12609656|FG001|COMPLETED|Overall Study||1
11413130|NCT01869478|12609655|FG000|NOT COMPLETED|Overall Study||0
11413131|NCT01869478|12609656|FG001|NOT COMPLETED|Overall Study||0
11413132|NCT01851174|12609662|FG000|STARTED|Overall Study||15
11413133|NCT01851174|12609662|FG000|COMPLETED|Overall Study||15
11413134|NCT01851174|12609662|FG000|NOT COMPLETED|Overall Study||0
11413135|NCT01846182|12609669|FG000|STARTED|Overall Study|Unclear due to assignment records.|0
11413136|NCT01846182|12609670|FG001|STARTED|Overall Study|Unclear due to assignment records.|0
11413137|NCT01846182|12609671|FG002|STARTED|Overall Study|Unclear due to assignment records.|0
11413138|NCT01846182|12609669|FG000|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
11413139|NCT01846182|12609670|FG001|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
11413140|NCT01846182|12609671|FG002|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
11413141|NCT01846182|12609669|FG000|NOT COMPLETED|Overall Study||0
11413142|NCT01846182|12609670|FG001|NOT COMPLETED|Overall Study||0
11413143|NCT01846182|12609671|FG002|NOT COMPLETED|Overall Study||0
11413144|NCT01844206|12609683|FG000|STARTED|Overall Study||2
11413145|NCT01844206|12609684|FG001|STARTED|Overall Study||3
11413146|NCT01844206|12609683|FG000|COMPLETED|Overall Study||2
11413147|NCT01844206|12609684|FG001|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
11413148|NCT01844206|12609683|FG000|NOT COMPLETED|Overall Study||0
11413149|NCT01844206|12609684|FG001|NOT COMPLETED|Overall Study||1
11413150|NCT01856322|12609693|FG000|STARTED|Overall Study||0
11144120|NCT01475825|12330777|FG002|Completed Blinded Treatment Period|Overall Study||59
11144121|NCT01475825|12330778|FG003|Completed Blinded Treatment Period|Overall Study||40
11144122|NCT01475825|12330775|FG000|Entered Open-Label Continuation|Overall Study||45
11144123|NCT01475825|12330776|FG001|Entered Open-Label Continuation|Overall Study||31
11413151|NCT01856322|12609694|FG001|STARTED|Overall Study||0
11413152|NCT01856322|12609695|FG002|STARTED|Overall Study||3
11413153|NCT01856322|12609693|FG000|COMPLETED|Overall Study||0
11413154|NCT01856322|12609694|FG001|COMPLETED|Overall Study||0
11413155|NCT01856322|12609695|FG002|COMPLETED|Overall Study||0
11413156|NCT01856322|12609693|FG000|NOT COMPLETED|Overall Study||0
11413157|NCT01856322|12609694|FG001|NOT COMPLETED|Overall Study||0
11413158|NCT01856322|12609695|FG002|NOT COMPLETED|Overall Study||3
11413159|NCT01853176|12609704|FG000|STARTED|Overall Study||4
11413160|NCT01853176|12609705|FG001|STARTED|Overall Study||0
11413161|NCT01853176|12609704|FG000|COMPLETED|Overall Study||0
11413162|NCT01853176|12609705|FG001|COMPLETED|Overall Study||0
11413163|NCT01853176|12609704|FG000|NOT COMPLETED|Overall Study||4
11413164|NCT01853176|12609705|FG001|NOT COMPLETED|Overall Study||0
11413165|NCT01857271|12609711|FG000|STARTED|Overall Study||3
11413166|NCT01857271|12609711|FG000|COMPLETED|Overall Study||2
11413167|NCT01857271|12609711|FG000|NOT COMPLETED|Overall Study||1
11413168|NCT01856361|12609717|FG000|STARTED|Overall Study||1
11413169|NCT01856361|12609718|FG001|STARTED|Overall Study||1
11413170|NCT01856361|12609717|FG000|COMPLETED|Overall Study||1
11413171|NCT01856361|12609718|FG001|COMPLETED|Overall Study||1
11413172|NCT01856361|12609717|FG000|NOT COMPLETED|Overall Study||0
11413173|NCT01856361|12609718|FG001|NOT COMPLETED|Overall Study||0
11413174|NCT01853982|12609726|FG000|STARTED|Overall Study||2
11413175|NCT01853982|12609727|FG001|STARTED|Overall Study||2
11413176|NCT01853982|12609726|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
11413177|NCT01853982|12609727|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
11413178|NCT01853982|12609726|FG000|COMPLETED|Overall Study||0
11413179|NCT01853982|12609727|FG001|COMPLETED|Overall Study||1
11413180|NCT01853982|12609726|FG000|NOT COMPLETED|Overall Study||2
11413181|NCT01853982|12609727|FG001|NOT COMPLETED|Overall Study||1
11413182|NCT01841931|12609733|FG000|STARTED|Overall Study||4
11413183|NCT01841931|12609733|FG000|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
11413184|NCT01841931|12609733|FG000|NOT COMPLETED|Overall Study||4
11413185|NCT01836809|12609741|FG000|STARTED|Overall Study||0
11413186|NCT01836809|12609742|FG001|STARTED|Overall Study||0
11413187|NCT01836809|12609743|FG002|STARTED|Overall Study||0
11413188|NCT01836809|12609744|FG003|STARTED|Overall Study||2
11413189|NCT01836809|12609741|FG000|COMPLETED|Overall Study||0
11413190|NCT01836809|12609742|FG001|COMPLETED|Overall Study||0
11413191|NCT01836809|12609743|FG002|COMPLETED|Overall Study||0
11413192|NCT01836809|12609744|FG003|COMPLETED|Overall Study||0
11413193|NCT01836809|12609741|FG000|NOT COMPLETED|Overall Study||0
11413194|NCT01836809|12609742|FG001|NOT COMPLETED|Overall Study||0
11413195|NCT01836809|12609743|FG002|NOT COMPLETED|Overall Study||0
11413196|NCT01836809|12609744|FG003|NOT COMPLETED|Overall Study||2
11413197|NCT01834144|12609760|FG000|STARTED|Overall Study||1
11413198|NCT01834144|12609761|FG001|STARTED|Overall Study||3
11413199|NCT01834144|12609760|FG000|COMPLETED|Overall Study||1
11413200|NCT01834144|12609761|FG001|COMPLETED|Overall Study||2
11413201|NCT01834144|12609760|FG000|NOT COMPLETED|Overall Study||0
11413202|NCT01834144|12609761|FG001|NOT COMPLETED|Overall Study||1
11413203|NCT01821963|12609767|FG000|STARTED|Overall Study||1
11413204|NCT01821963|12609767|FG000|COMPLETED|Overall Study||0
11413205|NCT01821963|12609767|FG000|NOT COMPLETED|Overall Study||1
11413206|NCT01821898|12609773|FG000|STARTED|Overall Study||2
11413207|NCT01821898|12609774|FG001|STARTED|Overall Study||1
11413208|NCT01821898|12609773|FG000|COMPLETED|Overall Study||0
11413209|NCT01821898|12609774|FG001|COMPLETED|Overall Study||0
11413210|NCT01821898|12609773|FG000|NOT COMPLETED|Overall Study||2
11413211|NCT01821898|12609774|FG001|NOT COMPLETED|Overall Study||1
11413212|NCT01814722|12609784|FG000|STARTED|Overall Study||36
11413213|NCT01814722|12609785|FG001|STARTED|Overall Study||21
11413214|NCT01814722|12609786|FG002|STARTED|Overall Study||6
11413215|NCT01814722|12609784|FG000|COMPLETED|Overall Study||36
11413216|NCT01814722|12609785|FG001|COMPLETED|Overall Study||21
11413217|NCT01814722|12609786|FG002|COMPLETED|Overall Study||6
11413218|NCT01814722|12609784|FG000|NOT COMPLETED|Overall Study||0
11413219|NCT01814722|12609785|FG001|NOT COMPLETED|Overall Study||0
11413220|NCT01814722|12609786|FG002|NOT COMPLETED|Overall Study||0
11413221|NCT01830790|12609796|FG000|STARTED|Overall Study||0
11413222|NCT01830790|12609797|FG001|STARTED|Overall Study||10
11413223|NCT01830790|12609796|FG000|COMPLETED|Overall Study||0
11413224|NCT01830790|12609797|FG001|COMPLETED|Overall Study||10
11413225|NCT01830790|12609796|FG000|NOT COMPLETED|Overall Study||0
11413226|NCT01830790|12609797|FG001|NOT COMPLETED|Overall Study||0
11413227|NCT01829477|12609805|FG000|STARTED|Overall Study||17
11413228|NCT01829477|12609806|FG001|STARTED|Overall Study||16
11413229|NCT01829477|12609805|FG000|COMPLETED|Overall Study||1
11413230|NCT01829477|12609806|FG001|COMPLETED|Overall Study||1
11413231|NCT01829477|12609805|FG000|NOT COMPLETED|Overall Study||16
11413232|NCT01829477|12609806|FG001|NOT COMPLETED|Overall Study||15
11413233|NCT01803711|12609814|FG000|STARTED|Overall Study||2
11413234|NCT01803711|12609815|FG001|STARTED|Overall Study||3
11413235|NCT01803711|12609814|FG000|COMPLETED|Overall Study||1
11413236|NCT01803711|12609815|FG001|COMPLETED|Overall Study||2
11413237|NCT01803711|12609814|FG000|NOT COMPLETED|Overall Study||1
11413238|NCT01803711|12609815|FG001|NOT COMPLETED|Overall Study||1
11413239|NCT01821859|12609823|FG000|STARTED|Overall Study||5
11413240|NCT01821859|12609823|FG000|COMPLETED|Overall Study||0
11413241|NCT01821859|12609823|FG000|NOT COMPLETED|Overall Study||5
11413242|NCT01808950|12609830|FG000|STARTED|Overall Study||1
11413243|NCT01808950|12609831|FG001|STARTED|Overall Study||3
11413244|NCT01808950|12609832|FG002|STARTED|Overall Study||0
11413245|NCT01808950|12609830|FG000|COMPLETED|Overall Study||1
11413246|NCT01808950|12609831|FG001|COMPLETED|Overall Study||3
11413247|NCT01808950|12609832|FG002|COMPLETED|Overall Study||0
11413248|NCT01808950|12609830|FG000|NOT COMPLETED|Overall Study||0
11413249|NCT01808950|12609831|FG001|NOT COMPLETED|Overall Study||0
11413250|NCT01808950|12609832|FG002|NOT COMPLETED|Overall Study||0
11413251|NCT01806051|12609843|FG000|STARTED|Overall Study||6
11413252|NCT01806051|12609843|FG000|COMPLETED|Overall Study||0
11413253|NCT01806051|12609843|FG000|NOT COMPLETED|Overall Study||6
11413254|NCT01808794|12609851|FG000|STARTED|Overall Study||0
11413255|NCT01808794|12609852|FG001|STARTED|Overall Study||0
11413256|NCT01808794|12609851|FG000|COMPLETED|Overall Study||0
11413257|NCT01808794|12609852|FG001|COMPLETED|Overall Study||0
11413258|NCT01808794|12609851|FG000|NOT COMPLETED|Overall Study||0
11413259|NCT01808794|12609852|FG001|NOT COMPLETED|Overall Study||0
11413260|NCT01809899|12609860|FG000|STARTED|Overall Study||8
11413261|NCT01809899|12609861|FG001|STARTED|Overall Study||4
11413262|NCT01809899|12609860|FG000|COMPLETED|Overall Study||8
11413263|NCT01809899|12609861|FG001|COMPLETED|Overall Study||4
11413264|NCT01809899|12609860|FG000|NOT COMPLETED|Overall Study||0
11413265|NCT01809899|12609861|FG001|NOT COMPLETED|Overall Study||0
11413266|NCT01810302|12609870|FG000|STARTED|Overall Study||1
11413267|NCT01810302|12609871|FG001|STARTED|Overall Study||1
11413268|NCT01810302|12609870|FG000|COMPLETED|Overall Study||0
11413269|NCT01810302|12609871|FG001|COMPLETED|Overall Study||0
11413270|NCT01810302|12609870|FG000|NOT COMPLETED|Overall Study||1
11413271|NCT01810302|12609871|FG001|NOT COMPLETED|Overall Study||1
11413272|NCT01806961|12609877|FG000|STARTED|Overall Study||16
11413273|NCT01806961|12609877|FG000|COMPLETED|Overall Study||0
11413274|NCT01806961|12609877|FG000|NOT COMPLETED|Overall Study||16
11413275|NCT01804166|12609881|FG000|STARTED|Overall Study||1
11413276|NCT01804166|12609881|FG000|COMPLETED|Overall Study||1
11413277|NCT01804166|12609881|FG000|NOT COMPLETED|Overall Study||0
11413278|NCT01783015|12609887|FG000|STARTED|Blinded Treatment||11
11413279|NCT01783015|12609888|FG001|STARTED|Blinded Treatment||5
11413280|NCT01783015|12609889|FG002|STARTED|Blinded Treatment||0
11413281|NCT01783015|12609887|FG000|Treated|Blinded Treatment||11
11413282|NCT01783015|12609888|FG001|Treated|Blinded Treatment||5
11413283|NCT01783015|12609889|FG002|Treated|Blinded Treatment||0
11413284|NCT01783015|12609887|FG000|COMPLETED|Blinded Treatment||9
11413285|NCT01783015|12609888|FG001|COMPLETED|Blinded Treatment||2
11413286|NCT01783015|12609889|FG002|COMPLETED|Blinded Treatment||0
11413287|NCT01783015|12609887|FG000|NOT COMPLETED|Blinded Treatment||2
11413288|NCT01783015|12609888|FG001|NOT COMPLETED|Blinded Treatment||3
11413289|NCT01783015|12609889|FG002|NOT COMPLETED|Blinded Treatment||0
11413290|NCT01783015|12609887|FG000|STARTED|Open Label Treatment||0
11413291|NCT01783015|12609888|FG001|STARTED|Open Label Treatment||0
11413292|NCT01783015|12609889|FG002|STARTED|Open Label Treatment||11
11413293|NCT01783015|12609887|FG000|COMPLETED|Open Label Treatment||0
11413294|NCT01783015|12609888|FG001|COMPLETED|Open Label Treatment||0
11413295|NCT01783015|12609889|FG002|COMPLETED|Open Label Treatment||5
11413296|NCT01783015|12609887|FG000|NOT COMPLETED|Open Label Treatment||0
11413297|NCT01783015|12609888|FG001|NOT COMPLETED|Open Label Treatment||0
11413298|NCT01783015|12609889|FG002|NOT COMPLETED|Open Label Treatment||6
11413299|NCT01800162|12609900|FG000|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
11413300|NCT01800162|12609901|FG001|STARTED|Overall Study||0
11413301|NCT01800162|12609902|FG002|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
11413302|NCT01800162|12609900|FG000|COMPLETED|Overall Study||1
11413303|NCT01800162|12609901|FG001|COMPLETED|Overall Study||0
11413304|NCT01800162|12609902|FG002|COMPLETED|Overall Study||1
11413305|NCT01800162|12609900|FG000|NOT COMPLETED|Overall Study||0
11413306|NCT01800162|12609901|FG001|NOT COMPLETED|Overall Study||0
11413307|NCT01800162|12609902|FG002|NOT COMPLETED|Overall Study||0
11413308|NCT01794936|12609910|FG000|STARTED|Overall Study||9
11413309|NCT01794936|12609910|FG000|COMPLETED|Overall Study||9
11413310|NCT01794936|12609910|FG000|NOT COMPLETED|Overall Study||0
11413311|NCT01797380|12609916|FG000|STARTED|Overall Study|Terminated due to lack of enrollment|3
11413312|NCT01797380|12609917|FG001|STARTED|Overall Study||2
11413313|NCT01797380|12609916|FG000|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
11413314|NCT01797380|12609917|FG001|COMPLETED|Overall Study||0
11413315|NCT01797380|12609916|FG000|NOT COMPLETED|Overall Study||3
11413316|NCT01797380|12609917|FG001|NOT COMPLETED|Overall Study||2
11413317|NCT01781026|12609923|FG000|STARTED|Overall Study||2
11413318|NCT01781026|12609923|FG000|COMPLETED|Overall Study||0
11413319|NCT01781026|12609923|FG000|NOT COMPLETED|Overall Study||2
11413320|NCT01788475|12609930|FG000|STARTED|Overall Study||3
11413321|NCT01788475|12609931|FG001|STARTED|Overall Study||0
11413322|NCT01788475|12609932|FG002|STARTED|Overall Study||0
11413323|NCT01788475|12609930|FG000|COMPLETED|Overall Study||0
11413324|NCT01788475|12609931|FG001|COMPLETED|Overall Study||0
11413325|NCT01788475|12609932|FG002|COMPLETED|Overall Study||0
11413326|NCT01788475|12609930|FG000|NOT COMPLETED|Overall Study||3
11413327|NCT01788475|12609931|FG001|NOT COMPLETED|Overall Study||0
11413328|NCT01788475|12609932|FG002|NOT COMPLETED|Overall Study||0
11413329|NCT01784991|12609942|FG000|STARTED|Overall Study||0
11413330|NCT01784991|12609943|FG001|STARTED|Overall Study||0
11413331|NCT01784991|12609942|FG000|COMPLETED|Overall Study||0
11413332|NCT01784991|12609943|FG001|COMPLETED|Overall Study||0
11413333|NCT01784991|12609942|FG000|NOT COMPLETED|Overall Study||0
11413334|NCT01784991|12609943|FG001|NOT COMPLETED|Overall Study||0
11413335|NCT01777854|12609949|FG000|STARTED|Overall Study||3
11413336|NCT01777854|12609950|FG001|STARTED|Overall Study||3
11413337|NCT01777854|12609949|FG000|COMPLETED|Overall Study||0
11413338|NCT01777854|12609950|FG001|COMPLETED|Overall Study||0
11413339|NCT01777854|12609949|FG000|NOT COMPLETED|Overall Study||3
11413340|NCT01777854|12609950|FG001|NOT COMPLETED|Overall Study||3
11413341|NCT01760993|12609954|FG000|STARTED|Overall Study||0
11413342|NCT01760993|12609954|FG000|COMPLETED|Overall Study||0
11413343|NCT01760993|12609954|FG000|NOT COMPLETED|Overall Study||0
11413344|NCT01772719|12609958|FG000|STARTED|Overall Study||7
11413345|NCT01772719|12609958|FG000|COMPLETED|Overall Study||0
11413346|NCT01772719|12609958|FG000|NOT COMPLETED|Overall Study||7
11413347|NCT01764997|12609970|FG000|STARTED|Run-in Period||776
11413348|NCT01764997|12609971|FG001|STARTED|Run-in Period||0
11413349|NCT01764997|12609972|FG002|STARTED|Run-in Period||0
11413350|NCT01764997|12609973|FG003|STARTED|Run-in Period||0
11413351|NCT01764997|12609974|FG004|STARTED|Run-in Period||0
11413352|NCT01764997|12609970|FG000|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
11413353|NCT01764997|12609971|FG001|COMPLETED|Run-in Period||0
11413354|NCT01764997|12609972|FG002|COMPLETED|Run-in Period||0
11413355|NCT01764997|12609973|FG003|COMPLETED|Run-in Period||0
11413356|NCT01764997|12609974|FG004|COMPLETED|Run-in Period||0
11413357|NCT01764997|12609970|FG000|NOT COMPLETED|Run-in Period||38
11413358|NCT01764997|12609971|FG001|NOT COMPLETED|Run-in Period||0
11413359|NCT01764997|12609972|FG002|NOT COMPLETED|Run-in Period||0
11413360|NCT01764997|12609973|FG003|NOT COMPLETED|Run-in Period||0
11413361|NCT01764997|12609974|FG004|NOT COMPLETED|Run-in Period||0
11413362|NCT01764997|12609970|FG000|STARTED|Study Drug Treatment Period||0
11413363|NCT01764997|12609971|FG001|STARTED|Study Drug Treatment Period||17
11413364|NCT01764997|12609972|FG002|STARTED|Study Drug Treatment Period||13
11413365|NCT01764997|12609973|FG003|STARTED|Study Drug Treatment Period||13
11413366|NCT01764997|12609974|FG004|STARTED|Study Drug Treatment Period||322
11413367|NCT01764997|12609970|FG000|COMPLETED|Study Drug Treatment Period||0
11413368|NCT01764997|12609971|FG001|COMPLETED|Study Drug Treatment Period||16
11413369|NCT01764997|12609972|FG002|COMPLETED|Study Drug Treatment Period||13
11413370|NCT01764997|12609973|FG003|COMPLETED|Study Drug Treatment Period||13
11413371|NCT01764997|12609974|FG004|COMPLETED|Study Drug Treatment Period||286
11413372|NCT01764997|12609970|FG000|NOT COMPLETED|Study Drug Treatment Period||0
11413373|NCT01764997|12609971|FG001|NOT COMPLETED|Study Drug Treatment Period||1
11413374|NCT01764997|12609972|FG002|NOT COMPLETED|Study Drug Treatment Period||0
11413375|NCT01764997|12609973|FG003|NOT COMPLETED|Study Drug Treatment Period||0
11413376|NCT01764997|12609974|FG004|NOT COMPLETED|Study Drug Treatment Period||36
11413377|NCT01760941|12609984|FG000|STARTED|Overall Study||1
11413378|NCT01760941|12609984|FG000|COMPLETED|Overall Study||1
11413379|NCT01760941|12609984|FG000|NOT COMPLETED|Overall Study||0
11413380|NCT01769443|12609990|FG000|STARTED|Overall Study||1
11413381|NCT01769443|12609991|FG001|STARTED|Overall Study||1
11413382|NCT01769443|12609990|FG000|COMPLETED|Overall Study||0
11413383|NCT01769443|12609991|FG001|COMPLETED|Overall Study||1
11413384|NCT01769443|12609990|FG000|NOT COMPLETED|Overall Study||1
11413385|NCT01769443|12609991|FG001|NOT COMPLETED|Overall Study||0
11413386|NCT01760889|12610001|FG000|STARTED|Overall Study||0
11413387|NCT01760889|12610002|FG001|STARTED|Overall Study||0
11413388|NCT01760889|12610003|FG002|STARTED|Overall Study||0
11413389|NCT01760889|12610001|FG000|COMPLETED|Overall Study||0
11413390|NCT01760889|12610002|FG001|COMPLETED|Overall Study||0
11413391|NCT01760889|12610003|FG002|COMPLETED|Overall Study||0
11413392|NCT01760889|12610001|FG000|NOT COMPLETED|Overall Study||0
11413393|NCT01760889|12610002|FG001|NOT COMPLETED|Overall Study||0
11413394|NCT01760889|12610003|FG002|NOT COMPLETED|Overall Study||0
11413395|NCT01749826|12610013|FG000|STARTED|Overall Study||20
11413396|NCT01749826|12610014|FG001|STARTED|Overall Study||0
11413397|NCT01749826|12610013|FG000|COMPLETED|Overall Study||0
11413398|NCT01749826|12610014|FG001|COMPLETED|Overall Study||0
11413399|NCT01749826|12610013|FG000|NOT COMPLETED|Overall Study||20
11413400|NCT01749826|12610014|FG001|NOT COMPLETED|Overall Study||0
11413401|NCT01756586|12610022|FG000|STARTED|Overall Study||2
11413402|NCT01756586|12610023|FG001|STARTED|Overall Study||2
11413403|NCT01756586|12610022|FG000|COMPLETED|Overall Study||0
11413404|NCT01756586|12610023|FG001|COMPLETED|Overall Study||0
11413405|NCT01756586|12610022|FG000|NOT COMPLETED|Overall Study||2
11413406|NCT01756586|12610023|FG001|NOT COMPLETED|Overall Study||2
11413407|NCT01754987|12610031|FG000|STARTED|Overall Study||5
11413408|NCT01754987|12610032|FG001|STARTED|Overall Study||0
11413409|NCT01754987|12610031|FG000|COMPLETED|Overall Study||5
11413410|NCT01754987|12610032|FG001|COMPLETED|Overall Study||0
11413411|NCT01754987|12610031|FG000|NOT COMPLETED|Overall Study||0
11413412|NCT01754987|12610032|FG001|NOT COMPLETED|Overall Study||0
11413413|NCT01756560|12610040|FG000|STARTED|Overall Study||2
11413414|NCT01756560|12610041|FG001|STARTED|Overall Study||0
11413415|NCT01756560|12610040|FG000|COMPLETED|Overall Study||0
11413416|NCT01756560|12610041|FG001|COMPLETED|Overall Study||0
11413417|NCT01756560|12610040|FG000|NOT COMPLETED|Overall Study||2
11413418|NCT01756560|12610041|FG001|NOT COMPLETED|Overall Study||0
11413419|NCT01756573|12610050|FG000|STARTED|Overall Study||3
11413420|NCT01756573|12610051|FG001|STARTED|Overall Study||1
11413421|NCT01756573|12610052|FG002|STARTED|Overall Study||1
11413422|NCT01756573|12610050|FG000|COMPLETED|Overall Study||3
11413423|NCT01756573|12610051|FG001|COMPLETED|Overall Study||1
11413424|NCT01756573|12610052|FG002|COMPLETED|Overall Study||1
11413425|NCT01756573|12610050|FG000|NOT COMPLETED|Overall Study||0
11413426|NCT01756573|12610051|FG001|NOT COMPLETED|Overall Study||0
11413427|NCT01756573|12610052|FG002|NOT COMPLETED|Overall Study||0
11413428|NCT01745913|12610062|FG000|STARTED|Overall Study||1
11413429|NCT01745913|12610063|FG001|STARTED|Overall Study||1
11413430|NCT01745913|12610062|FG000|COMPLETED|Overall Study||0
11413431|NCT01745913|12610063|FG001|COMPLETED|Overall Study||0
11413432|NCT01745913|12610062|FG000|NOT COMPLETED|Overall Study||1
11413433|NCT01745913|12610063|FG001|NOT COMPLETED|Overall Study||1
11413434|NCT01752023|12610075|FG000|STARTED|Overall Study||2
11413435|NCT01752023|12610076|FG001|STARTED|Overall Study||1
11413436|NCT01752023|12610075|FG000|COMPLETED|Overall Study||0
11413437|NCT01752023|12610076|FG001|COMPLETED|Overall Study||0
11413438|NCT01752023|12610075|FG000|NOT COMPLETED|Overall Study||2
11413439|NCT01752023|12610076|FG001|NOT COMPLETED|Overall Study||1
11413440|NCT01740154|12610086|FG000|STARTED|Overall Study||13
11413441|NCT01740154|12610086|FG000|COMPLETED|Overall Study||12
11413442|NCT01740154|12610086|FG000|NOT COMPLETED|Overall Study||1
11413443|NCT01748890|12610090|FG000|STARTED|Overall Study||4
11413444|NCT01748890|12610090|FG000|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
11413445|NCT01748890|12610090|FG000|NOT COMPLETED|Overall Study||4
11413446|NCT01748162|12610096|FG000|STARTED|Overall Study||5
11413447|NCT01748162|12610097|FG001|STARTED|Overall Study||5
11413448|NCT01748162|12610096|FG000|Started 6 Month Initial Treatment Plan|Overall Study||2
11413449|NCT01748162|12610097|FG001|Started 6 Month Initial Treatment Plan|Overall Study||2
11413450|NCT01748162|12610096|FG000|Completed 6 Month Initial Treatment|Overall Study||0
11413451|NCT01748162|12610097|FG001|Completed 6 Month Initial Treatment|Overall Study||0
11413452|NCT01748162|12610096|FG000|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
11413453|NCT01748162|12610097|FG001|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
11413454|NCT01748162|12610096|FG000|COMPLETED|Overall Study||0
11413455|NCT01748162|12610097|FG001|COMPLETED|Overall Study||0
11413456|NCT01748162|12610096|FG000|NOT COMPLETED|Overall Study||5
11413457|NCT01748162|12610097|FG001|NOT COMPLETED|Overall Study||5
11413458|NCT01738698|12610107|FG000|STARTED|Overall Study||0
11413459|NCT01738698|12610108|FG001|STARTED|Overall Study||0
11413460|NCT01738698|12610109|FG002|STARTED|Overall Study||0
11413461|NCT01738698|12610110|FG003|STARTED|Overall Study||0
11413462|NCT01738698|12610107|FG000|COMPLETED|Overall Study||0
11413463|NCT01738698|12610108|FG001|COMPLETED|Overall Study||0
11413464|NCT01738698|12610109|FG002|COMPLETED|Overall Study||0
11413465|NCT01738698|12610110|FG003|COMPLETED|Overall Study||0
11413466|NCT01738698|12610107|FG000|NOT COMPLETED|Overall Study||0
11413467|NCT01738698|12610108|FG001|NOT COMPLETED|Overall Study||0
11413468|NCT01738698|12610109|FG002|NOT COMPLETED|Overall Study||0
11413469|NCT01738698|12610110|FG003|NOT COMPLETED|Overall Study||0
11413470|NCT01732926|12610122|FG000|STARTED|Overall Study||320
11413471|NCT01732926|12610123|FG001|STARTED|Overall Study||155
11413472|NCT01732926|12610122|FG000|COMPLETED|Overall Study||53
11413473|NCT01732926|12610123|FG001|COMPLETED|Overall Study||45
11413474|NCT01732926|12610122|FG000|NOT COMPLETED|Overall Study||267
11413475|NCT01732926|12610123|FG001|NOT COMPLETED|Overall Study||110
11413476|NCT01727167|12610131|FG000|STARTED|Overall Study||1
11413477|NCT01727167|12610132|FG001|STARTED|Overall Study||0
11413478|NCT01727167|12610131|FG000|COMPLETED|Overall Study||1
11413479|NCT01727167|12610132|FG001|COMPLETED|Overall Study||0
11413480|NCT01727167|12610131|FG000|NOT COMPLETED|Overall Study||0
11413481|NCT01727167|12610132|FG001|NOT COMPLETED|Overall Study||0
11413482|NCT01732913|12610140|FG000|STARTED|Overall Study||198
11413483|NCT01732913|12610141|FG001|STARTED|Overall Study||97
11413484|NCT01732913|12610140|FG000|COMPLETED|Overall Study||42
11413485|NCT01732913|12610141|FG001|COMPLETED|Overall Study||28
11413486|NCT01732913|12610140|FG000|NOT COMPLETED|Overall Study||156
11413487|NCT01732913|12610141|FG001|NOT COMPLETED|Overall Study||69
11413488|NCT01732211|12610147|FG000|STARTED|Overall Study||1
11413489|NCT01732211|12610147|FG000|COMPLETED|Overall Study||1
11413490|NCT01732211|12610147|FG000|NOT COMPLETED|Overall Study||0
11413491|NCT01716052|12610153|FG000|STARTED|Overall Study||1
11413492|NCT01716052|12610154|FG001|STARTED|Overall Study||1
11413493|NCT01716052|12610153|FG000|COMPLETED|Overall Study||0
11413494|NCT01716052|12610154|FG001|COMPLETED|Overall Study||0
11413495|NCT01716052|12610153|FG000|NOT COMPLETED|Overall Study||1
11413496|NCT01716052|12610154|FG001|NOT COMPLETED|Overall Study||1
11413497|NCT01718444|12610162|FG000|STARTED|Overall Study||0
11413498|NCT01718444|12610163|FG001|STARTED|Overall Study||0
11413499|NCT01718444|12610162|FG000|COMPLETED|Overall Study||0
11413500|NCT01718444|12610163|FG001|COMPLETED|Overall Study||0
11413501|NCT01718444|12610162|FG000|NOT COMPLETED|Overall Study||0
11413502|NCT01718444|12610163|FG001|NOT COMPLETED|Overall Study||0
11413503|NCT01712854|12610169|FG000|STARTED|Overall Study||9
11413504|NCT01712854|12610169|FG000|COMPLETED|Overall Study||8
11413505|NCT01712854|12610169|FG000|NOT COMPLETED|Overall Study||1
11413506|NCT01717482|12610175|FG000|STARTED|Overall Study||4
11413507|NCT01717482|12610176|FG001|STARTED|Overall Study||2
11413508|NCT01717482|12610175|FG000|COMPLETED|Overall Study||0
11413509|NCT01717482|12610176|FG001|COMPLETED|Overall Study||2
11413510|NCT01717482|12610175|FG000|NOT COMPLETED|Overall Study||4
11413511|NCT01717482|12610176|FG001|NOT COMPLETED|Overall Study||0
11413512|NCT01702896|12610183|FG000|STARTED|Overall Study||8
11413513|NCT01702896|12610183|FG000|COMPLETED|Overall Study||0
11413514|NCT01702896|12610183|FG000|NOT COMPLETED|Overall Study||8
11413515|NCT01709136|12610189|FG000|STARTED|Overall Study||3
11413516|NCT01709136|12610189|FG000|COMPLETED|Overall Study||3
11413517|NCT01709136|12610189|FG000|NOT COMPLETED|Overall Study||0
11413518|NCT01708057|12610196|FG000|STARTED|Overall Study||1
11413519|NCT01708057|12610197|FG001|STARTED|Overall Study||1
11413520|NCT01708057|12610198|FG002|STARTED|Overall Study||1
11413521|NCT01708057|12610196|FG000|COMPLETED|Overall Study||0
11413522|NCT01708057|12610197|FG001|COMPLETED|Overall Study||0
11413523|NCT01708057|12610198|FG002|COMPLETED|Overall Study||0
11413524|NCT01708057|12610196|FG000|NOT COMPLETED|Overall Study||1
11413525|NCT01708057|12610197|FG001|NOT COMPLETED|Overall Study||1
11413526|NCT01708057|12610198|FG002|NOT COMPLETED|Overall Study||1
11413527|NCT01697332|12610212|FG000|STARTED|Overall Study||1
11413528|NCT01697332|12610212|FG000|COMPLETED|Overall Study||1
11413529|NCT01697332|12610212|FG000|NOT COMPLETED|Overall Study||0
11413530|NCT01693367|12610218|FG000|STARTED|Overall Study||2
11413531|NCT01693367|12610219|FG001|STARTED|Overall Study||3
11413532|NCT01693367|12610218|FG000|COMPLETED|Overall Study||1
11413533|NCT01693367|12610219|FG001|COMPLETED|Overall Study||1
11413534|NCT01693367|12610218|FG000|NOT COMPLETED|Overall Study||1
11413535|NCT01693367|12610219|FG001|NOT COMPLETED|Overall Study||2
11413536|NCT01705106|12610225|FG000|STARTED|Overall Study||21
11413537|NCT01705106|12610225|FG000|COMPLETED|Overall Study||21
11413538|NCT01705106|12610225|FG000|NOT COMPLETED|Overall Study||0
11413539|NCT01702909|12610229|FG000|STARTED|Overall Study||7
11413540|NCT01702909|12610229|FG000|COMPLETED|Overall Study||7
11413541|NCT01702909|12610229|FG000|NOT COMPLETED|Overall Study||0
11413542|NCT01701622|12610233|FG000|STARTED|Overall Study||1
11413543|NCT01701622|12610233|FG000|COMPLETED|Overall Study||1
11413544|NCT01701622|12610233|FG000|NOT COMPLETED|Overall Study||0
11413545|NCT01697800|12610240|FG000|STARTED|Overall Study||15
11413546|NCT01697800|12610241|FG001|STARTED|Overall Study||25
11413547|NCT01697800|12610240|FG000|COMPLETED|Overall Study||15
11413548|NCT01697800|12610241|FG001|COMPLETED|Overall Study||24
11413549|NCT01697800|12610240|FG000|NOT COMPLETED|Overall Study||0
11413550|NCT01697800|12610241|FG001|NOT COMPLETED|Overall Study||1
11413551|NCT01700348|12610247|FG000|STARTED|Overall Study||116
11413552|NCT01700348|12610247|FG000|COMPLETED|Overall Study||93
11413553|NCT01700348|12610247|FG000|NOT COMPLETED|Overall Study||23
11413554|NCT01693484|12610253|FG000|STARTED|Overall Study||13
11413555|NCT01693484|12610253|FG000|COMPLETED|Overall Study|Study closed by PI|0
11413556|NCT01693484|12610253|FG000|NOT COMPLETED|Overall Study||13
11413557|NCT01693653|12610259|FG000|STARTED|Overall Study||1
11413558|NCT01693653|12610260|FG001|STARTED|Overall Study||0
11413559|NCT01693653|12610259|FG000|COMPLETED|Overall Study||1
11413560|NCT01693653|12610260|FG001|COMPLETED|Overall Study||0
11413561|NCT01693653|12610259|FG000|NOT COMPLETED|Overall Study||0
11413562|NCT01693653|12610260|FG001|NOT COMPLETED|Overall Study||0
11413563|NCT01692691|12610266|FG000|STARTED|Overall Study||1
11413564|NCT01692691|12610266|FG000|COMPLETED|Overall Study||1
11413565|NCT01692691|12610266|FG000|NOT COMPLETED|Overall Study||0
11413566|NCT01691079|12610274|FG000|STARTED|Overall Study||0
11413567|NCT01691079|12610275|FG001|STARTED|Overall Study||0
11413568|NCT01691079|12610274|FG000|COMPLETED|Overall Study||0
11413569|NCT01691079|12610275|FG001|COMPLETED|Overall Study||0
11413570|NCT01691079|12610274|FG000|NOT COMPLETED|Overall Study||0
11413571|NCT01691079|12610275|FG001|NOT COMPLETED|Overall Study||0
11413572|NCT01690910|12610283|FG000|STARTED|Overall Study|The study was never completed due to feasibility issues.|0
11413573|NCT01690910|12610284|FG001|STARTED|Overall Study||0
11413574|NCT01690910|12610283|FG000|COMPLETED|Overall Study||0
11413575|NCT01690910|12610284|FG001|COMPLETED|Overall Study||0
11413576|NCT01690910|12610283|FG000|NOT COMPLETED|Overall Study||0
11413577|NCT01690910|12610284|FG001|NOT COMPLETED|Overall Study||0
11413578|NCT01689974|12610292|FG000|STARTED|Overall Study||5
11413579|NCT01689974|12610293|FG001|STARTED|Overall Study||5
11413580|NCT01689974|12610292|FG000|COMPLETED|Overall Study||0
11413581|NCT01689974|12610293|FG001|COMPLETED|Overall Study||0
11413582|NCT01689974|12610292|FG000|NOT COMPLETED|Overall Study||5
11413583|NCT01689974|12610293|FG001|NOT COMPLETED|Overall Study||5
11413584|NCT01676961|12610299|FG000|STARTED|Overall Study||5
11413585|NCT01676961|12610299|FG000|COMPLETED|Overall Study||0
11413586|NCT01676961|12610299|FG000|NOT COMPLETED|Overall Study||5
11413587|NCT01681589|12610306|FG000|STARTED|Overall Study||0
11413588|NCT01681589|12610307|FG001|STARTED|Overall Study||0
11413589|NCT01681589|12610308|FG002|STARTED|Overall Study||0
11413590|NCT01681589|12610306|FG000|COMPLETED|Overall Study||0
11413591|NCT01681589|12610307|FG001|COMPLETED|Overall Study||0
11413592|NCT01681589|12610308|FG002|COMPLETED|Overall Study||0
11413593|NCT01681589|12610306|FG000|NOT COMPLETED|Overall Study||0
11413594|NCT01681589|12610307|FG001|NOT COMPLETED|Overall Study||0
11413595|NCT01681589|12610308|FG002|NOT COMPLETED|Overall Study||0
11413596|NCT01681745|12610316|FG000|STARTED|Overall Study||0
11413597|NCT01681745|12610316|FG000|COMPLETED|Overall Study||0
11413598|NCT01681745|12610316|FG000|NOT COMPLETED|Overall Study||0
11413599|NCT01682928|12610322|FG000|STARTED|Overall Study|2 subjects in this Arm|2
11413600|NCT01682928|12610323|FG001|STARTED|Overall Study|2 subjects in this Arm|2
11413601|NCT01682928|12610322|FG000|COMPLETED|Overall Study||2
11413602|NCT01682928|12610323|FG001|COMPLETED|Overall Study||2
11413603|NCT01682928|12610322|FG000|NOT COMPLETED|Overall Study||0
11413604|NCT01682928|12610323|FG001|NOT COMPLETED|Overall Study||0
11413605|NCT01668940|12610335|FG000|STARTED|Overall Study||17
11413606|NCT01668940|12610336|FG001|STARTED|Overall Study||14
11413607|NCT01668940|12610337|FG002|STARTED|Overall Study||9
11413608|NCT01668940|12610338|FG003|STARTED|Overall Study||14
11413609|NCT01668940|12610335|FG000|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|17
11413610|NCT01668940|12610336|FG001|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
11413611|NCT01668940|12610337|FG002|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|9
11413612|NCT01668940|12610338|FG003|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
11413613|NCT01668940|12610335|FG000|NOT COMPLETED|Overall Study||0
11413614|NCT01668940|12610336|FG001|NOT COMPLETED|Overall Study||0
11413615|NCT01668940|12610337|FG002|NOT COMPLETED|Overall Study||0
11413616|NCT01668940|12610338|FG003|NOT COMPLETED|Overall Study||0
11413617|NCT01663285|12610348|FG000|STARTED|Overall Study||1
11413618|NCT01663285|12610348|FG000|COMPLETED|Overall Study||1
11413619|NCT01663285|12610348|FG000|NOT COMPLETED|Overall Study||0
11413620|NCT01683864|12610355|FG000|STARTED|Overall Study||0
11413621|NCT01683864|12610356|FG001|STARTED|Overall Study||0
11413622|NCT01683864|12610357|FG002|STARTED|Overall Study||0
11413623|NCT01683864|12610355|FG000|COMPLETED|Overall Study||0
11413624|NCT01683864|12610356|FG001|COMPLETED|Overall Study||0
11413625|NCT01683864|12610357|FG002|COMPLETED|Overall Study||0
11413626|NCT01683864|12610355|FG000|NOT COMPLETED|Overall Study||0
11413627|NCT01683864|12610356|FG001|NOT COMPLETED|Overall Study||0
11413628|NCT01683864|12610357|FG002|NOT COMPLETED|Overall Study||0
11413629|NCT01675011|12610367|FG000|STARTED|Overall Study||3
11413630|NCT01675011|12610368|FG001|STARTED|Overall Study||1
11413631|NCT01675011|12610367|FG000|COMPLETED|Overall Study||0
11413632|NCT01675011|12610368|FG001|COMPLETED|Overall Study||0
11413633|NCT01675011|12610367|FG000|NOT COMPLETED|Overall Study||3
11413634|NCT01675011|12610368|FG001|NOT COMPLETED|Overall Study||1
11413635|NCT01673425|12610374|FG000|STARTED|Overall Study||5
11413636|NCT01673425|12610374|FG000|COMPLETED|Overall Study||4
11413637|NCT01673425|12610374|FG000|NOT COMPLETED|Overall Study||1
11413638|NCT01673061|12610380|FG000|STARTED|Overall Study||0
11413639|NCT01673061|12610381|FG001|STARTED|Overall Study||0
11413640|NCT01673061|12610380|FG000|COMPLETED|Overall Study||0
11413641|NCT01673061|12610381|FG001|COMPLETED|Overall Study||0
11413642|NCT01673061|12610380|FG000|NOT COMPLETED|Overall Study||0
11413643|NCT01673061|12610381|FG001|NOT COMPLETED|Overall Study||0
11413644|NCT01675960|12610389|FG000|STARTED|Overall Study||2
11413645|NCT01675960|12610390|FG001|STARTED|Overall Study||0
11413646|NCT01675960|12610389|FG000|COMPLETED|Overall Study||2
11413647|NCT01675960|12610390|FG001|COMPLETED|Overall Study||0
11413648|NCT01675960|12610389|FG000|NOT COMPLETED|Overall Study||0
11413649|NCT01675960|12610390|FG001|NOT COMPLETED|Overall Study||0
11413650|NCT01668147|12610396|FG000|STARTED|Overall Study||13
11413651|NCT01668147|12610396|FG000|COMPLETED|Overall Study||7
11413652|NCT01668147|12610396|FG000|NOT COMPLETED|Overall Study||6
11413653|NCT01676701|12610406|FG000|STARTED|Overall Study||4
11413654|NCT01676701|12610407|FG001|STARTED|Overall Study||4
11413655|NCT01676701|12610406|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
11413656|NCT01676701|12610407|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
11413657|NCT01676701|12610406|FG000|Completed Post-Treatment Follow-Up|Overall Study||4
11413658|NCT01676701|12610407|FG001|Completed Post-Treatment Follow-Up|Overall Study||4
11413659|NCT01676701|12610406|FG000|COMPLETED|Overall Study||0
11413660|NCT01676701|12610407|FG001|COMPLETED|Overall Study||0
11413661|NCT01676701|12610406|FG000|NOT COMPLETED|Overall Study||4
11413662|NCT01676701|12610407|FG001|NOT COMPLETED|Overall Study||4
11413663|NCT01669148|12610415|FG000|STARTED|Overall Study||496
11413664|NCT01669148|12610415|FG000|COMPLETED|Overall Study||426
11413665|NCT01669148|12610415|FG000|NOT COMPLETED|Overall Study||70
11413666|NCT01662102|12610422|FG000|STARTED|Overall Study||1
11413667|NCT01662102|12610423|FG001|STARTED|Overall Study||0
11413668|NCT01662102|12610422|FG000|COMPLETED|Overall Study||0
11413669|NCT01662102|12610423|FG001|COMPLETED|Overall Study||0
11413670|NCT01662102|12610422|FG000|NOT COMPLETED|Overall Study||1
11413671|NCT01662102|12610423|FG001|NOT COMPLETED|Overall Study||0
11413672|NCT01659554|12610430|FG000|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
11413673|NCT01659554|12610430|FG000|COMPLETED|Overall Study||0
11413674|NCT01659554|12610430|FG000|NOT COMPLETED|Overall Study||4
11413675|NCT01658813|12610434|FG000|STARTED|Overall Study||18
11413676|NCT01658813|12610434|FG000|Eligible|Overall Study||18
11413677|NCT01658813|12610434|FG000|Treated|Overall Study||18
11413678|NCT01658813|12610434|FG000|COMPLETED|Overall Study||15
11413679|NCT01658813|12610434|FG000|NOT COMPLETED|Overall Study||3
11413680|NCT01648296|12610444|FG000|STARTED|Overall Study||11
11413681|NCT01648296|12610445|FG001|STARTED|Overall Study||17
11413682|NCT01648296|12610444|FG000|COMPLETED|Overall Study||11
11413683|NCT01648296|12610445|FG001|COMPLETED|Overall Study||17
11413684|NCT01648296|12610444|FG000|NOT COMPLETED|Overall Study||0
11413685|NCT01648296|12610445|FG001|NOT COMPLETED|Overall Study||0
11413686|NCT01649505|12610455|FG000|STARTED|Overall Study||1
11413687|NCT01649505|12610456|FG001|STARTED|Overall Study||1
11413688|NCT01649505|12610455|FG000|COMPLETED|Overall Study||0
11413689|NCT01649505|12610456|FG001|COMPLETED|Overall Study||0
11413690|NCT01649505|12610455|FG000|NOT COMPLETED|Overall Study||1
11413691|NCT01649505|12610456|FG001|NOT COMPLETED|Overall Study||1
11413692|NCT01642732|12610462|FG000|STARTED|Overall Study||1
11413693|NCT01642732|12610462|FG000|COMPLETED|Overall Study||0
11413694|NCT01642732|12610462|FG000|NOT COMPLETED|Overall Study||1
11413695|NCT01645709|12610468|FG000|STARTED|Overall Study|Study was terminated; not made unblind|0
11413696|NCT01645709|12610469|FG001|STARTED|Overall Study|Study was terminated; not made unblind|0
11413697|NCT01645709|12610468|FG000|COMPLETED|Overall Study|Study was terminated; not made unblind|0
11413698|NCT01645709|12610469|FG001|COMPLETED|Overall Study|Study was terminated; not made unblind|0
11413699|NCT01645709|12610468|FG000|NOT COMPLETED|Overall Study||0
11413700|NCT01645709|12610469|FG001|NOT COMPLETED|Overall Study||0
11413701|NCT01648270|12610475|FG000|STARTED|Intravenous Buprenorphine||25
11413702|NCT01648270|12610475|FG000|COMPLETED|Intravenous Buprenorphine||13
11413703|NCT01648270|12610475|FG000|NOT COMPLETED|Intravenous Buprenorphine||12
11413704|NCT01648270|12610475|FG000|STARTED|Sublingual Buprenorphine||13
11413705|NCT01648270|12610475|FG000|COMPLETED|Sublingual Buprenorphine||13
11413706|NCT01648270|12610475|FG000|NOT COMPLETED|Sublingual Buprenorphine||0
11413707|NCT01648270|12610475|FG000|STARTED|Cyclosporine Plus IV Buprenorphine||13
11413708|NCT01648270|12610475|FG000|COMPLETED|Cyclosporine Plus IV Buprenorphine||13
11413709|NCT01648270|12610475|FG000|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0
11413710|NCT01648270|12610475|FG000|STARTED|Cyclosporine + Sublingual Buprenorphine||13
11413711|NCT01648270|12610475|FG000|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13
11413712|NCT01648270|12610475|FG000|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0
11413713|NCT01643525|12610485|FG000|STARTED|Overall Study||29
11413714|NCT01643525|12610485|FG000|COMPLETED|Overall Study||29
11413715|NCT01643525|12610485|FG000|NOT COMPLETED|Overall Study||0
11413716|NCT01641601|12610491|FG000|STARTED|Overall Study||3
11413717|NCT01641601|12610492|FG001|STARTED|Overall Study||5
11413718|NCT01641601|12610491|FG000|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
11413719|NCT01641601|12610492|FG001|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
11413720|NCT01641601|12610491|FG000|NOT COMPLETED|Overall Study||3
11413721|NCT01641601|12610492|FG001|NOT COMPLETED|Overall Study||5
11413722|NCT01633814|12610498|FG000|STARTED|Overall Study||4
11413723|NCT01633814|12610498|FG000|COMPLETED|Overall Study||4
11413724|NCT01633814|12610498|FG000|NOT COMPLETED|Overall Study||0
11413725|NCT01636466|12610504|FG000|STARTED|Overall Study||1
11413726|NCT01636466|12610505|FG001|STARTED|Overall Study||0
11413727|NCT01636466|12610504|FG000|COMPLETED|Overall Study||0
11413728|NCT01636466|12610505|FG001|COMPLETED|Overall Study||0
11413729|NCT01636466|12610504|FG000|NOT COMPLETED|Overall Study||1
11413730|NCT01636466|12610505|FG001|NOT COMPLETED|Overall Study||0
11413731|NCT01629329|12610513|FG000|STARTED|Overall Study||0
11413732|NCT01629329|12610514|FG001|STARTED|Overall Study||0
11413733|NCT01629329|12610513|FG000|COMPLETED|Overall Study||0
11413734|NCT01629329|12610514|FG001|COMPLETED|Overall Study||0
11413735|NCT01629329|12610513|FG000|NOT COMPLETED|Overall Study||0
11413736|NCT01629329|12610514|FG001|NOT COMPLETED|Overall Study||0
11413737|NCT01627899|12610520|FG000|STARTED|Overall Study||5
11413738|NCT01627899|12610520|FG000|COMPLETED|Overall Study||0
11413739|NCT01627899|12610520|FG000|NOT COMPLETED|Overall Study||5
11413740|NCT01632020|12610526|FG000|STARTED|Overall Study||4
11413741|NCT01632020|12610527|FG001|STARTED|Overall Study||3
11413742|NCT01632020|12610526|FG000|COMPLETED|Overall Study||2
11413743|NCT01632020|12610527|FG001|COMPLETED|Overall Study||3
11413744|NCT01632020|12610526|FG000|NOT COMPLETED|Overall Study||2
11413745|NCT01632020|12610527|FG001|NOT COMPLETED|Overall Study||0
11413746|NCT01602471|12610533|FG000|STARTED|Overall Study||4
11413747|NCT01602471|12610533|FG000|COMPLETED|Overall Study||4
11413748|NCT01602471|12610533|FG000|NOT COMPLETED|Overall Study||0
11413749|NCT01619800|12610539|FG000|STARTED|Overall Study||2
11413750|NCT01619800|12610540|FG001|STARTED|Overall Study||0
11413751|NCT01619800|12610539|FG000|COMPLETED|Overall Study||0
11413752|NCT01619800|12610540|FG001|COMPLETED|Overall Study||0
11413753|NCT01619800|12610539|FG000|NOT COMPLETED|Overall Study||2
11413754|NCT01619800|12610540|FG001|NOT COMPLETED|Overall Study||0
11413755|NCT01608906|12610546|FG000|STARTED|Overall Study||152
11413756|NCT01608906|12610546|FG000|COMPLETED|Overall Study||113
11413757|NCT01608906|12610546|FG000|NOT COMPLETED|Overall Study||39
11413758|NCT01621737|12610551|FG000|STARTED|Overall Study||0
11413759|NCT01621737|12610551|FG000|COMPLETED|Overall Study||0
11413760|NCT01621737|12610551|FG000|NOT COMPLETED|Overall Study||0
11413761|NCT01614067|12610557|FG000|STARTED|Overall Study||15
11413762|NCT01614067|12610558|FG001|STARTED|Overall Study||15
11413763|NCT01614067|12610557|FG000|COMPLETED|Overall Study||0
11413764|NCT01614067|12610558|FG001|COMPLETED|Overall Study||0
11413765|NCT01614067|12610557|FG000|NOT COMPLETED|Overall Study||15
11413766|NCT01614067|12610558|FG001|NOT COMPLETED|Overall Study||15
11413767|NCT01607320|12610564|FG000|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
11413768|NCT01607320|12610565|FG001|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
11413769|NCT01607320|12610564|FG000|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
11413770|NCT01607320|12610565|FG001|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
11413771|NCT01607320|12610564|FG000|NOT COMPLETED|Overall Study||0
11413772|NCT01607320|12610565|FG001|NOT COMPLETED|Overall Study||0
11413773|NCT01605019|12610571|FG000|STARTED|Overall Study||4
11413774|NCT01605019|12610572|FG001|STARTED|Overall Study||0
11413775|NCT01605019|12610571|FG000|COMPLETED|Overall Study||1
11413776|NCT01605019|12610572|FG001|COMPLETED|Overall Study||0
11413777|NCT01605019|12610571|FG000|NOT COMPLETED|Overall Study||3
11413778|NCT01605019|12610572|FG001|NOT COMPLETED|Overall Study||0
11413779|NCT01609231|12610580|FG000|STARTED|Overall Study||6
11413780|NCT01609231|12610581|FG001|STARTED|Overall Study||5
11413781|NCT01609231|12610580|FG000|COMPLETED|Overall Study||3
11413782|NCT01609231|12610581|FG001|COMPLETED|Overall Study||2
11413783|NCT01609231|12610580|FG000|NOT COMPLETED|Overall Study||3
11413784|NCT01609231|12610581|FG001|NOT COMPLETED|Overall Study||3
11413785|NCT01602198|12610589|FG000|STARTED|Overall Study||0
11413786|NCT01602198|12610590|FG001|STARTED|Overall Study||1
11413787|NCT01602198|12610589|FG000|COMPLETED|Overall Study||0
11413788|NCT01602198|12610590|FG001|COMPLETED|Overall Study||1
11413789|NCT01602198|12610589|FG000|NOT COMPLETED|Overall Study||0
11413790|NCT01602198|12610590|FG001|NOT COMPLETED|Overall Study||0
11413791|NCT01606150|12610598|FG000|STARTED|Overall Study||0
11413792|NCT01606150|12610599|FG001|STARTED|Overall Study||0
11413793|NCT01606150|12610598|FG000|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
11413794|NCT01606150|12610599|FG001|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
11413795|NCT01606150|12610598|FG000|NOT COMPLETED|Overall Study||0
11413796|NCT01606150|12610599|FG001|NOT COMPLETED|Overall Study||0
11413797|NCT01603043|12610607|FG000|STARTED|Overall Study||7
11413798|NCT01603043|12610608|FG001|STARTED|Overall Study||3
11413799|NCT01603043|12610607|FG000|COMPLETED|Overall Study||0
11413800|NCT01603043|12610608|FG001|COMPLETED|Overall Study||0
11413801|NCT01603043|12610607|FG000|NOT COMPLETED|Overall Study||7
11413802|NCT01603043|12610608|FG001|NOT COMPLETED|Overall Study||3
11413803|NCT01605370|12610616|FG000|STARTED|Overall Study||1
11413804|NCT01605370|12610617|FG001|STARTED|Overall Study||0
11413805|NCT01605370|12610616|FG000|COMPLETED|Overall Study||0
11413806|NCT01605370|12610617|FG001|COMPLETED|Overall Study||0
11413807|NCT01605370|12610616|FG000|NOT COMPLETED|Overall Study||1
11413808|NCT01605370|12610617|FG001|NOT COMPLETED|Overall Study||0
11413809|NCT01605617|12610625|FG000|STARTED|First Intervention||2
11413810|NCT01605617|12610626|FG001|STARTED|First Intervention||2
11413811|NCT01605617|12610625|FG000|COMPLETED|First Intervention||2
11413812|NCT01605617|12610626|FG001|COMPLETED|First Intervention||1
11413813|NCT01605617|12610625|FG000|NOT COMPLETED|First Intervention||0
11413814|NCT01605617|12610626|FG001|NOT COMPLETED|First Intervention||1
11413815|NCT01605617|12610625|FG000|STARTED|Washout Period of 4 Weeks||2
11413816|NCT01605617|12610626|FG001|STARTED|Washout Period of 4 Weeks||1
11413817|NCT01605617|12610625|FG000|COMPLETED|Washout Period of 4 Weeks||0
11413818|NCT01605617|12610626|FG001|COMPLETED|Washout Period of 4 Weeks||0
11413819|NCT01605617|12610625|FG000|NOT COMPLETED|Washout Period of 4 Weeks||2
11413820|NCT01605617|12610626|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1
11413821|NCT01605617|12610625|FG000|STARTED|Second Intervention||0
11413822|NCT01605617|12610626|FG001|STARTED|Second Intervention||0
11413823|NCT01605617|12610625|FG000|COMPLETED|Second Intervention||0
11413824|NCT01605617|12610626|FG001|COMPLETED|Second Intervention||0
11413825|NCT01605617|12610625|FG000|NOT COMPLETED|Second Intervention||0
11413826|NCT01605617|12610626|FG001|NOT COMPLETED|Second Intervention||0
11413827|NCT01606709|12610636|FG000|STARTED|Overall Study||4
11413828|NCT01606709|12610637|FG001|STARTED|Overall Study||3
11413829|NCT01606709|12610636|FG000|COMPLETED|Overall Study||4
11413830|NCT01606709|12610637|FG001|COMPLETED|Overall Study||3
11413831|NCT01606709|12610636|FG000|NOT COMPLETED|Overall Study||0
11413832|NCT01606709|12610637|FG001|NOT COMPLETED|Overall Study||0
11413833|NCT01603121|12610643|FG000|STARTED|First Intervention, 10 Hours||1
11413834|NCT01603121|12610644|FG001|STARTED|First Intervention, 10 Hours||0
11413835|NCT01603121|12610643|FG000|COMPLETED|First Intervention, 10 Hours||1
11413836|NCT01603121|12610644|FG001|COMPLETED|First Intervention, 10 Hours||0
11413837|NCT01603121|12610643|FG000|NOT COMPLETED|First Intervention, 10 Hours||0
11413838|NCT01603121|12610644|FG001|NOT COMPLETED|First Intervention, 10 Hours||0
11413839|NCT01603121|12610643|FG000|STARTED|Second Intervention, 10 Hours||1
11413840|NCT01603121|12610644|FG001|STARTED|Second Intervention, 10 Hours||0
11413841|NCT01603121|12610643|FG000|COMPLETED|Second Intervention, 10 Hours||0
11413842|NCT01603121|12610644|FG001|COMPLETED|Second Intervention, 10 Hours||0
11413843|NCT01603121|12610643|FG000|NOT COMPLETED|Second Intervention, 10 Hours||1
11413844|NCT01603121|12610644|FG001|NOT COMPLETED|Second Intervention, 10 Hours||0
11413845|NCT01602016|12610650|FG000|STARTED|Overall Study||0
11413846|NCT01602016|12610650|FG000|COMPLETED|Overall Study||0
11413847|NCT01602016|12610650|FG000|NOT COMPLETED|Overall Study||0
11413848|NCT01603394|12610657|FG000|STARTED|Overall Study||9
11413849|NCT01603394|12610657|FG000|COMPLETED|Overall Study||8
11413850|NCT01603394|12610657|FG000|NOT COMPLETED|Overall Study||1
11413851|NCT01592383|12610661|FG000|STARTED|Overall Study||2
11413852|NCT01592383|12610661|FG000|COMPLETED|Overall Study||1
11413853|NCT01592383|12610661|FG000|NOT COMPLETED|Overall Study||1
11413854|NCT01598025|12610668|FG000|STARTED|Overall Study||0
11413855|NCT01598025|12610669|FG001|STARTED|Overall Study||3
11413856|NCT01598025|12610668|FG000|COMPLETED|Overall Study||0
11413857|NCT01598025|12610669|FG001|COMPLETED|Overall Study||0
11413858|NCT01598025|12610668|FG000|NOT COMPLETED|Overall Study||0
11413859|NCT01598025|12610669|FG001|NOT COMPLETED|Overall Study||3
11413860|NCT01587963|12610676|FG000|STARTED|Overall Study||7
11413861|NCT01587963|12610677|FG001|STARTED|Overall Study||4
11413862|NCT01587963|12610676|FG000|COMPLETED|Overall Study||6
11413863|NCT01587963|12610677|FG001|COMPLETED|Overall Study||4
11413864|NCT01587963|12610676|FG000|NOT COMPLETED|Overall Study||1
11413865|NCT01587963|12610677|FG001|NOT COMPLETED|Overall Study||0
11413866|NCT01591096|12610683|FG000|STARTED|Overall Study||1
11413867|NCT01591096|12610683|FG000|COMPLETED|Overall Study||0
11413868|NCT01591096|12610683|FG000|NOT COMPLETED|Overall Study||1
11413869|NCT01591954|12610687|FG000|STARTED|Overall Study||1
11413870|NCT01591954|12610687|FG000|COMPLETED|Overall Study||1
11413871|NCT01591954|12610687|FG000|NOT COMPLETED|Overall Study||0
11413872|NCT01589926|12610693|FG000|STARTED|Overall Study||0
11413873|NCT01589926|12610694|FG001|STARTED|Overall Study||0
11413874|NCT01589926|12610693|FG000|COMPLETED|Overall Study||0
11413875|NCT01589926|12610694|FG001|COMPLETED|Overall Study||0
11413876|NCT01589926|12610693|FG000|NOT COMPLETED|Overall Study||0
11413877|NCT01589926|12610694|FG001|NOT COMPLETED|Overall Study||0
11413878|NCT01576575|12610700|FG000|STARTED|Buprenorphine Control||21
11413879|NCT01576575|12610700|FG000|COMPLETED|Buprenorphine Control||18
11413880|NCT01576575|12610700|FG000|NOT COMPLETED|Buprenorphine Control||3
11413881|NCT01576575|12610700|FG000|STARTED|Buprenorphine + Rifampin||18
11413882|NCT01576575|12610700|FG000|COMPLETED|Buprenorphine + Rifampin||15
11413883|NCT01576575|12610700|FG000|NOT COMPLETED|Buprenorphine + Rifampin||3
11413884|NCT01576575|12610700|FG000|STARTED|Buprenorphine + Grapefruit||15
11413885|NCT01576575|12610700|FG000|COMPLETED|Buprenorphine + Grapefruit||14
11413886|NCT01576575|12610700|FG000|NOT COMPLETED|Buprenorphine + Grapefruit||1
11413887|NCT01576575|12610700|FG000|STARTED|Buprenorphine + Ketoconazole||14
11413888|NCT01576575|12610700|FG000|COMPLETED|Buprenorphine + Ketoconazole||14
11413889|NCT01576575|12610700|FG000|NOT COMPLETED|Buprenorphine + Ketoconazole||0
11413890|NCT01590394|12610710|FG000|STARTED|Overall Study||3
11413891|NCT01590394|12610710|FG000|COMPLETED|Overall Study||3
11413892|NCT01590394|12610710|FG000|NOT COMPLETED|Overall Study||0
11413893|NCT01577628|12610716|FG000|STARTED|Overall Study||0
11413894|NCT01577628|12610717|FG001|STARTED|Overall Study||0
11413895|NCT01577628|12610718|FG002|STARTED|Overall Study||2
11413896|NCT01577628|12610716|FG000|COMPLETED|Overall Study||0
11413897|NCT01577628|12610717|FG001|COMPLETED|Overall Study||0
11413898|NCT01577628|12610718|FG002|COMPLETED|Overall Study||0
11413899|NCT01577628|12610716|FG000|NOT COMPLETED|Overall Study||0
11413900|NCT01577628|12610717|FG001|NOT COMPLETED|Overall Study||0
11413901|NCT01577628|12610718|FG002|NOT COMPLETED|Overall Study||2
11413902|NCT01582100|12610724|FG000|STARTED|Overall Study||2
11413903|NCT01582100|12610724|FG000|COMPLETED|Overall Study||0
11413904|NCT01582100|12610724|FG000|NOT COMPLETED|Overall Study||2
11413905|NCT01583647|12610728|FG000|STARTED|Overall Study||10
11413906|NCT01583647|12610729|FG001|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
11413907|NCT01583647|12610728|FG000|COMPLETED|Overall Study||10
11413908|NCT01583647|12610729|FG001|COMPLETED|Overall Study||0
11413909|NCT01583647|12610728|FG000|NOT COMPLETED|Overall Study||0
11413910|NCT01583647|12610729|FG001|NOT COMPLETED|Overall Study||0
11413911|NCT01575028|12610737|FG000|STARTED|Overall Study||2
11413912|NCT01575028|12610738|FG001|STARTED|Overall Study||1
11413913|NCT01575028|12610737|FG000|COMPLETED|Overall Study||2
11413914|NCT01575028|12610738|FG001|COMPLETED|Overall Study||0
11413915|NCT01575028|12610737|FG000|NOT COMPLETED|Overall Study||0
11413916|NCT01575028|12610738|FG001|NOT COMPLETED|Overall Study||1
11413917|NCT01578785|12610746|FG000|STARTED|Overall Study||59
11413918|NCT01578785|12610747|FG001|STARTED|Overall Study||119
11413919|NCT01578785|12610746|FG000|COMPLETED|Overall Study||0
11413920|NCT01578785|12610747|FG001|COMPLETED|Overall Study||0
11413921|NCT01578785|12610746|FG000|NOT COMPLETED|Overall Study||59
11413922|NCT01578785|12610747|FG001|NOT COMPLETED|Overall Study||119
11413923|NCT01576549|12610753|FG000|STARTED|Overall Study||2
11413924|NCT01576549|12610753|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
11413925|NCT01576549|12610753|FG000|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
11413926|NCT01576549|12610753|FG000|COMPLETED|Overall Study||0
11413927|NCT01576549|12610753|FG000|NOT COMPLETED|Overall Study||2
11413928|NCT01570634|12610758|FG000|STARTED|Overall Study||2
11413929|NCT01570634|12610758|FG000|COMPLETED|Overall Study||2
11413930|NCT01570634|12610758|FG000|NOT COMPLETED|Overall Study||0
11413931|NCT01566370|12610764|FG000|STARTED|Overall Study||2
11413932|NCT01566370|12610765|FG001|STARTED|Overall Study||1
11413933|NCT01566370|12610764|FG000|COMPLETED|Overall Study||0
11413934|NCT01566370|12610765|FG001|COMPLETED|Overall Study||0
11413935|NCT01566370|12610764|FG000|NOT COMPLETED|Overall Study||2
11413936|NCT01566370|12610765|FG001|NOT COMPLETED|Overall Study||1
11413937|NCT01561989|12610773|FG000|STARTED|Overall Study||5
11413938|NCT01561989|12610774|FG001|STARTED|Overall Study||6
11413939|NCT01561989|12610773|FG000|COMPLETED|Overall Study||0
11413940|NCT01561989|12610774|FG001|COMPLETED|Overall Study||0
11413941|NCT01561989|12610773|FG000|NOT COMPLETED|Overall Study||5
11413942|NCT01561989|12610774|FG001|NOT COMPLETED|Overall Study||6
11413943|NCT01564732|12610782|FG000|STARTED|Overall Study||6
11413944|NCT01564732|12610783|FG001|STARTED|Overall Study||5
11413945|NCT01564732|12610782|FG000|COMPLETED|Overall Study||0
11413946|NCT01564732|12610783|FG001|COMPLETED|Overall Study||0
11413947|NCT01564732|12610782|FG000|NOT COMPLETED|Overall Study||6
11413948|NCT01564732|12610783|FG001|NOT COMPLETED|Overall Study||5
11413949|NCT01560507|12610792|FG000|STARTED|Overall Study||5
11413950|NCT01560507|12610793|FG001|STARTED|Overall Study||2
11413951|NCT01560507|12610794|FG002|STARTED|Overall Study||2
11413952|NCT01560507|12610792|FG000|COMPLETED|Overall Study||1
11413953|NCT01560507|12610793|FG001|COMPLETED|Overall Study||0
11413954|NCT01560507|12610794|FG002|COMPLETED|Overall Study||0
11413955|NCT01560507|12610792|FG000|NOT COMPLETED|Overall Study||4
11413956|NCT01560507|12610793|FG001|NOT COMPLETED|Overall Study||2
11413957|NCT01560507|12610794|FG002|NOT COMPLETED|Overall Study||2
11413958|NCT01557881|12610805|FG000|STARTED|Overall Study||98
11413959|NCT01557881|12610805|FG000|COMPLETED|Overall Study||98
11413960|NCT01557881|12610805|FG000|NOT COMPLETED|Overall Study||0
11413961|NCT01555489|12610809|FG000|STARTED|Overall Study||11
11413962|NCT01555489|12610809|FG000|COMPLETED|Overall Study||11
11413963|NCT01555489|12610809|FG000|NOT COMPLETED|Overall Study||0
11413964|NCT01549977|12610815|FG000|STARTED|Overall Study||1
11413965|NCT01549977|12610816|FG001|STARTED|Overall Study||0
11413966|NCT01549977|12610815|FG000|COMPLETED|Overall Study||1
11413967|NCT01549977|12610816|FG001|COMPLETED|Overall Study||0
11413968|NCT01549977|12610815|FG000|NOT COMPLETED|Overall Study||0
11413969|NCT01549977|12610816|FG001|NOT COMPLETED|Overall Study||0
11413970|NCT01558492|12610822|FG000|STARTED|Overall Study||3
11413971|NCT01558492|12610822|FG000|COMPLETED|Overall Study||3
11413972|NCT01558492|12610822|FG000|NOT COMPLETED|Overall Study||0
11413973|NCT01550562|12610826|FG000|STARTED|First Intervention, 4 - 5 Days||1
11413974|NCT01550562|12610826|FG000|COMPLETED|First Intervention, 4 - 5 Days||1
11413975|NCT01550562|12610826|FG000|NOT COMPLETED|First Intervention, 4 - 5 Days||0
11413976|NCT01550562|12610826|FG000|STARTED|Second Intervention, 4 - 5 Days||1
11413977|NCT01550562|12610826|FG000|COMPLETED|Second Intervention, 4 - 5 Days||1
11413978|NCT01550562|12610826|FG000|NOT COMPLETED|Second Intervention, 4 - 5 Days||0
11413979|NCT01550562|12610826|FG000|STARTED|Third Intervention, 4 - 5 Days||1
11413980|NCT01550562|12610826|FG000|COMPLETED|Third Intervention, 4 - 5 Days||1
11413981|NCT01550562|12610826|FG000|NOT COMPLETED|Third Intervention, 4 - 5 Days||0
11413982|NCT01561495|12610830|FG000|STARTED|Overall Study||1
11413983|NCT01561495|12610830|FG000|COMPLETED|Overall Study||1
11413984|NCT01561495|12610830|FG000|NOT COMPLETED|Overall Study||0
11413985|NCT01555073|12610838|FG000|STARTED|Overall Study||7
11413986|NCT01555073|12610839|FG001|STARTED|Overall Study||3
11413987|NCT01555073|12610840|FG002|STARTED|Overall Study||7
11413988|NCT01555073|12610841|FG003|STARTED|Overall Study||6
11413989|NCT01555073|12610838|FG000|COMPLETED|Overall Study||6
11413990|NCT01555073|12610839|FG001|COMPLETED|Overall Study||1
11413991|NCT01555073|12610840|FG002|COMPLETED|Overall Study||7
11413992|NCT01555073|12610841|FG003|COMPLETED|Overall Study||1
11413993|NCT01555073|12610838|FG000|NOT COMPLETED|Overall Study||1
11413994|NCT01555073|12610839|FG001|NOT COMPLETED|Overall Study||2
11413995|NCT01555073|12610840|FG002|NOT COMPLETED|Overall Study||0
11413996|NCT01555073|12610841|FG003|NOT COMPLETED|Overall Study||5
11413997|NCT01551082|12610851|FG000|STARTED|Overall Study||12
11413998|NCT01551082|12610851|FG000|COMPLETED|Overall Study||12
11413999|NCT01551082|12610851|FG000|NOT COMPLETED|Overall Study||0
11414000|NCT01556009|12610857|FG000|STARTED|Overall Study||0
11414001|NCT01556009|12610858|FG001|STARTED|Overall Study||0
11414002|NCT01556009|12610857|FG000|COMPLETED|Overall Study||0
11414003|NCT01556009|12610858|FG001|COMPLETED|Overall Study||0
11414004|NCT01556009|12610857|FG000|NOT COMPLETED|Overall Study||0
11414005|NCT01556009|12610858|FG001|NOT COMPLETED|Overall Study||0
11414006|NCT01550510|12610866|FG000|STARTED|Overall Study||4
11414007|NCT01550510|12610867|FG001|STARTED|Overall Study||0
11414008|NCT01550510|12610866|FG000|COMPLETED|Overall Study||4
11414009|NCT01550510|12610867|FG001|COMPLETED|Overall Study||0
11414010|NCT01550510|12610866|FG000|NOT COMPLETED|Overall Study||0
11414011|NCT01550510|12610867|FG001|NOT COMPLETED|Overall Study||0
11414012|NCT01541397|12610876|FG000|STARTED|Overall Study||4
11414013|NCT01541397|12610877|FG001|STARTED|Overall Study||2
11414014|NCT01541397|12610876|FG000|COMPLETED|Overall Study||0
11414015|NCT01541397|12610877|FG001|COMPLETED|Overall Study||0
11414016|NCT01541397|12610876|FG000|NOT COMPLETED|Overall Study||4
11414017|NCT01541397|12610877|FG001|NOT COMPLETED|Overall Study||2
11414018|NCT01546207|12610883|FG000|STARTED|Overall Study||4
11414019|NCT01546207|12610883|FG000|COMPLETED|Overall Study||3
11414020|NCT01546207|12610883|FG000|NOT COMPLETED|Overall Study||1
11414021|NCT01553240|12610887|FG000|STARTED|Overall Study||0
11414022|NCT01553240|12610887|FG000|COMPLETED|Overall Study||0
11414023|NCT01553240|12610887|FG000|NOT COMPLETED|Overall Study||0
11414024|NCT01547728|12610891|FG000|STARTED|Overall Study||42
11414025|NCT01547728|12610891|FG000|COMPLETED|Overall Study||1
11414026|NCT01547728|12610891|FG000|NOT COMPLETED|Overall Study||41
11414027|NCT01548651|12610897|FG000|STARTED|Overall Study||4
11414028|NCT01548651|12610898|FG001|STARTED|Overall Study||4
11414029|NCT01548651|12610897|FG000|COMPLETED|Overall Study||3
11414030|NCT01548651|12610898|FG001|COMPLETED|Overall Study||4
11414031|NCT01548651|12610897|FG000|NOT COMPLETED|Overall Study||1
11414032|NCT01548651|12610898|FG001|NOT COMPLETED|Overall Study||0
11414033|NCT01545648|12610904|FG000|STARTED|Overall Study||4
11414034|NCT01545648|12610904|FG000|6 Months of Treatment|Overall Study||4
11414035|NCT01545648|12610904|FG000|COMPLETED|Overall Study||4
11414036|NCT01545648|12610904|FG000|NOT COMPLETED|Overall Study||0
11414037|NCT01546883|12610908|FG000|STARTED|Overall Study||14
11414038|NCT01546883|12610908|FG000|COMPLETED|Overall Study||2
11414039|NCT01546883|12610908|FG000|NOT COMPLETED|Overall Study||12
11414040|NCT01545518|12610912|FG000|STARTED|Overall Study||20
11414041|NCT01545518|12610912|FG000|COMPLETED|Overall Study||20
11414042|NCT01545518|12610912|FG000|NOT COMPLETED|Overall Study||0
11414043|NCT01536015|12610918|FG000|STARTED|Overall Study||12
11414044|NCT01536015|12610919|FG001|STARTED|Overall Study||13
11414045|NCT01536015|12610918|FG000|COMPLETED|Overall Study||4
11414046|NCT01536015|12610919|FG001|COMPLETED|Overall Study||3
11414047|NCT01536015|12610918|FG000|NOT COMPLETED|Overall Study||8
11414048|NCT01536015|12610919|FG001|NOT COMPLETED|Overall Study||10
11414049|NCT01539590|12610927|FG000|STARTED|Overall Study||3
11414050|NCT01539590|12610928|FG001|STARTED|Overall Study||2
11414051|NCT01539590|12610927|FG000|Complete Study Treatment|Overall Study||1
11414052|NCT01539590|12610928|FG001|Complete Study Treatment|Overall Study||2
11414053|NCT01539590|12610927|FG000|COMPLETED|Overall Study||0
11414054|NCT01539590|12610928|FG001|COMPLETED|Overall Study||2
11414055|NCT01539590|12610927|FG000|NOT COMPLETED|Overall Study||3
11414056|NCT01539590|12610928|FG001|NOT COMPLETED|Overall Study||0
11414057|NCT01534676|12610936|FG000|STARTED|Overall Study||2
11414058|NCT01534676|12610937|FG001|STARTED|Overall Study||1
11414059|NCT01534676|12610936|FG000|COMPLETED|Overall Study||0
11414060|NCT01534676|12610937|FG001|COMPLETED|Overall Study||0
11414061|NCT01534676|12610936|FG000|NOT COMPLETED|Overall Study||2
11414062|NCT01534676|12610937|FG001|NOT COMPLETED|Overall Study||1
11414063|NCT01533753|12610945|FG000|STARTED|Overall Study||2
11414064|NCT01533753|12610946|FG001|STARTED|Overall Study||3
11414065|NCT01533753|12610945|FG000|COMPLETED|Overall Study||2
11414066|NCT01533753|12610946|FG001|COMPLETED|Overall Study||3
11414067|NCT01533753|12610945|FG000|NOT COMPLETED|Overall Study||0
11414068|NCT01533753|12610946|FG001|NOT COMPLETED|Overall Study||0
11414069|NCT01534143|12610952|FG000|STARTED|Overall Study||1
11414070|NCT01534143|12610952|FG000|COMPLETED|Overall Study||1
11414071|NCT01534143|12610952|FG000|NOT COMPLETED|Overall Study||0
11414072|NCT01530880|12610956|FG000|STARTED|Overall Study||35
11414073|NCT01530880|12610956|FG000|COMPLETED|Overall Study||35
11414074|NCT01530880|12610956|FG000|NOT COMPLETED|Overall Study||0
11414075|NCT01530087|12610961|FG000|STARTED|Overall Study||3
11414076|NCT01530087|12610961|FG000|COMPLETED|Overall Study||1
11414077|NCT01530087|12610961|FG000|NOT COMPLETED|Overall Study||2
11414078|NCT01527942|12610968|FG000|STARTED|Overall Study||16
11414079|NCT01527942|12610969|FG001|STARTED|Overall Study||18
11414080|NCT01527942|12610968|FG000|COMPLETED|Overall Study||16
11414081|NCT01527942|12610969|FG001|COMPLETED|Overall Study||18
11414082|NCT01527942|12610968|FG000|NOT COMPLETED|Overall Study||0
11414083|NCT01527942|12610969|FG001|NOT COMPLETED|Overall Study||0
11414084|NCT01521143|12610979|FG000|STARTED|Overall Study||40
11414085|NCT01521143|12610980|FG001|STARTED|Overall Study||36
11414086|NCT01521143|12610981|FG002|STARTED|Overall Study||8
11414087|NCT01521143|12610982|FG003|STARTED|Overall Study||7
11414088|NCT01521143|12610979|FG000|Received Treatment|Overall Study||20
11414089|NCT01521143|12610980|FG001|Received Treatment|Overall Study||20
11414090|NCT01521143|12610981|FG002|Received Treatment|Overall Study||3
11414091|NCT01521143|12610982|FG003|Received Treatment|Overall Study||4
11414092|NCT01521143|12610979|FG000|COMPLETED|Overall Study||11
11414093|NCT01521143|12610980|FG001|COMPLETED|Overall Study||10
11414094|NCT01521143|12610981|FG002|COMPLETED|Overall Study||0
11414095|NCT01521143|12610982|FG003|COMPLETED|Overall Study||0
11414096|NCT01521143|12610979|FG000|NOT COMPLETED|Overall Study||29
11414097|NCT01521143|12610980|FG001|NOT COMPLETED|Overall Study||26
11414098|NCT01521143|12610981|FG002|NOT COMPLETED|Overall Study||8
11414099|NCT01521143|12610982|FG003|NOT COMPLETED|Overall Study||7
11414100|NCT01532635|12610992|FG000|STARTED|Overall Study||4
11414101|NCT01532635|12610992|FG000|COMPLETED|Overall Study||4
11414102|NCT01532635|12610992|FG000|NOT COMPLETED|Overall Study||0
11414103|NCT01531387|12610998|FG000|STARTED|Overall Study||11
11414104|NCT01531387|12610999|FG001|STARTED|Overall Study||11
11414105|NCT01531387|12610998|FG000|COMPLETED|Overall Study||0
11414106|NCT01531387|12610999|FG001|COMPLETED|Overall Study||0
11414107|NCT01531387|12610998|FG000|NOT COMPLETED|Overall Study||11
11414108|NCT01531387|12610999|FG001|NOT COMPLETED|Overall Study||11
11414109|NCT01532362|12611007|FG000|STARTED|Overall Study||1
11414110|NCT01532362|12611008|FG001|STARTED|Overall Study||0
11414111|NCT01532362|12611007|FG000|COMPLETED|Overall Study||1
11414112|NCT01532362|12611008|FG001|COMPLETED|Overall Study||0
11414113|NCT01532362|12611007|FG000|NOT COMPLETED|Overall Study||0
11414114|NCT01532362|12611008|FG001|NOT COMPLETED|Overall Study||0
11414115|NCT01527292|12611018|FG000|STARTED|Overall Study||0
11414116|NCT01527292|12611019|FG001|STARTED|Overall Study||3
11414117|NCT01527292|12611018|FG000|COMPLETED|Overall Study||0
11414118|NCT01527292|12611019|FG001|COMPLETED|Overall Study||0
11414119|NCT01527292|12611018|FG000|NOT COMPLETED|Overall Study||0
11414120|NCT01527292|12611019|FG001|NOT COMPLETED|Overall Study||3
11414121|NCT01525745|12611027|FG000|STARTED|Overall Study||4
11414122|NCT01525745|12611028|FG001|STARTED|Overall Study||2
11414123|NCT01525745|12611027|FG000|COMPLETED|Overall Study||3
11414124|NCT01525745|12611028|FG001|COMPLETED|Overall Study||1
11414125|NCT01525745|12611027|FG000|NOT COMPLETED|Overall Study||1
11414126|NCT01525745|12611028|FG001|NOT COMPLETED|Overall Study||1
11414127|NCT01528696|12611038|FG000|STARTED|Overall Study||18
11414128|NCT01528696|12611039|FG001|STARTED|Overall Study||19
11414129|NCT01528696|12611038|FG000|Hospital Stay (2-5 Days)|Overall Study||18
11414130|NCT01528696|12611039|FG001|Hospital Stay (2-5 Days)|Overall Study||19
11414131|NCT01528696|12611038|FG000|COMPLETED|Overall Study||0
11414132|NCT01528696|12611039|FG001|COMPLETED|Overall Study||0
11414133|NCT01528696|12611038|FG000|NOT COMPLETED|Overall Study||18
11414134|NCT01528696|12611039|FG001|NOT COMPLETED|Overall Study||19
11414135|NCT01526408|12611047|FG000|STARTED|Overall Study|early termination of study and sponsor organization closed|0
11414136|NCT01526408|12611048|FG001|STARTED|Overall Study|early termination of study and sponsor organization closed|0
11414137|NCT01526408|12611047|FG000|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
11414138|NCT01526408|12611048|FG001|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
11414139|NCT01526408|12611047|FG000|NOT COMPLETED|Overall Study||0
11414140|NCT01526408|12611048|FG001|NOT COMPLETED|Overall Study||0
11414141|NCT01528293|12611056|FG000|STARTED|Overall Study||1
11414142|NCT01528293|12611057|FG001|STARTED|Overall Study||1
11414143|NCT01528293|12611056|FG000|COMPLETED|Overall Study||0
11414144|NCT01528293|12611057|FG001|COMPLETED|Overall Study||1
11414145|NCT01528293|12611056|FG000|NOT COMPLETED|Overall Study||1
11414146|NCT01528293|12611057|FG001|NOT COMPLETED|Overall Study||0
11414147|NCT01525927|12611065|FG000|STARTED|Overall Study||0
11414148|NCT01525927|12611065|FG000|COMPLETED|Overall Study||0
11414149|NCT01525927|12611065|FG000|NOT COMPLETED|Overall Study||0
11414150|NCT01520714|12611073|FG000|STARTED|Overall Study||0
11414151|NCT01520714|12611074|FG001|STARTED|Overall Study||11
11414152|NCT01520714|12611073|FG000|COMPLETED|Overall Study||0
11414153|NCT01520714|12611074|FG001|COMPLETED|Overall Study||5
11414154|NCT01520714|12611073|FG000|NOT COMPLETED|Overall Study||0
11414155|NCT01520714|12611074|FG001|NOT COMPLETED|Overall Study||6
11414156|NCT01507233|12611082|FG000|STARTED|Overall Study||5
11414157|NCT01507233|12611083|FG001|STARTED|Overall Study||0
11414158|NCT01507233|12611082|FG000|COMPLETED|Overall Study||5
11414159|NCT01507233|12611083|FG001|COMPLETED|Overall Study||0
11414160|NCT01507233|12611082|FG000|NOT COMPLETED|Overall Study||0
11414161|NCT01507233|12611083|FG001|NOT COMPLETED|Overall Study||0
11414162|NCT01516034|12611089|FG000|STARTED|Overall Study||8
11414163|NCT01516034|12611089|FG000|COMPLETED|Overall Study||0
11414164|NCT01516034|12611089|FG000|NOT COMPLETED|Overall Study||8
11414165|NCT01500772|12611093|FG000|STARTED|Overall Study||6
11414166|NCT01500772|12611093|FG000|COMPLETED|Overall Study||0
11414167|NCT01500772|12611093|FG000|NOT COMPLETED|Overall Study||6
11414168|NCT01517763|12611100|FG000|STARTED|Overall Study||0
11414169|NCT01517763|12611101|FG001|STARTED|Overall Study||0
11414170|NCT01517763|12611102|FG002|STARTED|Overall Study||0
11414171|NCT01517763|12611100|FG000|COMPLETED|Overall Study||0
11414172|NCT01517763|12611101|FG001|COMPLETED|Overall Study||0
11414173|NCT01517763|12611102|FG002|COMPLETED|Overall Study||0
11414174|NCT01517763|12611100|FG000|NOT COMPLETED|Overall Study||0
11414175|NCT01517763|12611101|FG001|NOT COMPLETED|Overall Study||0
11414176|NCT01517763|12611102|FG002|NOT COMPLETED|Overall Study||0
11414177|NCT01507584|12611110|FG000|STARTED|Overall Study||0
11414178|NCT01507584|12611110|FG000|COMPLETED|Overall Study||0
11414179|NCT01507584|12611110|FG000|NOT COMPLETED|Overall Study||0
11414180|NCT01510756|12611114|FG000|STARTED|Overall Study||4
11414181|NCT01510756|12611114|FG000|COMPLETED|Overall Study||0
11414182|NCT01510756|12611114|FG000|NOT COMPLETED|Overall Study||4
11414183|NCT01511081|12611120|FG000|STARTED|Overall Study||8
11414184|NCT01511081|12611121|FG001|STARTED|Overall Study||9
11414185|NCT01511081|12611120|FG000|COMPLETED|Overall Study||8
11414186|NCT01511081|12611121|FG001|COMPLETED|Overall Study||9
11414187|NCT01511081|12611120|FG000|NOT COMPLETED|Overall Study||0
11414188|NCT01511081|12611121|FG001|NOT COMPLETED|Overall Study||0
11414189|NCT01500109|12611130|FG000|STARTED|Overall Study||0
11414190|NCT01500109|12611131|FG001|STARTED|Overall Study||0
11414191|NCT01500109|12611132|FG002|STARTED|Overall Study||0
11414192|NCT01500109|12611130|FG000|COMPLETED|Overall Study||0
11414193|NCT01500109|12611131|FG001|COMPLETED|Overall Study||0
11414194|NCT01500109|12611132|FG002|COMPLETED|Overall Study||0
11414195|NCT01500109|12611130|FG000|NOT COMPLETED|Overall Study||0
11414196|NCT01500109|12611131|FG001|NOT COMPLETED|Overall Study||0
11414197|NCT01500109|12611132|FG002|NOT COMPLETED|Overall Study||0
11414198|NCT01509053|12611140|FG000|STARTED|Oral Aripirazole (Phase A)||19
11414199|NCT01509053|12611140|FG000|COMPLETED|Oral Aripirazole (Phase A)||8
11414200|NCT01509053|12611140|FG000|NOT COMPLETED|Oral Aripirazole (Phase A)||11
11414201|NCT01509053|12611140|FG000|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
11414202|NCT01509053|12611140|FG000|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
11414203|NCT01509053|12611140|FG000|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
11414204|NCT01509053|12611140|FG000|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
11414205|NCT01509053|12611140|FG000|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
11414206|NCT01509053|12611140|FG000|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
11414207|NCT01495988|12611152|FG000|STARTED|Vem +/- Bev (Protocol v2.0)||0
11414208|NCT01495988|12611153|FG001|STARTED|Vem +/- Bev (Protocol v2.0)||0
11414209|NCT01495988|12611154|FG002|STARTED|Vem +/- Bev (Protocol v2.0)||5
11414210|NCT01495988|12611155|FG003|STARTED|Vem +/- Bev (Protocol v2.0)||3
11414211|NCT01495988|12611152|FG000|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
11414212|NCT01495988|12611153|FG001|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
11414213|NCT01495988|12611154|FG002|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
11414214|NCT01495988|12611155|FG003|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
11414215|NCT01495988|12611152|FG000|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
11414216|NCT01495988|12611153|FG001|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
11414217|NCT01495988|12611154|FG002|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
11414218|NCT01495988|12611155|FG003|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
11414219|NCT01495988|12611152|FG000|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
11414220|NCT01495988|12611153|FG001|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
11414221|NCT01495988|12611154|FG002|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
11414222|NCT01495988|12611155|FG003|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
11414223|NCT01495988|12611152|FG000|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
11414224|NCT01495988|12611153|FG001|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
11414225|NCT01495988|12611154|FG002|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
11414226|NCT01495988|12611155|FG003|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
11414227|NCT01495988|12611152|FG000|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
11414228|NCT01495988|12611153|FG001|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
11414229|NCT01495988|12611154|FG002|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
11414230|NCT01495988|12611155|FG003|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
11414231|NCT01498991|12611165|FG000|STARTED|Overall Study||2
11414232|NCT01498991|12611165|FG000|COMPLETED|Overall Study||2
11414233|NCT01498991|12611165|FG000|NOT COMPLETED|Overall Study||0
11414234|NCT01497171|12611171|FG000|STARTED|Overall Study||2
11414235|NCT01497171|12611172|FG001|STARTED|Overall Study||3
11414236|NCT01497171|12611171|FG000|COMPLETED|Overall Study||2
11414237|NCT01497171|12611172|FG001|COMPLETED|Overall Study||3
11414238|NCT01497171|12611171|FG000|NOT COMPLETED|Overall Study||0
11414239|NCT01497171|12611172|FG001|NOT COMPLETED|Overall Study||0
11414240|NCT01483872|12611178|FG000|STARTED|Overall Study||0
11414241|NCT01483872|12611179|FG001|STARTED|Overall Study||1
11414242|NCT01483872|12611178|FG000|COMPLETED|Overall Study||0
11414243|NCT01483872|12611179|FG001|COMPLETED|Overall Study||1
11414244|NCT01483872|12611178|FG000|NOT COMPLETED|Overall Study||0
11414245|NCT01483872|12611179|FG001|NOT COMPLETED|Overall Study||0
11414246|NCT01487499|12611183|FG000|STARTED|Overall Study||4
11414247|NCT01487499|12611183|FG000|COMPLETED|Overall Study||4
11414248|NCT01487499|12611183|FG000|NOT COMPLETED|Overall Study||0
11414249|NCT01478113|12611189|FG000|STARTED|Overall Study||2
11414250|NCT01478113|12611190|FG001|STARTED|Overall Study||2
11414251|NCT01478113|12611189|FG000|COMPLETED|Overall Study||1
11414252|NCT01478113|12611190|FG001|COMPLETED|Overall Study||1
11414253|NCT01478113|12611189|FG000|NOT COMPLETED|Overall Study||1
11414254|NCT01478113|12611190|FG001|NOT COMPLETED|Overall Study||1
11414255|NCT01483209|12611198|FG000|STARTED|Overall Study||2
11414256|NCT01483209|12611198|FG000|COMPLETED|Overall Study||1
11414257|NCT01483209|12611198|FG000|NOT COMPLETED|Overall Study||1
11414258|NCT01484314|12611202|FG000|STARTED|Overall Study||1
11414259|NCT01484314|12611202|FG000|COMPLETED|Overall Study||1
11414260|NCT01484314|12611202|FG000|NOT COMPLETED|Overall Study||0
11414261|NCT01482598|12611208|FG000|STARTED|Overall Study||66
11414262|NCT01482598|12611209|FG001|STARTED|Overall Study||73
11414263|NCT01482598|12611208|FG000|COMPLETED|Overall Study||50
11414264|NCT01482598|12611209|FG001|COMPLETED|Overall Study||51
11414265|NCT01482598|12611208|FG000|NOT COMPLETED|Overall Study||16
11414266|NCT01482598|12611209|FG001|NOT COMPLETED|Overall Study||22
11414267|NCT01479010|12611215|FG000|STARTED|Overall Study||2
11414268|NCT01479010|12611215|FG000|COMPLETED|Overall Study||1
11414269|NCT01479010|12611215|FG000|NOT COMPLETED|Overall Study||1
11414270|NCT01482325|12611219|FG000|STARTED|Overall Study||31
11414271|NCT01482325|12611219|FG000|COMPLETED|Overall Study||31
11414272|NCT01482325|12611219|FG000|NOT COMPLETED|Overall Study||0
11414273|NCT01477177|12611223|FG000|STARTED|Overall Study||4
11414274|NCT01477177|12611223|FG000|COMPLETED|Overall Study||4
11414275|NCT01477177|12611223|FG000|NOT COMPLETED|Overall Study||0
11414276|NCT01473732|12611229|FG000|STARTED|Overall Study||2
11414277|NCT01473732|12611230|FG001|STARTED|Overall Study||0
11414278|NCT01473732|12611229|FG000|COMPLETED|Overall Study||0
11414279|NCT01473732|12611230|FG001|COMPLETED|Overall Study||0
11414280|NCT01473732|12611229|FG000|NOT COMPLETED|Overall Study||2
11414281|NCT01473732|12611230|FG001|NOT COMPLETED|Overall Study||0
11414282|NCT01472692|12611238|FG000|STARTED|Overall Study||0
11414283|NCT01472692|12611239|FG001|STARTED|Overall Study||0
11414284|NCT01472692|12611238|FG000|COMPLETED|Overall Study||0
11414285|NCT01472692|12611239|FG001|COMPLETED|Overall Study||0
11414286|NCT01472692|12611238|FG000|NOT COMPLETED|Overall Study||0
11414287|NCT01472692|12611239|FG001|NOT COMPLETED|Overall Study||0
11414288|NCT01465230|12611245|FG000|STARTED|Overall Study||2
11414289|NCT01465230|12611245|FG000|COMPLETED|Overall Study||0
11414290|NCT01465230|12611245|FG000|NOT COMPLETED|Overall Study||2
11414291|NCT01464723|12611249|FG000|STARTED|Overall Study||0
11414292|NCT01464723|12611249|FG000|COMPLETED|Overall Study||0
11414293|NCT01464723|12611249|FG000|NOT COMPLETED|Overall Study||0
11414294|NCT01446250|12611253|FG000|STARTED|Treatment Period 1||5
11414295|NCT01446250|12611254|FG001|STARTED|Treatment Period 1||3
11414296|NCT01446250|12611255|FG002|STARTED|Treatment Period 1||0
11414297|NCT01446250|12611256|FG003|STARTED|Treatment Period 1||0
11414298|NCT01446250|12611253|FG000|COMPLETED|Treatment Period 1||5
11414299|NCT01446250|12611254|FG001|COMPLETED|Treatment Period 1||2
11414300|NCT01446250|12611255|FG002|COMPLETED|Treatment Period 1||0
11414301|NCT01446250|12611256|FG003|COMPLETED|Treatment Period 1||0
11414302|NCT01446250|12611253|FG000|NOT COMPLETED|Treatment Period 1||0
11414303|NCT01446250|12611254|FG001|NOT COMPLETED|Treatment Period 1||1
11414304|NCT01446250|12611255|FG002|NOT COMPLETED|Treatment Period 1||0
11414305|NCT01446250|12611256|FG003|NOT COMPLETED|Treatment Period 1||0
11414306|NCT01446250|12611253|FG000|STARTED|Clinical Hold||0
11414307|NCT01446250|12611254|FG001|STARTED|Clinical Hold||2
11414308|NCT01446250|12611255|FG002|STARTED|Clinical Hold||5
11414309|NCT01446250|12611256|FG003|STARTED|Clinical Hold||0
11414310|NCT01446250|12611253|FG000|COMPLETED|Clinical Hold||0
11414311|NCT01446250|12611254|FG001|COMPLETED|Clinical Hold||2
11414312|NCT01446250|12611255|FG002|COMPLETED|Clinical Hold||5
11414313|NCT01446250|12611256|FG003|COMPLETED|Clinical Hold||0
11414314|NCT01446250|12611253|FG000|NOT COMPLETED|Clinical Hold||0
11414315|NCT01446250|12611254|FG001|NOT COMPLETED|Clinical Hold||0
11414316|NCT01446250|12611255|FG002|NOT COMPLETED|Clinical Hold||0
11414317|NCT01446250|12611256|FG003|NOT COMPLETED|Clinical Hold||0
11414318|NCT01446250|12611253|FG000|STARTED|Treatment Period 2||0
11414319|NCT01446250|12611254|FG001|STARTED|Treatment Period 2||7
11414320|NCT01446250|12611255|FG002|STARTED|Treatment Period 2||0
11414321|NCT01446250|12611256|FG003|STARTED|Treatment Period 2||0
11414322|NCT01446250|12611253|FG000|COMPLETED|Treatment Period 2||0
11414323|NCT01446250|12611254|FG001|COMPLETED|Treatment Period 2||6
11414324|NCT01446250|12611255|FG002|COMPLETED|Treatment Period 2||0
11414325|NCT01446250|12611256|FG003|COMPLETED|Treatment Period 2||0
11414326|NCT01446250|12611253|FG000|NOT COMPLETED|Treatment Period 2||0
11414327|NCT01446250|12611254|FG001|NOT COMPLETED|Treatment Period 2||1
11414328|NCT01446250|12611255|FG002|NOT COMPLETED|Treatment Period 2||0
11414329|NCT01446250|12611256|FG003|NOT COMPLETED|Treatment Period 2||0
11414330|NCT01446250|12611253|FG000|STARTED|Follow-up||0
11414331|NCT01446250|12611254|FG001|STARTED|Follow-up||0
11414332|NCT01446250|12611255|FG002|STARTED|Follow-up||0
11414333|NCT01446250|12611256|FG003|STARTED|Follow-up||6
11414334|NCT01446250|12611253|FG000|COMPLETED|Follow-up||0
11414335|NCT01446250|12611254|FG001|COMPLETED|Follow-up||0
11414336|NCT01446250|12611255|FG002|COMPLETED|Follow-up||0
11414337|NCT01446250|12611256|FG003|COMPLETED|Follow-up||0
11414338|NCT01446250|12611253|FG000|NOT COMPLETED|Follow-up||0
11414339|NCT01446250|12611254|FG001|NOT COMPLETED|Follow-up||0
11414340|NCT01446250|12611255|FG002|NOT COMPLETED|Follow-up||0
11414341|NCT01446250|12611256|FG003|NOT COMPLETED|Follow-up||6
11414342|NCT01463293|12611267|FG000|STARTED|Overall Study||74
11414343|NCT01463293|12611268|FG001|STARTED|Overall Study||79
11414344|NCT01463293|12611269|FG002|STARTED|Overall Study||71
11414345|NCT01463293|12611267|FG000|COMPLETED|Overall Study||68
11414346|NCT01463293|12611268|FG001|COMPLETED|Overall Study||63
11414347|NCT01463293|12611269|FG002|COMPLETED|Overall Study||59
11414348|NCT01463293|12611267|FG000|NOT COMPLETED|Overall Study||6
11414349|NCT01463293|12611268|FG001|NOT COMPLETED|Overall Study||16
11414350|NCT01463293|12611269|FG002|NOT COMPLETED|Overall Study||12
11414351|NCT01457053|12611277|FG000|STARTED|Overall Study||2
11414352|NCT01457053|12611278|FG001|STARTED|Overall Study||2
11414353|NCT01457053|12611277|FG000|COMPLETED|Overall Study||1
11414354|NCT01457053|12611278|FG001|COMPLETED|Overall Study||1
11414355|NCT01457053|12611277|FG000|NOT COMPLETED|Overall Study||1
11414356|NCT01457053|12611278|FG001|NOT COMPLETED|Overall Study||1
11414357|NCT01451723|12611286|FG000|STARTED|Overall Study||6
11414358|NCT01451723|12611287|FG001|STARTED|Overall Study||5
11414359|NCT01451723|12611286|FG000|COMPLETED|Overall Study||0
11414360|NCT01451723|12611287|FG001|COMPLETED|Overall Study||0
11414361|NCT01451723|12611286|FG000|NOT COMPLETED|Overall Study||6
11414362|NCT01451723|12611287|FG001|NOT COMPLETED|Overall Study||5
11414363|NCT01440517|12611293|FG000|STARTED|Overall Study||5
11414364|NCT01440517|12611293|FG000|COMPLETED|Overall Study||4
11414365|NCT01440517|12611293|FG000|NOT COMPLETED|Overall Study||1
11414366|NCT01440595|12611299|FG000|STARTED|Overall Study||1
11414367|NCT01440595|12611300|FG001|STARTED|Overall Study||3
11414368|NCT01440595|12611301|FG002|STARTED|Overall Study||1
11414369|NCT01440595|12611299|FG000|COMPLETED|Overall Study||0
11414370|NCT01440595|12611300|FG001|COMPLETED|Overall Study||0
11414371|NCT01440595|12611301|FG002|COMPLETED|Overall Study||0
11414372|NCT01440595|12611299|FG000|NOT COMPLETED|Overall Study||1
11414373|NCT01440595|12611300|FG001|NOT COMPLETED|Overall Study||3
11414374|NCT01440595|12611301|FG002|NOT COMPLETED|Overall Study||1
11414375|NCT01446796|12611307|FG000|STARTED|Overall Study||3
11414376|NCT01446796|12611308|FG001|STARTED|Overall Study||0
11414377|NCT01446796|12611307|FG000|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
11414378|NCT01446796|12611308|FG001|COMPLETED|Overall Study|Study terminated early|0
11414379|NCT01446796|12611307|FG000|NOT COMPLETED|Overall Study||1
11414380|NCT01446796|12611308|FG001|NOT COMPLETED|Overall Study||0
11414381|NCT01443923|12611318|FG000|STARTED|Overall Study||3
11414382|NCT01443923|12611319|FG001|STARTED|Overall Study||1
11414383|NCT01443923|12611318|FG000|COMPLETED|Overall Study||2
11414384|NCT01443923|12611319|FG001|COMPLETED|Overall Study||1
11414385|NCT01443923|12611318|FG000|NOT COMPLETED|Overall Study||1
11414386|NCT01443923|12611319|FG001|NOT COMPLETED|Overall Study||0
11414387|NCT01439347|12611327|FG000|STARTED|Overall Study||13
11414388|NCT01439347|12611328|FG001|STARTED|Overall Study||13
11414389|NCT01439347|12611327|FG000|COMPLETED|Overall Study||0
11414390|NCT01439347|12611328|FG001|COMPLETED|Overall Study||0
11414391|NCT01439347|12611327|FG000|NOT COMPLETED|Overall Study||13
11414392|NCT01439347|12611328|FG001|NOT COMPLETED|Overall Study||13
11414393|NCT01440452|12611338|FG000|STARTED|Overall Study||6
11414394|NCT01440452|12611339|FG001|STARTED|Overall Study||7
11414395|NCT01440452|12611340|FG002|STARTED|Overall Study||8
11022478|NCT00809159|12200735|FG002|PK Analysis Set|Part 1 and 2||30
11022479|NCT00809159|12200736|FG003|PK Analysis Set|Part 1 and 2||12
11022480|NCT00809159|12200737|FG004|PK Analysis Set|Part 1 and 2||12
11022481|NCT00809159|12200738|FG005|PK Analysis Set|Part 1 and 2||6
11022482|NCT00809159|12200733|FG000|PD Analysis Set|Part 1 and 2||0
11022483|NCT00809159|12200734|FG001|PD Analysis Set|Part 1 and 2||0
11414396|NCT01440452|12611341|FG003|STARTED|Overall Study||4
11414397|NCT01440452|12611338|FG000|COMPLETED|Overall Study||6
11414398|NCT01440452|12611339|FG001|COMPLETED|Overall Study||7
11414399|NCT01440452|12611340|FG002|COMPLETED|Overall Study||8
11414400|NCT01440452|12611341|FG003|COMPLETED|Overall Study||4
11414401|NCT01440452|12611338|FG000|NOT COMPLETED|Overall Study||0
11414402|NCT01440452|12611339|FG001|NOT COMPLETED|Overall Study||0
11414403|NCT01440452|12611340|FG002|NOT COMPLETED|Overall Study||0
11414404|NCT01440452|12611341|FG003|NOT COMPLETED|Overall Study||0
11414405|NCT01433471|12611353|FG000|STARTED|Overall Study||2
11414406|NCT01433471|12611354|FG001|STARTED|Overall Study||2
11414407|NCT01433471|12611353|FG000|COMPLETED|Overall Study||2
11414408|NCT01433471|12611354|FG001|COMPLETED|Overall Study||1
11414409|NCT01433471|12611353|FG000|NOT COMPLETED|Overall Study||0
11414410|NCT01433471|12611354|FG001|NOT COMPLETED|Overall Study||1
11414411|NCT01436084|12611362|FG000|STARTED|Overall Study||4
11414412|NCT01436084|12611362|FG000|COMPLETED|Overall Study||0
11414413|NCT01436084|12611362|FG000|NOT COMPLETED|Overall Study||4
11414414|NCT01434511|12611366|FG000|STARTED|Overall Study||1
11414415|NCT01434511|12611366|FG000|COMPLETED|Overall Study||1
11414416|NCT01434511|12611366|FG000|NOT COMPLETED|Overall Study||0
11414417|NCT01426555|12611372|FG000|STARTED|Overall Study||35
11414418|NCT01426555|12611373|FG001|STARTED|Overall Study||35
11414419|NCT01426555|12611372|FG000|COMPLETED|Overall Study||17
11414420|NCT01426555|12611373|FG001|COMPLETED|Overall Study||20
11414421|NCT01426555|12611372|FG000|NOT COMPLETED|Overall Study||18
11414422|NCT01426555|12611373|FG001|NOT COMPLETED|Overall Study||15
11414423|NCT01434745|12611383|FG000|STARTED|Overall Study||0
11414424|NCT01434745|12611384|FG001|STARTED|Overall Study||0
11414425|NCT01434745|12611383|FG000|COMPLETED|Overall Study||0
11414426|NCT01434745|12611384|FG001|COMPLETED|Overall Study||0
11414427|NCT01434745|12611383|FG000|NOT COMPLETED|Overall Study||0
11414428|NCT01434745|12611384|FG001|NOT COMPLETED|Overall Study||0
11414429|NCT01415986|12611390|FG000|STARTED|Overall Study||1
11414430|NCT01415986|12611390|FG000|COMPLETED|Overall Study|Study terminated|0
11414431|NCT01415986|12611390|FG000|NOT COMPLETED|Overall Study||1
11414432|NCT01410799|12611395|FG000|STARTED|Overall Study||13
11414433|NCT01410799|12611395|FG000|COMPLETED|Overall Study||0
11414434|NCT01410799|12611395|FG000|NOT COMPLETED|Overall Study||13
11414435|NCT01426113|12611401|FG000|STARTED|Overall Study||3
11414436|NCT01426113|12611402|FG001|STARTED|Overall Study||3
11414437|NCT01426113|12611401|FG000|COMPLETED|Overall Study||2
11414438|NCT01426113|12611402|FG001|COMPLETED|Overall Study||1
11414439|NCT01426113|12611401|FG000|NOT COMPLETED|Overall Study||1
11414440|NCT01426113|12611402|FG001|NOT COMPLETED|Overall Study||2
11414441|NCT01426516|12611410|FG000|STARTED|Overall Study||12
11414442|NCT01426516|12611411|FG001|STARTED|Overall Study||17
11414443|NCT01426516|12611410|FG000|COMPLETED|Overall Study||12
11414444|NCT01426516|12611411|FG001|COMPLETED|Overall Study||17
11414445|NCT01426516|12611410|FG000|NOT COMPLETED|Overall Study||0
11414446|NCT01426516|12611411|FG001|NOT COMPLETED|Overall Study||0
11414447|NCT01420965|12611420|FG000|STARTED|Overall Study||2
11414448|NCT01420965|12611421|FG001|STARTED|Overall Study||2
11414449|NCT01420965|12611422|FG002|STARTED|Overall Study||3
11414450|NCT01420965|12611420|FG000|COMPLETED|Overall Study||1
11414451|NCT01420965|12611421|FG001|COMPLETED|Overall Study||1
11414452|NCT01420965|12611422|FG002|COMPLETED|Overall Study||3
11414453|NCT01420965|12611420|FG000|NOT COMPLETED|Overall Study||1
11414454|NCT01420965|12611421|FG001|NOT COMPLETED|Overall Study||1
11414455|NCT01420965|12611422|FG002|NOT COMPLETED|Overall Study||0
11414456|NCT01417377|12611430|FG000|STARTED|Overall Study||22
11414457|NCT01417377|12611430|FG000|Treated|Overall Study||21
11414458|NCT01417377|12611430|FG000|COMPLETED|Overall Study||9
11414459|NCT01417377|12611430|FG000|NOT COMPLETED|Overall Study||13
11414460|NCT01416272|12611434|FG000|STARTED|Overall Study||12
11414461|NCT01416272|12611434|FG000|COMPLETED|Overall Study||8
11414462|NCT01416272|12611434|FG000|NOT COMPLETED|Overall Study||4
11414463|NCT01414166|12611440|FG000|STARTED|Overall Study||122
11414464|NCT01414166|12611441|FG001|STARTED|Overall Study||122
11414465|NCT01414166|12611440|FG000|Treated|Overall Study||120
11414466|NCT01414166|12611441|FG001|Treated|Overall Study||121
11414467|NCT01414166|12611440|FG000|COMPLETED|Overall Study||31
11414468|NCT01414166|12611441|FG001|COMPLETED|Overall Study||39
11414469|NCT01414166|12611440|FG000|NOT COMPLETED|Overall Study||91
11414470|NCT01414166|12611441|FG001|NOT COMPLETED|Overall Study||83
11414471|NCT01406860|12611449|FG000|STARTED|Overall Study||11
11414472|NCT01406860|12611450|FG001|STARTED|Overall Study||8
11414473|NCT01406860|12611449|FG000|COMPLETED|Overall Study||11
11414474|NCT01406860|12611450|FG001|COMPLETED|Overall Study||8
11414475|NCT01406860|12611449|FG000|NOT COMPLETED|Overall Study||0
11414476|NCT01406860|12611450|FG001|NOT COMPLETED|Overall Study||0
11414477|NCT01401049|12611459|FG000|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
11414478|NCT01401049|12611460|FG001|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
11414479|NCT01401049|12611459|FG000|COMPLETED|Overall Study||0
11414480|NCT01401049|12611460|FG001|COMPLETED|Overall Study||0
11414481|NCT01401049|12611459|FG000|NOT COMPLETED|Overall Study||0
11414482|NCT01401049|12611460|FG001|NOT COMPLETED|Overall Study||0
11414483|NCT01409031|12611468|FG000|STARTED|Overall Study||1
11414484|NCT01409031|12611469|FG001|STARTED|Overall Study||2
11414485|NCT01409031|12611468|FG000|COMPLETED|Overall Study||0
11414486|NCT01409031|12611469|FG001|COMPLETED|Overall Study||2
11414487|NCT01409031|12611468|FG000|NOT COMPLETED|Overall Study||1
11414488|NCT01409031|12611469|FG001|NOT COMPLETED|Overall Study||0
11414489|NCT01402531|12611475|FG000|STARTED|Overall Study||0
11414490|NCT01402531|12611475|FG000|COMPLETED|Overall Study||0
11414491|NCT01402531|12611475|FG000|NOT COMPLETED|Overall Study||0
11414492|NCT01394926|12611479|FG000|STARTED|Overall Study||21
11414493|NCT01394926|12611479|FG000|COMPLETED|Overall Study||21
11414494|NCT01394926|12611479|FG000|NOT COMPLETED|Overall Study||0
11414495|NCT01383681|12611488|FG000|STARTED|Overall Study||235
11414496|NCT01383681|12611488|FG000|COMPLETED|Overall Study||189
11414497|NCT01383681|12611488|FG000|NOT COMPLETED|Overall Study||46
11414498|NCT01403194|12611492|FG000|STARTED|Overall Study||11
11414499|NCT01403194|12611492|FG000|COMPLETED|Overall Study||1
11414500|NCT01403194|12611492|FG000|NOT COMPLETED|Overall Study||10
11414501|NCT01397552|12611498|FG000|STARTED|Overall Study||4
11414502|NCT01397552|12611499|FG001|STARTED|Overall Study||4
11414503|NCT01397552|12611498|FG000|COMPLETED|Overall Study||1
11414504|NCT01397552|12611499|FG001|COMPLETED|Overall Study||3
11414505|NCT01397552|12611498|FG000|NOT COMPLETED|Overall Study||3
11414506|NCT01397552|12611499|FG001|NOT COMPLETED|Overall Study||1
11414507|NCT01392170|12611505|FG000|STARTED|Overall Study||2
11414508|NCT01392170|12611505|FG000|COMPLETED|Overall Study||0
11414509|NCT01392170|12611505|FG000|NOT COMPLETED|Overall Study||2
11414510|NCT01389817|12611511|FG000|STARTED|Overall Study||4
11414511|NCT01389817|12611512|FG001|STARTED|Overall Study||0
11414512|NCT01389817|12611511|FG000|COMPLETED|Overall Study||0
11414513|NCT01389817|12611512|FG001|COMPLETED|Overall Study||0
11414514|NCT01389817|12611511|FG000|NOT COMPLETED|Overall Study||4
11414515|NCT01389817|12611512|FG001|NOT COMPLETED|Overall Study||0
11414516|NCT01397695|12611518|FG000|STARTED|Overall Study||0
11414517|NCT01397695|12611518|FG000|COMPLETED|Overall Study||0
11414518|NCT01397695|12611518|FG000|NOT COMPLETED|Overall Study||0
11414519|NCT01390181|12611522|FG000|STARTED|Overall Study||4
11414520|NCT01390181|12611522|FG000|COMPLETED|Overall Study||0
11414521|NCT01390181|12611522|FG000|NOT COMPLETED|Overall Study||4
11414522|NCT01385033|12611528|FG000|STARTED|Part I|These subjects did not participate in Part II or III|6
11414523|NCT01385033|12611529|FG001|STARTED|Part I|These subjects did not participate in Part II or III|14
11414524|NCT01385033|12611530|FG002|STARTED|Part I||0
11414525|NCT01385033|12611531|FG003|STARTED|Part I||0
11414526|NCT01385033|12611532|FG004|STARTED|Part I||0
11414527|NCT01385033|12611533|FG005|STARTED|Part I||0
11414528|NCT01385033|12611528|FG000|COMPLETED|Part I||6
11414529|NCT01385033|12611529|FG001|COMPLETED|Part I||14
11414530|NCT01385033|12611530|FG002|COMPLETED|Part I||0
11414531|NCT01385033|12611531|FG003|COMPLETED|Part I||0
11414532|NCT01385033|12611532|FG004|COMPLETED|Part I||0
11414533|NCT01385033|12611533|FG005|COMPLETED|Part I||0
11414534|NCT01385033|12611528|FG000|NOT COMPLETED|Part I||0
11414535|NCT01385033|12611529|FG001|NOT COMPLETED|Part I||0
11414536|NCT01385033|12611530|FG002|NOT COMPLETED|Part I||0
11414537|NCT01385033|12611531|FG003|NOT COMPLETED|Part I||0
11414538|NCT01385033|12611532|FG004|NOT COMPLETED|Part I||0
11414539|NCT01385033|12611533|FG005|NOT COMPLETED|Part I||0
11414540|NCT01385033|12611528|FG000|STARTED|Part II||0
11414541|NCT01385033|12611529|FG001|STARTED|Part II||0
11414542|NCT01385033|12611530|FG002|STARTED|Part II||0
11414543|NCT01385033|12611531|FG003|STARTED|Part II||0
11414544|NCT01385033|12611532|FG004|STARTED|Part II||0
11414545|NCT01385033|12611533|FG005|STARTED|Part II||0
11414546|NCT01385033|12611528|FG000|COMPLETED|Part II||0
11414547|NCT01385033|12611529|FG001|COMPLETED|Part II||0
11414548|NCT01385033|12611530|FG002|COMPLETED|Part II||0
11414549|NCT01385033|12611531|FG003|COMPLETED|Part II||0
11414550|NCT01385033|12611532|FG004|COMPLETED|Part II||0
11414551|NCT01385033|12611533|FG005|COMPLETED|Part II||0
11414552|NCT01385033|12611528|FG000|NOT COMPLETED|Part II||0
11414553|NCT01385033|12611529|FG001|NOT COMPLETED|Part II||0
11414554|NCT01385033|12611530|FG002|NOT COMPLETED|Part II||0
11414555|NCT01385033|12611531|FG003|NOT COMPLETED|Part II||0
11414556|NCT01385033|12611532|FG004|NOT COMPLETED|Part II||0
11414557|NCT01385033|12611533|FG005|NOT COMPLETED|Part II||0
11414558|NCT01385033|12611528|FG000|STARTED|Part III||0
11414559|NCT01385033|12611529|FG001|STARTED|Part III||0
11414560|NCT01385033|12611530|FG002|STARTED|Part III||0
11414561|NCT01385033|12611531|FG003|STARTED|Part III||0
11414562|NCT01385033|12611532|FG004|STARTED|Part III||0
11414563|NCT01385033|12611533|FG005|STARTED|Part III||0
11414564|NCT01385033|12611528|FG000|COMPLETED|Part III||0
11414565|NCT01385033|12611529|FG001|COMPLETED|Part III||0
11414566|NCT01385033|12611530|FG002|COMPLETED|Part III||0
11414567|NCT01385033|12611531|FG003|COMPLETED|Part III||0
11414568|NCT01385033|12611532|FG004|COMPLETED|Part III||0
11414569|NCT01385033|12611533|FG005|COMPLETED|Part III||0
11414570|NCT01385033|12611528|FG000|NOT COMPLETED|Part III||0
11414571|NCT01385033|12611529|FG001|NOT COMPLETED|Part III||0
11414572|NCT01385033|12611530|FG002|NOT COMPLETED|Part III||0
11414573|NCT01385033|12611531|FG003|NOT COMPLETED|Part III||0
11414574|NCT01385033|12611532|FG004|NOT COMPLETED|Part III||0
11414575|NCT01385033|12611533|FG005|NOT COMPLETED|Part III||0
11414576|NCT01394211|12611540|FG000|STARTED|Overall Study||2
11414577|NCT01394211|12611540|FG000|COMPLETED|Overall Study||0
11414578|NCT01394211|12611540|FG000|NOT COMPLETED|Overall Study||2
11414579|NCT01377441|12611546|FG000|STARTED|Overall Study||0
11414580|NCT01377441|12611547|FG001|STARTED|Overall Study||0
11414581|NCT01377441|12611546|FG000|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
11414582|NCT01377441|12611547|FG001|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
11414583|NCT01377441|12611546|FG000|NOT COMPLETED|Overall Study||0
11414584|NCT01377441|12611547|FG001|NOT COMPLETED|Overall Study||0
11414585|NCT01383447|12611553|FG000|STARTED|Overall Study||2
11414586|NCT01383447|12611553|FG000|COMPLETED|Overall Study||0
11414587|NCT01383447|12611553|FG000|NOT COMPLETED|Overall Study||2
11414588|NCT01372618|12611557|FG000|STARTED|Overall Study||9
11414589|NCT01372618|12611557|FG000|COMPLETED|Overall Study||0
11414590|NCT01372618|12611557|FG000|NOT COMPLETED|Overall Study||9
11414591|NCT01385280|12611561|FG000|STARTED|Overall Study||13
11414592|NCT01385280|12611561|FG000|COMPLETED|Overall Study||13
11414593|NCT01385280|12611561|FG000|NOT COMPLETED|Overall Study||0
11414594|NCT01379274|12611565|FG000|STARTED|Overall Study||2
11414595|NCT01379274|12611565|FG000|COMPLETED|Overall Study||1
11414596|NCT01379274|12611565|FG000|NOT COMPLETED|Overall Study||1
11414597|NCT01379469|12611571|FG000|STARTED|Overall Study||13
11414598|NCT01379469|12611572|FG001|STARTED|Overall Study||7
11414599|NCT01379469|12611571|FG000|COMPLETED|Overall Study||1
11414600|NCT01379469|12611572|FG001|COMPLETED|Overall Study||3
11414601|NCT01379469|12611571|FG000|NOT COMPLETED|Overall Study||12
11414602|NCT01379469|12611572|FG001|NOT COMPLETED|Overall Study||4
11414603|NCT01369641|12611578|FG000|STARTED|Overall Study||1
11414604|NCT01369641|12611578|FG000|COMPLETED|Overall Study||0
11414605|NCT01369641|12611578|FG000|NOT COMPLETED|Overall Study||1
11414606|NCT01365156|12611584|FG000|STARTED|Overall Study||14
11414607|NCT01365156|12611585|FG001|STARTED|Overall Study||14
11414608|NCT01365156|12611584|FG000|COMPLETED|Overall Study||14
11414609|NCT01365156|12611585|FG001|COMPLETED|Overall Study||14
11414610|NCT01365156|12611584|FG000|NOT COMPLETED|Overall Study||0
11414611|NCT01365156|12611585|FG001|NOT COMPLETED|Overall Study||0
11414612|NCT01359254|12611593|FG000|STARTED|Overall Study||1
11414613|NCT01359254|12611594|FG001|STARTED|Overall Study||0
11414614|NCT01359254|12611593|FG000|COMPLETED|Overall Study||0
11414615|NCT01359254|12611594|FG001|COMPLETED|Overall Study||0
11414616|NCT01359254|12611593|FG000|NOT COMPLETED|Overall Study||1
11414617|NCT01359254|12611594|FG001|NOT COMPLETED|Overall Study||0
11414618|NCT01347632|12611600|FG000|STARTED|Overall Study||35
11414619|NCT01347632|12611600|FG000|COMPLETED|Overall Study||33
11414620|NCT01347632|12611600|FG000|NOT COMPLETED|Overall Study||2
11414621|NCT01356667|12611606|FG000|STARTED|Overall Study||4
11414622|NCT01356667|12611607|FG001|STARTED|Overall Study||6
11414623|NCT01356667|12611606|FG000|COMPLETED|Overall Study||0
11414624|NCT01356667|12611607|FG001|COMPLETED|Overall Study||0
11414625|NCT01356667|12611606|FG000|NOT COMPLETED|Overall Study||4
11414626|NCT01356667|12611607|FG001|NOT COMPLETED|Overall Study||6
11414627|NCT01354951|12611615|FG000|STARTED|Overall Study||3
11414628|NCT01354951|12611615|FG000|COMPLETED|Overall Study||1
11414629|NCT01354951|12611615|FG000|NOT COMPLETED|Overall Study||2
11414630|NCT01350232|12611619|FG000|STARTED|Overall Study||2
11414631|NCT01350232|12611619|FG000|COMPLETED|Overall Study||2
11414632|NCT01350232|12611619|FG000|NOT COMPLETED|Overall Study||0
11414633|NCT01350583|12611623|FG000|STARTED|Overall Study||2
11414634|NCT01350583|12611623|FG000|COMPLETED|Overall Study||2
11414635|NCT01350583|12611623|FG000|NOT COMPLETED|Overall Study||0
11414636|NCT01352416|12611631|FG000|STARTED|Overall Study||4
11414637|NCT01352416|12611632|FG001|STARTED|Overall Study||7
11414638|NCT01352416|12611633|FG002|STARTED|Overall Study||2
11414639|NCT01352416|12611634|FG003|STARTED|Overall Study||2
11414640|NCT01352416|12611631|FG000|COMPLETED|Overall Study||3
11414641|NCT01352416|12611632|FG001|COMPLETED|Overall Study||5
11414642|NCT01352416|12611633|FG002|COMPLETED|Overall Study||0
11414643|NCT01352416|12611634|FG003|COMPLETED|Overall Study||1
11414644|NCT01352416|12611631|FG000|NOT COMPLETED|Overall Study||1
11414645|NCT01352416|12611632|FG001|NOT COMPLETED|Overall Study||2
11414646|NCT01352416|12611633|FG002|NOT COMPLETED|Overall Study||2
11414647|NCT01352416|12611634|FG003|NOT COMPLETED|Overall Study||1
11414648|NCT01350258|12611644|FG000|STARTED|Overall Study||8
11414649|NCT01350258|12611644|FG000|COMPLETED|Overall Study||8
11414650|NCT01350258|12611644|FG000|NOT COMPLETED|Overall Study||0
11414651|NCT01349595|12611650|FG000|STARTED|Overall Study||2
11414652|NCT01349595|12611651|FG001|STARTED|Overall Study||2
11414653|NCT01349595|12611650|FG000|COMPLETED|Overall Study||0
11414654|NCT01349595|12611651|FG001|COMPLETED|Overall Study||0
11414655|NCT01349595|12611650|FG000|NOT COMPLETED|Overall Study||2
11414656|NCT01349595|12611651|FG001|NOT COMPLETED|Overall Study||2
11414657|NCT01337609|12611660|FG000|STARTED|Overall Study||1
11414658|NCT01337609|12611661|FG001|STARTED|Overall Study||2
11414659|NCT01337609|12611662|FG002|STARTED|Overall Study||2
11414660|NCT01337609|12611660|FG000|COMPLETED|Overall Study||0
11414661|NCT01337609|12611661|FG001|COMPLETED|Overall Study||2
11414662|NCT01337609|12611662|FG002|COMPLETED|Overall Study||2
11414663|NCT01337609|12611660|FG000|NOT COMPLETED|Overall Study||1
11414664|NCT01337609|12611661|FG001|NOT COMPLETED|Overall Study||0
11414665|NCT01337609|12611662|FG002|NOT COMPLETED|Overall Study||0
11414666|NCT01347840|12611670|FG000|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
11414667|NCT01347840|12611670|FG000|COMPLETED|Overall Study||0
11414668|NCT01347840|12611670|FG000|NOT COMPLETED|Overall Study||1
11414669|NCT01340573|12611674|FG000|STARTED|Overall Study||3
11414670|NCT01340573|12611674|FG000|COMPLETED|Overall Study||0
11414671|NCT01340573|12611674|FG000|NOT COMPLETED|Overall Study||3
11414672|NCT01335997|12611681|FG000|STARTED|Period I and II||577
11414673|NCT01335997|12611682|FG001|STARTED|Period I and II||562
11414674|NCT01335997|12611681|FG000|COMPLETED|Period I and II||84
11414675|NCT01335997|12611682|FG001|COMPLETED|Period I and II||83
11414676|NCT01335997|12611681|FG000|NOT COMPLETED|Period I and II||493
11414677|NCT01335997|12611682|FG001|NOT COMPLETED|Period I and II||479
11414678|NCT01335997|12611681|FG000|STARTED|Period III||84
11414679|NCT01335997|12611682|FG001|STARTED|Period III||83
11414680|NCT01335997|12611681|FG000|COMPLETED|Period III||6
11414681|NCT01335997|12611682|FG001|COMPLETED|Period III||4
11414682|NCT01335997|12611681|FG000|NOT COMPLETED|Period III||78
11414683|NCT01335997|12611682|FG001|NOT COMPLETED|Period III||79
11414684|NCT01340885|12611693|FG000|STARTED|Overall Study||0
11414685|NCT01340885|12611694|FG001|STARTED|Overall Study||0
11414686|NCT01340885|12611695|FG002|STARTED|Overall Study||0
11414687|NCT01340885|12611693|FG000|COMPLETED|Overall Study||0
11414688|NCT01340885|12611694|FG001|COMPLETED|Overall Study||0
11414689|NCT01340885|12611695|FG002|COMPLETED|Overall Study||0
11414690|NCT01340885|12611693|FG000|NOT COMPLETED|Overall Study||0
11414691|NCT01340885|12611694|FG001|NOT COMPLETED|Overall Study||0
11414692|NCT01340885|12611695|FG002|NOT COMPLETED|Overall Study||0
11414693|NCT01341587|12611705|FG000|STARTED|Overall Study||4
11414694|NCT01341587|12611706|FG001|STARTED|Overall Study||10
11414695|NCT01341587|12611705|FG000|COMPLETED|Overall Study||0
11414696|NCT01341587|12611706|FG001|COMPLETED|Overall Study||0
11414697|NCT01341587|12611705|FG000|NOT COMPLETED|Overall Study||4
11414698|NCT01341587|12611706|FG001|NOT COMPLETED|Overall Study||10
11144124|NCT01475825|12330777|FG002|Entered Open-Label Continuation|Overall Study||44
11144125|NCT01475825|12330778|FG003|Entered Open-Label Continuation|Overall Study||29
11144126|NCT01475825|12330775|FG000|Completed Open-Label Continuation|Overall Study||37
11144127|NCT01475825|12330776|FG001|Completed Open-Label Continuation|Overall Study||19
11144128|NCT01475825|12330777|FG002|Completed Open-Label Continuation|Overall Study||38
11144129|NCT01475825|12330778|FG003|Completed Open-Label Continuation|Overall Study||22
11144130|NCT01475825|12330775|FG000|COMPLETED|Overall Study||37
11144131|NCT01475825|12330776|FG001|COMPLETED|Overall Study||19
11144132|NCT01475825|12330777|FG002|COMPLETED|Overall Study||38
11144133|NCT01475825|12330778|FG003|COMPLETED|Overall Study||22
11144134|NCT01475825|12330775|FG000|NOT COMPLETED|Overall Study||67
11144135|NCT01475825|12330776|FG001|NOT COMPLETED|Overall Study||32
11414699|NCT01326923|12611712|FG000|STARTED|Overall Study||7
11414700|NCT01326923|12611712|FG000|COMPLETED|Overall Study||7
11414701|NCT01326923|12611712|FG000|NOT COMPLETED|Overall Study||0
11414702|NCT01332799|12611718|FG000|STARTED|Overall Study||10
11414703|NCT01332799|12611719|FG001|STARTED|Overall Study||10
11414704|NCT01332799|12611718|FG000|COMPLETED|Overall Study||0
11414705|NCT01332799|12611719|FG001|COMPLETED|Overall Study||0
11414706|NCT01332799|12611718|FG000|NOT COMPLETED|Overall Study||10
11414707|NCT01332799|12611719|FG001|NOT COMPLETED|Overall Study||10
11414708|NCT01329549|12611725|FG000|STARTED|Overall Study||2
11414709|NCT01329549|12611725|FG000|COMPLETED|Overall Study||0
11414710|NCT01329549|12611725|FG000|NOT COMPLETED|Overall Study||2
11414711|NCT01326845|12611731|FG000|STARTED|Overall Study||7
11414712|NCT01326845|12611732|FG001|STARTED|Overall Study||5
11414713|NCT01326845|12611731|FG000|COMPLETED|Overall Study|Study terminated early|0
11414714|NCT01326845|12611732|FG001|COMPLETED|Overall Study|Study terminated early|0
11414715|NCT01326845|12611731|FG000|NOT COMPLETED|Overall Study||7
11414716|NCT01326845|12611732|FG001|NOT COMPLETED|Overall Study||5
11414717|NCT01329341|12611738|FG000|STARTED|Overall Study||60
11414718|NCT01329341|12611738|FG000|COMPLETED|Overall Study||16
11414719|NCT01329341|12611738|FG000|NOT COMPLETED|Overall Study||44
11414720|NCT01319760|12611744|FG000|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
11414721|NCT01319760|12611745|FG001|STARTED|Overall Study||5
11414722|NCT01319760|12611744|FG000|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
11414723|NCT01319760|12611745|FG001|COMPLETED|Overall Study||5
11414724|NCT01319760|12611744|FG000|NOT COMPLETED|Overall Study||0
11414725|NCT01319760|12611745|FG001|NOT COMPLETED|Overall Study||0
11414726|NCT01320683|12611751|FG000|STARTED|Overall Study||1
11414727|NCT01320683|12611751|FG000|COMPLETED|Overall Study||0
11414728|NCT01320683|12611751|FG000|NOT COMPLETED|Overall Study||1
11414729|NCT01313273|12611757|FG000|STARTED|Overall Study||2
11414730|NCT01313273|12611758|FG001|STARTED|Overall Study||1
11414731|NCT01313273|12611757|FG000|COMPLETED|Overall Study||0
11414732|NCT01313273|12611758|FG001|COMPLETED|Overall Study||0
11414733|NCT01313273|12611757|FG000|NOT COMPLETED|Overall Study||2
11414734|NCT01313273|12611758|FG001|NOT COMPLETED|Overall Study||1
11414735|NCT01321008|12611764|FG000|STARTED|Overall Study||1
11414736|NCT01321008|12611764|FG000|COMPLETED|Overall Study||0
11414737|NCT01321008|12611764|FG000|NOT COMPLETED|Overall Study||1
11414738|NCT01310803|12611770|FG000|STARTED|Overall Study||1
11414739|NCT01310803|12611771|FG001|STARTED|Overall Study||0
11414740|NCT01310803|12611770|FG000|COMPLETED|Overall Study||0
11414741|NCT01310803|12611771|FG001|COMPLETED|Overall Study||0
11414742|NCT01310803|12611770|FG000|NOT COMPLETED|Overall Study||1
11144136|NCT01475825|12330777|FG002|NOT COMPLETED|Overall Study||64
11144137|NCT01475825|12330778|FG003|NOT COMPLETED|Overall Study||30
11144138|NCT01475838|12330790|FG000|STARTED|Randomized Phase||293
11144139|NCT01475838|12330791|FG001|STARTED|Randomized Phase||145
11414743|NCT01310803|12611771|FG001|NOT COMPLETED|Overall Study||0
11414744|NCT01309581|12611779|FG000|STARTED|Overall Study||2
11414745|NCT01309581|12611780|FG001|STARTED|Overall Study||1
11414746|NCT01309581|12611779|FG000|COMPLETED|Overall Study||2
11414747|NCT01309581|12611780|FG001|COMPLETED|Overall Study||1
11414748|NCT01309581|12611779|FG000|NOT COMPLETED|Overall Study||0
11414749|NCT01309581|12611780|FG001|NOT COMPLETED|Overall Study||0
11414750|NCT01315873|12611786|FG000|STARTED|Overall Study||24
11414751|NCT01315873|12611786|FG000|COMPLETED|Overall Study||24
11414752|NCT01315873|12611786|FG000|NOT COMPLETED|Overall Study||0
11414753|NCT01313923|12611790|FG000|STARTED|Overall Study||3
11414754|NCT01313923|12611790|FG000|COMPLETED|Overall Study||0
11414755|NCT01313923|12611790|FG000|NOT COMPLETED|Overall Study||3
11414756|NCT01321697|12611794|FG000|STARTED|Overall Study||7
11414757|NCT01321697|12611794|FG000|COMPLETED|Overall Study||0
11414758|NCT01321697|12611794|FG000|NOT COMPLETED|Overall Study||7
11414759|NCT01312428|12611800|FG000|STARTED|Overall Study||3
11414760|NCT01312428|12611801|FG001|STARTED|Overall Study||4
11414761|NCT01312428|12611800|FG000|COMPLETED|Overall Study||0
11414762|NCT01312428|12611801|FG001|COMPLETED|Overall Study||0
11414763|NCT01312428|12611800|FG000|NOT COMPLETED|Overall Study||3
11414764|NCT01312428|12611801|FG001|NOT COMPLETED|Overall Study||4
11414765|NCT01313416|12611809|FG000|STARTED|Overall Study||2
11414766|NCT01313416|12611809|FG000|COMPLETED|Overall Study||2
11414767|NCT01313416|12611809|FG000|NOT COMPLETED|Overall Study||0
11414768|NCT01303003|12611815|FG000|STARTED|Overall Study||0
11414769|NCT01303003|12611816|FG001|STARTED|Overall Study||0
11414770|NCT01303003|12611815|FG000|COMPLETED|Overall Study||0
11414771|NCT01303003|12611816|FG001|COMPLETED|Overall Study||0
11414772|NCT01303003|12611815|FG000|NOT COMPLETED|Overall Study||0
11414773|NCT01303003|12611816|FG001|NOT COMPLETED|Overall Study||0
11414774|NCT01302444|12611824|FG000|STARTED|Overall Study||1
11414775|NCT01302444|12611825|FG001|STARTED|Overall Study||0
11414776|NCT01302444|12611824|FG000|COMPLETED|Overall Study||1
11414777|NCT01302444|12611825|FG001|COMPLETED|Overall Study||0
11414778|NCT01302444|12611824|FG000|NOT COMPLETED|Overall Study||0
11414779|NCT01302444|12611825|FG001|NOT COMPLETED|Overall Study||0
11414780|NCT01301963|12611833|FG000|STARTED|Overall Study||5
11414781|NCT01301963|12611834|FG001|STARTED|Overall Study||4
11414782|NCT01301963|12611833|FG000|COMPLETED|Overall Study||5
11414783|NCT01301963|12611834|FG001|COMPLETED|Overall Study||4
11414784|NCT01301963|12611833|FG000|NOT COMPLETED|Overall Study||0
11414785|NCT01301963|12611834|FG001|NOT COMPLETED|Overall Study||0
11414786|NCT01298921|12611842|FG000|STARTED|Overall Study||0
11414787|NCT01298921|12611843|FG001|STARTED|Overall Study||0
11414788|NCT01298921|12611842|FG000|COMPLETED|Overall Study||0
11414789|NCT01298921|12611843|FG001|COMPLETED|Overall Study||0
11414790|NCT01298921|12611842|FG000|NOT COMPLETED|Overall Study||0
11414791|NCT01298921|12611843|FG001|NOT COMPLETED|Overall Study||0
11414792|NCT01292070|12611851|FG000|STARTED|Overall Study||4
11414793|NCT01292070|12611851|FG000|COMPLETED|Overall Study||4
11414794|NCT01292070|12611851|FG000|NOT COMPLETED|Overall Study||0
11414795|NCT01292265|12611855|FG000|STARTED|Overall Study||3
11414796|NCT01292265|12611855|FG000|COMPLETED|Overall Study||3
11414797|NCT01292265|12611855|FG000|NOT COMPLETED|Overall Study||0
11414798|NCT01290822|12611859|FG000|STARTED|Overall Study||12
11414799|NCT01290822|12611859|FG000|COMPLETED|Overall Study||1
11414800|NCT01290822|12611859|FG000|NOT COMPLETED|Overall Study||11
11414801|NCT01290718|12611863|FG000|STARTED|Overall Study||4
11414802|NCT01290718|12611863|FG000|COMPLETED|Overall Study||0
11414803|NCT01290718|12611863|FG000|NOT COMPLETED|Overall Study||4
11414804|NCT01293123|12611869|FG000|STARTED|Overall Study||1
11414805|NCT01293123|12611870|FG001|STARTED|Overall Study||1
11414806|NCT01293123|12611869|FG000|COMPLETED|Overall Study||1
11414807|NCT01293123|12611870|FG001|COMPLETED|Overall Study||0
11414808|NCT01293123|12611869|FG000|NOT COMPLETED|Overall Study||0
11414809|NCT01293123|12611870|FG001|NOT COMPLETED|Overall Study||1
11414810|NCT01294046|12611876|FG000|STARTED|Overall Study||3
11414811|NCT01294046|12611876|FG000|COMPLETED|Overall Study||0
11414812|NCT01294046|12611876|FG000|NOT COMPLETED|Overall Study||3
11414813|NCT01280643|12611892|FG000|STARTED|Overall Study||0
11414814|NCT01280643|12611893|FG001|STARTED|Overall Study||1
11414815|NCT01280643|12611894|FG002|STARTED|Overall Study||1
11414816|NCT01280643|12611895|FG003|STARTED|Overall Study||1
11414817|NCT01280643|12611896|FG004|STARTED|Overall Study||0
11414818|NCT01280643|12611897|FG005|STARTED|Overall Study||0
11414819|NCT01280643|12611898|FG006|STARTED|Overall Study||0
11414820|NCT01280643|12611899|FG007|STARTED|Overall Study||0
11414821|NCT01280643|12611900|FG008|STARTED|Overall Study||0
11414822|NCT01280643|12611892|FG000|COMPLETED|Overall Study||0
11414823|NCT01280643|12611893|FG001|COMPLETED|Overall Study||0
11414824|NCT01280643|12611894|FG002|COMPLETED|Overall Study||1
11414825|NCT01280643|12611895|FG003|COMPLETED|Overall Study||1
11414826|NCT01280643|12611896|FG004|COMPLETED|Overall Study||0
11414827|NCT01280643|12611897|FG005|COMPLETED|Overall Study||0
11414828|NCT01280643|12611898|FG006|COMPLETED|Overall Study||0
11414829|NCT01280643|12611899|FG007|COMPLETED|Overall Study||0
11414830|NCT01280643|12611900|FG008|COMPLETED|Overall Study||0
11414831|NCT01280643|12611892|FG000|NOT COMPLETED|Overall Study||0
11414832|NCT01280643|12611893|FG001|NOT COMPLETED|Overall Study||1
11414833|NCT01280643|12611894|FG002|NOT COMPLETED|Overall Study||0
11414834|NCT01280643|12611895|FG003|NOT COMPLETED|Overall Study||0
11414835|NCT01280643|12611896|FG004|NOT COMPLETED|Overall Study||0
11414836|NCT01280643|12611897|FG005|NOT COMPLETED|Overall Study||0
11414837|NCT01280643|12611898|FG006|NOT COMPLETED|Overall Study||0
11414838|NCT01280643|12611899|FG007|NOT COMPLETED|Overall Study||0
11414839|NCT01280643|12611900|FG008|NOT COMPLETED|Overall Study||0
11414840|NCT01281124|12611920|FG000|STARTED|Overall Study||1
11414841|NCT01281124|12611920|FG000|COMPLETED|Overall Study||0
11414842|NCT01281124|12611920|FG000|NOT COMPLETED|Overall Study||1
11414843|NCT01272141|12611926|FG000|STARTED|Overall Study||5
11414844|NCT01272141|12611926|FG000|COMPLETED|Overall Study||5
11414845|NCT01272141|12611926|FG000|NOT COMPLETED|Overall Study||0
11414846|NCT01282216|12611932|FG000|STARTED|Overall Study||18
11414847|NCT01282216|12611933|FG001|STARTED|Overall Study||26
11414848|NCT01282216|12611934|FG002|STARTED|Overall Study||52
11414849|NCT01282216|12611935|FG003|STARTED|Overall Study||8
11414850|NCT01282216|12611932|FG000|COMPLETED|Overall Study||18
11414851|NCT01282216|12611933|FG001|COMPLETED|Overall Study||26
11414852|NCT01282216|12611934|FG002|COMPLETED|Overall Study||19
11414853|NCT01282216|12611935|FG003|COMPLETED|Overall Study||0
11414854|NCT01282216|12611932|FG000|NOT COMPLETED|Overall Study||0
11414855|NCT01282216|12611933|FG001|NOT COMPLETED|Overall Study||0
11414856|NCT01282216|12611934|FG002|NOT COMPLETED|Overall Study||33
11414857|NCT01282216|12611935|FG003|NOT COMPLETED|Overall Study||8
11414858|NCT01284491|12611941|FG000|STARTED|Overall Study||13
11414859|NCT01284491|12611941|FG000|COMPLETED|Overall Study||0
11414860|NCT01284491|12611941|FG000|NOT COMPLETED|Overall Study||13
11414861|NCT01284504|12611949|FG000|STARTED|Overall Study||0
11414862|NCT01284504|12611950|FG001|STARTED|Overall Study||0
11414863|NCT01284504|12611949|FG000|COMPLETED|Overall Study||0
11414864|NCT01284504|12611950|FG001|COMPLETED|Overall Study||0
11414865|NCT01284504|12611949|FG000|NOT COMPLETED|Overall Study||0
11414866|NCT01284504|12611950|FG001|NOT COMPLETED|Overall Study||0
11414867|NCT01269034|12611960|FG000|STARTED|Overall Study||1
11414868|NCT01269034|12611961|FG001|STARTED|Overall Study||2
11414869|NCT01269034|12611962|FG002|STARTED|Overall Study||1
11414870|NCT01269034|12611963|FG003|STARTED|Overall Study||9
11414871|NCT01269034|12611960|FG000|COMPLETED|Overall Study||0
11414872|NCT01269034|12611961|FG001|COMPLETED|Overall Study||2
11414873|NCT01269034|12611962|FG002|COMPLETED|Overall Study||1
11414874|NCT01269034|12611963|FG003|COMPLETED|Overall Study||9
11414875|NCT01269034|12611960|FG000|NOT COMPLETED|Overall Study||1
11414876|NCT01269034|12611961|FG001|NOT COMPLETED|Overall Study||0
11414877|NCT01269034|12611962|FG002|NOT COMPLETED|Overall Study||0
11414878|NCT01269034|12611963|FG003|NOT COMPLETED|Overall Study||0
11414879|NCT01274533|12611973|FG000|STARTED|Overall Study||4
11414880|NCT01274533|12611973|FG000|COMPLETED|Overall Study||0
11414881|NCT01274533|12611973|FG000|NOT COMPLETED|Overall Study||4
11414882|NCT01279616|12611977|FG000|STARTED|Overall Study||8
11414883|NCT01279616|12611977|FG000|COMPLETED|Overall Study||1
11414884|NCT01279616|12611977|FG000|NOT COMPLETED|Overall Study||7
11414885|NCT01276054|12611983|FG000|STARTED|Overall Study||2
11414886|NCT01276054|12611984|FG001|STARTED|Overall Study||2
11414887|NCT01276054|12611983|FG000|COMPLETED|Overall Study||0
11414888|NCT01276054|12611984|FG001|COMPLETED|Overall Study||0
11414889|NCT01276054|12611983|FG000|NOT COMPLETED|Overall Study||2
11414890|NCT01276054|12611984|FG001|NOT COMPLETED|Overall Study||2
11414891|NCT01264965|12611990|FG000|STARTED|Overall Study||25
11414892|NCT01264965|12611990|FG000|COMPLETED|Overall Study||15
11414893|NCT01264965|12611990|FG000|NOT COMPLETED|Overall Study||10
11414894|NCT01266824|12611996|FG000|STARTED|Overall Study||2
11414895|NCT01266824|12611997|FG001|STARTED|Overall Study||3
11414896|NCT01266824|12611996|FG000|COMPLETED|Overall Study||0
11414897|NCT01266824|12611997|FG001|COMPLETED|Overall Study||0
11144140|NCT01475838|12330790|FG000|COMPLETED|Randomized Phase||263
11144141|NCT01475838|12330791|FG001|COMPLETED|Randomized Phase||109
11144142|NCT01475838|12330790|FG000|NOT COMPLETED|Randomized Phase||30
11144143|NCT01475838|12330791|FG001|NOT COMPLETED|Randomized Phase||36
11144144|NCT01475838|12330790|FG000|STARTED|Extension Phase||42
11414898|NCT01266824|12611996|FG000|NOT COMPLETED|Overall Study||2
11414899|NCT01266824|12611997|FG001|NOT COMPLETED|Overall Study||3
11414900|NCT01264835|12612003|FG000|STARTED|Overall Study||2
11414901|NCT01264835|12612003|FG000|COMPLETED|Overall Study||1
11414902|NCT01264835|12612003|FG000|NOT COMPLETED|Overall Study||1
11414903|NCT01274429|12612007|FG000|STARTED|Overall Study||5
11414904|NCT01274429|12612007|FG000|COMPLETED|Overall Study||0
11414905|NCT01274429|12612007|FG000|NOT COMPLETED|Overall Study||5
11414906|NCT01273064|12612016|FG000|STARTED|Overall Study||23
11414907|NCT01273064|12612017|FG001|STARTED|Overall Study||30
11414908|NCT01273064|12612018|FG002|STARTED|Overall Study||31
11414909|NCT01273064|12612019|FG003|STARTED|Overall Study||20
11414910|NCT01273064|12612020|FG004|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
11414911|NCT01273064|12612016|FG000|COMPLETED|Overall Study||0
11414912|NCT01273064|12612017|FG001|COMPLETED|Overall Study||0
11414913|NCT01273064|12612018|FG002|COMPLETED|Overall Study||0
11414914|NCT01273064|12612019|FG003|COMPLETED|Overall Study||0
11414915|NCT01273064|12612020|FG004|COMPLETED|Overall Study||0
11414916|NCT01273064|12612016|FG000|NOT COMPLETED|Overall Study||23
11414917|NCT01273064|12612017|FG001|NOT COMPLETED|Overall Study||30
11414918|NCT01273064|12612018|FG002|NOT COMPLETED|Overall Study||31
11414919|NCT01273064|12612019|FG003|NOT COMPLETED|Overall Study||20
11414920|NCT01273064|12612020|FG004|NOT COMPLETED|Overall Study||10
11414921|NCT01274559|12612034|FG000|STARTED|Overall Study||587
11414922|NCT01274559|12612035|FG001|STARTED|Overall Study||586
11414923|NCT01274559|12612034|FG000|Treated|Overall Study||572
11414924|NCT01274559|12612035|FG001|Treated|Overall Study||572
11414925|NCT01274559|12612034|FG000|COMPLETED|Overall Study||390
11414926|NCT01274559|12612035|FG001|COMPLETED|Overall Study||441
11414927|NCT01274559|12612034|FG000|NOT COMPLETED|Overall Study||197
11414928|NCT01274559|12612035|FG001|NOT COMPLETED|Overall Study||145
11414929|NCT01270581|12612043|FG000|STARTED|Overall Study||4
11414930|NCT01270581|12612044|FG001|STARTED|Overall Study||3
11414931|NCT01270581|12612043|FG000|COMPLETED|Overall Study||3
11414932|NCT01270581|12612044|FG001|COMPLETED|Overall Study||3
11414933|NCT01270581|12612043|FG000|NOT COMPLETED|Overall Study||1
11414934|NCT01270581|12612044|FG001|NOT COMPLETED|Overall Study||0
11414935|NCT01269749|12612052|FG000|STARTED|Overall Study||16
11414936|NCT01269749|12612053|FG001|STARTED|Overall Study||3
11414937|NCT01269749|12612052|FG000|COMPLETED|Overall Study||16
11414938|NCT01269749|12612053|FG001|COMPLETED|Overall Study||3
11414939|NCT01269749|12612052|FG000|NOT COMPLETED|Overall Study||0
11414940|NCT01269749|12612053|FG001|NOT COMPLETED|Overall Study||0
11414941|NCT01270919|12612059|FG000|STARTED|Overall Study|One participant was enrolled but was censored.|0
11414942|NCT01270919|12612059|FG000|COMPLETED|Overall Study||0
11414943|NCT01270919|12612059|FG000|NOT COMPLETED|Overall Study||0
11414944|NCT01262339|12612063|FG000|STARTED|Overall Study||2
11414945|NCT01262339|12612063|FG000|COMPLETED|Overall Study||2
11414946|NCT01262339|12612063|FG000|NOT COMPLETED|Overall Study||0
11414947|NCT01267825|12612069|FG000|STARTED|Overall Study||1
11414948|NCT01267825|12612070|FG001|STARTED|Overall Study||0
11414949|NCT01267825|12612069|FG000|COMPLETED|Overall Study||0
11144145|NCT01475838|12330791|FG001|STARTED|Extension Phase||20
11144146|NCT01475838|12330790|FG000|COMPLETED|Extension Phase||41
11414950|NCT01267825|12612070|FG001|COMPLETED|Overall Study||0
11414951|NCT01267825|12612069|FG000|NOT COMPLETED|Overall Study||1
11414952|NCT01267825|12612070|FG001|NOT COMPLETED|Overall Study||0
11414953|NCT01259284|12612079|FG000|STARTED|Overall Study||2
11414954|NCT01259284|12612080|FG001|STARTED|Overall Study||0
11414955|NCT01259284|12612081|FG002|STARTED|Overall Study||0
11414956|NCT01259284|12612079|FG000|COMPLETED|Overall Study||0
11414957|NCT01259284|12612080|FG001|COMPLETED|Overall Study||0
11414958|NCT01259284|12612081|FG002|COMPLETED|Overall Study||0
11414959|NCT01259284|12612079|FG000|NOT COMPLETED|Overall Study||2
11414960|NCT01259284|12612080|FG001|NOT COMPLETED|Overall Study||0
11414961|NCT01259284|12612081|FG002|NOT COMPLETED|Overall Study||0
11414962|NCT01249157|12612089|FG000|STARTED|Overall Study||1
11414963|NCT01249157|12612089|FG000|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
11414964|NCT01249157|12612089|FG000|NOT COMPLETED|Overall Study||1
11414965|NCT01263028|12612093|FG000|STARTED|Overall Study||6
11414966|NCT01263028|12612093|FG000|COMPLETED|Overall Study||0
11414967|NCT01263028|12612093|FG000|NOT COMPLETED|Overall Study||6
11414968|NCT01256281|12612097|FG000|STARTED|Overall Study||2
11414969|NCT01256281|12612097|FG000|COMPLETED|Overall Study||2
11414970|NCT01256281|12612097|FG000|NOT COMPLETED|Overall Study||0
11144147|NCT01475838|12330791|FG001|COMPLETED|Extension Phase||20
11144148|NCT01475838|12330790|FG000|NOT COMPLETED|Extension Phase||1
11144149|NCT01475838|12330791|FG001|NOT COMPLETED|Extension Phase||0
11022484|NCT00809159|12200735|FG002|PD Analysis Set|Part 1 and 2||28
11022485|NCT00809159|12200736|FG003|PD Analysis Set|Part 1 and 2||12
11022486|NCT00809159|12200737|FG004|PD Analysis Set|Part 1 and 2||12
11022487|NCT00809159|12200738|FG005|PD Analysis Set|Part 1 and 2||6
11022488|NCT00809159|12200733|FG000|COMPLETED|Part 1 and 2||0
11022489|NCT00809159|12200734|FG001|COMPLETED|Part 1 and 2||0
11022490|NCT00809159|12200735|FG002|COMPLETED|Part 1 and 2||20
11022491|NCT00809159|12200736|FG003|COMPLETED|Part 1 and 2||7
11022492|NCT00809159|12200737|FG004|COMPLETED|Part 1 and 2||6
11022493|NCT00809159|12200738|FG005|COMPLETED|Part 1 and 2||3
11022494|NCT00809159|12200733|FG000|NOT COMPLETED|Part 1 and 2||0
11022495|NCT00809159|12200734|FG001|NOT COMPLETED|Part 1 and 2||0
11022496|NCT00809159|12200735|FG002|NOT COMPLETED|Part 1 and 2||10
11022497|NCT00809159|12200736|FG003|NOT COMPLETED|Part 1 and 2||5
11022498|NCT00809159|12200737|FG004|NOT COMPLETED|Part 1 and 2||6
11144150|NCT01475851|12330800|FG000|STARTED|Overall Study||13
11144151|NCT01475851|12330801|FG001|STARTED|Overall Study||21
11144152|NCT01475851|12330800|FG000|COMPLETED|Overall Study||12
11414971|NCT01253668|12612101|FG000|STARTED|Overall Study||0
11414972|NCT01253668|12612101|FG000|COMPLETED|Overall Study||0
11414973|NCT01253668|12612101|FG000|NOT COMPLETED|Overall Study||0
11414974|NCT01259024|12612105|FG000|STARTED|Overall Study||1
11414975|NCT01259024|12612105|FG000|COMPLETED|Overall Study||0
11414976|NCT01259024|12612105|FG000|NOT COMPLETED|Overall Study||1
11414977|NCT01251952|12612109|FG000|STARTED|Overall Study||2
11414978|NCT01251952|12612109|FG000|COMPLETED|Overall Study||1
11414979|NCT01251952|12612109|FG000|NOT COMPLETED|Overall Study||1
11414980|NCT01251120|12612115|FG000|STARTED|Overall Study||1
11414981|NCT01251120|12612116|FG001|STARTED|Overall Study||1
11414982|NCT01251120|12612115|FG000|COMPLETED|Overall Study||1
11414983|NCT01251120|12612116|FG001|COMPLETED|Overall Study||0
11414984|NCT01251120|12612115|FG000|NOT COMPLETED|Overall Study||0
11414985|NCT01251120|12612116|FG001|NOT COMPLETED|Overall Study||1
11414986|NCT01248130|12612124|FG000|STARTED|Overall Study||3
11414987|NCT01248130|12612125|FG001|STARTED|Overall Study||4
11414988|NCT01248130|12612124|FG000|COMPLETED|Overall Study||1
11414989|NCT01248130|12612125|FG001|COMPLETED|Overall Study||4
11414990|NCT01248130|12612124|FG000|NOT COMPLETED|Overall Study||2
11414991|NCT01248130|12612125|FG001|NOT COMPLETED|Overall Study||0
11414992|NCT01243892|12612133|FG000|STARTED|Overall Study||15
11414993|NCT01243892|12612134|FG001|STARTED|Overall Study||3
11414994|NCT01243892|12612133|FG000|COMPLETED|Overall Study||13
11414995|NCT01243892|12612134|FG001|COMPLETED|Overall Study||3
11414996|NCT01243892|12612133|FG000|NOT COMPLETED|Overall Study||2
11414997|NCT01243892|12612134|FG001|NOT COMPLETED|Overall Study||0
11414998|NCT01246011|12612143|FG000|STARTED|Overall Study||0
11414999|NCT01246011|12612144|FG001|STARTED|Overall Study||0
11415000|NCT01246011|12612145|FG002|STARTED|Overall Study||9
11415001|NCT01246011|12612143|FG000|COMPLETED|Overall Study||0
11415002|NCT01246011|12612144|FG001|COMPLETED|Overall Study||0
11415003|NCT01246011|12612145|FG002|COMPLETED|Overall Study||5
11415004|NCT01246011|12612143|FG000|NOT COMPLETED|Overall Study||0
11415005|NCT01246011|12612144|FG001|NOT COMPLETED|Overall Study||0
11415006|NCT01246011|12612145|FG002|NOT COMPLETED|Overall Study||4
11415007|NCT01242020|12612156|FG000|STARTED|Overall Study||6
11415008|NCT01242020|12612157|FG001|STARTED|Overall Study||0
11415009|NCT01242020|12612156|FG000|COMPLETED|Overall Study||3
11415010|NCT01242020|12612157|FG001|COMPLETED|Overall Study||0
11415011|NCT01242020|12612156|FG000|NOT COMPLETED|Overall Study||3
11415012|NCT01242020|12612157|FG001|NOT COMPLETED|Overall Study||0
11415013|NCT01244620|12612163|FG000|STARTED|Overall Study||4
11415014|NCT01244620|12612164|FG001|STARTED|Overall Study||4
11415015|NCT01244620|12612165|FG002|STARTED|Overall Study||4
11415016|NCT01244620|12612166|FG003|STARTED|Overall Study||4
11415017|NCT01244620|12612163|FG000|COMPLETED|Overall Study||0
11415018|NCT01244620|12612164|FG001|COMPLETED|Overall Study||0
11415019|NCT01244620|12612165|FG002|COMPLETED|Overall Study||0
11415020|NCT01244620|12612166|FG003|COMPLETED|Overall Study||0
11415021|NCT01244620|12612163|FG000|NOT COMPLETED|Overall Study||4
11415022|NCT01244620|12612164|FG001|NOT COMPLETED|Overall Study||4
11415023|NCT01244620|12612165|FG002|NOT COMPLETED|Overall Study||4
11415024|NCT01244620|12612166|FG003|NOT COMPLETED|Overall Study||4
11415025|NCT01240304|12612176|FG000|STARTED|Overall Study||10
11415026|NCT01240304|12612176|FG000|COMPLETED|Overall Study||0
11415027|NCT01240304|12612176|FG000|NOT COMPLETED|Overall Study||10
11415028|NCT01241279|12612182|FG000|STARTED|Overall Study||4
11415029|NCT01241279|12612183|FG001|STARTED|Overall Study||2
11415030|NCT01241279|12612182|FG000|COMPLETED|Overall Study||4
11415031|NCT01241279|12612183|FG001|COMPLETED|Overall Study||1
11415032|NCT01241279|12612182|FG000|NOT COMPLETED|Overall Study||0
11415033|NCT01241279|12612183|FG001|NOT COMPLETED|Overall Study||1
11415034|NCT01230788|12612189|FG000|STARTED|Overall Study||1
11415035|NCT01230788|12612189|FG000|COMPLETED|Overall Study||0
11415036|NCT01230788|12612189|FG000|NOT COMPLETED|Overall Study||1
11415037|NCT01239680|12612195|FG000|STARTED|Overall Study||3
11415038|NCT01239680|12612196|FG001|STARTED|Overall Study||2
11415039|NCT01239680|12612195|FG000|COMPLETED|Overall Study||1
11415040|NCT01239680|12612196|FG001|COMPLETED|Overall Study||2
11415041|NCT01239680|12612195|FG000|NOT COMPLETED|Overall Study||2
11415042|NCT01239680|12612196|FG001|NOT COMPLETED|Overall Study||0
11415043|NCT01237613|12612202|FG000|STARTED|Overall Study||4
11415044|NCT01237613|12612202|FG000|COMPLETED|Overall Study||4
11415045|NCT01237613|12612202|FG000|NOT COMPLETED|Overall Study||0
11415046|NCT01234103|12612209|FG000|STARTED|Overall Study||542
11415047|NCT01234103|12612210|FG001|STARTED|Overall Study||391
11415048|NCT01234103|12612209|FG000|COMPLETED|Overall Study||542
11415049|NCT01234103|12612210|FG001|COMPLETED|Overall Study||391
11415050|NCT01234103|12612209|FG000|NOT COMPLETED|Overall Study||0
11415051|NCT01234103|12612210|FG001|NOT COMPLETED|Overall Study||0
11415052|NCT01231750|12612218|FG000|STARTED|Overall Study||3
11415053|NCT01231750|12612219|FG001|STARTED|Overall Study||4
11415054|NCT01231750|12612218|FG000|COMPLETED|Overall Study||3
11415055|NCT01231750|12612219|FG001|COMPLETED|Overall Study||4
11415056|NCT01231750|12612218|FG000|NOT COMPLETED|Overall Study||0
11415057|NCT01231750|12612219|FG001|NOT COMPLETED|Overall Study||0
11415058|NCT01230307|12612227|FG000|STARTED|Overall Study||6
11415059|NCT01230307|12612228|FG001|STARTED|Overall Study||6
11415060|NCT01230307|12612227|FG000|COMPLETED|Overall Study||6
11415061|NCT01230307|12612228|FG001|COMPLETED|Overall Study||4
11415062|NCT01230307|12612227|FG000|NOT COMPLETED|Overall Study||0
11415063|NCT01230307|12612228|FG001|NOT COMPLETED|Overall Study||2
11415064|NCT01230489|12612234|FG000|STARTED|Overall Study||13
11415065|NCT01230489|12612234|FG000|COMPLETED|Overall Study||8
11415066|NCT01230489|12612234|FG000|NOT COMPLETED|Overall Study||5
11415067|NCT01222871|12612240|FG000|STARTED|Overall Study||0
11415068|NCT01222871|12612241|FG001|STARTED|Overall Study||0
11415069|NCT01222871|12612240|FG000|COMPLETED|Overall Study||0
11415070|NCT01222871|12612241|FG001|COMPLETED|Overall Study||0
11415071|NCT01222871|12612240|FG000|NOT COMPLETED|Overall Study||0
11415072|NCT01222871|12612241|FG001|NOT COMPLETED|Overall Study||0
11415073|NCT01219673|12612256|FG000|STARTED|Overall Study||0
11415074|NCT01219673|12612257|FG001|STARTED|Overall Study||0
11415075|NCT01219673|12612258|FG002|STARTED|Overall Study||1
11415076|NCT01219673|12612259|FG003|STARTED|Overall Study||0
11415077|NCT01219673|12612260|FG004|STARTED|Overall Study||0
11415078|NCT01219673|12612261|FG005|STARTED|Overall Study||0
11415079|NCT01219673|12612262|FG006|STARTED|Overall Study||0
11415080|NCT01219673|12612263|FG007|STARTED|Overall Study||0
11415081|NCT01219673|12612256|FG000|COMPLETED|Overall Study||0
11415082|NCT01219673|12612257|FG001|COMPLETED|Overall Study||0
11415083|NCT01219673|12612258|FG002|COMPLETED|Overall Study||1
11415084|NCT01219673|12612259|FG003|COMPLETED|Overall Study||0
11415085|NCT01219673|12612260|FG004|COMPLETED|Overall Study||0
11415086|NCT01219673|12612261|FG005|COMPLETED|Overall Study||0
11415087|NCT01219673|12612262|FG006|COMPLETED|Overall Study||0
11415088|NCT01219673|12612263|FG007|COMPLETED|Overall Study||0
11415089|NCT01219673|12612256|FG000|NOT COMPLETED|Overall Study||0
11415090|NCT01219673|12612257|FG001|NOT COMPLETED|Overall Study||0
11415091|NCT01219673|12612258|FG002|NOT COMPLETED|Overall Study||0
11415092|NCT01219673|12612259|FG003|NOT COMPLETED|Overall Study||0
11415093|NCT01219673|12612260|FG004|NOT COMPLETED|Overall Study||0
11415094|NCT01219673|12612261|FG005|NOT COMPLETED|Overall Study||0
11415095|NCT01219673|12612262|FG006|NOT COMPLETED|Overall Study||0
11415096|NCT01219673|12612263|FG007|NOT COMPLETED|Overall Study||0
11415097|NCT01223001|12612283|FG000|STARTED|Overall Study||4
11415098|NCT01223001|12612284|FG001|STARTED|Overall Study||4
11415099|NCT01223001|12612283|FG000|COMPLETED|Overall Study||0
11415100|NCT01223001|12612284|FG001|COMPLETED|Overall Study||0
11415101|NCT01223001|12612283|FG000|NOT COMPLETED|Overall Study||4
11415102|NCT01223001|12612284|FG001|NOT COMPLETED|Overall Study||4
11415103|NCT01217060|12612290|FG000|STARTED|Overall Study||4
11415104|NCT01217060|12612290|FG000|COMPLETED|Overall Study||3
11415105|NCT01217060|12612290|FG000|NOT COMPLETED|Overall Study||1
11415106|NCT01217047|12612298|FG000|STARTED|Overall Study||3
11415107|NCT01217047|12612299|FG001|STARTED|Overall Study||4
11415108|NCT01217047|12612300|FG002|STARTED|Overall Study||3
11415109|NCT01217047|12612298|FG000|COMPLETED|Overall Study||3
11415110|NCT01217047|12612299|FG001|COMPLETED|Overall Study||3
11415111|NCT01217047|12612300|FG002|COMPLETED|Overall Study||3
11415112|NCT01217047|12612298|FG000|NOT COMPLETED|Overall Study||0
11415113|NCT01217047|12612299|FG001|NOT COMPLETED|Overall Study||1
11415114|NCT01217047|12612300|FG002|NOT COMPLETED|Overall Study||0
11415115|NCT01206101|12612311|FG000|STARTED|Overall Study||2
11415116|NCT01206101|12612312|FG001|STARTED|Overall Study||1
11415117|NCT01206101|12612311|FG000|COMPLETED|Overall Study||0
11415118|NCT01206101|12612312|FG001|COMPLETED|Overall Study||0
11415119|NCT01206101|12612311|FG000|NOT COMPLETED|Overall Study||2
11415120|NCT01206101|12612312|FG001|NOT COMPLETED|Overall Study||1
11415121|NCT01216631|12612321|FG000|STARTED|Overall Study||0
11415122|NCT01216631|12612322|FG001|STARTED|Overall Study||0
11415123|NCT01216631|12612323|FG002|STARTED|Overall Study||1
11415124|NCT01216631|12612321|FG000|COMPLETED|Overall Study||0
11415125|NCT01216631|12612322|FG001|COMPLETED|Overall Study||0
11415126|NCT01216631|12612323|FG002|COMPLETED|Overall Study||1
11415127|NCT01216631|12612321|FG000|NOT COMPLETED|Overall Study||0
11415128|NCT01216631|12612322|FG001|NOT COMPLETED|Overall Study||0
11415129|NCT01216631|12612323|FG002|NOT COMPLETED|Overall Study||0
11415130|NCT01211756|12612331|FG000|STARTED|Overall Study||1
11415131|NCT01211756|12612331|FG000|COMPLETED|Overall Study||1
11415132|NCT01211756|12612331|FG000|NOT COMPLETED|Overall Study||0
11415133|NCT01209520|12612335|FG000|STARTED|Overall Study||6
11415134|NCT01209520|12612335|FG000|COMPLETED|Overall Study||3
11415135|NCT01209520|12612335|FG000|NOT COMPLETED|Overall Study||3
11415136|NCT01207726|12612341|FG000|STARTED|Overall Study||7
11415137|NCT01207726|12612342|FG001|STARTED|Overall Study||6
11415138|NCT01207726|12612341|FG000|COMPLETED|Overall Study||7
11415139|NCT01207726|12612342|FG001|COMPLETED|Overall Study||6
11415140|NCT01207726|12612341|FG000|NOT COMPLETED|Overall Study||0
11415141|NCT01207726|12612342|FG001|NOT COMPLETED|Overall Study||0
11415142|NCT01206296|12612352|FG000|STARTED|Overall Study||0
11415143|NCT01206296|12612352|FG000|COMPLETED|Overall Study||0
11415144|NCT01206296|12612352|FG000|NOT COMPLETED|Overall Study||0
11415145|NCT01207102|12612356|FG000|STARTED|Overall Study||10
11415146|NCT01207102|12612356|FG000|COMPLETED|Overall Study||0
11415147|NCT01207102|12612356|FG000|NOT COMPLETED|Overall Study||10
11415148|NCT01213329|12612362|FG000|STARTED|Screening||25
11415149|NCT01213329|12612363|FG001|STARTED|Screening||25
11415150|NCT01213329|12612362|FG000|COMPLETED|Screening||25
11415151|NCT01213329|12612363|FG001|COMPLETED|Screening||25
11415152|NCT01213329|12612362|FG000|NOT COMPLETED|Screening||0
11415153|NCT01213329|12612363|FG001|NOT COMPLETED|Screening||0
11415154|NCT01213329|12612362|FG000|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
11415155|NCT01213329|12612363|FG001|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
11415156|NCT01213329|12612362|FG000|COMPLETED|Phase 2||0
11415157|NCT01213329|12612363|FG001|COMPLETED|Phase 2||0
11415158|NCT01213329|12612362|FG000|NOT COMPLETED|Phase 2||0
11415159|NCT01213329|12612363|FG001|NOT COMPLETED|Phase 2||0
11415160|NCT01202110|12612369|FG000|STARTED|Overall Study||10
11415161|NCT01202110|12612370|FG001|STARTED|Overall Study||0
11415162|NCT01202110|12612369|FG000|COMPLETED|Overall Study||10
11415163|NCT01202110|12612370|FG001|COMPLETED|Overall Study||0
11415164|NCT01202110|12612369|FG000|NOT COMPLETED|Overall Study||0
11415165|NCT01202110|12612370|FG001|NOT COMPLETED|Overall Study||0
11415166|NCT01206439|12612374|FG000|STARTED|Overall Study||2
11415167|NCT01206439|12612374|FG000|COMPLETED|Overall Study||1
11415168|NCT01206439|12612374|FG000|NOT COMPLETED|Overall Study||1
11415169|NCT01204788|12612380|FG000|STARTED|Overall Study||1
11415170|NCT01204788|12612381|FG001|STARTED|Overall Study||3
11415171|NCT01204788|12612380|FG000|COMPLETED|Overall Study||0
11415172|NCT01204788|12612381|FG001|COMPLETED|Overall Study||0
11415173|NCT01204788|12612380|FG000|NOT COMPLETED|Overall Study||1
11415174|NCT01204788|12612381|FG001|NOT COMPLETED|Overall Study||3
11415175|NCT01200602|12612389|FG000|STARTED|Overall Study||0
11415176|NCT01200602|12612390|FG001|STARTED|Overall Study||0
11415177|NCT01200602|12612389|FG000|COMPLETED|Overall Study||0
11415178|NCT01200602|12612390|FG001|COMPLETED|Overall Study||0
11415179|NCT01200602|12612389|FG000|NOT COMPLETED|Overall Study||0
11415180|NCT01200602|12612390|FG001|NOT COMPLETED|Overall Study||0
11415181|NCT01198548|12612396|FG000|STARTED|Overall Study||10
11415182|NCT01198548|12612396|FG000|COMPLETED|Overall Study||0
11415183|NCT01198548|12612396|FG000|NOT COMPLETED|Overall Study||10
11415184|NCT01194908|12612400|FG000|STARTED|Overall Study||5
11415185|NCT01194908|12612400|FG000|COMPLETED|Overall Study||5
11415186|NCT01194908|12612400|FG000|NOT COMPLETED|Overall Study||0
11415187|NCT01194856|12612406|FG000|STARTED|Overall Study||1
11415188|NCT01194856|12612407|FG001|STARTED|Overall Study||0
11415189|NCT01194856|12612406|FG000|COMPLETED|Overall Study||0
11415190|NCT01194856|12612407|FG001|COMPLETED|Overall Study||0
11415191|NCT01194856|12612406|FG000|NOT COMPLETED|Overall Study||1
11415192|NCT01194856|12612407|FG001|NOT COMPLETED|Overall Study||0
11415193|NCT01194427|12612413|FG000|STARTED|Overall Study||2
11415194|NCT01194427|12612413|FG000|COMPLETED|Overall Study||2
11415195|NCT01194427|12612413|FG000|NOT COMPLETED|Overall Study||0
11415196|NCT01193556|12612419|FG000|STARTED|Overall Study||26
11415197|NCT01193556|12612420|FG001|STARTED|Overall Study||25
11415198|NCT01193556|12612419|FG000|COMPLETED|Overall Study||0
11415199|NCT01193556|12612420|FG001|COMPLETED|Overall Study||0
11415200|NCT01193556|12612419|FG000|NOT COMPLETED|Overall Study||26
11415201|NCT01193556|12612420|FG001|NOT COMPLETED|Overall Study||25
11415202|NCT01189435|12612426|FG000|STARTED|Overall Study||2
11415203|NCT01189435|12612426|FG000|COMPLETED|Overall Study||0
11415204|NCT01189435|12612426|FG000|NOT COMPLETED|Overall Study||2
11415205|NCT01193530|12612432|FG000|STARTED|Overall Study||4
11415206|NCT01193530|12612433|FG001|STARTED|Overall Study||8
11415207|NCT01193530|12612432|FG000|COMPLETED|Overall Study||1
11415208|NCT01193530|12612433|FG001|COMPLETED|Overall Study||3
11415209|NCT01193530|12612432|FG000|NOT COMPLETED|Overall Study||3
11415210|NCT01193530|12612433|FG001|NOT COMPLETED|Overall Study||5
11415211|NCT01182610|12612439|FG000|STARTED|Overall Study||1
11415212|NCT01182610|12612439|FG000|COMPLETED|Overall Study||1
11415213|NCT01182610|12612439|FG000|NOT COMPLETED|Overall Study||0
11415214|NCT01189071|12612445|FG000|STARTED|Overall Study||0
11415215|NCT01189071|12612446|FG001|STARTED|Overall Study||0
11415216|NCT01189071|12612445|FG000|COMPLETED|Overall Study||0
11415217|NCT01189071|12612446|FG001|COMPLETED|Overall Study||0
11415218|NCT01189071|12612445|FG000|NOT COMPLETED|Overall Study||0
11415219|NCT01189071|12612446|FG001|NOT COMPLETED|Overall Study||0
11415220|NCT01183416|12612452|FG000|STARTED|Overall Study||4
11415221|NCT01183416|12612452|FG000|COMPLETED|Overall Study||4
11415222|NCT01183416|12612452|FG000|NOT COMPLETED|Overall Study||0
11415223|NCT01184456|12612458|FG000|STARTED|Overall Study||0
11415224|NCT01184456|12612459|FG001|STARTED|Overall Study||0
11415225|NCT01184456|12612458|FG000|COMPLETED|Overall Study||0
11415226|NCT01184456|12612459|FG001|COMPLETED|Overall Study||0
11415227|NCT01184456|12612458|FG000|NOT COMPLETED|Overall Study||0
11415228|NCT01184456|12612459|FG001|NOT COMPLETED|Overall Study||0
11415229|NCT01183221|12612467|FG000|STARTED|First Dose||15
11415230|NCT01183221|12612468|FG001|STARTED|First Dose||15
11415231|NCT01183221|12612467|FG000|COMPLETED|First Dose||15
11415232|NCT01183221|12612468|FG001|COMPLETED|First Dose||15
11415233|NCT01183221|12612467|FG000|NOT COMPLETED|First Dose||0
11415234|NCT01183221|12612468|FG001|NOT COMPLETED|First Dose||0
11415235|NCT01183221|12612467|FG000|STARTED|3 Weeks Wash Out||15
11415236|NCT01183221|12612468|FG001|STARTED|3 Weeks Wash Out||15
11415237|NCT01183221|12612467|FG000|COMPLETED|3 Weeks Wash Out||14
11415238|NCT01183221|12612468|FG001|COMPLETED|3 Weeks Wash Out||14
11415239|NCT01183221|12612467|FG000|NOT COMPLETED|3 Weeks Wash Out||1
11415240|NCT01183221|12612468|FG001|NOT COMPLETED|3 Weeks Wash Out||1
11415241|NCT01183221|12612467|FG000|STARTED|Second Dose||14
11415242|NCT01183221|12612468|FG001|STARTED|Second Dose||14
11415243|NCT01183221|12612467|FG000|COMPLETED|Second Dose||14
11415244|NCT01183221|12612468|FG001|COMPLETED|Second Dose||14
11415245|NCT01183221|12612467|FG000|NOT COMPLETED|Second Dose||0
11415246|NCT01183221|12612468|FG001|NOT COMPLETED|Second Dose||0
11415247|NCT01189227|12612476|FG000|STARTED|Overall Study||6
11415248|NCT01189227|12612477|FG001|STARTED|Overall Study||3
11415249|NCT01189227|12612476|FG000|COMPLETED|Overall Study||0
11415250|NCT01189227|12612477|FG001|COMPLETED|Overall Study||0
11415251|NCT01189227|12612476|FG000|NOT COMPLETED|Overall Study||6
11415252|NCT01189227|12612477|FG001|NOT COMPLETED|Overall Study||3
11415253|NCT01179737|12612487|FG000|STARTED|Cohort 1 & Cohort 2||12
11415254|NCT01179737|12612488|FG001|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
11415255|NCT01179737|12612489|FG002|STARTED|Cohort 1 & Cohort 2||4
11415256|NCT01179737|12612490|FG003|STARTED|Cohort 1 & Cohort 2||4
11415257|NCT01179737|12612487|FG000|COMPLETED|Cohort 1 & Cohort 2||7
11415258|NCT01179737|12612488|FG001|COMPLETED|Cohort 1 & Cohort 2||1
11415259|NCT01179737|12612489|FG002|COMPLETED|Cohort 1 & Cohort 2||0
11415260|NCT01179737|12612490|FG003|COMPLETED|Cohort 1 & Cohort 2||0
11415261|NCT01179737|12612487|FG000|NOT COMPLETED|Cohort 1 & Cohort 2||5
11415262|NCT01179737|12612488|FG001|NOT COMPLETED|Cohort 1 & Cohort 2||2
11415263|NCT01179737|12612489|FG002|NOT COMPLETED|Cohort 1 & Cohort 2||4
11415264|NCT01179737|12612490|FG003|NOT COMPLETED|Cohort 1 & Cohort 2||4
11415265|NCT01179737|12612487|FG000|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
11415266|NCT01179737|12612488|FG001|STARTED|Cohort 1 & Cohort 2 Expansion||1
11415267|NCT01179737|12612489|FG002|STARTED|Cohort 1 & Cohort 2 Expansion||0
11415268|NCT01179737|12612490|FG003|STARTED|Cohort 1 & Cohort 2 Expansion||0
11415269|NCT01179737|12612487|FG000|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
11415270|NCT01179737|12612488|FG001|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
11415271|NCT01179737|12612489|FG002|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
11415272|NCT01179737|12612490|FG003|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
11415273|NCT01179737|12612487|FG000|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
11415274|NCT01179737|12612488|FG001|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
11415275|NCT01179737|12612489|FG002|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
11415276|NCT01179737|12612490|FG003|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
11415277|NCT01179737|12612487|FG000|STARTED|Extension|Two patients did not enrol in the extension|3
11415278|NCT01179737|12612488|FG001|STARTED|Extension|One patient did not enrol in the extension|0
11415279|NCT01179737|12612489|FG002|STARTED|Extension||0
11415280|NCT01179737|12612490|FG003|STARTED|Extension||0
11415281|NCT01179737|12612487|FG000|COMPLETED|Extension||0
11415282|NCT01179737|12612488|FG001|COMPLETED|Extension||0
11415283|NCT01179737|12612489|FG002|COMPLETED|Extension||0
11415284|NCT01179737|12612490|FG003|COMPLETED|Extension||0
11415285|NCT01179737|12612487|FG000|NOT COMPLETED|Extension||3
11415286|NCT01179737|12612488|FG001|NOT COMPLETED|Extension||0
11415287|NCT01179737|12612489|FG002|NOT COMPLETED|Extension||0
11415288|NCT01179737|12612490|FG003|NOT COMPLETED|Extension||0
11415289|NCT01183468|12612503|FG000|STARTED|Overall Study||8
11415290|NCT01183468|12612504|FG001|STARTED|Overall Study||9
11415291|NCT01183468|12612505|FG002|STARTED|Overall Study||0
11415292|NCT01183468|12612506|FG003|STARTED|Overall Study||0
11415293|NCT01183468|12612503|FG000|COMPLETED|Overall Study||5
11415294|NCT01183468|12612504|FG001|COMPLETED|Overall Study||7
11415295|NCT01183468|12612505|FG002|COMPLETED|Overall Study||0
11415296|NCT01183468|12612506|FG003|COMPLETED|Overall Study||0
11415297|NCT01183468|12612503|FG000|NOT COMPLETED|Overall Study||3
11415298|NCT01183468|12612504|FG001|NOT COMPLETED|Overall Study||2
11415299|NCT01183468|12612505|FG002|NOT COMPLETED|Overall Study||0
11415300|NCT01183468|12612506|FG003|NOT COMPLETED|Overall Study||0
11415301|NCT01181921|12612514|FG000|STARTED|Overall Study||1
11415302|NCT01181921|12612514|FG000|COMPLETED|Overall Study||0
11415303|NCT01181921|12612514|FG000|NOT COMPLETED|Overall Study||1
11415304|NCT01188798|12612520|FG000|STARTED|Overall Study||2
11415305|NCT01188798|12612521|FG001|STARTED|Overall Study||4
11415306|NCT01188798|12612520|FG000|COMPLETED|Overall Study||0
11415307|NCT01188798|12612521|FG001|COMPLETED|Overall Study||1
11415308|NCT01188798|12612520|FG000|NOT COMPLETED|Overall Study||2
11415309|NCT01188798|12612521|FG001|NOT COMPLETED|Overall Study||3
11415310|NCT01174368|12612528|FG000|STARTED|Overall Study||1
11415311|NCT01174368|12612528|FG000|COMPLETED|Overall Study||0
11415312|NCT01174368|12612528|FG000|NOT COMPLETED|Overall Study||1
11415313|NCT01183897|12612532|FG000|STARTED|Overall Study||31
11415314|NCT01183897|12612532|FG000|COMPLETED|Overall Study||31
11415315|NCT01183897|12612532|FG000|NOT COMPLETED|Overall Study||0
11415316|NCT01183884|12612536|FG000|STARTED|Overall Study||46
11415317|NCT01183884|12612536|FG000|COMPLETED|Overall Study||8
11415318|NCT01183884|12612536|FG000|NOT COMPLETED|Overall Study||38
11415319|NCT01183429|12612540|FG000|STARTED|Overall Study||39
11415320|NCT01183429|12612540|FG000|COMPLETED|Overall Study||39
11415321|NCT01183429|12612540|FG000|NOT COMPLETED|Overall Study||0
11415322|NCT01166178|12612546|FG000|STARTED|Overall Study||21
11415323|NCT01166178|12612547|FG001|STARTED|Overall Study||8
11415324|NCT01166178|12612546|FG000|COMPLETED|Overall Study||0
11415325|NCT01166178|12612547|FG001|COMPLETED|Overall Study||0
11415326|NCT01166178|12612546|FG000|NOT COMPLETED|Overall Study||21
11415327|NCT01166178|12612547|FG001|NOT COMPLETED|Overall Study||8
11415328|NCT01176513|12612553|FG000|STARTED|Overall Study||25
11415329|NCT01176513|12612553|FG000|COMPLETED|Overall Study||22
11415330|NCT01176513|12612553|FG000|NOT COMPLETED|Overall Study||3
11415331|NCT01165450|12612557|FG000|STARTED|Overall Study||2
11415332|NCT01165450|12612557|FG000|COMPLETED|Overall Study||2
11415333|NCT01165450|12612557|FG000|NOT COMPLETED|Overall Study||0
11415334|NCT01179399|12612561|FG000|STARTED|Overall Study||32
11415335|NCT01179399|12612561|FG000|COMPLETED|Overall Study||0
11415336|NCT01179399|12612561|FG000|NOT COMPLETED|Overall Study||32
11415337|NCT01169753|12612567|FG000|STARTED|Overall Study||0
11415338|NCT01169753|12612568|FG001|STARTED|Overall Study||1
11415339|NCT01169753|12612567|FG000|COMPLETED|Overall Study||0
11415340|NCT01169753|12612568|FG001|COMPLETED|Overall Study||0
11415341|NCT01169753|12612567|FG000|NOT COMPLETED|Overall Study||0
11415342|NCT01169753|12612568|FG001|NOT COMPLETED|Overall Study||1
11415343|NCT01171534|12612576|FG000|STARTED|Overall Study|retrospective arm never performed on study|0
11415344|NCT01171534|12612577|FG001|STARTED|Overall Study||7
11415345|NCT01171534|12612576|FG000|COMPLETED|Overall Study||0
11415346|NCT01171534|12612577|FG001|COMPLETED|Overall Study||4
11415347|NCT01171534|12612576|FG000|NOT COMPLETED|Overall Study||0
11415348|NCT01171534|12612577|FG001|NOT COMPLETED|Overall Study||3
11415349|NCT01169610|12612583|FG000|STARTED|Overall Study||1
11415350|NCT01169610|12612583|FG000|COMPLETED|Overall Study||1
11415351|NCT01169610|12612583|FG000|NOT COMPLETED|Overall Study||0
11415352|NCT01163084|12612589|FG000|STARTED|Overall Study||4
11415353|NCT01163084|12612590|FG001|STARTED|Overall Study||5
11415354|NCT01163084|12612589|FG000|COMPLETED|Overall Study||4
11415355|NCT01163084|12612590|FG001|COMPLETED|Overall Study||5
11415356|NCT01163084|12612589|FG000|NOT COMPLETED|Overall Study||0
11415357|NCT01163084|12612590|FG001|NOT COMPLETED|Overall Study||0
11415358|NCT01166724|12612598|FG000|STARTED|Overall Study||7
11415359|NCT01166724|12612599|FG001|STARTED|Overall Study||5
11415360|NCT01166724|12612598|FG000|COMPLETED|Overall Study||0
11415361|NCT01166724|12612599|FG001|COMPLETED|Overall Study||0
11415362|NCT01166724|12612598|FG000|NOT COMPLETED|Overall Study||7
11415363|NCT01166724|12612599|FG001|NOT COMPLETED|Overall Study||5
11022499|NCT00809159|12200738|FG005|NOT COMPLETED|Part 1 and 2||3
11022500|NCT00809185|12200752|FG000|STARTED|Overall Study||7
11022501|NCT00809185|12200752|FG000|COMPLETED|Overall Study||7
11022502|NCT00809185|12200752|FG000|NOT COMPLETED|Overall Study||0
11022503|NCT00809276|12200757|FG000|STARTED|Overall Study||92
11022504|NCT00809276|12200757|FG000|COMPLETED|Overall Study||92
11022505|NCT00809276|12200757|FG000|NOT COMPLETED|Overall Study||0
11022506|NCT00809328|12200761|FG000|STARTED|Overall Study||102
11022507|NCT00809328|12200761|FG000|COMPLETED|Overall Study||73
11022508|NCT00809328|12200761|FG000|NOT COMPLETED|Overall Study||29
11022509|NCT00809354|12200775|FG000|STARTED|Overall Study||288
11022510|NCT00809354|12200776|FG001|STARTED|Overall Study||289
11415364|NCT01162382|12612605|FG000|STARTED|Overall Study||0
11415365|NCT01162382|12612605|FG000|COMPLETED|Overall Study||0
11415366|NCT01162382|12612605|FG000|NOT COMPLETED|Overall Study||0
11415367|NCT01157533|12612609|FG000|STARTED|Overall Study||1
11415368|NCT01157533|12612609|FG000|COMPLETED|Overall Study||1
11415369|NCT01157533|12612609|FG000|NOT COMPLETED|Overall Study||0
11415370|NCT01162304|12612613|FG000|STARTED|Overall Study||18
11415371|NCT01162304|12612613|FG000|COMPLETED|Overall Study||7
11415372|NCT01162304|12612613|FG000|NOT COMPLETED|Overall Study||11
11415373|NCT01151904|12612619|FG000|STARTED|Overall Study||17
11415374|NCT01151904|12612619|FG000|COMPLETED|Overall Study||17
11415375|NCT01151904|12612619|FG000|NOT COMPLETED|Overall Study||0
11415376|NCT01155518|12612629|FG000|STARTED|Overall Study||1
11415377|NCT01155518|12612630|FG001|STARTED|Overall Study||1
11415378|NCT01155518|12612631|FG002|STARTED|Overall Study||0
11415379|NCT01155518|12612632|FG003|STARTED|Overall Study||0
11415380|NCT01155518|12612633|FG004|STARTED|Overall Study||1
11415381|NCT01155518|12612634|FG005|STARTED|Overall Study||2
11415382|NCT01155518|12612629|FG000|COMPLETED|Overall Study||1
11415383|NCT01155518|12612630|FG001|COMPLETED|Overall Study|never started the study|0
11415384|NCT01155518|12612631|FG002|COMPLETED|Overall Study||0
11415385|NCT01155518|12612632|FG003|COMPLETED|Overall Study||0
11415386|NCT01155518|12612633|FG004|COMPLETED|Overall Study||1
11415387|NCT01155518|12612634|FG005|COMPLETED|Overall Study||2
11415388|NCT01155518|12612629|FG000|NOT COMPLETED|Overall Study||0
11415389|NCT01155518|12612630|FG001|NOT COMPLETED|Overall Study||1
11415390|NCT01155518|12612631|FG002|NOT COMPLETED|Overall Study||0
11415391|NCT01155518|12612632|FG003|NOT COMPLETED|Overall Study||0
11415392|NCT01155518|12612633|FG004|NOT COMPLETED|Overall Study||0
11415393|NCT01155518|12612634|FG005|NOT COMPLETED|Overall Study||0
11415394|NCT01150409|12612650|FG000|STARTED|Overall Study||11
11415395|NCT01150409|12612651|FG001|STARTED|Overall Study||0
11415396|NCT01150409|12612650|FG000|COMPLETED|Overall Study||11
11415397|NCT01150409|12612651|FG001|COMPLETED|Overall Study||0
11415398|NCT01150409|12612650|FG000|NOT COMPLETED|Overall Study||0
11415399|NCT01150409|12612651|FG001|NOT COMPLETED|Overall Study||0
11415400|NCT01151553|12612657|FG000|STARTED|Overall Study||5
11415401|NCT01151553|12612657|FG000|COMPLETED|Overall Study||5
11415402|NCT01151553|12612657|FG000|NOT COMPLETED|Overall Study||0
11415403|NCT01148056|12612661|FG000|STARTED|Overall Study||2
11415404|NCT01148056|12612661|FG000|COMPLETED|Overall Study||2
11415405|NCT01148056|12612661|FG000|NOT COMPLETED|Overall Study||0
11415406|NCT01147393|12612665|FG000|STARTED|Dose Level 1||3
11415407|NCT01147393|12612665|FG000|COMPLETED|Dose Level 1||1
11415408|NCT01147393|12612665|FG000|NOT COMPLETED|Dose Level 1||2
11415409|NCT01147393|12612665|FG000|STARTED|Dose Level -1||1
11415410|NCT01147393|12612665|FG000|COMPLETED|Dose Level -1||0
11415411|NCT01147393|12612665|FG000|NOT COMPLETED|Dose Level -1||1
11415412|NCT01147042|12612672|FG000|STARTED|Overall Study||2
11415413|NCT01147042|12612673|FG001|STARTED|Overall Study||0
11415414|NCT01147042|12612672|FG000|COMPLETED|Overall Study||2
11415415|NCT01147042|12612673|FG001|COMPLETED|Overall Study||0
11022511|NCT00809354|12200777|FG002|STARTED|Overall Study||286
11022512|NCT00809354|12200778|FG003|STARTED|Overall Study||288
11415416|NCT01147042|12612672|FG000|NOT COMPLETED|Overall Study||0
11415417|NCT01147042|12612673|FG001|NOT COMPLETED|Overall Study||0
11415418|NCT01147536|12612678|FG000|STARTED|Overall Study||12
11415419|NCT01147536|12612678|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
11415420|NCT01147536|12612678|FG000|COMPLETED|Overall Study||9
11415421|NCT01147536|12612678|FG000|NOT COMPLETED|Overall Study||3
11415422|NCT01139996|12612684|FG000|STARTED|Overall Study||11
11415423|NCT01139996|12612685|FG001|STARTED|Overall Study||11
11415424|NCT01139996|12612684|FG000|COMPLETED|Overall Study||11
11415425|NCT01139996|12612685|FG001|COMPLETED|Overall Study||11
11415426|NCT01139996|12612684|FG000|NOT COMPLETED|Overall Study||0
11415427|NCT01139996|12612685|FG001|NOT COMPLETED|Overall Study||0
11415428|NCT01133288|12612691|FG000|STARTED|Eligibility Assessment||7
11415429|NCT01133288|12612691|FG000|COMPLETED|Eligibility Assessment||2
11415430|NCT01133288|12612691|FG000|NOT COMPLETED|Eligibility Assessment||5
11415431|NCT01133288|12612691|FG000|STARTED|Intervention Allocation||2
11415432|NCT01133288|12612691|FG000|COMPLETED|Intervention Allocation||0
11415433|NCT01133288|12612691|FG000|NOT COMPLETED|Intervention Allocation||2
11415434|NCT01142128|12612699|FG000|STARTED|Overall Study||8
11415435|NCT01142128|12612699|FG000|Nexium Alone|Overall Study||3
11415436|NCT01142128|12612699|FG000|Placebo to Nexium, Alone|Overall Study||3
11415437|NCT01142128|12612699|FG000|Viokase 16 Plus Nexium|Overall Study||2
11415438|NCT01142128|12612699|FG000|Viokase 16 Plus Placebo to Nexium|Overall Study||0
11415439|NCT01142128|12612699|FG000|COMPLETED|Overall Study||4
11415440|NCT01142128|12612699|FG000|NOT COMPLETED|Overall Study||4
11415441|NCT01131884|12612711|FG000|STARTED|Overall Study||1
11415442|NCT01131884|12612712|FG001|STARTED|Overall Study||0
11415443|NCT01131884|12612711|FG000|COMPLETED|Overall Study||1
11415444|NCT01131884|12612712|FG001|COMPLETED|Overall Study||0
11415445|NCT01131884|12612711|FG000|NOT COMPLETED|Overall Study||0
11415446|NCT01131884|12612712|FG001|NOT COMPLETED|Overall Study||0
11415447|NCT01128114|12612718|FG000|STARTED|Overall Study||32
11415448|NCT01128114|12612718|FG000|COMPLETED|Overall Study||24
11415449|NCT01128114|12612718|FG000|NOT COMPLETED|Overall Study||8
11415450|NCT01126879|12612724|FG000|STARTED|Overall Study||8
11415451|NCT01126879|12612725|FG001|STARTED|Overall Study||4
11415452|NCT01126879|12612724|FG000|Started 3 Months of Genistein/Placebo|Overall Study||8
11415453|NCT01126879|12612725|FG001|Started 3 Months of Genistein/Placebo|Overall Study||4
11415454|NCT01126879|12612724|FG000|Prostatectomy or Radiation|Overall Study||8
11415455|NCT01126879|12612725|FG001|Prostatectomy or Radiation|Overall Study||4
11415456|NCT01126879|12612724|FG000|Completed 3 Months Genistein/Placebo|Overall Study||4
11415457|NCT01126879|12612725|FG001|Completed 3 Months Genistein/Placebo|Overall Study||2
11415458|NCT01126879|12612724|FG000|COMPLETED|Overall Study||3
11415459|NCT01126879|12612725|FG001|COMPLETED|Overall Study||2
11415460|NCT01126879|12612724|FG000|NOT COMPLETED|Overall Study||5
11415461|NCT01126879|12612725|FG001|NOT COMPLETED|Overall Study||2
11415462|NCT01136811|12612731|FG000|STARTED|Overall Study||11
11415463|NCT01136811|12612731|FG000|COMPLETED|Overall Study||0
11415464|NCT01136811|12612731|FG000|NOT COMPLETED|Overall Study||11
11415465|NCT01139294|12612737|FG000|STARTED|Overall Study||0
11415466|NCT01139294|12612738|FG001|STARTED|Overall Study||0
11415467|NCT01139294|12612737|FG000|COMPLETED|Overall Study||0
11415468|NCT01139294|12612738|FG001|COMPLETED|Overall Study||0
11415469|NCT01139294|12612737|FG000|NOT COMPLETED|Overall Study||0
11415470|NCT01139294|12612738|FG001|NOT COMPLETED|Overall Study||0
11415471|NCT01139125|12612744|FG000|STARTED|Overall Study||3
11415472|NCT01139125|12612744|FG000|COMPLETED|Overall Study||2
11415473|NCT01139125|12612744|FG000|NOT COMPLETED|Overall Study||1
11415474|NCT01136668|12612750|FG000|STARTED|Overall Study||7
11415475|NCT01136668|12612751|FG001|STARTED|Overall Study||6
11415476|NCT01136668|12612750|FG000|COMPLETED|Overall Study||7
11415477|NCT01136668|12612751|FG001|COMPLETED|Overall Study||6
11415478|NCT01136668|12612750|FG000|NOT COMPLETED|Overall Study||0
11415479|NCT01136668|12612751|FG001|NOT COMPLETED|Overall Study||0
11415480|NCT01133639|12612759|FG000|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
11415481|NCT01133639|12612760|FG001|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
11415482|NCT01133639|12612759|FG000|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
11415483|NCT01133639|12612760|FG001|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0
11415484|NCT01133639|12612759|FG000|NOT COMPLETED|Overall Study||0
11415485|NCT01133639|12612760|FG001|NOT COMPLETED|Overall Study||0
11415486|NCT01131455|12612768|FG000|STARTED|Overall Study||6
11415487|NCT01131455|12612769|FG001|STARTED|Overall Study||4
11415488|NCT01131455|12612770|FG002|STARTED|Overall Study||0
11415489|NCT01131455|12612768|FG000|COMPLETED|Overall Study||0
11415490|NCT01131455|12612769|FG001|COMPLETED|Overall Study||0
11415491|NCT01131455|12612770|FG002|COMPLETED|Overall Study||0
11415492|NCT01131455|12612768|FG000|NOT COMPLETED|Overall Study||6
11415493|NCT01131455|12612769|FG001|NOT COMPLETED|Overall Study||4
11415494|NCT01131455|12612770|FG002|NOT COMPLETED|Overall Study||0
11415495|NCT01126801|12612780|FG000|STARTED|Overall Study||1
11415496|NCT01126801|12612781|FG001|STARTED|Overall Study||1
11415497|NCT01126801|12612780|FG000|COMPLETED|Overall Study||1
11415498|NCT01126801|12612781|FG001|COMPLETED|Overall Study||1
11415499|NCT01126801|12612780|FG000|NOT COMPLETED|Overall Study||0
11415500|NCT01126801|12612781|FG001|NOT COMPLETED|Overall Study||0
11415501|NCT01123850|12612787|FG000|STARTED|Overall Study||45
11415502|NCT01123850|12612787|FG000|COMPLETED|Overall Study||0
11415503|NCT01123850|12612787|FG000|NOT COMPLETED|Overall Study||45
11415504|NCT01126957|12612791|FG000|STARTED|Overall Study||103
11415505|NCT01126957|12612791|FG000|COMPLETED|Overall Study||103
11415506|NCT01126957|12612791|FG000|NOT COMPLETED|Overall Study||0
11415507|NCT01127503|12612798|FG000|STARTED|Overall Study||1
11415508|NCT01127503|12612799|FG001|STARTED|Overall Study||1
11415509|NCT01127503|12612798|FG000|COMPLETED|Overall Study||1
11415510|NCT01127503|12612799|FG001|COMPLETED|Overall Study||1
11415511|NCT01127503|12612798|FG000|NOT COMPLETED|Overall Study||0
11415512|NCT01127503|12612799|FG001|NOT COMPLETED|Overall Study||0
11415513|NCT01122511|12612807|FG000|STARTED|Overall Study||2
11415514|NCT01122511|12612808|FG001|STARTED|Overall Study||2
11415515|NCT01122511|12612807|FG000|COMPLETED|Overall Study||0
11415516|NCT01122511|12612808|FG001|COMPLETED|Overall Study||0
11415517|NCT01122511|12612807|FG000|NOT COMPLETED|Overall Study||2
11415518|NCT01122511|12612808|FG001|NOT COMPLETED|Overall Study||2
11415519|NCT01118013|12612814|FG000|STARTED|Overall Study||6
11415520|NCT01118013|12612814|FG000|COMPLETED|Overall Study||6
11415521|NCT01118013|12612814|FG000|NOT COMPLETED|Overall Study||0
11415522|NCT01122381|12612820|FG000|STARTED|Overall Study||1
11415523|NCT01122381|12612821|FG001|STARTED|Overall Study||1
11415524|NCT01122381|12612820|FG000|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
11415525|NCT01122381|12612821|FG001|COMPLETED|Overall Study||0
11415526|NCT01122381|12612820|FG000|NOT COMPLETED|Overall Study||0
11415527|NCT01122381|12612821|FG001|NOT COMPLETED|Overall Study||1
11415528|NCT01116232|12612827|FG000|STARTED|Overall Study||4
11415529|NCT01116232|12612827|FG000|COMPLETED|Overall Study||0
11415530|NCT01116232|12612827|FG000|NOT COMPLETED|Overall Study||4
11415531|NCT01110174|12612834|FG000|STARTED|Overall Study||8
11415532|NCT01110174|12612834|FG000|COMPLETED|Overall Study||8
11415533|NCT01110174|12612834|FG000|NOT COMPLETED|Overall Study||0
11415534|NCT01115699|12612838|FG000|STARTED|Overall Study||2
11415535|NCT01115699|12612838|FG000|COMPLETED|Overall Study||2
11415536|NCT01115699|12612838|FG000|NOT COMPLETED|Overall Study||0
11415537|NCT01108666|12612842|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
11415538|NCT01108666|12612842|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
11415539|NCT01108666|12612842|FG000|NOT COMPLETED|Overall Study||0
11415540|NCT01115244|12612848|FG000|STARTED|Overall Study||0
11415541|NCT01115244|12612849|FG001|STARTED|Overall Study||0
11415542|NCT01115244|12612848|FG000|COMPLETED|Overall Study||0
11415543|NCT01115244|12612849|FG001|COMPLETED|Overall Study||0
11415544|NCT01115244|12612848|FG000|NOT COMPLETED|Overall Study||0
11415545|NCT01115244|12612849|FG001|NOT COMPLETED|Overall Study||0
11415546|NCT01108523|12612855|FG000|STARTED|Overall Study||7
11415547|NCT01108523|12612855|FG000|COMPLETED|Overall Study||3
11415548|NCT01108523|12612855|FG000|NOT COMPLETED|Overall Study||4
11415549|NCT01107795|12612859|FG000|STARTED|Overall Study||41
11415550|NCT01107795|12612859|FG000|COMPLETED|Overall Study||41
11415551|NCT01107795|12612859|FG000|NOT COMPLETED|Overall Study||0
11415552|NCT01106534|12612863|FG000|STARTED|Overall Study||2997
11415553|NCT01106534|12612863|FG000|COMPLETED|Overall Study||2960
11415554|NCT01106534|12612863|FG000|NOT COMPLETED|Overall Study||37
11415555|NCT01104116|12612868|FG000|STARTED|Overall Study||1
11415556|NCT01104116|12612868|FG000|COMPLETED|Overall Study||1
11415557|NCT01104116|12612868|FG000|NOT COMPLETED|Overall Study||0
11415558|NCT01100658|12612872|FG000|STARTED|Overall Study||1
11415559|NCT01100658|12612872|FG000|COMPLETED|Overall Study||0
11415560|NCT01100658|12612872|FG000|NOT COMPLETED|Overall Study||1
11415561|NCT01103180|12612878|FG000|STARTED|Overall Study||35
11415562|NCT01103180|12612879|FG001|STARTED|Overall Study||35
11415563|NCT01103180|12612878|FG000|COMPLETED|Overall Study||13
11415564|NCT01103180|12612879|FG001|COMPLETED|Overall Study||14
11415565|NCT01103180|12612878|FG000|NOT COMPLETED|Overall Study||22
11415566|NCT01103180|12612879|FG001|NOT COMPLETED|Overall Study||21
11415567|NCT01090141|12612887|FG000|STARTED|Overall Study||0
11415568|NCT01090141|12612888|FG001|STARTED|Overall Study||0
11415569|NCT01090141|12612887|FG000|COMPLETED|Overall Study||0
11415570|NCT01090141|12612888|FG001|COMPLETED|Overall Study||0
11415571|NCT01090141|12612887|FG000|NOT COMPLETED|Overall Study||0
11415572|NCT01090141|12612888|FG001|NOT COMPLETED|Overall Study||0
11415573|NCT01102140|12612896|FG000|STARTED|Overall Study||13
11415574|NCT01102140|12612897|FG001|STARTED|Overall Study||7
11415575|NCT01102140|12612896|FG000|COMPLETED|Overall Study||10
11415576|NCT01102140|12612897|FG001|COMPLETED|Overall Study||5
11415577|NCT01102140|12612896|FG000|NOT COMPLETED|Overall Study||3
11415578|NCT01102140|12612897|FG001|NOT COMPLETED|Overall Study||2
11415579|NCT01095250|12612909|FG000|STARTED|Overall Study||8
11415580|NCT01095250|12612910|FG001|STARTED|Overall Study||10
11415581|NCT01095250|12612911|FG002|STARTED|Overall Study||8
11415582|NCT01095250|12612912|FG003|STARTED|Overall Study||5
11415583|NCT01095250|12612909|FG000|COMPLETED|Overall Study||0
11415584|NCT01095250|12612910|FG001|COMPLETED|Overall Study||0
11415585|NCT01095250|12612911|FG002|COMPLETED|Overall Study||0
11415586|NCT01095250|12612912|FG003|COMPLETED|Overall Study||0
11415587|NCT01095250|12612909|FG000|NOT COMPLETED|Overall Study||8
11415588|NCT01095250|12612910|FG001|NOT COMPLETED|Overall Study||10
11415589|NCT01095250|12612911|FG002|NOT COMPLETED|Overall Study||8
11415590|NCT01095250|12612912|FG003|NOT COMPLETED|Overall Study||5
11415591|NCT01094561|12612922|FG000|STARTED|Overall Study||23
11415592|NCT01094561|12612922|FG000|COMPLETED|Overall Study||17
11415593|NCT01094561|12612922|FG000|NOT COMPLETED|Overall Study||6
11415594|NCT01093846|12612929|FG000|STARTED|Overall Study||19
11415595|NCT01093846|12612930|FG001|STARTED|Overall Study||18
11415596|NCT01093846|12612931|FG002|STARTED|Overall Study||22
11415597|NCT01093846|12612929|FG000|COMPLETED|Overall Study||0
11415598|NCT01093846|12612930|FG001|COMPLETED|Overall Study||0
11415599|NCT01093846|12612931|FG002|COMPLETED|Overall Study||1
11415600|NCT01093846|12612929|FG000|NOT COMPLETED|Overall Study||19
11415601|NCT01093846|12612930|FG001|NOT COMPLETED|Overall Study||18
11415602|NCT01093846|12612931|FG002|NOT COMPLETED|Overall Study||21
11415603|NCT01078844|12612937|FG000|STARTED|Overall Study||4
11415604|NCT01078844|12612937|FG000|COMPLETED|Overall Study||0
11415605|NCT01078844|12612937|FG000|NOT COMPLETED|Overall Study||4
11415606|NCT01081886|12612944|FG000|STARTED|Overall Study||11
11415607|NCT01081886|12612945|FG001|STARTED|Overall Study||13
11415608|NCT01081886|12612944|FG000|COMPLETED|Overall Study||0
11415609|NCT01081886|12612945|FG001|COMPLETED|Overall Study||0
11415610|NCT01081886|12612944|FG000|NOT COMPLETED|Overall Study||11
11415611|NCT01081886|12612945|FG001|NOT COMPLETED|Overall Study||13
11415612|NCT01085643|12612951|FG000|STARTED|Overall Study||4
11415613|NCT01085643|12612951|FG000|COMPLETED|Overall Study||4
11415614|NCT01085643|12612951|FG000|NOT COMPLETED|Overall Study||0
11415615|NCT01083472|12612957|FG000|STARTED|Overall Study||18
11415616|NCT01083472|12612958|FG001|STARTED|Overall Study||19
11415617|NCT01083472|12612957|FG000|COMPLETED|Overall Study||18
11415618|NCT01083472|12612958|FG001|COMPLETED|Overall Study||19
11415619|NCT01083472|12612957|FG000|NOT COMPLETED|Overall Study||0
11415620|NCT01083472|12612958|FG001|NOT COMPLETED|Overall Study||0
11415621|NCT01080768|12612966|FG000|STARTED|Overall Study||14
11415622|NCT01080768|12612967|FG001|STARTED|Overall Study||17
11415623|NCT01080768|12612966|FG000|COMPLETED|Overall Study||12
11415624|NCT01080768|12612967|FG001|COMPLETED|Overall Study||16
11415625|NCT01080768|12612966|FG000|NOT COMPLETED|Overall Study||2
11415626|NCT01080768|12612967|FG001|NOT COMPLETED|Overall Study||1
11415627|NCT01079598|12612973|FG000|STARTED|Overall Study||8
11415628|NCT01079598|12612973|FG000|COMPLETED|Overall Study||8
11415629|NCT01079598|12612973|FG000|NOT COMPLETED|Overall Study||0
11415630|NCT01074502|12612977|FG000|STARTED|Overall Study||3
11415631|NCT01074502|12612977|FG000|COMPLETED|Overall Study||2
11415632|NCT01074502|12612977|FG000|NOT COMPLETED|Overall Study||1
11415633|NCT01074437|12612983|FG000|STARTED|Overall Study||4
11415634|NCT01074437|12612984|FG001|STARTED|Overall Study||5
11415635|NCT01074437|12612983|FG000|COMPLETED|Overall Study||4
11415636|NCT01074437|12612984|FG001|COMPLETED|Overall Study||5
11415637|NCT01074437|12612983|FG000|NOT COMPLETED|Overall Study||0
11415638|NCT01074437|12612984|FG001|NOT COMPLETED|Overall Study||0
11415639|NCT01069861|12612990|FG000|STARTED|Overall Study||4
11415640|NCT01069861|12612990|FG000|COMPLETED|Overall Study||1
11415641|NCT01069861|12612990|FG000|NOT COMPLETED|Overall Study||3
11415642|NCT01072526|12612994|FG000|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
11415643|NCT01072526|12612995|FG001|STARTED|Overall Study||0
11415644|NCT01072526|12612994|FG000|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
11415645|NCT01072526|12612995|FG001|COMPLETED|Overall Study||0
11415646|NCT01072526|12612994|FG000|NOT COMPLETED|Overall Study||0
11415647|NCT01072526|12612995|FG001|NOT COMPLETED|Overall Study||0
11415648|NCT01071993|12613005|FG000|STARTED|Overall Study||0
11415649|NCT01071993|12613006|FG001|STARTED|Overall Study||0
11415650|NCT01071993|12613005|FG000|COMPLETED|Overall Study||0
11415651|NCT01071993|12613006|FG001|COMPLETED|Overall Study||0
11415652|NCT01071993|12613005|FG000|NOT COMPLETED|Overall Study||0
11415653|NCT01071993|12613006|FG001|NOT COMPLETED|Overall Study||0
11415654|NCT01065051|12613014|FG000|STARTED|Overall Study||1
11415655|NCT01065051|12613015|FG001|STARTED|Overall Study||0
11415656|NCT01065051|12613014|FG000|COMPLETED|Overall Study||1
11415657|NCT01065051|12613015|FG001|COMPLETED|Overall Study||0
11415658|NCT01065051|12613014|FG000|NOT COMPLETED|Overall Study||0
11415659|NCT01065051|12613015|FG001|NOT COMPLETED|Overall Study||0
11415660|NCT01069120|12613023|FG000|STARTED|Overall Study||27
11415661|NCT01069120|12613023|FG000|COMPLETED|Overall Study||0
11415662|NCT01069120|12613023|FG000|NOT COMPLETED|Overall Study||27
11415663|NCT01066637|12613031|FG000|STARTED|Overall Study||16
11415664|NCT01066637|12613032|FG001|STARTED|Overall Study||10
11415665|NCT01066637|12613031|FG000|COMPLETED|Overall Study||16
11415666|NCT01066637|12613032|FG001|COMPLETED|Overall Study||10
11415667|NCT01066637|12613031|FG000|NOT COMPLETED|Overall Study||0
11415668|NCT01066637|12613032|FG001|NOT COMPLETED|Overall Study||0
11415669|NCT01058642|12613042|FG000|STARTED|Treatment Period 1||9
11415670|NCT01058642|12613043|FG001|STARTED|Treatment Period 1||12
11415671|NCT01058642|12613044|FG002|STARTED|Treatment Period 1||11
11415672|NCT01058642|12613045|FG003|STARTED|Treatment Period 1||9
11415673|NCT01058642|12613042|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
11415674|NCT01058642|12613043|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
11415675|NCT01058642|12613044|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
11415676|NCT01058642|12613045|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
11415677|NCT01058642|12613042|FG000|COMPLETED|Treatment Period 1||7
11415678|NCT01058642|12613043|FG001|COMPLETED|Treatment Period 1||11
11415679|NCT01058642|12613044|FG002|COMPLETED|Treatment Period 1||9
11415680|NCT01058642|12613045|FG003|COMPLETED|Treatment Period 1||7
11415681|NCT01058642|12613042|FG000|NOT COMPLETED|Treatment Period 1||2
11415682|NCT01058642|12613043|FG001|NOT COMPLETED|Treatment Period 1||1
11415683|NCT01058642|12613044|FG002|NOT COMPLETED|Treatment Period 1||2
11415684|NCT01058642|12613045|FG003|NOT COMPLETED|Treatment Period 1||2
11415685|NCT01058642|12613042|FG000|STARTED|Washout Period||7
11415686|NCT01058642|12613043|FG001|STARTED|Washout Period||11
11415687|NCT01058642|12613044|FG002|STARTED|Washout Period||9
11415688|NCT01058642|12613045|FG003|STARTED|Washout Period||7
11415689|NCT01058642|12613042|FG000|COMPLETED|Washout Period||7
11415690|NCT01058642|12613043|FG001|COMPLETED|Washout Period||11
11415691|NCT01058642|12613044|FG002|COMPLETED|Washout Period||9
11415692|NCT01058642|12613045|FG003|COMPLETED|Washout Period||7
11415693|NCT01058642|12613042|FG000|NOT COMPLETED|Washout Period||0
11415694|NCT01058642|12613043|FG001|NOT COMPLETED|Washout Period||0
11415695|NCT01058642|12613044|FG002|NOT COMPLETED|Washout Period||0
11415696|NCT01058642|12613045|FG003|NOT COMPLETED|Washout Period||0
11415697|NCT01058642|12613042|FG000|STARTED|Treatment Period 2||7
11415698|NCT01058642|12613043|FG001|STARTED|Treatment Period 2||11
11415699|NCT01058642|12613044|FG002|STARTED|Treatment Period 2||9
11415700|NCT01058642|12613045|FG003|STARTED|Treatment Period 2||7
11415701|NCT01058642|12613042|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
11415702|NCT01058642|12613043|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
11415703|NCT01058642|12613044|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
11415704|NCT01058642|12613045|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
11415705|NCT01058642|12613042|FG000|COMPLETED|Treatment Period 2||7
11415706|NCT01058642|12613043|FG001|COMPLETED|Treatment Period 2||11
11415707|NCT01058642|12613044|FG002|COMPLETED|Treatment Period 2||9
11415708|NCT01058642|12613045|FG003|COMPLETED|Treatment Period 2||7
11415709|NCT01058642|12613042|FG000|NOT COMPLETED|Treatment Period 2||0
11415710|NCT01058642|12613043|FG001|NOT COMPLETED|Treatment Period 2||0
11415711|NCT01058642|12613044|FG002|NOT COMPLETED|Treatment Period 2||0
11415712|NCT01058642|12613045|FG003|NOT COMPLETED|Treatment Period 2||0
11415713|NCT01065818|12613053|FG000|STARTED|Overall Study||6
11415714|NCT01065818|12613053|FG000|COMPLETED|Overall Study||4
11415715|NCT01065818|12613053|FG000|NOT COMPLETED|Overall Study||2
11415716|NCT01051921|12613057|FG000|STARTED|Overall Study||67
11415717|NCT01051921|12613057|FG000|COMPLETED|Overall Study||37
11415718|NCT01051921|12613057|FG000|NOT COMPLETED|Overall Study||30
11415719|NCT01048125|12613063|FG000|STARTED|Overall Study||0
11415720|NCT01048125|12613064|FG001|STARTED|Overall Study||0
11415721|NCT01048125|12613063|FG000|COMPLETED|Overall Study||0
11415722|NCT01048125|12613064|FG001|COMPLETED|Overall Study||0
11415723|NCT01048125|12613063|FG000|NOT COMPLETED|Overall Study||0
11415724|NCT01048125|12613064|FG001|NOT COMPLETED|Overall Study||0
11415725|NCT01056315|12613072|FG000|STARTED|Overall Study||27
11415726|NCT01056315|12613073|FG001|STARTED|Overall Study||23
11415727|NCT01056315|12613072|FG000|COMPLETED|Overall Study||13
11415728|NCT01056315|12613073|FG001|COMPLETED|Overall Study||12
11415729|NCT01056315|12613072|FG000|NOT COMPLETED|Overall Study||14
11415730|NCT01056315|12613073|FG001|NOT COMPLETED|Overall Study||11
11415731|NCT01058369|12613079|FG000|STARTED|Overall Study||2
11415732|NCT01058369|12613079|FG000|COMPLETED|Overall Study||0
11415733|NCT01058369|12613079|FG000|NOT COMPLETED|Overall Study||2
11415734|NCT01048723|12613083|FG000|STARTED|Overall Study||2
11415735|NCT01048723|12613083|FG000|COMPLETED|Overall Study||2
11415736|NCT01048723|12613083|FG000|NOT COMPLETED|Overall Study||0
11415737|NCT01053221|12613089|FG000|STARTED|Overall Study||5
11415738|NCT01053221|12613090|FG001|STARTED|Overall Study||9
11415739|NCT01053221|12613089|FG000|COMPLETED|Overall Study||0
11415740|NCT01053221|12613090|FG001|COMPLETED|Overall Study||0
11415741|NCT01053221|12613089|FG000|NOT COMPLETED|Overall Study||5
11415742|NCT01053221|12613090|FG001|NOT COMPLETED|Overall Study||9
11415743|NCT01038752|12613098|FG000|STARTED|Overall Study||8
11415744|NCT01038752|12613099|FG001|STARTED|Overall Study||6
11415745|NCT01038752|12613098|FG000|COMPLETED|Overall Study||3
11415746|NCT01038752|12613099|FG001|COMPLETED|Overall Study||1
11415747|NCT01038752|12613098|FG000|NOT COMPLETED|Overall Study||5
11415748|NCT01038752|12613099|FG001|NOT COMPLETED|Overall Study||5
11415749|NCT01050218|12613105|FG000|STARTED|Overall Study||237
11415750|NCT01050218|12613105|FG000|COMPLETED|Overall Study||142
11415751|NCT01050218|12613105|FG000|NOT COMPLETED|Overall Study||95
11415752|NCT01045694|12613109|FG000|STARTED|Overall Study||8
11415753|NCT01045694|12613109|FG000|COMPLETED|Overall Study||6
11415754|NCT01045694|12613109|FG000|NOT COMPLETED|Overall Study||2
11415755|NCT01035944|12613117|FG000|STARTED|Overall Study||14
11415756|NCT01035944|12613118|FG001|STARTED|Overall Study||14
11415757|NCT01035944|12613119|FG002|STARTED|Overall Study||5
11415758|NCT01035944|12613120|FG003|STARTED|Overall Study||4
11415759|NCT01035944|12613117|FG000|COMPLETED|Overall Study||11
11415760|NCT01035944|12613118|FG001|COMPLETED|Overall Study||13
11415761|NCT01035944|12613119|FG002|COMPLETED|Overall Study||4
11415762|NCT01035944|12613120|FG003|COMPLETED|Overall Study||4
11415763|NCT01035944|12613117|FG000|NOT COMPLETED|Overall Study||3
11415764|NCT01035944|12613118|FG001|NOT COMPLETED|Overall Study||1
11415765|NCT01035944|12613119|FG002|NOT COMPLETED|Overall Study||1
11415766|NCT01035944|12613120|FG003|NOT COMPLETED|Overall Study||0
11415767|NCT01031628|12613134|FG000|STARTED|Overall Study||0
11415768|NCT01031628|12613135|FG001|STARTED|Overall Study||1
11415769|NCT01031628|12613136|FG002|STARTED|Overall Study||3
11415770|NCT01031628|12613137|FG003|STARTED|Overall Study||0
11415771|NCT01031628|12613134|FG000|COMPLETED|Overall Study||0
11415772|NCT01031628|12613135|FG001|COMPLETED|Overall Study||0
11415773|NCT01031628|12613136|FG002|COMPLETED|Overall Study||0
11415774|NCT01031628|12613137|FG003|COMPLETED|Overall Study||0
11415775|NCT01031628|12613134|FG000|NOT COMPLETED|Overall Study||0
11415776|NCT01031628|12613135|FG001|NOT COMPLETED|Overall Study||1
11415777|NCT01031628|12613136|FG002|NOT COMPLETED|Overall Study||3
11415778|NCT01031628|12613137|FG003|NOT COMPLETED|Overall Study||0
11415779|NCT01030757|12613147|FG000|STARTED|Overall Study||2
11415780|NCT01030757|12613147|FG000|COMPLETED|Overall Study||2
11415781|NCT01030757|12613147|FG000|NOT COMPLETED|Overall Study||0
11415782|NCT01035073|12613151|FG000|STARTED|Overall Study||0
11415783|NCT01035073|12613151|FG000|COMPLETED|Overall Study||0
11415784|NCT01035073|12613151|FG000|NOT COMPLETED|Overall Study||0
11415785|NCT01031550|12613157|FG000|STARTED|Overall Study||5
11415786|NCT01031550|12613158|FG001|STARTED|Overall Study||3
11415787|NCT01031550|12613157|FG000|COMPLETED|Overall Study||5
11415788|NCT01031550|12613158|FG001|COMPLETED|Overall Study||3
11415789|NCT01031550|12613157|FG000|NOT COMPLETED|Overall Study||0
11415790|NCT01031550|12613158|FG001|NOT COMPLETED|Overall Study||0
11415791|NCT01030198|12613168|FG000|STARTED|Overall Study|None recruited|0
11415792|NCT01030198|12613169|FG001|STARTED|Overall Study||7
11415793|NCT01030198|12613168|FG000|COMPLETED|Overall Study|None recruited|0
11415794|NCT01030198|12613169|FG001|COMPLETED|Overall Study|Study terminated due to poor results and lack of enrollment|0
11415795|NCT01030198|12613168|FG000|NOT COMPLETED|Overall Study||0
11415796|NCT01030198|12613169|FG001|NOT COMPLETED|Overall Study||7
11415797|NCT01028300|12613175|FG000|STARTED|Overall Study||4
11415798|NCT01028300|12613175|FG000|COMPLETED|Overall Study||0
11415799|NCT01028300|12613175|FG000|NOT COMPLETED|Overall Study||4
11415800|NCT01025271|12613179|FG000|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
11415801|NCT01025271|12613179|FG000|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
11415802|NCT01025271|12613179|FG000|NOT COMPLETED|Overall Study||0
11415803|NCT01022398|12613186|FG000|STARTED|Overall Study||2
11415804|NCT01022398|12613187|FG001|STARTED|Overall Study||2
11415805|NCT01022398|12613186|FG000|COMPLETED|Overall Study||0
11415806|NCT01022398|12613187|FG001|COMPLETED|Overall Study||0
11415807|NCT01022398|12613186|FG000|NOT COMPLETED|Overall Study||2
11415808|NCT01022398|12613187|FG001|NOT COMPLETED|Overall Study||2
11415809|NCT01019980|12613194|FG000|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
11415810|NCT01019980|12613195|FG001|STARTED|Overall Study||0
11415811|NCT01019980|12613194|FG000|Discontinued|Overall Study||2
11415812|NCT01019980|12613195|FG001|Discontinued|Overall Study||0
11415813|NCT01019980|12613194|FG000|COMPLETED|Overall Study||0
11415814|NCT01019980|12613195|FG001|COMPLETED|Overall Study||0
11415815|NCT01019980|12613194|FG000|NOT COMPLETED|Overall Study||2
11415816|NCT01019980|12613195|FG001|NOT COMPLETED|Overall Study||0
11415817|NCT01025492|12613201|FG000|STARTED|Overall Study||24
11415818|NCT01025492|12613201|FG000|COMPLETED|Overall Study||24
11415819|NCT01025492|12613201|FG000|NOT COMPLETED|Overall Study||0
11415820|NCT01017263|12613205|FG000|STARTED|Overall Study||14
11415821|NCT01017263|12613205|FG000|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
11415822|NCT01017263|12613205|FG000|NOT COMPLETED|Overall Study||12
11415823|NCT01020903|12613211|FG000|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
11415824|NCT01020903|12613212|FG001|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
11415825|NCT01020903|12613211|FG000|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
11415826|NCT01020903|12613212|FG001|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
11415827|NCT01020903|12613211|FG000|NOT COMPLETED|Overall Study||0
11415828|NCT01020903|12613212|FG001|NOT COMPLETED|Overall Study||0
11415829|NCT01023620|12613220|FG000|STARTED|Overall Study||0
11415830|NCT01023620|12613221|FG001|STARTED|Overall Study||0
11415831|NCT01023620|12613220|FG000|COMPLETED|Overall Study||0
11415832|NCT01023620|12613221|FG001|COMPLETED|Overall Study||0
11415833|NCT01023620|12613220|FG000|NOT COMPLETED|Overall Study||0
11415834|NCT01023620|12613221|FG001|NOT COMPLETED|Overall Study||0
11415835|NCT01018810|12613232|FG000|STARTED|Overall Study||4
11415836|NCT01018810|12613233|FG001|STARTED|Overall Study||1
11415837|NCT01018810|12613234|FG002|STARTED|Overall Study||1
11415838|NCT01018810|12613235|FG003|STARTED|Overall Study||1
11415839|NCT01018810|12613236|FG004|STARTED|Overall Study||1
11415840|NCT01018810|12613232|FG000|COMPLETED|Overall Study||2
11415841|NCT01018810|12613233|FG001|COMPLETED|Overall Study||0
11415842|NCT01018810|12613234|FG002|COMPLETED|Overall Study||0
11415843|NCT01018810|12613235|FG003|COMPLETED|Overall Study||0
11415844|NCT01018810|12613236|FG004|COMPLETED|Overall Study||0
11415845|NCT01018810|12613232|FG000|NOT COMPLETED|Overall Study||2
11415846|NCT01018810|12613233|FG001|NOT COMPLETED|Overall Study||1
11415847|NCT01018810|12613234|FG002|NOT COMPLETED|Overall Study||1
11415848|NCT01018810|12613235|FG003|NOT COMPLETED|Overall Study||1
11415849|NCT01018810|12613236|FG004|NOT COMPLETED|Overall Study||1
11415850|NCT01016561|12613248|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
11415851|NCT01016561|12613248|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
11415852|NCT01016561|12613248|FG000|NOT COMPLETED|Overall Study||0
11415853|NCT01016847|12613254|FG000|STARTED|Overall Study||1
11415854|NCT01016847|12613255|FG001|STARTED|Overall Study||2
11415855|NCT01016847|12613254|FG000|COMPLETED|Overall Study||1
11415856|NCT01016847|12613255|FG001|COMPLETED|Overall Study||2
11415857|NCT01016847|12613254|FG000|NOT COMPLETED|Overall Study||0
11415858|NCT01016847|12613255|FG001|NOT COMPLETED|Overall Study||0
11415859|NCT01014767|12613265|FG000|STARTED|Overall Study||12
11415860|NCT01014767|12613266|FG001|STARTED|Overall Study||1
11415861|NCT01014767|12613267|FG002|STARTED|Overall Study||4
11415862|NCT01014767|12613268|FG003|STARTED|Overall Study||1
11415863|NCT01014767|12613265|FG000|COMPLETED|Overall Study||0
11415864|NCT01014767|12613266|FG001|COMPLETED|Overall Study||0
11415865|NCT01014767|12613267|FG002|COMPLETED|Overall Study||0
11415866|NCT01014767|12613268|FG003|COMPLETED|Overall Study||0
11415867|NCT01014767|12613265|FG000|NOT COMPLETED|Overall Study||12
11415868|NCT01014767|12613266|FG001|NOT COMPLETED|Overall Study||1
11415869|NCT01014767|12613267|FG002|NOT COMPLETED|Overall Study||4
11415870|NCT01014767|12613268|FG003|NOT COMPLETED|Overall Study||1
11415871|NCT01013701|12613278|FG000|STARTED|Overall Study||7
11415872|NCT01013701|12613278|FG000|COMPLETED|Overall Study||0
11415873|NCT01013701|12613278|FG000|NOT COMPLETED|Overall Study||7
11415874|NCT01012414|12613283|FG000|STARTED|Overall Study||10
11415875|NCT01012414|12613283|FG000|COMPLETED|Overall Study|No subjects completed the study.|0
11415876|NCT01012414|12613283|FG000|NOT COMPLETED|Overall Study||10
11415877|NCT01011634|12613291|FG000|STARTED|Overall Study||9
11415878|NCT01011634|12613292|FG001|STARTED|Overall Study||9
11415879|NCT01011634|12613291|FG000|COMPLETED|Overall Study||9
11415880|NCT01011634|12613292|FG001|COMPLETED|Overall Study||8
11415881|NCT01011634|12613291|FG000|NOT COMPLETED|Overall Study||0
11415882|NCT01011634|12613292|FG001|NOT COMPLETED|Overall Study||1
11415883|NCT01009931|12613298|FG000|STARTED|Overall Study||1
11415884|NCT01009931|12613298|FG000|COMPLETED|Overall Study||0
11415885|NCT01009931|12613298|FG000|NOT COMPLETED|Overall Study||1
11415886|NCT01001390|12613302|FG000|STARTED|Overall Study||2
11415887|NCT01001390|12613303|FG001|STARTED|Overall Study||0
11415888|NCT01001390|12613302|FG000|COMPLETED|Overall Study||0
11415889|NCT01001390|12613303|FG001|COMPLETED|Overall Study||0
11415890|NCT01001390|12613302|FG000|NOT COMPLETED|Overall Study||2
11415891|NCT01001390|12613303|FG001|NOT COMPLETED|Overall Study||0
11415892|NCT01006018|12613311|FG000|STARTED|Overall Study||0
11415893|NCT01006018|12613312|FG001|STARTED|Overall Study||0
11415894|NCT01006018|12613313|FG002|STARTED|Overall Study||0
11415895|NCT01006018|12613311|FG000|COMPLETED|Overall Study||0
11415896|NCT01006018|12613312|FG001|COMPLETED|Overall Study||0
11415897|NCT01006018|12613313|FG002|COMPLETED|Overall Study||0
11415898|NCT01006018|12613311|FG000|NOT COMPLETED|Overall Study||0
11415899|NCT01006018|12613312|FG001|NOT COMPLETED|Overall Study||0
11415900|NCT01006018|12613313|FG002|NOT COMPLETED|Overall Study||0
11415901|NCT01004510|12613321|FG000|STARTED|Overall Study||3
11415902|NCT01004510|12613321|FG000|COMPLETED|Overall Study||2
11415903|NCT01004510|12613321|FG000|NOT COMPLETED|Overall Study||1
11415904|NCT01005914|12613325|FG000|STARTED|Overall Study||11
11415905|NCT01005914|12613325|FG000|COMPLETED|Overall Study||1
11415906|NCT01005914|12613325|FG000|NOT COMPLETED|Overall Study||10
11415907|NCT00996333|12613329|FG000|STARTED|Overall Study||46
11415908|NCT00996333|12613329|FG000|COMPLETED|Overall Study||33
11415909|NCT00996333|12613329|FG000|NOT COMPLETED|Overall Study||13
11415910|NCT00998738|12613333|FG000|STARTED|Overall Study||1
11415911|NCT00998738|12613333|FG000|COMPLETED|Overall Study||0
11415912|NCT00998738|12613333|FG000|NOT COMPLETED|Overall Study||1
11415913|NCT00996502|12613337|FG000|STARTED|Overall Study||4
11415914|NCT00996502|12613337|FG000|COMPLETED|Overall Study||4
11415915|NCT00996502|12613337|FG000|NOT COMPLETED|Overall Study||0
11415916|NCT00997386|12613341|FG000|STARTED|Overall Study||16
11415917|NCT00997386|12613341|FG000|COMPLETED|Overall Study||9
11415918|NCT00997386|12613341|FG000|NOT COMPLETED|Overall Study||7
11415919|NCT00985738|12613347|FG000|STARTED|Overall Study||8
11415920|NCT00985738|12613348|FG001|STARTED|Overall Study||8
11415921|NCT00985738|12613347|FG000|COMPLETED|Overall Study||0
11415922|NCT00985738|12613348|FG001|COMPLETED|Overall Study||0
11415923|NCT00985738|12613347|FG000|NOT COMPLETED|Overall Study||8
11415924|NCT00985738|12613348|FG001|NOT COMPLETED|Overall Study||8
11415925|NCT00986999|12613354|FG000|STARTED|Overall Study||7
11415926|NCT00986999|12613354|FG000|COMPLETED|Overall Study||6
11415927|NCT00986999|12613354|FG000|NOT COMPLETED|Overall Study||1
11415928|NCT00989937|12613358|FG000|STARTED|Overall Study||0
11415929|NCT00989937|12613358|FG000|COMPLETED|Overall Study||0
11415930|NCT00989937|12613358|FG000|NOT COMPLETED|Overall Study||0
11415931|NCT00986947|12613362|FG000|STARTED|Overall Study||20
11415932|NCT00986947|12613362|FG000|COMPLETED|Overall Study||0
11415933|NCT00986947|12613362|FG000|NOT COMPLETED|Overall Study||20
11415934|NCT00982995|12613366|FG000|STARTED|Overall Study||3
11415935|NCT00982995|12613366|FG000|COMPLETED|Overall Study||3
11415936|NCT00982995|12613366|FG000|NOT COMPLETED|Overall Study||0
11415937|NCT00984490|12613370|FG000|STARTED|Overall Study||5
11415938|NCT00984490|12613370|FG000|COMPLETED|Overall Study||5
11415939|NCT00984490|12613370|FG000|NOT COMPLETED|Overall Study||0
11415940|NCT00986310|12613377|FG000|STARTED|Overall Study||0
11415941|NCT00986310|12613378|FG001|STARTED|Overall Study||0
11415942|NCT00986310|12613377|FG000|COMPLETED|Overall Study||0
11415943|NCT00986310|12613378|FG001|COMPLETED|Overall Study||0
11415944|NCT00986310|12613377|FG000|NOT COMPLETED|Overall Study||0
11415945|NCT00986310|12613378|FG001|NOT COMPLETED|Overall Study||0
11415946|NCT00978874|12613384|FG000|STARTED|Overall Study|The study was terminated and no data are available to be reported|0
11415947|NCT00978874|12613384|FG000|COMPLETED|Overall Study|The study was terminated and no data are available to be reported|0
11415948|NCT00978874|12613384|FG000|NOT COMPLETED|Overall Study||0
11415949|NCT00983645|12613390|FG000|STARTED|Overall Study||8
11415950|NCT00983645|12613391|FG001|STARTED|Overall Study||7
11144153|NCT01475851|12330801|FG001|COMPLETED|Overall Study||21
11144154|NCT01475851|12330800|FG000|NOT COMPLETED|Overall Study||1
11144155|NCT01475851|12330801|FG001|NOT COMPLETED|Overall Study||0
11144156|NCT01475955|12330812|FG000|STARTED|Overall Study||48
11144157|NCT01475955|12330813|FG001|STARTED|Overall Study||48
11144158|NCT01475955|12330814|FG002|STARTED|Overall Study||47
11144159|NCT01475955|12330815|FG003|STARTED|Overall Study||46
11144160|NCT01475955|12330816|FG004|STARTED|Overall Study||46
11144161|NCT01475955|12330812|FG000|COMPLETED|Overall Study||47
11144162|NCT01475955|12330813|FG001|COMPLETED|Overall Study||48
11144163|NCT01475955|12330814|FG002|COMPLETED|Overall Study||44
11144164|NCT01475955|12330815|FG003|COMPLETED|Overall Study||46
11415951|NCT00983645|12613390|FG000|COMPLETED|Overall Study||8
11415952|NCT00983645|12613391|FG001|COMPLETED|Overall Study||7
11415953|NCT00983645|12613390|FG000|NOT COMPLETED|Overall Study||0
11415954|NCT00983645|12613391|FG001|NOT COMPLETED|Overall Study||0
11144165|NCT01475955|12330816|FG004|COMPLETED|Overall Study||46
11415955|NCT00979147|12613399|FG000|STARTED|Overall Study||0
11415956|NCT00979147|12613400|FG001|STARTED|Overall Study||0
11415957|NCT00979147|12613399|FG000|COMPLETED|Overall Study||0
11415958|NCT00979147|12613400|FG001|COMPLETED|Overall Study||0
11415959|NCT00979147|12613399|FG000|NOT COMPLETED|Overall Study||0
11415960|NCT00979147|12613400|FG001|NOT COMPLETED|Overall Study||0
11415961|NCT00967447|12613406|FG000|STARTED|Overall Study|there are no collected data in CRF|2
11415962|NCT00967447|12613406|FG000|COMPLETED|Overall Study|there are no collected data in CRF|2
11415963|NCT00967447|12613406|FG000|NOT COMPLETED|Overall Study||0
11415964|NCT00970606|12613412|FG000|STARTED|Overall Study||4
11415965|NCT00970606|12613413|FG001|STARTED|Overall Study||3
11415966|NCT00970606|12613412|FG000|COMPLETED|Overall Study||4
11415967|NCT00970606|12613413|FG001|COMPLETED|Overall Study||3
11415968|NCT00970606|12613412|FG000|NOT COMPLETED|Overall Study||0
11415969|NCT00970606|12613413|FG001|NOT COMPLETED|Overall Study||0
11415970|NCT00979550|12613421|FG000|STARTED|Overall Study||4
11415971|NCT00979550|12613422|FG001|STARTED|Overall Study||3
11415972|NCT00979550|12613421|FG000|COMPLETED|Overall Study||4
11415973|NCT00979550|12613422|FG001|COMPLETED|Overall Study||3
11415974|NCT00979550|12613421|FG000|NOT COMPLETED|Overall Study||0
11415975|NCT00979550|12613422|FG001|NOT COMPLETED|Overall Study||0
11415976|NCT00966992|12613430|FG000|STARTED|Overall Study||3
11415977|NCT00966992|12613431|FG001|STARTED|Overall Study||0
11415978|NCT00966992|12613430|FG000|COMPLETED|Overall Study||3
11415979|NCT00966992|12613431|FG001|COMPLETED|Overall Study||0
11415980|NCT00966992|12613430|FG000|NOT COMPLETED|Overall Study||0
11415981|NCT00966992|12613431|FG001|NOT COMPLETED|Overall Study||0
11415982|NCT00981370|12613437|FG000|STARTED|Overall Study||0
11415983|NCT00981370|12613437|FG000|COMPLETED|Overall Study||0
11415984|NCT00981370|12613437|FG000|NOT COMPLETED|Overall Study||0
11415985|NCT00975611|12613441|FG000|STARTED|Overall Study||22
11415986|NCT00975611|12613441|FG000|COMPLETED|Overall Study||5
11415987|NCT00975611|12613441|FG000|NOT COMPLETED|Overall Study||17
11415988|NCT00978419|12613447|FG000|STARTED|Overall Study||0
11415989|NCT00978419|12613448|FG001|STARTED|Overall Study||0
11415990|NCT00978419|12613447|FG000|COMPLETED|Overall Study||0
11415991|NCT00978419|12613448|FG001|COMPLETED|Overall Study||0
11415992|NCT00978419|12613447|FG000|NOT COMPLETED|Overall Study||0
11415993|NCT00978419|12613448|FG001|NOT COMPLETED|Overall Study||0
11415994|NCT00973856|12613456|FG000|STARTED|Overall Study||3
11415995|NCT00973856|12613457|FG001|STARTED|Overall Study||2
11415996|NCT00973856|12613456|FG000|COMPLETED|Overall Study||3
11415997|NCT00973856|12613457|FG001|COMPLETED|Overall Study||2
11415998|NCT00973856|12613456|FG000|NOT COMPLETED|Overall Study||0
11415999|NCT00973856|12613457|FG001|NOT COMPLETED|Overall Study||0
11416000|NCT00979810|12613462|FG000|STARTED|Overall Study||11
11416001|NCT00979810|12613462|FG000|COMPLETED|Overall Study||11
11416002|NCT00979810|12613462|FG000|NOT COMPLETED|Overall Study||0
11416003|NCT00974922|12613466|FG000|STARTED|Overall Study||40
11416004|NCT00974922|12613466|FG000|COMPLETED|Overall Study||16
11416005|NCT00974922|12613466|FG000|NOT COMPLETED|Overall Study||24
11416006|NCT00976339|12613472|FG000|STARTED|Overall Study||10
11416007|NCT00976339|12613473|FG001|STARTED|Overall Study||10
11416008|NCT00976339|12613472|FG000|COMPLETED|Overall Study||10
11416009|NCT00976339|12613473|FG001|COMPLETED|Overall Study||10
11416010|NCT00976339|12613472|FG000|NOT COMPLETED|Overall Study||0
11416011|NCT00976339|12613473|FG001|NOT COMPLETED|Overall Study||0
11416012|NCT00965146|12613481|FG000|STARTED|Overall Study||210
11416013|NCT00965146|12613481|FG000|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
11416014|NCT00965146|12613481|FG000|NOT COMPLETED|Overall Study||210
11416015|NCT00972023|12613485|FG000|STARTED|Overall Study||1
11416016|NCT00972023|12613485|FG000|COMPLETED|Overall Study||0
11416017|NCT00972023|12613485|FG000|NOT COMPLETED|Overall Study||1
11416018|NCT00970736|12613491|FG000|STARTED|Overall Study||20
11416019|NCT00970736|12613491|FG000|COMPLETED|Overall Study||18
11416020|NCT00970736|12613491|FG000|NOT COMPLETED|Overall Study||2
11416021|NCT00957827|12613497|FG000|STARTED|Overall Study||2
11416022|NCT00957827|12613498|FG001|STARTED|Overall Study||2
11416023|NCT00957827|12613497|FG000|COMPLETED|Overall Study||2
11416024|NCT00957827|12613498|FG001|COMPLETED|Overall Study||2
11416025|NCT00957827|12613497|FG000|NOT COMPLETED|Overall Study||0
11416026|NCT00957827|12613498|FG001|NOT COMPLETED|Overall Study||0
11416027|NCT00953329|12613504|FG000|STARTED|Overall Study||1
11416028|NCT00953329|12613504|FG000|COMPLETED|Overall Study||0
11416029|NCT00953329|12613504|FG000|NOT COMPLETED|Overall Study||1
11416030|NCT00965055|12613508|FG000|STARTED|Overall Study||2
11416031|NCT00965055|12613508|FG000|COMPLETED|Overall Study||2
11416032|NCT00965055|12613508|FG000|NOT COMPLETED|Overall Study||0
11416033|NCT00962429|12613514|FG000|STARTED|Overall Study||0
11416034|NCT00962429|12613515|FG001|STARTED|Overall Study||0
11416035|NCT00962429|12613514|FG000|COMPLETED|Overall Study||0
11416036|NCT00962429|12613515|FG001|COMPLETED|Overall Study||0
11416037|NCT00962429|12613514|FG000|NOT COMPLETED|Overall Study||0
11416038|NCT00962429|12613515|FG001|NOT COMPLETED|Overall Study||0
11416039|NCT00958893|12613521|FG000|STARTED|Overall Study||4
11416040|NCT00958893|12613521|FG000|COMPLETED|Overall Study||0
11416041|NCT00958893|12613521|FG000|NOT COMPLETED|Overall Study||4
11416042|NCT00966654|12613525|FG000|STARTED|Overall Study||12
11416043|NCT00966654|12613525|FG000|COMPLETED|Overall Study||0
11416044|NCT00966654|12613525|FG000|NOT COMPLETED|Overall Study||12
11416045|NCT00960154|12613533|FG000|STARTED|Overall Study||25
11416046|NCT00960154|12613534|FG001|STARTED|Overall Study||25
11416047|NCT00960154|12613533|FG000|COMPLETED|Overall Study||0
11416048|NCT00960154|12613534|FG001|COMPLETED|Overall Study||0
11416049|NCT00960154|12613533|FG000|NOT COMPLETED|Overall Study||25
11416050|NCT00960154|12613534|FG001|NOT COMPLETED|Overall Study||25
11416051|NCT00960752|12613543|FG000|STARTED|Overall Study||13
11416052|NCT00960752|12613544|FG001|STARTED|Overall Study||13
11416053|NCT00960752|12613545|FG002|STARTED|Overall Study||19
11416054|NCT00960752|12613543|FG000|COMPLETED|Overall Study||13
11416055|NCT00960752|12613544|FG001|COMPLETED|Overall Study||13
11416056|NCT00960752|12613545|FG002|COMPLETED|Overall Study||17
11416057|NCT00960752|12613543|FG000|NOT COMPLETED|Overall Study||0
11416058|NCT00960752|12613544|FG001|NOT COMPLETED|Overall Study||0
11416059|NCT00960752|12613545|FG002|NOT COMPLETED|Overall Study||2
11416060|NCT00958347|12613553|FG000|STARTED|Overall Study||226
11416061|NCT00958347|12613553|FG000|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
11416062|NCT00958347|12613553|FG000|NOT COMPLETED|Overall Study||226
11416063|NCT00954187|12613559|FG000|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
11416064|NCT00954187|12613560|FG001|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
11416065|NCT00954187|12613559|FG000|COMPLETED|Overall Study||0
11416066|NCT00954187|12613560|FG001|COMPLETED|Overall Study||0
11416067|NCT00954187|12613559|FG000|NOT COMPLETED|Overall Study||0
11416068|NCT00954187|12613560|FG001|NOT COMPLETED|Overall Study||0
11416069|NCT00953615|12613566|FG000|STARTED|Overall Study||1
11416070|NCT00953615|12613566|FG000|COMPLETED|Overall Study||0
11416071|NCT00953615|12613566|FG000|NOT COMPLETED|Overall Study||1
11416072|NCT00947284|12613570|FG000|STARTED|Overall Study||0
11416073|NCT00947284|12613571|FG001|STARTED|Overall Study||3
11416074|NCT00947284|12613570|FG000|COMPLETED|Overall Study||0
11416075|NCT00947284|12613571|FG001|COMPLETED|Overall Study||0
11416076|NCT00947284|12613570|FG000|NOT COMPLETED|Overall Study||0
11416077|NCT00947284|12613571|FG001|NOT COMPLETED|Overall Study||3
11416078|NCT00957034|12613578|FG000|STARTED|Overall Study||6
11416079|NCT00957034|12613579|FG001|STARTED|Overall Study||4
11416080|NCT00957034|12613580|FG002|STARTED|Overall Study||7
11416081|NCT00957034|12613578|FG000|COMPLETED|Overall Study||0
11416082|NCT00957034|12613579|FG001|COMPLETED|Overall Study||0
11416083|NCT00957034|12613580|FG002|COMPLETED|Overall Study||1
11416084|NCT00957034|12613578|FG000|NOT COMPLETED|Overall Study||6
11416085|NCT00957034|12613579|FG001|NOT COMPLETED|Overall Study||4
11416086|NCT00957034|12613580|FG002|NOT COMPLETED|Overall Study||6
11416087|NCT00949988|12613588|FG000|STARTED|Overall Study||3
11416088|NCT00949988|12613588|FG000|COMPLETED|Overall Study||0
11416089|NCT00949988|12613588|FG000|NOT COMPLETED|Overall Study||3
11416090|NCT00948194|12613594|FG000|STARTED|Overall Study||6
11416091|NCT00948194|12613595|FG001|STARTED|Overall Study||7
11416092|NCT00948194|12613594|FG000|COMPLETED|Overall Study||5
11416093|NCT00948194|12613595|FG001|COMPLETED|Overall Study||7
11416094|NCT00948194|12613594|FG000|NOT COMPLETED|Overall Study||1
11416095|NCT00948194|12613595|FG001|NOT COMPLETED|Overall Study||0
11416096|NCT00946985|12613601|FG000|STARTED|Stabilization Phase (25 Weeks)||162
11416097|NCT00946985|12613601|FG000|COMPLETED|Stabilization Phase (25 Weeks)||2
11416098|NCT00946985|12613601|FG000|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
11416099|NCT00946985|12613601|FG000|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
11416100|NCT00946985|12613601|FG000|COMPLETED|Relapse Prevention Phase (24 Months)||0
11416101|NCT00946985|12613601|FG000|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
11416102|NCT00950183|12613605|FG000|STARTED|Overall Study||36
11416103|NCT00950183|12613605|FG000|COMPLETED|Overall Study||0
11416104|NCT00950183|12613605|FG000|NOT COMPLETED|Overall Study||36
11416105|NCT00950690|12613609|FG000|STARTED|Overall Study||1349
11416106|NCT00950690|12613609|FG000|COMPLETED|Overall Study||1105
11022513|NCT00809354|12200779|FG004|STARTED|Overall Study||288
11022514|NCT00809354|12200780|FG005|STARTED|Overall Study||256
11022515|NCT00809354|12200781|FG006|STARTED|Overall Study||255
11022516|NCT00809354|12200782|FG007|STARTED|Overall Study||257
11022517|NCT00809354|12200783|FG008|STARTED|Overall Study||256
11022518|NCT00809354|12200784|FG009|STARTED|Overall Study||257
11022519|NCT00809354|12200775|FG000|Treated|Overall Study||285
11416107|NCT00950690|12613609|FG000|NOT COMPLETED|Overall Study||244
11416108|NCT00944229|12613613|FG000|STARTED|Overall Study||58
11416109|NCT00944229|12613613|FG000|COMPLETED|Overall Study||33
11416110|NCT00944229|12613613|FG000|NOT COMPLETED|Overall Study||25
11416111|NCT00941928|12613617|FG000|STARTED|Overall Study||2
11416112|NCT00941928|12613617|FG000|COMPLETED|Overall Study||0
11416113|NCT00941928|12613617|FG000|NOT COMPLETED|Overall Study||2
11416114|NCT00949403|12613621|FG000|STARTED|Overall Study||9
11416115|NCT00949403|12613621|FG000|COMPLETED|Overall Study||9
11416116|NCT00949403|12613621|FG000|NOT COMPLETED|Overall Study||0
11416117|NCT00947791|12613627|FG000|STARTED|Overall Study||0
11416118|NCT00947791|12613628|FG001|STARTED|Overall Study||1
11416119|NCT00947791|12613627|FG000|COMPLETED|Overall Study||0
11416120|NCT00947791|12613628|FG001|COMPLETED|Overall Study||1
11416121|NCT00947791|12613627|FG000|NOT COMPLETED|Overall Study||0
11416122|NCT00947791|12613628|FG001|NOT COMPLETED|Overall Study||0
11022520|NCT00809354|12200776|FG001|Treated|Overall Study||288
11022521|NCT00809354|12200777|FG002|Treated|Overall Study||280
11022522|NCT00809354|12200778|FG003|Treated|Overall Study||288
11022523|NCT00809354|12200779|FG004|Treated|Overall Study||283
11022524|NCT00809354|12200780|FG005|Treated|Overall Study||256
11416123|NCT00947011|12613634|FG000|STARTED|Overall Study||12
11416124|NCT00947011|12613634|FG000|COMPLETED|Overall Study||0
11022525|NCT00809354|12200781|FG006|Treated|Overall Study||254
11416125|NCT00947011|12613634|FG000|NOT COMPLETED|Overall Study||12
11022526|NCT00809354|12200782|FG007|Treated|Overall Study||256
11022527|NCT00809354|12200783|FG008|Treated|Overall Study||254
11022528|NCT00809354|12200784|FG009|Treated|Overall Study||256
11022529|NCT00809354|12200775|FG000|COMPLETED|Overall Study||33
11022530|NCT00809354|12200776|FG001|COMPLETED|Overall Study||31
11022531|NCT00809354|12200777|FG002|COMPLETED|Overall Study||32
11416126|NCT00943605|12613642|FG000|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
11416127|NCT00943605|12613643|FG001|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
11416128|NCT00943605|12613642|FG000|COMPLETED|Overall Study||0
11416129|NCT00943605|12613643|FG001|COMPLETED|Overall Study||0
11416130|NCT00943605|12613642|FG000|NOT COMPLETED|Overall Study||30
11416131|NCT00943605|12613643|FG001|NOT COMPLETED|Overall Study||30
11022532|NCT00809354|12200778|FG003|COMPLETED|Overall Study||32
11022533|NCT00809354|12200779|FG004|COMPLETED|Overall Study||32
11022534|NCT00809354|12200780|FG005|COMPLETED|Overall Study||31
11022535|NCT00809354|12200781|FG006|COMPLETED|Overall Study||32
11416132|NCT00942409|12613649|FG000|STARTED|Overall Study||5
11416133|NCT00942409|12613649|FG000|COMPLETED|Overall Study||2
11416134|NCT00942409|12613649|FG000|NOT COMPLETED|Overall Study||3
11416135|NCT00936585|12613653|FG000|STARTED|Overall Study||2
11416136|NCT00936585|12613653|FG000|COMPLETED|Overall Study||2
11416137|NCT00936585|12613653|FG000|NOT COMPLETED|Overall Study||0
11416138|NCT00936598|12613659|FG000|STARTED|Overall Study||4
11416139|NCT00936598|12613660|FG001|STARTED|Overall Study||1
11416140|NCT00936598|12613659|FG000|COMPLETED|Overall Study||2
11416141|NCT00936598|12613660|FG001|COMPLETED|Overall Study||1
11416142|NCT00936598|12613659|FG000|NOT COMPLETED|Overall Study||2
11416143|NCT00936598|12613660|FG001|NOT COMPLETED|Overall Study||0
11416144|NCT00920309|12613668|FG000|STARTED|Overall Study||14
11416145|NCT00920309|12613669|FG001|STARTED|Overall Study||7
11416146|NCT00920309|12613668|FG000|COMPLETED|Overall Study||14
11416147|NCT00920309|12613669|FG001|COMPLETED|Overall Study||7
11416148|NCT00920309|12613668|FG000|NOT COMPLETED|Overall Study||0
11416149|NCT00920309|12613669|FG001|NOT COMPLETED|Overall Study||0
11416150|NCT00935649|12613676|FG000|STARTED|Overall Study||139
11416151|NCT00935649|12613676|FG000|COMPLETED|Overall Study||134
11416152|NCT00935649|12613676|FG000|NOT COMPLETED|Overall Study||5
11416153|NCT00934791|12613684|FG000|STARTED|Overall Study||1
11416154|NCT00934791|12613685|FG001|STARTED|Overall Study||0
11416155|NCT00934791|12613684|FG000|COMPLETED|Overall Study||0
11416156|NCT00934791|12613685|FG001|COMPLETED|Overall Study||0
11416157|NCT00934791|12613684|FG000|NOT COMPLETED|Overall Study||1
11416158|NCT00934791|12613685|FG001|NOT COMPLETED|Overall Study||0
11416159|NCT00932152|12613693|FG000|STARTED|Overall Study||1
11416160|NCT00932152|12613694|FG001|STARTED|Overall Study||2
11416161|NCT00932152|12613693|FG000|COMPLETED|Overall Study||0
11416162|NCT00932152|12613694|FG001|COMPLETED|Overall Study||0
11416163|NCT00932152|12613693|FG000|NOT COMPLETED|Overall Study||1
11416164|NCT00932152|12613694|FG001|NOT COMPLETED|Overall Study||2
11416165|NCT00928499|12613702|FG000|STARTED|Overall Study||18
11416166|NCT00928499|12613703|FG001|STARTED|Overall Study||14
11416167|NCT00928499|12613702|FG000|COMPLETED|Overall Study||18
11416168|NCT00928499|12613703|FG001|COMPLETED|Overall Study||14
11416169|NCT00928499|12613702|FG000|NOT COMPLETED|Overall Study||0
11416170|NCT00928499|12613703|FG001|NOT COMPLETED|Overall Study||0
11416171|NCT00924807|12613709|FG000|STARTED|Overall Study||4
11416172|NCT00924807|12613709|FG000|COMPLETED|Overall Study||4
11416173|NCT00924807|12613709|FG000|NOT COMPLETED|Overall Study||0
11416174|NCT00930787|12613715|FG000|STARTED|Overall Study||14
11416175|NCT00930787|12613716|FG001|STARTED|Overall Study||9
11416176|NCT00930787|12613715|FG000|COMPLETED|Overall Study||14
11416177|NCT00930787|12613716|FG001|COMPLETED|Overall Study||9
11416178|NCT00930787|12613715|FG000|NOT COMPLETED|Overall Study||0
11416179|NCT00930787|12613716|FG001|NOT COMPLETED|Overall Study||0
11416180|NCT00929474|12613724|FG000|STARTED|Overall Study||8
11416181|NCT00929474|12613725|FG001|STARTED|Overall Study||9
11416182|NCT00929474|12613724|FG000|COMPLETED|Overall Study||0
11416183|NCT00929474|12613725|FG001|COMPLETED|Overall Study||0
11416184|NCT00929474|12613724|FG000|NOT COMPLETED|Overall Study||8
11416185|NCT00929474|12613725|FG001|NOT COMPLETED|Overall Study||9
11416186|NCT00925548|12613733|FG000|STARTED|Overall Study||11
11416187|NCT00925548|12613734|FG001|STARTED|Overall Study||5
11416188|NCT00925548|12613733|FG000|COMPLETED|Overall Study||1
11416189|NCT00925548|12613734|FG001|COMPLETED|Overall Study||0
11416190|NCT00925548|12613733|FG000|NOT COMPLETED|Overall Study||10
11416191|NCT00925548|12613734|FG001|NOT COMPLETED|Overall Study||5
11416192|NCT00926575|12613743|FG000|STARTED|Overall Study||70
11416193|NCT00926575|12613744|FG001|STARTED|Overall Study||70
11416194|NCT00926575|12613743|FG000|COMPLETED|Overall Study||54
11416195|NCT00926575|12613744|FG001|COMPLETED|Overall Study||53
11416196|NCT00926575|12613743|FG000|NOT COMPLETED|Overall Study||16
11416197|NCT00926575|12613744|FG001|NOT COMPLETED|Overall Study||17
11416198|NCT00911053|12613755|FG000|STARTED|Overall Study||0
11416199|NCT00911053|12613756|FG001|STARTED|Overall Study||0
11416200|NCT00911053|12613757|FG002|STARTED|Overall Study||0
11416201|NCT00911053|12613758|FG003|STARTED|Overall Study||0
11416202|NCT00911053|12613759|FG004|STARTED|Overall Study||0
11416203|NCT00911053|12613755|FG000|COMPLETED|Overall Study||0
11416204|NCT00911053|12613756|FG001|COMPLETED|Overall Study||0
11416205|NCT00911053|12613757|FG002|COMPLETED|Overall Study||0
11416206|NCT00911053|12613758|FG003|COMPLETED|Overall Study||0
11416207|NCT00911053|12613759|FG004|COMPLETED|Overall Study||0
11416208|NCT00911053|12613755|FG000|NOT COMPLETED|Overall Study||0
11416209|NCT00911053|12613756|FG001|NOT COMPLETED|Overall Study||0
11416210|NCT00911053|12613757|FG002|NOT COMPLETED|Overall Study||0
11416211|NCT00911053|12613758|FG003|NOT COMPLETED|Overall Study||0
11416212|NCT00911053|12613759|FG004|NOT COMPLETED|Overall Study||0
11416213|NCT00918463|12613771|FG000|STARTED|Overall Study||2
11416214|NCT00918463|12613771|FG000|COMPLETED|Overall Study||0
11416215|NCT00918463|12613771|FG000|NOT COMPLETED|Overall Study||2
11416216|NCT00913692|12613775|FG000|STARTED|Screening (4 Months)||11
11416217|NCT00913692|12613775|FG000|COMPLETED|Screening (4 Months)||2
11416218|NCT00913692|12613775|FG000|NOT COMPLETED|Screening (4 Months)||9
11416219|NCT00913692|12613775|FG000|STARTED|Treatment Phase 1 (5 Months)||2
11416220|NCT00913692|12613775|FG000|COMPLETED|Treatment Phase 1 (5 Months)||1
11416221|NCT00913692|12613775|FG000|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
11416222|NCT00913692|12613775|FG000|STARTED|Washout (2 Weeks)||1
11416223|NCT00913692|12613775|FG000|COMPLETED|Washout (2 Weeks)||1
11416224|NCT00913692|12613775|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11416225|NCT00913692|12613775|FG000|STARTED|Treatment Phase 2 (5 Months)||1
11416226|NCT00913692|12613775|FG000|COMPLETED|Treatment Phase 2 (5 Months)||1
11416227|NCT00913692|12613775|FG000|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
11416228|NCT00918645|12613782|FG000|STARTED|Overall Study||13
11416229|NCT00918645|12613782|FG000|COMPLETED|Overall Study||12
11416230|NCT00918645|12613782|FG000|NOT COMPLETED|Overall Study||1
11416231|NCT00907218|12613786|FG000|STARTED|Overall Study||2
11416232|NCT00907218|12613786|FG000|COMPLETED|Overall Study||2
11416233|NCT00907218|12613786|FG000|NOT COMPLETED|Overall Study||0
11416234|NCT00895284|12613792|FG000|STARTED|Overall Study||3
11416235|NCT00895284|12613793|FG001|STARTED|Overall Study||0
11416236|NCT00895284|12613792|FG000|COMPLETED|Overall Study||3
11416237|NCT00895284|12613793|FG001|COMPLETED|Overall Study||0
11416238|NCT00895284|12613792|FG000|NOT COMPLETED|Overall Study||0
11416239|NCT00895284|12613793|FG001|NOT COMPLETED|Overall Study||0
11416240|NCT00897910|12613799|FG000|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
11416241|NCT00897910|12613799|FG000|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
11416242|NCT00897910|12613799|FG000|NOT COMPLETED|Overall Study||0
11416243|NCT00901303|12613805|FG000|STARTED|Overall Study||5
11416244|NCT00901303|12613806|FG001|STARTED|Overall Study||1
11416245|NCT00901303|12613805|FG000|COMPLETED|Overall Study||5
11416246|NCT00901303|12613806|FG001|COMPLETED|Overall Study||1
11416247|NCT00901303|12613805|FG000|NOT COMPLETED|Overall Study||0
11416248|NCT00901303|12613806|FG001|NOT COMPLETED|Overall Study||0
11416249|NCT00906035|12613815|FG000|STARTED|Overall Study||8
11416250|NCT00906035|12613816|FG001|STARTED|Overall Study||9
11416251|NCT00906035|12613817|FG002|STARTED|Overall Study||8
11416252|NCT00906035|12613815|FG000|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
11416253|NCT00906035|12613816|FG001|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
11416254|NCT00906035|12613817|FG002|COMPLETED|Overall Study||8
11416255|NCT00906035|12613815|FG000|NOT COMPLETED|Overall Study||2
11416256|NCT00906035|12613816|FG001|NOT COMPLETED|Overall Study||3
11416257|NCT00906035|12613817|FG002|NOT COMPLETED|Overall Study||0
11416258|NCT00904423|12613825|FG000|STARTED|Overall Study||8
11416259|NCT00904423|12613825|FG000|COMPLETED|Overall Study||8
11416260|NCT00904423|12613825|FG000|NOT COMPLETED|Overall Study||0
11416261|NCT00903396|12613833|FG000|STARTED|Overall Study||2
11416262|NCT00903396|12613834|FG001|STARTED|Overall Study||1
11416263|NCT00903396|12613835|FG002|STARTED|Overall Study||3
11416264|NCT00903396|12613836|FG003|STARTED|Overall Study||1
11416265|NCT00903396|12613833|FG000|COMPLETED|Overall Study||2
11416266|NCT00903396|12613834|FG001|COMPLETED|Overall Study||1
11416267|NCT00903396|12613835|FG002|COMPLETED|Overall Study||3
11416268|NCT00903396|12613836|FG003|COMPLETED|Overall Study||1
11416269|NCT00903396|12613833|FG000|NOT COMPLETED|Overall Study||0
11416270|NCT00903396|12613834|FG001|NOT COMPLETED|Overall Study||0
11416271|NCT00903396|12613835|FG002|NOT COMPLETED|Overall Study||0
11416272|NCT00903396|12613836|FG003|NOT COMPLETED|Overall Study||0
11416273|NCT00894790|12613848|FG000|STARTED|Overall Study||4
11416274|NCT00894790|12613849|FG001|STARTED|Overall Study||4
11416275|NCT00894790|12613848|FG000|COMPLETED|Overall Study||3
11022536|NCT00809354|12200782|FG007|COMPLETED|Overall Study||19
11022537|NCT00809354|12200783|FG008|COMPLETED|Overall Study||28
11022538|NCT00809354|12200784|FG009|COMPLETED|Overall Study||31
11022539|NCT00809354|12200775|FG000|NOT COMPLETED|Overall Study||255
11022540|NCT00809354|12200776|FG001|NOT COMPLETED|Overall Study||258
11022541|NCT00809354|12200777|FG002|NOT COMPLETED|Overall Study||254
11416276|NCT00894790|12613849|FG001|COMPLETED|Overall Study||2
11416277|NCT00894790|12613848|FG000|NOT COMPLETED|Overall Study||1
11416278|NCT00894790|12613849|FG001|NOT COMPLETED|Overall Study||2
11416279|NCT00902668|12613855|FG000|STARTED|Overall Study||3
11416280|NCT00902668|12613855|FG000|COMPLETED|Overall Study||0
11416281|NCT00902668|12613855|FG000|NOT COMPLETED|Overall Study||3
11416282|NCT00881205|12613861|FG000|STARTED|Overall Study||45
11416283|NCT00881205|12613862|FG001|STARTED|Overall Study||41
11416284|NCT00881205|12613861|FG000|COMPLETED|Overall Study||34
11416285|NCT00881205|12613862|FG001|COMPLETED|Overall Study||34
11416286|NCT00881205|12613861|FG000|NOT COMPLETED|Overall Study||11
11416287|NCT00881205|12613862|FG001|NOT COMPLETED|Overall Study||7
11416288|NCT00896025|12613869|FG000|STARTED|Overall Study||8
11416289|NCT00896025|12613869|FG000|COMPLETED|Overall Study||8
11416290|NCT00896025|12613869|FG000|NOT COMPLETED|Overall Study||0
11416291|NCT00903006|12613879|FG000|STARTED|Overall Study||2
11416292|NCT00903006|12613880|FG001|STARTED|Overall Study||3
11416293|NCT00903006|12613881|FG002|STARTED|Overall Study||1
11416294|NCT00903006|12613882|FG003|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
11416295|NCT00903006|12613879|FG000|COMPLETED|Overall Study||0
11416296|NCT00903006|12613880|FG001|COMPLETED|Overall Study||0
11416297|NCT00903006|12613881|FG002|COMPLETED|Overall Study||0
11416298|NCT00903006|12613882|FG003|COMPLETED|Overall Study||0
11416299|NCT00903006|12613879|FG000|NOT COMPLETED|Overall Study||2
11416300|NCT00903006|12613880|FG001|NOT COMPLETED|Overall Study||3
11416301|NCT00903006|12613881|FG002|NOT COMPLETED|Overall Study||1
11416302|NCT00903006|12613882|FG003|NOT COMPLETED|Overall Study||0
11416303|NCT00904189|12613892|FG000|STARTED|Overall Study||2
11416304|NCT00904189|12613892|FG000|COMPLETED|Overall Study||2
11416305|NCT00904189|12613892|FG000|NOT COMPLETED|Overall Study||0
11416306|NCT00887315|12613899|FG000|STARTED|Overall Study||7
11416307|NCT00887315|12613900|FG001|STARTED|Overall Study||4
11416308|NCT00887315|12613899|FG000|COMPLETED|Overall Study||0
11416309|NCT00887315|12613900|FG001|COMPLETED|Overall Study||0
11416310|NCT00887315|12613899|FG000|NOT COMPLETED|Overall Study||7
11416311|NCT00887315|12613900|FG001|NOT COMPLETED|Overall Study||4
11416312|NCT00891904|12613906|FG000|STARTED|Overall Study||2
11416313|NCT00891904|12613906|FG000|COMPLETED|Overall Study||0
11416314|NCT00891904|12613906|FG000|NOT COMPLETED|Overall Study||2
11416315|NCT00881608|12613915|FG000|STARTED|Overall Study||11
11416316|NCT00881608|12613915|FG000|COMPLETED|Overall Study||0
11022542|NCT00809354|12200778|FG003|NOT COMPLETED|Overall Study||256
11022543|NCT00809354|12200779|FG004|NOT COMPLETED|Overall Study||256
11022544|NCT00809354|12200780|FG005|NOT COMPLETED|Overall Study||225
11144166|NCT01475955|12330812|FG000|NOT COMPLETED|Overall Study||1
11144167|NCT01475955|12330813|FG001|NOT COMPLETED|Overall Study||0
11416317|NCT00881608|12613915|FG000|NOT COMPLETED|Overall Study||11
11416318|NCT00889421|12613927|FG000|STARTED|Overall Study||3
11416319|NCT00889421|12613927|FG000|COMPLETED|Overall Study||0
11022545|NCT00809354|12200781|FG006|NOT COMPLETED|Overall Study||223
11022546|NCT00809354|12200782|FG007|NOT COMPLETED|Overall Study||238
11022547|NCT00809354|12200783|FG008|NOT COMPLETED|Overall Study||228
11022548|NCT00809354|12200784|FG009|NOT COMPLETED|Overall Study||226
11022549|NCT00809445|12200814|FG000|STARTED|1 Month Follow-up||429
11022550|NCT00809445|12200815|FG001|STARTED|1 Month Follow-up||433
11022551|NCT00809445|12200816|FG002|STARTED|1 Month Follow-up||419
11022552|NCT00809445|12200814|FG000|COMPLETED|1 Month Follow-up||427
11022553|NCT00809445|12200815|FG001|COMPLETED|1 Month Follow-up||429
11022554|NCT00809445|12200816|FG002|COMPLETED|1 Month Follow-up||415
11022555|NCT00809445|12200814|FG000|NOT COMPLETED|1 Month Follow-up||2
11022556|NCT00809445|12200815|FG001|NOT COMPLETED|1 Month Follow-up||4
11022557|NCT00809445|12200816|FG002|NOT COMPLETED|1 Month Follow-up||4
11022558|NCT00809445|12200814|FG000|STARTED|6 Month Follow-up||429
11022559|NCT00809445|12200815|FG001|STARTED|6 Month Follow-up||433
11022560|NCT00809445|12200816|FG002|STARTED|6 Month Follow-up||419
11022561|NCT00809445|12200814|FG000|COMPLETED|6 Month Follow-up||405
11022562|NCT00809445|12200815|FG001|COMPLETED|6 Month Follow-up||410
11022563|NCT00809445|12200816|FG002|COMPLETED|6 Month Follow-up||395
11022564|NCT00809445|12200814|FG000|NOT COMPLETED|6 Month Follow-up||24
11022565|NCT00809445|12200815|FG001|NOT COMPLETED|6 Month Follow-up||23
11022566|NCT00809445|12200816|FG002|NOT COMPLETED|6 Month Follow-up||24
11022567|NCT00809471|12200827|FG000|STARTED|Overall Study||130
11022568|NCT00809471|12200828|FG001|STARTED|Overall Study||129
11022569|NCT00809471|12200829|FG002|STARTED|Overall Study||131
11022570|NCT00809471|12200827|FG000|COMPLETED|Overall Study||110
11022571|NCT00809471|12200828|FG001|COMPLETED|Overall Study||109
11022572|NCT00809471|12200829|FG002|COMPLETED|Overall Study||114
11022573|NCT00809471|12200827|FG000|NOT COMPLETED|Overall Study||20
11022574|NCT00809471|12200828|FG001|NOT COMPLETED|Overall Study||20
11022575|NCT00809471|12200829|FG002|NOT COMPLETED|Overall Study||17
11022576|NCT00809523|12200839|FG000|STARTED|Overall Study||54
11022577|NCT00809523|12200840|FG001|STARTED|Overall Study||52
11022578|NCT00809523|12200839|FG000|COMPLETED|Overall Study||47
11022579|NCT00809523|12200840|FG001|COMPLETED|Overall Study||48
11022580|NCT00809523|12200839|FG000|NOT COMPLETED|Overall Study||7
11022581|NCT00809523|12200840|FG001|NOT COMPLETED|Overall Study||4
11022582|NCT00809614|12200848|FG000|STARTED|Overall Study||28
11416320|NCT00889421|12613927|FG000|NOT COMPLETED|Overall Study||3
11416321|NCT00875394|12613934|FG000|STARTED|Overall Study||36
11416322|NCT00875394|12613935|FG001|STARTED|Overall Study||23
11416323|NCT00875394|12613936|FG002|STARTED|Overall Study||9
11416324|NCT00875394|12613934|FG000|COMPLETED|Overall Study||36
11416325|NCT00875394|12613935|FG001|COMPLETED|Overall Study||23
11416326|NCT00875394|12613936|FG002|COMPLETED|Overall Study||9
11416327|NCT00875394|12613934|FG000|NOT COMPLETED|Overall Study||0
11416328|NCT00875394|12613935|FG001|NOT COMPLETED|Overall Study||0
11416329|NCT00875394|12613936|FG002|NOT COMPLETED|Overall Study||0
11416330|NCT00882310|12613944|FG000|STARTED|Overall Study||37
11416331|NCT00882310|12613944|FG000|COMPLETED|Overall Study||15
11416332|NCT00882310|12613944|FG000|NOT COMPLETED|Overall Study||22
11416333|NCT00880542|12613948|FG000|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
11416334|NCT00880542|12613948|FG000|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
11022583|NCT00809614|12200849|FG001|STARTED|Overall Study||14
11022584|NCT00809614|12200848|FG000|Pharmacokinetic Safety Set|Overall Study||27
11022585|NCT00809614|12200849|FG001|Pharmacokinetic Safety Set|Overall Study||14
11022586|NCT00809614|12200848|FG000|Pharmacodynamic (PD) Set|Overall Study||24
11022587|NCT00809614|12200849|FG001|Pharmacodynamic (PD) Set|Overall Study||13
11022588|NCT00809614|12200848|FG000|COMPLETED|Overall Study||25
11022589|NCT00809614|12200849|FG001|COMPLETED|Overall Study||10
11022590|NCT00809614|12200848|FG000|NOT COMPLETED|Overall Study||3
11022591|NCT00809614|12200849|FG001|NOT COMPLETED|Overall Study||4
11022592|NCT00809757|12200858|FG000|STARTED|Overall Study||68
11022593|NCT00809757|12200859|FG001|STARTED|Overall Study||65
11022594|NCT00809757|12200860|FG002|STARTED|Overall Study||64
11022595|NCT00809757|12200858|FG000|COMPLETED|Overall Study||62
11022596|NCT00809757|12200859|FG001|COMPLETED|Overall Study||60
11022597|NCT00809757|12200860|FG002|COMPLETED|Overall Study||53
11022598|NCT00809757|12200858|FG000|NOT COMPLETED|Overall Study||6
11022599|NCT00809757|12200859|FG001|NOT COMPLETED|Overall Study||5
11022600|NCT00809757|12200860|FG002|NOT COMPLETED|Overall Study||11
11022601|NCT00809783|12200877|FG000|STARTED|Overall Study||525
11022602|NCT00809783|12200878|FG001|STARTED|Overall Study||832
11022603|NCT00809783|12200879|FG002|STARTED|Overall Study||790
11022604|NCT00809783|12200877|FG000|Treated|Overall Study||522
11022605|NCT00809783|12200878|FG001|Treated|Overall Study||832
11022606|NCT00809783|12200879|FG002|Treated|Overall Study||788
11022607|NCT00809783|12200877|FG000|COMPLETED|Overall Study||0
11022608|NCT00809783|12200878|FG001|COMPLETED|Overall Study||0
11022609|NCT00809783|12200879|FG002|COMPLETED|Overall Study||0
11022610|NCT00809783|12200877|FG000|NOT COMPLETED|Overall Study||525
11022611|NCT00809783|12200878|FG001|NOT COMPLETED|Overall Study||832
11416335|NCT00880542|12613948|FG000|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
11416336|NCT00880542|12613948|FG000|STARTED|Response Evaluation Period(REP): PET/CT||4
11416337|NCT00880542|12613948|FG000|COMPLETED|Response Evaluation Period(REP): PET/CT||4
11416338|NCT00880542|12613948|FG000|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
11416339|NCT00880542|12613948|FG000|STARTED|REP: Surgical Resection||4
11416340|NCT00880542|12613948|FG000|COMPLETED|REP: Surgical Resection||3
11416341|NCT00880542|12613948|FG000|NOT COMPLETED|REP: Surgical Resection||1
11022612|NCT00809783|12200879|FG002|NOT COMPLETED|Overall Study||790
11022613|NCT00809809|12200889|FG000|STARTED|Overall Study||78
11022614|NCT00809809|12200890|FG001|STARTED|Overall Study||79
11416342|NCT00880542|12613948|FG000|STARTED|Post Surgical Evaluation||3
11416343|NCT00880542|12613948|FG000|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
11416344|NCT00880542|12613948|FG000|NOT COMPLETED|Post Surgical Evaluation||0
11416345|NCT00880542|12613948|FG000|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
11416346|NCT00880542|12613948|FG000|COMPLETED|Continued Treatment Period||0
11416347|NCT00880542|12613948|FG000|NOT COMPLETED|Continued Treatment Period||0
11416348|NCT00880542|12613948|FG000|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
11416349|NCT00880542|12613948|FG000|COMPLETED|Follow-up Period||7
11416350|NCT00880542|12613948|FG000|NOT COMPLETED|Follow-up Period||0
11416351|NCT00879619|12613952|FG000|STARTED|Overall Study||4
11416352|NCT00879619|12613952|FG000|COMPLETED|Overall Study||4
11416353|NCT00879619|12613952|FG000|NOT COMPLETED|Overall Study||0
11416354|NCT00874939|12613956|FG000|STARTED|Overall Study||4
11416355|NCT00874939|12613956|FG000|Treated|Overall Study||0
11416356|NCT00874939|12613956|FG000|COMPLETED|Overall Study||0
11416357|NCT00874939|12613956|FG000|NOT COMPLETED|Overall Study||4
11416358|NCT00878605|12613970|FG000|STARTED|Overall Study||10
11416359|NCT00878605|12613971|FG001|STARTED|Overall Study||10
11416360|NCT00878605|12613972|FG002|STARTED|Overall Study||9
11416361|NCT00878605|12613973|FG003|STARTED|Overall Study||9
11416362|NCT00878605|12613970|FG000|COMPLETED|Overall Study||7
11416363|NCT00878605|12613971|FG001|COMPLETED|Overall Study||7
11416364|NCT00878605|12613972|FG002|COMPLETED|Overall Study||8
11416365|NCT00878605|12613973|FG003|COMPLETED|Overall Study||6
11416366|NCT00878605|12613970|FG000|NOT COMPLETED|Overall Study||3
11416367|NCT00878605|12613971|FG001|NOT COMPLETED|Overall Study||3
11416368|NCT00878605|12613972|FG002|NOT COMPLETED|Overall Study||1
11416369|NCT00878605|12613973|FG003|NOT COMPLETED|Overall Study||3
11416370|NCT00877071|12613983|FG000|STARTED|Overall Study||2
11416371|NCT00877071|12613983|FG000|COMPLETED|Overall Study||0
11416372|NCT00877071|12613983|FG000|NOT COMPLETED|Overall Study||2
11416373|NCT00878969|12613990|FG000|STARTED|Overall Study||25
11416374|NCT00878969|12613991|FG001|STARTED|Overall Study||27
11416375|NCT00878969|12613992|FG002|STARTED|Overall Study||26
11416376|NCT00878969|12613990|FG000|COMPLETED|Overall Study||10
11416377|NCT00878969|12613991|FG001|COMPLETED|Overall Study||12
11144168|NCT01475955|12330814|FG002|NOT COMPLETED|Overall Study||3
11144169|NCT01475955|12330815|FG003|NOT COMPLETED|Overall Study||0
11144170|NCT01475955|12330816|FG004|NOT COMPLETED|Overall Study||0
11144171|NCT01476202|12330850|FG000|STARTED|Overall Study||40
11144172|NCT01476202|12330851|FG001|STARTED|Overall Study||40
11022615|NCT00809809|12200889|FG000|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
11022616|NCT00809809|12200890|FG001|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
11022617|NCT00809809|12200889|FG000|NOT COMPLETED|Overall Study||3
11022618|NCT00809809|12200890|FG001|NOT COMPLETED|Overall Study||2
11022619|NCT00809835|12200900|FG000|STARTED|Overall Study||28
11144173|NCT01476202|12330852|FG002|STARTED|Overall Study||40
11144174|NCT01476202|12330850|FG000|COMPLETED|Overall Study||40
11416378|NCT00878969|12613992|FG002|COMPLETED|Overall Study||15
11416379|NCT00878969|12613990|FG000|NOT COMPLETED|Overall Study||15
11416380|NCT00878969|12613991|FG001|NOT COMPLETED|Overall Study||15
11416381|NCT00878969|12613992|FG002|NOT COMPLETED|Overall Study||11
11416382|NCT00865514|12614000|FG000|STARTED|Overall Study||2
11416383|NCT00865514|12614000|FG000|COMPLETED|Overall Study||0
11416384|NCT00865514|12614000|FG000|NOT COMPLETED|Overall Study||2
11416385|NCT00869414|12614005|FG000|STARTED|Overall Study||0
11416386|NCT00869414|12614006|FG001|STARTED|Overall Study||0
11022620|NCT00809835|12200901|FG001|STARTED|Overall Study||27
11022621|NCT00809835|12200902|FG002|STARTED|Overall Study||38
11022622|NCT00809835|12200903|FG003|STARTED|Overall Study||27
11022623|NCT00809835|12200900|FG000|COMPLETED|Overall Study||20
11144175|NCT01476202|12330851|FG001|COMPLETED|Overall Study||40
11144176|NCT01476202|12330852|FG002|COMPLETED|Overall Study||40
11144177|NCT01476202|12330850|FG000|NOT COMPLETED|Overall Study||0
11144178|NCT01476202|12330851|FG001|NOT COMPLETED|Overall Study||0
11144179|NCT01476202|12330852|FG002|NOT COMPLETED|Overall Study||0
11144180|NCT01476267|12330863|FG000|STARTED|Overall Study||6
11144181|NCT01476267|12330863|FG000|COMPLETED|Overall Study||6
11416387|NCT00869414|12614007|FG002|STARTED|Overall Study||0
11416388|NCT00869414|12614005|FG000|COMPLETED|Overall Study||0
11416389|NCT00869414|12614006|FG001|COMPLETED|Overall Study||0
11416390|NCT00869414|12614007|FG002|COMPLETED|Overall Study||0
11416391|NCT00869414|12614005|FG000|NOT COMPLETED|Overall Study||0
11416392|NCT00869414|12614006|FG001|NOT COMPLETED|Overall Study||0
11416393|NCT00869414|12614007|FG002|NOT COMPLETED|Overall Study||0
11416394|NCT00863512|12614017|FG000|STARTED|Overall Study||17
11416395|NCT00863512|12614018|FG001|STARTED|Overall Study||17
11416396|NCT00863512|12614017|FG000|COMPLETED|Overall Study||3
11416397|NCT00863512|12614018|FG001|COMPLETED|Overall Study||17
11416398|NCT00863512|12614017|FG000|NOT COMPLETED|Overall Study||14
11416399|NCT00863512|12614018|FG001|NOT COMPLETED|Overall Study||0
11416400|NCT00868998|12614024|FG000|STARTED|Overall Study||5
11416401|NCT00868998|12614024|FG000|COMPLETED|Overall Study||0
11416402|NCT00868998|12614024|FG000|NOT COMPLETED|Overall Study||5
11416403|NCT00869258|12614028|FG000|STARTED|Overall Study||32
11416404|NCT00869258|12614028|FG000|COMPLETED|Overall Study||31
11416405|NCT00869258|12614028|FG000|NOT COMPLETED|Overall Study||1
11416406|NCT00863330|12614032|FG000|STARTED|Overall Study||6
11416407|NCT00863330|12614032|FG000|COMPLETED|Overall Study||0
11416408|NCT00863330|12614032|FG000|NOT COMPLETED|Overall Study||6
11416409|NCT00853229|12614038|FG000|STARTED|Phase 1: Initial Intervention||8
11416410|NCT00853229|12614039|FG001|STARTED|Phase 1: Initial Intervention||8
11416411|NCT00853229|12614038|FG000|COMPLETED|Phase 1: Initial Intervention||0
11416412|NCT00853229|12614039|FG001|COMPLETED|Phase 1: Initial Intervention||0
11416413|NCT00853229|12614038|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8
11022624|NCT00809835|12200901|FG001|COMPLETED|Overall Study||20
11022625|NCT00809835|12200902|FG002|COMPLETED|Overall Study||27
11022626|NCT00809835|12200903|FG003|COMPLETED|Overall Study||25
11022627|NCT00809835|12200900|FG000|NOT COMPLETED|Overall Study||8
11022628|NCT00809835|12200901|FG001|NOT COMPLETED|Overall Study||7
11022629|NCT00809835|12200902|FG002|NOT COMPLETED|Overall Study||11
11022630|NCT00809835|12200903|FG003|NOT COMPLETED|Overall Study||2
11022631|NCT00809848|12200918|FG000|STARTED|Overall Study||36
11022632|NCT00809848|12200919|FG001|STARTED|Overall Study||34
11022633|NCT00809848|12200920|FG002|STARTED|Overall Study||34
11022634|NCT00809848|12200921|FG003|STARTED|Overall Study||31
11022635|NCT00809848|12200922|FG004|STARTED|Overall Study||37
11022636|NCT00809848|12200918|FG000|COMPLETED|Overall Study||36
11022637|NCT00809848|12200919|FG001|COMPLETED|Overall Study||34
11022638|NCT00809848|12200920|FG002|COMPLETED|Overall Study||34
11022639|NCT00809848|12200921|FG003|COMPLETED|Overall Study||30
11022640|NCT00809848|12200922|FG004|COMPLETED|Overall Study||34
11022641|NCT00809848|12200918|FG000|NOT COMPLETED|Overall Study||0
11022642|NCT00809848|12200919|FG001|NOT COMPLETED|Overall Study||0
11022643|NCT00809848|12200920|FG002|NOT COMPLETED|Overall Study||0
11022644|NCT00809848|12200921|FG003|NOT COMPLETED|Overall Study||1
11022645|NCT00809848|12200922|FG004|NOT COMPLETED|Overall Study||3
11022646|NCT00809926|12200937|FG000|STARTED|Overall Study||232
11022647|NCT00809926|12200938|FG001|STARTED|Overall Study||219
11022648|NCT00809926|12200937|FG000|COMPLETED|Overall Study||201
11022649|NCT00809926|12200938|FG001|COMPLETED|Overall Study||196
11022650|NCT00809926|12200937|FG000|NOT COMPLETED|Overall Study||31
11022651|NCT00809926|12200938|FG001|NOT COMPLETED|Overall Study||23
11022652|NCT00809965|12200947|FG000|STARTED|Overall Study||5176
11022653|NCT00809965|12200948|FG001|STARTED|Overall Study||5174
11022654|NCT00809965|12200949|FG002|STARTED|Overall Study||5176
11022655|NCT00809965|12200947|FG000|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
11022656|NCT00809965|12200948|FG001|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
11022657|NCT00809965|12200949|FG002|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
11022658|NCT00809965|12200947|FG000|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
11022659|NCT00809965|12200948|FG001|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
11022660|NCT00809965|12200949|FG002|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
11144182|NCT01476267|12330863|FG000|NOT COMPLETED|Overall Study||0
11022661|NCT00809965|12200947|FG000|COMPLETED|Overall Study||4393
11022662|NCT00809965|12200948|FG001|COMPLETED|Overall Study||4399
11416414|NCT00853229|12614039|FG001|NOT COMPLETED|Phase 1: Initial Intervention||8
11416415|NCT00853229|12614038|FG000|STARTED|Phase 2: Cross Over||0
11416416|NCT00853229|12614039|FG001|STARTED|Phase 2: Cross Over||0
11416417|NCT00853229|12614038|FG000|COMPLETED|Phase 2: Cross Over||0
11416418|NCT00853229|12614039|FG001|COMPLETED|Phase 2: Cross Over||0
11416419|NCT00853229|12614038|FG000|NOT COMPLETED|Phase 2: Cross Over||0
11022663|NCT00809965|12200949|FG002|COMPLETED|Overall Study||4332
11022664|NCT00809965|12200947|FG000|NOT COMPLETED|Overall Study||783
11416420|NCT00853229|12614039|FG001|NOT COMPLETED|Phase 2: Cross Over||0
11022665|NCT00809965|12200948|FG001|NOT COMPLETED|Overall Study||775
11022666|NCT00809965|12200949|FG002|NOT COMPLETED|Overall Study||844
11022667|NCT00810043|12200959|FG000|STARTED|Overall Study||57
11416421|NCT00860249|12614050|FG000|STARTED|Overall Study||21
11416422|NCT00860249|12614051|FG001|STARTED|Overall Study||18
11416423|NCT00860249|12614052|FG002|STARTED|Overall Study||21
11416424|NCT00860249|12614050|FG000|COMPLETED|Overall Study||0
11144183|NCT01476345|12330867|FG000|STARTED|Period 1||40
11144184|NCT01476345|12330868|FG001|STARTED|Period 1||40
11144185|NCT01476345|12330867|FG000|Received at Least 1 Dose of Study Drug|Period 1||40
11144186|NCT01476345|12330868|FG001|Received at Least 1 Dose of Study Drug|Period 1||40
11144187|NCT01476345|12330867|FG000|COMPLETED|Period 1||40
11144188|NCT01476345|12330868|FG001|COMPLETED|Period 1||40
11144189|NCT01476345|12330867|FG000|NOT COMPLETED|Period 1||0
11144190|NCT01476345|12330868|FG001|NOT COMPLETED|Period 1||0
11144191|NCT01476345|12330867|FG000|STARTED|Period 2||40
11144192|NCT01476345|12330868|FG001|STARTED|Period 2||40
11144193|NCT01476345|12330867|FG000|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
11144194|NCT01476345|12330868|FG001|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
11144195|NCT01476345|12330867|FG000|NOT COMPLETED|Period 2||0
11144196|NCT01476345|12330868|FG001|NOT COMPLETED|Period 2||0
11416425|NCT00860249|12614051|FG001|COMPLETED|Overall Study||0
11416426|NCT00860249|12614052|FG002|COMPLETED|Overall Study||0
11416427|NCT00860249|12614050|FG000|NOT COMPLETED|Overall Study||21
11416428|NCT00860249|12614051|FG001|NOT COMPLETED|Overall Study||18
11416429|NCT00860249|12614052|FG002|NOT COMPLETED|Overall Study||21
11416430|NCT00860158|12614060|FG000|STARTED|Overall Study||1
11416431|NCT00860158|12614060|FG000|COMPLETED|Overall Study||0
11416432|NCT00860158|12614060|FG000|NOT COMPLETED|Overall Study||1
11416433|NCT00853567|12614067|FG000|STARTED|Overall Study||71
11416434|NCT00853567|12614067|FG000|COMPLETED|Overall Study||0
11416435|NCT00853567|12614067|FG000|NOT COMPLETED|Overall Study||71
11416436|NCT00849524|12614075|FG000|STARTED|Overall Study||6
11416437|NCT00849524|12614075|FG000|COMPLETED|Overall Study||3
11416438|NCT00849524|12614075|FG000|NOT COMPLETED|Overall Study||3
11416439|NCT00843986|12614081|FG000|STARTED|Overall Study||3
11416440|NCT00843986|12614082|FG001|STARTED|Overall Study||6
11416441|NCT00843986|12614081|FG000|Completed Treatment (Infusion)|Overall Study||2
11416442|NCT00843986|12614082|FG001|Completed Treatment (Infusion)|Overall Study||6
11416443|NCT00843986|12614081|FG000|COMPLETED|Overall Study||2
11416444|NCT00843986|12614082|FG001|COMPLETED|Overall Study||5
11416445|NCT00843986|12614081|FG000|NOT COMPLETED|Overall Study||1
11416446|NCT00843986|12614082|FG001|NOT COMPLETED|Overall Study||1
11416447|NCT00851682|12614090|FG000|STARTED|Overall Study||60
11416448|NCT00851682|12614091|FG001|STARTED|Overall Study||5
11416449|NCT00851682|12614090|FG000|COMPLETED|Overall Study||55
11416450|NCT00851682|12614091|FG001|COMPLETED|Overall Study||5
11022668|NCT00810043|12200960|FG001|STARTED|Overall Study||55
11022669|NCT00810043|12200961|FG002|STARTED|Overall Study||8
11022670|NCT00810043|12200959|FG000|COMPLETED|Overall Study||53
11022671|NCT00810043|12200960|FG001|COMPLETED|Overall Study||54
11022672|NCT00810043|12200961|FG002|COMPLETED|Overall Study||0
11022673|NCT00810043|12200959|FG000|NOT COMPLETED|Overall Study||4
11022674|NCT00810043|12200960|FG001|NOT COMPLETED|Overall Study||1
11416451|NCT00851682|12614090|FG000|NOT COMPLETED|Overall Study||5
11022675|NCT00810043|12200961|FG002|NOT COMPLETED|Overall Study||8
11416452|NCT00851682|12614091|FG001|NOT COMPLETED|Overall Study||0
11416453|NCT00852124|12614099|FG000|STARTED|Overall Study||3
11416454|NCT00852124|12614100|FG001|STARTED|Overall Study||0
11416455|NCT00852124|12614099|FG000|COMPLETED|Overall Study||3
11416456|NCT00852124|12614100|FG001|COMPLETED|Overall Study||0
11416457|NCT00852124|12614099|FG000|NOT COMPLETED|Overall Study||0
11416458|NCT00852124|12614100|FG001|NOT COMPLETED|Overall Study||0
11416459|NCT00850421|12614105|FG000|STARTED|Overall Study||35
11416460|NCT00850421|12614105|FG000|COMPLETED|Overall Study||18
11416461|NCT00850421|12614105|FG000|NOT COMPLETED|Overall Study||17
11416462|NCT00851747|12614113|FG000|STARTED|Overall Study||6
11416463|NCT00851747|12614114|FG001|STARTED|Overall Study||6
11416464|NCT00851747|12614115|FG002|STARTED|Overall Study||6
11416465|NCT00851747|12614113|FG000|COMPLETED|Overall Study||0
11416466|NCT00851747|12614114|FG001|COMPLETED|Overall Study||0
11416467|NCT00851747|12614115|FG002|COMPLETED|Overall Study||0
11416468|NCT00851747|12614113|FG000|NOT COMPLETED|Overall Study||6
11416469|NCT00851747|12614114|FG001|NOT COMPLETED|Overall Study||6
11416470|NCT00851747|12614115|FG002|NOT COMPLETED|Overall Study||6
11416471|NCT00852241|12614122|FG000|STARTED|Overall Study||18
11416472|NCT00852241|12614122|FG000|COMPLETED|Overall Study||0
11416473|NCT00852241|12614122|FG000|NOT COMPLETED|Overall Study||18
11416474|NCT00851552|12614126|FG000|STARTED|Overall Study||9
11416475|NCT00851552|12614126|FG000|COMPLETED|Overall Study||2
11416476|NCT00851552|12614126|FG000|NOT COMPLETED|Overall Study||7
11416477|NCT00850720|12614130|FG000|STARTED|Overall Study||0
11416478|NCT00850720|12614130|FG000|COMPLETED|Overall Study||0
11416479|NCT00850720|12614130|FG000|NOT COMPLETED|Overall Study||0
11416480|NCT00845845|12614136|FG000|STARTED|Overall Study||3
11416481|NCT00845845|12614137|FG001|STARTED|Overall Study||6
11416482|NCT00845845|12614136|FG000|COMPLETED|Overall Study||3
11416483|NCT00845845|12614137|FG001|COMPLETED|Overall Study||2
11416484|NCT00845845|12614136|FG000|NOT COMPLETED|Overall Study||0
11416485|NCT00845845|12614137|FG001|NOT COMPLETED|Overall Study||4
11416486|NCT00851591|12614145|FG000|STARTED|Overall Study|These 2 participants did not receive treatment.|2
11416487|NCT00851591|12614146|FG001|STARTED|Overall Study|One received treatment.|1
11416488|NCT00851591|12614145|FG000|COMPLETED|Overall Study||0
11416489|NCT00851591|12614146|FG001|COMPLETED|Overall Study||1
11416490|NCT00851591|12614145|FG000|NOT COMPLETED|Overall Study||2
11416491|NCT00851591|12614146|FG001|NOT COMPLETED|Overall Study||0
11416492|NCT00847509|12614152|FG000|STARTED|Overall Study||49
11416493|NCT00847509|12614152|FG000|COMPLETED|Overall Study||38
11416494|NCT00847509|12614152|FG000|NOT COMPLETED|Overall Study||11
11416495|NCT00843310|12614156|FG000|STARTED|Overall Study||8
11416496|NCT00843310|12614156|FG000|COMPLETED|Overall Study||1
11416497|NCT00843310|12614156|FG000|NOT COMPLETED|Overall Study||7
11416498|NCT00847002|12614162|FG000|STARTED|Overall Study||4
11416499|NCT00847002|12614163|FG001|STARTED|Overall Study||4
11144197|NCT01476345|12330867|FG000|STARTED|Period 3||39
11144198|NCT01476345|12330868|FG001|STARTED|Period 3||39
11144199|NCT01476345|12330867|FG000|COMPLETED|Period 3||39
11144200|NCT01476345|12330868|FG001|COMPLETED|Period 3||39
11144201|NCT01476345|12330867|FG000|NOT COMPLETED|Period 3||0
11144202|NCT01476345|12330868|FG001|NOT COMPLETED|Period 3||0
11144203|NCT01476345|12330867|FG000|STARTED|Period 4||39
11144204|NCT01476345|12330868|FG001|STARTED|Period 4||39
11144205|NCT01476345|12330867|FG000|COMPLETED|Period 4||39
11144206|NCT01476345|12330868|FG001|COMPLETED|Period 4||39
11144207|NCT01476345|12330867|FG000|NOT COMPLETED|Period 4||0
11144208|NCT01476345|12330868|FG001|NOT COMPLETED|Period 4||0
11144209|NCT01476449|12330876|FG000|STARTED|Overall Study||10
11144210|NCT01476449|12330877|FG001|STARTED|Overall Study||10
11416500|NCT00847002|12614162|FG000|COMPLETED|Overall Study||4
11416501|NCT00847002|12614163|FG001|COMPLETED|Overall Study||4
11022676|NCT00810069|12200972|FG000|STARTED|Lead-in Period I||840
11022677|NCT00810069|12200973|FG001|STARTED|Lead-in Period I||0
11022678|NCT00810069|12200974|FG002|STARTED|Lead-in Period I||0
11022679|NCT00810069|12200972|FG000|COMPLETED|Lead-in Period I||566
11022680|NCT00810069|12200973|FG001|COMPLETED|Lead-in Period I||0
11022681|NCT00810069|12200974|FG002|COMPLETED|Lead-in Period I||0
11022682|NCT00810069|12200972|FG000|NOT COMPLETED|Lead-in Period I||274
11022683|NCT00810069|12200973|FG001|NOT COMPLETED|Lead-in Period I||0
11022684|NCT00810069|12200974|FG002|NOT COMPLETED|Lead-in Period I||0
11022685|NCT00810069|12200972|FG000|STARTED|Double-Blind Period II||0
11022686|NCT00810069|12200973|FG001|STARTED|Double-Blind Period II||282
11022687|NCT00810069|12200974|FG002|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
11022688|NCT00810069|12200972|FG000|COMPLETED|Double-Blind Period II||0
11022689|NCT00810069|12200973|FG001|COMPLETED|Double-Blind Period II||226
11022690|NCT00810069|12200974|FG002|COMPLETED|Double-Blind Period II||212
11022691|NCT00810069|12200972|FG000|NOT COMPLETED|Double-Blind Period II||0
11022692|NCT00810069|12200973|FG001|NOT COMPLETED|Double-Blind Period II||56
11022693|NCT00810069|12200974|FG002|NOT COMPLETED|Double-Blind Period II||72
11022694|NCT00810082|12200985|FG000|STARTED|Overall Study||34
11022695|NCT00810082|12200986|FG001|STARTED|Overall Study||31
11022696|NCT00810082|12200985|FG000|COMPLETED|Overall Study||34
11022697|NCT00810082|12200986|FG001|COMPLETED|Overall Study||27
11022698|NCT00810082|12200985|FG000|NOT COMPLETED|Overall Study||0
11022699|NCT00810082|12200986|FG001|NOT COMPLETED|Overall Study||4
11022700|NCT00810095|12200992|FG000|STARTED|Overall Study||40
11022701|NCT00810095|12200992|FG000|COMPLETED|Overall Study||40
11022702|NCT00810095|12200992|FG000|NOT COMPLETED|Overall Study||0
11022703|NCT00810108|12200998|FG000|STARTED|Overall Study||6
11022704|NCT00810108|12200999|FG001|STARTED|Overall Study||7
11022705|NCT00810108|12200998|FG000|COMPLETED|Overall Study||5
11022706|NCT00810108|12200999|FG001|COMPLETED|Overall Study||7
11022707|NCT00810108|12200998|FG000|NOT COMPLETED|Overall Study||1
11022708|NCT00810108|12200999|FG001|NOT COMPLETED|Overall Study||0
11022709|NCT00810199|12201006|FG000|STARTED|Overall Study||279
11022710|NCT00810199|12201007|FG001|STARTED|Overall Study||277
11022711|NCT00810199|12201006|FG000|Received Study Drug|Overall Study||277
11022712|NCT00810199|12201007|FG001|Received Study Drug|Overall Study||276
11022713|NCT00810199|12201006|FG000|Completed Week 24|Overall Study||259
11022714|NCT00810199|12201007|FG001|Completed Week 24|Overall Study||250
11022715|NCT00810199|12201006|FG000|Completed Week 52|Overall Study||243
11022716|NCT00810199|12201007|FG001|Completed Week 52|Overall Study||229
11022717|NCT00810199|12201006|FG000|Completed Week 104|Overall Study||222
11022718|NCT00810199|12201007|FG001|Completed Week 104|Overall Study||201
11022719|NCT00810199|12201006|FG000|COMPLETED|Overall Study||220
11022720|NCT00810199|12201007|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|195
11022721|NCT00810199|12201006|FG000|NOT COMPLETED|Overall Study||59
11022722|NCT00810199|12201007|FG001|NOT COMPLETED|Overall Study||82
11022723|NCT00810264|12201019|FG000|STARTED|Overall Study||2499
11022724|NCT00810264|12201019|FG000|COMPLETED|Overall Study||946
11022725|NCT00810264|12201019|FG000|NOT COMPLETED|Overall Study||1553
11022726|NCT00810277|12201027|FG000|STARTED|Overall Study||14
11022727|NCT00810277|12201027|FG000|COMPLETED|Overall Study||13
11022728|NCT00810277|12201027|FG000|NOT COMPLETED|Overall Study||1
11022729|NCT00810303|12201031|FG000|STARTED|Efavirenz Alone - Day 1-5||12
11022730|NCT00810303|12201031|FG000|COMPLETED|Efavirenz Alone - Day 1-5||12
11022731|NCT00810303|12201031|FG000|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
11022732|NCT00810303|12201031|FG000|STARTED|Ezetimibe Alone - Day 6-15||12
11022733|NCT00810303|12201031|FG000|COMPLETED|Ezetimibe Alone - Day 6-15||12
11022734|NCT00810303|12201031|FG000|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
11022735|NCT00810303|12201031|FG000|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
11022736|NCT00810303|12201031|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
11022737|NCT00810303|12201031|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
11022738|NCT00810303|12201031|FG000|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
11416502|NCT00847002|12614162|FG000|NOT COMPLETED|Overall Study||0
11416503|NCT00847002|12614163|FG001|NOT COMPLETED|Overall Study||0
11416504|NCT00845702|12614169|FG000|STARTED|TOF MRA||33
11416505|NCT00845702|12614169|FG000|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
11416506|NCT00845702|12614169|FG000|NOT COMPLETED|TOF MRA||1
11416507|NCT00845702|12614169|FG000|STARTED|Dotarem MRA||32
11416508|NCT00845702|12614169|FG000|COMPLETED|Dotarem MRA||32
11416509|NCT00845702|12614169|FG000|NOT COMPLETED|Dotarem MRA||0
11416510|NCT00843830|12614175|FG000|STARTED|Overall Study||4
11416511|NCT00843830|12614175|FG000|COMPLETED|Overall Study||4
11416512|NCT00843830|12614175|FG000|NOT COMPLETED|Overall Study||0
11416513|NCT00835679|12614183|FG000|STARTED|Overall Study||9
11416514|NCT00835679|12614184|FG001|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
11416515|NCT00835679|12614185|FG002|STARTED|Overall Study||0
11416516|NCT00835679|12614186|FG003|STARTED|Overall Study||0
11022739|NCT00810303|12201031|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
11022740|NCT00810303|12201031|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
11022741|NCT00810342|12201041|FG000|STARTED|Month 1 Follow-up||154
11022742|NCT00810342|12201042|FG001|STARTED|Month 1 Follow-up||157
11022743|NCT00810342|12201041|FG000|COMPLETED|Month 1 Follow-up||149
11022744|NCT00810342|12201042|FG001|COMPLETED|Month 1 Follow-up||155
11022745|NCT00810342|12201041|FG000|NOT COMPLETED|Month 1 Follow-up||5
11022746|NCT00810342|12201042|FG001|NOT COMPLETED|Month 1 Follow-up||2
11022747|NCT00810342|12201041|FG000|STARTED|6-month Follow-up||149
11022748|NCT00810342|12201042|FG001|STARTED|6-month Follow-up||155
11022749|NCT00810342|12201041|FG000|COMPLETED|6-month Follow-up||125
11022750|NCT00810342|12201042|FG001|COMPLETED|6-month Follow-up||147
11022751|NCT00810342|12201041|FG000|NOT COMPLETED|6-month Follow-up||24
11022752|NCT00810342|12201042|FG001|NOT COMPLETED|6-month Follow-up||8
11022753|NCT00810342|12201041|FG000|STARTED|12-month Followup||125
11022754|NCT00810342|12201042|FG001|STARTED|12-month Followup||147
11022755|NCT00810342|12201041|FG000|COMPLETED|12-month Followup||113
11022756|NCT00810342|12201042|FG001|COMPLETED|12-month Followup||136
11022757|NCT00810342|12201041|FG000|NOT COMPLETED|12-month Followup||12
11022758|NCT00810342|12201042|FG001|NOT COMPLETED|12-month Followup||11
11022759|NCT00810355|12201053|FG000|STARTED|Overall Study||25
11022760|NCT00810355|12201054|FG001|STARTED|Overall Study||25
11022761|NCT00810355|12201055|FG002|STARTED|Overall Study||25
11022762|NCT00810355|12201053|FG000|COMPLETED|Overall Study||11
11022763|NCT00810355|12201054|FG001|COMPLETED|Overall Study||8
11022764|NCT00810355|12201055|FG002|COMPLETED|Overall Study||14
11022765|NCT00810355|12201053|FG000|NOT COMPLETED|Overall Study||14
11022766|NCT00810355|12201054|FG001|NOT COMPLETED|Overall Study||17
11416517|NCT00835679|12614183|FG000|COMPLETED|Overall Study||8
11416518|NCT00835679|12614184|FG001|COMPLETED|Overall Study||0
11416519|NCT00835679|12614185|FG002|COMPLETED|Overall Study||0
11416520|NCT00835679|12614186|FG003|COMPLETED|Overall Study||0
11416521|NCT00835679|12614183|FG000|NOT COMPLETED|Overall Study||1
11416522|NCT00835679|12614184|FG001|NOT COMPLETED|Overall Study||0
11416523|NCT00835679|12614185|FG002|NOT COMPLETED|Overall Study||0
11416524|NCT00835679|12614186|FG003|NOT COMPLETED|Overall Study||0
11416525|NCT00841035|12614200|FG000|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
11416526|NCT00841035|12614200|FG000|COMPLETED|Phase 1 Overall Study||6
11416527|NCT00841035|12614200|FG000|NOT COMPLETED|Phase 1 Overall Study||13
11416528|NCT00841035|12614200|FG000|STARTED|Phase 2 of Overall Study||6
11416529|NCT00841035|12614200|FG000|COMPLETED|Phase 2 of Overall Study||6
11416530|NCT00841035|12614200|FG000|NOT COMPLETED|Phase 2 of Overall Study||0
11416531|NCT00832520|12614205|FG000|STARTED|Overall Study||13
11416532|NCT00832520|12614205|FG000|COMPLETED|Overall Study||13
11416533|NCT00832520|12614205|FG000|NOT COMPLETED|Overall Study||0
11416534|NCT00833859|12614209|FG000|STARTED|Overall Study||2
11416535|NCT00833859|12614209|FG000|COMPLETED|Overall Study||2
11416536|NCT00833859|12614209|FG000|NOT COMPLETED|Overall Study||0
11416537|NCT00843050|12614213|FG000|STARTED|Overall Study||13
11416538|NCT00843050|12614213|FG000|COMPLETED|Overall Study||0
11416539|NCT00843050|12614213|FG000|NOT COMPLETED|Overall Study||13
11416540|NCT00840827|12614218|FG000|STARTED|Overall Study||6
11416541|NCT00840827|12614218|FG000|COMPLETED|Overall Study||0
11416542|NCT00840827|12614218|FG000|NOT COMPLETED|Overall Study||6
11416543|NCT00835328|12614226|FG000|STARTED|Cohort 1: Dose Level 1||5
11416544|NCT00835328|12614227|FG001|STARTED|Cohort 1: Dose Level 1||0
11416545|NCT00835328|12614228|FG002|STARTED|Cohort 1: Dose Level 1||0
11416546|NCT00835328|12614229|FG003|STARTED|Cohort 1: Dose Level 1||0
11416547|NCT00835328|12614226|FG000|COMPLETED|Cohort 1: Dose Level 1||5
11416548|NCT00835328|12614227|FG001|COMPLETED|Cohort 1: Dose Level 1||0
11416549|NCT00835328|12614228|FG002|COMPLETED|Cohort 1: Dose Level 1||0
11416550|NCT00835328|12614229|FG003|COMPLETED|Cohort 1: Dose Level 1||0
11416551|NCT00835328|12614226|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0
11416552|NCT00835328|12614227|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0
11416553|NCT00835328|12614228|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
11416554|NCT00835328|12614229|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0
11416555|NCT00835328|12614226|FG000|STARTED|Cohort 2: Dose Level 2||0
11416556|NCT00835328|12614227|FG001|STARTED|Cohort 2: Dose Level 2||2
11416557|NCT00835328|12614228|FG002|STARTED|Cohort 2: Dose Level 2||0
11416558|NCT00835328|12614229|FG003|STARTED|Cohort 2: Dose Level 2||0
11416559|NCT00835328|12614226|FG000|COMPLETED|Cohort 2: Dose Level 2||0
11416560|NCT00835328|12614227|FG001|COMPLETED|Cohort 2: Dose Level 2||2
11416561|NCT00835328|12614228|FG002|COMPLETED|Cohort 2: Dose Level 2||0
11416562|NCT00835328|12614229|FG003|COMPLETED|Cohort 2: Dose Level 2||0
11416563|NCT00835328|12614226|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
11416564|NCT00835328|12614227|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0
11416565|NCT00835328|12614228|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0
11416566|NCT00835328|12614229|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||0
11416567|NCT00835328|12614226|FG000|STARTED|Cohort 3: Dose Level 3||0
11416568|NCT00835328|12614227|FG001|STARTED|Cohort 3: Dose Level 3||0
11416569|NCT00835328|12614228|FG002|STARTED|Cohort 3: Dose Level 3||2
11416570|NCT00835328|12614229|FG003|STARTED|Cohort 3: Dose Level 3||0
11416571|NCT00835328|12614226|FG000|COMPLETED|Cohort 3: Dose Level 3||0
11416572|NCT00835328|12614227|FG001|COMPLETED|Cohort 3: Dose Level 3||0
11416573|NCT00835328|12614228|FG002|COMPLETED|Cohort 3: Dose Level 3||2
11416574|NCT00835328|12614229|FG003|COMPLETED|Cohort 3: Dose Level 3||0
11416575|NCT00835328|12614226|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
11416576|NCT00835328|12614227|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
11416577|NCT00835328|12614228|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0
11416578|NCT00835328|12614229|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0
11416579|NCT00835328|12614226|FG000|STARTED|Cohort 4: Dose Level 4|Cohort#4 enrolled 4 subsequent subjects|0
11416580|NCT00835328|12614227|FG001|STARTED|Cohort 4: Dose Level 4||0
11416581|NCT00835328|12614228|FG002|STARTED|Cohort 4: Dose Level 4||0
11416582|NCT00835328|12614229|FG003|STARTED|Cohort 4: Dose Level 4||4
11416583|NCT00835328|12614226|FG000|COMPLETED|Cohort 4: Dose Level 4||0
11416584|NCT00835328|12614227|FG001|COMPLETED|Cohort 4: Dose Level 4||0
11416585|NCT00835328|12614228|FG002|COMPLETED|Cohort 4: Dose Level 4||0
11416586|NCT00835328|12614229|FG003|COMPLETED|Cohort 4: Dose Level 4||4
11416587|NCT00835328|12614226|FG000|NOT COMPLETED|Cohort 4: Dose Level 4||0
11416588|NCT00835328|12614227|FG001|NOT COMPLETED|Cohort 4: Dose Level 4||0
11416589|NCT00835328|12614228|FG002|NOT COMPLETED|Cohort 4: Dose Level 4||0
11416590|NCT00835328|12614229|FG003|NOT COMPLETED|Cohort 4: Dose Level 4||0
11416591|NCT00832572|12614243|FG000|STARTED|Period 1||3
11416592|NCT00832572|12614244|FG001|STARTED|Period 1||2
11416593|NCT00832572|12614243|FG000|COMPLETED|Period 1||3
11416594|NCT00832572|12614244|FG001|COMPLETED|Period 1||2
11416595|NCT00832572|12614243|FG000|NOT COMPLETED|Period 1||0
11416596|NCT00832572|12614244|FG001|NOT COMPLETED|Period 1||0
11416597|NCT00832572|12614243|FG000|STARTED|Period 2||3
11416598|NCT00832572|12614244|FG001|STARTED|Period 2||2
11416599|NCT00832572|12614243|FG000|COMPLETED|Period 2||3
11416600|NCT00832572|12614244|FG001|COMPLETED|Period 2||2
11416601|NCT00832572|12614243|FG000|NOT COMPLETED|Period 2||0
11416602|NCT00832572|12614244|FG001|NOT COMPLETED|Period 2||0
11416603|NCT00832624|12614252|FG000|STARTED|Overall Study||10
11416604|NCT00832624|12614252|FG000|COMPLETED|Overall Study||0
11416605|NCT00832624|12614252|FG000|NOT COMPLETED|Overall Study||10
11416606|NCT00832299|12614256|FG000|STARTED|Overall Study||2
11416607|NCT00832299|12614256|FG000|COMPLETED|Overall Study||2
11416608|NCT00832299|12614256|FG000|NOT COMPLETED|Overall Study||0
11416609|NCT00836355|12614264|FG000|STARTED|Overall Study||0
11416610|NCT00836355|12614265|FG001|STARTED|Overall Study||4
11416611|NCT00836355|12614266|FG002|STARTED|Overall Study||0
11416612|NCT00836355|12614267|FG003|STARTED|Overall Study||2
11416613|NCT00836355|12614264|FG000|COMPLETED|Overall Study||0
11416614|NCT00836355|12614265|FG001|COMPLETED|Overall Study||4
11416615|NCT00836355|12614266|FG002|COMPLETED|Overall Study||0
11416616|NCT00836355|12614267|FG003|COMPLETED|Overall Study||2
11416617|NCT00836355|12614264|FG000|NOT COMPLETED|Overall Study||0
11416618|NCT00836355|12614265|FG001|NOT COMPLETED|Overall Study||0
11416619|NCT00836355|12614266|FG002|NOT COMPLETED|Overall Study||0
11416620|NCT00836355|12614267|FG003|NOT COMPLETED|Overall Study||0
11416621|NCT00832598|12614277|FG000|STARTED|Overall Study||13
11416622|NCT00832598|12614277|FG000|COMPLETED|Overall Study||13
11416623|NCT00832598|12614277|FG000|NOT COMPLETED|Overall Study||0
11416624|NCT00816777|12614283|FG000|STARTED|Overall Study||2
11416625|NCT00816777|12614284|FG001|STARTED|Overall Study||2
11416626|NCT00816777|12614283|FG000|COMPLETED|Overall Study||2
11416627|NCT00816777|12614284|FG001|COMPLETED|Overall Study||2
11416628|NCT00816777|12614283|FG000|NOT COMPLETED|Overall Study||0
11416629|NCT00816777|12614284|FG001|NOT COMPLETED|Overall Study||0
11416630|NCT00823095|12614290|FG000|STARTED|Overall Study||7
11416631|NCT00823095|12614290|FG000|COMPLETED|Overall Study||7
11416632|NCT00823095|12614290|FG000|NOT COMPLETED|Overall Study||0
11416633|NCT00827567|12614295|FG000|STARTED|Overall Study||4
11416634|NCT00827567|12614295|FG000|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
11416635|NCT00827567|12614295|FG000|NOT COMPLETED|Overall Study||4
11416636|NCT00815633|12614299|FG000|STARTED|Overall Study||1
11416637|NCT00815633|12614299|FG000|COMPLETED|Overall Study||0
11416638|NCT00815633|12614299|FG000|NOT COMPLETED|Overall Study||1
11416639|NCT00814983|12614305|FG000|STARTED|Overall Study||15
11416640|NCT00814983|12614306|FG001|STARTED|Overall Study||0
11416641|NCT00814983|12614305|FG000|COMPLETED|Overall Study||12
11416642|NCT00814983|12614306|FG001|COMPLETED|Overall Study||0
11416643|NCT00814983|12614305|FG000|NOT COMPLETED|Overall Study||3
11416644|NCT00814983|12614306|FG001|NOT COMPLETED|Overall Study||0
11416645|NCT00825227|12614314|FG000|STARTED|Overall Study||6
11416646|NCT00825227|12614315|FG001|STARTED|Overall Study||4
11416647|NCT00825227|12614314|FG000|COMPLETED|Overall Study||6
11416648|NCT00825227|12614315|FG001|COMPLETED|Overall Study||4
11416649|NCT00825227|12614314|FG000|NOT COMPLETED|Overall Study||0
11416650|NCT00825227|12614315|FG001|NOT COMPLETED|Overall Study||0
11416651|NCT00819832|12614329|FG000|STARTED|Overall Study|No patient data analysis.|3
11416652|NCT00819832|12614330|FG001|STARTED|Overall Study||0
11416653|NCT00819832|12614331|FG002|STARTED|Overall Study||0
11416654|NCT00819832|12614332|FG003|STARTED|Overall Study||0
11416655|NCT00819832|12614333|FG004|STARTED|Overall Study||0
11416656|NCT00819832|12614334|FG005|STARTED|Overall Study||0
11416657|NCT00819832|12614329|FG000|COMPLETED|Overall Study||0
11416658|NCT00819832|12614330|FG001|COMPLETED|Overall Study||0
11416659|NCT00819832|12614331|FG002|COMPLETED|Overall Study||0
11416660|NCT00819832|12614332|FG003|COMPLETED|Overall Study||0
11416661|NCT00819832|12614333|FG004|COMPLETED|Overall Study||0
11416662|NCT00819832|12614334|FG005|COMPLETED|Overall Study||0
11416663|NCT00819832|12614329|FG000|NOT COMPLETED|Overall Study||3
11416664|NCT00819832|12614330|FG001|NOT COMPLETED|Overall Study||0
11416665|NCT00819832|12614331|FG002|NOT COMPLETED|Overall Study||0
11416666|NCT00819832|12614332|FG003|NOT COMPLETED|Overall Study||0
11416667|NCT00819832|12614333|FG004|NOT COMPLETED|Overall Study||0
11416668|NCT00819832|12614334|FG005|NOT COMPLETED|Overall Study||0
11416669|NCT00822679|12614350|FG000|STARTED|Overall Study||0
11416670|NCT00822679|12614351|FG001|STARTED|Overall Study||0
11416671|NCT00822679|12614350|FG000|COMPLETED|Overall Study||0
11416672|NCT00822679|12614351|FG001|COMPLETED|Overall Study||0
11416673|NCT00822679|12614350|FG000|NOT COMPLETED|Overall Study||0
11416674|NCT00822679|12614351|FG001|NOT COMPLETED|Overall Study||0
11416675|NCT00814892|12614357|FG000|STARTED|Overall Study||2
11416676|NCT00814892|12614357|FG000|COMPLETED|Overall Study||0
11022767|NCT00810355|12201055|FG002|NOT COMPLETED|Overall Study||11
11022768|NCT00810368|12201065|FG000|STARTED|Overall Study||18
11022769|NCT00810368|12201066|FG001|STARTED|Overall Study||15
11022770|NCT00810368|12201065|FG000|COMPLETED|Overall Study||12
11022771|NCT00810368|12201066|FG001|COMPLETED|Overall Study||13
11022772|NCT00810368|12201065|FG000|NOT COMPLETED|Overall Study||6
11022773|NCT00810368|12201066|FG001|NOT COMPLETED|Overall Study||2
11022774|NCT00810394|12201074|FG000|STARTED|Overall Study||50
11022775|NCT00810394|12201074|FG000|Cycle 2 600mg Twice Daily|Overall Study||13
11022776|NCT00810394|12201074|FG000|Cycle 2 400mg Once Daily|Overall Study||22
11022777|NCT00810394|12201074|FG000|Cycle 3 800 mg Twice Daily|Overall Study||4
11022778|NCT00810394|12201074|FG000|Cycle 3 400mg Twice Daily|Overall Study||5
11022779|NCT00810394|12201074|FG000|COMPLETED|Overall Study||47
11022780|NCT00810394|12201074|FG000|NOT COMPLETED|Overall Study||3
11022781|NCT00810407|12201078|FG000|STARTED|Overall Study||594
11416677|NCT00814892|12614357|FG000|NOT COMPLETED|Overall Study||2
11022782|NCT00810407|12201078|FG000|COMPLETED|Overall Study||588
11022783|NCT00810407|12201078|FG000|NOT COMPLETED|Overall Study||6
11022784|NCT00810459|12201082|FG000|STARTED|Overall Study||4
11144211|NCT01476449|12330876|FG000|COMPLETED|Overall Study||8
11144212|NCT01476449|12330877|FG001|COMPLETED|Overall Study||8
11144213|NCT01476449|12330876|FG000|NOT COMPLETED|Overall Study||2
11416678|NCT00809458|12614363|FG000|STARTED|Overall Study||9
11416679|NCT00809458|12614364|FG001|STARTED|Overall Study||6
11416680|NCT00809458|12614363|FG000|COMPLETED|Overall Study||8
11416681|NCT00809458|12614364|FG001|COMPLETED|Overall Study||5
11022785|NCT00810459|12201083|FG001|STARTED|Overall Study||2
11022786|NCT00810459|12201082|FG000|COMPLETED|Overall Study||4
11022787|NCT00810459|12201083|FG001|COMPLETED|Overall Study||2
11022788|NCT00810459|12201082|FG000|NOT COMPLETED|Overall Study||0
11022789|NCT00810459|12201083|FG001|NOT COMPLETED|Overall Study||0
11022790|NCT00810498|12201090|FG000|STARTED|Overall Study||6
11022791|NCT00810498|12201091|FG001|STARTED|Overall Study||5
11022792|NCT00810498|12201090|FG000|COMPLETED|Overall Study||6
11022793|NCT00810498|12201091|FG001|COMPLETED|Overall Study||5
11022794|NCT00810498|12201090|FG000|NOT COMPLETED|Overall Study||0
11022795|NCT00810498|12201091|FG001|NOT COMPLETED|Overall Study||0
11022796|NCT00810511|12201099|FG000|STARTED|Overall Study||107
11022797|NCT00810511|12201100|FG001|STARTED|Overall Study||106
11022798|NCT00810511|12201099|FG000|COMPLETED|Overall Study||97
11022799|NCT00810511|12201100|FG001|COMPLETED|Overall Study||102
11022800|NCT00810511|12201099|FG000|NOT COMPLETED|Overall Study||10
11022801|NCT00810511|12201100|FG001|NOT COMPLETED|Overall Study||4
11022802|NCT00810576|12201106|FG000|STARTED|Overall Study||1
11022803|NCT00810576|12201106|FG000|COMPLETED|Overall Study||1
11022804|NCT00810576|12201106|FG000|NOT COMPLETED|Overall Study||0
11022805|NCT00810602|12201110|FG000|STARTED|Overall Study||27
11022806|NCT00810602|12201111|FG001|STARTED|Overall Study||34
11022807|NCT00810602|12201110|FG000|COMPLETED|Overall Study||19
11022808|NCT00810602|12201111|FG001|COMPLETED|Overall Study||31
11022809|NCT00810602|12201110|FG000|NOT COMPLETED|Overall Study||8
11022810|NCT00810602|12201111|FG001|NOT COMPLETED|Overall Study||3
11416682|NCT00809458|12614363|FG000|NOT COMPLETED|Overall Study||1
11022811|NCT00810615|12201117|FG000|STARTED|Overall Study||25
11022812|NCT00810615|12201118|FG001|STARTED|Overall Study||25
11022813|NCT00810615|12201117|FG000|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
11022814|NCT00810615|12201118|FG001|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
11022815|NCT00810615|12201117|FG000|NOT COMPLETED|Overall Study||1
11022816|NCT00810615|12201118|FG001|NOT COMPLETED|Overall Study||1
11022817|NCT00810641|12201139|FG000|STARTED|Overall Study||52
11416683|NCT00809458|12614364|FG001|NOT COMPLETED|Overall Study||1
11416684|NCT00802659|12614374|FG000|STARTED|Overall Study||0
11416685|NCT00802659|12614375|FG001|STARTED|Overall Study||2
11416686|NCT00802659|12614376|FG002|STARTED|Overall Study||0
11416687|NCT00802659|12614377|FG003|STARTED|Overall Study||0
11416688|NCT00802659|12614374|FG000|COMPLETED|Overall Study||0
11416689|NCT00802659|12614375|FG001|COMPLETED|Overall Study||1
11416690|NCT00802659|12614376|FG002|COMPLETED|Overall Study||0
11416691|NCT00802659|12614377|FG003|COMPLETED|Overall Study||0
11416692|NCT00802659|12614374|FG000|NOT COMPLETED|Overall Study||0
11416693|NCT00802659|12614375|FG001|NOT COMPLETED|Overall Study||1
11416694|NCT00802659|12614376|FG002|NOT COMPLETED|Overall Study||0
11416695|NCT00802659|12614377|FG003|NOT COMPLETED|Overall Study||0
11416696|NCT00807365|12614387|FG000|STARTED|Overall Study||5
11416697|NCT00807365|12614387|FG000|COMPLETED|Overall Study||0
11416698|NCT00807365|12614387|FG000|NOT COMPLETED|Overall Study||5
11416699|NCT00814333|12614393|FG000|STARTED|Enrollment||1
11416700|NCT00814333|12614394|FG001|STARTED|Enrollment||0
11416701|NCT00814333|12614393|FG000|COMPLETED|Enrollment||0
11416702|NCT00814333|12614394|FG001|COMPLETED|Enrollment||0
11416703|NCT00814333|12614393|FG000|NOT COMPLETED|Enrollment||1
11416704|NCT00814333|12614394|FG001|NOT COMPLETED|Enrollment||0
11416705|NCT00814333|12614393|FG000|STARTED|Treatment Period||0
11416706|NCT00814333|12614394|FG001|STARTED|Treatment Period||0
11416707|NCT00814333|12614393|FG000|COMPLETED|Treatment Period||0
11416708|NCT00814333|12614394|FG001|COMPLETED|Treatment Period||0
11416709|NCT00814333|12614393|FG000|NOT COMPLETED|Treatment Period||0
11416710|NCT00814333|12614394|FG001|NOT COMPLETED|Treatment Period||0
11416711|NCT00808080|12614400|FG000|STARTED|Overall Study||6
11416712|NCT00808080|12614400|FG000|COMPLETED|Overall Study||0
11416713|NCT00808080|12614400|FG000|NOT COMPLETED|Overall Study||6
11416714|NCT00802893|12614405|FG000|STARTED|Overall Study||3
11416715|NCT00802893|12614405|FG000|COMPLETED|Overall Study||0
11416716|NCT00802893|12614405|FG000|NOT COMPLETED|Overall Study||3
11416717|NCT00809341|12614411|FG000|STARTED|Overall Study||20
11416718|NCT00809341|12614412|FG001|STARTED|Overall Study||5
11416719|NCT00809341|12614411|FG000|COMPLETED|Overall Study||20
11416720|NCT00809341|12614412|FG001|COMPLETED|Overall Study||4
11416721|NCT00809341|12614411|FG000|NOT COMPLETED|Overall Study||0
11416722|NCT00809341|12614412|FG001|NOT COMPLETED|Overall Study||1
11416723|NCT00804349|12614420|FG000|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available.|0
11416724|NCT00804349|12614421|FG001|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
11416725|NCT00804349|12614420|FG000|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
11416726|NCT00804349|12614421|FG001|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
11416727|NCT00804349|12614420|FG000|NOT COMPLETED|Overall Study||0
11416728|NCT00804349|12614421|FG001|NOT COMPLETED|Overall Study||0
11416729|NCT00803283|12614429|FG000|STARTED|Overall Study||1
11416730|NCT00803283|12614430|FG001|STARTED|Overall Study||1
11416731|NCT00803283|12614429|FG000|COMPLETED|Overall Study||1
11416732|NCT00803283|12614430|FG001|COMPLETED|Overall Study||1
11416733|NCT00803283|12614429|FG000|NOT COMPLETED|Overall Study||0
11416734|NCT00803283|12614430|FG001|NOT COMPLETED|Overall Study||0
11416735|NCT00811590|12614436|FG000|STARTED|Overall Study||3
11416736|NCT00811590|12614436|FG000|COMPLETED|Overall Study||3
11416737|NCT00811590|12614436|FG000|NOT COMPLETED|Overall Study||0
11416738|NCT00808899|12614440|FG000|STARTED|Overall Study||4
11416739|NCT00808899|12614440|FG000|COMPLETED|Overall Study||0
11416740|NCT00808899|12614440|FG000|NOT COMPLETED|Overall Study||4
11416741|NCT00808769|12614444|FG000|STARTED|First Intervention||15
11416742|NCT00808769|12614445|FG001|STARTED|First Intervention||15
11416743|NCT00808769|12614444|FG000|COMPLETED|First Intervention||15
11416744|NCT00808769|12614445|FG001|COMPLETED|First Intervention||15
11416745|NCT00808769|12614444|FG000|NOT COMPLETED|First Intervention||0
11416746|NCT00808769|12614445|FG001|NOT COMPLETED|First Intervention||0
11416747|NCT00808769|12614444|FG000|STARTED|Second Intervention||15
11416748|NCT00808769|12614445|FG001|STARTED|Second Intervention||15
11416749|NCT00808769|12614444|FG000|COMPLETED|Second Intervention||15
11416750|NCT00808769|12614445|FG001|COMPLETED|Second Intervention||15
11416751|NCT00808769|12614444|FG000|NOT COMPLETED|Second Intervention||0
11416752|NCT00808769|12614445|FG001|NOT COMPLETED|Second Intervention||0
11022818|NCT00810641|12201140|FG001|STARTED|Overall Study||54
11022819|NCT00810641|12201141|FG002|STARTED|Overall Study||51
11022820|NCT00810641|12201139|FG000|COMPLETED|Overall Study||52
11022821|NCT00810641|12201140|FG001|COMPLETED|Overall Study||53
11022822|NCT00810641|12201141|FG002|COMPLETED|Overall Study||49
11022823|NCT00810641|12201139|FG000|NOT COMPLETED|Overall Study||0
11022824|NCT00810641|12201140|FG001|NOT COMPLETED|Overall Study||1
11022825|NCT00810641|12201141|FG002|NOT COMPLETED|Overall Study||2
11022826|NCT00810693|12201152|FG000|STARTED|Treatment Period||254
11022827|NCT00810693|12201153|FG001|STARTED|Treatment Period|1 randomized but not treated|64
11022828|NCT00810693|12201154|FG002|STARTED|Treatment Period|1 randomized but not treated|127
11022829|NCT00810693|12201152|FG000|Participants Received Treatment|Treatment Period||254
11022830|NCT00810693|12201153|FG001|Participants Received Treatment|Treatment Period||63
11022831|NCT00810693|12201154|FG002|Participants Received Treatment|Treatment Period||126
11022832|NCT00810693|12201152|FG000|COMPLETED|Treatment Period||237
11022833|NCT00810693|12201153|FG001|COMPLETED|Treatment Period||57
11022834|NCT00810693|12201154|FG002|COMPLETED|Treatment Period||111
11022835|NCT00810693|12201152|FG000|NOT COMPLETED|Treatment Period||17
11022836|NCT00810693|12201153|FG001|NOT COMPLETED|Treatment Period||7
11022837|NCT00810693|12201154|FG002|NOT COMPLETED|Treatment Period||16
11022838|NCT00810693|12201152|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
11022839|NCT00810693|12201153|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
11022840|NCT00810693|12201154|FG002|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
11022841|NCT00810693|12201152|FG000|COMPLETED|Follow-up Period (FUP)||15
11022842|NCT00810693|12201153|FG001|COMPLETED|Follow-up Period (FUP)||4
11022843|NCT00810693|12201154|FG002|COMPLETED|Follow-up Period (FUP)||12
11022844|NCT00810693|12201152|FG000|NOT COMPLETED|Follow-up Period (FUP)||8
11022845|NCT00810693|12201153|FG001|NOT COMPLETED|Follow-up Period (FUP)||3
11022846|NCT00810693|12201154|FG002|NOT COMPLETED|Follow-up Period (FUP)||4
11022847|NCT00810719|12201162|FG000|STARTED|Overall Study||30
11022848|NCT00810719|12201162|FG000|COMPLETED|Overall Study||30
11022849|NCT00810719|12201162|FG000|NOT COMPLETED|Overall Study||0
11022850|NCT00810771|12201169|FG000|STARTED|Overall Study||232
11022851|NCT00810771|12201170|FG001|STARTED|Overall Study||234
11022852|NCT00810771|12201171|FG002|STARTED|Overall Study||84
11022853|NCT00810771|12201169|FG000|COMPLETED|Overall Study||232
11022854|NCT00810771|12201170|FG001|COMPLETED|Overall Study||234
11022855|NCT00810771|12201171|FG002|COMPLETED|Overall Study||84
11022856|NCT00810771|12201169|FG000|NOT COMPLETED|Overall Study||0
11022857|NCT00810771|12201170|FG001|NOT COMPLETED|Overall Study||0
11022858|NCT00810771|12201171|FG002|NOT COMPLETED|Overall Study||0
11022859|NCT00810797|12201181|FG000|STARTED|Overall Study||36
11416753|NCT00803179|12614451|FG000|STARTED|Overall Study||5
11416754|NCT00803179|12614451|FG000|COMPLETED|Overall Study||2
11416755|NCT00803179|12614451|FG000|NOT COMPLETED|Overall Study||3
11416756|NCT00801931|12614455|FG000|STARTED|Overall Study||1
11022860|NCT00810797|12201181|FG000|COMPLETED|Overall Study||36
11022861|NCT00810797|12201181|FG000|NOT COMPLETED|Overall Study||0
11022862|NCT00810810|12201189|FG000|STARTED|Overall Study||124
11022863|NCT00810810|12201190|FG001|STARTED|Overall Study||49
11022864|NCT00810810|12201191|FG002|STARTED|Overall Study||56
11022865|NCT00810810|12201192|FG003|STARTED|Overall Study||51
11022866|NCT00810810|12201189|FG000|COMPLETED|Overall Study||124
11144214|NCT01476449|12330877|FG001|NOT COMPLETED|Overall Study||2
11144215|NCT01476475|12330885|FG000|STARTED|Overall Study||161
11144216|NCT01476475|12330886|FG001|STARTED|Overall Study||162
11144217|NCT01476475|12330885|FG000|COMPLETED|Overall Study||150
11144218|NCT01476475|12330886|FG001|COMPLETED|Overall Study||159
11144219|NCT01476475|12330885|FG000|NOT COMPLETED|Overall Study||11
11416757|NCT00801931|12614455|FG000|COMPLETED|Overall Study||1
11416758|NCT00801931|12614455|FG000|NOT COMPLETED|Overall Study||0
11416759|NCT00793520|12614461|FG000|STARTED|Milnacipran Crossover to Placebo||1
11416760|NCT00793520|12614462|FG001|STARTED|Milnacipran Crossover to Placebo||0
11416761|NCT00793520|12614461|FG000|COMPLETED|Milnacipran Crossover to Placebo||0
11416762|NCT00793520|12614462|FG001|COMPLETED|Milnacipran Crossover to Placebo||0
11416763|NCT00793520|12614461|FG000|NOT COMPLETED|Milnacipran Crossover to Placebo||1
11144220|NCT01476475|12330886|FG001|NOT COMPLETED|Overall Study||3
11144221|NCT01476644|12330893|FG000|STARTED|Overall Study||161
11144222|NCT01476644|12330893|FG000|COMPLETED|Overall Study||122
11144223|NCT01476644|12330893|FG000|NOT COMPLETED|Overall Study||39
11144224|NCT01476696|12330898|FG000|STARTED|Overall Study||15
11144225|NCT01476696|12330899|FG001|STARTED|Overall Study||9
11144226|NCT01476696|12330900|FG002|STARTED|Overall Study||9
11144227|NCT01476696|12330898|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
11144228|NCT01476696|12330899|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9
11144229|NCT01476696|12330900|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
11144230|NCT01476696|12330898|FG000|COMPLETED|Overall Study||12
11144231|NCT01476696|12330899|FG001|COMPLETED|Overall Study||8
11144232|NCT01476696|12330900|FG002|COMPLETED|Overall Study||9
11144233|NCT01476696|12330898|FG000|NOT COMPLETED|Overall Study||3
11144234|NCT01476696|12330899|FG001|NOT COMPLETED|Overall Study||1
11144235|NCT01476696|12330900|FG002|NOT COMPLETED|Overall Study||0
11144236|NCT01476722|12330913|FG000|STARTED|Overall Study||125
11144237|NCT01476722|12330913|FG000|COMPLETED|Overall Study||124
11144238|NCT01476722|12330913|FG000|NOT COMPLETED|Overall Study||1
11144239|NCT01476748|12330920|FG000|STARTED|Overall Study||5
11144240|NCT01476748|12330921|FG001|STARTED|Overall Study||5
11144241|NCT01476748|12330922|FG002|STARTED|Overall Study||5
11144242|NCT01476748|12330920|FG000|COMPLETED|Overall Study||5
11144243|NCT01476748|12330921|FG001|COMPLETED|Overall Study||5
11144244|NCT01476748|12330922|FG002|COMPLETED|Overall Study||5
11144245|NCT01476748|12330920|FG000|NOT COMPLETED|Overall Study||0
11144246|NCT01476748|12330921|FG001|NOT COMPLETED|Overall Study||0
11144247|NCT01476748|12330922|FG002|NOT COMPLETED|Overall Study||0
11144248|NCT01477320|12330932|FG000|STARTED|Overall Study||62
11144249|NCT01477320|12330933|FG001|STARTED|Overall Study||62
11144250|NCT01477320|12330932|FG000|COMPLETED|Overall Study||55
11144251|NCT01477320|12330933|FG001|COMPLETED|Overall Study||47
11144252|NCT01477320|12330932|FG000|NOT COMPLETED|Overall Study||7
11144253|NCT01477320|12330933|FG001|NOT COMPLETED|Overall Study||15
11144254|NCT01477333|12330939|FG000|STARTED|Overall Study||18
11144255|NCT01477333|12330939|FG000|COMPLETED|Overall Study||15
11144256|NCT01477333|12330939|FG000|NOT COMPLETED|Overall Study||3
11144257|NCT01477450|12330950|FG000|STARTED|Overall Study||10
11144258|NCT01477450|12330951|FG001|STARTED|Overall Study||10
11144259|NCT01477450|12330952|FG002|STARTED|Overall Study||10
11144260|NCT01477450|12330950|FG000|COMPLETED|Overall Study||10
11144261|NCT01477450|12330951|FG001|COMPLETED|Overall Study||10
11144262|NCT01477450|12330952|FG002|COMPLETED|Overall Study||10
11144263|NCT01477450|12330950|FG000|NOT COMPLETED|Overall Study||0
11144264|NCT01477450|12330951|FG001|NOT COMPLETED|Overall Study||0
11144265|NCT01477450|12330952|FG002|NOT COMPLETED|Overall Study||0
11144266|NCT01477463|12330962|FG000|STARTED|Overall Study||18
11144267|NCT01477463|12330963|FG001|STARTED|Overall Study||6
11144268|NCT01477463|12330962|FG000|COMPLETED|Overall Study||18
11144269|NCT01477463|12330963|FG001|COMPLETED|Overall Study||6
11144270|NCT01477463|12330962|FG000|NOT COMPLETED|Overall Study||0
11144271|NCT01477463|12330963|FG001|NOT COMPLETED|Overall Study||0
11144272|NCT01477567|12330978|FG000|STARTED|Overall Study||5
11144273|NCT01477567|12330979|FG001|STARTED|Overall Study||6
11144274|NCT01477567|12330980|FG002|STARTED|Overall Study||6
11144275|NCT01477567|12330981|FG003|STARTED|Overall Study||6
11144276|NCT01477567|12330982|FG004|STARTED|Overall Study||6
11144277|NCT01477567|12330983|FG005|STARTED|Overall Study||5
11144278|NCT01477567|12330984|FG006|STARTED|Overall Study||6
11144279|NCT01477567|12330978|FG000|Received at Least 1 Dose of Study Drug|Overall Study||5
11144280|NCT01477567|12330979|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
11144281|NCT01477567|12330980|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11144282|NCT01477567|12330981|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
11144283|NCT01477567|12330982|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
11416764|NCT00793520|12614462|FG001|NOT COMPLETED|Milnacipran Crossover to Placebo||0
11416765|NCT00793520|12614461|FG000|STARTED|Placebo Crossover to Milnacipran||0
11416766|NCT00793520|12614462|FG001|STARTED|Placebo Crossover to Milnacipran||1
11416767|NCT00793520|12614461|FG000|COMPLETED|Placebo Crossover to Milnacipran||0
11416768|NCT00793520|12614462|FG001|COMPLETED|Placebo Crossover to Milnacipran||0
11416769|NCT00793520|12614461|FG000|NOT COMPLETED|Placebo Crossover to Milnacipran||0
11416770|NCT00793520|12614462|FG001|NOT COMPLETED|Placebo Crossover to Milnacipran||1
11416771|NCT00795236|12614470|FG000|STARTED|Overall Study||0
11416772|NCT00795236|12614471|FG001|STARTED|Overall Study||0
11022867|NCT00810810|12201190|FG001|COMPLETED|Overall Study||38
11022868|NCT00810810|12201191|FG002|COMPLETED|Overall Study||45
11022869|NCT00810810|12201192|FG003|COMPLETED|Overall Study||38
11022870|NCT00810810|12201189|FG000|NOT COMPLETED|Overall Study||0
11022871|NCT00810810|12201190|FG001|NOT COMPLETED|Overall Study||11
11022872|NCT00810810|12201191|FG002|NOT COMPLETED|Overall Study||11
11022873|NCT00810810|12201192|FG003|NOT COMPLETED|Overall Study||13
11022874|NCT00810888|12201205|FG000|STARTED|Overall Study||10
11022875|NCT00810888|12201206|FG001|STARTED|Overall Study||9
11022876|NCT00810888|12201207|FG002|STARTED|Overall Study||73
11022877|NCT00810888|12201205|FG000|COMPLETED|Overall Study||10
11022878|NCT00810888|12201206|FG001|COMPLETED|Overall Study||9
11022879|NCT00810888|12201207|FG002|COMPLETED|Overall Study||73
11022880|NCT00810888|12201205|FG000|NOT COMPLETED|Overall Study||0
11022881|NCT00810888|12201206|FG001|NOT COMPLETED|Overall Study||0
11022882|NCT00810888|12201207|FG002|NOT COMPLETED|Overall Study||0
11022883|NCT00810901|12201217|FG000|STARTED|Overall Study||253
11022884|NCT00810901|12201218|FG001|STARTED|Overall Study||176
11416773|NCT00795236|12614470|FG000|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0
11144284|NCT01477567|12330983|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
11416774|NCT00795236|12614471|FG001|COMPLETED|Overall Study||0
11416775|NCT00795236|12614470|FG000|NOT COMPLETED|Overall Study||0
11416776|NCT00795236|12614471|FG001|NOT COMPLETED|Overall Study||0
11416777|NCT00799773|12614481|FG000|STARTED|Overall Study||2
11022885|NCT00810901|12201217|FG000|1-month Follow up|Overall Study||242
11022886|NCT00810901|12201218|FG001|1-month Follow up|Overall Study||146
11022887|NCT00810901|12201217|FG000|6-month Follow-up|Overall Study||181
11022888|NCT00810901|12201218|FG001|6-month Follow-up|Overall Study||122
11022889|NCT00810901|12201217|FG000|COMPLETED|Overall Study||165
11022890|NCT00810901|12201218|FG001|COMPLETED|Overall Study||118
11022891|NCT00810901|12201217|FG000|NOT COMPLETED|Overall Study||88
11416778|NCT00799773|12614482|FG001|STARTED|Overall Study||1
11416779|NCT00799773|12614481|FG000|COMPLETED|Overall Study||2
11416780|NCT00799773|12614482|FG001|COMPLETED|Overall Study||1
11416781|NCT00799773|12614481|FG000|NOT COMPLETED|Overall Study||0
11416782|NCT00799773|12614482|FG001|NOT COMPLETED|Overall Study||0
11416783|NCT00790452|12614490|FG000|STARTED|Overall Study||1
11416784|NCT00790452|12614491|FG001|STARTED|Overall Study||0
11416785|NCT00790452|12614490|FG000|COMPLETED|Overall Study||0
11416786|NCT00790452|12614491|FG001|COMPLETED|Overall Study||0
11416787|NCT00790452|12614490|FG000|NOT COMPLETED|Overall Study||1
11416788|NCT00790452|12614491|FG001|NOT COMPLETED|Overall Study||0
11416789|NCT00795665|12614497|FG000|STARTED|Overall Study||7
11416790|NCT00795665|12614497|FG000|COMPLETED|Overall Study||7
11416791|NCT00795665|12614497|FG000|NOT COMPLETED|Overall Study||0
11416792|NCT00787917|12614503|FG000|STARTED|Blinded Treatment||9
11416793|NCT00787917|12614504|FG001|STARTED|Blinded Treatment||5
11416794|NCT00787917|12614503|FG000|COMPLETED|Blinded Treatment||4
11416795|NCT00787917|12614504|FG001|COMPLETED|Blinded Treatment||3
11416796|NCT00787917|12614503|FG000|NOT COMPLETED|Blinded Treatment||5
11416797|NCT00787917|12614504|FG001|NOT COMPLETED|Blinded Treatment||2
11416798|NCT00787917|12614503|FG000|STARTED|Open Label||7
11416799|NCT00787917|12614504|FG001|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
11022892|NCT00810901|12201218|FG001|NOT COMPLETED|Overall Study||58
11022893|NCT00811018|12201224|FG000|STARTED|Overall Study||1192
11022894|NCT00811018|12201224|FG000|COMPLETED|Overall Study||224
11022895|NCT00811018|12201224|FG000|NOT COMPLETED|Overall Study||968
11022896|NCT00811057|12201231|FG000|STARTED|Overall Study||90
11022897|NCT00811057|12201232|FG001|STARTED|Overall Study||114
11022898|NCT00811057|12201233|FG002|STARTED|Overall Study||97
11022899|NCT00811057|12201231|FG000|COMPLETED|Overall Study||85
11022900|NCT00811057|12201232|FG001|COMPLETED|Overall Study||104
11022901|NCT00811057|12201233|FG002|COMPLETED|Overall Study||87
11022902|NCT00811057|12201231|FG000|NOT COMPLETED|Overall Study||5
11022903|NCT00811057|12201232|FG001|NOT COMPLETED|Overall Study||10
11022904|NCT00811057|12201233|FG002|NOT COMPLETED|Overall Study||10
11022905|NCT00811070|12201247|FG000|STARTED|Overall Study||7
11022906|NCT00811070|12201248|FG001|STARTED|Overall Study||7
11022907|NCT00811070|12201249|FG002|STARTED|Overall Study||3
11022908|NCT00811070|12201250|FG003|STARTED|Overall Study||28
11022909|NCT00811070|12201251|FG004|STARTED|Overall Study||7
11022910|NCT00811070|12201252|FG005|STARTED|Overall Study||11
11022911|NCT00811070|12201247|FG000|COMPLETED|Overall Study||6
11022912|NCT00811070|12201248|FG001|COMPLETED|Overall Study||6
11022913|NCT00811070|12201249|FG002|COMPLETED|Overall Study||3
11022914|NCT00811070|12201250|FG003|COMPLETED|Overall Study||26
11022915|NCT00811070|12201251|FG004|COMPLETED|Overall Study||2
11022916|NCT00811070|12201252|FG005|COMPLETED|Overall Study||10
11022917|NCT00811070|12201247|FG000|NOT COMPLETED|Overall Study||1
11022918|NCT00811070|12201248|FG001|NOT COMPLETED|Overall Study||1
11022919|NCT00811070|12201249|FG002|NOT COMPLETED|Overall Study||0
11022920|NCT00811070|12201250|FG003|NOT COMPLETED|Overall Study||2
11022921|NCT00811070|12201251|FG004|NOT COMPLETED|Overall Study||5
11022922|NCT00811070|12201252|FG005|NOT COMPLETED|Overall Study||1
11022923|NCT00811135|12201268|FG000|STARTED|Overall Study||88
11022924|NCT00811135|12201268|FG000|COMPLETED|Overall Study||0
11022925|NCT00811135|12201268|FG000|NOT COMPLETED|Overall Study||88
11022926|NCT00811174|12201272|FG000|STARTED|Overall Study||5
11022927|NCT00811174|12201272|FG000|COMPLETED|Overall Study||2
11022928|NCT00811174|12201272|FG000|NOT COMPLETED|Overall Study||3
11022929|NCT00811187|12201278|FG000|STARTED|Overall Study||40
11022930|NCT00811187|12201279|FG001|STARTED|Overall Study||40
11022931|NCT00811187|12201278|FG000|COMPLETED|Overall Study||37
11022932|NCT00811187|12201279|FG001|COMPLETED|Overall Study||37
11022933|NCT00811187|12201278|FG000|NOT COMPLETED|Overall Study||3
11022934|NCT00811187|12201279|FG001|NOT COMPLETED|Overall Study||3
11022935|NCT00811252|12201288|FG000|STARTED|Overall Study||145
11022936|NCT00811252|12201289|FG001|STARTED|Overall Study||156
11022937|NCT00811252|12201290|FG002|STARTED|Overall Study||151
11022938|NCT00811252|12201288|FG000|COMPLETED|Overall Study||128
11022939|NCT00811252|12201289|FG001|COMPLETED|Overall Study||136
11022940|NCT00811252|12201290|FG002|COMPLETED|Overall Study||128
11022941|NCT00811252|12201288|FG000|NOT COMPLETED|Overall Study||17
11022942|NCT00811252|12201289|FG001|NOT COMPLETED|Overall Study||20
11022943|NCT00811252|12201290|FG002|NOT COMPLETED|Overall Study||23
11022944|NCT00811317|12201298|FG000|STARTED|Overall Study||11
11022945|NCT00811317|12201298|FG000|COMPLETED|Overall Study||11
11022946|NCT00811317|12201298|FG000|NOT COMPLETED|Overall Study||0
11022947|NCT00811382|12201304|FG000|STARTED|Overall Study||88
11022948|NCT00811382|12201305|FG001|STARTED|Overall Study||75
11022949|NCT00811382|12201304|FG000|COMPLETED|Overall Study||88
11022950|NCT00811382|12201305|FG001|COMPLETED|Overall Study||75
11022951|NCT00811382|12201304|FG000|NOT COMPLETED|Overall Study||0
11022952|NCT00811382|12201305|FG001|NOT COMPLETED|Overall Study||0
11022953|NCT00811395|12201319|FG000|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
11416800|NCT00787917|12614503|FG000|COMPLETED|Open Label||3
11416801|NCT00787917|12614504|FG001|COMPLETED|Open Label||0
11416802|NCT00787917|12614503|FG000|NOT COMPLETED|Open Label||4
11416803|NCT00787917|12614504|FG001|NOT COMPLETED|Open Label||0
11416804|NCT00798590|12614514|FG000|STARTED|Overall Study||11
11416805|NCT00798590|12614515|FG001|STARTED|Overall Study||8
11416806|NCT00798590|12614514|FG000|COMPLETED|Overall Study||0
11416807|NCT00798590|12614515|FG001|COMPLETED|Overall Study||0
11416808|NCT00798590|12614514|FG000|NOT COMPLETED|Overall Study||11
11416809|NCT00798590|12614515|FG001|NOT COMPLETED|Overall Study||8
11416810|NCT00796510|12614523|FG000|STARTED|Overall Study||3
11416811|NCT00796510|12614524|FG001|STARTED|Overall Study||0
11416812|NCT00796510|12614523|FG000|COMPLETED|Overall Study||0
11416813|NCT00796510|12614524|FG001|COMPLETED|Overall Study||0
11416814|NCT00796510|12614523|FG000|NOT COMPLETED|Overall Study||3
11022954|NCT00811395|12201320|FG001|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
11416815|NCT00796510|12614524|FG001|NOT COMPLETED|Overall Study||0
11416816|NCT00796861|12614530|FG000|STARTED|Overall Study||4
11416817|NCT00796861|12614530|FG000|COMPLETED|Overall Study||0
11022955|NCT00811395|12201321|FG002|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
11022956|NCT00811395|12201322|FG003|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
11022957|NCT00811395|12201323|FG004|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
11022958|NCT00811395|12201324|FG005|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
11022959|NCT00811395|12201319|FG000|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
11022960|NCT00811395|12201320|FG001|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
11022961|NCT00811395|12201321|FG002|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
11022962|NCT00811395|12201322|FG003|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
11022963|NCT00811395|12201323|FG004|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
11022964|NCT00811395|12201324|FG005|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
11022965|NCT00811395|12201319|FG000|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
11022966|NCT00811395|12201320|FG001|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
11022967|NCT00811395|12201321|FG002|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
11022968|NCT00811395|12201322|FG003|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
11022969|NCT00811395|12201323|FG004|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
11022970|NCT00811395|12201324|FG005|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
11022971|NCT00811395|12201319|FG000|STARTED|Extension Treatment|continued initial treatment|31
11022972|NCT00811395|12201320|FG001|STARTED|Extension Treatment|continued initial treatment|28
11022973|NCT00811395|12201321|FG002|STARTED|Extension Treatment|continued initial treatment|27
11022974|NCT00811395|12201322|FG003|STARTED|Extension Treatment|continued initial treatment|37
11022975|NCT00811395|12201323|FG004|STARTED|Extension Treatment|continued initial treatment|30
11022976|NCT00811395|12201324|FG005|STARTED|Extension Treatment|continued initial treatment|29
11022977|NCT00811395|12201319|FG000|COMPLETED|Extension Treatment|completed 48-week treatment|29
11022978|NCT00811395|12201320|FG001|COMPLETED|Extension Treatment|completed 48-week treatment|22
11022979|NCT00811395|12201321|FG002|COMPLETED|Extension Treatment|completed 48-week treatment|24
11022980|NCT00811395|12201322|FG003|COMPLETED|Extension Treatment|completed 48-week treatment|34
11022981|NCT00811395|12201323|FG004|COMPLETED|Extension Treatment|completed 48-week treatment|30
11022982|NCT00811395|12201324|FG005|COMPLETED|Extension Treatment|completed 48-week treatment|27
11022983|NCT00811395|12201319|FG000|NOT COMPLETED|Extension Treatment||2
11022984|NCT00811395|12201320|FG001|NOT COMPLETED|Extension Treatment||6
11022985|NCT00811395|12201321|FG002|NOT COMPLETED|Extension Treatment||3
11022986|NCT00811395|12201322|FG003|NOT COMPLETED|Extension Treatment||3
11144285|NCT01477567|12330984|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
11144286|NCT01477567|12330978|FG000|COMPLETED|Overall Study||5
11144287|NCT01477567|12330979|FG001|COMPLETED|Overall Study||6
11144288|NCT01477567|12330980|FG002|COMPLETED|Overall Study||6
11144289|NCT01477567|12330981|FG003|COMPLETED|Overall Study||6
11144290|NCT01477567|12330982|FG004|COMPLETED|Overall Study||6
11416818|NCT00796861|12614530|FG000|NOT COMPLETED|Overall Study||4
11416819|NCT00791076|12614534|FG000|STARTED|Overall Study||8
11416820|NCT00791076|12614534|FG000|COMPLETED|Overall Study||0
11416821|NCT00791076|12614534|FG000|NOT COMPLETED|Overall Study||8
11416822|NCT00790478|12614542|FG000|STARTED|Overall Study||0
11416823|NCT00790478|12614543|FG001|STARTED|Overall Study||0
11416824|NCT00790478|12614542|FG000|COMPLETED|Overall Study||0
11416825|NCT00790478|12614543|FG001|COMPLETED|Overall Study||0
11416826|NCT00790478|12614542|FG000|NOT COMPLETED|Overall Study||0
11416827|NCT00790478|12614543|FG001|NOT COMPLETED|Overall Study||0
11416828|NCT00796107|12614549|FG000|STARTED|Overall Study||6
11416829|NCT00796107|12614549|FG000|COMPLETED|Overall Study||0
11416830|NCT00796107|12614549|FG000|NOT COMPLETED|Overall Study||6
11416831|NCT00791336|12614553|FG000|STARTED|Overall Study||1
11022987|NCT00811395|12201323|FG004|NOT COMPLETED|Extension Treatment||0
11022988|NCT00811395|12201324|FG005|NOT COMPLETED|Extension Treatment||2
11416832|NCT00791336|12614553|FG000|COMPLETED|Overall Study||1
11022989|NCT00811434|12201341|FG000|STARTED|First Intervention||7
11416833|NCT00791336|12614553|FG000|NOT COMPLETED|Overall Study||0
11416834|NCT00786682|12614557|FG000|STARTED|Overall Study||11
11416835|NCT00786682|12614557|FG000|COMPLETED|Overall Study||11
11416836|NCT00786682|12614557|FG000|NOT COMPLETED|Overall Study||0
11416837|NCT00787124|12614563|FG000|STARTED|Overall Study||4
11416838|NCT00787124|12614564|FG001|STARTED|Overall Study||4
11416839|NCT00787124|12614563|FG000|COMPLETED|Overall Study||4
11416840|NCT00787124|12614564|FG001|COMPLETED|Overall Study||4
11416841|NCT00787124|12614563|FG000|NOT COMPLETED|Overall Study||0
11416842|NCT00787124|12614564|FG001|NOT COMPLETED|Overall Study||0
11416843|NCT00785356|12614573|FG000|STARTED|Overall Study||8
11416844|NCT00785356|12614573|FG000|COMPLETED|Overall Study||0
11416845|NCT00785356|12614573|FG000|NOT COMPLETED|Overall Study||8
11416846|NCT00782483|12614581|FG000|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
11416847|NCT00782483|12614581|FG000|COMPLETED|Overall Study||0
11416848|NCT00782483|12614581|FG000|NOT COMPLETED|Overall Study||6
11022990|NCT00811434|12201342|FG001|STARTED|First Intervention||5
11022991|NCT00811434|12201341|FG000|COMPLETED|First Intervention||4
11022992|NCT00811434|12201342|FG001|COMPLETED|First Intervention||5
11022993|NCT00811434|12201341|FG000|NOT COMPLETED|First Intervention||3
11022994|NCT00811434|12201342|FG001|NOT COMPLETED|First Intervention||0
11022995|NCT00811434|12201341|FG000|STARTED|Washout (1 Month)||4
11022996|NCT00811434|12201342|FG001|STARTED|Washout (1 Month)||5
11022997|NCT00811434|12201341|FG000|COMPLETED|Washout (1 Month)||4
11022998|NCT00811434|12201342|FG001|COMPLETED|Washout (1 Month)||5
11022999|NCT00811434|12201341|FG000|NOT COMPLETED|Washout (1 Month)||0
11023000|NCT00811434|12201342|FG001|NOT COMPLETED|Washout (1 Month)||0
11023001|NCT00811434|12201341|FG000|STARTED|Second Intervention||4
11023002|NCT00811434|12201342|FG001|STARTED|Second Intervention||5
11023003|NCT00811434|12201341|FG000|COMPLETED|Second Intervention||4
11416849|NCT00791843|12614585|FG000|STARTED|Overall Study|Data unavailable for the study|0
11416850|NCT00791843|12614585|FG000|COMPLETED|Overall Study|Data unavailable for the study|0
11416851|NCT00791843|12614585|FG000|NOT COMPLETED|Overall Study||0
11416852|NCT00784043|12614591|FG000|STARTED|Overall Study||31
11416853|NCT00784043|12614592|FG001|STARTED|Overall Study||6
11416854|NCT00784043|12614591|FG000|COMPLETED|Overall Study||0
11023004|NCT00811434|12201342|FG001|COMPLETED|Second Intervention||5
11023005|NCT00811434|12201341|FG000|NOT COMPLETED|Second Intervention||0
11023006|NCT00811434|12201342|FG001|NOT COMPLETED|Second Intervention||0
11023007|NCT00811473|12201351|FG000|STARTED|Overall Study||93
11023008|NCT00811473|12201352|FG001|STARTED|Overall Study||100
11023009|NCT00811473|12201351|FG000|COMPLETED|Overall Study||70
11023010|NCT00811473|12201352|FG001|COMPLETED|Overall Study||74
11023011|NCT00811473|12201351|FG000|NOT COMPLETED|Overall Study||23
11023012|NCT00811473|12201352|FG001|NOT COMPLETED|Overall Study||26
11023013|NCT00811564|12201360|FG000|STARTED|Overall Study||73
11023014|NCT00811564|12201361|FG001|STARTED|Overall Study||75
11023015|NCT00811564|12201360|FG000|COMPLETED|Overall Study||64
11023016|NCT00811564|12201361|FG001|COMPLETED|Overall Study||73
11023017|NCT00811564|12201360|FG000|NOT COMPLETED|Overall Study||9
11023018|NCT00811564|12201361|FG001|NOT COMPLETED|Overall Study||2
11023019|NCT00811577|12201369|FG000|STARTED|Overall Study||126
11023020|NCT00811577|12201370|FG001|STARTED|Overall Study||24
11023021|NCT00811577|12201369|FG000|COMPLETED|Overall Study||116
11023022|NCT00811577|12201370|FG001|COMPLETED|Overall Study||23
11023023|NCT00811577|12201369|FG000|NOT COMPLETED|Overall Study||10
11023024|NCT00811577|12201370|FG001|NOT COMPLETED|Overall Study||1
11023025|NCT00811642|12201419|FG000|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
11023026|NCT00811642|12201419|FG000|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
11023027|NCT00811642|12201419|FG000|NOT COMPLETED|Overall Study||15
11023028|NCT00811655|12201423|FG000|STARTED|Overall Study||6
11023029|NCT00811655|12201423|FG000|COMPLETED|Overall Study||5
11023030|NCT00811655|12201423|FG000|NOT COMPLETED|Overall Study||1
11023031|NCT00811720|12201429|FG000|STARTED|All Randomised Patients||298
11023032|NCT00811720|12201430|FG001|STARTED|All Randomised Patients||306
11023033|NCT00811720|12201429|FG000|COMPLETED|All Randomised Patients||296
11023034|NCT00811720|12201430|FG001|COMPLETED|All Randomised Patients||302
11023035|NCT00811720|12201429|FG000|NOT COMPLETED|All Randomised Patients||2
11416855|NCT00784043|12614592|FG001|COMPLETED|Overall Study||0
11416856|NCT00784043|12614591|FG000|NOT COMPLETED|Overall Study||31
11416857|NCT00784043|12614592|FG001|NOT COMPLETED|Overall Study||6
11416858|NCT00787618|12614601|FG000|STARTED|Overall Study||3
11416859|NCT00787618|12614602|FG001|STARTED|Overall Study||0
11023036|NCT00811720|12201430|FG001|NOT COMPLETED|All Randomised Patients||4
11023037|NCT00811720|12201429|FG000|STARTED|All Treated Patients||296
11023038|NCT00811720|12201430|FG001|STARTED|All Treated Patients||302
11023039|NCT00811720|12201429|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
11023040|NCT00811720|12201430|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
11023041|NCT00811720|12201429|FG000|NOT COMPLETED|All Treated Patients||96
11023042|NCT00811720|12201430|FG001|NOT COMPLETED|All Treated Patients||164
11144291|NCT01477567|12330983|FG005|COMPLETED|Overall Study||5
11144292|NCT01477567|12330984|FG006|COMPLETED|Overall Study||6
11144293|NCT01477567|12330978|FG000|NOT COMPLETED|Overall Study||0
11144294|NCT01477567|12330979|FG001|NOT COMPLETED|Overall Study||0
11144295|NCT01477567|12330980|FG002|NOT COMPLETED|Overall Study||0
11144296|NCT01477567|12330981|FG003|NOT COMPLETED|Overall Study||0
11144297|NCT01477567|12330982|FG004|NOT COMPLETED|Overall Study||0
11144298|NCT01477567|12330983|FG005|NOT COMPLETED|Overall Study||0
11144299|NCT01477567|12330984|FG006|NOT COMPLETED|Overall Study||0
11144300|NCT01477710|12331005|FG000|STARTED|Overall Study||30
11144301|NCT01477710|12331005|FG000|COMPLETED|Overall Study||30
11144302|NCT01477710|12331005|FG000|NOT COMPLETED|Overall Study||0
11202639|NCT01841697|12393054|FG000|COMPLETED|Overall Study||302
11202640|NCT01841697|12393055|FG001|COMPLETED|Overall Study||302
11202641|NCT01841697|12393054|FG000|NOT COMPLETED|Overall Study||20
11202642|NCT01841697|12393055|FG001|NOT COMPLETED|Overall Study||18
11202643|NCT01841762|12393061|FG000|STARTED|Screening Period||335
11202644|NCT01841762|12393061|FG000|COMPLETED|Screening Period||284
11202645|NCT01841762|12393061|FG000|NOT COMPLETED|Screening Period||51
11202646|NCT01841762|12393061|FG000|STARTED|Treatment Period||284
11202647|NCT01841762|12393061|FG000|COMPLETED|Treatment Period||252
11202648|NCT01841762|12393061|FG000|NOT COMPLETED|Treatment Period||32
11416860|NCT00787618|12614603|FG002|STARTED|Overall Study||3
11416861|NCT00787618|12614601|FG000|COMPLETED|Overall Study||3
11416862|NCT00787618|12614602|FG001|COMPLETED|Overall Study||0
11416863|NCT00787618|12614603|FG002|COMPLETED|Overall Study||3
11202649|NCT01841762|12393061|FG000|STARTED|Post-Treatment Safety Follow-Up Period||284
11202650|NCT01841762|12393061|FG000|COMPLETED|Post-Treatment Safety Follow-Up Period||269
11416864|NCT00787618|12614601|FG000|NOT COMPLETED|Overall Study||0
11416865|NCT00787618|12614602|FG001|NOT COMPLETED|Overall Study||0
11416866|NCT00787618|12614603|FG002|NOT COMPLETED|Overall Study||0
11416867|NCT00774306|12614615|FG000|STARTED|Overall Study||24
11416868|NCT00774306|12614616|FG001|STARTED|Overall Study||5
11416869|NCT00774306|12614617|FG002|STARTED|Overall Study||16
11416870|NCT00774306|12614618|FG003|STARTED|Overall Study||7
11416871|NCT00774306|12614615|FG000|COMPLETED|Overall Study||6
11416872|NCT00774306|12614616|FG001|COMPLETED|Overall Study||3
11416873|NCT00774306|12614617|FG002|COMPLETED|Overall Study||8
11416874|NCT00774306|12614618|FG003|COMPLETED|Overall Study||2
11416875|NCT00774306|12614615|FG000|NOT COMPLETED|Overall Study||18
11416876|NCT00774306|12614616|FG001|NOT COMPLETED|Overall Study||2
11416877|NCT00774306|12614617|FG002|NOT COMPLETED|Overall Study||8
11416878|NCT00774306|12614618|FG003|NOT COMPLETED|Overall Study||5
11416879|NCT00771602|12614631|FG000|STARTED|Overall Study||1
11416880|NCT00771602|12614632|FG001|STARTED|Overall Study||0
11416881|NCT00771602|12614633|FG002|STARTED|Overall Study||0
11416882|NCT00771602|12614631|FG000|COMPLETED|Overall Study||1
11416883|NCT00771602|12614632|FG001|COMPLETED|Overall Study||0
11416884|NCT00771602|12614633|FG002|COMPLETED|Overall Study||0
11416885|NCT00771602|12614631|FG000|NOT COMPLETED|Overall Study||0
11416886|NCT00771602|12614632|FG001|NOT COMPLETED|Overall Study||0
11416887|NCT00771602|12614633|FG002|NOT COMPLETED|Overall Study||0
11416888|NCT00779038|12614641|FG000|STARTED|Overall Study||13
11416889|NCT00779038|12614641|FG000|COMPLETED|Overall Study||0
11416890|NCT00779038|12614641|FG000|NOT COMPLETED|Overall Study||13
11416891|NCT00780455|12614647|FG000|STARTED|Overall Study||2
11416892|NCT00780455|12614648|FG001|STARTED|Overall Study||2
11023043|NCT00811733|12201438|FG000|STARTED|Overall Study||15
11023044|NCT00811733|12201439|FG001|STARTED|Overall Study||22
11023045|NCT00811733|12201438|FG000|COMPLETED|Overall Study||4
11416893|NCT00780455|12614647|FG000|COMPLETED|Overall Study||2
11416894|NCT00780455|12614648|FG001|COMPLETED|Overall Study||2
11416895|NCT00780455|12614647|FG000|NOT COMPLETED|Overall Study||0
11416896|NCT00780455|12614648|FG001|NOT COMPLETED|Overall Study||0
11416897|NCT00776100|12614656|FG000|STARTED|Overall Study||1
11416898|NCT00776100|12614657|FG001|STARTED|Overall Study||1
11416899|NCT00776100|12614656|FG000|COMPLETED|Overall Study||0
11416900|NCT00776100|12614657|FG001|COMPLETED|Overall Study||1
11416901|NCT00776100|12614656|FG000|NOT COMPLETED|Overall Study||1
11416902|NCT00776100|12614657|FG001|NOT COMPLETED|Overall Study||0
11416903|NCT00771316|12614665|FG000|STARTED|Overall Study||4
11416904|NCT00771316|12614666|FG001|STARTED|Overall Study||2
11416905|NCT00771316|12614665|FG000|COMPLETED|Overall Study||2
11416906|NCT00771316|12614666|FG001|COMPLETED|Overall Study||1
11416907|NCT00771316|12614665|FG000|NOT COMPLETED|Overall Study||2
11416908|NCT00771316|12614666|FG001|NOT COMPLETED|Overall Study||1
11416909|NCT00780481|12614672|FG000|STARTED|Overall Study||13
11416910|NCT00780481|12614672|FG000|COMPLETED|Overall Study||13
11416911|NCT00780481|12614672|FG000|NOT COMPLETED|Overall Study||0
11416912|NCT00769652|12614678|FG000|STARTED|Overall Study||6
11416913|NCT00769652|12614679|FG001|STARTED|Overall Study||1
11416914|NCT00769652|12614678|FG000|COMPLETED|Overall Study||6
11416915|NCT00769652|12614679|FG001|COMPLETED|Overall Study||1
11416916|NCT00769652|12614678|FG000|NOT COMPLETED|Overall Study||0
11416917|NCT00769652|12614679|FG001|NOT COMPLETED|Overall Study||0
11416918|NCT00768040|12614687|FG000|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
11416919|NCT00768040|12614688|FG001|STARTED|Overall Study||19
11416920|NCT00768040|12614687|FG000|COMPLETED|Overall Study||16
11416921|NCT00768040|12614688|FG001|COMPLETED|Overall Study||16
11416922|NCT00768040|12614687|FG000|NOT COMPLETED|Overall Study||4
11416923|NCT00768040|12614688|FG001|NOT COMPLETED|Overall Study||3
11416924|NCT00776555|12614696|FG000|STARTED|Overall Study||3
11416925|NCT00776555|12614697|FG001|STARTED|Overall Study||0
11416926|NCT00776555|12614696|FG000|COMPLETED|Overall Study||0
11416927|NCT00776555|12614697|FG001|COMPLETED|Overall Study||0
11416928|NCT00776555|12614696|FG000|NOT COMPLETED|Overall Study||3
11416929|NCT00776555|12614697|FG001|NOT COMPLETED|Overall Study||0
11416930|NCT00775190|12614705|FG000|STARTED|Overall Study||7
11416931|NCT00775190|12614706|FG001|STARTED|Overall Study||5
11416932|NCT00775190|12614705|FG000|COMPLETED|Overall Study||3
11416933|NCT00775190|12614706|FG001|COMPLETED|Overall Study||0
11416934|NCT00775190|12614705|FG000|NOT COMPLETED|Overall Study||4
11416935|NCT00775190|12614706|FG001|NOT COMPLETED|Overall Study||5
11416936|NCT00755261|12614712|FG000|STARTED|Overall Study||6
11416937|NCT00755261|12614712|FG000|COMPLETED|Overall Study||4
11416938|NCT00755261|12614712|FG000|NOT COMPLETED|Overall Study||2
11416939|NCT00762723|12614719|FG000|STARTED|Overall Study||5
11416940|NCT00762723|12614720|FG001|STARTED|Overall Study||11
11416941|NCT00762723|12614721|FG002|STARTED|Overall Study||3
11416942|NCT00762723|12614719|FG000|COMPLETED|Overall Study||0
11023046|NCT00811733|12201439|FG001|COMPLETED|Overall Study||12
11023047|NCT00811733|12201438|FG000|NOT COMPLETED|Overall Study||11
11023048|NCT00811733|12201439|FG001|NOT COMPLETED|Overall Study||10
11023049|NCT00811798|12201445|FG000|STARTED|Overall Study||92
11023050|NCT00811798|12201445|FG000|COMPLETED|Overall Study||92
11023051|NCT00811798|12201445|FG000|NOT COMPLETED|Overall Study||0
11023052|NCT00811850|12201449|FG000|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
11023053|NCT00811850|12201449|FG000|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
11023054|NCT00811850|12201449|FG000|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
11023055|NCT00811850|12201449|FG000|STARTED|Treatment Period 2: Wash Out||15
11023056|NCT00811850|12201449|FG000|COMPLETED|Treatment Period 2: Wash Out||15
11023057|NCT00811850|12201449|FG000|NOT COMPLETED|Treatment Period 2: Wash Out||0
11023058|NCT00811850|12201449|FG000|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
11023059|NCT00811850|12201449|FG000|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
11023060|NCT00811850|12201449|FG000|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
11023061|NCT00811928|12201457|FG000|STARTED|Overall Study||129
11023062|NCT00811928|12201458|FG001|STARTED|Overall Study||123
11023063|NCT00811928|12201457|FG000|COMPLETED|Overall Study||90
11023064|NCT00811928|12201458|FG001|COMPLETED|Overall Study||90
11023065|NCT00811928|12201457|FG000|NOT COMPLETED|Overall Study||39
11023066|NCT00811928|12201458|FG001|NOT COMPLETED|Overall Study||33
11023067|NCT00811941|12201466|FG000|STARTED|All Randomised Patients||166
11023068|NCT00811941|12201467|FG001|STARTED|All Randomised Patients||509
11023069|NCT00811941|12201466|FG000|COMPLETED|All Randomised Patients||164
11023070|NCT00811941|12201467|FG001|COMPLETED|All Randomised Patients||501
11023071|NCT00811941|12201466|FG000|NOT COMPLETED|All Randomised Patients||2
11023072|NCT00811941|12201467|FG001|NOT COMPLETED|All Randomised Patients||8
11023073|NCT00811941|12201466|FG000|STARTED|All Treated Patients||164
11023074|NCT00811941|12201467|FG001|STARTED|All Treated Patients||501
11023075|NCT00811941|12201466|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
11023076|NCT00811941|12201467|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
11023077|NCT00811941|12201466|FG000|NOT COMPLETED|All Treated Patients||52
11023078|NCT00811941|12201467|FG001|NOT COMPLETED|All Treated Patients||191
11023079|NCT00811954|12201476|FG000|STARTED|Overall Study||605
11023080|NCT00811954|12201477|FG001|STARTED|Overall Study||603
11023081|NCT00811954|12201478|FG002|STARTED|Overall Study||601
11023082|NCT00811954|12201476|FG000|COMPLETED|Overall Study||516
11023083|NCT00811954|12201477|FG001|COMPLETED|Overall Study||531
11023084|NCT00811954|12201478|FG002|COMPLETED|Overall Study||500
11023085|NCT00811954|12201476|FG000|NOT COMPLETED|Overall Study||89
11023086|NCT00811954|12201477|FG001|NOT COMPLETED|Overall Study||72
11023087|NCT00811954|12201478|FG002|NOT COMPLETED|Overall Study||101
11023088|NCT00812097|12201490|FG000|STARTED|Overall Study||572
11023089|NCT00812097|12201491|FG001|STARTED|Overall Study||190
11023090|NCT00812097|12201492|FG002|STARTED|Overall Study||124
11023091|NCT00812097|12201493|FG003|STARTED|Overall Study||69
11023092|NCT00812097|12201490|FG000|COMPLETED|Overall Study||327
11023093|NCT00812097|12201491|FG001|COMPLETED|Overall Study||101
11023094|NCT00812097|12201492|FG002|COMPLETED|Overall Study||67
11023095|NCT00812097|12201493|FG003|COMPLETED|Overall Study||34
11023096|NCT00812097|12201490|FG000|NOT COMPLETED|Overall Study||245
11023097|NCT00812097|12201491|FG001|NOT COMPLETED|Overall Study||89
11416943|NCT00762723|12614720|FG001|COMPLETED|Overall Study||6
11416944|NCT00762723|12614721|FG002|COMPLETED|Overall Study||0
11416945|NCT00762723|12614719|FG000|NOT COMPLETED|Overall Study||5
11416946|NCT00762723|12614720|FG001|NOT COMPLETED|Overall Study||5
11416947|NCT00762723|12614721|FG002|NOT COMPLETED|Overall Study||3
11416948|NCT00770965|12614733|FG000|STARTED|Safety Set||2
11416949|NCT00770965|12614734|FG001|STARTED|Safety Set||4
11416950|NCT00770965|12614735|FG002|STARTED|Safety Set||4
11416951|NCT00770965|12614736|FG003|STARTED|Safety Set||5
11416952|NCT00770965|12614733|FG000|COMPLETED|Safety Set||2
11416953|NCT00770965|12614734|FG001|COMPLETED|Safety Set||4
11416954|NCT00770965|12614735|FG002|COMPLETED|Safety Set||3
11416955|NCT00770965|12614736|FG003|COMPLETED|Safety Set||4
11416956|NCT00770965|12614733|FG000|NOT COMPLETED|Safety Set||0
11416957|NCT00770965|12614734|FG001|NOT COMPLETED|Safety Set||0
11416958|NCT00770965|12614735|FG002|NOT COMPLETED|Safety Set||1
11416959|NCT00770965|12614736|FG003|NOT COMPLETED|Safety Set||1
11416960|NCT00770965|12614733|FG000|STARTED|Excluded Set||18
11416961|NCT00770965|12614734|FG001|STARTED|Excluded Set||16
11416962|NCT00770965|12614735|FG002|STARTED|Excluded Set||16
11416963|NCT00770965|12614736|FG003|STARTED|Excluded Set||15
11416964|NCT00770965|12614733|FG000|COMPLETED|Excluded Set||3
11416965|NCT00770965|12614734|FG001|COMPLETED|Excluded Set||3
11416966|NCT00770965|12614735|FG002|COMPLETED|Excluded Set||2
11416967|NCT00770965|12614736|FG003|COMPLETED|Excluded Set||2
11416968|NCT00770965|12614733|FG000|NOT COMPLETED|Excluded Set||15
11416969|NCT00770965|12614734|FG001|NOT COMPLETED|Excluded Set||13
11416970|NCT00770965|12614735|FG002|NOT COMPLETED|Excluded Set||14
11416971|NCT00770965|12614736|FG003|NOT COMPLETED|Excluded Set||13
11416972|NCT00769002|12614750|FG000|STARTED|Overall Study||9
11416973|NCT00769002|12614751|FG001|STARTED|Overall Study||9
11416974|NCT00769002|12614750|FG000|COMPLETED|Overall Study||0
11416975|NCT00769002|12614751|FG001|COMPLETED|Overall Study||0
11416976|NCT00769002|12614750|FG000|NOT COMPLETED|Overall Study||9
11416977|NCT00769002|12614751|FG001|NOT COMPLETED|Overall Study||9
11416978|NCT00766636|12614758|FG000|STARTED|Overall Study||3
11416979|NCT00766636|12614759|FG001|STARTED|Overall Study||2
11416980|NCT00766636|12614758|FG000|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
11416981|NCT00766636|12614759|FG001|COMPLETED|Overall Study||0
11416982|NCT00766636|12614758|FG000|NOT COMPLETED|Overall Study||3
11416983|NCT00766636|12614759|FG001|NOT COMPLETED|Overall Study||2
11416984|NCT00768248|12614767|FG000|STARTED|Overall Study||1
11416985|NCT00768248|12614768|FG001|STARTED|Overall Study||1
11416986|NCT00768248|12614767|FG000|COMPLETED|Overall Study||0
11416987|NCT00768248|12614768|FG001|COMPLETED|Overall Study||0
11416988|NCT00768248|12614767|FG000|NOT COMPLETED|Overall Study||1
11416989|NCT00768248|12614768|FG001|NOT COMPLETED|Overall Study||1
11023098|NCT00812097|12201492|FG002|NOT COMPLETED|Overall Study||57
11023099|NCT00812097|12201493|FG003|NOT COMPLETED|Overall Study||35
11416990|NCT00765765|12614774|FG000|STARTED|Overall Study||6
11416991|NCT00765765|12614774|FG000|COMPLETED|Overall Study||6
11416992|NCT00765765|12614774|FG000|NOT COMPLETED|Overall Study||0
11416993|NCT00764699|12614778|FG000|STARTED|Overall Study||3
11416994|NCT00764699|12614778|FG000|COMPLETED|Overall Study||0
11416995|NCT00764699|12614778|FG000|NOT COMPLETED|Overall Study||3
11416996|NCT00759577|12614782|FG000|STARTED|Overall Study||36
11416997|NCT00759577|12614782|FG000|COMPLETED|Overall Study||36
11416998|NCT00759577|12614782|FG000|NOT COMPLETED|Overall Study||0
11416999|NCT00763009|12614786|FG000|STARTED|Overall Study||8
11417000|NCT00763009|12614786|FG000|COMPLETED|Overall Study||7
11417001|NCT00763009|12614786|FG000|NOT COMPLETED|Overall Study||1
11417002|NCT00761176|12614793|FG000|STARTED|Overall Study||4
11417003|NCT00761176|12614794|FG001|STARTED|Overall Study||4
11417004|NCT00761176|12614793|FG000|COMPLETED|Overall Study||2
11417005|NCT00761176|12614794|FG001|COMPLETED|Overall Study||3
11417006|NCT00761176|12614793|FG000|NOT COMPLETED|Overall Study||2
11417007|NCT00761176|12614794|FG001|NOT COMPLETED|Overall Study||1
11417008|NCT00749476|12614800|FG000|STARTED|Overall Study||1
11417009|NCT00749476|12614800|FG000|COMPLETED|Overall Study||1
11417010|NCT00749476|12614800|FG000|NOT COMPLETED|Overall Study||0
11417011|NCT00760461|12614804|FG000|STARTED|Overall Study||44
11417012|NCT00760461|12614804|FG000|COMPLETED|Overall Study||0
11417013|NCT00760461|12614804|FG000|NOT COMPLETED|Overall Study||44
11417014|NCT00749658|12614810|FG000|STARTED|Overall Study||60
11417015|NCT00749658|12614811|FG001|STARTED|Overall Study||61
11417016|NCT00749658|12614810|FG000|COMPLETED|Overall Study||60
11417017|NCT00749658|12614811|FG001|COMPLETED|Overall Study||61
11417018|NCT00749658|12614810|FG000|NOT COMPLETED|Overall Study||0
11417019|NCT00749658|12614811|FG001|NOT COMPLETED|Overall Study||0
11417020|NCT00754793|12614819|FG000|STARTED|Overall Study||1
11417021|NCT00754793|12614820|FG001|STARTED|Overall Study||2
11417022|NCT00754793|12614819|FG000|COMPLETED|Overall Study||1
11417023|NCT00754793|12614820|FG001|COMPLETED|Overall Study||1
11417024|NCT00754793|12614819|FG000|NOT COMPLETED|Overall Study||0
11417025|NCT00754793|12614820|FG001|NOT COMPLETED|Overall Study||1
11417026|NCT00754052|12614828|FG000|STARTED|Overall Study||5
11417027|NCT00754052|12614829|FG001|STARTED|Overall Study||3
11417028|NCT00754052|12614828|FG000|COMPLETED|Overall Study||0
11417029|NCT00754052|12614829|FG001|COMPLETED|Overall Study||0
11417030|NCT00754052|12614828|FG000|NOT COMPLETED|Overall Study||5
11417031|NCT00754052|12614829|FG001|NOT COMPLETED|Overall Study||3
11417032|NCT00750555|12614835|FG000|STARTED|Overall Study||0
11417033|NCT00750555|12614835|FG000|COMPLETED|Overall Study||0
11417034|NCT00750555|12614835|FG000|NOT COMPLETED|Overall Study||0
11417035|NCT00754767|12614842|FG000|STARTED|Overall Study||2
11417036|NCT00754767|12614843|FG001|STARTED|Overall Study||0
11417037|NCT00754767|12614842|FG000|COMPLETED|Overall Study||2
11417038|NCT00754767|12614843|FG001|COMPLETED|Overall Study||0
11417039|NCT00754767|12614842|FG000|NOT COMPLETED|Overall Study||0
11417040|NCT00754767|12614843|FG001|NOT COMPLETED|Overall Study||0
11417041|NCT00750204|12614851|FG000|STARTED|Overall Study||1
11417042|NCT00750204|12614852|FG001|STARTED|Overall Study||1
11417043|NCT00750204|12614851|FG000|COMPLETED|Overall Study||0
11417044|NCT00750204|12614852|FG001|COMPLETED|Overall Study||0
11417045|NCT00750204|12614851|FG000|NOT COMPLETED|Overall Study||1
11417046|NCT00750204|12614852|FG001|NOT COMPLETED|Overall Study||1
11417047|NCT00748579|12614860|FG000|STARTED|Overall Study||2
11417048|NCT00748579|12614861|FG001|STARTED|Overall Study||0
11417049|NCT00748579|12614860|FG000|COMPLETED|Overall Study||2
11417050|NCT00748579|12614861|FG001|COMPLETED|Overall Study||0
11417051|NCT00748579|12614860|FG000|NOT COMPLETED|Overall Study||0
11417052|NCT00748579|12614861|FG001|NOT COMPLETED|Overall Study||0
11417053|NCT00748085|12614867|FG000|STARTED|Overall Study||5
11144303|NCT01477749|12331013|FG000|STARTED|Overall Study||47
11144304|NCT01477749|12331013|FG000|COMPLETED|Overall Study||43
11144305|NCT01477749|12331013|FG000|NOT COMPLETED|Overall Study||4
11144306|NCT01477762|12331021|FG000|STARTED|Overall Study||25
11144307|NCT01477762|12331022|FG001|STARTED|Overall Study||33
11144308|NCT01477762|12331023|FG002|STARTED|Overall Study||20
11144309|NCT01477762|12331024|FG003|STARTED|Overall Study||13
11144310|NCT01477762|12331021|FG000|COMPLETED|Overall Study||16
11144311|NCT01477762|12331022|FG001|COMPLETED|Overall Study||20
11144312|NCT01477762|12331023|FG002|COMPLETED|Overall Study||16
11144313|NCT01477762|12331024|FG003|COMPLETED|Overall Study||11
11144314|NCT01477762|12331021|FG000|NOT COMPLETED|Overall Study||9
11144315|NCT01477762|12331022|FG001|NOT COMPLETED|Overall Study||13
11144316|NCT01477762|12331023|FG002|NOT COMPLETED|Overall Study||4
11144317|NCT01477762|12331024|FG003|NOT COMPLETED|Overall Study||2
11417054|NCT00748085|12614867|FG000|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
11417055|NCT00748085|12614867|FG000|NOT COMPLETED|Overall Study||0
11417056|NCT00752986|12614874|FG000|STARTED|Overall Study||16
11417057|NCT00752986|12614875|FG001|STARTED|Overall Study||12
11417058|NCT00752986|12614876|FG002|STARTED|Overall Study||11
11023100|NCT00812110|12201503|FG000|STARTED|Overall Study||292
11023101|NCT00812110|12201503|FG000|COMPLETED|Overall Study||292
11023102|NCT00812110|12201503|FG000|NOT COMPLETED|Overall Study||0
11023103|NCT00812253|12201509|FG000|STARTED|Overall Study||32
11023104|NCT00812253|12201510|FG001|STARTED|Overall Study||42
11023105|NCT00812253|12201509|FG000|COMPLETED|Overall Study||26
11023106|NCT00812253|12201510|FG001|COMPLETED|Overall Study||39
11023107|NCT00812253|12201509|FG000|NOT COMPLETED|Overall Study||6
11023108|NCT00812253|12201510|FG001|NOT COMPLETED|Overall Study||3
11023109|NCT00812331|12201521|FG000|STARTED|Overall Study||6
11023110|NCT00812331|12201522|FG001|STARTED|Overall Study||8
11023111|NCT00812331|12201523|FG002|STARTED|Overall Study||8
11023112|NCT00812331|12201524|FG003|STARTED|Overall Study||7
11023113|NCT00812331|12201525|FG004|STARTED|Overall Study||8
11023114|NCT00812331|12201521|FG000|COMPLETED|Overall Study||5
11417059|NCT00752986|12614874|FG000|COMPLETED|Overall Study||11
11417060|NCT00752986|12614875|FG001|COMPLETED|Overall Study||11
11417061|NCT00752986|12614876|FG002|COMPLETED|Overall Study||9
11417062|NCT00752986|12614874|FG000|NOT COMPLETED|Overall Study||5
11417063|NCT00752986|12614875|FG001|NOT COMPLETED|Overall Study||1
11417064|NCT00752986|12614876|FG002|NOT COMPLETED|Overall Study||2
11417065|NCT00751335|12614886|FG000|STARTED|Overall Study||0
11417066|NCT00751335|12614887|FG001|STARTED|Overall Study||0
11417067|NCT00751335|12614886|FG000|COMPLETED|Overall Study||0
11417068|NCT00751335|12614887|FG001|COMPLETED|Overall Study||0
11417069|NCT00751335|12614886|FG000|NOT COMPLETED|Overall Study||0
11417070|NCT00751335|12614887|FG001|NOT COMPLETED|Overall Study||0
11417071|NCT00746239|12614893|FG000|STARTED|Overall Study||11
11417072|NCT00746239|12614893|FG000|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
11417073|NCT00746239|12614893|FG000|NOT COMPLETED|Overall Study||6
11417074|NCT00754013|12614899|FG000|STARTED|Overall Study||4
11417075|NCT00754013|12614900|FG001|STARTED|Overall Study||5
11417076|NCT00754013|12614899|FG000|COMPLETED|Overall Study||0
11417077|NCT00754013|12614900|FG001|COMPLETED|Overall Study||0
11417078|NCT00754013|12614899|FG000|NOT COMPLETED|Overall Study||4
11417079|NCT00754013|12614900|FG001|NOT COMPLETED|Overall Study||5
11417080|NCT00735553|12614909|FG000|STARTED|Overall Study||77
11417081|NCT00735553|12614909|FG000|COMPLETED|Overall Study||0
11417082|NCT00735553|12614909|FG000|NOT COMPLETED|Overall Study||77
11417083|NCT00751933|12614917|FG000|STARTED|Overall Study||0
11417084|NCT00751933|12614918|FG001|STARTED|Overall Study||1
11417085|NCT00751933|12614919|FG002|STARTED|Overall Study||1
11417086|NCT00751933|12614920|FG003|STARTED|Overall Study||1
11417087|NCT00751933|12614917|FG000|COMPLETED|Overall Study||0
11417088|NCT00751933|12614918|FG001|COMPLETED|Overall Study||0
11417089|NCT00751933|12614919|FG002|COMPLETED|Overall Study||0
11417090|NCT00751933|12614920|FG003|COMPLETED|Overall Study||0
11417091|NCT00751933|12614917|FG000|NOT COMPLETED|Overall Study||0
11417092|NCT00751933|12614918|FG001|NOT COMPLETED|Overall Study||1
11417093|NCT00751933|12614919|FG002|NOT COMPLETED|Overall Study||1
11417094|NCT00751933|12614920|FG003|NOT COMPLETED|Overall Study||1
11417095|NCT00747916|12614924|FG000|STARTED|Overall Study||3
11417096|NCT00747916|12614924|FG000|COMPLETED|Overall Study||3
11417097|NCT00747916|12614924|FG000|NOT COMPLETED|Overall Study||0
11417098|NCT00745030|12614930|FG000|STARTED|Overall Study||1
11417099|NCT00745030|12614931|FG001|STARTED|Overall Study||2
11417100|NCT00745030|12614930|FG000|COMPLETED|Overall Study||1
11417101|NCT00745030|12614931|FG001|COMPLETED|Overall Study||2
11417102|NCT00745030|12614930|FG000|NOT COMPLETED|Overall Study||0
11417103|NCT00745030|12614931|FG001|NOT COMPLETED|Overall Study||0
11417104|NCT00747461|12614937|FG000|STARTED|Overall Study||5
11417105|NCT00747461|12614937|FG000|COMPLETED|Overall Study||0
11417106|NCT00747461|12614937|FG000|NOT COMPLETED|Overall Study||5
11417107|NCT00746018|12614942|FG000|STARTED|Overall Study||39
11417108|NCT00746018|12614942|FG000|COMPLETED|Overall Study||39
11417109|NCT00746018|12614942|FG000|NOT COMPLETED|Overall Study||0
11417110|NCT00746603|12614946|FG000|STARTED|Overall Study||3
11417111|NCT00746603|12614946|FG000|COMPLETED|Overall Study||3
11417112|NCT00746603|12614946|FG000|NOT COMPLETED|Overall Study||0
11417113|NCT00736385|12614952|FG000|STARTED|Overall Study||4
11417114|NCT00736385|12614953|FG001|STARTED|Overall Study||5
11417115|NCT00736385|12614952|FG000|COMPLETED|Overall Study||2
11417116|NCT00736385|12614953|FG001|COMPLETED|Overall Study||2
11417117|NCT00736385|12614952|FG000|NOT COMPLETED|Overall Study||2
11417118|NCT00736385|12614953|FG001|NOT COMPLETED|Overall Study||3
11417119|NCT00738972|12614963|FG000|STARTED|Overall Study||3
11417120|NCT00738972|12614964|FG001|STARTED|Overall Study||3
11417121|NCT00738972|12614965|FG002|STARTED|Overall Study||3
11417122|NCT00738972|12614966|FG003|STARTED|Overall Study||3
11417123|NCT00738972|12614963|FG000|COMPLETED|Overall Study||3
11417124|NCT00738972|12614964|FG001|COMPLETED|Overall Study||3
11417125|NCT00738972|12614965|FG002|COMPLETED|Overall Study||3
11417126|NCT00738972|12614966|FG003|COMPLETED|Overall Study||2
11417127|NCT00738972|12614963|FG000|NOT COMPLETED|Overall Study||0
11417128|NCT00738972|12614964|FG001|NOT COMPLETED|Overall Study||0
11417129|NCT00738972|12614965|FG002|NOT COMPLETED|Overall Study||0
11417130|NCT00738972|12614966|FG003|NOT COMPLETED|Overall Study||1
11417131|NCT00739063|12614976|FG000|STARTED|Overall Study||11
11417132|NCT00739063|12614976|FG000|COMPLETED|Overall Study||3
11417133|NCT00739063|12614976|FG000|NOT COMPLETED|Overall Study||8
11417134|NCT00740597|12614980|FG000|STARTED|Overall Study||1
11417135|NCT00740597|12614980|FG000|COMPLETED|Overall Study||0
11417136|NCT00740597|12614980|FG000|NOT COMPLETED|Overall Study||1
11417137|NCT00737594|12614987|FG000|STARTED|Overall Study||0
11417138|NCT00737594|12614988|FG001|STARTED|Overall Study||0
11417139|NCT00737594|12614989|FG002|STARTED|Overall Study||0
11417140|NCT00737594|12614987|FG000|COMPLETED|Overall Study||0
11417141|NCT00737594|12614988|FG001|COMPLETED|Overall Study||0
11417142|NCT00737594|12614989|FG002|COMPLETED|Overall Study||0
11417143|NCT00737594|12614987|FG000|NOT COMPLETED|Overall Study||0
11417144|NCT00737594|12614988|FG001|NOT COMPLETED|Overall Study||0
11417145|NCT00737594|12614989|FG002|NOT COMPLETED|Overall Study||0
11417146|NCT00737282|12614999|FG000|STARTED|Overall Study||175
11417147|NCT00737282|12614999|FG000|COMPLETED|Overall Study||0
11417148|NCT00737282|12614999|FG000|NOT COMPLETED|Overall Study||175
11417149|NCT00739882|12615007|FG000|STARTED|Double-blind Period||51
11417150|NCT00739882|12615008|FG001|STARTED|Double-blind Period||25
11417151|NCT00739882|12615007|FG000|COMPLETED|Double-blind Period||32
11417152|NCT00739882|12615008|FG001|COMPLETED|Double-blind Period||14
11417153|NCT00739882|12615007|FG000|NOT COMPLETED|Double-blind Period||19
11417154|NCT00739882|12615008|FG001|NOT COMPLETED|Double-blind Period||11
11417155|NCT00739882|12615007|FG000|STARTED|Open-label Period||17
11417156|NCT00739882|12615008|FG001|STARTED|Open-label Period||14
11417157|NCT00739882|12615007|FG000|COMPLETED|Open-label Period||7
11417158|NCT00739882|12615008|FG001|COMPLETED|Open-label Period||9
11417159|NCT00739882|12615007|FG000|NOT COMPLETED|Open-label Period||10
11417160|NCT00739882|12615008|FG001|NOT COMPLETED|Open-label Period||5
11417161|NCT00739024|12615018|FG000|STARTED|Overall Study||7
11417162|NCT00739024|12615019|FG001|STARTED|Overall Study||6
11417163|NCT00739024|12615018|FG000|COMPLETED|Overall Study||7
11417164|NCT00739024|12615019|FG001|COMPLETED|Overall Study||6
11417165|NCT00739024|12615018|FG000|NOT COMPLETED|Overall Study||0
11417166|NCT00739024|12615019|FG001|NOT COMPLETED|Overall Study||0
11417167|NCT00731770|12615027|FG000|STARTED|Overall Study||5
11417168|NCT00731770|12615028|FG001|STARTED|Overall Study||5
11417169|NCT00731770|12615027|FG000|COMPLETED|Overall Study||5
11417170|NCT00731770|12615028|FG001|COMPLETED|Overall Study||5
11417171|NCT00731770|12615027|FG000|NOT COMPLETED|Overall Study||0
11417172|NCT00731770|12615028|FG001|NOT COMPLETED|Overall Study||0
11417173|NCT00735254|12615040|FG000|STARTED|Overall Study||1
11417174|NCT00735254|12615041|FG001|STARTED|Overall Study||1
11417175|NCT00735254|12615042|FG002|STARTED|Overall Study||1
11023115|NCT00812331|12201522|FG001|COMPLETED|Overall Study||8
11023116|NCT00812331|12201523|FG002|COMPLETED|Overall Study||8
11023117|NCT00812331|12201524|FG003|COMPLETED|Overall Study||7
11023118|NCT00812331|12201525|FG004|COMPLETED|Overall Study||8
11023119|NCT00812331|12201521|FG000|NOT COMPLETED|Overall Study||1
11023120|NCT00812331|12201522|FG001|NOT COMPLETED|Overall Study||0
11023121|NCT00812331|12201523|FG002|NOT COMPLETED|Overall Study||0
11023122|NCT00812331|12201524|FG003|NOT COMPLETED|Overall Study||0
11023123|NCT00812331|12201525|FG004|NOT COMPLETED|Overall Study||0
11023124|NCT00812461|12201535|FG000|STARTED|All Randomised Patients||360
11023125|NCT00812461|12201536|FG001|STARTED|All Randomised Patients||358
11023126|NCT00812461|12201535|FG000|COMPLETED|All Randomised Patients||337
11023127|NCT00812461|12201536|FG001|COMPLETED|All Randomised Patients||341
11023128|NCT00812461|12201535|FG000|NOT COMPLETED|All Randomised Patients||23
11417176|NCT00735254|12615043|FG003|STARTED|Overall Study||0
11417177|NCT00735254|12615040|FG000|COMPLETED|Overall Study||0
11023129|NCT00812461|12201536|FG001|NOT COMPLETED|All Randomised Patients||17
11023130|NCT00812461|12201535|FG000|STARTED|All Treated Patients||337
11023131|NCT00812461|12201536|FG001|STARTED|All Treated Patients||341
11023132|NCT00812461|12201535|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
11023133|NCT00812461|12201536|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
11023134|NCT00812461|12201535|FG000|NOT COMPLETED|All Treated Patients||132
11023135|NCT00812461|12201536|FG001|NOT COMPLETED|All Treated Patients||147
11023136|NCT00812487|12201544|FG000|STARTED|Overall Study||32
11023137|NCT00812487|12201545|FG001|STARTED|Overall Study||42
11023138|NCT00812487|12201544|FG000|COMPLETED|Overall Study||26
11023139|NCT00812487|12201545|FG001|COMPLETED|Overall Study||39
11023140|NCT00812487|12201544|FG000|NOT COMPLETED|Overall Study||6
11023141|NCT00812487|12201545|FG001|NOT COMPLETED|Overall Study||3
11023142|NCT00812565|12201559|FG000|STARTED|Overall Study||8
11023143|NCT00812565|12201560|FG001|STARTED|Overall Study||7
11023144|NCT00812565|12201561|FG002|STARTED|Overall Study||7
11023145|NCT00812565|12201562|FG003|STARTED|Overall Study||7
11023146|NCT00812565|12201563|FG004|STARTED|Overall Study||7
11023147|NCT00812565|12201564|FG005|STARTED|Overall Study||7
11023148|NCT00812565|12201565|FG006|STARTED|Overall Study||8
11023149|NCT00812565|12201566|FG007|STARTED|Overall Study||7
11023150|NCT00812565|12201559|FG000|COMPLETED|Overall Study||5
11417178|NCT00735254|12615041|FG001|COMPLETED|Overall Study||0
11417179|NCT00735254|12615042|FG002|COMPLETED|Overall Study||0
11417180|NCT00735254|12615043|FG003|COMPLETED|Overall Study||0
11417181|NCT00735254|12615040|FG000|NOT COMPLETED|Overall Study||1
11417182|NCT00735254|12615041|FG001|NOT COMPLETED|Overall Study||1
11417183|NCT00735254|12615042|FG002|NOT COMPLETED|Overall Study||1
11417184|NCT00735254|12615043|FG003|NOT COMPLETED|Overall Study||0
11023151|NCT00812565|12201560|FG001|COMPLETED|Overall Study||6
11417185|NCT00729365|12615056|FG000|STARTED|Overall Study||33
11417186|NCT00729365|12615057|FG001|STARTED|Overall Study||6
11417187|NCT00729365|12615058|FG002|STARTED|Overall Study||7
11417188|NCT00729365|12615056|FG000|COMPLETED|Overall Study|Study terminated|0
11417189|NCT00729365|12615057|FG001|COMPLETED|Overall Study|Study Terminated|0
11023152|NCT00812565|12201561|FG002|COMPLETED|Overall Study||7
11023153|NCT00812565|12201562|FG003|COMPLETED|Overall Study||5
11023154|NCT00812565|12201563|FG004|COMPLETED|Overall Study||6
11023155|NCT00812565|12201564|FG005|COMPLETED|Overall Study||6
11023156|NCT00812565|12201565|FG006|COMPLETED|Overall Study||8
11023157|NCT00812565|12201566|FG007|COMPLETED|Overall Study||6
11023158|NCT00812565|12201559|FG000|NOT COMPLETED|Overall Study||3
11023159|NCT00812565|12201560|FG001|NOT COMPLETED|Overall Study||1
11023160|NCT00812565|12201561|FG002|NOT COMPLETED|Overall Study||0
11023161|NCT00812565|12201562|FG003|NOT COMPLETED|Overall Study||2
11023162|NCT00812565|12201563|FG004|NOT COMPLETED|Overall Study||1
11023163|NCT00812565|12201564|FG005|NOT COMPLETED|Overall Study||1
11023164|NCT00812565|12201565|FG006|NOT COMPLETED|Overall Study||0
11023165|NCT00812565|12201566|FG007|NOT COMPLETED|Overall Study||1
11023166|NCT00812604|12201586|FG000|STARTED|Overall Study||28
11417190|NCT00729365|12615058|FG002|COMPLETED|Overall Study|Study terminated|0
11417191|NCT00729365|12615056|FG000|NOT COMPLETED|Overall Study||33
11417192|NCT00729365|12615057|FG001|NOT COMPLETED|Overall Study||6
11417193|NCT00729365|12615058|FG002|NOT COMPLETED|Overall Study||7
11417194|NCT00732680|12615068|FG000|STARTED|Overall Study||9
11417195|NCT00732680|12615068|FG000|COMPLETED|Overall Study||9
11417196|NCT00732680|12615068|FG000|NOT COMPLETED|Overall Study||0
11417197|NCT00726180|12615072|FG000|STARTED|Overall Study||1
11417198|NCT00726180|12615072|FG000|COMPLETED|Overall Study||1
11417199|NCT00726180|12615072|FG000|NOT COMPLETED|Overall Study||0
11417200|NCT00724282|12615076|FG000|STARTED|Overall Study||20
11417201|NCT00724282|12615076|FG000|COMPLETED|Overall Study||16
11417202|NCT00724282|12615076|FG000|NOT COMPLETED|Overall Study||4
11417203|NCT00730886|12615082|FG000|STARTED|Overall Study||2
11144318|NCT01477853|12331037|FG000|STARTED|Phase A||55
11144319|NCT01477853|12331038|FG001|STARTED|Phase A||56
11144320|NCT01477853|12331039|FG002|STARTED|Phase A||55
11417204|NCT00730886|12615083|FG001|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
11417205|NCT00730886|12615082|FG000|COMPLETED|Overall Study||0
11417206|NCT00730886|12615083|FG001|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
11144321|NCT01477853|12331037|FG000|COMPLETED|Phase A||12
11144322|NCT01477853|12331038|FG001|COMPLETED|Phase A||11
11144323|NCT01477853|12331039|FG002|COMPLETED|Phase A||11
11144324|NCT01477853|12331037|FG000|NOT COMPLETED|Phase A||43
11144325|NCT01477853|12331038|FG001|NOT COMPLETED|Phase A||45
11144326|NCT01477853|12331039|FG002|NOT COMPLETED|Phase A||44
11144327|NCT01477853|12331037|FG000|STARTED|Phase B||12
11144328|NCT01477853|12331038|FG001|STARTED|Phase B||11
11144329|NCT01477853|12331039|FG002|STARTED|Phase B||11
11144330|NCT01477853|12331037|FG000|COMPLETED|Phase B||0
11144331|NCT01477853|12331038|FG001|COMPLETED|Phase B||0
11144332|NCT01477853|12331039|FG002|COMPLETED|Phase B||0
11023167|NCT00812604|12201587|FG001|STARTED|Overall Study||27
11023168|NCT00812604|12201586|FG000|COMPLETED|Overall Study||23
11023169|NCT00812604|12201587|FG001|COMPLETED|Overall Study||22
11023170|NCT00812604|12201586|FG000|NOT COMPLETED|Overall Study||5
11023171|NCT00812604|12201587|FG001|NOT COMPLETED|Overall Study||5
11023172|NCT00812812|12201595|FG000|STARTED|Overall Study||27
11023173|NCT00812812|12201596|FG001|STARTED|Overall Study||29
11023174|NCT00812812|12201595|FG000|COMPLETED|Overall Study||24
11023175|NCT00812812|12201596|FG001|COMPLETED|Overall Study||25
11023176|NCT00812812|12201595|FG000|NOT COMPLETED|Overall Study||3
11023177|NCT00812812|12201596|FG001|NOT COMPLETED|Overall Study||4
11023178|NCT00812838|12201606|FG000|STARTED|Treatment Period of 16 Weeks||6
11023179|NCT00812838|12201607|FG001|STARTED|Treatment Period of 16 Weeks||6
11144333|NCT01477853|12331037|FG000|NOT COMPLETED|Phase B||12
11144334|NCT01477853|12331038|FG001|NOT COMPLETED|Phase B||11
11023180|NCT00812838|12201606|FG000|COMPLETED|Treatment Period of 16 Weeks||6
11023181|NCT00812838|12201607|FG001|COMPLETED|Treatment Period of 16 Weeks||6
11023182|NCT00812838|12201606|FG000|NOT COMPLETED|Treatment Period of 16 Weeks||0
11023183|NCT00812838|12201607|FG001|NOT COMPLETED|Treatment Period of 16 Weeks||0
11023184|NCT00812838|12201606|FG000|STARTED|Optional Crossover of 16 Weeks||0
11023185|NCT00812838|12201607|FG001|STARTED|Optional Crossover of 16 Weeks||4
11023186|NCT00812838|12201606|FG000|COMPLETED|Optional Crossover of 16 Weeks||0
11023187|NCT00812838|12201607|FG001|COMPLETED|Optional Crossover of 16 Weeks||4
11023188|NCT00812838|12201606|FG000|NOT COMPLETED|Optional Crossover of 16 Weeks||0
11023189|NCT00812838|12201607|FG001|NOT COMPLETED|Optional Crossover of 16 Weeks||0
11023190|NCT00812877|12201617|FG000|STARTED|Overall Study||195
11023191|NCT00812877|12201618|FG001|STARTED|Overall Study||181
11023192|NCT00812877|12201617|FG000|COMPLETED|Overall Study||158
11023193|NCT00812877|12201618|FG001|COMPLETED|Overall Study||130
11023194|NCT00812877|12201617|FG000|NOT COMPLETED|Overall Study||37
11023195|NCT00812877|12201618|FG001|NOT COMPLETED|Overall Study||51
11023196|NCT00812916|12201624|FG000|STARTED|Overall Study|206 enrolled (consented)|206
11023197|NCT00812916|12201624|FG000|Data Available|Overall Study||205
11023198|NCT00812916|12201624|FG000|CFAE - Guided Ablation|Overall Study||203
11023199|NCT00812916|12201624|FG000|COMPLETED|Overall Study||203
11023200|NCT00812916|12201624|FG000|NOT COMPLETED|Overall Study||3
11023201|NCT00812929|12201630|FG000|STARTED|Treatment Period 1||5
11023202|NCT00812929|12201631|FG001|STARTED|Treatment Period 1||4
11023203|NCT00812929|12201632|FG002|STARTED|Treatment Period 1||5
11023204|NCT00812929|12201633|FG003|STARTED|Treatment Period 1||4
11023205|NCT00812929|12201634|FG004|STARTED|Treatment Period 1||5
11023206|NCT00812929|12201635|FG005|STARTED|Treatment Period 1||5
11023207|NCT00812929|12201636|FG006|STARTED|Treatment Period 1||5
11023208|NCT00812929|12201637|FG007|STARTED|Treatment Period 1||5
11023209|NCT00812929|12201638|FG008|STARTED|Treatment Period 1||4
11023210|NCT00812929|12201639|FG009|STARTED|Treatment Period 1||5
11023211|NCT00812929|12201630|FG000|COMPLETED|Treatment Period 1||5
11023212|NCT00812929|12201631|FG001|COMPLETED|Treatment Period 1||4
11023213|NCT00812929|12201632|FG002|COMPLETED|Treatment Period 1||5
11023214|NCT00812929|12201633|FG003|COMPLETED|Treatment Period 1||4
11023215|NCT00812929|12201634|FG004|COMPLETED|Treatment Period 1||5
11023216|NCT00812929|12201635|FG005|COMPLETED|Treatment Period 1||5
11023217|NCT00812929|12201636|FG006|COMPLETED|Treatment Period 1||5
11023218|NCT00812929|12201637|FG007|COMPLETED|Treatment Period 1||5
11023219|NCT00812929|12201638|FG008|COMPLETED|Treatment Period 1||4
11023220|NCT00812929|12201639|FG009|COMPLETED|Treatment Period 1||5
11023221|NCT00812929|12201630|FG000|NOT COMPLETED|Treatment Period 1||0
11023222|NCT00812929|12201631|FG001|NOT COMPLETED|Treatment Period 1||0
11023223|NCT00812929|12201632|FG002|NOT COMPLETED|Treatment Period 1||0
11023224|NCT00812929|12201633|FG003|NOT COMPLETED|Treatment Period 1||0
11023225|NCT00812929|12201634|FG004|NOT COMPLETED|Treatment Period 1||0
11023226|NCT00812929|12201635|FG005|NOT COMPLETED|Treatment Period 1||0
11023227|NCT00812929|12201636|FG006|NOT COMPLETED|Treatment Period 1||0
11023228|NCT00812929|12201637|FG007|NOT COMPLETED|Treatment Period 1||0
11023229|NCT00812929|12201638|FG008|NOT COMPLETED|Treatment Period 1||0
11023230|NCT00812929|12201639|FG009|NOT COMPLETED|Treatment Period 1||0
11023231|NCT00812929|12201630|FG000|STARTED|Washout Period 1 (7 Days)||5
11023232|NCT00812929|12201631|FG001|STARTED|Washout Period 1 (7 Days)||4
11023233|NCT00812929|12201632|FG002|STARTED|Washout Period 1 (7 Days)||5
11023234|NCT00812929|12201633|FG003|STARTED|Washout Period 1 (7 Days)||4
11023235|NCT00812929|12201634|FG004|STARTED|Washout Period 1 (7 Days)||5
11023236|NCT00812929|12201635|FG005|STARTED|Washout Period 1 (7 Days)||5
11023237|NCT00812929|12201636|FG006|STARTED|Washout Period 1 (7 Days)||5
11023238|NCT00812929|12201637|FG007|STARTED|Washout Period 1 (7 Days)||5
11023239|NCT00812929|12201638|FG008|STARTED|Washout Period 1 (7 Days)||4
11023240|NCT00812929|12201639|FG009|STARTED|Washout Period 1 (7 Days)||5
11023241|NCT00812929|12201630|FG000|COMPLETED|Washout Period 1 (7 Days)||5
11023242|NCT00812929|12201631|FG001|COMPLETED|Washout Period 1 (7 Days)||4
11023243|NCT00812929|12201632|FG002|COMPLETED|Washout Period 1 (7 Days)||4
11023244|NCT00812929|12201633|FG003|COMPLETED|Washout Period 1 (7 Days)||4
11417207|NCT00730886|12615082|FG000|NOT COMPLETED|Overall Study||2
11417208|NCT00730886|12615083|FG001|NOT COMPLETED|Overall Study||0
11417209|NCT00728845|12615091|FG000|STARTED|Overall Study||8
11417210|NCT00728845|12615092|FG001|STARTED|Overall Study||0
11023245|NCT00812929|12201634|FG004|COMPLETED|Washout Period 1 (7 Days)||5
11023246|NCT00812929|12201635|FG005|COMPLETED|Washout Period 1 (7 Days)||5
11023247|NCT00812929|12201636|FG006|COMPLETED|Washout Period 1 (7 Days)||5
11023248|NCT00812929|12201637|FG007|COMPLETED|Washout Period 1 (7 Days)||5
11023249|NCT00812929|12201638|FG008|COMPLETED|Washout Period 1 (7 Days)||4
11023250|NCT00812929|12201639|FG009|COMPLETED|Washout Period 1 (7 Days)||5
11023251|NCT00812929|12201630|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
11023252|NCT00812929|12201631|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
11417211|NCT00728845|12615091|FG000|COMPLETED|Overall Study||8
11417212|NCT00728845|12615092|FG001|COMPLETED|Overall Study||0
11417213|NCT00728845|12615091|FG000|NOT COMPLETED|Overall Study||0
11417214|NCT00728845|12615092|FG001|NOT COMPLETED|Overall Study||0
11417215|NCT00726830|12615100|FG000|STARTED|Overall Study||1
11417216|NCT00726830|12615101|FG001|STARTED|Overall Study||0
11417217|NCT00726830|12615100|FG000|COMPLETED|Overall Study||1
11417218|NCT00726830|12615101|FG001|COMPLETED|Overall Study||0
11417219|NCT00726830|12615100|FG000|NOT COMPLETED|Overall Study||0
11417220|NCT00726830|12615101|FG001|NOT COMPLETED|Overall Study||0
11417221|NCT00726037|12615107|FG000|STARTED|Overall Study||7
11417222|NCT00726037|12615107|FG000|COMPLETED|Overall Study||7
11417223|NCT00726037|12615107|FG000|NOT COMPLETED|Overall Study||0
11417224|NCT00729560|12615111|FG000|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
11417225|NCT00729560|12615111|FG000|COMPLETED|Overall Study||5
11417226|NCT00729560|12615111|FG000|NOT COMPLETED|Overall Study||3
11417227|NCT00716807|12615119|FG000|STARTED|Overall Study||8
11417228|NCT00716807|12615120|FG001|STARTED|Overall Study||5
11417229|NCT00716807|12615121|FG002|STARTED|Overall Study||18
11417230|NCT00716807|12615122|FG003|STARTED|Overall Study||15
11417231|NCT00716807|12615119|FG000|COMPLETED|Overall Study||8
11417232|NCT00716807|12615120|FG001|COMPLETED|Overall Study||5
11417233|NCT00716807|12615121|FG002|COMPLETED|Overall Study||18
11417234|NCT00716807|12615122|FG003|COMPLETED|Overall Study||15
11417235|NCT00716807|12615119|FG000|NOT COMPLETED|Overall Study||0
11417236|NCT00716807|12615120|FG001|NOT COMPLETED|Overall Study||0
11417237|NCT00716807|12615121|FG002|NOT COMPLETED|Overall Study||0
11417238|NCT00716807|12615122|FG003|NOT COMPLETED|Overall Study||0
11023253|NCT00812929|12201632|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
11023254|NCT00812929|12201633|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
11023255|NCT00812929|12201634|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
11023256|NCT00812929|12201635|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
11023257|NCT00812929|12201636|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
11023258|NCT00812929|12201637|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
11023259|NCT00812929|12201638|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
11023260|NCT00812929|12201639|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
11023261|NCT00812929|12201630|FG000|STARTED|Treatment Period 2||5
11023262|NCT00812929|12201631|FG001|STARTED|Treatment Period 2||4
11023263|NCT00812929|12201632|FG002|STARTED|Treatment Period 2||4
11023264|NCT00812929|12201633|FG003|STARTED|Treatment Period 2||4
11023265|NCT00812929|12201634|FG004|STARTED|Treatment Period 2||5
11023266|NCT00812929|12201635|FG005|STARTED|Treatment Period 2||5
11023267|NCT00812929|12201636|FG006|STARTED|Treatment Period 2||5
11023268|NCT00812929|12201637|FG007|STARTED|Treatment Period 2||5
11023269|NCT00812929|12201638|FG008|STARTED|Treatment Period 2||4
11023270|NCT00812929|12201639|FG009|STARTED|Treatment Period 2||5
11023271|NCT00812929|12201630|FG000|COMPLETED|Treatment Period 2||5
11023272|NCT00812929|12201631|FG001|COMPLETED|Treatment Period 2||4
11023273|NCT00812929|12201632|FG002|COMPLETED|Treatment Period 2||4
11023274|NCT00812929|12201633|FG003|COMPLETED|Treatment Period 2||4
11023275|NCT00812929|12201634|FG004|COMPLETED|Treatment Period 2||5
11023276|NCT00812929|12201635|FG005|COMPLETED|Treatment Period 2||5
11023277|NCT00812929|12201636|FG006|COMPLETED|Treatment Period 2||5
11023278|NCT00812929|12201637|FG007|COMPLETED|Treatment Period 2||5
11023279|NCT00812929|12201638|FG008|COMPLETED|Treatment Period 2||4
11023280|NCT00812929|12201639|FG009|COMPLETED|Treatment Period 2||5
11023281|NCT00812929|12201630|FG000|NOT COMPLETED|Treatment Period 2||0
11023282|NCT00812929|12201631|FG001|NOT COMPLETED|Treatment Period 2||0
11023283|NCT00812929|12201632|FG002|NOT COMPLETED|Treatment Period 2||0
11023284|NCT00812929|12201633|FG003|NOT COMPLETED|Treatment Period 2||0
11023285|NCT00812929|12201634|FG004|NOT COMPLETED|Treatment Period 2||0
11023286|NCT00812929|12201635|FG005|NOT COMPLETED|Treatment Period 2||0
11023287|NCT00812929|12201636|FG006|NOT COMPLETED|Treatment Period 2||0
11023288|NCT00812929|12201637|FG007|NOT COMPLETED|Treatment Period 2||0
11023289|NCT00812929|12201638|FG008|NOT COMPLETED|Treatment Period 2||0
11023290|NCT00812929|12201639|FG009|NOT COMPLETED|Treatment Period 2||0
11023291|NCT00812929|12201630|FG000|STARTED|Washout Period 2 (7 Days)||5
11023292|NCT00812929|12201631|FG001|STARTED|Washout Period 2 (7 Days)||4
11023293|NCT00812929|12201632|FG002|STARTED|Washout Period 2 (7 Days)||4
11023294|NCT00812929|12201633|FG003|STARTED|Washout Period 2 (7 Days)||4
11023295|NCT00812929|12201634|FG004|STARTED|Washout Period 2 (7 Days)||5
11023296|NCT00812929|12201635|FG005|STARTED|Washout Period 2 (7 Days)||5
11023297|NCT00812929|12201636|FG006|STARTED|Washout Period 2 (7 Days)||5
11023298|NCT00812929|12201637|FG007|STARTED|Washout Period 2 (7 Days)||5
11023299|NCT00812929|12201638|FG008|STARTED|Washout Period 2 (7 Days)||4
11023300|NCT00812929|12201639|FG009|STARTED|Washout Period 2 (7 Days)||5
11023301|NCT00812929|12201630|FG000|COMPLETED|Washout Period 2 (7 Days)||5
11023302|NCT00812929|12201631|FG001|COMPLETED|Washout Period 2 (7 Days)||4
11023303|NCT00812929|12201632|FG002|COMPLETED|Washout Period 2 (7 Days)||4
11023304|NCT00812929|12201633|FG003|COMPLETED|Washout Period 2 (7 Days)||4
11023305|NCT00812929|12201634|FG004|COMPLETED|Washout Period 2 (7 Days)||5
11417239|NCT00714948|12615132|FG000|STARTED|Overall Study||2
11417240|NCT00714948|12615132|FG000|COMPLETED|Overall Study||0
11417241|NCT00714948|12615132|FG000|NOT COMPLETED|Overall Study||2
11417242|NCT00720343|12615136|FG000|STARTED|Overall Study||54
11417243|NCT00720343|12615136|FG000|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
11417244|NCT00720343|12615136|FG000|NOT COMPLETED|Overall Study||6
11023306|NCT00812929|12201635|FG005|COMPLETED|Washout Period 2 (7 Days)||5
11023307|NCT00812929|12201636|FG006|COMPLETED|Washout Period 2 (7 Days)||5
11023308|NCT00812929|12201637|FG007|COMPLETED|Washout Period 2 (7 Days)||5
11023309|NCT00812929|12201638|FG008|COMPLETED|Washout Period 2 (7 Days)||4
11023310|NCT00812929|12201639|FG009|COMPLETED|Washout Period 2 (7 Days)||4
11023311|NCT00812929|12201630|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
11023312|NCT00812929|12201631|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
11023313|NCT00812929|12201632|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
11023314|NCT00812929|12201633|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
11023315|NCT00812929|12201634|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
11023316|NCT00812929|12201635|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
11023317|NCT00812929|12201636|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
11023318|NCT00812929|12201637|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
11023319|NCT00812929|12201638|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
11023320|NCT00812929|12201639|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||1
11023321|NCT00812929|12201630|FG000|STARTED|Treatment Period 3||5
11023322|NCT00812929|12201631|FG001|STARTED|Treatment Period 3||4
11023323|NCT00812929|12201632|FG002|STARTED|Treatment Period 3||4
11023324|NCT00812929|12201633|FG003|STARTED|Treatment Period 3||4
11023325|NCT00812929|12201634|FG004|STARTED|Treatment Period 3||5
11023326|NCT00812929|12201635|FG005|STARTED|Treatment Period 3||5
11023327|NCT00812929|12201636|FG006|STARTED|Treatment Period 3||5
11023328|NCT00812929|12201637|FG007|STARTED|Treatment Period 3||5
11023329|NCT00812929|12201638|FG008|STARTED|Treatment Period 3||4
11023330|NCT00812929|12201639|FG009|STARTED|Treatment Period 3||4
11023331|NCT00812929|12201630|FG000|COMPLETED|Treatment Period 3||5
11023332|NCT00812929|12201631|FG001|COMPLETED|Treatment Period 3||4
11023333|NCT00812929|12201632|FG002|COMPLETED|Treatment Period 3||4
11023334|NCT00812929|12201633|FG003|COMPLETED|Treatment Period 3||4
11023335|NCT00812929|12201634|FG004|COMPLETED|Treatment Period 3||5
11023336|NCT00812929|12201635|FG005|COMPLETED|Treatment Period 3||5
11023337|NCT00812929|12201636|FG006|COMPLETED|Treatment Period 3||5
11023338|NCT00812929|12201637|FG007|COMPLETED|Treatment Period 3||5
11023339|NCT00812929|12201638|FG008|COMPLETED|Treatment Period 3||4
11023340|NCT00812929|12201639|FG009|COMPLETED|Treatment Period 3||4
11023341|NCT00812929|12201630|FG000|NOT COMPLETED|Treatment Period 3||0
11023342|NCT00812929|12201631|FG001|NOT COMPLETED|Treatment Period 3||0
11023343|NCT00812929|12201632|FG002|NOT COMPLETED|Treatment Period 3||0
11023344|NCT00812929|12201633|FG003|NOT COMPLETED|Treatment Period 3||0
11023345|NCT00812929|12201634|FG004|NOT COMPLETED|Treatment Period 3||0
11023346|NCT00812929|12201635|FG005|NOT COMPLETED|Treatment Period 3||0
11023347|NCT00812929|12201636|FG006|NOT COMPLETED|Treatment Period 3||0
11023348|NCT00812929|12201637|FG007|NOT COMPLETED|Treatment Period 3||0
11023349|NCT00812929|12201638|FG008|NOT COMPLETED|Treatment Period 3||0
11023350|NCT00812929|12201639|FG009|NOT COMPLETED|Treatment Period 3||0
11023351|NCT00812929|12201630|FG000|STARTED|Washout Period 3 (7 Days)||5
11023352|NCT00812929|12201631|FG001|STARTED|Washout Period 3 (7 Days)||4
11023353|NCT00812929|12201632|FG002|STARTED|Washout Period 3 (7 Days)||4
11023354|NCT00812929|12201633|FG003|STARTED|Washout Period 3 (7 Days)||4
11023355|NCT00812929|12201634|FG004|STARTED|Washout Period 3 (7 Days)||5
11417245|NCT00719914|12615144|FG000|STARTED|Overall Study||10
11417246|NCT00719914|12615145|FG001|STARTED|Overall Study||7
11417247|NCT00719914|12615144|FG000|COMPLETED|Overall Study||10
11417248|NCT00719914|12615145|FG001|COMPLETED|Overall Study||7
11417249|NCT00719914|12615144|FG000|NOT COMPLETED|Overall Study||0
11417250|NCT00719914|12615145|FG001|NOT COMPLETED|Overall Study||0
11417251|NCT00718640|12615151|FG000|STARTED|Overall Study||10
11417252|NCT00718640|12615151|FG000|COMPLETED|Overall Study||3
11417253|NCT00718640|12615151|FG000|NOT COMPLETED|Overall Study||7
11417254|NCT00720083|12615157|FG000|STARTED|Overall Study||17
11417255|NCT00720083|12615158|FG001|STARTED|Overall Study||15
11417256|NCT00720083|12615157|FG000|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
11417257|NCT00720083|12615158|FG001|COMPLETED|Overall Study||13
11417258|NCT00720083|12615157|FG000|NOT COMPLETED|Overall Study||1
11417259|NCT00720083|12615158|FG001|NOT COMPLETED|Overall Study||2
11417260|NCT00717275|12615164|FG000|STARTED|Overall Study||3
11417261|NCT00717275|12615164|FG000|COMPLETED|Overall Study||0
11417262|NCT00717275|12615164|FG000|NOT COMPLETED|Overall Study||3
11417263|NCT00708734|12615168|FG000|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
11417264|NCT00708734|12615168|FG000|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
11417265|NCT00708734|12615168|FG000|NOT COMPLETED|Overall Study||7
11417266|NCT00711087|12615174|FG000|STARTED|Overall Study||1
11417267|NCT00711087|12615175|FG001|STARTED|Overall Study||0
11417268|NCT00711087|12615174|FG000|COMPLETED|Overall Study||0
11023356|NCT00812929|12201635|FG005|STARTED|Washout Period 3 (7 Days)||5
11023357|NCT00812929|12201636|FG006|STARTED|Washout Period 3 (7 Days)||5
11023358|NCT00812929|12201637|FG007|STARTED|Washout Period 3 (7 Days)||5
11417269|NCT00711087|12615175|FG001|COMPLETED|Overall Study||0
11417270|NCT00711087|12615174|FG000|NOT COMPLETED|Overall Study||1
11023359|NCT00812929|12201638|FG008|STARTED|Washout Period 3 (7 Days)||4
11417271|NCT00711087|12615175|FG001|NOT COMPLETED|Overall Study||0
11417272|NCT00706797|12615183|FG000|STARTED|Overall Study||70
11417273|NCT00706797|12615184|FG001|STARTED|Overall Study||71
11417274|NCT00706797|12615183|FG000|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
11417275|NCT00706797|12615184|FG001|Safety Population|Overall Study||71
11417276|NCT00706797|12615183|FG000|COMPLETED|Overall Study||1
11417277|NCT00706797|12615184|FG001|COMPLETED|Overall Study||0
11417278|NCT00706797|12615183|FG000|NOT COMPLETED|Overall Study||69
11417279|NCT00706797|12615184|FG001|NOT COMPLETED|Overall Study||71
11417280|NCT00713596|12615193|FG000|STARTED|Overall Study||9
11417281|NCT00713596|12615194|FG001|STARTED|Overall Study||8
11417282|NCT00713596|12615195|FG002|STARTED|Overall Study||8
11417283|NCT00713596|12615193|FG000|COMPLETED|Overall Study||7
11417284|NCT00713596|12615194|FG001|COMPLETED|Overall Study||5
11417285|NCT00713596|12615195|FG002|COMPLETED|Overall Study||6
11417286|NCT00713596|12615193|FG000|NOT COMPLETED|Overall Study||2
11417287|NCT00713596|12615194|FG001|NOT COMPLETED|Overall Study||3
11417288|NCT00713596|12615195|FG002|NOT COMPLETED|Overall Study||2
11417289|NCT00703885|12615203|FG000|STARTED|Overall Study||16
11417290|NCT00703885|12615203|FG000|COMPLETED|Overall Study||16
11417291|NCT00703885|12615203|FG000|NOT COMPLETED|Overall Study||0
11417292|NCT00703092|12615208|FG000|STARTED|Overall Study||2
11417293|NCT00703092|12615208|FG000|COMPLETED|Overall Study||0
11417294|NCT00703092|12615208|FG000|NOT COMPLETED|Overall Study||2
11417295|NCT00713258|12615214|FG000|STARTED|Overall Study||41
11417296|NCT00713258|12615215|FG001|STARTED|Overall Study||34
11417297|NCT00713258|12615214|FG000|COMPLETED|Overall Study||36
11417298|NCT00713258|12615215|FG001|COMPLETED|Overall Study||28
11417299|NCT00713258|12615214|FG000|NOT COMPLETED|Overall Study||5
11417300|NCT00713258|12615215|FG001|NOT COMPLETED|Overall Study||6
11417301|NCT00706329|12615221|FG000|STARTED|Overall Study||25
11417302|NCT00706329|12615221|FG000|COMPLETED|Overall Study||25
11417303|NCT00706329|12615221|FG000|NOT COMPLETED|Overall Study||0
11417304|NCT00707434|12615225|FG000|STARTED|Overall Study||6
11417305|NCT00707434|12615225|FG000|COMPLETED|Overall Study||5
11417306|NCT00707434|12615225|FG000|NOT COMPLETED|Overall Study||1
11023360|NCT00812929|12201639|FG009|STARTED|Washout Period 3 (7 Days)||4
11023361|NCT00812929|12201630|FG000|COMPLETED|Washout Period 3 (7 Days)||5
11023362|NCT00812929|12201631|FG001|COMPLETED|Washout Period 3 (7 Days)||4
11023363|NCT00812929|12201632|FG002|COMPLETED|Washout Period 3 (7 Days)||4
11023364|NCT00812929|12201633|FG003|COMPLETED|Washout Period 3 (7 Days)||4
11023365|NCT00812929|12201634|FG004|COMPLETED|Washout Period 3 (7 Days)||5
11023366|NCT00812929|12201635|FG005|COMPLETED|Washout Period 3 (7 Days)||4
11023367|NCT00812929|12201636|FG006|COMPLETED|Washout Period 3 (7 Days)||5
11023368|NCT00812929|12201637|FG007|COMPLETED|Washout Period 3 (7 Days)||5
11023369|NCT00812929|12201638|FG008|COMPLETED|Washout Period 3 (7 Days)||4
11023370|NCT00812929|12201639|FG009|COMPLETED|Washout Period 3 (7 Days)||4
11023371|NCT00812929|12201630|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
11023372|NCT00812929|12201631|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
11023373|NCT00812929|12201632|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
11023374|NCT00812929|12201633|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
11023375|NCT00812929|12201634|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
11023376|NCT00812929|12201635|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||1
11023377|NCT00812929|12201636|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
11023378|NCT00812929|12201637|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
11023379|NCT00812929|12201638|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
11023380|NCT00812929|12201639|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
11023381|NCT00812929|12201630|FG000|STARTED|Treatment Period 4||5
11023382|NCT00812929|12201631|FG001|STARTED|Treatment Period 4||4
11023383|NCT00812929|12201632|FG002|STARTED|Treatment Period 4||4
11023384|NCT00812929|12201633|FG003|STARTED|Treatment Period 4||4
11023385|NCT00812929|12201634|FG004|STARTED|Treatment Period 4||5
11023386|NCT00812929|12201635|FG005|STARTED|Treatment Period 4||4
11023387|NCT00812929|12201636|FG006|STARTED|Treatment Period 4||5
11144335|NCT01477853|12331039|FG002|NOT COMPLETED|Phase B||11
11144336|NCT01477892|12331049|FG000|STARTED|Overall Study||7
11144337|NCT01477892|12331050|FG001|STARTED|Overall Study||7
11417307|NCT00707161|12615229|FG000|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
11417308|NCT00707161|12615229|FG000|COMPLETED|Overall Study||0
11144338|NCT01477892|12331049|FG000|COMPLETED|Overall Study||7
11144339|NCT01477892|12331050|FG001|COMPLETED|Overall Study||5
11144340|NCT01477892|12331049|FG000|NOT COMPLETED|Overall Study||0
11144341|NCT01477892|12331050|FG001|NOT COMPLETED|Overall Study||2
11417309|NCT00707161|12615229|FG000|NOT COMPLETED|Overall Study||6
11417310|NCT00704496|12615235|FG000|STARTED|Overall Study||0
11417311|NCT00704496|12615236|FG001|STARTED|Overall Study||0
11417312|NCT00704496|12615235|FG000|COMPLETED|Overall Study||0
11417313|NCT00704496|12615236|FG001|COMPLETED|Overall Study||0
11417314|NCT00704496|12615235|FG000|NOT COMPLETED|Overall Study||0
11417315|NCT00704496|12615236|FG001|NOT COMPLETED|Overall Study||0
11417316|NCT00708916|12615242|FG000|STARTED|Overall Study||12
11417317|NCT00708916|12615242|FG000|COMPLETED|Overall Study||8
11417318|NCT00708916|12615242|FG000|NOT COMPLETED|Overall Study||4
11417319|NCT00700778|12615247|FG000|STARTED|Overall Study||2
11417320|NCT00700778|12615247|FG000|COMPLETED|Overall Study||0
11417321|NCT00700778|12615247|FG000|NOT COMPLETED|Overall Study||2
11417322|NCT00699842|12615254|FG000|STARTED|Overall Study||3
11417323|NCT00699842|12615255|FG001|STARTED|Overall Study||5
11417324|NCT00699842|12615256|FG002|STARTED|Overall Study||0
11417325|NCT00699842|12615254|FG000|COMPLETED|Overall Study||3
11417326|NCT00699842|12615255|FG001|COMPLETED|Overall Study||4
11417327|NCT00699842|12615256|FG002|COMPLETED|Overall Study||0
11417328|NCT00699842|12615254|FG000|NOT COMPLETED|Overall Study||0
11417329|NCT00699842|12615255|FG001|NOT COMPLETED|Overall Study||1
11417330|NCT00699842|12615256|FG002|NOT COMPLETED|Overall Study||0
11417331|NCT00702962|12615266|FG000|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
11417332|NCT00702962|12615267|FG001|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
11417333|NCT00702962|12615266|FG000|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
11417334|NCT00702962|12615267|FG001|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
11417335|NCT00702962|12615266|FG000|NOT COMPLETED|Overall Study||1
11417336|NCT00702962|12615267|FG001|NOT COMPLETED|Overall Study||1
11417337|NCT00703534|12615277|FG000|STARTED|Overall Study||235
11417338|NCT00703534|12615278|FG001|STARTED|Overall Study||243
11417339|NCT00703534|12615277|FG000|COMPLETED|Overall Study||205
11417340|NCT00703534|12615278|FG001|COMPLETED|Overall Study||218
11417341|NCT00703534|12615277|FG000|NOT COMPLETED|Overall Study||30
11417342|NCT00703534|12615278|FG001|NOT COMPLETED|Overall Study||25
11417343|NCT00698009|12615284|FG000|STARTED|Overall Study||1
11417344|NCT00698009|12615284|FG000|COMPLETED|Overall Study||0
11417345|NCT00698009|12615284|FG000|NOT COMPLETED|Overall Study||1
11417346|NCT00703339|12615288|FG000|STARTED|Overall Study||1
11417347|NCT00703339|12615288|FG000|COMPLETED|Overall Study||1
11417348|NCT00703339|12615288|FG000|NOT COMPLETED|Overall Study||0
11417349|NCT00691444|12615295|FG000|STARTED|Overall Study||0
11417350|NCT00691444|12615296|FG001|STARTED|Overall Study||0
11417351|NCT00691444|12615297|FG002|STARTED|Overall Study||0
11417352|NCT00691444|12615295|FG000|COMPLETED|Overall Study||0
11417353|NCT00691444|12615296|FG001|COMPLETED|Overall Study||0
11417354|NCT00691444|12615297|FG002|COMPLETED|Overall Study||0
11417355|NCT00691444|12615295|FG000|NOT COMPLETED|Overall Study||0
11417356|NCT00691444|12615296|FG001|NOT COMPLETED|Overall Study||0
11417357|NCT00691444|12615297|FG002|NOT COMPLETED|Overall Study||0
11417358|NCT00702702|12615308|FG000|STARTED|Overall Study||56
11417359|NCT00702702|12615308|FG000|COMPLETED|Overall Study||0
11417360|NCT00702702|12615308|FG000|NOT COMPLETED|Overall Study||56
11417361|NCT00693628|12615318|FG000|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
11417362|NCT00693628|12615319|FG001|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
11417363|NCT00693628|12615318|FG000|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
11417364|NCT00693628|12615319|FG001|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
11417365|NCT00693628|12615318|FG000|NOT COMPLETED|Overall Study||0
11417366|NCT00693628|12615319|FG001|NOT COMPLETED|Overall Study||0
11417367|NCT00699413|12615327|FG000|STARTED|Overall Study||4
11417368|NCT00699413|12615328|FG001|STARTED|Overall Study||4
11417369|NCT00699413|12615327|FG000|COMPLETED|Overall Study||0
11417370|NCT00699413|12615328|FG001|COMPLETED|Overall Study||0
11417371|NCT00699413|12615327|FG000|NOT COMPLETED|Overall Study||4
11417372|NCT00699413|12615328|FG001|NOT COMPLETED|Overall Study||4
11417373|NCT00691652|12615334|FG000|STARTED|Overall Study||2
11417374|NCT00691652|12615334|FG000|COMPLETED|Overall Study||1
11417375|NCT00691652|12615334|FG000|NOT COMPLETED|Overall Study||1
11417376|NCT00686972|12615338|FG000|STARTED|Overall Study||51
11417377|NCT00686972|12615338|FG000|COMPLETED|Overall Study||0
11023388|NCT00812929|12201637|FG007|STARTED|Treatment Period 4||5
11023389|NCT00812929|12201638|FG008|STARTED|Treatment Period 4||4
11023390|NCT00812929|12201639|FG009|STARTED|Treatment Period 4||4
11023391|NCT00812929|12201630|FG000|COMPLETED|Treatment Period 4||5
11023392|NCT00812929|12201631|FG001|COMPLETED|Treatment Period 4||4
11023393|NCT00812929|12201632|FG002|COMPLETED|Treatment Period 4||4
11023394|NCT00812929|12201633|FG003|COMPLETED|Treatment Period 4||4
11023395|NCT00812929|12201634|FG004|COMPLETED|Treatment Period 4||5
11023396|NCT00812929|12201635|FG005|COMPLETED|Treatment Period 4||4
11023397|NCT00812929|12201636|FG006|COMPLETED|Treatment Period 4||5
11023398|NCT00812929|12201637|FG007|COMPLETED|Treatment Period 4||5
11023399|NCT00812929|12201638|FG008|COMPLETED|Treatment Period 4||4
11023400|NCT00812929|12201639|FG009|COMPLETED|Treatment Period 4||4
11023401|NCT00812929|12201630|FG000|NOT COMPLETED|Treatment Period 4||0
11023402|NCT00812929|12201631|FG001|NOT COMPLETED|Treatment Period 4||0
11023403|NCT00812929|12201632|FG002|NOT COMPLETED|Treatment Period 4||0
11023404|NCT00812929|12201633|FG003|NOT COMPLETED|Treatment Period 4||0
11023405|NCT00812929|12201634|FG004|NOT COMPLETED|Treatment Period 4||0
11417378|NCT00686972|12615338|FG000|NOT COMPLETED|Overall Study||51
11417379|NCT00693017|12615344|FG000|STARTED|Overall Study||2
11417380|NCT00693017|12615345|FG001|STARTED|Overall Study||2
11417381|NCT00693017|12615344|FG000|COMPLETED|Overall Study||0
11417382|NCT00693017|12615345|FG001|COMPLETED|Overall Study||0
11417383|NCT00693017|12615344|FG000|NOT COMPLETED|Overall Study||2
11417384|NCT00693017|12615345|FG001|NOT COMPLETED|Overall Study||2
11144342|NCT01478009|12331058|FG000|STARTED|Overall Study||50
11417385|NCT00691574|12615353|FG000|STARTED|Overall Study||0
11417386|NCT00691574|12615354|FG001|STARTED|Overall Study||0
11417387|NCT00691574|12615353|FG000|COMPLETED|Overall Study||0
11417388|NCT00691574|12615354|FG001|COMPLETED|Overall Study||0
11417389|NCT00691574|12615353|FG000|NOT COMPLETED|Overall Study||0
11417390|NCT00691574|12615354|FG001|NOT COMPLETED|Overall Study||0
11417391|NCT00692094|12615364|FG000|STARTED|Overall Study||0
11417392|NCT00692094|12615365|FG001|STARTED|Overall Study||0
11417393|NCT00692094|12615366|FG002|STARTED|Overall Study||0
11417394|NCT00692094|12615367|FG003|STARTED|Overall Study||0
11417395|NCT00692094|12615364|FG000|COMPLETED|Overall Study||0
11417396|NCT00692094|12615365|FG001|COMPLETED|Overall Study||0
11417397|NCT00692094|12615366|FG002|COMPLETED|Overall Study||0
11417398|NCT00692094|12615367|FG003|COMPLETED|Overall Study||0
11417399|NCT00692094|12615364|FG000|NOT COMPLETED|Overall Study||0
11417400|NCT00692094|12615365|FG001|NOT COMPLETED|Overall Study||0
11417401|NCT00692094|12615366|FG002|NOT COMPLETED|Overall Study||0
11417402|NCT00692094|12615367|FG003|NOT COMPLETED|Overall Study||0
11417403|NCT00689884|12615377|FG000|STARTED|Overall Study||7
11417404|NCT00689884|12615377|FG000|COMPLETED|Overall Study||7
11417405|NCT00689884|12615377|FG000|NOT COMPLETED|Overall Study||0
11417406|NCT00692003|12615384|FG000|STARTED|Overall Study||5
11417407|NCT00692003|12615385|FG001|STARTED|Overall Study||1
11417408|NCT00692003|12615384|FG000|COMPLETED|Overall Study||0
11417409|NCT00692003|12615385|FG001|COMPLETED|Overall Study||0
11417410|NCT00692003|12615384|FG000|NOT COMPLETED|Overall Study||5
11417411|NCT00692003|12615385|FG001|NOT COMPLETED|Overall Study||1
11417412|NCT00678288|12615393|FG000|STARTED|Overall Study||10
11417413|NCT00678288|12615394|FG001|STARTED|Overall Study||6
11417414|NCT00678288|12615393|FG000|COMPLETED|Overall Study||0
11417415|NCT00678288|12615394|FG001|COMPLETED|Overall Study||0
11417416|NCT00678288|12615393|FG000|NOT COMPLETED|Overall Study||10
11417417|NCT00678288|12615394|FG001|NOT COMPLETED|Overall Study||6
11417418|NCT00676026|12615400|FG000|STARTED|Overall Study||8
11417419|NCT00676026|12615400|FG000|COMPLETED|Overall Study||8
11417420|NCT00676026|12615400|FG000|NOT COMPLETED|Overall Study||0
11417421|NCT00689052|12615406|FG000|STARTED|Overall Study||31
11417422|NCT00689052|12615407|FG001|STARTED|Overall Study||30
11417423|NCT00689052|12615406|FG000|COMPLETED|Overall Study||0
11417424|NCT00689052|12615407|FG001|COMPLETED|Overall Study||0
11417425|NCT00689052|12615406|FG000|NOT COMPLETED|Overall Study||31
11417426|NCT00689052|12615407|FG001|NOT COMPLETED|Overall Study||30
11417427|NCT00678574|12615417|FG000|STARTED|Overall Study||18
11417428|NCT00678574|12615418|FG001|STARTED|Overall Study||27
11417429|NCT00678574|12615417|FG000|COMPLETED|Overall Study||18
11417430|NCT00678574|12615418|FG001|COMPLETED|Overall Study||27
11144343|NCT01478009|12331059|FG001|STARTED|Overall Study||50
11144344|NCT01478009|12331058|FG000|COMPLETED|Overall Study||49
11144345|NCT01478009|12331059|FG001|COMPLETED|Overall Study||49
11144346|NCT01478009|12331058|FG000|NOT COMPLETED|Overall Study||1
11144347|NCT01478009|12331059|FG001|NOT COMPLETED|Overall Study||1
11144348|NCT01478048|12331067|FG000|STARTED|Overall Study||77
11144349|NCT01478048|12331068|FG001|STARTED|Overall Study||75
11144350|NCT01478048|12331067|FG000|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
11144351|NCT01478048|12331068|FG001|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
11144352|NCT01478048|12331067|FG000|COMPLETED|Overall Study||0
11144353|NCT01478048|12331068|FG001|COMPLETED|Overall Study||0
11144354|NCT01478048|12331067|FG000|NOT COMPLETED|Overall Study||77
11144355|NCT01478048|12331068|FG001|NOT COMPLETED|Overall Study||75
11144356|NCT01478087|12331074|FG000|STARTED|Overall Study||3
11417431|NCT00678574|12615417|FG000|NOT COMPLETED|Overall Study||0
11417432|NCT00678574|12615418|FG001|NOT COMPLETED|Overall Study||0
11417433|NCT00683917|12615427|FG000|STARTED|Overall Study||10
11417434|NCT00683917|12615427|FG000|COMPLETED|Overall Study||0
11417435|NCT00683917|12615427|FG000|NOT COMPLETED|Overall Study||10
11417436|NCT00688935|12615435|FG000|STARTED|Overall Study||0
11417437|NCT00688935|12615435|FG000|COMPLETED|Overall Study||0
11417438|NCT00688935|12615435|FG000|NOT COMPLETED|Overall Study||0
11144357|NCT01478087|12331074|FG000|COMPLETED|Overall Study||2
11144358|NCT01478087|12331074|FG000|NOT COMPLETED|Overall Study||1
11144359|NCT01478256|12331080|FG000|STARTED|Overall Study||15
11144360|NCT01478256|12331081|FG001|STARTED|Overall Study||15
11144361|NCT01478256|12331080|FG000|COMPLETED|Overall Study||15
11144362|NCT01478256|12331081|FG001|COMPLETED|Overall Study||15
11144363|NCT01478256|12331080|FG000|NOT COMPLETED|Overall Study||0
11144364|NCT01478256|12331081|FG001|NOT COMPLETED|Overall Study||0
11144365|NCT01478321|12331089|FG000|STARTED|Concurrent Therapy (5 Weeks)||54
11144366|NCT01478321|12331089|FG000|COMPLETED|Concurrent Therapy (5 Weeks)||38
11144367|NCT01478321|12331089|FG000|NOT COMPLETED|Concurrent Therapy (5 Weeks)||16
11144368|NCT01478321|12331089|FG000|STARTED|Started Adjuvant Therapy||38
11144369|NCT01478321|12331089|FG000|Completed First Cycle|Started Adjuvant Therapy||37
11144370|NCT01478321|12331089|FG000|COMPLETED|Started Adjuvant Therapy||37
11144371|NCT01478321|12331089|FG000|NOT COMPLETED|Started Adjuvant Therapy||1
11144372|NCT01478321|12331089|FG000|STARTED|Adjuvant Therapy Until PD or Toxicity||37
11144373|NCT01478321|12331089|FG000|Went on to Cycle 2 +|Adjuvant Therapy Until PD or Toxicity||27
11144374|NCT01478321|12331089|FG000|COMPLETED|Adjuvant Therapy Until PD or Toxicity||27
11144375|NCT01478321|12331089|FG000|NOT COMPLETED|Adjuvant Therapy Until PD or Toxicity||10
11144376|NCT01478321|12331089|FG000|STARTED|Follow-up Until Death or 12.31.18 Occurs||54
11144377|NCT01478321|12331089|FG000|COMPLETED|Follow-up Until Death or 12.31.18 Occurs||54
11144378|NCT01478321|12331089|FG000|NOT COMPLETED|Follow-up Until Death or 12.31.18 Occurs||0
11144379|NCT01478347|12331093|FG000|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
11144380|NCT01478347|12331093|FG000|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
11144381|NCT01478347|12331093|FG000|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
11144382|NCT01478347|12331093|FG000|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
11144383|NCT01478347|12331093|FG000|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
11144384|NCT01478347|12331093|FG000|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
11144385|NCT01478360|12331099|FG000|STARTED|Overall Study||31
11144386|NCT01478360|12331100|FG001|STARTED|Overall Study||15
11144387|NCT01478360|12331099|FG000|PD (Pharmacodynamic) Analysis Set|Overall Study||31
11144388|NCT01478360|12331100|FG001|PD (Pharmacodynamic) Analysis Set|Overall Study||15
11144389|NCT01478360|12331099|FG000|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
11144390|NCT01478360|12331100|FG001|PK (Pharmacokinetics) Analysis Set|Overall Study||0
11144391|NCT01478360|12331099|FG000|COMPLETED|Overall Study||29
11023406|NCT00812929|12201635|FG005|NOT COMPLETED|Treatment Period 4||0
11023407|NCT00812929|12201636|FG006|NOT COMPLETED|Treatment Period 4||0
11023408|NCT00812929|12201637|FG007|NOT COMPLETED|Treatment Period 4||0
11023409|NCT00812929|12201638|FG008|NOT COMPLETED|Treatment Period 4||0
11023410|NCT00812929|12201639|FG009|NOT COMPLETED|Treatment Period 4||0
11023411|NCT00812929|12201630|FG000|STARTED|Washout Period 4 (7 Days)||5
11023412|NCT00812929|12201631|FG001|STARTED|Washout Period 4 (7 Days)||4
11023413|NCT00812929|12201632|FG002|STARTED|Washout Period 4 (7 Days)||4
11023414|NCT00812929|12201633|FG003|STARTED|Washout Period 4 (7 Days)||4
11023415|NCT00812929|12201634|FG004|STARTED|Washout Period 4 (7 Days)||5
11023416|NCT00812929|12201635|FG005|STARTED|Washout Period 4 (7 Days)||4
11023417|NCT00812929|12201636|FG006|STARTED|Washout Period 4 (7 Days)||5
11023418|NCT00812929|12201637|FG007|STARTED|Washout Period 4 (7 Days)||5
11023419|NCT00812929|12201638|FG008|STARTED|Washout Period 4 (7 Days)||4
11023420|NCT00812929|12201639|FG009|STARTED|Washout Period 4 (7 Days)||4
11023421|NCT00812929|12201630|FG000|COMPLETED|Washout Period 4 (7 Days)||5
11023422|NCT00812929|12201631|FG001|COMPLETED|Washout Period 4 (7 Days)||4
11023423|NCT00812929|12201632|FG002|COMPLETED|Washout Period 4 (7 Days)||4
11023424|NCT00812929|12201633|FG003|COMPLETED|Washout Period 4 (7 Days)||4
11023425|NCT00812929|12201634|FG004|COMPLETED|Washout Period 4 (7 Days)||5
11023426|NCT00812929|12201635|FG005|COMPLETED|Washout Period 4 (7 Days)||4
11023427|NCT00812929|12201636|FG006|COMPLETED|Washout Period 4 (7 Days)||5
11023428|NCT00812929|12201637|FG007|COMPLETED|Washout Period 4 (7 Days)||5
11023429|NCT00812929|12201638|FG008|COMPLETED|Washout Period 4 (7 Days)||4
11023430|NCT00812929|12201639|FG009|COMPLETED|Washout Period 4 (7 Days)||4
11023431|NCT00812929|12201630|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0
11023432|NCT00812929|12201631|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0
11023433|NCT00812929|12201632|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0
11023434|NCT00812929|12201633|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0
11023435|NCT00812929|12201634|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0
11023436|NCT00812929|12201635|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||0
11023437|NCT00812929|12201636|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0
11023438|NCT00812929|12201637|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||0
11023439|NCT00812929|12201638|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0
11023440|NCT00812929|12201639|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0
11023441|NCT00812929|12201630|FG000|STARTED|Treatment Period 5||5
11023442|NCT00812929|12201631|FG001|STARTED|Treatment Period 5||4
11023443|NCT00812929|12201632|FG002|STARTED|Treatment Period 5||4
11023444|NCT00812929|12201633|FG003|STARTED|Treatment Period 5||4
11023445|NCT00812929|12201634|FG004|STARTED|Treatment Period 5||5
11023446|NCT00812929|12201635|FG005|STARTED|Treatment Period 5||4
11023447|NCT00812929|12201636|FG006|STARTED|Treatment Period 5||5
11023448|NCT00812929|12201637|FG007|STARTED|Treatment Period 5||5
11023449|NCT00812929|12201638|FG008|STARTED|Treatment Period 5||4
11023450|NCT00812929|12201639|FG009|STARTED|Treatment Period 5||4
11023451|NCT00812929|12201630|FG000|COMPLETED|Treatment Period 5||5
11023452|NCT00812929|12201631|FG001|COMPLETED|Treatment Period 5||4
11023453|NCT00812929|12201632|FG002|COMPLETED|Treatment Period 5||4
11023454|NCT00812929|12201633|FG003|COMPLETED|Treatment Period 5||4
11023455|NCT00812929|12201634|FG004|COMPLETED|Treatment Period 5||5
11023456|NCT00812929|12201635|FG005|COMPLETED|Treatment Period 5||4
11023457|NCT00812929|12201636|FG006|COMPLETED|Treatment Period 5||5
11023458|NCT00812929|12201637|FG007|COMPLETED|Treatment Period 5||5
11023459|NCT00812929|12201638|FG008|COMPLETED|Treatment Period 5||4
11023460|NCT00812929|12201639|FG009|COMPLETED|Treatment Period 5||4
11023461|NCT00812929|12201630|FG000|NOT COMPLETED|Treatment Period 5||0
11023462|NCT00812929|12201631|FG001|NOT COMPLETED|Treatment Period 5||0
11023463|NCT00812929|12201632|FG002|NOT COMPLETED|Treatment Period 5||0
11023464|NCT00812929|12201633|FG003|NOT COMPLETED|Treatment Period 5||0
11023465|NCT00812929|12201634|FG004|NOT COMPLETED|Treatment Period 5||0
11023466|NCT00812929|12201635|FG005|NOT COMPLETED|Treatment Period 5||0
11023467|NCT00812929|12201636|FG006|NOT COMPLETED|Treatment Period 5||0
11023468|NCT00812929|12201637|FG007|NOT COMPLETED|Treatment Period 5||0
11023469|NCT00812929|12201638|FG008|NOT COMPLETED|Treatment Period 5||0
11023470|NCT00812929|12201639|FG009|NOT COMPLETED|Treatment Period 5||0
11144392|NCT01478360|12331100|FG001|COMPLETED|Overall Study||12
11144393|NCT01478360|12331099|FG000|NOT COMPLETED|Overall Study||2
11144394|NCT01478360|12331100|FG001|NOT COMPLETED|Overall Study||3
11144395|NCT01478373|12331106|FG000|STARTED|Treatment Phase||39
11144396|NCT01478373|12331106|FG000|COMPLETED|Treatment Phase||38
11144397|NCT01478373|12331106|FG000|NOT COMPLETED|Treatment Phase||1
11144398|NCT01478373|12331106|FG000|STARTED|Survival Phase||38
11144399|NCT01478373|12331106|FG000|COMPLETED|Survival Phase||0
11144400|NCT01478373|12331106|FG000|NOT COMPLETED|Survival Phase||38
11144401|NCT01478581|12331114|FG000|STARTED|Overall Study||13
11144402|NCT01478581|12331115|FG001|STARTED|Overall Study||18
11144403|NCT01478581|12331116|FG002|STARTED|Overall Study||18
11144404|NCT01478581|12331117|FG003|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
11144405|NCT01478581|12331114|FG000|COMPLETED|Overall Study||13
11144406|NCT01478581|12331115|FG001|COMPLETED|Overall Study||18
11144407|NCT01478581|12331116|FG002|COMPLETED|Overall Study||18
11144408|NCT01478581|12331117|FG003|COMPLETED|Overall Study||43
11144409|NCT01478581|12331114|FG000|NOT COMPLETED|Overall Study||0
11144410|NCT01478581|12331115|FG001|NOT COMPLETED|Overall Study||0
11144411|NCT01478581|12331116|FG002|NOT COMPLETED|Overall Study||0
11144412|NCT01478581|12331117|FG003|NOT COMPLETED|Overall Study||0
11144413|NCT01478594|12331133|FG000|STARTED|Overall Study||177
11144414|NCT01478594|12331134|FG001|STARTED|Overall Study||88
11144415|NCT01478594|12331133|FG000|Treated|Overall Study||177
11144416|NCT01478594|12331134|FG001|Treated|Overall Study||87
11144417|NCT01478594|12331133|FG000|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
11144418|NCT01478594|12331134|FG001|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
11144419|NCT01478594|12331133|FG000|NOT COMPLETED|Overall Study||65
11144420|NCT01478594|12331134|FG001|NOT COMPLETED|Overall Study||28
11144421|NCT01478620|12331193|FG000|STARTED|Overall Study||125
11144422|NCT01478620|12331193|FG000|COMPLETED|Overall Study||119
11144423|NCT01478620|12331193|FG000|NOT COMPLETED|Overall Study||6
11144424|NCT01478828|12331197|FG000|STARTED|Overall Study||2
11144425|NCT01478828|12331197|FG000|COMPLETED|Overall Study||1
11144426|NCT01478828|12331197|FG000|NOT COMPLETED|Overall Study||1
11144427|NCT01478854|12331202|FG000|STARTED|Overall Study||30
11144428|NCT01478854|12331202|FG000|COMPLETED|Overall Study||30
11144429|NCT01478854|12331202|FG000|NOT COMPLETED|Overall Study||0
11144430|NCT01478958|12331209|FG000|STARTED|Overall Study||67
11144431|NCT01478958|12331210|FG001|STARTED|Overall Study||66
11144432|NCT01478958|12331211|FG002|STARTED|Overall Study||69
11144433|NCT01478958|12331209|FG000|COMPLETED|Overall Study||65
11144434|NCT01478958|12331210|FG001|COMPLETED|Overall Study||64
11144435|NCT01478958|12331211|FG002|COMPLETED|Overall Study||66
11144436|NCT01478958|12331209|FG000|NOT COMPLETED|Overall Study||2
11144437|NCT01478958|12331210|FG001|NOT COMPLETED|Overall Study||2
11144438|NCT01478958|12331211|FG002|NOT COMPLETED|Overall Study||3
11144439|NCT01478971|12331219|FG000|STARTED|Standard of Care Period||184
11144440|NCT01478971|12331219|FG000|Received Treatment|Standard of Care Period||178
11144441|NCT01478971|12331219|FG000|COMPLETED|Standard of Care Period||159
11144442|NCT01478971|12331219|FG000|NOT COMPLETED|Standard of Care Period||25
11144443|NCT01478971|12331219|FG000|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
11144444|NCT01478971|12331219|FG000|COMPLETED|Peginesatide Treatment Period||143
11144445|NCT01478971|12331219|FG000|NOT COMPLETED|Peginesatide Treatment Period||14
11144446|NCT01479127|12331227|FG000|STARTED|Overall Study|started oral study drug (full safety sample)|8
11144447|NCT01479127|12331227|FG000|Started LCIG|Overall Study||6
11144448|NCT01479127|12331227|FG000|COMPLETED|Overall Study||5
11144449|NCT01479127|12331227|FG000|NOT COMPLETED|Overall Study||3
11144450|NCT01479270|12331237|FG000|STARTED|Overall Study||28
11417439|NCT00685880|12615441|FG000|STARTED|Overall Study||0
11417440|NCT00685880|12615442|FG001|STARTED|Overall Study||2
11417441|NCT00685880|12615441|FG000|COMPLETED|Overall Study||0
11417442|NCT00685880|12615442|FG001|COMPLETED|Overall Study||2
11417443|NCT00685880|12615441|FG000|NOT COMPLETED|Overall Study||0
11417444|NCT00685880|12615442|FG001|NOT COMPLETED|Overall Study||0
11417445|NCT00686036|12615450|FG000|STARTED|Overall Study||9
11144451|NCT01479270|12331238|FG001|STARTED|Overall Study||28
11417446|NCT00686036|12615451|FG001|STARTED|Overall Study||8
11417447|NCT00686036|12615450|FG000|COMPLETED|Overall Study||0
11417448|NCT00686036|12615451|FG001|COMPLETED|Overall Study||2
11144452|NCT01479270|12331237|FG000|COMPLETED|Overall Study||28
11144453|NCT01479270|12331238|FG001|COMPLETED|Overall Study||28
11144454|NCT01479270|12331237|FG000|NOT COMPLETED|Overall Study||0
11144455|NCT01479270|12331238|FG001|NOT COMPLETED|Overall Study||0
11144456|NCT01479348|12331247|FG000|STARTED|Overall Study||5
11144457|NCT01479348|12331248|FG001|STARTED|Overall Study||0
11144458|NCT01479348|12331247|FG000|COMPLETED|Overall Study||5
11144459|NCT01479348|12331248|FG001|COMPLETED|Overall Study||0
11144460|NCT01479348|12331247|FG000|NOT COMPLETED|Overall Study||0
11144461|NCT01479348|12331248|FG001|NOT COMPLETED|Overall Study||0
11144462|NCT01479374|12331255|FG000|STARTED|Overall Study||66
11144463|NCT01479374|12331256|FG001|STARTED|Overall Study||68
11144464|NCT01479374|12331257|FG002|STARTED|Overall Study||68
11144465|NCT01479374|12331255|FG000|COMPLETED|Overall Study||63
11144466|NCT01479374|12331256|FG001|COMPLETED|Overall Study||60
11144467|NCT01479374|12331257|FG002|COMPLETED|Overall Study||63
11144468|NCT01479374|12331255|FG000|NOT COMPLETED|Overall Study||3
11144469|NCT01479374|12331256|FG001|NOT COMPLETED|Overall Study||8
11144470|NCT01479374|12331257|FG002|NOT COMPLETED|Overall Study||5
11144471|NCT01479426|12331267|FG000|STARTED|Overall Study||40
11144472|NCT01479426|12331268|FG001|STARTED|Overall Study||40
11144473|NCT01479426|12331267|FG000|COMPLETED|Overall Study||36
11144474|NCT01479426|12331268|FG001|COMPLETED|Overall Study||37
11144475|NCT01479426|12331267|FG000|NOT COMPLETED|Overall Study||4
11144476|NCT01479426|12331268|FG001|NOT COMPLETED|Overall Study||3
11144477|NCT01479439|12331277|FG000|STARTED|Overall Study||15
11144478|NCT01479439|12331278|FG001|STARTED|Overall Study||13
11144479|NCT01479439|12331279|FG002|STARTED|Overall Study||8
11023471|NCT00812955|12201660|FG000|STARTED|Overall Study||119
11023472|NCT00812955|12201661|FG001|STARTED|Overall Study||118
11023473|NCT00812955|12201662|FG002|STARTED|Overall Study||119
11023474|NCT00812955|12201663|FG003|STARTED|Overall Study||118
11023475|NCT00812955|12201660|FG000|COMPLETED|Overall Study||109
11023476|NCT00812955|12201661|FG001|COMPLETED|Overall Study||111
11023477|NCT00812955|12201662|FG002|COMPLETED|Overall Study||113
11023478|NCT00812955|12201663|FG003|COMPLETED|Overall Study||110
11023479|NCT00812955|12201660|FG000|NOT COMPLETED|Overall Study||10
11023480|NCT00812955|12201661|FG001|NOT COMPLETED|Overall Study||7
11023481|NCT00812955|12201662|FG002|NOT COMPLETED|Overall Study||6
11023482|NCT00812955|12201663|FG003|NOT COMPLETED|Overall Study||8
11023483|NCT00812968|12201677|FG000|STARTED|Overall Study||11
11023484|NCT00812968|12201677|FG000|COMPLETED|Overall Study||0
11023485|NCT00812968|12201677|FG000|NOT COMPLETED|Overall Study||11
11023486|NCT00812981|12201685|FG000|STARTED|Overall Study||160
11023487|NCT00812981|12201686|FG001|STARTED|Overall Study||160
11023488|NCT00812981|12201685|FG000|COMPLETED|Overall Study||160
11023489|NCT00812981|12201686|FG001|COMPLETED|Overall Study||159
11023490|NCT00812981|12201685|FG000|NOT COMPLETED|Overall Study||0
11023491|NCT00812981|12201686|FG001|NOT COMPLETED|Overall Study||1
11023492|NCT00813098|12201695|FG000|STARTED|Overall Study||49
11023493|NCT00813098|12201696|FG001|STARTED|Overall Study||54
11023494|NCT00813098|12201697|FG002|STARTED|Overall Study||52
11023495|NCT00813098|12201695|FG000|COMPLETED|Overall Study||46
11023496|NCT00813098|12201696|FG001|COMPLETED|Overall Study||46
11023497|NCT00813098|12201697|FG002|COMPLETED|Overall Study||50
11023498|NCT00813098|12201695|FG000|NOT COMPLETED|Overall Study||3
11023499|NCT00813098|12201696|FG001|NOT COMPLETED|Overall Study||8
11023500|NCT00813098|12201697|FG002|NOT COMPLETED|Overall Study||2
11023501|NCT00813111|12201707|FG000|STARTED|Overall Study||66
11023502|NCT00813111|12201708|FG001|STARTED|Overall Study||70
11023503|NCT00813111|12201707|FG000|COMPLETED|Overall Study||64
11023504|NCT00813111|12201708|FG001|COMPLETED|Overall Study||70
11023505|NCT00813111|12201707|FG000|NOT COMPLETED|Overall Study||2
11023506|NCT00813111|12201708|FG001|NOT COMPLETED|Overall Study||0
11023507|NCT00813124|12201714|FG000|STARTED|Overall Study||24
11023508|NCT00813124|12201714|FG000|COMPLETED|Overall Study||12
11023509|NCT00813124|12201714|FG000|NOT COMPLETED|Overall Study||12
11023510|NCT00813150|12201720|FG000|STARTED|Treatment Period|Number of randomized and treated participants|46
11023511|NCT00813150|12201721|FG001|STARTED|Treatment Period|Number of randomized and treated participants|47
11023512|NCT00813150|12201720|FG000|Intent-to-treat Participants|Treatment Period||43
11023513|NCT00813150|12201721|FG001|Intent-to-treat Participants|Treatment Period||47
11023514|NCT00813150|12201720|FG000|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
11023515|NCT00813150|12201721|FG001|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
11023516|NCT00813150|12201720|FG000|NOT COMPLETED|Treatment Period||32
11023517|NCT00813150|12201721|FG001|NOT COMPLETED|Treatment Period||32
11023518|NCT00813150|12201720|FG000|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
11057008|NCT00996892|12238676|FG005|COMPLETED|Dose-Escalation Stage 1||0
11144480|NCT01479439|12331277|FG000|COMPLETED|Overall Study||14
11144481|NCT01479439|12331278|FG001|COMPLETED|Overall Study||12
11417449|NCT00686036|12615450|FG000|NOT COMPLETED|Overall Study||9
11417450|NCT00686036|12615451|FG001|NOT COMPLETED|Overall Study||6
11417451|NCT00681044|12615457|FG000|STARTED|Overall Study||4
11417452|NCT00681044|12615457|FG000|COMPLETED|Overall Study||4
11417453|NCT00681044|12615457|FG000|NOT COMPLETED|Overall Study||0
11417454|NCT00676455|12615461|FG000|STARTED|Overall Study||14
11417455|NCT00676455|12615461|FG000|COMPLETED|Overall Study||14
11417456|NCT00676455|12615461|FG000|NOT COMPLETED|Overall Study||0
11417457|NCT00684255|12615465|FG000|STARTED|Overall Study||1
11417458|NCT00684255|12615465|FG000|COMPLETED|Overall Study||1
11417459|NCT00684255|12615465|FG000|NOT COMPLETED|Overall Study||0
11417460|NCT00683787|12615473|FG000|STARTED|Overall Study||3
11417461|NCT00683787|12615474|FG001|STARTED|Overall Study||3
11417462|NCT00683787|12615475|FG002|STARTED|Overall Study||2
11417463|NCT00683787|12615473|FG000|COMPLETED|Overall Study||0
11417464|NCT00683787|12615474|FG001|COMPLETED|Overall Study||0
11417465|NCT00683787|12615475|FG002|COMPLETED|Overall Study||0
11417466|NCT00683787|12615473|FG000|NOT COMPLETED|Overall Study||3
11417467|NCT00683787|12615474|FG001|NOT COMPLETED|Overall Study||3
11417468|NCT00683787|12615475|FG002|NOT COMPLETED|Overall Study||2
11417469|NCT00679926|12615483|FG000|STARTED|Overall Study||15
11417470|NCT00679926|12615483|FG000|COMPLETED|Overall Study||2
11417471|NCT00679926|12615483|FG000|NOT COMPLETED|Overall Study||13
11417472|NCT00678041|12615490|FG000|STARTED|Overall Study||5
11417473|NCT00678041|12615491|FG001|STARTED|Overall Study||5
11417474|NCT00678041|12615490|FG000|COMPLETED|Overall Study||0
11417475|NCT00678041|12615491|FG001|COMPLETED|Overall Study||0
11417476|NCT00678041|12615490|FG000|NOT COMPLETED|Overall Study||5
11417477|NCT00678041|12615491|FG001|NOT COMPLETED|Overall Study||5
11417478|NCT00680316|12615500|FG000|STARTED|Overall Study||1
11417479|NCT00680316|12615501|FG001|STARTED|Overall Study||2
11417480|NCT00680316|12615500|FG000|COMPLETED|Overall Study||1
11417481|NCT00680316|12615501|FG001|COMPLETED|Overall Study||2
11417482|NCT00680316|12615500|FG000|NOT COMPLETED|Overall Study||0
11417483|NCT00680316|12615501|FG001|NOT COMPLETED|Overall Study||0
11417484|NCT00681629|12615509|FG000|STARTED|Overall Study|It was planned to recruit 100 patient|5
11417485|NCT00681629|12615510|FG001|STARTED|Overall Study|It was planned to recruit 100 patient|2
11417486|NCT00681629|12615509|FG000|COMPLETED|Overall Study||0
11023519|NCT00813150|12201721|FG001|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
11023520|NCT00813150|12201720|FG000|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
11417487|NCT00681629|12615510|FG001|COMPLETED|Overall Study||0
11417488|NCT00681629|12615509|FG000|NOT COMPLETED|Overall Study||5
11417489|NCT00681629|12615510|FG001|NOT COMPLETED|Overall Study||2
11417490|NCT00669461|12615516|FG000|STARTED|Overall Study||1
11417491|NCT00669461|12615516|FG000|COMPLETED|Overall Study||1
11417492|NCT00669461|12615516|FG000|NOT COMPLETED|Overall Study||0
11417493|NCT00671606|12615521|FG000|STARTED|Overall Study||5
11417494|NCT00671606|12615521|FG000|COMPLETED|Overall Study||5
11417495|NCT00671606|12615521|FG000|NOT COMPLETED|Overall Study||0
11417496|NCT00673309|12615535|FG000|STARTED|Overall Study||64
11417497|NCT00673309|12615536|FG001|STARTED|Overall Study||14
11417498|NCT00673309|12615537|FG002|STARTED|Overall Study||14
11417499|NCT00673309|12615538|FG003|STARTED|Overall Study||25
11417500|NCT00673309|12615539|FG004|STARTED|Overall Study||18
11417501|NCT00673309|12615540|FG005|STARTED|Overall Study||35
11417502|NCT00673309|12615541|FG006|STARTED|Overall Study||14
11417503|NCT00673309|12615542|FG007|STARTED|Overall Study||13
11417504|NCT00673309|12615543|FG008|STARTED|Overall Study||17
11417505|NCT00673309|12615544|FG009|STARTED|Overall Study||30
11417506|NCT00673309|12615535|FG000|COMPLETED|Overall Study||64
11417507|NCT00673309|12615536|FG001|COMPLETED|Overall Study||14
11417508|NCT00673309|12615537|FG002|COMPLETED|Overall Study||14
11417509|NCT00673309|12615538|FG003|COMPLETED|Overall Study||25
11417510|NCT00673309|12615539|FG004|COMPLETED|Overall Study||18
11417511|NCT00673309|12615540|FG005|COMPLETED|Overall Study||35
11417512|NCT00673309|12615541|FG006|COMPLETED|Overall Study||14
11417513|NCT00673309|12615542|FG007|COMPLETED|Overall Study||13
11417514|NCT00673309|12615543|FG008|COMPLETED|Overall Study||17
11417515|NCT00673309|12615544|FG009|COMPLETED|Overall Study||30
11417516|NCT00673309|12615535|FG000|NOT COMPLETED|Overall Study||0
11417517|NCT00673309|12615536|FG001|NOT COMPLETED|Overall Study||0
11417518|NCT00673309|12615537|FG002|NOT COMPLETED|Overall Study||0
11417519|NCT00673309|12615538|FG003|NOT COMPLETED|Overall Study||0
11417520|NCT00673309|12615539|FG004|NOT COMPLETED|Overall Study||0
11417521|NCT00673309|12615540|FG005|NOT COMPLETED|Overall Study||0
11417522|NCT00673309|12615541|FG006|NOT COMPLETED|Overall Study||0
11417523|NCT00673309|12615542|FG007|NOT COMPLETED|Overall Study||0
11417524|NCT00673309|12615543|FG008|NOT COMPLETED|Overall Study||0
11417525|NCT00673309|12615544|FG009|NOT COMPLETED|Overall Study||0
11417526|NCT00672178|12615557|FG000|STARTED|Overall Study||1
11417527|NCT00672178|12615557|FG000|COMPLETED|Overall Study||1
11417528|NCT00672178|12615557|FG000|NOT COMPLETED|Overall Study||0
11417529|NCT00673595|12615563|FG000|STARTED|Overall Study||8
11417530|NCT00673595|12615564|FG001|STARTED|Overall Study||11
11417531|NCT00673595|12615563|FG000|COMPLETED|Overall Study||8
11417532|NCT00673595|12615564|FG001|COMPLETED|Overall Study||11
11417533|NCT00673595|12615563|FG000|NOT COMPLETED|Overall Study||0
11417534|NCT00673595|12615564|FG001|NOT COMPLETED|Overall Study||0
11417535|NCT00673361|12615570|FG000|STARTED|Overall Study||9
11417536|NCT00673361|12615570|FG000|COMPLETED|Overall Study||7
11417537|NCT00673361|12615570|FG000|NOT COMPLETED|Overall Study||2
11417538|NCT00670631|12615574|FG000|STARTED|Overall Study||0
11417539|NCT00670631|12615574|FG000|COMPLETED|Overall Study||0
11417540|NCT00670631|12615574|FG000|NOT COMPLETED|Overall Study||0
11417541|NCT00668785|12615579|FG000|STARTED|Overall Study||6
11417542|NCT00668785|12615579|FG000|COMPLETED|Overall Study||6
11417543|NCT00668785|12615579|FG000|NOT COMPLETED|Overall Study||0
11417544|NCT00673179|12615587|FG000|STARTED|Overall Study||7
11417545|NCT00673179|12615588|FG001|STARTED|Overall Study||0
11417546|NCT00673179|12615587|FG000|COMPLETED|Overall Study||4
11417547|NCT00673179|12615588|FG001|COMPLETED|Overall Study||0
11417548|NCT00673179|12615587|FG000|NOT COMPLETED|Overall Study||3
11417549|NCT00673179|12615588|FG001|NOT COMPLETED|Overall Study||0
11417550|NCT00668265|12615596|FG000|STARTED|Overall Study||9
11417551|NCT00668265|12615597|FG001|STARTED|Overall Study||5
11417552|NCT00668265|12615596|FG000|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
11417553|NCT00668265|12615597|FG001|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
11417554|NCT00668265|12615596|FG000|NOT COMPLETED|Overall Study||9
11417555|NCT00668265|12615597|FG001|NOT COMPLETED|Overall Study||5
11417556|NCT00660348|12615607|FG000|STARTED|Overall Study||1
11417557|NCT00660348|12615608|FG001|STARTED|Overall Study||0
11417558|NCT00660348|12615607|FG000|COMPLETED|Overall Study||0
11417559|NCT00660348|12615608|FG001|COMPLETED|Overall Study||0
11417560|NCT00660348|12615607|FG000|NOT COMPLETED|Overall Study||1
11417561|NCT00660348|12615608|FG001|NOT COMPLETED|Overall Study||0
11417562|NCT00664066|12615614|FG000|STARTED|Overall Study||3
11417563|NCT00664066|12615614|FG000|COMPLETED|Overall Study||0
11417564|NCT00664066|12615614|FG000|NOT COMPLETED|Overall Study||3
11417565|NCT00667017|12615618|FG000|STARTED|Overall Study||1
11417566|NCT00667017|12615618|FG000|COMPLETED|Overall Study||0
11417567|NCT00667017|12615618|FG000|NOT COMPLETED|Overall Study||1
11417568|NCT00665444|12615622|FG000|STARTED|Overall Study||3
11417569|NCT00665444|12615622|FG000|COMPLETED|Overall Study||1
11417570|NCT00665444|12615622|FG000|NOT COMPLETED|Overall Study||2
11417571|NCT00656916|12615628|FG000|STARTED|Overall Study||1
11417572|NCT00656916|12615629|FG001|STARTED|Overall Study||0
11417573|NCT00656916|12615628|FG000|COMPLETED|Overall Study||1
11417574|NCT00656916|12615629|FG001|COMPLETED|Overall Study||0
11417575|NCT00656916|12615628|FG000|NOT COMPLETED|Overall Study||0
11417576|NCT00656916|12615629|FG001|NOT COMPLETED|Overall Study||0
11417577|NCT00660595|12615637|FG000|STARTED|Overall Study||19
11417578|NCT00660595|12615638|FG001|STARTED|Overall Study||10
11417579|NCT00660595|12615637|FG000|COMPLETED|Overall Study||1
11417580|NCT00660595|12615638|FG001|COMPLETED|Overall Study|One of the two was lost to follow-up|1
11417581|NCT00660595|12615637|FG000|NOT COMPLETED|Overall Study||18
11417582|NCT00660595|12615638|FG001|NOT COMPLETED|Overall Study||9
11417583|NCT00661466|12615646|FG000|STARTED|Overall Study|Participants|4
11417584|NCT00661466|12615647|FG001|STARTED|Overall Study|Participants|3
11417585|NCT00661466|12615646|FG000|COMPLETED|Overall Study|Participants|4
11417586|NCT00661466|12615647|FG001|COMPLETED|Overall Study|Participants|3
11417587|NCT00661466|12615646|FG000|NOT COMPLETED|Overall Study||0
11417588|NCT00661466|12615647|FG001|NOT COMPLETED|Overall Study||0
11417589|NCT00646282|12615655|FG000|STARTED|Overall Study||4
11417590|NCT00646282|12615656|FG001|STARTED|Overall Study||4
11417591|NCT00646282|12615655|FG000|COMPLETED|Overall Study||0
11417592|NCT00646282|12615656|FG001|COMPLETED|Overall Study||0
11417593|NCT00646282|12615655|FG000|NOT COMPLETED|Overall Study||4
11023521|NCT00813150|12201721|FG001|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
11417594|NCT00646282|12615656|FG001|NOT COMPLETED|Overall Study||4
11417595|NCT00657553|12615664|FG000|STARTED|Overall Study||5
11417596|NCT00657553|12615665|FG001|STARTED|Overall Study||5
11417597|NCT00657553|12615664|FG000|COMPLETED|Overall Study||0
11417598|NCT00657553|12615665|FG001|COMPLETED|Overall Study||0
11417599|NCT00657553|12615664|FG000|NOT COMPLETED|Overall Study||5
11417600|NCT00657553|12615665|FG001|NOT COMPLETED|Overall Study||5
11417601|NCT00655057|12615674|FG000|STARTED|Overall Study||0
11417602|NCT00655057|12615675|FG001|STARTED|Overall Study||0
11417603|NCT00655057|12615676|FG002|STARTED|Overall Study||0
11417604|NCT00655057|12615674|FG000|COMPLETED|Overall Study||0
11417605|NCT00655057|12615675|FG001|COMPLETED|Overall Study||0
11417606|NCT00655057|12615676|FG002|COMPLETED|Overall Study||0
11417607|NCT00655057|12615674|FG000|NOT COMPLETED|Overall Study||0
11417608|NCT00655057|12615675|FG001|NOT COMPLETED|Overall Study||0
11417609|NCT00655057|12615676|FG002|NOT COMPLETED|Overall Study||0
11417610|NCT00648895|12615686|FG000|STARTED|Overall Study||6
11417611|NCT00648895|12615687|FG001|STARTED|Overall Study||6
11417612|NCT00648895|12615686|FG000|COMPLETED|Overall Study||6
11417613|NCT00648895|12615687|FG001|COMPLETED|Overall Study||5
11417614|NCT00648895|12615686|FG000|NOT COMPLETED|Overall Study||0
11417615|NCT00648895|12615687|FG001|NOT COMPLETED|Overall Study||1
11417616|NCT00647426|12615693|FG000|STARTED|Overall Study||7
11417617|NCT00647426|12615693|FG000|COMPLETED|Overall Study||5
11417618|NCT00647426|12615693|FG000|NOT COMPLETED|Overall Study||2
11417619|NCT00645567|12615698|FG000|STARTED|Overall Study||5
11417620|NCT00645567|12615698|FG000|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
11417621|NCT00645567|12615698|FG000|NOT COMPLETED|Overall Study||1
11417622|NCT00637806|12615709|FG000|STARTED|Double-blind Phase||2
11417623|NCT00637806|12615710|FG001|STARTED|Double-blind Phase||0
11417624|NCT00637806|12615711|FG002|STARTED|Double-blind Phase||2
11417625|NCT00637806|12615712|FG003|STARTED|Double-blind Phase||0
11417626|NCT00637806|12615709|FG000|COMPLETED|Double-blind Phase||0
11417627|NCT00637806|12615710|FG001|COMPLETED|Double-blind Phase||0
11417628|NCT00637806|12615711|FG002|COMPLETED|Double-blind Phase||1
11417629|NCT00637806|12615712|FG003|COMPLETED|Double-blind Phase||0
11417630|NCT00637806|12615709|FG000|NOT COMPLETED|Double-blind Phase||2
11417631|NCT00637806|12615710|FG001|NOT COMPLETED|Double-blind Phase||0
11417632|NCT00637806|12615711|FG002|NOT COMPLETED|Double-blind Phase||1
11417633|NCT00637806|12615712|FG003|NOT COMPLETED|Double-blind Phase||0
11417634|NCT00637806|12615709|FG000|STARTED|Extension Phase||0
11417635|NCT00637806|12615710|FG001|STARTED|Extension Phase||0
11023522|NCT00813150|12201720|FG000|NOT COMPLETED|Long Term Follow-up||24
11023523|NCT00813150|12201721|FG001|NOT COMPLETED|Long Term Follow-up||31
11023524|NCT00813176|12201729|FG000|STARTED|Overall Study||25
11023525|NCT00813176|12201730|FG001|STARTED|Overall Study||25
11023526|NCT00813176|12201729|FG000|COMPLETED|Overall Study||25
11023527|NCT00813176|12201730|FG001|COMPLETED|Overall Study||25
11023528|NCT00813176|12201729|FG000|NOT COMPLETED|Overall Study||0
11417636|NCT00637806|12615711|FG002|STARTED|Extension Phase||0
11417637|NCT00637806|12615712|FG003|STARTED|Extension Phase||1
11417638|NCT00637806|12615709|FG000|COMPLETED|Extension Phase||0
11417639|NCT00637806|12615710|FG001|COMPLETED|Extension Phase||0
11417640|NCT00637806|12615711|FG002|COMPLETED|Extension Phase||0
11417641|NCT00637806|12615712|FG003|COMPLETED|Extension Phase||0
11417642|NCT00637806|12615709|FG000|NOT COMPLETED|Extension Phase||0
11417643|NCT00637806|12615710|FG001|NOT COMPLETED|Extension Phase||0
11417644|NCT00637806|12615711|FG002|NOT COMPLETED|Extension Phase||0
11417645|NCT00637806|12615712|FG003|NOT COMPLETED|Extension Phase||1
11417646|NCT00652457|12615721|FG000|STARTED|Overall Study||23
11417647|NCT00652457|12615722|FG001|STARTED|Overall Study||27
11417648|NCT00652457|12615721|FG000|COMPLETED|Overall Study||23
11417649|NCT00652457|12615722|FG001|COMPLETED|Overall Study||27
11417650|NCT00652457|12615721|FG000|NOT COMPLETED|Overall Study||0
11417651|NCT00652457|12615722|FG001|NOT COMPLETED|Overall Study||0
11417652|NCT00642603|12615730|FG000|STARTED|Overall Study||21
11417653|NCT00642603|12615731|FG001|STARTED|Overall Study||20
11417654|NCT00642603|12615730|FG000|Safety Population|Overall Study||19
11417655|NCT00642603|12615731|FG001|Safety Population|Overall Study||20
11417656|NCT00642603|12615730|FG000|COMPLETED|Overall Study||0
11417657|NCT00642603|12615731|FG001|COMPLETED|Overall Study||2
11417658|NCT00642603|12615730|FG000|NOT COMPLETED|Overall Study||21
11417659|NCT00642603|12615731|FG001|NOT COMPLETED|Overall Study||18
11417660|NCT00629798|12615737|FG000|STARTED|Overall Study||64
11417661|NCT00629798|12615737|FG000|COMPLETED|Overall Study||60
11417662|NCT00629798|12615737|FG000|NOT COMPLETED|Overall Study||4
11417663|NCT00645359|12615741|FG000|STARTED|Overall Study||9
11417664|NCT00645359|12615741|FG000|COMPLETED|Overall Study||9
11417665|NCT00645359|12615741|FG000|NOT COMPLETED|Overall Study||0
11417666|NCT00637728|12615747|FG000|STARTED|Double-blind Phase||4
11417667|NCT00637728|12615748|FG001|STARTED|Double-blind Phase||1
11417668|NCT00637728|12615749|FG002|STARTED|Double-blind Phase||0
11023529|NCT00813176|12201730|FG001|NOT COMPLETED|Overall Study||0
11023530|NCT00813293|12201740|FG000|STARTED|Overall Study||10
11417669|NCT00637728|12615747|FG000|COMPLETED|Double-blind Phase||0
11417670|NCT00637728|12615748|FG001|COMPLETED|Double-blind Phase||0
11417671|NCT00637728|12615749|FG002|COMPLETED|Double-blind Phase||0
11417672|NCT00637728|12615747|FG000|NOT COMPLETED|Double-blind Phase||4
11417673|NCT00637728|12615748|FG001|NOT COMPLETED|Double-blind Phase||1
11417674|NCT00637728|12615749|FG002|NOT COMPLETED|Double-blind Phase||0
11417675|NCT00637728|12615747|FG000|STARTED|Extension Phase||0
11417676|NCT00637728|12615748|FG001|STARTED|Extension Phase||0
11417677|NCT00637728|12615749|FG002|STARTED|Extension Phase||0
11417678|NCT00637728|12615747|FG000|COMPLETED|Extension Phase||0
11417679|NCT00637728|12615748|FG001|COMPLETED|Extension Phase||0
11417680|NCT00637728|12615749|FG002|COMPLETED|Extension Phase||0
11417681|NCT00637728|12615747|FG000|NOT COMPLETED|Extension Phase||0
11417682|NCT00637728|12615748|FG001|NOT COMPLETED|Extension Phase||0
11023531|NCT00813293|12201741|FG001|STARTED|Overall Study||10
11417683|NCT00637728|12615749|FG002|NOT COMPLETED|Extension Phase||0
11417684|NCT00639626|12615756|FG000|STARTED|Overall Study||0
11417685|NCT00639626|12615756|FG000|COMPLETED|Overall Study||0
11417686|NCT00639626|12615756|FG000|NOT COMPLETED|Overall Study||0
11417687|NCT00634582|12615760|FG000|STARTED|Overall Study||2
11417688|NCT00634582|12615760|FG000|COMPLETED|Overall Study||2
11417689|NCT00634582|12615760|FG000|NOT COMPLETED|Overall Study||0
11417690|NCT00641108|12615766|FG000|STARTED|Overall Study||0
11417691|NCT00641108|12615767|FG001|STARTED|Overall Study||0
11417692|NCT00641108|12615766|FG000|COMPLETED|Overall Study||0
11417693|NCT00641108|12615767|FG001|COMPLETED|Overall Study||0
11417694|NCT00641108|12615766|FG000|NOT COMPLETED|Overall Study||0
11417695|NCT00641108|12615767|FG001|NOT COMPLETED|Overall Study||0
11417696|NCT00642382|12615775|FG000|STARTED|Overall Study||0
11417697|NCT00642382|12615776|FG001|STARTED|Overall Study||0
11417698|NCT00642382|12615775|FG000|COMPLETED|Overall Study||0
11417699|NCT00642382|12615776|FG001|COMPLETED|Overall Study||0
11417700|NCT00642382|12615775|FG000|NOT COMPLETED|Overall Study||0
11417701|NCT00642382|12615776|FG001|NOT COMPLETED|Overall Study||0
11417702|NCT00637416|12615784|FG000|STARTED|Overall Study||4
11417703|NCT00637416|12615785|FG001|STARTED|Overall Study||5
11417704|NCT00637416|12615784|FG000|COMPLETED|Overall Study||3
11417705|NCT00637416|12615785|FG001|COMPLETED|Overall Study||3
11417706|NCT00637416|12615784|FG000|NOT COMPLETED|Overall Study||1
11417707|NCT00637416|12615785|FG001|NOT COMPLETED|Overall Study||2
11417708|NCT00635167|12615791|FG000|STARTED|Overall Study||1
11417709|NCT00635167|12615791|FG000|COMPLETED|Overall Study||1
11417710|NCT00635167|12615791|FG000|NOT COMPLETED|Overall Study||0
11144482|NCT01479439|12331279|FG002|COMPLETED|Overall Study||6
11144483|NCT01479439|12331277|FG000|NOT COMPLETED|Overall Study||1
11144484|NCT01479439|12331278|FG001|NOT COMPLETED|Overall Study||1
11144485|NCT01479439|12331279|FG002|NOT COMPLETED|Overall Study||2
11144486|NCT01479465|12331294|FG000|STARTED|Overall Study||11
11144487|NCT01479465|12331295|FG001|STARTED|Overall Study||84
11144488|NCT01479465|12331296|FG002|STARTED|Overall Study||86
11144489|NCT01479465|12331297|FG003|STARTED|Overall Study||85
11144490|NCT01479465|12331294|FG000|COMPLETED|Overall Study||0
11144491|NCT01479465|12331295|FG001|COMPLETED|Overall Study||0
11144492|NCT01479465|12331296|FG002|COMPLETED|Overall Study||0
11144493|NCT01479465|12331297|FG003|COMPLETED|Overall Study||0
11144494|NCT01479465|12331294|FG000|NOT COMPLETED|Overall Study||11
11144495|NCT01479465|12331295|FG001|NOT COMPLETED|Overall Study||84
11144496|NCT01479465|12331296|FG002|NOT COMPLETED|Overall Study||86
11144497|NCT01479465|12331297|FG003|NOT COMPLETED|Overall Study||85
11144498|NCT01479478|12331309|FG000|STARTED|Overall Study||125
11144499|NCT01479478|12331310|FG001|STARTED|Overall Study||126
11144500|NCT01479478|12331309|FG000|COMPLETED|Overall Study||125
11144501|NCT01479478|12331310|FG001|COMPLETED|Overall Study||126
11417711|NCT00637312|12615797|FG000|STARTED|Overall Study||72
11417712|NCT00637312|12615798|FG001|STARTED|Overall Study||36
11144502|NCT01479478|12331309|FG000|NOT COMPLETED|Overall Study||0
11417713|NCT00637312|12615797|FG000|COMPLETED|Overall Study||30
11417714|NCT00637312|12615798|FG001|COMPLETED|Overall Study||19
11417715|NCT00637312|12615797|FG000|NOT COMPLETED|Overall Study||42
11417716|NCT00637312|12615798|FG001|NOT COMPLETED|Overall Study||17
11417717|NCT00638222|12615807|FG000|STARTED|Overall Study||0
11417718|NCT00638222|12615808|FG001|STARTED|Overall Study||0
11417719|NCT00638222|12615809|FG002|STARTED|Overall Study||6
11417720|NCT00638222|12615807|FG000|COMPLETED|Overall Study||0
11417721|NCT00638222|12615808|FG001|COMPLETED|Overall Study||0
11417722|NCT00638222|12615809|FG002|COMPLETED|Overall Study||6
11417723|NCT00638222|12615807|FG000|NOT COMPLETED|Overall Study||0
11417724|NCT00638222|12615808|FG001|NOT COMPLETED|Overall Study||0
11417725|NCT00638222|12615809|FG002|NOT COMPLETED|Overall Study||0
11417726|NCT00634322|12615819|FG000|STARTED|Overall Study||1
11417727|NCT00634322|12615820|FG001|STARTED|Overall Study||1
11417728|NCT00634322|12615821|FG002|STARTED|Overall Study||5
11023532|NCT00813293|12201740|FG000|Started Treatment|Overall Study||9
11023533|NCT00813293|12201741|FG001|Started Treatment|Overall Study||10
11023534|NCT00813293|12201740|FG000|Evaluable RFA|Overall Study||7
11023535|NCT00813293|12201741|FG001|Evaluable RFA|Overall Study||8
11023536|NCT00813293|12201740|FG000|COMPLETED|Overall Study||9
11023537|NCT00813293|12201741|FG001|COMPLETED|Overall Study||9
11023538|NCT00813293|12201740|FG000|NOT COMPLETED|Overall Study||1
11023539|NCT00813293|12201741|FG001|NOT COMPLETED|Overall Study||1
11023540|NCT00813319|12201749|FG000|STARTED|Overall Study||108
11023541|NCT00813319|12201750|FG001|STARTED|Overall Study||108
11023542|NCT00813319|12201749|FG000|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
11023543|NCT00813319|12201750|FG001|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
11023544|NCT00813319|12201749|FG000|NOT COMPLETED|Overall Study||0
11023545|NCT00813319|12201750|FG001|NOT COMPLETED|Overall Study||0
11023546|NCT00813358|12201756|FG000|STARTED|Overall Study||115
11023547|NCT00813358|12201756|FG000|COMPLETED|Overall Study||46
11023548|NCT00813358|12201756|FG000|NOT COMPLETED|Overall Study||69
11023549|NCT00813488|12201760|FG000|STARTED|Titration Period 1||107
11144503|NCT01479478|12331310|FG001|NOT COMPLETED|Overall Study||0
11417729|NCT00634322|12615819|FG000|COMPLETED|Overall Study||1
11417730|NCT00634322|12615820|FG001|COMPLETED|Overall Study||1
11417731|NCT00634322|12615821|FG002|COMPLETED|Overall Study||5
11417732|NCT00634322|12615819|FG000|NOT COMPLETED|Overall Study||0
11417733|NCT00634322|12615820|FG001|NOT COMPLETED|Overall Study||0
11417734|NCT00634322|12615821|FG002|NOT COMPLETED|Overall Study||0
11417735|NCT00633087|12615829|FG000|STARTED|Overall Study||12
11417736|NCT00633087|12615829|FG000|COMPLETED|Overall Study||12
11417737|NCT00633087|12615829|FG000|NOT COMPLETED|Overall Study||0
11417738|NCT00631137|12615835|FG000|STARTED|Overall Study||1
11417739|NCT00631137|12615836|FG001|STARTED|Overall Study||0
11417740|NCT00631137|12615835|FG000|COMPLETED|Overall Study||0
11417741|NCT00631137|12615836|FG001|COMPLETED|Overall Study||0
11417742|NCT00631137|12615835|FG000|NOT COMPLETED|Overall Study||1
11417743|NCT00631137|12615836|FG001|NOT COMPLETED|Overall Study||0
11417744|NCT00634972|12615844|FG000|STARTED|Overall Study||40
11417745|NCT00634972|12615845|FG001|STARTED|Overall Study||43
11417746|NCT00634972|12615844|FG000|COMPLETED|Overall Study||40
11417747|NCT00634972|12615845|FG001|COMPLETED|Overall Study||43
11417748|NCT00634972|12615844|FG000|NOT COMPLETED|Overall Study||0
11417749|NCT00634972|12615845|FG001|NOT COMPLETED|Overall Study||0
11417750|NCT00633061|12615853|FG000|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136
11417751|NCT00633061|12615854|FG001|STARTED|Overall Study||0
11417752|NCT00633061|12615853|FG000|Met Criteria for Imaging|Overall Study||25
11417753|NCT00633061|12615854|FG001|Met Criteria for Imaging|Overall Study||0
11417754|NCT00633061|12615853|FG000|Had Prior Thrombosis Identified|Overall Study||25
11417755|NCT00633061|12615854|FG001|Had Prior Thrombosis Identified|Overall Study||0
11417756|NCT00633061|12615853|FG000|COMPLETED|Overall Study||50
11417757|NCT00633061|12615854|FG001|COMPLETED|Overall Study||0
11417758|NCT00633061|12615853|FG000|NOT COMPLETED|Overall Study||86
11417759|NCT00633061|12615854|FG001|NOT COMPLETED|Overall Study||0
11417760|NCT00626444|12615862|FG000|STARTED|Overall Study||2
11417761|NCT00626444|12615862|FG000|COMPLETED|Overall Study||2
11417762|NCT00626444|12615862|FG000|NOT COMPLETED|Overall Study||0
11417763|NCT00630292|12615866|FG000|STARTED|Overall Study||6
11417764|NCT00630292|12615866|FG000|COMPLETED|Overall Study||5
11417765|NCT00630292|12615866|FG000|NOT COMPLETED|Overall Study||1
11417766|NCT00634010|12615872|FG000|STARTED|Overall Study||18
11417767|NCT00634010|12615873|FG001|STARTED|Overall Study||18
11417768|NCT00634010|12615872|FG000|COMPLETED|Overall Study||8
11417769|NCT00634010|12615873|FG001|COMPLETED|Overall Study||4
11417770|NCT00634010|12615872|FG000|NOT COMPLETED|Overall Study||10
11417771|NCT00634010|12615873|FG001|NOT COMPLETED|Overall Study||14
11417772|NCT00630487|12615881|FG000|STARTED|Overall Study||0
11417773|NCT00630487|12615882|FG001|STARTED|Overall Study||0
11417774|NCT00630487|12615881|FG000|COMPLETED|Overall Study||0
11417775|NCT00630487|12615882|FG001|COMPLETED|Overall Study||0
11417776|NCT00630487|12615881|FG000|NOT COMPLETED|Overall Study||0
11417777|NCT00630487|12615882|FG001|NOT COMPLETED|Overall Study||0
11417778|NCT00629850|12615890|FG000|STARTED|Overall Study||1
11417779|NCT00629850|12615891|FG001|STARTED|Overall Study||0
11417780|NCT00629850|12615890|FG000|COMPLETED|Overall Study||1
11417781|NCT00629850|12615891|FG001|COMPLETED|Overall Study||0
11023550|NCT00813488|12201761|FG001|STARTED|Titration Period 1||106
11023551|NCT00813488|12201760|FG000|COMPLETED|Titration Period 1||80
11023552|NCT00813488|12201761|FG001|COMPLETED|Titration Period 1||89
11023553|NCT00813488|12201760|FG000|NOT COMPLETED|Titration Period 1||27
11023554|NCT00813488|12201761|FG001|NOT COMPLETED|Titration Period 1||17
11023555|NCT00813488|12201760|FG000|STARTED|Titration Period 2||80
11023556|NCT00813488|12201761|FG001|STARTED|Titration Period 2||89
11023557|NCT00813488|12201760|FG000|COMPLETED|Titration Period 2||64
11023558|NCT00813488|12201761|FG001|COMPLETED|Titration Period 2||79
11023559|NCT00813488|12201760|FG000|NOT COMPLETED|Titration Period 2||16
11023560|NCT00813488|12201761|FG001|NOT COMPLETED|Titration Period 2||10
11023561|NCT00813488|12201760|FG000|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
11023562|NCT00813488|12201761|FG001|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
11023563|NCT00813488|12201760|FG000|COMPLETED|Double-blind Treatment Period 1||71
11023564|NCT00813488|12201761|FG001|COMPLETED|Double-blind Treatment Period 1||66
11023565|NCT00813488|12201760|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1
11023566|NCT00813488|12201761|FG001|NOT COMPLETED|Double-blind Treatment Period 1||5
11023567|NCT00813488|12201760|FG000|STARTED|Double-blind Treatment Period 2||71
11023568|NCT00813488|12201761|FG001|STARTED|Double-blind Treatment Period 2||66
11023569|NCT00813488|12201760|FG000|COMPLETED|Double-blind Treatment Period 2||66
11023570|NCT00813488|12201761|FG001|COMPLETED|Double-blind Treatment Period 2||65
11023571|NCT00813488|12201760|FG000|NOT COMPLETED|Double-blind Treatment Period 2||5
11023572|NCT00813488|12201761|FG001|NOT COMPLETED|Double-blind Treatment Period 2||1
11023573|NCT00813488|12201760|FG000|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
11023574|NCT00813488|12201761|FG001|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
11023575|NCT00813488|12201760|FG000|COMPLETED|Open-label Extension|This group received FBT open--label|53
11023576|NCT00813488|12201761|FG001|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
11417782|NCT00629850|12615890|FG000|NOT COMPLETED|Overall Study||0
11417783|NCT00629850|12615891|FG001|NOT COMPLETED|Overall Study||0
11417784|NCT00623974|12615901|FG000|STARTED|Overall Study||0
11417785|NCT00623974|12615902|FG001|STARTED|Overall Study||0
11417786|NCT00623974|12615903|FG002|STARTED|Overall Study||0
11417787|NCT00623974|12615904|FG003|STARTED|Overall Study||0
11417788|NCT00623974|12615901|FG000|COMPLETED|Overall Study||0
11417789|NCT00623974|12615902|FG001|COMPLETED|Overall Study||0
11417790|NCT00623974|12615903|FG002|COMPLETED|Overall Study||0
11417791|NCT00623974|12615904|FG003|COMPLETED|Overall Study||0
11023577|NCT00813488|12201760|FG000|NOT COMPLETED|Open-label Extension||12
11023578|NCT00813488|12201761|FG001|NOT COMPLETED|Open-label Extension||7
11023579|NCT00813592|12201771|FG000|STARTED|Overall Study||2
11023580|NCT00813592|12201771|FG000|Treated|Overall Study|Two patients were treated.|2
11023581|NCT00813592|12201771|FG000|Response Assessment|Overall Study|One patient met the response assessment.|1
11023582|NCT00813592|12201771|FG000|COMPLETED|Overall Study||0
11023583|NCT00813592|12201771|FG000|NOT COMPLETED|Overall Study||2
11023584|NCT00813709|12201779|FG000|STARTED|Double Blind Period||84
11023585|NCT00813709|12201780|FG001|STARTED|Double Blind Period||117
11023586|NCT00813709|12201781|FG002|STARTED|Double Blind Period||99
11023587|NCT00813709|12201782|FG003|STARTED|Double Blind Period||0
11023588|NCT00813709|12201783|FG004|STARTED|Double Blind Period||0
11023589|NCT00813709|12201784|FG005|STARTED|Double Blind Period||0
11023590|NCT00813709|12201779|FG000|Treated|Double Blind Period||83
11023591|NCT00813709|12201780|FG001|Treated|Double Blind Period||114
11023592|NCT00813709|12201781|FG002|Treated|Double Blind Period||98
11023593|NCT00813709|12201782|FG003|Treated|Double Blind Period||0
11023594|NCT00813709|12201783|FG004|Treated|Double Blind Period||0
11023595|NCT00813709|12201784|FG005|Treated|Double Blind Period||0
11023596|NCT00813709|12201779|FG000|COMPLETED|Double Blind Period||53
11023597|NCT00813709|12201780|FG001|COMPLETED|Double Blind Period||76
11023598|NCT00813709|12201781|FG002|COMPLETED|Double Blind Period||68
11023599|NCT00813709|12201782|FG003|COMPLETED|Double Blind Period||0
11023600|NCT00813709|12201783|FG004|COMPLETED|Double Blind Period||0
11023601|NCT00813709|12201784|FG005|COMPLETED|Double Blind Period||0
11023602|NCT00813709|12201779|FG000|NOT COMPLETED|Double Blind Period||31
11023603|NCT00813709|12201780|FG001|NOT COMPLETED|Double Blind Period||41
11023604|NCT00813709|12201781|FG002|NOT COMPLETED|Double Blind Period||31
11023605|NCT00813709|12201782|FG003|NOT COMPLETED|Double Blind Period||0
11023606|NCT00813709|12201783|FG004|NOT COMPLETED|Double Blind Period||0
11023607|NCT00813709|12201784|FG005|NOT COMPLETED|Double Blind Period||0
11023608|NCT00813709|12201779|FG000|STARTED|Open Label Period||0
11023609|NCT00813709|12201780|FG001|STARTED|Open Label Period||0
11023610|NCT00813709|12201781|FG002|STARTED|Open Label Period||0
11023611|NCT00813709|12201782|FG003|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
11023612|NCT00813709|12201783|FG004|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
11023613|NCT00813709|12201784|FG005|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
11023614|NCT00813709|12201779|FG000|Treated|Open Label Period||0
11023615|NCT00813709|12201780|FG001|Treated|Open Label Period||0
11023616|NCT00813709|12201781|FG002|Treated|Open Label Period||0
11023617|NCT00813709|12201782|FG003|Treated|Open Label Period||57
11023618|NCT00813709|12201783|FG004|Treated|Open Label Period||51
11023619|NCT00813709|12201784|FG005|Treated|Open Label Period||45
11023620|NCT00813709|12201779|FG000|COMPLETED|Open Label Period||0
11023621|NCT00813709|12201780|FG001|COMPLETED|Open Label Period||0
11023622|NCT00813709|12201781|FG002|COMPLETED|Open Label Period||0
11023623|NCT00813709|12201782|FG003|COMPLETED|Open Label Period||38
11023624|NCT00813709|12201783|FG004|COMPLETED|Open Label Period||41
11023625|NCT00813709|12201784|FG005|COMPLETED|Open Label Period||35
11023626|NCT00813709|12201779|FG000|NOT COMPLETED|Open Label Period||0
11023627|NCT00813709|12201780|FG001|NOT COMPLETED|Open Label Period||0
11023628|NCT00813709|12201781|FG002|NOT COMPLETED|Open Label Period||0
11023629|NCT00813709|12201782|FG003|NOT COMPLETED|Open Label Period||20
11023630|NCT00813709|12201783|FG004|NOT COMPLETED|Open Label Period||10
11023631|NCT00813709|12201784|FG005|NOT COMPLETED|Open Label Period||11
11023632|NCT00813748|12201815|FG000|STARTED|Main Observational Study||30
11023633|NCT00813748|12201816|FG001|STARTED|Main Observational Study||88
11023634|NCT00813748|12201815|FG000|COMPLETED|Main Observational Study||30
11023635|NCT00813748|12201816|FG001|COMPLETED|Main Observational Study||88
11023636|NCT00813748|12201815|FG000|NOT COMPLETED|Main Observational Study||0
11023637|NCT00813748|12201816|FG001|NOT COMPLETED|Main Observational Study||0
11023638|NCT00813748|12201815|FG000|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
11023639|NCT00813748|12201816|FG001|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
11023640|NCT00813748|12201815|FG000|COMPLETED|Skin Test Substudy||3
11023641|NCT00813748|12201816|FG001|COMPLETED|Skin Test Substudy||7
11023642|NCT00813748|12201815|FG000|NOT COMPLETED|Skin Test Substudy||0
11023643|NCT00813748|12201816|FG001|NOT COMPLETED|Skin Test Substudy||1
11023644|NCT00813761|12201826|FG000|STARTED|Phase 1 (Baseline to 4 Weeks)||121
11023645|NCT00813761|12201827|FG001|STARTED|Phase 1 (Baseline to 4 Weeks)||103
11023646|NCT00813761|12201828|FG002|STARTED|Phase 1 (Baseline to 4 Weeks)||115
11023647|NCT00813761|12201829|FG003|STARTED|Phase 1 (Baseline to 4 Weeks)||107
11023648|NCT00813761|12201826|FG000|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
11023649|NCT00813761|12201827|FG001|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
11023650|NCT00813761|12201828|FG002|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
11023651|NCT00813761|12201829|FG003|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
11023652|NCT00813761|12201826|FG000|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
11023653|NCT00813761|12201827|FG001|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
11023654|NCT00813761|12201828|FG002|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
11023655|NCT00813761|12201829|FG003|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
11023656|NCT00813761|12201826|FG000|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
11023657|NCT00813761|12201827|FG001|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
11023658|NCT00813761|12201828|FG002|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
11023659|NCT00813761|12201829|FG003|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
11023660|NCT00813761|12201826|FG000|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
11023661|NCT00813761|12201827|FG001|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
11023662|NCT00813761|12201828|FG002|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
11023663|NCT00813761|12201829|FG003|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
11023664|NCT00813761|12201826|FG000|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
11023665|NCT00813761|12201827|FG001|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
11023666|NCT00813761|12201828|FG002|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
11023667|NCT00813761|12201829|FG003|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
11023668|NCT00813800|12201845|FG000|STARTED|Overall Study||11
11023669|NCT00813800|12201845|FG000|COMPLETED|Overall Study||5
11023670|NCT00813800|12201845|FG000|NOT COMPLETED|Overall Study||6
11023671|NCT00813813|12201851|FG000|STARTED|Overall Study||7
11023672|NCT00813813|12201852|FG001|STARTED|Overall Study||25
11023673|NCT00813813|12201851|FG000|COMPLETED|Overall Study||4
11023674|NCT00813813|12201852|FG001|COMPLETED|Overall Study||16
11023675|NCT00813813|12201851|FG000|NOT COMPLETED|Overall Study||3
11023676|NCT00813813|12201852|FG001|NOT COMPLETED|Overall Study||9
11023677|NCT00813865|12201858|FG000|STARTED|Overall Study||8
11023678|NCT00813865|12201858|FG000|Safety Population|Overall Study||8
11023679|NCT00813865|12201858|FG000|Pharmacodynamic (PD) Population|Overall Study||8
11023680|NCT00813865|12201858|FG000|COMPLETED|Overall Study||1
11023681|NCT00813865|12201858|FG000|NOT COMPLETED|Overall Study||7
11023682|NCT00813904|12201862|FG000|STARTED|Overall Study||31
11023683|NCT00813904|12201862|FG000|COMPLETED|Overall Study||30
11023684|NCT00813904|12201862|FG000|NOT COMPLETED|Overall Study||1
11023685|NCT00813917|12201868|FG000|STARTED|Overall Study||38
11023686|NCT00813917|12201869|FG001|STARTED|Overall Study||38
11023687|NCT00813917|12201868|FG000|COMPLETED|Overall Study||32
11023688|NCT00813917|12201869|FG001|COMPLETED|Overall Study||32
11023689|NCT00813917|12201868|FG000|NOT COMPLETED|Overall Study||6
11023690|NCT00813917|12201869|FG001|NOT COMPLETED|Overall Study||6
11023691|NCT00813943|12201878|FG000|STARTED|Overall Study||88
11023692|NCT00813943|12201879|FG001|STARTED|Overall Study||88
11023693|NCT00813943|12201880|FG002|STARTED|Overall Study||89
11023694|NCT00813943|12201878|FG000|COMPLETED|Overall Study||83
11023695|NCT00813943|12201879|FG001|COMPLETED|Overall Study||83
11023696|NCT00813943|12201880|FG002|COMPLETED|Overall Study||86
11023697|NCT00813943|12201878|FG000|NOT COMPLETED|Overall Study||5
11023698|NCT00813943|12201879|FG001|NOT COMPLETED|Overall Study||5
11023699|NCT00813943|12201880|FG002|NOT COMPLETED|Overall Study||3
11023700|NCT00813982|12201889|FG000|STARTED|Overall Study||59
11023701|NCT00813982|12201889|FG000|COMPLETED|Overall Study||59
11023702|NCT00813982|12201889|FG000|NOT COMPLETED|Overall Study||0
11023703|NCT00813995|12201897|FG000|STARTED|Overall Study||197
11023704|NCT00813995|12201898|FG001|STARTED|Overall Study||198
11023705|NCT00813995|12201897|FG000|COMPLETED|Overall Study||174
11023706|NCT00813995|12201898|FG001|COMPLETED|Overall Study||182
11023707|NCT00813995|12201897|FG000|NOT COMPLETED|Overall Study||23
11023708|NCT00813995|12201898|FG001|NOT COMPLETED|Overall Study||16
11023709|NCT00814138|12201910|FG000|STARTED|Overall Study||25
11023710|NCT00814138|12201911|FG001|STARTED|Overall Study||25
11023711|NCT00814138|12201910|FG000|COMPLETED|Overall Study||24
11023712|NCT00814138|12201911|FG001|COMPLETED|Overall Study||18
11023713|NCT00814138|12201910|FG000|NOT COMPLETED|Overall Study||1
11023714|NCT00814138|12201911|FG001|NOT COMPLETED|Overall Study||7
11023715|NCT00814164|12201919|FG000|STARTED|Overall Study||21
11023716|NCT00814164|12201919|FG000|COMPLETED|Overall Study||2
11023717|NCT00814164|12201919|FG000|NOT COMPLETED|Overall Study||19
11023718|NCT00814177|12201925|FG000|STARTED|Overall Study||80
11023719|NCT00814177|12201926|FG001|STARTED|Overall Study||80
11023720|NCT00814177|12201925|FG000|COMPLETED|Overall Study||80
11023721|NCT00814177|12201926|FG001|COMPLETED|Overall Study||80
11023722|NCT00814177|12201925|FG000|NOT COMPLETED|Overall Study||0
11023723|NCT00814177|12201926|FG001|NOT COMPLETED|Overall Study||0
11023724|NCT00814255|12201935|FG000|STARTED|Overall Study||8
11023725|NCT00814255|12201936|FG001|STARTED|Overall Study||7
11023726|NCT00814255|12201937|FG002|STARTED|Overall Study||8
11023727|NCT00814255|12201935|FG000|COMPLETED|Overall Study||7
11023728|NCT00814255|12201936|FG001|COMPLETED|Overall Study||7
11023729|NCT00814255|12201937|FG002|COMPLETED|Overall Study||7
11023730|NCT00814255|12201935|FG000|NOT COMPLETED|Overall Study||1
11023731|NCT00814255|12201936|FG001|NOT COMPLETED|Overall Study||0
11023732|NCT00814255|12201937|FG002|NOT COMPLETED|Overall Study||1
11023733|NCT00814307|12201952|FG000|STARTED|Overall Study||244
11023734|NCT00814307|12201953|FG001|STARTED|Overall Study||245
11023735|NCT00814307|12201954|FG002|STARTED|Overall Study||61
11023736|NCT00814307|12201955|FG003|STARTED|Overall Study||61
11023737|NCT00814307|12201952|FG000|Treated|Overall Study||243
11023738|NCT00814307|12201953|FG001|Treated|Overall Study||245
11023739|NCT00814307|12201954|FG002|Treated|Overall Study||61
11023740|NCT00814307|12201955|FG003|Treated|Overall Study||61
11023741|NCT00814307|12201952|FG000|COMPLETED|Overall Study||232
11023742|NCT00814307|12201953|FG001|COMPLETED|Overall Study||218
11023743|NCT00814307|12201954|FG002|COMPLETED|Overall Study||54
11023744|NCT00814307|12201955|FG003|COMPLETED|Overall Study||51
11023745|NCT00814307|12201952|FG000|NOT COMPLETED|Overall Study||12
11023746|NCT00814307|12201953|FG001|NOT COMPLETED|Overall Study||27
11023747|NCT00814307|12201954|FG002|NOT COMPLETED|Overall Study||7
11023748|NCT00814307|12201955|FG003|NOT COMPLETED|Overall Study||10
11023749|NCT00814320|12201969|FG000|STARTED|Epoch 1 (IV Treatment)||14
11023750|NCT00814320|12201970|FG001|STARTED|Epoch 1 (IV Treatment)||73
11023751|NCT00814320|12201969|FG000|COMPLETED|Epoch 1 (IV Treatment)||13
11023752|NCT00814320|12201970|FG001|COMPLETED|Epoch 1 (IV Treatment)||71
11023753|NCT00814320|12201969|FG000|NOT COMPLETED|Epoch 1 (IV Treatment)||1
11023754|NCT00814320|12201970|FG001|NOT COMPLETED|Epoch 1 (IV Treatment)||2
11023755|NCT00814320|12201969|FG000|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
11023756|NCT00814320|12201970|FG001|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
11023757|NCT00814320|12201969|FG000|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
11023758|NCT00814320|12201970|FG001|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
11023759|NCT00814320|12201969|FG000|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
11023760|NCT00814320|12201970|FG001|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
11023761|NCT00814320|12201969|FG000|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
11023762|NCT00814320|12201970|FG001|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
11023763|NCT00814320|12201969|FG000|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
11023764|NCT00814320|12201970|FG001|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
11023765|NCT00814320|12201969|FG000|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
11023766|NCT00814320|12201970|FG001|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
11023767|NCT00814320|12201969|FG000|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
11023768|NCT00814320|12201970|FG001|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
11023769|NCT00814320|12201969|FG000|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
11023770|NCT00814320|12201970|FG001|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
11023771|NCT00814320|12201969|FG000|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
11023772|NCT00814320|12201970|FG001|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
11023773|NCT00814346|12201995|FG000|STARTED|Double-blind Phase (4 Weeks)||23
11023774|NCT00814346|12201996|FG001|STARTED|Double-blind Phase (4 Weeks)||26
11023775|NCT00814346|12201995|FG000|CNE|Double-blind Phase (4 Weeks)||10
11023776|NCT00814346|12201996|FG001|CNE|Double-blind Phase (4 Weeks)||13
11023777|NCT00814346|12201995|FG000|MC|Double-blind Phase (4 Weeks)||10
11023778|NCT00814346|12201996|FG001|MC|Double-blind Phase (4 Weeks)||11
11023779|NCT00814346|12201995|FG000|AD|Double-blind Phase (4 Weeks)||3
11023780|NCT00814346|12201996|FG001|AD|Double-blind Phase (4 Weeks)||2
11023781|NCT00814346|12201995|FG000|COMPLETED|Double-blind Phase (4 Weeks)||23
11023782|NCT00814346|12201996|FG001|COMPLETED|Double-blind Phase (4 Weeks)||23
11023783|NCT00814346|12201995|FG000|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
11023784|NCT00814346|12201996|FG001|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
11023785|NCT00814346|12201995|FG000|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
11023786|NCT00814346|12201996|FG001|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
11023787|NCT00814346|12201995|FG000|CNE|Open Phase (17 Months)||21
11023788|NCT00814346|12201996|FG001|CNE|Open Phase (17 Months)||0
11023789|NCT00814346|12201995|FG000|MC|Open Phase (17 Months)||20
11023790|NCT00814346|12201996|FG001|MC|Open Phase (17 Months)||0
11023791|NCT00814346|12201995|FG000|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
11023792|NCT00814346|12201996|FG001|AD|Open Phase (17 Months)||0
11023793|NCT00814346|12201995|FG000|COMPLETED|Open Phase (17 Months)||31
11023794|NCT00814346|12201996|FG001|COMPLETED|Open Phase (17 Months)||0
11023795|NCT00814346|12201995|FG000|NOT COMPLETED|Open Phase (17 Months)||10
11023796|NCT00814346|12201996|FG001|NOT COMPLETED|Open Phase (17 Months)||0
11023797|NCT00814463|12202015|FG000|STARTED|Overall Study||1
11023798|NCT00814463|12202015|FG000|COMPLETED|Overall Study||0
11023799|NCT00814463|12202015|FG000|NOT COMPLETED|Overall Study||1
11023800|NCT00814489|12202023|FG000|STARTED|Overall Study||15
11023801|NCT00814489|12202024|FG001|STARTED|Overall Study||17
11023802|NCT00814489|12202025|FG002|STARTED|Overall Study||8
11023803|NCT00814489|12202023|FG000|COMPLETED|Overall Study||13
11023804|NCT00814489|12202024|FG001|COMPLETED|Overall Study||17
11023805|NCT00814489|12202025|FG002|COMPLETED|Overall Study||7
11023806|NCT00814489|12202023|FG000|NOT COMPLETED|Overall Study||2
11023807|NCT00814489|12202024|FG001|NOT COMPLETED|Overall Study||0
11023808|NCT00814489|12202025|FG002|NOT COMPLETED|Overall Study||1
11023809|NCT00814502|12202037|FG000|STARTED|Overall Study||8
11023810|NCT00814502|12202038|FG001|STARTED|Overall Study||9
11023811|NCT00814502|12202037|FG000|COMPLETED|Overall Study||7
11023812|NCT00814502|12202038|FG001|COMPLETED|Overall Study||7
11023813|NCT00814502|12202037|FG000|NOT COMPLETED|Overall Study||1
11023814|NCT00814502|12202038|FG001|NOT COMPLETED|Overall Study||2
11023815|NCT00814580|12202048|FG000|STARTED|Overall Study||194
11023816|NCT00814580|12202049|FG001|STARTED|Overall Study||188
11023817|NCT00814580|12202048|FG000|COMPLETED|Overall Study||163
11023818|NCT00814580|12202049|FG001|COMPLETED|Overall Study||141
11023819|NCT00814580|12202048|FG000|NOT COMPLETED|Overall Study||31
11144504|NCT01479517|12331319|FG000|STARTED|Overall Study||10
11023820|NCT00814580|12202049|FG001|NOT COMPLETED|Overall Study||47
11023821|NCT00814632|12202067|FG000|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
11023822|NCT00814632|12202067|FG000|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
11144505|NCT01479517|12331320|FG001|STARTED|Overall Study||10
11144506|NCT01479517|12331321|FG002|STARTED|Overall Study||10
11023823|NCT00814632|12202067|FG000|NOT COMPLETED|Overall Study||2
11023824|NCT00814658|12202073|FG000|STARTED|Overall Study||9
11023825|NCT00814658|12202074|FG001|STARTED|Overall Study||12
11023826|NCT00814658|12202073|FG000|COMPLETED|Overall Study||5
11023827|NCT00814658|12202074|FG001|COMPLETED|Overall Study||8
11023828|NCT00814658|12202073|FG000|NOT COMPLETED|Overall Study||4
11023829|NCT00814658|12202074|FG001|NOT COMPLETED|Overall Study||4
11057009|NCT00996892|12238677|FG006|COMPLETED|Dose-Escalation Stage 1||0
11057010|NCT00996892|12238678|FG007|COMPLETED|Dose-Escalation Stage 1||0
11057011|NCT00996892|12238679|FG008|COMPLETED|Dose-Escalation Stage 1||0
11057012|NCT00996892|12238680|FG009|COMPLETED|Dose-Escalation Stage 1||0
11057013|NCT00996892|12238681|FG010|COMPLETED|Dose-Escalation Stage 1||0
11417792|NCT00623974|12615901|FG000|NOT COMPLETED|Overall Study||0
11417793|NCT00623974|12615902|FG001|NOT COMPLETED|Overall Study||0
11417794|NCT00623974|12615903|FG002|NOT COMPLETED|Overall Study||0
11057014|NCT00996892|12238682|FG011|COMPLETED|Dose-Escalation Stage 1||0
11057015|NCT00996892|12238683|FG012|COMPLETED|Dose-Escalation Stage 1||0
11057016|NCT00996892|12238684|FG013|COMPLETED|Dose-Escalation Stage 1||0
11057017|NCT00996892|12238685|FG014|COMPLETED|Dose-Escalation Stage 1||0
11057018|NCT00996892|12238686|FG015|COMPLETED|Dose-Escalation Stage 1||0
11057019|NCT00996892|12238687|FG016|COMPLETED|Dose-Escalation Stage 1||0
11057020|NCT00996892|12238688|FG017|COMPLETED|Dose-Escalation Stage 1||0
11057021|NCT00996892|12238689|FG018|COMPLETED|Dose-Escalation Stage 1||0
11057022|NCT00996892|12238690|FG019|COMPLETED|Dose-Escalation Stage 1||0
11057023|NCT00996892|12238671|FG000|NOT COMPLETED|Dose-Escalation Stage 1||4
11057024|NCT00996892|12238672|FG001|NOT COMPLETED|Dose-Escalation Stage 1||3
11057025|NCT00996892|12238673|FG002|NOT COMPLETED|Dose-Escalation Stage 1||3
11057026|NCT00996892|12238674|FG003|NOT COMPLETED|Dose-Escalation Stage 1||9
11057027|NCT00996892|12238675|FG004|NOT COMPLETED|Dose-Escalation Stage 1||11
11057028|NCT00996892|12238676|FG005|NOT COMPLETED|Dose-Escalation Stage 1||10
11057029|NCT00996892|12238677|FG006|NOT COMPLETED|Dose-Escalation Stage 1||4
11057030|NCT00996892|12238678|FG007|NOT COMPLETED|Dose-Escalation Stage 1||0
11057031|NCT00996892|12238679|FG008|NOT COMPLETED|Dose-Escalation Stage 1||0
11057032|NCT00996892|12238680|FG009|NOT COMPLETED|Dose-Escalation Stage 1||0
11057033|NCT00996892|12238681|FG010|NOT COMPLETED|Dose-Escalation Stage 1||0
11057034|NCT00996892|12238682|FG011|NOT COMPLETED|Dose-Escalation Stage 1||0
11057035|NCT00996892|12238683|FG012|NOT COMPLETED|Dose-Escalation Stage 1||0
11057036|NCT00996892|12238684|FG013|NOT COMPLETED|Dose-Escalation Stage 1||0
11057037|NCT00996892|12238685|FG014|NOT COMPLETED|Dose-Escalation Stage 1||0
11057038|NCT00996892|12238686|FG015|NOT COMPLETED|Dose-Escalation Stage 1||0
11057039|NCT00996892|12238687|FG016|NOT COMPLETED|Dose-Escalation Stage 1||0
11057040|NCT00996892|12238688|FG017|NOT COMPLETED|Dose-Escalation Stage 1||0
11057041|NCT00996892|12238689|FG018|NOT COMPLETED|Dose-Escalation Stage 1||0
11057042|NCT00996892|12238690|FG019|NOT COMPLETED|Dose-Escalation Stage 1||0
11057043|NCT00996892|12238671|FG000|STARTED|Dose-Escalation Stage 1A||0
11057044|NCT00996892|12238672|FG001|STARTED|Dose-Escalation Stage 1A||0
11057045|NCT00996892|12238673|FG002|STARTED|Dose-Escalation Stage 1A||0
11057046|NCT00996892|12238674|FG003|STARTED|Dose-Escalation Stage 1A||0
11057047|NCT00996892|12238675|FG004|STARTED|Dose-Escalation Stage 1A||0
11057048|NCT00996892|12238676|FG005|STARTED|Dose-Escalation Stage 1A||0
11057049|NCT00996892|12238677|FG006|STARTED|Dose-Escalation Stage 1A||0
11057050|NCT00996892|12238678|FG007|STARTED|Dose-Escalation Stage 1A||3
11057051|NCT00996892|12238679|FG008|STARTED|Dose-Escalation Stage 1A||3
11057052|NCT00996892|12238680|FG009|STARTED|Dose-Escalation Stage 1A||4
11057053|NCT00996892|12238681|FG010|STARTED|Dose-Escalation Stage 1A||7
11057054|NCT00996892|12238682|FG011|STARTED|Dose-Escalation Stage 1A||9
11057055|NCT00996892|12238683|FG012|STARTED|Dose-Escalation Stage 1A||8
11057056|NCT00996892|12238684|FG013|STARTED|Dose-Escalation Stage 1A||5
11057057|NCT00996892|12238685|FG014|STARTED|Dose-Escalation Stage 1A||0
11057058|NCT00996892|12238686|FG015|STARTED|Dose-Escalation Stage 1A||0
11057059|NCT00996892|12238687|FG016|STARTED|Dose-Escalation Stage 1A||0
11057060|NCT00996892|12238688|FG017|STARTED|Dose-Escalation Stage 1A||0
11057061|NCT00996892|12238689|FG018|STARTED|Dose-Escalation Stage 1A||0
11057062|NCT00996892|12238690|FG019|STARTED|Dose-Escalation Stage 1A||0
11057063|NCT00996892|12238671|FG000|COMPLETED|Dose-Escalation Stage 1A||0
11057064|NCT00996892|12238672|FG001|COMPLETED|Dose-Escalation Stage 1A||0
11057065|NCT00996892|12238673|FG002|COMPLETED|Dose-Escalation Stage 1A||0
11057066|NCT00996892|12238674|FG003|COMPLETED|Dose-Escalation Stage 1A||0
11057067|NCT00996892|12238675|FG004|COMPLETED|Dose-Escalation Stage 1A||0
11057068|NCT00996892|12238676|FG005|COMPLETED|Dose-Escalation Stage 1A||0
11057069|NCT00996892|12238677|FG006|COMPLETED|Dose-Escalation Stage 1A||0
11417795|NCT00623974|12615904|FG003|NOT COMPLETED|Overall Study||0
11417796|NCT00624650|12615916|FG000|STARTED|Overall Study||17
11417797|NCT00624650|12615917|FG001|STARTED|Overall Study||16
11057070|NCT00996892|12238678|FG007|COMPLETED|Dose-Escalation Stage 1A||0
11057071|NCT00996892|12238679|FG008|COMPLETED|Dose-Escalation Stage 1A||0
11057072|NCT00996892|12238680|FG009|COMPLETED|Dose-Escalation Stage 1A||0
11057073|NCT00996892|12238681|FG010|COMPLETED|Dose-Escalation Stage 1A||0
11057074|NCT00996892|12238682|FG011|COMPLETED|Dose-Escalation Stage 1A||0
11057075|NCT00996892|12238683|FG012|COMPLETED|Dose-Escalation Stage 1A||0
11057076|NCT00996892|12238684|FG013|COMPLETED|Dose-Escalation Stage 1A||0
11057077|NCT00996892|12238685|FG014|COMPLETED|Dose-Escalation Stage 1A||0
11417798|NCT00624650|12615916|FG000|COMPLETED|Overall Study||16
11417799|NCT00624650|12615917|FG001|COMPLETED|Overall Study||15
11417800|NCT00624650|12615916|FG000|NOT COMPLETED|Overall Study||1
11057078|NCT00996892|12238686|FG015|COMPLETED|Dose-Escalation Stage 1A||0
11023830|NCT00814671|12202093|FG000|STARTED|Overall Study||54
11023831|NCT00814671|12202094|FG001|STARTED|Overall Study||48
11023832|NCT00814671|12202095|FG002|STARTED|Overall Study||51
11023833|NCT00814671|12202093|FG000|COMPLETED|Overall Study||47
11023834|NCT00814671|12202094|FG001|COMPLETED|Overall Study||44
11023835|NCT00814671|12202095|FG002|COMPLETED|Overall Study||49
11023836|NCT00814671|12202093|FG000|NOT COMPLETED|Overall Study||7
11023837|NCT00814671|12202094|FG001|NOT COMPLETED|Overall Study||4
11023838|NCT00814671|12202095|FG002|NOT COMPLETED|Overall Study||2
11023839|NCT00814697|12202107|FG000|STARTED|Overall Study||12
11023840|NCT00814697|12202107|FG000|COMPLETED|Overall Study||12
11023841|NCT00814697|12202107|FG000|NOT COMPLETED|Overall Study||0
11023842|NCT00814710|12202113|FG000|STARTED|Overall Study||240
11023843|NCT00814710|12202114|FG001|STARTED|Overall Study||120
11023844|NCT00814710|12202113|FG000|COMPLETED|Overall Study||232
11023845|NCT00814710|12202114|FG001|COMPLETED|Overall Study||117
11023846|NCT00814710|12202113|FG000|NOT COMPLETED|Overall Study||8
11023847|NCT00814710|12202114|FG001|NOT COMPLETED|Overall Study||3
11023848|NCT00814775|12202122|FG000|STARTED|Overall Study||23
11023849|NCT00814775|12202123|FG001|STARTED|Overall Study||20
11023850|NCT00814775|12202122|FG000|COMPLETED|Overall Study||23
11023851|NCT00814775|12202123|FG001|COMPLETED|Overall Study||20
11023852|NCT00814775|12202122|FG000|NOT COMPLETED|Overall Study||0
11023853|NCT00814775|12202123|FG001|NOT COMPLETED|Overall Study||0
11023854|NCT00814788|12202129|FG000|STARTED|Overall Study||24
11023855|NCT00814788|12202129|FG000|COMPLETED|Overall Study||24
11023856|NCT00814788|12202129|FG000|NOT COMPLETED|Overall Study||0
11023857|NCT00814801|12202138|FG000|STARTED|Overall Study||194
11023858|NCT00814801|12202139|FG001|STARTED|Overall Study||192
11023859|NCT00814801|12202140|FG002|STARTED|Overall Study||194
11023860|NCT00814801|12202138|FG000|COMPLETED|Overall Study||160
11023861|NCT00814801|12202139|FG001|COMPLETED|Overall Study||154
11023862|NCT00814801|12202140|FG002|COMPLETED|Overall Study||151
11023863|NCT00814801|12202138|FG000|NOT COMPLETED|Overall Study||34
11023864|NCT00814801|12202139|FG001|NOT COMPLETED|Overall Study||38
11023865|NCT00814801|12202140|FG002|NOT COMPLETED|Overall Study||43
11023866|NCT00814879|12202150|FG000|STARTED|By Week 24||28
11023867|NCT00814879|12202151|FG001|STARTED|By Week 24||30
11023868|NCT00814879|12202150|FG000|COMPLETED|By Week 24||27
11023869|NCT00814879|12202151|FG001|COMPLETED|By Week 24||29
11023870|NCT00814879|12202150|FG000|NOT COMPLETED|By Week 24||1
11023871|NCT00814879|12202151|FG001|NOT COMPLETED|By Week 24||1
11023872|NCT00814879|12202150|FG000|STARTED|By Week 48||27
11023873|NCT00814879|12202151|FG001|STARTED|By Week 48||29
11023874|NCT00814879|12202150|FG000|COMPLETED|By Week 48||25
11023875|NCT00814879|12202151|FG001|COMPLETED|By Week 48||26
11023876|NCT00814879|12202150|FG000|NOT COMPLETED|By Week 48||2
11023877|NCT00814879|12202151|FG001|NOT COMPLETED|By Week 48||3
11023878|NCT00814970|12202158|FG000|STARTED|Overall Study||196
11023879|NCT00814970|12202158|FG000|COMPLETED|Overall Study||146
11023880|NCT00814970|12202158|FG000|NOT COMPLETED|Overall Study||50
11023881|NCT00815035|12202166|FG000|STARTED|Blinded Phase||10
11023882|NCT00815035|12202167|FG001|STARTED|Blinded Phase||6
11023883|NCT00815035|12202168|FG002|STARTED|Blinded Phase||0
11023884|NCT00815035|12202166|FG000|COMPLETED|Blinded Phase||9
11023885|NCT00815035|12202167|FG001|COMPLETED|Blinded Phase||6
11023886|NCT00815035|12202168|FG002|COMPLETED|Blinded Phase||0
11417801|NCT00624650|12615917|FG001|NOT COMPLETED|Overall Study||1
11023887|NCT00815035|12202166|FG000|NOT COMPLETED|Blinded Phase||1
11023888|NCT00815035|12202167|FG001|NOT COMPLETED|Blinded Phase||0
11023889|NCT00815035|12202168|FG002|NOT COMPLETED|Blinded Phase||0
11023890|NCT00815035|12202166|FG000|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
11023891|NCT00815035|12202167|FG001|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
11023892|NCT00815035|12202168|FG002|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
11023893|NCT00815035|12202166|FG000|COMPLETED|Open Label Extension Phase||0
11023894|NCT00815035|12202167|FG001|COMPLETED|Open Label Extension Phase||0
11023895|NCT00815035|12202168|FG002|COMPLETED|Open Label Extension Phase||9
11023896|NCT00815035|12202166|FG000|NOT COMPLETED|Open Label Extension Phase||0
11023897|NCT00815035|12202167|FG001|NOT COMPLETED|Open Label Extension Phase||0
11023898|NCT00815035|12202168|FG002|NOT COMPLETED|Open Label Extension Phase||6
11023899|NCT00815087|12202179|FG000|STARTED|Overall Study||10
11023900|NCT00815087|12202180|FG001|STARTED|Overall Study||10
11023901|NCT00815087|12202179|FG000|COMPLETED|Overall Study||10
11023902|NCT00815087|12202180|FG001|COMPLETED|Overall Study||10
11023903|NCT00815087|12202179|FG000|NOT COMPLETED|Overall Study||0
11023904|NCT00815087|12202180|FG001|NOT COMPLETED|Overall Study||0
11023905|NCT00815191|12202188|FG000|STARTED|Overall Study||38
11023906|NCT00815191|12202189|FG001|STARTED|Overall Study||35
11023907|NCT00815191|12202188|FG000|COMPLETED|Overall Study||37
11023908|NCT00815191|12202189|FG001|COMPLETED|Overall Study||34
11144507|NCT01479517|12331319|FG000|COMPLETED|Overall Study||10
11144508|NCT01479517|12331320|FG001|COMPLETED|Overall Study||10
11144509|NCT01479517|12331321|FG002|COMPLETED|Overall Study||10
11144510|NCT01479517|12331319|FG000|NOT COMPLETED|Overall Study||0
11417802|NCT00626561|12615923|FG000|STARTED|Overall Study||4
11417803|NCT00626561|12615923|FG000|COMPLETED|Overall Study||0
11144511|NCT01479517|12331320|FG001|NOT COMPLETED|Overall Study||0
11144512|NCT01479517|12331321|FG002|NOT COMPLETED|Overall Study||0
11144513|NCT01479530|12331331|FG000|STARTED|Overall Study||158
11144514|NCT01479530|12331332|FG001|STARTED|Overall Study||163
11144515|NCT01479530|12331331|FG000|COMPLETED|Overall Study||148
11144516|NCT01479530|12331332|FG001|COMPLETED|Overall Study||151
11144517|NCT01479530|12331331|FG000|NOT COMPLETED|Overall Study||10
11144518|NCT01479530|12331332|FG001|NOT COMPLETED|Overall Study||12
11144519|NCT01479543|12331343|FG000|STARTED|Overall Study||21
11144520|NCT01479543|12331344|FG001|STARTED|Overall Study||20
11144521|NCT01479543|12331345|FG002|STARTED|Overall Study||21
11144522|NCT01479543|12331346|FG003|STARTED|Overall Study||20
11144523|NCT01479543|12331347|FG004|STARTED|Overall Study||21
11144524|NCT01479543|12331343|FG000|COMPLETED|Overall Study||20
11144525|NCT01479543|12331344|FG001|COMPLETED|Overall Study||20
11144526|NCT01479543|12331345|FG002|COMPLETED|Overall Study||20
11144527|NCT01479543|12331346|FG003|COMPLETED|Overall Study||20
11144528|NCT01479543|12331347|FG004|COMPLETED|Overall Study||20
11144529|NCT01479543|12331343|FG000|NOT COMPLETED|Overall Study||1
11144530|NCT01479543|12331344|FG001|NOT COMPLETED|Overall Study||0
11144531|NCT01479543|12331345|FG002|NOT COMPLETED|Overall Study||1
11144532|NCT01479543|12331346|FG003|NOT COMPLETED|Overall Study||0
11144533|NCT01479543|12331347|FG004|NOT COMPLETED|Overall Study||1
11144534|NCT01479595|12331361|FG000|STARTED|Overall Study||44
11144535|NCT01479595|12331362|FG001|STARTED|Overall Study||21
11144536|NCT01479595|12331361|FG000|PK Analysis Set|Overall Study||42
11144537|NCT01479595|12331362|FG001|PK Analysis Set|Overall Study||0
11144538|NCT01479595|12331361|FG000|Per Protocol Analysis Set|Overall Study||41
11144539|NCT01479595|12331362|FG001|Per Protocol Analysis Set|Overall Study||20
11144540|NCT01479595|12331361|FG000|COMPLETED|Overall Study||42
11144541|NCT01479595|12331362|FG001|COMPLETED|Overall Study||19
11144542|NCT01479595|12331361|FG000|NOT COMPLETED|Overall Study||2
11144543|NCT01479595|12331362|FG001|NOT COMPLETED|Overall Study||2
11144544|NCT01479621|12331374|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||909
11144545|NCT01479621|12331375|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0
11144546|NCT01479621|12331376|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0
11144547|NCT01479621|12331377|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0
11144548|NCT01479621|12331378|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0
11144549|NCT01479621|12331379|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0
11144550|NCT01479621|12331380|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0
11144551|NCT01479621|12331374|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
11144552|NCT01479621|12331375|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11144553|NCT01479621|12331376|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11144554|NCT01479621|12331377|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11144555|NCT01479621|12331378|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11144556|NCT01479621|12331379|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11144557|NCT01479621|12331380|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11144558|NCT01479621|12331374|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
11144559|NCT01479621|12331375|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11144560|NCT01479621|12331376|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11144561|NCT01479621|12331377|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11144562|NCT01479621|12331378|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11144563|NCT01479621|12331379|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11144564|NCT01479621|12331380|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11144565|NCT01479621|12331374|FG000|STARTED|Treatment Period||0
11144566|NCT01479621|12331375|FG001|STARTED|Treatment Period||103
11144567|NCT01479621|12331376|FG002|STARTED|Treatment Period||104
11144568|NCT01479621|12331377|FG003|STARTED|Treatment Period||104
11144569|NCT01479621|12331378|FG004|STARTED|Treatment Period||103
11144570|NCT01479621|12331379|FG005|STARTED|Treatment Period||104
11144571|NCT01479621|12331380|FG006|STARTED|Treatment Period||104
11144572|NCT01479621|12331374|FG000|Safety Population|Treatment Period||0
11144573|NCT01479621|12331375|FG001|Safety Population|Treatment Period||103
11144574|NCT01479621|12331376|FG002|Safety Population|Treatment Period||104
11144575|NCT01479621|12331377|FG003|Safety Population|Treatment Period||104
11417804|NCT00626561|12615923|FG000|NOT COMPLETED|Overall Study||4
11144576|NCT01479621|12331378|FG004|Safety Population|Treatment Period||103
11144577|NCT01479621|12331379|FG005|Safety Population|Treatment Period||104
11144578|NCT01479621|12331380|FG006|Safety Population|Treatment Period||104
11144579|NCT01479621|12331374|FG000|Full Analysis Set|Treatment Period||0
11144580|NCT01479621|12331375|FG001|Full Analysis Set|Treatment Period||102
11144581|NCT01479621|12331376|FG002|Full Analysis Set|Treatment Period||101
11144582|NCT01479621|12331377|FG003|Full Analysis Set|Treatment Period||102
11144583|NCT01479621|12331378|FG004|Full Analysis Set|Treatment Period||102
11144584|NCT01479621|12331379|FG005|Full Analysis Set|Treatment Period||102
11144585|NCT01479621|12331380|FG006|Full Analysis Set|Treatment Period||102
11417805|NCT00613730|12615927|FG000|STARTED|Overall Study||3
11417806|NCT00613730|12615927|FG000|COMPLETED|Overall Study||0
11023909|NCT00815191|12202188|FG000|NOT COMPLETED|Overall Study||1
11023910|NCT00815191|12202189|FG001|NOT COMPLETED|Overall Study||1
11023911|NCT00815295|12202198|FG000|STARTED|Overall Study||8
11417807|NCT00613730|12615927|FG000|NOT COMPLETED|Overall Study||3
11417808|NCT00625586|12615931|FG000|STARTED|Overall Study||2
11023912|NCT00815295|12202199|FG001|STARTED|Overall Study||8
11023913|NCT00815295|12202200|FG002|STARTED|Overall Study||12
11023914|NCT00815295|12202198|FG000|COMPLETED|Overall Study||8
11023915|NCT00815295|12202199|FG001|COMPLETED|Overall Study||7
11023916|NCT00815295|12202200|FG002|COMPLETED|Overall Study||9
11023917|NCT00815295|12202198|FG000|NOT COMPLETED|Overall Study||0
11023918|NCT00815295|12202199|FG001|NOT COMPLETED|Overall Study||1
11023919|NCT00815295|12202200|FG002|NOT COMPLETED|Overall Study||3
11023920|NCT00815308|12202208|FG000|STARTED|Overall Study||55
11023921|NCT00815308|12202208|FG000|COMPLETED|Overall Study||45
11023922|NCT00815308|12202208|FG000|NOT COMPLETED|Overall Study||10
11023923|NCT00815347|12202212|FG000|STARTED|Overall Study||11
11023924|NCT00815347|12202212|FG000|COMPLETED|Overall Study||7
11023925|NCT00815347|12202212|FG000|NOT COMPLETED|Overall Study||4
11023926|NCT00815360|12202220|FG000|STARTED|Overall Study||11
11023927|NCT00815360|12202221|FG001|STARTED|Overall Study||11
11023928|NCT00815360|12202220|FG000|COMPLETED|Overall Study||11
11023929|NCT00815360|12202221|FG001|COMPLETED|Overall Study||11
11023930|NCT00815360|12202220|FG000|NOT COMPLETED|Overall Study||0
11023931|NCT00815360|12202221|FG001|NOT COMPLETED|Overall Study||0
11023932|NCT00815490|12202229|FG000|STARTED|Overall Study||9
11023933|NCT00815490|12202230|FG001|STARTED|Overall Study||9
11023934|NCT00815490|12202229|FG000|COMPLETED|Overall Study||9
11023935|NCT00815490|12202230|FG001|COMPLETED|Overall Study||9
11023936|NCT00815490|12202229|FG000|NOT COMPLETED|Overall Study||0
11023937|NCT00815490|12202230|FG001|NOT COMPLETED|Overall Study||0
11023938|NCT00815516|12202238|FG000|STARTED|Overall Study||20
11023939|NCT00815516|12202239|FG001|STARTED|Overall Study||10
11023940|NCT00815516|12202238|FG000|COMPLETED|Overall Study||16
11023941|NCT00815516|12202239|FG001|COMPLETED|Overall Study||9
11023942|NCT00815516|12202238|FG000|NOT COMPLETED|Overall Study||4
11023943|NCT00815516|12202239|FG001|NOT COMPLETED|Overall Study||1
11023944|NCT00815659|12202245|FG000|STARTED|Overall Study||97
11023945|NCT00815659|12202245|FG000|COMPLETED|Overall Study||74
11023946|NCT00815659|12202245|FG000|NOT COMPLETED|Overall Study||23
11023947|NCT00815685|12202249|FG000|STARTED|Overall Study||36
11023948|NCT00815685|12202249|FG000|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
11023949|NCT00815685|12202249|FG000|NOT COMPLETED|Overall Study||22
11023950|NCT00815698|12202255|FG000|STARTED|Overall Study||163
11023951|NCT00815698|12202256|FG001|STARTED|Overall Study||171
11023952|NCT00815698|12202255|FG000|COMPLETED|Overall Study||163
11023953|NCT00815698|12202256|FG001|COMPLETED|Overall Study||171
11023954|NCT00815698|12202255|FG000|NOT COMPLETED|Overall Study||0
11023955|NCT00815698|12202256|FG001|NOT COMPLETED|Overall Study||0
11023956|NCT00815776|12202265|FG000|STARTED|Overall Study||60
11023957|NCT00815776|12202266|FG001|STARTED|Overall Study||64
11023958|NCT00815776|12202267|FG002|STARTED|Overall Study||28
11023959|NCT00815776|12202265|FG000|COMPLETED|Overall Study||52
11023960|NCT00815776|12202266|FG001|COMPLETED|Overall Study||56
11023961|NCT00815776|12202267|FG002|COMPLETED|Overall Study||22
11023962|NCT00815776|12202265|FG000|NOT COMPLETED|Overall Study||8
11023963|NCT00815776|12202266|FG001|NOT COMPLETED|Overall Study||8
11023964|NCT00815776|12202267|FG002|NOT COMPLETED|Overall Study||6
11023965|NCT00815919|12202278|FG000|STARTED|Overall Study||22
11023966|NCT00815919|12202278|FG000|COMPLETED|Overall Study||18
11023967|NCT00815919|12202278|FG000|NOT COMPLETED|Overall Study||4
11023968|NCT00815997|12202284|FG000|STARTED|Overall Study||80
11023969|NCT00815997|12202285|FG001|STARTED|Overall Study||80
11023970|NCT00815997|12202284|FG000|COMPLETED|Overall Study||80
11023971|NCT00815997|12202285|FG001|COMPLETED|Overall Study||80
11023972|NCT00815997|12202284|FG000|NOT COMPLETED|Overall Study||0
11023973|NCT00815997|12202285|FG001|NOT COMPLETED|Overall Study||0
11023974|NCT00816023|12202297|FG000|STARTED|Overall Study||71
11023975|NCT00816023|12202298|FG001|STARTED|Overall Study||62
11023976|NCT00816023|12202299|FG002|STARTED|Overall Study||69
11023977|NCT00816023|12202300|FG003|STARTED|Overall Study||74
11023978|NCT00816023|12202297|FG000|Completed Therapy|Overall Study||65
11023979|NCT00816023|12202298|FG001|Completed Therapy|Overall Study||59
11023980|NCT00816023|12202299|FG002|Completed Therapy|Overall Study||61
11023981|NCT00816023|12202300|FG003|Completed Therapy|Overall Study||63
11023982|NCT00816023|12202297|FG000|COMPLETED|Overall Study||62
11023983|NCT00816023|12202298|FG001|COMPLETED|Overall Study||56
11023984|NCT00816023|12202299|FG002|COMPLETED|Overall Study||60
11023985|NCT00816023|12202300|FG003|COMPLETED|Overall Study||62
11023986|NCT00816023|12202297|FG000|NOT COMPLETED|Overall Study||9
11023987|NCT00816023|12202298|FG001|NOT COMPLETED|Overall Study||6
11023988|NCT00816023|12202299|FG002|NOT COMPLETED|Overall Study||9
11023989|NCT00816023|12202300|FG003|NOT COMPLETED|Overall Study||12
11023990|NCT00816036|12202312|FG000|STARTED|Overall Study||503
11023991|NCT00816036|12202313|FG001|STARTED|Overall Study||395
11023992|NCT00816036|12202312|FG000|COMPLETED|Overall Study||327
11023993|NCT00816036|12202313|FG001|COMPLETED|Overall Study||287
11023994|NCT00816036|12202312|FG000|NOT COMPLETED|Overall Study||176
11023995|NCT00816036|12202313|FG001|NOT COMPLETED|Overall Study||108
11023996|NCT00816062|12202319|FG000|STARTED|Overall Study||260
11417809|NCT00625586|12615931|FG000|COMPLETED|Overall Study||1
11023997|NCT00816062|12202319|FG000|COMPLETED|Overall Study||133
11023998|NCT00816062|12202319|FG000|NOT COMPLETED|Overall Study||127
11023999|NCT00816101|12202327|FG000|STARTED|Overall Study||13
11024000|NCT00816101|12202328|FG001|STARTED|Overall Study||8
11024001|NCT00816101|12202329|FG002|STARTED|Overall Study||5
11024002|NCT00816101|12202327|FG000|COMPLETED|Overall Study||13
11024003|NCT00816101|12202328|FG001|COMPLETED|Overall Study||8
11024004|NCT00816101|12202329|FG002|COMPLETED|Overall Study||5
11024005|NCT00816101|12202327|FG000|NOT COMPLETED|Overall Study||0
11024006|NCT00816101|12202328|FG001|NOT COMPLETED|Overall Study||0
11024007|NCT00816101|12202329|FG002|NOT COMPLETED|Overall Study||0
11024008|NCT00816166|12202339|FG000|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
11024009|NCT00816166|12202340|FG001|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
11024010|NCT00816166|12202339|FG000|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
11024011|NCT00816166|12202340|FG001|ITT Population (Met Eligibility)|Overall Study||53
11024012|NCT00816166|12202339|FG000|COMPLETED|Overall Study||49
11024013|NCT00816166|12202340|FG001|COMPLETED|Overall Study||41
11024014|NCT00816166|12202339|FG000|NOT COMPLETED|Overall Study||10
11024015|NCT00816166|12202340|FG001|NOT COMPLETED|Overall Study||12
11024016|NCT00816348|12202346|FG000|STARTED|Overall Study||15
11024017|NCT00816348|12202346|FG000|COMPLETED|Overall Study||15
11024018|NCT00816348|12202346|FG000|NOT COMPLETED|Overall Study||0
11024019|NCT00816361|12202357|FG000|STARTED|Overall Study||4
11024020|NCT00816361|12202358|FG001|STARTED|Overall Study||3
11024021|NCT00816361|12202359|FG002|STARTED|Overall Study||4
11024022|NCT00816361|12202360|FG003|STARTED|Overall Study||3
11024023|NCT00816361|12202361|FG004|STARTED|Overall Study||3
11024024|NCT00816361|12202362|FG005|STARTED|Overall Study||3
11024025|NCT00816361|12202363|FG006|STARTED|Overall Study||3
11024026|NCT00816361|12202364|FG007|STARTED|Overall Study||10
11024027|NCT00816361|12202365|FG008|STARTED|Overall Study||10
11024028|NCT00816361|12202357|FG000|COMPLETED|Overall Study||0
11024029|NCT00816361|12202358|FG001|COMPLETED|Overall Study||0
11024030|NCT00816361|12202359|FG002|COMPLETED|Overall Study||1
11024031|NCT00816361|12202360|FG003|COMPLETED|Overall Study||0
11024032|NCT00816361|12202361|FG004|COMPLETED|Overall Study||1
11024033|NCT00816361|12202362|FG005|COMPLETED|Overall Study||0
11024034|NCT00816361|12202363|FG006|COMPLETED|Overall Study||0
11024035|NCT00816361|12202364|FG007|COMPLETED|Overall Study||1
11024036|NCT00816361|12202365|FG008|COMPLETED|Overall Study||0
11024037|NCT00816361|12202357|FG000|NOT COMPLETED|Overall Study||4
11024038|NCT00816361|12202358|FG001|NOT COMPLETED|Overall Study||3
11024039|NCT00816361|12202359|FG002|NOT COMPLETED|Overall Study||3
11024040|NCT00816361|12202360|FG003|NOT COMPLETED|Overall Study||3
11024041|NCT00816361|12202361|FG004|NOT COMPLETED|Overall Study||2
11024042|NCT00816361|12202362|FG005|NOT COMPLETED|Overall Study||3
11024043|NCT00816361|12202363|FG006|NOT COMPLETED|Overall Study||3
11024044|NCT00816361|12202364|FG007|NOT COMPLETED|Overall Study||9
11024045|NCT00816361|12202365|FG008|NOT COMPLETED|Overall Study||10
11024046|NCT00816400|12202395|FG000|STARTED|Overall Study||3
11024047|NCT00816400|12202396|FG001|STARTED|Overall Study||3
11024048|NCT00816400|12202397|FG002|STARTED|Overall Study||5
11024049|NCT00816400|12202398|FG003|STARTED|Overall Study||3
11024050|NCT00816400|12202399|FG004|STARTED|Overall Study||3
11024051|NCT00816400|12202400|FG005|STARTED|Overall Study||3
11024052|NCT00816400|12202401|FG006|STARTED|Overall Study||3
11024053|NCT00816400|12202402|FG007|STARTED|Overall Study||6
11024054|NCT00816400|12202403|FG008|STARTED|Overall Study||6
11024055|NCT00816400|12202395|FG000|COMPLETED|Overall Study||1
11024056|NCT00816400|12202396|FG001|COMPLETED|Overall Study||0
11024057|NCT00816400|12202397|FG002|COMPLETED|Overall Study||0
11024058|NCT00816400|12202398|FG003|COMPLETED|Overall Study||0
11024059|NCT00816400|12202399|FG004|COMPLETED|Overall Study||1
11024060|NCT00816400|12202400|FG005|COMPLETED|Overall Study||0
11024061|NCT00816400|12202401|FG006|COMPLETED|Overall Study||1
11024062|NCT00816400|12202402|FG007|COMPLETED|Overall Study||1
11024063|NCT00816400|12202403|FG008|COMPLETED|Overall Study||0
11024064|NCT00816400|12202395|FG000|NOT COMPLETED|Overall Study||2
11024065|NCT00816400|12202396|FG001|NOT COMPLETED|Overall Study||3
11024066|NCT00816400|12202397|FG002|NOT COMPLETED|Overall Study||5
11024067|NCT00816400|12202398|FG003|NOT COMPLETED|Overall Study||3
11024068|NCT00816400|12202399|FG004|NOT COMPLETED|Overall Study||2
11024069|NCT00816400|12202400|FG005|NOT COMPLETED|Overall Study||3
11024070|NCT00816400|12202401|FG006|NOT COMPLETED|Overall Study||2
11024071|NCT00816400|12202402|FG007|NOT COMPLETED|Overall Study||5
11024072|NCT00816400|12202403|FG008|NOT COMPLETED|Overall Study||6
11024073|NCT00816556|12202427|FG000|STARTED|Overall Study||20
11024074|NCT00816556|12202428|FG001|STARTED|Overall Study||21
11024075|NCT00816556|12202429|FG002|STARTED|Overall Study||22
11024076|NCT00816556|12202427|FG000|COMPLETED|Overall Study||18
11024077|NCT00816556|12202428|FG001|COMPLETED|Overall Study||19
11024078|NCT00816556|12202429|FG002|COMPLETED|Overall Study||19
11024079|NCT00816556|12202427|FG000|NOT COMPLETED|Overall Study||2
11024080|NCT00816556|12202428|FG001|NOT COMPLETED|Overall Study||2
11024081|NCT00816556|12202429|FG002|NOT COMPLETED|Overall Study||3
11024082|NCT00816595|12202439|FG000|STARTED|Overall Study||35
11024083|NCT00816595|12202440|FG001|STARTED|Overall Study||33
11024084|NCT00816595|12202439|FG000|COMPLETED|Overall Study||33
11024085|NCT00816595|12202440|FG001|COMPLETED|Overall Study||33
11024086|NCT00816595|12202439|FG000|NOT COMPLETED|Overall Study||2
11024087|NCT00816595|12202440|FG001|NOT COMPLETED|Overall Study||0
11024088|NCT00816751|12202450|FG000|STARTED|Overall Study||45
11024089|NCT00816751|12202451|FG001|STARTED|Overall Study||44
11024090|NCT00816751|12202450|FG000|COMPLETED|Overall Study||45
11024091|NCT00816751|12202451|FG001|COMPLETED|Overall Study||44
11024092|NCT00816751|12202450|FG000|NOT COMPLETED|Overall Study||0
11024093|NCT00816751|12202451|FG001|NOT COMPLETED|Overall Study||0
11024094|NCT00816829|12202459|FG000|STARTED|Overall Study||16
11024095|NCT00816829|12202460|FG001|STARTED|Overall Study||18
11024096|NCT00816829|12202459|FG000|COMPLETED|Overall Study||16
11024097|NCT00816829|12202460|FG001|COMPLETED|Overall Study||18
11024098|NCT00816829|12202459|FG000|NOT COMPLETED|Overall Study||0
11024099|NCT00816829|12202460|FG001|NOT COMPLETED|Overall Study||0
11024100|NCT00816907|12202468|FG000|STARTED|Overall Study||71
11024101|NCT00816907|12202469|FG001|STARTED|Overall Study||75
11024102|NCT00816907|12202468|FG000|COMPLETED|Overall Study||58
11024103|NCT00816907|12202469|FG001|COMPLETED|Overall Study||58
11024104|NCT00816907|12202468|FG000|NOT COMPLETED|Overall Study||13
11024105|NCT00816907|12202469|FG001|NOT COMPLETED|Overall Study||17
11024106|NCT00817063|12202479|FG000|STARTED|Overall Study||298
11024107|NCT00817063|12202480|FG001|STARTED|Overall Study||298
11024108|NCT00817063|12202479|FG000|COMPLETED|Overall Study||161
11024109|NCT00817063|12202480|FG001|COMPLETED|Overall Study||128
11024110|NCT00817063|12202479|FG000|NOT COMPLETED|Overall Study||137
11024111|NCT00817063|12202480|FG001|NOT COMPLETED|Overall Study||170
11024112|NCT00817089|12202490|FG000|STARTED|First Alcohol Challenge||6
11024113|NCT00817089|12202491|FG001|STARTED|First Alcohol Challenge||8
11024114|NCT00817089|12202492|FG002|STARTED|First Alcohol Challenge||4
11024115|NCT00817089|12202493|FG003|STARTED|First Alcohol Challenge||6
11024116|NCT00817089|12202490|FG000|COMPLETED|First Alcohol Challenge||6
11024117|NCT00817089|12202491|FG001|COMPLETED|First Alcohol Challenge||8
11024118|NCT00817089|12202492|FG002|COMPLETED|First Alcohol Challenge||4
11024119|NCT00817089|12202493|FG003|COMPLETED|First Alcohol Challenge||5
11024120|NCT00817089|12202490|FG000|NOT COMPLETED|First Alcohol Challenge||0
11024121|NCT00817089|12202491|FG001|NOT COMPLETED|First Alcohol Challenge||0
11024122|NCT00817089|12202492|FG002|NOT COMPLETED|First Alcohol Challenge||0
11024123|NCT00817089|12202493|FG003|NOT COMPLETED|First Alcohol Challenge||1
11417810|NCT00625586|12615931|FG000|NOT COMPLETED|Overall Study||1
11417811|NCT00625703|12615935|FG000|STARTED|Overall Study||0
11417812|NCT00625703|12615935|FG000|COMPLETED|Overall Study||0
11417813|NCT00625703|12615935|FG000|NOT COMPLETED|Overall Study||0
11024124|NCT00817089|12202490|FG000|STARTED|Second Alcohol Challenge||6
11024125|NCT00817089|12202491|FG001|STARTED|Second Alcohol Challenge||8
11024126|NCT00817089|12202492|FG002|STARTED|Second Alcohol Challenge||4
11024127|NCT00817089|12202493|FG003|STARTED|Second Alcohol Challenge||5
11024128|NCT00817089|12202490|FG000|COMPLETED|Second Alcohol Challenge||6
11024129|NCT00817089|12202491|FG001|COMPLETED|Second Alcohol Challenge||7
11024130|NCT00817089|12202492|FG002|COMPLETED|Second Alcohol Challenge||4
11024131|NCT00817089|12202493|FG003|COMPLETED|Second Alcohol Challenge||5
11024132|NCT00817089|12202490|FG000|NOT COMPLETED|Second Alcohol Challenge||0
11024133|NCT00817089|12202491|FG001|NOT COMPLETED|Second Alcohol Challenge||1
11024134|NCT00817089|12202492|FG002|NOT COMPLETED|Second Alcohol Challenge||0
11024135|NCT00817089|12202493|FG003|NOT COMPLETED|Second Alcohol Challenge||0
11024136|NCT00817206|12202509|FG000|STARTED|Overall Study||163
11024137|NCT00817206|12202510|FG001|STARTED|Overall Study||163
11024138|NCT00817206|12202509|FG000|COMPLETED|Overall Study||142
11024139|NCT00817206|12202510|FG001|COMPLETED|Overall Study||154
11024140|NCT00817206|12202509|FG000|NOT COMPLETED|Overall Study||21
11024141|NCT00817206|12202510|FG001|NOT COMPLETED|Overall Study||9
11024142|NCT00817219|12202516|FG000|STARTED|Overall Study||33
11024143|NCT00817219|12202516|FG000|COMPLETED|Overall Study||33
11024144|NCT00817219|12202516|FG000|NOT COMPLETED|Overall Study||0
11024145|NCT00817336|12202522|FG000|STARTED|Overall Study||8
11024146|NCT00817336|12202523|FG001|STARTED|Overall Study||8
11024147|NCT00817336|12202522|FG000|COMPLETED|Overall Study||7
11024148|NCT00817336|12202523|FG001|COMPLETED|Overall Study||7
11024149|NCT00817336|12202522|FG000|NOT COMPLETED|Overall Study||1
11024150|NCT00817336|12202523|FG001|NOT COMPLETED|Overall Study||1
11024151|NCT00817414|12202533|FG000|STARTED|Overall Study||12
11024152|NCT00817414|12202534|FG001|STARTED|Overall Study||12
11024153|NCT00817414|12202535|FG002|STARTED|Overall Study||13
11024154|NCT00817414|12202536|FG003|STARTED|Overall Study||13
11024155|NCT00817414|12202537|FG004|STARTED|Overall Study||13
11024156|NCT00817414|12202533|FG000|COMPLETED|Overall Study||10
11024157|NCT00817414|12202534|FG001|COMPLETED|Overall Study||9
11024158|NCT00817414|12202535|FG002|COMPLETED|Overall Study||9
11024159|NCT00817414|12202536|FG003|COMPLETED|Overall Study||1
11024160|NCT00817414|12202537|FG004|COMPLETED|Overall Study||11
11024161|NCT00817414|12202533|FG000|NOT COMPLETED|Overall Study||2
11024162|NCT00817414|12202534|FG001|NOT COMPLETED|Overall Study||3
11417814|NCT00625742|12615939|FG000|STARTED|Overall Study||15
11024163|NCT00817414|12202535|FG002|NOT COMPLETED|Overall Study||4
11417815|NCT00625742|12615939|FG000|COMPLETED|Overall Study||3
11024164|NCT00817414|12202536|FG003|NOT COMPLETED|Overall Study||12
11024165|NCT00817414|12202537|FG004|NOT COMPLETED|Overall Study||2
11024166|NCT00817479|12202556|FG000|STARTED|Overall Study||6
11024167|NCT00817479|12202557|FG001|STARTED|Overall Study||14
11024168|NCT00817479|12202556|FG000|COMPLETED|Overall Study||5
11024169|NCT00817479|12202557|FG001|COMPLETED|Overall Study||13
11024170|NCT00817479|12202556|FG000|NOT COMPLETED|Overall Study||1
11024171|NCT00817479|12202557|FG001|NOT COMPLETED|Overall Study||1
11024172|NCT00817531|12202563|FG000|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
11024173|NCT00817531|12202563|FG000|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
11024174|NCT00817531|12202563|FG000|NOT COMPLETED|Overall Study||2
11024175|NCT00817596|12202567|FG000|STARTED|Overall Study||110
11024176|NCT00817596|12202567|FG000|COMPLETED|Overall Study||62
11024177|NCT00817596|12202567|FG000|NOT COMPLETED|Overall Study||48
11024178|NCT00817635|12202576|FG000|STARTED|Overall Study||32
11024179|NCT00817635|12202577|FG001|STARTED|Overall Study||26
11024180|NCT00817635|12202578|FG002|STARTED|Overall Study||31
11024181|NCT00817635|12202579|FG003|STARTED|Overall Study||33
11024182|NCT00817635|12202580|FG004|STARTED|Overall Study||33
11024183|NCT00817635|12202576|FG000|COMPLETED|Overall Study||23
11024184|NCT00817635|12202577|FG001|COMPLETED|Overall Study||22
11024185|NCT00817635|12202578|FG002|COMPLETED|Overall Study||28
11024186|NCT00817635|12202579|FG003|COMPLETED|Overall Study||28
11024187|NCT00817635|12202580|FG004|COMPLETED|Overall Study||25
11024188|NCT00817635|12202576|FG000|NOT COMPLETED|Overall Study||9
11024189|NCT00817635|12202577|FG001|NOT COMPLETED|Overall Study||4
11024190|NCT00817635|12202578|FG002|NOT COMPLETED|Overall Study||3
11024191|NCT00817635|12202579|FG003|NOT COMPLETED|Overall Study||5
11024192|NCT00817635|12202580|FG004|NOT COMPLETED|Overall Study||8
11024193|NCT00817778|12202601|FG000|STARTED|Overall Study||19
11024194|NCT00817778|12202602|FG001|STARTED|Overall Study||8
11024195|NCT00817778|12202601|FG000|COMPLETED|Overall Study||16
11024196|NCT00817778|12202602|FG001|COMPLETED|Overall Study||5
11024197|NCT00817778|12202601|FG000|NOT COMPLETED|Overall Study||3
11024198|NCT00817778|12202602|FG001|NOT COMPLETED|Overall Study||3
11024199|NCT00817804|12202610|FG000|STARTED|Overall Study||1
11024200|NCT00817804|12202611|FG001|STARTED|Overall Study||2
11024201|NCT00817804|12202610|FG000|COMPLETED|Overall Study||1
11024202|NCT00817804|12202611|FG001|COMPLETED|Overall Study||2
11024203|NCT00817804|12202610|FG000|NOT COMPLETED|Overall Study||0
11024204|NCT00817804|12202611|FG001|NOT COMPLETED|Overall Study||0
11024205|NCT00817843|12202617|FG000|STARTED|First Period (6 Weeks)||50
11024206|NCT00817843|12202618|FG001|STARTED|First Period (6 Weeks)||50
11024207|NCT00817843|12202617|FG000|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
11024208|NCT00817843|12202618|FG001|COMPLETED|First Period (6 Weeks)||46
11024209|NCT00817843|12202617|FG000|NOT COMPLETED|First Period (6 Weeks)||8
11024210|NCT00817843|12202618|FG001|NOT COMPLETED|First Period (6 Weeks)||4
11024211|NCT00817843|12202617|FG000|STARTED|Washout Period (6 Weeks)||42
11024212|NCT00817843|12202618|FG001|STARTED|Washout Period (6 Weeks)||46
11024213|NCT00817843|12202617|FG000|COMPLETED|Washout Period (6 Weeks)||41
11024214|NCT00817843|12202618|FG001|COMPLETED|Washout Period (6 Weeks)||45
11024215|NCT00817843|12202617|FG000|NOT COMPLETED|Washout Period (6 Weeks)||1
11024216|NCT00817843|12202618|FG001|NOT COMPLETED|Washout Period (6 Weeks)||1
11024217|NCT00817843|12202617|FG000|STARTED|Second Period (6 Weeks)||41
11024218|NCT00817843|12202618|FG001|STARTED|Second Period (6 Weeks)||45
11024219|NCT00817843|12202617|FG000|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
11024220|NCT00817843|12202618|FG001|COMPLETED|Second Period (6 Weeks)||44
11024221|NCT00817843|12202617|FG000|NOT COMPLETED|Second Period (6 Weeks)||0
11024222|NCT00817843|12202618|FG001|NOT COMPLETED|Second Period (6 Weeks)||1
11024223|NCT00817999|12202625|FG000|STARTED|Grapefruit Juice||15
11024224|NCT00817999|12202626|FG001|STARTED|Grapefruit Juice||17
11024225|NCT00817999|12202625|FG000|COMPLETED|Grapefruit Juice||15
11024226|NCT00817999|12202626|FG001|COMPLETED|Grapefruit Juice||17
11024227|NCT00817999|12202625|FG000|NOT COMPLETED|Grapefruit Juice||0
11024228|NCT00817999|12202626|FG001|NOT COMPLETED|Grapefruit Juice||0
11024229|NCT00817999|12202625|FG000|STARTED|No Grapefruit Juice||15
11024230|NCT00817999|12202626|FG001|STARTED|No Grapefruit Juice||17
11024231|NCT00817999|12202625|FG000|COMPLETED|No Grapefruit Juice||15
11024232|NCT00817999|12202626|FG001|COMPLETED|No Grapefruit Juice||17
11024233|NCT00817999|12202625|FG000|NOT COMPLETED|No Grapefruit Juice||0
11024234|NCT00817999|12202626|FG001|NOT COMPLETED|No Grapefruit Juice||0
11024235|NCT00818116|12202634|FG000|STARTED|Overall Study||34
11024236|NCT00818116|12202634|FG000|COMPLETED|Overall Study||34
11024237|NCT00818116|12202634|FG000|NOT COMPLETED|Overall Study||0
11024238|NCT00818168|12202638|FG000|STARTED|Overall Study||320
11024239|NCT00818168|12202638|FG000|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
11024240|NCT00818168|12202638|FG000|NOT COMPLETED|Overall Study||70
11024241|NCT00818207|12202644|FG000|STARTED|Overall Study||696
11024242|NCT00818207|12202645|FG001|STARTED|Overall Study||684
11024243|NCT00818207|12202644|FG000|COMPLETED|Overall Study||474
11024244|NCT00818207|12202645|FG001|COMPLETED|Overall Study||417
11024245|NCT00818207|12202644|FG000|NOT COMPLETED|Overall Study||222
11024246|NCT00818207|12202645|FG001|NOT COMPLETED|Overall Study||267
11024247|NCT00818246|12202651|FG000|STARTED|Overall Study||40
11024248|NCT00818246|12202651|FG000|COMPLETED|Overall Study|split-face study|35
11024249|NCT00818246|12202651|FG000|NOT COMPLETED|Overall Study||5
11024250|NCT00818259|12202662|FG000|STARTED|Randomization||12
11024251|NCT00818259|12202663|FG001|STARTED|Randomization||11
11024252|NCT00818259|12202664|FG002|STARTED|Randomization||19
11024253|NCT00818259|12202665|FG003|STARTED|Randomization||20
11024254|NCT00818259|12202666|FG004|STARTED|Randomization||19
11024255|NCT00818259|12202667|FG005|STARTED|Randomization||0
11024256|NCT00818259|12202668|FG006|STARTED|Randomization||5
11024257|NCT00818259|12202669|FG007|STARTED|Randomization||0
11024258|NCT00818259|12202670|FG008|STARTED|Randomization||6
11024259|NCT00818259|12202662|FG000|COMPLETED|Randomization||12
11024260|NCT00818259|12202663|FG001|COMPLETED|Randomization||11
11024261|NCT00818259|12202664|FG002|COMPLETED|Randomization||19
11024262|NCT00818259|12202665|FG003|COMPLETED|Randomization||20
11024263|NCT00818259|12202666|FG004|COMPLETED|Randomization||19
11024264|NCT00818259|12202667|FG005|COMPLETED|Randomization||0
11024265|NCT00818259|12202668|FG006|COMPLETED|Randomization||5
11024266|NCT00818259|12202669|FG007|COMPLETED|Randomization||0
11024267|NCT00818259|12202670|FG008|COMPLETED|Randomization||6
11024268|NCT00818259|12202662|FG000|NOT COMPLETED|Randomization||0
11024269|NCT00818259|12202663|FG001|NOT COMPLETED|Randomization||0
11024270|NCT00818259|12202664|FG002|NOT COMPLETED|Randomization||0
11024271|NCT00818259|12202665|FG003|NOT COMPLETED|Randomization||0
11024272|NCT00818259|12202666|FG004|NOT COMPLETED|Randomization||0
11024273|NCT00818259|12202667|FG005|NOT COMPLETED|Randomization||0
11024274|NCT00818259|12202668|FG006|NOT COMPLETED|Randomization||0
11024275|NCT00818259|12202669|FG007|NOT COMPLETED|Randomization||0
11024276|NCT00818259|12202670|FG008|NOT COMPLETED|Randomization||0
11024277|NCT00818259|12202662|FG000|STARTED|Part I|Newly enrolled participants|12
11024278|NCT00818259|12202663|FG001|STARTED|Part I|Newly enrolled participants|11
11024279|NCT00818259|12202664|FG002|STARTED|Part I||0
11024280|NCT00818259|12202665|FG003|STARTED|Part I||0
11024281|NCT00818259|12202666|FG004|STARTED|Part I||0
11024282|NCT00818259|12202667|FG005|STARTED|Part I||0
11024283|NCT00818259|12202668|FG006|STARTED|Part I||0
11024284|NCT00818259|12202669|FG007|STARTED|Part I||0
11024285|NCT00818259|12202670|FG008|STARTED|Part I||0
11024286|NCT00818259|12202662|FG000|COMPLETED|Part I||11
11024287|NCT00818259|12202663|FG001|COMPLETED|Part I||11
11024288|NCT00818259|12202664|FG002|COMPLETED|Part I||0
11024289|NCT00818259|12202665|FG003|COMPLETED|Part I||0
11024290|NCT00818259|12202666|FG004|COMPLETED|Part I||0
11024291|NCT00818259|12202667|FG005|COMPLETED|Part I||0
11024292|NCT00818259|12202668|FG006|COMPLETED|Part I||0
11024293|NCT00818259|12202669|FG007|COMPLETED|Part I||0
11024294|NCT00818259|12202670|FG008|COMPLETED|Part I||0
11024295|NCT00818259|12202662|FG000|NOT COMPLETED|Part I||1
11024296|NCT00818259|12202663|FG001|NOT COMPLETED|Part I||0
11024297|NCT00818259|12202664|FG002|NOT COMPLETED|Part I||0
11024298|NCT00818259|12202665|FG003|NOT COMPLETED|Part I||0
11024299|NCT00818259|12202666|FG004|NOT COMPLETED|Part I||0
11024300|NCT00818259|12202667|FG005|NOT COMPLETED|Part I||0
11024301|NCT00818259|12202668|FG006|NOT COMPLETED|Part I||0
11024302|NCT00818259|12202669|FG007|NOT COMPLETED|Part I||0
11024303|NCT00818259|12202670|FG008|NOT COMPLETED|Part I||0
11024304|NCT00818259|12202662|FG000|STARTED|Part II||0
11024305|NCT00818259|12202663|FG001|STARTED|Part II||0
11024306|NCT00818259|12202664|FG002|STARTED|Part II|Newly enrolled participants|19
11024307|NCT00818259|12202665|FG003|STARTED|Part II|Newly enrolled participants|20
11024308|NCT00818259|12202666|FG004|STARTED|Part II||0
11024309|NCT00818259|12202667|FG005|STARTED|Part II||0
11024310|NCT00818259|12202668|FG006|STARTED|Part II||0
11024311|NCT00818259|12202669|FG007|STARTED|Part II||0
11024312|NCT00818259|12202670|FG008|STARTED|Part II||0
11024313|NCT00818259|12202662|FG000|Treated|Part II||0
11024314|NCT00818259|12202663|FG001|Treated|Part II||0
11024315|NCT00818259|12202664|FG002|Treated|Part II||19
11024316|NCT00818259|12202665|FG003|Treated|Part II||19
11024317|NCT00818259|12202666|FG004|Treated|Part II||0
11024318|NCT00818259|12202667|FG005|Treated|Part II||0
11024319|NCT00818259|12202668|FG006|Treated|Part II||0
11024320|NCT00818259|12202669|FG007|Treated|Part II||0
11024321|NCT00818259|12202670|FG008|Treated|Part II||0
11024322|NCT00818259|12202662|FG000|COMPLETED|Part II||0
11024323|NCT00818259|12202663|FG001|COMPLETED|Part II||0
11024324|NCT00818259|12202664|FG002|COMPLETED|Part II||18
11024325|NCT00818259|12202665|FG003|COMPLETED|Part II||18
11024326|NCT00818259|12202666|FG004|COMPLETED|Part II||0
11024327|NCT00818259|12202667|FG005|COMPLETED|Part II||0
11024328|NCT00818259|12202668|FG006|COMPLETED|Part II||0
11024329|NCT00818259|12202669|FG007|COMPLETED|Part II||0
11024330|NCT00818259|12202670|FG008|COMPLETED|Part II||0
11024331|NCT00818259|12202662|FG000|NOT COMPLETED|Part II||0
11024332|NCT00818259|12202663|FG001|NOT COMPLETED|Part II||0
11024333|NCT00818259|12202664|FG002|NOT COMPLETED|Part II||1
11024334|NCT00818259|12202665|FG003|NOT COMPLETED|Part II||2
11024335|NCT00818259|12202666|FG004|NOT COMPLETED|Part II||0
11024336|NCT00818259|12202667|FG005|NOT COMPLETED|Part II||0
11024337|NCT00818259|12202668|FG006|NOT COMPLETED|Part II||0
11024338|NCT00818259|12202669|FG007|NOT COMPLETED|Part II||0
11024339|NCT00818259|12202670|FG008|NOT COMPLETED|Part II||0
11024340|NCT00818259|12202662|FG000|STARTED|Part III||0
11024341|NCT00818259|12202663|FG001|STARTED|Part III||0
11024342|NCT00818259|12202664|FG002|STARTED|Part III||0
11024343|NCT00818259|12202665|FG003|STARTED|Part III||0
11024344|NCT00818259|12202666|FG004|STARTED|Part III|Newly enrolled participants|19
11024345|NCT00818259|12202667|FG005|STARTED|Part III||0
11024346|NCT00818259|12202668|FG006|STARTED|Part III||0
11024347|NCT00818259|12202669|FG007|STARTED|Part III||0
11024348|NCT00818259|12202670|FG008|STARTED|Part III||0
11024349|NCT00818259|12202662|FG000|COMPLETED|Part III||0
11024350|NCT00818259|12202663|FG001|COMPLETED|Part III||0
11024351|NCT00818259|12202664|FG002|COMPLETED|Part III||0
11024352|NCT00818259|12202665|FG003|COMPLETED|Part III||0
11024353|NCT00818259|12202666|FG004|COMPLETED|Part III||19
11024354|NCT00818259|12202667|FG005|COMPLETED|Part III||0
11024355|NCT00818259|12202668|FG006|COMPLETED|Part III||0
11024356|NCT00818259|12202669|FG007|COMPLETED|Part III||0
11024357|NCT00818259|12202670|FG008|COMPLETED|Part III||0
11024358|NCT00818259|12202662|FG000|NOT COMPLETED|Part III||0
11024359|NCT00818259|12202663|FG001|NOT COMPLETED|Part III||0
11024360|NCT00818259|12202664|FG002|NOT COMPLETED|Part III||0
11024361|NCT00818259|12202665|FG003|NOT COMPLETED|Part III||0
11024362|NCT00818259|12202666|FG004|NOT COMPLETED|Part III||0
11024363|NCT00818259|12202667|FG005|NOT COMPLETED|Part III||0
11024364|NCT00818259|12202668|FG006|NOT COMPLETED|Part III||0
11024365|NCT00818259|12202669|FG007|NOT COMPLETED|Part III||0
11024366|NCT00818259|12202670|FG008|NOT COMPLETED|Part III||0
11024367|NCT00818259|12202662|FG000|STARTED|Part IV||0
11024368|NCT00818259|12202663|FG001|STARTED|Part IV||0
11024369|NCT00818259|12202664|FG002|STARTED|Part IV||0
11024370|NCT00818259|12202665|FG003|STARTED|Part IV||0
11024371|NCT00818259|12202666|FG004|STARTED|Part IV||0
11024372|NCT00818259|12202667|FG005|STARTED|Part IV|Participants continuing from Part III|15
11024373|NCT00818259|12202668|FG006|STARTED|Part IV|Newly enrolled participants|5
11024374|NCT00818259|12202669|FG007|STARTED|Part IV||0
11024375|NCT00818259|12202670|FG008|STARTED|Part IV||0
11024376|NCT00818259|12202662|FG000|COMPLETED|Part IV||0
11024377|NCT00818259|12202663|FG001|COMPLETED|Part IV||0
11024378|NCT00818259|12202664|FG002|COMPLETED|Part IV||0
11024379|NCT00818259|12202665|FG003|COMPLETED|Part IV||0
11024380|NCT00818259|12202666|FG004|COMPLETED|Part IV||0
11024381|NCT00818259|12202667|FG005|COMPLETED|Part IV||14
11024382|NCT00818259|12202668|FG006|COMPLETED|Part IV||5
11024383|NCT00818259|12202669|FG007|COMPLETED|Part IV||0
11024384|NCT00818259|12202670|FG008|COMPLETED|Part IV||0
11024385|NCT00818259|12202662|FG000|NOT COMPLETED|Part IV||0
11024386|NCT00818259|12202663|FG001|NOT COMPLETED|Part IV||0
11024387|NCT00818259|12202664|FG002|NOT COMPLETED|Part IV||0
11024388|NCT00818259|12202665|FG003|NOT COMPLETED|Part IV||0
11024389|NCT00818259|12202666|FG004|NOT COMPLETED|Part IV||0
11024390|NCT00818259|12202667|FG005|NOT COMPLETED|Part IV||1
11024391|NCT00818259|12202668|FG006|NOT COMPLETED|Part IV||0
11024392|NCT00818259|12202669|FG007|NOT COMPLETED|Part IV||0
11024393|NCT00818259|12202670|FG008|NOT COMPLETED|Part IV||0
11024394|NCT00818259|12202662|FG000|STARTED|Part V||0
11024395|NCT00818259|12202663|FG001|STARTED|Part V||0
11024396|NCT00818259|12202664|FG002|STARTED|Part V||0
11024397|NCT00818259|12202665|FG003|STARTED|Part V||0
11024398|NCT00818259|12202666|FG004|STARTED|Part V||0
11024399|NCT00818259|12202667|FG005|STARTED|Part V||0
11024400|NCT00818259|12202668|FG006|STARTED|Part V||0
11024401|NCT00818259|12202669|FG007|STARTED|Part V|Participants continuing from Part IV|17
11024402|NCT00818259|12202670|FG008|STARTED|Part V|Newly enrolled participants|6
11024403|NCT00818259|12202662|FG000|COMPLETED|Part V||0
11024404|NCT00818259|12202663|FG001|COMPLETED|Part V||0
11024405|NCT00818259|12202664|FG002|COMPLETED|Part V||0
11024406|NCT00818259|12202665|FG003|COMPLETED|Part V||0
11024407|NCT00818259|12202666|FG004|COMPLETED|Part V||0
11024408|NCT00818259|12202667|FG005|COMPLETED|Part V||0
11024409|NCT00818259|12202668|FG006|COMPLETED|Part V||0
11024410|NCT00818259|12202669|FG007|COMPLETED|Part V||16
11024411|NCT00818259|12202670|FG008|COMPLETED|Part V||6
11024412|NCT00818259|12202662|FG000|NOT COMPLETED|Part V||0
11024413|NCT00818259|12202663|FG001|NOT COMPLETED|Part V||0
11024414|NCT00818259|12202664|FG002|NOT COMPLETED|Part V||0
11024415|NCT00818259|12202665|FG003|NOT COMPLETED|Part V||0
11024416|NCT00818259|12202666|FG004|NOT COMPLETED|Part V||0
11024417|NCT00818259|12202667|FG005|NOT COMPLETED|Part V||0
11024418|NCT00818259|12202668|FG006|NOT COMPLETED|Part V||0
11024419|NCT00818259|12202669|FG007|NOT COMPLETED|Part V||1
11024420|NCT00818259|12202670|FG008|NOT COMPLETED|Part V||0
11024421|NCT00818272|12202686|FG000|STARTED|Overall Study||148
11024422|NCT00818272|12202686|FG000|COMPLETED|Overall Study||74
11024423|NCT00818272|12202686|FG000|NOT COMPLETED|Overall Study||74
11024424|NCT00818324|12202690|FG000|STARTED|Overall Study||154
11024425|NCT00818324|12202690|FG000|COMPLETED|Overall Study||127
11024426|NCT00818324|12202690|FG000|NOT COMPLETED|Overall Study||27
11024427|NCT00818337|12202694|FG000|STARTED|Overall Study||36
11024428|NCT00818337|12202694|FG000|COMPLETED|Overall Study||36
11024429|NCT00818337|12202694|FG000|NOT COMPLETED|Overall Study||0
11024430|NCT00818363|12202701|FG000|STARTED|Overall Study||40
11024431|NCT00818363|12202702|FG001|STARTED|Overall Study||20
11024432|NCT00818363|12202701|FG000|COMPLETED|Overall Study||40
11024433|NCT00818363|12202702|FG001|COMPLETED|Overall Study||19
11024434|NCT00818363|12202701|FG000|NOT COMPLETED|Overall Study||0
11024435|NCT00818363|12202702|FG001|NOT COMPLETED|Overall Study||1
11024436|NCT00818389|12202710|FG000|STARTED|Overall Study||40
11024437|NCT00818389|12202711|FG001|STARTED|Overall Study||44
11024438|NCT00818389|12202710|FG000|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
11024439|NCT00818389|12202711|FG001|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
11024440|NCT00818389|12202710|FG000|NOT COMPLETED|Overall Study||4
11024441|NCT00818389|12202711|FG001|NOT COMPLETED|Overall Study||6
11024442|NCT00818441|12202719|FG000|STARTED|Overall Study||89
11024443|NCT00818441|12202720|FG001|STARTED|Overall Study||30
11024444|NCT00818441|12202719|FG000|COMPLETED|Overall Study||0
11024445|NCT00818441|12202720|FG001|COMPLETED|Overall Study||0
11024446|NCT00818441|12202719|FG000|NOT COMPLETED|Overall Study||89
11024447|NCT00818441|12202720|FG001|NOT COMPLETED|Overall Study||30
11024448|NCT00818454|12202727|FG000|STARTED|Treatment Period 1||115
11024449|NCT00818454|12202728|FG001|STARTED|Treatment Period 1||111
11024450|NCT00818454|12202729|FG002|STARTED|Treatment Period 1||0
11024451|NCT00818454|12202730|FG003|STARTED|Treatment Period 1||0
11024452|NCT00818454|12202727|FG000|COMPLETED|Treatment Period 1||112
11024453|NCT00818454|12202728|FG001|COMPLETED|Treatment Period 1||110
11024454|NCT00818454|12202729|FG002|COMPLETED|Treatment Period 1||0
11024455|NCT00818454|12202730|FG003|COMPLETED|Treatment Period 1||0
11024456|NCT00818454|12202727|FG000|NOT COMPLETED|Treatment Period 1||3
11024457|NCT00818454|12202728|FG001|NOT COMPLETED|Treatment Period 1||1
11024458|NCT00818454|12202729|FG002|NOT COMPLETED|Treatment Period 1||0
11024459|NCT00818454|12202730|FG003|NOT COMPLETED|Treatment Period 1||0
11024460|NCT00818454|12202727|FG000|STARTED|Washout Period of 1 Week||112
11024461|NCT00818454|12202728|FG001|STARTED|Washout Period of 1 Week||110
11024462|NCT00818454|12202729|FG002|STARTED|Washout Period of 1 Week||0
11024463|NCT00818454|12202730|FG003|STARTED|Washout Period of 1 Week||0
11024464|NCT00818454|12202727|FG000|COMPLETED|Washout Period of 1 Week||108
11024465|NCT00818454|12202728|FG001|COMPLETED|Washout Period of 1 Week||107
11024466|NCT00818454|12202729|FG002|COMPLETED|Washout Period of 1 Week||0
11024467|NCT00818454|12202730|FG003|COMPLETED|Washout Period of 1 Week||0
11024468|NCT00818454|12202727|FG000|NOT COMPLETED|Washout Period of 1 Week||4
11024469|NCT00818454|12202728|FG001|NOT COMPLETED|Washout Period of 1 Week||3
11024470|NCT00818454|12202729|FG002|NOT COMPLETED|Washout Period of 1 Week||0
11024471|NCT00818454|12202730|FG003|NOT COMPLETED|Washout Period of 1 Week||0
11024472|NCT00818454|12202727|FG000|STARTED|Treatment Period 2||108
11024473|NCT00818454|12202728|FG001|STARTED|Treatment Period 2||107
11024474|NCT00818454|12202729|FG002|STARTED|Treatment Period 2||0
11024475|NCT00818454|12202730|FG003|STARTED|Treatment Period 2||0
11024476|NCT00818454|12202727|FG000|COMPLETED|Treatment Period 2||106
11024477|NCT00818454|12202728|FG001|COMPLETED|Treatment Period 2||106
11024478|NCT00818454|12202729|FG002|COMPLETED|Treatment Period 2||0
11024479|NCT00818454|12202730|FG003|COMPLETED|Treatment Period 2||0
11024480|NCT00818454|12202727|FG000|NOT COMPLETED|Treatment Period 2||2
11024481|NCT00818454|12202728|FG001|NOT COMPLETED|Treatment Period 2||1
11417816|NCT00625742|12615939|FG000|NOT COMPLETED|Overall Study||12
11417817|NCT00619242|12615943|FG000|STARTED|Overall Study||3
11417818|NCT00619242|12615943|FG000|COMPLETED|Overall Study||3
11417819|NCT00619242|12615943|FG000|NOT COMPLETED|Overall Study||0
11417820|NCT00619151|12615949|FG000|STARTED|Overall Study||2
11417821|NCT00619151|12615950|FG001|STARTED|Overall Study||0
11417822|NCT00619151|12615949|FG000|COMPLETED|Overall Study||1
11417823|NCT00619151|12615950|FG001|COMPLETED|Overall Study||0
11417824|NCT00619151|12615949|FG000|NOT COMPLETED|Overall Study||1
11417825|NCT00619151|12615950|FG001|NOT COMPLETED|Overall Study||0
11024482|NCT00818454|12202729|FG002|NOT COMPLETED|Treatment Period 2||0
11024483|NCT00818454|12202730|FG003|NOT COMPLETED|Treatment Period 2||0
11024484|NCT00818454|12202727|FG000|STARTED|Treatment Period 3||0
11024485|NCT00818454|12202728|FG001|STARTED|Treatment Period 3||0
11024486|NCT00818454|12202729|FG002|STARTED|Treatment Period 3||26
11024487|NCT00818454|12202730|FG003|STARTED|Treatment Period 3||139
11024488|NCT00818454|12202727|FG000|COMPLETED|Treatment Period 3||0
11024489|NCT00818454|12202728|FG001|COMPLETED|Treatment Period 3||0
11024490|NCT00818454|12202729|FG002|COMPLETED|Treatment Period 3||26
11024491|NCT00818454|12202730|FG003|COMPLETED|Treatment Period 3||138
11024492|NCT00818454|12202727|FG000|NOT COMPLETED|Treatment Period 3||0
11417826|NCT00622167|12615956|FG000|STARTED|Overall Study||24
11417827|NCT00622167|12615956|FG000|COMPLETED|Overall Study||4
11417828|NCT00622167|12615956|FG000|NOT COMPLETED|Overall Study||20
11417829|NCT00616577|12615963|FG000|STARTED|Overall Study||6
11417830|NCT00616577|12615964|FG001|STARTED|Overall Study||9
11024493|NCT00818454|12202728|FG001|NOT COMPLETED|Treatment Period 3||0
11024494|NCT00818454|12202729|FG002|NOT COMPLETED|Treatment Period 3||0
11024495|NCT00818454|12202730|FG003|NOT COMPLETED|Treatment Period 3||1
11024496|NCT00818519|12202742|FG000|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
11024497|NCT00818519|12202743|FG001|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
11024498|NCT00818519|12202742|FG000|Participants Received Treatment|Overall Study|= Baseline|87
11024499|NCT00818519|12202743|FG001|Participants Received Treatment|Overall Study|= Baseline|86
11024500|NCT00818519|12202742|FG000|COMPLETED|Overall Study||75
11024501|NCT00818519|12202743|FG001|COMPLETED|Overall Study||71
11024502|NCT00818519|12202742|FG000|NOT COMPLETED|Overall Study||14
11024503|NCT00818519|12202743|FG001|NOT COMPLETED|Overall Study||19
11024504|NCT00818623|12202757|FG000|STARTED|Overall Study||26
11024505|NCT00818623|12202758|FG001|STARTED|Overall Study||12
11024506|NCT00818623|12202759|FG002|STARTED|Overall Study||13
11024507|NCT00818623|12202760|FG003|STARTED|Overall Study||24
11024508|NCT00818623|12202761|FG004|STARTED|Overall Study||27
11024509|NCT00818623|12202762|FG005|STARTED|Overall Study||24
11024510|NCT00818623|12202763|FG006|STARTED|Overall Study||27
11024511|NCT00818623|12202764|FG007|STARTED|Overall Study||27
11024512|NCT00818623|12202757|FG000|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
11024513|NCT00818623|12202758|FG001|Intent-to-treat (ITT) Population|Overall Study||12
11024514|NCT00818623|12202759|FG002|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
11024515|NCT00818623|12202760|FG003|Intent-to-treat (ITT) Population|Overall Study||24
11024516|NCT00818623|12202761|FG004|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
11417831|NCT00616577|12615965|FG002|STARTED|Overall Study||7
11417832|NCT00616577|12615963|FG000|COMPLETED|Overall Study||6
11024517|NCT00818623|12202762|FG005|Intent-to-treat (ITT) Population|Overall Study||24
11024518|NCT00818623|12202763|FG006|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
11024519|NCT00818623|12202764|FG007|Intent-to-treat (ITT) Population|Overall Study||27
11024520|NCT00818623|12202757|FG000|COMPLETED|Overall Study||24
11024521|NCT00818623|12202758|FG001|COMPLETED|Overall Study||8
11024522|NCT00818623|12202759|FG002|COMPLETED|Overall Study||9
11024523|NCT00818623|12202760|FG003|COMPLETED|Overall Study||19
11024524|NCT00818623|12202761|FG004|COMPLETED|Overall Study||23
11024525|NCT00818623|12202762|FG005|COMPLETED|Overall Study||21
11024526|NCT00818623|12202763|FG006|COMPLETED|Overall Study||23
11024527|NCT00818623|12202764|FG007|COMPLETED|Overall Study||26
11024528|NCT00818623|12202757|FG000|NOT COMPLETED|Overall Study||2
11024529|NCT00818623|12202758|FG001|NOT COMPLETED|Overall Study||4
11024530|NCT00818623|12202759|FG002|NOT COMPLETED|Overall Study||4
11024531|NCT00818623|12202760|FG003|NOT COMPLETED|Overall Study||5
11024532|NCT00818623|12202761|FG004|NOT COMPLETED|Overall Study||4
11024533|NCT00818623|12202762|FG005|NOT COMPLETED|Overall Study||3
11024534|NCT00818623|12202763|FG006|NOT COMPLETED|Overall Study||4
11024535|NCT00818623|12202764|FG007|NOT COMPLETED|Overall Study||1
11024536|NCT00818649|12202782|FG000|STARTED|Overall Study||16
11024537|NCT00818649|12202782|FG000|COMPLETED|Overall Study||12
11024538|NCT00818649|12202782|FG000|NOT COMPLETED|Overall Study||4
11024539|NCT00818662|12202791|FG000|STARTED|Overall Study||127
11024540|NCT00818662|12202792|FG001|STARTED|Overall Study||135
11024541|NCT00818662|12202793|FG002|STARTED|Overall Study||58
11024542|NCT00818662|12202794|FG003|STARTED|Overall Study||63
11024543|NCT00818662|12202791|FG000|COMPLETED|Overall Study||104
11024544|NCT00818662|12202792|FG001|COMPLETED|Overall Study||102
11024545|NCT00818662|12202793|FG002|COMPLETED|Overall Study||49
11024546|NCT00818662|12202794|FG003|COMPLETED|Overall Study||47
11024547|NCT00818662|12202791|FG000|NOT COMPLETED|Overall Study||23
11024548|NCT00818662|12202792|FG001|NOT COMPLETED|Overall Study||33
11024549|NCT00818662|12202793|FG002|NOT COMPLETED|Overall Study||9
11024550|NCT00818662|12202794|FG003|NOT COMPLETED|Overall Study||16
11024551|NCT00818753|12202808|FG000|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
11024552|NCT00818753|12202809|FG001|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
11024553|NCT00818753|12202810|FG002|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
11024554|NCT00818753|12202808|FG000|COMPLETED|Overall Study||19
11024555|NCT00818753|12202809|FG001|COMPLETED|Overall Study||21
11024556|NCT00818753|12202810|FG002|COMPLETED|Overall Study||9
11024557|NCT00818753|12202808|FG000|NOT COMPLETED|Overall Study||3
11024558|NCT00818753|12202809|FG001|NOT COMPLETED|Overall Study||0
11024559|NCT00818753|12202810|FG002|NOT COMPLETED|Overall Study||1
11024560|NCT00818766|12202820|FG000|STARTED|Overall Study||125
11024561|NCT00818766|12202821|FG001|STARTED|Overall Study||126
11024562|NCT00818766|12202820|FG000|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
11024563|NCT00818766|12202821|FG001|Received Allocated Intervention|Overall Study||126
11024564|NCT00818766|12202820|FG000|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
11024565|NCT00818766|12202821|FG001|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
11024566|NCT00818766|12202820|FG000|COMPLETED|Overall Study||110
11024567|NCT00818766|12202821|FG001|COMPLETED|Overall Study||116
11024568|NCT00818766|12202820|FG000|NOT COMPLETED|Overall Study||15
11024569|NCT00818766|12202821|FG001|NOT COMPLETED|Overall Study||10
11024570|NCT00818779|12202829|FG000|STARTED|Overall Study||22
11024571|NCT00818779|12202830|FG001|STARTED|Overall Study||16
11024572|NCT00818779|12202829|FG000|COMPLETED|Overall Study||16
11024573|NCT00818779|12202830|FG001|COMPLETED|Overall Study||15
11024574|NCT00818779|12202829|FG000|NOT COMPLETED|Overall Study||6
11024575|NCT00818779|12202830|FG001|NOT COMPLETED|Overall Study||1
11024576|NCT00818805|12202836|FG000|STARTED|First Intervention||25
11024577|NCT00818805|12202837|FG001|STARTED|First Intervention||25
11024578|NCT00818805|12202836|FG000|COMPLETED|First Intervention||25
11024579|NCT00818805|12202837|FG001|COMPLETED|First Intervention||25
11024580|NCT00818805|12202836|FG000|NOT COMPLETED|First Intervention||0
11024581|NCT00818805|12202837|FG001|NOT COMPLETED|First Intervention||0
11024582|NCT00818805|12202836|FG000|STARTED|Second Intervention||25
11024583|NCT00818805|12202837|FG001|STARTED|Second Intervention||25
11024584|NCT00818805|12202836|FG000|COMPLETED|Second Intervention||25
11024585|NCT00818805|12202837|FG001|COMPLETED|Second Intervention||25
11024586|NCT00818805|12202836|FG000|NOT COMPLETED|Second Intervention||0
11024587|NCT00818805|12202837|FG001|NOT COMPLETED|Second Intervention||0
11024588|NCT00818883|12202849|FG000|STARTED|Overall Study||303
11024589|NCT00818883|12202850|FG001|STARTED|Overall Study||306
11024590|NCT00818883|12202849|FG000|COMPLETED|Overall Study||252
11024591|NCT00818883|12202850|FG001|COMPLETED|Overall Study||260
11024592|NCT00818883|12202849|FG000|NOT COMPLETED|Overall Study||51
11024593|NCT00818883|12202850|FG001|NOT COMPLETED|Overall Study||46
11024594|NCT00818961|12202856|FG000|STARTED|Overall Study||36
11024595|NCT00818961|12202856|FG000|COMPLETED|Overall Study||36
11024596|NCT00818961|12202856|FG000|NOT COMPLETED|Overall Study||0
11024597|NCT00819013|12202864|FG000|STARTED|Overall Study||22
11024598|NCT00819013|12202865|FG001|STARTED|Overall Study||23
11024599|NCT00819013|12202866|FG002|STARTED|Overall Study||21
11024600|NCT00819013|12202867|FG003|STARTED|Overall Study||21
11024601|NCT00819013|12202864|FG000|COMPLETED|Overall Study||19
11024602|NCT00819013|12202865|FG001|COMPLETED|Overall Study||22
11024603|NCT00819013|12202866|FG002|COMPLETED|Overall Study||16
11024604|NCT00819013|12202867|FG003|COMPLETED|Overall Study||17
11024605|NCT00819013|12202864|FG000|NOT COMPLETED|Overall Study||3
11024606|NCT00819013|12202865|FG001|NOT COMPLETED|Overall Study||1
11024607|NCT00819013|12202866|FG002|NOT COMPLETED|Overall Study||5
11024608|NCT00819013|12202867|FG003|NOT COMPLETED|Overall Study||4
11024609|NCT00819039|12202880|FG000|STARTED|Overall Study||46
11024610|NCT00819039|12202881|FG001|STARTED|Overall Study||27
11024611|NCT00819039|12202882|FG002|STARTED|Overall Study||25
11024612|NCT00819039|12202880|FG000|COMPLETED|Overall Study||44
11024613|NCT00819039|12202881|FG001|COMPLETED|Overall Study||27
11024614|NCT00819039|12202882|FG002|COMPLETED|Overall Study||24
11024615|NCT00819039|12202880|FG000|NOT COMPLETED|Overall Study||2
11024616|NCT00819039|12202881|FG001|NOT COMPLETED|Overall Study||0
11024617|NCT00819039|12202882|FG002|NOT COMPLETED|Overall Study||1
11024618|NCT00819052|12202894|FG000|STARTED|Overall Study||148
11024619|NCT00819052|12202895|FG001|STARTED|Overall Study||295
11024620|NCT00819052|12202894|FG000|COMPLETED|Overall Study||142
11024621|NCT00819052|12202895|FG001|COMPLETED|Overall Study||281
11024622|NCT00819052|12202894|FG000|NOT COMPLETED|Overall Study||6
11024623|NCT00819052|12202895|FG001|NOT COMPLETED|Overall Study||14
11024624|NCT00819091|12202906|FG000|STARTED|Overall Study||84
11024625|NCT00819091|12202907|FG001|STARTED|Overall Study||161
11024626|NCT00819091|12202906|FG000|COMPLETED|Overall Study||77
11024627|NCT00819091|12202907|FG001|COMPLETED|Overall Study||151
11024628|NCT00819091|12202906|FG000|NOT COMPLETED|Overall Study||7
11024629|NCT00819091|12202907|FG001|NOT COMPLETED|Overall Study||10
11024630|NCT00819156|12202919|FG000|STARTED|Overall Study||30
11024631|NCT00819156|12202920|FG001|STARTED|Overall Study||33
11024632|NCT00819156|12202921|FG002|STARTED|Overall Study||32
11024633|NCT00819156|12202922|FG003|STARTED|Overall Study||30
11024634|NCT00819156|12202923|FG004|STARTED|Overall Study||33
11024635|NCT00819156|12202924|FG005|STARTED|Overall Study||31
11024636|NCT00819156|12202919|FG000|Randomised and Treated (ITT Population)|Overall Study||30
11024637|NCT00819156|12202920|FG001|Randomised and Treated (ITT Population)|Overall Study||32
11024638|NCT00819156|12202921|FG002|Randomised and Treated (ITT Population)|Overall Study||32
11024639|NCT00819156|12202922|FG003|Randomised and Treated (ITT Population)|Overall Study||30
11024640|NCT00819156|12202923|FG004|Randomised and Treated (ITT Population)|Overall Study||33
11024641|NCT00819156|12202924|FG005|Randomised and Treated (ITT Population)|Overall Study||30
11024642|NCT00819156|12202919|FG000|COMPLETED|Overall Study||20
11024643|NCT00819156|12202920|FG001|COMPLETED|Overall Study||23
11024644|NCT00819156|12202921|FG002|COMPLETED|Overall Study||26
11024645|NCT00819156|12202922|FG003|COMPLETED|Overall Study||28
11024646|NCT00819156|12202923|FG004|COMPLETED|Overall Study||27
11024647|NCT00819156|12202924|FG005|COMPLETED|Overall Study||23
11024648|NCT00819156|12202919|FG000|NOT COMPLETED|Overall Study||10
11024649|NCT00819156|12202920|FG001|NOT COMPLETED|Overall Study||10
11024650|NCT00819156|12202921|FG002|NOT COMPLETED|Overall Study||6
11024651|NCT00819156|12202922|FG003|NOT COMPLETED|Overall Study||2
11024652|NCT00819156|12202923|FG004|NOT COMPLETED|Overall Study||6
11024653|NCT00819156|12202924|FG005|NOT COMPLETED|Overall Study||8
11024654|NCT00819182|12202949|FG000|STARTED|Overall Study|Consented participants allocated to this arm.|88
11024655|NCT00819182|12202950|FG001|STARTED|Overall Study|Consented participants allocated to this arm.|86
11024656|NCT00819182|12202951|FG002|STARTED|Overall Study|Consented participants allocated to this arm.|44
11024657|NCT00819182|12202949|FG000|Week 16 Visit|Overall Study||75
11024658|NCT00819182|12202950|FG001|Week 16 Visit|Overall Study||78
11024659|NCT00819182|12202951|FG002|Week 16 Visit|Overall Study||43
11024660|NCT00819182|12202949|FG000|COMPLETED|Overall Study||75
11024661|NCT00819182|12202950|FG001|COMPLETED|Overall Study||78
11024662|NCT00819182|12202951|FG002|COMPLETED|Overall Study||43
11024663|NCT00819182|12202949|FG000|NOT COMPLETED|Overall Study||13
11024664|NCT00819182|12202950|FG001|NOT COMPLETED|Overall Study||8
11024665|NCT00819182|12202951|FG002|NOT COMPLETED|Overall Study||1
11024666|NCT00819234|12202959|FG000|STARTED|Overall Study||31
11024667|NCT00819234|12202960|FG001|STARTED|Overall Study||35
11024668|NCT00819234|12202961|FG002|STARTED|Overall Study||36
11024669|NCT00819234|12202962|FG003|STARTED|Overall Study||28
11024670|NCT00819234|12202963|FG004|STARTED|Overall Study||13
11024671|NCT00819234|12202964|FG005|STARTED|Overall Study||14
11024672|NCT00819234|12202965|FG006|STARTED|Overall Study||13
11024673|NCT00819234|12202966|FG007|STARTED|Overall Study||29
11024674|NCT00819234|12202967|FG008|STARTED|Overall Study||37
11024675|NCT00819234|12202968|FG009|STARTED|Overall Study||37
11024676|NCT00819234|12202959|FG000|COMPLETED|Overall Study||21
11024677|NCT00819234|12202960|FG001|COMPLETED|Overall Study||20
11024678|NCT00819234|12202961|FG002|COMPLETED|Overall Study||28
11024679|NCT00819234|12202962|FG003|COMPLETED|Overall Study||22
11024680|NCT00819234|12202963|FG004|COMPLETED|Overall Study||12
11024681|NCT00819234|12202964|FG005|COMPLETED|Overall Study||7
11024682|NCT00819234|12202965|FG006|COMPLETED|Overall Study||8
11024683|NCT00819234|12202966|FG007|COMPLETED|Overall Study||20
11024684|NCT00819234|12202967|FG008|COMPLETED|Overall Study||31
11024685|NCT00819234|12202968|FG009|COMPLETED|Overall Study||30
11024686|NCT00819234|12202959|FG000|NOT COMPLETED|Overall Study||10
11024687|NCT00819234|12202960|FG001|NOT COMPLETED|Overall Study||15
11024688|NCT00819234|12202961|FG002|NOT COMPLETED|Overall Study||8
11024689|NCT00819234|12202962|FG003|NOT COMPLETED|Overall Study||6
11024690|NCT00819234|12202963|FG004|NOT COMPLETED|Overall Study||1
11024691|NCT00819234|12202964|FG005|NOT COMPLETED|Overall Study||7
11024692|NCT00819234|12202965|FG006|NOT COMPLETED|Overall Study||5
11024693|NCT00819234|12202966|FG007|NOT COMPLETED|Overall Study||9
11024694|NCT00819234|12202967|FG008|NOT COMPLETED|Overall Study||6
11024695|NCT00819234|12202968|FG009|NOT COMPLETED|Overall Study||7
11024696|NCT00819247|12203026|FG000|STARTED|Overall Study||43
11024697|NCT00819247|12203027|FG001|STARTED|Overall Study||46
11024698|NCT00819247|12203028|FG002|STARTED|Overall Study||40
11024699|NCT00819247|12203026|FG000|Randomized|Overall Study||43
11024700|NCT00819247|12203027|FG001|Randomized|Overall Study||46
11024701|NCT00819247|12203028|FG002|Randomized|Overall Study||40
11024702|NCT00819247|12203026|FG000|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
11024703|NCT00819247|12203027|FG001|Intent-to-treat Population|Overall Study||46
11024704|NCT00819247|12203028|FG002|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
11024705|NCT00819247|12203026|FG000|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
11024706|NCT00819247|12203027|FG001|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
11024707|NCT00819247|12203028|FG002|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
11024708|NCT00819247|12203026|FG000|COMPLETED|Overall Study||32
11024709|NCT00819247|12203027|FG001|COMPLETED|Overall Study||30
11024710|NCT00819247|12203028|FG002|COMPLETED|Overall Study||26
11024711|NCT00819247|12203026|FG000|NOT COMPLETED|Overall Study||11
11024712|NCT00819247|12203027|FG001|NOT COMPLETED|Overall Study||16
11024713|NCT00819247|12203028|FG002|NOT COMPLETED|Overall Study||14
11024714|NCT00819260|12203036|FG000|STARTED|Overall Study||31
11024715|NCT00819260|12203036|FG000|COMPLETED|Overall Study||31
11024716|NCT00819260|12203036|FG000|NOT COMPLETED|Overall Study||0
11024717|NCT00819286|12203044|FG000|STARTED|Overall Study||70
11024718|NCT00819286|12203045|FG001|STARTED|Overall Study||70
11024719|NCT00819286|12203044|FG000|COMPLETED|Overall Study||56
11024720|NCT00819286|12203045|FG001|COMPLETED|Overall Study||45
11024721|NCT00819286|12203044|FG000|NOT COMPLETED|Overall Study||14
11024722|NCT00819286|12203045|FG001|NOT COMPLETED|Overall Study||25
11024723|NCT00819390|12203055|FG000|STARTED|Overall Study||16
11024724|NCT00819390|12203056|FG001|STARTED|Overall Study||17
11024725|NCT00819390|12203057|FG002|STARTED|Overall Study||18
11024726|NCT00819390|12203058|FG003|STARTED|Overall Study||19
11024727|NCT00819390|12203055|FG000|COMPLETED|Overall Study||13
11024728|NCT00819390|12203056|FG001|COMPLETED|Overall Study||16
11024729|NCT00819390|12203057|FG002|COMPLETED|Overall Study||17
11024730|NCT00819390|12203058|FG003|COMPLETED|Overall Study||19
11024731|NCT00819390|12203055|FG000|NOT COMPLETED|Overall Study||3
11024732|NCT00819390|12203056|FG001|NOT COMPLETED|Overall Study||1
11024733|NCT00819390|12203057|FG002|NOT COMPLETED|Overall Study||1
11024734|NCT00819390|12203058|FG003|NOT COMPLETED|Overall Study||0
11024735|NCT00819403|12203073|FG000|STARTED|First Intervention (6 Weeks)||7
11024736|NCT00819403|12203074|FG001|STARTED|First Intervention (6 Weeks)||8
11024737|NCT00819403|12203073|FG000|COMPLETED|First Intervention (6 Weeks)||7
11024738|NCT00819403|12203074|FG001|COMPLETED|First Intervention (6 Weeks)||8
11024739|NCT00819403|12203073|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
11024740|NCT00819403|12203074|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
11024741|NCT00819403|12203073|FG000|STARTED|Washout (14 Days)||7
11024742|NCT00819403|12203074|FG001|STARTED|Washout (14 Days)||8
11024743|NCT00819403|12203073|FG000|COMPLETED|Washout (14 Days)||7
11024744|NCT00819403|12203074|FG001|COMPLETED|Washout (14 Days)||8
11024745|NCT00819403|12203073|FG000|NOT COMPLETED|Washout (14 Days)||0
11024746|NCT00819403|12203074|FG001|NOT COMPLETED|Washout (14 Days)||0
11024747|NCT00819403|12203073|FG000|STARTED|Second Intervention (6 Weeks)||7
11024748|NCT00819403|12203074|FG001|STARTED|Second Intervention (6 Weeks)||8
11024749|NCT00819403|12203073|FG000|COMPLETED|Second Intervention (6 Weeks)||7
11024750|NCT00819403|12203074|FG001|COMPLETED|Second Intervention (6 Weeks)||8
11024751|NCT00819403|12203073|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
11024752|NCT00819403|12203074|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
11024753|NCT00819507|12203081|FG000|STARTED|Overall Study||25
11024754|NCT00819507|12203081|FG000|COMPLETED|Overall Study||25
11024755|NCT00819507|12203081|FG000|NOT COMPLETED|Overall Study||0
11024756|NCT00819585|12203092|FG000|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
11024757|NCT00819585|12203093|FG001|STARTED|Core Study||54
11024758|NCT00819585|12203094|FG002|STARTED|Core Study||54
11024759|NCT00819585|12203095|FG003|STARTED|Core Study||54
11024760|NCT00819585|12203096|FG004|STARTED|Core Study||53
11024761|NCT00819585|12203097|FG005|STARTED|Core Study||54
11024762|NCT00819585|12203098|FG006|STARTED|Core Study||108
11024763|NCT00819585|12203099|FG007|STARTED|Core Study|There were no participants in this arm during the core study.|0
11024764|NCT00819585|12203100|FG008|STARTED|Core Study|There were no participants in this arm during the core study.|0
11024765|NCT00819585|12203101|FG009|STARTED|Core Study|There were no participants in this arm during the core study.|0
11024766|NCT00819585|12203102|FG010|STARTED|Core Study|There were no participants in this arm during the core study.|0
11024767|NCT00819585|12203092|FG000|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
11024768|NCT00819585|12203093|FG001|Received Study Medication|Core Study||54
11024769|NCT00819585|12203094|FG002|Received Study Medication|Core Study||54
11024770|NCT00819585|12203095|FG003|Received Study Medication|Core Study||54
11024771|NCT00819585|12203096|FG004|Received Study Medication|Core Study||53
11057079|NCT00996892|12238687|FG016|COMPLETED|Dose-Escalation Stage 1A||0
11024772|NCT00819585|12203097|FG005|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
11024773|NCT00819585|12203098|FG006|Received Study Medication|Core Study||108
11024774|NCT00819585|12203099|FG007|Received Study Medication|Core Study||0
11024775|NCT00819585|12203100|FG008|Received Study Medication|Core Study||0
11024776|NCT00819585|12203101|FG009|Received Study Medication|Core Study||0
11024777|NCT00819585|12203102|FG010|Received Study Medication|Core Study||0
11024778|NCT00819585|12203092|FG000|COMPLETED|Core Study||49
11024779|NCT00819585|12203093|FG001|COMPLETED|Core Study||48
11024780|NCT00819585|12203094|FG002|COMPLETED|Core Study||48
11024781|NCT00819585|12203095|FG003|COMPLETED|Core Study||49
11024782|NCT00819585|12203096|FG004|COMPLETED|Core Study||50
11024783|NCT00819585|12203097|FG005|COMPLETED|Core Study||52
11024784|NCT00819585|12203098|FG006|COMPLETED|Core Study||95
11024785|NCT00819585|12203099|FG007|COMPLETED|Core Study||0
11024786|NCT00819585|12203100|FG008|COMPLETED|Core Study||0
11024787|NCT00819585|12203101|FG009|COMPLETED|Core Study||0
11024788|NCT00819585|12203102|FG010|COMPLETED|Core Study||0
11024789|NCT00819585|12203092|FG000|NOT COMPLETED|Core Study||6
11024790|NCT00819585|12203093|FG001|NOT COMPLETED|Core Study||6
11024791|NCT00819585|12203094|FG002|NOT COMPLETED|Core Study||6
11024792|NCT00819585|12203095|FG003|NOT COMPLETED|Core Study||5
11024793|NCT00819585|12203096|FG004|NOT COMPLETED|Core Study||3
11024794|NCT00819585|12203097|FG005|NOT COMPLETED|Core Study||2
11024795|NCT00819585|12203098|FG006|NOT COMPLETED|Core Study||13
11024796|NCT00819585|12203099|FG007|NOT COMPLETED|Core Study||0
11024797|NCT00819585|12203100|FG008|NOT COMPLETED|Core Study||0
11024798|NCT00819585|12203101|FG009|NOT COMPLETED|Core Study||0
11024799|NCT00819585|12203102|FG010|NOT COMPLETED|Core Study||0
11024800|NCT00819585|12203092|FG000|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
11024801|NCT00819585|12203093|FG001|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
11024802|NCT00819585|12203094|FG002|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
11024803|NCT00819585|12203095|FG003|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
11024804|NCT00819585|12203096|FG004|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
11024805|NCT00819585|12203097|FG005|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
11024806|NCT00819585|12203098|FG006|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
11024807|NCT00819585|12203099|FG007|STARTED|Extension Study||75
11024808|NCT00819585|12203100|FG008|STARTED|Extension Study||181
11024809|NCT00819585|12203101|FG009|STARTED|Extension Study||25
11024810|NCT00819585|12203102|FG010|STARTED|Extension Study||60
11024811|NCT00819585|12203092|FG000|COMPLETED|Extension Study||0
11024812|NCT00819585|12203093|FG001|COMPLETED|Extension Study||0
11024813|NCT00819585|12203094|FG002|COMPLETED|Extension Study||0
11024814|NCT00819585|12203095|FG003|COMPLETED|Extension Study||0
11024815|NCT00819585|12203096|FG004|COMPLETED|Extension Study||0
11024816|NCT00819585|12203097|FG005|COMPLETED|Extension Study||0
11024817|NCT00819585|12203098|FG006|COMPLETED|Extension Study||0
11024818|NCT00819585|12203099|FG007|COMPLETED|Extension Study||75
11024819|NCT00819585|12203100|FG008|COMPLETED|Extension Study||173
11024820|NCT00819585|12203101|FG009|COMPLETED|Extension Study||24
11024821|NCT00819585|12203102|FG010|COMPLETED|Extension Study||58
11024822|NCT00819585|12203092|FG000|NOT COMPLETED|Extension Study||0
11024823|NCT00819585|12203093|FG001|NOT COMPLETED|Extension Study||0
11024824|NCT00819585|12203094|FG002|NOT COMPLETED|Extension Study||0
11024825|NCT00819585|12203095|FG003|NOT COMPLETED|Extension Study||0
11024826|NCT00819585|12203096|FG004|NOT COMPLETED|Extension Study||0
11024827|NCT00819585|12203097|FG005|NOT COMPLETED|Extension Study||0
11024828|NCT00819585|12203098|FG006|NOT COMPLETED|Extension Study||0
11024829|NCT00819585|12203099|FG007|NOT COMPLETED|Extension Study||0
11024830|NCT00819585|12203100|FG008|NOT COMPLETED|Extension Study||8
11024831|NCT00819585|12203101|FG009|NOT COMPLETED|Extension Study||1
11024832|NCT00819585|12203102|FG010|NOT COMPLETED|Extension Study||2
11024833|NCT00819637|12203133|FG000|STARTED|Overall Study||2
11024834|NCT00819637|12203134|FG001|STARTED|Overall Study||0
11024835|NCT00819637|12203135|FG002|STARTED|Overall Study||0
11024836|NCT00819637|12203133|FG000|COMPLETED|Overall Study||2
11024837|NCT00819637|12203134|FG001|COMPLETED|Overall Study||0
11024838|NCT00819637|12203135|FG002|COMPLETED|Overall Study||0
11024839|NCT00819637|12203133|FG000|NOT COMPLETED|Overall Study||0
11024840|NCT00819637|12203134|FG001|NOT COMPLETED|Overall Study||0
11024841|NCT00819637|12203135|FG002|NOT COMPLETED|Overall Study||0
11024842|NCT00819741|12203145|FG000|STARTED|Overall Study||218
11024843|NCT00819741|12203146|FG001|STARTED|Overall Study||215
11024844|NCT00819741|12203145|FG000|Exposed to Drug|Overall Study||218
11024845|NCT00819741|12203146|FG001|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
11024846|NCT00819741|12203145|FG000|COMPLETED|Overall Study||196
11024847|NCT00819741|12203146|FG001|COMPLETED|Overall Study||201
11024848|NCT00819741|12203145|FG000|NOT COMPLETED|Overall Study||22
11024849|NCT00819741|12203146|FG001|NOT COMPLETED|Overall Study||14
11024850|NCT00819767|12203154|FG000|STARTED|Overall Study||33
11024851|NCT00819767|12203155|FG001|STARTED|Overall Study||35
11024852|NCT00819767|12203154|FG000|COMPLETED|Overall Study||32
11024853|NCT00819767|12203155|FG001|COMPLETED|Overall Study||33
11024854|NCT00819767|12203154|FG000|NOT COMPLETED|Overall Study||1
11024855|NCT00819767|12203155|FG001|NOT COMPLETED|Overall Study||2
11024856|NCT00819910|12203165|FG000|STARTED|Overall Study||10
11024857|NCT00819910|12203166|FG001|STARTED|Overall Study||10
11024858|NCT00819910|12203167|FG002|STARTED|Overall Study||10
11024859|NCT00819910|12203168|FG003|STARTED|Overall Study||11
11024860|NCT00819910|12203165|FG000|COMPLETED|Overall Study||8
11024861|NCT00819910|12203166|FG001|COMPLETED|Overall Study||9
11024862|NCT00819910|12203167|FG002|COMPLETED|Overall Study||7
11024863|NCT00819910|12203168|FG003|COMPLETED|Overall Study||10
11024864|NCT00819910|12203165|FG000|NOT COMPLETED|Overall Study||2
11024865|NCT00819910|12203166|FG001|NOT COMPLETED|Overall Study||1
11024866|NCT00819910|12203167|FG002|NOT COMPLETED|Overall Study||3
11024867|NCT00819910|12203168|FG003|NOT COMPLETED|Overall Study||1
11024868|NCT00820040|12203180|FG000|STARTED|Overall Study||10
11024869|NCT00820040|12203180|FG000|Safety Evaluable Population|Overall Study||8
11024870|NCT00820040|12203180|FG000|Full Analysis Set|Overall Study||8
11024871|NCT00820040|12203180|FG000|COMPLETED|Overall Study||7
11024872|NCT00820040|12203180|FG000|NOT COMPLETED|Overall Study||3
11024873|NCT00820170|12203189|FG000|STARTED|Overall Study||3
11024874|NCT00820170|12203190|FG001|STARTED|Overall Study||5
11024875|NCT00820170|12203191|FG002|STARTED|Overall Study||3
11024876|NCT00820170|12203192|FG003|STARTED|Overall Study||40
11024877|NCT00820170|12203193|FG004|STARTED|Overall Study||4
11024878|NCT00820170|12203189|FG000|COMPLETED|Overall Study||3
11024879|NCT00820170|12203190|FG001|COMPLETED|Overall Study||5
11024880|NCT00820170|12203191|FG002|COMPLETED|Overall Study||3
11024881|NCT00820170|12203192|FG003|COMPLETED|Overall Study||40
11024882|NCT00820170|12203193|FG004|COMPLETED|Overall Study||0
11024883|NCT00820170|12203189|FG000|NOT COMPLETED|Overall Study||0
11024884|NCT00820170|12203190|FG001|NOT COMPLETED|Overall Study||0
11024885|NCT00820170|12203191|FG002|NOT COMPLETED|Overall Study||0
11024886|NCT00820170|12203192|FG003|NOT COMPLETED|Overall Study||0
11024887|NCT00820170|12203193|FG004|NOT COMPLETED|Overall Study||4
11024888|NCT00820222|12203212|FG000|STARTED|Overall Study||271
11024889|NCT00820222|12203213|FG001|STARTED|Overall Study||269
11024890|NCT00820222|12203212|FG000|COMPLETED|Overall Study||95
11024891|NCT00820222|12203213|FG001|COMPLETED|Overall Study||79
11024892|NCT00820222|12203212|FG000|NOT COMPLETED|Overall Study||176
11024893|NCT00820222|12203213|FG001|NOT COMPLETED|Overall Study||190
11024894|NCT00820235|12203222|FG000|STARTED|Overall Study||48
11024895|NCT00820235|12203223|FG001|STARTED|Overall Study||49
11024896|NCT00820235|12203224|FG002|STARTED|Overall Study||44
11024897|NCT00820235|12203222|FG000|COMPLETED|Overall Study||33
11024898|NCT00820235|12203223|FG001|COMPLETED|Overall Study||28
11024899|NCT00820235|12203224|FG002|COMPLETED|Overall Study||27
11024900|NCT00820235|12203222|FG000|NOT COMPLETED|Overall Study||15
11024901|NCT00820235|12203223|FG001|NOT COMPLETED|Overall Study||21
11024902|NCT00820235|12203224|FG002|NOT COMPLETED|Overall Study||17
11024903|NCT00820248|12203234|FG000|STARTED|Overall Study||160
11024904|NCT00820248|12203235|FG001|STARTED|Overall Study||160
11024905|NCT00820248|12203234|FG000|Received Protocol Treatment|Overall Study||156
11024906|NCT00820248|12203235|FG001|Received Protocol Treatment|Overall Study||159
11024907|NCT00820248|12203234|FG000|COMPLETED|Overall Study||156
11024908|NCT00820248|12203235|FG001|COMPLETED|Overall Study||159
11024909|NCT00820248|12203234|FG000|NOT COMPLETED|Overall Study||4
11024910|NCT00820248|12203235|FG001|NOT COMPLETED|Overall Study||1
11024911|NCT00820443|12203241|FG000|STARTED|Pre-Op||253
11024912|NCT00820443|12203241|FG000|COMPLETED|Pre-Op||253
11024913|NCT00820443|12203241|FG000|NOT COMPLETED|Pre-Op||0
11024914|NCT00820443|12203241|FG000|STARTED|Op||253
11024915|NCT00820443|12203241|FG000|COMPLETED|Op||253
11024916|NCT00820443|12203241|FG000|NOT COMPLETED|Op||0
11024917|NCT00820443|12203241|FG000|STARTED|Immediately||253
11024918|NCT00820443|12203241|FG000|COMPLETED|Immediately||248
11024919|NCT00820443|12203241|FG000|NOT COMPLETED|Immediately||5
11024920|NCT00820443|12203241|FG000|STARTED|3 Month||253
11024921|NCT00820443|12203241|FG000|COMPLETED|3 Month||244
11024922|NCT00820443|12203241|FG000|NOT COMPLETED|3 Month||9
11417833|NCT00616577|12615964|FG001|COMPLETED|Overall Study||9
11417834|NCT00616577|12615965|FG002|COMPLETED|Overall Study||7
11417835|NCT00616577|12615963|FG000|NOT COMPLETED|Overall Study||0
11024923|NCT00820443|12203241|FG000|STARTED|6 Month||253
11024924|NCT00820443|12203241|FG000|COMPLETED|6 Month||233
11024925|NCT00820443|12203241|FG000|NOT COMPLETED|6 Month||20
11024926|NCT00820443|12203241|FG000|STARTED|12 Month||250
11024927|NCT00820443|12203241|FG000|COMPLETED|12 Month||226
11024928|NCT00820443|12203241|FG000|NOT COMPLETED|12 Month||24
11024929|NCT00820443|12203241|FG000|STARTED|24 Month||245
11024930|NCT00820443|12203241|FG000|COMPLETED|24 Month||202
11024931|NCT00820443|12203241|FG000|NOT COMPLETED|24 Month||43
11024932|NCT00820534|12203248|FG000|STARTED|Overall Study||64
11024933|NCT00820534|12203249|FG001|STARTED|Overall Study||62
11024934|NCT00820534|12203248|FG000|COMPLETED|Overall Study||64
11024935|NCT00820534|12203249|FG001|COMPLETED|Overall Study||62
11024936|NCT00820534|12203248|FG000|NOT COMPLETED|Overall Study||0
11024937|NCT00820534|12203249|FG001|NOT COMPLETED|Overall Study||0
11024938|NCT00820573|12203259|FG000|STARTED|Overall Study||4
11024939|NCT00820573|12203260|FG001|STARTED|Overall Study||4
11024940|NCT00820573|12203261|FG002|STARTED|Overall Study||4
11024941|NCT00820573|12203262|FG003|STARTED|Overall Study||4
11024942|NCT00820573|12203259|FG000|COMPLETED|Overall Study||4
11024943|NCT00820573|12203260|FG001|COMPLETED|Overall Study||4
11024944|NCT00820573|12203261|FG002|COMPLETED|Overall Study||4
11024945|NCT00820573|12203262|FG003|COMPLETED|Overall Study||4
11024946|NCT00820573|12203259|FG000|NOT COMPLETED|Overall Study||0
11024947|NCT00820573|12203260|FG001|NOT COMPLETED|Overall Study||0
11024948|NCT00820573|12203261|FG002|NOT COMPLETED|Overall Study||0
11024949|NCT00820573|12203262|FG003|NOT COMPLETED|Overall Study||0
11024950|NCT00820599|12203281|FG000|STARTED|Overall Study||211
11024951|NCT00820599|12203281|FG000|COMPLETED|Overall Study||80
11024952|NCT00820599|12203281|FG000|NOT COMPLETED|Overall Study||131
11024953|NCT00820612|12203287|FG000|STARTED|Overall Study||307
11024954|NCT00820612|12203288|FG001|STARTED|Overall Study||295
11024955|NCT00820612|12203287|FG000|COMPLETED|Overall Study||307
11024956|NCT00820612|12203288|FG001|COMPLETED|Overall Study||295
11024957|NCT00820612|12203287|FG000|NOT COMPLETED|Overall Study||0
11024958|NCT00820612|12203288|FG001|NOT COMPLETED|Overall Study||0
11057080|NCT00996892|12238688|FG017|COMPLETED|Dose-Escalation Stage 1A||0
11057081|NCT00996892|12238689|FG018|COMPLETED|Dose-Escalation Stage 1A||0
11057082|NCT00996892|12238690|FG019|COMPLETED|Dose-Escalation Stage 1A||0
11057083|NCT00996892|12238671|FG000|NOT COMPLETED|Dose-Escalation Stage 1A||0
11057084|NCT00996892|12238672|FG001|NOT COMPLETED|Dose-Escalation Stage 1A||0
11057085|NCT00996892|12238673|FG002|NOT COMPLETED|Dose-Escalation Stage 1A||0
11057086|NCT00996892|12238674|FG003|NOT COMPLETED|Dose-Escalation Stage 1A||0
11057087|NCT00996892|12238675|FG004|NOT COMPLETED|Dose-Escalation Stage 1A||0
11057088|NCT00996892|12238676|FG005|NOT COMPLETED|Dose-Escalation Stage 1A||0
11057089|NCT00996892|12238677|FG006|NOT COMPLETED|Dose-Escalation Stage 1A||0
11057090|NCT00996892|12238678|FG007|NOT COMPLETED|Dose-Escalation Stage 1A||3
11057091|NCT00996892|12238679|FG008|NOT COMPLETED|Dose-Escalation Stage 1A||3
11057092|NCT00996892|12238680|FG009|NOT COMPLETED|Dose-Escalation Stage 1A||4
11057093|NCT00996892|12238681|FG010|NOT COMPLETED|Dose-Escalation Stage 1A||7
11057094|NCT00996892|12238682|FG011|NOT COMPLETED|Dose-Escalation Stage 1A||9
11057095|NCT00996892|12238683|FG012|NOT COMPLETED|Dose-Escalation Stage 1A||8
11057096|NCT00996892|12238684|FG013|NOT COMPLETED|Dose-Escalation Stage 1A||5
11057097|NCT00996892|12238685|FG014|NOT COMPLETED|Dose-Escalation Stage 1A||0
11057098|NCT00996892|12238686|FG015|NOT COMPLETED|Dose-Escalation Stage 1A||0
11057099|NCT00996892|12238687|FG016|NOT COMPLETED|Dose-Escalation Stage 1A||0
11057100|NCT00996892|12238688|FG017|NOT COMPLETED|Dose-Escalation Stage 1A||0
11057101|NCT00996892|12238689|FG018|NOT COMPLETED|Dose-Escalation Stage 1A||0
11057102|NCT00996892|12238690|FG019|NOT COMPLETED|Dose-Escalation Stage 1A||0
11057103|NCT00996892|12238671|FG000|STARTED|Dose-Escalation Stage 1B||0
11057104|NCT00996892|12238672|FG001|STARTED|Dose-Escalation Stage 1B||0
11057105|NCT00996892|12238673|FG002|STARTED|Dose-Escalation Stage 1B||0
11057106|NCT00996892|12238674|FG003|STARTED|Dose-Escalation Stage 1B||0
11057107|NCT00996892|12238675|FG004|STARTED|Dose-Escalation Stage 1B||0
11057108|NCT00996892|12238676|FG005|STARTED|Dose-Escalation Stage 1B||0
11057109|NCT00996892|12238677|FG006|STARTED|Dose-Escalation Stage 1B||0
11057110|NCT00996892|12238678|FG007|STARTED|Dose-Escalation Stage 1B||0
11057111|NCT00996892|12238679|FG008|STARTED|Dose-Escalation Stage 1B||0
11057112|NCT00996892|12238680|FG009|STARTED|Dose-Escalation Stage 1B||0
11057113|NCT00996892|12238681|FG010|STARTED|Dose-Escalation Stage 1B||0
11057114|NCT00996892|12238682|FG011|STARTED|Dose-Escalation Stage 1B||0
11057115|NCT00996892|12238683|FG012|STARTED|Dose-Escalation Stage 1B||0
11057116|NCT00996892|12238684|FG013|STARTED|Dose-Escalation Stage 1B||0
11057117|NCT00996892|12238685|FG014|STARTED|Dose-Escalation Stage 1B||4
11057118|NCT00996892|12238686|FG015|STARTED|Dose-Escalation Stage 1B||3
11057119|NCT00996892|12238687|FG016|STARTED|Dose-Escalation Stage 1B||3
11057120|NCT00996892|12238688|FG017|STARTED|Dose-Escalation Stage 1B||5
11057121|NCT00996892|12238689|FG018|STARTED|Dose-Escalation Stage 1B||0
11417836|NCT00616577|12615964|FG001|NOT COMPLETED|Overall Study||0
11417837|NCT00616577|12615965|FG002|NOT COMPLETED|Overall Study||0
11057122|NCT00996892|12238690|FG019|STARTED|Dose-Escalation Stage 1B||0
11057123|NCT00996892|12238671|FG000|COMPLETED|Dose-Escalation Stage 1B||0
11057124|NCT00996892|12238672|FG001|COMPLETED|Dose-Escalation Stage 1B||0
11057125|NCT00996892|12238673|FG002|COMPLETED|Dose-Escalation Stage 1B||0
11057126|NCT00996892|12238674|FG003|COMPLETED|Dose-Escalation Stage 1B||0
11057127|NCT00996892|12238675|FG004|COMPLETED|Dose-Escalation Stage 1B||0
11057128|NCT00996892|12238676|FG005|COMPLETED|Dose-Escalation Stage 1B||0
11057129|NCT00996892|12238677|FG006|COMPLETED|Dose-Escalation Stage 1B||0
11057130|NCT00996892|12238678|FG007|COMPLETED|Dose-Escalation Stage 1B||0
11417838|NCT00616759|12615975|FG000|STARTED|Overall Study||10
11417839|NCT00616759|12615976|FG001|STARTED|Overall Study||10
11057131|NCT00996892|12238679|FG008|COMPLETED|Dose-Escalation Stage 1B||0
11057132|NCT00996892|12238680|FG009|COMPLETED|Dose-Escalation Stage 1B||0
11057133|NCT00996892|12238681|FG010|COMPLETED|Dose-Escalation Stage 1B||0
11417840|NCT00616759|12615975|FG000|COMPLETED|Overall Study||7
11057134|NCT00996892|12238682|FG011|COMPLETED|Dose-Escalation Stage 1B||0
11057135|NCT00996892|12238683|FG012|COMPLETED|Dose-Escalation Stage 1B||0
11057136|NCT00996892|12238684|FG013|COMPLETED|Dose-Escalation Stage 1B||0
11057137|NCT00996892|12238685|FG014|COMPLETED|Dose-Escalation Stage 1B||0
11057138|NCT00996892|12238686|FG015|COMPLETED|Dose-Escalation Stage 1B||0
11057139|NCT00996892|12238687|FG016|COMPLETED|Dose-Escalation Stage 1B||0
11057140|NCT00996892|12238688|FG017|COMPLETED|Dose-Escalation Stage 1B||0
11057141|NCT00996892|12238689|FG018|COMPLETED|Dose-Escalation Stage 1B||0
11057142|NCT00996892|12238690|FG019|COMPLETED|Dose-Escalation Stage 1B||0
11057143|NCT00996892|12238671|FG000|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057144|NCT00996892|12238672|FG001|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057145|NCT00996892|12238673|FG002|NOT COMPLETED|Dose-Escalation Stage 1B||0
11417841|NCT00616759|12615976|FG001|COMPLETED|Overall Study||8
11417842|NCT00616759|12615975|FG000|NOT COMPLETED|Overall Study||3
11417843|NCT00616759|12615976|FG001|NOT COMPLETED|Overall Study||2
11417844|NCT00616642|12615984|FG000|STARTED|Overall Study||0
11417845|NCT00616642|12615985|FG001|STARTED|Overall Study||1
11024959|NCT00820664|12203297|FG000|STARTED|Overall Study||9
11024960|NCT00820664|12203298|FG001|STARTED|Overall Study||11
11024961|NCT00820664|12203299|FG002|STARTED|Overall Study||9
11024962|NCT00820664|12203297|FG000|COMPLETED|Overall Study||9
11024963|NCT00820664|12203298|FG001|COMPLETED|Overall Study||11
11024964|NCT00820664|12203299|FG002|COMPLETED|Overall Study||9
11024965|NCT00820664|12203297|FG000|NOT COMPLETED|Overall Study||0
11024966|NCT00820664|12203298|FG001|NOT COMPLETED|Overall Study||0
11024967|NCT00820664|12203299|FG002|NOT COMPLETED|Overall Study||0
11024968|NCT00820755|12203307|FG000|STARTED|Period 1: Combination Therapy Phase||583
11024969|NCT00820755|12203308|FG001|STARTED|Period 1: Combination Therapy Phase||0
11024970|NCT00820755|12203309|FG002|STARTED|Period 1: Combination Therapy Phase||0
11024971|NCT00820755|12203307|FG000|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
11024972|NCT00820755|12203308|FG001|COMPLETED|Period 1: Combination Therapy Phase||0
11024973|NCT00820755|12203309|FG002|COMPLETED|Period 1: Combination Therapy Phase||0
11024974|NCT00820755|12203307|FG000|NOT COMPLETED|Period 1: Combination Therapy Phase||270
11024975|NCT00820755|12203308|FG001|NOT COMPLETED|Period 1: Combination Therapy Phase||0
11024976|NCT00820755|12203309|FG002|NOT COMPLETED|Period 1: Combination Therapy Phase||0
11024977|NCT00820755|12203307|FG000|STARTED|Period 2: Maintenance Therapy Phase||0
11024978|NCT00820755|12203308|FG001|STARTED|Period 2: Maintenance Therapy Phase||157
11024979|NCT00820755|12203309|FG002|STARTED|Period 2: Maintenance Therapy Phase||154
11024980|NCT00820755|12203307|FG000|COMPLETED|Period 2: Maintenance Therapy Phase||0
11024981|NCT00820755|12203308|FG001|COMPLETED|Period 2: Maintenance Therapy Phase||112
11024982|NCT00820755|12203309|FG002|COMPLETED|Period 2: Maintenance Therapy Phase||109
11024983|NCT00820755|12203307|FG000|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
11024984|NCT00820755|12203308|FG001|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
11024985|NCT00820755|12203309|FG002|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
11024986|NCT00820872|12203317|FG000|STARTED|Overall Study||30
11024987|NCT00820872|12203317|FG000|COMPLETED|Overall Study||30
11024988|NCT00820872|12203317|FG000|NOT COMPLETED|Overall Study||0
11024989|NCT00820898|12203321|FG000|STARTED|Overall Study||24
11024990|NCT00820898|12203321|FG000|COMPLETED|Overall Study||23
11024991|NCT00820898|12203321|FG000|NOT COMPLETED|Overall Study||1
11024992|NCT00821015|12203331|FG000|STARTED|Overall Study||27
11024993|NCT00821015|12203331|FG000|COMPLETED|Overall Study||15
11024994|NCT00821015|12203331|FG000|NOT COMPLETED|Overall Study||12
11024995|NCT00821041|12203337|FG000|STARTED|Overall Study||59
11024996|NCT00821041|12203338|FG001|STARTED|Overall Study||59
11024997|NCT00821041|12203337|FG000|COMPLETED|Overall Study||59
11024998|NCT00821041|12203338|FG001|COMPLETED|Overall Study||59
11024999|NCT00821041|12203337|FG000|NOT COMPLETED|Overall Study||0
11025000|NCT00821041|12203338|FG001|NOT COMPLETED|Overall Study||0
11025001|NCT00821093|12203346|FG000|STARTED|Overall Study||560
11025002|NCT00821093|12203347|FG001|STARTED|Overall Study||563
11025003|NCT00821093|12203346|FG000|Exposed to Drug|Overall Study||559
11417846|NCT00616642|12615984|FG000|COMPLETED|Overall Study||0
11417847|NCT00616642|12615985|FG001|COMPLETED|Overall Study||0
11417848|NCT00616642|12615984|FG000|NOT COMPLETED|Overall Study||0
11025004|NCT00821093|12203347|FG001|Exposed to Drug|Overall Study||562
11025005|NCT00821093|12203346|FG000|COMPLETED|Overall Study||511
11025006|NCT00821093|12203347|FG001|COMPLETED|Overall Study||523
11025007|NCT00821093|12203346|FG000|NOT COMPLETED|Overall Study||49
11025008|NCT00821093|12203347|FG001|NOT COMPLETED|Overall Study||40
11025009|NCT00821119|12203355|FG000|STARTED|Overall Study||100
11025010|NCT00821119|12203356|FG001|STARTED|Overall Study||100
11025011|NCT00821119|12203355|FG000|COMPLETED|Overall Study||100
11417849|NCT00616642|12615985|FG001|NOT COMPLETED|Overall Study||1
11025012|NCT00821119|12203356|FG001|COMPLETED|Overall Study||100
11025013|NCT00821119|12203355|FG000|NOT COMPLETED|Overall Study||0
11025014|NCT00821119|12203356|FG001|NOT COMPLETED|Overall Study||0
11025015|NCT00821184|12203366|FG000|STARTED|Overall Study||6
11025016|NCT00821184|12203367|FG001|STARTED|Overall Study||6
11025017|NCT00821184|12203366|FG000|COMPLETED|Overall Study||6
11025018|NCT00821184|12203367|FG001|COMPLETED|Overall Study||6
11025019|NCT00821184|12203366|FG000|NOT COMPLETED|Overall Study||0
11025020|NCT00821184|12203367|FG001|NOT COMPLETED|Overall Study||0
11057146|NCT00996892|12238674|FG003|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057147|NCT00996892|12238675|FG004|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057148|NCT00996892|12238676|FG005|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057149|NCT00996892|12238677|FG006|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057150|NCT00996892|12238678|FG007|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057151|NCT00996892|12238679|FG008|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057152|NCT00996892|12238680|FG009|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057153|NCT00996892|12238681|FG010|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057154|NCT00996892|12238682|FG011|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057155|NCT00996892|12238683|FG012|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057156|NCT00996892|12238684|FG013|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057157|NCT00996892|12238685|FG014|NOT COMPLETED|Dose-Escalation Stage 1B||4
11144586|NCT01479621|12331374|FG000|COMPLETED|Treatment Period||0
11144587|NCT01479621|12331375|FG001|COMPLETED|Treatment Period||79
11144588|NCT01479621|12331376|FG002|COMPLETED|Treatment Period||83
11144589|NCT01479621|12331377|FG003|COMPLETED|Treatment Period||92
11144590|NCT01479621|12331378|FG004|COMPLETED|Treatment Period||82
11144591|NCT01479621|12331379|FG005|COMPLETED|Treatment Period||63
11144592|NCT01479621|12331380|FG006|COMPLETED|Treatment Period||84
11417850|NCT00619515|12615991|FG000|STARTED|Overall Study||73
11144593|NCT01479621|12331374|FG000|NOT COMPLETED|Treatment Period||0
11144594|NCT01479621|12331375|FG001|NOT COMPLETED|Treatment Period||24
11144595|NCT01479621|12331376|FG002|NOT COMPLETED|Treatment Period||21
11144596|NCT01479621|12331377|FG003|NOT COMPLETED|Treatment Period||12
11144597|NCT01479621|12331378|FG004|NOT COMPLETED|Treatment Period||21
11144598|NCT01479621|12331379|FG005|NOT COMPLETED|Treatment Period||41
11144599|NCT01479621|12331380|FG006|NOT COMPLETED|Treatment Period||20
11144600|NCT01479725|12331396|FG000|STARTED|Overall Study||6
11144601|NCT01479725|12331397|FG001|STARTED|Overall Study||2
11144602|NCT01479725|12331396|FG000|COMPLETED|Overall Study||4
11144603|NCT01479725|12331397|FG001|COMPLETED|Overall Study||1
11144604|NCT01479725|12331396|FG000|NOT COMPLETED|Overall Study||2
11144605|NCT01479725|12331397|FG001|NOT COMPLETED|Overall Study||1
11144606|NCT01479764|12331405|FG000|STARTED|Randomized||76
11144607|NCT01479764|12331406|FG001|STARTED|Randomized||78
11144608|NCT01479764|12331405|FG000|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
11144609|NCT01479764|12331406|FG001|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
11144610|NCT01479764|12331405|FG000|NOT COMPLETED|Randomized||2
11144611|NCT01479764|12331406|FG001|NOT COMPLETED|Randomized||1
11144612|NCT01479764|12331405|FG000|STARTED|Treated||74
11144613|NCT01479764|12331406|FG001|STARTED|Treated||77
11144614|NCT01479764|12331405|FG000|COMPLETED|Treated||74
11144615|NCT01479764|12331406|FG001|COMPLETED|Treated||75
11144616|NCT01479764|12331405|FG000|NOT COMPLETED|Treated||0
11144617|NCT01479764|12331406|FG001|NOT COMPLETED|Treated||2
11144618|NCT01479777|12331412|FG000|STARTED|Overall Study||12
11144619|NCT01479777|12331412|FG000|COMPLETED|Overall Study||10
11144620|NCT01479777|12331412|FG000|NOT COMPLETED|Overall Study||2
11144621|NCT01479868|12331416|FG000|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
11144622|NCT01479868|12331416|FG000|COMPLETED|Overall Study||97
11144623|NCT01479868|12331416|FG000|NOT COMPLETED|Overall Study||9
11144624|NCT01479985|12331422|FG000|STARTED|Overall Study||167
11144625|NCT01479985|12331423|FG001|STARTED|Overall Study||86
11144626|NCT01479985|12331422|FG000|Baseline Survey|Overall Study||166
11144627|NCT01479985|12331423|FG001|Baseline Survey|Overall Study||85
11144628|NCT01479985|12331422|FG000|COMPLETED|Overall Study||161
11144629|NCT01479985|12331423|FG001|COMPLETED|Overall Study||80
11144630|NCT01479985|12331422|FG000|NOT COMPLETED|Overall Study||6
11144631|NCT01479985|12331423|FG001|NOT COMPLETED|Overall Study||6
11144632|NCT01480076|12331431|FG000|STARTED|Overall Study|enrolled and started run-in treatment|901
11144633|NCT01480076|12331431|FG000|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
11144634|NCT01480076|12331431|FG000|COMPLETED|Overall Study||611
11144635|NCT01480076|12331431|FG000|NOT COMPLETED|Overall Study||290
11144636|NCT01480089|12331449|FG000|STARTED|Overall Study||25
11144637|NCT01480089|12331450|FG001|STARTED|Overall Study||30
11025021|NCT04187989|12203377|FG000|STARTED|Overall Study - 3-Month Follow-Up||76
11025022|NCT04187989|12203378|FG001|STARTED|Overall Study - 3-Month Follow-Up||73
11025023|NCT04187989|12203377|FG000|COMPLETED|Overall Study - 3-Month Follow-Up||70
11025024|NCT04187989|12203378|FG001|COMPLETED|Overall Study - 3-Month Follow-Up||65
11025025|NCT04187989|12203377|FG000|NOT COMPLETED|Overall Study - 3-Month Follow-Up||6
11025026|NCT04187989|12203378|FG001|NOT COMPLETED|Overall Study - 3-Month Follow-Up||8
11025027|NCT04187989|12203377|FG000|STARTED|Overall Study - 6-Month Follow-Up||76
11025028|NCT04187989|12203378|FG001|STARTED|Overall Study - 6-Month Follow-Up||73
11025029|NCT04187989|12203377|FG000|COMPLETED|Overall Study - 6-Month Follow-Up||68
11025030|NCT04187989|12203378|FG001|COMPLETED|Overall Study - 6-Month Follow-Up||65
11025031|NCT04187989|12203377|FG000|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8
11144638|NCT01480089|12331449|FG000|COMPLETED|Overall Study||25
11144639|NCT01480089|12331450|FG001|COMPLETED|Overall Study||30
11144640|NCT01480089|12331449|FG000|NOT COMPLETED|Overall Study||0
11144641|NCT01480089|12331450|FG001|NOT COMPLETED|Overall Study||0
11144642|NCT01480219|12331458|FG000|STARTED|Overall Study||325
11144643|NCT01480219|12331459|FG001|STARTED|Overall Study||142
11144644|NCT01480219|12331458|FG000|COMPLETED|Overall Study||325
11144645|NCT01480219|12331459|FG001|COMPLETED|Overall Study||142
11025032|NCT04187989|12203378|FG001|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8
11025033|NCT04109118|12203384|FG000|STARTED|Overall Study||4
11025034|NCT04109118|12203384|FG000|COMPLETED|Overall Study||1
11025035|NCT04109118|12203384|FG000|NOT COMPLETED|Overall Study||3
11025036|NCT03846219|12203392|FG000|STARTED|Overall Study||72
11025037|NCT03846219|12203393|FG001|STARTED|Overall Study||69
11025038|NCT03846219|12203394|FG002|STARTED|Overall Study||69
11025039|NCT03846219|12203392|FG000|Patients Treated|Overall Study||71
11025040|NCT03846219|12203393|FG001|Patients Treated|Overall Study||69
11025041|NCT03846219|12203394|FG002|Patients Treated|Overall Study||69
11025042|NCT03846219|12203392|FG000|COMPLETED|Overall Study||69
11025043|NCT03846219|12203393|FG001|COMPLETED|Overall Study||65
11025044|NCT03846219|12203394|FG002|COMPLETED|Overall Study||64
11025045|NCT03846219|12203392|FG000|NOT COMPLETED|Overall Study||3
11025046|NCT03846219|12203393|FG001|NOT COMPLETED|Overall Study||4
11025047|NCT03846219|12203394|FG002|NOT COMPLETED|Overall Study||5
11025048|NCT03758404|12203413|FG000|STARTED|Overall Study||3
11025049|NCT03758404|12203414|FG001|STARTED|Overall Study||3
11025050|NCT03758404|12203415|FG002|STARTED|Overall Study||5
11025051|NCT03758404|12203413|FG000|COMPLETED|Overall Study||3
11025052|NCT03758404|12203414|FG001|COMPLETED|Overall Study||3
11025053|NCT03758404|12203415|FG002|COMPLETED|Overall Study||5
11025054|NCT03758404|12203413|FG000|NOT COMPLETED|Overall Study||0
11025055|NCT03758404|12203414|FG001|NOT COMPLETED|Overall Study||0
11025056|NCT03758404|12203415|FG002|NOT COMPLETED|Overall Study||0
11025057|NCT03698708|12203425|FG000|STARTED|Overall Study||17
11025058|NCT03698708|12203426|FG001|STARTED|Overall Study||20
11025059|NCT03698708|12203425|FG000|COMPLETED|Overall Study||13
11025060|NCT03698708|12203426|FG001|COMPLETED|Overall Study||16
11025061|NCT03698708|12203425|FG000|NOT COMPLETED|Overall Study||4
11025062|NCT03698708|12203426|FG001|NOT COMPLETED|Overall Study||4
11025063|NCT03608696|12203432|FG000|STARTED|Overall Study||10
11025064|NCT03608696|12203432|FG000|COMPLETED|Overall Study||10
11025065|NCT03608696|12203432|FG000|NOT COMPLETED|Overall Study||0
11025066|NCT03606668|12203436|FG000|STARTED|Overall Study||20
11025067|NCT03606668|12203436|FG000|COMPLETED|Overall Study||18
11025068|NCT03606668|12203436|FG000|NOT COMPLETED|Overall Study||2
11025069|NCT03575897|12203442|FG000|STARTED|Overall Study||25
11025070|NCT03575897|12203443|FG001|STARTED|Overall Study||25
11025071|NCT03575897|12203442|FG000|COMPLETED|Overall Study||13
11025072|NCT03575897|12203443|FG001|COMPLETED|Overall Study||12
11025073|NCT03575897|12203442|FG000|NOT COMPLETED|Overall Study||12
11025074|NCT03575897|12203443|FG001|NOT COMPLETED|Overall Study||13
11057158|NCT00996892|12238686|FG015|NOT COMPLETED|Dose-Escalation Stage 1B||3
11057159|NCT00996892|12238687|FG016|NOT COMPLETED|Dose-Escalation Stage 1B||3
11057160|NCT00996892|12238688|FG017|NOT COMPLETED|Dose-Escalation Stage 1B||5
11057161|NCT00996892|12238689|FG018|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057162|NCT00996892|12238690|FG019|NOT COMPLETED|Dose-Escalation Stage 1B||0
11057163|NCT00996892|12238671|FG000|STARTED|Expansion Stage 2||0
11057164|NCT00996892|12238672|FG001|STARTED|Expansion Stage 2||0
11057165|NCT00996892|12238673|FG002|STARTED|Expansion Stage 2||0
11057166|NCT00996892|12238674|FG003|STARTED|Expansion Stage 2||0
11057167|NCT00996892|12238675|FG004|STARTED|Expansion Stage 2||0
11057168|NCT00996892|12238676|FG005|STARTED|Expansion Stage 2||0
11057169|NCT00996892|12238677|FG006|STARTED|Expansion Stage 2||0
11057170|NCT00996892|12238678|FG007|STARTED|Expansion Stage 2||0
11057171|NCT00996892|12238679|FG008|STARTED|Expansion Stage 2||0
11057172|NCT00996892|12238680|FG009|STARTED|Expansion Stage 2||0
11057173|NCT00996892|12238681|FG010|STARTED|Expansion Stage 2||0
11057174|NCT00996892|12238682|FG011|STARTED|Expansion Stage 2||0
11057175|NCT00996892|12238683|FG012|STARTED|Expansion Stage 2||0
11057176|NCT00996892|12238684|FG013|STARTED|Expansion Stage 2||0
11057177|NCT00996892|12238685|FG014|STARTED|Expansion Stage 2||0
11057178|NCT00996892|12238686|FG015|STARTED|Expansion Stage 2||0
11057179|NCT00996892|12238687|FG016|STARTED|Expansion Stage 2||0
11057180|NCT00996892|12238688|FG017|STARTED|Expansion Stage 2||0
11057181|NCT00996892|12238689|FG018|STARTED|Expansion Stage 2||35
11057182|NCT00996892|12238690|FG019|STARTED|Expansion Stage 2||0
11057183|NCT00996892|12238671|FG000|COMPLETED|Expansion Stage 2||0
11057184|NCT00996892|12238672|FG001|COMPLETED|Expansion Stage 2||0
11057185|NCT00996892|12238673|FG002|COMPLETED|Expansion Stage 2||0
11057186|NCT00996892|12238674|FG003|COMPLETED|Expansion Stage 2||0
11057187|NCT00996892|12238675|FG004|COMPLETED|Expansion Stage 2||0
11057188|NCT00996892|12238676|FG005|COMPLETED|Expansion Stage 2||0
11057189|NCT00996892|12238677|FG006|COMPLETED|Expansion Stage 2||0
11057190|NCT00996892|12238678|FG007|COMPLETED|Expansion Stage 2||0
11057191|NCT00996892|12238679|FG008|COMPLETED|Expansion Stage 2||0
11057192|NCT00996892|12238680|FG009|COMPLETED|Expansion Stage 2||0
11057193|NCT00996892|12238681|FG010|COMPLETED|Expansion Stage 2||0
11057194|NCT00996892|12238682|FG011|COMPLETED|Expansion Stage 2||0
11057195|NCT00996892|12238683|FG012|COMPLETED|Expansion Stage 2||0
11057196|NCT00996892|12238684|FG013|COMPLETED|Expansion Stage 2||0
11057197|NCT00996892|12238685|FG014|COMPLETED|Expansion Stage 2||0
11057198|NCT00996892|12238686|FG015|COMPLETED|Expansion Stage 2||0
11057199|NCT00996892|12238687|FG016|COMPLETED|Expansion Stage 2||0
11057200|NCT00996892|12238688|FG017|COMPLETED|Expansion Stage 2||0
11057201|NCT00996892|12238689|FG018|COMPLETED|Expansion Stage 2||0
11057202|NCT00996892|12238690|FG019|COMPLETED|Expansion Stage 2||0
11057203|NCT00996892|12238671|FG000|NOT COMPLETED|Expansion Stage 2||0
11057204|NCT00996892|12238672|FG001|NOT COMPLETED|Expansion Stage 2||0
11057205|NCT00996892|12238673|FG002|NOT COMPLETED|Expansion Stage 2||0
11057206|NCT00996892|12238674|FG003|NOT COMPLETED|Expansion Stage 2||0
11057207|NCT00996892|12238675|FG004|NOT COMPLETED|Expansion Stage 2||0
11057208|NCT00996892|12238676|FG005|NOT COMPLETED|Expansion Stage 2||0
11057209|NCT00996892|12238677|FG006|NOT COMPLETED|Expansion Stage 2||0
11057210|NCT00996892|12238678|FG007|NOT COMPLETED|Expansion Stage 2||0
11057211|NCT00996892|12238679|FG008|NOT COMPLETED|Expansion Stage 2||0
11057212|NCT00996892|12238680|FG009|NOT COMPLETED|Expansion Stage 2||0
11057213|NCT00996892|12238681|FG010|NOT COMPLETED|Expansion Stage 2||0
11057214|NCT00996892|12238682|FG011|NOT COMPLETED|Expansion Stage 2||0
11057215|NCT00996892|12238683|FG012|NOT COMPLETED|Expansion Stage 2||0
11057216|NCT00996892|12238684|FG013|NOT COMPLETED|Expansion Stage 2||0
11057217|NCT00996892|12238685|FG014|NOT COMPLETED|Expansion Stage 2||0
11057218|NCT00996892|12238686|FG015|NOT COMPLETED|Expansion Stage 2||0
11057219|NCT00996892|12238687|FG016|NOT COMPLETED|Expansion Stage 2||0
11057220|NCT00996892|12238688|FG017|NOT COMPLETED|Expansion Stage 2||0
11057221|NCT00996892|12238689|FG018|NOT COMPLETED|Expansion Stage 2||35
11057222|NCT00996892|12238690|FG019|NOT COMPLETED|Expansion Stage 2||0
11057223|NCT00996892|12238671|FG000|STARTED|Expansion Stage 2A||0
11057224|NCT00996892|12238672|FG001|STARTED|Expansion Stage 2A||0
11057225|NCT00996892|12238673|FG002|STARTED|Expansion Stage 2A||0
11057226|NCT00996892|12238674|FG003|STARTED|Expansion Stage 2A||0
11057227|NCT00996892|12238675|FG004|STARTED|Expansion Stage 2A||0
11057228|NCT00996892|12238676|FG005|STARTED|Expansion Stage 2A||0
11025075|NCT03343626|12203457|FG000|STARTED|Overall Study||31
11025076|NCT03343626|12203458|FG001|STARTED|Overall Study||31
11025077|NCT03343626|12203459|FG002|STARTED|Overall Study||31
11025078|NCT03343626|12203460|FG003|STARTED|Overall Study||32
11025079|NCT03343626|12203461|FG004|STARTED|Overall Study||36
11025080|NCT03343626|12203462|FG005|STARTED|Overall Study||37
11025081|NCT03343626|12203463|FG006|STARTED|Overall Study||37
11025082|NCT03343626|12203464|FG007|STARTED|Overall Study||36
11025083|NCT03343626|12203457|FG000|Safety Analysis Set|Overall Study||31
11025084|NCT03343626|12203458|FG001|Safety Analysis Set|Overall Study||31
11025085|NCT03343626|12203459|FG002|Safety Analysis Set|Overall Study||31
11025086|NCT03343626|12203460|FG003|Safety Analysis Set|Overall Study||32
11025087|NCT03343626|12203461|FG004|Safety Analysis Set|Overall Study||36
11025088|NCT03343626|12203462|FG005|Safety Analysis Set|Overall Study||37
11025089|NCT03343626|12203463|FG006|Safety Analysis Set|Overall Study||37
11025090|NCT03343626|12203464|FG007|Safety Analysis Set|Overall Study||36
11025091|NCT03343626|12203457|FG000|Full Analysis Set|Overall Study||30
11025092|NCT03343626|12203458|FG001|Full Analysis Set|Overall Study||28
11025093|NCT03343626|12203459|FG002|Full Analysis Set|Overall Study||31
11025094|NCT03343626|12203460|FG003|Full Analysis Set|Overall Study||30
11025095|NCT03343626|12203461|FG004|Full Analysis Set|Overall Study||34
11025096|NCT03343626|12203462|FG005|Full Analysis Set|Overall Study||34
11025097|NCT03343626|12203463|FG006|Full Analysis Set|Overall Study||34
11025098|NCT03343626|12203464|FG007|Full Analysis Set|Overall Study||34
11025099|NCT03343626|12203457|FG000|Per Protocol Set|Overall Study||28
11025100|NCT03343626|12203458|FG001|Per Protocol Set|Overall Study||25
11025101|NCT03343626|12203459|FG002|Per Protocol Set|Overall Study||29
11025102|NCT03343626|12203460|FG003|Per Protocol Set|Overall Study||30
11025103|NCT03343626|12203461|FG004|Per Protocol Set|Overall Study||34
11025104|NCT03343626|12203462|FG005|Per Protocol Set|Overall Study||33
11025105|NCT03343626|12203463|FG006|Per Protocol Set|Overall Study||34
11025106|NCT03343626|12203464|FG007|Per Protocol Set|Overall Study||33
11025107|NCT03343626|12203457|FG000|COMPLETED|Overall Study||25
11025108|NCT03343626|12203458|FG001|COMPLETED|Overall Study||26
11025109|NCT03343626|12203459|FG002|COMPLETED|Overall Study||29
11025110|NCT03343626|12203460|FG003|COMPLETED|Overall Study||24
11025111|NCT03343626|12203461|FG004|COMPLETED|Overall Study||29
11025112|NCT03343626|12203462|FG005|COMPLETED|Overall Study||32
11025113|NCT03343626|12203463|FG006|COMPLETED|Overall Study||32
11025114|NCT03343626|12203464|FG007|COMPLETED|Overall Study||25
11025115|NCT03343626|12203457|FG000|NOT COMPLETED|Overall Study||6
11025116|NCT03343626|12203458|FG001|NOT COMPLETED|Overall Study||5
11025117|NCT03343626|12203459|FG002|NOT COMPLETED|Overall Study||2
11025118|NCT03343626|12203460|FG003|NOT COMPLETED|Overall Study||8
11025119|NCT03343626|12203461|FG004|NOT COMPLETED|Overall Study||7
11025120|NCT03343626|12203462|FG005|NOT COMPLETED|Overall Study||5
11025121|NCT03343626|12203463|FG006|NOT COMPLETED|Overall Study||5
11025122|NCT03343626|12203464|FG007|NOT COMPLETED|Overall Study||11
11025123|NCT03088930|12203485|FG000|STARTED|Overall Study||3
11025124|NCT03088930|12203485|FG000|COMPLETED|Overall Study||3
11025125|NCT03088930|12203485|FG000|NOT COMPLETED|Overall Study||0
11025126|NCT02960204|12203493|FG000|STARTED|Overall Study||65
11025127|NCT02960204|12203494|FG001|STARTED|Overall Study||65
11025128|NCT02960204|12203495|FG002|STARTED|Overall Study||66
11025129|NCT02960204|12203496|FG003|STARTED|Overall Study||67
11025130|NCT02960204|12203493|FG000|Randomized|Overall Study||65
11025131|NCT02960204|12203494|FG001|Randomized|Overall Study||65
11025132|NCT02960204|12203495|FG002|Randomized|Overall Study||66
11025133|NCT02960204|12203496|FG003|Randomized|Overall Study||67
11025134|NCT02960204|12203493|FG000|Completed Week 24 of Study|Overall Study||62
11025135|NCT02960204|12203494|FG001|Completed Week 24 of Study|Overall Study||62
11025136|NCT02960204|12203495|FG002|Completed Week 24 of Study|Overall Study||60
11025137|NCT02960204|12203496|FG003|Completed Week 24 of Study|Overall Study||66
11025138|NCT02960204|12203493|FG000|Completed Week 48 of Study|Overall Study||55
11025139|NCT02960204|12203494|FG001|Completed Week 48 of Study|Overall Study||55
11025140|NCT02960204|12203495|FG002|Completed Week 48 of Study|Overall Study||50
11025141|NCT02960204|12203496|FG003|Completed Week 48 of Study|Overall Study||59
11025142|NCT02960204|12203493|FG000|COMPLETED|Overall Study||36
11025143|NCT02960204|12203494|FG001|COMPLETED|Overall Study||44
11025144|NCT02960204|12203495|FG002|COMPLETED|Overall Study||37
11025145|NCT02960204|12203496|FG003|COMPLETED|Overall Study||38
11025146|NCT02960204|12203493|FG000|NOT COMPLETED|Overall Study||29
11025147|NCT02960204|12203494|FG001|NOT COMPLETED|Overall Study||21
11025148|NCT02960204|12203495|FG002|NOT COMPLETED|Overall Study||29
11025149|NCT02960204|12203496|FG003|NOT COMPLETED|Overall Study||29
11025150|NCT02856269|12203508|FG000|STARTED|Overall Study||25
11025151|NCT02856269|12203509|FG001|STARTED|Overall Study||27
11025152|NCT02856269|12203508|FG000|COMPLETED|Overall Study||24
11417851|NCT00619515|12615991|FG000|COMPLETED|Overall Study||0
11417852|NCT00619515|12615991|FG000|NOT COMPLETED|Overall Study||73
11417853|NCT00616343|12615995|FG000|STARTED|Overall Study||9
11417854|NCT00616343|12615995|FG000|COMPLETED|Overall Study||9
11417855|NCT00616343|12615995|FG000|NOT COMPLETED|Overall Study||0
11417856|NCT00612677|12615999|FG000|STARTED|Overall Study||1
11025153|NCT02856269|12203509|FG001|COMPLETED|Overall Study||24
11025154|NCT02856269|12203508|FG000|NOT COMPLETED|Overall Study||1
11025155|NCT02856269|12203509|FG001|NOT COMPLETED|Overall Study||3
11417857|NCT00612677|12615999|FG000|COMPLETED|Overall Study||0
11417858|NCT00612677|12615999|FG000|NOT COMPLETED|Overall Study||1
11417859|NCT00616603|12616006|FG000|STARTED|Overall Study||14
11417860|NCT00616603|12616007|FG001|STARTED|Overall Study||14
11417861|NCT00616603|12616008|FG002|STARTED|Overall Study||15
11417862|NCT00616603|12616006|FG000|COMPLETED|Overall Study||12
11417863|NCT00616603|12616007|FG001|COMPLETED|Overall Study||14
11417864|NCT00616603|12616008|FG002|COMPLETED|Overall Study||13
11417865|NCT00616603|12616006|FG000|NOT COMPLETED|Overall Study||2
11417866|NCT00616603|12616007|FG001|NOT COMPLETED|Overall Study||0
11417867|NCT00616603|12616008|FG002|NOT COMPLETED|Overall Study||2
11417868|NCT00613886|12616016|FG000|STARTED|Overall Study||24
11025156|NCT02807363|12203519|FG000|STARTED|Dosing Period||9
11025157|NCT02807363|12203520|FG001|STARTED|Dosing Period||9
11025158|NCT02807363|12203521|FG002|STARTED|Dosing Period||5
11025159|NCT02807363|12203522|FG003|STARTED|Dosing Period||12
11025160|NCT02807363|12203519|FG000|COMPLETED|Dosing Period||9
11025161|NCT02807363|12203520|FG001|COMPLETED|Dosing Period||8
11025162|NCT02807363|12203521|FG002|COMPLETED|Dosing Period||5
11025163|NCT02807363|12203522|FG003|COMPLETED|Dosing Period||12
11025164|NCT02807363|12203519|FG000|NOT COMPLETED|Dosing Period||0
11417869|NCT00613886|12616016|FG000|COMPLETED|Overall Study||0
11417870|NCT00613886|12616016|FG000|NOT COMPLETED|Overall Study||24
11417871|NCT00610467|12616023|FG000|STARTED|Overall Study||1
11417872|NCT00610467|12616024|FG001|STARTED|Overall Study||1
11417873|NCT00610467|12616023|FG000|COMPLETED|Overall Study||1
11417874|NCT00610467|12616024|FG001|COMPLETED|Overall Study||1
11025165|NCT02807363|12203520|FG001|NOT COMPLETED|Dosing Period||1
11025166|NCT02807363|12203521|FG002|NOT COMPLETED|Dosing Period||0
11025167|NCT02807363|12203522|FG003|NOT COMPLETED|Dosing Period||0
11025168|NCT02807363|12203519|FG000|STARTED|Post- Dosing Period||9
11025169|NCT02807363|12203520|FG001|STARTED|Post- Dosing Period||8
11025170|NCT02807363|12203521|FG002|STARTED|Post- Dosing Period||5
11025171|NCT02807363|12203522|FG003|STARTED|Post- Dosing Period||12
11025172|NCT02807363|12203519|FG000|COMPLETED|Post- Dosing Period||9
11417875|NCT00610467|12616023|FG000|NOT COMPLETED|Overall Study||0
11417876|NCT00610467|12616024|FG001|NOT COMPLETED|Overall Study||0
11417877|NCT00610558|12616033|FG000|STARTED|Overall Study||20
11025173|NCT02807363|12203520|FG001|COMPLETED|Post- Dosing Period||8
11025174|NCT02807363|12203521|FG002|COMPLETED|Post- Dosing Period||5
11025175|NCT02807363|12203522|FG003|COMPLETED|Post- Dosing Period||12
11025176|NCT02807363|12203519|FG000|NOT COMPLETED|Post- Dosing Period||0
11025177|NCT02807363|12203520|FG001|NOT COMPLETED|Post- Dosing Period||0
11025178|NCT02807363|12203521|FG002|NOT COMPLETED|Post- Dosing Period||0
11025179|NCT02807363|12203522|FG003|NOT COMPLETED|Post- Dosing Period||0
11025180|NCT02756403|12203538|FG000|STARTED|Overall Study||46
11025181|NCT02756403|12203539|FG001|STARTED|Overall Study||45
11025182|NCT02756403|12203540|FG002|STARTED|Overall Study||43
11025183|NCT02756403|12203541|FG003|STARTED|Overall Study||47
11025184|NCT02756403|12203538|FG000|COMPLETED|Overall Study||46
11025185|NCT02756403|12203539|FG001|COMPLETED|Overall Study||42
11025186|NCT02756403|12203540|FG002|COMPLETED|Overall Study||41
11025187|NCT02756403|12203541|FG003|COMPLETED|Overall Study||45
11025188|NCT02756403|12203538|FG000|NOT COMPLETED|Overall Study||0
11025189|NCT02756403|12203539|FG001|NOT COMPLETED|Overall Study||3
11025190|NCT02756403|12203540|FG002|NOT COMPLETED|Overall Study||2
11025191|NCT02756403|12203541|FG003|NOT COMPLETED|Overall Study||2
11025192|NCT02751502|12203551|FG000|STARTED|Overall Study||4
11025193|NCT02751502|12203551|FG000|COMPLETED|Overall Study||0
11025194|NCT02751502|12203551|FG000|NOT COMPLETED|Overall Study||4
11025195|NCT02487797|12203557|FG000|STARTED|Overall Study||502
11025196|NCT02487797|12203558|FG001|STARTED|Overall Study||501
11025197|NCT02487797|12203557|FG000|COMPLETED|Overall Study||502
11025198|NCT02487797|12203558|FG001|COMPLETED|Overall Study||501
11025199|NCT02487797|12203557|FG000|NOT COMPLETED|Overall Study||0
11025200|NCT02487797|12203558|FG001|NOT COMPLETED|Overall Study||0
11025201|NCT02348359|12203568|FG000|STARTED|Overall Study||40
11025202|NCT02348359|12203569|FG001|STARTED|Overall Study||39
11025203|NCT02348359|12203570|FG002|STARTED|Overall Study||39
11025204|NCT02348359|12203571|FG003|STARTED|Overall Study||39
11025205|NCT02348359|12203568|FG000|COMPLETED|Overall Study||29
11025206|NCT02348359|12203569|FG001|COMPLETED|Overall Study||22
11025207|NCT02348359|12203570|FG002|COMPLETED|Overall Study||25
11025208|NCT02348359|12203571|FG003|COMPLETED|Overall Study||27
11025209|NCT02348359|12203568|FG000|NOT COMPLETED|Overall Study||11
11025210|NCT02348359|12203569|FG001|NOT COMPLETED|Overall Study||17
11025211|NCT02348359|12203570|FG002|NOT COMPLETED|Overall Study||14
11025212|NCT02348359|12203571|FG003|NOT COMPLETED|Overall Study||12
11025213|NCT01981096|12203583|FG000|STARTED|Overall Study||20
11025214|NCT01981096|12203584|FG001|STARTED|Overall Study||20
11025215|NCT01981096|12203583|FG000|Post-treatment|Overall Study||17
11025216|NCT01981096|12203584|FG001|Post-treatment|Overall Study||19
11025217|NCT01981096|12203583|FG000|COMPLETED|Overall Study||17
11025218|NCT01981096|12203584|FG001|COMPLETED|Overall Study||19
11025219|NCT01981096|12203583|FG000|NOT COMPLETED|Overall Study||3
11025220|NCT01981096|12203584|FG001|NOT COMPLETED|Overall Study||1
11025221|NCT01935336|12203594|FG000|STARTED|Overall Study|Only one subject was treated due to the black box warning RE: ponatinib-associated vascular issues. The protocol was modified with additional inclusion and exclusion criteria, which severely limited the number of cases treated with the drug|6
11025222|NCT01935336|12203595|FG001|STARTED|Overall Study|no subjects were treated in this arm|3
11025223|NCT01935336|12203596|FG002|STARTED|Overall Study|Only three subjects were treated due to the black box warning RE: ponatinib-associated vascular issues. The protocol was modified with additional inclusion and exclusion criteria, which severely limited the number of cases treated with the drug|47
11025224|NCT01935336|12203597|FG003|STARTED|Overall Study|No subjects were treated in this arm|66
11025225|NCT01935336|12203594|FG000|Started Treatment|Overall Study||1
11025226|NCT01935336|12203595|FG001|Started Treatment|Overall Study||0
11025227|NCT01935336|12203596|FG002|Started Treatment|Overall Study||3
11025228|NCT01935336|12203597|FG003|Started Treatment|Overall Study||0
11025229|NCT01935336|12203594|FG000|COMPLETED|Overall Study||0
11025230|NCT01935336|12203595|FG001|COMPLETED|Overall Study||0
11025231|NCT01935336|12203596|FG002|COMPLETED|Overall Study||0
11025232|NCT01935336|12203597|FG003|COMPLETED|Overall Study||0
11025233|NCT01935336|12203594|FG000|NOT COMPLETED|Overall Study||6
11025234|NCT01935336|12203595|FG001|NOT COMPLETED|Overall Study||3
11025235|NCT01935336|12203596|FG002|NOT COMPLETED|Overall Study||47
11025236|NCT01935336|12203597|FG003|NOT COMPLETED|Overall Study||66
11025237|NCT01712490|12203615|FG000|STARTED|Overall Study||664
11025238|NCT01712490|12203616|FG001|STARTED|Overall Study||670
11025239|NCT01712490|12203615|FG000|Treated|Overall Study||662
11025240|NCT01712490|12203616|FG001|Treated|Overall Study||659
11025241|NCT01712490|12203615|FG000|COMPLETED|Overall Study||0
11025242|NCT01712490|12203616|FG001|COMPLETED|Overall Study||0
11025243|NCT01712490|12203615|FG000|NOT COMPLETED|Overall Study||664
11025244|NCT01712490|12203616|FG001|NOT COMPLETED|Overall Study||670
11025245|NCT01702805|12203624|FG000|STARTED|Overall Study||911
11025246|NCT01702805|12203625|FG001|STARTED|Overall Study||913
11025247|NCT01702805|12203624|FG000|Completed Assessment for Neurodevelopmental Impairment|Overall Study||699
11025248|NCT01702805|12203625|FG001|Completed Assessment for Neurodevelopmental Impairment|Overall Study||712
11025249|NCT01702805|12203624|FG000|Died After Discharge|Overall Study||19
11025250|NCT01702805|12203625|FG001|Died After Discharge|Overall Study||10
11025251|NCT01702805|12203624|FG000|Died Before Discharge|Overall Study||127
11025252|NCT01702805|12203625|FG001|Died Before Discharge|Overall Study||125
11025253|NCT01702805|12203624|FG000|Survived to Discharge|Overall Study||781
11025254|NCT01702805|12203625|FG001|Survived to Discharge|Overall Study||781
11025255|NCT01702805|12203624|FG000|COMPLETED|Overall Study||845
11025256|NCT01702805|12203625|FG001|COMPLETED|Overall Study||847
11025257|NCT01702805|12203624|FG000|NOT COMPLETED|Overall Study||66
11025258|NCT01702805|12203625|FG001|NOT COMPLETED|Overall Study||66
11025259|NCT01499160|12203631|FG000|STARTED|Overall Study||7
11025260|NCT01499160|12203631|FG000|COMPLETED|Overall Study|"1 pt-withdrew consent~1pt-had cardiac toxicity"|5
11025261|NCT01499160|12203631|FG000|NOT COMPLETED|Overall Study||2
11025262|NCT01333436|12203638|FG000|STARTED|Overall Study||43
11025263|NCT01333436|12203639|FG001|STARTED|Overall Study||50
11025264|NCT01333436|12203638|FG000|COMPLETED|Overall Study||43
11025265|NCT01333436|12203639|FG001|COMPLETED|Overall Study||50
11025266|NCT01333436|12203638|FG000|NOT COMPLETED|Overall Study||0
11025267|NCT01333436|12203639|FG001|NOT COMPLETED|Overall Study||0
11025268|NCT01307631|12203645|FG000|STARTED|Overall Study||9
11025269|NCT01307631|12203646|FG001|STARTED|Overall Study||28
11025270|NCT01307631|12203645|FG000|COMPLETED|Overall Study||9
11025271|NCT01307631|12203646|FG001|COMPLETED|Overall Study||28
11025272|NCT01307631|12203645|FG000|NOT COMPLETED|Overall Study||0
11025273|NCT01307631|12203646|FG001|NOT COMPLETED|Overall Study||0
11025274|NCT01256086|12203656|FG000|STARTED|Treatment Day 1||11
11025275|NCT01256086|12203657|FG001|STARTED|Treatment Day 1||11
11025276|NCT01256086|12203658|FG002|STARTED|Treatment Day 1||11
11025277|NCT01256086|12203659|FG003|STARTED|Treatment Day 1||11
11025278|NCT01256086|12203656|FG000|COMPLETED|Treatment Day 1||11
11025279|NCT01256086|12203657|FG001|COMPLETED|Treatment Day 1||11
11025280|NCT01256086|12203658|FG002|COMPLETED|Treatment Day 1||11
11025281|NCT01256086|12203659|FG003|COMPLETED|Treatment Day 1||11
11025282|NCT01256086|12203656|FG000|NOT COMPLETED|Treatment Day 1||0
11025283|NCT01256086|12203657|FG001|NOT COMPLETED|Treatment Day 1||0
11025284|NCT01256086|12203658|FG002|NOT COMPLETED|Treatment Day 1||0
11025285|NCT01256086|12203659|FG003|NOT COMPLETED|Treatment Day 1||0
11025286|NCT01256086|12203656|FG000|STARTED|Treatment Day 2||11
11025287|NCT01256086|12203657|FG001|STARTED|Treatment Day 2||10
11025288|NCT01256086|12203658|FG002|STARTED|Treatment Day 2||9
11025289|NCT01256086|12203659|FG003|STARTED|Treatment Day 2||11
11025290|NCT01256086|12203656|FG000|COMPLETED|Treatment Day 2||11
11025291|NCT01256086|12203657|FG001|COMPLETED|Treatment Day 2||10
11025292|NCT01256086|12203658|FG002|COMPLETED|Treatment Day 2||9
11025293|NCT01256086|12203659|FG003|COMPLETED|Treatment Day 2||11
11025294|NCT01256086|12203656|FG000|NOT COMPLETED|Treatment Day 2||0
11025295|NCT01256086|12203657|FG001|NOT COMPLETED|Treatment Day 2||0
11025296|NCT01256086|12203658|FG002|NOT COMPLETED|Treatment Day 2||0
11025297|NCT01256086|12203659|FG003|NOT COMPLETED|Treatment Day 2||0
11025298|NCT01256086|12203656|FG000|STARTED|Treatment Day 3||11
11025299|NCT01256086|12203657|FG001|STARTED|Treatment Day 3||10
11025300|NCT01256086|12203658|FG002|STARTED|Treatment Day 3||9
11025301|NCT01256086|12203659|FG003|STARTED|Treatment Day 3||11
11025302|NCT01256086|12203656|FG000|COMPLETED|Treatment Day 3||11
11025303|NCT01256086|12203657|FG001|COMPLETED|Treatment Day 3||10
11025304|NCT01256086|12203658|FG002|COMPLETED|Treatment Day 3||9
11025305|NCT01256086|12203659|FG003|COMPLETED|Treatment Day 3||11
11025306|NCT01256086|12203656|FG000|NOT COMPLETED|Treatment Day 3||0
11025307|NCT01256086|12203657|FG001|NOT COMPLETED|Treatment Day 3||0
11025308|NCT01256086|12203658|FG002|NOT COMPLETED|Treatment Day 3||0
11025309|NCT01256086|12203659|FG003|NOT COMPLETED|Treatment Day 3||0
11025310|NCT01256086|12203656|FG000|STARTED|Treatment Day 4||11
11025311|NCT01256086|12203657|FG001|STARTED|Treatment Day 4||10
11025312|NCT01256086|12203658|FG002|STARTED|Treatment Day 4||9
11025313|NCT01256086|12203659|FG003|STARTED|Treatment Day 4||11
11025314|NCT01256086|12203656|FG000|COMPLETED|Treatment Day 4||11
11025315|NCT01256086|12203657|FG001|COMPLETED|Treatment Day 4||10
11025316|NCT01256086|12203658|FG002|COMPLETED|Treatment Day 4||9
11025317|NCT01256086|12203659|FG003|COMPLETED|Treatment Day 4||11
11025318|NCT01256086|12203656|FG000|NOT COMPLETED|Treatment Day 4||0
11025319|NCT01256086|12203657|FG001|NOT COMPLETED|Treatment Day 4||0
11025320|NCT01256086|12203658|FG002|NOT COMPLETED|Treatment Day 4||0
11025321|NCT01256086|12203659|FG003|NOT COMPLETED|Treatment Day 4||0
11025322|NCT01061151|12203673|FG000|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
11025323|NCT01061151|12203674|FG001|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
11025324|NCT01061151|12203675|FG002|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
11025325|NCT01061151|12203676|FG003|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
11025326|NCT01061151|12203673|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
11025327|NCT01061151|12203674|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
11025328|NCT01061151|12203675|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
11025329|NCT01061151|12203676|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
11025330|NCT01061151|12203673|FG000|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
11025331|NCT01061151|12203674|FG001|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
11025332|NCT01061151|12203675|FG002|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
11025333|NCT01061151|12203676|FG003|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
11025334|NCT01061151|12203673|FG000|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
11025335|NCT01061151|12203674|FG001|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
11025336|NCT01061151|12203675|FG002|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
11025337|NCT01061151|12203676|FG003|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
11025338|NCT01061151|12203673|FG000|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
11025339|NCT01061151|12203674|FG001|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
11025340|NCT01061151|12203675|FG002|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
11025341|NCT01061151|12203676|FG003|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
11025342|NCT01061151|12203673|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
11025343|NCT01061151|12203674|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
11025344|NCT01061151|12203675|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
11025345|NCT01061151|12203676|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
11025346|NCT01061151|12203673|FG000|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
11025347|NCT01061151|12203674|FG001|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
11025348|NCT01061151|12203675|FG002|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
11025349|NCT01061151|12203676|FG003|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
11025350|NCT01061151|12203673|FG000|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
11025351|NCT01061151|12203674|FG001|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
11025352|NCT01061151|12203675|FG002|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
11025353|NCT01061151|12203676|FG003|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
11025354|NCT00981058|12203698|FG000|STARTED|Overall Study||545
11025355|NCT00981058|12203699|FG001|STARTED|Overall Study||548
11025356|NCT00981058|12203698|FG000|Received at Least 1 Dose of Study Drug|Overall Study||538
11025357|NCT00981058|12203699|FG001|Received at Least 1 Dose of Study Drug|Overall Study||541
11025358|NCT00981058|12203698|FG000|Death Due to Any Cause|Overall Study||418
11025359|NCT00981058|12203699|FG001|Death Due to Any Cause|Overall Study||442
11025360|NCT00981058|12203698|FG000|COMPLETED|Overall Study||425
11025361|NCT00981058|12203699|FG001|COMPLETED|Overall Study||451
11025362|NCT00981058|12203698|FG000|NOT COMPLETED|Overall Study||120
11025363|NCT00981058|12203699|FG001|NOT COMPLETED|Overall Study||97
11025364|NCT00885495|12203707|FG000|STARTED|Overall Study||8
11417878|NCT00610558|12616034|FG001|STARTED|Overall Study||20
11417879|NCT00610558|12616035|FG002|STARTED|Overall Study||20
11417880|NCT00610558|12616033|FG000|COMPLETED|Overall Study||15
11417881|NCT00610558|12616034|FG001|COMPLETED|Overall Study||14
11417882|NCT00610558|12616035|FG002|COMPLETED|Overall Study||14
11417883|NCT00610558|12616033|FG000|NOT COMPLETED|Overall Study||5
11417884|NCT00610558|12616034|FG001|NOT COMPLETED|Overall Study||6
11417885|NCT00610558|12616035|FG002|NOT COMPLETED|Overall Study||6
11417886|NCT00610532|12616043|FG000|STARTED|Intravenous Phenytoin Alone||8
11025365|NCT00885495|12203708|FG001|STARTED|Overall Study||9
11025366|NCT00885495|12203707|FG000|COMPLETED|Overall Study||6
11025367|NCT00885495|12203708|FG001|COMPLETED|Overall Study||6
11025368|NCT00885495|12203707|FG000|NOT COMPLETED|Overall Study||2
11025369|NCT00885495|12203708|FG001|NOT COMPLETED|Overall Study||3
11057229|NCT00996892|12238677|FG006|STARTED|Expansion Stage 2A||0
11057230|NCT00996892|12238678|FG007|STARTED|Expansion Stage 2A||0
11057231|NCT00996892|12238679|FG008|STARTED|Expansion Stage 2A||0
11057232|NCT00996892|12238680|FG009|STARTED|Expansion Stage 2A||0
11057233|NCT00996892|12238681|FG010|STARTED|Expansion Stage 2A||0
11057234|NCT00996892|12238682|FG011|STARTED|Expansion Stage 2A||0
11057235|NCT00996892|12238683|FG012|STARTED|Expansion Stage 2A||0
11057236|NCT00996892|12238684|FG013|STARTED|Expansion Stage 2A||0
11057237|NCT00996892|12238685|FG014|STARTED|Expansion Stage 2A||0
11057238|NCT00996892|12238686|FG015|STARTED|Expansion Stage 2A||0
11057239|NCT00996892|12238687|FG016|STARTED|Expansion Stage 2A||0
11057240|NCT00996892|12238688|FG017|STARTED|Expansion Stage 2A||0
11057241|NCT00996892|12238689|FG018|STARTED|Expansion Stage 2A||0
11057242|NCT00996892|12238690|FG019|STARTED|Expansion Stage 2A||45
11057243|NCT00996892|12238671|FG000|COMPLETED|Expansion Stage 2A||0
11057244|NCT00996892|12238672|FG001|COMPLETED|Expansion Stage 2A||0
11057245|NCT00996892|12238673|FG002|COMPLETED|Expansion Stage 2A||0
11025370|NCT00084799|12203721|FG000|STARTED|Overall Study||5
11025371|NCT00084799|12203722|FG001|STARTED|Overall Study||5
11025372|NCT00084799|12203721|FG000|COMPLETED|Overall Study||4
11025373|NCT00084799|12203722|FG001|COMPLETED|Overall Study||5
11025374|NCT00084799|12203721|FG000|NOT COMPLETED|Overall Study||1
11025375|NCT00084799|12203722|FG001|NOT COMPLETED|Overall Study||0
11025376|NCT00821236|12203731|FG000|STARTED|Overall Study||40
11025377|NCT00821236|12203731|FG000|COMPLETED|Overall Study||37
11025378|NCT00821236|12203731|FG000|NOT COMPLETED|Overall Study||3
11025379|NCT00821327|12203739|FG000|STARTED|Overall Study||36
11025380|NCT00821327|12203739|FG000|COMPLETED|Overall Study||1
11025381|NCT00821327|12203739|FG000|NOT COMPLETED|Overall Study||35
11025382|NCT00821431|12203745|FG000|STARTED|Overall Study||38
11025383|NCT00821431|12203746|FG001|STARTED|Overall Study||52
11025384|NCT00821431|12203745|FG000|COMPLETED|Overall Study||23
11025385|NCT00821431|12203746|FG001|COMPLETED|Overall Study||47
11417887|NCT00610532|12616043|FG000|COMPLETED|Intravenous Phenytoin Alone||8
11417888|NCT00610532|12616043|FG000|NOT COMPLETED|Intravenous Phenytoin Alone||0
11417889|NCT00610532|12616043|FG000|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
11025386|NCT00821431|12203745|FG000|NOT COMPLETED|Overall Study||15
11025387|NCT00821431|12203746|FG001|NOT COMPLETED|Overall Study||5
11025388|NCT00821509|12203755|FG000|STARTED|Overall Study||257
11025389|NCT00821509|12203756|FG001|STARTED|Overall Study||202
11025390|NCT00821509|12203757|FG002|STARTED|Overall Study||224
11025391|NCT00821509|12203755|FG000|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
11025392|NCT00821509|12203756|FG001|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
11025393|NCT00821509|12203757|FG002|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
11025394|NCT00821509|12203755|FG000|NOT COMPLETED|Overall Study||12
11025395|NCT00821509|12203756|FG001|NOT COMPLETED|Overall Study||11
11025396|NCT00821509|12203757|FG002|NOT COMPLETED|Overall Study||34
11417890|NCT00610532|12616043|FG000|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
11025397|NCT00821626|12203767|FG000|STARTED|Overall Study||60
11025398|NCT00821626|12203768|FG001|STARTED|Overall Study||33
11025399|NCT00821626|12203767|FG000|COMPLETED|Overall Study||60
11025400|NCT00821626|12203768|FG001|COMPLETED|Overall Study||33
11025401|NCT00821626|12203767|FG000|NOT COMPLETED|Overall Study||0
11417891|NCT00610532|12616043|FG000|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
11417892|NCT00609765|12616049|FG000|STARTED|Overall Study||1
11417893|NCT00609765|12616049|FG000|COMPLETED|Overall Study||0
11417894|NCT00609765|12616049|FG000|NOT COMPLETED|Overall Study||1
11417895|NCT00608465|12616053|FG000|STARTED|Overall Study||4
11025402|NCT00821626|12203768|FG001|NOT COMPLETED|Overall Study||0
11025403|NCT00821678|12203778|FG000|STARTED|Overall Study||133
11025404|NCT00821678|12203779|FG001|STARTED|Overall Study||132
11025405|NCT00821678|12203778|FG000|COMPLETED|Overall Study||112
11025406|NCT00821678|12203779|FG001|COMPLETED|Overall Study||118
11025407|NCT00821678|12203778|FG000|NOT COMPLETED|Overall Study||21
11025408|NCT00821678|12203779|FG001|NOT COMPLETED|Overall Study||14
11025409|NCT00821795|12203789|FG000|STARTED|Overall Study||50
11025410|NCT00821795|12203790|FG001|STARTED|Overall Study||64
11025411|NCT00821795|12203789|FG000|COMPLETED|Overall Study||44
11025412|NCT00821795|12203790|FG001|COMPLETED|Overall Study||60
11025413|NCT00821795|12203789|FG000|NOT COMPLETED|Overall Study||6
11025414|NCT00821795|12203790|FG001|NOT COMPLETED|Overall Study||4
11025415|NCT00821821|12203799|FG000|STARTED|Overall Study||12
11025416|NCT00821821|12203800|FG001|STARTED|Overall Study||13
11025417|NCT00821821|12203801|FG002|STARTED|Overall Study||11
11025418|NCT00821821|12203799|FG000|COMPLETED|Overall Study||12
11025419|NCT00821821|12203800|FG001|COMPLETED|Overall Study||13
11025420|NCT00821821|12203801|FG002|COMPLETED|Overall Study||11
11025421|NCT00821821|12203799|FG000|NOT COMPLETED|Overall Study||0
11025422|NCT00821821|12203800|FG001|NOT COMPLETED|Overall Study||0
11025423|NCT00821821|12203801|FG002|NOT COMPLETED|Overall Study||0
11025424|NCT00821873|12203811|FG000|STARTED|Overall Study||9
11025425|NCT00821873|12203811|FG000|COMPLETED|Overall Study||5
11025426|NCT00821873|12203811|FG000|NOT COMPLETED|Overall Study||4
11025427|NCT00821886|12203815|FG000|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
11025428|NCT00821886|12203815|FG000|COMPLETED|Overall Study||49
11025429|NCT00821886|12203815|FG000|NOT COMPLETED|Overall Study||9
11025430|NCT00821951|12203819|FG000|STARTED|Overall Study||17
11025431|NCT00821951|12203819|FG000|COMPLETED|Overall Study||12
11025432|NCT00821951|12203819|FG000|NOT COMPLETED|Overall Study||5
11025433|NCT00821964|12203823|FG000|STARTED|Overall Study||15
11025434|NCT00821964|12203823|FG000|Evaluable for Clinical Response|Overall Study||14
11025435|NCT00821964|12203823|FG000|Evaluable for Pathologic Response|Overall Study||7
11025436|NCT00821964|12203823|FG000|COMPLETED|Overall Study||9
11025437|NCT00821964|12203823|FG000|NOT COMPLETED|Overall Study||6
11025438|NCT00822094|12203832|FG000|STARTED|Overall Study||81
11025439|NCT00822094|12203833|FG001|STARTED|Overall Study||45
11025440|NCT00822094|12203832|FG000|COMPLETED|Overall Study||37
11025441|NCT00822094|12203833|FG001|COMPLETED|Overall Study||20
11025442|NCT00822094|12203832|FG000|NOT COMPLETED|Overall Study||44
11025443|NCT00822094|12203833|FG001|NOT COMPLETED|Overall Study||25
11025444|NCT00822107|12203839|FG000|STARTED|Overall Study||5
11025445|NCT00822107|12203839|FG000|COMPLETED|Overall Study||5
11025446|NCT00822107|12203839|FG000|NOT COMPLETED|Overall Study||0
11025447|NCT00822172|12203845|FG000|STARTED|Overall Study||80
11025448|NCT00822172|12203846|FG001|STARTED|Overall Study||83
11025449|NCT00822172|12203845|FG000|COMPLETED|Overall Study||65
11025450|NCT00822172|12203846|FG001|COMPLETED|Overall Study||64
11025451|NCT00822172|12203845|FG000|NOT COMPLETED|Overall Study||15
11025452|NCT00822172|12203846|FG001|NOT COMPLETED|Overall Study||19
11025453|NCT00822185|12203857|FG000|STARTED|Overall Study||6
11025454|NCT00822185|12203858|FG001|STARTED|Overall Study||6
11025455|NCT00822185|12203859|FG002|STARTED|Overall Study||6
11025456|NCT00822185|12203860|FG003|STARTED|Overall Study||6
11025457|NCT00822185|12203861|FG004|STARTED|Overall Study||8
11025458|NCT00822185|12203857|FG000|COMPLETED|Overall Study||6
11025459|NCT00822185|12203858|FG001|COMPLETED|Overall Study||6
11025460|NCT00822185|12203859|FG002|COMPLETED|Overall Study||6
11025461|NCT00822185|12203860|FG003|COMPLETED|Overall Study||6
11025462|NCT00822185|12203861|FG004|COMPLETED|Overall Study||8
11025463|NCT00822185|12203857|FG000|NOT COMPLETED|Overall Study||0
11025464|NCT00822185|12203858|FG001|NOT COMPLETED|Overall Study||0
11025465|NCT00822185|12203859|FG002|NOT COMPLETED|Overall Study||0
11025466|NCT00822185|12203860|FG003|NOT COMPLETED|Overall Study||0
11025467|NCT00822185|12203861|FG004|NOT COMPLETED|Overall Study||0
11025468|NCT00822237|12203875|FG000|STARTED|Dose 1 Vaccination|Number randomized|299
11025469|NCT00822237|12203876|FG001|STARTED|Dose 1 Vaccination|Number randomized|299
11417896|NCT00608465|12616053|FG000|COMPLETED|Overall Study||4
11417897|NCT00608465|12616053|FG000|NOT COMPLETED|Overall Study||0
11025470|NCT00822237|12203875|FG000|COMPLETED|Dose 1 Vaccination||274
11025471|NCT00822237|12203876|FG001|COMPLETED|Dose 1 Vaccination||273
11025472|NCT00822237|12203875|FG000|NOT COMPLETED|Dose 1 Vaccination||25
11025473|NCT00822237|12203876|FG001|NOT COMPLETED|Dose 1 Vaccination||26
11025474|NCT00822237|12203875|FG000|STARTED|Dose 2 Vaccination|Number who received second dose|274
11025475|NCT00822237|12203876|FG001|STARTED|Dose 2 Vaccination|Number who received second dose|273
11417898|NCT00608777|12616057|FG000|STARTED|Overall Study||6
11025476|NCT00822237|12203875|FG000|COMPLETED|Dose 2 Vaccination||270
11025477|NCT00822237|12203876|FG001|COMPLETED|Dose 2 Vaccination||262
11025478|NCT00822237|12203875|FG000|NOT COMPLETED|Dose 2 Vaccination||4
11025479|NCT00822237|12203876|FG001|NOT COMPLETED|Dose 2 Vaccination||11
11025480|NCT00822328|12203883|FG000|STARTED|Overall Study||12
11025481|NCT00822328|12203884|FG001|STARTED|Overall Study||12
11025482|NCT00822328|12203883|FG000|COMPLETED|Overall Study||12
11025483|NCT00822328|12203884|FG001|COMPLETED|Overall Study||12
11025484|NCT00822328|12203883|FG000|NOT COMPLETED|Overall Study||0
11025485|NCT00822328|12203884|FG001|NOT COMPLETED|Overall Study||0
11025486|NCT00822354|12203892|FG000|STARTED|First Intervention (28 Days)||5
11025487|NCT00822354|12203893|FG001|STARTED|First Intervention (28 Days)||5
11025488|NCT00822354|12203892|FG000|COMPLETED|First Intervention (28 Days)||4
11025489|NCT00822354|12203893|FG001|COMPLETED|First Intervention (28 Days)||5
11025490|NCT00822354|12203892|FG000|NOT COMPLETED|First Intervention (28 Days)||1
11025491|NCT00822354|12203893|FG001|NOT COMPLETED|First Intervention (28 Days)||0
11025492|NCT00822354|12203892|FG000|STARTED|Washout (7 Days)||4
11025493|NCT00822354|12203893|FG001|STARTED|Washout (7 Days)||5
11025494|NCT00822354|12203892|FG000|COMPLETED|Washout (7 Days)||4
11025495|NCT00822354|12203893|FG001|COMPLETED|Washout (7 Days)||5
11025496|NCT00822354|12203892|FG000|NOT COMPLETED|Washout (7 Days)||0
11025497|NCT00822354|12203893|FG001|NOT COMPLETED|Washout (7 Days)||0
11025498|NCT00822354|12203892|FG000|STARTED|Second Intervention (28 Days)||4
11025499|NCT00822354|12203893|FG001|STARTED|Second Intervention (28 Days)||5
11025500|NCT00822354|12203892|FG000|COMPLETED|Second Intervention (28 Days)||3
11025501|NCT00822354|12203893|FG001|COMPLETED|Second Intervention (28 Days)||5
11025502|NCT00822354|12203892|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
11025503|NCT00822354|12203893|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
11025504|NCT00822510|12203903|FG000|STARTED|Overall Study||38
11025505|NCT00822510|12203904|FG001|STARTED|Overall Study||41
11025506|NCT00822510|12203903|FG000|COMPLETED|Overall Study||35
11025507|NCT00822510|12203904|FG001|COMPLETED|Overall Study||36
11025508|NCT00822510|12203903|FG000|NOT COMPLETED|Overall Study||3
11025509|NCT00822510|12203904|FG001|NOT COMPLETED|Overall Study||5
11025510|NCT00822523|12203915|FG000|STARTED|Overall Study||5
11025511|NCT00822523|12203916|FG001|STARTED|Overall Study||4
11025512|NCT00822523|12203917|FG002|STARTED|Overall Study||4
11025513|NCT00822523|12203915|FG000|COMPLETED|Overall Study||5
11025514|NCT00822523|12203916|FG001|COMPLETED|Overall Study||4
11025515|NCT00822523|12203917|FG002|COMPLETED|Overall Study||4
11025516|NCT00822523|12203915|FG000|NOT COMPLETED|Overall Study||0
11025517|NCT00822523|12203916|FG001|NOT COMPLETED|Overall Study||0
11025518|NCT00822523|12203917|FG002|NOT COMPLETED|Overall Study||0
11025519|NCT00822588|12203935|FG000|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
11025520|NCT00822588|12203936|FG001|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
11025521|NCT00822588|12203935|FG000|COMPLETED|Overall Study|APT/ITT analysis set|106
11025522|NCT00822588|12203936|FG001|COMPLETED|Overall Study|APT/ITT analysis set|110
11025523|NCT00822588|12203935|FG000|NOT COMPLETED|Overall Study||7
11025524|NCT00822588|12203936|FG001|NOT COMPLETED|Overall Study||4
11025525|NCT00822692|12203944|FG000|STARTED|Overall Study|July 1, 2008|63
11025526|NCT00822692|12203945|FG001|STARTED|Overall Study|July 1, 2008|76
11025527|NCT00822692|12203944|FG000|COMPLETED|Overall Study|June 1, 2009|46
11025528|NCT00822692|12203945|FG001|COMPLETED|Overall Study|June 1 , 2009|51
11025529|NCT00822692|12203944|FG000|NOT COMPLETED|Overall Study||17
11025530|NCT00822692|12203945|FG001|NOT COMPLETED|Overall Study||25
11025531|NCT00822757|12203953|FG000|STARTED|Overall Study||41
11025532|NCT00822757|12203954|FG001|STARTED|Overall Study||10
11025533|NCT00822757|12203953|FG000|COMPLETED|Overall Study||41
11025534|NCT00822757|12203954|FG001|COMPLETED|Overall Study||10
11025535|NCT00822757|12203953|FG000|NOT COMPLETED|Overall Study||0
11025536|NCT00822757|12203954|FG001|NOT COMPLETED|Overall Study||0
11025537|NCT00822770|12203962|FG000|STARTED|Overall Study||18
11025538|NCT00822770|12203963|FG001|STARTED|Overall Study||29
11025539|NCT00822770|12203962|FG000|COMPLETED|Overall Study||15
11025540|NCT00822770|12203963|FG001|COMPLETED|Overall Study||28
11025541|NCT00822770|12203962|FG000|NOT COMPLETED|Overall Study||3
11025542|NCT00822770|12203963|FG001|NOT COMPLETED|Overall Study||1
11025543|NCT00822900|12203971|FG000|STARTED|Overall Study||442
11025544|NCT00822900|12203972|FG001|STARTED|Overall Study||440
11025545|NCT00822900|12203971|FG000|COMPLETED|Overall Study||334
11025546|NCT00822900|12203972|FG001|COMPLETED|Overall Study||347
11025547|NCT00822900|12203971|FG000|NOT COMPLETED|Overall Study||108
11025548|NCT00822900|12203972|FG001|NOT COMPLETED|Overall Study||93
11025549|NCT00822926|12203980|FG000|STARTED|First Injection Visit||2
11025550|NCT00822926|12203981|FG001|STARTED|First Injection Visit||3
11025551|NCT00822926|12203980|FG000|COMPLETED|First Injection Visit||2
11025552|NCT00822926|12203981|FG001|COMPLETED|First Injection Visit||3
11025553|NCT00822926|12203980|FG000|NOT COMPLETED|First Injection Visit||0
11025554|NCT00822926|12203981|FG001|NOT COMPLETED|First Injection Visit||0
11025555|NCT00822926|12203980|FG000|STARTED|Washout (Varies Based on Scheduling)||2
11025556|NCT00822926|12203981|FG001|STARTED|Washout (Varies Based on Scheduling)||3
11025557|NCT00822926|12203980|FG000|COMPLETED|Washout (Varies Based on Scheduling)||2
11025558|NCT00822926|12203981|FG001|COMPLETED|Washout (Varies Based on Scheduling)||3
11025559|NCT00822926|12203980|FG000|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
11025560|NCT00822926|12203981|FG001|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
11025561|NCT00822926|12203980|FG000|STARTED|Second Injection Visit||2
11025562|NCT00822926|12203981|FG001|STARTED|Second Injection Visit||3
11025563|NCT00822926|12203980|FG000|COMPLETED|Second Injection Visit||1
11025564|NCT00822926|12203981|FG001|COMPLETED|Second Injection Visit||2
11025565|NCT00822926|12203980|FG000|NOT COMPLETED|Second Injection Visit||1
11025566|NCT00822926|12203981|FG001|NOT COMPLETED|Second Injection Visit||1
11025567|NCT00823043|12203990|FG000|STARTED|Overall Study||64
11025568|NCT00823043|12203991|FG001|STARTED|Overall Study||39
11025569|NCT00823043|12203990|FG000|COMPLETED|Overall Study||64
11025570|NCT00823043|12203991|FG001|COMPLETED|Overall Study||39
11025571|NCT00823043|12203990|FG000|NOT COMPLETED|Overall Study||0
11025572|NCT00823043|12203991|FG001|NOT COMPLETED|Overall Study||0
11025573|NCT00823069|12203996|FG000|STARTED|Overall Study||60
11025574|NCT00823069|12203996|FG000|COMPLETED|Overall Study||60
11025575|NCT00823069|12203996|FG000|NOT COMPLETED|Overall Study||0
11025576|NCT00823082|12204005|FG000|STARTED|Overall Study||100
11025577|NCT00823082|12204006|FG001|STARTED|Overall Study||100
11025578|NCT00823082|12204005|FG000|Safety Population|Overall Study||100
11025579|NCT00823082|12204006|FG001|Safety Population|Overall Study||99
11025580|NCT00823082|12204005|FG000|Intent-to-Treat/Per Protocol Populations|Overall Study||100
11025581|NCT00823082|12204006|FG001|Intent-to-Treat/Per Protocol Populations|Overall Study||94
11025582|NCT00823082|12204005|FG000|COMPLETED|Overall Study||100
11025583|NCT00823082|12204006|FG001|COMPLETED|Overall Study||99
11025584|NCT00823082|12204005|FG000|NOT COMPLETED|Overall Study||0
11025585|NCT00823082|12204006|FG001|NOT COMPLETED|Overall Study||1
11025586|NCT00823134|12204012|FG000|STARTED|Overall Study||23
11025587|NCT00823134|12204012|FG000|COMPLETED|Overall Study||22
11025588|NCT00823134|12204012|FG000|NOT COMPLETED|Overall Study||1
11025589|NCT00823199|12204017|FG000|STARTED|Overall Study||10
11025590|NCT00823199|12204017|FG000|COMPLETED|Overall Study||8
11025591|NCT00823199|12204017|FG000|NOT COMPLETED|Overall Study||2
11025592|NCT00823212|12204024|FG000|STARTED|Overall Study||762
11025593|NCT00823212|12204025|FG001|STARTED|Overall Study||768
11025594|NCT00823212|12204024|FG000|COMPLETED|Overall Study|12-month follow-up|727
11025595|NCT00823212|12204025|FG001|COMPLETED|Overall Study|12-month follow-up|735
11025596|NCT00823212|12204024|FG000|NOT COMPLETED|Overall Study||35
11025597|NCT00823212|12204025|FG001|NOT COMPLETED|Overall Study||33
11025598|NCT00823264|12204035|FG000|STARTED|Overall Study||10
11025599|NCT00823264|12204036|FG001|STARTED|Overall Study||7
11025600|NCT00823264|12204035|FG000|COMPLETED|Overall Study||8
11025601|NCT00823264|12204036|FG001|COMPLETED|Overall Study||7
11025602|NCT00823264|12204035|FG000|NOT COMPLETED|Overall Study||2
11025603|NCT00823264|12204036|FG001|NOT COMPLETED|Overall Study||0
11025604|NCT00823303|12204044|FG000|STARTED|Overall Study||54
11025605|NCT00823303|12204045|FG001|STARTED|Overall Study||56
11025606|NCT00823303|12204044|FG000|COMPLETED|Overall Study||45
11025607|NCT00823303|12204045|FG001|COMPLETED|Overall Study||45
11025608|NCT00823303|12204044|FG000|NOT COMPLETED|Overall Study||9
11025609|NCT00823303|12204045|FG001|NOT COMPLETED|Overall Study||11
11025610|NCT00823459|12204051|FG000|STARTED|Overall Study||58
11025611|NCT00823459|12204051|FG000|COMPLETED|Overall Study||58
11025612|NCT00823459|12204051|FG000|NOT COMPLETED|Overall Study||0
11025613|NCT00823472|12204058|FG000|STARTED|Overall Study||80
11025614|NCT00823472|12204059|FG001|STARTED|Overall Study||67
11025615|NCT00823472|12204058|FG000|COMPLETED|Overall Study||56
11025616|NCT00823472|12204059|FG001|COMPLETED|Overall Study||39
11025617|NCT00823472|12204058|FG000|NOT COMPLETED|Overall Study||24
11025618|NCT00823472|12204059|FG001|NOT COMPLETED|Overall Study||28
11025619|NCT00823615|12204065|FG000|STARTED|Period 1||19
11025620|NCT00823615|12204066|FG001|STARTED|Period 1||19
11025621|NCT00823615|12204065|FG000|COMPLETED|Period 1||19
11025622|NCT00823615|12204066|FG001|COMPLETED|Period 1||19
11025623|NCT00823615|12204065|FG000|NOT COMPLETED|Period 1||0
11025624|NCT00823615|12204066|FG001|NOT COMPLETED|Period 1||0
11025625|NCT00823615|12204065|FG000|STARTED|Period 2||19
11025626|NCT00823615|12204066|FG001|STARTED|Period 2||19
11025627|NCT00823615|12204065|FG000|COMPLETED|Period 2||16
11025628|NCT00823615|12204066|FG001|COMPLETED|Period 2||17
11025629|NCT00823615|12204065|FG000|NOT COMPLETED|Period 2||3
11025630|NCT00823615|12204066|FG001|NOT COMPLETED|Period 2||2
11025631|NCT00823719|12204074|FG000|STARTED|Overall Study||26
11025632|NCT00823719|12204075|FG001|STARTED|Overall Study||35
11025633|NCT00823719|12204074|FG000|COMPLETED|Overall Study||20
11025634|NCT00823719|12204075|FG001|COMPLETED|Overall Study||24
11025635|NCT00823719|12204074|FG000|NOT COMPLETED|Overall Study||6
11025636|NCT00823719|12204075|FG001|NOT COMPLETED|Overall Study||11
11025637|NCT00823797|12204085|FG000|STARTED|Overall Study||29
11025638|NCT00823797|12204086|FG001|STARTED|Overall Study||16
11025639|NCT00823797|12204085|FG000|COMPLETED|Overall Study||29
11025640|NCT00823797|12204086|FG001|COMPLETED|Overall Study||16
11025641|NCT00823797|12204085|FG000|NOT COMPLETED|Overall Study||0
11025642|NCT00823797|12204086|FG001|NOT COMPLETED|Overall Study||0
11025643|NCT00823823|12204093|FG000|STARTED|Overall Study||109
11025644|NCT00823823|12204094|FG001|STARTED|Overall Study||107
11025645|NCT00823823|12204093|FG000|COMPLETED|Overall Study||101
11025646|NCT00823823|12204094|FG001|COMPLETED|Overall Study||101
11025647|NCT00823823|12204093|FG000|NOT COMPLETED|Overall Study||8
11025648|NCT00823823|12204094|FG001|NOT COMPLETED|Overall Study||6
11025649|NCT00823836|12204102|FG000|STARTED|NV and PR/XR Switching Phases||156
11025650|NCT00823836|12204103|FG001|STARTED|NV and PR/XR Switching Phases||146
11025651|NCT00823836|12204102|FG000|COMPLETED|NV and PR/XR Switching Phases||124
11025652|NCT00823836|12204103|FG001|COMPLETED|NV and PR/XR Switching Phases||117
11025653|NCT00823836|12204102|FG000|NOT COMPLETED|NV and PR/XR Switching Phases||32
11025654|NCT00823836|12204103|FG001|NOT COMPLETED|NV and PR/XR Switching Phases||29
11025655|NCT00823836|12204102|FG000|STARTED|Long-term Phase||73
11025656|NCT00823836|12204103|FG001|STARTED|Long-term Phase||84
11025657|NCT00823836|12204102|FG000|COMPLETED|Long-term Phase||68
11025658|NCT00823836|12204103|FG001|COMPLETED|Long-term Phase||79
11025659|NCT00823836|12204102|FG000|NOT COMPLETED|Long-term Phase||5
11025660|NCT00823836|12204103|FG001|NOT COMPLETED|Long-term Phase||5
11025661|NCT00823901|12204114|FG000|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
11025662|NCT00823901|12204115|FG001|STARTED|Overall Study|Randomized to placebo gel|40
11025663|NCT00823901|12204114|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
11025664|NCT00823901|12204115|FG001|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
11025665|NCT00823901|12204114|FG000|NOT COMPLETED|Overall Study||4
11025666|NCT00823901|12204115|FG001|NOT COMPLETED|Overall Study||2
11025667|NCT00823966|12204121|FG000|STARTED|Overall Study||3
11025668|NCT00823966|12204121|FG000|COMPLETED|Overall Study||3
11025669|NCT00823966|12204121|FG000|NOT COMPLETED|Overall Study||0
11025670|NCT00823979|12204128|FG000|STARTED|Overall Study||35
11025671|NCT00823979|12204129|FG001|STARTED|Overall Study||35
11025672|NCT00823979|12204130|FG002|STARTED|Overall Study||35
11025673|NCT00823979|12204128|FG000|Treated|Overall Study||31
11025674|NCT00823979|12204129|FG001|Treated|Overall Study||32
11025675|NCT00823979|12204130|FG002|Treated|Overall Study||34
11025676|NCT00823979|12204128|FG000|COMPLETED|Overall Study||6
11025677|NCT00823979|12204129|FG001|COMPLETED|Overall Study||3
11025678|NCT00823979|12204130|FG002|COMPLETED|Overall Study||11
11025679|NCT00823979|12204128|FG000|NOT COMPLETED|Overall Study||29
11025680|NCT00823979|12204129|FG001|NOT COMPLETED|Overall Study||32
11025681|NCT00823979|12204130|FG002|NOT COMPLETED|Overall Study||24
11025682|NCT00824005|12204140|FG000|STARTED|Overall Study||31
11025683|NCT00824005|12204141|FG001|STARTED|Overall Study||61
11025684|NCT00824005|12204140|FG000|COMPLETED|Overall Study||31
11025685|NCT00824005|12204141|FG001|COMPLETED|Overall Study||59
11025686|NCT00824005|12204140|FG000|NOT COMPLETED|Overall Study||0
11025687|NCT00824005|12204141|FG001|NOT COMPLETED|Overall Study||2
11025688|NCT00824044|12204149|FG000|STARTED|Overall Study||23
11025689|NCT00824044|12204150|FG001|STARTED|Overall Study||16
11025690|NCT00824044|12204149|FG000|COMPLETED|Overall Study||14
11025691|NCT00824044|12204150|FG001|COMPLETED|Overall Study||10
11025692|NCT00824044|12204149|FG000|NOT COMPLETED|Overall Study||9
11025693|NCT00824044|12204150|FG001|NOT COMPLETED|Overall Study||6
11025694|NCT00824070|12204163|FG000|STARTED|Overall Study||34
11025695|NCT00824070|12204164|FG001|STARTED|Overall Study||35
11025696|NCT00824070|12204165|FG002|STARTED|Overall Study||36
11025697|NCT00824070|12204163|FG000|COMPLETED|Overall Study||34
11025698|NCT00824070|12204164|FG001|COMPLETED|Overall Study||35
11025699|NCT00824070|12204165|FG002|COMPLETED|Overall Study||36
11025700|NCT00824070|12204163|FG000|NOT COMPLETED|Overall Study||0
11025701|NCT00824070|12204164|FG001|NOT COMPLETED|Overall Study||0
11025702|NCT00824070|12204165|FG002|NOT COMPLETED|Overall Study||0
11025703|NCT00824161|12204173|FG000|STARTED|Overall Study||28
11025704|NCT00824161|12204173|FG000|COMPLETED|Overall Study||26
11025705|NCT00824161|12204173|FG000|NOT COMPLETED|Overall Study||2
11025706|NCT00824265|12204180|FG000|STARTED|Treatment Phase||183
11025707|NCT00824265|12204181|FG001|STARTED|Treatment Phase||182
11025708|NCT00824265|12204180|FG000|COMPLETED|Treatment Phase||119
11025709|NCT00824265|12204181|FG001|COMPLETED|Treatment Phase||102
11025710|NCT00824265|12204180|FG000|NOT COMPLETED|Treatment Phase||64
11025711|NCT00824265|12204181|FG001|NOT COMPLETED|Treatment Phase||80
11025712|NCT00824265|12204180|FG000|STARTED|Follow-up Phase||172
11025713|NCT00824265|12204181|FG001|STARTED|Follow-up Phase||160
11025714|NCT00824265|12204180|FG000|COMPLETED|Follow-up Phase||154
11025715|NCT00824265|12204181|FG001|COMPLETED|Follow-up Phase||129
11025716|NCT00824265|12204180|FG000|NOT COMPLETED|Follow-up Phase||18
11025717|NCT00824265|12204181|FG001|NOT COMPLETED|Follow-up Phase||31
11025718|NCT00824265|12204180|FG000|STARTED|Survival Follow-up Phase||96
11025719|NCT00824265|12204181|FG001|STARTED|Survival Follow-up Phase||89
11025720|NCT00824265|12204180|FG000|COMPLETED|Survival Follow-up Phase||87
11025721|NCT00824265|12204181|FG001|COMPLETED|Survival Follow-up Phase||73
11025722|NCT00824265|12204180|FG000|NOT COMPLETED|Survival Follow-up Phase||9
11025723|NCT00824265|12204181|FG001|NOT COMPLETED|Survival Follow-up Phase||16
11025724|NCT00824291|12204193|FG000|STARTED|Overall Study||285
11025725|NCT00824291|12204194|FG001|STARTED|Overall Study||142
11025726|NCT00824291|12204193|FG000|COMPLETED|Overall Study||231
11025727|NCT00824291|12204194|FG001|COMPLETED|Overall Study||107
11025728|NCT00824291|12204193|FG000|NOT COMPLETED|Overall Study||54
11025729|NCT00824291|12204194|FG001|NOT COMPLETED|Overall Study||35
11025730|NCT00824369|12204206|FG000|STARTED|Overall Study||5
11025731|NCT00824369|12204207|FG001|STARTED|Overall Study||4
11025732|NCT00824369|12204208|FG002|STARTED|Overall Study||3
11025733|NCT00824369|12204209|FG003|STARTED|Overall Study||11
11025734|NCT00824369|12204210|FG004|STARTED|Overall Study||12
11025735|NCT00824369|12204211|FG005|STARTED|Overall Study||17
11025736|NCT00824369|12204206|FG000|COMPLETED|Overall Study||4
11025737|NCT00824369|12204207|FG001|COMPLETED|Overall Study||4
11025738|NCT00824369|12204208|FG002|COMPLETED|Overall Study||2
11025739|NCT00824369|12204209|FG003|COMPLETED|Overall Study||9
11025740|NCT00824369|12204210|FG004|COMPLETED|Overall Study||11
11025741|NCT00824369|12204211|FG005|COMPLETED|Overall Study||16
11025742|NCT00824369|12204206|FG000|NOT COMPLETED|Overall Study||1
11025743|NCT00824369|12204207|FG001|NOT COMPLETED|Overall Study||0
11025744|NCT00824369|12204208|FG002|NOT COMPLETED|Overall Study||1
11025745|NCT00824369|12204209|FG003|NOT COMPLETED|Overall Study||2
11025746|NCT00824369|12204210|FG004|NOT COMPLETED|Overall Study||1
11025747|NCT00824369|12204211|FG005|NOT COMPLETED|Overall Study||1
11025748|NCT00824382|12204229|FG000|STARTED|Overall Study||79
11025749|NCT00824382|12204230|FG001|STARTED|Overall Study||84
11025750|NCT00824382|12204231|FG002|STARTED|Overall Study||79
11025751|NCT00824382|12204232|FG003|STARTED|Overall Study||86
11025752|NCT00824382|12204229|FG000|COMPLETED|Overall Study||74
11025753|NCT00824382|12204230|FG001|COMPLETED|Overall Study||82
11025754|NCT00824382|12204231|FG002|COMPLETED|Overall Study||76
11025755|NCT00824382|12204232|FG003|COMPLETED|Overall Study||81
11025756|NCT00824382|12204229|FG000|NOT COMPLETED|Overall Study||5
11025757|NCT00824382|12204230|FG001|NOT COMPLETED|Overall Study||2
11025758|NCT00824382|12204231|FG002|NOT COMPLETED|Overall Study||3
11025759|NCT00824382|12204232|FG003|NOT COMPLETED|Overall Study||5
11025760|NCT00824408|12204249|FG000|STARTED|Run-in Phase||6
11025761|NCT00824408|12204250|FG001|STARTED|Run-in Phase||6
11025762|NCT00824408|12204251|FG002|STARTED|Run-in Phase||0
11025763|NCT00824408|12204252|FG003|STARTED|Run-in Phase||0
11025764|NCT00824408|12204253|FG004|STARTED|Run-in Phase||0
11025765|NCT00824408|12204249|FG000|COMPLETED|Run-in Phase||0
11025766|NCT00824408|12204250|FG001|COMPLETED|Run-in Phase||0
11025767|NCT00824408|12204251|FG002|COMPLETED|Run-in Phase||0
11025768|NCT00824408|12204252|FG003|COMPLETED|Run-in Phase||0
11025769|NCT00824408|12204253|FG004|COMPLETED|Run-in Phase||0
11025770|NCT00824408|12204249|FG000|NOT COMPLETED|Run-in Phase||6
11025771|NCT00824408|12204250|FG001|NOT COMPLETED|Run-in Phase||6
11025772|NCT00824408|12204251|FG002|NOT COMPLETED|Run-in Phase||0
11025773|NCT00824408|12204252|FG003|NOT COMPLETED|Run-in Phase||0
11025774|NCT00824408|12204253|FG004|NOT COMPLETED|Run-in Phase||0
11025775|NCT00824408|12204249|FG000|STARTED|Randomized Phase||0
11417899|NCT00608777|12616057|FG000|COMPLETED|Overall Study||6
11417900|NCT00608777|12616057|FG000|NOT COMPLETED|Overall Study||0
11417901|NCT00601848|12616061|FG000|STARTED|Overall Study||9
11417902|NCT00601848|12616061|FG000|COMPLETED|Overall Study||0
11417903|NCT00601848|12616061|FG000|NOT COMPLETED|Overall Study||9
11025776|NCT00824408|12204250|FG001|STARTED|Randomized Phase||0
11025777|NCT00824408|12204251|FG002|STARTED|Randomized Phase||37
11025778|NCT00824408|12204252|FG003|STARTED|Randomized Phase||47
11025779|NCT00824408|12204253|FG004|STARTED|Randomized Phase||47
11025780|NCT00824408|12204249|FG000|COMPLETED|Randomized Phase||0
11025781|NCT00824408|12204250|FG001|COMPLETED|Randomized Phase||0
11025782|NCT00824408|12204251|FG002|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
11025783|NCT00824408|12204252|FG003|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
11025784|NCT00824408|12204253|FG004|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
11025785|NCT00824408|12204249|FG000|NOT COMPLETED|Randomized Phase||0
11025786|NCT00824408|12204250|FG001|NOT COMPLETED|Randomized Phase||0
11025787|NCT00824408|12204251|FG002|NOT COMPLETED|Randomized Phase||36
11025788|NCT00824408|12204252|FG003|NOT COMPLETED|Randomized Phase||46
11025789|NCT00824408|12204253|FG004|NOT COMPLETED|Randomized Phase||46
11025790|NCT00824421|12204274|FG000|STARTED|Overall Study||66
11025791|NCT00824421|12204275|FG001|STARTED|Overall Study||66
11025792|NCT00824421|12204276|FG002|STARTED|Overall Study||63
11025793|NCT00824421|12204274|FG000|Treated|Overall Study||65
11025794|NCT00824421|12204275|FG001|Treated|Overall Study||65
11025795|NCT00824421|12204276|FG002|Treated|Overall Study||63
11025796|NCT00824421|12204274|FG000|COMPLETED|Overall Study||49
11025797|NCT00824421|12204275|FG001|COMPLETED|Overall Study||44
11025798|NCT00824421|12204276|FG002|COMPLETED|Overall Study||49
11025799|NCT00824421|12204274|FG000|NOT COMPLETED|Overall Study||17
11025800|NCT00824421|12204275|FG001|NOT COMPLETED|Overall Study||22
11025801|NCT00824421|12204276|FG002|NOT COMPLETED|Overall Study||14
11025802|NCT00824434|12204286|FG000|STARTED|Overall Study||100
11025803|NCT00824434|12204286|FG000|COMPLETED|Overall Study||100
11025804|NCT00824434|12204286|FG000|NOT COMPLETED|Overall Study||0
11025805|NCT00824460|12204296|FG000|STARTED|Overall Study||26
11025806|NCT00824460|12204297|FG001|STARTED|Overall Study||26
11025807|NCT00824460|12204298|FG002|STARTED|Overall Study||25
11025808|NCT00824460|12204299|FG003|STARTED|Overall Study||27
11025809|NCT00824460|12204300|FG004|STARTED|Overall Study||24
11025810|NCT00824460|12204301|FG005|STARTED|Overall Study||26
11025811|NCT00824460|12204296|FG000|COMPLETED|Overall Study||18
11025812|NCT00824460|12204297|FG001|COMPLETED|Overall Study||17
11025813|NCT00824460|12204298|FG002|COMPLETED|Overall Study||20
11417904|NCT00607477|12616067|FG000|STARTED|Overall Study||0
11417905|NCT00607477|12616068|FG001|STARTED|Overall Study||2
11417906|NCT00607477|12616067|FG000|COMPLETED|Overall Study||0
11025814|NCT00824460|12204299|FG003|COMPLETED|Overall Study||15
11025815|NCT00824460|12204300|FG004|COMPLETED|Overall Study||15
11025816|NCT00824460|12204301|FG005|COMPLETED|Overall Study||18
11025817|NCT00824460|12204296|FG000|NOT COMPLETED|Overall Study||8
11025818|NCT00824460|12204297|FG001|NOT COMPLETED|Overall Study||9
11025819|NCT00824460|12204298|FG002|NOT COMPLETED|Overall Study||5
11417907|NCT00607477|12616068|FG001|COMPLETED|Overall Study||2
11025820|NCT00824460|12204299|FG003|NOT COMPLETED|Overall Study||12
11025821|NCT00824460|12204300|FG004|NOT COMPLETED|Overall Study||9
11025822|NCT00824460|12204301|FG005|NOT COMPLETED|Overall Study||8
11025823|NCT00824473|12204325|FG000|STARTED|Overall Study|1 subject was randomized in error|255
11025824|NCT00824473|12204326|FG001|STARTED|Overall Study||251
11417908|NCT00607477|12616067|FG000|NOT COMPLETED|Overall Study||0
11025825|NCT00824473|12204325|FG000|COMPLETED|Overall Study||240
11025826|NCT00824473|12204326|FG001|COMPLETED|Overall Study||238
11025827|NCT00824473|12204325|FG000|NOT COMPLETED|Overall Study||15
11025828|NCT00824473|12204326|FG001|NOT COMPLETED|Overall Study||13
11025829|NCT00824512|12204334|FG000|STARTED|Overall Study||11
11025830|NCT00824512|12204335|FG001|STARTED|Overall Study||11
11025831|NCT00824512|12204334|FG000|COMPLETED|Overall Study||11
11025832|NCT00824512|12204335|FG001|COMPLETED|Overall Study||11
11025833|NCT00824512|12204334|FG000|NOT COMPLETED|Overall Study||0
11025834|NCT00824512|12204335|FG001|NOT COMPLETED|Overall Study||0
11025835|NCT00824538|12204341|FG000|STARTED|Overall Study|13 patients entered the study|13
11025836|NCT00824538|12204341|FG000|COMPLETED|Overall Study||11
11025837|NCT00824538|12204341|FG000|NOT COMPLETED|Overall Study||2
11025838|NCT00824564|12204348|FG000|STARTED|Overall Study||42
11144646|NCT01480219|12331458|FG000|NOT COMPLETED|Overall Study||0
11144647|NCT01480219|12331459|FG001|NOT COMPLETED|Overall Study||0
11144648|NCT01480232|12331469|FG000|STARTED|Overall Study||40
11144649|NCT01480232|12331470|FG001|STARTED|Overall Study||41
11144650|NCT01480232|12331471|FG002|STARTED|Overall Study||38
11144651|NCT01480232|12331472|FG003|STARTED|Overall Study||41
11144652|NCT01480232|12331469|FG000|COMPLETED|Overall Study||22
11144653|NCT01480232|12331470|FG001|COMPLETED|Overall Study||19
11144654|NCT01480232|12331471|FG002|COMPLETED|Overall Study||21
11144655|NCT01480232|12331472|FG003|COMPLETED|Overall Study||22
11144656|NCT01480232|12331469|FG000|NOT COMPLETED|Overall Study||18
11144657|NCT01480232|12331470|FG001|NOT COMPLETED|Overall Study||22
11144658|NCT01480232|12331471|FG002|NOT COMPLETED|Overall Study||17
11144659|NCT01480232|12331472|FG003|NOT COMPLETED|Overall Study||19
11144660|NCT01480258|12331484|FG000|STARTED|Infant Series||656
11144661|NCT01480258|12331485|FG001|STARTED|Infant Series||659
11144662|NCT01480258|12331484|FG000|Vaccinated|Infant Series||653
11144663|NCT01480258|12331485|FG001|Vaccinated|Infant Series||659
11144664|NCT01480258|12331484|FG000|COMPLETED|Infant Series||649
11144665|NCT01480258|12331485|FG001|COMPLETED|Infant Series||651
11144666|NCT01480258|12331484|FG000|NOT COMPLETED|Infant Series||7
11144667|NCT01480258|12331485|FG001|NOT COMPLETED|Infant Series||8
11144668|NCT01480258|12331484|FG000|STARTED|Interim Period||649
11144669|NCT01480258|12331485|FG001|STARTED|Interim Period||651
11144670|NCT01480258|12331484|FG000|COMPLETED|Interim Period||639
11144671|NCT01480258|12331485|FG001|COMPLETED|Interim Period||642
11144672|NCT01480258|12331484|FG000|NOT COMPLETED|Interim Period||10
11144673|NCT01480258|12331485|FG001|NOT COMPLETED|Interim Period||9
11144674|NCT01480258|12331484|FG000|STARTED|Toddler Dose||639
11144675|NCT01480258|12331485|FG001|STARTED|Toddler Dose||642
11144676|NCT01480258|12331484|FG000|COMPLETED|Toddler Dose||639
11417909|NCT00607477|12616068|FG001|NOT COMPLETED|Overall Study||0
11417910|NCT00595920|12616074|FG000|STARTED|Overall Study||116
11417911|NCT00595920|12616074|FG000|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
11417912|NCT00595920|12616074|FG000|COMPLETED|Overall Study||0
11144677|NCT01480258|12331485|FG001|COMPLETED|Toddler Dose||642
11144678|NCT01480258|12331484|FG000|NOT COMPLETED|Toddler Dose||0
11144679|NCT01480258|12331485|FG001|NOT COMPLETED|Toddler Dose||0
11144680|NCT01480284|12331493|FG000|STARTED|Overall Study||110
11144681|NCT01480284|12331494|FG001|STARTED|Overall Study||56
11144682|NCT01480284|12331493|FG000|COMPLETED|Overall Study||102
11144683|NCT01480284|12331494|FG001|COMPLETED|Overall Study||56
11144684|NCT01480284|12331493|FG000|NOT COMPLETED|Overall Study||8
11144685|NCT01480284|12331494|FG001|NOT COMPLETED|Overall Study||0
11144686|NCT01480297|12331500|FG000|STARTED|Overall Study||8
11144687|NCT01480297|12331500|FG000|COMPLETED|Overall Study||8
11025839|NCT00824564|12204349|FG001|STARTED|Overall Study||40
11144688|NCT01480297|12331500|FG000|NOT COMPLETED|Overall Study||0
11144689|NCT01480596|12331506|FG000|STARTED|Overall Study||22
11144690|NCT01480596|12331507|FG001|STARTED|Overall Study||18
11144691|NCT01480596|12331506|FG000|COMPLETED|Overall Study||17
11144692|NCT01480596|12331507|FG001|COMPLETED|Overall Study||16
11144693|NCT01480596|12331506|FG000|NOT COMPLETED|Overall Study||5
11144694|NCT01480596|12331507|FG001|NOT COMPLETED|Overall Study||2
11144695|NCT01480674|12331513|FG000|STARTED|Overall Study||160
11417913|NCT00595920|12616074|FG000|NOT COMPLETED|Overall Study||116
11417914|NCT00596947|12616080|FG000|STARTED|Overall Study||9
11417915|NCT00596947|12616081|FG001|STARTED|Overall Study||9
11417916|NCT00596947|12616080|FG000|COMPLETED|Overall Study||3
11417917|NCT00596947|12616081|FG001|COMPLETED|Overall Study||6
11417918|NCT00596947|12616080|FG000|NOT COMPLETED|Overall Study||6
11144696|NCT01480674|12331513|FG000|Safety Set|Overall Study||154
11144697|NCT01480674|12331513|FG000|Analysed Set|Overall Study||128
11144698|NCT01480674|12331513|FG000|COMPLETED|Overall Study||125
11144699|NCT01480674|12331513|FG000|NOT COMPLETED|Overall Study||35
11144700|NCT01480843|12331517|FG000|STARTED|Overall Study||65
11144701|NCT01480843|12331517|FG000|COMPLETED|Overall Study||60
11417919|NCT00596947|12616081|FG001|NOT COMPLETED|Overall Study||3
11025840|NCT00824564|12204348|FG000|Treated|Overall Study||41
11025841|NCT00824564|12204349|FG001|Treated|Overall Study||40
11025842|NCT00824564|12204348|FG000|COMPLETED|Overall Study||34
11025843|NCT00824564|12204349|FG001|COMPLETED|Overall Study||30
11144702|NCT01480843|12331517|FG000|NOT COMPLETED|Overall Study||5
11144703|NCT01481116|12331524|FG000|STARTED|Overall Study||824
11144704|NCT01481116|12331525|FG001|STARTED|Overall Study||817
11144705|NCT01481116|12331526|FG002|STARTED|Overall Study||813
11417920|NCT00584012|12616087|FG000|STARTED|Overall Study||9
11025844|NCT00824564|12204348|FG000|NOT COMPLETED|Overall Study||8
11025845|NCT00824564|12204349|FG001|NOT COMPLETED|Overall Study||10
11025846|NCT00824616|12204357|FG000|STARTED|Overall Study||34
11025847|NCT00824616|12204358|FG001|STARTED|Overall Study||34
11025848|NCT00824616|12204357|FG000|COMPLETED|Overall Study||28
11025849|NCT00824616|12204358|FG001|COMPLETED|Overall Study||27
11025850|NCT00824616|12204357|FG000|NOT COMPLETED|Overall Study||6
11025851|NCT00824616|12204358|FG001|NOT COMPLETED|Overall Study||7
11025852|NCT00824655|12204366|FG000|STARTED|Infant Series (5 Months of Age)||118
11025853|NCT00824655|12204367|FG001|STARTED|Infant Series (5 Months of Age)||0
11025854|NCT00824655|12204366|FG000|COMPLETED|Infant Series (5 Months of Age)||118
11025855|NCT00824655|12204367|FG001|COMPLETED|Infant Series (5 Months of Age)||0
11025856|NCT00824655|12204366|FG000|NOT COMPLETED|Infant Series (5 Months of Age)||0
11025857|NCT00824655|12204367|FG001|NOT COMPLETED|Infant Series (5 Months of Age)||0
11025858|NCT00824655|12204366|FG000|STARTED|After Infant Dose (6 Months of Age)||118
11025859|NCT00824655|12204367|FG001|STARTED|After Infant Dose (6 Months of Age)||0
11025860|NCT00824655|12204366|FG000|COMPLETED|After Infant Dose (6 Months of Age)||118
11025861|NCT00824655|12204367|FG001|COMPLETED|After Infant Dose (6 Months of Age)||0
11025862|NCT00824655|12204366|FG000|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
11025863|NCT00824655|12204367|FG001|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
11025864|NCT00824655|12204366|FG000|STARTED|Toddler Dose (12 Months of Age)||118
11025865|NCT00824655|12204367|FG001|STARTED|Toddler Dose (12 Months of Age)||116
11025866|NCT00824655|12204366|FG000|COMPLETED|Toddler Dose (12 Months of Age)||116
11025867|NCT00824655|12204367|FG001|COMPLETED|Toddler Dose (12 Months of Age)||116
11025868|NCT00824655|12204366|FG000|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
11025869|NCT00824655|12204367|FG001|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
11025870|NCT00824720|12204378|FG000|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
11025871|NCT00824720|12204379|FG001|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
11025872|NCT00824720|12204380|FG002|STARTED|Overall Study||20
11025873|NCT00824720|12204378|FG000|COMPLETED|Overall Study||16
11025874|NCT00824720|12204379|FG001|COMPLETED|Overall Study||15
11025875|NCT00824720|12204380|FG002|COMPLETED|Overall Study||19
11025876|NCT00824720|12204378|FG000|NOT COMPLETED|Overall Study||3
11025877|NCT00824720|12204379|FG001|NOT COMPLETED|Overall Study||1
11025878|NCT00824720|12204380|FG002|NOT COMPLETED|Overall Study||1
11025879|NCT00824733|12204388|FG000|STARTED|Overall Study||6
11025880|NCT00824733|12204388|FG000|COMPLETED|Overall Study||6
11025881|NCT00824733|12204388|FG000|NOT COMPLETED|Overall Study||0
11025882|NCT00824746|12204392|FG000|STARTED|Overall Study||23
11025883|NCT00824746|12204392|FG000|COMPLETED|Overall Study||23
11025884|NCT00824746|12204392|FG000|NOT COMPLETED|Overall Study||0
11025885|NCT00824772|12204398|FG000|STARTED|Overall Study||204
11025886|NCT00824772|12204398|FG000|COMPLETED|Overall Study||196
11025887|NCT00824772|12204398|FG000|NOT COMPLETED|Overall Study||8
11025888|NCT00824824|12204404|FG000|STARTED|Overall Study||4
11025889|NCT00824824|12204405|FG001|STARTED|Overall Study||3
11025890|NCT00824824|12204404|FG000|COMPLETED|Overall Study||4
11025891|NCT00824824|12204405|FG001|COMPLETED|Overall Study||3
11025892|NCT00824824|12204404|FG000|NOT COMPLETED|Overall Study||0
11025893|NCT00824824|12204405|FG001|NOT COMPLETED|Overall Study||0
11025894|NCT00824850|12204413|FG000|STARTED|Overall Study||38
11025895|NCT00824850|12204414|FG001|STARTED|Overall Study||37
11025896|NCT00824850|12204413|FG000|Received Vaccination 13vPnC|Overall Study||38
11025897|NCT00824850|12204414|FG001|Received Vaccination 13vPnC|Overall Study||36
11025898|NCT00824850|12204413|FG000|COMPLETED|Overall Study||38
11025899|NCT00824850|12204414|FG001|COMPLETED|Overall Study||36
11025900|NCT00824850|12204413|FG000|NOT COMPLETED|Overall Study||0
11025901|NCT00824850|12204414|FG001|NOT COMPLETED|Overall Study||1
11144706|NCT01481116|12331524|FG000|Treated|Overall Study||822
11144707|NCT01481116|12331525|FG001|Treated|Overall Study||816
11025902|NCT00824993|12204428|FG000|STARTED|Overall Study||39
11025903|NCT00824993|12204429|FG001|STARTED|Overall Study||39
11025904|NCT00824993|12204428|FG000|6 Month Follow up|Overall Study||33
11025905|NCT00824993|12204429|FG001|6 Month Follow up|Overall Study||27
11025906|NCT00824993|12204428|FG000|COMPLETED|Overall Study||25
11025907|NCT00824993|12204429|FG001|COMPLETED|Overall Study||22
11025908|NCT00824993|12204428|FG000|NOT COMPLETED|Overall Study||14
11025909|NCT00824993|12204429|FG001|NOT COMPLETED|Overall Study||17
11025910|NCT00825162|12204438|FG000|STARTED|Overall Study||710
11025911|NCT00825162|12204439|FG001|STARTED|Overall Study||880
11025912|NCT00825162|12204440|FG002|STARTED|Overall Study||402
11417921|NCT00584012|12616087|FG000|COMPLETED|Overall Study||8
11417922|NCT00584012|12616087|FG000|NOT COMPLETED|Overall Study||1
11417923|NCT00599131|12616091|FG000|STARTED|Overall Study||4
11417924|NCT00599131|12616091|FG000|COMPLETED|Overall Study||4
11417925|NCT00599131|12616091|FG000|NOT COMPLETED|Overall Study||0
11025913|NCT00825162|12204438|FG000|COMPLETED|Overall Study||682
11025914|NCT00825162|12204439|FG001|COMPLETED|Overall Study||859
11025915|NCT00825162|12204440|FG002|COMPLETED|Overall Study||396
11025916|NCT00825162|12204438|FG000|NOT COMPLETED|Overall Study||28
11025917|NCT00825162|12204439|FG001|NOT COMPLETED|Overall Study||21
11025918|NCT00825162|12204440|FG002|NOT COMPLETED|Overall Study||6
11025919|NCT00825175|12204455|FG000|STARTED|Overall Study||10
11025920|NCT00825175|12204456|FG001|STARTED|Overall Study||12
11025921|NCT00825175|12204455|FG000|COMPLETED|Overall Study||10
11025922|NCT00825175|12204456|FG001|COMPLETED|Overall Study||7
11025923|NCT00825175|12204455|FG000|NOT COMPLETED|Overall Study||0
11417926|NCT00597909|12616098|FG000|STARTED|Overall Study||0
11025924|NCT00825175|12204456|FG001|NOT COMPLETED|Overall Study||5
11417927|NCT00597909|12616099|FG001|STARTED|Overall Study||0
11417928|NCT00597909|12616100|FG002|STARTED|Overall Study||0
11417929|NCT00597909|12616098|FG000|COMPLETED|Overall Study||0
11417930|NCT00597909|12616099|FG001|COMPLETED|Overall Study||0
11417931|NCT00597909|12616100|FG002|COMPLETED|Overall Study||0
11417932|NCT00597909|12616098|FG000|NOT COMPLETED|Overall Study||0
11417933|NCT00597909|12616099|FG001|NOT COMPLETED|Overall Study||0
11417934|NCT00597909|12616100|FG002|NOT COMPLETED|Overall Study||0
11417935|NCT00593320|12616110|FG000|STARTED|Overall Study||1
11417936|NCT00593320|12616111|FG001|STARTED|Overall Study||1
11417937|NCT00593320|12616110|FG000|COMPLETED|Overall Study||1
11417938|NCT00593320|12616111|FG001|COMPLETED|Overall Study||1
11417939|NCT00593320|12616110|FG000|NOT COMPLETED|Overall Study||0
11417940|NCT00593320|12616111|FG001|NOT COMPLETED|Overall Study||0
11417941|NCT00589550|12616117|FG000|STARTED|Overall Study||1
11417942|NCT00589550|12616117|FG000|Withdrew From Study|Overall Study||1
11417943|NCT00589550|12616117|FG000|COMPLETED|Overall Study||0
11417944|NCT00589550|12616117|FG000|NOT COMPLETED|Overall Study||1
11417945|NCT00577772|12616123|FG000|STARTED|Overall Study||10
11417946|NCT00577772|12616124|FG001|STARTED|Overall Study||7
11417947|NCT00577772|12616123|FG000|COMPLETED|Overall Study||10
11417948|NCT00577772|12616124|FG001|COMPLETED|Overall Study||6
11417949|NCT00577772|12616123|FG000|NOT COMPLETED|Overall Study||0
11417950|NCT00577772|12616124|FG001|NOT COMPLETED|Overall Study||1
11417951|NCT00592007|12616130|FG000|STARTED|Overall Study||7
11417952|NCT00592007|12616130|FG000|COMPLETED|Overall Study||5
11417953|NCT00592007|12616130|FG000|NOT COMPLETED|Overall Study||2
11417954|NCT00595582|12616134|FG000|STARTED|Overall Study||10
11417955|NCT00595582|12616134|FG000|COMPLETED|Overall Study||0
11417956|NCT00595582|12616134|FG000|NOT COMPLETED|Overall Study||10
11417957|NCT00588146|12616138|FG000|STARTED|First Intervention (Baseline to 6 mo)||5
11417958|NCT00588146|12616139|FG001|STARTED|First Intervention (Baseline to 6 mo)||5
11417959|NCT00588146|12616138|FG000|COMPLETED|First Intervention (Baseline to 6 mo)||1
11417960|NCT00588146|12616139|FG001|COMPLETED|First Intervention (Baseline to 6 mo)||2
11417961|NCT00588146|12616138|FG000|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
11417962|NCT00588146|12616139|FG001|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
11417963|NCT00588146|12616138|FG000|STARTED|Second Intervention (6 Months to 1 Year)||1
11417964|NCT00588146|12616139|FG001|STARTED|Second Intervention (6 Months to 1 Year)||2
11417965|NCT00588146|12616138|FG000|COMPLETED|Second Intervention (6 Months to 1 Year)||1
11417966|NCT00588146|12616139|FG001|COMPLETED|Second Intervention (6 Months to 1 Year)||2
11417967|NCT00588146|12616138|FG000|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
11417968|NCT00588146|12616139|FG001|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
11417969|NCT00586209|12616147|FG000|STARTED|Overall Study||5
11417970|NCT00586209|12616148|FG001|STARTED|Overall Study||10
11417971|NCT00586209|12616147|FG000|COMPLETED|Overall Study||5
11417972|NCT00586209|12616148|FG001|COMPLETED|Overall Study||10
11417973|NCT00586209|12616147|FG000|NOT COMPLETED|Overall Study||0
11417974|NCT00586209|12616148|FG001|NOT COMPLETED|Overall Study||0
11417975|NCT00590538|12616154|FG000|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
11417976|NCT00590538|12616154|FG000|COMPLETED|Overall Study||7
11417977|NCT00590538|12616154|FG000|NOT COMPLETED|Overall Study||2
11417978|NCT00583115|12616158|FG000|STARTED|Overall Study||1
11417979|NCT00583115|12616158|FG000|COMPLETED|Overall Study||0
11417980|NCT00583115|12616158|FG000|NOT COMPLETED|Overall Study||1
11417981|NCT00582712|12616162|FG000|STARTED|Overall Study||5
11417982|NCT00582712|12616162|FG000|COMPLETED|Overall Study||1
11417983|NCT00582712|12616162|FG000|NOT COMPLETED|Overall Study||4
11417984|NCT00586716|12616168|FG000|STARTED|Overall Study||14
11417985|NCT00586716|12616169|FG001|STARTED|Overall Study||8
11417986|NCT00586716|12616168|FG000|COMPLETED|Overall Study||14
11417987|NCT00586716|12616169|FG001|COMPLETED|Overall Study||8
11417988|NCT00586716|12616168|FG000|NOT COMPLETED|Overall Study||0
11417989|NCT00586716|12616169|FG001|NOT COMPLETED|Overall Study||0
11417990|NCT00583466|12616176|FG000|STARTED|Overall Study||18
11417991|NCT00583466|12616176|FG000|COMPLETED|Overall Study||18
11417992|NCT00583466|12616176|FG000|NOT COMPLETED|Overall Study||0
11417993|NCT00588471|12616184|FG000|STARTED|Overall Study||28
11417994|NCT00588471|12616185|FG001|STARTED|Overall Study||29
11417995|NCT00588471|12616184|FG000|COMPLETED|Overall Study||28
11417996|NCT00588471|12616185|FG001|COMPLETED|Overall Study||29
11417997|NCT00588471|12616184|FG000|NOT COMPLETED|Overall Study||0
11417998|NCT00588471|12616185|FG001|NOT COMPLETED|Overall Study||0
11417999|NCT00587795|12616193|FG000|STARTED|Overall Study||1
11418000|NCT00587795|12616194|FG001|STARTED|Overall Study||0
11418001|NCT00587795|12616193|FG000|COMPLETED|Overall Study||0
11418002|NCT00587795|12616194|FG001|COMPLETED|Overall Study||0
11418003|NCT00587795|12616193|FG000|NOT COMPLETED|Overall Study||1
11418004|NCT00587795|12616194|FG001|NOT COMPLETED|Overall Study||0
11418005|NCT00590135|12616200|FG000|STARTED|Overall Study||59
11418006|NCT00590135|12616200|FG000|COMPLETED|Overall Study||0
11418007|NCT00590135|12616200|FG000|NOT COMPLETED|Overall Study||59
11418008|NCT00582036|12616207|FG000|STARTED|Overall Study||5
11418009|NCT00582036|12616208|FG001|STARTED|Overall Study||6
11418010|NCT00582036|12616207|FG000|COMPLETED|Overall Study||5
11418011|NCT00582036|12616208|FG001|COMPLETED|Overall Study|One patient withdrew consent|5
11418012|NCT00582036|12616207|FG000|NOT COMPLETED|Overall Study||0
11418013|NCT00582036|12616208|FG001|NOT COMPLETED|Overall Study||1
11418014|NCT00585585|12616214|FG000|STARTED|Overall Study||1
11418015|NCT00585585|12616214|FG000|Patients Receiving Drug|Overall Study||1
11418016|NCT00585585|12616214|FG000|COMPLETED|Overall Study||0
11418017|NCT00585585|12616214|FG000|NOT COMPLETED|Overall Study||1
11418018|NCT00585221|12616218|FG000|STARTED|Overall Study||8
11418019|NCT00585221|12616218|FG000|COMPLETED|Overall Study||0
11418020|NCT00585221|12616218|FG000|NOT COMPLETED|Overall Study||8
11418021|NCT00581113|12616224|FG000|STARTED|Overall Study||4
11418022|NCT00581113|12616225|FG001|STARTED|Overall Study||4
11418023|NCT00581113|12616224|FG000|COMPLETED|Overall Study||4
11418024|NCT00581113|12616225|FG001|COMPLETED|Overall Study||3
11418025|NCT00581113|12616224|FG000|NOT COMPLETED|Overall Study||0
11418026|NCT00581113|12616225|FG001|NOT COMPLETED|Overall Study||1
11418027|NCT00579254|12616231|FG000|STARTED|Overall Study||112
11418028|NCT00579254|12616231|FG000|COMPLETED|Overall Study||0
11418029|NCT00579254|12616231|FG000|NOT COMPLETED|Overall Study||112
11025925|NCT00825266|12204464|FG000|STARTED|Overall Study||1
11025926|NCT00825266|12204465|FG001|STARTED|Overall Study||1
11025927|NCT00825266|12204464|FG000|COMPLETED|Overall Study||1
11025928|NCT00825266|12204465|FG001|COMPLETED|Overall Study||1
11025929|NCT00825266|12204464|FG000|NOT COMPLETED|Overall Study||0
11025930|NCT00825266|12204465|FG001|NOT COMPLETED|Overall Study||0
11025931|NCT00825305|12204473|FG000|STARTED|Overall Study||550
11025932|NCT00825305|12204474|FG001|STARTED|Overall Study||275
11025933|NCT00825305|12204473|FG000|COMPLETED|Overall Study||533
11025934|NCT00825305|12204474|FG001|COMPLETED|Overall Study||252
11025935|NCT00825305|12204473|FG000|NOT COMPLETED|Overall Study||17
11025936|NCT00825305|12204474|FG001|NOT COMPLETED|Overall Study||23
11025937|NCT00825318|12204480|FG000|STARTED|Overall Study||13
11025938|NCT00825318|12204480|FG000|COMPLETED|Overall Study||12
11025939|NCT00825318|12204480|FG000|NOT COMPLETED|Overall Study||1
11025940|NCT00825344|12204490|FG000|STARTED|Overall Study||34
11025941|NCT00825344|12204491|FG001|STARTED|Overall Study||43
11025942|NCT00825344|12204490|FG000|COMPLETED|Overall Study||33
11025943|NCT00825344|12204491|FG001|COMPLETED|Overall Study||42
11025944|NCT00825344|12204490|FG000|NOT COMPLETED|Overall Study||1
11025945|NCT00825344|12204491|FG001|NOT COMPLETED|Overall Study||1
11025946|NCT00825370|12204499|FG000|STARTED|Overall Study||175
11025947|NCT00825370|12204500|FG001|STARTED|Overall Study||175
11025948|NCT00825370|12204499|FG000|COMPLETED|Overall Study||175
11025949|NCT00825370|12204500|FG001|COMPLETED|Overall Study||175
11025950|NCT00825370|12204499|FG000|NOT COMPLETED|Overall Study||0
11025951|NCT00825370|12204500|FG001|NOT COMPLETED|Overall Study||0
11025952|NCT00825500|12204509|FG000|STARTED|Overall Study||125
11025953|NCT00825500|12204510|FG001|STARTED|Overall Study||121
11025954|NCT00825500|12204511|FG002|STARTED|Overall Study||120
11025955|NCT00825500|12204509|FG000|COMPLETED|Overall Study||125
11025956|NCT00825500|12204510|FG001|COMPLETED|Overall Study||121
11025957|NCT00825500|12204511|FG002|COMPLETED|Overall Study||120
11025958|NCT00825500|12204509|FG000|NOT COMPLETED|Overall Study||0
11025959|NCT00825500|12204510|FG001|NOT COMPLETED|Overall Study||0
11144708|NCT01481116|12331526|FG002|Treated|Overall Study||813
11418030|NCT00587223|12616235|FG000|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
11418031|NCT00587223|12616235|FG000|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
11025960|NCT00825500|12204511|FG002|NOT COMPLETED|Overall Study||0
11025961|NCT00825565|12204519|FG000|STARTED|Overall Study||8
11025962|NCT00825565|12204519|FG000|COMPLETED|Overall Study||8
11025963|NCT00825565|12204519|FG000|NOT COMPLETED|Overall Study||0
11025964|NCT00825630|12204533|FG000|STARTED|Overall Study||29
11025965|NCT00825630|12204534|FG001|STARTED|Overall Study||62
11025966|NCT00825630|12204535|FG002|STARTED|Overall Study||19
11144709|NCT01481116|12331524|FG000|COMPLETED|Overall Study||0
11144710|NCT01481116|12331525|FG001|COMPLETED|Overall Study||0
11418032|NCT00587223|12616235|FG000|NOT COMPLETED|Overall Study||1
11418033|NCT00585611|12616244|FG000|STARTED|Overall Study||0
11025967|NCT00825630|12204536|FG003|STARTED|Overall Study||13
11418034|NCT00585611|12616245|FG001|STARTED|Overall Study||0
11418035|NCT00585611|12616244|FG000|COMPLETED|Overall Study||0
11418036|NCT00585611|12616245|FG001|COMPLETED|Overall Study||0
11418037|NCT00585611|12616244|FG000|NOT COMPLETED|Overall Study||0
11418038|NCT00585611|12616245|FG001|NOT COMPLETED|Overall Study||0
11418039|NCT00572260|12616251|FG000|STARTED|Overall Study||11
11418040|NCT00572260|12616251|FG000|COMPLETED|Overall Study||11
11025968|NCT00825630|12204533|FG000|COMPLETED|Overall Study||29
11025969|NCT00825630|12204534|FG001|COMPLETED|Overall Study||62
11025970|NCT00825630|12204535|FG002|COMPLETED|Overall Study||19
11025971|NCT00825630|12204536|FG003|COMPLETED|Overall Study||13
11025972|NCT00825630|12204533|FG000|NOT COMPLETED|Overall Study||0
11025973|NCT00825630|12204534|FG001|NOT COMPLETED|Overall Study||0
11025974|NCT00825630|12204535|FG002|NOT COMPLETED|Overall Study||0
11025975|NCT00825630|12204536|FG003|NOT COMPLETED|Overall Study||0
11025976|NCT00825682|12204548|FG000|STARTED|Overall Study||47
11025977|NCT00825682|12204549|FG001|STARTED|Overall Study||25
11025978|NCT00825682|12204548|FG000|COMPLETED|Overall Study||34
11025979|NCT00825682|12204549|FG001|COMPLETED|Overall Study||20
11025980|NCT00825682|12204548|FG000|NOT COMPLETED|Overall Study||13
11025981|NCT00825682|12204549|FG001|NOT COMPLETED|Overall Study||5
11418041|NCT00572260|12616251|FG000|NOT COMPLETED|Overall Study||0
11418042|NCT00571194|12616255|FG000|STARTED|Overall Study||7
11418043|NCT00571194|12616255|FG000|COMPLETED|Overall Study||7
11418044|NCT00571194|12616255|FG000|NOT COMPLETED|Overall Study||0
11418045|NCT00584935|12616259|FG000|STARTED|Overall Study||3
11025982|NCT00825734|12204556|FG000|STARTED|Phase I||4
11025983|NCT00825734|12204557|FG001|STARTED|Phase I||3
11025984|NCT00825734|12204558|FG002|STARTED|Phase I||3
11025985|NCT00825734|12204556|FG000|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
11025986|NCT00825734|12204557|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
11025987|NCT00825734|12204558|FG002|COMPLETED|Phase I||3
11025988|NCT00825734|12204556|FG000|NOT COMPLETED|Phase I||4
11025989|NCT00825734|12204557|FG001|NOT COMPLETED|Phase I||3
11025990|NCT00825734|12204558|FG002|NOT COMPLETED|Phase I||0
11025991|NCT00825734|12204556|FG000|STARTED|Phase II||0
11025992|NCT00825734|12204557|FG001|STARTED|Phase II||0
11025993|NCT00825734|12204558|FG002|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
11025994|NCT00825734|12204556|FG000|COMPLETED|Phase II||0
11025995|NCT00825734|12204557|FG001|COMPLETED|Phase II||0
11025996|NCT00825734|12204558|FG002|COMPLETED|Phase II||0
11025997|NCT00825734|12204556|FG000|NOT COMPLETED|Phase II||0
11025998|NCT00825734|12204557|FG001|NOT COMPLETED|Phase II||0
11025999|NCT00825734|12204558|FG002|NOT COMPLETED|Phase II||76
11026000|NCT00825786|12204565|FG000|STARTED|Overall Study||52
11026001|NCT00825786|12204566|FG001|STARTED|Overall Study||51
11026002|NCT00825786|12204565|FG000|COMPLETED|Overall Study||52
11026003|NCT00825786|12204566|FG001|COMPLETED|Overall Study||51
11026004|NCT00825786|12204565|FG000|NOT COMPLETED|Overall Study||0
11026005|NCT00825786|12204566|FG001|NOT COMPLETED|Overall Study||0
11026006|NCT00825812|12204576|FG000|STARTED|Overall Study||29
11026007|NCT00825812|12204577|FG001|STARTED|Overall Study||32
11026008|NCT00825812|12204578|FG002|STARTED|Overall Study||126
11026009|NCT00825812|12204579|FG003|STARTED|Overall Study||121
11026010|NCT00825812|12204576|FG000|TREATED|Overall Study||29
11026011|NCT00825812|12204577|FG001|TREATED|Overall Study||31
11026012|NCT00825812|12204578|FG002|TREATED|Overall Study||120
11026013|NCT00825812|12204579|FG003|TREATED|Overall Study||111
11026014|NCT00825812|12204576|FG000|COMPLETED|Overall Study||29
11026015|NCT00825812|12204577|FG001|COMPLETED|Overall Study||31
11026016|NCT00825812|12204578|FG002|COMPLETED|Overall Study||120
11026017|NCT00825812|12204579|FG003|COMPLETED|Overall Study||111
11026018|NCT00825812|12204576|FG000|NOT COMPLETED|Overall Study||0
11026019|NCT00825812|12204577|FG001|NOT COMPLETED|Overall Study||1
11026020|NCT00825812|12204578|FG002|NOT COMPLETED|Overall Study||6
11026021|NCT00825812|12204579|FG003|NOT COMPLETED|Overall Study||10
11026022|NCT00825825|12204589|FG000|STARTED|First Medication Period (14 Days)||6
11026023|NCT00825825|12204590|FG001|STARTED|First Medication Period (14 Days)||4
11026024|NCT00825825|12204591|FG002|STARTED|First Medication Period (14 Days)||3
11026025|NCT00825825|12204592|FG003|STARTED|First Medication Period (14 Days)||5
11026026|NCT00825825|12204593|FG004|STARTED|First Medication Period (14 Days)||4
11026027|NCT00825825|12204594|FG005|STARTED|First Medication Period (14 Days)||5
11026028|NCT00825825|12204589|FG000|COMPLETED|First Medication Period (14 Days)||3
11026029|NCT00825825|12204590|FG001|COMPLETED|First Medication Period (14 Days)||4
11026030|NCT00825825|12204591|FG002|COMPLETED|First Medication Period (14 Days)||2
11026031|NCT00825825|12204592|FG003|COMPLETED|First Medication Period (14 Days)||5
11026032|NCT00825825|12204593|FG004|COMPLETED|First Medication Period (14 Days)||4
11026033|NCT00825825|12204594|FG005|COMPLETED|First Medication Period (14 Days)||3
11026034|NCT00825825|12204589|FG000|NOT COMPLETED|First Medication Period (14 Days)||3
11026035|NCT00825825|12204590|FG001|NOT COMPLETED|First Medication Period (14 Days)||0
11026036|NCT00825825|12204591|FG002|NOT COMPLETED|First Medication Period (14 Days)||1
11026037|NCT00825825|12204592|FG003|NOT COMPLETED|First Medication Period (14 Days)||0
11026038|NCT00825825|12204593|FG004|NOT COMPLETED|First Medication Period (14 Days)||0
11026039|NCT00825825|12204594|FG005|NOT COMPLETED|First Medication Period (14 Days)||2
11026040|NCT00825825|12204589|FG000|STARTED|First Washout Period (14 Days)||3
11026041|NCT00825825|12204590|FG001|STARTED|First Washout Period (14 Days)||4
11418046|NCT00584935|12616259|FG000|COMPLETED|Overall Study||3
11026042|NCT00825825|12204591|FG002|STARTED|First Washout Period (14 Days)||2
11026043|NCT00825825|12204592|FG003|STARTED|First Washout Period (14 Days)||5
11026044|NCT00825825|12204593|FG004|STARTED|First Washout Period (14 Days)||4
11026045|NCT00825825|12204594|FG005|STARTED|First Washout Period (14 Days)||3
11026046|NCT00825825|12204589|FG000|COMPLETED|First Washout Period (14 Days)||3
11026047|NCT00825825|12204590|FG001|COMPLETED|First Washout Period (14 Days)||4
11026048|NCT00825825|12204591|FG002|COMPLETED|First Washout Period (14 Days)||2
11026049|NCT00825825|12204592|FG003|COMPLETED|First Washout Period (14 Days)||5
11418047|NCT00584935|12616259|FG000|NOT COMPLETED|Overall Study||0
11418048|NCT00577395|12616266|FG000|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
11418049|NCT00577395|12616267|FG001|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
11418050|NCT00577395|12616266|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
11026050|NCT00825825|12204593|FG004|COMPLETED|First Washout Period (14 Days)||4
11026051|NCT00825825|12204594|FG005|COMPLETED|First Washout Period (14 Days)||3
11026052|NCT00825825|12204589|FG000|NOT COMPLETED|First Washout Period (14 Days)||0
11026053|NCT00825825|12204590|FG001|NOT COMPLETED|First Washout Period (14 Days)||0
11026054|NCT00825825|12204591|FG002|NOT COMPLETED|First Washout Period (14 Days)||0
11026055|NCT00825825|12204592|FG003|NOT COMPLETED|First Washout Period (14 Days)||0
11026056|NCT00825825|12204593|FG004|NOT COMPLETED|First Washout Period (14 Days)||0
11026057|NCT00825825|12204594|FG005|NOT COMPLETED|First Washout Period (14 Days)||0
11026058|NCT00825825|12204589|FG000|STARTED|Second Medication Period (14 Days)||3
11026059|NCT00825825|12204590|FG001|STARTED|Second Medication Period (14 Days)||4
11026060|NCT00825825|12204591|FG002|STARTED|Second Medication Period (14 Days)||2
11026061|NCT00825825|12204592|FG003|STARTED|Second Medication Period (14 Days)||5
11026062|NCT00825825|12204593|FG004|STARTED|Second Medication Period (14 Days)||4
11026063|NCT00825825|12204594|FG005|STARTED|Second Medication Period (14 Days)||3
11026064|NCT00825825|12204589|FG000|COMPLETED|Second Medication Period (14 Days)||1
11026065|NCT00825825|12204590|FG001|COMPLETED|Second Medication Period (14 Days)||4
11026066|NCT00825825|12204591|FG002|COMPLETED|Second Medication Period (14 Days)||2
11026067|NCT00825825|12204592|FG003|COMPLETED|Second Medication Period (14 Days)||3
11026068|NCT00825825|12204593|FG004|COMPLETED|Second Medication Period (14 Days)||3
11026069|NCT00825825|12204594|FG005|COMPLETED|Second Medication Period (14 Days)||3
11026070|NCT00825825|12204589|FG000|NOT COMPLETED|Second Medication Period (14 Days)||2
11026071|NCT00825825|12204590|FG001|NOT COMPLETED|Second Medication Period (14 Days)||0
11026072|NCT00825825|12204591|FG002|NOT COMPLETED|Second Medication Period (14 Days)||0
11026073|NCT00825825|12204592|FG003|NOT COMPLETED|Second Medication Period (14 Days)||2
11026074|NCT00825825|12204593|FG004|NOT COMPLETED|Second Medication Period (14 Days)||1
11026075|NCT00825825|12204594|FG005|NOT COMPLETED|Second Medication Period (14 Days)||0
11026076|NCT00825825|12204589|FG000|STARTED|Second Washout Period (14 Days)||1
11026077|NCT00825825|12204590|FG001|STARTED|Second Washout Period (14 Days)||4
11026078|NCT00825825|12204591|FG002|STARTED|Second Washout Period (14 Days)||2
11026079|NCT00825825|12204592|FG003|STARTED|Second Washout Period (14 Days)||3
11026080|NCT00825825|12204593|FG004|STARTED|Second Washout Period (14 Days)||3
11026081|NCT00825825|12204594|FG005|STARTED|Second Washout Period (14 Days)||3
11026082|NCT00825825|12204589|FG000|COMPLETED|Second Washout Period (14 Days)||1
11026083|NCT00825825|12204590|FG001|COMPLETED|Second Washout Period (14 Days)||4
11026084|NCT00825825|12204591|FG002|COMPLETED|Second Washout Period (14 Days)||2
11026085|NCT00825825|12204592|FG003|COMPLETED|Second Washout Period (14 Days)||3
11026086|NCT00825825|12204593|FG004|COMPLETED|Second Washout Period (14 Days)||3
11026087|NCT00825825|12204594|FG005|COMPLETED|Second Washout Period (14 Days)||3
11026088|NCT00825825|12204589|FG000|NOT COMPLETED|Second Washout Period (14 Days)||0
11026089|NCT00825825|12204590|FG001|NOT COMPLETED|Second Washout Period (14 Days)||0
11026090|NCT00825825|12204591|FG002|NOT COMPLETED|Second Washout Period (14 Days)||0
11026091|NCT00825825|12204592|FG003|NOT COMPLETED|Second Washout Period (14 Days)||0
11026092|NCT00825825|12204593|FG004|NOT COMPLETED|Second Washout Period (14 Days)||0
11026093|NCT00825825|12204594|FG005|NOT COMPLETED|Second Washout Period (14 Days)||0
11026094|NCT00825825|12204589|FG000|STARTED|Third Medication Period (14 Days)||1
11026095|NCT00825825|12204590|FG001|STARTED|Third Medication Period (14 Days)||4
11026096|NCT00825825|12204591|FG002|STARTED|Third Medication Period (14 Days)||2
11026097|NCT00825825|12204592|FG003|STARTED|Third Medication Period (14 Days)||3
11026098|NCT00825825|12204593|FG004|STARTED|Third Medication Period (14 Days)||3
11026099|NCT00825825|12204594|FG005|STARTED|Third Medication Period (14 Days)||3
11026100|NCT00825825|12204589|FG000|COMPLETED|Third Medication Period (14 Days)||1
11026101|NCT00825825|12204590|FG001|COMPLETED|Third Medication Period (14 Days)||2
11026102|NCT00825825|12204591|FG002|COMPLETED|Third Medication Period (14 Days)||2
11026103|NCT00825825|12204592|FG003|COMPLETED|Third Medication Period (14 Days)||3
11026104|NCT00825825|12204593|FG004|COMPLETED|Third Medication Period (14 Days)||3
11026105|NCT00825825|12204594|FG005|COMPLETED|Third Medication Period (14 Days)||1
11026106|NCT00825825|12204589|FG000|NOT COMPLETED|Third Medication Period (14 Days)||0
11026107|NCT00825825|12204590|FG001|NOT COMPLETED|Third Medication Period (14 Days)||2
11026108|NCT00825825|12204591|FG002|NOT COMPLETED|Third Medication Period (14 Days)||0
11026109|NCT00825825|12204592|FG003|NOT COMPLETED|Third Medication Period (14 Days)||0
11026110|NCT00825825|12204593|FG004|NOT COMPLETED|Third Medication Period (14 Days)||0
11026111|NCT00825825|12204594|FG005|NOT COMPLETED|Third Medication Period (14 Days)||2
11026112|NCT00825916|12204604|FG000|STARTED|Overall Study||19
11026113|NCT00825916|12204605|FG001|STARTED|Overall Study||20
11026114|NCT00825916|12204606|FG002|STARTED|Overall Study||20
11026115|NCT00825916|12204604|FG000|COMPLETED|Overall Study||15
11026116|NCT00825916|12204605|FG001|COMPLETED|Overall Study||18
11026117|NCT00825916|12204606|FG002|COMPLETED|Overall Study||19
11026118|NCT00825916|12204604|FG000|NOT COMPLETED|Overall Study||4
11026119|NCT00825916|12204605|FG001|NOT COMPLETED|Overall Study||2
11026120|NCT00825916|12204606|FG002|NOT COMPLETED|Overall Study||1
11026121|NCT00825994|12204647|FG000|STARTED|Overall Study||24
11026122|NCT00825994|12204647|FG000|COMPLETED|Overall Study||19
11026123|NCT00825994|12204647|FG000|NOT COMPLETED|Overall Study||5
11026124|NCT00826007|12204653|FG000|STARTED|Overall Study|Retrospective review|308
11026125|NCT00826007|12204654|FG001|STARTED|Overall Study||279
11026126|NCT00826007|12204653|FG000|COMPLETED|Overall Study|Retrospective review|308
11026127|NCT00826007|12204654|FG001|COMPLETED|Overall Study||279
11026128|NCT00826007|12204653|FG000|NOT COMPLETED|Overall Study||0
11026129|NCT00826007|12204654|FG001|NOT COMPLETED|Overall Study||0
11057246|NCT00996892|12238674|FG003|COMPLETED|Expansion Stage 2A||0
11057247|NCT00996892|12238675|FG004|COMPLETED|Expansion Stage 2A||0
11057248|NCT00996892|12238676|FG005|COMPLETED|Expansion Stage 2A||0
11057249|NCT00996892|12238677|FG006|COMPLETED|Expansion Stage 2A||0
11057250|NCT00996892|12238678|FG007|COMPLETED|Expansion Stage 2A||0
11057251|NCT00996892|12238679|FG008|COMPLETED|Expansion Stage 2A||0
11057252|NCT00996892|12238680|FG009|COMPLETED|Expansion Stage 2A||0
11057253|NCT00996892|12238681|FG010|COMPLETED|Expansion Stage 2A||0
11057254|NCT00996892|12238682|FG011|COMPLETED|Expansion Stage 2A||0
11057255|NCT00996892|12238683|FG012|COMPLETED|Expansion Stage 2A||0
11057256|NCT00996892|12238684|FG013|COMPLETED|Expansion Stage 2A||0
11057257|NCT00996892|12238685|FG014|COMPLETED|Expansion Stage 2A||0
11057258|NCT00996892|12238686|FG015|COMPLETED|Expansion Stage 2A||0
11057259|NCT00996892|12238687|FG016|COMPLETED|Expansion Stage 2A||0
11057260|NCT00996892|12238688|FG017|COMPLETED|Expansion Stage 2A||0
11057261|NCT00996892|12238689|FG018|COMPLETED|Expansion Stage 2A||0
11057262|NCT00996892|12238690|FG019|COMPLETED|Expansion Stage 2A||0
11057263|NCT00996892|12238671|FG000|NOT COMPLETED|Expansion Stage 2A||0
11057264|NCT00996892|12238672|FG001|NOT COMPLETED|Expansion Stage 2A||0
11057265|NCT00996892|12238673|FG002|NOT COMPLETED|Expansion Stage 2A||0
11057266|NCT00996892|12238674|FG003|NOT COMPLETED|Expansion Stage 2A||0
11057267|NCT00996892|12238675|FG004|NOT COMPLETED|Expansion Stage 2A||0
11057268|NCT00996892|12238676|FG005|NOT COMPLETED|Expansion Stage 2A||0
11057269|NCT00996892|12238677|FG006|NOT COMPLETED|Expansion Stage 2A||0
11057270|NCT00996892|12238678|FG007|NOT COMPLETED|Expansion Stage 2A||0
11057271|NCT00996892|12238679|FG008|NOT COMPLETED|Expansion Stage 2A||0
11057272|NCT00996892|12238680|FG009|NOT COMPLETED|Expansion Stage 2A||0
11057273|NCT00996892|12238681|FG010|NOT COMPLETED|Expansion Stage 2A||0
11057274|NCT00996892|12238682|FG011|NOT COMPLETED|Expansion Stage 2A||0
11057275|NCT00996892|12238683|FG012|NOT COMPLETED|Expansion Stage 2A||0
11057276|NCT00996892|12238684|FG013|NOT COMPLETED|Expansion Stage 2A||0
11057277|NCT00996892|12238685|FG014|NOT COMPLETED|Expansion Stage 2A||0
11057278|NCT00996892|12238686|FG015|NOT COMPLETED|Expansion Stage 2A||0
11057279|NCT00996892|12238687|FG016|NOT COMPLETED|Expansion Stage 2A||0
11057280|NCT00996892|12238688|FG017|NOT COMPLETED|Expansion Stage 2A||0
11057281|NCT00996892|12238689|FG018|NOT COMPLETED|Expansion Stage 2A||0
11057282|NCT00996892|12238690|FG019|NOT COMPLETED|Expansion Stage 2A||45
11057283|NCT00996918|12238756|FG000|STARTED|Overall Study||39
11057284|NCT00996918|12238757|FG001|STARTED|Overall Study||66
11057285|NCT00996918|12238758|FG002|STARTED|Overall Study||37
11057286|NCT00996918|12238759|FG003|STARTED|Overall Study||56
11057287|NCT00996918|12238760|FG004|STARTED|Overall Study||4
11057288|NCT00996918|12238756|FG000|Treated|Overall Study||39
11057289|NCT00996918|12238757|FG001|Treated|Overall Study||66
11057290|NCT00996918|12238758|FG002|Treated|Overall Study||37
11057291|NCT00996918|12238759|FG003|Treated|Overall Study||56
11057292|NCT00996918|12238760|FG004|Treated|Overall Study||4
11057293|NCT00996918|12238756|FG000|COMPLETED|Overall Study||0
11057294|NCT00996918|12238757|FG001|COMPLETED|Overall Study||0
11057295|NCT00996918|12238758|FG002|COMPLETED|Overall Study||0
11057296|NCT00996918|12238759|FG003|COMPLETED|Overall Study||0
11057297|NCT00996918|12238760|FG004|COMPLETED|Overall Study||0
11057298|NCT00996918|12238756|FG000|NOT COMPLETED|Overall Study||39
11057299|NCT00996918|12238757|FG001|NOT COMPLETED|Overall Study||66
11057300|NCT00996918|12238758|FG002|NOT COMPLETED|Overall Study||37
11057301|NCT00996918|12238759|FG003|NOT COMPLETED|Overall Study||56
11057302|NCT00996918|12238760|FG004|NOT COMPLETED|Overall Study||4
11057303|NCT00996931|12238772|FG000|STARTED|Overall Study||6
11057304|NCT00996931|12238772|FG000|COMPLETED|Overall Study||6
11057305|NCT00996931|12238772|FG000|NOT COMPLETED|Overall Study||0
11057306|NCT00996944|12238779|FG000|STARTED|Double-blind Treatment Period||22
11057307|NCT00996944|12238780|FG001|STARTED|Double-blind Treatment Period||12
11057308|NCT00996944|12238779|FG000|COMPLETED|Double-blind Treatment Period||12
11057309|NCT00996944|12238780|FG001|COMPLETED|Double-blind Treatment Period||5
11057310|NCT00996944|12238779|FG000|NOT COMPLETED|Double-blind Treatment Period||10
11057311|NCT00996944|12238780|FG001|NOT COMPLETED|Double-blind Treatment Period||7
11057312|NCT00996944|12238779|FG000|STARTED|Long-term Treatment Period||12
11057313|NCT00996944|12238780|FG001|STARTED|Long-term Treatment Period||5
11057314|NCT00996944|12238779|FG000|COMPLETED|Long-term Treatment Period||0
11057315|NCT00996944|12238780|FG001|COMPLETED|Long-term Treatment Period||0
11057316|NCT00996944|12238779|FG000|NOT COMPLETED|Long-term Treatment Period||12
11057317|NCT00996944|12238780|FG001|NOT COMPLETED|Long-term Treatment Period||5
11026130|NCT00826020|12204659|FG000|STARTED|Overall Study||72
11026131|NCT00826020|12204659|FG000|COMPLETED|Overall Study||72
11026132|NCT00826020|12204659|FG000|NOT COMPLETED|Overall Study||0
11026133|NCT00826111|12204665|FG000|STARTED|Overall Study||14
11026134|NCT00826111|12204666|FG001|STARTED|Overall Study||5
11026135|NCT00826111|12204665|FG000|COMPLETED|Overall Study||7
11026136|NCT00826111|12204666|FG001|COMPLETED|Overall Study||3
11026137|NCT00826111|12204665|FG000|NOT COMPLETED|Overall Study||7
11026138|NCT00826111|12204666|FG001|NOT COMPLETED|Overall Study||2
11026139|NCT00826150|12204678|FG000|STARTED|Overall Study||8
11026140|NCT00826150|12204679|FG001|STARTED|Overall Study||3
11026141|NCT00826150|12204680|FG002|STARTED|Overall Study||3
11026142|NCT00826150|12204678|FG000|COMPLETED|Overall Study||2
11026143|NCT00826150|12204679|FG001|COMPLETED|Overall Study||1
11026144|NCT00826150|12204680|FG002|COMPLETED|Overall Study||0
11026145|NCT00826150|12204678|FG000|NOT COMPLETED|Overall Study||6
11026146|NCT00826150|12204679|FG001|NOT COMPLETED|Overall Study||2
11026147|NCT00826150|12204680|FG002|NOT COMPLETED|Overall Study||3
11026148|NCT00826176|12204692|FG000|STARTED|Overall Study|enrolled|128
11026149|NCT00826176|12204693|FG001|STARTED|Overall Study|enrolled|36
11026150|NCT00826176|12204692|FG000|COMPLETED|Overall Study|treated and completed|115
11026151|NCT00826176|12204693|FG001|COMPLETED|Overall Study|treated and completed|36
11026152|NCT00826176|12204692|FG000|NOT COMPLETED|Overall Study||13
11026153|NCT00826176|12204693|FG001|NOT COMPLETED|Overall Study||0
11026154|NCT00826202|12204701|FG000|STARTED|Overall Study||20
11026155|NCT00826202|12204702|FG001|STARTED|Overall Study||24
11026156|NCT00826202|12204701|FG000|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
11026157|NCT00826202|12204702|FG001|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
11026158|NCT00826202|12204701|FG000|COMPLETED|Overall Study||10
11026159|NCT00826202|12204702|FG001|COMPLETED|Overall Study||11
11026160|NCT00826202|12204701|FG000|NOT COMPLETED|Overall Study||10
11026161|NCT00826202|12204702|FG001|NOT COMPLETED|Overall Study||13
11026162|NCT00826228|12204708|FG000|STARTED|Overall Study||12
11026163|NCT00826228|12204708|FG000|COMPLETED|Overall Study||11
11026164|NCT00826228|12204708|FG000|NOT COMPLETED|Overall Study||1
11026165|NCT00826241|12204713|FG000|STARTED|Overall Study||58
11026166|NCT00826241|12204713|FG000|COMPLETED|Overall Study||31
11026167|NCT00826241|12204713|FG000|NOT COMPLETED|Overall Study||27
11026168|NCT00826267|12204720|FG000|STARTED|Overall Study||10
11026169|NCT00826267|12204721|FG001|STARTED|Overall Study||8
11026170|NCT00826267|12204722|FG002|STARTED|Overall Study||11
11026171|NCT00826267|12204720|FG000|COMPLETED|Overall Study||9
11026172|NCT00826267|12204721|FG001|COMPLETED|Overall Study||8
11026173|NCT00826267|12204722|FG002|COMPLETED|Overall Study||11
11026174|NCT00826267|12204720|FG000|NOT COMPLETED|Overall Study||1
11026175|NCT00826267|12204721|FG001|NOT COMPLETED|Overall Study||0
11026176|NCT00826267|12204722|FG002|NOT COMPLETED|Overall Study||0
11026177|NCT00826280|12204734|FG000|STARTED|Overall Study||114
11026178|NCT00826280|12204735|FG001|STARTED|Overall Study||116
11026179|NCT00826280|12204736|FG002|STARTED|Overall Study||117
11026180|NCT00826280|12204734|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
11026181|NCT00826280|12204735|FG001|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
11026182|NCT00826280|12204736|FG002|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
11026183|NCT00826280|12204734|FG000|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
11026184|NCT00826280|12204735|FG001|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
11026185|NCT00826280|12204736|FG002|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
11026186|NCT00826280|12204734|FG000|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
11026187|NCT00826280|12204735|FG001|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
11026188|NCT00826280|12204736|FG002|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
11026189|NCT00826280|12204734|FG000|NOT COMPLETED|Overall Study||48
11026190|NCT00826280|12204735|FG001|NOT COMPLETED|Overall Study||46
11026191|NCT00826280|12204736|FG002|NOT COMPLETED|Overall Study||46
11026192|NCT00826449|12204746|FG000|STARTED|Overall Study||47
11026193|NCT00826449|12204746|FG000|Phase I|Overall Study||12
11026194|NCT00826449|12204746|FG000|Phase II|Overall Study||35
11026195|NCT00826449|12204746|FG000|COMPLETED|Overall Study||42
11026196|NCT00826449|12204746|FG000|NOT COMPLETED|Overall Study||5
11026197|NCT00826514|12204753|FG000|STARTED|Overall Study||30
11026198|NCT00826514|12204754|FG001|STARTED|Overall Study||32
11026199|NCT00826514|12204753|FG000|COMPLETED|Overall Study||27
11026200|NCT00826514|12204754|FG001|COMPLETED|Overall Study||27
11026201|NCT00826514|12204753|FG000|NOT COMPLETED|Overall Study||3
11026202|NCT00826514|12204754|FG001|NOT COMPLETED|Overall Study||5
11026203|NCT00826540|12204760|FG000|STARTED|Overall Study||83
11026204|NCT00826540|12204760|FG000|COMPLETED|Overall Study||79
11026205|NCT00826540|12204760|FG000|NOT COMPLETED|Overall Study||4
11026206|NCT00826618|12204764|FG000|STARTED|Overall Study||6
11026207|NCT00826618|12204764|FG000|COMPLETED|Overall Study||5
11026208|NCT00826618|12204764|FG000|NOT COMPLETED|Overall Study||1
11026209|NCT00826748|12204771|FG000|STARTED|Overall Study||6
11026210|NCT00826748|12204772|FG001|STARTED|Overall Study||4
11026211|NCT00826748|12204773|FG002|STARTED|Overall Study||12
11026212|NCT00826748|12204771|FG000|COMPLETED|Overall Study||6
11026213|NCT00826748|12204772|FG001|COMPLETED|Overall Study||4
11026214|NCT00826748|12204773|FG002|COMPLETED|Overall Study||8
11026215|NCT00826748|12204771|FG000|NOT COMPLETED|Overall Study||0
11026216|NCT00826748|12204772|FG001|NOT COMPLETED|Overall Study||0
11026217|NCT00826748|12204773|FG002|NOT COMPLETED|Overall Study||4
11026218|NCT00826800|12204781|FG000|STARTED|Overall Study||2
11026219|NCT00826800|12204781|FG000|COMPLETED|Overall Study||2
11026220|NCT00826800|12204781|FG000|NOT COMPLETED|Overall Study||0
11026221|NCT00826943|12204785|FG000|STARTED|Overall Study||6
11026222|NCT00826943|12204786|FG001|STARTED|Overall Study||6
11026223|NCT00826943|12204787|FG002|STARTED|Overall Study||4
11026224|NCT00826943|12204788|FG003|STARTED|Overall Study||5
11026225|NCT00826943|12204789|FG004|STARTED|Overall Study||7
11026226|NCT00826943|12204790|FG005|STARTED|Overall Study||2
11026227|NCT00826943|12204785|FG000|COMPLETED|Overall Study||6
11026228|NCT00826943|12204786|FG001|COMPLETED|Overall Study||6
11026229|NCT00826943|12204787|FG002|COMPLETED|Overall Study||4
11026230|NCT00826943|12204788|FG003|COMPLETED|Overall Study||5
11026231|NCT00826943|12204789|FG004|COMPLETED|Overall Study||6
11026232|NCT00826943|12204790|FG005|COMPLETED|Overall Study||2
11026233|NCT00826943|12204785|FG000|NOT COMPLETED|Overall Study||0
11026234|NCT00826943|12204786|FG001|NOT COMPLETED|Overall Study||0
11026235|NCT00826943|12204787|FG002|NOT COMPLETED|Overall Study||0
11026236|NCT00826943|12204788|FG003|NOT COMPLETED|Overall Study||0
11026237|NCT00826943|12204789|FG004|NOT COMPLETED|Overall Study||1
11026238|NCT00826943|12204790|FG005|NOT COMPLETED|Overall Study||0
11026239|NCT00827073|12204800|FG000|STARTED|Overall Study||20
11026240|NCT00827073|12204801|FG001|STARTED|Overall Study||20
11026241|NCT00827073|12204800|FG000|COMPLETED|Overall Study||20
11026242|NCT00827073|12204801|FG001|COMPLETED|Overall Study||20
11026243|NCT00827073|12204800|FG000|NOT COMPLETED|Overall Study||0
11026244|NCT00827073|12204801|FG001|NOT COMPLETED|Overall Study||0
11026245|NCT00827099|12204807|FG000|STARTED|Overall Study||5
11026246|NCT00827099|12204807|FG000|COMPLETED|Overall Study||5
11026247|NCT00827099|12204807|FG000|NOT COMPLETED|Overall Study||0
11026248|NCT00827112|12204813|FG000|STARTED|Overall Study||65
11026249|NCT00827112|12204814|FG001|STARTED|Overall Study||64
11026250|NCT00827112|12204813|FG000|Treated|Overall Study||60
11026251|NCT00827112|12204814|FG001|Treated|Overall Study||61
11026252|NCT00827112|12204813|FG000|COMPLETED|Overall Study||50
11026253|NCT00827112|12204814|FG001|COMPLETED|Overall Study||52
11026254|NCT00827112|12204813|FG000|NOT COMPLETED|Overall Study||15
11026255|NCT00827112|12204814|FG001|NOT COMPLETED|Overall Study||12
11026256|NCT00827242|12204822|FG000|STARTED|Overall Study||161
11026257|NCT00827242|12204823|FG001|STARTED|Overall Study||164
11026258|NCT00827242|12204822|FG000|COMPLETED|Overall Study||148
11026259|NCT00827242|12204823|FG001|COMPLETED|Overall Study||152
11026260|NCT00827242|12204822|FG000|NOT COMPLETED|Overall Study||13
11026261|NCT00827242|12204823|FG001|NOT COMPLETED|Overall Study||12
11026262|NCT00827255|12204829|FG000|STARTED|Overall Study||35
11026263|NCT00827255|12204829|FG000|COMPLETED|Overall Study||35
11026264|NCT00827255|12204829|FG000|NOT COMPLETED|Overall Study||0
11026265|NCT00827359|12204833|FG000|STARTED|Overall Study||25
11026266|NCT00827359|12204833|FG000|Treated|Overall Study||24
11026267|NCT00827359|12204833|FG000|COMPLETED|Overall Study||0
11026268|NCT00827359|12204833|FG000|NOT COMPLETED|Overall Study||25
11026269|NCT00827372|12204837|FG000|STARTED|Overall Study||10
11026270|NCT00827372|12204837|FG000|COMPLETED|Overall Study||2
11026271|NCT00827372|12204837|FG000|NOT COMPLETED|Overall Study||8
11026272|NCT00827502|12204842|FG000|STARTED|Overall Study||421
11026273|NCT00827502|12204842|FG000|Received Treatment (Number Treated)|Overall Study||410
11026274|NCT00827502|12204842|FG000|COMPLETED|Overall Study||400
11026275|NCT00827502|12204842|FG000|NOT COMPLETED|Overall Study||21
11026276|NCT00827541|12204848|FG000|STARTED|Overall Study||19
11026277|NCT00827541|12204849|FG001|STARTED|Overall Study||96
11026278|NCT00827541|12204848|FG000|COMPLETED|Overall Study||15
11026279|NCT00827541|12204849|FG001|COMPLETED|Overall Study||85
11026280|NCT00827541|12204848|FG000|NOT COMPLETED|Overall Study||4
11026281|NCT00827541|12204849|FG001|NOT COMPLETED|Overall Study||11
11026282|NCT00827606|12204857|FG000|STARTED|Overall Study||139
11026283|NCT00827606|12204858|FG001|STARTED|Overall Study||132
11026284|NCT00827606|12204857|FG000|COMPLETED|Overall Study||112
11026285|NCT00827606|12204858|FG001|COMPLETED|Overall Study||94
11026286|NCT00827606|12204857|FG000|NOT COMPLETED|Overall Study||27
11026287|NCT00827606|12204858|FG001|NOT COMPLETED|Overall Study||38
11026288|NCT00827632|12204872|FG000|STARTED|Overall Study||128
11026289|NCT00827632|12204873|FG001|STARTED|Overall Study||98
11026290|NCT00827632|12204872|FG000|COMPLETED|Overall Study||106
11026291|NCT00827632|12204873|FG001|COMPLETED|Overall Study||75
11026292|NCT00827632|12204872|FG000|NOT COMPLETED|Overall Study||22
11026293|NCT00827632|12204873|FG001|NOT COMPLETED|Overall Study||23
11026294|NCT00827775|12204881|FG000|STARTED|Overall Study||25
11026295|NCT00827775|12204882|FG001|STARTED|Overall Study||30
11026296|NCT00827775|12204881|FG000|COMPLETED|Overall Study||25
11026297|NCT00827775|12204882|FG001|COMPLETED|Overall Study||25
11026298|NCT00827775|12204881|FG000|NOT COMPLETED|Overall Study||0
11026299|NCT00827775|12204882|FG001|NOT COMPLETED|Overall Study||5
11026300|NCT00827827|12204890|FG000|STARTED|Overall Study||22
11026301|NCT00827827|12204891|FG001|STARTED|Overall Study||16
11026302|NCT00827827|12204890|FG000|COMPLETED|Overall Study||14
11026303|NCT00827827|12204891|FG001|COMPLETED|Overall Study||16
11026304|NCT00827827|12204890|FG000|NOT COMPLETED|Overall Study||8
11026305|NCT00827827|12204891|FG001|NOT COMPLETED|Overall Study||0
11026306|NCT00827918|12204901|FG000|STARTED|Overall Study||86
11026307|NCT00827918|12204902|FG001|STARTED|Overall Study||47
11026308|NCT00827918|12204903|FG002|STARTED|Overall Study||83
11026309|NCT00827918|12204901|FG000|COMPLETED|Overall Study||58
11026310|NCT00827918|12204902|FG001|COMPLETED|Overall Study||38
11026311|NCT00827918|12204903|FG002|COMPLETED|Overall Study||62
11026312|NCT00827918|12204901|FG000|NOT COMPLETED|Overall Study||28
11026313|NCT00827918|12204902|FG001|NOT COMPLETED|Overall Study||9
11026314|NCT00827918|12204903|FG002|NOT COMPLETED|Overall Study||21
11026315|NCT00827931|12204913|FG000|STARTED|Overall Study||49
11026316|NCT00827931|12204914|FG001|STARTED|Overall Study||45
11026317|NCT00827931|12204913|FG000|COMPLETED|Overall Study||43
11026318|NCT00827931|12204914|FG001|COMPLETED|Overall Study||39
11026319|NCT00827931|12204913|FG000|NOT COMPLETED|Overall Study||6
11026320|NCT00827931|12204914|FG001|NOT COMPLETED|Overall Study||6
11026321|NCT00827944|12204922|FG000|STARTED|Overall Study||304
11026322|NCT00827944|12204923|FG001|STARTED|Overall Study||299
11026323|NCT00827944|12204922|FG000|COMPLETED|Overall Study||241
11026324|NCT00827944|12204923|FG001|COMPLETED|Overall Study||240
11026325|NCT00827944|12204922|FG000|NOT COMPLETED|Overall Study||63
11026326|NCT00827944|12204923|FG001|NOT COMPLETED|Overall Study||59
11026327|NCT00827983|12204931|FG000|STARTED|Overall Study|All randomised patients|339
11026328|NCT00827983|12204932|FG001|STARTED|Overall Study|all randomised patients|344
11026329|NCT00827983|12204931|FG000|COMPLETED|Overall Study|patients who performed the pregnancy test|321
11026330|NCT00827983|12204932|FG001|COMPLETED|Overall Study|patients who performed the pregnancy test|328
11026331|NCT00827983|12204931|FG000|NOT COMPLETED|Overall Study||18
11026332|NCT00827983|12204932|FG001|NOT COMPLETED|Overall Study||16
11026333|NCT00828009|12204938|FG000|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70
11026334|NCT00828009|12204938|FG000|Started Treatment|Step 1 - Chemo RT/Consolidation Chemo||68
11026335|NCT00828009|12204938|FG000|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39
11026336|NCT00828009|12204938|FG000|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31
11026337|NCT00828009|12204938|FG000|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33
11026338|NCT00828009|12204938|FG000|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0
11418051|NCT00577395|12616267|FG001|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
11418052|NCT00577395|12616266|FG000|NOT COMPLETED|Overall Study||7
11418053|NCT00577395|12616267|FG001|NOT COMPLETED|Overall Study||6
11418054|NCT00573391|12616275|FG000|STARTED|Overall Study||3
11418055|NCT00573391|12616276|FG001|STARTED|Overall Study||2
11418056|NCT00573391|12616275|FG000|COMPLETED|Overall Study||0
11026339|NCT00828009|12204938|FG000|NOT COMPLETED|Step 2 - Maintenance Therapy||33
11026340|NCT00828061|12204943|FG000|STARTED|Period 1||4
11026341|NCT00828061|12204944|FG001|STARTED|Period 1||3
11026342|NCT00828061|12204945|FG002|STARTED|Period 1||3
11026343|NCT00828061|12204946|FG003|STARTED|Period 1||3
11418057|NCT00573391|12616276|FG001|COMPLETED|Overall Study||0
11418058|NCT00573391|12616275|FG000|NOT COMPLETED|Overall Study||3
11418059|NCT00573391|12616276|FG001|NOT COMPLETED|Overall Study||2
11418060|NCT00570258|12616284|FG000|STARTED|Overall Study||12
11418061|NCT00570258|12616285|FG001|STARTED|Overall Study||15
11418062|NCT00570258|12616284|FG000|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
11418063|NCT00570258|12616285|FG001|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
11418064|NCT00570258|12616284|FG000|NOT COMPLETED|Overall Study||12
11418065|NCT00570258|12616285|FG001|NOT COMPLETED|Overall Study||15
11418066|NCT00568802|12616293|FG000|STARTED|Overall Study||27
11418067|NCT00568802|12616293|FG000|COMPLETED|Overall Study||24
11418068|NCT00568802|12616293|FG000|NOT COMPLETED|Overall Study||3
11418069|NCT00576524|12616301|FG000|STARTED|Overall Study||2
11418070|NCT00576524|12616302|FG001|STARTED|Overall Study||0
11418071|NCT00576524|12616301|FG000|COMPLETED|Overall Study||2
11418072|NCT00576524|12616302|FG001|COMPLETED|Overall Study||0
11418073|NCT00576524|12616301|FG000|NOT COMPLETED|Overall Study||0
11418074|NCT00576524|12616302|FG001|NOT COMPLETED|Overall Study||0
11418075|NCT00568698|12616312|FG000|STARTED|Overall Study||29
11418076|NCT00568698|12616312|FG000|COMPLETED|Overall Study||18
11418077|NCT00568698|12616312|FG000|NOT COMPLETED|Overall Study||11
11418078|NCT00574080|12616320|FG000|STARTED|Overall Study||10
11418079|NCT00574080|12616321|FG001|STARTED|Overall Study||10
11418080|NCT00574080|12616320|FG000|COMPLETED|Overall Study||0
11418081|NCT00574080|12616321|FG001|COMPLETED|Overall Study||0
11418082|NCT00574080|12616320|FG000|NOT COMPLETED|Overall Study||10
11418083|NCT00574080|12616321|FG001|NOT COMPLETED|Overall Study||10
11418084|NCT00558558|12616327|FG000|STARTED|Overall Study||6
11418085|NCT00558558|12616327|FG000|COMPLETED|Overall Study||0
11418086|NCT00558558|12616327|FG000|NOT COMPLETED|Overall Study||6
11418087|NCT00577356|12616331|FG000|STARTED|Overall Study||6
11418088|NCT00577356|12616331|FG000|COMPLETED|Overall Study||6
11418089|NCT00577356|12616331|FG000|NOT COMPLETED|Overall Study||0
11418090|NCT00573937|12616337|FG000|STARTED|Overall Study||0
11418091|NCT00573937|12616338|FG001|STARTED|Overall Study||1
11418092|NCT00573937|12616337|FG000|COMPLETED|Overall Study||0
11418093|NCT00573937|12616338|FG001|COMPLETED|Overall Study||0
11026344|NCT00828061|12204947|FG004|STARTED|Period 1||3
11026345|NCT00828061|12204948|FG005|STARTED|Period 1||3
11026346|NCT00828061|12204943|FG000|COMPLETED|Period 1||4
11026347|NCT00828061|12204944|FG001|COMPLETED|Period 1||3
11026348|NCT00828061|12204945|FG002|COMPLETED|Period 1||3
11418094|NCT00573937|12616337|FG000|NOT COMPLETED|Overall Study||0
11418095|NCT00573937|12616338|FG001|NOT COMPLETED|Overall Study||1
11418096|NCT00577317|12616346|FG000|STARTED|Overall Study||0
11418097|NCT00577317|12616347|FG001|STARTED|Overall Study||2
11418098|NCT00577317|12616346|FG000|COMPLETED|Overall Study||0
11418099|NCT00577317|12616347|FG001|COMPLETED|Overall Study||0
11418100|NCT00577317|12616346|FG000|NOT COMPLETED|Overall Study||0
11418101|NCT00577317|12616347|FG001|NOT COMPLETED|Overall Study||2
11418102|NCT00571922|12616355|FG000|STARTED|Overall Study||36
11418103|NCT00571922|12616356|FG001|STARTED|Overall Study||36
11418104|NCT00571922|12616355|FG000|COMPLETED|Overall Study||0
11418105|NCT00571922|12616356|FG001|COMPLETED|Overall Study||0
11418106|NCT00571922|12616355|FG000|NOT COMPLETED|Overall Study||36
11418107|NCT00571922|12616356|FG001|NOT COMPLETED|Overall Study||36
11418108|NCT00569868|12616362|FG000|STARTED|Overall Study||11
11418109|NCT00569868|12616362|FG000|COMPLETED|Overall Study||11
11418110|NCT00569868|12616362|FG000|NOT COMPLETED|Overall Study||0
11418111|NCT00573157|12616368|FG000|STARTED|Overall Study||4
11418112|NCT00573157|12616369|FG001|STARTED|Overall Study||2
11418113|NCT00573157|12616368|FG000|COMPLETED|Overall Study||0
11418114|NCT00573157|12616369|FG001|COMPLETED|Overall Study||0
11418115|NCT00573157|12616368|FG000|NOT COMPLETED|Overall Study||4
11418116|NCT00573157|12616369|FG001|NOT COMPLETED|Overall Study||2
11418117|NCT00570531|12616375|FG000|STARTED|Overall Study||6
11418118|NCT00570531|12616375|FG000|COMPLETED|Overall Study||6
11418119|NCT00570531|12616375|FG000|NOT COMPLETED|Overall Study||0
11418120|NCT00566462|12616381|FG000|STARTED|Overall Study||1
11418121|NCT00566462|12616382|FG001|STARTED|Overall Study||0
11418122|NCT00566462|12616381|FG000|COMPLETED|Overall Study||1
11418123|NCT00566462|12616382|FG001|COMPLETED|Overall Study||0
11418124|NCT00566462|12616381|FG000|NOT COMPLETED|Overall Study||0
11418125|NCT00566462|12616382|FG001|NOT COMPLETED|Overall Study||0
11418126|NCT00561912|12616388|FG000|STARTED|Overall Study||2
11418127|NCT00561912|12616388|FG000|COMPLETED|Overall Study||1
11418128|NCT00561912|12616388|FG000|NOT COMPLETED|Overall Study||1
11418129|NCT00561795|12616394|FG000|STARTED|Overall Study||6
11418130|NCT00561795|12616395|FG001|STARTED|Overall Study||6
11418131|NCT00561795|12616396|FG002|STARTED|Overall Study||0
11418132|NCT00561795|12616397|FG003|STARTED|Overall Study||0
11418133|NCT00561795|12616394|FG000|COMPLETED|Overall Study||2
11418134|NCT00561795|12616395|FG001|COMPLETED|Overall Study||0
11418135|NCT00561795|12616396|FG002|COMPLETED|Overall Study||0
11418136|NCT00561795|12616397|FG003|COMPLETED|Overall Study||0
11418137|NCT00561795|12616394|FG000|NOT COMPLETED|Overall Study||4
11418138|NCT00561795|12616395|FG001|NOT COMPLETED|Overall Study||6
11418139|NCT00561795|12616396|FG002|NOT COMPLETED|Overall Study||0
11418140|NCT00561795|12616397|FG003|NOT COMPLETED|Overall Study||0
11418141|NCT00564876|12616405|FG000|STARTED|Overall Study||2
11418142|NCT00564876|12616405|FG000|COMPLETED|Overall Study||2
11418143|NCT00564876|12616405|FG000|NOT COMPLETED|Overall Study||0
11418144|NCT00558870|12616411|FG000|STARTED|Overall Study||2
11418145|NCT00558870|12616412|FG001|STARTED|Overall Study||2
11418146|NCT00558870|12616411|FG000|COMPLETED|Overall Study||2
11418147|NCT00558870|12616412|FG001|COMPLETED|Overall Study||2
11418148|NCT00558870|12616411|FG000|NOT COMPLETED|Overall Study||0
11418149|NCT00558870|12616412|FG001|NOT COMPLETED|Overall Study||0
11418150|NCT00559897|12616418|FG000|STARTED|Overall Study||6
11418151|NCT00559897|12616418|FG000|COMPLETED|Overall Study||6
11418152|NCT00559897|12616418|FG000|NOT COMPLETED|Overall Study||0
11418153|NCT00556400|12616424|FG000|STARTED|Overall Study||1
11418154|NCT00556400|12616425|FG001|STARTED|Overall Study||0
11418155|NCT00556400|12616424|FG000|COMPLETED|Overall Study||1
11418156|NCT00556400|12616425|FG001|COMPLETED|Overall Study||0
11418157|NCT00556400|12616424|FG000|NOT COMPLETED|Overall Study||0
11418158|NCT00556400|12616425|FG001|NOT COMPLETED|Overall Study||0
11418159|NCT00556075|12616433|FG000|STARTED|Overall Study||22
11418160|NCT00556075|12616434|FG001|STARTED|Overall Study||22
11418161|NCT00556075|12616435|FG002|STARTED|Overall Study||23
11418162|NCT00556075|12616433|FG000|COMPLETED|Overall Study||9
11418163|NCT00556075|12616434|FG001|COMPLETED|Overall Study||13
11418164|NCT00556075|12616435|FG002|COMPLETED|Overall Study||15
11418165|NCT00556075|12616433|FG000|NOT COMPLETED|Overall Study||13
11418166|NCT00556075|12616434|FG001|NOT COMPLETED|Overall Study||9
11418167|NCT00556075|12616435|FG002|NOT COMPLETED|Overall Study||8
11418168|NCT00556166|12616447|FG000|STARTED|Overall Study||4
11418169|NCT00556166|12616447|FG000|COMPLETED|Overall Study||3
11418170|NCT00556166|12616447|FG000|NOT COMPLETED|Overall Study||1
11418171|NCT00521924|12616453|FG000|STARTED|Overall Study|Subjects randomized|4
11418172|NCT00521924|12616454|FG001|STARTED|Overall Study|Subjects randomized|4
11418173|NCT00521924|12616453|FG000|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
11418174|NCT00521924|12616454|FG001|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
11418175|NCT00521924|12616453|FG000|NOT COMPLETED|Overall Study||4
11418176|NCT00521924|12616454|FG001|NOT COMPLETED|Overall Study||4
11418177|NCT00548886|12616460|FG000|STARTED|Overall Study||7
11418178|NCT00548886|12616460|FG000|COMPLETED|Overall Study||7
11418179|NCT00548886|12616460|FG000|NOT COMPLETED|Overall Study||0
11418180|NCT00547456|12616464|FG000|STARTED|Overall Study||20
11418181|NCT00547456|12616464|FG000|COMPLETED|Overall Study||20
11418182|NCT00547456|12616464|FG000|NOT COMPLETED|Overall Study||0
11418183|NCT00539838|12616471|FG000|STARTED|Overall Study||12
11418184|NCT00539838|12616472|FG001|STARTED|Overall Study||11
11418185|NCT00539838|12616473|FG002|STARTED|Overall Study||10
11418186|NCT00539838|12616471|FG000|COMPLETED|Overall Study||5
11418187|NCT00539838|12616472|FG001|COMPLETED|Overall Study||5
11418188|NCT00539838|12616473|FG002|COMPLETED|Overall Study||1
11418189|NCT00539838|12616471|FG000|NOT COMPLETED|Overall Study||7
11418190|NCT00539838|12616472|FG001|NOT COMPLETED|Overall Study||6
11418191|NCT00539838|12616473|FG002|NOT COMPLETED|Overall Study||9
11418192|NCT00549328|12616483|FG000|STARTED|Overall Study||14
11418193|NCT00549328|12616483|FG000|COMPLETED|Overall Study||0
11418194|NCT00549328|12616483|FG000|NOT COMPLETED|Overall Study||14
11418195|NCT00548327|12616489|FG000|STARTED|Overall Study||6
11418196|NCT00548327|12616490|FG001|STARTED|Overall Study||5
11418197|NCT00548327|12616489|FG000|COMPLETED|Overall Study||6
11418198|NCT00548327|12616490|FG001|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
11418199|NCT00548327|12616489|FG000|NOT COMPLETED|Overall Study||0
11418200|NCT00548327|12616490|FG001|NOT COMPLETED|Overall Study||1
11418201|NCT00542542|12616503|FG000|STARTED|Overall Study||44
11418202|NCT00542542|12616504|FG001|STARTED|Overall Study||44
11418203|NCT00542542|12616503|FG000|COMPLETED|Overall Study||44
11418204|NCT00542542|12616504|FG001|COMPLETED|Overall Study||44
11418205|NCT00542542|12616503|FG000|NOT COMPLETED|Overall Study||0
11418206|NCT00542542|12616504|FG001|NOT COMPLETED|Overall Study||0
11418207|NCT00545506|12616512|FG000|STARTED|Overall Study||3
11418208|NCT00545506|12616513|FG001|STARTED|Overall Study||3
11418209|NCT00545506|12616512|FG000|COMPLETED|Overall Study||3
11418210|NCT00545506|12616513|FG001|COMPLETED|Overall Study||3
11418211|NCT00545506|12616512|FG000|NOT COMPLETED|Overall Study||0
11418212|NCT00545506|12616513|FG001|NOT COMPLETED|Overall Study||0
11418213|NCT00547300|12616521|FG000|STARTED|Overall Study||25
11418214|NCT00547300|12616522|FG001|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26
11418215|NCT00547300|12616521|FG000|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
11418216|NCT00547300|12616522|FG001|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
11418217|NCT00547300|12616521|FG000|NOT COMPLETED|Overall Study||25
11418218|NCT00547300|12616522|FG001|NOT COMPLETED|Overall Study||26
11418219|NCT00539617|12616528|FG000|STARTED|Pre-screening Period||7
11418220|NCT00539617|12616528|FG000|COMPLETED|Pre-screening Period||4
11418221|NCT00539617|12616528|FG000|NOT COMPLETED|Pre-screening Period||3
11418222|NCT00539617|12616528|FG000|STARTED|Run-In Period||4
11418223|NCT00539617|12616528|FG000|COMPLETED|Run-In Period||3
11418224|NCT00539617|12616528|FG000|NOT COMPLETED|Run-In Period||1
11418225|NCT00539617|12616528|FG000|STARTED|Treatment Period||3
11418226|NCT00539617|12616528|FG000|COMPLETED|Treatment Period||3
11418227|NCT00539617|12616528|FG000|NOT COMPLETED|Treatment Period||0
11418228|NCT00546455|12616534|FG000|STARTED|Overall Study||0
11418229|NCT00546455|12616535|FG001|STARTED|Overall Study||0
11418230|NCT00546455|12616534|FG000|COMPLETED|Overall Study||0
11418231|NCT00546455|12616535|FG001|COMPLETED|Overall Study||0
11418232|NCT00546455|12616534|FG000|NOT COMPLETED|Overall Study||0
11418233|NCT00546455|12616535|FG001|NOT COMPLETED|Overall Study||0
11418234|NCT00538980|12616541|FG000|STARTED|Overall Study||10
11418235|NCT00538980|12616541|FG000|COMPLETED|Overall Study||0
11418236|NCT00538980|12616541|FG000|NOT COMPLETED|Overall Study||10
11418237|NCT00540969|12616547|FG000|STARTED|Overall Study||2
11418238|NCT00540969|12616548|FG001|STARTED|Overall Study||1
11418239|NCT00540969|12616547|FG000|COMPLETED|Overall Study||2
11418240|NCT00540969|12616548|FG001|COMPLETED|Overall Study||1
11418241|NCT00540969|12616547|FG000|NOT COMPLETED|Overall Study||0
11418242|NCT00540969|12616548|FG001|NOT COMPLETED|Overall Study||0
11418243|NCT00535262|12616554|FG000|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
11418244|NCT00535262|12616554|FG000|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
11418245|NCT00535262|12616554|FG000|NOT COMPLETED|Overall Study||3
11418246|NCT00529464|12616561|FG000|STARTED|Overall Study||0
11418247|NCT00529464|12616562|FG001|STARTED|Overall Study||0
11418248|NCT00529464|12616563|FG002|STARTED|Overall Study||0
11418249|NCT00529464|12616561|FG000|COMPLETED|Overall Study||0
11418250|NCT00529464|12616562|FG001|COMPLETED|Overall Study||0
11418251|NCT00529464|12616563|FG002|COMPLETED|Overall Study||0
11418252|NCT00529464|12616561|FG000|NOT COMPLETED|Overall Study||0
11418253|NCT00529464|12616562|FG001|NOT COMPLETED|Overall Study||0
11418254|NCT00529464|12616563|FG002|NOT COMPLETED|Overall Study||0
11418255|NCT00537199|12616571|FG000|STARTED|Overall Study||1
11418256|NCT00537199|12616571|FG000|COMPLETED|Overall Study||0
11418257|NCT00537199|12616571|FG000|NOT COMPLETED|Overall Study||1
11418258|NCT00537446|12616575|FG000|STARTED|Overall Study||8
11418259|NCT00537446|12616575|FG000|COMPLETED|Overall Study||8
11418260|NCT00537446|12616575|FG000|NOT COMPLETED|Overall Study||0
11418261|NCT00536978|12616581|FG000|STARTED|Overall Study||22
11418262|NCT00536978|12616581|FG000|COMPLETED|Overall Study||0
11418263|NCT00536978|12616581|FG000|NOT COMPLETED|Overall Study||22
11418264|NCT00524485|12616585|FG000|STARTED|Overall Study||12
11418265|NCT00524485|12616585|FG000|COMPLETED|Overall Study||7
11418266|NCT00524485|12616585|FG000|NOT COMPLETED|Overall Study||5
11418267|NCT00533351|12616591|FG000|STARTED|Period 1||7
11418268|NCT00533351|12616592|FG001|STARTED|Period 1||2
11418269|NCT00533351|12616591|FG000|COMPLETED|Period 1||5
11418270|NCT00533351|12616592|FG001|COMPLETED|Period 1||1
11418271|NCT00533351|12616591|FG000|NOT COMPLETED|Period 1||2
11418272|NCT00533351|12616592|FG001|NOT COMPLETED|Period 1||1
11418273|NCT00533351|12616591|FG000|STARTED|Period 2||5
11418274|NCT00533351|12616592|FG001|STARTED|Period 2||1
11418275|NCT00533351|12616591|FG000|COMPLETED|Period 2||5
11418276|NCT00533351|12616592|FG001|COMPLETED|Period 2||1
11418277|NCT00533351|12616591|FG000|NOT COMPLETED|Period 2||0
11418278|NCT00533351|12616592|FG001|NOT COMPLETED|Period 2||0
11418279|NCT00533351|12616591|FG000|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
11418280|NCT00533351|12616592|FG001|STARTED|Period 3|No patients continued to Period 3|0
11418281|NCT00533351|12616591|FG000|COMPLETED|Period 3||3
11418282|NCT00533351|12616592|FG001|COMPLETED|Period 3||0
11418283|NCT00533351|12616591|FG000|NOT COMPLETED|Period 3||0
11418284|NCT00533351|12616592|FG001|NOT COMPLETED|Period 3||0
11418285|NCT00529282|12616600|FG000|STARTED|Overall Study||0
11418286|NCT00529282|12616601|FG001|STARTED|Overall Study||2
11418287|NCT00529282|12616600|FG000|COMPLETED|Overall Study||0
11418288|NCT00529282|12616601|FG001|COMPLETED|Overall Study||2
11418289|NCT00529282|12616600|FG000|NOT COMPLETED|Overall Study||0
11418290|NCT00529282|12616601|FG001|NOT COMPLETED|Overall Study||0
11418291|NCT00524134|12616607|FG000|STARTED|Overall Study||6
11418292|NCT00524134|12616607|FG000|COMPLETED|Overall Study||4
11418293|NCT00524134|12616607|FG000|NOT COMPLETED|Overall Study||2
11026349|NCT00828061|12204946|FG003|COMPLETED|Period 1||3
11026350|NCT00828061|12204947|FG004|COMPLETED|Period 1||3
11026351|NCT00828061|12204948|FG005|COMPLETED|Period 1||3
11026352|NCT00828061|12204943|FG000|NOT COMPLETED|Period 1||0
11026353|NCT00828061|12204944|FG001|NOT COMPLETED|Period 1||0
11026354|NCT00828061|12204945|FG002|NOT COMPLETED|Period 1||0
11026355|NCT00828061|12204946|FG003|NOT COMPLETED|Period 1||0
11026356|NCT00828061|12204947|FG004|NOT COMPLETED|Period 1||0
11026357|NCT00828061|12204948|FG005|NOT COMPLETED|Period 1||0
11026358|NCT00828061|12204943|FG000|STARTED|Period 2||4
11026359|NCT00828061|12204944|FG001|STARTED|Period 2||3
11026360|NCT00828061|12204945|FG002|STARTED|Period 2||3
11026361|NCT00828061|12204946|FG003|STARTED|Period 2||3
11026362|NCT00828061|12204947|FG004|STARTED|Period 2||3
11026363|NCT00828061|12204948|FG005|STARTED|Period 2||3
11026364|NCT00828061|12204943|FG000|COMPLETED|Period 2||4
11026365|NCT00828061|12204944|FG001|COMPLETED|Period 2||3
11026366|NCT00828061|12204945|FG002|COMPLETED|Period 2||3
11026367|NCT00828061|12204946|FG003|COMPLETED|Period 2||3
11026368|NCT00828061|12204947|FG004|COMPLETED|Period 2||3
11026369|NCT00828061|12204948|FG005|COMPLETED|Period 2||3
11026370|NCT00828061|12204943|FG000|NOT COMPLETED|Period 2||0
11026371|NCT00828061|12204944|FG001|NOT COMPLETED|Period 2||0
11026372|NCT00828061|12204945|FG002|NOT COMPLETED|Period 2||0
11026373|NCT00828061|12204946|FG003|NOT COMPLETED|Period 2||0
11026374|NCT00828061|12204947|FG004|NOT COMPLETED|Period 2||0
11026375|NCT00828061|12204948|FG005|NOT COMPLETED|Period 2||0
11026376|NCT00828061|12204943|FG000|STARTED|Period 3||4
11026377|NCT00828061|12204944|FG001|STARTED|Period 3||3
11026378|NCT00828061|12204945|FG002|STARTED|Period 3||3
11026379|NCT00828061|12204946|FG003|STARTED|Period 3||3
11026380|NCT00828061|12204947|FG004|STARTED|Period 3||3
11026381|NCT00828061|12204948|FG005|STARTED|Period 3||3
11026382|NCT00828061|12204943|FG000|COMPLETED|Period 3||4
11026383|NCT00828061|12204944|FG001|COMPLETED|Period 3||3
11026384|NCT00828061|12204945|FG002|COMPLETED|Period 3||3
11026385|NCT00828061|12204946|FG003|COMPLETED|Period 3||3
11026386|NCT00828061|12204947|FG004|COMPLETED|Period 3||3
11026387|NCT00828061|12204948|FG005|COMPLETED|Period 3||3
11026388|NCT00828061|12204943|FG000|NOT COMPLETED|Period 3||0
11026389|NCT00828061|12204944|FG001|NOT COMPLETED|Period 3||0
11026390|NCT00828061|12204945|FG002|NOT COMPLETED|Period 3||0
11026391|NCT00828061|12204946|FG003|NOT COMPLETED|Period 3||0
11026392|NCT00828061|12204947|FG004|NOT COMPLETED|Period 3||0
11026393|NCT00828061|12204948|FG005|NOT COMPLETED|Period 3||0
11026394|NCT00828074|12204958|FG000|STARTED|Overall Study||6
11026395|NCT00828074|12204959|FG001|STARTED|Overall Study||5
11026396|NCT00828074|12204960|FG002|STARTED|Overall Study||35
11026397|NCT00828074|12204958|FG000|COMPLETED|Overall Study||6
11026398|NCT00828074|12204959|FG001|COMPLETED|Overall Study||5
11026399|NCT00828074|12204960|FG002|COMPLETED|Overall Study||35
11026400|NCT00828074|12204958|FG000|NOT COMPLETED|Overall Study||0
11026401|NCT00828074|12204959|FG001|NOT COMPLETED|Overall Study||0
11026402|NCT00828074|12204960|FG002|NOT COMPLETED|Overall Study||0
11026403|NCT00828113|12204972|FG000|STARTED|Overall Study||50
11026404|NCT00828113|12204973|FG001|STARTED|Overall Study||51
11026405|NCT00828113|12204972|FG000|COMPLETED|Overall Study||20
11026406|NCT00828113|12204973|FG001|COMPLETED|Overall Study||20
11026407|NCT00828113|12204972|FG000|NOT COMPLETED|Overall Study||30
11026408|NCT00828113|12204973|FG001|NOT COMPLETED|Overall Study||31
11026409|NCT00828139|12204983|FG000|STARTED|Overall Study||42
11026410|NCT00828139|12204984|FG001|STARTED|Overall Study||41
11026411|NCT00828139|12204985|FG002|STARTED|Overall Study||55
11026412|NCT00828139|12204986|FG003|STARTED|Overall Study||51
11026413|NCT00828139|12204983|FG000|COMPLETED|Overall Study||1
11026414|NCT00828139|12204984|FG001|COMPLETED|Overall Study||0
11026415|NCT00828139|12204985|FG002|COMPLETED|Overall Study||0
11026416|NCT00828139|12204986|FG003|COMPLETED|Overall Study||0
11026417|NCT00828139|12204983|FG000|NOT COMPLETED|Overall Study||41
11026418|NCT00828139|12204984|FG001|NOT COMPLETED|Overall Study||41
11026419|NCT00828139|12204985|FG002|NOT COMPLETED|Overall Study||55
11026420|NCT00828139|12204986|FG003|NOT COMPLETED|Overall Study||51
11026421|NCT00828178|12204998|FG000|STARTED|Overall Study||42
11026422|NCT00828178|12204999|FG001|STARTED|Overall Study|Eighty seven participants were randomized.|45
11026423|NCT00828178|12204998|FG000|COMPLETED|Overall Study||42
11026424|NCT00828178|12204999|FG001|COMPLETED|Overall Study|Two patients did not complete the study.|43
11026425|NCT00828178|12204998|FG000|NOT COMPLETED|Overall Study||0
11026426|NCT00828178|12204999|FG001|NOT COMPLETED|Overall Study||2
11026427|NCT00828191|12205009|FG000|STARTED|Overall Study|Randomized patients|400
11026428|NCT00828191|12205010|FG001|STARTED|Overall Study|Randomized patients|400
11026429|NCT00828191|12205009|FG000|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
11026430|NCT00828191|12205010|FG001|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
11026431|NCT00828191|12205009|FG000|NOT COMPLETED|Overall Study||8
11026432|NCT00828191|12205010|FG001|NOT COMPLETED|Overall Study||10
11026433|NCT00828204|12205018|FG000|STARTED|Main Study: Prior to Study Suspension||21
11026434|NCT00828204|12205019|FG001|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
11026435|NCT00828204|12205018|FG000|Completed Manual Injection|Main Study: Prior to Study Suspension||21
11026436|NCT00828204|12205019|FG001|Completed Manual Injection|Main Study: Prior to Study Suspension||0
11026437|NCT00828204|12205018|FG000|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
11026438|NCT00828204|12205019|FG001|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
11026439|NCT00828204|12205018|FG000|COMPLETED|Main Study: Prior to Study Suspension||7
11026440|NCT00828204|12205019|FG001|COMPLETED|Main Study: Prior to Study Suspension||0
11026441|NCT00828204|12205018|FG000|NOT COMPLETED|Main Study: Prior to Study Suspension||14
11026442|NCT00828204|12205019|FG001|NOT COMPLETED|Main Study: Prior to Study Suspension||0
11026443|NCT00828204|12205018|FG000|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
11026444|NCT00828204|12205019|FG001|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
11026445|NCT00828204|12205018|FG000|Completed Manual Injection|Main Study: After Study Restart||0
11026446|NCT00828204|12205019|FG001|Completed Manual Injection|Main Study: After Study Restart||74
11026447|NCT00828204|12205018|FG000|Continued With Autoinjector Injections|Main Study: After Study Restart||0
11026448|NCT00828204|12205019|FG001|Continued With Autoinjector Injections|Main Study: After Study Restart||72
11026449|NCT00828204|12205018|FG000|COMPLETED|Main Study: After Study Restart||0
11026450|NCT00828204|12205019|FG001|COMPLETED|Main Study: After Study Restart||71
11026451|NCT00828204|12205018|FG000|NOT COMPLETED|Main Study: After Study Restart||0
11026452|NCT00828204|12205019|FG001|NOT COMPLETED|Main Study: After Study Restart||3
11026453|NCT00828204|12205018|FG000|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
11026454|NCT00828204|12205019|FG001|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
11026455|NCT00828204|12205018|FG000|COMPLETED|Extension Study||0
11026456|NCT00828204|12205019|FG001|COMPLETED|Extension Study||61
11026457|NCT00828204|12205018|FG000|NOT COMPLETED|Extension Study||0
11026458|NCT00828204|12205019|FG001|NOT COMPLETED|Extension Study||3
11026459|NCT00828295|12205028|FG000|STARTED|Overall Study||75
11026460|NCT00828295|12205029|FG001|STARTED|Overall Study||75
11026461|NCT00828295|12205028|FG000|COMPLETED|Overall Study||75
11026462|NCT00828295|12205029|FG001|COMPLETED|Overall Study||75
11026463|NCT00828295|12205028|FG000|NOT COMPLETED|Overall Study||0
11026464|NCT00828295|12205029|FG001|NOT COMPLETED|Overall Study||0
11026465|NCT00828347|12205037|FG000|STARTED|Overall Study||12
11026466|NCT00828347|12205038|FG001|STARTED|Overall Study||11
11026467|NCT00828347|12205037|FG000|COMPLETED|Overall Study||12
11026468|NCT00828347|12205038|FG001|COMPLETED|Overall Study||11
11026469|NCT00828347|12205037|FG000|NOT COMPLETED|Overall Study||0
11026470|NCT00828347|12205038|FG001|NOT COMPLETED|Overall Study||0
11026471|NCT00828412|12205046|FG000|STARTED|Overall Study||50
11026472|NCT00828412|12205047|FG001|STARTED|Overall Study||50
11026473|NCT00828412|12205046|FG000|COMPLETED|Overall Study||41
11026474|NCT00828412|12205047|FG001|COMPLETED|Overall Study||48
11026475|NCT00828412|12205046|FG000|NOT COMPLETED|Overall Study||9
11026476|NCT00828412|12205047|FG001|NOT COMPLETED|Overall Study||2
11026477|NCT00828451|12205053|FG000|STARTED|Overall Study||29
11026478|NCT00828451|12205053|FG000|COMPLETED|Overall Study||18
11026479|NCT00828451|12205053|FG000|NOT COMPLETED|Overall Study||11
11026480|NCT00828464|12205057|FG000|STARTED|Overall Study||30
11026481|NCT00828464|12205057|FG000|COMPLETED|Overall Study||29
11026482|NCT00828464|12205057|FG000|NOT COMPLETED|Overall Study||1
11026483|NCT00828516|12205061|FG000|STARTED|Clinical Phase: Series 1||35
11026484|NCT00828516|12205061|FG000|COMPLETED|Clinical Phase: Series 1||33
11026485|NCT00828516|12205061|FG000|NOT COMPLETED|Clinical Phase: Series 1||2
11026486|NCT00828516|12205061|FG000|STARTED|Clinical Phase: Series 2||30
11026487|NCT00828516|12205061|FG000|COMPLETED|Clinical Phase: Series 2||30
11026488|NCT00828516|12205061|FG000|NOT COMPLETED|Clinical Phase: Series 2||0
11026489|NCT00828542|12205067|FG000|STARTED|Overall Study||23
11026490|NCT00828542|12205068|FG001|STARTED|Overall Study||23
11026491|NCT00828542|12205067|FG000|COMPLETED|Overall Study||20
11026492|NCT00828542|12205068|FG001|COMPLETED|Overall Study||20
11026493|NCT00828542|12205067|FG000|NOT COMPLETED|Overall Study||3
11026494|NCT00828542|12205068|FG001|NOT COMPLETED|Overall Study||3
11026495|NCT00828568|12205077|FG000|STARTED|Randomized||184
11026496|NCT00828568|12205078|FG001|STARTED|Randomized||179
11026497|NCT00828568|12205079|FG002|STARTED|Randomized||62
11026498|NCT00828568|12205077|FG000|COMPLETED|Randomized||183
11026499|NCT00828568|12205078|FG001|COMPLETED|Randomized||179
11026500|NCT00828568|12205079|FG002|COMPLETED|Randomized||60
11026501|NCT00828568|12205077|FG000|NOT COMPLETED|Randomized||1
11026502|NCT00828568|12205078|FG001|NOT COMPLETED|Randomized||0
11026503|NCT00828568|12205079|FG002|NOT COMPLETED|Randomized||2
11026504|NCT00828568|12205077|FG000|STARTED|Treated - Received at Least One Dose||183
11026505|NCT00828568|12205078|FG001|STARTED|Treated - Received at Least One Dose||179
11026506|NCT00828568|12205079|FG002|STARTED|Treated - Received at Least One Dose||60
11026507|NCT00828568|12205077|FG000|COMPLETED|Treated - Received at Least One Dose||153
11026508|NCT00828568|12205078|FG001|COMPLETED|Treated - Received at Least One Dose||150
11026509|NCT00828568|12205079|FG002|COMPLETED|Treated - Received at Least One Dose||55
11026510|NCT00828568|12205077|FG000|NOT COMPLETED|Treated - Received at Least One Dose||30
11026511|NCT00828568|12205078|FG001|NOT COMPLETED|Treated - Received at Least One Dose||29
11026512|NCT00828568|12205079|FG002|NOT COMPLETED|Treated - Received at Least One Dose||5
11026513|NCT00828672|12205090|FG000|STARTED|Pre-treatment (Baseline)||43
11026514|NCT00828672|12205091|FG001|STARTED|Pre-treatment (Baseline)||41
11026515|NCT00828672|12205090|FG000|COMPLETED|Pre-treatment (Baseline)||43
11026516|NCT00828672|12205091|FG001|COMPLETED|Pre-treatment (Baseline)||41
11026517|NCT00828672|12205090|FG000|NOT COMPLETED|Pre-treatment (Baseline)||0
11026518|NCT00828672|12205091|FG001|NOT COMPLETED|Pre-treatment (Baseline)||0
11026519|NCT00828672|12205090|FG000|STARTED|Study Treatment||43
11026520|NCT00828672|12205091|FG001|STARTED|Study Treatment||41
11026521|NCT00828672|12205090|FG000|COMPLETED|Study Treatment||41
11026522|NCT00828672|12205091|FG001|COMPLETED|Study Treatment||39
11026523|NCT00828672|12205090|FG000|NOT COMPLETED|Study Treatment||2
11026524|NCT00828672|12205091|FG001|NOT COMPLETED|Study Treatment||2
11026525|NCT00828672|12205090|FG000|STARTED|Post-surgery (<30 Days)||41
11026526|NCT00828672|12205091|FG001|STARTED|Post-surgery (<30 Days)||39
11026527|NCT00828672|12205090|FG000|COMPLETED|Post-surgery (<30 Days)||41
11026528|NCT00828672|12205091|FG001|COMPLETED|Post-surgery (<30 Days)||38
11026529|NCT00828672|12205090|FG000|NOT COMPLETED|Post-surgery (<30 Days)||0
11026530|NCT00828672|12205091|FG001|NOT COMPLETED|Post-surgery (<30 Days)||1
11026531|NCT00828672|12205090|FG000|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42
11026532|NCT00828672|12205091|FG001|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41
11026533|NCT00828672|12205090|FG000|COMPLETED|Follow-up||42
11026534|NCT00828672|12205091|FG001|COMPLETED|Follow-up||41
11026535|NCT00828672|12205090|FG000|NOT COMPLETED|Follow-up||0
11026536|NCT00828672|12205091|FG001|NOT COMPLETED|Follow-up||0
11026537|NCT00828711|12205100|FG000|STARTED|Overall Study||118
11026538|NCT00828711|12205101|FG001|STARTED|Overall Study||125
11026539|NCT00828711|12205102|FG002|STARTED|Overall Study||131
11026540|NCT00828711|12205100|FG000|COMPLETED|Overall Study||117
11026541|NCT00828711|12205101|FG001|COMPLETED|Overall Study||125
11026542|NCT00828711|12205102|FG002|COMPLETED|Overall Study||131
11026543|NCT00828711|12205100|FG000|NOT COMPLETED|Overall Study||1
11026544|NCT00828711|12205101|FG001|NOT COMPLETED|Overall Study||0
11026545|NCT00828711|12205102|FG002|NOT COMPLETED|Overall Study||0
11026546|NCT00828750|12205110|FG000|STARTED|Overall Study||19
11026547|NCT00828750|12205110|FG000|COMPLETED|Overall Study||15
11026548|NCT00828750|12205110|FG000|NOT COMPLETED|Overall Study||4
11026549|NCT00828841|12205118|FG000|STARTED|Overall Study||235
11026550|NCT00828841|12205119|FG001|STARTED|Overall Study||236
11026551|NCT00828841|12205120|FG002|STARTED|Overall Study||130
11026552|NCT00828841|12205118|FG000|COMPLETED|Overall Study||231
11026553|NCT00828841|12205119|FG001|COMPLETED|Overall Study||232
11026554|NCT00828841|12205120|FG002|COMPLETED|Overall Study||126
11026555|NCT00828841|12205118|FG000|NOT COMPLETED|Overall Study||4
11026556|NCT00828841|12205119|FG001|NOT COMPLETED|Overall Study||4
11026557|NCT00828841|12205120|FG002|NOT COMPLETED|Overall Study||4
11026558|NCT00828945|12205130|FG000|STARTED|Overall Study||257
11026559|NCT00828945|12205130|FG000|COMPLETED|Overall Study||216
11026560|NCT00828945|12205130|FG000|NOT COMPLETED|Overall Study||41
11026561|NCT00828984|12205137|FG000|STARTED|Overall Study||28
11026562|NCT00828984|12205138|FG001|STARTED|Overall Study||31
11026563|NCT00828984|12205139|FG002|STARTED|Overall Study||28
11026564|NCT00828984|12205137|FG000|Randomization|Overall Study||28
11026565|NCT00828984|12205138|FG001|Randomization|Overall Study||31
11026566|NCT00828984|12205139|FG002|Randomization|Overall Study||28
11026567|NCT00828984|12205137|FG000|Treatment|Overall Study||24
11026568|NCT00828984|12205138|FG001|Treatment|Overall Study||26
11026569|NCT00828984|12205139|FG002|Treatment|Overall Study||24
11026570|NCT00828984|12205137|FG000|Flexible Sigmoidoscopy|Overall Study||20
11026571|NCT00828984|12205138|FG001|Flexible Sigmoidoscopy|Overall Study||19
11026572|NCT00828984|12205139|FG002|Flexible Sigmoidoscopy|Overall Study||19
11026573|NCT00828984|12205137|FG000|Post Intervention Follow-Up|Overall Study||15
11026574|NCT00828984|12205138|FG001|Post Intervention Follow-Up|Overall Study||16
11026575|NCT00828984|12205139|FG002|Post Intervention Follow-Up|Overall Study||19
11026576|NCT00828984|12205137|FG000|COMPLETED|Overall Study||14
11026577|NCT00828984|12205138|FG001|COMPLETED|Overall Study||15
11026578|NCT00828984|12205139|FG002|COMPLETED|Overall Study||19
11026579|NCT00828984|12205137|FG000|NOT COMPLETED|Overall Study||14
11026580|NCT00828984|12205138|FG001|NOT COMPLETED|Overall Study||16
11026581|NCT00828984|12205139|FG002|NOT COMPLETED|Overall Study||9
11026582|NCT00829010|12205152|FG000|STARTED|Overall Study||83
11026583|NCT00829010|12205153|FG001|STARTED|Overall Study||101
11026584|NCT00829010|12205154|FG002|STARTED|Overall Study||100
11026585|NCT00829010|12205155|FG003|STARTED|Overall Study||100
11026586|NCT00829010|12205156|FG004|STARTED|Overall Study||100
11026587|NCT00829010|12205152|FG000|COMPLETED|Overall Study||73
11026588|NCT00829010|12205153|FG001|COMPLETED|Overall Study||92
11026589|NCT00829010|12205154|FG002|COMPLETED|Overall Study||97
11026590|NCT00829010|12205155|FG003|COMPLETED|Overall Study||92
11026591|NCT00829010|12205156|FG004|COMPLETED|Overall Study||98
11026592|NCT00829010|12205152|FG000|NOT COMPLETED|Overall Study||10
11144711|NCT01481116|12331526|FG002|COMPLETED|Overall Study||0
11144712|NCT01481116|12331524|FG000|NOT COMPLETED|Overall Study||824
11144713|NCT01481116|12331525|FG001|NOT COMPLETED|Overall Study||817
11144714|NCT01481116|12331526|FG002|NOT COMPLETED|Overall Study||813
11144715|NCT01481129|12331534|FG000|STARTED|Overall Study||22
11144716|NCT01481129|12331534|FG000|COMPLETED|Overall Study||22
11144717|NCT01481129|12331534|FG000|NOT COMPLETED|Overall Study||0
11144718|NCT01481324|12331541|FG000|STARTED|Overall Study||21
11144719|NCT01481324|12331542|FG001|STARTED|Overall Study||24
11144720|NCT01481324|12331543|FG002|STARTED|Overall Study||22
11144721|NCT01481324|12331541|FG000|Month 1-Wear Rate Data|Overall Study||15
11144722|NCT01481324|12331542|FG001|Month 1-Wear Rate Data|Overall Study||16
11144723|NCT01481324|12331543|FG002|Month 1-Wear Rate Data|Overall Study||8
11144724|NCT01481324|12331541|FG000|Month 2-Wear Rate Data|Overall Study||9
11144725|NCT01481324|12331542|FG001|Month 2-Wear Rate Data|Overall Study||13
11144726|NCT01481324|12331543|FG002|Month 2-Wear Rate Data|Overall Study||7
11144727|NCT01481324|12331541|FG000|Month 3-Wear Rate Data|Overall Study||7
11144728|NCT01481324|12331542|FG001|Month 3-Wear Rate Data|Overall Study||11
11144729|NCT01481324|12331543|FG002|Month 3-Wear Rate Data|Overall Study||6
11144730|NCT01481324|12331541|FG000|COMPLETED|Overall Study||21
11144731|NCT01481324|12331542|FG001|COMPLETED|Overall Study||22
11144732|NCT01481324|12331543|FG002|COMPLETED|Overall Study||20
11144733|NCT01481324|12331541|FG000|NOT COMPLETED|Overall Study||0
11144734|NCT01481324|12331542|FG001|NOT COMPLETED|Overall Study||2
11144735|NCT01481324|12331543|FG002|NOT COMPLETED|Overall Study||2
11144736|NCT01481376|12331551|FG000|STARTED|Overall Study||200
11026593|NCT00829010|12205153|FG001|NOT COMPLETED|Overall Study||9
11026594|NCT00829010|12205154|FG002|NOT COMPLETED|Overall Study||3
11144737|NCT01481376|12331551|FG000|COMPLETED|Overall Study||169
11026595|NCT00829010|12205155|FG003|NOT COMPLETED|Overall Study||8
11026596|NCT00829010|12205156|FG004|NOT COMPLETED|Overall Study||2
11026597|NCT00829036|12205168|FG000|STARTED|Overall Study||24
11026598|NCT00829036|12205168|FG000|COMPLETED|Overall Study||24
11026599|NCT00829036|12205168|FG000|NOT COMPLETED|Overall Study||0
11144738|NCT01481376|12331551|FG000|NOT COMPLETED|Overall Study||31
11144739|NCT01481545|12331557|FG000|STARTED|Overall Study||16
11144740|NCT01481545|12331558|FG001|STARTED|Overall Study||46
11144741|NCT01481545|12331557|FG000|COMPLETED|Overall Study||11
11144742|NCT01481545|12331558|FG001|COMPLETED|Overall Study||40
11144743|NCT01481545|12331557|FG000|NOT COMPLETED|Overall Study||5
11144744|NCT01481545|12331558|FG001|NOT COMPLETED|Overall Study||6
11144745|NCT01481558|12331568|FG000|STARTED|Overall Study||20
11144746|NCT01481558|12331569|FG001|STARTED|Overall Study||20
11144747|NCT01481558|12331568|FG000|COMPLETED|Overall Study||20
11144748|NCT01481558|12331569|FG001|COMPLETED|Overall Study||20
11144749|NCT01481558|12331568|FG000|NOT COMPLETED|Overall Study||0
11144750|NCT01481558|12331569|FG001|NOT COMPLETED|Overall Study||0
11144751|NCT01481740|12331577|FG000|STARTED|Overall Study||90
11144752|NCT01481740|12331578|FG001|STARTED|Overall Study||88
11144753|NCT01481740|12331577|FG000|COMPLETED|Overall Study||79
11144754|NCT01481740|12331578|FG001|COMPLETED|Overall Study||81
11144755|NCT01481740|12331577|FG000|NOT COMPLETED|Overall Study||11
11144756|NCT01481740|12331578|FG001|NOT COMPLETED|Overall Study||7
11144757|NCT01481779|12331586|FG000|STARTED|Overall Study||295
11144758|NCT01481779|12331587|FG001|STARTED|Overall Study||160
11144759|NCT01481779|12331586|FG000|Received at Least 1 Dose of Study Drug|Overall Study||294
11144760|NCT01481779|12331587|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159
11144761|NCT01481779|12331586|FG000|COMPLETED|Overall Study||225
11144762|NCT01481779|12331587|FG001|COMPLETED|Overall Study||132
11144763|NCT01481779|12331586|FG000|NOT COMPLETED|Overall Study||70
11144764|NCT01481779|12331587|FG001|NOT COMPLETED|Overall Study||28
11144765|NCT01481896|12331593|FG000|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
11144766|NCT01481896|12331593|FG000|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
11144767|NCT01481896|12331593|FG000|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
11144768|NCT01481896|12331593|FG000|NOT COMPLETED|Overall Study||12
11144769|NCT01482065|12331609|FG000|STARTED|Overall Study||4
11144770|NCT01482065|12331610|FG001|STARTED|Overall Study||5
11144771|NCT01482065|12331609|FG000|COMPLETED|Overall Study||4
11144772|NCT01482065|12331610|FG001|COMPLETED|Overall Study||4
11144773|NCT01482065|12331609|FG000|NOT COMPLETED|Overall Study||0
11144774|NCT01482065|12331610|FG001|NOT COMPLETED|Overall Study||1
11144775|NCT01482091|12331618|FG000|STARTED|Overall Study||25
11144776|NCT01482091|12331619|FG001|STARTED|Overall Study||24
11144777|NCT01482091|12331618|FG000|COMPLETED|Overall Study||25
11144778|NCT01482091|12331619|FG001|COMPLETED|Overall Study||24
11144779|NCT01482091|12331618|FG000|NOT COMPLETED|Overall Study||0
11144780|NCT01482091|12331619|FG001|NOT COMPLETED|Overall Study||0
11144781|NCT01482169|12331625|FG000|STARTED|Overall Study||48
11144782|NCT01482169|12331625|FG000|COMPLETED|Overall Study||46
11144783|NCT01482169|12331625|FG000|NOT COMPLETED|Overall Study||2
11144784|NCT01482221|12331635|FG000|STARTED|Overall Study||101
11144785|NCT01482221|12331636|FG001|STARTED|Overall Study||101
11144786|NCT01482221|12331637|FG002|STARTED|Overall Study||100
11144787|NCT01482221|12331635|FG000|COMPLETED|Overall Study||80
11144788|NCT01482221|12331636|FG001|COMPLETED|Overall Study||81
11144789|NCT01482221|12331637|FG002|COMPLETED|Overall Study||77
11144790|NCT01482221|12331635|FG000|NOT COMPLETED|Overall Study||21
11144791|NCT01482221|12331636|FG001|NOT COMPLETED|Overall Study||20
11144792|NCT01482221|12331637|FG002|NOT COMPLETED|Overall Study||23
11144793|NCT01482312|12331645|FG000|STARTED|Period 1, 90 Minutes of Wear||10
11144794|NCT01482312|12331646|FG001|STARTED|Period 1, 90 Minutes of Wear||9
11144795|NCT01482312|12331647|FG002|STARTED|Period 1, 90 Minutes of Wear||10
11144796|NCT01482312|12331645|FG000|COMPLETED|Period 1, 90 Minutes of Wear||9
11144797|NCT01482312|12331646|FG001|COMPLETED|Period 1, 90 Minutes of Wear||9
11144798|NCT01482312|12331647|FG002|COMPLETED|Period 1, 90 Minutes of Wear||10
11144799|NCT01482312|12331645|FG000|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
11144800|NCT01482312|12331646|FG001|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
11144801|NCT01482312|12331647|FG002|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
11144802|NCT01482312|12331645|FG000|STARTED|Period 2, 90 Minutes of Wear||9
11144803|NCT01482312|12331646|FG001|STARTED|Period 2, 90 Minutes of Wear||9
11144804|NCT01482312|12331647|FG002|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
11144805|NCT01482312|12331645|FG000|COMPLETED|Period 2, 90 Minutes of Wear||8
11144806|NCT01482312|12331646|FG001|COMPLETED|Period 2, 90 Minutes of Wear||9
11144807|NCT01482312|12331647|FG002|COMPLETED|Period 2, 90 Minutes of Wear||9
11144808|NCT01482312|12331645|FG000|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
11144809|NCT01482312|12331646|FG001|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
11144810|NCT01482312|12331647|FG002|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
11144811|NCT01482312|12331645|FG000|STARTED|Period 3, 90 Minutes of Wear||8
11144812|NCT01482312|12331646|FG001|STARTED|Period 3, 90 Minutes of Wear||9
11144813|NCT01482312|12331647|FG002|STARTED|Period 3, 90 Minutes of Wear||9
11144814|NCT01482312|12331645|FG000|COMPLETED|Period 3, 90 Minutes of Wear||8
11144815|NCT01482312|12331646|FG001|COMPLETED|Period 3, 90 Minutes of Wear||9
11144816|NCT01482312|12331647|FG002|COMPLETED|Period 3, 90 Minutes of Wear||9
11144817|NCT01482312|12331645|FG000|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
11144818|NCT01482312|12331646|FG001|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
11144819|NCT01482312|12331647|FG002|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
11144820|NCT01482351|12331657|FG000|STARTED|Overall Study||68
11144821|NCT01482351|12331657|FG000|6 Months|Overall Study|14 dropped out|54
11144822|NCT01482351|12331657|FG000|12 Months|Overall Study||54
11144823|NCT01482351|12331657|FG000|COMPLETED|Overall Study||54
11144824|NCT01482351|12331657|FG000|NOT COMPLETED|Overall Study||14
11144825|NCT01482429|12331667|FG000|STARTED|Care Usual||0
11144826|NCT01482429|12331668|FG001|STARTED|Care Usual||269
11144827|NCT01482429|12331667|FG000|COMPLETED|Care Usual||0
11144828|NCT01482429|12331668|FG001|COMPLETED|Care Usual||96
11144829|NCT01482429|12331667|FG000|NOT COMPLETED|Care Usual||0
11144830|NCT01482429|12331668|FG001|NOT COMPLETED|Care Usual||173
11144831|NCT01482429|12331667|FG000|STARTED|Protocol||414
11144832|NCT01482429|12331668|FG001|STARTED|Protocol||0
11144833|NCT01482429|12331667|FG000|COMPLETED|Protocol||139
11144834|NCT01482429|12331668|FG001|COMPLETED|Protocol||0
11144835|NCT01482429|12331667|FG000|NOT COMPLETED|Protocol||275
11144836|NCT01482429|12331668|FG001|NOT COMPLETED|Protocol||0
11144837|NCT01482715|12331687|FG000|STARTED|Overall Study||6
11144838|NCT01482715|12331688|FG001|STARTED|Overall Study||3
11144839|NCT01482715|12331689|FG002|STARTED|Overall Study||4
11144840|NCT01482715|12331690|FG003|STARTED|Overall Study||9
11144841|NCT01482715|12331691|FG004|STARTED|Overall Study||4
11144842|NCT01482715|12331692|FG005|STARTED|Overall Study||3
11144843|NCT01482715|12331693|FG006|STARTED|Overall Study||8
11144844|NCT01482715|12331694|FG007|STARTED|Overall Study||9
11144845|NCT01482715|12331695|FG008|STARTED|Overall Study||7
11144846|NCT01482715|12331696|FG009|STARTED|Overall Study||3
11144847|NCT01482715|12331697|FG010|STARTED|Overall Study||42
11144848|NCT01482715|12331698|FG011|STARTED|Overall Study||12
11144849|NCT01482715|12331699|FG012|STARTED|Overall Study||26
11144850|NCT01482715|12331687|FG000|COMPLETED|Overall Study||6
11144851|NCT01482715|12331688|FG001|COMPLETED|Overall Study||3
11144852|NCT01482715|12331689|FG002|COMPLETED|Overall Study||4
11144853|NCT01482715|12331690|FG003|COMPLETED|Overall Study||9
11144854|NCT01482715|12331691|FG004|COMPLETED|Overall Study||4
11144855|NCT01482715|12331692|FG005|COMPLETED|Overall Study||3
11144856|NCT01482715|12331693|FG006|COMPLETED|Overall Study||8
11144857|NCT01482715|12331694|FG007|COMPLETED|Overall Study||9
11144858|NCT01482715|12331695|FG008|COMPLETED|Overall Study||7
11144859|NCT01482715|12331696|FG009|COMPLETED|Overall Study||3
11144860|NCT01482715|12331697|FG010|COMPLETED|Overall Study||42
11144861|NCT01482715|12331698|FG011|COMPLETED|Overall Study||12
11144862|NCT01482715|12331699|FG012|COMPLETED|Overall Study||26
11144863|NCT01482715|12331687|FG000|NOT COMPLETED|Overall Study||0
11144864|NCT01482715|12331688|FG001|NOT COMPLETED|Overall Study||0
11144865|NCT01482715|12331689|FG002|NOT COMPLETED|Overall Study||0
11144866|NCT01482715|12331690|FG003|NOT COMPLETED|Overall Study||0
11144867|NCT01482715|12331691|FG004|NOT COMPLETED|Overall Study||0
11144868|NCT01482715|12331692|FG005|NOT COMPLETED|Overall Study||0
11144869|NCT01482715|12331693|FG006|NOT COMPLETED|Overall Study||0
11144870|NCT01482715|12331694|FG007|NOT COMPLETED|Overall Study||0
11144871|NCT01482715|12331695|FG008|NOT COMPLETED|Overall Study||0
11144872|NCT01482715|12331696|FG009|NOT COMPLETED|Overall Study||0
11144873|NCT01482715|12331697|FG010|NOT COMPLETED|Overall Study||0
11144874|NCT01482715|12331698|FG011|NOT COMPLETED|Overall Study||0
11144875|NCT01482715|12331699|FG012|NOT COMPLETED|Overall Study||0
11144876|NCT01482767|12331742|FG000|STARTED|Overall Study||135
11144877|NCT01482767|12331743|FG001|STARTED|Overall Study||127
11144878|NCT01482767|12331742|FG000|COMPLETED|Overall Study||81
11144879|NCT01482767|12331743|FG001|COMPLETED|Overall Study||78
11144880|NCT01482767|12331742|FG000|NOT COMPLETED|Overall Study||54
11144881|NCT01482767|12331743|FG001|NOT COMPLETED|Overall Study||49
11144882|NCT01482819|12331749|FG000|STARTED|Overall Study||21
11144883|NCT01482819|12331749|FG000|COMPLETED|Overall Study||19
11144884|NCT01482819|12331749|FG000|NOT COMPLETED|Overall Study||2
11144885|NCT01482884|12331759|FG000|STARTED|Overall Study|One participant did not receive study treatment|56
11144886|NCT01482884|12331760|FG001|STARTED|Overall Study||55
11144887|NCT01482884|12331759|FG000|COMPLETED|Overall Study||43
11144888|NCT01482884|12331760|FG001|COMPLETED|Overall Study||37
11144889|NCT01482884|12331759|FG000|NOT COMPLETED|Overall Study||13
11144890|NCT01482884|12331760|FG001|NOT COMPLETED|Overall Study||18
11144891|NCT01482910|12331768|FG000|STARTED|Overall Study||228
11144892|NCT01482910|12331769|FG001|STARTED|Overall Study||76
11144893|NCT01482910|12331768|FG000|Completed Week 28|Overall Study||216
11144894|NCT01482910|12331769|FG001|Completed Week 28|Overall Study||71
11144895|NCT01482910|12331768|FG000|COMPLETED|Overall Study||213
11144896|NCT01482910|12331769|FG001|COMPLETED|Overall Study||67
11144897|NCT01482910|12331768|FG000|NOT COMPLETED|Overall Study||15
11144898|NCT01482910|12331769|FG001|NOT COMPLETED|Overall Study||9
11144899|NCT01482962|12331779|FG000|STARTED|Overall Study||138
11144900|NCT01482962|12331780|FG001|STARTED|Overall Study||133
11144901|NCT01482962|12331779|FG000|Safety Population: Received Study Drug|Overall Study||137
11144902|NCT01482962|12331780|FG001|Safety Population: Received Study Drug|Overall Study||127
11144903|NCT01482962|12331779|FG000|COMPLETED|Overall Study||0
11144904|NCT01482962|12331780|FG001|COMPLETED|Overall Study||0
11144905|NCT01482962|12331779|FG000|NOT COMPLETED|Overall Study||138
11144906|NCT01482962|12331780|FG001|NOT COMPLETED|Overall Study||133
11144907|NCT01483118|12331790|FG000|STARTED|Overall Study||23
11144908|NCT01483118|12331791|FG001|STARTED|Overall Study||22
11144909|NCT01483118|12331790|FG000|Completed 3 Months|Overall Study||15
11144910|NCT01483118|12331791|FG001|Completed 3 Months|Overall Study||11
11144911|NCT01483118|12331790|FG000|COMPLETED|Overall Study||11
11144912|NCT01483118|12331791|FG001|COMPLETED|Overall Study||6
11144913|NCT01483118|12331790|FG000|NOT COMPLETED|Overall Study||12
11144914|NCT01483118|12331791|FG001|NOT COMPLETED|Overall Study||16
11144915|NCT01483144|12331802|FG000|STARTED|Overall Study||56
11144916|NCT01483144|12331803|FG001|STARTED|Overall Study||57
11144917|NCT01483144|12331804|FG002|STARTED|Overall Study||58
11144918|NCT01483144|12331802|FG000|COMPLETED|Overall Study||41
11144919|NCT01483144|12331803|FG001|COMPLETED|Overall Study||44
11144920|NCT01483144|12331804|FG002|COMPLETED|Overall Study||43
11144921|NCT01483144|12331802|FG000|NOT COMPLETED|Overall Study||15
11144922|NCT01483144|12331803|FG001|NOT COMPLETED|Overall Study||13
11144923|NCT01483144|12331804|FG002|NOT COMPLETED|Overall Study||15
11144924|NCT01483183|12331822|FG000|STARTED|Overall Study||4
11144925|NCT01483183|12331823|FG001|STARTED|Overall Study||1
11144926|NCT01483183|12331824|FG002|STARTED|Overall Study||5
11144927|NCT01483183|12331825|FG003|STARTED|Overall Study||3
11144928|NCT01483183|12331826|FG004|STARTED|Overall Study||4
11144929|NCT01483183|12331827|FG005|STARTED|Overall Study||4
11144930|NCT01483183|12331828|FG006|STARTED|Overall Study||6
11144931|NCT01483183|12331829|FG007|STARTED|Overall Study||4
11144932|NCT01483183|12331830|FG008|STARTED|Overall Study||4
11144933|NCT01483183|12331831|FG009|STARTED|Overall Study||5
11144934|NCT01483183|12331822|FG000|COMPLETED|Overall Study||4
11144935|NCT01483183|12331823|FG001|COMPLETED|Overall Study||1
11144936|NCT01483183|12331824|FG002|COMPLETED|Overall Study||5
11144937|NCT01483183|12331825|FG003|COMPLETED|Overall Study||3
11144938|NCT01483183|12331826|FG004|COMPLETED|Overall Study||4
11144939|NCT01483183|12331827|FG005|COMPLETED|Overall Study||4
11144940|NCT01483183|12331828|FG006|COMPLETED|Overall Study||4
11144941|NCT01483183|12331829|FG007|COMPLETED|Overall Study||4
11144942|NCT01483183|12331830|FG008|COMPLETED|Overall Study||4
11144943|NCT01483183|12331831|FG009|COMPLETED|Overall Study||4
11144944|NCT01483183|12331822|FG000|NOT COMPLETED|Overall Study||0
11144945|NCT01483183|12331823|FG001|NOT COMPLETED|Overall Study||0
11144946|NCT01483183|12331824|FG002|NOT COMPLETED|Overall Study||0
11144947|NCT01483183|12331825|FG003|NOT COMPLETED|Overall Study||0
11144948|NCT01483183|12331826|FG004|NOT COMPLETED|Overall Study||0
11144949|NCT01483183|12331827|FG005|NOT COMPLETED|Overall Study||0
11144950|NCT01483183|12331828|FG006|NOT COMPLETED|Overall Study||2
11144951|NCT01483183|12331829|FG007|NOT COMPLETED|Overall Study||0
11144952|NCT01483183|12331830|FG008|NOT COMPLETED|Overall Study||0
11144953|NCT01483183|12331831|FG009|NOT COMPLETED|Overall Study||1
11144954|NCT01483352|12331859|FG000|STARTED|Overall Study||12
11144955|NCT01483352|12331859|FG000|COMPLETED|Overall Study||12
11144956|NCT01483352|12331859|FG000|NOT COMPLETED|Overall Study||0
11144957|NCT01483378|12331863|FG000|STARTED|Overall Study||100
11144958|NCT01483378|12331864|FG001|STARTED|Overall Study||66
11144959|NCT01483378|12331863|FG000|COMPLETED|Overall Study||100
11144960|NCT01483378|12331864|FG001|COMPLETED|Overall Study||66
11144961|NCT01483378|12331863|FG000|NOT COMPLETED|Overall Study||0
11144962|NCT01483378|12331864|FG001|NOT COMPLETED|Overall Study||0
11144963|NCT01483560|12331872|FG000|STARTED|Overall Study||219
11144964|NCT01483560|12331873|FG001|STARTED|Overall Study||209
11144965|NCT01483560|12331872|FG000|COMPLETED|Overall Study||193
11144966|NCT01483560|12331873|FG001|COMPLETED|Overall Study||194
11144967|NCT01483560|12331872|FG000|NOT COMPLETED|Overall Study||26
11144968|NCT01483560|12331873|FG001|NOT COMPLETED|Overall Study||15
11144969|NCT01483599|12331886|FG000|STARTED|Controlled Period (CP) (up to Week 16)||42
11144970|NCT01483599|12331887|FG001|STARTED|Controlled Period (CP) (up to Week 16)||41
11144971|NCT01483599|12331888|FG002|STARTED|Controlled Period (CP) (up to Week 16)||41
11144972|NCT01483599|12331889|FG003|STARTED|Controlled Period (CP) (up to Week 16)||42
11144973|NCT01483599|12331890|FG004|STARTED|Controlled Period (CP) (up to Week 16)||42
11026600|NCT00829049|12205174|FG000|STARTED|Overall Study||77
11026601|NCT00829049|12205175|FG001|STARTED|Overall Study||88
11026602|NCT00829049|12205174|FG000|COMPLETED|Overall Study||60
11026603|NCT00829049|12205175|FG001|COMPLETED|Overall Study||68
11026604|NCT00829049|12205174|FG000|NOT COMPLETED|Overall Study||17
11026605|NCT00829049|12205175|FG001|NOT COMPLETED|Overall Study||20
11026606|NCT00829166|12205183|FG000|STARTED|Overall Study||495
11026607|NCT00829166|12205184|FG001|STARTED|Overall Study||496
11026608|NCT00829166|12205183|FG000|Treated|Overall Study||490
11144974|NCT01483599|12331891|FG005|STARTED|Controlled Period (CP) (up to Week 16)||42
11144975|NCT01483599|12331892|FG006|STARTED|Controlled Period (CP) (up to Week 16)||43
11144976|NCT01483599|12331893|FG007|STARTED|Controlled Period (CP) (up to Week 16)||0
11144977|NCT01483599|12331894|FG008|STARTED|Controlled Period (CP) (up to Week 16)||0
11144978|NCT01483599|12331895|FG009|STARTED|Controlled Period (CP) (up to Week 16)||0
11144979|NCT01483599|12331896|FG010|STARTED|Controlled Period (CP) (up to Week 16)||0
11144980|NCT01483599|12331897|FG011|STARTED|Controlled Period (CP) (up to Week 16)||0
11144981|NCT01483599|12331898|FG012|STARTED|Controlled Period (CP) (up to Week 16)||0
11144982|NCT01483599|12331899|FG013|STARTED|Controlled Period (CP) (up to Week 16)||0
11144983|NCT01483599|12331886|FG000|Treated|Controlled Period (CP) (up to Week 16)||42
11144984|NCT01483599|12331887|FG001|Treated|Controlled Period (CP) (up to Week 16)||41
11418294|NCT00527748|12616611|FG000|STARTED|Overall Study||26
11418295|NCT00527748|12616611|FG000|COMPLETED|Overall Study||23
11418296|NCT00527748|12616611|FG000|NOT COMPLETED|Overall Study||3
11418297|NCT00517699|12616615|FG000|STARTED|Overall Study||5
11144985|NCT01483599|12331888|FG002|Treated|Controlled Period (CP) (up to Week 16)||41
11144986|NCT01483599|12331889|FG003|Treated|Controlled Period (CP) (up to Week 16)||42
11144987|NCT01483599|12331890|FG004|Treated|Controlled Period (CP) (up to Week 16)||42
11418298|NCT00517699|12616615|FG000|COMPLETED|Overall Study||0
11144988|NCT01483599|12331891|FG005|Treated|Controlled Period (CP) (up to Week 16)||41
11144989|NCT01483599|12331892|FG006|Treated|Controlled Period (CP) (up to Week 16)||43
11144990|NCT01483599|12331893|FG007|Treated|Controlled Period (CP) (up to Week 16)||0
11144991|NCT01483599|12331894|FG008|Treated|Controlled Period (CP) (up to Week 16)||0
11144992|NCT01483599|12331895|FG009|Treated|Controlled Period (CP) (up to Week 16)||0
11418299|NCT00517699|12616615|FG000|NOT COMPLETED|Overall Study||5
11418300|NCT00528775|12616619|FG000|STARTED|Overall Study||6
11144993|NCT01483599|12331896|FG010|Treated|Controlled Period (CP) (up to Week 16)||0
11144994|NCT01483599|12331897|FG011|Treated|Controlled Period (CP) (up to Week 16)||0
11144995|NCT01483599|12331898|FG012|Treated|Controlled Period (CP) (up to Week 16)||0
11144996|NCT01483599|12331899|FG013|Treated|Controlled Period (CP) (up to Week 16)||0
11144997|NCT01483599|12331886|FG000|COMPLETED|Controlled Period (CP) (up to Week 16)||39
11144998|NCT01483599|12331887|FG001|COMPLETED|Controlled Period (CP) (up to Week 16)||38
11144999|NCT01483599|12331888|FG002|COMPLETED|Controlled Period (CP) (up to Week 16)||41
11145000|NCT01483599|12331889|FG003|COMPLETED|Controlled Period (CP) (up to Week 16)||39
11145001|NCT01483599|12331890|FG004|COMPLETED|Controlled Period (CP) (up to Week 16)||40
11145002|NCT01483599|12331891|FG005|COMPLETED|Controlled Period (CP) (up to Week 16)||38
11322631|NCT02427568|12519888|FG001|NOT COMPLETED|Overall Study||0
11322632|NCT02340676|12519898|FG000|STARTED|Overall Study||25
11322633|NCT02340676|12519898|FG000|COMPLETED|Overall Study||25
11322634|NCT02340676|12519898|FG000|NOT COMPLETED|Overall Study||0
11322635|NCT02282345|12519904|FG000|STARTED|Overall Study||13
11322636|NCT02282345|12519905|FG001|STARTED|Overall Study||20
11322637|NCT02282345|12519904|FG000|COMPLETED|Overall Study||13
11322638|NCT02282345|12519905|FG001|COMPLETED|Overall Study||19
11322639|NCT02282345|12519904|FG000|NOT COMPLETED|Overall Study||0
11322640|NCT02282345|12519905|FG001|NOT COMPLETED|Overall Study||1
11322641|NCT02120469|12519917|FG000|STARTED|Overall Study||13
11322642|NCT02120469|12519918|FG001|STARTED|Overall Study||10
11322643|NCT02120469|12519919|FG002|STARTED|Overall Study||4
11322644|NCT02120469|12519917|FG000|COMPLETED|Overall Study||12
11322645|NCT02120469|12519918|FG001|COMPLETED|Overall Study||10
11322646|NCT02120469|12519919|FG002|COMPLETED|Overall Study||3
11322647|NCT02120469|12519917|FG000|NOT COMPLETED|Overall Study||1
11322648|NCT02120469|12519918|FG001|NOT COMPLETED|Overall Study||0
11322649|NCT02120469|12519919|FG002|NOT COMPLETED|Overall Study||1
11322650|NCT02109744|12519932|FG000|STARTED|Overall Study||26
11322651|NCT02109744|12519933|FG001|STARTED|Overall Study||1
11322652|NCT02109744|12519932|FG000|COMPLETED|Overall Study||24
11322653|NCT02109744|12519933|FG001|COMPLETED|Overall Study||0
11322654|NCT02109744|12519932|FG000|NOT COMPLETED|Overall Study||2
11322655|NCT02109744|12519933|FG001|NOT COMPLETED|Overall Study||1
11322656|NCT02008396|12519941|FG000|STARTED|Overall Study||4
11322657|NCT02008396|12519942|FG001|STARTED|Overall Study||8
11322658|NCT02008396|12519941|FG000|COMPLETED|Overall Study||4
11322659|NCT02008396|12519942|FG001|COMPLETED|Overall Study||7
11322660|NCT02008396|12519941|FG000|NOT COMPLETED|Overall Study||0
11322661|NCT02008396|12519942|FG001|NOT COMPLETED|Overall Study||1
11322662|NCT02000622|12519951|FG000|STARTED|Overall Study||205
11322663|NCT02000622|12519952|FG001|STARTED|Overall Study||97
11322664|NCT02000622|12519951|FG000|COMPLETED|Overall Study||36
11322665|NCT02000622|12519952|FG001|COMPLETED|Overall Study||17
11322666|NCT02000622|12519951|FG000|NOT COMPLETED|Overall Study||169
11322667|NCT02000622|12519952|FG001|NOT COMPLETED|Overall Study||80
11322668|NCT01954966|12519960|FG000|STARTED|Overall Study||34
11322669|NCT01954966|12519961|FG001|STARTED|Overall Study||32
11322670|NCT01954966|12519960|FG000|Completed Week 1 of Intervention (Drug Assigned to Receive First)|Overall Study||30
11322671|NCT01954966|12519961|FG001|Completed Week 1 of Intervention (Drug Assigned to Receive First)|Overall Study||30
11322672|NCT01954966|12519960|FG000|Started Phase 2 After Washout Period (1-2 Week for Males, 1-3 Month for Females)|Overall Study||30
11322673|NCT01954966|12519961|FG001|Started Phase 2 After Washout Period (1-2 Week for Males, 1-3 Month for Females)|Overall Study||30
11322674|NCT01954966|12519960|FG000|Completed Week 2 of Intervention (Drug Assigned to Receive Second)|Overall Study||24
11322675|NCT01954966|12519961|FG001|Completed Week 2 of Intervention (Drug Assigned to Receive Second)|Overall Study||28
11322676|NCT01954966|12519960|FG000|COMPLETED|Overall Study||24
11322677|NCT01954966|12519961|FG001|COMPLETED|Overall Study||28
11322678|NCT01954966|12519960|FG000|NOT COMPLETED|Overall Study||10
11322679|NCT01954966|12519961|FG001|NOT COMPLETED|Overall Study||4
11322680|NCT01940341|12519969|FG000|STARTED|Double-Blind Phase||285
11322681|NCT01940341|12519970|FG001|STARTED|Double-Blind Phase||141
11322682|NCT01940341|12519969|FG000|COMPLETED|Double-Blind Phase||4
11322683|NCT01940341|12519970|FG001|COMPLETED|Double-Blind Phase||1
11322684|NCT01940341|12519969|FG000|NOT COMPLETED|Double-Blind Phase||281
11322685|NCT01940341|12519970|FG001|NOT COMPLETED|Double-Blind Phase||140
11322686|NCT01940341|12519969|FG000|STARTED|Open-label Extension Phase||4
11322687|NCT01940341|12519970|FG001|STARTED|Open-label Extension Phase||1
11322688|NCT01940341|12519969|FG000|COMPLETED|Open-label Extension Phase||0
11322689|NCT01940341|12519970|FG001|COMPLETED|Open-label Extension Phase||0
11322690|NCT01940341|12519969|FG000|NOT COMPLETED|Open-label Extension Phase||4
11145003|NCT01483599|12331892|FG006|COMPLETED|Controlled Period (CP) (up to Week 16)||39
11145004|NCT01483599|12331893|FG007|COMPLETED|Controlled Period (CP) (up to Week 16)||0
11145005|NCT01483599|12331894|FG008|COMPLETED|Controlled Period (CP) (up to Week 16)||0
11145006|NCT01483599|12331895|FG009|COMPLETED|Controlled Period (CP) (up to Week 16)||0
11145007|NCT01483599|12331896|FG010|COMPLETED|Controlled Period (CP) (up to Week 16)||0
11145008|NCT01483599|12331897|FG011|COMPLETED|Controlled Period (CP) (up to Week 16)||0
11145009|NCT01483599|12331898|FG012|COMPLETED|Controlled Period (CP) (up to Week 16)||0
11145010|NCT01483599|12331899|FG013|COMPLETED|Controlled Period (CP) (up to Week 16)||0
11322691|NCT01940341|12519970|FG001|NOT COMPLETED|Open-label Extension Phase||1
11322692|NCT01866657|12519980|FG000|STARTED|Overall Study||38
11322693|NCT01866657|12519981|FG001|STARTED|Overall Study||36
11322694|NCT01866657|12519980|FG000|COMPLETED|Overall Study||36
11322695|NCT01866657|12519981|FG001|COMPLETED|Overall Study||36
11322696|NCT01866657|12519980|FG000|NOT COMPLETED|Overall Study||2
11145011|NCT01483599|12331886|FG000|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
11145012|NCT01483599|12331887|FG001|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
11145013|NCT01483599|12331888|FG002|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
11145014|NCT01483599|12331889|FG003|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
11145015|NCT01483599|12331890|FG004|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
11145016|NCT01483599|12331891|FG005|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
11145017|NCT01483599|12331892|FG006|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
11145018|NCT01483599|12331893|FG007|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
11145019|NCT01483599|12331894|FG008|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
11145020|NCT01483599|12331895|FG009|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
11145021|NCT01483599|12331896|FG010|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
11145022|NCT01483599|12331897|FG011|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
11145023|NCT01483599|12331898|FG012|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
11145024|NCT01483599|12331899|FG013|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
11145025|NCT01483599|12331886|FG000|STARTED|After Controlled Period(Week 16-Week 40)||0
11145026|NCT01483599|12331887|FG001|STARTED|After Controlled Period(Week 16-Week 40)||0
11145027|NCT01483599|12331888|FG002|STARTED|After Controlled Period(Week 16-Week 40)||0
11145028|NCT01483599|12331889|FG003|STARTED|After Controlled Period(Week 16-Week 40)||0
11145029|NCT01483599|12331890|FG004|STARTED|After Controlled Period(Week 16-Week 40)||0
11145030|NCT01483599|12331891|FG005|STARTED|After Controlled Period(Week 16-Week 40)||0
11145031|NCT01483599|12331892|FG006|STARTED|After Controlled Period(Week 16-Week 40)||0
11145032|NCT01483599|12331893|FG007|STARTED|After Controlled Period(Week 16-Week 40)||39
11145033|NCT01483599|12331894|FG008|STARTED|After Controlled Period(Week 16-Week 40)||38
11145034|NCT01483599|12331895|FG009|STARTED|After Controlled Period(Week 16-Week 40)||41
11145035|NCT01483599|12331896|FG010|STARTED|After Controlled Period(Week 16-Week 40)||39
11145036|NCT01483599|12331897|FG011|STARTED|After Controlled Period(Week 16-Week 40)||40
11145037|NCT01483599|12331898|FG012|STARTED|After Controlled Period(Week 16-Week 40)||38
11145038|NCT01483599|12331899|FG013|STARTED|After Controlled Period(Week 16-Week 40)||39
11145039|NCT01483599|12331886|FG000|COMPLETED|After Controlled Period(Week 16-Week 40)||0
11145040|NCT01483599|12331887|FG001|COMPLETED|After Controlled Period(Week 16-Week 40)||0
11145041|NCT01483599|12331888|FG002|COMPLETED|After Controlled Period(Week 16-Week 40)||0
11145042|NCT01483599|12331889|FG003|COMPLETED|After Controlled Period(Week 16-Week 40)||0
11145043|NCT01483599|12331890|FG004|COMPLETED|After Controlled Period(Week 16-Week 40)||0
11145044|NCT01483599|12331891|FG005|COMPLETED|After Controlled Period(Week 16-Week 40)||0
11145045|NCT01483599|12331892|FG006|COMPLETED|After Controlled Period(Week 16-Week 40)||0
11145046|NCT01483599|12331893|FG007|COMPLETED|After Controlled Period(Week 16-Week 40)||37
11145047|NCT01483599|12331894|FG008|COMPLETED|After Controlled Period(Week 16-Week 40)||29
11145048|NCT01483599|12331895|FG009|COMPLETED|After Controlled Period(Week 16-Week 40)||37
11145049|NCT01483599|12331896|FG010|COMPLETED|After Controlled Period(Week 16-Week 40)||37
11145050|NCT01483599|12331897|FG011|COMPLETED|After Controlled Period(Week 16-Week 40)||39
11145051|NCT01483599|12331898|FG012|COMPLETED|After Controlled Period(Week 16-Week 40)||35
11145052|NCT01483599|12331899|FG013|COMPLETED|After Controlled Period(Week 16-Week 40)||32
11145053|NCT01483599|12331886|FG000|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
11145054|NCT01483599|12331887|FG001|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
11145055|NCT01483599|12331888|FG002|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
11145056|NCT01483599|12331889|FG003|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
11145057|NCT01483599|12331890|FG004|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
11145058|NCT01483599|12331891|FG005|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
11145059|NCT01483599|12331892|FG006|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
11145060|NCT01483599|12331893|FG007|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
11145061|NCT01483599|12331894|FG008|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
11145062|NCT01483599|12331895|FG009|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
11145063|NCT01483599|12331896|FG010|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
11145064|NCT01483599|12331897|FG011|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
11145065|NCT01483599|12331898|FG012|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
11145066|NCT01483599|12331899|FG013|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
11145067|NCT01483625|12331930|FG000|STARTED|Overall Study||72
11145068|NCT01483625|12331931|FG001|STARTED|Overall Study||68
11145069|NCT01483625|12331930|FG000|COMPLETED|Overall Study||68
11145070|NCT01483625|12331931|FG001|COMPLETED|Overall Study||66
11145071|NCT01483625|12331930|FG000|NOT COMPLETED|Overall Study||4
11145072|NCT01483625|12331931|FG001|NOT COMPLETED|Overall Study||2
11145073|NCT01483651|12331937|FG000|STARTED|Overall Study||1
11145074|NCT01483651|12331938|FG001|STARTED|Overall Study||3
11145075|NCT01483651|12331939|FG002|STARTED|Overall Study||2
11145076|NCT01483651|12331940|FG003|STARTED|Overall Study||1
11145077|NCT01483651|12331941|FG004|STARTED|Overall Study||2
11145078|NCT01483651|12331942|FG005|STARTED|Overall Study||2
11145079|NCT01483651|12331937|FG000|COMPLETED|Overall Study||1
11145080|NCT01483651|12331938|FG001|COMPLETED|Overall Study||2
11145081|NCT01483651|12331939|FG002|COMPLETED|Overall Study||1
11145082|NCT01483651|12331940|FG003|COMPLETED|Overall Study||1
11145083|NCT01483651|12331941|FG004|COMPLETED|Overall Study||2
11145084|NCT01483651|12331942|FG005|COMPLETED|Overall Study||1
11145085|NCT01483651|12331937|FG000|NOT COMPLETED|Overall Study||0
11145086|NCT01483651|12331938|FG001|NOT COMPLETED|Overall Study||1
11145087|NCT01483651|12331939|FG002|NOT COMPLETED|Overall Study||1
11145088|NCT01483651|12331940|FG003|NOT COMPLETED|Overall Study||0
11145089|NCT01483651|12331941|FG004|NOT COMPLETED|Overall Study||0
11145090|NCT01483651|12331942|FG005|NOT COMPLETED|Overall Study||1
11145091|NCT01483690|12331952|FG000|STARTED|Overall Study||5
11145092|NCT01483690|12331953|FG001|STARTED|Overall Study||18
11145093|NCT01483690|12331952|FG000|COMPLETED|Overall Study||3
11145094|NCT01483690|12331953|FG001|COMPLETED|Overall Study||13
11145095|NCT01483690|12331952|FG000|NOT COMPLETED|Overall Study||2
11145096|NCT01483690|12331953|FG001|NOT COMPLETED|Overall Study||5
11145097|NCT01483807|12331959|FG000|STARTED|First Treatment Phase (7 Weeks)||10
11145098|NCT01483807|12331960|FG001|STARTED|First Treatment Phase (7 Weeks)||10
11145099|NCT01483807|12331959|FG000|COMPLETED|First Treatment Phase (7 Weeks)||10
11145100|NCT01483807|12331960|FG001|COMPLETED|First Treatment Phase (7 Weeks)||10
11145101|NCT01483807|12331959|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
11145102|NCT01483807|12331960|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
11145103|NCT01483807|12331959|FG000|STARTED|Washout (2 Weeks)||10
11145104|NCT01483807|12331960|FG001|STARTED|Washout (2 Weeks)||10
11145105|NCT01483807|12331959|FG000|COMPLETED|Washout (2 Weeks)||10
11145106|NCT01483807|12331960|FG001|COMPLETED|Washout (2 Weeks)||10
11145107|NCT01483807|12331959|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11145108|NCT01483807|12331960|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11145109|NCT01483807|12331959|FG000|STARTED|Second Treatment Phase (7 Weeks)||10
11145110|NCT01483807|12331960|FG001|STARTED|Second Treatment Phase (7 Weeks)||10
11145111|NCT01483807|12331959|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||10
11145112|NCT01483807|12331960|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||10
11145113|NCT01483807|12331959|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
11145114|NCT01483807|12331960|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
11145115|NCT01483924|12331973|FG000|STARTED|Overall Study||12
11145116|NCT01483924|12331974|FG001|STARTED|Overall Study||12
11145117|NCT01483924|12331975|FG002|STARTED|Overall Study||12
11145118|NCT01483924|12331976|FG003|STARTED|Overall Study||12
11145119|NCT01483924|12331977|FG004|STARTED|Overall Study||12
11145120|NCT01483924|12331973|FG000|COMPLETED|Overall Study||10
11145121|NCT01483924|12331974|FG001|COMPLETED|Overall Study||12
11145122|NCT01483924|12331975|FG002|COMPLETED|Overall Study||11
11145123|NCT01483924|12331976|FG003|COMPLETED|Overall Study||8
11145124|NCT01483924|12331977|FG004|COMPLETED|Overall Study||10
11145125|NCT01483924|12331973|FG000|NOT COMPLETED|Overall Study||2
11145126|NCT01483924|12331974|FG001|NOT COMPLETED|Overall Study||0
11145127|NCT01483924|12331975|FG002|NOT COMPLETED|Overall Study||1
11145128|NCT01483924|12331976|FG003|NOT COMPLETED|Overall Study||4
11145129|NCT01483924|12331977|FG004|NOT COMPLETED|Overall Study||2
11145130|NCT01483937|12332000|FG000|STARTED|Overall Study||15
11145131|NCT01483937|12332001|FG001|STARTED|Overall Study||17
11145132|NCT01483937|12332000|FG000|COMPLETED|Overall Study||11
11145133|NCT01483937|12332001|FG001|COMPLETED|Overall Study||14
11145134|NCT01483937|12332000|FG000|NOT COMPLETED|Overall Study||4
11145135|NCT01483937|12332001|FG001|NOT COMPLETED|Overall Study||3
11145136|NCT01483963|12332015|FG000|STARTED|Overall Study||10
11145137|NCT01483963|12332016|FG001|STARTED|Overall Study||10
11145138|NCT01483963|12332017|FG002|STARTED|Overall Study||10
11145139|NCT01483963|12332018|FG003|STARTED|Overall Study||10
11145140|NCT01483963|12332019|FG004|STARTED|Overall Study||10
11145141|NCT01483963|12332015|FG000|COMPLETED|Overall Study||10
11145142|NCT01483963|12332016|FG001|COMPLETED|Overall Study||10
11026609|NCT00829166|12205184|FG001|Treated|Overall Study||488
11026610|NCT00829166|12205183|FG000|COMPLETED|Overall Study||0
11418301|NCT00528775|12616619|FG000|COMPLETED|Overall Study||5
11418302|NCT00528775|12616619|FG000|NOT COMPLETED|Overall Study||1
11418303|NCT00528437|12616623|FG000|STARTED|Overall Study||46
11418304|NCT00528437|12616623|FG000|COMPLETED|Overall Study||46
11418305|NCT00528437|12616623|FG000|NOT COMPLETED|Overall Study||0
11418306|NCT00524511|12616629|FG000|STARTED|Overall Study||68
11418307|NCT00524511|12616630|FG001|STARTED|Overall Study||68
11026611|NCT00829166|12205184|FG001|COMPLETED|Overall Study||0
11026612|NCT00829166|12205183|FG000|NOT COMPLETED|Overall Study||495
11026613|NCT00829166|12205184|FG001|NOT COMPLETED|Overall Study||496
11026614|NCT00829179|12205191|FG000|STARTED|Overall Study||20
11145143|NCT01483963|12332017|FG002|COMPLETED|Overall Study||10
11145144|NCT01483963|12332018|FG003|COMPLETED|Overall Study||10
11145145|NCT01483963|12332019|FG004|COMPLETED|Overall Study||10
11145146|NCT01483963|12332015|FG000|NOT COMPLETED|Overall Study||0
11145147|NCT01483963|12332016|FG001|NOT COMPLETED|Overall Study||0
11145148|NCT01483963|12332017|FG002|NOT COMPLETED|Overall Study||0
11145149|NCT01483963|12332018|FG003|NOT COMPLETED|Overall Study||0
11145150|NCT01483963|12332019|FG004|NOT COMPLETED|Overall Study||0
11145151|NCT01484028|12332032|FG000|STARTED|Period 1||66
11145152|NCT01484028|12332033|FG001|STARTED|Period 1||70
11145153|NCT01484028|12332034|FG002|STARTED|Period 1||64
11145154|NCT01484028|12332035|FG003|STARTED|Period 1||67
11145155|NCT01484028|12332032|FG000|COMPLETED|Period 1||66
11145156|NCT01484028|12332033|FG001|COMPLETED|Period 1||67
11145157|NCT01484028|12332034|FG002|COMPLETED|Period 1||64
11145158|NCT01484028|12332035|FG003|COMPLETED|Period 1||66
11145159|NCT01484028|12332032|FG000|NOT COMPLETED|Period 1||0
11145160|NCT01484028|12332033|FG001|NOT COMPLETED|Period 1||3
11026615|NCT00829179|12205191|FG000|COMPLETED|Overall Study||19
11145161|NCT01484028|12332034|FG002|NOT COMPLETED|Period 1||0
11418308|NCT00524511|12616629|FG000|COMPLETED|Overall Study||64
11418309|NCT00524511|12616630|FG001|COMPLETED|Overall Study||61
11145162|NCT01484028|12332035|FG003|NOT COMPLETED|Period 1||1
11145163|NCT01484028|12332032|FG000|STARTED|Period 2||66
11145164|NCT01484028|12332033|FG001|STARTED|Period 2||67
11145165|NCT01484028|12332034|FG002|STARTED|Period 2||64
11145166|NCT01484028|12332035|FG003|STARTED|Period 2||66
11145167|NCT01484028|12332032|FG000|COMPLETED|Period 2||66
11145168|NCT01484028|12332033|FG001|COMPLETED|Period 2||67
11145169|NCT01484028|12332034|FG002|COMPLETED|Period 2||64
11145170|NCT01484028|12332035|FG003|COMPLETED|Period 2||66
11145171|NCT01484028|12332032|FG000|NOT COMPLETED|Period 2||0
11145172|NCT01484028|12332033|FG001|NOT COMPLETED|Period 2||0
11145173|NCT01484028|12332034|FG002|NOT COMPLETED|Period 2||0
11145174|NCT01484028|12332035|FG003|NOT COMPLETED|Period 2||0
11145175|NCT01484041|12332043|FG000|STARTED|Overall Study||12
11145176|NCT01484041|12332043|FG000|COMPLETED|Overall Study||12
11145177|NCT01484041|12332043|FG000|NOT COMPLETED|Overall Study||0
11145178|NCT01484054|12332047|FG000|STARTED|Period 1||50
11145179|NCT01484054|12332048|FG001|STARTED|Period 1||50
11145180|NCT01484054|12332047|FG000|COMPLETED|Period 1||50
11145181|NCT01484054|12332048|FG001|COMPLETED|Period 1||49
11145182|NCT01484054|12332047|FG000|NOT COMPLETED|Period 1||0
11145183|NCT01484054|12332048|FG001|NOT COMPLETED|Period 1||1
11145184|NCT01484054|12332047|FG000|STARTED|Period 2||50
11145185|NCT01484054|12332048|FG001|STARTED|Period 2||49
11145186|NCT01484054|12332047|FG000|COMPLETED|Period 2||50
11145187|NCT01484054|12332048|FG001|COMPLETED|Period 2||49
11145188|NCT01484054|12332047|FG000|NOT COMPLETED|Period 2||0
11145189|NCT01484054|12332048|FG001|NOT COMPLETED|Period 2||0
11145190|NCT01484132|12332055|FG000|STARTED|Overall Study||113
11145191|NCT01484132|12332055|FG000|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
11145192|NCT01484132|12332055|FG000|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
11145193|NCT01484132|12332055|FG000|NOT COMPLETED|Overall Study||22
11145194|NCT01484197|12332059|FG000|STARTED|Treatment Period 1||9
11145195|NCT01484197|12332060|FG001|STARTED|Treatment Period 1||9
11145196|NCT01484197|12332061|FG002|STARTED|Treatment Period 1||9
11145197|NCT01484197|12332062|FG003|STARTED|Treatment Period 1||9
11145198|NCT01484197|12332059|FG000|COMPLETED|Treatment Period 1||8
11145199|NCT01484197|12332060|FG001|COMPLETED|Treatment Period 1||9
11145200|NCT01484197|12332061|FG002|COMPLETED|Treatment Period 1||9
11145201|NCT01484197|12332062|FG003|COMPLETED|Treatment Period 1||9
11145202|NCT01484197|12332059|FG000|NOT COMPLETED|Treatment Period 1||1
11145203|NCT01484197|12332060|FG001|NOT COMPLETED|Treatment Period 1||0
11145204|NCT01484197|12332061|FG002|NOT COMPLETED|Treatment Period 1||0
11145205|NCT01484197|12332062|FG003|NOT COMPLETED|Treatment Period 1||0
11145206|NCT01484197|12332059|FG000|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
11145207|NCT01484197|12332060|FG001|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
11145208|NCT01484197|12332061|FG002|STARTED|Treatment Period 2||9
11145209|NCT01484197|12332062|FG003|STARTED|Treatment Period 2||9
11145210|NCT01484197|12332059|FG000|COMPLETED|Treatment Period 2||7
11145211|NCT01484197|12332060|FG001|COMPLETED|Treatment Period 2||8
11145212|NCT01484197|12332061|FG002|COMPLETED|Treatment Period 2||9
11145213|NCT01484197|12332062|FG003|COMPLETED|Treatment Period 2||8
11145214|NCT01484197|12332059|FG000|NOT COMPLETED|Treatment Period 2||0
11145215|NCT01484197|12332060|FG001|NOT COMPLETED|Treatment Period 2||0
11145216|NCT01484197|12332061|FG002|NOT COMPLETED|Treatment Period 2||0
11145217|NCT01484197|12332062|FG003|NOT COMPLETED|Treatment Period 2||1
11145218|NCT01484197|12332059|FG000|STARTED|Treatment Period 3||7
11145219|NCT01484197|12332060|FG001|STARTED|Treatment Period 3||8
11145220|NCT01484197|12332061|FG002|STARTED|Treatment Period 3||9
11145221|NCT01484197|12332062|FG003|STARTED|Treatment Period 3||8
11145222|NCT01484197|12332059|FG000|COMPLETED|Treatment Period 3||7
11145223|NCT01484197|12332060|FG001|COMPLETED|Treatment Period 3||8
11145224|NCT01484197|12332061|FG002|COMPLETED|Treatment Period 3||9
11145225|NCT01484197|12332062|FG003|COMPLETED|Treatment Period 3||8
11145226|NCT01484197|12332059|FG000|NOT COMPLETED|Treatment Period 3||0
11145227|NCT01484197|12332060|FG001|NOT COMPLETED|Treatment Period 3||0
11145228|NCT01484197|12332061|FG002|NOT COMPLETED|Treatment Period 3||0
11145229|NCT01484197|12332062|FG003|NOT COMPLETED|Treatment Period 3||0
11145230|NCT01484197|12332059|FG000|STARTED|Treatment Period 4||7
11145231|NCT01484197|12332060|FG001|STARTED|Treatment Period 4||8
11145232|NCT01484197|12332061|FG002|STARTED|Treatment Period 4||9
11145233|NCT01484197|12332062|FG003|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
11145234|NCT01484197|12332059|FG000|COMPLETED|Treatment Period 4||7
11145235|NCT01484197|12332060|FG001|COMPLETED|Treatment Period 4||8
11145236|NCT01484197|12332061|FG002|COMPLETED|Treatment Period 4||9
11145237|NCT01484197|12332062|FG003|COMPLETED|Treatment Period 4||6
11145238|NCT01484197|12332059|FG000|NOT COMPLETED|Treatment Period 4||0
11145239|NCT01484197|12332060|FG001|NOT COMPLETED|Treatment Period 4||0
11145240|NCT01484197|12332061|FG002|NOT COMPLETED|Treatment Period 4||0
11145241|NCT01484197|12332062|FG003|NOT COMPLETED|Treatment Period 4||0
11145242|NCT01484275|12332074|FG000|STARTED|Overall Study||43
11145243|NCT01484275|12332075|FG001|STARTED|Overall Study||42
11145244|NCT01484275|12332074|FG000|COMPLETED|Overall Study||0
11145245|NCT01484275|12332075|FG001|COMPLETED|Overall Study||0
11145246|NCT01484275|12332074|FG000|NOT COMPLETED|Overall Study||43
11145247|NCT01484275|12332075|FG001|NOT COMPLETED|Overall Study||42
11145248|NCT01484288|12332081|FG000|STARTED|Overall Study||11
11145249|NCT01484288|12332081|FG000|COMPLETED|Overall Study||11
11145250|NCT01484288|12332081|FG000|NOT COMPLETED|Overall Study||0
11145251|NCT01484340|12332087|FG000|STARTED|Overall Study||281
11145252|NCT01484340|12332088|FG001|STARTED|Overall Study||279
11145253|NCT01484340|12332087|FG000|COMPLETED|Overall Study||281
11145254|NCT01484340|12332088|FG001|COMPLETED|Overall Study||279
11145255|NCT01484340|12332087|FG000|NOT COMPLETED|Overall Study||0
11145256|NCT01484340|12332088|FG001|NOT COMPLETED|Overall Study||0
11145257|NCT01484431|12332097|FG000|STARTED|Period 1: Low Dose||6
11145258|NCT01484431|12332098|FG001|STARTED|Period 1: Low Dose||7
11145259|NCT01484431|12332099|FG002|STARTED|Period 1: Low Dose||6
11145260|NCT01484431|12332097|FG000|Received 2 mg|Period 1: Low Dose||1
11145261|NCT01484431|12332098|FG001|Received 2 mg|Period 1: Low Dose||0
11145262|NCT01484431|12332099|FG002|Received 2 mg|Period 1: Low Dose||0
11145263|NCT01484431|12332097|FG000|Received 4 mg|Period 1: Low Dose||5
11145264|NCT01484431|12332098|FG001|Received 4 mg|Period 1: Low Dose||0
11145265|NCT01484431|12332099|FG002|Received 4 mg|Period 1: Low Dose||0
11145266|NCT01484431|12332097|FG000|Received 5 mg|Period 1: Low Dose||0
11145267|NCT01484431|12332098|FG001|Received 5 mg|Period 1: Low Dose||7
11145268|NCT01484431|12332099|FG002|Received 5 mg|Period 1: Low Dose||0
11145269|NCT01484431|12332097|FG000|Received 10 mg|Period 1: Low Dose||0
11145270|NCT01484431|12332098|FG001|Received 10 mg|Period 1: Low Dose||0
11145271|NCT01484431|12332099|FG002|Received 10 mg|Period 1: Low Dose||6
11145272|NCT01484431|12332097|FG000|COMPLETED|Period 1: Low Dose||6
11145273|NCT01484431|12332098|FG001|COMPLETED|Period 1: Low Dose||7
11145274|NCT01484431|12332099|FG002|COMPLETED|Period 1: Low Dose||6
11145275|NCT01484431|12332097|FG000|NOT COMPLETED|Period 1: Low Dose||0
11145276|NCT01484431|12332098|FG001|NOT COMPLETED|Period 1: Low Dose||0
11145277|NCT01484431|12332099|FG002|NOT COMPLETED|Period 1: Low Dose||0
11145278|NCT01484431|12332097|FG000|STARTED|Period 1: High Dose||6
11145279|NCT01484431|12332098|FG001|STARTED|Period 1: High Dose||7
11145280|NCT01484431|12332099|FG002|STARTED|Period 1: High Dose||6
11145281|NCT01484431|12332097|FG000|Received 8 mg|Period 1: High Dose||1
11145282|NCT01484431|12332098|FG001|Received 8 mg|Period 1: High Dose||0
11145283|NCT01484431|12332099|FG002|Received 8 mg|Period 1: High Dose||0
11145284|NCT01484431|12332097|FG000|Received 10 mg|Period 1: High Dose||1
11145285|NCT01484431|12332098|FG001|Received 10 mg|Period 1: High Dose||1
11145286|NCT01484431|12332099|FG002|Received 10 mg|Period 1: High Dose||0
11145287|NCT01484431|12332097|FG000|Received 15 mg|Period 1: High Dose||1
11145288|NCT01484431|12332098|FG001|Received 15 mg|Period 1: High Dose||1
11145289|NCT01484431|12332099|FG002|Received 15 mg|Period 1: High Dose||0
11145290|NCT01484431|12332097|FG000|Received 20 mg|Period 1: High Dose||3
11145291|NCT01484431|12332098|FG001|Received 20 mg|Period 1: High Dose||5
11145292|NCT01484431|12332099|FG002|Received 20 mg|Period 1: High Dose||1
11145293|NCT01484431|12332097|FG000|Received 40 mg|Period 1: High Dose||0
11145294|NCT01484431|12332098|FG001|Received 40 mg|Period 1: High Dose||0
11145295|NCT01484431|12332099|FG002|Received 40 mg|Period 1: High Dose||5
11145296|NCT01484431|12332097|FG000|COMPLETED|Period 1: High Dose||6
11145297|NCT01484431|12332098|FG001|COMPLETED|Period 1: High Dose||6
11145298|NCT01484431|12332099|FG002|COMPLETED|Period 1: High Dose||6
11145299|NCT01484431|12332097|FG000|NOT COMPLETED|Period 1: High Dose||0
11145300|NCT01484431|12332098|FG001|NOT COMPLETED|Period 1: High Dose||1
11145301|NCT01484431|12332099|FG002|NOT COMPLETED|Period 1: High Dose||0
11145302|NCT01484431|12332097|FG000|STARTED|Period 2||6
11145303|NCT01484431|12332098|FG001|STARTED|Period 2||6
11418310|NCT00524511|12616629|FG000|NOT COMPLETED|Overall Study||4
11418311|NCT00524511|12616630|FG001|NOT COMPLETED|Overall Study||7
11145304|NCT01484431|12332099|FG002|STARTED|Period 2||6
11145305|NCT01484431|12332097|FG000|Received 7 mg|Period 2||1
11145306|NCT01484431|12332098|FG001|Received 7 mg|Period 2||0
11145307|NCT01484431|12332099|FG002|Received 7 mg|Period 2||0
11145308|NCT01484431|12332097|FG000|Received 7.5 mg|Period 2||0
11145309|NCT01484431|12332098|FG001|Received 7.5 mg|Period 2||2
11145310|NCT01484431|12332099|FG002|Received 7.5 mg|Period 2||0
11145311|NCT01484431|12332097|FG000|Received 8 mg|Period 2||1
11145312|NCT01484431|12332098|FG001|Received 8 mg|Period 2||0
11145313|NCT01484431|12332099|FG002|Received 8 mg|Period 2||0
11145314|NCT01484431|12332097|FG000|Received 10 mg|Period 2||0
11145315|NCT01484431|12332098|FG001|Received 10 mg|Period 2||1
11145316|NCT01484431|12332099|FG002|Received 10 mg|Period 2||0
11145317|NCT01484431|12332097|FG000|Received 15 mg|Period 2||1
11145318|NCT01484431|12332098|FG001|Received 15 mg|Period 2||2
11145319|NCT01484431|12332099|FG002|Received 15 mg|Period 2||1
11145320|NCT01484431|12332097|FG000|Received 20 mg|Period 2||3
11145321|NCT01484431|12332098|FG001|Received 20 mg|Period 2||1
11145322|NCT01484431|12332099|FG002|Received 20 mg|Period 2||4
11145323|NCT01484431|12332097|FG000|Received 40 mg|Period 2||0
11145324|NCT01484431|12332098|FG001|Received 40 mg|Period 2||0
11145325|NCT01484431|12332099|FG002|Received 40 mg|Period 2||1
11145326|NCT01484431|12332097|FG000|COMPLETED|Period 2||5
11145327|NCT01484431|12332098|FG001|COMPLETED|Period 2||5
11145328|NCT01484431|12332099|FG002|COMPLETED|Period 2||4
11145329|NCT01484431|12332097|FG000|NOT COMPLETED|Period 2||1
11145330|NCT01484431|12332098|FG001|NOT COMPLETED|Period 2||1
11145331|NCT01484431|12332099|FG002|NOT COMPLETED|Period 2||2
11145332|NCT01484496|12332114|FG000|STARTED|Period 1||280
11145333|NCT01484496|12332115|FG001|STARTED|Period 1||556
11145334|NCT01484496|12332116|FG002|STARTED|Period 1||0
11145335|NCT01484496|12332117|FG003|STARTED|Period 1||0
11145336|NCT01484496|12332114|FG000|COMPLETED|Period 1||214
11145337|NCT01484496|12332115|FG001|COMPLETED|Period 1||463
11145338|NCT01484496|12332116|FG002|COMPLETED|Period 1||0
11145339|NCT01484496|12332117|FG003|COMPLETED|Period 1||0
11145340|NCT01484496|12332114|FG000|NOT COMPLETED|Period 1||66
11145341|NCT01484496|12332115|FG001|NOT COMPLETED|Period 1||93
11145342|NCT01484496|12332116|FG002|NOT COMPLETED|Period 1||0
11145343|NCT01484496|12332117|FG003|NOT COMPLETED|Period 1||0
11145344|NCT01484496|12332114|FG000|STARTED|Period 2||0
11145345|NCT01484496|12332115|FG001|STARTED|Period 2||0
11145346|NCT01484496|12332116|FG002|STARTED|Period 2||206
11145347|NCT01484496|12332117|FG003|STARTED|Period 2||456
11145348|NCT01484496|12332114|FG000|COMPLETED|Period 2||0
11145349|NCT01484496|12332115|FG001|COMPLETED|Period 2||0
11145350|NCT01484496|12332116|FG002|COMPLETED|Period 2||191
11145351|NCT01484496|12332117|FG003|COMPLETED|Period 2||434
11145352|NCT01484496|12332114|FG000|NOT COMPLETED|Period 2||0
11145353|NCT01484496|12332115|FG001|NOT COMPLETED|Period 2||0
11145354|NCT01484496|12332116|FG002|NOT COMPLETED|Period 2||15
11145355|NCT01484496|12332117|FG003|NOT COMPLETED|Period 2||22
11145356|NCT01484561|12332127|FG000|STARTED|Overall Study||97
11145357|NCT01484561|12332128|FG001|STARTED|Overall Study||51
11145358|NCT01484561|12332127|FG000|COMPLETED|Overall Study||88
11145359|NCT01484561|12332128|FG001|COMPLETED|Overall Study||45
11145360|NCT01484561|12332127|FG000|NOT COMPLETED|Overall Study||9
11145361|NCT01484561|12332128|FG001|NOT COMPLETED|Overall Study||6
11145362|NCT01484626|12332134|FG000|STARTED|Overall Study||3
11145363|NCT01484626|12332134|FG000|COMPLETED|Overall Study||3
11145364|NCT01484626|12332134|FG000|NOT COMPLETED|Overall Study||0
11145365|NCT01484652|12332140|FG000|STARTED|Overall Study||166
11145366|NCT01484652|12332141|FG001|STARTED|Overall Study||163
11145367|NCT01484652|12332140|FG000|COMPLETED|Overall Study||151
11145368|NCT01484652|12332141|FG001|COMPLETED|Overall Study||142
11145369|NCT01484652|12332140|FG000|NOT COMPLETED|Overall Study||15
11145370|NCT01484652|12332141|FG001|NOT COMPLETED|Overall Study||21
11145371|NCT01484834|12332151|FG000|STARTED|Overall Study||65
11145372|NCT01484834|12332152|FG001|STARTED|Overall Study||62
11145373|NCT01484834|12332153|FG002|STARTED|Overall Study||39
11145374|NCT01484834|12332154|FG003|STARTED|Overall Study||24
11145375|NCT01484834|12332151|FG000|COMPLETED|Overall Study||60
11145376|NCT01484834|12332152|FG001|COMPLETED|Overall Study||54
11145377|NCT01484834|12332153|FG002|COMPLETED|Overall Study||38
11145378|NCT01484834|12332154|FG003|COMPLETED|Overall Study||20
11145379|NCT01484834|12332151|FG000|NOT COMPLETED|Overall Study||5
11145380|NCT01484834|12332152|FG001|NOT COMPLETED|Overall Study||8
11145381|NCT01484834|12332153|FG002|NOT COMPLETED|Overall Study||1
11145382|NCT01484834|12332154|FG003|NOT COMPLETED|Overall Study||4
11145383|NCT01484873|12332164|FG000|STARTED|Overall Study||10
11145384|NCT01484873|12332164|FG000|COMPLETED|Overall Study||8
11145385|NCT01484873|12332164|FG000|NOT COMPLETED|Overall Study||2
11145386|NCT01484912|12332171|FG000|STARTED|Overall Study||39
11145387|NCT01484912|12332172|FG001|STARTED|Overall Study||40
11145388|NCT01484912|12332171|FG000|COMPLETED|Overall Study||38
11145389|NCT01484912|12332172|FG001|COMPLETED|Overall Study||39
11145390|NCT01484912|12332171|FG000|NOT COMPLETED|Overall Study||1
11145391|NCT01484912|12332172|FG001|NOT COMPLETED|Overall Study||1
11145392|NCT01484938|12332178|FG000|STARTED|Overall Study||175
11145393|NCT01484938|12332178|FG000|COMPLETED|Overall Study||171
11145394|NCT01484938|12332178|FG000|NOT COMPLETED|Overall Study||4
11202651|NCT01841762|12393061|FG000|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
11202652|NCT01841970|12393065|FG000|STARTED|Overall Study||20
11202653|NCT01841970|12393065|FG000|COMPLETED|Overall Study||9
11202654|NCT01841970|12393065|FG000|NOT COMPLETED|Overall Study||11
11202655|NCT01842061|12393074|FG000|STARTED|Overall Study||13
11202656|NCT01842061|12393075|FG001|STARTED|Overall Study||12
11202657|NCT01842061|12393074|FG000|COMPLETED|Overall Study||12
11202658|NCT01842061|12393075|FG001|COMPLETED|Overall Study||8
11202659|NCT01842061|12393074|FG000|NOT COMPLETED|Overall Study||1
11202660|NCT01842061|12393075|FG001|NOT COMPLETED|Overall Study||4
11202661|NCT01842308|12393086|FG000|STARTED|Overall Study||6
11202662|NCT01842308|12393087|FG001|STARTED|Overall Study||3
11202663|NCT01842308|12393088|FG002|STARTED|Overall Study||3
11202664|NCT01842308|12393089|FG003|STARTED|Overall Study||2
11202665|NCT01842308|12393090|FG004|STARTED|Overall Study||36
11202666|NCT01842308|12393086|FG000|COMPLETED|Overall Study||6
11202667|NCT01842308|12393087|FG001|COMPLETED|Overall Study||3
11202668|NCT01842308|12393088|FG002|COMPLETED|Overall Study||3
11202669|NCT01842308|12393089|FG003|COMPLETED|Overall Study||2
11202670|NCT01842308|12393090|FG004|COMPLETED|Overall Study||35
11202671|NCT01842308|12393086|FG000|NOT COMPLETED|Overall Study||0
11202672|NCT01842308|12393087|FG001|NOT COMPLETED|Overall Study||0
11202673|NCT01842308|12393088|FG002|NOT COMPLETED|Overall Study||0
11202674|NCT01842308|12393089|FG003|NOT COMPLETED|Overall Study||0
11202675|NCT01842308|12393090|FG004|NOT COMPLETED|Overall Study||1
11202676|NCT01842334|12393105|FG000|STARTED|Overall Study||5
11202677|NCT01842334|12393106|FG001|STARTED|Overall Study||7
11202678|NCT01842334|12393105|FG000|COMPLETED|Overall Study||2
11202679|NCT01842334|12393106|FG001|COMPLETED|Overall Study||3
11202680|NCT01842334|12393105|FG000|NOT COMPLETED|Overall Study||3
11202681|NCT01842334|12393106|FG001|NOT COMPLETED|Overall Study||4
11202682|NCT01842438|12393114|FG000|STARTED|T1: Immediately After the Intervention||42
11202683|NCT01842438|12393115|FG001|STARTED|T1: Immediately After the Intervention||44
11202684|NCT01842438|12393114|FG000|COMPLETED|T1: Immediately After the Intervention||36
11202685|NCT01842438|12393115|FG001|COMPLETED|T1: Immediately After the Intervention||36
11202686|NCT01842438|12393114|FG000|NOT COMPLETED|T1: Immediately After the Intervention||6
11145395|NCT01484951|12332182|FG000|STARTED|Overall Study||74
11145396|NCT01484951|12332182|FG000|COMPLETED|Overall Study||69
11145397|NCT01484951|12332182|FG000|NOT COMPLETED|Overall Study||5
11145398|NCT01484977|12332186|FG000|STARTED|Overall Study||120
11145399|NCT01484977|12332186|FG000|COMPLETED|Overall Study||93
11145400|NCT01484977|12332186|FG000|NOT COMPLETED|Overall Study||27
11145401|NCT01485055|12332190|FG000|STARTED|Overall Study||11
11145402|NCT01485055|12332190|FG000|COMPLETED|Overall Study||11
11145403|NCT01485055|12332190|FG000|NOT COMPLETED|Overall Study||0
11145404|NCT01485094|12332197|FG000|STARTED|Overall Study||20
11145405|NCT01485094|12332198|FG001|STARTED|Overall Study||20
11145406|NCT01485094|12332199|FG002|STARTED|Overall Study||19
11145407|NCT01485094|12332197|FG000|COMPLETED|Overall Study||17
11145408|NCT01485094|12332198|FG001|COMPLETED|Overall Study||18
11145409|NCT01485094|12332199|FG002|COMPLETED|Overall Study||18
11145410|NCT01485094|12332197|FG000|NOT COMPLETED|Overall Study||3
11145411|NCT01485094|12332198|FG001|NOT COMPLETED|Overall Study||2
11145412|NCT01485094|12332199|FG002|NOT COMPLETED|Overall Study||1
11145413|NCT01485120|12332207|FG000|STARTED|Overall Study||34
11145414|NCT01485120|12332207|FG000|COMPLETED|Overall Study||32
11145415|NCT01485120|12332207|FG000|NOT COMPLETED|Overall Study||2
11145416|NCT01485172|12332218|FG000|STARTED|Overall Study||40
11145417|NCT01485172|12332219|FG001|STARTED|Overall Study||13
11145418|NCT01485172|12332220|FG002|STARTED|Overall Study||41
11145419|NCT01485172|12332221|FG003|STARTED|Overall Study||40
11145420|NCT01485172|12332222|FG004|STARTED|Overall Study||39
11145421|NCT01485172|12332223|FG005|STARTED|Overall Study||13
11145422|NCT01485172|12332218|FG000|COMPLETED|Overall Study||33
11145423|NCT01485172|12332219|FG001|COMPLETED|Overall Study||12
11145424|NCT01485172|12332220|FG002|COMPLETED|Overall Study||34
11145425|NCT01485172|12332221|FG003|COMPLETED|Overall Study||32
11145426|NCT01485172|12332222|FG004|COMPLETED|Overall Study||34
11145427|NCT01485172|12332223|FG005|COMPLETED|Overall Study||9
11145428|NCT01485172|12332218|FG000|NOT COMPLETED|Overall Study||7
11145429|NCT01485172|12332219|FG001|NOT COMPLETED|Overall Study||1
11145430|NCT01485172|12332220|FG002|NOT COMPLETED|Overall Study||7
11145431|NCT01485172|12332221|FG003|NOT COMPLETED|Overall Study||8
11145432|NCT01485172|12332222|FG004|NOT COMPLETED|Overall Study||5
11145433|NCT01485172|12332223|FG005|NOT COMPLETED|Overall Study||4
11145434|NCT01485354|12332237|FG000|STARTED|Overall Study||17
11145435|NCT01485354|12332237|FG000|COMPLETED|Overall Study||12
11145436|NCT01485354|12332237|FG000|NOT COMPLETED|Overall Study||5
11145437|NCT01485380|12332241|FG000|STARTED|Overall Study||20
11145438|NCT01485380|12332241|FG000|COMPLETED|Overall Study||17
11145439|NCT01485380|12332241|FG000|NOT COMPLETED|Overall Study||3
11145440|NCT01485393|12332245|FG000|STARTED|Overall Study||5
11145441|NCT01485393|12332246|FG001|STARTED|Overall Study||5
11145442|NCT01485393|12332245|FG000|COMPLETED|Overall Study||5
11145443|NCT01485393|12332246|FG001|COMPLETED|Overall Study||5
11145444|NCT01485393|12332245|FG000|NOT COMPLETED|Overall Study||0
11145445|NCT01485393|12332246|FG001|NOT COMPLETED|Overall Study||0
11145446|NCT01485536|12332253|FG000|STARTED|Overall Study||21
11145447|NCT01485536|12332253|FG000|COMPLETED|Overall Study||17
11145448|NCT01485536|12332253|FG000|NOT COMPLETED|Overall Study||4
11145449|NCT01485588|12332260|FG000|STARTED|Overall Study||6
11145450|NCT01485588|12332261|FG001|STARTED|Overall Study||6
11145451|NCT01485588|12332262|FG002|STARTED|Overall Study||6
11145452|NCT01485588|12332260|FG000|COMPLETED|Overall Study||6
11145453|NCT01485588|12332261|FG001|COMPLETED|Overall Study||6
11145454|NCT01485588|12332262|FG002|COMPLETED|Overall Study||6
11145455|NCT01485588|12332260|FG000|NOT COMPLETED|Overall Study||0
11145456|NCT01485588|12332261|FG001|NOT COMPLETED|Overall Study||0
11145457|NCT01485588|12332262|FG002|NOT COMPLETED|Overall Study||0
11145458|NCT01485627|12332274|FG000|STARTED|Overall Study|139 patients and 105 caregivers|244
11145459|NCT01485627|12332275|FG001|STARTED|Overall Study|142 patients and 99 caregivers|241
11145460|NCT01485627|12332274|FG000|Allocated Caregivers: Total|Overall Study||105
11145461|NCT01485627|12332275|FG001|Allocated Caregivers: Total|Overall Study||99
11145462|NCT01485627|12332274|FG000|Bereaved Caregivers: Total|Overall Study||63
11145463|NCT01485627|12332275|FG001|Bereaved Caregivers: Total|Overall Study||64
11145464|NCT01485627|12332274|FG000|Bereaved Caregivers: 1 Month|Overall Study||51
11145465|NCT01485627|12332275|FG001|Bereaved Caregivers: 1 Month|Overall Study||51
11145466|NCT01485627|12332274|FG000|Bereaved Caregivers: 2 Month Completed|Overall Study||49
11145467|NCT01485627|12332275|FG001|Bereaved Caregivers: 2 Month Completed|Overall Study||52
11145468|NCT01485627|12332274|FG000|Bereaved Caregivers: 7 Month Completed|Overall Study||48
11145469|NCT01485627|12332275|FG001|Bereaved Caregivers: 7 Month Completed|Overall Study||49
11145470|NCT01485627|12332274|FG000|COMPLETED|Overall Study|130 patients and 48 caregivers|178
11145471|NCT01485627|12332275|FG001|COMPLETED|Overall Study|135 patients and 49 caregivers|184
11145472|NCT01485627|12332274|FG000|NOT COMPLETED|Overall Study||66
11145473|NCT01485627|12332275|FG001|NOT COMPLETED|Overall Study||57
11145474|NCT01485640|12332285|FG000|STARTED|Overall Study||162
11145475|NCT01485640|12332285|FG000|COMPLETED|Overall Study||40
11145476|NCT01485640|12332285|FG000|NOT COMPLETED|Overall Study||122
11145477|NCT01485770|12332291|FG000|STARTED|First Intervention (2 Weeks)||17
11145478|NCT01485770|12332292|FG001|STARTED|First Intervention (2 Weeks)||16
11145479|NCT01485770|12332291|FG000|COMPLETED|First Intervention (2 Weeks)||17
11145480|NCT01485770|12332292|FG001|COMPLETED|First Intervention (2 Weeks)||16
11145481|NCT01485770|12332291|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
11145482|NCT01485770|12332292|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
11145483|NCT01485770|12332291|FG000|STARTED|Second Intervention (2 Weeks)||17
11145484|NCT01485770|12332292|FG001|STARTED|Second Intervention (2 Weeks)||16
11145485|NCT01485770|12332291|FG000|COMPLETED|Second Intervention (2 Weeks)||17
11145486|NCT01485770|12332292|FG001|COMPLETED|Second Intervention (2 Weeks)||16
11145487|NCT01485770|12332291|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
11145488|NCT01485770|12332292|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
11145489|NCT01485796|12332300|FG000|STARTED|Period 1: Epoch 1 (Ramp-up)||37
11145490|NCT01485796|12332300|FG000|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
11145491|NCT01485796|12332300|FG000|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
11145492|NCT01485796|12332300|FG000|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
11145493|NCT01485796|12332300|FG000|STARTED|Period 2: Epoch 2||36
11145494|NCT01485796|12332300|FG000|Treated in Epoch 2|Period 2: Epoch 2||36
11145495|NCT01485796|12332300|FG000|COMPLETED|Period 2: Epoch 2||1
11145496|NCT01485796|12332300|FG000|NOT COMPLETED|Period 2: Epoch 2||35
11145497|NCT01485796|12332300|FG000|STARTED|Overall Trial (Incl. Safety Follow-up)||37
11145498|NCT01485796|12332300|FG000|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
11145499|NCT01485796|12332300|FG000|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
11145500|NCT01485796|12332300|FG000|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
11145501|NCT01485796|12332300|FG000|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
11145502|NCT01485796|12332300|FG000|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
11145503|NCT01485796|12332300|FG000|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
11145504|NCT01485796|12332300|FG000|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
11145505|NCT01485796|12332300|FG000|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
11145506|NCT01485796|12332300|FG000|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
11145507|NCT01485887|12332308|FG000|STARTED|Overall Study||50
11145508|NCT01485887|12332308|FG000|COMPLETED|Overall Study||38
11145509|NCT01485887|12332308|FG000|NOT COMPLETED|Overall Study||12
11145510|NCT01485991|12332314|FG000|STARTED|Overall Study||385
11145511|NCT01485991|12332315|FG001|STARTED|Overall Study||386
11145512|NCT01485991|12332314|FG000|Treated|Overall Study||379
11145513|NCT01485991|12332315|FG001|Treated|Overall Study||384
11145514|NCT01485991|12332314|FG000|COMPLETED|Overall Study||353
11145515|NCT01485991|12332315|FG001|COMPLETED|Overall Study||350
11145516|NCT01485991|12332314|FG000|NOT COMPLETED|Overall Study||32
11145517|NCT01485991|12332315|FG001|NOT COMPLETED|Overall Study||36
11145518|NCT01486043|12332321|FG000|STARTED|Overall Study||4
11145519|NCT01486043|12332321|FG000|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
11145520|NCT01486043|12332321|FG000|NOT COMPLETED|Overall Study||2
11145521|NCT01486199|12332327|FG000|STARTED|Baseline Study Day||10
11145522|NCT01486199|12332328|FG001|STARTED|Baseline Study Day||10
11145523|NCT01486199|12332327|FG000|COMPLETED|Baseline Study Day||10
11145524|NCT01486199|12332328|FG001|COMPLETED|Baseline Study Day||9
11145525|NCT01486199|12332327|FG000|NOT COMPLETED|Baseline Study Day||0
11145526|NCT01486199|12332328|FG001|NOT COMPLETED|Baseline Study Day||1
11145527|NCT01486199|12332327|FG000|STARTED|Two Year Period Between Study Days||10
11145528|NCT01486199|12332328|FG001|STARTED|Two Year Period Between Study Days||0
11145529|NCT01486199|12332327|FG000|COMPLETED|Two Year Period Between Study Days||9
11145530|NCT01486199|12332328|FG001|COMPLETED|Two Year Period Between Study Days||0
11145531|NCT01486199|12332327|FG000|NOT COMPLETED|Two Year Period Between Study Days||1
11145532|NCT01486199|12332328|FG001|NOT COMPLETED|Two Year Period Between Study Days||0
11145533|NCT01486199|12332327|FG000|STARTED|Study Day at t= 2 Years||9
11145534|NCT01486199|12332328|FG001|STARTED|Study Day at t= 2 Years||0
11145535|NCT01486199|12332327|FG000|COMPLETED|Study Day at t= 2 Years||9
11145536|NCT01486199|12332328|FG001|COMPLETED|Study Day at t= 2 Years||0
11145537|NCT01486199|12332327|FG000|NOT COMPLETED|Study Day at t= 2 Years||0
11145538|NCT01486199|12332328|FG001|NOT COMPLETED|Study Day at t= 2 Years||0
11145539|NCT01486238|12332336|FG000|STARTED|Overall Study||23
11145540|NCT01486238|12332337|FG001|STARTED|Overall Study||49
11145541|NCT01486238|12332336|FG000|COMPLETED|Overall Study||21
11145542|NCT01486238|12332337|FG001|COMPLETED|Overall Study||43
11145543|NCT01486238|12332336|FG000|NOT COMPLETED|Overall Study||2
11145544|NCT01486238|12332337|FG001|NOT COMPLETED|Overall Study||6
11145545|NCT01486316|12332346|FG000|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
11145546|NCT01486316|12332347|FG001|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
11145547|NCT01486316|12332348|FG002|STARTED|Overall Study|Exited prior to implant|5
11145548|NCT01486316|12332349|FG003|STARTED|Overall Study|Exited prior to 6 month visit|2
11145549|NCT01486316|12332346|FG000|COMPLETED|Overall Study||3
11145550|NCT01486316|12332347|FG001|COMPLETED|Overall Study||7
11145551|NCT01486316|12332348|FG002|COMPLETED|Overall Study||0
11145552|NCT01486316|12332349|FG003|COMPLETED|Overall Study||0
11145553|NCT01486316|12332346|FG000|NOT COMPLETED|Overall Study||4
11145554|NCT01486316|12332347|FG001|NOT COMPLETED|Overall Study||3
11145555|NCT01486316|12332348|FG002|NOT COMPLETED|Overall Study||5
11145556|NCT01486316|12332349|FG003|NOT COMPLETED|Overall Study||2
11145557|NCT01486446|12332360|FG000|STARTED|Overall Study||7
11145558|NCT01486446|12332361|FG001|STARTED|Overall Study||1
11145559|NCT01486446|12332360|FG000|COMPLETED|Overall Study||6
11145560|NCT01486446|12332361|FG001|COMPLETED|Overall Study||1
11145561|NCT01486446|12332360|FG000|NOT COMPLETED|Overall Study||1
11145562|NCT01486446|12332361|FG001|NOT COMPLETED|Overall Study||0
11145563|NCT01486615|12332371|FG000|STARTED|Overall Study||20
11145564|NCT01486615|12332372|FG001|STARTED|Overall Study||20
11145565|NCT01486615|12332373|FG002|STARTED|Overall Study||20
11145566|NCT01486615|12332374|FG003|STARTED|Overall Study||20
11145567|NCT01486615|12332371|FG000|COMPLETED|Overall Study||20
11145568|NCT01486615|12332372|FG001|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
11145569|NCT01486615|12332373|FG002|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
11145570|NCT01486615|12332374|FG003|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
11145571|NCT01486615|12332371|FG000|NOT COMPLETED|Overall Study||0
11145572|NCT01486615|12332372|FG001|NOT COMPLETED|Overall Study||1
11145573|NCT01486615|12332373|FG002|NOT COMPLETED|Overall Study||2
11145574|NCT01486615|12332374|FG003|NOT COMPLETED|Overall Study||2
11145575|NCT01486758|12332386|FG000|STARTED|Overall Study||20
11145576|NCT01486758|12332387|FG001|STARTED|Overall Study||20
11145577|NCT01486758|12332386|FG000|COMPLETED|Overall Study||20
11145578|NCT01486758|12332387|FG001|COMPLETED|Overall Study||19
11145579|NCT01486758|12332386|FG000|NOT COMPLETED|Overall Study||0
11145580|NCT01486758|12332387|FG001|NOT COMPLETED|Overall Study||1
11145581|NCT01486784|12332400|FG000|STARTED|Overall Study||3
11145582|NCT01486784|12332401|FG001|STARTED|Overall Study||7
11145583|NCT01486784|12332402|FG002|STARTED|Overall Study||6
11145584|NCT01486784|12332403|FG003|STARTED|Overall Study||1
11145585|NCT01486784|12332404|FG004|STARTED|Overall Study||5
11145586|NCT01486784|12332405|FG005|STARTED|Overall Study||5
11145587|NCT01486784|12332400|FG000|Completed Cycle 1|Overall Study||2
11145588|NCT01486784|12332401|FG001|Completed Cycle 1|Overall Study||6
11145589|NCT01486784|12332402|FG002|Completed Cycle 1|Overall Study||3
11145590|NCT01486784|12332403|FG003|Completed Cycle 1|Overall Study||1
11145591|NCT01486784|12332404|FG004|Completed Cycle 1|Overall Study||3
11418312|NCT00517075|12616640|FG000|STARTED|Overall Study||0
11418313|NCT00517075|12616641|FG001|STARTED|Overall Study||0
11418314|NCT00517075|12616642|FG002|STARTED|Overall Study||0
11145592|NCT01486784|12332405|FG005|Completed Cycle 1|Overall Study||2
11145593|NCT01486784|12332400|FG000|Received Treatment|Overall Study||3
11145594|NCT01486784|12332401|FG001|Received Treatment|Overall Study||7
11145595|NCT01486784|12332402|FG002|Received Treatment|Overall Study||5
11145596|NCT01486784|12332403|FG003|Received Treatment|Overall Study||1
11145597|NCT01486784|12332404|FG004|Received Treatment|Overall Study||3
11145598|NCT01486784|12332405|FG005|Received Treatment|Overall Study||2
11145599|NCT01486784|12332400|FG000|COMPLETED|Overall Study||3
11145600|NCT01486784|12332401|FG001|COMPLETED|Overall Study||7
11145601|NCT01486784|12332402|FG002|COMPLETED|Overall Study||5
11145602|NCT01486784|12332403|FG003|COMPLETED|Overall Study||1
11145603|NCT01486784|12332404|FG004|COMPLETED|Overall Study||3
11145604|NCT01486784|12332405|FG005|COMPLETED|Overall Study||2
11145605|NCT01486784|12332400|FG000|NOT COMPLETED|Overall Study||0
11145606|NCT01486784|12332401|FG001|NOT COMPLETED|Overall Study||0
11145607|NCT01486784|12332402|FG002|NOT COMPLETED|Overall Study||1
11145608|NCT01486784|12332403|FG003|NOT COMPLETED|Overall Study||0
11145609|NCT01486784|12332404|FG004|NOT COMPLETED|Overall Study||2
11145610|NCT01486784|12332405|FG005|NOT COMPLETED|Overall Study||3
11145611|NCT01486810|12332419|FG000|STARTED|Overall Study||17
11145612|NCT01486810|12332419|FG000|COMPLETED|Overall Study||9
11145613|NCT01486810|12332419|FG000|NOT COMPLETED|Overall Study||8
11145614|NCT01486927|12332423|FG000|STARTED|Overall Study||174
11145615|NCT01486927|12332423|FG000|COMPLETED|Overall Study||161
11145616|NCT01486927|12332423|FG000|NOT COMPLETED|Overall Study||13
11145617|NCT01486966|12332436|FG000|STARTED|Overall Study||29
11145618|NCT01486966|12332437|FG001|STARTED|Overall Study||29
11145619|NCT01486966|12332436|FG000|COMPLETED|Overall Study||29
11145620|NCT01486966|12332437|FG001|COMPLETED|Overall Study||27
11145621|NCT01486966|12332436|FG000|NOT COMPLETED|Overall Study||0
11145622|NCT01486966|12332437|FG001|NOT COMPLETED|Overall Study||2
11145623|NCT01487161|12332447|FG000|STARTED|Overall Study||58
11145624|NCT01487161|12332448|FG001|STARTED|Overall Study||59
11145625|NCT01487161|12332449|FG002|STARTED|Overall Study||60
11145626|NCT01487161|12332450|FG003|STARTED|Overall Study||52
11145627|NCT01487161|12332447|FG000|COMPLETED|Overall Study||56
11145628|NCT01487161|12332448|FG001|COMPLETED|Overall Study||57
11145629|NCT01487161|12332449|FG002|COMPLETED|Overall Study||59
11145630|NCT01487161|12332450|FG003|COMPLETED|Overall Study||50
11145631|NCT01487161|12332447|FG000|NOT COMPLETED|Overall Study||2
11145632|NCT01487161|12332448|FG001|NOT COMPLETED|Overall Study||2
11145633|NCT01487161|12332449|FG002|NOT COMPLETED|Overall Study||1
11145634|NCT01487161|12332450|FG003|NOT COMPLETED|Overall Study||2
11145635|NCT01487200|12332469|FG000|STARTED|Overall Study||5
11145636|NCT01487200|12332470|FG001|STARTED|Overall Study||7
11145637|NCT01487200|12332471|FG002|STARTED|Overall Study||7
11145638|NCT01487200|12332472|FG003|STARTED|Overall Study||5
11145639|NCT01487200|12332469|FG000|COMPLETED|Overall Study||5
11145640|NCT01487200|12332470|FG001|COMPLETED|Overall Study||6
11145641|NCT01487200|12332471|FG002|COMPLETED|Overall Study||7
11145642|NCT01487200|12332472|FG003|COMPLETED|Overall Study||5
11145643|NCT01487200|12332469|FG000|NOT COMPLETED|Overall Study||0
11145644|NCT01487200|12332470|FG001|NOT COMPLETED|Overall Study||1
11145645|NCT01487200|12332471|FG002|NOT COMPLETED|Overall Study||0
11145646|NCT01487200|12332472|FG003|NOT COMPLETED|Overall Study||0
11145647|NCT01487265|12332483|FG000|STARTED|Overall Study||37
11145648|NCT01487265|12332483|FG000|COMPLETED|Overall Study||0
11145649|NCT01487265|12332483|FG000|NOT COMPLETED|Overall Study||37
11145650|NCT01487525|12332489|FG000|STARTED|Overall Study||22
11145651|NCT01487525|12332490|FG001|STARTED|Overall Study||20
11145652|NCT01487525|12332489|FG000|COMPLETED|Overall Study||22
11145653|NCT01487525|12332490|FG001|COMPLETED|Overall Study||19
11145654|NCT01487525|12332489|FG000|NOT COMPLETED|Overall Study||0
11145655|NCT01487525|12332490|FG001|NOT COMPLETED|Overall Study||1
11145656|NCT01487577|12332496|FG000|STARTED|Overall Study||19
11145657|NCT01487577|12332496|FG000|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
11145658|NCT01487577|12332496|FG000|NOT COMPLETED|Overall Study||1
11145659|NCT01487668|12332502|FG000|STARTED|Overall Study||146
11145660|NCT01487668|12332503|FG001|STARTED|Overall Study||141
11145661|NCT01487668|12332502|FG000|COMPLETED|Overall Study||121
11145662|NCT01487668|12332503|FG001|COMPLETED|Overall Study||124
11145663|NCT01487668|12332502|FG000|NOT COMPLETED|Overall Study||25
11145664|NCT01487668|12332503|FG001|NOT COMPLETED|Overall Study||17
11145665|NCT01487863|12332513|FG000|STARTED|Overall Study||35
11145666|NCT01487863|12332514|FG001|STARTED|Overall Study||34
11145667|NCT01487863|12332513|FG000|Subjects Randomized (Efficacy Analysis)|Overall Study||35
11145668|NCT01487863|12332514|FG001|Subjects Randomized (Efficacy Analysis)|Overall Study||34
11145669|NCT01487863|12332513|FG000|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
11145670|NCT01487863|12332514|FG001|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
11145671|NCT01487863|12332513|FG000|COMPLETED|Overall Study||16
11145672|NCT01487863|12332514|FG001|COMPLETED|Overall Study||15
11145673|NCT01487863|12332513|FG000|NOT COMPLETED|Overall Study||19
11145674|NCT01487863|12332514|FG001|NOT COMPLETED|Overall Study||19
11145675|NCT01487954|12332522|FG000|STARTED|Overall Study||29
11145676|NCT01487954|12332523|FG001|STARTED|Overall Study||16
11145677|NCT01487954|12332522|FG000|Safety lead-in|Overall Study||10
11145678|NCT01487954|12332523|FG001|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
11145679|NCT01487954|12332522|FG000|COMPLETED|Overall Study||29
11145680|NCT01487954|12332523|FG001|COMPLETED|Overall Study||16
11145681|NCT01487954|12332522|FG000|NOT COMPLETED|Overall Study||0
11145682|NCT01487954|12332523|FG001|NOT COMPLETED|Overall Study||0
11145683|NCT01488019|12332531|FG000|STARTED|Overall Study||541
11145684|NCT01488019|12332532|FG001|STARTED|Overall Study||530
11145685|NCT01488019|12332531|FG000|COMPLETED|Overall Study||294
11145686|NCT01488019|12332532|FG001|COMPLETED|Overall Study||226
11145687|NCT01488019|12332531|FG000|NOT COMPLETED|Overall Study||247
11145688|NCT01488019|12332532|FG001|NOT COMPLETED|Overall Study||304
11145689|NCT01488071|12332542|FG000|STARTED|Overall Study|all-patients-treated set (APTS)|253
11145690|NCT01488071|12332543|FG001|STARTED|Overall Study|APTS|242
11145691|NCT01488071|12332542|FG000|COMPLETED|Overall Study||200
11145692|NCT01488071|12332543|FG001|COMPLETED|Overall Study||179
11145693|NCT01488071|12332542|FG000|NOT COMPLETED|Overall Study||53
11145694|NCT01488071|12332543|FG001|NOT COMPLETED|Overall Study||63
11145695|NCT01488097|12332549|FG000|STARTED|Overall Study||8
11145696|NCT01488097|12332549|FG000|Received Study Drug in Extension Study|Overall Study||8
11145697|NCT01488097|12332549|FG000|COMPLETED|Overall Study||7
11145698|NCT01488097|12332549|FG000|NOT COMPLETED|Overall Study||1
11145699|NCT01488188|12332555|FG000|STARTED|Overall Study||20
11145700|NCT01488188|12332556|FG001|STARTED|Overall Study||20
11145701|NCT01488188|12332555|FG000|COMPLETED|Overall Study||20
11145702|NCT01488188|12332556|FG001|COMPLETED|Overall Study||20
11145703|NCT01488188|12332555|FG000|NOT COMPLETED|Overall Study||0
11145704|NCT01488188|12332556|FG001|NOT COMPLETED|Overall Study||0
11145705|NCT01488279|12332564|FG000|STARTED|Overall Study||5
11145706|NCT01488279|12332565|FG001|STARTED|Overall Study||5
11145707|NCT01488279|12332564|FG000|COMPLETED|Overall Study||5
11145708|NCT01488279|12332565|FG001|COMPLETED|Overall Study||5
11145709|NCT01488279|12332564|FG000|NOT COMPLETED|Overall Study||0
11145710|NCT01488279|12332565|FG001|NOT COMPLETED|Overall Study||0
11145711|NCT01488318|12332574|FG000|STARTED|Overall Study||14
11145712|NCT01488318|12332574|FG000|COMPLETED|Overall Study||14
11145713|NCT01488318|12332574|FG000|NOT COMPLETED|Overall Study||0
11145714|NCT01488370|12332581|FG000|STARTED|Overall Study||22
11145715|NCT01488370|12332582|FG001|STARTED|Overall Study||23
11145716|NCT01488370|12332583|FG002|STARTED|Overall Study||20
11145717|NCT01488370|12332581|FG000|COMPLETED|Overall Study||22
11145718|NCT01488370|12332582|FG001|COMPLETED|Overall Study||22
11145719|NCT01488370|12332583|FG002|COMPLETED|Overall Study||19
11145720|NCT01488370|12332581|FG000|NOT COMPLETED|Overall Study||0
11145721|NCT01488370|12332582|FG001|NOT COMPLETED|Overall Study||1
11145722|NCT01488370|12332583|FG002|NOT COMPLETED|Overall Study||1
11145723|NCT01488409|12332593|FG000|STARTED|Overall Study||20
11145724|NCT01488409|12332594|FG001|STARTED|Overall Study||19
11145725|NCT01488409|12332593|FG000|COMPLETED|Overall Study||16
11145726|NCT01488409|12332594|FG001|COMPLETED|Overall Study||15
11145727|NCT01488409|12332593|FG000|NOT COMPLETED|Overall Study||4
11145728|NCT01488409|12332594|FG001|NOT COMPLETED|Overall Study||4
11145729|NCT01488448|12332602|FG000|STARTED|Overall Study||113
11145730|NCT01488448|12332603|FG001|STARTED|Overall Study||114
11145731|NCT01488448|12332602|FG000|COMPLETED|Overall Study||93
11145732|NCT01488448|12332603|FG001|COMPLETED|Overall Study||97
11145733|NCT01488448|12332602|FG000|NOT COMPLETED|Overall Study||20
11145734|NCT01488448|12332603|FG001|NOT COMPLETED|Overall Study||17
11145735|NCT01488487|12332611|FG000|STARTED|Overall Study||24
11145736|NCT01488487|12332611|FG000|Received Treatment|Overall Study||24
11145737|NCT01488487|12332611|FG000|COMPLETED|Overall Study||15
11145738|NCT01488487|12332611|FG000|NOT COMPLETED|Overall Study||9
11145739|NCT01488578|12332615|FG000|STARTED|Overall Study||11157
11145740|NCT01488578|12332615|FG000|COMPLETED|Overall Study||9321
11145741|NCT01488578|12332615|FG000|NOT COMPLETED|Overall Study||1836
11145742|NCT01488708|12332647|FG000|STARTED|Overall Study||940
11145743|NCT01488708|12332648|FG001|STARTED|Overall Study||578
11145744|NCT01488708|12332647|FG000|Received at Least 1 Dose of Study Drug|Overall Study||937
11145745|NCT01488708|12332648|FG001|Received at Least 1 Dose of Study Drug|Overall Study||578
11145746|NCT01488708|12332647|FG000|Participated in Follow Up|Overall Study||810
11145747|NCT01488708|12332648|FG001|Participated in Follow Up|Overall Study||526
11145748|NCT01488708|12332647|FG000|COMPLETED|Overall Study||0
11145749|NCT01488708|12332648|FG001|COMPLETED|Overall Study||0
11145750|NCT01488708|12332647|FG000|NOT COMPLETED|Overall Study||940
11145751|NCT01488708|12332648|FG001|NOT COMPLETED|Overall Study||578
11145752|NCT01488877|12332656|FG000|STARTED|Initial Randomization||1
11145753|NCT01488877|12332657|FG001|STARTED|Initial Randomization||5
11145754|NCT01488877|12332658|FG002|STARTED|Initial Randomization||0
11145755|NCT01488877|12332656|FG000|COMPLETED|Initial Randomization||1
11145756|NCT01488877|12332657|FG001|COMPLETED|Initial Randomization||5
11145757|NCT01488877|12332658|FG002|COMPLETED|Initial Randomization||0
11145758|NCT01488877|12332656|FG000|NOT COMPLETED|Initial Randomization||0
11145759|NCT01488877|12332657|FG001|NOT COMPLETED|Initial Randomization||0
11145760|NCT01488877|12332658|FG002|NOT COMPLETED|Initial Randomization||0
11145761|NCT01488877|12332656|FG000|STARTED|Re-randomization||0
11145762|NCT01488877|12332657|FG001|STARTED|Re-randomization||0
11145763|NCT01488877|12332658|FG002|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
11145764|NCT01488877|12332656|FG000|COMPLETED|Re-randomization||0
11145765|NCT01488877|12332657|FG001|COMPLETED|Re-randomization||0
11145766|NCT01488877|12332658|FG002|COMPLETED|Re-randomization||3
11145767|NCT01488877|12332656|FG000|NOT COMPLETED|Re-randomization||0
11145768|NCT01488877|12332657|FG001|NOT COMPLETED|Re-randomization||0
11145769|NCT01488877|12332658|FG002|NOT COMPLETED|Re-randomization||0
11145770|NCT01488994|12332667|FG000|STARTED|Overall Study||11
11145771|NCT01488994|12332668|FG001|STARTED|Overall Study||12
11145772|NCT01488994|12332667|FG000|COMPLETED|Overall Study||11
11145773|NCT01488994|12332668|FG001|COMPLETED|Overall Study||11
11145774|NCT01488994|12332667|FG000|NOT COMPLETED|Overall Study||0
11145775|NCT01488994|12332668|FG001|NOT COMPLETED|Overall Study||1
11145776|NCT01489020|12332685|FG000|STARTED|Overall Study||12
11145777|NCT01489020|12332686|FG001|STARTED|Overall Study||4
11145778|NCT01489020|12332687|FG002|STARTED|Overall Study||12
11145779|NCT01489020|12332688|FG003|STARTED|Overall Study||4
11145780|NCT01489020|12332689|FG004|STARTED|Overall Study||12
11145781|NCT01489020|12332690|FG005|STARTED|Overall Study||4
11145782|NCT01489020|12332685|FG000|COMPLETED|Overall Study||11
11145783|NCT01489020|12332686|FG001|COMPLETED|Overall Study||4
11145784|NCT01489020|12332687|FG002|COMPLETED|Overall Study||9
11145785|NCT01489020|12332688|FG003|COMPLETED|Overall Study||4
11145786|NCT01489020|12332689|FG004|COMPLETED|Overall Study||6
11145787|NCT01489020|12332690|FG005|COMPLETED|Overall Study||4
11145788|NCT01489020|12332685|FG000|NOT COMPLETED|Overall Study||1
11145789|NCT01489020|12332686|FG001|NOT COMPLETED|Overall Study||0
11145790|NCT01489020|12332687|FG002|NOT COMPLETED|Overall Study||3
11145791|NCT01489020|12332688|FG003|NOT COMPLETED|Overall Study||0
11145792|NCT01489020|12332689|FG004|NOT COMPLETED|Overall Study||6
11145793|NCT01489020|12332690|FG005|NOT COMPLETED|Overall Study||0
11145794|NCT01489111|12332710|FG000|STARTED|Overall Study||36
11145795|NCT01489111|12332710|FG000|COMPLETED|Overall Study||35
11145796|NCT01489111|12332710|FG000|NOT COMPLETED|Overall Study||1
11145797|NCT01489189|12332716|FG000|STARTED|Overall Study|Number of Eyes|191
11145798|NCT01489189|12332717|FG001|STARTED|Overall Study|Number of Eyes|203
11145799|NCT01489189|12332716|FG000|COMPLETED|Overall Study|Number of Eyes|160
11145800|NCT01489189|12332717|FG001|COMPLETED|Overall Study|Number of Eyes|168
11145801|NCT01489189|12332716|FG000|NOT COMPLETED|Overall Study||31
11145802|NCT01489189|12332717|FG001|NOT COMPLETED|Overall Study||35
11145803|NCT01489254|12332727|FG000|STARTED|Double-blind Part||355
11145804|NCT01489254|12332728|FG001|STARTED|Double-blind Part||357
11145805|NCT01489254|12332729|FG002|STARTED|Double-blind Part||84
11145806|NCT01489254|12332730|FG003|STARTED|Double-blind Part||0
11145807|NCT01489254|12332727|FG000|COMPLETED|Double-blind Part||330
11145808|NCT01489254|12332728|FG001|COMPLETED|Double-blind Part||324
11145809|NCT01489254|12332729|FG002|COMPLETED|Double-blind Part||81
11145810|NCT01489254|12332730|FG003|COMPLETED|Double-blind Part||0
11145811|NCT01489254|12332727|FG000|NOT COMPLETED|Double-blind Part||25
11145812|NCT01489254|12332728|FG001|NOT COMPLETED|Double-blind Part||33
11145813|NCT01489254|12332729|FG002|NOT COMPLETED|Double-blind Part||3
11145814|NCT01489254|12332730|FG003|NOT COMPLETED|Double-blind Part||0
11145815|NCT01489254|12332727|FG000|STARTED|Open-label Extension Part||0
11145816|NCT01489254|12332728|FG001|STARTED|Open-label Extension Part||0
11145817|NCT01489254|12332729|FG002|STARTED|Open-label Extension Part||0
11145818|NCT01489254|12332730|FG003|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
11145819|NCT01489254|12332727|FG000|COMPLETED|Open-label Extension Part||0
11145820|NCT01489254|12332728|FG001|COMPLETED|Open-label Extension Part||0
11145821|NCT01489254|12332729|FG002|COMPLETED|Open-label Extension Part||0
11145822|NCT01489254|12332730|FG003|COMPLETED|Open-label Extension Part||670
11145823|NCT01489254|12332727|FG000|NOT COMPLETED|Open-label Extension Part||0
11145824|NCT01489254|12332728|FG001|NOT COMPLETED|Open-label Extension Part||0
11145825|NCT01489254|12332729|FG002|NOT COMPLETED|Open-label Extension Part||0
11145826|NCT01489254|12332730|FG003|NOT COMPLETED|Open-label Extension Part||58
11145827|NCT01489358|12332742|FG000|STARTED|Overall Study||5
11145828|NCT01489358|12332743|FG001|STARTED|Overall Study||10
11145829|NCT01489358|12332744|FG002|STARTED|Overall Study||10
11145830|NCT01489358|12332742|FG000|COMPLETED|Overall Study||5
11145831|NCT01489358|12332743|FG001|COMPLETED|Overall Study||10
11145832|NCT01489358|12332744|FG002|COMPLETED|Overall Study||8
11145833|NCT01489358|12332742|FG000|NOT COMPLETED|Overall Study||0
11145834|NCT01489358|12332743|FG001|NOT COMPLETED|Overall Study||0
11145835|NCT01489358|12332744|FG002|NOT COMPLETED|Overall Study||2
11145836|NCT01489527|12332754|FG000|STARTED|Overall Study||205
11145837|NCT01489527|12332755|FG001|STARTED|Overall Study||201
11145838|NCT01489527|12332754|FG000|COMPLETED|Overall Study||183
11145839|NCT01489527|12332755|FG001|COMPLETED|Overall Study||175
11145840|NCT01489527|12332754|FG000|NOT COMPLETED|Overall Study||22
11145841|NCT01489527|12332755|FG001|NOT COMPLETED|Overall Study||26
11145842|NCT01489579|12332763|FG000|STARTED|Overall Study||56
11145843|NCT01489579|12332764|FG001|STARTED|Overall Study||64
11145844|NCT01489579|12332763|FG000|COMPLETED|Overall Study||47
11145845|NCT01489579|12332764|FG001|COMPLETED|Overall Study||57
11145846|NCT01489579|12332763|FG000|NOT COMPLETED|Overall Study||9
11145847|NCT01489579|12332764|FG001|NOT COMPLETED|Overall Study||7
11145848|NCT01489670|12332772|FG000|STARTED|Overall Study||387
11145849|NCT01489670|12332772|FG000|COMPLETED|Overall Study||334
11145850|NCT01489670|12332772|FG000|NOT COMPLETED|Overall Study||53
11145851|NCT01489826|12332785|FG000|STARTED|Overall Study||3
11145852|NCT01489826|12332786|FG001|STARTED|Overall Study||3
11145853|NCT01489826|12332787|FG002|STARTED|Overall Study||3
11145854|NCT01489826|12332788|FG003|STARTED|Overall Study||7
11145855|NCT01489826|12332789|FG004|STARTED|Overall Study||3
11145856|NCT01489826|12332790|FG005|STARTED|Overall Study||3
11145857|NCT01489826|12332791|FG006|STARTED|Overall Study||9
11145858|NCT01489826|12332792|FG007|STARTED|Overall Study||3
11145859|NCT01489826|12332793|FG008|STARTED|Overall Study||6
11145860|NCT01489826|12332785|FG000|COMPLETED|Overall Study||3
11145861|NCT01489826|12332786|FG001|COMPLETED|Overall Study||3
11145862|NCT01489826|12332787|FG002|COMPLETED|Overall Study||3
11145863|NCT01489826|12332788|FG003|COMPLETED|Overall Study||7
11145864|NCT01489826|12332789|FG004|COMPLETED|Overall Study||3
11145865|NCT01489826|12332790|FG005|COMPLETED|Overall Study||3
11145866|NCT01489826|12332791|FG006|COMPLETED|Overall Study||9
11145867|NCT01489826|12332792|FG007|COMPLETED|Overall Study||3
11145868|NCT01489826|12332793|FG008|COMPLETED|Overall Study||6
11145869|NCT01489826|12332785|FG000|NOT COMPLETED|Overall Study||0
11145870|NCT01489826|12332786|FG001|NOT COMPLETED|Overall Study||0
11145871|NCT01489826|12332787|FG002|NOT COMPLETED|Overall Study||0
11145872|NCT01489826|12332788|FG003|NOT COMPLETED|Overall Study||0
11145873|NCT01489826|12332789|FG004|NOT COMPLETED|Overall Study||0
11145874|NCT01489826|12332790|FG005|NOT COMPLETED|Overall Study||0
11145875|NCT01489826|12332791|FG006|NOT COMPLETED|Overall Study||0
11145876|NCT01489826|12332792|FG007|NOT COMPLETED|Overall Study||0
11145877|NCT01489826|12332793|FG008|NOT COMPLETED|Overall Study||0
11145878|NCT01489891|12332823|FG000|STARTED|Overall Study||60
11145879|NCT01489891|12332824|FG001|STARTED|Overall Study||60
11145880|NCT01489891|12332823|FG000|COMPLETED|Overall Study||59
11145881|NCT01489891|12332824|FG001|COMPLETED|Overall Study||60
11145882|NCT01489891|12332823|FG000|NOT COMPLETED|Overall Study||1
11145883|NCT01489891|12332824|FG001|NOT COMPLETED|Overall Study||0
11145884|NCT01489956|12332832|FG000|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
11145885|NCT01489956|12332833|FG001|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
11145886|NCT01489956|12332834|FG002|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
11145887|NCT01489956|12332832|FG000|COMPLETED|Overall Study||12
11145888|NCT01489956|12332833|FG001|COMPLETED|Overall Study||0
11145889|NCT01489956|12332834|FG002|COMPLETED|Overall Study||5
11145890|NCT01489956|12332832|FG000|NOT COMPLETED|Overall Study||1
11145891|NCT01489956|12332833|FG001|NOT COMPLETED|Overall Study||0
11145892|NCT01489956|12332834|FG002|NOT COMPLETED|Overall Study||1
11145893|NCT01489969|12332845|FG000|STARTED|Overall Study||45
11322697|NCT01866657|12519981|FG001|NOT COMPLETED|Overall Study||0
11145894|NCT01489969|12332846|FG001|STARTED|Overall Study||47
11145895|NCT01489969|12332847|FG002|STARTED|Overall Study||45
11145896|NCT01489969|12332845|FG000|COMPLETED|Overall Study||40
11026616|NCT00829179|12205191|FG000|NOT COMPLETED|Overall Study||1
11026617|NCT00829244|12205197|FG000|STARTED|Overall Study||96
11026618|NCT00829244|12205198|FG001|STARTED|Overall Study||104
11026619|NCT00829244|12205197|FG000|COMPLETED|Overall Study||82
11026620|NCT00829244|12205198|FG001|COMPLETED|Overall Study||83
11145897|NCT01489969|12332846|FG001|COMPLETED|Overall Study||43
11145898|NCT01489969|12332847|FG002|COMPLETED|Overall Study||44
11145899|NCT01489969|12332845|FG000|NOT COMPLETED|Overall Study||5
11145900|NCT01489969|12332846|FG001|NOT COMPLETED|Overall Study||4
11145901|NCT01489969|12332847|FG002|NOT COMPLETED|Overall Study||1
11145902|NCT01490060|12332857|FG000|STARTED|Cycle 1||11
11145903|NCT01490060|12332858|FG001|STARTED|Cycle 1||13
11145904|NCT01490060|12332859|FG002|STARTED|Cycle 1||12
11145905|NCT01490060|12332860|FG003|STARTED|Cycle 1||11
11145906|NCT01490060|12332857|FG000|COMPLETED|Cycle 1||11
11145907|NCT01490060|12332858|FG001|COMPLETED|Cycle 1||12
11145908|NCT01490060|12332859|FG002|COMPLETED|Cycle 1||9
11145909|NCT01490060|12332860|FG003|COMPLETED|Cycle 1||8
11145910|NCT01490060|12332857|FG000|NOT COMPLETED|Cycle 1||0
11145911|NCT01490060|12332858|FG001|NOT COMPLETED|Cycle 1||1
11145912|NCT01490060|12332859|FG002|NOT COMPLETED|Cycle 1||3
11145913|NCT01490060|12332860|FG003|NOT COMPLETED|Cycle 1||3
11145914|NCT01490060|12332857|FG000|STARTED|Cycle 2||11
11145915|NCT01490060|12332858|FG001|STARTED|Cycle 2||12
11145916|NCT01490060|12332859|FG002|STARTED|Cycle 2||9
11145917|NCT01490060|12332860|FG003|STARTED|Cycle 2||8
11145918|NCT01490060|12332857|FG000|COMPLETED|Cycle 2||9
11145919|NCT01490060|12332858|FG001|COMPLETED|Cycle 2||11
11145920|NCT01490060|12332859|FG002|COMPLETED|Cycle 2||8
11145921|NCT01490060|12332860|FG003|COMPLETED|Cycle 2||8
11145922|NCT01490060|12332857|FG000|NOT COMPLETED|Cycle 2||2
11145923|NCT01490060|12332858|FG001|NOT COMPLETED|Cycle 2||1
11145924|NCT01490060|12332859|FG002|NOT COMPLETED|Cycle 2||1
11145925|NCT01490060|12332860|FG003|NOT COMPLETED|Cycle 2||0
11145926|NCT01490073|12332870|FG000|STARTED|Overall Study||12
11145927|NCT01490073|12332871|FG001|STARTED|Overall Study||12
11145928|NCT01490073|12332870|FG000|COMPLETED|Overall Study||12
11145929|NCT01490073|12332871|FG001|COMPLETED|Overall Study||12
11145930|NCT01490073|12332870|FG000|NOT COMPLETED|Overall Study||0
11145931|NCT01490073|12332871|FG001|NOT COMPLETED|Overall Study||0
11145932|NCT01490086|12332882|FG000|STARTED|Overall Study||58
11145933|NCT01490086|12332883|FG001|STARTED|Overall Study||59
11145934|NCT01490086|12332884|FG002|STARTED|Overall Study||58
11145935|NCT01490086|12332885|FG003|STARTED|Overall Study||20
11145936|NCT01490086|12332886|FG004|STARTED|Overall Study||39
11145937|NCT01490086|12332882|FG000|COMPLETED|Overall Study||50
11145938|NCT01490086|12332883|FG001|COMPLETED|Overall Study||44
11145939|NCT01490086|12332884|FG002|COMPLETED|Overall Study||51
11145940|NCT01490086|12332885|FG003|COMPLETED|Overall Study||13
11418315|NCT00517075|12616643|FG003|STARTED|Overall Study||0
11418316|NCT00517075|12616640|FG000|COMPLETED|Overall Study||0
11418317|NCT00517075|12616641|FG001|COMPLETED|Overall Study||0
11418318|NCT00517075|12616642|FG002|COMPLETED|Overall Study||0
11418319|NCT00517075|12616643|FG003|COMPLETED|Overall Study||0
11418320|NCT00517075|12616640|FG000|NOT COMPLETED|Overall Study||0
11418321|NCT00517075|12616641|FG001|NOT COMPLETED|Overall Study||0
11145941|NCT01490086|12332886|FG004|COMPLETED|Overall Study||28
11145942|NCT01490086|12332882|FG000|NOT COMPLETED|Overall Study||8
11145943|NCT01490086|12332883|FG001|NOT COMPLETED|Overall Study||15
11145944|NCT01490086|12332884|FG002|NOT COMPLETED|Overall Study||7
11145945|NCT01490086|12332885|FG003|NOT COMPLETED|Overall Study||7
11145946|NCT01490086|12332886|FG004|NOT COMPLETED|Overall Study||11
11145947|NCT01490125|12332898|FG000|STARTED|Period I||43
11145948|NCT01490125|12332899|FG001|STARTED|Period I||42
11145949|NCT01490125|12332900|FG002|STARTED|Period I||41
11145950|NCT01490125|12332901|FG003|STARTED|Period I||38
11145951|NCT01490125|12332902|FG004|STARTED|Period I||40
11145952|NCT01490125|12332903|FG005|STARTED|Period I||42
11145953|NCT01490125|12332898|FG000|COMPLETED|Period I||37
11145954|NCT01490125|12332899|FG001|COMPLETED|Period I||37
11145955|NCT01490125|12332900|FG002|COMPLETED|Period I||37
11145956|NCT01490125|12332901|FG003|COMPLETED|Period I||33
11145957|NCT01490125|12332902|FG004|COMPLETED|Period I||36
11145958|NCT01490125|12332903|FG005|COMPLETED|Period I||37
11145959|NCT01490125|12332898|FG000|NOT COMPLETED|Period I||6
11145960|NCT01490125|12332899|FG001|NOT COMPLETED|Period I||5
11145961|NCT01490125|12332900|FG002|NOT COMPLETED|Period I||4
11145962|NCT01490125|12332901|FG003|NOT COMPLETED|Period I||5
11418322|NCT00517075|12616642|FG002|NOT COMPLETED|Overall Study||0
11418323|NCT00517075|12616643|FG003|NOT COMPLETED|Overall Study||0
11145963|NCT01490125|12332902|FG004|NOT COMPLETED|Period I||4
11145964|NCT01490125|12332903|FG005|NOT COMPLETED|Period I||5
11145965|NCT01490125|12332898|FG000|STARTED|Period II||37
11145966|NCT01490125|12332899|FG001|STARTED|Period II||37
11145967|NCT01490125|12332900|FG002|STARTED|Period II||37
11145968|NCT01490125|12332901|FG003|STARTED|Period II||33
11145969|NCT01490125|12332902|FG004|STARTED|Period II||36
11145970|NCT01490125|12332903|FG005|STARTED|Period II||37
11145971|NCT01490125|12332898|FG000|COMPLETED|Period II||34
11145972|NCT01490125|12332899|FG001|COMPLETED|Period II||33
11145973|NCT01490125|12332900|FG002|COMPLETED|Period II||34
11026621|NCT00829244|12205197|FG000|NOT COMPLETED|Overall Study||14
11026622|NCT00829244|12205198|FG001|NOT COMPLETED|Overall Study||21
11026623|NCT00829283|12205206|FG000|STARTED|Overall Study||39
11026624|NCT00829283|12205207|FG001|STARTED|Overall Study||152
11026625|NCT00829283|12205206|FG000|COMPLETED|Overall Study||32
11026626|NCT00829283|12205207|FG001|COMPLETED|Overall Study||127
11026627|NCT00829283|12205206|FG000|NOT COMPLETED|Overall Study||7
11026628|NCT00829283|12205207|FG001|NOT COMPLETED|Overall Study||25
11026629|NCT00829296|12205215|FG000|STARTED|Overall Study||34
11026630|NCT00829296|12205216|FG001|STARTED|Overall Study||36
11145974|NCT01490125|12332901|FG003|COMPLETED|Period II||30
11145975|NCT01490125|12332902|FG004|COMPLETED|Period II||32
11145976|NCT01490125|12332903|FG005|COMPLETED|Period II||35
11145977|NCT01490125|12332898|FG000|NOT COMPLETED|Period II||3
11145978|NCT01490125|12332899|FG001|NOT COMPLETED|Period II||4
11145979|NCT01490125|12332900|FG002|NOT COMPLETED|Period II||3
11145980|NCT01490125|12332901|FG003|NOT COMPLETED|Period II||3
11145981|NCT01490125|12332902|FG004|NOT COMPLETED|Period II||4
11145982|NCT01490125|12332903|FG005|NOT COMPLETED|Period II||2
11145983|NCT01490125|12332898|FG000|STARTED|Period III||34
11145984|NCT01490125|12332899|FG001|STARTED|Period III||33
11145985|NCT01490125|12332900|FG002|STARTED|Period III||34
11145986|NCT01490125|12332901|FG003|STARTED|Period III||30
11145987|NCT01490125|12332902|FG004|STARTED|Period III||32
11145988|NCT01490125|12332903|FG005|STARTED|Period III||35
11145989|NCT01490125|12332898|FG000|COMPLETED|Period III||31
11145990|NCT01490125|12332899|FG001|COMPLETED|Period III||32
11145991|NCT01490125|12332900|FG002|COMPLETED|Period III||34
11026631|NCT00829296|12205215|FG000|COMPLETED|Overall Study||29
11322698|NCT01705977|12519989|FG000|STARTED|Overall Study||2002
11418324|NCT00527982|12616655|FG000|STARTED|Overall Study||1
11418325|NCT00527982|12616656|FG001|STARTED|Overall Study||0
11418326|NCT00527982|12616655|FG000|COMPLETED|Overall Study||0
11418327|NCT00527982|12616656|FG001|COMPLETED|Overall Study||0
11418328|NCT00527982|12616655|FG000|NOT COMPLETED|Overall Study||1
11418329|NCT00527982|12616656|FG001|NOT COMPLETED|Overall Study||0
11322699|NCT01705977|12519990|FG001|STARTED|Overall Study||2001
11322700|NCT01705977|12519989|FG000|COMPLETED|Overall Study||1729
11322701|NCT01705977|12519990|FG001|COMPLETED|Overall Study||1741
11322702|NCT01705977|12519989|FG000|NOT COMPLETED|Overall Study||273
11322703|NCT01705977|12519990|FG001|NOT COMPLETED|Overall Study||260
11322704|NCT01689740|12519999|FG000|STARTED|Overall Study||2
11322705|NCT01689740|12520000|FG001|STARTED|Overall Study||3
11322706|NCT01689740|12520001|FG002|STARTED|Overall Study||5
11322707|NCT01689740|12519999|FG000|COMPLETED|Overall Study||2
11322708|NCT01689740|12520000|FG001|COMPLETED|Overall Study||3
11322709|NCT01689740|12520001|FG002|COMPLETED|Overall Study||5
11322710|NCT01689740|12519999|FG000|NOT COMPLETED|Overall Study||0
11322711|NCT01689740|12520000|FG001|NOT COMPLETED|Overall Study||0
11322712|NCT01689740|12520001|FG002|NOT COMPLETED|Overall Study||0
11322713|NCT01366092|12520011|FG000|STARTED|Overall Study||35
11322714|NCT01366092|12520011|FG000|COMPLETED|Overall Study||31
11322715|NCT01366092|12520011|FG000|NOT COMPLETED|Overall Study||4
11322716|NCT01222247|12520017|FG000|STARTED|Overall Study||1429
11322717|NCT01222247|12520018|FG001|STARTED|Overall Study||1402
11322718|NCT01222247|12520017|FG000|Received 2 Doses|Overall Study||860
11322719|NCT01222247|12520018|FG001|Received 2 Doses|Overall Study||826
11322720|NCT01222247|12520017|FG000|Received 1 Dose|Overall Study||568
11322721|NCT01222247|12520018|FG001|Received 1 Dose|Overall Study||571
11322722|NCT01222247|12520017|FG000|Did Not Receive Assigned Medication|Overall Study||1
11322723|NCT01222247|12520018|FG001|Did Not Receive Assigned Medication|Overall Study||5
11322724|NCT01222247|12520017|FG000|COMPLETED|Overall Study||1427
11322725|NCT01222247|12520018|FG001|COMPLETED|Overall Study||1400
11322726|NCT01222247|12520017|FG000|NOT COMPLETED|Overall Study||2
11322727|NCT01222247|12520018|FG001|NOT COMPLETED|Overall Study||2
11322728|NCT01107626|12520028|FG000|STARTED|Step 1: Induction Therapy||642
11322729|NCT01107626|12520029|FG001|STARTED|Step 1: Induction Therapy||287
11322730|NCT01107626|12520030|FG002|STARTED|Step 1: Induction Therapy||294
11322731|NCT01107626|12520031|FG003|STARTED|Step 1: Induction Therapy||293
11322732|NCT01107626|12520028|FG000|COMPLETED|Step 1: Induction Therapy||65
11322733|NCT01107626|12520029|FG001|COMPLETED|Step 1: Induction Therapy||287
11322734|NCT01107626|12520030|FG002|COMPLETED|Step 1: Induction Therapy||294
11322735|NCT01107626|12520031|FG003|COMPLETED|Step 1: Induction Therapy||293
11322736|NCT01107626|12520028|FG000|NOT COMPLETED|Step 1: Induction Therapy||577
11322737|NCT01107626|12520029|FG001|NOT COMPLETED|Step 1: Induction Therapy||0
11322738|NCT01107626|12520030|FG002|NOT COMPLETED|Step 1: Induction Therapy||0
11322739|NCT01107626|12520031|FG003|NOT COMPLETED|Step 1: Induction Therapy||0
11322740|NCT01107626|12520028|FG000|STARTED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
11322741|NCT01107626|12520029|FG001|STARTED|Step 2: Maintenance Therapy||287
11322742|NCT01107626|12520030|FG002|STARTED|Step 2: Maintenance Therapy||294
11322743|NCT01107626|12520031|FG003|STARTED|Step 2: Maintenance Therapy||293
11322744|NCT01107626|12520028|FG000|COMPLETED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
11322745|NCT01107626|12520029|FG001|COMPLETED|Step 2: Maintenance Therapy||1
11322746|NCT01107626|12520030|FG002|COMPLETED|Step 2: Maintenance Therapy||0
11322747|NCT01107626|12520031|FG003|COMPLETED|Step 2: Maintenance Therapy||1
11322748|NCT01107626|12520028|FG000|NOT COMPLETED|Step 2: Maintenance Therapy||0
11322749|NCT01107626|12520029|FG001|NOT COMPLETED|Step 2: Maintenance Therapy||286
11322750|NCT01107626|12520030|FG002|NOT COMPLETED|Step 2: Maintenance Therapy||294
11322751|NCT01107626|12520031|FG003|NOT COMPLETED|Step 2: Maintenance Therapy||292
11322752|NCT00920387|12520042|FG000|STARTED|Stage 1||8
11418330|NCT00524459|12616662|FG000|STARTED|Overall Study||6
11145992|NCT01490125|12332901|FG003|COMPLETED|Period III||28
11145993|NCT01490125|12332902|FG004|COMPLETED|Period III||31
11145994|NCT01490125|12332903|FG005|COMPLETED|Period III||35
11145995|NCT01490125|12332898|FG000|NOT COMPLETED|Period III||3
11145996|NCT01490125|12332899|FG001|NOT COMPLETED|Period III||1
11145997|NCT01490125|12332900|FG002|NOT COMPLETED|Period III||0
11145998|NCT01490125|12332901|FG003|NOT COMPLETED|Period III||2
11145999|NCT01490125|12332902|FG004|NOT COMPLETED|Period III||1
11146000|NCT01490125|12332903|FG005|NOT COMPLETED|Period III||0
11146001|NCT01490151|12332911|FG000|STARTED|Overall Study||22
11146002|NCT01490151|12332911|FG000|COMPLETED|Overall Study||22
11146003|NCT01490151|12332911|FG000|NOT COMPLETED|Overall Study||0
11146004|NCT01490294|12332921|FG000|STARTED|Overall Study||58
11146005|NCT01490294|12332922|FG001|STARTED|Overall Study||60
11146006|NCT01490294|12332923|FG002|STARTED|Overall Study||59
11146007|NCT01490294|12332924|FG003|STARTED|Overall Study||55
11146008|NCT01490294|12332921|FG000|Participant Received Treatment|Overall Study||54
11146009|NCT01490294|12332922|FG001|Participant Received Treatment|Overall Study||60
11146010|NCT01490294|12332923|FG002|Participant Received Treatment|Overall Study||58
11146011|NCT01490294|12332924|FG003|Participant Received Treatment|Overall Study||54
11146012|NCT01490294|12332921|FG000|COMPLETED|Overall Study||53
11026632|NCT00829296|12205216|FG001|COMPLETED|Overall Study||32
11146013|NCT01490294|12332922|FG001|COMPLETED|Overall Study||60
11146014|NCT01490294|12332923|FG002|COMPLETED|Overall Study||58
11146015|NCT01490294|12332924|FG003|COMPLETED|Overall Study||54
11146016|NCT01490294|12332921|FG000|NOT COMPLETED|Overall Study||5
11146017|NCT01490294|12332922|FG001|NOT COMPLETED|Overall Study||0
11146018|NCT01490294|12332923|FG002|NOT COMPLETED|Overall Study||1
11146019|NCT01490294|12332924|FG003|NOT COMPLETED|Overall Study||1
11146020|NCT01490359|12332936|FG000|STARTED|Overall Study||609
11146021|NCT01490359|12332937|FG001|STARTED|Overall Study||572
11146022|NCT01490359|12332936|FG000|Followed-up at 6 mo|Overall Study||558
11146023|NCT01490359|12332937|FG001|Followed-up at 6 mo|Overall Study||535
11146024|NCT01490359|12332936|FG000|Followed-up at 12 mo|Overall Study||569
11146025|NCT01490359|12332937|FG001|Followed-up at 12 mo|Overall Study||537
11146026|NCT01490359|12332936|FG000|COMPLETED|Overall Study||585
11146027|NCT01490359|12332937|FG001|COMPLETED|Overall Study||555
11146028|NCT01490359|12332936|FG000|NOT COMPLETED|Overall Study||24
11146029|NCT01490359|12332937|FG001|NOT COMPLETED|Overall Study||17
11146030|NCT01490450|12332948|FG000|STARTED|Period 1||41
11146031|NCT01490450|12332949|FG001|STARTED|Period 1||41
11146032|NCT01490450|12332950|FG002|STARTED|Period 1||42
11146033|NCT01490450|12332951|FG003|STARTED|Period 1||41
11146034|NCT01490450|12332948|FG000|COMPLETED|Period 1||38
11146035|NCT01490450|12332949|FG001|COMPLETED|Period 1||40
11146036|NCT01490450|12332950|FG002|COMPLETED|Period 1||38
11146037|NCT01490450|12332951|FG003|COMPLETED|Period 1||33
11146038|NCT01490450|12332948|FG000|NOT COMPLETED|Period 1||3
11146039|NCT01490450|12332949|FG001|NOT COMPLETED|Period 1||1
11146040|NCT01490450|12332950|FG002|NOT COMPLETED|Period 1||4
11146041|NCT01490450|12332951|FG003|NOT COMPLETED|Period 1||8
11146042|NCT01490450|12332948|FG000|STARTED|Period 2||38
11146043|NCT01490450|12332949|FG001|STARTED|Period 2||40
11146044|NCT01490450|12332950|FG002|STARTED|Period 2||37
11146045|NCT01490450|12332951|FG003|STARTED|Period 2||32
11146046|NCT01490450|12332948|FG000|COMPLETED|Period 2||36
11146047|NCT01490450|12332949|FG001|COMPLETED|Period 2||39
11146048|NCT01490450|12332950|FG002|COMPLETED|Period 2||37
11146049|NCT01490450|12332951|FG003|COMPLETED|Period 2||28
11146050|NCT01490450|12332948|FG000|NOT COMPLETED|Period 2||2
11146051|NCT01490450|12332949|FG001|NOT COMPLETED|Period 2||1
11146052|NCT01490450|12332950|FG002|NOT COMPLETED|Period 2||0
11146053|NCT01490450|12332951|FG003|NOT COMPLETED|Period 2||4
11146054|NCT01490580|12332966|FG000|STARTED|Overall Study||82
11146055|NCT01490580|12332967|FG001|STARTED|Overall Study||91
11146056|NCT01490580|12332966|FG000|COMPLETED|Overall Study||82
11146057|NCT01490580|12332967|FG001|COMPLETED|Overall Study||89
11146058|NCT01490580|12332966|FG000|NOT COMPLETED|Overall Study||0
11146059|NCT01490580|12332967|FG001|NOT COMPLETED|Overall Study||2
11146060|NCT01490632|12332982|FG000|STARTED|Part A: Initial Treatment Period||34
11146061|NCT01490632|12332983|FG001|STARTED|Part A: Initial Treatment Period||32
11146062|NCT01490632|12332984|FG002|STARTED|Part A: Initial Treatment Period||72
11146063|NCT01490632|12332985|FG003|STARTED|Part A: Initial Treatment Period||64
11146064|NCT01490632|12332986|FG004|STARTED|Part A: Initial Treatment Period||69
11146065|NCT01490632|12332987|FG005|STARTED|Part A: Initial Treatment Period||0
11146066|NCT01490632|12332988|FG006|STARTED|Part A: Initial Treatment Period||0
11146067|NCT01490632|12332989|FG007|STARTED|Part A: Initial Treatment Period||0
11146068|NCT01490632|12332990|FG008|STARTED|Part A: Initial Treatment Period||0
11146069|NCT01490632|12332991|FG009|STARTED|Part A: Initial Treatment Period||0
11146070|NCT01490632|12332992|FG010|STARTED|Part A: Initial Treatment Period||0
11146071|NCT01490632|12332993|FG011|STARTED|Part A: Initial Treatment Period||0
11146072|NCT01490632|12332994|FG012|STARTED|Part A: Initial Treatment Period||0
11146073|NCT01490632|12332995|FG013|STARTED|Part A: Initial Treatment Period||0
11146074|NCT01490632|12332996|FG014|STARTED|Part A: Initial Treatment Period||0
11146075|NCT01490632|12332997|FG015|STARTED|Part A: Initial Treatment Period||0
11146076|NCT01490632|12332998|FG016|STARTED|Part A: Initial Treatment Period||0
11146077|NCT01490632|12332999|FG017|STARTED|Part A: Initial Treatment Period||0
11146078|NCT01490632|12333000|FG018|STARTED|Part A: Initial Treatment Period||0
11146079|NCT01490632|12333001|FG019|STARTED|Part A: Initial Treatment Period||0
11146080|NCT01490632|12332982|FG000|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
11146081|NCT01490632|12332983|FG001|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
11146082|NCT01490632|12332984|FG002|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
11146083|NCT01490632|12332985|FG003|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
11146084|NCT01490632|12332986|FG004|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
11146085|NCT01490632|12332987|FG005|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146086|NCT01490632|12332988|FG006|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146087|NCT01490632|12332989|FG007|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146088|NCT01490632|12332990|FG008|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146089|NCT01490632|12332991|FG009|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146090|NCT01490632|12332992|FG010|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146091|NCT01490632|12332993|FG011|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146092|NCT01490632|12332994|FG012|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146093|NCT01490632|12332995|FG013|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146094|NCT01490632|12332996|FG014|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146095|NCT01490632|12332997|FG015|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146096|NCT01490632|12332998|FG016|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146097|NCT01490632|12332999|FG017|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146098|NCT01490632|12333000|FG018|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146099|NCT01490632|12333001|FG019|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
11146100|NCT01490632|12332982|FG000|COMPLETED|Part A: Initial Treatment Period||27
11146101|NCT01490632|12332983|FG001|COMPLETED|Part A: Initial Treatment Period||28
11146102|NCT01490632|12332984|FG002|COMPLETED|Part A: Initial Treatment Period||67
11146103|NCT01490632|12332985|FG003|COMPLETED|Part A: Initial Treatment Period||55
11146104|NCT01490632|12332986|FG004|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
11146105|NCT01490632|12332987|FG005|COMPLETED|Part A: Initial Treatment Period||0
11146106|NCT01490632|12332988|FG006|COMPLETED|Part A: Initial Treatment Period||0
11146107|NCT01490632|12332989|FG007|COMPLETED|Part A: Initial Treatment Period||0
11146108|NCT01490632|12332990|FG008|COMPLETED|Part A: Initial Treatment Period||0
11146109|NCT01490632|12332991|FG009|COMPLETED|Part A: Initial Treatment Period||0
11146110|NCT01490632|12332992|FG010|COMPLETED|Part A: Initial Treatment Period||0
11146111|NCT01490632|12332993|FG011|COMPLETED|Part A: Initial Treatment Period||0
11146112|NCT01490632|12332994|FG012|COMPLETED|Part A: Initial Treatment Period||0
11146113|NCT01490632|12332995|FG013|COMPLETED|Part A: Initial Treatment Period||0
11146114|NCT01490632|12332996|FG014|COMPLETED|Part A: Initial Treatment Period||0
11146115|NCT01490632|12332997|FG015|COMPLETED|Part A: Initial Treatment Period||0
11146116|NCT01490632|12332998|FG016|COMPLETED|Part A: Initial Treatment Period||0
11146117|NCT01490632|12332999|FG017|COMPLETED|Part A: Initial Treatment Period||0
11146118|NCT01490632|12333000|FG018|COMPLETED|Part A: Initial Treatment Period||0
11146119|NCT01490632|12333001|FG019|COMPLETED|Part A: Initial Treatment Period||0
11146120|NCT01490632|12332982|FG000|NOT COMPLETED|Part A: Initial Treatment Period||7
11146121|NCT01490632|12332983|FG001|NOT COMPLETED|Part A: Initial Treatment Period||4
11146122|NCT01490632|12332984|FG002|NOT COMPLETED|Part A: Initial Treatment Period||5
11146123|NCT01490632|12332985|FG003|NOT COMPLETED|Part A: Initial Treatment Period||9
11146124|NCT01490632|12332986|FG004|NOT COMPLETED|Part A: Initial Treatment Period||17
11146125|NCT01490632|12332987|FG005|NOT COMPLETED|Part A: Initial Treatment Period||0
11146126|NCT01490632|12332988|FG006|NOT COMPLETED|Part A: Initial Treatment Period||0
11146127|NCT01490632|12332989|FG007|NOT COMPLETED|Part A: Initial Treatment Period||0
11146128|NCT01490632|12332990|FG008|NOT COMPLETED|Part A: Initial Treatment Period||0
11146129|NCT01490632|12332991|FG009|NOT COMPLETED|Part A: Initial Treatment Period||0
11146130|NCT01490632|12332992|FG010|NOT COMPLETED|Part A: Initial Treatment Period||0
11146131|NCT01490632|12332993|FG011|NOT COMPLETED|Part A: Initial Treatment Period||0
11146132|NCT01490632|12332994|FG012|NOT COMPLETED|Part A: Initial Treatment Period||0
11146133|NCT01490632|12332995|FG013|NOT COMPLETED|Part A: Initial Treatment Period||0
11146134|NCT01490632|12332996|FG014|NOT COMPLETED|Part A: Initial Treatment Period||0
11146135|NCT01490632|12332997|FG015|NOT COMPLETED|Part A: Initial Treatment Period||0
11146136|NCT01490632|12332998|FG016|NOT COMPLETED|Part A: Initial Treatment Period||0
11146137|NCT01490632|12332999|FG017|NOT COMPLETED|Part A: Initial Treatment Period||0
11146138|NCT01490632|12333000|FG018|NOT COMPLETED|Part A: Initial Treatment Period||0
11146139|NCT01490632|12333001|FG019|NOT COMPLETED|Part A: Initial Treatment Period||0
11146140|NCT01490632|12332982|FG000|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
11146141|NCT01490632|12332983|FG001|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
11146142|NCT01490632|12332984|FG002|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
11322753|NCT00920387|12520043|FG001|STARTED|Stage 1||4
11322754|NCT00920387|12520044|FG002|STARTED|Stage 1||0
11322755|NCT00920387|12520042|FG000|COMPLETED|Stage 1||7
11322756|NCT00920387|12520043|FG001|COMPLETED|Stage 1||4
11322757|NCT00920387|12520044|FG002|COMPLETED|Stage 1||0
11322758|NCT00920387|12520042|FG000|NOT COMPLETED|Stage 1||1
11322759|NCT00920387|12520043|FG001|NOT COMPLETED|Stage 1||0
11322760|NCT00920387|12520044|FG002|NOT COMPLETED|Stage 1||0
11322761|NCT00920387|12520042|FG000|STARTED|Stage 2||0
11322762|NCT00920387|12520043|FG001|STARTED|Stage 2||0
11322763|NCT00920387|12520044|FG002|STARTED|Stage 2||3
11322764|NCT00920387|12520042|FG000|COMPLETED|Stage 2||0
11322765|NCT00920387|12520043|FG001|COMPLETED|Stage 2||0
11322766|NCT00920387|12520044|FG002|COMPLETED|Stage 2||3
11322767|NCT00920387|12520042|FG000|NOT COMPLETED|Stage 2||0
11322768|NCT00920387|12520043|FG001|NOT COMPLETED|Stage 2||0
11322769|NCT00920387|12520044|FG002|NOT COMPLETED|Stage 2||0
11322770|NCT00353938|12520053|FG000|STARTED|Stage 1||9
11146143|NCT01490632|12332985|FG003|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
11146144|NCT01490632|12332986|FG004|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
11146145|NCT01490632|12332987|FG005|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
11146146|NCT01490632|12332988|FG006|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
11146147|NCT01490632|12332989|FG007|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
11202687|NCT01842438|12393115|FG001|NOT COMPLETED|T1: Immediately After the Intervention||8
11322771|NCT00353938|12520054|FG001|STARTED|Stage 1||5
11322772|NCT00353938|12520055|FG002|STARTED|Stage 1||0
11322773|NCT00353938|12520056|FG003|STARTED|Stage 1||0
11146148|NCT01490632|12332990|FG008|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
11146149|NCT01490632|12332991|FG009|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
11146150|NCT01490632|12332992|FG010|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
11146151|NCT01490632|12332993|FG011|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
11146152|NCT01490632|12332994|FG012|STARTED|Part B: Extension or Step-Up Period||0
11146153|NCT01490632|12332995|FG013|STARTED|Part B: Extension or Step-Up Period||0
11146154|NCT01490632|12332996|FG014|STARTED|Part B: Extension or Step-Up Period||0
11146155|NCT01490632|12332997|FG015|STARTED|Part B: Extension or Step-Up Period||0
11146156|NCT01490632|12332998|FG016|STARTED|Part B: Extension or Step-Up Period||0
11146157|NCT01490632|12332999|FG017|STARTED|Part B: Extension or Step-Up Period||0
11418331|NCT00524459|12616662|FG000|COMPLETED|Overall Study||4
11418332|NCT00524459|12616662|FG000|NOT COMPLETED|Overall Study||2
11418333|NCT00517361|12616666|FG000|STARTED|Overall Study||11
11418334|NCT00517361|12616666|FG000|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
11418335|NCT00517361|12616666|FG000|NOT COMPLETED|Overall Study||11
11418336|NCT00523939|12616672|FG000|STARTED|Overall Study||2
11418337|NCT00523939|12616673|FG001|STARTED|Overall Study||2
11146158|NCT01490632|12333000|FG018|STARTED|Part B: Extension or Step-Up Period||0
11146159|NCT01490632|12333001|FG019|STARTED|Part B: Extension or Step-Up Period||0
11146160|NCT01490632|12332982|FG000|COMPLETED|Part B: Extension or Step-Up Period||0
11146161|NCT01490632|12332983|FG001|COMPLETED|Part B: Extension or Step-Up Period||0
11146162|NCT01490632|12332984|FG002|COMPLETED|Part B: Extension or Step-Up Period||0
11146163|NCT01490632|12332985|FG003|COMPLETED|Part B: Extension or Step-Up Period||0
11146164|NCT01490632|12332986|FG004|COMPLETED|Part B: Extension or Step-Up Period||0
11418338|NCT00523939|12616672|FG000|COMPLETED|Overall Study||2
11418339|NCT00523939|12616673|FG001|COMPLETED|Overall Study||2
11418340|NCT00523939|12616672|FG000|NOT COMPLETED|Overall Study||0
11418341|NCT00523939|12616673|FG001|NOT COMPLETED|Overall Study||0
11418342|NCT00522457|12616678|FG000|STARTED|Overall Study||19
11418343|NCT00522457|12616678|FG000|COMPLETED|Overall Study||1
11418344|NCT00522457|12616678|FG000|NOT COMPLETED|Overall Study||18
11418345|NCT00526331|12616682|FG000|STARTED|Overall Study||55
11146165|NCT01490632|12332987|FG005|COMPLETED|Part B: Extension or Step-Up Period||25
11146166|NCT01490632|12332988|FG006|COMPLETED|Part B: Extension or Step-Up Period||51
11146167|NCT01490632|12332989|FG007|COMPLETED|Part B: Extension or Step-Up Period||13
11146168|NCT01490632|12332990|FG008|COMPLETED|Part B: Extension or Step-Up Period||6
11146169|NCT01490632|12332991|FG009|COMPLETED|Part B: Extension or Step-Up Period||25
11418346|NCT00526331|12616682|FG000|COMPLETED|Overall Study||0
11418347|NCT00526331|12616682|FG000|NOT COMPLETED|Overall Study||55
11418348|NCT00519090|12616688|FG000|STARTED|Overall Study||2
11418349|NCT00519090|12616689|FG001|STARTED|Overall Study||4
11146170|NCT01490632|12332992|FG010|COMPLETED|Part B: Extension or Step-Up Period||22
11146171|NCT01490632|12332993|FG011|COMPLETED|Part B: Extension or Step-Up Period||0
11146172|NCT01490632|12332994|FG012|COMPLETED|Part B: Extension or Step-Up Period||0
11146173|NCT01490632|12332995|FG013|COMPLETED|Part B: Extension or Step-Up Period||0
11146174|NCT01490632|12332996|FG014|COMPLETED|Part B: Extension or Step-Up Period||0
11146175|NCT01490632|12332997|FG015|COMPLETED|Part B: Extension or Step-Up Period||0
11146176|NCT01490632|12332998|FG016|COMPLETED|Part B: Extension or Step-Up Period||0
11146177|NCT01490632|12332999|FG017|COMPLETED|Part B: Extension or Step-Up Period||0
11146178|NCT01490632|12333000|FG018|COMPLETED|Part B: Extension or Step-Up Period||0
11146179|NCT01490632|12333001|FG019|COMPLETED|Part B: Extension or Step-Up Period||0
11146180|NCT01490632|12332982|FG000|NOT COMPLETED|Part B: Extension or Step-Up Period||0
11146181|NCT01490632|12332983|FG001|NOT COMPLETED|Part B: Extension or Step-Up Period||0
11146182|NCT01490632|12332984|FG002|NOT COMPLETED|Part B: Extension or Step-Up Period||0
11146183|NCT01490632|12332985|FG003|NOT COMPLETED|Part B: Extension or Step-Up Period||0
11146184|NCT01490632|12332986|FG004|NOT COMPLETED|Part B: Extension or Step-Up Period||0
11146185|NCT01490632|12332987|FG005|NOT COMPLETED|Part B: Extension or Step-Up Period||4
11202688|NCT01842438|12393114|FG000|STARTED|T2: 6month Follow-up||36
11146186|NCT01490632|12332988|FG006|NOT COMPLETED|Part B: Extension or Step-Up Period||13
11146187|NCT01490632|12332989|FG007|NOT COMPLETED|Part B: Extension or Step-Up Period||6
11146188|NCT01490632|12332990|FG008|NOT COMPLETED|Part B: Extension or Step-Up Period||10
11146189|NCT01490632|12332991|FG009|NOT COMPLETED|Part B: Extension or Step-Up Period||25
11146190|NCT01490632|12332992|FG010|NOT COMPLETED|Part B: Extension or Step-Up Period||21
11146191|NCT01490632|12332993|FG011|NOT COMPLETED|Part B: Extension or Step-Up Period||8
11146192|NCT01490632|12332994|FG012|NOT COMPLETED|Part B: Extension or Step-Up Period||0
11146193|NCT01490632|12332995|FG013|NOT COMPLETED|Part B: Extension or Step-Up Period||0
11146194|NCT01490632|12332996|FG014|NOT COMPLETED|Part B: Extension or Step-Up Period||0
11146195|NCT01490632|12332997|FG015|NOT COMPLETED|Part B: Extension or Step-Up Period||0
11146196|NCT01490632|12332998|FG016|NOT COMPLETED|Part B: Extension or Step-Up Period||0
11146197|NCT01490632|12332999|FG017|NOT COMPLETED|Part B: Extension or Step-Up Period||0
11146198|NCT01490632|12333000|FG018|NOT COMPLETED|Part B: Extension or Step-Up Period||0
11146199|NCT01490632|12333001|FG019|NOT COMPLETED|Part B: Extension or Step-Up Period||0
11146200|NCT01490632|12332982|FG000|STARTED|Part C: Washout or Step-Down Period||0
11146201|NCT01490632|12332983|FG001|STARTED|Part C: Washout or Step-Down Period||0
11146202|NCT01490632|12332984|FG002|STARTED|Part C: Washout or Step-Down Period||0
11146203|NCT01490632|12332985|FG003|STARTED|Part C: Washout or Step-Down Period||0
11146204|NCT01490632|12332986|FG004|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
11146205|NCT01490632|12332987|FG005|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
11146206|NCT01490632|12332988|FG006|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
11146207|NCT01490632|12332989|FG007|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
11146208|NCT01490632|12332990|FG008|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
11146209|NCT01490632|12332991|FG009|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
11146210|NCT01490632|12332992|FG010|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
11146211|NCT01490632|12332993|FG011|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
11146212|NCT01490632|12332994|FG012|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
11146213|NCT01490632|12332995|FG013|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
11146214|NCT01490632|12332996|FG014|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
11146215|NCT01490632|12332997|FG015|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
11146216|NCT01490632|12332998|FG016|STARTED|Part C: Washout or Step-Down Period||0
11146217|NCT01490632|12332999|FG017|STARTED|Part C: Washout or Step-Down Period||0
11146218|NCT01490632|12333000|FG018|STARTED|Part C: Washout or Step-Down Period||0
11146219|NCT01490632|12333001|FG019|STARTED|Part C: Washout or Step-Down Period||0
11146220|NCT01490632|12332982|FG000|COMPLETED|Part C: Washout or Step-Down Period||0
11146221|NCT01490632|12332983|FG001|COMPLETED|Part C: Washout or Step-Down Period||0
11146222|NCT01490632|12332984|FG002|COMPLETED|Part C: Washout or Step-Down Period||0
11146223|NCT01490632|12332985|FG003|COMPLETED|Part C: Washout or Step-Down Period||0
11146224|NCT01490632|12332986|FG004|COMPLETED|Part C: Washout or Step-Down Period||0
11146225|NCT01490632|12332987|FG005|COMPLETED|Part C: Washout or Step-Down Period||0
11146226|NCT01490632|12332988|FG006|COMPLETED|Part C: Washout or Step-Down Period||0
11146227|NCT01490632|12332989|FG007|COMPLETED|Part C: Washout or Step-Down Period||0
11146228|NCT01490632|12332990|FG008|COMPLETED|Part C: Washout or Step-Down Period||0
11146229|NCT01490632|12332991|FG009|COMPLETED|Part C: Washout or Step-Down Period||0
11146230|NCT01490632|12332992|FG010|COMPLETED|Part C: Washout or Step-Down Period||0
11146231|NCT01490632|12332993|FG011|COMPLETED|Part C: Washout or Step-Down Period||0
11146232|NCT01490632|12332994|FG012|COMPLETED|Part C: Washout or Step-Down Period||10
11146233|NCT01490632|12332995|FG013|COMPLETED|Part C: Washout or Step-Down Period||6
11146234|NCT01490632|12332996|FG014|COMPLETED|Part C: Washout or Step-Down Period||37
11146235|NCT01490632|12332997|FG015|COMPLETED|Part C: Washout or Step-Down Period||18
11146236|NCT01490632|12332998|FG016|COMPLETED|Part C: Washout or Step-Down Period||0
11146237|NCT01490632|12332999|FG017|COMPLETED|Part C: Washout or Step-Down Period||0
11146238|NCT01490632|12333000|FG018|COMPLETED|Part C: Washout or Step-Down Period||0
11146239|NCT01490632|12333001|FG019|COMPLETED|Part C: Washout or Step-Down Period||0
11146240|NCT01490632|12332982|FG000|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146241|NCT01490632|12332983|FG001|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146242|NCT01490632|12332984|FG002|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146243|NCT01490632|12332985|FG003|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146244|NCT01490632|12332986|FG004|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146245|NCT01490632|12332987|FG005|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146246|NCT01490632|12332988|FG006|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146247|NCT01490632|12332989|FG007|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146248|NCT01490632|12332990|FG008|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146249|NCT01490632|12332991|FG009|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146250|NCT01490632|12332992|FG010|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146251|NCT01490632|12332993|FG011|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146252|NCT01490632|12332994|FG012|NOT COMPLETED|Part C: Washout or Step-Down Period||5
11146253|NCT01490632|12332995|FG013|NOT COMPLETED|Part C: Washout or Step-Down Period||10
11146254|NCT01490632|12332996|FG014|NOT COMPLETED|Part C: Washout or Step-Down Period||18
11146255|NCT01490632|12332997|FG015|NOT COMPLETED|Part C: Washout or Step-Down Period||37
11146256|NCT01490632|12332998|FG016|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146257|NCT01490632|12332999|FG017|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146258|NCT01490632|12333000|FG018|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146259|NCT01490632|12333001|FG019|NOT COMPLETED|Part C: Washout or Step-Down Period||0
11146260|NCT01490632|12332982|FG000|STARTED|Part D: Re-Treatment Period||0
11146261|NCT01490632|12332983|FG001|STARTED|Part D: Re-Treatment Period||0
11146262|NCT01490632|12332984|FG002|STARTED|Part D: Re-Treatment Period||0
11146263|NCT01490632|12332985|FG003|STARTED|Part D: Re-Treatment Period||0
11146264|NCT01490632|12332986|FG004|STARTED|Part D: Re-Treatment Period||0
11146265|NCT01490632|12332987|FG005|STARTED|Part D: Re-Treatment Period||0
11146266|NCT01490632|12332988|FG006|STARTED|Part D: Re-Treatment Period||0
11146267|NCT01490632|12332989|FG007|STARTED|Part D: Re-Treatment Period||0
11146268|NCT01490632|12332990|FG008|STARTED|Part D: Re-Treatment Period||0
11146269|NCT01490632|12332991|FG009|STARTED|Part D: Re-Treatment Period||0
11146270|NCT01490632|12332992|FG010|STARTED|Part D: Re-Treatment Period||0
11146271|NCT01490632|12332993|FG011|STARTED|Part D: Re-Treatment Period||0
11146272|NCT01490632|12332994|FG012|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
11146273|NCT01490632|12332995|FG013|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
11146274|NCT01490632|12332996|FG014|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
11146275|NCT01490632|12332997|FG015|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
11146276|NCT01490632|12332998|FG016|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
11146277|NCT01490632|12332999|FG017|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
11146278|NCT01490632|12333000|FG018|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
11146279|NCT01490632|12333001|FG019|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
11146280|NCT01490632|12332982|FG000|COMPLETED|Part D: Re-Treatment Period||0
11146281|NCT01490632|12332983|FG001|COMPLETED|Part D: Re-Treatment Period||0
11146282|NCT01490632|12332984|FG002|COMPLETED|Part D: Re-Treatment Period||0
11146283|NCT01490632|12332985|FG003|COMPLETED|Part D: Re-Treatment Period||0
11146284|NCT01490632|12332986|FG004|COMPLETED|Part D: Re-Treatment Period||0
11146285|NCT01490632|12332987|FG005|COMPLETED|Part D: Re-Treatment Period||0
11146286|NCT01490632|12332988|FG006|COMPLETED|Part D: Re-Treatment Period||0
11146287|NCT01490632|12332989|FG007|COMPLETED|Part D: Re-Treatment Period||0
11146288|NCT01490632|12332990|FG008|COMPLETED|Part D: Re-Treatment Period||0
11146289|NCT01490632|12332991|FG009|COMPLETED|Part D: Re-Treatment Period||0
11146290|NCT01490632|12332992|FG010|COMPLETED|Part D: Re-Treatment Period||0
11146291|NCT01490632|12332993|FG011|COMPLETED|Part D: Re-Treatment Period||0
11146292|NCT01490632|12332994|FG012|COMPLETED|Part D: Re-Treatment Period||0
11146293|NCT01490632|12332995|FG013|COMPLETED|Part D: Re-Treatment Period||0
11146294|NCT01490632|12332996|FG014|COMPLETED|Part D: Re-Treatment Period||0
11146295|NCT01490632|12332997|FG015|COMPLETED|Part D: Re-Treatment Period||0
11146296|NCT01490632|12332998|FG016|COMPLETED|Part D: Re-Treatment Period||3
11146297|NCT01490632|12332999|FG017|COMPLETED|Part D: Re-Treatment Period||8
11146298|NCT01490632|12333000|FG018|COMPLETED|Part D: Re-Treatment Period||12
11146299|NCT01490632|12333001|FG019|COMPLETED|Part D: Re-Treatment Period||30
11146300|NCT01490632|12332982|FG000|NOT COMPLETED|Part D: Re-Treatment Period||0
11146301|NCT01490632|12332983|FG001|NOT COMPLETED|Part D: Re-Treatment Period||0
11146302|NCT01490632|12332984|FG002|NOT COMPLETED|Part D: Re-Treatment Period||0
11146303|NCT01490632|12332985|FG003|NOT COMPLETED|Part D: Re-Treatment Period||0
11146304|NCT01490632|12332986|FG004|NOT COMPLETED|Part D: Re-Treatment Period||0
11146305|NCT01490632|12332987|FG005|NOT COMPLETED|Part D: Re-Treatment Period||0
11146306|NCT01490632|12332988|FG006|NOT COMPLETED|Part D: Re-Treatment Period||0
11146307|NCT01490632|12332989|FG007|NOT COMPLETED|Part D: Re-Treatment Period||0
11146308|NCT01490632|12332990|FG008|NOT COMPLETED|Part D: Re-Treatment Period||0
11146309|NCT01490632|12332991|FG009|NOT COMPLETED|Part D: Re-Treatment Period||0
11146310|NCT01490632|12332992|FG010|NOT COMPLETED|Part D: Re-Treatment Period||0
11146311|NCT01490632|12332993|FG011|NOT COMPLETED|Part D: Re-Treatment Period||0
11146312|NCT01490632|12332994|FG012|NOT COMPLETED|Part D: Re-Treatment Period||0
11146313|NCT01490632|12332995|FG013|NOT COMPLETED|Part D: Re-Treatment Period||0
11146314|NCT01490632|12332996|FG014|NOT COMPLETED|Part D: Re-Treatment Period||0
11146315|NCT01490632|12332997|FG015|NOT COMPLETED|Part D: Re-Treatment Period||0
11146316|NCT01490632|12332998|FG016|NOT COMPLETED|Part D: Re-Treatment Period||0
11146317|NCT01490632|12332999|FG017|NOT COMPLETED|Part D: Re-Treatment Period||5
11146318|NCT01490632|12333000|FG018|NOT COMPLETED|Part D: Re-Treatment Period||7
11146319|NCT01490632|12333001|FG019|NOT COMPLETED|Part D: Re-Treatment Period||7
11146320|NCT01490684|12333044|FG000|STARTED|Overall Study||162
11146321|NCT01490684|12333044|FG000|COMPLETED|Overall Study||162
11146322|NCT01490684|12333044|FG000|NOT COMPLETED|Overall Study||0
11146323|NCT01490697|12333050|FG000|STARTED|Overall Study||16
11146324|NCT01490697|12333051|FG001|STARTED|Overall Study||18
11146325|NCT01490697|12333050|FG000|COMPLETED|Overall Study||15
11146326|NCT01490697|12333051|FG001|COMPLETED|Overall Study||16
11146327|NCT01490697|12333050|FG000|NOT COMPLETED|Overall Study||1
11146328|NCT01490697|12333051|FG001|NOT COMPLETED|Overall Study||2
11146329|NCT01490723|12333057|FG000|STARTED|Overall Study||20
11146330|NCT01490723|12333057|FG000|COMPLETED|Overall Study||20
11146331|NCT01490723|12333057|FG000|NOT COMPLETED|Overall Study||0
11146332|NCT01490788|12333061|FG000|STARTED|Overall Study||5
11146333|NCT01490788|12333062|FG001|STARTED|Overall Study||5
11146334|NCT01490788|12333063|FG002|STARTED|Overall Study||5
11146335|NCT01490788|12333064|FG003|STARTED|Overall Study||5
11146336|NCT01490788|12333065|FG004|STARTED|Overall Study||5
11146337|NCT01490788|12333066|FG005|STARTED|Overall Study||5
11146338|NCT01490788|12333061|FG000|COMPLETED|Overall Study||4
11146339|NCT01490788|12333062|FG001|COMPLETED|Overall Study||5
11146340|NCT01490788|12333063|FG002|COMPLETED|Overall Study||5
11146341|NCT01490788|12333064|FG003|COMPLETED|Overall Study||5
11146342|NCT01490788|12333065|FG004|COMPLETED|Overall Study||5
11146343|NCT01490788|12333066|FG005|COMPLETED|Overall Study||5
11146344|NCT01490788|12333061|FG000|NOT COMPLETED|Overall Study||1
11146345|NCT01490788|12333062|FG001|NOT COMPLETED|Overall Study||0
11146346|NCT01490788|12333063|FG002|NOT COMPLETED|Overall Study||0
11146347|NCT01490788|12333064|FG003|NOT COMPLETED|Overall Study||0
11146348|NCT01490788|12333065|FG004|NOT COMPLETED|Overall Study||0
11146349|NCT01490788|12333066|FG005|NOT COMPLETED|Overall Study||0
11146350|NCT01490814|12333076|FG000|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
11146351|NCT01490814|12333077|FG001|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
11146352|NCT01490814|12333076|FG000|COMPLETED|Overall Study|374 received ablation|374
11146353|NCT01490814|12333077|FG001|COMPLETED|Overall Study|376 received ablation|376
11146354|NCT01490814|12333076|FG000|NOT COMPLETED|Overall Study||4
11146355|NCT01490814|12333077|FG001|NOT COMPLETED|Overall Study||8
11146356|NCT01490840|12333085|FG000|STARTED|Phase 1||94
11146357|NCT01490840|12333086|FG001|STARTED|Phase 1||84
11146358|NCT01490840|12333085|FG000|Modified Full Analysis Set|Phase 1||56
11146359|NCT01490840|12333086|FG001|Modified Full Analysis Set|Phase 1||83
11146360|NCT01490840|12333085|FG000|COMPLETED|Phase 1||84
11146361|NCT01490840|12333086|FG001|COMPLETED|Phase 1||78
11146362|NCT01490840|12333085|FG000|NOT COMPLETED|Phase 1||10
11146363|NCT01490840|12333086|FG001|NOT COMPLETED|Phase 1||6
11146364|NCT01490840|12333085|FG000|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
11146365|NCT01490840|12333086|FG001|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
11146366|NCT01490840|12333085|FG000|COMPLETED|Phase 2||75
11146367|NCT01490840|12333086|FG001|COMPLETED|Phase 2||68
11146368|NCT01490840|12333085|FG000|NOT COMPLETED|Phase 2||6
11146369|NCT01490840|12333086|FG001|NOT COMPLETED|Phase 2||6
11146370|NCT01490866|12333092|FG000|STARTED|FOLFOX/Bevacizumab Treatment||70
11146371|NCT01490866|12333092|FG000|COMPLETED|FOLFOX/Bevacizumab Treatment||49
11146372|NCT01490866|12333092|FG000|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
11146373|NCT01490866|12333092|FG000|STARTED|Axitinib Maintenance Therapy||49
11146374|NCT01490866|12333092|FG000|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
11146375|NCT01490866|12333092|FG000|NOT COMPLETED|Axitinib Maintenance Therapy||49
11146376|NCT01490892|12333099|FG000|STARTED|Overall Study||219
11146377|NCT01490892|12333099|FG000|COMPLETED|Overall Study||219
11146378|NCT01490892|12333099|FG000|NOT COMPLETED|Overall Study||0
11146379|NCT01490918|12333106|FG000|STARTED|Overall Study||65
11146380|NCT01490918|12333107|FG001|STARTED|Overall Study||66
11146381|NCT01490918|12333108|FG002|STARTED|Overall Study||34
11146382|NCT01490918|12333106|FG000|COMPLETED|Overall Study||52
11146383|NCT01490918|12333107|FG001|COMPLETED|Overall Study||52
11146384|NCT01490918|12333108|FG002|COMPLETED|Overall Study||22
11146385|NCT01490918|12333106|FG000|NOT COMPLETED|Overall Study||13
11146386|NCT01490918|12333107|FG001|NOT COMPLETED|Overall Study||14
11146387|NCT01490918|12333108|FG002|NOT COMPLETED|Overall Study||12
11146388|NCT01490931|12333120|FG000|STARTED|Overall Study||25
11146389|NCT01490931|12333120|FG000|COMPLETED|Overall Study||25
11146390|NCT01490931|12333120|FG000|NOT COMPLETED|Overall Study||0
11146391|NCT01491022|12333126|FG000|STARTED|Intervention 1||10
11146392|NCT01491022|12333127|FG001|STARTED|Intervention 1||12
11146393|NCT01491022|12333126|FG000|COMPLETED|Intervention 1||9
11146394|NCT01491022|12333127|FG001|COMPLETED|Intervention 1||11
11146395|NCT01491022|12333126|FG000|NOT COMPLETED|Intervention 1||1
11146396|NCT01491022|12333127|FG001|NOT COMPLETED|Intervention 1||1
11146397|NCT01491022|12333126|FG000|STARTED|2 Week Washout||9
11146398|NCT01491022|12333127|FG001|STARTED|2 Week Washout||11
11146399|NCT01491022|12333126|FG000|COMPLETED|2 Week Washout||9
11146400|NCT01491022|12333127|FG001|COMPLETED|2 Week Washout||11
11146401|NCT01491022|12333126|FG000|NOT COMPLETED|2 Week Washout||0
11146402|NCT01491022|12333127|FG001|NOT COMPLETED|2 Week Washout||0
11146403|NCT01491022|12333126|FG000|STARTED|Intervention 2||9
11146404|NCT01491022|12333127|FG001|STARTED|Intervention 2||11
11146405|NCT01491022|12333126|FG000|COMPLETED|Intervention 2||8
11146406|NCT01491022|12333127|FG001|COMPLETED|Intervention 2||11
11146407|NCT01491022|12333126|FG000|NOT COMPLETED|Intervention 2||1
11146408|NCT01491022|12333127|FG001|NOT COMPLETED|Intervention 2||0
11146409|NCT01491035|12333145|FG000|STARTED|Overall Study||6
11146410|NCT01491035|12333146|FG001|STARTED|Overall Study||6
11146411|NCT01491035|12333147|FG002|STARTED|Overall Study||6
11146412|NCT01491035|12333148|FG003|STARTED|Overall Study||6
11146413|NCT01491035|12333149|FG004|STARTED|Overall Study||6
11146414|NCT01491035|12333150|FG005|STARTED|Overall Study||6
11146415|NCT01491035|12333151|FG006|STARTED|Overall Study||6
11146416|NCT01491035|12333152|FG007|STARTED|Overall Study||6
11146417|NCT01491035|12333145|FG000|COMPLETED|Overall Study||6
11146418|NCT01491035|12333146|FG001|COMPLETED|Overall Study||6
11146419|NCT01491035|12333147|FG002|COMPLETED|Overall Study||6
11146420|NCT01491035|12333148|FG003|COMPLETED|Overall Study||6
11146421|NCT01491035|12333149|FG004|COMPLETED|Overall Study||5
11146422|NCT01491035|12333150|FG005|COMPLETED|Overall Study||6
11146423|NCT01491035|12333151|FG006|COMPLETED|Overall Study||6
11146424|NCT01491035|12333152|FG007|COMPLETED|Overall Study||6
11146425|NCT01491035|12333145|FG000|NOT COMPLETED|Overall Study||0
11146426|NCT01491035|12333146|FG001|NOT COMPLETED|Overall Study||0
11146427|NCT01491035|12333147|FG002|NOT COMPLETED|Overall Study||0
11146428|NCT01491035|12333148|FG003|NOT COMPLETED|Overall Study||0
11146429|NCT01491035|12333149|FG004|NOT COMPLETED|Overall Study||1
11146430|NCT01491035|12333150|FG005|NOT COMPLETED|Overall Study||0
11146431|NCT01491035|12333151|FG006|NOT COMPLETED|Overall Study||0
11146432|NCT01491035|12333152|FG007|NOT COMPLETED|Overall Study||0
11146433|NCT01491113|12333175|FG000|STARTED|Overall Study||6
11146434|NCT01491113|12333176|FG001|STARTED|Overall Study||6
11146435|NCT01491113|12333177|FG002|STARTED|Overall Study||6
11146436|NCT01491113|12333178|FG003|STARTED|Overall Study||6
11146437|NCT01491113|12333179|FG004|STARTED|Overall Study||6
11146438|NCT01491113|12333175|FG000|COMPLETED|Overall Study||6
11146439|NCT01491113|12333176|FG001|COMPLETED|Overall Study||6
11146440|NCT01491113|12333177|FG002|COMPLETED|Overall Study||6
11146441|NCT01491113|12333178|FG003|COMPLETED|Overall Study||6
11146442|NCT01491113|12333179|FG004|COMPLETED|Overall Study||6
11146443|NCT01491113|12333175|FG000|NOT COMPLETED|Overall Study||0
11146444|NCT01491113|12333176|FG001|NOT COMPLETED|Overall Study||0
11146445|NCT01491113|12333177|FG002|NOT COMPLETED|Overall Study||0
11146446|NCT01491113|12333178|FG003|NOT COMPLETED|Overall Study||0
11146447|NCT01491113|12333179|FG004|NOT COMPLETED|Overall Study||0
11146448|NCT01491178|12333193|FG000|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
11146449|NCT01491178|12333193|FG000|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
11146450|NCT01491178|12333193|FG000|NOT COMPLETED|Overall Study||2794
11146451|NCT01491490|12333199|FG000|STARTED|Overall Study||1
11146452|NCT01491490|12333200|FG001|STARTED|Overall Study||1
11146453|NCT01491490|12333199|FG000|COMPLETED|Overall Study||1
11146454|NCT01491490|12333200|FG001|COMPLETED|Overall Study||1
11146455|NCT01491490|12333199|FG000|NOT COMPLETED|Overall Study||0
11146456|NCT01491490|12333200|FG001|NOT COMPLETED|Overall Study||0
11146457|NCT01491607|12333210|FG000|STARTED|Overall Study||200
11146458|NCT01491607|12333210|FG000|COMPLETED|Overall Study||190
11146459|NCT01491607|12333210|FG000|NOT COMPLETED|Overall Study||10
11146460|NCT01491633|12333276|FG000|STARTED|Overall Study||5
11146461|NCT01491633|12333276|FG000|COMPLETED|Overall Study||0
11146462|NCT01491633|12333276|FG000|NOT COMPLETED|Overall Study||5
11146463|NCT01491672|12333283|FG000|STARTED|Overall Study||58
11146464|NCT01491672|12333284|FG001|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
11146465|NCT01491672|12333285|FG002|STARTED|Overall Study||14
11146466|NCT01491672|12333283|FG000|Safety Set|Overall Study||58
11146467|NCT01491672|12333284|FG001|Safety Set|Overall Study||61
11146468|NCT01491672|12333285|FG002|Safety Set|Overall Study||14
11146469|NCT01491672|12333283|FG000|COMPLETED|Overall Study||2
11146470|NCT01491672|12333284|FG001|COMPLETED|Overall Study||2
11146471|NCT01491672|12333285|FG002|COMPLETED|Overall Study||3
11146472|NCT01491672|12333283|FG000|NOT COMPLETED|Overall Study||56
11146473|NCT01491672|12333284|FG001|NOT COMPLETED|Overall Study||60
11146474|NCT01491672|12333285|FG002|NOT COMPLETED|Overall Study||11
11146475|NCT01491737|12333297|FG000|STARTED|Overall Study||129
11146476|NCT01491737|12333298|FG001|STARTED|Overall Study||129
11146477|NCT01491737|12333297|FG000|Received at Least One Dose of Study Drug|Overall Study||127
11146478|NCT01491737|12333298|FG001|Received at Least One Dose of Study Drug|Overall Study||124
11146479|NCT01491737|12333297|FG000|Entered Follow-Up (Post-Treatment)|Overall Study||120
11146480|NCT01491737|12333298|FG001|Entered Follow-Up (Post-Treatment)|Overall Study||116
11146481|NCT01491737|12333297|FG000|COMPLETED|Overall Study||0
11146482|NCT01491737|12333298|FG001|COMPLETED|Overall Study||0
11146483|NCT01491737|12333297|FG000|NOT COMPLETED|Overall Study||129
11146484|NCT01491737|12333298|FG001|NOT COMPLETED|Overall Study||129
11146485|NCT01491802|12333304|FG000|STARTED|Overall Study||9
11146486|NCT01491802|12333305|FG001|STARTED|Overall Study||8
11146487|NCT01491802|12333304|FG000|COMPLETED|Overall Study||8
11146488|NCT01491802|12333305|FG001|COMPLETED|Overall Study||6
11146489|NCT01491802|12333304|FG000|NOT COMPLETED|Overall Study||1
11146490|NCT01491802|12333305|FG001|NOT COMPLETED|Overall Study||2
11146491|NCT01491841|12333312|FG000|STARTED|Overall Study||33
11146492|NCT01491841|12333312|FG000|COMPLETED|Overall Study||22
11146493|NCT01491841|12333312|FG000|NOT COMPLETED|Overall Study||11
11146494|NCT01491854|12333324|FG000|STARTED|Overall Study||130
11146495|NCT01491854|12333324|FG000|COMPLETED|Overall Study||0
11146496|NCT01491854|12333324|FG000|NOT COMPLETED|Overall Study||130
11146497|NCT01491919|12333331|FG000|STARTED|Overall Study||13
11146498|NCT01491919|12333332|FG001|STARTED|Overall Study||10
11146499|NCT01491919|12333333|FG002|STARTED|Overall Study||3
11146500|NCT01491919|12333331|FG000|COMPLETED|Overall Study||12
11146501|NCT01491919|12333332|FG001|COMPLETED|Overall Study||8
11146502|NCT01491919|12333333|FG002|COMPLETED|Overall Study||2
11146503|NCT01491919|12333331|FG000|NOT COMPLETED|Overall Study||1
11146504|NCT01491919|12333332|FG001|NOT COMPLETED|Overall Study||2
11146505|NCT01491919|12333333|FG002|NOT COMPLETED|Overall Study||1
11146506|NCT01491945|12333343|FG000|STARTED|Overall Study||76
11146507|NCT01491945|12333343|FG000|COMPLETED|Overall Study||25
11146508|NCT01491945|12333343|FG000|NOT COMPLETED|Overall Study||51
11146509|NCT01491958|12333350|FG000|STARTED|Overall Study||40
11146510|NCT01491958|12333351|FG001|STARTED|Overall Study||40
11146511|NCT01491958|12333350|FG000|COMPLETED|Overall Study||40
11146512|NCT01491958|12333351|FG001|COMPLETED|Overall Study||40
11146513|NCT01491958|12333350|FG000|NOT COMPLETED|Overall Study||0
11146514|NCT01491958|12333351|FG001|NOT COMPLETED|Overall Study||0
11146515|NCT01491984|12333358|FG000|STARTED|Overall Study||49
11146516|NCT01491984|12333359|FG001|STARTED|Overall Study||45
11146517|NCT01491984|12333358|FG000|COMPLETED|Overall Study||47
11146518|NCT01491984|12333359|FG001|COMPLETED|Overall Study||44
11146519|NCT01491984|12333358|FG000|NOT COMPLETED|Overall Study||2
11146520|NCT01491984|12333359|FG001|NOT COMPLETED|Overall Study||1
11146521|NCT01492088|12333368|FG000|STARTED|Overall Study||3
11146522|NCT01492088|12333369|FG001|STARTED|Overall Study||16
11146523|NCT01492088|12333370|FG002|STARTED|Overall Study||17
11146524|NCT01492088|12333368|FG000|COMPLETED|Overall Study||0
11146525|NCT01492088|12333369|FG001|COMPLETED|Overall Study||2
11146526|NCT01492088|12333370|FG002|COMPLETED|Overall Study||3
11146527|NCT01492088|12333368|FG000|NOT COMPLETED|Overall Study||3
11146528|NCT01492088|12333369|FG001|NOT COMPLETED|Overall Study||14
11146529|NCT01492088|12333370|FG002|NOT COMPLETED|Overall Study||14
11146530|NCT01492101|12333383|FG000|STARTED|Overall Study||429
11146531|NCT01492101|12333384|FG001|STARTED|Overall Study||423
11146532|NCT01492101|12333383|FG000|COMPLETED|Overall Study||92
11146533|NCT01492101|12333384|FG001|COMPLETED|Overall Study||81
11146534|NCT01492101|12333383|FG000|NOT COMPLETED|Overall Study||337
11146535|NCT01492101|12333384|FG001|NOT COMPLETED|Overall Study||342
11202689|NCT01842438|12393115|FG001|STARTED|T2: 6month Follow-up||36
11202690|NCT01842438|12393114|FG000|COMPLETED|T2: 6month Follow-up||32
11202691|NCT01842438|12393115|FG001|COMPLETED|T2: 6month Follow-up||32
11202692|NCT01842438|12393114|FG000|NOT COMPLETED|T2: 6month Follow-up||4
11202693|NCT01842438|12393115|FG001|NOT COMPLETED|T2: 6month Follow-up||4
11202694|NCT01842464|12393125|FG000|STARTED|Overall Study||44
11202695|NCT01842464|12393125|FG000|COMPLETED|Overall Study||44
11202696|NCT01842464|12393125|FG000|NOT COMPLETED|Overall Study||0
11202697|NCT01842581|12393132|FG000|STARTED|Overall Study||113
11202698|NCT01842581|12393133|FG001|STARTED|Overall Study||109
11202699|NCT01842581|12393132|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113
11202700|NCT01842581|12393133|FG001|Received at Least 1 Dose of Study Drug|Overall Study||108
11202701|NCT01842581|12393132|FG000|COMPLETED|Overall Study||69
11202702|NCT01842581|12393133|FG001|COMPLETED|Overall Study||79
11202703|NCT01842581|12393132|FG000|NOT COMPLETED|Overall Study||44
11202704|NCT01842581|12393133|FG001|NOT COMPLETED|Overall Study||30
11202705|NCT01842594|12393139|FG000|STARTED|Overall Study||13
11202706|NCT01842594|12393139|FG000|COMPLETED|Overall Study||10
11202707|NCT01842594|12393139|FG000|NOT COMPLETED|Overall Study||3
11202708|NCT01842607|12393143|FG000|STARTED|Overall Study||651
11202709|NCT01842607|12393143|FG000|COMPLETED|Overall Study||585
11202710|NCT01842607|12393143|FG000|NOT COMPLETED|Overall Study||66
11202711|NCT01842620|12393147|FG000|STARTED|Period 1||13
11202712|NCT01842620|12393148|FG001|STARTED|Period 1||12
11202713|NCT01842620|12393147|FG000|COMPLETED|Period 1||12
11202714|NCT01842620|12393148|FG001|COMPLETED|Period 1||12
11202715|NCT01842620|12393147|FG000|NOT COMPLETED|Period 1||1
11202716|NCT01842620|12393148|FG001|NOT COMPLETED|Period 1||0
11202717|NCT01842620|12393147|FG000|STARTED|Washout Period||12
11202718|NCT01842620|12393148|FG001|STARTED|Washout Period||12
11202719|NCT01842620|12393147|FG000|COMPLETED|Washout Period||12
11202720|NCT01842620|12393148|FG001|COMPLETED|Washout Period||12
11202721|NCT01842620|12393147|FG000|NOT COMPLETED|Washout Period||0
11202722|NCT01842620|12393148|FG001|NOT COMPLETED|Washout Period||0
11202723|NCT01842620|12393147|FG000|STARTED|Period 2||12
11202724|NCT01842620|12393148|FG001|STARTED|Period 2||12
11202725|NCT01842620|12393147|FG000|COMPLETED|Period 2||12
11202726|NCT01842620|12393148|FG001|COMPLETED|Period 2||12
11202727|NCT01842620|12393147|FG000|NOT COMPLETED|Period 2||0
11202728|NCT01842620|12393148|FG001|NOT COMPLETED|Period 2||0
11202729|NCT01842633|12393157|FG000|STARTED|Overall Study||65
11202730|NCT01842633|12393158|FG001|STARTED|Overall Study||66
11202731|NCT01842633|12393159|FG002|STARTED|Overall Study||34
11202732|NCT01842633|12393157|FG000|COMPLETED|Overall Study||62
11202733|NCT01842633|12393158|FG001|COMPLETED|Overall Study||64
11202734|NCT01842633|12393159|FG002|COMPLETED|Overall Study||34
11202735|NCT01842633|12393157|FG000|NOT COMPLETED|Overall Study||3
11202736|NCT01842633|12393158|FG001|NOT COMPLETED|Overall Study||2
11202737|NCT01842633|12393159|FG002|NOT COMPLETED|Overall Study||0
11202738|NCT01842646|12393169|FG000|STARTED|Overall Study||35
11202739|NCT01842646|12393169|FG000|COMPLETED|Overall Study||35
11202740|NCT01842646|12393169|FG000|NOT COMPLETED|Overall Study||0
11202741|NCT01842789|12393175|FG000|STARTED|Overall Study||10
11202742|NCT01842789|12393176|FG001|STARTED|Overall Study||8
11202743|NCT01842789|12393175|FG000|COMPLETED|Overall Study||10
11202744|NCT01842789|12393176|FG001|COMPLETED|Overall Study||8
11202745|NCT01842789|12393175|FG000|NOT COMPLETED|Overall Study||0
11202746|NCT01842789|12393176|FG001|NOT COMPLETED|Overall Study||0
11202747|NCT01842815|12393183|FG000|STARTED|Overall Study||20
11202748|NCT01842815|12393183|FG000|COMPLETED|Overall Study||16
11202749|NCT01842815|12393183|FG000|NOT COMPLETED|Overall Study||4
11202750|NCT01842841|12393188|FG000|STARTED|Overall Study||5
11202751|NCT01842841|12393188|FG000|COMPLETED|Overall Study||5
11202752|NCT01842841|12393188|FG000|NOT COMPLETED|Overall Study||0
11146536|NCT01492309|12333392|FG000|STARTED|Overall Study||11
11146537|NCT01492309|12333393|FG001|STARTED|Overall Study||11
11146538|NCT01492309|12333392|FG000|COMPLETED|Overall Study||11
11146539|NCT01492309|12333393|FG001|COMPLETED|Overall Study||11
11146540|NCT01492309|12333392|FG000|NOT COMPLETED|Overall Study||0
11146541|NCT01492309|12333393|FG001|NOT COMPLETED|Overall Study||0
11146542|NCT01492400|12333401|FG000|STARTED|Overall Study||181
11146543|NCT01492400|12333402|FG001|STARTED|Overall Study||182
11146544|NCT01492400|12333401|FG000|COMPLETED|Overall Study||165
11146545|NCT01492400|12333402|FG001|COMPLETED|Overall Study||166
11146546|NCT01492400|12333401|FG000|NOT COMPLETED|Overall Study||16
11146547|NCT01492400|12333402|FG001|NOT COMPLETED|Overall Study||16
11146548|NCT01492426|12333410|FG000|STARTED|Treatment||402
11146549|NCT01492426|12333411|FG001|STARTED|Treatment||200
11146550|NCT01492426|12333410|FG000|COMPLETED|Treatment||319
11146551|NCT01492426|12333411|FG001|COMPLETED|Treatment||160
11146552|NCT01492426|12333410|FG000|NOT COMPLETED|Treatment||83
11146553|NCT01492426|12333411|FG001|NOT COMPLETED|Treatment||40
11146554|NCT01492426|12333410|FG000|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
11146555|NCT01492426|12333411|FG001|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
11146556|NCT01492426|12333410|FG000|COMPLETED|Follow-Up||359
11146557|NCT01492426|12333411|FG001|COMPLETED|Follow-Up||181
11146558|NCT01492426|12333410|FG000|NOT COMPLETED|Follow-Up||25
11146559|NCT01492426|12333411|FG001|NOT COMPLETED|Follow-Up||10
11146560|NCT01492439|12333423|FG000|STARTED|Overall Study||19
11146561|NCT01492439|12333424|FG001|STARTED|Overall Study||18
11146562|NCT01492439|12333423|FG000|Post-intervention|Overall Study||18
11146563|NCT01492439|12333424|FG001|Post-intervention|Overall Study||13
11146564|NCT01492439|12333423|FG000|COMPLETED|Overall Study||15
11146565|NCT01492439|12333424|FG001|COMPLETED|Overall Study||9
11146566|NCT01492439|12333423|FG000|NOT COMPLETED|Overall Study||4
11146567|NCT01492439|12333424|FG001|NOT COMPLETED|Overall Study||9
11146568|NCT01492582|12333432|FG000|STARTED|Overall Study|Consented to the vaccine arm (265 quadrivalent vaccine; 188 nonavalent vaccine)|453
11146569|NCT01492582|12333433|FG001|STARTED|Overall Study|Consented to the survey arm of the study|1046
11418350|NCT00519090|12616688|FG000|COMPLETED|Overall Study||2
11418351|NCT00519090|12616689|FG001|COMPLETED|Overall Study||4
11418352|NCT00519090|12616688|FG000|NOT COMPLETED|Overall Study||0
11146570|NCT01492582|12333432|FG000|Received First Quadrivalent Vaccine Dose|Overall Study||254
11146571|NCT01492582|12333433|FG001|Received First Quadrivalent Vaccine Dose|Overall Study|Does not apply|0
11146572|NCT01492582|12333432|FG000|Received First Nonavalent Vaccine Dose|Overall Study||182
11146573|NCT01492582|12333433|FG001|Received First Nonavalent Vaccine Dose|Overall Study||0
11146574|NCT01492582|12333432|FG000|COMPLETED|Overall Study|Received 3 vaccine doses and completed Month 7 blood draw (224 quadrivalent; 160 nonavalent)|384
11146575|NCT01492582|12333433|FG001|COMPLETED|Overall Study|Returned evaluable survey|982
11146576|NCT01492582|12333432|FG000|NOT COMPLETED|Overall Study||69
11146577|NCT01492582|12333433|FG001|NOT COMPLETED|Overall Study||64
11146578|NCT01492673|12333456|FG000|STARTED|Overall Study||9
11146579|NCT01492673|12333456|FG000|COMPLETED|Overall Study||9
11146580|NCT01492673|12333456|FG000|NOT COMPLETED|Overall Study||0
11146581|NCT01492686|12333462|FG000|STARTED|Double-blind Phase||69
11418353|NCT00519090|12616689|FG001|NOT COMPLETED|Overall Study||0
11418354|NCT00524394|12616695|FG000|STARTED|Overall Study||2
11146582|NCT01492686|12333463|FG001|STARTED|Double-blind Phase||68
11146583|NCT01492686|12333462|FG000|COMPLETED|Double-blind Phase||67
11146584|NCT01492686|12333463|FG001|COMPLETED|Double-blind Phase||60
11146585|NCT01492686|12333462|FG000|NOT COMPLETED|Double-blind Phase||2
11146586|NCT01492686|12333463|FG001|NOT COMPLETED|Double-blind Phase||8
11146587|NCT01492686|12333462|FG000|STARTED|Open-label Phase||65
11146588|NCT01492686|12333463|FG001|STARTED|Open-label Phase||58
11146589|NCT01492686|12333462|FG000|COMPLETED|Open-label Phase||53
11146590|NCT01492686|12333463|FG001|COMPLETED|Open-label Phase||40
11146591|NCT01492686|12333462|FG000|NOT COMPLETED|Open-label Phase||12
11146592|NCT01492686|12333463|FG001|NOT COMPLETED|Open-label Phase||18
11146593|NCT01493024|12333475|FG000|STARTED|Overall Study||30
11146594|NCT01493024|12333476|FG001|STARTED|Overall Study||12
11146595|NCT01493024|12333477|FG002|STARTED|Overall Study||24
11146596|NCT01493024|12333478|FG003|STARTED|Overall Study||24
11146597|NCT01493024|12333475|FG000|COMPLETED|Overall Study||30
11146598|NCT01493024|12333476|FG001|COMPLETED|Overall Study||12
11146599|NCT01493024|12333477|FG002|COMPLETED|Overall Study||24
11146600|NCT01493024|12333478|FG003|COMPLETED|Overall Study||24
11146601|NCT01493024|12333475|FG000|NOT COMPLETED|Overall Study||0
11146602|NCT01493024|12333476|FG001|NOT COMPLETED|Overall Study||0
11146603|NCT01493024|12333477|FG002|NOT COMPLETED|Overall Study||0
11146604|NCT01493024|12333478|FG003|NOT COMPLETED|Overall Study||0
11146605|NCT01493089|12333491|FG000|STARTED|Overall Study||122
11146606|NCT01493089|12333492|FG001|STARTED|Overall Study||117
11146607|NCT01493089|12333491|FG000|COMPLETED|Overall Study||119
11146608|NCT01493089|12333492|FG001|COMPLETED|Overall Study||114
11146609|NCT01493089|12333491|FG000|NOT COMPLETED|Overall Study||3
11146610|NCT01493089|12333492|FG001|NOT COMPLETED|Overall Study||3
11146611|NCT01493167|12333500|FG000|STARTED|Overall Study||97
11146612|NCT01493167|12333500|FG000|COMPLETED|Overall Study||97
11146613|NCT01493167|12333500|FG000|NOT COMPLETED|Overall Study||0
11146614|NCT01493180|12333506|FG000|STARTED|Overall Study||51
11146615|NCT01493180|12333507|FG001|STARTED|Overall Study||51
11146616|NCT01493180|12333506|FG000|COMPLETED|Overall Study||48
11146617|NCT01493180|12333507|FG001|COMPLETED|Overall Study||49
11146618|NCT01493180|12333506|FG000|NOT COMPLETED|Overall Study||3
11146619|NCT01493180|12333507|FG001|NOT COMPLETED|Overall Study||2
11146620|NCT01493284|12333513|FG000|STARTED|Overall Study||222
11146621|NCT01493284|12333513|FG000|COMPLETED|Overall Study||161
11146622|NCT01493284|12333513|FG000|NOT COMPLETED|Overall Study||61
11146623|NCT01493414|12333517|FG000|STARTED|Overall Study||2233
11146624|NCT01493414|12333517|FG000|COMPLETED|Overall Study||1283
11146625|NCT01493414|12333517|FG000|NOT COMPLETED|Overall Study||950
11146626|NCT01493427|12333525|FG000|STARTED|Overall Study||199
11146627|NCT01493427|12333525|FG000|COMPLETED|Overall Study||179
11146628|NCT01493427|12333525|FG000|NOT COMPLETED|Overall Study||20
11146629|NCT01493531|12333532|FG000|STARTED|Overall Study||204
11146630|NCT01493531|12333533|FG001|STARTED|Overall Study||200
11146631|NCT01493531|12333534|FG002|STARTED|Overall Study||206
11146632|NCT01493531|12333532|FG000|COMPLETED|Overall Study||163
11146633|NCT01493531|12333533|FG001|COMPLETED|Overall Study||150
11146634|NCT01493531|12333534|FG002|COMPLETED|Overall Study||158
11146635|NCT01493531|12333532|FG000|NOT COMPLETED|Overall Study||41
11146636|NCT01493531|12333533|FG001|NOT COMPLETED|Overall Study||50
11146637|NCT01493531|12333534|FG002|NOT COMPLETED|Overall Study||48
11146638|NCT01493557|12333545|FG000|STARTED|Not Randomized to Management Strategies||0
11146639|NCT01493557|12333546|FG001|STARTED|Not Randomized to Management Strategies||0
11146640|NCT01493557|12333547|FG002|STARTED|Not Randomized to Management Strategies||950
11146641|NCT01493557|12333545|FG000|Without Experiencing GIS|Not Randomized to Management Strategies||0
11146642|NCT01493557|12333546|FG001|Without Experiencing GIS|Not Randomized to Management Strategies||0
11146643|NCT01493557|12333547|FG002|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
11146644|NCT01493557|12333545|FG000|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
11146645|NCT01493557|12333546|FG001|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
11146646|NCT01493557|12333547|FG002|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
11146647|NCT01493557|12333545|FG000|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
11146648|NCT01493557|12333546|FG001|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
11146649|NCT01493557|12333547|FG002|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
11146650|NCT01493557|12333545|FG000|COMPLETED|Not Randomized to Management Strategies||0
11146651|NCT01493557|12333546|FG001|COMPLETED|Not Randomized to Management Strategies||0
11146652|NCT01493557|12333547|FG002|COMPLETED|Not Randomized to Management Strategies||816
11146653|NCT01493557|12333545|FG000|NOT COMPLETED|Not Randomized to Management Strategies||0
11146654|NCT01493557|12333546|FG001|NOT COMPLETED|Not Randomized to Management Strategies||0
11146655|NCT01493557|12333547|FG002|NOT COMPLETED|Not Randomized to Management Strategies||134
11146656|NCT01493557|12333545|FG000|STARTED|Randomized to Management Strategies||59
11146657|NCT01493557|12333546|FG001|STARTED|Randomized to Management Strategies||58
11146658|NCT01493557|12333547|FG002|STARTED|Randomized to Management Strategies||0
11146659|NCT01493557|12333545|FG000|COMPLETED|Randomized to Management Strategies||44
11146660|NCT01493557|12333546|FG001|COMPLETED|Randomized to Management Strategies||47
11146661|NCT01493557|12333547|FG002|COMPLETED|Randomized to Management Strategies||0
11146662|NCT01493557|12333545|FG000|NOT COMPLETED|Randomized to Management Strategies||15
11146663|NCT01493557|12333546|FG001|NOT COMPLETED|Randomized to Management Strategies||11
11146664|NCT01493557|12333547|FG002|NOT COMPLETED|Randomized to Management Strategies||0
11146665|NCT01493557|12333545|FG000|STARTED|Adding the Second Strategy||14
11146666|NCT01493557|12333546|FG001|STARTED|Adding the Second Strategy||15
11146667|NCT01493557|12333547|FG002|STARTED|Adding the Second Strategy||0
11146668|NCT01493557|12333545|FG000|COMPLETED|Adding the Second Strategy||12
11146669|NCT01493557|12333546|FG001|COMPLETED|Adding the Second Strategy||11
11146670|NCT01493557|12333547|FG002|COMPLETED|Adding the Second Strategy||0
11146671|NCT01493557|12333545|FG000|NOT COMPLETED|Adding the Second Strategy||2
11146672|NCT01493557|12333546|FG001|NOT COMPLETED|Adding the Second Strategy||4
11146673|NCT01493557|12333547|FG002|NOT COMPLETED|Adding the Second Strategy||0
11146674|NCT01493596|12333561|FG000|STARTED|Overall Study||8
11146675|NCT01493596|12333562|FG001|STARTED|Overall Study||8
11146676|NCT01493596|12333563|FG002|STARTED|Overall Study|Repeat of dose cohort because of incidences of hyperkalemia observed in cohort 2(a).|7
11146677|NCT01493596|12333564|FG003|STARTED|Overall Study||8
11146678|NCT01493596|12333565|FG004|STARTED|Overall Study||8
11146679|NCT01493596|12333566|FG005|STARTED|Overall Study||8
11146680|NCT01493596|12333567|FG006|STARTED|Overall Study||8
11146681|NCT01493596|12333561|FG000|COMPLETED|Overall Study||8
11146682|NCT01493596|12333562|FG001|COMPLETED|Overall Study||8
11146683|NCT01493596|12333563|FG002|COMPLETED|Overall Study||7
11146684|NCT01493596|12333564|FG003|COMPLETED|Overall Study||8
11146685|NCT01493596|12333565|FG004|COMPLETED|Overall Study||8
11146686|NCT01493596|12333566|FG005|COMPLETED|Overall Study||8
11146687|NCT01493596|12333567|FG006|COMPLETED|Overall Study||8
11146688|NCT01493596|12333561|FG000|NOT COMPLETED|Overall Study||0
11146689|NCT01493596|12333562|FG001|NOT COMPLETED|Overall Study||0
11146690|NCT01493596|12333563|FG002|NOT COMPLETED|Overall Study||0
11146691|NCT01493596|12333564|FG003|NOT COMPLETED|Overall Study||0
11146692|NCT01493596|12333565|FG004|NOT COMPLETED|Overall Study||0
11146693|NCT01493596|12333566|FG005|NOT COMPLETED|Overall Study||0
11146694|NCT01493596|12333567|FG006|NOT COMPLETED|Overall Study||0
11146695|NCT01493687|12333583|FG000|STARTED|Part A Vehicle Control (12 Weeks)||451
11146696|NCT01493687|12333584|FG001|STARTED|Part A Vehicle Control (12 Weeks)||232
11202753|NCT01842906|12393194|FG000|STARTED|Overall Study||115
11146697|NCT01493687|12333583|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||414
11146698|NCT01493687|12333584|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||210
11146699|NCT01493687|12333583|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
11146700|NCT01493687|12333584|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
11146701|NCT01493687|12333583|FG000|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
11146702|NCT01493687|12333584|FG001|STARTED|Part B Long Term Active Control 40 Weeks||210
11146703|NCT01493687|12333583|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||351
11146704|NCT01493687|12333584|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||175
11146705|NCT01493687|12333583|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
11146706|NCT01493687|12333584|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
11146707|NCT01493687|12333583|FG000|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
11146708|NCT01493687|12333584|FG001|STARTED|Part C Safety Follow up (4 Weeks)||175
11146709|NCT01493687|12333583|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||350
11146710|NCT01493687|12333584|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||174
11146711|NCT01493687|12333583|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
11146712|NCT01493687|12333584|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
11146713|NCT01493778|12333596|FG000|STARTED|Overall Study||60
11146714|NCT01493778|12333596|FG000|COMPLETED|Overall Study||52
11146715|NCT01493778|12333596|FG000|NOT COMPLETED|Overall Study||8
11146716|NCT01493947|12333611|FG000|STARTED|Period A Efficacy and Safety Data||478
11146717|NCT01493947|12333612|FG001|STARTED|Period A Efficacy and Safety Data||484
11146718|NCT01493947|12333611|FG000|COMPLETED|Period A Efficacy and Safety Data||446
11146719|NCT01493947|12333612|FG001|COMPLETED|Period A Efficacy and Safety Data||456
11146720|NCT01493947|12333611|FG000|NOT COMPLETED|Period A Efficacy and Safety Data||32
11146721|NCT01493947|12333612|FG001|NOT COMPLETED|Period A Efficacy and Safety Data||28
11146722|NCT01493947|12333611|FG000|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
11146723|NCT01493947|12333612|FG001|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
11146724|NCT01493947|12333611|FG000|COMPLETED|Period B Extension Period||366
11146725|NCT01493947|12333612|FG001|COMPLETED|Period B Extension Period||326
11146726|NCT01493947|12333611|FG000|NOT COMPLETED|Period B Extension Period||33
11146727|NCT01493947|12333612|FG001|NOT COMPLETED|Period B Extension Period||32
11146728|NCT01493960|12333623|FG000|STARTED|Overall Study||87
11146729|NCT01493960|12333624|FG001|STARTED|Overall Study||44
11146730|NCT01493960|12333623|FG000|Received Study Drug|Overall Study||87
11146731|NCT01493960|12333624|FG001|Received Study Drug|Overall Study||43
11146732|NCT01493960|12333623|FG000|COMPLETED|Overall Study||55
11146733|NCT01493960|12333624|FG001|COMPLETED|Overall Study||26
11146734|NCT01493960|12333623|FG000|NOT COMPLETED|Overall Study||32
11146735|NCT01493960|12333624|FG001|NOT COMPLETED|Overall Study||18
11146736|NCT01494038|12333632|FG000|STARTED|Overall Study||477
11146737|NCT01494038|12333633|FG001|STARTED|Overall Study||479
11146738|NCT01494038|12333632|FG000|COMPLETED|Overall Study||389
11146739|NCT01494038|12333633|FG001|COMPLETED|Overall Study||396
11146740|NCT01494038|12333632|FG000|NOT COMPLETED|Overall Study||88
11146741|NCT01494038|12333633|FG001|NOT COMPLETED|Overall Study||83
11146742|NCT01494051|12333656|FG000|STARTED|Overall Study||6
11146743|NCT01494051|12333657|FG001|STARTED|Overall Study||7
11146744|NCT01494051|12333656|FG000|COMPLETED|Overall Study||6
11146745|NCT01494051|12333657|FG001|COMPLETED|Overall Study||7
11146746|NCT01494051|12333656|FG000|NOT COMPLETED|Overall Study||0
11146747|NCT01494051|12333657|FG001|NOT COMPLETED|Overall Study||0
11146748|NCT01494298|12333665|FG000|STARTED|Overall Study||56
11146749|NCT01494298|12333666|FG001|STARTED|Overall Study||55
11146750|NCT01494298|12333665|FG000|COMPLETED|Overall Study||54
11146751|NCT01494298|12333666|FG001|COMPLETED|Overall Study||47
11146752|NCT01494298|12333665|FG000|NOT COMPLETED|Overall Study||2
11146753|NCT01494298|12333666|FG001|NOT COMPLETED|Overall Study||8
11146754|NCT01494350|12333674|FG000|STARTED|Overall Study||50
11146755|NCT01494350|12333674|FG000|COMPLETED|Overall Study||49
11146756|NCT01494350|12333674|FG000|NOT COMPLETED|Overall Study||1
11146757|NCT01494467|12333680|FG000|STARTED|Part A Vehicle Control (12 Weeks)||459
11146758|NCT01494467|12333681|FG001|STARTED|Part A Vehicle Control (12 Weeks)||229
11146759|NCT01494467|12333680|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||429
11146760|NCT01494467|12333681|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||208
11146761|NCT01494467|12333680|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
11146762|NCT01494467|12333681|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
11146763|NCT01494467|12333680|FG000|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
11146764|NCT01494467|12333681|FG001|STARTED|Part B Long Term Active Control 40 Weeks||208
11146765|NCT01494467|12333680|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||353
11146766|NCT01494467|12333681|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||159
11146767|NCT01494467|12333680|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
11146768|NCT01494467|12333681|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
11146769|NCT01494467|12333680|FG000|STARTED|Part C Safety Follow up (4 Weeks)||353
11146770|NCT01494467|12333681|FG001|STARTED|Part C Safety Follow up (4 Weeks)||159
11146771|NCT01494467|12333680|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||353
11146772|NCT01494467|12333681|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||159
11146773|NCT01494467|12333680|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
11146774|NCT01494467|12333681|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
11146775|NCT01494506|12333696|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
11146776|NCT01494506|12333697|FG001|STARTED|Overall Study||149
11146777|NCT01494506|12333698|FG002|STARTED|Overall Study||117
11146778|NCT01494506|12333696|FG000|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
11146779|NCT01494506|12333697|FG001|Treated Population|Overall Study||134
11146780|NCT01494506|12333698|FG002|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
11146781|NCT01494506|12333696|FG000|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
11146782|NCT01494506|12333697|FG001|COMPLETED|Overall Study||6
11146783|NCT01494506|12333698|FG002|COMPLETED|Overall Study||14
11146784|NCT01494506|12333696|FG000|NOT COMPLETED|Overall Study||148
11146785|NCT01494506|12333697|FG001|NOT COMPLETED|Overall Study||143
11146786|NCT01494506|12333698|FG002|NOT COMPLETED|Overall Study||103
11146787|NCT01494532|12333714|FG000|STARTED|Overall Study||75
11146788|NCT01494532|12333715|FG001|STARTED|Overall Study||25
11146789|NCT01494532|12333716|FG002|STARTED|Overall Study||76
11146790|NCT01494532|12333717|FG003|STARTED|Overall Study||75
11146791|NCT01494532|12333718|FG004|STARTED|Overall Study||76
11146792|NCT01494532|12333719|FG005|STARTED|Overall Study||25
11146793|NCT01494532|12333714|FG000|COMPLETED|Overall Study||65
11146794|NCT01494532|12333715|FG001|COMPLETED|Overall Study||21
11146795|NCT01494532|12333716|FG002|COMPLETED|Overall Study||59
11146796|NCT01494532|12333717|FG003|COMPLETED|Overall Study||60
11146797|NCT01494532|12333718|FG004|COMPLETED|Overall Study||64
11146798|NCT01494532|12333719|FG005|COMPLETED|Overall Study||25
11146799|NCT01494532|12333714|FG000|NOT COMPLETED|Overall Study||10
11146800|NCT01494532|12333715|FG001|NOT COMPLETED|Overall Study||4
11146801|NCT01494532|12333716|FG002|NOT COMPLETED|Overall Study||17
11146802|NCT01494532|12333717|FG003|NOT COMPLETED|Overall Study||15
11146803|NCT01494532|12333718|FG004|NOT COMPLETED|Overall Study||12
11146804|NCT01494532|12333719|FG005|NOT COMPLETED|Overall Study||0
11146805|NCT01494545|12333734|FG000|STARTED|Overall Study||102
11146806|NCT01494545|12333734|FG000|COMPLETED|Overall Study||92
11146807|NCT01494545|12333734|FG000|NOT COMPLETED|Overall Study||10
11146808|NCT01494584|12333741|FG000|STARTED|Overall Study||5
11146809|NCT01494584|12333741|FG000|COMPLETED|Overall Study||4
11146810|NCT01494584|12333741|FG000|NOT COMPLETED|Overall Study||1
11146811|NCT01494610|12333764|FG000|STARTED|Period 1||31
11146812|NCT01494610|12333765|FG001|STARTED|Period 1||29
11146813|NCT01494610|12333764|FG000|COMPLETED|Period 1||30
11146814|NCT01494610|12333765|FG001|COMPLETED|Period 1||28
11146815|NCT01494610|12333764|FG000|NOT COMPLETED|Period 1||1
11146816|NCT01494610|12333765|FG001|NOT COMPLETED|Period 1||1
11146817|NCT01494610|12333764|FG000|STARTED|Period 2||30
11146818|NCT01494610|12333765|FG001|STARTED|Period 2||28
11146819|NCT01494610|12333764|FG000|COMPLETED|Period 2||30
11146820|NCT01494610|12333765|FG001|COMPLETED|Period 2||28
11146821|NCT01494610|12333764|FG000|NOT COMPLETED|Period 2||0
11146822|NCT01494610|12333765|FG001|NOT COMPLETED|Period 2||0
11146823|NCT01494610|12333764|FG000|STARTED|Period 3||30
11146824|NCT01494610|12333765|FG001|STARTED|Period 3||28
11146825|NCT01494610|12333764|FG000|COMPLETED|Period 3||28
11146826|NCT01494610|12333765|FG001|COMPLETED|Period 3||28
11146827|NCT01494610|12333764|FG000|NOT COMPLETED|Period 3||2
11146828|NCT01494610|12333765|FG001|NOT COMPLETED|Period 3||0
11146829|NCT01494610|12333764|FG000|STARTED|Period 4||28
11146830|NCT01494610|12333765|FG001|STARTED|Period 4||28
11146831|NCT01494610|12333764|FG000|COMPLETED|Period 4||27
11146832|NCT01494610|12333765|FG001|COMPLETED|Period 4||28
11146833|NCT01494610|12333764|FG000|NOT COMPLETED|Period 4||1
11146834|NCT01494610|12333765|FG001|NOT COMPLETED|Period 4||0
11146835|NCT01494649|12333779|FG000|STARTED|Overall Study||59
11146836|NCT01494649|12333780|FG001|STARTED|Overall Study||59
11146837|NCT01494649|12333779|FG000|COMPLETED|Overall Study||59
11146838|NCT01494649|12333780|FG001|COMPLETED|Overall Study||58
11146839|NCT01494649|12333779|FG000|NOT COMPLETED|Overall Study||0
11146840|NCT01494649|12333780|FG001|NOT COMPLETED|Overall Study||1
11146841|NCT01494753|12333790|FG000|STARTED|Day0-Day42||15
11146842|NCT01494753|12333791|FG001|STARTED|Day0-Day42||15
11146843|NCT01494753|12333790|FG000|COMPLETED|Day0-Day42||15
11146844|NCT01494753|12333791|FG001|COMPLETED|Day0-Day42||15
11146845|NCT01494753|12333790|FG000|NOT COMPLETED|Day0-Day42||0
11146846|NCT01494753|12333791|FG001|NOT COMPLETED|Day0-Day42||0
11146847|NCT01494753|12333790|FG000|STARTED|Day42-Day84||15
11146848|NCT01494753|12333791|FG001|STARTED|Day42-Day84||15
11146849|NCT01494753|12333790|FG000|COMPLETED|Day42-Day84||15
11146850|NCT01494753|12333791|FG001|COMPLETED|Day42-Day84||15
11146851|NCT01494753|12333790|FG000|NOT COMPLETED|Day42-Day84||0
11146852|NCT01494753|12333791|FG001|NOT COMPLETED|Day42-Day84||0
11146853|NCT01494818|12333799|FG000|STARTED|Overall Study||39
11146854|NCT01494818|12333800|FG001|STARTED|Overall Study||39
11146855|NCT01494818|12333799|FG000|COMPLETED|Overall Study||37
11146856|NCT01494818|12333800|FG001|COMPLETED|Overall Study||37
11146857|NCT01494818|12333799|FG000|NOT COMPLETED|Overall Study||2
11146858|NCT01494818|12333800|FG001|NOT COMPLETED|Overall Study||2
11146859|NCT01494922|12333806|FG000|STARTED|Overall Study||14
11146860|NCT01494922|12333806|FG000|COMPLETED|Overall Study||13
11146861|NCT01494922|12333806|FG000|NOT COMPLETED|Overall Study||1
11146862|NCT01494987|12333812|FG000|STARTED|Overall Study||216
11146863|NCT01494987|12333813|FG001|STARTED|Overall Study||215
11146864|NCT01494987|12333812|FG000|COMPLETED|Overall Study||188
11146865|NCT01494987|12333813|FG001|COMPLETED|Overall Study||187
11146866|NCT01494987|12333812|FG000|NOT COMPLETED|Overall Study||28
11146867|NCT01494987|12333813|FG001|NOT COMPLETED|Overall Study||28
11146868|NCT01495000|12333821|FG000|STARTED|Overall Study||124
11146869|NCT01495000|12333822|FG001|STARTED|Overall Study||126
11146870|NCT01495000|12333821|FG000|COMPLETED|Overall Study||111
11146871|NCT01495000|12333822|FG001|COMPLETED|Overall Study||114
11146872|NCT01495000|12333821|FG000|NOT COMPLETED|Overall Study||13
11146873|NCT01495000|12333822|FG001|NOT COMPLETED|Overall Study||12
11146874|NCT01495221|12333828|FG000|STARTED|Overall Study|First Patient enrolled December 2011.|9
11146875|NCT01495221|12333828|FG000|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
11146876|NCT01495221|12333828|FG000|NOT COMPLETED|Overall Study||0
11146877|NCT01495286|12333832|FG000|STARTED|Overall Study||30
11146878|NCT01495286|12333832|FG000|COMPLETED|Overall Study||30
11146879|NCT01495286|12333832|FG000|NOT COMPLETED|Overall Study||0
11146880|NCT01495481|12333836|FG000|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
11146881|NCT01495481|12333836|FG000|COMPLETED|Adenosine||22
11146882|NCT01495481|12333836|FG000|NOT COMPLETED|Adenosine||0
11146883|NCT01495481|12333836|FG000|STARTED|Washout||22
11146884|NCT01495481|12333836|FG000|COMPLETED|Washout||22
11146885|NCT01495481|12333836|FG000|NOT COMPLETED|Washout||0
11146886|NCT01495481|12333836|FG000|STARTED|Dexmedetomidine||22
11146887|NCT01495481|12333836|FG000|COMPLETED|Dexmedetomidine||22
11146888|NCT01495481|12333836|FG000|NOT COMPLETED|Dexmedetomidine||0
11146889|NCT01495572|12333846|FG000|STARTED|Overall Study||0
11146890|NCT01495572|12333847|FG001|STARTED|Overall Study||5
11146891|NCT01495572|12333846|FG000|COMPLETED|Overall Study||0
11146892|NCT01495572|12333847|FG001|COMPLETED|Overall Study||5
11146893|NCT01495572|12333846|FG000|NOT COMPLETED|Overall Study||0
11146894|NCT01495572|12333847|FG001|NOT COMPLETED|Overall Study||0
11146895|NCT01495585|12333857|FG000|STARTED|Overall Study||4
11146896|NCT01495585|12333858|FG001|STARTED|Overall Study||6
11146897|NCT01495585|12333859|FG002|STARTED|Overall Study||4
11146898|NCT01495585|12333857|FG000|Open Label Lonafarnib 200 mg|Overall Study||2
11418355|NCT00524394|12616695|FG000|COMPLETED|Overall Study||1
11418356|NCT00524394|12616695|FG000|NOT COMPLETED|Overall Study||1
11418357|NCT00523809|12616699|FG000|STARTED|Overall Study||5
11418358|NCT00523809|12616699|FG000|COMPLETED|Overall Study||5
11418359|NCT00523809|12616699|FG000|NOT COMPLETED|Overall Study||0
11146899|NCT01495585|12333858|FG001|Open Label Lonafarnib 200 mg|Overall Study||0
11146900|NCT01495585|12333859|FG002|Open Label Lonafarnib 200 mg|Overall Study||0
11146901|NCT01495585|12333857|FG000|COMPLETED|Overall Study||4
11146902|NCT01495585|12333858|FG001|COMPLETED|Overall Study||6
11146903|NCT01495585|12333859|FG002|COMPLETED|Overall Study||4
11146904|NCT01495585|12333857|FG000|NOT COMPLETED|Overall Study||0
11146905|NCT01495585|12333858|FG001|NOT COMPLETED|Overall Study||0
11146906|NCT01495585|12333859|FG002|NOT COMPLETED|Overall Study||0
11146907|NCT01495689|12333869|FG000|STARTED|Overall Study||26
11146908|NCT01495689|12333870|FG001|STARTED|Overall Study||23
11146909|NCT01495689|12333869|FG000|COMPLETED|Overall Study||16
11146910|NCT01495689|12333870|FG001|COMPLETED|Overall Study||16
11418360|NCT00522301|12616703|FG000|STARTED|Overall Study||6
11146911|NCT01495689|12333869|FG000|NOT COMPLETED|Overall Study||10
11146912|NCT01495689|12333870|FG001|NOT COMPLETED|Overall Study||7
11146913|NCT01495702|12333878|FG000|STARTED|Randomized Phase||292
11146914|NCT01495702|12333879|FG001|STARTED|Randomized Phase||147
11146915|NCT01495702|12333878|FG000|COMPLETED|Randomized Phase||266
11146916|NCT01495702|12333879|FG001|COMPLETED|Randomized Phase||119
11146917|NCT01495702|12333878|FG000|NOT COMPLETED|Randomized Phase||26
11146918|NCT01495702|12333879|FG001|NOT COMPLETED|Randomized Phase||28
11146919|NCT01495702|12333878|FG000|STARTED|Extension Phase||26
11146920|NCT01495702|12333879|FG001|STARTED|Extension Phase||2
11146921|NCT01495702|12333878|FG000|COMPLETED|Extension Phase||26
11146922|NCT01495702|12333879|FG001|COMPLETED|Extension Phase||2
11146923|NCT01495702|12333878|FG000|NOT COMPLETED|Extension Phase||0
11146924|NCT01495702|12333879|FG001|NOT COMPLETED|Extension Phase||0
11146925|NCT01495793|12333886|FG000|STARTED|Overall Study||24
11146926|NCT01495793|12333886|FG000|COMPLETED|Overall Study||22
11146927|NCT01495793|12333886|FG000|NOT COMPLETED|Overall Study||2
11146928|NCT01495819|12333890|FG000|STARTED|Overall Study||34
11146929|NCT01495819|12333890|FG000|Nicotine 0.0125|Overall Study||31
11146930|NCT01495819|12333890|FG000|Nicotine 0.025|Overall Study||32
11146931|NCT01495819|12333890|FG000|Nicotine 0.05|Overall Study||33
11146932|NCT01495819|12333890|FG000|Nicotine 0.1|Overall Study||31
11146933|NCT01495819|12333890|FG000|NIcotine 0.2|Overall Study||33
11146934|NCT01495819|12333890|FG000|COMPLETED|Overall Study||30
11146935|NCT01495819|12333890|FG000|NOT COMPLETED|Overall Study||4
11146936|NCT01495858|12333902|FG000|STARTED|Overall Study||107
11146937|NCT01495858|12333903|FG001|STARTED|Overall Study||106
11146938|NCT01495858|12333904|FG002|STARTED|Overall Study||54
11146939|NCT01495858|12333902|FG000|COMPLETED|Overall Study||107
11146940|NCT01495858|12333903|FG001|COMPLETED|Overall Study||106
11146941|NCT01495858|12333904|FG002|COMPLETED|Overall Study||54
11146942|NCT01495858|12333902|FG000|NOT COMPLETED|Overall Study||0
11146943|NCT01495858|12333903|FG001|NOT COMPLETED|Overall Study||0
11146944|NCT01495858|12333904|FG002|NOT COMPLETED|Overall Study||0
11146945|NCT01495923|12333914|FG000|STARTED|Overall Study||73
11146946|NCT01495923|12333915|FG001|STARTED|Overall Study||72
11146947|NCT01495923|12333914|FG000|COMPLETED|Overall Study||73
11146948|NCT01495923|12333915|FG001|COMPLETED|Overall Study||72
11146949|NCT01495923|12333914|FG000|NOT COMPLETED|Overall Study||0
11146950|NCT01495923|12333915|FG001|NOT COMPLETED|Overall Study||0
11146951|NCT01495975|12333925|FG000|STARTED|Overall Study||15
11146952|NCT01495975|12333926|FG001|STARTED|Overall Study||14
11418361|NCT00522301|12616703|FG000|COMPLETED|Overall Study||0
11418362|NCT00522301|12616703|FG000|NOT COMPLETED|Overall Study||6
11418363|NCT00517192|12616709|FG000|STARTED|Overall Study||19
11418364|NCT00517192|12616710|FG001|STARTED|Overall Study||20
11418365|NCT00517192|12616709|FG000|COMPLETED|Overall Study||0
11418366|NCT00517192|12616710|FG001|COMPLETED|Overall Study||0
11418367|NCT00517192|12616709|FG000|NOT COMPLETED|Overall Study||19
11418368|NCT00517192|12616710|FG001|NOT COMPLETED|Overall Study||20
11418369|NCT00504985|12616716|FG000|STARTED|Overall Study||14
11418370|NCT00504985|12616716|FG000|COMPLETED|Overall Study||14
11418371|NCT00504985|12616716|FG000|NOT COMPLETED|Overall Study||0
11418372|NCT00503581|12616723|FG000|STARTED|Overall Study||3
11418373|NCT00503581|12616724|FG001|STARTED|Overall Study||4
11418374|NCT00503581|12616725|FG002|STARTED|Overall Study||2
11418375|NCT00503581|12616723|FG000|COMPLETED|Overall Study||0
11418376|NCT00503581|12616724|FG001|COMPLETED|Overall Study||0
11418377|NCT00503581|12616725|FG002|COMPLETED|Overall Study||0
11418378|NCT00503581|12616723|FG000|NOT COMPLETED|Overall Study||3
11418379|NCT00503581|12616724|FG001|NOT COMPLETED|Overall Study||4
11418380|NCT00503581|12616725|FG002|NOT COMPLETED|Overall Study||2
11418381|NCT00509600|12616733|FG000|STARTED|Overall Study||1
11418382|NCT00509600|12616733|FG000|COMPLETED|Overall Study||0
11418383|NCT00509600|12616733|FG000|NOT COMPLETED|Overall Study||1
11418384|NCT00515112|12616739|FG000|STARTED|Overall Study||3
11418385|NCT00515112|12616740|FG001|STARTED|Overall Study||3
11418386|NCT00515112|12616739|FG000|COMPLETED|Overall Study||0
11418387|NCT00515112|12616740|FG001|COMPLETED|Overall Study||0
11418388|NCT00515112|12616739|FG000|NOT COMPLETED|Overall Study||3
11418389|NCT00515112|12616740|FG001|NOT COMPLETED|Overall Study||3
11418390|NCT00508872|12616746|FG000|STARTED|Overall Study||2
11418391|NCT00508872|12616746|FG000|COMPLETED|Overall Study||0
11418392|NCT00508872|12616746|FG000|NOT COMPLETED|Overall Study||2
11418393|NCT00514813|12616754|FG000|STARTED|Overall Study||15
11418394|NCT00514813|12616755|FG001|STARTED|Overall Study||86
11418395|NCT00514813|12616756|FG002|STARTED|Overall Study||47
11146953|NCT01495975|12333925|FG000|COMPLETED|Overall Study||14
11146954|NCT01495975|12333926|FG001|COMPLETED|Overall Study||14
11146955|NCT01495975|12333925|FG000|NOT COMPLETED|Overall Study||1
11146956|NCT01495975|12333926|FG001|NOT COMPLETED|Overall Study||0
11146957|NCT01496066|12333934|FG000|STARTED|Overall Study||403
11146958|NCT01496066|12333935|FG001|STARTED|Overall Study||197
11146959|NCT01496066|12333934|FG000|COMPLETED|Overall Study||391
11146960|NCT01496066|12333935|FG001|COMPLETED|Overall Study||188
11322774|NCT00353938|12520053|FG000|COMPLETED|Stage 1||8
11146961|NCT01496066|12333934|FG000|NOT COMPLETED|Overall Study||12
11146962|NCT01496066|12333935|FG001|NOT COMPLETED|Overall Study||9
11146963|NCT01496131|12333950|FG000|STARTED|Overall Study||14
11146964|NCT01496131|12333951|FG001|STARTED|Overall Study||14
11146965|NCT01496131|12333950|FG000|COMPLETED|Overall Study||14
11146966|NCT01496131|12333951|FG001|COMPLETED|Overall Study||14
11146967|NCT01496131|12333950|FG000|NOT COMPLETED|Overall Study||0
11146968|NCT01496131|12333951|FG001|NOT COMPLETED|Overall Study||0
11146969|NCT01496157|12333957|FG000|STARTED|Overall Study||13
11146970|NCT01496157|12333957|FG000|COMPLETED|Overall Study||13
11146971|NCT01496157|12333957|FG000|NOT COMPLETED|Overall Study||0
11146972|NCT01496183|12333963|FG000|STARTED|Overall Study||9
11146973|NCT01496183|12333964|FG001|STARTED|Overall Study||15
11146974|NCT01496183|12333963|FG000|COMPLETED|Overall Study||6
11146975|NCT01496183|12333964|FG001|COMPLETED|Overall Study||13
11146976|NCT01496183|12333963|FG000|NOT COMPLETED|Overall Study||3
11146977|NCT01496183|12333964|FG001|NOT COMPLETED|Overall Study||2
11146978|NCT01496248|12333971|FG000|STARTED|Overall Study||35
11146979|NCT01496248|12333971|FG000|COMPLETED|Overall Study||25
11146980|NCT01496248|12333971|FG000|NOT COMPLETED|Overall Study||10
11146981|NCT01496274|12333977|FG000|STARTED|Overall Study||40
11146982|NCT01496274|12333978|FG001|STARTED|Overall Study||23
11146983|NCT01496274|12333977|FG000|COMPLETED|Overall Study||37
11146984|NCT01496274|12333978|FG001|COMPLETED|Overall Study||18
11146985|NCT01496274|12333977|FG000|NOT COMPLETED|Overall Study||3
11146986|NCT01496274|12333978|FG001|NOT COMPLETED|Overall Study||5
11146987|NCT01496287|12333999|FG000|STARTED|Overall Study||70
11146988|NCT01496287|12333999|FG000|COMPLETED|Overall Study||64
11146989|NCT01496287|12333999|FG000|NOT COMPLETED|Overall Study||6
11322775|NCT00353938|12520054|FG001|COMPLETED|Stage 1||5
11322776|NCT00353938|12520055|FG002|COMPLETED|Stage 1||0
11322777|NCT00353938|12520056|FG003|COMPLETED|Stage 1||0
11322778|NCT00353938|12520053|FG000|NOT COMPLETED|Stage 1||1
11322779|NCT00353938|12520054|FG001|NOT COMPLETED|Stage 1||0
11322780|NCT00353938|12520055|FG002|NOT COMPLETED|Stage 1||0
11322781|NCT00353938|12520056|FG003|NOT COMPLETED|Stage 1||0
11322782|NCT00353938|12520053|FG000|STARTED|Stage 2||0
11322783|NCT00353938|12520054|FG001|STARTED|Stage 2||0
11322784|NCT00353938|12520055|FG002|STARTED|Stage 2||4
11322785|NCT00353938|12520056|FG003|STARTED|Stage 2||0
11322786|NCT00353938|12520053|FG000|COMPLETED|Stage 2||0
11322787|NCT00353938|12520054|FG001|COMPLETED|Stage 2||0
11322788|NCT00353938|12520055|FG002|COMPLETED|Stage 2||4
11322789|NCT00353938|12520056|FG003|COMPLETED|Stage 2||0
11322790|NCT00353938|12520053|FG000|NOT COMPLETED|Stage 2||0
11322791|NCT00353938|12520054|FG001|NOT COMPLETED|Stage 2||0
11322792|NCT00353938|12520055|FG002|NOT COMPLETED|Stage 2||0
11322793|NCT00353938|12520056|FG003|NOT COMPLETED|Stage 2||0
11146990|NCT01496313|12334006|FG000|STARTED|Overall Study||40
11146991|NCT01496313|12334007|FG001|STARTED|Overall Study||41
11146992|NCT01496313|12334006|FG000|COMPLETED|Overall Study||35
11146993|NCT01496313|12334007|FG001|COMPLETED|Overall Study||26
11146994|NCT01496313|12334006|FG000|NOT COMPLETED|Overall Study||5
11146995|NCT01496313|12334007|FG001|NOT COMPLETED|Overall Study||15
11146996|NCT01496352|12334015|FG000|STARTED|Overall Study||24
11146997|NCT01496352|12334016|FG001|STARTED|Overall Study||6
11146998|NCT01496352|12334015|FG000|COMPLETED|Overall Study||24
11146999|NCT01496352|12334016|FG001|COMPLETED|Overall Study||6
11147000|NCT01496352|12334015|FG000|NOT COMPLETED|Overall Study||0
11147001|NCT01496352|12334016|FG001|NOT COMPLETED|Overall Study||0
11147002|NCT01496365|12334038|FG000|STARTED|Overall Study||112
11147003|NCT01496365|12334039|FG001|STARTED|Overall Study||56
11147004|NCT01496365|12334040|FG002|STARTED|Overall Study||57
11147005|NCT01496365|12334041|FG003|STARTED|Overall Study||57
11147006|NCT01496365|12334042|FG004|STARTED|Overall Study||57
11147007|NCT01496365|12334043|FG005|STARTED|Overall Study||56
11147008|NCT01496365|12334044|FG006|STARTED|Overall Study||57
11147009|NCT01496365|12334038|FG000|COMPLETED|Overall Study||97
11147010|NCT01496365|12334039|FG001|COMPLETED|Overall Study||41
11147011|NCT01496365|12334040|FG002|COMPLETED|Overall Study||51
11147012|NCT01496365|12334041|FG003|COMPLETED|Overall Study||53
11147013|NCT01496365|12334042|FG004|COMPLETED|Overall Study||44
11147014|NCT01496365|12334043|FG005|COMPLETED|Overall Study||46
11147015|NCT01496365|12334044|FG006|COMPLETED|Overall Study||51
11147016|NCT01496365|12334038|FG000|NOT COMPLETED|Overall Study||15
11147017|NCT01496365|12334039|FG001|NOT COMPLETED|Overall Study||15
11147018|NCT01496365|12334040|FG002|NOT COMPLETED|Overall Study||6
11147019|NCT01496365|12334041|FG003|NOT COMPLETED|Overall Study||4
11147020|NCT01496365|12334042|FG004|NOT COMPLETED|Overall Study||13
11147021|NCT01496365|12334043|FG005|NOT COMPLETED|Overall Study||10
11147022|NCT01496365|12334044|FG006|NOT COMPLETED|Overall Study||6
11147023|NCT01496430|12334063|FG000|STARTED|Overall Study||35
11147024|NCT01496430|12334064|FG001|STARTED|Overall Study||35
11147025|NCT01496430|12334065|FG002|STARTED|Overall Study||35
11147026|NCT01496430|12334063|FG000|COMPLETED|Overall Study||29
11147027|NCT01496430|12334064|FG001|COMPLETED|Overall Study||30
11147028|NCT01496430|12334065|FG002|COMPLETED|Overall Study||25
11147029|NCT01496430|12334063|FG000|NOT COMPLETED|Overall Study||6
11147030|NCT01496430|12334064|FG001|NOT COMPLETED|Overall Study||5
11147031|NCT01496430|12334065|FG002|NOT COMPLETED|Overall Study||10
11147032|NCT01496456|12334073|FG000|STARTED|Overall Study||17
11147033|NCT01496456|12334073|FG000|Baseline|Overall Study|Baseline group started with 16 patients.|16
11147034|NCT01496456|12334073|FG000|1-yr Recall|Overall Study||12
11147035|NCT01496456|12334073|FG000|2-yr Recall|Overall Study||10
11147036|NCT01496456|12334073|FG000|3-yr Final Recall|Overall Study||9
11147037|NCT01496456|12334073|FG000|COMPLETED|Overall Study||9
11147038|NCT01496456|12334073|FG000|NOT COMPLETED|Overall Study||8
11418396|NCT00514813|12616757|FG003|STARTED|Overall Study||4
11418397|NCT00514813|12616754|FG000|COMPLETED|Overall Study||0
11147039|NCT01496469|12334082|FG000|STARTED|Overall Study||60
11147040|NCT01496469|12334083|FG001|STARTED|Overall Study||61
11147041|NCT01496469|12334082|FG000|COMPLETED|Overall Study||50
11147042|NCT01496469|12334083|FG001|COMPLETED|Overall Study||53
11147043|NCT01496469|12334082|FG000|NOT COMPLETED|Overall Study||10
11147044|NCT01496469|12334083|FG001|NOT COMPLETED|Overall Study||8
11147045|NCT01496612|12334089|FG000|STARTED|1st Intervention||3
11418398|NCT00514813|12616755|FG001|COMPLETED|Overall Study||0
11147046|NCT01496612|12334090|FG001|STARTED|1st Intervention||4
11147047|NCT01496612|12334089|FG000|COMPLETED|1st Intervention||1
11147048|NCT01496612|12334090|FG001|COMPLETED|1st Intervention||4
11147049|NCT01496612|12334089|FG000|NOT COMPLETED|1st Intervention||2
11147050|NCT01496612|12334090|FG001|NOT COMPLETED|1st Intervention||0
11147051|NCT01496612|12334089|FG000|STARTED|2nd Intervention||1
11147052|NCT01496612|12334090|FG001|STARTED|2nd Intervention||4
11147053|NCT01496612|12334089|FG000|COMPLETED|2nd Intervention||1
11147054|NCT01496612|12334090|FG001|COMPLETED|2nd Intervention||4
11147055|NCT01496612|12334089|FG000|NOT COMPLETED|2nd Intervention||0
11147056|NCT01496612|12334090|FG001|NOT COMPLETED|2nd Intervention||0
11147057|NCT01496807|12334098|FG000|STARTED|Overall Study||31
11147058|NCT01496807|12334098|FG000|COMPLETED|Overall Study||1
11147059|NCT01496807|12334098|FG000|NOT COMPLETED|Overall Study||30
11147060|NCT01496846|12334108|FG000|STARTED|IANB Articaine (All Participants)||28
11147061|NCT01496846|12334109|FG001|STARTED|IANB Articaine (All Participants)||24
11147062|NCT01496846|12334110|FG002|STARTED|IANB Articaine (All Participants)||36
11147063|NCT01496846|12334111|FG003|STARTED|IANB Articaine (All Participants)||40
11147064|NCT01496846|12334112|FG004|STARTED|IANB Articaine (All Participants)||35
11147065|NCT01496846|12334113|FG005|STARTED|IANB Articaine (All Participants)||38
11147066|NCT01496846|12334108|FG000|COMPLETED|IANB Articaine (All Participants)||27
11147067|NCT01496846|12334109|FG001|COMPLETED|IANB Articaine (All Participants)||23
11147068|NCT01496846|12334110|FG002|COMPLETED|IANB Articaine (All Participants)||36
11147069|NCT01496846|12334111|FG003|COMPLETED|IANB Articaine (All Participants)||40
11147070|NCT01496846|12334112|FG004|COMPLETED|IANB Articaine (All Participants)||35
11147071|NCT01496846|12334113|FG005|COMPLETED|IANB Articaine (All Participants)||38
11147072|NCT01496846|12334108|FG000|NOT COMPLETED|IANB Articaine (All Participants)||1
11147073|NCT01496846|12334109|FG001|NOT COMPLETED|IANB Articaine (All Participants)||1
11147074|NCT01496846|12334110|FG002|NOT COMPLETED|IANB Articaine (All Participants)||0
11147075|NCT01496846|12334111|FG003|NOT COMPLETED|IANB Articaine (All Participants)||0
11147076|NCT01496846|12334112|FG004|NOT COMPLETED|IANB Articaine (All Participants)||0
11147077|NCT01496846|12334113|FG005|NOT COMPLETED|IANB Articaine (All Participants)||0
11147078|NCT01496846|12334108|FG000|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
11147079|NCT01496846|12334109|FG001|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
11147080|NCT01496846|12334110|FG002|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
11147081|NCT01496846|12334111|FG003|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
11147082|NCT01496846|12334112|FG004|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
11147083|NCT01496846|12334113|FG005|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
11147084|NCT01496846|12334108|FG000|COMPLETED|Supplemental Buccal Infiltration||0
11147085|NCT01496846|12334109|FG001|COMPLETED|Supplemental Buccal Infiltration||0
11147086|NCT01496846|12334110|FG002|COMPLETED|Supplemental Buccal Infiltration||36
11147087|NCT01496846|12334111|FG003|COMPLETED|Supplemental Buccal Infiltration||40
11147088|NCT01496846|12334112|FG004|COMPLETED|Supplemental Buccal Infiltration||35
11147089|NCT01496846|12334113|FG005|COMPLETED|Supplemental Buccal Infiltration||38
11147090|NCT01496846|12334108|FG000|NOT COMPLETED|Supplemental Buccal Infiltration||0
11147091|NCT01496846|12334109|FG001|NOT COMPLETED|Supplemental Buccal Infiltration||0
11147092|NCT01496846|12334110|FG002|NOT COMPLETED|Supplemental Buccal Infiltration||0
11147093|NCT01496846|12334111|FG003|NOT COMPLETED|Supplemental Buccal Infiltration||0
11147094|NCT01496846|12334112|FG004|NOT COMPLETED|Supplemental Buccal Infiltration||0
11147095|NCT01496846|12334113|FG005|NOT COMPLETED|Supplemental Buccal Infiltration||0
11147096|NCT01496885|12334124|FG000|STARTED|Overall Study||120
11147097|NCT01496885|12334124|FG000|COMPLETED|Overall Study||97
11147098|NCT01496885|12334124|FG000|NOT COMPLETED|Overall Study||23
11147099|NCT01497067|12334128|FG000|STARTED|Overall Study||657
11147100|NCT01497067|12334128|FG000|COMPLETED|Overall Study||575
11147101|NCT01497067|12334128|FG000|NOT COMPLETED|Overall Study||82
11147102|NCT01497197|12334135|FG000|STARTED|Overall Study||89
11147103|NCT01497197|12334136|FG001|STARTED|Overall Study||85
11147104|NCT01497197|12334135|FG000|COMPLETED|Overall Study||72
11147105|NCT01497197|12334136|FG001|COMPLETED|Overall Study||70
11147106|NCT01497197|12334135|FG000|NOT COMPLETED|Overall Study||17
11147107|NCT01497197|12334136|FG001|NOT COMPLETED|Overall Study||15
11147108|NCT01497262|12334142|FG000|STARTED|Overall Study||162
11147109|NCT01497262|12334142|FG000|COMPLETED|Overall Study||151
11147110|NCT01497262|12334142|FG000|NOT COMPLETED|Overall Study||11
11147111|NCT01497275|12334146|FG000|STARTED|Overall Study||5
11147112|NCT01497275|12334146|FG000|COMPLETED|Overall Study||3
11147113|NCT01497275|12334146|FG000|NOT COMPLETED|Overall Study||2
11147114|NCT01497366|12334152|FG000|STARTED|Overall Study||263
11147115|NCT01497366|12334153|FG001|STARTED|Overall Study||264
11147116|NCT01497366|12334152|FG000|Randomized But Not Treated|Overall Study||7
11147117|NCT01497366|12334153|FG001|Randomized But Not Treated|Overall Study||21
11147118|NCT01497366|12334152|FG000|COMPLETED|Overall Study||224
11147119|NCT01497366|12334153|FG001|COMPLETED|Overall Study||176
11147120|NCT01497366|12334152|FG000|NOT COMPLETED|Overall Study||39
11147121|NCT01497366|12334153|FG001|NOT COMPLETED|Overall Study||88
11147122|NCT01497496|12334160|FG000|STARTED|Overall Study||29
11147123|NCT01497496|12334160|FG000|COMPLETED|Overall Study||29
11147124|NCT01497496|12334160|FG000|NOT COMPLETED|Overall Study||0
11147125|NCT01497613|12334166|FG000|STARTED|Overall Study||150
11147126|NCT01497613|12334167|FG001|STARTED|Overall Study||150
11147127|NCT01497613|12334166|FG000|COMPLETED|Overall Study||113
11147128|NCT01497613|12334167|FG001|COMPLETED|Overall Study||131
11147129|NCT01497613|12334166|FG000|NOT COMPLETED|Overall Study||37
11147130|NCT01497613|12334167|FG001|NOT COMPLETED|Overall Study||19
11147131|NCT01497665|12334173|FG000|STARTED|Overall Study||16
11147132|NCT01497665|12334173|FG000|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
11147133|NCT01497665|12334173|FG000|COMPLETED|Overall Study||16
11147134|NCT01497665|12334173|FG000|NOT COMPLETED|Overall Study||0
11147135|NCT01497756|12334177|FG000|STARTED|Overall Study||10
11147136|NCT01497756|12334177|FG000|COMPLETED|Overall Study||10
11147137|NCT01497756|12334177|FG000|NOT COMPLETED|Overall Study||0
11147138|NCT01497808|12334185|FG000|STARTED|Overall Study||6
11147139|NCT01497808|12334186|FG001|STARTED|Overall Study||4
11147140|NCT01497808|12334187|FG002|STARTED|Overall Study||6
11147141|NCT01497808|12334188|FG003|STARTED|Overall Study||6
11147142|NCT01497808|12334185|FG000|COMPLETED|Overall Study||6
11147143|NCT01497808|12334186|FG001|COMPLETED|Overall Study||4
11147144|NCT01497808|12334187|FG002|COMPLETED|Overall Study||6
11147145|NCT01497808|12334188|FG003|COMPLETED|Overall Study||6
11147146|NCT01497808|12334185|FG000|NOT COMPLETED|Overall Study||0
11147147|NCT01497808|12334186|FG001|NOT COMPLETED|Overall Study||0
11147148|NCT01497808|12334187|FG002|NOT COMPLETED|Overall Study||0
11147149|NCT01497808|12334188|FG003|NOT COMPLETED|Overall Study||0
11147150|NCT01497860|12334198|FG000|STARTED|Overall Study||12
11147151|NCT01497860|12334198|FG000|COMPLETED|Overall Study||12
11147152|NCT01497860|12334198|FG000|NOT COMPLETED|Overall Study||0
11147153|NCT01497899|12334206|FG000|STARTED|Double-Blind Phase||113
11147154|NCT01497899|12334207|FG001|STARTED|Double-Blind Phase||58
11147155|NCT01497899|12334208|FG002|STARTED|Double-Blind Phase||0
11147156|NCT01497899|12334209|FG003|STARTED|Double-Blind Phase||0
11147157|NCT01497899|12334206|FG000|COMPLETED|Double-Blind Phase||107
11147158|NCT01497899|12334207|FG001|COMPLETED|Double-Blind Phase||53
11147159|NCT01497899|12334208|FG002|COMPLETED|Double-Blind Phase||0
11147160|NCT01497899|12334209|FG003|COMPLETED|Double-Blind Phase||0
11147161|NCT01497899|12334206|FG000|NOT COMPLETED|Double-Blind Phase||6
11147162|NCT01497899|12334207|FG001|NOT COMPLETED|Double-Blind Phase||5
11147163|NCT01497899|12334208|FG002|NOT COMPLETED|Double-Blind Phase||0
11147164|NCT01497899|12334209|FG003|NOT COMPLETED|Double-Blind Phase||0
11147165|NCT01497899|12334206|FG000|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
11147166|NCT01497899|12334207|FG001|STARTED|Open-Label Extension Phase||53
11147167|NCT01497899|12334208|FG002|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
11147168|NCT01497899|12334209|FG003|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
11147169|NCT01497899|12334206|FG000|COMPLETED|Open-Label Extension Phase||86
11147170|NCT01497899|12334207|FG001|COMPLETED|Open-Label Extension Phase||46
11147171|NCT01497899|12334208|FG002|COMPLETED|Open-Label Extension Phase||61
11147172|NCT01497899|12334209|FG003|COMPLETED|Open-Label Extension Phase||33
11147173|NCT01497899|12334206|FG000|NOT COMPLETED|Open-Label Extension Phase||19
11147174|NCT01497899|12334207|FG001|NOT COMPLETED|Open-Label Extension Phase||7
11147175|NCT01497899|12334208|FG002|NOT COMPLETED|Open-Label Extension Phase||9
11147176|NCT01497899|12334209|FG003|NOT COMPLETED|Open-Label Extension Phase||5
11147177|NCT01497938|12334218|FG000|STARTED|Overall Study||121
11147178|NCT01497938|12334219|FG001|STARTED|Overall Study||126
11147179|NCT01497938|12334218|FG000|COMPLETED|Overall Study||116
11147180|NCT01497938|12334219|FG001|COMPLETED|Overall Study||124
11147181|NCT01497938|12334218|FG000|NOT COMPLETED|Overall Study||5
11147182|NCT01497938|12334219|FG001|NOT COMPLETED|Overall Study||2
11147183|NCT01498068|12334227|FG000|STARTED|Overall Study||16
11147184|NCT01498068|12334228|FG001|STARTED|Overall Study||20
11147185|NCT01498068|12334227|FG000|COMPLETED|Overall Study||15
11147186|NCT01498068|12334228|FG001|COMPLETED|Overall Study||19
11147187|NCT01498068|12334227|FG000|NOT COMPLETED|Overall Study||1
11147188|NCT01498068|12334228|FG001|NOT COMPLETED|Overall Study||1
11147189|NCT01498120|12334234|FG000|STARTED|Overall Study||14
11147190|NCT01498120|12334234|FG000|COMPLETED|Overall Study||1
11147191|NCT01498120|12334234|FG000|NOT COMPLETED|Overall Study||13
11147192|NCT01498185|12334243|FG000|STARTED|Overall Study||13
11147193|NCT01498185|12334244|FG001|STARTED|Overall Study||13
11147194|NCT01498185|12334245|FG002|STARTED|Overall Study||15
11147195|NCT01498185|12334246|FG003|STARTED|Overall Study||14
11147196|NCT01498185|12334247|FG004|STARTED|Overall Study||15
11147197|NCT01498185|12334243|FG000|COMPLETED|Overall Study||12
11147198|NCT01498185|12334244|FG001|COMPLETED|Overall Study||12
11147199|NCT01498185|12334245|FG002|COMPLETED|Overall Study||15
11147200|NCT01498185|12334246|FG003|COMPLETED|Overall Study||11
11147201|NCT01498185|12334247|FG004|COMPLETED|Overall Study||12
11147202|NCT01498185|12334243|FG000|NOT COMPLETED|Overall Study||1
11147203|NCT01498185|12334244|FG001|NOT COMPLETED|Overall Study||1
11147204|NCT01498185|12334245|FG002|NOT COMPLETED|Overall Study||0
11147205|NCT01498185|12334246|FG003|NOT COMPLETED|Overall Study||3
11147206|NCT01498185|12334247|FG004|NOT COMPLETED|Overall Study||3
11147207|NCT01498289|12334265|FG000|STARTED|Overall Study||98
11147208|NCT01498289|12334266|FG001|STARTED|Overall Study||104
11147209|NCT01498289|12334265|FG000|Participants Assessed for AEs|Overall Study||91
11147210|NCT01498289|12334266|FG001|Participants Assessed for AEs|Overall Study||98
11147211|NCT01498289|12334265|FG000|COMPLETED|Overall Study||0
11147212|NCT01498289|12334266|FG001|COMPLETED|Overall Study||0
11147213|NCT01498289|12334265|FG000|NOT COMPLETED|Overall Study||98
11147214|NCT01498289|12334266|FG001|NOT COMPLETED|Overall Study||104
11147215|NCT01498419|12334280|FG000|STARTED|Overall Study||60
11147216|NCT01498419|12334281|FG001|STARTED|Overall Study||62
11147217|NCT01498419|12334282|FG002|STARTED|Overall Study||59
11147218|NCT01498419|12334283|FG003|STARTED|Overall Study||26
11147219|NCT01498419|12334280|FG000|COMPLETED|Overall Study||42
11147220|NCT01498419|12334281|FG001|COMPLETED|Overall Study||39
11147221|NCT01498419|12334282|FG002|COMPLETED|Overall Study||41
11147222|NCT01498419|12334283|FG003|COMPLETED|Overall Study||7
11147223|NCT01498419|12334280|FG000|NOT COMPLETED|Overall Study||18
11147224|NCT01498419|12334281|FG001|NOT COMPLETED|Overall Study||23
11147225|NCT01498419|12334282|FG002|NOT COMPLETED|Overall Study||18
11026633|NCT00829296|12205215|FG000|NOT COMPLETED|Overall Study||5
11026634|NCT00829296|12205216|FG001|NOT COMPLETED|Overall Study||4
11026635|NCT00829387|12205224|FG000|STARTED|Overall Study||23
11147226|NCT01498419|12334283|FG003|NOT COMPLETED|Overall Study||19
11147227|NCT01498445|12334299|FG000|STARTED|Overall Study||4
11147228|NCT01498445|12334300|FG001|STARTED|Overall Study||3
11147229|NCT01498445|12334301|FG002|STARTED|Overall Study||8
11147230|NCT01498445|12334302|FG003|STARTED|Overall Study||8
11147231|NCT01498445|12334303|FG004|STARTED|Overall Study||4
11147232|NCT01498445|12334304|FG005|STARTED|Overall Study||5
11147233|NCT01498445|12334299|FG000|COMPLETED|Overall Study||4
11147234|NCT01498445|12334300|FG001|COMPLETED|Overall Study||3
11147235|NCT01498445|12334301|FG002|COMPLETED|Overall Study||7
11147236|NCT01498445|12334302|FG003|COMPLETED|Overall Study||6
11147237|NCT01498445|12334303|FG004|COMPLETED|Overall Study||3
11147238|NCT01498445|12334304|FG005|COMPLETED|Overall Study||4
11147239|NCT01498445|12334299|FG000|NOT COMPLETED|Overall Study||0
11147240|NCT01498445|12334300|FG001|NOT COMPLETED|Overall Study||0
11147241|NCT01498445|12334301|FG002|NOT COMPLETED|Overall Study||1
11147242|NCT01498445|12334302|FG003|NOT COMPLETED|Overall Study||2
11147243|NCT01498445|12334303|FG004|NOT COMPLETED|Overall Study||1
11147244|NCT01498445|12334304|FG005|NOT COMPLETED|Overall Study||1
11147245|NCT01498549|12334318|FG000|STARTED|Overall Study||39
11147246|NCT01498549|12334318|FG000|Atomoxetine 40 mg|Overall Study||39
11147247|NCT01498549|12334318|FG000|Atomoxetine 80 mg|Overall Study||37
11147248|NCT01498549|12334318|FG000|Sugar Pill 0 mg|Overall Study||36
11147249|NCT01498549|12334318|FG000|COMPLETED|Overall Study||35
11147250|NCT01498549|12334318|FG000|NOT COMPLETED|Overall Study||4
11147251|NCT01498575|12334329|FG000|STARTED|Overall Sample||610
11147252|NCT01498575|12334330|FG001|STARTED|Overall Sample||414
11147253|NCT01498575|12334329|FG000|COMPLETED|Overall Sample||550
11147254|NCT01498575|12334330|FG001|COMPLETED|Overall Sample||400
11147255|NCT01498575|12334329|FG000|NOT COMPLETED|Overall Sample||60
11147256|NCT01498575|12334330|FG001|NOT COMPLETED|Overall Sample||14
11147257|NCT01498575|12334329|FG000|STARTED|On the Road Driving Assessment (ODA)||128
11147258|NCT01498575|12334330|FG001|STARTED|On the Road Driving Assessment (ODA)||89
11147259|NCT01498575|12334329|FG000|COMPLETED|On the Road Driving Assessment (ODA)||86
11147260|NCT01498575|12334330|FG001|COMPLETED|On the Road Driving Assessment (ODA)||65
11147261|NCT01498575|12334329|FG000|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
11147262|NCT01498575|12334330|FG001|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
11147263|NCT01498588|12334336|FG000|STARTED|Overall Study||7
11147264|NCT01498588|12334336|FG000|COMPLETED|Overall Study||7
11147265|NCT01498588|12334336|FG000|NOT COMPLETED|Overall Study||0
11147266|NCT01498601|12334342|FG000|STARTED|Overall Study||51
11147267|NCT01498601|12334343|FG001|STARTED|Overall Study||32
11147268|NCT01498601|12334342|FG000|COMPLETED|Overall Study||51
11147269|NCT01498601|12334343|FG001|COMPLETED|Overall Study||32
11147270|NCT01498601|12334342|FG000|NOT COMPLETED|Overall Study||0
11147271|NCT01498601|12334343|FG001|NOT COMPLETED|Overall Study||0
11147272|NCT01498640|12334349|FG000|STARTED|Overall Study||52
11147273|NCT01498640|12334349|FG000|COMPLETED|Overall Study||47
11147274|NCT01498640|12334349|FG000|NOT COMPLETED|Overall Study||5
11147275|NCT01498653|12334359|FG000|STARTED|Overall Study||155
11147276|NCT01498653|12334360|FG001|STARTED|Overall Study||154
11147277|NCT01498653|12334359|FG000|COMPLETED|Overall Study||136
11147278|NCT01498653|12334360|FG001|COMPLETED|Overall Study||119
11147279|NCT01498653|12334359|FG000|NOT COMPLETED|Overall Study||19
11147280|NCT01498653|12334360|FG001|NOT COMPLETED|Overall Study||35
11147281|NCT01498679|12334368|FG000|STARTED|Overall Study||154
11147282|NCT01498679|12334369|FG001|STARTED|Overall Study||153
11147283|NCT01498679|12334368|FG000|COMPLETED|Overall Study||65
11147284|NCT01498679|12334369|FG001|COMPLETED|Overall Study||131
11147285|NCT01498679|12334368|FG000|NOT COMPLETED|Overall Study||89
11147286|NCT01498679|12334369|FG001|NOT COMPLETED|Overall Study||22
11147287|NCT01498692|12334375|FG000|STARTED|Overall Study||94
11147288|NCT01498692|12334375|FG000|COMPLETED|Overall Study||86
11147289|NCT01498692|12334375|FG000|NOT COMPLETED|Overall Study||8
11147290|NCT01498744|12334381|FG000|STARTED|Overall Study||22
11147291|NCT01498744|12334382|FG001|STARTED|Overall Study||31
11147292|NCT01498744|12334381|FG000|COMPLETED|Overall Study||22
11147293|NCT01498744|12334382|FG001|COMPLETED|Overall Study||31
11147294|NCT01498744|12334381|FG000|NOT COMPLETED|Overall Study||0
11147295|NCT01498744|12334382|FG001|NOT COMPLETED|Overall Study||0
11147296|NCT01498822|12334390|FG000|STARTED|Overall Study||175
11147297|NCT01498822|12334391|FG001|STARTED|Overall Study||178
11147298|NCT01498822|12334390|FG000|COMPLETED|Overall Study||121
11147299|NCT01498822|12334391|FG001|COMPLETED|Overall Study||122
11147300|NCT01498822|12334390|FG000|NOT COMPLETED|Overall Study||54
11147301|NCT01498822|12334391|FG001|NOT COMPLETED|Overall Study||56
11147302|NCT01498887|12334401|FG000|STARTED|Overall Study||200
11147303|NCT01498887|12334402|FG001|STARTED|Overall Study||147
11147304|NCT01498887|12334401|FG000|Safety Set|Overall Study||200
11147305|NCT01498887|12334402|FG001|Safety Set|Overall Study||147
11147306|NCT01498887|12334401|FG000|Intent-to-treat|Overall Study||185
11147307|NCT01498887|12334402|FG001|Intent-to-treat|Overall Study||135
11147308|NCT01498887|12334401|FG000|COMPLETED|Overall Study||184
11147309|NCT01498887|12334402|FG001|COMPLETED|Overall Study||136
11147310|NCT01498887|12334401|FG000|NOT COMPLETED|Overall Study||16
11147311|NCT01498887|12334402|FG001|NOT COMPLETED|Overall Study||11
11147312|NCT01498952|12334411|FG000|STARTED|Overall Study||3
11147313|NCT01498952|12334412|FG001|STARTED|Overall Study||3
11147314|NCT01498952|12334413|FG002|STARTED|Overall Study||0
11147315|NCT01498952|12334414|FG003|STARTED|Overall Study||0
11147316|NCT01498952|12334415|FG004|STARTED|Overall Study||0
11147317|NCT01498952|12334411|FG000|COMPLETED|Overall Study||1
11147318|NCT01498952|12334412|FG001|COMPLETED|Overall Study||1
11147319|NCT01498952|12334413|FG002|COMPLETED|Overall Study||0
11147320|NCT01498952|12334414|FG003|COMPLETED|Overall Study||0
11147321|NCT01498952|12334415|FG004|COMPLETED|Overall Study||0
11147322|NCT01498952|12334411|FG000|NOT COMPLETED|Overall Study||2
11147323|NCT01498952|12334412|FG001|NOT COMPLETED|Overall Study||2
11147324|NCT01498952|12334413|FG002|NOT COMPLETED|Overall Study||0
11147325|NCT01498952|12334414|FG003|NOT COMPLETED|Overall Study||0
11147326|NCT01498952|12334415|FG004|NOT COMPLETED|Overall Study||0
11147327|NCT01498978|12334428|FG000|STARTED|Overall Study||10
11147328|NCT01498978|12334428|FG000|COMPLETED|Overall Study||8
11147329|NCT01498978|12334428|FG000|NOT COMPLETED|Overall Study||2
11147330|NCT01499043|12334434|FG000|STARTED|Overall Study||6
11147331|NCT01499043|12334434|FG000|COMPLETED|Overall Study||0
11147332|NCT01499043|12334434|FG000|NOT COMPLETED|Overall Study||6
11147333|NCT01499134|12334445|FG000|STARTED|Overall Study||9
11147334|NCT01499134|12334446|FG001|STARTED|Overall Study||8
11147335|NCT01499134|12334445|FG000|COMPLETED|Overall Study||9
11147336|NCT01499134|12334446|FG001|COMPLETED|Overall Study||7
11147337|NCT01499134|12334445|FG000|NOT COMPLETED|Overall Study||0
11147338|NCT01499134|12334446|FG001|NOT COMPLETED|Overall Study||1
11202754|NCT01842906|12393195|FG001|STARTED|Overall Study||104
11202755|NCT01842906|12393194|FG000|COMPLETED|Overall Study||115
11202756|NCT01842906|12393195|FG001|COMPLETED|Overall Study||104
11202757|NCT01842906|12393194|FG000|NOT COMPLETED|Overall Study||0
11202758|NCT01842906|12393195|FG001|NOT COMPLETED|Overall Study||0
11202759|NCT01842958|12393203|FG000|STARTED|Overall Study||25
11202760|NCT01842958|12393204|FG001|STARTED|Overall Study||25
11202761|NCT01842958|12393203|FG000|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
11202762|NCT01842958|12393204|FG001|Randomized|Overall Study||25
11202763|NCT01842958|12393203|FG000|COMPLETED|Overall Study||24
11202764|NCT01842958|12393204|FG001|COMPLETED|Overall Study||24
11202765|NCT01842958|12393203|FG000|NOT COMPLETED|Overall Study||1
11202766|NCT01842958|12393204|FG001|NOT COMPLETED|Overall Study||1
11202767|NCT01843023|12393212|FG000|STARTED|Overall Study||144
11202768|NCT01843023|12393213|FG001|STARTED|Overall Study||144
11202769|NCT01843023|12393212|FG000|3 Months|Overall Study||110
11202770|NCT01843023|12393213|FG001|3 Months|Overall Study||114
11202771|NCT01843023|12393212|FG000|COMPLETED|Overall Study||111
11202772|NCT01843023|12393213|FG001|COMPLETED|Overall Study||109
11202773|NCT01843023|12393212|FG000|NOT COMPLETED|Overall Study||33
11202774|NCT01843023|12393213|FG001|NOT COMPLETED|Overall Study||35
11202775|NCT01843062|12393221|FG000|STARTED|Overall Study||155
11202776|NCT01843062|12393222|FG001|STARTED|Overall Study||78
11202777|NCT01843062|12393221|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||155
11202778|NCT01843062|12393222|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||78
11202779|NCT01843062|12393221|FG000|Safety Analysis Set|Overall Study||154
11202780|NCT01843062|12393222|FG001|Safety Analysis Set|Overall Study||77
11202781|NCT01843062|12393221|FG000|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91
11202782|NCT01843062|12393222|FG001|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51
11202783|NCT01843062|12393221|FG000|Ongoing at Primary Analysis Data Cut-off|Overall Study||134
11202784|NCT01843062|12393222|FG001|Ongoing at Primary Analysis Data Cut-off|Overall Study||71
11202785|NCT01843062|12393221|FG000|COMPLETED|Overall Study||133
11202786|NCT01843062|12393222|FG001|COMPLETED|Overall Study||69
11202787|NCT01843062|12393221|FG000|NOT COMPLETED|Overall Study||22
11202788|NCT01843062|12393222|FG001|NOT COMPLETED|Overall Study||9
11202789|NCT01843192|12393231|FG000|STARTED|Overall Study||26
11202790|NCT01843192|12393232|FG001|STARTED|Overall Study||34
11202791|NCT01843192|12393233|FG002|STARTED|Overall Study||11
11202792|NCT01843192|12393231|FG000|COMPLETED|Overall Study||24
11202793|NCT01843192|12393232|FG001|COMPLETED|Overall Study||28
11202794|NCT01843192|12393233|FG002|COMPLETED|Overall Study||9
11202795|NCT01843192|12393231|FG000|NOT COMPLETED|Overall Study||2
11202796|NCT01843192|12393232|FG001|NOT COMPLETED|Overall Study||6
11202797|NCT01843192|12393233|FG002|NOT COMPLETED|Overall Study||2
11202798|NCT01843205|12393241|FG000|STARTED|First Treatment (11 Days)||5
11202799|NCT01843205|12393242|FG001|STARTED|First Treatment (11 Days)||4
11202800|NCT01843205|12393241|FG000|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
11202801|NCT01843205|12393242|FG001|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
11202802|NCT01843205|12393241|FG000|NOT COMPLETED|First Treatment (11 Days)||1
11202803|NCT01843205|12393242|FG001|NOT COMPLETED|First Treatment (11 Days)||0
11202804|NCT01843205|12393241|FG000|STARTED|Second Treatment (11 Days)||4
11202805|NCT01843205|12393242|FG001|STARTED|Second Treatment (11 Days)||4
11202806|NCT01843205|12393241|FG000|COMPLETED|Second Treatment (11 Days)||4
11202807|NCT01843205|12393242|FG001|COMPLETED|Second Treatment (11 Days)||4
11202808|NCT01843205|12393241|FG000|NOT COMPLETED|Second Treatment (11 Days)||0
11202809|NCT01843205|12393242|FG001|NOT COMPLETED|Second Treatment (11 Days)||0
11202810|NCT01843348|12393251|FG000|STARTED|Overall Study||205
11202811|NCT01843348|12393252|FG001|STARTED|Overall Study||208
11202812|NCT01843348|12393253|FG002|STARTED|Overall Study||199
11202813|NCT01843348|12393251|FG000|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
11202814|NCT01843348|12393252|FG001|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
11202815|NCT01843348|12393253|FG002|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
11202816|NCT01843348|12393251|FG000|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
11202817|NCT01843348|12393252|FG001|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
11202818|NCT01843348|12393253|FG002|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
11202819|NCT01843348|12393251|FG000|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
11202820|NCT01843348|12393252|FG001|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
11202821|NCT01843348|12393253|FG002|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
11202822|NCT01843348|12393251|FG000|COMPLETED|Overall Study||182
11202823|NCT01843348|12393252|FG001|COMPLETED|Overall Study||168
11202824|NCT01843348|12393253|FG002|COMPLETED|Overall Study||158
11202825|NCT01843348|12393251|FG000|NOT COMPLETED|Overall Study||23
11202826|NCT01843348|12393252|FG001|NOT COMPLETED|Overall Study||40
11202827|NCT01843348|12393253|FG002|NOT COMPLETED|Overall Study||41
11205257|NCT01858363|12396008|FG001|STARTED|Overall Study||72
11147339|NCT01499147|12334454|FG000|STARTED|Overall Study||33
11147340|NCT01499147|12334455|FG001|STARTED|Overall Study||17
11147341|NCT01499147|12334454|FG000|COMPLETED|Overall Study||18
11147342|NCT01499147|12334455|FG001|COMPLETED|Overall Study||12
11147343|NCT01499147|12334454|FG000|NOT COMPLETED|Overall Study||15
11147344|NCT01499147|12334455|FG001|NOT COMPLETED|Overall Study||5
11147345|NCT01499173|12334465|FG000|STARTED|Overall Study||101
11147346|NCT01499173|12334465|FG000|COMPLETED|Overall Study||64
11147347|NCT01499173|12334465|FG000|NOT COMPLETED|Overall Study||37
11147348|NCT01499199|12334470|FG000|STARTED|Overall Study||13
11147349|NCT01499199|12334470|FG000|COMPLETED|Overall Study||11
11147350|NCT01499199|12334470|FG000|NOT COMPLETED|Overall Study||2
11147351|NCT01499277|12334476|FG000|STARTED|Overall Study||506
11147352|NCT01499277|12334477|FG001|STARTED|Overall Study||255
11147353|NCT01499277|12334476|FG000|COMPLETED|Overall Study||459
11147354|NCT01499277|12334477|FG001|COMPLETED|Overall Study||223
11147355|NCT01499277|12334476|FG000|NOT COMPLETED|Overall Study||47
11147356|NCT01499277|12334477|FG001|NOT COMPLETED|Overall Study||32
11147357|NCT01499290|12334485|FG000|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
11147358|NCT01499290|12334486|FG001|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
11147359|NCT01499290|12334485|FG000|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
11147360|NCT01499290|12334486|FG001|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
11147361|NCT01499290|12334485|FG000|NOT COMPLETED|Overall Study||55
11147362|NCT01499290|12334486|FG001|NOT COMPLETED|Overall Study||35
11147363|NCT01499303|12334513|FG000|STARTED|Overall Study||21
11147364|NCT01499303|12334514|FG001|STARTED|Overall Study||47
11147365|NCT01499303|12334513|FG000|COMPLETED|Overall Study||18
11147366|NCT01499303|12334514|FG001|COMPLETED|Overall Study||40
11147367|NCT01499303|12334513|FG000|NOT COMPLETED|Overall Study||3
11147368|NCT01499303|12334514|FG001|NOT COMPLETED|Overall Study||7
11147369|NCT01499355|12334520|FG000|STARTED|Run-In Period||276
11147370|NCT01499355|12334521|FG001|STARTED|Run-In Period||0
11147371|NCT01499355|12334522|FG002|STARTED|Run-In Period||0
11147372|NCT01499355|12334523|FG003|STARTED|Run-In Period||0
11147373|NCT01499355|12334520|FG000|COMPLETED|Run-In Period||245
11147374|NCT01499355|12334521|FG001|COMPLETED|Run-In Period||0
11147375|NCT01499355|12334522|FG002|COMPLETED|Run-In Period||0
11147376|NCT01499355|12334523|FG003|COMPLETED|Run-In Period||0
11147377|NCT01499355|12334520|FG000|NOT COMPLETED|Run-In Period||31
11147378|NCT01499355|12334521|FG001|NOT COMPLETED|Run-In Period||0
11147379|NCT01499355|12334522|FG002|NOT COMPLETED|Run-In Period||0
11147380|NCT01499355|12334523|FG003|NOT COMPLETED|Run-In Period||0
11147381|NCT01499355|12334520|FG000|STARTED|Double-Blind Period||0
11147382|NCT01499355|12334521|FG001|STARTED|Double-Blind Period||63
11147383|NCT01499355|12334522|FG002|STARTED|Double-Blind Period||63
11147384|NCT01499355|12334523|FG003|STARTED|Double-Blind Period||62
11147385|NCT01499355|12334520|FG000|COMPLETED|Double-Blind Period||0
11147386|NCT01499355|12334521|FG001|COMPLETED|Double-Blind Period||40
11147387|NCT01499355|12334522|FG002|COMPLETED|Double-Blind Period||38
11147388|NCT01499355|12334523|FG003|COMPLETED|Double-Blind Period||39
11147389|NCT01499355|12334520|FG000|NOT COMPLETED|Double-Blind Period||0
11147390|NCT01499355|12334521|FG001|NOT COMPLETED|Double-Blind Period||23
11147391|NCT01499355|12334522|FG002|NOT COMPLETED|Double-Blind Period||25
11147392|NCT01499355|12334523|FG003|NOT COMPLETED|Double-Blind Period||23
11147393|NCT01499368|12334536|FG000|STARTED|Overall Study||165
11418399|NCT00514813|12616756|FG002|COMPLETED|Overall Study||0
11418400|NCT00514813|12616757|FG003|COMPLETED|Overall Study||0
11418401|NCT00514813|12616754|FG000|NOT COMPLETED|Overall Study||15
11418402|NCT00514813|12616755|FG001|NOT COMPLETED|Overall Study||86
11147394|NCT01499368|12334537|FG001|STARTED|Overall Study||163
11147395|NCT01499368|12334538|FG002|STARTED|Overall Study||167
11147396|NCT01499368|12334536|FG000|COMPLETED|Overall Study||138
11147397|NCT01499368|12334537|FG001|COMPLETED|Overall Study||145
11147398|NCT01499368|12334538|FG002|COMPLETED|Overall Study||146
11147399|NCT01499368|12334536|FG000|NOT COMPLETED|Overall Study||27
11147400|NCT01499368|12334537|FG001|NOT COMPLETED|Overall Study||18
11147401|NCT01499368|12334538|FG002|NOT COMPLETED|Overall Study||21
11147402|NCT01499498|12334546|FG000|STARTED|Overall Study||13
11147403|NCT01499498|12334546|FG000|COMPLETED|Overall Study||13
11147404|NCT01499498|12334546|FG000|NOT COMPLETED|Overall Study||0
11147405|NCT01499511|12334555|FG000|STARTED|Overall Study||885
11147406|NCT01499511|12334556|FG001|STARTED|Overall Study||833
11147407|NCT01499511|12334555|FG000|COMPLETED|Overall Study||884
11147408|NCT01499511|12334556|FG001|COMPLETED|Overall Study||833
11147409|NCT01499511|12334555|FG000|NOT COMPLETED|Overall Study||1
11147410|NCT01499511|12334556|FG001|NOT COMPLETED|Overall Study||0
11147411|NCT01499576|12334563|FG000|STARTED|Overall Study||126
11147412|NCT01499576|12334563|FG000|COMPLETED|Overall Study||105
11147413|NCT01499576|12334563|FG000|NOT COMPLETED|Overall Study||21
11147414|NCT01499654|12334568|FG000|STARTED|Overall Study||64
11147415|NCT01499654|12334568|FG000|COMPLETED|Overall Study||64
11147416|NCT01499654|12334568|FG000|NOT COMPLETED|Overall Study||0
11147417|NCT01499667|12334581|FG000|STARTED|Overall Study|"Started indicates randomized as well as safety population."|50
11147418|NCT01499667|12334582|FG001|STARTED|Overall Study||42
11147419|NCT01499667|12334583|FG002|STARTED|Overall Study||50
11147420|NCT01499667|12334581|FG000|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
11147421|NCT01499667|12334582|FG001|Full Analysis Set (FAS)|Overall Study||42
11147422|NCT01499667|12334583|FG002|Full Analysis Set (FAS)|Overall Study||50
11147423|NCT01499667|12334581|FG000|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
11147424|NCT01499667|12334582|FG001|Modified Full Analysis Set|Overall Study||29
11147425|NCT01499667|12334583|FG002|Modified Full Analysis Set|Overall Study||39
11147426|NCT01499667|12334581|FG000|COMPLETED|Overall Study||41
11147427|NCT01499667|12334582|FG001|COMPLETED|Overall Study||31
11147428|NCT01499667|12334583|FG002|COMPLETED|Overall Study||40
11147429|NCT01499667|12334581|FG000|NOT COMPLETED|Overall Study||9
11147430|NCT01499667|12334582|FG001|NOT COMPLETED|Overall Study||11
11147431|NCT01499667|12334583|FG002|NOT COMPLETED|Overall Study||10
11147432|NCT01499810|12334591|FG000|STARTED|Overall Study||53
11147433|NCT01499810|12334591|FG000|COMPLETED|Overall Study||41
11147434|NCT01499810|12334591|FG000|NOT COMPLETED|Overall Study||12
11147435|NCT01499849|12334598|FG000|STARTED|Overall Study|Number of randomized patients|266
11418403|NCT00514813|12616756|FG002|NOT COMPLETED|Overall Study||47
11147436|NCT01499849|12334599|FG001|STARTED|Overall Study||266
11147437|NCT01499849|12334598|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
11147438|NCT01499849|12334599|FG001|COMPLETED|Overall Study||40
11147439|NCT01499849|12334598|FG000|NOT COMPLETED|Overall Study||224
11147440|NCT01499849|12334599|FG001|NOT COMPLETED|Overall Study||226
11147441|NCT01499862|12334605|FG000|STARTED|Overall Study||3
11147442|NCT01499862|12334605|FG000|COMPLETED|Overall Study||3
11147443|NCT01499862|12334605|FG000|NOT COMPLETED|Overall Study||0
11147444|NCT01499940|12334623|FG000|STARTED|Overall Study||9
11147445|NCT01499940|12334623|FG000|COMPLETED|Overall Study||0
11147446|NCT01499940|12334623|FG000|NOT COMPLETED|Overall Study||9
11147447|NCT01500031|12334627|FG000|STARTED|Overall Study||92
11147448|NCT01500031|12334627|FG000|COMPLETED|Overall Study||87
11147449|NCT01500031|12334627|FG000|NOT COMPLETED|Overall Study||5
11147450|NCT01500057|12334633|FG000|STARTED|Overall Study||31
11147451|NCT01500057|12334634|FG001|STARTED|Overall Study||35
11147452|NCT01500057|12334633|FG000|COMPLETED|Overall Study||25
11322794|NCT00353938|12520053|FG000|STARTED|Stage 3||0
11322795|NCT00353938|12520054|FG001|STARTED|Stage 3||0
11322796|NCT00353938|12520055|FG002|STARTED|Stage 3||0
11322797|NCT00353938|12520056|FG003|STARTED|Stage 3||3
11322798|NCT00353938|12520053|FG000|COMPLETED|Stage 3||0
11322799|NCT00353938|12520054|FG001|COMPLETED|Stage 3||0
11322800|NCT00353938|12520055|FG002|COMPLETED|Stage 3||0
11322801|NCT00353938|12520056|FG003|COMPLETED|Stage 3||3
11418404|NCT00514813|12616757|FG003|NOT COMPLETED|Overall Study||4
11322802|NCT00353938|12520053|FG000|NOT COMPLETED|Stage 3||0
11322803|NCT00353938|12520054|FG001|NOT COMPLETED|Stage 3||0
11322804|NCT00353938|12520055|FG002|NOT COMPLETED|Stage 3||0
11322805|NCT00353938|12520056|FG003|NOT COMPLETED|Stage 3||0
11322806|NCT00090064|12520066|FG000|STARTED|Overall Study||15
11322807|NCT00090064|12520067|FG001|STARTED|Overall Study||8
11322808|NCT00090064|12520066|FG000|COMPLETED|Overall Study||12
11322809|NCT00090064|12520067|FG001|COMPLETED|Overall Study||8
11322810|NCT00090064|12520066|FG000|NOT COMPLETED|Overall Study||3
11322811|NCT00090064|12520067|FG001|NOT COMPLETED|Overall Study||0
11342815|NCT02948582|12540170|FG003|STARTED|Treatment Period 6||6
11342816|NCT02948582|12540171|FG004|STARTED|Treatment Period 6||7
11342817|NCT02948582|12540172|FG005|STARTED|Treatment Period 6||6
11147453|NCT01500057|12334634|FG001|COMPLETED|Overall Study||31
11147454|NCT01500057|12334633|FG000|NOT COMPLETED|Overall Study||6
11147455|NCT01500057|12334634|FG001|NOT COMPLETED|Overall Study||4
11147456|NCT01500083|12334642|FG000|STARTED|Overall Study||16
11147457|NCT01500083|12334643|FG001|STARTED|Overall Study||74
11147458|NCT01500083|12334642|FG000|COMPLETED|Overall Study||4
11147459|NCT01500083|12334643|FG001|COMPLETED|Overall Study||31
11147460|NCT01500083|12334642|FG000|NOT COMPLETED|Overall Study||12
11147461|NCT01500083|12334643|FG001|NOT COMPLETED|Overall Study||43
11147462|NCT01500096|12334653|FG000|STARTED|Overall Study||32
11147463|NCT01500096|12334654|FG001|STARTED|Overall Study||17
11147464|NCT01500096|12334655|FG002|STARTED|Overall Study||31
11147465|NCT01500096|12334656|FG003|STARTED|Overall Study||16
11147466|NCT01500096|12334653|FG000|COMPLETED|Overall Study||31
11147467|NCT01500096|12334654|FG001|COMPLETED|Overall Study||17
11147468|NCT01500096|12334655|FG002|COMPLETED|Overall Study||31
11147469|NCT01500096|12334656|FG003|COMPLETED|Overall Study||14
11147470|NCT01500096|12334653|FG000|NOT COMPLETED|Overall Study||1
11147471|NCT01500096|12334654|FG001|NOT COMPLETED|Overall Study||0
11147472|NCT01500096|12334655|FG002|NOT COMPLETED|Overall Study||0
11147473|NCT01500096|12334656|FG003|NOT COMPLETED|Overall Study||2
11147474|NCT01500135|12334668|FG000|STARTED|Overall Study||100
11147475|NCT01500135|12334669|FG001|STARTED|Overall Study||50
11147476|NCT01500135|12334668|FG000|COMPLETED|Overall Study||83
11147477|NCT01500135|12334669|FG001|COMPLETED|Overall Study||39
11147478|NCT01500135|12334668|FG000|NOT COMPLETED|Overall Study||17
11147479|NCT01500135|12334669|FG001|NOT COMPLETED|Overall Study||11
11147480|NCT01500187|12334677|FG000|STARTED|Overall Study||23
11147481|NCT01500187|12334678|FG001|STARTED|Overall Study||15
11147482|NCT01500187|12334677|FG000|COMPLETED|Overall Study||17
11147483|NCT01500187|12334678|FG001|COMPLETED|Overall Study||15
11147484|NCT01500187|12334677|FG000|NOT COMPLETED|Overall Study||6
11147485|NCT01500187|12334678|FG001|NOT COMPLETED|Overall Study||0
11147486|NCT01500200|12334687|FG000|STARTED|Stage 1||98
11147487|NCT01500200|12334688|FG001|STARTED|Stage 1||24
11147488|NCT01500200|12334689|FG002|STARTED|Stage 1||19
11342818|NCT02948582|12540167|FG000|COMPLETED|Treatment Period 6||6
11342819|NCT02948582|12540168|FG001|COMPLETED|Treatment Period 6||4
11147489|NCT01500200|12334690|FG003|STARTED|Stage 1||0
11147490|NCT01500200|12334691|FG004|STARTED|Stage 1||0
11147491|NCT01500200|12334692|FG005|STARTED|Stage 1||0
11147492|NCT01500200|12334687|FG000|COMPLETED|Stage 1||90
11147493|NCT01500200|12334688|FG001|COMPLETED|Stage 1||18
11147494|NCT01500200|12334689|FG002|COMPLETED|Stage 1||13
11147495|NCT01500200|12334690|FG003|COMPLETED|Stage 1||0
11147496|NCT01500200|12334691|FG004|COMPLETED|Stage 1||0
11147497|NCT01500200|12334692|FG005|COMPLETED|Stage 1||0
11147498|NCT01500200|12334687|FG000|NOT COMPLETED|Stage 1||8
11147499|NCT01500200|12334688|FG001|NOT COMPLETED|Stage 1||6
11147500|NCT01500200|12334689|FG002|NOT COMPLETED|Stage 1||6
11147501|NCT01500200|12334690|FG003|NOT COMPLETED|Stage 1||0
11147502|NCT01500200|12334691|FG004|NOT COMPLETED|Stage 1||0
11147503|NCT01500200|12334692|FG005|NOT COMPLETED|Stage 1||0
11147504|NCT01500200|12334687|FG000|STARTED|Stage 2||0
11147505|NCT01500200|12334688|FG001|STARTED|Stage 2||0
11147506|NCT01500200|12334689|FG002|STARTED|Stage 2||0
11147507|NCT01500200|12334690|FG003|STARTED|Stage 2||20
11147508|NCT01500200|12334691|FG004|STARTED|Stage 2||23
11147509|NCT01500200|12334692|FG005|STARTED|Stage 2||22
11147510|NCT01500200|12334687|FG000|COMPLETED|Stage 2||0
11147511|NCT01500200|12334688|FG001|COMPLETED|Stage 2||0
11147512|NCT01500200|12334689|FG002|COMPLETED|Stage 2||0
11147513|NCT01500200|12334690|FG003|COMPLETED|Stage 2||20
11147514|NCT01500200|12334691|FG004|COMPLETED|Stage 2||18
11147515|NCT01500200|12334692|FG005|COMPLETED|Stage 2||18
11147516|NCT01500200|12334687|FG000|NOT COMPLETED|Stage 2||0
11147517|NCT01500200|12334688|FG001|NOT COMPLETED|Stage 2||0
11147518|NCT01500200|12334689|FG002|NOT COMPLETED|Stage 2||0
11147519|NCT01500200|12334690|FG003|NOT COMPLETED|Stage 2||0
11147520|NCT01500200|12334691|FG004|NOT COMPLETED|Stage 2||5
11147521|NCT01500200|12334692|FG005|NOT COMPLETED|Stage 2||4
11147522|NCT01500213|12334708|FG000|STARTED|Overall Study|Number of randomized patients|278
11147523|NCT01500213|12334709|FG001|STARTED|Overall Study||277
11147524|NCT01500213|12334708|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
11147525|NCT01500213|12334709|FG001|COMPLETED|Overall Study||53
11147526|NCT01500213|12334708|FG000|NOT COMPLETED|Overall Study||217
11147527|NCT01500213|12334709|FG001|NOT COMPLETED|Overall Study||224
11147528|NCT01500226|12334717|FG000|STARTED|Overall Study|Number of randomized patients|684
11147529|NCT01500226|12334718|FG001|STARTED|Overall Study||685
11147530|NCT01500226|12334717|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
11147531|NCT01500226|12334718|FG001|COMPLETED|Overall Study||191
11147532|NCT01500226|12334717|FG000|NOT COMPLETED|Overall Study||499
11147533|NCT01500226|12334718|FG001|NOT COMPLETED|Overall Study||494
11147534|NCT01500252|12334726|FG000|STARTED|Overall Study||21
11147535|NCT01500252|12334727|FG001|STARTED|Overall Study||17
11147536|NCT01500252|12334726|FG000|One Years|Overall Study||20
11147537|NCT01500252|12334727|FG001|One Years|Overall Study||16
11147538|NCT01500252|12334726|FG000|Five Years|Overall Study||17
11147539|NCT01500252|12334727|FG001|Five Years|Overall Study||13
11147540|NCT01500252|12334726|FG000|Ten Years|Overall Study||12
11147541|NCT01500252|12334727|FG001|Ten Years|Overall Study||11
11147542|NCT01500252|12334726|FG000|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
11147543|NCT01500252|12334727|FG001|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
11147544|NCT01500252|12334726|FG000|NOT COMPLETED|Overall Study||9
11147545|NCT01500252|12334727|FG001|NOT COMPLETED|Overall Study||6
11147546|NCT01500278|12334736|FG000|STARTED|Week 0 - Week 12||457
11147547|NCT01500278|12334737|FG001|STARTED|Week 0 - Week 12||458
11147548|NCT01500278|12334736|FG000|COMPLETED|Week 0 - Week 12||426
11147549|NCT01500278|12334737|FG001|COMPLETED|Week 0 - Week 12||428
11147550|NCT01500278|12334736|FG000|NOT COMPLETED|Week 0 - Week 12||31
11147551|NCT01500278|12334737|FG001|NOT COMPLETED|Week 0 - Week 12||30
11147552|NCT01500278|12334736|FG000|STARTED|Week 13 - Week 104||426
11147553|NCT01500278|12334737|FG001|STARTED|Week 13 - Week 104||428
11147554|NCT01500278|12334736|FG000|COMPLETED|Week 13 - Week 104||287
11147555|NCT01500278|12334737|FG001|COMPLETED|Week 13 - Week 104||302
11147556|NCT01500278|12334736|FG000|NOT COMPLETED|Week 13 - Week 104||139
11147557|NCT01500278|12334737|FG001|NOT COMPLETED|Week 13 - Week 104||126
11147558|NCT01500317|12334748|FG000|STARTED|Overall Study||13
11147559|NCT01500317|12334749|FG001|STARTED|Overall Study||12
11147560|NCT01500317|12334750|FG002|STARTED|Overall Study||13
11147561|NCT01500317|12334748|FG000|COMPLETED|Overall Study||10
11147562|NCT01500317|12334749|FG001|COMPLETED|Overall Study||10
11147563|NCT01500317|12334750|FG002|COMPLETED|Overall Study||13
11147564|NCT01500317|12334748|FG000|NOT COMPLETED|Overall Study||3
11147565|NCT01500317|12334749|FG001|NOT COMPLETED|Overall Study||2
11147566|NCT01500317|12334750|FG002|NOT COMPLETED|Overall Study||0
11147567|NCT01500382|12334762|FG000|STARTED|Treatment Period 1||1
11147568|NCT01500382|12334763|FG001|STARTED|Treatment Period 1||1
11147569|NCT01500382|12334764|FG002|STARTED|Treatment Period 1||1
11147570|NCT01500382|12334765|FG003|STARTED|Treatment Period 1||1
11147571|NCT01500382|12334762|FG000|COMPLETED|Treatment Period 1||1
11147572|NCT01500382|12334763|FG001|COMPLETED|Treatment Period 1||1
11147573|NCT01500382|12334764|FG002|COMPLETED|Treatment Period 1||1
11147574|NCT01500382|12334765|FG003|COMPLETED|Treatment Period 1||1
11147575|NCT01500382|12334762|FG000|NOT COMPLETED|Treatment Period 1||0
11147576|NCT01500382|12334763|FG001|NOT COMPLETED|Treatment Period 1||0
11147577|NCT01500382|12334764|FG002|NOT COMPLETED|Treatment Period 1||0
11147578|NCT01500382|12334765|FG003|NOT COMPLETED|Treatment Period 1||0
11147579|NCT01500382|12334762|FG000|STARTED|Washout Period||1
11147580|NCT01500382|12334763|FG001|STARTED|Washout Period||1
11147581|NCT01500382|12334764|FG002|STARTED|Washout Period||1
11147582|NCT01500382|12334765|FG003|STARTED|Washout Period||1
11147583|NCT01500382|12334762|FG000|COMPLETED|Washout Period||1
11147584|NCT01500382|12334763|FG001|COMPLETED|Washout Period||1
11147585|NCT01500382|12334764|FG002|COMPLETED|Washout Period||0
11147586|NCT01500382|12334765|FG003|COMPLETED|Washout Period||1
11147587|NCT01500382|12334762|FG000|NOT COMPLETED|Washout Period||0
11147588|NCT01500382|12334763|FG001|NOT COMPLETED|Washout Period||0
11147589|NCT01500382|12334764|FG002|NOT COMPLETED|Washout Period||1
11147590|NCT01500382|12334765|FG003|NOT COMPLETED|Washout Period||0
11147591|NCT01500382|12334762|FG000|STARTED|Treatment Period 2||1
11147592|NCT01500382|12334763|FG001|STARTED|Treatment Period 2||1
11147593|NCT01500382|12334764|FG002|STARTED|Treatment Period 2||0
11147594|NCT01500382|12334765|FG003|STARTED|Treatment Period 2||1
11147595|NCT01500382|12334762|FG000|COMPLETED|Treatment Period 2||1
11147596|NCT01500382|12334763|FG001|COMPLETED|Treatment Period 2||1
11147597|NCT01500382|12334764|FG002|COMPLETED|Treatment Period 2||0
11147598|NCT01500382|12334765|FG003|COMPLETED|Treatment Period 2||1
11147599|NCT01500382|12334762|FG000|NOT COMPLETED|Treatment Period 2||0
11147600|NCT01500382|12334763|FG001|NOT COMPLETED|Treatment Period 2||0
11147601|NCT01500382|12334764|FG002|NOT COMPLETED|Treatment Period 2||0
11147602|NCT01500382|12334765|FG003|NOT COMPLETED|Treatment Period 2||0
11147603|NCT01500434|12334775|FG000|STARTED|Overall Study||102
11147604|NCT01500434|12334775|FG000|COMPLETED|Overall Study||95
11147605|NCT01500434|12334775|FG000|NOT COMPLETED|Overall Study||7
11147606|NCT01500525|12334781|FG000|STARTED|Overall Study||286
11147607|NCT01500525|12334782|FG001|STARTED|Overall Study||301
11147608|NCT01500525|12334781|FG000|COMPLETED|Overall Study||286
11147609|NCT01500525|12334782|FG001|COMPLETED|Overall Study||301
11147610|NCT01500525|12334781|FG000|NOT COMPLETED|Overall Study||0
11147611|NCT01500525|12334782|FG001|NOT COMPLETED|Overall Study||0
11147612|NCT01500629|12334790|FG000|STARTED|Period 1 (Single Dose)||11
11147613|NCT01500629|12334791|FG001|STARTED|Period 1 (Single Dose)||10
11147614|NCT01500629|12334790|FG000|COMPLETED|Period 1 (Single Dose)||11
11147615|NCT01500629|12334791|FG001|COMPLETED|Period 1 (Single Dose)||10
11147616|NCT01500629|12334790|FG000|NOT COMPLETED|Period 1 (Single Dose)||0
11147617|NCT01500629|12334791|FG001|NOT COMPLETED|Period 1 (Single Dose)||0
11147618|NCT01500629|12334790|FG000|STARTED|Washout Period of 14 to 30 Days||11
11147619|NCT01500629|12334791|FG001|STARTED|Washout Period of 14 to 30 Days||10
11147620|NCT01500629|12334790|FG000|COMPLETED|Washout Period of 14 to 30 Days||10
11147621|NCT01500629|12334791|FG001|COMPLETED|Washout Period of 14 to 30 Days||10
11147622|NCT01500629|12334790|FG000|NOT COMPLETED|Washout Period of 14 to 30 Days||1
11147623|NCT01500629|12334791|FG001|NOT COMPLETED|Washout Period of 14 to 30 Days||0
11147624|NCT01500629|12334790|FG000|STARTED|Period 2 (Single Dose)||10
11147625|NCT01500629|12334791|FG001|STARTED|Period 2 (Single Dose)||10
11147626|NCT01500629|12334790|FG000|COMPLETED|Period 2 (Single Dose)||10
11147627|NCT01500629|12334791|FG001|COMPLETED|Period 2 (Single Dose)||10
11147628|NCT01500629|12334790|FG000|NOT COMPLETED|Period 2 (Single Dose)||0
11147629|NCT01500629|12334791|FG001|NOT COMPLETED|Period 2 (Single Dose)||0
11147630|NCT01500694|12334806|FG000|STARTED|Overall Study||131
11147631|NCT01500694|12334807|FG001|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
11147632|NCT01500694|12334806|FG000|COMPLETED|Overall Study||79
11147633|NCT01500694|12334807|FG001|COMPLETED|Overall Study||54
11147634|NCT01500694|12334806|FG000|NOT COMPLETED|Overall Study||52
11147635|NCT01500694|12334807|FG001|NOT COMPLETED|Overall Study||29
11147636|NCT01500720|12334815|FG000|STARTED|Overall Study|Randomized|90
11147637|NCT01500720|12334816|FG001|STARTED|Overall Study|Randomized|89
11147638|NCT01500720|12334815|FG000|Treated|Overall Study||89
11147639|NCT01500720|12334816|FG001|Treated|Overall Study||88
11147640|NCT01500720|12334815|FG000|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
11147641|NCT01500720|12334816|FG001|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
11147642|NCT01500720|12334815|FG000|NOT COMPLETED|Overall Study||5
11147643|NCT01500720|12334816|FG001|NOT COMPLETED|Overall Study||9
11147644|NCT01500746|12334824|FG000|STARTED|Overall Study||4
11147645|NCT01500746|12334825|FG001|STARTED|Overall Study||4
11147646|NCT01500746|12334824|FG000|COMPLETED|Overall Study||4
11147647|NCT01500746|12334825|FG001|COMPLETED|Overall Study||4
11147648|NCT01500746|12334824|FG000|NOT COMPLETED|Overall Study||0
11147649|NCT01500746|12334825|FG001|NOT COMPLETED|Overall Study||0
11147650|NCT01500759|12334833|FG000|STARTED|Overall Study||3686
11147651|NCT01500759|12334834|FG001|STARTED|Overall Study||3190
11147652|NCT01500759|12334833|FG000|COMPLETED|Overall Study||3686
11147653|NCT01500759|12334834|FG001|COMPLETED|Overall Study||3190
11147654|NCT01500759|12334833|FG000|NOT COMPLETED|Overall Study||0
11147655|NCT01500759|12334834|FG001|NOT COMPLETED|Overall Study||0
11147656|NCT01501110|12334851|FG000|STARTED|Overall Study||34
11147657|NCT01501110|12334852|FG001|STARTED|Overall Study||34
11147658|NCT01501110|12334851|FG000|COMPLETED|Overall Study||34
11147659|NCT01501110|12334852|FG001|COMPLETED|Overall Study||33
11147660|NCT01501110|12334851|FG000|NOT COMPLETED|Overall Study||0
11147661|NCT01501110|12334852|FG001|NOT COMPLETED|Overall Study||1
11147662|NCT01501162|12334860|FG000|STARTED|Overall Study||65
11147663|NCT01501162|12334861|FG001|STARTED|Overall Study||65
11147664|NCT01501162|12334860|FG000|COMPLETED|Overall Study||57
11147665|NCT01501162|12334861|FG001|COMPLETED|Overall Study||60
11147666|NCT01501162|12334860|FG000|NOT COMPLETED|Overall Study||8
11147667|NCT01501162|12334861|FG001|NOT COMPLETED|Overall Study||5
11147668|NCT01501929|12334867|FG000|STARTED|First Intervention||8
11147669|NCT01501929|12334868|FG001|STARTED|First Intervention||17
11147670|NCT01501929|12334867|FG000|COMPLETED|First Intervention||8
11147671|NCT01501929|12334868|FG001|COMPLETED|First Intervention||17
11147672|NCT01501929|12334867|FG000|NOT COMPLETED|First Intervention||0
11147673|NCT01501929|12334868|FG001|NOT COMPLETED|First Intervention||0
11147674|NCT01501929|12334867|FG000|STARTED|Second Intervention||8
11147675|NCT01501929|12334868|FG001|STARTED|Second Intervention||17
11147676|NCT01501929|12334867|FG000|COMPLETED|Second Intervention||8
11147677|NCT01501929|12334868|FG001|COMPLETED|Second Intervention||17
11147678|NCT01501929|12334867|FG000|NOT COMPLETED|Second Intervention||0
11147679|NCT01501929|12334868|FG001|NOT COMPLETED|Second Intervention||0
11147680|NCT01502033|12334874|FG000|STARTED|Overall Study|Milestone (10 participants) met.|10
11147681|NCT01502033|12334874|FG000|COMPLETED|Overall Study|Milestone (10 participants) met|7
11147682|NCT01502033|12334874|FG000|NOT COMPLETED|Overall Study||3
11147683|NCT01502072|12334883|FG000|STARTED|Overall Study||14
11147684|NCT01502072|12334884|FG001|STARTED|Overall Study||10
11147685|NCT01502072|12334885|FG002|STARTED|Overall Study||20
11147686|NCT01502072|12334883|FG000|COMPLETED|Overall Study||13
11147687|NCT01502072|12334884|FG001|COMPLETED|Overall Study||9
11147688|NCT01502072|12334885|FG002|COMPLETED|Overall Study||20
11147689|NCT01502072|12334883|FG000|NOT COMPLETED|Overall Study||1
11147690|NCT01502072|12334884|FG001|NOT COMPLETED|Overall Study||1
11147691|NCT01502072|12334885|FG002|NOT COMPLETED|Overall Study||0
11147692|NCT01502228|12334893|FG000|STARTED|Overall Study||14
11147693|NCT01502228|12334893|FG000|COMPLETED|Overall Study||13
11147694|NCT01502228|12334893|FG000|NOT COMPLETED|Overall Study||1
11147695|NCT01502293|12334900|FG000|STARTED|Overall Study||30
11147696|NCT01502293|12334901|FG001|STARTED|Overall Study||17
11147697|NCT01502293|12334902|FG002|STARTED|Overall Study||4
11147698|NCT01502293|12334900|FG000|COMPLETED|Overall Study||5
11147699|NCT01502293|12334901|FG001|COMPLETED|Overall Study||0
11147700|NCT01502293|12334902|FG002|COMPLETED|Overall Study||0
11147701|NCT01502293|12334900|FG000|NOT COMPLETED|Overall Study||25
11147702|NCT01502293|12334901|FG001|NOT COMPLETED|Overall Study||17
11147703|NCT01502293|12334902|FG002|NOT COMPLETED|Overall Study||4
11147704|NCT01502306|12334916|FG000|STARTED|Overall Study||1004
11147705|NCT01502306|12334917|FG001|STARTED|Overall Study||1405
11147706|NCT01502306|12334918|FG002|STARTED|Overall Study||1407
11147707|NCT01502306|12334916|FG000|COMPLETED|Overall Study||1004
11147708|NCT01502306|12334917|FG001|COMPLETED|Overall Study||1405
11147709|NCT01502306|12334918|FG002|COMPLETED|Overall Study||1407
11147710|NCT01502306|12334916|FG000|NOT COMPLETED|Overall Study||0
11147711|NCT01502306|12334917|FG001|NOT COMPLETED|Overall Study||0
11147712|NCT01502306|12334918|FG002|NOT COMPLETED|Overall Study||0
11147713|NCT01502332|12334928|FG000|STARTED|Overall Study||157
11147714|NCT01502332|12334929|FG001|STARTED|Overall Study||163
11147715|NCT01502332|12334928|FG000|COMPLETED|Overall Study||157
11147716|NCT01502332|12334929|FG001|COMPLETED|Overall Study||163
11147717|NCT01502332|12334928|FG000|NOT COMPLETED|Overall Study||0
11147718|NCT01502332|12334929|FG001|NOT COMPLETED|Overall Study||0
11147719|NCT01502410|12334939|FG000|STARTED|Overall Study||10
11147720|NCT01502410|12334940|FG001|STARTED|Overall Study||10
11147721|NCT01502410|12334941|FG002|STARTED|Overall Study||0
11147722|NCT01502410|12334942|FG003|STARTED|Overall Study||0
11147723|NCT01502410|12334939|FG000|COMPLETED|Overall Study||0
11147724|NCT01502410|12334940|FG001|COMPLETED|Overall Study||0
11147725|NCT01502410|12334941|FG002|COMPLETED|Overall Study||0
11147726|NCT01502410|12334942|FG003|COMPLETED|Overall Study||0
11147727|NCT01502410|12334939|FG000|NOT COMPLETED|Overall Study||10
11147728|NCT01502410|12334940|FG001|NOT COMPLETED|Overall Study||10
11147729|NCT01502410|12334941|FG002|NOT COMPLETED|Overall Study||0
11147730|NCT01502410|12334942|FG003|NOT COMPLETED|Overall Study||0
11147731|NCT01502423|12334953|FG000|STARTED|Overall Study||31
11147732|NCT01502423|12334954|FG001|STARTED|Overall Study||30
11147733|NCT01502423|12334953|FG000|COMPLETED|Overall Study||31
11147734|NCT01502423|12334954|FG001|COMPLETED|Overall Study||29
11147735|NCT01502423|12334953|FG000|NOT COMPLETED|Overall Study||0
11147736|NCT01502423|12334954|FG001|NOT COMPLETED|Overall Study||1
11147737|NCT01502631|12334962|FG000|STARTED|Overall Study||30
11147738|NCT01502631|12334963|FG001|STARTED|Overall Study||31
11147739|NCT01502631|12334962|FG000|COMPLETED|Overall Study||10
11147740|NCT01502631|12334963|FG001|COMPLETED|Overall Study||11
11147741|NCT01502631|12334962|FG000|NOT COMPLETED|Overall Study||20
11147742|NCT01502631|12334963|FG001|NOT COMPLETED|Overall Study||20
11147743|NCT01502644|12334972|FG000|STARTED|Enrolled at Visit 1 After Pre-screening||81
11147744|NCT01502644|12334973|FG001|STARTED|Enrolled at Visit 1 After Pre-screening||0
11147745|NCT01502644|12334974|FG002|STARTED|Enrolled at Visit 1 After Pre-screening||0
11147746|NCT01502644|12334975|FG003|STARTED|Enrolled at Visit 1 After Pre-screening||0
11147747|NCT01502644|12334972|FG000|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
11147748|NCT01502644|12334973|FG001|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
11147749|NCT01502644|12334974|FG002|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
11147750|NCT01502644|12334975|FG003|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
11147751|NCT01502644|12334972|FG000|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
11147752|NCT01502644|12334973|FG001|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
11147753|NCT01502644|12334974|FG002|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
11147754|NCT01502644|12334975|FG003|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
11147755|NCT01502644|12334972|FG000|STARTED|Assigned to NA Groups||0
11147756|NCT01502644|12334973|FG001|STARTED|Assigned to NA Groups||30
11147757|NCT01502644|12334974|FG002|STARTED|Assigned to NA Groups||10
11147758|NCT01502644|12334975|FG003|STARTED|Assigned to NA Groups||32
11147759|NCT01502644|12334972|FG000|COMPLETED|Assigned to NA Groups||0
11147760|NCT01502644|12334973|FG001|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
11147761|NCT01502644|12334974|FG002|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
11147762|NCT01502644|12334975|FG003|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
11147763|NCT01502644|12334972|FG000|NOT COMPLETED|Assigned to NA Groups||0
11147764|NCT01502644|12334973|FG001|NOT COMPLETED|Assigned to NA Groups||6
11147765|NCT01502644|12334974|FG002|NOT COMPLETED|Assigned to NA Groups||3
11147766|NCT01502644|12334975|FG003|NOT COMPLETED|Assigned to NA Groups||8
11026636|NCT00829387|12205225|FG001|STARTED|Overall Study||24
11147767|NCT01502709|12334985|FG000|STARTED|Overall Study||5
11147768|NCT01502709|12334986|FG001|STARTED|Overall Study||0
11147769|NCT01502709|12334985|FG000|COMPLETED|Overall Study||1
11147770|NCT01502709|12334986|FG001|COMPLETED|Overall Study||0
11418405|NCT00506064|12616769|FG000|STARTED|Overall Study||1
11418406|NCT00506064|12616770|FG001|STARTED|Overall Study||0
11147771|NCT01502709|12334985|FG000|NOT COMPLETED|Overall Study||4
11147772|NCT01502709|12334986|FG001|NOT COMPLETED|Overall Study||0
11147773|NCT01502761|12334997|FG000|STARTED|Overall Study||4
11147774|NCT01502761|12334998|FG001|STARTED|Overall Study||0
11147775|NCT01502761|12334999|FG002|STARTED|Overall Study||0
11147776|NCT01502761|12335000|FG003|STARTED|Overall Study||0
11147777|NCT01502761|12334997|FG000|COMPLETED|Overall Study||4
11147778|NCT01502761|12334998|FG001|COMPLETED|Overall Study||0
11147779|NCT01502761|12334999|FG002|COMPLETED|Overall Study||0
11147780|NCT01502761|12335000|FG003|COMPLETED|Overall Study||0
11147781|NCT01502761|12334997|FG000|NOT COMPLETED|Overall Study||0
11147782|NCT01502761|12334998|FG001|NOT COMPLETED|Overall Study||0
11147783|NCT01502761|12334999|FG002|NOT COMPLETED|Overall Study||0
11147784|NCT01502761|12335000|FG003|NOT COMPLETED|Overall Study||0
11147785|NCT01502787|12335010|FG000|STARTED|Overall Study||11
11147786|NCT01502787|12335011|FG001|STARTED|Overall Study||10
11147787|NCT01502787|12335010|FG000|COMPLETED|Overall Study||11
11147788|NCT01502787|12335011|FG001|COMPLETED|Overall Study||10
11147789|NCT01502787|12335010|FG000|NOT COMPLETED|Overall Study||0
11147790|NCT01502787|12335011|FG001|NOT COMPLETED|Overall Study||0
11147791|NCT01502813|12335021|FG000|STARTED|Overall Study||40
11147792|NCT01502813|12335021|FG000|COMPLETED|Overall Study||40
11147793|NCT01502813|12335021|FG000|NOT COMPLETED|Overall Study||0
11147794|NCT01502956|12335027|FG000|STARTED|Overall Study||192
11147795|NCT01502956|12335028|FG001|STARTED|Overall Study||194
11147796|NCT01502956|12335027|FG000|COMPLETED|Overall Study||168
11147797|NCT01502956|12335028|FG001|COMPLETED|Overall Study||168
11147798|NCT01502956|12335027|FG000|NOT COMPLETED|Overall Study||24
11147799|NCT01502956|12335028|FG001|NOT COMPLETED|Overall Study||26
11147800|NCT01503021|12335036|FG000|STARTED|Overall Study||360
11147801|NCT01503021|12335037|FG001|STARTED|Overall Study||358
11147802|NCT01503021|12335036|FG000|Dosed|Overall Study||351
11147803|NCT01503021|12335037|FG001|Dosed|Overall Study||352
11147804|NCT01503021|12335036|FG000|Completed Treatment|Overall Study||333
11147805|NCT01503021|12335037|FG001|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
11147806|NCT01503021|12335036|FG000|COMPLETED|Overall Study||333
11147807|NCT01503021|12335037|FG001|COMPLETED|Overall Study||332
11147808|NCT01503021|12335036|FG000|NOT COMPLETED|Overall Study||27
11147809|NCT01503021|12335037|FG001|NOT COMPLETED|Overall Study||26
11147810|NCT01503164|12335050|FG000|STARTED|Overall Study||55
11147811|NCT01503164|12335051|FG001|STARTED|Overall Study||56
11147812|NCT01503164|12335050|FG000|COMPLETED|Overall Study||53
11147813|NCT01503164|12335051|FG001|COMPLETED|Overall Study||55
11147814|NCT01503164|12335050|FG000|NOT COMPLETED|Overall Study||2
11147815|NCT01503164|12335051|FG001|NOT COMPLETED|Overall Study||1
11147816|NCT01503229|12335057|FG000|STARTED|Overall Study||30
11147817|NCT01503229|12335057|FG000|COMPLETED|Overall Study||29
11147818|NCT01503229|12335057|FG000|NOT COMPLETED|Overall Study||1
11147819|NCT01503333|12335063|FG000|STARTED|Overall Study||777
11147820|NCT01503333|12335064|FG001|STARTED|Overall Study||766
11147821|NCT01503333|12335063|FG000|Completed Baseline|Overall Study||766
11147822|NCT01503333|12335064|FG001|Completed Baseline|Overall Study||753
11147823|NCT01503333|12335063|FG000|Completed Post-intervention|Overall Study||680
11147824|NCT01503333|12335064|FG001|Completed Post-intervention|Overall Study||706
11147825|NCT01503333|12335063|FG000|COMPLETED|Overall Study||437
11147826|NCT01503333|12335064|FG001|COMPLETED|Overall Study||461
11147827|NCT01503333|12335063|FG000|NOT COMPLETED|Overall Study||340
11147828|NCT01503333|12335064|FG001|NOT COMPLETED|Overall Study||305
11147829|NCT01503749|12335081|FG000|STARTED|Overall Study||3
11147830|NCT01503749|12335082|FG001|STARTED|Overall Study||3
11147831|NCT01503749|12335083|FG002|STARTED|Overall Study||3
11147832|NCT01503749|12335081|FG000|COMPLETED|Overall Study||3
11147833|NCT01503749|12335082|FG001|COMPLETED|Overall Study||3
11147834|NCT01503749|12335083|FG002|COMPLETED|Overall Study||3
11147835|NCT01503749|12335081|FG000|NOT COMPLETED|Overall Study||0
11147836|NCT01503749|12335082|FG001|NOT COMPLETED|Overall Study||0
11147837|NCT01503749|12335083|FG002|NOT COMPLETED|Overall Study||0
11147838|NCT01504204|12335093|FG000|STARTED|Overall Study||10
11147839|NCT01504204|12335094|FG001|STARTED|Overall Study||10
11147840|NCT01504204|12335093|FG000|COMPLETED|Overall Study||9
11147841|NCT01504204|12335094|FG001|COMPLETED|Overall Study||9
11147842|NCT01504204|12335093|FG000|NOT COMPLETED|Overall Study||1
11147843|NCT01504204|12335094|FG001|NOT COMPLETED|Overall Study||1
11147844|NCT01504412|12335105|FG000|STARTED|Overall Study||89
11147845|NCT01504412|12335106|FG001|STARTED|Overall Study||87
11147846|NCT01504412|12335107|FG002|STARTED|Overall Study||90
11147847|NCT01504412|12335108|FG003|STARTED|Overall Study||94
11147848|NCT01504412|12335109|FG004|STARTED|Overall Study||90
11147849|NCT01504412|12335105|FG000|COMPLETED|Overall Study||84
11147850|NCT01504412|12335106|FG001|COMPLETED|Overall Study||75
11147851|NCT01504412|12335107|FG002|COMPLETED|Overall Study||86
11147852|NCT01504412|12335108|FG003|COMPLETED|Overall Study||75
11147853|NCT01504412|12335109|FG004|COMPLETED|Overall Study||77
11147854|NCT01504412|12335105|FG000|NOT COMPLETED|Overall Study||5
11147855|NCT01504412|12335106|FG001|NOT COMPLETED|Overall Study||12
11147856|NCT01504412|12335107|FG002|NOT COMPLETED|Overall Study||4
11147857|NCT01504412|12335108|FG003|NOT COMPLETED|Overall Study||19
11147858|NCT01504412|12335109|FG004|NOT COMPLETED|Overall Study||13
11147859|NCT01504477|12335121|FG000|STARTED|Overall Study||6
11147860|NCT01504477|12335121|FG000|COMPLETED|Overall Study||6
11147861|NCT01504477|12335121|FG000|NOT COMPLETED|Overall Study||0
11147862|NCT01504672|12335127|FG000|STARTED|Overall Study||230
11147863|NCT01504672|12335128|FG001|STARTED|Overall Study||230
11147864|NCT01504672|12335127|FG000|COMPLETED|Overall Study||212
11147865|NCT01504672|12335128|FG001|COMPLETED|Overall Study||217
11147866|NCT01504672|12335127|FG000|NOT COMPLETED|Overall Study||18
11147867|NCT01504672|12335128|FG001|NOT COMPLETED|Overall Study||13
11147868|NCT01504711|12335136|FG000|STARTED|Overall Study||30
11147869|NCT01504711|12335136|FG000|COMPLETED|Overall Study||27
11147870|NCT01504711|12335136|FG000|NOT COMPLETED|Overall Study||3
11147871|NCT01504841|12335143|FG000|STARTED|Overall Study||20
11147872|NCT01504841|12335144|FG001|STARTED|Overall Study||6
11147873|NCT01504841|12335145|FG002|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0
11147874|NCT01504841|12335143|FG000|COMPLETED|Overall Study||19
11147875|NCT01504841|12335144|FG001|COMPLETED|Overall Study||5
11147876|NCT01504841|12335145|FG002|COMPLETED|Overall Study||0
11147877|NCT01504841|12335143|FG000|NOT COMPLETED|Overall Study||1
11147878|NCT01504841|12335144|FG001|NOT COMPLETED|Overall Study||1
11147879|NCT01504841|12335145|FG002|NOT COMPLETED|Overall Study||0
11147880|NCT01504854|12335154|FG000|STARTED|Overall Study||64
11147881|NCT01504854|12335155|FG001|STARTED|Overall Study||55
11147882|NCT01504854|12335154|FG000|COMPLETED|Overall Study||56
11147883|NCT01504854|12335155|FG001|COMPLETED|Overall Study||48
11147884|NCT01504854|12335154|FG000|NOT COMPLETED|Overall Study||8
11147885|NCT01504854|12335155|FG001|NOT COMPLETED|Overall Study||7
11147886|NCT01504867|12335163|FG000|STARTED|Overall Study||202
11147887|NCT01504867|12335164|FG001|STARTED|Overall Study||198
11147888|NCT01504867|12335163|FG000|COMPLETED|Overall Study||195
11147889|NCT01504867|12335164|FG001|COMPLETED|Overall Study||195
11147890|NCT01504867|12335163|FG000|NOT COMPLETED|Overall Study||7
11147891|NCT01504867|12335164|FG001|NOT COMPLETED|Overall Study||3
11147892|NCT01504958|12335173|FG000|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
11147893|NCT01504958|12335174|FG001|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
11147894|NCT01504958|12335175|FG002|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
11147895|NCT01504958|12335173|FG000|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
11147896|NCT01504958|12335174|FG001|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
11147897|NCT01504958|12335175|FG002|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
11147898|NCT01504958|12335173|FG000|NOT COMPLETED|Overall Study||0
11147899|NCT01504958|12335174|FG001|NOT COMPLETED|Overall Study||0
11147900|NCT01504958|12335175|FG002|NOT COMPLETED|Overall Study||0
11147901|NCT01504971|12335183|FG000|STARTED|Overall Study||95
11147902|NCT01504971|12335183|FG000|COMPLETED|Overall Study||82
11147903|NCT01504971|12335183|FG000|NOT COMPLETED|Overall Study||13
11147904|NCT01504997|12335191|FG000|STARTED|Overall Study||18
11147905|NCT01504997|12335191|FG000|COMPLETED|Overall Study||18
11147906|NCT01504997|12335191|FG000|NOT COMPLETED|Overall Study||0
11147907|NCT01505010|12335197|FG000|STARTED|Overall Study||9
11147908|NCT01505010|12335198|FG001|STARTED|Overall Study||8
11147909|NCT01505010|12335197|FG000|COMPLETED|Overall Study||9
11147910|NCT01505010|12335198|FG001|COMPLETED|Overall Study||6
11147911|NCT01505010|12335197|FG000|NOT COMPLETED|Overall Study||0
11147912|NCT01505010|12335198|FG001|NOT COMPLETED|Overall Study||2
11147913|NCT01505114|12335208|FG000|STARTED|Overall Study||148
11147914|NCT01505114|12335209|FG001|STARTED|Overall Study||148
11147915|NCT01505114|12335210|FG002|STARTED|Overall Study||147
11147916|NCT01505114|12335211|FG003|STARTED|Overall Study||151
11147917|NCT01505114|12335208|FG000|COMPLETED|Overall Study||123
11147918|NCT01505114|12335209|FG001|COMPLETED|Overall Study||135
11147919|NCT01505114|12335210|FG002|COMPLETED|Overall Study||129
11147920|NCT01505114|12335211|FG003|COMPLETED|Overall Study||128
11147921|NCT01505114|12335208|FG000|NOT COMPLETED|Overall Study||25
11147922|NCT01505114|12335209|FG001|NOT COMPLETED|Overall Study||13
11147923|NCT01505114|12335210|FG002|NOT COMPLETED|Overall Study||18
11147924|NCT01505114|12335211|FG003|NOT COMPLETED|Overall Study||23
11147925|NCT01505166|12335224|FG000|STARTED|Overall Study||3
11147926|NCT01505166|12335225|FG001|STARTED|Overall Study||0
11147927|NCT01505166|12335226|FG002|STARTED|Overall Study||0
11147928|NCT01505166|12335224|FG000|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
11147929|NCT01505166|12335225|FG001|COMPLETED|Overall Study||0
11147930|NCT01505166|12335226|FG002|COMPLETED|Overall Study||0
11147931|NCT01505166|12335224|FG000|NOT COMPLETED|Overall Study||0
11147932|NCT01505166|12335225|FG001|NOT COMPLETED|Overall Study||0
11147933|NCT01505166|12335226|FG002|NOT COMPLETED|Overall Study||0
11147934|NCT01505179|12335238|FG000|STARTED|Overall Study||6
11147935|NCT01505179|12335239|FG001|STARTED|Overall Study||4
11147936|NCT01505179|12335238|FG000|COMPLETED|Overall Study||6
11147937|NCT01505179|12335239|FG001|COMPLETED|Overall Study||4
11147938|NCT01505179|12335238|FG000|NOT COMPLETED|Overall Study||0
11147939|NCT01505179|12335239|FG001|NOT COMPLETED|Overall Study||0
11147940|NCT01505374|12335245|FG000|STARTED|Overall Study||30
11147941|NCT01505374|12335246|FG001|STARTED|Overall Study||30
11147942|NCT01505374|12335245|FG000|COMPLETED|Overall Study||29
11147943|NCT01505374|12335246|FG001|COMPLETED|Overall Study||30
11147944|NCT01505374|12335245|FG000|NOT COMPLETED|Overall Study||1
11147945|NCT01505374|12335246|FG001|NOT COMPLETED|Overall Study||0
11147946|NCT01505387|12335255|FG000|STARTED|Overall Study||25
11147947|NCT01505387|12335256|FG001|STARTED|Overall Study||25
11147948|NCT01505387|12335255|FG000|Treated|Overall Study||24
11147949|NCT01505387|12335256|FG001|Treated|Overall Study||24
11147950|NCT01505387|12335255|FG000|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
11147951|NCT01505387|12335256|FG001|COMPLETED|Overall Study||24
11147952|NCT01505387|12335255|FG000|NOT COMPLETED|Overall Study||2
11147953|NCT01505387|12335256|FG001|NOT COMPLETED|Overall Study||1
11147954|NCT01505491|12335265|FG000|STARTED|Overall Study||67
11147955|NCT01505491|12335266|FG001|STARTED|Overall Study||62
11147956|NCT01505491|12335267|FG002|STARTED|Overall Study||64
11147957|NCT01505491|12335265|FG000|COMPLETED|Overall Study||65
11147958|NCT01505491|12335266|FG001|COMPLETED|Overall Study||61
11147959|NCT01505491|12335267|FG002|COMPLETED|Overall Study||59
11147960|NCT01505491|12335265|FG000|NOT COMPLETED|Overall Study||2
11147961|NCT01505491|12335266|FG001|NOT COMPLETED|Overall Study||1
11147962|NCT01505491|12335267|FG002|NOT COMPLETED|Overall Study||5
11147963|NCT01505530|12335278|FG000|STARTED|Overall Study||41
11147964|NCT01505530|12335279|FG001|STARTED|Overall Study||43
11147965|NCT01505530|12335280|FG002|STARTED|Overall Study||41
11147966|NCT01505530|12335278|FG000|Received At Least One Dose of Study Drug|Overall Study||41
11147967|NCT01505530|12335279|FG001|Received At Least One Dose of Study Drug|Overall Study||42
11147968|NCT01505530|12335280|FG002|Received At Least One Dose of Study Drug|Overall Study||41
11147969|NCT01505530|12335278|FG000|Completed One Cycle of Study Drug|Overall Study||29
11147970|NCT01505530|12335279|FG001|Completed One Cycle of Study Drug|Overall Study||27
11147971|NCT01505530|12335280|FG002|Completed One Cycle of Study Drug|Overall Study||31
11147972|NCT01505530|12335278|FG000|COMPLETED|Overall Study||0
11147973|NCT01505530|12335279|FG001|COMPLETED|Overall Study||0
11147974|NCT01505530|12335280|FG002|COMPLETED|Overall Study||0
11147975|NCT01505530|12335278|FG000|NOT COMPLETED|Overall Study||41
11147976|NCT01505530|12335279|FG001|NOT COMPLETED|Overall Study||43
11147977|NCT01505530|12335280|FG002|NOT COMPLETED|Overall Study||41
11147978|NCT01505634|12335291|FG000|STARTED|Overall Study||101
11147979|NCT01505634|12335292|FG001|STARTED|Overall Study||101
11147980|NCT01505634|12335293|FG002|STARTED|Overall Study||100
11147981|NCT01505634|12335291|FG000|Treated|Overall Study||99
11147982|NCT01505634|12335292|FG001|Treated|Overall Study||99
11147983|NCT01505634|12335293|FG002|Treated|Overall Study||100
11147984|NCT01505634|12335291|FG000|COMPLETED|Overall Study||92
11147985|NCT01505634|12335292|FG001|COMPLETED|Overall Study||91
11147986|NCT01505634|12335293|FG002|COMPLETED|Overall Study||94
11147987|NCT01505634|12335291|FG000|NOT COMPLETED|Overall Study||9
11147988|NCT01505634|12335292|FG001|NOT COMPLETED|Overall Study||10
11147989|NCT01505634|12335293|FG002|NOT COMPLETED|Overall Study||6
11147990|NCT01505647|12335303|FG000|STARTED|Day 1 Through Day 42 Follow-up||332
11147991|NCT01505647|12335304|FG001|STARTED|Day 1 Through Day 42 Follow-up||166
11147992|NCT01505647|12335303|FG000|Vaccinated|Day 1 Through Day 42 Follow-up||331
11147993|NCT01505647|12335304|FG001|Vaccinated|Day 1 Through Day 42 Follow-up||166
11147994|NCT01505647|12335303|FG000|COMPLETED|Day 1 Through Day 42 Follow-up||329
11147995|NCT01505647|12335304|FG001|COMPLETED|Day 1 Through Day 42 Follow-up||166
11147996|NCT01505647|12335303|FG000|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
11147997|NCT01505647|12335304|FG001|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
11147998|NCT01505647|12335303|FG000|STARTED|Day 43 Through Day 182 Follow-up||329
11147999|NCT01505647|12335304|FG001|STARTED|Day 43 Through Day 182 Follow-up||166
11148000|NCT01505647|12335303|FG000|COMPLETED|Day 43 Through Day 182 Follow-up||328
11148001|NCT01505647|12335304|FG001|COMPLETED|Day 43 Through Day 182 Follow-up||163
11148002|NCT01505647|12335303|FG000|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
11148003|NCT01505647|12335304|FG001|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
11148004|NCT01505673|12335312|FG000|STARTED|Overall Study||35
11148005|NCT01505673|12335313|FG001|STARTED|Overall Study||36
11148006|NCT01505673|12335312|FG000|COMPLETED|Overall Study||32
11148007|NCT01505673|12335313|FG001|COMPLETED|Overall Study||34
11148008|NCT01505673|12335312|FG000|NOT COMPLETED|Overall Study||3
11148009|NCT01505673|12335313|FG001|NOT COMPLETED|Overall Study||2
11148010|NCT01505764|12335321|FG000|STARTED|Overall Study||6
11148011|NCT01505764|12335322|FG001|STARTED|Overall Study||3
11148012|NCT01505764|12335321|FG000|COMPLETED|Overall Study||3
11148013|NCT01505764|12335322|FG001|COMPLETED|Overall Study||2
11148014|NCT01505764|12335321|FG000|NOT COMPLETED|Overall Study||3
11148015|NCT01505764|12335322|FG001|NOT COMPLETED|Overall Study||1
11148016|NCT01505868|12335334|FG000|STARTED|Overall Study||4
11148017|NCT01505868|12335335|FG001|STARTED|Overall Study||3
11148018|NCT01505868|12335336|FG002|STARTED|Overall Study||3
11148019|NCT01505868|12335337|FG003|STARTED|Overall Study||79
11148020|NCT01505868|12335338|FG004|STARTED|Overall Study||81
11418407|NCT00506064|12616769|FG000|COMPLETED|Overall Study||1
11418408|NCT00506064|12616770|FG001|COMPLETED|Overall Study||0
11418409|NCT00506064|12616769|FG000|NOT COMPLETED|Overall Study||0
11418410|NCT00506064|12616770|FG001|NOT COMPLETED|Overall Study||0
11418411|NCT00503880|12616776|FG000|STARTED|Overall Study||2
11148021|NCT01505868|12335334|FG000|COMPLETED|Overall Study||3
11148022|NCT01505868|12335335|FG001|COMPLETED|Overall Study||3
11148023|NCT01505868|12335336|FG002|COMPLETED|Overall Study||3
11148024|NCT01505868|12335337|FG003|COMPLETED|Overall Study||79
11148025|NCT01505868|12335338|FG004|COMPLETED|Overall Study||81
11148026|NCT01505868|12335334|FG000|NOT COMPLETED|Overall Study||1
11148027|NCT01505868|12335335|FG001|NOT COMPLETED|Overall Study||0
11148028|NCT01505868|12335336|FG002|NOT COMPLETED|Overall Study||0
11148029|NCT01505868|12335337|FG003|NOT COMPLETED|Overall Study||0
11148030|NCT01505868|12335338|FG004|NOT COMPLETED|Overall Study||0
11148031|NCT01505881|12335352|FG000|STARTED|Overall Study||99
11148032|NCT01505881|12335353|FG001|STARTED|Overall Study||59
11148033|NCT01505881|12335352|FG000|COMPLETED|Overall Study||95
11148034|NCT01505881|12335353|FG001|COMPLETED|Overall Study||58
11148035|NCT01505881|12335352|FG000|NOT COMPLETED|Overall Study||4
11148036|NCT01505881|12335353|FG001|NOT COMPLETED|Overall Study||1
11148037|NCT01505933|12335362|FG000|STARTED|Overall Study||10
11148038|NCT01505933|12335363|FG001|STARTED|Overall Study||14
11148039|NCT01505933|12335362|FG000|COMPLETED|Overall Study||10
11148040|NCT01505933|12335363|FG001|COMPLETED|Overall Study||14
11148041|NCT01505933|12335362|FG000|NOT COMPLETED|Overall Study||0
11148042|NCT01505933|12335363|FG001|NOT COMPLETED|Overall Study||0
11148043|NCT01506193|12335372|FG000|STARTED|Overall Study||351
11148044|NCT01506193|12335373|FG001|STARTED|Overall Study||183
11148045|NCT01506193|12335374|FG002|STARTED|Overall Study||182
11148046|NCT01506193|12335372|FG000|COMPLETED|Overall Study||337
11148047|NCT01506193|12335373|FG001|COMPLETED|Overall Study||179
11418412|NCT00503880|12616777|FG001|STARTED|Overall Study||0
11418413|NCT00503880|12616778|FG002|STARTED|Overall Study||0
11148048|NCT01506193|12335374|FG002|COMPLETED|Overall Study||168
11148049|NCT01506193|12335372|FG000|NOT COMPLETED|Overall Study||14
11148050|NCT01506193|12335373|FG001|NOT COMPLETED|Overall Study||4
11148051|NCT01506193|12335374|FG002|NOT COMPLETED|Overall Study||14
11148052|NCT01506271|12335386|FG000|STARTED|Overall Study||118
11148053|NCT01506271|12335387|FG001|STARTED|Overall Study||116
11148054|NCT01506271|12335388|FG002|STARTED|Overall Study||117
11148055|NCT01506271|12335386|FG000|Treated|Overall Study||117
11148056|NCT01506271|12335387|FG001|Treated|Overall Study||116
11148057|NCT01506271|12335388|FG002|Treated|Overall Study||114
11148058|NCT01506271|12335386|FG000|COMPLETED|Overall Study||114
11148059|NCT01506271|12335387|FG001|COMPLETED|Overall Study||109
11148060|NCT01506271|12335388|FG002|COMPLETED|Overall Study||114
11148061|NCT01506271|12335386|FG000|NOT COMPLETED|Overall Study||4
11148062|NCT01506271|12335387|FG001|NOT COMPLETED|Overall Study||7
11148063|NCT01506271|12335388|FG002|NOT COMPLETED|Overall Study||3
11148064|NCT01506323|12335398|FG000|STARTED|Overall Study||89
11148065|NCT01506323|12335399|FG001|STARTED|Overall Study||84
11148066|NCT01506323|12335398|FG000|Post-treatment Completers|Overall Study||69
11148067|NCT01506323|12335399|FG001|Post-treatment Completers|Overall Study||72
11148068|NCT01506323|12335398|FG000|Post-treatment Completed CAPS|Overall Study||68
11148069|NCT01506323|12335399|FG001|Post-treatment Completed CAPS|Overall Study||72
11148070|NCT01506323|12335398|FG000|COMPLETED|Overall Study||65
11148071|NCT01506323|12335399|FG001|COMPLETED|Overall Study||71
11148072|NCT01506323|12335398|FG000|NOT COMPLETED|Overall Study||24
11148073|NCT01506323|12335399|FG001|NOT COMPLETED|Overall Study||13
11148074|NCT01506362|12335410|FG000|STARTED|Overall Study||22
11148075|NCT01506362|12335410|FG000|COMPLETED|Overall Study||16
11148076|NCT01506362|12335410|FG000|NOT COMPLETED|Overall Study||6
11148077|NCT01506453|12335416|FG000|STARTED|Overall Study||25
11148078|NCT01506453|12335417|FG001|STARTED|Overall Study||26
11148079|NCT01506453|12335416|FG000|COMPLETED|Overall Study||25
11148080|NCT01506453|12335417|FG001|COMPLETED|Overall Study||24
11148081|NCT01506453|12335416|FG000|NOT COMPLETED|Overall Study||0
11148082|NCT01506453|12335417|FG001|NOT COMPLETED|Overall Study||2
11148083|NCT01506479|12335426|FG000|STARTED|Overall Study||40
11148084|NCT01506479|12335427|FG001|STARTED|Overall Study||43
11148085|NCT01506479|12335428|FG002|STARTED|Overall Study||45
11148086|NCT01506479|12335426|FG000|COMPLETED|Overall Study||37
11148087|NCT01506479|12335427|FG001|COMPLETED|Overall Study||38
11148088|NCT01506479|12335428|FG002|COMPLETED|Overall Study||42
11148089|NCT01506479|12335426|FG000|NOT COMPLETED|Overall Study||3
11148090|NCT01506479|12335427|FG001|NOT COMPLETED|Overall Study||5
11148091|NCT01506479|12335428|FG002|NOT COMPLETED|Overall Study||3
11148092|NCT01506596|12335438|FG000|STARTED|Overall Study||42
11148093|NCT01506596|12335438|FG000|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
11148094|NCT01506596|12335438|FG000|NOT COMPLETED|Overall Study||1
11148095|NCT01506609|12335448|FG000|STARTED|Overall Study||2
11148096|NCT01506609|12335449|FG001|STARTED|Overall Study||1
11148097|NCT01506609|12335450|FG002|STARTED|Overall Study||1
11418414|NCT00503880|12616779|FG003|STARTED|Overall Study||0
11148098|NCT01506609|12335451|FG003|STARTED|Overall Study||99
11148099|NCT01506609|12335452|FG004|STARTED|Overall Study||97
11148100|NCT01506609|12335453|FG005|STARTED|Overall Study||94
11148101|NCT01506609|12335448|FG000|COMPLETED|Overall Study||0
11148102|NCT01506609|12335449|FG001|COMPLETED|Overall Study||0
11148103|NCT01506609|12335450|FG002|COMPLETED|Overall Study||0
11148104|NCT01506609|12335451|FG003|COMPLETED|Overall Study||0
11148105|NCT01506609|12335452|FG004|COMPLETED|Overall Study||1
11148106|NCT01506609|12335453|FG005|COMPLETED|Overall Study||0
11148107|NCT01506609|12335448|FG000|NOT COMPLETED|Overall Study||2
11148108|NCT01506609|12335449|FG001|NOT COMPLETED|Overall Study||1
11148109|NCT01506609|12335450|FG002|NOT COMPLETED|Overall Study||1
11148110|NCT01506609|12335451|FG003|NOT COMPLETED|Overall Study||99
11148111|NCT01506609|12335452|FG004|NOT COMPLETED|Overall Study||96
11148112|NCT01506609|12335453|FG005|NOT COMPLETED|Overall Study||94
11148113|NCT01506726|12335466|FG000|STARTED|Overall Study||6
11148114|NCT01506726|12335467|FG001|STARTED|Overall Study||5
11148115|NCT01506726|12335466|FG000|COMPLETED|Overall Study||5
11148116|NCT01506726|12335467|FG001|COMPLETED|Overall Study||3
11148117|NCT01506726|12335466|FG000|NOT COMPLETED|Overall Study||1
11148118|NCT01506726|12335467|FG001|NOT COMPLETED|Overall Study||2
11148119|NCT01506882|12335475|FG000|STARTED|Overall Study||61
11148120|NCT01506882|12335476|FG001|STARTED|Overall Study||10
11148121|NCT01506882|12335475|FG000|COMPLETED|Overall Study||39
11148122|NCT01506882|12335476|FG001|COMPLETED|Overall Study||3
11148123|NCT01506882|12335475|FG000|NOT COMPLETED|Overall Study||22
11148124|NCT01506882|12335476|FG001|NOT COMPLETED|Overall Study||7
11148125|NCT01506908|12335486|FG000|STARTED|Overall Study||162
11148126|NCT01506908|12335487|FG001|STARTED|Overall Study||161
11148127|NCT01506908|12335486|FG000|COMPLETED|Overall Study||161
11148128|NCT01506908|12335487|FG001|COMPLETED|Overall Study||161
11148129|NCT01506908|12335486|FG000|NOT COMPLETED|Overall Study||1
11148130|NCT01506908|12335487|FG001|NOT COMPLETED|Overall Study||0
11148131|NCT01506947|12335495|FG000|STARTED|Overall Study||65
11148132|NCT01506947|12335495|FG000|COMPLETED|Overall Study||49
11148133|NCT01506947|12335495|FG000|NOT COMPLETED|Overall Study||16
11148134|NCT01506960|12335501|FG000|STARTED|Overall Study||64
11148135|NCT01506960|12335501|FG000|COMPLETED|Overall Study||17
11148136|NCT01506960|12335501|FG000|NOT COMPLETED|Overall Study||47
11148137|NCT01507051|12335511|FG000|STARTED|Overall Study||29
11148138|NCT01507051|12335512|FG001|STARTED|Overall Study||31
11148139|NCT01507051|12335513|FG002|STARTED|Overall Study||29
11148140|NCT01507051|12335514|FG003|STARTED|Overall Study||7
11148141|NCT01507051|12335511|FG000|Warfarin run-in Phase|Overall Study||28
11148142|NCT01507051|12335512|FG001|Warfarin run-in Phase|Overall Study||28
11148143|NCT01507051|12335513|FG002|Warfarin run-in Phase|Overall Study||0
11148144|NCT01507051|12335514|FG003|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
11148145|NCT01507051|12335511|FG000|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
11148146|NCT01507051|12335512|FG001|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
11148147|NCT01507051|12335513|FG002|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
11148148|NCT01507051|12335514|FG003|Received Placebo or Rivaroxaban|Overall Study||0
11148149|NCT01507051|12335511|FG000|COMPLETED|Overall Study||27
11148150|NCT01507051|12335512|FG001|COMPLETED|Overall Study||28
11148151|NCT01507051|12335513|FG002|COMPLETED|Overall Study||28
11148152|NCT01507051|12335514|FG003|COMPLETED|Overall Study||0
11148153|NCT01507051|12335511|FG000|NOT COMPLETED|Overall Study||2
11148154|NCT01507051|12335512|FG001|NOT COMPLETED|Overall Study||3
11148155|NCT01507051|12335513|FG002|NOT COMPLETED|Overall Study||1
11148156|NCT01507051|12335514|FG003|NOT COMPLETED|Overall Study||7
11202828|NCT01843465|12393263|FG000|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
11202829|NCT01843465|12393263|FG000|COMPLETED|Overall Study||34
11202830|NCT01843465|12393263|FG000|NOT COMPLETED|Overall Study||0
11202831|NCT01843621|12393267|FG000|STARTED|Overall Study||7
11202832|NCT01843621|12393267|FG000|COMPLETED|Overall Study||7
11202833|NCT01843621|12393267|FG000|NOT COMPLETED|Overall Study||0
11202834|NCT01843660|12393279|FG000|STARTED|Overall Study||1059
11202835|NCT01843660|12393279|FG000|COMPLETED|Overall Study||1029
11202836|NCT01843660|12393279|FG000|NOT COMPLETED|Overall Study||30
11202837|NCT01843673|12393283|FG000|STARTED|Overall Study||16
11202838|NCT01843673|12393283|FG000|COMPLETED|Overall Study||10
11202839|NCT01843673|12393283|FG000|NOT COMPLETED|Overall Study||6
11202840|NCT01843751|12393291|FG000|STARTED|Overall Study||11
11202841|NCT01843751|12393292|FG001|STARTED|Overall Study||10
11202842|NCT01843751|12393291|FG000|COMPLETED|Overall Study||0
11202843|NCT01843751|12393292|FG001|COMPLETED|Overall Study||3
11202844|NCT01843751|12393291|FG000|NOT COMPLETED|Overall Study||11
11202845|NCT01843751|12393292|FG001|NOT COMPLETED|Overall Study||7
11202846|NCT01843777|12393300|FG000|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
11202847|NCT01843777|12393301|FG001|STARTED|Overall Study|Number of participants randomized to treatment.|10
11202848|NCT01843777|12393300|FG000|Per Protocol Population|Overall Study||11
11202849|NCT01843777|12393301|FG001|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
11202850|NCT01843777|12393300|FG000|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
11202851|NCT01843777|12393301|FG001|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
11202852|NCT01843777|12393300|FG000|NOT COMPLETED|Overall Study||1
11202853|NCT01843777|12393301|FG001|NOT COMPLETED|Overall Study||0
11148157|NCT01507090|12335524|FG000|STARTED|Overall Study||642
11148158|NCT01507090|12335524|FG000|COMPLETED|Overall Study||624
11148159|NCT01507090|12335524|FG000|NOT COMPLETED|Overall Study||18
11148160|NCT01507103|12335536|FG000|STARTED|Overall Study||41
11148161|NCT01507103|12335537|FG001|STARTED|Overall Study||41
11148162|NCT01507103|12335538|FG002|STARTED|Overall Study||42
11148163|NCT01507103|12335536|FG000|COMPLETED|Overall Study||41
11148164|NCT01507103|12335537|FG001|COMPLETED|Overall Study||41
11148165|NCT01507103|12335538|FG002|COMPLETED|Overall Study||42
11148166|NCT01507103|12335536|FG000|NOT COMPLETED|Overall Study||0
11148167|NCT01507103|12335537|FG001|NOT COMPLETED|Overall Study||0
11148168|NCT01507103|12335538|FG002|NOT COMPLETED|Overall Study||0
11148169|NCT01507155|12335546|FG000|STARTED|Overall Study||625
11148170|NCT01507155|12335547|FG001|STARTED|Overall Study||60
11148171|NCT01507155|12335546|FG000|COMPLETED|Overall Study||625
11148172|NCT01507155|12335547|FG001|COMPLETED|Overall Study||60
11148173|NCT01507155|12335546|FG000|NOT COMPLETED|Overall Study||0
11148174|NCT01507155|12335547|FG001|NOT COMPLETED|Overall Study||0
11148175|NCT01507181|12335554|FG000|STARTED|Overall Study||12
11148176|NCT01507181|12335555|FG001|STARTED|Overall Study||12
11148177|NCT01507181|12335554|FG000|COMPLETED|Overall Study||12
11148178|NCT01507181|12335555|FG001|COMPLETED|Overall Study||12
11148179|NCT01507181|12335554|FG000|NOT COMPLETED|Overall Study||0
11148180|NCT01507181|12335555|FG001|NOT COMPLETED|Overall Study||0
11148181|NCT01507220|12335563|FG000|STARTED|Overall Study||2
11148182|NCT01507220|12335564|FG001|STARTED|Overall Study||0
11148183|NCT01507220|12335563|FG000|COMPLETED|Overall Study||2
11148184|NCT01507220|12335564|FG001|COMPLETED|Overall Study||0
11148185|NCT01507220|12335563|FG000|NOT COMPLETED|Overall Study||0
11148186|NCT01507220|12335564|FG001|NOT COMPLETED|Overall Study||0
11148187|NCT01507246|12335572|FG000|STARTED|Overall Study||20
11148188|NCT01507246|12335573|FG001|STARTED|Overall Study||22
11148189|NCT01507246|12335572|FG000|COMPLETED|Overall Study||18
11148190|NCT01507246|12335573|FG001|COMPLETED|Overall Study||21
11148191|NCT01507246|12335572|FG000|NOT COMPLETED|Overall Study||2
11148192|NCT01507246|12335573|FG001|NOT COMPLETED|Overall Study||1
11148193|NCT01507298|12335584|FG000|STARTED|Overall Study||1
11148194|NCT01507298|12335585|FG001|STARTED|Overall Study||20
11148195|NCT01507298|12335584|FG000|COMPLETED|Overall Study||1
11148196|NCT01507298|12335585|FG001|COMPLETED|Overall Study||14
11148197|NCT01507298|12335584|FG000|NOT COMPLETED|Overall Study||0
11148198|NCT01507298|12335585|FG001|NOT COMPLETED|Overall Study||6
11148199|NCT01507350|12335592|FG000|STARTED|Overall Study||9
11148200|NCT01507350|12335592|FG000|COMPLETED|Overall Study||9
11148201|NCT01507350|12335592|FG000|NOT COMPLETED|Overall Study||0
11148202|NCT01507493|12335598|FG000|STARTED|Overall Study||22
11148203|NCT01507493|12335599|FG001|STARTED|Overall Study||178
11148204|NCT01507493|12335598|FG000|COMPLETED|Overall Study||22
11148205|NCT01507493|12335599|FG001|COMPLETED|Overall Study||178
11148206|NCT01507493|12335598|FG000|NOT COMPLETED|Overall Study||0
11148207|NCT01507493|12335599|FG001|NOT COMPLETED|Overall Study||0
11148208|NCT01507662|12335607|FG000|STARTED|Overall Study||3898
11148209|NCT01507662|12335608|FG001|STARTED|Overall Study||3851
11148210|NCT01507662|12335607|FG000|COMPLETED|Overall Study||3082
11148211|NCT01507662|12335608|FG001|COMPLETED|Overall Study||3020
11148212|NCT01507662|12335607|FG000|NOT COMPLETED|Overall Study||816
11148213|NCT01507662|12335608|FG001|NOT COMPLETED|Overall Study||831
11148214|NCT01507688|12335616|FG000|STARTED|Baseline to 6 Month Assessment||129
11148215|NCT01507688|12335617|FG001|STARTED|Baseline to 6 Month Assessment||129
11148216|NCT01507688|12335616|FG000|COMPLETED|Baseline to 6 Month Assessment||113
11148217|NCT01507688|12335617|FG001|COMPLETED|Baseline to 6 Month Assessment||119
11148218|NCT01507688|12335616|FG000|NOT COMPLETED|Baseline to 6 Month Assessment||16
11148219|NCT01507688|12335617|FG001|NOT COMPLETED|Baseline to 6 Month Assessment||10
11148220|NCT01507688|12335616|FG000|STARTED|6 Month to 12 Month Assessment||113
11148221|NCT01507688|12335617|FG001|STARTED|6 Month to 12 Month Assessment||119
11148222|NCT01507688|12335616|FG000|COMPLETED|6 Month to 12 Month Assessment||108
11148223|NCT01507688|12335617|FG001|COMPLETED|6 Month to 12 Month Assessment||116
11148224|NCT01507688|12335616|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||5
11148225|NCT01507688|12335617|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||3
11148226|NCT01507779|12335625|FG000|STARTED|Overall Study||23
11148227|NCT01507779|12335626|FG001|STARTED|Overall Study||25
11148228|NCT01507779|12335625|FG000|COMPLETED|Overall Study||23
11148229|NCT01507779|12335626|FG001|COMPLETED|Overall Study||25
11148230|NCT01507779|12335625|FG000|NOT COMPLETED|Overall Study||0
11148231|NCT01507779|12335626|FG001|NOT COMPLETED|Overall Study||0
11148232|NCT01507831|12335636|FG000|STARTED|Overall Study|Randomized|788
11148233|NCT01507831|12335637|FG001|STARTED|Overall Study|Randomized|1553
11148234|NCT01507831|12335636|FG000|Treated|Overall Study||788
11148235|NCT01507831|12335637|FG001|Treated|Overall Study||1550
11148236|NCT01507831|12335636|FG000|COMPLETED|Overall Study||595
11148237|NCT01507831|12335637|FG001|COMPLETED|Overall Study||1113
11148238|NCT01507831|12335636|FG000|NOT COMPLETED|Overall Study||193
11148239|NCT01507831|12335637|FG001|NOT COMPLETED|Overall Study||440
11148240|NCT01507896|12335643|FG000|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
11148241|NCT01507896|12335643|FG000|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
11148242|NCT01507896|12335643|FG000|NOT COMPLETED|Overall Study||2
11148243|NCT01507987|12335656|FG000|STARTED|Overall Study||982
11148244|NCT01507987|12335657|FG001|STARTED|Overall Study||670
11148245|NCT01507987|12335658|FG002|STARTED|Overall Study||458
11148246|NCT01507987|12335659|FG003|STARTED|Overall Study||737
11148247|NCT01507987|12335656|FG000|COMPLETED|Overall Study||618
11148248|NCT01507987|12335657|FG001|COMPLETED|Overall Study||335
11148249|NCT01507987|12335658|FG002|COMPLETED|Overall Study||252
11148250|NCT01507987|12335659|FG003|COMPLETED|Overall Study||480
11148251|NCT01507987|12335656|FG000|NOT COMPLETED|Overall Study||364
11148252|NCT01507987|12335657|FG001|NOT COMPLETED|Overall Study||335
11148253|NCT01507987|12335658|FG002|NOT COMPLETED|Overall Study||206
11148254|NCT01507987|12335659|FG003|NOT COMPLETED|Overall Study||257
11148255|NCT01508013|12335688|FG000|STARTED|Overall Study||214
11148256|NCT01508013|12335689|FG001|STARTED|Overall Study||229
11148257|NCT01508013|12335688|FG000|COMPLETED|Overall Study||182
11148258|NCT01508013|12335689|FG001|COMPLETED|Overall Study||206
11148259|NCT01508013|12335688|FG000|NOT COMPLETED|Overall Study||32
11148260|NCT01508013|12335689|FG001|NOT COMPLETED|Overall Study||23
11148261|NCT01508052|12335697|FG000|STARTED|Overall Study||20
11148262|NCT01508052|12335698|FG001|STARTED|Overall Study||20
11148263|NCT01508052|12335697|FG000|COMPLETED|Overall Study||20
11148264|NCT01508052|12335698|FG001|COMPLETED|Overall Study||20
11148265|NCT01508052|12335697|FG000|NOT COMPLETED|Overall Study||0
11148266|NCT01508052|12335698|FG001|NOT COMPLETED|Overall Study||0
11148267|NCT01508117|12335704|FG000|STARTED|Overall Study||1
11148268|NCT01508117|12335704|FG000|COMPLETED|Overall Study||1
11148269|NCT01508117|12335704|FG000|NOT COMPLETED|Overall Study||0
11148270|NCT01508130|12335710|FG000|STARTED|Overall Study||493
11148271|NCT01508130|12335711|FG001|STARTED|Overall Study||142
11148272|NCT01508130|12335710|FG000|mTRT|Overall Study||493
11148273|NCT01508130|12335711|FG001|mTRT|Overall Study||142
11148274|NCT01508130|12335710|FG000|COMPLETED|Overall Study||266
11148275|NCT01508130|12335711|FG001|COMPLETED|Overall Study||73
11148276|NCT01508130|12335710|FG000|NOT COMPLETED|Overall Study||227
11148277|NCT01508130|12335711|FG001|NOT COMPLETED|Overall Study||69
11148278|NCT01508169|12335721|FG000|STARTED|Overall Study||47
11148279|NCT01508169|12335722|FG001|STARTED|Overall Study||47
11148280|NCT01508169|12335721|FG000|COMPLETED|Overall Study||44
11148281|NCT01508169|12335722|FG001|COMPLETED|Overall Study||45
11148282|NCT01508169|12335721|FG000|NOT COMPLETED|Overall Study||3
11148283|NCT01508169|12335722|FG001|NOT COMPLETED|Overall Study||2
11148284|NCT01508325|12335736|FG000|STARTED|Overall Study||93
11322812|NCT05028426|12520079|FG000|STARTED|Overall Study||214
11148285|NCT01508325|12335737|FG001|STARTED|Overall Study||93
11148286|NCT01508325|12335736|FG000|COMPLETED|Overall Study||75
11148287|NCT01508325|12335737|FG001|COMPLETED|Overall Study||72
11148288|NCT01508325|12335736|FG000|NOT COMPLETED|Overall Study||18
11148289|NCT01508325|12335737|FG001|NOT COMPLETED|Overall Study||21
11148290|NCT01508455|12335743|FG000|STARTED|Overall Study||6
11148291|NCT01508455|12335743|FG000|COMPLETED|Overall Study||6
11148292|NCT01508455|12335743|FG000|NOT COMPLETED|Overall Study||0
11148293|NCT01508650|12335749|FG000|STARTED|Overall Study||12
11148294|NCT01508650|12335750|FG001|STARTED|Overall Study||15
11148295|NCT01508650|12335749|FG000|COMPLETED|Overall Study||12
11148296|NCT01508650|12335750|FG001|COMPLETED|Overall Study||12
11148297|NCT01508650|12335749|FG000|NOT COMPLETED|Overall Study||0
11148298|NCT01508650|12335750|FG001|NOT COMPLETED|Overall Study||3
11148299|NCT01508676|12335758|FG000|STARTED|Phase I (2 Weeks)||18
11148300|NCT01508676|12335759|FG001|STARTED|Phase I (2 Weeks)||17
11148301|NCT01508676|12335758|FG000|COMPLETED|Phase I (2 Weeks)||16
11148302|NCT01508676|12335759|FG001|COMPLETED|Phase I (2 Weeks)||14
11148303|NCT01508676|12335758|FG000|NOT COMPLETED|Phase I (2 Weeks)||2
11148304|NCT01508676|12335759|FG001|NOT COMPLETED|Phase I (2 Weeks)||3
11148305|NCT01508676|12335758|FG000|STARTED|Washout Period (1 Week)||16
11148306|NCT01508676|12335759|FG001|STARTED|Washout Period (1 Week)||14
11148307|NCT01508676|12335758|FG000|COMPLETED|Washout Period (1 Week)||16
11148308|NCT01508676|12335759|FG001|COMPLETED|Washout Period (1 Week)||14
11148309|NCT01508676|12335758|FG000|NOT COMPLETED|Washout Period (1 Week)||0
11148310|NCT01508676|12335759|FG001|NOT COMPLETED|Washout Period (1 Week)||0
11148311|NCT01508676|12335758|FG000|STARTED|Phase II (2 Weeks)||16
11148312|NCT01508676|12335759|FG001|STARTED|Phase II (2 Weeks)||14
11148313|NCT01508676|12335758|FG000|COMPLETED|Phase II (2 Weeks)||15
11148314|NCT01508676|12335759|FG001|COMPLETED|Phase II (2 Weeks)||13
11148315|NCT01508676|12335758|FG000|NOT COMPLETED|Phase II (2 Weeks)||1
11148316|NCT01508676|12335759|FG001|NOT COMPLETED|Phase II (2 Weeks)||1
11148317|NCT01508702|12335768|FG000|STARTED|Overall Study||107
11148318|NCT01508702|12335769|FG001|STARTED|Overall Study||107
11148319|NCT01508702|12335768|FG000|COMPLETED|Overall Study||84
11148320|NCT01508702|12335769|FG001|COMPLETED|Overall Study||94
11148321|NCT01508702|12335768|FG000|NOT COMPLETED|Overall Study||23
11148322|NCT01508702|12335769|FG001|NOT COMPLETED|Overall Study||13
11148323|NCT01508832|12335777|FG000|STARTED|Overall Study||6
11148324|NCT01508832|12335778|FG001|STARTED|Overall Study||6
11148325|NCT01508832|12335777|FG000|COMPLETED|Overall Study||6
11148326|NCT01508832|12335778|FG001|COMPLETED|Overall Study||6
11148327|NCT01508832|12335777|FG000|NOT COMPLETED|Overall Study||0
11148328|NCT01508832|12335778|FG001|NOT COMPLETED|Overall Study||0
11148329|NCT01508910|12335787|FG000|STARTED|Randomization||57
11148330|NCT01508910|12335788|FG001|STARTED|Randomization||27
11148331|NCT01508910|12335789|FG002|STARTED|Randomization||28
11148332|NCT01508910|12335790|FG003|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
11148333|NCT01508910|12335787|FG000|COMPLETED|Randomization||57
11148334|NCT01508910|12335788|FG001|COMPLETED|Randomization||27
11148335|NCT01508910|12335789|FG002|COMPLETED|Randomization||28
11148336|NCT01508910|12335790|FG003|COMPLETED|Randomization||0
11148337|NCT01508910|12335787|FG000|NOT COMPLETED|Randomization||0
11148338|NCT01508910|12335788|FG001|NOT COMPLETED|Randomization||0
11148339|NCT01508910|12335789|FG002|NOT COMPLETED|Randomization||0
11148340|NCT01508910|12335790|FG003|NOT COMPLETED|Randomization||0
11148341|NCT01508910|12335787|FG000|STARTED|Treatment||50
11148342|NCT01508910|12335788|FG001|STARTED|Treatment||28
11148343|NCT01508910|12335789|FG002|STARTED|Treatment||28
11148344|NCT01508910|12335790|FG003|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
11148345|NCT01508910|12335787|FG000|COMPLETED|Treatment||48
11148346|NCT01508910|12335788|FG001|COMPLETED|Treatment||24
11148347|NCT01508910|12335789|FG002|COMPLETED|Treatment||18
11148348|NCT01508910|12335790|FG003|COMPLETED|Treatment||3
11148349|NCT01508910|12335787|FG000|NOT COMPLETED|Treatment||2
11148350|NCT01508910|12335788|FG001|NOT COMPLETED|Treatment||4
11148351|NCT01508910|12335789|FG002|NOT COMPLETED|Treatment||10
11148352|NCT01508910|12335790|FG003|NOT COMPLETED|Treatment||3
11148353|NCT01508936|12335804|FG000|STARTED|Overall Study||102
11148354|NCT01508936|12335805|FG001|STARTED|Overall Study||409
11148355|NCT01508936|12335804|FG000|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
11148356|NCT01508936|12335805|FG001|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
11148357|NCT01508936|12335804|FG000|Randomized|Overall Study||98
11148358|NCT01508936|12335805|FG001|Randomized|Overall Study||398
11148359|NCT01508936|12335804|FG000|Randomized, Not Treated|Overall Study||1
11148360|NCT01508936|12335805|FG001|Randomized, Not Treated|Overall Study||3
11148361|NCT01508936|12335804|FG000|Safety Analysis Set|Overall Study||97
11148362|NCT01508936|12335805|FG001|Safety Analysis Set|Overall Study||395
11148363|NCT01508936|12335804|FG000|Full Analysis Set|Overall Study||97
11148364|NCT01508936|12335805|FG001|Full Analysis Set|Overall Study||395
11148365|NCT01508936|12335804|FG000|FEV1 Subpopulation Analysis Set|Overall Study||91
11148366|NCT01508936|12335805|FG001|FEV1 Subpopulation Analysis Set|Overall Study||346
11148367|NCT01508936|12335804|FG000|COMPLETED|Overall Study||79
11148368|NCT01508936|12335805|FG001|COMPLETED|Overall Study||330
11148369|NCT01508936|12335804|FG000|NOT COMPLETED|Overall Study||23
11148370|NCT01508936|12335805|FG001|NOT COMPLETED|Overall Study||79
11148371|NCT01509040|12335814|FG000|STARTED|Overall Study||0
11148372|NCT01509040|12335815|FG001|STARTED|Overall Study||2
11148373|NCT01509040|12335816|FG002|STARTED|Overall Study||0
11148374|NCT01509040|12335814|FG000|COMPLETED|Overall Study||0
11148375|NCT01509040|12335815|FG001|COMPLETED|Overall Study||1
11148376|NCT01509040|12335816|FG002|COMPLETED|Overall Study||0
11148377|NCT01509040|12335814|FG000|NOT COMPLETED|Overall Study||0
11148378|NCT01509040|12335815|FG001|NOT COMPLETED|Overall Study||1
11148379|NCT01509040|12335816|FG002|NOT COMPLETED|Overall Study||0
11148380|NCT01509079|12335833|FG000|STARTED|Overall Study||57
11148381|NCT01509079|12335834|FG001|STARTED|Overall Study||59
11148382|NCT01509079|12335833|FG000|COMPLETED|Overall Study||57
11148383|NCT01509079|12335834|FG001|COMPLETED|Overall Study||56
11148384|NCT01509079|12335833|FG000|NOT COMPLETED|Overall Study||0
11148385|NCT01509079|12335834|FG001|NOT COMPLETED|Overall Study||3
11148386|NCT01509105|12335840|FG000|STARTED|Overall Study||649
11148387|NCT01509105|12335840|FG000|COMPLETED|Overall Study||649
11148388|NCT01509105|12335840|FG000|NOT COMPLETED|Overall Study||0
11148389|NCT01509183|12335846|FG000|STARTED|Overall Study||250
11148390|NCT01509183|12335847|FG001|STARTED|Overall Study||245
11148391|NCT01509183|12335846|FG000|COMPLETED|Overall Study||141
11148392|NCT01509183|12335847|FG001|COMPLETED|Overall Study||134
11148393|NCT01509183|12335846|FG000|NOT COMPLETED|Overall Study||109
11148394|NCT01509183|12335847|FG001|NOT COMPLETED|Overall Study||111
11148395|NCT01509404|12335857|FG000|STARTED|Overall Study||20
11148396|NCT01509404|12335858|FG001|STARTED|Overall Study||20
11148397|NCT01509404|12335857|FG000|COMPLETED|Overall Study||20
11148398|NCT01509404|12335858|FG001|COMPLETED|Overall Study||20
11148399|NCT01509404|12335857|FG000|NOT COMPLETED|Overall Study||0
11148400|NCT01509404|12335858|FG001|NOT COMPLETED|Overall Study||0
11148401|NCT01509547|12335866|FG000|STARTED|Overall Study||77
11148402|NCT01509547|12335867|FG001|STARTED|Overall Study||80
11148403|NCT01509547|12335866|FG000|COMPLETED|Overall Study||42
11148404|NCT01509547|12335867|FG001|COMPLETED|Overall Study||41
11148405|NCT01509547|12335866|FG000|NOT COMPLETED|Overall Study||35
11148406|NCT01509547|12335867|FG001|NOT COMPLETED|Overall Study||39
11148407|NCT01509586|12335875|FG000|STARTED|Overall Study|Week 0|626
11148408|NCT01509586|12335876|FG001|STARTED|Overall Study|Week 0|610
11148409|NCT01509586|12335875|FG000|Week 3|Overall Study||574
11148410|NCT01509586|12335876|FG001|Week 3|Overall Study||585
11148411|NCT01509586|12335875|FG000|Week 6|Overall Study||551
11148412|NCT01509586|12335876|FG001|Week 6|Overall Study||585
11148413|NCT01509586|12335875|FG000|Week 10|Overall Study||537
11148414|NCT01509586|12335876|FG001|Week 10|Overall Study||574
11148415|NCT01509586|12335875|FG000|Week 14|Overall Study||528
11148416|NCT01509586|12335876|FG001|Week 14|Overall Study||566
11148417|NCT01509586|12335875|FG000|Week18|Overall Study||529
11148418|NCT01509586|12335876|FG001|Week18|Overall Study||555
11148419|NCT01509586|12335875|FG000|Week 32 (Month 6)|Overall Study||504
11148420|NCT01509586|12335876|FG001|Week 32 (Month 6)|Overall Study||523
11148421|NCT01509586|12335875|FG000|Week 46|Overall Study||483
11148422|NCT01509586|12335876|FG001|Week 46|Overall Study||494
11148423|NCT01509586|12335875|FG000|Week 58 (Month 12)|Overall Study||492
11148424|NCT01509586|12335876|FG001|Week 58 (Month 12)|Overall Study||499
11148425|NCT01509586|12335875|FG000|COMPLETED|Overall Study|final intent to treat sample|626
11148426|NCT01509586|12335876|FG001|COMPLETED|Overall Study|final intent to treat sample|610
11148427|NCT01509586|12335875|FG000|NOT COMPLETED|Overall Study||0
11148428|NCT01509586|12335876|FG001|NOT COMPLETED|Overall Study||0
11148429|NCT01509612|12335885|FG000|STARTED|Overall Study||47
11148430|NCT01509612|12335886|FG001|STARTED|Overall Study||51
11148431|NCT01509612|12335887|FG002|STARTED|Overall Study||52
11148432|NCT01509612|12335885|FG000|COMPLETED|Overall Study||47
11148433|NCT01509612|12335886|FG001|COMPLETED|Overall Study||51
11148434|NCT01509612|12335887|FG002|COMPLETED|Overall Study||52
11148435|NCT01509612|12335885|FG000|NOT COMPLETED|Overall Study||0
11148436|NCT01509612|12335886|FG001|NOT COMPLETED|Overall Study||0
11148437|NCT01509612|12335887|FG002|NOT COMPLETED|Overall Study||0
11148438|NCT01509625|12335898|FG000|STARTED|Overall Study||272
11148439|NCT01509625|12335898|FG000|COMPLETED|Overall Study||263
11148440|NCT01509625|12335898|FG000|NOT COMPLETED|Overall Study||9
11148441|NCT01509638|12335913|FG000|STARTED|Overall Study||23
11148442|NCT01509638|12335914|FG001|STARTED|Overall Study||26
11148443|NCT01509638|12335913|FG000|COMPLETED|Overall Study||20
11148444|NCT01509638|12335914|FG001|COMPLETED|Overall Study||24
11148445|NCT01509638|12335913|FG000|NOT COMPLETED|Overall Study||3
11148446|NCT01509638|12335914|FG001|NOT COMPLETED|Overall Study||2
11148447|NCT01509664|12335922|FG000|STARTED|Overall Study||49
11148448|NCT01509664|12335923|FG001|STARTED|Overall Study||49
11148449|NCT01509664|12335922|FG000|T2 Follow-up|Overall Study||45
11148450|NCT01509664|12335923|FG001|T2 Follow-up|Overall Study||38
11148451|NCT01509664|12335922|FG000|T3 Follow-up|Overall Study||40
11148452|NCT01509664|12335923|FG001|T3 Follow-up|Overall Study||33
11148453|NCT01509664|12335922|FG000|COMPLETED|Overall Study||34
11148454|NCT01509664|12335923|FG001|COMPLETED|Overall Study||28
11148455|NCT01509664|12335922|FG000|NOT COMPLETED|Overall Study||15
11148456|NCT01509664|12335923|FG001|NOT COMPLETED|Overall Study||21
11148457|NCT01509677|12335931|FG000|STARTED|Overall Study||79
11148458|NCT01509677|12335932|FG001|STARTED|Overall Study||79
11148459|NCT01509677|12335931|FG000|COMPLETED|Overall Study||76
11148460|NCT01509677|12335932|FG001|COMPLETED|Overall Study||73
11148461|NCT01509677|12335931|FG000|NOT COMPLETED|Overall Study||3
11148462|NCT01509677|12335932|FG001|NOT COMPLETED|Overall Study||6
11148463|NCT01509807|12335940|FG000|STARTED|Overall Study||16
11148464|NCT01509807|12335941|FG001|STARTED|Overall Study||17
11148465|NCT01509807|12335940|FG000|COMPLETED|Overall Study||15
11148466|NCT01509807|12335941|FG001|COMPLETED|Overall Study||16
11148467|NCT01509807|12335940|FG000|NOT COMPLETED|Overall Study||1
11148468|NCT01509807|12335941|FG001|NOT COMPLETED|Overall Study||1
11148469|NCT01509846|12335952|FG000|STARTED|Received Vaccination 1||5
11148470|NCT01509846|12335953|FG001|STARTED|Received Vaccination 1||20
11148471|NCT01509846|12335954|FG002|STARTED|Received Vaccination 1||20
11148472|NCT01509846|12335955|FG003|STARTED|Received Vaccination 1||20
11148473|NCT01509846|12335956|FG004|STARTED|Received Vaccination 1||17
11148474|NCT01509846|12335952|FG000|COMPLETED|Received Vaccination 1||5
11148475|NCT01509846|12335953|FG001|COMPLETED|Received Vaccination 1||20
11148476|NCT01509846|12335954|FG002|COMPLETED|Received Vaccination 1||20
11148477|NCT01509846|12335955|FG003|COMPLETED|Received Vaccination 1||20
11148478|NCT01509846|12335956|FG004|COMPLETED|Received Vaccination 1||17
11148479|NCT01509846|12335952|FG000|NOT COMPLETED|Received Vaccination 1||0
11148480|NCT01509846|12335953|FG001|NOT COMPLETED|Received Vaccination 1||0
11148481|NCT01509846|12335954|FG002|NOT COMPLETED|Received Vaccination 1||0
11148482|NCT01509846|12335955|FG003|NOT COMPLETED|Received Vaccination 1||0
11148483|NCT01509846|12335956|FG004|NOT COMPLETED|Received Vaccination 1||0
11148484|NCT01509846|12335952|FG000|STARTED|Received Vaccination 2||5
11148485|NCT01509846|12335953|FG001|STARTED|Received Vaccination 2||20
11148486|NCT01509846|12335954|FG002|STARTED|Received Vaccination 2||20
11148487|NCT01509846|12335955|FG003|STARTED|Received Vaccination 2||20
11148488|NCT01509846|12335956|FG004|STARTED|Received Vaccination 2||17
11148489|NCT01509846|12335952|FG000|COMPLETED|Received Vaccination 2||0
11148490|NCT01509846|12335953|FG001|COMPLETED|Received Vaccination 2||20
11148491|NCT01509846|12335954|FG002|COMPLETED|Received Vaccination 2||19
11148492|NCT01509846|12335955|FG003|COMPLETED|Received Vaccination 2||20
11148493|NCT01509846|12335956|FG004|COMPLETED|Received Vaccination 2||14
11148494|NCT01509846|12335952|FG000|NOT COMPLETED|Received Vaccination 2||5
11148495|NCT01509846|12335953|FG001|NOT COMPLETED|Received Vaccination 2||0
11148496|NCT01509846|12335954|FG002|NOT COMPLETED|Received Vaccination 2||1
11148497|NCT01509846|12335955|FG003|NOT COMPLETED|Received Vaccination 2||0
11148498|NCT01509846|12335956|FG004|NOT COMPLETED|Received Vaccination 2||3
11148499|NCT01509846|12335952|FG000|STARTED|Received Vaccination 3||0
11148500|NCT01509846|12335953|FG001|STARTED|Received Vaccination 3||20
11148501|NCT01509846|12335954|FG002|STARTED|Received Vaccination 3||19
11148502|NCT01509846|12335955|FG003|STARTED|Received Vaccination 3||20
11148503|NCT01509846|12335956|FG004|STARTED|Received Vaccination 3||14
11148504|NCT01509846|12335952|FG000|COMPLETED|Received Vaccination 3||0
11148505|NCT01509846|12335953|FG001|COMPLETED|Received Vaccination 3||19
11148506|NCT01509846|12335954|FG002|COMPLETED|Received Vaccination 3||18
11148507|NCT01509846|12335955|FG003|COMPLETED|Received Vaccination 3||19
11148508|NCT01509846|12335956|FG004|COMPLETED|Received Vaccination 3||14
11148509|NCT01509846|12335952|FG000|NOT COMPLETED|Received Vaccination 3||0
11148510|NCT01509846|12335953|FG001|NOT COMPLETED|Received Vaccination 3||1
11148511|NCT01509846|12335954|FG002|NOT COMPLETED|Received Vaccination 3||1
11148512|NCT01509846|12335955|FG003|NOT COMPLETED|Received Vaccination 3||1
11148513|NCT01509846|12335956|FG004|NOT COMPLETED|Received Vaccination 3||0
11148514|NCT01509872|12335977|FG000|STARTED|Overall Study||26
11148515|NCT01509872|12335978|FG001|STARTED|Overall Study||24
11322813|NCT05028426|12520080|FG001|STARTED|Overall Study||132
11322814|NCT05028426|12520081|FG002|STARTED|Overall Study||109
11322815|NCT05028426|12520079|FG000|COMPLETED|Overall Study||214
11322816|NCT05028426|12520080|FG001|COMPLETED|Overall Study||132
11322817|NCT05028426|12520081|FG002|COMPLETED|Overall Study||109
11322818|NCT05028426|12520079|FG000|NOT COMPLETED|Overall Study||0
11322819|NCT05028426|12520080|FG001|NOT COMPLETED|Overall Study||0
11322820|NCT05028426|12520081|FG002|NOT COMPLETED|Overall Study||0
11342820|NCT02948582|12540169|FG002|COMPLETED|Treatment Period 6||6
11342821|NCT02948582|12540170|FG003|COMPLETED|Treatment Period 6||6
11342822|NCT02948582|12540171|FG004|COMPLETED|Treatment Period 6||7
11342823|NCT02948582|12540172|FG005|COMPLETED|Treatment Period 6||6
11342824|NCT02948582|12540167|FG000|NOT COMPLETED|Treatment Period 6||0
11342825|NCT02948582|12540168|FG001|NOT COMPLETED|Treatment Period 6||0
11342826|NCT02948582|12540169|FG002|NOT COMPLETED|Treatment Period 6||0
11342827|NCT02948582|12540170|FG003|NOT COMPLETED|Treatment Period 6||0
11342828|NCT02948582|12540171|FG004|NOT COMPLETED|Treatment Period 6||0
11342829|NCT02948582|12540172|FG005|NOT COMPLETED|Treatment Period 6||0
11342830|NCT02948582|12540167|FG000|STARTED|Wshout Period 6||6
11342831|NCT02948582|12540168|FG001|STARTED|Wshout Period 6||4
11342832|NCT02948582|12540169|FG002|STARTED|Wshout Period 6||6
11342833|NCT02948582|12540170|FG003|STARTED|Wshout Period 6||6
11342834|NCT02948582|12540171|FG004|STARTED|Wshout Period 6||7
11342835|NCT02948582|12540172|FG005|STARTED|Wshout Period 6||6
11342836|NCT02948582|12540167|FG000|COMPLETED|Wshout Period 6||6
11342837|NCT02948582|12540168|FG001|COMPLETED|Wshout Period 6||4
11342838|NCT02948582|12540169|FG002|COMPLETED|Wshout Period 6||6
11342839|NCT02948582|12540170|FG003|COMPLETED|Wshout Period 6||6
11342840|NCT02948582|12540171|FG004|COMPLETED|Wshout Period 6||7
11342841|NCT02948582|12540172|FG005|COMPLETED|Wshout Period 6||6
11342842|NCT02948582|12540167|FG000|NOT COMPLETED|Wshout Period 6||0
11342843|NCT02948582|12540168|FG001|NOT COMPLETED|Wshout Period 6||0
11342844|NCT02948582|12540169|FG002|NOT COMPLETED|Wshout Period 6||0
11342845|NCT02948582|12540170|FG003|NOT COMPLETED|Wshout Period 6||0
11342846|NCT02948582|12540171|FG004|NOT COMPLETED|Wshout Period 6||0
11342847|NCT02948582|12540172|FG005|NOT COMPLETED|Wshout Period 6||0
11342848|NCT02948634|12540188|FG000|STARTED|Overall Study||17
11342849|NCT02948634|12540189|FG001|STARTED|Overall Study||11
11342850|NCT02948634|12540188|FG000|COMPLETED|Overall Study||7
11342851|NCT02948634|12540189|FG001|COMPLETED|Overall Study||9
11148516|NCT01509872|12335977|FG000|Post-Intervention Assessment|Overall Study||26
11148517|NCT01509872|12335978|FG001|Post-Intervention Assessment|Overall Study||24
11148518|NCT01509872|12335977|FG000|COMPLETED|Overall Study||25
11148519|NCT01509872|12335978|FG001|COMPLETED|Overall Study||24
11148520|NCT01509872|12335977|FG000|NOT COMPLETED|Overall Study||1
11148521|NCT01509872|12335978|FG001|NOT COMPLETED|Overall Study||0
11148522|NCT01509950|12335988|FG000|STARTED|Overall Study||7
11148523|NCT01509950|12335989|FG001|STARTED|Overall Study||8
11148524|NCT01509950|12335990|FG002|STARTED|Overall Study||0
11148525|NCT01509950|12335988|FG000|COMPLETED|Overall Study||7
11148526|NCT01509950|12335989|FG001|COMPLETED|Overall Study||8
11148527|NCT01509950|12335990|FG002|COMPLETED|Overall Study||0
11148528|NCT01509950|12335988|FG000|NOT COMPLETED|Overall Study||0
11148529|NCT01509950|12335989|FG001|NOT COMPLETED|Overall Study||0
11148530|NCT01509950|12335990|FG002|NOT COMPLETED|Overall Study||0
11148531|NCT01510028|12336000|FG000|STARTED|Overall Study||6
11148532|NCT01510028|12336001|FG001|STARTED|Overall Study||6
11148533|NCT01510028|12336002|FG002|STARTED|Overall Study||6
11148534|NCT01510028|12336003|FG003|STARTED|Overall Study||6
11148535|NCT01510028|12336000|FG000|COMPLETED|Overall Study||5
11148536|NCT01510028|12336001|FG001|COMPLETED|Overall Study||6
11148537|NCT01510028|12336002|FG002|COMPLETED|Overall Study||6
11148538|NCT01510028|12336003|FG003|COMPLETED|Overall Study||6
11148539|NCT01510028|12336000|FG000|NOT COMPLETED|Overall Study||1
11148540|NCT01510028|12336001|FG001|NOT COMPLETED|Overall Study||0
11148541|NCT01510028|12336002|FG002|NOT COMPLETED|Overall Study||0
11148542|NCT01510028|12336003|FG003|NOT COMPLETED|Overall Study||0
11148543|NCT01510145|12336015|FG000|STARTED|Overall Study||191
11148544|NCT01510145|12336015|FG000|COMPLETED|Overall Study||173
11148545|NCT01510145|12336015|FG000|NOT COMPLETED|Overall Study||18
11148546|NCT01510158|12336022|FG000|STARTED|Overall Study||202
11148547|NCT01510158|12336023|FG001|STARTED|Overall Study||203
11148548|NCT01510158|12336024|FG002|STARTED|Overall Study||202
11148549|NCT01510158|12336022|FG000|COMPLETED|Overall Study||151
11148550|NCT01510158|12336023|FG001|COMPLETED|Overall Study||150
11148551|NCT01510158|12336024|FG002|COMPLETED|Overall Study||152
11148552|NCT01510158|12336022|FG000|NOT COMPLETED|Overall Study||51
11148553|NCT01510158|12336023|FG001|NOT COMPLETED|Overall Study||53
11148554|NCT01510158|12336024|FG002|NOT COMPLETED|Overall Study||50
11148555|NCT01510327|12336032|FG000|STARTED|Overall Study||22
11148556|NCT01510327|12336032|FG000|COMPLETED|Overall Study||22
11148557|NCT01510327|12336032|FG000|NOT COMPLETED|Overall Study||0
11148558|NCT01510379|12336044|FG000|STARTED|Overall Study||49
11148559|NCT01510379|12336045|FG001|STARTED|Overall Study||51
11148560|NCT01510379|12336044|FG000|COMPLETED|Overall Study||49
11148561|NCT01510379|12336045|FG001|COMPLETED|Overall Study||51
11148562|NCT01510379|12336044|FG000|NOT COMPLETED|Overall Study||0
11148563|NCT01510379|12336045|FG001|NOT COMPLETED|Overall Study||0
11148564|NCT01510457|12336053|FG000|STARTED|Overall Study||17
11148565|NCT01510457|12336054|FG001|STARTED|Overall Study||29
11342852|NCT02948634|12540188|FG000|NOT COMPLETED|Overall Study||10
11342853|NCT02948634|12540189|FG001|NOT COMPLETED|Overall Study||2
11342854|NCT02948777|12540195|FG000|STARTED|Overall Study||14
11148566|NCT01510457|12336053|FG000|COMPLETED|Overall Study||12
11148567|NCT01510457|12336054|FG001|COMPLETED|Overall Study||26
11148568|NCT01510457|12336053|FG000|NOT COMPLETED|Overall Study||5
11148569|NCT01510457|12336054|FG001|NOT COMPLETED|Overall Study||3
11148570|NCT01510652|12336064|FG000|STARTED|Overall Study||719
11148571|NCT01510652|12336065|FG001|STARTED|Overall Study||355
11148572|NCT01510652|12336064|FG000|Baseline|Overall Study||718
11148573|NCT01510652|12336065|FG001|Baseline|Overall Study||348
11148574|NCT01510652|12336064|FG000|COMPLETED|Overall Study||627
11148575|NCT01510652|12336065|FG001|COMPLETED|Overall Study||288
11148576|NCT01510652|12336064|FG000|NOT COMPLETED|Overall Study||92
11148577|NCT01510652|12336065|FG001|NOT COMPLETED|Overall Study||67
11148578|NCT01510704|12336075|FG000|STARTED|Overall Study||54
11148579|NCT01510704|12336076|FG001|STARTED|Overall Study||58
11148580|NCT01510704|12336077|FG002|STARTED|Overall Study||50
11148581|NCT01510704|12336078|FG003|STARTED|Overall Study||53
11148582|NCT01510704|12336075|FG000|COMPLETED|Overall Study||54
11148583|NCT01510704|12336076|FG001|COMPLETED|Overall Study||58
11148584|NCT01510704|12336077|FG002|COMPLETED|Overall Study||50
11148585|NCT01510704|12336078|FG003|COMPLETED|Overall Study||53
11148586|NCT01510704|12336075|FG000|NOT COMPLETED|Overall Study||0
11148587|NCT01510704|12336076|FG001|NOT COMPLETED|Overall Study||0
11148588|NCT01510704|12336077|FG002|NOT COMPLETED|Overall Study||0
11148589|NCT01510704|12336078|FG003|NOT COMPLETED|Overall Study||0
11148590|NCT01510717|12336090|FG000|STARTED|Overall Study||155
11148591|NCT01510717|12336091|FG001|STARTED|Overall Study||165
11148592|NCT01510717|12336090|FG000|COMPLETED|Overall Study||153
11148593|NCT01510717|12336091|FG001|COMPLETED|Overall Study||160
11148594|NCT01510717|12336090|FG000|NOT COMPLETED|Overall Study||2
11148595|NCT01510717|12336091|FG001|NOT COMPLETED|Overall Study||5
11148596|NCT01510769|12336101|FG000|STARTED|Overall Study||106
11148597|NCT01510769|12336102|FG001|STARTED|Overall Study||109
11148598|NCT01510769|12336103|FG002|STARTED|Overall Study||109
11148599|NCT01510769|12336101|FG000|COMPLETED|Overall Study||79
11148600|NCT01510769|12336102|FG001|COMPLETED|Overall Study||84
11148601|NCT01510769|12336103|FG002|COMPLETED|Overall Study||87
11148602|NCT01510769|12336101|FG000|NOT COMPLETED|Overall Study||27
11148603|NCT01510769|12336102|FG001|NOT COMPLETED|Overall Study||25
11148604|NCT01510769|12336103|FG002|NOT COMPLETED|Overall Study||22
11148605|NCT01510834|12336111|FG000|STARTED|Overall Study||90
11148606|NCT01510834|12336111|FG000|COMPLETED|Overall Study||57
11148607|NCT01510834|12336111|FG000|NOT COMPLETED|Overall Study||33
11418415|NCT00503880|12616780|FG004|STARTED|Overall Study||0
11418416|NCT00503880|12616776|FG000|COMPLETED|Overall Study||0
11418417|NCT00503880|12616777|FG001|COMPLETED|Overall Study||0
11148608|NCT01510912|12336118|FG000|STARTED|Overall Study||602
11148609|NCT01510912|12336118|FG000|COMPLETED|Overall Study||360
11148610|NCT01510912|12336118|FG000|NOT COMPLETED|Overall Study||242
11148611|NCT01511016|12336124|FG000|STARTED|Overall Study||8
11148612|NCT01511016|12336125|FG001|STARTED|Overall Study||9
11148613|NCT01511016|12336124|FG000|COMPLETED|Overall Study||6
11148614|NCT01511016|12336125|FG001|COMPLETED|Overall Study||7
11148615|NCT01511016|12336124|FG000|NOT COMPLETED|Overall Study||2
11148616|NCT01511016|12336125|FG001|NOT COMPLETED|Overall Study||2
11148617|NCT01511055|12336132|FG000|STARTED|Overall Study||27
11148618|NCT01511055|12336132|FG000|COMPLETED|Overall Study||21
11148619|NCT01511055|12336132|FG000|NOT COMPLETED|Overall Study||6
11148620|NCT01511068|12336136|FG000|STARTED|Overall Study||2
11148621|NCT01511068|12336136|FG000|COMPLETED|Overall Study||2
11148622|NCT01511068|12336136|FG000|NOT COMPLETED|Overall Study||0
11148623|NCT01511107|12336142|FG000|STARTED|Overall Study|Randomized to the treatment group.|260
11148624|NCT01511107|12336143|FG001|STARTED|Overall Study|Randomized to the treatment group.|260
11148625|NCT01511107|12336142|FG000|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
11148626|NCT01511107|12336143|FG001|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
11148627|NCT01511107|12336142|FG000|NOT COMPLETED|Overall Study||22
11148628|NCT01511107|12336143|FG001|NOT COMPLETED|Overall Study||41
11148629|NCT01511250|12336159|FG000|STARTED|Overall Study||24
11148630|NCT01511250|12336160|FG001|STARTED|Overall Study||14
11148631|NCT01511250|12336161|FG002|STARTED|Overall Study||22
11148632|NCT01511250|12336162|FG003|STARTED|Overall Study||14
11148633|NCT01511250|12336163|FG004|STARTED|Overall Study||21
11148634|NCT01511250|12336164|FG005|STARTED|Overall Study||17
11148635|NCT01511250|12336165|FG006|STARTED|Overall Study||23
11148636|NCT01511250|12336166|FG007|STARTED|Overall Study||13
11148637|NCT01511250|12336167|FG008|STARTED|Overall Study||159
11148638|NCT01511250|12336168|FG009|STARTED|Overall Study||53
11148639|NCT01511250|12336159|FG000|COMPLETED|Overall Study||15
11148640|NCT01511250|12336160|FG001|COMPLETED|Overall Study||9
11148641|NCT01511250|12336161|FG002|COMPLETED|Overall Study||18
11148642|NCT01511250|12336162|FG003|COMPLETED|Overall Study||11
11148643|NCT01511250|12336163|FG004|COMPLETED|Overall Study||21
11148644|NCT01511250|12336164|FG005|COMPLETED|Overall Study||17
11148645|NCT01511250|12336165|FG006|COMPLETED|Overall Study||21
11148646|NCT01511250|12336166|FG007|COMPLETED|Overall Study||9
11148647|NCT01511250|12336167|FG008|COMPLETED|Overall Study||145
11148648|NCT01511250|12336168|FG009|COMPLETED|Overall Study||48
11148649|NCT01511250|12336159|FG000|NOT COMPLETED|Overall Study||9
11148650|NCT01511250|12336160|FG001|NOT COMPLETED|Overall Study||5
11148651|NCT01511250|12336161|FG002|NOT COMPLETED|Overall Study||4
11148652|NCT01511250|12336162|FG003|NOT COMPLETED|Overall Study||3
11418418|NCT00503880|12616778|FG002|COMPLETED|Overall Study||0
11148653|NCT01511250|12336163|FG004|NOT COMPLETED|Overall Study||0
11148654|NCT01511250|12336164|FG005|NOT COMPLETED|Overall Study||0
11148655|NCT01511250|12336165|FG006|NOT COMPLETED|Overall Study||2
11148656|NCT01511250|12336166|FG007|NOT COMPLETED|Overall Study||4
11148657|NCT01511250|12336167|FG008|NOT COMPLETED|Overall Study||14
11148658|NCT01511250|12336168|FG009|NOT COMPLETED|Overall Study||5
11148659|NCT01511315|12336190|FG000|STARTED|Overall Study||36
11148660|NCT01511315|12336190|FG000|COMPLETED|Overall Study||32
11148661|NCT01511315|12336190|FG000|NOT COMPLETED|Overall Study||4
11148662|NCT01511419|12336196|FG000|STARTED|Dose 1||30
11148663|NCT01511419|12336197|FG001|STARTED|Dose 1||10
11148664|NCT01511419|12336196|FG000|COMPLETED|Dose 1||30
11148665|NCT01511419|12336197|FG001|COMPLETED|Dose 1||10
11148666|NCT01511419|12336196|FG000|NOT COMPLETED|Dose 1||0
11148667|NCT01511419|12336197|FG001|NOT COMPLETED|Dose 1||0
11148668|NCT01511419|12336196|FG000|STARTED|Dose 2||30
11148669|NCT01511419|12336197|FG001|STARTED|Dose 2||10
11148670|NCT01511419|12336196|FG000|COMPLETED|Dose 2||29
11148671|NCT01511419|12336197|FG001|COMPLETED|Dose 2||10
11148672|NCT01511419|12336196|FG000|NOT COMPLETED|Dose 2||1
11148673|NCT01511419|12336197|FG001|NOT COMPLETED|Dose 2||0
11148674|NCT01511445|12336229|FG000|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
11148675|NCT01511445|12336230|FG001|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
11148676|NCT01511445|12336229|FG000|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
11148677|NCT01511445|12336230|FG001|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
11148678|NCT01511445|12336229|FG000|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
11148679|NCT01511445|12336230|FG001|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
11148680|NCT01511445|12336229|FG000|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
11148681|NCT01511445|12336230|FG001|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
11148682|NCT01511445|12336229|FG000|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
11418419|NCT00503880|12616779|FG003|COMPLETED|Overall Study||0
11148683|NCT01511445|12336230|FG001|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
11148684|NCT01511445|12336229|FG000|NOT COMPLETED|Overall Study||5
11148685|NCT01511445|12336230|FG001|NOT COMPLETED|Overall Study||4
11148686|NCT01511536|12336239|FG000|STARTED|Phase 1||3
11148687|NCT01511536|12336240|FG001|STARTED|Phase 1||7
11148688|NCT01511536|12336241|FG002|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
11148689|NCT01511536|12336239|FG000|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
11148690|NCT01511536|12336240|FG001|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
11148691|NCT01511536|12336241|FG002|COMPLETED|Phase 1||0
11148692|NCT01511536|12336239|FG000|NOT COMPLETED|Phase 1||0
11148693|NCT01511536|12336240|FG001|NOT COMPLETED|Phase 1||1
11148694|NCT01511536|12336241|FG002|NOT COMPLETED|Phase 1||0
11148695|NCT01511536|12336239|FG000|STARTED|Phase 2||0
11148696|NCT01511536|12336240|FG001|STARTED|Phase 2||0
11148697|NCT01511536|12336241|FG002|STARTED|Phase 2||27
11148698|NCT01511536|12336239|FG000|COMPLETED|Phase 2||0
11148699|NCT01511536|12336240|FG001|COMPLETED|Phase 2||0
11148700|NCT01511536|12336241|FG002|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
11148701|NCT01511536|12336239|FG000|NOT COMPLETED|Phase 2||0
11148702|NCT01511536|12336240|FG001|NOT COMPLETED|Phase 2||0
11148703|NCT01511536|12336241|FG002|NOT COMPLETED|Phase 2||9
11148704|NCT01511640|12336253|FG000|STARTED|First Intervention (11-15 Days)||7
11148705|NCT01511640|12336254|FG001|STARTED|First Intervention (11-15 Days)||8
11148706|NCT01511640|12336255|FG002|STARTED|First Intervention (11-15 Days)||7
11148707|NCT01511640|12336256|FG003|STARTED|First Intervention (11-15 Days)||8
11418420|NCT00503880|12616780|FG004|COMPLETED|Overall Study||0
11418421|NCT00503880|12616776|FG000|NOT COMPLETED|Overall Study||2
11418422|NCT00503880|12616777|FG001|NOT COMPLETED|Overall Study||0
11418423|NCT00503880|12616778|FG002|NOT COMPLETED|Overall Study||0
11418424|NCT00503880|12616779|FG003|NOT COMPLETED|Overall Study||0
11418425|NCT00503880|12616780|FG004|NOT COMPLETED|Overall Study||0
11418426|NCT00511329|12616786|FG000|STARTED|Overall Study||0
11418427|NCT00511329|12616786|FG000|COMPLETED|Overall Study||0
11418428|NCT00511329|12616786|FG000|NOT COMPLETED|Overall Study||0
11418429|NCT00501228|12616790|FG000|STARTED|Overall Study||2
11418430|NCT00501228|12616790|FG000|COMPLETED|Overall Study||1
11418431|NCT00501228|12616790|FG000|NOT COMPLETED|Overall Study||1
11148708|NCT01511640|12336253|FG000|COMPLETED|First Intervention (11-15 Days)||5
11148709|NCT01511640|12336254|FG001|COMPLETED|First Intervention (11-15 Days)||8
11148710|NCT01511640|12336255|FG002|COMPLETED|First Intervention (11-15 Days)||7
11148711|NCT01511640|12336256|FG003|COMPLETED|First Intervention (11-15 Days)||7
11148712|NCT01511640|12336253|FG000|NOT COMPLETED|First Intervention (11-15 Days)||2
11148713|NCT01511640|12336254|FG001|NOT COMPLETED|First Intervention (11-15 Days)||0
11148714|NCT01511640|12336255|FG002|NOT COMPLETED|First Intervention (11-15 Days)||0
11148715|NCT01511640|12336256|FG003|NOT COMPLETED|First Intervention (11-15 Days)||1
11148716|NCT01511640|12336253|FG000|STARTED|Washout (6-10 Days)||5
11148717|NCT01511640|12336254|FG001|STARTED|Washout (6-10 Days)||8
11148718|NCT01511640|12336255|FG002|STARTED|Washout (6-10 Days)||7
11148719|NCT01511640|12336256|FG003|STARTED|Washout (6-10 Days)||7
11148720|NCT01511640|12336253|FG000|COMPLETED|Washout (6-10 Days)||5
11148721|NCT01511640|12336254|FG001|COMPLETED|Washout (6-10 Days)||8
11418432|NCT00496782|12616796|FG000|STARTED|Overall Study||9
11418433|NCT00496782|12616797|FG001|STARTED|Overall Study||7
11418434|NCT00496782|12616796|FG000|COMPLETED|Overall Study||8
11418435|NCT00496782|12616797|FG001|COMPLETED|Overall Study||5
11418436|NCT00496782|12616796|FG000|NOT COMPLETED|Overall Study||1
11418437|NCT00496782|12616797|FG001|NOT COMPLETED|Overall Study||2
11418438|NCT00506909|12616803|FG000|STARTED|Overall Study||0
11418439|NCT00506909|12616803|FG000|COMPLETED|Overall Study||0
11418440|NCT00506909|12616803|FG000|NOT COMPLETED|Overall Study||0
11418441|NCT00487578|12616809|FG000|STARTED|Overall Study||3
11418442|NCT00487578|12616810|FG001|STARTED|Overall Study||9
11418443|NCT00487578|12616809|FG000|COMPLETED|Overall Study||2
11418444|NCT00487578|12616810|FG001|COMPLETED|Overall Study||5
11418445|NCT00487578|12616809|FG000|NOT COMPLETED|Overall Study||1
11418446|NCT00487578|12616810|FG001|NOT COMPLETED|Overall Study||4
11418447|NCT00503009|12616819|FG000|STARTED|Overall Study||5
11418448|NCT00503009|12616820|FG001|STARTED|Overall Study||5
11418449|NCT00503009|12616821|FG002|STARTED|Overall Study||6
11418450|NCT00503009|12616819|FG000|COMPLETED|Overall Study||4
11418451|NCT00503009|12616820|FG001|COMPLETED|Overall Study||3
11418452|NCT00503009|12616821|FG002|COMPLETED|Overall Study||3
11418453|NCT00503009|12616819|FG000|NOT COMPLETED|Overall Study||1
11418454|NCT00503009|12616820|FG001|NOT COMPLETED|Overall Study||2
11418455|NCT00503009|12616821|FG002|NOT COMPLETED|Overall Study||3
11418456|NCT00500045|12616829|FG000|STARTED|Overall Study||0
11418457|NCT00500045|12616829|FG000|COMPLETED|Overall Study||0
11418458|NCT00500045|12616829|FG000|NOT COMPLETED|Overall Study||0
11418459|NCT00499590|12616836|FG000|STARTED|Overall Study||113
11418460|NCT00499590|12616837|FG001|STARTED|Overall Study||112
11418461|NCT00499590|12616838|FG002|STARTED|Overall Study||113
11418462|NCT00499590|12616836|FG000|COMPLETED|Overall Study||0
11418463|NCT00499590|12616837|FG001|COMPLETED|Overall Study||0
11418464|NCT00499590|12616838|FG002|COMPLETED|Overall Study||0
11418465|NCT00499590|12616836|FG000|NOT COMPLETED|Overall Study||113
11418466|NCT00499590|12616837|FG001|NOT COMPLETED|Overall Study||112
11148722|NCT01511640|12336255|FG002|COMPLETED|Washout (6-10 Days)||7
11418467|NCT00499590|12616838|FG002|NOT COMPLETED|Overall Study||113
11418468|NCT00501345|12616847|FG000|STARTED|Overall Study||5
11418469|NCT00501345|12616847|FG000|COMPLETED|Overall Study||5
11418470|NCT00501345|12616847|FG000|NOT COMPLETED|Overall Study||0
11418471|NCT00496756|12616851|FG000|STARTED|Overall Study||14
11418472|NCT00496756|12616851|FG000|COMPLETED|Overall Study||11
11418473|NCT00496756|12616851|FG000|NOT COMPLETED|Overall Study||3
11418474|NCT00495716|12616857|FG000|STARTED|Overall Study||35
11418475|NCT00495716|12616858|FG001|STARTED|Overall Study||37
11418476|NCT00495716|12616857|FG000|COMPLETED|Overall Study||20
11418477|NCT00495716|12616858|FG001|COMPLETED|Overall Study||24
11418478|NCT00495716|12616857|FG000|NOT COMPLETED|Overall Study||15
11026637|NCT00829387|12205224|FG000|COMPLETED|Overall Study||20
11026638|NCT00829387|12205225|FG001|COMPLETED|Overall Study||21
11026639|NCT00829387|12205224|FG000|NOT COMPLETED|Overall Study||3
11026640|NCT00829387|12205225|FG001|NOT COMPLETED|Overall Study||3
11026641|NCT00829413|12205231|FG000|STARTED|Overall Study||353
11026642|NCT00829413|12205231|FG000|COMPLETED|Overall Study||259
11418479|NCT00495716|12616858|FG001|NOT COMPLETED|Overall Study||13
11418480|NCT00500890|12616866|FG000|STARTED|Overall Study||1
11418481|NCT00500890|12616867|FG001|STARTED|Overall Study||1
11418482|NCT00500890|12616866|FG000|COMPLETED|Overall Study||1
11418483|NCT00500890|12616867|FG001|COMPLETED|Overall Study||1
11418484|NCT00500890|12616866|FG000|NOT COMPLETED|Overall Study||0
11418485|NCT00500890|12616867|FG001|NOT COMPLETED|Overall Study||0
11418486|NCT00503841|12616873|FG000|STARTED|Overall Study||44
11418487|NCT00503841|12616873|FG000|COMPLETED|Overall Study||0
11418488|NCT00503841|12616873|FG000|NOT COMPLETED|Overall Study||44
11418489|NCT00493025|12616879|FG000|STARTED|Overall Study||19
11418490|NCT00493025|12616879|FG000|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
11418491|NCT00493025|12616879|FG000|NOT COMPLETED|Overall Study||19
11418492|NCT00491400|12616886|FG000|STARTED|Overall Study||15
11418493|NCT00491400|12616887|FG001|STARTED|Overall Study||13
11418494|NCT00491400|12616886|FG000|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
11418495|NCT00491400|12616887|FG001|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
11418496|NCT00491400|12616886|FG000|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
11418497|NCT00491400|12616887|FG001|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
11418498|NCT00491400|12616886|FG000|Started Second Treatment|Overall Study|2 withdrew during washout period|12
11418499|NCT00491400|12616887|FG001|Started Second Treatment|Overall Study|None withdrew during the washout period|9
11418500|NCT00491400|12616886|FG000|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
11418501|NCT00491400|12616887|FG001|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
11148723|NCT01511640|12336256|FG003|COMPLETED|Washout (6-10 Days)||6
11148724|NCT01511640|12336253|FG000|NOT COMPLETED|Washout (6-10 Days)||0
11148725|NCT01511640|12336254|FG001|NOT COMPLETED|Washout (6-10 Days)||0
11148726|NCT01511640|12336255|FG002|NOT COMPLETED|Washout (6-10 Days)||0
11148727|NCT01511640|12336256|FG003|NOT COMPLETED|Washout (6-10 Days)||1
11148728|NCT01511640|12336253|FG000|STARTED|Third Intervention (11-15 Days)||5
11148729|NCT01511640|12336254|FG001|STARTED|Third Intervention (11-15 Days)||8
11026643|NCT00829413|12205231|FG000|NOT COMPLETED|Overall Study||94
11148730|NCT01511640|12336255|FG002|STARTED|Third Intervention (11-15 Days)||7
11148731|NCT01511640|12336256|FG003|STARTED|Third Intervention (11-15 Days)||6
11148732|NCT01511640|12336253|FG000|COMPLETED|Third Intervention (11-15 Days)||4
11148733|NCT01511640|12336254|FG001|COMPLETED|Third Intervention (11-15 Days)||7
11148734|NCT01511640|12336255|FG002|COMPLETED|Third Intervention (11-15 Days)||7
11148735|NCT01511640|12336256|FG003|COMPLETED|Third Intervention (11-15 Days)||6
11148736|NCT01511640|12336253|FG000|NOT COMPLETED|Third Intervention (11-15 Days)||1
11148737|NCT01511640|12336254|FG001|NOT COMPLETED|Third Intervention (11-15 Days)||1
11148738|NCT01511640|12336255|FG002|NOT COMPLETED|Third Intervention (11-15 Days)||0
11148739|NCT01511640|12336256|FG003|NOT COMPLETED|Third Intervention (11-15 Days)||0
11148740|NCT01511809|12336268|FG000|STARTED|Overall Study||58
11418502|NCT00491400|12616886|FG000|COMPLETED|Overall Study||10
11418503|NCT00491400|12616887|FG001|COMPLETED|Overall Study||9
11418504|NCT00491400|12616886|FG000|NOT COMPLETED|Overall Study||5
11418505|NCT00491400|12616887|FG001|NOT COMPLETED|Overall Study||4
11148741|NCT01511809|12336269|FG001|STARTED|Overall Study||59
11148742|NCT01511809|12336268|FG000|COMPLETED|Overall Study||51
11148743|NCT01511809|12336269|FG001|COMPLETED|Overall Study||52
11148744|NCT01511809|12336268|FG000|NOT COMPLETED|Overall Study||7
11148745|NCT01511809|12336269|FG001|NOT COMPLETED|Overall Study||7
11148746|NCT01511939|12336278|FG000|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
11148747|NCT01511939|12336279|FG001|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
11418506|NCT00490776|12616895|FG000|STARTED|Overall Study||9
11418507|NCT00490776|12616895|FG000|COMPLETED|Overall Study||0
11418508|NCT00490776|12616895|FG000|NOT COMPLETED|Overall Study||9
11418509|NCT00487162|12616901|FG000|STARTED|Overall Study||30
11418510|NCT00487162|12616902|FG001|STARTED|Overall Study||26
11418511|NCT00487162|12616901|FG000|COMPLETED|Overall Study||28
11418512|NCT00487162|12616902|FG001|COMPLETED|Overall Study||21
11418513|NCT00487162|12616901|FG000|NOT COMPLETED|Overall Study||2
11418514|NCT00487162|12616902|FG001|NOT COMPLETED|Overall Study||5
11418515|NCT00487981|12616908|FG000|STARTED|Overall Study||1
11418516|NCT00487981|12616908|FG000|COMPLETED|Overall Study||0
11418517|NCT00487981|12616908|FG000|NOT COMPLETED|Overall Study||1
11418518|NCT00491387|12616912|FG000|STARTED|Overall Study||24
11418519|NCT00491387|12616912|FG000|Study Enrollment|Overall Study||24
11418520|NCT00491387|12616912|FG000|COMPLETED|Overall Study||4
11418521|NCT00491387|12616912|FG000|NOT COMPLETED|Overall Study||20
11148748|NCT01511939|12336280|FG002|STARTED|Overall Study||8
11148749|NCT01511939|12336278|FG000|COMPLETED|Overall Study||7
11148750|NCT01511939|12336279|FG001|COMPLETED|Overall Study||4
11148751|NCT01511939|12336280|FG002|COMPLETED|Overall Study||8
11148752|NCT01511939|12336278|FG000|NOT COMPLETED|Overall Study||2
11148753|NCT01511939|12336279|FG001|NOT COMPLETED|Overall Study||1
11148754|NCT01511939|12336280|FG002|NOT COMPLETED|Overall Study||0
11148755|NCT01511978|12336290|FG000|STARTED|Overall Study||14
11148756|NCT01511978|12336291|FG001|STARTED|Overall Study||18
11148757|NCT01511978|12336290|FG000|COMPLETED|Overall Study||14
11148758|NCT01511978|12336291|FG001|COMPLETED|Overall Study||18
11148759|NCT01511978|12336290|FG000|NOT COMPLETED|Overall Study||0
11148760|NCT01511978|12336291|FG001|NOT COMPLETED|Overall Study||0
11148761|NCT01512108|12336301|FG000|STARTED|Overall Study||243
11148762|NCT01512108|12336302|FG001|STARTED|Overall Study||120
11148763|NCT01512108|12336301|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
11148764|NCT01512108|12336302|FG001|Exposed|Overall Study||120
11148765|NCT01512108|12336301|FG000|COMPLETED|Overall Study||221
11148766|NCT01512108|12336302|FG001|COMPLETED|Overall Study||111
11148767|NCT01512108|12336301|FG000|NOT COMPLETED|Overall Study||22
11148768|NCT01512108|12336302|FG001|NOT COMPLETED|Overall Study||9
11148769|NCT01512160|12336312|FG000|STARTED|Overall Study||22
11148770|NCT01512160|12336313|FG001|STARTED|Overall Study||23
11148771|NCT01512160|12336314|FG002|STARTED|Overall Study||22
11148772|NCT01512160|12336315|FG003|STARTED|Overall Study||23
11148773|NCT01512160|12336312|FG000|COMPLETED|Overall Study||20
11148774|NCT01512160|12336313|FG001|COMPLETED|Overall Study||23
11148775|NCT01512160|12336314|FG002|COMPLETED|Overall Study||22
11148776|NCT01512160|12336315|FG003|COMPLETED|Overall Study||22
11148777|NCT01512160|12336312|FG000|NOT COMPLETED|Overall Study||2
11148778|NCT01512160|12336313|FG001|NOT COMPLETED|Overall Study||0
11148779|NCT01512160|12336314|FG002|NOT COMPLETED|Overall Study||0
11148780|NCT01512160|12336315|FG003|NOT COMPLETED|Overall Study||1
11148781|NCT01512225|12336328|FG000|STARTED|Overall Study||45
11148782|NCT01512225|12336329|FG001|STARTED|Overall Study||45
11148783|NCT01512225|12336328|FG000|Provided Day 14 Volume|Overall Study||45
11148784|NCT01512225|12336329|FG001|Provided Day 14 Volume|Overall Study||40
11148785|NCT01512225|12336328|FG000|COMPLETED|Overall Study||45
11148786|NCT01512225|12336329|FG001|COMPLETED|Overall Study||45
11148787|NCT01512225|12336328|FG000|NOT COMPLETED|Overall Study||0
11148788|NCT01512225|12336329|FG001|NOT COMPLETED|Overall Study||0
11148789|NCT01512251|12336339|FG000|STARTED|Dose Level -1||3
11148790|NCT01512251|12336340|FG001|STARTED|Dose Level -1||5
11148791|NCT01512251|12336339|FG000|COMPLETED|Dose Level -1||3
11148792|NCT01512251|12336340|FG001|COMPLETED|Dose Level -1||5
11148793|NCT01512251|12336339|FG000|NOT COMPLETED|Dose Level -1||0
11148794|NCT01512251|12336340|FG001|NOT COMPLETED|Dose Level -1||0
11148795|NCT01512251|12336339|FG000|STARTED|Phase I, Dose 1||3
11148796|NCT01512251|12336340|FG001|STARTED|Phase I, Dose 1||5
11148797|NCT01512251|12336339|FG000|COMPLETED|Phase I, Dose 1||0
11148798|NCT01512251|12336340|FG001|COMPLETED|Phase I, Dose 1||0
11148799|NCT01512251|12336339|FG000|NOT COMPLETED|Phase I, Dose 1||3
11148800|NCT01512251|12336340|FG001|NOT COMPLETED|Phase I, Dose 1||5
11148801|NCT01512251|12336339|FG000|STARTED|Phase I, Dose 2||0
11148802|NCT01512251|12336340|FG001|STARTED|Phase I, Dose 2||0
11148803|NCT01512251|12336339|FG000|COMPLETED|Phase I, Dose 2||0
11148804|NCT01512251|12336340|FG001|COMPLETED|Phase I, Dose 2||0
11148805|NCT01512251|12336339|FG000|NOT COMPLETED|Phase I, Dose 2||0
11148806|NCT01512251|12336340|FG001|NOT COMPLETED|Phase I, Dose 2||0
11148807|NCT01512251|12336339|FG000|STARTED|Phase I, Dose 3||0
11148808|NCT01512251|12336340|FG001|STARTED|Phase I, Dose 3||0
11148809|NCT01512251|12336339|FG000|COMPLETED|Phase I, Dose 3||0
11148810|NCT01512251|12336340|FG001|COMPLETED|Phase I, Dose 3||0
11148811|NCT01512251|12336339|FG000|NOT COMPLETED|Phase I, Dose 3||0
11148812|NCT01512251|12336340|FG001|NOT COMPLETED|Phase I, Dose 3||0
11418522|NCT00475332|12616916|FG000|STARTED|Overall Study||2
11418523|NCT00475332|12616916|FG000|COMPLETED|Overall Study||2
11418524|NCT00475332|12616916|FG000|NOT COMPLETED|Overall Study||0
11418525|NCT00483119|12616923|FG000|STARTED|Overall Study||5
11148813|NCT01512251|12336339|FG000|STARTED|Phase I, Dose 4||0
11148814|NCT01512251|12336340|FG001|STARTED|Phase I, Dose 4||0
11148815|NCT01512251|12336339|FG000|COMPLETED|Phase I, Dose 4||0
11148816|NCT01512251|12336340|FG001|COMPLETED|Phase I, Dose 4||0
11148817|NCT01512251|12336339|FG000|NOT COMPLETED|Phase I, Dose 4||0
11148818|NCT01512251|12336340|FG001|NOT COMPLETED|Phase I, Dose 4||0
11148819|NCT01512251|12336339|FG000|STARTED|Phase II||0
11148820|NCT01512251|12336340|FG001|STARTED|Phase II||0
11148821|NCT01512251|12336339|FG000|COMPLETED|Phase II||0
11148822|NCT01512251|12336340|FG001|COMPLETED|Phase II||0
11148823|NCT01512251|12336339|FG000|NOT COMPLETED|Phase II||0
11148824|NCT01512251|12336340|FG001|NOT COMPLETED|Phase II||0
11148825|NCT01512264|12336351|FG000|STARTED|Overall Study||7
11148826|NCT01512264|12336352|FG001|STARTED|Overall Study||7
11148827|NCT01512264|12336353|FG002|STARTED|Overall Study||7
11148828|NCT01512264|12336354|FG003|STARTED|Overall Study||7
11418526|NCT00483119|12616924|FG001|STARTED|Overall Study||4
11418527|NCT00483119|12616923|FG000|COMPLETED|Overall Study||4
11148829|NCT01512264|12336351|FG000|COMPLETED|Overall Study||7
11148830|NCT01512264|12336352|FG001|COMPLETED|Overall Study||7
11148831|NCT01512264|12336353|FG002|COMPLETED|Overall Study||7
11148832|NCT01512264|12336354|FG003|COMPLETED|Overall Study||6
11148833|NCT01512264|12336351|FG000|NOT COMPLETED|Overall Study||0
11148834|NCT01512264|12336352|FG001|NOT COMPLETED|Overall Study||0
11148835|NCT01512264|12336353|FG002|NOT COMPLETED|Overall Study||0
11148836|NCT01512264|12336354|FG003|NOT COMPLETED|Overall Study||1
11148837|NCT01512368|12336364|FG000|STARTED|Overall Study||63
11148838|NCT01512368|12336364|FG000|COMPLETED|Overall Study||60
11148839|NCT01512368|12336364|FG000|NOT COMPLETED|Overall Study||3
11148840|NCT01512446|12336370|FG000|STARTED|Overall Study||221
11148841|NCT01512446|12336371|FG001|STARTED|Overall Study||215
11148842|NCT01512446|12336370|FG000|Safety Analysis Set|Overall Study||197
11148843|NCT01512446|12336371|FG001|Safety Analysis Set|Overall Study||188
11148844|NCT01512446|12336370|FG000|COMPLETED|Overall Study||0
11148845|NCT01512446|12336371|FG001|COMPLETED|Overall Study||0
11148846|NCT01512446|12336370|FG000|NOT COMPLETED|Overall Study||221
11148847|NCT01512446|12336371|FG001|NOT COMPLETED|Overall Study||215
11148848|NCT01512667|12336379|FG000|STARTED|Overall Study||13
11148849|NCT01512667|12336380|FG001|STARTED|Overall Study||12
11148850|NCT01512667|12336379|FG000|Matched Participants|Overall Study||12
11148851|NCT01512667|12336380|FG001|Matched Participants|Overall Study||12
11148852|NCT01512667|12336379|FG000|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
11148853|NCT01512667|12336380|FG001|Unmatched Participants|Overall Study||0
11148854|NCT01512667|12336379|FG000|COMPLETED|Overall Study||13
11148855|NCT01512667|12336380|FG001|COMPLETED|Overall Study||12
11148856|NCT01512667|12336379|FG000|NOT COMPLETED|Overall Study||0
11148857|NCT01512667|12336380|FG001|NOT COMPLETED|Overall Study||0
11148858|NCT01512693|12336388|FG000|STARTED|Overall Study||8
11148859|NCT01512693|12336389|FG001|STARTED|Overall Study||9
11148860|NCT01512693|12336388|FG000|COMPLETED|Overall Study||8
11148861|NCT01512693|12336389|FG001|COMPLETED|Overall Study||8
11148862|NCT01512693|12336388|FG000|NOT COMPLETED|Overall Study||0
11148863|NCT01512693|12336389|FG001|NOT COMPLETED|Overall Study||1
11148864|NCT01512745|12336397|FG000|STARTED|Overall Study||176
11148865|NCT01512745|12336398|FG001|STARTED|Overall Study||91
11148866|NCT01512745|12336397|FG000|COMPLETED|Overall Study||136
11148867|NCT01512745|12336398|FG001|COMPLETED|Overall Study||71
11148868|NCT01512745|12336397|FG000|NOT COMPLETED|Overall Study||40
11148869|NCT01512745|12336398|FG001|NOT COMPLETED|Overall Study||20
11148870|NCT01512758|12336406|FG000|STARTED|Overall Study||30
11148871|NCT01512758|12336407|FG001|STARTED|Overall Study||6
11148872|NCT01512758|12336406|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30
11148873|NCT01512758|12336407|FG001|COMPLETED|Overall Study||6
11148874|NCT01512758|12336406|FG000|NOT COMPLETED|Overall Study||0
11148875|NCT01512758|12336407|FG001|NOT COMPLETED|Overall Study||0
11148876|NCT01512797|12336416|FG000|STARTED|Overall Study||16
11148877|NCT01512797|12336417|FG001|STARTED|Overall Study||16
11148878|NCT01512797|12336416|FG000|COMPLETED|Overall Study||16
11148879|NCT01512797|12336417|FG001|COMPLETED|Overall Study||16
11148880|NCT01512797|12336416|FG000|NOT COMPLETED|Overall Study||0
11148881|NCT01512797|12336417|FG001|NOT COMPLETED|Overall Study||0
11148882|NCT01512849|12336425|FG000|STARTED|Crossover Period 1||6
11148883|NCT01512849|12336426|FG001|STARTED|Crossover Period 1||6
11148884|NCT01512849|12336427|FG002|STARTED|Crossover Period 1||6
11148885|NCT01512849|12336428|FG003|STARTED|Crossover Period 1||6
11148886|NCT01512849|12336425|FG000|COMPLETED|Crossover Period 1||6
11148887|NCT01512849|12336426|FG001|COMPLETED|Crossover Period 1||6
11148888|NCT01512849|12336427|FG002|COMPLETED|Crossover Period 1||6
11148889|NCT01512849|12336428|FG003|COMPLETED|Crossover Period 1||6
11148890|NCT01512849|12336425|FG000|NOT COMPLETED|Crossover Period 1||0
11148891|NCT01512849|12336426|FG001|NOT COMPLETED|Crossover Period 1||0
11148892|NCT01512849|12336427|FG002|NOT COMPLETED|Crossover Period 1||0
11148893|NCT01512849|12336428|FG003|NOT COMPLETED|Crossover Period 1||0
11148894|NCT01512849|12336425|FG000|STARTED|Crossover Period 2||6
11148895|NCT01512849|12336426|FG001|STARTED|Crossover Period 2||6
11148896|NCT01512849|12336427|FG002|STARTED|Crossover Period 2||6
11148897|NCT01512849|12336428|FG003|STARTED|Crossover Period 2||6
11148898|NCT01512849|12336425|FG000|COMPLETED|Crossover Period 2||6
11148899|NCT01512849|12336426|FG001|COMPLETED|Crossover Period 2||6
11148900|NCT01512849|12336427|FG002|COMPLETED|Crossover Period 2||6
11148901|NCT01512849|12336428|FG003|COMPLETED|Crossover Period 2||6
11148902|NCT01512849|12336425|FG000|NOT COMPLETED|Crossover Period 2||0
11148903|NCT01512849|12336426|FG001|NOT COMPLETED|Crossover Period 2||0
11148904|NCT01512849|12336427|FG002|NOT COMPLETED|Crossover Period 2||0
11148905|NCT01512849|12336428|FG003|NOT COMPLETED|Crossover Period 2||0
11148906|NCT01512979|12336440|FG000|STARTED|Overall Study|Randomised and treated|159
11148907|NCT01512979|12336441|FG001|STARTED|Overall Study|Randomised and treated|157
11148908|NCT01512979|12336440|FG000|COMPLETED|Overall Study||140
11148909|NCT01512979|12336441|FG001|COMPLETED|Overall Study||135
11148910|NCT01512979|12336440|FG000|NOT COMPLETED|Overall Study||19
11148911|NCT01512979|12336441|FG001|NOT COMPLETED|Overall Study||22
11148912|NCT01513122|12336449|FG000|STARTED|Overall Study||102
11148913|NCT01513122|12336450|FG001|STARTED|Overall Study||108
11148914|NCT01513122|12336449|FG000|COMPLETED|Overall Study||91
11418528|NCT00483119|12616924|FG001|COMPLETED|Overall Study||3
11418529|NCT00483119|12616923|FG000|NOT COMPLETED|Overall Study||1
11418530|NCT00483119|12616924|FG001|NOT COMPLETED|Overall Study||1
11418531|NCT00487461|12616933|FG000|STARTED|Overall Study||2
11148915|NCT01513122|12336450|FG001|COMPLETED|Overall Study||105
11148916|NCT01513122|12336449|FG000|NOT COMPLETED|Overall Study||11
11148917|NCT01513122|12336450|FG001|NOT COMPLETED|Overall Study||3
11148918|NCT01513148|12336458|FG000|STARTED|Overall Study||16
11148919|NCT01513148|12336459|FG001|STARTED|Overall Study||16
11148920|NCT01513148|12336458|FG000|COMPLETED|Overall Study||14
11148921|NCT01513148|12336459|FG001|COMPLETED|Overall Study||14
11148922|NCT01513148|12336458|FG000|NOT COMPLETED|Overall Study||2
11148923|NCT01513148|12336459|FG001|NOT COMPLETED|Overall Study||2
11148924|NCT01513239|12336508|FG000|STARTED|Period 1: Main Phase|Randomized participants|397
11148925|NCT01513239|12336509|FG001|STARTED|Period 1: Main Phase|Randomized participants|407
11148926|NCT01513239|12336510|FG002|STARTED|Period 1: Main Phase|Randomized participants|399
11148927|NCT01513239|12336511|FG003|STARTED|Period 1: Main Phase||0
11148928|NCT01513239|12336512|FG004|STARTED|Period 1: Main Phase||0
11148929|NCT01513239|12336513|FG005|STARTED|Period 1: Main Phase||0
11148930|NCT01513239|12336508|FG000|Treated|Period 1: Main Phase|Treated participants|391
11148931|NCT01513239|12336509|FG001|Treated|Period 1: Main Phase|Treated participants|396
11148932|NCT01513239|12336510|FG002|Treated|Period 1: Main Phase|Treated participants|381
11148933|NCT01513239|12336511|FG003|Treated|Period 1: Main Phase||0
11148934|NCT01513239|12336512|FG004|Treated|Period 1: Main Phase||0
11418532|NCT00487461|12616934|FG001|STARTED|Overall Study||12
11418533|NCT00487461|12616935|FG002|STARTED|Overall Study||11
11418534|NCT00487461|12616933|FG000|COMPLETED|Overall Study||2
11418535|NCT00487461|12616934|FG001|COMPLETED|Overall Study||10
11418536|NCT00487461|12616935|FG002|COMPLETED|Overall Study||7
11148935|NCT01513239|12336513|FG005|Treated|Period 1: Main Phase||0
11148936|NCT01513239|12336508|FG000|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
11148937|NCT01513239|12336509|FG001|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
11148938|NCT01513239|12336510|FG002|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
11148939|NCT01513239|12336511|FG003|All Participants as Treated|Period 1: Main Phase||0
11148940|NCT01513239|12336512|FG004|All Participants as Treated|Period 1: Main Phase||0
11148941|NCT01513239|12336513|FG005|All Participants as Treated|Period 1: Main Phase||0
11148942|NCT01513239|12336508|FG000|COMPLETED|Period 1: Main Phase||322
11148943|NCT01513239|12336509|FG001|COMPLETED|Period 1: Main Phase||337
11148944|NCT01513239|12336510|FG002|COMPLETED|Period 1: Main Phase||311
11148945|NCT01513239|12336511|FG003|COMPLETED|Period 1: Main Phase||0
11148946|NCT01513239|12336512|FG004|COMPLETED|Period 1: Main Phase||0
11148947|NCT01513239|12336513|FG005|COMPLETED|Period 1: Main Phase||0
11148948|NCT01513239|12336508|FG000|NOT COMPLETED|Period 1: Main Phase||75
11148949|NCT01513239|12336509|FG001|NOT COMPLETED|Period 1: Main Phase||70
11148950|NCT01513239|12336510|FG002|NOT COMPLETED|Period 1: Main Phase||88
11148951|NCT01513239|12336511|FG003|NOT COMPLETED|Period 1: Main Phase||0
11148952|NCT01513239|12336512|FG004|NOT COMPLETED|Period 1: Main Phase||0
11148953|NCT01513239|12336513|FG005|NOT COMPLETED|Period 1: Main Phase||0
11148954|NCT01513239|12336508|FG000|STARTED|Period 2: 9 Month Extension Phase||0
11148955|NCT01513239|12336509|FG001|STARTED|Period 2: 9 Month Extension Phase||0
11148956|NCT01513239|12336510|FG002|STARTED|Period 2: 9 Month Extension Phase||0
11148957|NCT01513239|12336511|FG003|STARTED|Period 2: 9 Month Extension Phase||112
11148958|NCT01513239|12336512|FG004|STARTED|Period 2: 9 Month Extension Phase||100
11148959|NCT01513239|12336513|FG005|STARTED|Period 2: 9 Month Extension Phase||83
11148960|NCT01513239|12336508|FG000|COMPLETED|Period 2: 9 Month Extension Phase||0
11418537|NCT00487461|12616933|FG000|NOT COMPLETED|Overall Study||0
11148961|NCT01513239|12336509|FG001|COMPLETED|Period 2: 9 Month Extension Phase||0
11148962|NCT01513239|12336510|FG002|COMPLETED|Period 2: 9 Month Extension Phase||0
11148963|NCT01513239|12336511|FG003|COMPLETED|Period 2: 9 Month Extension Phase||102
11148964|NCT01513239|12336512|FG004|COMPLETED|Period 2: 9 Month Extension Phase||90
11148965|NCT01513239|12336513|FG005|COMPLETED|Period 2: 9 Month Extension Phase||78
11148966|NCT01513239|12336508|FG000|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
11148967|NCT01513239|12336509|FG001|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
11148968|NCT01513239|12336510|FG002|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
11148969|NCT01513239|12336511|FG003|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
11148970|NCT01513239|12336512|FG004|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
11148971|NCT01513239|12336513|FG005|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
11148972|NCT01513291|12336527|FG000|STARTED|Treatment Period||120
11148973|NCT01513291|12336528|FG001|STARTED|Treatment Period||117
11148974|NCT01513291|12336529|FG002|STARTED|Treatment Period||0
11148975|NCT01513291|12336530|FG003|STARTED|Treatment Period||0
11148976|NCT01513291|12336531|FG004|STARTED|Treatment Period||0
11148977|NCT01513291|12336527|FG000|Treated|Treatment Period||120
11148978|NCT01513291|12336528|FG001|Treated|Treatment Period||115
11148979|NCT01513291|12336529|FG002|Treated|Treatment Period||0
11148980|NCT01513291|12336530|FG003|Treated|Treatment Period||0
11148981|NCT01513291|12336531|FG004|Treated|Treatment Period||0
11148982|NCT01513291|12336527|FG000|COMPLETED|Treatment Period||97
11148983|NCT01513291|12336528|FG001|COMPLETED|Treatment Period||101
11148984|NCT01513291|12336529|FG002|COMPLETED|Treatment Period||0
11148985|NCT01513291|12336530|FG003|COMPLETED|Treatment Period||0
11148986|NCT01513291|12336531|FG004|COMPLETED|Treatment Period||0
11148987|NCT01513291|12336527|FG000|NOT COMPLETED|Treatment Period||23
11148988|NCT01513291|12336528|FG001|NOT COMPLETED|Treatment Period||16
11148989|NCT01513291|12336529|FG002|NOT COMPLETED|Treatment Period||0
11148990|NCT01513291|12336530|FG003|NOT COMPLETED|Treatment Period||0
11148991|NCT01513291|12336531|FG004|NOT COMPLETED|Treatment Period||0
11148992|NCT01513291|12336527|FG000|STARTED|Run-out Period||0
11148993|NCT01513291|12336528|FG001|STARTED|Run-out Period||0
11148994|NCT01513291|12336529|FG002|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
11148995|NCT01513291|12336530|FG003|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
11148996|NCT01513291|12336531|FG004|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
11148997|NCT01513291|12336527|FG000|COMPLETED|Run-out Period||0
11148998|NCT01513291|12336528|FG001|COMPLETED|Run-out Period||0
11148999|NCT01513291|12336529|FG002|COMPLETED|Run-out Period||50
11149000|NCT01513291|12336530|FG003|COMPLETED|Run-out Period||45
11149001|NCT01513291|12336531|FG004|COMPLETED|Run-out Period||101
11149002|NCT01513291|12336527|FG000|NOT COMPLETED|Run-out Period||0
11149003|NCT01513291|12336528|FG001|NOT COMPLETED|Run-out Period||0
11149004|NCT01513291|12336529|FG002|NOT COMPLETED|Run-out Period||0
11149005|NCT01513291|12336530|FG003|NOT COMPLETED|Run-out Period||2
11149006|NCT01513291|12336531|FG004|NOT COMPLETED|Run-out Period||0
11149007|NCT01513317|12336545|FG000|STARTED|Overall Study||50
11149008|NCT01513317|12336546|FG001|STARTED|Overall Study||26
11149009|NCT01513317|12336545|FG000|COMPLETED|Overall Study||16
11149010|NCT01513317|12336546|FG001|COMPLETED|Overall Study||2
11149011|NCT01513317|12336545|FG000|NOT COMPLETED|Overall Study||34
11149012|NCT01513317|12336546|FG001|NOT COMPLETED|Overall Study||24
11149013|NCT01513330|12336552|FG000|STARTED|SenSura Mio First,||64
11149014|NCT01513330|12336553|FG001|STARTED|SenSura Mio First,||58
11149015|NCT01513330|12336552|FG000|COMPLETED|SenSura Mio First,||60
11149016|NCT01513330|12336553|FG001|COMPLETED|SenSura Mio First,||56
11149017|NCT01513330|12336552|FG000|NOT COMPLETED|SenSura Mio First,||4
11149018|NCT01513330|12336553|FG001|NOT COMPLETED|SenSura Mio First,||2
11149019|NCT01513330|12336552|FG000|STARTED|Standard Care First,||60
11149020|NCT01513330|12336553|FG001|STARTED|Standard Care First,||56
11149021|NCT01513330|12336552|FG000|COMPLETED|Standard Care First,||56
11149022|NCT01513330|12336553|FG001|COMPLETED|Standard Care First,||52
11149023|NCT01513330|12336552|FG000|NOT COMPLETED|Standard Care First,||4
11149024|NCT01513330|12336553|FG001|NOT COMPLETED|Standard Care First,||4
11149025|NCT01513447|12336561|FG000|STARTED|Overall Study||3
11149026|NCT01513447|12336562|FG001|STARTED|Overall Study||5
11149027|NCT01513447|12336561|FG000|COMPLETED|Overall Study||3
11149028|NCT01513447|12336562|FG001|COMPLETED|Overall Study||5
11149029|NCT01513447|12336561|FG000|NOT COMPLETED|Overall Study||0
11149030|NCT01513447|12336562|FG001|NOT COMPLETED|Overall Study||0
11149031|NCT01513460|12336571|FG000|STARTED|Overall Study||258
11149032|NCT01513460|12336572|FG001|STARTED|Overall Study||258
11149033|NCT01513460|12336573|FG002|STARTED|Overall Study||257
11149034|NCT01513460|12336571|FG000|Full Analysis Set|Overall Study||257
11149035|NCT01513460|12336572|FG001|Full Analysis Set|Overall Study||258
11149036|NCT01513460|12336573|FG002|Full Analysis Set|Overall Study||257
11149037|NCT01513460|12336571|FG000|Per-protocol Set|Overall Study||196
11149038|NCT01513460|12336572|FG001|Per-protocol Set|Overall Study||186
11149039|NCT01513460|12336573|FG002|Per-protocol Set|Overall Study||166
11149040|NCT01513460|12336571|FG000|COMPLETED|Overall Study||229
11149041|NCT01513460|12336572|FG001|COMPLETED|Overall Study||226
11149042|NCT01513460|12336573|FG002|COMPLETED|Overall Study||201
11149043|NCT01513460|12336571|FG000|NOT COMPLETED|Overall Study||29
11149044|NCT01513460|12336572|FG001|NOT COMPLETED|Overall Study||32
11149045|NCT01513460|12336573|FG002|NOT COMPLETED|Overall Study||56
11149046|NCT01513473|12336585|FG000|STARTED|Main Trial (26 Weeks)||174
11149047|NCT01513473|12336586|FG001|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
11149048|NCT01513473|12336585|FG000|Exposed|Main Trial (26 Weeks)||174
11149049|NCT01513473|12336586|FG001|Exposed|Main Trial (26 Weeks)||175
11149050|NCT01513473|12336585|FG000|COMPLETED|Main Trial (26 Weeks)||170
11149051|NCT01513473|12336586|FG001|COMPLETED|Main Trial (26 Weeks)||165
11149052|NCT01513473|12336585|FG000|NOT COMPLETED|Main Trial (26 Weeks)||4
11149053|NCT01513473|12336586|FG001|NOT COMPLETED|Main Trial (26 Weeks)||11
11149054|NCT01513473|12336585|FG000|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
11149055|NCT01513473|12336586|FG001|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
11149056|NCT01513473|12336585|FG000|COMPLETED|Extension Trial (26 Weeks)||151
11149057|NCT01513473|12336586|FG001|COMPLETED|Extension Trial (26 Weeks)||122
11149058|NCT01513473|12336585|FG000|NOT COMPLETED|Extension Trial (26 Weeks)||1
11149059|NCT01513473|12336586|FG001|NOT COMPLETED|Extension Trial (26 Weeks)||6
11149060|NCT01513538|12336592|FG000|STARTED|Overall Study||578
11149061|NCT01513538|12336592|FG000|COMPLETED|Overall Study||573
11149062|NCT01513538|12336592|FG000|NOT COMPLETED|Overall Study||5
11149063|NCT01513551|12336599|FG000|STARTED|Overall Study||230
11149064|NCT01513551|12336600|FG001|STARTED|Overall Study||231
11149065|NCT01513551|12336601|FG002|STARTED|Overall Study||231
11149066|NCT01513551|12336599|FG000|Vaccinated|Overall Study||230
11149067|NCT01513551|12336600|FG001|Vaccinated|Overall Study||231
11149068|NCT01513551|12336601|FG002|Vaccinated|Overall Study||230
11149069|NCT01513551|12336599|FG000|COMPLETED|Overall Study||226
11149070|NCT01513551|12336600|FG001|COMPLETED|Overall Study||225
11149071|NCT01513551|12336601|FG002|COMPLETED|Overall Study||226
11149072|NCT01513551|12336599|FG000|NOT COMPLETED|Overall Study||4
11418538|NCT00487461|12616934|FG001|NOT COMPLETED|Overall Study||2
11418539|NCT00487461|12616935|FG002|NOT COMPLETED|Overall Study||4
11418540|NCT00484718|12616943|FG000|STARTED|Treatment Period 1 (2 Weeks)||1
11418541|NCT00484718|12616944|FG001|STARTED|Treatment Period 1 (2 Weeks)||1
11418542|NCT00484718|12616945|FG002|STARTED|Treatment Period 1 (2 Weeks)||1
11149073|NCT01513551|12336600|FG001|NOT COMPLETED|Overall Study||6
11149074|NCT01513551|12336601|FG002|NOT COMPLETED|Overall Study||5
11149075|NCT01513590|12336611|FG000|STARTED|Overall Study||197
11149076|NCT01513590|12336612|FG001|STARTED|Overall Study||197
11149077|NCT01513590|12336611|FG000|Exposed|Overall Study|"One (1) subject was withdrawn prior to exposure due to non fulfilment of inclusion criteria"|196
11149078|NCT01513590|12336612|FG001|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
11149079|NCT01513590|12336611|FG000|COMPLETED|Overall Study||187
11149080|NCT01513590|12336612|FG001|COMPLETED|Overall Study||184
11149081|NCT01513590|12336611|FG000|NOT COMPLETED|Overall Study||10
11149082|NCT01513590|12336612|FG001|NOT COMPLETED|Overall Study||13
11149083|NCT01513759|12336618|FG000|STARTED|Overall Study||150
11149084|NCT01513759|12336618|FG000|At Least One Device Successfully Placed|Overall Study||149
11149085|NCT01513759|12336618|FG000|COMPLETED|Overall Study||145
11149086|NCT01513759|12336618|FG000|NOT COMPLETED|Overall Study||5
11149087|NCT01513902|12336625|FG000|STARTED|Overall Study||8
11149088|NCT01513902|12336626|FG001|STARTED|Overall Study||9
11149089|NCT01513902|12336627|FG002|STARTED|Overall Study||9
11149090|NCT01513902|12336625|FG000|COMPLETED|Overall Study||8
11149091|NCT01513902|12336626|FG001|COMPLETED|Overall Study||9
11149092|NCT01513902|12336627|FG002|COMPLETED|Overall Study||9
11149093|NCT01513902|12336625|FG000|NOT COMPLETED|Overall Study||0
11149094|NCT01513902|12336626|FG001|NOT COMPLETED|Overall Study||0
11149095|NCT01513902|12336627|FG002|NOT COMPLETED|Overall Study||0
11149096|NCT01513967|12336643|FG000|STARTED|Overall Study||4
11149097|NCT01513967|12336644|FG001|STARTED|Overall Study||4
11149098|NCT01513967|12336645|FG002|STARTED|Overall Study||4
11149099|NCT01513967|12336646|FG003|STARTED|Overall Study||6
11149100|NCT01513967|12336647|FG004|STARTED|Overall Study||4
11149101|NCT01513967|12336648|FG005|STARTED|Overall Study||4
11149102|NCT01513967|12336649|FG006|STARTED|Overall Study||5
11149103|NCT01513967|12336650|FG007|STARTED|Overall Study||8
11149104|NCT01513967|12336643|FG000|COMPLETED|Overall Study||4
11149105|NCT01513967|12336644|FG001|COMPLETED|Overall Study||4
11149106|NCT01513967|12336645|FG002|COMPLETED|Overall Study||4
11149107|NCT01513967|12336646|FG003|COMPLETED|Overall Study||6
11149108|NCT01513967|12336647|FG004|COMPLETED|Overall Study||4
11149109|NCT01513967|12336648|FG005|COMPLETED|Overall Study||3
11149110|NCT01513967|12336649|FG006|COMPLETED|Overall Study||3
11149111|NCT01513967|12336650|FG007|COMPLETED|Overall Study||6
11149112|NCT01513967|12336643|FG000|NOT COMPLETED|Overall Study||0
11149113|NCT01513967|12336644|FG001|NOT COMPLETED|Overall Study||0
11149114|NCT01513967|12336645|FG002|NOT COMPLETED|Overall Study||0
11149115|NCT01513967|12336646|FG003|NOT COMPLETED|Overall Study||0
11418543|NCT00484718|12616946|FG003|STARTED|Treatment Period 1 (2 Weeks)||1
11418544|NCT00484718|12616947|FG004|STARTED|Treatment Period 1 (2 Weeks)||1
11418545|NCT00484718|12616948|FG005|STARTED|Treatment Period 1 (2 Weeks)||1
11418546|NCT00484718|12616943|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||1
11418547|NCT00484718|12616944|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||1
11418548|NCT00484718|12616945|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||1
11418549|NCT00484718|12616946|FG003|COMPLETED|Treatment Period 1 (2 Weeks)||1
11418550|NCT00484718|12616947|FG004|COMPLETED|Treatment Period 1 (2 Weeks)||1
11418551|NCT00484718|12616948|FG005|COMPLETED|Treatment Period 1 (2 Weeks)||1
11418552|NCT00484718|12616943|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
11149116|NCT01513967|12336647|FG004|NOT COMPLETED|Overall Study||0
11149117|NCT01513967|12336648|FG005|NOT COMPLETED|Overall Study||1
11149118|NCT01513967|12336649|FG006|NOT COMPLETED|Overall Study||2
11149119|NCT01513967|12336650|FG007|NOT COMPLETED|Overall Study||2
11149120|NCT01514136|12336670|FG000|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
11149121|NCT01514136|12336671|FG001|STARTED|Test Period 1; Test A||0
11149122|NCT01514136|12336672|FG002|STARTED|Test Period 1; Test A||0
11149123|NCT01514136|12336673|FG003|STARTED|Test Period 1; Test A||0
11149124|NCT01514136|12336674|FG004|STARTED|Test Period 1; Test A||0
11149125|NCT01514136|12336675|FG005|STARTED|Test Period 1; Test A||0
11149126|NCT01514136|12336676|FG006|STARTED|Test Period 1; Test A||0
11149127|NCT01514136|12336677|FG007|STARTED|Test Period 1; Test A||0
11149128|NCT01514136|12336670|FG000|COMPLETED|Test Period 1; Test A||22
11149129|NCT01514136|12336671|FG001|COMPLETED|Test Period 1; Test A||0
11149130|NCT01514136|12336672|FG002|COMPLETED|Test Period 1; Test A||0
11149131|NCT01514136|12336673|FG003|COMPLETED|Test Period 1; Test A||0
11149132|NCT01514136|12336674|FG004|COMPLETED|Test Period 1; Test A||0
11149133|NCT01514136|12336675|FG005|COMPLETED|Test Period 1; Test A||0
11149134|NCT01514136|12336676|FG006|COMPLETED|Test Period 1; Test A||0
11149135|NCT01514136|12336677|FG007|COMPLETED|Test Period 1; Test A||0
11149136|NCT01514136|12336670|FG000|NOT COMPLETED|Test Period 1; Test A||3
11149137|NCT01514136|12336671|FG001|NOT COMPLETED|Test Period 1; Test A||0
11149138|NCT01514136|12336672|FG002|NOT COMPLETED|Test Period 1; Test A||0
11149139|NCT01514136|12336673|FG003|NOT COMPLETED|Test Period 1; Test A||0
11149140|NCT01514136|12336674|FG004|NOT COMPLETED|Test Period 1; Test A||0
11149141|NCT01514136|12336675|FG005|NOT COMPLETED|Test Period 1; Test A||0
11149142|NCT01514136|12336676|FG006|NOT COMPLETED|Test Period 1; Test A||0
11149143|NCT01514136|12336677|FG007|NOT COMPLETED|Test Period 1; Test A||0
11149144|NCT01514136|12336670|FG000|STARTED|Test Period 1; Test B||0
11149145|NCT01514136|12336671|FG001|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
11149146|NCT01514136|12336672|FG002|STARTED|Test Period 1; Test B||0
11149147|NCT01514136|12336673|FG003|STARTED|Test Period 1; Test B||0
11149148|NCT01514136|12336674|FG004|STARTED|Test Period 1; Test B||0
11149149|NCT01514136|12336675|FG005|STARTED|Test Period 1; Test B||0
11149150|NCT01514136|12336676|FG006|STARTED|Test Period 1; Test B||0
11149151|NCT01514136|12336677|FG007|STARTED|Test Period 1; Test B||0
11149152|NCT01514136|12336670|FG000|COMPLETED|Test Period 1; Test B||0
11149153|NCT01514136|12336671|FG001|COMPLETED|Test Period 1; Test B||23
11149154|NCT01514136|12336672|FG002|COMPLETED|Test Period 1; Test B||0
11149155|NCT01514136|12336673|FG003|COMPLETED|Test Period 1; Test B||0
11149156|NCT01514136|12336674|FG004|COMPLETED|Test Period 1; Test B||0
11149157|NCT01514136|12336675|FG005|COMPLETED|Test Period 1; Test B||0
11149158|NCT01514136|12336676|FG006|COMPLETED|Test Period 1; Test B||0
11149159|NCT01514136|12336677|FG007|COMPLETED|Test Period 1; Test B||0
11149160|NCT01514136|12336670|FG000|NOT COMPLETED|Test Period 1; Test B||0
11149161|NCT01514136|12336671|FG001|NOT COMPLETED|Test Period 1; Test B||1
11149162|NCT01514136|12336672|FG002|NOT COMPLETED|Test Period 1; Test B||0
11149163|NCT01514136|12336673|FG003|NOT COMPLETED|Test Period 1; Test B||0
11149164|NCT01514136|12336674|FG004|NOT COMPLETED|Test Period 1; Test B||0
11149165|NCT01514136|12336675|FG005|NOT COMPLETED|Test Period 1; Test B||0
11149166|NCT01514136|12336676|FG006|NOT COMPLETED|Test Period 1; Test B||0
11149167|NCT01514136|12336677|FG007|NOT COMPLETED|Test Period 1; Test B||0
11149168|NCT01514136|12336670|FG000|STARTED|Test Period 1; Test C||0
11149169|NCT01514136|12336671|FG001|STARTED|Test Period 1; Test C||0
11149170|NCT01514136|12336672|FG002|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
11149171|NCT01514136|12336673|FG003|STARTED|Test Period 1; Test C||0
11149172|NCT01514136|12336674|FG004|STARTED|Test Period 1; Test C||0
11149173|NCT01514136|12336675|FG005|STARTED|Test Period 1; Test C||0
11149174|NCT01514136|12336676|FG006|STARTED|Test Period 1; Test C||0
11149175|NCT01514136|12336677|FG007|STARTED|Test Period 1; Test C||0
11149176|NCT01514136|12336670|FG000|COMPLETED|Test Period 1; Test C||0
11149177|NCT01514136|12336671|FG001|COMPLETED|Test Period 1; Test C||0
11149178|NCT01514136|12336672|FG002|COMPLETED|Test Period 1; Test C||24
11149179|NCT01514136|12336673|FG003|COMPLETED|Test Period 1; Test C||0
11149180|NCT01514136|12336674|FG004|COMPLETED|Test Period 1; Test C||0
11149181|NCT01514136|12336675|FG005|COMPLETED|Test Period 1; Test C||0
11149182|NCT01514136|12336676|FG006|COMPLETED|Test Period 1; Test C||0
11149183|NCT01514136|12336677|FG007|COMPLETED|Test Period 1; Test C||0
11149184|NCT01514136|12336670|FG000|NOT COMPLETED|Test Period 1; Test C||0
11149185|NCT01514136|12336671|FG001|NOT COMPLETED|Test Period 1; Test C||0
11149186|NCT01514136|12336672|FG002|NOT COMPLETED|Test Period 1; Test C||0
11149187|NCT01514136|12336673|FG003|NOT COMPLETED|Test Period 1; Test C||0
11149188|NCT01514136|12336674|FG004|NOT COMPLETED|Test Period 1; Test C||0
11149189|NCT01514136|12336675|FG005|NOT COMPLETED|Test Period 1; Test C||0
11149190|NCT01514136|12336676|FG006|NOT COMPLETED|Test Period 1; Test C||0
11149191|NCT01514136|12336677|FG007|NOT COMPLETED|Test Period 1; Test C||0
11149192|NCT01514136|12336670|FG000|STARTED|Test Period 1; Test D||0
11149193|NCT01514136|12336671|FG001|STARTED|Test Period 1; Test D||0
11149194|NCT01514136|12336672|FG002|STARTED|Test Period 1; Test D||0
11149195|NCT01514136|12336673|FG003|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
11149196|NCT01514136|12336674|FG004|STARTED|Test Period 1; Test D||0
11149197|NCT01514136|12336675|FG005|STARTED|Test Period 1; Test D||0
11149198|NCT01514136|12336676|FG006|STARTED|Test Period 1; Test D||0
11149199|NCT01514136|12336677|FG007|STARTED|Test Period 1; Test D||0
11149200|NCT01514136|12336670|FG000|COMPLETED|Test Period 1; Test D||0
11149201|NCT01514136|12336671|FG001|COMPLETED|Test Period 1; Test D||0
11149202|NCT01514136|12336672|FG002|COMPLETED|Test Period 1; Test D||0
11149203|NCT01514136|12336673|FG003|COMPLETED|Test Period 1; Test D||24
11149204|NCT01514136|12336674|FG004|COMPLETED|Test Period 1; Test D||0
11149205|NCT01514136|12336675|FG005|COMPLETED|Test Period 1; Test D||0
11149206|NCT01514136|12336676|FG006|COMPLETED|Test Period 1; Test D||0
11149207|NCT01514136|12336677|FG007|COMPLETED|Test Period 1; Test D||0
11149208|NCT01514136|12336670|FG000|NOT COMPLETED|Test Period 1; Test D||0
11149209|NCT01514136|12336671|FG001|NOT COMPLETED|Test Period 1; Test D||0
11149210|NCT01514136|12336672|FG002|NOT COMPLETED|Test Period 1; Test D||0
11149211|NCT01514136|12336673|FG003|NOT COMPLETED|Test Period 1; Test D||2
11149212|NCT01514136|12336674|FG004|NOT COMPLETED|Test Period 1; Test D||0
11149213|NCT01514136|12336675|FG005|NOT COMPLETED|Test Period 1; Test D||0
11149214|NCT01514136|12336676|FG006|NOT COMPLETED|Test Period 1; Test D||0
11149215|NCT01514136|12336677|FG007|NOT COMPLETED|Test Period 1; Test D||0
11149216|NCT01514136|12336670|FG000|STARTED|Test Period 2; Test A*||0
11149217|NCT01514136|12336671|FG001|STARTED|Test Period 2; Test A*||0
11149218|NCT01514136|12336672|FG002|STARTED|Test Period 2; Test A*||0
11149219|NCT01514136|12336673|FG003|STARTED|Test Period 2; Test A*||0
11149220|NCT01514136|12336674|FG004|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
11149221|NCT01514136|12336675|FG005|STARTED|Test Period 2; Test A*||0
11149222|NCT01514136|12336676|FG006|STARTED|Test Period 2; Test A*||0
11149223|NCT01514136|12336677|FG007|STARTED|Test Period 2; Test A*||0
11149224|NCT01514136|12336670|FG000|COMPLETED|Test Period 2; Test A*||0
11149225|NCT01514136|12336671|FG001|COMPLETED|Test Period 2; Test A*||0
11149226|NCT01514136|12336672|FG002|COMPLETED|Test Period 2; Test A*||0
11149227|NCT01514136|12336673|FG003|COMPLETED|Test Period 2; Test A*||0
11149228|NCT01514136|12336674|FG004|COMPLETED|Test Period 2; Test A*||26
11149229|NCT01514136|12336675|FG005|COMPLETED|Test Period 2; Test A*||0
11149230|NCT01514136|12336676|FG006|COMPLETED|Test Period 2; Test A*||0
11149231|NCT01514136|12336677|FG007|COMPLETED|Test Period 2; Test A*||0
11149232|NCT01514136|12336670|FG000|NOT COMPLETED|Test Period 2; Test A*||0
11149233|NCT01514136|12336671|FG001|NOT COMPLETED|Test Period 2; Test A*||0
11149234|NCT01514136|12336672|FG002|NOT COMPLETED|Test Period 2; Test A*||0
11149235|NCT01514136|12336673|FG003|NOT COMPLETED|Test Period 2; Test A*||0
11149236|NCT01514136|12336674|FG004|NOT COMPLETED|Test Period 2; Test A*||2
11149237|NCT01514136|12336675|FG005|NOT COMPLETED|Test Period 2; Test A*||0
11149238|NCT01514136|12336676|FG006|NOT COMPLETED|Test Period 2; Test A*||0
11149239|NCT01514136|12336677|FG007|NOT COMPLETED|Test Period 2; Test A*||0
11149240|NCT01514136|12336670|FG000|STARTED|Test Period 2; Test B*||0
11149241|NCT01514136|12336671|FG001|STARTED|Test Period 2; Test B*||0
11149242|NCT01514136|12336672|FG002|STARTED|Test Period 2; Test B*||0
11149243|NCT01514136|12336673|FG003|STARTED|Test Period 2; Test B*||0
11149244|NCT01514136|12336674|FG004|STARTED|Test Period 2; Test B*||0
11149245|NCT01514136|12336675|FG005|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
11149246|NCT01514136|12336676|FG006|STARTED|Test Period 2; Test B*||0
11149247|NCT01514136|12336677|FG007|STARTED|Test Period 2; Test B*||0
11149248|NCT01514136|12336670|FG000|COMPLETED|Test Period 2; Test B*||0
11149249|NCT01514136|12336671|FG001|COMPLETED|Test Period 2; Test B*||0
11149250|NCT01514136|12336672|FG002|COMPLETED|Test Period 2; Test B*||0
11149251|NCT01514136|12336673|FG003|COMPLETED|Test Period 2; Test B*||0
11149252|NCT01514136|12336674|FG004|COMPLETED|Test Period 2; Test B*||0
11149253|NCT01514136|12336675|FG005|COMPLETED|Test Period 2; Test B*||26
11149254|NCT01514136|12336676|FG006|COMPLETED|Test Period 2; Test B*||0
11149255|NCT01514136|12336677|FG007|COMPLETED|Test Period 2; Test B*||0
11149256|NCT01514136|12336670|FG000|NOT COMPLETED|Test Period 2; Test B*||0
11149257|NCT01514136|12336671|FG001|NOT COMPLETED|Test Period 2; Test B*||0
11149258|NCT01514136|12336672|FG002|NOT COMPLETED|Test Period 2; Test B*||0
11149259|NCT01514136|12336673|FG003|NOT COMPLETED|Test Period 2; Test B*||0
11149260|NCT01514136|12336674|FG004|NOT COMPLETED|Test Period 2; Test B*||0
11149261|NCT01514136|12336675|FG005|NOT COMPLETED|Test Period 2; Test B*||2
11149262|NCT01514136|12336676|FG006|NOT COMPLETED|Test Period 2; Test B*||0
11149263|NCT01514136|12336677|FG007|NOT COMPLETED|Test Period 2; Test B*||0
11149264|NCT01514136|12336670|FG000|STARTED|Test Period 2; Test C*||0
11149265|NCT01514136|12336671|FG001|STARTED|Test Period 2; Test C*||0
11149266|NCT01514136|12336672|FG002|STARTED|Test Period 2; Test C*||0
11149267|NCT01514136|12336673|FG003|STARTED|Test Period 2; Test C*||0
11149268|NCT01514136|12336674|FG004|STARTED|Test Period 2; Test C*||0
11149269|NCT01514136|12336675|FG005|STARTED|Test Period 2; Test C*||0
11149270|NCT01514136|12336676|FG006|STARTED|Test Period 2; Test C*||26
11149271|NCT01514136|12336677|FG007|STARTED|Test Period 2; Test C*||0
11149272|NCT01514136|12336670|FG000|COMPLETED|Test Period 2; Test C*||0
11149273|NCT01514136|12336671|FG001|COMPLETED|Test Period 2; Test C*||0
11149274|NCT01514136|12336672|FG002|COMPLETED|Test Period 2; Test C*||0
11149275|NCT01514136|12336673|FG003|COMPLETED|Test Period 2; Test C*||0
11149276|NCT01514136|12336674|FG004|COMPLETED|Test Period 2; Test C*||0
11149277|NCT01514136|12336675|FG005|COMPLETED|Test Period 2; Test C*||0
11149278|NCT01514136|12336676|FG006|COMPLETED|Test Period 2; Test C*||23
11149279|NCT01514136|12336677|FG007|COMPLETED|Test Period 2; Test C*||0
11149280|NCT01514136|12336670|FG000|NOT COMPLETED|Test Period 2; Test C*||0
11149281|NCT01514136|12336671|FG001|NOT COMPLETED|Test Period 2; Test C*||0
11149282|NCT01514136|12336672|FG002|NOT COMPLETED|Test Period 2; Test C*||0
11149283|NCT01514136|12336673|FG003|NOT COMPLETED|Test Period 2; Test C*||0
11149284|NCT01514136|12336674|FG004|NOT COMPLETED|Test Period 2; Test C*||0
11149285|NCT01514136|12336675|FG005|NOT COMPLETED|Test Period 2; Test C*||0
11149286|NCT01514136|12336676|FG006|NOT COMPLETED|Test Period 2; Test C*||3
11149287|NCT01514136|12336677|FG007|NOT COMPLETED|Test Period 2; Test C*||0
11149288|NCT01514136|12336670|FG000|STARTED|Test Period; Test D*||0
11149289|NCT01514136|12336671|FG001|STARTED|Test Period; Test D*||0
11149290|NCT01514136|12336672|FG002|STARTED|Test Period; Test D*||0
11149291|NCT01514136|12336673|FG003|STARTED|Test Period; Test D*||0
11149292|NCT01514136|12336674|FG004|STARTED|Test Period; Test D*||0
11149293|NCT01514136|12336675|FG005|STARTED|Test Period; Test D*||0
11149294|NCT01514136|12336676|FG006|STARTED|Test Period; Test D*||0
11149295|NCT01514136|12336677|FG007|STARTED|Test Period; Test D*||23
11149296|NCT01514136|12336670|FG000|COMPLETED|Test Period; Test D*||0
11149297|NCT01514136|12336671|FG001|COMPLETED|Test Period; Test D*||0
11149298|NCT01514136|12336672|FG002|COMPLETED|Test Period; Test D*||0
11149299|NCT01514136|12336673|FG003|COMPLETED|Test Period; Test D*||0
11149300|NCT01514136|12336674|FG004|COMPLETED|Test Period; Test D*||0
11149301|NCT01514136|12336675|FG005|COMPLETED|Test Period; Test D*||0
11149302|NCT01514136|12336676|FG006|COMPLETED|Test Period; Test D*||0
11149303|NCT01514136|12336677|FG007|COMPLETED|Test Period; Test D*||23
11149304|NCT01514136|12336670|FG000|NOT COMPLETED|Test Period; Test D*||0
11149305|NCT01514136|12336671|FG001|NOT COMPLETED|Test Period; Test D*||0
11149306|NCT01514136|12336672|FG002|NOT COMPLETED|Test Period; Test D*||0
11149307|NCT01514136|12336673|FG003|NOT COMPLETED|Test Period; Test D*||0
11149308|NCT01514136|12336674|FG004|NOT COMPLETED|Test Period; Test D*||0
11149309|NCT01514136|12336675|FG005|NOT COMPLETED|Test Period; Test D*||0
11418553|NCT00484718|12616944|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
11418554|NCT00484718|12616945|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
11418555|NCT00484718|12616946|FG003|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
11418556|NCT00484718|12616947|FG004|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
11418557|NCT00484718|12616948|FG005|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
11418558|NCT00484718|12616943|FG000|STARTED|Washout Period (2 Weeks)||1
11418559|NCT00484718|12616944|FG001|STARTED|Washout Period (2 Weeks)||1
11418560|NCT00484718|12616945|FG002|STARTED|Washout Period (2 Weeks)||1
11418561|NCT00484718|12616946|FG003|STARTED|Washout Period (2 Weeks)||1
11418562|NCT00484718|12616947|FG004|STARTED|Washout Period (2 Weeks)||1
11418563|NCT00484718|12616948|FG005|STARTED|Washout Period (2 Weeks)||1
11418564|NCT00484718|12616943|FG000|COMPLETED|Washout Period (2 Weeks)||1
11418565|NCT00484718|12616944|FG001|COMPLETED|Washout Period (2 Weeks)||1
11149310|NCT01514136|12336676|FG006|NOT COMPLETED|Test Period; Test D*||0
11149311|NCT01514136|12336677|FG007|NOT COMPLETED|Test Period; Test D*||0
11149312|NCT01514149|12336708|FG000|STARTED|Overall Study||15
11149313|NCT01514149|12336709|FG001|STARTED|Overall Study||15
11149314|NCT01514149|12336710|FG002|STARTED|Overall Study||14
11149315|NCT01514149|12336711|FG003|STARTED|Overall Study||14
11149316|NCT01514149|12336712|FG004|STARTED|Overall Study||15
11149317|NCT01514149|12336708|FG000|COMPLETED|Overall Study||12
11149318|NCT01514149|12336709|FG001|COMPLETED|Overall Study||14
11149319|NCT01514149|12336710|FG002|COMPLETED|Overall Study||11
11149320|NCT01514149|12336711|FG003|COMPLETED|Overall Study||13
11149321|NCT01514149|12336712|FG004|COMPLETED|Overall Study||14
11149322|NCT01514149|12336708|FG000|NOT COMPLETED|Overall Study||3
11149323|NCT01514149|12336709|FG001|NOT COMPLETED|Overall Study||1
11149324|NCT01514149|12336710|FG002|NOT COMPLETED|Overall Study||3
11149325|NCT01514149|12336711|FG003|NOT COMPLETED|Overall Study||1
11149326|NCT01514149|12336712|FG004|NOT COMPLETED|Overall Study||1
11202854|NCT01843803|12393309|FG000|STARTED|Overall Study||137
11202855|NCT01843803|12393310|FG001|STARTED|Overall Study||139
11202856|NCT01843803|12393309|FG000|COMPLETED|Overall Study||136
11202857|NCT01843803|12393310|FG001|COMPLETED|Overall Study||136
11202858|NCT01843803|12393309|FG000|NOT COMPLETED|Overall Study||1
11202859|NCT01843803|12393310|FG001|NOT COMPLETED|Overall Study||3
11202860|NCT01843842|12393318|FG000|STARTED|Overall Study||154
11202861|NCT01843842|12393319|FG001|STARTED|Overall Study||152
11202862|NCT01843842|12393318|FG000|COMPLETED|Overall Study||153
11202863|NCT01843842|12393319|FG001|COMPLETED|Overall Study||151
11202864|NCT01843842|12393318|FG000|NOT COMPLETED|Overall Study||1
11202865|NCT01843842|12393319|FG001|NOT COMPLETED|Overall Study||1
11202866|NCT01843920|12393327|FG000|STARTED|Overall Study||12
11418566|NCT00484718|12616945|FG002|COMPLETED|Washout Period (2 Weeks)||1
11149327|NCT01514162|12336724|FG000|STARTED|Overall Study||245
11149328|NCT01514162|12336724|FG000|COMPLETED|Overall Study||160
11149329|NCT01514162|12336724|FG000|NOT COMPLETED|Overall Study||85
11149330|NCT01514201|12336732|FG000|STARTED|PHASE I: Veliparib + Radiation Therapy||6
11149331|NCT01514201|12336733|FG001|STARTED|PHASE I: Veliparib + Radiation Therapy||6
11149332|NCT01514201|12336734|FG002|STARTED|PHASE I: Veliparib + Radiation Therapy||6
11149333|NCT01514201|12336735|FG003|STARTED|PHASE I: Veliparib + Radiation Therapy||0
11149334|NCT01514201|12336732|FG000|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5
11149335|NCT01514201|12336733|FG001|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
11149336|NCT01514201|12336734|FG002|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
11149337|NCT01514201|12336735|FG003|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
11149338|NCT01514201|12336732|FG000|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1
11149339|NCT01514201|12336733|FG001|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
11149340|NCT01514201|12336734|FG002|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
11149341|NCT01514201|12336735|FG003|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
11149342|NCT01514201|12336732|FG000|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5
11149343|NCT01514201|12336733|FG001|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
11149344|NCT01514201|12336734|FG002|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
11149345|NCT01514201|12336735|FG003|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0
11149346|NCT01514201|12336732|FG000|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
11149347|NCT01514201|12336733|FG001|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
11418567|NCT00484718|12616946|FG003|COMPLETED|Washout Period (2 Weeks)||1
11149348|NCT01514201|12336734|FG002|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
11149349|NCT01514201|12336735|FG003|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
11149350|NCT01514201|12336732|FG000|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5
11149351|NCT01514201|12336733|FG001|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
11149352|NCT01514201|12336734|FG002|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
11149353|NCT01514201|12336735|FG003|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
11149354|NCT01514201|12336732|FG000|STARTED|PHASE II: Veliparib + Radiation Therapy||0
11149355|NCT01514201|12336733|FG001|STARTED|PHASE II: Veliparib + Radiation Therapy||0
11149356|NCT01514201|12336734|FG002|STARTED|PHASE II: Veliparib + Radiation Therapy||0
11149357|NCT01514201|12336735|FG003|STARTED|PHASE II: Veliparib + Radiation Therapy||47
11149358|NCT01514201|12336732|FG000|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
11149359|NCT01514201|12336733|FG001|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
11149360|NCT01514201|12336734|FG002|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
11149361|NCT01514201|12336735|FG003|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35
11149362|NCT01514201|12336732|FG000|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
11149363|NCT01514201|12336733|FG001|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
11149364|NCT01514201|12336734|FG002|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
11149365|NCT01514201|12336735|FG003|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12
11149366|NCT01514201|12336732|FG000|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
11149367|NCT01514201|12336733|FG001|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
11149368|NCT01514201|12336734|FG002|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
11149369|NCT01514201|12336735|FG003|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35
11149370|NCT01514201|12336732|FG000|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
11149371|NCT01514201|12336733|FG001|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
11149372|NCT01514201|12336734|FG002|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
11149373|NCT01514201|12336735|FG003|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2
11149374|NCT01514201|12336732|FG000|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
11149375|NCT01514201|12336733|FG001|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
11149376|NCT01514201|12336734|FG002|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
11149377|NCT01514201|12336735|FG003|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33
11149378|NCT01514240|12336757|FG000|STARTED|Overall Study||56
11149379|NCT01514240|12336758|FG001|STARTED|Overall Study||56
11149380|NCT01514240|12336757|FG000|COMPLETED|Overall Study||50
11149381|NCT01514240|12336758|FG001|COMPLETED|Overall Study||45
11149382|NCT01514240|12336757|FG000|NOT COMPLETED|Overall Study||6
11149383|NCT01514240|12336758|FG001|NOT COMPLETED|Overall Study||11
11149384|NCT01514279|12336767|FG000|STARTED|Overall Study||118
11149385|NCT01514279|12336768|FG001|STARTED|Overall Study||123
11149386|NCT01514279|12336769|FG002|STARTED|Overall Study||119
11149387|NCT01514279|12336767|FG000|COMPLETED|Overall Study||107
11149388|NCT01514279|12336768|FG001|COMPLETED|Overall Study||110
11149389|NCT01514279|12336769|FG002|COMPLETED|Overall Study||114
11149390|NCT01514279|12336767|FG000|NOT COMPLETED|Overall Study||11
11149391|NCT01514279|12336768|FG001|NOT COMPLETED|Overall Study||13
11149392|NCT01514279|12336769|FG002|NOT COMPLETED|Overall Study||5
11149393|NCT01514292|12336777|FG000|STARTED|Overall Study||72
11149394|NCT01514292|12336777|FG000|COMPLETED|Overall Study||72
11149395|NCT01514292|12336777|FG000|NOT COMPLETED|Overall Study||0
11149396|NCT01514318|12336781|FG000|STARTED|Overall Study||8
11149397|NCT01514318|12336781|FG000|COMPLETED|Overall Study||8
11149398|NCT01514318|12336781|FG000|NOT COMPLETED|Overall Study||0
11149399|NCT01514357|12336787|FG000|STARTED|Overall Study||12
11149400|NCT01514357|12336788|FG001|STARTED|Overall Study||0
11149401|NCT01514357|12336787|FG000|COMPLETED|Overall Study||8
11149402|NCT01514357|12336788|FG001|COMPLETED|Overall Study||0
11149403|NCT01514357|12336787|FG000|NOT COMPLETED|Overall Study||4
11149404|NCT01514357|12336788|FG001|NOT COMPLETED|Overall Study||0
11149405|NCT01514370|12336796|FG000|STARTED|Overall Study||40
11149406|NCT01514370|12336797|FG001|STARTED|Overall Study||40
11149407|NCT01514370|12336796|FG000|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38
11149408|NCT01514370|12336797|FG001|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40
11149409|NCT01514370|12336796|FG000|COMPLETED|Overall Study||29
11149410|NCT01514370|12336797|FG001|COMPLETED|Overall Study||24
11149411|NCT01514370|12336796|FG000|NOT COMPLETED|Overall Study||11
11149412|NCT01514370|12336797|FG001|NOT COMPLETED|Overall Study||16
11149413|NCT01514383|12336804|FG000|STARTED|Overall Study||34
11149414|NCT01514383|12336804|FG000|COMPLETED|Overall Study||34
11149415|NCT01514383|12336804|FG000|NOT COMPLETED|Overall Study||0
11149416|NCT01514396|12336809|FG000|STARTED|Overall Study||8
11149417|NCT01514396|12336809|FG000|COMPLETED|Overall Study||8
11149418|NCT01514396|12336809|FG000|NOT COMPLETED|Overall Study||0
11149419|NCT01514422|12336814|FG000|STARTED|Overall Study||20
11149420|NCT01514422|12336814|FG000|COMPLETED|Overall Study||19
11149421|NCT01514422|12336814|FG000|NOT COMPLETED|Overall Study||1
11149422|NCT01514448|12336820|FG000|STARTED|Overall Study||16
11149423|NCT01514448|12336821|FG001|STARTED|Overall Study||13
11149424|NCT01514448|12336820|FG000|Full Analysis Set (FAS)|Overall Study||12
11149425|NCT01514448|12336821|FG001|Full Analysis Set (FAS)|Overall Study||13
11149426|NCT01514448|12336820|FG000|COMPLETED|Overall Study||4
11149427|NCT01514448|12336821|FG001|COMPLETED|Overall Study||5
11149428|NCT01514448|12336820|FG000|NOT COMPLETED|Overall Study||12
11149429|NCT01514448|12336821|FG001|NOT COMPLETED|Overall Study||8
11149430|NCT01514461|12336831|FG000|STARTED|Overall Study||15
11149431|NCT01514461|12336832|FG001|STARTED|Overall Study||15
11149432|NCT01514461|12336833|FG002|STARTED|Overall Study||15
11149433|NCT01514461|12336831|FG000|COMPLETED|Overall Study||10
11149434|NCT01514461|12336832|FG001|COMPLETED|Overall Study||12
11149435|NCT01514461|12336833|FG002|COMPLETED|Overall Study||11
11149436|NCT01514461|12336831|FG000|NOT COMPLETED|Overall Study||5
11149437|NCT01514461|12336832|FG001|NOT COMPLETED|Overall Study||3
11149438|NCT01514461|12336833|FG002|NOT COMPLETED|Overall Study||4
11149439|NCT01514513|12336846|FG000|STARTED|Overall Study||21
11149440|NCT01514513|12336847|FG001|STARTED|Overall Study||21
11149441|NCT01514513|12336846|FG000|COMPLETED|Overall Study||20
11149442|NCT01514513|12336847|FG001|COMPLETED|Overall Study||20
11149443|NCT01514513|12336846|FG000|NOT COMPLETED|Overall Study||1
11149444|NCT01514513|12336847|FG001|NOT COMPLETED|Overall Study||1
11149445|NCT01514630|12336853|FG000|STARTED|Overall Study||14
11149446|NCT01514630|12336853|FG000|COMPLETED|Overall Study||11
11149447|NCT01514630|12336853|FG000|NOT COMPLETED|Overall Study||3
11149448|NCT01514734|12336857|FG000|STARTED|Overall Study||9
11149449|NCT01514734|12336857|FG000|COMPLETED|Overall Study||9
11149450|NCT01514734|12336857|FG000|NOT COMPLETED|Overall Study||0
11149451|NCT01514760|12336861|FG000|STARTED|Overall Study||22
11149452|NCT01514760|12336861|FG000|COMPLETED|Overall Study||20
11149453|NCT01514760|12336861|FG000|NOT COMPLETED|Overall Study||2
11149454|NCT01514786|12336867|FG000|STARTED|Overall Study||286
11149455|NCT01514786|12336868|FG001|STARTED|Overall Study||284
11149456|NCT01514786|12336867|FG000|COMPLETED|Overall Study||286
11149457|NCT01514786|12336868|FG001|COMPLETED|Overall Study||284
11149458|NCT01514786|12336867|FG000|NOT COMPLETED|Overall Study||0
11149459|NCT01514786|12336868|FG001|NOT COMPLETED|Overall Study||0
11149460|NCT01514864|12336876|FG000|STARTED|Overall Study||9
11149461|NCT01514864|12336877|FG001|STARTED|Overall Study||5
11149462|NCT01514864|12336876|FG000|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
11149463|NCT01514864|12336877|FG001|COMPLETED|Overall Study||0
11149464|NCT01514864|12336876|FG000|NOT COMPLETED|Overall Study||9
11149465|NCT01514864|12336877|FG001|NOT COMPLETED|Overall Study||5
11149466|NCT01515046|12336884|FG000|STARTED|Overall Study||1
11149467|NCT01515046|12336884|FG000|COMPLETED|Overall Study||1
11149468|NCT01515046|12336884|FG000|NOT COMPLETED|Overall Study||0
11149469|NCT01515072|12336890|FG000|STARTED|Overall Study||166
11149470|NCT01515072|12336891|FG001|STARTED|Overall Study||155
11149471|NCT01515072|12336890|FG000|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
11149472|NCT01515072|12336891|FG001|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
11149473|NCT01515072|12336890|FG000|NOT COMPLETED|Overall Study||0
11149474|NCT01515072|12336891|FG001|NOT COMPLETED|Overall Study||0
11149475|NCT01515176|12336913|FG000|STARTED|Overall Study||4
11149476|NCT01515176|12336914|FG001|STARTED|Overall Study||32
11149477|NCT01515176|12336913|FG000|COMPLETED|Overall Study||4
11149478|NCT01515176|12336914|FG001|COMPLETED|Overall Study||32
11149479|NCT01515176|12336913|FG000|NOT COMPLETED|Overall Study||0
11149480|NCT01515176|12336914|FG001|NOT COMPLETED|Overall Study||0
11149481|NCT01515189|12336924|FG000|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
11149482|NCT01515189|12336925|FG001|STARTED|Induction||362
11149483|NCT01515189|12336924|FG000|COMPLETED|Induction||128
11149484|NCT01515189|12336925|FG001|COMPLETED|Induction||130
11149485|NCT01515189|12336924|FG000|NOT COMPLETED|Induction||237
11149486|NCT01515189|12336925|FG001|NOT COMPLETED|Induction||232
11149487|NCT01515189|12336924|FG000|STARTED|First Re-Induction Phase||23
11149488|NCT01515189|12336925|FG001|STARTED|First Re-Induction Phase||32
11149489|NCT01515189|12336924|FG000|COMPLETED|First Re-Induction Phase||9
11149490|NCT01515189|12336925|FG001|COMPLETED|First Re-Induction Phase||17
11149491|NCT01515189|12336924|FG000|NOT COMPLETED|First Re-Induction Phase||14
11149492|NCT01515189|12336925|FG001|NOT COMPLETED|First Re-Induction Phase||15
11149493|NCT01515319|12336941|FG000|STARTED|Overall Study||3
11149494|NCT01515319|12336942|FG001|STARTED|Overall Study||3
11149495|NCT01515319|12336943|FG002|STARTED|Overall Study||6
11149496|NCT01515319|12336944|FG003|STARTED|Overall Study||6
11149497|NCT01515319|12336945|FG004|STARTED|Overall Study||6
11149498|NCT01515319|12336946|FG005|STARTED|Overall Study||6
11149499|NCT01515319|12336947|FG006|STARTED|Overall Study||10
11149500|NCT01515319|12336948|FG007|STARTED|Overall Study||6
11149501|NCT01515319|12336949|FG008|STARTED|Overall Study||14
11149502|NCT01515319|12336950|FG009|STARTED|Overall Study||8
11149503|NCT01515319|12336941|FG000|COMPLETED|Overall Study||3
11149504|NCT01515319|12336942|FG001|COMPLETED|Overall Study||3
11149505|NCT01515319|12336943|FG002|COMPLETED|Overall Study||6
11149506|NCT01515319|12336944|FG003|COMPLETED|Overall Study||6
11149507|NCT01515319|12336945|FG004|COMPLETED|Overall Study||6
11149508|NCT01515319|12336946|FG005|COMPLETED|Overall Study||6
11149509|NCT01515319|12336947|FG006|COMPLETED|Overall Study||9
11149510|NCT01515319|12336948|FG007|COMPLETED|Overall Study||6
11149511|NCT01515319|12336949|FG008|COMPLETED|Overall Study||9
11149512|NCT01515319|12336950|FG009|COMPLETED|Overall Study||8
11149513|NCT01515319|12336941|FG000|NOT COMPLETED|Overall Study||0
11149514|NCT01515319|12336942|FG001|NOT COMPLETED|Overall Study||0
11149515|NCT01515319|12336943|FG002|NOT COMPLETED|Overall Study||0
11149516|NCT01515319|12336944|FG003|NOT COMPLETED|Overall Study||0
11149517|NCT01515319|12336945|FG004|NOT COMPLETED|Overall Study||0
11149518|NCT01515319|12336946|FG005|NOT COMPLETED|Overall Study||0
11149519|NCT01515319|12336947|FG006|NOT COMPLETED|Overall Study||1
11149520|NCT01515319|12336948|FG007|NOT COMPLETED|Overall Study||0
11149521|NCT01515319|12336949|FG008|NOT COMPLETED|Overall Study||5
11149522|NCT01515319|12336950|FG009|NOT COMPLETED|Overall Study||0
11149523|NCT01515345|12336974|FG000|STARTED|Overall Study||665
11149524|NCT01515345|12336975|FG001|STARTED|Overall Study||343
11149525|NCT01515345|12336974|FG000|COMPLETED|Overall Study||664
11149526|NCT01515345|12336975|FG001|COMPLETED|Overall Study||343
11149527|NCT01515345|12336974|FG000|NOT COMPLETED|Overall Study||1
11149528|NCT01515345|12336975|FG001|NOT COMPLETED|Overall Study||0
11149529|NCT01515410|12336981|FG000|STARTED|Overall Study||19
11149530|NCT01515410|12336982|FG001|STARTED|Overall Study||15
11149531|NCT01515410|12336981|FG000|COMPLETED|Overall Study||19
11149532|NCT01515410|12336982|FG001|COMPLETED|Overall Study||15
11149533|NCT01515410|12336981|FG000|NOT COMPLETED|Overall Study||0
11149534|NCT01515410|12336982|FG001|NOT COMPLETED|Overall Study||0
11149535|NCT01515423|12336990|FG000|STARTED|Open Label Phase||1429
11149536|NCT01515423|12336991|FG001|STARTED|Open Label Phase||0
11149537|NCT01515423|12336992|FG002|STARTED|Open Label Phase||0
11149538|NCT01515423|12336990|FG000|COMPLETED|Open Label Phase||1016
11149539|NCT01515423|12336991|FG001|COMPLETED|Open Label Phase||0
11149540|NCT01515423|12336992|FG002|COMPLETED|Open Label Phase||0
11149541|NCT01515423|12336990|FG000|NOT COMPLETED|Open Label Phase||413
11149542|NCT01515423|12336991|FG001|NOT COMPLETED|Open Label Phase||0
11149543|NCT01515423|12336992|FG002|NOT COMPLETED|Open Label Phase||0
11149544|NCT01515423|12336990|FG000|STARTED|DOUBLE BLIND||0
11149545|NCT01515423|12336991|FG001|STARTED|DOUBLE BLIND||504
11149546|NCT01515423|12336992|FG002|STARTED|DOUBLE BLIND||512
11149547|NCT01515423|12336990|FG000|COMPLETED|DOUBLE BLIND||0
11149548|NCT01515423|12336991|FG001|COMPLETED|DOUBLE BLIND||422
11149549|NCT01515423|12336992|FG002|COMPLETED|DOUBLE BLIND||420
11149550|NCT01515423|12336990|FG000|NOT COMPLETED|DOUBLE BLIND||0
11149551|NCT01515423|12336991|FG001|NOT COMPLETED|DOUBLE BLIND||82
11149552|NCT01515423|12336992|FG002|NOT COMPLETED|DOUBLE BLIND||92
11149553|NCT01515475|12337003|FG000|STARTED|Overall Study||61
11149554|NCT01515475|12337004|FG001|STARTED|Overall Study||58
11149555|NCT01515475|12337005|FG002|STARTED|Overall Study||65
11149556|NCT01515475|12337006|FG003|STARTED|Overall Study||65
11149557|NCT01515475|12337003|FG000|COMPLETED|Overall Study||41
11149558|NCT01515475|12337004|FG001|COMPLETED|Overall Study||43
11149559|NCT01515475|12337005|FG002|COMPLETED|Overall Study||53
11149560|NCT01515475|12337006|FG003|COMPLETED|Overall Study||53
11149561|NCT01515475|12337003|FG000|NOT COMPLETED|Overall Study||20
11149562|NCT01515475|12337004|FG001|NOT COMPLETED|Overall Study||15
11149563|NCT01515475|12337005|FG002|NOT COMPLETED|Overall Study||12
11149564|NCT01515475|12337006|FG003|NOT COMPLETED|Overall Study||12
11149565|NCT01515488|12337018|FG000|STARTED|Overall Study||200
11149566|NCT01515488|12337019|FG001|STARTED|Overall Study||200
11149567|NCT01515488|12337018|FG000|COMPLETED|Overall Study||200
11149568|NCT01515488|12337019|FG001|COMPLETED|Overall Study||200
11149569|NCT01515488|12337018|FG000|NOT COMPLETED|Overall Study||0
11149570|NCT01515488|12337019|FG001|NOT COMPLETED|Overall Study||0
11149571|NCT01515540|12337027|FG000|STARTED|Overall Study||20
11149572|NCT01515540|12337028|FG001|STARTED|Overall Study||18
11149573|NCT01515540|12337027|FG000|COMPLETED|Overall Study||15
11149574|NCT01515540|12337028|FG001|COMPLETED|Overall Study||15
11149575|NCT01515540|12337027|FG000|NOT COMPLETED|Overall Study||5
11149576|NCT01515540|12337028|FG001|NOT COMPLETED|Overall Study||3
11149577|NCT01515566|12337036|FG000|STARTED|Overall Study||10
11149578|NCT01515566|12337037|FG001|STARTED|Overall Study||10
11149579|NCT01515566|12337036|FG000|COMPLETED|Overall Study||10
11149580|NCT01515566|12337037|FG001|COMPLETED|Overall Study||10
11149581|NCT01515566|12337036|FG000|NOT COMPLETED|Overall Study||0
11149582|NCT01515566|12337037|FG001|NOT COMPLETED|Overall Study||0
11149583|NCT01515657|12337043|FG000|STARTED|First Intervention||14
11149584|NCT01515657|12337044|FG001|STARTED|First Intervention||13
11149585|NCT01515657|12337045|FG002|STARTED|First Intervention||13
11149586|NCT01515657|12337043|FG000|COMPLETED|First Intervention||14
11149587|NCT01515657|12337044|FG001|COMPLETED|First Intervention||12
11149588|NCT01515657|12337045|FG002|COMPLETED|First Intervention||13
11149589|NCT01515657|12337043|FG000|NOT COMPLETED|First Intervention||0
11149590|NCT01515657|12337044|FG001|NOT COMPLETED|First Intervention||1
11149591|NCT01515657|12337045|FG002|NOT COMPLETED|First Intervention||0
11149592|NCT01515657|12337043|FG000|STARTED|Second Intervention||14
11149593|NCT01515657|12337044|FG001|STARTED|Second Intervention||12
11149594|NCT01515657|12337045|FG002|STARTED|Second Intervention||13
11149595|NCT01515657|12337043|FG000|COMPLETED|Second Intervention||14
11149596|NCT01515657|12337044|FG001|COMPLETED|Second Intervention||11
11149597|NCT01515657|12337045|FG002|COMPLETED|Second Intervention||13
11149598|NCT01515657|12337043|FG000|NOT COMPLETED|Second Intervention||0
11149599|NCT01515657|12337044|FG001|NOT COMPLETED|Second Intervention||1
11149600|NCT01515657|12337045|FG002|NOT COMPLETED|Second Intervention||0
11149601|NCT01515657|12337043|FG000|STARTED|Third Intervention||14
11149602|NCT01515657|12337044|FG001|STARTED|Third Intervention||11
11149603|NCT01515657|12337045|FG002|STARTED|Third Intervention||13
11149604|NCT01515657|12337043|FG000|COMPLETED|Third Intervention||13
11149605|NCT01515657|12337044|FG001|COMPLETED|Third Intervention||11
11149606|NCT01515657|12337045|FG002|COMPLETED|Third Intervention||13
11149607|NCT01515657|12337043|FG000|NOT COMPLETED|Third Intervention||1
11149608|NCT01515657|12337044|FG001|NOT COMPLETED|Third Intervention||0
11149609|NCT01515657|12337045|FG002|NOT COMPLETED|Third Intervention||0
11149610|NCT01515696|12337055|FG000|STARTED|Overall Study||47
11149611|NCT01515696|12337056|FG001|STARTED|Overall Study||49
11149612|NCT01515696|12337055|FG000|COMPLETED|Overall Study||39
11149613|NCT01515696|12337056|FG001|COMPLETED|Overall Study||39
11149614|NCT01515696|12337055|FG000|NOT COMPLETED|Overall Study||8
11149615|NCT01515696|12337056|FG001|NOT COMPLETED|Overall Study||10
11149616|NCT01515865|12337062|FG000|STARTED|Part A (Open-label)||98
11149617|NCT01515865|12337063|FG001|STARTED|Part A (Open-label)||0
11149618|NCT01515865|12337064|FG002|STARTED|Part A (Open-label)||0
11149619|NCT01515865|12337062|FG000|COMPLETED|Part A (Open-label)||95
11149620|NCT01515865|12337063|FG001|COMPLETED|Part A (Open-label)||0
11149621|NCT01515865|12337064|FG002|COMPLETED|Part A (Open-label)||0
11149622|NCT01515865|12337062|FG000|NOT COMPLETED|Part A (Open-label)||3
11149623|NCT01515865|12337063|FG001|NOT COMPLETED|Part A (Open-label)||0
11149624|NCT01515865|12337064|FG002|NOT COMPLETED|Part A (Open-label)||0
11149625|NCT01515865|12337062|FG000|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
11149626|NCT01515865|12337063|FG001|STARTED|Part B (Open-label)||0
11149627|NCT01515865|12337064|FG002|STARTED|Part B (Open-label)||0
11149628|NCT01515865|12337062|FG000|COMPLETED|Part B (Open-label)||69
11149629|NCT01515865|12337063|FG001|COMPLETED|Part B (Open-label)||0
11149630|NCT01515865|12337064|FG002|COMPLETED|Part B (Open-label)||0
11149631|NCT01515865|12337062|FG000|NOT COMPLETED|Part B (Open-label)||2
11149632|NCT01515865|12337063|FG001|NOT COMPLETED|Part B (Open-label)||0
11149633|NCT01515865|12337064|FG002|NOT COMPLETED|Part B (Open-label)||0
11149634|NCT01515865|12337062|FG000|STARTED|Part C (Randomized)||0
11149635|NCT01515865|12337063|FG001|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
11149636|NCT01515865|12337064|FG002|STARTED|Part C (Randomized)||34
11149637|NCT01515865|12337062|FG000|COMPLETED|Part C (Randomized)||0
11149638|NCT01515865|12337063|FG001|COMPLETED|Part C (Randomized)||33
11149639|NCT01515865|12337064|FG002|COMPLETED|Part C (Randomized)||34
11149640|NCT01515865|12337062|FG000|NOT COMPLETED|Part C (Randomized)||0
11149641|NCT01515865|12337063|FG001|NOT COMPLETED|Part C (Randomized)||0
11149642|NCT01515865|12337064|FG002|NOT COMPLETED|Part C (Randomized)||0
11149643|NCT01515891|12337072|FG000|STARTED|Overall Study||4
11149644|NCT01515891|12337072|FG000|COMPLETED|Overall Study||4
11149645|NCT01515891|12337072|FG000|NOT COMPLETED|Overall Study||0
11149646|NCT01515943|12337079|FG000|STARTED|Overall Study||75
11149647|NCT01515943|12337080|FG001|STARTED|Overall Study||85
11149648|NCT01515943|12337081|FG002|STARTED|Overall Study||44
11149649|NCT01515943|12337079|FG000|COMPLETED|Overall Study||69
11149650|NCT01515943|12337080|FG001|COMPLETED|Overall Study||69
11149651|NCT01515943|12337081|FG002|COMPLETED|Overall Study||31
11149652|NCT01515943|12337079|FG000|NOT COMPLETED|Overall Study||6
11149653|NCT01515943|12337080|FG001|NOT COMPLETED|Overall Study||16
11149654|NCT01515943|12337081|FG002|NOT COMPLETED|Overall Study||13
11149655|NCT01515956|12337091|FG000|STARTED|Overall Study||15
11149656|NCT01515956|12337091|FG000|COMPLETED|Overall Study||15
11149657|NCT01515956|12337091|FG000|NOT COMPLETED|Overall Study||0
11149658|NCT01515995|12337098|FG000|STARTED|Overall Study||25
11149659|NCT01515995|12337099|FG001|STARTED|Overall Study||25
11149660|NCT01515995|12337098|FG000|COMPLETED|Overall Study||22
11149661|NCT01515995|12337099|FG001|COMPLETED|Overall Study||21
11149662|NCT01515995|12337098|FG000|NOT COMPLETED|Overall Study||3
11149663|NCT01515995|12337099|FG001|NOT COMPLETED|Overall Study||4
11149664|NCT01516008|12337108|FG000|STARTED|Overall Study||114
11149665|NCT01516008|12337109|FG001|STARTED|Overall Study||121
11149666|NCT01516008|12337110|FG002|STARTED|Overall Study||117
11149667|NCT01516008|12337108|FG000|COMPLETED|Overall Study||69
11149668|NCT01516008|12337109|FG001|COMPLETED|Overall Study||105
11149669|NCT01516008|12337110|FG002|COMPLETED|Overall Study||99
11149670|NCT01516008|12337108|FG000|NOT COMPLETED|Overall Study||45
11149671|NCT01516008|12337109|FG001|NOT COMPLETED|Overall Study||16
11149672|NCT01516008|12337110|FG002|NOT COMPLETED|Overall Study||18
11149673|NCT01516268|12337120|FG000|STARTED|Overall Study||25
11149674|NCT01516268|12337121|FG001|STARTED|Overall Study||25
11149675|NCT01516268|12337120|FG000|COMPLETED|Overall Study||25
11149676|NCT01516268|12337121|FG001|COMPLETED|Overall Study||25
11149677|NCT01516268|12337120|FG000|NOT COMPLETED|Overall Study||0
11149678|NCT01516268|12337121|FG001|NOT COMPLETED|Overall Study||0
11149679|NCT01516424|12337129|FG000|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
11149680|NCT01516424|12337130|FG001|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
11149681|NCT01516424|12337129|FG000|COMPLETED|Overall Study||96
11149682|NCT01516424|12337130|FG001|COMPLETED|Overall Study||114
11149683|NCT01516424|12337129|FG000|NOT COMPLETED|Overall Study||35
11149684|NCT01516424|12337130|FG001|NOT COMPLETED|Overall Study||22
11149685|NCT01516437|12337140|FG000|STARTED|Overall Study||24
11149686|NCT01516437|12337141|FG001|STARTED|Overall Study||24
11149687|NCT01516437|12337142|FG002|STARTED|Overall Study||15
11149688|NCT01516437|12337143|FG003|STARTED|Overall Study||7
11149689|NCT01516437|12337140|FG000|COMPLETED|Overall Study||24
11149690|NCT01516437|12337141|FG001|COMPLETED|Overall Study||24
11149691|NCT01516437|12337142|FG002|COMPLETED|Overall Study||14
11149692|NCT01516437|12337143|FG003|COMPLETED|Overall Study||6
11149693|NCT01516437|12337140|FG000|NOT COMPLETED|Overall Study||0
11149694|NCT01516437|12337141|FG001|NOT COMPLETED|Overall Study||0
11149695|NCT01516437|12337142|FG002|NOT COMPLETED|Overall Study||1
11149696|NCT01516437|12337143|FG003|NOT COMPLETED|Overall Study||1
11149697|NCT01516632|12337157|FG000|STARTED|Overall Study||101
11149698|NCT01516632|12337158|FG001|STARTED|Overall Study||63
11149699|NCT01516632|12337157|FG000|COMPLETED|Overall Study||77
11149700|NCT01516632|12337158|FG001|COMPLETED|Overall Study||48
11149701|NCT01516632|12337157|FG000|NOT COMPLETED|Overall Study||24
11149702|NCT01516632|12337158|FG001|NOT COMPLETED|Overall Study||15
11149703|NCT01516684|12337168|FG000|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|
11149704|NCT01516684|12337169|FG001|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|
11149705|NCT01516684|12337168|FG000|COMPLETED|Overall Study|Trials were randomized for each arm, not participants|
11149706|NCT01516684|12337169|FG001|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152~Trials were randomized for each arm, not participants"|
11149707|NCT01516684|12337168|FG000|NOT COMPLETED|Overall Study||
11149708|NCT01516684|12337169|FG001|NOT COMPLETED|Overall Study||
11149709|NCT01516736|12337179|FG000|STARTED|Overall Study||155
11149710|NCT01516736|12337180|FG001|STARTED|Overall Study||153
11322821|NCT04526574|12520091|FG000|STARTED|Overall Study||898
11322822|NCT04526574|12520092|FG001|STARTED|Overall Study||898
11322823|NCT04526574|12520091|FG000|Vaccination 1|Overall Study||895
11322824|NCT04526574|12520092|FG001|Vaccination 1|Overall Study||896
11322825|NCT04526574|12520091|FG000|Vaccination 2|Overall Study||874
11322826|NCT04526574|12520092|FG001|Vaccination 2|Overall Study||878
11322827|NCT04526574|12520091|FG000|COMPLETED|Overall Study||862
11322828|NCT04526574|12520092|FG001|COMPLETED|Overall Study||865
11322829|NCT04526574|12520091|FG000|NOT COMPLETED|Overall Study||36
11322830|NCT04526574|12520092|FG001|NOT COMPLETED|Overall Study||33
11322831|NCT04522206|12520102|FG000|STARTED|Overall Study||44
11322832|NCT04522206|12520102|FG000|COMPLETED|Overall Study||44
11322833|NCT04522206|12520102|FG000|NOT COMPLETED|Overall Study||0
11342855|NCT02948777|12540195|FG000|COMPLETED|Overall Study||13
11342856|NCT02948777|12540195|FG000|NOT COMPLETED|Overall Study||1
11342857|NCT02949011|12540203|FG000|STARTED|Overall Study||730
11342858|NCT02949011|12540204|FG001|STARTED|Overall Study||729
11342859|NCT02949011|12540205|FG002|STARTED|Overall Study||725
11342860|NCT02949011|12540203|FG000|Received Study Drug|Overall Study||728
11342861|NCT02949011|12540204|FG001|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728
11342862|NCT02949011|12540205|FG002|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722
11342863|NCT02949011|12540203|FG000|Intention to Treat Infected Population|Overall Study||388
11342864|NCT02949011|12540204|FG001|Intention to Treat Infected Population|Overall Study||386
11342865|NCT02949011|12540205|FG002|Intention to Treat Infected Population|Overall Study||389
11342866|NCT02949011|12540203|FG000|COMPLETED|Overall Study||697
11342867|NCT02949011|12540204|FG001|COMPLETED|Overall Study||695
11342868|NCT02949011|12540205|FG002|COMPLETED|Overall Study||683
11342869|NCT02949011|12540203|FG000|NOT COMPLETED|Overall Study||33
11342870|NCT02949011|12540204|FG001|NOT COMPLETED|Overall Study||34
11342871|NCT02949011|12540205|FG002|NOT COMPLETED|Overall Study||42
11342872|NCT02949024|12540215|FG000|STARTED|Overall Study||10
11342873|NCT02949024|12540216|FG001|STARTED|Overall Study||10
11342874|NCT02949024|12540215|FG000|COMPLETED|Overall Study||10
11342875|NCT02949024|12540216|FG001|COMPLETED|Overall Study||9
11342876|NCT02949024|12540215|FG000|NOT COMPLETED|Overall Study||0
11342877|NCT02949024|12540216|FG001|NOT COMPLETED|Overall Study||1
11342878|NCT02949141|12540224|FG000|STARTED|Overall Study||62
11342879|NCT02949141|12540224|FG000|COMPLETED|Overall Study||62
11342880|NCT02949141|12540224|FG000|NOT COMPLETED|Overall Study||0
11342881|NCT02949271|12540233|FG000|STARTED|Overall Study||90
11342882|NCT02949271|12540234|FG001|STARTED|Overall Study||89
11342883|NCT02949271|12540233|FG000|COMPLETED|Overall Study||61
11342884|NCT02949271|12540234|FG001|COMPLETED|Overall Study||59
11342885|NCT02949271|12540233|FG000|NOT COMPLETED|Overall Study||29
11342886|NCT02949271|12540234|FG001|NOT COMPLETED|Overall Study||30
11342887|NCT02949362|12540242|FG000|STARTED|Retrospective Period||24
11342888|NCT02949362|12540243|FG001|STARTED|Retrospective Period||5
11322834|NCT04345367|12520108|FG000|STARTED|Overall Study||362
11322835|NCT04345367|12520109|FG001|STARTED|Overall Study||365
11322836|NCT04345367|12520108|FG000|COMPLETED|Overall Study||327
11322837|NCT04345367|12520109|FG001|COMPLETED|Overall Study||334
11322838|NCT04345367|12520108|FG000|NOT COMPLETED|Overall Study||35
11322839|NCT04345367|12520109|FG001|NOT COMPLETED|Overall Study||31
11342889|NCT02949362|12540244|FG002|STARTED|Retrospective Period||0
11342890|NCT02949362|12540245|FG003|STARTED|Retrospective Period||0
11342891|NCT02949362|12540242|FG000|COMPLETED|Retrospective Period||20
11342892|NCT02949362|12540243|FG001|COMPLETED|Retrospective Period||4
11342893|NCT02949362|12540244|FG002|COMPLETED|Retrospective Period||0
11342894|NCT02949362|12540245|FG003|COMPLETED|Retrospective Period||0
11342895|NCT02949362|12540242|FG000|NOT COMPLETED|Retrospective Period||4
11342896|NCT02949362|12540243|FG001|NOT COMPLETED|Retrospective Period||1
11342897|NCT02949362|12540244|FG002|NOT COMPLETED|Retrospective Period||0
11342898|NCT02949362|12540245|FG003|NOT COMPLETED|Retrospective Period||0
11342899|NCT02949362|12540242|FG000|STARTED|Prospective Period||0
11342900|NCT02949362|12540243|FG001|STARTED|Prospective Period||0
11342901|NCT02949362|12540244|FG002|STARTED|Prospective Period|Participants were enrolled from retrospective period.|5
11342902|NCT02949362|12540245|FG003|STARTED|Prospective Period|Participants were enrolled from retrospective period.|19
11342903|NCT02949362|12540242|FG000|COMPLETED|Prospective Period||0
11342904|NCT02949362|12540243|FG001|COMPLETED|Prospective Period||0
11418568|NCT00484718|12616947|FG004|COMPLETED|Washout Period (2 Weeks)||1
11418569|NCT00484718|12616948|FG005|COMPLETED|Washout Period (2 Weeks)||1
11418570|NCT00484718|12616943|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
11149711|NCT01516736|12337179|FG000|COMPLETED|Overall Study||135
11149712|NCT01516736|12337180|FG001|COMPLETED|Overall Study||140
11149713|NCT01516736|12337179|FG000|NOT COMPLETED|Overall Study||20
11149714|NCT01516736|12337180|FG001|NOT COMPLETED|Overall Study||13
11149715|NCT01516749|12337186|FG000|STARTED|Active Therapy||6
11149716|NCT01516749|12337186|FG000|COMPLETED|Active Therapy||5
11149717|NCT01516749|12337186|FG000|NOT COMPLETED|Active Therapy||1
11149718|NCT01516749|12337186|FG000|STARTED|Follow-up Off Therapy||5
11149719|NCT01516749|12337186|FG000|COMPLETED|Follow-up Off Therapy||4
11149720|NCT01516749|12337186|FG000|NOT COMPLETED|Follow-up Off Therapy||1
11149721|NCT01516892|12337190|FG000|STARTED|Overall Study||716
11149722|NCT01516892|12337190|FG000|COMPLETED|Overall Study||373
11149723|NCT01516892|12337190|FG000|NOT COMPLETED|Overall Study||343
11149724|NCT01516957|12337197|FG000|STARTED|Placebo-controlled Phase||55
11149725|NCT01516957|12337198|FG001|STARTED|Placebo-controlled Phase||57
11149726|NCT01516957|12337199|FG002|STARTED|Placebo-controlled Phase||56
11149727|NCT01516957|12337200|FG003|STARTED|Placebo-controlled Phase||0
11149728|NCT01516957|12337197|FG000|COMPLETED|Placebo-controlled Phase||52
11149729|NCT01516957|12337198|FG001|COMPLETED|Placebo-controlled Phase||53
11149730|NCT01516957|12337199|FG002|COMPLETED|Placebo-controlled Phase||51
11149731|NCT01516957|12337200|FG003|COMPLETED|Placebo-controlled Phase||0
11149732|NCT01516957|12337197|FG000|NOT COMPLETED|Placebo-controlled Phase||3
11149733|NCT01516957|12337198|FG001|NOT COMPLETED|Placebo-controlled Phase||4
11149734|NCT01516957|12337199|FG002|NOT COMPLETED|Placebo-controlled Phase||5
11149735|NCT01516957|12337200|FG003|NOT COMPLETED|Placebo-controlled Phase||0
11149736|NCT01516957|12337197|FG000|STARTED|Open-label Phase||0
11149737|NCT01516957|12337198|FG001|STARTED|Open-label Phase||0
11149738|NCT01516957|12337199|FG002|STARTED|Open-label Phase||0
11149739|NCT01516957|12337200|FG003|STARTED|Open-label Phase||156
11149740|NCT01516957|12337197|FG000|COMPLETED|Open-label Phase||0
11149741|NCT01516957|12337198|FG001|COMPLETED|Open-label Phase||0
11149742|NCT01516957|12337199|FG002|COMPLETED|Open-label Phase||0
11149743|NCT01516957|12337200|FG003|COMPLETED|Open-label Phase||0
11149744|NCT01516957|12337197|FG000|NOT COMPLETED|Open-label Phase||0
11149745|NCT01516957|12337198|FG001|NOT COMPLETED|Open-label Phase||0
11149746|NCT01516957|12337199|FG002|NOT COMPLETED|Open-label Phase||0
11149747|NCT01516957|12337200|FG003|NOT COMPLETED|Open-label Phase||156
11149748|NCT01516970|12337211|FG000|STARTED|Overall Study||159
11149749|NCT01516970|12337212|FG001|STARTED|Overall Study||153
11149750|NCT01516970|12337211|FG000|COMPLETED|Overall Study||141
11149751|NCT01516970|12337212|FG001|COMPLETED|Overall Study||132
11149752|NCT01516970|12337211|FG000|NOT COMPLETED|Overall Study||18
11149753|NCT01516970|12337212|FG001|NOT COMPLETED|Overall Study||21
11149754|NCT01517074|12337218|FG000|STARTED|Overall Study||5
11149755|NCT01517074|12337218|FG000|COMPLETED|Overall Study||5
11149756|NCT01517074|12337218|FG000|NOT COMPLETED|Overall Study||0
11149757|NCT01517178|12337227|FG000|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
11149758|NCT01517178|12337228|FG001|STARTED|Period 1||11
11149759|NCT01517178|12337227|FG000|COMPLETED|Period 1||12
11149760|NCT01517178|12337228|FG001|COMPLETED|Period 1||6
11149761|NCT01517178|12337227|FG000|NOT COMPLETED|Period 1||4
11149762|NCT01517178|12337228|FG001|NOT COMPLETED|Period 1||5
11149763|NCT01517178|12337227|FG000|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
11149764|NCT01517178|12337228|FG001|STARTED|Period 2||6
11149765|NCT01517178|12337227|FG000|COMPLETED|Period 2||5
11149766|NCT01517178|12337228|FG001|COMPLETED|Period 2||4
11149767|NCT01517178|12337227|FG000|NOT COMPLETED|Period 2||6
11149768|NCT01517178|12337228|FG001|NOT COMPLETED|Period 2||2
11149769|NCT01517282|12337238|FG000|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
11149770|NCT01517282|12337239|FG001|STARTED|Overall Study||8
11418571|NCT00484718|12616944|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
11418572|NCT00484718|12616945|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
11418573|NCT00484718|12616946|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0
11418574|NCT00484718|12616947|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0
11418575|NCT00484718|12616948|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0
11418576|NCT00484718|12616943|FG000|STARTED|Treatment Period 2 (2 Weeks)||1
11418577|NCT00484718|12616944|FG001|STARTED|Treatment Period 2 (2 Weeks)||1
11418578|NCT00484718|12616945|FG002|STARTED|Treatment Period 2 (2 Weeks)||1
11418579|NCT00484718|12616946|FG003|STARTED|Treatment Period 2 (2 Weeks)||1
11149771|NCT01517282|12337240|FG002|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
11149772|NCT01517282|12337241|FG003|STARTED|Overall Study||6
11418580|NCT00484718|12616947|FG004|STARTED|Treatment Period 2 (2 Weeks)||1
11149773|NCT01517282|12337238|FG000|COMPLETED|Overall Study||8
11149774|NCT01517282|12337239|FG001|COMPLETED|Overall Study||7
11149775|NCT01517282|12337240|FG002|COMPLETED|Overall Study||8
11149776|NCT01517282|12337241|FG003|COMPLETED|Overall Study||5
11149777|NCT01517282|12337238|FG000|NOT COMPLETED|Overall Study||1
11149778|NCT01517282|12337239|FG001|NOT COMPLETED|Overall Study||1
11149779|NCT01517282|12337240|FG002|NOT COMPLETED|Overall Study||1
11149780|NCT01517282|12337241|FG003|NOT COMPLETED|Overall Study||1
11149781|NCT01517295|12337253|FG000|STARTED|Overall Study||16
11149782|NCT01517295|12337254|FG001|STARTED|Overall Study||14
11149783|NCT01517295|12337253|FG000|COMPLETED|Overall Study||15
11149784|NCT01517295|12337254|FG001|COMPLETED|Overall Study||14
11149785|NCT01517295|12337253|FG000|NOT COMPLETED|Overall Study||1
11149786|NCT01517295|12337254|FG001|NOT COMPLETED|Overall Study||0
11149787|NCT01517373|12337265|FG000|STARTED|Run-in Period||361
11149788|NCT01517373|12337266|FG001|STARTED|Run-in Period||0
11149789|NCT01517373|12337267|FG002|STARTED|Run-in Period||0
11149790|NCT01517373|12337268|FG003|STARTED|Run-in Period||0
11149791|NCT01517373|12337269|FG004|STARTED|Run-in Period||0
11149792|NCT01517373|12337270|FG005|STARTED|Run-in Period||0
11149793|NCT01517373|12337265|FG000|COMPLETED|Run-in Period||304
11149794|NCT01517373|12337266|FG001|COMPLETED|Run-in Period||0
11149795|NCT01517373|12337267|FG002|COMPLETED|Run-in Period||0
11149796|NCT01517373|12337268|FG003|COMPLETED|Run-in Period||0
11149797|NCT01517373|12337269|FG004|COMPLETED|Run-in Period||0
11149798|NCT01517373|12337270|FG005|COMPLETED|Run-in Period||0
11149799|NCT01517373|12337265|FG000|NOT COMPLETED|Run-in Period||57
11149800|NCT01517373|12337266|FG001|NOT COMPLETED|Run-in Period||0
11149801|NCT01517373|12337267|FG002|NOT COMPLETED|Run-in Period||0
11149802|NCT01517373|12337268|FG003|NOT COMPLETED|Run-in Period||0
11149803|NCT01517373|12337269|FG004|NOT COMPLETED|Run-in Period||0
11149804|NCT01517373|12337270|FG005|NOT COMPLETED|Run-in Period||0
11149805|NCT01517373|12337265|FG000|STARTED|Treatment Period||0
11149806|NCT01517373|12337266|FG001|STARTED|Treatment Period||61
11149807|NCT01517373|12337267|FG002|STARTED|Treatment Period||60
11149808|NCT01517373|12337268|FG003|STARTED|Treatment Period||61
11149809|NCT01517373|12337269|FG004|STARTED|Treatment Period||61
11149810|NCT01517373|12337270|FG005|STARTED|Treatment Period||61
11149811|NCT01517373|12337265|FG000|COMPLETED|Treatment Period||0
11149812|NCT01517373|12337266|FG001|COMPLETED|Treatment Period||57
11149813|NCT01517373|12337267|FG002|COMPLETED|Treatment Period||54
11149814|NCT01517373|12337268|FG003|COMPLETED|Treatment Period||54
11149815|NCT01517373|12337269|FG004|COMPLETED|Treatment Period||55
11149816|NCT01517373|12337270|FG005|COMPLETED|Treatment Period||54
11149817|NCT01517373|12337265|FG000|NOT COMPLETED|Treatment Period||0
11149818|NCT01517373|12337266|FG001|NOT COMPLETED|Treatment Period||4
11149819|NCT01517373|12337267|FG002|NOT COMPLETED|Treatment Period||6
11149820|NCT01517373|12337268|FG003|NOT COMPLETED|Treatment Period||7
11149821|NCT01517373|12337269|FG004|NOT COMPLETED|Treatment Period||6
11149822|NCT01517373|12337270|FG005|NOT COMPLETED|Treatment Period||7
11149823|NCT01517412|12337285|FG000|STARTED|Overall Study||225
11149824|NCT01517412|12337286|FG001|STARTED|Overall Study||226
11149825|NCT01517412|12337285|FG000|COMPLETED|Overall Study||189
11149826|NCT01517412|12337286|FG001|COMPLETED|Overall Study||202
11149827|NCT01517412|12337285|FG000|NOT COMPLETED|Overall Study||36
11149828|NCT01517412|12337286|FG001|NOT COMPLETED|Overall Study||24
11149829|NCT01517529|12337292|FG000|STARTED|Overall Study||10
11149830|NCT01517529|12337292|FG000|COMPLETED|Overall Study||10
11149831|NCT01517529|12337292|FG000|NOT COMPLETED|Overall Study||0
11149832|NCT01517750|12337300|FG000|STARTED|Overall Study||21
11149833|NCT01517750|12337301|FG001|STARTED|Overall Study||19
11149834|NCT01517750|12337302|FG002|STARTED|Overall Study||21
11149835|NCT01517750|12337303|FG003|STARTED|Overall Study||19
11149836|NCT01517750|12337300|FG000|COMPLETED|Overall Study||20
11149837|NCT01517750|12337301|FG001|COMPLETED|Overall Study||17
11149838|NCT01517750|12337302|FG002|COMPLETED|Overall Study||17
11149839|NCT01517750|12337303|FG003|COMPLETED|Overall Study||18
11149840|NCT01517750|12337300|FG000|NOT COMPLETED|Overall Study||1
11149841|NCT01517750|12337301|FG001|NOT COMPLETED|Overall Study||2
11149842|NCT01517750|12337302|FG002|NOT COMPLETED|Overall Study||4
11149843|NCT01517750|12337303|FG003|NOT COMPLETED|Overall Study||1
11149844|NCT01517867|12337319|FG000|STARTED|Overall Study||81
11149845|NCT01517867|12337320|FG001|STARTED|Overall Study||80
11149846|NCT01517867|12337319|FG000|COMPLETED|Overall Study||18
11149847|NCT01517867|12337320|FG001|COMPLETED|Overall Study||15
11149848|NCT01517867|12337319|FG000|NOT COMPLETED|Overall Study||63
11149849|NCT01517867|12337320|FG001|NOT COMPLETED|Overall Study||65
11149850|NCT01517893|12337328|FG000|STARTED|Overall Study||8
11149851|NCT01517893|12337329|FG001|STARTED|Overall Study||7
11149852|NCT01517893|12337328|FG000|COMPLETED|Overall Study||5
11149853|NCT01517893|12337329|FG001|COMPLETED|Overall Study||7
11149854|NCT01517893|12337328|FG000|NOT COMPLETED|Overall Study||3
11149855|NCT01517893|12337329|FG001|NOT COMPLETED|Overall Study||0
11149856|NCT01517984|12337338|FG000|STARTED|Overall Study||5
11149857|NCT01517984|12337339|FG001|STARTED|Overall Study||26
11149858|NCT01517984|12337340|FG002|STARTED|Overall Study||14
11149859|NCT01517984|12337341|FG003|STARTED|Overall Study||7
11149860|NCT01517984|12337338|FG000|COMPLETED|Overall Study||0
11149861|NCT01517984|12337339|FG001|COMPLETED|Overall Study||3
11418581|NCT00484718|12616948|FG005|STARTED|Treatment Period 2 (2 Weeks)||1
11418582|NCT00484718|12616943|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||1
11149862|NCT01517984|12337340|FG002|COMPLETED|Overall Study||10
11149863|NCT01517984|12337341|FG003|COMPLETED|Overall Study||6
11149864|NCT01517984|12337338|FG000|NOT COMPLETED|Overall Study||5
11149865|NCT01517984|12337339|FG001|NOT COMPLETED|Overall Study||23
11149866|NCT01517984|12337340|FG002|NOT COMPLETED|Overall Study||4
11149867|NCT01517984|12337341|FG003|NOT COMPLETED|Overall Study||1
11149868|NCT01518153|12337348|FG000|STARTED|Stem Cell Transplant||16
11149869|NCT01518153|12337349|FG001|STARTED|Stem Cell Transplant||0
11149870|NCT01518153|12337350|FG002|STARTED|Stem Cell Transplant||0
11418583|NCT00484718|12616944|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||1
11149871|NCT01518153|12337348|FG000|COMPLETED|Stem Cell Transplant||7
11149872|NCT01518153|12337349|FG001|COMPLETED|Stem Cell Transplant||0
11149873|NCT01518153|12337350|FG002|COMPLETED|Stem Cell Transplant||0
11149874|NCT01518153|12337348|FG000|NOT COMPLETED|Stem Cell Transplant||9
11149875|NCT01518153|12337349|FG001|NOT COMPLETED|Stem Cell Transplant||0
11149876|NCT01518153|12337350|FG002|NOT COMPLETED|Stem Cell Transplant||0
11149877|NCT01518153|12337348|FG000|STARTED|Donor Lymphocyte Infusion||0
11149878|NCT01518153|12337349|FG001|STARTED|Donor Lymphocyte Infusion||3
11149879|NCT01518153|12337350|FG002|STARTED|Donor Lymphocyte Infusion||4
11149880|NCT01518153|12337348|FG000|COMPLETED|Donor Lymphocyte Infusion||0
11149881|NCT01518153|12337349|FG001|COMPLETED|Donor Lymphocyte Infusion||1
11149882|NCT01518153|12337350|FG002|COMPLETED|Donor Lymphocyte Infusion||3
11149883|NCT01518153|12337348|FG000|NOT COMPLETED|Donor Lymphocyte Infusion||0
11149884|NCT01518153|12337349|FG001|NOT COMPLETED|Donor Lymphocyte Infusion||2
11149885|NCT01518153|12337350|FG002|NOT COMPLETED|Donor Lymphocyte Infusion||1
11149886|NCT01518192|12337361|FG000|STARTED|Overall Study||145
11149887|NCT01518192|12337362|FG001|STARTED|Overall Study||140
11149888|NCT01518192|12337363|FG002|STARTED|Overall Study||259
11149889|NCT01518192|12337361|FG000|COMPLETED|Overall Study||116
11149890|NCT01518192|12337362|FG001|COMPLETED|Overall Study||114
11149891|NCT01518192|12337363|FG002|COMPLETED|Overall Study||224
11149892|NCT01518192|12337361|FG000|NOT COMPLETED|Overall Study||29
11149893|NCT01518192|12337362|FG001|NOT COMPLETED|Overall Study||26
11149894|NCT01518192|12337363|FG002|NOT COMPLETED|Overall Study||35
11149895|NCT01518244|12337377|FG000|STARTED|Overall Study||50
11149896|NCT01518244|12337377|FG000|COMPLETED|Overall Study||47
11149897|NCT01518244|12337377|FG000|NOT COMPLETED|Overall Study||3
11149898|NCT01518257|12337383|FG000|STARTED|Overall Study||61
11149899|NCT01518257|12337384|FG001|STARTED|Overall Study||60
11149900|NCT01518257|12337383|FG000|COMPLETED|Overall Study||59
11149901|NCT01518257|12337384|FG001|COMPLETED|Overall Study||60
11149902|NCT01518257|12337383|FG000|NOT COMPLETED|Overall Study||2
11149903|NCT01518257|12337384|FG001|NOT COMPLETED|Overall Study||0
11149904|NCT01518270|12337390|FG000|STARTED|Overall Study||179
11149905|NCT01518270|12337390|FG000|COMPLETED|Overall Study||179
11149906|NCT01518270|12337390|FG000|NOT COMPLETED|Overall Study||0
11149907|NCT01518309|12337394|FG000|STARTED|Overall Study||39
11149908|NCT01518309|12337394|FG000|COMPLETED|Overall Study||0
11149909|NCT01518309|12337394|FG000|NOT COMPLETED|Overall Study||39
11149910|NCT01518322|12337398|FG000|STARTED|Overall Study||235
11149911|NCT01518322|12337398|FG000|COMPLETED|Overall Study||222
11149912|NCT01518322|12337398|FG000|NOT COMPLETED|Overall Study||13
11149913|NCT01518374|12337407|FG000|STARTED|Overall Study||1768
11149914|NCT01518374|12337407|FG000|COMPLETED|Overall Study||1761
11149915|NCT01518374|12337407|FG000|NOT COMPLETED|Overall Study||7
11149916|NCT01518530|12337411|FG000|STARTED|Active Treatment Period||10
11149917|NCT01518530|12337411|FG000|COMPLETED|Active Treatment Period||9
11149918|NCT01518530|12337411|FG000|NOT COMPLETED|Active Treatment Period||1
11149919|NCT01518530|12337411|FG000|STARTED|Post-Treatment Follow-up||9
11149920|NCT01518530|12337411|FG000|COMPLETED|Post-Treatment Follow-up||9
11149921|NCT01518530|12337411|FG000|NOT COMPLETED|Post-Treatment Follow-up||0
11149922|NCT01518699|12337421|FG000|STARTED|Period 1||10
11149923|NCT01518699|12337422|FG001|STARTED|Period 1||9
11149924|NCT01518699|12337423|FG002|STARTED|Period 1||9
11149925|NCT01518699|12337424|FG003|STARTED|Period 1||10
11149926|NCT01518699|12337425|FG004|STARTED|Period 1||10
11149927|NCT01518699|12337426|FG005|STARTED|Period 1||9
11149928|NCT01518699|12337421|FG000|COMPLETED|Period 1||10
11149929|NCT01518699|12337422|FG001|COMPLETED|Period 1||9
11149930|NCT01518699|12337423|FG002|COMPLETED|Period 1||9
11149931|NCT01518699|12337424|FG003|COMPLETED|Period 1||10
11149932|NCT01518699|12337425|FG004|COMPLETED|Period 1||10
11149933|NCT01518699|12337426|FG005|COMPLETED|Period 1||9
11149934|NCT01518699|12337421|FG000|NOT COMPLETED|Period 1||0
11149935|NCT01518699|12337422|FG001|NOT COMPLETED|Period 1||0
11149936|NCT01518699|12337423|FG002|NOT COMPLETED|Period 1||0
11149937|NCT01518699|12337424|FG003|NOT COMPLETED|Period 1||0
11149938|NCT01518699|12337425|FG004|NOT COMPLETED|Period 1||0
11149939|NCT01518699|12337426|FG005|NOT COMPLETED|Period 1||0
11149940|NCT01518699|12337421|FG000|STARTED|Period 2||10
11149941|NCT01518699|12337422|FG001|STARTED|Period 2||9
11149942|NCT01518699|12337423|FG002|STARTED|Period 2||9
11149943|NCT01518699|12337424|FG003|STARTED|Period 2||10
11149944|NCT01518699|12337425|FG004|STARTED|Period 2||10
11149945|NCT01518699|12337426|FG005|STARTED|Period 2||9
11149946|NCT01518699|12337421|FG000|COMPLETED|Period 2||8
11149947|NCT01518699|12337422|FG001|COMPLETED|Period 2||7
11149948|NCT01518699|12337423|FG002|COMPLETED|Period 2||9
11149949|NCT01518699|12337424|FG003|COMPLETED|Period 2||10
11149950|NCT01518699|12337425|FG004|COMPLETED|Period 2||10
11149951|NCT01518699|12337426|FG005|COMPLETED|Period 2||9
11149952|NCT01518699|12337421|FG000|NOT COMPLETED|Period 2||2
11149953|NCT01518699|12337422|FG001|NOT COMPLETED|Period 2||2
11149954|NCT01518699|12337423|FG002|NOT COMPLETED|Period 2||0
11149955|NCT01518699|12337424|FG003|NOT COMPLETED|Period 2||0
11149956|NCT01518699|12337425|FG004|NOT COMPLETED|Period 2||0
11149957|NCT01518699|12337426|FG005|NOT COMPLETED|Period 2||0
11149958|NCT01518699|12337421|FG000|STARTED|Period 3||8
11149959|NCT01518699|12337422|FG001|STARTED|Period 3||7
11149960|NCT01518699|12337423|FG002|STARTED|Period 3||9
11149961|NCT01518699|12337424|FG003|STARTED|Period 3||10
11149962|NCT01518699|12337425|FG004|STARTED|Period 3||10
11149963|NCT01518699|12337426|FG005|STARTED|Period 3||9
11149964|NCT01518699|12337421|FG000|COMPLETED|Period 3||8
11149965|NCT01518699|12337422|FG001|COMPLETED|Period 3||7
11149966|NCT01518699|12337423|FG002|COMPLETED|Period 3||9
11149967|NCT01518699|12337424|FG003|COMPLETED|Period 3||10
11149968|NCT01518699|12337425|FG004|COMPLETED|Period 3||10
11149969|NCT01518699|12337426|FG005|COMPLETED|Period 3||9
11149970|NCT01518699|12337421|FG000|NOT COMPLETED|Period 3||0
11149971|NCT01518699|12337422|FG001|NOT COMPLETED|Period 3||0
11149972|NCT01518699|12337423|FG002|NOT COMPLETED|Period 3||0
11149973|NCT01518699|12337424|FG003|NOT COMPLETED|Period 3||0
11149974|NCT01518699|12337425|FG004|NOT COMPLETED|Period 3||0
11149975|NCT01518699|12337426|FG005|NOT COMPLETED|Period 3||0
11149976|NCT01518868|12337434|FG000|STARTED|Overall Study||63
11149977|NCT01518868|12337435|FG001|STARTED|Overall Study||63
11149978|NCT01518868|12337434|FG000|COMPLETED|Overall Study||59
11149979|NCT01518868|12337435|FG001|COMPLETED|Overall Study||59
11149980|NCT01518868|12337434|FG000|NOT COMPLETED|Overall Study||4
11149981|NCT01518868|12337435|FG001|NOT COMPLETED|Overall Study||4
11149982|NCT01518946|12337443|FG000|STARTED|Open-label Phase||24
11149983|NCT01518946|12337444|FG001|STARTED|Open-label Phase||0
11149984|NCT01518946|12337445|FG002|STARTED|Open-label Phase||0
11149985|NCT01518946|12337443|FG000|COMPLETED|Open-label Phase||20
11149986|NCT01518946|12337444|FG001|COMPLETED|Open-label Phase||0
11149987|NCT01518946|12337445|FG002|COMPLETED|Open-label Phase||0
11149988|NCT01518946|12337443|FG000|NOT COMPLETED|Open-label Phase||4
11149989|NCT01518946|12337444|FG001|NOT COMPLETED|Open-label Phase||0
11149990|NCT01518946|12337445|FG002|NOT COMPLETED|Open-label Phase||0
11149991|NCT01518946|12337443|FG000|STARTED|Randomized Phase (First Intervention)||0
11149992|NCT01518946|12337444|FG001|STARTED|Randomized Phase (First Intervention)||10
11149993|NCT01518946|12337445|FG002|STARTED|Randomized Phase (First Intervention)||10
11149994|NCT01518946|12337443|FG000|COMPLETED|Randomized Phase (First Intervention)||0
11149995|NCT01518946|12337444|FG001|COMPLETED|Randomized Phase (First Intervention)||9
11149996|NCT01518946|12337445|FG002|COMPLETED|Randomized Phase (First Intervention)||10
11149997|NCT01518946|12337443|FG000|NOT COMPLETED|Randomized Phase (First Intervention)||0
11149998|NCT01518946|12337444|FG001|NOT COMPLETED|Randomized Phase (First Intervention)||1
11149999|NCT01518946|12337445|FG002|NOT COMPLETED|Randomized Phase (First Intervention)||0
11150000|NCT01518946|12337443|FG000|STARTED|Randomized Phase (Second Intervention)||0
11150001|NCT01518946|12337444|FG001|STARTED|Randomized Phase (Second Intervention)||9
11150002|NCT01518946|12337445|FG002|STARTED|Randomized Phase (Second Intervention)||10
11150003|NCT01518946|12337443|FG000|COMPLETED|Randomized Phase (Second Intervention)||0
11150004|NCT01518946|12337444|FG001|COMPLETED|Randomized Phase (Second Intervention)||9
11150005|NCT01518946|12337445|FG002|COMPLETED|Randomized Phase (Second Intervention)||10
11150006|NCT01518946|12337443|FG000|NOT COMPLETED|Randomized Phase (Second Intervention)||0
11150007|NCT01518946|12337444|FG001|NOT COMPLETED|Randomized Phase (Second Intervention)||0
11150008|NCT01518946|12337445|FG002|NOT COMPLETED|Randomized Phase (Second Intervention)||0
11150009|NCT01518972|12337454|FG000|STARTED|Overall Study||15
11150010|NCT01518972|12337455|FG001|STARTED|Overall Study||15
11150011|NCT01518972|12337454|FG000|COMPLETED|Overall Study||9
11150012|NCT01518972|12337455|FG001|COMPLETED|Overall Study||11
11150013|NCT01518972|12337454|FG000|NOT COMPLETED|Overall Study||6
11150014|NCT01518972|12337455|FG001|NOT COMPLETED|Overall Study||4
11150015|NCT01519063|12337463|FG000|STARTED|Overall Study||26
11150016|NCT01519063|12337464|FG001|STARTED|Overall Study||30
11150017|NCT01519063|12337463|FG000|COMPLETED|Overall Study||19
11150018|NCT01519063|12337464|FG001|COMPLETED|Overall Study||25
11150019|NCT01519063|12337463|FG000|NOT COMPLETED|Overall Study||7
11150020|NCT01519063|12337464|FG001|NOT COMPLETED|Overall Study||5
11150021|NCT01519089|12337472|FG000|STARTED|Overall Study||47
11150022|NCT01519089|12337473|FG001|STARTED|Overall Study||48
11150023|NCT01519089|12337472|FG000|Received Treatment|Overall Study||47
11150024|NCT01519089|12337473|FG001|Received Treatment|Overall Study||47
11150025|NCT01519089|12337472|FG000|COMPLETED|Overall Study||40
11418584|NCT00484718|12616945|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||1
11150026|NCT01519089|12337473|FG001|COMPLETED|Overall Study||33
11150027|NCT01519089|12337472|FG000|NOT COMPLETED|Overall Study||7
11150028|NCT01519089|12337473|FG001|NOT COMPLETED|Overall Study||15
11150029|NCT01519167|12337483|FG000|STARTED|Overall Study||1
11150030|NCT01519167|12337484|FG001|STARTED|Overall Study||89
11150031|NCT01519167|12337483|FG000|COMPLETED|Overall Study||1
11150032|NCT01519167|12337484|FG001|COMPLETED|Overall Study||81
11150033|NCT01519167|12337483|FG000|NOT COMPLETED|Overall Study||0
11150034|NCT01519167|12337484|FG001|NOT COMPLETED|Overall Study||8
11150035|NCT01519206|12337490|FG000|STARTED|Overall Study||32
11150036|NCT01519206|12337490|FG000|COMPLETED|Overall Study||27
11150037|NCT01519206|12337490|FG000|NOT COMPLETED|Overall Study||5
11150038|NCT01519245|12337503|FG000|STARTED|Overall Study||24
11150039|NCT01519245|12337504|FG001|STARTED|Overall Study||20
11150040|NCT01519245|12337503|FG000|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
11150041|NCT01519245|12337504|FG001|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
11150042|NCT01519245|12337503|FG000|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
11150043|NCT01519245|12337504|FG001|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
11150044|NCT01519245|12337503|FG000|COMPLETED|Overall Study||23
11150045|NCT01519245|12337504|FG001|COMPLETED|Overall Study||18
11150046|NCT01519245|12337503|FG000|NOT COMPLETED|Overall Study||1
11150047|NCT01519245|12337504|FG001|NOT COMPLETED|Overall Study||2
11150048|NCT01519271|12337514|FG000|STARTED|Phase 1||14
11150049|NCT01519271|12337515|FG001|STARTED|Phase 1||14
11150050|NCT01519271|12337514|FG000|COMPLETED|Phase 1||14
11150051|NCT01519271|12337515|FG001|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
11150052|NCT01519271|12337514|FG000|NOT COMPLETED|Phase 1||0
11150053|NCT01519271|12337515|FG001|NOT COMPLETED|Phase 1||1
11150054|NCT01519271|12337514|FG000|STARTED|Phase 2|2 participants discontinued after Phase 1|12
11150055|NCT01519271|12337515|FG001|STARTED|Phase 2||14
11150056|NCT01519271|12337514|FG000|COMPLETED|Phase 2||12
11150057|NCT01519271|12337515|FG001|COMPLETED|Phase 2||14
11150058|NCT01519271|12337514|FG000|NOT COMPLETED|Phase 2||0
11150059|NCT01519271|12337515|FG001|NOT COMPLETED|Phase 2||0
11150060|NCT01519284|12337528|FG000|STARTED|Overall Study||16
11150061|NCT01519284|12337529|FG001|STARTED|Overall Study||16
11150062|NCT01519284|12337530|FG002|STARTED|Overall Study||18
11150063|NCT01519284|12337531|FG003|STARTED|Overall Study||16
11150064|NCT01519284|12337532|FG004|STARTED|Overall Study||16
11150065|NCT01519284|12337528|FG000|COMPLETED|Overall Study||16
11150066|NCT01519284|12337529|FG001|COMPLETED|Overall Study||16
11150067|NCT01519284|12337530|FG002|COMPLETED|Overall Study||16
11150068|NCT01519284|12337531|FG003|COMPLETED|Overall Study||16
11150069|NCT01519284|12337532|FG004|COMPLETED|Overall Study||16
11150070|NCT01519284|12337528|FG000|NOT COMPLETED|Overall Study||0
11150071|NCT01519284|12337529|FG001|NOT COMPLETED|Overall Study||0
11150072|NCT01519284|12337530|FG002|NOT COMPLETED|Overall Study||2
11150073|NCT01519284|12337531|FG003|NOT COMPLETED|Overall Study||0
11150074|NCT01519284|12337532|FG004|NOT COMPLETED|Overall Study||0
11150075|NCT01519323|12337544|FG000|STARTED|Overall Study||3
11150076|NCT01519323|12337545|FG001|STARTED|Overall Study||3
11150077|NCT01519323|12337544|FG000|COMPLETED|Overall Study||0
11150078|NCT01519323|12337545|FG001|COMPLETED|Overall Study||0
11150079|NCT01519323|12337544|FG000|NOT COMPLETED|Overall Study||3
11150080|NCT01519323|12337545|FG001|NOT COMPLETED|Overall Study||3
11150081|NCT01519414|12337553|FG000|STARTED|Pre Cross-over||52
11150082|NCT01519414|12337554|FG001|STARTED|Pre Cross-over||26
11150083|NCT01519414|12337555|FG002|STARTED|Pre Cross-over||0
11150084|NCT01519414|12337553|FG000|COMPLETED|Pre Cross-over||52
11150085|NCT01519414|12337554|FG001|COMPLETED|Pre Cross-over||26
11150086|NCT01519414|12337555|FG002|COMPLETED|Pre Cross-over||0
11150087|NCT01519414|12337553|FG000|NOT COMPLETED|Pre Cross-over||0
11150088|NCT01519414|12337554|FG001|NOT COMPLETED|Pre Cross-over||0
11150089|NCT01519414|12337555|FG002|NOT COMPLETED|Pre Cross-over||0
11150090|NCT01519414|12337553|FG000|STARTED|Post Cross-over||52
11150091|NCT01519414|12337554|FG001|STARTED|Post Cross-over||14
11150092|NCT01519414|12337555|FG002|STARTED|Post Cross-over||12
11150093|NCT01519414|12337553|FG000|COMPLETED|Post Cross-over||52
11150094|NCT01519414|12337554|FG001|COMPLETED|Post Cross-over||14
11150095|NCT01519414|12337555|FG002|COMPLETED|Post Cross-over||12
11150096|NCT01519414|12337553|FG000|NOT COMPLETED|Post Cross-over||0
11150097|NCT01519414|12337554|FG001|NOT COMPLETED|Post Cross-over||0
11150098|NCT01519414|12337555|FG002|NOT COMPLETED|Post Cross-over||0
11150099|NCT01519427|12337566|FG000|STARTED|Overall Study||2
11150100|NCT01519427|12337566|FG000|COMPLETED|Overall Study||0
11150101|NCT01519427|12337566|FG000|NOT COMPLETED|Overall Study||2
11150102|NCT01519453|12337572|FG000|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
11150103|NCT01519453|12337573|FG001|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
11150104|NCT01519453|12337572|FG000|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 320 individuals|160
11150105|NCT01519453|12337573|FG001|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 362 individuals|181
11150106|NCT01519453|12337572|FG000|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 306 individuals|153
11150107|NCT01519453|12337573|FG001|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 350 individuals|175
11150108|NCT01519453|12337572|FG000|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 318 individuals|159
11150109|NCT01519453|12337573|FG001|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 332 individuals|166
11150110|NCT01519453|12337572|FG000|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 294 individuals|147
11150111|NCT01519453|12337573|FG001|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 326 individuals|163
11150112|NCT01519453|12337572|FG000|NOT COMPLETED|Overall Study||52
11150113|NCT01519453|12337573|FG001|NOT COMPLETED|Overall Study||36
11150114|NCT01519466|12337581|FG000|STARTED|Overall Study||33
11150115|NCT01519466|12337582|FG001|STARTED|Overall Study||16
11150116|NCT01519466|12337581|FG000|COMPLETED|Overall Study||33
11150117|NCT01519466|12337582|FG001|COMPLETED|Overall Study||16
11150118|NCT01519466|12337581|FG000|NOT COMPLETED|Overall Study||0
11150119|NCT01519466|12337582|FG001|NOT COMPLETED|Overall Study||0
11150120|NCT01519518|12337590|FG000|STARTED|Overall Study||914
11150121|NCT01519518|12337591|FG001|STARTED|Overall Study||915
11150122|NCT01519518|12337590|FG000|COMPLETED|Overall Study||907
11150123|NCT01519518|12337591|FG001|COMPLETED|Overall Study||905
11150124|NCT01519518|12337590|FG000|NOT COMPLETED|Overall Study||7
11150125|NCT01519518|12337591|FG001|NOT COMPLETED|Overall Study||10
11150126|NCT01519570|12337599|FG000|STARTED|Overall Study||500
11150127|NCT01519570|12337600|FG001|STARTED|Overall Study||2089
11150128|NCT01519570|12337599|FG000|COMPLETED|Overall Study||500
11150129|NCT01519570|12337600|FG001|COMPLETED|Overall Study||2089
11150130|NCT01519570|12337599|FG000|NOT COMPLETED|Overall Study||0
11150131|NCT01519570|12337600|FG001|NOT COMPLETED|Overall Study||0
11150132|NCT01519635|12337608|FG000|STARTED|Overall Study||12
11150133|NCT01519635|12337609|FG001|STARTED|Overall Study||12
11150134|NCT01519635|12337608|FG000|COMPLETED|Overall Study||11
11150135|NCT01519635|12337609|FG001|COMPLETED|Overall Study||9
11150136|NCT01519635|12337608|FG000|NOT COMPLETED|Overall Study||1
11150137|NCT01519635|12337609|FG001|NOT COMPLETED|Overall Study||3
11150138|NCT01519648|12337617|FG000|STARTED|Overall Study||502
11150139|NCT01519648|12337618|FG001|STARTED|Overall Study||306
11150140|NCT01519648|12337617|FG000|COMPLETED|Overall Study||502
11150141|NCT01519648|12337618|FG001|COMPLETED|Overall Study||306
11150142|NCT01519648|12337617|FG000|NOT COMPLETED|Overall Study||0
11150143|NCT01519648|12337618|FG001|NOT COMPLETED|Overall Study||0
11150144|NCT01519661|12337624|FG000|STARTED|Overall Study||157
11150145|NCT01519661|12337624|FG000|COMPLETED|Overall Study||96
11150146|NCT01519661|12337624|FG000|NOT COMPLETED|Overall Study||61
11150147|NCT01519674|12337632|FG000|STARTED|Overall Study||194
11150148|NCT01519674|12337633|FG001|STARTED|Overall Study||195
11150149|NCT01519674|12337634|FG002|STARTED|Overall Study||193
11150150|NCT01519674|12337632|FG000|Exposed|Overall Study||192
11150151|NCT01519674|12337633|FG001|Exposed|Overall Study||193
11150152|NCT01519674|12337634|FG002|Exposed|Overall Study||190
11150153|NCT01519674|12337632|FG000|COMPLETED|Overall Study||173
11150154|NCT01519674|12337633|FG001|COMPLETED|Overall Study||182
11150155|NCT01519674|12337634|FG002|COMPLETED|Overall Study||181
11150156|NCT01519674|12337632|FG000|NOT COMPLETED|Overall Study||21
11150157|NCT01519674|12337633|FG001|NOT COMPLETED|Overall Study||13
11150158|NCT01519674|12337634|FG002|NOT COMPLETED|Overall Study||12
11150159|NCT01519700|12337646|FG000|STARTED|Overall Study||54
11150160|NCT01519700|12337647|FG001|STARTED|Overall Study||55
11150161|NCT01519700|12337648|FG002|STARTED|Overall Study||55
11150162|NCT01519700|12337649|FG003|STARTED|Overall Study||54
11150163|NCT01519700|12337646|FG000|Treated Cycle 1 EP2006|Overall Study||53
11150164|NCT01519700|12337647|FG001|Treated Cycle 1 EP2006|Overall Study||54
11150165|NCT01519700|12337648|FG002|Treated Cycle 1 EP2006|Overall Study||0
11150166|NCT01519700|12337649|FG003|Treated Cycle 1 EP2006|Overall Study||0
11150167|NCT01519700|12337646|FG000|Treated Cycle 1 Neupogen|Overall Study||0
11150168|NCT01519700|12337647|FG001|Treated Cycle 1 Neupogen|Overall Study||0
11150169|NCT01519700|12337648|FG002|Treated Cycle 1 Neupogen|Overall Study||55
11150170|NCT01519700|12337649|FG003|Treated Cycle 1 Neupogen|Overall Study||52
11150171|NCT01519700|12337646|FG000|Treated Cycle 2 EP2006|Overall Study||52
11150172|NCT01519700|12337647|FG001|Treated Cycle 2 EP2006|Overall Study||0
11150173|NCT01519700|12337648|FG002|Treated Cycle 2 EP2006|Overall Study||55
11150174|NCT01519700|12337649|FG003|Treated Cycle 2 EP2006|Overall Study||0
11150175|NCT01519700|12337646|FG000|Treated Cycle 2 Neupogen|Overall Study||0
11150176|NCT01519700|12337647|FG001|Treated Cycle 2 Neupogen|Overall Study||52
11150177|NCT01519700|12337648|FG002|Treated Cycle 2 Neupogen|Overall Study||0
11150178|NCT01519700|12337649|FG003|Treated Cycle 2 Neupogen|Overall Study||51
11150179|NCT01519700|12337646|FG000|Treated Cycle 3 EP2006|Overall Study||51
11150180|NCT01519700|12337647|FG001|Treated Cycle 3 EP2006|Overall Study||51
11150181|NCT01519700|12337648|FG002|Treated Cycle 3 EP2006|Overall Study||0
11150182|NCT01519700|12337649|FG003|Treated Cycle 3 EP2006|Overall Study||0
11150183|NCT01519700|12337646|FG000|Treated Cycle 3 Neupogen|Overall Study||0
11150184|NCT01519700|12337647|FG001|Treated Cycle 3 Neupogen|Overall Study||0
11150185|NCT01519700|12337648|FG002|Treated Cycle 3 Neupogen|Overall Study||54
11150186|NCT01519700|12337649|FG003|Treated Cycle 3 Neupogen|Overall Study||51
11150187|NCT01519700|12337646|FG000|Treated Cycle 4 EP2006|Overall Study||51
11150188|NCT01519700|12337647|FG001|Treated Cycle 4 EP2006|Overall Study||0
11150189|NCT01519700|12337648|FG002|Treated Cycle 4 EP2006|Overall Study||50
11418585|NCT00484718|12616946|FG003|COMPLETED|Treatment Period 2 (2 Weeks)||1
11418586|NCT00484718|12616947|FG004|COMPLETED|Treatment Period 2 (2 Weeks)||1
11418587|NCT00484718|12616948|FG005|COMPLETED|Treatment Period 2 (2 Weeks)||1
11418588|NCT00484718|12616943|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
11418589|NCT00484718|12616944|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
11418590|NCT00484718|12616945|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
11418591|NCT00484718|12616946|FG003|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
11418592|NCT00484718|12616947|FG004|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
11150190|NCT01519700|12337649|FG003|Treated Cycle 4 EP2006|Overall Study||0
11150191|NCT01519700|12337646|FG000|Treated Cycle 4 Neupogen|Overall Study||0
11150192|NCT01519700|12337647|FG001|Treated Cycle 4 Neupogen|Overall Study||51
11150193|NCT01519700|12337648|FG002|Treated Cycle 4 Neupogen|Overall Study||0
11150194|NCT01519700|12337649|FG003|Treated Cycle 4 Neupogen|Overall Study||50
11150195|NCT01519700|12337646|FG000|Treated Cycle 5 EP2006|Overall Study||46
11150196|NCT01519700|12337647|FG001|Treated Cycle 5 EP2006|Overall Study||49
11150197|NCT01519700|12337648|FG002|Treated Cycle 5 EP2006|Overall Study||0
11150198|NCT01519700|12337649|FG003|Treated Cycle 5 EP2006|Overall Study||0
11150199|NCT01519700|12337646|FG000|Treated Cycle 5 Neupogen|Overall Study||0
11150200|NCT01519700|12337647|FG001|Treated Cycle 5 Neupogen|Overall Study||0
11418593|NCT00484718|12616948|FG005|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
11418594|NCT00484718|12616943|FG000|STARTED|Washout Period (2 Weeks)||1
11150201|NCT01519700|12337648|FG002|Treated Cycle 5 Neupogen|Overall Study||48
11418595|NCT00484718|12616944|FG001|STARTED|Washout Period (2 Weeks)||1
11418596|NCT00484718|12616945|FG002|STARTED|Washout Period (2 Weeks)||1
11418597|NCT00484718|12616946|FG003|STARTED|Washout Period (2 Weeks)||1
11150202|NCT01519700|12337649|FG003|Treated Cycle 5 Neupogen|Overall Study||50
11150203|NCT01519700|12337646|FG000|Treated Cycle 6 EP2006|Overall Study||45
11150204|NCT01519700|12337647|FG001|Treated Cycle 6 EP2006|Overall Study||0
11150205|NCT01519700|12337648|FG002|Treated Cycle 6 EP2006|Overall Study||48
11150206|NCT01519700|12337649|FG003|Treated Cycle 6 EP2006|Overall Study||0
11150207|NCT01519700|12337646|FG000|Treated Cycle 6 Neupogen|Overall Study||0
11150208|NCT01519700|12337647|FG001|Treated Cycle 6 Neupogen|Overall Study||49
11150209|NCT01519700|12337648|FG002|Treated Cycle 6 Neupogen|Overall Study||0
11150210|NCT01519700|12337649|FG003|Treated Cycle 6 Neupogen|Overall Study||49
11150211|NCT01519700|12337646|FG000|COMPLETED|Overall Study||45
11150212|NCT01519700|12337647|FG001|COMPLETED|Overall Study||49
11150213|NCT01519700|12337648|FG002|COMPLETED|Overall Study||48
11150214|NCT01519700|12337649|FG003|COMPLETED|Overall Study||47
11150215|NCT01519700|12337646|FG000|NOT COMPLETED|Overall Study||9
11150216|NCT01519700|12337647|FG001|NOT COMPLETED|Overall Study||6
11150217|NCT01519700|12337648|FG002|NOT COMPLETED|Overall Study||7
11150218|NCT01519700|12337649|FG003|NOT COMPLETED|Overall Study||7
11150219|NCT01519713|12337668|FG000|STARTED|Overall Study||194
11150220|NCT01519713|12337669|FG001|STARTED|Overall Study||2
11150221|NCT01519713|12337670|FG002|STARTED|Overall Study||4
11150222|NCT01519713|12337668|FG000|COMPLETED|Overall Study||194
11150223|NCT01519713|12337669|FG001|COMPLETED|Overall Study||2
11150224|NCT01519713|12337670|FG002|COMPLETED|Overall Study||4
11150225|NCT01519713|12337668|FG000|NOT COMPLETED|Overall Study||0
11150226|NCT01519713|12337669|FG001|NOT COMPLETED|Overall Study||0
11150227|NCT01519713|12337670|FG002|NOT COMPLETED|Overall Study||0
11150228|NCT01519765|12337680|FG000|STARTED|Overall Study||37
11150229|NCT01519765|12337681|FG001|STARTED|Overall Study||36
11150230|NCT01519765|12337680|FG000|COMPLETED|Overall Study||34
11150231|NCT01519765|12337681|FG001|COMPLETED|Overall Study||34
11150232|NCT01519765|12337680|FG000|NOT COMPLETED|Overall Study||3
11150233|NCT01519765|12337681|FG001|NOT COMPLETED|Overall Study||2
11150234|NCT01519778|12337688|FG000|STARTED|Overall Study||200
11150235|NCT01519778|12337688|FG000|COMPLETED|Overall Study||186
11150236|NCT01519778|12337688|FG000|NOT COMPLETED|Overall Study||14
11150237|NCT01519791|12337694|FG000|STARTED|Overall Study||219
11150238|NCT01519791|12337695|FG001|STARTED|Overall Study||660
11150239|NCT01519791|12337694|FG000|Completed Week 52|Overall Study||143
11150240|NCT01519791|12337695|FG001|Completed Week 52|Overall Study||500
11150241|NCT01519791|12337694|FG000|COMPLETED|Overall Study||67
11150242|NCT01519791|12337695|FG001|COMPLETED|Overall Study||292
11150243|NCT01519791|12337694|FG000|NOT COMPLETED|Overall Study||152
11150244|NCT01519791|12337695|FG001|NOT COMPLETED|Overall Study||368
11150245|NCT01519817|12337703|FG000|STARTED|Overall Study||4
11418598|NCT00484718|12616947|FG004|STARTED|Washout Period (2 Weeks)||1
11418599|NCT00484718|12616948|FG005|STARTED|Washout Period (2 Weeks)||1
11418600|NCT00484718|12616943|FG000|COMPLETED|Washout Period (2 Weeks)||1
11418601|NCT00484718|12616944|FG001|COMPLETED|Washout Period (2 Weeks)||1
11418602|NCT00484718|12616945|FG002|COMPLETED|Washout Period (2 Weeks)||1
11418603|NCT00484718|12616946|FG003|COMPLETED|Washout Period (2 Weeks)||1
11150246|NCT01519817|12337704|FG001|STARTED|Overall Study||3
11150247|NCT01519817|12337705|FG002|STARTED|Overall Study||16
11150248|NCT01519817|12337706|FG003|STARTED|Overall Study||11
11150249|NCT01519817|12337703|FG000|COMPLETED|Overall Study||3
11150250|NCT01519817|12337704|FG001|COMPLETED|Overall Study||3
11150251|NCT01519817|12337705|FG002|COMPLETED|Overall Study||16
11150252|NCT01519817|12337706|FG003|COMPLETED|Overall Study||10
11150253|NCT01519817|12337703|FG000|NOT COMPLETED|Overall Study||1
11150254|NCT01519817|12337704|FG001|NOT COMPLETED|Overall Study||0
11150255|NCT01519817|12337705|FG002|NOT COMPLETED|Overall Study||0
11150256|NCT01519817|12337706|FG003|NOT COMPLETED|Overall Study||1
11150257|NCT01519869|12337716|FG000|STARTED|Overall Study||28
11150258|NCT01519869|12337716|FG000|COMPLETED|Overall Study||27
11150259|NCT01519869|12337716|FG000|NOT COMPLETED|Overall Study||1
11150260|NCT01519882|12337722|FG000|STARTED|Overall Study||1
11150261|NCT01519882|12337723|FG001|STARTED|Overall Study||0
11150262|NCT01519882|12337722|FG000|COMPLETED|Overall Study||1
11150263|NCT01519882|12337723|FG001|COMPLETED|Overall Study||0
11150264|NCT01519882|12337722|FG000|NOT COMPLETED|Overall Study||0
11150265|NCT01519882|12337723|FG001|NOT COMPLETED|Overall Study||0
11150266|NCT01519921|12337731|FG000|STARTED|Overall Study||86
11150267|NCT01519921|12337732|FG001|STARTED|Overall Study||64
11418604|NCT00484718|12616947|FG004|COMPLETED|Washout Period (2 Weeks)||1
11418605|NCT00484718|12616948|FG005|COMPLETED|Washout Period (2 Weeks)||1
11418606|NCT00484718|12616943|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
11150268|NCT01519921|12337731|FG000|COMPLETED|Overall Study||65
11150269|NCT01519921|12337732|FG001|COMPLETED|Overall Study||49
11150270|NCT01519921|12337731|FG000|NOT COMPLETED|Overall Study||21
11150271|NCT01519921|12337732|FG001|NOT COMPLETED|Overall Study||15
11202867|NCT01843920|12393328|FG001|STARTED|Overall Study||9
11202868|NCT01843920|12393327|FG000|COMPLETED|Overall Study||12
11202869|NCT01843920|12393328|FG001|COMPLETED|Overall Study||9
11202870|NCT01843920|12393327|FG000|NOT COMPLETED|Overall Study||0
11202871|NCT01843920|12393328|FG001|NOT COMPLETED|Overall Study||0
11202872|NCT01843933|12393336|FG000|STARTED|Overall Study||104
11202873|NCT01843933|12393337|FG001|STARTED|Overall Study||107
11202874|NCT01843933|12393336|FG000|COMPLETED|Overall Study||98
11202875|NCT01843933|12393337|FG001|COMPLETED|Overall Study||103
11202876|NCT01843933|12393336|FG000|NOT COMPLETED|Overall Study||6
11202877|NCT01843933|12393337|FG001|NOT COMPLETED|Overall Study||4
11202878|NCT01843972|12393353|FG000|STARTED|Overall Study||13
11202879|NCT01843972|12393354|FG001|STARTED|Overall Study||6
11202880|NCT01843972|12393355|FG002|STARTED|Overall Study||5
11202881|NCT01843972|12393356|FG003|STARTED|Overall Study||6
11202882|NCT01843972|12393357|FG004|STARTED|Overall Study||6
11202883|NCT01843972|12393358|FG005|STARTED|Overall Study||6
11202884|NCT01843972|12393359|FG006|STARTED|Overall Study||5
11202885|NCT01843972|12393360|FG007|STARTED|Overall Study||5
11202886|NCT01843972|12393361|FG008|STARTED|Overall Study||17
11202887|NCT01843972|12393362|FG009|STARTED|Overall Study||12
11202888|NCT01843972|12393353|FG000|COMPLETED|Overall Study||13
11202889|NCT01843972|12393354|FG001|COMPLETED|Overall Study||6
11202890|NCT01843972|12393355|FG002|COMPLETED|Overall Study||5
11202891|NCT01843972|12393356|FG003|COMPLETED|Overall Study||6
11202892|NCT01843972|12393357|FG004|COMPLETED|Overall Study||5
11202893|NCT01843972|12393358|FG005|COMPLETED|Overall Study||6
11202894|NCT01843972|12393359|FG006|COMPLETED|Overall Study||5
11202895|NCT01843972|12393360|FG007|COMPLETED|Overall Study||5
11202896|NCT01843972|12393361|FG008|COMPLETED|Overall Study||17
11202897|NCT01843972|12393362|FG009|COMPLETED|Overall Study||12
11202898|NCT01843972|12393353|FG000|NOT COMPLETED|Overall Study||0
11202899|NCT01843972|12393354|FG001|NOT COMPLETED|Overall Study||0
11202900|NCT01843972|12393355|FG002|NOT COMPLETED|Overall Study||0
11202901|NCT01843972|12393356|FG003|NOT COMPLETED|Overall Study||0
11202902|NCT01843972|12393357|FG004|NOT COMPLETED|Overall Study||1
11202903|NCT01843972|12393358|FG005|NOT COMPLETED|Overall Study||0
11202904|NCT01843972|12393359|FG006|NOT COMPLETED|Overall Study||0
11202905|NCT01843972|12393360|FG007|NOT COMPLETED|Overall Study||0
11202906|NCT01843972|12393361|FG008|NOT COMPLETED|Overall Study||0
11202907|NCT01843972|12393362|FG009|NOT COMPLETED|Overall Study||0
11202908|NCT01844076|12393402|FG000|STARTED|Overall Study||3
11202909|NCT01844076|12393403|FG001|STARTED|Overall Study||6
11202910|NCT01844076|12393404|FG002|STARTED|Overall Study||3
11202911|NCT01844076|12393405|FG003|STARTED|Overall Study||7
11202912|NCT01844076|12393402|FG000|COMPLETED|Overall Study||1
11202913|NCT01844076|12393403|FG001|COMPLETED|Overall Study||6
11202914|NCT01844076|12393404|FG002|COMPLETED|Overall Study||3
11202915|NCT01844076|12393405|FG003|COMPLETED|Overall Study||7
11202916|NCT01844076|12393402|FG000|NOT COMPLETED|Overall Study||2
11202917|NCT01844076|12393403|FG001|NOT COMPLETED|Overall Study||0
11202918|NCT01844076|12393404|FG002|NOT COMPLETED|Overall Study||0
11202919|NCT01844076|12393405|FG003|NOT COMPLETED|Overall Study||0
11202920|NCT01844115|12393417|FG000|STARTED|Overall Study||202
11202921|NCT01844115|12393418|FG001|STARTED|Overall Study||202
11202922|NCT01844115|12393417|FG000|COMPLETED|Overall Study||163
11202923|NCT01844115|12393418|FG001|COMPLETED|Overall Study||144
11202924|NCT01844115|12393417|FG000|NOT COMPLETED|Overall Study||39
11202925|NCT01844115|12393418|FG001|NOT COMPLETED|Overall Study||58
11202926|NCT01844193|12393426|FG000|STARTED|Overall Study||19
11202927|NCT01844193|12393427|FG001|STARTED|Overall Study||21
11202928|NCT01844193|12393426|FG000|COMPLETED|Overall Study||13
11202929|NCT01844193|12393427|FG001|COMPLETED|Overall Study||15
11202930|NCT01844193|12393426|FG000|NOT COMPLETED|Overall Study||6
11202931|NCT01844193|12393427|FG001|NOT COMPLETED|Overall Study||6
11202932|NCT01844284|12393435|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|266
11202933|NCT01844284|12393436|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|134
11202934|NCT01844284|12393435|FG000|COMPLETED|Overall Study||254
11202935|NCT01844284|12393436|FG001|COMPLETED|Overall Study||127
11202936|NCT01844284|12393435|FG000|NOT COMPLETED|Overall Study||12
11202937|NCT01844284|12393436|FG001|NOT COMPLETED|Overall Study||7
11202938|NCT01844375|12393444|FG000|STARTED|Overall Study||35
11202939|NCT01844375|12393445|FG001|STARTED|Overall Study||35
11202940|NCT01844375|12393444|FG000|COMPLETED|Overall Study||34
11202941|NCT01844375|12393445|FG001|COMPLETED|Overall Study||34
11202942|NCT01844375|12393444|FG000|NOT COMPLETED|Overall Study||1
11202943|NCT01844375|12393445|FG001|NOT COMPLETED|Overall Study||1
11202944|NCT01844388|12393453|FG000|STARTED|Overall Study||244
11202945|NCT01844388|12393454|FG001|STARTED|Overall Study||121
11202946|NCT01844388|12393453|FG000|COMPLETED|Overall Study||236
11202947|NCT01844388|12393454|FG001|COMPLETED|Overall Study||114
11202948|NCT01844388|12393453|FG000|NOT COMPLETED|Overall Study||8
11202949|NCT01844388|12393454|FG001|NOT COMPLETED|Overall Study||7
11202950|NCT01844479|12393460|FG000|STARTED|First Intervention up to 30 Minutes||14
11202951|NCT01844479|12393461|FG001|STARTED|First Intervention up to 30 Minutes||13
11202952|NCT01844479|12393460|FG000|COMPLETED|First Intervention up to 30 Minutes||14
11202953|NCT01844479|12393461|FG001|COMPLETED|First Intervention up to 30 Minutes||13
11202954|NCT01844479|12393460|FG000|NOT COMPLETED|First Intervention up to 30 Minutes||0
11150272|NCT01519934|12337738|FG000|STARTED|Overall Study||48
11150273|NCT01519934|12337738|FG000|COMPLETED|Overall Study||45
11150274|NCT01519934|12337738|FG000|NOT COMPLETED|Overall Study||3
11150275|NCT01519947|12337746|FG000|STARTED|Overall Study||19
11150276|NCT01519947|12337747|FG001|STARTED|Overall Study||11
11150277|NCT01519947|12337748|FG002|STARTED|Overall Study||15
11150278|NCT01519947|12337749|FG003|STARTED|Overall Study||42
11150279|NCT01519947|12337746|FG000|COMPLETED|Overall Study||17
11150280|NCT01519947|12337747|FG001|COMPLETED|Overall Study||7
11150281|NCT01519947|12337748|FG002|COMPLETED|Overall Study||8
11150282|NCT01519947|12337749|FG003|COMPLETED|Overall Study||34
11150283|NCT01519947|12337746|FG000|NOT COMPLETED|Overall Study||2
11150284|NCT01519947|12337747|FG001|NOT COMPLETED|Overall Study||4
11150285|NCT01519947|12337748|FG002|NOT COMPLETED|Overall Study||7
11150286|NCT01519947|12337749|FG003|NOT COMPLETED|Overall Study||8
11150287|NCT01520038|12337759|FG000|STARTED|Overall Study||2
11150288|NCT01520038|12337759|FG000|COMPLETED|Overall Study||1
11150289|NCT01520038|12337759|FG000|NOT COMPLETED|Overall Study||1
11150290|NCT01520207|12337765|FG000|STARTED|Overall Study||27
11150291|NCT01520207|12337766|FG001|STARTED|Overall Study||25
11150292|NCT01520207|12337765|FG000|COMPLETED|Overall Study||25
11150293|NCT01520207|12337766|FG001|COMPLETED|Overall Study||25
11150294|NCT01520207|12337765|FG000|NOT COMPLETED|Overall Study||2
11150295|NCT01520207|12337766|FG001|NOT COMPLETED|Overall Study||0
11150296|NCT01520324|12337772|FG000|STARTED|Overall Study||53
11150297|NCT01520324|12337772|FG000|COMPLETED|Overall Study||52
11150298|NCT01520324|12337772|FG000|NOT COMPLETED|Overall Study||1
11150299|NCT01520363|12337778|FG000|STARTED|Overall Study||26
11150300|NCT01520363|12337779|FG001|STARTED|Overall Study||26
11150301|NCT01520363|12337778|FG000|COMPLETED|Overall Study||24
11150302|NCT01520363|12337779|FG001|COMPLETED|Overall Study||26
11150303|NCT01520363|12337778|FG000|NOT COMPLETED|Overall Study||2
11150304|NCT01520363|12337779|FG001|NOT COMPLETED|Overall Study||0
11150305|NCT01520402|12337809|FG000|STARTED|Overall Study||35
11150306|NCT01520402|12337809|FG000|COMPLETED|Overall Study||30
11150307|NCT01520402|12337809|FG000|NOT COMPLETED|Overall Study||5
11150308|NCT01520454|12337824|FG000|STARTED|Overall Study||9
11150309|NCT01520454|12337825|FG001|STARTED|Overall Study||6
11150310|NCT01520454|12337826|FG002|STARTED|Overall Study||5
11150311|NCT01520454|12337827|FG003|STARTED|Overall Study||6
11150312|NCT01520454|12337824|FG000|COMPLETED|Overall Study||9
11150313|NCT01520454|12337825|FG001|COMPLETED|Overall Study||6
11150314|NCT01520454|12337826|FG002|COMPLETED|Overall Study||5
11150315|NCT01520454|12337827|FG003|COMPLETED|Overall Study||6
11150316|NCT01520454|12337824|FG000|NOT COMPLETED|Overall Study||0
11150317|NCT01520454|12337825|FG001|NOT COMPLETED|Overall Study||0
11150318|NCT01520454|12337826|FG002|NOT COMPLETED|Overall Study||0
11150319|NCT01520454|12337827|FG003|NOT COMPLETED|Overall Study||0
11150320|NCT01520506|12337840|FG000|STARTED|Overall Study||50
11150321|NCT01520506|12337840|FG000|COMPLETED|Overall Study||44
11150322|NCT01520506|12337840|FG000|NOT COMPLETED|Overall Study||6
11150323|NCT01520519|12337844|FG000|STARTED|Overall Study||40
11150324|NCT01520519|12337844|FG000|COMPLETED|Overall Study||40
11150325|NCT01520519|12337844|FG000|NOT COMPLETED|Overall Study||0
11150326|NCT01520532|12337848|FG000|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
11150327|NCT01520532|12337848|FG000|COMPLETED|Overall Study||60
11150328|NCT01520532|12337848|FG000|NOT COMPLETED|Overall Study||0
11150329|NCT01520558|12337855|FG000|STARTED|Overall Study||3
11150330|NCT01520558|12337856|FG001|STARTED|Overall Study||3
11150331|NCT01520558|12337857|FG002|STARTED|Overall Study||6
11150332|NCT01520558|12337855|FG000|COMPLETED|Overall Study||1
11150333|NCT01520558|12337856|FG001|COMPLETED|Overall Study||1
11150334|NCT01520558|12337857|FG002|COMPLETED|Overall Study||3
11150335|NCT01520558|12337855|FG000|NOT COMPLETED|Overall Study||2
11150336|NCT01520558|12337856|FG001|NOT COMPLETED|Overall Study||2
11150337|NCT01520558|12337857|FG002|NOT COMPLETED|Overall Study||3
11150338|NCT01520688|12337865|FG000|STARTED|Overall Study||4
11150339|NCT01520688|12337866|FG001|STARTED|Overall Study||4
11150340|NCT01520688|12337867|FG002|STARTED|Overall Study||4
11150341|NCT01520688|12337868|FG003|STARTED|Overall Study||5
11150342|NCT01520688|12337869|FG004|STARTED|Overall Study||5
11150343|NCT01520688|12337870|FG005|STARTED|Overall Study||5
11150344|NCT01520688|12337871|FG006|STARTED|Overall Study||5
11150345|NCT01520688|12337865|FG000|COMPLETED|Overall Study||4
11150346|NCT01520688|12337866|FG001|COMPLETED|Overall Study||2
11150347|NCT01520688|12337867|FG002|COMPLETED|Overall Study||4
11150348|NCT01520688|12337868|FG003|COMPLETED|Overall Study||4
11150349|NCT01520688|12337869|FG004|COMPLETED|Overall Study||4
11150350|NCT01520688|12337870|FG005|COMPLETED|Overall Study||5
11150351|NCT01520688|12337871|FG006|COMPLETED|Overall Study||0
11150352|NCT01520688|12337865|FG000|NOT COMPLETED|Overall Study||0
11150353|NCT01520688|12337866|FG001|NOT COMPLETED|Overall Study||2
11150354|NCT01520688|12337867|FG002|NOT COMPLETED|Overall Study||0
11150355|NCT01520688|12337868|FG003|NOT COMPLETED|Overall Study||1
11150356|NCT01520688|12337869|FG004|NOT COMPLETED|Overall Study||1
11150357|NCT01520688|12337870|FG005|NOT COMPLETED|Overall Study||0
11150358|NCT01520688|12337871|FG006|NOT COMPLETED|Overall Study||5
11150359|NCT01520727|12337888|FG000|STARTED|Overall Study||6
11150360|NCT01520727|12337889|FG001|STARTED|Overall Study||6
11150361|NCT01520727|12337890|FG002|STARTED|Overall Study||6
11150362|NCT01520727|12337891|FG003|STARTED|Overall Study||6
11150363|NCT01520727|12337892|FG004|STARTED|Overall Study||6
11150364|NCT01520727|12337893|FG005|STARTED|Overall Study||6
11150365|NCT01520727|12337894|FG006|STARTED|Overall Study||6
11150366|NCT01520727|12337895|FG007|STARTED|Overall Study||6
11150367|NCT01520727|12337896|FG008|STARTED|Overall Study||16
11150368|NCT01520727|12337888|FG000|COMPLETED|Overall Study||6
11150369|NCT01520727|12337889|FG001|COMPLETED|Overall Study||6
11150370|NCT01520727|12337890|FG002|COMPLETED|Overall Study||6
11150371|NCT01520727|12337891|FG003|COMPLETED|Overall Study||6
11150372|NCT01520727|12337892|FG004|COMPLETED|Overall Study||6
11150373|NCT01520727|12337893|FG005|COMPLETED|Overall Study||6
11150374|NCT01520727|12337894|FG006|COMPLETED|Overall Study||6
11150375|NCT01520727|12337895|FG007|COMPLETED|Overall Study||6
11150376|NCT01520727|12337896|FG008|COMPLETED|Overall Study||16
11150377|NCT01520727|12337888|FG000|NOT COMPLETED|Overall Study||0
11150378|NCT01520727|12337889|FG001|NOT COMPLETED|Overall Study||0
11150379|NCT01520727|12337890|FG002|NOT COMPLETED|Overall Study||0
11150380|NCT01520727|12337891|FG003|NOT COMPLETED|Overall Study||0
11150381|NCT01520727|12337892|FG004|NOT COMPLETED|Overall Study||0
11150382|NCT01520727|12337893|FG005|NOT COMPLETED|Overall Study||0
11150383|NCT01520727|12337894|FG006|NOT COMPLETED|Overall Study||0
11150384|NCT01520727|12337895|FG007|NOT COMPLETED|Overall Study||0
11150385|NCT01520727|12337896|FG008|NOT COMPLETED|Overall Study||0
11150386|NCT01520870|12337916|FG000|STARTED|Overall Study||49
11150387|NCT01520870|12337916|FG000|COMPLETED|Overall Study||47
11150388|NCT01520870|12337916|FG000|NOT COMPLETED|Overall Study||2
11150389|NCT01520909|12337922|FG000|STARTED|Part 1 (Randomized Period)||29
11150390|NCT01520909|12337923|FG001|STARTED|Part 1 (Randomized Period)||63
11150391|NCT01520909|12337924|FG002|STARTED|Part 1 (Randomized Period)||0
11150392|NCT01520909|12337922|FG000|COMPLETED|Part 1 (Randomized Period)||28
11150393|NCT01520909|12337923|FG001|COMPLETED|Part 1 (Randomized Period)||61
11150394|NCT01520909|12337924|FG002|COMPLETED|Part 1 (Randomized Period)||0
11150395|NCT01520909|12337922|FG000|NOT COMPLETED|Part 1 (Randomized Period)||1
11150396|NCT01520909|12337923|FG001|NOT COMPLETED|Part 1 (Randomized Period)||2
11150397|NCT01520909|12337924|FG002|NOT COMPLETED|Part 1 (Randomized Period)||0
11150398|NCT01520909|12337922|FG000|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
11150399|NCT01520909|12337923|FG001|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
11150400|NCT01520909|12337924|FG002|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
11150401|NCT01520909|12337922|FG000|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
11150402|NCT01520909|12337923|FG001|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
11150403|NCT01520909|12337924|FG002|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
11150404|NCT01520909|12337922|FG000|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
11150405|NCT01520909|12337923|FG001|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
11150406|NCT01520909|12337924|FG002|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
11150407|NCT01520922|12337946|FG000|STARTED|Treatment Phase||44
11150408|NCT01520922|12337947|FG001|STARTED|Treatment Phase||53
11150409|NCT01520922|12337946|FG000|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
11150410|NCT01520922|12337947|FG001|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
11150411|NCT01520922|12337946|FG000|NOT COMPLETED|Treatment Phase||5
11150412|NCT01520922|12337947|FG001|NOT COMPLETED|Treatment Phase||8
11150413|NCT01520922|12337946|FG000|STARTED|Follow up||44
11150414|NCT01520922|12337947|FG001|STARTED|Follow up||45
11150415|NCT01520922|12337946|FG000|COMPLETED|Follow up||44
11150416|NCT01520922|12337947|FG001|COMPLETED|Follow up||44
11150417|NCT01520922|12337946|FG000|NOT COMPLETED|Follow up||0
11150418|NCT01520922|12337947|FG001|NOT COMPLETED|Follow up||1
11150419|NCT01520922|12337946|FG000|STARTED|Survival Follow-up||21
11150420|NCT01520922|12337947|FG001|STARTED|Survival Follow-up||40
11150421|NCT01520922|12337946|FG000|COMPLETED|Survival Follow-up||20
11150422|NCT01520922|12337947|FG001|COMPLETED|Survival Follow-up||40
11150423|NCT01520922|12337946|FG000|NOT COMPLETED|Survival Follow-up||1
11150424|NCT01520922|12337947|FG001|NOT COMPLETED|Survival Follow-up||0
11150425|NCT01520987|12337961|FG000|STARTED|Overall Study||13
11150426|NCT01520987|12337962|FG001|STARTED|Overall Study||12
11150427|NCT01520987|12337963|FG002|STARTED|Overall Study||11
11150428|NCT01520987|12337964|FG003|STARTED|Overall Study||15
11150429|NCT01520987|12337965|FG004|STARTED|Overall Study||14
11150430|NCT01520987|12337966|FG005|STARTED|Overall Study||14
11150431|NCT01520987|12337967|FG006|STARTED|Overall Study||12
11150432|NCT01520987|12337968|FG007|STARTED|Overall Study||14
11150433|NCT01520987|12337961|FG000|Dosed|Overall Study||13
11150434|NCT01520987|12337962|FG001|Dosed|Overall Study||12
11150435|NCT01520987|12337963|FG002|Dosed|Overall Study||11
11150436|NCT01520987|12337964|FG003|Dosed|Overall Study||15
11150437|NCT01520987|12337965|FG004|Dosed|Overall Study||14
11150438|NCT01520987|12337966|FG005|Dosed|Overall Study||14
11150439|NCT01520987|12337967|FG006|Dosed|Overall Study||12
11150440|NCT01520987|12337968|FG007|Dosed|Overall Study||14
11150441|NCT01520987|12337961|FG000|COMPLETED|Overall Study||12
11150442|NCT01520987|12337962|FG001|COMPLETED|Overall Study||12
11150443|NCT01520987|12337963|FG002|COMPLETED|Overall Study||11
11150444|NCT01520987|12337964|FG003|COMPLETED|Overall Study||15
11150445|NCT01520987|12337965|FG004|COMPLETED|Overall Study||14
11150446|NCT01520987|12337966|FG005|COMPLETED|Overall Study||13
11150447|NCT01520987|12337967|FG006|COMPLETED|Overall Study||12
11150448|NCT01520987|12337968|FG007|COMPLETED|Overall Study||14
11150449|NCT01520987|12337961|FG000|NOT COMPLETED|Overall Study||1
11150450|NCT01520987|12337962|FG001|NOT COMPLETED|Overall Study||0
11150451|NCT01520987|12337963|FG002|NOT COMPLETED|Overall Study||0
11150452|NCT01520987|12337964|FG003|NOT COMPLETED|Overall Study||0
11150453|NCT01520987|12337965|FG004|NOT COMPLETED|Overall Study||0
11150454|NCT01520987|12337966|FG005|NOT COMPLETED|Overall Study||1
11150455|NCT01520987|12337967|FG006|NOT COMPLETED|Overall Study||0
11150456|NCT01520987|12337968|FG007|NOT COMPLETED|Overall Study||0
11150457|NCT01521026|12337986|FG000|STARTED|Overall Study||38
11150458|NCT01521026|12337987|FG001|STARTED|Overall Study||31
11150459|NCT01521026|12337986|FG000|COMPLETED|Overall Study||23
11150460|NCT01521026|12337987|FG001|COMPLETED|Overall Study||28
11150461|NCT01521026|12337986|FG000|NOT COMPLETED|Overall Study||15
11150462|NCT01521026|12337987|FG001|NOT COMPLETED|Overall Study||3
11150463|NCT01521117|12337993|FG000|STARTED|First Intervention (6 Weeks)||10
11150464|NCT01521117|12337994|FG001|STARTED|First Intervention (6 Weeks)||11
11150465|NCT01521117|12337993|FG000|COMPLETED|First Intervention (6 Weeks)||5
11150466|NCT01521117|12337994|FG001|COMPLETED|First Intervention (6 Weeks)||8
11150467|NCT01521117|12337993|FG000|NOT COMPLETED|First Intervention (6 Weeks)||5
11150468|NCT01521117|12337994|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3
11150469|NCT01521117|12337993|FG000|STARTED|Washout (4 Weeks)||5
11150470|NCT01521117|12337994|FG001|STARTED|Washout (4 Weeks)||8
11150471|NCT01521117|12337993|FG000|COMPLETED|Washout (4 Weeks)||5
11150472|NCT01521117|12337994|FG001|COMPLETED|Washout (4 Weeks)||8
11150473|NCT01521117|12337993|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11150474|NCT01521117|12337994|FG001|NOT COMPLETED|Washout (4 Weeks)||0
11150475|NCT01521117|12337993|FG000|STARTED|Second Intervention (6 Weeks)||5
11150476|NCT01521117|12337994|FG001|STARTED|Second Intervention (6 Weeks)||8
11150477|NCT01521117|12337993|FG000|COMPLETED|Second Intervention (6 Weeks)||5
11150478|NCT01521117|12337994|FG001|COMPLETED|Second Intervention (6 Weeks)||5
11150479|NCT01521117|12337993|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
11150480|NCT01521117|12337994|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3
11150481|NCT01521260|12338002|FG000|STARTED|Overall Study||15
11150482|NCT01521260|12338003|FG001|STARTED|Overall Study||15
11150483|NCT01521260|12338002|FG000|COMPLETED|Overall Study||15
11150484|NCT01521260|12338003|FG001|COMPLETED|Overall Study||15
11150485|NCT01521260|12338002|FG000|NOT COMPLETED|Overall Study||0
11150486|NCT01521260|12338003|FG001|NOT COMPLETED|Overall Study||0
11150487|NCT01521364|12338009|FG000|STARTED|Linezolid Without Clarithromycin (1 wk)||7
11150488|NCT01521364|12338009|FG000|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
11150489|NCT01521364|12338009|FG000|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
11150490|NCT01521364|12338009|FG000|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
11150491|NCT01521364|12338009|FG000|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
11150492|NCT01521364|12338009|FG000|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
11150493|NCT01521364|12338009|FG000|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
11150494|NCT01521364|12338009|FG000|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
11150495|NCT01521364|12338009|FG000|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
11150496|NCT01521494|12338025|FG000|STARTED|Overall Study||39
11150497|NCT01521494|12338026|FG001|STARTED|Overall Study||36
11150498|NCT01521494|12338027|FG002|STARTED|Overall Study||35
11150499|NCT01521494|12338028|FG003|STARTED|Overall Study||36
11150500|NCT01521494|12338029|FG004|STARTED|Overall Study||37
11150501|NCT01521494|12338025|FG000|COMPLETED|Overall Study||37
11150502|NCT01521494|12338026|FG001|COMPLETED|Overall Study||31
11150503|NCT01521494|12338027|FG002|COMPLETED|Overall Study||23
11150504|NCT01521494|12338028|FG003|COMPLETED|Overall Study||15
11150505|NCT01521494|12338029|FG004|COMPLETED|Overall Study||30
11150506|NCT01521494|12338025|FG000|NOT COMPLETED|Overall Study||2
11150507|NCT01521494|12338026|FG001|NOT COMPLETED|Overall Study||5
11150508|NCT01521494|12338027|FG002|NOT COMPLETED|Overall Study||12
11150509|NCT01521494|12338028|FG003|NOT COMPLETED|Overall Study||21
11150510|NCT01521494|12338029|FG004|NOT COMPLETED|Overall Study||7
11150511|NCT01521507|12338043|FG000|STARTED|Stage 1: Randomized Design||101
11150512|NCT01521507|12338044|FG001|STARTED|Stage 1: Randomized Design||99
11418607|NCT00484718|12616944|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
11418608|NCT00484718|12616945|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
11418609|NCT00484718|12616946|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0
11418610|NCT00484718|12616947|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0
11418611|NCT00484718|12616948|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0
11150513|NCT01521507|12338043|FG000|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
11150514|NCT01521507|12338044|FG001|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
11150515|NCT01521507|12338043|FG000|COMPLETED|Stage 1: Randomized Design||98
11150516|NCT01521507|12338044|FG001|COMPLETED|Stage 1: Randomized Design||94
11150517|NCT01521507|12338043|FG000|NOT COMPLETED|Stage 1: Randomized Design||3
11150518|NCT01521507|12338044|FG001|NOT COMPLETED|Stage 1: Randomized Design||5
11150519|NCT01521507|12338043|FG000|STARTED|Stage 2: Observational Design||98
11150520|NCT01521507|12338044|FG001|STARTED|Stage 2: Observational Design||94
11150521|NCT01521507|12338043|FG000|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
11150522|NCT01521507|12338044|FG001|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
11150523|NCT01521507|12338043|FG000|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
11150524|NCT01521507|12338044|FG001|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
11150525|NCT01521507|12338043|FG000|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
11150526|NCT01521507|12338044|FG001|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
11150527|NCT01521507|12338043|FG000|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
11150528|NCT01521507|12338044|FG001|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
11150529|NCT01521507|12338043|FG000|COMPLETED|Stage 2: Observational Design||94
11150530|NCT01521507|12338044|FG001|COMPLETED|Stage 2: Observational Design||92
11150531|NCT01521507|12338043|FG000|NOT COMPLETED|Stage 2: Observational Design||4
11150532|NCT01521507|12338044|FG001|NOT COMPLETED|Stage 2: Observational Design||2
11150533|NCT01521546|12338059|FG000|STARTED|Overall Study||22
11418612|NCT00484718|12616943|FG000|STARTED|Treatment Period 3 (2 Weeks)||1
11418613|NCT00484718|12616944|FG001|STARTED|Treatment Period 3 (2 Weeks)||1
11150534|NCT01521546|12338060|FG001|STARTED|Overall Study||20
11150535|NCT01521546|12338059|FG000|COMPLETED|Overall Study||20
11150536|NCT01521546|12338060|FG001|COMPLETED|Overall Study||20
11150537|NCT01521546|12338059|FG000|NOT COMPLETED|Overall Study||2
11150538|NCT01521546|12338060|FG001|NOT COMPLETED|Overall Study||0
11202955|NCT01844479|12393461|FG001|NOT COMPLETED|First Intervention up to 30 Minutes||0
11202956|NCT01844479|12393460|FG000|STARTED|Second Intervention up to 30 Minutes||14
11202957|NCT01844479|12393461|FG001|STARTED|Second Intervention up to 30 Minutes||13
11202958|NCT01844479|12393460|FG000|COMPLETED|Second Intervention up to 30 Minutes||14
11202959|NCT01844479|12393461|FG001|COMPLETED|Second Intervention up to 30 Minutes||13
11202960|NCT01844479|12393460|FG000|NOT COMPLETED|Second Intervention up to 30 Minutes||0
11202961|NCT01844479|12393461|FG001|NOT COMPLETED|Second Intervention up to 30 Minutes||0
11202962|NCT01844531|12393472|FG000|STARTED|Overall Study||6
11202963|NCT01844531|12393473|FG001|STARTED|Overall Study||6
11202964|NCT01844531|12393474|FG002|STARTED|Overall Study||6
11202965|NCT01844531|12393475|FG003|STARTED|Overall Study||6
11202966|NCT01844531|12393472|FG000|COMPLETED|Overall Study||6
11202967|NCT01844531|12393473|FG001|COMPLETED|Overall Study||5
11202968|NCT01844531|12393474|FG002|COMPLETED|Overall Study||6
11202969|NCT01844531|12393475|FG003|COMPLETED|Overall Study||6
11202970|NCT01844531|12393472|FG000|NOT COMPLETED|Overall Study||0
11202971|NCT01844531|12393473|FG001|NOT COMPLETED|Overall Study||1
11202972|NCT01844531|12393474|FG002|NOT COMPLETED|Overall Study||0
11202973|NCT01844531|12393475|FG003|NOT COMPLETED|Overall Study||0
11202974|NCT01844583|12393487|FG000|STARTED|Overall Study||26
11202975|NCT01844583|12393488|FG001|STARTED|Overall Study||29
11202976|NCT01844583|12393487|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18
11202977|NCT01844583|12393488|FG001|COMPLETED|Overall Study||19
11202978|NCT01844583|12393487|FG000|NOT COMPLETED|Overall Study||8
11202979|NCT01844583|12393488|FG001|NOT COMPLETED|Overall Study||10
11202980|NCT01844687|12393499|FG000|STARTED|Visit 1||50
11202981|NCT01844687|12393499|FG000|COMPLETED|Visit 1||42
11202982|NCT01844687|12393499|FG000|NOT COMPLETED|Visit 1||8
11202983|NCT01844687|12393499|FG000|STARTED|Visit 2||42
11202984|NCT01844687|12393499|FG000|COMPLETED|Visit 2||40
11202985|NCT01844687|12393499|FG000|NOT COMPLETED|Visit 2||2
11202986|NCT01844687|12393499|FG000|STARTED|Visit 3||40
11202987|NCT01844687|12393499|FG000|COMPLETED|Visit 3||35
11202988|NCT01844687|12393499|FG000|NOT COMPLETED|Visit 3||5
11202989|NCT01844687|12393499|FG000|STARTED|Visit 4||35
11202990|NCT01844687|12393499|FG000|COMPLETED|Visit 4||31
11202991|NCT01844687|12393499|FG000|NOT COMPLETED|Visit 4||4
11202992|NCT01844687|12393499|FG000|STARTED|Visit 5||31
11202993|NCT01844687|12393499|FG000|COMPLETED|Visit 5||31
11202994|NCT01844687|12393499|FG000|NOT COMPLETED|Visit 5||0
11202995|NCT01844687|12393499|FG000|STARTED|Visit 6||31
11202996|NCT01844687|12393499|FG000|COMPLETED|Visit 6||31
11202997|NCT01844687|12393499|FG000|NOT COMPLETED|Visit 6||0
11202998|NCT01844687|12393499|FG000|STARTED|Visit 7||31
11202999|NCT01844687|12393499|FG000|COMPLETED|Visit 7||31
11203000|NCT01844687|12393499|FG000|NOT COMPLETED|Visit 7||0
11203001|NCT01844687|12393499|FG000|STARTED|Visit 8||31
11203002|NCT01844687|12393499|FG000|COMPLETED|Visit 8||31
11203003|NCT01844687|12393499|FG000|NOT COMPLETED|Visit 8||0
11203004|NCT01844700|12393523|FG000|STARTED|Overall Study||4
11203005|NCT01844700|12393524|FG001|STARTED|Overall Study||3
11203006|NCT01844700|12393523|FG000|COMPLETED|Overall Study||1
11203007|NCT01844700|12393524|FG001|COMPLETED|Overall Study||2
11203008|NCT01844700|12393523|FG000|NOT COMPLETED|Overall Study||3
11203009|NCT01844700|12393524|FG001|NOT COMPLETED|Overall Study||1
11203010|NCT01844765|12393532|FG000|STARTED|Overall Study||34
11203011|NCT01844765|12393533|FG001|STARTED|Overall Study||25
11203012|NCT01844765|12393532|FG000|Treated|Overall Study||33
11203013|NCT01844765|12393533|FG001|Treated|Overall Study||25
11203014|NCT01844765|12393532|FG000|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
11203015|NCT01844765|12393533|FG001|Untreated|Overall Study||0
11203016|NCT01844765|12393532|FG000|COMPLETED|Overall Study||19
11203017|NCT01844765|12393533|FG001|COMPLETED|Overall Study||10
11203018|NCT01844765|12393532|FG000|NOT COMPLETED|Overall Study||15
11203019|NCT01844765|12393533|FG001|NOT COMPLETED|Overall Study||15
11203020|NCT01844778|12393547|FG000|STARTED|Overall Study||14
11203021|NCT01844778|12393548|FG001|STARTED|Overall Study||28
11203022|NCT01844778|12393549|FG002|STARTED|Overall Study||18
11203023|NCT01844778|12393547|FG000|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
11203024|NCT01844778|12393548|FG001|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
11203025|NCT01844778|12393549|FG002|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
11203026|NCT01844778|12393547|FG000|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
11203027|NCT01844778|12393548|FG001|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
11203028|NCT01844778|12393549|FG002|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
11203029|NCT01844778|12393547|FG000|COMPLETED|Overall Study||12
11203030|NCT01844778|12393548|FG001|COMPLETED|Overall Study||25
11203031|NCT01844778|12393549|FG002|COMPLETED|Overall Study||14
11203032|NCT01844778|12393547|FG000|NOT COMPLETED|Overall Study||2
11150539|NCT01521559|12338068|FG000|STARTED|Overall Study||92
11150540|NCT01521559|12338069|FG001|STARTED|Overall Study||91
11150541|NCT01521559|12338068|FG000|Completed Week 24|Overall Study||83
11150542|NCT01521559|12338069|FG001|Completed Week 24|Overall Study||85
11150543|NCT01521559|12338068|FG000|Completed Week 52|Overall Study||77
11150544|NCT01521559|12338069|FG001|Completed Week 52|Overall Study||73
11150545|NCT01521559|12338068|FG000|COMPLETED|Overall Study||77
11150546|NCT01521559|12338069|FG001|COMPLETED|Overall Study||73
11150547|NCT01521559|12338068|FG000|NOT COMPLETED|Overall Study||15
11150548|NCT01521559|12338069|FG001|NOT COMPLETED|Overall Study||18
11150549|NCT01521780|12338076|FG000|STARTED|Overall Study||9
11150550|NCT01521780|12338077|FG001|STARTED|Overall Study||1
11150551|NCT01521780|12338078|FG002|STARTED|Overall Study||2
11150552|NCT01521780|12338076|FG000|COMPLETED|Overall Study||9
11150553|NCT01521780|12338077|FG001|COMPLETED|Overall Study||1
11150554|NCT01521780|12338078|FG002|COMPLETED|Overall Study||2
11150555|NCT01521780|12338076|FG000|NOT COMPLETED|Overall Study||0
11150556|NCT01521780|12338077|FG001|NOT COMPLETED|Overall Study||0
11150557|NCT01521780|12338078|FG002|NOT COMPLETED|Overall Study||0
11150558|NCT01521845|12338089|FG000|STARTED|Overall Study||52
11150559|NCT01521845|12338090|FG001|STARTED|Overall Study||52
11150560|NCT01521845|12338089|FG000|COMPLETED|Overall Study||43
11150561|NCT01521845|12338090|FG001|COMPLETED|Overall Study||47
11150562|NCT01521845|12338089|FG000|NOT COMPLETED|Overall Study||9
11150563|NCT01521845|12338090|FG001|NOT COMPLETED|Overall Study||5
11150564|NCT01521871|12338098|FG000|STARTED|Overall Study||32
11150565|NCT01521871|12338099|FG001|STARTED|Overall Study||32
11150566|NCT01521871|12338098|FG000|COMPLETED|Overall Study||32
11150567|NCT01521871|12338099|FG001|COMPLETED|Overall Study||32
11150568|NCT01521871|12338098|FG000|NOT COMPLETED|Overall Study||0
11150569|NCT01521871|12338099|FG001|NOT COMPLETED|Overall Study||0
11150570|NCT01521884|12338105|FG000|STARTED|Overall Study||62
11150571|NCT01521884|12338105|FG000|COMPLETED|Overall Study||35
11150572|NCT01521884|12338105|FG000|NOT COMPLETED|Overall Study||27
11150573|NCT01521897|12338109|FG000|STARTED|Overall Study||1143
11150574|NCT01521897|12338109|FG000|COMPLETED|Overall Study||1120
11150575|NCT01521897|12338109|FG000|NOT COMPLETED|Overall Study||23
11150576|NCT01521923|12338117|FG000|STARTED|Overall Study||66
11150577|NCT01521923|12338118|FG001|STARTED|Overall Study||81
11150578|NCT01521923|12338119|FG002|STARTED|Overall Study||127
11150579|NCT01521923|12338120|FG003|STARTED|Overall Study||83
11150580|NCT01521923|12338117|FG000|COMPLETED|Overall Study||59
11150581|NCT01521923|12338118|FG001|COMPLETED|Overall Study||72
11150582|NCT01521923|12338119|FG002|COMPLETED|Overall Study||112
11150583|NCT01521923|12338120|FG003|COMPLETED|Overall Study||70
11150584|NCT01521923|12338117|FG000|NOT COMPLETED|Overall Study||7
11150585|NCT01521923|12338118|FG001|NOT COMPLETED|Overall Study||9
11150586|NCT01521923|12338119|FG002|NOT COMPLETED|Overall Study||15
11150587|NCT01521923|12338120|FG003|NOT COMPLETED|Overall Study||13
11150588|NCT01521949|12338133|FG000|STARTED|Overall Study||21
11150589|NCT01521949|12338133|FG000|COMPLETED|Overall Study||21
11150590|NCT01521949|12338133|FG000|NOT COMPLETED|Overall Study||0
11150591|NCT01522131|12338139|FG000|STARTED|Overall Study||16
11150592|NCT01522131|12338140|FG001|STARTED|Overall Study||17
11150593|NCT01522131|12338139|FG000|COMPLETED|Overall Study||14
11150594|NCT01522131|12338140|FG001|COMPLETED|Overall Study||17
11150595|NCT01522131|12338139|FG000|NOT COMPLETED|Overall Study||2
11150596|NCT01522131|12338140|FG001|NOT COMPLETED|Overall Study||0
11150597|NCT01522235|12338148|FG000|STARTED|Overall Study||3
11150598|NCT01522235|12338149|FG001|STARTED|Overall Study||3
11150599|NCT01522235|12338148|FG000|Randomized|Overall Study||2
11150600|NCT01522235|12338149|FG001|Randomized|Overall Study||3
11150601|NCT01522235|12338148|FG000|COMPLETED|Overall Study||2
11150602|NCT01522235|12338149|FG001|COMPLETED|Overall Study||2
11150603|NCT01522235|12338148|FG000|NOT COMPLETED|Overall Study||1
11150604|NCT01522235|12338149|FG001|NOT COMPLETED|Overall Study||1
11150605|NCT01522248|12338161|FG000|STARTED|Overall Study||10
11150606|NCT01522248|12338162|FG001|STARTED|Overall Study||10
11150607|NCT01522248|12338161|FG000|COMPLETED|Overall Study||9
11150608|NCT01522248|12338162|FG001|COMPLETED|Overall Study||10
11150609|NCT01522248|12338161|FG000|NOT COMPLETED|Overall Study||1
11150610|NCT01522248|12338162|FG001|NOT COMPLETED|Overall Study||0
11150611|NCT01522339|12338173|FG000|STARTED|Overall Study||15
11150612|NCT01522339|12338173|FG000|COMPLETED|Overall Study||15
11150613|NCT01522339|12338173|FG000|NOT COMPLETED|Overall Study||0
11150614|NCT01522391|12338180|FG000|STARTED|Overall Study||20
11150615|NCT01522391|12338181|FG001|STARTED|Overall Study||21
11150616|NCT01522391|12338180|FG000|COMPLETED|Overall Study||19
11150617|NCT01522391|12338181|FG001|COMPLETED|Overall Study||20
11150618|NCT01522391|12338180|FG000|NOT COMPLETED|Overall Study||1
11150619|NCT01522391|12338181|FG001|NOT COMPLETED|Overall Study||1
11150620|NCT01522404|12338189|FG000|STARTED|First Intervention (up to Week 29)||20
11150621|NCT01522404|12338190|FG001|STARTED|First Intervention (up to Week 29)||19
11150622|NCT01522404|12338189|FG000|COMPLETED|First Intervention (up to Week 29)||18
11150623|NCT01522404|12338190|FG001|COMPLETED|First Intervention (up to Week 29)||19
11150624|NCT01522404|12338189|FG000|NOT COMPLETED|First Intervention (up to Week 29)||2
11150625|NCT01522404|12338190|FG001|NOT COMPLETED|First Intervention (up to Week 29)||0
11150626|NCT01522404|12338189|FG000|STARTED|Second Intervention (up to Week 58)||18
11150627|NCT01522404|12338190|FG001|STARTED|Second Intervention (up to Week 58)||19
11150628|NCT01522404|12338189|FG000|COMPLETED|Second Intervention (up to Week 58)||17
11150629|NCT01522404|12338190|FG001|COMPLETED|Second Intervention (up to Week 58)||19
11150630|NCT01522404|12338189|FG000|NOT COMPLETED|Second Intervention (up to Week 58)||1
11150631|NCT01522404|12338190|FG001|NOT COMPLETED|Second Intervention (up to Week 58)||0
11150632|NCT01522417|12338207|FG000|STARTED|Overall Study||209
11150633|NCT01522417|12338208|FG001|STARTED|Overall Study||202
11150634|NCT01522417|12338209|FG002|STARTED|Overall Study|Randomization into the long tirofiban arm was initiated on 14 June 2013.|124
11150635|NCT01522417|12338207|FG000|COMPLETED|Overall Study||209
11150636|NCT01522417|12338208|FG001|COMPLETED|Overall Study||202
11150637|NCT01522417|12338209|FG002|COMPLETED|Overall Study|Randomization into the long tirofiban arm was completed on 1 February 2018.|124
11150638|NCT01522417|12338207|FG000|NOT COMPLETED|Overall Study||0
11150639|NCT01522417|12338208|FG001|NOT COMPLETED|Overall Study||0
11150640|NCT01522417|12338209|FG002|NOT COMPLETED|Overall Study||0
11150641|NCT01522443|12338219|FG000|STARTED|Overall Study||61
11150642|NCT01522443|12338220|FG001|STARTED|Overall Study||58
11150643|NCT01522443|12338219|FG000|COMPLETED|Overall Study||8
11150644|NCT01522443|12338220|FG001|COMPLETED|Overall Study||3
11150645|NCT01522443|12338219|FG000|NOT COMPLETED|Overall Study||53
11150646|NCT01522443|12338220|FG001|NOT COMPLETED|Overall Study||55
11150647|NCT01522651|12338231|FG000|STARTED|Overall Study||26
11150648|NCT01522651|12338232|FG001|STARTED|Overall Study||27
11150649|NCT01522651|12338233|FG002|STARTED|Overall Study||26
11150650|NCT01522651|12338234|FG003|STARTED|Overall Study||28
11150651|NCT01522651|12338235|FG004|STARTED|Overall Study||27
11150652|NCT01522651|12338231|FG000|COMPLETED|Overall Study||17
11150653|NCT01522651|12338232|FG001|COMPLETED|Overall Study||19
11150654|NCT01522651|12338233|FG002|COMPLETED|Overall Study||22
11150655|NCT01522651|12338234|FG003|COMPLETED|Overall Study||20
11150656|NCT01522651|12338235|FG004|COMPLETED|Overall Study||21
11150657|NCT01522651|12338231|FG000|NOT COMPLETED|Overall Study||9
11418614|NCT00484718|12616945|FG002|STARTED|Treatment Period 3 (2 Weeks)||1
11418615|NCT00484718|12616946|FG003|STARTED|Treatment Period 3 (2 Weeks)||1
11418616|NCT00484718|12616947|FG004|STARTED|Treatment Period 3 (2 Weeks)||1
11418617|NCT00484718|12616948|FG005|STARTED|Treatment Period 3 (2 Weeks)||1
11418618|NCT00484718|12616943|FG000|COMPLETED|Treatment Period 3 (2 Weeks)||1
11418619|NCT00484718|12616944|FG001|COMPLETED|Treatment Period 3 (2 Weeks)||1
11418620|NCT00484718|12616945|FG002|COMPLETED|Treatment Period 3 (2 Weeks)||1
11418621|NCT00484718|12616946|FG003|COMPLETED|Treatment Period 3 (2 Weeks)||1
11418622|NCT00484718|12616947|FG004|COMPLETED|Treatment Period 3 (2 Weeks)||1
11418623|NCT00484718|12616948|FG005|COMPLETED|Treatment Period 3 (2 Weeks)||1
11418624|NCT00484718|12616943|FG000|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
11418625|NCT00484718|12616944|FG001|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
11418626|NCT00484718|12616945|FG002|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
11418627|NCT00484718|12616946|FG003|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
11418628|NCT00484718|12616947|FG004|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
11418629|NCT00484718|12616948|FG005|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
11418630|NCT00477230|12616958|FG000|STARTED|Overall Study||32
11418631|NCT00477230|12616959|FG001|STARTED|Overall Study||32
11418632|NCT00477230|12616958|FG000|COMPLETED|Overall Study||12
11418633|NCT00477230|12616959|FG001|COMPLETED|Overall Study||1
11150658|NCT01522651|12338232|FG001|NOT COMPLETED|Overall Study||8
11150659|NCT01522651|12338233|FG002|NOT COMPLETED|Overall Study||4
11150660|NCT01522651|12338234|FG003|NOT COMPLETED|Overall Study||8
11150661|NCT01522651|12338235|FG004|NOT COMPLETED|Overall Study||6
11150662|NCT01522703|12338249|FG000|STARTED|Overall Study||25
11150663|NCT01522703|12338250|FG001|STARTED|Overall Study||26
11150664|NCT01522703|12338249|FG000|COMPLETED|Overall Study||20
11150665|NCT01522703|12338250|FG001|COMPLETED|Overall Study||20
11150666|NCT01522703|12338249|FG000|NOT COMPLETED|Overall Study||5
11150667|NCT01522703|12338250|FG001|NOT COMPLETED|Overall Study||6
11150668|NCT01522755|12338256|FG000|STARTED|Overall Study||409
11150669|NCT01522755|12338256|FG000|COMPLETED|Overall Study||409
11150670|NCT01522755|12338256|FG000|NOT COMPLETED|Overall Study||0
11150671|NCT01522924|12338263|FG000|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
11150672|NCT01522924|12338264|FG001|STARTED|Overall Study|There were 52 dental students in the control group.|52
11150673|NCT01522924|12338263|FG000|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
11150674|NCT01522924|12338264|FG001|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
11150675|NCT01522924|12338263|FG000|NOT COMPLETED|Overall Study||0
11150676|NCT01522924|12338264|FG001|NOT COMPLETED|Overall Study||0
11150677|NCT01522937|12338270|FG000|STARTED|Overall Study||146
11150678|NCT01522937|12338270|FG000|COMPLETED|Overall Study||146
11150679|NCT01522937|12338270|FG000|NOT COMPLETED|Overall Study||0
11150680|NCT01522950|12338277|FG000|STARTED|Overall Study||26
11150681|NCT01522950|12338278|FG001|STARTED|Overall Study||23
11150682|NCT01522950|12338279|FG002|STARTED|Overall Study||27
11150683|NCT01522950|12338277|FG000|COMPLETED|Overall Study||20
11150684|NCT01522950|12338278|FG001|COMPLETED|Overall Study||18
11150685|NCT01522950|12338279|FG002|COMPLETED|Overall Study||22
11150686|NCT01522950|12338277|FG000|NOT COMPLETED|Overall Study||6
11150687|NCT01522950|12338278|FG001|NOT COMPLETED|Overall Study||5
11150688|NCT01522950|12338279|FG002|NOT COMPLETED|Overall Study||5
11150689|NCT01522963|12338291|FG000|STARTED|Overall Study||24
11150690|NCT01522963|12338292|FG001|STARTED|Overall Study||25
11150691|NCT01522963|12338293|FG002|STARTED|Overall Study||25
11150692|NCT01522963|12338294|FG003|STARTED|Overall Study||24
11150693|NCT01522963|12338291|FG000|COMPLETED|Overall Study||22
11150694|NCT01522963|12338292|FG001|COMPLETED|Overall Study||22
11150695|NCT01522963|12338293|FG002|COMPLETED|Overall Study||22
11418634|NCT00477230|12616958|FG000|NOT COMPLETED|Overall Study||20
11418635|NCT00477230|12616959|FG001|NOT COMPLETED|Overall Study||31
11418636|NCT00470067|12616965|FG000|STARTED|Overall Study||9
11418637|NCT00470067|12616965|FG000|COMPLETED|Overall Study||2
11150696|NCT01522963|12338294|FG003|COMPLETED|Overall Study||18
11150697|NCT01522963|12338291|FG000|NOT COMPLETED|Overall Study||2
11150698|NCT01522963|12338292|FG001|NOT COMPLETED|Overall Study||3
11150699|NCT01522963|12338293|FG002|NOT COMPLETED|Overall Study||3
11150700|NCT01522963|12338294|FG003|NOT COMPLETED|Overall Study||6
11150701|NCT01523275|12338304|FG000|STARTED|Overall Study||6
11150702|NCT01523275|12338305|FG001|STARTED|Overall Study||9
11150703|NCT01523275|12338304|FG000|COMPLETED|Overall Study||4
11150704|NCT01523275|12338305|FG001|COMPLETED|Overall Study||7
11150705|NCT01523275|12338304|FG000|NOT COMPLETED|Overall Study||2
11150706|NCT01523275|12338305|FG001|NOT COMPLETED|Overall Study||2
11150707|NCT01523301|12338313|FG000|STARTED|Overall Study||184
11150708|NCT01523301|12338314|FG001|STARTED|Overall Study||196
11150709|NCT01523301|12338313|FG000|COMPLETED|Overall Study||149
11150710|NCT01523301|12338314|FG001|COMPLETED|Overall Study||164
11150711|NCT01523301|12338313|FG000|NOT COMPLETED|Overall Study||35
11150712|NCT01523301|12338314|FG001|NOT COMPLETED|Overall Study||32
11150713|NCT01523366|12338322|FG000|STARTED|Treatment Period 1||20
11150714|NCT01523366|12338323|FG001|STARTED|Treatment Period 1||20
11150715|NCT01523366|12338322|FG000|COMPLETED|Treatment Period 1||19
11150716|NCT01523366|12338323|FG001|COMPLETED|Treatment Period 1||20
11150717|NCT01523366|12338322|FG000|NOT COMPLETED|Treatment Period 1||1
11418638|NCT00470067|12616965|FG000|NOT COMPLETED|Overall Study||7
11418639|NCT00476827|12616975|FG000|STARTED|Overall Study||3
11418640|NCT00476827|12616976|FG001|STARTED|Overall Study||0
11418641|NCT00476827|12616977|FG002|STARTED|Overall Study||1
11150718|NCT01523366|12338323|FG001|NOT COMPLETED|Treatment Period 1||0
11150719|NCT01523366|12338322|FG000|STARTED|Washout Period - 10-14 Days||19
11150720|NCT01523366|12338323|FG001|STARTED|Washout Period - 10-14 Days||20
11150721|NCT01523366|12338322|FG000|COMPLETED|Washout Period - 10-14 Days||19
11150722|NCT01523366|12338323|FG001|COMPLETED|Washout Period - 10-14 Days||20
11150723|NCT01523366|12338322|FG000|NOT COMPLETED|Washout Period - 10-14 Days||0
11150724|NCT01523366|12338323|FG001|NOT COMPLETED|Washout Period - 10-14 Days||0
11418642|NCT00476827|12616978|FG003|STARTED|Overall Study||0
11418643|NCT00476827|12616979|FG004|STARTED|Overall Study||2
11150725|NCT01523366|12338322|FG000|STARTED|Treatment Period 2||19
11150726|NCT01523366|12338323|FG001|STARTED|Treatment Period 2||20
11150727|NCT01523366|12338322|FG000|COMPLETED|Treatment Period 2||18
11150728|NCT01523366|12338323|FG001|COMPLETED|Treatment Period 2||20
11150729|NCT01523366|12338322|FG000|NOT COMPLETED|Treatment Period 2||1
11150730|NCT01523366|12338323|FG001|NOT COMPLETED|Treatment Period 2||0
11150731|NCT01523392|12338333|FG000|STARTED|Treatment Period 1||20
11150732|NCT01523392|12338334|FG001|STARTED|Treatment Period 1||14
11150733|NCT01523392|12338333|FG000|COMPLETED|Treatment Period 1||17
11150734|NCT01523392|12338334|FG001|COMPLETED|Treatment Period 1||14
11150735|NCT01523392|12338333|FG000|NOT COMPLETED|Treatment Period 1||3
11150736|NCT01523392|12338334|FG001|NOT COMPLETED|Treatment Period 1||0
11150737|NCT01523392|12338333|FG000|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
11150738|NCT01523392|12338334|FG001|STARTED|Washout Period - 10 to 14 Days||14
11150739|NCT01523392|12338333|FG000|COMPLETED|Washout Period - 10 to 14 Days||17
11150740|NCT01523392|12338334|FG001|COMPLETED|Washout Period - 10 to 14 Days||14
11150741|NCT01523392|12338333|FG000|NOT COMPLETED|Washout Period - 10 to 14 Days||1
11150742|NCT01523392|12338334|FG001|NOT COMPLETED|Washout Period - 10 to 14 Days||0
11150743|NCT01523392|12338333|FG000|STARTED|Treatment Period 2||17
11150744|NCT01523392|12338334|FG001|STARTED|Treatment Period 2||14
11150745|NCT01523392|12338333|FG000|COMPLETED|Treatment Period 2||17
11150746|NCT01523392|12338334|FG001|COMPLETED|Treatment Period 2||14
11150747|NCT01523392|12338333|FG000|NOT COMPLETED|Treatment Period 2||0
11150748|NCT01523392|12338334|FG001|NOT COMPLETED|Treatment Period 2||0
11150749|NCT01523457|12338344|FG000|STARTED|Overall Study||44
11150750|NCT01523457|12338345|FG001|STARTED|Overall Study||31
11150751|NCT01523457|12338344|FG000|COMPLETED|Overall Study||37
11150752|NCT01523457|12338345|FG001|COMPLETED|Overall Study||29
11150753|NCT01523457|12338344|FG000|NOT COMPLETED|Overall Study||7
11150754|NCT01523457|12338345|FG001|NOT COMPLETED|Overall Study||2
11150755|NCT01523496|12338355|FG000|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
11150756|NCT01523496|12338356|FG001|STARTED|Overall Study||36
11150757|NCT01523496|12338357|FG002|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
11150758|NCT01523496|12338358|FG003|STARTED|Overall Study||30
11150759|NCT01523496|12338355|FG000|COMPLETED|Overall Study||56
11150760|NCT01523496|12338356|FG001|COMPLETED|Overall Study||32
11150761|NCT01523496|12338357|FG002|COMPLETED|Overall Study||46
11150762|NCT01523496|12338358|FG003|COMPLETED|Overall Study||27
11150763|NCT01523496|12338355|FG000|NOT COMPLETED|Overall Study||10
11150764|NCT01523496|12338356|FG001|NOT COMPLETED|Overall Study||4
11150765|NCT01523496|12338357|FG002|NOT COMPLETED|Overall Study||12
11150766|NCT01523496|12338358|FG003|NOT COMPLETED|Overall Study||3
11150767|NCT01523587|12338374|FG000|STARTED|Overall Study||398
11150768|NCT01523587|12338375|FG001|STARTED|Overall Study||397
11150769|NCT01523587|12338374|FG000|Treated|Overall Study||392
11150770|NCT01523587|12338375|FG001|Treated|Overall Study||395
11150771|NCT01523587|12338374|FG000|COMPLETED|Overall Study||0
11150772|NCT01523587|12338375|FG001|COMPLETED|Overall Study||0
11150773|NCT01523587|12338374|FG000|NOT COMPLETED|Overall Study||398
11150774|NCT01523587|12338375|FG001|NOT COMPLETED|Overall Study||397
11150775|NCT01523613|12338384|FG000|STARTED|Overall Study|- 30 single restorations (30 R)|30
11150776|NCT01523613|12338385|FG001|STARTED|Overall Study|- 30 single restorations (30 F)|30
11150777|NCT01523613|12338386|FG002|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
11150778|NCT01523613|12338384|FG000|COMPLETED|Overall Study|- 23 single restorations (23R)|23
11150779|NCT01523613|12338385|FG001|COMPLETED|Overall Study|- 25 single restorations (25F)|25
11150780|NCT01523613|12338386|FG002|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
11150781|NCT01523613|12338384|FG000|NOT COMPLETED|Overall Study||7
11150782|NCT01523613|12338385|FG001|NOT COMPLETED|Overall Study||5
11150783|NCT01523613|12338386|FG002|NOT COMPLETED|Overall Study||12
11150784|NCT01523704|12338396|FG000|STARTED|Overall Study|January 2012|636
11026644|NCT00829439|12205242|FG000|STARTED|Overall Study||3
11026645|NCT00829439|12205243|FG001|STARTED|Overall Study||3
11026646|NCT00829439|12205244|FG002|STARTED|Overall Study||6
11026647|NCT00829439|12205245|FG003|STARTED|Overall Study||4
11026648|NCT00829439|12205242|FG000|COMPLETED|Overall Study||3
11026649|NCT00829439|12205243|FG001|COMPLETED|Overall Study||3
11150785|NCT01523704|12338397|FG001|STARTED|Overall Study|January 2012|638
11150786|NCT01523704|12338396|FG000|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|558
11150787|NCT01523704|12338397|FG001|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|550
11150788|NCT01523704|12338396|FG000|NOT COMPLETED|Overall Study||78
11150789|NCT01523704|12338397|FG001|NOT COMPLETED|Overall Study||88
11150790|NCT01523743|12338404|FG000|STARTED|Period 1||63
11150791|NCT01523743|12338405|FG001|STARTED|Period 1||62
11150792|NCT01523743|12338404|FG000|COMPLETED|Period 1||53
11150793|NCT01523743|12338405|FG001|COMPLETED|Period 1||60
11150794|NCT01523743|12338404|FG000|NOT COMPLETED|Period 1||10
11150795|NCT01523743|12338405|FG001|NOT COMPLETED|Period 1||2
11150796|NCT01523743|12338404|FG000|STARTED|Period 2||53
11150797|NCT01523743|12338405|FG001|STARTED|Period 2||60
11150798|NCT01523743|12338404|FG000|COMPLETED|Period 2||52
11150799|NCT01523743|12338405|FG001|COMPLETED|Period 2||58
11150800|NCT01523743|12338404|FG000|NOT COMPLETED|Period 2||1
11150801|NCT01523743|12338405|FG001|NOT COMPLETED|Period 2||2
11150802|NCT01523756|12338411|FG000|STARTED|Baseline Period||11
11150803|NCT01523756|12338412|FG001|STARTED|Baseline Period||9
11150804|NCT01523756|12338411|FG000|COMPLETED|Baseline Period||11
11150805|NCT01523756|12338412|FG001|COMPLETED|Baseline Period||8
11150806|NCT01523756|12338411|FG000|NOT COMPLETED|Baseline Period||0
11150807|NCT01523756|12338412|FG001|NOT COMPLETED|Baseline Period||1
11150808|NCT01523756|12338411|FG000|STARTED|Test Period 1||11
11150809|NCT01523756|12338412|FG001|STARTED|Test Period 1||8
11150810|NCT01523756|12338411|FG000|COMPLETED|Test Period 1||10
11150811|NCT01523756|12338412|FG001|COMPLETED|Test Period 1||8
11150812|NCT01523756|12338411|FG000|NOT COMPLETED|Test Period 1||1
11150813|NCT01523756|12338412|FG001|NOT COMPLETED|Test Period 1||0
11150814|NCT01523756|12338411|FG000|STARTED|Test Period 2||10
11150815|NCT01523756|12338412|FG001|STARTED|Test Period 2||8
11150816|NCT01523756|12338411|FG000|COMPLETED|Test Period 2||10
11150817|NCT01523756|12338412|FG001|COMPLETED|Test Period 2||7
11150818|NCT01523756|12338411|FG000|NOT COMPLETED|Test Period 2||0
11150819|NCT01523756|12338412|FG001|NOT COMPLETED|Test Period 2||1
11150820|NCT01523782|12338423|FG000|STARTED|Overall Study||3
11150821|NCT01523782|12338424|FG001|STARTED|Overall Study||13
11150822|NCT01523782|12338425|FG002|STARTED|Overall Study||14
11150823|NCT01523782|12338423|FG000|COMPLETED|Overall Study||2
11150824|NCT01523782|12338424|FG001|COMPLETED|Overall Study||13
11150825|NCT01523782|12338425|FG002|COMPLETED|Overall Study||9
11150826|NCT01523782|12338423|FG000|NOT COMPLETED|Overall Study||1
11322840|NCT04109599|12520124|FG000|STARTED|Overall Study||3
11322841|NCT04109599|12520125|FG001|STARTED|Overall Study||4
11322842|NCT04109599|12520126|FG002|STARTED|Overall Study||4
11322843|NCT04109599|12520127|FG003|STARTED|Overall Study||4
11322844|NCT04109599|12520128|FG004|STARTED|Overall Study||4
11322845|NCT04109599|12520129|FG005|STARTED|Overall Study||4
11322846|NCT04109599|12520130|FG006|STARTED|Overall Study||4
11322847|NCT04109599|12520131|FG007|STARTED|Overall Study||3
11322848|NCT04109599|12520132|FG008|STARTED|Overall Study||3
11322849|NCT04109599|12520124|FG000|COMPLETED|Overall Study||3
11322850|NCT04109599|12520125|FG001|COMPLETED|Overall Study||4
11322851|NCT04109599|12520126|FG002|COMPLETED|Overall Study||4
11322852|NCT04109599|12520127|FG003|COMPLETED|Overall Study||4
11150827|NCT01523782|12338424|FG001|NOT COMPLETED|Overall Study||0
11150828|NCT01523782|12338425|FG002|NOT COMPLETED|Overall Study||5
11150829|NCT01523808|12338437|FG000|STARTED|Overall Study||3
11150830|NCT01523808|12338438|FG001|STARTED|Overall Study||3
11150831|NCT01523808|12338439|FG002|STARTED|Overall Study||3
11150832|NCT01523808|12338440|FG003|STARTED|Overall Study||3
11150833|NCT01523808|12338437|FG000|COMPLETED|Overall Study||0
11150834|NCT01523808|12338438|FG001|COMPLETED|Overall Study||3
11150835|NCT01523808|12338439|FG002|COMPLETED|Overall Study||1
11150836|NCT01523808|12338440|FG003|COMPLETED|Overall Study||0
11150837|NCT01523808|12338437|FG000|NOT COMPLETED|Overall Study||3
11150838|NCT01523808|12338438|FG001|NOT COMPLETED|Overall Study||0
11150839|NCT01523808|12338439|FG002|NOT COMPLETED|Overall Study||2
11150840|NCT01523808|12338440|FG003|NOT COMPLETED|Overall Study||3
11150841|NCT01523821|12338462|FG000|STARTED|Overall Study||8
11150842|NCT01523821|12338463|FG001|STARTED|Overall Study||6
11150843|NCT01523821|12338464|FG002|STARTED|Overall Study||6
11150844|NCT01523821|12338462|FG000|COMPLETED|Overall Study||8
11150845|NCT01523821|12338463|FG001|COMPLETED|Overall Study||6
11150846|NCT01523821|12338464|FG002|COMPLETED|Overall Study||6
11150847|NCT01523821|12338462|FG000|NOT COMPLETED|Overall Study||0
11150848|NCT01523821|12338463|FG001|NOT COMPLETED|Overall Study||0
11150849|NCT01523821|12338464|FG002|NOT COMPLETED|Overall Study||0
11150850|NCT01523834|12338472|FG000|STARTED|Overall Study|Started Induction Phase|35
11150851|NCT01523834|12338472|FG000|Consolidation Phase|Overall Study|Started Consolidation Phase|7
11150852|NCT01523834|12338472|FG000|Maintenance Phase|Overall Study|Started Maintenance Phase|6
11150853|NCT01523834|12338472|FG000|COMPLETED|Overall Study||4
11150854|NCT01523834|12338472|FG000|NOT COMPLETED|Overall Study||31
11150855|NCT01523873|12338477|FG000|STARTED|Overall Study||35921
11150856|NCT01523873|12338477|FG000|Administered With Dotarem|Overall Study||35474
11150857|NCT01523873|12338477|FG000|COMPLETED|Overall Study||35499
11150858|NCT01523873|12338477|FG000|NOT COMPLETED|Overall Study||422
11150859|NCT01523886|12338485|FG000|STARTED|Overall Study||25
11150860|NCT01523886|12338486|FG001|STARTED|Overall Study||24
11150861|NCT01523886|12338485|FG000|COMPLETED|Overall Study||25
11150862|NCT01523886|12338486|FG001|COMPLETED|Overall Study||23
11150863|NCT01523886|12338485|FG000|NOT COMPLETED|Overall Study||0
11150864|NCT01523886|12338486|FG001|NOT COMPLETED|Overall Study||1
11150865|NCT01523899|12338494|FG000|STARTED|Overall Study||126
11150866|NCT01523899|12338495|FG001|STARTED|Overall Study||126
11150867|NCT01523899|12338494|FG000|COMPLETED|Overall Study||126
11150868|NCT01523899|12338495|FG001|COMPLETED|Overall Study||126
11150869|NCT01523899|12338494|FG000|NOT COMPLETED|Overall Study||0
11150870|NCT01523899|12338495|FG001|NOT COMPLETED|Overall Study||0
11150871|NCT01523964|12338506|FG000|STARTED|Overall Study||31
11150872|NCT01523964|12338507|FG001|STARTED|Overall Study||30
11150873|NCT01523964|12338508|FG002|STARTED|Overall Study||16
11150874|NCT01523964|12338509|FG003|STARTED|Overall Study||15
11150875|NCT01523964|12338506|FG000|COMPLETED|Overall Study||31
11150876|NCT01523964|12338507|FG001|COMPLETED|Overall Study||30
11150877|NCT01523964|12338508|FG002|COMPLETED|Overall Study||16
11150878|NCT01523964|12338509|FG003|COMPLETED|Overall Study||15
11150879|NCT01523964|12338506|FG000|NOT COMPLETED|Overall Study||0
11150880|NCT01523964|12338507|FG001|NOT COMPLETED|Overall Study||0
11150881|NCT01523964|12338508|FG002|NOT COMPLETED|Overall Study||0
11150882|NCT01523964|12338509|FG003|NOT COMPLETED|Overall Study||0
11150883|NCT01524133|12338522|FG000|STARTED|Treatment Phase||71
11150884|NCT01524133|12338523|FG001|STARTED|Treatment Phase||69
11150885|NCT01524133|12338524|FG002|STARTED|Treatment Phase||67
11150886|NCT01524133|12338522|FG000|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
11150887|NCT01524133|12338523|FG001|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
11150888|NCT01524133|12338524|FG002|COMPLETED|Treatment Phase|Completed both assigned treatments|31
11150889|NCT01524133|12338522|FG000|NOT COMPLETED|Treatment Phase||19
11150890|NCT01524133|12338523|FG001|NOT COMPLETED|Treatment Phase||32
11150891|NCT01524133|12338524|FG002|NOT COMPLETED|Treatment Phase||36
11150892|NCT01524133|12338522|FG000|STARTED|Overall Study 52 Weeks||71
11150893|NCT01524133|12338523|FG001|STARTED|Overall Study 52 Weeks||69
11150894|NCT01524133|12338524|FG002|STARTED|Overall Study 52 Weeks||67
11150895|NCT01524133|12338522|FG000|COMPLETED|Overall Study 52 Weeks||50
11150896|NCT01524133|12338523|FG001|COMPLETED|Overall Study 52 Weeks||49
11150897|NCT01524133|12338524|FG002|COMPLETED|Overall Study 52 Weeks||40
11150898|NCT01524133|12338522|FG000|NOT COMPLETED|Overall Study 52 Weeks||21
11150899|NCT01524133|12338523|FG001|NOT COMPLETED|Overall Study 52 Weeks||20
11150900|NCT01524133|12338524|FG002|NOT COMPLETED|Overall Study 52 Weeks||27
11150901|NCT01524198|12338534|FG000|STARTED|Overall Study||471
11150902|NCT01524198|12338535|FG001|STARTED|Overall Study||474
11150903|NCT01524198|12338534|FG000|COMPLETED|Overall Study||448
11150904|NCT01524198|12338535|FG001|COMPLETED|Overall Study||458
11150905|NCT01524198|12338534|FG000|NOT COMPLETED|Overall Study||23
11150906|NCT01524198|12338535|FG001|NOT COMPLETED|Overall Study||16
11150907|NCT01524224|12338549|FG000|STARTED|Overall Study||4
11150908|NCT01524224|12338550|FG001|STARTED|Overall Study||3
11150909|NCT01524224|12338551|FG002|STARTED|Overall Study||3
11150910|NCT01524224|12338552|FG003|STARTED|Overall Study||3
11150911|NCT01524224|12338553|FG004|STARTED|Overall Study||4
11150912|NCT01524224|12338554|FG005|STARTED|Overall Study||3
11150913|NCT01524224|12338555|FG006|STARTED|Overall Study||3
11150914|NCT01524224|12338556|FG007|STARTED|Overall Study||6
11150915|NCT01524224|12338549|FG000|Received at Least One Dose of Study Drug|Overall Study||4
11150916|NCT01524224|12338550|FG001|Received at Least One Dose of Study Drug|Overall Study||3
11150917|NCT01524224|12338551|FG002|Received at Least One Dose of Study Drug|Overall Study||3
11150918|NCT01524224|12338552|FG003|Received at Least One Dose of Study Drug|Overall Study||3
11150919|NCT01524224|12338553|FG004|Received at Least One Dose of Study Drug|Overall Study||4
11150920|NCT01524224|12338554|FG005|Received at Least One Dose of Study Drug|Overall Study||3
11150921|NCT01524224|12338555|FG006|Received at Least One Dose of Study Drug|Overall Study||3
11150922|NCT01524224|12338556|FG007|Received at Least One Dose of Study Drug|Overall Study||6
11150923|NCT01524224|12338549|FG000|COMPLETED|Overall Study||1
11150924|NCT01524224|12338550|FG001|COMPLETED|Overall Study||2
11150925|NCT01524224|12338551|FG002|COMPLETED|Overall Study||1
11150926|NCT01524224|12338552|FG003|COMPLETED|Overall Study||1
11150927|NCT01524224|12338553|FG004|COMPLETED|Overall Study||0
11150928|NCT01524224|12338554|FG005|COMPLETED|Overall Study||1
11150929|NCT01524224|12338555|FG006|COMPLETED|Overall Study||0
11150930|NCT01524224|12338556|FG007|COMPLETED|Overall Study||0
11150931|NCT01524224|12338549|FG000|NOT COMPLETED|Overall Study||3
11150932|NCT01524224|12338550|FG001|NOT COMPLETED|Overall Study||1
11150933|NCT01524224|12338551|FG002|NOT COMPLETED|Overall Study||2
11150934|NCT01524224|12338552|FG003|NOT COMPLETED|Overall Study||2
11150935|NCT01524224|12338553|FG004|NOT COMPLETED|Overall Study||4
11150936|NCT01524224|12338554|FG005|NOT COMPLETED|Overall Study||2
11150937|NCT01524224|12338555|FG006|NOT COMPLETED|Overall Study||3
11150938|NCT01524224|12338556|FG007|NOT COMPLETED|Overall Study||6
11150939|NCT01524289|12338576|FG000|STARTED|Overall Study||204
11150940|NCT01524289|12338577|FG001|STARTED|Overall Study||102
11150941|NCT01524289|12338576|FG000|Treated|Overall Study||203
11150942|NCT01524289|12338577|FG001|Treated|Overall Study||102
11150943|NCT01524289|12338576|FG000|COMPLETED|Overall Study||174
11150944|NCT01524289|12338577|FG001|COMPLETED|Overall Study||88
11150945|NCT01524289|12338576|FG000|NOT COMPLETED|Overall Study||30
11150946|NCT01524289|12338577|FG001|NOT COMPLETED|Overall Study||14
11150947|NCT01524302|12338587|FG000|STARTED|Overall Study||6
11150948|NCT01524302|12338588|FG001|STARTED|Overall Study||6
11150949|NCT01524302|12338587|FG000|COMPLETED|Overall Study||6
11150950|NCT01524302|12338588|FG001|COMPLETED|Overall Study||6
11150951|NCT01524302|12338587|FG000|NOT COMPLETED|Overall Study||0
11150952|NCT01524302|12338588|FG001|NOT COMPLETED|Overall Study||0
11150953|NCT01524627|12338600|FG000|STARTED|Overall Study||22
11150954|NCT01524627|12338601|FG001|STARTED|Overall Study||21
11150955|NCT01524627|12338600|FG000|COMPLETED|Overall Study||21
11150956|NCT01524627|12338601|FG001|COMPLETED|Overall Study||19
11150957|NCT01524627|12338600|FG000|NOT COMPLETED|Overall Study||1
11150958|NCT01524627|12338601|FG001|NOT COMPLETED|Overall Study||2
11150959|NCT01524679|12338609|FG000|STARTED|Overall Study||112
11150960|NCT01524679|12338610|FG001|STARTED|Overall Study||58
11150961|NCT01524679|12338609|FG000|COMPLETED|Overall Study||89
11150962|NCT01524679|12338610|FG001|COMPLETED|Overall Study||49
11150963|NCT01524679|12338609|FG000|NOT COMPLETED|Overall Study||23
11150964|NCT01524679|12338610|FG001|NOT COMPLETED|Overall Study||9
11150965|NCT01524692|12338616|FG000|STARTED|Overall Study||35
11150966|NCT01524692|12338616|FG000|COMPLETED|Overall Study||32
11150967|NCT01524692|12338616|FG000|NOT COMPLETED|Overall Study||3
11150968|NCT01524770|12338621|FG000|STARTED|First Intervention||26
11150969|NCT01524770|12338622|FG001|STARTED|First Intervention||24
11150970|NCT01524770|12338621|FG000|Received at Least 1 Dose of Study Drug|First Intervention||26
11150971|NCT01524770|12338622|FG001|Received at Least 1 Dose of Study Drug|First Intervention||24
11150972|NCT01524770|12338621|FG000|COMPLETED|First Intervention||23
11150973|NCT01524770|12338622|FG001|COMPLETED|First Intervention||23
11150974|NCT01524770|12338621|FG000|NOT COMPLETED|First Intervention||3
11150975|NCT01524770|12338622|FG001|NOT COMPLETED|First Intervention||1
11150976|NCT01524770|12338621|FG000|STARTED|Washout Period of at Least 28 Days||23
11150977|NCT01524770|12338622|FG001|STARTED|Washout Period of at Least 28 Days||23
11418644|NCT00476827|12616980|FG005|STARTED|Overall Study||2
11150978|NCT01524770|12338621|FG000|COMPLETED|Washout Period of at Least 28 Days||23
11150979|NCT01524770|12338622|FG001|COMPLETED|Washout Period of at Least 28 Days||23
11150980|NCT01524770|12338621|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0
11150981|NCT01524770|12338622|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0
11150982|NCT01524770|12338621|FG000|STARTED|Second Intervention||23
11150983|NCT01524770|12338622|FG001|STARTED|Second Intervention||23
11150984|NCT01524770|12338621|FG000|COMPLETED|Second Intervention||23
11150985|NCT01524770|12338622|FG001|COMPLETED|Second Intervention||23
11150986|NCT01524770|12338621|FG000|NOT COMPLETED|Second Intervention||0
11150987|NCT01524770|12338622|FG001|NOT COMPLETED|Second Intervention||0
11150988|NCT01524783|12338630|FG000|STARTED|Blinded Period||205
11150989|NCT01524783|12338631|FG001|STARTED|Blinded Period||97
11150990|NCT01524783|12338632|FG002|STARTED|Blinded Period||0
11150991|NCT01524783|12338630|FG000|COMPLETED|Blinded Period||26
11150992|NCT01524783|12338631|FG001|COMPLETED|Blinded Period||6
11150993|NCT01524783|12338632|FG002|COMPLETED|Blinded Period||0
11150994|NCT01524783|12338630|FG000|NOT COMPLETED|Blinded Period||179
11418645|NCT00476827|12616975|FG000|COMPLETED|Overall Study||3
11150995|NCT01524783|12338631|FG001|NOT COMPLETED|Blinded Period||91
11150996|NCT01524783|12338632|FG002|NOT COMPLETED|Blinded Period||0
11150997|NCT01524783|12338630|FG000|STARTED|Open-label Period||26
11150998|NCT01524783|12338631|FG001|STARTED|Open-label Period||0
11150999|NCT01524783|12338632|FG002|STARTED|Open-label Period||6
11151000|NCT01524783|12338630|FG000|COMPLETED|Open-label Period||0
11418646|NCT00476827|12616976|FG001|COMPLETED|Overall Study||0
11151001|NCT01524783|12338631|FG001|COMPLETED|Open-label Period||0
11151002|NCT01524783|12338632|FG002|COMPLETED|Open-label Period||0
11151003|NCT01524783|12338630|FG000|NOT COMPLETED|Open-label Period||26
11151004|NCT01524783|12338631|FG001|NOT COMPLETED|Open-label Period||0
11151005|NCT01524783|12338632|FG002|NOT COMPLETED|Open-label Period||6
11151006|NCT01524796|12338644|FG000|STARTED|Overall Study||128
11151007|NCT01524796|12338644|FG000|COMPLETED|Overall Study||100
11151008|NCT01524796|12338644|FG000|NOT COMPLETED|Overall Study||28
11151009|NCT01524887|12338651|FG000|STARTED|Overall Study||85
11151010|NCT01524887|12338652|FG001|STARTED|Overall Study||90
11151011|NCT01524887|12338653|FG002|STARTED|Overall Study||86
11151012|NCT01524887|12338651|FG000|Received Treatment|Overall Study||83
11151013|NCT01524887|12338652|FG001|Received Treatment|Overall Study||85
11151014|NCT01524887|12338653|FG002|Received Treatment|Overall Study||83
11151015|NCT01524887|12338651|FG000|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
11151016|NCT01524887|12338652|FG001|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
11151017|NCT01524887|12338653|FG002|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
11151018|NCT01524887|12338651|FG000|NOT COMPLETED|Overall Study||85
11151019|NCT01524887|12338652|FG001|NOT COMPLETED|Overall Study||90
11151020|NCT01524887|12338653|FG002|NOT COMPLETED|Overall Study||86
11151021|NCT01524900|12338666|FG000|STARTED|Overall Study||49
11151022|NCT01524900|12338667|FG001|STARTED|Overall Study||246
11151023|NCT01524900|12338668|FG002|STARTED|Overall Study||30
11151024|NCT01524900|12338669|FG003|STARTED|Overall Study||22
11151025|NCT01524900|12338670|FG004|STARTED|Overall Study||40
11151026|NCT01524900|12338666|FG000|COMPLETED|Overall Study||43
11151027|NCT01524900|12338667|FG001|COMPLETED|Overall Study||232
11151028|NCT01524900|12338668|FG002|COMPLETED|Overall Study||29
11151029|NCT01524900|12338669|FG003|COMPLETED|Overall Study||21
11151030|NCT01524900|12338670|FG004|COMPLETED|Overall Study||40
11151031|NCT01524900|12338666|FG000|NOT COMPLETED|Overall Study||6
11151032|NCT01524900|12338667|FG001|NOT COMPLETED|Overall Study||14
11151033|NCT01524900|12338668|FG002|NOT COMPLETED|Overall Study||1
11151034|NCT01524900|12338669|FG003|NOT COMPLETED|Overall Study||1
11151035|NCT01524900|12338670|FG004|NOT COMPLETED|Overall Study||0
11151036|NCT01524913|12338686|FG000|STARTED|Overall Study||35
11151037|NCT01524913|12338687|FG001|STARTED|Overall Study||36
11151038|NCT01524913|12338688|FG002|STARTED|Overall Study||31
11151039|NCT01524913|12338686|FG000|COMPLETED|Overall Study||31
11151040|NCT01524913|12338687|FG001|COMPLETED|Overall Study||36
11151041|NCT01524913|12338688|FG002|COMPLETED|Overall Study||31
11151042|NCT01524913|12338686|FG000|NOT COMPLETED|Overall Study||4
11151043|NCT01524913|12338687|FG001|NOT COMPLETED|Overall Study||0
11151044|NCT01524913|12338688|FG002|NOT COMPLETED|Overall Study||0
11151045|NCT01524978|12338707|FG000|STARTED|Overall Study||62
11151046|NCT01524978|12338708|FG001|STARTED|Overall Study||4
11151047|NCT01524978|12338709|FG002|STARTED|Overall Study||10
11151048|NCT01524978|12338710|FG003|STARTED|Overall Study||27
11151049|NCT01524978|12338711|FG004|STARTED|Overall Study||9
11151050|NCT01524978|12338712|FG005|STARTED|Overall Study||9
11151051|NCT01524978|12338713|FG006|STARTED|Overall Study||26
11151052|NCT01524978|12338714|FG007|STARTED|Overall Study||12
11151053|NCT01524978|12338715|FG008|STARTED|Overall Study||12
11151054|NCT01524978|12338716|FG009|STARTED|Overall Study||9
11151055|NCT01524978|12338717|FG010|STARTED|Overall Study||28
11151056|NCT01524978|12338707|FG000|COMPLETED|Overall Study||0
11151057|NCT01524978|12338708|FG001|COMPLETED|Overall Study||0
11151058|NCT01524978|12338709|FG002|COMPLETED|Overall Study||0
11151059|NCT01524978|12338710|FG003|COMPLETED|Overall Study||0
11151060|NCT01524978|12338711|FG004|COMPLETED|Overall Study||0
11151061|NCT01524978|12338712|FG005|COMPLETED|Overall Study||0
11151062|NCT01524978|12338713|FG006|COMPLETED|Overall Study||0
11151063|NCT01524978|12338714|FG007|COMPLETED|Overall Study||0
11151064|NCT01524978|12338715|FG008|COMPLETED|Overall Study||0
11151065|NCT01524978|12338716|FG009|COMPLETED|Overall Study||0
11151066|NCT01524978|12338717|FG010|COMPLETED|Overall Study||0
11151067|NCT01524978|12338707|FG000|NOT COMPLETED|Overall Study||62
11151068|NCT01524978|12338708|FG001|NOT COMPLETED|Overall Study||4
11151069|NCT01524978|12338709|FG002|NOT COMPLETED|Overall Study||10
11151070|NCT01524978|12338710|FG003|NOT COMPLETED|Overall Study||27
11151071|NCT01524978|12338711|FG004|NOT COMPLETED|Overall Study||9
11151072|NCT01524978|12338712|FG005|NOT COMPLETED|Overall Study||9
11151073|NCT01524978|12338713|FG006|NOT COMPLETED|Overall Study||26
11151074|NCT01524978|12338714|FG007|NOT COMPLETED|Overall Study||12
11151075|NCT01524978|12338715|FG008|NOT COMPLETED|Overall Study||12
11151076|NCT01524978|12338716|FG009|NOT COMPLETED|Overall Study||9
11151077|NCT01524978|12338717|FG010|NOT COMPLETED|Overall Study||28
11151078|NCT01525082|12338732|FG000|STARTED|Overall Study||20
11151079|NCT01525082|12338732|FG000|COMPLETED|Overall Study||19
11151080|NCT01525082|12338732|FG000|NOT COMPLETED|Overall Study||1
11151081|NCT01525173|12338741|FG000|STARTED|Overall Study||70
11151082|NCT01525173|12338742|FG001|STARTED|Overall Study||67
11151083|NCT01525173|12338741|FG000|COMPLETED|Overall Study||63
11151084|NCT01525173|12338742|FG001|COMPLETED|Overall Study||62
11151085|NCT01525173|12338741|FG000|NOT COMPLETED|Overall Study||7
11151086|NCT01525173|12338742|FG001|NOT COMPLETED|Overall Study||5
11151087|NCT01525225|12338748|FG000|STARTED|Enrollment||4
11151088|NCT01525225|12338748|FG000|COMPLETED|Enrollment||2
11151089|NCT01525225|12338748|FG000|NOT COMPLETED|Enrollment||2
11151090|NCT01525225|12338748|FG000|STARTED|Treated||2
11151091|NCT01525225|12338748|FG000|COMPLETED|Treated||2
11151092|NCT01525225|12338748|FG000|NOT COMPLETED|Treated||0
11151093|NCT01525238|12338755|FG000|STARTED|Overall Study||8
11151094|NCT01525238|12338756|FG001|STARTED|Overall Study||8
11151095|NCT01525238|12338757|FG002|STARTED|Overall Study||8
11151096|NCT01525238|12338755|FG000|COMPLETED|Overall Study||7
11151097|NCT01525238|12338756|FG001|COMPLETED|Overall Study||8
11151098|NCT01525238|12338757|FG002|COMPLETED|Overall Study||8
11151099|NCT01525238|12338755|FG000|NOT COMPLETED|Overall Study||1
11151100|NCT01525238|12338756|FG001|NOT COMPLETED|Overall Study||0
11151101|NCT01525238|12338757|FG002|NOT COMPLETED|Overall Study||0
11151102|NCT01525407|12338767|FG000|STARTED|Overall Study||41
11151103|NCT01525407|12338768|FG001|STARTED|Overall Study||42
11151104|NCT01525407|12338767|FG000|COMPLETED|Overall Study||38
11151105|NCT01525407|12338768|FG001|COMPLETED|Overall Study||38
11151106|NCT01525407|12338767|FG000|NOT COMPLETED|Overall Study||3
11151107|NCT01525407|12338768|FG001|NOT COMPLETED|Overall Study||4
11151108|NCT01525420|12338776|FG000|STARTED|Overall Study||59
11151109|NCT01525420|12338777|FG001|STARTED|Overall Study||62
11151110|NCT01525420|12338776|FG000|COMPLETED|Overall Study||43
11151111|NCT01525420|12338777|FG001|COMPLETED|Overall Study||38
11151112|NCT01525420|12338776|FG000|NOT COMPLETED|Overall Study||16
11151113|NCT01525420|12338777|FG001|NOT COMPLETED|Overall Study||24
11151114|NCT01525550|12338785|FG000|STARTED|Overall Study||61
11151115|NCT01525550|12338786|FG001|STARTED|Overall Study||45
11151116|NCT01525550|12338785|FG000|COMPLETED|Overall Study||0
11151117|NCT01525550|12338786|FG001|COMPLETED|Overall Study||0
11151118|NCT01525550|12338785|FG000|NOT COMPLETED|Overall Study||61
11151119|NCT01525550|12338786|FG001|NOT COMPLETED|Overall Study||45
11151120|NCT01525563|12338792|FG000|STARTED|Overall Study||1000
11151121|NCT01525563|12338792|FG000|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
11151122|NCT01525563|12338792|FG000|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
11151123|NCT01525563|12338792|FG000|COMPLETED|Overall Study|6 Months Follow-up|788
11151124|NCT01525563|12338792|FG000|NOT COMPLETED|Overall Study||212
11151125|NCT01525589|12338799|FG000|STARTED|Overall Study||56
11151126|NCT01525589|12338800|FG001|STARTED|Overall Study||20
11151127|NCT01525589|12338801|FG002|STARTED|Overall Study||35
11151128|NCT01525589|12338799|FG000|COMPLETED|Overall Study||0
11151129|NCT01525589|12338800|FG001|COMPLETED|Overall Study||0
11151130|NCT01525589|12338801|FG002|COMPLETED|Overall Study||0
11151131|NCT01525589|12338799|FG000|NOT COMPLETED|Overall Study||56
11151132|NCT01525589|12338800|FG001|NOT COMPLETED|Overall Study||20
11151133|NCT01525589|12338801|FG002|NOT COMPLETED|Overall Study||35
11151134|NCT01525602|12338817|FG000|STARTED|Overall Study||9
11151135|NCT01525602|12338818|FG001|STARTED|Overall Study||3
11151136|NCT01525602|12338819|FG002|STARTED|Overall Study||3
11151137|NCT01525602|12338820|FG003|STARTED|Overall Study||6
11151138|NCT01525602|12338821|FG004|STARTED|Overall Study||33
11151139|NCT01525602|12338822|FG005|STARTED|Overall Study||7
11151140|NCT01525602|12338823|FG006|STARTED|Overall Study||6
11151141|NCT01525602|12338824|FG007|STARTED|Overall Study||7
11151142|NCT01525602|12338817|FG000|COMPLETED|Overall Study||0
11151143|NCT01525602|12338818|FG001|COMPLETED|Overall Study||0
11151144|NCT01525602|12338819|FG002|COMPLETED|Overall Study||0
11151145|NCT01525602|12338820|FG003|COMPLETED|Overall Study||0
11151146|NCT01525602|12338821|FG004|COMPLETED|Overall Study||0
11151147|NCT01525602|12338822|FG005|COMPLETED|Overall Study||0
11151148|NCT01525602|12338823|FG006|COMPLETED|Overall Study||0
11151149|NCT01525602|12338824|FG007|COMPLETED|Overall Study||0
11151150|NCT01525602|12338817|FG000|NOT COMPLETED|Overall Study||9
11151151|NCT01525602|12338818|FG001|NOT COMPLETED|Overall Study||3
11151152|NCT01525602|12338819|FG002|NOT COMPLETED|Overall Study||3
11151153|NCT01525602|12338820|FG003|NOT COMPLETED|Overall Study||6
11151154|NCT01525602|12338821|FG004|NOT COMPLETED|Overall Study||33
11151155|NCT01525602|12338822|FG005|NOT COMPLETED|Overall Study||7
11151156|NCT01525602|12338823|FG006|NOT COMPLETED|Overall Study||6
11151157|NCT01525602|12338824|FG007|NOT COMPLETED|Overall Study||7
11151158|NCT01525615|12338852|FG000|STARTED|Overall Study||132
11151159|NCT01525615|12338853|FG001|STARTED|Overall Study||133
11151160|NCT01525615|12338854|FG002|STARTED|Overall Study||139
11151161|NCT01525615|12338852|FG000|COMPLETED|Overall Study||118
11151162|NCT01525615|12338853|FG001|COMPLETED|Overall Study||126
11151163|NCT01525615|12338854|FG002|COMPLETED|Overall Study||133
11151164|NCT01525615|12338852|FG000|NOT COMPLETED|Overall Study||14
11151165|NCT01525615|12338853|FG001|NOT COMPLETED|Overall Study||7
11151166|NCT01525615|12338854|FG002|NOT COMPLETED|Overall Study||6
11151167|NCT01525628|12338867|FG000|STARTED|Overall Study||16
11151168|NCT01525628|12338868|FG001|STARTED|Overall Study||19
11151169|NCT01525628|12338869|FG002|STARTED|Overall Study||16
11151170|NCT01525628|12338870|FG003|STARTED|Overall Study||14
11151171|NCT01525628|12338871|FG004|STARTED|Overall Study||7
11151172|NCT01525628|12338867|FG000|COMPLETED|Overall Study||14
11151173|NCT01525628|12338868|FG001|COMPLETED|Overall Study||14
11151174|NCT01525628|12338869|FG002|COMPLETED|Overall Study||11
11151175|NCT01525628|12338870|FG003|COMPLETED|Overall Study||10
11151176|NCT01525628|12338871|FG004|COMPLETED|Overall Study||4
11151177|NCT01525628|12338867|FG000|NOT COMPLETED|Overall Study||2
11151178|NCT01525628|12338868|FG001|NOT COMPLETED|Overall Study||5
11151179|NCT01525628|12338869|FG002|NOT COMPLETED|Overall Study||5
11151180|NCT01525628|12338870|FG003|NOT COMPLETED|Overall Study||4
11151181|NCT01525628|12338871|FG004|NOT COMPLETED|Overall Study||3
11151182|NCT01525641|12338885|FG000|STARTED|Overall Study||615
11151183|NCT01525641|12338885|FG000|COMPLETED|Overall Study||435
11151184|NCT01525641|12338885|FG000|NOT COMPLETED|Overall Study||180
11151185|NCT01525667|12338892|FG000|STARTED|Overall Study||7
11151186|NCT01525667|12338893|FG001|STARTED|Overall Study||6
11151187|NCT01525667|12338894|FG002|STARTED|Overall Study||7
11151188|NCT01525667|12338892|FG000|COMPLETED|Overall Study||7
11151189|NCT01525667|12338893|FG001|COMPLETED|Overall Study||6
11151190|NCT01525667|12338894|FG002|COMPLETED|Overall Study||7
11151191|NCT01525667|12338892|FG000|NOT COMPLETED|Overall Study||0
11151192|NCT01525667|12338893|FG001|NOT COMPLETED|Overall Study||0
11151193|NCT01525667|12338894|FG002|NOT COMPLETED|Overall Study||0
11151194|NCT01525849|12338906|FG000|STARTED|Overall Study||76
11151195|NCT01525849|12338907|FG001|STARTED|Overall Study||75
11151196|NCT01525849|12338906|FG000|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
11151197|NCT01525849|12338907|FG001|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
11151198|NCT01525849|12338906|FG000|6-Months|Overall Study||73
11151199|NCT01525849|12338907|FG001|6-Months|Overall Study||60
11151200|NCT01525849|12338906|FG000|COMPLETED|Overall Study||71
11151201|NCT01525849|12338907|FG001|COMPLETED|Overall Study||59
11151202|NCT01525849|12338906|FG000|NOT COMPLETED|Overall Study||5
11151203|NCT01525849|12338907|FG001|NOT COMPLETED|Overall Study||16
11151204|NCT01525862|12338913|FG000|STARTED|Overall Study||21
11151205|NCT01525862|12338913|FG000|COMPLETED|Overall Study||21
11151206|NCT01525862|12338913|FG000|NOT COMPLETED|Overall Study||0
11151207|NCT01525875|12338919|FG000|STARTED|Placebo-controlled Period||22
11151208|NCT01525875|12338920|FG001|STARTED|Placebo-controlled Period||22
11151209|NCT01525875|12338919|FG000|COMPLETED|Placebo-controlled Period||21
11151210|NCT01525875|12338920|FG001|COMPLETED|Placebo-controlled Period||20
11151211|NCT01525875|12338919|FG000|NOT COMPLETED|Placebo-controlled Period||1
11151212|NCT01525875|12338920|FG001|NOT COMPLETED|Placebo-controlled Period||2
11151213|NCT01525875|12338919|FG000|STARTED|Open-label Period||21
11151214|NCT01525875|12338920|FG001|STARTED|Open-label Period||20
11151215|NCT01525875|12338919|FG000|COMPLETED|Open-label Period||21
11151216|NCT01525875|12338920|FG001|COMPLETED|Open-label Period||18
11151217|NCT01525875|12338919|FG000|NOT COMPLETED|Open-label Period||0
11151218|NCT01525875|12338920|FG001|NOT COMPLETED|Open-label Period||2
11151219|NCT01526057|12338929|FG000|STARTED|Overall Study||73
11151220|NCT01526057|12338930|FG001|STARTED|Overall Study||74
11151221|NCT01526057|12338931|FG002|STARTED|Overall Study||73
11151222|NCT01526057|12338929|FG000|COMPLETED|Overall Study||64
11151223|NCT01526057|12338930|FG001|COMPLETED|Overall Study||71
11151224|NCT01526057|12338931|FG002|COMPLETED|Overall Study||67
11151225|NCT01526057|12338929|FG000|NOT COMPLETED|Overall Study||9
11151226|NCT01526057|12338930|FG001|NOT COMPLETED|Overall Study||3
11151227|NCT01526057|12338931|FG002|NOT COMPLETED|Overall Study||6
11203033|NCT01844778|12393548|FG001|NOT COMPLETED|Overall Study||3
11203034|NCT01844778|12393549|FG002|NOT COMPLETED|Overall Study||4
11203035|NCT01844817|12393563|FG000|STARTED|Enrolled and Randomized||66
11203036|NCT01844817|12393564|FG001|STARTED|Enrolled and Randomized||66
11203037|NCT01844817|12393563|FG000|COMPLETED|Enrolled and Randomized||64
11203038|NCT01844817|12393564|FG001|COMPLETED|Enrolled and Randomized||63
11203039|NCT01844817|12393563|FG000|NOT COMPLETED|Enrolled and Randomized||2
11203040|NCT01844817|12393564|FG001|NOT COMPLETED|Enrolled and Randomized||3
11203041|NCT01844817|12393563|FG000|STARTED|Treatment||64
11203042|NCT01844817|12393564|FG001|STARTED|Treatment||63
11203043|NCT01844817|12393563|FG000|COMPLETED|Treatment||0
11203044|NCT01844817|12393564|FG001|COMPLETED|Treatment||0
11203045|NCT01844817|12393563|FG000|NOT COMPLETED|Treatment||64
11203046|NCT01844817|12393564|FG001|NOT COMPLETED|Treatment||63
11203047|NCT01844830|12393573|FG000|STARTED|Overall Study||60
11203048|NCT01844830|12393574|FG001|STARTED|Overall Study||30
11203049|NCT01844830|12393573|FG000|100 µL Dose|Overall Study||16
11203050|NCT01844830|12393574|FG001|100 µL Dose|Overall Study||8
11203051|NCT01844830|12393573|FG000|200 µL Dose|Overall Study||24
11203052|NCT01844830|12393574|FG001|200 µL Dose|Overall Study||12
11203053|NCT01844830|12393573|FG000|400 µL Dose|Overall Study||20
11203054|NCT01844830|12393574|FG001|400 µL Dose|Overall Study||10
11203055|NCT01844830|12393573|FG000|COMPLETED|Overall Study||59
11203056|NCT01844830|12393574|FG001|COMPLETED|Overall Study||30
11203057|NCT01844830|12393573|FG000|NOT COMPLETED|Overall Study||1
11203058|NCT01844830|12393574|FG001|NOT COMPLETED|Overall Study||0
11203059|NCT01844895|12393580|FG000|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
11203060|NCT01844895|12393580|FG000|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
11203061|NCT01844895|12393580|FG000|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
11203062|NCT01844895|12393580|FG000|STARTED|Day 29 - Day113 - Autoinjector||117
11203063|NCT01844895|12393580|FG000|COMPLETED|Day 29 - Day113 - Autoinjector||111
11203064|NCT01844895|12393580|FG000|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
11203065|NCT01845025|12393595|FG000|STARTED|Overall Study||411
11203066|NCT01845025|12393596|FG001|STARTED|Overall Study||409
11203067|NCT01845025|12393595|FG000|COMPLETED|Overall Study||326
11203068|NCT01845025|12393596|FG001|COMPLETED|Overall Study||332
11203069|NCT01845025|12393595|FG000|NOT COMPLETED|Overall Study||85
11203070|NCT01845025|12393596|FG001|NOT COMPLETED|Overall Study||77
11203071|NCT01845077|12393605|FG000|STARTED|Treatment Period 1||12
11203072|NCT01845077|12393606|FG001|STARTED|Treatment Period 1||12
11203073|NCT01845077|12393607|FG002|STARTED|Treatment Period 1||12
11203074|NCT01845077|12393608|FG003|STARTED|Treatment Period 1||12
11203075|NCT01845077|12393609|FG004|STARTED|Treatment Period 1||12
11203076|NCT01845077|12393610|FG005|STARTED|Treatment Period 1||12
11203077|NCT01845077|12393605|FG000|COMPLETED|Treatment Period 1||12
11203078|NCT01845077|12393606|FG001|COMPLETED|Treatment Period 1||12
11203079|NCT01845077|12393607|FG002|COMPLETED|Treatment Period 1||12
11203080|NCT01845077|12393608|FG003|COMPLETED|Treatment Period 1||12
11203081|NCT01845077|12393609|FG004|COMPLETED|Treatment Period 1||12
11203082|NCT01845077|12393610|FG005|COMPLETED|Treatment Period 1||12
11203083|NCT01845077|12393605|FG000|NOT COMPLETED|Treatment Period 1||0
11203084|NCT01845077|12393606|FG001|NOT COMPLETED|Treatment Period 1||0
11203085|NCT01845077|12393607|FG002|NOT COMPLETED|Treatment Period 1||0
11203086|NCT01845077|12393608|FG003|NOT COMPLETED|Treatment Period 1||0
11203087|NCT01845077|12393609|FG004|NOT COMPLETED|Treatment Period 1||0
11203088|NCT01845077|12393610|FG005|NOT COMPLETED|Treatment Period 1||0
11203089|NCT01845077|12393605|FG000|STARTED|Washout Period||12
11203090|NCT01845077|12393606|FG001|STARTED|Washout Period||12
11203091|NCT01845077|12393607|FG002|STARTED|Washout Period||12
11203092|NCT01845077|12393608|FG003|STARTED|Washout Period||12
11203093|NCT01845077|12393609|FG004|STARTED|Washout Period||12
11203094|NCT01845077|12393610|FG005|STARTED|Washout Period||12
11203095|NCT01845077|12393605|FG000|COMPLETED|Washout Period||11
11151228|NCT01526148|12338941|FG000|STARTED|Overall Study||18
11151229|NCT01526148|12338942|FG001|STARTED|Overall Study||24
11151230|NCT01526148|12338941|FG000|COMPLETED|Overall Study||4
11151231|NCT01526148|12338942|FG001|COMPLETED|Overall Study||11
11418647|NCT00476827|12616977|FG002|COMPLETED|Overall Study||1
11418648|NCT00476827|12616978|FG003|COMPLETED|Overall Study||0
11151232|NCT01526148|12338941|FG000|NOT COMPLETED|Overall Study||14
11151233|NCT01526148|12338942|FG001|NOT COMPLETED|Overall Study||13
11151234|NCT01526213|12338954|FG000|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151235|NCT01526213|12338955|FG001|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151236|NCT01526213|12338956|FG002|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151237|NCT01526213|12338957|FG003|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151238|NCT01526213|12338958|FG004|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151239|NCT01526213|12338959|FG005|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
11151240|NCT01526213|12338954|FG000|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
11151241|NCT01526213|12338955|FG001|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
11151242|NCT01526213|12338956|FG002|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
11151243|NCT01526213|12338957|FG003|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
11151244|NCT01526213|12338958|FG004|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
11151245|NCT01526213|12338959|FG005|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
11151246|NCT01526213|12338954|FG000|NOT COMPLETED|Period 1 (5 Days)||0
11151247|NCT01526213|12338955|FG001|NOT COMPLETED|Period 1 (5 Days)||0
11151248|NCT01526213|12338956|FG002|NOT COMPLETED|Period 1 (5 Days)||0
11151249|NCT01526213|12338957|FG003|NOT COMPLETED|Period 1 (5 Days)||0
11151250|NCT01526213|12338958|FG004|NOT COMPLETED|Period 1 (5 Days)||0
11151251|NCT01526213|12338959|FG005|NOT COMPLETED|Period 1 (5 Days)||0
11151252|NCT01526213|12338954|FG000|STARTED|Washout 1 (10 Days)||3
11151253|NCT01526213|12338955|FG001|STARTED|Washout 1 (10 Days)||3
11151254|NCT01526213|12338956|FG002|STARTED|Washout 1 (10 Days)||3
11151255|NCT01526213|12338957|FG003|STARTED|Washout 1 (10 Days)||3
11151256|NCT01526213|12338958|FG004|STARTED|Washout 1 (10 Days)||3
11151257|NCT01526213|12338959|FG005|STARTED|Washout 1 (10 Days)||3
11151258|NCT01526213|12338954|FG000|COMPLETED|Washout 1 (10 Days)||3
11151259|NCT01526213|12338955|FG001|COMPLETED|Washout 1 (10 Days)||3
11151260|NCT01526213|12338956|FG002|COMPLETED|Washout 1 (10 Days)||3
11151261|NCT01526213|12338957|FG003|COMPLETED|Washout 1 (10 Days)||3
11151262|NCT01526213|12338958|FG004|COMPLETED|Washout 1 (10 Days)||3
11151263|NCT01526213|12338959|FG005|COMPLETED|Washout 1 (10 Days)||3
11151264|NCT01526213|12338954|FG000|NOT COMPLETED|Washout 1 (10 Days)||0
11151265|NCT01526213|12338955|FG001|NOT COMPLETED|Washout 1 (10 Days)||0
11151266|NCT01526213|12338956|FG002|NOT COMPLETED|Washout 1 (10 Days)||0
11151267|NCT01526213|12338957|FG003|NOT COMPLETED|Washout 1 (10 Days)||0
11418649|NCT00476827|12616979|FG004|COMPLETED|Overall Study||2
11151268|NCT01526213|12338958|FG004|NOT COMPLETED|Washout 1 (10 Days)||0
11151269|NCT01526213|12338959|FG005|NOT COMPLETED|Washout 1 (10 Days)||0
11151270|NCT01526213|12338954|FG000|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11418650|NCT00476827|12616980|FG005|COMPLETED|Overall Study||2
11151271|NCT01526213|12338955|FG001|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151272|NCT01526213|12338956|FG002|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151273|NCT01526213|12338957|FG003|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151274|NCT01526213|12338958|FG004|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151275|NCT01526213|12338959|FG005|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151276|NCT01526213|12338954|FG000|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
11151277|NCT01526213|12338955|FG001|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
11151278|NCT01526213|12338956|FG002|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
11151279|NCT01526213|12338957|FG003|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
11151280|NCT01526213|12338958|FG004|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
11151281|NCT01526213|12338959|FG005|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
11151282|NCT01526213|12338954|FG000|NOT COMPLETED|Period 2 (5 Days)||0
11151283|NCT01526213|12338955|FG001|NOT COMPLETED|Period 2 (5 Days)||0
11151284|NCT01526213|12338956|FG002|NOT COMPLETED|Period 2 (5 Days)||0
11418651|NCT00476827|12616975|FG000|NOT COMPLETED|Overall Study||0
11151285|NCT01526213|12338957|FG003|NOT COMPLETED|Period 2 (5 Days)||0
11151286|NCT01526213|12338958|FG004|NOT COMPLETED|Period 2 (5 Days)||0
11151287|NCT01526213|12338959|FG005|NOT COMPLETED|Period 2 (5 Days)||0
11151288|NCT01526213|12338954|FG000|STARTED|Washout 2 (10 Days)||3
11151289|NCT01526213|12338955|FG001|STARTED|Washout 2 (10 Days)||3
11151290|NCT01526213|12338956|FG002|STARTED|Washout 2 (10 Days)||3
11151291|NCT01526213|12338957|FG003|STARTED|Washout 2 (10 Days)||3
11151292|NCT01526213|12338958|FG004|STARTED|Washout 2 (10 Days)||3
11151293|NCT01526213|12338959|FG005|STARTED|Washout 2 (10 Days)||3
11151294|NCT01526213|12338954|FG000|COMPLETED|Washout 2 (10 Days)||3
11151295|NCT01526213|12338955|FG001|COMPLETED|Washout 2 (10 Days)||3
11151296|NCT01526213|12338956|FG002|COMPLETED|Washout 2 (10 Days)||3
11151297|NCT01526213|12338957|FG003|COMPLETED|Washout 2 (10 Days)||3
11151298|NCT01526213|12338958|FG004|COMPLETED|Washout 2 (10 Days)||3
11151299|NCT01526213|12338959|FG005|COMPLETED|Washout 2 (10 Days)||3
11151300|NCT01526213|12338954|FG000|NOT COMPLETED|Washout 2 (10 Days)||0
11151301|NCT01526213|12338955|FG001|NOT COMPLETED|Washout 2 (10 Days)||0
11151302|NCT01526213|12338956|FG002|NOT COMPLETED|Washout 2 (10 Days)||0
11151303|NCT01526213|12338957|FG003|NOT COMPLETED|Washout 2 (10 Days)||0
11151304|NCT01526213|12338958|FG004|NOT COMPLETED|Washout 2 (10 Days)||0
11151305|NCT01526213|12338959|FG005|NOT COMPLETED|Washout 2 (10 Days)||0
11151306|NCT01526213|12338954|FG000|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151307|NCT01526213|12338955|FG001|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151308|NCT01526213|12338956|FG002|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151309|NCT01526213|12338957|FG003|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151310|NCT01526213|12338958|FG004|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151311|NCT01526213|12338959|FG005|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
11151312|NCT01526213|12338954|FG000|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
11151313|NCT01526213|12338955|FG001|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
11151314|NCT01526213|12338956|FG002|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
11151315|NCT01526213|12338957|FG003|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
11151316|NCT01526213|12338958|FG004|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
11151317|NCT01526213|12338959|FG005|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
11151318|NCT01526213|12338954|FG000|NOT COMPLETED|Period 3 (5 Days)||0
11151319|NCT01526213|12338955|FG001|NOT COMPLETED|Period 3 (5 Days)||0
11151320|NCT01526213|12338956|FG002|NOT COMPLETED|Period 3 (5 Days)||0
11151321|NCT01526213|12338957|FG003|NOT COMPLETED|Period 3 (5 Days)||0
11151322|NCT01526213|12338958|FG004|NOT COMPLETED|Period 3 (5 Days)||0
11151323|NCT01526213|12338959|FG005|NOT COMPLETED|Period 3 (5 Days)||0
11151324|NCT01526343|12338970|FG000|STARTED|Overall Study||47
11151325|NCT01526343|12338970|FG000|COMPLETED|Overall Study||47
11151326|NCT01526343|12338970|FG000|NOT COMPLETED|Overall Study||0
11151327|NCT01526356|12338977|FG000|STARTED|Overall Study||59
11151328|NCT01526356|12338978|FG001|STARTED|Overall Study||63
11151329|NCT01526356|12338979|FG002|STARTED|Overall Study||57
11151330|NCT01526356|12338977|FG000|COMPLETED|Overall Study||51
11151331|NCT01526356|12338978|FG001|COMPLETED|Overall Study||53
11151332|NCT01526356|12338979|FG002|COMPLETED|Overall Study||45
11151333|NCT01526356|12338977|FG000|NOT COMPLETED|Overall Study||8
11151334|NCT01526356|12338978|FG001|NOT COMPLETED|Overall Study||10
11151335|NCT01526356|12338979|FG002|NOT COMPLETED|Overall Study||12
11151336|NCT01526538|12338991|FG000|STARTED|Overall Study||30
11151337|NCT01526538|12338992|FG001|STARTED|Overall Study||22
11151338|NCT01526538|12338991|FG000|COMPLETED|Overall Study||21
11151339|NCT01526538|12338992|FG001|COMPLETED|Overall Study||18
11151340|NCT01526538|12338991|FG000|NOT COMPLETED|Overall Study||9
11151341|NCT01526538|12338992|FG001|NOT COMPLETED|Overall Study||4
11151342|NCT01526551|12339000|FG000|STARTED|Overall Study||935
11151343|NCT01526551|12339000|FG000|COMPLETED|Overall Study||511
11151344|NCT01526551|12339000|FG000|NOT COMPLETED|Overall Study||424
11151345|NCT01526577|12339009|FG000|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
11151346|NCT01526577|12339010|FG001|STARTED|Overall Study||12
11151347|NCT01526577|12339011|FG002|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
11151348|NCT01526577|12339012|FG003|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
11151349|NCT01526577|12339013|FG004|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
11151350|NCT01526577|12339009|FG000|COMPLETED|Overall Study||48
11151351|NCT01526577|12339010|FG001|COMPLETED|Overall Study||12
11151352|NCT01526577|12339011|FG002|COMPLETED|Overall Study||32
11151353|NCT01526577|12339012|FG003|COMPLETED|Overall Study||8
11151354|NCT01526577|12339013|FG004|COMPLETED|Overall Study||8
11151355|NCT01526577|12339009|FG000|NOT COMPLETED|Overall Study||1
11151356|NCT01526577|12339010|FG001|NOT COMPLETED|Overall Study||0
11151357|NCT01526577|12339011|FG002|NOT COMPLETED|Overall Study||1
11151358|NCT01526577|12339012|FG003|NOT COMPLETED|Overall Study||1
11151359|NCT01526577|12339013|FG004|NOT COMPLETED|Overall Study||2
11151360|NCT01526629|12339021|FG000|STARTED|Overall Study||354
11151361|NCT01526629|12339021|FG000|COMPLETED|Overall Study||308
11151362|NCT01526629|12339021|FG000|NOT COMPLETED|Overall Study||46
11151363|NCT01526733|12339025|FG000|STARTED|Phase 1||12
11151364|NCT01526733|12339026|FG001|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
11151365|NCT01526733|12339025|FG000|Received at Least 1 Dose of Study Drug|Phase 1||12
11151366|NCT01526733|12339026|FG001|Received at Least 1 Dose of Study Drug|Phase 1||13
11151367|NCT01526733|12339025|FG000|COMPLETED|Phase 1||10
11151368|NCT01526733|12339026|FG001|COMPLETED|Phase 1||12
11151369|NCT01526733|12339025|FG000|NOT COMPLETED|Phase 1||2
11151370|NCT01526733|12339026|FG001|NOT COMPLETED|Phase 1||1
11151371|NCT01526733|12339025|FG000|STARTED|Washout Period of 5 to 21 Days||10
11151372|NCT01526733|12339026|FG001|STARTED|Washout Period of 5 to 21 Days||12
11151373|NCT01526733|12339025|FG000|COMPLETED|Washout Period of 5 to 21 Days||10
11151374|NCT01526733|12339026|FG001|COMPLETED|Washout Period of 5 to 21 Days||12
11151375|NCT01526733|12339025|FG000|NOT COMPLETED|Washout Period of 5 to 21 Days||0
11151376|NCT01526733|12339026|FG001|NOT COMPLETED|Washout Period of 5 to 21 Days||0
11151377|NCT01526733|12339025|FG000|STARTED|Phase 2||10
11151378|NCT01526733|12339026|FG001|STARTED|Phase 2||12
11151379|NCT01526733|12339025|FG000|COMPLETED|Phase 2||10
11151380|NCT01526733|12339026|FG001|COMPLETED|Phase 2||12
11151381|NCT01526733|12339025|FG000|NOT COMPLETED|Phase 2||0
11151382|NCT01526733|12339026|FG001|NOT COMPLETED|Phase 2||0
11151383|NCT01526785|12339033|FG000|STARTED|Overall Study||113
11151384|NCT01526785|12339033|FG000|COMPLETED|Overall Study||100
11151385|NCT01526785|12339033|FG000|NOT COMPLETED|Overall Study||13
11151386|NCT01526889|12339039|FG000|STARTED|Treatment Period||18
11151387|NCT01526889|12339040|FG001|STARTED|Treatment Period||7
11151388|NCT01526889|12339039|FG000|COMPLETED|Treatment Period||16
11151389|NCT01526889|12339040|FG001|COMPLETED|Treatment Period||7
11151390|NCT01526889|12339039|FG000|NOT COMPLETED|Treatment Period||2
11151391|NCT01526889|12339040|FG001|NOT COMPLETED|Treatment Period||0
11151392|NCT01526889|12339039|FG000|STARTED|Treatment Extension Period||5
11151393|NCT01526889|12339040|FG001|STARTED|Treatment Extension Period||0
11151394|NCT01526889|12339039|FG000|COMPLETED|Treatment Extension Period||4
11151395|NCT01526889|12339040|FG001|COMPLETED|Treatment Extension Period||0
11151396|NCT01526889|12339039|FG000|NOT COMPLETED|Treatment Extension Period||1
11151397|NCT01526889|12339040|FG001|NOT COMPLETED|Treatment Extension Period||0
11151398|NCT01526902|12339046|FG000|STARTED|Overall Study||25
11151399|NCT01526902|12339047|FG001|STARTED|Overall Study||24
11151400|NCT01526902|12339046|FG000|COMPLETED|Overall Study||25
11151401|NCT01526902|12339047|FG001|COMPLETED|Overall Study||24
11151402|NCT01526902|12339046|FG000|NOT COMPLETED|Overall Study||0
11418652|NCT00476827|12616976|FG001|NOT COMPLETED|Overall Study||0
11151403|NCT01526902|12339047|FG001|NOT COMPLETED|Overall Study||0
11151404|NCT01526928|12339059|FG000|STARTED|Overall Study||38
11151405|NCT01526928|12339060|FG001|STARTED|Overall Study||19
11151406|NCT01526928|12339061|FG002|STARTED|Overall Study||209
11151407|NCT01526928|12339062|FG003|STARTED|Overall Study||245
11151408|NCT01526928|12339063|FG004|STARTED|Overall Study||95
11151409|NCT01526928|12339064|FG005|STARTED|Overall Study||6
11151410|NCT01526928|12339059|FG000|Started Phase 1|Overall Study||38
11151411|NCT01526928|12339060|FG001|Started Phase 1|Overall Study||19
11151412|NCT01526928|12339061|FG002|Started Phase 1|Overall Study||18
11151413|NCT01526928|12339062|FG003|Started Phase 1|Overall Study||17
11151414|NCT01526928|12339063|FG004|Started Phase 1|Overall Study||13
11151415|NCT01526928|12339064|FG005|Started Phase 1|Overall Study||6
11151416|NCT01526928|12339059|FG000|Started Phase 2|Overall Study||0
11151417|NCT01526928|12339060|FG001|Started Phase 2|Overall Study||0
11151418|NCT01526928|12339061|FG002|Started Phase 2|Overall Study||191
11151419|NCT01526928|12339062|FG003|Started Phase 2|Overall Study||228
11151420|NCT01526928|12339063|FG004|Started Phase 2|Overall Study||82
11151421|NCT01526928|12339064|FG005|Started Phase 2|Overall Study||0
11151422|NCT01526928|12339059|FG000|COMPLETED|Overall Study||0
11151423|NCT01526928|12339060|FG001|COMPLETED|Overall Study||0
11151424|NCT01526928|12339061|FG002|COMPLETED|Overall Study||0
11151425|NCT01526928|12339062|FG003|COMPLETED|Overall Study||0
11151426|NCT01526928|12339063|FG004|COMPLETED|Overall Study||0
11151427|NCT01526928|12339064|FG005|COMPLETED|Overall Study||0
11151428|NCT01526928|12339059|FG000|NOT COMPLETED|Overall Study||38
11151429|NCT01526928|12339060|FG001|NOT COMPLETED|Overall Study||19
11151430|NCT01526928|12339061|FG002|NOT COMPLETED|Overall Study||209
11151431|NCT01526928|12339062|FG003|NOT COMPLETED|Overall Study||245
11151432|NCT01526928|12339063|FG004|NOT COMPLETED|Overall Study||95
11151433|NCT01526928|12339064|FG005|NOT COMPLETED|Overall Study||6
11151434|NCT01527006|12339122|FG000|STARTED|Core Study||22
11151435|NCT01527006|12339123|FG001|STARTED|Core Study||28
11151436|NCT01527006|12339122|FG000|COMPLETED|Core Study||20
11151437|NCT01527006|12339123|FG001|COMPLETED|Core Study||22
11151438|NCT01527006|12339122|FG000|NOT COMPLETED|Core Study||2
11151439|NCT01527006|12339123|FG001|NOT COMPLETED|Core Study||6
11151440|NCT01527006|12339122|FG000|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
11151441|NCT01527006|12339123|FG001|STARTED|Extension Phase||22
11151442|NCT01527006|12339122|FG000|COMPLETED|Extension Phase||13
11151443|NCT01527006|12339123|FG001|COMPLETED|Extension Phase||14
11151444|NCT01527006|12339122|FG000|NOT COMPLETED|Extension Phase||6
11151445|NCT01527006|12339123|FG001|NOT COMPLETED|Extension Phase||8
11151446|NCT01527045|12339138|FG000|STARTED|Overall Study||30
11151447|NCT01527045|12339139|FG001|STARTED|Overall Study||5
11151448|NCT01527045|12339140|FG002|STARTED|Overall Study||12
11151449|NCT01527045|12339138|FG000|COMPLETED|Overall Study||29
11151450|NCT01527045|12339139|FG001|COMPLETED|Overall Study||5
11151451|NCT01527045|12339140|FG002|COMPLETED|Overall Study||12
11151452|NCT01527045|12339138|FG000|NOT COMPLETED|Overall Study||1
11151453|NCT01527045|12339139|FG001|NOT COMPLETED|Overall Study||0
11151454|NCT01527045|12339140|FG002|NOT COMPLETED|Overall Study||0
11151455|NCT01527110|12339148|FG000|STARTED|Overall Study||21
11151456|NCT01527110|12339148|FG000|COMPLETED|Overall Study||20
11151457|NCT01527110|12339148|FG000|NOT COMPLETED|Overall Study||1
11151458|NCT01527162|12339152|FG000|STARTED|Overall Study||6
11151459|NCT01527162|12339153|FG001|STARTED|Overall Study||5
11151460|NCT01527162|12339152|FG000|COMPLETED|Overall Study||6
11151461|NCT01527162|12339153|FG001|COMPLETED|Overall Study||5
11151462|NCT01527162|12339152|FG000|NOT COMPLETED|Overall Study||0
11151463|NCT01527162|12339153|FG001|NOT COMPLETED|Overall Study||0
11151464|NCT01527357|12339163|FG000|STARTED|Overall Study||482
11151465|NCT01527357|12339164|FG001|STARTED|Overall Study||239
11151466|NCT01527357|12339163|FG000|Efficacy Population|Overall Study|Two participants did not receive study treatment.|480
11151467|NCT01527357|12339164|FG001|Efficacy Population|Overall Study||239
11151468|NCT01527357|12339163|FG000|COMPLETED|Overall Study||465
11151469|NCT01527357|12339164|FG001|COMPLETED|Overall Study||230
11151470|NCT01527357|12339163|FG000|NOT COMPLETED|Overall Study||17
11151471|NCT01527357|12339164|FG001|NOT COMPLETED|Overall Study||9
11151472|NCT01527370|12339170|FG000|STARTED|Overall Study||250
11151473|NCT01527370|12339170|FG000|COMPLETED|Overall Study||244
11151474|NCT01527370|12339170|FG000|NOT COMPLETED|Overall Study||6
11151475|NCT01527383|12339176|FG000|STARTED|Overall Study||292
11151476|NCT01527383|12339177|FG001|STARTED|Overall Study||62
11151477|NCT01527383|12339176|FG000|Vaccination 1 (Day 1)|Overall Study||291
11151478|NCT01527383|12339177|FG001|Vaccination 1 (Day 1)|Overall Study||62
11151479|NCT01527383|12339176|FG000|Vaccination 2 (~Day 30)|Overall Study||283
11151480|NCT01527383|12339177|FG001|Vaccination 2 (~Day 30)|Overall Study||61
11151481|NCT01527383|12339176|FG000|Vaccination 3 (~Day 60)|Overall Study||278
11151482|NCT01527383|12339177|FG001|Vaccination 3 (~Day 60)|Overall Study||58
11151483|NCT01527383|12339176|FG000|Vaccination 4 (~Day 90)|Overall Study||277
11151484|NCT01527383|12339177|FG001|Vaccination 4 (~Day 90)|Overall Study||58
11151485|NCT01527383|12339176|FG000|COMPLETED|Overall Study||277
11151486|NCT01527383|12339177|FG001|COMPLETED|Overall Study||58
11151487|NCT01527383|12339176|FG000|NOT COMPLETED|Overall Study||15
11151488|NCT01527383|12339177|FG001|NOT COMPLETED|Overall Study||4
11151489|NCT01527487|12339185|FG000|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
11151490|NCT01527487|12339186|FG001|STARTED|Overall Study||22
11151491|NCT01527487|12339185|FG000|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
11151492|NCT01527487|12339186|FG001|COMPLETED|Overall Study||15
11151493|NCT01527487|12339185|FG000|NOT COMPLETED|Overall Study||8
11151494|NCT01527487|12339186|FG001|NOT COMPLETED|Overall Study||7
11151495|NCT01527500|12339201|FG000|STARTED|Part A||99
11151496|NCT01527500|12339202|FG001|STARTED|Part A||51
11151497|NCT01527500|12339201|FG000|COMPLETED|Part A||69
11151498|NCT01527500|12339202|FG001|COMPLETED|Part A||38
11151499|NCT01527500|12339201|FG000|NOT COMPLETED|Part A||30
11151500|NCT01527500|12339202|FG001|NOT COMPLETED|Part A||13
11151501|NCT01527500|12339201|FG000|STARTED|Part B||7
11151502|NCT01527500|12339202|FG001|STARTED|Part B||1
11151503|NCT01527500|12339201|FG000|COMPLETED|Part B||6
11151504|NCT01527500|12339202|FG001|COMPLETED|Part B||1
11151505|NCT01527500|12339201|FG000|NOT COMPLETED|Part B||1
11151506|NCT01527500|12339202|FG001|NOT COMPLETED|Part B||0
11151507|NCT01527513|12339220|FG000|STARTED|Double Blind Period (DB) - Part I||40
11151508|NCT01527513|12339221|FG001|STARTED|Double Blind Period (DB) - Part I||83
11151509|NCT01527513|12339220|FG000|Randomized|Double Blind Period (DB) - Part I||40
11151510|NCT01527513|12339221|FG001|Randomized|Double Blind Period (DB) - Part I||83
11151511|NCT01527513|12339220|FG000|Safety Population|Double Blind Period (DB) - Part I||40
11151512|NCT01527513|12339221|FG001|Safety Population|Double Blind Period (DB) - Part I||83
11151513|NCT01527513|12339220|FG000|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
11151514|NCT01527513|12339221|FG001|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
11151515|NCT01527513|12339220|FG000|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
11151516|NCT01527513|12339221|FG001|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
11151517|NCT01527513|12339220|FG000|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
11151518|NCT01527513|12339221|FG001|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
11151519|NCT01527513|12339220|FG000|Efficacy PP Population|Double Blind Period (DB) - Part I||37
11151520|NCT01527513|12339221|FG001|Efficacy PP Population|Double Blind Period (DB) - Part I||67
11151521|NCT01527513|12339220|FG000|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
11151522|NCT01527513|12339221|FG001|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
11151523|NCT01527513|12339220|FG000|COMPLETED|Double Blind Period (DB) - Part I||37
11151524|NCT01527513|12339221|FG001|COMPLETED|Double Blind Period (DB) - Part I||75
11151525|NCT01527513|12339220|FG000|NOT COMPLETED|Double Blind Period (DB) - Part I||3
11151526|NCT01527513|12339221|FG001|NOT COMPLETED|Double Blind Period (DB) - Part I||8
11151527|NCT01527513|12339220|FG000|STARTED|Eligible for 1-Year Open Label Period||0
11151528|NCT01527513|12339221|FG001|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
11151529|NCT01527513|12339220|FG000|COMPLETED|Eligible for 1-Year Open Label Period||0
11151530|NCT01527513|12339221|FG001|COMPLETED|Eligible for 1-Year Open Label Period||95
11151531|NCT01527513|12339220|FG000|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
11151532|NCT01527513|12339221|FG001|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
11151533|NCT01527682|12339229|FG000|STARTED|Overall Study||37
11151534|NCT01527682|12339229|FG000|COMPLETED|Overall Study||29
11151535|NCT01527682|12339229|FG000|NOT COMPLETED|Overall Study||8
11151536|NCT01528033|12339235|FG000|STARTED|Primary Endpoint Assessment ITT||273
11151537|NCT01528033|12339236|FG001|STARTED|Primary Endpoint Assessment ITT||266
11151538|NCT01528033|12339235|FG000|COMPLETED|Primary Endpoint Assessment ITT||256
11151539|NCT01528033|12339236|FG001|COMPLETED|Primary Endpoint Assessment ITT||251
11151540|NCT01528033|12339235|FG000|NOT COMPLETED|Primary Endpoint Assessment ITT||17
11151541|NCT01528033|12339236|FG001|NOT COMPLETED|Primary Endpoint Assessment ITT||15
11151542|NCT01528033|12339235|FG000|STARTED|Follow Up||256
11418653|NCT00476827|12616977|FG002|NOT COMPLETED|Overall Study||0
11418654|NCT00476827|12616978|FG003|NOT COMPLETED|Overall Study||0
11418655|NCT00476827|12616979|FG004|NOT COMPLETED|Overall Study||0
11151543|NCT01528033|12339236|FG001|STARTED|Follow Up||251
11151544|NCT01528033|12339235|FG000|COMPLETED|Follow Up||210
11151545|NCT01528033|12339236|FG001|COMPLETED|Follow Up||207
11151546|NCT01528033|12339235|FG000|NOT COMPLETED|Follow Up||46
11151547|NCT01528033|12339236|FG001|NOT COMPLETED|Follow Up||44
11151548|NCT01528072|12339242|FG000|STARTED|Overall Study||140
11151549|NCT01528072|12339242|FG000|COMPLETED|Overall Study||66
11151550|NCT01528072|12339242|FG000|NOT COMPLETED|Overall Study||74
11151551|NCT01528124|12339253|FG000|STARTED|Overall Study||6
11151552|NCT01528124|12339254|FG001|STARTED|Overall Study||6
11151553|NCT01528124|12339255|FG002|STARTED|Overall Study||6
11151554|NCT01528124|12339256|FG003|STARTED|Overall Study||6
11151555|NCT01528124|12339257|FG004|STARTED|Overall Study||5
11151556|NCT01528124|12339258|FG005|STARTED|Overall Study||6
11151557|NCT01528124|12339259|FG006|STARTED|Overall Study||6
11151558|NCT01528124|12339253|FG000|Received Study Drug|Overall Study||6
11151559|NCT01528124|12339254|FG001|Received Study Drug|Overall Study||6
11151560|NCT01528124|12339255|FG002|Received Study Drug|Overall Study||6
11151561|NCT01528124|12339256|FG003|Received Study Drug|Overall Study||6
11151562|NCT01528124|12339257|FG004|Received Study Drug|Overall Study||5
11151563|NCT01528124|12339258|FG005|Received Study Drug|Overall Study||6
11151564|NCT01528124|12339259|FG006|Received Study Drug|Overall Study||6
11151565|NCT01528124|12339253|FG000|COMPLETED|Overall Study||6
11151566|NCT01528124|12339254|FG001|COMPLETED|Overall Study||6
11151567|NCT01528124|12339255|FG002|COMPLETED|Overall Study||6
11151568|NCT01528124|12339256|FG003|COMPLETED|Overall Study||6
11151569|NCT01528124|12339257|FG004|COMPLETED|Overall Study||5
11151570|NCT01528124|12339258|FG005|COMPLETED|Overall Study||6
11151571|NCT01528124|12339259|FG006|COMPLETED|Overall Study||6
11151572|NCT01528124|12339253|FG000|NOT COMPLETED|Overall Study||0
11151573|NCT01528124|12339254|FG001|NOT COMPLETED|Overall Study||0
11151574|NCT01528124|12339255|FG002|NOT COMPLETED|Overall Study||0
11151575|NCT01528124|12339256|FG003|NOT COMPLETED|Overall Study||0
11151576|NCT01528124|12339257|FG004|NOT COMPLETED|Overall Study||0
11151577|NCT01528124|12339258|FG005|NOT COMPLETED|Overall Study||0
11151578|NCT01528124|12339259|FG006|NOT COMPLETED|Overall Study||0
11151579|NCT01528150|12339281|FG000|STARTED|Overall Study||466
11151580|NCT01528150|12339281|FG000|COMPLETED|Overall Study||422
11151581|NCT01528150|12339281|FG000|NOT COMPLETED|Overall Study||44
11151582|NCT01528215|12339287|FG000|STARTED|Enrollment to 1 Year Follow-up||59
11151583|NCT01528215|12339288|FG001|STARTED|Enrollment to 1 Year Follow-up||61
11151584|NCT01528215|12339287|FG000|COMPLETED|Enrollment to 1 Year Follow-up||55
11151585|NCT01528215|12339288|FG001|COMPLETED|Enrollment to 1 Year Follow-up||60
11151586|NCT01528215|12339287|FG000|NOT COMPLETED|Enrollment to 1 Year Follow-up||4
11151587|NCT01528215|12339288|FG001|NOT COMPLETED|Enrollment to 1 Year Follow-up||1
11151588|NCT01528215|12339287|FG000|STARTED|1 Year Follow-up to 5 Year Follow-up||55
11151589|NCT01528215|12339288|FG001|STARTED|1 Year Follow-up to 5 Year Follow-up||60
11151590|NCT01528215|12339287|FG000|COMPLETED|1 Year Follow-up to 5 Year Follow-up||40
11151591|NCT01528215|12339288|FG001|COMPLETED|1 Year Follow-up to 5 Year Follow-up||45
11151592|NCT01528215|12339287|FG000|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
11151593|NCT01528215|12339288|FG001|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
11151594|NCT01528228|12339296|FG000|STARTED|Overall Study||10
11151595|NCT01528228|12339297|FG001|STARTED|Overall Study||10
11151596|NCT01528228|12339296|FG000|COMPLETED|Overall Study||9
11151597|NCT01528228|12339297|FG001|COMPLETED|Overall Study||9
11151598|NCT01528228|12339296|FG000|NOT COMPLETED|Overall Study||1
11151599|NCT01528228|12339297|FG001|NOT COMPLETED|Overall Study||1
11151600|NCT01528254|12339305|FG000|STARTED|Overall Study||998
11151601|NCT01528254|12339306|FG001|STARTED|Overall Study||1003
11151602|NCT01528254|12339305|FG000|Safety Set|Overall Study||998
11151603|NCT01528254|12339306|FG001|Safety Set|Overall Study||1001
11151604|NCT01528254|12339305|FG000|Full Analysis Set (FAS)|Overall Study||983
11151605|NCT01528254|12339306|FG001|Full Analysis Set (FAS)|Overall Study||989
11151606|NCT01528254|12339305|FG000|Completed Treatment Period 1|Overall Study||458
11151607|NCT01528254|12339306|FG001|Completed Treatment Period 1|Overall Study||273
11151608|NCT01528254|12339305|FG000|Completed Treatment Period 2|Overall Study||244
11151609|NCT01528254|12339306|FG001|Completed Treatment Period 2|Overall Study||399
11151610|NCT01528254|12339305|FG000|Completed Treatment Period 3|Overall Study||109
11151611|NCT01528254|12339306|FG001|Completed Treatment Period 3|Overall Study||115
11151612|NCT01528254|12339305|FG000|COMPLETED|Overall Study||811
11151613|NCT01528254|12339306|FG001|COMPLETED|Overall Study||787
11151614|NCT01528254|12339305|FG000|NOT COMPLETED|Overall Study||187
11151615|NCT01528254|12339306|FG001|NOT COMPLETED|Overall Study||216
11151616|NCT01528319|12339313|FG000|STARTED|Overall Study||24
11151617|NCT01528319|12339313|FG000|12 Weeks After Surgery|Overall Study||24
11151618|NCT01528319|12339313|FG000|COMPLETED|Overall Study||23
11151619|NCT01528319|12339313|FG000|NOT COMPLETED|Overall Study||1
11151620|NCT01528332|12339319|FG000|STARTED|Overall Study||85
11418656|NCT00476827|12616980|FG005|NOT COMPLETED|Overall Study||0
11151621|NCT01528332|12339320|FG001|STARTED|Overall Study||86
11151622|NCT01528332|12339319|FG000|COMPLETED|Overall Study||81
11151623|NCT01528332|12339320|FG001|COMPLETED|Overall Study||84
11151624|NCT01528332|12339319|FG000|NOT COMPLETED|Overall Study||4
11151625|NCT01528332|12339320|FG001|NOT COMPLETED|Overall Study||2
11151626|NCT01528345|12339328|FG000|STARTED|Overall Study||47
11151627|NCT01528345|12339329|FG001|STARTED|Overall Study||50
11151628|NCT01528345|12339328|FG000|COMPLETED|Overall Study||0
11151629|NCT01528345|12339329|FG001|COMPLETED|Overall Study||0
11151630|NCT01528345|12339328|FG000|NOT COMPLETED|Overall Study||47
11151631|NCT01528345|12339329|FG001|NOT COMPLETED|Overall Study||50
11151632|NCT01528592|12339335|FG000|STARTED|Overall Study||18
11151633|NCT01528592|12339335|FG000|COMPLETED|Overall Study||18
11151634|NCT01528592|12339335|FG000|NOT COMPLETED|Overall Study||0
11151635|NCT01528605|12339345|FG000|STARTED|Overall Study||28
11151636|NCT01528605|12339346|FG001|STARTED|Overall Study||28
11151637|NCT01528605|12339347|FG002|STARTED|Overall Study||28
11151638|NCT01528605|12339348|FG003|STARTED|Overall Study||28
11151639|NCT01528605|12339349|FG004|STARTED|Overall Study||28
11151640|NCT01528605|12339350|FG005|STARTED|Overall Study||28
11151641|NCT01528605|12339345|FG000|COMPLETED|Overall Study||26
11151642|NCT01528605|12339346|FG001|COMPLETED|Overall Study||28
11151643|NCT01528605|12339347|FG002|COMPLETED|Overall Study||27
11151644|NCT01528605|12339348|FG003|COMPLETED|Overall Study||27
11151645|NCT01528605|12339349|FG004|COMPLETED|Overall Study||28
11151646|NCT01528605|12339350|FG005|COMPLETED|Overall Study||28
11151647|NCT01528605|12339345|FG000|NOT COMPLETED|Overall Study||2
11151648|NCT01528605|12339346|FG001|NOT COMPLETED|Overall Study||0
11151649|NCT01528605|12339347|FG002|NOT COMPLETED|Overall Study||1
11151650|NCT01528605|12339348|FG003|NOT COMPLETED|Overall Study||1
11151651|NCT01528605|12339349|FG004|NOT COMPLETED|Overall Study||0
11151652|NCT01528605|12339350|FG005|NOT COMPLETED|Overall Study||0
11151653|NCT01528709|12339366|FG000|STARTED|Overall Study||86
11151654|NCT01528709|12339367|FG001|STARTED|Overall Study||87
11151655|NCT01528709|12339366|FG000|COMPLETED|Overall Study||73
11151656|NCT01528709|12339367|FG001|COMPLETED|Overall Study||72
11151657|NCT01528709|12339366|FG000|NOT COMPLETED|Overall Study||13
11151658|NCT01528709|12339367|FG001|NOT COMPLETED|Overall Study||15
11151659|NCT01528735|12339375|FG000|STARTED|Treatment Period 1: Faldap/Del/RBV||12
11151660|NCT01528735|12339376|FG001|STARTED|Treatment Period 1: Faldap/Del/RBV||13
11151661|NCT01528735|12339375|FG000|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
11151662|NCT01528735|12339376|FG001|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
11151663|NCT01528735|12339375|FG000|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
11151664|NCT01528735|12339376|FG001|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
11151665|NCT01528735|12339375|FG000|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
11151666|NCT01528735|12339376|FG001|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
11151667|NCT01528735|12339375|FG000|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
11151668|NCT01528735|12339376|FG001|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
11151669|NCT01528735|12339375|FG000|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
11151670|NCT01528735|12339376|FG001|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
11151671|NCT01528787|12339388|FG000|STARTED|Overall Study||22
11151672|NCT01528787|12339389|FG001|STARTED|Overall Study||21
11151673|NCT01528787|12339390|FG002|STARTED|Overall Study||19
11151674|NCT01528787|12339391|FG003|STARTED|Overall Study||23
11151675|NCT01528787|12339388|FG000|COMPLETED|Overall Study||22
11151676|NCT01528787|12339389|FG001|COMPLETED|Overall Study||21
11151677|NCT01528787|12339390|FG002|COMPLETED|Overall Study||18
11151678|NCT01528787|12339391|FG003|COMPLETED|Overall Study||22
11151679|NCT01528787|12339388|FG000|NOT COMPLETED|Overall Study||0
11151680|NCT01528787|12339389|FG001|NOT COMPLETED|Overall Study||0
11151681|NCT01528787|12339390|FG002|NOT COMPLETED|Overall Study||1
11151682|NCT01528787|12339391|FG003|NOT COMPLETED|Overall Study||1
11151683|NCT01528878|12339401|FG000|STARTED|Overall Study||30
11151684|NCT01528878|12339401|FG000|COMPLETED|Overall Study||30
11151685|NCT01528878|12339401|FG000|NOT COMPLETED|Overall Study||0
11151686|NCT01528891|12339409|FG000|STARTED|Overall Study||200
11151687|NCT01528891|12339410|FG001|STARTED|Overall Study||200
11151688|NCT01528891|12339409|FG000|COMPLETED|Overall Study||200
11151689|NCT01528891|12339410|FG001|COMPLETED|Overall Study||200
11151690|NCT01528891|12339409|FG000|NOT COMPLETED|Overall Study||0
11151691|NCT01528891|12339410|FG001|NOT COMPLETED|Overall Study||0
11151692|NCT01528969|12339420|FG000|STARTED|Overall Study||37
11151693|NCT01528969|12339421|FG001|STARTED|Overall Study||38
11151694|NCT01528969|12339420|FG000|COMPLETED|Overall Study||35
11151695|NCT01528969|12339421|FG001|COMPLETED|Overall Study||38
11151696|NCT01528969|12339420|FG000|NOT COMPLETED|Overall Study||2
11151697|NCT01528969|12339421|FG001|NOT COMPLETED|Overall Study||0
11151698|NCT01529034|12339427|FG000|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175
11151699|NCT01529034|12339427|FG000|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161
11151700|NCT01529034|12339427|FG000|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1
11151701|NCT01529034|12339427|FG000|NOT COMPLETED|Overall Study||174
11151702|NCT01529060|12339434|FG000|STARTED|Overall Study||10
11151703|NCT01529060|12339435|FG001|STARTED|Overall Study||10
11151704|NCT01529060|12339434|FG000|COMPLETED|Overall Study||10
11151705|NCT01529060|12339435|FG001|COMPLETED|Overall Study||10
11151706|NCT01529060|12339434|FG000|NOT COMPLETED|Overall Study||0
11151707|NCT01529060|12339435|FG001|NOT COMPLETED|Overall Study||0
11151708|NCT01529112|12339444|FG000|STARTED|Overall Study||89
11151709|NCT01529112|12339445|FG001|STARTED|Overall Study||46
11151710|NCT01529112|12339444|FG000|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
11151711|NCT01529112|12339445|FG001|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
11151712|NCT01529112|12339444|FG000|NOT COMPLETED|Overall Study||69
11151713|NCT01529112|12339445|FG001|NOT COMPLETED|Overall Study||41
11151714|NCT01529203|12339451|FG000|STARTED|Overall Study||60
11151715|NCT01529203|12339451|FG000|COMPLETED|Overall Study||57
11151716|NCT01529203|12339451|FG000|NOT COMPLETED|Overall Study||3
11151717|NCT01529268|12339457|FG000|STARTED|Overall Study||88
11151718|NCT01529268|12339458|FG001|STARTED|Overall Study||81
11151719|NCT01529268|12339457|FG000|Completed 52-week Biopsy|Overall Study||71
11151720|NCT01529268|12339458|FG001|Completed 52-week Biopsy|Overall Study||75
11151721|NCT01529268|12339457|FG000|COMPLETED|Overall Study||76
11151722|NCT01529268|12339458|FG001|COMPLETED|Overall Study||78
11151723|NCT01529268|12339457|FG000|NOT COMPLETED|Overall Study||12
11151724|NCT01529268|12339458|FG001|NOT COMPLETED|Overall Study||3
11151725|NCT01529346|12339469|FG000|STARTED|Overall Study||55
11151726|NCT01529346|12339470|FG001|STARTED|Overall Study||54
11151727|NCT01529346|12339471|FG002|STARTED|Overall Study||54
11151728|NCT01529346|12339472|FG003|STARTED|Overall Study||36
11151729|NCT01529346|12339473|FG004|STARTED|Overall Study||36
11151730|NCT01529346|12339469|FG000|COMPLETED|Overall Study||53
11151731|NCT01529346|12339470|FG001|COMPLETED|Overall Study||53
11151732|NCT01529346|12339471|FG002|COMPLETED|Overall Study||52
11151733|NCT01529346|12339472|FG003|COMPLETED|Overall Study||36
11151734|NCT01529346|12339473|FG004|COMPLETED|Overall Study||36
11151735|NCT01529346|12339469|FG000|NOT COMPLETED|Overall Study||2
11151736|NCT01529346|12339470|FG001|NOT COMPLETED|Overall Study||1
11151737|NCT01529346|12339471|FG002|NOT COMPLETED|Overall Study||2
11151738|NCT01529346|12339472|FG003|NOT COMPLETED|Overall Study||0
11151739|NCT01529346|12339473|FG004|NOT COMPLETED|Overall Study||0
11151740|NCT01529385|12339488|FG000|STARTED|Overall Study||40
11151741|NCT01529385|12339489|FG001|STARTED|Overall Study||40
11151742|NCT01529385|12339488|FG000|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
11151743|NCT01529385|12339489|FG001|Received Intervention|Overall Study||40
11026650|NCT00829439|12205244|FG002|COMPLETED|Overall Study||5
11026651|NCT00829439|12205245|FG003|COMPLETED|Overall Study||4
11026652|NCT00829439|12205242|FG000|NOT COMPLETED|Overall Study||0
11026653|NCT00829439|12205243|FG001|NOT COMPLETED|Overall Study||0
11026654|NCT00829439|12205244|FG002|NOT COMPLETED|Overall Study||1
11026655|NCT00829439|12205245|FG003|NOT COMPLETED|Overall Study||0
11026656|NCT00829621|12205251|FG000|STARTED|Overall Study||8
11026657|NCT00829621|12205252|FG001|STARTED|Overall Study||12
11151744|NCT01529385|12339488|FG000|COMPLETED|Overall Study||38
11151745|NCT01529385|12339489|FG001|COMPLETED|Overall Study||39
11151746|NCT01529385|12339488|FG000|NOT COMPLETED|Overall Study||2
11151747|NCT01529385|12339489|FG001|NOT COMPLETED|Overall Study||1
11151748|NCT01529450|12339497|FG000|STARTED|Overall Study||3
11151749|NCT01529450|12339498|FG001|STARTED|Overall Study||8
11151750|NCT01529450|12339497|FG000|COMPLETED|Overall Study||3
11151751|NCT01529450|12339498|FG001|COMPLETED|Overall Study||6
11151752|NCT01529450|12339497|FG000|NOT COMPLETED|Overall Study||0
11151753|NCT01529450|12339498|FG001|NOT COMPLETED|Overall Study||2
11151754|NCT01529502|12339511|FG000|STARTED|Overall Study||2
11151755|NCT01529502|12339512|FG001|STARTED|Overall Study||3
11151756|NCT01529502|12339513|FG002|STARTED|Overall Study||2
11151757|NCT01529502|12339514|FG003|STARTED|Overall Study||3
11151758|NCT01529502|12339515|FG004|STARTED|Overall Study||2
11151759|NCT01529502|12339516|FG005|STARTED|Overall Study||2
11151760|NCT01529502|12339511|FG000|COMPLETED|Overall Study||2
11151761|NCT01529502|12339512|FG001|COMPLETED|Overall Study||3
11151762|NCT01529502|12339513|FG002|COMPLETED|Overall Study||2
11151763|NCT01529502|12339514|FG003|COMPLETED|Overall Study||1
11151764|NCT01529502|12339515|FG004|COMPLETED|Overall Study||2
11151765|NCT01529502|12339516|FG005|COMPLETED|Overall Study||2
11151766|NCT01529502|12339511|FG000|NOT COMPLETED|Overall Study||0
11151767|NCT01529502|12339512|FG001|NOT COMPLETED|Overall Study||0
11418657|NCT00475657|12616992|FG000|STARTED|Overall Study||5
11418658|NCT00475657|12616992|FG000|COMPLETED|Overall Study||1
11418659|NCT00475657|12616992|FG000|NOT COMPLETED|Overall Study||4
11418660|NCT00472082|12616996|FG000|STARTED|Overall Study||5
11418661|NCT00472082|12616996|FG000|COMPLETED|Overall Study||0
11418662|NCT00472082|12616996|FG000|NOT COMPLETED|Overall Study||5
11418663|NCT00478062|12617000|FG000|STARTED|Overall Study||1
11418664|NCT00478062|12617000|FG000|COMPLETED|Overall Study||1
11418665|NCT00478062|12617000|FG000|NOT COMPLETED|Overall Study||0
11418666|NCT00470574|12617004|FG000|STARTED|Overall Study||7
11418667|NCT00470574|12617004|FG000|COMPLETED|Overall Study||7
11418668|NCT00470574|12617004|FG000|NOT COMPLETED|Overall Study||0
11151768|NCT01529502|12339513|FG002|NOT COMPLETED|Overall Study||0
11151769|NCT01529502|12339514|FG003|NOT COMPLETED|Overall Study||2
11418669|NCT00467753|12617010|FG000|STARTED|Overall Study||3
11418670|NCT00467753|12617011|FG001|STARTED|Overall Study||2
11418671|NCT00467753|12617010|FG000|COMPLETED|Overall Study||0
11418672|NCT00467753|12617011|FG001|COMPLETED|Overall Study||0
11418673|NCT00467753|12617010|FG000|NOT COMPLETED|Overall Study||3
11151770|NCT01529502|12339515|FG004|NOT COMPLETED|Overall Study||0
11418674|NCT00467753|12617011|FG001|NOT COMPLETED|Overall Study||2
11026658|NCT00829621|12205251|FG000|COMPLETED|Overall Study||4
11151771|NCT01529502|12339516|FG005|NOT COMPLETED|Overall Study||0
11151772|NCT01529515|12339526|FG000|STARTED|TRANSITION PHASE||506
11151773|NCT01529515|12339527|FG001|STARTED|TRANSITION PHASE||0
11151774|NCT01529515|12339528|FG002|STARTED|TRANSITION PHASE||0
11151775|NCT01529515|12339529|FG003|STARTED|TRANSITION PHASE||0
11151776|NCT01529515|12339526|FG000|COMPLETED|TRANSITION PHASE||379
11151777|NCT01529515|12339527|FG001|COMPLETED|TRANSITION PHASE||0
11151778|NCT01529515|12339528|FG002|COMPLETED|TRANSITION PHASE||0
11151779|NCT01529515|12339529|FG003|COMPLETED|TRANSITION PHASE||0
11151780|NCT01529515|12339526|FG000|NOT COMPLETED|TRANSITION PHASE||127
11151781|NCT01529515|12339527|FG001|NOT COMPLETED|TRANSITION PHASE||0
11151782|NCT01529515|12339528|FG002|NOT COMPLETED|TRANSITION PHASE||0
11151783|NCT01529515|12339529|FG003|NOT COMPLETED|TRANSITION PHASE||0
11151784|NCT01529515|12339526|FG000|STARTED|MAINTENANCE PHASE||0
11151785|NCT01529515|12339527|FG001|STARTED|MAINTENANCE PHASE||379
11151786|NCT01529515|12339528|FG002|STARTED|MAINTENANCE PHASE||0
11151787|NCT01529515|12339529|FG003|STARTED|MAINTENANCE PHASE||0
11151788|NCT01529515|12339526|FG000|COMPLETED|MAINTENANCE PHASE||0
11151789|NCT01529515|12339527|FG001|COMPLETED|MAINTENANCE PHASE||305
11151790|NCT01529515|12339528|FG002|COMPLETED|MAINTENANCE PHASE||0
11151791|NCT01529515|12339529|FG003|COMPLETED|MAINTENANCE PHASE||0
11322853|NCT04109599|12520128|FG004|COMPLETED|Overall Study||4
11151792|NCT01529515|12339526|FG000|NOT COMPLETED|MAINTENANCE PHASE||0
11151793|NCT01529515|12339527|FG001|NOT COMPLETED|MAINTENANCE PHASE||74
11151794|NCT01529515|12339528|FG002|NOT COMPLETED|MAINTENANCE PHASE||0
11151795|NCT01529515|12339529|FG003|NOT COMPLETED|MAINTENANCE PHASE||0
11151796|NCT01529515|12339526|FG000|STARTED|DOUBLE BLIND PHASE||0
11151797|NCT01529515|12339527|FG001|STARTED|DOUBLE BLIND PHASE||0
11151798|NCT01529515|12339528|FG002|STARTED|DOUBLE BLIND PHASE||145
11151799|NCT01529515|12339529|FG003|STARTED|DOUBLE BLIND PHASE||160
11151800|NCT01529515|12339526|FG000|COMPLETED|DOUBLE BLIND PHASE||0
11151801|NCT01529515|12339527|FG001|COMPLETED|DOUBLE BLIND PHASE||0
11151802|NCT01529515|12339528|FG002|COMPLETED|DOUBLE BLIND PHASE||122
11151803|NCT01529515|12339529|FG003|COMPLETED|DOUBLE BLIND PHASE||148
11151804|NCT01529515|12339526|FG000|NOT COMPLETED|DOUBLE BLIND PHASE||0
11151805|NCT01529515|12339527|FG001|NOT COMPLETED|DOUBLE BLIND PHASE||0
11151806|NCT01529515|12339528|FG002|NOT COMPLETED|DOUBLE BLIND PHASE||23
11151807|NCT01529515|12339529|FG003|NOT COMPLETED|DOUBLE BLIND PHASE||12
11151808|NCT01529606|12339538|FG000|STARTED|Overall Study||55
11151809|NCT01529606|12339539|FG001|STARTED|Overall Study||47
11151810|NCT01529606|12339538|FG000|COMPLETED|Overall Study||34
11151811|NCT01529606|12339539|FG001|COMPLETED|Overall Study||29
11151812|NCT01529606|12339538|FG000|NOT COMPLETED|Overall Study||21
11151813|NCT01529606|12339539|FG001|NOT COMPLETED|Overall Study||18
11151814|NCT01529632|12339547|FG000|STARTED|Overall Study||90
11151815|NCT01529632|12339548|FG001|STARTED|Overall Study||103
11151816|NCT01529632|12339547|FG000|COMPLETED|Overall Study||87
11151817|NCT01529632|12339548|FG001|COMPLETED|Overall Study||100
11151818|NCT01529632|12339547|FG000|NOT COMPLETED|Overall Study||3
11151819|NCT01529632|12339548|FG001|NOT COMPLETED|Overall Study||3
11151820|NCT01529645|12339564|FG000|STARTED|Overall Study||42
11151821|NCT01529645|12339565|FG001|STARTED|Overall Study||42
11151822|NCT01529645|12339566|FG002|STARTED|Overall Study||42
11151823|NCT01529645|12339567|FG003|STARTED|Overall Study||42
11151824|NCT01529645|12339568|FG004|STARTED|Overall Study||42
11151825|NCT01529645|12339569|FG005|STARTED|Overall Study||42
11151826|NCT01529645|12339570|FG006|STARTED|Overall Study||42
11151827|NCT01529645|12339571|FG007|STARTED|Overall Study||42
11151828|NCT01529645|12339572|FG008|STARTED|Overall Study||42
11151829|NCT01529645|12339573|FG009|STARTED|Overall Study||42
11151830|NCT01529645|12339564|FG000|COMPLETED|Overall Study||40
11151831|NCT01529645|12339565|FG001|COMPLETED|Overall Study||41
11151832|NCT01529645|12339566|FG002|COMPLETED|Overall Study||40
11151833|NCT01529645|12339567|FG003|COMPLETED|Overall Study||40
11151834|NCT01529645|12339568|FG004|COMPLETED|Overall Study||40
11151835|NCT01529645|12339569|FG005|COMPLETED|Overall Study||41
11151836|NCT01529645|12339570|FG006|COMPLETED|Overall Study||40
11151837|NCT01529645|12339571|FG007|COMPLETED|Overall Study||42
11151838|NCT01529645|12339572|FG008|COMPLETED|Overall Study||41
11151839|NCT01529645|12339573|FG009|COMPLETED|Overall Study||42
11151840|NCT01529645|12339564|FG000|NOT COMPLETED|Overall Study||2
11418675|NCT00456612|12617021|FG000|STARTED|Overall Study||4
11418676|NCT00456612|12617021|FG000|COMPLETED|Overall Study||1
11151841|NCT01529645|12339565|FG001|NOT COMPLETED|Overall Study||1
11151842|NCT01529645|12339566|FG002|NOT COMPLETED|Overall Study||2
11151843|NCT01529645|12339567|FG003|NOT COMPLETED|Overall Study||2
11151844|NCT01529645|12339568|FG004|NOT COMPLETED|Overall Study||2
11151845|NCT01529645|12339569|FG005|NOT COMPLETED|Overall Study||1
11151846|NCT01529645|12339570|FG006|NOT COMPLETED|Overall Study||2
11151847|NCT01529645|12339571|FG007|NOT COMPLETED|Overall Study||0
11151848|NCT01529645|12339572|FG008|NOT COMPLETED|Overall Study||1
11151849|NCT01529645|12339573|FG009|NOT COMPLETED|Overall Study||0
11151850|NCT01529749|12339607|FG000|STARTED|Overall Study||12
11151851|NCT01529749|12339608|FG001|STARTED|Overall Study||12
11151852|NCT01529749|12339609|FG002|STARTED|Overall Study||12
11151853|NCT01529749|12339610|FG003|STARTED|Overall Study||12
11151854|NCT01529749|12339607|FG000|COMPLETED|Overall Study||12
11151855|NCT01529749|12339608|FG001|COMPLETED|Overall Study||10
11151856|NCT01529749|12339609|FG002|COMPLETED|Overall Study||10
11151857|NCT01529749|12339610|FG003|COMPLETED|Overall Study||10
11151858|NCT01529749|12339607|FG000|NOT COMPLETED|Overall Study||0
11322854|NCT04109599|12520129|FG005|COMPLETED|Overall Study||4
11151859|NCT01529749|12339608|FG001|NOT COMPLETED|Overall Study||2
11151860|NCT01529749|12339609|FG002|NOT COMPLETED|Overall Study||2
11151861|NCT01529749|12339610|FG003|NOT COMPLETED|Overall Study||2
11151862|NCT01529827|12339620|FG000|STARTED|Overall Study||94
11151863|NCT01529827|12339620|FG000|COMPLETED|Overall Study||94
11151864|NCT01529827|12339620|FG000|NOT COMPLETED|Overall Study||0
11322855|NCT04109599|12520130|FG006|COMPLETED|Overall Study||4
11322856|NCT04109599|12520131|FG007|COMPLETED|Overall Study||3
11322857|NCT04109599|12520132|FG008|COMPLETED|Overall Study||3
11322858|NCT04109599|12520124|FG000|NOT COMPLETED|Overall Study||0
11322859|NCT04109599|12520125|FG001|NOT COMPLETED|Overall Study||0
11322860|NCT04109599|12520126|FG002|NOT COMPLETED|Overall Study||0
11322861|NCT04109599|12520127|FG003|NOT COMPLETED|Overall Study||0
11322862|NCT04109599|12520128|FG004|NOT COMPLETED|Overall Study||0
11322863|NCT04109599|12520129|FG005|NOT COMPLETED|Overall Study||0
11322864|NCT04109599|12520130|FG006|NOT COMPLETED|Overall Study||0
11322865|NCT04109599|12520131|FG007|NOT COMPLETED|Overall Study||0
11322866|NCT04109599|12520132|FG008|NOT COMPLETED|Overall Study||0
11322867|NCT04048382|12520154|FG000|STARTED|3-Month Follow Up||28
11322868|NCT04048382|12520155|FG001|STARTED|3-Month Follow Up||29
11322869|NCT04048382|12520154|FG000|COMPLETED|3-Month Follow Up||26
11322870|NCT04048382|12520155|FG001|COMPLETED|3-Month Follow Up||28
11418677|NCT00456612|12617021|FG000|NOT COMPLETED|Overall Study||3
11418678|NCT00469612|12617028|FG000|STARTED|Overall Study||2
11418679|NCT00469612|12617029|FG001|STARTED|Overall Study||0
11151865|NCT01530178|12339626|FG000|STARTED|Overall Study||2
11151866|NCT01530178|12339627|FG001|STARTED|Overall Study||6
11151867|NCT01530178|12339626|FG000|COMPLETED|Overall Study||2
11151868|NCT01530178|12339627|FG001|COMPLETED|Overall Study||6
11151869|NCT01530178|12339626|FG000|NOT COMPLETED|Overall Study||0
11151870|NCT01530178|12339627|FG001|NOT COMPLETED|Overall Study||0
11418680|NCT00469612|12617028|FG000|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
11418681|NCT00469612|12617029|FG001|COMPLETED|Overall Study||0
11151871|NCT01530243|12339641|FG000|STARTED|Overall Study||26
11151872|NCT01530243|12339642|FG001|STARTED|Overall Study||26
11151873|NCT01530243|12339643|FG002|STARTED|Overall Study||26
11151874|NCT01530243|12339644|FG003|STARTED|Overall Study||26
11151875|NCT01530243|12339641|FG000|COMPLETED|Overall Study||24
11151876|NCT01530243|12339642|FG001|COMPLETED|Overall Study||23
11151877|NCT01530243|12339643|FG002|COMPLETED|Overall Study||23
11151878|NCT01530243|12339644|FG003|COMPLETED|Overall Study||24
11151879|NCT01530243|12339641|FG000|NOT COMPLETED|Overall Study||2
11151880|NCT01530243|12339642|FG001|NOT COMPLETED|Overall Study||3
11151881|NCT01530243|12339643|FG002|NOT COMPLETED|Overall Study||3
11151882|NCT01530243|12339644|FG003|NOT COMPLETED|Overall Study||2
11151883|NCT01530256|12339655|FG000|STARTED|Overall Study||3
11151884|NCT01530256|12339655|FG000|COMPLETED|Overall Study||1
11151885|NCT01530256|12339655|FG000|NOT COMPLETED|Overall Study||2
11151886|NCT01530334|12339659|FG000|STARTED|Overall Study||61
11151887|NCT01530334|12339659|FG000|COMPLETED|Overall Study||10
11151888|NCT01530334|12339659|FG000|NOT COMPLETED|Overall Study||51
11151889|NCT01530399|12339669|FG000|STARTED|Overall Study||8
11151890|NCT01530399|12339670|FG001|STARTED|Overall Study||10
11151891|NCT01530399|12339671|FG002|STARTED|Overall Study||8
11151892|NCT01530399|12339672|FG003|STARTED|Overall Study||10
11151893|NCT01530399|12339673|FG004|STARTED|Overall Study||6
11151894|NCT01530399|12339674|FG005|STARTED|Overall Study||7
11151895|NCT01530399|12339669|FG000|COMPLETED|Overall Study||7
11151896|NCT01530399|12339670|FG001|COMPLETED|Overall Study||8
11151897|NCT01530399|12339671|FG002|COMPLETED|Overall Study||7
11151898|NCT01530399|12339672|FG003|COMPLETED|Overall Study||10
11151899|NCT01530399|12339673|FG004|COMPLETED|Overall Study||6
11151900|NCT01530399|12339674|FG005|COMPLETED|Overall Study||6
11151901|NCT01530399|12339669|FG000|NOT COMPLETED|Overall Study||1
11151902|NCT01530399|12339670|FG001|NOT COMPLETED|Overall Study||2
11151903|NCT01530399|12339671|FG002|NOT COMPLETED|Overall Study||1
11151904|NCT01530399|12339672|FG003|NOT COMPLETED|Overall Study||0
11151905|NCT01530399|12339673|FG004|NOT COMPLETED|Overall Study||0
11151906|NCT01530399|12339674|FG005|NOT COMPLETED|Overall Study||1
11151907|NCT01530464|12339690|FG000|STARTED|First Intervention (24h)||10
11151908|NCT01530464|12339691|FG001|STARTED|First Intervention (24h)||8
11151909|NCT01530464|12339690|FG000|COMPLETED|First Intervention (24h)||10
11151910|NCT01530464|12339691|FG001|COMPLETED|First Intervention (24h)||8
11151911|NCT01530464|12339690|FG000|NOT COMPLETED|First Intervention (24h)||0
11151912|NCT01530464|12339691|FG001|NOT COMPLETED|First Intervention (24h)||0
11151913|NCT01530464|12339690|FG000|STARTED|Washout (24h)||10
11151914|NCT01530464|12339691|FG001|STARTED|Washout (24h)||8
11151915|NCT01530464|12339690|FG000|COMPLETED|Washout (24h)||10
11151916|NCT01530464|12339691|FG001|COMPLETED|Washout (24h)||8
11151917|NCT01530464|12339690|FG000|NOT COMPLETED|Washout (24h)||0
11151918|NCT01530464|12339691|FG001|NOT COMPLETED|Washout (24h)||0
11151919|NCT01530464|12339690|FG000|STARTED|Second Intervention (24h)||10
11151920|NCT01530464|12339691|FG001|STARTED|Second Intervention (24h)||8
11151921|NCT01530464|12339690|FG000|COMPLETED|Second Intervention (24h)||10
11151922|NCT01530464|12339691|FG001|COMPLETED|Second Intervention (24h)||8
11151923|NCT01530464|12339690|FG000|NOT COMPLETED|Second Intervention (24h)||0
11151924|NCT01530464|12339691|FG001|NOT COMPLETED|Second Intervention (24h)||0
11151925|NCT01530464|12339690|FG000|STARTED|Washout (24h)||10
11151926|NCT01530464|12339691|FG001|STARTED|Washout (24h)||8
11151927|NCT01530464|12339690|FG000|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
11151928|NCT01530464|12339691|FG001|COMPLETED|Washout (24h)||8
11151929|NCT01530464|12339690|FG000|NOT COMPLETED|Washout (24h)||1
11151930|NCT01530464|12339691|FG001|NOT COMPLETED|Washout (24h)||0
11151931|NCT01530464|12339690|FG000|STARTED|Third Intervention (24h)||9
11151932|NCT01530464|12339691|FG001|STARTED|Third Intervention (24h)||8
11151933|NCT01530464|12339690|FG000|COMPLETED|Third Intervention (24h)||9
11151934|NCT01530464|12339691|FG001|COMPLETED|Third Intervention (24h)||8
11151935|NCT01530464|12339690|FG000|NOT COMPLETED|Third Intervention (24h)||0
11151936|NCT01530464|12339691|FG001|NOT COMPLETED|Third Intervention (24h)||0
11151937|NCT01530464|12339690|FG000|STARTED|Washout (24h)||9
11151938|NCT01530464|12339691|FG001|STARTED|Washout (24h)||8
11151939|NCT01530464|12339690|FG000|COMPLETED|Washout (24h)||9
11151940|NCT01530464|12339691|FG001|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
11151941|NCT01530464|12339690|FG000|NOT COMPLETED|Washout (24h)||0
11151942|NCT01530464|12339691|FG001|NOT COMPLETED|Washout (24h)||1
11151943|NCT01530477|12339705|FG000|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
11151944|NCT01530477|12339706|FG001|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
11151945|NCT01530477|12339707|FG002|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
11151946|NCT01530477|12339705|FG000|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
11151947|NCT01530477|12339706|FG001|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
11151948|NCT01530477|12339707|FG002|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
11151949|NCT01530477|12339705|FG000|NOT COMPLETED|Overall Study||0
11151950|NCT01530477|12339706|FG001|NOT COMPLETED|Overall Study||0
11151951|NCT01530477|12339707|FG002|NOT COMPLETED|Overall Study||0
11151952|NCT01531153|12339716|FG000|STARTED|Overall Study||32
11151953|NCT01531153|12339717|FG001|STARTED|Overall Study||31
11151954|NCT01531153|12339718|FG002|STARTED|Overall Study||30
11151955|NCT01531153|12339716|FG000|COMPLETED|Overall Study||22
11151956|NCT01531153|12339717|FG001|COMPLETED|Overall Study||22
11151957|NCT01531153|12339718|FG002|COMPLETED|Overall Study||15
11151958|NCT01531153|12339716|FG000|NOT COMPLETED|Overall Study||10
11151959|NCT01531153|12339717|FG001|NOT COMPLETED|Overall Study||9
11151960|NCT01531153|12339718|FG002|NOT COMPLETED|Overall Study||15
11151961|NCT01531205|12339729|FG000|STARTED|Overall Study||2
11151962|NCT01531205|12339729|FG000|COMPLETED|Overall Study||1
11151963|NCT01531205|12339729|FG000|NOT COMPLETED|Overall Study||1
11151964|NCT01531335|12339737|FG000|STARTED|Overall Study||40
11151965|NCT01531335|12339738|FG001|STARTED|Overall Study||40
11151966|NCT01531335|12339737|FG000|COMPLETED|Overall Study||40
11151967|NCT01531335|12339738|FG001|COMPLETED|Overall Study||40
11151968|NCT01531335|12339737|FG000|NOT COMPLETED|Overall Study||0
11151969|NCT01531335|12339738|FG001|NOT COMPLETED|Overall Study||0
11151970|NCT01531439|12339746|FG000|STARTED|Overall Study||41
11151971|NCT01531439|12339747|FG001|STARTED|Overall Study||43
11151972|NCT01531439|12339746|FG000|COMPLETED|Overall Study||37
11151973|NCT01531439|12339747|FG001|COMPLETED|Overall Study||42
11151974|NCT01531439|12339746|FG000|NOT COMPLETED|Overall Study||4
11151975|NCT01531439|12339747|FG001|NOT COMPLETED|Overall Study||1
11151976|NCT01531673|12339766|FG000|STARTED|Overall Study||33
11151977|NCT01531673|12339767|FG001|STARTED|Overall Study||8
11151978|NCT01531673|12339768|FG002|STARTED|Overall Study||8
11151979|NCT01531673|12339769|FG003|STARTED|Overall Study||18
11151980|NCT01531673|12339770|FG004|STARTED|Overall Study||8
11151981|NCT01531673|12339771|FG005|STARTED|Overall Study||19
11151982|NCT01531673|12339772|FG006|STARTED|Overall Study||17
11151983|NCT01531673|12339773|FG007|STARTED|Overall Study||9
11151984|NCT01531673|12339774|FG008|STARTED|Overall Study||17
11151985|NCT01531673|12339775|FG009|STARTED|Overall Study||19
11151986|NCT01531673|12339776|FG010|STARTED|Overall Study||16
11151987|NCT01531673|12339777|FG011|STARTED|Overall Study||4
11151988|NCT01531673|12339778|FG012|STARTED|Overall Study||14
11151989|NCT01531673|12339766|FG000|COMPLETED|Overall Study||33
11151990|NCT01531673|12339767|FG001|COMPLETED|Overall Study||7
11151991|NCT01531673|12339768|FG002|COMPLETED|Overall Study||8
11151992|NCT01531673|12339769|FG003|COMPLETED|Overall Study||17
11151993|NCT01531673|12339770|FG004|COMPLETED|Overall Study||7
11151994|NCT01531673|12339771|FG005|COMPLETED|Overall Study||18
11151995|NCT01531673|12339772|FG006|COMPLETED|Overall Study||17
11151996|NCT01531673|12339773|FG007|COMPLETED|Overall Study||9
11151997|NCT01531673|12339774|FG008|COMPLETED|Overall Study||17
11151998|NCT01531673|12339775|FG009|COMPLETED|Overall Study||18
11151999|NCT01531673|12339776|FG010|COMPLETED|Overall Study||16
11152000|NCT01531673|12339777|FG011|COMPLETED|Overall Study||4
11152001|NCT01531673|12339778|FG012|COMPLETED|Overall Study||14
11152002|NCT01531673|12339766|FG000|NOT COMPLETED|Overall Study||0
11152003|NCT01531673|12339767|FG001|NOT COMPLETED|Overall Study||1
11152004|NCT01531673|12339768|FG002|NOT COMPLETED|Overall Study||0
11152005|NCT01531673|12339769|FG003|NOT COMPLETED|Overall Study||1
11152006|NCT01531673|12339770|FG004|NOT COMPLETED|Overall Study||1
11152007|NCT01531673|12339771|FG005|NOT COMPLETED|Overall Study||1
11152008|NCT01531673|12339772|FG006|NOT COMPLETED|Overall Study||0
11152009|NCT01531673|12339773|FG007|NOT COMPLETED|Overall Study||0
11152010|NCT01531673|12339774|FG008|NOT COMPLETED|Overall Study||0
11152011|NCT01531673|12339775|FG009|NOT COMPLETED|Overall Study||1
11152012|NCT01531673|12339776|FG010|NOT COMPLETED|Overall Study||0
11152013|NCT01531673|12339777|FG011|NOT COMPLETED|Overall Study||0
11152014|NCT01531673|12339778|FG012|NOT COMPLETED|Overall Study||0
11152015|NCT01531725|12339830|FG000|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
11152016|NCT01531725|12339830|FG000|COMPLETED|Overall Study||197
11152017|NCT01531725|12339830|FG000|NOT COMPLETED|Overall Study||5
11152018|NCT01531738|12339836|FG000|STARTED|Overall Study||11
11152019|NCT01531738|12339837|FG001|STARTED|Overall Study||11
11152020|NCT01531738|12339836|FG000|COMPLETED|Overall Study||11
11152021|NCT01531738|12339837|FG001|COMPLETED|Overall Study||11
11152022|NCT01531738|12339836|FG000|NOT COMPLETED|Overall Study||0
11152023|NCT01531738|12339837|FG001|NOT COMPLETED|Overall Study||0
11152024|NCT01531803|12339845|FG000|STARTED|Overall Study||1
11152025|NCT01531803|12339846|FG001|STARTED|Overall Study||2
11152026|NCT01531803|12339845|FG000|COMPLETED|Overall Study||1
11152027|NCT01531803|12339846|FG001|COMPLETED|Overall Study||2
11152028|NCT01531803|12339845|FG000|NOT COMPLETED|Overall Study||0
11152029|NCT01531803|12339846|FG001|NOT COMPLETED|Overall Study||0
11152030|NCT01531894|12339852|FG000|STARTED|Overall Study||11
11152031|NCT01531894|12339852|FG000|COMPLETED|Overall Study||2
11152032|NCT01531894|12339852|FG000|NOT COMPLETED|Overall Study||9
11152033|NCT01531959|12339858|FG000|STARTED|Overall Study||68
11152034|NCT01531959|12339859|FG001|STARTED|Overall Study||68
11322871|NCT04048382|12520154|FG000|NOT COMPLETED|3-Month Follow Up||2
11152035|NCT01531959|12339858|FG000|COMPLETED|Overall Study||66
11152036|NCT01531959|12339859|FG001|COMPLETED|Overall Study||66
11152037|NCT01531959|12339858|FG000|NOT COMPLETED|Overall Study||2
11152038|NCT01531959|12339859|FG001|NOT COMPLETED|Overall Study||2
11152039|NCT01531998|12339865|FG000|STARTED|Overall Study||11
11152040|NCT01531998|12339865|FG000|COMPLETED|Overall Study||8
11152041|NCT01531998|12339865|FG000|NOT COMPLETED|Overall Study||3
11152042|NCT01532089|12339871|FG000|STARTED|Overall Study||45
11152043|NCT01532089|12339872|FG001|STARTED|Overall Study||43
11152044|NCT01532089|12339871|FG000|COMPLETED|Overall Study||45
11152045|NCT01532089|12339872|FG001|COMPLETED|Overall Study||43
11152046|NCT01532089|12339871|FG000|NOT COMPLETED|Overall Study||0
11152047|NCT01532089|12339872|FG001|NOT COMPLETED|Overall Study||0
11152048|NCT01532128|12339883|FG000|STARTED|Overall Study||8
11152049|NCT01532128|12339884|FG001|STARTED|Overall Study||8
11152050|NCT01532128|12339885|FG002|STARTED|Overall Study||8
11152051|NCT01532128|12339883|FG000|COMPLETED|Overall Study||8
11152052|NCT01532128|12339884|FG001|COMPLETED|Overall Study||8
11152053|NCT01532128|12339885|FG002|COMPLETED|Overall Study||8
11152054|NCT01532128|12339883|FG000|NOT COMPLETED|Overall Study||0
11152055|NCT01532128|12339884|FG001|NOT COMPLETED|Overall Study||0
11152056|NCT01532128|12339885|FG002|NOT COMPLETED|Overall Study||0
11152057|NCT01532141|12339897|FG000|STARTED|Overall Study||9
11152058|NCT01532141|12339898|FG001|STARTED|Overall Study||8
11152059|NCT01532141|12339899|FG002|STARTED|Overall Study||8
11152060|NCT01532141|12339897|FG000|Period 1|Overall Study||9
11152061|NCT01532141|12339898|FG001|Period 1|Overall Study||8
11152062|NCT01532141|12339899|FG002|Period 1|Overall Study||8
11152063|NCT01532141|12339897|FG000|Period 2|Overall Study||8
11152064|NCT01532141|12339898|FG001|Period 2|Overall Study||8
11152065|NCT01532141|12339899|FG002|Period 2|Overall Study||8
11152066|NCT01532141|12339897|FG000|Period 3|Overall Study||8
11152067|NCT01532141|12339898|FG001|Period 3|Overall Study||8
11152068|NCT01532141|12339899|FG002|Period 3|Overall Study||8
11152069|NCT01532141|12339897|FG000|COMPLETED|Overall Study||8
11152070|NCT01532141|12339898|FG001|COMPLETED|Overall Study||8
11152071|NCT01532141|12339899|FG002|COMPLETED|Overall Study||8
11152072|NCT01532141|12339897|FG000|NOT COMPLETED|Overall Study||1
11152073|NCT01532141|12339898|FG001|NOT COMPLETED|Overall Study||0
11152074|NCT01532141|12339899|FG002|NOT COMPLETED|Overall Study||0
11152075|NCT01532349|12339910|FG000|STARTED|Overall Study||17
11152076|NCT01532349|12339911|FG001|STARTED|Overall Study||17
11152077|NCT01532349|12339910|FG000|COMPLETED|Overall Study||15
11152078|NCT01532349|12339911|FG001|COMPLETED|Overall Study||12
11152079|NCT01532349|12339910|FG000|NOT COMPLETED|Overall Study||2
11152080|NCT01532349|12339911|FG001|NOT COMPLETED|Overall Study||5
11152081|NCT01532388|12339919|FG000|STARTED|3-month Follow-up||101
11152082|NCT01532388|12339920|FG001|STARTED|3-month Follow-up||101
11152083|NCT01532388|12339919|FG000|COMPLETED|3-month Follow-up||33
11152084|NCT01532388|12339920|FG001|COMPLETED|3-month Follow-up||33
11152085|NCT01532388|12339919|FG000|NOT COMPLETED|3-month Follow-up||68
11152086|NCT01532388|12339920|FG001|NOT COMPLETED|3-month Follow-up||68
11152087|NCT01532388|12339919|FG000|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
11152088|NCT01532388|12339920|FG001|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
11152089|NCT01532388|12339919|FG000|COMPLETED|6-month Follow-up||27
11152090|NCT01532388|12339920|FG001|COMPLETED|6-month Follow-up||35
11152091|NCT01532388|12339919|FG000|NOT COMPLETED|6-month Follow-up||74
11152092|NCT01532388|12339920|FG001|NOT COMPLETED|6-month Follow-up||66
11152093|NCT01532388|12339919|FG000|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
11152094|NCT01532388|12339920|FG001|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
11152095|NCT01532388|12339919|FG000|COMPLETED|12-month Follow-up||32
11152096|NCT01532388|12339920|FG001|COMPLETED|12-month Follow-up||34
11152097|NCT01532388|12339919|FG000|NOT COMPLETED|12-month Follow-up||69
11152098|NCT01532388|12339920|FG001|NOT COMPLETED|12-month Follow-up||67
11152099|NCT01532414|12339929|FG000|STARTED|Overall Study||92
11152100|NCT01532414|12339930|FG001|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
11152101|NCT01532414|12339931|FG002|STARTED|Overall Study||38
11152102|NCT01532414|12339929|FG000|COMPLETED|Overall Study||85
11152103|NCT01532414|12339930|FG001|COMPLETED|Overall Study||19
11152104|NCT01532414|12339931|FG002|COMPLETED|Overall Study||35
11152105|NCT01532414|12339929|FG000|NOT COMPLETED|Overall Study||7
11152106|NCT01532414|12339930|FG001|NOT COMPLETED|Overall Study||2
11152107|NCT01532414|12339931|FG002|NOT COMPLETED|Overall Study||3
11152108|NCT01532453|12339941|FG000|STARTED|Overall Study||81
11152109|NCT01532453|12339942|FG001|STARTED|Overall Study||160
11152110|NCT01532453|12339941|FG000|COMPLETED|Overall Study||54
11152111|NCT01532453|12339942|FG001|COMPLETED|Overall Study||90
11152112|NCT01532453|12339941|FG000|NOT COMPLETED|Overall Study||27
11152113|NCT01532453|12339942|FG001|NOT COMPLETED|Overall Study||70
11152114|NCT01532570|12339952|FG000|STARTED|Overall Study||11
11152115|NCT01532570|12339953|FG001|STARTED|Overall Study||2
11152116|NCT01532570|12339954|FG002|STARTED|Overall Study||1
11152117|NCT01532570|12339955|FG003|STARTED|Overall Study||4
11152118|NCT01532570|12339952|FG000|COMPLETED|Overall Study||10
11152119|NCT01532570|12339953|FG001|COMPLETED|Overall Study||1
11152120|NCT01532570|12339954|FG002|COMPLETED|Overall Study||1
11152121|NCT01532570|12339955|FG003|COMPLETED|Overall Study||4
11152122|NCT01532570|12339952|FG000|NOT COMPLETED|Overall Study||1
11152123|NCT01532570|12339953|FG001|NOT COMPLETED|Overall Study||1
11152124|NCT01532570|12339954|FG002|NOT COMPLETED|Overall Study||0
11152125|NCT01532570|12339955|FG003|NOT COMPLETED|Overall Study||0
11152126|NCT01532648|12339974|FG000|STARTED|Overall Study||255
11152127|NCT01532648|12339975|FG001|STARTED|Overall Study||255
11152128|NCT01532648|12339974|FG000|Safety Population|Overall Study||255
11152129|NCT01532648|12339975|FG001|Safety Population|Overall Study||255
11152130|NCT01532648|12339974|FG000|Intent-To-Treat Population|Overall Study||230
11152131|NCT01532648|12339975|FG001|Intent-To-Treat Population|Overall Study||228
11152132|NCT01532648|12339974|FG000|COMPLETED|Overall Study||219
11152133|NCT01532648|12339975|FG001|COMPLETED|Overall Study||238
11152134|NCT01532648|12339974|FG000|NOT COMPLETED|Overall Study||36
11152135|NCT01532648|12339975|FG001|NOT COMPLETED|Overall Study||17
11152136|NCT01532687|12339983|FG000|STARTED|Overall Study||29
11152137|NCT01532687|12339984|FG001|STARTED|Overall Study||25
11152138|NCT01532687|12339983|FG000|Crossover to Open-label Pazopanib|Overall Study||0
11152139|NCT01532687|12339984|FG001|Crossover to Open-label Pazopanib|Overall Study||14
11152140|NCT01532687|12339983|FG000|COMPLETED|Overall Study|Participants remain on treatment until time of progression and through the AE assessment period|15
11152141|NCT01532687|12339984|FG001|COMPLETED|Overall Study|Participants remain on treatment until time of progression|23
11152142|NCT01532687|12339983|FG000|NOT COMPLETED|Overall Study||14
11152143|NCT01532687|12339984|FG001|NOT COMPLETED|Overall Study||2
11152144|NCT01532700|12339992|FG000|STARTED|Overall Study||28
11152145|NCT01532700|12339992|FG000|COMPLETED|Overall Study||28
11152146|NCT01532700|12339992|FG000|NOT COMPLETED|Overall Study||0
11152147|NCT01532817|12339996|FG000|STARTED|Overall Study||30
11152148|NCT01532817|12339996|FG000|COMPLETED|Overall Study||30
11152149|NCT01532817|12339996|FG000|NOT COMPLETED|Overall Study||0
11152150|NCT01532830|12340000|FG000|STARTED|Overall Study||30
11152151|NCT01532830|12340000|FG000|COMPLETED|Overall Study||26
11152152|NCT01532830|12340000|FG000|NOT COMPLETED|Overall Study||4
11152153|NCT01532869|12340006|FG000|STARTED|Blinded-Treatment Period (Up to Week 24)||44
11152154|NCT01532869|12340007|FG001|STARTED|Blinded-Treatment Period (Up to Week 24)||43
11152155|NCT01532869|12340006|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
11152156|NCT01532869|12340007|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
11152157|NCT01532869|12340006|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
11152158|NCT01532869|12340007|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
11152159|NCT01532869|12340006|FG000|STARTED|Blinded-Treatment Period (Up to Week 48)||44
11152160|NCT01532869|12340007|FG001|STARTED|Blinded-Treatment Period (Up to Week 48)||43
11152161|NCT01532869|12340006|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
11152162|NCT01532869|12340007|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
11152163|NCT01532869|12340006|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
11152164|NCT01532869|12340007|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
11152165|NCT01532869|12340006|FG000|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
11152166|NCT01532869|12340007|FG001|STARTED|Open-label Period (Week 48 to Week 96)||30
11152167|NCT01532869|12340006|FG000|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
11152168|NCT01532869|12340007|FG001|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
11152169|NCT01532869|12340006|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
11152170|NCT01532869|12340007|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
11152171|NCT01532908|12340020|FG000|STARTED|Overall Study||9
11152172|NCT01532908|12340021|FG001|STARTED|Overall Study||2
11152173|NCT01532908|12340020|FG000|Infused|Overall Study||9
11152174|NCT01532908|12340021|FG001|Infused|Overall Study||2
11152175|NCT01532908|12340020|FG000|Transplanted|Overall Study||8
11152176|NCT01532908|12340021|FG001|Transplanted|Overall Study||2
11152177|NCT01532908|12340020|FG000|COMPLETED|Overall Study||8
11152178|NCT01532908|12340021|FG001|COMPLETED|Overall Study||2
11152179|NCT01532908|12340020|FG000|NOT COMPLETED|Overall Study||1
11152180|NCT01532908|12340021|FG001|NOT COMPLETED|Overall Study||0
11152181|NCT01532921|12340027|FG000|STARTED|Overall Study||85
11152182|NCT01532921|12340027|FG000|Implantation Procedure|Overall Study||76
11152183|NCT01532921|12340027|FG000|Discharge|Overall Study||75
11152184|NCT01532921|12340027|FG000|6 Months Follow Up|Overall Study||68
11152185|NCT01532921|12340027|FG000|COMPLETED|Overall Study||69
11152186|NCT01532921|12340027|FG000|NOT COMPLETED|Overall Study||16
11152187|NCT01532934|12340037|FG000|STARTED|Overall Study||53
11152188|NCT01532934|12340038|FG001|STARTED|Overall Study||52
11152189|NCT01532934|12340037|FG000|COMPLETED|Overall Study||39
11152190|NCT01532934|12340038|FG001|COMPLETED|Overall Study||39
11152191|NCT01532934|12340037|FG000|NOT COMPLETED|Overall Study||14
11152192|NCT01532934|12340038|FG001|NOT COMPLETED|Overall Study||13
11152193|NCT01532973|12340055|FG000|STARTED|Part 1||6
11152194|NCT01532973|12340056|FG001|STARTED|Part 1||6
11152195|NCT01532973|12340057|FG002|STARTED|Part 1||6
11152196|NCT01532973|12340058|FG003|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
11152197|NCT01532973|12340059|FG004|STARTED|Part 1||0
11152198|NCT01532973|12340060|FG005|STARTED|Part 1||0
11152199|NCT01532973|12340061|FG006|STARTED|Part 1||0
11152200|NCT01532973|12340062|FG007|STARTED|Part 1||0
11152201|NCT01532973|12340063|FG008|STARTED|Part 1||0
11152202|NCT01532973|12340064|FG009|STARTED|Part 1||0
11152203|NCT01532973|12340055|FG000|COMPLETED|Part 1||6
11152204|NCT01532973|12340056|FG001|COMPLETED|Part 1||6
11152205|NCT01532973|12340057|FG002|COMPLETED|Part 1||6
11152206|NCT01532973|12340058|FG003|COMPLETED|Part 1||0
11152207|NCT01532973|12340059|FG004|COMPLETED|Part 1||0
11152208|NCT01532973|12340060|FG005|COMPLETED|Part 1||0
11152209|NCT01532973|12340061|FG006|COMPLETED|Part 1||0
11152210|NCT01532973|12340062|FG007|COMPLETED|Part 1||0
11152211|NCT01532973|12340063|FG008|COMPLETED|Part 1||0
11152212|NCT01532973|12340064|FG009|COMPLETED|Part 1||0
11152213|NCT01532973|12340055|FG000|NOT COMPLETED|Part 1||0
11152214|NCT01532973|12340056|FG001|NOT COMPLETED|Part 1||0
11152215|NCT01532973|12340057|FG002|NOT COMPLETED|Part 1||0
11152216|NCT01532973|12340058|FG003|NOT COMPLETED|Part 1||0
11152217|NCT01532973|12340059|FG004|NOT COMPLETED|Part 1||0
11152218|NCT01532973|12340060|FG005|NOT COMPLETED|Part 1||0
11152219|NCT01532973|12340061|FG006|NOT COMPLETED|Part 1||0
11152220|NCT01532973|12340062|FG007|NOT COMPLETED|Part 1||0
11152221|NCT01532973|12340063|FG008|NOT COMPLETED|Part 1||0
11152222|NCT01532973|12340064|FG009|NOT COMPLETED|Part 1||0
11152223|NCT01532973|12340055|FG000|STARTED|Part 2||0
11152224|NCT01532973|12340056|FG001|STARTED|Part 2||0
11152225|NCT01532973|12340057|FG002|STARTED|Part 2||0
11152226|NCT01532973|12340058|FG003|STARTED|Part 2||0
11152227|NCT01532973|12340059|FG004|STARTED|Part 2||6
11152228|NCT01532973|12340060|FG005|STARTED|Part 2||6
11152229|NCT01532973|12340061|FG006|STARTED|Part 2||6
11152230|NCT01532973|12340062|FG007|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
11152231|NCT01532973|12340063|FG008|STARTED|Part 2||0
11152232|NCT01532973|12340064|FG009|STARTED|Part 2||0
11152233|NCT01532973|12340055|FG000|COMPLETED|Part 2||0
11152234|NCT01532973|12340056|FG001|COMPLETED|Part 2||0
11152235|NCT01532973|12340057|FG002|COMPLETED|Part 2||0
11152236|NCT01532973|12340058|FG003|COMPLETED|Part 2||0
11152237|NCT01532973|12340059|FG004|COMPLETED|Part 2||6
11152238|NCT01532973|12340060|FG005|COMPLETED|Part 2||6
11152239|NCT01532973|12340061|FG006|COMPLETED|Part 2||6
11152240|NCT01532973|12340062|FG007|COMPLETED|Part 2||0
11152241|NCT01532973|12340063|FG008|COMPLETED|Part 2||0
11152242|NCT01532973|12340064|FG009|COMPLETED|Part 2||0
11152243|NCT01532973|12340055|FG000|NOT COMPLETED|Part 2||0
11152244|NCT01532973|12340056|FG001|NOT COMPLETED|Part 2||0
11152245|NCT01532973|12340057|FG002|NOT COMPLETED|Part 2||0
11152246|NCT01532973|12340058|FG003|NOT COMPLETED|Part 2||0
11152247|NCT01532973|12340059|FG004|NOT COMPLETED|Part 2||0
11152248|NCT01532973|12340060|FG005|NOT COMPLETED|Part 2||0
11152249|NCT01532973|12340061|FG006|NOT COMPLETED|Part 2||0
11152250|NCT01532973|12340062|FG007|NOT COMPLETED|Part 2||0
11152251|NCT01532973|12340063|FG008|NOT COMPLETED|Part 2||0
11152252|NCT01532973|12340064|FG009|NOT COMPLETED|Part 2||0
11152253|NCT01532973|12340055|FG000|STARTED|Part 3||0
11152254|NCT01532973|12340056|FG001|STARTED|Part 3||0
11152255|NCT01532973|12340057|FG002|STARTED|Part 3||0
11152256|NCT01532973|12340058|FG003|STARTED|Part 3||0
11152257|NCT01532973|12340059|FG004|STARTED|Part 3||0
11152258|NCT01532973|12340060|FG005|STARTED|Part 3||0
11152259|NCT01532973|12340061|FG006|STARTED|Part 3||0
11152260|NCT01532973|12340062|FG007|STARTED|Part 3||0
11152261|NCT01532973|12340063|FG008|STARTED|Part 3||6
11152262|NCT01532973|12340064|FG009|STARTED|Part 3||6
11152263|NCT01532973|12340055|FG000|COMPLETED|Part 3||0
11152264|NCT01532973|12340056|FG001|COMPLETED|Part 3||0
11152265|NCT01532973|12340057|FG002|COMPLETED|Part 3||0
11152266|NCT01532973|12340058|FG003|COMPLETED|Part 3||0
11152267|NCT01532973|12340059|FG004|COMPLETED|Part 3||0
11152268|NCT01532973|12340060|FG005|COMPLETED|Part 3||0
11152269|NCT01532973|12340061|FG006|COMPLETED|Part 3||0
11152270|NCT01532973|12340062|FG007|COMPLETED|Part 3||0
11152271|NCT01532973|12340063|FG008|COMPLETED|Part 3||6
11152272|NCT01532973|12340064|FG009|COMPLETED|Part 3||6
11152273|NCT01532973|12340055|FG000|NOT COMPLETED|Part 3||0
11152274|NCT01532973|12340056|FG001|NOT COMPLETED|Part 3||0
11152275|NCT01532973|12340057|FG002|NOT COMPLETED|Part 3||0
11152276|NCT01532973|12340058|FG003|NOT COMPLETED|Part 3||0
11152277|NCT01532973|12340059|FG004|NOT COMPLETED|Part 3||0
11152278|NCT01532973|12340060|FG005|NOT COMPLETED|Part 3||0
11152279|NCT01532973|12340061|FG006|NOT COMPLETED|Part 3||0
11152280|NCT01532973|12340062|FG007|NOT COMPLETED|Part 3||0
11152281|NCT01532973|12340063|FG008|NOT COMPLETED|Part 3||0
11152282|NCT01532973|12340064|FG009|NOT COMPLETED|Part 3||0
11152283|NCT01532986|12340090|FG000|STARTED|Overall Study||166
11152284|NCT01532986|12340091|FG001|STARTED|Overall Study||162
11152285|NCT01532986|12340090|FG000|COMPLETED|Overall Study||143
11152286|NCT01532986|12340091|FG001|COMPLETED|Overall Study||138
11152287|NCT01532986|12340090|FG000|NOT COMPLETED|Overall Study||23
11152288|NCT01532986|12340091|FG001|NOT COMPLETED|Overall Study||24
11152289|NCT01532999|12340100|FG000|STARTED|Overall Study||96
11152290|NCT01532999|12340101|FG001|STARTED|Overall Study||95
11152291|NCT01532999|12340100|FG000|COMPLETED|Overall Study||65
11152292|NCT01532999|12340101|FG001|COMPLETED|Overall Study||77
11152293|NCT01532999|12340100|FG000|NOT COMPLETED|Overall Study||31
11152294|NCT01532999|12340101|FG001|NOT COMPLETED|Overall Study||18
11152295|NCT01533038|12340109|FG000|STARTED|Overall Study||45
11152296|NCT01533038|12340110|FG001|STARTED|Overall Study||35
11152297|NCT01533038|12340109|FG000|COMPLETED|Overall Study||45
11152298|NCT01533038|12340110|FG001|COMPLETED|Overall Study||34
11152299|NCT01533038|12340109|FG000|NOT COMPLETED|Overall Study||0
11152300|NCT01533038|12340110|FG001|NOT COMPLETED|Overall Study||1
11152301|NCT01533077|12340120|FG000|STARTED|Overall Study||5
11152302|NCT01533077|12340121|FG001|STARTED|Overall Study||5
11152303|NCT01533077|12340122|FG002|STARTED|Overall Study||4
11152304|NCT01533077|12340123|FG003|STARTED|Overall Study||4
11152305|NCT01533077|12340120|FG000|BIA 9-1067 50 mg|Overall Study||5
11152306|NCT01533077|12340121|FG001|BIA 9-1067 50 mg|Overall Study||5
11152307|NCT01533077|12340122|FG002|BIA 9-1067 50 mg|Overall Study||4
11152308|NCT01533077|12340123|FG003|BIA 9-1067 50 mg|Overall Study||4
11152309|NCT01533077|12340120|FG000|Sinemet® 100/25|Overall Study||4
11152310|NCT01533077|12340121|FG001|Sinemet® 100/25|Overall Study||5
11152311|NCT01533077|12340122|FG002|Sinemet® 100/25|Overall Study||4
11152312|NCT01533077|12340123|FG003|Sinemet® 100/25|Overall Study||4
11152313|NCT01533077|12340120|FG000|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
11152314|NCT01533077|12340121|FG001|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
11152315|NCT01533077|12340122|FG002|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
11152316|NCT01533077|12340123|FG003|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
11152317|NCT01533077|12340120|FG000|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
11152318|NCT01533077|12340121|FG001|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
11152319|NCT01533077|12340122|FG002|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
11152320|NCT01533077|12340123|FG003|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
11152321|NCT01533077|12340120|FG000|COMPLETED|Overall Study||4
11152322|NCT01533077|12340121|FG001|COMPLETED|Overall Study||4
11152323|NCT01533077|12340122|FG002|COMPLETED|Overall Study||4
11152324|NCT01533077|12340123|FG003|COMPLETED|Overall Study||4
11152325|NCT01533077|12340120|FG000|NOT COMPLETED|Overall Study||1
11152326|NCT01533077|12340121|FG001|NOT COMPLETED|Overall Study||1
11152327|NCT01533077|12340122|FG002|NOT COMPLETED|Overall Study||0
11152328|NCT01533077|12340123|FG003|NOT COMPLETED|Overall Study||0
11152329|NCT01533116|12340137|FG000|STARTED|Overall Study||14
11152330|NCT01533116|12340138|FG001|STARTED|Overall Study||13
11152331|NCT01533116|12340139|FG002|STARTED|Overall Study||13
11152332|NCT01533116|12340140|FG003|STARTED|Overall Study||12
11152333|NCT01533116|12340137|FG000|COMPLETED|Overall Study||12
11152334|NCT01533116|12340138|FG001|COMPLETED|Overall Study||12
11152335|NCT01533116|12340139|FG002|COMPLETED|Overall Study||12
11152336|NCT01533116|12340140|FG003|COMPLETED|Overall Study||12
11152337|NCT01533116|12340137|FG000|NOT COMPLETED|Overall Study||2
11152338|NCT01533116|12340138|FG001|NOT COMPLETED|Overall Study||1
11152339|NCT01533116|12340139|FG002|NOT COMPLETED|Overall Study||1
11152340|NCT01533116|12340140|FG003|NOT COMPLETED|Overall Study||0
11152341|NCT01533181|12340152|FG000|STARTED|Overall Study||15
11152342|NCT01533181|12340153|FG001|STARTED|Overall Study||29
11152343|NCT01533181|12340152|FG000|COMPLETED|Overall Study||14
11152344|NCT01533181|12340153|FG001|COMPLETED|Overall Study||28
11152345|NCT01533181|12340152|FG000|NOT COMPLETED|Overall Study||1
11152346|NCT01533181|12340153|FG001|NOT COMPLETED|Overall Study||1
11152347|NCT01533207|12340161|FG000|STARTED|Overall Study||20
11152348|NCT01533207|12340162|FG001|STARTED|Overall Study||18
11152349|NCT01533207|12340161|FG000|COMPLETED|Overall Study||20
11152350|NCT01533207|12340162|FG001|COMPLETED|Overall Study||18
11152351|NCT01533207|12340161|FG000|NOT COMPLETED|Overall Study||0
11152352|NCT01533207|12340162|FG001|NOT COMPLETED|Overall Study||0
11203096|NCT01845077|12393606|FG001|COMPLETED|Washout Period||11
11203097|NCT01845077|12393607|FG002|COMPLETED|Washout Period||11
11203098|NCT01845077|12393608|FG003|COMPLETED|Washout Period||10
11203099|NCT01845077|12393609|FG004|COMPLETED|Washout Period||11
11203100|NCT01845077|12393610|FG005|COMPLETED|Washout Period||11
11203101|NCT01845077|12393605|FG000|NOT COMPLETED|Washout Period||1
11203102|NCT01845077|12393606|FG001|NOT COMPLETED|Washout Period||1
11203103|NCT01845077|12393607|FG002|NOT COMPLETED|Washout Period||1
11203104|NCT01845077|12393608|FG003|NOT COMPLETED|Washout Period||2
11418682|NCT00469612|12617028|FG000|NOT COMPLETED|Overall Study||2
11203105|NCT01845077|12393609|FG004|NOT COMPLETED|Washout Period||1
11203106|NCT01845077|12393610|FG005|NOT COMPLETED|Washout Period||1
11203107|NCT01845077|12393605|FG000|STARTED|Treatment Period 2||11
11203108|NCT01845077|12393606|FG001|STARTED|Treatment Period 2||11
11203109|NCT01845077|12393607|FG002|STARTED|Treatment Period 2||11
11203110|NCT01845077|12393608|FG003|STARTED|Treatment Period 2||10
11203111|NCT01845077|12393609|FG004|STARTED|Treatment Period 2||11
11152353|NCT01533246|12340168|FG000|STARTED|Overall Study||17
11152354|NCT01533246|12340168|FG000|COMPLETED|Overall Study||15
11152355|NCT01533246|12340168|FG000|NOT COMPLETED|Overall Study||2
11152356|NCT01533259|12340172|FG000|STARTED|Overall Study||48
11152357|NCT01533259|12340172|FG000|COMPLETED|Overall Study||48
11152358|NCT01533259|12340172|FG000|NOT COMPLETED|Overall Study||0
11152359|NCT01533428|12340178|FG000|STARTED|Overall Study||186
11152360|NCT01533428|12340179|FG001|STARTED|Overall Study||183
11152361|NCT01533428|12340178|FG000|COMPLETED|Overall Study||177
11152362|NCT01533428|12340179|FG001|COMPLETED|Overall Study||175
11152363|NCT01533428|12340178|FG000|NOT COMPLETED|Overall Study||9
11152364|NCT01533428|12340179|FG001|NOT COMPLETED|Overall Study||8
11152365|NCT01533493|12340187|FG000|STARTED|Overall Study||12
11152366|NCT01533493|12340188|FG001|STARTED|Overall Study||14
11152367|NCT01533493|12340187|FG000|COMPLETED|Overall Study||7
11152368|NCT01533493|12340188|FG001|COMPLETED|Overall Study||11
11152369|NCT01533493|12340187|FG000|NOT COMPLETED|Overall Study||5
11152370|NCT01533493|12340188|FG001|NOT COMPLETED|Overall Study||3
11152371|NCT01533597|12340196|FG000|STARTED|Overall Study||35
11152372|NCT01533597|12340197|FG001|STARTED|Overall Study||35
11152373|NCT01533597|12340196|FG000|COMPLETED|Overall Study||29
11152374|NCT01533597|12340197|FG001|COMPLETED|Overall Study||25
11152375|NCT01533597|12340196|FG000|NOT COMPLETED|Overall Study||6
11152376|NCT01533597|12340197|FG001|NOT COMPLETED|Overall Study||10
11152377|NCT01533688|12340206|FG000|STARTED|Overall Study||71
11152378|NCT01533688|12340207|FG001|STARTED|Overall Study||70
11152379|NCT01533688|12340208|FG002|STARTED|Overall Study||71
11152380|NCT01533688|12340206|FG000|COMPLETED|Overall Study||63
11152381|NCT01533688|12340207|FG001|COMPLETED|Overall Study||60
11152382|NCT01533688|12340208|FG002|COMPLETED|Overall Study||63
11152383|NCT01533688|12340206|FG000|NOT COMPLETED|Overall Study||8
11152384|NCT01533688|12340207|FG001|NOT COMPLETED|Overall Study||10
11152385|NCT01533688|12340208|FG002|NOT COMPLETED|Overall Study||8
11152386|NCT01533922|12340218|FG000|STARTED|Overall Study||59
11152387|NCT01533922|12340219|FG001|STARTED|Overall Study||59
11152388|NCT01533922|12340220|FG002|STARTED|Overall Study||60
11152389|NCT01533922|12340221|FG003|STARTED|Overall Study||58
11152390|NCT01533922|12340222|FG004|STARTED|Overall Study||59
11152391|NCT01533922|12340218|FG000|Received Placebo|Overall Study||0
11152392|NCT01533922|12340219|FG001|Received Placebo|Overall Study||49
11152393|NCT01533922|12340220|FG002|Received Placebo|Overall Study||57
11152394|NCT01533922|12340221|FG003|Received Placebo|Overall Study||57
11152395|NCT01533922|12340222|FG004|Received Placebo|Overall Study||59
11152396|NCT01533922|12340218|FG000|Received Olo 5|Overall Study||51
11152397|NCT01533922|12340219|FG001|Received Olo 5|Overall Study||52
11152398|NCT01533922|12340220|FG002|Received Olo 5|Overall Study||57
11418683|NCT00469612|12617029|FG001|NOT COMPLETED|Overall Study||0
11418684|NCT00461812|12617035|FG000|STARTED|Overall Study||10
11418685|NCT00461812|12617035|FG000|COMPLETED|Overall Study||0
11418686|NCT00461812|12617035|FG000|NOT COMPLETED|Overall Study||10
11152399|NCT01533922|12340221|FG003|Received Olo 5|Overall Study||57
11152400|NCT01533922|12340222|FG004|Received Olo 5|Overall Study||0
11152401|NCT01533922|12340218|FG000|Received Tio 5|Overall Study||54
11152402|NCT01533922|12340219|FG001|Received Tio 5|Overall Study||58
11152403|NCT01533922|12340220|FG002|Received Tio 5|Overall Study||59
11152404|NCT01533922|12340221|FG003|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
11152405|NCT01533922|12340222|FG004|Received Tio 5|Overall Study||54
11152406|NCT01533922|12340218|FG000|Received Tio+Olo 2.5/5|Overall Study||59
11152407|NCT01533922|12340219|FG001|Received Tio+Olo 2.5/5|Overall Study||0
11152408|NCT01533922|12340220|FG002|Received Tio+Olo 2.5/5|Overall Study||52
11152409|NCT01533922|12340221|FG003|Received Tio+Olo 2.5/5|Overall Study||55
11152410|NCT01533922|12340222|FG004|Received Tio+Olo 2.5/5|Overall Study||56
11152411|NCT01533922|12340218|FG000|Received Tio+Olo 5/5|Overall Study||58
11152412|NCT01533922|12340219|FG001|Received Tio+Olo 5/5|Overall Study||59
11152413|NCT01533922|12340220|FG002|Received Tio+Olo 5/5|Overall Study||0
11152414|NCT01533922|12340221|FG003|Received Tio+Olo 5/5|Overall Study||53
11152415|NCT01533922|12340222|FG004|Received Tio+Olo 5/5|Overall Study||56
11152416|NCT01533922|12340218|FG000|COMPLETED|Overall Study|Completed all treatment arms|49
11152417|NCT01533922|12340219|FG001|COMPLETED|Overall Study|Completed all treatment arms|47
11152418|NCT01533922|12340220|FG002|COMPLETED|Overall Study|Completed all treatment arms|50
11152419|NCT01533922|12340221|FG003|COMPLETED|Overall Study|Completed all treatment arms|53
11152420|NCT01533922|12340222|FG004|COMPLETED|Overall Study|Completed all treatment arms|53
11152421|NCT01533922|12340218|FG000|NOT COMPLETED|Overall Study||10
11152422|NCT01533922|12340219|FG001|NOT COMPLETED|Overall Study||12
11152423|NCT01533922|12340220|FG002|NOT COMPLETED|Overall Study||10
11152424|NCT01533922|12340221|FG003|NOT COMPLETED|Overall Study||5
11152425|NCT01533922|12340222|FG004|NOT COMPLETED|Overall Study||6
11152426|NCT01533935|12340234|FG000|STARTED|Overall Study||58
11152427|NCT01533935|12340235|FG001|STARTED|Overall Study||58
11152428|NCT01533935|12340236|FG002|STARTED|Overall Study||58
11152429|NCT01533935|12340237|FG003|STARTED|Overall Study||59
11152430|NCT01533935|12340238|FG004|STARTED|Overall Study||58
11152431|NCT01533935|12340234|FG000|Received Placebo|Overall Study||0
11152432|NCT01533935|12340235|FG001|Received Placebo|Overall Study||47
11152433|NCT01533935|12340236|FG002|Received Placebo|Overall Study||52
11152434|NCT01533935|12340237|FG003|Received Placebo|Overall Study||57
11152435|NCT01533935|12340238|FG004|Received Placebo|Overall Study||58
11152436|NCT01533935|12340234|FG000|Received Olo 5|Overall Study||52
11418687|NCT00459121|12617040|FG000|STARTED|Overall Study||2
11152437|NCT01533935|12340235|FG001|Received Olo 5|Overall Study||52
11152438|NCT01533935|12340236|FG002|Received Olo 5|Overall Study||55
11152439|NCT01533935|12340237|FG003|Received Olo 5|Overall Study||59
11152440|NCT01533935|12340238|FG004|Received Olo 5|Overall Study||0
11152441|NCT01533935|12340234|FG000|Received Tio 5|Overall Study||54
11152442|NCT01533935|12340235|FG001|Received Tio 5|Overall Study||54
11152443|NCT01533935|12340236|FG002|Received Tio 5|Overall Study||58
11152444|NCT01533935|12340237|FG003|Received Tio 5|Overall Study||0
11152445|NCT01533935|12340238|FG004|Received Tio 5|Overall Study||52
11152446|NCT01533935|12340234|FG000|Received Tio+Olo 2.5/5|Overall Study||58
11152447|NCT01533935|12340235|FG001|Received Tio+Olo 2.5/5|Overall Study||0
11152448|NCT01533935|12340236|FG002|Received Tio+Olo 2.5/5|Overall Study||49
11152449|NCT01533935|12340237|FG003|Received Tio+Olo 2.5/5|Overall Study||56
11152450|NCT01533935|12340238|FG004|Received Tio+Olo 2.5/5|Overall Study||56
11152451|NCT01533935|12340234|FG000|Received Tio+Olo 5/5|Overall Study||56
11152452|NCT01533935|12340235|FG001|Received Tio+Olo 5/5|Overall Study||58
11418688|NCT00459121|12617040|FG000|COMPLETED|Overall Study||2
11418689|NCT00459121|12617040|FG000|NOT COMPLETED|Overall Study||0
11152453|NCT01533935|12340236|FG002|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
11152454|NCT01533935|12340237|FG003|Received Tio+Olo 5/5|Overall Study||54
11152455|NCT01533935|12340238|FG004|Received Tio+Olo 5/5|Overall Study||55
11152456|NCT01533935|12340234|FG000|COMPLETED|Overall Study|All treatment periods|52
11152457|NCT01533935|12340235|FG001|COMPLETED|Overall Study|All treatment periods|45
11152458|NCT01533935|12340236|FG002|COMPLETED|Overall Study|All treatment periods|50
11152459|NCT01533935|12340237|FG003|COMPLETED|Overall Study|All treatment periods|52
11152460|NCT01533935|12340238|FG004|COMPLETED|Overall Study|All treatment periods|50
11152461|NCT01533935|12340234|FG000|NOT COMPLETED|Overall Study||6
11152462|NCT01533935|12340235|FG001|NOT COMPLETED|Overall Study||13
11152463|NCT01533935|12340236|FG002|NOT COMPLETED|Overall Study||8
11152464|NCT01533935|12340237|FG003|NOT COMPLETED|Overall Study||7
11152465|NCT01533935|12340238|FG004|NOT COMPLETED|Overall Study||8
11152466|NCT01533948|12340250|FG000|STARTED|Overall Study||25
11152467|NCT01533948|12340250|FG000|COMPLETED|Overall Study||25
11152468|NCT01533948|12340250|FG000|NOT COMPLETED|Overall Study||0
11152469|NCT01533974|12340256|FG000|STARTED|Overall Study||224
11152470|NCT01533974|12340257|FG001|STARTED|Overall Study||226
11152471|NCT01533974|12340256|FG000|COMPLETED|Overall Study||173
11152472|NCT01533974|12340257|FG001|COMPLETED|Overall Study||176
11152473|NCT01533974|12340256|FG000|NOT COMPLETED|Overall Study||51
11152474|NCT01533974|12340257|FG001|NOT COMPLETED|Overall Study||50
11152475|NCT01534013|12340265|FG000|STARTED|Overall Study||8
11152476|NCT01534013|12340266|FG001|STARTED|Overall Study||6
11152477|NCT01534013|12340265|FG000|COMPLETED|Overall Study||6
11152478|NCT01534013|12340266|FG001|COMPLETED|Overall Study||6
11152479|NCT01534013|12340265|FG000|NOT COMPLETED|Overall Study||2
11152480|NCT01534013|12340266|FG001|NOT COMPLETED|Overall Study||0
11152481|NCT01534052|12340272|FG000|STARTED|Overall Study||52
11152482|NCT01534052|12340272|FG000|Treatment Received|Overall Study||52
11152483|NCT01534052|12340272|FG000|COMPLETED|Overall Study||52
11152484|NCT01534052|12340272|FG000|NOT COMPLETED|Overall Study||0
11152485|NCT01534078|12340276|FG000|STARTED|Overall Study||34
11152486|NCT01534078|12340276|FG000|COMPLETED|Overall Study||32
11152487|NCT01534078|12340276|FG000|NOT COMPLETED|Overall Study||2
11152488|NCT01534182|12340282|FG000|STARTED|Overall Study||230
11152489|NCT01534182|12340283|FG001|STARTED|Overall Study||68
11152490|NCT01534182|12340282|FG000|Safety Set|Overall Study||230
11152491|NCT01534182|12340283|FG001|Safety Set|Overall Study||64
11152492|NCT01534182|12340282|FG000|Full Analysis Set|Overall Study||229
11152493|NCT01534182|12340283|FG001|Full Analysis Set|Overall Study||62
11152494|NCT01534182|12340282|FG000|COMPLETED|Overall Study||218
11152495|NCT01534182|12340283|FG001|COMPLETED|Overall Study||58
11152496|NCT01534182|12340282|FG000|NOT COMPLETED|Overall Study||12
11152497|NCT01534182|12340283|FG001|NOT COMPLETED|Overall Study||10
11152498|NCT01534195|12340292|FG000|STARTED|Overall Study||5
11152499|NCT01534195|12340293|FG001|STARTED|Overall Study||6
11152500|NCT01534195|12340292|FG000|COMPLETED|Overall Study||4
11152501|NCT01534195|12340293|FG001|COMPLETED|Overall Study||5
11152502|NCT01534195|12340292|FG000|NOT COMPLETED|Overall Study||1
11152503|NCT01534195|12340293|FG001|NOT COMPLETED|Overall Study||1
11152504|NCT01534208|12340301|FG000|STARTED|Overall Study||216
11152505|NCT01534208|12340302|FG001|STARTED|Overall Study||283
11152506|NCT01534208|12340301|FG000|COMPLETED|Overall Study||159
11152507|NCT01534208|12340302|FG001|COMPLETED|Overall Study||234
11152508|NCT01534208|12340301|FG000|NOT COMPLETED|Overall Study||57
11152509|NCT01534208|12340302|FG001|NOT COMPLETED|Overall Study||49
11152510|NCT01534260|12340310|FG000|STARTED|Overall Study||17
11152511|NCT01534260|12340311|FG001|STARTED|Overall Study||20
11152512|NCT01534260|12340310|FG000|COMPLETED|Overall Study||1
11152513|NCT01534260|12340311|FG001|COMPLETED|Overall Study||0
11152514|NCT01534260|12340310|FG000|NOT COMPLETED|Overall Study||16
11152515|NCT01534260|12340311|FG001|NOT COMPLETED|Overall Study||20
11152516|NCT01534273|12340321|FG000|STARTED|Period 1||3
11152517|NCT01534273|12340322|FG001|STARTED|Period 1||6
11152518|NCT01534273|12340323|FG002|STARTED|Period 1||2
11152519|NCT01534273|12340324|FG003|STARTED|Period 1||7
11152520|NCT01534273|12340325|FG004|STARTED|Period 1||3
11152521|NCT01534273|12340326|FG005|STARTED|Period 1||3
11152522|NCT01534273|12340327|FG006|STARTED|Period 1||6
11152523|NCT01534273|12340321|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
11152524|NCT01534273|12340322|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
11152525|NCT01534273|12340323|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
11152526|NCT01534273|12340324|FG003|Received at Least 1 Dose of Study Drug|Period 1||7
11152527|NCT01534273|12340325|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
11152528|NCT01534273|12340326|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
11152529|NCT01534273|12340327|FG006|Received at Least 1 Dose of Study Drug|Period 1||6
11152530|NCT01534273|12340321|FG000|COMPLETED|Period 1||3
11152531|NCT01534273|12340322|FG001|COMPLETED|Period 1||6
11152532|NCT01534273|12340323|FG002|COMPLETED|Period 1||2
11152533|NCT01534273|12340324|FG003|COMPLETED|Period 1||6
11152534|NCT01534273|12340325|FG004|COMPLETED|Period 1||3
11152535|NCT01534273|12340326|FG005|COMPLETED|Period 1||3
11152536|NCT01534273|12340327|FG006|COMPLETED|Period 1||6
11152537|NCT01534273|12340321|FG000|NOT COMPLETED|Period 1||0
11152538|NCT01534273|12340322|FG001|NOT COMPLETED|Period 1||0
11152539|NCT01534273|12340323|FG002|NOT COMPLETED|Period 1||0
11152540|NCT01534273|12340324|FG003|NOT COMPLETED|Period 1||1
11152541|NCT01534273|12340325|FG004|NOT COMPLETED|Period 1||0
11152542|NCT01534273|12340326|FG005|NOT COMPLETED|Period 1||0
11152543|NCT01534273|12340327|FG006|NOT COMPLETED|Period 1||0
11152544|NCT01534273|12340321|FG000|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
11152545|NCT01534273|12340322|FG001|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
11152546|NCT01534273|12340323|FG002|STARTED|Period 2||2
11152547|NCT01534273|12340324|FG003|STARTED|Period 2||6
11152548|NCT01534273|12340325|FG004|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
11152549|NCT01534273|12340326|FG005|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
11152550|NCT01534273|12340327|FG006|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
11152551|NCT01534273|12340321|FG000|COMPLETED|Period 2||0
11152552|NCT01534273|12340322|FG001|COMPLETED|Period 2||0
11152553|NCT01534273|12340323|FG002|COMPLETED|Period 2||2
11152554|NCT01534273|12340324|FG003|COMPLETED|Period 2||6
11152555|NCT01534273|12340325|FG004|COMPLETED|Period 2||0
11152556|NCT01534273|12340326|FG005|COMPLETED|Period 2||0
11152557|NCT01534273|12340327|FG006|COMPLETED|Period 2||0
11152558|NCT01534273|12340321|FG000|NOT COMPLETED|Period 2||0
11152559|NCT01534273|12340322|FG001|NOT COMPLETED|Period 2||0
11152560|NCT01534273|12340323|FG002|NOT COMPLETED|Period 2||0
11152561|NCT01534273|12340324|FG003|NOT COMPLETED|Period 2||0
11152562|NCT01534273|12340325|FG004|NOT COMPLETED|Period 2||0
11152563|NCT01534273|12340326|FG005|NOT COMPLETED|Period 2||0
11152564|NCT01534273|12340327|FG006|NOT COMPLETED|Period 2||0
11152565|NCT01534351|12340351|FG000|STARTED|Overall Study||1
11152566|NCT01534351|12340352|FG001|STARTED|Overall Study||0
11152567|NCT01534351|12340353|FG002|STARTED|Overall Study||0
11152568|NCT01534351|12340351|FG000|COMPLETED|Overall Study||0
11152569|NCT01534351|12340352|FG001|COMPLETED|Overall Study||0
11152570|NCT01534351|12340353|FG002|COMPLETED|Overall Study||0
11152571|NCT01534351|12340351|FG000|NOT COMPLETED|Overall Study||1
11152572|NCT01534351|12340352|FG001|NOT COMPLETED|Overall Study||0
11152573|NCT01534351|12340353|FG002|NOT COMPLETED|Overall Study||0
11152574|NCT01534416|12340363|FG000|STARTED|Overall Study||68
11152575|NCT01534416|12340364|FG001|STARTED|Overall Study||64
11152576|NCT01534416|12340363|FG000|COMPLETED|Overall Study||68
11152577|NCT01534416|12340364|FG001|COMPLETED|Overall Study||64
11152578|NCT01534416|12340363|FG000|NOT COMPLETED|Overall Study||0
11152579|NCT01534416|12340364|FG001|NOT COMPLETED|Overall Study||0
11152580|NCT01534520|12340382|FG000|STARTED|Overall Study||30
11152581|NCT01534520|12340383|FG001|STARTED|Overall Study||29
11152582|NCT01534520|12340382|FG000|COMPLETED|Overall Study||30
11152583|NCT01534520|12340383|FG001|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
11152584|NCT01534520|12340382|FG000|NOT COMPLETED|Overall Study||0
11152585|NCT01534520|12340383|FG001|NOT COMPLETED|Overall Study||1
11152586|NCT01534533|12340397|FG000|STARTED|Overall Study||48
11152587|NCT01534533|12340398|FG001|STARTED|Overall Study||48
11152588|NCT01534533|12340399|FG002|STARTED|Overall Study||48
11152589|NCT01534533|12340400|FG003|STARTED|Overall Study||48
11152590|NCT01534533|12340397|FG000|COMPLETED|Overall Study||40
11152591|NCT01534533|12340398|FG001|COMPLETED|Overall Study||45
11152592|NCT01534533|12340399|FG002|COMPLETED|Overall Study||40
11152593|NCT01534533|12340400|FG003|COMPLETED|Overall Study||44
11152594|NCT01534533|12340397|FG000|NOT COMPLETED|Overall Study||8
11152595|NCT01534533|12340398|FG001|NOT COMPLETED|Overall Study||3
11152596|NCT01534533|12340399|FG002|NOT COMPLETED|Overall Study||8
11152597|NCT01534533|12340400|FG003|NOT COMPLETED|Overall Study||4
11152598|NCT01534637|12340412|FG000|STARTED|Overall Study||22
11152599|NCT01534637|12340412|FG000|COMPLETED|Overall Study||13
11152600|NCT01534637|12340412|FG000|NOT COMPLETED|Overall Study||9
11152601|NCT01534663|12340418|FG000|STARTED|Overall Study||14
11152602|NCT01534663|12340419|FG001|STARTED|Overall Study||17
11152603|NCT01534663|12340418|FG000|COMPLETED|Overall Study||12
11152604|NCT01534663|12340419|FG001|COMPLETED|Overall Study||14
11152605|NCT01534663|12340418|FG000|NOT COMPLETED|Overall Study||2
11152606|NCT01534663|12340419|FG001|NOT COMPLETED|Overall Study||3
11152607|NCT01534689|12340425|FG000|STARTED|Overall Study||105
11418690|NCT00461682|12617045|FG000|STARTED|Overall Study||1
11418691|NCT00461682|12617045|FG000|COMPLETED|Overall Study||0
11152608|NCT01534689|12340425|FG000|COMPLETED|Overall Study||105
11152609|NCT01534689|12340425|FG000|NOT COMPLETED|Overall Study||0
11152610|NCT01534897|12340429|FG000|STARTED|Overall Study||10
11152611|NCT01534897|12340429|FG000|Day 25 Iodine-131 Scan|Overall Study||10
11152612|NCT01534897|12340429|FG000|Day 37 Iodine-131 Treatment|Overall Study||6
11152613|NCT01534897|12340429|FG000|COMPLETED|Overall Study||10
11152614|NCT01534897|12340429|FG000|NOT COMPLETED|Overall Study||0
11152615|NCT01534910|12340436|FG000|STARTED|Overall Study||33
11152616|NCT01534910|12340437|FG001|STARTED|Overall Study||32
11418692|NCT00461682|12617045|FG000|NOT COMPLETED|Overall Study||1
11152617|NCT01534910|12340436|FG000|COMPLETED|Overall Study||29
11152618|NCT01534910|12340437|FG001|COMPLETED|Overall Study||28
11152619|NCT01534910|12340436|FG000|NOT COMPLETED|Overall Study||4
11152620|NCT01534910|12340437|FG001|NOT COMPLETED|Overall Study||4
11152621|NCT01534962|12340449|FG000|STARTED|Overall Study||67
11152622|NCT01534962|12340450|FG001|STARTED|Overall Study||60
11026659|NCT00829621|12205252|FG001|COMPLETED|Overall Study||8
11026660|NCT00829621|12205251|FG000|NOT COMPLETED|Overall Study||4
11152623|NCT01534962|12340451|FG002|STARTED|Overall Study||58
11152624|NCT01534962|12340452|FG003|STARTED|Overall Study||56
11152625|NCT01534962|12340449|FG000|COMPLETED|Overall Study||30
11152626|NCT01534962|12340450|FG001|COMPLETED|Overall Study||34
11152627|NCT01534962|12340451|FG002|COMPLETED|Overall Study||34
11152628|NCT01534962|12340452|FG003|COMPLETED|Overall Study||24
11152629|NCT01534962|12340449|FG000|NOT COMPLETED|Overall Study||37
11152630|NCT01534962|12340450|FG001|NOT COMPLETED|Overall Study||26
11152631|NCT01534962|12340451|FG002|NOT COMPLETED|Overall Study||24
11152632|NCT01534962|12340452|FG003|NOT COMPLETED|Overall Study||32
11152633|NCT01534975|12340466|FG000|STARTED|Overall Study||136
11152634|NCT01534975|12340467|FG001|STARTED|Overall Study||133
11152635|NCT01534975|12340468|FG002|STARTED|Overall Study||160
11152636|NCT01534975|12340469|FG003|STARTED|Overall Study||84
11152637|NCT01534975|12340466|FG000|COMPLETED|Overall Study||136
11418693|NCT00462904|12617051|FG000|STARTED|Overall Study||4
11418694|NCT00462904|12617051|FG000|COMPLETED|Overall Study||3
11152638|NCT01534975|12340467|FG001|COMPLETED|Overall Study||133
11152639|NCT01534975|12340468|FG002|COMPLETED|Overall Study||160
11152640|NCT01534975|12340469|FG003|COMPLETED|Overall Study||84
11152641|NCT01534975|12340466|FG000|NOT COMPLETED|Overall Study||0
11152642|NCT01534975|12340467|FG001|NOT COMPLETED|Overall Study||0
11152643|NCT01534975|12340468|FG002|NOT COMPLETED|Overall Study||0
11152644|NCT01534975|12340469|FG003|NOT COMPLETED|Overall Study||0
11152645|NCT01535001|12340481|FG000|STARTED|Overall Study||50
11152646|NCT01535001|12340482|FG001|STARTED|Overall Study||50
11152647|NCT01535001|12340481|FG000|COMPLETED|Overall Study||47
11152648|NCT01535001|12340482|FG001|COMPLETED|Overall Study||44
11152649|NCT01535001|12340481|FG000|NOT COMPLETED|Overall Study||3
11152650|NCT01535001|12340482|FG001|NOT COMPLETED|Overall Study||6
11152651|NCT01535014|12340492|FG000|STARTED|Overall Study||210
11152652|NCT01535014|12340493|FG001|STARTED|Overall Study||200
11152653|NCT01535014|12340494|FG002|STARTED|Overall Study||50
11152654|NCT01535014|12340495|FG003|STARTED|Overall Study||33
11152655|NCT01535014|12340492|FG000|COMPLETED|Overall Study||208
11152656|NCT01535014|12340493|FG001|COMPLETED|Overall Study||194
11152657|NCT01535014|12340494|FG002|COMPLETED|Overall Study||49
11152658|NCT01535014|12340495|FG003|COMPLETED|Overall Study||33
11152659|NCT01535014|12340492|FG000|NOT COMPLETED|Overall Study||2
11152660|NCT01535014|12340493|FG001|NOT COMPLETED|Overall Study||6
11152661|NCT01535014|12340494|FG002|NOT COMPLETED|Overall Study||1
11152662|NCT01535014|12340495|FG003|NOT COMPLETED|Overall Study||0
11152663|NCT01535040|12340505|FG000|STARTED|Overall Study||65
11152664|NCT01535040|12340506|FG001|STARTED|Overall Study||65
11152665|NCT01535040|12340505|FG000|COMPLETED|Overall Study||35
11152666|NCT01535040|12340506|FG001|COMPLETED|Overall Study||44
11152667|NCT01535040|12340505|FG000|NOT COMPLETED|Overall Study||30
11152668|NCT01535040|12340506|FG001|NOT COMPLETED|Overall Study||21
11152669|NCT01535118|12340512|FG000|STARTED|Overall Study||2765
11152670|NCT01535118|12340512|FG000|COMPLETED|Overall Study||2765
11152671|NCT01535118|12340512|FG000|NOT COMPLETED|Overall Study||0
11152672|NCT01535222|12340522|FG000|STARTED|Overall Study||3
11152673|NCT01535222|12340523|FG001|STARTED|Overall Study||3
11152674|NCT01535222|12340524|FG002|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
11152675|NCT01535222|12340525|FG003|STARTED|Overall Study||6
11152676|NCT01535222|12340526|FG004|STARTED|Overall Study||6
11418695|NCT00462904|12617051|FG000|NOT COMPLETED|Overall Study||1
11152677|NCT01535222|12340527|FG005|STARTED|Overall Study||8
11152678|NCT01535222|12340522|FG000|COMPLETED|Overall Study||3
11152679|NCT01535222|12340523|FG001|COMPLETED|Overall Study||3
11152680|NCT01535222|12340524|FG002|COMPLETED|Overall Study||6
11152681|NCT01535222|12340525|FG003|COMPLETED|Overall Study||6
11152682|NCT01535222|12340526|FG004|COMPLETED|Overall Study||6
11152683|NCT01535222|12340527|FG005|COMPLETED|Overall Study||8
11152684|NCT01535222|12340522|FG000|NOT COMPLETED|Overall Study||0
11152685|NCT01535222|12340523|FG001|NOT COMPLETED|Overall Study||0
11152686|NCT01535222|12340524|FG002|NOT COMPLETED|Overall Study||1
11152687|NCT01535222|12340525|FG003|NOT COMPLETED|Overall Study||0
11152688|NCT01535222|12340526|FG004|NOT COMPLETED|Overall Study||0
11152689|NCT01535222|12340527|FG005|NOT COMPLETED|Overall Study||0
11152690|NCT01535235|12340543|FG000|STARTED|Overall Study||16
11152691|NCT01535235|12340544|FG001|STARTED|Overall Study||15
11152692|NCT01535235|12340543|FG000|COMPLETED|Overall Study||15
11152693|NCT01535235|12340544|FG001|COMPLETED|Overall Study||15
11152694|NCT01535235|12340543|FG000|NOT COMPLETED|Overall Study||1
11152695|NCT01535235|12340544|FG001|NOT COMPLETED|Overall Study||0
11152696|NCT01535261|12340550|FG000|STARTED|Overall Study||357
11152697|NCT01535261|12340550|FG000|COMPLETED|Overall Study||307
11152698|NCT01535261|12340550|FG000|NOT COMPLETED|Overall Study||50
11152699|NCT01535287|12340556|FG000|STARTED|Overall Study||70
11152700|NCT01535287|12340557|FG001|STARTED|Overall Study||70
11152701|NCT01535287|12340556|FG000|COMPLETED|Overall Study||65
11152702|NCT01535287|12340557|FG001|COMPLETED|Overall Study||64
11152703|NCT01535287|12340556|FG000|NOT COMPLETED|Overall Study||5
11152704|NCT01535287|12340557|FG001|NOT COMPLETED|Overall Study||6
11152705|NCT01535326|12340566|FG000|STARTED|Overall Study||90
11152706|NCT01535326|12340567|FG001|STARTED|Overall Study||90
11152707|NCT01535326|12340568|FG002|STARTED|Overall Study||90
11152708|NCT01535326|12340566|FG000|COMPLETED|Overall Study||90
11152709|NCT01535326|12340567|FG001|COMPLETED|Overall Study||90
11152710|NCT01535326|12340568|FG002|COMPLETED|Overall Study||90
11152711|NCT01535326|12340566|FG000|NOT COMPLETED|Overall Study||0
11152712|NCT01535326|12340567|FG001|NOT COMPLETED|Overall Study||0
11152713|NCT01535326|12340568|FG002|NOT COMPLETED|Overall Study||0
11152714|NCT01535365|12340581|FG000|STARTED|Overall Study||31
11152715|NCT01535365|12340582|FG001|STARTED|Overall Study||29
11152716|NCT01535365|12340581|FG000|COMPLETED|Overall Study||31
11152717|NCT01535365|12340582|FG001|COMPLETED|Overall Study||29
11152718|NCT01535365|12340581|FG000|NOT COMPLETED|Overall Study||0
11152719|NCT01535365|12340582|FG001|NOT COMPLETED|Overall Study||0
11152720|NCT01535443|12340590|FG000|STARTED|Overall Study||35
11152721|NCT01535443|12340590|FG000|COMPLETED|Overall Study||32
11152722|NCT01535443|12340590|FG000|NOT COMPLETED|Overall Study||3
11152723|NCT01535560|12340597|FG000|STARTED|Overall Study||274
11152724|NCT01535560|12340598|FG001|STARTED|Overall Study||275
11152725|NCT01535560|12340597|FG000|COMPLETED|Overall Study||237
11152726|NCT01535560|12340598|FG001|COMPLETED|Overall Study||179
11152727|NCT01535560|12340597|FG000|NOT COMPLETED|Overall Study||37
11152728|NCT01535560|12340598|FG001|NOT COMPLETED|Overall Study||96
11152729|NCT01535573|12340607|FG000|STARTED|Overall Study||21
11152730|NCT01535573|12340608|FG001|STARTED|Overall Study||44
11152731|NCT01535573|12340609|FG002|STARTED|Overall Study||43
11152732|NCT01535573|12340607|FG000|COMPLETED|Overall Study||13
11152733|NCT01535573|12340608|FG001|COMPLETED|Overall Study||23
11152734|NCT01535573|12340609|FG002|COMPLETED|Overall Study||24
11152735|NCT01535573|12340607|FG000|NOT COMPLETED|Overall Study||8
11152736|NCT01535573|12340608|FG001|NOT COMPLETED|Overall Study||21
11152737|NCT01535573|12340609|FG002|NOT COMPLETED|Overall Study||19
11152738|NCT01535599|12340619|FG000|STARTED|Overall Study||347
11152739|NCT01535599|12340620|FG001|STARTED|Overall Study||346
11152740|NCT01535599|12340619|FG000|COMPLETED|Overall Study||297
11152741|NCT01535599|12340620|FG001|COMPLETED|Overall Study||250
11152742|NCT01535599|12340619|FG000|NOT COMPLETED|Overall Study||50
11152743|NCT01535599|12340620|FG001|NOT COMPLETED|Overall Study||96
11152744|NCT01535638|12340626|FG000|STARTED|Treatment 1 (Single Dose)||3
11152745|NCT01535638|12340627|FG001|STARTED|Treatment 1 (Single Dose)||3
11152746|NCT01535638|12340628|FG002|STARTED|Treatment 1 (Single Dose)||3
11152747|NCT01535638|12340629|FG003|STARTED|Treatment 1 (Single Dose)||3
11152748|NCT01535638|12340630|FG004|STARTED|Treatment 1 (Single Dose)||3
11152749|NCT01535638|12340631|FG005|STARTED|Treatment 1 (Single Dose)||3
11152750|NCT01535638|12340626|FG000|COMPLETED|Treatment 1 (Single Dose)||3
11152751|NCT01535638|12340627|FG001|COMPLETED|Treatment 1 (Single Dose)||3
11152752|NCT01535638|12340628|FG002|COMPLETED|Treatment 1 (Single Dose)||3
11152753|NCT01535638|12340629|FG003|COMPLETED|Treatment 1 (Single Dose)||3
11152754|NCT01535638|12340630|FG004|COMPLETED|Treatment 1 (Single Dose)||3
11152755|NCT01535638|12340631|FG005|COMPLETED|Treatment 1 (Single Dose)||2
11152756|NCT01535638|12340626|FG000|NOT COMPLETED|Treatment 1 (Single Dose)||0
11152757|NCT01535638|12340627|FG001|NOT COMPLETED|Treatment 1 (Single Dose)||0
11152758|NCT01535638|12340628|FG002|NOT COMPLETED|Treatment 1 (Single Dose)||0
11152759|NCT01535638|12340629|FG003|NOT COMPLETED|Treatment 1 (Single Dose)||0
11152760|NCT01535638|12340630|FG004|NOT COMPLETED|Treatment 1 (Single Dose)||0
11152761|NCT01535638|12340631|FG005|NOT COMPLETED|Treatment 1 (Single Dose)||1
11152762|NCT01535638|12340626|FG000|STARTED|Treatment 2 (Single Dose)||3
11152763|NCT01535638|12340627|FG001|STARTED|Treatment 2 (Single Dose)||3
11152764|NCT01535638|12340628|FG002|STARTED|Treatment 2 (Single Dose)||3
11152765|NCT01535638|12340629|FG003|STARTED|Treatment 2 (Single Dose)||3
11152766|NCT01535638|12340630|FG004|STARTED|Treatment 2 (Single Dose)||3
11152767|NCT01535638|12340631|FG005|STARTED|Treatment 2 (Single Dose)||2
11152768|NCT01535638|12340626|FG000|COMPLETED|Treatment 2 (Single Dose)||3
11152769|NCT01535638|12340627|FG001|COMPLETED|Treatment 2 (Single Dose)||3
11152770|NCT01535638|12340628|FG002|COMPLETED|Treatment 2 (Single Dose)||3
11152771|NCT01535638|12340629|FG003|COMPLETED|Treatment 2 (Single Dose)||3
11152772|NCT01535638|12340630|FG004|COMPLETED|Treatment 2 (Single Dose)||3
11152773|NCT01535638|12340631|FG005|COMPLETED|Treatment 2 (Single Dose)||2
11152774|NCT01535638|12340626|FG000|NOT COMPLETED|Treatment 2 (Single Dose)||0
11152775|NCT01535638|12340627|FG001|NOT COMPLETED|Treatment 2 (Single Dose)||0
11152776|NCT01535638|12340628|FG002|NOT COMPLETED|Treatment 2 (Single Dose)||0
11152777|NCT01535638|12340629|FG003|NOT COMPLETED|Treatment 2 (Single Dose)||0
11152778|NCT01535638|12340630|FG004|NOT COMPLETED|Treatment 2 (Single Dose)||0
11152779|NCT01535638|12340631|FG005|NOT COMPLETED|Treatment 2 (Single Dose)||0
11152780|NCT01535638|12340626|FG000|STARTED|Treatment 3 (Single Dose)||3
11152781|NCT01535638|12340627|FG001|STARTED|Treatment 3 (Single Dose)||3
11152782|NCT01535638|12340628|FG002|STARTED|Treatment 3 (Single Dose)||3
11152783|NCT01535638|12340629|FG003|STARTED|Treatment 3 (Single Dose)||3
11152784|NCT01535638|12340630|FG004|STARTED|Treatment 3 (Single Dose)||3
11152785|NCT01535638|12340631|FG005|STARTED|Treatment 3 (Single Dose)||2
11152786|NCT01535638|12340626|FG000|COMPLETED|Treatment 3 (Single Dose)||3
11152787|NCT01535638|12340627|FG001|COMPLETED|Treatment 3 (Single Dose)||3
11152788|NCT01535638|12340628|FG002|COMPLETED|Treatment 3 (Single Dose)||3
11152789|NCT01535638|12340629|FG003|COMPLETED|Treatment 3 (Single Dose)||2
11152790|NCT01535638|12340630|FG004|COMPLETED|Treatment 3 (Single Dose)||3
11152791|NCT01535638|12340631|FG005|COMPLETED|Treatment 3 (Single Dose)||2
11152792|NCT01535638|12340626|FG000|NOT COMPLETED|Treatment 3 (Single Dose)||0
11152793|NCT01535638|12340627|FG001|NOT COMPLETED|Treatment 3 (Single Dose)||0
11152794|NCT01535638|12340628|FG002|NOT COMPLETED|Treatment 3 (Single Dose)||0
11152795|NCT01535638|12340629|FG003|NOT COMPLETED|Treatment 3 (Single Dose)||1
11152796|NCT01535638|12340630|FG004|NOT COMPLETED|Treatment 3 (Single Dose)||0
11152797|NCT01535638|12340631|FG005|NOT COMPLETED|Treatment 3 (Single Dose)||0
11152798|NCT01535664|12340640|FG000|STARTED|Overall Study||20
11322872|NCT04048382|12520155|FG001|NOT COMPLETED|3-Month Follow Up||1
11322873|NCT04048382|12520154|FG000|STARTED|6-Month Follow up||28
11322874|NCT04048382|12520155|FG001|STARTED|6-Month Follow up||28
11322875|NCT04048382|12520154|FG000|COMPLETED|6-Month Follow up||26
11322876|NCT04048382|12520155|FG001|COMPLETED|6-Month Follow up||28
11322877|NCT04048382|12520154|FG000|NOT COMPLETED|6-Month Follow up||2
11322878|NCT04048382|12520155|FG001|NOT COMPLETED|6-Month Follow up||0
11322879|NCT03928821|12520165|FG000|STARTED|Overall Study||6
11322880|NCT03928821|12520166|FG001|STARTED|Overall Study||6
11322881|NCT03928821|12520167|FG002|STARTED|Overall Study||6
11322882|NCT03928821|12520168|FG003|STARTED|Overall Study||9
11322883|NCT03928821|12520165|FG000|COMPLETED|Overall Study||6
11322884|NCT03928821|12520166|FG001|COMPLETED|Overall Study||3
11322885|NCT03928821|12520167|FG002|COMPLETED|Overall Study||3
11322886|NCT03928821|12520168|FG003|COMPLETED|Overall Study||8
11322887|NCT03928821|12520165|FG000|NOT COMPLETED|Overall Study||0
11322888|NCT03928821|12520166|FG001|NOT COMPLETED|Overall Study||3
11322889|NCT03928821|12520167|FG002|NOT COMPLETED|Overall Study||3
11322890|NCT03928821|12520168|FG003|NOT COMPLETED|Overall Study||1
11342905|NCT02949362|12540244|FG002|COMPLETED|Prospective Period||4
11342906|NCT02949362|12540245|FG003|COMPLETED|Prospective Period||15
11342907|NCT02949362|12540242|FG000|NOT COMPLETED|Prospective Period||0
11342908|NCT02949362|12540243|FG001|NOT COMPLETED|Prospective Period||0
11342909|NCT02949362|12540244|FG002|NOT COMPLETED|Prospective Period||1
11342910|NCT02949362|12540245|FG003|NOT COMPLETED|Prospective Period||4
11342911|NCT02949518|12540259|FG000|STARTED|Overall Study||28
11342912|NCT02949518|12540260|FG001|STARTED|Overall Study||28
11342913|NCT02949518|12540259|FG000|COMPLETED|Overall Study||25
11342914|NCT02949518|12540260|FG001|COMPLETED|Overall Study||26
11342915|NCT02949518|12540259|FG000|NOT COMPLETED|Overall Study||3
11342916|NCT02949518|12540260|FG001|NOT COMPLETED|Overall Study||2
11342917|NCT02949674|12540271|FG000|STARTED|Overall Study||31
11342918|NCT02949674|12540272|FG001|STARTED|Overall Study||31
11342919|NCT02949674|12540273|FG002|STARTED|Overall Study||31
11342920|NCT02949674|12540271|FG000|COMPLETED|Overall Study||31
11342921|NCT02949674|12540272|FG001|COMPLETED|Overall Study||31
11342922|NCT02949674|12540273|FG002|COMPLETED|Overall Study||31
11342923|NCT02949674|12540271|FG000|NOT COMPLETED|Overall Study||0
11342924|NCT02949674|12540272|FG001|NOT COMPLETED|Overall Study||0
11342925|NCT02949674|12540273|FG002|NOT COMPLETED|Overall Study||0
11342926|NCT02949908|12540281|FG000|STARTED|Overall Study||2
11342927|NCT02949908|12540281|FG000|COMPLETED|Overall Study||0
11342928|NCT02949908|12540281|FG000|NOT COMPLETED|Overall Study||2
11342929|NCT02949921|12540287|FG000|STARTED|Overall Study||10
11342930|NCT02949921|12540288|FG001|STARTED|Overall Study||10
11342931|NCT02949921|12540287|FG000|COMPLETED|Overall Study||10
11342932|NCT02949921|12540288|FG001|COMPLETED|Overall Study||10
11342933|NCT02949921|12540287|FG000|NOT COMPLETED|Overall Study||0
11342934|NCT02949921|12540288|FG001|NOT COMPLETED|Overall Study||0
11342935|NCT02949973|12540294|FG000|STARTED|Overall Study||10
11342936|NCT02949973|12540294|FG000|COMPLETED|Overall Study||9
11342937|NCT02949973|12540294|FG000|NOT COMPLETED|Overall Study||1
11342938|NCT02950025|12540300|FG000|STARTED|Overall Study||2
11342939|NCT02950025|12540301|FG001|STARTED|Overall Study||3
11342940|NCT02950025|12540300|FG000|COMPLETED|Overall Study||2
11342941|NCT02950025|12540301|FG001|COMPLETED|Overall Study||3
11342942|NCT02950025|12540300|FG000|NOT COMPLETED|Overall Study||0
11342943|NCT02950025|12540301|FG001|NOT COMPLETED|Overall Study||0
11342944|NCT02950467|12540307|FG000|STARTED|Open-label Treatment||18
11342945|NCT02950467|12540307|FG000|COMPLETED|Open-label Treatment|1 participant completed study period but missed some visits due to an adverse event (AE).|18
11342946|NCT02950467|12540307|FG000|NOT COMPLETED|Open-label Treatment||0
11342947|NCT02950467|12540307|FG000|STARTED|3-month Follow-up||18
11342948|NCT02950467|12540307|FG000|COMPLETED|3-month Follow-up|All participants completed the safety follow-up assessment, but not all completed outcomes measures.|18
11342949|NCT02950467|12540307|FG000|NOT COMPLETED|3-month Follow-up||0
11342950|NCT02950545|12540317|FG000|STARTED|Session 1 (70 Minutes)||9
11342951|NCT02950545|12540318|FG001|STARTED|Session 1 (70 Minutes)||9
11342952|NCT02950545|12540319|FG002|STARTED|Session 1 (70 Minutes)||7
11342953|NCT02950545|12540320|FG003|STARTED|Session 1 (70 Minutes)||8
11342954|NCT02950545|12540321|FG004|STARTED|Session 1 (70 Minutes)||8
11342955|NCT02950545|12540322|FG005|STARTED|Session 1 (70 Minutes)||10
11342956|NCT02950545|12540317|FG000|COMPLETED|Session 1 (70 Minutes)||9
11342957|NCT02950545|12540318|FG001|COMPLETED|Session 1 (70 Minutes)||9
11342958|NCT02950545|12540319|FG002|COMPLETED|Session 1 (70 Minutes)||7
11342959|NCT02950545|12540320|FG003|COMPLETED|Session 1 (70 Minutes)||8
11152799|NCT01535664|12340640|FG000|COMPLETED|Overall Study||20
11152800|NCT01535664|12340640|FG000|NOT COMPLETED|Overall Study||0
11152801|NCT01535729|12340648|FG000|STARTED|Overall Study||465
11152802|NCT01535729|12340648|FG000|Treated|Overall Study||385
11152803|NCT01535729|12340648|FG000|COMPLETED|Overall Study||49
11152804|NCT01535729|12340648|FG000|NOT COMPLETED|Overall Study||416
11152805|NCT01535924|12340658|FG000|STARTED|Overall Study||3
11152806|NCT01535924|12340659|FG001|STARTED|Overall Study||3
11152807|NCT01535924|12340660|FG002|STARTED|Overall Study||3
11152808|NCT01535924|12340661|FG003|STARTED|Overall Study||4
11152809|NCT01535924|12340662|FG004|STARTED|Overall Study||6
11152810|NCT01535924|12340663|FG005|STARTED|Overall Study||7
11152811|NCT01535924|12340658|FG000|COMPLETED|Overall Study||3
11152812|NCT01535924|12340659|FG001|COMPLETED|Overall Study||3
11152813|NCT01535924|12340660|FG002|COMPLETED|Overall Study||3
11152814|NCT01535924|12340661|FG003|COMPLETED|Overall Study||4
11152815|NCT01535924|12340662|FG004|COMPLETED|Overall Study||6
11152816|NCT01535924|12340663|FG005|COMPLETED|Overall Study||7
11152817|NCT01535924|12340658|FG000|NOT COMPLETED|Overall Study||0
11152818|NCT01535924|12340659|FG001|NOT COMPLETED|Overall Study||0
11152819|NCT01535924|12340660|FG002|NOT COMPLETED|Overall Study||0
11152820|NCT01535924|12340661|FG003|NOT COMPLETED|Overall Study||0
11152821|NCT01535924|12340662|FG004|NOT COMPLETED|Overall Study||0
11152822|NCT01535924|12340663|FG005|NOT COMPLETED|Overall Study||0
11152823|NCT01535937|12340680|FG000|STARTED|Overall Study||27
11152824|NCT01535937|12340681|FG001|STARTED|Overall Study||28
11152825|NCT01535937|12340680|FG000|COMPLETED|Overall Study||27
11152826|NCT01535937|12340681|FG001|COMPLETED|Overall Study||28
11152827|NCT01535937|12340680|FG000|NOT COMPLETED|Overall Study||0
11152828|NCT01535937|12340681|FG001|NOT COMPLETED|Overall Study||0
11152829|NCT01535976|12340689|FG000|STARTED|Overall Study||27
11152830|NCT01535976|12340690|FG001|STARTED|Overall Study||27
11152831|NCT01535976|12340689|FG000|COMPLETED|Overall Study||26
11152832|NCT01535976|12340690|FG001|COMPLETED|Overall Study||26
11152833|NCT01535976|12340689|FG000|NOT COMPLETED|Overall Study||1
11152834|NCT01535976|12340690|FG001|NOT COMPLETED|Overall Study||1
11152835|NCT01536067|12340696|FG000|STARTED|Overall Study||3
11152836|NCT01536067|12340696|FG000|COMPLETED|Overall Study||2
11152837|NCT01536067|12340696|FG000|NOT COMPLETED|Overall Study||1
11152838|NCT01536093|12340702|FG000|STARTED|Overall Study||24
11152839|NCT01536093|12340703|FG001|STARTED|Overall Study||24
11152840|NCT01536093|12340702|FG000|COMPLETED|Overall Study||21
11152841|NCT01536093|12340703|FG001|COMPLETED|Overall Study||21
11152842|NCT01536093|12340702|FG000|NOT COMPLETED|Overall Study||3
11152843|NCT01536093|12340703|FG001|NOT COMPLETED|Overall Study||3
11152844|NCT01536119|12340711|FG000|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
11152845|NCT01536119|12340712|FG001|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
11152846|NCT01536119|12340711|FG000|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
11152847|NCT01536119|12340712|FG001|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
11152848|NCT01536119|12340711|FG000|NOT COMPLETED|Overall Study||17
11152849|NCT01536119|12340712|FG001|NOT COMPLETED|Overall Study||14
11152850|NCT01536145|12340718|FG000|STARTED|Overall Study||3
11152851|NCT01536145|12340719|FG001|STARTED|Overall Study||4
11152852|NCT01536145|12340720|FG002|STARTED|Overall Study||3
11152853|NCT01536145|12340721|FG003|STARTED|Overall Study||3
11152854|NCT01536145|12340722|FG004|STARTED|Overall Study||4
11152855|NCT01536145|12340723|FG005|STARTED|Overall Study||3
11152856|NCT01536145|12340724|FG006|STARTED|Overall Study||3
11152857|NCT01536145|12340725|FG007|STARTED|Overall Study||4
11152858|NCT01536145|12340726|FG008|STARTED|Overall Study||3
11152859|NCT01536145|12340727|FG009|STARTED|Overall Study||7
11152860|NCT01536145|12340728|FG010|STARTED|Overall Study||10
11152861|NCT01536145|12340718|FG000|COMPLETED|Overall Study||0
11152862|NCT01536145|12340719|FG001|COMPLETED|Overall Study||0
11152863|NCT01536145|12340720|FG002|COMPLETED|Overall Study||1
11152864|NCT01536145|12340721|FG003|COMPLETED|Overall Study||1
11152865|NCT01536145|12340722|FG004|COMPLETED|Overall Study||2
11152866|NCT01536145|12340723|FG005|COMPLETED|Overall Study||0
11152867|NCT01536145|12340724|FG006|COMPLETED|Overall Study||1
11152868|NCT01536145|12340725|FG007|COMPLETED|Overall Study||0
11152869|NCT01536145|12340726|FG008|COMPLETED|Overall Study||0
11152870|NCT01536145|12340727|FG009|COMPLETED|Overall Study||1
11152871|NCT01536145|12340728|FG010|COMPLETED|Overall Study||0
11152872|NCT01536145|12340718|FG000|NOT COMPLETED|Overall Study||3
11152873|NCT01536145|12340719|FG001|NOT COMPLETED|Overall Study||4
11152874|NCT01536145|12340720|FG002|NOT COMPLETED|Overall Study||2
11152875|NCT01536145|12340721|FG003|NOT COMPLETED|Overall Study||2
11152876|NCT01536145|12340722|FG004|NOT COMPLETED|Overall Study||2
11152877|NCT01536145|12340723|FG005|NOT COMPLETED|Overall Study||3
11152878|NCT01536145|12340724|FG006|NOT COMPLETED|Overall Study||2
11152879|NCT01536145|12340725|FG007|NOT COMPLETED|Overall Study||4
11152880|NCT01536145|12340726|FG008|NOT COMPLETED|Overall Study||3
11152881|NCT01536145|12340727|FG009|NOT COMPLETED|Overall Study||6
11152882|NCT01536145|12340728|FG010|NOT COMPLETED|Overall Study||10
11152883|NCT01536171|12340759|FG000|STARTED|Overall Study||22
11152884|NCT01536171|12340759|FG000|COMPLETED|Overall Study||21
11152885|NCT01536171|12340759|FG000|NOT COMPLETED|Overall Study||1
11152886|NCT01536184|12340766|FG000|STARTED|Overall Study||8
11152887|NCT01536184|12340767|FG001|STARTED|Overall Study||4
11152888|NCT01536184|12340766|FG000|COMPLETED|Overall Study||8
11152889|NCT01536184|12340767|FG001|COMPLETED|Overall Study||4
11152890|NCT01536184|12340766|FG000|NOT COMPLETED|Overall Study||0
11152891|NCT01536184|12340767|FG001|NOT COMPLETED|Overall Study||0
11152892|NCT01536197|12340775|FG000|STARTED|Overall Study||23
11152893|NCT01536197|12340776|FG001|STARTED|Overall Study||10
11152894|NCT01536197|12340775|FG000|COMPLETED|Overall Study||23
11152895|NCT01536197|12340776|FG001|COMPLETED|Overall Study||10
11152896|NCT01536197|12340775|FG000|NOT COMPLETED|Overall Study||0
11152897|NCT01536197|12340776|FG001|NOT COMPLETED|Overall Study||0
11152898|NCT01536262|12340785|FG000|STARTED|Overall Study||41
11152899|NCT01536262|12340786|FG001|STARTED|Overall Study||40
11152900|NCT01536262|12340787|FG002|STARTED|Overall Study||41
11152901|NCT01536262|12340785|FG000|COMPLETED|Overall Study||33
11152902|NCT01536262|12340786|FG001|COMPLETED|Overall Study||38
11152903|NCT01536262|12340787|FG002|COMPLETED|Overall Study||39
11152904|NCT01536262|12340785|FG000|NOT COMPLETED|Overall Study||8
11152905|NCT01536262|12340786|FG001|NOT COMPLETED|Overall Study||2
11152906|NCT01536262|12340787|FG002|NOT COMPLETED|Overall Study||2
11152907|NCT01536366|12340798|FG000|STARTED|Overall Study||14
11152908|NCT01536366|12340799|FG001|STARTED|Overall Study||13
11152909|NCT01536366|12340798|FG000|BIA 9-1067 + Repaglinide|Overall Study||14
11152910|NCT01536366|12340799|FG001|BIA 9-1067 + Repaglinide|Overall Study||10
11152911|NCT01536366|12340798|FG000|Repaglinide|Overall Study||14
11152912|NCT01536366|12340799|FG001|Repaglinide|Overall Study||13
11152913|NCT01536366|12340798|FG000|Follow-up|Overall Study||13
11152914|NCT01536366|12340799|FG001|Follow-up|Overall Study||9
11152915|NCT01536366|12340798|FG000|COMPLETED|Overall Study||1
11152916|NCT01536366|12340799|FG001|COMPLETED|Overall Study||9
11152917|NCT01536366|12340798|FG000|NOT COMPLETED|Overall Study||13
11152918|NCT01536366|12340799|FG001|NOT COMPLETED|Overall Study||4
11152919|NCT01536379|12340807|FG000|STARTED|Overall Study||13
11152920|NCT01536379|12340808|FG001|STARTED|Overall Study||12
11152921|NCT01536379|12340807|FG000|COMPLETED|Overall Study||11
11152922|NCT01536379|12340808|FG001|COMPLETED|Overall Study||9
11152923|NCT01536379|12340807|FG000|NOT COMPLETED|Overall Study||2
11152924|NCT01536379|12340808|FG001|NOT COMPLETED|Overall Study||3
11152925|NCT01536392|12340816|FG000|STARTED|Overall Study||41
11152926|NCT01536392|12340817|FG001|STARTED|Overall Study||34
11152927|NCT01536392|12340816|FG000|COMPLETED|Overall Study||28
11152928|NCT01536392|12340817|FG001|COMPLETED|Overall Study||19
11152929|NCT01536392|12340816|FG000|NOT COMPLETED|Overall Study||13
11152930|NCT01536392|12340817|FG001|NOT COMPLETED|Overall Study||15
11152931|NCT01536405|12340825|FG000|STARTED|Randomization to Visit 1 (Vaccination 1)||706
11152932|NCT01536405|12340826|FG001|STARTED|Randomization to Visit 1 (Vaccination 1)||706
11152933|NCT01536405|12340825|FG000|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
11152934|NCT01536405|12340826|FG001|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
11152935|NCT01536405|12340825|FG000|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
11152936|NCT01536405|12340826|FG001|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
11152937|NCT01536405|12340825|FG000|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
11152938|NCT01536405|12340826|FG001|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
11152939|NCT01536405|12340825|FG000|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
11152940|NCT01536405|12340826|FG001|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
11152941|NCT01536405|12340825|FG000|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
11152942|NCT01536405|12340826|FG001|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
11152943|NCT01536405|12340825|FG000|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
11152944|NCT01536405|12340826|FG001|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
11152945|NCT01536405|12340825|FG000|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
11152946|NCT01536405|12340826|FG001|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
11152947|NCT01536405|12340825|FG000|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
11152948|NCT01536405|12340826|FG001|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
11152949|NCT01536405|12340825|FG000|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
11152950|NCT01536405|12340826|FG001|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
11152951|NCT01536405|12340825|FG000|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
11152952|NCT01536405|12340826|FG001|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
11152953|NCT01536405|12340825|FG000|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
11152954|NCT01536405|12340826|FG001|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
11152955|NCT01536405|12340825|FG000|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
11152956|NCT01536405|12340826|FG001|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
11152957|NCT01536405|12340825|FG000|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
11152958|NCT01536405|12340826|FG001|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
11152959|NCT01536405|12340825|FG000|STARTED|Visit 4 to Extended Study Follow-up||615
11152960|NCT01536405|12340826|FG001|STARTED|Visit 4 to Extended Study Follow-up||618
11152961|NCT01536405|12340825|FG000|COMPLETED|Visit 4 to Extended Study Follow-up||595
11152962|NCT01536405|12340826|FG001|COMPLETED|Visit 4 to Extended Study Follow-up||595
11152963|NCT01536405|12340825|FG000|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
11152964|NCT01536405|12340826|FG001|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
11152965|NCT01536418|12340834|FG000|STARTED|Overall Study||127
11152966|NCT01536418|12340835|FG001|STARTED|Overall Study||126
11152967|NCT01536418|12340834|FG000|COMPLETED|Overall Study||58
11152968|NCT01536418|12340835|FG001|COMPLETED|Overall Study||60
11152969|NCT01536418|12340834|FG000|NOT COMPLETED|Overall Study||69
11152970|NCT01536418|12340835|FG001|NOT COMPLETED|Overall Study||66
11152971|NCT01536496|12340844|FG000|STARTED|Overall Study||57
11152972|NCT01536496|12340845|FG001|STARTED|Overall Study||57
11152973|NCT01536496|12340844|FG000|COMPLETED|Overall Study||55
11152974|NCT01536496|12340845|FG001|COMPLETED|Overall Study||56
11152975|NCT01536496|12340844|FG000|NOT COMPLETED|Overall Study||2
11152976|NCT01536496|12340845|FG001|NOT COMPLETED|Overall Study||1
11152977|NCT01536535|12340855|FG000|STARTED|Overall Study||178
11152978|NCT01536535|12340856|FG001|STARTED|Overall Study||250
11152979|NCT01536535|12340855|FG000|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163
11152980|NCT01536535|12340856|FG001|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237
11152981|NCT01536535|12340855|FG000|NOT COMPLETED|Overall Study||15
11152982|NCT01536535|12340856|FG001|NOT COMPLETED|Overall Study||13
11152983|NCT01536561|12340863|FG000|STARTED|Dosimetric and Therapeutic Treatment||59
11152984|NCT01536561|12340863|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
11152985|NCT01536561|12340863|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
11152986|NCT01536561|12340863|FG000|STARTED|Long-Term Follow-Up||13
11152987|NCT01536561|12340863|FG000|COMPLETED|Long-Term Follow-Up||13
11152988|NCT01536561|12340863|FG000|NOT COMPLETED|Long-Term Follow-Up||0
11152989|NCT01536574|12340872|FG000|STARTED|Overall Study||162
11152990|NCT01536574|12340873|FG001|STARTED|Overall Study||133
11152991|NCT01536574|12340872|FG000|COMPLETED|Overall Study||156
11152992|NCT01536574|12340873|FG001|COMPLETED|Overall Study||126
11152993|NCT01536574|12340872|FG000|NOT COMPLETED|Overall Study||6
11152994|NCT01536574|12340873|FG001|NOT COMPLETED|Overall Study||7
11152995|NCT01536587|12340879|FG000|STARTED|Overall Study||32
11152996|NCT01536587|12340879|FG000|COMPLETED|Overall Study||30
11152997|NCT01536587|12340879|FG000|NOT COMPLETED|Overall Study||2
11152998|NCT01536704|12340883|FG000|STARTED|Period 1||12
11152999|NCT01536704|12340884|FG001|STARTED|Period 1||12
11153000|NCT01536704|12340885|FG002|STARTED|Period 1||13
11153001|NCT01536704|12340886|FG003|STARTED|Period 1||13
11153002|NCT01536704|12340883|FG000|COMPLETED|Period 1||12
11153003|NCT01536704|12340884|FG001|COMPLETED|Period 1||12
11153004|NCT01536704|12340885|FG002|COMPLETED|Period 1||13
11153005|NCT01536704|12340886|FG003|COMPLETED|Period 1||13
11153006|NCT01536704|12340883|FG000|NOT COMPLETED|Period 1||0
11153007|NCT01536704|12340884|FG001|NOT COMPLETED|Period 1||0
11153008|NCT01536704|12340885|FG002|NOT COMPLETED|Period 1||0
11153009|NCT01536704|12340886|FG003|NOT COMPLETED|Period 1||0
11153010|NCT01536704|12340883|FG000|STARTED|Washout Period 1||12
11153011|NCT01536704|12340884|FG001|STARTED|Washout Period 1||12
11153012|NCT01536704|12340885|FG002|STARTED|Washout Period 1||13
11153013|NCT01536704|12340886|FG003|STARTED|Washout Period 1||13
11153014|NCT01536704|12340883|FG000|COMPLETED|Washout Period 1||11
11153015|NCT01536704|12340884|FG001|COMPLETED|Washout Period 1||10
11153016|NCT01536704|12340885|FG002|COMPLETED|Washout Period 1||13
11153017|NCT01536704|12340886|FG003|COMPLETED|Washout Period 1||13
11153018|NCT01536704|12340883|FG000|NOT COMPLETED|Washout Period 1||1
11153019|NCT01536704|12340884|FG001|NOT COMPLETED|Washout Period 1||2
11153020|NCT01536704|12340885|FG002|NOT COMPLETED|Washout Period 1||0
11153021|NCT01536704|12340886|FG003|NOT COMPLETED|Washout Period 1||0
11153022|NCT01536704|12340883|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
11153023|NCT01536704|12340884|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
11153024|NCT01536704|12340885|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
11153025|NCT01536704|12340886|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
11153026|NCT01536704|12340883|FG000|COMPLETED|Period 2||13
11153027|NCT01536704|12340884|FG001|COMPLETED|Period 2||11
11153028|NCT01536704|12340885|FG002|COMPLETED|Period 2||10
11153029|NCT01536704|12340886|FG003|COMPLETED|Period 2||13
11153030|NCT01536704|12340883|FG000|NOT COMPLETED|Period 2||0
11153031|NCT01536704|12340884|FG001|NOT COMPLETED|Period 2||0
11153032|NCT01536704|12340885|FG002|NOT COMPLETED|Period 2||0
11153033|NCT01536704|12340886|FG003|NOT COMPLETED|Period 2||0
11153034|NCT01536704|12340883|FG000|STARTED|Washout Period 2||13
11153035|NCT01536704|12340884|FG001|STARTED|Washout Period 2||11
11153036|NCT01536704|12340885|FG002|STARTED|Washout Period 2||10
11153037|NCT01536704|12340886|FG003|STARTED|Washout Period 2||13
11153038|NCT01536704|12340883|FG000|COMPLETED|Washout Period 2||12
11153039|NCT01536704|12340884|FG001|COMPLETED|Washout Period 2||11
11153040|NCT01536704|12340885|FG002|COMPLETED|Washout Period 2||10
11153041|NCT01536704|12340886|FG003|COMPLETED|Washout Period 2||12
11153042|NCT01536704|12340883|FG000|NOT COMPLETED|Washout Period 2||1
11153043|NCT01536704|12340884|FG001|NOT COMPLETED|Washout Period 2||0
11153044|NCT01536704|12340885|FG002|NOT COMPLETED|Washout Period 2||0
11153045|NCT01536704|12340886|FG003|NOT COMPLETED|Washout Period 2||1
11153046|NCT01536704|12340883|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
11153047|NCT01536704|12340884|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
11153048|NCT01536704|12340885|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
11153049|NCT01536704|12340886|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
11153050|NCT01536704|12340883|FG000|COMPLETED|Period 3||10
11153051|NCT01536704|12340884|FG001|COMPLETED|Period 3||12
11153052|NCT01536704|12340885|FG002|COMPLETED|Period 3||12
11153053|NCT01536704|12340886|FG003|COMPLETED|Period 3||10
11153054|NCT01536704|12340883|FG000|NOT COMPLETED|Period 3||0
11153055|NCT01536704|12340884|FG001|NOT COMPLETED|Period 3||0
11153056|NCT01536704|12340885|FG002|NOT COMPLETED|Period 3||0
11153057|NCT01536704|12340886|FG003|NOT COMPLETED|Period 3||1
11153058|NCT01536704|12340883|FG000|STARTED|Washout Period 3||10
11153059|NCT01536704|12340884|FG001|STARTED|Washout Period 3||12
11153060|NCT01536704|12340885|FG002|STARTED|Washout Period 3||12
11153061|NCT01536704|12340886|FG003|STARTED|Washout Period 3||10
11153062|NCT01536704|12340883|FG000|COMPLETED|Washout Period 3||10
11153063|NCT01536704|12340884|FG001|COMPLETED|Washout Period 3||12
11153064|NCT01536704|12340885|FG002|COMPLETED|Washout Period 3||11
11153065|NCT01536704|12340886|FG003|COMPLETED|Washout Period 3||10
11153066|NCT01536704|12340883|FG000|NOT COMPLETED|Washout Period 3||0
11153067|NCT01536704|12340884|FG001|NOT COMPLETED|Washout Period 3||0
11153068|NCT01536704|12340885|FG002|NOT COMPLETED|Washout Period 3||1
11153069|NCT01536704|12340886|FG003|NOT COMPLETED|Washout Period 3||0
11153070|NCT01536704|12340883|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
11153071|NCT01536704|12340884|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
11153072|NCT01536704|12340885|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
11153073|NCT01536704|12340886|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
11153074|NCT01536704|12340883|FG000|COMPLETED|Period 4||12
11153075|NCT01536704|12340884|FG001|COMPLETED|Period 4||11
11153076|NCT01536704|12340885|FG002|COMPLETED|Period 4||10
11153077|NCT01536704|12340886|FG003|COMPLETED|Period 4||10
11153078|NCT01536704|12340883|FG000|NOT COMPLETED|Period 4||0
11153079|NCT01536704|12340884|FG001|NOT COMPLETED|Period 4||0
11153080|NCT01536704|12340885|FG002|NOT COMPLETED|Period 4||0
11153081|NCT01536704|12340886|FG003|NOT COMPLETED|Period 4||0
11153082|NCT01536795|12340902|FG000|STARTED|Overall Study||24
11153083|NCT01536795|12340903|FG001|STARTED|Overall Study||24
11153084|NCT01536795|12340902|FG000|COMPLETED|Overall Study||23
11153085|NCT01536795|12340903|FG001|COMPLETED|Overall Study||22
11153086|NCT01536795|12340902|FG000|NOT COMPLETED|Overall Study||1
11153087|NCT01536795|12340903|FG001|NOT COMPLETED|Overall Study||2
11153088|NCT01536860|12340909|FG000|STARTED|First Intervention (1 Day)||4
11153089|NCT01536860|12340910|FG001|STARTED|First Intervention (1 Day)||4
11153090|NCT01536860|12340911|FG002|STARTED|First Intervention (1 Day)||4
11153091|NCT01536860|12340909|FG000|COMPLETED|First Intervention (1 Day)||4
11153092|NCT01536860|12340910|FG001|COMPLETED|First Intervention (1 Day)||4
11153093|NCT01536860|12340911|FG002|COMPLETED|First Intervention (1 Day)||4
11153094|NCT01536860|12340909|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11153095|NCT01536860|12340910|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11153096|NCT01536860|12340911|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11153097|NCT01536860|12340909|FG000|STARTED|Washout Period (3 Days)||4
11153098|NCT01536860|12340910|FG001|STARTED|Washout Period (3 Days)||4
11153099|NCT01536860|12340911|FG002|STARTED|Washout Period (3 Days)||4
11153100|NCT01536860|12340909|FG000|COMPLETED|Washout Period (3 Days)||4
11153101|NCT01536860|12340910|FG001|COMPLETED|Washout Period (3 Days)||4
11153102|NCT01536860|12340911|FG002|COMPLETED|Washout Period (3 Days)||4
11153103|NCT01536860|12340909|FG000|NOT COMPLETED|Washout Period (3 Days)||0
11153104|NCT01536860|12340910|FG001|NOT COMPLETED|Washout Period (3 Days)||0
11153105|NCT01536860|12340911|FG002|NOT COMPLETED|Washout Period (3 Days)||0
11153106|NCT01536860|12340909|FG000|STARTED|Second Intervention (1 Day)||4
11153107|NCT01536860|12340910|FG001|STARTED|Second Intervention (1 Day)||4
11153108|NCT01536860|12340911|FG002|STARTED|Second Intervention (1 Day)||4
11153109|NCT01536860|12340909|FG000|COMPLETED|Second Intervention (1 Day)||4
11153110|NCT01536860|12340910|FG001|COMPLETED|Second Intervention (1 Day)||4
11153111|NCT01536860|12340911|FG002|COMPLETED|Second Intervention (1 Day)||4
11153112|NCT01536860|12340909|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11153113|NCT01536860|12340910|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11153114|NCT01536860|12340911|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11153115|NCT01536860|12340909|FG000|STARTED|Washout Period (3 Days)||4
11153116|NCT01536860|12340910|FG001|STARTED|Washout Period (3 Days)||4
11153117|NCT01536860|12340911|FG002|STARTED|Washout Period (3 Days)||4
11153118|NCT01536860|12340909|FG000|COMPLETED|Washout Period (3 Days)||3
11153119|NCT01536860|12340910|FG001|COMPLETED|Washout Period (3 Days)||4
11153120|NCT01536860|12340911|FG002|COMPLETED|Washout Period (3 Days)||4
11153121|NCT01536860|12340909|FG000|NOT COMPLETED|Washout Period (3 Days)||1
11153122|NCT01536860|12340910|FG001|NOT COMPLETED|Washout Period (3 Days)||0
11153123|NCT01536860|12340911|FG002|NOT COMPLETED|Washout Period (3 Days)||0
11153124|NCT01536860|12340909|FG000|STARTED|Third Intervention (1 Day)||3
11153125|NCT01536860|12340910|FG001|STARTED|Third Intervention (1 Day)||4
11153126|NCT01536860|12340911|FG002|STARTED|Third Intervention (1 Day)||4
11153127|NCT01536860|12340909|FG000|COMPLETED|Third Intervention (1 Day)||3
11153128|NCT01536860|12340910|FG001|COMPLETED|Third Intervention (1 Day)||4
11153129|NCT01536860|12340911|FG002|COMPLETED|Third Intervention (1 Day)||4
11153130|NCT01536860|12340909|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11153131|NCT01536860|12340910|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11153132|NCT01536860|12340911|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
11153133|NCT01536886|12340923|FG000|STARTED|Overall Study||141
11153134|NCT01536886|12340924|FG001|STARTED|Overall Study||135
11153135|NCT01536886|12340925|FG002|STARTED|Overall Study||49
11153136|NCT01536886|12340926|FG003|STARTED|Overall Study||51
11153137|NCT01536886|12340923|FG000|COMPLETED|Overall Study||136
11153138|NCT01536886|12340924|FG001|COMPLETED|Overall Study||127
11153139|NCT01536886|12340925|FG002|COMPLETED|Overall Study||47
11153140|NCT01536886|12340926|FG003|COMPLETED|Overall Study||48
11153141|NCT01536886|12340923|FG000|NOT COMPLETED|Overall Study||5
11153142|NCT01536886|12340924|FG001|NOT COMPLETED|Overall Study||8
11153143|NCT01536886|12340925|FG002|NOT COMPLETED|Overall Study||2
11153144|NCT01536886|12340926|FG003|NOT COMPLETED|Overall Study||3
11153145|NCT01536938|12340939|FG000|STARTED|Overall Study||100
11153146|NCT01536938|12340940|FG001|STARTED|Overall Study||101
11153147|NCT01536938|12340941|FG002|STARTED|Overall Study||101
11153148|NCT01536938|12340939|FG000|COMPLETED|Overall Study||94
11153149|NCT01536938|12340940|FG001|COMPLETED|Overall Study||94
11153150|NCT01536938|12340941|FG002|COMPLETED|Overall Study||93
11153151|NCT01536938|12340939|FG000|NOT COMPLETED|Overall Study||6
11153152|NCT01536938|12340940|FG001|NOT COMPLETED|Overall Study||7
11153153|NCT01536938|12340941|FG002|NOT COMPLETED|Overall Study||8
11153154|NCT01536951|12340951|FG000|STARTED|First Intervention and Washout Period 1||3
11153155|NCT01536951|12340952|FG001|STARTED|First Intervention and Washout Period 1||3
11153156|NCT01536951|12340953|FG002|STARTED|First Intervention and Washout Period 1||3
11153157|NCT01536951|12340954|FG003|STARTED|First Intervention and Washout Period 1||8
11153158|NCT01536951|12340955|FG004|STARTED|First Intervention and Washout Period 1||9
11153159|NCT01536951|12340956|FG005|STARTED|First Intervention and Washout Period 1||9
11153160|NCT01536951|12340957|FG006|STARTED|First Intervention and Washout Period 1||9
11153161|NCT01536951|12340958|FG007|STARTED|First Intervention and Washout Period 1||9
11153162|NCT01536951|12340959|FG008|STARTED|First Intervention and Washout Period 1||9
11153163|NCT01536951|12340951|FG000|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
11153164|NCT01536951|12340952|FG001|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
11153165|NCT01536951|12340953|FG002|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
11153166|NCT01536951|12340954|FG003|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
11153167|NCT01536951|12340955|FG004|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
11153168|NCT01536951|12340956|FG005|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
11153169|NCT01536951|12340957|FG006|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
11153170|NCT01536951|12340958|FG007|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
11153171|NCT01536951|12340959|FG008|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
11153172|NCT01536951|12340951|FG000|COMPLETED|First Intervention and Washout Period 1||3
11153173|NCT01536951|12340952|FG001|COMPLETED|First Intervention and Washout Period 1||3
11153174|NCT01536951|12340953|FG002|COMPLETED|First Intervention and Washout Period 1||2
11153175|NCT01536951|12340954|FG003|COMPLETED|First Intervention and Washout Period 1||8
11153176|NCT01536951|12340955|FG004|COMPLETED|First Intervention and Washout Period 1||9
11153177|NCT01536951|12340956|FG005|COMPLETED|First Intervention and Washout Period 1||9
11153178|NCT01536951|12340957|FG006|COMPLETED|First Intervention and Washout Period 1||9
11153179|NCT01536951|12340958|FG007|COMPLETED|First Intervention and Washout Period 1||9
11153180|NCT01536951|12340959|FG008|COMPLETED|First Intervention and Washout Period 1||9
11153181|NCT01536951|12340951|FG000|NOT COMPLETED|First Intervention and Washout Period 1||0
11153182|NCT01536951|12340952|FG001|NOT COMPLETED|First Intervention and Washout Period 1||0
11153183|NCT01536951|12340953|FG002|NOT COMPLETED|First Intervention and Washout Period 1||1
11153184|NCT01536951|12340954|FG003|NOT COMPLETED|First Intervention and Washout Period 1||0
11153185|NCT01536951|12340955|FG004|NOT COMPLETED|First Intervention and Washout Period 1||0
11153186|NCT01536951|12340956|FG005|NOT COMPLETED|First Intervention and Washout Period 1||0
11153187|NCT01536951|12340957|FG006|NOT COMPLETED|First Intervention and Washout Period 1||0
11153188|NCT01536951|12340958|FG007|NOT COMPLETED|First Intervention and Washout Period 1||0
11153189|NCT01536951|12340959|FG008|NOT COMPLETED|First Intervention and Washout Period 1||0
11153190|NCT01536951|12340951|FG000|STARTED|Second Intervention and Washout Period 2||3
11153191|NCT01536951|12340952|FG001|STARTED|Second Intervention and Washout Period 2||3
11153192|NCT01536951|12340953|FG002|STARTED|Second Intervention and Washout Period 2||2
11153193|NCT01536951|12340954|FG003|STARTED|Second Intervention and Washout Period 2||8
11153194|NCT01536951|12340955|FG004|STARTED|Second Intervention and Washout Period 2||9
11153195|NCT01536951|12340956|FG005|STARTED|Second Intervention and Washout Period 2||9
11153196|NCT01536951|12340957|FG006|STARTED|Second Intervention and Washout Period 2||9
11153197|NCT01536951|12340958|FG007|STARTED|Second Intervention and Washout Period 2||9
11153198|NCT01536951|12340959|FG008|STARTED|Second Intervention and Washout Period 2||9
11153199|NCT01536951|12340951|FG000|COMPLETED|Second Intervention and Washout Period 2||3
11153200|NCT01536951|12340952|FG001|COMPLETED|Second Intervention and Washout Period 2||3
11153201|NCT01536951|12340953|FG002|COMPLETED|Second Intervention and Washout Period 2||2
11153202|NCT01536951|12340954|FG003|COMPLETED|Second Intervention and Washout Period 2||8
11153203|NCT01536951|12340955|FG004|COMPLETED|Second Intervention and Washout Period 2||9
11153204|NCT01536951|12340956|FG005|COMPLETED|Second Intervention and Washout Period 2||9
11153205|NCT01536951|12340957|FG006|COMPLETED|Second Intervention and Washout Period 2||9
11153206|NCT01536951|12340958|FG007|COMPLETED|Second Intervention and Washout Period 2||8
11153207|NCT01536951|12340959|FG008|COMPLETED|Second Intervention and Washout Period 2||9
11153208|NCT01536951|12340951|FG000|NOT COMPLETED|Second Intervention and Washout Period 2||0
11153209|NCT01536951|12340952|FG001|NOT COMPLETED|Second Intervention and Washout Period 2||0
11153210|NCT01536951|12340953|FG002|NOT COMPLETED|Second Intervention and Washout Period 2||0
11153211|NCT01536951|12340954|FG003|NOT COMPLETED|Second Intervention and Washout Period 2||0
11153212|NCT01536951|12340955|FG004|NOT COMPLETED|Second Intervention and Washout Period 2||0
11153213|NCT01536951|12340956|FG005|NOT COMPLETED|Second Intervention and Washout Period 2||0
11153214|NCT01536951|12340957|FG006|NOT COMPLETED|Second Intervention and Washout Period 2||0
11153215|NCT01536951|12340958|FG007|NOT COMPLETED|Second Intervention and Washout Period 2||1
11153216|NCT01536951|12340959|FG008|NOT COMPLETED|Second Intervention and Washout Period 2||0
11153217|NCT01536951|12340951|FG000|STARTED|Third Intervention||3
11153218|NCT01536951|12340952|FG001|STARTED|Third Intervention||3
11153219|NCT01536951|12340953|FG002|STARTED|Third Intervention||2
11153220|NCT01536951|12340954|FG003|STARTED|Third Intervention||8
11153221|NCT01536951|12340955|FG004|STARTED|Third Intervention||9
11153222|NCT01536951|12340956|FG005|STARTED|Third Intervention||9
11153223|NCT01536951|12340957|FG006|STARTED|Third Intervention||9
11153224|NCT01536951|12340958|FG007|STARTED|Third Intervention||8
11153225|NCT01536951|12340959|FG008|STARTED|Third Intervention||9
11153226|NCT01536951|12340951|FG000|COMPLETED|Third Intervention||3
11153227|NCT01536951|12340952|FG001|COMPLETED|Third Intervention||3
11153228|NCT01536951|12340953|FG002|COMPLETED|Third Intervention||2
11153229|NCT01536951|12340954|FG003|COMPLETED|Third Intervention||8
11153230|NCT01536951|12340955|FG004|COMPLETED|Third Intervention||9
11153231|NCT01536951|12340956|FG005|COMPLETED|Third Intervention||9
11153232|NCT01536951|12340957|FG006|COMPLETED|Third Intervention||9
11153233|NCT01536951|12340958|FG007|COMPLETED|Third Intervention||8
11153234|NCT01536951|12340959|FG008|COMPLETED|Third Intervention||9
11153235|NCT01536951|12340951|FG000|NOT COMPLETED|Third Intervention||0
11153236|NCT01536951|12340952|FG001|NOT COMPLETED|Third Intervention||0
11153237|NCT01536951|12340953|FG002|NOT COMPLETED|Third Intervention||0
11153238|NCT01536951|12340954|FG003|NOT COMPLETED|Third Intervention||0
11153239|NCT01536951|12340955|FG004|NOT COMPLETED|Third Intervention||0
11153240|NCT01536951|12340956|FG005|NOT COMPLETED|Third Intervention||0
11153241|NCT01536951|12340957|FG006|NOT COMPLETED|Third Intervention||0
11153242|NCT01536951|12340958|FG007|NOT COMPLETED|Third Intervention||0
11153243|NCT01536951|12340959|FG008|NOT COMPLETED|Third Intervention||0
11153244|NCT01537029|12340982|FG000|STARTED|Overall Study||15
11153245|NCT01537029|12340982|FG000|COMPLETED|Overall Study||15
11153246|NCT01537029|12340982|FG000|NOT COMPLETED|Overall Study||0
11153247|NCT01537042|12340988|FG000|STARTED|Overall Study||10
11153248|NCT01537042|12340989|FG001|STARTED|Overall Study||20
11153249|NCT01537042|12340988|FG000|COMPLETED|Overall Study||10
11153250|NCT01537042|12340989|FG001|COMPLETED|Overall Study||15
11153251|NCT01537042|12340988|FG000|NOT COMPLETED|Overall Study||0
11153252|NCT01537042|12340989|FG001|NOT COMPLETED|Overall Study||5
11153253|NCT01537068|12341001|FG000|STARTED|Overall Study||30
11153254|NCT01537068|12341002|FG001|STARTED|Overall Study||29
11153255|NCT01537068|12341001|FG000|COMPLETED|Overall Study||26
11153256|NCT01537068|12341002|FG001|COMPLETED|Overall Study||26
11153257|NCT01537068|12341001|FG000|NOT COMPLETED|Overall Study||4
11153258|NCT01537068|12341002|FG001|NOT COMPLETED|Overall Study||3
11153259|NCT01537081|12341011|FG000|STARTED|Overall Study||1123
11153260|NCT01537081|12341012|FG001|STARTED|Overall Study||1124
11153261|NCT01537081|12341013|FG002|STARTED|Overall Study||563
11153262|NCT01537081|12341011|FG000|Safety Population|Overall Study||1122
11153263|NCT01537081|12341012|FG001|Safety Population|Overall Study||1122
11153264|NCT01537081|12341013|FG002|Safety Population|Overall Study||561
11153265|NCT01537081|12341011|FG000|Modified Intent to Treat Population|Overall Study||1106
11153266|NCT01537081|12341012|FG001|Modified Intent to Treat Population|Overall Study||1109
11153267|NCT01537081|12341013|FG002|Modified Intent to Treat Population|Overall Study||556
11153268|NCT01537081|12341011|FG000|COMPLETED|Overall Study||1084
11153269|NCT01537081|12341012|FG001|COMPLETED|Overall Study||1086
11153270|NCT01537081|12341013|FG002|COMPLETED|Overall Study||547
11153271|NCT01537081|12341011|FG000|NOT COMPLETED|Overall Study||39
11153272|NCT01537081|12341012|FG001|NOT COMPLETED|Overall Study||38
11153273|NCT01537081|12341013|FG002|NOT COMPLETED|Overall Study||16
11153274|NCT01537120|12341022|FG000|STARTED|Enrolled||25
11153275|NCT01537120|12341022|FG000|COMPLETED|Enrolled||25
11153276|NCT01537120|12341022|FG000|NOT COMPLETED|Enrolled||0
11153277|NCT01537120|12341022|FG000|STARTED|8 Weeks Washout||25
11153278|NCT01537120|12341022|FG000|COMPLETED|8 Weeks Washout||24
11153279|NCT01537120|12341022|FG000|NOT COMPLETED|8 Weeks Washout||1
11153280|NCT01537120|12341022|FG000|STARTED|3 Weeks Placebo||24
11153281|NCT01537120|12341022|FG000|COMPLETED|3 Weeks Placebo||23
11153282|NCT01537120|12341022|FG000|NOT COMPLETED|3 Weeks Placebo||1
11153283|NCT01537120|12341022|FG000|STARTED|12 Weeks Vildagliptin||23
11153284|NCT01537120|12341022|FG000|COMPLETED|12 Weeks Vildagliptin||23
11153285|NCT01537120|12341022|FG000|NOT COMPLETED|12 Weeks Vildagliptin||0
11153286|NCT01537133|12341032|FG000|STARTED|Overall Study||28
11153287|NCT01537133|12341033|FG001|STARTED|Overall Study||14
11153288|NCT01537133|12341034|FG002|STARTED|Overall Study||21
11153289|NCT01537133|12341035|FG003|STARTED|Overall Study||21
11153290|NCT01537133|12341032|FG000|COMPLETED|Overall Study||25
11153291|NCT01537133|12341033|FG001|COMPLETED|Overall Study||14
11153292|NCT01537133|12341034|FG002|COMPLETED|Overall Study||21
11153293|NCT01537133|12341035|FG003|COMPLETED|Overall Study||21
11153294|NCT01537133|12341032|FG000|NOT COMPLETED|Overall Study||3
11153295|NCT01537133|12341033|FG001|NOT COMPLETED|Overall Study||0
11153296|NCT01537133|12341034|FG002|NOT COMPLETED|Overall Study||0
11153297|NCT01537133|12341035|FG003|NOT COMPLETED|Overall Study||0
11418696|NCT00450333|12617059|FG000|STARTED|Overall Study||98
11418697|NCT00450333|12617060|FG001|STARTED|Overall Study||107
11418698|NCT00450333|12617061|FG002|STARTED|Overall Study||100
11418699|NCT00450333|12617062|FG003|STARTED|Overall Study||102
11153298|NCT01537185|12341047|FG000|STARTED|Overall Study||10
11153299|NCT01537185|12341048|FG001|STARTED|Overall Study||12
11153300|NCT01537185|12341049|FG002|STARTED|Overall Study||10
11153301|NCT01537185|12341050|FG003|STARTED|Overall Study||10
11153302|NCT01537185|12341047|FG000|COMPLETED|Overall Study||7
11153303|NCT01537185|12341048|FG001|COMPLETED|Overall Study||6
11153304|NCT01537185|12341049|FG002|COMPLETED|Overall Study||4
11153305|NCT01537185|12341050|FG003|COMPLETED|Overall Study||8
11153306|NCT01537185|12341047|FG000|NOT COMPLETED|Overall Study||3
11153307|NCT01537185|12341048|FG001|NOT COMPLETED|Overall Study||6
11153308|NCT01537185|12341049|FG002|NOT COMPLETED|Overall Study||6
11153309|NCT01537185|12341050|FG003|NOT COMPLETED|Overall Study||2
11153310|NCT01537198|12341062|FG000|STARTED|Overall Study||617
11153311|NCT01537198|12341062|FG000|COMPLETED|Overall Study||463
11153312|NCT01537198|12341062|FG000|NOT COMPLETED|Overall Study||154
11153313|NCT01537211|12341068|FG000|STARTED|Overall Study||4
11153314|NCT01537211|12341069|FG001|STARTED|Overall Study||6
11153315|NCT01537211|12341068|FG000|COMPLETED|Overall Study||4
11153316|NCT01537211|12341069|FG001|COMPLETED|Overall Study||5
11153317|NCT01537211|12341068|FG000|NOT COMPLETED|Overall Study||0
11153318|NCT01537211|12341069|FG001|NOT COMPLETED|Overall Study||1
11153319|NCT01537302|12341079|FG000|STARTED|Overall Study||100
11153320|NCT01537302|12341079|FG000|COMPLETED|Overall Study||100
11153321|NCT01537302|12341079|FG000|NOT COMPLETED|Overall Study||0
11153322|NCT01537315|12341085|FG000|STARTED|Overall Study||1
11153323|NCT01537315|12341086|FG001|STARTED|Overall Study||7
11153324|NCT01537315|12341085|FG000|COMPLETED|Overall Study||1
11153325|NCT01537315|12341086|FG001|COMPLETED|Overall Study||7
11153326|NCT01537315|12341085|FG000|NOT COMPLETED|Overall Study||0
11153327|NCT01537315|12341086|FG001|NOT COMPLETED|Overall Study||0
11153328|NCT01537367|12341095|FG000|STARTED|Overall Study||615
11153329|NCT01537367|12341096|FG001|STARTED|Overall Study||610
11153330|NCT01537367|12341097|FG002|STARTED|Overall Study||613
11153331|NCT01537367|12341095|FG000|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
11153332|NCT01537367|12341096|FG001|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
11153333|NCT01537367|12341097|FG002|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
11153334|NCT01537367|12341095|FG000|NOT COMPLETED|Overall Study||0
11153335|NCT01537367|12341096|FG001|NOT COMPLETED|Overall Study||0
11153336|NCT01537367|12341097|FG002|NOT COMPLETED|Overall Study||0
11153337|NCT01537393|12341107|FG000|STARTED|Overall Study||707
11153338|NCT01537393|12341108|FG001|STARTED|Overall Study||698
11153339|NCT01537393|12341107|FG000|COMPLETED|Overall Study||553
11153340|NCT01537393|12341108|FG001|COMPLETED|Overall Study||507
11153341|NCT01537393|12341107|FG000|NOT COMPLETED|Overall Study||154
11153342|NCT01537393|12341108|FG001|NOT COMPLETED|Overall Study||191
11153343|NCT01537419|12341116|FG000|STARTED|Overall Study||63
11153344|NCT01537419|12341117|FG001|STARTED|Overall Study||66
11153345|NCT01537419|12341116|FG000|COMPLETED|Overall Study||52
11153346|NCT01537419|12341117|FG001|COMPLETED|Overall Study||54
11153347|NCT01537419|12341116|FG000|NOT COMPLETED|Overall Study||11
11153348|NCT01537419|12341117|FG001|NOT COMPLETED|Overall Study||12
11153349|NCT01537432|12341125|FG000|STARTED|Overall Study||24
11153350|NCT01537432|12341126|FG001|STARTED|Overall Study||12
11153351|NCT01537432|12341125|FG000|COMPLETED|Overall Study||18
11153352|NCT01537432|12341126|FG001|COMPLETED|Overall Study||10
11153353|NCT01537432|12341125|FG000|NOT COMPLETED|Overall Study||6
11153354|NCT01537432|12341126|FG001|NOT COMPLETED|Overall Study||2
11153355|NCT01537549|12341132|FG000|STARTED|Overall Study||11
11153356|NCT01537549|12341132|FG000|COMPLETED|Overall Study||8
11153357|NCT01537549|12341132|FG000|NOT COMPLETED|Overall Study||3
11153358|NCT01537666|12341142|FG000|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
11153359|NCT01537666|12341143|FG001|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
11153360|NCT01537666|12341144|FG002|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
11153361|NCT01537666|12341145|FG003|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
11153362|NCT01537666|12341142|FG000|COMPLETED|Overall Study||6
11153363|NCT01537666|12341143|FG001|COMPLETED|Overall Study||6
11153364|NCT01537666|12341144|FG002|COMPLETED|Overall Study||6
11153365|NCT01537666|12341145|FG003|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
11153366|NCT01537666|12341142|FG000|NOT COMPLETED|Overall Study||0
11153367|NCT01537666|12341143|FG001|NOT COMPLETED|Overall Study||0
11153368|NCT01537666|12341144|FG002|NOT COMPLETED|Overall Study||0
11153369|NCT01537666|12341145|FG003|NOT COMPLETED|Overall Study||0
11153370|NCT01537783|12341167|FG000|STARTED|Overall Study||25
11153371|NCT01537783|12341168|FG001|STARTED|Overall Study||25
11153372|NCT01537783|12341167|FG000|COMPLETED|Overall Study||14
11153373|NCT01537783|12341168|FG001|COMPLETED|Overall Study||23
11418700|NCT00450333|12617059|FG000|COMPLETED|Overall Study||44
11418701|NCT00450333|12617060|FG001|COMPLETED|Overall Study||44
11418702|NCT00450333|12617061|FG002|COMPLETED|Overall Study||75
11418703|NCT00450333|12617062|FG003|COMPLETED|Overall Study||74
11153374|NCT01537783|12341167|FG000|NOT COMPLETED|Overall Study||11
11153375|NCT01537783|12341168|FG001|NOT COMPLETED|Overall Study||2
11153376|NCT01537835|12341177|FG000|STARTED|Overall Study||37
11153377|NCT01537835|12341178|FG001|STARTED|Overall Study||37
11153378|NCT01537835|12341179|FG002|STARTED|Overall Study||35
11153379|NCT01537835|12341177|FG000|COMPLETED|Overall Study||37
11153380|NCT01537835|12341178|FG001|COMPLETED|Overall Study||37
11153381|NCT01537835|12341179|FG002|COMPLETED|Overall Study||35
11153382|NCT01537835|12341177|FG000|NOT COMPLETED|Overall Study||0
11153383|NCT01537835|12341178|FG001|NOT COMPLETED|Overall Study||0
11153384|NCT01537835|12341179|FG002|NOT COMPLETED|Overall Study||0
11153385|NCT01537887|12341187|FG000|STARTED|Period 1||12
11153386|NCT01537887|12341188|FG001|STARTED|Period 1||12
11153387|NCT01537887|12341189|FG002|STARTED|Period 1||12
11153388|NCT01537887|12341190|FG003|STARTED|Period 1||12
11153389|NCT01537887|12341191|FG004|STARTED|Period 1||12
11153390|NCT01537887|12341192|FG005|STARTED|Period 1||12
11153391|NCT01537887|12341187|FG000|Received at Least 1 Dose of Study Drug|Period 1||12
11153392|NCT01537887|12341188|FG001|Received at Least 1 Dose of Study Drug|Period 1||12
11153393|NCT01537887|12341189|FG002|Received at Least 1 Dose of Study Drug|Period 1||11
11153394|NCT01537887|12341190|FG003|Received at Least 1 Dose of Study Drug|Period 1||12
11153395|NCT01537887|12341191|FG004|Received at Least 1 Dose of Study Drug|Period 1||12
11153396|NCT01537887|12341192|FG005|Received at Least 1 Dose of Study Drug|Period 1||12
11153397|NCT01537887|12341187|FG000|COMPLETED|Period 1||12
11153398|NCT01537887|12341188|FG001|COMPLETED|Period 1||12
11153399|NCT01537887|12341189|FG002|COMPLETED|Period 1||11
11153400|NCT01537887|12341190|FG003|COMPLETED|Period 1||12
11153401|NCT01537887|12341191|FG004|COMPLETED|Period 1||11
11153402|NCT01537887|12341192|FG005|COMPLETED|Period 1||11
11153403|NCT01537887|12341187|FG000|NOT COMPLETED|Period 1||0
11153404|NCT01537887|12341188|FG001|NOT COMPLETED|Period 1||0
11153405|NCT01537887|12341189|FG002|NOT COMPLETED|Period 1||1
11153406|NCT01537887|12341190|FG003|NOT COMPLETED|Period 1||0
11153407|NCT01537887|12341191|FG004|NOT COMPLETED|Period 1||1
11153408|NCT01537887|12341192|FG005|NOT COMPLETED|Period 1||1
11153409|NCT01537887|12341187|FG000|STARTED|Period 2||12
11153410|NCT01537887|12341188|FG001|STARTED|Period 2||12
11153411|NCT01537887|12341189|FG002|STARTED|Period 2||11
11153412|NCT01537887|12341190|FG003|STARTED|Period 2||12
11153413|NCT01537887|12341191|FG004|STARTED|Period 2||11
11153414|NCT01537887|12341192|FG005|STARTED|Period 2||11
11153415|NCT01537887|12341187|FG000|COMPLETED|Period 2||12
11153416|NCT01537887|12341188|FG001|COMPLETED|Period 2||11
11418704|NCT00450333|12617059|FG000|NOT COMPLETED|Overall Study||54
11153417|NCT01537887|12341189|FG002|COMPLETED|Period 2||11
11153418|NCT01537887|12341190|FG003|COMPLETED|Period 2||12
11153419|NCT01537887|12341191|FG004|COMPLETED|Period 2||11
11153420|NCT01537887|12341192|FG005|COMPLETED|Period 2||11
11153421|NCT01537887|12341187|FG000|NOT COMPLETED|Period 2||0
11153422|NCT01537887|12341188|FG001|NOT COMPLETED|Period 2||1
11153423|NCT01537887|12341189|FG002|NOT COMPLETED|Period 2||0
11153424|NCT01537887|12341190|FG003|NOT COMPLETED|Period 2||0
11153425|NCT01537887|12341191|FG004|NOT COMPLETED|Period 2||0
11153426|NCT01537887|12341192|FG005|NOT COMPLETED|Period 2||0
11153427|NCT01537887|12341187|FG000|STARTED|Period 3||12
11153428|NCT01537887|12341188|FG001|STARTED|Period 3||11
11153429|NCT01537887|12341189|FG002|STARTED|Period 3||11
11153430|NCT01537887|12341190|FG003|STARTED|Period 3||12
11153431|NCT01537887|12341191|FG004|STARTED|Period 3||11
11153432|NCT01537887|12341192|FG005|STARTED|Period 3||11
11153433|NCT01537887|12341187|FG000|COMPLETED|Period 3||12
11153434|NCT01537887|12341188|FG001|COMPLETED|Period 3||10
11153435|NCT01537887|12341189|FG002|COMPLETED|Period 3||10
11153436|NCT01537887|12341190|FG003|COMPLETED|Period 3||12
11153437|NCT01537887|12341191|FG004|COMPLETED|Period 3||11
11153438|NCT01537887|12341192|FG005|COMPLETED|Period 3||11
11153439|NCT01537887|12341187|FG000|NOT COMPLETED|Period 3||0
11418705|NCT00450333|12617060|FG001|NOT COMPLETED|Overall Study||63
11418706|NCT00450333|12617061|FG002|NOT COMPLETED|Overall Study||25
11418707|NCT00450333|12617062|FG003|NOT COMPLETED|Overall Study||28
11418708|NCT00455143|12617072|FG000|STARTED|Overall Study||27
11418709|NCT00455143|12617072|FG000|COMPLETED|Overall Study||21
11418710|NCT00455143|12617072|FG000|NOT COMPLETED|Overall Study||6
11418711|NCT00456989|12617077|FG000|STARTED|Overall Study||39
11418712|NCT00456989|12617077|FG000|COMPLETED|Overall Study||39
11418713|NCT00456989|12617077|FG000|NOT COMPLETED|Overall Study||0
11418714|NCT00448682|12617082|FG000|STARTED|Overall Study||25
11418715|NCT00448682|12617082|FG000|COMPLETED|Overall Study||25
11418716|NCT00448682|12617082|FG000|NOT COMPLETED|Overall Study||0
11153440|NCT01537887|12341188|FG001|NOT COMPLETED|Period 3||1
11153441|NCT01537887|12341189|FG002|NOT COMPLETED|Period 3||1
11153442|NCT01537887|12341190|FG003|NOT COMPLETED|Period 3||0
11153443|NCT01537887|12341191|FG004|NOT COMPLETED|Period 3||0
11153444|NCT01537887|12341192|FG005|NOT COMPLETED|Period 3||0
11153445|NCT01537900|12341200|FG000|STARTED|Overall Study||4
11153446|NCT01537900|12341200|FG000|COMPLETED|Overall Study||4
11153447|NCT01537900|12341200|FG000|NOT COMPLETED|Overall Study||0
11153448|NCT01537926|12341206|FG000|STARTED|Overall Study||29
11153449|NCT01537926|12341207|FG001|STARTED|Overall Study||13
11153450|NCT01537926|12341206|FG000|COMPLETED|Overall Study||24
11153451|NCT01537926|12341207|FG001|COMPLETED|Overall Study||11
11153452|NCT01537926|12341206|FG000|NOT COMPLETED|Overall Study||5
11153453|NCT01537926|12341207|FG001|NOT COMPLETED|Overall Study||2
11153454|NCT01538199|12341220|FG000|STARTED|Overall Study||10
11153455|NCT01538199|12341221|FG001|STARTED|Overall Study||11
11153456|NCT01538199|12341222|FG002|STARTED|Overall Study||4
11153457|NCT01538199|12341223|FG003|STARTED|Overall Study||3
11203112|NCT01845077|12393610|FG005|STARTED|Treatment Period 2||11
11418717|NCT00454571|12617088|FG000|STARTED|Overall Study||18
11418718|NCT00454571|12617089|FG001|STARTED|Overall Study||19
11153458|NCT01538199|12341220|FG000|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
11153459|NCT01538199|12341221|FG001|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
11153460|NCT01538199|12341222|FG002|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
11153461|NCT01538199|12341223|FG003|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
11153462|NCT01538199|12341220|FG000|NOT COMPLETED|Overall Study||2
11153463|NCT01538199|12341221|FG001|NOT COMPLETED|Overall Study||3
11153464|NCT01538199|12341222|FG002|NOT COMPLETED|Overall Study||1
11153465|NCT01538199|12341223|FG003|NOT COMPLETED|Overall Study||2
11153466|NCT01538472|12341240|FG000|STARTED|Overall Study||40
11153467|NCT01538472|12341240|FG000|COMPLETED|Overall Study||36
11153468|NCT01538472|12341240|FG000|NOT COMPLETED|Overall Study||4
11153469|NCT01538615|12341246|FG000|STARTED|Overall Study||162
11153470|NCT01538615|12341247|FG001|STARTED|Overall Study||158
11153471|NCT01538615|12341246|FG000|COMPLETED|Overall Study||140
11153472|NCT01538615|12341247|FG001|COMPLETED|Overall Study||146
11153473|NCT01538615|12341246|FG000|NOT COMPLETED|Overall Study||22
11153474|NCT01538615|12341247|FG001|NOT COMPLETED|Overall Study||12
11153475|NCT01538628|12341255|FG000|STARTED|Overall Study||149
11153476|NCT01538628|12341256|FG001|STARTED|Overall Study||73
11153477|NCT01538628|12341255|FG000|COMPLETED|Overall Study||148
11153478|NCT01538628|12341256|FG001|COMPLETED|Overall Study||71
11153479|NCT01538628|12341255|FG000|NOT COMPLETED|Overall Study||1
11153480|NCT01538628|12341256|FG001|NOT COMPLETED|Overall Study||2
11153481|NCT01538719|12341265|FG000|STARTED|Overall Study||7
11153482|NCT01538719|12341266|FG001|STARTED|Overall Study||12
11153483|NCT01538719|12341265|FG000|COMPLETED|Overall Study||5
11153484|NCT01538719|12341266|FG001|COMPLETED|Overall Study||12
11153485|NCT01538719|12341265|FG000|NOT COMPLETED|Overall Study||2
11153486|NCT01538719|12341266|FG001|NOT COMPLETED|Overall Study||0
11203113|NCT01845077|12393605|FG000|COMPLETED|Treatment Period 2||11
11203114|NCT01845077|12393606|FG001|COMPLETED|Treatment Period 2||11
11203115|NCT01845077|12393607|FG002|COMPLETED|Treatment Period 2||11
11203116|NCT01845077|12393608|FG003|COMPLETED|Treatment Period 2||10
11203117|NCT01845077|12393609|FG004|COMPLETED|Treatment Period 2||11
11203118|NCT01845077|12393610|FG005|COMPLETED|Treatment Period 2||11
11203119|NCT01845077|12393605|FG000|NOT COMPLETED|Treatment Period 2||0
11203120|NCT01845077|12393606|FG001|NOT COMPLETED|Treatment Period 2||0
11203121|NCT01845077|12393607|FG002|NOT COMPLETED|Treatment Period 2||0
11203122|NCT01845077|12393608|FG003|NOT COMPLETED|Treatment Period 2||0
11203123|NCT01845077|12393609|FG004|NOT COMPLETED|Treatment Period 2||0
11203124|NCT01845077|12393610|FG005|NOT COMPLETED|Treatment Period 2||0
11203125|NCT01845103|12393625|FG000|STARTED|Overall Study||1
11203126|NCT01845103|12393625|FG000|COMPLETED|Overall Study||1
11203127|NCT01845103|12393625|FG000|NOT COMPLETED|Overall Study||0
11203128|NCT01845155|12393631|FG000|STARTED|Overall Study||146
11203129|NCT01845155|12393632|FG001|STARTED|Overall Study||144
11203130|NCT01845155|12393631|FG000|COMPLETED|Overall Study||145
11203131|NCT01845155|12393632|FG001|COMPLETED|Overall Study||144
11203132|NCT01845155|12393631|FG000|NOT COMPLETED|Overall Study||1
11203133|NCT01845155|12393632|FG001|NOT COMPLETED|Overall Study||0
11203134|NCT01845220|12393638|FG000|STARTED|Overall Study||30
11203135|NCT01845220|12393639|FG001|STARTED|Overall Study||30
11203136|NCT01845220|12393638|FG000|COMPLETED|Overall Study||30
11203137|NCT01845220|12393639|FG001|COMPLETED|Overall Study||30
11203138|NCT01845220|12393638|FG000|NOT COMPLETED|Overall Study||0
11203139|NCT01845220|12393639|FG001|NOT COMPLETED|Overall Study||0
11203140|NCT01845636|12393645|FG000|STARTED|Overall Study||41
11203141|NCT01845636|12393645|FG000|COMPLETED|Overall Study||37
11203142|NCT01845636|12393645|FG000|NOT COMPLETED|Overall Study||4
11203143|NCT01845792|12393651|FG000|STARTED|Overall Study||5
11203144|NCT01845792|12393652|FG001|STARTED|Overall Study||2
11203145|NCT01845792|12393651|FG000|COMPLETED|Overall Study||5
11203146|NCT01845792|12393652|FG001|COMPLETED|Overall Study||2
11203147|NCT01845792|12393651|FG000|NOT COMPLETED|Overall Study||0
11203148|NCT01845792|12393652|FG001|NOT COMPLETED|Overall Study||0
11205185|NCT01857869|12395948|FG008|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
11205186|NCT01857869|12395949|FG009|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
11205187|NCT01857869|12395940|FG000|NOT COMPLETED|Primary/Challenge Phase||5
11205188|NCT01857869|12395941|FG001|NOT COMPLETED|Primary/Challenge Phase||1
11205189|NCT01857869|12395942|FG002|NOT COMPLETED|Primary/Challenge Phase||0
11205190|NCT01857869|12395943|FG003|NOT COMPLETED|Primary/Challenge Phase||0
11205191|NCT01857869|12395944|FG004|NOT COMPLETED|Primary/Challenge Phase||0
11205192|NCT01857869|12395945|FG005|NOT COMPLETED|Primary/Challenge Phase||0
11205193|NCT01857869|12395946|FG006|NOT COMPLETED|Primary/Challenge Phase||0
11205194|NCT01857869|12395947|FG007|NOT COMPLETED|Primary/Challenge Phase||0
11205195|NCT01857869|12395948|FG008|NOT COMPLETED|Primary/Challenge Phase||0
11205196|NCT01857869|12395949|FG009|NOT COMPLETED|Primary/Challenge Phase||0
11205197|NCT01857869|12395940|FG000|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
11205198|NCT01857869|12395941|FG001|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
11205199|NCT01857869|12395942|FG002|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
11153487|NCT01538745|12341274|FG000|STARTED|Overall Study||24
11153488|NCT01538745|12341275|FG001|STARTED|Overall Study||21
11153489|NCT01538745|12341274|FG000|COMPLETED|Overall Study||24
11153490|NCT01538745|12341275|FG001|COMPLETED|Overall Study||21
11153491|NCT01538745|12341274|FG000|NOT COMPLETED|Overall Study||0
11153492|NCT01538745|12341275|FG001|NOT COMPLETED|Overall Study||0
11153493|NCT01538862|12341281|FG000|STARTED|Overall Study||7
11153494|NCT01538862|12341281|FG000|COMPLETED|Overall Study||7
11153495|NCT01538862|12341281|FG000|NOT COMPLETED|Overall Study||0
11153496|NCT01539070|12341288|FG000|STARTED|Overall Study||168
11153497|NCT01539070|12341289|FG001|STARTED|Overall Study||138
11153498|NCT01539070|12341288|FG000|COMPLETED|Overall Study||109
11153499|NCT01539070|12341289|FG001|COMPLETED|Overall Study||99
11153500|NCT01539070|12341288|FG000|NOT COMPLETED|Overall Study||59
11153501|NCT01539070|12341289|FG001|NOT COMPLETED|Overall Study||39
11153502|NCT01539083|12341295|FG000|STARTED|Before Randomization (VCD Induction)||256
11153503|NCT01539083|12341296|FG001|STARTED|Before Randomization (VCD Induction)||0
11153504|NCT01539083|12341297|FG002|STARTED|Before Randomization (VCD Induction)||0
11153505|NCT01539083|12341295|FG000|Treated|Before Randomization (VCD Induction)||254
11153506|NCT01539083|12341296|FG001|Treated|Before Randomization (VCD Induction)||0
11153507|NCT01539083|12341297|FG002|Treated|Before Randomization (VCD Induction)||0
11153508|NCT01539083|12341295|FG000|COMPLETED|Before Randomization (VCD Induction)||203
11153509|NCT01539083|12341296|FG001|COMPLETED|Before Randomization (VCD Induction)||0
11153510|NCT01539083|12341297|FG002|COMPLETED|Before Randomization (VCD Induction)||0
11153511|NCT01539083|12341295|FG000|NOT COMPLETED|Before Randomization (VCD Induction)||53
11153512|NCT01539083|12341296|FG001|NOT COMPLETED|Before Randomization (VCD Induction)||0
11153513|NCT01539083|12341297|FG002|NOT COMPLETED|Before Randomization (VCD Induction)||0
11153514|NCT01539083|12341295|FG000|STARTED|After Randomization (TP and VTP)||0
11153515|NCT01539083|12341296|FG001|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
11153516|NCT01539083|12341297|FG002|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
11153517|NCT01539083|12341295|FG000|Safety Population|After Randomization (TP and VTP)||0
11153518|NCT01539083|12341296|FG001|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
11153519|NCT01539083|12341297|FG002|Safety Population|After Randomization (TP and VTP)||103
11153520|NCT01539083|12341295|FG000|COMPLETED|After Randomization (TP and VTP)||0
11153521|NCT01539083|12341296|FG001|COMPLETED|After Randomization (TP and VTP)||79
11153522|NCT01539083|12341297|FG002|COMPLETED|After Randomization (TP and VTP)||80
11153523|NCT01539083|12341295|FG000|NOT COMPLETED|After Randomization (TP and VTP)||0
11153524|NCT01539083|12341296|FG001|NOT COMPLETED|After Randomization (TP and VTP)||21
11153525|NCT01539083|12341297|FG002|NOT COMPLETED|After Randomization (TP and VTP)||23
11153526|NCT01539135|12341306|FG000|STARTED|Overall Study||43
11153527|NCT01539135|12341307|FG001|STARTED|Overall Study||37
11153528|NCT01539135|12341306|FG000|COMPLETED|Overall Study||43
11153529|NCT01539135|12341307|FG001|COMPLETED|Overall Study||37
11153530|NCT01539135|12341306|FG000|NOT COMPLETED|Overall Study||0
11153531|NCT01539135|12341307|FG001|NOT COMPLETED|Overall Study||0
11153532|NCT01539239|12341315|FG000|STARTED|Overall Study||369
11153533|NCT01539239|12341316|FG001|STARTED|Overall Study||187
11153534|NCT01539239|12341315|FG000|COMPLETED|Overall Study||357
11153535|NCT01539239|12341316|FG001|COMPLETED|Overall Study||170
11153536|NCT01539239|12341315|FG000|NOT COMPLETED|Overall Study||12
11153537|NCT01539239|12341316|FG001|NOT COMPLETED|Overall Study||17
11153538|NCT01539291|12341325|FG000|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106
11153539|NCT01539291|12341326|FG001|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4
11153540|NCT01539291|12341327|FG002|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42
11153541|NCT01539291|12341328|FG003|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44
11153542|NCT01539291|12341325|FG000|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81
11153543|NCT01539291|12341326|FG001|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4
11153544|NCT01539291|12341327|FG002|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42
11153545|NCT01539291|12341328|FG003|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44
11153546|NCT01539291|12341325|FG000|NOT COMPLETED|Study GS-US-312-0116||25
11153547|NCT01539291|12341326|FG001|NOT COMPLETED|Study GS-US-312-0116||0
11153548|NCT01539291|12341327|FG002|NOT COMPLETED|Study GS-US-312-0116||0
11153549|NCT01539291|12341328|FG003|NOT COMPLETED|Study GS-US-312-0116||0
11153550|NCT01539291|12341325|FG000|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71
11153551|NCT01539291|12341326|FG001|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4
11153552|NCT01539291|12341327|FG002|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42
11153553|NCT01539291|12341328|FG003|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44
11153554|NCT01539291|12341325|FG000|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30
11153555|NCT01539291|12341326|FG001|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2
11203149|NCT01845818|12393660|FG000|STARTED|Overall Study||126
11153556|NCT01539291|12341327|FG002|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20
11153557|NCT01539291|12341328|FG003|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18
11153558|NCT01539291|12341325|FG000|NOT COMPLETED|Study GS-US-312-0117||41
11153559|NCT01539291|12341326|FG001|NOT COMPLETED|Study GS-US-312-0117||2
11153560|NCT01539291|12341327|FG002|NOT COMPLETED|Study GS-US-312-0117||22
11153561|NCT01539291|12341328|FG003|NOT COMPLETED|Study GS-US-312-0117||26
11153562|NCT01539317|12341347|FG000|STARTED|Overall Study||25
11153563|NCT01539317|12341348|FG001|STARTED|Overall Study||25
11153564|NCT01539317|12341347|FG000|COMPLETED|Overall Study||24
11153565|NCT01539317|12341348|FG001|COMPLETED|Overall Study||25
11153566|NCT01539317|12341347|FG000|NOT COMPLETED|Overall Study||1
11153567|NCT01539317|12341348|FG001|NOT COMPLETED|Overall Study||0
11153568|NCT01539512|12341359|FG000|STARTED|Overall Study||110
11153569|NCT01539512|12341360|FG001|STARTED|Overall Study||110
11153570|NCT01539512|12341359|FG000|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
11153571|NCT01539512|12341360|FG001|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
11153572|NCT01539512|12341359|FG000|NOT COMPLETED|Overall Study||23
11153573|NCT01539512|12341360|FG001|NOT COMPLETED|Overall Study||13
11153574|NCT01539525|12341369|FG000|STARTED|Overall Study||145
11153575|NCT01539525|12341370|FG001|STARTED|Overall Study||143
11153576|NCT01539525|12341371|FG002|STARTED|Overall Study||151
11153577|NCT01539525|12341369|FG000|COMPLETED|Overall Study||125
11153578|NCT01539525|12341370|FG001|COMPLETED|Overall Study||127
11153579|NCT01539525|12341371|FG002|COMPLETED|Overall Study||134
11153580|NCT01539525|12341369|FG000|NOT COMPLETED|Overall Study||20
11153581|NCT01539525|12341370|FG001|NOT COMPLETED|Overall Study||16
11153582|NCT01539525|12341371|FG002|NOT COMPLETED|Overall Study||17
11153583|NCT01539538|12341384|FG000|STARTED|Overall Study||177
11153584|NCT01539538|12341385|FG001|STARTED|Overall Study||180
11153585|NCT01539538|12341384|FG000|COMPLETED|Overall Study||146
11153586|NCT01539538|12341385|FG001|COMPLETED|Overall Study||136
11153587|NCT01539538|12341384|FG000|NOT COMPLETED|Overall Study||31
11153588|NCT01539538|12341385|FG001|NOT COMPLETED|Overall Study||44
11153589|NCT01539642|12341393|FG000|STARTED|Overall Study||114
11153590|NCT01539642|12341394|FG001|STARTED|Overall Study||58
11153591|NCT01539642|12341393|FG000|COMPLETED|Overall Study||78
11153592|NCT01539642|12341394|FG001|COMPLETED|Overall Study||27
11153593|NCT01539642|12341393|FG000|NOT COMPLETED|Overall Study||36
11153594|NCT01539642|12341394|FG001|NOT COMPLETED|Overall Study||31
11153595|NCT01539694|12341400|FG000|STARTED|Overall Study||63
11153596|NCT01539694|12341401|FG001|STARTED|Overall Study||63
11153597|NCT01539694|12341400|FG000|COMPLETED|Overall Study||62
11153598|NCT01539694|12341401|FG001|COMPLETED|Overall Study||62
11153599|NCT01539694|12341400|FG000|NOT COMPLETED|Overall Study||1
11153600|NCT01539694|12341401|FG001|NOT COMPLETED|Overall Study||1
11153601|NCT01539759|12341409|FG000|STARTED|Overall Study||56
11153602|NCT01539759|12341410|FG001|STARTED|Overall Study||56
11153603|NCT01539759|12341409|FG000|Had Successful IUD Placement|Overall Study||34
11153604|NCT01539759|12341410|FG001|Had Successful IUD Placement|Overall Study||53
11153605|NCT01539759|12341409|FG000|IUD Expulsion|Overall Study||1
11153606|NCT01539759|12341410|FG001|IUD Expulsion|Overall Study||4
11153607|NCT01539759|12341409|FG000|IUD Removal|Overall Study||2
11153608|NCT01539759|12341410|FG001|IUD Removal|Overall Study||7
11153609|NCT01539759|12341409|FG000|IUD in Place at 6 Months Posptartum|Overall Study||32
11153610|NCT01539759|12341410|FG001|IUD in Place at 6 Months Posptartum|Overall Study||40
11153611|NCT01539759|12341409|FG000|COMPLETED|Overall Study||50
11153612|NCT01539759|12341410|FG001|COMPLETED|Overall Study||48
11153613|NCT01539759|12341409|FG000|NOT COMPLETED|Overall Study||6
11153614|NCT01539759|12341410|FG001|NOT COMPLETED|Overall Study||8
11153615|NCT01539837|12341419|FG000|STARTED|Overall Study||8
11153616|NCT01539837|12341420|FG001|STARTED|Overall Study||7
11153617|NCT01539837|12341421|FG002|STARTED|Overall Study||7
11153618|NCT01539837|12341419|FG000|COMPLETED|Overall Study||8
11153619|NCT01539837|12341420|FG001|COMPLETED|Overall Study||6
11153620|NCT01539837|12341421|FG002|COMPLETED|Overall Study||5
11153621|NCT01539837|12341419|FG000|NOT COMPLETED|Overall Study||0
11153622|NCT01539837|12341420|FG001|NOT COMPLETED|Overall Study||1
11153623|NCT01539837|12341421|FG002|NOT COMPLETED|Overall Study||2
11153624|NCT01539980|12341429|FG000|STARTED|Overall Study||30
11153625|NCT01539980|12341429|FG000|COMPLETED|Overall Study||30
11153626|NCT01539980|12341429|FG000|NOT COMPLETED|Overall Study||0
11153627|NCT01540045|12341433|FG000|STARTED|Overall Study||40
11153628|NCT01540045|12341433|FG000|COMPLETED|Overall Study||40
11153629|NCT01540045|12341433|FG000|NOT COMPLETED|Overall Study||0
11153630|NCT01540071|12341458|FG000|STARTED|Overall Study||38
11153631|NCT01540071|12341458|FG000|COMPLETED|Overall Study||38
11153632|NCT01540071|12341458|FG000|NOT COMPLETED|Overall Study||0
11153633|NCT01540162|12341465|FG000|STARTED|Overall Study||30
11153634|NCT01540162|12341466|FG001|STARTED|Overall Study||32
11153635|NCT01540162|12341465|FG000|COMPLETED|Overall Study||30
11153636|NCT01540162|12341466|FG001|COMPLETED|Overall Study||32
11153637|NCT01540162|12341465|FG000|NOT COMPLETED|Overall Study||0
11153638|NCT01540162|12341466|FG001|NOT COMPLETED|Overall Study||0
11153639|NCT01540266|12341478|FG000|STARTED|Overall Study||63
11153640|NCT01540266|12341479|FG001|STARTED|Overall Study||42
11153641|NCT01540266|12341480|FG002|STARTED|Overall Study||60
11153642|NCT01540266|12341481|FG003|STARTED|Overall Study||38
11153643|NCT01540266|12341482|FG004|STARTED|Overall Study||20
11153644|NCT01540266|12341483|FG005|STARTED|Overall Study||19
11153645|NCT01540266|12341478|FG000|COMPLETED|Overall Study||57
11153646|NCT01540266|12341479|FG001|COMPLETED|Overall Study||41
11153647|NCT01540266|12341480|FG002|COMPLETED|Overall Study||59
11153648|NCT01540266|12341481|FG003|COMPLETED|Overall Study||38
11153649|NCT01540266|12341482|FG004|COMPLETED|Overall Study||20
11153650|NCT01540266|12341483|FG005|COMPLETED|Overall Study||19
11153651|NCT01540266|12341478|FG000|NOT COMPLETED|Overall Study||6
11153652|NCT01540266|12341479|FG001|NOT COMPLETED|Overall Study||1
11153653|NCT01540266|12341480|FG002|NOT COMPLETED|Overall Study||1
11153654|NCT01540266|12341481|FG003|NOT COMPLETED|Overall Study||0
11153655|NCT01540266|12341482|FG004|NOT COMPLETED|Overall Study||0
11153656|NCT01540266|12341483|FG005|NOT COMPLETED|Overall Study||0
11153657|NCT01540370|12341497|FG000|STARTED|Overall Study||102
11153658|NCT01540370|12341497|FG000|COMPLETED|Overall Study||100
11153659|NCT01540370|12341497|FG000|NOT COMPLETED|Overall Study||2
11153660|NCT01540409|12341503|FG000|STARTED|Overall Study||6
11153661|NCT01540409|12341504|FG001|STARTED|Overall Study||6
11153662|NCT01540409|12341503|FG000|COMPLETED|Overall Study||6
11153663|NCT01540409|12341504|FG001|COMPLETED|Overall Study||6
11153664|NCT01540409|12341503|FG000|NOT COMPLETED|Overall Study||0
11153665|NCT01540409|12341504|FG001|NOT COMPLETED|Overall Study||0
11153666|NCT01540474|12341517|FG000|STARTED|Vaccination Period||10
11153667|NCT01540474|12341518|FG001|STARTED|Vaccination Period||10
11153668|NCT01540474|12341519|FG002|STARTED|Vaccination Period||10
11322891|NCT03856996|12520180|FG000|STARTED|Overall Study||15
11322892|NCT03856996|12520181|FG001|STARTED|Overall Study||15
11322893|NCT03856996|12520180|FG000|COMPLETED|Overall Study||12
11322894|NCT03856996|12520181|FG001|COMPLETED|Overall Study||13
11322895|NCT03856996|12520180|FG000|NOT COMPLETED|Overall Study||3
11322896|NCT03856996|12520181|FG001|NOT COMPLETED|Overall Study||2
11322897|NCT03770689|12520191|FG000|STARTED|Overall Study||1
11322898|NCT03770689|12520192|FG001|STARTED|Overall Study||6
11322899|NCT03770689|12520193|FG002|STARTED|Overall Study||6
11322900|NCT03770689|12520194|FG003|STARTED|Overall Study||6
11322901|NCT03770689|12520191|FG000|Pharmacokinetic Analysis Set|Overall Study|Number of participants analyzed in 50 mg group for PK outcome is different than PK analysis set. Because 1 participant from peposertib 100 mg took peposertib 50 mg from Fraction Day (FD) 1 through FD 10. PK results for this participant was summarized by actual dose received (50 mg) whereas non-PK results are summarized by planned dose (100 mg). Number of participants analyzed for 50 mg dose level in PK outputs that is 2 was therefore higher than non-PK outputs that is 1.|1
11322902|NCT03770689|12520192|FG001|Pharmacokinetic Analysis Set|Overall Study|Number of participants analyzed in 100 mg group for PK outcome is different than PK analysis set. Because 1 participant from peposertib 100 mg took peposertib 50 mg from Fraction Day (FD) 1 through FD 10. PK results for this participant was summarized by actual dose received (50 mg) whereas non-PK results are summarized by planned dose (100 mg). Number of participants analyzed for 100 mg dose level in PK outputs that is 5 was therefore lesser than non-PK outputs that is 6.|6
11322903|NCT03770689|12520193|FG002|Pharmacokinetic Analysis Set|Overall Study||6
11322904|NCT03770689|12520194|FG003|Pharmacokinetic Analysis Set|Overall Study||6
11322905|NCT03770689|12520191|FG000|Full Analysis Set (FAS)|Overall Study||1
11322906|NCT03770689|12520192|FG001|Full Analysis Set (FAS)|Overall Study||6
11322907|NCT03770689|12520193|FG002|Full Analysis Set (FAS)|Overall Study||6
11322908|NCT03770689|12520194|FG003|Full Analysis Set (FAS)|Overall Study||6
11322909|NCT03770689|12520191|FG000|Safety Analysis Set (SAF)|Overall Study||1
11322910|NCT03770689|12520192|FG001|Safety Analysis Set (SAF)|Overall Study||6
11322911|NCT03770689|12520193|FG002|Safety Analysis Set (SAF)|Overall Study||6
11322912|NCT03770689|12520194|FG003|Safety Analysis Set (SAF)|Overall Study||6
11322913|NCT03770689|12520191|FG000|COMPLETED|Overall Study||1
11322914|NCT03770689|12520192|FG001|COMPLETED|Overall Study||6
11322915|NCT03770689|12520193|FG002|COMPLETED|Overall Study||6
11418719|NCT00454571|12617088|FG000|COMPLETED|Overall Study||5
11418720|NCT00454571|12617089|FG001|COMPLETED|Overall Study||13
11418721|NCT00454571|12617088|FG000|NOT COMPLETED|Overall Study||13
11418722|NCT00454571|12617089|FG001|NOT COMPLETED|Overall Study||6
11418723|NCT00452361|12617097|FG000|STARTED|Overall Study||21
11418724|NCT00452361|12617098|FG001|STARTED|Overall Study||10
11418725|NCT00452361|12617097|FG000|COMPLETED|Overall Study||0
11418726|NCT00452361|12617098|FG001|COMPLETED|Overall Study||0
11418727|NCT00452361|12617097|FG000|NOT COMPLETED|Overall Study||21
11418728|NCT00452361|12617098|FG001|NOT COMPLETED|Overall Study||10
11418729|NCT00443040|12617107|FG000|STARTED|Overall Study||14
11418730|NCT00443040|12617108|FG001|STARTED|Overall Study||11
11418731|NCT00443040|12617109|FG002|STARTED|Overall Study||10
11418732|NCT00443040|12617107|FG000|COMPLETED|Overall Study||10
11418733|NCT00443040|12617108|FG001|COMPLETED|Overall Study||11
11418734|NCT00443040|12617109|FG002|COMPLETED|Overall Study||9
11418735|NCT00443040|12617107|FG000|NOT COMPLETED|Overall Study||4
11418736|NCT00443040|12617108|FG001|NOT COMPLETED|Overall Study||0
11418737|NCT00443040|12617109|FG002|NOT COMPLETED|Overall Study||1
11418738|NCT00447421|12617117|FG000|STARTED|Overall Study||9
11418739|NCT00447421|12617117|FG000|COMPLETED|Overall Study||3
11418740|NCT00447421|12617117|FG000|NOT COMPLETED|Overall Study||6
11418741|NCT00441272|12617123|FG000|STARTED|Overall Study||25
11418742|NCT00441272|12617124|FG001|STARTED|Overall Study||25
11418743|NCT00441272|12617123|FG000|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
11418744|NCT00441272|12617124|FG001|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
11418745|NCT00441272|12617123|FG000|NOT COMPLETED|Overall Study||25
11418746|NCT00441272|12617124|FG001|NOT COMPLETED|Overall Study||25
11418747|NCT00437398|12617130|FG000|STARTED|Overall Study||2
11418748|NCT00437398|12617130|FG000|COMPLETED|Overall Study||2
11418749|NCT00437398|12617130|FG000|NOT COMPLETED|Overall Study||0
11418750|NCT00440271|12617136|FG000|STARTED|Overall Study||15
11418751|NCT00440271|12617137|FG001|STARTED|Overall Study||18
11418752|NCT00440271|12617136|FG000|COMPLETED|Overall Study||3
11418753|NCT00440271|12617137|FG001|COMPLETED|Overall Study||3
11418754|NCT00440271|12617136|FG000|NOT COMPLETED|Overall Study||12
11418755|NCT00440271|12617137|FG001|NOT COMPLETED|Overall Study||15
11418756|NCT00442260|12617143|FG000|STARTED|Overall Study||2
11418757|NCT00442260|12617143|FG000|COMPLETED|Overall Study||2
11418758|NCT00442260|12617143|FG000|NOT COMPLETED|Overall Study||0
11418759|NCT00429026|12617147|FG000|STARTED|Overall Study||40
11418760|NCT00429026|12617147|FG000|COMPLETED|Overall Study||0
11418761|NCT00429026|12617147|FG000|NOT COMPLETED|Overall Study||40
11418762|NCT00428207|12617151|FG000|STARTED|Overall Study||2
11418763|NCT00428207|12617152|FG001|STARTED|Overall Study||2
11418764|NCT00428207|12617151|FG000|COMPLETED|Overall Study||2
11418765|NCT00428207|12617152|FG001|COMPLETED|Overall Study||2
11418766|NCT00428207|12617151|FG000|NOT COMPLETED|Overall Study||0
11418767|NCT00428207|12617152|FG001|NOT COMPLETED|Overall Study||0
11418768|NCT00439569|12617158|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||7
11418769|NCT00439569|12617158|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
11418770|NCT00439569|12617158|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
11418771|NCT00439569|12617158|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
11418772|NCT00439569|12617158|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
11418773|NCT00439569|12617158|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
11418774|NCT00422669|12617165|FG000|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
11418775|NCT00422669|12617166|FG001|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
11418776|NCT00422669|12617167|FG002|STARTED|Overall Study||7
11418777|NCT00422669|12617165|FG000|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
11418778|NCT00422669|12617166|FG001|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
11418779|NCT00422669|12617167|FG002|COMPLETED|Overall Study||0
11418780|NCT00422669|12617165|FG000|NOT COMPLETED|Overall Study||98
11418781|NCT00422669|12617166|FG001|NOT COMPLETED|Overall Study||100
11418782|NCT00422669|12617167|FG002|NOT COMPLETED|Overall Study||7
11418783|NCT00432445|12617173|FG000|STARTED|Overall Study||2
11418784|NCT00432445|12617173|FG000|COMPLETED|Overall Study||2
11418785|NCT00432445|12617173|FG000|NOT COMPLETED|Overall Study||0
11418786|NCT00434590|12617179|FG000|STARTED|Overall Study||5
11418787|NCT00434590|12617180|FG001|STARTED|Overall Study||5
11322916|NCT03770689|12520194|FG003|COMPLETED|Overall Study||6
11322917|NCT03770689|12520191|FG000|NOT COMPLETED|Overall Study||0
11322918|NCT03770689|12520192|FG001|NOT COMPLETED|Overall Study||0
11322919|NCT03770689|12520193|FG002|NOT COMPLETED|Overall Study||0
11322920|NCT03770689|12520194|FG003|NOT COMPLETED|Overall Study||0
11418788|NCT00434590|12617179|FG000|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
11418789|NCT00434590|12617180|FG001|COMPLETED|Overall Study||0
11418790|NCT00434590|12617179|FG000|NOT COMPLETED|Overall Study||5
11418791|NCT00434590|12617180|FG001|NOT COMPLETED|Overall Study||5
11418792|NCT00424645|12617188|FG000|STARTED|Overall Study||3
11342960|NCT02950545|12540321|FG004|COMPLETED|Session 1 (70 Minutes)||8
11342961|NCT02950545|12540322|FG005|COMPLETED|Session 1 (70 Minutes)||9
11342962|NCT02950545|12540317|FG000|NOT COMPLETED|Session 1 (70 Minutes)||0
11342963|NCT02950545|12540318|FG001|NOT COMPLETED|Session 1 (70 Minutes)||0
11342964|NCT02950545|12540319|FG002|NOT COMPLETED|Session 1 (70 Minutes)||0
11342965|NCT02950545|12540320|FG003|NOT COMPLETED|Session 1 (70 Minutes)||0
11342966|NCT02950545|12540321|FG004|NOT COMPLETED|Session 1 (70 Minutes)||0
11342967|NCT02950545|12540322|FG005|NOT COMPLETED|Session 1 (70 Minutes)||1
11342968|NCT02950545|12540317|FG000|STARTED|Washout 1 (5 Minutes)||9
11342969|NCT02950545|12540318|FG001|STARTED|Washout 1 (5 Minutes)||9
11342970|NCT02950545|12540319|FG002|STARTED|Washout 1 (5 Minutes)||7
11342971|NCT02950545|12540320|FG003|STARTED|Washout 1 (5 Minutes)||8
11342972|NCT02950545|12540321|FG004|STARTED|Washout 1 (5 Minutes)||8
11342973|NCT02950545|12540322|FG005|STARTED|Washout 1 (5 Minutes)||9
11342974|NCT02950545|12540317|FG000|COMPLETED|Washout 1 (5 Minutes)||8
11342975|NCT02950545|12540318|FG001|COMPLETED|Washout 1 (5 Minutes)||9
11342976|NCT02950545|12540319|FG002|COMPLETED|Washout 1 (5 Minutes)||7
11342977|NCT02950545|12540320|FG003|COMPLETED|Washout 1 (5 Minutes)||7
11342978|NCT02950545|12540321|FG004|COMPLETED|Washout 1 (5 Minutes)||8
11342979|NCT02950545|12540322|FG005|COMPLETED|Washout 1 (5 Minutes)||8
11342980|NCT02950545|12540317|FG000|NOT COMPLETED|Washout 1 (5 Minutes)||1
11342981|NCT02950545|12540318|FG001|NOT COMPLETED|Washout 1 (5 Minutes)||0
11342982|NCT02950545|12540319|FG002|NOT COMPLETED|Washout 1 (5 Minutes)||0
11342983|NCT02950545|12540320|FG003|NOT COMPLETED|Washout 1 (5 Minutes)||1
11342984|NCT02950545|12540321|FG004|NOT COMPLETED|Washout 1 (5 Minutes)||0
11342985|NCT02950545|12540322|FG005|NOT COMPLETED|Washout 1 (5 Minutes)||1
11342986|NCT02950545|12540317|FG000|STARTED|Session 2 (70 Minutes)||8
11342987|NCT02950545|12540318|FG001|STARTED|Session 2 (70 Minutes)||9
11342988|NCT02950545|12540319|FG002|STARTED|Session 2 (70 Minutes)||7
11342989|NCT02950545|12540320|FG003|STARTED|Session 2 (70 Minutes)||7
11342990|NCT02950545|12540321|FG004|STARTED|Session 2 (70 Minutes)||8
11342991|NCT02950545|12540322|FG005|STARTED|Session 2 (70 Minutes)||8
11342992|NCT02950545|12540317|FG000|COMPLETED|Session 2 (70 Minutes)||8
11342993|NCT02950545|12540318|FG001|COMPLETED|Session 2 (70 Minutes)||9
11418793|NCT00424645|12617189|FG001|STARTED|Overall Study||0
11418794|NCT00424645|12617188|FG000|COMPLETED|Overall Study||2
11342994|NCT02950545|12540319|FG002|COMPLETED|Session 2 (70 Minutes)||7
11342995|NCT02950545|12540320|FG003|COMPLETED|Session 2 (70 Minutes)||7
11342996|NCT02950545|12540321|FG004|COMPLETED|Session 2 (70 Minutes)||7
11418795|NCT00424645|12617189|FG001|COMPLETED|Overall Study||0
11153669|NCT01540474|12341520|FG003|STARTED|Vaccination Period||0
11153670|NCT01540474|12341517|FG000|COMPLETED|Vaccination Period||10
11153671|NCT01540474|12341518|FG001|COMPLETED|Vaccination Period||9
11153672|NCT01540474|12341519|FG002|COMPLETED|Vaccination Period||10
11153673|NCT01540474|12341520|FG003|COMPLETED|Vaccination Period||0
11153674|NCT01540474|12341517|FG000|NOT COMPLETED|Vaccination Period||0
11153675|NCT01540474|12341518|FG001|NOT COMPLETED|Vaccination Period||1
11153676|NCT01540474|12341519|FG002|NOT COMPLETED|Vaccination Period||0
11153677|NCT01540474|12341520|FG003|NOT COMPLETED|Vaccination Period||0
11153678|NCT01540474|12341517|FG000|STARTED|Malaria Challenge||10
11153679|NCT01540474|12341518|FG001|STARTED|Malaria Challenge||9
11153680|NCT01540474|12341519|FG002|STARTED|Malaria Challenge||10
11153681|NCT01540474|12341520|FG003|STARTED|Malaria Challenge||6
11153682|NCT01540474|12341517|FG000|COMPLETED|Malaria Challenge||10
11153683|NCT01540474|12341518|FG001|COMPLETED|Malaria Challenge||9
11153684|NCT01540474|12341519|FG002|COMPLETED|Malaria Challenge||10
11153685|NCT01540474|12341520|FG003|COMPLETED|Malaria Challenge||5
11153686|NCT01540474|12341517|FG000|NOT COMPLETED|Malaria Challenge||0
11153687|NCT01540474|12341518|FG001|NOT COMPLETED|Malaria Challenge||0
11153688|NCT01540474|12341519|FG002|NOT COMPLETED|Malaria Challenge||0
11153689|NCT01540474|12341520|FG003|NOT COMPLETED|Malaria Challenge||1
11153690|NCT01540487|12341533|FG000|STARTED|Overall Study||24
11153691|NCT01540487|12341534|FG001|STARTED|Overall Study||24
11153692|NCT01540487|12341533|FG000|COMPLETED|Overall Study||23
11342997|NCT02950545|12540322|FG005|COMPLETED|Session 2 (70 Minutes)||8
11342998|NCT02950545|12540317|FG000|NOT COMPLETED|Session 2 (70 Minutes)||0
11342999|NCT02950545|12540318|FG001|NOT COMPLETED|Session 2 (70 Minutes)||0
11343000|NCT02950545|12540319|FG002|NOT COMPLETED|Session 2 (70 Minutes)||0
11343001|NCT02950545|12540320|FG003|NOT COMPLETED|Session 2 (70 Minutes)||0
11343002|NCT02950545|12540321|FG004|NOT COMPLETED|Session 2 (70 Minutes)||1
11153693|NCT01540487|12341534|FG001|COMPLETED|Overall Study||24
11153694|NCT01540487|12341533|FG000|NOT COMPLETED|Overall Study||1
11153695|NCT01540487|12341534|FG001|NOT COMPLETED|Overall Study||0
11153696|NCT01540513|12341544|FG000|STARTED|Overall Study||12
11153697|NCT01540513|12341544|FG000|COMPLETED|Overall Study||12
11153698|NCT01540513|12341544|FG000|NOT COMPLETED|Overall Study||0
11153699|NCT01540565|12341548|FG000|STARTED|Overall Study||52
11153700|NCT01540565|12341548|FG000|COMPLETED|Overall Study||50
11153701|NCT01540565|12341548|FG000|NOT COMPLETED|Overall Study||2
11153702|NCT01540773|12341552|FG000|STARTED|First Intervention||8
11153703|NCT01540773|12341553|FG001|STARTED|First Intervention||8
11153704|NCT01540773|12341552|FG000|COMPLETED|First Intervention||8
11153705|NCT01540773|12341553|FG001|COMPLETED|First Intervention||8
11153706|NCT01540773|12341552|FG000|NOT COMPLETED|First Intervention||0
11153707|NCT01540773|12341553|FG001|NOT COMPLETED|First Intervention||0
11153708|NCT01540773|12341552|FG000|STARTED|Wash Out Period of 1 Week||8
11153709|NCT01540773|12341553|FG001|STARTED|Wash Out Period of 1 Week||8
11153710|NCT01540773|12341552|FG000|COMPLETED|Wash Out Period of 1 Week||8
11153711|NCT01540773|12341553|FG001|COMPLETED|Wash Out Period of 1 Week||8
11153712|NCT01540773|12341552|FG000|NOT COMPLETED|Wash Out Period of 1 Week||0
11153713|NCT01540773|12341553|FG001|NOT COMPLETED|Wash Out Period of 1 Week||0
11153714|NCT01540773|12341552|FG000|STARTED|Second Intervention||8
11153715|NCT01540773|12341553|FG001|STARTED|Second Intervention||8
11153716|NCT01540773|12341552|FG000|COMPLETED|Second Intervention||8
11153717|NCT01540773|12341553|FG001|COMPLETED|Second Intervention||8
11153718|NCT01540773|12341552|FG000|NOT COMPLETED|Second Intervention||0
11153719|NCT01540773|12341553|FG001|NOT COMPLETED|Second Intervention||0
11153720|NCT01540825|12341572|FG000|STARTED|Overall Study||20
11153721|NCT01540825|12341573|FG001|STARTED|Overall Study||6
11153722|NCT01540825|12341574|FG002|STARTED|Overall Study||6
11153723|NCT01540825|12341575|FG003|STARTED|Overall Study||6
11153724|NCT01540825|12341576|FG004|STARTED|Overall Study||6
11153725|NCT01540825|12341577|FG005|STARTED|Overall Study||6
11153726|NCT01540825|12341578|FG006|STARTED|Overall Study||6
11153727|NCT01540825|12341579|FG007|STARTED|Overall Study||6
11153728|NCT01540825|12341580|FG008|STARTED|Overall Study||6
11153729|NCT01540825|12341581|FG009|STARTED|Overall Study||6
11153730|NCT01540825|12341582|FG010|STARTED|Overall Study||6
11153731|NCT01540825|12341572|FG000|COMPLETED|Overall Study||20
11153732|NCT01540825|12341573|FG001|COMPLETED|Overall Study||6
11153733|NCT01540825|12341574|FG002|COMPLETED|Overall Study||6
11153734|NCT01540825|12341575|FG003|COMPLETED|Overall Study||6
11153735|NCT01540825|12341576|FG004|COMPLETED|Overall Study||6
11153736|NCT01540825|12341577|FG005|COMPLETED|Overall Study||6
11153737|NCT01540825|12341578|FG006|COMPLETED|Overall Study||6
11153738|NCT01540825|12341579|FG007|COMPLETED|Overall Study||6
11153739|NCT01540825|12341580|FG008|COMPLETED|Overall Study||6
11153740|NCT01540825|12341581|FG009|COMPLETED|Overall Study||6
11153741|NCT01540825|12341582|FG010|COMPLETED|Overall Study||6
11153742|NCT01540825|12341572|FG000|NOT COMPLETED|Overall Study||0
11153743|NCT01540825|12341573|FG001|NOT COMPLETED|Overall Study||0
11153744|NCT01540825|12341574|FG002|NOT COMPLETED|Overall Study||0
11153745|NCT01540825|12341575|FG003|NOT COMPLETED|Overall Study||0
11153746|NCT01540825|12341576|FG004|NOT COMPLETED|Overall Study||0
11153747|NCT01540825|12341577|FG005|NOT COMPLETED|Overall Study||0
11153748|NCT01540825|12341578|FG006|NOT COMPLETED|Overall Study||0
11153749|NCT01540825|12341579|FG007|NOT COMPLETED|Overall Study||0
11153750|NCT01540825|12341580|FG008|NOT COMPLETED|Overall Study||0
11153751|NCT01540825|12341581|FG009|NOT COMPLETED|Overall Study||0
11153752|NCT01540825|12341582|FG010|NOT COMPLETED|Overall Study||0
11153753|NCT01540838|12341618|FG000|STARTED|Overall Study||188
11153754|NCT01540838|12341619|FG001|STARTED|Overall Study||187
11153755|NCT01540838|12341618|FG000|COMPLETED|Overall Study||166
11153756|NCT01540838|12341619|FG001|COMPLETED|Overall Study||164
11153757|NCT01540838|12341618|FG000|NOT COMPLETED|Overall Study||22
11153758|NCT01540838|12341619|FG001|NOT COMPLETED|Overall Study||23
11153759|NCT01540851|12341627|FG000|STARTED|Overall Study||154
11153760|NCT01540851|12341628|FG001|STARTED|Overall Study||154
11153761|NCT01540851|12341627|FG000|COMPLETED|Overall Study||133
11153762|NCT01540851|12341628|FG001|COMPLETED|Overall Study||136
11153763|NCT01540851|12341627|FG000|NOT COMPLETED|Overall Study||21
11153764|NCT01540851|12341628|FG001|NOT COMPLETED|Overall Study||18
11153765|NCT01540981|12341638|FG000|STARTED|Overall Study||6
11153766|NCT01540981|12341639|FG001|STARTED|Overall Study||6
11153767|NCT01540981|12341638|FG000|COMPLETED|Overall Study||5
11153768|NCT01540981|12341639|FG001|COMPLETED|Overall Study||6
11153769|NCT01540981|12341638|FG000|NOT COMPLETED|Overall Study||1
11153770|NCT01540981|12341639|FG001|NOT COMPLETED|Overall Study||0
11153771|NCT01541215|12341647|FG000|STARTED|Treatment Period (52 Weeks)||66
11153772|NCT01541215|12341648|FG001|STARTED|Treatment Period (52 Weeks)||69
11153773|NCT01541215|12341647|FG000|Exposed|Treatment Period (52 Weeks)||66
11153774|NCT01541215|12341648|FG001|Exposed|Treatment Period (52 Weeks)||68
11153775|NCT01541215|12341647|FG000|COMPLETED|Treatment Period (52 Weeks)||56
11153776|NCT01541215|12341648|FG001|COMPLETED|Treatment Period (52 Weeks)||53
11153777|NCT01541215|12341647|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||10
11153778|NCT01541215|12341648|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||16
11153779|NCT01541215|12341647|FG000|STARTED|Follow up 1 (Weeks 53-104)|Subjects who attended safety follow up visit at week 104 were included.|52
11153780|NCT01541215|12341648|FG001|STARTED|Follow up 1 (Weeks 53-104)|Follow up was not planned for the subjects who received placebo.|0
11153781|NCT01541215|12341647|FG000|COMPLETED|Follow up 1 (Weeks 53-104)||50
11153782|NCT01541215|12341648|FG001|COMPLETED|Follow up 1 (Weeks 53-104)||0
11153783|NCT01541215|12341647|FG000|NOT COMPLETED|Follow up 1 (Weeks 53-104)||2
11153784|NCT01541215|12341648|FG001|NOT COMPLETED|Follow up 1 (Weeks 53-104)||0
11153785|NCT01541215|12341647|FG000|STARTED|Follow up 2 (Weeks 105-156)|Subjects who attended safety follow up visit at week 156 were included.|48
11153786|NCT01541215|12341648|FG001|STARTED|Follow up 2 (Weeks 105-156)||0
11153787|NCT01541215|12341647|FG000|COMPLETED|Follow up 2 (Weeks 105-156)||48
11153788|NCT01541215|12341648|FG001|COMPLETED|Follow up 2 (Weeks 105-156)||0
11153789|NCT01541215|12341647|FG000|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
11153790|NCT01541215|12341648|FG001|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
11153791|NCT01541254|12341658|FG000|STARTED|Overall Study||36
11153792|NCT01541254|12341658|FG000|COMPLETED|Overall Study||30
11153793|NCT01541254|12341658|FG000|NOT COMPLETED|Overall Study||6
11153794|NCT01541358|12341662|FG000|STARTED|Overall Study||2
11153795|NCT01541358|12341662|FG000|COMPLETED|Overall Study||2
11418796|NCT00424645|12617188|FG000|NOT COMPLETED|Overall Study||1
11418797|NCT00424645|12617189|FG001|NOT COMPLETED|Overall Study||0
11418798|NCT00430027|12617195|FG000|STARTED|Overall Study||8
11418799|NCT00430027|12617195|FG000|COMPLETED|Overall Study||0
11418800|NCT00430027|12617195|FG000|NOT COMPLETED|Overall Study||8
11153796|NCT01541358|12341662|FG000|NOT COMPLETED|Overall Study||0
11153797|NCT01541371|12341667|FG000|STARTED|Overall Study||403
11153798|NCT01541371|12341667|FG000|Full Analysis Set|Overall Study||394
11153799|NCT01541371|12341667|FG000|COMPLETED|Overall Study||326
11153800|NCT01541371|12341667|FG000|NOT COMPLETED|Overall Study||77
11153801|NCT01541384|12341678|FG000|STARTED|Overall Study||40
11153802|NCT01541384|12341679|FG001|STARTED|Overall Study||40
11153803|NCT01541384|12341680|FG002|STARTED|Overall Study||40
11153804|NCT01541384|12341678|FG000|COMPLETED|Overall Study||40
11153805|NCT01541384|12341679|FG001|COMPLETED|Overall Study||39
11153806|NCT01541384|12341680|FG002|COMPLETED|Overall Study||38
11153807|NCT01541384|12341678|FG000|NOT COMPLETED|Overall Study||0
11153808|NCT01541384|12341679|FG001|NOT COMPLETED|Overall Study||1
11153809|NCT01541384|12341680|FG002|NOT COMPLETED|Overall Study||2
11153810|NCT01541553|12341690|FG000|STARTED|Overall Study||167
11153811|NCT01541553|12341691|FG001|STARTED|Overall Study||162
11153812|NCT01541553|12341690|FG000|COMPLETED|Overall Study||155
11153813|NCT01541553|12341691|FG001|COMPLETED|Overall Study||148
11153814|NCT01541553|12341690|FG000|NOT COMPLETED|Overall Study||12
11153815|NCT01541553|12341691|FG001|NOT COMPLETED|Overall Study||14
11153816|NCT01541644|12341697|FG000|STARTED|Overall Study||27
11153817|NCT01541644|12341697|FG000|COMPLETED|Overall Study||24
11153818|NCT01541644|12341697|FG000|NOT COMPLETED|Overall Study||3
11153819|NCT01541735|12341703|FG000|STARTED|Overall Study||7
11153820|NCT01541735|12341704|FG001|STARTED|Overall Study||7
11153821|NCT01541735|12341703|FG000|COMPLETED|Overall Study||7
11153822|NCT01541735|12341704|FG001|COMPLETED|Overall Study||7
11153823|NCT01541735|12341703|FG000|NOT COMPLETED|Overall Study||0
11153824|NCT01541735|12341704|FG001|NOT COMPLETED|Overall Study||0
11153825|NCT01541748|12341710|FG000|STARTED|Overall Study|74 subjects were consented; however, 5 were screen failures and 1 did not receive the study device.|74
11153826|NCT01541748|12341710|FG000|COMPLETED|Overall Study||43
11153827|NCT01541748|12341710|FG000|NOT COMPLETED|Overall Study||31
11153828|NCT01541826|12341726|FG000|STARTED|Overall Study||28
11153829|NCT01541826|12341727|FG001|STARTED|Overall Study||28
11153830|NCT01541826|12341728|FG002|STARTED|Overall Study||6
11153831|NCT01541826|12341726|FG000|COMPLETED|Overall Study||24
11153832|NCT01541826|12341727|FG001|COMPLETED|Overall Study||25
11418801|NCT00429858|12617199|FG000|STARTED|Overall Study||21
11153833|NCT01541826|12341728|FG002|COMPLETED|Overall Study||6
11153834|NCT01541826|12341726|FG000|NOT COMPLETED|Overall Study||4
11153835|NCT01541826|12341727|FG001|NOT COMPLETED|Overall Study||3
11153836|NCT01541826|12341728|FG002|NOT COMPLETED|Overall Study||0
11153837|NCT01541865|12341736|FG000|STARTED|Overall Study||146
11153838|NCT01541865|12341736|FG000|COMPLETED|Overall Study||124
11153839|NCT01541865|12341736|FG000|NOT COMPLETED|Overall Study||22
11153840|NCT01541891|12341742|FG000|STARTED|Overall Study||15
11153841|NCT01541891|12341743|FG001|STARTED|Overall Study||15
11153842|NCT01541891|12341742|FG000|COMPLETED|Overall Study||14
11153843|NCT01541891|12341743|FG001|COMPLETED|Overall Study||14
11153844|NCT01541891|12341742|FG000|NOT COMPLETED|Overall Study||1
11153845|NCT01541891|12341743|FG001|NOT COMPLETED|Overall Study||1
11153846|NCT01541917|12341754|FG000|STARTED|Overall Study||144
11153847|NCT01541917|12341755|FG001|STARTED|Overall Study||145
11153848|NCT01541917|12341754|FG000|COMPLETED|Overall Study||129
11153849|NCT01541917|12341755|FG001|COMPLETED|Overall Study||136
11153850|NCT01541917|12341754|FG000|NOT COMPLETED|Overall Study||15
11153851|NCT01541917|12341755|FG001|NOT COMPLETED|Overall Study||9
11153852|NCT01541930|12341764|FG000|STARTED|Overall Study||21
11153853|NCT01541930|12341764|FG000|COMPLETED|Overall Study||20
11153854|NCT01541930|12341764|FG000|NOT COMPLETED|Overall Study||1
11153855|NCT01541969|12341781|FG000|STARTED|Double-blind (0-12 Weeks)||50
11153856|NCT01541969|12341782|FG001|STARTED|Double-blind (0-12 Weeks)||50
11153857|NCT01541969|12341781|FG000|COMPLETED|Double-blind (0-12 Weeks)||44
11153858|NCT01541969|12341782|FG001|COMPLETED|Double-blind (0-12 Weeks)||48
11153859|NCT01541969|12341781|FG000|NOT COMPLETED|Double-blind (0-12 Weeks)||6
11153860|NCT01541969|12341782|FG001|NOT COMPLETED|Double-blind (0-12 Weeks)||2
11153861|NCT01541969|12341781|FG000|STARTED|Open Label Extension (12-36 Weeks)||44
11153862|NCT01541969|12341782|FG001|STARTED|Open Label Extension (12-36 Weeks)||48
11153863|NCT01541969|12341781|FG000|COMPLETED|Open Label Extension (12-36 Weeks)||33
11153864|NCT01541969|12341782|FG001|COMPLETED|Open Label Extension (12-36 Weeks)||35
11153865|NCT01541969|12341781|FG000|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
11153866|NCT01541969|12341782|FG001|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
11153867|NCT01542034|12341793|FG000|STARTED|Overall Study||256
11153868|NCT01542034|12341794|FG001|STARTED|Overall Study||250
11153869|NCT01542034|12341793|FG000|Received Treatment|Overall Study||256
11153870|NCT01542034|12341794|FG001|Received Treatment|Overall Study||249
11153871|NCT01542034|12341793|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
11153872|NCT01542034|12341794|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
11153873|NCT01542034|12341793|FG000|NOT COMPLETED|Overall Study||30
11153874|NCT01542034|12341794|FG001|NOT COMPLETED|Overall Study||23
11153875|NCT01542125|12341802|FG000|STARTED|Overall Study||140
11153876|NCT01542125|12341803|FG001|STARTED|Overall Study||141
11153877|NCT01542125|12341802|FG000|COMPLETED|Overall Study||140
11153878|NCT01542125|12341803|FG001|COMPLETED|Overall Study||141
11153879|NCT01542125|12341802|FG000|NOT COMPLETED|Overall Study||0
11153880|NCT01542125|12341803|FG001|NOT COMPLETED|Overall Study||0
11153881|NCT01542229|12341811|FG000|STARTED|Overall Study||68
11153882|NCT01542229|12341812|FG001|STARTED|Overall Study||66
11153883|NCT01542229|12341811|FG000|COMPLETED|Overall Study||45
11153884|NCT01542229|12341812|FG001|COMPLETED|Overall Study||30
11153885|NCT01542229|12341811|FG000|NOT COMPLETED|Overall Study||23
11153886|NCT01542229|12341812|FG001|NOT COMPLETED|Overall Study||36
11153887|NCT01542255|12341819|FG000|STARTED|Overall Study||7
11153888|NCT01542255|12341819|FG000|Analyzed for Time to Progression|Overall Study||7
11153889|NCT01542255|12341819|FG000|COMPLETED|Overall Study||7
11153890|NCT01542255|12341819|FG000|NOT COMPLETED|Overall Study||0
11153891|NCT01542307|12341824|FG000|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
11153892|NCT01542307|12341825|FG001|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
11153893|NCT01542307|12341824|FG000|COMPLETED|Overall Study||22
11153894|NCT01542307|12341825|FG001|COMPLETED|Overall Study||22
11153895|NCT01542307|12341824|FG000|NOT COMPLETED|Overall Study||0
11153896|NCT01542307|12341825|FG001|NOT COMPLETED|Overall Study||0
11153897|NCT01542372|12341831|FG000|STARTED|Overall Study||11
11153898|NCT01542372|12341832|FG001|STARTED|Overall Study||11
11153899|NCT01542372|12341831|FG000|COMPLETED|Overall Study||11
11153900|NCT01542372|12341832|FG001|COMPLETED|Overall Study||11
11153901|NCT01542372|12341831|FG000|NOT COMPLETED|Overall Study||0
11153902|NCT01542372|12341832|FG001|NOT COMPLETED|Overall Study||0
11153903|NCT01542398|12341839|FG000|STARTED|Overall Study||79
11153904|NCT01542398|12341840|FG001|STARTED|Overall Study||80
11153905|NCT01542398|12341839|FG000|Post-Intervention Assessment|Overall Study||78
11153906|NCT01542398|12341840|FG001|Post-Intervention Assessment|Overall Study||80
11153907|NCT01542398|12341839|FG000|COMPLETED|Overall Study||71
11153908|NCT01542398|12341840|FG001|COMPLETED|Overall Study||67
11153909|NCT01542398|12341839|FG000|NOT COMPLETED|Overall Study||8
11153910|NCT01542398|12341840|FG001|NOT COMPLETED|Overall Study||13
11153911|NCT01542502|12341848|FG000|STARTED|Overall Study||6
11153912|NCT01542502|12341849|FG001|STARTED|Overall Study||6
11153913|NCT01542502|12341848|FG000|COMPLETED|Overall Study||6
11153914|NCT01542502|12341849|FG001|COMPLETED|Overall Study||6
11153915|NCT01542502|12341848|FG000|NOT COMPLETED|Overall Study||0
11153916|NCT01542502|12341849|FG001|NOT COMPLETED|Overall Study||0
11153917|NCT01542528|12341858|FG000|STARTED|Overall Study||61
11153918|NCT01542528|12341859|FG001|STARTED|Overall Study||56
11153919|NCT01542528|12341858|FG000|COMPLETED|Overall Study||49
11153920|NCT01542528|12341859|FG001|COMPLETED|Overall Study||49
11153921|NCT01542528|12341858|FG000|NOT COMPLETED|Overall Study||12
11153922|NCT01542528|12341859|FG001|NOT COMPLETED|Overall Study||7
11153923|NCT01542541|12341867|FG000|STARTED|Overall Study||38
11153924|NCT01542541|12341868|FG001|STARTED|Overall Study||30
11153925|NCT01542541|12341867|FG000|COMPLETED|Overall Study||30
11153926|NCT01542541|12341868|FG001|COMPLETED|Overall Study||30
11153927|NCT01542541|12341867|FG000|NOT COMPLETED|Overall Study||8
11153928|NCT01542541|12341868|FG001|NOT COMPLETED|Overall Study||0
11153929|NCT01542632|12341880|FG000|STARTED|Overall Study||25
11153930|NCT01542632|12341881|FG001|STARTED|Overall Study||25
11153931|NCT01542632|12341882|FG002|STARTED|Overall Study||24
11153932|NCT01542632|12341883|FG003|STARTED|Overall Study||21
11153933|NCT01542632|12341884|FG004|STARTED|Overall Study||21
11153934|NCT01542632|12341885|FG005|STARTED|Overall Study||24
11153935|NCT01542632|12341880|FG000|COMPLETED|Overall Study||25
11153936|NCT01542632|12341881|FG001|COMPLETED|Overall Study||24
11153937|NCT01542632|12341882|FG002|COMPLETED|Overall Study||23
11153938|NCT01542632|12341883|FG003|COMPLETED|Overall Study||19
11153939|NCT01542632|12341884|FG004|COMPLETED|Overall Study||17
11153940|NCT01542632|12341885|FG005|COMPLETED|Overall Study||24
11153941|NCT01542632|12341880|FG000|NOT COMPLETED|Overall Study||0
11153942|NCT01542632|12341881|FG001|NOT COMPLETED|Overall Study||1
11153943|NCT01542632|12341882|FG002|NOT COMPLETED|Overall Study||1
11153944|NCT01542632|12341883|FG003|NOT COMPLETED|Overall Study||2
11153945|NCT01542632|12341884|FG004|NOT COMPLETED|Overall Study||4
11153946|NCT01542632|12341885|FG005|NOT COMPLETED|Overall Study||0
11153947|NCT01542645|12341906|FG000|STARTED|Overall Study||82
11153948|NCT01542645|12341907|FG001|STARTED|Overall Study||82
11153949|NCT01542645|12341906|FG000|COMPLETED|Overall Study||77
11153950|NCT01542645|12341907|FG001|COMPLETED|Overall Study||79
11153951|NCT01542645|12341906|FG000|NOT COMPLETED|Overall Study||5
11153952|NCT01542645|12341907|FG001|NOT COMPLETED|Overall Study||3
11153953|NCT01542684|12341917|FG000|STARTED|Overall Study||8
11153954|NCT01542684|12341917|FG000|COMPLETED|Overall Study||8
11153955|NCT01542684|12341917|FG000|NOT COMPLETED|Overall Study||0
11153956|NCT01542788|12341923|FG000|STARTED|Overall Study||209
11153957|NCT01542788|12341924|FG001|STARTED|Overall Study||71
11153958|NCT01542788|12341923|FG000|Randomized and Treated|Overall Study||207
11153959|NCT01542788|12341924|FG001|Randomized and Treated|Overall Study||71
11153960|NCT01542788|12341923|FG000|COMPLETED|Overall Study||154
11153961|NCT01542788|12341924|FG001|COMPLETED|Overall Study||0
11153962|NCT01542788|12341923|FG000|NOT COMPLETED|Overall Study||55
11153963|NCT01542788|12341924|FG001|NOT COMPLETED|Overall Study||71
11153964|NCT01542957|12341932|FG000|STARTED|End of Therapy||65
11153965|NCT01542957|12341933|FG001|STARTED|End of Therapy||63
11153966|NCT01542957|12341932|FG000|COMPLETED|End of Therapy||53
11153967|NCT01542957|12341933|FG001|COMPLETED|End of Therapy||53
11153968|NCT01542957|12341932|FG000|NOT COMPLETED|End of Therapy||12
11153969|NCT01542957|12341933|FG001|NOT COMPLETED|End of Therapy||10
11153970|NCT01542957|12341932|FG000|STARTED|3-month Follow-up||53
11153971|NCT01542957|12341933|FG001|STARTED|3-month Follow-up||53
11153972|NCT01542957|12341932|FG000|COMPLETED|3-month Follow-up||50
11153973|NCT01542957|12341933|FG001|COMPLETED|3-month Follow-up||45
11153974|NCT01542957|12341932|FG000|NOT COMPLETED|3-month Follow-up||3
11153975|NCT01542957|12341933|FG001|NOT COMPLETED|3-month Follow-up||8
11153976|NCT01542957|12341932|FG000|STARTED|12-month Follow-up||53
11418802|NCT00429858|12617199|FG000|COMPLETED|Overall Study||19
11418803|NCT00429858|12617199|FG000|NOT COMPLETED|Overall Study||2
11153977|NCT01542957|12341933|FG001|STARTED|12-month Follow-up||53
11153978|NCT01542957|12341932|FG000|COMPLETED|12-month Follow-up||37
11153979|NCT01542957|12341933|FG001|COMPLETED|12-month Follow-up||40
11153980|NCT01542957|12341932|FG000|NOT COMPLETED|12-month Follow-up||16
11153981|NCT01542957|12341933|FG001|NOT COMPLETED|12-month Follow-up||13
11153982|NCT01543074|12341943|FG000|STARTED|Overall Study||5
11153983|NCT01543074|12341944|FG001|STARTED|Overall Study||7
11153984|NCT01543074|12341945|FG002|STARTED|Overall Study||5
11153985|NCT01543074|12341946|FG003|STARTED|Overall Study||6
11153986|NCT01543074|12341943|FG000|COMPLETED|Overall Study||5
11153987|NCT01543074|12341944|FG001|COMPLETED|Overall Study||7
11153988|NCT01543074|12341945|FG002|COMPLETED|Overall Study||5
11153989|NCT01543074|12341946|FG003|COMPLETED|Overall Study||6
11153990|NCT01543074|12341943|FG000|NOT COMPLETED|Overall Study||0
11153991|NCT01543074|12341944|FG001|NOT COMPLETED|Overall Study||0
11153992|NCT01543074|12341945|FG002|NOT COMPLETED|Overall Study||0
11153993|NCT01543074|12341946|FG003|NOT COMPLETED|Overall Study||0
11153994|NCT01543087|12341966|FG000|STARTED|Stage 1 (48 Months)||70
11153995|NCT01543087|12341967|FG001|STARTED|Stage 1 (48 Months)||103
11153996|NCT01543087|12341968|FG002|STARTED|Stage 1 (48 Months)||277
11153997|NCT01543087|12341969|FG003|STARTED|Stage 1 (48 Months)||116
11153998|NCT01543087|12341970|FG004|STARTED|Stage 1 (48 Months)||86
11153999|NCT01543087|12341971|FG005|STARTED|Stage 1 (48 Months)||46
11154000|NCT01543087|12341966|FG000|Safety Population|Stage 1 (48 Months)||70
11154001|NCT01543087|12341967|FG001|Safety Population|Stage 1 (48 Months)||101
11418804|NCT00425438|12617206|FG000|STARTED|Overall Study||25
11418805|NCT00425438|12617207|FG001|STARTED|Overall Study||27
11418806|NCT00425438|12617206|FG000|COMPLETED|Overall Study||0
11418807|NCT00425438|12617207|FG001|COMPLETED|Overall Study||0
11154002|NCT01543087|12341968|FG002|Safety Population|Stage 1 (48 Months)||277
11154003|NCT01543087|12341969|FG003|Safety Population|Stage 1 (48 Months)||116
11154004|NCT01543087|12341970|FG004|Safety Population|Stage 1 (48 Months)||86
11154005|NCT01543087|12341971|FG005|Safety Population|Stage 1 (48 Months)||46
11154006|NCT01543087|12341966|FG000|COMPLETED|Stage 1 (48 Months)||56
11154007|NCT01543087|12341967|FG001|COMPLETED|Stage 1 (48 Months)||93
11154008|NCT01543087|12341968|FG002|COMPLETED|Stage 1 (48 Months)||237
11154009|NCT01543087|12341969|FG003|COMPLETED|Stage 1 (48 Months)||108
11154010|NCT01543087|12341970|FG004|COMPLETED|Stage 1 (48 Months)||83
11154011|NCT01543087|12341971|FG005|COMPLETED|Stage 1 (48 Months)||46
11418808|NCT00425438|12617206|FG000|NOT COMPLETED|Overall Study||25
11154012|NCT01543087|12341966|FG000|NOT COMPLETED|Stage 1 (48 Months)||14
11154013|NCT01543087|12341967|FG001|NOT COMPLETED|Stage 1 (48 Months)||10
11154014|NCT01543087|12341968|FG002|NOT COMPLETED|Stage 1 (48 Months)||40
11154015|NCT01543087|12341969|FG003|NOT COMPLETED|Stage 1 (48 Months)||8
11154016|NCT01543087|12341970|FG004|NOT COMPLETED|Stage 1 (48 Months)||3
11154017|NCT01543087|12341971|FG005|NOT COMPLETED|Stage 1 (48 Months)||0
11154018|NCT01543087|12341966|FG000|STARTED|Booster Stage (26 Months)|Group1 participants (primary study B1971015)were not invited to participate in Booster stage (BS).|0
11154019|NCT01543087|12341967|FG001|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|60
11154020|NCT01543087|12341968|FG002|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|92
11154021|NCT01543087|12341969|FG003|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|64
11154022|NCT01543087|12341970|FG004|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|56
11154023|NCT01543087|12341971|FG005|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|32
11154024|NCT01543087|12341966|FG000|Vaccinated|Booster Stage (26 Months)||0
11154025|NCT01543087|12341967|FG001|Vaccinated|Booster Stage (26 Months)||59
11154026|NCT01543087|12341968|FG002|Vaccinated|Booster Stage (26 Months)||92
11154027|NCT01543087|12341969|FG003|Vaccinated|Booster Stage (26 Months)||64
11154028|NCT01543087|12341970|FG004|Vaccinated|Booster Stage (26 Months)||54
11154029|NCT01543087|12341971|FG005|Vaccinated|Booster Stage (26 Months)||32
11154030|NCT01543087|12341966|FG000|COMPLETED|Booster Stage (26 Months)||0
11154031|NCT01543087|12341967|FG001|COMPLETED|Booster Stage (26 Months)||59
11154032|NCT01543087|12341968|FG002|COMPLETED|Booster Stage (26 Months)||91
11154033|NCT01543087|12341969|FG003|COMPLETED|Booster Stage (26 Months)||64
11154034|NCT01543087|12341970|FG004|COMPLETED|Booster Stage (26 Months)||54
11154035|NCT01543087|12341971|FG005|COMPLETED|Booster Stage (26 Months)||32
11154036|NCT01543087|12341966|FG000|NOT COMPLETED|Booster Stage (26 Months)||0
11154037|NCT01543087|12341967|FG001|NOT COMPLETED|Booster Stage (26 Months)||1
11154038|NCT01543087|12341968|FG002|NOT COMPLETED|Booster Stage (26 Months)||1
11154039|NCT01543087|12341969|FG003|NOT COMPLETED|Booster Stage (26 Months)||0
11154040|NCT01543087|12341970|FG004|NOT COMPLETED|Booster Stage (26 Months)||2
11154041|NCT01543087|12341971|FG005|NOT COMPLETED|Booster Stage (26 Months)||0
11154042|NCT01543152|12342012|FG000|STARTED|Overall Study||3
11154043|NCT01543152|12342013|FG001|STARTED|Overall Study||6
11154044|NCT01543152|12342014|FG002|STARTED|Overall Study||11
11154045|NCT01543152|12342015|FG003|STARTED|Overall Study||3
11154046|NCT01543152|12342016|FG004|STARTED|Overall Study||3
11154047|NCT01543152|12342012|FG000|COMPLETED|Overall Study||3
11154048|NCT01543152|12342013|FG001|COMPLETED|Overall Study||4
11154049|NCT01543152|12342014|FG002|COMPLETED|Overall Study||11
11154050|NCT01543152|12342015|FG003|COMPLETED|Overall Study||3
11154051|NCT01543152|12342016|FG004|COMPLETED|Overall Study||3
11154052|NCT01543152|12342012|FG000|NOT COMPLETED|Overall Study||0
11154053|NCT01543152|12342013|FG001|NOT COMPLETED|Overall Study||2
11154054|NCT01543152|12342014|FG002|NOT COMPLETED|Overall Study||0
11154055|NCT01543152|12342015|FG003|NOT COMPLETED|Overall Study||0
11154056|NCT01543152|12342016|FG004|NOT COMPLETED|Overall Study||0
11154057|NCT01543178|12342031|FG000|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
11154058|NCT01543178|12342032|FG001|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
11154059|NCT01543178|12342033|FG002|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
11154060|NCT01543178|12342031|FG000|COMPLETED|Open-label Period||636
11154061|NCT01543178|12342032|FG001|COMPLETED|Open-label Period||0
11154062|NCT01543178|12342033|FG002|COMPLETED|Open-label Period||0
11154063|NCT01543178|12342031|FG000|NOT COMPLETED|Open-label Period||1947
11154064|NCT01543178|12342032|FG001|NOT COMPLETED|Open-label Period||0
11154065|NCT01543178|12342033|FG002|NOT COMPLETED|Open-label Period||0
11154066|NCT01543178|12342031|FG000|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
11154067|NCT01543178|12342032|FG001|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
11154068|NCT01543178|12342033|FG002|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
11154069|NCT01543178|12342031|FG000|COMPLETED|Double-blind Period||0
11154070|NCT01543178|12342032|FG001|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
11154071|NCT01543178|12342033|FG002|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
11154072|NCT01543178|12342031|FG000|NOT COMPLETED|Double-blind Period||0
11154073|NCT01543178|12342032|FG001|NOT COMPLETED|Double-blind Period||44
11154074|NCT01543178|12342033|FG002|NOT COMPLETED|Double-blind Period||37
11154075|NCT01543204|12342040|FG000|STARTED|Overall Study||64
11154076|NCT01543204|12342040|FG000|COMPLETED|Overall Study||56
11154077|NCT01543204|12342040|FG000|NOT COMPLETED|Overall Study||8
11154078|NCT01543490|12342050|FG000|STARTED|Overall Study||368
11154079|NCT01543490|12342051|FG001|STARTED|Overall Study||190
11154080|NCT01543490|12342050|FG000|COMPLETED|Overall Study||352
11154081|NCT01543490|12342051|FG001|COMPLETED|Overall Study||185
11154082|NCT01543490|12342050|FG000|NOT COMPLETED|Overall Study||16
11154083|NCT01543490|12342051|FG001|NOT COMPLETED|Overall Study||5
11154084|NCT01543503|12342059|FG000|STARTED|Overall Study||426
11154085|NCT01543503|12342060|FG001|STARTED|Overall Study||798
11154086|NCT01543503|12342059|FG000|COMPLETED|Overall Study||350
11154087|NCT01543503|12342060|FG001|COMPLETED|Overall Study||711
11154088|NCT01543503|12342059|FG000|NOT COMPLETED|Overall Study||76
11154089|NCT01543503|12342060|FG001|NOT COMPLETED|Overall Study||87
11154090|NCT01543568|12342066|FG000|STARTED|Overall Study||46
11154091|NCT01543568|12342066|FG000|COMPLETED|Overall Study||45
11154092|NCT01543568|12342066|FG000|NOT COMPLETED|Overall Study||1
11154093|NCT01543581|12342070|FG000|STARTED|Overall Study||1
11154094|NCT01543581|12342071|FG001|STARTED|Overall Study||0
11154095|NCT01543581|12342070|FG000|COMPLETED|Overall Study||1
11154096|NCT01543581|12342071|FG001|COMPLETED|Overall Study||0
11154097|NCT01543581|12342070|FG000|NOT COMPLETED|Overall Study||0
11154098|NCT01543581|12342071|FG001|NOT COMPLETED|Overall Study||0
11154099|NCT01543607|12342077|FG000|STARTED|Overall Study||1
11154100|NCT01543607|12342077|FG000|COMPLETED|Overall Study||1
11154101|NCT01543607|12342077|FG000|NOT COMPLETED|Overall Study||0
11154102|NCT01543685|12342086|FG000|STARTED|Overall Study||93
11154103|NCT01543685|12342087|FG001|STARTED|Overall Study||91
11154104|NCT01543685|12342088|FG002|STARTED|Overall Study||91
11154105|NCT01543685|12342089|FG003|STARTED|Overall Study||93
11154106|NCT01543685|12342090|FG004|STARTED|Overall Study||94
11154107|NCT01543685|12342086|FG000|COMPLETED|Overall Study||90
11154108|NCT01543685|12342087|FG001|COMPLETED|Overall Study||88
11154109|NCT01543685|12342088|FG002|COMPLETED|Overall Study||89
11154110|NCT01543685|12342089|FG003|COMPLETED|Overall Study||93
11154111|NCT01543685|12342090|FG004|COMPLETED|Overall Study||90
11154112|NCT01543685|12342086|FG000|NOT COMPLETED|Overall Study||3
11154113|NCT01543685|12342087|FG001|NOT COMPLETED|Overall Study||3
11154114|NCT01543685|12342088|FG002|NOT COMPLETED|Overall Study||2
11154115|NCT01543685|12342089|FG003|NOT COMPLETED|Overall Study||0
11154116|NCT01543685|12342090|FG004|NOT COMPLETED|Overall Study||4
11154117|NCT01543776|12342104|FG000|STARTED|Overall Study||36
11154118|NCT01543776|12342105|FG001|STARTED|Overall Study||36
11154119|NCT01543776|12342104|FG000|COMPLETED|Overall Study||34
11154120|NCT01543776|12342105|FG001|COMPLETED|Overall Study||34
11154121|NCT01543776|12342104|FG000|NOT COMPLETED|Overall Study||2
11154122|NCT01543776|12342105|FG001|NOT COMPLETED|Overall Study||2
11154123|NCT01543828|12342113|FG000|STARTED|Treatment 1||20
11154124|NCT01543828|12342114|FG001|STARTED|Treatment 1||20
11154125|NCT01543828|12342113|FG000|COMPLETED|Treatment 1||20
11154126|NCT01543828|12342114|FG001|COMPLETED|Treatment 1||20
11154127|NCT01543828|12342113|FG000|NOT COMPLETED|Treatment 1||0
11154128|NCT01543828|12342114|FG001|NOT COMPLETED|Treatment 1||0
11154129|NCT01543828|12342113|FG000|STARTED|Treatment 2||20
11154130|NCT01543828|12342114|FG001|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
11154131|NCT01543828|12342113|FG000|COMPLETED|Treatment 2||19
11154132|NCT01543828|12342114|FG001|COMPLETED|Treatment 2||19
11154133|NCT01543828|12342113|FG000|NOT COMPLETED|Treatment 2||1
11154134|NCT01543828|12342114|FG001|NOT COMPLETED|Treatment 2||0
11154135|NCT01543958|12342122|FG000|STARTED|Overall Study||40
11154136|NCT01543958|12342122|FG000|COMPLETED|Overall Study||36
11154137|NCT01543958|12342122|FG000|NOT COMPLETED|Overall Study||4
11154138|NCT01544023|12342126|FG000|STARTED|Overall Study|retrospective|207
11154139|NCT01544023|12342126|FG000|COMPLETED|Overall Study||207
11154140|NCT01544023|12342126|FG000|NOT COMPLETED|Overall Study||0
11154141|NCT01544062|12342132|FG000|STARTED|Overall Study||33
11154142|NCT01544062|12342133|FG001|STARTED|Overall Study||35
11154143|NCT01544062|12342132|FG000|COMPLETED|Overall Study||33
11154144|NCT01544062|12342133|FG001|COMPLETED|Overall Study||35
11154145|NCT01544062|12342132|FG000|NOT COMPLETED|Overall Study||0
11154146|NCT01544062|12342133|FG001|NOT COMPLETED|Overall Study||0
11154147|NCT01544088|12342142|FG000|STARTED|Overall Study||98
11154148|NCT01544088|12342143|FG001|STARTED|Overall Study||100
11418809|NCT00425438|12617207|FG001|NOT COMPLETED|Overall Study||27
11418810|NCT00421954|12617213|FG000|STARTED|Overall Study||0
11418811|NCT00421954|12617213|FG000|COMPLETED|Overall Study||0
11154149|NCT01544088|12342142|FG000|COMPLETED|Overall Study||61
11154150|NCT01544088|12342143|FG001|COMPLETED|Overall Study||79
11154151|NCT01544088|12342142|FG000|NOT COMPLETED|Overall Study||37
11154152|NCT01544088|12342143|FG001|NOT COMPLETED|Overall Study||21
11418812|NCT00421954|12617213|FG000|NOT COMPLETED|Overall Study||0
11418813|NCT00422942|12617217|FG000|STARTED|Overall Study||3
11418814|NCT00422942|12617217|FG000|COMPLETED|Overall Study||0
11418815|NCT00422942|12617217|FG000|NOT COMPLETED|Overall Study||3
11418816|NCT00409344|12617223|FG000|STARTED|Overall Study|No participants enrolled|0
11154153|NCT01544114|12342152|FG000|STARTED|Overall Study||4
11154154|NCT01544114|12342153|FG001|STARTED|Overall Study||20
11154155|NCT01544114|12342154|FG002|STARTED|Overall Study||22
11154156|NCT01544114|12342152|FG000|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
11154157|NCT01544114|12342153|FG001|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
11154158|NCT01544114|12342154|FG002|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
11154159|NCT01544114|12342152|FG000|NOT COMPLETED|Overall Study||1
11418817|NCT00409344|12617224|FG001|STARTED|Overall Study|No participants enrolled|0
11418818|NCT00409344|12617223|FG000|COMPLETED|Overall Study|No participants were enrolled to completion|0
11418819|NCT00409344|12617224|FG001|COMPLETED|Overall Study|No participants were enrolled to completion|0
11418820|NCT00409344|12617223|FG000|NOT COMPLETED|Overall Study||0
11154160|NCT01544114|12342153|FG001|NOT COMPLETED|Overall Study||4
11418821|NCT00409344|12617224|FG001|NOT COMPLETED|Overall Study||0
11418822|NCT00414453|12617230|FG000|STARTED|Overall Study||19
11418823|NCT00414453|12617230|FG000|COMPLETED|Overall Study||3
11418824|NCT00414453|12617230|FG000|NOT COMPLETED|Overall Study||16
11418825|NCT00417248|12617240|FG000|STARTED|Overall Study||8
11418826|NCT00417248|12617240|FG000|COMPLETED|Overall Study||0
11418827|NCT00417248|12617240|FG000|NOT COMPLETED|Overall Study||8
11418828|NCT00418145|12617245|FG000|STARTED|Overall Study||16
11418829|NCT00418145|12617245|FG000|COMPLETED|Overall Study||10
11418830|NCT00418145|12617245|FG000|NOT COMPLETED|Overall Study||6
11154161|NCT01544114|12342154|FG002|NOT COMPLETED|Overall Study||5
11154162|NCT01544153|12342168|FG000|STARTED|Overall Study||1337
11154163|NCT01544153|12342169|FG001|STARTED|Overall Study||1324
11154164|NCT01544153|12342170|FG002|STARTED|Overall Study||1314
11154165|NCT01544153|12342171|FG003|STARTED|Overall Study||1317
11154166|NCT01544153|12342168|FG000|COMPLETED|Overall Study||1337
11154167|NCT01544153|12342169|FG001|COMPLETED|Overall Study||1323
11154168|NCT01544153|12342170|FG002|COMPLETED|Overall Study||1313
11154169|NCT01544153|12342171|FG003|COMPLETED|Overall Study||1317
11154170|NCT01544153|12342168|FG000|NOT COMPLETED|Overall Study||0
11154171|NCT01544153|12342169|FG001|NOT COMPLETED|Overall Study||1
11154172|NCT01544153|12342170|FG002|NOT COMPLETED|Overall Study||1
11154173|NCT01544153|12342171|FG003|NOT COMPLETED|Overall Study||0
11154174|NCT01544166|12342181|FG000|STARTED|Overall Study||44
11154175|NCT01544166|12342181|FG000|COMPLETED|Overall Study||44
11154176|NCT01544166|12342181|FG000|NOT COMPLETED|Overall Study||0
11154177|NCT01544179|12342190|FG000|STARTED|Overall Study||133
11154178|NCT01544179|12342191|FG001|STARTED|Overall Study||132
11154179|NCT01544179|12342190|FG000|Received Treatment|Overall Study||132
11154180|NCT01544179|12342191|FG001|Received Treatment|Overall Study||132
11154181|NCT01544179|12342190|FG000|Did Not Receive Treatment|Overall Study||1
11154182|NCT01544179|12342191|FG001|Did Not Receive Treatment|Overall Study||0
11154183|NCT01544179|12342190|FG000|COMPLETED|Overall Study|Patients are ongoing in the study|70
11154184|NCT01544179|12342191|FG001|COMPLETED|Overall Study|Patients are ongoing in the study|86
11154185|NCT01544179|12342190|FG000|NOT COMPLETED|Overall Study||63
11154186|NCT01544179|12342191|FG001|NOT COMPLETED|Overall Study||46
11154187|NCT01544309|12342199|FG000|STARTED|Overall Study||524
11154188|NCT01544309|12342200|FG001|STARTED|Overall Study||525
11154189|NCT01544309|12342199|FG000|COMPLETED|Overall Study||504
11154190|NCT01544309|12342200|FG001|COMPLETED|Overall Study||514
11154191|NCT01544309|12342199|FG000|NOT COMPLETED|Overall Study||20
11154192|NCT01544309|12342200|FG001|NOT COMPLETED|Overall Study||11
11154193|NCT01544348|12342216|FG000|STARTED|Overall Study||17
11154194|NCT01544348|12342217|FG001|STARTED|Overall Study||6
11154195|NCT01544348|12342218|FG002|STARTED|Overall Study||3
11154196|NCT01544348|12342219|FG003|STARTED|Overall Study||3
11154197|NCT01544348|12342220|FG004|STARTED|Overall Study||16
11154198|NCT01544348|12342221|FG005|STARTED|Overall Study||19
11154199|NCT01544348|12342222|FG006|STARTED|Overall Study||14
11154200|NCT01544348|12342223|FG007|STARTED|Overall Study||8
11154201|NCT01544348|12342216|FG000|Treated|Overall Study||17
11154202|NCT01544348|12342217|FG001|Treated|Overall Study||6
11154203|NCT01544348|12342218|FG002|Treated|Overall Study||3
11154204|NCT01544348|12342219|FG003|Treated|Overall Study||3
11154205|NCT01544348|12342220|FG004|Treated|Overall Study||15
11154206|NCT01544348|12342221|FG005|Treated|Overall Study||18
11154207|NCT01544348|12342222|FG006|Treated|Overall Study||14
11154208|NCT01544348|12342223|FG007|Treated|Overall Study||8
11154209|NCT01544348|12342216|FG000|COMPLETED|Overall Study||15
11154210|NCT01544348|12342217|FG001|COMPLETED|Overall Study||6
11154211|NCT01544348|12342218|FG002|COMPLETED|Overall Study||3
11154212|NCT01544348|12342219|FG003|COMPLETED|Overall Study||3
11154213|NCT01544348|12342220|FG004|COMPLETED|Overall Study||15
11154214|NCT01544348|12342221|FG005|COMPLETED|Overall Study||16
11154215|NCT01544348|12342222|FG006|COMPLETED|Overall Study||12
11154216|NCT01544348|12342223|FG007|COMPLETED|Overall Study||8
11154217|NCT01544348|12342216|FG000|NOT COMPLETED|Overall Study||2
11154218|NCT01544348|12342217|FG001|NOT COMPLETED|Overall Study||0
11154219|NCT01544348|12342218|FG002|NOT COMPLETED|Overall Study||0
11154220|NCT01544348|12342219|FG003|NOT COMPLETED|Overall Study||0
11154221|NCT01544348|12342220|FG004|NOT COMPLETED|Overall Study||1
11418831|NCT00409331|12617251|FG000|STARTED|Overall Study||1
11418832|NCT00409331|12617251|FG000|COMPLETED|Overall Study||0
11418833|NCT00409331|12617251|FG000|NOT COMPLETED|Overall Study||1
11418834|NCT00392860|12617257|FG000|STARTED|Overall Study||3
11418835|NCT00392860|12617258|FG001|STARTED|Overall Study||0
11418836|NCT00392860|12617259|FG002|STARTED|Overall Study||1
11418837|NCT00392860|12617257|FG000|COMPLETED|Overall Study||3
11154222|NCT01544348|12342221|FG005|NOT COMPLETED|Overall Study||3
11154223|NCT01544348|12342222|FG006|NOT COMPLETED|Overall Study||2
11154224|NCT01544348|12342223|FG007|NOT COMPLETED|Overall Study||0
11154225|NCT01544361|12342253|FG000|STARTED|Overall Study||8
11154226|NCT01544361|12342254|FG001|STARTED|Overall Study||6
11154227|NCT01544361|12342255|FG002|STARTED|Overall Study||6
11154228|NCT01544361|12342256|FG003|STARTED|Overall Study||6
11154229|NCT01544361|12342257|FG004|STARTED|Overall Study||6
11154230|NCT01544361|12342253|FG000|COMPLETED|Overall Study||8
11154231|NCT01544361|12342254|FG001|COMPLETED|Overall Study||6
11154232|NCT01544361|12342255|FG002|COMPLETED|Overall Study||6
11154233|NCT01544361|12342256|FG003|COMPLETED|Overall Study||6
11154234|NCT01544361|12342257|FG004|COMPLETED|Overall Study||6
11154235|NCT01544361|12342253|FG000|NOT COMPLETED|Overall Study||0
11154236|NCT01544361|12342254|FG001|NOT COMPLETED|Overall Study||0
11154237|NCT01544361|12342255|FG002|NOT COMPLETED|Overall Study||0
11154238|NCT01544361|12342256|FG003|NOT COMPLETED|Overall Study||0
11154239|NCT01544361|12342257|FG004|NOT COMPLETED|Overall Study||0
11154240|NCT01544478|12342269|FG000|STARTED|Overall Study||1030
11154241|NCT01544478|12342269|FG000|Vaccination 1|Overall Study||1030
11154242|NCT01544478|12342269|FG000|Vaccination 2|Overall Study||1026
11418838|NCT00392860|12617258|FG001|COMPLETED|Overall Study||0
11418839|NCT00392860|12617259|FG002|COMPLETED|Overall Study||1
11418840|NCT00392860|12617257|FG000|NOT COMPLETED|Overall Study||0
11154243|NCT01544478|12342269|FG000|Vaccination 3|Overall Study||1019
11154244|NCT01544478|12342269|FG000|COMPLETED|Overall Study||912
11154245|NCT01544478|12342269|FG000|NOT COMPLETED|Overall Study||118
11154246|NCT01544491|12342275|FG000|STARTED|Overall Study||52
11154247|NCT01544491|12342276|FG001|STARTED|Overall Study||54
11154248|NCT01544491|12342275|FG000|COMPLETED|Overall Study||47
11154249|NCT01544491|12342276|FG001|COMPLETED|Overall Study||51
11154250|NCT01544491|12342275|FG000|NOT COMPLETED|Overall Study||5
11154251|NCT01544491|12342276|FG001|NOT COMPLETED|Overall Study||3
11154252|NCT01544582|12342285|FG000|STARTED|Screening/Eligibility||713
11154253|NCT01544582|12342286|FG001|STARTED|Screening/Eligibility||0
11154254|NCT01544582|12342287|FG002|STARTED|Screening/Eligibility||0
11154255|NCT01544582|12342288|FG003|STARTED|Screening/Eligibility||0
11154256|NCT01544582|12342285|FG000|Analysis Population|Screening/Eligibility||679
11154257|NCT01544582|12342286|FG001|Analysis Population|Screening/Eligibility||0
11154258|NCT01544582|12342287|FG002|Analysis Population|Screening/Eligibility||0
11154259|NCT01544582|12342288|FG003|Analysis Population|Screening/Eligibility||0
11154260|NCT01544582|12342285|FG000|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
11154261|NCT01544582|12342286|FG001|COMPLETED|Screening/Eligibility||0
11154262|NCT01544582|12342287|FG002|COMPLETED|Screening/Eligibility||0
11154263|NCT01544582|12342288|FG003|COMPLETED|Screening/Eligibility||0
11154264|NCT01544582|12342285|FG000|NOT COMPLETED|Screening/Eligibility||34
11154265|NCT01544582|12342286|FG001|NOT COMPLETED|Screening/Eligibility||0
11154266|NCT01544582|12342287|FG002|NOT COMPLETED|Screening/Eligibility||0
11154267|NCT01544582|12342288|FG003|NOT COMPLETED|Screening/Eligibility||0
11154268|NCT01544582|12342285|FG000|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
11154269|NCT01544582|12342286|FG001|STARTED|Analysis Population||298
11154270|NCT01544582|12342287|FG002|STARTED|Analysis Population||307
11154271|NCT01544582|12342288|FG003|STARTED|Analysis Population||74
11154272|NCT01544582|12342285|FG000|COMPLETED|Analysis Population||0
11154273|NCT01544582|12342286|FG001|COMPLETED|Analysis Population||180
11154274|NCT01544582|12342287|FG002|COMPLETED|Analysis Population||205
11154275|NCT01544582|12342288|FG003|COMPLETED|Analysis Population||35
11154276|NCT01544582|12342285|FG000|NOT COMPLETED|Analysis Population||0
11154277|NCT01544582|12342286|FG001|NOT COMPLETED|Analysis Population||118
11154278|NCT01544582|12342287|FG002|NOT COMPLETED|Analysis Population||102
11154279|NCT01544582|12342288|FG003|NOT COMPLETED|Analysis Population||39
11154280|NCT01544595|12342307|FG000|STARTED|Status at Week 68||301
11154281|NCT01544595|12342308|FG001|STARTED|Status at Week 68||363
11154282|NCT01544595|12342309|FG002|STARTED|Status at Week 68||150
11154283|NCT01544595|12342310|FG003|STARTED|Status at Week 68||181
11154284|NCT01544595|12342311|FG004|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
11154285|NCT01544595|12342312|FG005|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
11154286|NCT01544595|12342307|FG000|COMPLETED|Status at Week 68||262
11154287|NCT01544595|12342308|FG001|COMPLETED|Status at Week 68||346
11154288|NCT01544595|12342309|FG002|COMPLETED|Status at Week 68||87
11154289|NCT01544595|12342310|FG003|COMPLETED|Status at Week 68||130
11154290|NCT01544595|12342311|FG004|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
11154291|NCT01544595|12342312|FG005|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
11154292|NCT01544595|12342307|FG000|NOT COMPLETED|Status at Week 68||39
11154293|NCT01544595|12342308|FG001|NOT COMPLETED|Status at Week 68||17
11154294|NCT01544595|12342309|FG002|NOT COMPLETED|Status at Week 68||63
11154295|NCT01544595|12342310|FG003|NOT COMPLETED|Status at Week 68||51
11154296|NCT01544595|12342311|FG004|NOT COMPLETED|Status at Week 68||0
11154297|NCT01544595|12342312|FG005|NOT COMPLETED|Status at Week 68||0
11154298|NCT01544595|12342307|FG000|STARTED|Status at Week 156||301
11154299|NCT01544595|12342308|FG001|STARTED|Status at Week 156||363
11154300|NCT01544595|12342309|FG002|STARTED|Status at Week 156||150
11154301|NCT01544595|12342310|FG003|STARTED|Status at Week 156||181
11154302|NCT01544595|12342311|FG004|STARTED|Status at Week 156||98
11154303|NCT01544595|12342312|FG005|STARTED|Status at Week 156||53
11154304|NCT01544595|12342307|FG000|COMPLETED|Status at Week 156||184
11154305|NCT01544595|12342308|FG001|COMPLETED|Status at Week 156||285
11154306|NCT01544595|12342309|FG002|COMPLETED|Status at Week 156||10
11154307|NCT01544595|12342310|FG003|COMPLETED|Status at Week 156||15
11154308|NCT01544595|12342311|FG004|COMPLETED|Status at Week 156||60
11154309|NCT01544595|12342312|FG005|COMPLETED|Status at Week 156||38
11154310|NCT01544595|12342307|FG000|NOT COMPLETED|Status at Week 156||117
11418841|NCT00392860|12617258|FG001|NOT COMPLETED|Overall Study||0
11418842|NCT00392860|12617259|FG002|NOT COMPLETED|Overall Study||0
11418843|NCT00391430|12617268|FG000|STARTED|Overall Study||8
11418844|NCT00391430|12617269|FG001|STARTED|Overall Study||0
11154311|NCT01544595|12342308|FG001|NOT COMPLETED|Status at Week 156||78
11154312|NCT01544595|12342309|FG002|NOT COMPLETED|Status at Week 156||140
11154313|NCT01544595|12342310|FG003|NOT COMPLETED|Status at Week 156||166
11154314|NCT01544595|12342311|FG004|NOT COMPLETED|Status at Week 156||38
11154315|NCT01544595|12342312|FG005|NOT COMPLETED|Status at Week 156||15
11154316|NCT01544920|12342332|FG000|STARTED|Overall Study||368
11154317|NCT01544920|12342333|FG001|STARTED|Overall Study||369
11154318|NCT01544920|12342332|FG000|COMPLETED|Overall Study||349
11154319|NCT01544920|12342333|FG001|COMPLETED|Overall Study||346
11154320|NCT01544920|12342332|FG000|NOT COMPLETED|Overall Study||19
11154321|NCT01544920|12342333|FG001|NOT COMPLETED|Overall Study||23
11154322|NCT01544998|12342341|FG000|STARTED|First Intervention (3 Hours)||26
11154323|NCT01544998|12342342|FG001|STARTED|First Intervention (3 Hours)||15
11154324|NCT01544998|12342341|FG000|COMPLETED|First Intervention (3 Hours)||26
11154325|NCT01544998|12342342|FG001|COMPLETED|First Intervention (3 Hours)||15
11154326|NCT01544998|12342341|FG000|NOT COMPLETED|First Intervention (3 Hours)||0
11154327|NCT01544998|12342342|FG001|NOT COMPLETED|First Intervention (3 Hours)||0
11154328|NCT01544998|12342341|FG000|STARTED|Washout (1 Week)||26
11154329|NCT01544998|12342342|FG001|STARTED|Washout (1 Week)||15
11154330|NCT01544998|12342341|FG000|COMPLETED|Washout (1 Week)||26
11154331|NCT01544998|12342342|FG001|COMPLETED|Washout (1 Week)||15
11154332|NCT01544998|12342341|FG000|NOT COMPLETED|Washout (1 Week)||0
11154333|NCT01544998|12342342|FG001|NOT COMPLETED|Washout (1 Week)||0
11154334|NCT01544998|12342341|FG000|STARTED|Second Intervention (3 Hours)||26
11154335|NCT01544998|12342342|FG001|STARTED|Second Intervention (3 Hours)||15
11154336|NCT01544998|12342341|FG000|COMPLETED|Second Intervention (3 Hours)||26
11154337|NCT01544998|12342342|FG001|COMPLETED|Second Intervention (3 Hours)||15
11154338|NCT01544998|12342341|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0
11154339|NCT01544998|12342342|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0
11154340|NCT01545076|12342350|FG000|STARTED|IgPro10 Restabilization Period||208
11154341|NCT01545076|12342351|FG001|STARTED|IgPro10 Restabilization Period||0
11154342|NCT01545076|12342352|FG002|STARTED|IgPro10 Restabilization Period||0
11154343|NCT01545076|12342353|FG003|STARTED|IgPro10 Restabilization Period||0
11154344|NCT01545076|12342354|FG004|STARTED|IgPro10 Restabilization Period||0
11154345|NCT01545076|12342350|FG000|COMPLETED|IgPro10 Restabilization Period||172
11154346|NCT01545076|12342351|FG001|COMPLETED|IgPro10 Restabilization Period||0
11154347|NCT01545076|12342352|FG002|COMPLETED|IgPro10 Restabilization Period||0
11154348|NCT01545076|12342353|FG003|COMPLETED|IgPro10 Restabilization Period||0
11154349|NCT01545076|12342354|FG004|COMPLETED|IgPro10 Restabilization Period||0
11154350|NCT01545076|12342350|FG000|NOT COMPLETED|IgPro10 Restabilization Period||36
11154351|NCT01545076|12342351|FG001|NOT COMPLETED|IgPro10 Restabilization Period||0
11154352|NCT01545076|12342352|FG002|NOT COMPLETED|IgPro10 Restabilization Period||0
11154353|NCT01545076|12342353|FG003|NOT COMPLETED|IgPro10 Restabilization Period||0
11154354|NCT01545076|12342354|FG004|NOT COMPLETED|IgPro10 Restabilization Period||0
11154355|NCT01545076|12342350|FG000|STARTED|IgPro20 Subcutaneous Treatment Period||0
11154356|NCT01545076|12342351|FG001|STARTED|IgPro20 Subcutaneous Treatment Period||58
11154357|NCT01545076|12342352|FG002|STARTED|IgPro20 Subcutaneous Treatment Period||57
11154358|NCT01545076|12342353|FG003|STARTED|IgPro20 Subcutaneous Treatment Period||57
11154359|NCT01545076|12342354|FG004|STARTED|IgPro20 Subcutaneous Treatment Period||0
11154360|NCT01545076|12342350|FG000|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
11154361|NCT01545076|12342351|FG001|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
11154362|NCT01545076|12342352|FG002|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
11154363|NCT01545076|12342353|FG003|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
11154364|NCT01545076|12342354|FG004|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
11154365|NCT01545076|12342350|FG000|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
11154366|NCT01545076|12342351|FG001|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
11154367|NCT01545076|12342352|FG002|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
11154368|NCT01545076|12342353|FG003|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
11154369|NCT01545076|12342354|FG004|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
11154370|NCT01545076|12342350|FG000|STARTED|IgPro10 Rescue Period||0
11154371|NCT01545076|12342351|FG001|STARTED|IgPro10 Rescue Period||0
11154372|NCT01545076|12342352|FG002|STARTED|IgPro10 Rescue Period||0
11154373|NCT01545076|12342353|FG003|STARTED|IgPro10 Rescue Period||0
11154374|NCT01545076|12342354|FG004|STARTED|IgPro10 Rescue Period||60
11154375|NCT01545076|12342350|FG000|COMPLETED|IgPro10 Rescue Period||0
11154376|NCT01545076|12342351|FG001|COMPLETED|IgPro10 Rescue Period||0
11154377|NCT01545076|12342352|FG002|COMPLETED|IgPro10 Rescue Period||0
11154378|NCT01545076|12342353|FG003|COMPLETED|IgPro10 Rescue Period||0
11154379|NCT01545076|12342354|FG004|COMPLETED|IgPro10 Rescue Period||60
11154380|NCT01545076|12342350|FG000|NOT COMPLETED|IgPro10 Rescue Period||0
11154381|NCT01545076|12342351|FG001|NOT COMPLETED|IgPro10 Rescue Period||0
11154382|NCT01545076|12342352|FG002|NOT COMPLETED|IgPro10 Rescue Period||0
11154383|NCT01545076|12342353|FG003|NOT COMPLETED|IgPro10 Rescue Period||0
11154384|NCT01545076|12342354|FG004|NOT COMPLETED|IgPro10 Rescue Period||0
11154385|NCT01545141|12342371|FG000|STARTED|Overall Study||2
11154386|NCT01545141|12342372|FG001|STARTED|Overall Study||3
11154387|NCT01545141|12342373|FG002|STARTED|Overall Study||3
11154388|NCT01545141|12342374|FG003|STARTED|Overall Study||7
11154389|NCT01545141|12342371|FG000|COMPLETED|Overall Study||2
11154390|NCT01545141|12342372|FG001|COMPLETED|Overall Study||3
11154391|NCT01545141|12342373|FG002|COMPLETED|Overall Study||3
11154392|NCT01545141|12342374|FG003|COMPLETED|Overall Study||7
11154393|NCT01545141|12342371|FG000|NOT COMPLETED|Overall Study||0
11154394|NCT01545141|12342372|FG001|NOT COMPLETED|Overall Study||0
11154395|NCT01545141|12342373|FG002|NOT COMPLETED|Overall Study||0
11154396|NCT01545141|12342374|FG003|NOT COMPLETED|Overall Study||0
11154397|NCT01545193|12342385|FG000|STARTED|Overall Study||150
11154398|NCT01545193|12342386|FG001|STARTED|Overall Study||150
11154399|NCT01545193|12342385|FG000|COMPLETED|Overall Study||150
11154400|NCT01545193|12342386|FG001|COMPLETED|Overall Study||149
11154401|NCT01545193|12342385|FG000|NOT COMPLETED|Overall Study||0
11154402|NCT01545193|12342386|FG001|NOT COMPLETED|Overall Study||1
11154403|NCT01545232|12342394|FG000|STARTED|Overall Study||338
11154404|NCT01545232|12342395|FG001|STARTED|Overall Study||342
11154405|NCT01545232|12342394|FG000|COMPLETED|Overall Study||338
11154406|NCT01545232|12342395|FG001|COMPLETED|Overall Study||342
11154407|NCT01545232|12342394|FG000|NOT COMPLETED|Overall Study||0
11154408|NCT01545232|12342395|FG001|NOT COMPLETED|Overall Study||0
11154409|NCT01545336|12342405|FG000|STARTED|Overall Study||12
11154410|NCT01545336|12342406|FG001|STARTED|Overall Study||6
11154411|NCT01545336|12342405|FG000|COMPLETED|Overall Study||12
11154412|NCT01545336|12342406|FG001|COMPLETED|Overall Study||6
11154413|NCT01545336|12342405|FG000|NOT COMPLETED|Overall Study||0
11154414|NCT01545336|12342406|FG001|NOT COMPLETED|Overall Study||0
11154415|NCT01545375|12342416|FG000|STARTED|Overall Study||900
11418845|NCT00391430|12617270|FG002|STARTED|Overall Study||31
11418846|NCT00391430|12617268|FG000|COMPLETED|Overall Study||5
11418847|NCT00391430|12617269|FG001|COMPLETED|Overall Study||0
11154416|NCT01545375|12342417|FG001|STARTED|Overall Study||903
11154417|NCT01545375|12342416|FG000|COMPLETED|Overall Study||803
11154418|NCT01545375|12342417|FG001|COMPLETED|Overall Study||813
11154419|NCT01545375|12342416|FG000|NOT COMPLETED|Overall Study||97
11154420|NCT01545375|12342417|FG001|NOT COMPLETED|Overall Study||90
11154421|NCT01545388|12342426|FG000|STARTED|Overall Study||138
11154422|NCT01545388|12342427|FG001|STARTED|Overall Study||133
11154423|NCT01545388|12342428|FG002|STARTED|Overall Study||66
11154424|NCT01545388|12342426|FG000|COMPLETED|Overall Study||130
11154425|NCT01545388|12342427|FG001|COMPLETED|Overall Study||122
11154426|NCT01545388|12342428|FG002|COMPLETED|Overall Study||58
11154427|NCT01545388|12342426|FG000|NOT COMPLETED|Overall Study||8
11154428|NCT01545388|12342427|FG001|NOT COMPLETED|Overall Study||11
11154429|NCT01545388|12342428|FG002|NOT COMPLETED|Overall Study||8
11154430|NCT01545583|12342445|FG000|STARTED|Overall Study||12
11154431|NCT01545583|12342446|FG001|STARTED|Overall Study||2
11154432|NCT01545583|12342447|FG002|STARTED|Overall Study||6
11154433|NCT01545583|12342448|FG003|STARTED|Overall Study||6
11154434|NCT01545583|12342449|FG004|STARTED|Overall Study||6
11154435|NCT01545583|12342450|FG005|STARTED|Overall Study||6
11154436|NCT01545583|12342451|FG006|STARTED|Overall Study||6
11154437|NCT01545583|12342452|FG007|STARTED|Overall Study||6
11154438|NCT01545583|12342453|FG008|STARTED|Overall Study||6
11154439|NCT01545583|12342445|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
11154440|NCT01545583|12342446|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
11154441|NCT01545583|12342447|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11154442|NCT01545583|12342448|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
11154443|NCT01545583|12342449|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
11154444|NCT01545583|12342450|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
11154445|NCT01545583|12342451|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
11154446|NCT01545583|12342452|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
11154447|NCT01545583|12342453|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6
11154448|NCT01545583|12342445|FG000|COMPLETED|Overall Study||12
11154449|NCT01545583|12342446|FG001|COMPLETED|Overall Study||2
11154450|NCT01545583|12342447|FG002|COMPLETED|Overall Study||6
11154451|NCT01545583|12342448|FG003|COMPLETED|Overall Study||6
11154452|NCT01545583|12342449|FG004|COMPLETED|Overall Study||6
11154453|NCT01545583|12342450|FG005|COMPLETED|Overall Study||6
11154454|NCT01545583|12342451|FG006|COMPLETED|Overall Study||6
11154455|NCT01545583|12342452|FG007|COMPLETED|Overall Study||6
11154456|NCT01545583|12342453|FG008|COMPLETED|Overall Study||6
11154457|NCT01545583|12342445|FG000|NOT COMPLETED|Overall Study||0
11154458|NCT01545583|12342446|FG001|NOT COMPLETED|Overall Study||0
11154459|NCT01545583|12342447|FG002|NOT COMPLETED|Overall Study||0
11418848|NCT00391430|12617270|FG002|COMPLETED|Overall Study||19
11154460|NCT01545583|12342448|FG003|NOT COMPLETED|Overall Study||0
11154461|NCT01545583|12342449|FG004|NOT COMPLETED|Overall Study||0
11154462|NCT01545583|12342450|FG005|NOT COMPLETED|Overall Study||0
11154463|NCT01545583|12342451|FG006|NOT COMPLETED|Overall Study||0
11154464|NCT01545583|12342452|FG007|NOT COMPLETED|Overall Study||0
11154465|NCT01545583|12342453|FG008|NOT COMPLETED|Overall Study||0
11154466|NCT01545700|12342486|FG000|STARTED|Overall Study||34
11154467|NCT01545700|12342487|FG001|STARTED|Overall Study||33
11154468|NCT01545700|12342488|FG002|STARTED|Overall Study||33
11154469|NCT01545700|12342489|FG003|STARTED|Overall Study||34
11154470|NCT01545700|12342490|FG004|STARTED|Overall Study||33
11154471|NCT01545700|12342491|FG005|STARTED|Overall Study||33
11154472|NCT01545700|12342486|FG000|COMPLETED|Overall Study||33
11154473|NCT01545700|12342487|FG001|COMPLETED|Overall Study||32
11154474|NCT01545700|12342488|FG002|COMPLETED|Overall Study||31
11418849|NCT00391430|12617268|FG000|NOT COMPLETED|Overall Study||3
11418850|NCT00391430|12617269|FG001|NOT COMPLETED|Overall Study||0
11154475|NCT01545700|12342489|FG003|COMPLETED|Overall Study||34
11154476|NCT01545700|12342490|FG004|COMPLETED|Overall Study||32
11154477|NCT01545700|12342491|FG005|COMPLETED|Overall Study||33
11154478|NCT01545700|12342486|FG000|NOT COMPLETED|Overall Study||1
11154479|NCT01545700|12342487|FG001|NOT COMPLETED|Overall Study||1
11154480|NCT01545700|12342488|FG002|NOT COMPLETED|Overall Study||2
11154481|NCT01545700|12342489|FG003|NOT COMPLETED|Overall Study||0
11154482|NCT01545700|12342490|FG004|NOT COMPLETED|Overall Study||1
11154483|NCT01545700|12342491|FG005|NOT COMPLETED|Overall Study||0
11203150|NCT01845818|12393661|FG001|STARTED|Overall Study||57
11203151|NCT01845818|12393660|FG000|COMPLETED|Overall Study||81
11203152|NCT01845818|12393661|FG001|COMPLETED|Overall Study||40
11203153|NCT01845818|12393660|FG000|NOT COMPLETED|Overall Study||45
11203154|NCT01845818|12393661|FG001|NOT COMPLETED|Overall Study||17
11203155|NCT01845831|12393671|FG000|STARTED|Inpatient Phase||140
11203156|NCT01845831|12393672|FG001|STARTED|Inpatient Phase||139
11203157|NCT01845831|12393673|FG002|STARTED|Inpatient Phase||0
11203158|NCT01845831|12393674|FG003|STARTED|Inpatient Phase||0
11203159|NCT01845831|12393675|FG004|STARTED|Inpatient Phase||0
11203160|NCT01845831|12393671|FG000|COMPLETED|Inpatient Phase||139
11203161|NCT01845831|12393672|FG001|COMPLETED|Inpatient Phase||138
11203162|NCT01845831|12393673|FG002|COMPLETED|Inpatient Phase||0
11203163|NCT01845831|12393674|FG003|COMPLETED|Inpatient Phase||0
11203164|NCT01845831|12393675|FG004|COMPLETED|Inpatient Phase||0
11203165|NCT01845831|12393671|FG000|NOT COMPLETED|Inpatient Phase||1
11203166|NCT01845831|12393672|FG001|NOT COMPLETED|Inpatient Phase||1
11203167|NCT01845831|12393673|FG002|NOT COMPLETED|Inpatient Phase||0
11203168|NCT01845831|12393674|FG003|NOT COMPLETED|Inpatient Phase||0
11203169|NCT01845831|12393675|FG004|NOT COMPLETED|Inpatient Phase||0
11203170|NCT01845831|12393671|FG000|STARTED|Outpatient Phase||0
11203171|NCT01845831|12393672|FG001|STARTED|Outpatient Phase||0
11203172|NCT01845831|12393673|FG002|STARTED|Outpatient Phase||68
11203173|NCT01845831|12393674|FG003|STARTED|Outpatient Phase||98
11203174|NCT01845831|12393675|FG004|STARTED|Outpatient Phase||87
11154484|NCT01545765|12342525|FG000|STARTED|Overall Study||31
11154485|NCT01545765|12342525|FG000|COMPLETED|Overall Study||31
11154486|NCT01545765|12342525|FG000|NOT COMPLETED|Overall Study||0
11154487|NCT01545817|12342532|FG000|STARTED|Pazopanib||74
11154488|NCT01545817|12342533|FG001|STARTED|Pazopanib||0
11154489|NCT01545817|12342532|FG000|COMPLETED|Pazopanib||0
11154490|NCT01545817|12342533|FG001|COMPLETED|Pazopanib||0
11154491|NCT01545817|12342532|FG000|NOT COMPLETED|Pazopanib||74
11154492|NCT01545817|12342533|FG001|NOT COMPLETED|Pazopanib||0
11154493|NCT01545817|12342532|FG000|STARTED|Everolimus||0
11154494|NCT01545817|12342533|FG001|STARTED|Everolimus||38
11154495|NCT01545817|12342532|FG000|COMPLETED|Everolimus||0
11154496|NCT01545817|12342533|FG001|COMPLETED|Everolimus||0
11154497|NCT01545817|12342532|FG000|NOT COMPLETED|Everolimus||0
11154498|NCT01545817|12342533|FG001|NOT COMPLETED|Everolimus||38
11154499|NCT01545843|12342544|FG000|STARTED|Overall Study||19
11154500|NCT01545843|12342545|FG001|STARTED|Overall Study||24
11154501|NCT01545843|12342546|FG002|STARTED|Overall Study||25
11154502|NCT01545843|12342544|FG000|COMPLETED|Overall Study||16
11154503|NCT01545843|12342545|FG001|COMPLETED|Overall Study||17
11154504|NCT01545843|12342546|FG002|COMPLETED|Overall Study||21
11154505|NCT01545843|12342544|FG000|NOT COMPLETED|Overall Study||3
11154506|NCT01545843|12342545|FG001|NOT COMPLETED|Overall Study||7
11154507|NCT01545843|12342546|FG002|NOT COMPLETED|Overall Study||4
11154508|NCT01545934|12342559|FG000|STARTED|Overall Study||132
11154509|NCT01545934|12342560|FG001|STARTED|Overall Study||132
11154510|NCT01545934|12342559|FG000|COMPLETED|Overall Study||127
11154511|NCT01545934|12342560|FG001|COMPLETED|Overall Study||129
11154512|NCT01545934|12342559|FG000|NOT COMPLETED|Overall Study||5
11154513|NCT01545934|12342560|FG001|NOT COMPLETED|Overall Study||3
11154514|NCT01546038|12342573|FG000|STARTED|Overall Study||17
11154515|NCT01546038|12342574|FG001|STARTED|Overall Study||6
11154516|NCT01546038|12342575|FG002|STARTED|Overall Study||4
11154517|NCT01546038|12342576|FG003|STARTED|Overall Study||3
11154518|NCT01546038|12342577|FG004|STARTED|Overall Study||16
11154519|NCT01546038|12342578|FG005|STARTED|Overall Study||6
11154520|NCT01546038|12342579|FG006|STARTED|Overall Study||71
11154521|NCT01546038|12342580|FG007|STARTED|Overall Study||88
11154522|NCT01546038|12342581|FG008|STARTED|Overall Study||44
11154523|NCT01546038|12342573|FG000|Received Treatment|Overall Study||17
11154524|NCT01546038|12342574|FG001|Received Treatment|Overall Study||6
11154525|NCT01546038|12342575|FG002|Received Treatment|Overall Study||4
11154526|NCT01546038|12342576|FG003|Received Treatment|Overall Study||3
11154527|NCT01546038|12342577|FG004|Received Treatment|Overall Study||16
11154528|NCT01546038|12342578|FG005|Received Treatment|Overall Study||6
11154529|NCT01546038|12342579|FG006|Received Treatment|Overall Study||69
11154530|NCT01546038|12342580|FG007|Received Treatment|Overall Study||84
11154531|NCT01546038|12342581|FG008|Received Treatment|Overall Study||41
11154532|NCT01546038|12342573|FG000|COMPLETED|Overall Study||1
11154533|NCT01546038|12342574|FG001|COMPLETED|Overall Study||0
11154534|NCT01546038|12342575|FG002|COMPLETED|Overall Study||0
11154535|NCT01546038|12342576|FG003|COMPLETED|Overall Study||0
11154536|NCT01546038|12342577|FG004|COMPLETED|Overall Study||6
11154537|NCT01546038|12342578|FG005|COMPLETED|Overall Study||2
11154538|NCT01546038|12342579|FG006|COMPLETED|Overall Study||18
11154539|NCT01546038|12342580|FG007|COMPLETED|Overall Study||4
11154540|NCT01546038|12342581|FG008|COMPLETED|Overall Study||1
11154541|NCT01546038|12342573|FG000|NOT COMPLETED|Overall Study||16
11154542|NCT01546038|12342574|FG001|NOT COMPLETED|Overall Study||6
11154543|NCT01546038|12342575|FG002|NOT COMPLETED|Overall Study||4
11154544|NCT01546038|12342576|FG003|NOT COMPLETED|Overall Study||3
11154545|NCT01546038|12342577|FG004|NOT COMPLETED|Overall Study||10
11322921|NCT03402607|12520208|FG000|STARTED|Overall Study||6
11322922|NCT03402607|12520209|FG001|STARTED|Overall Study||6
11322923|NCT03402607|12520208|FG000|COMPLETED|Overall Study||6
11322924|NCT03402607|12520209|FG001|COMPLETED|Overall Study||6
11322925|NCT03402607|12520208|FG000|NOT COMPLETED|Overall Study||0
11322926|NCT03402607|12520209|FG001|NOT COMPLETED|Overall Study||0
11322927|NCT03374891|12520217|FG000|STARTED|Overall Study||346
11322928|NCT03374891|12520218|FG001|STARTED|Overall Study||444
11322929|NCT03374891|12520217|FG000|COMPLETED|Overall Study||323
11322930|NCT03374891|12520218|FG001|COMPLETED|Overall Study||437
11322931|NCT03374891|12520217|FG000|NOT COMPLETED|Overall Study||23
11322932|NCT03374891|12520218|FG001|NOT COMPLETED|Overall Study||7
11322933|NCT03282123|12520224|FG000|STARTED|Overall Study||38
11322934|NCT03282123|12520224|FG000|COMPLETED|Overall Study||33
11322935|NCT03282123|12520224|FG000|NOT COMPLETED|Overall Study||5
11343003|NCT02950545|12540322|FG005|NOT COMPLETED|Session 2 (70 Minutes)||0
11343004|NCT02950545|12540317|FG000|STARTED|Washout 2 (5 Minutes)||8
11343005|NCT02950545|12540318|FG001|STARTED|Washout 2 (5 Minutes)||9
11343006|NCT02950545|12540319|FG002|STARTED|Washout 2 (5 Minutes)||7
11343007|NCT02950545|12540320|FG003|STARTED|Washout 2 (5 Minutes)||7
11343008|NCT02950545|12540321|FG004|STARTED|Washout 2 (5 Minutes)||7
11154546|NCT01546038|12342578|FG005|NOT COMPLETED|Overall Study||4
11154547|NCT01546038|12342579|FG006|NOT COMPLETED|Overall Study||53
11154548|NCT01546038|12342580|FG007|NOT COMPLETED|Overall Study||84
11154549|NCT01546038|12342581|FG008|NOT COMPLETED|Overall Study||43
11154550|NCT01546142|12342633|FG000|STARTED|Overall Study||258
11343009|NCT02950545|12540322|FG005|STARTED|Washout 2 (5 Minutes)||8
11343010|NCT02950545|12540317|FG000|COMPLETED|Washout 2 (5 Minutes)||7
11343011|NCT02950545|12540318|FG001|COMPLETED|Washout 2 (5 Minutes)||9
11343012|NCT02950545|12540319|FG002|COMPLETED|Washout 2 (5 Minutes)||7
11343013|NCT02950545|12540320|FG003|COMPLETED|Washout 2 (5 Minutes)||7
11322936|NCT03199391|12520229|FG000|STARTED|Overall Study||71
11322937|NCT03199391|12520229|FG000|COMPLETED|Overall Study||55
11322938|NCT03199391|12520229|FG000|NOT COMPLETED|Overall Study||16
11322939|NCT03122886|12520235|FG000|STARTED|Overall Study||10
11322940|NCT03122886|12520236|FG001|STARTED|Overall Study||9
11322941|NCT03122886|12520235|FG000|COMPLETED|Overall Study||9
11322942|NCT03122886|12520236|FG001|COMPLETED|Overall Study||7
11322943|NCT03122886|12520235|FG000|NOT COMPLETED|Overall Study||1
11322944|NCT03122886|12520236|FG001|NOT COMPLETED|Overall Study||2
11322945|NCT03042611|12520244|FG000|STARTED|Core Phase||308
11322946|NCT03042611|12520245|FG001|STARTED|Core Phase||152
11322947|NCT03042611|12520246|FG002|STARTED|Core Phase||0
11322948|NCT03042611|12520247|FG003|STARTED|Core Phase||0
11322949|NCT03042611|12520244|FG000|Received at Least 1 Dose of Study Drug|Core Phase||307
11322950|NCT03042611|12520245|FG001|Received at Least 1 Dose of Study Drug|Core Phase||151
11322951|NCT03042611|12520246|FG002|Received at Least 1 Dose of Study Drug|Core Phase||0
11322952|NCT03042611|12520247|FG003|Received at Least 1 Dose of Study Drug|Core Phase||0
11322953|NCT03042611|12520244|FG000|COMPLETED|Core Phase||52
11322954|NCT03042611|12520245|FG001|COMPLETED|Core Phase||28
11322955|NCT03042611|12520246|FG002|COMPLETED|Core Phase||0
11322956|NCT03042611|12520247|FG003|COMPLETED|Core Phase||0
11322957|NCT03042611|12520244|FG000|NOT COMPLETED|Core Phase||256
11322958|NCT03042611|12520245|FG001|NOT COMPLETED|Core Phase||124
11322959|NCT03042611|12520246|FG002|NOT COMPLETED|Core Phase||0
11322960|NCT03042611|12520247|FG003|NOT COMPLETED|Core Phase||0
11322961|NCT03042611|12520244|FG000|STARTED|Extension Phase||0
11322962|NCT03042611|12520245|FG001|STARTED|Extension Phase||0
11322963|NCT03042611|12520246|FG002|STARTED|Extension Phase||52
11322964|NCT03042611|12520247|FG003|STARTED|Extension Phase||28
11322965|NCT03042611|12520244|FG000|COMPLETED|Extension Phase||0
11322966|NCT03042611|12520245|FG001|COMPLETED|Extension Phase||0
11322967|NCT03042611|12520246|FG002|COMPLETED|Extension Phase||0
11322968|NCT03042611|12520247|FG003|COMPLETED|Extension Phase||0
11322969|NCT03042611|12520244|FG000|NOT COMPLETED|Extension Phase||0
11322970|NCT03042611|12520245|FG001|NOT COMPLETED|Extension Phase||0
11322971|NCT03042611|12520246|FG002|NOT COMPLETED|Extension Phase||52
11322972|NCT03042611|12520247|FG003|NOT COMPLETED|Extension Phase||28
11322973|NCT03041181|12520255|FG000|STARTED|Overall Study||1
11322974|NCT03041181|12520256|FG001|STARTED|Overall Study||2
11322975|NCT03041181|12520255|FG000|COMPLETED|Overall Study||0
11322976|NCT03041181|12520256|FG001|COMPLETED|Overall Study||0
11322977|NCT03041181|12520255|FG000|NOT COMPLETED|Overall Study||1
11322978|NCT03041181|12520256|FG001|NOT COMPLETED|Overall Study||2
11322979|NCT03017742|12520262|FG000|STARTED|Overall Study||813
11322980|NCT03017742|12520262|FG000|COMPLETED|Overall Study||740
11322981|NCT03017742|12520262|FG000|NOT COMPLETED|Overall Study||73
11322982|NCT02941926|12520266|FG000|STARTED|Overall Study||3246
11322983|NCT02941926|12520266|FG000|Canadian Sub-study|Overall Study||88
11322984|NCT02941926|12520266|FG000|COMPLETED|Overall Study||1301
11322985|NCT02941926|12520266|FG000|NOT COMPLETED|Overall Study||1945
11322986|NCT02879448|12520274|FG000|STARTED|Overall Study||934
11322987|NCT02879448|12520275|FG001|STARTED|Overall Study||944
11322988|NCT02879448|12520274|FG000|COMPLETED|Overall Study||796
11322989|NCT02879448|12520275|FG001|COMPLETED|Overall Study||742
11322990|NCT02879448|12520274|FG000|NOT COMPLETED|Overall Study||138
11322991|NCT02879448|12520275|FG001|NOT COMPLETED|Overall Study||202
11322992|NCT02739347|12520283|FG000|STARTED|Overall Study||5
11322993|NCT02739347|12520284|FG001|STARTED|Overall Study||7
11322994|NCT02739347|12520283|FG000|COMPLETED|Overall Study||2
11322995|NCT02739347|12520284|FG001|COMPLETED|Overall Study||4
11154551|NCT01546142|12342634|FG001|STARTED|Overall Study||258
11154552|NCT01546142|12342633|FG000|Received Treatment|Overall Study||257
11154553|NCT01546142|12342634|FG001|Received Treatment|Overall Study||257
11154554|NCT01546142|12342633|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
11154555|NCT01546142|12342634|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
11154556|NCT01546142|12342633|FG000|NOT COMPLETED|Overall Study||44
11154557|NCT01546142|12342634|FG001|NOT COMPLETED|Overall Study||34
11154558|NCT01546155|12342640|FG000|STARTED|Overall Study||11
11154559|NCT01546155|12342640|FG000|COMPLETED|Overall Study||8
11154560|NCT01546155|12342640|FG000|NOT COMPLETED|Overall Study||3
11154561|NCT01546168|12342646|FG000|STARTED|Overall Study||55
11154562|NCT01546168|12342647|FG001|STARTED|Overall Study||33
11154563|NCT01546168|12342646|FG000|COMPLETED|Overall Study||51
11154564|NCT01546168|12342647|FG001|COMPLETED|Overall Study||33
11154565|NCT01546168|12342646|FG000|NOT COMPLETED|Overall Study||4
11154566|NCT01546168|12342647|FG001|NOT COMPLETED|Overall Study||0
11154567|NCT01546194|12342655|FG000|STARTED|Overall Study||100
11154568|NCT01546194|12342656|FG001|STARTED|Overall Study||100
11154569|NCT01546194|12342655|FG000|COMPLETED|Overall Study||64
11154570|NCT01546194|12342656|FG001|COMPLETED|Overall Study||65
11154571|NCT01546194|12342655|FG000|NOT COMPLETED|Overall Study||36
11154572|NCT01546194|12342656|FG001|NOT COMPLETED|Overall Study||35
11154573|NCT01546285|12342662|FG000|STARTED|Overall Study||66
11154574|NCT01546285|12342662|FG000|COMPLETED|Overall Study||66
11154575|NCT01546285|12342662|FG000|NOT COMPLETED|Overall Study||0
11154576|NCT01546402|12342670|FG000|STARTED|Overall Study||10
11418851|NCT00391430|12617270|FG002|NOT COMPLETED|Overall Study||12
11322996|NCT02739347|12520283|FG000|NOT COMPLETED|Overall Study||3
11322997|NCT02739347|12520284|FG001|NOT COMPLETED|Overall Study||3
11343014|NCT02950545|12540321|FG004|COMPLETED|Washout 2 (5 Minutes)||7
11343015|NCT02950545|12540322|FG005|COMPLETED|Washout 2 (5 Minutes)||8
11418852|NCT00399841|12617278|FG000|STARTED|Overall Study||13
11418853|NCT00399841|12617279|FG001|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
11418854|NCT00399841|12617280|FG002|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
11418855|NCT00399841|12617278|FG000|Permanent Implant|Overall Study||6
11418856|NCT00399841|12617279|FG001|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
11418857|NCT00399841|12617280|FG002|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
11418858|NCT00399841|12617278|FG000|12-week|Overall Study||2
11154577|NCT01546402|12342671|FG001|STARTED|Overall Study||10
11154578|NCT01546402|12342670|FG000|COMPLETED|Overall Study||10
11154579|NCT01546402|12342671|FG001|COMPLETED|Overall Study||10
11154580|NCT01546402|12342670|FG000|NOT COMPLETED|Overall Study||0
11154581|NCT01546402|12342671|FG001|NOT COMPLETED|Overall Study||0
11154582|NCT01546454|12342677|FG000|STARTED|Natural Menstrual Cycle||4
11154583|NCT01546454|12342677|FG000|COMPLETED|Natural Menstrual Cycle||4
11154584|NCT01546454|12342677|FG000|NOT COMPLETED|Natural Menstrual Cycle||0
11154585|NCT01546454|12342677|FG000|STARTED|Oral Contraceptive Cycle||4
11154586|NCT01546454|12342677|FG000|COMPLETED|Oral Contraceptive Cycle||4
11154587|NCT01546454|12342677|FG000|NOT COMPLETED|Oral Contraceptive Cycle||0
11154588|NCT01546454|12342677|FG000|STARTED|Eligard Treatment||4
11154589|NCT01546454|12342677|FG000|COMPLETED|Eligard Treatment||4
11154590|NCT01546454|12342677|FG000|NOT COMPLETED|Eligard Treatment||0
11154591|NCT01546454|12342677|FG000|STARTED|Estrogen/Progesterone Replacement Cycle||4
11154592|NCT01546454|12342677|FG000|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
11154593|NCT01546454|12342677|FG000|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
11154594|NCT01546519|12342687|FG000|STARTED|Overall Study||9
11154595|NCT01546519|12342688|FG001|STARTED|Overall Study||8
11154596|NCT01546519|12342689|FG002|STARTED|Overall Study||8
11154597|NCT01546519|12342690|FG003|STARTED|Overall Study||6
11154598|NCT01546519|12342687|FG000|Safety-Evaluable Participants|Overall Study||9
11154599|NCT01546519|12342688|FG001|Safety-Evaluable Participants|Overall Study||8
11154600|NCT01546519|12342689|FG002|Safety-Evaluable Participants|Overall Study||8
11154601|NCT01546519|12342690|FG003|Safety-Evaluable Participants|Overall Study||6
11154602|NCT01546519|12342687|FG000|COMPLETED|Overall Study||0
11154603|NCT01546519|12342688|FG001|COMPLETED|Overall Study||0
11154604|NCT01546519|12342689|FG002|COMPLETED|Overall Study||0
11154605|NCT01546519|12342690|FG003|COMPLETED|Overall Study||0
11154606|NCT01546519|12342687|FG000|NOT COMPLETED|Overall Study||9
11154607|NCT01546519|12342688|FG001|NOT COMPLETED|Overall Study||8
11154608|NCT01546519|12342689|FG002|NOT COMPLETED|Overall Study||8
11154609|NCT01546519|12342690|FG003|NOT COMPLETED|Overall Study||6
11154610|NCT01546623|12342706|FG000|STARTED|Overall Study||82
11154611|NCT01546623|12342707|FG001|STARTED|Overall Study||80
11154612|NCT01546623|12342706|FG000|Received Study Drug|Overall Study||81
11154613|NCT01546623|12342707|FG001|Received Study Drug|Overall Study||79
11154614|NCT01546623|12342706|FG000|COMPLETED|Overall Study||76
11154615|NCT01546623|12342707|FG001|COMPLETED|Overall Study||74
11154616|NCT01546623|12342706|FG000|NOT COMPLETED|Overall Study||6
11154617|NCT01546623|12342707|FG001|NOT COMPLETED|Overall Study||6
11154618|NCT01546636|12342715|FG000|STARTED|Overall Study||36
11154619|NCT01546636|12342716|FG001|STARTED|Overall Study||34
11154620|NCT01546636|12342715|FG000|COMPLETED|Overall Study||36
11154621|NCT01546636|12342716|FG001|COMPLETED|Overall Study||34
11154622|NCT01546636|12342715|FG000|NOT COMPLETED|Overall Study||0
11154623|NCT01546636|12342716|FG001|NOT COMPLETED|Overall Study||0
11154624|NCT01546649|12342724|FG000|STARTED|Overall Study||83
11154625|NCT01546649|12342725|FG001|STARTED|Overall Study||84
11154626|NCT01546649|12342724|FG000|COMPLETED|Overall Study||75
11154627|NCT01546649|12342725|FG001|COMPLETED|Overall Study||75
11154628|NCT01546649|12342724|FG000|NOT COMPLETED|Overall Study||8
11154629|NCT01546649|12342725|FG001|NOT COMPLETED|Overall Study||9
11154630|NCT01546675|12342733|FG000|STARTED|Overall Study||1
11154631|NCT01546675|12342734|FG001|STARTED|Overall Study||1
11154632|NCT01546675|12342733|FG000|COMPLETED|Overall Study||1
11154633|NCT01546675|12342734|FG001|COMPLETED|Overall Study||1
11154634|NCT01546675|12342733|FG000|NOT COMPLETED|Overall Study||0
11154635|NCT01546675|12342734|FG001|NOT COMPLETED|Overall Study||0
11154636|NCT01546688|12342742|FG000|STARTED|Overall Study||18
11154637|NCT01546688|12342743|FG001|STARTED|Overall Study||33
11154638|NCT01546688|12342742|FG000|COMPLETED|Overall Study||15
11154639|NCT01546688|12342743|FG001|COMPLETED|Overall Study||28
11154640|NCT01546688|12342742|FG000|NOT COMPLETED|Overall Study||3
11154641|NCT01546688|12342743|FG001|NOT COMPLETED|Overall Study||5
11154642|NCT01546857|12342751|FG000|STARTED|Overall Study||14
11154643|NCT01546857|12342752|FG001|STARTED|Overall Study||20
11154644|NCT01546857|12342751|FG000|COMPLETED|Overall Study||12
11154645|NCT01546857|12342752|FG001|COMPLETED|Overall Study||17
11154646|NCT01546857|12342751|FG000|NOT COMPLETED|Overall Study||2
11154647|NCT01546857|12342752|FG001|NOT COMPLETED|Overall Study||3
11154648|NCT01546922|12342759|FG000|STARTED|First Period of 10 Weeks||30
11154649|NCT01546922|12342760|FG001|STARTED|First Period of 10 Weeks||30
11154650|NCT01546922|12342759|FG000|COMPLETED|First Period of 10 Weeks||25
11154651|NCT01546922|12342760|FG001|COMPLETED|First Period of 10 Weeks||28
11154652|NCT01546922|12342759|FG000|NOT COMPLETED|First Period of 10 Weeks||5
11154653|NCT01546922|12342760|FG001|NOT COMPLETED|First Period of 10 Weeks||2
11154654|NCT01546922|12342759|FG000|STARTED|Second Period of 10 Weeks||25
11154655|NCT01546922|12342760|FG001|STARTED|Second Period of 10 Weeks||28
11154656|NCT01546922|12342759|FG000|COMPLETED|Second Period of 10 Weeks||22
11154657|NCT01546922|12342760|FG001|COMPLETED|Second Period of 10 Weeks||25
11154658|NCT01546922|12342759|FG000|NOT COMPLETED|Second Period of 10 Weeks||3
11154659|NCT01546922|12342760|FG001|NOT COMPLETED|Second Period of 10 Weeks||3
11154660|NCT01547000|12342768|FG000|STARTED|Overall Study||18
11154661|NCT01547000|12342769|FG001|STARTED|Overall Study||16
11154662|NCT01547000|12342768|FG000|COMPLETED|Overall Study||18
11154663|NCT01547000|12342769|FG001|COMPLETED|Overall Study||16
11154664|NCT01547000|12342768|FG000|NOT COMPLETED|Overall Study||0
11154665|NCT01547000|12342769|FG001|NOT COMPLETED|Overall Study||0
11154666|NCT01547130|12342777|FG000|STARTED|Overall Study||74
11154667|NCT01547130|12342778|FG001|STARTED|Overall Study||73
11154668|NCT01547130|12342777|FG000|COMPLETED|Overall Study||65
11154669|NCT01547130|12342778|FG001|COMPLETED|Overall Study||68
11154670|NCT01547130|12342777|FG000|NOT COMPLETED|Overall Study||9
11154671|NCT01547130|12342778|FG001|NOT COMPLETED|Overall Study||5
11154672|NCT01547247|12342794|FG000|STARTED|Overall Study||104
11154673|NCT01547247|12342795|FG001|STARTED|Overall Study||104
11154674|NCT01547247|12342794|FG000|COMPLETED|Overall Study||98
11154675|NCT01547247|12342795|FG001|COMPLETED|Overall Study||98
11154676|NCT01547247|12342794|FG000|NOT COMPLETED|Overall Study||6
11154677|NCT01547247|12342795|FG001|NOT COMPLETED|Overall Study||6
11154678|NCT01547286|12342801|FG000|STARTED|Overall Study||7
11154679|NCT01547286|12342801|FG000|COMPLETED|Overall Study||5
11154680|NCT01547286|12342801|FG000|NOT COMPLETED|Overall Study||2
11154681|NCT01547299|12342808|FG000|STARTED|Overall Study||25
11154682|NCT01547299|12342809|FG001|STARTED|Overall Study||27
11154683|NCT01547299|12342808|FG000|COMPLETED|Overall Study||23
11154684|NCT01547299|12342809|FG001|COMPLETED|Overall Study||25
11154685|NCT01547299|12342808|FG000|NOT COMPLETED|Overall Study||2
11154686|NCT01547299|12342809|FG001|NOT COMPLETED|Overall Study||2
11154687|NCT01547390|12342817|FG000|STARTED|Overall Study||27
11154688|NCT01547390|12342818|FG001|STARTED|Overall Study||26
11154689|NCT01547390|12342817|FG000|COMPLETED|Overall Study||14
11154690|NCT01547390|12342818|FG001|COMPLETED|Overall Study||16
11154691|NCT01547390|12342817|FG000|NOT COMPLETED|Overall Study||13
11154692|NCT01547390|12342818|FG001|NOT COMPLETED|Overall Study||10
11154693|NCT01547598|12342826|FG000|STARTED|Overall Study||67
11154694|NCT01547598|12342827|FG001|STARTED|Overall Study||68
11154695|NCT01547598|12342826|FG000|COMPLETED|Overall Study||61
11154696|NCT01547598|12342827|FG001|COMPLETED|Overall Study||63
11154697|NCT01547598|12342826|FG000|NOT COMPLETED|Overall Study||6
11154698|NCT01547598|12342827|FG001|NOT COMPLETED|Overall Study||5
11154699|NCT01547715|12342837|FG000|STARTED|Overall Study||60
11154700|NCT01547715|12342838|FG001|STARTED|Overall Study||60
11154701|NCT01547715|12342839|FG002|STARTED|Overall Study||60
11154702|NCT01547715|12342837|FG000|COMPLETED|Overall Study||60
11154703|NCT01547715|12342838|FG001|COMPLETED|Overall Study||60
11154704|NCT01547715|12342839|FG002|COMPLETED|Overall Study||60
11154705|NCT01547715|12342837|FG000|NOT COMPLETED|Overall Study||0
11154706|NCT01547715|12342838|FG001|NOT COMPLETED|Overall Study||0
11154707|NCT01547715|12342839|FG002|NOT COMPLETED|Overall Study||0
11154708|NCT01547780|12342852|FG000|STARTED|Baseline PET Scan||12
11154709|NCT01547780|12342853|FG001|STARTED|Baseline PET Scan||0
11154710|NCT01547780|12342854|FG002|STARTED|Baseline PET Scan||19
11154711|NCT01547780|12342855|FG003|STARTED|Baseline PET Scan||19
11154712|NCT01547780|12342852|FG000|COMPLETED|Baseline PET Scan||9
11154713|NCT01547780|12342853|FG001|COMPLETED|Baseline PET Scan||0
11154714|NCT01547780|12342854|FG002|COMPLETED|Baseline PET Scan||17
11154715|NCT01547780|12342855|FG003|COMPLETED|Baseline PET Scan||19
11154716|NCT01547780|12342852|FG000|NOT COMPLETED|Baseline PET Scan||3
11154717|NCT01547780|12342853|FG001|NOT COMPLETED|Baseline PET Scan||0
11154718|NCT01547780|12342854|FG002|NOT COMPLETED|Baseline PET Scan||2
11154719|NCT01547780|12342855|FG003|NOT COMPLETED|Baseline PET Scan||0
11154720|NCT01547780|12342852|FG000|STARTED|Repeat PET Scan||0
11154721|NCT01547780|12342853|FG001|STARTED|Repeat PET Scan||4
11154722|NCT01547780|12342854|FG002|STARTED|Repeat PET Scan||0
11154723|NCT01547780|12342855|FG003|STARTED|Repeat PET Scan||0
11154724|NCT01547780|12342852|FG000|COMPLETED|Repeat PET Scan||0
11154725|NCT01547780|12342853|FG001|COMPLETED|Repeat PET Scan||4
11154726|NCT01547780|12342854|FG002|COMPLETED|Repeat PET Scan||0
11154727|NCT01547780|12342855|FG003|COMPLETED|Repeat PET Scan||0
11154728|NCT01547780|12342852|FG000|NOT COMPLETED|Repeat PET Scan||0
11154729|NCT01547780|12342853|FG001|NOT COMPLETED|Repeat PET Scan||0
11154730|NCT01547780|12342854|FG002|NOT COMPLETED|Repeat PET Scan||0
11154731|NCT01547780|12342855|FG003|NOT COMPLETED|Repeat PET Scan||0
11154732|NCT01547806|12342865|FG000|STARTED|Overall Study||49
11154733|NCT01547806|12342865|FG000|COMPLETED|Overall Study||49
11154734|NCT01547806|12342865|FG000|NOT COMPLETED|Overall Study||0
11154735|NCT01548040|12342872|FG000|STARTED|Overall Study||56
11154736|NCT01548040|12342873|FG001|STARTED|Overall Study||55
11154737|NCT01548040|12342872|FG000|COMPLETED|Overall Study||43
11154738|NCT01548040|12342873|FG001|COMPLETED|Overall Study||45
11154739|NCT01548040|12342872|FG000|NOT COMPLETED|Overall Study||13
11154740|NCT01548040|12342873|FG001|NOT COMPLETED|Overall Study||10
11154741|NCT01548287|12342883|FG000|STARTED|Screening||19
11154742|NCT01548287|12342884|FG001|STARTED|Screening||22
11154743|NCT01548287|12342885|FG002|STARTED|Screening||20
11154744|NCT01548287|12342886|FG003|STARTED|Screening||20
11154745|NCT01548287|12342887|FG004|STARTED|Screening||83
11154746|NCT01548287|12342883|FG000|COMPLETED|Screening||19
11154747|NCT01548287|12342884|FG001|COMPLETED|Screening||22
11154748|NCT01548287|12342885|FG002|COMPLETED|Screening||20
11154749|NCT01548287|12342886|FG003|COMPLETED|Screening||20
11154750|NCT01548287|12342887|FG004|COMPLETED|Screening||0
11154751|NCT01548287|12342883|FG000|NOT COMPLETED|Screening||0
11154752|NCT01548287|12342884|FG001|NOT COMPLETED|Screening||0
11154753|NCT01548287|12342885|FG002|NOT COMPLETED|Screening||0
11154754|NCT01548287|12342886|FG003|NOT COMPLETED|Screening||0
11154755|NCT01548287|12342887|FG004|NOT COMPLETED|Screening||83
11154756|NCT01548287|12342883|FG000|STARTED|Randomized Period||19
11154757|NCT01548287|12342884|FG001|STARTED|Randomized Period||22
11154758|NCT01548287|12342885|FG002|STARTED|Randomized Period||20
11154759|NCT01548287|12342886|FG003|STARTED|Randomized Period||20
11154760|NCT01548287|12342887|FG004|STARTED|Randomized Period||0
11154761|NCT01548287|12342883|FG000|COMPLETED|Randomized Period||19
11154762|NCT01548287|12342884|FG001|COMPLETED|Randomized Period||20
11154763|NCT01548287|12342885|FG002|COMPLETED|Randomized Period||13
11154764|NCT01548287|12342886|FG003|COMPLETED|Randomized Period||20
11154765|NCT01548287|12342887|FG004|COMPLETED|Randomized Period||0
11154766|NCT01548287|12342883|FG000|NOT COMPLETED|Randomized Period||0
11154767|NCT01548287|12342884|FG001|NOT COMPLETED|Randomized Period||2
11154768|NCT01548287|12342885|FG002|NOT COMPLETED|Randomized Period||7
11154769|NCT01548287|12342886|FG003|NOT COMPLETED|Randomized Period||0
11154770|NCT01548287|12342887|FG004|NOT COMPLETED|Randomized Period||0
11154771|NCT01548339|12342899|FG000|STARTED|Overall Study||44
11154772|NCT01548339|12342900|FG001|STARTED|Overall Study||42
11154773|NCT01548339|12342899|FG000|COMPLETED|Overall Study||38
11154774|NCT01548339|12342900|FG001|COMPLETED|Overall Study||41
11154775|NCT01548339|12342899|FG000|NOT COMPLETED|Overall Study||6
11154776|NCT01548339|12342900|FG001|NOT COMPLETED|Overall Study||1
11154777|NCT01548404|12342908|FG000|STARTED|Overall Study||54
11154778|NCT01548404|12342909|FG001|STARTED|Overall Study||55
11154779|NCT01548404|12342908|FG000|COMPLETED|Overall Study||24
11154780|NCT01548404|12342909|FG001|COMPLETED|Overall Study||41
11154781|NCT01548404|12342908|FG000|NOT COMPLETED|Overall Study||30
11154782|NCT01548404|12342909|FG001|NOT COMPLETED|Overall Study||14
11154783|NCT01548417|12342918|FG000|STARTED|Overall Study||28
11154784|NCT01548417|12342919|FG001|STARTED|Overall Study||28
11418859|NCT00399841|12617279|FG001|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
11418860|NCT00399841|12617280|FG002|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
11418861|NCT00399841|12617278|FG000|COMPLETED|Overall Study||1
11418862|NCT00399841|12617279|FG001|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
11418863|NCT00399841|12617280|FG002|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
11418864|NCT00399841|12617278|FG000|NOT COMPLETED|Overall Study||12
11154785|NCT01548417|12342918|FG000|COMPLETED|Overall Study||28
11154786|NCT01548417|12342919|FG001|COMPLETED|Overall Study||26
11154787|NCT01548417|12342918|FG000|NOT COMPLETED|Overall Study||0
11154788|NCT01548417|12342919|FG001|NOT COMPLETED|Overall Study||2
11154789|NCT01548573|12342925|FG000|STARTED|Overall Study||19
11154790|NCT01548573|12342925|FG000|COMPLETED|Overall Study||14
11154791|NCT01548573|12342925|FG000|NOT COMPLETED|Overall Study||5
11418865|NCT00399841|12617279|FG001|NOT COMPLETED|Overall Study||0
11418866|NCT00399841|12617280|FG002|NOT COMPLETED|Overall Study||0
11154792|NCT01548599|12342932|FG000|STARTED|Overall Study||72
11154793|NCT01548599|12342933|FG001|STARTED|Overall Study||68
11154794|NCT01548599|12342932|FG000|COMPLETED|Overall Study||66
11154795|NCT01548599|12342933|FG001|COMPLETED|Overall Study||66
11154796|NCT01548599|12342932|FG000|NOT COMPLETED|Overall Study||6
11154797|NCT01548599|12342933|FG001|NOT COMPLETED|Overall Study||2
11154798|NCT01548638|12342942|FG000|STARTED|Overall Study||13
11154799|NCT01548638|12342942|FG000|COMPLETED|Overall Study||9
11154800|NCT01548638|12342942|FG000|NOT COMPLETED|Overall Study||4
11154801|NCT01548690|12342951|FG000|STARTED|Overall Study||9
11154802|NCT01548690|12342952|FG001|STARTED|Overall Study||10
11154803|NCT01548690|12342953|FG002|STARTED|Overall Study||13
11154804|NCT01548690|12342954|FG003|STARTED|Overall Study||15
11154805|NCT01548690|12342951|FG000|Evaluable (72 Hours on Infusion)|Overall Study||6
11154806|NCT01548690|12342952|FG001|Evaluable (72 Hours on Infusion)|Overall Study||6
11154807|NCT01548690|12342953|FG002|Evaluable (72 Hours on Infusion)|Overall Study||12
11418867|NCT00387673|12617285|FG000|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
11154808|NCT01548690|12342954|FG003|Evaluable (72 Hours on Infusion)|Overall Study||12
11154809|NCT01548690|12342951|FG000|COMPLETED|Overall Study||9
11154810|NCT01548690|12342952|FG001|COMPLETED|Overall Study||7
11154811|NCT01548690|12342953|FG002|COMPLETED|Overall Study||8
11154812|NCT01548690|12342954|FG003|COMPLETED|Overall Study||10
11154813|NCT01548690|12342951|FG000|NOT COMPLETED|Overall Study||0
11154814|NCT01548690|12342952|FG001|NOT COMPLETED|Overall Study||3
11154815|NCT01548690|12342953|FG002|NOT COMPLETED|Overall Study||5
11154816|NCT01548690|12342954|FG003|NOT COMPLETED|Overall Study||5
11154817|NCT01548742|12342969|FG000|STARTED|Overall Study||58
11154818|NCT01548742|12342970|FG001|STARTED|Overall Study||58
11154819|NCT01548742|12342969|FG000|COMPLETED|Overall Study||45
11154820|NCT01548742|12342970|FG001|COMPLETED|Overall Study||54
11154821|NCT01548742|12342969|FG000|NOT COMPLETED|Overall Study||13
11154822|NCT01548742|12342970|FG001|NOT COMPLETED|Overall Study||4
11154823|NCT01548768|12342982|FG000|STARTED|Overall Study||8
11154824|NCT01548768|12342983|FG001|STARTED|Overall Study||4
11418868|NCT00387673|12617286|FG001|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
11418869|NCT00387673|12617287|FG002|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
11418870|NCT00387673|12617285|FG000|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
11418871|NCT00387673|12617286|FG001|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
11418872|NCT00387673|12617287|FG002|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
11418873|NCT00387673|12617285|FG000|NOT COMPLETED|Overall Study||0
11154825|NCT01548768|12342984|FG002|STARTED|Overall Study||16
11154826|NCT01548768|12342985|FG003|STARTED|Overall Study||121
11154827|NCT01548768|12342982|FG000|COMPLETED|Overall Study||7
11154828|NCT01548768|12342983|FG001|COMPLETED|Overall Study||2
11154829|NCT01548768|12342984|FG002|COMPLETED|Overall Study||15
11154830|NCT01548768|12342985|FG003|COMPLETED|Overall Study||117
11154831|NCT01548768|12342982|FG000|NOT COMPLETED|Overall Study||1
11154832|NCT01548768|12342983|FG001|NOT COMPLETED|Overall Study||2
11154833|NCT01548768|12342984|FG002|NOT COMPLETED|Overall Study||1
11154834|NCT01548768|12342985|FG003|NOT COMPLETED|Overall Study||4
11154835|NCT01548833|12342997|FG000|STARTED|Overall Study||39
11154836|NCT01548833|12342997|FG000|COMPLETED|Overall Study||39
11154837|NCT01548833|12342997|FG000|NOT COMPLETED|Overall Study||0
11154838|NCT01548885|12343005|FG000|STARTED|Overall Study||146
11154839|NCT01548885|12343005|FG000|COMPLETED|Overall Study||146
11154840|NCT01548885|12343005|FG000|NOT COMPLETED|Overall Study||0
11154841|NCT01549002|12343011|FG000|STARTED|Overall Study||10
11154842|NCT01549002|12343012|FG001|STARTED|Overall Study||10
11154843|NCT01549002|12343011|FG000|COMPLETED|Overall Study||10
11154844|NCT01549002|12343012|FG001|COMPLETED|Overall Study||6
11154845|NCT01549002|12343011|FG000|NOT COMPLETED|Overall Study||0
11154846|NCT01549002|12343012|FG001|NOT COMPLETED|Overall Study||4
11154847|NCT01549041|12343020|FG000|STARTED|Overall Study||12
11154848|NCT01549041|12343021|FG001|STARTED|Overall Study||18
11154849|NCT01549041|12343020|FG000|COMPLETED|Overall Study||10
11154850|NCT01549041|12343021|FG001|COMPLETED|Overall Study||10
11154851|NCT01549041|12343020|FG000|NOT COMPLETED|Overall Study||2
11154852|NCT01549041|12343021|FG001|NOT COMPLETED|Overall Study||8
11154853|NCT01549223|12343029|FG000|STARTED|Overall Study||30
11154854|NCT01549223|12343030|FG001|STARTED|Overall Study||30
11154855|NCT01549223|12343029|FG000|COMPLETED|Overall Study||30
11154856|NCT01549223|12343030|FG001|COMPLETED|Overall Study||30
11154857|NCT01549223|12343029|FG000|NOT COMPLETED|Overall Study||0
11154858|NCT01549223|12343030|FG001|NOT COMPLETED|Overall Study||0
11154859|NCT01549275|12343038|FG000|STARTED|Overall Study||76
11154860|NCT01549275|12343039|FG001|STARTED|Overall Study||29
11154861|NCT01549275|12343038|FG000|COMPLETED|Overall Study||75
11154862|NCT01549275|12343039|FG001|COMPLETED|Overall Study||29
11154863|NCT01549275|12343038|FG000|NOT COMPLETED|Overall Study||1
11154864|NCT01549275|12343039|FG001|NOT COMPLETED|Overall Study||0
11154865|NCT01549314|12343052|FG000|STARTED|Overall Study|1 subject signed the consent form but dropped out prior to any study procedures or data collection.|27
11154866|NCT01549314|12343053|FG001|STARTED|Overall Study||26
11154867|NCT01549314|12343054|FG002|STARTED|Overall Study||26
11154868|NCT01549314|12343052|FG000|COMPLETED|Overall Study||23
11154869|NCT01549314|12343053|FG001|COMPLETED|Overall Study||21
11418874|NCT00387673|12617286|FG001|NOT COMPLETED|Overall Study||0
11418875|NCT00387673|12617287|FG002|NOT COMPLETED|Overall Study||0
11418876|NCT00386724|12617293|FG000|STARTED|Overall Study||8
11418877|NCT00386724|12617293|FG000|3 Months Post-activation|Overall Study||4
11154870|NCT01549314|12343054|FG002|COMPLETED|Overall Study||24
11154871|NCT01549314|12343052|FG000|NOT COMPLETED|Overall Study||4
11154872|NCT01549314|12343053|FG001|NOT COMPLETED|Overall Study||5
11154873|NCT01549314|12343054|FG002|NOT COMPLETED|Overall Study||2
11154874|NCT01549340|12343062|FG000|STARTED|Overall Study|Advised to receive AIT|8790
11418878|NCT00386724|12617293|FG000|COMPLETED|Overall Study||3
11418879|NCT00386724|12617293|FG000|NOT COMPLETED|Overall Study||5
11418880|NCT00387244|12617297|FG000|STARTED|Overall Study||7
11418881|NCT00387244|12617297|FG000|End of Trial|Overall Study||0
11154875|NCT01549340|12343062|FG000|Started AIT|Overall Study||3182
11154876|NCT01549340|12343062|FG000|COMPLETED|Overall Study|Completed 5 years of AIT|385
11154877|NCT01549340|12343062|FG000|NOT COMPLETED|Overall Study||8405
11154878|NCT01549392|12343073|FG000|STARTED|Overall Study||3
11154879|NCT01549392|12343074|FG001|STARTED|Overall Study||0
11154880|NCT01549392|12343073|FG000|COMPLETED|Overall Study||2
11154881|NCT01549392|12343074|FG001|COMPLETED|Overall Study||0
11154882|NCT01549392|12343073|FG000|NOT COMPLETED|Overall Study||1
11154883|NCT01549392|12343074|FG001|NOT COMPLETED|Overall Study||0
11154884|NCT01549405|12343082|FG000|STARTED|Overall Study||20
11154885|NCT01549405|12343083|FG001|STARTED|Overall Study||20
11154886|NCT01549405|12343082|FG000|COMPLETED|Overall Study||20
11154887|NCT01549405|12343083|FG001|COMPLETED|Overall Study||20
11154888|NCT01549405|12343082|FG000|NOT COMPLETED|Overall Study||0
11154889|NCT01549405|12343083|FG001|NOT COMPLETED|Overall Study||0
11154890|NCT01549587|12343093|FG000|STARTED|Overall Study||373
11154891|NCT01549587|12343094|FG001|STARTED|Overall Study||373
11154892|NCT01549587|12343093|FG000|COMPLETED|Overall Study||334
11154893|NCT01549587|12343094|FG001|COMPLETED|Overall Study||336
11154894|NCT01549587|12343093|FG000|NOT COMPLETED|Overall Study||39
11154895|NCT01549587|12343094|FG001|NOT COMPLETED|Overall Study||37
11154896|NCT01549613|12343102|FG000|STARTED|Overall Study||50
11154897|NCT01549613|12343103|FG001|STARTED|Overall Study||50
11154898|NCT01549613|12343102|FG000|COMPLETED|Overall Study||39
11154899|NCT01549613|12343103|FG001|COMPLETED|Overall Study||39
11154900|NCT01549613|12343102|FG000|NOT COMPLETED|Overall Study||11
11154901|NCT01549613|12343103|FG001|NOT COMPLETED|Overall Study||11
11154902|NCT01549652|12343112|FG000|STARTED|Overall Study||27
11154903|NCT01549652|12343113|FG001|STARTED|Overall Study||30
11154904|NCT01549652|12343114|FG002|STARTED|Overall Study||40
11154905|NCT01549652|12343115|FG003|STARTED|Overall Study||36
11154906|NCT01549652|12343112|FG000|COMPLETED|Overall Study||15
11154907|NCT01549652|12343113|FG001|COMPLETED|Overall Study||18
11154908|NCT01549652|12343114|FG002|COMPLETED|Overall Study||23
11154909|NCT01549652|12343115|FG003|COMPLETED|Overall Study||25
11154910|NCT01549652|12343112|FG000|NOT COMPLETED|Overall Study||12
11154911|NCT01549652|12343113|FG001|NOT COMPLETED|Overall Study||12
11154912|NCT01549652|12343114|FG002|NOT COMPLETED|Overall Study||17
11154913|NCT01549652|12343115|FG003|NOT COMPLETED|Overall Study||11
11154914|NCT01549860|12343123|FG000|STARTED|Overall Study||40
11154915|NCT01549860|12343124|FG001|STARTED|Overall Study||41
11154916|NCT01549860|12343123|FG000|COMPLETED|Overall Study||38
11154917|NCT01549860|12343124|FG001|COMPLETED|Overall Study||40
11154918|NCT01549860|12343123|FG000|NOT COMPLETED|Overall Study||2
11154919|NCT01549860|12343124|FG001|NOT COMPLETED|Overall Study||1
11154920|NCT01549873|12343132|FG000|STARTED|Overall Study||15
11154921|NCT01549873|12343133|FG001|STARTED|Overall Study||15
11154922|NCT01549873|12343132|FG000|COMPLETED|Overall Study||15
11154923|NCT01549873|12343133|FG001|COMPLETED|Overall Study||14
11154924|NCT01549873|12343132|FG000|NOT COMPLETED|Overall Study||0
11154925|NCT01549873|12343133|FG001|NOT COMPLETED|Overall Study||1
11154926|NCT01549886|12343141|FG000|STARTED|Overall Study||2
11154927|NCT01549886|12343142|FG001|STARTED|Overall Study||3
11154928|NCT01549886|12343141|FG000|COMPLETED|Overall Study||0
11154929|NCT01549886|12343142|FG001|COMPLETED|Overall Study||0
11154930|NCT01549886|12343141|FG000|NOT COMPLETED|Overall Study||2
11154931|NCT01549886|12343142|FG001|NOT COMPLETED|Overall Study||3
11154932|NCT01549925|12343152|FG000|STARTED|Overall Study||25
11154933|NCT01549925|12343153|FG001|STARTED|Overall Study||25
11154934|NCT01549925|12343152|FG000|COMPLETED|Overall Study||25
11154935|NCT01549925|12343153|FG001|COMPLETED|Overall Study||25
11154936|NCT01549925|12343152|FG000|NOT COMPLETED|Overall Study||0
11154937|NCT01549925|12343153|FG001|NOT COMPLETED|Overall Study||0
11154938|NCT01549951|12343159|FG000|STARTED|Overall Study||50
11154939|NCT01549951|12343159|FG000|Primary Reason Off Study Treatment|Overall Study||50
11154940|NCT01549951|12343159|FG000|COMPLETED|Overall Study||0
11154941|NCT01549951|12343159|FG000|NOT COMPLETED|Overall Study||50
11154942|NCT01549964|12343167|FG000|STARTED|24-Week Treatment Period||132
11154943|NCT01549964|12343168|FG001|STARTED|24-Week Treatment Period||260
11154944|NCT01549964|12343169|FG002|STARTED|24-Week Treatment Period||263
11154945|NCT01549964|12343170|FG003|STARTED|24-Week Treatment Period||261
11154946|NCT01549964|12343167|FG000|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
11418882|NCT00387244|12617297|FG000|COMPLETED|Overall Study||0
11418883|NCT00387244|12617297|FG000|NOT COMPLETED|Overall Study||7
11154947|NCT01549964|12343168|FG001|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
11154948|NCT01549964|12343169|FG002|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
11154949|NCT01549964|12343170|FG003|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
11154950|NCT01549964|12343167|FG000|COMPLETED|24-Week Treatment Period||71
11154951|NCT01549964|12343168|FG001|COMPLETED|24-Week Treatment Period||149
11154952|NCT01549964|12343169|FG002|COMPLETED|24-Week Treatment Period||147
11154953|NCT01549964|12343170|FG003|COMPLETED|24-Week Treatment Period||140
11154954|NCT01549964|12343167|FG000|NOT COMPLETED|24-Week Treatment Period||61
11154955|NCT01549964|12343168|FG001|NOT COMPLETED|24-Week Treatment Period||111
11154956|NCT01549964|12343169|FG002|NOT COMPLETED|24-Week Treatment Period||116
11154957|NCT01549964|12343170|FG003|NOT COMPLETED|24-Week Treatment Period||121
11154958|NCT01549964|12343167|FG000|STARTED|80-Week Extension Period||66
11154959|NCT01549964|12343168|FG001|STARTED|80-Week Extension Period||138
11154960|NCT01549964|12343169|FG002|STARTED|80-Week Extension Period||140
11154961|NCT01549964|12343170|FG003|STARTED|80-Week Extension Period||137
11154962|NCT01549964|12343167|FG000|COMPLETED|80-Week Extension Period||0
11154963|NCT01549964|12343168|FG001|COMPLETED|80-Week Extension Period||0
11154964|NCT01549964|12343169|FG002|COMPLETED|80-Week Extension Period||0
11154965|NCT01549964|12343170|FG003|COMPLETED|80-Week Extension Period||0
11154966|NCT01549964|12343167|FG000|NOT COMPLETED|80-Week Extension Period||66
11154967|NCT01549964|12343168|FG001|NOT COMPLETED|80-Week Extension Period||138
11154968|NCT01549964|12343169|FG002|NOT COMPLETED|80-Week Extension Period||140
11154969|NCT01549964|12343170|FG003|NOT COMPLETED|80-Week Extension Period||137
11154970|NCT01550224|12343182|FG000|STARTED|Overall Study||3
11154971|NCT01550224|12343183|FG001|STARTED|Overall Study||20
11154972|NCT01550224|12343182|FG000|COMPLETED|Overall Study||3
11154973|NCT01550224|12343183|FG001|COMPLETED|Overall Study||20
11154974|NCT01550224|12343182|FG000|NOT COMPLETED|Overall Study||0
11154975|NCT01550224|12343183|FG001|NOT COMPLETED|Overall Study||0
11154976|NCT01550341|12343191|FG000|STARTED|Overall Study||32
11154977|NCT01550341|12343192|FG001|STARTED|Overall Study||18
11154978|NCT01550341|12343191|FG000|COMPLETED|Overall Study||32
11154979|NCT01550341|12343192|FG001|COMPLETED|Overall Study||18
11154980|NCT01550341|12343191|FG000|NOT COMPLETED|Overall Study||0
11154981|NCT01550341|12343192|FG001|NOT COMPLETED|Overall Study||0
11154982|NCT01550367|12343198|FG000|STARTED|Overall Study||30
11154983|NCT01550367|12343198|FG000|1200 mg/d HCQ|Overall Study||13
11154984|NCT01550367|12343198|FG000|600 mg/d HCQ|Overall Study||17
11154985|NCT01550367|12343198|FG000|COMPLETED|Overall Study||30
11154986|NCT01550367|12343198|FG000|NOT COMPLETED|Overall Study||0
11154987|NCT01550471|12343207|FG000|STARTED|Run-In Period (3 Weeks)||3
11154988|NCT01550471|12343208|FG001|STARTED|Run-In Period (3 Weeks)||4
11154989|NCT01550471|12343209|FG002|STARTED|Run-In Period (3 Weeks)||3
11154990|NCT01550471|12343210|FG003|STARTED|Run-In Period (3 Weeks)||4
11154991|NCT01550471|12343211|FG004|STARTED|Run-In Period (3 Weeks)||4
11154992|NCT01550471|12343212|FG005|STARTED|Run-In Period (3 Weeks)||4
11154993|NCT01550471|12343207|FG000|COMPLETED|Run-In Period (3 Weeks)||3
11154994|NCT01550471|12343208|FG001|COMPLETED|Run-In Period (3 Weeks)||4
11154995|NCT01550471|12343209|FG002|COMPLETED|Run-In Period (3 Weeks)||3
11154996|NCT01550471|12343210|FG003|COMPLETED|Run-In Period (3 Weeks)||4
11154997|NCT01550471|12343211|FG004|COMPLETED|Run-In Period (3 Weeks)||4
11154998|NCT01550471|12343212|FG005|COMPLETED|Run-In Period (3 Weeks)||4
11154999|NCT01550471|12343207|FG000|NOT COMPLETED|Run-In Period (3 Weeks)||0
11155000|NCT01550471|12343208|FG001|NOT COMPLETED|Run-In Period (3 Weeks)||0
11155001|NCT01550471|12343209|FG002|NOT COMPLETED|Run-In Period (3 Weeks)||0
11155002|NCT01550471|12343210|FG003|NOT COMPLETED|Run-In Period (3 Weeks)||0
11155003|NCT01550471|12343211|FG004|NOT COMPLETED|Run-In Period (3 Weeks)||0
11155004|NCT01550471|12343212|FG005|NOT COMPLETED|Run-In Period (3 Weeks)||0
11155005|NCT01550471|12343207|FG000|STARTED|First Treatment Period (3 Weeks)||3
11155006|NCT01550471|12343208|FG001|STARTED|First Treatment Period (3 Weeks)||4
11155007|NCT01550471|12343209|FG002|STARTED|First Treatment Period (3 Weeks)||3
11155008|NCT01550471|12343210|FG003|STARTED|First Treatment Period (3 Weeks)||4
11155009|NCT01550471|12343211|FG004|STARTED|First Treatment Period (3 Weeks)||4
11155010|NCT01550471|12343212|FG005|STARTED|First Treatment Period (3 Weeks)||4
11155011|NCT01550471|12343207|FG000|COMPLETED|First Treatment Period (3 Weeks)||3
11155012|NCT01550471|12343208|FG001|COMPLETED|First Treatment Period (3 Weeks)||4
11155013|NCT01550471|12343209|FG002|COMPLETED|First Treatment Period (3 Weeks)||3
11155014|NCT01550471|12343210|FG003|COMPLETED|First Treatment Period (3 Weeks)||4
11155015|NCT01550471|12343211|FG004|COMPLETED|First Treatment Period (3 Weeks)||4
11155016|NCT01550471|12343212|FG005|COMPLETED|First Treatment Period (3 Weeks)||4
11155017|NCT01550471|12343207|FG000|NOT COMPLETED|First Treatment Period (3 Weeks)||0
11155018|NCT01550471|12343208|FG001|NOT COMPLETED|First Treatment Period (3 Weeks)||0
11155019|NCT01550471|12343209|FG002|NOT COMPLETED|First Treatment Period (3 Weeks)||0
11155020|NCT01550471|12343210|FG003|NOT COMPLETED|First Treatment Period (3 Weeks)||0
11155021|NCT01550471|12343211|FG004|NOT COMPLETED|First Treatment Period (3 Weeks)||0
11155022|NCT01550471|12343212|FG005|NOT COMPLETED|First Treatment Period (3 Weeks)||0
11155023|NCT01550471|12343207|FG000|STARTED|First Wash Out Period (3 Weeks)||3
11155024|NCT01550471|12343208|FG001|STARTED|First Wash Out Period (3 Weeks)||4
11155025|NCT01550471|12343209|FG002|STARTED|First Wash Out Period (3 Weeks)||3
11155026|NCT01550471|12343210|FG003|STARTED|First Wash Out Period (3 Weeks)||4
11155027|NCT01550471|12343211|FG004|STARTED|First Wash Out Period (3 Weeks)||4
11155028|NCT01550471|12343212|FG005|STARTED|First Wash Out Period (3 Weeks)||4
11155029|NCT01550471|12343207|FG000|COMPLETED|First Wash Out Period (3 Weeks)||3
11155030|NCT01550471|12343208|FG001|COMPLETED|First Wash Out Period (3 Weeks)||4
11155031|NCT01550471|12343209|FG002|COMPLETED|First Wash Out Period (3 Weeks)||3
11155032|NCT01550471|12343210|FG003|COMPLETED|First Wash Out Period (3 Weeks)||4
11155033|NCT01550471|12343211|FG004|COMPLETED|First Wash Out Period (3 Weeks)||4
11155034|NCT01550471|12343212|FG005|COMPLETED|First Wash Out Period (3 Weeks)||4
11155035|NCT01550471|12343207|FG000|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
11155036|NCT01550471|12343208|FG001|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
11155037|NCT01550471|12343209|FG002|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
11155038|NCT01550471|12343210|FG003|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
11155039|NCT01550471|12343211|FG004|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
11155040|NCT01550471|12343212|FG005|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
11155041|NCT01550471|12343207|FG000|STARTED|Second Treatment Period (3 Weeks)||3
11155042|NCT01550471|12343208|FG001|STARTED|Second Treatment Period (3 Weeks)||4
11155043|NCT01550471|12343209|FG002|STARTED|Second Treatment Period (3 Weeks)||3
11155044|NCT01550471|12343210|FG003|STARTED|Second Treatment Period (3 Weeks)||4
11155045|NCT01550471|12343211|FG004|STARTED|Second Treatment Period (3 Weeks)||4
11155046|NCT01550471|12343212|FG005|STARTED|Second Treatment Period (3 Weeks)||4
11155047|NCT01550471|12343207|FG000|COMPLETED|Second Treatment Period (3 Weeks)||3
11155048|NCT01550471|12343208|FG001|COMPLETED|Second Treatment Period (3 Weeks)||4
11155049|NCT01550471|12343209|FG002|COMPLETED|Second Treatment Period (3 Weeks)||3
11155050|NCT01550471|12343210|FG003|COMPLETED|Second Treatment Period (3 Weeks)||4
11155051|NCT01550471|12343211|FG004|COMPLETED|Second Treatment Period (3 Weeks)||4
11155052|NCT01550471|12343212|FG005|COMPLETED|Second Treatment Period (3 Weeks)||4
11155053|NCT01550471|12343207|FG000|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
11155054|NCT01550471|12343208|FG001|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
11155055|NCT01550471|12343209|FG002|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
11155056|NCT01550471|12343210|FG003|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
11155057|NCT01550471|12343211|FG004|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
11155058|NCT01550471|12343212|FG005|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
11155059|NCT01550471|12343207|FG000|STARTED|Second Wash Out Period (3 Weeks)||3
11155060|NCT01550471|12343208|FG001|STARTED|Second Wash Out Period (3 Weeks)||4
11155061|NCT01550471|12343209|FG002|STARTED|Second Wash Out Period (3 Weeks)||3
11155062|NCT01550471|12343210|FG003|STARTED|Second Wash Out Period (3 Weeks)||4
11155063|NCT01550471|12343211|FG004|STARTED|Second Wash Out Period (3 Weeks)||4
11155064|NCT01550471|12343212|FG005|STARTED|Second Wash Out Period (3 Weeks)||4
11155065|NCT01550471|12343207|FG000|COMPLETED|Second Wash Out Period (3 Weeks)||3
11155066|NCT01550471|12343208|FG001|COMPLETED|Second Wash Out Period (3 Weeks)||4
11155067|NCT01550471|12343209|FG002|COMPLETED|Second Wash Out Period (3 Weeks)||3
11155068|NCT01550471|12343210|FG003|COMPLETED|Second Wash Out Period (3 Weeks)||4
11155069|NCT01550471|12343211|FG004|COMPLETED|Second Wash Out Period (3 Weeks)||4
11155070|NCT01550471|12343212|FG005|COMPLETED|Second Wash Out Period (3 Weeks)||3
11155071|NCT01550471|12343207|FG000|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
11155072|NCT01550471|12343208|FG001|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
11155073|NCT01550471|12343209|FG002|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
11155074|NCT01550471|12343210|FG003|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
11155075|NCT01550471|12343211|FG004|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
11155076|NCT01550471|12343212|FG005|NOT COMPLETED|Second Wash Out Period (3 Weeks)||1
11155077|NCT01550471|12343207|FG000|STARTED|Third Treatment Period (3 Weeks)||3
11155078|NCT01550471|12343208|FG001|STARTED|Third Treatment Period (3 Weeks)||4
11155079|NCT01550471|12343209|FG002|STARTED|Third Treatment Period (3 Weeks)||3
11155080|NCT01550471|12343210|FG003|STARTED|Third Treatment Period (3 Weeks)||4
11155081|NCT01550471|12343211|FG004|STARTED|Third Treatment Period (3 Weeks)||4
11155082|NCT01550471|12343212|FG005|STARTED|Third Treatment Period (3 Weeks)||3
11155083|NCT01550471|12343207|FG000|COMPLETED|Third Treatment Period (3 Weeks)||3
11155084|NCT01550471|12343208|FG001|COMPLETED|Third Treatment Period (3 Weeks)||4
11155085|NCT01550471|12343209|FG002|COMPLETED|Third Treatment Period (3 Weeks)||3
11155086|NCT01550471|12343210|FG003|COMPLETED|Third Treatment Period (3 Weeks)||4
11155087|NCT01550471|12343211|FG004|COMPLETED|Third Treatment Period (3 Weeks)||4
11155088|NCT01550471|12343212|FG005|COMPLETED|Third Treatment Period (3 Weeks)||3
11155089|NCT01550471|12343207|FG000|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
11155090|NCT01550471|12343208|FG001|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
11155091|NCT01550471|12343209|FG002|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
11155092|NCT01550471|12343210|FG003|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
11155093|NCT01550471|12343211|FG004|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
11155094|NCT01550471|12343212|FG005|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
11155095|NCT01550471|12343207|FG000|STARTED|Third Wash Out Period (3 Weeks)||3
11155096|NCT01550471|12343208|FG001|STARTED|Third Wash Out Period (3 Weeks)||4
11155097|NCT01550471|12343209|FG002|STARTED|Third Wash Out Period (3 Weeks)||3
11155098|NCT01550471|12343210|FG003|STARTED|Third Wash Out Period (3 Weeks)||4
11155099|NCT01550471|12343211|FG004|STARTED|Third Wash Out Period (3 Weeks)||4
11155100|NCT01550471|12343212|FG005|STARTED|Third Wash Out Period (3 Weeks)||3
11155101|NCT01550471|12343207|FG000|COMPLETED|Third Wash Out Period (3 Weeks)||3
11155102|NCT01550471|12343208|FG001|COMPLETED|Third Wash Out Period (3 Weeks)||4
11155103|NCT01550471|12343209|FG002|COMPLETED|Third Wash Out Period (3 Weeks)||3
11155104|NCT01550471|12343210|FG003|COMPLETED|Third Wash Out Period (3 Weeks)||4
11155105|NCT01550471|12343211|FG004|COMPLETED|Third Wash Out Period (3 Weeks)||4
11155106|NCT01550471|12343212|FG005|COMPLETED|Third Wash Out Period (3 Weeks)||3
11155107|NCT01550471|12343207|FG000|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
11155108|NCT01550471|12343208|FG001|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
11155109|NCT01550471|12343209|FG002|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
11155110|NCT01550471|12343210|FG003|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
11155111|NCT01550471|12343211|FG004|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
11155112|NCT01550471|12343212|FG005|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
11155113|NCT01550549|12343221|FG000|STARTED|Overall Study||151
11155114|NCT01550549|12343221|FG000|COMPLETED|Overall Study||151
11155115|NCT01550549|12343221|FG000|NOT COMPLETED|Overall Study||0
11155116|NCT01550705|12343231|FG000|STARTED|Overall Study||11
11155117|NCT01550705|12343231|FG000|COMPLETED|Overall Study||10
11155118|NCT01550705|12343231|FG000|NOT COMPLETED|Overall Study||1
11155119|NCT01550731|12343237|FG000|STARTED|Overall Study||205
11155120|NCT01550731|12343238|FG001|STARTED|Overall Study||209
11155121|NCT01550731|12343237|FG000|COMPLETED|Overall Study||205
11155122|NCT01550731|12343238|FG001|COMPLETED|Overall Study||209
11155123|NCT01550731|12343237|FG000|NOT COMPLETED|Overall Study||0
11155124|NCT01550731|12343238|FG001|NOT COMPLETED|Overall Study||0
11155125|NCT01550744|12343244|FG000|STARTED|Open-Label||478
11155126|NCT01550744|12343245|FG001|STARTED|Open-Label||0
11155127|NCT01550744|12343246|FG002|STARTED|Open-Label||0
11155128|NCT01550744|12343244|FG000|COMPLETED|Open-Label||378
11155129|NCT01550744|12343245|FG001|COMPLETED|Open-Label||0
11155130|NCT01550744|12343246|FG002|COMPLETED|Open-Label||0
11155131|NCT01550744|12343244|FG000|NOT COMPLETED|Open-Label||100
11155132|NCT01550744|12343245|FG001|NOT COMPLETED|Open-Label||0
11155133|NCT01550744|12343246|FG002|NOT COMPLETED|Open-Label||0
11155134|NCT01550744|12343244|FG000|STARTED|Double-Blind||0
11155135|NCT01550744|12343245|FG001|STARTED|Double-Blind||76
11155136|NCT01550744|12343246|FG002|STARTED|Double-Blind||302
11155137|NCT01550744|12343244|FG000|COMPLETED|Double-Blind||0
11155138|NCT01550744|12343245|FG001|COMPLETED|Double-Blind||59
11155139|NCT01550744|12343246|FG002|COMPLETED|Double-Blind||235
11155140|NCT01550744|12343244|FG000|NOT COMPLETED|Double-Blind||0
11155141|NCT01550744|12343245|FG001|NOT COMPLETED|Double-Blind||17
11155142|NCT01550744|12343246|FG002|NOT COMPLETED|Double-Blind||67
11155143|NCT01550757|12343257|FG000|STARTED|Overall Study||56
11155144|NCT01550757|12343258|FG001|STARTED|Overall Study||52
11155145|NCT01550757|12343259|FG002|STARTED|Overall Study||130
11155146|NCT01550757|12343260|FG003|STARTED|Overall Study||144
11155147|NCT01550757|12343257|FG000|COMPLETED|Overall Study||33
11155148|NCT01550757|12343258|FG001|COMPLETED|Overall Study||38
11155149|NCT01550757|12343259|FG002|COMPLETED|Overall Study||85
11155150|NCT01550757|12343260|FG003|COMPLETED|Overall Study||90
11155151|NCT01550757|12343257|FG000|NOT COMPLETED|Overall Study||23
11155152|NCT01550757|12343258|FG001|NOT COMPLETED|Overall Study||14
11155153|NCT01550757|12343259|FG002|NOT COMPLETED|Overall Study||45
11155154|NCT01550757|12343260|FG003|NOT COMPLETED|Overall Study||54
11155155|NCT01550809|12343272|FG000|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
11155156|NCT01550809|12343273|FG001|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
11155157|NCT01550809|12343272|FG000|COMPLETED|Overall Study||6
11155158|NCT01550809|12343273|FG001|COMPLETED|Overall Study||6
11155159|NCT01550809|12343272|FG000|NOT COMPLETED|Overall Study||0
11155160|NCT01550809|12343273|FG001|NOT COMPLETED|Overall Study||0
11155161|NCT01550952|12343279|FG000|STARTED|Overall Study||10
11155162|NCT01550952|12343279|FG000|COMPLETED|Overall Study||10
11155163|NCT01550952|12343279|FG000|NOT COMPLETED|Overall Study||0
11155164|NCT01550965|12343283|FG000|STARTED|Overall Study||463
11155165|NCT01550965|12343283|FG000|COMPLETED|Overall Study||353
11155166|NCT01550965|12343283|FG000|NOT COMPLETED|Overall Study||110
11155167|NCT01551030|12343288|FG000|STARTED|Overall Study||19
11155168|NCT01551030|12343288|FG000|COMPLETED|Overall Study||19
11155169|NCT01551030|12343288|FG000|NOT COMPLETED|Overall Study||0
11155170|NCT01551056|12343294|FG000|STARTED|Overall Study||46
11155171|NCT01551056|12343295|FG001|STARTED|Overall Study||45
11155172|NCT01551056|12343294|FG000|COMPLETED|Overall Study||44
11155173|NCT01551056|12343295|FG001|COMPLETED|Overall Study||45
11155174|NCT01551056|12343294|FG000|NOT COMPLETED|Overall Study||2
11155175|NCT01551056|12343295|FG001|NOT COMPLETED|Overall Study||0
11155176|NCT01551095|12343301|FG000|STARTED|Overall Study||7
11155177|NCT01551095|12343301|FG000|COMPLETED|Overall Study||7
11155178|NCT01551095|12343301|FG000|NOT COMPLETED|Overall Study||0
11155179|NCT01551173|12343307|FG000|STARTED|Overall Study|"Started indicates randomized"|218
11155180|NCT01551173|12343308|FG001|STARTED|Overall Study||218
11155181|NCT01551173|12343307|FG000|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
11155182|NCT01551173|12343308|FG001|Full Analysis Set (FAS)|Overall Study||214
11155183|NCT01551173|12343307|FG000|COMPLETED|Overall Study||190
11155184|NCT01551173|12343308|FG001|COMPLETED|Overall Study||186
11155185|NCT01551173|12343307|FG000|NOT COMPLETED|Overall Study||28
11155186|NCT01551173|12343308|FG001|NOT COMPLETED|Overall Study||32
11155187|NCT01551186|12343317|FG000|STARTED|Overall Study||50
11155188|NCT01551186|12343318|FG001|STARTED|Overall Study||53
11155189|NCT01551186|12343317|FG000|COMPLETED|Overall Study||30
11155190|NCT01551186|12343318|FG001|COMPLETED|Overall Study||40
11155191|NCT01551186|12343317|FG000|NOT COMPLETED|Overall Study||20
11155192|NCT01551186|12343318|FG001|NOT COMPLETED|Overall Study||13
11155193|NCT01551199|12343324|FG000|STARTED|Overall Study||7
11155194|NCT01551199|12343324|FG000|COMPLETED|Overall Study||2
11155195|NCT01551199|12343324|FG000|NOT COMPLETED|Overall Study||5
11155196|NCT01551212|12343330|FG000|STARTED|Overall Study||171
11155197|NCT01551212|12343331|FG001|STARTED|Overall Study||168
11155198|NCT01551212|12343330|FG000|Full Anylsis Set (FAS)|Overall Study||169
11155199|NCT01551212|12343331|FG001|Full Anylsis Set (FAS)|Overall Study||164
11155200|NCT01551212|12343330|FG000|Safety Set|Overall Study||169
11155201|NCT01551212|12343331|FG001|Safety Set|Overall Study||164
11155202|NCT01551212|12343330|FG000|Per Protocol Set (PP)|Overall Study||110
11155203|NCT01551212|12343331|FG001|Per Protocol Set (PP)|Overall Study||101
11155204|NCT01551212|12343330|FG000|COMPLETED|Overall Study||166
11155205|NCT01551212|12343331|FG001|COMPLETED|Overall Study||148
11155206|NCT01551212|12343330|FG000|NOT COMPLETED|Overall Study||5
11155207|NCT01551212|12343331|FG001|NOT COMPLETED|Overall Study||20
11155208|NCT01551264|12343339|FG000|STARTED|Overall Study||70
11155209|NCT01551264|12343340|FG001|STARTED|Overall Study||69
11155210|NCT01551264|12343339|FG000|Started Bracing|Overall Study||69
11155211|NCT01551264|12343340|FG001|Started Bracing|Overall Study||67
11155212|NCT01551264|12343339|FG000|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|44
11155213|NCT01551264|12343340|FG001|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|55
11155214|NCT01551264|12343339|FG000|COMPLETED|Overall Study|Attended 60 month follow-up visit|38
11155215|NCT01551264|12343340|FG001|COMPLETED|Overall Study|Attended 36 month follow-up visit|41
11155216|NCT01551264|12343339|FG000|NOT COMPLETED|Overall Study||32
11155217|NCT01551264|12343340|FG001|NOT COMPLETED|Overall Study||28
11155218|NCT01551303|12343348|FG000|STARTED|Overall Study||25
11155219|NCT01551303|12343349|FG001|STARTED|Overall Study||22
11155220|NCT01551303|12343348|FG000|COMPLETED|Overall Study||21
11155221|NCT01551303|12343349|FG001|COMPLETED|Overall Study||15
11155222|NCT01551303|12343348|FG000|NOT COMPLETED|Overall Study||4
11155223|NCT01551303|12343349|FG001|NOT COMPLETED|Overall Study||7
11155224|NCT01551355|12343361|FG000|STARTED|Overall Study||622
11155225|NCT01551355|12343362|FG001|STARTED|Overall Study||594
11155226|NCT01551355|12343363|FG002|STARTED|Overall Study||493
11155227|NCT01551355|12343364|FG003|STARTED|Overall Study||435
11155228|NCT01551355|12343365|FG004|STARTED|Overall Study||64
11155229|NCT01551355|12343366|FG005|STARTED|Overall Study||71
11155230|NCT01551355|12343361|FG000|COMPLETED|Overall Study||571
11155231|NCT01551355|12343362|FG001|COMPLETED|Overall Study||545
11155232|NCT01551355|12343363|FG002|COMPLETED|Overall Study||459
11155233|NCT01551355|12343364|FG003|COMPLETED|Overall Study||411
11155234|NCT01551355|12343365|FG004|COMPLETED|Overall Study||55
11155235|NCT01551355|12343366|FG005|COMPLETED|Overall Study||65
11155236|NCT01551355|12343361|FG000|NOT COMPLETED|Overall Study||51
11155237|NCT01551355|12343362|FG001|NOT COMPLETED|Overall Study||49
11155238|NCT01551355|12343363|FG002|NOT COMPLETED|Overall Study||34
11155239|NCT01551355|12343364|FG003|NOT COMPLETED|Overall Study||24
11155240|NCT01551355|12343365|FG004|NOT COMPLETED|Overall Study||9
11155241|NCT01551355|12343366|FG005|NOT COMPLETED|Overall Study||6
11155242|NCT01551420|12343376|FG000|STARTED|In-laboratory (Part A)||39
11155243|NCT01551420|12343377|FG001|STARTED|In-laboratory (Part A)||13
11155244|NCT01551420|12343376|FG000|COMPLETED|In-laboratory (Part A)||33
11155245|NCT01551420|12343377|FG001|COMPLETED|In-laboratory (Part A)||11
11155246|NCT01551420|12343376|FG000|NOT COMPLETED|In-laboratory (Part A)||6
11155247|NCT01551420|12343377|FG001|NOT COMPLETED|In-laboratory (Part A)||2
11155248|NCT01551420|12343376|FG000|STARTED|Screened for Part B Eligibility||33
11155249|NCT01551420|12343377|FG001|STARTED|Screened for Part B Eligibility||11
11155250|NCT01551420|12343376|FG000|COMPLETED|Screened for Part B Eligibility||24
11155251|NCT01551420|12343377|FG001|COMPLETED|Screened for Part B Eligibility||8
11155252|NCT01551420|12343376|FG000|NOT COMPLETED|Screened for Part B Eligibility||9
11155253|NCT01551420|12343377|FG001|NOT COMPLETED|Screened for Part B Eligibility||3
11155254|NCT01551420|12343376|FG000|STARTED|Home Use (Part B)||24
11155255|NCT01551420|12343377|FG001|STARTED|Home Use (Part B)||8
11155256|NCT01551420|12343376|FG000|COMPLETED|Home Use (Part B)||18
11155257|NCT01551420|12343377|FG001|COMPLETED|Home Use (Part B)||7
11155258|NCT01551420|12343376|FG000|NOT COMPLETED|Home Use (Part B)||6
11155259|NCT01551420|12343377|FG001|NOT COMPLETED|Home Use (Part B)||1
11155260|NCT01551693|12343385|FG000|STARTED|Overall Study||1
11155261|NCT01551693|12343386|FG001|STARTED|Overall Study||2
11155262|NCT01551693|12343385|FG000|COMPLETED|Overall Study||0
11155263|NCT01551693|12343386|FG001|COMPLETED|Overall Study||0
11155264|NCT01551693|12343385|FG000|NOT COMPLETED|Overall Study||1
11155265|NCT01551693|12343386|FG001|NOT COMPLETED|Overall Study||2
11155266|NCT01551745|12343392|FG000|STARTED|Overall Study||5
11155267|NCT01551745|12343392|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
11155268|NCT01551745|12343392|FG000|NOT COMPLETED|Overall Study||3
11155269|NCT01551758|12343398|FG000|STARTED|Overall Study||1403
11155270|NCT01551758|12343399|FG001|STARTED|Overall Study||1396
11155271|NCT01551758|12343398|FG000|COMPLETED|Overall Study||1309
11155272|NCT01551758|12343399|FG001|COMPLETED|Overall Study||1291
11155273|NCT01551758|12343398|FG000|NOT COMPLETED|Overall Study||94
11155274|NCT01551758|12343399|FG001|NOT COMPLETED|Overall Study||105
11155275|NCT01551888|12343409|FG000|STARTED|Period 1||12
11418884|NCT00384293|12617303|FG000|STARTED|MK0524A Active Run-In, Pre-randomization||937
11418885|NCT00384293|12617304|FG001|STARTED|MK0524A Active Run-In, Pre-randomization||0
11418886|NCT00384293|12617305|FG002|STARTED|MK0524A Active Run-In, Pre-randomization||0
11418887|NCT00384293|12617303|FG000|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
11155276|NCT01551888|12343410|FG001|STARTED|Period 1||12
11155277|NCT01551888|12343409|FG000|COMPLETED|Period 1||12
11155278|NCT01551888|12343410|FG001|COMPLETED|Period 1||12
11155279|NCT01551888|12343409|FG000|NOT COMPLETED|Period 1||0
11155280|NCT01551888|12343410|FG001|NOT COMPLETED|Period 1||0
11155281|NCT01551888|12343409|FG000|STARTED|Period 2||12
11155282|NCT01551888|12343410|FG001|STARTED|Period 2||12
11155283|NCT01551888|12343409|FG000|COMPLETED|Period 2||12
11155284|NCT01551888|12343410|FG001|COMPLETED|Period 2||12
11155285|NCT01551888|12343409|FG000|NOT COMPLETED|Period 2||0
11155286|NCT01551888|12343410|FG001|NOT COMPLETED|Period 2||0
11155287|NCT01551979|12343418|FG000|STARTED|Overall Study||10
11155288|NCT01551979|12343419|FG001|STARTED|Overall Study||7
11155289|NCT01551979|12343418|FG000|Last Day of Treatment (After 5 Days)|Overall Study||10
11155290|NCT01551979|12343419|FG001|Last Day of Treatment (After 5 Days)|Overall Study||7
11155291|NCT01551979|12343418|FG000|1 Week Post Treatment|Overall Study||10
11155292|NCT01551979|12343419|FG001|1 Week Post Treatment|Overall Study||6
11155293|NCT01551979|12343418|FG000|COMPLETED|Overall Study||8
11155294|NCT01551979|12343419|FG001|COMPLETED|Overall Study||5
11155295|NCT01551979|12343418|FG000|NOT COMPLETED|Overall Study||2
11155296|NCT01551979|12343419|FG001|NOT COMPLETED|Overall Study||2
11155297|NCT01552057|12343427|FG000|STARTED|Overall Study||196
11155298|NCT01552057|12343428|FG001|STARTED|Overall Study||197
11155299|NCT01552057|12343427|FG000|Received at Least 1 Dose of Study Drug|Overall Study||194
11155300|NCT01552057|12343428|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
11155301|NCT01552057|12343427|FG000|COMPLETED|Overall Study||166
11155302|NCT01552057|12343428|FG001|COMPLETED|Overall Study||149
11155303|NCT01552057|12343427|FG000|NOT COMPLETED|Overall Study||30
11155304|NCT01552057|12343428|FG001|NOT COMPLETED|Overall Study||48
11155305|NCT01552213|12343436|FG000|STARTED|Overall Study||50
11155306|NCT01552213|12343437|FG001|STARTED|Overall Study||45
11155307|NCT01552213|12343436|FG000|Analyzed|Overall Study||42
11155308|NCT01552213|12343437|FG001|Analyzed|Overall Study||41
11155309|NCT01552213|12343436|FG000|COMPLETED|Overall Study||37
11155310|NCT01552213|12343437|FG001|COMPLETED|Overall Study||37
11155311|NCT01552213|12343436|FG000|NOT COMPLETED|Overall Study||13
11155312|NCT01552213|12343437|FG001|NOT COMPLETED|Overall Study||8
11155313|NCT01552343|12343445|FG000|STARTED|Overall Study||29
11155314|NCT01552343|12343446|FG001|STARTED|Overall Study||27
11155315|NCT01552343|12343445|FG000|COMPLETED|Overall Study||29
11155316|NCT01552343|12343446|FG001|COMPLETED|Overall Study||27
11155317|NCT01552343|12343445|FG000|NOT COMPLETED|Overall Study||0
11155318|NCT01552343|12343446|FG001|NOT COMPLETED|Overall Study||0
11155319|NCT01552369|12343463|FG000|STARTED|Overall Study||100
11155320|NCT01552369|12343464|FG001|STARTED|Overall Study||105
11155321|NCT01552369|12343463|FG000|One Year|Overall Study||100
11155322|NCT01552369|12343464|FG001|One Year|Overall Study||105
11155323|NCT01552369|12343463|FG000|Final Follow up|Overall Study||92
11155324|NCT01552369|12343464|FG001|Final Follow up|Overall Study||96
11155325|NCT01552369|12343463|FG000|COMPLETED|Overall Study||92
11155326|NCT01552369|12343464|FG001|COMPLETED|Overall Study||96
11155327|NCT01552369|12343463|FG000|NOT COMPLETED|Overall Study||8
11155328|NCT01552369|12343464|FG001|NOT COMPLETED|Overall Study||9
11155329|NCT01552408|12343474|FG000|STARTED|Overall Study||20
11155330|NCT01552408|12343475|FG001|STARTED|Overall Study||20
11155331|NCT01552408|12343474|FG000|COMPLETED|Overall Study||16
11155332|NCT01552408|12343475|FG001|COMPLETED|Overall Study||18
11155333|NCT01552408|12343474|FG000|NOT COMPLETED|Overall Study||4
11155334|NCT01552408|12343475|FG001|NOT COMPLETED|Overall Study||2
11155335|NCT01552603|12343482|FG000|STARTED|Overall Study||14
11155336|NCT01552603|12343482|FG000|COMPLETED|Overall Study||13
11155337|NCT01552603|12343482|FG000|NOT COMPLETED|Overall Study||1
11155338|NCT01552681|12343488|FG000|STARTED|Overall Study||33
11155339|NCT01552681|12343489|FG001|STARTED|Overall Study||19
11155340|NCT01552681|12343488|FG000|COMPLETED|Overall Study||28
11155341|NCT01552681|12343489|FG001|COMPLETED|Overall Study||18
11155342|NCT01552681|12343488|FG000|NOT COMPLETED|Overall Study||5
11155343|NCT01552681|12343489|FG001|NOT COMPLETED|Overall Study||1
11155344|NCT01552694|12343497|FG000|STARTED|Overall Study||18
11155345|NCT01552694|12343498|FG001|STARTED|Overall Study||20
11155346|NCT01552694|12343497|FG000|COMPLETED|Overall Study||18
11155347|NCT01552694|12343498|FG001|COMPLETED|Overall Study||18
11155348|NCT01552694|12343497|FG000|NOT COMPLETED|Overall Study||0
11155349|NCT01552694|12343498|FG001|NOT COMPLETED|Overall Study||2
11155350|NCT01552772|12343504|FG000|STARTED|Overall Study||60
11155351|NCT01552772|12343504|FG000|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
11155352|NCT01552772|12343504|FG000|NOT COMPLETED|Overall Study||4
11155353|NCT01552876|12343509|FG000|STARTED|Overall Study||20
11155354|NCT01552876|12343510|FG001|STARTED|Overall Study||20
11155355|NCT01552876|12343509|FG000|COMPLETED|Overall Study||20
11155356|NCT01552876|12343510|FG001|COMPLETED|Overall Study||20
11155357|NCT01552876|12343509|FG000|NOT COMPLETED|Overall Study||0
11155358|NCT01552876|12343510|FG001|NOT COMPLETED|Overall Study||0
11155359|NCT01552889|12343524|FG000|STARTED|Overall Study||101
11155360|NCT01552889|12343525|FG001|STARTED|Overall Study||100
11155361|NCT01552889|12343524|FG000|COMPLETED|Overall Study||90
11155362|NCT01552889|12343525|FG001|COMPLETED|Overall Study||95
11155363|NCT01552889|12343524|FG000|NOT COMPLETED|Overall Study||11
11155364|NCT01552889|12343525|FG001|NOT COMPLETED|Overall Study||5
11155365|NCT01552902|12343536|FG000|STARTED|Overall Study||110
11155366|NCT01552902|12343537|FG001|STARTED|Overall Study||218
11155367|NCT01552902|12343538|FG002|STARTED|Overall Study||219
11155368|NCT01552902|12343536|FG000|COMPLETED|Overall Study||97
11155369|NCT01552902|12343537|FG001|COMPLETED|Overall Study||181
11155370|NCT01552902|12343538|FG002|COMPLETED|Overall Study||186
11155371|NCT01552902|12343536|FG000|NOT COMPLETED|Overall Study||13
11155372|NCT01552902|12343537|FG001|NOT COMPLETED|Overall Study||37
11155373|NCT01552902|12343538|FG002|NOT COMPLETED|Overall Study||33
11203175|NCT01845831|12393671|FG000|COMPLETED|Outpatient Phase||0
11203176|NCT01845831|12393672|FG001|COMPLETED|Outpatient Phase||0
11203177|NCT01845831|12393673|FG002|COMPLETED|Outpatient Phase||68
11203178|NCT01845831|12393674|FG003|COMPLETED|Outpatient Phase||98
11203179|NCT01845831|12393675|FG004|COMPLETED|Outpatient Phase||87
11203180|NCT01845831|12393671|FG000|NOT COMPLETED|Outpatient Phase||0
11203181|NCT01845831|12393672|FG001|NOT COMPLETED|Outpatient Phase||0
11203182|NCT01845831|12393673|FG002|NOT COMPLETED|Outpatient Phase||0
11203183|NCT01845831|12393674|FG003|NOT COMPLETED|Outpatient Phase||0
11203184|NCT01845831|12393675|FG004|NOT COMPLETED|Outpatient Phase||0
11203185|NCT01845974|12393688|FG000|STARTED|Overall Study||4
11203186|NCT01845974|12393689|FG001|STARTED|Overall Study||9
11203187|NCT01845974|12393688|FG000|COMPLETED|Overall Study||3
11203188|NCT01845974|12393689|FG001|COMPLETED|Overall Study||9
11203189|NCT01845974|12393688|FG000|NOT COMPLETED|Overall Study||1
11203190|NCT01845974|12393689|FG001|NOT COMPLETED|Overall Study||0
11203191|NCT01846039|12393695|FG000|STARTED|Overall Study||29
11203192|NCT01846039|12393695|FG000|COMPLETED|Overall Study||27
11203193|NCT01846039|12393695|FG000|NOT COMPLETED|Overall Study||2
11203194|NCT01846104|12393699|FG000|STARTED|Overall Study||4
11203195|NCT01846104|12393699|FG000|COMPLETED|Overall Study||3
11203196|NCT01846104|12393699|FG000|NOT COMPLETED|Overall Study||1
11203197|NCT01846208|12393706|FG000|STARTED|Overall Study||28
11203198|NCT01846208|12393707|FG001|STARTED|Overall Study||24
11203199|NCT01846208|12393708|FG002|STARTED|Overall Study||40
11203200|NCT01846208|12393706|FG000|Initiatiated Treatment|Overall Study||27
11203201|NCT01846208|12393707|FG001|Initiatiated Treatment|Overall Study||23
11203202|NCT01846208|12393708|FG002|Initiatiated Treatment|Overall Study||39
11203203|NCT01846208|12393706|FG000|Year 1 Desensitization OFC|Overall Study||23
11203204|NCT01846208|12393707|FG001|Year 1 Desensitization OFC|Overall Study||20
11203205|NCT01846208|12393708|FG002|Year 1 Desensitization OFC|Overall Study||34
11203206|NCT01846208|12393706|FG000|Year 2 Desensitization OFC|Overall Study||19
11203207|NCT01846208|12393707|FG001|Year 2 Desensitization OFC|Overall Study||20
11203208|NCT01846208|12393708|FG002|Year 2 Desensitization OFC|Overall Study||33
11155374|NCT01552915|12343549|FG000|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
11155375|NCT01552915|12343550|FG001|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
11155376|NCT01552915|12343551|FG002|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
11155377|NCT01552915|12343549|FG000|COMPLETED|Overall Study||68
11155378|NCT01552915|12343550|FG001|COMPLETED|Overall Study||155
11155379|NCT01552915|12343551|FG002|COMPLETED|Overall Study||157
11155380|NCT01552915|12343549|FG000|NOT COMPLETED|Overall Study||23
11155381|NCT01552915|12343550|FG001|NOT COMPLETED|Overall Study||29
11155382|NCT01552915|12343551|FG002|NOT COMPLETED|Overall Study||27
11155383|NCT01552928|12343563|FG000|STARTED|Period 1||14
11155384|NCT01552928|12343564|FG001|STARTED|Period 1||15
11155385|NCT01552928|12343565|FG002|STARTED|Period 1||15
11155386|NCT01552928|12343566|FG003|STARTED|Period 1||16
11155387|NCT01552928|12343563|FG000|COMPLETED|Period 1||14
11155388|NCT01552928|12343564|FG001|COMPLETED|Period 1||15
11155389|NCT01552928|12343565|FG002|COMPLETED|Period 1||15
11155390|NCT01552928|12343566|FG003|COMPLETED|Period 1||16
11155391|NCT01552928|12343563|FG000|NOT COMPLETED|Period 1||0
11155392|NCT01552928|12343564|FG001|NOT COMPLETED|Period 1||0
11155393|NCT01552928|12343565|FG002|NOT COMPLETED|Period 1||0
11155394|NCT01552928|12343566|FG003|NOT COMPLETED|Period 1||0
11155395|NCT01552928|12343563|FG000|STARTED|Period 2||14
11155396|NCT01552928|12343564|FG001|STARTED|Period 2||15
11155397|NCT01552928|12343565|FG002|STARTED|Period 2||15
11155398|NCT01552928|12343566|FG003|STARTED|Period 2||16
11155399|NCT01552928|12343563|FG000|COMPLETED|Period 2||14
11155400|NCT01552928|12343564|FG001|COMPLETED|Period 2||15
11155401|NCT01552928|12343565|FG002|COMPLETED|Period 2||15
11155402|NCT01552928|12343566|FG003|COMPLETED|Period 2||16
11155403|NCT01552928|12343563|FG000|NOT COMPLETED|Period 2||0
11155404|NCT01552928|12343564|FG001|NOT COMPLETED|Period 2||0
11155405|NCT01552928|12343565|FG002|NOT COMPLETED|Period 2||0
11155406|NCT01552928|12343566|FG003|NOT COMPLETED|Period 2||0
11155407|NCT01552928|12343563|FG000|STARTED|Period 3||14
11155408|NCT01552928|12343564|FG001|STARTED|Period 3||15
11155409|NCT01552928|12343565|FG002|STARTED|Period 3||15
11155410|NCT01552928|12343566|FG003|STARTED|Period 3||16
11155411|NCT01552928|12343563|FG000|COMPLETED|Period 3||14
11155412|NCT01552928|12343564|FG001|COMPLETED|Period 3||15
11155413|NCT01552928|12343565|FG002|COMPLETED|Period 3||14
11155414|NCT01552928|12343566|FG003|COMPLETED|Period 3||16
11155415|NCT01552928|12343563|FG000|NOT COMPLETED|Period 3||0
11155416|NCT01552928|12343564|FG001|NOT COMPLETED|Period 3||0
11155417|NCT01552928|12343565|FG002|NOT COMPLETED|Period 3||1
11155418|NCT01552928|12343566|FG003|NOT COMPLETED|Period 3||0
11155419|NCT01552928|12343563|FG000|STARTED|Period 4||14
11155420|NCT01552928|12343564|FG001|STARTED|Period 4||15
11155421|NCT01552928|12343565|FG002|STARTED|Period 4||14
11155422|NCT01552928|12343566|FG003|STARTED|Period 4||16
11155423|NCT01552928|12343563|FG000|COMPLETED|Period 4||14
11155424|NCT01552928|12343564|FG001|COMPLETED|Period 4||15
11155425|NCT01552928|12343565|FG002|COMPLETED|Period 4||14
11155426|NCT01552928|12343566|FG003|COMPLETED|Period 4||16
11155427|NCT01552928|12343563|FG000|NOT COMPLETED|Period 4||0
11155428|NCT01552928|12343564|FG001|NOT COMPLETED|Period 4||0
11155429|NCT01552928|12343565|FG002|NOT COMPLETED|Period 4||0
11155430|NCT01552928|12343566|FG003|NOT COMPLETED|Period 4||0
11155431|NCT01552954|12343585|FG000|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
11155432|NCT01552954|12343586|FG001|STARTED|Overall Study||125
11155433|NCT01552954|12343585|FG000|COMPLETED|Overall Study||126
11155434|NCT01552954|12343586|FG001|COMPLETED|Overall Study||119
11155435|NCT01552954|12343585|FG000|NOT COMPLETED|Overall Study||5
11155436|NCT01552954|12343586|FG001|NOT COMPLETED|Overall Study||6
11155437|NCT01553058|12343595|FG000|STARTED|Overall Study||33
11155438|NCT01553058|12343596|FG001|STARTED|Overall Study||31
11155439|NCT01553058|12343597|FG002|STARTED|Overall Study||33
11155440|NCT01553058|12343595|FG000|COMPLETED|Overall Study||32
11155441|NCT01553058|12343596|FG001|COMPLETED|Overall Study||30
11155442|NCT01553058|12343597|FG002|COMPLETED|Overall Study||30
11155443|NCT01553058|12343595|FG000|NOT COMPLETED|Overall Study||1
11155444|NCT01553058|12343596|FG001|NOT COMPLETED|Overall Study||1
11155445|NCT01553058|12343597|FG002|NOT COMPLETED|Overall Study||3
11155446|NCT01553084|12343612|FG000|STARTED|Overall Study||241
11155447|NCT01553084|12343613|FG001|STARTED|Overall Study||421
11155448|NCT01553084|12343614|FG002|STARTED|Overall Study||424
11155449|NCT01553084|12343612|FG000|COMPLETED|Overall Study||226
11155450|NCT01553084|12343613|FG001|COMPLETED|Overall Study||408
11155451|NCT01553084|12343614|FG002|COMPLETED|Overall Study||389
11155452|NCT01553084|12343612|FG000|NOT COMPLETED|Overall Study||15
11155453|NCT01553084|12343613|FG001|NOT COMPLETED|Overall Study||13
11155454|NCT01553084|12343614|FG002|NOT COMPLETED|Overall Study||35
11155455|NCT01553136|12343626|FG000|STARTED|Overall Study||64
11155456|NCT01553136|12343627|FG001|STARTED|Overall Study||67
11155457|NCT01553136|12343626|FG000|Completed Treatment|Overall Study||55
11155458|NCT01553136|12343627|FG001|Completed Treatment|Overall Study||52
11155459|NCT01553136|12343626|FG000|COMPLETED|Overall Study||48
11155460|NCT01553136|12343627|FG001|COMPLETED|Overall Study||45
11155461|NCT01553136|12343626|FG000|NOT COMPLETED|Overall Study||16
11155462|NCT01553136|12343627|FG001|NOT COMPLETED|Overall Study||22
11155463|NCT01553188|12343637|FG000|STARTED|Overall Study||3
11155464|NCT01553188|12343638|FG001|STARTED|Overall Study||6
11155465|NCT01553188|12343639|FG002|STARTED|Overall Study||16
11155466|NCT01553188|12343640|FG003|STARTED|Overall Study||11
11155467|NCT01553188|12343637|FG000|COMPLETED|Overall Study||2
11155468|NCT01553188|12343638|FG001|COMPLETED|Overall Study||5
11155469|NCT01553188|12343639|FG002|COMPLETED|Overall Study||14
11155470|NCT01553188|12343640|FG003|COMPLETED|Overall Study||11
11155471|NCT01553188|12343637|FG000|NOT COMPLETED|Overall Study||1
11155472|NCT01553188|12343638|FG001|NOT COMPLETED|Overall Study||1
11155473|NCT01553188|12343639|FG002|NOT COMPLETED|Overall Study||2
11155474|NCT01553188|12343640|FG003|NOT COMPLETED|Overall Study||0
11155475|NCT01553201|12343655|FG000|STARTED|Overall Study||15
11155476|NCT01553201|12343656|FG001|STARTED|Overall Study||15
11155477|NCT01553201|12343655|FG000|COMPLETED|Overall Study||15
11155478|NCT01553201|12343656|FG001|COMPLETED|Overall Study||15
11155479|NCT01553201|12343655|FG000|NOT COMPLETED|Overall Study||0
11155480|NCT01553201|12343656|FG001|NOT COMPLETED|Overall Study||0
11155481|NCT01553279|12343664|FG000|STARTED|Part 1 (Infant Vaccinations)||142
11155482|NCT01553279|12343665|FG001|STARTED|Part 1 (Infant Vaccinations)||142
11155483|NCT01553279|12343664|FG000|COMPLETED|Part 1 (Infant Vaccinations)||140
11155484|NCT01553279|12343665|FG001|COMPLETED|Part 1 (Infant Vaccinations)||141
11155485|NCT01553279|12343664|FG000|NOT COMPLETED|Part 1 (Infant Vaccinations)||2
11155486|NCT01553279|12343665|FG001|NOT COMPLETED|Part 1 (Infant Vaccinations)||1
11155487|NCT01553279|12343664|FG000|STARTED|Interim Period||140
11155488|NCT01553279|12343665|FG001|STARTED|Interim Period||141
11155489|NCT01553279|12343664|FG000|COMPLETED|Interim Period||137
11155490|NCT01553279|12343665|FG001|COMPLETED|Interim Period||139
11155491|NCT01553279|12343664|FG000|NOT COMPLETED|Interim Period||3
11155492|NCT01553279|12343665|FG001|NOT COMPLETED|Interim Period||2
11155493|NCT01553279|12343664|FG000|STARTED|Period 2: Toddler Vaccinations||137
11155494|NCT01553279|12343665|FG001|STARTED|Period 2: Toddler Vaccinations||139
11155495|NCT01553279|12343664|FG000|COMPLETED|Period 2: Toddler Vaccinations||134
11155496|NCT01553279|12343665|FG001|COMPLETED|Period 2: Toddler Vaccinations||132
11155497|NCT01553279|12343664|FG000|NOT COMPLETED|Period 2: Toddler Vaccinations||3
11155498|NCT01553279|12343665|FG001|NOT COMPLETED|Period 2: Toddler Vaccinations||7
11155499|NCT01553292|12343672|FG000|STARTED|Overall Study||21
11155500|NCT01553292|12343672|FG000|COMPLETED|Overall Study||21
11155501|NCT01553292|12343672|FG000|NOT COMPLETED|Overall Study||0
11155502|NCT01553318|12343680|FG000|STARTED|Overall Study||24
11155503|NCT01553318|12343681|FG001|STARTED|Overall Study||27
11155504|NCT01553318|12343680|FG000|COMPLETED|Overall Study||21
11155505|NCT01553318|12343681|FG001|COMPLETED|Overall Study||25
11155506|NCT01553318|12343680|FG000|NOT COMPLETED|Overall Study||3
11155507|NCT01553318|12343681|FG001|NOT COMPLETED|Overall Study||2
11155508|NCT01553539|12343689|FG000|STARTED|Overall Study||20
11155509|NCT01553539|12343689|FG000|COMPLETED|Overall Study||20
11155510|NCT01553539|12343689|FG000|NOT COMPLETED|Overall Study||0
11155511|NCT01553591|12343696|FG000|STARTED|Overall Study||429
11155512|NCT01553591|12343697|FG001|STARTED|Overall Study||426
11155513|NCT01553591|12343698|FG002|STARTED|Overall Study||427
11155514|NCT01553591|12343696|FG000|Attended Week 12 Visit|Overall Study||341
11155515|NCT01553591|12343697|FG001|Attended Week 12 Visit|Overall Study||330
11155516|NCT01553591|12343698|FG002|Attended Week 12 Visit|Overall Study||342
11155517|NCT01553591|12343696|FG000|Attended Week 26 Visit|Overall Study||289
11155518|NCT01553591|12343697|FG001|Attended Week 26 Visit|Overall Study||291
11155519|NCT01553591|12343698|FG002|Attended Week 26 Visit|Overall Study||290
11155520|NCT01553591|12343696|FG000|COMPLETED|Overall Study||257
11155521|NCT01553591|12343697|FG001|COMPLETED|Overall Study||257
11155522|NCT01553591|12343698|FG002|COMPLETED|Overall Study||269
11155523|NCT01553591|12343696|FG000|NOT COMPLETED|Overall Study||172
11155524|NCT01553591|12343697|FG001|NOT COMPLETED|Overall Study||169
11155525|NCT01553591|12343698|FG002|NOT COMPLETED|Overall Study||158
11155526|NCT01553708|12343708|FG000|STARTED|Overall Study||17
11155527|NCT01553708|12343709|FG001|STARTED|Overall Study||17
11155528|NCT01553708|12343708|FG000|COMPLETED|Overall Study||17
11155529|NCT01553708|12343709|FG001|COMPLETED|Overall Study||17
11155530|NCT01553708|12343708|FG000|NOT COMPLETED|Overall Study||0
11155531|NCT01553708|12343709|FG001|NOT COMPLETED|Overall Study||0
11155532|NCT01553747|12343718|FG000|STARTED|Overall Study||381
11155533|NCT01553747|12343719|FG001|STARTED|Overall Study||383
11155534|NCT01553747|12343720|FG002|STARTED|Overall Study||382
11155535|NCT01553747|12343718|FG000|Attended Week 12 Visit|Overall Study||296
11155536|NCT01553747|12343719|FG001|Attended Week 12 Visit|Overall Study||301
11155537|NCT01553747|12343720|FG002|Attended Week 12 Visit|Overall Study||312
11155538|NCT01553747|12343718|FG000|Attended Week 26 Visit|Overall Study||259
11155539|NCT01553747|12343719|FG001|Attended Week 26 Visit|Overall Study||271
11155540|NCT01553747|12343720|FG002|Attended Week 26 Visit|Overall Study||278
11155541|NCT01553747|12343718|FG000|Participated in Blinded-Placebo Period|Overall Study||246
11155542|NCT01553747|12343719|FG001|Participated in Blinded-Placebo Period|Overall Study||253
11155543|NCT01553747|12343720|FG002|Participated in Blinded-Placebo Period|Overall Study||272
11155544|NCT01553747|12343718|FG000|COMPLETED|Overall Study||250
11155545|NCT01553747|12343719|FG001|COMPLETED|Overall Study||264
11155546|NCT01553747|12343720|FG002|COMPLETED|Overall Study||273
11155547|NCT01553747|12343718|FG000|NOT COMPLETED|Overall Study||131
11155548|NCT01553747|12343719|FG001|NOT COMPLETED|Overall Study||119
11155549|NCT01553747|12343720|FG002|NOT COMPLETED|Overall Study||109
11155550|NCT01553851|12343731|FG000|STARTED|Overall Study||20
11155551|NCT01553851|12343731|FG000|COMPLETED|Overall Study||17
11155552|NCT01553851|12343731|FG000|NOT COMPLETED|Overall Study||3
11155553|NCT01553916|12343735|FG000|STARTED|Overall Study||19
11155554|NCT01553916|12343735|FG000|COMPLETED|Overall Study||16
11155555|NCT01553916|12343735|FG000|NOT COMPLETED|Overall Study||3
11418888|NCT00384293|12617304|FG001|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
11418889|NCT00384293|12617305|FG002|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
11418890|NCT00384293|12617303|FG000|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
11418891|NCT00384293|12617304|FG001|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
11418892|NCT00384293|12617305|FG002|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
11155556|NCT01554176|12343741|FG000|STARTED|Treatment Phase||65
11155557|NCT01554176|12343742|FG001|STARTED|Treatment Phase||64
11155558|NCT01554176|12343743|FG002|STARTED|Treatment Phase||0
11155559|NCT01554176|12343744|FG003|STARTED|Treatment Phase||0
11155560|NCT01554176|12343745|FG004|STARTED|Treatment Phase||0
11155561|NCT01554176|12343741|FG000|Treated|Treatment Phase||64
11155562|NCT01554176|12343742|FG001|Treated|Treatment Phase||64
11155563|NCT01554176|12343743|FG002|Treated|Treatment Phase||0
11155564|NCT01554176|12343744|FG003|Treated|Treatment Phase||0
11155565|NCT01554176|12343745|FG004|Treated|Treatment Phase||0
11155566|NCT01554176|12343741|FG000|COMPLETED|Treatment Phase||57
11155567|NCT01554176|12343742|FG001|COMPLETED|Treatment Phase||59
11155568|NCT01554176|12343743|FG002|COMPLETED|Treatment Phase||0
11155569|NCT01554176|12343744|FG003|COMPLETED|Treatment Phase||0
11155570|NCT01554176|12343745|FG004|COMPLETED|Treatment Phase||0
11155571|NCT01554176|12343741|FG000|NOT COMPLETED|Treatment Phase||8
11026661|NCT00829621|12205252|FG001|NOT COMPLETED|Overall Study||4
11026662|NCT00829738|12205258|FG000|STARTED|Overall Study||4188
11155572|NCT01554176|12343742|FG001|NOT COMPLETED|Treatment Phase||5
11155573|NCT01554176|12343743|FG002|NOT COMPLETED|Treatment Phase||0
11155574|NCT01554176|12343744|FG003|NOT COMPLETED|Treatment Phase||0
11155575|NCT01554176|12343745|FG004|NOT COMPLETED|Treatment Phase||0
11155576|NCT01554176|12343741|FG000|STARTED|Run-out Phase||0
11155577|NCT01554176|12343742|FG001|STARTED|Run-out Phase||0
11155578|NCT01554176|12343743|FG002|STARTED|Run-out Phase||29
11155579|NCT01554176|12343744|FG003|STARTED|Run-out Phase||28
11155580|NCT01554176|12343745|FG004|STARTED|Run-out Phase||59
11155581|NCT01554176|12343741|FG000|Treated|Run-out Phase||0
11155582|NCT01554176|12343742|FG001|Treated|Run-out Phase||0
11155583|NCT01554176|12343743|FG002|Treated|Run-out Phase||29
11155584|NCT01554176|12343744|FG003|Treated|Run-out Phase||28
11155585|NCT01554176|12343745|FG004|Treated|Run-out Phase||59
11155586|NCT01554176|12343741|FG000|COMPLETED|Run-out Phase||0
11155587|NCT01554176|12343742|FG001|COMPLETED|Run-out Phase||0
11155588|NCT01554176|12343743|FG002|COMPLETED|Run-out Phase||29
11155589|NCT01554176|12343744|FG003|COMPLETED|Run-out Phase||27
11155590|NCT01554176|12343745|FG004|COMPLETED|Run-out Phase||59
11155591|NCT01554176|12343741|FG000|NOT COMPLETED|Run-out Phase||0
11155592|NCT01554176|12343742|FG001|NOT COMPLETED|Run-out Phase||0
11155593|NCT01554176|12343743|FG002|NOT COMPLETED|Run-out Phase||0
11155594|NCT01554176|12343744|FG003|NOT COMPLETED|Run-out Phase||1
11155595|NCT01554176|12343745|FG004|NOT COMPLETED|Run-out Phase||0
11155596|NCT01554241|12343761|FG000|STARTED|Overall Study||23
11155597|NCT01554241|12343762|FG001|STARTED|Overall Study||20
11155598|NCT01554241|12343763|FG002|STARTED|Overall Study||24
11155599|NCT01554241|12343764|FG003|STARTED|Overall Study||14
11155600|NCT01554241|12343761|FG000|COMPLETED|Overall Study||20
11155601|NCT01554241|12343762|FG001|COMPLETED|Overall Study||19
11155602|NCT01554241|12343763|FG002|COMPLETED|Overall Study||20
11155603|NCT01554241|12343764|FG003|COMPLETED|Overall Study||13
11155604|NCT01554241|12343761|FG000|NOT COMPLETED|Overall Study||3
11155605|NCT01554241|12343762|FG001|NOT COMPLETED|Overall Study||1
11155606|NCT01554241|12343763|FG002|NOT COMPLETED|Overall Study||4
11155607|NCT01554241|12343764|FG003|NOT COMPLETED|Overall Study||1
11155608|NCT01554371|12343777|FG000|STARTED|Overall Study||3
11155609|NCT01554371|12343778|FG001|STARTED|Overall Study||3
11155610|NCT01554371|12343779|FG002|STARTED|Overall Study||38
11155611|NCT01554371|12343777|FG000|COMPLETED|Overall Study||3
11155612|NCT01554371|12343778|FG001|COMPLETED|Overall Study||3
11155613|NCT01554371|12343779|FG002|COMPLETED|Overall Study||38
11155614|NCT01554371|12343777|FG000|NOT COMPLETED|Overall Study||0
11155615|NCT01554371|12343778|FG001|NOT COMPLETED|Overall Study||0
11155616|NCT01554371|12343779|FG002|NOT COMPLETED|Overall Study||0
11155617|NCT01554488|12343792|FG000|STARTED|Overall Study||13
11155618|NCT01554488|12343793|FG001|STARTED|Overall Study||12
11155619|NCT01554488|12343792|FG000|COMPLETED|Overall Study||12
11155620|NCT01554488|12343793|FG001|COMPLETED|Overall Study||9
11155621|NCT01554488|12343792|FG000|NOT COMPLETED|Overall Study||1
11155622|NCT01554488|12343793|FG001|NOT COMPLETED|Overall Study||3
11155623|NCT01554514|12343799|FG000|STARTED|Overall Study||19
11155624|NCT01554514|12343799|FG000|COMPLETED|Overall Study||17
11155625|NCT01554514|12343799|FG000|NOT COMPLETED|Overall Study||2
11155626|NCT01554527|12343806|FG000|STARTED|Overall Study||34
11155627|NCT01554527|12343807|FG001|STARTED|Overall Study||38
11155628|NCT01554527|12343808|FG002|STARTED|Overall Study||33
11155629|NCT01554527|12343806|FG000|Crossed Over to Control|Overall Study||0
11155630|NCT01554527|12343807|FG001|Crossed Over to Control|Overall Study||0
11155631|NCT01554527|12343808|FG002|Crossed Over to Control|Overall Study||2
11155632|NCT01554527|12343806|FG000|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0
11155633|NCT01554527|12343807|FG001|Had CPAP Titration|Overall Study||38
11155634|NCT01554527|12343808|FG002|Had CPAP Titration|Overall Study||30
11155635|NCT01554527|12343806|FG000|Initiated CPAP Treatment at Home|Overall Study||0
11155636|NCT01554527|12343807|FG001|Initiated CPAP Treatment at Home|Overall Study||38
11155637|NCT01554527|12343808|FG002|Initiated CPAP Treatment at Home|Overall Study||28
11155638|NCT01554527|12343806|FG000|Completed as a Control|Overall Study||33
11155639|NCT01554527|12343807|FG001|Completed as a Control|Overall Study||0
11155640|NCT01554527|12343808|FG002|Completed as a Control|Overall Study||1
11155641|NCT01554527|12343806|FG000|COMPLETED|Overall Study||33
11155642|NCT01554527|12343807|FG001|COMPLETED|Overall Study||38
11155643|NCT01554527|12343808|FG002|COMPLETED|Overall Study||25
11155644|NCT01554527|12343806|FG000|NOT COMPLETED|Overall Study||1
11155645|NCT01554527|12343807|FG001|NOT COMPLETED|Overall Study||0
11155646|NCT01554527|12343808|FG002|NOT COMPLETED|Overall Study||8
11155647|NCT01554579|12343819|FG000|STARTED|Overall Study||86
11155648|NCT01554579|12343820|FG001|STARTED|Overall Study||85
11155649|NCT01554579|12343819|FG000|COMPLETED|Overall Study||76
11155650|NCT01554579|12343820|FG001|COMPLETED|Overall Study||58
11155651|NCT01554579|12343819|FG000|NOT COMPLETED|Overall Study||10
11155652|NCT01554579|12343820|FG001|NOT COMPLETED|Overall Study||27
11155653|NCT01554618|12343829|FG000|STARTED|Randomized Through Start of Treatment||59
11155654|NCT01554618|12343830|FG001|STARTED|Randomized Through Start of Treatment||24
11155655|NCT01554618|12343829|FG000|COMPLETED|Randomized Through Start of Treatment||58
11155656|NCT01554618|12343830|FG001|COMPLETED|Randomized Through Start of Treatment||24
11155657|NCT01554618|12343829|FG000|NOT COMPLETED|Randomized Through Start of Treatment||1
11155658|NCT01554618|12343830|FG001|NOT COMPLETED|Randomized Through Start of Treatment||0
11155659|NCT01554618|12343829|FG000|STARTED|Controlled Assessment Period||58
11155660|NCT01554618|12343830|FG001|STARTED|Controlled Assessment Period||24
11155661|NCT01554618|12343829|FG000|COMPLETED|Controlled Assessment Period||50
11155662|NCT01554618|12343830|FG001|COMPLETED|Controlled Assessment Period||23
11155663|NCT01554618|12343829|FG000|NOT COMPLETED|Controlled Assessment Period||8
11155664|NCT01554618|12343830|FG001|NOT COMPLETED|Controlled Assessment Period||1
11155665|NCT01554618|12343829|FG000|STARTED|Open-Label Extension Period|1 patient who was noncompliant with study medication did not enter the open-label extension period|49
11155666|NCT01554618|12343830|FG001|STARTED|Open-Label Extension Period||23
11155667|NCT01554618|12343829|FG000|COMPLETED|Open-Label Extension Period||46
11155668|NCT01554618|12343830|FG001|COMPLETED|Open-Label Extension Period||18
11155669|NCT01554618|12343829|FG000|NOT COMPLETED|Open-Label Extension Period||3
11155670|NCT01554618|12343830|FG001|NOT COMPLETED|Open-Label Extension Period||5
11155671|NCT01554683|12343840|FG000|STARTED|Overall Study||2
11155672|NCT01554683|12343841|FG001|STARTED|Overall Study||1
11155673|NCT01554683|12343842|FG002|STARTED|Overall Study||3
11155674|NCT01554683|12343843|FG003|STARTED|Overall Study||2
11155675|NCT01554683|12343844|FG004|STARTED|Overall Study||1
11155676|NCT01554683|12343845|FG005|STARTED|Overall Study||0
11155677|NCT01554683|12343840|FG000|COMPLETED|Overall Study||2
11155678|NCT01554683|12343841|FG001|COMPLETED|Overall Study||1
11155679|NCT01554683|12343842|FG002|COMPLETED|Overall Study||3
11155680|NCT01554683|12343843|FG003|COMPLETED|Overall Study||2
11155681|NCT01554683|12343844|FG004|COMPLETED|Overall Study||1
11155682|NCT01554683|12343845|FG005|COMPLETED|Overall Study||0
11155683|NCT01554683|12343840|FG000|NOT COMPLETED|Overall Study||0
11155684|NCT01554683|12343841|FG001|NOT COMPLETED|Overall Study||0
11155685|NCT01554683|12343842|FG002|NOT COMPLETED|Overall Study||0
11155686|NCT01554683|12343843|FG003|NOT COMPLETED|Overall Study||0
11155687|NCT01554683|12343844|FG004|NOT COMPLETED|Overall Study||0
11155688|NCT01554683|12343845|FG005|NOT COMPLETED|Overall Study||0
11155689|NCT01554891|12343856|FG000|STARTED|Overall Study||105
11155690|NCT01554891|12343857|FG001|STARTED|Overall Study||120
11155691|NCT01554891|12343858|FG002|STARTED|Overall Study||57
11155692|NCT01554891|12343856|FG000|COMPLETED|Overall Study||98
11155693|NCT01554891|12343857|FG001|COMPLETED|Overall Study||115
11155694|NCT01554891|12343858|FG002|COMPLETED|Overall Study||55
11155695|NCT01554891|12343856|FG000|NOT COMPLETED|Overall Study||7
11155696|NCT01554891|12343857|FG001|NOT COMPLETED|Overall Study||5
11155697|NCT01554891|12343858|FG002|NOT COMPLETED|Overall Study||2
11155698|NCT01554904|12343866|FG000|STARTED|Overall Study||18
11155699|NCT01554904|12343866|FG000|Home Sleep Study 1|Overall Study|After informed consent signed.|18
11155700|NCT01554904|12343866|FG000|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
11155701|NCT01554904|12343866|FG000|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
11155702|NCT01554904|12343866|FG000|Home Sleep Study 2|Overall Study||14
11155703|NCT01554904|12343866|FG000|COMPLETED|Overall Study||14
11155704|NCT01554904|12343866|FG000|NOT COMPLETED|Overall Study||4
11155705|NCT01554982|12343870|FG000|STARTED|Overall Study||168
11155706|NCT01554982|12343870|FG000|Received Drug|Overall Study||166
11155707|NCT01554982|12343870|FG000|COMPLETED|Overall Study||125
11155708|NCT01554982|12343870|FG000|NOT COMPLETED|Overall Study||43
11155709|NCT01555125|12343877|FG000|STARTED|Induction Period||59
11155710|NCT01555125|12343878|FG001|STARTED|Induction Period||59
11155711|NCT01555125|12343879|FG002|STARTED|Induction Period||0
11155712|NCT01555125|12343880|FG003|STARTED|Induction Period||0
11155713|NCT01555125|12343881|FG004|STARTED|Induction Period||59
11155714|NCT01555125|12343877|FG000|COMPLETED|Induction Period||58
11155715|NCT01555125|12343878|FG001|COMPLETED|Induction Period||56
11155716|NCT01555125|12343879|FG002|COMPLETED|Induction Period||0
11155717|NCT01555125|12343880|FG003|COMPLETED|Induction Period||0
11155718|NCT01555125|12343881|FG004|COMPLETED|Induction Period||56
11155719|NCT01555125|12343877|FG000|NOT COMPLETED|Induction Period||1
11155720|NCT01555125|12343878|FG001|NOT COMPLETED|Induction Period||3
11322998|NCT02582749|12520292|FG000|STARTED|Overall Study||5
11322999|NCT02582749|12520293|FG001|STARTED|Overall Study||11
11323000|NCT02582749|12520292|FG000|COMPLETED|Overall Study||0
11323001|NCT02582749|12520293|FG001|COMPLETED|Overall Study||0
11323002|NCT02582749|12520292|FG000|NOT COMPLETED|Overall Study||5
11323003|NCT02582749|12520293|FG001|NOT COMPLETED|Overall Study||11
11323004|NCT02535247|12520301|FG000|STARTED|Overall Study||17
11323005|NCT02535247|12520302|FG001|STARTED|Overall Study||0
11323006|NCT02535247|12520301|FG000|COMPLETED|Overall Study||13
11323007|NCT02535247|12520302|FG001|COMPLETED|Overall Study||0
11323008|NCT02535247|12520301|FG000|NOT COMPLETED|Overall Study||4
11026663|NCT00829738|12205258|FG000|COMPLETED|Overall Study||4180
11026664|NCT00829738|12205258|FG000|NOT COMPLETED|Overall Study||8
11026665|NCT00829829|12205266|FG000|STARTED|Overall Study||80
11026666|NCT00829829|12205267|FG001|STARTED|Overall Study||80
11418893|NCT00384293|12617303|FG000|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
11323009|NCT02535247|12520302|FG001|NOT COMPLETED|Overall Study||0
11323010|NCT02499952|12520308|FG000|STARTED|Overall Study||12
11418894|NCT00384293|12617304|FG001|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
11418895|NCT00384293|12617305|FG002|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
11323011|NCT02499952|12520308|FG000|COMPLETED|Overall Study||2
11323012|NCT02499952|12520308|FG000|NOT COMPLETED|Overall Study||10
11323013|NCT02450331|12520314|FG000|STARTED|Overall Study||403
11323014|NCT02450331|12520315|FG001|STARTED|Overall Study||406
11323015|NCT02450331|12520314|FG000|COMPLETED|Overall Study||0
11323016|NCT02450331|12520315|FG001|COMPLETED|Overall Study||0
11323017|NCT02450331|12520314|FG000|NOT COMPLETED|Overall Study||403
11155721|NCT01555125|12343879|FG002|NOT COMPLETED|Induction Period||0
11155722|NCT01555125|12343880|FG003|NOT COMPLETED|Induction Period||0
11155723|NCT01555125|12343881|FG004|NOT COMPLETED|Induction Period||3
11155724|NCT01555125|12343877|FG000|STARTED|Maintenance Period||58
11155725|NCT01555125|12343878|FG001|STARTED|Maintenance Period||56
11155726|NCT01555125|12343879|FG002|STARTED|Maintenance Period||29
11155727|NCT01555125|12343880|FG003|STARTED|Maintenance Period||27
11155728|NCT01555125|12343881|FG004|STARTED|Maintenance Period||0
11155729|NCT01555125|12343877|FG000|COMPLETED|Maintenance Period||48
11155730|NCT01555125|12343878|FG001|COMPLETED|Maintenance Period||52
11155731|NCT01555125|12343879|FG002|COMPLETED|Maintenance Period||25
11155732|NCT01555125|12343880|FG003|COMPLETED|Maintenance Period||25
11155733|NCT01555125|12343881|FG004|COMPLETED|Maintenance Period||0
11155734|NCT01555125|12343877|FG000|NOT COMPLETED|Maintenance Period||10
11155735|NCT01555125|12343878|FG001|NOT COMPLETED|Maintenance Period||4
11155736|NCT01555125|12343879|FG002|NOT COMPLETED|Maintenance Period||4
11155737|NCT01555125|12343880|FG003|NOT COMPLETED|Maintenance Period||2
11155738|NCT01555125|12343881|FG004|NOT COMPLETED|Maintenance Period||0
11155739|NCT01555125|12343877|FG000|STARTED|Extension||46
11155740|NCT01555125|12343878|FG001|STARTED|Extension||51
11155741|NCT01555125|12343879|FG002|STARTED|Extension||23
11155742|NCT01555125|12343880|FG003|STARTED|Extension||23
11155743|NCT01555125|12343881|FG004|STARTED|Extension||0
11155744|NCT01555125|12343877|FG000|COMPLETED|Extension||1
11155745|NCT01555125|12343878|FG001|COMPLETED|Extension||0
11155746|NCT01555125|12343879|FG002|COMPLETED|Extension||0
11155747|NCT01555125|12343880|FG003|COMPLETED|Extension||1
11155748|NCT01555125|12343881|FG004|COMPLETED|Extension||0
11155749|NCT01555125|12343877|FG000|NOT COMPLETED|Extension||45
11155750|NCT01555125|12343878|FG001|NOT COMPLETED|Extension||51
11155751|NCT01555125|12343879|FG002|NOT COMPLETED|Extension||23
11155752|NCT01555125|12343880|FG003|NOT COMPLETED|Extension||22
11155753|NCT01555125|12343881|FG004|NOT COMPLETED|Extension||0
11155754|NCT01555125|12343877|FG000|STARTED|Follow-Up Period||36
11155755|NCT01555125|12343878|FG001|STARTED|Follow-Up Period||31
11155756|NCT01555125|12343879|FG002|STARTED|Follow-Up Period||19
11155757|NCT01555125|12343880|FG003|STARTED|Follow-Up Period||18
11155758|NCT01555125|12343881|FG004|STARTED|Follow-Up Period||0
11155759|NCT01555125|12343877|FG000|COMPLETED|Follow-Up Period||32
11155760|NCT01555125|12343878|FG001|COMPLETED|Follow-Up Period||30
11155761|NCT01555125|12343879|FG002|COMPLETED|Follow-Up Period||18
11155762|NCT01555125|12343880|FG003|COMPLETED|Follow-Up Period||17
11155763|NCT01555125|12343881|FG004|COMPLETED|Follow-Up Period||0
11155764|NCT01555125|12343877|FG000|NOT COMPLETED|Follow-Up Period||4
11155765|NCT01555125|12343878|FG001|NOT COMPLETED|Follow-Up Period||1
11155766|NCT01555125|12343879|FG002|NOT COMPLETED|Follow-Up Period||1
11155767|NCT01555125|12343880|FG003|NOT COMPLETED|Follow-Up Period||1
11155768|NCT01555125|12343881|FG004|NOT COMPLETED|Follow-Up Period||0
11155769|NCT01555138|12343898|FG000|STARTED|Overall Study||293
11155770|NCT01555138|12343899|FG001|STARTED|Overall Study||288
11155771|NCT01555138|12343898|FG000|COMPLETED|Overall Study||246
11155772|NCT01555138|12343899|FG001|COMPLETED|Overall Study||250
11155773|NCT01555138|12343898|FG000|NOT COMPLETED|Overall Study||47
11155774|NCT01555138|12343899|FG001|NOT COMPLETED|Overall Study||38
11155775|NCT01555151|12343909|FG000|STARTED|Overall Study||188
11155776|NCT01555151|12343910|FG001|STARTED|Overall Study||181
11155777|NCT01555151|12343911|FG002|STARTED|Overall Study||184
11155778|NCT01555151|12343912|FG003|STARTED|Overall Study||186
11155779|NCT01555151|12343909|FG000|Safety Set (SAF)|Overall Study||186
11155780|NCT01555151|12343910|FG001|Safety Set (SAF)|Overall Study||180
11155781|NCT01555151|12343911|FG002|Safety Set (SAF)|Overall Study||183
11155782|NCT01555151|12343912|FG003|Safety Set (SAF)|Overall Study||186
11155783|NCT01555151|12343909|FG000|COMPLETED|Overall Study||175
11155784|NCT01555151|12343910|FG001|COMPLETED|Overall Study||173
11155785|NCT01555151|12343911|FG002|COMPLETED|Overall Study||178
11155786|NCT01555151|12343912|FG003|COMPLETED|Overall Study||176
11155787|NCT01555151|12343909|FG000|NOT COMPLETED|Overall Study||13
11155788|NCT01555151|12343910|FG001|NOT COMPLETED|Overall Study||8
11155789|NCT01555151|12343911|FG002|NOT COMPLETED|Overall Study||6
11155790|NCT01555151|12343912|FG003|NOT COMPLETED|Overall Study||10
11155791|NCT01555164|12343925|FG000|STARTED|Overall Study||222
11155792|NCT01555164|12343926|FG001|STARTED|Overall Study||220
11155793|NCT01555164|12343925|FG000|COMPLETED|Overall Study||182
11155794|NCT01555164|12343926|FG001|COMPLETED|Overall Study||185
11155795|NCT01555164|12343925|FG000|NOT COMPLETED|Overall Study||40
11155796|NCT01555164|12343926|FG001|NOT COMPLETED|Overall Study||35
11155797|NCT01555463|12343934|FG000|STARTED|Treatment||483
11155798|NCT01555463|12343935|FG001|STARTED|Treatment||478
11155799|NCT01555463|12343934|FG000|COMPLETED|Treatment||419
11155800|NCT01555463|12343935|FG001|COMPLETED|Treatment||399
11155801|NCT01555463|12343934|FG000|NOT COMPLETED|Treatment||64
11155802|NCT01555463|12343935|FG001|NOT COMPLETED|Treatment||79
11155803|NCT01555463|12343934|FG000|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
11155804|NCT01555463|12343935|FG001|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
11155805|NCT01555463|12343934|FG000|COMPLETED|Follow up||409
11155806|NCT01555463|12343935|FG001|COMPLETED|Follow up||394
11155807|NCT01555463|12343934|FG000|NOT COMPLETED|Follow up||38
11155808|NCT01555463|12343935|FG001|NOT COMPLETED|Follow up||45
11155809|NCT01555567|12343945|FG000|STARTED|12 Week||12
11155810|NCT01555567|12343946|FG001|STARTED|12 Week||13
11155811|NCT01555567|12343947|FG002|STARTED|12 Week||9
11155812|NCT01555567|12343948|FG003|STARTED|12 Week||9
11155813|NCT01555567|12343945|FG000|COMPLETED|12 Week||11
11155814|NCT01555567|12343946|FG001|COMPLETED|12 Week||12
11155815|NCT01555567|12343947|FG002|COMPLETED|12 Week||8
11155816|NCT01555567|12343948|FG003|COMPLETED|12 Week||9
11155817|NCT01555567|12343945|FG000|NOT COMPLETED|12 Week||1
11155818|NCT01555567|12343946|FG001|NOT COMPLETED|12 Week||1
11155819|NCT01555567|12343947|FG002|NOT COMPLETED|12 Week||1
11155820|NCT01555567|12343948|FG003|NOT COMPLETED|12 Week||0
11155821|NCT01555567|12343945|FG000|STARTED|Return to Activity||11
11155822|NCT01555567|12343946|FG001|STARTED|Return to Activity||12
11155823|NCT01555567|12343947|FG002|STARTED|Return to Activity||8
11155824|NCT01555567|12343948|FG003|STARTED|Return to Activity||9
11155825|NCT01555567|12343945|FG000|COMPLETED|Return to Activity||10
11155826|NCT01555567|12343946|FG001|COMPLETED|Return to Activity||10
11155827|NCT01555567|12343947|FG002|COMPLETED|Return to Activity||8
11155828|NCT01555567|12343948|FG003|COMPLETED|Return to Activity||8
11155829|NCT01555567|12343945|FG000|NOT COMPLETED|Return to Activity||1
11155830|NCT01555567|12343946|FG001|NOT COMPLETED|Return to Activity||2
11155831|NCT01555567|12343947|FG002|NOT COMPLETED|Return to Activity||0
11155832|NCT01555567|12343948|FG003|NOT COMPLETED|Return to Activity||1
11155833|NCT01555671|12343960|FG000|STARTED|Overall Study||125
11155834|NCT01555671|12343961|FG001|STARTED|Overall Study||125
11155835|NCT01555671|12343960|FG000|COMPLETED|Overall Study||105
11155836|NCT01555671|12343961|FG001|COMPLETED|Overall Study||100
11155837|NCT01555671|12343960|FG000|NOT COMPLETED|Overall Study||20
11155838|NCT01555671|12343961|FG001|NOT COMPLETED|Overall Study||25
11155839|NCT01555762|12343969|FG000|STARTED|Overall Study||402
11155840|NCT01555762|12343969|FG000|Safety Population|Overall Study||383
11155841|NCT01555762|12343969|FG000|Efficacy Population|Overall Study||358
11155842|NCT01555762|12343969|FG000|COMPLETED|Overall Study||128
11155843|NCT01555762|12343969|FG000|NOT COMPLETED|Overall Study||274
11155844|NCT01555931|12343975|FG000|STARTED|Overall Study||17
11155845|NCT01555931|12343976|FG001|STARTED|Overall Study||18
11155846|NCT01555931|12343975|FG000|COMPLETED|Overall Study||15
11155847|NCT01555931|12343976|FG001|COMPLETED|Overall Study||13
11155848|NCT01555931|12343975|FG000|NOT COMPLETED|Overall Study||2
11155849|NCT01555931|12343976|FG001|NOT COMPLETED|Overall Study||5
11155850|NCT01555957|12343984|FG000|STARTED|Overall Study||20
11155851|NCT01555957|12343985|FG001|STARTED|Overall Study||20
11155852|NCT01555957|12343984|FG000|COMPLETED|Overall Study||20
11155853|NCT01555957|12343985|FG001|COMPLETED|Overall Study||20
11155854|NCT01555957|12343984|FG000|NOT COMPLETED|Overall Study||0
11155855|NCT01555957|12343985|FG001|NOT COMPLETED|Overall Study||0
11155856|NCT01555983|12343991|FG000|STARTED|Overall Study||9
11155857|NCT01555983|12343992|FG001|STARTED|Overall Study||7
11155858|NCT01555983|12343993|FG002|STARTED|Overall Study||7
11155859|NCT01555983|12343994|FG003|STARTED|Overall Study||7
11155860|NCT01555983|12343995|FG004|STARTED|Overall Study||5
11155861|NCT01555983|12343996|FG005|STARTED|Overall Study||7
11155862|NCT01555983|12343991|FG000|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
11155863|NCT01555983|12343992|FG001|COMPLETED|Overall Study||7
11155864|NCT01555983|12343993|FG002|COMPLETED|Overall Study||7
11155865|NCT01555983|12343994|FG003|COMPLETED|Overall Study||7
11155866|NCT01555983|12343995|FG004|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
11155867|NCT01555983|12343996|FG005|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
11155868|NCT01555983|12343991|FG000|NOT COMPLETED|Overall Study||1
11155869|NCT01555983|12343992|FG001|NOT COMPLETED|Overall Study||0
11155870|NCT01555983|12343993|FG002|NOT COMPLETED|Overall Study||0
11155871|NCT01555983|12343994|FG003|NOT COMPLETED|Overall Study||0
11155872|NCT01555983|12343995|FG004|NOT COMPLETED|Overall Study||1
11155873|NCT01555983|12343996|FG005|NOT COMPLETED|Overall Study||1
11155874|NCT01556061|12344006|FG000|STARTED|Overall Study||25
11155875|NCT01556061|12344007|FG001|STARTED|Overall Study||25
11155876|NCT01556061|12344006|FG000|COMPLETED|Overall Study||25
11155877|NCT01556061|12344007|FG001|COMPLETED|Overall Study||25
11155878|NCT01556061|12344006|FG000|NOT COMPLETED|Overall Study||0
11155879|NCT01556061|12344007|FG001|NOT COMPLETED|Overall Study||0
11155880|NCT01556100|12344015|FG000|STARTED|Overall Study||40
11155881|NCT01556100|12344015|FG000|COMPLETED|Overall Study||34
11155882|NCT01556100|12344015|FG000|NOT COMPLETED|Overall Study||6
11155883|NCT01556165|12344021|FG000|STARTED|Overall Study||65
11155884|NCT01556165|12344022|FG001|STARTED|Overall Study||65
11155885|NCT01556165|12344021|FG000|COMPLETED|Overall Study||53
11155886|NCT01556165|12344022|FG001|COMPLETED|Overall Study||58
11155887|NCT01556165|12344021|FG000|NOT COMPLETED|Overall Study||12
11155888|NCT01556165|12344022|FG001|NOT COMPLETED|Overall Study||7
11155889|NCT01556204|12344030|FG000|STARTED|Overall Study||35
11155890|NCT01556204|12344031|FG001|STARTED|Overall Study||38
11155891|NCT01556204|12344030|FG000|COMPLETED|Overall Study||35
11155892|NCT01556204|12344031|FG001|COMPLETED|Overall Study||38
11155893|NCT01556204|12344030|FG000|NOT COMPLETED|Overall Study||0
11155894|NCT01556204|12344031|FG001|NOT COMPLETED|Overall Study||0
11155895|NCT01556347|12344037|FG000|STARTED|Induction Immunotherapy||2
11155896|NCT01556347|12344037|FG000|COMPLETED|Induction Immunotherapy||2
11155897|NCT01556347|12344037|FG000|NOT COMPLETED|Induction Immunotherapy||0
11155898|NCT01556347|12344037|FG000|STARTED|Bortezomib Treatment Phase||2
11155899|NCT01556347|12344037|FG000|COMPLETED|Bortezomib Treatment Phase||2
11155900|NCT01556347|12344037|FG000|NOT COMPLETED|Bortezomib Treatment Phase||0
11155901|NCT01556347|12344037|FG000|STARTED|Recovery Phase||2
11155902|NCT01556347|12344037|FG000|COMPLETED|Recovery Phase||2
11155903|NCT01556347|12344037|FG000|NOT COMPLETED|Recovery Phase||0
11155904|NCT01556425|12344069|FG000|STARTED|Overall Study||25
11155905|NCT01556425|12344070|FG001|STARTED|Overall Study||23
11155906|NCT01556425|12344071|FG002|STARTED|Overall Study||18
11155907|NCT01556425|12344072|FG003|STARTED|Overall Study||18
11155908|NCT01556425|12344069|FG000|COMPLETED|Overall Study||25
11155909|NCT01556425|12344070|FG001|COMPLETED|Overall Study||23
11155910|NCT01556425|12344071|FG002|COMPLETED|Overall Study||18
11155911|NCT01556425|12344072|FG003|COMPLETED|Overall Study||18
11155912|NCT01556425|12344069|FG000|NOT COMPLETED|Overall Study||0
11155913|NCT01556425|12344070|FG001|NOT COMPLETED|Overall Study||0
11155914|NCT01556425|12344071|FG002|NOT COMPLETED|Overall Study||0
11155915|NCT01556425|12344072|FG003|NOT COMPLETED|Overall Study||0
11155916|NCT01556438|12344084|FG000|STARTED|Overall Study||4
11155917|NCT01556438|12344085|FG001|STARTED|Overall Study||12
11155918|NCT01556438|12344084|FG000|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4
11155919|NCT01556438|12344085|FG001|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12
11155920|NCT01556438|12344084|FG000|Received BTZ IV|Overall Study||4
11155921|NCT01556438|12344085|FG001|Received BTZ IV|Overall Study||4
11155922|NCT01556438|12344084|FG000|Received BTZ SC|Overall Study||0
11155923|NCT01556438|12344085|FG001|Received BTZ SC|Overall Study||8
11155924|NCT01556438|12344084|FG000|COMPLETED|Overall Study||0
11155925|NCT01556438|12344085|FG001|COMPLETED|Overall Study||1
11155926|NCT01556438|12344084|FG000|NOT COMPLETED|Overall Study||4
11155927|NCT01556438|12344085|FG001|NOT COMPLETED|Overall Study||11
11155928|NCT01556451|12344099|FG000|STARTED|Overall Study||180
11155929|NCT01556451|12344099|FG000|COMPLETED|Overall Study||180
11155930|NCT01556451|12344099|FG000|NOT COMPLETED|Overall Study||0
11155931|NCT01556581|12344105|FG000|STARTED|Overall Study||61
11155932|NCT01556581|12344106|FG001|STARTED|Overall Study||58
11155933|NCT01556581|12344105|FG000|COMPLETED|Overall Study||61
11155934|NCT01556581|12344106|FG001|COMPLETED|Overall Study||58
11155935|NCT01556581|12344105|FG000|NOT COMPLETED|Overall Study||0
11155936|NCT01556581|12344106|FG001|NOT COMPLETED|Overall Study||0
11155937|NCT01556594|12344115|FG000|STARTED|Overall Study||10
11155938|NCT01556594|12344116|FG001|STARTED|Overall Study||2
11155939|NCT01556594|12344117|FG002|STARTED|Overall Study||6
11155940|NCT01556594|12344115|FG000|COMPLETED|Overall Study||10
11155941|NCT01556594|12344116|FG001|COMPLETED|Overall Study||2
11155942|NCT01556594|12344117|FG002|COMPLETED|Overall Study||6
11155943|NCT01556594|12344115|FG000|NOT COMPLETED|Overall Study||0
11155944|NCT01556594|12344116|FG001|NOT COMPLETED|Overall Study||0
11155945|NCT01556594|12344117|FG002|NOT COMPLETED|Overall Study||0
11155946|NCT01556633|12344129|FG000|STARTED|Overall Study||10
11155947|NCT01556633|12344130|FG001|STARTED|Overall Study||6
11155948|NCT01556633|12344129|FG000|COMPLETED|Overall Study||10
11155949|NCT01556633|12344130|FG001|COMPLETED|Overall Study||6
11155950|NCT01556633|12344129|FG000|NOT COMPLETED|Overall Study||0
11155951|NCT01556633|12344130|FG001|NOT COMPLETED|Overall Study||0
11155952|NCT01556724|12344141|FG000|STARTED|Overall Study||16
11155953|NCT01556724|12344142|FG001|STARTED|Overall Study||14
11155954|NCT01556724|12344141|FG000|COMPLETED|Overall Study||16
11155955|NCT01556724|12344142|FG001|COMPLETED|Overall Study||14
11155956|NCT01556724|12344141|FG000|NOT COMPLETED|Overall Study||0
11155957|NCT01556724|12344142|FG001|NOT COMPLETED|Overall Study||0
11155958|NCT01556763|12344154|FG000|STARTED|Overall Study||4
11155959|NCT01556763|12344155|FG001|STARTED|Overall Study||9
11155960|NCT01556763|12344156|FG002|STARTED|Overall Study||8
11155961|NCT01556763|12344154|FG000|COMPLETED|Overall Study||4
11155962|NCT01556763|12344155|FG001|COMPLETED|Overall Study||8
11155963|NCT01556763|12344156|FG002|COMPLETED|Overall Study||8
11155964|NCT01556763|12344154|FG000|NOT COMPLETED|Overall Study||0
11155965|NCT01556763|12344155|FG001|NOT COMPLETED|Overall Study||1
11155966|NCT01556763|12344156|FG002|NOT COMPLETED|Overall Study||0
11155967|NCT01556906|12344166|FG000|STARTED|Overall Study||6
11155968|NCT01556906|12344166|FG000|COMPLETED|Overall Study||6
11155969|NCT01556906|12344166|FG000|NOT COMPLETED|Overall Study||0
11155970|NCT01556932|12344170|FG000|STARTED|Baseline First Treatment||13
11155971|NCT01556932|12344171|FG001|STARTED|Baseline First Treatment||9
11155972|NCT01556932|12344170|FG000|Recieved|Baseline First Treatment||13
11155973|NCT01556932|12344171|FG001|Recieved|Baseline First Treatment||9
11155974|NCT01556932|12344170|FG000|COMPLETED|Baseline First Treatment||13
11155975|NCT01556932|12344171|FG001|COMPLETED|Baseline First Treatment||9
11155976|NCT01556932|12344170|FG000|NOT COMPLETED|Baseline First Treatment||0
11155977|NCT01556932|12344171|FG001|NOT COMPLETED|Baseline First Treatment||0
11155978|NCT01556932|12344170|FG000|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
11155979|NCT01556932|12344171|FG001|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
11155980|NCT01556932|12344170|FG000|Recieved|Time Point 60 Minutes||12
11155981|NCT01556932|12344171|FG001|Recieved|Time Point 60 Minutes||8
11155982|NCT01556932|12344170|FG000|COMPLETED|Time Point 60 Minutes||12
11155983|NCT01556932|12344171|FG001|COMPLETED|Time Point 60 Minutes||8
11155984|NCT01556932|12344170|FG000|NOT COMPLETED|Time Point 60 Minutes||1
11155985|NCT01556932|12344171|FG001|NOT COMPLETED|Time Point 60 Minutes||1
11155986|NCT01556932|12344170|FG000|STARTED|Second Treament||12
11155987|NCT01556932|12344171|FG001|STARTED|Second Treament||8
11155988|NCT01556932|12344170|FG000|Recieved|Second Treament||12
11155989|NCT01556932|12344171|FG001|Recieved|Second Treament||8
11155990|NCT01556932|12344170|FG000|COMPLETED|Second Treament||12
11155991|NCT01556932|12344171|FG001|COMPLETED|Second Treament||8
11155992|NCT01556932|12344170|FG000|NOT COMPLETED|Second Treament||0
11155993|NCT01556932|12344171|FG001|NOT COMPLETED|Second Treament||0
11155994|NCT01556997|12344179|FG000|STARTED|Overall Study||279
11155995|NCT01556997|12344180|FG001|STARTED|Overall Study||280
11155996|NCT01556997|12344181|FG002|STARTED|Overall Study||278
11155997|NCT01556997|12344179|FG000|COMPLETED|Overall Study||253
11155998|NCT01556997|12344180|FG001|COMPLETED|Overall Study||252
11155999|NCT01556997|12344181|FG002|COMPLETED|Overall Study||246
11156000|NCT01556997|12344179|FG000|NOT COMPLETED|Overall Study||26
11156001|NCT01556997|12344180|FG001|NOT COMPLETED|Overall Study||28
11156002|NCT01556997|12344181|FG002|NOT COMPLETED|Overall Study||32
11156003|NCT01557166|12344191|FG000|STARTED|Overall Study||180
11156004|NCT01557166|12344192|FG001|STARTED|Overall Study||179
11156005|NCT01557166|12344191|FG000|Exposed|Overall Study||176
11156006|NCT01557166|12344192|FG001|Exposed|Overall Study||179
11156007|NCT01557166|12344191|FG000|COMPLETED|Overall Study||134
11156008|NCT01557166|12344192|FG001|COMPLETED|Overall Study||142
11156009|NCT01557166|12344191|FG000|NOT COMPLETED|Overall Study||46
11156010|NCT01557166|12344192|FG001|NOT COMPLETED|Overall Study||37
11156011|NCT01557244|12344203|FG000|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
11156012|NCT01557244|12344204|FG001|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
11156013|NCT01557244|12344205|FG002|STARTED|Active Comparator/Efficacy Phase:12Weeks||40
11156014|NCT01557244|12344206|FG003|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
11156015|NCT01557244|12344207|FG004|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
11156016|NCT01557244|12344208|FG005|STARTED|Active Comparator/Efficacy Phase:12Weeks||28
11156017|NCT01557244|12344209|FG006|STARTED|Active Comparator/Efficacy Phase:12Weeks||29
11156018|NCT01557244|12344203|FG000|Treated|Active Comparator/Efficacy Phase:12Weeks||42
11156019|NCT01557244|12344204|FG001|Treated|Active Comparator/Efficacy Phase:12Weeks||42
11156020|NCT01557244|12344205|FG002|Treated|Active Comparator/Efficacy Phase:12Weeks||40
11156021|NCT01557244|12344206|FG003|Treated|Active Comparator/Efficacy Phase:12Weeks||0
11156022|NCT01557244|12344207|FG004|Treated|Active Comparator/Efficacy Phase:12Weeks||0
11156023|NCT01557244|12344208|FG005|Treated|Active Comparator/Efficacy Phase:12Weeks||28
11156024|NCT01557244|12344209|FG006|Treated|Active Comparator/Efficacy Phase:12Weeks||29
11156025|NCT01557244|12344203|FG000|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||33
11156026|NCT01557244|12344204|FG001|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||40
11156027|NCT01557244|12344205|FG002|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||36
11156028|NCT01557244|12344206|FG003|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
11156029|NCT01557244|12344207|FG004|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
11156030|NCT01557244|12344208|FG005|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||21
11156031|NCT01557244|12344209|FG006|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||28
11156032|NCT01557244|12344203|FG000|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||9
11156033|NCT01557244|12344204|FG001|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||2
11156034|NCT01557244|12344205|FG002|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||4
11156035|NCT01557244|12344206|FG003|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
11156036|NCT01557244|12344207|FG004|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
11156037|NCT01557244|12344208|FG005|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||7
11156038|NCT01557244|12344209|FG006|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||1
11156039|NCT01557244|12344203|FG000|STARTED|Safety Extension Phase: 12 Weeks||33
11156040|NCT01557244|12344204|FG001|STARTED|Safety Extension Phase: 12 Weeks||40
11156041|NCT01557244|12344205|FG002|STARTED|Safety Extension Phase: 12 Weeks|Did not receive oxybutynin in safety extension phase.|0
11156042|NCT01557244|12344206|FG003|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|16
11156043|NCT01557244|12344207|FG004|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|20
11156044|NCT01557244|12344208|FG005|STARTED|Safety Extension Phase: 12 Weeks||21
11156045|NCT01557244|12344209|FG006|STARTED|Safety Extension Phase: 12 Weeks||28
11156046|NCT01557244|12344203|FG000|Treated|Safety Extension Phase: 12 Weeks||30
11156047|NCT01557244|12344204|FG001|Treated|Safety Extension Phase: 12 Weeks||37
11156048|NCT01557244|12344205|FG002|Treated|Safety Extension Phase: 12 Weeks||0
11156049|NCT01557244|12344206|FG003|Treated|Safety Extension Phase: 12 Weeks||16
11156050|NCT01557244|12344207|FG004|Treated|Safety Extension Phase: 12 Weeks||20
11156051|NCT01557244|12344208|FG005|Treated|Safety Extension Phase: 12 Weeks||20
11156052|NCT01557244|12344209|FG006|Treated|Safety Extension Phase: 12 Weeks||28
11156053|NCT01557244|12344203|FG000|COMPLETED|Safety Extension Phase: 12 Weeks||30
11156054|NCT01557244|12344204|FG001|COMPLETED|Safety Extension Phase: 12 Weeks||36
11156055|NCT01557244|12344205|FG002|COMPLETED|Safety Extension Phase: 12 Weeks||0
11156056|NCT01557244|12344206|FG003|COMPLETED|Safety Extension Phase: 12 Weeks||15
11156057|NCT01557244|12344207|FG004|COMPLETED|Safety Extension Phase: 12 Weeks||20
11156058|NCT01557244|12344208|FG005|COMPLETED|Safety Extension Phase: 12 Weeks||20
11156059|NCT01557244|12344209|FG006|COMPLETED|Safety Extension Phase: 12 Weeks||28
11156060|NCT01557244|12344203|FG000|NOT COMPLETED|Safety Extension Phase: 12 Weeks||3
11156061|NCT01557244|12344204|FG001|NOT COMPLETED|Safety Extension Phase: 12 Weeks||4
11156062|NCT01557244|12344205|FG002|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
11156063|NCT01557244|12344206|FG003|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
11156064|NCT01557244|12344207|FG004|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
11156065|NCT01557244|12344208|FG005|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
11156066|NCT01557244|12344209|FG006|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
11156067|NCT01557283|12344237|FG000|STARTED|Overall Study||140
11156068|NCT01557283|12344237|FG000|COMPLETED|Overall Study||96
11156069|NCT01557283|12344237|FG000|NOT COMPLETED|Overall Study||44
11156070|NCT01557322|12344243|FG000|STARTED|Overall Study||211
11156071|NCT01557322|12344244|FG001|STARTED|Overall Study||1543
11156072|NCT01557322|12344243|FG000|COMPLETED|Overall Study||211
11156073|NCT01557322|12344244|FG001|COMPLETED|Overall Study||1543
11156074|NCT01557322|12344243|FG000|NOT COMPLETED|Overall Study||0
11156075|NCT01557322|12344244|FG001|NOT COMPLETED|Overall Study||0
11156076|NCT01557348|12344252|FG000|STARTED|Overall Study||604
11156077|NCT01557348|12344253|FG001|STARTED|Overall Study||507
11156078|NCT01557348|12344252|FG000|Safety Population|Overall Study||604
11156079|NCT01557348|12344253|FG001|Safety Population|Overall Study||507
11156080|NCT01557348|12344252|FG000|COMPLETED|Overall Study||524
11156081|NCT01557348|12344253|FG001|COMPLETED|Overall Study||417
11156082|NCT01557348|12344252|FG000|NOT COMPLETED|Overall Study||80
11156083|NCT01557348|12344253|FG001|NOT COMPLETED|Overall Study||90
11156084|NCT01557400|12344260|FG000|STARTED|Overall Study||94
11156085|NCT01557400|12344260|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94
11156086|NCT01557400|12344260|FG000|COMPLETED|Overall Study||37
11156087|NCT01557400|12344260|FG000|NOT COMPLETED|Overall Study||57
11156088|NCT01557452|12344264|FG000|STARTED|Overall Study||1
11156089|NCT01557452|12344264|FG000|COMPLETED|Overall Study||1
11156090|NCT01557452|12344264|FG000|NOT COMPLETED|Overall Study||0
11156091|NCT01557504|12344271|FG000|STARTED|Overall Study||13
11156092|NCT01557504|12344272|FG001|STARTED|Overall Study||12
11156093|NCT01557504|12344271|FG000|COMPLETED|Overall Study||12
11156094|NCT01557504|12344272|FG001|COMPLETED|Overall Study||12
11156095|NCT01557504|12344271|FG000|NOT COMPLETED|Overall Study||1
11156096|NCT01557504|12344272|FG001|NOT COMPLETED|Overall Study||0
11156097|NCT01557517|12344286|FG000|STARTED|Overall Study||19
11156098|NCT01557517|12344287|FG001|STARTED|Overall Study||21
11156099|NCT01557517|12344286|FG000|COMPLETED|Overall Study||17
11156100|NCT01557517|12344287|FG001|COMPLETED|Overall Study||17
11156101|NCT01557517|12344286|FG000|NOT COMPLETED|Overall Study||2
11156102|NCT01557517|12344287|FG001|NOT COMPLETED|Overall Study||4
11156103|NCT01557569|12344302|FG000|STARTED|Overall Study|Those who received at least one dose of medication|6
11156104|NCT01557569|12344303|FG001|STARTED|Overall Study|Those who received at least one dose of medication|7
11156105|NCT01557569|12344302|FG000|Completed 2-wk Residential Stay|Overall Study||3
11156106|NCT01557569|12344303|FG001|Completed 2-wk Residential Stay|Overall Study||1
11156107|NCT01557569|12344302|FG000|COMPLETED|Overall Study||1
11156108|NCT01557569|12344303|FG001|COMPLETED|Overall Study||0
11156109|NCT01557569|12344302|FG000|NOT COMPLETED|Overall Study||5
11156110|NCT01557569|12344303|FG001|NOT COMPLETED|Overall Study||7
11156111|NCT01557582|12344309|FG000|STARTED|Overall Study||103
11156112|NCT01557582|12344309|FG000|COMPLETED|Overall Study||97
11156113|NCT01557582|12344309|FG000|NOT COMPLETED|Overall Study||6
11156114|NCT01557595|12344313|FG000|STARTED|Overall Study||22
11156115|NCT01557595|12344313|FG000|COMPLETED|Overall Study||14
11156116|NCT01557595|12344313|FG000|NOT COMPLETED|Overall Study||8
11156117|NCT01557699|12344320|FG000|STARTED|Overall Study||20
11156118|NCT01557699|12344321|FG001|STARTED|Overall Study||20
11156119|NCT01557699|12344322|FG002|STARTED|Overall Study||20
11156120|NCT01557699|12344320|FG000|COMPLETED|Overall Study||20
11156121|NCT01557699|12344321|FG001|COMPLETED|Overall Study||20
11156122|NCT01557699|12344322|FG002|COMPLETED|Overall Study||20
11156123|NCT01557699|12344320|FG000|NOT COMPLETED|Overall Study||0
11156124|NCT01557699|12344321|FG001|NOT COMPLETED|Overall Study||0
11156125|NCT01557699|12344322|FG002|NOT COMPLETED|Overall Study||0
11156126|NCT01557790|12344333|FG000|STARTED|Overall Study||5
11156127|NCT01557790|12344333|FG000|COMPLETED|Overall Study||4
11156128|NCT01557790|12344333|FG000|NOT COMPLETED|Overall Study||1
11156129|NCT01557842|12344339|FG000|STARTED|Overall Study||9
11156130|NCT01557842|12344340|FG001|STARTED|Overall Study||6
11156131|NCT01557842|12344339|FG000|COMPLETED|Overall Study||0
11156132|NCT01557842|12344340|FG001|COMPLETED|Overall Study||0
11156133|NCT01557842|12344339|FG000|NOT COMPLETED|Overall Study||9
11156134|NCT01557842|12344340|FG001|NOT COMPLETED|Overall Study||6
11156135|NCT01557868|12344348|FG000|STARTED|Overall Study||103
11156136|NCT01557868|12344349|FG001|STARTED|Overall Study||95
11156137|NCT01557868|12344348|FG000|COMPLETED|Overall Study||76
11156138|NCT01557868|12344349|FG001|COMPLETED|Overall Study||65
11026667|NCT00829829|12205268|FG002|STARTED|Overall Study||81
11026668|NCT00829829|12205266|FG000|Treated|Overall Study||79
11026669|NCT00829829|12205267|FG001|Treated|Overall Study||80
11026670|NCT00829829|12205268|FG002|Treated|Overall Study||81
11026671|NCT00829829|12205266|FG000|COMPLETED|Overall Study||58
11026672|NCT00829829|12205267|FG001|COMPLETED|Overall Study||64
11026673|NCT00829829|12205268|FG002|COMPLETED|Overall Study||70
11026674|NCT00829829|12205266|FG000|NOT COMPLETED|Overall Study||22
11026675|NCT00829829|12205267|FG001|NOT COMPLETED|Overall Study||16
11156139|NCT01557868|12344348|FG000|NOT COMPLETED|Overall Study||27
11156140|NCT01557868|12344349|FG001|NOT COMPLETED|Overall Study||30
11156141|NCT01557894|12344357|FG000|STARTED|Overall Study||38
11156142|NCT01557894|12344358|FG001|STARTED|Overall Study||38
11156143|NCT01557894|12344357|FG000|COMPLETED|Overall Study||35
11156144|NCT01557894|12344358|FG001|COMPLETED|Overall Study||33
11156145|NCT01557894|12344357|FG000|NOT COMPLETED|Overall Study||3
11156146|NCT01557894|12344358|FG001|NOT COMPLETED|Overall Study||5
11156147|NCT01557920|12344365|FG000|STARTED|Overall Study||9
11156148|NCT01557920|12344366|FG001|STARTED|Overall Study||9
11156149|NCT01557920|12344365|FG000|COMPLETED|Overall Study||6
11156150|NCT01557920|12344366|FG001|COMPLETED|Overall Study||6
11156151|NCT01557920|12344365|FG000|NOT COMPLETED|Overall Study||3
11156152|NCT01557920|12344366|FG001|NOT COMPLETED|Overall Study||3
11156153|NCT01557946|12344401|FG000|STARTED|Overall Study||20
11156154|NCT01557946|12344402|FG001|STARTED|Overall Study||12
11156155|NCT01557946|12344401|FG000|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
11156156|NCT01557946|12344402|FG001|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
11156157|NCT01557946|12344401|FG000|NOT COMPLETED|Overall Study||3
11156158|NCT01557946|12344402|FG001|NOT COMPLETED|Overall Study||0
11156159|NCT01557959|12344407|FG000|STARTED|Overall Study||45
11156160|NCT01557959|12344407|FG000|COMPLETED|Overall Study||45
11156161|NCT01557959|12344407|FG000|NOT COMPLETED|Overall Study||0
11156162|NCT01558063|12344419|FG000|STARTED|Overall Study||5
11156163|NCT01558063|12344420|FG001|STARTED|Overall Study||6
11156164|NCT01558063|12344421|FG002|STARTED|Overall Study||8
11156165|NCT01558063|12344422|FG003|STARTED|Overall Study||5
11156166|NCT01558063|12344423|FG004|STARTED|Overall Study||9
11156167|NCT01558063|12344424|FG005|STARTED|Overall Study||5
11156168|NCT01558063|12344419|FG000|COMPLETED|Overall Study||5
11156169|NCT01558063|12344420|FG001|COMPLETED|Overall Study||6
11156170|NCT01558063|12344421|FG002|COMPLETED|Overall Study||8
11156171|NCT01558063|12344422|FG003|COMPLETED|Overall Study||5
11156172|NCT01558063|12344423|FG004|COMPLETED|Overall Study||9
11156173|NCT01558063|12344424|FG005|COMPLETED|Overall Study||5
11156174|NCT01558063|12344419|FG000|NOT COMPLETED|Overall Study||0
11156175|NCT01558063|12344420|FG001|NOT COMPLETED|Overall Study||0
11156176|NCT01558063|12344421|FG002|NOT COMPLETED|Overall Study||0
11156177|NCT01558063|12344422|FG003|NOT COMPLETED|Overall Study||0
11156178|NCT01558063|12344423|FG004|NOT COMPLETED|Overall Study||0
11156179|NCT01558063|12344424|FG005|NOT COMPLETED|Overall Study||0
11156180|NCT01558089|12344433|FG000|STARTED|Overall Study||76
11156181|NCT01558089|12344433|FG000|COMPLETED|Overall Study||63
11156182|NCT01558089|12344433|FG000|NOT COMPLETED|Overall Study||13
11156183|NCT01558128|12344437|FG000|STARTED|Overall Study||1
11156184|NCT01558128|12344437|FG000|COMPLETED|Overall Study||1
11156185|NCT01558128|12344437|FG000|NOT COMPLETED|Overall Study||0
11156186|NCT01558271|12344444|FG000|STARTED|Overall Study||281
11156187|NCT01558271|12344445|FG001|STARTED|Overall Study||70
11156188|NCT01558271|12344446|FG002|STARTED|Overall Study||141
11156189|NCT01558271|12344444|FG000|Received at Least 1 Dose of Study Drug|Overall Study||280
11156190|NCT01558271|12344445|FG001|Received at Least 1 Dose of Study Drug|Overall Study||70
11156191|NCT01558271|12344446|FG002|Received at Least 1 Dose of Study Drug|Overall Study||137
11156192|NCT01558271|12344444|FG000|Completed 26 Weeks|Overall Study||271
11156193|NCT01558271|12344445|FG001|Completed 26 Weeks|Overall Study||63
11156194|NCT01558271|12344446|FG002|Completed 26 Weeks|Overall Study||128
11156195|NCT01558271|12344444|FG000|COMPLETED|Overall Study||263
11156196|NCT01558271|12344445|FG001|COMPLETED|Overall Study||59
11156197|NCT01558271|12344446|FG002|COMPLETED|Overall Study||124
11156198|NCT01558271|12344444|FG000|NOT COMPLETED|Overall Study||18
11156199|NCT01558271|12344445|FG001|NOT COMPLETED|Overall Study||11
11156200|NCT01558271|12344446|FG002|NOT COMPLETED|Overall Study||17
11156201|NCT01558297|12344461|FG000|STARTED|Overall Study||30
11156202|NCT01558297|12344462|FG001|STARTED|Overall Study||29
11156203|NCT01558297|12344463|FG002|STARTED|Overall Study||30
11156204|NCT01558297|12344461|FG000|COMPLETED|Overall Study||28
11156205|NCT01558297|12344462|FG001|COMPLETED|Overall Study||27
11156206|NCT01558297|12344463|FG002|COMPLETED|Overall Study||29
11156207|NCT01558297|12344461|FG000|NOT COMPLETED|Overall Study||2
11156208|NCT01558297|12344462|FG001|NOT COMPLETED|Overall Study||2
11156209|NCT01558297|12344463|FG002|NOT COMPLETED|Overall Study||1
11156210|NCT01558596|12344473|FG000|STARTED|Overall Study||104
11156211|NCT01558596|12344474|FG001|STARTED|Overall Study||101
11156212|NCT01558596|12344473|FG000|COMPLETED|Overall Study||101
11156213|NCT01558596|12344474|FG001|COMPLETED|Overall Study||100
11156214|NCT01558596|12344473|FG000|NOT COMPLETED|Overall Study||3
11156215|NCT01558596|12344474|FG001|NOT COMPLETED|Overall Study||1
11156216|NCT01558635|12344480|FG000|STARTED|Overall Study||17
11156217|NCT01558635|12344480|FG000|Treated|Overall Study||17
11156218|NCT01558635|12344480|FG000|Discharge /1 Month Post-procedure|Overall Study||15
11156219|NCT01558635|12344480|FG000|3 Months Post-procedure|Overall Study||14
11156220|NCT01558635|12344480|FG000|6 Months Post-procedure|Overall Study||14
11156221|NCT01558635|12344480|FG000|COMPLETED|Overall Study||11
11156222|NCT01558635|12344480|FG000|NOT COMPLETED|Overall Study||6
11156223|NCT01558661|12344491|FG000|STARTED|Overall Study||33
11156224|NCT01558661|12344491|FG000|First Stage|Overall Study||18
11156225|NCT01558661|12344491|FG000|Second Stage|Overall Study||15
11156226|NCT01558661|12344491|FG000|COMPLETED|Overall Study||33
11156227|NCT01558661|12344491|FG000|NOT COMPLETED|Overall Study||0
11156228|NCT01558674|12344497|FG000|STARTED|Part 1||11
11156229|NCT01558674|12344498|FG001|STARTED|Part 1||0
11156230|NCT01558674|12344497|FG000|COMPLETED|Part 1||0
11156231|NCT01558674|12344498|FG001|COMPLETED|Part 1||0
11156232|NCT01558674|12344497|FG000|NOT COMPLETED|Part 1||11
11156233|NCT01558674|12344498|FG001|NOT COMPLETED|Part 1||0
11156234|NCT01558674|12344497|FG000|STARTED|Part 2||0
11156235|NCT01558674|12344498|FG001|STARTED|Part 2||0
11156236|NCT01558674|12344497|FG000|COMPLETED|Part 2||0
11156237|NCT01558674|12344498|FG001|COMPLETED|Part 2||0
11156238|NCT01558674|12344497|FG000|NOT COMPLETED|Part 2||0
11156239|NCT01558674|12344498|FG001|NOT COMPLETED|Part 2||0
11156240|NCT01558700|12344519|FG000|STARTED|Overall Study||19
11156241|NCT01558700|12344520|FG001|STARTED|Overall Study||21
11156242|NCT01558700|12344519|FG000|COMPLETED|Overall Study||19
11156243|NCT01558700|12344520|FG001|COMPLETED|Overall Study||21
11156244|NCT01558700|12344519|FG000|NOT COMPLETED|Overall Study||0
11156245|NCT01558700|12344520|FG001|NOT COMPLETED|Overall Study||0
11156246|NCT01558739|12344526|FG000|STARTED|Overall Study||48
11156247|NCT01558739|12344526|FG000|COMPLETED|Overall Study||31
11156248|NCT01558739|12344526|FG000|NOT COMPLETED|Overall Study||17
11156249|NCT01558752|12344532|FG000|STARTED|Overall Study||42
11156250|NCT01558752|12344533|FG001|STARTED|Overall Study||46
11156251|NCT01558752|12344532|FG000|COMPLETED|Overall Study||40
11156252|NCT01558752|12344533|FG001|COMPLETED|Overall Study||46
11156253|NCT01558752|12344532|FG000|NOT COMPLETED|Overall Study||2
11156254|NCT01558752|12344533|FG001|NOT COMPLETED|Overall Study||0
11156255|NCT01558791|12344541|FG000|STARTED|Overall Study||607
11156256|NCT01558791|12344542|FG001|STARTED|Overall Study||629
11156257|NCT01558791|12344541|FG000|COMPLETED|Overall Study||607
11156258|NCT01558791|12344542|FG001|COMPLETED|Overall Study||629
11156259|NCT01558791|12344541|FG000|NOT COMPLETED|Overall Study||0
11156260|NCT01558791|12344542|FG001|NOT COMPLETED|Overall Study||0
11156261|NCT01559012|12344552|FG000|STARTED|Overall Study||6
11156262|NCT01559012|12344553|FG001|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
11156263|NCT01559012|12344552|FG000|COMPLETED|Overall Study||6
11156264|NCT01559012|12344553|FG001|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
11156265|NCT01559012|12344552|FG000|NOT COMPLETED|Overall Study||0
11156266|NCT01559012|12344553|FG001|NOT COMPLETED|Overall Study||1
11156267|NCT01559064|12344577|FG000|STARTED|Overall Study||16
11156268|NCT01559064|12344578|FG001|STARTED|Overall Study||40
11156269|NCT01559064|12344579|FG002|STARTED|Overall Study||59
11156270|NCT01559064|12344577|FG000|COMPLETED|Overall Study||15
11156271|NCT01559064|12344578|FG001|COMPLETED|Overall Study||39
11156272|NCT01559064|12344579|FG002|COMPLETED|Overall Study||57
11156273|NCT01559064|12344577|FG000|NOT COMPLETED|Overall Study||1
11156274|NCT01559064|12344578|FG001|NOT COMPLETED|Overall Study||1
11156275|NCT01559064|12344579|FG002|NOT COMPLETED|Overall Study||2
11156276|NCT01559090|12344590|FG000|STARTED|Stage I||6
11156277|NCT01559090|12344591|FG001|STARTED|Stage I||5
11156278|NCT01559090|12344592|FG002|STARTED|Stage I||6
11156279|NCT01559090|12344590|FG000|COMPLETED|Stage I||4
11156280|NCT01559090|12344591|FG001|COMPLETED|Stage I||3
11156281|NCT01559090|12344592|FG002|COMPLETED|Stage I||3
11156282|NCT01559090|12344590|FG000|NOT COMPLETED|Stage I||2
11156283|NCT01559090|12344591|FG001|NOT COMPLETED|Stage I||2
11156284|NCT01559090|12344592|FG002|NOT COMPLETED|Stage I||3
11156285|NCT01559090|12344590|FG000|STARTED|Stage II||4
11156286|NCT01559090|12344591|FG001|STARTED|Stage II||3
11156287|NCT01559090|12344592|FG002|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2
11156288|NCT01559090|12344590|FG000|COMPLETED|Stage II||3
11156289|NCT01559090|12344591|FG001|COMPLETED|Stage II||3
11156290|NCT01559090|12344592|FG002|COMPLETED|Stage II||2
11156291|NCT01559090|12344590|FG000|NOT COMPLETED|Stage II||1
11156292|NCT01559090|12344591|FG001|NOT COMPLETED|Stage II||0
11156293|NCT01559090|12344592|FG002|NOT COMPLETED|Stage II||0
11156294|NCT01559116|12344600|FG000|STARTED|Overall Study|Randomised|219
11156295|NCT01559116|12344600|FG000|COMPLETED|Overall Study|Completed all 4 treatment periods|193
11156296|NCT01559116|12344600|FG000|NOT COMPLETED|Overall Study||26
11156297|NCT01559129|12344619|FG000|STARTED|Treatment Phase||12
11156298|NCT01559129|12344620|FG001|STARTED|Treatment Phase||11
11156299|NCT01559129|12344619|FG000|Received Treatment|Treatment Phase||12
11156300|NCT01559129|12344620|FG001|Received Treatment|Treatment Phase||10
11156301|NCT01559129|12344619|FG000|COMPLETED|Treatment Phase||7
11156302|NCT01559129|12344620|FG001|COMPLETED|Treatment Phase||4
11156303|NCT01559129|12344619|FG000|NOT COMPLETED|Treatment Phase||5
11156304|NCT01559129|12344620|FG001|NOT COMPLETED|Treatment Phase||7
11156305|NCT01559129|12344619|FG000|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6
11203209|NCT01846208|12393706|FG000|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
11156306|NCT01559129|12344620|FG001|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2
11156307|NCT01559129|12344619|FG000|COMPLETED|Open-label Extension Period||0
11156308|NCT01559129|12344620|FG001|COMPLETED|Open-label Extension Period||0
11156309|NCT01559129|12344619|FG000|NOT COMPLETED|Open-label Extension Period||6
11156310|NCT01559129|12344620|FG001|NOT COMPLETED|Open-label Extension Period||2
11156311|NCT01559259|12344637|FG000|STARTED|Overall Study||30
11156312|NCT01559259|12344638|FG001|STARTED|Overall Study||90
11156313|NCT01559259|12344639|FG002|STARTED|Overall Study||93
11156314|NCT01559259|12344640|FG003|STARTED|Overall Study||89
11156315|NCT01559259|12344641|FG004|STARTED|Overall Study||92
11156316|NCT01559259|12344637|FG000|COMPLETED|Overall Study||30
11156317|NCT01559259|12344638|FG001|COMPLETED|Overall Study||89
11156318|NCT01559259|12344639|FG002|COMPLETED|Overall Study||92
11156319|NCT01559259|12344640|FG003|COMPLETED|Overall Study||88
11156320|NCT01559259|12344641|FG004|COMPLETED|Overall Study||92
11156321|NCT01559259|12344637|FG000|NOT COMPLETED|Overall Study||0
11156322|NCT01559259|12344638|FG001|NOT COMPLETED|Overall Study||1
11156323|NCT01559259|12344639|FG002|NOT COMPLETED|Overall Study||1
11156324|NCT01559259|12344640|FG003|NOT COMPLETED|Overall Study||1
11156325|NCT01559259|12344641|FG004|NOT COMPLETED|Overall Study||0
11156326|NCT01559311|12344656|FG000|STARTED|Overall Study|Enrollment & Baseline|30
11156327|NCT01559311|12344657|FG001|STARTED|Overall Study|Enrollment & Baseline|34
11156328|NCT01559311|12344658|FG002|STARTED|Overall Study|Enrollment & Baseline|34
11156329|NCT01559311|12344656|FG000|Implant|Overall Study||28
11156330|NCT01559311|12344657|FG001|Implant|Overall Study||34
11156331|NCT01559311|12344658|FG002|Implant|Overall Study||32
11156332|NCT01559311|12344656|FG000|1-Month|Overall Study||27
11156333|NCT01559311|12344657|FG001|1-Month|Overall Study||34
11156334|NCT01559311|12344658|FG002|1-Month|Overall Study||29
11156335|NCT01559311|12344656|FG000|3-Month|Overall Study||27
11156336|NCT01559311|12344657|FG001|3-Month|Overall Study||34
11156337|NCT01559311|12344658|FG002|3-Month|Overall Study||29
11156338|NCT01559311|12344656|FG000|6-Month|Overall Study||27
11156339|NCT01559311|12344657|FG001|6-Month|Overall Study||33
11156340|NCT01559311|12344658|FG002|6-Month|Overall Study||28
11156341|NCT01559311|12344656|FG000|COMPLETED|Overall Study|12-Month|27
11156342|NCT01559311|12344657|FG001|COMPLETED|Overall Study|12-Month|28
11156343|NCT01559311|12344658|FG002|COMPLETED|Overall Study|12-Month|26
11156344|NCT01559311|12344656|FG000|NOT COMPLETED|Overall Study||3
11156345|NCT01559311|12344657|FG001|NOT COMPLETED|Overall Study||6
11156346|NCT01559311|12344658|FG002|NOT COMPLETED|Overall Study||8
11156347|NCT01559389|12344668|FG000|STARTED|Overall Study||69
11156348|NCT01559389|12344669|FG001|STARTED|Overall Study||69
11156349|NCT01559389|12344668|FG000|COMPLETED|Overall Study||49
11156350|NCT01559389|12344669|FG001|COMPLETED|Overall Study||49
11156351|NCT01559389|12344668|FG000|NOT COMPLETED|Overall Study||20
11156352|NCT01559389|12344669|FG001|NOT COMPLETED|Overall Study||20
11156353|NCT01559454|12344681|FG000|STARTED|Overall Study||9
11156354|NCT01559454|12344682|FG001|STARTED|Overall Study||10
11156355|NCT01559454|12344681|FG000|COMPLETED|Overall Study||6
11156356|NCT01559454|12344682|FG001|COMPLETED|Overall Study||4
11156357|NCT01559454|12344681|FG000|NOT COMPLETED|Overall Study||3
11156358|NCT01559454|12344682|FG001|NOT COMPLETED|Overall Study||6
11156359|NCT01559506|12344690|FG000|STARTED|Overall Study||20
11156360|NCT01559506|12344691|FG001|STARTED|Overall Study||21
11156361|NCT01559506|12344690|FG000|COMPLETED|Overall Study||20
11156362|NCT01559506|12344691|FG001|COMPLETED|Overall Study||18
11156363|NCT01559506|12344690|FG000|NOT COMPLETED|Overall Study||0
11156364|NCT01559506|12344691|FG001|NOT COMPLETED|Overall Study||3
11156365|NCT01559649|12344699|FG000|STARTED|Overall Study||269
11156366|NCT01559649|12344700|FG001|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
11156367|NCT01559649|12344699|FG000|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
11156368|NCT01559649|12344700|FG001|COMPLETED|Overall Study||9
11156369|NCT01559649|12344699|FG000|NOT COMPLETED|Overall Study||19
11156370|NCT01559649|12344700|FG001|NOT COMPLETED|Overall Study||6
11203210|NCT01846208|12393707|FG001|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
11203211|NCT01846208|12393708|FG002|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
11203212|NCT01846208|12393706|FG000|COMPLETED|Overall Study||19
11203213|NCT01846208|12393707|FG001|COMPLETED|Overall Study||20
11203214|NCT01846208|12393708|FG002|COMPLETED|Overall Study||32
11203215|NCT01846208|12393706|FG000|NOT COMPLETED|Overall Study||9
11203216|NCT01846208|12393707|FG001|NOT COMPLETED|Overall Study||4
11203217|NCT01846208|12393708|FG002|NOT COMPLETED|Overall Study||8
11203218|NCT01846221|12393718|FG000|STARTED|Overall Study||50
11203219|NCT01846221|12393719|FG001|STARTED|Overall Study||51
11203220|NCT01846221|12393718|FG000|COMPLETED|Overall Study||47
11203221|NCT01846221|12393719|FG001|COMPLETED|Overall Study||51
11203222|NCT01846221|12393718|FG000|NOT COMPLETED|Overall Study||3
11203223|NCT01846221|12393719|FG001|NOT COMPLETED|Overall Study||0
11203224|NCT01846299|12393727|FG000|STARTED|Overall Study||118
11203225|NCT01846299|12393728|FG001|STARTED|Overall Study||60
11203226|NCT01846299|12393727|FG000|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
11203227|NCT01846299|12393728|FG001|Full Analysis Set|Overall Study||60
11418896|NCT00384293|12617303|FG000|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
11203228|NCT01846299|12393727|FG000|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
11203229|NCT01846299|12393728|FG001|Safety Set|Overall Study||58
11156371|NCT01559675|12344709|FG000|STARTED|Overall Study||58
11156372|NCT01559675|12344710|FG001|STARTED|Overall Study||63
11156373|NCT01559675|12344709|FG000|COMPLETED|Overall Study||43
11156374|NCT01559675|12344710|FG001|COMPLETED|Overall Study||49
11156375|NCT01559675|12344709|FG000|NOT COMPLETED|Overall Study||15
11156376|NCT01559675|12344710|FG001|NOT COMPLETED|Overall Study||14
11156377|NCT01559844|12344716|FG000|STARTED|Overall Study||61
11156378|NCT01559844|12344716|FG000|COMPLETED|Overall Study||36
11156379|NCT01559844|12344716|FG000|NOT COMPLETED|Overall Study||25
11156380|NCT01559857|12344722|FG000|STARTED|Overall Study||19
11156381|NCT01559857|12344723|FG001|STARTED|Overall Study||18
11156382|NCT01559857|12344722|FG000|COMPLETED|Overall Study||19
11156383|NCT01559857|12344723|FG001|COMPLETED|Overall Study||18
11156384|NCT01559857|12344722|FG000|NOT COMPLETED|Overall Study||0
11156385|NCT01559857|12344723|FG001|NOT COMPLETED|Overall Study||0
11156386|NCT01559922|12344733|FG000|STARTED|Overall Study||50
11156387|NCT01559922|12344734|FG001|STARTED|Overall Study||97
11156388|NCT01559922|12344733|FG000|COMPLETED|Overall Study||46
11156389|NCT01559922|12344734|FG001|COMPLETED|Overall Study||87
11156390|NCT01559922|12344733|FG000|NOT COMPLETED|Overall Study||4
11418897|NCT00384293|12617304|FG001|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
11156391|NCT01559922|12344734|FG001|NOT COMPLETED|Overall Study||10
11156392|NCT01559948|12344742|FG000|STARTED|Overall Study||15
11156393|NCT01559948|12344743|FG001|STARTED|Overall Study||15
11156394|NCT01559948|12344742|FG000|COMPLETED|Overall Study||15
11156395|NCT01559948|12344743|FG001|COMPLETED|Overall Study||15
11156396|NCT01559948|12344742|FG000|NOT COMPLETED|Overall Study||0
11156397|NCT01559948|12344743|FG001|NOT COMPLETED|Overall Study||0
11156398|NCT01560143|12344753|FG000|STARTED|Overall Study||12
11156399|NCT01560143|12344753|FG000|COMPLETED|Overall Study||12
11156400|NCT01560143|12344753|FG000|NOT COMPLETED|Overall Study||0
11156401|NCT01560234|12344765|FG000|STARTED|Overall Study||16
11156402|NCT01560234|12344766|FG001|STARTED|Overall Study||4
11156403|NCT01560234|12344767|FG002|STARTED|Overall Study||4
11156404|NCT01560234|12344768|FG003|STARTED|Overall Study||3
11156405|NCT01560234|12344769|FG004|STARTED|Overall Study||4
11156406|NCT01560234|12344770|FG005|STARTED|Overall Study||4
11156407|NCT01560234|12344771|FG006|STARTED|Overall Study||4
11156408|NCT01560234|12344772|FG007|STARTED|Overall Study||8
11156409|NCT01560234|12344765|FG000|COMPLETED|Overall Study||13
11156410|NCT01560234|12344766|FG001|COMPLETED|Overall Study||4
11156411|NCT01560234|12344767|FG002|COMPLETED|Overall Study||3
11156412|NCT01560234|12344768|FG003|COMPLETED|Overall Study||3
11156413|NCT01560234|12344769|FG004|COMPLETED|Overall Study||4
11156414|NCT01560234|12344770|FG005|COMPLETED|Overall Study||2
11156415|NCT01560234|12344771|FG006|COMPLETED|Overall Study||4
11156416|NCT01560234|12344772|FG007|COMPLETED|Overall Study||6
11156417|NCT01560234|12344765|FG000|NOT COMPLETED|Overall Study||3
11156418|NCT01560234|12344766|FG001|NOT COMPLETED|Overall Study||0
11156419|NCT01560234|12344767|FG002|NOT COMPLETED|Overall Study||1
11156420|NCT01560234|12344768|FG003|NOT COMPLETED|Overall Study||0
11156421|NCT01560234|12344769|FG004|NOT COMPLETED|Overall Study||0
11156422|NCT01560234|12344770|FG005|NOT COMPLETED|Overall Study||2
11156423|NCT01560234|12344771|FG006|NOT COMPLETED|Overall Study||0
11156424|NCT01560234|12344772|FG007|NOT COMPLETED|Overall Study||2
11156425|NCT01560260|12344790|FG000|STARTED|Overall Study||20
11156426|NCT01560260|12344790|FG000|COMPLETED|Overall Study||20
11156427|NCT01560260|12344790|FG000|NOT COMPLETED|Overall Study||0
11156428|NCT01560286|12344796|FG000|STARTED|Overall Study||24
11156429|NCT01560286|12344796|FG000|COMPLETED|Overall Study||24
11156430|NCT01560286|12344796|FG000|NOT COMPLETED|Overall Study||0
11156431|NCT01560377|12344800|FG000|STARTED|Overall Study||147
11156432|NCT01560377|12344800|FG000|Eligible for Analysis|Overall Study||139
11156433|NCT01560377|12344800|FG000|COMPLETED|Overall Study||147
11156434|NCT01560377|12344800|FG000|NOT COMPLETED|Overall Study||0
11156435|NCT01560403|12344806|FG000|STARTED|Overall Study||5
11156436|NCT01560403|12344807|FG001|STARTED|Overall Study||9
11156437|NCT01560403|12344806|FG000|COMPLETED|Overall Study||5
11156438|NCT01560403|12344807|FG001|COMPLETED|Overall Study||8
11156439|NCT01560403|12344806|FG000|NOT COMPLETED|Overall Study||0
11156440|NCT01560403|12344807|FG001|NOT COMPLETED|Overall Study||1
11156441|NCT01560416|12344815|FG000|STARTED|Randomized Phase||15
11156442|NCT01560416|12344816|FG001|STARTED|Randomized Phase||35
11156443|NCT01560416|12344815|FG000|COMPLETED|Randomized Phase||8
11156444|NCT01560416|12344816|FG001|COMPLETED|Randomized Phase||35
11156445|NCT01560416|12344815|FG000|NOT COMPLETED|Randomized Phase||7
11156446|NCT01560416|12344816|FG001|NOT COMPLETED|Randomized Phase||0
11156447|NCT01560416|12344815|FG000|STARTED|Crossover Phase||7
11156448|NCT01560416|12344816|FG001|STARTED|Crossover Phase||0
11156449|NCT01560416|12344815|FG000|COMPLETED|Crossover Phase||7
11156450|NCT01560416|12344816|FG001|COMPLETED|Crossover Phase||0
11156451|NCT01560416|12344815|FG000|NOT COMPLETED|Crossover Phase||0
11156452|NCT01560416|12344816|FG001|NOT COMPLETED|Crossover Phase||0
11156453|NCT01560429|12344826|FG000|STARTED|Overall Study||26
11156454|NCT01560429|12344827|FG001|STARTED|Overall Study||26
11156455|NCT01560429|12344826|FG000|COMPLETED|Overall Study||23
11156456|NCT01560429|12344827|FG001|COMPLETED|Overall Study||20
11156457|NCT01560429|12344826|FG000|NOT COMPLETED|Overall Study||3
11156458|NCT01560429|12344827|FG001|NOT COMPLETED|Overall Study||6
11156459|NCT01560624|12344837|FG000|STARTED|Overall Study||346
11156460|NCT01560624|12344838|FG001|STARTED|Overall Study||344
11156461|NCT01560624|12344837|FG000|Clinical Worsening Event|Overall Study||91
11156462|NCT01560624|12344838|FG001|Clinical Worsening Event|Overall Study||133
11156463|NCT01560624|12344837|FG000|Early Discontinuation From Treatment|Overall Study||107
11156464|NCT01560624|12344838|FG001|Early Discontinuation From Treatment|Overall Study||56
11156465|NCT01560624|12344837|FG000|COMPLETED|Overall Study||148
11156466|NCT01560624|12344838|FG001|COMPLETED|Overall Study||155
11156467|NCT01560624|12344837|FG000|NOT COMPLETED|Overall Study||198
11156468|NCT01560624|12344838|FG001|NOT COMPLETED|Overall Study||189
11156469|NCT01560780|12344846|FG000|STARTED|Overall Study||42
11156470|NCT01560780|12344847|FG001|STARTED|Overall Study||42
11156471|NCT01560780|12344846|FG000|Clinical Follow-Up at 12 Months|Overall Study||42
11156472|NCT01560780|12344847|FG001|Clinical Follow-Up at 12 Months|Overall Study||42
11156473|NCT01560780|12344846|FG000|Completed Study Drug for 12 Months|Overall Study||27
11156474|NCT01560780|12344847|FG001|Completed Study Drug for 12 Months|Overall Study||27
11156475|NCT01560780|12344846|FG000|COMPLETED|Overall Study||29
11156476|NCT01560780|12344847|FG001|COMPLETED|Overall Study||30
11156477|NCT01560780|12344846|FG000|NOT COMPLETED|Overall Study||13
11156478|NCT01560780|12344847|FG001|NOT COMPLETED|Overall Study||12
11156479|NCT01560819|12344855|FG000|STARTED|Overall Study||10
11156480|NCT01560819|12344856|FG001|STARTED|Overall Study||10
11156481|NCT01560819|12344855|FG000|COMPLETED|Overall Study||9
11156482|NCT01560819|12344856|FG001|COMPLETED|Overall Study||10
11156483|NCT01560819|12344855|FG000|NOT COMPLETED|Overall Study||1
11156484|NCT01560819|12344856|FG001|NOT COMPLETED|Overall Study||0
11156485|NCT01560871|12344862|FG000|STARTED|Overall Study||9
11156486|NCT01560871|12344863|FG001|STARTED|Overall Study||7
11156487|NCT01560871|12344862|FG000|COMPLETED|Overall Study||3
11156488|NCT01560871|12344863|FG001|COMPLETED|Overall Study||5
11156489|NCT01560871|12344862|FG000|NOT COMPLETED|Overall Study||6
11156490|NCT01560871|12344863|FG001|NOT COMPLETED|Overall Study||2
11156491|NCT01560923|12344872|FG000|STARTED|Overall Study||24
11156492|NCT01560923|12344873|FG001|STARTED|Overall Study||22
11156493|NCT01560923|12344872|FG000|COMPLETED|Overall Study||24
11156494|NCT01560923|12344873|FG001|COMPLETED|Overall Study||22
11156495|NCT01560923|12344872|FG000|NOT COMPLETED|Overall Study||0
11156496|NCT01560923|12344873|FG001|NOT COMPLETED|Overall Study||0
11156497|NCT01560949|12344879|FG000|STARTED|Systemic Phase: mFOLFIRINOX||33
11156498|NCT01560949|12344879|FG000|COMPLETED|Systemic Phase: mFOLFIRINOX||27
11156499|NCT01560949|12344879|FG000|NOT COMPLETED|Systemic Phase: mFOLFIRINOX||6
11156500|NCT01560949|12344879|FG000|STARTED|Chemoradiation Phase: With Gemcitabine||23
11156501|NCT01560949|12344879|FG000|COMPLETED|Chemoradiation Phase: With Gemcitabine||23
11156502|NCT01560949|12344879|FG000|NOT COMPLETED|Chemoradiation Phase: With Gemcitabine||0
11156503|NCT01560949|12344879|FG000|STARTED|Surgery Phase||18
11156504|NCT01560949|12344879|FG000|COMPLETED|Surgery Phase||15
11156505|NCT01560949|12344879|FG000|NOT COMPLETED|Surgery Phase||3
11156506|NCT01560975|12344887|FG000|STARTED|Overall Study||10
11156507|NCT01560975|12344887|FG000|COMPLETED|Overall Study||10
11156508|NCT01560975|12344887|FG000|NOT COMPLETED|Overall Study||0
11156509|NCT01560988|12344895|FG000|STARTED|First Intervention (Six Weeks)||32
11156510|NCT01560988|12344896|FG001|STARTED|First Intervention (Six Weeks)||30
11156511|NCT01560988|12344895|FG000|COMPLETED|First Intervention (Six Weeks)||22
11156512|NCT01560988|12344896|FG001|COMPLETED|First Intervention (Six Weeks)||26
11156513|NCT01560988|12344895|FG000|NOT COMPLETED|First Intervention (Six Weeks)||10
11156514|NCT01560988|12344896|FG001|NOT COMPLETED|First Intervention (Six Weeks)||4
11156515|NCT01560988|12344895|FG000|STARTED|Washout (Six Weeks)||22
11156516|NCT01560988|12344896|FG001|STARTED|Washout (Six Weeks)||26
11156517|NCT01560988|12344895|FG000|COMPLETED|Washout (Six Weeks)||20
11156518|NCT01560988|12344896|FG001|COMPLETED|Washout (Six Weeks)||24
11156519|NCT01560988|12344895|FG000|NOT COMPLETED|Washout (Six Weeks)||2
11156520|NCT01560988|12344896|FG001|NOT COMPLETED|Washout (Six Weeks)||2
11156521|NCT01560988|12344895|FG000|STARTED|Second Intervention (Six Weeks)||20
11156522|NCT01560988|12344896|FG001|STARTED|Second Intervention (Six Weeks)||24
11156523|NCT01560988|12344895|FG000|COMPLETED|Second Intervention (Six Weeks)||18
11156524|NCT01560988|12344896|FG001|COMPLETED|Second Intervention (Six Weeks)||22
11156525|NCT01560988|12344895|FG000|NOT COMPLETED|Second Intervention (Six Weeks)||2
11156526|NCT01560988|12344896|FG001|NOT COMPLETED|Second Intervention (Six Weeks)||2
11156527|NCT01561053|12344911|FG000|STARTED|Overall Study||86
11156528|NCT01561053|12344912|FG001|STARTED|Overall Study||92
11156529|NCT01561053|12344913|FG002|STARTED|Overall Study||82
11156530|NCT01561053|12344914|FG003|STARTED|Overall Study||87
11156531|NCT01561053|12344911|FG000|Patients With Baseline MMSE:18-21|Overall Study||47
11156532|NCT01561053|12344912|FG001|Patients With Baseline MMSE:18-21|Overall Study||40
11156533|NCT01561053|12344913|FG002|Patients With Baseline MMSE:18-21|Overall Study||47
11156534|NCT01561053|12344914|FG003|Patients With Baseline MMSE:18-21|Overall Study||42
11156535|NCT01561053|12344911|FG000|Patients With Baseline MMSE:22-26|Overall Study||39
11156536|NCT01561053|12344912|FG001|Patients With Baseline MMSE:22-26|Overall Study||52
11156537|NCT01561053|12344913|FG002|Patients With Baseline MMSE:22-26|Overall Study||35
11156538|NCT01561053|12344914|FG003|Patients With Baseline MMSE:22-26|Overall Study||45
11156539|NCT01561053|12344911|FG000|Randomized Not Treated|Overall Study||8
11156540|NCT01561053|12344912|FG001|Randomized Not Treated|Overall Study||6
11156541|NCT01561053|12344913|FG002|Randomized Not Treated|Overall Study||4
11156542|NCT01561053|12344914|FG003|Randomized Not Treated|Overall Study||7
11156543|NCT01561053|12344911|FG000|Evaluable Subjects|Overall Study||78
11156544|NCT01561053|12344912|FG001|Evaluable Subjects|Overall Study||86
11156545|NCT01561053|12344913|FG002|Evaluable Subjects|Overall Study||78
11156546|NCT01561053|12344914|FG003|Evaluable Subjects|Overall Study||80
11156547|NCT01561053|12344911|FG000|COMPLETED|Overall Study||51
11156548|NCT01561053|12344912|FG001|COMPLETED|Overall Study||56
11156549|NCT01561053|12344913|FG002|COMPLETED|Overall Study||61
11156550|NCT01561053|12344914|FG003|COMPLETED|Overall Study||64
11156551|NCT01561053|12344911|FG000|NOT COMPLETED|Overall Study||35
11156552|NCT01561053|12344912|FG001|NOT COMPLETED|Overall Study||36
11156553|NCT01561053|12344913|FG002|NOT COMPLETED|Overall Study||21
11156554|NCT01561053|12344914|FG003|NOT COMPLETED|Overall Study||23
11156555|NCT01561079|12344925|FG000|STARTED|Overall Study||127
11156556|NCT01561079|12344925|FG000|COMPLETED|Overall Study||49
11156557|NCT01561079|12344925|FG000|NOT COMPLETED|Overall Study||78
11156558|NCT01561300|12344968|FG000|STARTED|Run in on Placebo||15
11156559|NCT01561300|12344969|FG001|STARTED|Run in on Placebo||15
11156560|NCT01561300|12344968|FG000|COMPLETED|Run in on Placebo||14
11156561|NCT01561300|12344969|FG001|COMPLETED|Run in on Placebo||15
11156562|NCT01561300|12344968|FG000|NOT COMPLETED|Run in on Placebo||1
11156563|NCT01561300|12344969|FG001|NOT COMPLETED|Run in on Placebo||0
11156564|NCT01561300|12344968|FG000|STARTED|First Intervention||14
11156565|NCT01561300|12344969|FG001|STARTED|First Intervention||15
11156566|NCT01561300|12344968|FG000|COMPLETED|First Intervention||14
11156567|NCT01561300|12344969|FG001|COMPLETED|First Intervention||15
11156568|NCT01561300|12344968|FG000|NOT COMPLETED|First Intervention||0
11156569|NCT01561300|12344969|FG001|NOT COMPLETED|First Intervention||0
11156570|NCT01561300|12344968|FG000|STARTED|Washout on Placebo||14
11156571|NCT01561300|12344969|FG001|STARTED|Washout on Placebo||15
11156572|NCT01561300|12344968|FG000|COMPLETED|Washout on Placebo||14
11156573|NCT01561300|12344969|FG001|COMPLETED|Washout on Placebo||15
11156574|NCT01561300|12344968|FG000|NOT COMPLETED|Washout on Placebo||0
11156575|NCT01561300|12344969|FG001|NOT COMPLETED|Washout on Placebo||0
11156576|NCT01561300|12344968|FG000|STARTED|Second Intervention||14
11156577|NCT01561300|12344969|FG001|STARTED|Second Intervention||15
11156578|NCT01561300|12344968|FG000|COMPLETED|Second Intervention||14
11156579|NCT01561300|12344969|FG001|COMPLETED|Second Intervention||15
11156580|NCT01561300|12344968|FG000|NOT COMPLETED|Second Intervention||0
11156581|NCT01561300|12344969|FG001|NOT COMPLETED|Second Intervention||0
11156582|NCT01561313|12344978|FG000|STARTED|Overall Study||33
11156583|NCT01561313|12344979|FG001|STARTED|Overall Study||31
11156584|NCT01561313|12344978|FG000|COMPLETED|Overall Study||31
11156585|NCT01561313|12344979|FG001|COMPLETED|Overall Study||31
11156586|NCT01561313|12344978|FG000|NOT COMPLETED|Overall Study||2
11156587|NCT01561313|12344979|FG001|NOT COMPLETED|Overall Study||0
11156588|NCT01561469|12344987|FG000|STARTED|Overall Study||101
11156589|NCT01561469|12344988|FG001|STARTED|Overall Study||87
11156590|NCT01561469|12344987|FG000|COMPLETED|Overall Study||101
11156591|NCT01561469|12344988|FG001|COMPLETED|Overall Study||87
11156592|NCT01561469|12344987|FG000|NOT COMPLETED|Overall Study||0
11156593|NCT01561469|12344988|FG001|NOT COMPLETED|Overall Study||0
11156594|NCT01561560|12344994|FG000|STARTED|First Two Weeks of Wear||60
11156595|NCT01561560|12344995|FG001|STARTED|First Two Weeks of Wear||61
11156596|NCT01561560|12344994|FG000|COMPLETED|First Two Weeks of Wear||60
11156597|NCT01561560|12344995|FG001|COMPLETED|First Two Weeks of Wear||59
11156598|NCT01561560|12344994|FG000|NOT COMPLETED|First Two Weeks of Wear||0
11156599|NCT01561560|12344995|FG001|NOT COMPLETED|First Two Weeks of Wear||2
11156600|NCT01561560|12344994|FG000|STARTED|Second Two Weeks of Wear||60
11156601|NCT01561560|12344995|FG001|STARTED|Second Two Weeks of Wear||59
11156602|NCT01561560|12344994|FG000|COMPLETED|Second Two Weeks of Wear||60
11156603|NCT01561560|12344995|FG001|COMPLETED|Second Two Weeks of Wear||58
11156604|NCT01561560|12344994|FG000|NOT COMPLETED|Second Two Weeks of Wear||0
11156605|NCT01561560|12344995|FG001|NOT COMPLETED|Second Two Weeks of Wear||1
11156606|NCT01561703|12345003|FG000|STARTED|Overall Study||28
11156607|NCT01561703|12345004|FG001|STARTED|Overall Study||30
11156608|NCT01561703|12345003|FG000|COMPLETED|Overall Study||20
11156609|NCT01561703|12345004|FG001|COMPLETED|Overall Study||24
11156610|NCT01561703|12345003|FG000|NOT COMPLETED|Overall Study||8
11156611|NCT01561703|12345004|FG001|NOT COMPLETED|Overall Study||6
11156612|NCT01561716|12345016|FG000|STARTED|Overall Study||5
11156613|NCT01561716|12345017|FG001|STARTED|Overall Study||5
11156614|NCT01561716|12345018|FG002|STARTED|Overall Study||5
11156615|NCT01561716|12345019|FG003|STARTED|Overall Study||5
11156616|NCT01561716|12345020|FG004|STARTED|Overall Study||5
11156617|NCT01561716|12345021|FG005|STARTED|Overall Study||5
11156618|NCT01561716|12345016|FG000|COMPLETED|Overall Study||5
11156619|NCT01561716|12345017|FG001|COMPLETED|Overall Study||5
11156620|NCT01561716|12345018|FG002|COMPLETED|Overall Study||5
11156621|NCT01561716|12345019|FG003|COMPLETED|Overall Study||5
11156622|NCT01561716|12345020|FG004|COMPLETED|Overall Study||5
11156623|NCT01561716|12345021|FG005|COMPLETED|Overall Study||5
11156624|NCT01561716|12345016|FG000|NOT COMPLETED|Overall Study||0
11156625|NCT01561716|12345017|FG001|NOT COMPLETED|Overall Study||0
11156626|NCT01561716|12345018|FG002|NOT COMPLETED|Overall Study||0
11156627|NCT01561716|12345019|FG003|NOT COMPLETED|Overall Study||0
11156628|NCT01561716|12345020|FG004|NOT COMPLETED|Overall Study||0
11156629|NCT01561716|12345021|FG005|NOT COMPLETED|Overall Study||0
11156630|NCT01561755|12345037|FG000|STARTED|Overall Study||6
11156631|NCT01561755|12345038|FG001|STARTED|Overall Study||6
11156632|NCT01561755|12345037|FG000|COMPLETED|Overall Study||6
11156633|NCT01561755|12345038|FG001|COMPLETED|Overall Study||5
11156634|NCT01561755|12345037|FG000|NOT COMPLETED|Overall Study||0
11156635|NCT01561755|12345038|FG001|NOT COMPLETED|Overall Study||1
11156636|NCT01561833|12345044|FG000|STARTED|Overall Study||12
11156637|NCT01561833|12345044|FG000|COMPLETED|Overall Study||12
11156638|NCT01561833|12345044|FG000|NOT COMPLETED|Overall Study||0
11156639|NCT01561898|12345052|FG000|STARTED|Overall Study||7
11156640|NCT01561898|12345053|FG001|STARTED|Overall Study||92
11156641|NCT01561898|12345054|FG002|STARTED|Overall Study||97
11156642|NCT01561898|12345055|FG003|STARTED|Overall Study||32
11156643|NCT01561898|12345052|FG000|COMPLETED|Overall Study||5
11156644|NCT01561898|12345053|FG001|COMPLETED|Overall Study||51
11156645|NCT01561898|12345054|FG002|COMPLETED|Overall Study||53
11156646|NCT01561898|12345055|FG003|COMPLETED|Overall Study||12
11156647|NCT01561898|12345052|FG000|NOT COMPLETED|Overall Study||2
11156648|NCT01561898|12345053|FG001|NOT COMPLETED|Overall Study||41
11156649|NCT01561898|12345054|FG002|NOT COMPLETED|Overall Study||44
11156650|NCT01561898|12345055|FG003|NOT COMPLETED|Overall Study||20
11156651|NCT01561963|12345063|FG000|STARTED|Overall Study||21
11156652|NCT01561963|12345063|FG000|Received Period 1 Treatment|Overall Study||21
11156653|NCT01561963|12345063|FG000|Received Period 2 Treatment|Overall Study||20
11156654|NCT01561963|12345063|FG000|Received Period 3 Treatment|Overall Study||20
11156655|NCT01561963|12345063|FG000|COMPLETED|Overall Study||20
11156656|NCT01561963|12345063|FG000|NOT COMPLETED|Overall Study||1
11156657|NCT01561976|12345078|FG000|STARTED|Period 1||5
11156658|NCT01561976|12345079|FG001|STARTED|Period 1||5
11156659|NCT01561976|12345080|FG002|STARTED|Period 1||5
11156660|NCT01561976|12345081|FG003|STARTED|Period 1||5
11156661|NCT01561976|12345082|FG004|STARTED|Period 1||5
11156662|NCT01561976|12345083|FG005|STARTED|Period 1||5
11156663|NCT01561976|12345078|FG000|COMPLETED|Period 1||5
11156664|NCT01561976|12345079|FG001|COMPLETED|Period 1||5
11156665|NCT01561976|12345080|FG002|COMPLETED|Period 1||4
11156666|NCT01561976|12345081|FG003|COMPLETED|Period 1||5
11156667|NCT01561976|12345082|FG004|COMPLETED|Period 1||5
11156668|NCT01561976|12345083|FG005|COMPLETED|Period 1||5
11156669|NCT01561976|12345078|FG000|NOT COMPLETED|Period 1||0
11156670|NCT01561976|12345079|FG001|NOT COMPLETED|Period 1||0
11156671|NCT01561976|12345080|FG002|NOT COMPLETED|Period 1||1
11156672|NCT01561976|12345081|FG003|NOT COMPLETED|Period 1||0
11156673|NCT01561976|12345082|FG004|NOT COMPLETED|Period 1||0
11156674|NCT01561976|12345083|FG005|NOT COMPLETED|Period 1||0
11156675|NCT01561976|12345078|FG000|STARTED|Washout Period 1 (7 Days)||5
11156676|NCT01561976|12345079|FG001|STARTED|Washout Period 1 (7 Days)||5
11156677|NCT01561976|12345080|FG002|STARTED|Washout Period 1 (7 Days)||4
11156678|NCT01561976|12345081|FG003|STARTED|Washout Period 1 (7 Days)||5
11156679|NCT01561976|12345082|FG004|STARTED|Washout Period 1 (7 Days)||5
11156680|NCT01561976|12345083|FG005|STARTED|Washout Period 1 (7 Days)||5
11156681|NCT01561976|12345078|FG000|COMPLETED|Washout Period 1 (7 Days)||5
11156682|NCT01561976|12345079|FG001|COMPLETED|Washout Period 1 (7 Days)||5
11156683|NCT01561976|12345080|FG002|COMPLETED|Washout Period 1 (7 Days)||4
11156684|NCT01561976|12345081|FG003|COMPLETED|Washout Period 1 (7 Days)||4
11156685|NCT01561976|12345082|FG004|COMPLETED|Washout Period 1 (7 Days)||5
11156686|NCT01561976|12345083|FG005|COMPLETED|Washout Period 1 (7 Days)||4
11156687|NCT01561976|12345078|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
11156688|NCT01561976|12345079|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
11156689|NCT01561976|12345080|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
11156690|NCT01561976|12345081|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
11156691|NCT01561976|12345082|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
11156692|NCT01561976|12345083|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1
11156693|NCT01561976|12345078|FG000|STARTED|Period 2||5
11156694|NCT01561976|12345079|FG001|STARTED|Period 2||5
11156695|NCT01561976|12345080|FG002|STARTED|Period 2||4
11156696|NCT01561976|12345081|FG003|STARTED|Period 2||4
11156697|NCT01561976|12345082|FG004|STARTED|Period 2||5
11156698|NCT01561976|12345083|FG005|STARTED|Period 2||4
11156699|NCT01561976|12345078|FG000|COMPLETED|Period 2||5
11156700|NCT01561976|12345079|FG001|COMPLETED|Period 2||5
11156701|NCT01561976|12345080|FG002|COMPLETED|Period 2||4
11156702|NCT01561976|12345081|FG003|COMPLETED|Period 2||4
11156703|NCT01561976|12345082|FG004|COMPLETED|Period 2||5
11156704|NCT01561976|12345083|FG005|COMPLETED|Period 2||4
11156705|NCT01561976|12345078|FG000|NOT COMPLETED|Period 2||0
11156706|NCT01561976|12345079|FG001|NOT COMPLETED|Period 2||0
11418898|NCT00384293|12617305|FG002|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
11418899|NCT00384293|12617303|FG000|STARTED|Post-randomization Period||0
11156707|NCT01561976|12345080|FG002|NOT COMPLETED|Period 2||0
11156708|NCT01561976|12345081|FG003|NOT COMPLETED|Period 2||0
11156709|NCT01561976|12345082|FG004|NOT COMPLETED|Period 2||0
11156710|NCT01561976|12345083|FG005|NOT COMPLETED|Period 2||0
11156711|NCT01561976|12345078|FG000|STARTED|Washout Period 2 (7 Days)||5
11156712|NCT01561976|12345079|FG001|STARTED|Washout Period 2 (7 Days)||5
11156713|NCT01561976|12345080|FG002|STARTED|Washout Period 2 (7 Days)||4
11156714|NCT01561976|12345081|FG003|STARTED|Washout Period 2 (7 Days)||4
11156715|NCT01561976|12345082|FG004|STARTED|Washout Period 2 (7 Days)||5
11156716|NCT01561976|12345083|FG005|STARTED|Washout Period 2 (7 Days)||4
11156717|NCT01561976|12345078|FG000|COMPLETED|Washout Period 2 (7 Days)||4
11156718|NCT01561976|12345079|FG001|COMPLETED|Washout Period 2 (7 Days)||5
11156719|NCT01561976|12345080|FG002|COMPLETED|Washout Period 2 (7 Days)||3
11156720|NCT01561976|12345081|FG003|COMPLETED|Washout Period 2 (7 Days)||4
11156721|NCT01561976|12345082|FG004|COMPLETED|Washout Period 2 (7 Days)||5
11156722|NCT01561976|12345083|FG005|COMPLETED|Washout Period 2 (7 Days)||4
11156723|NCT01561976|12345078|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1
11156724|NCT01561976|12345079|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
11156725|NCT01561976|12345080|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||1
11156726|NCT01561976|12345081|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
11156727|NCT01561976|12345082|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
11156728|NCT01561976|12345083|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
11156729|NCT01561976|12345078|FG000|STARTED|Period 3||4
11156730|NCT01561976|12345079|FG001|STARTED|Period 3||5
11156731|NCT01561976|12345080|FG002|STARTED|Period 3||3
11156732|NCT01561976|12345081|FG003|STARTED|Period 3||4
11156733|NCT01561976|12345082|FG004|STARTED|Period 3||5
11156734|NCT01561976|12345083|FG005|STARTED|Period 3||4
11156735|NCT01561976|12345078|FG000|COMPLETED|Period 3||4
11418900|NCT00384293|12617304|FG001|STARTED|Post-randomization Period||214
11156736|NCT01561976|12345079|FG001|COMPLETED|Period 3||5
11156737|NCT01561976|12345080|FG002|COMPLETED|Period 3||3
11156738|NCT01561976|12345081|FG003|COMPLETED|Period 3||4
11156739|NCT01561976|12345082|FG004|COMPLETED|Period 3||5
11156740|NCT01561976|12345083|FG005|COMPLETED|Period 3||4
11156741|NCT01561976|12345078|FG000|NOT COMPLETED|Period 3||0
11156742|NCT01561976|12345079|FG001|NOT COMPLETED|Period 3||0
11156743|NCT01561976|12345080|FG002|NOT COMPLETED|Period 3||0
11156744|NCT01561976|12345081|FG003|NOT COMPLETED|Period 3||0
11418901|NCT00384293|12617305|FG002|STARTED|Post-randomization Period||219
11156745|NCT01561976|12345082|FG004|NOT COMPLETED|Period 3||0
11156746|NCT01561976|12345083|FG005|NOT COMPLETED|Period 3||0
11156747|NCT01562041|12345091|FG000|STARTED|Overall Study||14
11156748|NCT01562041|12345091|FG000|COMPLETED|Overall Study||14
11156749|NCT01562041|12345091|FG000|NOT COMPLETED|Overall Study||0
11156750|NCT01562132|12345097|FG000|STARTED|Overall Study||3
11156751|NCT01562132|12345098|FG001|STARTED|Overall Study||3
11156752|NCT01562132|12345097|FG000|COMPLETED|Overall Study||3
11156753|NCT01562132|12345098|FG001|COMPLETED|Overall Study||3
11156754|NCT01562132|12345097|FG000|NOT COMPLETED|Overall Study||0
11156755|NCT01562132|12345098|FG001|NOT COMPLETED|Overall Study||0
11156756|NCT01562275|12345117|FG000|STARTED|Stage 1||3
11156757|NCT01562275|12345118|FG001|STARTED|Stage 1||7
11156758|NCT01562275|12345119|FG002|STARTED|Stage 1||3
11156759|NCT01562275|12345120|FG003|STARTED|Stage 1||4
11156760|NCT01562275|12345121|FG004|STARTED|Stage 1||4
11156761|NCT01562275|12345122|FG005|STARTED|Stage 1||4
11156762|NCT01562275|12345123|FG006|STARTED|Stage 1||3
11156763|NCT01562275|12345124|FG007|STARTED|Stage 1||7
11156764|NCT01562275|12345125|FG008|STARTED|Stage 1||3
11156765|NCT01562275|12345126|FG009|STARTED|Stage 1||7
11156766|NCT01562275|12345127|FG010|STARTED|Stage 1||3
11156767|NCT01562275|12345128|FG011|STARTED|Stage 1||0
11156768|NCT01562275|12345129|FG012|STARTED|Stage 1||0
11156769|NCT01562275|12345117|FG000|COMPLETED|Stage 1||0
11156770|NCT01562275|12345118|FG001|COMPLETED|Stage 1||0
11156771|NCT01562275|12345119|FG002|COMPLETED|Stage 1||0
11156772|NCT01562275|12345120|FG003|COMPLETED|Stage 1||0
11156773|NCT01562275|12345121|FG004|COMPLETED|Stage 1||0
11156774|NCT01562275|12345122|FG005|COMPLETED|Stage 1||0
11156775|NCT01562275|12345123|FG006|COMPLETED|Stage 1||0
11156776|NCT01562275|12345124|FG007|COMPLETED|Stage 1||0
11156777|NCT01562275|12345125|FG008|COMPLETED|Stage 1||0
11156778|NCT01562275|12345126|FG009|COMPLETED|Stage 1||0
11156779|NCT01562275|12345127|FG010|COMPLETED|Stage 1||0
11156780|NCT01562275|12345128|FG011|COMPLETED|Stage 1||0
11156781|NCT01562275|12345129|FG012|COMPLETED|Stage 1||0
11156782|NCT01562275|12345117|FG000|NOT COMPLETED|Stage 1||3
11156783|NCT01562275|12345118|FG001|NOT COMPLETED|Stage 1||7
11156784|NCT01562275|12345119|FG002|NOT COMPLETED|Stage 1||3
11156785|NCT01562275|12345120|FG003|NOT COMPLETED|Stage 1||4
11156786|NCT01562275|12345121|FG004|NOT COMPLETED|Stage 1||4
11156787|NCT01562275|12345122|FG005|NOT COMPLETED|Stage 1||4
11156788|NCT01562275|12345123|FG006|NOT COMPLETED|Stage 1||3
11156789|NCT01562275|12345124|FG007|NOT COMPLETED|Stage 1||7
11156790|NCT01562275|12345125|FG008|NOT COMPLETED|Stage 1||3
11156791|NCT01562275|12345126|FG009|NOT COMPLETED|Stage 1||7
11156792|NCT01562275|12345127|FG010|NOT COMPLETED|Stage 1||3
11156793|NCT01562275|12345128|FG011|NOT COMPLETED|Stage 1||0
11156794|NCT01562275|12345129|FG012|NOT COMPLETED|Stage 1||0
11156795|NCT01562275|12345117|FG000|STARTED|Stage 2||0
11156796|NCT01562275|12345118|FG001|STARTED|Stage 2||0
11156797|NCT01562275|12345119|FG002|STARTED|Stage 2||0
11156798|NCT01562275|12345120|FG003|STARTED|Stage 2||0
11156799|NCT01562275|12345121|FG004|STARTED|Stage 2||0
11156800|NCT01562275|12345122|FG005|STARTED|Stage 2||0
11156801|NCT01562275|12345123|FG006|STARTED|Stage 2||0
11156802|NCT01562275|12345124|FG007|STARTED|Stage 2||0
11156803|NCT01562275|12345125|FG008|STARTED|Stage 2||0
11156804|NCT01562275|12345126|FG009|STARTED|Stage 2||0
11156805|NCT01562275|12345127|FG010|STARTED|Stage 2||0
11156806|NCT01562275|12345128|FG011|STARTED|Stage 2||14
11156807|NCT01562275|12345129|FG012|STARTED|Stage 2||5
11156808|NCT01562275|12345117|FG000|COMPLETED|Stage 2||0
11156809|NCT01562275|12345118|FG001|COMPLETED|Stage 2||0
11156810|NCT01562275|12345119|FG002|COMPLETED|Stage 2||0
11156811|NCT01562275|12345120|FG003|COMPLETED|Stage 2||0
11156812|NCT01562275|12345121|FG004|COMPLETED|Stage 2||0
11156813|NCT01562275|12345122|FG005|COMPLETED|Stage 2||0
11156814|NCT01562275|12345123|FG006|COMPLETED|Stage 2||0
11156815|NCT01562275|12345124|FG007|COMPLETED|Stage 2||0
11156816|NCT01562275|12345125|FG008|COMPLETED|Stage 2||0
11156817|NCT01562275|12345126|FG009|COMPLETED|Stage 2||0
11156818|NCT01562275|12345127|FG010|COMPLETED|Stage 2||0
11156819|NCT01562275|12345128|FG011|COMPLETED|Stage 2||0
11156820|NCT01562275|12345129|FG012|COMPLETED|Stage 2||0
11156821|NCT01562275|12345117|FG000|NOT COMPLETED|Stage 2||0
11156822|NCT01562275|12345118|FG001|NOT COMPLETED|Stage 2||0
11156823|NCT01562275|12345119|FG002|NOT COMPLETED|Stage 2||0
11156824|NCT01562275|12345120|FG003|NOT COMPLETED|Stage 2||0
11156825|NCT01562275|12345121|FG004|NOT COMPLETED|Stage 2||0
11156826|NCT01562275|12345122|FG005|NOT COMPLETED|Stage 2||0
11156827|NCT01562275|12345123|FG006|NOT COMPLETED|Stage 2||0
11156828|NCT01562275|12345124|FG007|NOT COMPLETED|Stage 2||0
11156829|NCT01562275|12345125|FG008|NOT COMPLETED|Stage 2||0
11156830|NCT01562275|12345126|FG009|NOT COMPLETED|Stage 2||0
11156831|NCT01562275|12345127|FG010|NOT COMPLETED|Stage 2||0
11156832|NCT01562275|12345128|FG011|NOT COMPLETED|Stage 2||14
11156833|NCT01562275|12345129|FG012|NOT COMPLETED|Stage 2||5
11156834|NCT01562314|12345161|FG000|STARTED|Overall Study||29
11156835|NCT01562314|12345162|FG001|STARTED|Overall Study||31
11156836|NCT01562314|12345161|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29
11156837|NCT01562314|12345162|FG001|Received at Least 1 Dose of Study Drug|Overall Study||31
11156838|NCT01562314|12345161|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
11156839|NCT01562314|12345162|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
11156840|NCT01562314|12345161|FG000|Per Protocol (PP) Analysis Set|Overall Study||17
11156841|NCT01562314|12345162|FG001|Per Protocol (PP) Analysis Set|Overall Study||27
11156842|NCT01562314|12345161|FG000|COMPLETED|Overall Study||16
11156843|NCT01562314|12345162|FG001|COMPLETED|Overall Study||23
11156844|NCT01562314|12345161|FG000|NOT COMPLETED|Overall Study||13
11156845|NCT01562314|12345162|FG001|NOT COMPLETED|Overall Study||8
11156846|NCT01562327|12345168|FG000|STARTED|Overall Study||50
11156847|NCT01562327|12345168|FG000|COMPLETED|Overall Study||42
11156848|NCT01562327|12345168|FG000|NOT COMPLETED|Overall Study||8
11156849|NCT01562379|12345178|FG000|STARTED|Overall Study||1438
11156850|NCT01562379|12345179|FG001|STARTED|Overall Study||1492
11156851|NCT01562379|12345180|FG002|STARTED|Overall Study||851
11156852|NCT01562379|12345181|FG003|STARTED|Overall Study||843
11156853|NCT01562379|12345182|FG004|STARTED|Overall Study||825
11156854|NCT01562379|12345178|FG000|COMPLETED|Overall Study||1312
11156855|NCT01562379|12345179|FG001|COMPLETED|Overall Study||1395
11156856|NCT01562379|12345180|FG002|COMPLETED|Overall Study||789
11156857|NCT01562379|12345181|FG003|COMPLETED|Overall Study||786
11156858|NCT01562379|12345182|FG004|COMPLETED|Overall Study||785
11156859|NCT01562379|12345178|FG000|NOT COMPLETED|Overall Study||126
11156860|NCT01562379|12345179|FG001|NOT COMPLETED|Overall Study||97
11156861|NCT01562379|12345180|FG002|NOT COMPLETED|Overall Study||62
11156862|NCT01562379|12345181|FG003|NOT COMPLETED|Overall Study||57
11156863|NCT01562379|12345182|FG004|NOT COMPLETED|Overall Study||40
11156864|NCT01562444|12345197|FG000|STARTED|Overall Study||48
11156865|NCT01562444|12345198|FG001|STARTED|Overall Study||51
11156866|NCT01562444|12345199|FG002|STARTED|Overall Study||106
11156867|NCT01562444|12345197|FG000|COMPLETED|Overall Study||43
11156868|NCT01562444|12345198|FG001|COMPLETED|Overall Study||49
11156869|NCT01562444|12345199|FG002|COMPLETED|Overall Study||99
11156870|NCT01562444|12345197|FG000|NOT COMPLETED|Overall Study||5
11156871|NCT01562444|12345198|FG001|NOT COMPLETED|Overall Study||2
11156872|NCT01562444|12345199|FG002|NOT COMPLETED|Overall Study||7
11156873|NCT01562548|12345211|FG000|STARTED|Overall Study||25
11156874|NCT01562548|12345212|FG001|STARTED|Overall Study||15
11156875|NCT01562548|12345213|FG002|STARTED|Overall Study||25
11156876|NCT01562548|12345214|FG003|STARTED|Overall Study||14
11156877|NCT01562548|12345211|FG000|COMPLETED|Overall Study||25
11156878|NCT01562548|12345212|FG001|COMPLETED|Overall Study||15
11156879|NCT01562548|12345213|FG002|COMPLETED|Overall Study||24
11156880|NCT01562548|12345214|FG003|COMPLETED|Overall Study||14
11156881|NCT01562548|12345211|FG000|NOT COMPLETED|Overall Study||0
11156882|NCT01562548|12345212|FG001|NOT COMPLETED|Overall Study||0
11156883|NCT01562548|12345213|FG002|NOT COMPLETED|Overall Study||1
11156884|NCT01562548|12345214|FG003|NOT COMPLETED|Overall Study||0
11156885|NCT01562613|12345226|FG000|STARTED|Overall Study||533
11156886|NCT01562613|12345226|FG000|COMPLETED|Overall Study||529
11156887|NCT01562613|12345226|FG000|NOT COMPLETED|Overall Study||4
11156888|NCT01562678|12345232|FG000|STARTED|Overall Study||14
11156889|NCT01562678|12345233|FG001|STARTED|Overall Study||14
11156890|NCT01562678|12345232|FG000|COMPLETED|Overall Study||8
11156891|NCT01562678|12345233|FG001|COMPLETED|Overall Study||12
11156892|NCT01562678|12345232|FG000|NOT COMPLETED|Overall Study||6
11156893|NCT01562678|12345233|FG001|NOT COMPLETED|Overall Study||2
11156894|NCT01562743|12345239|FG000|STARTED|Overall Study||185
11156895|NCT01562743|12345239|FG000|COMPLETED|Overall Study||133
11156896|NCT01562743|12345239|FG000|NOT COMPLETED|Overall Study||52
11156897|NCT01562756|12345243|FG000|STARTED|Overall Study||6
11156898|NCT01562756|12345243|FG000|COMPLETED|Overall Study||6
11156899|NCT01562756|12345243|FG000|NOT COMPLETED|Overall Study||0
11156900|NCT01562782|12345249|FG000|STARTED|Overall Study||19
11156901|NCT01562782|12345250|FG001|STARTED|Overall Study||20
11156902|NCT01562782|12345249|FG000|COMPLETED|Overall Study||15
11156903|NCT01562782|12345250|FG001|COMPLETED|Overall Study||15
11156904|NCT01562782|12345249|FG000|NOT COMPLETED|Overall Study||4
11156905|NCT01562782|12345250|FG001|NOT COMPLETED|Overall Study||5
11156906|NCT01562873|12345256|FG000|STARTED|Overall Study||21
11156907|NCT01562873|12345257|FG001|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
11156908|NCT01562873|12345256|FG000|COMPLETED|Overall Study||0
11156909|NCT01562873|12345257|FG001|COMPLETED|Overall Study||0
11156910|NCT01562873|12345256|FG000|NOT COMPLETED|Overall Study||21
11156911|NCT01562873|12345257|FG001|NOT COMPLETED|Overall Study||0
11156912|NCT01562886|12345261|FG000|STARTED|Overall Study||14
11156913|NCT01562886|12345261|FG000|COMPLETED|Overall Study||13
11156914|NCT01562886|12345261|FG000|NOT COMPLETED|Overall Study||1
11156915|NCT01563003|12345267|FG000|STARTED|Overall Study||16
11156916|NCT01563003|12345268|FG001|STARTED|Overall Study||15
11156917|NCT01563003|12345267|FG000|COMPLETED|Overall Study||16
11156918|NCT01563003|12345268|FG001|COMPLETED|Overall Study||15
11156919|NCT01563003|12345267|FG000|NOT COMPLETED|Overall Study||0
11156920|NCT01563003|12345268|FG001|NOT COMPLETED|Overall Study||0
11156921|NCT01563029|12345279|FG000|STARTED|Overall Study||119
11156922|NCT01563029|12345280|FG001|STARTED|Overall Study||118
11156923|NCT01563029|12345281|FG002|STARTED|Overall Study||120
11156924|NCT01563029|12345282|FG003|STARTED|Overall Study||118
11156925|NCT01563029|12345283|FG004|STARTED|Overall Study||118
11156926|NCT01563029|12345279|FG000|COMPLETED|Overall Study||66
11156927|NCT01563029|12345280|FG001|COMPLETED|Overall Study||94
11156928|NCT01563029|12345281|FG002|COMPLETED|Overall Study||87
11156929|NCT01563029|12345282|FG003|COMPLETED|Overall Study||85
11156930|NCT01563029|12345283|FG004|COMPLETED|Overall Study||89
11026676|NCT00829829|12205268|FG002|NOT COMPLETED|Overall Study||11
11026677|NCT00829933|12205281|FG000|STARTED|Overall Study||135
11026678|NCT00829933|12205282|FG001|STARTED|Overall Study||135
11026679|NCT00829933|12205283|FG002|STARTED|Overall Study||132
11026680|NCT00829933|12205284|FG003|STARTED|Overall Study||134
11026681|NCT00829933|12205281|FG000|Baseline Analysis Population|Overall Study||131
11026682|NCT00829933|12205282|FG001|Baseline Analysis Population|Overall Study||134
11057318|NCT00996996|12238788|FG000|STARTED|Overall Study||77
11156931|NCT01563029|12345279|FG000|NOT COMPLETED|Overall Study||53
11156932|NCT01563029|12345280|FG001|NOT COMPLETED|Overall Study||24
11156933|NCT01563029|12345281|FG002|NOT COMPLETED|Overall Study||33
11156934|NCT01563029|12345282|FG003|NOT COMPLETED|Overall Study||33
11156935|NCT01563029|12345283|FG004|NOT COMPLETED|Overall Study||29
11156936|NCT01563055|12345296|FG000|STARTED|Overall Study||10
11156937|NCT01563055|12345296|FG000|COMPLETED|Overall Study||10
11156938|NCT01563055|12345296|FG000|NOT COMPLETED|Overall Study||0
11156939|NCT01563081|12345305|FG000|STARTED|Overall Study||30
11323018|NCT02450331|12520315|FG001|NOT COMPLETED|Overall Study||406
11323019|NCT02028221|12520324|FG000|STARTED|Overall Study||75
11323020|NCT02028221|12520325|FG001|STARTED|Overall Study||76
11323021|NCT02028221|12520324|FG000|COMPLETED|Overall Study||62
11323022|NCT02028221|12520325|FG001|COMPLETED|Overall Study||56
11323023|NCT02028221|12520324|FG000|NOT COMPLETED|Overall Study||13
11323024|NCT02028221|12520325|FG001|NOT COMPLETED|Overall Study||20
11323025|NCT01984346|12520333|FG000|STARTED|Overall Study|Date of full approval was 8/22/13. Date of first treated patient was 01/08/14|115
11323026|NCT01984346|12520334|FG001|STARTED|Overall Study||55
11323027|NCT01984346|12520333|FG000|Treated|Overall Study||102
11323028|NCT01984346|12520334|FG001|Treated|Overall Study||51
11323029|NCT01984346|12520333|FG000|COMPLETED|Overall Study||98
11323030|NCT01984346|12520334|FG001|COMPLETED|Overall Study||50
11323031|NCT01984346|12520333|FG000|NOT COMPLETED|Overall Study||17
11323032|NCT01984346|12520334|FG001|NOT COMPLETED|Overall Study||5
11323033|NCT01963780|12520340|FG000|STARTED|Overall Study|Patients received lung transplant|79
11323034|NCT01963780|12520340|FG000|COMPLETED|Overall Study||72
11323035|NCT01963780|12520340|FG000|NOT COMPLETED|Overall Study||7
11323036|NCT01958593|12520346|FG000|STARTED|Overall Study||2
11323037|NCT01958593|12520347|FG001|STARTED|Overall Study||4
11323038|NCT01958593|12520346|FG000|COMPLETED|Overall Study||2
11323039|NCT01958593|12520347|FG001|COMPLETED|Overall Study||4
11323040|NCT01958593|12520346|FG000|NOT COMPLETED|Overall Study||0
11323041|NCT01958593|12520347|FG001|NOT COMPLETED|Overall Study||0
11323042|NCT01793610|12520357|FG000|STARTED|Overall Study||6
11323043|NCT01793610|12520358|FG001|STARTED|Overall Study||9
11323044|NCT01793610|12520359|FG002|STARTED|Overall Study||13
11323045|NCT01793610|12520357|FG000|COMPLETED|Overall Study||5
11323046|NCT01793610|12520358|FG001|COMPLETED|Overall Study||9
11323047|NCT01793610|12520359|FG002|COMPLETED|Overall Study||12
11323048|NCT01793610|12520357|FG000|NOT COMPLETED|Overall Study||1
11323049|NCT01793610|12520358|FG001|NOT COMPLETED|Overall Study||0
11323050|NCT01793610|12520359|FG002|NOT COMPLETED|Overall Study||1
11323051|NCT01780545|12520373|FG000|STARTED|Overall Study||99
11323052|NCT01780545|12520374|FG001|STARTED|Overall Study||101
11323053|NCT01780545|12520373|FG000|COMPLETED|Overall Study||95
11323054|NCT01780545|12520374|FG001|COMPLETED|Overall Study||99
11323055|NCT01780545|12520373|FG000|NOT COMPLETED|Overall Study||4
11323056|NCT01780545|12520374|FG001|NOT COMPLETED|Overall Study||2
11323057|NCT01732107|12520383|FG000|STARTED|Overall Study||13
11323058|NCT01732107|12520383|FG000|COMPLETED|Overall Study||0
11323059|NCT01732107|12520383|FG000|NOT COMPLETED|Overall Study||13
11323060|NCT01681433|12520389|FG000|STARTED|Overall Study||36
11323061|NCT01681433|12520390|FG001|STARTED|Overall Study||36
11323062|NCT01681433|12520389|FG000|COMPLETED|Overall Study||4
11323063|NCT01681433|12520390|FG001|COMPLETED|Overall Study||3
11323064|NCT01681433|12520389|FG000|NOT COMPLETED|Overall Study||32
11323065|NCT01681433|12520390|FG001|NOT COMPLETED|Overall Study||33
11323066|NCT01630434|12520398|FG000|STARTED|Overall Study||151
11323067|NCT01630434|12520399|FG001|STARTED|Overall Study||169
11323068|NCT01630434|12520398|FG000|Safety Population|Overall Study||150
11323069|NCT01630434|12520399|FG001|Safety Population|Overall Study||169
11323070|NCT01630434|12520398|FG000|Per Protocol Population|Overall Study||141
11323071|NCT01630434|12520399|FG001|Per Protocol Population|Overall Study||165
11323072|NCT01630434|12520398|FG000|COMPLETED|Overall Study||121
11323073|NCT01630434|12520399|FG001|COMPLETED|Overall Study||139
11156940|NCT01563081|12345306|FG001|STARTED|Overall Study||30
11156941|NCT01563081|12345305|FG000|COMPLETED|Overall Study||30
11323074|NCT01630434|12520398|FG000|NOT COMPLETED|Overall Study||30
11323075|NCT01630434|12520399|FG001|NOT COMPLETED|Overall Study||30
11343016|NCT02950545|12540317|FG000|NOT COMPLETED|Washout 2 (5 Minutes)||1
11343017|NCT02950545|12540318|FG001|NOT COMPLETED|Washout 2 (5 Minutes)||0
11343018|NCT02950545|12540319|FG002|NOT COMPLETED|Washout 2 (5 Minutes)||0
11323076|NCT01524991|12520409|FG000|STARTED|Overall Study||36
11323077|NCT01524991|12520409|FG000|COMPLETED|Overall Study||2
11418902|NCT00384293|12617303|FG000|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
11323078|NCT01524991|12520409|FG000|NOT COMPLETED|Overall Study||34
11323079|NCT01452854|12520413|FG000|STARTED|Overall Study||2
11323080|NCT01452854|12520413|FG000|COMPLETED|Overall Study||2
11323081|NCT01452854|12520413|FG000|NOT COMPLETED|Overall Study||0
11323082|NCT01211405|12520420|FG000|STARTED|Overall Study||7
11323083|NCT01211405|12520421|FG001|STARTED|Overall Study||7
11323084|NCT01211405|12520422|FG002|STARTED|Overall Study||12
11323085|NCT01211405|12520420|FG000|Completed Primary Endpoint|Overall Study||7
11323086|NCT01211405|12520421|FG001|Completed Primary Endpoint|Overall Study||7
11323087|NCT01211405|12520422|FG002|Completed Primary Endpoint|Overall Study||12
11343019|NCT02950545|12540320|FG003|NOT COMPLETED|Washout 2 (5 Minutes)||0
11156942|NCT01563081|12345306|FG001|COMPLETED|Overall Study||30
11156943|NCT01563081|12345305|FG000|NOT COMPLETED|Overall Study||0
11156944|NCT01563081|12345306|FG001|NOT COMPLETED|Overall Study||0
11156945|NCT01563172|12345316|FG000|STARTED|Overall Study||65
11156946|NCT01563172|12345316|FG000|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
11156947|NCT01563172|12345316|FG000|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
11156948|NCT01563172|12345316|FG000|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
11156949|NCT01563172|12345316|FG000|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
11156950|NCT01563172|12345316|FG000|Control Dentifrice|Overall Study||60
11156951|NCT01563172|12345316|FG000|COMPLETED|Overall Study||52
11156952|NCT01563172|12345316|FG000|NOT COMPLETED|Overall Study||13
11156953|NCT01563185|12345331|FG000|STARTED|Overall Study||12
11156954|NCT01563185|12345331|FG000|COMPLETED|Overall Study||10
11156955|NCT01563185|12345331|FG000|NOT COMPLETED|Overall Study||2
11156956|NCT01563198|12345335|FG000|STARTED|Baseline||49733
11156957|NCT01563198|12345335|FG000|COMPLETED|Baseline||49733
11156958|NCT01563198|12345335|FG000|NOT COMPLETED|Baseline||0
11156959|NCT01563198|12345335|FG000|STARTED|After Training||47979
11156960|NCT01563198|12345335|FG000|COMPLETED|After Training||47979
11156961|NCT01563198|12345335|FG000|NOT COMPLETED|After Training||0
11156962|NCT01563237|12345339|FG000|STARTED|Overall Study||64
11156963|NCT01563237|12345340|FG001|STARTED|Overall Study||5
11156964|NCT01563237|12345339|FG000|COMPLETED|Overall Study||54
11156965|NCT01563237|12345340|FG001|COMPLETED|Overall Study||5
11156966|NCT01563237|12345339|FG000|NOT COMPLETED|Overall Study||10
11156967|NCT01563237|12345340|FG001|NOT COMPLETED|Overall Study||0
11156968|NCT01563354|12345348|FG000|STARTED|Core Phase||41
11156969|NCT01563354|12345349|FG001|STARTED|Core Phase||42
11156970|NCT01563354|12345350|FG002|STARTED|Core Phase||41
11156971|NCT01563354|12345348|FG000|Entered Extension Phase|Core Phase||12
11156972|NCT01563354|12345349|FG001|Entered Extension Phase|Core Phase||14
11156973|NCT01563354|12345350|FG002|Entered Extension Phase|Core Phase||15
11156974|NCT01563354|12345348|FG000|COMPLETED|Core Phase||12
11156975|NCT01563354|12345349|FG001|COMPLETED|Core Phase||14
11156976|NCT01563354|12345350|FG002|COMPLETED|Core Phase||15
11156977|NCT01563354|12345348|FG000|NOT COMPLETED|Core Phase||29
11156978|NCT01563354|12345349|FG001|NOT COMPLETED|Core Phase||28
11156979|NCT01563354|12345350|FG002|NOT COMPLETED|Core Phase||26
11156980|NCT01563354|12345348|FG000|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|12
11156981|NCT01563354|12345349|FG001|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|14
11156982|NCT01563354|12345350|FG002|STARTED|Extension Phase||15
11156983|NCT01563354|12345348|FG000|COMPLETED|Extension Phase||0
11156984|NCT01563354|12345349|FG001|COMPLETED|Extension Phase||0
11156985|NCT01563354|12345350|FG002|COMPLETED|Extension Phase||0
11156986|NCT01563354|12345348|FG000|NOT COMPLETED|Extension Phase||12
11156987|NCT01563354|12345349|FG001|NOT COMPLETED|Extension Phase||14
11156988|NCT01563354|12345350|FG002|NOT COMPLETED|Extension Phase||15
11156989|NCT01563406|12345362|FG000|STARTED|Overall Study|194 hubs|60
11156990|NCT01563406|12345363|FG001|STARTED|Overall Study|102 hubs|30
11156991|NCT01563406|12345364|FG002|STARTED|Overall Study|101 hubs|30
11156992|NCT01563406|12345365|FG003|STARTED|Overall Study|112 hubs|29
11156993|NCT01563406|12345362|FG000|COMPLETED|Overall Study|194 hubs|60
11156994|NCT01563406|12345363|FG001|COMPLETED|Overall Study|102 hubs|30
11156995|NCT01563406|12345364|FG002|COMPLETED|Overall Study|101 hubs|30
11156996|NCT01563406|12345365|FG003|COMPLETED|Overall Study|112 hubs|29
11156997|NCT01563406|12345362|FG000|NOT COMPLETED|Overall Study||0
11156998|NCT01563406|12345363|FG001|NOT COMPLETED|Overall Study||0
11156999|NCT01563406|12345364|FG002|NOT COMPLETED|Overall Study||0
11157000|NCT01563406|12345365|FG003|NOT COMPLETED|Overall Study||0
11157001|NCT01563536|12345381|FG000|STARTED|Overall Study||6
11157002|NCT01563536|12345382|FG001|STARTED|Overall Study||6
11157003|NCT01563536|12345381|FG000|COMPLETED|Overall Study||5
11157004|NCT01563536|12345382|FG001|COMPLETED|Overall Study||4
11157005|NCT01563536|12345381|FG000|NOT COMPLETED|Overall Study||1
11157006|NCT01563536|12345382|FG001|NOT COMPLETED|Overall Study||2
11157007|NCT01563913|12345390|FG000|STARTED|Overall Study||15
11157008|NCT01563913|12345391|FG001|STARTED|Overall Study||15
11157009|NCT01563913|12345390|FG000|COMPLETED|Overall Study||13
11157010|NCT01563913|12345391|FG001|COMPLETED|Overall Study||15
11157011|NCT01563913|12345390|FG000|NOT COMPLETED|Overall Study||2
11157012|NCT01563913|12345391|FG001|NOT COMPLETED|Overall Study||0
11157013|NCT01563978|12345399|FG000|STARTED|Overall Study|Patients who received treatment.|68
11157014|NCT01563978|12345400|FG001|STARTED|Overall Study|Patients who received treatment.|67
11157015|NCT01563978|12345399|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
11157016|NCT01563978|12345400|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
11157017|NCT01563978|12345399|FG000|COMPLETED|Overall Study||64
11157018|NCT01563978|12345400|FG001|COMPLETED|Overall Study||65
11157019|NCT01563978|12345399|FG000|NOT COMPLETED|Overall Study||4
11157020|NCT01563978|12345400|FG001|NOT COMPLETED|Overall Study||2
11157021|NCT01564277|12345408|FG000|STARTED|Overall Study||12
11157022|NCT01564277|12345409|FG001|STARTED|Overall Study||12
11157023|NCT01564277|12345408|FG000|COMPLETED|Overall Study||11
11157024|NCT01564277|12345409|FG001|COMPLETED|Overall Study||11
11157025|NCT01564277|12345408|FG000|NOT COMPLETED|Overall Study||1
11157026|NCT01564277|12345409|FG001|NOT COMPLETED|Overall Study||1
11157027|NCT01564394|12345417|FG000|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
11157028|NCT01564394|12345418|FG001|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
11157029|NCT01564394|12345417|FG000|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
11157030|NCT01564394|12345418|FG001|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
11157031|NCT01564394|12345417|FG000|NOT COMPLETED|Overall Study||6
11157032|NCT01564394|12345418|FG001|NOT COMPLETED|Overall Study||10
11157033|NCT01564407|12345429|FG000|STARTED|Overall Study||4
11157034|NCT01564407|12345430|FG001|STARTED|Overall Study||5
11157035|NCT01564407|12345431|FG002|STARTED|Overall Study||4
11157036|NCT01564407|12345432|FG003|STARTED|Overall Study||2
11157037|NCT01564407|12345433|FG004|STARTED|Overall Study||0
11157038|NCT01564407|12345429|FG000|COMPLETED|Overall Study||4
11157039|NCT01564407|12345430|FG001|COMPLETED|Overall Study||3
11157040|NCT01564407|12345431|FG002|COMPLETED|Overall Study||4
11157041|NCT01564407|12345432|FG003|COMPLETED|Overall Study||1
11157042|NCT01564407|12345433|FG004|COMPLETED|Overall Study||0
11418903|NCT00384293|12617304|FG001|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
11418904|NCT00384293|12617305|FG002|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
11418905|NCT00384293|12617303|FG000|COMPLETED|Post-randomization Period||0
11418906|NCT00384293|12617304|FG001|COMPLETED|Post-randomization Period||0
11418907|NCT00384293|12617305|FG002|COMPLETED|Post-randomization Period||0
11418908|NCT00384293|12617303|FG000|NOT COMPLETED|Post-randomization Period||0
11418909|NCT00384293|12617304|FG001|NOT COMPLETED|Post-randomization Period||214
11418910|NCT00384293|12617305|FG002|NOT COMPLETED|Post-randomization Period||219
11418911|NCT00383630|12617313|FG000|STARTED|Overall Study||1
11418912|NCT00383630|12617313|FG000|COMPLETED|Overall Study||1
11418913|NCT00383630|12617313|FG000|NOT COMPLETED|Overall Study||0
11418914|NCT00374543|12617319|FG000|STARTED|Overall Study||2
11418915|NCT00374543|12617320|FG001|STARTED|Overall Study||1
11418916|NCT00374543|12617319|FG000|COMPLETED|Overall Study||2
11418917|NCT00374543|12617320|FG001|COMPLETED|Overall Study||1
11418918|NCT00374543|12617319|FG000|NOT COMPLETED|Overall Study||0
11418919|NCT00374543|12617320|FG001|NOT COMPLETED|Overall Study||0
11157043|NCT01564407|12345429|FG000|NOT COMPLETED|Overall Study||0
11157044|NCT01564407|12345430|FG001|NOT COMPLETED|Overall Study||2
11157045|NCT01564407|12345431|FG002|NOT COMPLETED|Overall Study||0
11157046|NCT01564407|12345432|FG003|NOT COMPLETED|Overall Study||1
11157047|NCT01564407|12345433|FG004|NOT COMPLETED|Overall Study||0
11157048|NCT01564459|12345457|FG000|STARTED|Run-In||12
11157049|NCT01564459|12345458|FG001|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
11157050|NCT01564459|12345459|FG002|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
11157051|NCT01564459|12345457|FG000|COMPLETED|Run-In||0
11157052|NCT01564459|12345458|FG001|COMPLETED|Run-In||87
11026683|NCT00829933|12205283|FG002|Baseline Analysis Population|Overall Study||131
11026684|NCT00829933|12205284|FG003|Baseline Analysis Population|Overall Study||129
11026685|NCT00829933|12205281|FG000|COMPLETED|Overall Study||121
11026686|NCT00829933|12205282|FG001|COMPLETED|Overall Study||122
11026687|NCT00829933|12205283|FG002|COMPLETED|Overall Study||119
11026688|NCT00829933|12205284|FG003|COMPLETED|Overall Study||120
11026689|NCT00829933|12205281|FG000|NOT COMPLETED|Overall Study||14
11026690|NCT00829933|12205282|FG001|NOT COMPLETED|Overall Study||13
11026691|NCT00829933|12205283|FG002|NOT COMPLETED|Overall Study||13
11026692|NCT00829933|12205284|FG003|NOT COMPLETED|Overall Study||14
11026693|NCT00829985|12205296|FG000|STARTED|Overall Study||28
11026694|NCT00829985|12205297|FG001|STARTED|Overall Study||26
11026695|NCT00829985|12205296|FG000|COMPLETED|Overall Study||19
11026696|NCT00829985|12205297|FG001|COMPLETED|Overall Study||22
11026697|NCT00829985|12205296|FG000|NOT COMPLETED|Overall Study||9
11026698|NCT00829985|12205297|FG001|NOT COMPLETED|Overall Study||4
11026699|NCT00830037|12205305|FG000|STARTED|Overall Study||67
11026700|NCT00830037|12205306|FG001|STARTED|Overall Study||69
11026701|NCT00830037|12205305|FG000|COMPLETED|Overall Study||49
11026702|NCT00830037|12205306|FG001|COMPLETED|Overall Study||50
11157053|NCT01564459|12345459|FG002|COMPLETED|Run-In||83
11157054|NCT01564459|12345457|FG000|NOT COMPLETED|Run-In||12
11157055|NCT01564459|12345458|FG001|NOT COMPLETED|Run-In||0
11157056|NCT01564459|12345459|FG002|NOT COMPLETED|Run-In||0
11157057|NCT01564459|12345457|FG000|STARTED|Double-blind Treatment||0
11157058|NCT01564459|12345458|FG001|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
11157059|NCT01564459|12345459|FG002|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
11157060|NCT01564459|12345457|FG000|COMPLETED|Double-blind Treatment||0
11157061|NCT01564459|12345458|FG001|COMPLETED|Double-blind Treatment||87
11157062|NCT01564459|12345459|FG002|COMPLETED|Double-blind Treatment||82
11157063|NCT01564459|12345457|FG000|NOT COMPLETED|Double-blind Treatment||0
11157064|NCT01564459|12345458|FG001|NOT COMPLETED|Double-blind Treatment||0
11157065|NCT01564459|12345459|FG002|NOT COMPLETED|Double-blind Treatment||1
11157066|NCT01564485|12345472|FG000|STARTED|Overall Study||92
11157067|NCT01564485|12345473|FG001|STARTED|Overall Study||101
11157068|NCT01564485|12345472|FG000|COMPLETED|Overall Study||84
11157069|NCT01564485|12345473|FG001|COMPLETED|Overall Study||78
11157070|NCT01564485|12345472|FG000|NOT COMPLETED|Overall Study||8
11157071|NCT01564485|12345473|FG001|NOT COMPLETED|Overall Study||23
11418920|NCT00377455|12617326|FG000|STARTED|Overall Study||5
11157072|NCT01564628|12345479|FG000|STARTED|Overall Study||185
11157073|NCT01564628|12345480|FG001|STARTED|Overall Study||58
11157074|NCT01564628|12345481|FG002|STARTED|Overall Study||63
11157075|NCT01564628|12345479|FG000|COMPLETED|Overall Study||181
11157076|NCT01564628|12345480|FG001|COMPLETED|Overall Study||56
11157077|NCT01564628|12345481|FG002|COMPLETED|Overall Study||61
11157078|NCT01564628|12345479|FG000|NOT COMPLETED|Overall Study||4
11157079|NCT01564628|12345480|FG001|NOT COMPLETED|Overall Study||2
11157080|NCT01564628|12345481|FG002|NOT COMPLETED|Overall Study||2
11157081|NCT01564654|12345485|FG000|STARTED|Overall Study|106 knees (bilateral)|89
11157082|NCT01564654|12345485|FG000|COMPLETED|Overall Study|106 knees (bilateral)|89
11157083|NCT01564654|12345485|FG000|NOT COMPLETED|Overall Study||0
11157084|NCT01564693|12345492|FG000|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
11157085|NCT01564693|12345493|FG001|STARTED|Overall Study||4
11157086|NCT01564693|12345494|FG002|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
11157087|NCT01564693|12345492|FG000|COMPLETED|Overall Study||9
11157088|NCT01564693|12345493|FG001|COMPLETED|Overall Study||4
11157089|NCT01564693|12345494|FG002|COMPLETED|Overall Study||2
11157090|NCT01564693|12345492|FG000|NOT COMPLETED|Overall Study||0
11157091|NCT01564693|12345493|FG001|NOT COMPLETED|Overall Study||0
11157092|NCT01564693|12345494|FG002|NOT COMPLETED|Overall Study||0
11157093|NCT01564706|12345502|FG000|STARTED|Overall Study||9
11157094|NCT01564706|12345502|FG000|COMPLETED|Overall Study||9
11157095|NCT01564706|12345502|FG000|NOT COMPLETED|Overall Study||0
11157096|NCT01564758|12345506|FG000|STARTED|Overall Study||99
11157097|NCT01564758|12345506|FG000|COMPLETED|Overall Study||85
11157098|NCT01564758|12345506|FG000|NOT COMPLETED|Overall Study||14
11157099|NCT01564784|12345512|FG000|STARTED|Overall Study|Treated (164 randomized)|164
11157100|NCT01564784|12345513|FG001|STARTED|Overall Study|Treated (162 randomized)|143
11157101|NCT01564784|12345512|FG000|COMPLETED|Overall Study||30
11418921|NCT00377455|12617326|FG000|COMPLETED|Overall Study||4
11418922|NCT00377455|12617326|FG000|NOT COMPLETED|Overall Study||1
11418923|NCT00371462|12617332|FG000|STARTED|Overall Study||35
11418924|NCT00371462|12617333|FG001|STARTED|Overall Study||35
11418925|NCT00371462|12617332|FG000|COMPLETED|Overall Study||27
11418926|NCT00371462|12617333|FG001|COMPLETED|Overall Study||27
11418927|NCT00371462|12617332|FG000|NOT COMPLETED|Overall Study||8
11157102|NCT01564784|12345513|FG001|COMPLETED|Overall Study||10
11157103|NCT01564784|12345512|FG000|NOT COMPLETED|Overall Study||134
11157104|NCT01564784|12345513|FG001|NOT COMPLETED|Overall Study||133
11157105|NCT01564862|12345522|FG000|STARTED|Overall Study||198
11157106|NCT01564862|12345523|FG001|STARTED|Overall Study||210
11157107|NCT01564862|12345524|FG002|STARTED|Overall Study||194
11157108|NCT01564862|12345522|FG000|Received Treatment|Overall Study||196
11157109|NCT01564862|12345523|FG001|Received Treatment|Overall Study||207
11157110|NCT01564862|12345524|FG002|Received Treatment|Overall Study||191
11157111|NCT01564862|12345522|FG000|COMPLETED|Overall Study||168
11157112|NCT01564862|12345523|FG001|COMPLETED|Overall Study||176
11157113|NCT01564862|12345524|FG002|COMPLETED|Overall Study||164
11157114|NCT01564862|12345522|FG000|NOT COMPLETED|Overall Study||30
11157115|NCT01564862|12345523|FG001|NOT COMPLETED|Overall Study||34
11157116|NCT01564862|12345524|FG002|NOT COMPLETED|Overall Study||30
11157117|NCT01564914|12345534|FG000|STARTED|Overall Study||16
11157118|NCT01564914|12345535|FG001|STARTED|Overall Study||6
11157119|NCT01564914|12345534|FG000|COMPLETED|Overall Study||16
11157120|NCT01564914|12345535|FG001|COMPLETED|Overall Study||6
11157121|NCT01564914|12345534|FG000|NOT COMPLETED|Overall Study||0
11157122|NCT01564914|12345535|FG001|NOT COMPLETED|Overall Study||0
11157123|NCT01564953|12345544|FG000|STARTED|Overall Study||143
11157124|NCT01564953|12345544|FG000|COMPLETED|Overall Study||143
11157125|NCT01564953|12345544|FG000|NOT COMPLETED|Overall Study||0
11157126|NCT01565083|12345554|FG000|STARTED|Overall Study||106
11157127|NCT01565083|12345555|FG001|STARTED|Overall Study||107
11157128|NCT01565083|12345554|FG000|COMPLETED|Overall Study||73
11157129|NCT01565083|12345555|FG001|COMPLETED|Overall Study||68
11157130|NCT01565083|12345554|FG000|NOT COMPLETED|Overall Study||33
11157131|NCT01565083|12345555|FG001|NOT COMPLETED|Overall Study||39
11157132|NCT01565148|12345565|FG000|STARTED|Overall Study||47
11157133|NCT01565148|12345566|FG001|STARTED|Overall Study||46
11157134|NCT01565148|12345567|FG002|STARTED|Overall Study||47
11157135|NCT01565148|12345568|FG003|STARTED|Overall Study||45
11157136|NCT01565148|12345565|FG000|COMPLETED|Overall Study||32
11157137|NCT01565148|12345566|FG001|COMPLETED|Overall Study||31
11157138|NCT01565148|12345567|FG002|COMPLETED|Overall Study||40
11157139|NCT01565148|12345568|FG003|COMPLETED|Overall Study||32
11157140|NCT01565148|12345565|FG000|NOT COMPLETED|Overall Study||15
11157141|NCT01565148|12345566|FG001|NOT COMPLETED|Overall Study||15
11157142|NCT01565148|12345567|FG002|NOT COMPLETED|Overall Study||7
11157143|NCT01565148|12345568|FG003|NOT COMPLETED|Overall Study||13
11157144|NCT01565291|12345584|FG000|STARTED|Overall Study||16
11157145|NCT01565291|12345585|FG001|STARTED|Overall Study||16
11157146|NCT01565291|12345584|FG000|COMPLETED|Overall Study||15
11157147|NCT01565291|12345585|FG001|COMPLETED|Overall Study||16
11157148|NCT01565291|12345584|FG000|NOT COMPLETED|Overall Study||1
11418928|NCT00371462|12617333|FG001|NOT COMPLETED|Overall Study||8
11418929|NCT00369265|12617341|FG000|STARTED|Overall Study||4
11418930|NCT00369265|12617342|FG001|STARTED|Overall Study||7
11157149|NCT01565291|12345585|FG001|NOT COMPLETED|Overall Study||0
11157150|NCT01565330|12345595|FG000|STARTED|Overall Study||5
11157151|NCT01565330|12345596|FG001|STARTED|Overall Study||4
11157152|NCT01565330|12345597|FG002|STARTED|Overall Study||4
11157153|NCT01565330|12345598|FG003|STARTED|Overall Study||7
11157154|NCT01565330|12345595|FG000|COMPLETED|Overall Study||5
11157155|NCT01565330|12345596|FG001|COMPLETED|Overall Study||4
11157156|NCT01565330|12345597|FG002|COMPLETED|Overall Study||4
11157157|NCT01565330|12345598|FG003|COMPLETED|Overall Study||7
11157158|NCT01565330|12345595|FG000|NOT COMPLETED|Overall Study||0
11157159|NCT01565330|12345596|FG001|NOT COMPLETED|Overall Study||0
11157160|NCT01565330|12345597|FG002|NOT COMPLETED|Overall Study||0
11157161|NCT01565330|12345598|FG003|NOT COMPLETED|Overall Study||0
11157162|NCT01565343|12345612|FG000|STARTED|Overall Study||11
11157163|NCT01565343|12345613|FG001|STARTED|Overall Study||4
11157164|NCT01565343|12345614|FG002|STARTED|Overall Study||10
11157165|NCT01565343|12345612|FG000|COMPLETED|Overall Study||10
11157166|NCT01565343|12345613|FG001|COMPLETED|Overall Study||4
11157167|NCT01565343|12345614|FG002|COMPLETED|Overall Study||10
11157168|NCT01565343|12345612|FG000|NOT COMPLETED|Overall Study||1
11157169|NCT01565343|12345613|FG001|NOT COMPLETED|Overall Study||0
11157170|NCT01565343|12345614|FG002|NOT COMPLETED|Overall Study||0
11157171|NCT01565356|12345621|FG000|STARTED|Overall Study||41
11157172|NCT01565356|12345621|FG000|COMPLETED|Overall Study||41
11157173|NCT01565356|12345621|FG000|NOT COMPLETED|Overall Study||0
11157174|NCT01565369|12345625|FG000|STARTED|Overall Study||35
11157175|NCT01565369|12345625|FG000|COMPLETED|Overall Study||35
11157176|NCT01565369|12345625|FG000|NOT COMPLETED|Overall Study||0
11157177|NCT01565499|12345630|FG000|STARTED|Overall Study||83
11157178|NCT01565499|12345630|FG000|COMPLETED|Overall Study||75
11157179|NCT01565499|12345630|FG000|NOT COMPLETED|Overall Study||8
11157180|NCT01565538|12345636|FG000|STARTED|Overall Study||61
11157181|NCT01565538|12345637|FG001|STARTED|Overall Study||62
11418931|NCT00369265|12617341|FG000|COMPLETED|Overall Study||0
11418932|NCT00369265|12617342|FG001|COMPLETED|Overall Study||0
11157182|NCT01565538|12345636|FG000|COMPLETED|Overall Study||61
11157183|NCT01565538|12345637|FG001|COMPLETED|Overall Study||62
11157184|NCT01565538|12345636|FG000|NOT COMPLETED|Overall Study||0
11157185|NCT01565538|12345637|FG001|NOT COMPLETED|Overall Study||0
11157186|NCT01565551|12345645|FG000|STARTED|Overall Study||586
11157187|NCT01565551|12345646|FG001|STARTED|Overall Study||51
11157188|NCT01565551|12345645|FG000|Clinical/Demographics|Overall Study||586
11157189|NCT01565551|12345646|FG001|Clinical/Demographics|Overall Study||51
11157190|NCT01565551|12345645|FG000|Biospecimens/Biomarkers|Overall Study||479
11157191|NCT01565551|12345646|FG001|Biospecimens/Biomarkers|Overall Study||22
11157192|NCT01565551|12345645|FG000|Neuroimaging|Overall Study||233
11157193|NCT01565551|12345646|FG001|Neuroimaging|Overall Study||25
11157194|NCT01565551|12345645|FG000|6-Month Outcomes|Overall Study||412
11157195|NCT01565551|12345646|FG001|6-Month Outcomes|Overall Study||30
11157196|NCT01565551|12345645|FG000|COMPLETED|Overall Study||586
11157197|NCT01565551|12345646|FG001|COMPLETED|Overall Study||51
11157198|NCT01565551|12345645|FG000|NOT COMPLETED|Overall Study||0
11157199|NCT01565551|12345646|FG001|NOT COMPLETED|Overall Study||0
11157200|NCT01565564|12345654|FG000|STARTED|Overall Study||344
11157201|NCT01565564|12345655|FG001|STARTED|Overall Study||362
11157202|NCT01565564|12345654|FG000|COMPLETED|Overall Study||339
11157203|NCT01565564|12345655|FG001|COMPLETED|Overall Study||361
11157204|NCT01565564|12345654|FG000|NOT COMPLETED|Overall Study||5
11157205|NCT01565564|12345655|FG001|NOT COMPLETED|Overall Study||1
11157206|NCT01565616|12345661|FG000|STARTED|Overall Study||22
11157207|NCT01565616|12345661|FG000|First Component: 5 Related Donors|Overall Study||5
11157208|NCT01565616|12345661|FG000|Second Component: Related or Unrelated|Overall Study||17
11157209|NCT01565616|12345661|FG000|COMPLETED|Overall Study||22
11157210|NCT01565616|12345661|FG000|NOT COMPLETED|Overall Study||0
11157211|NCT01565642|12345667|FG000|STARTED|Overall Study||151
11157212|NCT01565642|12345668|FG001|STARTED|Overall Study||151
11157213|NCT01565642|12345667|FG000|COMPLETED|Overall Study||149
11157214|NCT01565642|12345668|FG001|COMPLETED|Overall Study||150
11157215|NCT01565642|12345667|FG000|NOT COMPLETED|Overall Study||2
11157216|NCT01565642|12345668|FG001|NOT COMPLETED|Overall Study||1
11157217|NCT01565668|12345676|FG000|STARTED|Overall Study||38
11157218|NCT01565668|12345677|FG001|STARTED|Overall Study||38
11157219|NCT01565668|12345676|FG000|Completed Treatment Per Protocol|Overall Study||0
11157220|NCT01565668|12345677|FG001|Completed Treatment Per Protocol|Overall Study||0
11157221|NCT01565668|12345676|FG000|Started 30-day Follow-up|Overall Study||37
11157222|NCT01565668|12345677|FG001|Started 30-day Follow-up|Overall Study||37
11157223|NCT01565668|12345676|FG000|Completed 30-day Follow-up|Overall Study||11
11157224|NCT01565668|12345677|FG001|Completed 30-day Follow-up|Overall Study||5
11157225|NCT01565668|12345676|FG000|Started Long-term Follow-up|Overall Study||36
11418933|NCT00369265|12617341|FG000|NOT COMPLETED|Overall Study||4
11418934|NCT00369265|12617342|FG001|NOT COMPLETED|Overall Study||7
11157226|NCT01565668|12345677|FG001|Started Long-term Follow-up|Overall Study||33
11157227|NCT01565668|12345676|FG000|Completed Long-term Follow-up|Overall Study||0
11157228|NCT01565668|12345677|FG001|Completed Long-term Follow-up|Overall Study||0
11157229|NCT01565668|12345676|FG000|COMPLETED|Overall Study||0
11157230|NCT01565668|12345677|FG001|COMPLETED|Overall Study||0
11157231|NCT01565668|12345676|FG000|NOT COMPLETED|Overall Study||38
11157232|NCT01565668|12345677|FG001|NOT COMPLETED|Overall Study||38
11157233|NCT01565694|12345683|FG000|STARTED|Dose-Titration Period||76
11343020|NCT02950545|12540321|FG004|NOT COMPLETED|Washout 2 (5 Minutes)||0
11157234|NCT01565694|12345683|FG000|COMPLETED|Dose-Titration Period||62
11157235|NCT01565694|12345683|FG000|NOT COMPLETED|Dose-Titration Period||14
11157236|NCT01565694|12345683|FG000|STARTED|Fixed-Dose Assessment Period||62
11157237|NCT01565694|12345683|FG000|COMPLETED|Fixed-Dose Assessment Period||58
11157238|NCT01565694|12345683|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||4
11157239|NCT01565707|12345691|FG000|STARTED|Overall Study||75
11157240|NCT01565707|12345692|FG001|STARTED|Overall Study||73
11157241|NCT01565707|12345693|FG002|STARTED|Overall Study||19
11157242|NCT01565707|12345694|FG003|STARTED|Overall Study||22
11157243|NCT01565707|12345691|FG000|Treated|Overall Study||73
11157244|NCT01565707|12345692|FG001|Treated|Overall Study||73
11157245|NCT01565707|12345693|FG002|Treated|Overall Study||19
11157246|NCT01565707|12345694|FG003|Treated|Overall Study||22
11157247|NCT01565707|12345691|FG000|COMPLETED|Overall Study||66
11157248|NCT01565707|12345692|FG001|COMPLETED|Overall Study||65
11157249|NCT01565707|12345693|FG002|COMPLETED|Overall Study||16
11157250|NCT01565707|12345694|FG003|COMPLETED|Overall Study||17
11157251|NCT01565707|12345691|FG000|NOT COMPLETED|Overall Study||9
11157252|NCT01565707|12345692|FG001|NOT COMPLETED|Overall Study||8
11157253|NCT01565707|12345693|FG002|NOT COMPLETED|Overall Study||3
11157254|NCT01565707|12345694|FG003|NOT COMPLETED|Overall Study||5
11157255|NCT01565850|12345713|FG000|STARTED|Overall Study||103
11157256|NCT01565850|12345714|FG001|STARTED|Overall Study||50
11157257|NCT01565850|12345713|FG000|COMPLETED|Overall Study||83
11157258|NCT01565850|12345714|FG001|COMPLETED|Overall Study||42
11157259|NCT01565850|12345713|FG000|NOT COMPLETED|Overall Study||20
11157260|NCT01565850|12345714|FG001|NOT COMPLETED|Overall Study||8
11157261|NCT01565889|12345726|FG000|STARTED|Part A||12
11157262|NCT01565889|12345727|FG001|STARTED|Part A||4
11157263|NCT01565889|12345728|FG002|STARTED|Part A||8
11157264|NCT01565889|12345729|FG003|STARTED|Part A||7
11157265|NCT01565889|12345730|FG004|STARTED|Part A||7
11157266|NCT01565889|12345731|FG005|STARTED|Part A||0
11157267|NCT01565889|12345726|FG000|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
11157268|NCT01565889|12345727|FG001|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
11157269|NCT01565889|12345728|FG002|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
11026703|NCT00830037|12205305|FG000|NOT COMPLETED|Overall Study||18
11026704|NCT00830037|12205306|FG001|NOT COMPLETED|Overall Study||19
11157270|NCT01565889|12345729|FG003|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
11157271|NCT01565889|12345730|FG004|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
11157272|NCT01565889|12345731|FG005|COMPLETED|Part A||0
11157273|NCT01565889|12345726|FG000|NOT COMPLETED|Part A||1
11157274|NCT01565889|12345727|FG001|NOT COMPLETED|Part A||0
11157275|NCT01565889|12345728|FG002|NOT COMPLETED|Part A||0
11157276|NCT01565889|12345729|FG003|NOT COMPLETED|Part A||0
11157277|NCT01565889|12345730|FG004|NOT COMPLETED|Part A||0
11157278|NCT01565889|12345731|FG005|NOT COMPLETED|Part A||0
11157279|NCT01565889|12345726|FG000|STARTED|Part B||0
11157280|NCT01565889|12345727|FG001|STARTED|Part B||0
11157281|NCT01565889|12345728|FG002|STARTED|Part B||0
11157282|NCT01565889|12345729|FG003|STARTED|Part B||0
11157283|NCT01565889|12345730|FG004|STARTED|Part B||0
11157284|NCT01565889|12345731|FG005|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
11157285|NCT01565889|12345726|FG000|COMPLETED|Part B||0
11157286|NCT01565889|12345727|FG001|COMPLETED|Part B||0
11157287|NCT01565889|12345728|FG002|COMPLETED|Part B||0
11157288|NCT01565889|12345729|FG003|COMPLETED|Part B||0
11157289|NCT01565889|12345730|FG004|COMPLETED|Part B||0
11157290|NCT01565889|12345731|FG005|COMPLETED|Part B||19
11157291|NCT01565889|12345726|FG000|NOT COMPLETED|Part B||0
11157292|NCT01565889|12345727|FG001|NOT COMPLETED|Part B||0
11157293|NCT01565889|12345728|FG002|NOT COMPLETED|Part B||0
11157294|NCT01565889|12345729|FG003|NOT COMPLETED|Part B||0
11157295|NCT01565889|12345730|FG004|NOT COMPLETED|Part B||0
11157296|NCT01565889|12345731|FG005|NOT COMPLETED|Part B||4
11157297|NCT01565902|12345750|FG000|STARTED|Overall Study||8
11157298|NCT01565902|12345751|FG001|STARTED|Overall Study||8
11157299|NCT01565902|12345752|FG002|STARTED|Overall Study||8
11157300|NCT01565902|12345753|FG003|STARTED|Overall Study||16
11157301|NCT01565902|12345750|FG000|COMPLETED|Overall Study||8
11157302|NCT01565902|12345751|FG001|COMPLETED|Overall Study||8
11157303|NCT01565902|12345752|FG002|COMPLETED|Overall Study||8
11157304|NCT01565902|12345753|FG003|COMPLETED|Overall Study||16
11157305|NCT01565902|12345750|FG000|NOT COMPLETED|Overall Study||0
11157306|NCT01565902|12345751|FG001|NOT COMPLETED|Overall Study||0
11157307|NCT01565902|12345752|FG002|NOT COMPLETED|Overall Study||0
11157308|NCT01565902|12345753|FG003|NOT COMPLETED|Overall Study||0
11157309|NCT01565928|12345766|FG000|STARTED|Overall Study||22
11157310|NCT01565928|12345766|FG000|COMPLETED|Overall Study||0
11157311|NCT01565928|12345766|FG000|NOT COMPLETED|Overall Study||22
11157312|NCT01565980|12345775|FG000|STARTED|Overall Study||20
11157313|NCT01565980|12345776|FG001|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
11157314|NCT01565980|12345775|FG000|COMPLETED|Overall Study||16
11157315|NCT01565980|12345776|FG001|COMPLETED|Overall Study||16
11157316|NCT01565980|12345775|FG000|NOT COMPLETED|Overall Study||4
11157317|NCT01565980|12345776|FG001|NOT COMPLETED|Overall Study||4
11026705|NCT00830063|12205316|FG000|STARTED|Overall Study||208
11157318|NCT01565993|12345788|FG000|STARTED|Overall Study||66
11157319|NCT01565993|12345789|FG001|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
11157320|NCT01565993|12345788|FG000|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
11157321|NCT01565993|12345789|FG001|COMPLETED|Overall Study||39
11157322|NCT01565993|12345788|FG000|NOT COMPLETED|Overall Study||0
11157323|NCT01565993|12345789|FG001|NOT COMPLETED|Overall Study||3
11157324|NCT01566084|12345797|FG000|STARTED|Overall Study||7
11157325|NCT01566084|12345798|FG001|STARTED|Overall Study||10
11157326|NCT01566084|12345797|FG000|COMPLETED|Overall Study||7
11157327|NCT01566084|12345798|FG001|COMPLETED|Overall Study||10
11157328|NCT01566084|12345797|FG000|NOT COMPLETED|Overall Study||0
11157329|NCT01566084|12345798|FG001|NOT COMPLETED|Overall Study||0
11157330|NCT01566162|12345812|FG000|STARTED|Overall Study||191
11157331|NCT01566162|12345812|FG000|COMPLETED|Overall Study||155
11157332|NCT01566162|12345812|FG000|NOT COMPLETED|Overall Study||36
11203230|NCT01846299|12393727|FG000|COMPLETED|Overall Study||106
11203231|NCT01846299|12393728|FG001|COMPLETED|Overall Study||50
11203232|NCT01846299|12393727|FG000|NOT COMPLETED|Overall Study||12
11203233|NCT01846299|12393728|FG001|NOT COMPLETED|Overall Study||10
11203234|NCT01846416|12393739|FG000|STARTED|Treatment Phase||31
11203235|NCT01846416|12393740|FG001|STARTED|Treatment Phase||93
11203236|NCT01846416|12393741|FG002|STARTED|Treatment Phase||13
11203237|NCT01846416|12393739|FG000|COMPLETED|Treatment Phase||0
11203238|NCT01846416|12393740|FG001|COMPLETED|Treatment Phase||0
11203239|NCT01846416|12393741|FG002|COMPLETED|Treatment Phase||0
11203240|NCT01846416|12393739|FG000|NOT COMPLETED|Treatment Phase||31
11203241|NCT01846416|12393740|FG001|NOT COMPLETED|Treatment Phase||93
11203242|NCT01846416|12393741|FG002|NOT COMPLETED|Treatment Phase||13
11203243|NCT01846416|12393739|FG000|STARTED|Survival Follow-up||28
11418935|NCT00370695|12617348|FG000|STARTED|Overall Study||15
11418936|NCT00370695|12617348|FG000|12 Weeks Post-activation|Overall Study||2
11418937|NCT00370695|12617348|FG000|COMPLETED|Overall Study||0
11418938|NCT00370695|12617348|FG000|NOT COMPLETED|Overall Study||15
11418939|NCT00364689|12617355|FG000|STARTED|Overall Study||13
11203244|NCT01846416|12393740|FG001|STARTED|Survival Follow-up||80
11203245|NCT01846416|12393741|FG002|STARTED|Survival Follow-up||12
11203246|NCT01846416|12393739|FG000|COMPLETED|Survival Follow-up||0
11203247|NCT01846416|12393740|FG001|COMPLETED|Survival Follow-up||0
11203248|NCT01846416|12393741|FG002|COMPLETED|Survival Follow-up||0
11203249|NCT01846416|12393739|FG000|NOT COMPLETED|Survival Follow-up||28
11203250|NCT01846416|12393740|FG001|NOT COMPLETED|Survival Follow-up||80
11203251|NCT01846416|12393741|FG002|NOT COMPLETED|Survival Follow-up||12
11203252|NCT01846442|12393754|FG000|STARTED|Overall Study||54
11203253|NCT01846442|12393755|FG001|STARTED|Overall Study||54
11203254|NCT01846442|12393756|FG002|STARTED|Overall Study||56
11203255|NCT01846442|12393757|FG003|STARTED|Overall Study||54
11203256|NCT01846442|12393754|FG000|Safety Population|Overall Study||54
11203257|NCT01846442|12393755|FG001|Safety Population|Overall Study||53
11203258|NCT01846442|12393756|FG002|Safety Population|Overall Study||56
11203259|NCT01846442|12393757|FG003|Safety Population|Overall Study||54
11203260|NCT01846442|12393754|FG000|ITT Population|Overall Study||53
11203261|NCT01846442|12393755|FG001|ITT Population|Overall Study||53
11203262|NCT01846442|12393756|FG002|ITT Population|Overall Study||56
11203263|NCT01846442|12393757|FG003|ITT Population|Overall Study||54
11203264|NCT01846442|12393754|FG000|COMPLETED|Overall Study||48
11203265|NCT01846442|12393755|FG001|COMPLETED|Overall Study||48
11203266|NCT01846442|12393756|FG002|COMPLETED|Overall Study||52
11203267|NCT01846442|12393757|FG003|COMPLETED|Overall Study||51
11203268|NCT01846442|12393754|FG000|NOT COMPLETED|Overall Study||6
11203269|NCT01846442|12393755|FG001|NOT COMPLETED|Overall Study||6
11203270|NCT01846442|12393756|FG002|NOT COMPLETED|Overall Study||4
11203271|NCT01846442|12393757|FG003|NOT COMPLETED|Overall Study||3
11203272|NCT01846455|12393772|FG000|STARTED|Overall Study||9
11203273|NCT01846455|12393773|FG001|STARTED|Overall Study||8
11203274|NCT01846455|12393774|FG002|STARTED|Overall Study||8
11203275|NCT01846455|12393775|FG003|STARTED|Overall Study||10
11203276|NCT01846455|12393776|FG004|STARTED|Overall Study||8
11203277|NCT01846455|12393772|FG000|PK Population|Overall Study||6
11203278|NCT01846455|12393773|FG001|PK Population|Overall Study||7
11203279|NCT01846455|12393774|FG002|PK Population|Overall Study||6
11203280|NCT01846455|12393775|FG003|PK Population|Overall Study||6
11203281|NCT01846455|12393776|FG004|PK Population|Overall Study||8
11203282|NCT01846455|12393772|FG000|COMPLETED|Overall Study||9
11203283|NCT01846455|12393773|FG001|COMPLETED|Overall Study||8
11203284|NCT01846455|12393774|FG002|COMPLETED|Overall Study||8
11203285|NCT01846455|12393775|FG003|COMPLETED|Overall Study||10
11203286|NCT01846455|12393776|FG004|COMPLETED|Overall Study||8
11203287|NCT01846455|12393772|FG000|NOT COMPLETED|Overall Study||0
11203288|NCT01846455|12393773|FG001|NOT COMPLETED|Overall Study||0
11157333|NCT01566214|12345818|FG000|STARTED|Overall Study||6
11157334|NCT01566214|12345819|FG001|STARTED|Overall Study||6
11157335|NCT01566214|12345818|FG000|COMPLETED|Overall Study||3
11157336|NCT01566214|12345819|FG001|COMPLETED|Overall Study||6
11157337|NCT01566214|12345818|FG000|NOT COMPLETED|Overall Study||3
11157338|NCT01566214|12345819|FG001|NOT COMPLETED|Overall Study||0
11157339|NCT01566331|12345827|FG000|STARTED|Overall Study||40
11157340|NCT01566331|12345828|FG001|STARTED|Overall Study||40
11157341|NCT01566331|12345827|FG000|COMPLETED|Overall Study||40
11157342|NCT01566331|12345828|FG001|COMPLETED|Overall Study||40
11157343|NCT01566331|12345827|FG000|NOT COMPLETED|Overall Study||0
11157344|NCT01566331|12345828|FG001|NOT COMPLETED|Overall Study||0
11157345|NCT01566409|12345836|FG000|STARTED|Overall Study||49
11157346|NCT01566409|12345837|FG001|STARTED|Overall Study||53
11157347|NCT01566409|12345836|FG000|COMPLETED|Overall Study||47
11157348|NCT01566409|12345837|FG001|COMPLETED|Overall Study||48
11157349|NCT01566409|12345836|FG000|NOT COMPLETED|Overall Study||2
11157350|NCT01566409|12345837|FG001|NOT COMPLETED|Overall Study||5
11157351|NCT01566435|12345843|FG000|STARTED|ACF Induction Therapy||30
11157352|NCT01566435|12345843|FG000|COMPLETED|ACF Induction Therapy||30
11157353|NCT01566435|12345843|FG000|NOT COMPLETED|ACF Induction Therapy||0
11157354|NCT01566435|12345843|FG000|STARTED|ACF Definitive Chemoradiation-cisplatin||28
11157355|NCT01566435|12345843|FG000|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
11157356|NCT01566435|12345843|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
11157357|NCT01566435|12345843|FG000|STARTED|ACF Definitive Chemoradiation-cetuximab||2
11157358|NCT01566435|12345843|FG000|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
11157359|NCT01566435|12345843|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
11157360|NCT01566448|12345851|FG000|STARTED|Overall Study||30
11157361|NCT01566448|12345851|FG000|COMPLETED|Overall Study||30
11157362|NCT01566448|12345851|FG000|NOT COMPLETED|Overall Study||0
11157363|NCT01566461|12345857|FG000|STARTED|IN.PACT SFA I Phase||99
11157364|NCT01566461|12345858|FG001|STARTED|IN.PACT SFA I Phase||51
11157365|NCT01566461|12345857|FG000|COMPLETED|IN.PACT SFA I Phase||88
11157366|NCT01566461|12345858|FG001|COMPLETED|IN.PACT SFA I Phase||49
11157367|NCT01566461|12345857|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11
11157368|NCT01566461|12345858|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2
11157369|NCT01566461|12345857|FG000|STARTED|IN.PACT SFA II Phase||121
11157370|NCT01566461|12345858|FG001|STARTED|IN.PACT SFA II Phase||60
11157371|NCT01566461|12345857|FG000|COMPLETED|IN.PACT SFA II Phase||109
11157372|NCT01566461|12345858|FG001|COMPLETED|IN.PACT SFA II Phase||55
11157373|NCT01566461|12345857|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12
11157374|NCT01566461|12345858|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5
11157375|NCT01566500|12345864|FG000|STARTED|Overall Study||140
11157376|NCT01566500|12345864|FG000|COMPLETED|Overall Study||140
11157377|NCT01566500|12345864|FG000|NOT COMPLETED|Overall Study||0
11157378|NCT01566526|12345868|FG000|STARTED|Overall Study||26
11157379|NCT01566526|12345868|FG000|COMPLETED|Overall Study||26
11157380|NCT01566526|12345868|FG000|NOT COMPLETED|Overall Study||0
11157381|NCT01566539|12345880|FG000|STARTED|Main Study Period||101
11157382|NCT01566539|12345881|FG001|STARTED|Main Study Period||100
11157383|NCT01566539|12345882|FG002|STARTED|Main Study Period||104
11157384|NCT01566539|12345883|FG003|STARTED|Main Study Period||0
11157385|NCT01566539|12345884|FG004|STARTED|Main Study Period||40
11157386|NCT01566539|12345885|FG005|STARTED|Main Study Period||43
11157387|NCT01566539|12345886|FG006|STARTED|Main Study Period||30
11157388|NCT01566539|12345887|FG007|STARTED|Main Study Period||30
11157389|NCT01566539|12345888|FG008|STARTED|Main Study Period||1
11157390|NCT01566539|12345880|FG000|COMPLETED|Main Study Period||100
11157391|NCT01566539|12345881|FG001|COMPLETED|Main Study Period||100
11157392|NCT01566539|12345882|FG002|COMPLETED|Main Study Period||104
11157393|NCT01566539|12345883|FG003|COMPLETED|Main Study Period||0
11157394|NCT01566539|12345884|FG004|COMPLETED|Main Study Period||40
11157395|NCT01566539|12345885|FG005|COMPLETED|Main Study Period||40
11157396|NCT01566539|12345886|FG006|COMPLETED|Main Study Period||30
11157397|NCT01566539|12345887|FG007|COMPLETED|Main Study Period||30
11157398|NCT01566539|12345888|FG008|COMPLETED|Main Study Period||1
11157399|NCT01566539|12345880|FG000|NOT COMPLETED|Main Study Period||1
11157400|NCT01566539|12345881|FG001|NOT COMPLETED|Main Study Period||0
11157401|NCT01566539|12345882|FG002|NOT COMPLETED|Main Study Period||0
11157402|NCT01566539|12345883|FG003|NOT COMPLETED|Main Study Period||0
11157403|NCT01566539|12345884|FG004|NOT COMPLETED|Main Study Period||0
11157404|NCT01566539|12345885|FG005|NOT COMPLETED|Main Study Period||3
11157405|NCT01566539|12345886|FG006|NOT COMPLETED|Main Study Period||0
11157406|NCT01566539|12345887|FG007|NOT COMPLETED|Main Study Period||0
11157407|NCT01566539|12345888|FG008|NOT COMPLETED|Main Study Period||0
11157408|NCT01566539|12345880|FG000|STARTED|Within Subject Group||0
11157409|NCT01566539|12345881|FG001|STARTED|Within Subject Group||0
11157410|NCT01566539|12345882|FG002|STARTED|Within Subject Group||0
11157411|NCT01566539|12345883|FG003|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
11157412|NCT01566539|12345884|FG004|STARTED|Within Subject Group||0
11157413|NCT01566539|12345885|FG005|STARTED|Within Subject Group||0
11157414|NCT01566539|12345886|FG006|STARTED|Within Subject Group||0
11157415|NCT01566539|12345887|FG007|STARTED|Within Subject Group||0
11157416|NCT01566539|12345888|FG008|STARTED|Within Subject Group||0
11157417|NCT01566539|12345880|FG000|COMPLETED|Within Subject Group||0
11157418|NCT01566539|12345881|FG001|COMPLETED|Within Subject Group||0
11157419|NCT01566539|12345882|FG002|COMPLETED|Within Subject Group||0
11203289|NCT01846455|12393774|FG002|NOT COMPLETED|Overall Study||0
11157420|NCT01566539|12345883|FG003|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
11157421|NCT01566539|12345884|FG004|COMPLETED|Within Subject Group||0
11157422|NCT01566539|12345885|FG005|COMPLETED|Within Subject Group||0
11157423|NCT01566539|12345886|FG006|COMPLETED|Within Subject Group||0
11157424|NCT01566539|12345887|FG007|COMPLETED|Within Subject Group||0
11157425|NCT01566539|12345888|FG008|COMPLETED|Within Subject Group||0
11157426|NCT01566539|12345880|FG000|NOT COMPLETED|Within Subject Group||0
11157427|NCT01566539|12345881|FG001|NOT COMPLETED|Within Subject Group||0
11157428|NCT01566539|12345882|FG002|NOT COMPLETED|Within Subject Group||0
11157429|NCT01566539|12345883|FG003|NOT COMPLETED|Within Subject Group||3
11157430|NCT01566539|12345884|FG004|NOT COMPLETED|Within Subject Group||0
11157431|NCT01566539|12345885|FG005|NOT COMPLETED|Within Subject Group||0
11157432|NCT01566539|12345886|FG006|NOT COMPLETED|Within Subject Group||0
11157433|NCT01566539|12345887|FG007|NOT COMPLETED|Within Subject Group||0
11157434|NCT01566539|12345888|FG008|NOT COMPLETED|Within Subject Group||0
11157435|NCT01566604|12345912|FG000|STARTED|Overall Study||306
11157436|NCT01566604|12345913|FG001|STARTED|Overall Study||154
11157437|NCT01566604|12345912|FG000|Safety Set|Overall Study||305
11157438|NCT01566604|12345913|FG001|Safety Set|Overall Study||154
11157439|NCT01566604|12345912|FG000|Full Analysis Set (FAS)|Overall Study||305
11157440|NCT01566604|12345913|FG001|Full Analysis Set (FAS)|Overall Study||154
11157441|NCT01566604|12345912|FG000|FAS, Serial Spirometry Subgroup|Overall Study||134
11157442|NCT01566604|12345913|FG001|FAS, Serial Spirometry Subgroup|Overall Study||58
11157443|NCT01566604|12345912|FG000|COMPLETED|Overall Study||282
11157444|NCT01566604|12345913|FG001|COMPLETED|Overall Study||143
11157445|NCT01566604|12345912|FG000|NOT COMPLETED|Overall Study||24
11157446|NCT01566604|12345913|FG001|NOT COMPLETED|Overall Study||11
11157447|NCT01566630|12345921|FG000|STARTED|Overall Study||2
11157448|NCT01566630|12345922|FG001|STARTED|Overall Study||1
11157449|NCT01566630|12345921|FG000|COMPLETED|Overall Study||2
11157450|NCT01566630|12345922|FG001|COMPLETED|Overall Study||1
11157451|NCT01566630|12345921|FG000|NOT COMPLETED|Overall Study||0
11157452|NCT01566630|12345922|FG001|NOT COMPLETED|Overall Study||0
11157453|NCT01566682|12345934|FG000|STARTED|Overall Study||420
11157454|NCT01566682|12345934|FG000|COMPLETED|Overall Study||374
11157455|NCT01566682|12345934|FG000|NOT COMPLETED|Overall Study||46
11157456|NCT01566721|12345940|FG000|STARTED|Treatment Period||1867
11157457|NCT01566721|12345941|FG001|STARTED|Treatment Period||710
11157458|NCT01566721|12345940|FG000|COMPLETED|Treatment Period||1670
11157459|NCT01566721|12345941|FG001|COMPLETED|Treatment Period||652
11157460|NCT01566721|12345940|FG000|NOT COMPLETED|Treatment Period||197
11157461|NCT01566721|12345941|FG001|NOT COMPLETED|Treatment Period||58
11157462|NCT01566721|12345940|FG000|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|1865
11157463|NCT01566721|12345941|FG001|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|708
11157464|NCT01566721|12345940|FG000|COMPLETED|Safety Follow-up||1318
11157465|NCT01566721|12345941|FG001|COMPLETED|Safety Follow-up||501
11157466|NCT01566721|12345940|FG000|NOT COMPLETED|Safety Follow-up||547
11157467|NCT01566721|12345941|FG001|NOT COMPLETED|Safety Follow-up||207
11157468|NCT01566773|12345954|FG000|STARTED|Overall Study||140
11157469|NCT01566773|12345954|FG000|GP MDI 18 µg BID|Overall Study||64
11157470|NCT01566773|12345954|FG000|GP MDI 9 µg BID|Overall Study||64
11157471|NCT01566773|12345954|FG000|GP MDI 4.6 µg BID|Overall Study||62
11157472|NCT01566773|12345954|FG000|GP MDI 2.4 µg BID|Overall Study||64
11157473|NCT01566773|12345954|FG000|GP MDI 1.2 µg BID|Overall Study||57
11157474|NCT01566773|12345954|FG000|GP MDI 0.6 µg BID|Overall Study||59
11157475|NCT01566773|12345954|FG000|Placebo MDI|Overall Study||62
11157476|NCT01566773|12345954|FG000|Spiriva® Handihaler®|Overall Study||62
11157477|NCT01566773|12345954|FG000|COMPLETED|Overall Study||110
11157478|NCT01566773|12345954|FG000|NOT COMPLETED|Overall Study||30
11157479|NCT01566838|12345976|FG000|STARTED|Overall Study||41
11157480|NCT01566838|12345977|FG001|STARTED|Overall Study||42
11418940|NCT00364689|12617355|FG000|COMPLETED|Overall Study||12
11418941|NCT00364689|12617355|FG000|NOT COMPLETED|Overall Study||1
11418942|NCT00352118|12617361|FG000|STARTED|Overall Study||4
11157481|NCT01566838|12345976|FG000|COMPLETED|Overall Study||38
11157482|NCT01566838|12345977|FG001|COMPLETED|Overall Study||42
11157483|NCT01566838|12345976|FG000|NOT COMPLETED|Overall Study||3
11157484|NCT01566838|12345977|FG001|NOT COMPLETED|Overall Study||0
11157485|NCT01566981|12345985|FG000|STARTED|Overall Study||58
11157486|NCT01566981|12345986|FG001|STARTED|Overall Study||62
11418943|NCT00352118|12617361|FG000|COMPLETED|Overall Study||0
11418944|NCT00352118|12617361|FG000|NOT COMPLETED|Overall Study||4
11418945|NCT00368654|12617369|FG000|STARTED|Overall Study||3
11418946|NCT00368654|12617370|FG001|STARTED|Overall Study||3
11418947|NCT00368654|12617371|FG002|STARTED|Overall Study||3
11418948|NCT00368654|12617372|FG003|STARTED|Overall Study||3
11418949|NCT00368654|12617369|FG000|COMPLETED|Overall Study||0
11418950|NCT00368654|12617370|FG001|COMPLETED|Overall Study||0
11157487|NCT01566981|12345985|FG000|COMPLETED|Overall Study||53
11157488|NCT01566981|12345986|FG001|COMPLETED|Overall Study||54
11157489|NCT01566981|12345985|FG000|NOT COMPLETED|Overall Study||5
11157490|NCT01566981|12345986|FG001|NOT COMPLETED|Overall Study||8
11157491|NCT01567020|12345998|FG000|STARTED|Overall Study||28
11418951|NCT00368654|12617371|FG002|COMPLETED|Overall Study||0
11418952|NCT00368654|12617372|FG003|COMPLETED|Overall Study||0
11418953|NCT00368654|12617369|FG000|NOT COMPLETED|Overall Study||3
11418954|NCT00368654|12617370|FG001|NOT COMPLETED|Overall Study||3
11157492|NCT01567020|12345999|FG001|STARTED|Overall Study||46
11157493|NCT01567020|12346000|FG002|STARTED|Overall Study||20
11157494|NCT01567020|12346001|FG003|STARTED|Overall Study||11
11157495|NCT01567020|12345998|FG000|COMPLETED|Overall Study||21
11157496|NCT01567020|12345999|FG001|COMPLETED|Overall Study||41
11157497|NCT01567020|12346000|FG002|COMPLETED|Overall Study||18
11157498|NCT01567020|12346001|FG003|COMPLETED|Overall Study||10
11157499|NCT01567020|12345998|FG000|NOT COMPLETED|Overall Study||7
11157500|NCT01567020|12345999|FG001|NOT COMPLETED|Overall Study||5
11157501|NCT01567020|12346000|FG002|NOT COMPLETED|Overall Study||2
11157502|NCT01567020|12346001|FG003|NOT COMPLETED|Overall Study||1
11157503|NCT01567085|12346011|FG000|STARTED|Overall Study||80
11157504|NCT01567085|12346011|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80
11157505|NCT01567085|12346011|FG000|COMPLETED|Overall Study||60
11418955|NCT00368654|12617371|FG002|NOT COMPLETED|Overall Study||3
11418956|NCT00368654|12617372|FG003|NOT COMPLETED|Overall Study||3
11418957|NCT00356421|12617384|FG000|STARTED|Overall Study||38
11157506|NCT01567085|12346011|FG000|NOT COMPLETED|Overall Study||20
11157507|NCT01567150|12346017|FG000|STARTED|Overall Study||21
11157508|NCT01567150|12346018|FG001|STARTED|Overall Study||18
11157509|NCT01567150|12346017|FG000|COMPLETED|Overall Study||19
11157510|NCT01567150|12346018|FG001|COMPLETED|Overall Study||16
11157511|NCT01567150|12346017|FG000|NOT COMPLETED|Overall Study||2
11157512|NCT01567150|12346018|FG001|NOT COMPLETED|Overall Study||2
11157513|NCT01567163|12346024|FG000|STARTED|Overall Study||22
11157514|NCT01567163|12346024|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
11157515|NCT01567163|12346024|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
11157516|NCT01567163|12346024|FG000|COMPLETED|Overall Study||18
11157517|NCT01567163|12346024|FG000|NOT COMPLETED|Overall Study||4
11157518|NCT01567306|12346039|FG000|STARTED|Overall Study||27
11157519|NCT01567306|12346040|FG001|STARTED|Overall Study||25
11157520|NCT01567306|12346041|FG002|STARTED|Overall Study||24
11157521|NCT01567306|12346042|FG003|STARTED|Overall Study||24
11157522|NCT01567306|12346043|FG004|STARTED|Overall Study||25
11157523|NCT01567306|12346044|FG005|STARTED|Overall Study||26
11157524|NCT01567306|12346039|FG000|COMPLETED|Overall Study||24
11157525|NCT01567306|12346040|FG001|COMPLETED|Overall Study||23
11157526|NCT01567306|12346041|FG002|COMPLETED|Overall Study||24
11157527|NCT01567306|12346042|FG003|COMPLETED|Overall Study||19
11157528|NCT01567306|12346043|FG004|COMPLETED|Overall Study||18
11157529|NCT01567306|12346044|FG005|COMPLETED|Overall Study||23
11157530|NCT01567306|12346039|FG000|NOT COMPLETED|Overall Study||3
11157531|NCT01567306|12346040|FG001|NOT COMPLETED|Overall Study||2
11157532|NCT01567306|12346041|FG002|NOT COMPLETED|Overall Study||0
11157533|NCT01567306|12346042|FG003|NOT COMPLETED|Overall Study||5
11157534|NCT01567306|12346043|FG004|NOT COMPLETED|Overall Study||7
11157535|NCT01567306|12346044|FG005|NOT COMPLETED|Overall Study||3
11157536|NCT01567371|12346058|FG000|STARTED|Overall Study||30
11157537|NCT01567371|12346058|FG000|COMPLETED|Overall Study||30
11157538|NCT01567371|12346058|FG000|NOT COMPLETED|Overall Study||0
11157539|NCT01567462|12346064|FG000|STARTED|Overall Study||45
11157540|NCT01567462|12346065|FG001|STARTED|Overall Study||45
11157541|NCT01567462|12346064|FG000|COMPLETED|Overall Study||41
11157542|NCT01567462|12346065|FG001|COMPLETED|Overall Study||38
11157543|NCT01567462|12346064|FG000|NOT COMPLETED|Overall Study||4
11157544|NCT01567462|12346065|FG001|NOT COMPLETED|Overall Study||7
11157545|NCT01567527|12346073|FG000|STARTED|Conversion Phase.||466
11157546|NCT01567527|12346074|FG001|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
11157547|NCT01567527|12346075|FG002|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
11157548|NCT01567527|12346076|FG003|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
11157549|NCT01567527|12346077|FG004|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
11157550|NCT01567527|12346073|FG000|COMPLETED|Conversion Phase.||367
11157551|NCT01567527|12346074|FG001|COMPLETED|Conversion Phase.||0
11157552|NCT01567527|12346075|FG002|COMPLETED|Conversion Phase.||0
11157553|NCT01567527|12346076|FG003|COMPLETED|Conversion Phase.||0
11157554|NCT01567527|12346077|FG004|COMPLETED|Conversion Phase.||0
11157555|NCT01567527|12346073|FG000|NOT COMPLETED|Conversion Phase.||99
11157556|NCT01567527|12346074|FG001|NOT COMPLETED|Conversion Phase.||0
11157557|NCT01567527|12346075|FG002|NOT COMPLETED|Conversion Phase.||0
11157558|NCT01567527|12346076|FG003|NOT COMPLETED|Conversion Phase.||0
11157559|NCT01567527|12346077|FG004|NOT COMPLETED|Conversion Phase.||0
11157560|NCT01567527|12346073|FG000|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
11203290|NCT01846455|12393775|FG003|NOT COMPLETED|Overall Study||0
11418958|NCT00356421|12617385|FG001|STARTED|Overall Study||20
11418959|NCT00356421|12617384|FG000|COMPLETED|Overall Study||6
11418960|NCT00356421|12617385|FG001|COMPLETED|Overall Study||3
11418961|NCT00356421|12617384|FG000|NOT COMPLETED|Overall Study||32
11418962|NCT00356421|12617385|FG001|NOT COMPLETED|Overall Study||17
11418963|NCT00350623|12617394|FG000|STARTED|Overall Study||71
11418964|NCT00350623|12617395|FG001|STARTED|Overall Study||71
11418965|NCT00350623|12617396|FG002|STARTED|Overall Study||68
11418966|NCT00350623|12617394|FG000|COMPLETED|Overall Study||63
11418967|NCT00350623|12617395|FG001|COMPLETED|Overall Study||67
11418968|NCT00350623|12617396|FG002|COMPLETED|Overall Study||62
11418969|NCT00350623|12617394|FG000|NOT COMPLETED|Overall Study||8
11418970|NCT00350623|12617395|FG001|NOT COMPLETED|Overall Study||4
11157561|NCT01567527|12346074|FG001|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
11418971|NCT00350623|12617396|FG002|NOT COMPLETED|Overall Study||6
11157562|NCT01567527|12346075|FG002|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
11157563|NCT01567527|12346076|FG003|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
11157564|NCT01567527|12346077|FG004|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
11157565|NCT01567527|12346073|FG000|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
11157566|NCT01567527|12346074|FG001|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
11157567|NCT01567527|12346075|FG002|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
11157568|NCT01567527|12346076|FG003|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
11157569|NCT01567527|12346077|FG004|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
11157570|NCT01567527|12346073|FG000|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
11157571|NCT01567527|12346074|FG001|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
11157572|NCT01567527|12346075|FG002|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
11157573|NCT01567527|12346076|FG003|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
11418972|NCT00356187|12617406|FG000|STARTED|Overall Study||0
11418973|NCT00356187|12617407|FG001|STARTED|Overall Study||0
11418974|NCT00356187|12617406|FG000|COMPLETED|Overall Study||0
11418975|NCT00356187|12617407|FG001|COMPLETED|Overall Study||0
11418976|NCT00356187|12617406|FG000|NOT COMPLETED|Overall Study||0
11418977|NCT00356187|12617407|FG001|NOT COMPLETED|Overall Study||0
11418978|NCT00353275|12617417|FG000|STARTED|Overall Study||2
11418979|NCT00353275|12617418|FG001|STARTED|Overall Study||3
11418980|NCT00353275|12617417|FG000|COMPLETED|Overall Study||2
11418981|NCT00353275|12617418|FG001|COMPLETED|Overall Study||3
11157574|NCT01567527|12346077|FG004|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
11157575|NCT01567527|12346073|FG000|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
11157576|NCT01567527|12346074|FG001|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
11157577|NCT01567527|12346075|FG002|STARTED|IM Depot Stabilization.||425
11157578|NCT01567527|12346076|FG003|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
11157579|NCT01567527|12346077|FG004|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
11157580|NCT01567527|12346073|FG000|COMPLETED|IM Depot Stabilization.||0
11157581|NCT01567527|12346074|FG001|COMPLETED|IM Depot Stabilization.||0
11157582|NCT01567527|12346075|FG002|COMPLETED|IM Depot Stabilization.||266
11157583|NCT01567527|12346076|FG003|COMPLETED|IM Depot Stabilization.||0
11157584|NCT01567527|12346077|FG004|COMPLETED|IM Depot Stabilization.||0
11157585|NCT01567527|12346073|FG000|NOT COMPLETED|IM Depot Stabilization.||0
11157586|NCT01567527|12346074|FG001|NOT COMPLETED|IM Depot Stabilization.||0
11157587|NCT01567527|12346075|FG002|NOT COMPLETED|IM Depot Stabilization.||159
11157588|NCT01567527|12346076|FG003|NOT COMPLETED|IM Depot Stabilization.||0
11157589|NCT01567527|12346077|FG004|NOT COMPLETED|IM Depot Stabilization.||0
11157590|NCT01567527|12346073|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
11157591|NCT01567527|12346074|FG001|STARTED|Double-blind, Placebo-controlled Phase||0
11157592|NCT01567527|12346075|FG002|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
11157593|NCT01567527|12346076|FG003|STARTED|Double-blind, Placebo-controlled Phase||133
11157594|NCT01567527|12346077|FG004|STARTED|Double-blind, Placebo-controlled Phase||133
11157595|NCT01567527|12346073|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
11157596|NCT01567527|12346074|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||0
11157597|NCT01567527|12346075|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||0
11157598|NCT01567527|12346076|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||64
11157599|NCT01567527|12346077|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||38
11157600|NCT01567527|12346073|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
11157601|NCT01567527|12346074|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
11157602|NCT01567527|12346075|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
11157603|NCT01567527|12346076|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
11157604|NCT01567527|12346077|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
11418982|NCT00353275|12617417|FG000|NOT COMPLETED|Overall Study||0
11418983|NCT00353275|12617418|FG001|NOT COMPLETED|Overall Study||0
11418984|NCT00350844|12617424|FG000|STARTED|Overall Study||6
11418985|NCT00350844|12617424|FG000|COMPLETED|Overall Study||5
11418986|NCT00350844|12617424|FG000|NOT COMPLETED|Overall Study||1
11418987|NCT00348556|12617428|FG000|STARTED|Overall Study||4
11418988|NCT00348556|12617428|FG000|COMPLETED|Overall Study||3
11418989|NCT00348556|12617428|FG000|NOT COMPLETED|Overall Study||1
11418990|NCT00319839|12617432|FG000|STARTED|Overall Study||7
11418991|NCT00319839|12617432|FG000|COMPLETED|Overall Study||1
11418992|NCT00319839|12617432|FG000|NOT COMPLETED|Overall Study||6
11418993|NCT00344019|12617439|FG000|STARTED|Overall Study||12
11418994|NCT00344019|12617440|FG001|STARTED|Overall Study||11
11418995|NCT00344019|12617441|FG002|STARTED|Overall Study||74
11418996|NCT00344019|12617439|FG000|COMPLETED|Overall Study||12
11418997|NCT00344019|12617440|FG001|COMPLETED|Overall Study||11
11418998|NCT00344019|12617441|FG002|COMPLETED|Overall Study||0
11418999|NCT00344019|12617439|FG000|NOT COMPLETED|Overall Study||0
11419000|NCT00344019|12617440|FG001|NOT COMPLETED|Overall Study||0
11419001|NCT00344019|12617441|FG002|NOT COMPLETED|Overall Study||74
11419002|NCT00338455|12617454|FG000|STARTED|Overall Study||9
11157605|NCT01567826|12346088|FG000|STARTED|Overall Study||43
11419003|NCT00338455|12617455|FG001|STARTED|Overall Study||7
11419004|NCT00338455|12617454|FG000|Administered Study Drug|Overall Study||8
11419005|NCT00338455|12617455|FG001|Administered Study Drug|Overall Study||7
11419006|NCT00338455|12617454|FG000|COMPLETED|Overall Study||6
11419007|NCT00338455|12617455|FG001|COMPLETED|Overall Study||6
11419008|NCT00338455|12617454|FG000|NOT COMPLETED|Overall Study||3
11419009|NCT00338455|12617455|FG001|NOT COMPLETED|Overall Study||1
11419010|NCT00329108|12617463|FG000|STARTED|Overall Study|study terminated due to poor recruitment|15
11419011|NCT00329108|12617464|FG001|STARTED|Overall Study|study terminated due to poor recruitment|14
11419012|NCT00329108|12617463|FG000|COMPLETED|Overall Study||5
11419013|NCT00329108|12617464|FG001|COMPLETED|Overall Study||2
11419014|NCT00329108|12617463|FG000|NOT COMPLETED|Overall Study||10
11419015|NCT00329108|12617464|FG001|NOT COMPLETED|Overall Study||12
11419016|NCT00325572|12617472|FG000|STARTED|PHASE I||45
11419017|NCT00325572|12617473|FG001|STARTED|PHASE I||44
11419018|NCT00325572|12617472|FG000|COMPLETED|PHASE I||45
11419019|NCT00325572|12617473|FG001|COMPLETED|PHASE I||44
11419020|NCT00325572|12617472|FG000|NOT COMPLETED|PHASE I||0
11419021|NCT00325572|12617473|FG001|NOT COMPLETED|PHASE I||0
11419022|NCT00325572|12617472|FG000|STARTED|PHASE ii||0
11419023|NCT00325572|12617473|FG001|STARTED|PHASE ii||0
11419024|NCT00325572|12617472|FG000|COMPLETED|PHASE ii||0
11419025|NCT00325572|12617473|FG001|COMPLETED|PHASE ii||0
11419026|NCT00325572|12617472|FG000|NOT COMPLETED|PHASE ii||0
11419027|NCT00325572|12617473|FG001|NOT COMPLETED|PHASE ii||0
11419028|NCT00333762|12617479|FG000|STARTED|Overall Study||4
11419029|NCT00333762|12617479|FG000|COMPLETED|Overall Study||0
11419030|NCT00333762|12617479|FG000|NOT COMPLETED|Overall Study||4
11419031|NCT00333229|12617485|FG000|STARTED|Overall Study||6
11419032|NCT00333229|12617486|FG001|STARTED|Overall Study||5
11419033|NCT00333229|12617485|FG000|COMPLETED|Overall Study||6
11419034|NCT00333229|12617486|FG001|COMPLETED|Overall Study||4
11419035|NCT00333229|12617485|FG000|NOT COMPLETED|Overall Study||0
11419036|NCT00333229|12617486|FG001|NOT COMPLETED|Overall Study||1
11419037|NCT00322855|12617492|FG000|STARTED|Overall Study||1
11419038|NCT00322855|12617492|FG000|COMPLETED|Overall Study||1
11419039|NCT00322855|12617492|FG000|NOT COMPLETED|Overall Study||0
11419040|NCT00323635|12617498|FG000|STARTED|Overall Study||10
11419041|NCT00323635|12617499|FG001|STARTED|Overall Study||9
11419042|NCT00323635|12617498|FG000|COMPLETED|Overall Study||10
11419043|NCT00323635|12617499|FG001|COMPLETED|Overall Study||9
11419044|NCT00323635|12617498|FG000|NOT COMPLETED|Overall Study||0
11419045|NCT00323635|12617499|FG001|NOT COMPLETED|Overall Study||0
11419046|NCT00329732|12617509|FG000|STARTED|Overall Study||2
11419047|NCT00329732|12617510|FG001|STARTED|Overall Study||0
11157606|NCT01567826|12346089|FG001|STARTED|Overall Study||44
11157607|NCT01567826|12346088|FG000|COMPLETED|Overall Study||40
11157608|NCT01567826|12346089|FG001|COMPLETED|Overall Study||42
11157609|NCT01567826|12346088|FG000|NOT COMPLETED|Overall Study||3
11157610|NCT01567826|12346089|FG001|NOT COMPLETED|Overall Study||2
11157611|NCT01567839|12346097|FG000|STARTED|Overall Study||60
11157612|NCT01567839|12346097|FG000|COMPLETED|Overall Study||60
11157613|NCT01567839|12346097|FG000|NOT COMPLETED|Overall Study||0
11157614|NCT01567852|12346107|FG000|STARTED|Overall Study||8
11157615|NCT01567852|12346108|FG001|STARTED|Overall Study||12
11157616|NCT01567852|12346107|FG000|COMPLETED|Overall Study||4
11157617|NCT01567852|12346108|FG001|COMPLETED|Overall Study||5
11157618|NCT01567852|12346107|FG000|NOT COMPLETED|Overall Study||4
11157619|NCT01567852|12346108|FG001|NOT COMPLETED|Overall Study||7
11157620|NCT01567865|12346118|FG000|STARTED|Enrolled and Vaccinated (Day 0)||163
11157621|NCT01567865|12346119|FG001|STARTED|Enrolled and Vaccinated (Day 0)||220
11157622|NCT01567865|12346120|FG002|STARTED|Enrolled and Vaccinated (Day 0)||211
11157623|NCT01567865|12346121|FG003|STARTED|Enrolled and Vaccinated (Day 0)||224
11157624|NCT01567865|12346118|FG000|COMPLETED|Enrolled and Vaccinated (Day 0)||163
11157625|NCT01567865|12346119|FG001|COMPLETED|Enrolled and Vaccinated (Day 0)||220
11157626|NCT01567865|12346120|FG002|COMPLETED|Enrolled and Vaccinated (Day 0)||211
11157627|NCT01567865|12346121|FG003|COMPLETED|Enrolled and Vaccinated (Day 0)||224
11157628|NCT01567865|12346118|FG000|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
11157629|NCT01567865|12346119|FG001|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
11157630|NCT01567865|12346120|FG002|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
11157631|NCT01567865|12346121|FG003|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
11157632|NCT01567865|12346118|FG000|STARTED|Evaluated for Immunogenicity||163
11157633|NCT01567865|12346119|FG001|STARTED|Evaluated for Immunogenicity||220
11157634|NCT01567865|12346120|FG002|STARTED|Evaluated for Immunogenicity||211
11157635|NCT01567865|12346121|FG003|STARTED|Evaluated for Immunogenicity||224
11157636|NCT01567865|12346118|FG000|COMPLETED|Evaluated for Immunogenicity||146
11157637|NCT01567865|12346119|FG001|COMPLETED|Evaluated for Immunogenicity||195
11157638|NCT01567865|12346120|FG002|COMPLETED|Evaluated for Immunogenicity||192
11157639|NCT01567865|12346121|FG003|COMPLETED|Evaluated for Immunogenicity||194
11157640|NCT01567865|12346118|FG000|NOT COMPLETED|Evaluated for Immunogenicity||17
11157641|NCT01567865|12346119|FG001|NOT COMPLETED|Evaluated for Immunogenicity||25
11157642|NCT01567865|12346120|FG002|NOT COMPLETED|Evaluated for Immunogenicity||19
11157643|NCT01567865|12346121|FG003|NOT COMPLETED|Evaluated for Immunogenicity||30
11157644|NCT01567891|12346132|FG000|STARTED|Overall Study||9
11419048|NCT00329732|12617509|FG000|COMPLETED|Overall Study||2
11419049|NCT00329732|12617510|FG001|COMPLETED|Overall Study||0
11419050|NCT00329732|12617509|FG000|NOT COMPLETED|Overall Study||0
11419051|NCT00329732|12617510|FG001|NOT COMPLETED|Overall Study||0
11157645|NCT01567891|12346132|FG000|Received T-cell|Overall Study||6
11157646|NCT01567891|12346132|FG000|COMPLETED|Overall Study||6
11157647|NCT01567891|12346132|FG000|NOT COMPLETED|Overall Study||3
11157648|NCT01567943|12346147|FG000|STARTED|Overall Study||40
11157649|NCT01567943|12346148|FG001|STARTED|Overall Study||39
11157650|NCT01567943|12346149|FG002|STARTED|Overall Study||44
11157651|NCT01567943|12346147|FG000|COMPLETED|Overall Study||26
11157652|NCT01567943|12346148|FG001|COMPLETED|Overall Study||29
11157653|NCT01567943|12346149|FG002|COMPLETED|Overall Study||44
11157654|NCT01567943|12346147|FG000|NOT COMPLETED|Overall Study||14
11157655|NCT01567943|12346148|FG001|NOT COMPLETED|Overall Study||10
11157656|NCT01567943|12346149|FG002|NOT COMPLETED|Overall Study||0
11157657|NCT01568008|12346155|FG000|STARTED|Overall Study||933
11157658|NCT01568008|12346155|FG000|COMPLETED|Overall Study||699
11157659|NCT01568008|12346155|FG000|NOT COMPLETED|Overall Study||234
11157660|NCT01568021|12346159|FG000|STARTED|Overall Study||99
11157661|NCT01568021|12346159|FG000|COMPLETED|Overall Study||83
11157662|NCT01568021|12346159|FG000|NOT COMPLETED|Overall Study||16
11157663|NCT01568034|12346163|FG000|STARTED|Overall Study||2
11157664|NCT01568034|12346164|FG001|STARTED|Overall Study||2
11157665|NCT01568034|12346165|FG002|STARTED|Overall Study||3
11157666|NCT01568034|12346166|FG003|STARTED|Overall Study||3
11157667|NCT01568034|12346163|FG000|25 mg BIA 9-1067|Overall Study||2
11157668|NCT01568034|12346164|FG001|25 mg BIA 9-1067|Overall Study||2
11157669|NCT01568034|12346165|FG002|25 mg BIA 9-1067|Overall Study||3
11157670|NCT01568034|12346166|FG003|25 mg BIA 9-1067|Overall Study||3
11157671|NCT01568034|12346163|FG000|50 mg BIA 9-1067|Overall Study||2
11157672|NCT01568034|12346164|FG001|50 mg BIA 9-1067|Overall Study||2
11157673|NCT01568034|12346165|FG002|50 mg BIA 9-1067|Overall Study||3
11157674|NCT01568034|12346166|FG003|50 mg BIA 9-1067|Overall Study||3
11157675|NCT01568034|12346163|FG000|100 mg BIA 9-1067|Overall Study||2
11157676|NCT01568034|12346164|FG001|100 mg BIA 9-1067|Overall Study||2
11157677|NCT01568034|12346165|FG002|100 mg BIA 9-1067|Overall Study||3
11157678|NCT01568034|12346166|FG003|100 mg BIA 9-1067|Overall Study||3
11157679|NCT01568034|12346163|FG000|Placebo|Overall Study||1
11157680|NCT01568034|12346164|FG001|Placebo|Overall Study||2
11157681|NCT01568034|12346165|FG002|Placebo|Overall Study||3
11157682|NCT01568034|12346166|FG003|Placebo|Overall Study||3
11157683|NCT01568034|12346163|FG000|COMPLETED|Overall Study||1
11157684|NCT01568034|12346164|FG001|COMPLETED|Overall Study||2
11157685|NCT01568034|12346165|FG002|COMPLETED|Overall Study||3
11157686|NCT01568034|12346166|FG003|COMPLETED|Overall Study||3
11157687|NCT01568034|12346163|FG000|NOT COMPLETED|Overall Study||1
11157688|NCT01568034|12346164|FG001|NOT COMPLETED|Overall Study||0
11157689|NCT01568034|12346165|FG002|NOT COMPLETED|Overall Study||0
11157690|NCT01568034|12346166|FG003|NOT COMPLETED|Overall Study||0
11157691|NCT01568047|12346180|FG000|STARTED|Overall Study||10
11157692|NCT01568047|12346181|FG001|STARTED|Overall Study||10
11157693|NCT01568047|12346182|FG002|STARTED|Overall Study||10
11157694|NCT01568047|12346183|FG003|STARTED|Overall Study||10
11157695|NCT01568047|12346180|FG000|COMPLETED|Overall Study||9
11157696|NCT01568047|12346181|FG001|COMPLETED|Overall Study||9
11157697|NCT01568047|12346182|FG002|COMPLETED|Overall Study||9
11157698|NCT01568047|12346183|FG003|COMPLETED|Overall Study||9
11157699|NCT01568047|12346180|FG000|NOT COMPLETED|Overall Study||1
11157700|NCT01568047|12346181|FG001|NOT COMPLETED|Overall Study||1
11157701|NCT01568047|12346182|FG002|NOT COMPLETED|Overall Study||1
11157702|NCT01568047|12346183|FG003|NOT COMPLETED|Overall Study||1
11157703|NCT01568073|12346198|FG000|STARTED|Overall Study||121
11157704|NCT01568073|12346199|FG001|STARTED|Overall Study||122
11157705|NCT01568073|12346200|FG002|STARTED|Overall Study||122
11157706|NCT01568073|12346201|FG003|STARTED|Overall Study||119
11157707|NCT01568073|12346202|FG004|STARTED|Overall Study||116
11157708|NCT01568073|12346198|FG000|COMPLETED|Overall Study||110
11157709|NCT01568073|12346199|FG001|COMPLETED|Overall Study||107
11157710|NCT01568073|12346200|FG002|COMPLETED|Overall Study||110
11157711|NCT01568073|12346201|FG003|COMPLETED|Overall Study||108
11157712|NCT01568073|12346202|FG004|COMPLETED|Overall Study||107
11157713|NCT01568073|12346198|FG000|NOT COMPLETED|Overall Study||11
11157714|NCT01568073|12346199|FG001|NOT COMPLETED|Overall Study||15
11157715|NCT01568073|12346200|FG002|NOT COMPLETED|Overall Study||12
11157716|NCT01568073|12346201|FG003|NOT COMPLETED|Overall Study||11
11157717|NCT01568073|12346202|FG004|NOT COMPLETED|Overall Study||9
11157718|NCT01568112|12346218|FG000|STARTED|Overall Study||44
11157719|NCT01568112|12346219|FG001|STARTED|Overall Study||44
11157720|NCT01568112|12346220|FG002|STARTED|Overall Study||43
11157721|NCT01568112|12346221|FG003|STARTED|Overall Study||42
11157722|NCT01568112|12346218|FG000|COMPLETED|Overall Study||39
11157723|NCT01568112|12346219|FG001|COMPLETED|Overall Study||36
11157724|NCT01568112|12346220|FG002|COMPLETED|Overall Study||36
11157725|NCT01568112|12346221|FG003|COMPLETED|Overall Study||30
11157726|NCT01568112|12346218|FG000|NOT COMPLETED|Overall Study||5
11157727|NCT01568112|12346219|FG001|NOT COMPLETED|Overall Study||8
11157728|NCT01568112|12346220|FG002|NOT COMPLETED|Overall Study||7
11157729|NCT01568112|12346221|FG003|NOT COMPLETED|Overall Study||12
11157730|NCT01568255|12346234|FG000|STARTED|Overall Study||5
11157731|NCT01568255|12346235|FG001|STARTED|Overall Study||6
11157732|NCT01568255|12346234|FG000|COMPLETED|Overall Study||5
11157733|NCT01568255|12346235|FG001|COMPLETED|Overall Study||6
11157734|NCT01568255|12346234|FG000|NOT COMPLETED|Overall Study||0
11157735|NCT01568255|12346235|FG001|NOT COMPLETED|Overall Study||0
11157736|NCT01568320|12346241|FG000|STARTED|Overall Study||73
11157737|NCT01568320|12346241|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|36
11157738|NCT01568320|12346241|FG000|COMPLETED|Overall Study||32
11157739|NCT01568320|12346241|FG000|NOT COMPLETED|Overall Study||41
11157740|NCT01568528|12346248|FG000|STARTED|Overall Study||19
11157741|NCT01568528|12346249|FG001|STARTED|Overall Study||11
11157742|NCT01568528|12346250|FG002|STARTED|Overall Study||9
11157743|NCT01568528|12346248|FG000|COMPLETED|Overall Study||19
11157744|NCT01568528|12346249|FG001|COMPLETED|Overall Study||11
11157745|NCT01568528|12346250|FG002|COMPLETED|Overall Study||9
11157746|NCT01568528|12346248|FG000|NOT COMPLETED|Overall Study||0
11157747|NCT01568528|12346249|FG001|NOT COMPLETED|Overall Study||0
11157748|NCT01568528|12346250|FG002|NOT COMPLETED|Overall Study||0
11157749|NCT01568593|12346260|FG000|STARTED|Overall Study||48
11157750|NCT01568593|12346261|FG001|STARTED|Overall Study||45
11157751|NCT01568593|12346260|FG000|COMPLETED|Overall Study||41
11157752|NCT01568593|12346261|FG001|COMPLETED|Overall Study||42
11157753|NCT01568593|12346260|FG000|NOT COMPLETED|Overall Study||7
11157754|NCT01568593|12346261|FG001|NOT COMPLETED|Overall Study||3
11157755|NCT01568606|12346267|FG000|STARTED|Overall Study||20
11157756|NCT01568606|12346267|FG000|COMPLETED|Overall Study||20
11157757|NCT01568606|12346267|FG000|NOT COMPLETED|Overall Study||0
11157758|NCT01568827|12346273|FG000|STARTED|First Intervention (6 Days)||5
11157759|NCT01568827|12346274|FG001|STARTED|First Intervention (6 Days)||5
11157760|NCT01568827|12346273|FG000|COMPLETED|First Intervention (6 Days)||5
11157761|NCT01568827|12346274|FG001|COMPLETED|First Intervention (6 Days)||5
11157762|NCT01568827|12346273|FG000|NOT COMPLETED|First Intervention (6 Days)||0
11157763|NCT01568827|12346274|FG001|NOT COMPLETED|First Intervention (6 Days)||0
11157764|NCT01568827|12346273|FG000|STARTED|Washout (2 Days)||5
11157765|NCT01568827|12346274|FG001|STARTED|Washout (2 Days)||5
11157766|NCT01568827|12346273|FG000|COMPLETED|Washout (2 Days)||5
11157767|NCT01568827|12346274|FG001|COMPLETED|Washout (2 Days)||5
11157768|NCT01568827|12346273|FG000|NOT COMPLETED|Washout (2 Days)||0
11157769|NCT01568827|12346274|FG001|NOT COMPLETED|Washout (2 Days)||0
11157770|NCT01568827|12346273|FG000|STARTED|Intervention 2 (5 Days)||5
11157771|NCT01568827|12346274|FG001|STARTED|Intervention 2 (5 Days)||5
11157772|NCT01568827|12346273|FG000|COMPLETED|Intervention 2 (5 Days)||5
11157773|NCT01568827|12346274|FG001|COMPLETED|Intervention 2 (5 Days)||5
11157774|NCT01568827|12346273|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0
11157775|NCT01568827|12346274|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0
11157776|NCT01568892|12346282|FG000|STARTED|Double-blind Phase||14
11157777|NCT01568892|12346283|FG001|STARTED|Double-blind Phase||16
11157778|NCT01568892|12346282|FG000|COMPLETED|Double-blind Phase||14
11157779|NCT01568892|12346283|FG001|COMPLETED|Double-blind Phase||16
11157780|NCT01568892|12346282|FG000|NOT COMPLETED|Double-blind Phase||0
11157781|NCT01568892|12346283|FG001|NOT COMPLETED|Double-blind Phase||0
11157782|NCT01568892|12346282|FG000|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
11157783|NCT01568892|12346283|FG001|STARTED|Open-label Phase||16
11157784|NCT01568892|12346282|FG000|COMPLETED|Open-label Phase||7
11157785|NCT01568892|12346283|FG001|COMPLETED|Open-label Phase||13
11157786|NCT01568892|12346282|FG000|NOT COMPLETED|Open-label Phase||6
11157787|NCT01568892|12346283|FG001|NOT COMPLETED|Open-label Phase||3
11157788|NCT01568905|12346293|FG000|STARTED|Overall Study||13
11157789|NCT01568905|12346294|FG001|STARTED|Overall Study||11
11157790|NCT01568905|12346295|FG002|STARTED|Overall Study||12
11157791|NCT01568905|12346293|FG000|COMPLETED|Overall Study||12
11157792|NCT01568905|12346294|FG001|COMPLETED|Overall Study||11
11157793|NCT01568905|12346295|FG002|COMPLETED|Overall Study||12
11323088|NCT01211405|12520420|FG000|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||6
11323089|NCT01211405|12520421|FG001|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||6
11323090|NCT01211405|12520422|FG002|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||12
11323091|NCT01211405|12520420|FG000|COMPLETED|Overall Study||6
11323092|NCT01211405|12520421|FG001|COMPLETED|Overall Study||7
11323093|NCT01211405|12520422|FG002|COMPLETED|Overall Study||11
11323094|NCT01211405|12520420|FG000|NOT COMPLETED|Overall Study||1
11323095|NCT01211405|12520421|FG001|NOT COMPLETED|Overall Study||0
11323096|NCT01211405|12520422|FG002|NOT COMPLETED|Overall Study||1
11323097|NCT01085084|12520433|FG000|STARTED|Overall Study||26
11323098|NCT01085084|12520434|FG001|STARTED|Overall Study||28
11323099|NCT01085084|12520435|FG002|STARTED|Overall Study||28
11323100|NCT01085084|12520433|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
11323101|NCT01085084|12520434|FG001|Received at Least 1 Dose of Study Drug|Overall Study||28
11323102|NCT01085084|12520435|FG002|Received at Least 1 Dose of Study Drug|Overall Study||28
11323103|NCT01085084|12520433|FG000|Safety Analysis Set|Overall Study||25
11323104|NCT01085084|12520434|FG001|Safety Analysis Set|Overall Study|1 participant was assigned to placebo but received laquinimod 0.5 mg by mistake.|29
11323105|NCT01085084|12520435|FG002|Safety Analysis Set|Overall Study||28
11323106|NCT01085084|12520433|FG000|COMPLETED|Overall Study||19
11323107|NCT01085084|12520434|FG001|COMPLETED|Overall Study||23
11323108|NCT01085084|12520435|FG002|COMPLETED|Overall Study||19
11323109|NCT01085084|12520433|FG000|NOT COMPLETED|Overall Study||7
11323110|NCT01085084|12520434|FG001|NOT COMPLETED|Overall Study||5
11323111|NCT01085084|12520435|FG002|NOT COMPLETED|Overall Study||9
11323112|NCT01084252|12520457|FG000|STARTED|Phase 1 (120 Weeks)||16
11157794|NCT01568905|12346293|FG000|NOT COMPLETED|Overall Study||1
11157795|NCT01568905|12346294|FG001|NOT COMPLETED|Overall Study||0
11157796|NCT01568905|12346295|FG002|NOT COMPLETED|Overall Study||0
11157797|NCT01568944|12346305|FG000|STARTED|Overall Study||8
11157798|NCT01568944|12346306|FG001|STARTED|Overall Study||10
11157799|NCT01568944|12346305|FG000|COMPLETED|Overall Study||8
11157800|NCT01568944|12346306|FG001|COMPLETED|Overall Study||10
11157801|NCT01568944|12346305|FG000|NOT COMPLETED|Overall Study||0
11157802|NCT01568944|12346306|FG001|NOT COMPLETED|Overall Study||0
11157803|NCT01569022|12346312|FG000|STARTED|First Intervention||21
11157804|NCT01569022|12346313|FG001|STARTED|First Intervention||21
11157805|NCT01569022|12346312|FG000|COMPLETED|First Intervention||19
11157806|NCT01569022|12346313|FG001|COMPLETED|First Intervention||20
11157807|NCT01569022|12346312|FG000|NOT COMPLETED|First Intervention||2
11157808|NCT01569022|12346313|FG001|NOT COMPLETED|First Intervention||1
11157809|NCT01569022|12346312|FG000|STARTED|Second Intervention||19
11157810|NCT01569022|12346313|FG001|STARTED|Second Intervention||20
11157811|NCT01569022|12346312|FG000|COMPLETED|Second Intervention||17
11157812|NCT01569022|12346313|FG001|COMPLETED|Second Intervention||18
11157813|NCT01569022|12346312|FG000|NOT COMPLETED|Second Intervention||2
11157814|NCT01569022|12346313|FG001|NOT COMPLETED|Second Intervention||2
11157815|NCT01569074|12346326|FG000|STARTED|Overall Study|Patients who received treatment|31
11157816|NCT01569074|12346327|FG001|STARTED|Overall Study|Patients who received treatment|33
11157817|NCT01569074|12346328|FG002|STARTED|Overall Study|Patients who received treatment|33
11157818|NCT01569074|12346329|FG003|STARTED|Overall Study|Patients who received treatment|33
11157819|NCT01569074|12346330|FG004|STARTED|Overall Study|Patients who received treatment|33
11157820|NCT01569074|12346326|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
11157821|NCT01569074|12346327|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
11157822|NCT01569074|12346328|FG002|Randomised But Did Not Receive Treatment|Overall Study||0
11157823|NCT01569074|12346329|FG003|Randomised But Did Not Receive Treatment|Overall Study||0
11157824|NCT01569074|12346330|FG004|Randomised But Did Not Receive Treatment|Overall Study||0
11157825|NCT01569074|12346326|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
11157826|NCT01569074|12346327|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
11157827|NCT01569074|12346328|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
11157828|NCT01569074|12346329|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
11157829|NCT01569074|12346330|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
11157830|NCT01569074|12346326|FG000|NOT COMPLETED|Overall Study||7
11157831|NCT01569074|12346327|FG001|NOT COMPLETED|Overall Study||9
11157832|NCT01569074|12346328|FG002|NOT COMPLETED|Overall Study||12
11157833|NCT01569074|12346329|FG003|NOT COMPLETED|Overall Study||8
11157834|NCT01569074|12346330|FG004|NOT COMPLETED|Overall Study||8
11157835|NCT01569087|12346349|FG000|STARTED|Overall Study||21
11157836|NCT01569087|12346350|FG001|STARTED|Overall Study||20
11157837|NCT01569087|12346351|FG002|STARTED|Overall Study||19
11157838|NCT01569087|12346349|FG000|COMPLETED|Overall Study||20
11157839|NCT01569087|12346350|FG001|COMPLETED|Overall Study||20
11157840|NCT01569087|12346351|FG002|COMPLETED|Overall Study||18
11157841|NCT01569087|12346349|FG000|NOT COMPLETED|Overall Study||1
11157842|NCT01569087|12346350|FG001|NOT COMPLETED|Overall Study||0
11157843|NCT01569087|12346351|FG002|NOT COMPLETED|Overall Study||1
11157844|NCT01569126|12346365|FG000|STARTED|Overall Study||8
11157845|NCT01569126|12346366|FG001|STARTED|Overall Study||8
11157846|NCT01569126|12346367|FG002|STARTED|Overall Study||8
11157847|NCT01569126|12346368|FG003|STARTED|Overall Study||8
11157848|NCT01569126|12346369|FG004|STARTED|Overall Study||12
11157849|NCT01569126|12346370|FG005|STARTED|Overall Study||12
11157850|NCT01569126|12346365|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
11157851|NCT01569126|12346366|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
11157852|NCT01569126|12346367|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
11157853|NCT01569126|12346368|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8
11157854|NCT01569126|12346369|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
11157855|NCT01569126|12346370|FG005|Received at Least 1 Dose of Study Drug|Overall Study||12
11157856|NCT01569126|12346365|FG000|COMPLETED|Overall Study||8
11157857|NCT01569126|12346366|FG001|COMPLETED|Overall Study||8
11157858|NCT01569126|12346367|FG002|COMPLETED|Overall Study||8
11157859|NCT01569126|12346368|FG003|COMPLETED|Overall Study||8
11157860|NCT01569126|12346369|FG004|COMPLETED|Overall Study||12
11157861|NCT01569126|12346370|FG005|COMPLETED|Overall Study||12
11157862|NCT01569126|12346365|FG000|NOT COMPLETED|Overall Study||0
11157863|NCT01569126|12346366|FG001|NOT COMPLETED|Overall Study||0
11157864|NCT01569126|12346367|FG002|NOT COMPLETED|Overall Study||0
11157865|NCT01569126|12346368|FG003|NOT COMPLETED|Overall Study||0
11157866|NCT01569126|12346369|FG004|NOT COMPLETED|Overall Study||0
11157867|NCT01569126|12346370|FG005|NOT COMPLETED|Overall Study||0
11157868|NCT01569152|12346391|FG000|STARTED|Phase IIa, Period 1||41
11157869|NCT01569152|12346392|FG001|STARTED|Phase IIa, Period 1||41
11157870|NCT01569152|12346393|FG002|STARTED|Phase IIa, Period 1||0
11157871|NCT01569152|12346391|FG000|COMPLETED|Phase IIa, Period 1||20
11157872|NCT01569152|12346392|FG001|COMPLETED|Phase IIa, Period 1||9
11157873|NCT01569152|12346393|FG002|COMPLETED|Phase IIa, Period 1||0
11157874|NCT01569152|12346391|FG000|NOT COMPLETED|Phase IIa, Period 1||21
11157875|NCT01569152|12346392|FG001|NOT COMPLETED|Phase IIa, Period 1||32
11157876|NCT01569152|12346393|FG002|NOT COMPLETED|Phase IIa, Period 1||0
11157877|NCT01569152|12346391|FG000|STARTED|Safety Extension, Period 3||0
11157878|NCT01569152|12346392|FG001|STARTED|Safety Extension, Period 3||0
11157879|NCT01569152|12346393|FG002|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
11157880|NCT01569152|12346391|FG000|COMPLETED|Safety Extension, Period 3||0
11157881|NCT01569152|12346392|FG001|COMPLETED|Safety Extension, Period 3||0
11157882|NCT01569152|12346393|FG002|COMPLETED|Safety Extension, Period 3||0
11157883|NCT01569152|12346391|FG000|NOT COMPLETED|Safety Extension, Period 3||0
11157884|NCT01569152|12346392|FG001|NOT COMPLETED|Safety Extension, Period 3||0
11157885|NCT01569152|12346393|FG002|NOT COMPLETED|Safety Extension, Period 3||55
11157886|NCT01569191|12346402|FG000|STARTED|Overall Study||11
11157887|NCT01569191|12346403|FG001|STARTED|Overall Study||7
11157888|NCT01569191|12346402|FG000|COMPLETED|Overall Study||11
11157889|NCT01569191|12346403|FG001|COMPLETED|Overall Study||7
11157890|NCT01569191|12346402|FG000|NOT COMPLETED|Overall Study||0
11157891|NCT01569191|12346403|FG001|NOT COMPLETED|Overall Study||0
11157892|NCT01569295|12346415|FG000|STARTED|Overall Study||207
11157893|NCT01569295|12346416|FG001|STARTED|Overall Study||209
11157894|NCT01569295|12346415|FG000|Long-Term Follow-up|Overall Study||109
11157895|NCT01569295|12346416|FG001|Long-Term Follow-up|Overall Study||161
11157896|NCT01569295|12346415|FG000|COMPLETED|Overall Study||0
11157897|NCT01569295|12346416|FG001|COMPLETED|Overall Study||0
11157898|NCT01569295|12346415|FG000|NOT COMPLETED|Overall Study||207
11157899|NCT01569295|12346416|FG001|NOT COMPLETED|Overall Study||209
11157900|NCT01569438|12346425|FG000|STARTED|Overall Study||52
11157901|NCT01569438|12346426|FG001|STARTED|Overall Study||55
11157902|NCT01569438|12346425|FG000|Treated|Overall Study||51
11157903|NCT01569438|12346426|FG001|Treated|Overall Study||54
11157904|NCT01569438|12346425|FG000|Titration Set|Overall Study||38
11157905|NCT01569438|12346426|FG001|Titration Set|Overall Study||36
11157906|NCT01569438|12346425|FG000|COMPLETED|Overall Study||45
11157907|NCT01569438|12346426|FG001|COMPLETED|Overall Study||33
11157908|NCT01569438|12346425|FG000|NOT COMPLETED|Overall Study||7
11157909|NCT01569438|12346426|FG001|NOT COMPLETED|Overall Study||22
11157910|NCT01569451|12346434|FG000|STARTED|Overall Study||26
11157911|NCT01569451|12346435|FG001|STARTED|Overall Study||27
11157912|NCT01569451|12346434|FG000|COMPLETED|Overall Study||12
11157913|NCT01569451|12346435|FG001|COMPLETED|Overall Study||14
11157914|NCT01569451|12346434|FG000|NOT COMPLETED|Overall Study||14
11157915|NCT01569451|12346435|FG001|NOT COMPLETED|Overall Study||13
11157916|NCT01569464|12346445|FG000|STARTED|Overall Study||101
11157917|NCT01569464|12346446|FG001|STARTED|Overall Study||49
11157918|NCT01569464|12346445|FG000|COMPLETED|Overall Study||91
11157919|NCT01569464|12346446|FG001|COMPLETED|Overall Study||44
11157920|NCT01569464|12346445|FG000|NOT COMPLETED|Overall Study||10
11157921|NCT01569464|12346446|FG001|NOT COMPLETED|Overall Study||5
11157922|NCT01569529|12346456|FG000|STARTED|Overall Study||2676
11157923|NCT01569529|12346457|FG001|STARTED|Overall Study||394
11157924|NCT01569529|12346456|FG000|COMPLETED|Overall Study||2676
11157925|NCT01569529|12346457|FG001|COMPLETED|Overall Study||394
11157926|NCT01569529|12346456|FG000|NOT COMPLETED|Overall Study||0
11157927|NCT01569529|12346457|FG001|NOT COMPLETED|Overall Study||0
11157928|NCT01569568|12346465|FG000|STARTED|Overall Study||20
11157929|NCT01569568|12346466|FG001|STARTED|Overall Study||29
11157930|NCT01569568|12346465|FG000|COMPLETED|Overall Study||20
11157931|NCT01569568|12346466|FG001|COMPLETED|Overall Study||27
11157932|NCT01569568|12346465|FG000|NOT COMPLETED|Overall Study||0
11157933|NCT01569568|12346466|FG001|NOT COMPLETED|Overall Study||2
11157934|NCT01569594|12346472|FG000|STARTED|Overall Study||230
11157935|NCT01569594|12346472|FG000|COMPLETED|Overall Study||163
11157936|NCT01569594|12346472|FG000|NOT COMPLETED|Overall Study||67
11157937|NCT01569607|12346478|FG000|STARTED|Overall Study||11
11157938|NCT01569607|12346479|FG001|STARTED|Overall Study||11
11157939|NCT01569607|12346478|FG000|COMPLETED|Overall Study||10
11157940|NCT01569607|12346479|FG001|COMPLETED|Overall Study||10
11157941|NCT01569607|12346478|FG000|NOT COMPLETED|Overall Study||1
11157942|NCT01569607|12346479|FG001|NOT COMPLETED|Overall Study||1
11157943|NCT01569737|12346485|FG000|STARTED|Overall Study||98
11157944|NCT01569737|12346485|FG000|COMPLETED|Overall Study||95
11157945|NCT01569737|12346485|FG000|NOT COMPLETED|Overall Study||3
11157946|NCT01569763|12346491|FG000|STARTED|Overall Study||102
11157947|NCT01569763|12346492|FG001|STARTED|Overall Study||51
11157948|NCT01569763|12346491|FG000|Treated|Overall Study||102
11157949|NCT01569763|12346492|FG001|Treated|Overall Study||51
11157950|NCT01569763|12346491|FG000|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
11157951|NCT01569763|12346492|FG001|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
11157952|NCT01569763|12346491|FG000|NOT COMPLETED|Overall Study||3
11157953|NCT01569763|12346492|FG001|NOT COMPLETED|Overall Study||7
11157954|NCT01569815|12346502|FG000|STARTED|Overall Study||8
11157955|NCT01569815|12346503|FG001|STARTED|Overall Study||8
11157956|NCT01569815|12346504|FG002|STARTED|Overall Study||8
11157957|NCT01569815|12346505|FG003|STARTED|Overall Study||8
11157958|NCT01569815|12346502|FG000|COMPLETED|Overall Study||8
11157959|NCT01569815|12346503|FG001|COMPLETED|Overall Study||8
11157960|NCT01569815|12346504|FG002|COMPLETED|Overall Study||8
11157961|NCT01569815|12346505|FG003|COMPLETED|Overall Study||8
11157962|NCT01569815|12346502|FG000|NOT COMPLETED|Overall Study||0
11157963|NCT01569815|12346503|FG001|NOT COMPLETED|Overall Study||0
11157964|NCT01569815|12346504|FG002|NOT COMPLETED|Overall Study||0
11157965|NCT01569815|12346505|FG003|NOT COMPLETED|Overall Study||0
11157966|NCT01569828|12346518|FG000|STARTED|Overall Study||6
11157967|NCT01569828|12346519|FG001|STARTED|Overall Study||6
11157968|NCT01569828|12346518|FG000|COMPLETED|Overall Study||6
11157969|NCT01569828|12346519|FG001|COMPLETED|Overall Study||6
11157970|NCT01569828|12346518|FG000|NOT COMPLETED|Overall Study||0
11157971|NCT01569828|12346519|FG001|NOT COMPLETED|Overall Study||0
11157972|NCT01569841|12346526|FG000|STARTED|Period A (6 Weeks)||12
11157973|NCT01569841|12346527|FG001|STARTED|Period A (6 Weeks)||12
11157974|NCT01569841|12346526|FG000|Exposed|Period A (6 Weeks)||12
11157975|NCT01569841|12346527|FG001|Exposed|Period A (6 Weeks)||12
11157976|NCT01569841|12346526|FG000|COMPLETED|Period A (6 Weeks)||12
11157977|NCT01569841|12346527|FG001|COMPLETED|Period A (6 Weeks)||11
11157978|NCT01569841|12346526|FG000|NOT COMPLETED|Period A (6 Weeks)||0
11157979|NCT01569841|12346527|FG001|NOT COMPLETED|Period A (6 Weeks)||1
11157980|NCT01569841|12346526|FG000|STARTED|Period B (6 Weeks)||12
11157981|NCT01569841|12346527|FG001|STARTED|Period B (6 Weeks)||11
11157982|NCT01569841|12346526|FG000|Exposed|Period B (6 Weeks)||12
11157983|NCT01569841|12346527|FG001|Exposed|Period B (6 Weeks)||11
11157984|NCT01569841|12346526|FG000|COMPLETED|Period B (6 Weeks)||12
11157985|NCT01569841|12346527|FG001|COMPLETED|Period B (6 Weeks)||11
11157986|NCT01569841|12346526|FG000|NOT COMPLETED|Period B (6 Weeks)||0
11157987|NCT01569841|12346527|FG001|NOT COMPLETED|Period B (6 Weeks)||0
11157988|NCT01570036|12346537|FG000|STARTED|Overall Study||136
11157989|NCT01570036|12346538|FG001|STARTED|Overall Study||139
11157990|NCT01570036|12346537|FG000|Primary Vaccine Series Completed|Overall Study||121
11157991|NCT01570036|12346538|FG001|Primary Vaccine Series Completed|Overall Study||132
11157992|NCT01570036|12346537|FG000|Booster Series Completed|Overall Study||40
11157993|NCT01570036|12346538|FG001|Booster Series Completed|Overall Study||30
11157994|NCT01570036|12346537|FG000|COMPLETED|Overall Study||18
11157995|NCT01570036|12346538|FG001|COMPLETED|Overall Study||17
11157996|NCT01570036|12346537|FG000|NOT COMPLETED|Overall Study||118
11157997|NCT01570036|12346538|FG001|NOT COMPLETED|Overall Study||122
11157998|NCT01570192|12346546|FG000|STARTED|Overall Study||13
11157999|NCT01570192|12346547|FG001|STARTED|Overall Study||30
11158000|NCT01570192|12346546|FG000|COMPLETED|Overall Study||6
11158001|NCT01570192|12346547|FG001|COMPLETED|Overall Study||17
11158002|NCT01570192|12346546|FG000|NOT COMPLETED|Overall Study||7
11158003|NCT01570192|12346547|FG001|NOT COMPLETED|Overall Study||13
11158004|NCT01570244|12346558|FG000|STARTED|Microgynon||16
11158005|NCT01570244|12346558|FG000|COMPLETED|Microgynon||16
11158006|NCT01570244|12346558|FG000|NOT COMPLETED|Microgynon||0
11158007|NCT01570244|12346558|FG000|STARTED|Microgynon+Faldaprevir||16
11158008|NCT01570244|12346558|FG000|COMPLETED|Microgynon+Faldaprevir||15
11158009|NCT01570244|12346558|FG000|NOT COMPLETED|Microgynon+Faldaprevir||1
11158010|NCT01570283|12346567|FG000|STARTED|Cohort 1: Dose Level 1||1
11158011|NCT01570283|12346568|FG001|STARTED|Cohort 1: Dose Level 1||3
11158012|NCT01570283|12346569|FG002|STARTED|Cohort 1: Dose Level 1||0
11158013|NCT01570283|12346570|FG003|STARTED|Cohort 1: Dose Level 1||0
11158014|NCT01570283|12346571|FG004|STARTED|Cohort 1: Dose Level 1||0
11158015|NCT01570283|12346572|FG005|STARTED|Cohort 1: Dose Level 1||0
11158016|NCT01570283|12346567|FG000|COMPLETED|Cohort 1: Dose Level 1||1
11158017|NCT01570283|12346568|FG001|COMPLETED|Cohort 1: Dose Level 1||1
11158018|NCT01570283|12346569|FG002|COMPLETED|Cohort 1: Dose Level 1||0
11158019|NCT01570283|12346570|FG003|COMPLETED|Cohort 1: Dose Level 1||0
11158020|NCT01570283|12346571|FG004|COMPLETED|Cohort 1: Dose Level 1||0
11158021|NCT01570283|12346572|FG005|COMPLETED|Cohort 1: Dose Level 1||0
11158022|NCT01570283|12346567|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0
11158023|NCT01570283|12346568|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||2
11158024|NCT01570283|12346569|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
11158025|NCT01570283|12346570|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0
11158026|NCT01570283|12346571|FG004|NOT COMPLETED|Cohort 1: Dose Level 1||0
11158027|NCT01570283|12346572|FG005|NOT COMPLETED|Cohort 1: Dose Level 1||0
11158028|NCT01570283|12346567|FG000|STARTED|Cohort 2: Dose Level 2||0
11158029|NCT01570283|12346568|FG001|STARTED|Cohort 2: Dose Level 2||0
11158030|NCT01570283|12346569|FG002|STARTED|Cohort 2: Dose Level 2||2
11158031|NCT01570283|12346570|FG003|STARTED|Cohort 2: Dose Level 2||2
11158032|NCT01570283|12346571|FG004|STARTED|Cohort 2: Dose Level 2||0
11158033|NCT01570283|12346572|FG005|STARTED|Cohort 2: Dose Level 2||0
11158034|NCT01570283|12346567|FG000|COMPLETED|Cohort 2: Dose Level 2||0
11158035|NCT01570283|12346568|FG001|COMPLETED|Cohort 2: Dose Level 2||0
11158036|NCT01570283|12346569|FG002|COMPLETED|Cohort 2: Dose Level 2||1
11419052|NCT00320931|12617515|FG000|STARTED|Overall Study||30
11419053|NCT00320931|12617515|FG000|COMPLETED|Overall Study||30
11419054|NCT00320931|12617515|FG000|NOT COMPLETED|Overall Study||0
11158037|NCT01570283|12346570|FG003|COMPLETED|Cohort 2: Dose Level 2||1
11158038|NCT01570283|12346571|FG004|COMPLETED|Cohort 2: Dose Level 2||0
11419055|NCT00314353|12617521|FG000|STARTED|Protocol Therapy (8 Cycles)||4
11419056|NCT00314353|12617522|FG001|STARTED|Protocol Therapy (8 Cycles)||3
11158039|NCT01570283|12346572|FG005|COMPLETED|Cohort 2: Dose Level 2||0
11158040|NCT01570283|12346567|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
11158041|NCT01570283|12346568|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0
11158042|NCT01570283|12346569|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||1
11158043|NCT01570283|12346570|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||1
11158044|NCT01570283|12346571|FG004|NOT COMPLETED|Cohort 2: Dose Level 2||0
11158045|NCT01570283|12346572|FG005|NOT COMPLETED|Cohort 2: Dose Level 2||0
11158046|NCT01570283|12346567|FG000|STARTED|Cohort 3: Dose Level 3||0
11158047|NCT01570283|12346568|FG001|STARTED|Cohort 3: Dose Level 3||0
11158048|NCT01570283|12346569|FG002|STARTED|Cohort 3: Dose Level 3||0
11158049|NCT01570283|12346570|FG003|STARTED|Cohort 3: Dose Level 3||0
11158050|NCT01570283|12346571|FG004|STARTED|Cohort 3: Dose Level 3||1
11158051|NCT01570283|12346572|FG005|STARTED|Cohort 3: Dose Level 3||12
11158052|NCT01570283|12346567|FG000|COMPLETED|Cohort 3: Dose Level 3||0
11158053|NCT01570283|12346568|FG001|COMPLETED|Cohort 3: Dose Level 3||0
11158054|NCT01570283|12346569|FG002|COMPLETED|Cohort 3: Dose Level 3||0
11158055|NCT01570283|12346570|FG003|COMPLETED|Cohort 3: Dose Level 3||0
11158056|NCT01570283|12346571|FG004|COMPLETED|Cohort 3: Dose Level 3||1
11158057|NCT01570283|12346572|FG005|COMPLETED|Cohort 3: Dose Level 3||10
11158058|NCT01570283|12346567|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
11158059|NCT01570283|12346568|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
11158060|NCT01570283|12346569|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0
11158061|NCT01570283|12346570|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0
11158062|NCT01570283|12346571|FG004|NOT COMPLETED|Cohort 3: Dose Level 3||0
11158063|NCT01570283|12346572|FG005|NOT COMPLETED|Cohort 3: Dose Level 3||2
11158064|NCT01570309|12346588|FG000|STARTED|Overall Study||48
11158065|NCT01570309|12346589|FG001|STARTED|Overall Study||48
11158066|NCT01570309|12346588|FG000|COMPLETED|Overall Study||45
11158067|NCT01570309|12346589|FG001|COMPLETED|Overall Study||45
11158068|NCT01570309|12346588|FG000|NOT COMPLETED|Overall Study||3
11158069|NCT01570309|12346589|FG001|NOT COMPLETED|Overall Study||3
11158070|NCT01570348|12346599|FG000|STARTED|Overall Study||2
11158071|NCT01570348|12346599|FG000|COMPLETED|Overall Study||2
11158072|NCT01570348|12346599|FG000|NOT COMPLETED|Overall Study||0
11158073|NCT01570361|12346605|FG000|STARTED|Overall Study||128
11158074|NCT01570361|12346606|FG001|STARTED|Overall Study||127
11158075|NCT01570361|12346605|FG000|Received Study Treatment|Overall Study||102
11158076|NCT01570361|12346606|FG001|Received Study Treatment|Overall Study||123
11158077|NCT01570361|12346605|FG000|Cross-over (AAD Therapy to RF Ablation)|Overall Study||0
11158078|NCT01570361|12346606|FG001|Cross-over (AAD Therapy to RF Ablation)|Overall Study||15
11158079|NCT01570361|12346605|FG000|AAD Therapy Only|Overall Study||0
11158080|NCT01570361|12346606|FG001|AAD Therapy Only|Overall Study||108
11158081|NCT01570361|12346605|FG000|COMPLETED|Overall Study||46
11158082|NCT01570361|12346606|FG001|COMPLETED|Overall Study||52
11158083|NCT01570361|12346605|FG000|NOT COMPLETED|Overall Study||82
11158084|NCT01570361|12346606|FG001|NOT COMPLETED|Overall Study||75
11158085|NCT01570387|12346619|FG000|STARTED|Overall Study||6
11158086|NCT01570387|12346620|FG001|STARTED|Overall Study||3
11158087|NCT01570387|12346621|FG002|STARTED|Overall Study||6
11158088|NCT01570387|12346622|FG003|STARTED|Overall Study||12
11158089|NCT01570387|12346619|FG000|Dose Limiting Toxicity|Overall Study||0
11158090|NCT01570387|12346620|FG001|Dose Limiting Toxicity|Overall Study||0
11158091|NCT01570387|12346621|FG002|Dose Limiting Toxicity|Overall Study||6
11158092|NCT01570387|12346622|FG003|Dose Limiting Toxicity|Overall Study||12
11158093|NCT01570387|12346619|FG000|Response to Maximal Tolerated Dose|Overall Study||0
11158094|NCT01570387|12346620|FG001|Response to Maximal Tolerated Dose|Overall Study||0
11158095|NCT01570387|12346621|FG002|Response to Maximal Tolerated Dose|Overall Study||3
11158096|NCT01570387|12346622|FG003|Response to Maximal Tolerated Dose|Overall Study||6
11158097|NCT01570387|12346619|FG000|COMPLETED|Overall Study||5
11158098|NCT01570387|12346620|FG001|COMPLETED|Overall Study||3
11158099|NCT01570387|12346621|FG002|COMPLETED|Overall Study||6
11158100|NCT01570387|12346622|FG003|COMPLETED|Overall Study||10
11158101|NCT01570387|12346619|FG000|NOT COMPLETED|Overall Study||1
11158102|NCT01570387|12346620|FG001|NOT COMPLETED|Overall Study||0
11158103|NCT01570387|12346621|FG002|NOT COMPLETED|Overall Study||0
11158104|NCT01570387|12346622|FG003|NOT COMPLETED|Overall Study||2
11158105|NCT01570491|12346631|FG000|STARTED|Overall Study||19
11158106|NCT01570491|12346632|FG001|STARTED|Overall Study||19
11158107|NCT01570491|12346631|FG000|COMPLETED|Overall Study||14
11158108|NCT01570491|12346632|FG001|COMPLETED|Overall Study||18
11158109|NCT01570491|12346631|FG000|NOT COMPLETED|Overall Study||5
11158110|NCT01570491|12346632|FG001|NOT COMPLETED|Overall Study||1
11158111|NCT01570686|12346640|FG000|STARTED|Overall Study||296
11158112|NCT01570686|12346641|FG001|STARTED|Overall Study||294
11158113|NCT01570686|12346640|FG000|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
11158114|NCT01570686|12346641|FG001|Safety and Full Analysis Set (FAS)|Overall Study||294
11158115|NCT01570686|12346640|FG000|COMPLETED|Overall Study||274
11158116|NCT01570686|12346641|FG001|COMPLETED|Overall Study||278
11158117|NCT01570686|12346640|FG000|NOT COMPLETED|Overall Study||22
11158118|NCT01570686|12346641|FG001|NOT COMPLETED|Overall Study||16
11158119|NCT01570751|12346649|FG000|STARTED|Period A (16 Weeks)||73
11158120|NCT01570751|12346650|FG001|STARTED|Period A (16 Weeks)||72
11158121|NCT01570751|12346649|FG000|Exposed|Period A (16 Weeks)||73
11158122|NCT01570751|12346650|FG001|Exposed|Period A (16 Weeks)||72
11158123|NCT01570751|12346649|FG000|COMPLETED|Period A (16 Weeks)||70
11158124|NCT01570751|12346650|FG001|COMPLETED|Period A (16 Weeks)||67
11158125|NCT01570751|12346649|FG000|NOT COMPLETED|Period A (16 Weeks)||3
11158126|NCT01570751|12346650|FG001|NOT COMPLETED|Period A (16 Weeks)||5
11158127|NCT01570751|12346649|FG000|STARTED|Period B (16 Weeks)||70
11158128|NCT01570751|12346650|FG001|STARTED|Period B (16 Weeks)||67
11158129|NCT01570751|12346649|FG000|Exposed|Period B (16 Weeks)||70
11158130|NCT01570751|12346650|FG001|Exposed|Period B (16 Weeks)||67
11158131|NCT01570751|12346649|FG000|COMPLETED|Period B (16 Weeks)||69
11158132|NCT01570751|12346650|FG001|COMPLETED|Period B (16 Weeks)||66
11158133|NCT01570751|12346649|FG000|NOT COMPLETED|Period B (16 Weeks)||1
11158134|NCT01570751|12346650|FG001|NOT COMPLETED|Period B (16 Weeks)||1
11158135|NCT01570829|12346660|FG000|STARTED|Overall Study||164
11158136|NCT01570829|12346661|FG001|STARTED|Overall Study||167
11158137|NCT01570829|12346660|FG000|COMPLETED|Overall Study||164
11158138|NCT01570829|12346661|FG001|COMPLETED|Overall Study||167
11158139|NCT01570829|12346660|FG000|NOT COMPLETED|Overall Study||0
11158140|NCT01570829|12346661|FG001|NOT COMPLETED|Overall Study||0
11158141|NCT01570868|12346669|FG000|STARTED|Overall Study||43
11158142|NCT01570868|12346670|FG001|STARTED|Overall Study||8
11158143|NCT01570868|12346669|FG000|COMPLETED|Overall Study||0
11158144|NCT01570868|12346670|FG001|COMPLETED|Overall Study||0
11158145|NCT01570868|12346669|FG000|NOT COMPLETED|Overall Study||43
11158146|NCT01570868|12346670|FG001|NOT COMPLETED|Overall Study||8
11158147|NCT01571232|12346682|FG000|STARTED|Overall Study||10
11158148|NCT01571232|12346683|FG001|STARTED|Overall Study||10
11158149|NCT01571232|12346682|FG000|COMPLETED|Overall Study||9
11158150|NCT01571232|12346683|FG001|COMPLETED|Overall Study||9
11158151|NCT01571232|12346682|FG000|NOT COMPLETED|Overall Study||1
11158152|NCT01571232|12346683|FG001|NOT COMPLETED|Overall Study||1
11158153|NCT01571284|12346690|FG000|STARTED|Overall Study||781
11158154|NCT01571284|12346690|FG000|Safety Population|Overall Study||779
11158155|NCT01571284|12346690|FG000|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
11158156|NCT01571284|12346690|FG000|NOT COMPLETED|Overall Study||169
11158157|NCT01571362|12346694|FG000|STARTED|Open-Label Conversion + Titration Period||410
11158158|NCT01571362|12346695|FG001|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
11158159|NCT01571362|12346696|FG002|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
11158160|NCT01571362|12346694|FG000|COMPLETED|Open-Label Conversion + Titration Period||281
11158161|NCT01571362|12346695|FG001|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
11158162|NCT01571362|12346696|FG002|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
11158163|NCT01571362|12346694|FG000|NOT COMPLETED|Open-Label Conversion + Titration Period||129
11158164|NCT01571362|12346695|FG001|NOT COMPLETED|Open-Label Conversion + Titration Period||0
11158165|NCT01571362|12346696|FG002|NOT COMPLETED|Open-Label Conversion + Titration Period||0
11158166|NCT01571362|12346694|FG000|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
11158167|NCT01571362|12346695|FG001|STARTED|Double-Blind Treatment Period||134
11158168|NCT01571362|12346696|FG002|STARTED|Double-Blind Treatment Period||146
11158169|NCT01571362|12346694|FG000|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
11158170|NCT01571362|12346695|FG001|COMPLETED|Double-Blind Treatment Period||81
11158171|NCT01571362|12346696|FG002|COMPLETED|Double-Blind Treatment Period||107
11158172|NCT01571362|12346694|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
11158173|NCT01571362|12346695|FG001|NOT COMPLETED|Double-Blind Treatment Period||53
11158174|NCT01571362|12346696|FG002|NOT COMPLETED|Double-Blind Treatment Period||39
11158175|NCT01571427|12346706|FG000|STARTED|Overall Study||41
11158176|NCT01571427|12346707|FG001|STARTED|Overall Study||42
11158177|NCT01571427|12346706|FG000|COMPLETED|Overall Study||41
11158178|NCT01571427|12346707|FG001|COMPLETED|Overall Study||42
11158179|NCT01571427|12346706|FG000|NOT COMPLETED|Overall Study||0
11158180|NCT01571427|12346707|FG001|NOT COMPLETED|Overall Study||0
11158181|NCT01571453|12346715|FG000|STARTED|Overall Study||211
11158182|NCT01571453|12346716|FG001|STARTED|Overall Study||226
11158183|NCT01571453|12346715|FG000|COMPLETED|Overall Study||173
11158184|NCT01571453|12346716|FG001|COMPLETED|Overall Study||164
11158185|NCT01571453|12346715|FG000|NOT COMPLETED|Overall Study||38
11158186|NCT01571453|12346716|FG001|NOT COMPLETED|Overall Study||62
11158187|NCT01571557|12346722|FG000|STARTED|Overall Study||573
11158188|NCT01571557|12346722|FG000|COMPLETED|Overall Study||573
11158189|NCT01571557|12346722|FG000|NOT COMPLETED|Overall Study||0
11158190|NCT01571596|12346729|FG000|STARTED|Overall Study||21
11158191|NCT01571596|12346730|FG001|STARTED|Overall Study||1
11158192|NCT01571596|12346731|FG002|STARTED|Overall Study||1
11158193|NCT01571596|12346729|FG000|COMPLETED|Overall Study||19
11158194|NCT01571596|12346730|FG001|COMPLETED|Overall Study||0
11158195|NCT01571596|12346731|FG002|COMPLETED|Overall Study||0
11158196|NCT01571596|12346729|FG000|NOT COMPLETED|Overall Study||2
11158197|NCT01571596|12346730|FG001|NOT COMPLETED|Overall Study||1
11158198|NCT01571596|12346731|FG002|NOT COMPLETED|Overall Study||1
11158199|NCT01572038|12346741|FG000|STARTED|Overall Study|All participants who were enrolled in the study.|1436
11158200|NCT01572038|12346741|FG000|Received at Least One Dose of Study Drug|Overall Study||1436
11158201|NCT01572038|12346741|FG000|COMPLETED|Overall Study||445
11158202|NCT01572038|12346741|FG000|NOT COMPLETED|Overall Study||991
11158203|NCT01572298|12346769|FG000|STARTED|Overall Study||14
11158204|NCT01572298|12346770|FG001|STARTED|Overall Study||13
11158205|NCT01572298|12346769|FG000|COMPLETED|Overall Study||12
11158206|NCT01572298|12346770|FG001|COMPLETED|Overall Study||12
11158207|NCT01572298|12346769|FG000|NOT COMPLETED|Overall Study||2
11158208|NCT01572298|12346770|FG001|NOT COMPLETED|Overall Study||1
11158209|NCT01572389|12346780|FG000|STARTED|Overall Study||136
11158210|NCT01572389|12346781|FG001|STARTED|Overall Study||89
11158211|NCT01572389|12346780|FG000|COMPLETED|Overall Study||90
11158212|NCT01572389|12346781|FG001|COMPLETED|Overall Study||68
11158213|NCT01572389|12346780|FG000|NOT COMPLETED|Overall Study||46
11158214|NCT01572389|12346781|FG001|NOT COMPLETED|Overall Study||21
11158215|NCT01572428|12346789|FG000|STARTED|Overall Study||402
11158216|NCT01572428|12346790|FG001|STARTED|Overall Study||402
11158217|NCT01572428|12346789|FG000|COMPLETED|Overall Study||399
11158218|NCT01572428|12346790|FG001|COMPLETED|Overall Study||401
11158219|NCT01572428|12346789|FG000|NOT COMPLETED|Overall Study||3
11158220|NCT01572428|12346790|FG001|NOT COMPLETED|Overall Study||1
11158221|NCT01572727|12346798|FG000|STARTED|Overall Study||207
11158222|NCT01572727|12346799|FG001|STARTED|Overall Study||209
11158223|NCT01572727|12346798|FG000|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
11158224|NCT01572727|12346799|FG001|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
11158225|NCT01572727|12346798|FG000|COMPLETED|Overall Study||0
11158226|NCT01572727|12346799|FG001|COMPLETED|Overall Study||0
11158227|NCT01572727|12346798|FG000|NOT COMPLETED|Overall Study||207
11158228|NCT01572727|12346799|FG001|NOT COMPLETED|Overall Study||209
11158229|NCT01572740|12346807|FG000|STARTED|Overall Study||127
11158230|NCT01572740|12346808|FG001|STARTED|Overall Study||130
11158231|NCT01572740|12346807|FG000|COMPLETED|Overall Study||121
11158232|NCT01572740|12346808|FG001|COMPLETED|Overall Study||125
11158233|NCT01572740|12346807|FG000|NOT COMPLETED|Overall Study||6
11158234|NCT01572740|12346808|FG001|NOT COMPLETED|Overall Study||5
11158235|NCT01572792|12346819|FG000|STARTED|Lead-in Study||337
11158236|NCT01572792|12346820|FG001|STARTED|Lead-in Study||338
11158237|NCT01572792|12346821|FG002|STARTED|Lead-in Study||338
11158238|NCT01572792|12346822|FG003|STARTED|Lead-in Study||340
11158239|NCT01572792|12346823|FG004|STARTED|Lead-in Study||339
11158240|NCT01572792|12346819|FG000|COMPLETED|Lead-in Study||236
11158241|NCT01572792|12346820|FG001|COMPLETED|Lead-in Study||272
11158242|NCT01572792|12346821|FG002|COMPLETED|Lead-in Study||276
11158243|NCT01572792|12346822|FG003|COMPLETED|Lead-in Study||268
11158244|NCT01572792|12346823|FG004|COMPLETED|Lead-in Study||270
11419057|NCT00314353|12617521|FG000|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
11158245|NCT01572792|12346819|FG000|NOT COMPLETED|Lead-in Study||101
11158246|NCT01572792|12346820|FG001|NOT COMPLETED|Lead-in Study||66
11158247|NCT01572792|12346821|FG002|NOT COMPLETED|Lead-in Study||62
11158248|NCT01572792|12346822|FG003|NOT COMPLETED|Lead-in Study||72
11158249|NCT01572792|12346823|FG004|NOT COMPLETED|Lead-in Study||69
11158250|NCT01572792|12346819|FG000|STARTED|Extension Study||146
11158251|NCT01572792|12346820|FG001|STARTED|Extension Study||184
11158252|NCT01572792|12346821|FG002|STARTED|Extension Study||205
11158253|NCT01572792|12346822|FG003|STARTED|Extension Study||194
11158254|NCT01572792|12346823|FG004|STARTED|Extension Study||192
11158255|NCT01572792|12346819|FG000|COMPLETED|Extension Study||121
11158256|NCT01572792|12346820|FG001|COMPLETED|Extension Study||155
11158257|NCT01572792|12346821|FG002|COMPLETED|Extension Study||179
11158258|NCT01572792|12346822|FG003|COMPLETED|Extension Study||165
11158259|NCT01572792|12346823|FG004|COMPLETED|Extension Study||160
11158260|NCT01572792|12346819|FG000|NOT COMPLETED|Extension Study||25
11158261|NCT01572792|12346820|FG001|NOT COMPLETED|Extension Study||29
11158262|NCT01572792|12346821|FG002|NOT COMPLETED|Extension Study||26
11158263|NCT01572792|12346822|FG003|NOT COMPLETED|Extension Study||29
11158264|NCT01572792|12346823|FG004|NOT COMPLETED|Extension Study||32
11158265|NCT01572844|12346836|FG000|STARTED|Overall Study||3
11158266|NCT01572844|12346837|FG001|STARTED|Overall Study||3
11158267|NCT01572844|12346836|FG000|COMPLETED|Overall Study||2
11158268|NCT01572844|12346837|FG001|COMPLETED|Overall Study||2
11158269|NCT01572844|12346836|FG000|NOT COMPLETED|Overall Study||1
11158270|NCT01572844|12346837|FG001|NOT COMPLETED|Overall Study||1
11158271|NCT01572909|12346848|FG000|STARTED|Overall Study||152
11158272|NCT01572909|12346849|FG001|STARTED|Overall Study||148
11158273|NCT01572909|12346848|FG000|COMPLETED|Overall Study||120
11158274|NCT01572909|12346849|FG001|COMPLETED|Overall Study||123
11158275|NCT01572909|12346848|FG000|NOT COMPLETED|Overall Study||32
11158276|NCT01572909|12346849|FG001|NOT COMPLETED|Overall Study||25
11158277|NCT01572922|12346857|FG000|STARTED|Overall Study||142
11158278|NCT01572922|12346857|FG000|COMPLETED|Overall Study||139
11158279|NCT01572922|12346857|FG000|NOT COMPLETED|Overall Study||3
11158280|NCT01572948|12346868|FG000|STARTED|Overall Study||11
11158281|NCT01572948|12346869|FG001|STARTED|Overall Study||16
11158282|NCT01572948|12346868|FG000|COMPLETED|Overall Study||10
11158283|NCT01572948|12346869|FG001|COMPLETED|Overall Study||15
11158284|NCT01572948|12346868|FG000|NOT COMPLETED|Overall Study||1
11158285|NCT01572948|12346869|FG001|NOT COMPLETED|Overall Study||1
11158286|NCT01573000|12346881|FG000|STARTED|Dosimetric and Therapeutic Treatment||42
11158287|NCT01573000|12346882|FG001|STARTED|Dosimetric and Therapeutic Treatment||36
11158288|NCT01573000|12346881|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
11158289|NCT01573000|12346882|FG001|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
11158290|NCT01573000|12346881|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
11158291|NCT01573000|12346882|FG001|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
11158292|NCT01573000|12346881|FG000|STARTED|Crossover Phase||0
11158293|NCT01573000|12346882|FG001|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
11158294|NCT01573000|12346881|FG000|COMPLETED|Crossover Phase||0
11158295|NCT01573000|12346882|FG001|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
11158296|NCT01573000|12346881|FG000|NOT COMPLETED|Crossover Phase||0
11158297|NCT01573000|12346882|FG001|NOT COMPLETED|Crossover Phase||18
11158298|NCT01573000|12346881|FG000|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
11158299|NCT01573000|12346882|FG001|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
11158300|NCT01573000|12346881|FG000|COMPLETED|Long-Term Follow-Up||11
11158301|NCT01573000|12346882|FG001|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
11158302|NCT01573000|12346881|FG000|NOT COMPLETED|Long-Term Follow-Up||3
11158303|NCT01573000|12346882|FG001|NOT COMPLETED|Long-Term Follow-Up||1
11158304|NCT01573052|12346894|FG000|STARTED|Overall Study||9
11158305|NCT01573052|12346895|FG001|STARTED|Overall Study||17
11158306|NCT01573052|12346894|FG000|COMPLETED|Overall Study||6
11158307|NCT01573052|12346895|FG001|COMPLETED|Overall Study||11
11158308|NCT01573052|12346894|FG000|NOT COMPLETED|Overall Study||3
11158309|NCT01573052|12346895|FG001|NOT COMPLETED|Overall Study||6
11158310|NCT01573169|12346904|FG000|STARTED|Overall Study||38
11158311|NCT01573169|12346905|FG001|STARTED|Overall Study||35
11158312|NCT01573169|12346904|FG000|COMPLETED|Overall Study||38
11158313|NCT01573169|12346905|FG001|COMPLETED|Overall Study||35
11158314|NCT01573169|12346904|FG000|NOT COMPLETED|Overall Study||0
11158315|NCT01573169|12346905|FG001|NOT COMPLETED|Overall Study||0
11158316|NCT01573260|12346913|FG000|STARTED|Overall Study||18
11158317|NCT01573260|12346914|FG001|STARTED|Overall Study||15
11158318|NCT01573260|12346913|FG000|COMPLETED|Overall Study||18
11158319|NCT01573260|12346914|FG001|COMPLETED|Overall Study||15
11158320|NCT01573260|12346913|FG000|NOT COMPLETED|Overall Study||0
11158321|NCT01573260|12346914|FG001|NOT COMPLETED|Overall Study||0
11158322|NCT01573273|12346926|FG000|STARTED|TSST : Trier Social Stress Task||24
11158323|NCT01573273|12346927|FG001|STARTED|TSST : Trier Social Stress Task||25
11158324|NCT01573273|12346928|FG002|STARTED|TSST : Trier Social Stress Task||0
11158325|NCT01573273|12346929|FG003|STARTED|TSST : Trier Social Stress Task||0
11158326|NCT01573273|12346930|FG004|STARTED|TSST : Trier Social Stress Task||0
11158327|NCT01573273|12346931|FG005|STARTED|TSST : Trier Social Stress Task||0
11158328|NCT01573273|12346932|FG006|STARTED|TSST : Trier Social Stress Task||32
11158329|NCT01573273|12346933|FG007|STARTED|TSST : Trier Social Stress Task||31
11158330|NCT01573273|12346934|FG008|STARTED|TSST : Trier Social Stress Task||0
11158331|NCT01573273|12346935|FG009|STARTED|TSST : Trier Social Stress Task||0
11158332|NCT01573273|12346936|FG010|STARTED|TSST : Trier Social Stress Task||0
11158333|NCT01573273|12346937|FG011|STARTED|TSST : Trier Social Stress Task||0
11158334|NCT01573273|12346926|FG000|COMPLETED|TSST : Trier Social Stress Task||24
11158335|NCT01573273|12346927|FG001|COMPLETED|TSST : Trier Social Stress Task||25
11158336|NCT01573273|12346928|FG002|COMPLETED|TSST : Trier Social Stress Task||0
11158337|NCT01573273|12346929|FG003|COMPLETED|TSST : Trier Social Stress Task||0
11158338|NCT01573273|12346930|FG004|COMPLETED|TSST : Trier Social Stress Task||0
11158339|NCT01573273|12346931|FG005|COMPLETED|TSST : Trier Social Stress Task||0
11158340|NCT01573273|12346932|FG006|COMPLETED|TSST : Trier Social Stress Task||32
11158341|NCT01573273|12346933|FG007|COMPLETED|TSST : Trier Social Stress Task||31
11158342|NCT01573273|12346934|FG008|COMPLETED|TSST : Trier Social Stress Task||0
11158343|NCT01573273|12346935|FG009|COMPLETED|TSST : Trier Social Stress Task||0
11158344|NCT01573273|12346936|FG010|COMPLETED|TSST : Trier Social Stress Task||0
11158345|NCT01573273|12346937|FG011|COMPLETED|TSST : Trier Social Stress Task||0
11158346|NCT01573273|12346926|FG000|NOT COMPLETED|TSST : Trier Social Stress Task||0
11158347|NCT01573273|12346927|FG001|NOT COMPLETED|TSST : Trier Social Stress Task||0
11158348|NCT01573273|12346928|FG002|NOT COMPLETED|TSST : Trier Social Stress Task||0
11158349|NCT01573273|12346929|FG003|NOT COMPLETED|TSST : Trier Social Stress Task||0
11158350|NCT01573273|12346930|FG004|NOT COMPLETED|TSST : Trier Social Stress Task||0
11158351|NCT01573273|12346931|FG005|NOT COMPLETED|TSST : Trier Social Stress Task||0
11158352|NCT01573273|12346932|FG006|NOT COMPLETED|TSST : Trier Social Stress Task||0
11158353|NCT01573273|12346933|FG007|NOT COMPLETED|TSST : Trier Social Stress Task||0
11158354|NCT01573273|12346934|FG008|NOT COMPLETED|TSST : Trier Social Stress Task||0
11158355|NCT01573273|12346935|FG009|NOT COMPLETED|TSST : Trier Social Stress Task||0
11158356|NCT01573273|12346936|FG010|NOT COMPLETED|TSST : Trier Social Stress Task||0
11158357|NCT01573273|12346937|FG011|NOT COMPLETED|TSST : Trier Social Stress Task||0
11158358|NCT01573273|12346926|FG000|STARTED|MRI 1||0
11158359|NCT01573273|12346927|FG001|STARTED|MRI 1||0
11158360|NCT01573273|12346928|FG002|STARTED|MRI 1||19
11158361|NCT01573273|12346929|FG003|STARTED|MRI 1||23
11158362|NCT01573273|12346930|FG004|STARTED|MRI 1||0
11158363|NCT01573273|12346931|FG005|STARTED|MRI 1||0
11158364|NCT01573273|12346932|FG006|STARTED|MRI 1||0
11158365|NCT01573273|12346933|FG007|STARTED|MRI 1||0
11158366|NCT01573273|12346934|FG008|STARTED|MRI 1||28
11158367|NCT01573273|12346935|FG009|STARTED|MRI 1||29
11158368|NCT01573273|12346936|FG010|STARTED|MRI 1||0
11158369|NCT01573273|12346937|FG011|STARTED|MRI 1||0
11158370|NCT01573273|12346926|FG000|COMPLETED|MRI 1||0
11158371|NCT01573273|12346927|FG001|COMPLETED|MRI 1||0
11158372|NCT01573273|12346928|FG002|COMPLETED|MRI 1||19
11158373|NCT01573273|12346929|FG003|COMPLETED|MRI 1||23
11158374|NCT01573273|12346930|FG004|COMPLETED|MRI 1||0
11158375|NCT01573273|12346931|FG005|COMPLETED|MRI 1||0
11158376|NCT01573273|12346932|FG006|COMPLETED|MRI 1||0
11158377|NCT01573273|12346933|FG007|COMPLETED|MRI 1||0
11158378|NCT01573273|12346934|FG008|COMPLETED|MRI 1||28
11158379|NCT01573273|12346935|FG009|COMPLETED|MRI 1||29
11158380|NCT01573273|12346936|FG010|COMPLETED|MRI 1||0
11158381|NCT01573273|12346937|FG011|COMPLETED|MRI 1||0
11158382|NCT01573273|12346926|FG000|NOT COMPLETED|MRI 1||0
11419058|NCT00314353|12617522|FG001|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
11158383|NCT01573273|12346927|FG001|NOT COMPLETED|MRI 1||0
11158384|NCT01573273|12346928|FG002|NOT COMPLETED|MRI 1||0
11158385|NCT01573273|12346929|FG003|NOT COMPLETED|MRI 1||0
11158386|NCT01573273|12346930|FG004|NOT COMPLETED|MRI 1||0
11158387|NCT01573273|12346931|FG005|NOT COMPLETED|MRI 1||0
11419059|NCT00314353|12617521|FG000|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
11419060|NCT00314353|12617522|FG001|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
11419061|NCT00314353|12617521|FG000|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
11419062|NCT00314353|12617522|FG001|STARTED|Follow-up||0
11158388|NCT01573273|12346932|FG006|NOT COMPLETED|MRI 1||0
11158389|NCT01573273|12346933|FG007|NOT COMPLETED|MRI 1||0
11158390|NCT01573273|12346934|FG008|NOT COMPLETED|MRI 1||0
11158391|NCT01573273|12346935|FG009|NOT COMPLETED|MRI 1||0
11158392|NCT01573273|12346936|FG010|NOT COMPLETED|MRI 1||0
11158393|NCT01573273|12346937|FG011|NOT COMPLETED|MRI 1||0
11158394|NCT01573273|12346926|FG000|STARTED|MRI 2||0
11158395|NCT01573273|12346927|FG001|STARTED|MRI 2||0
11158396|NCT01573273|12346928|FG002|STARTED|MRI 2||0
11158397|NCT01573273|12346929|FG003|STARTED|MRI 2||0
11158398|NCT01573273|12346930|FG004|STARTED|MRI 2||23
11158399|NCT01573273|12346931|FG005|STARTED|MRI 2||18
11158400|NCT01573273|12346932|FG006|STARTED|MRI 2||0
11158401|NCT01573273|12346933|FG007|STARTED|MRI 2||0
11158402|NCT01573273|12346934|FG008|STARTED|MRI 2||0
11158403|NCT01573273|12346935|FG009|STARTED|MRI 2||0
11158404|NCT01573273|12346936|FG010|STARTED|MRI 2||27
11158405|NCT01573273|12346937|FG011|STARTED|MRI 2||28
11158406|NCT01573273|12346926|FG000|COMPLETED|MRI 2||0
11158407|NCT01573273|12346927|FG001|COMPLETED|MRI 2||0
11158408|NCT01573273|12346928|FG002|COMPLETED|MRI 2||0
11158409|NCT01573273|12346929|FG003|COMPLETED|MRI 2||0
11158410|NCT01573273|12346930|FG004|COMPLETED|MRI 2||23
11158411|NCT01573273|12346931|FG005|COMPLETED|MRI 2||18
11158412|NCT01573273|12346932|FG006|COMPLETED|MRI 2||0
11158413|NCT01573273|12346933|FG007|COMPLETED|MRI 2||0
11158414|NCT01573273|12346934|FG008|COMPLETED|MRI 2||0
11158415|NCT01573273|12346935|FG009|COMPLETED|MRI 2||0
11158416|NCT01573273|12346936|FG010|COMPLETED|MRI 2||27
11158417|NCT01573273|12346937|FG011|COMPLETED|MRI 2||28
11158418|NCT01573273|12346926|FG000|NOT COMPLETED|MRI 2||0
11158419|NCT01573273|12346927|FG001|NOT COMPLETED|MRI 2||0
11158420|NCT01573273|12346928|FG002|NOT COMPLETED|MRI 2||0
11158421|NCT01573273|12346929|FG003|NOT COMPLETED|MRI 2||0
11158422|NCT01573273|12346930|FG004|NOT COMPLETED|MRI 2||0
11158423|NCT01573273|12346931|FG005|NOT COMPLETED|MRI 2||0
11158424|NCT01573273|12346932|FG006|NOT COMPLETED|MRI 2||0
11158425|NCT01573273|12346933|FG007|NOT COMPLETED|MRI 2||0
11158426|NCT01573273|12346934|FG008|NOT COMPLETED|MRI 2||0
11158427|NCT01573273|12346935|FG009|NOT COMPLETED|MRI 2||0
11158428|NCT01573273|12346936|FG010|NOT COMPLETED|MRI 2||0
11158429|NCT01573273|12346937|FG011|NOT COMPLETED|MRI 2||0
11203291|NCT01846455|12393776|FG004|NOT COMPLETED|Overall Study||0
11203292|NCT01846494|12393790|FG000|STARTED|Overall Study||50
11203293|NCT01846494|12393791|FG001|STARTED|Overall Study||63
11203294|NCT01846494|12393790|FG000|COMPLETED|Overall Study||20
11203295|NCT01846494|12393791|FG001|COMPLETED|Overall Study||25
11203296|NCT01846494|12393790|FG000|NOT COMPLETED|Overall Study||30
11203297|NCT01846494|12393791|FG001|NOT COMPLETED|Overall Study||38
11203298|NCT01846507|12393797|FG000|STARTED|Overall Study||32
11203299|NCT01846507|12393797|FG000|COMPLETED|Overall Study||25
11203300|NCT01846507|12393797|FG000|NOT COMPLETED|Overall Study||7
11203301|NCT01846611|12393805|FG000|STARTED|Overall Study||289
11203302|NCT01846611|12393806|FG001|STARTED|Overall Study||287
11203303|NCT01846611|12393805|FG000|Treated|Overall Study||286
11203304|NCT01846611|12393806|FG001|Treated|Overall Study||282
11203305|NCT01846611|12393805|FG000|COMPLETED|Overall Study||251
11203306|NCT01846611|12393806|FG001|COMPLETED|Overall Study||244
11203307|NCT01846611|12393805|FG000|NOT COMPLETED|Overall Study||38
11203308|NCT01846611|12393806|FG001|NOT COMPLETED|Overall Study||43
11203309|NCT01846624|12393812|FG000|STARTED|Overall Study||13
11203310|NCT01846624|12393812|FG000|COMPLETED|Overall Study||12
11203311|NCT01846624|12393812|FG000|NOT COMPLETED|Overall Study||1
11203312|NCT01846702|12393823|FG000|STARTED|Overall Study||6
11203313|NCT01846702|12393824|FG001|STARTED|Overall Study||6
11203314|NCT01846702|12393825|FG002|STARTED|Overall Study||7
11203315|NCT01846702|12393826|FG003|STARTED|Overall Study||6
11203316|NCT01846702|12393827|FG004|STARTED|Overall Study||6
11203317|NCT01846702|12393828|FG005|STARTED|Overall Study||6
11203318|NCT01846702|12393829|FG006|STARTED|Overall Study||6
11203319|NCT01846702|12393823|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
11203320|NCT01846702|12393824|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
11203321|NCT01846702|12393825|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11203322|NCT01846702|12393826|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
11203323|NCT01846702|12393827|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
11203324|NCT01846702|12393828|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
11203325|NCT01846702|12393829|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
11203326|NCT01846702|12393823|FG000|COMPLETED|Overall Study||6
11203327|NCT01846702|12393824|FG001|COMPLETED|Overall Study||6
11203328|NCT01846702|12393825|FG002|COMPLETED|Overall Study||6
11203329|NCT01846702|12393826|FG003|COMPLETED|Overall Study||6
11203330|NCT01846702|12393827|FG004|COMPLETED|Overall Study||6
11203331|NCT01846702|12393828|FG005|COMPLETED|Overall Study||6
11203332|NCT01846702|12393829|FG006|COMPLETED|Overall Study||6
11203333|NCT01846702|12393823|FG000|NOT COMPLETED|Overall Study||0
11203334|NCT01846702|12393824|FG001|NOT COMPLETED|Overall Study||0
11203335|NCT01846702|12393825|FG002|NOT COMPLETED|Overall Study||1
11203336|NCT01846702|12393826|FG003|NOT COMPLETED|Overall Study||0
11203337|NCT01846702|12393827|FG004|NOT COMPLETED|Overall Study||0
11203338|NCT01846702|12393828|FG005|NOT COMPLETED|Overall Study||0
11158430|NCT01573325|12346963|FG000|STARTED|Overall Study||50
11158431|NCT01573325|12346963|FG000|COMPLETED|Overall Study||50
11158432|NCT01573325|12346963|FG000|NOT COMPLETED|Overall Study||0
11158433|NCT01573442|12346970|FG000|STARTED|Overall Study||113
11158434|NCT01573442|12346971|FG001|STARTED|Overall Study||114
11158435|NCT01573442|12346970|FG000|COMPLETED|Overall Study||104
11158436|NCT01573442|12346971|FG001|COMPLETED|Overall Study||104
11158437|NCT01573442|12346970|FG000|NOT COMPLETED|Overall Study||9
11158438|NCT01573442|12346971|FG001|NOT COMPLETED|Overall Study||10
11158439|NCT01573533|12346977|FG000|STARTED|Overall Study||9
11158440|NCT01573533|12346977|FG000|COMPLETED|Overall Study||9
11158441|NCT01573533|12346977|FG000|NOT COMPLETED|Overall Study||0
11158442|NCT01573572|12346981|FG000|STARTED|Overall Study||131
11158443|NCT01573572|12346981|FG000|COMPLETED|Overall Study||103
11158444|NCT01573572|12346981|FG000|NOT COMPLETED|Overall Study||28
11158445|NCT01573624|12346985|FG000|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
11158446|NCT01573624|12346986|FG001|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
11158447|NCT01573624|12346987|FG002|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
11158448|NCT01573624|12346988|FG003|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
11158449|NCT01573624|12346989|FG004|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
11158450|NCT01573624|12346990|FG005|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
11158451|NCT01573624|12346991|FG006|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
11158452|NCT01573624|12346985|FG000|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
11158453|NCT01573624|12346986|FG001|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
11158454|NCT01573624|12346987|FG002|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
11158455|NCT01573624|12346988|FG003|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
11158456|NCT01573624|12346989|FG004|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
11158457|NCT01573624|12346990|FG005|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
11158458|NCT01573624|12346991|FG006|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
11158459|NCT01573624|12346985|FG000|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
11158460|NCT01573624|12346986|FG001|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
11158461|NCT01573624|12346987|FG002|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
11158462|NCT01573624|12346988|FG003|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
11158463|NCT01573624|12346989|FG004|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
11158464|NCT01573624|12346990|FG005|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
11158465|NCT01573624|12346991|FG006|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
11158466|NCT01573624|12346985|FG000|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
11158467|NCT01573624|12346986|FG001|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
11158468|NCT01573624|12346987|FG002|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
11158469|NCT01573624|12346988|FG003|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
11158470|NCT01573624|12346989|FG004|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
11158471|NCT01573624|12346990|FG005|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
11158472|NCT01573624|12346991|FG006|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
11158473|NCT01573624|12346985|FG000|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
11158474|NCT01573624|12346986|FG001|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
11158475|NCT01573624|12346987|FG002|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
11158476|NCT01573624|12346988|FG003|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
11158477|NCT01573624|12346989|FG004|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
11158478|NCT01573624|12346990|FG005|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
11158479|NCT01573624|12346991|FG006|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
11158480|NCT01573624|12346985|FG000|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
11158481|NCT01573624|12346986|FG001|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
11158482|NCT01573624|12346987|FG002|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
11158483|NCT01573624|12346988|FG003|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
11158484|NCT01573624|12346989|FG004|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
11158485|NCT01573624|12346990|FG005|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
11026706|NCT00830063|12205317|FG001|STARTED|Overall Study||208
11026707|NCT00830063|12205318|FG002|STARTED|Overall Study||208
11026708|NCT00830063|12205319|FG003|STARTED|Overall Study||208
11026709|NCT00830063|12205316|FG000|Treated|Overall Study||208
11026710|NCT00830063|12205317|FG001|Treated|Overall Study||206
11026711|NCT00830063|12205318|FG002|Treated|Overall Study||208
11026712|NCT00830063|12205319|FG003|Treated|Overall Study||206
11026713|NCT00830063|12205316|FG000|COMPLETED|Overall Study||8
11026714|NCT00830063|12205317|FG001|COMPLETED|Overall Study||16
11026715|NCT00830063|12205318|FG002|COMPLETED|Overall Study||10
11158486|NCT01573624|12346991|FG006|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
11158487|NCT01573624|12346985|FG000|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
11158488|NCT01573624|12346986|FG001|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
11158489|NCT01573624|12346987|FG002|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
11158490|NCT01573624|12346988|FG003|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
11158491|NCT01573624|12346989|FG004|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
11158492|NCT01573624|12346990|FG005|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
11158493|NCT01573624|12346991|FG006|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
11158494|NCT01573624|12346985|FG000|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
11419063|NCT00314353|12617521|FG000|COMPLETED|Follow-up||3
11026716|NCT00830063|12205319|FG003|COMPLETED|Overall Study||13
11026717|NCT00830063|12205316|FG000|NOT COMPLETED|Overall Study||200
11026718|NCT00830063|12205317|FG001|NOT COMPLETED|Overall Study||192
11158495|NCT01573624|12346986|FG001|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
11158496|NCT01573624|12346987|FG002|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
11158497|NCT01573624|12346988|FG003|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
11158498|NCT01573624|12346989|FG004|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
11158499|NCT01573624|12346990|FG005|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
11158500|NCT01573624|12346991|FG006|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
11158501|NCT01573624|12346985|FG000|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
11158502|NCT01573624|12346986|FG001|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
11158503|NCT01573624|12346987|FG002|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
11158504|NCT01573624|12346988|FG003|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
11158505|NCT01573624|12346989|FG004|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
11158506|NCT01573624|12346990|FG005|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
11158507|NCT01573624|12346991|FG006|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
11158508|NCT01573624|12346985|FG000|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
11158509|NCT01573624|12346986|FG001|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
11158510|NCT01573624|12346987|FG002|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
11158511|NCT01573624|12346988|FG003|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
11158512|NCT01573624|12346989|FG004|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
11158513|NCT01573624|12346990|FG005|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
11158514|NCT01573624|12346991|FG006|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
11158515|NCT01573624|12346985|FG000|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
11158516|NCT01573624|12346986|FG001|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
11158517|NCT01573624|12346987|FG002|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
11158518|NCT01573624|12346988|FG003|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
11158519|NCT01573624|12346989|FG004|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
11158520|NCT01573624|12346990|FG005|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
11158521|NCT01573624|12346991|FG006|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
11158522|NCT01573624|12346985|FG000|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
11158523|NCT01573624|12346986|FG001|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
11158524|NCT01573624|12346987|FG002|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
11158525|NCT01573624|12346988|FG003|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
11158526|NCT01573624|12346989|FG004|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
11158527|NCT01573624|12346990|FG005|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
11158528|NCT01573624|12346991|FG006|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
11158529|NCT01573624|12346985|FG000|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
11158530|NCT01573624|12346986|FG001|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
11158531|NCT01573624|12346987|FG002|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
11158532|NCT01573624|12346988|FG003|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
11158533|NCT01573624|12346989|FG004|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
11158534|NCT01573624|12346990|FG005|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
11158535|NCT01573624|12346991|FG006|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
11158536|NCT01573624|12346985|FG000|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
11158537|NCT01573624|12346986|FG001|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
11158538|NCT01573624|12346987|FG002|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
11158539|NCT01573624|12346988|FG003|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
11158540|NCT01573624|12346989|FG004|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
11158541|NCT01573624|12346990|FG005|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
11158542|NCT01573624|12346991|FG006|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
11158543|NCT01573624|12346985|FG000|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
11158544|NCT01573624|12346986|FG001|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
11158545|NCT01573624|12346987|FG002|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
11158546|NCT01573624|12346988|FG003|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
11158547|NCT01573624|12346989|FG004|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
11158548|NCT01573624|12346990|FG005|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
11158549|NCT01573624|12346991|FG006|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
11158550|NCT01573624|12346985|FG000|STARTED|Period 6 : Follow-up Period (7 Days)||46
11158551|NCT01573624|12346986|FG001|STARTED|Period 6 : Follow-up Period (7 Days)||47
11158552|NCT01573624|12346987|FG002|STARTED|Period 6 : Follow-up Period (7 Days)||43
11158553|NCT01573624|12346988|FG003|STARTED|Period 6 : Follow-up Period (7 Days)||53
11158554|NCT01573624|12346989|FG004|STARTED|Period 6 : Follow-up Period (7 Days)||51
11158555|NCT01573624|12346990|FG005|STARTED|Period 6 : Follow-up Period (7 Days)||39
11158556|NCT01573624|12346991|FG006|STARTED|Period 6 : Follow-up Period (7 Days)||48
11158557|NCT01573624|12346985|FG000|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
11158558|NCT01573624|12346986|FG001|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
11158559|NCT01573624|12346987|FG002|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
11158560|NCT01573624|12346988|FG003|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
11158561|NCT01573624|12346989|FG004|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
11158562|NCT01573624|12346990|FG005|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
11158563|NCT01573624|12346991|FG006|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
11203339|NCT01846702|12393829|FG006|NOT COMPLETED|Overall Study||0
11419064|NCT00314353|12617522|FG001|COMPLETED|Follow-up||0
11419065|NCT00314353|12617521|FG000|NOT COMPLETED|Follow-up||0
11419066|NCT00314353|12617522|FG001|NOT COMPLETED|Follow-up||0
11419067|NCT00314093|12617528|FG000|STARTED|Overall Study||0
11419068|NCT00314093|12617528|FG000|COMPLETED|Overall Study||0
11419069|NCT00314093|12617528|FG000|NOT COMPLETED|Overall Study||0
11419070|NCT00314327|12617532|FG000|STARTED|Overall Study||1
11419071|NCT00314327|12617532|FG000|COMPLETED|Overall Study||0
11419072|NCT00314327|12617532|FG000|NOT COMPLETED|Overall Study||1
11419073|NCT00308113|12617540|FG000|STARTED|Overall Study||0
11419074|NCT00308113|12617541|FG001|STARTED|Overall Study||0
11419075|NCT00308113|12617542|FG002|STARTED|Overall Study||1
11419076|NCT00308113|12617543|FG003|STARTED|Overall Study||2
11419077|NCT00308113|12617540|FG000|COMPLETED|Overall Study||0
11419078|NCT00308113|12617541|FG001|COMPLETED|Overall Study||0
11419079|NCT00308113|12617542|FG002|COMPLETED|Overall Study||1
11419080|NCT00308113|12617543|FG003|COMPLETED|Overall Study||1
11419081|NCT00308113|12617540|FG000|NOT COMPLETED|Overall Study||0
11419082|NCT00308113|12617541|FG001|NOT COMPLETED|Overall Study||0
11419083|NCT00308113|12617542|FG002|NOT COMPLETED|Overall Study||0
11419084|NCT00308113|12617543|FG003|NOT COMPLETED|Overall Study||1
11419085|NCT00305643|12617555|FG000|STARTED|Overall Study||6
11419086|NCT00305643|12617556|FG001|STARTED|Overall Study||5
11419087|NCT00305643|12617555|FG000|COMPLETED|Overall Study||6
11419088|NCT00305643|12617556|FG001|COMPLETED|Overall Study||5
11419089|NCT00305643|12617555|FG000|NOT COMPLETED|Overall Study||0
11419090|NCT00305643|12617556|FG001|NOT COMPLETED|Overall Study||0
11419091|NCT00298740|12617563|FG000|STARTED|Overall Study||12
11419092|NCT00298740|12617563|FG000|COMPLETED|Overall Study||3
11419093|NCT00298740|12617563|FG000|NOT COMPLETED|Overall Study||9
11419094|NCT00301080|12617567|FG000|STARTED|Original Version (2 Arms & 4 Weeks)||4
11419095|NCT00301080|12617568|FG001|STARTED|Original Version (2 Arms & 4 Weeks)||3
11419096|NCT00301080|12617569|FG002|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
11419097|NCT00301080|12617570|FG003|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
11419098|NCT00301080|12617571|FG004|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
11419099|NCT00301080|12617567|FG000|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
11419100|NCT00301080|12617568|FG001|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
11419101|NCT00301080|12617569|FG002|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
11419102|NCT00301080|12617570|FG003|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
11419103|NCT00301080|12617571|FG004|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
11419104|NCT00301080|12617567|FG000|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
11419105|NCT00301080|12617568|FG001|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
11419106|NCT00301080|12617569|FG002|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
11419107|NCT00301080|12617570|FG003|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
11419108|NCT00301080|12617571|FG004|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
11419109|NCT00301080|12617567|FG000|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
11419110|NCT00301080|12617568|FG001|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
11419111|NCT00301080|12617569|FG002|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
11419112|NCT00301080|12617570|FG003|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
11419113|NCT00301080|12617571|FG004|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
11419114|NCT00301080|12617567|FG000|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
11419115|NCT00301080|12617568|FG001|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
11419116|NCT00301080|12617569|FG002|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
11419117|NCT00301080|12617570|FG003|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
11419118|NCT00301080|12617571|FG004|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
11419119|NCT00301080|12617567|FG000|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
11419120|NCT00301080|12617568|FG001|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
11419121|NCT00301080|12617569|FG002|STARTED|Revised Version (3 Arms & 12 Weeks)||0
11419122|NCT00301080|12617570|FG003|STARTED|Revised Version (3 Arms & 12 Weeks)||0
11419123|NCT00301080|12617571|FG004|STARTED|Revised Version (3 Arms & 12 Weeks)||0
11158564|NCT01573624|12346985|FG000|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
11158565|NCT01573624|12346986|FG001|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
11158566|NCT01573624|12346987|FG002|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
11158567|NCT01573624|12346988|FG003|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
11158568|NCT01573624|12346989|FG004|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
11158569|NCT01573624|12346990|FG005|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
11158570|NCT01573624|12346991|FG006|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
11158571|NCT01573702|12347013|FG000|STARTED|Overall Study||25
11419124|NCT00301080|12617567|FG000|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
11419125|NCT00301080|12617568|FG001|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
11419126|NCT00301080|12617569|FG002|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
11158572|NCT01573702|12347013|FG000|COMPLETED|Overall Study||25
11158573|NCT01573702|12347013|FG000|NOT COMPLETED|Overall Study||0
11158574|NCT01573767|12347022|FG000|STARTED|Overall Study||115
11158575|NCT01573767|12347023|FG001|STARTED|Overall Study||114
11158576|NCT01573767|12347024|FG002|STARTED|Overall Study||113
11158577|NCT01573767|12347025|FG003|STARTED|Overall Study||114
11158578|NCT01573767|12347022|FG000|COMPLETED|Overall Study||93
11158579|NCT01573767|12347023|FG001|COMPLETED|Overall Study||93
11158580|NCT01573767|12347024|FG002|COMPLETED|Overall Study||99
11158581|NCT01573767|12347025|FG003|COMPLETED|Overall Study||90
11158582|NCT01573767|12347022|FG000|NOT COMPLETED|Overall Study||22
11158583|NCT01573767|12347023|FG001|NOT COMPLETED|Overall Study||21
11158584|NCT01573767|12347024|FG002|NOT COMPLETED|Overall Study||14
11158585|NCT01573767|12347025|FG003|NOT COMPLETED|Overall Study||24
11158586|NCT01573910|12347037|FG000|STARTED|Overall Study||489
11158587|NCT01573910|12347038|FG001|STARTED|Overall Study||493
11158588|NCT01573910|12347037|FG000|COMPLETED|Overall Study||469
11158589|NCT01573910|12347038|FG001|COMPLETED|Overall Study||476
11158590|NCT01573910|12347037|FG000|NOT COMPLETED|Overall Study||20
11158591|NCT01573910|12347038|FG001|NOT COMPLETED|Overall Study||17
11158592|NCT01573949|12347044|FG000|STARTED|Overall Study||7
11158593|NCT01573949|12347044|FG000|COMPLETED|Overall Study||7
11158594|NCT01573949|12347044|FG000|NOT COMPLETED|Overall Study||0
11158595|NCT01574079|12347050|FG000|STARTED|Overall Study||18
11158596|NCT01574079|12347051|FG001|STARTED|Overall Study||15
11158597|NCT01574079|12347050|FG000|COMPLETED|Overall Study||17
11158598|NCT01574079|12347051|FG001|COMPLETED|Overall Study||13
11158599|NCT01574079|12347050|FG000|NOT COMPLETED|Overall Study||1
11158600|NCT01574079|12347051|FG001|NOT COMPLETED|Overall Study||2
11158601|NCT01574105|12347059|FG000|STARTED|Overall Study||29
11158602|NCT01574105|12347060|FG001|STARTED|Overall Study||37
11158603|NCT01574105|12347059|FG000|COMPLETED|Overall Study||29
11158604|NCT01574105|12347060|FG001|COMPLETED|Overall Study||37
11158605|NCT01574105|12347059|FG000|NOT COMPLETED|Overall Study||0
11158606|NCT01574105|12347060|FG001|NOT COMPLETED|Overall Study||0
11158607|NCT01574144|12347066|FG000|STARTED|Overall Study||70
11158608|NCT01574144|12347066|FG000|COMPLETED|Overall Study||70
11158609|NCT01574144|12347066|FG000|NOT COMPLETED|Overall Study||0
11158610|NCT01574157|12347073|FG000|STARTED|Overall Study||35
11158611|NCT01574157|12347074|FG001|STARTED|Overall Study||39
11158612|NCT01574157|12347073|FG000|Month 3|Overall Study||31
11158613|NCT01574157|12347074|FG001|Month 3|Overall Study||33
11158614|NCT01574157|12347073|FG000|COMPLETED|Overall Study||31
11158615|NCT01574157|12347074|FG001|COMPLETED|Overall Study||31
11158616|NCT01574157|12347073|FG000|NOT COMPLETED|Overall Study||4
11158617|NCT01574157|12347074|FG001|NOT COMPLETED|Overall Study||8
11158618|NCT01574183|12347086|FG000|STARTED|Overall Study||41
11158619|NCT01574183|12347087|FG001|STARTED|Overall Study||35
11158620|NCT01574183|12347086|FG000|COMPLETED|Overall Study||14
11158621|NCT01574183|12347087|FG001|COMPLETED|Overall Study||17
11158622|NCT01574183|12347086|FG000|NOT COMPLETED|Overall Study||27
11158623|NCT01574183|12347087|FG001|NOT COMPLETED|Overall Study||18
11158624|NCT01574248|12347097|FG000|STARTED|Overall Study||15
11158625|NCT01574248|12347098|FG001|STARTED|Overall Study||18
11158626|NCT01574248|12347097|FG000|COMPLETED|Overall Study||12
11158627|NCT01574248|12347098|FG001|COMPLETED|Overall Study||18
11158628|NCT01574248|12347097|FG000|NOT COMPLETED|Overall Study||3
11158629|NCT01574248|12347098|FG001|NOT COMPLETED|Overall Study||0
11158630|NCT01574287|12347104|FG000|STARTED|Overall Study||4
11158631|NCT01574287|12347104|FG000|COMPLETED|Overall Study||4
11158632|NCT01574287|12347104|FG000|NOT COMPLETED|Overall Study||0
11158633|NCT01574326|12347110|FG000|STARTED|Overall Study||51
11158634|NCT01574326|12347111|FG001|STARTED|Overall Study||50
11158635|NCT01574326|12347110|FG000|Treated|Overall Study||51
11158636|NCT01574326|12347111|FG001|Treated|Overall Study||49
11158637|NCT01574326|12347110|FG000|COMPLETED|Overall Study||35
11158638|NCT01574326|12347111|FG001|COMPLETED|Overall Study||31
11158639|NCT01574326|12347110|FG000|NOT COMPLETED|Overall Study||16
11158640|NCT01574326|12347111|FG001|NOT COMPLETED|Overall Study||19
11158641|NCT01574352|12347124|FG000|STARTED|Overall Study|59 participants where randomized, but 4 dropped out prior to baseline measurements.|55
11158642|NCT01574352|12347125|FG001|STARTED|Overall Study|56 participants where randomized, but 5 dropped out prior to baseline measurements.|51
11158643|NCT01574352|12347124|FG000|COMPLETED|Overall Study|Participated in the last follow up measurement.|48
11158644|NCT01574352|12347125|FG001|COMPLETED|Overall Study|Participated in the last follow up measurement.|38
11158645|NCT01574352|12347124|FG000|NOT COMPLETED|Overall Study||7
11158646|NCT01574352|12347125|FG001|NOT COMPLETED|Overall Study||13
11158647|NCT01574612|12347131|FG000|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
11158648|NCT01574612|12347131|FG000|COMPLETED|Overall Study||46
11158649|NCT01574612|12347131|FG000|NOT COMPLETED|Overall Study||8
11158650|NCT01574651|12347137|FG000|STARTED|Overall Study||476
11158651|NCT01574651|12347138|FG001|STARTED|Overall Study||458
11158652|NCT01574651|12347137|FG000|Full Analysis Set (FAS)|Overall Study||476
11158653|NCT01574651|12347138|FG001|Full Analysis Set (FAS)|Overall Study||458
11158654|NCT01574651|12347137|FG000|Per Protocol Set (PPS)|Overall Study||373
11158655|NCT01574651|12347138|FG001|Per Protocol Set (PPS)|Overall Study||374
11158656|NCT01574651|12347137|FG000|COMPLETED|Overall Study||415
11158657|NCT01574651|12347138|FG001|COMPLETED|Overall Study||406
11158658|NCT01574651|12347137|FG000|NOT COMPLETED|Overall Study||61
11158659|NCT01574651|12347138|FG001|NOT COMPLETED|Overall Study||52
11158660|NCT01574703|12347148|FG000|STARTED|Overall Study||1192
11158661|NCT01574703|12347149|FG001|STARTED|Overall Study||1166
11158662|NCT01574703|12347150|FG002|STARTED|Overall Study||1116
11158663|NCT01574703|12347151|FG003|STARTED|Overall Study||1121
11158664|NCT01574703|12347148|FG000|COMPLETED|Overall Study||1067
11158665|NCT01574703|12347149|FG001|COMPLETED|Overall Study||1054
11158666|NCT01574703|12347150|FG002|COMPLETED|Overall Study||1011
11158667|NCT01574703|12347151|FG003|COMPLETED|Overall Study||1007
11158668|NCT01574703|12347148|FG000|NOT COMPLETED|Overall Study||125
11158669|NCT01574703|12347149|FG001|NOT COMPLETED|Overall Study||112
11158670|NCT01574703|12347150|FG002|NOT COMPLETED|Overall Study||105
11158671|NCT01574703|12347151|FG003|NOT COMPLETED|Overall Study||114
11158672|NCT01574716|12347166|FG000|STARTED|Part 1||3
11158673|NCT01574716|12347167|FG001|STARTED|Part 1||4
11158674|NCT01574716|12347168|FG002|STARTED|Part 1||9
11158675|NCT01574716|12347169|FG003|STARTED|Part 1||0
11158676|NCT01574716|12347170|FG004|STARTED|Part 1||0
11158677|NCT01574716|12347166|FG000|COMPLETED|Part 1||0
11158678|NCT01574716|12347167|FG001|COMPLETED|Part 1||0
11158679|NCT01574716|12347168|FG002|COMPLETED|Part 1||0
11158680|NCT01574716|12347169|FG003|COMPLETED|Part 1||0
11158681|NCT01574716|12347170|FG004|COMPLETED|Part 1||0
11158682|NCT01574716|12347166|FG000|NOT COMPLETED|Part 1||3
11158683|NCT01574716|12347167|FG001|NOT COMPLETED|Part 1||4
11158684|NCT01574716|12347168|FG002|NOT COMPLETED|Part 1||9
11158685|NCT01574716|12347169|FG003|NOT COMPLETED|Part 1||0
11158686|NCT01574716|12347170|FG004|NOT COMPLETED|Part 1||0
11158687|NCT01574716|12347166|FG000|STARTED|Part 2||0
11158688|NCT01574716|12347167|FG001|STARTED|Part 2||0
11158689|NCT01574716|12347168|FG002|STARTED|Part 2||0
11158690|NCT01574716|12347169|FG003|STARTED|Part 2||139
11158691|NCT01574716|12347170|FG004|STARTED|Part 2||70
11158692|NCT01574716|12347166|FG000|Treated Participants|Part 2||0
11158693|NCT01574716|12347167|FG001|Treated Participants|Part 2||0
11158694|NCT01574716|12347168|FG002|Treated Participants|Part 2||0
11158695|NCT01574716|12347169|FG003|Treated Participants|Part 2||140
11158696|NCT01574716|12347170|FG004|Treated Participants|Part 2||67
11158697|NCT01574716|12347166|FG000|COMPLETED|Part 2||0
11158698|NCT01574716|12347167|FG001|COMPLETED|Part 2||0
11158699|NCT01574716|12347168|FG002|COMPLETED|Part 2||0
11158700|NCT01574716|12347169|FG003|COMPLETED|Part 2||2
11158701|NCT01574716|12347170|FG004|COMPLETED|Part 2||0
11158702|NCT01574716|12347166|FG000|NOT COMPLETED|Part 2||0
11158703|NCT01574716|12347167|FG001|NOT COMPLETED|Part 2||0
11158704|NCT01574716|12347168|FG002|NOT COMPLETED|Part 2||0
11158705|NCT01574716|12347169|FG003|NOT COMPLETED|Part 2||137
11158706|NCT01574716|12347170|FG004|NOT COMPLETED|Part 2||70
11158707|NCT01574807|12347179|FG000|STARTED|First Appointment||50
11419127|NCT00301080|12617570|FG003|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
11419128|NCT00301080|12617571|FG004|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
11419129|NCT00301080|12617567|FG000|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
11419130|NCT00301080|12617568|FG001|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
11158708|NCT01574807|12347180|FG001|STARTED|First Appointment||50
11158709|NCT01574807|12347179|FG000|COMPLETED|First Appointment||50
11158710|NCT01574807|12347180|FG001|COMPLETED|First Appointment||50
11158711|NCT01574807|12347179|FG000|NOT COMPLETED|First Appointment||0
11158712|NCT01574807|12347180|FG001|NOT COMPLETED|First Appointment||0
11158713|NCT01574807|12347179|FG000|STARTED|Wash Out Period 2 Weeks||50
11158714|NCT01574807|12347180|FG001|STARTED|Wash Out Period 2 Weeks||50
11158715|NCT01574807|12347179|FG000|COMPLETED|Wash Out Period 2 Weeks||50
11158716|NCT01574807|12347180|FG001|COMPLETED|Wash Out Period 2 Weeks||50
11158717|NCT01574807|12347179|FG000|NOT COMPLETED|Wash Out Period 2 Weeks||0
11158718|NCT01574807|12347180|FG001|NOT COMPLETED|Wash Out Period 2 Weeks||0
11158719|NCT01574807|12347179|FG000|STARTED|Second Appointment||50
11158720|NCT01574807|12347180|FG001|STARTED|Second Appointment||50
11158721|NCT01574807|12347179|FG000|COMPLETED|Second Appointment||50
11158722|NCT01574807|12347180|FG001|COMPLETED|Second Appointment||50
11158723|NCT01574807|12347179|FG000|NOT COMPLETED|Second Appointment||0
11158724|NCT01574807|12347180|FG001|NOT COMPLETED|Second Appointment||0
11158725|NCT01575054|12347187|FG000|STARTED|Overall Study||233
11158726|NCT01575054|12347188|FG001|STARTED|Overall Study||235
11158727|NCT01575054|12347187|FG000|COMPLETED|Overall Study||204
11158728|NCT01575054|12347188|FG001|COMPLETED|Overall Study||209
11158729|NCT01575054|12347187|FG000|NOT COMPLETED|Overall Study||29
11158730|NCT01575054|12347188|FG001|NOT COMPLETED|Overall Study||26
11158731|NCT01575080|12347194|FG000|STARTED|Overall Study||102
11158732|NCT01575080|12347194|FG000|COMPLETED|Overall Study||102
11158733|NCT01575080|12347194|FG000|NOT COMPLETED|Overall Study||0
11158734|NCT01575106|12347198|FG000|STARTED|Overall Study||38
11158735|NCT01575106|12347198|FG000|COMPLETED|Overall Study||24
11158736|NCT01575106|12347198|FG000|NOT COMPLETED|Overall Study||14
11158737|NCT01575197|12347206|FG000|STARTED|Overall Study||152
11158738|NCT01575197|12347207|FG001|STARTED|Overall Study||152
11158739|NCT01575197|12347208|FG002|STARTED|Overall Study||152
11158740|NCT01575197|12347206|FG000|COMPLETED|Overall Study||149
11158741|NCT01575197|12347207|FG001|COMPLETED|Overall Study||143
11158742|NCT01575197|12347208|FG002|COMPLETED|Overall Study||146
11158743|NCT01575197|12347206|FG000|NOT COMPLETED|Overall Study||3
11158744|NCT01575197|12347207|FG001|NOT COMPLETED|Overall Study||9
11158745|NCT01575197|12347208|FG002|NOT COMPLETED|Overall Study||6
11158746|NCT01575275|12347216|FG000|STARTED|Overall Study||8
11158747|NCT01575275|12347216|FG000|COMPLETED|Overall Study||8
11158748|NCT01575275|12347216|FG000|NOT COMPLETED|Overall Study||0
11158749|NCT01575522|12347220|FG000|STARTED|Overall Study||22
11158750|NCT01575522|12347220|FG000|COMPLETED|Overall Study||22
11158751|NCT01575522|12347220|FG000|NOT COMPLETED|Overall Study||0
11158752|NCT01575561|12347227|FG000|STARTED|Overall Study||377
11158753|NCT01575561|12347227|FG000|COMPLETED|Overall Study||338
11158754|NCT01575561|12347227|FG000|NOT COMPLETED|Overall Study||39
11158755|NCT01575756|12347231|FG000|STARTED|Treatment Period 1||11
11158756|NCT01575756|12347232|FG001|STARTED|Treatment Period 1||11
11158757|NCT01575756|12347231|FG000|COMPLETED|Treatment Period 1||11
11158758|NCT01575756|12347232|FG001|COMPLETED|Treatment Period 1||11
11158759|NCT01575756|12347231|FG000|NOT COMPLETED|Treatment Period 1||0
11158760|NCT01575756|12347232|FG001|NOT COMPLETED|Treatment Period 1||0
11158761|NCT01575756|12347231|FG000|STARTED|Treatment Period 2||11
11158762|NCT01575756|12347232|FG001|STARTED|Treatment Period 2||11
11158763|NCT01575756|12347231|FG000|COMPLETED|Treatment Period 2||11
11158764|NCT01575756|12347232|FG001|COMPLETED|Treatment Period 2||11
11158765|NCT01575756|12347231|FG000|NOT COMPLETED|Treatment Period 2||0
11158766|NCT01575756|12347232|FG001|NOT COMPLETED|Treatment Period 2||0
11158767|NCT01575769|12347239|FG000|STARTED|Overall Study||41
11158768|NCT01575769|12347239|FG000|COMPLETED|Overall Study||0
11158769|NCT01575769|12347239|FG000|NOT COMPLETED|Overall Study||41
11158770|NCT01575808|12347247|FG000|STARTED|Overall Study||103
11158771|NCT01575808|12347248|FG001|STARTED|Overall Study||68
11158772|NCT01575808|12347247|FG000|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
11158773|NCT01575808|12347248|FG001|COMPLETED|Overall Study||68
11158774|NCT01575808|12347247|FG000|NOT COMPLETED|Overall Study||3
11158775|NCT01575808|12347248|FG001|NOT COMPLETED|Overall Study||0
11158776|NCT01575873|12347260|FG000|STARTED|Overall Study||145
11158777|NCT01575873|12347261|FG001|STARTED|Overall Study||145
11158778|NCT01575873|12347262|FG002|STARTED|Overall Study||252
11158779|NCT01575873|12347263|FG003|STARTED|Overall Study||253
11158780|NCT01575873|12347260|FG000|Received Study Drug|Overall Study|Participants who received oral risedronate|140
11158781|NCT01575873|12347261|FG001|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
11158782|NCT01575873|12347262|FG002|Received Study Drug|Overall Study|Participants who received oral risedronate|246
11158783|NCT01575873|12347263|FG003|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
11158784|NCT01575873|12347260|FG000|COMPLETED|Overall Study||117
11158785|NCT01575873|12347261|FG001|COMPLETED|Overall Study||109
11158786|NCT01575873|12347262|FG002|COMPLETED|Overall Study||178
11158787|NCT01575873|12347263|FG003|COMPLETED|Overall Study||186
11158788|NCT01575873|12347260|FG000|NOT COMPLETED|Overall Study||28
11158789|NCT01575873|12347261|FG001|NOT COMPLETED|Overall Study||36
11158790|NCT01575873|12347262|FG002|NOT COMPLETED|Overall Study||74
11158791|NCT01575873|12347263|FG003|NOT COMPLETED|Overall Study||67
11158792|NCT01575899|12347274|FG000|STARTED|Overall Study||73
11158793|NCT01575899|12347275|FG001|STARTED|Overall Study||73
11158794|NCT01575899|12347276|FG002|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
11158795|NCT01575899|12347274|FG000|COMPLETED|Overall Study||68
11158796|NCT01575899|12347275|FG001|COMPLETED|Overall Study||68
11158797|NCT01575899|12347276|FG002|COMPLETED|Overall Study||60
11158798|NCT01575899|12347274|FG000|NOT COMPLETED|Overall Study||5
11158799|NCT01575899|12347275|FG001|NOT COMPLETED|Overall Study||5
11158800|NCT01575899|12347276|FG002|NOT COMPLETED|Overall Study||2
11158801|NCT01575912|12347289|FG000|STARTED|Overall Study||30
11158802|NCT01575912|12347290|FG001|STARTED|Overall Study||32
11158803|NCT01575912|12347291|FG002|STARTED|Overall Study||30
11419131|NCT00301080|12617569|FG002|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
11419132|NCT00301080|12617570|FG003|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
11419133|NCT00301080|12617571|FG004|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
11419134|NCT00299195|12617582|FG000|STARTED|Overall Study||30
11158804|NCT01575912|12347289|FG000|COMPLETED|Overall Study||30
11158805|NCT01575912|12347290|FG001|COMPLETED|Overall Study||32
11158806|NCT01575912|12347291|FG002|COMPLETED|Overall Study||30
11158807|NCT01575912|12347289|FG000|NOT COMPLETED|Overall Study||0
11158808|NCT01575912|12347290|FG001|NOT COMPLETED|Overall Study||0
11158809|NCT01575912|12347291|FG002|NOT COMPLETED|Overall Study||0
11158810|NCT01576003|12347302|FG000|STARTED|Overall Study||2
11158811|NCT01576003|12347303|FG001|STARTED|Overall Study||3
11158812|NCT01576003|12347304|FG002|STARTED|Overall Study||4
11158813|NCT01576003|12347302|FG000|COMPLETED|Overall Study||1
11158814|NCT01576003|12347303|FG001|COMPLETED|Overall Study||1
11158815|NCT01576003|12347304|FG002|COMPLETED|Overall Study||4
11158816|NCT01576003|12347302|FG000|NOT COMPLETED|Overall Study||1
11158817|NCT01576003|12347303|FG001|NOT COMPLETED|Overall Study||2
11158818|NCT01576003|12347304|FG002|NOT COMPLETED|Overall Study||0
11158819|NCT01576016|12347314|FG000|STARTED|Lead Safety||920
11158820|NCT01576016|12347315|FG001|STARTED|Lead Safety||0
11158821|NCT01576016|12347314|FG000|COMPLETED|Lead Safety||647
11158822|NCT01576016|12347315|FG001|COMPLETED|Lead Safety||0
11158823|NCT01576016|12347314|FG000|NOT COMPLETED|Lead Safety||273
11158824|NCT01576016|12347315|FG001|NOT COMPLETED|Lead Safety||0
11158825|NCT01576016|12347314|FG000|STARTED|MRI Safety||0
11158826|NCT01576016|12347315|FG001|STARTED|MRI Safety|255 enrollments includes 30 supplemental scans performed in Australia using the same scan protocol.|255
11158827|NCT01576016|12347314|FG000|COMPLETED|MRI Safety||0
11158828|NCT01576016|12347315|FG001|COMPLETED|MRI Safety||181
11158829|NCT01576016|12347314|FG000|NOT COMPLETED|MRI Safety||0
11158830|NCT01576016|12347315|FG001|NOT COMPLETED|MRI Safety||74
11158831|NCT01576042|12347325|FG000|STARTED|Overall Study||13
11158832|NCT01576042|12347326|FG001|STARTED|Overall Study||14
11158833|NCT01576042|12347325|FG000|Switched to the Other Arm|Overall Study||5
11158834|NCT01576042|12347326|FG001|Switched to the Other Arm|Overall Study||1
11158835|NCT01576042|12347325|FG000|COMPLETED|Overall Study||11
11158836|NCT01576042|12347326|FG001|COMPLETED|Overall Study||14
11158837|NCT01576042|12347325|FG000|NOT COMPLETED|Overall Study||2
11158838|NCT01576042|12347326|FG001|NOT COMPLETED|Overall Study||0
11158839|NCT01576055|12347334|FG000|STARTED|Overall Study||197
11158840|NCT01576055|12347335|FG001|STARTED|Overall Study||70
11158841|NCT01576055|12347334|FG000|COMPLETED|Overall Study||178
11158842|NCT01576055|12347335|FG001|COMPLETED|Overall Study||64
11158843|NCT01576055|12347334|FG000|NOT COMPLETED|Overall Study||19
11158844|NCT01576055|12347335|FG001|NOT COMPLETED|Overall Study||6
11158845|NCT01576120|12347343|FG000|STARTED|Overall Study||21
11158846|NCT01576120|12347344|FG001|STARTED|Overall Study||19
11158847|NCT01576120|12347343|FG000|COMPLETED|Overall Study||21
11158848|NCT01576120|12347344|FG001|COMPLETED|Overall Study||19
11158849|NCT01576120|12347343|FG000|NOT COMPLETED|Overall Study||0
11158850|NCT01576120|12347344|FG001|NOT COMPLETED|Overall Study||0
11158851|NCT01576146|12347350|FG000|STARTED|Extension Period 1||30
11158852|NCT01576146|12347350|FG000|COMPLETED|Extension Period 1||20
11158853|NCT01576146|12347350|FG000|NOT COMPLETED|Extension Period 1||10
11158854|NCT01576146|12347350|FG000|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
11158855|NCT01576146|12347350|FG000|COMPLETED|Extension Period 2||0
11158856|NCT01576146|12347350|FG000|NOT COMPLETED|Extension Period 2||17
11158857|NCT01576159|12347358|FG000|STARTED|Overall Study||12
11158858|NCT01576159|12347359|FG001|STARTED|Overall Study||12
11158859|NCT01576159|12347360|FG002|STARTED|Overall Study||12
11158860|NCT01576159|12347361|FG003|STARTED|Overall Study||12
11158861|NCT01576159|12347358|FG000|COMPLETED|Overall Study||11
11158862|NCT01576159|12347359|FG001|COMPLETED|Overall Study||11
11158863|NCT01576159|12347360|FG002|COMPLETED|Overall Study||11
11158864|NCT01576159|12347361|FG003|COMPLETED|Overall Study||11
11158865|NCT01576159|12347358|FG000|NOT COMPLETED|Overall Study||1
11158866|NCT01576159|12347359|FG001|NOT COMPLETED|Overall Study||1
11158867|NCT01576159|12347360|FG002|NOT COMPLETED|Overall Study||1
11158868|NCT01576159|12347361|FG003|NOT COMPLETED|Overall Study||1
11158869|NCT01576172|12347380|FG000|STARTED|Overall Study||79
11158870|NCT01576172|12347381|FG001|STARTED|Overall Study||80
11158871|NCT01576172|12347380|FG000|COMPLETED|Overall Study||74
11158872|NCT01576172|12347381|FG001|COMPLETED|Overall Study||79
11158873|NCT01576172|12347380|FG000|NOT COMPLETED|Overall Study||5
11158874|NCT01576172|12347381|FG001|NOT COMPLETED|Overall Study||1
11158875|NCT01576276|12347391|FG000|STARTED|Overall Study||22
11158876|NCT01576276|12347392|FG001|STARTED|Overall Study||29
11158877|NCT01576276|12347391|FG000|COMPLETED|Overall Study||14
11158878|NCT01576276|12347392|FG001|COMPLETED|Overall Study||18
11158879|NCT01576276|12347391|FG000|NOT COMPLETED|Overall Study||8
11158880|NCT01576276|12347392|FG001|NOT COMPLETED|Overall Study||11
11158881|NCT01576341|12347399|FG000|STARTED|Overall Study||417
11158882|NCT01576341|12347399|FG000|COMPLETED|Overall Study||324
11158883|NCT01576341|12347399|FG000|NOT COMPLETED|Overall Study||93
11158884|NCT01576367|12347406|FG000|STARTED|Overall Study||17
11158885|NCT01576367|12347406|FG000|COMPLETED|Overall Study||14
11158886|NCT01576367|12347406|FG000|NOT COMPLETED|Overall Study||3
11158887|NCT01576406|12347416|FG000|STARTED|Overall Study||11
11158888|NCT01576406|12347417|FG001|STARTED|Overall Study||15
11158889|NCT01576406|12347418|FG002|STARTED|Overall Study||20
11158890|NCT01576406|12347419|FG003|STARTED|Overall Study||10
11158891|NCT01576406|12347420|FG004|STARTED|Overall Study||16
11158892|NCT01576406|12347421|FG005|STARTED|Overall Study||16
11158893|NCT01576406|12347416|FG000|COMPLETED|Overall Study||5
11158894|NCT01576406|12347417|FG001|COMPLETED|Overall Study||7
11158895|NCT01576406|12347418|FG002|COMPLETED|Overall Study||4
11158896|NCT01576406|12347419|FG003|COMPLETED|Overall Study||1
11158897|NCT01576406|12347420|FG004|COMPLETED|Overall Study||8
11158898|NCT01576406|12347421|FG005|COMPLETED|Overall Study||4
11158899|NCT01576406|12347416|FG000|NOT COMPLETED|Overall Study||6
11158900|NCT01576406|12347417|FG001|NOT COMPLETED|Overall Study||8
11158901|NCT01576406|12347418|FG002|NOT COMPLETED|Overall Study||16
11158902|NCT01576406|12347419|FG003|NOT COMPLETED|Overall Study||9
11323113|NCT01084252|12520458|FG001|STARTED|Phase 1 (120 Weeks)||6
11323114|NCT01084252|12520459|FG002|STARTED|Phase 1 (120 Weeks)||3
11323115|NCT01084252|12520460|FG003|STARTED|Phase 1 (120 Weeks)||26
11323116|NCT01084252|12520461|FG004|STARTED|Phase 1 (120 Weeks)||18
11323117|NCT01084252|12520462|FG005|STARTED|Phase 1 (120 Weeks)||6
11323118|NCT01084252|12520463|FG006|STARTED|Phase 1 (120 Weeks)||7
11323119|NCT01084252|12520464|FG007|STARTED|Phase 1 (120 Weeks)||7
11323120|NCT01084252|12520465|FG008|STARTED|Phase 1 (120 Weeks)||0
11419135|NCT00299195|12617583|FG001|STARTED|Overall Study||33
11419136|NCT00299195|12617582|FG000|COMPLETED|Overall Study||30
11419137|NCT00299195|12617583|FG001|COMPLETED|Overall Study||33
11419138|NCT00299195|12617582|FG000|NOT COMPLETED|Overall Study||0
11158903|NCT01576406|12347420|FG004|NOT COMPLETED|Overall Study||8
11158904|NCT01576406|12347421|FG005|NOT COMPLETED|Overall Study||12
11158905|NCT01576471|12347437|FG000|STARTED|Overall Study||125
11158906|NCT01576471|12347438|FG001|STARTED|Overall Study||125
11158907|NCT01576471|12347437|FG000|COMPLETED|Overall Study||117
11158908|NCT01576471|12347438|FG001|COMPLETED|Overall Study||116
11158909|NCT01576471|12347437|FG000|NOT COMPLETED|Overall Study||8
11158910|NCT01576471|12347438|FG001|NOT COMPLETED|Overall Study||9
11158911|NCT01576484|12347446|FG000|STARTED|Overall Study||12
11158912|NCT01576484|12347447|FG001|STARTED|Overall Study||46
11158913|NCT01576484|12347446|FG000|COMPLETED|Overall Study||7
11158914|NCT01576484|12347447|FG001|COMPLETED|Overall Study||27
11158915|NCT01576484|12347446|FG000|NOT COMPLETED|Overall Study||5
11158916|NCT01576484|12347447|FG001|NOT COMPLETED|Overall Study||19
11158917|NCT01576523|12347461|FG000|STARTED|Dosing Period 1||3
11158918|NCT01576523|12347462|FG001|STARTED|Dosing Period 1||3
11158919|NCT01576523|12347463|FG002|STARTED|Dosing Period 1||3
11158920|NCT01576523|12347464|FG003|STARTED|Dosing Period 1||3
11158921|NCT01576523|12347465|FG004|STARTED|Dosing Period 1||3
11158922|NCT01576523|12347466|FG005|STARTED|Dosing Period 1||3
11158923|NCT01576523|12347461|FG000|COMPLETED|Dosing Period 1||3
11158924|NCT01576523|12347462|FG001|COMPLETED|Dosing Period 1||3
11158925|NCT01576523|12347463|FG002|COMPLETED|Dosing Period 1||3
11158926|NCT01576523|12347464|FG003|COMPLETED|Dosing Period 1||3
11158927|NCT01576523|12347465|FG004|COMPLETED|Dosing Period 1||3
11158928|NCT01576523|12347466|FG005|COMPLETED|Dosing Period 1||3
11158929|NCT01576523|12347461|FG000|NOT COMPLETED|Dosing Period 1||0
11158930|NCT01576523|12347462|FG001|NOT COMPLETED|Dosing Period 1||0
11158931|NCT01576523|12347463|FG002|NOT COMPLETED|Dosing Period 1||0
11158932|NCT01576523|12347464|FG003|NOT COMPLETED|Dosing Period 1||0
11158933|NCT01576523|12347465|FG004|NOT COMPLETED|Dosing Period 1||0
11158934|NCT01576523|12347466|FG005|NOT COMPLETED|Dosing Period 1||0
11158935|NCT01576523|12347461|FG000|STARTED|Dosing Period 2||3
11158936|NCT01576523|12347462|FG001|STARTED|Dosing Period 2||3
11158937|NCT01576523|12347463|FG002|STARTED|Dosing Period 2||3
11158938|NCT01576523|12347464|FG003|STARTED|Dosing Period 2||3
11158939|NCT01576523|12347465|FG004|STARTED|Dosing Period 2||3
11158940|NCT01576523|12347466|FG005|STARTED|Dosing Period 2||3
11158941|NCT01576523|12347461|FG000|COMPLETED|Dosing Period 2||3
11158942|NCT01576523|12347462|FG001|COMPLETED|Dosing Period 2||3
11158943|NCT01576523|12347463|FG002|COMPLETED|Dosing Period 2||3
11158944|NCT01576523|12347464|FG003|COMPLETED|Dosing Period 2||3
11158945|NCT01576523|12347465|FG004|COMPLETED|Dosing Period 2||3
11158946|NCT01576523|12347466|FG005|COMPLETED|Dosing Period 2||3
11158947|NCT01576523|12347461|FG000|NOT COMPLETED|Dosing Period 2||0
11158948|NCT01576523|12347462|FG001|NOT COMPLETED|Dosing Period 2||0
11158949|NCT01576523|12347463|FG002|NOT COMPLETED|Dosing Period 2||0
11158950|NCT01576523|12347464|FG003|NOT COMPLETED|Dosing Period 2||0
11158951|NCT01576523|12347465|FG004|NOT COMPLETED|Dosing Period 2||0
11158952|NCT01576523|12347466|FG005|NOT COMPLETED|Dosing Period 2||0
11158953|NCT01576536|12347475|FG000|STARTED|Overall Study||117
11158954|NCT01576536|12347475|FG000|COMPLETED|Overall Study||117
11158955|NCT01576536|12347475|FG000|NOT COMPLETED|Overall Study||0
11158956|NCT01576588|12347479|FG000|STARTED|Overall Study||25
11158957|NCT01576588|12347479|FG000|COMPLETED|Overall Study||23
11158958|NCT01576588|12347479|FG000|NOT COMPLETED|Overall Study||2
11158959|NCT01576705|12347488|FG000|STARTED|Overall Study||43
11158960|NCT01576705|12347489|FG001|STARTED|Overall Study||45
11158961|NCT01576705|12347490|FG002|STARTED|Overall Study||43
11158962|NCT01576705|12347491|FG003|STARTED|Overall Study||44
11158963|NCT01576705|12347488|FG000|COMPLETED|Overall Study||40
11158964|NCT01576705|12347489|FG001|COMPLETED|Overall Study||37
11158965|NCT01576705|12347490|FG002|COMPLETED|Overall Study||38
11158966|NCT01576705|12347491|FG003|COMPLETED|Overall Study||41
11158967|NCT01576705|12347488|FG000|NOT COMPLETED|Overall Study||3
11158968|NCT01576705|12347489|FG001|NOT COMPLETED|Overall Study||8
11158969|NCT01576705|12347490|FG002|NOT COMPLETED|Overall Study||5
11158970|NCT01576705|12347491|FG003|NOT COMPLETED|Overall Study||3
11158971|NCT01576718|12347507|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||889
11158972|NCT01576718|12347508|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0
11158973|NCT01576718|12347509|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0
11158974|NCT01576718|12347510|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0
11158975|NCT01576718|12347511|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0
11158976|NCT01576718|12347512|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0
11419139|NCT00299195|12617583|FG001|NOT COMPLETED|Overall Study||0
11158977|NCT01576718|12347513|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0
11158978|NCT01576718|12347507|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
11158979|NCT01576718|12347508|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11158980|NCT01576718|12347509|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11158981|NCT01576718|12347510|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11158982|NCT01576718|12347511|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11158983|NCT01576718|12347512|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11158984|NCT01576718|12347513|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11158985|NCT01576718|12347507|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
11158986|NCT01576718|12347508|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11158987|NCT01576718|12347509|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11419140|NCT00290407|12617589|FG000|STARTED|Overall Study||2
11158988|NCT01576718|12347510|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11158989|NCT01576718|12347511|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11158990|NCT01576718|12347512|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11158991|NCT01576718|12347513|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
11158992|NCT01576718|12347507|FG000|STARTED|Treatment Period||0
11158993|NCT01576718|12347508|FG001|STARTED|Treatment Period||107
11158994|NCT01576718|12347509|FG002|STARTED|Treatment Period||107
11158995|NCT01576718|12347510|FG003|STARTED|Treatment Period||106
11158996|NCT01576718|12347511|FG004|STARTED|Treatment Period||107
11158997|NCT01576718|12347512|FG005|STARTED|Treatment Period||106
11158998|NCT01576718|12347513|FG006|STARTED|Treatment Period||107
11158999|NCT01576718|12347507|FG000|Safety Population|Treatment Period||0
11159000|NCT01576718|12347508|FG001|Safety Population|Treatment Period||107
11159001|NCT01576718|12347509|FG002|Safety Population|Treatment Period||107
11159002|NCT01576718|12347510|FG003|Safety Population|Treatment Period||106
11159003|NCT01576718|12347511|FG004|Safety Population|Treatment Period||107
11419141|NCT00290407|12617589|FG000|COMPLETED|Overall Study||0
11419142|NCT00290407|12617589|FG000|NOT COMPLETED|Overall Study||2
11419143|NCT00295490|12617597|FG000|STARTED|Overall Study||15
11159004|NCT01576718|12347512|FG005|Safety Population|Treatment Period||106
11159005|NCT01576718|12347513|FG006|Safety Population|Treatment Period||106
11159006|NCT01576718|12347507|FG000|Efficacy Population (Full Analysis Set)|Treatment Period||0
11159007|NCT01576718|12347508|FG001|Efficacy Population (Full Analysis Set)|Treatment Period||107
11159008|NCT01576718|12347509|FG002|Efficacy Population (Full Analysis Set)|Treatment Period||106
11159009|NCT01576718|12347510|FG003|Efficacy Population (Full Analysis Set)|Treatment Period||102
11159010|NCT01576718|12347511|FG004|Efficacy Population (Full Analysis Set)|Treatment Period||107
11159011|NCT01576718|12347512|FG005|Efficacy Population (Full Analysis Set)|Treatment Period||105
11159012|NCT01576718|12347513|FG006|Efficacy Population (Full Analysis Set)|Treatment Period||103
11159013|NCT01576718|12347507|FG000|COMPLETED|Treatment Period||0
11159014|NCT01576718|12347508|FG001|COMPLETED|Treatment Period||82
11159015|NCT01576718|12347509|FG002|COMPLETED|Treatment Period||87
11159016|NCT01576718|12347510|FG003|COMPLETED|Treatment Period||75
11159017|NCT01576718|12347511|FG004|COMPLETED|Treatment Period||80
11159018|NCT01576718|12347512|FG005|COMPLETED|Treatment Period||58
11159019|NCT01576718|12347513|FG006|COMPLETED|Treatment Period||77
11159020|NCT01576718|12347507|FG000|NOT COMPLETED|Treatment Period||0
11159021|NCT01576718|12347508|FG001|NOT COMPLETED|Treatment Period||25
11159022|NCT01576718|12347509|FG002|NOT COMPLETED|Treatment Period||20
11159023|NCT01576718|12347510|FG003|NOT COMPLETED|Treatment Period||31
11159024|NCT01576718|12347511|FG004|NOT COMPLETED|Treatment Period||27
11159025|NCT01576718|12347512|FG005|NOT COMPLETED|Treatment Period||48
11159026|NCT01576718|12347513|FG006|NOT COMPLETED|Treatment Period||30
11159027|NCT01576783|12347529|FG000|STARTED|Overall Study||189
11159028|NCT01576783|12347530|FG001|STARTED|Overall Study||188
11159029|NCT01576783|12347529|FG000|COMPLETED|Overall Study||169
11159030|NCT01576783|12347530|FG001|COMPLETED|Overall Study||171
11159031|NCT01576783|12347529|FG000|NOT COMPLETED|Overall Study||20
11159032|NCT01576783|12347530|FG001|NOT COMPLETED|Overall Study||17
11159033|NCT01576809|12347536|FG000|STARTED|Overall Study||51
11159034|NCT01576809|12347536|FG000|COMPLETED|Overall Study||51
11159035|NCT01576809|12347536|FG000|NOT COMPLETED|Overall Study||0
11159036|NCT01576874|12347542|FG000|STARTED|Overall Study||72
11159037|NCT01576874|12347543|FG001|STARTED|Overall Study||72
11159038|NCT01576874|12347542|FG000|COMPLETED|Overall Study||72
11159039|NCT01576874|12347543|FG001|COMPLETED|Overall Study||72
11159040|NCT01576874|12347542|FG000|NOT COMPLETED|Overall Study||0
11159041|NCT01576874|12347543|FG001|NOT COMPLETED|Overall Study||0
11159042|NCT01576939|12347549|FG000|STARTED|Overall Study||30
11159043|NCT01576939|12347549|FG000|COMPLETED|Overall Study||30
11159044|NCT01576939|12347549|FG000|NOT COMPLETED|Overall Study||0
11159045|NCT01576952|12347555|FG000|STARTED|Overall Study||180
11159046|NCT01576952|12347556|FG001|STARTED|Overall Study||88
11159047|NCT01576952|12347555|FG000|Safety Population|Overall Study||169
11159048|NCT01576952|12347556|FG001|Safety Population|Overall Study||85
11159049|NCT01576952|12347555|FG000|mITT Population|Overall Study||168
11159050|NCT01576952|12347556|FG001|mITT Population|Overall Study||85
11159051|NCT01576952|12347555|FG000|COMPLETED|Overall Study||139
11159052|NCT01576952|12347556|FG001|COMPLETED|Overall Study||33
11159053|NCT01576952|12347555|FG000|NOT COMPLETED|Overall Study||41
11159054|NCT01576952|12347556|FG001|NOT COMPLETED|Overall Study||55
11159055|NCT01577108|12347564|FG000|STARTED|Overall Study||54
11159056|NCT01577108|12347565|FG001|STARTED|Overall Study||56
11159057|NCT01577108|12347564|FG000|COMPLETED|Overall Study||49
11159058|NCT01577108|12347565|FG001|COMPLETED|Overall Study||50
11159059|NCT01577108|12347564|FG000|NOT COMPLETED|Overall Study||5
11419144|NCT00295490|12617598|FG001|STARTED|Overall Study||19
11159060|NCT01577108|12347565|FG001|NOT COMPLETED|Overall Study||6
11159061|NCT01577160|12347571|FG000|STARTED|Overall Study||353
11159062|NCT01577160|12347571|FG000|COMPLETED|Overall Study||255
11159063|NCT01577160|12347571|FG000|NOT COMPLETED|Overall Study||98
11159064|NCT01577186|12347575|FG000|STARTED|Overall Study||480
11159065|NCT01577186|12347575|FG000|COMPLETED|Overall Study||350
11159066|NCT01577186|12347575|FG000|NOT COMPLETED|Overall Study||130
11159067|NCT01577238|12347581|FG000|STARTED|Overall Study||127
11159068|NCT01577238|12347582|FG001|STARTED|Overall Study||123
11159069|NCT01577238|12347581|FG000|COMPLETED|Overall Study||117
11159070|NCT01577238|12347582|FG001|COMPLETED|Overall Study||111
11159071|NCT01577238|12347581|FG000|NOT COMPLETED|Overall Study||10
11419145|NCT00295490|12617599|FG002|STARTED|Overall Study||16
11159072|NCT01577238|12347582|FG001|NOT COMPLETED|Overall Study||12
11159073|NCT01577329|12347590|FG000|STARTED|Overall Study||19
11159074|NCT01577329|12347591|FG001|STARTED|Overall Study||22
11159075|NCT01577329|12347590|FG000|COMPLETED|Overall Study||16
11159076|NCT01577329|12347591|FG001|COMPLETED|Overall Study||22
11159077|NCT01577329|12347590|FG000|NOT COMPLETED|Overall Study||3
11159078|NCT01577329|12347591|FG001|NOT COMPLETED|Overall Study||0
11159079|NCT01577381|12347601|FG000|STARTED|Overall Study||2
11159080|NCT01577381|12347602|FG001|STARTED|Overall Study||3
11159081|NCT01577381|12347603|FG002|STARTED|Overall Study||3
11159082|NCT01577381|12347604|FG003|STARTED|Overall Study||2
11159083|NCT01577381|12347601|FG000|COMPLETED|Overall Study||0
11159084|NCT01577381|12347602|FG001|COMPLETED|Overall Study||0
11159085|NCT01577381|12347603|FG002|COMPLETED|Overall Study||0
11159086|NCT01577381|12347604|FG003|COMPLETED|Overall Study||0
11159087|NCT01577381|12347601|FG000|NOT COMPLETED|Overall Study||2
11159088|NCT01577381|12347602|FG001|NOT COMPLETED|Overall Study||3
11159089|NCT01577381|12347603|FG002|NOT COMPLETED|Overall Study||3
11159090|NCT01577381|12347604|FG003|NOT COMPLETED|Overall Study||2
11159091|NCT01577537|12347616|FG000|STARTED|Overall Study||128
11159092|NCT01577537|12347617|FG001|STARTED|Overall Study||123
11159093|NCT01577537|12347616|FG000|COMPLETED|Overall Study||120
11159094|NCT01577537|12347617|FG001|COMPLETED|Overall Study||116
11159095|NCT01577537|12347616|FG000|NOT COMPLETED|Overall Study||8
11159096|NCT01577537|12347617|FG001|NOT COMPLETED|Overall Study||7
11159097|NCT01577706|12347623|FG000|STARTED|First Intervention (1 Day)||3
11159098|NCT01577706|12347624|FG001|STARTED|First Intervention (1 Day)||1
11159099|NCT01577706|12347625|FG002|STARTED|First Intervention (1 Day)||3
11159100|NCT01577706|12347623|FG000|COMPLETED|First Intervention (1 Day)||3
11159101|NCT01577706|12347624|FG001|COMPLETED|First Intervention (1 Day)||1
11159102|NCT01577706|12347625|FG002|COMPLETED|First Intervention (1 Day)||3
11159103|NCT01577706|12347623|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11159104|NCT01577706|12347624|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11159105|NCT01577706|12347625|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11159106|NCT01577706|12347623|FG000|STARTED|Washout (at Least 1 Week)||3
11159107|NCT01577706|12347624|FG001|STARTED|Washout (at Least 1 Week)||1
11159108|NCT01577706|12347625|FG002|STARTED|Washout (at Least 1 Week)||3
11159109|NCT01577706|12347623|FG000|COMPLETED|Washout (at Least 1 Week)||3
11159110|NCT01577706|12347624|FG001|COMPLETED|Washout (at Least 1 Week)||1
11159111|NCT01577706|12347625|FG002|COMPLETED|Washout (at Least 1 Week)||3
11159112|NCT01577706|12347623|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
11159113|NCT01577706|12347624|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
11159114|NCT01577706|12347625|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0
11159115|NCT01577706|12347623|FG000|STARTED|Second Intervention (1 Day)||3
11159116|NCT01577706|12347624|FG001|STARTED|Second Intervention (1 Day)||1
11159117|NCT01577706|12347625|FG002|STARTED|Second Intervention (1 Day)||3
11159118|NCT01577706|12347623|FG000|COMPLETED|Second Intervention (1 Day)||3
11159119|NCT01577706|12347624|FG001|COMPLETED|Second Intervention (1 Day)||1
11159120|NCT01577706|12347625|FG002|COMPLETED|Second Intervention (1 Day)||3
11159121|NCT01577706|12347623|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11159122|NCT01577706|12347624|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11159123|NCT01577706|12347625|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11159124|NCT01577706|12347623|FG000|STARTED|Washout (at Least 1 Week)||3
11159125|NCT01577706|12347624|FG001|STARTED|Washout (at Least 1 Week)||1
11159126|NCT01577706|12347625|FG002|STARTED|Washout (at Least 1 Week)||3
11159127|NCT01577706|12347623|FG000|COMPLETED|Washout (at Least 1 Week)||3
11159128|NCT01577706|12347624|FG001|COMPLETED|Washout (at Least 1 Week)||1
11159129|NCT01577706|12347625|FG002|COMPLETED|Washout (at Least 1 Week)||3
11159130|NCT01577706|12347623|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
11159131|NCT01577706|12347624|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
11159132|NCT01577706|12347625|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0
11159133|NCT01577706|12347623|FG000|STARTED|Third Intervention (1 Day)||3
11159134|NCT01577706|12347624|FG001|STARTED|Third Intervention (1 Day)||1
11159135|NCT01577706|12347625|FG002|STARTED|Third Intervention (1 Day)||3
11159136|NCT01577706|12347623|FG000|COMPLETED|Third Intervention (1 Day)||3
11159137|NCT01577706|12347624|FG001|COMPLETED|Third Intervention (1 Day)||1
11159138|NCT01577706|12347625|FG002|COMPLETED|Third Intervention (1 Day)||3
11159139|NCT01577706|12347623|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11159140|NCT01577706|12347624|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11159141|NCT01577706|12347625|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
11159142|NCT01577732|12347633|FG000|STARTED|Overall Study||300
11159143|NCT01577732|12347633|FG000|COMPLETED|Overall Study||300
11159144|NCT01577732|12347633|FG000|NOT COMPLETED|Overall Study||0
11159145|NCT01577745|12347643|FG000|STARTED|Overall Study||3
11159146|NCT01577745|12347644|FG001|STARTED|Overall Study||3
11159147|NCT01577745|12347645|FG002|STARTED|Overall Study||3
11159148|NCT01577745|12347646|FG003|STARTED|Overall Study||6
11159149|NCT01577745|12347647|FG004|STARTED|Overall Study||5
11159150|NCT01577745|12347648|FG005|STARTED|Overall Study||5
11159151|NCT01577745|12347643|FG000|COMPLETED|Overall Study||0
11159152|NCT01577745|12347644|FG001|COMPLETED|Overall Study||0
11159153|NCT01577745|12347645|FG002|COMPLETED|Overall Study||1
11159154|NCT01577745|12347646|FG003|COMPLETED|Overall Study||0
11159155|NCT01577745|12347647|FG004|COMPLETED|Overall Study||0
11159156|NCT01577745|12347648|FG005|COMPLETED|Overall Study||1
11159157|NCT01577745|12347643|FG000|NOT COMPLETED|Overall Study||3
11159158|NCT01577745|12347644|FG001|NOT COMPLETED|Overall Study||3
11159159|NCT01577745|12347645|FG002|NOT COMPLETED|Overall Study||2
11159160|NCT01577745|12347646|FG003|NOT COMPLETED|Overall Study||6
11159161|NCT01577745|12347647|FG004|NOT COMPLETED|Overall Study||5
11159162|NCT01577745|12347648|FG005|NOT COMPLETED|Overall Study||4
11159163|NCT01577758|12347667|FG000|STARTED|Dose Escalation Phase||2
11159164|NCT01577758|12347668|FG001|STARTED|Dose Escalation Phase||2
11159165|NCT01577758|12347669|FG002|STARTED|Dose Escalation Phase||2
11159166|NCT01577758|12347670|FG003|STARTED|Dose Escalation Phase||2
11159167|NCT01577758|12347671|FG004|STARTED|Dose Escalation Phase||6
11159168|NCT01577758|12347672|FG005|STARTED|Dose Escalation Phase||4
11159169|NCT01577758|12347673|FG006|STARTED|Dose Escalation Phase||1
11159170|NCT01577758|12347674|FG007|STARTED|Dose Escalation Phase||0
11159171|NCT01577758|12347667|FG000|COMPLETED|Dose Escalation Phase||0
11159172|NCT01577758|12347668|FG001|COMPLETED|Dose Escalation Phase||0
11159173|NCT01577758|12347669|FG002|COMPLETED|Dose Escalation Phase||0
11159174|NCT01577758|12347670|FG003|COMPLETED|Dose Escalation Phase||0
11159175|NCT01577758|12347671|FG004|COMPLETED|Dose Escalation Phase||0
11159176|NCT01577758|12347672|FG005|COMPLETED|Dose Escalation Phase||0
11159177|NCT01577758|12347673|FG006|COMPLETED|Dose Escalation Phase||0
11159178|NCT01577758|12347674|FG007|COMPLETED|Dose Escalation Phase||0
11159179|NCT01577758|12347667|FG000|NOT COMPLETED|Dose Escalation Phase||2
11159180|NCT01577758|12347668|FG001|NOT COMPLETED|Dose Escalation Phase||2
11159181|NCT01577758|12347669|FG002|NOT COMPLETED|Dose Escalation Phase||2
11159182|NCT01577758|12347670|FG003|NOT COMPLETED|Dose Escalation Phase||2
11159183|NCT01577758|12347671|FG004|NOT COMPLETED|Dose Escalation Phase||6
11159184|NCT01577758|12347672|FG005|NOT COMPLETED|Dose Escalation Phase||4
11159185|NCT01577758|12347673|FG006|NOT COMPLETED|Dose Escalation Phase||1
11159186|NCT01577758|12347674|FG007|NOT COMPLETED|Dose Escalation Phase||0
11159187|NCT01577758|12347667|FG000|STARTED|mCRC Expansion Phase||0
11159188|NCT01577758|12347668|FG001|STARTED|mCRC Expansion Phase||0
11159189|NCT01577758|12347669|FG002|STARTED|mCRC Expansion Phase||0
11159190|NCT01577758|12347670|FG003|STARTED|mCRC Expansion Phase||0
11419146|NCT00295490|12617600|FG003|STARTED|Overall Study||17
11419147|NCT00295490|12617597|FG000|COMPLETED|Overall Study||14
11419148|NCT00295490|12617598|FG001|COMPLETED|Overall Study||15
11419149|NCT00295490|12617599|FG002|COMPLETED|Overall Study||12
11419150|NCT00295490|12617600|FG003|COMPLETED|Overall Study||12
11419151|NCT00295490|12617597|FG000|NOT COMPLETED|Overall Study||1
11419152|NCT00295490|12617598|FG001|NOT COMPLETED|Overall Study||4
11419153|NCT00295490|12617599|FG002|NOT COMPLETED|Overall Study||4
11419154|NCT00295490|12617600|FG003|NOT COMPLETED|Overall Study||5
11419155|NCT00268463|12617612|FG000|STARTED|Overall Study||10
11419156|NCT00268463|12617613|FG001|STARTED|Overall Study||12
11419157|NCT00268463|12617612|FG000|COMPLETED|Overall Study||0
11159191|NCT01577758|12347671|FG004|STARTED|mCRC Expansion Phase||0
11159192|NCT01577758|12347672|FG005|STARTED|mCRC Expansion Phase||0
11159193|NCT01577758|12347673|FG006|STARTED|mCRC Expansion Phase||0
11159194|NCT01577758|12347674|FG007|STARTED|mCRC Expansion Phase||25
11159195|NCT01577758|12347667|FG000|COMPLETED|mCRC Expansion Phase||0
11159196|NCT01577758|12347668|FG001|COMPLETED|mCRC Expansion Phase||0
11159197|NCT01577758|12347669|FG002|COMPLETED|mCRC Expansion Phase||0
11159198|NCT01577758|12347670|FG003|COMPLETED|mCRC Expansion Phase||0
11159199|NCT01577758|12347671|FG004|COMPLETED|mCRC Expansion Phase||0
11159200|NCT01577758|12347672|FG005|COMPLETED|mCRC Expansion Phase||0
11159201|NCT01577758|12347673|FG006|COMPLETED|mCRC Expansion Phase||0
11159202|NCT01577758|12347674|FG007|COMPLETED|mCRC Expansion Phase||0
11159203|NCT01577758|12347667|FG000|NOT COMPLETED|mCRC Expansion Phase||0
11159204|NCT01577758|12347668|FG001|NOT COMPLETED|mCRC Expansion Phase||0
11159205|NCT01577758|12347669|FG002|NOT COMPLETED|mCRC Expansion Phase||0
11159206|NCT01577758|12347670|FG003|NOT COMPLETED|mCRC Expansion Phase||0
11159207|NCT01577758|12347671|FG004|NOT COMPLETED|mCRC Expansion Phase||0
11419158|NCT00268463|12617613|FG001|COMPLETED|Overall Study||0
11419159|NCT00268463|12617612|FG000|NOT COMPLETED|Overall Study||10
11419160|NCT00268463|12617613|FG001|NOT COMPLETED|Overall Study||12
11419161|NCT00271102|12617621|FG000|STARTED|Overall Study||35
11159208|NCT01577758|12347672|FG005|NOT COMPLETED|mCRC Expansion Phase||0
11159209|NCT01577758|12347673|FG006|NOT COMPLETED|mCRC Expansion Phase||0
11159210|NCT01577758|12347674|FG007|NOT COMPLETED|mCRC Expansion Phase||25
11159211|NCT01577966|12347694|FG000|STARTED|Overall Study||9
11159212|NCT01577966|12347694|FG000|COMPLETED|Overall Study||9
11159213|NCT01577966|12347694|FG000|NOT COMPLETED|Overall Study||0
11159214|NCT01578031|12347702|FG000|STARTED|Overall Study||129
11159215|NCT01578031|12347703|FG001|STARTED|Overall Study||69
11159216|NCT01578031|12347704|FG002|STARTED|Overall Study||12
11159217|NCT01578031|12347705|FG003|STARTED|Overall Study||30
11159218|NCT01578031|12347702|FG000|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
11159219|NCT01578031|12347703|FG001|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
11159220|NCT01578031|12347704|FG002|COMPLETED|Overall Study|Only baseline data collected|12
11159221|NCT01578031|12347705|FG003|COMPLETED|Overall Study|Only baseline data collected|30
11159222|NCT01578031|12347702|FG000|NOT COMPLETED|Overall Study||62
11159223|NCT01578031|12347703|FG001|NOT COMPLETED|Overall Study||34
11159224|NCT01578031|12347704|FG002|NOT COMPLETED|Overall Study||0
11159225|NCT01578031|12347705|FG003|NOT COMPLETED|Overall Study||0
11159226|NCT01578044|12347715|FG000|STARTED|Overall Study||6
11159227|NCT01578044|12347716|FG001|STARTED|Overall Study||6
11159228|NCT01578044|12347715|FG000|COMPLETED|Overall Study||6
11419162|NCT00271102|12617622|FG001|STARTED|Overall Study||35
11159229|NCT01578044|12347716|FG001|COMPLETED|Overall Study||6
11159230|NCT01578044|12347715|FG000|NOT COMPLETED|Overall Study||0
11159231|NCT01578044|12347716|FG001|NOT COMPLETED|Overall Study||0
11159232|NCT01578187|12347722|FG000|STARTED|Label Comprehension Phase||63
11159233|NCT01578187|12347722|FG000|COMPLETED|Label Comprehension Phase||63
11159234|NCT01578187|12347722|FG000|NOT COMPLETED|Label Comprehension Phase||0
11159235|NCT01578187|12347722|FG000|STARTED|Usability Phase||48
11159236|NCT01578187|12347722|FG000|COMPLETED|Usability Phase||47
11159237|NCT01578187|12347722|FG000|NOT COMPLETED|Usability Phase||1
11159238|NCT01578278|12347732|FG000|STARTED|Overall Study||152
11159239|NCT01578278|12347733|FG001|STARTED|Overall Study||152
11159240|NCT01578278|12347734|FG002|STARTED|Overall Study||154
11159241|NCT01578278|12347735|FG003|STARTED|Overall Study||148
11159242|NCT01578278|12347732|FG000|COMPLETED|Overall Study||148
11159243|NCT01578278|12347733|FG001|COMPLETED|Overall Study||150
11159244|NCT01578278|12347734|FG002|COMPLETED|Overall Study||150
11159245|NCT01578278|12347735|FG003|COMPLETED|Overall Study||139
11159246|NCT01578278|12347732|FG000|NOT COMPLETED|Overall Study||4
11159247|NCT01578278|12347733|FG001|NOT COMPLETED|Overall Study||2
11159248|NCT01578278|12347734|FG002|NOT COMPLETED|Overall Study||4
11159249|NCT01578278|12347735|FG003|NOT COMPLETED|Overall Study||9
11159250|NCT01578317|12347747|FG000|STARTED|Overall Study||22
11159251|NCT01578317|12347748|FG001|STARTED|Overall Study||21
11159252|NCT01578317|12347747|FG000|Analysis Population|Overall Study||22
11159253|NCT01578317|12347748|FG001|Analysis Population|Overall Study||20
11159254|NCT01578317|12347747|FG000|COMPLETED|Overall Study||22
11159255|NCT01578317|12347748|FG001|COMPLETED|Overall Study||20
11159256|NCT01578317|12347747|FG000|NOT COMPLETED|Overall Study||0
11159257|NCT01578317|12347748|FG001|NOT COMPLETED|Overall Study||1
11159258|NCT01578330|12347754|FG000|STARTED|Overall Study||42
11159259|NCT01578330|12347754|FG000|Per Protocol Population|Overall Study||35
11159260|NCT01578330|12347754|FG000|COMPLETED|Overall Study||35
11159261|NCT01578330|12347754|FG000|NOT COMPLETED|Overall Study||7
11159262|NCT01578486|12347758|FG000|STARTED|Overall Study||13
11159263|NCT01578486|12347758|FG000|COMPLETED|Overall Study||8
11159264|NCT01578486|12347758|FG000|NOT COMPLETED|Overall Study||5
11159265|NCT01578499|12347764|FG000|STARTED|Overall Study||66
11159266|NCT01578499|12347765|FG001|STARTED|Overall Study||65
11159267|NCT01578499|12347764|FG000|Safety Population: Treated|Overall Study||66
11159268|NCT01578499|12347765|FG001|Safety Population: Treated|Overall Study||62
11159269|NCT01578499|12347764|FG000|Intent to Treat Population: CD30+|Overall Study||64
11159270|NCT01578499|12347765|FG001|Intent to Treat Population: CD30+|Overall Study||64
11159271|NCT01578499|12347764|FG000|COMPLETED|Overall Study||32
11159272|NCT01578499|12347765|FG001|COMPLETED|Overall Study||22
11159273|NCT01578499|12347764|FG000|NOT COMPLETED|Overall Study||34
11159274|NCT01578499|12347765|FG001|NOT COMPLETED|Overall Study||43
11159275|NCT01578551|12347777|FG000|STARTED|Overall Study||19
11159276|NCT01578551|12347778|FG001|STARTED|Overall Study||6
11159277|NCT01578551|12347777|FG000|COMPLETED|Overall Study||18
11159278|NCT01578551|12347778|FG001|COMPLETED|Overall Study||6
11159279|NCT01578551|12347777|FG000|NOT COMPLETED|Overall Study||1
11159280|NCT01578551|12347778|FG001|NOT COMPLETED|Overall Study||0
11159281|NCT01578577|12347788|FG000|STARTED|Overall Study||305
11159282|NCT01578577|12347789|FG001|STARTED|Overall Study||302
11159283|NCT01578577|12347790|FG002|STARTED|Overall Study||313
11159284|NCT01578577|12347788|FG000|COMPLETED|Overall Study||254
11159285|NCT01578577|12347789|FG001|COMPLETED|Overall Study||262
11159286|NCT01578577|12347790|FG002|COMPLETED|Overall Study||278
11159287|NCT01578577|12347788|FG000|NOT COMPLETED|Overall Study||51
11159288|NCT01578577|12347789|FG001|NOT COMPLETED|Overall Study||40
11159289|NCT01578577|12347790|FG002|NOT COMPLETED|Overall Study||35
11159290|NCT01578707|12347810|FG000|STARTED|Overall Study||196
11159291|NCT01578707|12347811|FG001|STARTED|Overall Study||195
11159292|NCT01578707|12347810|FG000|COMPLETED|Overall Study||196
11159293|NCT01578707|12347811|FG001|COMPLETED|Overall Study||195
11159294|NCT01578707|12347810|FG000|NOT COMPLETED|Overall Study||0
11159295|NCT01578707|12347811|FG001|NOT COMPLETED|Overall Study||0
11159296|NCT01578772|12347817|FG000|STARTED|Overall Study||17
11159297|NCT01578772|12347817|FG000|COMPLETED|Overall Study||17
11159298|NCT01578772|12347817|FG000|NOT COMPLETED|Overall Study||0
11159299|NCT01578850|12347824|FG000|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
11159300|NCT01578850|12347825|FG001|STARTED|Period 1||0
11159301|NCT01578850|12347826|FG002|STARTED|Period 1||0
11159302|NCT01578850|12347824|FG000|COMPLETED|Period 1||452
11159303|NCT01578850|12347825|FG001|COMPLETED|Period 1||0
11159304|NCT01578850|12347826|FG002|COMPLETED|Period 1||0
11159305|NCT01578850|12347824|FG000|NOT COMPLETED|Period 1||37
11159306|NCT01578850|12347825|FG001|NOT COMPLETED|Period 1||0
11159307|NCT01578850|12347826|FG002|NOT COMPLETED|Period 1||0
11159308|NCT01578850|12347824|FG000|STARTED|Period 2||0
11159309|NCT01578850|12347825|FG001|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
11159310|NCT01578850|12347826|FG002|STARTED|Period 2|One participants in PBO did not receive treatment.|176
11159311|NCT01578850|12347824|FG000|COMPLETED|Period 2||0
11159312|NCT01578850|12347825|FG001|COMPLETED|Period 2||154
11159313|NCT01578850|12347826|FG002|COMPLETED|Period 2||162
11159314|NCT01578850|12347824|FG000|NOT COMPLETED|Period 2||0
11159315|NCT01578850|12347825|FG001|NOT COMPLETED|Period 2||13
11159316|NCT01578850|12347826|FG002|NOT COMPLETED|Period 2||14
11159317|NCT01578902|12347834|FG000|STARTED|Overall Study||84
11159318|NCT01578902|12347834|FG000|COMPLETED|Overall Study||84
11159319|NCT01578902|12347834|FG000|NOT COMPLETED|Overall Study||0
11159320|NCT01578980|12347841|FG000|STARTED|Overall Study||20
11159321|NCT01578980|12347841|FG000|COMPLETED|Overall Study||20
11159322|NCT01578980|12347841|FG000|NOT COMPLETED|Overall Study||0
11159323|NCT01578993|12347845|FG000|STARTED|Overall Study||101
11159324|NCT01578993|12347845|FG000|COMPLETED|Overall Study||101
11159325|NCT01578993|12347845|FG000|NOT COMPLETED|Overall Study||0
11159326|NCT01579006|12347849|FG000|STARTED|Overall Study||184
11159327|NCT01579006|12347849|FG000|COMPLETED|Overall Study||151
11159328|NCT01579006|12347849|FG000|NOT COMPLETED|Overall Study||33
11159329|NCT01579045|12347853|FG000|STARTED|Overall Study||24
11159330|NCT01579045|12347853|FG000|COMPLETED|Overall Study||24
11159331|NCT01579045|12347853|FG000|NOT COMPLETED|Overall Study||0
11159332|NCT01579084|12347875|FG000|STARTED|Overall Study||8
11159333|NCT01579084|12347876|FG001|STARTED|Overall Study||8
11159334|NCT01579084|12347877|FG002|STARTED|Overall Study||8
11159335|NCT01579084|12347878|FG003|STARTED|Overall Study||8
11159336|NCT01579084|12347879|FG004|STARTED|Overall Study||8
11159337|NCT01579084|12347880|FG005|STARTED|Overall Study||8
11159338|NCT01579084|12347881|FG006|STARTED|Overall Study||4
11159339|NCT01579084|12347882|FG007|STARTED|Overall Study||4
11159340|NCT01579084|12347883|FG008|STARTED|Overall Study||4
11159341|NCT01579084|12347884|FG009|STARTED|Overall Study||4
11159342|NCT01579084|12347875|FG000|COMPLETED|Overall Study||8
11159343|NCT01579084|12347876|FG001|COMPLETED|Overall Study||8
11159344|NCT01579084|12347877|FG002|COMPLETED|Overall Study||8
11159345|NCT01579084|12347878|FG003|COMPLETED|Overall Study||8
11159346|NCT01579084|12347879|FG004|COMPLETED|Overall Study||8
11159347|NCT01579084|12347880|FG005|COMPLETED|Overall Study||8
11159348|NCT01579084|12347881|FG006|COMPLETED|Overall Study||4
11159349|NCT01579084|12347882|FG007|COMPLETED|Overall Study||4
11159350|NCT01579084|12347883|FG008|COMPLETED|Overall Study||4
11159351|NCT01579084|12347884|FG009|COMPLETED|Overall Study||4
11159352|NCT01579084|12347875|FG000|NOT COMPLETED|Overall Study||0
11159353|NCT01579084|12347876|FG001|NOT COMPLETED|Overall Study||0
11159354|NCT01579084|12347877|FG002|NOT COMPLETED|Overall Study||0
11159355|NCT01579084|12347878|FG003|NOT COMPLETED|Overall Study||0
11159356|NCT01579084|12347879|FG004|NOT COMPLETED|Overall Study||0
11159357|NCT01579084|12347880|FG005|NOT COMPLETED|Overall Study||0
11159358|NCT01579084|12347881|FG006|NOT COMPLETED|Overall Study||0
11159359|NCT01579084|12347882|FG007|NOT COMPLETED|Overall Study||0
11159360|NCT01579084|12347883|FG008|NOT COMPLETED|Overall Study||0
11159361|NCT01579084|12347884|FG009|NOT COMPLETED|Overall Study||0
11159362|NCT01579162|12347905|FG000|STARTED|Overall Study||16
11159363|NCT01579162|12347906|FG001|STARTED|Overall Study||8
11159364|NCT01579162|12347907|FG002|STARTED|Overall Study||8
11159365|NCT01579162|12347908|FG003|STARTED|Overall Study||8
11159366|NCT01579162|12347909|FG004|STARTED|Overall Study||8
11159367|NCT01579162|12347905|FG000|COMPLETED|Overall Study||16
11159368|NCT01579162|12347906|FG001|COMPLETED|Overall Study||8
11159369|NCT01579162|12347907|FG002|COMPLETED|Overall Study||8
11159370|NCT01579162|12347908|FG003|COMPLETED|Overall Study||8
11159371|NCT01579162|12347909|FG004|COMPLETED|Overall Study||8
11159372|NCT01579162|12347905|FG000|NOT COMPLETED|Overall Study||0
11159373|NCT01579162|12347906|FG001|NOT COMPLETED|Overall Study||0
11159374|NCT01579162|12347907|FG002|NOT COMPLETED|Overall Study||0
11159375|NCT01579162|12347908|FG003|NOT COMPLETED|Overall Study||0
11159376|NCT01579162|12347909|FG004|NOT COMPLETED|Overall Study||0
11159377|NCT01579214|12347924|FG000|STARTED|Overall Study||45
11159378|NCT01579214|12347925|FG001|STARTED|Overall Study||138
11159379|NCT01579214|12347924|FG000|COMPLETED|Overall Study||45
11159380|NCT01579214|12347925|FG001|COMPLETED|Overall Study||138
11159381|NCT01579214|12347924|FG000|NOT COMPLETED|Overall Study||0
11159382|NCT01579214|12347925|FG001|NOT COMPLETED|Overall Study||0
11159383|NCT01579305|12347933|FG000|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
11159384|NCT01579305|12347934|FG001|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
11159385|NCT01579305|12347933|FG000|Discontinued Before Treatment|Overall Study||0
11159386|NCT01579305|12347934|FG001|Discontinued Before Treatment|Overall Study||1
11159387|NCT01579305|12347933|FG000|Continued After Treatment|Overall Study||139
11159388|NCT01579305|12347934|FG001|Continued After Treatment|Overall Study||141
11159389|NCT01579305|12347933|FG000|COMPLETED|Overall Study||118
11159390|NCT01579305|12347934|FG001|COMPLETED|Overall Study||115
11159391|NCT01579305|12347933|FG000|NOT COMPLETED|Overall Study||21
11159392|NCT01579305|12347934|FG001|NOT COMPLETED|Overall Study||27
11159393|NCT01579318|12347940|FG000|STARTED|Overall Study||2
11159394|NCT01579318|12347940|FG000|COMPLETED|Overall Study||1
11159395|NCT01579318|12347940|FG000|NOT COMPLETED|Overall Study||1
11159396|NCT01579474|12347950|FG000|STARTED|Overall Study||44
11159397|NCT01579474|12347951|FG001|STARTED|Overall Study||43
11159398|NCT01579474|12347952|FG002|STARTED|Overall Study||29
11159399|NCT01579474|12347953|FG003|STARTED|Overall Study||3
11159400|NCT01579474|12347954|FG004|STARTED|Overall Study||10
11159401|NCT01579474|12347955|FG005|STARTED|Overall Study||2
11159402|NCT01579474|12347950|FG000|COMPLETED|Overall Study||41
11159403|NCT01579474|12347951|FG001|COMPLETED|Overall Study||30
11159404|NCT01579474|12347952|FG002|COMPLETED|Overall Study||27
11159405|NCT01579474|12347953|FG003|COMPLETED|Overall Study||3
11159406|NCT01579474|12347954|FG004|COMPLETED|Overall Study||9
11159407|NCT01579474|12347955|FG005|COMPLETED|Overall Study||1
11159408|NCT01579474|12347950|FG000|NOT COMPLETED|Overall Study||3
11159409|NCT01579474|12347951|FG001|NOT COMPLETED|Overall Study||13
11159410|NCT01579474|12347952|FG002|NOT COMPLETED|Overall Study||2
11159411|NCT01579474|12347953|FG003|NOT COMPLETED|Overall Study||0
11159412|NCT01579474|12347954|FG004|NOT COMPLETED|Overall Study||1
11159413|NCT01579474|12347955|FG005|NOT COMPLETED|Overall Study||1
11159414|NCT01579513|12347970|FG000|STARTED|Primary Hospitalization||91
11159415|NCT01579513|12347971|FG001|STARTED|Primary Hospitalization||99
11159416|NCT01579513|12347970|FG000|COMPLETED|Primary Hospitalization||81
11159417|NCT01579513|12347971|FG001|COMPLETED|Primary Hospitalization||95
11159418|NCT01579513|12347970|FG000|NOT COMPLETED|Primary Hospitalization||10
11159419|NCT01579513|12347971|FG001|NOT COMPLETED|Primary Hospitalization||4
11159420|NCT01579513|12347970|FG000|STARTED|1 Year Neurodevelopmental Follow up||81
11159421|NCT01579513|12347971|FG001|STARTED|1 Year Neurodevelopmental Follow up||95
11159422|NCT01579513|12347970|FG000|COMPLETED|1 Year Neurodevelopmental Follow up||61
11159423|NCT01579513|12347971|FG001|COMPLETED|1 Year Neurodevelopmental Follow up||68
11159424|NCT01579513|12347970|FG000|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20
11159425|NCT01579513|12347971|FG001|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27
11159426|NCT01579565|12347979|FG000|STARTED|Randomized||207
11159427|NCT01579565|12347980|FG001|STARTED|Randomized||209
11159428|NCT01579565|12347979|FG000|COMPLETED|Randomized||202
11159429|NCT01579565|12347980|FG001|COMPLETED|Randomized||204
11159430|NCT01579565|12347979|FG000|NOT COMPLETED|Randomized||5
11159431|NCT01579565|12347980|FG001|NOT COMPLETED|Randomized||5
11159432|NCT01579565|12347979|FG000|STARTED|Treated||202
11159433|NCT01579565|12347980|FG001|STARTED|Treated||204
11159434|NCT01579565|12347979|FG000|COMPLETED|Treated||200
11159435|NCT01579565|12347980|FG001|COMPLETED|Treated||201
11159436|NCT01579565|12347979|FG000|NOT COMPLETED|Treated||2
11159437|NCT01579565|12347980|FG001|NOT COMPLETED|Treated||3
11159438|NCT01579578|12347990|FG000|STARTED|Overall Study||13
11159439|NCT01579578|12347991|FG001|STARTED|Overall Study||12
11159440|NCT01579578|12347990|FG000|Ongoing|Overall Study||3
11159441|NCT01579578|12347991|FG001|Ongoing|Overall Study||0
11159442|NCT01579578|12347990|FG000|COMPLETED|Overall Study||0
11159443|NCT01579578|12347991|FG001|COMPLETED|Overall Study||0
11159444|NCT01579578|12347990|FG000|NOT COMPLETED|Overall Study||13
11159445|NCT01579578|12347991|FG001|NOT COMPLETED|Overall Study||12
11159446|NCT01579669|12347999|FG000|STARTED|Overall Study||170
11159447|NCT01579669|12348000|FG001|STARTED|Overall Study||41
11159448|NCT01579669|12347999|FG000|COMPLETED|Overall Study||134
11159449|NCT01579669|12348000|FG001|COMPLETED|Overall Study||41
11159450|NCT01579669|12347999|FG000|NOT COMPLETED|Overall Study||36
11159451|NCT01579669|12348000|FG001|NOT COMPLETED|Overall Study||0
11203340|NCT01846728|12393853|FG000|STARTED|Overall Study||6
11203341|NCT01846728|12393853|FG000|COMPLETED|Overall Study||6
11203342|NCT01846728|12393853|FG000|NOT COMPLETED|Overall Study||0
11203343|NCT01846741|12393857|FG000|STARTED|Baseline Visit||22
11203344|NCT01846741|12393857|FG000|COMPLETED|Baseline Visit||20
11203345|NCT01846741|12393857|FG000|NOT COMPLETED|Baseline Visit||2
11203346|NCT01846741|12393857|FG000|STARTED|Implantation to 18-Month/End of Study||20
11203347|NCT01846741|12393857|FG000|COMPLETED|Implantation to 18-Month/End of Study||20
11203348|NCT01846741|12393857|FG000|NOT COMPLETED|Implantation to 18-Month/End of Study||0
11203349|NCT01846871|12393896|FG000|STARTED|Overall Study||10
11203350|NCT01846871|12393896|FG000|COMPLETED|Overall Study||10
11203351|NCT01846871|12393896|FG000|NOT COMPLETED|Overall Study||0
11203352|NCT01846988|12393907|FG000|STARTED|APAP Pressurize Comparison (4-8 Weeks)||15
11203353|NCT01846988|12393908|FG001|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
11203354|NCT01846988|12393909|FG002|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
11203355|NCT01846988|12393907|FG000|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||15
11203356|NCT01846988|12393908|FG001|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
11203357|NCT01846988|12393909|FG002|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
11203358|NCT01846988|12393907|FG000|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
11203359|NCT01846988|12393908|FG001|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
11203360|NCT01846988|12393909|FG002|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
11203361|NCT01846988|12393907|FG000|STARTED|Intervention #1 - 4 Weeks||0
11203362|NCT01846988|12393908|FG001|STARTED|Intervention #1 - 4 Weeks|Only 10 of 15 participants completing Comparison period started periods 1 & 2|5
11203363|NCT01846988|12393909|FG002|STARTED|Intervention #1 - 4 Weeks||5
11203364|NCT01846988|12393907|FG000|COMPLETED|Intervention #1 - 4 Weeks||0
11203365|NCT01846988|12393908|FG001|COMPLETED|Intervention #1 - 4 Weeks||5
11203366|NCT01846988|12393909|FG002|COMPLETED|Intervention #1 - 4 Weeks||5
11203367|NCT01846988|12393907|FG000|NOT COMPLETED|Intervention #1 - 4 Weeks||0
11203368|NCT01846988|12393908|FG001|NOT COMPLETED|Intervention #1 - 4 Weeks||0
11203369|NCT01846988|12393909|FG002|NOT COMPLETED|Intervention #1 - 4 Weeks||0
11203370|NCT01846988|12393907|FG000|STARTED|Intervention #2 - 4 Weeks||0
11203371|NCT01846988|12393908|FG001|STARTED|Intervention #2 - 4 Weeks||5
11203372|NCT01846988|12393909|FG002|STARTED|Intervention #2 - 4 Weeks||5
11203373|NCT01846988|12393907|FG000|COMPLETED|Intervention #2 - 4 Weeks||0
11203374|NCT01846988|12393908|FG001|COMPLETED|Intervention #2 - 4 Weeks||5
11203375|NCT01846988|12393909|FG002|COMPLETED|Intervention #2 - 4 Weeks||5
11203376|NCT01846988|12393907|FG000|NOT COMPLETED|Intervention #2 - 4 Weeks||0
11203377|NCT01846988|12393908|FG001|NOT COMPLETED|Intervention #2 - 4 Weeks||0
11203378|NCT01846988|12393909|FG002|NOT COMPLETED|Intervention #2 - 4 Weeks||0
11203379|NCT01847001|12393926|FG000|STARTED|Overall Study||10
11203380|NCT01847001|12393926|FG000|COMPLETED|Overall Study||10
11203381|NCT01847001|12393926|FG000|NOT COMPLETED|Overall Study||0
11203382|NCT01847014|12393931|FG000|STARTED|Baseline Extension Visit||4
11203383|NCT01847014|12393931|FG000|COMPLETED|Baseline Extension Visit||4
11203384|NCT01847014|12393931|FG000|NOT COMPLETED|Baseline Extension Visit||0
11203385|NCT01847014|12393931|FG000|STARTED|Completion of Extension Study||4
11203386|NCT01847014|12393931|FG000|COMPLETED|Completion of Extension Study||0
11203387|NCT01847014|12393931|FG000|NOT COMPLETED|Completion of Extension Study||4
11203388|NCT01847027|12393937|FG000|STARTED|Overall Study||11
11203389|NCT01847027|12393938|FG001|STARTED|Overall Study||12
11203390|NCT01847027|12393937|FG000|COMPLETED|Overall Study||10
11203391|NCT01847027|12393938|FG001|COMPLETED|Overall Study||10
11203392|NCT01847027|12393937|FG000|NOT COMPLETED|Overall Study||1
11203393|NCT01847027|12393938|FG001|NOT COMPLETED|Overall Study||2
11203394|NCT01847092|12393946|FG000|STARTED|Overall Study||77
11203395|NCT01847092|12393947|FG001|STARTED|Overall Study||77
11203396|NCT01847092|12393946|FG000|COMPLETED|Overall Study||51
11203397|NCT01847092|12393947|FG001|COMPLETED|Overall Study||66
11203398|NCT01847092|12393946|FG000|NOT COMPLETED|Overall Study||26
11203399|NCT01847092|12393947|FG001|NOT COMPLETED|Overall Study||11
11203400|NCT01847131|12393955|FG000|STARTED|Overall Study||25
11203401|NCT01847131|12393956|FG001|STARTED|Overall Study||25
11203402|NCT01847131|12393955|FG000|COMPLETED|Overall Study||25
11159452|NCT01579747|12348008|FG000|STARTED|Overall Study||12
11159453|NCT01579747|12348009|FG001|STARTED|Overall Study||12
11159454|NCT01579747|12348008|FG000|COMPLETED|Overall Study||12
11159455|NCT01579747|12348009|FG001|COMPLETED|Overall Study||12
11159456|NCT01579747|12348008|FG000|NOT COMPLETED|Overall Study||0
11159457|NCT01579747|12348009|FG001|NOT COMPLETED|Overall Study||0
11159458|NCT01579812|12348015|FG000|STARTED|Overall Study||90
11159459|NCT01579812|12348015|FG000|COMPLETED|Overall Study||38
11159460|NCT01579812|12348015|FG000|NOT COMPLETED|Overall Study||52
11159461|NCT01579916|12348024|FG000|STARTED|Overall Study||242
11159462|NCT01579916|12348025|FG001|STARTED|Overall Study||61
11159463|NCT01579916|12348024|FG000|COMPLETED|Overall Study||234
11159464|NCT01579916|12348025|FG001|COMPLETED|Overall Study||59
11159465|NCT01579916|12348024|FG000|NOT COMPLETED|Overall Study||8
11159466|NCT01579916|12348025|FG001|NOT COMPLETED|Overall Study||2
11159467|NCT01580020|12348033|FG000|STARTED|Overall Study||52
11159468|NCT01580020|12348034|FG001|STARTED|Overall Study||40
11159469|NCT01580020|12348035|FG002|STARTED|Overall Study||61
11159470|NCT01580020|12348036|FG003|STARTED|Overall Study||22
11159471|NCT01580020|12348033|FG000|COMPLETED|Overall Study||51
11159472|NCT01580020|12348034|FG001|COMPLETED|Overall Study||33
11159473|NCT01580020|12348035|FG002|COMPLETED|Overall Study||57
11159474|NCT01580020|12348036|FG003|COMPLETED|Overall Study||20
11159475|NCT01580020|12348033|FG000|NOT COMPLETED|Overall Study||1
11159476|NCT01580020|12348034|FG001|NOT COMPLETED|Overall Study||7
11159477|NCT01580020|12348035|FG002|NOT COMPLETED|Overall Study||4
11159478|NCT01580020|12348036|FG003|NOT COMPLETED|Overall Study||2
11159479|NCT01580072|12348049|FG000|STARTED|Overall Study||28
11159480|NCT01580072|12348050|FG001|STARTED|Overall Study||37
11159481|NCT01580072|12348051|FG002|STARTED|Overall Study||0
11159482|NCT01580072|12348049|FG000|COMPLETED|Overall Study||16
11159483|NCT01580072|12348050|FG001|COMPLETED|Overall Study||28
11159484|NCT01580072|12348051|FG002|COMPLETED|Overall Study||0
11159485|NCT01580072|12348049|FG000|NOT COMPLETED|Overall Study||12
11159486|NCT01580072|12348050|FG001|NOT COMPLETED|Overall Study||9
11159487|NCT01580072|12348051|FG002|NOT COMPLETED|Overall Study||0
11159488|NCT01580098|12348061|FG000|STARTED|Overall Study||76
11159489|NCT01580098|12348062|FG001|STARTED|Overall Study||114
11159490|NCT01580098|12348063|FG002|STARTED|Overall Study||3
11159491|NCT01580098|12348061|FG000|COMPLETED|Overall Study||61
11159492|NCT01580098|12348062|FG001|COMPLETED|Overall Study||101
11159493|NCT01580098|12348063|FG002|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
11159494|NCT01580098|12348061|FG000|NOT COMPLETED|Overall Study||15
11159495|NCT01580098|12348062|FG001|NOT COMPLETED|Overall Study||13
11159496|NCT01580098|12348063|FG002|NOT COMPLETED|Overall Study||3
11159497|NCT01580293|12348077|FG000|STARTED|Part A_Main Trial||20
11159498|NCT01580293|12348078|FG001|STARTED|Part A_Main Trial||114
11159499|NCT01580293|12348079|FG002|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
11159500|NCT01580293|12348077|FG000|COMPLETED|Part A_Main Trial||18
11159501|NCT01580293|12348078|FG001|COMPLETED|Part A_Main Trial||108
11159502|NCT01580293|12348079|FG002|COMPLETED|Part A_Main Trial||0
11159503|NCT01580293|12348077|FG000|NOT COMPLETED|Part A_Main Trial||2
11159504|NCT01580293|12348078|FG001|NOT COMPLETED|Part A_Main Trial||6
11159505|NCT01580293|12348079|FG002|NOT COMPLETED|Part A_Main Trial||0
11159506|NCT01580293|12348077|FG000|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
11159507|NCT01580293|12348078|FG001|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
11159508|NCT01580293|12348079|FG002|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
11159509|NCT01580293|12348077|FG000|COMPLETED|Part A_Extension||14
11159510|NCT01580293|12348078|FG001|COMPLETED|Part A_Extension||95
11159511|NCT01580293|12348079|FG002|COMPLETED|Part A_Extension||0
11159512|NCT01580293|12348077|FG000|NOT COMPLETED|Part A_Extension||0
11159513|NCT01580293|12348078|FG001|NOT COMPLETED|Part A_Extension||12
11159514|NCT01580293|12348079|FG002|NOT COMPLETED|Part A_Extension||0
11159515|NCT01580293|12348077|FG000|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
11159516|NCT01580293|12348078|FG001|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
11159517|NCT01580293|12348079|FG002|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
11159518|NCT01580293|12348077|FG000|COMPLETED|Part B||0
11159519|NCT01580293|12348078|FG001|COMPLETED|Part B||0
11159520|NCT01580293|12348079|FG002|COMPLETED|Part B||17
11159521|NCT01580293|12348077|FG000|NOT COMPLETED|Part B||0
11159522|NCT01580293|12348078|FG001|NOT COMPLETED|Part B||0
11159523|NCT01580293|12348079|FG002|NOT COMPLETED|Part B||2
11159524|NCT01580306|12348110|FG000|STARTED|Overall Study||8
11159525|NCT01580306|12348111|FG001|STARTED|Overall Study||8
11159526|NCT01580306|12348112|FG002|STARTED|Overall Study||8
11159527|NCT01580306|12348113|FG003|STARTED|Overall Study||8
11159528|NCT01580306|12348110|FG000|COMPLETED|Overall Study||8
11159529|NCT01580306|12348111|FG001|COMPLETED|Overall Study||8
11159530|NCT01580306|12348112|FG002|COMPLETED|Overall Study||8
11159531|NCT01580306|12348113|FG003|COMPLETED|Overall Study||8
11159532|NCT01580306|12348110|FG000|NOT COMPLETED|Overall Study||0
11159533|NCT01580306|12348111|FG001|NOT COMPLETED|Overall Study||0
11159534|NCT01580306|12348112|FG002|NOT COMPLETED|Overall Study||0
11159535|NCT01580306|12348113|FG003|NOT COMPLETED|Overall Study||0
11159536|NCT01580410|12348125|FG000|STARTED|Overall Study||68
11159537|NCT01580410|12348126|FG001|STARTED|Overall Study||68
11159538|NCT01580410|12348125|FG000|COMPLETED|Overall Study||57
11159539|NCT01580410|12348126|FG001|COMPLETED|Overall Study||60
11159540|NCT01580410|12348125|FG000|NOT COMPLETED|Overall Study||11
11159541|NCT01580410|12348126|FG001|NOT COMPLETED|Overall Study||8
11159542|NCT01580423|12348132|FG000|STARTED|First Intervention||8
11159543|NCT01580423|12348133|FG001|STARTED|First Intervention||8
11159544|NCT01580423|12348132|FG000|COMPLETED|First Intervention||8
11159545|NCT01580423|12348133|FG001|COMPLETED|First Intervention||8
11159546|NCT01580423|12348132|FG000|NOT COMPLETED|First Intervention||0
11159547|NCT01580423|12348133|FG001|NOT COMPLETED|First Intervention||0
11159548|NCT01580423|12348132|FG000|STARTED|Second Intervention||8
11159549|NCT01580423|12348133|FG001|STARTED|Second Intervention||8
11159550|NCT01580423|12348132|FG000|COMPLETED|Second Intervention||8
11159551|NCT01580423|12348133|FG001|COMPLETED|Second Intervention||8
11159552|NCT01580423|12348132|FG000|NOT COMPLETED|Second Intervention||0
11159553|NCT01580423|12348133|FG001|NOT COMPLETED|Second Intervention||0
11159554|NCT01580488|12348140|FG000|STARTED|Overall Study||24
11159555|NCT01580488|12348140|FG000|COMPLETED|Overall Study||23
11159556|NCT01580488|12348140|FG000|NOT COMPLETED|Overall Study||1
11159557|NCT01580592|12348157|FG000|STARTED|Overall Study||10
11159558|NCT01580592|12348158|FG001|STARTED|Overall Study||9
11159559|NCT01580592|12348159|FG002|STARTED|Overall Study||12
11159560|NCT01580592|12348157|FG000|COMPLETED|Overall Study||10
11159561|NCT01580592|12348158|FG001|COMPLETED|Overall Study||9
11159562|NCT01580592|12348159|FG002|COMPLETED|Overall Study||12
11159563|NCT01580592|12348157|FG000|NOT COMPLETED|Overall Study||0
11159564|NCT01580592|12348158|FG001|NOT COMPLETED|Overall Study||0
11159565|NCT01580592|12348159|FG002|NOT COMPLETED|Overall Study||0
11159566|NCT01580618|12348169|FG000|STARTED|Overall Study||8
11159567|NCT01580618|12348170|FG001|STARTED|Overall Study||12
11159568|NCT01580618|12348169|FG000|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
11159569|NCT01580618|12348170|FG001|COMPLETED|Overall Study||12
11159570|NCT01580618|12348169|FG000|NOT COMPLETED|Overall Study||1
11159571|NCT01580618|12348170|FG001|NOT COMPLETED|Overall Study||0
11159572|NCT01580670|12348176|FG000|STARTED|Induction Period (Week 0 to 14)||14
11159573|NCT01580670|12348176|FG000|COMPLETED|Induction Period (Week 0 to 14)||14
11159574|NCT01580670|12348176|FG000|NOT COMPLETED|Induction Period (Week 0 to 14)||0
11159575|NCT01580670|12348176|FG000|STARTED|Maintenance Period (Week 14 to 54)||14
11159576|NCT01580670|12348176|FG000|COMPLETED|Maintenance Period (Week 14 to 54)||12
11159577|NCT01580670|12348176|FG000|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2
11159578|NCT01580904|12348182|FG000|STARTED|Overall Study||51
11159579|NCT01580904|12348183|FG001|STARTED|Overall Study||49
11159580|NCT01580904|12348182|FG000|COMPLETED|Overall Study||47
11159581|NCT01580904|12348183|FG001|COMPLETED|Overall Study||42
11159582|NCT01580904|12348182|FG000|NOT COMPLETED|Overall Study||4
11159583|NCT01580904|12348183|FG001|NOT COMPLETED|Overall Study||7
11159584|NCT01580969|12348193|FG000|STARTED|Overall Study||6
11159585|NCT01580969|12348194|FG001|STARTED|Overall Study||3
11159586|NCT01580969|12348195|FG002|STARTED|Overall Study||13
11159587|NCT01580969|12348193|FG000|COMPLETED|Overall Study||3
11159588|NCT01580969|12348194|FG001|COMPLETED|Overall Study||3
11159589|NCT01580969|12348195|FG002|COMPLETED|Overall Study||13
11159590|NCT01580969|12348193|FG000|NOT COMPLETED|Overall Study||3
11159591|NCT01580969|12348194|FG001|NOT COMPLETED|Overall Study||0
11159592|NCT01580969|12348195|FG002|NOT COMPLETED|Overall Study||0
11159593|NCT01580995|12348205|FG000|STARTED|Overall Study||10
11159594|NCT01580995|12348206|FG001|STARTED|Overall Study||9
11159595|NCT01580995|12348205|FG000|COMPLETED|Overall Study||8
11159596|NCT01580995|12348206|FG001|COMPLETED|Overall Study||7
11159597|NCT01580995|12348205|FG000|NOT COMPLETED|Overall Study||2
11159598|NCT01580995|12348206|FG001|NOT COMPLETED|Overall Study||2
11159599|NCT01581008|12348214|FG000|STARTED|Overall Study||17
11159600|NCT01581008|12348215|FG001|STARTED|Overall Study||13
11159601|NCT01581008|12348214|FG000|COMPLETED|Overall Study||16
11159602|NCT01581008|12348215|FG001|COMPLETED|Overall Study||7
11159603|NCT01581008|12348214|FG000|NOT COMPLETED|Overall Study||1
11159604|NCT01581008|12348215|FG001|NOT COMPLETED|Overall Study||6
11159605|NCT01581021|12348224|FG000|STARTED|Overall Study||29
11159606|NCT01581021|12348225|FG001|STARTED|Overall Study||29
11159607|NCT01581021|12348224|FG000|COMPLETED|Overall Study||19
11159608|NCT01581021|12348225|FG001|COMPLETED|Overall Study||18
11159609|NCT01581021|12348224|FG000|NOT COMPLETED|Overall Study||10
11159610|NCT01581021|12348225|FG001|NOT COMPLETED|Overall Study||11
11159611|NCT01581281|12348234|FG000|STARTED|Overall Study||145
11159612|NCT01581281|12348235|FG001|STARTED|Overall Study||72
11159613|NCT01581281|12348236|FG002|STARTED|Overall Study||144
11159614|NCT01581281|12348234|FG000|COMPLETED|Overall Study||130
11159615|NCT01581281|12348235|FG001|COMPLETED|Overall Study||66
11159616|NCT01581281|12348236|FG002|COMPLETED|Overall Study||132
11159617|NCT01581281|12348234|FG000|NOT COMPLETED|Overall Study||15
11159618|NCT01581281|12348235|FG001|NOT COMPLETED|Overall Study||6
11159619|NCT01581281|12348236|FG002|NOT COMPLETED|Overall Study||12
11159620|NCT01581307|12348245|FG000|STARTED|Overall Study||9
11159621|NCT01581307|12348245|FG000|COMPLETED|Overall Study||8
11159622|NCT01581307|12348245|FG000|NOT COMPLETED|Overall Study||1
11159623|NCT01581437|12348249|FG000|STARTED|Overall Study||78
11159624|NCT01581437|12348249|FG000|COMPLETED|Overall Study||78
11159625|NCT01581437|12348249|FG000|NOT COMPLETED|Overall Study||0
11159626|NCT01581541|12348257|FG000|STARTED|Overall Study||1
11159627|NCT01581541|12348258|FG001|STARTED|Overall Study||1
11159628|NCT01581541|12348259|FG002|STARTED|Overall Study||1
11159629|NCT01581541|12348260|FG003|STARTED|Overall Study||1
11159630|NCT01581541|12348261|FG004|STARTED|Overall Study||2
11159631|NCT01581541|12348262|FG005|STARTED|Overall Study||3
11159632|NCT01581541|12348263|FG006|STARTED|Overall Study||1
11159633|NCT01581541|12348264|FG007|STARTED|Overall Study||2
11159634|NCT01581541|12348265|FG008|STARTED|Overall Study||1
11159635|NCT01581541|12348266|FG009|STARTED|Overall Study||3
11159636|NCT01581541|12348267|FG010|STARTED|Overall Study||1
11159637|NCT01581541|12348257|FG000|COMPLETED|Overall Study||1
11159638|NCT01581541|12348258|FG001|COMPLETED|Overall Study||1
11159639|NCT01581541|12348259|FG002|COMPLETED|Overall Study||1
11159640|NCT01581541|12348260|FG003|COMPLETED|Overall Study||1
11159641|NCT01581541|12348261|FG004|COMPLETED|Overall Study||2
11159642|NCT01581541|12348262|FG005|COMPLETED|Overall Study||3
11159643|NCT01581541|12348263|FG006|COMPLETED|Overall Study||1
11159644|NCT01581541|12348264|FG007|COMPLETED|Overall Study||2
11159645|NCT01581541|12348265|FG008|COMPLETED|Overall Study||1
11159646|NCT01581541|12348266|FG009|COMPLETED|Overall Study||3
11159647|NCT01581541|12348267|FG010|COMPLETED|Overall Study||1
11159648|NCT01581541|12348257|FG000|NOT COMPLETED|Overall Study||0
11159649|NCT01581541|12348258|FG001|NOT COMPLETED|Overall Study||0
11159650|NCT01581541|12348259|FG002|NOT COMPLETED|Overall Study||0
11159651|NCT01581541|12348260|FG003|NOT COMPLETED|Overall Study||0
11159652|NCT01581541|12348261|FG004|NOT COMPLETED|Overall Study||0
11159653|NCT01581541|12348262|FG005|NOT COMPLETED|Overall Study||0
11159654|NCT01581541|12348263|FG006|NOT COMPLETED|Overall Study||0
11159655|NCT01581541|12348264|FG007|NOT COMPLETED|Overall Study||0
11159656|NCT01581541|12348265|FG008|NOT COMPLETED|Overall Study||0
11159657|NCT01581541|12348266|FG009|NOT COMPLETED|Overall Study||0
11159658|NCT01581541|12348267|FG010|NOT COMPLETED|Overall Study||0
11159659|NCT01581593|12348292|FG000|STARTED|Overall Study||45
11159660|NCT01581593|12348292|FG000|COMPLETED|Overall Study||44
11159661|NCT01581593|12348292|FG000|NOT COMPLETED|Overall Study||1
11159662|NCT01581619|12348300|FG000|STARTED|Overall Study||54
11159663|NCT01581619|12348300|FG000|COMPLETED|Overall Study||52
11159664|NCT01581619|12348300|FG000|NOT COMPLETED|Overall Study||2
11159665|NCT01581658|12348310|FG000|STARTED|Overall Study||8
11159666|NCT01581658|12348311|FG001|STARTED|Overall Study||8
11159667|NCT01581658|12348312|FG002|STARTED|Overall Study||8
11159668|NCT01581658|12348313|FG003|STARTED|Overall Study||8
11159669|NCT01581658|12348310|FG000|COMPLETED|Overall Study||8
11159670|NCT01581658|12348311|FG001|COMPLETED|Overall Study||8
11159671|NCT01581658|12348312|FG002|COMPLETED|Overall Study||8
11159672|NCT01581658|12348313|FG003|COMPLETED|Overall Study||8
11159673|NCT01581658|12348310|FG000|NOT COMPLETED|Overall Study||0
11159674|NCT01581658|12348311|FG001|NOT COMPLETED|Overall Study||0
11159675|NCT01581658|12348312|FG002|NOT COMPLETED|Overall Study||0
11159676|NCT01581658|12348313|FG003|NOT COMPLETED|Overall Study||0
11159677|NCT01581684|12348333|FG000|STARTED|Overall Study||14
11159678|NCT01581684|12348334|FG001|STARTED|Overall Study||6
11159679|NCT01581684|12348335|FG002|STARTED|Overall Study||6
11159680|NCT01581684|12348336|FG003|STARTED|Overall Study||6
11159681|NCT01581684|12348337|FG004|STARTED|Overall Study||6
11159682|NCT01581684|12348338|FG005|STARTED|Overall Study||6
11159683|NCT01581684|12348339|FG006|STARTED|Overall Study||6
11159684|NCT01581684|12348340|FG007|STARTED|Overall Study||6
11159685|NCT01581684|12348341|FG008|STARTED|Overall Study||1
11159686|NCT01581684|12348342|FG009|STARTED|Overall Study||5
11159687|NCT01581684|12348333|FG000|COMPLETED|Overall Study||14
11159688|NCT01581684|12348334|FG001|COMPLETED|Overall Study||6
11159689|NCT01581684|12348335|FG002|COMPLETED|Overall Study||6
11159690|NCT01581684|12348336|FG003|COMPLETED|Overall Study||6
11159691|NCT01581684|12348337|FG004|COMPLETED|Overall Study||6
11159692|NCT01581684|12348338|FG005|COMPLETED|Overall Study||6
11159693|NCT01581684|12348339|FG006|COMPLETED|Overall Study||6
11159694|NCT01581684|12348340|FG007|COMPLETED|Overall Study||6
11159695|NCT01581684|12348341|FG008|COMPLETED|Overall Study||0
11159696|NCT01581684|12348342|FG009|COMPLETED|Overall Study||5
11159697|NCT01581684|12348333|FG000|NOT COMPLETED|Overall Study||0
11159698|NCT01581684|12348334|FG001|NOT COMPLETED|Overall Study||0
11159699|NCT01581684|12348335|FG002|NOT COMPLETED|Overall Study||0
11159700|NCT01581684|12348336|FG003|NOT COMPLETED|Overall Study||0
11159701|NCT01581684|12348337|FG004|NOT COMPLETED|Overall Study||0
11159702|NCT01581684|12348338|FG005|NOT COMPLETED|Overall Study||0
11159703|NCT01581684|12348339|FG006|NOT COMPLETED|Overall Study||0
11159704|NCT01581684|12348340|FG007|NOT COMPLETED|Overall Study||0
11159705|NCT01581684|12348341|FG008|NOT COMPLETED|Overall Study||1
11159706|NCT01581684|12348342|FG009|NOT COMPLETED|Overall Study||0
11159707|NCT01581710|12348375|FG000|STARTED|First Intervention (14days)||18
11159708|NCT01581710|12348376|FG001|STARTED|First Intervention (14days)||14
11159709|NCT01581710|12348375|FG000|COMPLETED|First Intervention (14days)||18
11159710|NCT01581710|12348376|FG001|COMPLETED|First Intervention (14days)||14
11159711|NCT01581710|12348375|FG000|NOT COMPLETED|First Intervention (14days)||0
11159712|NCT01581710|12348376|FG001|NOT COMPLETED|First Intervention (14days)||0
11159713|NCT01581710|12348375|FG000|STARTED|Washout Period (14days)||18
11159714|NCT01581710|12348376|FG001|STARTED|Washout Period (14days)||14
11159715|NCT01581710|12348375|FG000|COMPLETED|Washout Period (14days)||18
11159716|NCT01581710|12348376|FG001|COMPLETED|Washout Period (14days)||14
11159717|NCT01581710|12348375|FG000|NOT COMPLETED|Washout Period (14days)||0
11159718|NCT01581710|12348376|FG001|NOT COMPLETED|Washout Period (14days)||0
11159719|NCT01581710|12348375|FG000|STARTED|Second Intervention (14days)||18
11159720|NCT01581710|12348376|FG001|STARTED|Second Intervention (14days)||14
11159721|NCT01581710|12348375|FG000|COMPLETED|Second Intervention (14days)||18
11159722|NCT01581710|12348376|FG001|COMPLETED|Second Intervention (14days)||12
11159723|NCT01581710|12348375|FG000|NOT COMPLETED|Second Intervention (14days)||0
11159724|NCT01581710|12348376|FG001|NOT COMPLETED|Second Intervention (14days)||2
11159725|NCT01581931|12348386|FG000|STARTED|First Period||16
11159726|NCT01581931|12348387|FG001|STARTED|First Period||16
11159727|NCT01581931|12348386|FG000|COMPLETED|First Period||16
11159728|NCT01581931|12348387|FG001|COMPLETED|First Period||16
11159729|NCT01581931|12348386|FG000|NOT COMPLETED|First Period||0
11159730|NCT01581931|12348387|FG001|NOT COMPLETED|First Period||0
11159731|NCT01581931|12348386|FG000|STARTED|Washout||16
11159732|NCT01581931|12348387|FG001|STARTED|Washout||16
11159733|NCT01581931|12348386|FG000|COMPLETED|Washout||16
11159734|NCT01581931|12348387|FG001|COMPLETED|Washout||15
11159735|NCT01581931|12348386|FG000|NOT COMPLETED|Washout||0
11159736|NCT01581931|12348387|FG001|NOT COMPLETED|Washout||1
11159737|NCT01581931|12348386|FG000|STARTED|Second Period||16
11159738|NCT01581931|12348387|FG001|STARTED|Second Period||15
11159739|NCT01581931|12348386|FG000|COMPLETED|Second Period||16
11159740|NCT01581931|12348387|FG001|COMPLETED|Second Period||15
11159741|NCT01581931|12348386|FG000|NOT COMPLETED|Second Period||0
11159742|NCT01581931|12348387|FG001|NOT COMPLETED|Second Period||0
11159743|NCT01581970|12348393|FG000|STARTED|Overall Study||7
11159744|NCT01581970|12348393|FG000|COMPLETED|Overall Study||7
11159745|NCT01581970|12348393|FG000|NOT COMPLETED|Overall Study||0
11159746|NCT01582061|12348399|FG000|STARTED|Overall Study||49
11159747|NCT01582061|12348400|FG001|STARTED|Overall Study||55
11159748|NCT01582061|12348399|FG000|COMPLETED|Overall Study||21
11159749|NCT01582061|12348400|FG001|COMPLETED|Overall Study||19
11159750|NCT01582061|12348399|FG000|NOT COMPLETED|Overall Study||28
11159751|NCT01582061|12348400|FG001|NOT COMPLETED|Overall Study||36
11159752|NCT01582139|12348418|FG000|STARTED|Overall Study||6
11159753|NCT01582139|12348419|FG001|STARTED|Overall Study||6
11159754|NCT01582139|12348418|FG000|COMPLETED|Overall Study||6
11159755|NCT01582139|12348419|FG001|COMPLETED|Overall Study||6
11159756|NCT01582139|12348418|FG000|NOT COMPLETED|Overall Study||0
11159757|NCT01582139|12348419|FG001|NOT COMPLETED|Overall Study||0
11159758|NCT01582152|12348427|FG000|STARTED|Overall Study||6
11159759|NCT01582152|12348428|FG001|STARTED|Overall Study||6
11159760|NCT01582152|12348427|FG000|COMPLETED|Overall Study||0
11159761|NCT01582152|12348428|FG001|COMPLETED|Overall Study||0
11159762|NCT01582152|12348427|FG000|NOT COMPLETED|Overall Study||6
11159763|NCT01582152|12348428|FG001|NOT COMPLETED|Overall Study||6
11159764|NCT01582178|12348436|FG000|STARTED|Overall Study||106
11159765|NCT01582178|12348437|FG001|STARTED|Overall Study||106
11159766|NCT01582178|12348436|FG000|COMPLETED|Overall Study||100
11159767|NCT01582178|12348437|FG001|COMPLETED|Overall Study||101
11159768|NCT01582178|12348436|FG000|NOT COMPLETED|Overall Study||6
11159769|NCT01582178|12348437|FG001|NOT COMPLETED|Overall Study||5
11159770|NCT01582243|12348443|FG000|STARTED|Overall Study||40
11159771|NCT01582243|12348443|FG000|COMPLETED|Overall Study||37
11159772|NCT01582243|12348443|FG000|NOT COMPLETED|Overall Study||3
11159773|NCT01582282|12348450|FG000|STARTED|Overall Study||15
11159774|NCT01582282|12348451|FG001|STARTED|Overall Study||14
11159775|NCT01582282|12348452|FG002|STARTED|Overall Study||8
11159776|NCT01582282|12348450|FG000|COMPLETED|Overall Study||13
11159777|NCT01582282|12348451|FG001|COMPLETED|Overall Study||12
11159778|NCT01582282|12348452|FG002|COMPLETED|Overall Study||8
11159779|NCT01582282|12348450|FG000|NOT COMPLETED|Overall Study||2
11159780|NCT01582282|12348451|FG001|NOT COMPLETED|Overall Study||2
11159781|NCT01582282|12348452|FG002|NOT COMPLETED|Overall Study||0
11159782|NCT01582308|12348460|FG000|STARTED|Period 1||2
11159783|NCT01582308|12348461|FG001|STARTED|Period 1||2
11159784|NCT01582308|12348462|FG002|STARTED|Period 1||2
11159785|NCT01582308|12348463|FG003|STARTED|Period 1||2
11159786|NCT01582308|12348464|FG004|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
11159787|NCT01582308|12348465|FG005|STARTED|Period 1||2
11159788|NCT01582308|12348466|FG006|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
11159789|NCT01582308|12348467|FG007|STARTED|Period 1||2
11159790|NCT01582308|12348468|FG008|STARTED|Period 1||2
11159791|NCT01582308|12348469|FG009|STARTED|Period 1||2
11159792|NCT01582308|12348460|FG000|COMPLETED|Period 1||2
11159793|NCT01582308|12348461|FG001|COMPLETED|Period 1||2
11159794|NCT01582308|12348462|FG002|COMPLETED|Period 1||2
11159795|NCT01582308|12348463|FG003|COMPLETED|Period 1||2
11159796|NCT01582308|12348464|FG004|COMPLETED|Period 1||3
11159797|NCT01582308|12348465|FG005|COMPLETED|Period 1||2
11159798|NCT01582308|12348466|FG006|COMPLETED|Period 1||2
11159799|NCT01582308|12348467|FG007|COMPLETED|Period 1||2
11159800|NCT01582308|12348468|FG008|COMPLETED|Period 1||2
11159801|NCT01582308|12348469|FG009|COMPLETED|Period 1||2
11159802|NCT01582308|12348460|FG000|NOT COMPLETED|Period 1||0
11159803|NCT01582308|12348461|FG001|NOT COMPLETED|Period 1||0
11159804|NCT01582308|12348462|FG002|NOT COMPLETED|Period 1||0
11159805|NCT01582308|12348463|FG003|NOT COMPLETED|Period 1||0
11159806|NCT01582308|12348464|FG004|NOT COMPLETED|Period 1||0
11159807|NCT01582308|12348465|FG005|NOT COMPLETED|Period 1||0
11159808|NCT01582308|12348466|FG006|NOT COMPLETED|Period 1||1
11159809|NCT01582308|12348467|FG007|NOT COMPLETED|Period 1||0
11159810|NCT01582308|12348468|FG008|NOT COMPLETED|Period 1||0
11159811|NCT01582308|12348469|FG009|NOT COMPLETED|Period 1||0
11159812|NCT01582308|12348460|FG000|STARTED|10-day Washout Following Period 1||2
11159813|NCT01582308|12348461|FG001|STARTED|10-day Washout Following Period 1||2
11159814|NCT01582308|12348462|FG002|STARTED|10-day Washout Following Period 1||2
11159815|NCT01582308|12348463|FG003|STARTED|10-day Washout Following Period 1||2
11159816|NCT01582308|12348464|FG004|STARTED|10-day Washout Following Period 1||3
11159817|NCT01582308|12348465|FG005|STARTED|10-day Washout Following Period 1||2
11159818|NCT01582308|12348466|FG006|STARTED|10-day Washout Following Period 1||2
11159819|NCT01582308|12348467|FG007|STARTED|10-day Washout Following Period 1||2
11159820|NCT01582308|12348468|FG008|STARTED|10-day Washout Following Period 1||2
11159821|NCT01582308|12348469|FG009|STARTED|10-day Washout Following Period 1||2
11159822|NCT01582308|12348460|FG000|COMPLETED|10-day Washout Following Period 1||2
11159823|NCT01582308|12348461|FG001|COMPLETED|10-day Washout Following Period 1||2
11159824|NCT01582308|12348462|FG002|COMPLETED|10-day Washout Following Period 1||2
11159825|NCT01582308|12348463|FG003|COMPLETED|10-day Washout Following Period 1||2
11159826|NCT01582308|12348464|FG004|COMPLETED|10-day Washout Following Period 1||2
11159827|NCT01582308|12348465|FG005|COMPLETED|10-day Washout Following Period 1||2
11159828|NCT01582308|12348466|FG006|COMPLETED|10-day Washout Following Period 1||2
11159829|NCT01582308|12348467|FG007|COMPLETED|10-day Washout Following Period 1||2
11159830|NCT01582308|12348468|FG008|COMPLETED|10-day Washout Following Period 1||2
11159831|NCT01582308|12348469|FG009|COMPLETED|10-day Washout Following Period 1||2
11159832|NCT01582308|12348460|FG000|NOT COMPLETED|10-day Washout Following Period 1||0
11159833|NCT01582308|12348461|FG001|NOT COMPLETED|10-day Washout Following Period 1||0
11159834|NCT01582308|12348462|FG002|NOT COMPLETED|10-day Washout Following Period 1||0
11159835|NCT01582308|12348463|FG003|NOT COMPLETED|10-day Washout Following Period 1||0
11159836|NCT01582308|12348464|FG004|NOT COMPLETED|10-day Washout Following Period 1||1
11159837|NCT01582308|12348465|FG005|NOT COMPLETED|10-day Washout Following Period 1||0
11159838|NCT01582308|12348466|FG006|NOT COMPLETED|10-day Washout Following Period 1||0
11159839|NCT01582308|12348467|FG007|NOT COMPLETED|10-day Washout Following Period 1||0
11159840|NCT01582308|12348468|FG008|NOT COMPLETED|10-day Washout Following Period 1||0
11159841|NCT01582308|12348469|FG009|NOT COMPLETED|10-day Washout Following Period 1||0
11159842|NCT01582308|12348460|FG000|STARTED|Period 2||2
11159843|NCT01582308|12348461|FG001|STARTED|Period 2||2
11159844|NCT01582308|12348462|FG002|STARTED|Period 2||2
11159845|NCT01582308|12348463|FG003|STARTED|Period 2||2
11159846|NCT01582308|12348464|FG004|STARTED|Period 2||2
11159847|NCT01582308|12348465|FG005|STARTED|Period 2||2
11159848|NCT01582308|12348466|FG006|STARTED|Period 2||2
11159849|NCT01582308|12348467|FG007|STARTED|Period 2||2
11159850|NCT01582308|12348468|FG008|STARTED|Period 2||2
11159851|NCT01582308|12348469|FG009|STARTED|Period 2||2
11159852|NCT01582308|12348460|FG000|COMPLETED|Period 2||2
11159853|NCT01582308|12348461|FG001|COMPLETED|Period 2||2
11159854|NCT01582308|12348462|FG002|COMPLETED|Period 2||2
11159855|NCT01582308|12348463|FG003|COMPLETED|Period 2||2
11159856|NCT01582308|12348464|FG004|COMPLETED|Period 2||2
11159857|NCT01582308|12348465|FG005|COMPLETED|Period 2||2
11159858|NCT01582308|12348466|FG006|COMPLETED|Period 2||2
11159859|NCT01582308|12348467|FG007|COMPLETED|Period 2||2
11159860|NCT01582308|12348468|FG008|COMPLETED|Period 2||2
11159861|NCT01582308|12348469|FG009|COMPLETED|Period 2||2
11159862|NCT01582308|12348460|FG000|NOT COMPLETED|Period 2||0
11159863|NCT01582308|12348461|FG001|NOT COMPLETED|Period 2||0
11159864|NCT01582308|12348462|FG002|NOT COMPLETED|Period 2||0
11159865|NCT01582308|12348463|FG003|NOT COMPLETED|Period 2||0
11159866|NCT01582308|12348464|FG004|NOT COMPLETED|Period 2||0
11159867|NCT01582308|12348465|FG005|NOT COMPLETED|Period 2||0
11159868|NCT01582308|12348466|FG006|NOT COMPLETED|Period 2||0
11159869|NCT01582308|12348467|FG007|NOT COMPLETED|Period 2||0
11159870|NCT01582308|12348468|FG008|NOT COMPLETED|Period 2||0
11159871|NCT01582308|12348469|FG009|NOT COMPLETED|Period 2||0
11159872|NCT01582308|12348460|FG000|STARTED|10-day Washout Following Period 2||2
11159873|NCT01582308|12348461|FG001|STARTED|10-day Washout Following Period 2||2
11159874|NCT01582308|12348462|FG002|STARTED|10-day Washout Following Period 2||2
11159875|NCT01582308|12348463|FG003|STARTED|10-day Washout Following Period 2||2
11159876|NCT01582308|12348464|FG004|STARTED|10-day Washout Following Period 2||2
11159877|NCT01582308|12348465|FG005|STARTED|10-day Washout Following Period 2||2
11159878|NCT01582308|12348466|FG006|STARTED|10-day Washout Following Period 2||2
11159879|NCT01582308|12348467|FG007|STARTED|10-day Washout Following Period 2||2
11159880|NCT01582308|12348468|FG008|STARTED|10-day Washout Following Period 2||2
11159881|NCT01582308|12348469|FG009|STARTED|10-day Washout Following Period 2||2
11159882|NCT01582308|12348460|FG000|COMPLETED|10-day Washout Following Period 2||2
11159883|NCT01582308|12348461|FG001|COMPLETED|10-day Washout Following Period 2||2
11159884|NCT01582308|12348462|FG002|COMPLETED|10-day Washout Following Period 2||2
11159885|NCT01582308|12348463|FG003|COMPLETED|10-day Washout Following Period 2||2
11159886|NCT01582308|12348464|FG004|COMPLETED|10-day Washout Following Period 2||2
11159887|NCT01582308|12348465|FG005|COMPLETED|10-day Washout Following Period 2||2
11159888|NCT01582308|12348466|FG006|COMPLETED|10-day Washout Following Period 2||2
11159889|NCT01582308|12348467|FG007|COMPLETED|10-day Washout Following Period 2||2
11159890|NCT01582308|12348468|FG008|COMPLETED|10-day Washout Following Period 2||2
11159891|NCT01582308|12348469|FG009|COMPLETED|10-day Washout Following Period 2||2
11159892|NCT01582308|12348460|FG000|NOT COMPLETED|10-day Washout Following Period 2||0
11159893|NCT01582308|12348461|FG001|NOT COMPLETED|10-day Washout Following Period 2||0
11323121|NCT01084252|12520466|FG009|STARTED|Phase 1 (120 Weeks)||0
11323122|NCT01084252|12520467|FG010|STARTED|Phase 1 (120 Weeks)||0
11323123|NCT01084252|12520468|FG011|STARTED|Phase 1 (120 Weeks)||0
11323124|NCT01084252|12520469|FG012|STARTED|Phase 1 (120 Weeks)||0
11323125|NCT01084252|12520470|FG013|STARTED|Phase 1 (120 Weeks)||0
11343021|NCT02950545|12540322|FG005|NOT COMPLETED|Washout 2 (5 Minutes)||0
11323126|NCT01084252|12520457|FG000|All Treated (AT) Population|Phase 1 (120 Weeks)||16
11323127|NCT01084252|12520458|FG001|All Treated (AT) Population|Phase 1 (120 Weeks)||6
11323128|NCT01084252|12520459|FG002|All Treated (AT) Population|Phase 1 (120 Weeks)||3
11323129|NCT01084252|12520460|FG003|All Treated (AT) Population|Phase 1 (120 Weeks)||26
11323130|NCT01084252|12520461|FG004|All Treated (AT) Population|Phase 1 (120 Weeks)||18
11323131|NCT01084252|12520462|FG005|All Treated (AT) Population|Phase 1 (120 Weeks)||6
11323132|NCT01084252|12520463|FG006|All Treated (AT) Population|Phase 1 (120 Weeks)||7
11323133|NCT01084252|12520464|FG007|All Treated (AT) Population|Phase 1 (120 Weeks)||7
11323134|NCT01084252|12520465|FG008|All Treated (AT) Population|Phase 1 (120 Weeks)||0
11323135|NCT01084252|12520466|FG009|All Treated (AT) Population|Phase 1 (120 Weeks)||0
11323136|NCT01084252|12520467|FG010|All Treated (AT) Population|Phase 1 (120 Weeks)||0
11323137|NCT01084252|12520468|FG011|All Treated (AT) Population|Phase 1 (120 Weeks)||0
11323138|NCT01084252|12520469|FG012|All Treated (AT) Population|Phase 1 (120 Weeks)||0
11323139|NCT01084252|12520470|FG013|All Treated (AT) Population|Phase 1 (120 Weeks)||0
11323140|NCT01084252|12520457|FG000|COMPLETED|Phase 1 (120 Weeks)||0
11323141|NCT01084252|12520458|FG001|COMPLETED|Phase 1 (120 Weeks)||0
11323142|NCT01084252|12520459|FG002|COMPLETED|Phase 1 (120 Weeks)||0
11323143|NCT01084252|12520460|FG003|COMPLETED|Phase 1 (120 Weeks)||0
11323144|NCT01084252|12520461|FG004|COMPLETED|Phase 1 (120 Weeks)||0
11323145|NCT01084252|12520462|FG005|COMPLETED|Phase 1 (120 Weeks)||0
11323146|NCT01084252|12520463|FG006|COMPLETED|Phase 1 (120 Weeks)||0
11323147|NCT01084252|12520464|FG007|COMPLETED|Phase 1 (120 Weeks)||0
11323148|NCT01084252|12520465|FG008|COMPLETED|Phase 1 (120 Weeks)||0
11323149|NCT01084252|12520466|FG009|COMPLETED|Phase 1 (120 Weeks)||0
11323150|NCT01084252|12520467|FG010|COMPLETED|Phase 1 (120 Weeks)||0
11323151|NCT01084252|12520468|FG011|COMPLETED|Phase 1 (120 Weeks)||0
11323152|NCT01084252|12520469|FG012|COMPLETED|Phase 1 (120 Weeks)||0
11323153|NCT01084252|12520470|FG013|COMPLETED|Phase 1 (120 Weeks)||0
11323154|NCT01084252|12520457|FG000|NOT COMPLETED|Phase 1 (120 Weeks)||16
11323155|NCT01084252|12520458|FG001|NOT COMPLETED|Phase 1 (120 Weeks)||6
11323156|NCT01084252|12520459|FG002|NOT COMPLETED|Phase 1 (120 Weeks)||3
11323157|NCT01084252|12520460|FG003|NOT COMPLETED|Phase 1 (120 Weeks)||26
11323158|NCT01084252|12520461|FG004|NOT COMPLETED|Phase 1 (120 Weeks)||18
11323159|NCT01084252|12520462|FG005|NOT COMPLETED|Phase 1 (120 Weeks)||6
11323160|NCT01084252|12520463|FG006|NOT COMPLETED|Phase 1 (120 Weeks)||7
11323161|NCT01084252|12520464|FG007|NOT COMPLETED|Phase 1 (120 Weeks)||7
11323162|NCT01084252|12520465|FG008|NOT COMPLETED|Phase 1 (120 Weeks)||0
11323163|NCT01084252|12520466|FG009|NOT COMPLETED|Phase 1 (120 Weeks)||0
11323164|NCT01084252|12520467|FG010|NOT COMPLETED|Phase 1 (120 Weeks)||0
11323165|NCT01084252|12520468|FG011|NOT COMPLETED|Phase 1 (120 Weeks)||0
11323166|NCT01084252|12520469|FG012|NOT COMPLETED|Phase 1 (120 Weeks)||0
11323167|NCT01084252|12520470|FG013|NOT COMPLETED|Phase 1 (120 Weeks)||0
11323168|NCT01084252|12520457|FG000|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323169|NCT01084252|12520458|FG001|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323170|NCT01084252|12520459|FG002|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323171|NCT01084252|12520460|FG003|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323172|NCT01084252|12520461|FG004|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323173|NCT01084252|12520462|FG005|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323174|NCT01084252|12520463|FG006|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323175|NCT01084252|12520464|FG007|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11159894|NCT01582308|12348462|FG002|NOT COMPLETED|10-day Washout Following Period 2||0
11159895|NCT01582308|12348463|FG003|NOT COMPLETED|10-day Washout Following Period 2||0
11159896|NCT01582308|12348464|FG004|NOT COMPLETED|10-day Washout Following Period 2||0
11159897|NCT01582308|12348465|FG005|NOT COMPLETED|10-day Washout Following Period 2||0
11159898|NCT01582308|12348466|FG006|NOT COMPLETED|10-day Washout Following Period 2||0
11159899|NCT01582308|12348467|FG007|NOT COMPLETED|10-day Washout Following Period 2||0
11159900|NCT01582308|12348468|FG008|NOT COMPLETED|10-day Washout Following Period 2||0
11159901|NCT01582308|12348469|FG009|NOT COMPLETED|10-day Washout Following Period 2||0
11159902|NCT01582308|12348460|FG000|STARTED|Period 3||2
11159903|NCT01582308|12348461|FG001|STARTED|Period 3||2
11159904|NCT01582308|12348462|FG002|STARTED|Period 3||2
11159905|NCT01582308|12348463|FG003|STARTED|Period 3||2
11159906|NCT01582308|12348464|FG004|STARTED|Period 3||2
11159907|NCT01582308|12348465|FG005|STARTED|Period 3||2
11159908|NCT01582308|12348466|FG006|STARTED|Period 3||2
11159909|NCT01582308|12348467|FG007|STARTED|Period 3||2
11159910|NCT01582308|12348468|FG008|STARTED|Period 3||2
11159911|NCT01582308|12348469|FG009|STARTED|Period 3||2
11159912|NCT01582308|12348460|FG000|COMPLETED|Period 3||2
11159913|NCT01582308|12348461|FG001|COMPLETED|Period 3||2
11159914|NCT01582308|12348462|FG002|COMPLETED|Period 3||2
11159915|NCT01582308|12348463|FG003|COMPLETED|Period 3||2
11159916|NCT01582308|12348464|FG004|COMPLETED|Period 3||2
11159917|NCT01582308|12348465|FG005|COMPLETED|Period 3||2
11159918|NCT01582308|12348466|FG006|COMPLETED|Period 3||2
11159919|NCT01582308|12348467|FG007|COMPLETED|Period 3||2
11159920|NCT01582308|12348468|FG008|COMPLETED|Period 3||2
11159921|NCT01582308|12348469|FG009|COMPLETED|Period 3||2
11159922|NCT01582308|12348460|FG000|NOT COMPLETED|Period 3||0
11159923|NCT01582308|12348461|FG001|NOT COMPLETED|Period 3||0
11159924|NCT01582308|12348462|FG002|NOT COMPLETED|Period 3||0
11159925|NCT01582308|12348463|FG003|NOT COMPLETED|Period 3||0
11159926|NCT01582308|12348464|FG004|NOT COMPLETED|Period 3||0
11159927|NCT01582308|12348465|FG005|NOT COMPLETED|Period 3||0
11159928|NCT01582308|12348466|FG006|NOT COMPLETED|Period 3||0
11159929|NCT01582308|12348467|FG007|NOT COMPLETED|Period 3||0
11159930|NCT01582308|12348468|FG008|NOT COMPLETED|Period 3||0
11159931|NCT01582308|12348469|FG009|NOT COMPLETED|Period 3||0
11159932|NCT01582308|12348460|FG000|STARTED|10-day Washout Following Period 3||2
11159933|NCT01582308|12348461|FG001|STARTED|10-day Washout Following Period 3||2
11159934|NCT01582308|12348462|FG002|STARTED|10-day Washout Following Period 3||2
11159935|NCT01582308|12348463|FG003|STARTED|10-day Washout Following Period 3||2
11159936|NCT01582308|12348464|FG004|STARTED|10-day Washout Following Period 3||2
11159937|NCT01582308|12348465|FG005|STARTED|10-day Washout Following Period 3||2
11159938|NCT01582308|12348466|FG006|STARTED|10-day Washout Following Period 3||2
11159939|NCT01582308|12348467|FG007|STARTED|10-day Washout Following Period 3||2
11159940|NCT01582308|12348468|FG008|STARTED|10-day Washout Following Period 3||2
11159941|NCT01582308|12348469|FG009|STARTED|10-day Washout Following Period 3||2
11159942|NCT01582308|12348460|FG000|COMPLETED|10-day Washout Following Period 3||2
11159943|NCT01582308|12348461|FG001|COMPLETED|10-day Washout Following Period 3||2
11159944|NCT01582308|12348462|FG002|COMPLETED|10-day Washout Following Period 3||2
11159945|NCT01582308|12348463|FG003|COMPLETED|10-day Washout Following Period 3||2
11159946|NCT01582308|12348464|FG004|COMPLETED|10-day Washout Following Period 3||2
11159947|NCT01582308|12348465|FG005|COMPLETED|10-day Washout Following Period 3||2
11159948|NCT01582308|12348466|FG006|COMPLETED|10-day Washout Following Period 3||2
11159949|NCT01582308|12348467|FG007|COMPLETED|10-day Washout Following Period 3||2
11159950|NCT01582308|12348468|FG008|COMPLETED|10-day Washout Following Period 3||2
11159951|NCT01582308|12348469|FG009|COMPLETED|10-day Washout Following Period 3||2
11159952|NCT01582308|12348460|FG000|NOT COMPLETED|10-day Washout Following Period 3||0
11159953|NCT01582308|12348461|FG001|NOT COMPLETED|10-day Washout Following Period 3||0
11159954|NCT01582308|12348462|FG002|NOT COMPLETED|10-day Washout Following Period 3||0
11159955|NCT01582308|12348463|FG003|NOT COMPLETED|10-day Washout Following Period 3||0
11159956|NCT01582308|12348464|FG004|NOT COMPLETED|10-day Washout Following Period 3||0
11159957|NCT01582308|12348465|FG005|NOT COMPLETED|10-day Washout Following Period 3||0
11159958|NCT01582308|12348466|FG006|NOT COMPLETED|10-day Washout Following Period 3||0
11159959|NCT01582308|12348467|FG007|NOT COMPLETED|10-day Washout Following Period 3||0
11159960|NCT01582308|12348468|FG008|NOT COMPLETED|10-day Washout Following Period 3||0
11159961|NCT01582308|12348469|FG009|NOT COMPLETED|10-day Washout Following Period 3||0
11159962|NCT01582308|12348460|FG000|STARTED|Period 4||2
11159963|NCT01582308|12348461|FG001|STARTED|Period 4||2
11159964|NCT01582308|12348462|FG002|STARTED|Period 4||2
11159965|NCT01582308|12348463|FG003|STARTED|Period 4||2
11159966|NCT01582308|12348464|FG004|STARTED|Period 4||2
11159967|NCT01582308|12348465|FG005|STARTED|Period 4||2
11159968|NCT01582308|12348466|FG006|STARTED|Period 4||2
11159969|NCT01582308|12348467|FG007|STARTED|Period 4||2
11159970|NCT01582308|12348468|FG008|STARTED|Period 4||2
11159971|NCT01582308|12348469|FG009|STARTED|Period 4||2
11159972|NCT01582308|12348460|FG000|COMPLETED|Period 4||1
11159973|NCT01582308|12348461|FG001|COMPLETED|Period 4||2
11159974|NCT01582308|12348462|FG002|COMPLETED|Period 4||2
11159975|NCT01582308|12348463|FG003|COMPLETED|Period 4||2
11159976|NCT01582308|12348464|FG004|COMPLETED|Period 4||2
11343022|NCT02950545|12540317|FG000|STARTED|Session 3 (70 Minutes)||7
11159977|NCT01582308|12348465|FG005|COMPLETED|Period 4||1
11159978|NCT01582308|12348466|FG006|COMPLETED|Period 4||2
11159979|NCT01582308|12348467|FG007|COMPLETED|Period 4||2
11159980|NCT01582308|12348468|FG008|COMPLETED|Period 4||2
11159981|NCT01582308|12348469|FG009|COMPLETED|Period 4||1
11159982|NCT01582308|12348460|FG000|NOT COMPLETED|Period 4||1
11159983|NCT01582308|12348461|FG001|NOT COMPLETED|Period 4||0
11159984|NCT01582308|12348462|FG002|NOT COMPLETED|Period 4||0
11159985|NCT01582308|12348463|FG003|NOT COMPLETED|Period 4||0
11159986|NCT01582308|12348464|FG004|NOT COMPLETED|Period 4||0
11159987|NCT01582308|12348465|FG005|NOT COMPLETED|Period 4||1
11159988|NCT01582308|12348466|FG006|NOT COMPLETED|Period 4||0
11159989|NCT01582308|12348467|FG007|NOT COMPLETED|Period 4||0
11159990|NCT01582308|12348468|FG008|NOT COMPLETED|Period 4||0
11159991|NCT01582308|12348469|FG009|NOT COMPLETED|Period 4||1
11159992|NCT01582308|12348460|FG000|STARTED|10-day Washout Following Period 4||1
11159993|NCT01582308|12348461|FG001|STARTED|10-day Washout Following Period 4||2
11159994|NCT01582308|12348462|FG002|STARTED|10-day Washout Following Period 4||2
11159995|NCT01582308|12348463|FG003|STARTED|10-day Washout Following Period 4||2
11159996|NCT01582308|12348464|FG004|STARTED|10-day Washout Following Period 4||2
11159997|NCT01582308|12348465|FG005|STARTED|10-day Washout Following Period 4||1
11159998|NCT01582308|12348466|FG006|STARTED|10-day Washout Following Period 4||2
11159999|NCT01582308|12348467|FG007|STARTED|10-day Washout Following Period 4||2
11160000|NCT01582308|12348468|FG008|STARTED|10-day Washout Following Period 4||2
11160001|NCT01582308|12348469|FG009|STARTED|10-day Washout Following Period 4||1
11160002|NCT01582308|12348460|FG000|COMPLETED|10-day Washout Following Period 4||1
11160003|NCT01582308|12348461|FG001|COMPLETED|10-day Washout Following Period 4||2
11160004|NCT01582308|12348462|FG002|COMPLETED|10-day Washout Following Period 4||2
11160005|NCT01582308|12348463|FG003|COMPLETED|10-day Washout Following Period 4||2
11160006|NCT01582308|12348464|FG004|COMPLETED|10-day Washout Following Period 4||2
11160007|NCT01582308|12348465|FG005|COMPLETED|10-day Washout Following Period 4||1
11160008|NCT01582308|12348466|FG006|COMPLETED|10-day Washout Following Period 4||2
11160009|NCT01582308|12348467|FG007|COMPLETED|10-day Washout Following Period 4||2
11160010|NCT01582308|12348468|FG008|COMPLETED|10-day Washout Following Period 4||2
11160011|NCT01582308|12348469|FG009|COMPLETED|10-day Washout Following Period 4||1
11160012|NCT01582308|12348460|FG000|NOT COMPLETED|10-day Washout Following Period 4||0
11160013|NCT01582308|12348461|FG001|NOT COMPLETED|10-day Washout Following Period 4||0
11160014|NCT01582308|12348462|FG002|NOT COMPLETED|10-day Washout Following Period 4||0
11160015|NCT01582308|12348463|FG003|NOT COMPLETED|10-day Washout Following Period 4||0
11160016|NCT01582308|12348464|FG004|NOT COMPLETED|10-day Washout Following Period 4||0
11160017|NCT01582308|12348465|FG005|NOT COMPLETED|10-day Washout Following Period 4||0
11160018|NCT01582308|12348466|FG006|NOT COMPLETED|10-day Washout Following Period 4||0
11160019|NCT01582308|12348467|FG007|NOT COMPLETED|10-day Washout Following Period 4||0
11160020|NCT01582308|12348468|FG008|NOT COMPLETED|10-day Washout Following Period 4||0
11160021|NCT01582308|12348469|FG009|NOT COMPLETED|10-day Washout Following Period 4||0
11160022|NCT01582308|12348460|FG000|STARTED|Period 5||1
11160023|NCT01582308|12348461|FG001|STARTED|Period 5||2
11160024|NCT01582308|12348462|FG002|STARTED|Period 5||2
11160025|NCT01582308|12348463|FG003|STARTED|Period 5||2
11160026|NCT01582308|12348464|FG004|STARTED|Period 5||2
11160027|NCT01582308|12348465|FG005|STARTED|Period 5||1
11160028|NCT01582308|12348466|FG006|STARTED|Period 5||2
11419163|NCT00271102|12617621|FG000|COMPLETED|Overall Study||30
11419164|NCT00271102|12617622|FG001|COMPLETED|Overall Study||30
11160029|NCT01582308|12348467|FG007|STARTED|Period 5||2
11160030|NCT01582308|12348468|FG008|STARTED|Period 5||2
11160031|NCT01582308|12348469|FG009|STARTED|Period 5||1
11160032|NCT01582308|12348460|FG000|COMPLETED|Period 5||1
11160033|NCT01582308|12348461|FG001|COMPLETED|Period 5||2
11160034|NCT01582308|12348462|FG002|COMPLETED|Period 5||2
11160035|NCT01582308|12348463|FG003|COMPLETED|Period 5||2
11160036|NCT01582308|12348464|FG004|COMPLETED|Period 5||2
11160037|NCT01582308|12348465|FG005|COMPLETED|Period 5||1
11160038|NCT01582308|12348466|FG006|COMPLETED|Period 5||2
11160039|NCT01582308|12348467|FG007|COMPLETED|Period 5||2
11160040|NCT01582308|12348468|FG008|COMPLETED|Period 5||2
11160041|NCT01582308|12348469|FG009|COMPLETED|Period 5||1
11160042|NCT01582308|12348460|FG000|NOT COMPLETED|Period 5||0
11160043|NCT01582308|12348461|FG001|NOT COMPLETED|Period 5||0
11160044|NCT01582308|12348462|FG002|NOT COMPLETED|Period 5||0
11160045|NCT01582308|12348463|FG003|NOT COMPLETED|Period 5||0
11160046|NCT01582308|12348464|FG004|NOT COMPLETED|Period 5||0
11160047|NCT01582308|12348465|FG005|NOT COMPLETED|Period 5||0
11160048|NCT01582308|12348466|FG006|NOT COMPLETED|Period 5||0
11160049|NCT01582308|12348467|FG007|NOT COMPLETED|Period 5||0
11160050|NCT01582308|12348468|FG008|NOT COMPLETED|Period 5||0
11419165|NCT00271102|12617621|FG000|NOT COMPLETED|Overall Study||5
11419166|NCT00271102|12617622|FG001|NOT COMPLETED|Overall Study||5
11419167|NCT00276419|12617630|FG000|STARTED|First Intervention||8
11160051|NCT01582308|12348469|FG009|NOT COMPLETED|Period 5||0
11160052|NCT01582451|12348484|FG000|STARTED|Overall Study||307
11160053|NCT01582451|12348485|FG001|STARTED|Overall Study||159
11160054|NCT01582451|12348484|FG000|Received at Least 1 Dose of Study Drug|Overall Study||305
11160055|NCT01582451|12348485|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159
11160056|NCT01582451|12348484|FG000|COMPLETED|Overall Study||275
11160057|NCT01582451|12348485|FG001|COMPLETED|Overall Study||139
11160058|NCT01582451|12348484|FG000|NOT COMPLETED|Overall Study||32
11160059|NCT01582451|12348485|FG001|NOT COMPLETED|Overall Study||20
11160060|NCT01582477|12348493|FG000|STARTED|Overall Study||12
11160061|NCT01582477|12348494|FG001|STARTED|Overall Study||12
11160062|NCT01582477|12348493|FG000|COMPLETED|Overall Study||12
11160063|NCT01582477|12348494|FG001|COMPLETED|Overall Study||12
11160064|NCT01582477|12348493|FG000|NOT COMPLETED|Overall Study||0
11419168|NCT00276419|12617631|FG001|STARTED|First Intervention||10
11160065|NCT01582477|12348494|FG001|NOT COMPLETED|Overall Study||0
11160066|NCT01582490|12348502|FG000|STARTED|Overall Study||9
11160067|NCT01582490|12348503|FG001|STARTED|Overall Study||10
11160068|NCT01582490|12348502|FG000|COMPLETED|Overall Study||8
11160069|NCT01582490|12348503|FG001|COMPLETED|Overall Study||9
11160070|NCT01582490|12348502|FG000|NOT COMPLETED|Overall Study||1
11160071|NCT01582490|12348503|FG001|NOT COMPLETED|Overall Study||1
11160072|NCT01582789|12348511|FG000|STARTED|First Intervention (14 Days)||34
11160073|NCT01582789|12348512|FG001|STARTED|First Intervention (14 Days)||27
11160074|NCT01582789|12348511|FG000|COMPLETED|First Intervention (14 Days)||34
11160075|NCT01582789|12348512|FG001|COMPLETED|First Intervention (14 Days)||27
11160076|NCT01582789|12348511|FG000|NOT COMPLETED|First Intervention (14 Days)||0
11160077|NCT01582789|12348512|FG001|NOT COMPLETED|First Intervention (14 Days)||0
11160078|NCT01582789|12348511|FG000|STARTED|Second Intervention (14 Days)||34
11160079|NCT01582789|12348512|FG001|STARTED|Second Intervention (14 Days)||27
11160080|NCT01582789|12348511|FG000|COMPLETED|Second Intervention (14 Days)||33
11160081|NCT01582789|12348512|FG001|COMPLETED|Second Intervention (14 Days)||27
11160082|NCT01582789|12348511|FG000|NOT COMPLETED|Second Intervention (14 Days)||1
11160083|NCT01582789|12348512|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
11160084|NCT01582854|12348522|FG000|STARTED|Overall Study||248
11160085|NCT01582854|12348523|FG001|STARTED|Overall Study||255
11160086|NCT01582854|12348522|FG000|COMPLETED|Overall Study||212
11160087|NCT01582854|12348523|FG001|COMPLETED|Overall Study||221
11160088|NCT01582854|12348522|FG000|NOT COMPLETED|Overall Study||36
11160089|NCT01582854|12348523|FG001|NOT COMPLETED|Overall Study||34
11160090|NCT01582880|12348529|FG000|STARTED|Overall Study||1
11160091|NCT01582880|12348529|FG000|COMPLETED|Overall Study||1
11160092|NCT01582880|12348529|FG000|NOT COMPLETED|Overall Study||0
11160093|NCT01582945|12348533|FG000|STARTED|Overall Study||14
11160094|NCT01582945|12348533|FG000|COMPLETED|Overall Study||12
11160095|NCT01582945|12348533|FG000|NOT COMPLETED|Overall Study||2
11160096|NCT01582971|12348539|FG000|STARTED|Overall Study||128
11160097|NCT01582971|12348540|FG001|STARTED|Overall Study||128
11160098|NCT01582971|12348539|FG000|COMPLETED|Overall Study||89
11160099|NCT01582971|12348540|FG001|COMPLETED|Overall Study||91
11160100|NCT01582971|12348539|FG000|NOT COMPLETED|Overall Study||39
11160101|NCT01582971|12348540|FG001|NOT COMPLETED|Overall Study||37
11160102|NCT01583101|12348554|FG000|STARTED|Overall Study||1076
11160103|NCT01583101|12348555|FG001|STARTED|Overall Study||1161
11160104|NCT01583101|12348554|FG000|COMPLETED|Overall Study||1076
11160105|NCT01583101|12348555|FG001|COMPLETED|Overall Study||1161
11160106|NCT01583101|12348554|FG000|NOT COMPLETED|Overall Study||0
11160107|NCT01583101|12348555|FG001|NOT COMPLETED|Overall Study||0
11160108|NCT01583166|12348563|FG000|STARTED|Overall Study||45
11160109|NCT01583166|12348564|FG001|STARTED|Overall Study||45
11160110|NCT01583166|12348563|FG000|COMPLETED|Overall Study||41
11160111|NCT01583166|12348564|FG001|COMPLETED|Overall Study||39
11160112|NCT01583166|12348563|FG000|NOT COMPLETED|Overall Study||4
11160113|NCT01583166|12348564|FG001|NOT COMPLETED|Overall Study||6
11160114|NCT01583179|12348572|FG000|STARTED|Overall Study||14
11160115|NCT01583179|12348573|FG001|STARTED|Overall Study||12
11160116|NCT01583179|12348572|FG000|COMPLETED|Overall Study||13
11160117|NCT01583179|12348573|FG001|COMPLETED|Overall Study||10
11160118|NCT01583179|12348572|FG000|NOT COMPLETED|Overall Study||1
11160119|NCT01583179|12348573|FG001|NOT COMPLETED|Overall Study||2
11160120|NCT01583218|12348581|FG000|STARTED|Overall Study||3759
11160121|NCT01583218|12348582|FG001|STARTED|Overall Study||3754
11419169|NCT00276419|12617630|FG000|COMPLETED|First Intervention||7
11419170|NCT00276419|12617631|FG001|COMPLETED|First Intervention||8
11419171|NCT00276419|12617630|FG000|NOT COMPLETED|First Intervention||1
11419172|NCT00276419|12617631|FG001|NOT COMPLETED|First Intervention||2
11419173|NCT00276419|12617630|FG000|STARTED|Wash-out Phase||7
11419174|NCT00276419|12617631|FG001|STARTED|Wash-out Phase||8
11419175|NCT00276419|12617630|FG000|COMPLETED|Wash-out Phase||7
11419176|NCT00276419|12617631|FG001|COMPLETED|Wash-out Phase||8
11419177|NCT00276419|12617630|FG000|NOT COMPLETED|Wash-out Phase||0
11160122|NCT01583218|12348581|FG000|COMPLETED|Overall Study||3470
11160123|NCT01583218|12348582|FG001|COMPLETED|Overall Study||3471
11160124|NCT01583218|12348581|FG000|NOT COMPLETED|Overall Study||289
11160125|NCT01583218|12348582|FG001|NOT COMPLETED|Overall Study||283
11160126|NCT01583296|12348590|FG000|STARTED|Overall Study||27
11419178|NCT00276419|12617631|FG001|NOT COMPLETED|Wash-out Phase||0
11160127|NCT01583296|12348591|FG001|STARTED|Overall Study||26
11160128|NCT01583296|12348590|FG000|COMPLETED|Overall Study||16
11419179|NCT00276419|12617630|FG000|STARTED|Second Intervention||7
11419180|NCT00276419|12617631|FG001|STARTED|Second Intervention||8
11160129|NCT01583296|12348591|FG001|COMPLETED|Overall Study||16
11160130|NCT01583296|12348590|FG000|NOT COMPLETED|Overall Study||11
11160131|NCT01583296|12348591|FG001|NOT COMPLETED|Overall Study||10
11160132|NCT01583374|12348600|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||164
11160133|NCT01583374|12348601|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||163
11160134|NCT01583374|12348602|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||163
11160135|NCT01583374|12348603|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0
11160136|NCT01583374|12348604|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0
11160137|NCT01583374|12348605|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0
11419181|NCT00276419|12617630|FG000|COMPLETED|Second Intervention||7
11160138|NCT01583374|12348606|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0
11160139|NCT01583374|12348607|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0
11160140|NCT01583374|12348608|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0
11160141|NCT01583374|12348600|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||164
11160142|NCT01583374|12348601|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
11160143|NCT01583374|12348602|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
11160144|NCT01583374|12348603|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
11160145|NCT01583374|12348604|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
11160146|NCT01583374|12348605|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
11160147|NCT01583374|12348606|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
11160148|NCT01583374|12348607|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
11160149|NCT01583374|12348608|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
11160150|NCT01583374|12348600|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150
11160151|NCT01583374|12348601|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151
11160152|NCT01583374|12348602|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144
11160153|NCT01583374|12348603|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
11160154|NCT01583374|12348604|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
11160155|NCT01583374|12348605|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
11160156|NCT01583374|12348606|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
11160157|NCT01583374|12348607|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
11160158|NCT01583374|12348608|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
11160159|NCT01583374|12348600|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51
11160160|NCT01583374|12348601|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49
11160161|NCT01583374|12348602|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49
11160162|NCT01583374|12348603|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
11160163|NCT01583374|12348604|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
11160164|NCT01583374|12348605|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
11160165|NCT01583374|12348606|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
11160166|NCT01583374|12348607|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
11160167|NCT01583374|12348608|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
11160168|NCT01583374|12348600|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145
11160169|NCT01583374|12348601|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147
11160170|NCT01583374|12348602|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138
11160171|NCT01583374|12348603|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11160172|NCT01583374|12348604|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11160173|NCT01583374|12348605|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11160174|NCT01583374|12348606|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11160175|NCT01583374|12348607|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11160176|NCT01583374|12348608|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11160177|NCT01583374|12348600|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19
11160178|NCT01583374|12348601|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16
11160179|NCT01583374|12348602|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25
11160180|NCT01583374|12348603|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11160181|NCT01583374|12348604|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11160182|NCT01583374|12348605|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11160183|NCT01583374|12348606|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11160184|NCT01583374|12348607|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11160185|NCT01583374|12348608|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11160186|NCT01583374|12348600|FG000|STARTED|Extension Phase (Weeks 24 to 52)||0
11160187|NCT01583374|12348601|FG001|STARTED|Extension Phase (Weeks 24 to 52)||74
11160188|NCT01583374|12348602|FG002|STARTED|Extension Phase (Weeks 24 to 52)||65
11160189|NCT01583374|12348603|FG003|STARTED|Extension Phase (Weeks 24 to 52)||47
11160190|NCT01583374|12348604|FG004|STARTED|Extension Phase (Weeks 24 to 52)||91
11160191|NCT01583374|12348605|FG005|STARTED|Extension Phase (Weeks 24 to 52)||48
11160192|NCT01583374|12348606|FG006|STARTED|Extension Phase (Weeks 24 to 52)||48
11160193|NCT01583374|12348607|FG007|STARTED|Extension Phase (Weeks 24 to 52)||25
11160194|NCT01583374|12348608|FG008|STARTED|Extension Phase (Weeks 24 to 52)||23
11160195|NCT01583374|12348600|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||0
11160196|NCT01583374|12348601|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||69
11160197|NCT01583374|12348602|FG002|COMPLETED|Extension Phase (Weeks 24 to 52)||61
11160198|NCT01583374|12348603|FG003|COMPLETED|Extension Phase (Weeks 24 to 52)||41
11160199|NCT01583374|12348604|FG004|COMPLETED|Extension Phase (Weeks 24 to 52)||85
11160200|NCT01583374|12348605|FG005|COMPLETED|Extension Phase (Weeks 24 to 52)||43
11160201|NCT01583374|12348606|FG006|COMPLETED|Extension Phase (Weeks 24 to 52)||43
11160202|NCT01583374|12348607|FG007|COMPLETED|Extension Phase (Weeks 24 to 52)||22
11160203|NCT01583374|12348608|FG008|COMPLETED|Extension Phase (Weeks 24 to 52)||21
11160204|NCT01583374|12348600|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0
11160205|NCT01583374|12348601|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
11419182|NCT00276419|12617631|FG001|COMPLETED|Second Intervention||8
11160206|NCT01583374|12348602|FG002|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4
11160207|NCT01583374|12348603|FG003|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
11419183|NCT00276419|12617630|FG000|NOT COMPLETED|Second Intervention||0
11419184|NCT00276419|12617631|FG001|NOT COMPLETED|Second Intervention||0
11419185|NCT00279409|12617639|FG000|STARTED|Overall Study||0
11419186|NCT00279409|12617640|FG001|STARTED|Overall Study||0
11419187|NCT00279409|12617639|FG000|COMPLETED|Overall Study||0
11160208|NCT01583374|12348604|FG004|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
11160209|NCT01583374|12348605|FG005|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
11160210|NCT01583374|12348606|FG006|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
11160211|NCT01583374|12348607|FG007|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3
11160212|NCT01583374|12348608|FG008|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2
11160213|NCT01583374|12348600|FG000|STARTED|Long-Term Extension Phase Weeks 52-260||0
11160214|NCT01583374|12348601|FG001|STARTED|Long-Term Extension Phase Weeks 52-260||66
11419188|NCT00279409|12617640|FG001|COMPLETED|Overall Study||0
11160215|NCT01583374|12348602|FG002|STARTED|Long-Term Extension Phase Weeks 52-260||61
11160216|NCT01583374|12348603|FG003|STARTED|Long-Term Extension Phase Weeks 52-260||35
11160217|NCT01583374|12348604|FG004|STARTED|Long-Term Extension Phase Weeks 52-260||81
11160218|NCT01583374|12348605|FG005|STARTED|Long-Term Extension Phase Weeks 52-260||39
11160219|NCT01583374|12348606|FG006|STARTED|Long-Term Extension Phase Weeks 52-260||38
11160220|NCT01583374|12348607|FG007|STARTED|Long-Term Extension Phase Weeks 52-260||21
11160221|NCT01583374|12348608|FG008|STARTED|Long-Term Extension Phase Weeks 52-260||20
11160222|NCT01583374|12348600|FG000|COMPLETED|Long-Term Extension Phase Weeks 52-260||0
11160223|NCT01583374|12348601|FG001|COMPLETED|Long-Term Extension Phase Weeks 52-260||40
11160224|NCT01583374|12348602|FG002|COMPLETED|Long-Term Extension Phase Weeks 52-260||41
11160225|NCT01583374|12348603|FG003|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
11160226|NCT01583374|12348604|FG004|COMPLETED|Long-Term Extension Phase Weeks 52-260||50
11160227|NCT01583374|12348605|FG005|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
11160228|NCT01583374|12348606|FG006|COMPLETED|Long-Term Extension Phase Weeks 52-260||20
11160229|NCT01583374|12348607|FG007|COMPLETED|Long-Term Extension Phase Weeks 52-260||12
11160230|NCT01583374|12348608|FG008|COMPLETED|Long-Term Extension Phase Weeks 52-260||10
11160231|NCT01583374|12348600|FG000|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0
11419189|NCT00279409|12617639|FG000|NOT COMPLETED|Overall Study||0
11160232|NCT01583374|12348601|FG001|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26
11160233|NCT01583374|12348602|FG002|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20
11160234|NCT01583374|12348603|FG003|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13
11160235|NCT01583374|12348604|FG004|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31
11160236|NCT01583374|12348605|FG005|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17
11160237|NCT01583374|12348606|FG006|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18
11160238|NCT01583374|12348607|FG007|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9
11160239|NCT01583374|12348608|FG008|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10
11160240|NCT01583452|12348629|FG000|STARTED|Overall Study||21
11160241|NCT01583452|12348630|FG001|STARTED|Overall Study||20
11160242|NCT01583452|12348629|FG000|COMPLETED|Overall Study||21
11160243|NCT01583452|12348630|FG001|COMPLETED|Overall Study||20
11160244|NCT01583452|12348629|FG000|NOT COMPLETED|Overall Study||0
11160245|NCT01583452|12348630|FG001|NOT COMPLETED|Overall Study||0
11160246|NCT01583530|12348645|FG000|STARTED|Overall Study||19
11160247|NCT01583530|12348646|FG001|STARTED|Overall Study||20
11160248|NCT01583530|12348647|FG002|STARTED|Overall Study||20
11160249|NCT01583530|12348648|FG003|STARTED|Overall Study||19
11160250|NCT01583530|12348649|FG004|STARTED|Overall Study||20
11160251|NCT01583530|12348650|FG005|STARTED|Overall Study||20
11160252|NCT01583530|12348645|FG000|COMPLETED|Overall Study||19
11160253|NCT01583530|12348646|FG001|COMPLETED|Overall Study||17
11160254|NCT01583530|12348647|FG002|COMPLETED|Overall Study||20
11160255|NCT01583530|12348648|FG003|COMPLETED|Overall Study||18
11160256|NCT01583530|12348649|FG004|COMPLETED|Overall Study||15
11160257|NCT01583530|12348650|FG005|COMPLETED|Overall Study||17
11160258|NCT01583530|12348645|FG000|NOT COMPLETED|Overall Study||0
11160259|NCT01583530|12348646|FG001|NOT COMPLETED|Overall Study||3
11160260|NCT01583530|12348647|FG002|NOT COMPLETED|Overall Study||0
11160261|NCT01583530|12348648|FG003|NOT COMPLETED|Overall Study||1
11160262|NCT01583530|12348649|FG004|NOT COMPLETED|Overall Study||5
11160263|NCT01583530|12348650|FG005|NOT COMPLETED|Overall Study||3
11160264|NCT01583543|12348667|FG000|STARTED|Overall Study||12
11160265|NCT01583543|12348667|FG000|COMPLETED|Overall Study||12
11160266|NCT01583543|12348667|FG000|NOT COMPLETED|Overall Study||0
11160267|NCT01583686|12348679|FG000|STARTED|Overall Study||3
11160268|NCT01583686|12348680|FG001|STARTED|Overall Study||3
11160269|NCT01583686|12348681|FG002|STARTED|Overall Study||3
11160270|NCT01583686|12348682|FG003|STARTED|Overall Study||3
11160271|NCT01583686|12348683|FG004|STARTED|Overall Study||3
11160272|NCT01583686|12348679|FG000|COMPLETED|Overall Study||3
11160273|NCT01583686|12348680|FG001|COMPLETED|Overall Study||3
11160274|NCT01583686|12348681|FG002|COMPLETED|Overall Study||3
11160275|NCT01583686|12348682|FG003|COMPLETED|Overall Study||3
11160276|NCT01583686|12348683|FG004|COMPLETED|Overall Study||3
11160277|NCT01583686|12348679|FG000|NOT COMPLETED|Overall Study||0
11160278|NCT01583686|12348680|FG001|NOT COMPLETED|Overall Study||0
11160279|NCT01583686|12348681|FG002|NOT COMPLETED|Overall Study||0
11160280|NCT01583686|12348682|FG003|NOT COMPLETED|Overall Study||0
11160281|NCT01583686|12348683|FG004|NOT COMPLETED|Overall Study||0
11160282|NCT01583868|12348700|FG000|STARTED|Overall Study||108
11160283|NCT01583868|12348701|FG001|STARTED|Overall Study||108
11160284|NCT01583868|12348700|FG000|COMPLETED|Overall Study||104
11160285|NCT01583868|12348701|FG001|COMPLETED|Overall Study||104
11160286|NCT01583868|12348700|FG000|NOT COMPLETED|Overall Study||4
11160287|NCT01583868|12348701|FG001|NOT COMPLETED|Overall Study||4
11160288|NCT01583894|12348711|FG000|STARTED|Overall Study||828
11160289|NCT01583894|12348711|FG000|COMPLETED|Overall Study||813
11160290|NCT01583894|12348711|FG000|NOT COMPLETED|Overall Study||15
11160291|NCT01583985|12348717|FG000|STARTED|Overall Study||120
11160292|NCT01583985|12348718|FG001|STARTED|Overall Study||120
11160293|NCT01583985|12348717|FG000|Included in Primary Analysis|Overall Study||119
11160294|NCT01583985|12348718|FG001|Included in Primary Analysis|Overall Study||119
11160295|NCT01583985|12348717|FG000|COMPLETED|Overall Study||117
11160296|NCT01583985|12348718|FG001|COMPLETED|Overall Study||117
11160297|NCT01583985|12348717|FG000|NOT COMPLETED|Overall Study||3
11160298|NCT01583985|12348718|FG001|NOT COMPLETED|Overall Study||3
11160299|NCT01584024|12348724|FG000|STARTED|Overall Study||42
11160300|NCT01584024|12348724|FG000|COMPLETED|Overall Study||29
11160301|NCT01584024|12348724|FG000|NOT COMPLETED|Overall Study||13
11160302|NCT01584232|12348731|FG000|STARTED|Overall Study||181
11160303|NCT01584232|12348732|FG001|STARTED|Overall Study||180
11160304|NCT01584232|12348731|FG000|Received at Least 1 Dose of Study Drug|Overall Study||181
11160305|NCT01584232|12348732|FG001|Received at Least 1 Dose of Study Drug|Overall Study||180
11160306|NCT01584232|12348731|FG000|COMPLETED|Overall Study||173
11160307|NCT01584232|12348732|FG001|COMPLETED|Overall Study||177
11419190|NCT00279409|12617640|FG001|NOT COMPLETED|Overall Study||0
11419191|NCT00281879|12617654|FG000|STARTED|Overall Study||128
11419192|NCT00281879|12617655|FG001|STARTED|Overall Study||36
11419193|NCT00281879|12617656|FG002|STARTED|Overall Study||20
11160308|NCT01584232|12348731|FG000|NOT COMPLETED|Overall Study||8
11160309|NCT01584232|12348732|FG001|NOT COMPLETED|Overall Study||3
11160310|NCT01584388|12348738|FG000|STARTED|Overall Study||30
11160311|NCT01584388|12348738|FG000|COMPLETED|Overall Study||30
11160312|NCT01584388|12348738|FG000|NOT COMPLETED|Overall Study||0
11160313|NCT01584440|12348758|FG000|STARTED|Stage 1 (5 Weeks)||93
11160314|NCT01584440|12348759|FG001|STARTED|Stage 1 (5 Weeks)||127
11160315|NCT01584440|12348760|FG002|STARTED|Stage 1 (5 Weeks)||0
11160316|NCT01584440|12348761|FG003|STARTED|Stage 1 (5 Weeks)||0
11160317|NCT01584440|12348762|FG004|STARTED|Stage 1 (5 Weeks)||0
11160318|NCT01584440|12348758|FG000|COMPLETED|Stage 1 (5 Weeks)||83
11160319|NCT01584440|12348759|FG001|COMPLETED|Stage 1 (5 Weeks)||119
11160320|NCT01584440|12348760|FG002|COMPLETED|Stage 1 (5 Weeks)||0
11160321|NCT01584440|12348761|FG003|COMPLETED|Stage 1 (5 Weeks)||0
11160322|NCT01584440|12348762|FG004|COMPLETED|Stage 1 (5 Weeks)||0
11160323|NCT01584440|12348758|FG000|NOT COMPLETED|Stage 1 (5 Weeks)||10
11160324|NCT01584440|12348759|FG001|NOT COMPLETED|Stage 1 (5 Weeks)||8
11160325|NCT01584440|12348760|FG002|NOT COMPLETED|Stage 1 (5 Weeks)||0
11160326|NCT01584440|12348761|FG003|NOT COMPLETED|Stage 1 (5 Weeks)||0
11160327|NCT01584440|12348762|FG004|NOT COMPLETED|Stage 1 (5 Weeks)||0
11160328|NCT01584440|12348758|FG000|STARTED|Stage 2 (5 Weeks)||0
11160329|NCT01584440|12348759|FG001|STARTED|Stage 2 (5 Weeks)||0
11160330|NCT01584440|12348760|FG002|STARTED|Stage 2 (5 Weeks)||83
11160331|NCT01584440|12348761|FG003|STARTED|Stage 2 (5 Weeks)||59
11160332|NCT01584440|12348762|FG004|STARTED|Stage 2 (5 Weeks)||60
11160333|NCT01584440|12348758|FG000|COMPLETED|Stage 2 (5 Weeks)||0
11160334|NCT01584440|12348759|FG001|COMPLETED|Stage 2 (5 Weeks)||0
11160335|NCT01584440|12348760|FG002|COMPLETED|Stage 2 (5 Weeks)||80
11160336|NCT01584440|12348761|FG003|COMPLETED|Stage 2 (5 Weeks)||55
11160337|NCT01584440|12348762|FG004|COMPLETED|Stage 2 (5 Weeks)||59
11160338|NCT01584440|12348758|FG000|NOT COMPLETED|Stage 2 (5 Weeks)||0
11160339|NCT01584440|12348759|FG001|NOT COMPLETED|Stage 2 (5 Weeks)||0
11160340|NCT01584440|12348760|FG002|NOT COMPLETED|Stage 2 (5 Weeks)||3
11160341|NCT01584440|12348761|FG003|NOT COMPLETED|Stage 2 (5 Weeks)||4
11160342|NCT01584440|12348762|FG004|NOT COMPLETED|Stage 2 (5 Weeks)||1
11160343|NCT01584479|12348779|FG000|STARTED|Overall Study||732
11160344|NCT01584479|12348780|FG001|STARTED|Overall Study||1686
11160345|NCT01584479|12348781|FG002|STARTED|Overall Study||852
11160346|NCT01584479|12348782|FG003|STARTED|Overall Study||1847
11160347|NCT01584479|12348779|FG000|COMPLETED|Overall Study||732
11160348|NCT01584479|12348780|FG001|COMPLETED|Overall Study||1686
11160349|NCT01584479|12348781|FG002|COMPLETED|Overall Study||852
11160350|NCT01584479|12348782|FG003|COMPLETED|Overall Study||1847
11160351|NCT01584479|12348779|FG000|NOT COMPLETED|Overall Study||0
11419194|NCT00281879|12617657|FG003|STARTED|Overall Study||0
11160352|NCT01584479|12348780|FG001|NOT COMPLETED|Overall Study||0
11160353|NCT01584479|12348781|FG002|NOT COMPLETED|Overall Study||0
11160354|NCT01584479|12348782|FG003|NOT COMPLETED|Overall Study||0
11419195|NCT00281879|12617658|FG004|STARTED|Overall Study||6
11419196|NCT00281879|12617659|FG005|STARTED|Overall Study||9
11419197|NCT00281879|12617660|FG006|STARTED|Overall Study||0
11160355|NCT01584518|12348794|FG000|STARTED|Overall Study||25
11160356|NCT01584518|12348795|FG001|STARTED|Overall Study||25
11160357|NCT01584518|12348794|FG000|COMPLETED|Overall Study||25
11160358|NCT01584518|12348795|FG001|COMPLETED|Overall Study||25
11160359|NCT01584518|12348794|FG000|NOT COMPLETED|Overall Study||0
11160360|NCT01584518|12348795|FG001|NOT COMPLETED|Overall Study||0
11160361|NCT01584544|12348806|FG000|STARTED|Overall Study||3
11160362|NCT01584544|12348807|FG001|STARTED|Overall Study||6
11160363|NCT01584544|12348808|FG002|STARTED|Overall Study||6
11160364|NCT01584544|12348809|FG003|STARTED|Overall Study||3
11160365|NCT01584544|12348810|FG004|STARTED|Overall Study||6
11160366|NCT01584544|12348806|FG000|COMPLETED|Overall Study||3
11160367|NCT01584544|12348807|FG001|COMPLETED|Overall Study||6
11160368|NCT01584544|12348808|FG002|COMPLETED|Overall Study||6
11160369|NCT01584544|12348809|FG003|COMPLETED|Overall Study||3
11419198|NCT00281879|12617661|FG007|STARTED|Overall Study||1
11160370|NCT01584544|12348810|FG004|COMPLETED|Overall Study||6
11160371|NCT01584544|12348806|FG000|NOT COMPLETED|Overall Study||0
11160372|NCT01584544|12348807|FG001|NOT COMPLETED|Overall Study||0
11160373|NCT01584544|12348808|FG002|NOT COMPLETED|Overall Study||0
11160374|NCT01584544|12348809|FG003|NOT COMPLETED|Overall Study||0
11160375|NCT01584544|12348810|FG004|NOT COMPLETED|Overall Study||0
11160376|NCT01584609|12348824|FG000|STARTED|Overall Study||98
11160377|NCT01584609|12348825|FG001|STARTED|Overall Study||100
11160378|NCT01584609|12348824|FG000|COMPLETED|Overall Study||86
11160379|NCT01584609|12348825|FG001|COMPLETED|Overall Study||96
11160380|NCT01584609|12348824|FG000|NOT COMPLETED|Overall Study||12
11160381|NCT01584609|12348825|FG001|NOT COMPLETED|Overall Study||4
11160382|NCT01584648|12348833|FG000|STARTED|Overall Study||211
11160383|NCT01584648|12348834|FG001|STARTED|Overall Study||212
11160384|NCT01584648|12348833|FG000|Safety Set|Overall Study||209
11160385|NCT01584648|12348834|FG001|Safety Set|Overall Study||211
11160386|NCT01584648|12348833|FG000|Crossover Population|Overall Study||0
11160387|NCT01584648|12348834|FG001|Crossover Population|Overall Study||28
11160388|NCT01584648|12348833|FG000|COMPLETED|Overall Study||0
11160389|NCT01584648|12348834|FG001|COMPLETED|Overall Study||0
11160390|NCT01584648|12348833|FG000|NOT COMPLETED|Overall Study||211
11160391|NCT01584648|12348834|FG001|NOT COMPLETED|Overall Study||212
11160392|NCT01584843|12348847|FG000|STARTED|First Treatment Period||3
11160393|NCT01584843|12348848|FG001|STARTED|First Treatment Period||4
11160394|NCT01584843|12348849|FG002|STARTED|First Treatment Period||3
11160395|NCT01584843|12348850|FG003|STARTED|First Treatment Period||10
11160396|NCT01584843|12348851|FG004|STARTED|First Treatment Period||10
11160397|NCT01584843|12348852|FG005|STARTED|First Treatment Period||11
11160398|NCT01584843|12348847|FG000|COMPLETED|First Treatment Period||3
11160399|NCT01584843|12348848|FG001|COMPLETED|First Treatment Period||4
11160400|NCT01584843|12348849|FG002|COMPLETED|First Treatment Period||2
11160401|NCT01584843|12348850|FG003|COMPLETED|First Treatment Period||10
11160402|NCT01584843|12348851|FG004|COMPLETED|First Treatment Period||10
11160403|NCT01584843|12348852|FG005|COMPLETED|First Treatment Period||9
11160404|NCT01584843|12348847|FG000|NOT COMPLETED|First Treatment Period||0
11160405|NCT01584843|12348848|FG001|NOT COMPLETED|First Treatment Period||0
11160406|NCT01584843|12348849|FG002|NOT COMPLETED|First Treatment Period||1
11160407|NCT01584843|12348850|FG003|NOT COMPLETED|First Treatment Period||0
11160408|NCT01584843|12348851|FG004|NOT COMPLETED|First Treatment Period||0
11160409|NCT01584843|12348852|FG005|NOT COMPLETED|First Treatment Period||2
11160410|NCT01584843|12348847|FG000|STARTED|Second Treatment Period||2
11160411|NCT01584843|12348848|FG001|STARTED|Second Treatment Period||1
11160412|NCT01584843|12348849|FG002|STARTED|Second Treatment Period||2
11160413|NCT01584843|12348850|FG003|STARTED|Second Treatment Period||6
11160414|NCT01584843|12348851|FG004|STARTED|Second Treatment Period||3
11160415|NCT01584843|12348852|FG005|STARTED|Second Treatment Period||1
11160416|NCT01584843|12348847|FG000|COMPLETED|Second Treatment Period||2
11160417|NCT01584843|12348848|FG001|COMPLETED|Second Treatment Period||1
11160418|NCT01584843|12348849|FG002|COMPLETED|Second Treatment Period||2
11160419|NCT01584843|12348850|FG003|COMPLETED|Second Treatment Period||6
11160420|NCT01584843|12348851|FG004|COMPLETED|Second Treatment Period||3
11160421|NCT01584843|12348852|FG005|COMPLETED|Second Treatment Period||0
11160422|NCT01584843|12348847|FG000|NOT COMPLETED|Second Treatment Period||0
11160423|NCT01584843|12348848|FG001|NOT COMPLETED|Second Treatment Period||0
11160424|NCT01584843|12348849|FG002|NOT COMPLETED|Second Treatment Period||0
11160425|NCT01584843|12348850|FG003|NOT COMPLETED|Second Treatment Period||0
11160426|NCT01584843|12348851|FG004|NOT COMPLETED|Second Treatment Period||0
11160427|NCT01584843|12348852|FG005|NOT COMPLETED|Second Treatment Period||1
11160428|NCT01585025|12348871|FG000|STARTED|Overall Study||10
11160429|NCT01585025|12348872|FG001|STARTED|Overall Study||13
11160430|NCT01585025|12348873|FG002|STARTED|Overall Study||12
11160431|NCT01585025|12348871|FG000|COMPLETED|Overall Study||10
11160432|NCT01585025|12348872|FG001|COMPLETED|Overall Study||10
11160433|NCT01585025|12348873|FG002|COMPLETED|Overall Study||8
11160434|NCT01585025|12348871|FG000|NOT COMPLETED|Overall Study||0
11160435|NCT01585025|12348872|FG001|NOT COMPLETED|Overall Study||3
11160436|NCT01585025|12348873|FG002|NOT COMPLETED|Overall Study||4
11160437|NCT01585038|12348883|FG000|STARTED|Overall Study||20
11160438|NCT01585038|12348884|FG001|STARTED|Overall Study||20
11160439|NCT01585038|12348883|FG000|COMPLETED|Overall Study||18
11160440|NCT01585038|12348884|FG001|COMPLETED|Overall Study||18
11160441|NCT01585038|12348883|FG000|NOT COMPLETED|Overall Study||2
11160442|NCT01585038|12348884|FG001|NOT COMPLETED|Overall Study||2
11160443|NCT01585129|12348892|FG000|STARTED|Overall Study||41
11160444|NCT01585129|12348893|FG001|STARTED|Overall Study||39
11160445|NCT01585129|12348892|FG000|COMPLETED|Overall Study||41
11160446|NCT01585129|12348893|FG001|COMPLETED|Overall Study||39
11160447|NCT01585129|12348892|FG000|NOT COMPLETED|Overall Study||0
11160448|NCT01585129|12348893|FG001|NOT COMPLETED|Overall Study||0
11160449|NCT01585155|12348899|FG000|STARTED|Overall Study||21
11160450|NCT01585155|12348899|FG000|COMPLETED|Overall Study||16
11160451|NCT01585155|12348899|FG000|NOT COMPLETED|Overall Study||5
11160452|NCT01585168|12348905|FG000|STARTED|Overall Study||18
11160453|NCT01585168|12348906|FG001|STARTED|Overall Study||18
11160454|NCT01585168|12348907|FG002|STARTED|Overall Study||16
11160455|NCT01585168|12348908|FG003|STARTED|Overall Study||19
11160456|NCT01585168|12348905|FG000|COMPLETED|Overall Study||15
11160457|NCT01585168|12348906|FG001|COMPLETED|Overall Study||17
11160458|NCT01585168|12348907|FG002|COMPLETED|Overall Study||15
11160459|NCT01585168|12348908|FG003|COMPLETED|Overall Study||18
11160460|NCT01585168|12348905|FG000|NOT COMPLETED|Overall Study||3
11160461|NCT01585168|12348906|FG001|NOT COMPLETED|Overall Study||1
11160462|NCT01585168|12348907|FG002|NOT COMPLETED|Overall Study||1
11160463|NCT01585168|12348908|FG003|NOT COMPLETED|Overall Study||1
11160464|NCT01585194|12348916|FG000|STARTED|Overall Study||39
11160465|NCT01585194|12348916|FG000|COMPLETED|Overall Study||35
11160466|NCT01585194|12348916|FG000|NOT COMPLETED|Overall Study||4
11160467|NCT01585207|12348920|FG000|STARTED|Overall Study||4
11160468|NCT01585207|12348920|FG000|COMPLETED|Overall Study||4
11160469|NCT01585207|12348920|FG000|NOT COMPLETED|Overall Study||0
11160470|NCT01585246|12348929|FG000|STARTED|Overall Study||3
11160471|NCT01585246|12348930|FG001|STARTED|Overall Study||4
11160472|NCT01585246|12348931|FG002|STARTED|Overall Study||20
11160473|NCT01585246|12348932|FG003|STARTED|Overall Study||10
11160474|NCT01585246|12348933|FG004|STARTED|Overall Study||11
11160475|NCT01585246|12348929|FG000|COMPLETED|Overall Study||3
11160476|NCT01585246|12348930|FG001|COMPLETED|Overall Study||3
11160477|NCT01585246|12348931|FG002|COMPLETED|Overall Study||16
11160478|NCT01585246|12348932|FG003|COMPLETED|Overall Study||6
11160479|NCT01585246|12348933|FG004|COMPLETED|Overall Study||9
11160480|NCT01585246|12348929|FG000|NOT COMPLETED|Overall Study||0
11160481|NCT01585246|12348930|FG001|NOT COMPLETED|Overall Study||1
11160482|NCT01585246|12348931|FG002|NOT COMPLETED|Overall Study||4
11160483|NCT01585246|12348932|FG003|NOT COMPLETED|Overall Study||4
11160484|NCT01585246|12348933|FG004|NOT COMPLETED|Overall Study||2
11160485|NCT01585272|12348948|FG000|STARTED|Overall Study||121
11160486|NCT01585272|12348948|FG000|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
11160487|NCT01585272|12348948|FG000|Exelon Patch 5 cm2|Overall Study||114
11160488|NCT01585272|12348948|FG000|Exelon Patch 10 cm2|Overall Study||96
11160489|NCT01585272|12348948|FG000|COMPLETED|Overall Study||82
11160490|NCT01585272|12348948|FG000|NOT COMPLETED|Overall Study||39
11160491|NCT01585298|12348952|FG000|STARTED|Overall Study||6998
11160492|NCT01585298|12348952|FG000|COMPLETED|Overall Study||6961
11160493|NCT01585298|12348952|FG000|NOT COMPLETED|Overall Study||37
11160494|NCT01585324|12348956|FG000|STARTED|Overall Study||30
11160495|NCT01585324|12348956|FG000|COMPLETED|Overall Study||30
11160496|NCT01585324|12348956|FG000|NOT COMPLETED|Overall Study||0
11160497|NCT01585428|12348964|FG000|STARTED|Overall Study||18
11160498|NCT01585428|12348965|FG001|STARTED|Overall Study||11
11160499|NCT01585428|12348964|FG000|COMPLETED|Overall Study||17
11160500|NCT01585428|12348965|FG001|COMPLETED|Overall Study||11
11160501|NCT01585428|12348964|FG000|NOT COMPLETED|Overall Study||1
11160502|NCT01585428|12348965|FG001|NOT COMPLETED|Overall Study||0
11160503|NCT01585441|12348974|FG000|STARTED|Overall Study||3
11160504|NCT01585441|12348975|FG001|STARTED|Overall Study||3
11160505|NCT01585441|12348974|FG000|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
11160506|NCT01585441|12348975|FG001|Month 3|Overall Study||3
11160507|NCT01585441|12348974|FG000|Received Finasteride at Month 3|Overall Study||2
11160508|NCT01585441|12348975|FG001|Received Finasteride at Month 3|Overall Study||2
11160509|NCT01585441|12348974|FG000|Final Study Safety Visit|Overall Study||3
11160510|NCT01585441|12348975|FG001|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
11160511|NCT01585441|12348974|FG000|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
11160512|NCT01585441|12348975|FG001|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
11160513|NCT01585441|12348974|FG000|NOT COMPLETED|Overall Study||0
11160514|NCT01585441|12348975|FG001|NOT COMPLETED|Overall Study||0
11160515|NCT01585558|12348984|FG000|STARTED|Overall Study||62
11160516|NCT01585558|12348985|FG001|STARTED|Overall Study||69
11160517|NCT01585558|12348986|FG002|STARTED|Overall Study||49
11160518|NCT01585558|12348984|FG000|COMPLETED|Overall Study||49
11160519|NCT01585558|12348985|FG001|COMPLETED|Overall Study||57
11160520|NCT01585558|12348986|FG002|COMPLETED|Overall Study||34
11160521|NCT01585558|12348984|FG000|NOT COMPLETED|Overall Study||13
11160522|NCT01585558|12348985|FG001|NOT COMPLETED|Overall Study||12
11160523|NCT01585558|12348986|FG002|NOT COMPLETED|Overall Study||15
11160524|NCT01585584|12348994|FG000|STARTED|Overall Study||10
11160525|NCT01585584|12348994|FG000|COMPLETED|Overall Study||6
11160526|NCT01585584|12348994|FG000|NOT COMPLETED|Overall Study||4
11160527|NCT01585597|12348998|FG000|STARTED|Overall Study||20
11160528|NCT01585597|12348998|FG000|COMPLETED|Overall Study||20
11160529|NCT01585597|12348998|FG000|NOT COMPLETED|Overall Study||0
11160530|NCT01585766|12349008|FG000|STARTED|Overall Study||7
11160531|NCT01585766|12349009|FG001|STARTED|Overall Study||5
11160532|NCT01585766|12349010|FG002|STARTED|Overall Study||3
11160533|NCT01585766|12349011|FG003|STARTED|Overall Study||4
11160534|NCT01585766|12349012|FG004|STARTED|Overall Study||3
11160535|NCT01585766|12349013|FG005|STARTED|Overall Study||6
11160536|NCT01585766|12349008|FG000|COMPLETED|Overall Study||7
11160537|NCT01585766|12349009|FG001|COMPLETED|Overall Study||3
11160538|NCT01585766|12349010|FG002|COMPLETED|Overall Study||1
11160539|NCT01585766|12349011|FG003|COMPLETED|Overall Study||4
11160540|NCT01585766|12349012|FG004|COMPLETED|Overall Study||3
11160541|NCT01585766|12349013|FG005|COMPLETED|Overall Study||6
11160542|NCT01585766|12349008|FG000|NOT COMPLETED|Overall Study||0
11343023|NCT02950545|12540318|FG001|STARTED|Session 3 (70 Minutes)||9
11160543|NCT01585766|12349009|FG001|NOT COMPLETED|Overall Study||2
11160544|NCT01585766|12349010|FG002|NOT COMPLETED|Overall Study||2
11160545|NCT01585766|12349011|FG003|NOT COMPLETED|Overall Study||0
11160546|NCT01585766|12349012|FG004|NOT COMPLETED|Overall Study||0
11160547|NCT01585766|12349013|FG005|NOT COMPLETED|Overall Study||0
11160548|NCT01585779|12349036|FG000|STARTED|Overall Study||36
11160549|NCT01585779|12349037|FG001|STARTED|Overall Study||28
11160550|NCT01585779|12349036|FG000|COMPLETED|Overall Study||26
11160551|NCT01585779|12349037|FG001|COMPLETED|Overall Study||21
11160552|NCT01585779|12349036|FG000|NOT COMPLETED|Overall Study||10
11160553|NCT01585779|12349037|FG001|NOT COMPLETED|Overall Study||7
11160554|NCT01585831|12349046|FG000|STARTED|Overall Study||28
11160555|NCT01585831|12349047|FG001|STARTED|Overall Study||20
11160556|NCT01585831|12349046|FG000|COMPLETED|Overall Study||26
11160557|NCT01585831|12349047|FG001|COMPLETED|Overall Study||18
11160558|NCT01585831|12349046|FG000|NOT COMPLETED|Overall Study||2
11160559|NCT01585831|12349047|FG001|NOT COMPLETED|Overall Study||2
11160560|NCT01585961|12349053|FG000|STARTED|Overall Study||511
11160561|NCT01585961|12349053|FG000|Safety|Overall Study|Patients ablated with study catheter|508
11160562|NCT01585961|12349053|FG000|COMPLETED|Overall Study||478
11160563|NCT01585961|12349053|FG000|NOT COMPLETED|Overall Study||33
11160564|NCT01585987|12349059|FG000|STARTED|Randomized||57
11160565|NCT01585987|12349060|FG001|STARTED|Randomized||57
11160566|NCT01585987|12349059|FG000|COMPLETED|Randomized||57
11160567|NCT01585987|12349060|FG001|COMPLETED|Randomized||51
11160568|NCT01585987|12349059|FG000|NOT COMPLETED|Randomized||0
11160569|NCT01585987|12349060|FG001|NOT COMPLETED|Randomized||6
11160570|NCT01585987|12349059|FG000|STARTED|Treated||57
11160571|NCT01585987|12349060|FG001|STARTED|Treated||51
11160572|NCT01585987|12349059|FG000|COMPLETED|Treated||3
11160573|NCT01585987|12349060|FG001|COMPLETED|Treated||2
11160574|NCT01585987|12349059|FG000|NOT COMPLETED|Treated||54
11160575|NCT01585987|12349060|FG001|NOT COMPLETED|Treated||49
11160576|NCT01586026|12349067|FG000|STARTED|Overall Study||350
11160577|NCT01586026|12349068|FG001|STARTED|Overall Study||414
11160578|NCT01586026|12349069|FG002|STARTED|Overall Study||271
11160579|NCT01586026|12349067|FG000|COMPLETED|Overall Study||350
11160580|NCT01586026|12349068|FG001|COMPLETED|Overall Study||414
11160581|NCT01586026|12349069|FG002|COMPLETED|Overall Study||271
11160582|NCT01586026|12349067|FG000|NOT COMPLETED|Overall Study||0
11160583|NCT01586026|12349068|FG001|NOT COMPLETED|Overall Study||0
11160584|NCT01586026|12349069|FG002|NOT COMPLETED|Overall Study||0
11160585|NCT01586039|12349081|FG000|STARTED|Overall Study||8
11160586|NCT01586039|12349082|FG001|STARTED|Overall Study||9
11160587|NCT01586039|12349083|FG002|STARTED|Overall Study||8
11160588|NCT01586039|12349084|FG003|STARTED|Overall Study||8
11160589|NCT01586039|12349081|FG000|COMPLETED|Overall Study||8
11160590|NCT01586039|12349082|FG001|COMPLETED|Overall Study||8
11160591|NCT01586039|12349083|FG002|COMPLETED|Overall Study||8
11160592|NCT01586039|12349084|FG003|COMPLETED|Overall Study||8
11160593|NCT01586039|12349081|FG000|NOT COMPLETED|Overall Study||0
11160594|NCT01586039|12349082|FG001|NOT COMPLETED|Overall Study||1
11160595|NCT01586039|12349083|FG002|NOT COMPLETED|Overall Study||0
11160596|NCT01586039|12349084|FG003|NOT COMPLETED|Overall Study||0
11160597|NCT01586091|12349097|FG000|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
11160598|NCT01586091|12349098|FG001|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
11160599|NCT01586091|12349099|FG002|STARTED|Overall Study||6
11160600|NCT01586091|12349097|FG000|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
11160601|NCT01586091|12349098|FG001|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
11160602|NCT01586091|12349099|FG002|COMPLETED|Overall Study||6
11160603|NCT01586091|12349097|FG000|NOT COMPLETED|Overall Study||0
11160604|NCT01586091|12349098|FG001|NOT COMPLETED|Overall Study||0
11160605|NCT01586091|12349099|FG002|NOT COMPLETED|Overall Study||0
11160606|NCT01586156|12349113|FG000|STARTED|Overall Study||10
11160607|NCT01586156|12349114|FG001|STARTED|Overall Study||10
11160608|NCT01586156|12349115|FG002|STARTED|Overall Study||10
11160609|NCT01586156|12349113|FG000|COMPLETED|Overall Study||10
11419199|NCT00281879|12617654|FG000|COMPLETED|Overall Study||0
11419200|NCT00281879|12617655|FG001|COMPLETED|Overall Study||0
11160610|NCT01586156|12349114|FG001|COMPLETED|Overall Study||9
11160611|NCT01586156|12349115|FG002|COMPLETED|Overall Study||10
11160612|NCT01586156|12349113|FG000|NOT COMPLETED|Overall Study||0
11160613|NCT01586156|12349114|FG001|NOT COMPLETED|Overall Study||1
11160614|NCT01586156|12349115|FG002|NOT COMPLETED|Overall Study||0
11160615|NCT01586195|12349123|FG000|STARTED|Overall Study||31
11160616|NCT01586195|12349123|FG000|COMPLETED|Overall Study||5
11160617|NCT01586195|12349123|FG000|NOT COMPLETED|Overall Study||26
11160618|NCT01586312|12349129|FG000|STARTED|Overall Study||15
11160619|NCT01586312|12349130|FG001|STARTED|Overall Study||15
11160620|NCT01586312|12349129|FG000|COMPLETED|Overall Study||15
11160621|NCT01586312|12349130|FG001|COMPLETED|Overall Study||15
11160622|NCT01586312|12349129|FG000|NOT COMPLETED|Overall Study||0
11160623|NCT01586312|12349130|FG001|NOT COMPLETED|Overall Study||0
11160624|NCT01586338|12349136|FG000|STARTED|Overall Study||237
11160625|NCT01586338|12349136|FG000|COMPLETED|Overall Study||229
11419201|NCT00281879|12617656|FG002|COMPLETED|Overall Study||0
11160626|NCT01586338|12349136|FG000|NOT COMPLETED|Overall Study||8
11160627|NCT01586364|12349140|FG000|STARTED|Overall Study||301
11160628|NCT01586364|12349140|FG000|COMPLETED|Overall Study||184
11160629|NCT01586364|12349140|FG000|NOT COMPLETED|Overall Study||117
11160630|NCT01586624|12349152|FG000|STARTED|Overall Study||6
11160631|NCT01586624|12349153|FG001|STARTED|Overall Study||6
11160632|NCT01586624|12349154|FG002|STARTED|Overall Study||6
11160633|NCT01586624|12349155|FG003|STARTED|Overall Study||7
11160634|NCT01586624|12349156|FG004|STARTED|Overall Study||9
11160635|NCT01586624|12349157|FG005|STARTED|Overall Study||8
11160636|NCT01586624|12349158|FG006|STARTED|Overall Study||8
11160637|NCT01586624|12349159|FG007|STARTED|Overall Study||11
11160638|NCT01586624|12349152|FG000|COMPLETED|Overall Study||2
11160639|NCT01586624|12349153|FG001|COMPLETED|Overall Study||2
11160640|NCT01586624|12349154|FG002|COMPLETED|Overall Study||1
11160641|NCT01586624|12349155|FG003|COMPLETED|Overall Study||0
11160642|NCT01586624|12349156|FG004|COMPLETED|Overall Study||1
11160643|NCT01586624|12349157|FG005|COMPLETED|Overall Study||0
11160644|NCT01586624|12349158|FG006|COMPLETED|Overall Study||0
11160645|NCT01586624|12349159|FG007|COMPLETED|Overall Study||1
11160646|NCT01586624|12349152|FG000|NOT COMPLETED|Overall Study||4
11160647|NCT01586624|12349153|FG001|NOT COMPLETED|Overall Study||4
11160648|NCT01586624|12349154|FG002|NOT COMPLETED|Overall Study||5
11160649|NCT01586624|12349155|FG003|NOT COMPLETED|Overall Study||7
11160650|NCT01586624|12349156|FG004|NOT COMPLETED|Overall Study||8
11160651|NCT01586624|12349157|FG005|NOT COMPLETED|Overall Study||8
11160652|NCT01586624|12349158|FG006|NOT COMPLETED|Overall Study||8
11160653|NCT01586624|12349159|FG007|NOT COMPLETED|Overall Study||10
11160654|NCT01586741|12349181|FG000|STARTED|Overall Study||28
11160655|NCT01586741|12349182|FG001|STARTED|Overall Study||29
11160656|NCT01586741|12349183|FG002|STARTED|Overall Study||32
11160657|NCT01586741|12349181|FG000|COMPLETED|Overall Study||27
11160658|NCT01586741|12349182|FG001|COMPLETED|Overall Study||29
11160659|NCT01586741|12349183|FG002|COMPLETED|Overall Study||30
11160660|NCT01586741|12349181|FG000|NOT COMPLETED|Overall Study||1
11160661|NCT01586741|12349182|FG001|NOT COMPLETED|Overall Study||0
11160662|NCT01586741|12349183|FG002|NOT COMPLETED|Overall Study||2
11160663|NCT01586806|12349194|FG000|STARTED|Overall Study||65
11160664|NCT01586806|12349195|FG001|STARTED|Overall Study||65
11160665|NCT01586806|12349196|FG002|STARTED|Overall Study||65
11160666|NCT01586806|12349194|FG000|COMPLETED|Overall Study||62
11160667|NCT01586806|12349195|FG001|COMPLETED|Overall Study||61
11160668|NCT01586806|12349196|FG002|COMPLETED|Overall Study||63
11160669|NCT01586806|12349194|FG000|NOT COMPLETED|Overall Study||3
11160670|NCT01586806|12349195|FG001|NOT COMPLETED|Overall Study||4
11160671|NCT01586806|12349196|FG002|NOT COMPLETED|Overall Study||2
11203403|NCT01847131|12393956|FG001|COMPLETED|Overall Study||25
11203404|NCT01847131|12393955|FG000|NOT COMPLETED|Overall Study||0
11203405|NCT01847131|12393956|FG001|NOT COMPLETED|Overall Study||0
11203406|NCT01847196|12393962|FG000|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
11203407|NCT01847196|12393962|FG000|COMPLETED|Overall Study||5
11203408|NCT01847196|12393962|FG000|NOT COMPLETED|Overall Study||0
11203409|NCT01847209|12393966|FG000|STARTED|Overall Study||25
11203410|NCT01847209|12393966|FG000|COMPLETED|Overall Study||23
11203411|NCT01847209|12393966|FG000|NOT COMPLETED|Overall Study||2
11203412|NCT01847313|12393972|FG000|STARTED|Overall Study||10
11203413|NCT01847313|12393973|FG001|STARTED|Overall Study||10
11419202|NCT00281879|12617657|FG003|COMPLETED|Overall Study||0
11419203|NCT00281879|12617658|FG004|COMPLETED|Overall Study||0
11419204|NCT00281879|12617659|FG005|COMPLETED|Overall Study||0
11419205|NCT00281879|12617660|FG006|COMPLETED|Overall Study||0
11419206|NCT00281879|12617661|FG007|COMPLETED|Overall Study||0
11419207|NCT00281879|12617654|FG000|NOT COMPLETED|Overall Study||128
11203414|NCT01847313|12393972|FG000|COMPLETED|Overall Study||10
11203415|NCT01847313|12393973|FG001|COMPLETED|Overall Study||8
11203416|NCT01847313|12393972|FG000|NOT COMPLETED|Overall Study||0
11203417|NCT01847313|12393973|FG001|NOT COMPLETED|Overall Study||2
11203418|NCT01847430|12393979|FG000|STARTED|Overall Study||302
11203419|NCT01847430|12393979|FG000|COMPLETED|Overall Study||302
11203420|NCT01847430|12393979|FG000|NOT COMPLETED|Overall Study||0
11203421|NCT01847443|12393983|FG000|STARTED|Study Period 1||21
11203422|NCT01847443|12393984|FG001|STARTED|Study Period 1||21
11203423|NCT01847443|12393985|FG002|STARTED|Study Period 1||21
11203424|NCT01847443|12393986|FG003|STARTED|Study Period 1||21
11203425|NCT01847443|12393983|FG000|COMPLETED|Study Period 1||21
11203426|NCT01847443|12393984|FG001|COMPLETED|Study Period 1||20
11203427|NCT01847443|12393985|FG002|COMPLETED|Study Period 1||21
11203428|NCT01847443|12393986|FG003|COMPLETED|Study Period 1||21
11203429|NCT01847443|12393983|FG000|NOT COMPLETED|Study Period 1||0
11203430|NCT01847443|12393984|FG001|NOT COMPLETED|Study Period 1||1
11203431|NCT01847443|12393985|FG002|NOT COMPLETED|Study Period 1||0
11203432|NCT01847443|12393986|FG003|NOT COMPLETED|Study Period 1||0
11323176|NCT01084252|12520465|FG008|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|23
11323177|NCT01084252|12520466|FG009|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|24
11323178|NCT01084252|12520467|FG010|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
11323179|NCT01084252|12520468|FG011|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
11323180|NCT01084252|12520469|FG012|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323181|NCT01084252|12520470|FG013|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11203433|NCT01847443|12393983|FG000|STARTED|Washout Period Before Study Period 2||21
11203434|NCT01847443|12393984|FG001|STARTED|Washout Period Before Study Period 2||20
11203435|NCT01847443|12393985|FG002|STARTED|Washout Period Before Study Period 2||21
11203436|NCT01847443|12393986|FG003|STARTED|Washout Period Before Study Period 2||21
11203437|NCT01847443|12393983|FG000|COMPLETED|Washout Period Before Study Period 2||19
11203438|NCT01847443|12393984|FG001|COMPLETED|Washout Period Before Study Period 2||19
11203439|NCT01847443|12393985|FG002|COMPLETED|Washout Period Before Study Period 2||21
11203440|NCT01847443|12393986|FG003|COMPLETED|Washout Period Before Study Period 2||21
11203441|NCT01847443|12393983|FG000|NOT COMPLETED|Washout Period Before Study Period 2||2
11203442|NCT01847443|12393984|FG001|NOT COMPLETED|Washout Period Before Study Period 2||1
11203443|NCT01847443|12393985|FG002|NOT COMPLETED|Washout Period Before Study Period 2||0
11203444|NCT01847443|12393986|FG003|NOT COMPLETED|Washout Period Before Study Period 2||0
11203445|NCT01847443|12393983|FG000|STARTED|Study Period 2||19
11203446|NCT01847443|12393984|FG001|STARTED|Study Period 2||19
11203447|NCT01847443|12393985|FG002|STARTED|Study Period 2||21
11203448|NCT01847443|12393986|FG003|STARTED|Study Period 2||21
11203449|NCT01847443|12393983|FG000|COMPLETED|Study Period 2||19
11203450|NCT01847443|12393984|FG001|COMPLETED|Study Period 2||19
11203451|NCT01847443|12393985|FG002|COMPLETED|Study Period 2||21
11203452|NCT01847443|12393986|FG003|COMPLETED|Study Period 2||21
11203453|NCT01847443|12393983|FG000|NOT COMPLETED|Study Period 2||0
11203454|NCT01847443|12393984|FG001|NOT COMPLETED|Study Period 2||0
11203455|NCT01847443|12393985|FG002|NOT COMPLETED|Study Period 2||0
11203456|NCT01847443|12393986|FG003|NOT COMPLETED|Study Period 2||0
11203457|NCT01847443|12393983|FG000|STARTED|Washout Period Before Study Period 3||19
11203458|NCT01847443|12393984|FG001|STARTED|Washout Period Before Study Period 3||19
11203459|NCT01847443|12393985|FG002|STARTED|Washout Period Before Study Period 3||21
11203460|NCT01847443|12393986|FG003|STARTED|Washout Period Before Study Period 3||21
11203461|NCT01847443|12393983|FG000|COMPLETED|Washout Period Before Study Period 3||18
11203462|NCT01847443|12393984|FG001|COMPLETED|Washout Period Before Study Period 3||19
11203463|NCT01847443|12393985|FG002|COMPLETED|Washout Period Before Study Period 3||21
11203464|NCT01847443|12393986|FG003|COMPLETED|Washout Period Before Study Period 3||21
11203465|NCT01847443|12393983|FG000|NOT COMPLETED|Washout Period Before Study Period 3||1
11203466|NCT01847443|12393984|FG001|NOT COMPLETED|Washout Period Before Study Period 3||0
11203467|NCT01847443|12393985|FG002|NOT COMPLETED|Washout Period Before Study Period 3||0
11203468|NCT01847443|12393986|FG003|NOT COMPLETED|Washout Period Before Study Period 3||0
11160672|NCT01586819|12349206|FG000|STARTED|Overall Study||12
11160673|NCT01586819|12349207|FG001|STARTED|Overall Study||14
11160674|NCT01586819|12349206|FG000|COMPLETED|Overall Study||11
11160675|NCT01586819|12349207|FG001|COMPLETED|Overall Study||14
11160676|NCT01586819|12349206|FG000|NOT COMPLETED|Overall Study||1
11160677|NCT01586819|12349207|FG001|NOT COMPLETED|Overall Study||0
11160678|NCT01586871|12349216|FG000|STARTED|Overall Study||560
11160679|NCT01586871|12349217|FG001|STARTED|Overall Study||554
11160680|NCT01586871|12349218|FG002|STARTED|Overall Study||33
11160681|NCT01586871|12349216|FG000|COMPLETED|Overall Study||560
11160682|NCT01586871|12349217|FG001|COMPLETED|Overall Study||554
11160683|NCT01586871|12349218|FG002|COMPLETED|Overall Study||33
11160684|NCT01586871|12349216|FG000|NOT COMPLETED|Overall Study||0
11160685|NCT01586871|12349217|FG001|NOT COMPLETED|Overall Study||0
11160686|NCT01586871|12349218|FG002|NOT COMPLETED|Overall Study||0
11160687|NCT01586897|12349228|FG000|STARTED|Overall Study||26
11160688|NCT01586897|12349229|FG001|STARTED|Overall Study||26
11160689|NCT01586897|12349228|FG000|COMPLETED|Overall Study||26
11160690|NCT01586897|12349229|FG001|COMPLETED|Overall Study||26
11160691|NCT01586897|12349228|FG000|NOT COMPLETED|Overall Study||0
11160692|NCT01586897|12349229|FG001|NOT COMPLETED|Overall Study||0
11160693|NCT01586962|12349237|FG000|STARTED|Overall Study||56
11160694|NCT01586962|12349237|FG000|COMPLETED|Overall Study||56
11160695|NCT01586962|12349237|FG000|NOT COMPLETED|Overall Study||0
11160696|NCT01586975|12349244|FG000|STARTED|Overall Study||15
11160697|NCT01586975|12349245|FG001|STARTED|Overall Study||32
11160698|NCT01586975|12349246|FG002|STARTED|Overall Study||46
11160699|NCT01586975|12349244|FG000|COMPLETED|Overall Study||15
11160700|NCT01586975|12349245|FG001|COMPLETED|Overall Study||32
11419208|NCT00281879|12617655|FG001|NOT COMPLETED|Overall Study||36
11419209|NCT00281879|12617656|FG002|NOT COMPLETED|Overall Study||20
11419210|NCT00281879|12617657|FG003|NOT COMPLETED|Overall Study||0
11419211|NCT00281879|12617658|FG004|NOT COMPLETED|Overall Study||6
11160701|NCT01586975|12349246|FG002|COMPLETED|Overall Study||46
11160702|NCT01586975|12349244|FG000|NOT COMPLETED|Overall Study||0
11160703|NCT01586975|12349245|FG001|NOT COMPLETED|Overall Study||0
11160704|NCT01586975|12349246|FG002|NOT COMPLETED|Overall Study||0
11160705|NCT01587001|12349256|FG000|STARTED|Overall Study||14
11160706|NCT01587001|12349257|FG001|STARTED|Overall Study||3
11160707|NCT01587001|12349256|FG000|COMPLETED|Overall Study||8
11160708|NCT01587001|12349257|FG001|COMPLETED|Overall Study||2
11160709|NCT01587001|12349256|FG000|NOT COMPLETED|Overall Study||6
11160710|NCT01587001|12349257|FG001|NOT COMPLETED|Overall Study||1
11160711|NCT01587014|12349264|FG000|STARTED|Overall Study||26
11160712|NCT01587014|12349264|FG000|COMPLETED|Overall Study||24
11160713|NCT01587014|12349264|FG000|NOT COMPLETED|Overall Study||2
11160714|NCT01587027|12349270|FG000|STARTED|First Intervention (1 Day)||8
11160715|NCT01587027|12349271|FG001|STARTED|First Intervention (1 Day)||8
11160716|NCT01587027|12349270|FG000|COMPLETED|First Intervention (1 Day)||8
11160717|NCT01587027|12349271|FG001|COMPLETED|First Intervention (1 Day)||8
11160718|NCT01587027|12349270|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11160719|NCT01587027|12349271|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11160720|NCT01587027|12349270|FG000|STARTED|Washout (1 Day)||8
11160721|NCT01587027|12349271|FG001|STARTED|Washout (1 Day)||8
11160722|NCT01587027|12349270|FG000|COMPLETED|Washout (1 Day)||8
11160723|NCT01587027|12349271|FG001|COMPLETED|Washout (1 Day)||8
11160724|NCT01587027|12349270|FG000|NOT COMPLETED|Washout (1 Day)||0
11160725|NCT01587027|12349271|FG001|NOT COMPLETED|Washout (1 Day)||0
11160726|NCT01587027|12349270|FG000|STARTED|Second Intervention (1 Day)||8
11160727|NCT01587027|12349271|FG001|STARTED|Second Intervention (1 Day)||8
11160728|NCT01587027|12349270|FG000|COMPLETED|Second Intervention (1 Day)||8
11160729|NCT01587027|12349271|FG001|COMPLETED|Second Intervention (1 Day)||8
11160730|NCT01587027|12349270|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11160731|NCT01587027|12349271|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11160732|NCT01587027|12349270|FG000|STARTED|Washout (1 Day)||8
11160733|NCT01587027|12349271|FG001|STARTED|Washout (1 Day)||8
11160734|NCT01587027|12349270|FG000|COMPLETED|Washout (1 Day)||8
11160735|NCT01587027|12349271|FG001|COMPLETED|Washout (1 Day)||8
11160736|NCT01587027|12349270|FG000|NOT COMPLETED|Washout (1 Day)||0
11160737|NCT01587027|12349271|FG001|NOT COMPLETED|Washout (1 Day)||0
11160738|NCT01587027|12349270|FG000|STARTED|Third Intervention (1 Day)||8
11160739|NCT01587027|12349271|FG001|STARTED|Third Intervention (1 Day)||8
11160740|NCT01587027|12349270|FG000|COMPLETED|Third Intervention (1 Day)||8
11160741|NCT01587027|12349271|FG001|COMPLETED|Third Intervention (1 Day)||8
11160742|NCT01587027|12349270|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11160743|NCT01587027|12349271|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11160744|NCT01587027|12349270|FG000|STARTED|Discharge (1 Day)||8
11160745|NCT01587027|12349271|FG001|STARTED|Discharge (1 Day)||8
11160746|NCT01587027|12349270|FG000|COMPLETED|Discharge (1 Day)||8
11160747|NCT01587027|12349271|FG001|COMPLETED|Discharge (1 Day)||8
11160748|NCT01587027|12349270|FG000|NOT COMPLETED|Discharge (1 Day)||0
11160749|NCT01587027|12349271|FG001|NOT COMPLETED|Discharge (1 Day)||0
11160750|NCT01587079|12349277|FG000|STARTED|Overall Study||159
11160751|NCT01587079|12349277|FG000|COMPLETED|Overall Study||120
11160752|NCT01587079|12349277|FG000|NOT COMPLETED|Overall Study||39
11160753|NCT01587105|12349313|FG000|STARTED|Overall Study||150
11160754|NCT01587105|12349314|FG001|STARTED|Overall Study||181
11160755|NCT01587105|12349313|FG000|COMPLETED|Overall Study||144
11160756|NCT01587105|12349314|FG001|COMPLETED|Overall Study||138
11160757|NCT01587105|12349313|FG000|NOT COMPLETED|Overall Study||6
11160758|NCT01587105|12349314|FG001|NOT COMPLETED|Overall Study||43
11160759|NCT01587118|12349320|FG000|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
11160760|NCT01587118|12349320|FG000|COMPLETED|Overall Study||11
11160761|NCT01587118|12349320|FG000|NOT COMPLETED|Overall Study||7
11160762|NCT01587274|12349327|FG000|STARTED|Overall Study||108
11160763|NCT01587274|12349328|FG001|STARTED|Overall Study||108
11160764|NCT01587274|12349329|FG002|STARTED|Overall Study||107
11160765|NCT01587274|12349327|FG000|COMPLETED|Overall Study||104
11160766|NCT01587274|12349328|FG001|COMPLETED|Overall Study||103
11160767|NCT01587274|12349329|FG002|COMPLETED|Overall Study||104
11160768|NCT01587274|12349327|FG000|NOT COMPLETED|Overall Study||4
11160769|NCT01587274|12349328|FG001|NOT COMPLETED|Overall Study||5
11160770|NCT01587274|12349329|FG002|NOT COMPLETED|Overall Study||3
11160771|NCT01587651|12349340|FG000|STARTED|Overall Study||34
11160772|NCT01587651|12349341|FG001|STARTED|Overall Study||41
11160773|NCT01587651|12349342|FG002|STARTED|Overall Study||35
11160774|NCT01587651|12349340|FG000|COMPLETED|Overall Study||34
11160775|NCT01587651|12349341|FG001|COMPLETED|Overall Study||38
11160776|NCT01587651|12349342|FG002|COMPLETED|Overall Study||34
11160777|NCT01587651|12349340|FG000|NOT COMPLETED|Overall Study||0
11160778|NCT01587651|12349341|FG001|NOT COMPLETED|Overall Study||3
11160779|NCT01587651|12349342|FG002|NOT COMPLETED|Overall Study||1
11160780|NCT01587703|12349369|FG000|STARTED|Part1 QD(Median Exposure of 1.38months)||3
11160781|NCT01587703|12349370|FG001|STARTED|Part1 QD(Median Exposure of 1.38months)||4
11160782|NCT01587703|12349371|FG002|STARTED|Part1 QD(Median Exposure of 1.38months)||1
11160783|NCT01587703|12349372|FG003|STARTED|Part1 QD(Median Exposure of 1.38months)||3
11160784|NCT01587703|12349373|FG004|STARTED|Part1 QD(Median Exposure of 1.38months)||4
11160785|NCT01587703|12349374|FG005|STARTED|Part1 QD(Median Exposure of 1.38months)||9
11160786|NCT01587703|12349375|FG006|STARTED|Part1 QD(Median Exposure of 1.38months)||32
11160787|NCT01587703|12349376|FG007|STARTED|Part1 QD(Median Exposure of 1.38months)||9
11160788|NCT01587703|12349377|FG008|STARTED|Part1 QD(Median Exposure of 1.38months)||0
11160789|NCT01587703|12349378|FG009|STARTED|Part1 QD(Median Exposure of 1.38months)||0
11160790|NCT01587703|12349379|FG010|STARTED|Part1 QD(Median Exposure of 1.38months)||0
11160791|NCT01587703|12349380|FG011|STARTED|Part1 QD(Median Exposure of 1.38months)||0
11160792|NCT01587703|12349381|FG012|STARTED|Part1 QD(Median Exposure of 1.38months)||0
11160793|NCT01587703|12349382|FG013|STARTED|Part1 QD(Median Exposure of 1.38months)||0
11160794|NCT01587703|12349383|FG014|STARTED|Part1 QD(Median Exposure of 1.38months)||0
11160795|NCT01587703|12349384|FG015|STARTED|Part1 QD(Median Exposure of 1.38months)||0
11160796|NCT01587703|12349385|FG016|STARTED|Part1 QD(Median Exposure of 1.38months)||0
11160797|NCT01587703|12349386|FG017|STARTED|Part1 QD(Median Exposure of 1.38months)||0
11160798|NCT01587703|12349387|FG018|STARTED|Part1 QD(Median Exposure of 1.38months)||0
11160799|NCT01587703|12349369|FG000|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160800|NCT01587703|12349370|FG001|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160801|NCT01587703|12349371|FG002|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160802|NCT01587703|12349372|FG003|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160803|NCT01587703|12349373|FG004|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160804|NCT01587703|12349374|FG005|COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
11160805|NCT01587703|12349375|FG006|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160806|NCT01587703|12349376|FG007|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160807|NCT01587703|12349377|FG008|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160808|NCT01587703|12349378|FG009|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160809|NCT01587703|12349379|FG010|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160810|NCT01587703|12349380|FG011|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160811|NCT01587703|12349381|FG012|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160812|NCT01587703|12349382|FG013|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160813|NCT01587703|12349383|FG014|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160814|NCT01587703|12349384|FG015|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160815|NCT01587703|12349385|FG016|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160816|NCT01587703|12349386|FG017|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160817|NCT01587703|12349387|FG018|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160818|NCT01587703|12349369|FG000|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
11160819|NCT01587703|12349370|FG001|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
11160820|NCT01587703|12349371|FG002|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
11160821|NCT01587703|12349372|FG003|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
11160822|NCT01587703|12349373|FG004|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
11160823|NCT01587703|12349374|FG005|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||8
11160824|NCT01587703|12349375|FG006|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||32
11160825|NCT01587703|12349376|FG007|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||9
11160826|NCT01587703|12349377|FG008|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160827|NCT01587703|12349378|FG009|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160828|NCT01587703|12349379|FG010|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160829|NCT01587703|12349380|FG011|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160830|NCT01587703|12349381|FG012|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160831|NCT01587703|12349382|FG013|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160832|NCT01587703|12349383|FG014|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160833|NCT01587703|12349384|FG015|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160834|NCT01587703|12349385|FG016|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11203469|NCT01847443|12393983|FG000|STARTED|Study Period 3||18
11160835|NCT01587703|12349386|FG017|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160836|NCT01587703|12349387|FG018|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
11160837|NCT01587703|12349369|FG000|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160838|NCT01587703|12349370|FG001|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160839|NCT01587703|12349371|FG002|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160840|NCT01587703|12349372|FG003|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160841|NCT01587703|12349373|FG004|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160842|NCT01587703|12349374|FG005|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160843|NCT01587703|12349375|FG006|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160844|NCT01587703|12349376|FG007|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160845|NCT01587703|12349377|FG008|STARTED|Part1 BID(Median Exposure of 1.41months)||4
11160846|NCT01587703|12349378|FG009|STARTED|Part1 BID(Median Exposure of 1.41months)||10
11160847|NCT01587703|12349379|FG010|STARTED|Part1 BID(Median Exposure of 1.41months)||5
11160848|NCT01587703|12349380|FG011|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160849|NCT01587703|12349381|FG012|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160850|NCT01587703|12349382|FG013|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160851|NCT01587703|12349383|FG014|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160852|NCT01587703|12349384|FG015|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160853|NCT01587703|12349385|FG016|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160854|NCT01587703|12349386|FG017|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160855|NCT01587703|12349387|FG018|STARTED|Part1 BID(Median Exposure of 1.41months)||0
11160856|NCT01587703|12349369|FG000|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160857|NCT01587703|12349370|FG001|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160858|NCT01587703|12349371|FG002|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160859|NCT01587703|12349372|FG003|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160860|NCT01587703|12349373|FG004|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160861|NCT01587703|12349374|FG005|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160862|NCT01587703|12349375|FG006|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160863|NCT01587703|12349376|FG007|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160864|NCT01587703|12349377|FG008|COMPLETED|Part1 BID(Median Exposure of 1.41months)||1
11160865|NCT01587703|12349378|FG009|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160866|NCT01587703|12349379|FG010|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160867|NCT01587703|12349380|FG011|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160868|NCT01587703|12349381|FG012|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160869|NCT01587703|12349382|FG013|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160870|NCT01587703|12349383|FG014|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160871|NCT01587703|12349384|FG015|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160872|NCT01587703|12349385|FG016|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160873|NCT01587703|12349386|FG017|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160874|NCT01587703|12349387|FG018|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160875|NCT01587703|12349369|FG000|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160876|NCT01587703|12349370|FG001|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160877|NCT01587703|12349371|FG002|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160878|NCT01587703|12349372|FG003|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160879|NCT01587703|12349373|FG004|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160880|NCT01587703|12349374|FG005|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160881|NCT01587703|12349375|FG006|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160882|NCT01587703|12349376|FG007|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160883|NCT01587703|12349377|FG008|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||3
11160884|NCT01587703|12349378|FG009|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||10
11160885|NCT01587703|12349379|FG010|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||5
11160886|NCT01587703|12349380|FG011|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160887|NCT01587703|12349381|FG012|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160888|NCT01587703|12349382|FG013|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160889|NCT01587703|12349383|FG014|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160890|NCT01587703|12349384|FG015|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160891|NCT01587703|12349385|FG016|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160892|NCT01587703|12349386|FG017|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160893|NCT01587703|12349387|FG018|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
11160894|NCT01587703|12349369|FG000|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160895|NCT01587703|12349370|FG001|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160896|NCT01587703|12349371|FG002|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160897|NCT01587703|12349372|FG003|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160898|NCT01587703|12349373|FG004|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160899|NCT01587703|12349374|FG005|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160900|NCT01587703|12349375|FG006|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160901|NCT01587703|12349376|FG007|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160902|NCT01587703|12349377|FG008|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160903|NCT01587703|12349378|FG009|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160904|NCT01587703|12349379|FG010|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160905|NCT01587703|12349380|FG011|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160906|NCT01587703|12349381|FG012|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160907|NCT01587703|12349382|FG013|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160908|NCT01587703|12349383|FG014|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160909|NCT01587703|12349384|FG015|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160910|NCT01587703|12349385|FG016|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160911|NCT01587703|12349386|FG017|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
11160912|NCT01587703|12349387|FG018|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
11160913|NCT01587703|12349369|FG000|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160914|NCT01587703|12349370|FG001|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160915|NCT01587703|12349371|FG002|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160916|NCT01587703|12349372|FG003|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160917|NCT01587703|12349373|FG004|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160918|NCT01587703|12349374|FG005|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160919|NCT01587703|12349375|FG006|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160920|NCT01587703|12349376|FG007|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160921|NCT01587703|12349377|FG008|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160922|NCT01587703|12349378|FG009|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160923|NCT01587703|12349379|FG010|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160924|NCT01587703|12349380|FG011|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160925|NCT01587703|12349381|FG012|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160926|NCT01587703|12349382|FG013|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160927|NCT01587703|12349383|FG014|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160928|NCT01587703|12349384|FG015|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160929|NCT01587703|12349385|FG016|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160930|NCT01587703|12349386|FG017|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
11160931|NCT01587703|12349387|FG018|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
11160932|NCT01587703|12349369|FG000|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160933|NCT01587703|12349370|FG001|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160934|NCT01587703|12349371|FG002|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160935|NCT01587703|12349372|FG003|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160936|NCT01587703|12349373|FG004|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160937|NCT01587703|12349374|FG005|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160938|NCT01587703|12349375|FG006|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160939|NCT01587703|12349376|FG007|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160940|NCT01587703|12349377|FG008|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160941|NCT01587703|12349378|FG009|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160942|NCT01587703|12349379|FG010|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160943|NCT01587703|12349380|FG011|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160944|NCT01587703|12349381|FG012|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160945|NCT01587703|12349382|FG013|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160946|NCT01587703|12349383|FG014|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160947|NCT01587703|12349384|FG015|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160948|NCT01587703|12349385|FG016|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160949|NCT01587703|12349386|FG017|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160950|NCT01587703|12349387|FG018|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
11160951|NCT01587703|12349369|FG000|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160952|NCT01587703|12349370|FG001|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160953|NCT01587703|12349371|FG002|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160954|NCT01587703|12349372|FG003|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160955|NCT01587703|12349373|FG004|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160956|NCT01587703|12349374|FG005|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160957|NCT01587703|12349375|FG006|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160958|NCT01587703|12349376|FG007|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160959|NCT01587703|12349377|FG008|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160960|NCT01587703|12349378|FG009|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160961|NCT01587703|12349379|FG010|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160962|NCT01587703|12349380|FG011|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160963|NCT01587703|12349381|FG012|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160964|NCT01587703|12349382|FG013|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160965|NCT01587703|12349383|FG014|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160966|NCT01587703|12349384|FG015|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160967|NCT01587703|12349385|FG016|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
11160968|NCT01587703|12349386|FG017|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
11160969|NCT01587703|12349387|FG018|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
11160970|NCT01587703|12349369|FG000|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160971|NCT01587703|12349370|FG001|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160972|NCT01587703|12349371|FG002|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160973|NCT01587703|12349372|FG003|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160974|NCT01587703|12349373|FG004|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160975|NCT01587703|12349374|FG005|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160976|NCT01587703|12349375|FG006|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160977|NCT01587703|12349376|FG007|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160978|NCT01587703|12349377|FG008|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160979|NCT01587703|12349378|FG009|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160980|NCT01587703|12349379|FG010|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160981|NCT01587703|12349380|FG011|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160982|NCT01587703|12349381|FG012|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160983|NCT01587703|12349382|FG013|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160984|NCT01587703|12349383|FG014|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160985|NCT01587703|12349384|FG015|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160986|NCT01587703|12349385|FG016|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160987|NCT01587703|12349386|FG017|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
11160988|NCT01587703|12349387|FG018|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
11160989|NCT01587703|12349369|FG000|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160990|NCT01587703|12349370|FG001|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160991|NCT01587703|12349371|FG002|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160992|NCT01587703|12349372|FG003|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160993|NCT01587703|12349373|FG004|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160994|NCT01587703|12349374|FG005|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160995|NCT01587703|12349375|FG006|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160996|NCT01587703|12349376|FG007|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160997|NCT01587703|12349377|FG008|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160998|NCT01587703|12349378|FG009|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11160999|NCT01587703|12349379|FG010|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11161000|NCT01587703|12349380|FG011|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11161001|NCT01587703|12349381|FG012|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11161002|NCT01587703|12349382|FG013|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11161003|NCT01587703|12349383|FG014|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11161004|NCT01587703|12349384|FG015|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11161005|NCT01587703|12349385|FG016|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11161006|NCT01587703|12349386|FG017|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11161007|NCT01587703|12349387|FG018|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
11161008|NCT01587703|12349369|FG000|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161009|NCT01587703|12349370|FG001|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161010|NCT01587703|12349371|FG002|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161011|NCT01587703|12349372|FG003|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161012|NCT01587703|12349373|FG004|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161013|NCT01587703|12349374|FG005|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161014|NCT01587703|12349375|FG006|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161015|NCT01587703|12349376|FG007|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161016|NCT01587703|12349377|FG008|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161017|NCT01587703|12349378|FG009|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161018|NCT01587703|12349379|FG010|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161019|NCT01587703|12349380|FG011|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161020|NCT01587703|12349381|FG012|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161021|NCT01587703|12349382|FG013|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161022|NCT01587703|12349383|FG014|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161023|NCT01587703|12349384|FG015|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161024|NCT01587703|12349385|FG016|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
11161025|NCT01587703|12349386|FG017|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
11161026|NCT01587703|12349387|FG018|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
11161027|NCT01587703|12349369|FG000|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161028|NCT01587703|12349370|FG001|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161029|NCT01587703|12349371|FG002|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161030|NCT01587703|12349372|FG003|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161031|NCT01587703|12349373|FG004|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161032|NCT01587703|12349374|FG005|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161033|NCT01587703|12349375|FG006|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161034|NCT01587703|12349376|FG007|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161035|NCT01587703|12349377|FG008|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161036|NCT01587703|12349378|FG009|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161037|NCT01587703|12349379|FG010|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161038|NCT01587703|12349380|FG011|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161039|NCT01587703|12349381|FG012|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161040|NCT01587703|12349382|FG013|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161041|NCT01587703|12349383|FG014|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161042|NCT01587703|12349384|FG015|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161043|NCT01587703|12349385|FG016|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161044|NCT01587703|12349386|FG017|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
11161045|NCT01587703|12349387|FG018|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
11161046|NCT01587703|12349369|FG000|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161047|NCT01587703|12349370|FG001|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161048|NCT01587703|12349371|FG002|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161049|NCT01587703|12349372|FG003|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161050|NCT01587703|12349373|FG004|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161051|NCT01587703|12349374|FG005|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161052|NCT01587703|12349375|FG006|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161053|NCT01587703|12349376|FG007|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161054|NCT01587703|12349377|FG008|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161055|NCT01587703|12349378|FG009|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161056|NCT01587703|12349379|FG010|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161057|NCT01587703|12349380|FG011|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161058|NCT01587703|12349381|FG012|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161059|NCT01587703|12349382|FG013|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161060|NCT01587703|12349383|FG014|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161061|NCT01587703|12349384|FG015|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161062|NCT01587703|12349385|FG016|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161063|NCT01587703|12349386|FG017|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161064|NCT01587703|12349387|FG018|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
11161065|NCT01587703|12349369|FG000|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161066|NCT01587703|12349370|FG001|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161067|NCT01587703|12349371|FG002|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161068|NCT01587703|12349372|FG003|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161069|NCT01587703|12349373|FG004|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161070|NCT01587703|12349374|FG005|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161071|NCT01587703|12349375|FG006|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161072|NCT01587703|12349376|FG007|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161073|NCT01587703|12349377|FG008|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161074|NCT01587703|12349378|FG009|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11419212|NCT00281879|12617659|FG005|NOT COMPLETED|Overall Study||9
11419213|NCT00281879|12617660|FG006|NOT COMPLETED|Overall Study||0
11161075|NCT01587703|12349379|FG010|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161076|NCT01587703|12349380|FG011|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161077|NCT01587703|12349381|FG012|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161078|NCT01587703|12349382|FG013|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161079|NCT01587703|12349383|FG014|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161080|NCT01587703|12349384|FG015|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161081|NCT01587703|12349385|FG016|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
11161082|NCT01587703|12349386|FG017|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
11343024|NCT02950545|12540319|FG002|STARTED|Session 3 (70 Minutes)||7
11161083|NCT01587703|12349387|FG018|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
11161084|NCT01587703|12349369|FG000|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161085|NCT01587703|12349370|FG001|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161086|NCT01587703|12349371|FG002|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161087|NCT01587703|12349372|FG003|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161088|NCT01587703|12349373|FG004|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161089|NCT01587703|12349374|FG005|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161090|NCT01587703|12349375|FG006|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161091|NCT01587703|12349376|FG007|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161092|NCT01587703|12349377|FG008|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161093|NCT01587703|12349378|FG009|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161094|NCT01587703|12349379|FG010|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161095|NCT01587703|12349380|FG011|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161096|NCT01587703|12349381|FG012|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161097|NCT01587703|12349382|FG013|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161098|NCT01587703|12349383|FG014|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161099|NCT01587703|12349384|FG015|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161100|NCT01587703|12349385|FG016|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161101|NCT01587703|12349386|FG017|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161102|NCT01587703|12349387|FG018|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161103|NCT01587703|12349369|FG000|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161104|NCT01587703|12349370|FG001|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161105|NCT01587703|12349371|FG002|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161106|NCT01587703|12349372|FG003|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161107|NCT01587703|12349373|FG004|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161108|NCT01587703|12349374|FG005|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161109|NCT01587703|12349375|FG006|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161110|NCT01587703|12349376|FG007|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161111|NCT01587703|12349377|FG008|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161112|NCT01587703|12349378|FG009|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161113|NCT01587703|12349379|FG010|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161114|NCT01587703|12349380|FG011|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161115|NCT01587703|12349381|FG012|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161116|NCT01587703|12349382|FG013|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161117|NCT01587703|12349383|FG014|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161118|NCT01587703|12349384|FG015|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11161119|NCT01587703|12349385|FG016|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
11343025|NCT02950545|12540320|FG003|STARTED|Session 3 (70 Minutes)||7
11343026|NCT02950545|12540321|FG004|STARTED|Session 3 (70 Minutes)||7
11343027|NCT02950545|12540322|FG005|STARTED|Session 3 (70 Minutes)||8
11161120|NCT01587703|12349386|FG017|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
11161121|NCT01587703|12349387|FG018|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
11161122|NCT01587703|12349369|FG000|STARTED|Part2(Median Exposure of 1.41 Months)||0
11161123|NCT01587703|12349370|FG001|STARTED|Part2(Median Exposure of 1.41 Months)||0
11161124|NCT01587703|12349371|FG002|STARTED|Part2(Median Exposure of 1.41 Months)||0
11161125|NCT01587703|12349372|FG003|STARTED|Part2(Median Exposure of 1.41 Months)||0
11161126|NCT01587703|12349373|FG004|STARTED|Part2(Median Exposure of 1.41 Months)||0
11419214|NCT00281879|12617661|FG007|NOT COMPLETED|Overall Study||1
11419215|NCT00271947|12617679|FG000|STARTED|Overall Study||1
11419216|NCT00271947|12617679|FG000|COMPLETED|Overall Study||0
11419217|NCT00271947|12617679|FG000|NOT COMPLETED|Overall Study||1
11419218|NCT00271011|12617683|FG000|STARTED|Overall Study||13
11419219|NCT00271011|12617683|FG000|COMPLETED|Overall Study||13
11419220|NCT00271011|12617683|FG000|NOT COMPLETED|Overall Study||0
11419221|NCT00253981|12617689|FG000|STARTED|Overall Study||16
11419222|NCT00253981|12617690|FG001|STARTED|Overall Study||14
11419223|NCT00253981|12617689|FG000|COMPLETED|Overall Study||16
11419224|NCT00253981|12617690|FG001|COMPLETED|Overall Study||14
11419225|NCT00253981|12617689|FG000|NOT COMPLETED|Overall Study||0
11419226|NCT00253981|12617690|FG001|NOT COMPLETED|Overall Study||0
11419227|NCT00252174|12617699|FG000|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
11419228|NCT00252174|12617700|FG001|STARTED|Overall Study|2 subjects entered the control arm in total|2
11419229|NCT00252174|12617701|FG002|STARTED|Overall Study|No subjects entered Stage 2|0
11419230|NCT00252174|12617699|FG000|COMPLETED|Overall Study||0
11161127|NCT01587703|12349374|FG005|STARTED|Part2(Median Exposure of 1.41 Months)||0
11161128|NCT01587703|12349375|FG006|STARTED|Part2(Median Exposure of 1.41 Months)||0
11161129|NCT01587703|12349376|FG007|STARTED|Part2(Median Exposure of 1.41 Months)||0
11161130|NCT01587703|12349377|FG008|STARTED|Part2(Median Exposure of 1.41 Months)||0
11161131|NCT01587703|12349378|FG009|STARTED|Part2(Median Exposure of 1.41 Months)||0
11161132|NCT01587703|12349379|FG010|STARTED|Part2(Median Exposure of 1.41 Months)||0
11161133|NCT01587703|12349380|FG011|STARTED|Part2(Median Exposure of 1.41 Months)||12
11161134|NCT01587703|12349381|FG012|STARTED|Part2(Median Exposure of 1.41 Months)||14
11161135|NCT01587703|12349382|FG013|STARTED|Part2(Median Exposure of 1.41 Months)||23
11161136|NCT01587703|12349383|FG014|STARTED|Part2(Median Exposure of 1.41 Months)||19
11161137|NCT01587703|12349384|FG015|STARTED|Part2(Median Exposure of 1.41 Months)||21
11419231|NCT00252174|12617700|FG001|COMPLETED|Overall Study||1
11419232|NCT00252174|12617701|FG002|COMPLETED|Overall Study||0
11419233|NCT00252174|12617699|FG000|NOT COMPLETED|Overall Study||0
11419234|NCT00252174|12617700|FG001|NOT COMPLETED|Overall Study||1
11419235|NCT00252174|12617701|FG002|NOT COMPLETED|Overall Study||0
11161138|NCT01587703|12349385|FG016|STARTED|Part2(Median Exposure of 1.41 Months)||13
11161139|NCT01587703|12349386|FG017|STARTED|Part2(Median Exposure of 1.41 Months)||0
11161140|NCT01587703|12349387|FG018|STARTED|Part2(Median Exposure of 1.41 Months)||0
11161141|NCT01587703|12349369|FG000|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161142|NCT01587703|12349370|FG001|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161143|NCT01587703|12349371|FG002|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161144|NCT01587703|12349372|FG003|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161145|NCT01587703|12349373|FG004|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161146|NCT01587703|12349374|FG005|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161147|NCT01587703|12349375|FG006|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161148|NCT01587703|12349376|FG007|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161149|NCT01587703|12349377|FG008|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161150|NCT01587703|12349378|FG009|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161151|NCT01587703|12349379|FG010|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161152|NCT01587703|12349380|FG011|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161153|NCT01587703|12349381|FG012|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161154|NCT01587703|12349382|FG013|COMPLETED|Part2(Median Exposure of 1.41 Months)||1
11161155|NCT01587703|12349383|FG014|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161156|NCT01587703|12349384|FG015|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161157|NCT01587703|12349385|FG016|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161158|NCT01587703|12349386|FG017|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161159|NCT01587703|12349387|FG018|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161160|NCT01587703|12349369|FG000|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161161|NCT01587703|12349370|FG001|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161162|NCT01587703|12349371|FG002|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161163|NCT01587703|12349372|FG003|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161164|NCT01587703|12349373|FG004|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161165|NCT01587703|12349374|FG005|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161166|NCT01587703|12349375|FG006|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161167|NCT01587703|12349376|FG007|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161168|NCT01587703|12349377|FG008|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161169|NCT01587703|12349378|FG009|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161170|NCT01587703|12349379|FG010|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161171|NCT01587703|12349380|FG011|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||12
11161172|NCT01587703|12349381|FG012|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||14
11203470|NCT01847443|12393984|FG001|STARTED|Study Period 3||19
11161173|NCT01587703|12349382|FG013|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||22
11161174|NCT01587703|12349383|FG014|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||19
11161175|NCT01587703|12349384|FG015|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||21
11161176|NCT01587703|12349385|FG016|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||13
11161177|NCT01587703|12349386|FG017|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161178|NCT01587703|12349387|FG018|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
11161179|NCT01587885|12349446|FG000|STARTED|Treatment Period 1||26
11161180|NCT01587885|12349447|FG001|STARTED|Treatment Period 1||22
11161181|NCT01587885|12349446|FG000|COMPLETED|Treatment Period 1||26
11161182|NCT01587885|12349447|FG001|COMPLETED|Treatment Period 1||19
11161183|NCT01587885|12349446|FG000|NOT COMPLETED|Treatment Period 1||0
11161184|NCT01587885|12349447|FG001|NOT COMPLETED|Treatment Period 1||3
11161185|NCT01587885|12349446|FG000|STARTED|Treatment Period 2||26
11161186|NCT01587885|12349447|FG001|STARTED|Treatment Period 2||19
11161187|NCT01587885|12349446|FG000|COMPLETED|Treatment Period 2||26
11161188|NCT01587885|12349447|FG001|COMPLETED|Treatment Period 2||19
11161189|NCT01587885|12349446|FG000|NOT COMPLETED|Treatment Period 2||0
11161190|NCT01587885|12349447|FG001|NOT COMPLETED|Treatment Period 2||0
11161191|NCT01587898|12349458|FG000|STARTED|Overall Study||18
11161192|NCT01587898|12349459|FG001|STARTED|Overall Study||17
11161193|NCT01587898|12349460|FG002|STARTED|Overall Study||18
11161194|NCT01587898|12349461|FG003|STARTED|Overall Study||19
11161195|NCT01587898|12349458|FG000|COMPLETED|Overall Study||14
11161196|NCT01587898|12349459|FG001|COMPLETED|Overall Study||12
11161197|NCT01587898|12349460|FG002|COMPLETED|Overall Study||16
11161198|NCT01587898|12349461|FG003|COMPLETED|Overall Study||17
11161199|NCT01587898|12349458|FG000|NOT COMPLETED|Overall Study||4
11161200|NCT01587898|12349459|FG001|NOT COMPLETED|Overall Study||5
11161201|NCT01587898|12349460|FG002|NOT COMPLETED|Overall Study||2
11161202|NCT01587898|12349461|FG003|NOT COMPLETED|Overall Study||2
11161203|NCT01587924|12349478|FG000|STARTED|Overall Study||21
11161204|NCT01587924|12349479|FG001|STARTED|Overall Study||21
11161205|NCT01587924|12349480|FG002|STARTED|Overall Study||21
11161206|NCT01587924|12349481|FG003|STARTED|Overall Study||20
11161207|NCT01587924|12349478|FG000|COMPLETED|Overall Study||17
11161208|NCT01587924|12349479|FG001|COMPLETED|Overall Study||17
11161209|NCT01587924|12349480|FG002|COMPLETED|Overall Study||17
11161210|NCT01587924|12349481|FG003|COMPLETED|Overall Study||19
11161211|NCT01587924|12349478|FG000|NOT COMPLETED|Overall Study||4
11161212|NCT01587924|12349479|FG001|NOT COMPLETED|Overall Study||4
11161213|NCT01587924|12349480|FG002|NOT COMPLETED|Overall Study||4
11161214|NCT01587924|12349481|FG003|NOT COMPLETED|Overall Study||1
11161215|NCT01587950|12349491|FG000|STARTED|Period 1||12
11161216|NCT01587950|12349491|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
11161217|NCT01587950|12349491|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
11161218|NCT01587950|12349491|FG000|Received Sterile Water (2 Minutes)|Period 1||2
11161219|NCT01587950|12349491|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
11161220|NCT01587950|12349491|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
11161221|NCT01587950|12349491|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
11161222|NCT01587950|12349491|FG000|Received Sterile Water (10 Minutes)|Period 1||5
11161223|NCT01587950|12349491|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
11161224|NCT01587950|12349491|FG000|Received Sterile Water (5 Minutes)|Period 1||5
11161225|NCT01587950|12349491|FG000|COMPLETED|Period 1||12
11161226|NCT01587950|12349491|FG000|NOT COMPLETED|Period 1||0
11161227|NCT01587950|12349491|FG000|STARTED|Washout 1||12
11161228|NCT01587950|12349491|FG000|COMPLETED|Washout 1||12
11161229|NCT01587950|12349491|FG000|NOT COMPLETED|Washout 1||0
11161230|NCT01587950|12349491|FG000|STARTED|Period 2||12
11161231|NCT01587950|12349491|FG000|Received Sterile Water (2 Minutes)|Period 2||8
11161232|NCT01587950|12349491|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
11161233|NCT01587950|12349491|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
11161234|NCT01587950|12349491|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
11161235|NCT01587950|12349491|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
11161236|NCT01587950|12349491|FG000|Received Sterile Water (5 Minutes)|Period 2||2
11161237|NCT01587950|12349491|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
11161238|NCT01587950|12349491|FG000|Received Sterile Water (10 Minutes)|Period 2||2
11161239|NCT01587950|12349491|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
11161240|NCT01587950|12349491|FG000|COMPLETED|Period 2||12
11419236|NCT00256295|12617709|FG000|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
11419237|NCT00256295|12617709|FG000|COMPLETED|Overall Study||3
11419238|NCT00256295|12617709|FG000|NOT COMPLETED|Overall Study||4
11419239|NCT00245128|12617713|FG000|STARTED|Overall Study||10
11419240|NCT00245128|12617713|FG000|COMPLETED|Overall Study||0
11419241|NCT00245128|12617713|FG000|NOT COMPLETED|Overall Study||10
11419242|NCT00268450|12617717|FG000|STARTED|Overall Study||21
11419243|NCT00268450|12617717|FG000|COMPLETED|Overall Study||21
11419244|NCT00268450|12617717|FG000|NOT COMPLETED|Overall Study||0
11419245|NCT00239720|12617723|FG000|STARTED|Overall Study||3
11161241|NCT01587950|12349491|FG000|NOT COMPLETED|Period 2||0
11161242|NCT01587950|12349491|FG000|STARTED|Washout 2||12
11161243|NCT01587950|12349491|FG000|COMPLETED|Washout 2||12
11161244|NCT01587950|12349491|FG000|NOT COMPLETED|Washout 2||0
11161245|NCT01587950|12349491|FG000|STARTED|Period 3||12
11161246|NCT01587950|12349491|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
11161247|NCT01587950|12349491|FG000|Received Sterile Water (10 Minutes)|Period 3||5
11161248|NCT01587950|12349491|FG000|Received Sterile Water (2 Minutes)|Period 3||2
11161249|NCT01587950|12349491|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
11161250|NCT01587950|12349491|FG000|Received Sterile Water (5 Minutes)|Period 3||5
11161251|NCT01587950|12349491|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
11161252|NCT01587950|12349491|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
11161253|NCT01587950|12349491|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
11161254|NCT01587950|12349491|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
11161255|NCT01587950|12349491|FG000|COMPLETED|Period 3||12
11161256|NCT01587950|12349491|FG000|NOT COMPLETED|Period 3||0
11161257|NCT01587989|12349506|FG000|STARTED|12-Week Open-Label Run-In Period||77
11161258|NCT01587989|12349507|FG001|STARTED|12-Week Open-Label Run-In Period||0
11161259|NCT01587989|12349508|FG002|STARTED|12-Week Open-Label Run-In Period||0
11161260|NCT01587989|12349506|FG000|COMPLETED|12-Week Open-Label Run-In Period||65
11161261|NCT01587989|12349507|FG001|COMPLETED|12-Week Open-Label Run-In Period||0
11161262|NCT01587989|12349508|FG002|COMPLETED|12-Week Open-Label Run-In Period||0
11161263|NCT01587989|12349506|FG000|NOT COMPLETED|12-Week Open-Label Run-In Period||12
11161264|NCT01587989|12349507|FG001|NOT COMPLETED|12-Week Open-Label Run-In Period||0
11161265|NCT01587989|12349508|FG002|NOT COMPLETED|12-Week Open-Label Run-In Period||0
11161266|NCT01587989|12349506|FG000|STARTED|Randomized Study Treatment||0
11161267|NCT01587989|12349507|FG001|STARTED|Randomized Study Treatment||32
11161268|NCT01587989|12349508|FG002|STARTED|Randomized Study Treatment||33
11161269|NCT01587989|12349506|FG000|COMPLETED|Randomized Study Treatment||0
11161270|NCT01587989|12349507|FG001|COMPLETED|Randomized Study Treatment||30
11161271|NCT01587989|12349508|FG002|COMPLETED|Randomized Study Treatment||32
11161272|NCT01587989|12349506|FG000|NOT COMPLETED|Randomized Study Treatment||0
11161273|NCT01587989|12349507|FG001|NOT COMPLETED|Randomized Study Treatment||2
11161274|NCT01587989|12349508|FG002|NOT COMPLETED|Randomized Study Treatment||1
11161275|NCT01588106|12349516|FG000|STARTED|Overall Study||78
11161276|NCT01588106|12349517|FG001|STARTED|Overall Study||76
11419246|NCT00239720|12617724|FG001|STARTED|Overall Study||1
11419247|NCT00239720|12617723|FG000|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
11161277|NCT01588106|12349516|FG000|COMPLETED|Overall Study||73
11161278|NCT01588106|12349517|FG001|COMPLETED|Overall Study||72
11323182|NCT01084252|12520457|FG000|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11419248|NCT00239720|12617724|FG001|COMPLETED|Overall Study|One participant lost to follow-up|0
11419249|NCT00239720|12617723|FG000|NOT COMPLETED|Overall Study||1
11161279|NCT01588106|12349516|FG000|NOT COMPLETED|Overall Study||5
11161280|NCT01588106|12349517|FG001|NOT COMPLETED|Overall Study||4
11161281|NCT01588158|12349525|FG000|STARTED|Overall Study||4
11161282|NCT01588158|12349526|FG001|STARTED|Overall Study||3
11161283|NCT01588158|12349525|FG000|COMPLETED|Overall Study||4
11161284|NCT01588158|12349526|FG001|COMPLETED|Overall Study||3
11161285|NCT01588158|12349525|FG000|NOT COMPLETED|Overall Study||0
11161286|NCT01588158|12349526|FG001|NOT COMPLETED|Overall Study||0
11161287|NCT01588184|12349538|FG000|STARTED|Overall Study||11
11161288|NCT01588184|12349539|FG001|STARTED|Overall Study||41
11161289|NCT01588184|12349540|FG002|STARTED|Overall Study||7
11161290|NCT01588184|12349541|FG003|STARTED|Overall Study||6
11161291|NCT01588184|12349542|FG004|STARTED|Overall Study||16
11161292|NCT01588184|12349543|FG005|STARTED|Overall Study||14
11161293|NCT01588184|12349538|FG000|COMPLETED|Overall Study||8
11161294|NCT01588184|12349539|FG001|COMPLETED|Overall Study||28
11161295|NCT01588184|12349540|FG002|COMPLETED|Overall Study||5
11161296|NCT01588184|12349541|FG003|COMPLETED|Overall Study||3
11161297|NCT01588184|12349542|FG004|COMPLETED|Overall Study||14
11161298|NCT01588184|12349543|FG005|COMPLETED|Overall Study||10
11161299|NCT01588184|12349538|FG000|NOT COMPLETED|Overall Study||3
11161300|NCT01588184|12349539|FG001|NOT COMPLETED|Overall Study||13
11161301|NCT01588184|12349540|FG002|NOT COMPLETED|Overall Study||2
11161302|NCT01588184|12349541|FG003|NOT COMPLETED|Overall Study||3
11161303|NCT01588184|12349542|FG004|NOT COMPLETED|Overall Study||2
11161304|NCT01588184|12349543|FG005|NOT COMPLETED|Overall Study||4
11161305|NCT01588197|12349559|FG000|STARTED|Overall Study||10
11161306|NCT01588197|12349560|FG001|STARTED|Overall Study||10
11161307|NCT01588197|12349559|FG000|COMPLETED|Overall Study||9
11161308|NCT01588197|12349560|FG001|COMPLETED|Overall Study||9
11161309|NCT01588197|12349559|FG000|NOT COMPLETED|Overall Study||1
11161310|NCT01588197|12349560|FG001|NOT COMPLETED|Overall Study||1
11161311|NCT01588236|12349569|FG000|STARTED|Overall Study||92
11161312|NCT01588236|12349570|FG001|STARTED|Overall Study||94
11161313|NCT01588236|12349571|FG002|STARTED|Overall Study||94
11161314|NCT01588236|12349569|FG000|COMPLETED|Overall Study||76
11161315|NCT01588236|12349570|FG001|COMPLETED|Overall Study||66
11161316|NCT01588236|12349571|FG002|COMPLETED|Overall Study||69
11161317|NCT01588236|12349569|FG000|NOT COMPLETED|Overall Study||16
11161318|NCT01588236|12349570|FG001|NOT COMPLETED|Overall Study||28
11161319|NCT01588236|12349571|FG002|NOT COMPLETED|Overall Study||25
11161320|NCT01588353|12349582|FG000|STARTED|Step1||6
11161321|NCT01588353|12349583|FG001|STARTED|Step1||0
11161322|NCT01588353|12349584|FG002|STARTED|Step1||0
11161323|NCT01588353|12349582|FG000|COMPLETED|Step1||6
11161324|NCT01588353|12349583|FG001|COMPLETED|Step1||0
11161325|NCT01588353|12349584|FG002|COMPLETED|Step1||0
11161326|NCT01588353|12349582|FG000|NOT COMPLETED|Step1||0
11161327|NCT01588353|12349583|FG001|NOT COMPLETED|Step1||0
11161328|NCT01588353|12349584|FG002|NOT COMPLETED|Step1||0
11161329|NCT01588353|12349582|FG000|STARTED|Step2||0
11161330|NCT01588353|12349583|FG001|STARTED|Step2||71
11161331|NCT01588353|12349584|FG002|STARTED|Step2||0
11161332|NCT01588353|12349582|FG000|COMPLETED|Step2||0
11161333|NCT01588353|12349583|FG001|COMPLETED|Step2||70
11161334|NCT01588353|12349584|FG002|COMPLETED|Step2||0
11161335|NCT01588353|12349582|FG000|NOT COMPLETED|Step2||0
11161336|NCT01588353|12349583|FG001|NOT COMPLETED|Step2||1
11161337|NCT01588353|12349584|FG002|NOT COMPLETED|Step2||0
11161338|NCT01588353|12349582|FG000|STARTED|Step3||0
11161339|NCT01588353|12349583|FG001|STARTED|Step3||0
11161340|NCT01588353|12349584|FG002|STARTED|Step3||25
11161341|NCT01588353|12349582|FG000|COMPLETED|Step3||0
11161342|NCT01588353|12349583|FG001|COMPLETED|Step3||0
11161343|NCT01588353|12349584|FG002|COMPLETED|Step3||23
11161344|NCT01588353|12349582|FG000|NOT COMPLETED|Step3||0
11161345|NCT01588353|12349583|FG001|NOT COMPLETED|Step3||0
11161346|NCT01588353|12349584|FG002|NOT COMPLETED|Step3||2
11161347|NCT01588366|12349596|FG000|STARTED|Overall Study||2
11161348|NCT01588366|12349597|FG001|STARTED|Overall Study||7
11161349|NCT01588366|12349598|FG002|STARTED|Overall Study||2
11161350|NCT01588366|12349599|FG003|STARTED|Overall Study||7
11161351|NCT01588366|12349600|FG004|STARTED|Overall Study||3
11161352|NCT01588366|12349601|FG005|STARTED|Overall Study||9
11161353|NCT01588366|12349596|FG000|Received at Least One Dose of Study Drug|Overall Study||2
11161354|NCT01588366|12349597|FG001|Received at Least One Dose of Study Drug|Overall Study||7
11161355|NCT01588366|12349598|FG002|Received at Least One Dose of Study Drug|Overall Study||2
11161356|NCT01588366|12349599|FG003|Received at Least One Dose of Study Drug|Overall Study||7
11161357|NCT01588366|12349600|FG004|Received at Least One Dose of Study Drug|Overall Study||3
11161358|NCT01588366|12349601|FG005|Received at Least One Dose of Study Drug|Overall Study||9
11161359|NCT01588366|12349596|FG000|COMPLETED|Overall Study||2
11161360|NCT01588366|12349597|FG001|COMPLETED|Overall Study||6
11161361|NCT01588366|12349598|FG002|COMPLETED|Overall Study||2
11161362|NCT01588366|12349599|FG003|COMPLETED|Overall Study||6
11161363|NCT01588366|12349600|FG004|COMPLETED|Overall Study||3
11161364|NCT01588366|12349601|FG005|COMPLETED|Overall Study||7
11161365|NCT01588366|12349596|FG000|NOT COMPLETED|Overall Study||0
11161366|NCT01588366|12349597|FG001|NOT COMPLETED|Overall Study||1
11161367|NCT01588366|12349598|FG002|NOT COMPLETED|Overall Study||0
11161368|NCT01588366|12349599|FG003|NOT COMPLETED|Overall Study||1
11161369|NCT01588366|12349600|FG004|NOT COMPLETED|Overall Study||0
11161370|NCT01588366|12349601|FG005|NOT COMPLETED|Overall Study||2
11161371|NCT01588405|12349617|FG000|STARTED|Overall Study||33
11161372|NCT01588405|12349617|FG000|COMPLETED|Overall Study||31
11161373|NCT01588405|12349617|FG000|NOT COMPLETED|Overall Study||2
11161374|NCT01588418|12349624|FG000|STARTED|Overall Study||11
11161375|NCT01588418|12349625|FG001|STARTED|Overall Study||4
11161376|NCT01588418|12349624|FG000|COMPLETED|Overall Study||11
11161377|NCT01588418|12349625|FG001|COMPLETED|Overall Study||4
11161378|NCT01588418|12349624|FG000|NOT COMPLETED|Overall Study||0
11161379|NCT01588418|12349625|FG001|NOT COMPLETED|Overall Study||0
11161380|NCT01588444|12349633|FG000|STARTED|Overall Study||20
11161381|NCT01588444|12349634|FG001|STARTED|Overall Study||20
11161382|NCT01588444|12349633|FG000|COMPLETED|Overall Study||20
11161383|NCT01588444|12349634|FG001|COMPLETED|Overall Study||20
11161384|NCT01588444|12349633|FG000|NOT COMPLETED|Overall Study||0
11161385|NCT01588444|12349634|FG001|NOT COMPLETED|Overall Study||0
11161386|NCT01588457|12349642|FG000|STARTED|Randomization 1||53
11161387|NCT01588457|12349643|FG001|STARTED|Randomization 1||59
11161388|NCT01588457|12349644|FG002|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
11161389|NCT01588457|12349645|FG003|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
11161390|NCT01588457|12349642|FG000|COMPLETED|Randomization 1||30
11161391|NCT01588457|12349643|FG001|COMPLETED|Randomization 1||43
11161392|NCT01588457|12349644|FG002|COMPLETED|Randomization 1||0
11161393|NCT01588457|12349645|FG003|COMPLETED|Randomization 1||0
11161394|NCT01588457|12349642|FG000|NOT COMPLETED|Randomization 1||23
11161395|NCT01588457|12349643|FG001|NOT COMPLETED|Randomization 1||16
11161396|NCT01588457|12349644|FG002|NOT COMPLETED|Randomization 1||0
11161397|NCT01588457|12349645|FG003|NOT COMPLETED|Randomization 1||0
11161398|NCT01588457|12349642|FG000|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|21
11161399|NCT01588457|12349643|FG001|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|31
11161400|NCT01588457|12349644|FG002|STARTED|Randomization 2|Assignment of Quetiapine plus monotherapy for symptoms of depression|17
11161401|NCT01588457|12349645|FG003|STARTED|Randomization 2|Assignment of Lamotrigine plus monotherapy for symptoms of depression|18
11161402|NCT01588457|12349642|FG000|COMPLETED|Randomization 2||1
11161403|NCT01588457|12349643|FG001|COMPLETED|Randomization 2||3
11161404|NCT01588457|12349644|FG002|COMPLETED|Randomization 2||12
11161405|NCT01588457|12349645|FG003|COMPLETED|Randomization 2||13
11161406|NCT01588457|12349642|FG000|NOT COMPLETED|Randomization 2||20
11161407|NCT01588457|12349643|FG001|NOT COMPLETED|Randomization 2||28
11161408|NCT01588457|12349644|FG002|NOT COMPLETED|Randomization 2||5
11161409|NCT01588457|12349645|FG003|NOT COMPLETED|Randomization 2||5
11161410|NCT01588470|12349665|FG000|STARTED|Overall Study|First enrolled April 2007|130
11161411|NCT01588470|12349665|FG000|COMPLETED|Overall Study|Completed Dec. 2011|50
11161412|NCT01588470|12349665|FG000|NOT COMPLETED|Overall Study||80
11161413|NCT01588496|12349677|FG000|STARTED|Overall Study||8
11161414|NCT01588496|12349678|FG001|STARTED|Overall Study||17
11161415|NCT01588496|12349679|FG002|STARTED|Overall Study||33
11161416|NCT01588496|12349677|FG000|Received Treatment|Overall Study||8
11161417|NCT01588496|12349678|FG001|Received Treatment|Overall Study||16
11161418|NCT01588496|12349679|FG002|Received Treatment|Overall Study||33
11161419|NCT01588496|12349677|FG000|COMPLETED|Overall Study||8
11161420|NCT01588496|12349678|FG001|COMPLETED|Overall Study||16
11161421|NCT01588496|12349679|FG002|COMPLETED|Overall Study||33
11161422|NCT01588496|12349677|FG000|NOT COMPLETED|Overall Study||0
11161423|NCT01588496|12349678|FG001|NOT COMPLETED|Overall Study||1
11161424|NCT01588496|12349679|FG002|NOT COMPLETED|Overall Study||0
11161425|NCT01588509|12349689|FG000|STARTED|Overall Study||30
11161426|NCT01588509|12349690|FG001|STARTED|Overall Study||30
11161427|NCT01588509|12349689|FG000|Received Treatment|Overall Study||30
11161428|NCT01588509|12349690|FG001|Received Treatment|Overall Study||30
11161429|NCT01588509|12349689|FG000|COMPLETED|Overall Study||29
11161430|NCT01588509|12349690|FG001|COMPLETED|Overall Study||30
11161431|NCT01588509|12349689|FG000|NOT COMPLETED|Overall Study||1
11161432|NCT01588509|12349690|FG001|NOT COMPLETED|Overall Study||0
11161433|NCT01588548|12349702|FG000|STARTED|Overall Study||3
11161434|NCT01588548|12349703|FG001|STARTED|Overall Study||7
11419250|NCT00239720|12617724|FG001|NOT COMPLETED|Overall Study||1
11419251|NCT00250718|12617730|FG000|STARTED|Overall Study||17
11419252|NCT00250718|12617730|FG000|Received Treatment|Overall Study||16
11419253|NCT00250718|12617730|FG000|COMPLETED|Overall Study||14
11161435|NCT01588548|12349704|FG002|STARTED|Overall Study||6
11161436|NCT01588548|12349705|FG003|STARTED|Overall Study||7
11161437|NCT01588548|12349706|FG004|STARTED|Overall Study||6
11161438|NCT01588548|12349707|FG005|STARTED|Overall Study||6
11161439|NCT01588548|12349702|FG000|Cycle 1 Day 21|Overall Study||3
11161440|NCT01588548|12349703|FG001|Cycle 1 Day 21|Overall Study||5
11161441|NCT01588548|12349704|FG002|Cycle 1 Day 21|Overall Study||2
11161442|NCT01588548|12349705|FG003|Cycle 1 Day 21|Overall Study||5
11161443|NCT01588548|12349706|FG004|Cycle 1 Day 21|Overall Study||3
11161444|NCT01588548|12349707|FG005|Cycle 1 Day 21|Overall Study||3
11161445|NCT01588548|12349702|FG000|COMPLETED|Overall Study||0
11161446|NCT01588548|12349703|FG001|COMPLETED|Overall Study||0
11161447|NCT01588548|12349704|FG002|COMPLETED|Overall Study||0
11161448|NCT01588548|12349705|FG003|COMPLETED|Overall Study||0
11161449|NCT01588548|12349706|FG004|COMPLETED|Overall Study||0
11161450|NCT01588548|12349707|FG005|COMPLETED|Overall Study||0
11161451|NCT01588548|12349702|FG000|NOT COMPLETED|Overall Study||3
11161452|NCT01588548|12349703|FG001|NOT COMPLETED|Overall Study||7
11161453|NCT01588548|12349704|FG002|NOT COMPLETED|Overall Study||6
11161454|NCT01588548|12349705|FG003|NOT COMPLETED|Overall Study||7
11161455|NCT01588548|12349706|FG004|NOT COMPLETED|Overall Study||6
11161456|NCT01588548|12349707|FG005|NOT COMPLETED|Overall Study||6
11419254|NCT00250718|12617730|FG000|NOT COMPLETED|Overall Study||3
11419255|NCT00244010|12617736|FG000|STARTED|Overall Study||2
11419256|NCT00244010|12617737|FG001|STARTED|Overall Study||2
11419257|NCT00244010|12617736|FG000|COMPLETED|Overall Study||2
11419258|NCT00244010|12617737|FG001|COMPLETED|Overall Study||2
11419259|NCT00244010|12617736|FG000|NOT COMPLETED|Overall Study||0
11419260|NCT00244010|12617737|FG001|NOT COMPLETED|Overall Study||0
11419261|NCT00218036|12617748|FG000|STARTED|Overall Study||11
11161457|NCT01588561|12349721|FG000|STARTED|Overall Study||14
11161458|NCT01588561|12349722|FG001|STARTED|Overall Study||1
11161459|NCT01588561|12349721|FG000|First Injection (Visit 1)|Overall Study||14
11161460|NCT01588561|12349722|FG001|First Injection (Visit 1)|Overall Study||1
11161461|NCT01588561|12349721|FG000|Rest Period|Overall Study||14
11161462|NCT01588561|12349722|FG001|Rest Period|Overall Study||1
11161463|NCT01588561|12349721|FG000|Second Injection (Visit 2)|Overall Study||14
11161464|NCT01588561|12349722|FG001|Second Injection (Visit 2)|Overall Study||1
11161465|NCT01588561|12349721|FG000|COMPLETED|Overall Study||14
11161466|NCT01588561|12349722|FG001|COMPLETED|Overall Study||1
11161467|NCT01588561|12349721|FG000|NOT COMPLETED|Overall Study||0
11161468|NCT01588561|12349722|FG001|NOT COMPLETED|Overall Study||0
11161469|NCT01588821|12349728|FG000|STARTED|Overall Study||37
11161470|NCT01588821|12349728|FG000|COMPLETED|Overall Study||37
11161471|NCT01588821|12349728|FG000|NOT COMPLETED|Overall Study||0
11161472|NCT01588951|12349736|FG000|STARTED|Overall Study||2
11161473|NCT01588951|12349737|FG001|STARTED|Overall Study||2
11161474|NCT01588951|12349738|FG002|STARTED|Overall Study||6
11161475|NCT01588951|12349736|FG000|COMPLETED|Overall Study||2
11161476|NCT01588951|12349737|FG001|COMPLETED|Overall Study||2
11161477|NCT01588951|12349738|FG002|COMPLETED|Overall Study||5
11161478|NCT01588951|12349736|FG000|NOT COMPLETED|Overall Study||0
11161479|NCT01588951|12349737|FG001|NOT COMPLETED|Overall Study||0
11161480|NCT01588951|12349738|FG002|NOT COMPLETED|Overall Study||1
11161481|NCT01588990|12349746|FG000|STARTED|Phase A||128
11161482|NCT01588990|12349746|FG000|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58
11161483|NCT01588990|12349746|FG000|NOT COMPLETED|Phase A||70
11161484|NCT01588990|12349746|FG000|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53
11161485|NCT01588990|12349746|FG000|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37
11161486|NCT01588990|12349746|FG000|NOT COMPLETED|Phase B||16
11161487|NCT01589094|12349754|FG000|STARTED|Overall Study||51
11161488|NCT01589094|12349754|FG000|COMPLETED|Overall Study||49
11161489|NCT01589094|12349754|FG000|NOT COMPLETED|Overall Study||2
11161490|NCT01589185|12349763|FG000|STARTED|Overall Study||6
11161491|NCT01589185|12349764|FG001|STARTED|Overall Study||8
11161492|NCT01589185|12349765|FG002|STARTED|Overall Study||10
11161493|NCT01589185|12349766|FG003|STARTED|Overall Study||8
11161494|NCT01589185|12349767|FG004|STARTED|Overall Study||16
11161495|NCT01589185|12349763|FG000|COMPLETED|Overall Study||4
11161496|NCT01589185|12349764|FG001|COMPLETED|Overall Study||6
11161497|NCT01589185|12349765|FG002|COMPLETED|Overall Study||6
11161498|NCT01589185|12349766|FG003|COMPLETED|Overall Study||5
11161499|NCT01589185|12349767|FG004|COMPLETED|Overall Study||15
11161500|NCT01589185|12349763|FG000|NOT COMPLETED|Overall Study||2
11161501|NCT01589185|12349764|FG001|NOT COMPLETED|Overall Study||2
11161502|NCT01589185|12349765|FG002|NOT COMPLETED|Overall Study||4
11161503|NCT01589185|12349766|FG003|NOT COMPLETED|Overall Study||3
11161504|NCT01589185|12349767|FG004|NOT COMPLETED|Overall Study||1
11161505|NCT01589237|12349784|FG000|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
11161506|NCT01589237|12349785|FG001|STARTED|Part A (52 Weeks)||12
11161507|NCT01589237|12349786|FG002|STARTED|Part A (52 Weeks)||10
11161508|NCT01589237|12349787|FG003|STARTED|Part A (52 Weeks)||5
11161509|NCT01589237|12349784|FG000|COMPLETED|Part A (52 Weeks)||9
11161510|NCT01589237|12349785|FG001|COMPLETED|Part A (52 Weeks)||9
11161511|NCT01589237|12349786|FG002|COMPLETED|Part A (52 Weeks)||8
11161512|NCT01589237|12349787|FG003|COMPLETED|Part A (52 Weeks)||5
11161513|NCT01589237|12349784|FG000|NOT COMPLETED|Part A (52 Weeks)||2
11161514|NCT01589237|12349785|FG001|NOT COMPLETED|Part A (52 Weeks)||3
11161515|NCT01589237|12349786|FG002|NOT COMPLETED|Part A (52 Weeks)||2
11161516|NCT01589237|12349787|FG003|NOT COMPLETED|Part A (52 Weeks)||0
11161517|NCT01589237|12349784|FG000|STARTED|Part B (Planned for 78 Week-terminated)||5
11161518|NCT01589237|12349785|FG001|STARTED|Part B (Planned for 78 Week-terminated)||6
11161519|NCT01589237|12349786|FG002|STARTED|Part B (Planned for 78 Week-terminated)||4
11161520|NCT01589237|12349787|FG003|STARTED|Part B (Planned for 78 Week-terminated)||4
11419262|NCT00218036|12617749|FG001|STARTED|Overall Study||6
11419263|NCT00218036|12617750|FG002|STARTED|Overall Study||13
11161521|NCT01589237|12349784|FG000|COMPLETED|Part B (Planned for 78 Week-terminated)||0
11161522|NCT01589237|12349785|FG001|COMPLETED|Part B (Planned for 78 Week-terminated)||0
11161523|NCT01589237|12349786|FG002|COMPLETED|Part B (Planned for 78 Week-terminated)||0
11161524|NCT01589237|12349787|FG003|COMPLETED|Part B (Planned for 78 Week-terminated)||0
11161525|NCT01589237|12349784|FG000|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
11161526|NCT01589237|12349785|FG001|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
11161527|NCT01589237|12349786|FG002|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
11161528|NCT01589237|12349787|FG003|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
11161529|NCT01589263|12349803|FG000|STARTED|Overall Study||9
11161530|NCT01589263|12349804|FG001|STARTED|Overall Study||12
11161531|NCT01589263|12349803|FG000|COMPLETED|Overall Study||9
11323183|NCT01084252|12520458|FG001|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11161532|NCT01589263|12349804|FG001|COMPLETED|Overall Study||12
11161533|NCT01589263|12349803|FG000|NOT COMPLETED|Overall Study||0
11161534|NCT01589263|12349804|FG001|NOT COMPLETED|Overall Study||0
11161535|NCT01589315|12349810|FG000|STARTED|Overall Study||17
11161536|NCT01589315|12349810|FG000|COMPLETED|Overall Study||16
11161537|NCT01589315|12349810|FG000|NOT COMPLETED|Overall Study||1
11161538|NCT01589445|12349814|FG000|STARTED|001 (Pioglitazone) -3 Months||77
11161539|NCT01589445|12349814|FG000|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
11161540|NCT01589445|12349814|FG000|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
11161541|NCT01589445|12349814|FG000|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
11161542|NCT01589445|12349814|FG000|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
11161543|NCT01589445|12349814|FG000|NOT COMPLETED|002 (Metformin)-3 Months||9
11161544|NCT01589484|12349822|FG000|STARTED|Overall Study||104
11161545|NCT01589484|12349822|FG000|COMPLETED|Overall Study||100
11161546|NCT01589484|12349822|FG000|NOT COMPLETED|Overall Study||4
11161547|NCT01589497|12349831|FG000|STARTED|Overall Study||18
11161548|NCT01589497|12349832|FG001|STARTED|Overall Study||17
11161549|NCT01589497|12349833|FG002|STARTED|Overall Study||16
11161550|NCT01589497|12349834|FG003|STARTED|Overall Study||18
11161551|NCT01589497|12349831|FG000|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
11161552|NCT01589497|12349832|FG001|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
11161553|NCT01589497|12349833|FG002|COMPLETED|Overall Study||15
11161554|NCT01589497|12349834|FG003|COMPLETED|Overall Study||17
11161555|NCT01589497|12349831|FG000|NOT COMPLETED|Overall Study||1
11161556|NCT01589497|12349832|FG001|NOT COMPLETED|Overall Study||1
11161557|NCT01589497|12349833|FG002|NOT COMPLETED|Overall Study||1
11161558|NCT01589497|12349834|FG003|NOT COMPLETED|Overall Study||1
11161559|NCT01589510|12349849|FG000|STARTED|Overall Study||419
11161560|NCT01589510|12349849|FG000|COMPLETED|Overall Study||386
11161561|NCT01589510|12349849|FG000|NOT COMPLETED|Overall Study||33
11161562|NCT01589601|12349855|FG000|STARTED|Overall Study||75
11161563|NCT01589601|12349856|FG001|STARTED|Overall Study||75
11161564|NCT01589601|12349855|FG000|COMPLETED|Overall Study||28
11161565|NCT01589601|12349856|FG001|COMPLETED|Overall Study||26
11161566|NCT01589601|12349855|FG000|NOT COMPLETED|Overall Study||47
11161567|NCT01589601|12349856|FG001|NOT COMPLETED|Overall Study||49
11161568|NCT01589653|12349864|FG000|STARTED|Overall Study||76
11161569|NCT01589653|12349865|FG001|STARTED|Overall Study||79
11161570|NCT01589653|12349864|FG000|Exposed|Overall Study||76
11161571|NCT01589653|12349865|FG001|Exposed|Overall Study||78
11161572|NCT01589653|12349864|FG000|COMPLETED|Overall Study||69
11161573|NCT01589653|12349865|FG001|COMPLETED|Overall Study||68
11161574|NCT01589653|12349864|FG000|NOT COMPLETED|Overall Study||7
11161575|NCT01589653|12349865|FG001|NOT COMPLETED|Overall Study||11
11161576|NCT01589770|12349873|FG000|STARTED|Overall Study||67
11161577|NCT01589770|12349874|FG001|STARTED|Overall Study||61
11419264|NCT00218036|12617751|FG003|STARTED|Overall Study||12
11161578|NCT01589770|12349873|FG000|COMPLETED|Overall Study||59
11161579|NCT01589770|12349874|FG001|COMPLETED|Overall Study||56
11161580|NCT01589770|12349873|FG000|NOT COMPLETED|Overall Study||8
11161581|NCT01589770|12349874|FG001|NOT COMPLETED|Overall Study||5
11161582|NCT01589822|12349883|FG000|STARTED|Overall Study||84
11161583|NCT01589822|12349884|FG001|STARTED|Overall Study||89
11161584|NCT01589822|12349885|FG002|STARTED|Overall Study||41
11161585|NCT01589822|12349883|FG000|COMPLETED|Overall Study||80
11161586|NCT01589822|12349884|FG001|COMPLETED|Overall Study||86
11161587|NCT01589822|12349885|FG002|COMPLETED|Overall Study||40
11161588|NCT01589822|12349883|FG000|NOT COMPLETED|Overall Study||4
11161589|NCT01589822|12349884|FG001|NOT COMPLETED|Overall Study||3
11161590|NCT01589822|12349885|FG002|NOT COMPLETED|Overall Study||1
11161591|NCT01589978|12349895|FG000|STARTED|Overall Study||2681
11161592|NCT01589978|12349895|FG000|COMPLETED|Overall Study||2681
11161593|NCT01589978|12349895|FG000|NOT COMPLETED|Overall Study||0
11161594|NCT01590082|12349902|FG000|STARTED|Overall Study||11
11161595|NCT01590082|12349903|FG001|STARTED|Overall Study||1
11161596|NCT01590082|12349902|FG000|COMPLETED|Overall Study||9
11161597|NCT01590082|12349903|FG001|COMPLETED|Overall Study||1
11161598|NCT01590082|12349902|FG000|NOT COMPLETED|Overall Study||2
11161599|NCT01590082|12349903|FG001|NOT COMPLETED|Overall Study||0
11161600|NCT01590212|12349912|FG000|STARTED|Overall Study||12
11161601|NCT01590212|12349913|FG001|STARTED|Overall Study||9
11161602|NCT01590212|12349914|FG002|STARTED|Overall Study||14
11161603|NCT01590212|12349912|FG000|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
11161604|NCT01590212|12349913|FG001|Baseline (Pre-intervention)|Overall Study||9
11161605|NCT01590212|12349914|FG002|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
11161606|NCT01590212|12349912|FG000|Post-intervention|Overall Study|failed contact=3|7
11161607|NCT01590212|12349913|FG001|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
11161608|NCT01590212|12349914|FG002|Post-intervention|Overall Study|failed contact=1|10
11161609|NCT01590212|12349912|FG000|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
11161610|NCT01590212|12349913|FG001|COMPLETED|Overall Study||5
11161611|NCT01590212|12349914|FG002|COMPLETED|Overall Study||9
11161612|NCT01590212|12349912|FG000|NOT COMPLETED|Overall Study||3
11161613|NCT01590212|12349913|FG001|NOT COMPLETED|Overall Study||4
11161614|NCT01590212|12349914|FG002|NOT COMPLETED|Overall Study||5
11161615|NCT01590238|12349923|FG000|STARTED|Overall Study||15
11161616|NCT01590238|12349923|FG000|COMPLETED|Overall Study||13
11161617|NCT01590238|12349923|FG000|NOT COMPLETED|Overall Study||2
11161618|NCT01590264|12349927|FG000|STARTED|Overall Study||5
11161619|NCT01590264|12349927|FG000|COMPLETED|Overall Study||5
11161620|NCT01590264|12349927|FG000|NOT COMPLETED|Overall Study||0
11161621|NCT01590433|12349933|FG000|STARTED|Overall Study||127
11161622|NCT01590433|12349934|FG001|STARTED|Overall Study||55
11161623|NCT01590433|12349933|FG000|COMPLETED|Overall Study||75
11161624|NCT01590433|12349934|FG001|COMPLETED|Overall Study||33
11161625|NCT01590433|12349933|FG000|NOT COMPLETED|Overall Study||52
11161626|NCT01590433|12349934|FG001|NOT COMPLETED|Overall Study||22
11161627|NCT01590550|12349940|FG000|STARTED|Overall Study||18
11161628|NCT01590550|12349940|FG000|COMPLETED|Overall Study||18
11161629|NCT01590550|12349940|FG000|NOT COMPLETED|Overall Study||0
11161630|NCT01590563|12349945|FG000|STARTED|Overall Study||15
11161631|NCT01590563|12349945|FG000|COMPLETED|Overall Study||14
11161632|NCT01590563|12349945|FG000|NOT COMPLETED|Overall Study||1
11161633|NCT01590758|12349952|FG000|STARTED|Overall Study||85
11161634|NCT01590758|12349953|FG001|STARTED|Overall Study||104
11161635|NCT01590758|12349952|FG000|COMPLETED|Overall Study||80
11161636|NCT01590758|12349953|FG001|COMPLETED|Overall Study||97
11161637|NCT01590758|12349952|FG000|NOT COMPLETED|Overall Study||5
11161638|NCT01590758|12349953|FG001|NOT COMPLETED|Overall Study||7
11161639|NCT01590771|12349961|FG000|STARTED|Overall Study||249
11161640|NCT01590771|12349962|FG001|STARTED|Overall Study||249
11161641|NCT01590771|12349961|FG000|COMPLETED|Overall Study||230
11161642|NCT01590771|12349962|FG001|COMPLETED|Overall Study||210
11161643|NCT01590771|12349961|FG000|NOT COMPLETED|Overall Study||19
11161644|NCT01590771|12349962|FG001|NOT COMPLETED|Overall Study||39
11161645|NCT01590797|12349970|FG000|STARTED|Overall Study||234
11161646|NCT01590797|12349971|FG001|STARTED|Overall Study||233
11161647|NCT01590797|12349970|FG000|COMPLETED|Overall Study||217
11161648|NCT01590797|12349971|FG001|COMPLETED|Overall Study||217
11161649|NCT01590797|12349970|FG000|NOT COMPLETED|Overall Study||17
11161650|NCT01590797|12349971|FG001|NOT COMPLETED|Overall Study||16
11161651|NCT01590810|12349982|FG000|STARTED|Overall Study||8
11161652|NCT01590810|12349983|FG001|STARTED|Overall Study||8
11161653|NCT01590810|12349984|FG002|STARTED|Overall Study||8
11161654|NCT01590810|12349985|FG003|STARTED|Overall Study||8
11161655|NCT01590810|12349986|FG004|STARTED|Overall Study||2
11161656|NCT01590810|12349982|FG000|COMPLETED|Overall Study||8
11161657|NCT01590810|12349983|FG001|COMPLETED|Overall Study||7
11161658|NCT01590810|12349984|FG002|COMPLETED|Overall Study||7
11161659|NCT01590810|12349985|FG003|COMPLETED|Overall Study||8
11161660|NCT01590810|12349986|FG004|COMPLETED|Overall Study||2
11161661|NCT01590810|12349982|FG000|NOT COMPLETED|Overall Study||0
11323184|NCT01084252|12520459|FG002|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323185|NCT01084252|12520460|FG003|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323186|NCT01084252|12520461|FG004|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323187|NCT01084252|12520462|FG005|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11161662|NCT01590810|12349983|FG001|NOT COMPLETED|Overall Study||1
11323188|NCT01084252|12520463|FG006|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323189|NCT01084252|12520464|FG007|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323190|NCT01084252|12520465|FG008|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
11323191|NCT01084252|12520466|FG009|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
11323192|NCT01084252|12520467|FG010|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
11323193|NCT01084252|12520468|FG011|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
11323194|NCT01084252|12520469|FG012|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323195|NCT01084252|12520470|FG013|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323196|NCT01084252|12520457|FG000|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323197|NCT01084252|12520458|FG001|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323198|NCT01084252|12520459|FG002|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323199|NCT01084252|12520460|FG003|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323200|NCT01084252|12520461|FG004|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323201|NCT01084252|12520462|FG005|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323202|NCT01084252|12520463|FG006|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323203|NCT01084252|12520464|FG007|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323204|NCT01084252|12520465|FG008|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323205|NCT01084252|12520466|FG009|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323206|NCT01084252|12520467|FG010|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323207|NCT01084252|12520468|FG011|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323208|NCT01084252|12520469|FG012|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323209|NCT01084252|12520470|FG013|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323210|NCT01084252|12520457|FG000|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323211|NCT01084252|12520458|FG001|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323212|NCT01084252|12520459|FG002|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11343028|NCT02950545|12540317|FG000|COMPLETED|Session 3 (70 Minutes)||7
11161663|NCT01590810|12349984|FG002|NOT COMPLETED|Overall Study||1
11161664|NCT01590810|12349985|FG003|NOT COMPLETED|Overall Study||0
11161665|NCT01590810|12349986|FG004|NOT COMPLETED|Overall Study||0
11161666|NCT01590875|12350021|FG000|STARTED|Overall Study||10
11161667|NCT01590875|12350022|FG001|STARTED|Overall Study||10
11161668|NCT01590875|12350021|FG000|COMPLETED|Overall Study||10
11161669|NCT01590875|12350022|FG001|COMPLETED|Overall Study||10
11161670|NCT01590875|12350021|FG000|NOT COMPLETED|Overall Study||0
11161671|NCT01590875|12350022|FG001|NOT COMPLETED|Overall Study||0
11161672|NCT01590888|12350033|FG000|STARTED|Overall Study||36
11161673|NCT01590888|12350034|FG001|STARTED|Overall Study||38
11161674|NCT01590888|12350035|FG002|STARTED|Overall Study||35
11161675|NCT01590888|12350033|FG000|COMPLETED|Overall Study||32
11161676|NCT01590888|12350034|FG001|COMPLETED|Overall Study||38
11161677|NCT01590888|12350035|FG002|COMPLETED|Overall Study||34
11161678|NCT01590888|12350033|FG000|NOT COMPLETED|Overall Study||4
11161679|NCT01590888|12350034|FG001|NOT COMPLETED|Overall Study||0
11161680|NCT01590888|12350035|FG002|NOT COMPLETED|Overall Study||1
11161681|NCT01590979|12350045|FG000|STARTED|Overall Study||27
11161682|NCT01590979|12350046|FG001|STARTED|Overall Study||27
11161683|NCT01590979|12350045|FG000|COMPLETED|Overall Study||27
11161684|NCT01590979|12350046|FG001|COMPLETED|Overall Study||27
11161685|NCT01590979|12350045|FG000|NOT COMPLETED|Overall Study||0
11161686|NCT01590979|12350046|FG001|NOT COMPLETED|Overall Study||0
11161687|NCT01591005|12350056|FG000|STARTED|Overall Study||53
11161688|NCT01591005|12350057|FG001|STARTED|Overall Study||53
11161689|NCT01591005|12350058|FG002|STARTED|Overall Study||68
11161690|NCT01591005|12350059|FG003|STARTED|Overall Study||68
11161691|NCT01591005|12350056|FG000|COMPLETED|Overall Study||53
11161692|NCT01591005|12350057|FG001|COMPLETED|Overall Study||53
11161693|NCT01591005|12350058|FG002|COMPLETED|Overall Study||68
11161694|NCT01591005|12350059|FG003|COMPLETED|Overall Study||68
11161695|NCT01591005|12350056|FG000|NOT COMPLETED|Overall Study||0
11161696|NCT01591005|12350057|FG001|NOT COMPLETED|Overall Study||0
11161697|NCT01591005|12350058|FG002|NOT COMPLETED|Overall Study||0
11161698|NCT01591005|12350059|FG003|NOT COMPLETED|Overall Study||0
11161699|NCT01591018|12350071|FG000|STARTED|Overall Study||60
11161700|NCT01591018|12350072|FG001|STARTED|Overall Study||60
11161701|NCT01591018|12350071|FG000|COMPLETED|Overall Study||60
11161702|NCT01591018|12350072|FG001|COMPLETED|Overall Study||60
11161703|NCT01591018|12350071|FG000|NOT COMPLETED|Overall Study||0
11161704|NCT01591018|12350072|FG001|NOT COMPLETED|Overall Study||0
11161705|NCT01591044|12350081|FG000|STARTED|Overall Study||101
11161706|NCT01591044|12350082|FG001|STARTED|Overall Study||100
11161707|NCT01591044|12350083|FG002|STARTED|Overall Study||100
11161708|NCT01591044|12350081|FG000|COMPLETED|Overall Study||94
11161709|NCT01591044|12350082|FG001|COMPLETED|Overall Study||91
11161710|NCT01591044|12350083|FG002|COMPLETED|Overall Study||96
11161711|NCT01591044|12350081|FG000|NOT COMPLETED|Overall Study||7
11161712|NCT01591044|12350082|FG001|NOT COMPLETED|Overall Study||9
11161713|NCT01591044|12350083|FG002|NOT COMPLETED|Overall Study||4
11161714|NCT01591161|12350093|FG000|STARTED|Overall Study||245
11161715|NCT01591161|12350094|FG001|STARTED|Overall Study||124
11161716|NCT01591161|12350093|FG000|COMPLETED|Overall Study||174
11161717|NCT01591161|12350094|FG001|COMPLETED|Overall Study||68
11161718|NCT01591161|12350093|FG000|NOT COMPLETED|Overall Study||71
11161719|NCT01591161|12350094|FG001|NOT COMPLETED|Overall Study||56
11161720|NCT01591317|12350103|FG000|STARTED|Overall Study||10
11161721|NCT01591317|12350104|FG001|STARTED|Overall Study||10
11161722|NCT01591317|12350105|FG002|STARTED|Overall Study||10
11161723|NCT01591317|12350103|FG000|COMPLETED|Overall Study||10
11161724|NCT01591317|12350104|FG001|COMPLETED|Overall Study||10
11161725|NCT01591317|12350105|FG002|COMPLETED|Overall Study||10
11161726|NCT01591317|12350103|FG000|NOT COMPLETED|Overall Study||0
11161727|NCT01591317|12350104|FG001|NOT COMPLETED|Overall Study||0
11161728|NCT01591317|12350105|FG002|NOT COMPLETED|Overall Study||0
11161729|NCT01591330|12350118|FG000|STARTED|Period 1||8
11161730|NCT01591330|12350119|FG001|STARTED|Period 1||9
11161731|NCT01591330|12350120|FG002|STARTED|Period 1||9
11161732|NCT01591330|12350121|FG003|STARTED|Period 1||9
11161733|NCT01591330|12350118|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
11161734|NCT01591330|12350119|FG001|Received at Least 1 Dose of Study Drug|Period 1||9
11161735|NCT01591330|12350120|FG002|Received at Least 1 Dose of Study Drug|Period 1||9
11161736|NCT01591330|12350121|FG003|Received at Least 1 Dose of Study Drug|Period 1||9
11161737|NCT01591330|12350118|FG000|COMPLETED|Period 1||7
11161738|NCT01591330|12350119|FG001|COMPLETED|Period 1||9
11161739|NCT01591330|12350120|FG002|COMPLETED|Period 1||9
11161740|NCT01591330|12350121|FG003|COMPLETED|Period 1||9
11161741|NCT01591330|12350118|FG000|NOT COMPLETED|Period 1||1
11161742|NCT01591330|12350119|FG001|NOT COMPLETED|Period 1||0
11161743|NCT01591330|12350120|FG002|NOT COMPLETED|Period 1||0
11161744|NCT01591330|12350121|FG003|NOT COMPLETED|Period 1||0
11161745|NCT01591330|12350118|FG000|STARTED|Washout of at Least 3 Days||7
11161746|NCT01591330|12350119|FG001|STARTED|Washout of at Least 3 Days||9
11161747|NCT01591330|12350120|FG002|STARTED|Washout of at Least 3 Days||9
11161748|NCT01591330|12350121|FG003|STARTED|Washout of at Least 3 Days||9
11161749|NCT01591330|12350118|FG000|COMPLETED|Washout of at Least 3 Days||6
11161750|NCT01591330|12350119|FG001|COMPLETED|Washout of at Least 3 Days||9
11161751|NCT01591330|12350120|FG002|COMPLETED|Washout of at Least 3 Days||9
11161752|NCT01591330|12350121|FG003|COMPLETED|Washout of at Least 3 Days||9
11161753|NCT01591330|12350118|FG000|NOT COMPLETED|Washout of at Least 3 Days||1
11161754|NCT01591330|12350119|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
11161755|NCT01591330|12350120|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
11161756|NCT01591330|12350121|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
11161757|NCT01591330|12350118|FG000|STARTED|Period 2||6
11161758|NCT01591330|12350119|FG001|STARTED|Period 2||9
11161759|NCT01591330|12350120|FG002|STARTED|Period 2||9
11161760|NCT01591330|12350121|FG003|STARTED|Period 2||9
11161761|NCT01591330|12350118|FG000|COMPLETED|Period 2||5
11161762|NCT01591330|12350119|FG001|COMPLETED|Period 2||9
11161763|NCT01591330|12350120|FG002|COMPLETED|Period 2||9
11161764|NCT01591330|12350121|FG003|COMPLETED|Period 2||9
11161765|NCT01591330|12350118|FG000|NOT COMPLETED|Period 2||1
11161766|NCT01591330|12350119|FG001|NOT COMPLETED|Period 2||0
11161767|NCT01591330|12350120|FG002|NOT COMPLETED|Period 2||0
11161768|NCT01591330|12350121|FG003|NOT COMPLETED|Period 2||0
11161769|NCT01591330|12350118|FG000|STARTED|Washout of at Least 3 Days||5
11161770|NCT01591330|12350119|FG001|STARTED|Washout of at Least 3 Days||9
11161771|NCT01591330|12350120|FG002|STARTED|Washout of at Least 3 Days||9
11161772|NCT01591330|12350121|FG003|STARTED|Washout of at Least 3 Days||9
11161773|NCT01591330|12350118|FG000|COMPLETED|Washout of at Least 3 Days||5
11161774|NCT01591330|12350119|FG001|COMPLETED|Washout of at Least 3 Days||9
11161775|NCT01591330|12350120|FG002|COMPLETED|Washout of at Least 3 Days||9
11161776|NCT01591330|12350121|FG003|COMPLETED|Washout of at Least 3 Days||9
11161777|NCT01591330|12350118|FG000|NOT COMPLETED|Washout of at Least 3 Days||0
11161778|NCT01591330|12350119|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
11161779|NCT01591330|12350120|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
11161780|NCT01591330|12350121|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
11161781|NCT01591330|12350118|FG000|STARTED|Period 3||5
11161782|NCT01591330|12350119|FG001|STARTED|Period 3||9
11161783|NCT01591330|12350120|FG002|STARTED|Period 3||9
11161784|NCT01591330|12350121|FG003|STARTED|Period 3||9
11161785|NCT01591330|12350118|FG000|COMPLETED|Period 3||5
11161786|NCT01591330|12350119|FG001|COMPLETED|Period 3||9
11161787|NCT01591330|12350120|FG002|COMPLETED|Period 3||9
11161788|NCT01591330|12350121|FG003|COMPLETED|Period 3||9
11161789|NCT01591330|12350118|FG000|NOT COMPLETED|Period 3||0
11161790|NCT01591330|12350119|FG001|NOT COMPLETED|Period 3||0
11161791|NCT01591330|12350120|FG002|NOT COMPLETED|Period 3||0
11161792|NCT01591330|12350121|FG003|NOT COMPLETED|Period 3||0
11161793|NCT01591330|12350118|FG000|STARTED|Washout of at Least 3 Days||5
11161794|NCT01591330|12350119|FG001|STARTED|Washout of at Least 3 Days||9
11161795|NCT01591330|12350120|FG002|STARTED|Washout of at Least 3 Days||9
11161796|NCT01591330|12350121|FG003|STARTED|Washout of at Least 3 Days||9
11161797|NCT01591330|12350118|FG000|COMPLETED|Washout of at Least 3 Days||5
11161798|NCT01591330|12350119|FG001|COMPLETED|Washout of at Least 3 Days||9
11161799|NCT01591330|12350120|FG002|COMPLETED|Washout of at Least 3 Days||9
11161800|NCT01591330|12350121|FG003|COMPLETED|Washout of at Least 3 Days||9
11161801|NCT01591330|12350118|FG000|NOT COMPLETED|Washout of at Least 3 Days||0
11161802|NCT01591330|12350119|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
11161803|NCT01591330|12350120|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
11161804|NCT01591330|12350121|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
11161805|NCT01591330|12350118|FG000|STARTED|Period 4||5
11161806|NCT01591330|12350119|FG001|STARTED|Period 4||9
11161807|NCT01591330|12350120|FG002|STARTED|Period 4||9
11161808|NCT01591330|12350121|FG003|STARTED|Period 4||9
11161809|NCT01591330|12350118|FG000|COMPLETED|Period 4||5
11161810|NCT01591330|12350119|FG001|COMPLETED|Period 4||9
11161811|NCT01591330|12350120|FG002|COMPLETED|Period 4||9
11161812|NCT01591330|12350121|FG003|COMPLETED|Period 4||9
11161813|NCT01591330|12350118|FG000|NOT COMPLETED|Period 4||0
11161814|NCT01591330|12350119|FG001|NOT COMPLETED|Period 4||0
11161815|NCT01591330|12350120|FG002|NOT COMPLETED|Period 4||0
11161816|NCT01591330|12350121|FG003|NOT COMPLETED|Period 4||0
11161817|NCT01591382|12350133|FG000|STARTED|Overall Study||32
11161818|NCT01591382|12350134|FG001|STARTED|Overall Study||32
11161819|NCT01591382|12350133|FG000|COMPLETED|Overall Study||29
11161820|NCT01591382|12350134|FG001|COMPLETED|Overall Study||30
11161821|NCT01591382|12350133|FG000|NOT COMPLETED|Overall Study||3
11161822|NCT01591382|12350134|FG001|NOT COMPLETED|Overall Study||2
11161823|NCT01591408|12350142|FG000|STARTED|Overall Study||36
11161824|NCT01591408|12350143|FG001|STARTED|Overall Study||32
11161825|NCT01591408|12350142|FG000|COMPLETED|Overall Study||24
11161826|NCT01591408|12350143|FG001|COMPLETED|Overall Study||24
11161827|NCT01591408|12350142|FG000|NOT COMPLETED|Overall Study||12
11161828|NCT01591408|12350143|FG001|NOT COMPLETED|Overall Study||8
11161829|NCT01591460|12350149|FG000|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
11161830|NCT01591460|12350149|FG000|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
11161831|NCT01591460|12350149|FG000|NOT COMPLETED|Overall Study||26
11161832|NCT01591499|12350161|FG000|STARTED|Baseline Visit||33
11161833|NCT01591499|12350162|FG001|STARTED|Baseline Visit||39
11161834|NCT01591499|12350163|FG002|STARTED|Baseline Visit||31
11161835|NCT01591499|12350164|FG003|STARTED|Baseline Visit||39
11161836|NCT01591499|12350161|FG000|COMPLETED|Baseline Visit||33
11161837|NCT01591499|12350162|FG001|COMPLETED|Baseline Visit||37
11161838|NCT01591499|12350163|FG002|COMPLETED|Baseline Visit||31
11161839|NCT01591499|12350164|FG003|COMPLETED|Baseline Visit||37
11161840|NCT01591499|12350161|FG000|NOT COMPLETED|Baseline Visit||0
11161841|NCT01591499|12350162|FG001|NOT COMPLETED|Baseline Visit||2
11161842|NCT01591499|12350163|FG002|NOT COMPLETED|Baseline Visit||0
11323213|NCT01084252|12520460|FG003|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323214|NCT01084252|12520461|FG004|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11161843|NCT01591499|12350164|FG003|NOT COMPLETED|Baseline Visit||2
11161844|NCT01591499|12350161|FG000|STARTED|First Intervention (up to 24 Days)||33
11161845|NCT01591499|12350162|FG001|STARTED|First Intervention (up to 24 Days)||37
11161846|NCT01591499|12350163|FG002|STARTED|First Intervention (up to 24 Days)||31
11161847|NCT01591499|12350164|FG003|STARTED|First Intervention (up to 24 Days)||37
11161848|NCT01591499|12350161|FG000|COMPLETED|First Intervention (up to 24 Days)||33
11161849|NCT01591499|12350162|FG001|COMPLETED|First Intervention (up to 24 Days)||37
11161850|NCT01591499|12350163|FG002|COMPLETED|First Intervention (up to 24 Days)||31
11161851|NCT01591499|12350164|FG003|COMPLETED|First Intervention (up to 24 Days)||37
11161852|NCT01591499|12350161|FG000|NOT COMPLETED|First Intervention (up to 24 Days)||0
11161853|NCT01591499|12350162|FG001|NOT COMPLETED|First Intervention (up to 24 Days)||0
11161854|NCT01591499|12350163|FG002|NOT COMPLETED|First Intervention (up to 24 Days)||0
11161855|NCT01591499|12350164|FG003|NOT COMPLETED|First Intervention (up to 24 Days)||0
11161856|NCT01591499|12350161|FG000|STARTED|Second Intervention (up to 24 Days)||33
11161857|NCT01591499|12350162|FG001|STARTED|Second Intervention (up to 24 Days)||37
11161858|NCT01591499|12350163|FG002|STARTED|Second Intervention (up to 24 Days)||31
11161859|NCT01591499|12350164|FG003|STARTED|Second Intervention (up to 24 Days)||37
11161860|NCT01591499|12350161|FG000|COMPLETED|Second Intervention (up to 24 Days)||27
11161861|NCT01591499|12350162|FG001|COMPLETED|Second Intervention (up to 24 Days)||34
11161862|NCT01591499|12350163|FG002|COMPLETED|Second Intervention (up to 24 Days)||28
11161863|NCT01591499|12350164|FG003|COMPLETED|Second Intervention (up to 24 Days)||34
11161864|NCT01591499|12350161|FG000|NOT COMPLETED|Second Intervention (up to 24 Days)||6
11161865|NCT01591499|12350162|FG001|NOT COMPLETED|Second Intervention (up to 24 Days)||3
11161866|NCT01591499|12350163|FG002|NOT COMPLETED|Second Intervention (up to 24 Days)||3
11161867|NCT01591499|12350164|FG003|NOT COMPLETED|Second Intervention (up to 24 Days)||3
11161868|NCT01591616|12350188|FG000|STARTED|Overall Study||16
11161869|NCT01591616|12350188|FG000|COMPLETED|Overall Study||15
11161870|NCT01591616|12350188|FG000|NOT COMPLETED|Overall Study||1
11161871|NCT01591655|12350329|FG000|STARTED|Overall Study||240
11161872|NCT01591655|12350330|FG001|STARTED|Overall Study||120
11161873|NCT01591655|12350329|FG000|COMPLETED|Overall Study||168
11161874|NCT01591655|12350330|FG001|COMPLETED|Overall Study||57
11161875|NCT01591655|12350329|FG000|NOT COMPLETED|Overall Study||72
11161876|NCT01591655|12350330|FG001|NOT COMPLETED|Overall Study||63
11026719|NCT00830063|12205318|FG002|NOT COMPLETED|Overall Study||198
11026720|NCT00830063|12205319|FG003|NOT COMPLETED|Overall Study||195
11026721|NCT00830076|12205331|FG000|STARTED|Sitagliptin + Placebo Metformin||18
11161877|NCT01591681|12350336|FG000|STARTED|Overall Study||49
11161878|NCT01591681|12350336|FG000|COMPLETED|Overall Study||45
11161879|NCT01591681|12350336|FG000|NOT COMPLETED|Overall Study||4
11161880|NCT01591733|12350342|FG000|STARTED|Overall Study||48
11161881|NCT01591733|12350342|FG000|COMPLETED|Overall Study||48
11161882|NCT01591733|12350342|FG000|NOT COMPLETED|Overall Study||0
11161883|NCT01591746|12350350|FG000|STARTED|Overall Study||68
11161884|NCT01591746|12350351|FG001|STARTED|Overall Study||63
11161885|NCT01591746|12350350|FG000|COMPLETED|Overall Study||68
11161886|NCT01591746|12350351|FG001|COMPLETED|Overall Study||63
11161887|NCT01591746|12350350|FG000|NOT COMPLETED|Overall Study||0
11161888|NCT01591746|12350351|FG001|NOT COMPLETED|Overall Study||0
11161889|NCT01591785|12350359|FG000|STARTED|Overall Study||30
11161890|NCT01591785|12350360|FG001|STARTED|Overall Study||30
11161891|NCT01591785|12350359|FG000|COMPLETED|Overall Study||26
11161892|NCT01591785|12350360|FG001|COMPLETED|Overall Study||28
11161893|NCT01591785|12350359|FG000|NOT COMPLETED|Overall Study||4
11161894|NCT01591785|12350360|FG001|NOT COMPLETED|Overall Study||2
11161895|NCT01591837|12350368|FG000|STARTED|Overall Study||60
11161896|NCT01591837|12350369|FG001|STARTED|Overall Study||60
11161897|NCT01591837|12350368|FG000|COMPLETED|Overall Study||60
11161898|NCT01591837|12350369|FG001|COMPLETED|Overall Study||60
11161899|NCT01591837|12350368|FG000|NOT COMPLETED|Overall Study||0
11161900|NCT01591837|12350369|FG001|NOT COMPLETED|Overall Study||0
11161901|NCT01591863|12350375|FG000|STARTED|Overall Study||38
11161902|NCT01591863|12350375|FG000|COMPLETED|Overall Study||24
11161903|NCT01591863|12350375|FG000|NOT COMPLETED|Overall Study||14
11161904|NCT01592006|12350379|FG000|STARTED|Overall Study||3
11161905|NCT01592006|12350379|FG000|COMPLETED|Overall Study||3
11419265|NCT00218036|12617752|FG004|STARTED|Overall Study||9
11161906|NCT01592006|12350379|FG000|NOT COMPLETED|Overall Study||0
11161907|NCT01592045|12350385|FG000|STARTED|Overall Study||14
11161908|NCT01592045|12350386|FG001|STARTED|Overall Study||14
11161909|NCT01592045|12350385|FG000|Completed Course 1|Overall Study||13
11161910|NCT01592045|12350386|FG001|Completed Course 1|Overall Study||14
11161911|NCT01592045|12350385|FG000|Completed Course 2|Overall Study||13
11161912|NCT01592045|12350386|FG001|Completed Course 2|Overall Study||13
11419266|NCT00218036|12617748|FG000|COMPLETED|Overall Study||6
11419267|NCT00218036|12617749|FG001|COMPLETED|Overall Study||3
11161913|NCT01592045|12350385|FG000|Completed Course 3|Overall Study||11
11161914|NCT01592045|12350386|FG001|Completed Course 3|Overall Study||13
11161915|NCT01592045|12350385|FG000|Completed Course 4|Overall Study||11
11161916|NCT01592045|12350386|FG001|Completed Course 4|Overall Study||12
11161917|NCT01592045|12350385|FG000|Completed Course 5|Overall Study||9
11161918|NCT01592045|12350386|FG001|Completed Course 5|Overall Study||12
11161919|NCT01592045|12350385|FG000|COMPLETED|Overall Study||9
11161920|NCT01592045|12350386|FG001|COMPLETED|Overall Study||12
11161921|NCT01592045|12350385|FG000|NOT COMPLETED|Overall Study||5
11161922|NCT01592045|12350386|FG001|NOT COMPLETED|Overall Study||2
11161923|NCT01592071|12350392|FG000|STARTED|Overall Study||120
11161924|NCT01592071|12350392|FG000|COMPLETED|Overall Study||120
11161925|NCT01592071|12350392|FG000|NOT COMPLETED|Overall Study||0
11161926|NCT01592240|12350403|FG000|STARTED|Overall Study||50
11161927|NCT01592240|12350404|FG001|STARTED|Overall Study||50
11161928|NCT01592240|12350405|FG002|STARTED|Overall Study||52
11161929|NCT01592240|12350406|FG003|STARTED|Overall Study||50
11161930|NCT01592240|12350407|FG004|STARTED|Overall Study||51
11161931|NCT01592240|12350408|FG005|STARTED|Overall Study||50
11161932|NCT01592240|12350409|FG006|STARTED|Overall Study||51
11161933|NCT01592240|12350403|FG000|COMPLETED|Overall Study||47
11161934|NCT01592240|12350404|FG001|COMPLETED|Overall Study||39
11161935|NCT01592240|12350405|FG002|COMPLETED|Overall Study||45
11161936|NCT01592240|12350406|FG003|COMPLETED|Overall Study||47
11161937|NCT01592240|12350407|FG004|COMPLETED|Overall Study||44
11161938|NCT01592240|12350408|FG005|COMPLETED|Overall Study||47
11161939|NCT01592240|12350409|FG006|COMPLETED|Overall Study||48
11161940|NCT01592240|12350403|FG000|NOT COMPLETED|Overall Study||3
11161941|NCT01592240|12350404|FG001|NOT COMPLETED|Overall Study||11
11161942|NCT01592240|12350405|FG002|NOT COMPLETED|Overall Study||7
11161943|NCT01592240|12350406|FG003|NOT COMPLETED|Overall Study||3
11161944|NCT01592240|12350407|FG004|NOT COMPLETED|Overall Study||7
11161945|NCT01592240|12350408|FG005|NOT COMPLETED|Overall Study||3
11161946|NCT01592240|12350409|FG006|NOT COMPLETED|Overall Study||3
11161947|NCT01592292|12350432|FG000|STARTED|Overall Study||46
11161948|NCT01592292|12350433|FG001|STARTED|Overall Study||20
11161949|NCT01592292|12350434|FG002|STARTED|Overall Study||13
11161950|NCT01592292|12350435|FG003|STARTED|Overall Study||11
11161951|NCT01592292|12350432|FG000|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
11161952|NCT01592292|12350433|FG001|Intention to Treat (ITT) Set|Overall Study||13
11161953|NCT01592292|12350434|FG002|Intention to Treat (ITT) Set|Overall Study||10
11161954|NCT01592292|12350435|FG003|Intention to Treat (ITT) Set|Overall Study||8
11161955|NCT01592292|12350432|FG000|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
11161956|NCT01592292|12350433|FG001|Standard Population Set (SPS)|Overall Study||10
11161957|NCT01592292|12350434|FG002|Standard Population Set (SPS)|Overall Study||7
11161958|NCT01592292|12350435|FG003|Standard Population Set (SPS)|Overall Study||7
11161959|NCT01592292|12350432|FG000|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
11161960|NCT01592292|12350433|FG001|COMPLETED|Overall Study||15
11161961|NCT01592292|12350434|FG002|COMPLETED|Overall Study||10
11161962|NCT01592292|12350435|FG003|COMPLETED|Overall Study||10
11161963|NCT01592292|12350432|FG000|NOT COMPLETED|Overall Study||6
11161964|NCT01592292|12350433|FG001|NOT COMPLETED|Overall Study||5
11161965|NCT01592292|12350434|FG002|NOT COMPLETED|Overall Study||3
11161966|NCT01592292|12350435|FG003|NOT COMPLETED|Overall Study||1
11161967|NCT01592344|12350443|FG000|STARTED|Overall Study||45
11161968|NCT01592344|12350444|FG001|STARTED|Overall Study||49
11161969|NCT01592344|12350443|FG000|COMPLETED|Overall Study||41
11161970|NCT01592344|12350444|FG001|COMPLETED|Overall Study||44
11161971|NCT01592344|12350443|FG000|NOT COMPLETED|Overall Study||4
11161972|NCT01592344|12350444|FG001|NOT COMPLETED|Overall Study||5
11161973|NCT01592396|12350452|FG000|STARTED|Overall Study||10
11161974|NCT01592396|12350453|FG001|STARTED|Overall Study||10
11161975|NCT01592396|12350452|FG000|COMPLETED|Overall Study||10
11161976|NCT01592396|12350453|FG001|COMPLETED|Overall Study||10
11161977|NCT01592396|12350452|FG000|NOT COMPLETED|Overall Study||0
11161978|NCT01592396|12350453|FG001|NOT COMPLETED|Overall Study||0
11161979|NCT01592409|12350462|FG000|STARTED|Overall Study||67
11161980|NCT01592409|12350463|FG001|STARTED|Overall Study||32
11161981|NCT01592409|12350462|FG000|COMPLETED|Overall Study||67
11161982|NCT01592409|12350463|FG001|COMPLETED|Overall Study||31
11161983|NCT01592409|12350462|FG000|NOT COMPLETED|Overall Study||0
11161984|NCT01592409|12350463|FG001|NOT COMPLETED|Overall Study||1
11161985|NCT01592435|12350469|FG000|STARTED|Overall Study||76
11161986|NCT01592435|12350469|FG000|COMPLETED|Overall Study||76
11161987|NCT01592435|12350469|FG000|NOT COMPLETED|Overall Study||0
11161988|NCT01592500|12350479|FG000|STARTED|Overall Study|Randomized Participants|14
11161989|NCT01592500|12350480|FG001|STARTED|Overall Study||15
11161990|NCT01592500|12350481|FG002|STARTED|Overall Study||14
11161991|NCT01592500|12350482|FG003|STARTED|Overall Study|Randomized Participants|13
11161992|NCT01592500|12350479|FG000|COMPLETED|Overall Study||13
11161993|NCT01592500|12350480|FG001|COMPLETED|Overall Study||15
11161994|NCT01592500|12350481|FG002|COMPLETED|Overall Study||14
11161995|NCT01592500|12350482|FG003|COMPLETED|Overall Study||11
11161996|NCT01592500|12350479|FG000|NOT COMPLETED|Overall Study||1
11161997|NCT01592500|12350480|FG001|NOT COMPLETED|Overall Study||0
11161998|NCT01592500|12350481|FG002|NOT COMPLETED|Overall Study||0
11161999|NCT01592500|12350482|FG003|NOT COMPLETED|Overall Study||2
11162000|NCT01592695|12350494|FG000|STARTED|Overall Study||31
11162001|NCT01592695|12350495|FG001|STARTED|Overall Study||32
11162002|NCT01592695|12350494|FG000|COMPLETED|Overall Study||23
11162003|NCT01592695|12350495|FG001|COMPLETED|Overall Study||28
11162004|NCT01592695|12350494|FG000|NOT COMPLETED|Overall Study||8
11162005|NCT01592695|12350495|FG001|NOT COMPLETED|Overall Study||4
11162006|NCT01592708|12350503|FG000|STARTED|Overall Study||96
11162007|NCT01592708|12350504|FG001|STARTED|Overall Study||137
11162008|NCT01592708|12350503|FG000|COMPLETED|Overall Study||93
11162009|NCT01592708|12350504|FG001|COMPLETED|Overall Study||137
11162010|NCT01592708|12350503|FG000|NOT COMPLETED|Overall Study||3
11162011|NCT01592708|12350504|FG001|NOT COMPLETED|Overall Study||0
11162012|NCT01592747|12350516|FG000|STARTED|Overall Study|Based on Randomized Population|160
11162013|NCT01592747|12350517|FG001|STARTED|Overall Study|Based on Randomized Population|161
11162014|NCT01592747|12350518|FG002|STARTED|Overall Study|Based on Randomized Population|158
11162015|NCT01592747|12350516|FG000|COMPLETED|Overall Study||44
11162016|NCT01592747|12350517|FG001|COMPLETED|Overall Study||50
11162017|NCT01592747|12350518|FG002|COMPLETED|Overall Study||50
11162018|NCT01592747|12350516|FG000|NOT COMPLETED|Overall Study||116
11162019|NCT01592747|12350517|FG001|NOT COMPLETED|Overall Study||111
11162020|NCT01592747|12350518|FG002|NOT COMPLETED|Overall Study||108
11162021|NCT01592760|12350530|FG000|STARTED|Perioperative to Discharge||90
11162022|NCT01592760|12350531|FG001|STARTED|Perioperative to Discharge||90
11162023|NCT01592760|12350532|FG002|STARTED|Perioperative to Discharge||45
11162024|NCT01592760|12350530|FG000|COMPLETED|Perioperative to Discharge||90
11162025|NCT01592760|12350531|FG001|COMPLETED|Perioperative to Discharge||90
11162026|NCT01592760|12350532|FG002|COMPLETED|Perioperative to Discharge||45
11162027|NCT01592760|12350530|FG000|NOT COMPLETED|Perioperative to Discharge||0
11162028|NCT01592760|12350531|FG001|NOT COMPLETED|Perioperative to Discharge||0
11162029|NCT01592760|12350532|FG002|NOT COMPLETED|Perioperative to Discharge||0
11162030|NCT01592760|12350530|FG000|STARTED|24-hour Follow-Up||90
11162031|NCT01592760|12350531|FG001|STARTED|24-hour Follow-Up||90
11162032|NCT01592760|12350532|FG002|STARTED|24-hour Follow-Up||45
11162033|NCT01592760|12350530|FG000|COMPLETED|24-hour Follow-Up||86
11162034|NCT01592760|12350531|FG001|COMPLETED|24-hour Follow-Up||87
11162035|NCT01592760|12350532|FG002|COMPLETED|24-hour Follow-Up||43
11162036|NCT01592760|12350530|FG000|NOT COMPLETED|24-hour Follow-Up||4
11162037|NCT01592760|12350531|FG001|NOT COMPLETED|24-hour Follow-Up||3
11162038|NCT01592760|12350532|FG002|NOT COMPLETED|24-hour Follow-Up||2
11162039|NCT01592773|12350543|FG000|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
11162040|NCT01592773|12350543|FG000|COMPLETED|Overall Study||81
11162041|NCT01592773|12350543|FG000|NOT COMPLETED|Overall Study||666
11162042|NCT01592786|12350547|FG000|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
11162043|NCT01592786|12350547|FG000|COMPLETED|Overall Study||765
11162044|NCT01592786|12350547|FG000|NOT COMPLETED|Overall Study||138
11203471|NCT01847443|12393985|FG002|STARTED|Study Period 3||21
11203472|NCT01847443|12393986|FG003|STARTED|Study Period 3||21
11203473|NCT01847443|12393983|FG000|COMPLETED|Study Period 3||18
11203474|NCT01847443|12393984|FG001|COMPLETED|Study Period 3||19
11203475|NCT01847443|12393985|FG002|COMPLETED|Study Period 3||21
11203476|NCT01847443|12393986|FG003|COMPLETED|Study Period 3||21
11203477|NCT01847443|12393983|FG000|NOT COMPLETED|Study Period 3||0
11203478|NCT01847443|12393984|FG001|NOT COMPLETED|Study Period 3||0
11203479|NCT01847443|12393985|FG002|NOT COMPLETED|Study Period 3||0
11203480|NCT01847443|12393986|FG003|NOT COMPLETED|Study Period 3||0
11203481|NCT01847443|12393983|FG000|STARTED|Washout Period Before Study Period 4||18
11203482|NCT01847443|12393984|FG001|STARTED|Washout Period Before Study Period 4||19
11203483|NCT01847443|12393985|FG002|STARTED|Washout Period Before Study Period 4||21
11203484|NCT01847443|12393986|FG003|STARTED|Washout Period Before Study Period 4||21
11203485|NCT01847443|12393983|FG000|COMPLETED|Washout Period Before Study Period 4||16
11203486|NCT01847443|12393984|FG001|COMPLETED|Washout Period Before Study Period 4||19
11203487|NCT01847443|12393985|FG002|COMPLETED|Washout Period Before Study Period 4||21
11203488|NCT01847443|12393986|FG003|COMPLETED|Washout Period Before Study Period 4||21
11203489|NCT01847443|12393983|FG000|NOT COMPLETED|Washout Period Before Study Period 4||2
11162045|NCT01592799|12350551|FG000|STARTED|Overall Study||501
11162046|NCT01592799|12350551|FG000|COMPLETED|Overall Study||501
11162047|NCT01592799|12350551|FG000|NOT COMPLETED|Overall Study||0
11162048|NCT01592851|12350559|FG000|STARTED|Overall Study||56
11162049|NCT01592851|12350560|FG001|STARTED|Overall Study||57
11162050|NCT01592851|12350559|FG000|COMPLETED|Overall Study||56
11162051|NCT01592851|12350560|FG001|COMPLETED|Overall Study||57
11162052|NCT01592851|12350559|FG000|NOT COMPLETED|Overall Study||0
11162053|NCT01592851|12350560|FG001|NOT COMPLETED|Overall Study||0
11162054|NCT01592864|12350568|FG000|STARTED|Overall Study||60
11162055|NCT01592864|12350569|FG001|STARTED|Overall Study||58
11162056|NCT01592864|12350568|FG000|COMPLETED|Overall Study||60
11162057|NCT01592864|12350569|FG001|COMPLETED|Overall Study||57
11162058|NCT01592864|12350568|FG000|NOT COMPLETED|Overall Study||0
11162059|NCT01592864|12350569|FG001|NOT COMPLETED|Overall Study||1
11162060|NCT01593020|12350577|FG000|STARTED|Overall Study||28
11162061|NCT01593020|12350578|FG001|STARTED|Overall Study||23
11162062|NCT01593020|12350577|FG000|COMPLETED|Overall Study||26
11162063|NCT01593020|12350578|FG001|COMPLETED|Overall Study||21
11162064|NCT01593020|12350577|FG000|NOT COMPLETED|Overall Study||2
11162065|NCT01593020|12350578|FG001|NOT COMPLETED|Overall Study||2
11162066|NCT01593215|12350586|FG000|STARTED|Overall Study||25
11162067|NCT01593215|12350587|FG001|STARTED|Overall Study||25
11162068|NCT01593215|12350586|FG000|COMPLETED|Overall Study||24
11162069|NCT01593215|12350587|FG001|COMPLETED|Overall Study||25
11162070|NCT01593215|12350586|FG000|NOT COMPLETED|Overall Study||1
11162071|NCT01593215|12350587|FG001|NOT COMPLETED|Overall Study||0
11162072|NCT01593592|12350595|FG000|STARTED|Overall Study||35
11162073|NCT01593592|12350596|FG001|STARTED|Overall Study||35
11162074|NCT01593592|12350595|FG000|COMPLETED|Overall Study||35
11162075|NCT01593592|12350596|FG001|COMPLETED|Overall Study||35
11162076|NCT01593592|12350595|FG000|NOT COMPLETED|Overall Study||0
11162077|NCT01593592|12350596|FG001|NOT COMPLETED|Overall Study||0
11162078|NCT01593670|12350602|FG000|STARTED|Overall Study||9
11162079|NCT01593670|12350602|FG000|COMPLETED|Overall Study||9
11162080|NCT01593670|12350602|FG000|NOT COMPLETED|Overall Study||0
11162081|NCT01593696|12350610|FG000|STARTED|Dose Escalation||16
11162082|NCT01593696|12350611|FG001|STARTED|Dose Escalation||5
11162083|NCT01593696|12350612|FG002|STARTED|Dose Escalation||0
11162084|NCT01593696|12350613|FG003|STARTED|Dose Escalation||0
11162085|NCT01593696|12350610|FG000|Prior Transplant|Dose Escalation||7
11162086|NCT01593696|12350611|FG001|Prior Transplant|Dose Escalation||1
11162087|NCT01593696|12350612|FG002|Prior Transplant|Dose Escalation||0
11162088|NCT01593696|12350613|FG003|Prior Transplant|Dose Escalation||0
11162089|NCT01593696|12350610|FG000|No Prior Transplant|Dose Escalation||9
11162090|NCT01593696|12350611|FG001|No Prior Transplant|Dose Escalation||4
11162091|NCT01593696|12350612|FG002|No Prior Transplant|Dose Escalation||0
11162092|NCT01593696|12350613|FG003|No Prior Transplant|Dose Escalation||0
11162093|NCT01593696|12350610|FG000|COMPLETED|Dose Escalation||14
11162094|NCT01593696|12350611|FG001|COMPLETED|Dose Escalation||5
11162095|NCT01593696|12350612|FG002|COMPLETED|Dose Escalation||0
11162096|NCT01593696|12350613|FG003|COMPLETED|Dose Escalation||0
11162097|NCT01593696|12350610|FG000|NOT COMPLETED|Dose Escalation||2
11162098|NCT01593696|12350611|FG001|NOT COMPLETED|Dose Escalation||0
11162099|NCT01593696|12350612|FG002|NOT COMPLETED|Dose Escalation||0
11162100|NCT01593696|12350613|FG003|NOT COMPLETED|Dose Escalation||0
11162101|NCT01593696|12350610|FG000|STARTED|Dose Expansion||0
11162102|NCT01593696|12350611|FG001|STARTED|Dose Expansion||0
11162103|NCT01593696|12350612|FG002|STARTED|Dose Expansion||16
11162104|NCT01593696|12350613|FG003|STARTED|Dose Expansion||16
11162105|NCT01593696|12350610|FG000|COMPLETED|Dose Expansion||0
11162106|NCT01593696|12350611|FG001|COMPLETED|Dose Expansion||0
11162107|NCT01593696|12350612|FG002|COMPLETED|Dose Expansion||15
11162108|NCT01593696|12350613|FG003|COMPLETED|Dose Expansion||16
11162109|NCT01593696|12350610|FG000|NOT COMPLETED|Dose Expansion||0
11162110|NCT01593696|12350611|FG001|NOT COMPLETED|Dose Expansion||0
11162111|NCT01593696|12350612|FG002|NOT COMPLETED|Dose Expansion||1
11162112|NCT01593696|12350613|FG003|NOT COMPLETED|Dose Expansion||0
11162113|NCT01593722|12350625|FG000|STARTED|Overall Study||6
11162114|NCT01593722|12350626|FG001|STARTED|Overall Study||6
11162115|NCT01593722|12350625|FG000|COMPLETED|Overall Study||6
11162116|NCT01593722|12350626|FG001|COMPLETED|Overall Study||6
11162117|NCT01593722|12350625|FG000|NOT COMPLETED|Overall Study||0
11162118|NCT01593722|12350626|FG001|NOT COMPLETED|Overall Study||0
11162119|NCT01593748|12350636|FG000|STARTED|Overall Study||45
11162120|NCT01593748|12350637|FG001|STARTED|Overall Study||45
11162121|NCT01593748|12350636|FG000|COMPLETED|Overall Study||45
11162122|NCT01593748|12350637|FG001|COMPLETED|Overall Study||45
11162123|NCT01593748|12350636|FG000|NOT COMPLETED|Overall Study||0
11162124|NCT01593748|12350637|FG001|NOT COMPLETED|Overall Study||0
11162125|NCT01593787|12350646|FG000|STARTED|Overall Study||6
11162126|NCT01593787|12350647|FG001|STARTED|Overall Study||8
11162127|NCT01593787|12350648|FG002|STARTED|Overall Study||18
11162128|NCT01593787|12350646|FG000|COMPLETED|Overall Study||5
11162129|NCT01593787|12350647|FG001|COMPLETED|Overall Study||8
11162130|NCT01593787|12350648|FG002|COMPLETED|Overall Study||18
11162131|NCT01593787|12350646|FG000|NOT COMPLETED|Overall Study||1
11162132|NCT01593787|12350647|FG001|NOT COMPLETED|Overall Study||0
11162133|NCT01593787|12350648|FG002|NOT COMPLETED|Overall Study||0
11162134|NCT01593917|12350658|FG000|STARTED|Overall Study||329
11162135|NCT01593917|12350658|FG000|COMPLETED|Overall Study||159
11162136|NCT01593917|12350658|FG000|NOT COMPLETED|Overall Study||170
11162137|NCT01594125|12350667|FG000|STARTED|Overall Study||4
11162138|NCT01594125|12350668|FG001|STARTED|Overall Study||12
11162139|NCT01594125|12350669|FG002|STARTED|Overall Study||3
11162140|NCT01594125|12350670|FG003|STARTED|Overall Study||4
11162141|NCT01594125|12350671|FG004|STARTED|Overall Study||7
11162142|NCT01594125|12350667|FG000|COMPLETED|Overall Study||0
11162143|NCT01594125|12350668|FG001|COMPLETED|Overall Study||0
11162144|NCT01594125|12350669|FG002|COMPLETED|Overall Study||0
11162145|NCT01594125|12350670|FG003|COMPLETED|Overall Study||0
11162146|NCT01594125|12350671|FG004|COMPLETED|Overall Study||0
11162147|NCT01594125|12350667|FG000|NOT COMPLETED|Overall Study||4
11162148|NCT01594125|12350668|FG001|NOT COMPLETED|Overall Study||12
11162149|NCT01594125|12350669|FG002|NOT COMPLETED|Overall Study||3
11162150|NCT01594125|12350670|FG003|NOT COMPLETED|Overall Study||4
11162151|NCT01594125|12350671|FG004|NOT COMPLETED|Overall Study||7
11162152|NCT01594281|12350686|FG000|STARTED|Interventional Core Phase||36
11162153|NCT01594281|12350687|FG001|STARTED|Interventional Core Phase||36
11162154|NCT01594281|12350688|FG002|STARTED|Interventional Core Phase||36
11162155|NCT01594281|12350686|FG000|Full Analysis Set (FAS)|Interventional Core Phase||35
11162156|NCT01594281|12350687|FG001|Full Analysis Set (FAS)|Interventional Core Phase||35
11162157|NCT01594281|12350688|FG002|Full Analysis Set (FAS)|Interventional Core Phase||36
11162158|NCT01594281|12350686|FG000|COMPLETED|Interventional Core Phase||29
11162159|NCT01594281|12350687|FG001|COMPLETED|Interventional Core Phase||26
11162160|NCT01594281|12350688|FG002|COMPLETED|Interventional Core Phase||28
11162161|NCT01594281|12350686|FG000|NOT COMPLETED|Interventional Core Phase||7
11162162|NCT01594281|12350687|FG001|NOT COMPLETED|Interventional Core Phase||10
11162163|NCT01594281|12350688|FG002|NOT COMPLETED|Interventional Core Phase||8
11162164|NCT01594281|12350686|FG000|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28
11162165|NCT01594281|12350687|FG001|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21
11162166|NCT01594281|12350688|FG002|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25
11162167|NCT01594281|12350686|FG000|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28
11162168|NCT01594281|12350687|FG001|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20
11162169|NCT01594281|12350688|FG002|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25
11162170|NCT01594281|12350686|FG000|COMPLETED|Non-Interventional Follow Up Phase||25
11162171|NCT01594281|12350687|FG001|COMPLETED|Non-Interventional Follow Up Phase||19
11162172|NCT01594281|12350688|FG002|COMPLETED|Non-Interventional Follow Up Phase||23
11162173|NCT01594281|12350686|FG000|NOT COMPLETED|Non-Interventional Follow Up Phase||3
11162174|NCT01594281|12350687|FG001|NOT COMPLETED|Non-Interventional Follow Up Phase||2
11162175|NCT01594281|12350688|FG002|NOT COMPLETED|Non-Interventional Follow Up Phase||2
11162176|NCT01594294|12350701|FG000|STARTED|Overall Study||39
11162177|NCT01594294|12350702|FG001|STARTED|Overall Study||40
11162178|NCT01594294|12350701|FG000|COMPLETED|Overall Study||36
11162179|NCT01594294|12350702|FG001|COMPLETED|Overall Study||36
11162180|NCT01594294|12350701|FG000|NOT COMPLETED|Overall Study||3
11162181|NCT01594294|12350702|FG001|NOT COMPLETED|Overall Study||4
11162182|NCT01594333|12350710|FG000|STARTED|Overall Study||2391
11162183|NCT01594333|12350711|FG001|STARTED|Overall Study||2395
11162184|NCT01594333|12350710|FG000|COMPLETED|Overall Study||2230
11162185|NCT01594333|12350711|FG001|COMPLETED|Overall Study||2244
11162186|NCT01594333|12350710|FG000|NOT COMPLETED|Overall Study||161
11162187|NCT01594333|12350711|FG001|NOT COMPLETED|Overall Study||151
11162188|NCT01594385|12350719|FG000|STARTED|Overall Study||17
11162189|NCT01594385|12350720|FG001|STARTED|Overall Study||13
11162190|NCT01594385|12350719|FG000|COMPLETED|Overall Study||17
11162191|NCT01594385|12350720|FG001|COMPLETED|Overall Study||13
11162192|NCT01594385|12350719|FG000|NOT COMPLETED|Overall Study||0
11162193|NCT01594385|12350720|FG001|NOT COMPLETED|Overall Study||0
11162194|NCT01594411|12350730|FG000|STARTED|Overall Study||251
11162195|NCT01594411|12350730|FG000|COMPLETED|Overall Study||249
11162196|NCT01594411|12350730|FG000|NOT COMPLETED|Overall Study||2
11162197|NCT01594424|12350737|FG000|STARTED|Overall Study||10
11162198|NCT01594424|12350737|FG000|COMPLETED|Overall Study||8
11162199|NCT01594424|12350737|FG000|NOT COMPLETED|Overall Study||2
11162200|NCT01594476|12350743|FG000|STARTED|Overall Study||101
11162201|NCT01594476|12350744|FG001|STARTED|Overall Study||100
11162202|NCT01594476|12350743|FG000|Received Intervention|Overall Study||66
11162203|NCT01594476|12350744|FG001|Received Intervention|Overall Study||73
11162204|NCT01594476|12350743|FG000|Excluded After Allocation|Overall Study||1
11162205|NCT01594476|12350744|FG001|Excluded After Allocation|Overall Study||3
11162206|NCT01594476|12350743|FG000|IUD Removal|Overall Study||3
11162207|NCT01594476|12350744|FG001|IUD Removal|Overall Study||5
11162208|NCT01594476|12350743|FG000|IUD Expulsion|Overall Study||2
11162209|NCT01594476|12350744|FG001|IUD Expulsion|Overall Study||0
11162210|NCT01594476|12350743|FG000|Pregnant|Overall Study||2
11162211|NCT01594476|12350744|FG001|Pregnant|Overall Study||5
11162212|NCT01594476|12350743|FG000|COMPLETED|Overall Study||100
11162213|NCT01594476|12350744|FG001|COMPLETED|Overall Study||97
11162214|NCT01594476|12350743|FG000|NOT COMPLETED|Overall Study||1
11162215|NCT01594476|12350744|FG001|NOT COMPLETED|Overall Study||3
11162216|NCT01594515|12350764|FG000|STARTED|Overall Study||6
11162217|NCT01594515|12350765|FG001|STARTED|Overall Study||6
11162218|NCT01594515|12350766|FG002|STARTED|Overall Study||6
11162219|NCT01594515|12350767|FG003|STARTED|Overall Study||6
11162220|NCT01594515|12350768|FG004|STARTED|Overall Study||6
11162221|NCT01594515|12350769|FG005|STARTED|Overall Study||6
11162222|NCT01594515|12350770|FG006|STARTED|Overall Study||6
11162223|NCT01594515|12350771|FG007|STARTED|Overall Study||6
11162224|NCT01594515|12350772|FG008|STARTED|Overall Study||6
11162225|NCT01594515|12350773|FG009|STARTED|Overall Study||16
11162226|NCT01594515|12350764|FG000|COMPLETED|Overall Study||6
11162227|NCT01594515|12350765|FG001|COMPLETED|Overall Study||6
11162228|NCT01594515|12350766|FG002|COMPLETED|Overall Study||6
11162229|NCT01594515|12350767|FG003|COMPLETED|Overall Study||6
11162230|NCT01594515|12350768|FG004|COMPLETED|Overall Study||6
11162231|NCT01594515|12350769|FG005|COMPLETED|Overall Study||6
11162232|NCT01594515|12350770|FG006|COMPLETED|Overall Study||6
11162233|NCT01594515|12350771|FG007|COMPLETED|Overall Study||6
11162234|NCT01594515|12350772|FG008|COMPLETED|Overall Study||6
11162235|NCT01594515|12350773|FG009|COMPLETED|Overall Study||16
11162236|NCT01594515|12350764|FG000|NOT COMPLETED|Overall Study||0
11162237|NCT01594515|12350765|FG001|NOT COMPLETED|Overall Study||0
11162238|NCT01594515|12350766|FG002|NOT COMPLETED|Overall Study||0
11162239|NCT01594515|12350767|FG003|NOT COMPLETED|Overall Study||0
11162240|NCT01594515|12350768|FG004|NOT COMPLETED|Overall Study||0
11162241|NCT01594515|12350769|FG005|NOT COMPLETED|Overall Study||0
11162242|NCT01594515|12350770|FG006|NOT COMPLETED|Overall Study||0
11162243|NCT01594515|12350771|FG007|NOT COMPLETED|Overall Study||0
11162244|NCT01594515|12350772|FG008|NOT COMPLETED|Overall Study||0
11162245|NCT01594515|12350773|FG009|NOT COMPLETED|Overall Study||0
11162246|NCT01594528|12350798|FG000|STARTED|Overall Study||16
11162247|NCT01594528|12350799|FG001|STARTED|Overall Study||17
11162248|NCT01594528|12350800|FG002|STARTED|Overall Study||16
11162249|NCT01594528|12350798|FG000|COMPLETED|Overall Study||16
11162250|NCT01594528|12350799|FG001|COMPLETED|Overall Study||17
11162251|NCT01594528|12350800|FG002|COMPLETED|Overall Study||16
11162252|NCT01594528|12350798|FG000|NOT COMPLETED|Overall Study||0
11162253|NCT01594528|12350799|FG001|NOT COMPLETED|Overall Study||0
11162254|NCT01594528|12350800|FG002|NOT COMPLETED|Overall Study||0
11162255|NCT01594749|12350808|FG000|STARTED|Overall Study||507
11162256|NCT01594749|12350809|FG001|STARTED|Overall Study||508
11162257|NCT01594749|12350808|FG000|Treated|Overall Study||503
11162258|NCT01594749|12350809|FG001|Treated|Overall Study||498
11162259|NCT01594749|12350808|FG000|COMPLETED|Overall Study||485
11162260|NCT01594749|12350809|FG001|COMPLETED|Overall Study||490
11162261|NCT01594749|12350808|FG000|NOT COMPLETED|Overall Study||22
11162262|NCT01594749|12350809|FG001|NOT COMPLETED|Overall Study||18
11162263|NCT01594762|12350817|FG000|STARTED|Overall Study||97
11162264|NCT01594762|12350818|FG001|STARTED|Overall Study||103
11162265|NCT01594762|12350817|FG000|COMPLETED|Overall Study||86
11162266|NCT01594762|12350818|FG001|COMPLETED|Overall Study||93
11162267|NCT01594762|12350817|FG000|NOT COMPLETED|Overall Study||11
11162268|NCT01594762|12350818|FG001|NOT COMPLETED|Overall Study||10
11162269|NCT01594827|12350826|FG000|STARTED|Overall Study||14
11162270|NCT01594827|12350827|FG001|STARTED|Overall Study||15
11162271|NCT01594827|12350826|FG000|COMPLETED|Overall Study||10
11162272|NCT01594827|12350827|FG001|COMPLETED|Overall Study||15
11162273|NCT01594827|12350826|FG000|NOT COMPLETED|Overall Study||4
11162274|NCT01594827|12350827|FG001|NOT COMPLETED|Overall Study||0
11162275|NCT01594853|12350837|FG000|STARTED|Overall Study||16
11162276|NCT01594853|12350838|FG001|STARTED|Overall Study||15
11162277|NCT01594853|12350837|FG000|COMPLETED|Overall Study||14
11162278|NCT01594853|12350838|FG001|COMPLETED|Overall Study||12
11162279|NCT01594853|12350837|FG000|NOT COMPLETED|Overall Study||2
11162280|NCT01594853|12350838|FG001|NOT COMPLETED|Overall Study||3
11162281|NCT01594931|12350847|FG000|STARTED|Overall Study||160
11162282|NCT01594931|12350848|FG001|STARTED|Overall Study||157
11162283|NCT01594931|12350849|FG002|STARTED|Overall Study|One randomized subject was not treated.|160
11162284|NCT01594931|12350847|FG000|COMPLETED|Overall Study||131
11162285|NCT01594931|12350848|FG001|COMPLETED|Overall Study||145
11162286|NCT01594931|12350849|FG002|COMPLETED|Overall Study||146
11162287|NCT01594931|12350847|FG000|NOT COMPLETED|Overall Study||29
11162288|NCT01594931|12350848|FG001|NOT COMPLETED|Overall Study||12
11162289|NCT01594931|12350849|FG002|NOT COMPLETED|Overall Study||14
11162290|NCT01594970|12350860|FG000|STARTED|Overall Study||295
11162291|NCT01594970|12350861|FG001|STARTED|Overall Study||248
11162292|NCT01594970|12350862|FG002|STARTED|Overall Study||257
11162293|NCT01594970|12350860|FG000|COMPLETED|Overall Study||220
11162294|NCT01594970|12350861|FG001|COMPLETED|Overall Study||166
11162295|NCT01594970|12350862|FG002|COMPLETED|Overall Study||191
11162296|NCT01594970|12350860|FG000|NOT COMPLETED|Overall Study||75
11162297|NCT01594970|12350861|FG001|NOT COMPLETED|Overall Study||82
11162298|NCT01594970|12350862|FG002|NOT COMPLETED|Overall Study||66
11162299|NCT01595282|12350872|FG000|STARTED|Overall Study||47
11162300|NCT01595282|12350873|FG001|STARTED|Overall Study||47
11162301|NCT01595282|12350872|FG000|COMPLETED|Overall Study||47
11162302|NCT01595282|12350873|FG001|COMPLETED|Overall Study||47
11162303|NCT01595282|12350872|FG000|NOT COMPLETED|Overall Study||0
11162304|NCT01595282|12350873|FG001|NOT COMPLETED|Overall Study||0
11162305|NCT01595386|12350881|FG000|STARTED|Overall Study||21
11162306|NCT01595386|12350882|FG001|STARTED|Overall Study||19
11162307|NCT01595386|12350881|FG000|COMPLETED|Overall Study||21
11162308|NCT01595386|12350882|FG001|COMPLETED|Overall Study||19
11162309|NCT01595386|12350881|FG000|NOT COMPLETED|Overall Study||0
11162310|NCT01595386|12350882|FG001|NOT COMPLETED|Overall Study||0
11162311|NCT01595438|12350890|FG000|STARTED|Overall Study||516
11162312|NCT01595438|12350891|FG001|STARTED|Overall Study||517
11162313|NCT01595438|12350890|FG000|COMPLETED|Overall Study||473
11162314|NCT01595438|12350891|FG001|COMPLETED|Overall Study||476
11162315|NCT01595438|12350890|FG000|NOT COMPLETED|Overall Study||43
11162316|NCT01595438|12350891|FG001|NOT COMPLETED|Overall Study||41
11162317|NCT01595516|12350900|FG000|STARTED|Overall Study||16
11162318|NCT01595516|12350901|FG001|STARTED|Overall Study||16
11162319|NCT01595516|12350902|FG002|STARTED|Overall Study||12
11162320|NCT01595516|12350900|FG000|COMPLETED|Overall Study||16
11162321|NCT01595516|12350901|FG001|COMPLETED|Overall Study||16
11162322|NCT01595516|12350902|FG002|COMPLETED|Overall Study||12
11162323|NCT01595516|12350900|FG000|NOT COMPLETED|Overall Study||0
11162324|NCT01595516|12350901|FG001|NOT COMPLETED|Overall Study||0
11162325|NCT01595516|12350902|FG002|NOT COMPLETED|Overall Study||0
11162326|NCT01595529|12350926|FG000|STARTED|Overall Study||348
11162327|NCT01595529|12350927|FG001|STARTED|Overall Study||345
11162328|NCT01595529|12350926|FG000|Treated|Overall Study||337
11162329|NCT01595529|12350927|FG001|Treated|Overall Study||340
11162330|NCT01595529|12350926|FG000|Evaluated for Primary Endpoint, ITT|Overall Study||328
11162331|NCT01595529|12350927|FG001|Evaluated for Primary Endpoint, ITT|Overall Study||336
11162332|NCT01595529|12350926|FG000|ITT Without Treatment Failure|Overall Study||326
11162333|NCT01595529|12350927|FG001|ITT Without Treatment Failure|Overall Study||322
11162334|NCT01595529|12350926|FG000|ITT With Stool Sample at TOC|Overall Study||298
11162335|NCT01595529|12350927|FG001|ITT With Stool Sample at TOC|Overall Study||310
11162336|NCT01595529|12350926|FG000|Per-protocol, Completed 80% of Dose|Overall Study||308
11162337|NCT01595529|12350927|FG001|Per-protocol, Completed 80% of Dose|Overall Study||314
11162338|NCT01595529|12350926|FG000|Per-protocol Without Treatment Failure|Overall Study||306
11162339|NCT01595529|12350927|FG001|Per-protocol Without Treatment Failure|Overall Study||305
11162340|NCT01595529|12350926|FG000|Per-protocol With Stool Sample at TOC|Overall Study||280
11162341|NCT01595529|12350927|FG001|Per-protocol With Stool Sample at TOC|Overall Study||289
11162342|NCT01595529|12350926|FG000|Completed All Milestones|Overall Study||318
11162343|NCT01595529|12350927|FG001|Completed All Milestones|Overall Study||318
11162344|NCT01595529|12350926|FG000|COMPLETED|Overall Study||324
11162345|NCT01595529|12350927|FG001|COMPLETED|Overall Study||325
11162346|NCT01595529|12350926|FG000|NOT COMPLETED|Overall Study||24
11162347|NCT01595529|12350927|FG001|NOT COMPLETED|Overall Study||20
11162348|NCT01595646|12350936|FG000|STARTED|Overall Study||13
11162349|NCT01595646|12350937|FG001|STARTED|Overall Study||12
11162350|NCT01595646|12350938|FG002|STARTED|Overall Study||12
11162351|NCT01595646|12350936|FG000|COMPLETED|Overall Study||12
11162352|NCT01595646|12350937|FG001|COMPLETED|Overall Study||12
11162353|NCT01595646|12350938|FG002|COMPLETED|Overall Study||12
11162354|NCT01595646|12350936|FG000|NOT COMPLETED|Overall Study||1
11162355|NCT01595646|12350937|FG001|NOT COMPLETED|Overall Study||0
11162356|NCT01595646|12350938|FG002|NOT COMPLETED|Overall Study||0
11419268|NCT00218036|12617750|FG002|COMPLETED|Overall Study||5
11419269|NCT00218036|12617751|FG003|COMPLETED|Overall Study||6
11419270|NCT00218036|12617752|FG004|COMPLETED|Overall Study||3
11419271|NCT00218036|12617748|FG000|NOT COMPLETED|Overall Study||5
11162357|NCT01595854|12350954|FG000|STARTED|Overall Study||8
11162358|NCT01595854|12350955|FG001|STARTED|Overall Study||4
11162359|NCT01595854|12350956|FG002|STARTED|Overall Study||8
11162360|NCT01595854|12350957|FG003|STARTED|Overall Study||4
11162361|NCT01595854|12350958|FG004|STARTED|Overall Study||12
11162362|NCT01595854|12350954|FG000|COMPLETED|Overall Study||8
11162363|NCT01595854|12350955|FG001|COMPLETED|Overall Study||4
11162364|NCT01595854|12350956|FG002|COMPLETED|Overall Study||8
11162365|NCT01595854|12350957|FG003|COMPLETED|Overall Study||4
11162366|NCT01595854|12350958|FG004|COMPLETED|Overall Study||12
11162367|NCT01595854|12350954|FG000|NOT COMPLETED|Overall Study||0
11162368|NCT01595854|12350955|FG001|NOT COMPLETED|Overall Study||0
11162369|NCT01595854|12350956|FG002|NOT COMPLETED|Overall Study||0
11162370|NCT01595854|12350957|FG003|NOT COMPLETED|Overall Study||0
11162371|NCT01595854|12350958|FG004|NOT COMPLETED|Overall Study||0
11162372|NCT01596062|12350979|FG000|STARTED|Overall Study||3
11162373|NCT01596062|12350980|FG001|STARTED|Overall Study||6
11162374|NCT01596062|12350981|FG002|STARTED|Overall Study||7
11162375|NCT01596062|12350979|FG000|COMPLETED|Overall Study||2
11162376|NCT01596062|12350980|FG001|COMPLETED|Overall Study||6
11162377|NCT01596062|12350981|FG002|COMPLETED|Overall Study||4
11162378|NCT01596062|12350979|FG000|NOT COMPLETED|Overall Study||1
11162379|NCT01596062|12350980|FG001|NOT COMPLETED|Overall Study||0
11162380|NCT01596062|12350981|FG002|NOT COMPLETED|Overall Study||3
11162381|NCT01596088|12350989|FG000|STARTED|Overall Study||2
11162382|NCT01596088|12350989|FG000|COMPLETED|Overall Study||2
11162383|NCT01596088|12350989|FG000|NOT COMPLETED|Overall Study||0
11162384|NCT01596127|12350993|FG000|STARTED|Overall Study||4
11162385|NCT01596127|12350993|FG000|COMPLETED|Overall Study||3
11162386|NCT01596127|12350993|FG000|NOT COMPLETED|Overall Study||1
11162387|NCT01596231|12350999|FG000|STARTED|Overall Study||10
11162388|NCT01596231|12351000|FG001|STARTED|Overall Study||10
11162389|NCT01596231|12350999|FG000|COMPLETED|Overall Study||10
11162390|NCT01596231|12351000|FG001|COMPLETED|Overall Study||10
11162391|NCT01596231|12350999|FG000|NOT COMPLETED|Overall Study||0
11162392|NCT01596231|12351000|FG001|NOT COMPLETED|Overall Study||0
11162393|NCT01596283|12351008|FG000|STARTED|Overall Study||69
11162394|NCT01596283|12351009|FG001|STARTED|Overall Study||66
11162395|NCT01596283|12351008|FG000|COMPLETED|Overall Study||69
11162396|NCT01596283|12351009|FG001|COMPLETED|Overall Study||66
11162397|NCT01596283|12351008|FG000|NOT COMPLETED|Overall Study||0
11162398|NCT01596283|12351009|FG001|NOT COMPLETED|Overall Study||0
11162399|NCT01596335|12351019|FG000|STARTED|Overall Study||16
11162400|NCT01596335|12351020|FG001|STARTED|Overall Study||15
11162401|NCT01596335|12351019|FG000|COMPLETED|Overall Study||11
11162402|NCT01596335|12351020|FG001|COMPLETED|Overall Study||6
11162403|NCT01596335|12351019|FG000|NOT COMPLETED|Overall Study||5
11162404|NCT01596335|12351020|FG001|NOT COMPLETED|Overall Study||9
11162405|NCT01596504|12351029|FG000|STARTED|Overall Study||48
11162406|NCT01596504|12351030|FG001|STARTED|Overall Study||47
11162407|NCT01596504|12351031|FG002|STARTED|Overall Study||47
11162408|NCT01596504|12351029|FG000|COMPLETED|Overall Study||46
11162409|NCT01596504|12351030|FG001|COMPLETED|Overall Study||44
11419272|NCT00218036|12617749|FG001|NOT COMPLETED|Overall Study||3
11419273|NCT00218036|12617750|FG002|NOT COMPLETED|Overall Study||8
11162410|NCT01596504|12351031|FG002|COMPLETED|Overall Study||46
11162411|NCT01596504|12351029|FG000|NOT COMPLETED|Overall Study||2
11162412|NCT01596504|12351030|FG001|NOT COMPLETED|Overall Study||3
11162413|NCT01596504|12351031|FG002|NOT COMPLETED|Overall Study||1
11162414|NCT01596582|12351042|FG000|STARTED|Overall Study||172
11162415|NCT01596582|12351043|FG001|STARTED|Overall Study||180
11162416|NCT01596582|12351042|FG000|COMPLETED|Overall Study||168
11162417|NCT01596582|12351043|FG001|COMPLETED|Overall Study||173
11162418|NCT01596582|12351042|FG000|NOT COMPLETED|Overall Study||4
11162419|NCT01596582|12351043|FG001|NOT COMPLETED|Overall Study||7
11162420|NCT01596595|12351056|FG000|STARTED|Overall Study||1779
11162421|NCT01596595|12351056|FG000|COMPLETED|Overall Study||814
11162422|NCT01596595|12351056|FG000|NOT COMPLETED|Overall Study||965
11162423|NCT01596699|12351062|FG000|STARTED|Overall Study||10
11162424|NCT01596699|12351063|FG001|STARTED|Overall Study||6
11162425|NCT01596699|12351062|FG000|COMPLETED|Overall Study||10
11162426|NCT01596699|12351063|FG001|COMPLETED|Overall Study||6
11162427|NCT01596699|12351062|FG000|NOT COMPLETED|Overall Study||0
11162428|NCT01596699|12351063|FG001|NOT COMPLETED|Overall Study||0
11162429|NCT01596751|12351078|FG000|STARTED|Overall Study||5
11162430|NCT01596751|12351079|FG001|STARTED|Overall Study||4
11162431|NCT01596751|12351080|FG002|STARTED|Overall Study||3
11162432|NCT01596751|12351081|FG003|STARTED|Overall Study||6
11162433|NCT01596751|12351082|FG004|STARTED|Overall Study||4
11162434|NCT01596751|12351083|FG005|STARTED|Overall Study||6
11162435|NCT01596751|12351084|FG006|STARTED|Overall Study||17
11162436|NCT01596751|12351085|FG007|STARTED|Overall Study||22
11162437|NCT01596751|12351078|FG000|COMPLETED|Overall Study||5
11162438|NCT01596751|12351079|FG001|COMPLETED|Overall Study||4
11162439|NCT01596751|12351080|FG002|COMPLETED|Overall Study||3
11162440|NCT01596751|12351081|FG003|COMPLETED|Overall Study||6
11162441|NCT01596751|12351082|FG004|COMPLETED|Overall Study||4
11162442|NCT01596751|12351083|FG005|COMPLETED|Overall Study||6
11162443|NCT01596751|12351084|FG006|COMPLETED|Overall Study||17
11162444|NCT01596751|12351085|FG007|COMPLETED|Overall Study||22
11162445|NCT01596751|12351078|FG000|NOT COMPLETED|Overall Study||0
11162446|NCT01596751|12351079|FG001|NOT COMPLETED|Overall Study||0
11162447|NCT01596751|12351080|FG002|NOT COMPLETED|Overall Study||0
11162448|NCT01596751|12351081|FG003|NOT COMPLETED|Overall Study||0
11162449|NCT01596751|12351082|FG004|NOT COMPLETED|Overall Study||0
11162450|NCT01596751|12351083|FG005|NOT COMPLETED|Overall Study||0
11162451|NCT01596751|12351084|FG006|NOT COMPLETED|Overall Study||0
11162452|NCT01596751|12351085|FG007|NOT COMPLETED|Overall Study||0
11162453|NCT01596842|12351105|FG000|STARTED|Overall Study||10
11162454|NCT01596842|12351106|FG001|STARTED|Overall Study||7
11162455|NCT01596842|12351105|FG000|COMPLETED|Overall Study||8
11162456|NCT01596842|12351106|FG001|COMPLETED|Overall Study||7
11162457|NCT01596842|12351105|FG000|NOT COMPLETED|Overall Study||2
11162458|NCT01596842|12351106|FG001|NOT COMPLETED|Overall Study||0
11162459|NCT01596972|12351114|FG000|STARTED|Overall Study||25
11162460|NCT01596972|12351115|FG001|STARTED|Overall Study||26
11162461|NCT01596972|12351114|FG000|COMPLETED|Overall Study||24
11162462|NCT01596972|12351115|FG001|COMPLETED|Overall Study||12
11162463|NCT01596972|12351114|FG000|NOT COMPLETED|Overall Study||1
11162464|NCT01596972|12351115|FG001|NOT COMPLETED|Overall Study||14
11162465|NCT01597050|12351123|FG000|STARTED|Overall Study||36
11162466|NCT01597050|12351124|FG001|STARTED|Overall Study||18
11162467|NCT01597050|12351123|FG000|COMPLETED|Overall Study||35
11162468|NCT01597050|12351124|FG001|COMPLETED|Overall Study||18
11162469|NCT01597050|12351123|FG000|NOT COMPLETED|Overall Study||1
11162470|NCT01597050|12351124|FG001|NOT COMPLETED|Overall Study||0
11162471|NCT01597128|12351132|FG000|STARTED|Overall Study||18
11162472|NCT01597128|12351133|FG001|STARTED|Overall Study||17
11162473|NCT01597128|12351132|FG000|COMPLETED|Overall Study||18
11162474|NCT01597128|12351133|FG001|COMPLETED|Overall Study||17
11162475|NCT01597128|12351132|FG000|NOT COMPLETED|Overall Study||0
11162476|NCT01597128|12351133|FG001|NOT COMPLETED|Overall Study||0
11162477|NCT01597141|12351141|FG000|STARTED|Overall Study||50
11162478|NCT01597141|12351142|FG001|STARTED|Overall Study||50
11162479|NCT01597141|12351141|FG000|COMPLETED|Overall Study||50
11162480|NCT01597141|12351142|FG001|COMPLETED|Overall Study||50
11162481|NCT01597141|12351141|FG000|NOT COMPLETED|Overall Study||0
11162482|NCT01597141|12351142|FG001|NOT COMPLETED|Overall Study||0
11162483|NCT01597193|12351157|FG000|STARTED|Stage 1: Dose Escalation (141 Days)||7
11162484|NCT01597193|12351158|FG001|STARTED|Stage 1: Dose Escalation (141 Days)||8
11162485|NCT01597193|12351159|FG002|STARTED|Stage 1: Dose Escalation (141 Days)||0
11162486|NCT01597193|12351160|FG003|STARTED|Stage 1: Dose Escalation (141 Days)||0
11162487|NCT01597193|12351161|FG004|STARTED|Stage 1: Dose Escalation (141 Days)||0
11162488|NCT01597193|12351162|FG005|STARTED|Stage 1: Dose Escalation (141 Days)||0
11162489|NCT01597193|12351163|FG006|STARTED|Stage 1: Dose Escalation (141 Days)||0
11162490|NCT01597193|12351157|FG000|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
11162491|NCT01597193|12351158|FG001|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
11162492|NCT01597193|12351159|FG002|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
11162493|NCT01597193|12351160|FG003|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
11162494|NCT01597193|12351161|FG004|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
11162495|NCT01597193|12351162|FG005|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
11162496|NCT01597193|12351163|FG006|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
11162497|NCT01597193|12351157|FG000|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7
11162498|NCT01597193|12351158|FG001|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8
11162499|NCT01597193|12351159|FG002|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
11162500|NCT01597193|12351160|FG003|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
11162501|NCT01597193|12351161|FG004|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
11162502|NCT01597193|12351162|FG005|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
11162503|NCT01597193|12351163|FG006|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
11162504|NCT01597193|12351157|FG000|STARTED|Stage 2: Dose Expansion (1067 Days)||0
11162505|NCT01597193|12351158|FG001|STARTED|Stage 2: Dose Expansion (1067 Days)||0
11162506|NCT01597193|12351159|FG002|STARTED|Stage 2: Dose Expansion (1067 Days)||14
11162507|NCT01597193|12351160|FG003|STARTED|Stage 2: Dose Expansion (1067 Days)||20
11162508|NCT01597193|12351161|FG004|STARTED|Stage 2: Dose Expansion (1067 Days)||16
11162509|NCT01597193|12351162|FG005|STARTED|Stage 2: Dose Expansion (1067 Days)||23
11162510|NCT01597193|12351163|FG006|STARTED|Stage 2: Dose Expansion (1067 Days)||11
11162511|NCT01597193|12351157|FG000|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
11162512|NCT01597193|12351158|FG001|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
11162513|NCT01597193|12351159|FG002|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
11162514|NCT01597193|12351160|FG003|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
11162515|NCT01597193|12351161|FG004|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
11162516|NCT01597193|12351162|FG005|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
11323215|NCT01084252|12520462|FG005|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323216|NCT01084252|12520463|FG006|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323217|NCT01084252|12520464|FG007|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323218|NCT01084252|12520465|FG008|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
11323219|NCT01084252|12520466|FG009|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
11323220|NCT01084252|12520467|FG010|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
11323221|NCT01084252|12520468|FG011|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
11323222|NCT01084252|12520469|FG012|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323223|NCT01084252|12520470|FG013|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
11323224|NCT01084252|12520457|FG000|STARTED|Phase 2 Stage 2 (97 Weeks)||0
11323225|NCT01084252|12520458|FG001|STARTED|Phase 2 Stage 2 (97 Weeks)||0
11323226|NCT01084252|12520459|FG002|STARTED|Phase 2 Stage 2 (97 Weeks)||0
11323227|NCT01084252|12520460|FG003|STARTED|Phase 2 Stage 2 (97 Weeks)||0
11323228|NCT01084252|12520461|FG004|STARTED|Phase 2 Stage 2 (97 Weeks)||0
11323229|NCT01084252|12520462|FG005|STARTED|Phase 2 Stage 2 (97 Weeks)||0
11323230|NCT01084252|12520463|FG006|STARTED|Phase 2 Stage 2 (97 Weeks)||0
11323231|NCT01084252|12520464|FG007|STARTED|Phase 2 Stage 2 (97 Weeks)||0
11323232|NCT01084252|12520465|FG008|STARTED|Phase 2 Stage 2 (97 Weeks)||0
11323233|NCT01084252|12520466|FG009|STARTED|Phase 2 Stage 2 (97 Weeks)||0
11323234|NCT01084252|12520467|FG010|STARTED|Phase 2 Stage 2 (97 Weeks)||0
11323235|NCT01084252|12520468|FG011|STARTED|Phase 2 Stage 2 (97 Weeks)||0
11323236|NCT01084252|12520469|FG012|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|110
11323237|NCT01084252|12520470|FG013|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|55
11323238|NCT01084252|12520457|FG000|AT Population|Phase 2 Stage 2 (97 Weeks)||0
11323239|NCT01084252|12520458|FG001|AT Population|Phase 2 Stage 2 (97 Weeks)||0
11323240|NCT01084252|12520459|FG002|AT Population|Phase 2 Stage 2 (97 Weeks)||0
11323241|NCT01084252|12520460|FG003|AT Population|Phase 2 Stage 2 (97 Weeks)||0
11323242|NCT01084252|12520461|FG004|AT Population|Phase 2 Stage 2 (97 Weeks)||0
11323243|NCT01084252|12520462|FG005|AT Population|Phase 2 Stage 2 (97 Weeks)||0
11323244|NCT01084252|12520463|FG006|AT Population|Phase 2 Stage 2 (97 Weeks)||0
11323245|NCT01084252|12520464|FG007|AT Population|Phase 2 Stage 2 (97 Weeks)||0
11323246|NCT01084252|12520465|FG008|AT Population|Phase 2 Stage 2 (97 Weeks)||0
11323247|NCT01084252|12520466|FG009|AT Population|Phase 2 Stage 2 (97 Weeks)||0
11323248|NCT01084252|12520467|FG010|AT Population|Phase 2 Stage 2 (97 Weeks)||0
11323249|NCT01084252|12520468|FG011|AT Population|Phase 2 Stage 2 (97 Weeks)||0
11323250|NCT01084252|12520469|FG012|AT Population|Phase 2 Stage 2 (97 Weeks)||109
11323251|NCT01084252|12520470|FG013|AT Population|Phase 2 Stage 2 (97 Weeks)||55
11323252|NCT01084252|12520457|FG000|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323253|NCT01084252|12520458|FG001|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323254|NCT01084252|12520459|FG002|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323255|NCT01084252|12520460|FG003|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323256|NCT01084252|12520461|FG004|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323257|NCT01084252|12520462|FG005|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323258|NCT01084252|12520463|FG006|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323259|NCT01084252|12520464|FG007|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323260|NCT01084252|12520465|FG008|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323261|NCT01084252|12520466|FG009|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323262|NCT01084252|12520467|FG010|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11419274|NCT00218036|12617751|FG003|NOT COMPLETED|Overall Study||6
11419275|NCT00218036|12617752|FG004|NOT COMPLETED|Overall Study||6
11323263|NCT01084252|12520468|FG011|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323264|NCT01084252|12520469|FG012|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323265|NCT01084252|12520470|FG013|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323266|NCT01084252|12520457|FG000|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323267|NCT01084252|12520458|FG001|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323268|NCT01084252|12520459|FG002|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323269|NCT01084252|12520460|FG003|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323270|NCT01084252|12520461|FG004|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323271|NCT01084252|12520462|FG005|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323272|NCT01084252|12520463|FG006|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11162517|NCT01597193|12351163|FG006|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
11162518|NCT01597193|12351157|FG000|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
11162519|NCT01597193|12351158|FG001|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
11162520|NCT01597193|12351159|FG002|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14
11162521|NCT01597193|12351160|FG003|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20
11162522|NCT01597193|12351161|FG004|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16
11162523|NCT01597193|12351162|FG005|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23
11162524|NCT01597193|12351163|FG006|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11
11162525|NCT01597245|12351188|FG000|STARTED|Induction Period (Week 0 - Week 12)||168
11162526|NCT01597245|12351189|FG001|STARTED|Induction Period (Week 0 - Week 12)||358
11162527|NCT01597245|12351190|FG002|STARTED|Induction Period (Week 0 - Week 12)||347
11162528|NCT01597245|12351191|FG003|STARTED|Induction Period (Week 0 - Week 12)||351
11162529|NCT01597245|12351192|FG004|STARTED|Induction Period (Week 0 - Week 12)||0
11162530|NCT01597245|12351193|FG005|STARTED|Induction Period (Week 0 - Week 12)||0
11162531|NCT01597245|12351194|FG006|STARTED|Induction Period (Week 0 - Week 12)||0
11162532|NCT01597245|12351195|FG007|STARTED|Induction Period (Week 0 - Week 12)||0
11162533|NCT01597245|12351196|FG008|STARTED|Induction Period (Week 0 - Week 12)||0
11162534|NCT01597245|12351197|FG009|STARTED|Induction Period (Week 0 - Week 12)||0
11162535|NCT01597245|12351198|FG010|STARTED|Induction Period (Week 0 - Week 12)||0
11162536|NCT01597245|12351199|FG011|STARTED|Induction Period (Week 0 - Week 12)||0
11162537|NCT01597245|12351200|FG012|STARTED|Induction Period (Week 0 - Week 12)||0
11162538|NCT01597245|12351201|FG013|STARTED|Induction Period (Week 0 - Week 12)||0
11162539|NCT01597245|12351202|FG014|STARTED|Induction Period (Week 0 - Week 12)||0
11162540|NCT01597245|12351203|FG015|STARTED|Induction Period (Week 0 - Week 12)||0
11162541|NCT01597245|12351204|FG016|STARTED|Induction Period (Week 0 - Week 12)||0
11162542|NCT01597245|12351205|FG017|STARTED|Induction Period (Week 0 - Week 12)||0
11162543|NCT01597245|12351206|FG018|STARTED|Induction Period (Week 0 - Week 12)||0
11162544|NCT01597245|12351207|FG019|STARTED|Induction Period (Week 0 - Week 12)||0
11162545|NCT01597245|12351208|FG020|STARTED|Induction Period (Week 0 - Week 12)||0
11162546|NCT01597245|12351188|FG000|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
11162547|NCT01597245|12351189|FG001|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
11162548|NCT01597245|12351190|FG002|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
11162549|NCT01597245|12351191|FG003|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
11162550|NCT01597245|12351192|FG004|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162551|NCT01597245|12351193|FG005|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162552|NCT01597245|12351194|FG006|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162553|NCT01597245|12351195|FG007|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162554|NCT01597245|12351196|FG008|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162555|NCT01597245|12351197|FG009|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162556|NCT01597245|12351198|FG010|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162557|NCT01597245|12351199|FG011|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162558|NCT01597245|12351200|FG012|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162559|NCT01597245|12351201|FG013|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162560|NCT01597245|12351202|FG014|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162561|NCT01597245|12351203|FG015|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162562|NCT01597245|12351204|FG016|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162563|NCT01597245|12351205|FG017|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162564|NCT01597245|12351206|FG018|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162565|NCT01597245|12351207|FG019|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162566|NCT01597245|12351208|FG020|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
11162567|NCT01597245|12351188|FG000|COMPLETED|Induction Period (Week 0 - Week 12)||158
11162568|NCT01597245|12351189|FG001|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
11162569|NCT01597245|12351190|FG002|COMPLETED|Induction Period (Week 0 - Week 12)||328
11162570|NCT01597245|12351191|FG003|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
11162571|NCT01597245|12351192|FG004|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162572|NCT01597245|12351193|FG005|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162573|NCT01597245|12351194|FG006|COMPLETED|Induction Period (Week 0 - Week 12)||0
11205200|NCT01857869|12395943|FG003|STARTED|Booster/Rechallenge Phase||9
11162574|NCT01597245|12351195|FG007|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162575|NCT01597245|12351196|FG008|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162576|NCT01597245|12351197|FG009|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162577|NCT01597245|12351198|FG010|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162578|NCT01597245|12351199|FG011|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162579|NCT01597245|12351200|FG012|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162580|NCT01597245|12351201|FG013|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162581|NCT01597245|12351202|FG014|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162582|NCT01597245|12351203|FG015|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162583|NCT01597245|12351204|FG016|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162584|NCT01597245|12351205|FG017|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162585|NCT01597245|12351206|FG018|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162586|NCT01597245|12351207|FG019|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162587|NCT01597245|12351208|FG020|COMPLETED|Induction Period (Week 0 - Week 12)||0
11162588|NCT01597245|12351188|FG000|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
11419276|NCT00240227|12617764|FG000|STARTED|Overall Study||8
11419277|NCT00240227|12617764|FG000|COMPLETED|Overall Study||8
11419278|NCT00240227|12617764|FG000|NOT COMPLETED|Overall Study||0
11419279|NCT00205868|12617771|FG000|STARTED|Overall Study||304
11419280|NCT00205868|12617771|FG000|COMPLETED|Overall Study||304
11419281|NCT00205868|12617771|FG000|NOT COMPLETED|Overall Study||0
11419282|NCT00206375|12617778|FG000|STARTED|Overall Study||6
11419283|NCT00206375|12617779|FG001|STARTED|Overall Study||3
11419284|NCT00206375|12617780|FG002|STARTED|Overall Study||7
11162589|NCT01597245|12351189|FG001|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
11162590|NCT01597245|12351190|FG002|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
11162591|NCT01597245|12351191|FG003|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
11162592|NCT01597245|12351192|FG004|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162593|NCT01597245|12351193|FG005|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162594|NCT01597245|12351194|FG006|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162595|NCT01597245|12351195|FG007|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162596|NCT01597245|12351196|FG008|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162597|NCT01597245|12351197|FG009|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162598|NCT01597245|12351198|FG010|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162599|NCT01597245|12351199|FG011|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162600|NCT01597245|12351200|FG012|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162601|NCT01597245|12351201|FG013|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162602|NCT01597245|12351202|FG014|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162603|NCT01597245|12351203|FG015|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11419285|NCT00206375|12617778|FG000|COMPLETED|Overall Study||3
11419286|NCT00206375|12617779|FG001|COMPLETED|Overall Study||1
11162604|NCT01597245|12351204|FG016|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162605|NCT01597245|12351205|FG017|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162606|NCT01597245|12351206|FG018|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162607|NCT01597245|12351207|FG019|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162608|NCT01597245|12351208|FG020|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
11162609|NCT01597245|12351188|FG000|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
11162610|NCT01597245|12351189|FG001|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
11162611|NCT01597245|12351190|FG002|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
11162612|NCT01597245|12351191|FG003|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
11162613|NCT01597245|12351192|FG004|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|176
11162614|NCT01597245|12351193|FG005|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|187
11162615|NCT01597245|12351194|FG006|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|181
11162616|NCT01597245|12351195|FG007|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|3
11162617|NCT01597245|12351196|FG008|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|155
11162618|NCT01597245|12351197|FG009|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|132
11162619|NCT01597245|12351198|FG010|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|200
11162620|NCT01597245|12351199|FG011|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|75
11162621|NCT01597245|12351200|FG012|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|49
11162622|NCT01597245|12351201|FG013|STARTED|Maintenance Period (Week 12 to Week 60)||0
11162623|NCT01597245|12351202|FG014|STARTED|Maintenance Period (Week 12 to Week 60)||0
11162624|NCT01597245|12351203|FG015|STARTED|Maintenance Period (Week 12 to Week 60)||0
11419287|NCT00206375|12617780|FG002|COMPLETED|Overall Study||3
11419288|NCT00206375|12617778|FG000|NOT COMPLETED|Overall Study||3
11419289|NCT00206375|12617779|FG001|NOT COMPLETED|Overall Study||2
11419290|NCT00206375|12617780|FG002|NOT COMPLETED|Overall Study||4
11162625|NCT01597245|12351204|FG016|STARTED|Maintenance Period (Week 12 to Week 60)||0
11162626|NCT01597245|12351205|FG017|STARTED|Maintenance Period (Week 12 to Week 60)||0
11162627|NCT01597245|12351206|FG018|STARTED|Maintenance Period (Week 12 to Week 60)||0
11162628|NCT01597245|12351207|FG019|STARTED|Maintenance Period (Week 12 to Week 60)||0
11162629|NCT01597245|12351208|FG020|STARTED|Maintenance Period (Week 12 to Week 60)||0
11162630|NCT01597245|12351188|FG000|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
11162631|NCT01597245|12351189|FG001|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
11162632|NCT01597245|12351190|FG002|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
11419291|NCT00229931|12617790|FG000|STARTED|Overall Study||6
11419292|NCT00229931|12617791|FG001|STARTED|Overall Study||5
11162633|NCT01597245|12351191|FG003|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
11162634|NCT01597245|12351192|FG004|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
11162635|NCT01597245|12351193|FG005|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
11162636|NCT01597245|12351194|FG006|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
11162637|NCT01597245|12351195|FG007|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
11162638|NCT01597245|12351196|FG008|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
11162639|NCT01597245|12351197|FG009|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
11162640|NCT01597245|12351198|FG010|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
11162641|NCT01597245|12351199|FG011|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
11162642|NCT01597245|12351200|FG012|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
11162643|NCT01597245|12351201|FG013|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
11162644|NCT01597245|12351202|FG014|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
11162645|NCT01597245|12351203|FG015|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
11162646|NCT01597245|12351204|FG016|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
11162647|NCT01597245|12351205|FG017|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
11162648|NCT01597245|12351206|FG018|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
11162649|NCT01597245|12351207|FG019|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
11162650|NCT01597245|12351208|FG020|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
11162651|NCT01597245|12351188|FG000|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162652|NCT01597245|12351189|FG001|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162653|NCT01597245|12351190|FG002|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162654|NCT01597245|12351191|FG003|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162655|NCT01597245|12351192|FG004|COMPLETED|Maintenance Period (Week 12 to Week 60)||15
11162656|NCT01597245|12351193|FG005|COMPLETED|Maintenance Period (Week 12 to Week 60)||149
11162657|NCT01597245|12351194|FG006|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
11162658|NCT01597245|12351195|FG007|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162659|NCT01597245|12351196|FG008|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
11162660|NCT01597245|12351197|FG009|COMPLETED|Maintenance Period (Week 12 to Week 60)||11
11162661|NCT01597245|12351198|FG010|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
11162662|NCT01597245|12351199|FG011|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
11162663|NCT01597245|12351200|FG012|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
11162664|NCT01597245|12351201|FG013|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162665|NCT01597245|12351202|FG014|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162666|NCT01597245|12351203|FG015|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162667|NCT01597245|12351204|FG016|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162668|NCT01597245|12351205|FG017|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162669|NCT01597245|12351206|FG018|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162670|NCT01597245|12351207|FG019|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162671|NCT01597245|12351208|FG020|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162672|NCT01597245|12351188|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162673|NCT01597245|12351189|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162674|NCT01597245|12351190|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162675|NCT01597245|12351191|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162676|NCT01597245|12351192|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||161
11162677|NCT01597245|12351193|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||38
11162678|NCT01597245|12351194|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
11162679|NCT01597245|12351195|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
11162680|NCT01597245|12351196|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
11162681|NCT01597245|12351197|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||121
11162682|NCT01597245|12351198|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
11162683|NCT01597245|12351199|FG011|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
11162684|NCT01597245|12351200|FG012|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
11162685|NCT01597245|12351201|FG013|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162686|NCT01597245|12351202|FG014|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162687|NCT01597245|12351203|FG015|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162688|NCT01597245|12351204|FG016|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162689|NCT01597245|12351205|FG017|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11419293|NCT00229931|12617790|FG000|COMPLETED|Overall Study||2
11419294|NCT00229931|12617791|FG001|COMPLETED|Overall Study||3
11162690|NCT01597245|12351206|FG018|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162691|NCT01597245|12351207|FG019|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162692|NCT01597245|12351208|FG020|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
11162693|NCT01597245|12351188|FG000|STARTED|Long Term Extension (Week 60 - Week 264)||0
11162694|NCT01597245|12351189|FG001|STARTED|Long Term Extension (Week 60 - Week 264)||0
11162695|NCT01597245|12351190|FG002|STARTED|Long Term Extension (Week 60 - Week 264)||0
11162696|NCT01597245|12351191|FG003|STARTED|Long Term Extension (Week 60 - Week 264)||0
11162697|NCT01597245|12351192|FG004|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
11162698|NCT01597245|12351193|FG005|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
11162699|NCT01597245|12351194|FG006|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
11162700|NCT01597245|12351195|FG007|STARTED|Long Term Extension (Week 60 - Week 264)||0
11162701|NCT01597245|12351196|FG008|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
11162702|NCT01597245|12351197|FG009|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
11162703|NCT01597245|12351198|FG010|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
11162704|NCT01597245|12351199|FG011|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
11162705|NCT01597245|12351200|FG012|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
11162706|NCT01597245|12351201|FG013|STARTED|Long Term Extension (Week 60 - Week 264)|Participants who received placebo at the start of the long-term extension period.|26
11162707|NCT01597245|12351202|FG014|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe at the start of the long-term extension.|979
11162708|NCT01597245|12351203|FG015|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe in all dosing regimens, including participants who switched PBO to ixe.|1002
11162709|NCT01597245|12351204|FG016|STARTED|Long Term Extension (Week 60 - Week 264)||0
11162710|NCT01597245|12351205|FG017|STARTED|Long Term Extension (Week 60 - Week 264)||0
11162711|NCT01597245|12351206|FG018|STARTED|Long Term Extension (Week 60 - Week 264)||0
11162712|NCT01597245|12351207|FG019|STARTED|Long Term Extension (Week 60 - Week 264)||0
11162713|NCT01597245|12351208|FG020|STARTED|Long Term Extension (Week 60 - Week 264)||0
11162714|NCT01597245|12351188|FG000|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162715|NCT01597245|12351189|FG001|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162716|NCT01597245|12351190|FG002|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162717|NCT01597245|12351191|FG003|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162718|NCT01597245|12351192|FG004|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162719|NCT01597245|12351193|FG005|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162720|NCT01597245|12351194|FG006|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162721|NCT01597245|12351195|FG007|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162722|NCT01597245|12351196|FG008|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162723|NCT01597245|12351197|FG009|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162724|NCT01597245|12351198|FG010|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162725|NCT01597245|12351199|FG011|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162726|NCT01597245|12351200|FG012|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162727|NCT01597245|12351201|FG013|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162728|NCT01597245|12351202|FG014|COMPLETED|Long Term Extension (Week 60 - Week 264)||754
11162729|NCT01597245|12351203|FG015|COMPLETED|Long Term Extension (Week 60 - Week 264)||774
11162730|NCT01597245|12351204|FG016|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162731|NCT01597245|12351205|FG017|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162732|NCT01597245|12351206|FG018|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162733|NCT01597245|12351207|FG019|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162734|NCT01597245|12351208|FG020|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162735|NCT01597245|12351188|FG000|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162736|NCT01597245|12351189|FG001|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162737|NCT01597245|12351190|FG002|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162738|NCT01597245|12351191|FG003|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162739|NCT01597245|12351192|FG004|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162740|NCT01597245|12351193|FG005|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162741|NCT01597245|12351194|FG006|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162742|NCT01597245|12351195|FG007|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162743|NCT01597245|12351196|FG008|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162744|NCT01597245|12351197|FG009|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162745|NCT01597245|12351198|FG010|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162746|NCT01597245|12351199|FG011|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162747|NCT01597245|12351200|FG012|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162748|NCT01597245|12351201|FG013|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||26
11162749|NCT01597245|12351202|FG014|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||225
11162750|NCT01597245|12351203|FG015|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||228
11162751|NCT01597245|12351204|FG016|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162752|NCT01597245|12351205|FG017|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162753|NCT01597245|12351206|FG018|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162754|NCT01597245|12351207|FG019|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162755|NCT01597245|12351208|FG020|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
11162756|NCT01597245|12351188|FG000|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162757|NCT01597245|12351189|FG001|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162758|NCT01597245|12351190|FG002|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162759|NCT01597245|12351191|FG003|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162760|NCT01597245|12351192|FG004|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11419295|NCT00229931|12617790|FG000|NOT COMPLETED|Overall Study||4
11419296|NCT00229931|12617791|FG001|NOT COMPLETED|Overall Study||2
11419297|NCT00209131|12617799|FG000|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
11419298|NCT00209131|12617800|FG001|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
11419299|NCT00209131|12617799|FG000|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
11419300|NCT00209131|12617800|FG001|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
11419301|NCT00209131|12617799|FG000|NOT COMPLETED|Overall Study||15
11162761|NCT01597245|12351193|FG005|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162762|NCT01597245|12351194|FG006|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162763|NCT01597245|12351195|FG007|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162764|NCT01597245|12351196|FG008|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162765|NCT01597245|12351197|FG009|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162766|NCT01597245|12351198|FG010|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162767|NCT01597245|12351199|FG011|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162768|NCT01597245|12351200|FG012|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162769|NCT01597245|12351201|FG013|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162770|NCT01597245|12351202|FG014|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
11162771|NCT01597245|12351203|FG015|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
11162772|NCT01597245|12351204|FG016|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|16
11162773|NCT01597245|12351205|FG017|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|6
11162774|NCT01597245|12351206|FG018|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|24
11162775|NCT01597245|12351207|FG019|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|656
11162776|NCT01597245|12351208|FG020|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|248
11162777|NCT01597245|12351188|FG000|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162778|NCT01597245|12351189|FG001|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162779|NCT01597245|12351190|FG002|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162780|NCT01597245|12351191|FG003|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162781|NCT01597245|12351192|FG004|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162782|NCT01597245|12351193|FG005|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162783|NCT01597245|12351194|FG006|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162784|NCT01597245|12351195|FG007|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162785|NCT01597245|12351196|FG008|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162786|NCT01597245|12351197|FG009|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162787|NCT01597245|12351198|FG010|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162788|NCT01597245|12351199|FG011|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162789|NCT01597245|12351200|FG012|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162790|NCT01597245|12351201|FG013|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162791|NCT01597245|12351202|FG014|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162792|NCT01597245|12351203|FG015|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162793|NCT01597245|12351204|FG016|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162794|NCT01597245|12351205|FG017|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162795|NCT01597245|12351206|FG018|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||14
11162796|NCT01597245|12351207|FG019|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||489
11162797|NCT01597245|12351208|FG020|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||212
11162798|NCT01597245|12351188|FG000|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162799|NCT01597245|12351189|FG001|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162800|NCT01597245|12351190|FG002|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162801|NCT01597245|12351191|FG003|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162802|NCT01597245|12351192|FG004|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162803|NCT01597245|12351193|FG005|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162804|NCT01597245|12351194|FG006|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162805|NCT01597245|12351195|FG007|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162806|NCT01597245|12351196|FG008|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162807|NCT01597245|12351197|FG009|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162808|NCT01597245|12351198|FG010|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162809|NCT01597245|12351199|FG011|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162810|NCT01597245|12351200|FG012|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162811|NCT01597245|12351201|FG013|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162812|NCT01597245|12351202|FG014|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11026722|NCT00830076|12205331|FG000|COMPLETED|Sitagliptin + Placebo Metformin||18
11162813|NCT01597245|12351203|FG015|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
11162814|NCT01597245|12351204|FG016|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||16
11419302|NCT00209131|12617800|FG001|NOT COMPLETED|Overall Study||11
11419303|NCT00233090|12617808|FG000|STARTED|Overall Study||12
11026723|NCT00830076|12205331|FG000|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
11026724|NCT00830076|12205331|FG000|STARTED|7-day Washout||18
11026725|NCT00830076|12205331|FG000|COMPLETED|7-day Washout||18
11026726|NCT00830076|12205331|FG000|NOT COMPLETED|7-day Washout||0
11026727|NCT00830076|12205331|FG000|STARTED|Metformin + Placebo Sitagliptin||18
11026728|NCT00830076|12205331|FG000|COMPLETED|Metformin + Placebo Sitagliptin||18
11026729|NCT00830076|12205331|FG000|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
11026730|NCT00830076|12205331|FG000|STARTED|7-day Washout||18
11026731|NCT00830076|12205331|FG000|COMPLETED|7-day Washout||18
11026732|NCT00830076|12205331|FG000|NOT COMPLETED|7-day Washout||0
11026733|NCT00830076|12205331|FG000|STARTED|Sitagliptin + Metformin||18
11026734|NCT00830076|12205331|FG000|COMPLETED|Sitagliptin + Metformin||18
11026735|NCT00830076|12205331|FG000|NOT COMPLETED|Sitagliptin + Metformin||0
11419304|NCT00233090|12617809|FG001|STARTED|Overall Study||9
11419305|NCT00233090|12617808|FG000|COMPLETED|Overall Study||12
11419306|NCT00233090|12617809|FG001|COMPLETED|Overall Study||9
11419307|NCT00233090|12617808|FG000|NOT COMPLETED|Overall Study||0
11419308|NCT00233090|12617809|FG001|NOT COMPLETED|Overall Study||0
11419309|NCT00214149|12617815|FG000|STARTED|Overall Study||127
11419310|NCT00214149|12617815|FG000|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
11419311|NCT00214149|12617815|FG000|NOT COMPLETED|Overall Study||127
11419312|NCT00205049|12617821|FG000|STARTED|Overall Study||0
11419313|NCT00205049|12617822|FG001|STARTED|Overall Study||0
11419314|NCT00205049|12617821|FG000|COMPLETED|Overall Study||0
11419315|NCT00205049|12617822|FG001|COMPLETED|Overall Study||0
11419316|NCT00205049|12617821|FG000|NOT COMPLETED|Overall Study||0
11419317|NCT00205049|12617822|FG001|NOT COMPLETED|Overall Study||0
11419318|NCT00209027|12617830|FG000|STARTED|Overall Study||10
11419319|NCT00209027|12617831|FG001|STARTED|Overall Study||10
11419320|NCT00209027|12617830|FG000|COMPLETED|Overall Study||0
11419321|NCT00209027|12617831|FG001|COMPLETED|Overall Study||10
11419322|NCT00209027|12617830|FG000|NOT COMPLETED|Overall Study||10
11419323|NCT00209027|12617831|FG001|NOT COMPLETED|Overall Study||0
11419324|NCT00182637|12617837|FG000|STARTED|Overall Study|active/on treatment date|5
11419325|NCT00182637|12617837|FG000|COMPLETED|Overall Study|off study date|2
11419326|NCT00182637|12617837|FG000|NOT COMPLETED|Overall Study||3
11419327|NCT00176488|12617842|FG000|STARTED|Overall Study||31
11419328|NCT00176488|12617842|FG000|COMPLETED|Overall Study||30
11419329|NCT00176488|12617842|FG000|NOT COMPLETED|Overall Study||1
11419330|NCT00179127|12617848|FG000|STARTED|Overall Study||0
11419331|NCT00179127|12617849|FG001|STARTED|Overall Study||0
11419332|NCT00179127|12617848|FG000|COMPLETED|Overall Study||0
11419333|NCT00179127|12617849|FG001|COMPLETED|Overall Study||0
11419334|NCT00179127|12617848|FG000|NOT COMPLETED|Overall Study||0
11419335|NCT00179127|12617849|FG001|NOT COMPLETED|Overall Study||0
11419336|NCT00183963|12617859|FG000|STARTED|Overall Study||1
11026736|NCT00830076|12205331|FG000|STARTED|7-day Washout||18
11026737|NCT00830076|12205331|FG000|COMPLETED|7-day Washout||18
11026738|NCT00830076|12205331|FG000|NOT COMPLETED|7-day Washout||0
11026739|NCT00830076|12205331|FG000|STARTED|Placebo Sitagliptin + Placebo Metformin||18
11026740|NCT00830076|12205331|FG000|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
11026741|NCT00830076|12205331|FG000|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
11026742|NCT00830115|12205338|FG000|STARTED|Overall Study||1045
11026743|NCT00830115|12205338|FG000|COMPLETED|Overall Study||1042
11026744|NCT00830115|12205338|FG000|NOT COMPLETED|Overall Study||3
11026745|NCT00830128|12205344|FG000|STARTED|Overall Study||106
11026746|NCT00830128|12205344|FG000|COMPLETED|Overall Study||87
11026747|NCT00830128|12205344|FG000|NOT COMPLETED|Overall Study||19
11026748|NCT00830167|12205350|FG000|STARTED|Overall Study|Treated|248
11026749|NCT00830167|12205351|FG001|STARTED|Overall Study|Treated|250
11026750|NCT00830167|12205350|FG000|COMPLETED|Overall Study||208
11026751|NCT00830167|12205351|FG001|COMPLETED|Overall Study||207
11026752|NCT00830167|12205350|FG000|NOT COMPLETED|Overall Study||40
11026753|NCT00830167|12205351|FG001|NOT COMPLETED|Overall Study||43
11026754|NCT00830180|12205357|FG000|STARTED|Overall Study||41
11026755|NCT00830180|12205357|FG000|Received Tanezumab in Parent Study A4091003|Overall Study||19
11026756|NCT00830180|12205357|FG000|Received Placebo in Parent Study A4091003|Overall Study||22
11026757|NCT00830180|12205357|FG000|COMPLETED|Overall Study||15
11026758|NCT00830180|12205357|FG000|NOT COMPLETED|Overall Study||26
11026759|NCT00830232|12205365|FG000|STARTED|Overall Study||20
11026760|NCT00830232|12205366|FG001|STARTED|Overall Study||20
11026761|NCT00830232|12205365|FG000|COMPLETED|Overall Study||20
11419337|NCT00183963|12617860|FG001|STARTED|Overall Study||1
11419338|NCT00183963|12617861|FG002|STARTED|Overall Study||1
11419339|NCT00183963|12617862|FG003|STARTED|Overall Study||1
11419340|NCT00183963|12617859|FG000|COMPLETED|Overall Study||0
11026762|NCT00830232|12205366|FG001|COMPLETED|Overall Study||20
11419341|NCT00183963|12617860|FG001|COMPLETED|Overall Study||0
11419342|NCT00183963|12617861|FG002|COMPLETED|Overall Study||0
11419343|NCT00183963|12617862|FG003|COMPLETED|Overall Study||0
11419344|NCT00183963|12617859|FG000|NOT COMPLETED|Overall Study||1
11419345|NCT00183963|12617860|FG001|NOT COMPLETED|Overall Study||1
11419346|NCT00183963|12617861|FG002|NOT COMPLETED|Overall Study||1
11419347|NCT00183963|12617862|FG003|NOT COMPLETED|Overall Study||1
11419348|NCT00178477|12617875|FG000|STARTED|Overall Study||10
11419349|NCT00178477|12617875|FG000|COMPLETED|Overall Study||5
11026763|NCT00830232|12205365|FG000|NOT COMPLETED|Overall Study||0
11026764|NCT00830232|12205366|FG001|NOT COMPLETED|Overall Study||0
11026765|NCT00830284|12205372|FG000|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
11026766|NCT00830284|12205372|FG000|COMPLETED|Overall Study||10
11026767|NCT00830284|12205372|FG000|NOT COMPLETED|Overall Study||2
11026768|NCT00830310|12205376|FG000|STARTED|Overall Study||43
11026769|NCT00830310|12205376|FG000|COMPLETED|Overall Study||30
11026770|NCT00830310|12205376|FG000|NOT COMPLETED|Overall Study||13
11026771|NCT00830362|12205382|FG000|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
11057319|NCT00996996|12238788|FG000|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
11162815|NCT01597245|12351205|FG017|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||6
11419350|NCT00178477|12617875|FG000|NOT COMPLETED|Overall Study||5
11419351|NCT00162773|12617879|FG000|STARTED|Overall Study||29
11419352|NCT00162773|12617879|FG000|COMPLETED|Overall Study||7
11419353|NCT00162773|12617879|FG000|NOT COMPLETED|Overall Study||22
11419354|NCT00176631|12617883|FG000|STARTED|Overall Study||10
11419355|NCT00176631|12617883|FG000|COMPLETED|Overall Study||10
11419356|NCT00176631|12617883|FG000|NOT COMPLETED|Overall Study||0
11419357|NCT00176501|12617887|FG000|STARTED|Overall Study||3
11419358|NCT00176501|12617887|FG000|COMPLETED|Overall Study||3
11419359|NCT00176501|12617887|FG000|NOT COMPLETED|Overall Study||0
11419360|NCT00177970|12617893|FG000|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
11162816|NCT01597245|12351206|FG018|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||10
11162817|NCT01597245|12351207|FG019|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||167
11162818|NCT01597245|12351208|FG020|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||36
11162819|NCT01597258|12351241|FG000|STARTED|Overall Study||2029
11162820|NCT01597258|12351241|FG000|COMPLETED|Overall Study||2028
11162821|NCT01597258|12351241|FG000|NOT COMPLETED|Overall Study||1
11162822|NCT01597375|12351245|FG000|STARTED|First Intervention (4 Weeks)||23
11162823|NCT01597375|12351246|FG001|STARTED|First Intervention (4 Weeks)||23
11162824|NCT01597375|12351245|FG000|COMPLETED|First Intervention (4 Weeks)||21
11162825|NCT01597375|12351246|FG001|COMPLETED|First Intervention (4 Weeks)||22
11162826|NCT01597375|12351245|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
11162827|NCT01597375|12351246|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
11162828|NCT01597375|12351245|FG000|STARTED|Washout (2 Weeks)||21
11162829|NCT01597375|12351246|FG001|STARTED|Washout (2 Weeks)||22
11162830|NCT01597375|12351245|FG000|COMPLETED|Washout (2 Weeks)||20
11162831|NCT01597375|12351246|FG001|COMPLETED|Washout (2 Weeks)||22
11162832|NCT01597375|12351245|FG000|NOT COMPLETED|Washout (2 Weeks)||1
11162833|NCT01597375|12351246|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11162834|NCT01597375|12351245|FG000|STARTED|Second Intervention||20
11162835|NCT01597375|12351246|FG001|STARTED|Second Intervention||22
11162836|NCT01597375|12351245|FG000|COMPLETED|Second Intervention||19
11162837|NCT01597375|12351246|FG001|COMPLETED|Second Intervention||21
11162838|NCT01597375|12351245|FG000|NOT COMPLETED|Second Intervention||1
11162839|NCT01597375|12351246|FG001|NOT COMPLETED|Second Intervention||1
11162840|NCT01597440|12351255|FG000|STARTED|Overall Study||1
11162841|NCT01597440|12351256|FG001|STARTED|Overall Study||0
11162842|NCT01597440|12351255|FG000|COMPLETED|Overall Study||1
11162843|NCT01597440|12351256|FG001|COMPLETED|Overall Study||0
11162844|NCT01597440|12351255|FG000|NOT COMPLETED|Overall Study||0
11162845|NCT01597440|12351256|FG001|NOT COMPLETED|Overall Study||0
11162846|NCT01597479|12351266|FG000|STARTED|Overall Study||26
11162847|NCT01597479|12351267|FG001|STARTED|Overall Study||26
11162848|NCT01597479|12351266|FG000|COMPLETED|Overall Study||24
11162849|NCT01597479|12351267|FG001|COMPLETED|Overall Study||26
11162850|NCT01597479|12351266|FG000|NOT COMPLETED|Overall Study||2
11162851|NCT01597479|12351267|FG001|NOT COMPLETED|Overall Study||0
11162852|NCT01597492|12351276|FG000|STARTED|Overall Study||34
11162853|NCT01597492|12351277|FG001|STARTED|Overall Study||45
11162854|NCT01597492|12351276|FG000|COMPLETED|Overall Study||28
11162855|NCT01597492|12351277|FG001|COMPLETED|Overall Study||41
11162856|NCT01597492|12351276|FG000|NOT COMPLETED|Overall Study||6
11162857|NCT01597492|12351277|FG001|NOT COMPLETED|Overall Study||4
11162858|NCT01597505|12351285|FG000|STARTED|Overall Study|Randomized participants|308
11162859|NCT01597505|12351286|FG001|STARTED|Overall Study|Randomized participants|298
11162860|NCT01597505|12351285|FG000|Treated|Overall Study|One participant was instead randomized to vancomycin|305
11162861|NCT01597505|12351286|FG001|Treated|Overall Study||286
11162862|NCT01597505|12351285|FG000|COMPLETED|Overall Study||264
11162863|NCT01597505|12351286|FG001|COMPLETED|Overall Study||265
11162864|NCT01597505|12351285|FG000|NOT COMPLETED|Overall Study||44
11162865|NCT01597505|12351286|FG001|NOT COMPLETED|Overall Study||33
11162866|NCT01597557|12351295|FG000|STARTED|Overall Study||132
11162867|NCT01597557|12351296|FG001|STARTED|Overall Study||129
11162868|NCT01597557|12351295|FG000|COMPLETED|Overall Study||128
11162869|NCT01597557|12351296|FG001|COMPLETED|Overall Study||126
11162870|NCT01597557|12351295|FG000|NOT COMPLETED|Overall Study||4
11162871|NCT01597557|12351296|FG001|NOT COMPLETED|Overall Study||3
11162872|NCT01597596|12351304|FG000|STARTED|Overall Study||1
11162873|NCT01597596|12351305|FG001|STARTED|Overall Study||3
11162874|NCT01597596|12351304|FG000|COMPLETED|Overall Study||0
11162875|NCT01597596|12351305|FG001|COMPLETED|Overall Study||2
11419361|NCT00177970|12617894|FG001|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
11419362|NCT00177970|12617893|FG000|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
11419363|NCT00177970|12617894|FG001|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
11162876|NCT01597596|12351304|FG000|NOT COMPLETED|Overall Study||1
11162877|NCT01597596|12351305|FG001|NOT COMPLETED|Overall Study||1
11162878|NCT01597622|12351311|FG000|STARTED|Overall Study||142
11162879|NCT01597622|12351311|FG000|COMPLETED|Overall Study||104
11162880|NCT01597622|12351311|FG000|NOT COMPLETED|Overall Study||38
11162881|NCT01597635|12351318|FG000|STARTED|Part A||5
11162882|NCT01597635|12351319|FG001|STARTED|Part A||0
11162883|NCT01597635|12351320|FG002|STARTED|Part A||0
11162884|NCT01597635|12351318|FG000|COMPLETED|Part A||2
11162885|NCT01597635|12351319|FG001|COMPLETED|Part A||0
11162886|NCT01597635|12351320|FG002|COMPLETED|Part A||0
11162887|NCT01597635|12351318|FG000|NOT COMPLETED|Part A||3
11162888|NCT01597635|12351319|FG001|NOT COMPLETED|Part A||0
11162889|NCT01597635|12351320|FG002|NOT COMPLETED|Part A||0
11162890|NCT01597635|12351318|FG000|STARTED|Part B||0
11162891|NCT01597635|12351319|FG001|STARTED|Part B||20
11162892|NCT01597635|12351320|FG002|STARTED|Part B||19
11162893|NCT01597635|12351318|FG000|COMPLETED|Part B||0
11162894|NCT01597635|12351319|FG001|COMPLETED|Part B||14
11162895|NCT01597635|12351320|FG002|COMPLETED|Part B||15
11162896|NCT01597635|12351318|FG000|NOT COMPLETED|Part B||0
11162897|NCT01597635|12351319|FG001|NOT COMPLETED|Part B||6
11162898|NCT01597635|12351320|FG002|NOT COMPLETED|Part B||4
11162899|NCT01597687|12351332|FG000|STARTED|Overall Study||76
11162900|NCT01597687|12351333|FG001|STARTED|Overall Study||89
11162901|NCT01597687|12351334|FG002|STARTED|Overall Study||147
11162902|NCT01597687|12351332|FG000|COMPLETED|Overall Study||76
11162903|NCT01597687|12351333|FG001|COMPLETED|Overall Study||89
11162904|NCT01597687|12351334|FG002|COMPLETED|Overall Study||147
11162905|NCT01597687|12351332|FG000|NOT COMPLETED|Overall Study||0
11162906|NCT01597687|12351333|FG001|NOT COMPLETED|Overall Study||0
11162907|NCT01597687|12351334|FG002|NOT COMPLETED|Overall Study||0
11162908|NCT01597791|12351360|FG000|STARTED|Overall Study||28
11162909|NCT01597791|12351361|FG001|STARTED|Overall Study||28
11162910|NCT01597791|12351360|FG000|COMPLETED|Overall Study||20
11162911|NCT01597791|12351361|FG001|COMPLETED|Overall Study||18
11162912|NCT01597791|12351360|FG000|NOT COMPLETED|Overall Study||8
11162913|NCT01597791|12351361|FG001|NOT COMPLETED|Overall Study||10
11162914|NCT01597843|12351370|FG000|STARTED|Overall Study||79
11162915|NCT01597843|12351371|FG001|STARTED|Overall Study||122
11162916|NCT01597843|12351372|FG002|STARTED|Overall Study||81
11162917|NCT01597843|12351370|FG000|Survey 1 Responses|Overall Study||45
11162918|NCT01597843|12351371|FG001|Survey 1 Responses|Overall Study||71
11162919|NCT01597843|12351372|FG002|Survey 1 Responses|Overall Study||59
11162920|NCT01597843|12351370|FG000|Survey 2 Responses|Overall Study||52
11162921|NCT01597843|12351371|FG001|Survey 2 Responses|Overall Study||42
11162922|NCT01597843|12351372|FG002|Survey 2 Responses|Overall Study||58
11162923|NCT01597843|12351370|FG000|Survey 3 Responses|Overall Study||65
11162924|NCT01597843|12351371|FG001|Survey 3 Responses|Overall Study||56
11162925|NCT01597843|12351372|FG002|Survey 3 Responses|Overall Study||76
11162926|NCT01597843|12351370|FG000|COMPLETED|Overall Study||79
11162927|NCT01597843|12351371|FG001|COMPLETED|Overall Study||122
11162928|NCT01597843|12351372|FG002|COMPLETED|Overall Study||81
11162929|NCT01597843|12351370|FG000|NOT COMPLETED|Overall Study||0
11162930|NCT01597843|12351371|FG001|NOT COMPLETED|Overall Study||0
11162931|NCT01597843|12351372|FG002|NOT COMPLETED|Overall Study||0
11162932|NCT01597856|12351383|FG000|STARTED|Overall Study||85
11162933|NCT01597856|12351384|FG001|STARTED|Overall Study||87
11162934|NCT01597856|12351385|FG002|STARTED|Overall Study||174
11162935|NCT01597856|12351383|FG000|Week 4 Follow-up|Overall Study||62
11162936|NCT01597856|12351384|FG001|Week 4 Follow-up|Overall Study||67
11162937|NCT01597856|12351385|FG002|Week 4 Follow-up|Overall Study||129
11162938|NCT01597856|12351383|FG000|COMPLETED|Overall Study||63
11162939|NCT01597856|12351384|FG001|COMPLETED|Overall Study||61
11162940|NCT01597856|12351385|FG002|COMPLETED|Overall Study||120
11162941|NCT01597856|12351383|FG000|NOT COMPLETED|Overall Study||22
11162942|NCT01597856|12351384|FG001|NOT COMPLETED|Overall Study||26
11162943|NCT01597856|12351385|FG002|NOT COMPLETED|Overall Study||54
11162944|NCT01597908|12351396|FG000|STARTED|Randomized Phase||352
11162945|NCT01597908|12351397|FG001|STARTED|Randomized Phase||352
11162946|NCT01597908|12351398|FG002|STARTED|Randomized Phase||0
11162947|NCT01597908|12351396|FG000|Safety Set|Randomized Phase||350
11162948|NCT01597908|12351397|FG001|Safety Set|Randomized Phase||349
11162949|NCT01597908|12351398|FG002|Safety Set|Randomized Phase||0
11162950|NCT01597908|12351396|FG000|COMPLETED|Randomized Phase||1
11162951|NCT01597908|12351397|FG001|COMPLETED|Randomized Phase||0
11162952|NCT01597908|12351398|FG002|COMPLETED|Randomized Phase||0
11162953|NCT01597908|12351396|FG000|NOT COMPLETED|Randomized Phase||351
11162954|NCT01597908|12351397|FG001|NOT COMPLETED|Randomized Phase||352
11162955|NCT01597908|12351398|FG002|NOT COMPLETED|Randomized Phase||0
11162956|NCT01597908|12351396|FG000|STARTED|Crossover Phase||0
11162957|NCT01597908|12351397|FG001|STARTED|Crossover Phase||0
11162958|NCT01597908|12351398|FG002|STARTED|Crossover Phase||34
11162959|NCT01597908|12351396|FG000|COMPLETED|Crossover Phase||0
11162960|NCT01597908|12351397|FG001|COMPLETED|Crossover Phase||0
11162961|NCT01597908|12351398|FG002|COMPLETED|Crossover Phase||0
11162962|NCT01597908|12351396|FG000|NOT COMPLETED|Crossover Phase||0
11162963|NCT01597908|12351397|FG001|NOT COMPLETED|Crossover Phase||0
11162964|NCT01597908|12351398|FG002|NOT COMPLETED|Crossover Phase||34
11162965|NCT01597973|12351409|FG000|STARTED|Overall Study||234
11162966|NCT01597973|12351410|FG001|STARTED|Overall Study||230
11162967|NCT01597973|12351409|FG000|Began First Dose|Overall Study||230
11162968|NCT01597973|12351410|FG001|Began First Dose|Overall Study||228
11162969|NCT01597973|12351409|FG000|COMPLETED|Overall Study||214
11162970|NCT01597973|12351410|FG001|COMPLETED|Overall Study||211
11162971|NCT01597973|12351409|FG000|NOT COMPLETED|Overall Study||20
11162972|NCT01597973|12351410|FG001|NOT COMPLETED|Overall Study||19
11162973|NCT01598064|12351420|FG000|STARTED|Overall Study||25
11162974|NCT01598064|12351421|FG001|STARTED|Overall Study||24
11162975|NCT01598064|12351420|FG000|COMPLETED|Overall Study||25
11162976|NCT01598064|12351421|FG001|COMPLETED|Overall Study||24
11162977|NCT01598064|12351420|FG000|NOT COMPLETED|Overall Study||0
11162978|NCT01598064|12351421|FG001|NOT COMPLETED|Overall Study||0
11162979|NCT01598090|12351432|FG000|STARTED|Treatment Period||27
11162980|NCT01598090|12351433|FG001|STARTED|Treatment Period||411
11162981|NCT01598090|12351434|FG002|STARTED|Treatment Period||206
11162982|NCT01598090|12351432|FG000|COMPLETED|Treatment Period||16
11162983|NCT01598090|12351433|FG001|COMPLETED|Treatment Period||339
11162984|NCT01598090|12351434|FG002|COMPLETED|Treatment Period||171
11162985|NCT01598090|12351432|FG000|NOT COMPLETED|Treatment Period||11
11162986|NCT01598090|12351433|FG001|NOT COMPLETED|Treatment Period||72
11162987|NCT01598090|12351434|FG002|NOT COMPLETED|Treatment Period||35
11162988|NCT01598090|12351432|FG000|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26
11419364|NCT00177970|12617893|FG000|NOT COMPLETED|Overall Study||0
11419365|NCT00177970|12617894|FG001|NOT COMPLETED|Overall Study||0
11419366|NCT00177866|12617902|FG000|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
11162989|NCT01598090|12351433|FG001|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399
11162990|NCT01598090|12351434|FG002|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199
11162991|NCT01598090|12351432|FG000|COMPLETED|Follow-up Period||21
11162992|NCT01598090|12351433|FG001|COMPLETED|Follow-up Period||364
11162993|NCT01598090|12351434|FG002|COMPLETED|Follow-up Period||171
11162994|NCT01598090|12351432|FG000|NOT COMPLETED|Follow-up Period||5
11162995|NCT01598090|12351433|FG001|NOT COMPLETED|Follow-up Period||35
11162996|NCT01598090|12351434|FG002|NOT COMPLETED|Follow-up Period||28
11162997|NCT01598129|12351445|FG000|STARTED|Overall Study||12
11162998|NCT01598129|12351445|FG000|COMPLETED|Overall Study||3
11162999|NCT01598129|12351445|FG000|NOT COMPLETED|Overall Study||9
11163000|NCT01598194|12351452|FG000|STARTED|Overall Study||30
11163001|NCT01598194|12351453|FG001|STARTED|Overall Study||30
11163002|NCT01598194|12351452|FG000|2 Passes With 25G for Cytology|Overall Study||30
11163003|NCT01598194|12351453|FG001|2 Passes With 25G for Cytology|Overall Study||30
11163004|NCT01598194|12351452|FG000|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
11163005|NCT01598194|12351453|FG001|1 Pass With 22Gpc for Cytology|Overall Study||30
11163006|NCT01598194|12351452|FG000|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
11163007|NCT01598194|12351453|FG001|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
11163008|NCT01598194|12351452|FG000|COMPLETED|Overall Study||30
11163009|NCT01598194|12351453|FG001|COMPLETED|Overall Study||30
11163010|NCT01598194|12351452|FG000|NOT COMPLETED|Overall Study||0
11163011|NCT01598194|12351453|FG001|NOT COMPLETED|Overall Study||0
11163012|NCT01598207|12351465|FG000|STARTED|Overall Study||7
11163013|NCT01598207|12351466|FG001|STARTED|Overall Study||6
11163014|NCT01598207|12351465|FG000|COMPLETED|Overall Study||6
11163015|NCT01598207|12351466|FG001|COMPLETED|Overall Study||6
11163016|NCT01598207|12351465|FG000|NOT COMPLETED|Overall Study||1
11163017|NCT01598207|12351466|FG001|NOT COMPLETED|Overall Study||0
11163018|NCT01598298|12351474|FG000|STARTED|Overall Study||150
11163019|NCT01598298|12351475|FG001|STARTED|Overall Study||149
11163020|NCT01598298|12351474|FG000|Patients Evaluable for Primary Endpoint|Overall Study||127
11163021|NCT01598298|12351475|FG001|Patients Evaluable for Primary Endpoint|Overall Study||128
11163022|NCT01598298|12351474|FG000|Patients Evaluable for Adverse Events|Overall Study||138
11163023|NCT01598298|12351475|FG001|Patients Evaluable for Adverse Events|Overall Study||141
11163024|NCT01598298|12351474|FG000|COMPLETED|Overall Study||110
11163025|NCT01598298|12351475|FG001|COMPLETED|Overall Study||108
11163026|NCT01598298|12351474|FG000|NOT COMPLETED|Overall Study||40
11163027|NCT01598298|12351475|FG001|NOT COMPLETED|Overall Study||41
11163028|NCT01598350|12351481|FG000|STARTED|Overall Study||6
11163029|NCT01598350|12351481|FG000|COMPLETED|Overall Study||6
11163030|NCT01598350|12351481|FG000|NOT COMPLETED|Overall Study||0
11163031|NCT01598428|12351485|FG000|STARTED|Overall Study||20
11163032|NCT01598428|12351485|FG000|COMPLETED|Overall Study||20
11163033|NCT01598428|12351485|FG000|NOT COMPLETED|Overall Study||0
11163034|NCT01598506|12351490|FG000|STARTED|Overall Study||22
11163035|NCT01598506|12351490|FG000|COMPLETED|Overall Study||20
11163036|NCT01598506|12351490|FG000|NOT COMPLETED|Overall Study||2
11163037|NCT01598532|12351495|FG000|STARTED|Overall Study||22
11163038|NCT01598532|12351495|FG000|COMPLETED|Overall Study||11
11163039|NCT01598532|12351495|FG000|NOT COMPLETED|Overall Study||11
11163040|NCT01598545|12351502|FG000|STARTED|Overall Study||20
11163041|NCT01598545|12351502|FG000|COMPLETED|Overall Study||20
11163042|NCT01598545|12351502|FG000|NOT COMPLETED|Overall Study||0
11163043|NCT01598610|12351506|FG000|STARTED|Overall Study||220
11163044|NCT01598610|12351506|FG000|COMPLETED|Overall Study||219
11163045|NCT01598610|12351506|FG000|NOT COMPLETED|Overall Study||1
11163046|NCT01598662|12351512|FG000|STARTED|Overall Study||11
11163047|NCT01598662|12351513|FG001|STARTED|Overall Study||21
11163048|NCT01598662|12351512|FG000|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
11163049|NCT01598662|12351513|FG001|Patients Who Received IUD|Overall Study||18
11163050|NCT01598662|12351512|FG000|Patients Returned for 6 wk Postpartum|Overall Study||0
11163051|NCT01598662|12351513|FG001|Patients Returned for 6 wk Postpartum|Overall Study||2
11163052|NCT01598662|12351512|FG000|COMPLETED|Overall Study||0
11163053|NCT01598662|12351513|FG001|COMPLETED|Overall Study||0
11163054|NCT01598662|12351512|FG000|NOT COMPLETED|Overall Study||11
11163055|NCT01598662|12351513|FG001|NOT COMPLETED|Overall Study||21
11163056|NCT01598701|12351521|FG000|STARTED|Overall Study||50
11163057|NCT01598701|12351522|FG001|STARTED|Overall Study||50
11163058|NCT01598701|12351521|FG000|COMPLETED|Overall Study||45
11163059|NCT01598701|12351522|FG001|COMPLETED|Overall Study||41
11163060|NCT01598701|12351521|FG000|NOT COMPLETED|Overall Study||5
11163061|NCT01598701|12351522|FG001|NOT COMPLETED|Overall Study||9
11163062|NCT01598740|12351530|FG000|STARTED|Period 1||9
11163063|NCT01598740|12351531|FG001|STARTED|Period 1||9
11163064|NCT01598740|12351530|FG000|COMPLETED|Period 1||9
11163065|NCT01598740|12351531|FG001|COMPLETED|Period 1||9
11163066|NCT01598740|12351530|FG000|NOT COMPLETED|Period 1||0
11163067|NCT01598740|12351531|FG001|NOT COMPLETED|Period 1||0
11163068|NCT01598740|12351530|FG000|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
11163069|NCT01598740|12351531|FG001|STARTED|Period 2||9
11163070|NCT01598740|12351530|FG000|COMPLETED|Period 2||7
11163071|NCT01598740|12351531|FG001|COMPLETED|Period 2||9
11163072|NCT01598740|12351530|FG000|NOT COMPLETED|Period 2||1
11163073|NCT01598740|12351531|FG001|NOT COMPLETED|Period 2||0
11163074|NCT01598753|12351542|FG000|STARTED|Overall Study||37
11163075|NCT01598753|12351543|FG001|STARTED|Overall Study||31
11163076|NCT01598753|12351544|FG002|STARTED|Overall Study||32
11163077|NCT01598753|12351545|FG003|STARTED|Overall Study||34
11163078|NCT01598753|12351542|FG000|COMPLETED|Overall Study||25
11163079|NCT01598753|12351543|FG001|COMPLETED|Overall Study||16
11163080|NCT01598753|12351544|FG002|COMPLETED|Overall Study||24
11163081|NCT01598753|12351545|FG003|COMPLETED|Overall Study||19
11163082|NCT01598753|12351542|FG000|NOT COMPLETED|Overall Study||12
11163083|NCT01598753|12351543|FG001|NOT COMPLETED|Overall Study||15
11163084|NCT01598753|12351544|FG002|NOT COMPLETED|Overall Study||8
11163085|NCT01598753|12351545|FG003|NOT COMPLETED|Overall Study||15
11163086|NCT01598779|12351555|FG000|STARTED|Overall Study||150
11163087|NCT01598779|12351555|FG000|COMPLETED|Overall Study||150
11163088|NCT01598779|12351555|FG000|NOT COMPLETED|Overall Study||0
11163089|NCT01598831|12351561|FG000|STARTED|Overall Study||402
11163090|NCT01598831|12351562|FG001|STARTED|Overall Study||414
11163091|NCT01598831|12351561|FG000|Received at Least 1 Dose Study Treatment|Overall Study||395
11163092|NCT01598831|12351562|FG001|Received at Least 1 Dose Study Treatment|Overall Study||405
11163093|NCT01598831|12351561|FG000|COMPLETED|Overall Study||283
11163094|NCT01598831|12351562|FG001|COMPLETED|Overall Study||278
11163095|NCT01598831|12351561|FG000|NOT COMPLETED|Overall Study||119
11163096|NCT01598831|12351562|FG001|NOT COMPLETED|Overall Study||136
11163097|NCT01598896|12351570|FG000|STARTED|Overall Study||3
11163098|NCT01598896|12351571|FG001|STARTED|Overall Study||4
11163099|NCT01598896|12351570|FG000|COMPLETED|Overall Study||3
11163100|NCT01598896|12351571|FG001|COMPLETED|Overall Study||2
11163101|NCT01598896|12351570|FG000|NOT COMPLETED|Overall Study||0
11163102|NCT01598896|12351571|FG001|NOT COMPLETED|Overall Study||2
11163103|NCT01598922|12351579|FG000|STARTED|Overall Study||37
11163104|NCT01598922|12351580|FG001|STARTED|Overall Study||40
11163105|NCT01598922|12351579|FG000|COMPLETED|Overall Study||34
11163106|NCT01598922|12351580|FG001|COMPLETED|Overall Study||30
11163107|NCT01598922|12351579|FG000|NOT COMPLETED|Overall Study||3
11163108|NCT01598922|12351580|FG001|NOT COMPLETED|Overall Study||10
11163109|NCT01598987|12351586|FG000|STARTED|Baseline to Month 12||56
11163110|NCT01598987|12351586|FG000|COMPLETED|Baseline to Month 12||50
11163111|NCT01598987|12351586|FG000|NOT COMPLETED|Baseline to Month 12||6
11163112|NCT01598987|12351586|FG000|STARTED|Baseline to 24 Month||56
11163113|NCT01598987|12351586|FG000|COMPLETED|Baseline to 24 Month||48
11163114|NCT01598987|12351586|FG000|NOT COMPLETED|Baseline to 24 Month||8
11163115|NCT01599104|12351600|FG000|STARTED|Overall Study||387
11163116|NCT01599104|12351601|FG001|STARTED|Overall Study||385
11163117|NCT01599104|12351602|FG002|STARTED|Overall Study||389
11163118|NCT01599104|12351600|FG000|COMPLETED|Overall Study||371
11163119|NCT01599104|12351601|FG001|COMPLETED|Overall Study||371
11163120|NCT01599104|12351602|FG002|COMPLETED|Overall Study||363
11163121|NCT01599104|12351600|FG000|NOT COMPLETED|Overall Study||16
11163122|NCT01599104|12351601|FG001|NOT COMPLETED|Overall Study||14
11163123|NCT01599104|12351602|FG002|NOT COMPLETED|Overall Study||26
11163124|NCT01599234|12351612|FG000|STARTED|Overall Study||167
11163125|NCT01599234|12351613|FG001|STARTED|Overall Study||170
11163126|NCT01599234|12351612|FG000|COMPLETED|Overall Study||150
11163127|NCT01599234|12351613|FG001|COMPLETED|Overall Study||155
11163128|NCT01599234|12351612|FG000|NOT COMPLETED|Overall Study||17
11163129|NCT01599234|12351613|FG001|NOT COMPLETED|Overall Study||15
11163130|NCT01599286|12351621|FG000|STARTED|Overall Study||24
11163131|NCT01599286|12351622|FG001|STARTED|Overall Study||23
11163132|NCT01599286|12351621|FG000|COMPLETED|Overall Study||24
11163133|NCT01599286|12351622|FG001|COMPLETED|Overall Study||23
11419367|NCT00177866|12617903|FG001|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
11163134|NCT01599286|12351621|FG000|NOT COMPLETED|Overall Study||0
11163135|NCT01599286|12351622|FG001|NOT COMPLETED|Overall Study||0
11163136|NCT01599325|12351628|FG000|STARTED|Primary Parent Phase||72
11163137|NCT01599325|12351628|FG000|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72
11163138|NCT01599325|12351628|FG000|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12
11163139|NCT01599325|12351628|FG000|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15
11163140|NCT01599325|12351628|FG000|NOT COMPLETED|Primary Parent Phase||57
11163141|NCT01599325|12351628|FG000|STARTED|Extension Phase||15
11163142|NCT01599325|12351628|FG000|COMPLETED|Extension Phase||0
11163143|NCT01599325|12351628|FG000|NOT COMPLETED|Extension Phase||15
11163144|NCT01599585|12351635|FG000|STARTED|Overall Study||62
11163145|NCT01599585|12351636|FG001|STARTED|Overall Study||59
11163146|NCT01599585|12351635|FG000|COMPLETED|Overall Study||40
11163147|NCT01599585|12351636|FG001|COMPLETED|Overall Study||42
11163148|NCT01599585|12351635|FG000|NOT COMPLETED|Overall Study||22
11163149|NCT01599585|12351636|FG001|NOT COMPLETED|Overall Study||17
11163150|NCT01599637|12351645|FG000|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
11163151|NCT01599637|12351646|FG001|STARTED|Overall Study||10
11163152|NCT01599637|12351647|FG002|STARTED|Overall Study||10
11163153|NCT01599637|12351645|FG000|COMPLETED|Overall Study||19
11163154|NCT01599637|12351646|FG001|COMPLETED|Overall Study||8
11163155|NCT01599637|12351647|FG002|COMPLETED|Overall Study||10
11163156|NCT01599637|12351645|FG000|NOT COMPLETED|Overall Study||1
11163157|NCT01599637|12351646|FG001|NOT COMPLETED|Overall Study||2
11163158|NCT01599637|12351647|FG002|NOT COMPLETED|Overall Study||0
11163159|NCT01599650|12351660|FG000|STARTED|Overall Study||183
11163160|NCT01599650|12351661|FG001|STARTED|Overall Study||180
11163161|NCT01599650|12351662|FG002|STARTED|Overall Study||92
11163162|NCT01599650|12351660|FG000|Completed 6 Mos|Overall Study||174
11163163|NCT01599650|12351661|FG001|Completed 6 Mos|Overall Study||170
11163164|NCT01599650|12351662|FG002|Completed 6 Mos|Overall Study||80
11163165|NCT01599650|12351660|FG000|COMPLETED|Overall Study||161
11163166|NCT01599650|12351661|FG001|COMPLETED|Overall Study||154
11163167|NCT01599650|12351662|FG002|COMPLETED|Overall Study||65
11163168|NCT01599650|12351660|FG000|NOT COMPLETED|Overall Study||22
11163169|NCT01599650|12351661|FG001|NOT COMPLETED|Overall Study||26
11163170|NCT01599650|12351662|FG002|NOT COMPLETED|Overall Study||27
11163171|NCT01599754|12351674|FG000|STARTED|Overall Study||363
11163172|NCT01599754|12351675|FG001|STARTED|Overall Study||361
11163173|NCT01599754|12351674|FG000|Treated|Overall Study||360
11163174|NCT01599754|12351675|FG001|Treated|Overall Study||360
11163175|NCT01599754|12351674|FG000|COMPLETED|Overall Study||0
11163176|NCT01599754|12351675|FG001|COMPLETED|Overall Study||1
11163177|NCT01599754|12351674|FG000|NOT COMPLETED|Overall Study||363
11163178|NCT01599754|12351675|FG001|NOT COMPLETED|Overall Study||360
11163179|NCT01599793|12351681|FG000|STARTED|Overall Study||19
11163180|NCT01599793|12351681|FG000|COMPLETED|Overall Study||17
11163181|NCT01599793|12351681|FG000|NOT COMPLETED|Overall Study||2
11163182|NCT01599806|12351687|FG000|STARTED|Overall Study||516
11163183|NCT01599806|12351688|FG001|STARTED|Overall Study||517
11163184|NCT01599806|12351687|FG000|COMPLETED|Overall Study||473
11163185|NCT01599806|12351688|FG001|COMPLETED|Overall Study||476
11163186|NCT01599806|12351687|FG000|NOT COMPLETED|Overall Study||43
11163187|NCT01599806|12351688|FG001|NOT COMPLETED|Overall Study||41
11203490|NCT01847443|12393984|FG001|NOT COMPLETED|Washout Period Before Study Period 4||0
11203491|NCT01847443|12393985|FG002|NOT COMPLETED|Washout Period Before Study Period 4||0
11203492|NCT01847443|12393986|FG003|NOT COMPLETED|Washout Period Before Study Period 4||0
11203493|NCT01847443|12393983|FG000|STARTED|Study Period 4||16
11203494|NCT01847443|12393984|FG001|STARTED|Study Period 4||19
11203495|NCT01847443|12393985|FG002|STARTED|Study Period 4||21
11203496|NCT01847443|12393986|FG003|STARTED|Study Period 4||21
11203497|NCT01847443|12393983|FG000|COMPLETED|Study Period 4||16
11203498|NCT01847443|12393984|FG001|COMPLETED|Study Period 4||19
11203499|NCT01847443|12393985|FG002|COMPLETED|Study Period 4||21
11203500|NCT01847443|12393986|FG003|COMPLETED|Study Period 4||21
11203501|NCT01847443|12393983|FG000|NOT COMPLETED|Study Period 4||0
11203502|NCT01847443|12393984|FG001|NOT COMPLETED|Study Period 4||0
11203503|NCT01847443|12393985|FG002|NOT COMPLETED|Study Period 4||0
11203504|NCT01847443|12393986|FG003|NOT COMPLETED|Study Period 4||0
11203505|NCT01847469|12394000|FG000|STARTED|Overall Study||18
11203506|NCT01847469|12394001|FG001|STARTED|Overall Study||6
11203507|NCT01847469|12394000|FG000|COMPLETED|Overall Study||9
11203508|NCT01847469|12394001|FG001|COMPLETED|Overall Study||3
11203509|NCT01847469|12394000|FG000|NOT COMPLETED|Overall Study||9
11203510|NCT01847469|12394001|FG001|NOT COMPLETED|Overall Study||3
11203511|NCT01847547|12394009|FG000|STARTED|Overall Study||2991
11203512|NCT01847547|12394010|FG001|STARTED|Overall Study||2991
11203513|NCT01847547|12394009|FG000|COMPLETED|Overall Study||2991
11203514|NCT01847547|12394010|FG001|COMPLETED|Overall Study||2991
11203515|NCT01847547|12394009|FG000|NOT COMPLETED|Overall Study||0
11203516|NCT01847547|12394010|FG001|NOT COMPLETED|Overall Study||0
11203517|NCT01847560|12394027|FG000|STARTED|Overall Study||13464
11203518|NCT01847560|12394028|FG001|STARTED|Overall Study||19955
11203519|NCT01847560|12394029|FG002|STARTED|Overall Study||9731
11203520|NCT01847560|12394030|FG003|STARTED|Overall Study||56655
11203521|NCT01847560|12394031|FG004|STARTED|Overall Study||27731
11163188|NCT01599832|12351694|FG000|STARTED|Overall Study||20
11163189|NCT01599832|12351694|FG000|COMPLETED|Overall Study||20
11163190|NCT01599832|12351694|FG000|NOT COMPLETED|Overall Study||0
11163191|NCT01600014|12351698|FG000|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
11163192|NCT01600014|12351699|FG001|STARTED|1. Cycle & Observation Period D1 to W52||0
11163193|NCT01600014|12351698|FG000|COMPLETED|1. Cycle & Observation Period D1 to W52||162
11163194|NCT01600014|12351699|FG001|COMPLETED|1. Cycle & Observation Period D1 to W52||0
11163195|NCT01600014|12351698|FG000|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
11163196|NCT01600014|12351699|FG001|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
11163197|NCT01600014|12351698|FG000|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
11163198|NCT01600014|12351699|FG001|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
11163199|NCT01600014|12351698|FG000|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
11163200|NCT01600014|12351699|FG001|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
11163201|NCT01600014|12351698|FG000|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
11163202|NCT01600014|12351699|FG001|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
11163203|NCT01600014|12351698|FG000|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
11163204|NCT01600014|12351699|FG001|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
11163205|NCT01600014|12351698|FG000|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
11163206|NCT01600014|12351699|FG001|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
11163207|NCT01600014|12351698|FG000|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
11163208|NCT01600014|12351699|FG001|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
11163209|NCT01600053|12351717|FG000|STARTED|Overall Study||11
11163210|NCT01600053|12351717|FG000|COMPLETED|Overall Study||0
11163211|NCT01600053|12351717|FG000|NOT COMPLETED|Overall Study||11
11163212|NCT01600092|12351723|FG000|STARTED|Overall Study||513
11163213|NCT01600092|12351724|FG001|STARTED|Overall Study||507
11163214|NCT01600092|12351723|FG000|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
11163215|NCT01600092|12351724|FG001|Received at Least 1 Vaccination|Overall Study||504
11163216|NCT01600092|12351723|FG000|Received All 3 Vaccinations|Overall Study||500
11163217|NCT01600092|12351724|FG001|Received All 3 Vaccinations|Overall Study||494
11163218|NCT01600092|12351723|FG000|COMPLETED|Overall Study||495
11163219|NCT01600092|12351724|FG001|COMPLETED|Overall Study||491
11163220|NCT01600092|12351723|FG000|NOT COMPLETED|Overall Study||18
11163221|NCT01600092|12351724|FG001|NOT COMPLETED|Overall Study||16
11163222|NCT01600105|12351732|FG000|STARTED|Total Participants||255
11163223|NCT01600105|12351733|FG001|STARTED|Total Participants||21
11163224|NCT01600105|12351732|FG000|COMPLETED|Total Participants||214
11163225|NCT01600105|12351733|FG001|COMPLETED|Total Participants||11
11163226|NCT01600105|12351732|FG000|NOT COMPLETED|Total Participants||41
11163227|NCT01600105|12351733|FG001|NOT COMPLETED|Total Participants||10
11163228|NCT01600105|12351732|FG000|STARTED|Sub Study I||19
11163229|NCT01600105|12351733|FG001|STARTED|Sub Study I||21
11163230|NCT01600105|12351732|FG000|COMPLETED|Sub Study I||19
11163231|NCT01600105|12351733|FG001|COMPLETED|Sub Study I||11
11163232|NCT01600105|12351732|FG000|NOT COMPLETED|Sub Study I||0
11163233|NCT01600105|12351733|FG001|NOT COMPLETED|Sub Study I||10
11163234|NCT01600105|12351732|FG000|STARTED|Sub Study II||65
11163235|NCT01600105|12351733|FG001|STARTED|Sub Study II||0
11163236|NCT01600105|12351732|FG000|COMPLETED|Sub Study II||60
11163237|NCT01600105|12351733|FG001|COMPLETED|Sub Study II||0
11163238|NCT01600105|12351732|FG000|NOT COMPLETED|Sub Study II||5
11163239|NCT01600105|12351733|FG001|NOT COMPLETED|Sub Study II||0
11163240|NCT01600105|12351732|FG000|STARTED|Sub Study III||39
11163241|NCT01600105|12351733|FG001|STARTED|Sub Study III||0
11163242|NCT01600105|12351732|FG000|COMPLETED|Sub Study III||34
11163243|NCT01600105|12351733|FG001|COMPLETED|Sub Study III||0
11163244|NCT01600105|12351732|FG000|NOT COMPLETED|Sub Study III||5
11163245|NCT01600105|12351733|FG001|NOT COMPLETED|Sub Study III||0
11163246|NCT01600105|12351732|FG000|STARTED|Sub Study IV||41
11163247|NCT01600105|12351733|FG001|STARTED|Sub Study IV||8
11163248|NCT01600105|12351732|FG000|COMPLETED|Sub Study IV||41
11163249|NCT01600105|12351733|FG001|COMPLETED|Sub Study IV||8
11163250|NCT01600105|12351732|FG000|NOT COMPLETED|Sub Study IV||0
11163251|NCT01600105|12351733|FG001|NOT COMPLETED|Sub Study IV||0
11163252|NCT01600105|12351732|FG000|STARTED|Sub Study V||52
11163253|NCT01600105|12351733|FG001|STARTED|Sub Study V||0
11163254|NCT01600105|12351732|FG000|COMPLETED|Sub Study V||50
11163255|NCT01600105|12351733|FG001|COMPLETED|Sub Study V||0
11163256|NCT01600105|12351732|FG000|NOT COMPLETED|Sub Study V||2
11163257|NCT01600105|12351733|FG001|NOT COMPLETED|Sub Study V||0
11163258|NCT01600170|12351745|FG000|STARTED|Period 1|Participants were assigned atorvastatin for 12 wks followed by a washout and then placebo.|6
11163259|NCT01600170|12351746|FG001|STARTED|Period 1|Participants were assigned placebo for 12 wks followed by a washout and then atorvastatin.|5
11163260|NCT01600170|12351745|FG000|COMPLETED|Period 1||6
11163261|NCT01600170|12351746|FG001|COMPLETED|Period 1||5
11163262|NCT01600170|12351745|FG000|NOT COMPLETED|Period 1||0
11163263|NCT01600170|12351746|FG001|NOT COMPLETED|Period 1||0
11163264|NCT01600170|12351745|FG000|STARTED|Period 2|These 6 were on atorvastatin in period 1 and on placebo in Period 2.|6
11163265|NCT01600170|12351746|FG001|STARTED|Period 2|These 5 were on placebo in Period 1 and on Atorvastatin in Period 2.|5
11163266|NCT01600170|12351745|FG000|COMPLETED|Period 2|One subject moved away from the area due to job responsibilities and dropped out of study.|5
11163267|NCT01600170|12351746|FG001|COMPLETED|Period 2||5
11163268|NCT01600170|12351745|FG000|NOT COMPLETED|Period 2||1
11163269|NCT01600170|12351746|FG001|NOT COMPLETED|Period 2||0
11163270|NCT01600222|12351754|FG000|STARTED|Overall Study||37
11163271|NCT01600222|12351754|FG000|COMPLETED|Overall Study||35
11163272|NCT01600222|12351754|FG000|NOT COMPLETED|Overall Study||2
11163273|NCT01600287|12351761|FG000|STARTED|Overall Study||20
11163274|NCT01600287|12351762|FG001|STARTED|Overall Study||20
11163275|NCT01600287|12351761|FG000|COMPLETED|Overall Study||20
11163276|NCT01600287|12351762|FG001|COMPLETED|Overall Study||20
11163277|NCT01600287|12351761|FG000|NOT COMPLETED|Overall Study||0
11163278|NCT01600287|12351762|FG001|NOT COMPLETED|Overall Study||0
11163279|NCT01600326|12351770|FG000|STARTED|Overall Study||15
11163280|NCT01600326|12351771|FG001|STARTED|Overall Study||15
11163281|NCT01600326|12351770|FG000|Primary Outcome Measure Data Collection|Overall Study||15
11163282|NCT01600326|12351771|FG001|Primary Outcome Measure Data Collection|Overall Study||15
11163283|NCT01600326|12351770|FG000|COMPLETED|Overall Study||14
11163284|NCT01600326|12351771|FG001|COMPLETED|Overall Study||14
11163285|NCT01600326|12351770|FG000|NOT COMPLETED|Overall Study||1
11163286|NCT01600326|12351771|FG001|NOT COMPLETED|Overall Study||1
11163287|NCT01600482|12351779|FG000|STARTED|Overall Study||148
11163288|NCT01600482|12351780|FG001|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
11163289|NCT01600482|12351779|FG000|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
11163290|NCT01600482|12351780|FG001|COMPLETED|Overall Study||59
11163291|NCT01600482|12351779|FG000|NOT COMPLETED|Overall Study||0
11163292|NCT01600482|12351780|FG001|NOT COMPLETED|Overall Study||0
11163293|NCT01600495|12351788|FG000|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
11163294|NCT01600495|12351789|FG001|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
11163295|NCT01600495|12351788|FG000|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
11163296|NCT01600495|12351789|FG001|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
11163297|NCT01600495|12351788|FG000|NOT COMPLETED|Overall Study||0
11163298|NCT01600495|12351789|FG001|NOT COMPLETED|Overall Study||0
11163299|NCT01600586|12351798|FG000|STARTED|Overall Study||49
11163300|NCT01600586|12351799|FG001|STARTED|Overall Study||51
11163301|NCT01600586|12351798|FG000|COMPLETED|Overall Study||46
11163302|NCT01600586|12351799|FG001|COMPLETED|Overall Study||48
11163303|NCT01600586|12351798|FG000|NOT COMPLETED|Overall Study||3
11163304|NCT01600586|12351799|FG001|NOT COMPLETED|Overall Study||3
11163305|NCT01600638|12351812|FG000|STARTED|Overall Study||25
11163306|NCT01600638|12351812|FG000|COMPLETED|Overall Study||25
11163307|NCT01600638|12351812|FG000|NOT COMPLETED|Overall Study||0
11163308|NCT01600677|12351818|FG000|STARTED|Overall Study||7
11163309|NCT01600677|12351819|FG001|STARTED|Overall Study||4
11163310|NCT01600677|12351818|FG000|COMPLETED|Overall Study||7
11163311|NCT01600677|12351819|FG001|COMPLETED|Overall Study||4
11163312|NCT01600677|12351818|FG000|NOT COMPLETED|Overall Study||0
11163313|NCT01600677|12351819|FG001|NOT COMPLETED|Overall Study||0
11163314|NCT01600703|12351825|FG000|STARTED|First Intervention||7
11163315|NCT01600703|12351826|FG001|STARTED|First Intervention||8
11163316|NCT01600703|12351825|FG000|COMPLETED|First Intervention||7
11163317|NCT01600703|12351826|FG001|COMPLETED|First Intervention||8
11163318|NCT01600703|12351825|FG000|NOT COMPLETED|First Intervention||0
11163319|NCT01600703|12351826|FG001|NOT COMPLETED|First Intervention||0
11163320|NCT01600703|12351825|FG000|STARTED|Second Intervention||7
11163321|NCT01600703|12351826|FG001|STARTED|Second Intervention||8
11163322|NCT01600703|12351825|FG000|COMPLETED|Second Intervention||7
11163323|NCT01600703|12351826|FG001|COMPLETED|Second Intervention||8
11163324|NCT01600703|12351825|FG000|NOT COMPLETED|Second Intervention||0
11163325|NCT01600703|12351826|FG001|NOT COMPLETED|Second Intervention||0
11163326|NCT01600716|12351834|FG000|STARTED|Overall Study||66
11163327|NCT01600716|12351835|FG001|STARTED|Overall Study||78
11163328|NCT01600716|12351834|FG000|COMPLETED|Overall Study||59
11163329|NCT01600716|12351835|FG001|COMPLETED|Overall Study||71
11163330|NCT01600716|12351834|FG000|NOT COMPLETED|Overall Study||7
11163331|NCT01600716|12351835|FG001|NOT COMPLETED|Overall Study||7
11163332|NCT01600729|12351843|FG000|STARTED|Overall Study||66
11419368|NCT00177866|12617902|FG000|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
11419369|NCT00177866|12617903|FG001|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
11419370|NCT00177866|12617902|FG000|NOT COMPLETED|Overall Study||0
11419371|NCT00177866|12617903|FG001|NOT COMPLETED|Overall Study||0
11163333|NCT01600729|12351843|FG000|COMPLETED|Overall Study||65
11163334|NCT01600729|12351843|FG000|NOT COMPLETED|Overall Study||1
11163335|NCT01600885|12351847|FG000|STARTED|First Period||10
11163336|NCT01600885|12351848|FG001|STARTED|First Period||9
11163337|NCT01600885|12351847|FG000|COMPLETED|First Period||8
11163338|NCT01600885|12351848|FG001|COMPLETED|First Period||8
11163339|NCT01600885|12351847|FG000|NOT COMPLETED|First Period||2
11163340|NCT01600885|12351848|FG001|NOT COMPLETED|First Period||1
11163341|NCT01600885|12351847|FG000|STARTED|Wash Out Period||8
11163342|NCT01600885|12351848|FG001|STARTED|Wash Out Period||8
11163343|NCT01600885|12351847|FG000|COMPLETED|Wash Out Period||8
11163344|NCT01600885|12351848|FG001|COMPLETED|Wash Out Period||8
11163345|NCT01600885|12351847|FG000|NOT COMPLETED|Wash Out Period||0
11163346|NCT01600885|12351848|FG001|NOT COMPLETED|Wash Out Period||0
11163347|NCT01600885|12351847|FG000|STARTED|Second Period||8
11163348|NCT01600885|12351848|FG001|STARTED|Second Period||8
11163349|NCT01600885|12351847|FG000|COMPLETED|Second Period||8
11163350|NCT01600885|12351848|FG001|COMPLETED|Second Period||8
11163351|NCT01600885|12351847|FG000|NOT COMPLETED|Second Period||0
11163352|NCT01600885|12351848|FG001|NOT COMPLETED|Second Period||0
11163353|NCT01600950|12351854|FG000|STARTED|Period 1||10
11163354|NCT01600950|12351855|FG001|STARTED|Period 1||10
11163355|NCT01600950|12351854|FG000|COMPLETED|Period 1||10
11163356|NCT01600950|12351855|FG001|COMPLETED|Period 1||10
11163357|NCT01600950|12351854|FG000|NOT COMPLETED|Period 1||0
11163358|NCT01600950|12351855|FG001|NOT COMPLETED|Period 1||0
11163359|NCT01600950|12351854|FG000|STARTED|Period 2||10
11163360|NCT01600950|12351855|FG001|STARTED|Period 2||10
11163361|NCT01600950|12351854|FG000|COMPLETED|Period 2||10
11163362|NCT01600950|12351855|FG001|COMPLETED|Period 2||10
11163363|NCT01600950|12351854|FG000|NOT COMPLETED|Period 2||0
11163364|NCT01600950|12351855|FG001|NOT COMPLETED|Period 2||0
11163365|NCT01601067|12351863|FG000|STARTED|Overall Study||63
11163366|NCT01601067|12351864|FG001|STARTED|Overall Study||56
11163367|NCT01601067|12351863|FG000|COMPLETED|Overall Study||30
11419372|NCT00147238|12617909|FG000|STARTED|Overall Study||10
11419373|NCT00147238|12617909|FG000|COMPLETED|Overall Study||2
11419374|NCT00147238|12617909|FG000|NOT COMPLETED|Overall Study||8
11419375|NCT00165503|12617913|FG000|STARTED|Overall Study||16
11419376|NCT00165503|12617913|FG000|COMPLETED|Overall Study||0
11419377|NCT00165503|12617913|FG000|NOT COMPLETED|Overall Study||16
11163368|NCT01601067|12351864|FG001|COMPLETED|Overall Study||34
11163369|NCT01601067|12351863|FG000|NOT COMPLETED|Overall Study||33
11163370|NCT01601067|12351864|FG001|NOT COMPLETED|Overall Study||22
11163371|NCT01601132|12351870|FG000|STARTED|Overall Study||30
11163372|NCT01601132|12351870|FG000|COMPLETED|Overall Study||28
11163373|NCT01601132|12351870|FG000|NOT COMPLETED|Overall Study||2
11163374|NCT01601236|12351883|FG000|STARTED|Overall Study||7
11163375|NCT01601236|12351884|FG001|STARTED|Overall Study||3
11163376|NCT01601236|12351885|FG002|STARTED|Overall Study||14
11163377|NCT01601236|12351886|FG003|STARTED|Overall Study||6
11163378|NCT01601236|12351887|FG004|STARTED|Overall Study||3
11163379|NCT01601236|12351888|FG005|STARTED|Overall Study||1
11163380|NCT01601236|12351883|FG000|COMPLETED|Overall Study||2
11163381|NCT01601236|12351884|FG001|COMPLETED|Overall Study||2
11163382|NCT01601236|12351885|FG002|COMPLETED|Overall Study||8
11163383|NCT01601236|12351886|FG003|COMPLETED|Overall Study||4
11163384|NCT01601236|12351887|FG004|COMPLETED|Overall Study||0
11163385|NCT01601236|12351888|FG005|COMPLETED|Overall Study||0
11323273|NCT01084252|12520464|FG007|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323274|NCT01084252|12520465|FG008|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323275|NCT01084252|12520466|FG009|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323276|NCT01084252|12520467|FG010|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323277|NCT01084252|12520468|FG011|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
11323278|NCT01084252|12520469|FG012|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||110
11323279|NCT01084252|12520470|FG013|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||55
11323280|NCT01034631|12520537|FG000|STARTED|Phase I||15
11323281|NCT01034631|12520538|FG001|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
11323282|NCT01034631|12520539|FG002|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
11323283|NCT01034631|12520537|FG000|COMPLETED|Phase I||12
11323284|NCT01034631|12520538|FG001|COMPLETED|Phase I||0
11323285|NCT01034631|12520539|FG002|COMPLETED|Phase I||0
11323286|NCT01034631|12520537|FG000|NOT COMPLETED|Phase I||3
11323287|NCT01034631|12520538|FG001|NOT COMPLETED|Phase I||0
11323288|NCT01034631|12520539|FG002|NOT COMPLETED|Phase I||0
11323289|NCT01034631|12520537|FG000|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
11323290|NCT01034631|12520538|FG001|STARTED|Phase II||70
11323291|NCT01034631|12520539|FG002|STARTED|Phase II||69
11323292|NCT01034631|12520537|FG000|COMPLETED|Phase II||0
11323293|NCT01034631|12520538|FG001|COMPLETED|Phase II||69
11323294|NCT01034631|12520539|FG002|COMPLETED|Phase II||67
11323295|NCT01034631|12520537|FG000|NOT COMPLETED|Phase II||0
11323296|NCT01034631|12520538|FG001|NOT COMPLETED|Phase II||1
11323297|NCT01034631|12520539|FG002|NOT COMPLETED|Phase II||2
11323298|NCT00402298|12520551|FG000|STARTED|Overall Study||3
11323299|NCT00402298|12520552|FG001|STARTED|Overall Study||2
11323300|NCT00402298|12520551|FG000|COMPLETED|Overall Study||2
11323301|NCT00402298|12520552|FG001|COMPLETED|Overall Study||2
11323302|NCT00402298|12520551|FG000|NOT COMPLETED|Overall Study||1
11323303|NCT00402298|12520552|FG001|NOT COMPLETED|Overall Study||0
11323304|NCT00212134|12520560|FG000|STARTED|Phase 1 (to Age 1 Year)||57
11323305|NCT00212134|12520561|FG001|STARTED|Phase 1 (to Age 1 Year)||57
11323306|NCT00212134|12520560|FG000|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
11323307|NCT00212134|12520561|FG001|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
11323308|NCT00212134|12520560|FG000|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
11419378|NCT00160563|12617920|FG000|STARTED|Overall Study||59
11323309|NCT00212134|12520561|FG001|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
11323310|NCT00212134|12520560|FG000|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
11323311|NCT00212134|12520561|FG001|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
11323312|NCT00212134|12520560|FG000|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
11323313|NCT00212134|12520561|FG001|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
11419379|NCT00160563|12617921|FG001|STARTED|Overall Study||47
11163386|NCT01601236|12351883|FG000|NOT COMPLETED|Overall Study||5
11163387|NCT01601236|12351884|FG001|NOT COMPLETED|Overall Study||1
11163388|NCT01601236|12351885|FG002|NOT COMPLETED|Overall Study||6
11163389|NCT01601236|12351886|FG003|NOT COMPLETED|Overall Study||2
11163390|NCT01601236|12351887|FG004|NOT COMPLETED|Overall Study||3
11163391|NCT01601236|12351888|FG005|NOT COMPLETED|Overall Study||1
11163392|NCT01601431|12351899|FG000|STARTED|Overall Study||223
11163393|NCT01601431|12351900|FG001|STARTED|Overall Study||217
11163394|NCT01601431|12351899|FG000|COMPLETED|Overall Study||211
11163395|NCT01601431|12351900|FG001|COMPLETED|Overall Study||214
11163396|NCT01601431|12351899|FG000|NOT COMPLETED|Overall Study||12
11163397|NCT01601431|12351900|FG001|NOT COMPLETED|Overall Study||3
11163398|NCT01601470|12351906|FG000|STARTED|Period 1 - Sildenafil||28
11163399|NCT01601470|12351906|FG000|PK Analysis Set|Period 1 - Sildenafil||28
11163400|NCT01601470|12351906|FG000|Safety Set|Period 1 - Sildenafil||28
11163401|NCT01601470|12351906|FG000|COMPLETED|Period 1 - Sildenafil||28
11163402|NCT01601470|12351906|FG000|NOT COMPLETED|Period 1 - Sildenafil||0
11163403|NCT01601470|12351906|FG000|STARTED|Period 2 - LCZ696||28
11163404|NCT01601470|12351906|FG000|PK Analysis Set|Period 2 - LCZ696||27
11163405|NCT01601470|12351906|FG000|Safety Set|Period 2 - LCZ696||27
11163406|NCT01601470|12351906|FG000|COMPLETED|Period 2 - LCZ696||27
11163407|NCT01601470|12351906|FG000|NOT COMPLETED|Period 2 - LCZ696||1
11163408|NCT01601470|12351906|FG000|STARTED|Period 3 - LCZ696+Sildenafil||27
11163409|NCT01601470|12351906|FG000|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
11163410|NCT01601470|12351906|FG000|Safety Set|Period 3 - LCZ696+Sildenafil||27
11163411|NCT01601470|12351906|FG000|COMPLETED|Period 3 - LCZ696+Sildenafil||27
11163412|NCT01601470|12351906|FG000|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
11163413|NCT01601496|12351912|FG000|STARTED|Overall Study|Enrolled|117
11163414|NCT01601496|12351912|FG000|COMPLETED|Overall Study|Completed 12-M F/up|102
11163415|NCT01601496|12351912|FG000|NOT COMPLETED|Overall Study||15
11163416|NCT01601535|12351922|FG000|STARTED|Phase 1||6
11163417|NCT01601535|12351923|FG001|STARTED|Phase 1||6
11163418|NCT01601535|12351924|FG002|STARTED|Phase 1||6
11163419|NCT01601535|12351925|FG003|STARTED|Phase 1||4
11163420|NCT01601535|12351926|FG004|STARTED|Phase 1||0
11163421|NCT01601535|12351927|FG005|STARTED|Phase 1||0
11163422|NCT01601535|12351922|FG000|COMPLETED|Phase 1||0
11163423|NCT01601535|12351923|FG001|COMPLETED|Phase 1||0
11163424|NCT01601535|12351924|FG002|COMPLETED|Phase 1||1
11163425|NCT01601535|12351925|FG003|COMPLETED|Phase 1||0
11163426|NCT01601535|12351926|FG004|COMPLETED|Phase 1||0
11163427|NCT01601535|12351927|FG005|COMPLETED|Phase 1||0
11163428|NCT01601535|12351922|FG000|NOT COMPLETED|Phase 1||6
11163429|NCT01601535|12351923|FG001|NOT COMPLETED|Phase 1||6
11163430|NCT01601535|12351924|FG002|NOT COMPLETED|Phase 1||5
11163431|NCT01601535|12351925|FG003|NOT COMPLETED|Phase 1||4
11163432|NCT01601535|12351926|FG004|NOT COMPLETED|Phase 1||0
11163433|NCT01601535|12351927|FG005|NOT COMPLETED|Phase 1||0
11163434|NCT01601535|12351922|FG000|STARTED|Phase 2||0
11163435|NCT01601535|12351923|FG001|STARTED|Phase 2||0
11163436|NCT01601535|12351924|FG002|STARTED|Phase 2||0
11163437|NCT01601535|12351925|FG003|STARTED|Phase 2||0
11163438|NCT01601535|12351926|FG004|STARTED|Phase 2||20
11163439|NCT01601535|12351927|FG005|STARTED|Phase 2||12
11163440|NCT01601535|12351922|FG000|COMPLETED|Phase 2||0
11163441|NCT01601535|12351923|FG001|COMPLETED|Phase 2||0
11163442|NCT01601535|12351924|FG002|COMPLETED|Phase 2||0
11163443|NCT01601535|12351925|FG003|COMPLETED|Phase 2||0
11419380|NCT00160563|12617922|FG002|STARTED|Overall Study||101
11419381|NCT00160563|12617920|FG000|COMPLETED|Overall Study||8
11419382|NCT00160563|12617921|FG001|COMPLETED|Overall Study||2
11163444|NCT01601535|12351926|FG004|COMPLETED|Phase 2||1
11163445|NCT01601535|12351927|FG005|COMPLETED|Phase 2||0
11163446|NCT01601535|12351922|FG000|NOT COMPLETED|Phase 2||0
11163447|NCT01601535|12351923|FG001|NOT COMPLETED|Phase 2||0
11163448|NCT01601535|12351924|FG002|NOT COMPLETED|Phase 2||0
11163449|NCT01601535|12351925|FG003|NOT COMPLETED|Phase 2||0
11163450|NCT01601535|12351926|FG004|NOT COMPLETED|Phase 2||19
11163451|NCT01601535|12351927|FG005|NOT COMPLETED|Phase 2||12
11163452|NCT01601626|12351953|FG000|STARTED|Overall Study||24
11163453|NCT01601626|12351954|FG001|STARTED|Overall Study||24
11163454|NCT01601626|12351955|FG002|STARTED|Overall Study||23
11163455|NCT01601626|12351953|FG000|COMPLETED|Overall Study||21
11163456|NCT01601626|12351954|FG001|COMPLETED|Overall Study||19
11163457|NCT01601626|12351955|FG002|COMPLETED|Overall Study||21
11163458|NCT01601626|12351953|FG000|NOT COMPLETED|Overall Study||3
11163459|NCT01601626|12351954|FG001|NOT COMPLETED|Overall Study||5
11163460|NCT01601626|12351955|FG002|NOT COMPLETED|Overall Study||2
11163461|NCT01601652|12351963|FG000|STARTED|Overall Study||12
11163462|NCT01601652|12351963|FG000|COMPLETED|Overall Study||11
11163463|NCT01601652|12351963|FG000|NOT COMPLETED|Overall Study||1
11419383|NCT00160563|12617922|FG002|COMPLETED|Overall Study||11
11419384|NCT00160563|12617920|FG000|NOT COMPLETED|Overall Study||51
11419385|NCT00160563|12617921|FG001|NOT COMPLETED|Overall Study||45
11419386|NCT00160563|12617922|FG002|NOT COMPLETED|Overall Study||90
11419387|NCT00142519|12617933|FG000|STARTED|Overall Study||25
11419388|NCT00142519|12617934|FG001|STARTED|Overall Study||25
11163464|NCT01601691|12351967|FG000|STARTED|Overall Study||10
11419389|NCT00142519|12617933|FG000|COMPLETED|Overall Study||7
11163465|NCT01601691|12351967|FG000|COMPLETED|Overall Study||10
11163466|NCT01601691|12351967|FG000|NOT COMPLETED|Overall Study||0
11163467|NCT01601704|12351973|FG000|STARTED|Overall Study||4456
11163468|NCT01601704|12351974|FG001|STARTED|Overall Study||4454
11163469|NCT01601704|12351973|FG000|Treated|Overall Study||4455
11163470|NCT01601704|12351974|FG001|Treated|Overall Study||4450
11163471|NCT01601704|12351973|FG000|COMPLETED|Overall Study||4455
11163472|NCT01601704|12351974|FG001|COMPLETED|Overall Study||4450
11163473|NCT01601704|12351973|FG000|NOT COMPLETED|Overall Study||1
11163474|NCT01601704|12351974|FG001|NOT COMPLETED|Overall Study||4
11419390|NCT00142519|12617934|FG001|COMPLETED|Overall Study||9
11163475|NCT01601782|12351980|FG000|STARTED|Overall Study||16
11163476|NCT01601782|12351980|FG000|COMPLETED|Overall Study||16
11163477|NCT01601782|12351980|FG000|NOT COMPLETED|Overall Study||0
11163478|NCT01601821|12351986|FG000|STARTED|Overall Study||125
11163479|NCT01601821|12351987|FG001|STARTED|Overall Study||120
11163480|NCT01601821|12351986|FG000|COMPLETED|Overall Study||96
11163481|NCT01601821|12351987|FG001|COMPLETED|Overall Study||91
11163482|NCT01601821|12351986|FG000|NOT COMPLETED|Overall Study||29
11163483|NCT01601821|12351987|FG001|NOT COMPLETED|Overall Study||29
11163484|NCT01601847|12351995|FG000|STARTED|Overall Study||153
11163485|NCT01601847|12351996|FG001|STARTED|Overall Study||147
11163486|NCT01601847|12351995|FG000|COMPLETED|Overall Study||140
11163487|NCT01601847|12351996|FG001|COMPLETED|Overall Study||137
11163488|NCT01601847|12351995|FG000|NOT COMPLETED|Overall Study||13
11419391|NCT00142519|12617933|FG000|NOT COMPLETED|Overall Study||18
11419392|NCT00142519|12617934|FG001|NOT COMPLETED|Overall Study||16
11419393|NCT00145704|12617942|FG000|STARTED|Overall Study||3
11419394|NCT00145704|12617943|FG001|STARTED|Overall Study||3
11419395|NCT00145704|12617942|FG000|COMPLETED|Overall Study||0
11419396|NCT00145704|12617943|FG001|COMPLETED|Overall Study||0
11419397|NCT00145704|12617942|FG000|NOT COMPLETED|Overall Study||3
11419398|NCT00145704|12617943|FG001|NOT COMPLETED|Overall Study||3
11419399|NCT00138073|12617949|FG000|STARTED|Overall Study||55
11419400|NCT00138073|12617949|FG000|Pre-intervention Testing|Overall Study||55
11419401|NCT00138073|12617949|FG000|COMPLETED|Overall Study||0
11419402|NCT00138073|12617949|FG000|NOT COMPLETED|Overall Study||55
11419403|NCT00113386|12617955|FG000|STARTED|Overall Study||10
11419404|NCT00113386|12617956|FG001|STARTED|Overall Study||9
11419405|NCT00113386|12617955|FG000|COMPLETED|Overall Study||3
11419406|NCT00113386|12617956|FG001|COMPLETED|Overall Study||5
11419407|NCT00113386|12617955|FG000|NOT COMPLETED|Overall Study||7
11419408|NCT00113386|12617956|FG001|NOT COMPLETED|Overall Study||4
11419409|NCT00138151|12617962|FG000|STARTED|Overall Study||33
11419410|NCT00138151|12617962|FG000|COMPLETED|Overall Study||29
11419411|NCT00138151|12617962|FG000|NOT COMPLETED|Overall Study||4
11419412|NCT00129974|12617966|FG000|STARTED|Overall Study||1
11419413|NCT00129974|12617966|FG000|COMPLETED|Overall Study||0
11419414|NCT00129974|12617966|FG000|NOT COMPLETED|Overall Study||1
11419415|NCT00126659|12617973|FG000|STARTED|Overall Study||3
11419416|NCT00126659|12617974|FG001|STARTED|Overall Study||3
11419417|NCT00126659|12617975|FG002|STARTED|Overall Study||4
11419418|NCT00126659|12617973|FG000|COMPLETED|Overall Study||3
11419419|NCT00126659|12617974|FG001|COMPLETED|Overall Study||3
11163489|NCT01601847|12351996|FG001|NOT COMPLETED|Overall Study||10
11163490|NCT01601860|12352004|FG000|STARTED|Overall Study||40
11163491|NCT01601860|12352005|FG001|STARTED|Overall Study||40
11163492|NCT01601860|12352004|FG000|COMPLETED|Overall Study||19
11163493|NCT01601860|12352005|FG001|COMPLETED|Overall Study||31
11163494|NCT01601860|12352004|FG000|NOT COMPLETED|Overall Study||21
11163495|NCT01601860|12352005|FG001|NOT COMPLETED|Overall Study||9
11163496|NCT01601873|12352014|FG000|STARTED|Overall Study||50
11163497|NCT01601873|12352015|FG001|STARTED|Overall Study||47
11163498|NCT01601873|12352014|FG000|COMPLETED|Overall Study||48
11163499|NCT01601873|12352015|FG001|COMPLETED|Overall Study||44
11163500|NCT01601873|12352014|FG000|NOT COMPLETED|Overall Study||2
11163501|NCT01601873|12352015|FG001|NOT COMPLETED|Overall Study||3
11163502|NCT01601977|12352021|FG000|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
11163503|NCT01601977|12352021|FG000|COMPLETED|Overall Study||10
11163504|NCT01601977|12352021|FG000|NOT COMPLETED|Overall Study||0
11163505|NCT01602068|12352029|FG000|STARTED|Overall Study|Day before surgery|23
11163506|NCT01602068|12352030|FG001|STARTED|Overall Study|Day before surgery|22
11163507|NCT01602068|12352029|FG000|COMPLETED|Overall Study||23
11163508|NCT01602068|12352030|FG001|COMPLETED|Overall Study||22
11163509|NCT01602068|12352029|FG000|NOT COMPLETED|Overall Study||0
11163510|NCT01602068|12352030|FG001|NOT COMPLETED|Overall Study||0
11163511|NCT01602120|12352040|FG000|STARTED|Overall Study||29
11163512|NCT01602120|12352041|FG001|STARTED|Overall Study||60
11163513|NCT01602120|12352042|FG002|STARTED|Overall Study||17
11163514|NCT01602120|12352043|FG003|STARTED|Overall Study||53
11163515|NCT01602120|12352040|FG000|COMPLETED|Overall Study||0
11163516|NCT01602120|12352041|FG001|COMPLETED|Overall Study||0
11163517|NCT01602120|12352042|FG002|COMPLETED|Overall Study||0
11163518|NCT01602120|12352043|FG003|COMPLETED|Overall Study||0
11163519|NCT01602120|12352040|FG000|NOT COMPLETED|Overall Study||29
11163520|NCT01602120|12352041|FG001|NOT COMPLETED|Overall Study||60
11163521|NCT01602120|12352042|FG002|NOT COMPLETED|Overall Study||17
11419420|NCT00126659|12617975|FG002|COMPLETED|Overall Study||2
11419421|NCT00126659|12617973|FG000|NOT COMPLETED|Overall Study||0
11163522|NCT01602120|12352043|FG003|NOT COMPLETED|Overall Study||53
11419422|NCT00126659|12617974|FG001|NOT COMPLETED|Overall Study||0
11163523|NCT01602172|12352058|FG000|STARTED|Overall Study||37
11163524|NCT01602172|12352059|FG001|STARTED|Overall Study||23
11163525|NCT01602172|12352060|FG002|STARTED|Overall Study||22
11163526|NCT01602172|12352058|FG000|COMPLETED|Overall Study||32
11163527|NCT01602172|12352059|FG001|COMPLETED|Overall Study||17
11163528|NCT01602172|12352060|FG002|COMPLETED|Overall Study||22
11163529|NCT01602172|12352058|FG000|NOT COMPLETED|Overall Study||5
11163530|NCT01602172|12352059|FG001|NOT COMPLETED|Overall Study||6
11163531|NCT01602172|12352060|FG002|NOT COMPLETED|Overall Study||0
11419423|NCT00126659|12617975|FG002|NOT COMPLETED|Overall Study||2
11419424|NCT00133679|12617983|FG000|STARTED|Overall Study||0
11419425|NCT00133679|12617984|FG001|STARTED|Overall Study||0
11163532|NCT01602224|12352077|FG000|STARTED|Overall Study||74
11163533|NCT01602224|12352078|FG001|STARTED|Overall Study||74
11163534|NCT01602224|12352079|FG002|STARTED|Overall Study||72
11163535|NCT01602224|12352077|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73
11163536|NCT01602224|12352078|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
11163537|NCT01602224|12352079|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72
11163538|NCT01602224|12352077|FG000|COMPLETED|Overall Study||66
11163539|NCT01602224|12352078|FG001|COMPLETED|Overall Study||66
11163540|NCT01602224|12352079|FG002|COMPLETED|Overall Study||66
11163541|NCT01602224|12352077|FG000|NOT COMPLETED|Overall Study||8
11163542|NCT01602224|12352078|FG001|NOT COMPLETED|Overall Study||8
11163543|NCT01602224|12352079|FG002|NOT COMPLETED|Overall Study||6
11163544|NCT01602315|12352096|FG000|STARTED|Overall Study||16
11163545|NCT01602315|12352097|FG001|STARTED|Overall Study||5
11163546|NCT01602315|12352098|FG002|STARTED|Overall Study||18
11163547|NCT01602315|12352099|FG003|STARTED|Overall Study||6
11163548|NCT01602315|12352100|FG004|STARTED|Overall Study||71
11163549|NCT01602315|12352101|FG005|STARTED|Overall Study||35
11163550|NCT01602315|12352102|FG006|STARTED|Overall Study||29
11163551|NCT01602315|12352096|FG000|COMPLETED|Overall Study||0
11163552|NCT01602315|12352097|FG001|COMPLETED|Overall Study||0
11163553|NCT01602315|12352098|FG002|COMPLETED|Overall Study||0
11163554|NCT01602315|12352099|FG003|COMPLETED|Overall Study||0
11163555|NCT01602315|12352100|FG004|COMPLETED|Overall Study||0
11163556|NCT01602315|12352101|FG005|COMPLETED|Overall Study||0
11163557|NCT01602315|12352102|FG006|COMPLETED|Overall Study||0
11163558|NCT01602315|12352096|FG000|NOT COMPLETED|Overall Study||16
11163559|NCT01602315|12352097|FG001|NOT COMPLETED|Overall Study||5
11163560|NCT01602315|12352098|FG002|NOT COMPLETED|Overall Study||18
11163561|NCT01602315|12352099|FG003|NOT COMPLETED|Overall Study||6
11163562|NCT01602315|12352100|FG004|NOT COMPLETED|Overall Study||71
11163563|NCT01602315|12352101|FG005|NOT COMPLETED|Overall Study||35
11163564|NCT01602315|12352102|FG006|NOT COMPLETED|Overall Study||29
11163565|NCT01602341|12352140|FG000|STARTED|Overall Study||44
11163566|NCT01602341|12352141|FG001|STARTED|Overall Study||42
11163567|NCT01602341|12352140|FG000|COMPLETED|Overall Study||44
11163568|NCT01602341|12352141|FG001|COMPLETED|Overall Study||41
11163569|NCT01602341|12352140|FG000|NOT COMPLETED|Overall Study||0
11163570|NCT01602341|12352141|FG001|NOT COMPLETED|Overall Study||1
11163571|NCT01602419|12352151|FG000|STARTED|Overall Study||120
11163572|NCT01602419|12352151|FG000|SAF Population|Overall Study||111
11163573|NCT01602419|12352151|FG000|ITT Population|Overall Study||102
11163574|NCT01602419|12352151|FG000|EFF Population|Overall Study||91
11163575|NCT01602419|12352151|FG000|COMPLETED|Overall Study||91
11163576|NCT01602419|12352151|FG000|NOT COMPLETED|Overall Study||29
11163577|NCT01602484|12352198|FG000|STARTED|Overall Study||25
11163578|NCT01602484|12352199|FG001|STARTED|Overall Study||25
11163579|NCT01602484|12352198|FG000|COMPLETED|Overall Study||25
11163580|NCT01602484|12352199|FG001|COMPLETED|Overall Study||24
11163581|NCT01602484|12352198|FG000|NOT COMPLETED|Overall Study||0
11163582|NCT01602484|12352199|FG001|NOT COMPLETED|Overall Study||1
11163583|NCT01602510|12352205|FG000|STARTED|Open Label Phase||420
11163584|NCT01602510|12352206|FG001|STARTED|Open Label Phase||0
11163585|NCT01602510|12352207|FG002|STARTED|Open Label Phase||0
11163586|NCT01602510|12352205|FG000|COMPLETED|Open Label Phase||117
11163587|NCT01602510|12352206|FG001|COMPLETED|Open Label Phase||0
11163588|NCT01602510|12352207|FG002|COMPLETED|Open Label Phase||0
11163589|NCT01602510|12352205|FG000|NOT COMPLETED|Open Label Phase||303
11163590|NCT01602510|12352206|FG001|NOT COMPLETED|Open Label Phase||0
11163591|NCT01602510|12352207|FG002|NOT COMPLETED|Open Label Phase||0
11163592|NCT01602510|12352205|FG000|STARTED|Randomized Phase||0
11163593|NCT01602510|12352206|FG001|STARTED|Randomized Phase||133
11163594|NCT01602510|12352207|FG002|STARTED|Randomized Phase||131
11163595|NCT01602510|12352205|FG000|COMPLETED|Randomized Phase||0
11163596|NCT01602510|12352206|FG001|COMPLETED|Randomized Phase||59
11163597|NCT01602510|12352207|FG002|COMPLETED|Randomized Phase||58
11163598|NCT01602510|12352205|FG000|NOT COMPLETED|Randomized Phase||0
11163599|NCT01602510|12352206|FG001|NOT COMPLETED|Randomized Phase||74
11163600|NCT01602510|12352207|FG002|NOT COMPLETED|Randomized Phase||73
11163601|NCT01602549|12352215|FG000|STARTED|Overall Study||19
11163602|NCT01602549|12352216|FG001|STARTED|Overall Study||38
11163603|NCT01602549|12352215|FG000|COMPLETED|Overall Study||18
11163604|NCT01602549|12352216|FG001|COMPLETED|Overall Study||37
11163605|NCT01602549|12352215|FG000|NOT COMPLETED|Overall Study||1
11163606|NCT01602549|12352216|FG001|NOT COMPLETED|Overall Study||1
11163607|NCT01602562|12352226|FG000|STARTED|Overall Study||21
11163608|NCT01602562|12352227|FG001|STARTED|Overall Study||19
11163609|NCT01602562|12352226|FG000|COMPLETED|Overall Study||16
11163610|NCT01602562|12352227|FG001|COMPLETED|Overall Study||16
11163611|NCT01602562|12352226|FG000|NOT COMPLETED|Overall Study||5
11163612|NCT01602562|12352227|FG001|NOT COMPLETED|Overall Study||3
11163613|NCT01602614|12352238|FG000|STARTED|Overall Study||0
11163614|NCT01602614|12352239|FG001|STARTED|Overall Study||10
11026772|NCT00830362|12205383|FG001|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
11026773|NCT00830362|12205382|FG000|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
11163615|NCT01602614|12352240|FG002|STARTED|Overall Study||8
11163616|NCT01602614|12352241|FG003|STARTED|Overall Study||0
11163617|NCT01602614|12352238|FG000|COMPLETED|Overall Study||0
11163618|NCT01602614|12352239|FG001|COMPLETED|Overall Study||10
11163619|NCT01602614|12352240|FG002|COMPLETED|Overall Study||8
11026774|NCT00830362|12205383|FG001|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
11163620|NCT01602614|12352241|FG003|COMPLETED|Overall Study||0
11163621|NCT01602614|12352238|FG000|NOT COMPLETED|Overall Study||0
11163622|NCT01602614|12352239|FG001|NOT COMPLETED|Overall Study||0
11163623|NCT01602614|12352240|FG002|NOT COMPLETED|Overall Study||0
11163624|NCT01602614|12352241|FG003|NOT COMPLETED|Overall Study||0
11163625|NCT01602679|12352257|FG000|STARTED|Overall Study||4
11163626|NCT01602679|12352258|FG001|STARTED|Overall Study||3
11163627|NCT01602679|12352257|FG000|COMPLETED|Overall Study||4
11163628|NCT01602679|12352258|FG001|COMPLETED|Overall Study||3
11163629|NCT01602679|12352257|FG000|NOT COMPLETED|Overall Study||0
11163630|NCT01602679|12352258|FG001|NOT COMPLETED|Overall Study||0
11163631|NCT01602692|12352266|FG000|STARTED|Overall Study||20
11163632|NCT01602692|12352267|FG001|STARTED|Overall Study||20
11163633|NCT01602692|12352266|FG000|COMPLETED|Overall Study||20
11163634|NCT01602692|12352267|FG001|COMPLETED|Overall Study||20
11163635|NCT01602692|12352266|FG000|NOT COMPLETED|Overall Study||0
11163636|NCT01602692|12352267|FG001|NOT COMPLETED|Overall Study||0
11163637|NCT01602731|12352277|FG000|STARTED|Overall Study||45
11163638|NCT01602731|12352277|FG000|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
11163639|NCT01602731|12352277|FG000|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
11163640|NCT01602731|12352277|FG000|COMPLETED|Overall Study||15
11163641|NCT01602731|12352277|FG000|NOT COMPLETED|Overall Study||30
11163642|NCT01602744|12352285|FG000|STARTED|Overall Study||176
11163643|NCT01602744|12352286|FG001|STARTED|Overall Study||183
11163644|NCT01602744|12352285|FG000|COMPLETED|Overall Study||146
11163645|NCT01602744|12352286|FG001|COMPLETED|Overall Study||160
11163646|NCT01602744|12352285|FG000|NOT COMPLETED|Overall Study||30
11163647|NCT01602744|12352286|FG001|NOT COMPLETED|Overall Study||23
11163648|NCT01602965|12352294|FG000|STARTED|Overall Study||20
11163649|NCT01602965|12352295|FG001|STARTED|Overall Study||20
11163650|NCT01602965|12352294|FG000|COMPLETED|Overall Study||16
11163651|NCT01602965|12352295|FG001|COMPLETED|Overall Study||18
11163652|NCT01602965|12352294|FG000|NOT COMPLETED|Overall Study||4
11163653|NCT01602965|12352295|FG001|NOT COMPLETED|Overall Study||2
11163654|NCT01603056|12352303|FG000|STARTED|Overall Study||413
11163655|NCT01603056|12352304|FG001|STARTED|Overall Study||204
11163656|NCT01603056|12352303|FG000|COMPLETED|Overall Study||379
11163657|NCT01603056|12352304|FG001|COMPLETED|Overall Study||190
11163658|NCT01603056|12352303|FG000|NOT COMPLETED|Overall Study||34
11163659|NCT01603056|12352304|FG001|NOT COMPLETED|Overall Study||14
11163660|NCT01603082|12352312|FG000|STARTED|Overall Study|Randomized|51
11163661|NCT01603082|12352313|FG001|STARTED|Overall Study|Randomized|49
11163662|NCT01603082|12352312|FG000|COMPLETED|Overall Study|Completed the study.|49
11163663|NCT01603082|12352313|FG001|COMPLETED|Overall Study|Completed the study|48
11163664|NCT01603082|12352312|FG000|NOT COMPLETED|Overall Study||2
11163665|NCT01603082|12352313|FG001|NOT COMPLETED|Overall Study||1
11163666|NCT01603277|12352321|FG000|STARTED|Overall Study||78
11163667|NCT01603277|12352322|FG001|STARTED|Overall Study||82
11163668|NCT01603277|12352321|FG000|COMPLETED|Overall Study||64
11163669|NCT01603277|12352322|FG001|COMPLETED|Overall Study||64
11163670|NCT01603277|12352321|FG000|NOT COMPLETED|Overall Study||14
11163671|NCT01603277|12352322|FG001|NOT COMPLETED|Overall Study||18
11163672|NCT01603355|12352328|FG000|STARTED|Overall Study||3
11163673|NCT01603355|12352328|FG000|COMPLETED|Overall Study||1
11163674|NCT01603355|12352328|FG000|NOT COMPLETED|Overall Study||2
11163675|NCT01603368|12352334|FG000|STARTED|Overall Study||68
11163676|NCT01603368|12352335|FG001|STARTED|Overall Study||66
11163677|NCT01603368|12352334|FG000|COMPLETED|Overall Study||68
11163678|NCT01603368|12352335|FG001|COMPLETED|Overall Study||66
11163679|NCT01603368|12352334|FG000|NOT COMPLETED|Overall Study||0
11163680|NCT01603368|12352335|FG001|NOT COMPLETED|Overall Study||0
11163681|NCT01603420|12352343|FG000|STARTED|Overall Study||1
11163682|NCT01603420|12352344|FG001|STARTED|Overall Study||1
11419426|NCT00133679|12617983|FG000|COMPLETED|Overall Study||0
11419427|NCT00133679|12617984|FG001|COMPLETED|Overall Study||0
11419428|NCT00133679|12617983|FG000|NOT COMPLETED|Overall Study||0
11419429|NCT00133679|12617984|FG001|NOT COMPLETED|Overall Study||0
11419430|NCT00125268|12617992|FG000|STARTED|Overall Study||16
11419431|NCT00125268|12617993|FG001|STARTED|Overall Study||14
11419432|NCT00125268|12617992|FG000|COMPLETED|Overall Study||15
11163683|NCT01603420|12352343|FG000|COMPLETED|Overall Study||1
11163684|NCT01603420|12352344|FG001|COMPLETED|Overall Study||1
11163685|NCT01603420|12352343|FG000|NOT COMPLETED|Overall Study||0
11163686|NCT01603420|12352344|FG001|NOT COMPLETED|Overall Study||0
11163687|NCT01603459|12352353|FG000|STARTED|Overall Study||155
11163688|NCT01603459|12352353|FG000|COMPLETED|Overall Study||137
11163689|NCT01603459|12352353|FG000|NOT COMPLETED|Overall Study||18
11163690|NCT01603602|12352378|FG000|STARTED|Overall Study||77
11163691|NCT01603602|12352379|FG001|STARTED|Overall Study||78
11163692|NCT01603602|12352380|FG002|STARTED|Overall Study||80
11163693|NCT01603602|12352378|FG000|COMPLETED|Overall Study||75
11163694|NCT01603602|12352379|FG001|COMPLETED|Overall Study||78
11163695|NCT01603602|12352380|FG002|COMPLETED|Overall Study||79
11419433|NCT00125268|12617993|FG001|COMPLETED|Overall Study||13
11163696|NCT01603602|12352378|FG000|NOT COMPLETED|Overall Study||2
11163697|NCT01603602|12352379|FG001|NOT COMPLETED|Overall Study||0
11163698|NCT01603602|12352380|FG002|NOT COMPLETED|Overall Study||1
11163699|NCT01603615|12352388|FG000|STARTED|Overall Study||220
11163700|NCT01603615|12352388|FG000|Safety Population (Treated)|Overall Study||213
11163701|NCT01603615|12352388|FG000|COMPLETED|Overall Study||186
11163702|NCT01603615|12352388|FG000|NOT COMPLETED|Overall Study||34
11163703|NCT01603628|12352395|FG000|STARTED|Overall Study||128
11163704|NCT01603628|12352396|FG001|STARTED|Overall Study||126
11163705|NCT01603628|12352397|FG002|STARTED|Overall Study||130
11163706|NCT01603628|12352395|FG000|Safety Population: Received Treatment|Overall Study||128
11163707|NCT01603628|12352396|FG001|Safety Population: Received Treatment|Overall Study||126
11163708|NCT01603628|12352397|FG002|Safety Population: Received Treatment|Overall Study||128
11163709|NCT01603628|12352395|FG000|COMPLETED|Overall Study||125
11163710|NCT01603628|12352396|FG001|COMPLETED|Overall Study||123
11163711|NCT01603628|12352397|FG002|COMPLETED|Overall Study||128
11163712|NCT01603628|12352395|FG000|NOT COMPLETED|Overall Study||3
11163713|NCT01603628|12352396|FG001|NOT COMPLETED|Overall Study||3
11163714|NCT01603628|12352397|FG002|NOT COMPLETED|Overall Study||2
11163715|NCT01603641|12352405|FG000|STARTED|Overall Study||370
11163716|NCT01603641|12352405|FG000|Safety Population (Treated)|Overall Study||367
11163717|NCT01603641|12352405|FG000|Modified Intent-to-treat Population|Overall Study||366
11163718|NCT01603641|12352405|FG000|COMPLETED|Overall Study||335
11163719|NCT01603641|12352405|FG000|NOT COMPLETED|Overall Study||35
11163720|NCT01603875|12352412|FG000|STARTED|Overall Study||35
11163721|NCT01603875|12352413|FG001|STARTED|Overall Study||35
11163722|NCT01603875|12352414|FG002|STARTED|Overall Study||35
11163723|NCT01603875|12352412|FG000|COMPLETED|Overall Study||28
11163724|NCT01603875|12352413|FG001|COMPLETED|Overall Study||27
11163725|NCT01603875|12352414|FG002|COMPLETED|Overall Study||26
11163726|NCT01603875|12352412|FG000|NOT COMPLETED|Overall Study||7
11163727|NCT01603875|12352413|FG001|NOT COMPLETED|Overall Study||8
11163728|NCT01603875|12352414|FG002|NOT COMPLETED|Overall Study||9
11163729|NCT01603940|12352424|FG000|STARTED|Overall Study||16
11163730|NCT01603940|12352425|FG001|STARTED|Overall Study||14
11163731|NCT01603940|12352424|FG000|COMPLETED|Overall Study||16
11163732|NCT01603940|12352425|FG001|COMPLETED|Overall Study||14
11163733|NCT01603940|12352424|FG000|NOT COMPLETED|Overall Study||0
11163734|NCT01603940|12352425|FG001|NOT COMPLETED|Overall Study||0
11163735|NCT01604109|12352433|FG000|STARTED|Overall Study||150
11163736|NCT01604109|12352434|FG001|STARTED|Overall Study||146
11163737|NCT01604109|12352433|FG000|COMPLETED|Overall Study||117
11163738|NCT01604109|12352434|FG001|COMPLETED|Overall Study||112
11163739|NCT01604109|12352433|FG000|NOT COMPLETED|Overall Study||33
11163740|NCT01604109|12352434|FG001|NOT COMPLETED|Overall Study||34
11163741|NCT01604122|12352442|FG000|STARTED|Overall Study||60
11163742|NCT01604122|12352443|FG001|STARTED|Overall Study||32
11163743|NCT01604122|12352442|FG000|COMPLETED|Overall Study||60
11163744|NCT01604122|12352443|FG001|COMPLETED|Overall Study||32
11163745|NCT01604122|12352442|FG000|NOT COMPLETED|Overall Study||0
11163746|NCT01604122|12352443|FG001|NOT COMPLETED|Overall Study||0
11163747|NCT01604265|12352452|FG000|STARTED|Overall Study||34
11163748|NCT01604265|12352453|FG001|STARTED|Overall Study||32
11163749|NCT01604265|12352452|FG000|COMPLETED|Overall Study||32
11163750|NCT01604265|12352453|FG001|COMPLETED|Overall Study||32
11163751|NCT01604265|12352452|FG000|NOT COMPLETED|Overall Study||2
11163752|NCT01604265|12352453|FG001|NOT COMPLETED|Overall Study||0
11163753|NCT01604278|12352461|FG000|STARTED|Overall Study||226
11163754|NCT01604278|12352462|FG001|STARTED|Overall Study||223
11163755|NCT01604278|12352461|FG000|Safety Set|Overall Study||226
11163756|NCT01604278|12352462|FG001|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
11163757|NCT01604278|12352461|FG000|Full Analysis Set|Overall Study||226
11163758|NCT01604278|12352462|FG001|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
11163759|NCT01604278|12352461|FG000|COMPLETED|Overall Study||212
11163760|NCT01604278|12352462|FG001|COMPLETED|Overall Study||210
11163761|NCT01604278|12352461|FG000|NOT COMPLETED|Overall Study||14
11163762|NCT01604278|12352462|FG001|NOT COMPLETED|Overall Study||13
11163763|NCT01604291|12352472|FG000|STARTED|Overall Study||311
11163764|NCT01604291|12352473|FG001|STARTED|Overall Study||443
11163765|NCT01604291|12352474|FG002|STARTED|Overall Study||193
11163766|NCT01604291|12352475|FG003|STARTED|Overall Study||44
11163767|NCT01604291|12352472|FG000|COMPLETED|Overall Study||311
11163768|NCT01604291|12352473|FG001|COMPLETED|Overall Study||443
11163769|NCT01604291|12352474|FG002|COMPLETED|Overall Study||193
11163770|NCT01604291|12352475|FG003|COMPLETED|Overall Study||44
11163771|NCT01604291|12352472|FG000|NOT COMPLETED|Overall Study||0
11163772|NCT01604291|12352473|FG001|NOT COMPLETED|Overall Study||0
11163773|NCT01604291|12352474|FG002|NOT COMPLETED|Overall Study||0
11163774|NCT01604291|12352475|FG003|NOT COMPLETED|Overall Study||0
11163775|NCT01604343|12352496|FG000|STARTED|Prior to W52 Administration(Through W52)||556
11163776|NCT01604343|12352497|FG001|STARTED|Prior to W52 Administration(Through W52)||0
11163777|NCT01604343|12352498|FG002|STARTED|Prior to W52 Administration(Through W52)||557
11163778|NCT01604343|12352499|FG003|STARTED|Prior to W52 Administration(Through W52)||0
11163779|NCT01604343|12352500|FG004|STARTED|Prior to W52 Administration(Through W52)||557
11163780|NCT01604343|12352496|FG000|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
11163781|NCT01604343|12352497|FG001|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
11163782|NCT01604343|12352498|FG002|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
11163783|NCT01604343|12352499|FG003|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
11203522|NCT01847560|12394032|FG005|STARTED|Overall Study||28343
11163784|NCT01604343|12352500|FG004|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
11163785|NCT01604343|12352496|FG000|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
11163786|NCT01604343|12352497|FG001|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
11163787|NCT01604343|12352498|FG002|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
11163788|NCT01604343|12352499|FG003|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
11163789|NCT01604343|12352500|FG004|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
11163790|NCT01604343|12352496|FG000|COMPLETED|Prior to W52 Administration(Through W52)||458
11163791|NCT01604343|12352497|FG001|COMPLETED|Prior to W52 Administration(Through W52)||0
11163792|NCT01604343|12352498|FG002|COMPLETED|Prior to W52 Administration(Through W52)||481
11163793|NCT01604343|12352499|FG003|COMPLETED|Prior to W52 Administration(Through W52)||0
11163794|NCT01604343|12352500|FG004|COMPLETED|Prior to W52 Administration(Through W52)||470
11163795|NCT01604343|12352496|FG000|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
11163796|NCT01604343|12352497|FG001|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
11163797|NCT01604343|12352498|FG002|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
11163798|NCT01604343|12352499|FG003|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
11163799|NCT01604343|12352500|FG004|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
11163800|NCT01604343|12352496|FG000|STARTED|Week 52 to Week 104||0
11163801|NCT01604343|12352497|FG001|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
11163802|NCT01604343|12352498|FG002|STARTED|Week 52 to Week 104||481
11163803|NCT01604343|12352499|FG003|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
11163804|NCT01604343|12352500|FG004|STARTED|Week 52 to Week 104||470
11163805|NCT01604343|12352496|FG000|Treated|Week 52 to Week 104||0
11163806|NCT01604343|12352497|FG001|Treated|Week 52 to Week 104||242
11163807|NCT01604343|12352498|FG002|Treated|Week 52 to Week 104||481
11163808|NCT01604343|12352499|FG003|Treated|Week 52 to Week 104||241
11163809|NCT01604343|12352500|FG004|Treated|Week 52 to Week 104||470
11163810|NCT01604343|12352496|FG000|COMPLETED|Week 52 to Week 104||0
11163811|NCT01604343|12352497|FG001|COMPLETED|Week 52 to Week 104||200
11163812|NCT01604343|12352498|FG002|COMPLETED|Week 52 to Week 104||414
11163813|NCT01604343|12352499|FG003|COMPLETED|Week 52 to Week 104||195
11163814|NCT01604343|12352500|FG004|COMPLETED|Week 52 to Week 104||429
11163815|NCT01604343|12352496|FG000|NOT COMPLETED|Week 52 to Week 104||0
11163816|NCT01604343|12352497|FG001|NOT COMPLETED|Week 52 to Week 104||43
11163817|NCT01604343|12352498|FG002|NOT COMPLETED|Week 52 to Week 104||67
11163818|NCT01604343|12352499|FG003|NOT COMPLETED|Week 52 to Week 104||46
11163819|NCT01604343|12352500|FG004|NOT COMPLETED|Week 52 to Week 104||41
11163820|NCT01604343|12352496|FG000|STARTED|Safety Follow-up Period (Week 104-120)||109
11163821|NCT01604343|12352497|FG001|STARTED|Safety Follow-up Period (Week 104-120)||27
11163822|NCT01604343|12352498|FG002|STARTED|Safety Follow-up Period (Week 104-120)||105
11163823|NCT01604343|12352499|FG003|STARTED|Safety Follow-up Period (Week 104-120)||36
11163824|NCT01604343|12352500|FG004|STARTED|Safety Follow-up Period (Week 104-120)||114
11163825|NCT01604343|12352496|FG000|Safety Population|Safety Follow-up Period (Week 104-120)||109
11163826|NCT01604343|12352497|FG001|Safety Population|Safety Follow-up Period (Week 104-120)||26
11163827|NCT01604343|12352498|FG002|Safety Population|Safety Follow-up Period (Week 104-120)||105
11163828|NCT01604343|12352499|FG003|Safety Population|Safety Follow-up Period (Week 104-120)||36
11163829|NCT01604343|12352500|FG004|Safety Population|Safety Follow-up Period (Week 104-120)||114
11163830|NCT01604343|12352496|FG000|COMPLETED|Safety Follow-up Period (Week 104-120)||79
11163831|NCT01604343|12352497|FG001|COMPLETED|Safety Follow-up Period (Week 104-120)||20
11163832|NCT01604343|12352498|FG002|COMPLETED|Safety Follow-up Period (Week 104-120)||72
11163833|NCT01604343|12352499|FG003|COMPLETED|Safety Follow-up Period (Week 104-120)||26
11163834|NCT01604343|12352500|FG004|COMPLETED|Safety Follow-up Period (Week 104-120)||85
11163835|NCT01604343|12352496|FG000|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
11163836|NCT01604343|12352497|FG001|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
11163837|NCT01604343|12352498|FG002|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
11163838|NCT01604343|12352499|FG003|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
11163839|NCT01604343|12352500|FG004|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
11163840|NCT01604408|12352512|FG000|STARTED|Treatment Period 1||102
11163841|NCT01604408|12352513|FG001|STARTED|Treatment Period 1||99
11163842|NCT01604408|12352512|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
11163843|NCT01604408|12352513|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
11163844|NCT01604408|12352512|FG000|COMPLETED|Treatment Period 1||102
11163845|NCT01604408|12352513|FG001|COMPLETED|Treatment Period 1||98
11163846|NCT01604408|12352512|FG000|NOT COMPLETED|Treatment Period 1||0
11163847|NCT01604408|12352513|FG001|NOT COMPLETED|Treatment Period 1||1
11163848|NCT01604408|12352512|FG000|STARTED|Treatment Period 2||102
11163849|NCT01604408|12352513|FG001|STARTED|Treatment Period 2||98
11163850|NCT01604408|12352512|FG000|COMPLETED|Treatment Period 2||100
11163851|NCT01604408|12352513|FG001|COMPLETED|Treatment Period 2||96
11163852|NCT01604408|12352512|FG000|NOT COMPLETED|Treatment Period 2||2
11163853|NCT01604408|12352513|FG001|NOT COMPLETED|Treatment Period 2||2
11163854|NCT01604408|12352512|FG000|STARTED|Treatment Period 3||100
11163855|NCT01604408|12352513|FG001|STARTED|Treatment Period 3||96
11163856|NCT01604408|12352512|FG000|COMPLETED|Treatment Period 3||95
11163857|NCT01604408|12352513|FG001|COMPLETED|Treatment Period 3||91
11163858|NCT01604408|12352512|FG000|NOT COMPLETED|Treatment Period 3||5
11163859|NCT01604408|12352513|FG001|NOT COMPLETED|Treatment Period 3||5
11163860|NCT01604408|12352512|FG000|STARTED|Treatment Period 4||95
11163861|NCT01604408|12352513|FG001|STARTED|Treatment Period 4||91
11163862|NCT01604408|12352512|FG000|COMPLETED|Treatment Period 4||92
11163863|NCT01604408|12352513|FG001|COMPLETED|Treatment Period 4||89
11163864|NCT01604408|12352512|FG000|NOT COMPLETED|Treatment Period 4||3
11163865|NCT01604408|12352513|FG001|NOT COMPLETED|Treatment Period 4||2
11163866|NCT01604408|12352512|FG000|STARTED|Treatment Period 5||92
11163867|NCT01604408|12352513|FG001|STARTED|Treatment Period 5||89
11163868|NCT01604408|12352512|FG000|COMPLETED|Treatment Period 5||88
11163869|NCT01604408|12352513|FG001|COMPLETED|Treatment Period 5||89
11163870|NCT01604408|12352512|FG000|NOT COMPLETED|Treatment Period 5||4
11163871|NCT01604408|12352513|FG001|NOT COMPLETED|Treatment Period 5||0
11163872|NCT01604408|12352512|FG000|STARTED|Treatment Period 6||88
11163873|NCT01604408|12352513|FG001|STARTED|Treatment Period 6||89
11419434|NCT00125268|12617992|FG000|NOT COMPLETED|Overall Study||1
11419435|NCT00125268|12617993|FG001|NOT COMPLETED|Overall Study||1
11419436|NCT00113399|12618001|FG000|STARTED|Overall Study||7
11419437|NCT00113399|12618002|FG001|STARTED|Overall Study||8
11419438|NCT00113399|12618001|FG000|COMPLETED|Overall Study||5
11163874|NCT01604408|12352512|FG000|COMPLETED|Treatment Period 6||86
11163875|NCT01604408|12352513|FG001|COMPLETED|Treatment Period 6||87
11163876|NCT01604408|12352512|FG000|NOT COMPLETED|Treatment Period 6||2
11163877|NCT01604408|12352513|FG001|NOT COMPLETED|Treatment Period 6||2
11163878|NCT01604408|12352512|FG000|STARTED|Observation Period||86
11163879|NCT01604408|12352513|FG001|STARTED|Observation Period||87
11163880|NCT01604408|12352512|FG000|COMPLETED|Observation Period||85
11163881|NCT01604408|12352513|FG001|COMPLETED|Observation Period||84
11163882|NCT01604408|12352512|FG000|NOT COMPLETED|Observation Period||1
11163883|NCT01604408|12352513|FG001|NOT COMPLETED|Observation Period||3
11163884|NCT01604772|12352519|FG000|STARTED|Overall Study||16
11163885|NCT01604772|12352519|FG000|COMPLETED|Overall Study||16
11163886|NCT01604772|12352519|FG000|NOT COMPLETED|Overall Study||0
11163887|NCT01604785|12352526|FG000|STARTED|Overall Study||37
11163888|NCT01604785|12352527|FG001|STARTED|Overall Study||37
11163889|NCT01604785|12352526|FG000|COMPLETED|Overall Study||30
11163890|NCT01604785|12352527|FG001|COMPLETED|Overall Study||36
11163891|NCT01604785|12352526|FG000|NOT COMPLETED|Overall Study||7
11163892|NCT01604785|12352527|FG001|NOT COMPLETED|Overall Study||1
11163893|NCT01604824|12352537|FG000|STARTED|Double-blind (DB) Period||6
11163894|NCT01604824|12352538|FG001|STARTED|Double-blind (DB) Period||7
11163895|NCT01604824|12352539|FG002|STARTED|Double-blind (DB) Period||5
11163896|NCT01604824|12352540|FG003|STARTED|Double-blind (DB) Period||5
11163897|NCT01604824|12352541|FG004|STARTED|Double-blind (DB) Period||0
11163898|NCT01604824|12352542|FG005|STARTED|Double-blind (DB) Period||0
11163899|NCT01604824|12352537|FG000|Completed DB Period (Day 99)|Double-blind (DB) Period||6
11163900|NCT01604824|12352538|FG001|Completed DB Period (Day 99)|Double-blind (DB) Period||7
11163901|NCT01604824|12352539|FG002|Completed DB Period (Day 99)|Double-blind (DB) Period||5
11163902|NCT01604824|12352540|FG003|Completed DB Period (Day 99)|Double-blind (DB) Period||5
11163903|NCT01604824|12352541|FG004|Completed DB Period (Day 99)|Double-blind (DB) Period||0
11163904|NCT01604824|12352542|FG005|Completed DB Period (Day 99)|Double-blind (DB) Period||0
11163905|NCT01604824|12352537|FG000|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||6
11163906|NCT01604824|12352538|FG001|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||7
11163907|NCT01604824|12352539|FG002|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
11163908|NCT01604824|12352540|FG003|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
11163909|NCT01604824|12352541|FG004|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
11163910|NCT01604824|12352542|FG005|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
11163911|NCT01604824|12352537|FG000|COMPLETED|Double-blind (DB) Period||6
11163912|NCT01604824|12352538|FG001|COMPLETED|Double-blind (DB) Period||7
11163913|NCT01604824|12352539|FG002|COMPLETED|Double-blind (DB) Period||5
11163914|NCT01604824|12352540|FG003|COMPLETED|Double-blind (DB) Period||5
11163915|NCT01604824|12352541|FG004|COMPLETED|Double-blind (DB) Period||0
11163916|NCT01604824|12352542|FG005|COMPLETED|Double-blind (DB) Period||0
11163917|NCT01604824|12352537|FG000|NOT COMPLETED|Double-blind (DB) Period||0
11163918|NCT01604824|12352538|FG001|NOT COMPLETED|Double-blind (DB) Period||0
11163919|NCT01604824|12352539|FG002|NOT COMPLETED|Double-blind (DB) Period||0
11163920|NCT01604824|12352540|FG003|NOT COMPLETED|Double-blind (DB) Period||0
11163921|NCT01604824|12352541|FG004|NOT COMPLETED|Double-blind (DB) Period||0
11163922|NCT01604824|12352542|FG005|NOT COMPLETED|Double-blind (DB) Period||0
11163923|NCT01604824|12352537|FG000|STARTED|Open-label Extension (OLE) Period||0
11163924|NCT01604824|12352538|FG001|STARTED|Open-label Extension (OLE) Period||0
11163925|NCT01604824|12352539|FG002|STARTED|Open-label Extension (OLE) Period||0
11163926|NCT01604824|12352540|FG003|STARTED|Open-label Extension (OLE) Period||0
11163927|NCT01604824|12352541|FG004|STARTED|Open-label Extension (OLE) Period|Completed DB Period (Day 99)|13
11163928|NCT01604824|12352542|FG005|STARTED|Open-label Extension (OLE) Period|Completed DB follow-up (Day 155)|10
11163929|NCT01604824|12352537|FG000|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
11163930|NCT01604824|12352538|FG001|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
11163931|NCT01604824|12352539|FG002|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
11163932|NCT01604824|12352540|FG003|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
11163933|NCT01604824|12352541|FG004|Started Open-label Extension Period|Open-label Extension (OLE) Period|Two subjects chose not to enter OLE period|11
11419439|NCT00113399|12618002|FG001|COMPLETED|Overall Study||3
11163934|NCT01604824|12352542|FG005|Started Open-label Extension Period|Open-label Extension (OLE) Period||10
11163935|NCT01604824|12352537|FG000|Completed Study|Open-label Extension (OLE) Period||0
11163936|NCT01604824|12352538|FG001|Completed Study|Open-label Extension (OLE) Period||0
11163937|NCT01604824|12352539|FG002|Completed Study|Open-label Extension (OLE) Period||0
11163938|NCT01604824|12352540|FG003|Completed Study|Open-label Extension (OLE) Period||0
11163939|NCT01604824|12352541|FG004|Completed Study|Open-label Extension (OLE) Period||10
11163940|NCT01604824|12352542|FG005|Completed Study|Open-label Extension (OLE) Period||10
11163941|NCT01604824|12352537|FG000|COMPLETED|Open-label Extension (OLE) Period||0
11163942|NCT01604824|12352538|FG001|COMPLETED|Open-label Extension (OLE) Period||0
11163943|NCT01604824|12352539|FG002|COMPLETED|Open-label Extension (OLE) Period||0
11163944|NCT01604824|12352540|FG003|COMPLETED|Open-label Extension (OLE) Period||0
11163945|NCT01604824|12352541|FG004|COMPLETED|Open-label Extension (OLE) Period||10
11163946|NCT01604824|12352542|FG005|COMPLETED|Open-label Extension (OLE) Period||10
11419440|NCT00113399|12618001|FG000|NOT COMPLETED|Overall Study||2
11419441|NCT00113399|12618002|FG001|NOT COMPLETED|Overall Study||5
11419442|NCT00118053|12618008|FG000|STARTED|Overall Study||5
11419443|NCT00118053|12618008|FG000|COMPLETED|Overall Study||5
11419444|NCT00118053|12618008|FG000|NOT COMPLETED|Overall Study||0
11419445|NCT00107614|12618012|FG000|STARTED|Overall Study||12
11419446|NCT00107614|12618012|FG000|COMPLETED|Overall Study||0
11419447|NCT00107614|12618012|FG000|NOT COMPLETED|Overall Study||12
11419448|NCT00107315|12618016|FG000|STARTED|Overall Study||16
11419449|NCT00107315|12618016|FG000|COMPLETED|Overall Study||1
11419450|NCT00107315|12618016|FG000|NOT COMPLETED|Overall Study||15
11419451|NCT00108433|12618022|FG000|STARTED|Overall Study||30
11419452|NCT00108433|12618023|FG001|STARTED|Overall Study||31
11419453|NCT00108433|12618022|FG000|COMPLETED|Overall Study||9
11419454|NCT00108433|12618023|FG001|COMPLETED|Overall Study||14
11163947|NCT01604824|12352537|FG000|NOT COMPLETED|Open-label Extension (OLE) Period||0
11163948|NCT01604824|12352538|FG001|NOT COMPLETED|Open-label Extension (OLE) Period||0
11163949|NCT01604824|12352539|FG002|NOT COMPLETED|Open-label Extension (OLE) Period||0
11163950|NCT01604824|12352540|FG003|NOT COMPLETED|Open-label Extension (OLE) Period||0
11163951|NCT01604824|12352541|FG004|NOT COMPLETED|Open-label Extension (OLE) Period||3
11163952|NCT01604824|12352542|FG005|NOT COMPLETED|Open-label Extension (OLE) Period||0
11163953|NCT01604850|12352556|FG000|STARTED|Overall Study||103
11163954|NCT01604850|12352557|FG001|STARTED|Overall Study||99
11163955|NCT01604850|12352556|FG000|Enrolled and Treated|Overall Study||103
11163956|NCT01604850|12352557|FG001|Enrolled and Treated|Overall Study||98
11163957|NCT01604850|12352556|FG000|COMPLETED|Overall Study||51
11163958|NCT01604850|12352557|FG001|COMPLETED|Overall Study||69
11163959|NCT01604850|12352556|FG000|NOT COMPLETED|Overall Study||52
11163960|NCT01604850|12352557|FG001|NOT COMPLETED|Overall Study||30
11163961|NCT01604941|12352565|FG000|STARTED|Overall Study||11
11163962|NCT01604941|12352566|FG001|STARTED|Overall Study||4
11163963|NCT01604941|12352567|FG002|STARTED|Overall Study||3
11163964|NCT01604941|12352568|FG003|STARTED|Overall Study||3
11163965|NCT01604941|12352569|FG004|STARTED|Overall Study||4
11163966|NCT01604941|12352570|FG005|STARTED|Overall Study||7
11163967|NCT01604941|12352565|FG000|COMPLETED|Overall Study||0
11163968|NCT01604941|12352566|FG001|COMPLETED|Overall Study||0
11163969|NCT01604941|12352567|FG002|COMPLETED|Overall Study||0
11163970|NCT01604941|12352568|FG003|COMPLETED|Overall Study||0
11163971|NCT01604941|12352569|FG004|COMPLETED|Overall Study||3
11163972|NCT01604941|12352570|FG005|COMPLETED|Overall Study||0
11163973|NCT01604941|12352565|FG000|NOT COMPLETED|Overall Study||11
11163974|NCT01604941|12352566|FG001|NOT COMPLETED|Overall Study||4
11163975|NCT01604941|12352567|FG002|NOT COMPLETED|Overall Study||3
11163976|NCT01604941|12352568|FG003|NOT COMPLETED|Overall Study||3
11163977|NCT01604941|12352569|FG004|NOT COMPLETED|Overall Study||1
11163978|NCT01604941|12352570|FG005|NOT COMPLETED|Overall Study||7
11163979|NCT01605032|12352576|FG000|STARTED|Overall Study||19
11163980|NCT01605032|12352576|FG000|COMPLETED|Overall Study||18
11163981|NCT01605032|12352576|FG000|NOT COMPLETED|Overall Study||1
11163982|NCT01605071|12352582|FG000|STARTED|Overall Study||27
11163983|NCT01605071|12352583|FG001|STARTED|Overall Study||26
11163984|NCT01605071|12352582|FG000|COMPLETED|Overall Study||24
11163985|NCT01605071|12352583|FG001|COMPLETED|Overall Study||24
11163986|NCT01605071|12352582|FG000|NOT COMPLETED|Overall Study||3
11163987|NCT01605071|12352583|FG001|NOT COMPLETED|Overall Study||2
11163988|NCT01605097|12352591|FG000|STARTED|Overall Study|One patient consented but was ineligible due to lack of lesion visible on mpMRI|26
11163989|NCT01605097|12352591|FG000|COMPLETED|Overall Study||25
11419455|NCT00108433|12618022|FG000|NOT COMPLETED|Overall Study||21
11419456|NCT00108433|12618023|FG001|NOT COMPLETED|Overall Study||17
11419457|NCT00113919|12618029|FG000|STARTED|Overall Study||14
11163990|NCT01605097|12352591|FG000|NOT COMPLETED|Overall Study||1
11163991|NCT01605136|12352598|FG000|STARTED|Study Period||48
11163992|NCT01605136|12352599|FG001|STARTED|Study Period||45
11163993|NCT01605136|12352598|FG000|COMPLETED|Study Period||45
11163994|NCT01605136|12352599|FG001|COMPLETED|Study Period||42
11163995|NCT01605136|12352598|FG000|NOT COMPLETED|Study Period||3
11163996|NCT01605136|12352599|FG001|NOT COMPLETED|Study Period||3
11163997|NCT01605136|12352598|FG000|STARTED|Safety Follow-Up Period||45
11163998|NCT01605136|12352599|FG001|STARTED|Safety Follow-Up Period||42
11163999|NCT01605136|12352598|FG000|COMPLETED|Safety Follow-Up Period||44
11164000|NCT01605136|12352599|FG001|COMPLETED|Safety Follow-Up Period||40
11164001|NCT01605136|12352598|FG000|NOT COMPLETED|Safety Follow-Up Period||1
11164002|NCT01605136|12352599|FG001|NOT COMPLETED|Safety Follow-Up Period||2
11164003|NCT01605227|12352607|FG000|STARTED|Overall Study||682
11164004|NCT01605227|12352608|FG001|STARTED|Overall Study||346
11164005|NCT01605227|12352607|FG000|COMPLETED|Overall Study||61
11164006|NCT01605227|12352608|FG001|COMPLETED|Overall Study||17
11164007|NCT01605227|12352607|FG000|NOT COMPLETED|Overall Study||621
11164008|NCT01605227|12352608|FG001|NOT COMPLETED|Overall Study||329
11164009|NCT01605292|12352616|FG000|STARTED|Overall Study||351
11164010|NCT01605292|12352617|FG001|STARTED|Overall Study||347
11164011|NCT01605292|12352616|FG000|COMPLETED|Overall Study||351
11164012|NCT01605292|12352617|FG001|COMPLETED|Overall Study||347
11164013|NCT01605292|12352616|FG000|NOT COMPLETED|Overall Study||0
11164014|NCT01605292|12352617|FG001|NOT COMPLETED|Overall Study||0
11164015|NCT01605396|12352625|FG000|STARTED|Overall Study||40
11164016|NCT01605396|12352626|FG001|STARTED|Overall Study||40
11164017|NCT01605396|12352625|FG000|Treated|Overall Study||39
11164018|NCT01605396|12352626|FG001|Treated|Overall Study||40
11164019|NCT01605396|12352625|FG000|COMPLETED|Overall Study||0
11164020|NCT01605396|12352626|FG001|COMPLETED|Overall Study||0
11164021|NCT01605396|12352625|FG000|NOT COMPLETED|Overall Study||40
11164022|NCT01605396|12352626|FG001|NOT COMPLETED|Overall Study||40
11164023|NCT01605435|12352632|FG000|STARTED|Overall Study||2
11164024|NCT01605435|12352633|FG001|STARTED|Overall Study||3
11164025|NCT01605435|12352632|FG000|COMPLETED|Overall Study||2
11164026|NCT01605435|12352633|FG001|COMPLETED|Overall Study||3
11164027|NCT01605435|12352632|FG000|NOT COMPLETED|Overall Study||0
11164028|NCT01605435|12352633|FG001|NOT COMPLETED|Overall Study||0
11164029|NCT01605461|12352650|FG000|STARTED|Overall Study||12
11164030|NCT01605461|12352650|FG000|COMPLETED|Overall Study||8
11164031|NCT01605461|12352650|FG000|NOT COMPLETED|Overall Study||4
11164032|NCT01605539|12352656|FG000|STARTED|Overall Study||3
11164033|NCT01605539|12352657|FG001|STARTED|Overall Study||3
11164034|NCT01605539|12352658|FG002|STARTED|Overall Study||4
11164035|NCT01605539|12352656|FG000|COMPLETED|Overall Study||3
11164036|NCT01605539|12352657|FG001|COMPLETED|Overall Study||2
11164037|NCT01605539|12352658|FG002|COMPLETED|Overall Study||4
11164038|NCT01605539|12352656|FG000|NOT COMPLETED|Overall Study||0
11164039|NCT01605539|12352657|FG001|NOT COMPLETED|Overall Study||1
11164040|NCT01605539|12352658|FG002|NOT COMPLETED|Overall Study||0
11164041|NCT01605552|12352669|FG000|STARTED|Overall Study||13
11164042|NCT01605552|12352670|FG001|STARTED|Overall Study||16
11164043|NCT01605552|12352669|FG000|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
11164044|NCT01605552|12352670|FG001|COMPLETED|Overall Study||14
11164045|NCT01605552|12352669|FG000|NOT COMPLETED|Overall Study||6
11164046|NCT01605552|12352670|FG001|NOT COMPLETED|Overall Study||2
11164047|NCT01605669|12352676|FG000|STARTED|Overall Study||50
11164048|NCT01605669|12352676|FG000|COMPLETED|Overall Study||50
11164049|NCT01605669|12352676|FG000|NOT COMPLETED|Overall Study||0
11164050|NCT01605799|12352683|FG000|STARTED|Overall Study||17
11164051|NCT01605799|12352684|FG001|STARTED|Overall Study||16
11164052|NCT01605799|12352683|FG000|COMPLETED|Overall Study||15
11164053|NCT01605799|12352684|FG001|COMPLETED|Overall Study||15
11164054|NCT01605799|12352683|FG000|NOT COMPLETED|Overall Study||2
11164055|NCT01605799|12352684|FG001|NOT COMPLETED|Overall Study||1
11164056|NCT01605825|12352692|FG000|STARTED|Overall Study||55
11164057|NCT01605825|12352693|FG001|STARTED|Overall Study||28
11164058|NCT01605825|12352692|FG000|COMPLETED|Overall Study||45
11164059|NCT01605825|12352693|FG001|COMPLETED|Overall Study||25
11164060|NCT01605825|12352692|FG000|NOT COMPLETED|Overall Study||10
11164061|NCT01605825|12352693|FG001|NOT COMPLETED|Overall Study||3
11164062|NCT01605877|12352699|FG000|STARTED|Overall Study||64
11164063|NCT01605877|12352699|FG000|COMPLETED|Overall Study||63
11164064|NCT01605877|12352699|FG000|NOT COMPLETED|Overall Study||1
11164065|NCT01605890|12352721|FG000|STARTED|Overall Study||30
11164066|NCT01605890|12352721|FG000|COMPLETED|Overall Study||28
11164067|NCT01605890|12352721|FG000|NOT COMPLETED|Overall Study||2
11164068|NCT01605903|12352727|FG000|STARTED|Overall Study||345
11164069|NCT01605903|12352728|FG001|STARTED|Overall Study||343
11164070|NCT01605903|12352727|FG000|COMPLETED|Overall Study||345
11164071|NCT01605903|12352728|FG001|COMPLETED|Overall Study||343
11164072|NCT01605903|12352727|FG000|NOT COMPLETED|Overall Study||0
11164073|NCT01605903|12352728|FG001|NOT COMPLETED|Overall Study||0
11164074|NCT01605916|12352739|FG000|STARTED|Overall Study||4
11164075|NCT01605916|12352740|FG001|STARTED|Overall Study||4
11164076|NCT01605916|12352741|FG002|STARTED|Overall Study||4
11164077|NCT01605916|12352742|FG003|STARTED|Overall Study||6
11164078|NCT01605916|12352743|FG004|STARTED|Overall Study||7
11164079|NCT01605916|12352739|FG000|COMPLETED|Overall Study||0
11164080|NCT01605916|12352740|FG001|COMPLETED|Overall Study||0
11164081|NCT01605916|12352741|FG002|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
11164082|NCT01605916|12352742|FG003|COMPLETED|Overall Study||0
11164083|NCT01605916|12352743|FG004|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
11164084|NCT01605916|12352739|FG000|NOT COMPLETED|Overall Study||4
11164085|NCT01605916|12352740|FG001|NOT COMPLETED|Overall Study||4
11164086|NCT01605916|12352741|FG002|NOT COMPLETED|Overall Study||3
11164087|NCT01605916|12352742|FG003|NOT COMPLETED|Overall Study||6
11164088|NCT01605916|12352743|FG004|NOT COMPLETED|Overall Study||6
11164089|NCT01605942|12352758|FG000|STARTED|Overall Study||6
11164090|NCT01605942|12352759|FG001|STARTED|Overall Study||2
11164091|NCT01605942|12352758|FG000|COMPLETED|Overall Study||6
11164092|NCT01605942|12352759|FG001|COMPLETED|Overall Study||2
11164093|NCT01605942|12352758|FG000|NOT COMPLETED|Overall Study||0
11164094|NCT01605942|12352759|FG001|NOT COMPLETED|Overall Study||0
11164095|NCT01606007|12352768|FG000|STARTED|Overall Study||176
11164096|NCT01606007|12352769|FG001|STARTED|Overall Study||179
11164097|NCT01606007|12352770|FG002|STARTED|Overall Study||179
11164098|NCT01606007|12352768|FG000|COMPLETED|Overall Study||161
11164099|NCT01606007|12352769|FG001|COMPLETED|Overall Study||160
11164100|NCT01606007|12352770|FG002|COMPLETED|Overall Study||169
11164101|NCT01606007|12352768|FG000|NOT COMPLETED|Overall Study||15
11164102|NCT01606007|12352769|FG001|NOT COMPLETED|Overall Study||19
11164103|NCT01606007|12352770|FG002|NOT COMPLETED|Overall Study||10
11164104|NCT01606124|12352780|FG000|STARTED|Overall Study||19
11164105|NCT01606124|12352781|FG001|STARTED|Overall Study||20
11164106|NCT01606124|12352780|FG000|COMPLETED|Overall Study||19
11164107|NCT01606124|12352781|FG001|COMPLETED|Overall Study||20
11164108|NCT01606124|12352780|FG000|NOT COMPLETED|Overall Study||0
11164109|NCT01606124|12352781|FG001|NOT COMPLETED|Overall Study||0
11164110|NCT01606137|12352787|FG000|STARTED|Overall Study||507
11164111|NCT01606137|12352787|FG000|COMPLETED|Overall Study||245
11164112|NCT01606137|12352787|FG000|NOT COMPLETED|Overall Study||262
11203523|NCT01847560|12394033|FG006|STARTED|Overall Study||40971
11203524|NCT01847560|12394034|FG007|STARTED|Overall Study||19829
11203525|NCT01847560|12394035|FG008|STARTED|Overall Study||77547
11203526|NCT01847560|12394036|FG009|STARTED|Overall Study||39438
11203527|NCT01847560|12394027|FG000|COMPLETED|Overall Study||13464
11203528|NCT01847560|12394028|FG001|COMPLETED|Overall Study||19955
11203529|NCT01847560|12394029|FG002|COMPLETED|Overall Study||9731
11203530|NCT01847560|12394030|FG003|COMPLETED|Overall Study||56655
11203531|NCT01847560|12394031|FG004|COMPLETED|Overall Study||27731
11203532|NCT01847560|12394032|FG005|COMPLETED|Overall Study||28343
11203533|NCT01847560|12394033|FG006|COMPLETED|Overall Study||40971
11203534|NCT01847560|12394034|FG007|COMPLETED|Overall Study||19829
11203535|NCT01847560|12394035|FG008|COMPLETED|Overall Study||77547
11203536|NCT01847560|12394036|FG009|COMPLETED|Overall Study||39438
11203537|NCT01847560|12394027|FG000|NOT COMPLETED|Overall Study||0
11203538|NCT01847560|12394028|FG001|NOT COMPLETED|Overall Study||0
11203539|NCT01847560|12394029|FG002|NOT COMPLETED|Overall Study||0
11203540|NCT01847560|12394030|FG003|NOT COMPLETED|Overall Study||0
11203541|NCT01847560|12394031|FG004|NOT COMPLETED|Overall Study||0
11203542|NCT01847560|12394032|FG005|NOT COMPLETED|Overall Study||0
11203543|NCT01847560|12394033|FG006|NOT COMPLETED|Overall Study||0
11203544|NCT01847560|12394034|FG007|NOT COMPLETED|Overall Study||0
11203545|NCT01847560|12394035|FG008|NOT COMPLETED|Overall Study||0
11203546|NCT01847560|12394036|FG009|NOT COMPLETED|Overall Study||0
11203547|NCT01847638|12394080|FG000|STARTED|Overall Study||25
11203548|NCT01847638|12394081|FG001|STARTED|Overall Study||25
11203549|NCT01847638|12394080|FG000|COMPLETED|Overall Study||25
11203550|NCT01847638|12394081|FG001|COMPLETED|Overall Study||25
11203551|NCT01847638|12394080|FG000|NOT COMPLETED|Overall Study||0
11203552|NCT01847638|12394081|FG001|NOT COMPLETED|Overall Study||0
11203553|NCT01847755|12394087|FG000|STARTED|Overall Study||18
11203554|NCT01847755|12394087|FG000|COMPLETED|Overall Study||13
11203555|NCT01847755|12394087|FG000|NOT COMPLETED|Overall Study||5
11203556|NCT01847885|12394093|FG000|STARTED|Initial Enrollment (Consented)||88
11203557|NCT01847885|12394094|FG001|STARTED|Initial Enrollment (Consented)||0
11203558|NCT01847885|12394095|FG002|STARTED|Initial Enrollment (Consented)||0
11203559|NCT01847885|12394093|FG000|Randomized|Initial Enrollment (Consented)||46
11203560|NCT01847885|12394094|FG001|Randomized|Initial Enrollment (Consented)||0
11203561|NCT01847885|12394095|FG002|Randomized|Initial Enrollment (Consented)||0
11203562|NCT01847885|12394093|FG000|Full Analysis Set|Initial Enrollment (Consented)||43
11203563|NCT01847885|12394094|FG001|Full Analysis Set|Initial Enrollment (Consented)||0
11203564|NCT01847885|12394095|FG002|Full Analysis Set|Initial Enrollment (Consented)||0
11203565|NCT01847885|12394093|FG000|Safety Set|Initial Enrollment (Consented)||41
11203566|NCT01847885|12394094|FG001|Safety Set|Initial Enrollment (Consented)||0
11203567|NCT01847885|12394095|FG002|Safety Set|Initial Enrollment (Consented)||0
11203568|NCT01847885|12394093|FG000|Per Protocol Set|Initial Enrollment (Consented)||40
11203569|NCT01847885|12394094|FG001|Per Protocol Set|Initial Enrollment (Consented)||0
11203570|NCT01847885|12394095|FG002|Per Protocol Set|Initial Enrollment (Consented)||0
11203571|NCT01847885|12394093|FG000|COMPLETED|Initial Enrollment (Consented)||40
11203572|NCT01847885|12394094|FG001|COMPLETED|Initial Enrollment (Consented)||0
11203573|NCT01847885|12394095|FG002|COMPLETED|Initial Enrollment (Consented)||0
11203574|NCT01847885|12394093|FG000|NOT COMPLETED|Initial Enrollment (Consented)||48
11203575|NCT01847885|12394094|FG001|NOT COMPLETED|Initial Enrollment (Consented)||0
11203576|NCT01847885|12394095|FG002|NOT COMPLETED|Initial Enrollment (Consented)||0
11203577|NCT01847885|12394093|FG000|STARTED|Randomization||0
11203578|NCT01847885|12394094|FG001|STARTED|Randomization||31
11203579|NCT01847885|12394095|FG002|STARTED|Randomization||15
11203580|NCT01847885|12394093|FG000|Full Analysis Set|Randomization||0
11203581|NCT01847885|12394094|FG001|Full Analysis Set|Randomization||28
11203582|NCT01847885|12394095|FG002|Full Analysis Set|Randomization||15
11203583|NCT01847885|12394093|FG000|Safety Set|Randomization||0
11203584|NCT01847885|12394094|FG001|Safety Set|Randomization||28
11203585|NCT01847885|12394095|FG002|Safety Set|Randomization||13
11203586|NCT01847885|12394093|FG000|Per Protocol Set|Randomization||0
11203587|NCT01847885|12394094|FG001|Per Protocol Set|Randomization||27
11203588|NCT01847885|12394095|FG002|Per Protocol Set|Randomization||13
11203589|NCT01847885|12394093|FG000|COMPLETED|Randomization||0
11203590|NCT01847885|12394094|FG001|COMPLETED|Randomization||27
11203591|NCT01847885|12394095|FG002|COMPLETED|Randomization||13
11203592|NCT01847885|12394093|FG000|NOT COMPLETED|Randomization||0
11203593|NCT01847885|12394094|FG001|NOT COMPLETED|Randomization||4
11164113|NCT01606176|12352793|FG000|STARTED|Overall Study||36
11164114|NCT01606176|12352794|FG001|STARTED|Overall Study||34
11164115|NCT01606176|12352793|FG000|COMPLETED|Overall Study||32
11164116|NCT01606176|12352794|FG001|COMPLETED|Overall Study||31
11164117|NCT01606176|12352793|FG000|NOT COMPLETED|Overall Study||4
11164118|NCT01606176|12352794|FG001|NOT COMPLETED|Overall Study||3
11164119|NCT01606189|12352800|FG000|STARTED|First Intenvention (14-20 Days)||8
11164120|NCT01606189|12352801|FG001|STARTED|First Intenvention (14-20 Days)||8
11164121|NCT01606189|12352802|FG002|STARTED|First Intenvention (14-20 Days)||8
11164122|NCT01606189|12352803|FG003|STARTED|First Intenvention (14-20 Days)||8
11164123|NCT01606189|12352804|FG004|STARTED|First Intenvention (14-20 Days)||8
11164124|NCT01606189|12352805|FG005|STARTED|First Intenvention (14-20 Days)||8
11164125|NCT01606189|12352800|FG000|COMPLETED|First Intenvention (14-20 Days)||8
11164126|NCT01606189|12352801|FG001|COMPLETED|First Intenvention (14-20 Days)||8
11164127|NCT01606189|12352802|FG002|COMPLETED|First Intenvention (14-20 Days)||8
11164128|NCT01606189|12352803|FG003|COMPLETED|First Intenvention (14-20 Days)||8
11164129|NCT01606189|12352804|FG004|COMPLETED|First Intenvention (14-20 Days)||8
11164130|NCT01606189|12352805|FG005|COMPLETED|First Intenvention (14-20 Days)||8
11164131|NCT01606189|12352800|FG000|NOT COMPLETED|First Intenvention (14-20 Days)||0
11164132|NCT01606189|12352801|FG001|NOT COMPLETED|First Intenvention (14-20 Days)||0
11164133|NCT01606189|12352802|FG002|NOT COMPLETED|First Intenvention (14-20 Days)||0
11164134|NCT01606189|12352803|FG003|NOT COMPLETED|First Intenvention (14-20 Days)||0
11164135|NCT01606189|12352804|FG004|NOT COMPLETED|First Intenvention (14-20 Days)||0
11164136|NCT01606189|12352805|FG005|NOT COMPLETED|First Intenvention (14-20 Days)||0
11164137|NCT01606189|12352800|FG000|STARTED|Second Intenvention (14-20 Days)||8
11164138|NCT01606189|12352801|FG001|STARTED|Second Intenvention (14-20 Days)||8
11164139|NCT01606189|12352802|FG002|STARTED|Second Intenvention (14-20 Days)||8
11419458|NCT00113919|12618029|FG000|COMPLETED|Overall Study||0
11419459|NCT00113919|12618029|FG000|NOT COMPLETED|Overall Study||14
11419460|NCT00108342|12618035|FG000|STARTED|Overall Study||8
11419461|NCT00108342|12618036|FG001|STARTED|Overall Study||9
11164140|NCT01606189|12352803|FG003|STARTED|Second Intenvention (14-20 Days)||8
11164141|NCT01606189|12352804|FG004|STARTED|Second Intenvention (14-20 Days)||8
11164142|NCT01606189|12352805|FG005|STARTED|Second Intenvention (14-20 Days)||8
11164143|NCT01606189|12352800|FG000|COMPLETED|Second Intenvention (14-20 Days)||8
11164144|NCT01606189|12352801|FG001|COMPLETED|Second Intenvention (14-20 Days)||8
11164145|NCT01606189|12352802|FG002|COMPLETED|Second Intenvention (14-20 Days)||8
11164146|NCT01606189|12352803|FG003|COMPLETED|Second Intenvention (14-20 Days)||8
11164147|NCT01606189|12352804|FG004|COMPLETED|Second Intenvention (14-20 Days)||8
11164148|NCT01606189|12352805|FG005|COMPLETED|Second Intenvention (14-20 Days)||7
11164149|NCT01606189|12352800|FG000|NOT COMPLETED|Second Intenvention (14-20 Days)||0
11164150|NCT01606189|12352801|FG001|NOT COMPLETED|Second Intenvention (14-20 Days)||0
11164151|NCT01606189|12352802|FG002|NOT COMPLETED|Second Intenvention (14-20 Days)||0
11164152|NCT01606189|12352803|FG003|NOT COMPLETED|Second Intenvention (14-20 Days)||0
11164153|NCT01606189|12352804|FG004|NOT COMPLETED|Second Intenvention (14-20 Days)||0
11164154|NCT01606189|12352805|FG005|NOT COMPLETED|Second Intenvention (14-20 Days)||1
11164155|NCT01606189|12352800|FG000|STARTED|Third Intenvention (14-20 Days)||8
11164156|NCT01606189|12352801|FG001|STARTED|Third Intenvention (14-20 Days)||8
11164157|NCT01606189|12352802|FG002|STARTED|Third Intenvention (14-20 Days)||8
11164158|NCT01606189|12352803|FG003|STARTED|Third Intenvention (14-20 Days)||8
11164159|NCT01606189|12352804|FG004|STARTED|Third Intenvention (14-20 Days)||8
11164160|NCT01606189|12352805|FG005|STARTED|Third Intenvention (14-20 Days)||7
11164161|NCT01606189|12352800|FG000|COMPLETED|Third Intenvention (14-20 Days)||8
11164162|NCT01606189|12352801|FG001|COMPLETED|Third Intenvention (14-20 Days)||8
11164163|NCT01606189|12352802|FG002|COMPLETED|Third Intenvention (14-20 Days)||8
11164164|NCT01606189|12352803|FG003|COMPLETED|Third Intenvention (14-20 Days)||8
11164165|NCT01606189|12352804|FG004|COMPLETED|Third Intenvention (14-20 Days)||8
11164166|NCT01606189|12352805|FG005|COMPLETED|Third Intenvention (14-20 Days)||6
11164167|NCT01606189|12352800|FG000|NOT COMPLETED|Third Intenvention (14-20 Days)||0
11164168|NCT01606189|12352801|FG001|NOT COMPLETED|Third Intenvention (14-20 Days)||0
11164169|NCT01606189|12352802|FG002|NOT COMPLETED|Third Intenvention (14-20 Days)||0
11164170|NCT01606189|12352803|FG003|NOT COMPLETED|Third Intenvention (14-20 Days)||0
11164171|NCT01606189|12352804|FG004|NOT COMPLETED|Third Intenvention (14-20 Days)||0
11164172|NCT01606189|12352805|FG005|NOT COMPLETED|Third Intenvention (14-20 Days)||1
11164173|NCT01606202|12352815|FG000|STARTED|Overall Study||56
11164174|NCT01606202|12352816|FG001|STARTED|Overall Study||60
11164175|NCT01606202|12352815|FG000|COMPLETED|Overall Study||49
11164176|NCT01606202|12352816|FG001|COMPLETED|Overall Study||57
11164177|NCT01606202|12352815|FG000|NOT COMPLETED|Overall Study||7
11164178|NCT01606202|12352816|FG001|NOT COMPLETED|Overall Study||3
11164179|NCT01606228|12352822|FG000|STARTED|Overall Study||188
11164180|NCT01606228|12352822|FG000|COMPLETED|Overall Study||159
11164181|NCT01606228|12352822|FG000|NOT COMPLETED|Overall Study||29
11164182|NCT01606254|12352830|FG000|STARTED|Overall Study||14
11164183|NCT01606254|12352831|FG001|STARTED|Overall Study||14
11164184|NCT01606254|12352832|FG002|STARTED|Overall Study||14
11164185|NCT01606254|12352833|FG003|STARTED|Overall Study||14
11164186|NCT01606254|12352830|FG000|COMPLETED|Overall Study||12
11164187|NCT01606254|12352831|FG001|COMPLETED|Overall Study||10
11164188|NCT01606254|12352832|FG002|COMPLETED|Overall Study||14
11164189|NCT01606254|12352833|FG003|COMPLETED|Overall Study||11
11164190|NCT01606254|12352830|FG000|NOT COMPLETED|Overall Study||2
11164191|NCT01606254|12352831|FG001|NOT COMPLETED|Overall Study||4
11164192|NCT01606254|12352832|FG002|NOT COMPLETED|Overall Study||0
11164193|NCT01606254|12352833|FG003|NOT COMPLETED|Overall Study||3
11164194|NCT01606306|12352849|FG000|STARTED|Overall Study||50
11164195|NCT01606306|12352850|FG001|STARTED|Overall Study||49
11164196|NCT01606306|12352851|FG002|STARTED|Overall Study||51
11164197|NCT01606306|12352852|FG003|STARTED|Overall Study||51
11164198|NCT01606306|12352853|FG004|STARTED|Overall Study||52
11164199|NCT01606306|12352854|FG005|STARTED|Overall Study||47
11164200|NCT01606306|12352849|FG000|Completed First Treatment Period|Overall Study||43
11164201|NCT01606306|12352850|FG001|Completed First Treatment Period|Overall Study||47
11164202|NCT01606306|12352851|FG002|Completed First Treatment Period|Overall Study||47
11164203|NCT01606306|12352852|FG003|Completed First Treatment Period|Overall Study||45
11164204|NCT01606306|12352853|FG004|Completed First Treatment Period|Overall Study||47
11164205|NCT01606306|12352854|FG005|Completed First Treatment Period|Overall Study||44
11164206|NCT01606306|12352849|FG000|Completed Second Treatment Period|Overall Study||41
11164207|NCT01606306|12352850|FG001|Completed Second Treatment Period|Overall Study||38
11164208|NCT01606306|12352851|FG002|Completed Second Treatment Period|Overall Study||43
11164209|NCT01606306|12352852|FG003|Completed Second Treatment Period|Overall Study||44
11164210|NCT01606306|12352853|FG004|Completed Second Treatment Period|Overall Study||46
11164211|NCT01606306|12352854|FG005|Completed Second Treatment Period|Overall Study||41
11164212|NCT01606306|12352849|FG000|Completed Third Treatment Period|Overall Study||35
11164213|NCT01606306|12352850|FG001|Completed Third Treatment Period|Overall Study||39
11164214|NCT01606306|12352851|FG002|Completed Third Treatment Period|Overall Study||37
11164215|NCT01606306|12352852|FG003|Completed Third Treatment Period|Overall Study||38
11164216|NCT01606306|12352853|FG004|Completed Third Treatment Period|Overall Study||41
11164217|NCT01606306|12352854|FG005|Completed Third Treatment Period|Overall Study||36
11164218|NCT01606306|12352849|FG000|COMPLETED|Overall Study||35
11164219|NCT01606306|12352850|FG001|COMPLETED|Overall Study||39
11164220|NCT01606306|12352851|FG002|COMPLETED|Overall Study||37
11164221|NCT01606306|12352852|FG003|COMPLETED|Overall Study||38
11164222|NCT01606306|12352853|FG004|COMPLETED|Overall Study||41
11164223|NCT01606306|12352854|FG005|COMPLETED|Overall Study||36
11164224|NCT01606306|12352849|FG000|NOT COMPLETED|Overall Study||15
11164225|NCT01606306|12352850|FG001|NOT COMPLETED|Overall Study||10
11164226|NCT01606306|12352851|FG002|NOT COMPLETED|Overall Study||14
11164227|NCT01606306|12352852|FG003|NOT COMPLETED|Overall Study||13
11164228|NCT01606306|12352853|FG004|NOT COMPLETED|Overall Study||11
11164229|NCT01606306|12352854|FG005|NOT COMPLETED|Overall Study||11
11164230|NCT01606319|12352862|FG000|STARTED|Overall Study||150
11164231|NCT01606319|12352863|FG001|STARTED|Overall Study||150
11164232|NCT01606319|12352862|FG000|COMPLETED|Overall Study||116
11164233|NCT01606319|12352863|FG001|COMPLETED|Overall Study||110
11164234|NCT01606319|12352862|FG000|NOT COMPLETED|Overall Study||34
11164235|NCT01606319|12352863|FG001|NOT COMPLETED|Overall Study||40
11164236|NCT01606670|12352869|FG000|STARTED|Overall Study||93
11164237|NCT01606670|12352869|FG000|Safety Set|Overall Study||93
11164238|NCT01606670|12352869|FG000|Full Analysis Set|Overall Study||70
11164239|NCT01606670|12352869|FG000|COMPLETED|Overall Study||77
11164240|NCT01606670|12352869|FG000|NOT COMPLETED|Overall Study||16
11164241|NCT01606735|12352876|FG000|STARTED|Overall Study||58
11164242|NCT01606735|12352877|FG001|STARTED|Overall Study||56
11164243|NCT01606735|12352878|FG002|STARTED|Overall Study||58
11164244|NCT01606735|12352876|FG000|COMPLETED|Overall Study||58
11164245|NCT01606735|12352877|FG001|COMPLETED|Overall Study||56
11164246|NCT01606735|12352878|FG002|COMPLETED|Overall Study||58
11164247|NCT01606735|12352876|FG000|NOT COMPLETED|Overall Study||0
11164248|NCT01606735|12352877|FG001|NOT COMPLETED|Overall Study||0
11164249|NCT01606735|12352878|FG002|NOT COMPLETED|Overall Study||0
11419462|NCT00108342|12618035|FG000|COMPLETED|Overall Study||7
11026775|NCT00830362|12205382|FG000|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
11026776|NCT00830362|12205383|FG001|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
11026777|NCT00830362|12205382|FG000|NOT COMPLETED|Overall Study||4
11026778|NCT00830362|12205383|FG001|NOT COMPLETED|Overall Study||4
11164250|NCT01606748|12352888|FG000|STARTED|Overall Study||18
11164251|NCT01606748|12352889|FG001|STARTED|Overall Study||17
11164252|NCT01606748|12352888|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
11164253|NCT01606748|12352889|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
11164254|NCT01606748|12352888|FG000|COMPLETED|Overall Study||15
11164255|NCT01606748|12352889|FG001|COMPLETED|Overall Study||17
11164256|NCT01606748|12352888|FG000|NOT COMPLETED|Overall Study||3
11164257|NCT01606748|12352889|FG001|NOT COMPLETED|Overall Study||0
11164258|NCT01606761|12352910|FG000|STARTED|Prior to Week 24||294
11164259|NCT01606761|12352911|FG001|STARTED|Prior to Week 24||292
11164260|NCT01606761|12352912|FG002|STARTED|Prior to Week 24||292
11164261|NCT01606761|12352913|FG003|STARTED|Prior to Week 24||0
11164262|NCT01606761|12352914|FG004|STARTED|Prior to Week 24||0
11164263|NCT01606761|12352910|FG000|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
11164264|NCT01606761|12352911|FG001|Participants Re-randomized at Week 18|Prior to Week 24||0
11164265|NCT01606761|12352912|FG002|Participants Re-randomized at Week 18|Prior to Week 24||0
11164266|NCT01606761|12352913|FG003|Participants Re-randomized at Week 18|Prior to Week 24||0
11164267|NCT01606761|12352914|FG004|Participants Re-randomized at Week 18|Prior to Week 24||0
11164268|NCT01606761|12352910|FG000|COMPLETED|Prior to Week 24||252
11164269|NCT01606761|12352911|FG001|COMPLETED|Prior to Week 24||237
11419463|NCT00108342|12618036|FG001|COMPLETED|Overall Study||9
11164270|NCT01606761|12352912|FG002|COMPLETED|Prior to Week 24||245
11164271|NCT01606761|12352913|FG003|COMPLETED|Prior to Week 24||0
11164272|NCT01606761|12352914|FG004|COMPLETED|Prior to Week 24||0
11164273|NCT01606761|12352910|FG000|NOT COMPLETED|Prior to Week 24||42
11164274|NCT01606761|12352911|FG001|NOT COMPLETED|Prior to Week 24||55
11164275|NCT01606761|12352912|FG002|NOT COMPLETED|Prior to Week 24||47
11164276|NCT01606761|12352913|FG003|NOT COMPLETED|Prior to Week 24||0
11164277|NCT01606761|12352914|FG004|NOT COMPLETED|Prior to Week 24||0
11164278|NCT01606761|12352910|FG000|STARTED|Week 24 to Week 52||0
11164279|NCT01606761|12352911|FG001|STARTED|Week 24 to Week 52||237
11164280|NCT01606761|12352912|FG002|STARTED|Week 24 to Week 52||245
11164281|NCT01606761|12352913|FG003|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
11164282|NCT01606761|12352914|FG004|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
11164283|NCT01606761|12352910|FG000|Treated|Week 24 to Week 52||0
11164284|NCT01606761|12352911|FG001|Treated|Week 24 to Week 52||237
11164285|NCT01606761|12352912|FG002|Treated|Week 24 to Week 52||245
11164286|NCT01606761|12352913|FG003|Treated|Week 24 to Week 52||124
11164287|NCT01606761|12352914|FG004|Treated|Week 24 to Week 52||126
11164288|NCT01606761|12352910|FG000|COMPLETED|Week 24 to Week 52||0
11164289|NCT01606761|12352911|FG001|COMPLETED|Week 24 to Week 52||204
11164290|NCT01606761|12352912|FG002|COMPLETED|Week 24 to Week 52||212
11164291|NCT01606761|12352913|FG003|COMPLETED|Week 24 to Week 52||109
11164292|NCT01606761|12352914|FG004|COMPLETED|Week 24 to Week 52||106
11164293|NCT01606761|12352910|FG000|NOT COMPLETED|Week 24 to Week 52||0
11164294|NCT01606761|12352911|FG001|NOT COMPLETED|Week 24 to Week 52||33
11164295|NCT01606761|12352912|FG002|NOT COMPLETED|Week 24 to Week 52||33
11164296|NCT01606761|12352913|FG003|NOT COMPLETED|Week 24 to Week 52||17
11164297|NCT01606761|12352914|FG004|NOT COMPLETED|Week 24 to Week 52||20
11164298|NCT01606761|12352910|FG000|STARTED|Safety Follow-up Period (Week 52-68)||28
11164299|NCT01606761|12352911|FG001|STARTED|Safety Follow-up Period (Week 52-68)||65
11419464|NCT00108342|12618035|FG000|NOT COMPLETED|Overall Study||1
11419465|NCT00108342|12618036|FG001|NOT COMPLETED|Overall Study||0
11419466|NCT00100828|12618042|FG000|STARTED|Overall Study||6
11419467|NCT00100828|12618042|FG000|COMPLETED|Overall Study||0
11419468|NCT00100828|12618042|FG000|NOT COMPLETED|Overall Study||6
11419469|NCT00104728|12618046|FG000|STARTED|Overall Study|42 consented on study|42
11419470|NCT00104728|12618046|FG000|COMPLETED|Overall Study||23
11419471|NCT00104728|12618046|FG000|NOT COMPLETED|Overall Study||19
11164300|NCT01606761|12352912|FG002|STARTED|Safety Follow-up Period (Week 52-68)||62
11164301|NCT01606761|12352913|FG003|STARTED|Safety Follow-up Period (Week 52-68)||9
11164302|NCT01606761|12352914|FG004|STARTED|Safety Follow-up Period (Week 52-68)||19
11164303|NCT01606761|12352910|FG000|Safety Population|Safety Follow-up Period (Week 52-68)||28
11164304|NCT01606761|12352911|FG001|Safety Population|Safety Follow-up Period (Week 52-68)||65
11164305|NCT01606761|12352912|FG002|Safety Population|Safety Follow-up Period (Week 52-68)||62
11164306|NCT01606761|12352913|FG003|Safety Population|Safety Follow-up Period (Week 52-68)||7
11164307|NCT01606761|12352914|FG004|Safety Population|Safety Follow-up Period (Week 52-68)||19
11164308|NCT01606761|12352910|FG000|COMPLETED|Safety Follow-up Period (Week 52-68)||24
11164309|NCT01606761|12352911|FG001|COMPLETED|Safety Follow-up Period (Week 52-68)||55
11164310|NCT01606761|12352912|FG002|COMPLETED|Safety Follow-up Period (Week 52-68)||45
11164311|NCT01606761|12352913|FG003|COMPLETED|Safety Follow-up Period (Week 52-68)||7
11164312|NCT01606761|12352914|FG004|COMPLETED|Safety Follow-up Period (Week 52-68)||11
11164313|NCT01606761|12352910|FG000|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
11164314|NCT01606761|12352911|FG001|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
11164315|NCT01606761|12352912|FG002|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
11164316|NCT01606761|12352913|FG003|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
11164317|NCT01606761|12352914|FG004|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
11164318|NCT01606787|12352931|FG000|STARTED|Overall Study||105
11164319|NCT01606787|12352932|FG001|STARTED|Overall Study||105
11164320|NCT01606787|12352931|FG000|COMPLETED|Overall Study||101
11164321|NCT01606787|12352932|FG001|COMPLETED|Overall Study||98
11419472|NCT00089414|12618053|FG000|STARTED|Overall Study||2
11419473|NCT00089414|12618054|FG001|STARTED|Overall Study||1
11419474|NCT00089414|12618055|FG002|STARTED|Overall Study||2
11419475|NCT00089414|12618053|FG000|COMPLETED|Overall Study||2
11164322|NCT01606787|12352931|FG000|NOT COMPLETED|Overall Study||4
11164323|NCT01606787|12352932|FG001|NOT COMPLETED|Overall Study||7
11164324|NCT01606800|12352940|FG000|STARTED|Overall Study||22
11419476|NCT00089414|12618054|FG001|COMPLETED|Overall Study||1
11419477|NCT00089414|12618055|FG002|COMPLETED|Overall Study||2
11419478|NCT00089414|12618053|FG000|NOT COMPLETED|Overall Study||0
11419479|NCT00089414|12618054|FG001|NOT COMPLETED|Overall Study||0
11164325|NCT01606800|12352941|FG001|STARTED|Overall Study||23
11164326|NCT01606800|12352940|FG000|Treated|Overall Study||22
11164327|NCT01606800|12352941|FG001|Treated|Overall Study||23
11164328|NCT01606800|12352940|FG000|COMPLETED|Overall Study||17
11164329|NCT01606800|12352941|FG001|COMPLETED|Overall Study||21
11164330|NCT01606800|12352940|FG000|NOT COMPLETED|Overall Study||5
11164331|NCT01606800|12352941|FG001|NOT COMPLETED|Overall Study||2
11164332|NCT01606852|12352949|FG000|STARTED|Overall Study||7
11164333|NCT01606852|12352950|FG001|STARTED|Overall Study||8
11164334|NCT01606852|12352949|FG000|COMPLETED|Overall Study||7
11164335|NCT01606852|12352950|FG001|COMPLETED|Overall Study||8
11164336|NCT01606852|12352949|FG000|NOT COMPLETED|Overall Study||0
11164337|NCT01606852|12352950|FG001|NOT COMPLETED|Overall Study||0
11164338|NCT01607073|12352956|FG000|STARTED|Overall Study||2
11164339|NCT01607073|12352956|FG000|COMPLETED|Overall Study||1
11164340|NCT01607073|12352956|FG000|NOT COMPLETED|Overall Study||1
11164341|NCT01607112|12352965|FG000|STARTED|Overall Study||60
11164342|NCT01607112|12352966|FG001|STARTED|Overall Study||59
11164343|NCT01607112|12352965|FG000|COMPLETED|Overall Study||60
11164344|NCT01607112|12352966|FG001|COMPLETED|Overall Study||59
11164345|NCT01607112|12352965|FG000|NOT COMPLETED|Overall Study||0
11164346|NCT01607112|12352966|FG001|NOT COMPLETED|Overall Study||0
11164347|NCT01607203|12352978|FG000|STARTED|Overall Study||59
11164348|NCT01607203|12352979|FG001|STARTED|Overall Study||61
11164349|NCT01607203|12352978|FG000|COMPLETED|Overall Study||59
11164350|NCT01607203|12352979|FG001|COMPLETED|Overall Study||61
11164351|NCT01607203|12352978|FG000|NOT COMPLETED|Overall Study||0
11164352|NCT01607203|12352979|FG001|NOT COMPLETED|Overall Study||0
11164353|NCT01607255|12352989|FG000|STARTED|Overall Study||161
11164354|NCT01607255|12352990|FG001|STARTED|Overall Study||160
11164355|NCT01607255|12352991|FG002|STARTED|Overall Study||159
11164356|NCT01607255|12352989|FG000|COMPLETED|Overall Study||161
11164357|NCT01607255|12352990|FG001|COMPLETED|Overall Study||160
11164358|NCT01607255|12352991|FG002|COMPLETED|Overall Study||159
11164359|NCT01607255|12352989|FG000|NOT COMPLETED|Overall Study||0
11164360|NCT01607255|12352990|FG001|NOT COMPLETED|Overall Study||0
11164361|NCT01607255|12352991|FG002|NOT COMPLETED|Overall Study||0
11164362|NCT01607346|12352999|FG000|STARTED|Overall Study||10
11164363|NCT01607346|12352999|FG000|COMPLETED|Overall Study||7
11164364|NCT01607346|12352999|FG000|NOT COMPLETED|Overall Study||3
11164365|NCT01607398|12353005|FG000|STARTED|Overall Study||28
11164366|NCT01607398|12353006|FG001|STARTED|Overall Study||28
11164367|NCT01607398|12353005|FG000|COMPLETED|Overall Study||26
11164368|NCT01607398|12353006|FG001|COMPLETED|Overall Study||26
11164369|NCT01607398|12353005|FG000|NOT COMPLETED|Overall Study||2
11164370|NCT01607398|12353006|FG001|NOT COMPLETED|Overall Study||2
11164371|NCT01607411|12353012|FG000|STARTED|Period I||14
11164372|NCT01607411|12353013|FG001|STARTED|Period I||13
11164373|NCT01607411|12353014|FG002|STARTED|Period I||14
11164374|NCT01607411|12353015|FG003|STARTED|Period I||14
11164375|NCT01607411|12353012|FG000|COMPLETED|Period I||14
11164376|NCT01607411|12353013|FG001|COMPLETED|Period I||13
11164377|NCT01607411|12353014|FG002|COMPLETED|Period I||14
11164378|NCT01607411|12353015|FG003|COMPLETED|Period I||14
11164379|NCT01607411|12353012|FG000|NOT COMPLETED|Period I||0
11164380|NCT01607411|12353013|FG001|NOT COMPLETED|Period I||0
11164381|NCT01607411|12353014|FG002|NOT COMPLETED|Period I||0
11164382|NCT01607411|12353015|FG003|NOT COMPLETED|Period I||0
11164383|NCT01607411|12353012|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
11164384|NCT01607411|12353013|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
11164385|NCT01607411|12353014|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
11164386|NCT01607411|12353015|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
11164387|NCT01607411|12353012|FG000|COMPLETED|Period II||14
11164388|NCT01607411|12353013|FG001|COMPLETED|Period II||14
11164389|NCT01607411|12353014|FG002|COMPLETED|Period II||13
11164390|NCT01607411|12353015|FG003|COMPLETED|Period II||14
11164391|NCT01607411|12353012|FG000|NOT COMPLETED|Period II||0
11164392|NCT01607411|12353013|FG001|NOT COMPLETED|Period II||0
11164393|NCT01607411|12353014|FG002|NOT COMPLETED|Period II||0
11164394|NCT01607411|12353015|FG003|NOT COMPLETED|Period II||0
11164395|NCT01607411|12353012|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
11164396|NCT01607411|12353013|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
11164397|NCT01607411|12353014|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
11164398|NCT01607411|12353015|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
11164399|NCT01607411|12353012|FG000|COMPLETED|Period III||14
11164400|NCT01607411|12353013|FG001|COMPLETED|Period III||14
11164401|NCT01607411|12353014|FG002|COMPLETED|Period III||14
11164402|NCT01607411|12353015|FG003|COMPLETED|Period III||13
11164403|NCT01607411|12353012|FG000|NOT COMPLETED|Period III||0
11164404|NCT01607411|12353013|FG001|NOT COMPLETED|Period III||0
11164405|NCT01607411|12353014|FG002|NOT COMPLETED|Period III||0
11419480|NCT00089414|12618055|FG002|NOT COMPLETED|Overall Study||0
11419481|NCT00083915|12618065|FG000|STARTED|Overall Study||52
11164406|NCT01607411|12353015|FG003|NOT COMPLETED|Period III||0
11164407|NCT01607411|12353012|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
11164408|NCT01607411|12353013|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
11164409|NCT01607411|12353014|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
11323314|NCT00212134|12520560|FG000|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
11323315|NCT00212134|12520561|FG001|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
11323316|NCT00212134|12520560|FG000|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
11323317|NCT00212134|12520561|FG001|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
11323318|NCT00212134|12520560|FG000|STARTED|Phase 3 (Age 10 Years)||57
11323319|NCT00212134|12520561|FG001|STARTED|Phase 3 (Age 10 Years)||56
11323320|NCT00212134|12520560|FG000|COMPLETED|Phase 3 (Age 10 Years)||55
11323321|NCT00212134|12520561|FG001|COMPLETED|Phase 3 (Age 10 Years)||55
11164410|NCT01607411|12353015|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
11164411|NCT01607411|12353012|FG000|COMPLETED|Period IV||13
11164412|NCT01607411|12353013|FG001|COMPLETED|Period IV||14
11323322|NCT00212134|12520560|FG000|NOT COMPLETED|Phase 3 (Age 10 Years)||2
11323323|NCT00212134|12520561|FG001|NOT COMPLETED|Phase 3 (Age 10 Years)||1
11343029|NCT02950545|12540318|FG001|COMPLETED|Session 3 (70 Minutes)||9
11343030|NCT02950545|12540319|FG002|COMPLETED|Session 3 (70 Minutes)||7
11343031|NCT02950545|12540320|FG003|COMPLETED|Session 3 (70 Minutes)||7
11343032|NCT02950545|12540321|FG004|COMPLETED|Session 3 (70 Minutes)||7
11343033|NCT02950545|12540322|FG005|COMPLETED|Session 3 (70 Minutes)||7
11343034|NCT02950545|12540317|FG000|NOT COMPLETED|Session 3 (70 Minutes)||0
11343035|NCT02950545|12540318|FG001|NOT COMPLETED|Session 3 (70 Minutes)||0
11343036|NCT02950545|12540319|FG002|NOT COMPLETED|Session 3 (70 Minutes)||0
11343037|NCT02950545|12540320|FG003|NOT COMPLETED|Session 3 (70 Minutes)||0
11343038|NCT02950545|12540321|FG004|NOT COMPLETED|Session 3 (70 Minutes)||0
11343039|NCT02950545|12540322|FG005|NOT COMPLETED|Session 3 (70 Minutes)||1
11343040|NCT02950558|12540330|FG000|STARTED|Overall Study||8
11343041|NCT02950558|12540331|FG001|STARTED|Overall Study||6
11343042|NCT02950558|12540330|FG000|12 Month Pain Questionnaire|Overall Study||6
11343043|NCT02950558|12540331|FG001|12 Month Pain Questionnaire|Overall Study||6
11343044|NCT02950558|12540330|FG000|COMPLETED|Overall Study||6
11343045|NCT02950558|12540331|FG001|COMPLETED|Overall Study||6
11343046|NCT02950558|12540330|FG000|NOT COMPLETED|Overall Study||2
11343047|NCT02950558|12540331|FG001|NOT COMPLETED|Overall Study||0
11343048|NCT02950753|12540340|FG000|STARTED|Overall Study||15
11343049|NCT02950753|12540341|FG001|STARTED|Overall Study||15
11343050|NCT02950753|12540340|FG000|COMPLETED|Overall Study||15
11343051|NCT02950753|12540341|FG001|COMPLETED|Overall Study||15
11343052|NCT02950753|12540340|FG000|NOT COMPLETED|Overall Study||0
11343053|NCT02950753|12540341|FG001|NOT COMPLETED|Overall Study||0
11343054|NCT02950831|12540347|FG000|STARTED|Overall Study||27
11343055|NCT02950831|12540347|FG000|Complete Trial|Overall Study||26
11343056|NCT02950831|12540347|FG000|Permanent Implant|Overall Study||20
11343057|NCT02950831|12540347|FG000|4 Week Follow up|Overall Study||20
11343058|NCT02950831|12540347|FG000|8 Weeks Follow up|Overall Study||19
11343059|NCT02950831|12540347|FG000|COMPLETED|Overall Study||18
11343060|NCT02950831|12540347|FG000|NOT COMPLETED|Overall Study||9
11343061|NCT02951143|12540357|FG000|STARTED|Overall Study||97
11343062|NCT02951143|12540358|FG001|STARTED|Overall Study||41
11343063|NCT02951143|12540359|FG002|STARTED|Overall Study||47
11343064|NCT02951143|12540360|FG003|STARTED|Overall Study||39
11343065|NCT02951143|12540361|FG004|STARTED|Overall Study||37
11343066|NCT02951143|12540362|FG005|STARTED|Overall Study||44
11343067|NCT02951143|12540357|FG000|COMPLETED|Overall Study||36
11343068|NCT02951143|12540358|FG001|COMPLETED|Overall Study||32
11343069|NCT02951143|12540359|FG002|COMPLETED|Overall Study||29
11343070|NCT02951143|12540360|FG003|COMPLETED|Overall Study||30
11343071|NCT02951143|12540361|FG004|COMPLETED|Overall Study||31
11343072|NCT02951143|12540362|FG005|COMPLETED|Overall Study||29
11343073|NCT02951143|12540357|FG000|NOT COMPLETED|Overall Study||61
11343074|NCT02951143|12540358|FG001|NOT COMPLETED|Overall Study||9
11343075|NCT02951143|12540359|FG002|NOT COMPLETED|Overall Study||18
11343076|NCT02951143|12540360|FG003|NOT COMPLETED|Overall Study||9
11343077|NCT02951143|12540361|FG004|NOT COMPLETED|Overall Study||6
11343078|NCT02951143|12540362|FG005|NOT COMPLETED|Overall Study||15
11343079|NCT02951156|12540379|FG000|STARTED|Overall Study||9
11343080|NCT02951156|12540380|FG001|STARTED|Overall Study||9
11343081|NCT02951156|12540381|FG002|STARTED|Overall Study||11
11343082|NCT02951156|12540379|FG000|COMPLETED|Overall Study||0
11343083|NCT02951156|12540380|FG001|COMPLETED|Overall Study||0
11343084|NCT02951156|12540381|FG002|COMPLETED|Overall Study||1
11343085|NCT02951156|12540379|FG000|NOT COMPLETED|Overall Study||9
11343086|NCT02951156|12540380|FG001|NOT COMPLETED|Overall Study||9
11343087|NCT02951156|12540381|FG002|NOT COMPLETED|Overall Study||10
11343088|NCT02951182|12540396|FG000|STARTED|Overall Study||11
11343089|NCT02951182|12540397|FG001|STARTED|Overall Study||9
11343090|NCT02951182|12540398|FG002|STARTED|Overall Study||9
11343091|NCT02951182|12540399|FG003|STARTED|Overall Study||18
11343092|NCT02951182|12540400|FG004|STARTED|Overall Study||6
11343093|NCT02951182|12540401|FG005|STARTED|Overall Study||20
11343094|NCT02951182|12540396|FG000|COMPLETED|Overall Study||11
11343095|NCT02951182|12540397|FG001|COMPLETED|Overall Study||9
11343096|NCT02951182|12540398|FG002|COMPLETED|Overall Study||9
11343097|NCT02951182|12540399|FG003|COMPLETED|Overall Study||18
11343098|NCT02951182|12540400|FG004|COMPLETED|Overall Study||6
11343099|NCT02951182|12540401|FG005|COMPLETED|Overall Study||20
11343100|NCT02951182|12540396|FG000|NOT COMPLETED|Overall Study||0
11164413|NCT01607411|12353014|FG002|COMPLETED|Period IV||14
11164414|NCT01607411|12353015|FG003|COMPLETED|Period IV||14
11164415|NCT01607411|12353012|FG000|NOT COMPLETED|Period IV||0
11164416|NCT01607411|12353013|FG001|NOT COMPLETED|Period IV||0
11164417|NCT01607411|12353014|FG002|NOT COMPLETED|Period IV||0
11164418|NCT01607411|12353015|FG003|NOT COMPLETED|Period IV||0
11164419|NCT01607450|12353032|FG000|STARTED|Overall Study||6
11164420|NCT01607450|12353033|FG001|STARTED|Overall Study||8
11164421|NCT01607450|12353034|FG002|STARTED|Overall Study||7
11164422|NCT01607450|12353035|FG003|STARTED|Overall Study||11
11164423|NCT01607450|12353036|FG004|STARTED|Overall Study||1
11164424|NCT01607450|12353037|FG005|STARTED|Overall Study||0
11164425|NCT01607450|12353038|FG006|STARTED|Overall Study||0
11164426|NCT01607450|12353032|FG000|COMPLETED|Overall Study||6
11164427|NCT01607450|12353033|FG001|COMPLETED|Overall Study||8
11164428|NCT01607450|12353034|FG002|COMPLETED|Overall Study||7
11164429|NCT01607450|12353035|FG003|COMPLETED|Overall Study||11
11164430|NCT01607450|12353036|FG004|COMPLETED|Overall Study||1
11164431|NCT01607450|12353037|FG005|COMPLETED|Overall Study||0
11164432|NCT01607450|12353038|FG006|COMPLETED|Overall Study||0
11164433|NCT01607450|12353032|FG000|NOT COMPLETED|Overall Study||0
11164434|NCT01607450|12353033|FG001|NOT COMPLETED|Overall Study||0
11164435|NCT01607450|12353034|FG002|NOT COMPLETED|Overall Study||0
11164436|NCT01607450|12353035|FG003|NOT COMPLETED|Overall Study||0
11164437|NCT01607450|12353036|FG004|NOT COMPLETED|Overall Study||0
11164438|NCT01607450|12353037|FG005|NOT COMPLETED|Overall Study||0
11164439|NCT01607450|12353038|FG006|NOT COMPLETED|Overall Study||0
11164440|NCT01607476|12353062|FG000|STARTED|Overall Study||25
11164441|NCT01607476|12353063|FG001|STARTED|Overall Study||30
11164442|NCT01607476|12353064|FG002|STARTED|Overall Study||33
11164443|NCT01607476|12353062|FG000|COMPLETED|Overall Study||24
11164444|NCT01607476|12353063|FG001|COMPLETED|Overall Study||30
11164445|NCT01607476|12353064|FG002|COMPLETED|Overall Study||30
11164446|NCT01607476|12353062|FG000|NOT COMPLETED|Overall Study||1
11164447|NCT01607476|12353063|FG001|NOT COMPLETED|Overall Study||0
11164448|NCT01607476|12353064|FG002|NOT COMPLETED|Overall Study||3
11164449|NCT01607554|12353072|FG000|STARTED|Overall Study||2
11164450|NCT01607554|12353072|FG000|COMPLETED|Overall Study||0
11164451|NCT01607554|12353072|FG000|NOT COMPLETED|Overall Study||2
11164452|NCT01607593|12353076|FG000|STARTED|Overall Study||122
11164453|NCT01607593|12353076|FG000|COMPLETED|Overall Study||29
11164454|NCT01607593|12353076|FG000|NOT COMPLETED|Overall Study||93
11164455|NCT01607645|12353082|FG000|STARTED|Overall Study||4
11164456|NCT01607645|12353083|FG001|STARTED|Overall Study||3
11164457|NCT01607645|12353082|FG000|COMPLETED|Overall Study||4
11164458|NCT01607645|12353083|FG001|COMPLETED|Overall Study||3
11164459|NCT01607645|12353082|FG000|NOT COMPLETED|Overall Study||0
11164460|NCT01607645|12353083|FG001|NOT COMPLETED|Overall Study||0
11164461|NCT01607658|12353093|FG000|STARTED|Overall Study||65
11164462|NCT01607658|12353094|FG001|STARTED|Overall Study||67
11164463|NCT01607658|12353095|FG002|STARTED|Overall Study||58
11164464|NCT01607658|12353096|FG003|STARTED|Overall Study||63
11164465|NCT01607658|12353093|FG000|COMPLETED|Overall Study||56
11164466|NCT01607658|12353094|FG001|COMPLETED|Overall Study||56
11164467|NCT01607658|12353095|FG002|COMPLETED|Overall Study||47
11164468|NCT01607658|12353096|FG003|COMPLETED|Overall Study||52
11164469|NCT01607658|12353093|FG000|NOT COMPLETED|Overall Study||9
11164470|NCT01607658|12353094|FG001|NOT COMPLETED|Overall Study||11
11164471|NCT01607658|12353095|FG002|NOT COMPLETED|Overall Study||11
11164472|NCT01607658|12353096|FG003|NOT COMPLETED|Overall Study||11
11164473|NCT01607853|12353106|FG000|STARTED|Overall Study||24
11164474|NCT01607853|12353106|FG000|COMPLETED|Overall Study||24
11164475|NCT01607853|12353106|FG000|NOT COMPLETED|Overall Study||0
11164476|NCT01607892|12353118|FG000|STARTED|Overall Study||58
11164477|NCT01607892|12353119|FG001|STARTED|Overall Study||27
11164478|NCT01607892|12353120|FG002|STARTED|Overall Study||81
11164479|NCT01607892|12353121|FG003|STARTED|Overall Study||95
11164480|NCT01607892|12353122|FG004|STARTED|Overall Study||24
11164481|NCT01607892|12353118|FG000|COMPLETED|Overall Study||0
11164482|NCT01607892|12353119|FG001|COMPLETED|Overall Study||0
11164483|NCT01607892|12353120|FG002|COMPLETED|Overall Study||0
11164484|NCT01607892|12353121|FG003|COMPLETED|Overall Study||0
11164485|NCT01607892|12353122|FG004|COMPLETED|Overall Study||0
11164486|NCT01607892|12353118|FG000|NOT COMPLETED|Overall Study||58
11164487|NCT01607892|12353119|FG001|NOT COMPLETED|Overall Study||27
11164488|NCT01607892|12353120|FG002|NOT COMPLETED|Overall Study||81
11164489|NCT01607892|12353121|FG003|NOT COMPLETED|Overall Study||95
11164490|NCT01607892|12353122|FG004|NOT COMPLETED|Overall Study||24
11164491|NCT01607905|12353155|FG000|STARTED|Overall Study||60
11164492|NCT01607905|12353156|FG001|STARTED|Overall Study||20
11164493|NCT01607905|12353157|FG002|STARTED|Overall Study||21
11164494|NCT01607905|12353158|FG003|STARTED|Overall Study||21
11164495|NCT01607905|12353159|FG004|STARTED|Overall Study||7
11164496|NCT01607905|12353160|FG005|STARTED|Overall Study||15
11164497|NCT01607905|12353161|FG006|STARTED|Overall Study||47
11164498|NCT01607905|12353155|FG000|Received Study Drug|Overall Study||59
11164499|NCT01607905|12353156|FG001|Received Study Drug|Overall Study||20
11164500|NCT01607905|12353157|FG002|Received Study Drug|Overall Study||21
11164501|NCT01607905|12353158|FG003|Received Study Drug|Overall Study||21
11164502|NCT01607905|12353159|FG004|Received Study Drug|Overall Study||6
11164503|NCT01607905|12353160|FG005|Received Study Drug|Overall Study||15
11164504|NCT01607905|12353161|FG006|Received Study Drug|Overall Study||47
11164505|NCT01607905|12353155|FG000|Low Dose (<30 mg/m^2)|Overall Study||16
11164506|NCT01607905|12353156|FG001|Low Dose (<30 mg/m^2)|Overall Study||5
11164507|NCT01607905|12353157|FG002|Low Dose (<30 mg/m^2)|Overall Study||3
11164508|NCT01607905|12353158|FG003|Low Dose (<30 mg/m^2)|Overall Study||0
11164509|NCT01607905|12353159|FG004|Low Dose (<30 mg/m^2)|Overall Study||0
11323324|NCT04336995|12520571|FG000|STARTED|Overall Study||14
11323325|NCT04336995|12520571|FG000|COMPLETED|Overall Study||14
11323326|NCT04336995|12520571|FG000|NOT COMPLETED|Overall Study||0
11323327|NCT04320745|12520575|FG000|STARTED|Overall Study||168
11323328|NCT04320745|12520575|FG000|COMPLETED|Overall Study||121
11323329|NCT04320745|12520575|FG000|NOT COMPLETED|Overall Study||47
11323330|NCT04077424|12520582|FG000|STARTED|Overall Study||2
11323331|NCT04077424|12520583|FG001|STARTED|Overall Study||2
11323332|NCT04077424|12520584|FG002|STARTED|Overall Study||6
11323333|NCT04077424|12520582|FG000|COMPLETED|Overall Study||2
11323334|NCT04077424|12520583|FG001|COMPLETED|Overall Study||2
11323335|NCT04077424|12520584|FG002|COMPLETED|Overall Study||6
11323336|NCT04077424|12520582|FG000|NOT COMPLETED|Overall Study||0
11323337|NCT04077424|12520583|FG001|NOT COMPLETED|Overall Study||0
11323338|NCT04077424|12520584|FG002|NOT COMPLETED|Overall Study||0
11323339|NCT04016779|12520594|FG000|STARTED|Overall Study||184
11323340|NCT04016779|12520595|FG001|STARTED|Overall Study||190
11323341|NCT04016779|12520594|FG000|Treated|Overall Study||183
11323342|NCT04016779|12520595|FG001|Treated|Overall Study||189
11323343|NCT04016779|12520594|FG000|COMPLETED|Overall Study||140
11323344|NCT04016779|12520595|FG001|COMPLETED|Overall Study||127
11323345|NCT04016779|12520594|FG000|NOT COMPLETED|Overall Study||44
11323346|NCT04016779|12520595|FG001|NOT COMPLETED|Overall Study||63
11323347|NCT04000165|12520603|FG000|STARTED|Overall Study||17
11323348|NCT04000165|12520603|FG000|Completed Study at 50 mg Dose|Overall Study||7
11323349|NCT04000165|12520603|FG000|Escalated to 100 mg|Overall Study||10
11323350|NCT04000165|12520603|FG000|COMPLETED|Overall Study||15
11323351|NCT04000165|12520603|FG000|NOT COMPLETED|Overall Study||2
11323352|NCT03952650|12520614|FG000|STARTED|Overall Study||4
11323353|NCT03952650|12520615|FG001|STARTED|Overall Study||90
11323354|NCT03952650|12520616|FG002|STARTED|Overall Study||4
11323355|NCT03952650|12520617|FG003|STARTED|Overall Study||60
11323356|NCT03952650|12520618|FG004|STARTED|Overall Study||4
11323357|NCT03952650|12520619|FG005|STARTED|Overall Study||54
11323358|NCT03952650|12520620|FG006|STARTED|Overall Study||36
11323359|NCT03952650|12520614|FG000|COMPLETED|Overall Study||4
11323360|NCT03952650|12520615|FG001|COMPLETED|Overall Study||83
11323361|NCT03952650|12520616|FG002|COMPLETED|Overall Study||4
11323362|NCT03952650|12520617|FG003|COMPLETED|Overall Study||53
11323363|NCT03952650|12520618|FG004|COMPLETED|Overall Study||4
11323364|NCT03952650|12520619|FG005|COMPLETED|Overall Study||47
11323365|NCT03952650|12520620|FG006|COMPLETED|Overall Study||32
11323366|NCT03952650|12520614|FG000|NOT COMPLETED|Overall Study||0
11323367|NCT03952650|12520615|FG001|NOT COMPLETED|Overall Study||7
11323368|NCT03952650|12520616|FG002|NOT COMPLETED|Overall Study||0
11323369|NCT03952650|12520617|FG003|NOT COMPLETED|Overall Study||7
11323370|NCT03952650|12520618|FG004|NOT COMPLETED|Overall Study||0
11323371|NCT03952650|12520619|FG005|NOT COMPLETED|Overall Study||7
11323372|NCT03952650|12520620|FG006|NOT COMPLETED|Overall Study||4
11323373|NCT03794089|12520638|FG000|STARTED|Overall Study||17
11323374|NCT03794089|12520639|FG001|STARTED|Overall Study||18
11323375|NCT03794089|12520638|FG000|Completed 4-week Assessment|Overall Study||16
11323376|NCT03794089|12520639|FG001|Completed 4-week Assessment|Overall Study||18
11323377|NCT03794089|12520638|FG000|Completed 8-week Assessment|Overall Study||14
11323378|NCT03794089|12520639|FG001|Completed 8-week Assessment|Overall Study||18
11323379|NCT03794089|12520638|FG000|Completed 12-week Assessment|Overall Study||13
11323380|NCT03794089|12520639|FG001|Completed 12-week Assessment|Overall Study||17
11323381|NCT03794089|12520638|FG000|COMPLETED|Overall Study||11
11323382|NCT03794089|12520639|FG001|COMPLETED|Overall Study||17
11323383|NCT03794089|12520638|FG000|NOT COMPLETED|Overall Study||6
11323384|NCT03794089|12520639|FG001|NOT COMPLETED|Overall Study||1
11323385|NCT03745716|12520647|FG000|STARTED|Overall Study||78
11323386|NCT03745716|12520648|FG001|STARTED|Overall Study||76
11323387|NCT03745716|12520647|FG000|COMPLETED|Overall Study||75
11323388|NCT03745716|12520648|FG001|COMPLETED|Overall Study||74
11323389|NCT03745716|12520647|FG000|NOT COMPLETED|Overall Study||3
11323390|NCT03745716|12520648|FG001|NOT COMPLETED|Overall Study||2
11323391|NCT03713021|12520654|FG000|STARTED|Overall Study||27
11323392|NCT03713021|12520654|FG000|COMPLETED|Overall Study||12
11323393|NCT03713021|12520654|FG000|NOT COMPLETED|Overall Study||15
11323394|NCT03631407|12520660|FG000|STARTED|Overall Study||21
11323395|NCT03631407|12520661|FG001|STARTED|Overall Study||20
11323396|NCT03631407|12520660|FG000|Treated|Overall Study||20
11323397|NCT03631407|12520661|FG001|Treated|Overall Study||20
11323398|NCT03631407|12520660|FG000|COMPLETED|Overall Study||1
11323399|NCT03631407|12520661|FG001|COMPLETED|Overall Study||0
11323400|NCT03631407|12520660|FG000|NOT COMPLETED|Overall Study||20
11164510|NCT01607905|12353160|FG005|Low Dose (<30 mg/m^2)|Overall Study||2
11164511|NCT01607905|12353161|FG006|Low Dose (<30 mg/m^2)|Overall Study||8
11164512|NCT01607905|12353155|FG000|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||27
11164513|NCT01607905|12353156|FG001|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||11
11164514|NCT01607905|12353157|FG002|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||15
11164515|NCT01607905|12353158|FG003|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||8
11164516|NCT01607905|12353159|FG004|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||6
11164517|NCT01607905|12353160|FG005|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||3
11164518|NCT01607905|12353161|FG006|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||21
11164519|NCT01607905|12353155|FG000|High Dose (>= 55 mg/m^2)|Overall Study||16
11164520|NCT01607905|12353156|FG001|High Dose (>= 55 mg/m^2)|Overall Study||4
11164521|NCT01607905|12353157|FG002|High Dose (>= 55 mg/m^2)|Overall Study||3
11164522|NCT01607905|12353158|FG003|High Dose (>= 55 mg/m^2)|Overall Study||13
11164523|NCT01607905|12353159|FG004|High Dose (>= 55 mg/m^2)|Overall Study||0
11164524|NCT01607905|12353160|FG005|High Dose (>= 55 mg/m^2)|Overall Study||10
11419482|NCT00083915|12618066|FG001|STARTED|Overall Study||45
11419483|NCT00083915|12618065|FG000|COMPLETED|Overall Study||2
11419484|NCT00083915|12618066|FG001|COMPLETED|Overall Study||8
11419485|NCT00083915|12618065|FG000|NOT COMPLETED|Overall Study||50
11419486|NCT00083915|12618066|FG001|NOT COMPLETED|Overall Study||37
11419487|NCT00090870|12618072|FG000|STARTED|Overall Study||10
11419488|NCT00090870|12618072|FG000|COMPLETED|Overall Study||10
11419489|NCT00090870|12618072|FG000|NOT COMPLETED|Overall Study||0
11419490|NCT00088972|12618078|FG000|STARTED|Overall Study||3
11323401|NCT03631407|12520661|FG001|NOT COMPLETED|Overall Study||20
11419491|NCT00088972|12618079|FG001|STARTED|Overall Study||5
11419492|NCT00088972|12618078|FG000|COMPLETED|Overall Study||1
11419493|NCT00088972|12618079|FG001|COMPLETED|Overall Study||1
11419494|NCT00088972|12618078|FG000|NOT COMPLETED|Overall Study||2
11419495|NCT00088972|12618079|FG001|NOT COMPLETED|Overall Study||4
11419496|NCT00088829|12618085|FG000|STARTED|Overall Study||22
11419497|NCT00088829|12618085|FG000|COMPLETED|Overall Study||0
11419498|NCT00088829|12618085|FG000|NOT COMPLETED|Overall Study||22
11419499|NCT00089128|12618089|FG000|STARTED|Overall Study||16
11164525|NCT01607905|12353161|FG006|High Dose (>= 55 mg/m^2)|Overall Study||18
11164526|NCT01607905|12353155|FG000|COMPLETED|Overall Study||0
11164527|NCT01607905|12353156|FG001|COMPLETED|Overall Study||0
11164528|NCT01607905|12353157|FG002|COMPLETED|Overall Study||0
11164529|NCT01607905|12353158|FG003|COMPLETED|Overall Study||0
11164530|NCT01607905|12353159|FG004|COMPLETED|Overall Study||0
11164531|NCT01607905|12353160|FG005|COMPLETED|Overall Study||0
11164532|NCT01607905|12353161|FG006|COMPLETED|Overall Study||0
11164533|NCT01607905|12353155|FG000|NOT COMPLETED|Overall Study||60
11164534|NCT01607905|12353156|FG001|NOT COMPLETED|Overall Study||20
11164535|NCT01607905|12353157|FG002|NOT COMPLETED|Overall Study||21
11164536|NCT01607905|12353158|FG003|NOT COMPLETED|Overall Study||21
11164537|NCT01607905|12353159|FG004|NOT COMPLETED|Overall Study||7
11164538|NCT01607905|12353160|FG005|NOT COMPLETED|Overall Study||15
11164539|NCT01607905|12353161|FG006|NOT COMPLETED|Overall Study||47
11164540|NCT01607957|12353221|FG000|STARTED|Overall Study||534
11164541|NCT01607957|12353222|FG001|STARTED|Overall Study||266
11164542|NCT01607957|12353221|FG000|Treated|Overall Study||533
11164543|NCT01607957|12353222|FG001|Treated|Overall Study||265
11164544|NCT01607957|12353221|FG000|COMPLETED|Overall Study||162
11164545|NCT01607957|12353222|FG001|COMPLETED|Overall Study||51
11164546|NCT01607957|12353221|FG000|NOT COMPLETED|Overall Study||372
11164547|NCT01607957|12353222|FG001|NOT COMPLETED|Overall Study||215
11164548|NCT01608061|12353230|FG000|STARTED|Blinded Period||21
11164549|NCT01608061|12353231|FG001|STARTED|Blinded Period||21
11164550|NCT01608061|12353230|FG000|COMPLETED|Blinded Period||21
11164551|NCT01608061|12353231|FG001|COMPLETED|Blinded Period||21
11164552|NCT01608061|12353230|FG000|NOT COMPLETED|Blinded Period||0
11164553|NCT01608061|12353231|FG001|NOT COMPLETED|Blinded Period||0
11164554|NCT01608061|12353230|FG000|STARTED|Long Term Follow-Up||21
11164555|NCT01608061|12353231|FG001|STARTED|Long Term Follow-Up||21
11164556|NCT01608061|12353230|FG000|COMPLETED|Long Term Follow-Up||14
11164557|NCT01608061|12353231|FG001|COMPLETED|Long Term Follow-Up||16
11164558|NCT01608061|12353230|FG000|NOT COMPLETED|Long Term Follow-Up||7
11164559|NCT01608061|12353231|FG001|NOT COMPLETED|Long Term Follow-Up||5
11419500|NCT00089128|12618089|FG000|COMPLETED|Overall Study||16
11419501|NCT00089128|12618089|FG000|NOT COMPLETED|Overall Study||0
11419502|NCT00075608|12618093|FG000|STARTED|Overall Study||12
11419503|NCT00075608|12618093|FG000|COMPLETED|Overall Study||12
11419504|NCT00075608|12618093|FG000|NOT COMPLETED|Overall Study||0
11419505|NCT00074724|12618101|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
11419506|NCT00074724|12618102|FG001|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
11419507|NCT00074724|12618101|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
11419508|NCT00074724|12618102|FG001|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
11419509|NCT00074724|12618101|FG000|NOT COMPLETED|Overall Study||0
11419510|NCT00074724|12618102|FG001|NOT COMPLETED|Overall Study||0
11419511|NCT00085631|12618108|FG000|STARTED|Overall Study||13
11419512|NCT00085631|12618109|FG001|STARTED|Overall Study||49
11419513|NCT00085631|12618110|FG002|STARTED|Overall Study||39
11419514|NCT00085631|12618108|FG000|COMPLETED|Overall Study||9
11419515|NCT00085631|12618109|FG001|COMPLETED|Overall Study||38
11419516|NCT00085631|12618110|FG002|COMPLETED|Overall Study||32
11419517|NCT00085631|12618108|FG000|NOT COMPLETED|Overall Study||4
11419518|NCT00085631|12618109|FG001|NOT COMPLETED|Overall Study||11
11419519|NCT00085631|12618110|FG002|NOT COMPLETED|Overall Study||7
11164560|NCT01608061|12353230|FG000|STARTED|Extension Period||14
11164561|NCT01608061|12353231|FG001|STARTED|Extension Period||16
11164562|NCT01608061|12353230|FG000|COMPLETED|Extension Period||14
11164563|NCT01608061|12353231|FG001|COMPLETED|Extension Period||14
11164564|NCT01608061|12353230|FG000|NOT COMPLETED|Extension Period||0
11164565|NCT01608061|12353231|FG001|NOT COMPLETED|Extension Period||2
11164566|NCT01608087|12353241|FG000|STARTED|Overall Study||30
11164567|NCT01608087|12353242|FG001|STARTED|Overall Study||30
11164568|NCT01608087|12353243|FG002|STARTED|Overall Study||31
11164569|NCT01608087|12353241|FG000|COMPLETED|Overall Study||30
11164570|NCT01608087|12353242|FG001|COMPLETED|Overall Study||28
11164571|NCT01608087|12353243|FG002|COMPLETED|Overall Study||31
11164572|NCT01608087|12353241|FG000|NOT COMPLETED|Overall Study||0
11164573|NCT01608087|12353242|FG001|NOT COMPLETED|Overall Study||2
11164574|NCT01608087|12353243|FG002|NOT COMPLETED|Overall Study||0
11164575|NCT01608100|12353251|FG000|STARTED|Overall Study||1101
11164576|NCT01608100|12353251|FG000|COMPLETED|Overall Study||1101
11164577|NCT01608100|12353251|FG000|NOT COMPLETED|Overall Study||0
11164578|NCT01608295|12353277|FG000|STARTED|Overall Study||26
11164579|NCT01608295|12353278|FG001|STARTED|Overall Study||30
11164580|NCT01608295|12353277|FG000|COMPLETED|Overall Study||20
11164581|NCT01608295|12353278|FG001|COMPLETED|Overall Study||25
11164582|NCT01608295|12353277|FG000|NOT COMPLETED|Overall Study||6
11164583|NCT01608295|12353278|FG001|NOT COMPLETED|Overall Study||5
11164584|NCT01608308|12353289|FG000|STARTED|Overall Study||31
11164585|NCT01608308|12353290|FG001|STARTED|Overall Study||31
11164586|NCT01608308|12353289|FG000|COMPLETED|Overall Study||31
11164587|NCT01608308|12353290|FG001|COMPLETED|Overall Study||29
11164588|NCT01608308|12353289|FG000|NOT COMPLETED|Overall Study||0
11164589|NCT01608308|12353290|FG001|NOT COMPLETED|Overall Study||2
11164590|NCT01608321|12353298|FG000|STARTED|Overall Study||13
11164591|NCT01608321|12353299|FG001|STARTED|Overall Study||4
11164592|NCT01608321|12353298|FG000|COMPLETED|Overall Study||12
11164593|NCT01608321|12353299|FG001|COMPLETED|Overall Study||4
11164594|NCT01608321|12353298|FG000|NOT COMPLETED|Overall Study||1
11164595|NCT01608321|12353299|FG001|NOT COMPLETED|Overall Study||0
11164596|NCT01608490|12353307|FG000|STARTED|Overall Study||158
11164597|NCT01608490|12353308|FG001|STARTED|Overall Study||157
11164598|NCT01608490|12353307|FG000|COMPLETED|Overall Study||141
11164599|NCT01608490|12353308|FG001|COMPLETED|Overall Study||142
11164600|NCT01608490|12353307|FG000|NOT COMPLETED|Overall Study||17
11164601|NCT01608490|12353308|FG001|NOT COMPLETED|Overall Study||15
11164602|NCT01608659|12353314|FG000|STARTED|Overall Study||110
11419520|NCT00062751|12618122|FG000|STARTED|Overall Study||33
11419521|NCT00062751|12618123|FG001|STARTED|Overall Study||30
11419522|NCT00062751|12618124|FG002|STARTED|Overall Study||33
11419523|NCT00062751|12618125|FG003|STARTED|Overall Study||6
11419524|NCT00062751|12618126|FG004|STARTED|Overall Study||6
11419525|NCT00062751|12618122|FG000|COMPLETED|Overall Study||0
11419526|NCT00062751|12618123|FG001|COMPLETED|Overall Study||0
11419527|NCT00062751|12618124|FG002|COMPLETED|Overall Study||3
11419528|NCT00062751|12618125|FG003|COMPLETED|Overall Study||1
11164603|NCT01608659|12353314|FG000|COMPLETED|Overall Study||94
11164604|NCT01608659|12353314|FG000|NOT COMPLETED|Overall Study||16
11164605|NCT01608672|12353318|FG000|STARTED|Overall Study||207
11164606|NCT01608672|12353318|FG000|COMPLETED|Overall Study||207
11419529|NCT00062751|12618126|FG004|COMPLETED|Overall Study||0
11419530|NCT00062751|12618122|FG000|NOT COMPLETED|Overall Study||33
11419531|NCT00062751|12618123|FG001|NOT COMPLETED|Overall Study||30
11419532|NCT00062751|12618124|FG002|NOT COMPLETED|Overall Study||30
11419533|NCT00062751|12618125|FG003|NOT COMPLETED|Overall Study||5
11419534|NCT00062751|12618126|FG004|NOT COMPLETED|Overall Study||6
11164607|NCT01608672|12353318|FG000|NOT COMPLETED|Overall Study||0
11164608|NCT01608724|12353322|FG000|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
11164609|NCT01608724|12353322|FG000|Treated|Overall Study||1361
11164610|NCT01608724|12353322|FG000|COMPLETED|Overall Study||1180
11164611|NCT01608724|12353322|FG000|NOT COMPLETED|Overall Study||243
11164612|NCT01608815|12353329|FG000|STARTED|Overall Study||188
11164613|NCT01608815|12353330|FG001|STARTED|Overall Study||7
11164614|NCT01608815|12353331|FG002|STARTED|Overall Study||5
11164615|NCT01608815|12353329|FG000|COMPLETED|Overall Study||188
11164616|NCT01608815|12353330|FG001|COMPLETED|Overall Study||7
11164617|NCT01608815|12353331|FG002|COMPLETED|Overall Study||5
11164618|NCT01608815|12353329|FG000|NOT COMPLETED|Overall Study||0
11164619|NCT01608815|12353330|FG001|NOT COMPLETED|Overall Study||0
11164620|NCT01608815|12353331|FG002|NOT COMPLETED|Overall Study||0
11164621|NCT01608971|12353342|FG000|STARTED|Overall Study||15
11164622|NCT01608971|12353343|FG001|STARTED|Overall Study||15
11164623|NCT01608971|12353342|FG000|COMPLETED|Overall Study||15
11164624|NCT01608971|12353343|FG001|COMPLETED|Overall Study||15
11164625|NCT01608971|12353342|FG000|NOT COMPLETED|Overall Study||0
11164626|NCT01608971|12353343|FG001|NOT COMPLETED|Overall Study||0
11164627|NCT01609010|12353353|FG000|STARTED|Overall Study||156
11164628|NCT01609010|12353354|FG001|STARTED|Overall Study||157
11164629|NCT01609010|12353353|FG000|Entering Cycle 2|Overall Study||120
11164630|NCT01609010|12353354|FG001|Entering Cycle 2|Overall Study||124
11164631|NCT01609010|12353353|FG000|COMPLETED|Overall Study||113
11164632|NCT01609010|12353354|FG001|COMPLETED|Overall Study||120
11164633|NCT01609010|12353353|FG000|NOT COMPLETED|Overall Study||43
11164634|NCT01609010|12353354|FG001|NOT COMPLETED|Overall Study||37
11164635|NCT01609023|12353360|FG000|STARTED|Overall Study||67
11164636|NCT01609023|12353360|FG000|COMPLETED|Overall Study||34
11164637|NCT01609023|12353360|FG000|NOT COMPLETED|Overall Study||33
11164638|NCT01609062|12353366|FG000|STARTED|Primary Phase||15
11164639|NCT01609062|12353367|FG001|STARTED|Primary Phase||10
11164640|NCT01609062|12353366|FG000|COMPLETED|Primary Phase||15
11164641|NCT01609062|12353367|FG001|COMPLETED|Primary Phase||10
11164642|NCT01609062|12353366|FG000|NOT COMPLETED|Primary Phase||0
11164643|NCT01609062|12353367|FG001|NOT COMPLETED|Primary Phase||0
11164644|NCT01609062|12353366|FG000|STARTED|Extension Phase||15
11164645|NCT01609062|12353367|FG001|STARTED|Extension Phase||10
11164646|NCT01609062|12353366|FG000|COMPLETED|Extension Phase||0
11164647|NCT01609062|12353367|FG001|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
11164648|NCT01609062|12353366|FG000|NOT COMPLETED|Extension Phase||15
11164649|NCT01609062|12353367|FG001|NOT COMPLETED|Extension Phase||10
11164650|NCT01609218|12353374|FG000|STARTED|Period 1||13
11164651|NCT01609218|12353375|FG001|STARTED|Period 1||14
11164652|NCT01609218|12353374|FG000|Received LY2140023|Period 1||13
11164653|NCT01609218|12353375|FG001|Received LY2140023|Period 1||14
11164654|NCT01609218|12353374|FG000|Received Activated Charcoal|Period 1|Participants in this treatment sequence did not receive activated charcoal during Period 1.|0
11164655|NCT01609218|12353375|FG001|Received Activated Charcoal|Period 1|Two participants discontinued after receiving LY2140023 but prior to receiving activated charcoal.|12
11164656|NCT01609218|12353374|FG000|COMPLETED|Period 1||10
11164657|NCT01609218|12353375|FG001|COMPLETED|Period 1||8
11164658|NCT01609218|12353374|FG000|NOT COMPLETED|Period 1||3
11164659|NCT01609218|12353375|FG001|NOT COMPLETED|Period 1||6
11164660|NCT01609218|12353374|FG000|STARTED|Period 2||10
11164661|NCT01609218|12353375|FG001|STARTED|Period 2|One participant did not complete Period 1 but did continue onto Period 2.|9
11164662|NCT01609218|12353374|FG000|Received LY2140023|Period 2||10
11164663|NCT01609218|12353375|FG001|Received LY2140023|Period 2||9
11164664|NCT01609218|12353374|FG000|Received Activated Charcoal|Period 2||9
11164665|NCT01609218|12353375|FG001|Received Activated Charcoal|Period 2|Participants in this treatment sequence did not receive activated charcoal during Period 2.|0
11164666|NCT01609218|12353374|FG000|COMPLETED|Period 2||9
11164667|NCT01609218|12353375|FG001|COMPLETED|Period 2||9
11164668|NCT01609218|12353374|FG000|NOT COMPLETED|Period 2||1
11164669|NCT01609218|12353375|FG001|NOT COMPLETED|Period 2||0
11164670|NCT01609257|12353383|FG000|STARTED|Overall Study||67
11164671|NCT01609257|12353384|FG001|STARTED|Overall Study||65
11164672|NCT01609257|12353383|FG000|Received 2 Doses|Overall Study||63
11164673|NCT01609257|12353384|FG001|Received 2 Doses|Overall Study||64
11164674|NCT01609257|12353383|FG000|Received Challenge Product|Overall Study||56
11164675|NCT01609257|12353384|FG001|Received Challenge Product|Overall Study||53
11164676|NCT01609257|12353383|FG000|COMPLETED|Overall Study||61
11164677|NCT01609257|12353384|FG001|COMPLETED|Overall Study||57
11164678|NCT01609257|12353383|FG000|NOT COMPLETED|Overall Study||6
11164679|NCT01609257|12353384|FG001|NOT COMPLETED|Overall Study||8
11164680|NCT01609296|12353393|FG000|STARTED|Overall Study||1406
11164681|NCT01609296|12353393|FG000|COMPLETED|Overall Study||918
11164682|NCT01609296|12353393|FG000|NOT COMPLETED|Overall Study||488
11164683|NCT01609348|12353403|FG000|STARTED|Overall Study||3
11164684|NCT01609348|12353404|FG001|STARTED|Overall Study||2
11164685|NCT01609348|12353403|FG000|COMPLETED|Overall Study||3
11164686|NCT01609348|12353404|FG001|COMPLETED|Overall Study||2
11164687|NCT01609348|12353403|FG000|NOT COMPLETED|Overall Study||0
11164688|NCT01609348|12353404|FG001|NOT COMPLETED|Overall Study||0
11164689|NCT01609478|12353413|FG000|STARTED|Overall Study||111
11164690|NCT01609478|12353414|FG001|STARTED|Overall Study||108
11164691|NCT01609478|12353415|FG002|STARTED|Overall Study||116
11164692|NCT01609478|12353413|FG000|Full Analysis Set (FAS)|Overall Study||110
11164693|NCT01609478|12353414|FG001|Full Analysis Set (FAS)|Overall Study||108
11164694|NCT01609478|12353415|FG002|Full Analysis Set (FAS)|Overall Study||115
11164695|NCT01609478|12353413|FG000|COMPLETED|Overall Study||104
11164696|NCT01609478|12353414|FG001|COMPLETED|Overall Study||106
11164697|NCT01609478|12353415|FG002|COMPLETED|Overall Study||107
11164698|NCT01609478|12353413|FG000|NOT COMPLETED|Overall Study||7
11164699|NCT01609478|12353414|FG001|NOT COMPLETED|Overall Study||2
11164700|NCT01609478|12353415|FG002|NOT COMPLETED|Overall Study||9
11164701|NCT01609543|12353423|FG000|STARTED|Overall Study||62
11164702|NCT01609543|12353423|FG000|COMPLETED|Overall Study||20
11164703|NCT01609543|12353423|FG000|NOT COMPLETED|Overall Study||42
11164704|NCT01609556|12353444|FG000|STARTED|Dose Escalation: Maximum 101.3 Weeks||2
11164705|NCT01609556|12353445|FG001|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
11164706|NCT01609556|12353446|FG002|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
11164707|NCT01609556|12353447|FG003|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
11164708|NCT01609556|12353448|FG004|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
11164709|NCT01609556|12353449|FG005|STARTED|Dose Escalation: Maximum 101.3 Weeks||18
11164710|NCT01609556|12353450|FG006|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
11164711|NCT01609556|12353451|FG007|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
11164712|NCT01609556|12353452|FG008|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
11164713|NCT01609556|12353453|FG009|STARTED|Dose Escalation: Maximum 101.3 Weeks||4
11164714|NCT01609556|12353454|FG010|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
11164715|NCT01609556|12353455|FG011|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
11164716|NCT01609556|12353456|FG012|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
11164717|NCT01609556|12353457|FG013|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
11164718|NCT01609556|12353458|FG014|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
11164719|NCT01609556|12353459|FG015|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
11164720|NCT01609556|12353444|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||2
11164721|NCT01609556|12353445|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
11164722|NCT01609556|12353446|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
11164723|NCT01609556|12353447|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
11164724|NCT01609556|12353448|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
11164725|NCT01609556|12353449|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||18
11164726|NCT01609556|12353450|FG006|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
11164727|NCT01609556|12353451|FG007|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
11164728|NCT01609556|12353452|FG008|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
11164729|NCT01609556|12353453|FG009|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||4
11164730|NCT01609556|12353454|FG010|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
11419535|NCT00066807|12618141|FG000|STARTED|Overall Study||14
11419536|NCT00066807|12618142|FG001|STARTED|Overall Study||15
11419537|NCT00066807|12618141|FG000|COMPLETED|Overall Study||0
11419538|NCT00066807|12618142|FG001|COMPLETED|Overall Study||0
11419539|NCT00066807|12618141|FG000|NOT COMPLETED|Overall Study||14
11419540|NCT00066807|12618142|FG001|NOT COMPLETED|Overall Study||15
11419541|NCT00058188|12618150|FG000|STARTED|Overall Study||0
11419542|NCT00058188|12618151|FG001|STARTED|Overall Study||0
11419543|NCT00058188|12618150|FG000|COMPLETED|Overall Study||0
11419544|NCT00058188|12618151|FG001|COMPLETED|Overall Study||0
11419545|NCT00058188|12618150|FG000|NOT COMPLETED|Overall Study||0
11419546|NCT00058188|12618151|FG001|NOT COMPLETED|Overall Study||0
11419547|NCT00014560|12618157|FG000|STARTED|Overall Study||3
11419548|NCT00014560|12618157|FG000|COMPLETED|Overall Study||0
11164731|NCT01609556|12353455|FG011|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
11164732|NCT01609556|12353456|FG012|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
11164733|NCT01609556|12353457|FG013|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
11164734|NCT01609556|12353458|FG014|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
11164735|NCT01609556|12353459|FG015|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
11164736|NCT01609556|12353444|FG000|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164737|NCT01609556|12353445|FG001|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164738|NCT01609556|12353446|FG002|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164739|NCT01609556|12353447|FG003|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164740|NCT01609556|12353448|FG004|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164741|NCT01609556|12353449|FG005|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164742|NCT01609556|12353450|FG006|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164743|NCT01609556|12353451|FG007|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164744|NCT01609556|12353452|FG008|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164745|NCT01609556|12353453|FG009|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164746|NCT01609556|12353454|FG010|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164747|NCT01609556|12353455|FG011|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164748|NCT01609556|12353456|FG012|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164749|NCT01609556|12353457|FG013|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164750|NCT01609556|12353458|FG014|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164751|NCT01609556|12353459|FG015|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164752|NCT01609556|12353444|FG000|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||2
11164753|NCT01609556|12353445|FG001|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
11419549|NCT00014560|12618157|FG000|NOT COMPLETED|Overall Study||3
11419550|NCT00038142|12618163|FG000|STARTED|Overall Study||32
11419551|NCT00038142|12618164|FG001|STARTED|Overall Study||14
11419552|NCT00038142|12618163|FG000|COMPLETED|Overall Study||10
11164754|NCT01609556|12353446|FG002|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
11164755|NCT01609556|12353447|FG003|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
11164756|NCT01609556|12353448|FG004|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
11419553|NCT00038142|12618164|FG001|COMPLETED|Overall Study||7
11419554|NCT00038142|12618163|FG000|NOT COMPLETED|Overall Study||22
11419555|NCT00038142|12618164|FG001|NOT COMPLETED|Overall Study||7
11419556|NCT00020722|12618170|FG000|STARTED|Overall Study||7
11419557|NCT00020722|12618170|FG000|COMPLETED|Overall Study||7
11419558|NCT00020722|12618170|FG000|NOT COMPLETED|Overall Study||0
11164757|NCT01609556|12353449|FG005|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||18
11164758|NCT01609556|12353450|FG006|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
11164759|NCT01609556|12353451|FG007|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
11164760|NCT01609556|12353452|FG008|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
11164761|NCT01609556|12353453|FG009|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||4
11164762|NCT01609556|12353454|FG010|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
11164763|NCT01609556|12353455|FG011|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
11164764|NCT01609556|12353456|FG012|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164765|NCT01609556|12353457|FG013|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164766|NCT01609556|12353458|FG014|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164767|NCT01609556|12353459|FG015|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
11164768|NCT01609556|12353444|FG000|STARTED|Dose Expansion: Maximum 124 Weeks||0
11164769|NCT01609556|12353445|FG001|STARTED|Dose Expansion: Maximum 124 Weeks||0
11164770|NCT01609556|12353446|FG002|STARTED|Dose Expansion: Maximum 124 Weeks||0
11164771|NCT01609556|12353447|FG003|STARTED|Dose Expansion: Maximum 124 Weeks||0
11164772|NCT01609556|12353448|FG004|STARTED|Dose Expansion: Maximum 124 Weeks||0
11164773|NCT01609556|12353449|FG005|STARTED|Dose Expansion: Maximum 124 Weeks||0
11164774|NCT01609556|12353450|FG006|STARTED|Dose Expansion: Maximum 124 Weeks||0
11164775|NCT01609556|12353451|FG007|STARTED|Dose Expansion: Maximum 124 Weeks||0
11164776|NCT01609556|12353452|FG008|STARTED|Dose Expansion: Maximum 124 Weeks||0
11164777|NCT01609556|12353453|FG009|STARTED|Dose Expansion: Maximum 124 Weeks||0
11164778|NCT01609556|12353454|FG010|STARTED|Dose Expansion: Maximum 124 Weeks||0
11164779|NCT01609556|12353455|FG011|STARTED|Dose Expansion: Maximum 124 Weeks||0
11164780|NCT01609556|12353456|FG012|STARTED|Dose Expansion: Maximum 124 Weeks||46
11164781|NCT01609556|12353457|FG013|STARTED|Dose Expansion: Maximum 124 Weeks||24
11164782|NCT01609556|12353458|FG014|STARTED|Dose Expansion: Maximum 124 Weeks||27
11164783|NCT01609556|12353459|FG015|STARTED|Dose Expansion: Maximum 124 Weeks||40
11164784|NCT01609556|12353444|FG000|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164785|NCT01609556|12353445|FG001|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164786|NCT01609556|12353446|FG002|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164787|NCT01609556|12353447|FG003|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164788|NCT01609556|12353448|FG004|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164789|NCT01609556|12353449|FG005|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164790|NCT01609556|12353450|FG006|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164791|NCT01609556|12353451|FG007|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164792|NCT01609556|12353452|FG008|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164793|NCT01609556|12353453|FG009|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164794|NCT01609556|12353454|FG010|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164795|NCT01609556|12353455|FG011|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164796|NCT01609556|12353456|FG012|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164797|NCT01609556|12353457|FG013|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164798|NCT01609556|12353458|FG014|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164799|NCT01609556|12353459|FG015|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164800|NCT01609556|12353444|FG000|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164801|NCT01609556|12353445|FG001|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164802|NCT01609556|12353446|FG002|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164803|NCT01609556|12353447|FG003|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164804|NCT01609556|12353448|FG004|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164805|NCT01609556|12353449|FG005|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11419559|NCT00002975|12618175|FG000|STARTED|Overall Study||180
11419560|NCT00002975|12618175|FG000|Treated With Study Therapy|Overall Study||175
11164806|NCT01609556|12353450|FG006|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164807|NCT01609556|12353451|FG007|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164808|NCT01609556|12353452|FG008|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164809|NCT01609556|12353453|FG009|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164810|NCT01609556|12353454|FG010|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164811|NCT01609556|12353455|FG011|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
11164812|NCT01609556|12353456|FG012|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||46
11164813|NCT01609556|12353457|FG013|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||24
11164814|NCT01609556|12353458|FG014|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||27
11164815|NCT01609556|12353459|FG015|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||40
11164816|NCT01609582|12353502|FG000|STARTED|Overall Study||1603
11164817|NCT01609582|12353503|FG001|STARTED|Overall Study||1604
11164818|NCT01609582|12353502|FG000|Treated|Overall Study||1603
11419561|NCT00002975|12618175|FG000|COMPLETED|Overall Study||175
11164819|NCT01609582|12353503|FG001|Treated|Overall Study||1601
11164820|NCT01609582|12353502|FG000|COMPLETED|Overall Study||0
11164821|NCT01609582|12353503|FG001|COMPLETED|Overall Study||0
11164822|NCT01609582|12353502|FG000|NOT COMPLETED|Overall Study||1603
11164823|NCT01609582|12353503|FG001|NOT COMPLETED|Overall Study||1604
11164824|NCT01609933|12353509|FG000|STARTED|Overall Study||32
11164825|NCT01609933|12353509|FG000|COMPLETED|Overall Study||28
11164826|NCT01609933|12353509|FG000|NOT COMPLETED|Overall Study||4
11164827|NCT01610011|12353517|FG000|STARTED|Overall Study||19
11164828|NCT01610011|12353518|FG001|STARTED|Overall Study||2
11164829|NCT01610011|12353517|FG000|COMPLETED|Overall Study||9
11164830|NCT01610011|12353518|FG001|COMPLETED|Overall Study||2
11164831|NCT01610011|12353517|FG000|NOT COMPLETED|Overall Study||10
11164832|NCT01610011|12353518|FG001|NOT COMPLETED|Overall Study||0
11164833|NCT01610037|12353527|FG000|STARTED|All Patients||407
11164834|NCT01610037|12353528|FG001|STARTED|All Patients||405
11164835|NCT01610037|12353529|FG002|STARTED|All Patients||404
11164836|NCT01610037|12353527|FG000|Randomized Set (RAN)|All Patients||407
11164837|NCT01610037|12353528|FG001|Randomized Set (RAN)|All Patients||405
11164838|NCT01610037|12353529|FG002|Randomized Set (RAN)|All Patients||404
11164839|NCT01610037|12353527|FG000|Full Analysis Set (FAS)|All Patients||407
11164840|NCT01610037|12353528|FG001|Full Analysis Set (FAS)|All Patients||405
11164841|NCT01610037|12353529|FG002|Full Analysis Set (FAS)|All Patients||403
11164842|NCT01610037|12353527|FG000|COMPLETED|All Patients||348
11164843|NCT01610037|12353528|FG001|COMPLETED|All Patients||354
11164844|NCT01610037|12353529|FG002|COMPLETED|All Patients||320
11164845|NCT01610037|12353527|FG000|NOT COMPLETED|All Patients||59
11164846|NCT01610037|12353528|FG001|NOT COMPLETED|All Patients||51
11164847|NCT01610037|12353529|FG002|NOT COMPLETED|All Patients||84
11164848|NCT01610037|12353527|FG000|STARTED|Treatment and Follow up Period||407
11164849|NCT01610037|12353528|FG001|STARTED|Treatment and Follow up Period||405
11164850|NCT01610037|12353529|FG002|STARTED|Treatment and Follow up Period||404
11164851|NCT01610037|12353527|FG000|COMPLETED|Treatment and Follow up Period||382
11164852|NCT01610037|12353528|FG001|COMPLETED|Treatment and Follow up Period||377
11164853|NCT01610037|12353529|FG002|COMPLETED|Treatment and Follow up Period||378
11164854|NCT01610037|12353527|FG000|NOT COMPLETED|Treatment and Follow up Period||25
11164855|NCT01610037|12353528|FG001|NOT COMPLETED|Treatment and Follow up Period||28
11164856|NCT01610037|12353529|FG002|NOT COMPLETED|Treatment and Follow up Period||26
11164857|NCT01610063|12353539|FG000|STARTED|Overall Study||114
11164858|NCT01610063|12353540|FG001|STARTED|Overall Study||113
11164859|NCT01610063|12353539|FG000|Baseline|Overall Study||114
11164860|NCT01610063|12353540|FG001|Baseline|Overall Study||113
11164861|NCT01610063|12353539|FG000|Completed 2-week|Overall Study||97
11164862|NCT01610063|12353540|FG001|Completed 2-week|Overall Study||105
11164863|NCT01610063|12353539|FG000|Completed 4-week|Overall Study||86
11164864|NCT01610063|12353540|FG001|Completed 4-week|Overall Study||98
11164865|NCT01610063|12353539|FG000|Completed 8-week|Overall Study||72
11164866|NCT01610063|12353540|FG001|Completed 8-week|Overall Study||93
11164867|NCT01610063|12353539|FG000|COMPLETED|Overall Study||72
11164868|NCT01610063|12353540|FG001|COMPLETED|Overall Study||93
11164869|NCT01610063|12353539|FG000|NOT COMPLETED|Overall Study||42
11164870|NCT01610063|12353540|FG001|NOT COMPLETED|Overall Study||20
11164871|NCT01610076|12353548|FG000|STARTED|Overall Study||103
11164872|NCT01610076|12353549|FG001|STARTED|Overall Study||105
11164873|NCT01610076|12353548|FG000|COMPLETED|Overall Study||100
11164874|NCT01610076|12353549|FG001|COMPLETED|Overall Study||100
11164875|NCT01610076|12353548|FG000|NOT COMPLETED|Overall Study||3
11164876|NCT01610076|12353549|FG001|NOT COMPLETED|Overall Study||5
11164877|NCT01610154|12353556|FG000|STARTED|Overall Study||85
11419562|NCT00002975|12618175|FG000|NOT COMPLETED|Overall Study||5
11419563|NCT00006478|12618179|FG000|STARTED|Overall Study||19
11419564|NCT00006478|12618179|FG000|COMPLETED|Overall Study||12
11419565|NCT00006478|12618179|FG000|NOT COMPLETED|Overall Study||7
11419566|NCT00019747|12618185|FG000|STARTED|Overall Study||23
11419567|NCT00019747|12618186|FG001|STARTED|Overall Study||16
11419568|NCT00019747|12618185|FG000|COMPLETED|Overall Study||23
11419569|NCT00019747|12618186|FG001|COMPLETED|Overall Study||16
11419570|NCT00019747|12618185|FG000|NOT COMPLETED|Overall Study||0
11164878|NCT01610154|12353556|FG000|COMPLETED|Overall Study||84
11164879|NCT01610154|12353556|FG000|NOT COMPLETED|Overall Study||1
11164880|NCT01610167|12353565|FG000|STARTED|Overall Study||52
11164881|NCT01610167|12353566|FG001|STARTED|Overall Study||49
11164882|NCT01610167|12353567|FG002|STARTED|Overall Study||50
11164883|NCT01610167|12353565|FG000|COMPLETED|Overall Study||52
11164884|NCT01610167|12353566|FG001|COMPLETED|Overall Study||49
11323402|NCT03531827|12520667|FG000|STARTED|Overall Study||4
11419571|NCT00019747|12618186|FG001|NOT COMPLETED|Overall Study||0
11419572|NCT00006916|12618192|FG000|STARTED|Overall Study||19
11419573|NCT00006916|12618192|FG000|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
11164885|NCT01610167|12353567|FG002|COMPLETED|Overall Study||48
11164886|NCT01610167|12353565|FG000|NOT COMPLETED|Overall Study||0
11419574|NCT00006916|12618192|FG000|NOT COMPLETED|Overall Study||5
11164887|NCT01610167|12353566|FG001|NOT COMPLETED|Overall Study||0
11164888|NCT01610167|12353567|FG002|NOT COMPLETED|Overall Study||2
11164889|NCT01610206|12353577|FG000|STARTED|Overall Study||73
11164890|NCT01610206|12353578|FG001|STARTED|Overall Study||75
11164891|NCT01610206|12353577|FG000|COMPLETED|Overall Study||63
11164892|NCT01610206|12353578|FG001|COMPLETED|Overall Study||45
11164893|NCT01610206|12353577|FG000|NOT COMPLETED|Overall Study||10
11164894|NCT01610206|12353578|FG001|NOT COMPLETED|Overall Study||30
11164895|NCT01610271|12353586|FG000|STARTED|Overall Study||150
11164896|NCT01610271|12353587|FG001|STARTED|Overall Study||150
11164897|NCT01610271|12353586|FG000|COMPLETED|Overall Study||148
11164898|NCT01610271|12353587|FG001|COMPLETED|Overall Study||146
11164899|NCT01610271|12353586|FG000|NOT COMPLETED|Overall Study||2
11164900|NCT01610271|12353587|FG001|NOT COMPLETED|Overall Study||4
11164901|NCT01610284|12353597|FG000|STARTED|Randomization Phase||576
11164902|NCT01610284|12353598|FG001|STARTED|Randomization Phase||571
11164903|NCT01610284|12353597|FG000|Safety Set (SS)|Randomization Phase||573
11164904|NCT01610284|12353598|FG001|Safety Set (SS)|Randomization Phase||570
11164905|NCT01610284|12353597|FG000|COMPLETED|Randomization Phase||574
11164906|NCT01610284|12353598|FG001|COMPLETED|Randomization Phase||569
11164907|NCT01610284|12353597|FG000|NOT COMPLETED|Randomization Phase||2
11164908|NCT01610284|12353598|FG001|NOT COMPLETED|Randomization Phase||2
11164909|NCT01610284|12353597|FG000|STARTED|Treatment Phase||574
11164910|NCT01610284|12353598|FG001|STARTED|Treatment Phase||569
11164911|NCT01610284|12353597|FG000|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||93
11164912|NCT01610284|12353598|FG001|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||0
11164913|NCT01610284|12353597|FG000|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||35
11164914|NCT01610284|12353598|FG001|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||0
11164915|NCT01610284|12353597|FG000|COMPLETED|Treatment Phase||0
11164916|NCT01610284|12353598|FG001|COMPLETED|Treatment Phase||0
11164917|NCT01610284|12353597|FG000|NOT COMPLETED|Treatment Phase||574
11164918|NCT01610284|12353598|FG001|NOT COMPLETED|Treatment Phase||569
11164919|NCT01610284|12353597|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|89
11164920|NCT01610284|12353598|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|29
11323403|NCT03531827|12520668|FG001|STARTED|Overall Study||0
11323404|NCT03531827|12520667|FG000|COMPLETED|Overall Study||1
11323405|NCT03531827|12520668|FG001|COMPLETED|Overall Study||0
11323406|NCT03531827|12520667|FG000|NOT COMPLETED|Overall Study||3
11323407|NCT03531827|12520668|FG001|NOT COMPLETED|Overall Study||0
11323408|NCT03452033|12520677|FG000|STARTED|Overall Study||21
11323409|NCT03452033|12520678|FG001|STARTED|Overall Study||22
11323410|NCT03452033|12520679|FG002|STARTED|Overall Study||22
11323411|NCT03452033|12520680|FG003|STARTED|Overall Study||22
11323412|NCT03452033|12520677|FG000|COMPLETED|Overall Study||21
11323413|NCT03452033|12520678|FG001|COMPLETED|Overall Study||22
11323414|NCT03452033|12520679|FG002|COMPLETED|Overall Study||22
11323415|NCT03452033|12520680|FG003|COMPLETED|Overall Study||22
11323416|NCT03452033|12520677|FG000|NOT COMPLETED|Overall Study||0
11323417|NCT03452033|12520678|FG001|NOT COMPLETED|Overall Study||0
11323418|NCT03452033|12520679|FG002|NOT COMPLETED|Overall Study||0
11323419|NCT03452033|12520680|FG003|NOT COMPLETED|Overall Study||0
11343101|NCT02951182|12540397|FG001|NOT COMPLETED|Overall Study||0
11343102|NCT02951182|12540398|FG002|NOT COMPLETED|Overall Study||0
11343103|NCT02951182|12540399|FG003|NOT COMPLETED|Overall Study||0
11343104|NCT02951182|12540400|FG004|NOT COMPLETED|Overall Study||0
11343105|NCT02951182|12540401|FG005|NOT COMPLETED|Overall Study||0
11343106|NCT02951195|12540429|FG000|STARTED|Overall Study||8
11343107|NCT02951195|12540430|FG001|STARTED|Overall Study||6
11343108|NCT02951195|12540431|FG002|STARTED|Overall Study||10
11343109|NCT02951195|12540432|FG003|STARTED|Overall Study||10
11343110|NCT02951195|12540433|FG004|STARTED|Overall Study||4
11343111|NCT02951195|12540434|FG005|STARTED|Overall Study||10
11343112|NCT02951195|12540435|FG006|STARTED|Overall Study||7
11343113|NCT02951195|12540436|FG007|STARTED|Overall Study||21
11343114|NCT02951195|12540429|FG000|COMPLETED|Overall Study||8
11343115|NCT02951195|12540430|FG001|COMPLETED|Overall Study||6
11343116|NCT02951195|12540431|FG002|COMPLETED|Overall Study||10
11343117|NCT02951195|12540432|FG003|COMPLETED|Overall Study||10
11343118|NCT02951195|12540433|FG004|COMPLETED|Overall Study||4
11343119|NCT02951195|12540434|FG005|COMPLETED|Overall Study||10
11343120|NCT02951195|12540435|FG006|COMPLETED|Overall Study||7
11343121|NCT02951195|12540436|FG007|COMPLETED|Overall Study||21
11343122|NCT02951195|12540429|FG000|NOT COMPLETED|Overall Study||0
11343123|NCT02951195|12540430|FG001|NOT COMPLETED|Overall Study||0
11343124|NCT02951195|12540431|FG002|NOT COMPLETED|Overall Study||0
11343125|NCT02951195|12540432|FG003|NOT COMPLETED|Overall Study||0
11343126|NCT02951195|12540433|FG004|NOT COMPLETED|Overall Study||0
11343127|NCT02951195|12540434|FG005|NOT COMPLETED|Overall Study||0
11164921|NCT01610284|12353597|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11164922|NCT01610284|12353598|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11164923|NCT01610284|12353597|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||89
11419575|NCT00003726|12618196|FG000|STARTED|Overall Study||1
11419576|NCT00003726|12618196|FG000|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
11419577|NCT00003726|12618196|FG000|NOT COMPLETED|Overall Study||1
11419578|NCT04051996|12618202|FG000|STARTED|Overall Study||1
11419579|NCT04051996|12618203|FG001|STARTED|Overall Study||0
11419580|NCT04051996|12618202|FG000|COMPLETED|Overall Study||1
11419581|NCT04051996|12618203|FG001|COMPLETED|Overall Study||0
11419582|NCT04051996|12618202|FG000|NOT COMPLETED|Overall Study||0
11164924|NCT01610284|12353598|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||29
11164925|NCT01610297|12353604|FG000|STARTED|Overall Study||27
11164926|NCT01610297|12353604|FG000|COMPLETED|Overall Study||26
11164927|NCT01610297|12353604|FG000|NOT COMPLETED|Overall Study||1
11164928|NCT01610336|12353619|FG000|STARTED|Overall Study||5
11164929|NCT01610336|12353620|FG001|STARTED|Overall Study||7
11419583|NCT04051996|12618203|FG001|NOT COMPLETED|Overall Study||0
11419584|NCT02970799|12618211|FG000|STARTED|Overall Study||0
11419585|NCT02970799|12618212|FG001|STARTED|Overall Study||0
11419586|NCT02970799|12618211|FG000|COMPLETED|Overall Study||0
11419587|NCT02970799|12618212|FG001|COMPLETED|Overall Study||0
11164930|NCT01610336|12353621|FG002|STARTED|Overall Study||6
11164931|NCT01610336|12353622|FG003|STARTED|Overall Study||7
11164932|NCT01610336|12353623|FG004|STARTED|Overall Study||4
11164933|NCT01610336|12353624|FG005|STARTED|Overall Study||12
11164934|NCT01610336|12353625|FG006|STARTED|Overall Study||5
11164935|NCT01610336|12353626|FG007|STARTED|Overall Study||7
11164936|NCT01610336|12353627|FG008|STARTED|Overall Study||8
11164937|NCT01610336|12353628|FG009|STARTED|Overall Study||53
11164938|NCT01610336|12353629|FG010|STARTED|Overall Study||47
11164939|NCT01610336|12353619|FG000|COMPLETED|Overall Study||0
11164940|NCT01610336|12353620|FG001|COMPLETED|Overall Study||0
11164941|NCT01610336|12353621|FG002|COMPLETED|Overall Study||0
11164942|NCT01610336|12353622|FG003|COMPLETED|Overall Study||0
11164943|NCT01610336|12353623|FG004|COMPLETED|Overall Study||0
11164944|NCT01610336|12353624|FG005|COMPLETED|Overall Study||0
11164945|NCT01610336|12353625|FG006|COMPLETED|Overall Study||0
11164946|NCT01610336|12353626|FG007|COMPLETED|Overall Study||0
11164947|NCT01610336|12353627|FG008|COMPLETED|Overall Study||0
11164948|NCT01610336|12353628|FG009|COMPLETED|Overall Study||0
11164949|NCT01610336|12353629|FG010|COMPLETED|Overall Study||0
11164950|NCT01610336|12353619|FG000|NOT COMPLETED|Overall Study||5
11164951|NCT01610336|12353620|FG001|NOT COMPLETED|Overall Study||7
11164952|NCT01610336|12353621|FG002|NOT COMPLETED|Overall Study||6
11164953|NCT01610336|12353622|FG003|NOT COMPLETED|Overall Study||7
11164954|NCT01610336|12353623|FG004|NOT COMPLETED|Overall Study||4
11164955|NCT01610336|12353624|FG005|NOT COMPLETED|Overall Study||12
11164956|NCT01610336|12353625|FG006|NOT COMPLETED|Overall Study||5
11164957|NCT01610336|12353626|FG007|NOT COMPLETED|Overall Study||7
11164958|NCT01610336|12353627|FG008|NOT COMPLETED|Overall Study||8
11164959|NCT01610336|12353628|FG009|NOT COMPLETED|Overall Study||53
11164960|NCT01610336|12353629|FG010|NOT COMPLETED|Overall Study||47
11164961|NCT01610414|12353659|FG000|STARTED|Study Start - Month 13||922
11343128|NCT02951195|12540435|FG006|NOT COMPLETED|Overall Study||0
11343129|NCT02951195|12540436|FG007|NOT COMPLETED|Overall Study||0
11343130|NCT02951273|12540464|FG000|STARTED|Overall Study||30
11343131|NCT02951273|12540464|FG000|COMPLETED|Overall Study||27
11419588|NCT02970799|12618211|FG000|NOT COMPLETED|Overall Study||0
11419589|NCT02970799|12618212|FG001|NOT COMPLETED|Overall Study||0
11164962|NCT01610414|12353660|FG001|STARTED|Study Start - Month 13||924
11164963|NCT01610414|12353659|FG000|COMPLETED|Study Start - Month 13||807
11164964|NCT01610414|12353660|FG001|COMPLETED|Study Start - Month 13||795
11164965|NCT01610414|12353659|FG000|NOT COMPLETED|Study Start - Month 13||115
11164966|NCT01610414|12353660|FG001|NOT COMPLETED|Study Start - Month 13||129
11164967|NCT01610414|12353659|FG000|STARTED|Month 13 - Month 25||922
11164968|NCT01610414|12353660|FG001|STARTED|Month 13 - Month 25||924
11164969|NCT01610414|12353659|FG000|COMPLETED|Month 13 - Month 25||857
11164970|NCT01610414|12353660|FG001|COMPLETED|Month 13 - Month 25||854
11164971|NCT01610414|12353659|FG000|NOT COMPLETED|Month 13 - Month 25||65
11164972|NCT01610414|12353660|FG001|NOT COMPLETED|Month 13 - Month 25||70
11164973|NCT01610414|12353659|FG000|STARTED|After Month 25||922
11164974|NCT01610414|12353660|FG001|STARTED|After Month 25||924
11164975|NCT01610414|12353659|FG000|COMPLETED|After Month 25||874
11164976|NCT01610414|12353660|FG001|COMPLETED|After Month 25||871
11164977|NCT01610414|12353659|FG000|NOT COMPLETED|After Month 25||48
11164978|NCT01610414|12353660|FG001|NOT COMPLETED|After Month 25||53
11164979|NCT01610427|12353667|FG000|STARTED|Overall Study||22
11164980|NCT01610427|12353667|FG000|COMPLETED|Overall Study||22
11164981|NCT01610427|12353667|FG000|NOT COMPLETED|Overall Study||0
11164982|NCT01610453|12353671|FG000|STARTED|Overall Study||150
11164983|NCT01610453|12353671|FG000|COMPLETED|Overall Study||150
11164984|NCT01610453|12353671|FG000|NOT COMPLETED|Overall Study||0
11164985|NCT01610492|12353676|FG000|STARTED|Overall Study||14
11164986|NCT01610492|12353676|FG000|COMPLETED|Overall Study||8
11164987|NCT01610492|12353676|FG000|NOT COMPLETED|Overall Study||6
11164988|NCT01610557|12353684|FG000|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
11164989|NCT01610557|12353685|FG001|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
11164990|NCT01610557|12353686|FG002|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
11164991|NCT01610557|12353687|FG003|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
11164992|NCT01610557|12353688|FG004|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
11164993|NCT01610557|12353684|FG000|COMPLETED|36-Week Randomized Crossover Phase||16
11164994|NCT01610557|12353685|FG001|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
11164995|NCT01610557|12353686|FG002|COMPLETED|36-Week Randomized Crossover Phase||14
11164996|NCT01610557|12353687|FG003|COMPLETED|36-Week Randomized Crossover Phase||13
11164997|NCT01610557|12353688|FG004|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
11164998|NCT01610557|12353684|FG000|NOT COMPLETED|36-Week Randomized Crossover Phase||0
11164999|NCT01610557|12353685|FG001|NOT COMPLETED|36-Week Randomized Crossover Phase||1
11165000|NCT01610557|12353686|FG002|NOT COMPLETED|36-Week Randomized Crossover Phase||0
11165001|NCT01610557|12353687|FG003|NOT COMPLETED|36-Week Randomized Crossover Phase||0
11165002|NCT01610557|12353688|FG004|NOT COMPLETED|36-Week Randomized Crossover Phase||0
11165003|NCT01610557|12353684|FG000|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
11165004|NCT01610557|12353685|FG001|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
11165005|NCT01610557|12353686|FG002|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
11165006|NCT01610557|12353687|FG003|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
11165007|NCT01610557|12353688|FG004|STARTED|Post-36-Week Extension Phase||55
11165008|NCT01610557|12353684|FG000|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
11165009|NCT01610557|12353685|FG001|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
11165010|NCT01610557|12353686|FG002|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
11165011|NCT01610557|12353687|FG003|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
11165012|NCT01610557|12353688|FG004|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
11165013|NCT01610557|12353684|FG000|NOT COMPLETED|Post-36-Week Extension Phase||0
11165014|NCT01610557|12353685|FG001|NOT COMPLETED|Post-36-Week Extension Phase||0
11165015|NCT01610557|12353686|FG002|NOT COMPLETED|Post-36-Week Extension Phase||0
11165016|NCT01610557|12353687|FG003|NOT COMPLETED|Post-36-Week Extension Phase||0
11165017|NCT01610557|12353688|FG004|NOT COMPLETED|Post-36-Week Extension Phase||3
11165018|NCT01610570|12353703|FG000|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
11165019|NCT01610570|12353704|FG001|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
11165020|NCT01610570|12353705|FG002|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
11165021|NCT01610570|12353706|FG003|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
11419590|NCT02385292|12618220|FG000|STARTED|Overall Study||0
11419591|NCT02385292|12618221|FG001|STARTED|Overall Study||0
11419592|NCT02385292|12618220|FG000|COMPLETED|Overall Study||0
11419593|NCT02385292|12618221|FG001|COMPLETED|Overall Study||0
11419594|NCT02385292|12618220|FG000|NOT COMPLETED|Overall Study||0
11419595|NCT02385292|12618221|FG001|NOT COMPLETED|Overall Study||0
11419596|NCT02126878|12618230|FG000|STARTED|Overall Study||0
11419597|NCT02126878|12618231|FG001|STARTED|Overall Study||0
11419598|NCT02126878|12618232|FG002|STARTED|Overall Study||0
11419599|NCT02126878|12618230|FG000|COMPLETED|Overall Study||0
11419600|NCT02126878|12618231|FG001|COMPLETED|Overall Study||0
11419601|NCT02126878|12618232|FG002|COMPLETED|Overall Study||0
11419602|NCT02126878|12618230|FG000|NOT COMPLETED|Overall Study||0
11419603|NCT02126878|12618231|FG001|NOT COMPLETED|Overall Study||0
11419604|NCT02126878|12618232|FG002|NOT COMPLETED|Overall Study||0
11165022|NCT01610570|12353703|FG000|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
11165023|NCT01610570|12353704|FG001|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
11165024|NCT01610570|12353705|FG002|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
11165025|NCT01610570|12353706|FG003|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
11165026|NCT01610570|12353703|FG000|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
11165027|NCT01610570|12353704|FG001|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
11165028|NCT01610570|12353705|FG002|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
11165029|NCT01610570|12353706|FG003|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
11165030|NCT01610570|12353703|FG000|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
11165031|NCT01610570|12353704|FG001|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
11165032|NCT01610570|12353705|FG002|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
11165033|NCT01610570|12353706|FG003|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
11165034|NCT01610570|12353703|FG000|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
11165035|NCT01610570|12353704|FG001|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
11165036|NCT01610570|12353705|FG002|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
11165037|NCT01610570|12353706|FG003|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
11165038|NCT01610570|12353703|FG000|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
11165039|NCT01610570|12353704|FG001|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
11165040|NCT01610570|12353705|FG002|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
11165041|NCT01610570|12353706|FG003|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
11165042|NCT01610570|12353703|FG000|STARTED|Ph II >/= 12 mo. & </=17yrs||0
11165043|NCT01610570|12353704|FG001|STARTED|Ph II >/= 12 mo. & </=17yrs||0
11165044|NCT01610570|12353705|FG002|STARTED|Ph II >/= 12 mo. & </=17yrs||0
11165045|NCT01610570|12353706|FG003|STARTED|Ph II >/= 12 mo. & </=17yrs||0
11419605|NCT02221817|12618242|FG000|STARTED|Overall Study||0
11165046|NCT01610570|12353703|FG000|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
11419606|NCT02221817|12618243|FG001|STARTED|Overall Study||0
11419607|NCT02221817|12618242|FG000|COMPLETED|Overall Study||0
11419608|NCT02221817|12618243|FG001|COMPLETED|Overall Study||0
11419609|NCT02221817|12618242|FG000|NOT COMPLETED|Overall Study||0
11165047|NCT01610570|12353704|FG001|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
11165048|NCT01610570|12353705|FG002|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
11165049|NCT01610570|12353706|FG003|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
11165050|NCT01610570|12353703|FG000|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
11165051|NCT01610570|12353704|FG001|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
11165052|NCT01610570|12353705|FG002|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
11165053|NCT01610570|12353706|FG003|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
11165054|NCT01610596|12353724|FG000|STARTED|Overall Study||36
11165055|NCT01610596|12353725|FG001|STARTED|Overall Study||36
11165056|NCT01610596|12353724|FG000|COMPLETED|Overall Study||36
11165057|NCT01610596|12353725|FG001|COMPLETED|Overall Study||35
11165058|NCT01610596|12353724|FG000|NOT COMPLETED|Overall Study||0
11165059|NCT01610596|12353725|FG001|NOT COMPLETED|Overall Study||1
11165060|NCT01610687|12353731|FG000|STARTED|Overall Study||137
11165061|NCT01610687|12353731|FG000|COMPLETED|Overall Study||70
11165062|NCT01610687|12353731|FG000|NOT COMPLETED|Overall Study||67
11165063|NCT01610700|12353737|FG000|STARTED|Overall Study||80
11165064|NCT01610700|12353738|FG001|STARTED|Overall Study||80
11165065|NCT01610700|12353737|FG000|COMPLETED|Overall Study||77
11165066|NCT01610700|12353738|FG001|COMPLETED|Overall Study||77
11165067|NCT01610700|12353737|FG000|NOT COMPLETED|Overall Study||3
11165068|NCT01610700|12353738|FG001|NOT COMPLETED|Overall Study||3
11165069|NCT01610713|12353747|FG000|STARTED|Overall Study||77
11165070|NCT01610713|12353748|FG001|STARTED|Overall Study||77
11165071|NCT01610713|12353747|FG000|COMPLETED|Overall Study||71
11165072|NCT01610713|12353748|FG001|COMPLETED|Overall Study||76
11165073|NCT01610713|12353747|FG000|NOT COMPLETED|Overall Study||6
11165074|NCT01610713|12353748|FG001|NOT COMPLETED|Overall Study||1
11165075|NCT01610752|12353757|FG000|STARTED|Overall Study||18
11165076|NCT01610752|12353758|FG001|STARTED|Overall Study||19
11165077|NCT01610752|12353759|FG002|STARTED|Overall Study||17
11165078|NCT01610752|12353757|FG000|COMPLETED|Overall Study||18
11165079|NCT01610752|12353758|FG001|COMPLETED|Overall Study||19
11165080|NCT01610752|12353759|FG002|COMPLETED|Overall Study||13
11165081|NCT01610752|12353757|FG000|NOT COMPLETED|Overall Study||0
11165082|NCT01610752|12353758|FG001|NOT COMPLETED|Overall Study||0
11165083|NCT01610752|12353759|FG002|NOT COMPLETED|Overall Study||4
11165084|NCT01610791|12353767|FG000|STARTED|Overall Study||121
11165085|NCT01610791|12353767|FG000|COMPLETED|Overall Study||100
11165086|NCT01610791|12353767|FG000|NOT COMPLETED|Overall Study||21
11165087|NCT01611090|12353773|FG000|STARTED|Randomized Period||289
11165088|NCT01611090|12353774|FG001|STARTED|Randomized Period||289
11165089|NCT01611090|12353775|FG002|STARTED|Randomized Period||0
11165090|NCT01611090|12353773|FG000|Treated|Randomized Period||287
11165091|NCT01611090|12353774|FG001|Treated|Randomized Period||287
11165092|NCT01611090|12353775|FG002|Treated|Randomized Period||0
11165093|NCT01611090|12353773|FG000|COMPLETED|Randomized Period||259
11165094|NCT01611090|12353774|FG001|COMPLETED|Randomized Period||260
11165095|NCT01611090|12353775|FG002|COMPLETED|Randomized Period||0
11165096|NCT01611090|12353773|FG000|NOT COMPLETED|Randomized Period||30
11165097|NCT01611090|12353774|FG001|NOT COMPLETED|Randomized Period||29
11165098|NCT01611090|12353775|FG002|NOT COMPLETED|Randomized Period||0
11165099|NCT01611090|12353773|FG000|STARTED|Cross Over (Placebo to Ibrutinib)||0
11165100|NCT01611090|12353774|FG001|STARTED|Cross Over (Placebo to Ibrutinib)||0
11165101|NCT01611090|12353775|FG002|STARTED|Cross Over (Placebo to Ibrutinib)||183
11165102|NCT01611090|12353773|FG000|Treated|Cross Over (Placebo to Ibrutinib)||0
11165103|NCT01611090|12353774|FG001|Treated|Cross Over (Placebo to Ibrutinib)||0
11165104|NCT01611090|12353775|FG002|Treated|Cross Over (Placebo to Ibrutinib)||183
11165105|NCT01611090|12353773|FG000|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
11165106|NCT01611090|12353774|FG001|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
11165107|NCT01611090|12353775|FG002|COMPLETED|Cross Over (Placebo to Ibrutinib)||178
11165108|NCT01611090|12353773|FG000|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
11165109|NCT01611090|12353774|FG001|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
11165110|NCT01611090|12353775|FG002|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||5
11165111|NCT01611155|12353784|FG000|STARTED|Overall Study||25
11165112|NCT01611155|12353785|FG001|STARTED|Overall Study||25
11165113|NCT01611155|12353784|FG000|Received Treatment|Overall Study||25
11165114|NCT01611155|12353785|FG001|Received Treatment|Overall Study||25
11165115|NCT01611155|12353784|FG000|COMPLETED|Overall Study||16
11165116|NCT01611155|12353785|FG001|COMPLETED|Overall Study||18
11165117|NCT01611155|12353784|FG000|NOT COMPLETED|Overall Study||9
11165118|NCT01611155|12353785|FG001|NOT COMPLETED|Overall Study||7
11165119|NCT01611194|12353793|FG000|STARTED|Overall Study||36
11165120|NCT01611194|12353794|FG001|STARTED|Overall Study||35
11165121|NCT01611194|12353793|FG000|COMPLETED|Overall Study||36
11165122|NCT01611194|12353794|FG001|COMPLETED|Overall Study||32
11165123|NCT01611194|12353793|FG000|NOT COMPLETED|Overall Study||0
11165124|NCT01611194|12353794|FG001|NOT COMPLETED|Overall Study||3
11165125|NCT01611259|12353800|FG000|STARTED|Overall Study||48
11165126|NCT01611259|12353800|FG000|COMPLETED|Overall Study||34
11165127|NCT01611259|12353800|FG000|NOT COMPLETED|Overall Study||14
11165128|NCT01611298|12353804|FG000|STARTED|Overall Study||7
11165129|NCT01611298|12353804|FG000|COMPLETED|Overall Study||5
11165130|NCT01611298|12353804|FG000|NOT COMPLETED|Overall Study||2
11165131|NCT01611454|12353810|FG000|STARTED|Overall Study||58
11165132|NCT01611454|12353811|FG001|STARTED|Overall Study||48
11165133|NCT01611454|12353810|FG000|COMPLETED|Overall Study||40
11165134|NCT01611454|12353811|FG001|COMPLETED|Overall Study||38
11165135|NCT01611454|12353810|FG000|NOT COMPLETED|Overall Study||18
11165136|NCT01611454|12353811|FG001|NOT COMPLETED|Overall Study||10
11165137|NCT01611558|12353821|FG000|STARTED|Induction Phase||40
11165138|NCT01611558|12353821|FG000|COMPLETED|Induction Phase||2
11165139|NCT01611558|12353821|FG000|NOT COMPLETED|Induction Phase||38
11165140|NCT01611558|12353821|FG000|STARTED|Maintenance Phase||2
11165141|NCT01611558|12353821|FG000|COMPLETED|Maintenance Phase||0
11165142|NCT01611558|12353821|FG000|NOT COMPLETED|Maintenance Phase||2
11165143|NCT01611571|12353829|FG000|STARTED|Overall Study||11
11165144|NCT01611571|12353830|FG001|STARTED|Overall Study||10
11165145|NCT01611571|12353831|FG002|STARTED|Overall Study||10
11165146|NCT01611571|12353829|FG000|COMPLETED|Overall Study||10
11165147|NCT01611571|12353830|FG001|COMPLETED|Overall Study||10
11165148|NCT01611571|12353831|FG002|COMPLETED|Overall Study||9
11165149|NCT01611571|12353829|FG000|NOT COMPLETED|Overall Study||1
11165150|NCT01611571|12353830|FG001|NOT COMPLETED|Overall Study||0
11165151|NCT01611571|12353831|FG002|NOT COMPLETED|Overall Study||1
11165152|NCT01611662|12353839|FG000|STARTED|Overall Study||32
11165153|NCT01611662|12353839|FG000|COMPLETED|Overall Study||31
11165154|NCT01611662|12353839|FG000|NOT COMPLETED|Overall Study||1
11165155|NCT01611779|12353843|FG000|STARTED|Overall Study||5
11165156|NCT01611779|12353843|FG000|COMPLETED|Overall Study||5
11165157|NCT01611779|12353843|FG000|NOT COMPLETED|Overall Study||0
11165158|NCT01611792|12353849|FG000|STARTED|Initial Period: Time 0||29
11165159|NCT01611792|12353850|FG001|STARTED|Initial Period: Time 0||29
11165160|NCT01611792|12353849|FG000|COMPLETED|Initial Period: Time 0||17
11165161|NCT01611792|12353850|FG001|COMPLETED|Initial Period: Time 0||20
11165162|NCT01611792|12353849|FG000|NOT COMPLETED|Initial Period: Time 0||12
11165163|NCT01611792|12353850|FG001|NOT COMPLETED|Initial Period: Time 0||9
11165164|NCT01611792|12353849|FG000|STARTED|Follow-up: at 11 Weeks||17
11165165|NCT01611792|12353850|FG001|STARTED|Follow-up: at 11 Weeks||20
11165166|NCT01611792|12353849|FG000|COMPLETED|Follow-up: at 11 Weeks||17
11165167|NCT01611792|12353850|FG001|COMPLETED|Follow-up: at 11 Weeks||20
11165168|NCT01611792|12353849|FG000|NOT COMPLETED|Follow-up: at 11 Weeks||0
11165169|NCT01611792|12353850|FG001|NOT COMPLETED|Follow-up: at 11 Weeks||0
11165170|NCT01611792|12353849|FG000|STARTED|Followup: at 6 Months||17
11165171|NCT01611792|12353850|FG001|STARTED|Followup: at 6 Months||20
11165172|NCT01611792|12353849|FG000|COMPLETED|Followup: at 6 Months||11
11165173|NCT01611792|12353850|FG001|COMPLETED|Followup: at 6 Months||7
11165174|NCT01611792|12353849|FG000|NOT COMPLETED|Followup: at 6 Months||6
11165175|NCT01611792|12353850|FG001|NOT COMPLETED|Followup: at 6 Months||13
11165176|NCT01611857|12353859|FG000|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
11165177|NCT01611857|12353860|FG001|STARTED|Overall Study||34
11165178|NCT01611857|12353859|FG000|Tivantinib 120 mg|Overall Study||5
11165179|NCT01611857|12353860|FG001|Tivantinib 120 mg|Overall Study||0
11165180|NCT01611857|12353859|FG000|Tivantinib 240 mg|Overall Study||3
11165181|NCT01611857|12353860|FG001|Tivantinib 240 mg|Overall Study||0
11165182|NCT01611857|12353859|FG000|Tivantinib 360 mg|Overall Study||7
11165183|NCT01611857|12353860|FG001|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
11165184|NCT01611857|12353859|FG000|COMPLETED|Overall Study||15
11165185|NCT01611857|12353860|FG001|COMPLETED|Overall Study||32
11419610|NCT02221817|12618243|FG001|NOT COMPLETED|Overall Study||0
11419611|NCT02595996|12618249|FG000|STARTED|Overall Study||1
11419612|NCT02595996|12618249|FG000|COMPLETED|Overall Study||1
11419613|NCT02595996|12618249|FG000|NOT COMPLETED|Overall Study||0
11419614|NCT03879044|12618253|FG000|STARTED|Overall Study||30
11419615|NCT03879044|12618253|FG000|COMPLETED|Overall Study||26
11419616|NCT03879044|12618253|FG000|NOT COMPLETED|Overall Study||4
11419617|NCT03198156|12618259|FG000|STARTED|Overall Study||19
11419618|NCT03198156|12618260|FG001|STARTED|Overall Study||19
11419619|NCT03198156|12618259|FG000|COMPLETED|Overall Study||19
11419620|NCT03198156|12618260|FG001|COMPLETED|Overall Study||19
11419621|NCT03198156|12618259|FG000|NOT COMPLETED|Overall Study||0
11419622|NCT03198156|12618260|FG001|NOT COMPLETED|Overall Study||0
11419623|NCT02009384|12618266|FG000|STARTED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|2
11419624|NCT02009384|12618266|FG000|COMPLETED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|0
11419625|NCT02009384|12618266|FG000|NOT COMPLETED|Overall Study||2
11419626|NCT04558125|12618270|FG000|STARTED|Overall Study||2
11419627|NCT04558125|12618270|FG000|COMPLETED|Overall Study||1
11419628|NCT04558125|12618270|FG000|NOT COMPLETED|Overall Study||1
11165186|NCT01611857|12353859|FG000|NOT COMPLETED|Overall Study||0
11165187|NCT01611857|12353860|FG001|NOT COMPLETED|Overall Study||2
11165188|NCT01611935|12353870|FG000|STARTED|Overall Study||50
11165189|NCT01611935|12353871|FG001|STARTED|Overall Study||51
11165190|NCT01611935|12353870|FG000|COMPLETED|Overall Study||49
11165191|NCT01611935|12353871|FG001|COMPLETED|Overall Study||51
11165192|NCT01611935|12353870|FG000|NOT COMPLETED|Overall Study||1
11165193|NCT01611935|12353871|FG001|NOT COMPLETED|Overall Study||0
11165194|NCT01611948|12353879|FG000|STARTED|Overall Study||32
11165195|NCT01611948|12353880|FG001|STARTED|Overall Study||38
11165196|NCT01611948|12353879|FG000|COMPLETED|Overall Study||18
11165197|NCT01611948|12353880|FG001|COMPLETED|Overall Study||26
11165198|NCT01611948|12353879|FG000|NOT COMPLETED|Overall Study||14
11165199|NCT01611948|12353880|FG001|NOT COMPLETED|Overall Study||12
11165200|NCT01611974|12353889|FG000|STARTED|Overall Study||40
11165201|NCT01611974|12353890|FG001|STARTED|Overall Study||40
11165202|NCT01611974|12353891|FG002|STARTED|Overall Study||40
11165203|NCT01611974|12353889|FG000|COMPLETED|Overall Study||25
11165204|NCT01611974|12353890|FG001|COMPLETED|Overall Study||25
11165205|NCT01611974|12353891|FG002|COMPLETED|Overall Study||24
11165206|NCT01611974|12353889|FG000|NOT COMPLETED|Overall Study||15
11165207|NCT01611974|12353890|FG001|NOT COMPLETED|Overall Study||15
11165208|NCT01611974|12353891|FG002|NOT COMPLETED|Overall Study||16
11165209|NCT01612000|12353903|FG000|STARTED|Overall Study||84
11165210|NCT01612000|12353904|FG001|STARTED|Overall Study||86
11165211|NCT01612000|12353905|FG002|STARTED|Overall Study||85
11165212|NCT01612000|12353906|FG003|STARTED|Overall Study||86
11165213|NCT01612000|12353903|FG000|COMPLETED|Overall Study||75
11165214|NCT01612000|12353904|FG001|COMPLETED|Overall Study||81
11165215|NCT01612000|12353905|FG002|COMPLETED|Overall Study||78
11165216|NCT01612000|12353906|FG003|COMPLETED|Overall Study||76
11165217|NCT01612000|12353903|FG000|NOT COMPLETED|Overall Study||9
11165218|NCT01612000|12353904|FG001|NOT COMPLETED|Overall Study||5
11165219|NCT01612000|12353905|FG002|NOT COMPLETED|Overall Study||7
11165220|NCT01612000|12353906|FG003|NOT COMPLETED|Overall Study||10
11165221|NCT01612156|12353918|FG000|STARTED|Overall Study||42
11165222|NCT01612156|12353919|FG001|STARTED|Overall Study||48
11165223|NCT01612156|12353918|FG000|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
11165224|NCT01612156|12353919|FG001|COMPLETED|Overall Study||48
11165225|NCT01612156|12353918|FG000|NOT COMPLETED|Overall Study||2
11165226|NCT01612156|12353919|FG001|NOT COMPLETED|Overall Study||0
11165227|NCT01612221|12353927|FG000|STARTED|Overall Study||50
11165228|NCT01612221|12353928|FG001|STARTED|Overall Study||50
11165229|NCT01612221|12353927|FG000|COMPLETED|Overall Study||50
11165230|NCT01612221|12353928|FG001|COMPLETED|Overall Study||50
11165231|NCT01612221|12353927|FG000|NOT COMPLETED|Overall Study||0
11165232|NCT01612221|12353928|FG001|NOT COMPLETED|Overall Study||0
11165233|NCT01612494|12353936|FG000|STARTED|Overall Study||21
11165234|NCT01612494|12353937|FG001|STARTED|Overall Study||23
11165235|NCT01612494|12353936|FG000|COMPLETED|Overall Study||21
11165236|NCT01612494|12353937|FG001|COMPLETED|Overall Study||23
11165237|NCT01612494|12353936|FG000|NOT COMPLETED|Overall Study||0
11165238|NCT01612494|12353937|FG001|NOT COMPLETED|Overall Study||0
11165239|NCT01612546|12353943|FG000|STARTED|Overall Study||10
11165240|NCT01612546|12353943|FG000|COMPLETED|Overall Study||10
11165241|NCT01612546|12353943|FG000|NOT COMPLETED|Overall Study||0
11165242|NCT01612676|12353951|FG000|STARTED|Overall Study||6
11165243|NCT01612676|12353952|FG001|STARTED|Overall Study||7
11165244|NCT01612676|12353953|FG002|STARTED|Overall Study||5
11165245|NCT01612676|12353954|FG003|STARTED|Overall Study||13
11165246|NCT01612676|12353951|FG000|Dosed|Overall Study||5
11165247|NCT01612676|12353952|FG001|Dosed|Overall Study||7
11165248|NCT01612676|12353953|FG002|Dosed|Overall Study||5
11165249|NCT01612676|12353954|FG003|Dosed|Overall Study||13
11165250|NCT01612676|12353951|FG000|COMPLETED|Overall Study||4
11165251|NCT01612676|12353952|FG001|COMPLETED|Overall Study||3
11165252|NCT01612676|12353953|FG002|COMPLETED|Overall Study||4
11165253|NCT01612676|12353954|FG003|COMPLETED|Overall Study||10
11165254|NCT01612676|12353951|FG000|NOT COMPLETED|Overall Study||2
11165255|NCT01612676|12353952|FG001|NOT COMPLETED|Overall Study||4
11165256|NCT01612676|12353953|FG002|NOT COMPLETED|Overall Study||1
11165257|NCT01612676|12353954|FG003|NOT COMPLETED|Overall Study||3
11165258|NCT01612702|12353968|FG000|STARTED|Overall Study||146
11165259|NCT01612702|12353969|FG001|STARTED|Overall Study||145
11165260|NCT01612702|12353968|FG000|COMPLETED|Overall Study||135
11165261|NCT01612702|12353969|FG001|COMPLETED|Overall Study||134
11165262|NCT01612702|12353968|FG000|NOT COMPLETED|Overall Study||11
11165263|NCT01612702|12353969|FG001|NOT COMPLETED|Overall Study||11
11203594|NCT01847885|12394095|FG002|NOT COMPLETED|Randomization||2
11203595|NCT01848041|12394110|FG000|STARTED|Overall Study||15
11203596|NCT01848041|12394111|FG001|STARTED|Overall Study||16
11203597|NCT01848041|12394112|FG002|STARTED|Overall Study||15
11203598|NCT01848041|12394110|FG000|COMPLETED|Overall Study||15
11203599|NCT01848041|12394111|FG001|COMPLETED|Overall Study||16
11203600|NCT01848041|12394112|FG002|COMPLETED|Overall Study||15
11203601|NCT01848041|12394110|FG000|NOT COMPLETED|Overall Study||0
11203602|NCT01848041|12394111|FG001|NOT COMPLETED|Overall Study||0
11203603|NCT01848041|12394112|FG002|NOT COMPLETED|Overall Study||0
11203604|NCT01848054|12394125|FG000|STARTED|Induction Phase||155
11203605|NCT01848054|12394126|FG001|STARTED|Induction Phase||155
11203606|NCT01848054|12394125|FG000|COMPLETED|Induction Phase||132
11203607|NCT01848054|12394126|FG001|COMPLETED|Induction Phase||147
11203608|NCT01848054|12394125|FG000|NOT COMPLETED|Induction Phase||23
11203609|NCT01848054|12394126|FG001|NOT COMPLETED|Induction Phase||8
11203610|NCT01848054|12394125|FG000|STARTED|Stabilization/Maintenance||132
11203611|NCT01848054|12394126|FG001|STARTED|Stabilization/Maintenance||147
11203612|NCT01848054|12394125|FG000|COMPLETED|Stabilization/Maintenance||92
11203613|NCT01848054|12394126|FG001|COMPLETED|Stabilization/Maintenance||107
11203614|NCT01848054|12394125|FG000|NOT COMPLETED|Stabilization/Maintenance||40
11203615|NCT01848054|12394126|FG001|NOT COMPLETED|Stabilization/Maintenance||40
11203616|NCT01848067|12394136|FG000|STARTED|Overall Study||9
11203617|NCT01848067|12394136|FG000|COMPLETED|Overall Study||9
11203618|NCT01848067|12394136|FG000|NOT COMPLETED|Overall Study||0
11203619|NCT01848145|12394140|FG000|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
11203620|NCT01848145|12394140|FG000|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
11203621|NCT01848145|12394140|FG000|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
11203622|NCT01848145|12394140|FG000|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
11203623|NCT01848145|12394140|FG000|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
11203624|NCT01848145|12394140|FG000|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
11203625|NCT01848145|12394140|FG000|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
11203626|NCT01848145|12394140|FG000|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
11203627|NCT01848145|12394140|FG000|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
11203628|NCT01848145|12394140|FG000|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
11203629|NCT01848145|12394140|FG000|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
11203630|NCT01848145|12394140|FG000|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
11203631|NCT01848145|12394140|FG000|STARTED|Subsequent Infusions: Weeks 3-8||30
11203632|NCT01848145|12394140|FG000|COMPLETED|Subsequent Infusions: Weeks 3-8||20
11203633|NCT01848145|12394140|FG000|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
11203634|NCT01848158|12394146|FG000|STARTED|Overall Study||10
11203635|NCT01848158|12394147|FG001|STARTED|Overall Study||7
11203636|NCT01848158|12394146|FG000|COMPLETED|Overall Study||10
11203637|NCT01848158|12394147|FG001|COMPLETED|Overall Study||7
11203638|NCT01848158|12394146|FG000|NOT COMPLETED|Overall Study||0
11203639|NCT01848158|12394147|FG001|NOT COMPLETED|Overall Study||0
11203640|NCT01848184|12394153|FG000|STARTED|Overall Study||126
11203641|NCT01848184|12394153|FG000|COMPLETED|Overall Study||100
11203642|NCT01848184|12394153|FG000|NOT COMPLETED|Overall Study||26
11203643|NCT01848210|12394165|FG000|STARTED|Overall Study||411
11203644|NCT01848210|12394166|FG001|STARTED|Overall Study||418
11203645|NCT01848210|12394165|FG000|Safety Population-Received Study Drug|Overall Study||394
11203646|NCT01848210|12394166|FG001|Safety Population-Received Study Drug|Overall Study||398
11203647|NCT01848210|12394165|FG000|Intent-to-Treat (ITT) Population|Overall Study||383
11203648|NCT01848210|12394166|FG001|Intent-to-Treat (ITT) Population|Overall Study||388
11203649|NCT01848210|12394165|FG000|Per Protocol Population|Overall Study||222
11203650|NCT01848210|12394166|FG001|Per Protocol Population|Overall Study||245
11203651|NCT01848210|12394165|FG000|COMPLETED|Overall Study||323
11203652|NCT01848210|12394166|FG001|COMPLETED|Overall Study||340
11203653|NCT01848210|12394165|FG000|NOT COMPLETED|Overall Study||88
11203654|NCT01848210|12394166|FG001|NOT COMPLETED|Overall Study||78
11203655|NCT01848288|12394172|FG000|STARTED|Overall Study||100
11203656|NCT01848288|12394172|FG000|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
11203657|NCT01848288|12394172|FG000|NOT COMPLETED|Overall Study||3
11203658|NCT01848353|12394181|FG000|STARTED|Phase 1||38
11203659|NCT01848353|12394182|FG001|STARTED|Phase 1||43
11203660|NCT01848353|12394183|FG002|STARTED|Phase 1||20
11203661|NCT01848353|12394184|FG003|STARTED|Phase 1||19
11203662|NCT01848353|12394181|FG000|COMPLETED|Phase 1||35
11203663|NCT01848353|12394182|FG001|COMPLETED|Phase 1||42
11203664|NCT01848353|12394183|FG002|COMPLETED|Phase 1||20
11203665|NCT01848353|12394184|FG003|COMPLETED|Phase 1||19
11203666|NCT01848353|12394181|FG000|NOT COMPLETED|Phase 1||3
11203667|NCT01848353|12394182|FG001|NOT COMPLETED|Phase 1||1
11203668|NCT01848353|12394183|FG002|NOT COMPLETED|Phase 1||0
11203669|NCT01848353|12394184|FG003|NOT COMPLETED|Phase 1||0
11203670|NCT01848353|12394181|FG000|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23
11165264|NCT01612767|12353975|FG000|STARTED|Overall Study||329
11165265|NCT01612767|12353975|FG000|COMPLETED|Overall Study||287
11165266|NCT01612767|12353975|FG000|NOT COMPLETED|Overall Study||42
11165267|NCT01612780|12354000|FG000|STARTED|Overall Study||82
11165268|NCT01612780|12354000|FG000|COMPLETED|Overall Study||76
11165269|NCT01612780|12354000|FG000|NOT COMPLETED|Overall Study||6
11165270|NCT01612793|12354006|FG000|STARTED|Overall Study||2
11165271|NCT01612793|12354007|FG001|STARTED|Overall Study||2
11165272|NCT01612793|12354006|FG000|COMPLETED|Overall Study||2
11165273|NCT01612793|12354007|FG001|COMPLETED|Overall Study||2
11165274|NCT01612793|12354006|FG000|NOT COMPLETED|Overall Study||0
11165275|NCT01612793|12354007|FG001|NOT COMPLETED|Overall Study||0
11165276|NCT01612858|12354015|FG000|STARTED|Overall Study||16
11165277|NCT01612858|12354016|FG001|STARTED|Overall Study||4
11165278|NCT01612858|12354015|FG000|COMPLETED|Overall Study||11
11165279|NCT01612858|12354016|FG001|COMPLETED|Overall Study||3
11165280|NCT01612858|12354015|FG000|NOT COMPLETED|Overall Study||5
11165281|NCT01612858|12354016|FG001|NOT COMPLETED|Overall Study||1
11165282|NCT01612884|12354024|FG000|STARTED|Overall Study||19
11165283|NCT01612884|12354025|FG001|STARTED|Overall Study||18
11165284|NCT01612884|12354024|FG000|COMPLETED|Overall Study||19
11419629|NCT02401308|12618276|FG000|STARTED|Overall Study||0
11419630|NCT02401308|12618277|FG001|STARTED|Overall Study||1
11165285|NCT01612884|12354025|FG001|COMPLETED|Overall Study||18
11165286|NCT01612884|12354024|FG000|NOT COMPLETED|Overall Study||0
11165287|NCT01612884|12354025|FG001|NOT COMPLETED|Overall Study||0
11165288|NCT01613014|12354033|FG000|STARTED|Overall Study||75
11165289|NCT01613014|12354034|FG001|STARTED|Overall Study||75
11165290|NCT01613014|12354033|FG000|COMPLETED|Overall Study||57
11165291|NCT01613014|12354034|FG001|COMPLETED|Overall Study||63
11165292|NCT01613014|12354033|FG000|NOT COMPLETED|Overall Study||18
11165293|NCT01613014|12354034|FG001|NOT COMPLETED|Overall Study||12
11165294|NCT01613027|12354040|FG000|STARTED|Overall Study||135
11165295|NCT01613027|12354040|FG000|COMPLETED|Overall Study||127
11165296|NCT01613027|12354040|FG000|NOT COMPLETED|Overall Study||8
11165297|NCT01613131|12354046|FG000|STARTED|Overall Study||20
11165298|NCT01613131|12354047|FG001|STARTED|Overall Study||18
11165299|NCT01613131|12354046|FG000|COMPLETED|Overall Study||17
11165300|NCT01613131|12354047|FG001|COMPLETED|Overall Study||13
11165301|NCT01613131|12354046|FG000|NOT COMPLETED|Overall Study||3
11165302|NCT01613131|12354047|FG001|NOT COMPLETED|Overall Study||5
11165303|NCT01613222|12354053|FG000|STARTED|Overall Study||63
11165304|NCT01613222|12354053|FG000|COMPLETED|Overall Study||51
11165305|NCT01613222|12354053|FG000|NOT COMPLETED|Overall Study||12
11165306|NCT01613248|12354072|FG000|STARTED|Overall Study||139
11165307|NCT01613248|12354073|FG001|STARTED|Overall Study||138
11165308|NCT01613248|12354074|FG002|STARTED|Overall Study||139
11165309|NCT01613248|12354075|FG003|STARTED|Overall Study||139
11165310|NCT01613248|12354076|FG004|STARTED|Overall Study||139
11165311|NCT01613248|12354077|FG005|STARTED|Overall Study||140
11165312|NCT01613248|12354072|FG000|COMPLETED|Overall Study||110
11165313|NCT01613248|12354073|FG001|COMPLETED|Overall Study||104
11165314|NCT01613248|12354074|FG002|COMPLETED|Overall Study||106
11165315|NCT01613248|12354075|FG003|COMPLETED|Overall Study||101
11165316|NCT01613248|12354076|FG004|COMPLETED|Overall Study||104
11165317|NCT01613248|12354077|FG005|COMPLETED|Overall Study||102
11165318|NCT01613248|12354072|FG000|NOT COMPLETED|Overall Study||29
11165319|NCT01613248|12354073|FG001|NOT COMPLETED|Overall Study||34
11165320|NCT01613248|12354074|FG002|NOT COMPLETED|Overall Study||33
11165321|NCT01613248|12354075|FG003|NOT COMPLETED|Overall Study||38
11165322|NCT01613248|12354076|FG004|NOT COMPLETED|Overall Study||35
11165323|NCT01613248|12354077|FG005|NOT COMPLETED|Overall Study||38
11165324|NCT01613313|12354095|FG000|STARTED|Overall Study||2
11165325|NCT01613313|12354096|FG001|STARTED|Overall Study||4
11165326|NCT01613313|12354097|FG002|STARTED|Overall Study||4
11165327|NCT01613313|12354098|FG003|STARTED|Overall Study||4
11165328|NCT01613313|12354095|FG000|COMPLETED|Overall Study||2
11165329|NCT01613313|12354096|FG001|COMPLETED|Overall Study||4
11165330|NCT01613313|12354097|FG002|COMPLETED|Overall Study||4
11165331|NCT01613313|12354098|FG003|COMPLETED|Overall Study||4
11165332|NCT01613313|12354095|FG000|NOT COMPLETED|Overall Study||0
11165333|NCT01613313|12354096|FG001|NOT COMPLETED|Overall Study||0
11165334|NCT01613313|12354097|FG002|NOT COMPLETED|Overall Study||0
11165335|NCT01613313|12354098|FG003|NOT COMPLETED|Overall Study||0
11165336|NCT01613326|12354110|FG000|STARTED|Overall Study||327
11165337|NCT01613326|12354111|FG001|STARTED|Overall Study||330
11165338|NCT01613326|12354110|FG000|COMPLETED|Overall Study||314
11165339|NCT01613326|12354111|FG001|COMPLETED|Overall Study||316
11165340|NCT01613326|12354110|FG000|NOT COMPLETED|Overall Study||13
11165341|NCT01613326|12354111|FG001|NOT COMPLETED|Overall Study||14
11165342|NCT01613339|12354119|FG000|STARTED|Overall Study||24
11165343|NCT01613339|12354120|FG001|STARTED|Overall Study||22
11165344|NCT01613339|12354119|FG000|COMPLETED|Overall Study||21
11165345|NCT01613339|12354120|FG001|COMPLETED|Overall Study||21
11165346|NCT01613339|12354119|FG000|NOT COMPLETED|Overall Study||3
11165347|NCT01613339|12354120|FG001|NOT COMPLETED|Overall Study||1
11165348|NCT01613378|12354125|FG000|STARTED|Overall Study||200
11165349|NCT01613378|12354125|FG000|COMPLETED|Overall Study||161
11165350|NCT01613378|12354125|FG000|NOT COMPLETED|Overall Study||39
11165351|NCT01613417|12354131|FG000|STARTED|First Injection||113
11165352|NCT01613417|12354132|FG001|STARTED|First Injection||116
11165353|NCT01613417|12354131|FG000|COMPLETED|First Injection||113
11165354|NCT01613417|12354132|FG001|COMPLETED|First Injection||116
11165355|NCT01613417|12354131|FG000|NOT COMPLETED|First Injection||0
11165356|NCT01613417|12354132|FG001|NOT COMPLETED|First Injection||0
11165357|NCT01613417|12354131|FG000|STARTED|Washout (no Second Injection/MRI)||113
11165358|NCT01613417|12354132|FG001|STARTED|Washout (no Second Injection/MRI)||116
11165359|NCT01613417|12354131|FG000|COMPLETED|Washout (no Second Injection/MRI)||100
11165360|NCT01613417|12354132|FG001|COMPLETED|Washout (no Second Injection/MRI)||109
11165361|NCT01613417|12354131|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||13
11165362|NCT01613417|12354132|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||7
11165363|NCT01613417|12354131|FG000|STARTED|Second Injection||100
11165364|NCT01613417|12354132|FG001|STARTED|Second Injection||109
11165365|NCT01613417|12354131|FG000|COMPLETED|Second Injection||100
11165366|NCT01613417|12354132|FG001|COMPLETED|Second Injection||109
11419631|NCT02401308|12618276|FG000|COMPLETED|Overall Study||0
11419632|NCT02401308|12618277|FG001|COMPLETED|Overall Study||0
11419633|NCT02401308|12618276|FG000|NOT COMPLETED|Overall Study||0
11419634|NCT02401308|12618277|FG001|NOT COMPLETED|Overall Study||1
11419635|NCT04381988|12618285|FG000|STARTED|Overall Study||4
11419636|NCT04381988|12618286|FG001|STARTED|Overall Study||0
11419637|NCT04381988|12618285|FG000|COMPLETED|Overall Study||0
11419638|NCT04381988|12618286|FG001|COMPLETED|Overall Study||0
11419639|NCT04381988|12618285|FG000|NOT COMPLETED|Overall Study||4
11419640|NCT04381988|12618286|FG001|NOT COMPLETED|Overall Study||0
11165367|NCT01613417|12354131|FG000|NOT COMPLETED|Second Injection||0
11419641|NCT00521885|12618294|FG000|STARTED|Overall Study||0
11419642|NCT00521885|12618295|FG001|STARTED|Overall Study||0
11419643|NCT00521885|12618294|FG000|COMPLETED|Overall Study||0
11419644|NCT00521885|12618295|FG001|COMPLETED|Overall Study||0
11419645|NCT00521885|12618294|FG000|NOT COMPLETED|Overall Study||0
11165368|NCT01613417|12354132|FG001|NOT COMPLETED|Second Injection||0
11165369|NCT01613599|12354148|FG000|STARTED|Overall Study||97
11165370|NCT01613599|12354148|FG000|COMPLETED|Overall Study||72
11165371|NCT01613599|12354148|FG000|NOT COMPLETED|Overall Study||25
11165372|NCT01613716|12354152|FG000|STARTED|Overall Study||30
11165373|NCT01613716|12354152|FG000|COMPLETED|Overall Study||23
11165374|NCT01613716|12354152|FG000|NOT COMPLETED|Overall Study||7
11165375|NCT01613768|12354156|FG000|STARTED|Overall Study||29
11165376|NCT01613768|12354156|FG000|COMPLETED|Overall Study||29
11165377|NCT01613768|12354156|FG000|NOT COMPLETED|Overall Study||0
11165378|NCT01614093|12354161|FG000|STARTED|Overall Study||17
11165379|NCT01614093|12354161|FG000|COMPLETED|Overall Study||16
11165380|NCT01614093|12354161|FG000|NOT COMPLETED|Overall Study||1
11165381|NCT01614210|12354166|FG000|STARTED|Overall Study||52
11165382|NCT01614210|12354166|FG000|COMPLETED|Overall Study||52
11165383|NCT01614210|12354166|FG000|NOT COMPLETED|Overall Study||0
11165384|NCT01614249|12354172|FG000|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
11165385|NCT01614249|12354173|FG001|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
11165386|NCT01614249|12354172|FG000|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
11165387|NCT01614249|12354173|FG001|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
11165388|NCT01614249|12354172|FG000|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
11165389|NCT01614249|12354173|FG001|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
11205201|NCT01857869|12395944|FG004|STARTED|Booster/Rechallenge Phase||10
11419646|NCT00521885|12618295|FG001|NOT COMPLETED|Overall Study||0
11419647|NCT02376946|12618303|FG000|STARTED|Overall Study|study terminated prior to being conducted|0
11419648|NCT02376946|12618304|FG001|STARTED|Overall Study|study terminated prior to being conducted|0
11419649|NCT02376946|12618303|FG000|COMPLETED|Overall Study|study terminated prior to being conducted|0
11419650|NCT02376946|12618304|FG001|COMPLETED|Overall Study|study terminated prior to being conducted|0
11419651|NCT02376946|12618303|FG000|NOT COMPLETED|Overall Study||0
11419652|NCT02376946|12618304|FG001|NOT COMPLETED|Overall Study||0
11419653|NCT01780636|12618310|FG000|STARTED|Overall Study||7
11419654|NCT01780636|12618310|FG000|COMPLETED|Overall Study||7
11419655|NCT01780636|12618310|FG000|NOT COMPLETED|Overall Study||0
11419656|NCT00479167|12618314|FG000|STARTED|Overall Study||1
11419657|NCT00479167|12618314|FG000|COMPLETED|Overall Study||0
11419658|NCT00479167|12618314|FG000|NOT COMPLETED|Overall Study||1
11419659|NCT03998189|12618321|FG000|STARTED|Overall Study||0
11419660|NCT03998189|12618322|FG001|STARTED|Overall Study||1
11419661|NCT03998189|12618321|FG000|COMPLETED|Overall Study||0
11419662|NCT03998189|12618322|FG001|COMPLETED|Overall Study|Samples were collected but were not analyzed as the analysis would have been done once a proper batch of samples were collected. This did not occur as the study was found to no longer be feasible and was terminated.|0
11419663|NCT03998189|12618321|FG000|NOT COMPLETED|Overall Study||0
11419664|NCT03998189|12618322|FG001|NOT COMPLETED|Overall Study||1
11419665|NCT02212574|12618328|FG000|STARTED|Overall Study||6
11419666|NCT02212574|12618328|FG000|COMPLETED|Overall Study||6
11419667|NCT02212574|12618328|FG000|NOT COMPLETED|Overall Study||0
11419668|NCT04422210|12618341|FG000|STARTED|Overall Study||0
11419669|NCT04422210|12618342|FG001|STARTED|Overall Study||0
11419670|NCT04422210|12618343|FG002|STARTED|Overall Study||0
11419671|NCT04422210|12618344|FG003|STARTED|Overall Study||0
11419672|NCT04422210|12618345|FG004|STARTED|Overall Study||0
11419673|NCT04422210|12618346|FG005|STARTED|Overall Study||0
11419674|NCT04422210|12618347|FG006|STARTED|Overall Study||0
11419675|NCT04422210|12618348|FG007|STARTED|Overall Study||0
11419676|NCT04422210|12618341|FG000|COMPLETED|Overall Study||0
11165390|NCT01614249|12354172|FG000|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
11165391|NCT01614249|12354173|FG001|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
11165392|NCT01614249|12354172|FG000|NOT COMPLETED|Overall Study||11
11165393|NCT01614249|12354173|FG001|NOT COMPLETED|Overall Study||23
11165394|NCT01614392|12354181|FG000|STARTED|Overall Study||25
11165395|NCT01614392|12354182|FG001|STARTED|Overall Study||27
11165396|NCT01614392|12354181|FG000|COMPLETED|Overall Study||24
11419677|NCT04422210|12618342|FG001|COMPLETED|Overall Study||0
11419678|NCT04422210|12618343|FG002|COMPLETED|Overall Study||0
11419679|NCT04422210|12618344|FG003|COMPLETED|Overall Study||0
11419680|NCT04422210|12618345|FG004|COMPLETED|Overall Study||0
11419681|NCT04422210|12618346|FG005|COMPLETED|Overall Study||0
11419682|NCT04422210|12618347|FG006|COMPLETED|Overall Study||0
11419683|NCT04422210|12618348|FG007|COMPLETED|Overall Study||0
11419684|NCT04422210|12618341|FG000|NOT COMPLETED|Overall Study||0
11419685|NCT04422210|12618342|FG001|NOT COMPLETED|Overall Study||0
11419686|NCT04422210|12618343|FG002|NOT COMPLETED|Overall Study||0
11165397|NCT01614392|12354182|FG001|COMPLETED|Overall Study||24
11165398|NCT01614392|12354181|FG000|NOT COMPLETED|Overall Study||1
11165399|NCT01614392|12354182|FG001|NOT COMPLETED|Overall Study||3
11165400|NCT01614457|12354190|FG000|STARTED|Overall Study||34
11165401|NCT01614457|12354191|FG001|STARTED|Overall Study||35
11165402|NCT01614457|12354190|FG000|COMPLETED|Overall Study||32
11165403|NCT01614457|12354191|FG001|COMPLETED|Overall Study||35
11165404|NCT01614457|12354190|FG000|NOT COMPLETED|Overall Study||2
11165405|NCT01614457|12354191|FG001|NOT COMPLETED|Overall Study||0
11165406|NCT01614470|12354199|FG000|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
11165407|NCT01614470|12354200|FG001|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
11165408|NCT01614470|12354201|FG002|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
11165409|NCT01614470|12354199|FG000|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
11165410|NCT01614470|12354200|FG001|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
11165411|NCT01614470|12354201|FG002|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
11165412|NCT01614470|12354199|FG000|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
11165413|NCT01614470|12354200|FG001|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
11165414|NCT01614470|12354201|FG002|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
11165415|NCT01614470|12354199|FG000|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
11165416|NCT01614470|12354200|FG001|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
11165417|NCT01614470|12354201|FG002|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
11165418|NCT01614470|12354199|FG000|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
11165419|NCT01614470|12354200|FG001|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
11165420|NCT01614470|12354201|FG002|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
11165421|NCT01614470|12354199|FG000|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
11165422|NCT01614470|12354200|FG001|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
11165423|NCT01614470|12354201|FG002|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
11026779|NCT00830375|12205389|FG000|STARTED|Overall Study||10
11026780|NCT00830375|12205389|FG000|COMPLETED|Overall Study||9
11026781|NCT00830375|12205389|FG000|NOT COMPLETED|Overall Study||1
11026782|NCT00830388|12205393|FG000|STARTED|Overall Study||11
11026783|NCT00830388|12205393|FG000|COMPLETED|Overall Study||11
11026784|NCT00830388|12205393|FG000|NOT COMPLETED|Overall Study||0
11026785|NCT00830440|12205399|FG000|STARTED|Overall Study||32
11165424|NCT01614470|12354199|FG000|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
11165425|NCT01614470|12354200|FG001|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
11165426|NCT01614470|12354201|FG002|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
11165427|NCT01614470|12354199|FG000|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
11165428|NCT01614470|12354200|FG001|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
11165429|NCT01614470|12354201|FG002|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
11165430|NCT01614470|12354199|FG000|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
11165431|NCT01614470|12354200|FG001|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
11165432|NCT01614470|12354201|FG002|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
11165433|NCT01614470|12354199|FG000|STARTED|Part 2: Open-label Period (16 Weeks)||0
11165434|NCT01614470|12354200|FG001|STARTED|Part 2: Open-label Period (16 Weeks)||0
11165435|NCT01614470|12354201|FG002|STARTED|Part 2: Open-label Period (16 Weeks)||36
11165436|NCT01614470|12354199|FG000|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
11165437|NCT01614470|12354200|FG001|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
11165438|NCT01614470|12354201|FG002|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
11165439|NCT01614470|12354199|FG000|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
11165440|NCT01614470|12354200|FG001|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
11165441|NCT01614470|12354201|FG002|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
11165442|NCT01614509|12354212|FG000|STARTED|Overall Study||24
11165443|NCT01614509|12354213|FG001|STARTED|Overall Study||21
11165444|NCT01614509|12354212|FG000|COMPLETED|Overall Study||23
11165445|NCT01614509|12354213|FG001|COMPLETED|Overall Study||18
11165446|NCT01614509|12354212|FG000|NOT COMPLETED|Overall Study||1
11165447|NCT01614509|12354213|FG001|NOT COMPLETED|Overall Study||3
11165448|NCT01614574|12354219|FG000|STARTED|Overall Study||6
11165449|NCT01614574|12354219|FG000|COMPLETED|Overall Study||6
11165450|NCT01614574|12354219|FG000|NOT COMPLETED|Overall Study||0
11165451|NCT01614600|12354223|FG000|STARTED|Overall Study||88
11165452|NCT01614600|12354223|FG000|COMPLETED|Overall Study||84
11165453|NCT01614600|12354223|FG000|NOT COMPLETED|Overall Study||4
11165454|NCT01614613|12354227|FG000|STARTED|Overall Study||146
11165455|NCT01614613|12354227|FG000|COMPLETED|Overall Study||146
11165456|NCT01614613|12354227|FG000|NOT COMPLETED|Overall Study||0
11165457|NCT01614743|12354234|FG000|STARTED|Overall Study||4
11165458|NCT01614743|12354235|FG001|STARTED|Overall Study||5
11165459|NCT01614743|12354234|FG000|COMPLETED|Overall Study||3
11165460|NCT01614743|12354235|FG001|COMPLETED|Overall Study|Subject in the placebo group (5) also received the treatment (IncobotulinumtoxinA) at Visit 5.|5
11165461|NCT01614743|12354234|FG000|NOT COMPLETED|Overall Study||1
11165462|NCT01614743|12354235|FG001|NOT COMPLETED|Overall Study||0
11165463|NCT01614769|12354241|FG000|STARTED|Period 1||2
11165464|NCT01614769|12354242|FG001|STARTED|Period 1||1
11026786|NCT00830440|12205400|FG001|STARTED|Overall Study||11
11165465|NCT01614769|12354243|FG002|STARTED|Period 1||2
11165466|NCT01614769|12354244|FG003|STARTED|Period 1||2
11165467|NCT01614769|12354245|FG004|STARTED|Period 1||1
11419687|NCT04422210|12618344|FG003|NOT COMPLETED|Overall Study||0
11419688|NCT04422210|12618345|FG004|NOT COMPLETED|Overall Study||0
11165468|NCT01614769|12354246|FG005|STARTED|Period 1||2
11165469|NCT01614769|12354241|FG000|COMPLETED|Period 1||1
11165470|NCT01614769|12354242|FG001|COMPLETED|Period 1||1
11165471|NCT01614769|12354243|FG002|COMPLETED|Period 1||2
11165472|NCT01614769|12354244|FG003|COMPLETED|Period 1||0
11165473|NCT01614769|12354245|FG004|COMPLETED|Period 1||1
11165474|NCT01614769|12354246|FG005|COMPLETED|Period 1||1
11165475|NCT01614769|12354241|FG000|NOT COMPLETED|Period 1||1
11165476|NCT01614769|12354242|FG001|NOT COMPLETED|Period 1||0
11165477|NCT01614769|12354243|FG002|NOT COMPLETED|Period 1||0
11165478|NCT01614769|12354244|FG003|NOT COMPLETED|Period 1||2
11165479|NCT01614769|12354245|FG004|NOT COMPLETED|Period 1||0
11165480|NCT01614769|12354246|FG005|NOT COMPLETED|Period 1||1
11165481|NCT01614769|12354241|FG000|STARTED|7-Day Washout||1
11165482|NCT01614769|12354242|FG001|STARTED|7-Day Washout||1
11165483|NCT01614769|12354243|FG002|STARTED|7-Day Washout||2
11165484|NCT01614769|12354244|FG003|STARTED|7-Day Washout||0
11165485|NCT01614769|12354245|FG004|STARTED|7-Day Washout||1
11165486|NCT01614769|12354246|FG005|STARTED|7-Day Washout||1
11165487|NCT01614769|12354241|FG000|COMPLETED|7-Day Washout||1
11165488|NCT01614769|12354242|FG001|COMPLETED|7-Day Washout||1
11165489|NCT01614769|12354243|FG002|COMPLETED|7-Day Washout||2
11165490|NCT01614769|12354244|FG003|COMPLETED|7-Day Washout||0
11165491|NCT01614769|12354245|FG004|COMPLETED|7-Day Washout||1
11165492|NCT01614769|12354246|FG005|COMPLETED|7-Day Washout||1
11165493|NCT01614769|12354241|FG000|NOT COMPLETED|7-Day Washout||0
11165494|NCT01614769|12354242|FG001|NOT COMPLETED|7-Day Washout||0
11165495|NCT01614769|12354243|FG002|NOT COMPLETED|7-Day Washout||0
11165496|NCT01614769|12354244|FG003|NOT COMPLETED|7-Day Washout||0
11165497|NCT01614769|12354245|FG004|NOT COMPLETED|7-Day Washout||0
11165498|NCT01614769|12354246|FG005|NOT COMPLETED|7-Day Washout||0
11165499|NCT01614769|12354241|FG000|STARTED|Period 2||1
11165500|NCT01614769|12354242|FG001|STARTED|Period 2||1
11165501|NCT01614769|12354243|FG002|STARTED|Period 2||2
11165502|NCT01614769|12354244|FG003|STARTED|Period 2||0
11165503|NCT01614769|12354245|FG004|STARTED|Period 2||1
11165504|NCT01614769|12354246|FG005|STARTED|Period 2||1
11165505|NCT01614769|12354241|FG000|COMPLETED|Period 2||1
11165506|NCT01614769|12354242|FG001|COMPLETED|Period 2||1
11165507|NCT01614769|12354243|FG002|COMPLETED|Period 2||2
11165508|NCT01614769|12354244|FG003|COMPLETED|Period 2||0
11165509|NCT01614769|12354245|FG004|COMPLETED|Period 2||1
11165510|NCT01614769|12354246|FG005|COMPLETED|Period 2||1
11165511|NCT01614769|12354241|FG000|NOT COMPLETED|Period 2||0
11165512|NCT01614769|12354242|FG001|NOT COMPLETED|Period 2||0
11165513|NCT01614769|12354243|FG002|NOT COMPLETED|Period 2||0
11165514|NCT01614769|12354244|FG003|NOT COMPLETED|Period 2||0
11165515|NCT01614769|12354245|FG004|NOT COMPLETED|Period 2||0
11165516|NCT01614769|12354246|FG005|NOT COMPLETED|Period 2||0
11165517|NCT01614769|12354241|FG000|STARTED|7-Day Washout||1
11165518|NCT01614769|12354242|FG001|STARTED|7-Day Washout||1
11165519|NCT01614769|12354243|FG002|STARTED|7-Day Washout||2
11165520|NCT01614769|12354244|FG003|STARTED|7-Day Washout||0
11165521|NCT01614769|12354245|FG004|STARTED|7-Day Washout||1
11165522|NCT01614769|12354246|FG005|STARTED|7-Day Washout||1
11165523|NCT01614769|12354241|FG000|COMPLETED|7-Day Washout||1
11165524|NCT01614769|12354242|FG001|COMPLETED|7-Day Washout||1
11165525|NCT01614769|12354243|FG002|COMPLETED|7-Day Washout||2
11165526|NCT01614769|12354244|FG003|COMPLETED|7-Day Washout||0
11165527|NCT01614769|12354245|FG004|COMPLETED|7-Day Washout||1
11165528|NCT01614769|12354246|FG005|COMPLETED|7-Day Washout||1
11165529|NCT01614769|12354241|FG000|NOT COMPLETED|7-Day Washout||0
11165530|NCT01614769|12354242|FG001|NOT COMPLETED|7-Day Washout||0
11165531|NCT01614769|12354243|FG002|NOT COMPLETED|7-Day Washout||0
11165532|NCT01614769|12354244|FG003|NOT COMPLETED|7-Day Washout||0
11165533|NCT01614769|12354245|FG004|NOT COMPLETED|7-Day Washout||0
11165534|NCT01614769|12354246|FG005|NOT COMPLETED|7-Day Washout||0
11165535|NCT01614769|12354241|FG000|STARTED|Period 3||1
11165536|NCT01614769|12354242|FG001|STARTED|Period 3||1
11165537|NCT01614769|12354243|FG002|STARTED|Period 3||2
11165538|NCT01614769|12354244|FG003|STARTED|Period 3||0
11165539|NCT01614769|12354245|FG004|STARTED|Period 3||1
11165540|NCT01614769|12354246|FG005|STARTED|Period 3||1
11165541|NCT01614769|12354241|FG000|COMPLETED|Period 3||1
11165542|NCT01614769|12354242|FG001|COMPLETED|Period 3||1
11165543|NCT01614769|12354243|FG002|COMPLETED|Period 3||1
11165544|NCT01614769|12354244|FG003|COMPLETED|Period 3||0
11165545|NCT01614769|12354245|FG004|COMPLETED|Period 3||1
11165546|NCT01614769|12354246|FG005|COMPLETED|Period 3||1
11165547|NCT01614769|12354241|FG000|NOT COMPLETED|Period 3||0
11165548|NCT01614769|12354242|FG001|NOT COMPLETED|Period 3||0
11165549|NCT01614769|12354243|FG002|NOT COMPLETED|Period 3||1
11165550|NCT01614769|12354244|FG003|NOT COMPLETED|Period 3||0
11165551|NCT01614769|12354245|FG004|NOT COMPLETED|Period 3||0
11165552|NCT01614769|12354246|FG005|NOT COMPLETED|Period 3||0
11165553|NCT01614795|12354258|FG000|STARTED|Overall Study||11
11165554|NCT01614795|12354259|FG001|STARTED|Overall Study||12
11165555|NCT01614795|12354260|FG002|STARTED|Overall Study||11
11419689|NCT04422210|12618346|FG005|NOT COMPLETED|Overall Study||0
11165556|NCT01614795|12354261|FG003|STARTED|Overall Study||12
11165557|NCT01614795|12354258|FG000|COMPLETED|Overall Study||0
11165558|NCT01614795|12354259|FG001|COMPLETED|Overall Study||0
11165559|NCT01614795|12354260|FG002|COMPLETED|Overall Study||0
11165560|NCT01614795|12354261|FG003|COMPLETED|Overall Study||0
11165561|NCT01614795|12354258|FG000|NOT COMPLETED|Overall Study||11
11419690|NCT04422210|12618347|FG006|NOT COMPLETED|Overall Study||0
11419691|NCT04422210|12618348|FG007|NOT COMPLETED|Overall Study||0
11165562|NCT01614795|12354259|FG001|NOT COMPLETED|Overall Study||12
11165563|NCT01614795|12354260|FG002|NOT COMPLETED|Overall Study||11
11165564|NCT01614795|12354261|FG003|NOT COMPLETED|Overall Study||12
11165565|NCT01614821|12354272|FG000|STARTED|Overall Study||63
11165566|NCT01614821|12354272|FG000|COMPLETED|Overall Study||63
11165567|NCT01614821|12354272|FG000|NOT COMPLETED|Overall Study||0
11165568|NCT01614847|12354278|FG000|STARTED|Day 1|Four subjects chosen at random received Drop A (hyaluronate) during Day 1.|4
11165569|NCT01614847|12354279|FG001|STARTED|Day 1|The other 4 subjects, not to Group 1, received Drop B (saline) on Day 1.|4
11165570|NCT01614847|12354278|FG000|COMPLETED|Day 1||4
11165571|NCT01614847|12354279|FG001|COMPLETED|Day 1|See Arm 1 comments.|4
11165572|NCT01614847|12354278|FG000|NOT COMPLETED|Day 1||0
11165573|NCT01614847|12354279|FG001|NOT COMPLETED|Day 1||0
11165574|NCT01614847|12354278|FG000|STARTED|Day 2 (24 Hours Later)|On Day 2, these subject will received Drop B (normal saline).|4
11165575|NCT01614847|12354279|FG001|STARTED|Day 2 (24 Hours Later)|On Day 2, these subjects received Drop A (hyaluronate).|4
11165576|NCT01614847|12354278|FG000|COMPLETED|Day 2 (24 Hours Later)||4
11165577|NCT01614847|12354279|FG001|COMPLETED|Day 2 (24 Hours Later)||4
11165578|NCT01614847|12354278|FG000|NOT COMPLETED|Day 2 (24 Hours Later)||0
11165579|NCT01614847|12354279|FG001|NOT COMPLETED|Day 2 (24 Hours Later)||0
11165580|NCT01614886|12354292|FG000|STARTED|Overall Study||107
11165581|NCT01614886|12354293|FG001|STARTED|Overall Study||109
11165582|NCT01614886|12354292|FG000|Safety Population (SAF)|Overall Study||107
11165583|NCT01614886|12354293|FG001|Safety Population (SAF)|Overall Study||108
11165584|NCT01614886|12354292|FG000|Full Analysis Set (FAS)|Overall Study||104
11165585|NCT01614886|12354293|FG001|Full Analysis Set (FAS)|Overall Study||105
11165586|NCT01614886|12354292|FG000|COMPLETED|Overall Study||87
11165587|NCT01614886|12354293|FG001|COMPLETED|Overall Study||83
11165588|NCT01614886|12354292|FG000|NOT COMPLETED|Overall Study||20
11165589|NCT01614886|12354293|FG001|NOT COMPLETED|Overall Study||26
11165590|NCT01614925|12354301|FG000|STARTED|Overall Study||18
11165591|NCT01614925|12354302|FG001|STARTED|Overall Study||17
11165592|NCT01614925|12354301|FG000|COMPLETED|Overall Study||14
11165593|NCT01614925|12354302|FG001|COMPLETED|Overall Study||15
11165594|NCT01614925|12354301|FG000|NOT COMPLETED|Overall Study||4
11165595|NCT01614925|12354302|FG001|NOT COMPLETED|Overall Study||2
11165596|NCT01615120|12354310|FG000|STARTED|Overall Study||38
11165597|NCT01615120|12354311|FG001|STARTED|Overall Study||39
11165598|NCT01615120|12354310|FG000|COMPLETED|Overall Study||23
11165599|NCT01615120|12354311|FG001|COMPLETED|Overall Study||19
11165600|NCT01615120|12354310|FG000|NOT COMPLETED|Overall Study||15
11165601|NCT01615120|12354311|FG001|NOT COMPLETED|Overall Study||20
11165602|NCT01615198|12354319|FG000|STARTED|Overall Study||296
11165603|NCT01615198|12354320|FG001|STARTED|Overall Study||292
11165604|NCT01615198|12354319|FG000|Full Analysis Set|Overall Study||296
11165605|NCT01615198|12354320|FG001|Full Analysis Set|Overall Study||292
11165606|NCT01615198|12354319|FG000|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
11165607|NCT01615198|12354320|FG001|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
11165608|NCT01615198|12354319|FG000|Safety Set|Overall Study||296
11165609|NCT01615198|12354320|FG001|Safety Set|Overall Study||292
11165610|NCT01615198|12354319|FG000|ABPM Dipper Status Subset|Overall Study||82
11165611|NCT01615198|12354320|FG001|ABPM Dipper Status Subset|Overall Study||84
11165612|NCT01615198|12354319|FG000|COMPLETED|Overall Study||272
11165613|NCT01615198|12354320|FG001|COMPLETED|Overall Study||273
11165614|NCT01615198|12354319|FG000|NOT COMPLETED|Overall Study||24
11165615|NCT01615198|12354320|FG001|NOT COMPLETED|Overall Study||19
11165616|NCT01615263|12354328|FG000|STARTED|Overall Study||20
11165617|NCT01615263|12354329|FG001|STARTED|Overall Study||20
11165618|NCT01615263|12354328|FG000|COMPLETED|Overall Study||20
11165619|NCT01615263|12354329|FG001|COMPLETED|Overall Study||18
11165620|NCT01615263|12354328|FG000|NOT COMPLETED|Overall Study||0
11165621|NCT01615263|12354329|FG001|NOT COMPLETED|Overall Study||2
11165622|NCT01615328|12354337|FG000|STARTED|Overall Study||42
11165623|NCT01615328|12354338|FG001|STARTED|Overall Study||43
11165624|NCT01615328|12354337|FG000|COMPLETED|Overall Study||39
11165625|NCT01615328|12354338|FG001|COMPLETED|Overall Study||38
11165626|NCT01615328|12354337|FG000|NOT COMPLETED|Overall Study||3
11165627|NCT01615328|12354338|FG001|NOT COMPLETED|Overall Study||5
11165628|NCT01615367|12354350|FG000|STARTED|Overall Study||19
11165629|NCT01615367|12354351|FG001|STARTED|Overall Study||19
11165630|NCT01615367|12354350|FG000|COMPLETED|Overall Study||14
11165631|NCT01615367|12354351|FG001|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
11165632|NCT01615367|12354350|FG000|NOT COMPLETED|Overall Study||5
11165633|NCT01615367|12354351|FG001|NOT COMPLETED|Overall Study||6
11165634|NCT01615484|12354359|FG000|STARTED|Overall Study||0
11165635|NCT01615484|12354360|FG001|STARTED|Overall Study||24
11165636|NCT01615484|12354359|FG000|COMPLETED|Overall Study||0
11165637|NCT01615484|12354360|FG001|COMPLETED|Overall Study||24
11165638|NCT01615484|12354359|FG000|NOT COMPLETED|Overall Study||0
11165639|NCT01615484|12354360|FG001|NOT COMPLETED|Overall Study||0
11165640|NCT01615731|12354368|FG000|STARTED|Overall Study||24
11165641|NCT01615731|12354369|FG001|STARTED|Overall Study||26
11165642|NCT01615731|12354368|FG000|COMPLETED|Overall Study||21
11165643|NCT01615731|12354369|FG001|COMPLETED|Overall Study||24
11165644|NCT01615731|12354368|FG000|NOT COMPLETED|Overall Study||3
11165645|NCT01615731|12354369|FG001|NOT COMPLETED|Overall Study||2
11165646|NCT01615809|12354375|FG000|STARTED|Overall Study|basal visit|32
11165647|NCT01615809|12354375|FG000|COMPLETED|Overall Study||22
11165648|NCT01615809|12354375|FG000|NOT COMPLETED|Overall Study||10
11165649|NCT01615822|12354382|FG000|STARTED|Period 1||8
11165650|NCT01615822|12354383|FG001|STARTED|Period 1||11
11165651|NCT01615822|12354384|FG002|STARTED|Period 1||6
11165652|NCT01615822|12354382|FG000|COMPLETED|Period 1||7
11165653|NCT01615822|12354383|FG001|COMPLETED|Period 1||9
11165654|NCT01615822|12354384|FG002|COMPLETED|Period 1||6
11165655|NCT01615822|12354382|FG000|NOT COMPLETED|Period 1||1
11165656|NCT01615822|12354383|FG001|NOT COMPLETED|Period 1||2
11165657|NCT01615822|12354384|FG002|NOT COMPLETED|Period 1||0
11165658|NCT01615822|12354382|FG000|STARTED|Period 2||7
11165659|NCT01615822|12354383|FG001|STARTED|Period 2||9
11165660|NCT01615822|12354384|FG002|STARTED|Period 2||6
11165661|NCT01615822|12354382|FG000|COMPLETED|Period 2||7
11165662|NCT01615822|12354383|FG001|COMPLETED|Period 2||8
11165663|NCT01615822|12354384|FG002|COMPLETED|Period 2||4
11165664|NCT01615822|12354382|FG000|NOT COMPLETED|Period 2||0
11165665|NCT01615822|12354383|FG001|NOT COMPLETED|Period 2||1
11165666|NCT01615822|12354384|FG002|NOT COMPLETED|Period 2||2
11165667|NCT01615939|12354397|FG000|STARTED|Overall Study||13
11165668|NCT01615939|12354398|FG001|STARTED|Overall Study||4
11165669|NCT01615939|12354397|FG000|COMPLETED|Overall Study||8
11165670|NCT01615939|12354398|FG001|COMPLETED|Overall Study||4
11165671|NCT01615939|12354397|FG000|NOT COMPLETED|Overall Study||5
11165672|NCT01615939|12354398|FG001|NOT COMPLETED|Overall Study||0
11165673|NCT01616056|12354404|FG000|STARTED|Overall Study||20
11165674|NCT01616056|12354404|FG000|COMPLETED|Overall Study||19
11165675|NCT01616056|12354404|FG000|NOT COMPLETED|Overall Study||1
11165676|NCT01616082|12354410|FG000|STARTED|Overall Study||19
11165677|NCT01616082|12354411|FG001|STARTED|Overall Study||20
11165678|NCT01616082|12354410|FG000|COMPLETED|Overall Study||19
11165679|NCT01616082|12354411|FG001|COMPLETED|Overall Study||18
11165680|NCT01616082|12354410|FG000|NOT COMPLETED|Overall Study||0
11165681|NCT01616082|12354411|FG001|NOT COMPLETED|Overall Study||2
11165682|NCT01616160|12354418|FG000|STARTED|Overall Study||11
11165683|NCT01616160|12354418|FG000|COMPLETED|Overall Study||9
11165684|NCT01616160|12354418|FG000|NOT COMPLETED|Overall Study||2
11165685|NCT01616173|12354425|FG000|STARTED|Overall Study||27
11165686|NCT01616173|12354426|FG001|STARTED|Overall Study||26
11165687|NCT01616173|12354427|FG002|STARTED|Overall Study||27
11165688|NCT01616173|12354425|FG000|COMPLETED|Overall Study||27
11165689|NCT01616173|12354426|FG001|COMPLETED|Overall Study||24
11165690|NCT01616173|12354427|FG002|COMPLETED|Overall Study||27
11165691|NCT01616173|12354425|FG000|NOT COMPLETED|Overall Study||0
11165692|NCT01616173|12354426|FG001|NOT COMPLETED|Overall Study||2
11165693|NCT01616173|12354427|FG002|NOT COMPLETED|Overall Study||0
11165694|NCT01616459|12354439|FG000|STARTED|Overall Study||240
11165695|NCT01616459|12354440|FG001|STARTED|Overall Study||240
11165696|NCT01616459|12354441|FG002|STARTED|Overall Study||230
11165697|NCT01616459|12354442|FG003|STARTED|Overall Study||241
11165698|NCT01616459|12354439|FG000|COMPLETED|Overall Study||236
11165699|NCT01616459|12354440|FG001|COMPLETED|Overall Study||223
11165700|NCT01616459|12354441|FG002|COMPLETED|Overall Study||220
11165701|NCT01616459|12354442|FG003|COMPLETED|Overall Study||233
11165702|NCT01616459|12354439|FG000|NOT COMPLETED|Overall Study||4
11165703|NCT01616459|12354440|FG001|NOT COMPLETED|Overall Study||17
11165704|NCT01616459|12354441|FG002|NOT COMPLETED|Overall Study||10
11165705|NCT01616459|12354442|FG003|NOT COMPLETED|Overall Study||8
11165706|NCT01616563|12354457|FG000|STARTED|Overall Study||293
11165707|NCT01616563|12354457|FG000|COMPLETED|Overall Study||253
11165708|NCT01616563|12354457|FG000|NOT COMPLETED|Overall Study||40
11165709|NCT01616576|12354464|FG000|STARTED|Overall Study||18
11165710|NCT01616576|12354465|FG001|STARTED|Overall Study||18
11165711|NCT01616576|12354464|FG000|COMPLETED|Overall Study||18
11165712|NCT01616576|12354465|FG001|COMPLETED|Overall Study||18
11165713|NCT01616576|12354464|FG000|NOT COMPLETED|Overall Study||0
11165714|NCT01616576|12354465|FG001|NOT COMPLETED|Overall Study||0
11165715|NCT01616654|12354479|FG000|STARTED|Overall Study||61
11165716|NCT01616654|12354480|FG001|STARTED|Overall Study||61
11165717|NCT01616654|12354481|FG002|STARTED|Overall Study||60
11165718|NCT01616654|12354482|FG003|STARTED|Overall Study||61
11165719|NCT01616654|12354483|FG004|STARTED|Overall Study||61
11165720|NCT01616654|12354479|FG000|COMPLETED|Overall Study||56
11165721|NCT01616654|12354480|FG001|COMPLETED|Overall Study||53
11165722|NCT01616654|12354481|FG002|COMPLETED|Overall Study||50
11165723|NCT01616654|12354482|FG003|COMPLETED|Overall Study||53
11165724|NCT01616654|12354483|FG004|COMPLETED|Overall Study||49
11165725|NCT01616654|12354479|FG000|NOT COMPLETED|Overall Study||5
11165726|NCT01616654|12354480|FG001|NOT COMPLETED|Overall Study||8
11165727|NCT01616654|12354481|FG002|NOT COMPLETED|Overall Study||10
11165728|NCT01616654|12354482|FG003|NOT COMPLETED|Overall Study||8
11165729|NCT01616654|12354483|FG004|NOT COMPLETED|Overall Study||12
11165730|NCT01616693|12354500|FG000|STARTED|Evaluated for Safety||155
11165731|NCT01616693|12354501|FG001|STARTED|Evaluated for Safety||155
11165732|NCT01616693|12354502|FG002|STARTED|Evaluated for Safety||155
11165733|NCT01616693|12354503|FG003|STARTED|Evaluated for Safety||155
11165734|NCT01616693|12354500|FG000|COMPLETED|Evaluated for Safety||154
11165735|NCT01616693|12354501|FG001|COMPLETED|Evaluated for Safety||155
11165736|NCT01616693|12354502|FG002|COMPLETED|Evaluated for Safety||154
11165737|NCT01616693|12354503|FG003|COMPLETED|Evaluated for Safety||155
11165738|NCT01616693|12354500|FG000|NOT COMPLETED|Evaluated for Safety||1
11165739|NCT01616693|12354501|FG001|NOT COMPLETED|Evaluated for Safety||0
11165740|NCT01616693|12354502|FG002|NOT COMPLETED|Evaluated for Safety||1
11165741|NCT01616693|12354503|FG003|NOT COMPLETED|Evaluated for Safety||0
11165742|NCT01616693|12354500|FG000|STARTED|Received Both Vaccines||154
11165743|NCT01616693|12354501|FG001|STARTED|Received Both Vaccines||155
11165744|NCT01616693|12354502|FG002|STARTED|Received Both Vaccines||154
11165745|NCT01616693|12354503|FG003|STARTED|Received Both Vaccines||155
11165746|NCT01616693|12354500|FG000|COMPLETED|Received Both Vaccines||141
11165747|NCT01616693|12354501|FG001|COMPLETED|Received Both Vaccines||145
11165748|NCT01616693|12354502|FG002|COMPLETED|Received Both Vaccines||142
11165749|NCT01616693|12354503|FG003|COMPLETED|Received Both Vaccines||136
11165750|NCT01616693|12354500|FG000|NOT COMPLETED|Received Both Vaccines||13
11165751|NCT01616693|12354501|FG001|NOT COMPLETED|Received Both Vaccines||10
11165752|NCT01616693|12354502|FG002|NOT COMPLETED|Received Both Vaccines||12
11165753|NCT01616693|12354503|FG003|NOT COMPLETED|Received Both Vaccines||19
11165754|NCT01616693|12354500|FG000|STARTED|Blood Analyzed for Immunogenicity||141
11165755|NCT01616693|12354501|FG001|STARTED|Blood Analyzed for Immunogenicity||145
11165756|NCT01616693|12354502|FG002|STARTED|Blood Analyzed for Immunogenicity||142
11165757|NCT01616693|12354503|FG003|STARTED|Blood Analyzed for Immunogenicity||136
11165758|NCT01616693|12354500|FG000|COMPLETED|Blood Analyzed for Immunogenicity||137
11165759|NCT01616693|12354501|FG001|COMPLETED|Blood Analyzed for Immunogenicity||143
11165760|NCT01616693|12354502|FG002|COMPLETED|Blood Analyzed for Immunogenicity||136
11165761|NCT01616693|12354503|FG003|COMPLETED|Blood Analyzed for Immunogenicity||135
11165762|NCT01616693|12354500|FG000|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
11165763|NCT01616693|12354501|FG001|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
11165764|NCT01616693|12354502|FG002|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
11165765|NCT01616693|12354503|FG003|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
11165766|NCT01616771|12354517|FG000|STARTED|Macintosh Laryngoscopy for 5 Sec||23
11165767|NCT01616771|12354517|FG000|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
11165768|NCT01616771|12354517|FG000|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
11165769|NCT01616771|12354517|FG000|STARTED|GVL Selected by Weight for 5 Sec||23
11165770|NCT01616771|12354517|FG000|COMPLETED|GVL Selected by Weight for 5 Sec||23
11165771|NCT01616771|12354517|FG000|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
11165772|NCT01616771|12354517|FG000|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
11165773|NCT01616771|12354517|FG000|COMPLETED|Smaller Sized GVL for 5 Sec||19
11165774|NCT01616771|12354517|FG000|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
11165775|NCT01616953|12354528|FG000|STARTED|Overall Study||10
11165776|NCT01616953|12354529|FG001|STARTED|Overall Study||8
11165777|NCT01616953|12354528|FG000|Implant Placement Surgery|Overall Study||9
11165778|NCT01616953|12354529|FG001|Implant Placement Surgery|Overall Study||8
11165779|NCT01616953|12354528|FG000|Implant Uncovery|Overall Study||8
11165780|NCT01616953|12354529|FG001|Implant Uncovery|Overall Study||8
11165781|NCT01616953|12354528|FG000|6 Months Post-loading|Overall Study||8
11165782|NCT01616953|12354529|FG001|6 Months Post-loading|Overall Study||8
11026787|NCT00830440|12205399|FG000|Received Device|Overall Study||26
11026788|NCT00830440|12205400|FG001|Received Device|Overall Study||0
11026789|NCT00830440|12205399|FG000|Completed 12 Week Follow up|Overall Study||24
11026790|NCT00830440|12205400|FG001|Completed 12 Week Follow up|Overall Study||11
11026791|NCT00830440|12205399|FG000|Completed 16 Week Follow up|Overall Study||4
11165783|NCT01616953|12354528|FG000|COMPLETED|Overall Study||8
11165784|NCT01616953|12354529|FG001|COMPLETED|Overall Study||8
11165785|NCT01616953|12354528|FG000|NOT COMPLETED|Overall Study||2
11165786|NCT01616953|12354529|FG001|NOT COMPLETED|Overall Study||0
11165787|NCT01617005|12354535|FG000|STARTED|Overall Study||50
11165788|NCT01617005|12354535|FG000|COMPLETED|Overall Study||48
11165789|NCT01617005|12354535|FG000|NOT COMPLETED|Overall Study||2
11165790|NCT01617070|12354539|FG000|STARTED|LNAA (4 Weeks)||10
11165791|NCT01617070|12354539|FG000|COMPLETED|LNAA (4 Weeks)||10
11165792|NCT01617070|12354539|FG000|NOT COMPLETED|LNAA (4 Weeks)||0
11165793|NCT01617070|12354539|FG000|STARTED|Washout (4 Weeks)||10
11165794|NCT01617070|12354539|FG000|COMPLETED|Washout (4 Weeks)||10
11165795|NCT01617070|12354539|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11165796|NCT01617070|12354539|FG000|STARTED|BH4 Therapy (4 Weeks)||10
11165797|NCT01617070|12354539|FG000|COMPLETED|BH4 Therapy (4 Weeks)||10
11165798|NCT01617070|12354539|FG000|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
11165799|NCT01617070|12354539|FG000|STARTED|BH4 and LNAA (4 Weeks)||10
11165800|NCT01617070|12354539|FG000|COMPLETED|BH4 and LNAA (4 Weeks)||9
11165801|NCT01617070|12354539|FG000|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
11165802|NCT01617083|12354552|FG000|STARTED|Overall Study||18
11165803|NCT01617083|12354553|FG001|STARTED|Overall Study||14
11165804|NCT01617083|12354554|FG002|STARTED|Overall Study||15
11165805|NCT01617083|12354552|FG000|COMPLETED|Overall Study||18
11165806|NCT01617083|12354553|FG001|COMPLETED|Overall Study||14
11165807|NCT01617083|12354554|FG002|COMPLETED|Overall Study||15
11323420|NCT03395340|12520693|FG000|STARTED|Overall Study||1
11323421|NCT03395340|12520693|FG000|COMPLETED|Overall Study||1
11323422|NCT03395340|12520693|FG000|NOT COMPLETED|Overall Study||0
11323423|NCT03380000|12520699|FG000|STARTED|First Intervention (1day)||8
11323424|NCT03380000|12520700|FG001|STARTED|First Intervention (1day)||8
11323425|NCT03380000|12520699|FG000|COMPLETED|First Intervention (1day)||8
11323426|NCT03380000|12520700|FG001|COMPLETED|First Intervention (1day)||8
11323427|NCT03380000|12520699|FG000|NOT COMPLETED|First Intervention (1day)||0
11323428|NCT03380000|12520700|FG001|NOT COMPLETED|First Intervention (1day)||0
11165808|NCT01617083|12354552|FG000|NOT COMPLETED|Overall Study||0
11165809|NCT01617083|12354553|FG001|NOT COMPLETED|Overall Study||0
11165810|NCT01617083|12354554|FG002|NOT COMPLETED|Overall Study||0
11165811|NCT01617148|12354561|FG000|STARTED|Overall Study||26
11165812|NCT01617148|12354561|FG000|COMPLETED|Overall Study||26
11165813|NCT01617148|12354561|FG000|NOT COMPLETED|Overall Study||0
11165814|NCT01617369|12354566|FG000|STARTED|Overall Study||12
11165815|NCT01617369|12354566|FG000|COMPLETED|Overall Study||12
11165816|NCT01617369|12354566|FG000|NOT COMPLETED|Overall Study||0
11165817|NCT01617421|12354572|FG000|STARTED|Overall Study||18
11165818|NCT01617421|12354572|FG000|COMPLETED|Overall Study||12
11165819|NCT01617421|12354572|FG000|NOT COMPLETED|Overall Study||6
11165820|NCT01617434|12354578|FG000|STARTED|Overall Study||226
11165821|NCT01617434|12354579|FG001|STARTED|Overall Study||225
11165822|NCT01617434|12354578|FG000|Exposed|Overall Study||225
11165823|NCT01617434|12354579|FG001|Exposed|Overall Study||225
11165824|NCT01617434|12354578|FG000|COMPLETED|Overall Study||191
11165825|NCT01617434|12354579|FG001|COMPLETED|Overall Study||174
11165826|NCT01617434|12354578|FG000|NOT COMPLETED|Overall Study||35
11165827|NCT01617434|12354579|FG001|NOT COMPLETED|Overall Study||51
11165828|NCT01617447|12354587|FG000|STARTED|Overall Study||47
11165829|NCT01617447|12354588|FG001|STARTED|Overall Study||45
11165830|NCT01617447|12354587|FG000|COMPLETED|Overall Study||47
11165831|NCT01617447|12354588|FG001|COMPLETED|Overall Study||42
11165832|NCT01617447|12354587|FG000|NOT COMPLETED|Overall Study||0
11165833|NCT01617447|12354588|FG001|NOT COMPLETED|Overall Study||3
11165834|NCT01617460|12354594|FG000|STARTED|Overall Study||86
11165835|NCT01617460|12354594|FG000|COMPLETED|Overall Study||46
11165836|NCT01617460|12354594|FG000|NOT COMPLETED|Overall Study||40
11165837|NCT01617577|12354600|FG000|STARTED|Overall Study||5
11165838|NCT01617577|12354601|FG001|STARTED|Overall Study||3
11165839|NCT01617577|12354600|FG000|COMPLETED|Overall Study||5
11165840|NCT01617577|12354601|FG001|COMPLETED|Overall Study||3
11165841|NCT01617577|12354600|FG000|NOT COMPLETED|Overall Study||0
11165842|NCT01617577|12354601|FG001|NOT COMPLETED|Overall Study||0
11165843|NCT01617603|12354611|FG000|STARTED|Overall Study||20
11165844|NCT01617603|12354612|FG001|STARTED|Overall Study||21
11165845|NCT01617603|12354613|FG002|STARTED|Overall Study||21
11165846|NCT01617603|12354611|FG000|COMPLETED|Overall Study||17
11165847|NCT01617603|12354612|FG001|COMPLETED|Overall Study||19
11165848|NCT01617603|12354613|FG002|COMPLETED|Overall Study||20
11165849|NCT01617603|12354611|FG000|NOT COMPLETED|Overall Study||3
11165850|NCT01617603|12354612|FG001|NOT COMPLETED|Overall Study||2
11165851|NCT01617603|12354613|FG002|NOT COMPLETED|Overall Study||1
11165852|NCT01617629|12354621|FG000|STARTED|Overall Study||9
11165853|NCT01617629|12354621|FG000|COMPLETED|Overall Study||3
11165854|NCT01617629|12354621|FG000|NOT COMPLETED|Overall Study||6
11165855|NCT01617655|12354627|FG000|STARTED|Overall Study|Randomized|35
11165856|NCT01617655|12354628|FG001|STARTED|Overall Study|Randomized|72
11165857|NCT01617655|12354627|FG000|Treated|Overall Study||35
11165858|NCT01617655|12354628|FG001|Treated|Overall Study||72
11165859|NCT01617655|12354627|FG000|COMPLETED|Overall Study||26
11165860|NCT01617655|12354628|FG001|COMPLETED|Overall Study||43
11165861|NCT01617655|12354627|FG000|NOT COMPLETED|Overall Study||9
11165862|NCT01617655|12354628|FG001|NOT COMPLETED|Overall Study||29
11165863|NCT01617668|12354638|FG000|STARTED|Overall Study||51
11165864|NCT01617668|12354639|FG001|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
11165865|NCT01617668|12354640|FG002|STARTED|Overall Study||55
11165866|NCT01617668|12354641|FG003|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
11165867|NCT01617668|12354638|FG000|Randomized Patients|Overall Study||51
11165868|NCT01617668|12354639|FG001|Randomized Patients|Overall Study||54
11165869|NCT01617668|12354640|FG002|Randomized Patients|Overall Study||55
11165870|NCT01617668|12354641|FG003|Randomized Patients|Overall Study||55
11165871|NCT01617668|12354638|FG000|COMPLETED|Overall Study||38
11165872|NCT01617668|12354639|FG001|COMPLETED|Overall Study||41
11165873|NCT01617668|12354640|FG002|COMPLETED|Overall Study||32
11165874|NCT01617668|12354641|FG003|COMPLETED|Overall Study||38
11165875|NCT01617668|12354638|FG000|NOT COMPLETED|Overall Study||13
11165876|NCT01617668|12354639|FG001|NOT COMPLETED|Overall Study||9
11165877|NCT01617668|12354640|FG002|NOT COMPLETED|Overall Study||23
11165878|NCT01617668|12354641|FG003|NOT COMPLETED|Overall Study||15
11165879|NCT01617681|12354659|FG000|STARTED|Period 1 Double Blind||32
11165880|NCT01617681|12354660|FG001|STARTED|Period 1 Double Blind||31
11165881|NCT01617681|12354661|FG002|STARTED|Period 1 Double Blind||33
11165882|NCT01617681|12354662|FG003|STARTED|Period 1 Double Blind||31
11165883|NCT01617681|12354663|FG004|STARTED|Period 1 Double Blind||0
11165884|NCT01617681|12354659|FG000|Full Analysis Set (FAS)|Period 1 Double Blind||31
11165885|NCT01617681|12354660|FG001|Full Analysis Set (FAS)|Period 1 Double Blind||31
11165886|NCT01617681|12354661|FG002|Full Analysis Set (FAS)|Period 1 Double Blind||33
11165887|NCT01617681|12354662|FG003|Full Analysis Set (FAS)|Period 1 Double Blind||31
11165888|NCT01617681|12354663|FG004|Full Analysis Set (FAS)|Period 1 Double Blind||0
11165889|NCT01617681|12354659|FG000|COMPLETED|Period 1 Double Blind||29
11165890|NCT01617681|12354660|FG001|COMPLETED|Period 1 Double Blind||30
11165891|NCT01617681|12354661|FG002|COMPLETED|Period 1 Double Blind||32
11165892|NCT01617681|12354662|FG003|COMPLETED|Period 1 Double Blind||29
11165893|NCT01617681|12354663|FG004|COMPLETED|Period 1 Double Blind||0
11165894|NCT01617681|12354659|FG000|NOT COMPLETED|Period 1 Double Blind||3
11165895|NCT01617681|12354660|FG001|NOT COMPLETED|Period 1 Double Blind||1
11165896|NCT01617681|12354661|FG002|NOT COMPLETED|Period 1 Double Blind||1
11165897|NCT01617681|12354662|FG003|NOT COMPLETED|Period 1 Double Blind||2
11165898|NCT01617681|12354663|FG004|NOT COMPLETED|Period 1 Double Blind||0
11165899|NCT01617681|12354659|FG000|STARTED|Period 2 Open Label||0
11165900|NCT01617681|12354660|FG001|STARTED|Period 2 Open Label||0
11165901|NCT01617681|12354661|FG002|STARTED|Period 2 Open Label||0
11165902|NCT01617681|12354662|FG003|STARTED|Period 2 Open Label||0
11165903|NCT01617681|12354663|FG004|STARTED|Period 2 Open Label||120
11165904|NCT01617681|12354659|FG000|COMPLETED|Period 2 Open Label||0
11165905|NCT01617681|12354660|FG001|COMPLETED|Period 2 Open Label||0
11165906|NCT01617681|12354661|FG002|COMPLETED|Period 2 Open Label||0
11165907|NCT01617681|12354662|FG003|COMPLETED|Period 2 Open Label||0
11165908|NCT01617681|12354663|FG004|COMPLETED|Period 2 Open Label||114
11165909|NCT01617681|12354659|FG000|NOT COMPLETED|Period 2 Open Label||0
11165910|NCT01617681|12354660|FG001|NOT COMPLETED|Period 2 Open Label||0
11165911|NCT01617681|12354661|FG002|NOT COMPLETED|Period 2 Open Label||0
11165912|NCT01617681|12354662|FG003|NOT COMPLETED|Period 2 Open Label||0
11165913|NCT01617681|12354663|FG004|NOT COMPLETED|Period 2 Open Label||6
11165914|NCT01617967|12354678|FG000|STARTED|Overall Study||4
11165915|NCT01617967|12354679|FG001|STARTED|Overall Study||3
11165916|NCT01617967|12354680|FG002|STARTED|Overall Study||3
11165917|NCT01617967|12354681|FG003|STARTED|Overall Study||7
11165918|NCT01617967|12354682|FG004|STARTED|Overall Study||3
11165919|NCT01617967|12354683|FG005|STARTED|Overall Study||9
11165920|NCT01617967|12354678|FG000|COMPLETED|Overall Study||3
11165921|NCT01617967|12354679|FG001|COMPLETED|Overall Study||3
11165922|NCT01617967|12354680|FG002|COMPLETED|Overall Study||3
11165923|NCT01617967|12354681|FG003|COMPLETED|Overall Study||6
11165924|NCT01617967|12354682|FG004|COMPLETED|Overall Study||3
11165925|NCT01617967|12354683|FG005|COMPLETED|Overall Study||8
11165926|NCT01617967|12354678|FG000|NOT COMPLETED|Overall Study||1
11165927|NCT01617967|12354679|FG001|NOT COMPLETED|Overall Study||0
11165928|NCT01617967|12354680|FG002|NOT COMPLETED|Overall Study||0
11165929|NCT01617967|12354681|FG003|NOT COMPLETED|Overall Study||1
11165930|NCT01617967|12354682|FG004|NOT COMPLETED|Overall Study||0
11165931|NCT01617967|12354683|FG005|NOT COMPLETED|Overall Study||1
11165932|NCT01618019|12354700|FG000|STARTED|Overall Study||55
11165933|NCT01618019|12354701|FG001|STARTED|Overall Study||54
11165934|NCT01618019|12354700|FG000|COMPLETED|Overall Study||41
11165935|NCT01618019|12354701|FG001|COMPLETED|Overall Study||40
11165936|NCT01618019|12354700|FG000|NOT COMPLETED|Overall Study||14
11165937|NCT01618019|12354701|FG001|NOT COMPLETED|Overall Study||14
11165938|NCT01618162|12354709|FG000|STARTED|Overall Study||289
11165939|NCT01618162|12354710|FG001|STARTED|Overall Study||146
11165940|NCT01618162|12354709|FG000|Exposed|Overall Study||288
11165941|NCT01618162|12354710|FG001|Exposed|Overall Study||146
11165942|NCT01618162|12354709|FG000|COMPLETED|Overall Study||251
11165943|NCT01618162|12354710|FG001|COMPLETED|Overall Study||111
11165944|NCT01618162|12354709|FG000|NOT COMPLETED|Overall Study||38
11165945|NCT01618162|12354710|FG001|NOT COMPLETED|Overall Study||35
11165946|NCT01618214|12354718|FG000|STARTED|Overall Study||172
11165947|NCT01618214|12354719|FG001|STARTED|Overall Study||172
11165948|NCT01618214|12354718|FG000|Exposed|Overall Study||172
11165949|NCT01618214|12354719|FG001|Exposed|Overall Study||172
11165950|NCT01618214|12354718|FG000|COMPLETED|Overall Study||162
11165951|NCT01618214|12354719|FG001|COMPLETED|Overall Study||159
11165952|NCT01618214|12354718|FG000|NOT COMPLETED|Overall Study||10
11165953|NCT01618214|12354719|FG001|NOT COMPLETED|Overall Study||13
11165954|NCT01618227|12354727|FG000|STARTED|Overall Study||2
11165955|NCT01618227|12354728|FG001|STARTED|Overall Study||2
11165956|NCT01618227|12354727|FG000|COMPLETED|Overall Study||2
11165957|NCT01618227|12354728|FG001|COMPLETED|Overall Study||0
11165958|NCT01618227|12354727|FG000|NOT COMPLETED|Overall Study||0
11165959|NCT01618227|12354728|FG001|NOT COMPLETED|Overall Study||2
11165960|NCT01618240|12354734|FG000|STARTED|Overall Study||30
11165961|NCT01618240|12354734|FG000|COMPLETED|Overall Study||30
11165962|NCT01618240|12354734|FG000|NOT COMPLETED|Overall Study||0
11165963|NCT01618266|12354738|FG000|STARTED|Overall Study||375
11165964|NCT01618266|12354738|FG000|COMPLETED|Overall Study||279
11165965|NCT01618266|12354738|FG000|NOT COMPLETED|Overall Study||96
11165966|NCT01618305|12354744|FG000|STARTED|Overall Study||202
11165967|NCT01618305|12354745|FG001|STARTED|Overall Study||206
11165968|NCT01618305|12354744|FG000|COMPLETED|Overall Study||187
11165969|NCT01618305|12354745|FG001|COMPLETED|Overall Study||196
11165970|NCT01618305|12354744|FG000|NOT COMPLETED|Overall Study||15
11165971|NCT01618305|12354745|FG001|NOT COMPLETED|Overall Study||10
11165972|NCT01618344|12354755|FG000|STARTED|Overall Study||32
11165973|NCT01618344|12354755|FG000|COMPLETED|Overall Study||23
11165974|NCT01618344|12354755|FG000|NOT COMPLETED|Overall Study||9
11165975|NCT01618422|12354761|FG000|STARTED|Overall Study||114
11165976|NCT01618422|12354762|FG001|STARTED|Overall Study||111
11165977|NCT01618422|12354761|FG000|COMPLETED|Overall Study||114
11165978|NCT01618422|12354762|FG001|COMPLETED|Overall Study||111
11165979|NCT01618422|12354761|FG000|NOT COMPLETED|Overall Study||0
11165980|NCT01618422|12354762|FG001|NOT COMPLETED|Overall Study||0
11165981|NCT01618669|12354770|FG000|STARTED|Overall Study||578
11165982|NCT01618669|12354771|FG001|STARTED|Overall Study||569
11165983|NCT01618669|12354770|FG000|Received Treatment|Overall Study||575
11165984|NCT01618669|12354771|FG001|Received Treatment|Overall Study||567
11165985|NCT01618669|12354770|FG000|COMPLETED|Overall Study||544
11165986|NCT01618669|12354771|FG001|COMPLETED|Overall Study||546
11165987|NCT01618669|12354770|FG000|NOT COMPLETED|Overall Study||34
11165988|NCT01618669|12354771|FG001|NOT COMPLETED|Overall Study||23
11165989|NCT01618695|12354793|FG000|STARTED|Core Phase||177
11165990|NCT01618695|12354794|FG001|STARTED|Core Phase||176
11165991|NCT01618695|12354795|FG002|STARTED|Core Phase||177
11165992|NCT01618695|12354796|FG003|STARTED|Core Phase||180
11165993|NCT01618695|12354793|FG000|Treated (Safety Analysis Set)|Core Phase||176
11165994|NCT01618695|12354794|FG001|Treated (Safety Analysis Set)|Core Phase||176
11165995|NCT01618695|12354795|FG002|Treated (Safety Analysis Set)|Core Phase||175
11165996|NCT01618695|12354796|FG003|Treated (Safety Analysis Set)|Core Phase||180
11165997|NCT01618695|12354793|FG000|COMPLETED|Core Phase||152
11165998|NCT01618695|12354794|FG001|COMPLETED|Core Phase||156
11165999|NCT01618695|12354795|FG002|COMPLETED|Core Phase||147
11166000|NCT01618695|12354796|FG003|COMPLETED|Core Phase||144
11166001|NCT01618695|12354793|FG000|NOT COMPLETED|Core Phase||25
11166002|NCT01618695|12354794|FG001|NOT COMPLETED|Core Phase||20
11166003|NCT01618695|12354795|FG002|NOT COMPLETED|Core Phase||30
11166004|NCT01618695|12354796|FG003|NOT COMPLETED|Core Phase||36
11166005|NCT01618695|12354793|FG000|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|151
11166006|NCT01618695|12354794|FG001|STARTED|Extension Phase||156
11166007|NCT01618695|12354795|FG002|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|146
11166008|NCT01618695|12354796|FG003|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|143
11166009|NCT01618695|12354793|FG000|COMPLETED|Extension Phase||56
11166010|NCT01618695|12354794|FG001|COMPLETED|Extension Phase||40
11166011|NCT01618695|12354795|FG002|COMPLETED|Extension Phase||54
11166012|NCT01618695|12354796|FG003|COMPLETED|Extension Phase||46
11166013|NCT01618695|12354793|FG000|NOT COMPLETED|Extension Phase||95
11166014|NCT01618695|12354794|FG001|NOT COMPLETED|Extension Phase||116
11166015|NCT01618695|12354795|FG002|NOT COMPLETED|Extension Phase||92
11166016|NCT01618695|12354796|FG003|NOT COMPLETED|Extension Phase||97
11166017|NCT01618708|12354809|FG000|STARTED|Overall Study||175
11166018|NCT01618708|12354810|FG001|STARTED|Overall Study||182
11166019|NCT01618708|12354809|FG000|Treated|Overall Study||172
11166020|NCT01618708|12354810|FG001|Treated|Overall Study||180
11166021|NCT01618708|12354809|FG000|COMPLETED|Overall Study||131
11166022|NCT01618708|12354810|FG001|COMPLETED|Overall Study||136
11166023|NCT01618708|12354809|FG000|NOT COMPLETED|Overall Study||44
11166024|NCT01618708|12354810|FG001|NOT COMPLETED|Overall Study||46
11166025|NCT01618838|12354817|FG000|STARTED|Overall Study||4
11166026|NCT01618838|12354817|FG000|COMPLETED|Overall Study||0
11166027|NCT01618838|12354817|FG000|NOT COMPLETED|Overall Study||4
11166028|NCT01618864|12354822|FG000|STARTED|Overall Study||23
11166029|NCT01618864|12354822|FG000|Completed 2 Weeks|Overall Study||19
11166030|NCT01618864|12354822|FG000|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
11166031|NCT01618864|12354822|FG000|NOT COMPLETED|Overall Study||4
11166032|NCT01618916|12354837|FG000|STARTED|Overall Study||12
11166033|NCT01618916|12354838|FG001|STARTED|Overall Study||10
11166034|NCT01618916|12354839|FG002|STARTED|Overall Study||11
11166035|NCT01618916|12354840|FG003|STARTED|Overall Study||9
11166036|NCT01618916|12354841|FG004|STARTED|Overall Study||5
11166037|NCT01618916|12354842|FG005|STARTED|Overall Study||4
11166038|NCT01618916|12354837|FG000|Received At Least 1 Dose of Study Drug|Overall Study||12
11166039|NCT01618916|12354838|FG001|Received At Least 1 Dose of Study Drug|Overall Study||10
11166040|NCT01618916|12354839|FG002|Received At Least 1 Dose of Study Drug|Overall Study||11
11166041|NCT01618916|12354840|FG003|Received At Least 1 Dose of Study Drug|Overall Study||9
11166042|NCT01618916|12354841|FG004|Received At Least 1 Dose of Study Drug|Overall Study||5
11166043|NCT01618916|12354842|FG005|Received At Least 1 Dose of Study Drug|Overall Study||4
11166044|NCT01618916|12354837|FG000|COMPLETED|Overall Study||10
11166045|NCT01618916|12354838|FG001|COMPLETED|Overall Study||9
11166046|NCT01618916|12354839|FG002|COMPLETED|Overall Study||10
11166047|NCT01618916|12354840|FG003|COMPLETED|Overall Study||7
11166048|NCT01618916|12354841|FG004|COMPLETED|Overall Study||4
11166049|NCT01618916|12354842|FG005|COMPLETED|Overall Study||4
11166050|NCT01618916|12354837|FG000|NOT COMPLETED|Overall Study||2
11166051|NCT01618916|12354838|FG001|NOT COMPLETED|Overall Study||1
11166052|NCT01618916|12354839|FG002|NOT COMPLETED|Overall Study||1
11166053|NCT01618916|12354840|FG003|NOT COMPLETED|Overall Study||2
11166054|NCT01618916|12354841|FG004|NOT COMPLETED|Overall Study||1
11323429|NCT03380000|12520699|FG000|STARTED|Washout (>7days)||8
11323430|NCT03380000|12520700|FG001|STARTED|Washout (>7days)||8
11323431|NCT03380000|12520699|FG000|COMPLETED|Washout (>7days)||8
11323432|NCT03380000|12520700|FG001|COMPLETED|Washout (>7days)||8
11323433|NCT03380000|12520699|FG000|NOT COMPLETED|Washout (>7days)||0
11323434|NCT03380000|12520700|FG001|NOT COMPLETED|Washout (>7days)||0
11323435|NCT03380000|12520699|FG000|STARTED|Second Intervention (1day)||8
11323436|NCT03380000|12520700|FG001|STARTED|Second Intervention (1day)||8
11323437|NCT03380000|12520699|FG000|COMPLETED|Second Intervention (1day)||8
11323438|NCT03380000|12520700|FG001|COMPLETED|Second Intervention (1day)||8
11323439|NCT03380000|12520699|FG000|NOT COMPLETED|Second Intervention (1day)||0
11323440|NCT03380000|12520700|FG001|NOT COMPLETED|Second Intervention (1day)||0
11323441|NCT03368664|12520706|FG000|STARTED|Phase1: Prior DMT:Month -4 to Month 0||16
11323442|NCT03368664|12520706|FG000|COMPLETED|Phase1: Prior DMT:Month -4 to Month 0||12
11323443|NCT03368664|12520706|FG000|NOT COMPLETED|Phase1: Prior DMT:Month -4 to Month 0||4
11323444|NCT03368664|12520706|FG000|STARTED|Phase2:AlemtuzumabTreatment:Month 0 to 8|Out of 12 participants who had completed Phase 1, one participant did not enter Phase 2.|11
11343132|NCT02951273|12540464|FG000|NOT COMPLETED|Overall Study||3
11166055|NCT01618916|12354842|FG005|NOT COMPLETED|Overall Study||0
11166056|NCT01618942|12354857|FG000|STARTED|Overall Study||50
11166057|NCT01618942|12354858|FG001|STARTED|Overall Study||50
11166058|NCT01618942|12354857|FG000|COMPLETED|Overall Study||50
11166059|NCT01618942|12354858|FG001|COMPLETED|Overall Study||50
11166060|NCT01618942|12354857|FG000|NOT COMPLETED|Overall Study||0
11166061|NCT01618942|12354858|FG001|NOT COMPLETED|Overall Study||0
11166062|NCT01618955|12354868|FG000|STARTED|Overall Study||20
11166063|NCT01618955|12354869|FG001|STARTED|Overall Study||30
11166064|NCT01618955|12354870|FG002|STARTED|Overall Study||31
11166065|NCT01618955|12354871|FG003|STARTED|Overall Study||20
11166066|NCT01618955|12354868|FG000|COMPLETED|Overall Study||20
11166067|NCT01618955|12354869|FG001|COMPLETED|Overall Study||30
11166068|NCT01618955|12354870|FG002|COMPLETED|Overall Study||31
11166069|NCT01618955|12354871|FG003|COMPLETED|Overall Study||20
11166070|NCT01618955|12354868|FG000|NOT COMPLETED|Overall Study||0
11166071|NCT01618955|12354869|FG001|NOT COMPLETED|Overall Study||0
11166072|NCT01618955|12354870|FG002|NOT COMPLETED|Overall Study||0
11166073|NCT01618955|12354871|FG003|NOT COMPLETED|Overall Study||0
11166074|NCT01618968|12354885|FG000|STARTED|Overall Study||13
11166075|NCT01618968|12354886|FG001|STARTED|Overall Study||12
11166076|NCT01618968|12354887|FG002|STARTED|Overall Study||12
11166077|NCT01618968|12354888|FG003|STARTED|Overall Study||12
11166078|NCT01618968|12354885|FG000|Received Treatment A|Overall Study||12
11166079|NCT01618968|12354886|FG001|Received Treatment A|Overall Study||12
11166080|NCT01618968|12354887|FG002|Received Treatment A|Overall Study||12
11166081|NCT01618968|12354888|FG003|Received Treatment A|Overall Study||11
11166082|NCT01618968|12354885|FG000|Received Treatment B|Overall Study||13
11166083|NCT01618968|12354886|FG001|Received Treatment B|Overall Study||12
11166084|NCT01618968|12354887|FG002|Received Treatment B|Overall Study||12
11166085|NCT01618968|12354888|FG003|Received Treatment B|Overall Study||12
11166086|NCT01618968|12354885|FG000|Received Treatment C|Overall Study||12
11166087|NCT01618968|12354886|FG001|Received Treatment C|Overall Study||12
11166088|NCT01618968|12354887|FG002|Received Treatment C|Overall Study||12
11166089|NCT01618968|12354888|FG003|Received Treatment C|Overall Study||11
11166090|NCT01618968|12354885|FG000|COMPLETED|Overall Study||12
11166091|NCT01618968|12354886|FG001|COMPLETED|Overall Study||12
11166092|NCT01618968|12354887|FG002|COMPLETED|Overall Study||12
11166093|NCT01618968|12354888|FG003|COMPLETED|Overall Study||11
11166094|NCT01618968|12354885|FG000|NOT COMPLETED|Overall Study||1
11166095|NCT01618968|12354886|FG001|NOT COMPLETED|Overall Study||0
11166096|NCT01618968|12354887|FG002|NOT COMPLETED|Overall Study||0
11166097|NCT01618968|12354888|FG003|NOT COMPLETED|Overall Study||1
11166098|NCT01619059|12354899|FG000|STARTED|Short-Term (ST) Treatment Period||162
11166099|NCT01619059|12354900|FG001|STARTED|Short-Term (ST) Treatment Period||153
11166100|NCT01619059|12354899|FG000|COMPLETED|Short-Term (ST) Treatment Period||156
11166101|NCT01619059|12354900|FG001|COMPLETED|Short-Term (ST) Treatment Period||142
11166102|NCT01619059|12354899|FG000|NOT COMPLETED|Short-Term (ST) Treatment Period||6
11166103|NCT01619059|12354900|FG001|NOT COMPLETED|Short-Term (ST) Treatment Period||11
11166104|NCT01619059|12354899|FG000|STARTED|Long-Term (LT) Treatment Period||155
11166105|NCT01619059|12354900|FG001|STARTED|Long-Term (LT) Treatment Period||142
11166106|NCT01619059|12354899|FG000|COMPLETED|Long-Term (LT) Treatment Period||147
11166107|NCT01619059|12354900|FG001|COMPLETED|Long-Term (LT) Treatment Period||133
11166108|NCT01619059|12354899|FG000|NOT COMPLETED|Long-Term (LT) Treatment Period||8
11166109|NCT01619059|12354900|FG001|NOT COMPLETED|Long-Term (LT) Treatment Period||9
11166110|NCT01619410|12354908|FG000|STARTED|Overall Study||14
11166111|NCT01619410|12354909|FG001|STARTED|Overall Study||11
11166112|NCT01619410|12354908|FG000|COMPLETED|Overall Study||7
11166113|NCT01619410|12354909|FG001|COMPLETED|Overall Study||7
11166114|NCT01619410|12354908|FG000|NOT COMPLETED|Overall Study||7
11166115|NCT01619410|12354909|FG001|NOT COMPLETED|Overall Study||4
11166116|NCT01619423|12354919|FG000|STARTED|Part 1 (Dose Escalation)||0
11166117|NCT01619423|12354920|FG001|STARTED|Part 1 (Dose Escalation)||5
11166118|NCT01619423|12354921|FG002|STARTED|Part 1 (Dose Escalation)||3
11166119|NCT01619423|12354922|FG003|STARTED|Part 1 (Dose Escalation)||5
11166120|NCT01619423|12354919|FG000|COMPLETED|Part 1 (Dose Escalation)||0
11166121|NCT01619423|12354920|FG001|COMPLETED|Part 1 (Dose Escalation)||3
11166122|NCT01619423|12354921|FG002|COMPLETED|Part 1 (Dose Escalation)||3
11166123|NCT01619423|12354922|FG003|COMPLETED|Part 1 (Dose Escalation)||5
11166124|NCT01619423|12354919|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||0
11166125|NCT01619423|12354920|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||2
11166126|NCT01619423|12354921|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||0
11166127|NCT01619423|12354922|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||0
11166128|NCT01619423|12354919|FG000|STARTED|Part 2a||15
11166129|NCT01619423|12354920|FG001|STARTED|Part 2a||13
11166130|NCT01619423|12354921|FG002|STARTED|Part 2a||0
11166131|NCT01619423|12354922|FG003|STARTED|Part 2a||11
11166132|NCT01619423|12354919|FG000|COMPLETED|Part 2a||15
11166133|NCT01619423|12354920|FG001|COMPLETED|Part 2a||13
11166134|NCT01619423|12354921|FG002|COMPLETED|Part 2a||0
11166135|NCT01619423|12354922|FG003|COMPLETED|Part 2a||11
11166136|NCT01619423|12354919|FG000|NOT COMPLETED|Part 2a||0
11166137|NCT01619423|12354920|FG001|NOT COMPLETED|Part 2a||0
11166138|NCT01619423|12354921|FG002|NOT COMPLETED|Part 2a||0
11166139|NCT01619423|12354922|FG003|NOT COMPLETED|Part 2a||0
11166140|NCT01619423|12354919|FG000|STARTED|Part 2b||45
11166141|NCT01619423|12354920|FG001|STARTED|Part 2b||44
11166142|NCT01619423|12354921|FG002|STARTED|Part 2b||45
11166143|NCT01619423|12354922|FG003|STARTED|Part 2b||0
11166144|NCT01619423|12354919|FG000|COMPLETED|Part 2b||45
11166145|NCT01619423|12354920|FG001|COMPLETED|Part 2b||44
11166146|NCT01619423|12354921|FG002|COMPLETED|Part 2b||45
11166147|NCT01619423|12354922|FG003|COMPLETED|Part 2b||0
11166148|NCT01619423|12354919|FG000|NOT COMPLETED|Part 2b||0
11166149|NCT01619423|12354920|FG001|NOT COMPLETED|Part 2b||0
11166150|NCT01619423|12354921|FG002|NOT COMPLETED|Part 2b||0
11166151|NCT01619423|12354922|FG003|NOT COMPLETED|Part 2b||0
11166152|NCT01619579|12354935|FG000|STARTED|Overall Study||5
11166153|NCT01619579|12354936|FG001|STARTED|Overall Study||17
11166154|NCT01619579|12354935|FG000|COMPLETED|Overall Study||5
11166155|NCT01619579|12354936|FG001|COMPLETED|Overall Study||14
11166156|NCT01619579|12354935|FG000|NOT COMPLETED|Overall Study||0
11166157|NCT01619579|12354936|FG001|NOT COMPLETED|Overall Study||3
11166158|NCT01619774|12354942|FG000|STARTED|Overall Study||23
11166159|NCT01619774|12354942|FG000|COMPLETED|Overall Study||23
11166160|NCT01619774|12354942|FG000|NOT COMPLETED|Overall Study||0
11166161|NCT01619787|12354948|FG000|STARTED|Overall Study||217
11166162|NCT01619787|12354948|FG000|COMPLETED|Overall Study||212
11166163|NCT01619787|12354948|FG000|NOT COMPLETED|Overall Study||5
11166164|NCT01619839|12354959|FG000|STARTED|Overall Study||48
11166165|NCT01619839|12354960|FG001|STARTED|Overall Study||31
11166166|NCT01619839|12354961|FG002|STARTED|Overall Study||18
11166167|NCT01619839|12354962|FG003|STARTED|Overall Study||10
11166168|NCT01619839|12354963|FG004|STARTED|Overall Study||106
11166169|NCT01619839|12354959|FG000|COMPLETED|Overall Study||43
11166170|NCT01619839|12354960|FG001|COMPLETED|Overall Study||27
11166171|NCT01619839|12354961|FG002|COMPLETED|Overall Study||17
11166172|NCT01619839|12354962|FG003|COMPLETED|Overall Study||9
11166173|NCT01619839|12354963|FG004|COMPLETED|Overall Study||97
11166174|NCT01619839|12354959|FG000|NOT COMPLETED|Overall Study||5
11166175|NCT01619839|12354960|FG001|NOT COMPLETED|Overall Study||4
11166176|NCT01619839|12354961|FG002|NOT COMPLETED|Overall Study||1
11166177|NCT01619839|12354962|FG003|NOT COMPLETED|Overall Study||1
11166178|NCT01619839|12354963|FG004|NOT COMPLETED|Overall Study||9
11166179|NCT01619852|12354974|FG000|STARTED|24 Hour Assessment||75
11166180|NCT01619852|12354975|FG001|STARTED|24 Hour Assessment||75
11166181|NCT01619852|12354974|FG000|COMPLETED|24 Hour Assessment||74
11166182|NCT01619852|12354975|FG001|COMPLETED|24 Hour Assessment||74
11166183|NCT01619852|12354974|FG000|NOT COMPLETED|24 Hour Assessment||1
11166184|NCT01619852|12354975|FG001|NOT COMPLETED|24 Hour Assessment||1
11166185|NCT01619852|12354974|FG000|STARTED|3 Month Follow up||74
11166186|NCT01619852|12354975|FG001|STARTED|3 Month Follow up||74
11166187|NCT01619852|12354974|FG000|COMPLETED|3 Month Follow up||43
11166188|NCT01619852|12354975|FG001|COMPLETED|3 Month Follow up||40
11166189|NCT01619852|12354974|FG000|NOT COMPLETED|3 Month Follow up||31
11166190|NCT01619852|12354975|FG001|NOT COMPLETED|3 Month Follow up||34
11166191|NCT01619865|12354982|FG000|STARTED|Overall Study||223
11166192|NCT01619865|12354982|FG000|COMPLETED|Overall Study||219
11166193|NCT01619865|12354982|FG000|NOT COMPLETED|Overall Study||4
11166194|NCT01619878|12354987|FG000|STARTED|6 Week Follow-up Phase||20
11166195|NCT01619878|12354987|FG000|COMPLETED|6 Week Follow-up Phase||19
11166196|NCT01619878|12354987|FG000|NOT COMPLETED|6 Week Follow-up Phase||1
11166197|NCT01619878|12354987|FG000|STARTED|Follow-up at 12 Months of Age||20
11166198|NCT01619878|12354987|FG000|COMPLETED|Follow-up at 12 Months of Age||17
11166199|NCT01619878|12354987|FG000|NOT COMPLETED|Follow-up at 12 Months of Age||3
11203671|NCT01848353|12394182|FG001|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28
11203672|NCT01848353|12394183|FG002|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
11203673|NCT01848353|12394184|FG003|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
11203674|NCT01848353|12394181|FG000|COMPLETED|Phase 2||20
11203675|NCT01848353|12394182|FG001|COMPLETED|Phase 2||26
11203676|NCT01848353|12394183|FG002|COMPLETED|Phase 2||0
11203677|NCT01848353|12394184|FG003|COMPLETED|Phase 2||0
11203678|NCT01848353|12394181|FG000|NOT COMPLETED|Phase 2||3
11203679|NCT01848353|12394182|FG001|NOT COMPLETED|Phase 2||2
11203680|NCT01848353|12394183|FG002|NOT COMPLETED|Phase 2||0
11203681|NCT01848353|12394184|FG003|NOT COMPLETED|Phase 2||0
11203682|NCT01848353|12394181|FG000|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5
11203683|NCT01848353|12394182|FG001|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10
11203684|NCT01848353|12394183|FG002|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
11203685|NCT01848353|12394184|FG003|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
11203686|NCT01848353|12394181|FG000|COMPLETED|Phase 3||4
11203687|NCT01848353|12394182|FG001|COMPLETED|Phase 3||9
11203688|NCT01848353|12394183|FG002|COMPLETED|Phase 3||0
11166200|NCT01619982|12354993|FG000|STARTED|Overall Study||20
11166201|NCT01619982|12354994|FG001|STARTED|Overall Study||12
11166202|NCT01619982|12354993|FG000|COMPLETED|Overall Study||20
11166203|NCT01619982|12354994|FG001|COMPLETED|Overall Study||12
11166204|NCT01619982|12354993|FG000|NOT COMPLETED|Overall Study||0
11166205|NCT01619982|12354994|FG001|NOT COMPLETED|Overall Study||0
11166206|NCT01620047|12355007|FG000|STARTED|Overall Study||20
11166207|NCT01620047|12355008|FG001|STARTED|Overall Study||20
11166208|NCT01620047|12355009|FG002|STARTED|Overall Study||20
11166209|NCT01620047|12355007|FG000|COMPLETED|Overall Study||20
11166210|NCT01620047|12355008|FG001|COMPLETED|Overall Study||20
11166211|NCT01620047|12355009|FG002|COMPLETED|Overall Study||20
11166212|NCT01620047|12355007|FG000|NOT COMPLETED|Overall Study||0
11166213|NCT01620047|12355008|FG001|NOT COMPLETED|Overall Study||0
11166214|NCT01620047|12355009|FG002|NOT COMPLETED|Overall Study||0
11166215|NCT01620060|12355017|FG000|STARTED|Overall Study||105
11166216|NCT01620060|12355017|FG000|COMPLETED|Overall Study||90
11166217|NCT01620060|12355017|FG000|NOT COMPLETED|Overall Study||15
11166218|NCT01620086|12355023|FG000|STARTED|Overall Study||13
11166219|NCT01620086|12355024|FG001|STARTED|Overall Study||11
11166220|NCT01620086|12355025|FG002|STARTED|Overall Study||2
11166221|NCT01620086|12355023|FG000|COMPLETED|Overall Study||8
11166222|NCT01620086|12355024|FG001|COMPLETED|Overall Study||4
11166223|NCT01620086|12355025|FG002|COMPLETED|Overall Study||2
11166224|NCT01620086|12355023|FG000|NOT COMPLETED|Overall Study||5
11166225|NCT01620086|12355024|FG001|NOT COMPLETED|Overall Study||7
11166226|NCT01620086|12355025|FG002|NOT COMPLETED|Overall Study||0
11166227|NCT01620138|12355036|FG000|STARTED|Overall Study||12
11166228|NCT01620138|12355037|FG001|STARTED|Overall Study||9
11166229|NCT01620138|12355036|FG000|COMPLETED|Overall Study||6
11166230|NCT01620138|12355037|FG001|COMPLETED|Overall Study||9
11166231|NCT01620138|12355036|FG000|NOT COMPLETED|Overall Study||6
11166232|NCT01620138|12355037|FG001|NOT COMPLETED|Overall Study||0
11166233|NCT01620177|12355043|FG000|STARTED|Overall Study||98
11166234|NCT01620177|12355043|FG000|COMPLETED|Overall Study||19
11166235|NCT01620177|12355043|FG000|NOT COMPLETED|Overall Study||79
11166236|NCT01620190|12355060|FG000|STARTED|Overall Study||26
11166237|NCT01620190|12355060|FG000|COMPLETED|Overall Study||26
11166238|NCT01620190|12355060|FG000|NOT COMPLETED|Overall Study||0
11166239|NCT01620216|12355071|FG000|STARTED|Overall Study||4
11166240|NCT01620216|12355072|FG001|STARTED|Overall Study||2
11166241|NCT01620216|12355073|FG002|STARTED|Overall Study||6
11166242|NCT01620216|12355074|FG003|STARTED|Overall Study||0
11166243|NCT01620216|12355075|FG004|STARTED|Overall Study||0
11166244|NCT01620216|12355076|FG005|STARTED|Overall Study||0
11166245|NCT01620216|12355077|FG006|STARTED|Overall Study||0
11166246|NCT01620216|12355071|FG000|COMPLETED|Overall Study||4
11166247|NCT01620216|12355072|FG001|COMPLETED|Overall Study||2
11166248|NCT01620216|12355073|FG002|COMPLETED|Overall Study||6
11166249|NCT01620216|12355074|FG003|COMPLETED|Overall Study||0
11166250|NCT01620216|12355075|FG004|COMPLETED|Overall Study||0
11166251|NCT01620216|12355076|FG005|COMPLETED|Overall Study||0
11166252|NCT01620216|12355077|FG006|COMPLETED|Overall Study||0
11166253|NCT01620216|12355071|FG000|NOT COMPLETED|Overall Study||0
11166254|NCT01620216|12355072|FG001|NOT COMPLETED|Overall Study||0
11166255|NCT01620216|12355073|FG002|NOT COMPLETED|Overall Study||0
11166256|NCT01620216|12355074|FG003|NOT COMPLETED|Overall Study||0
11166257|NCT01620216|12355075|FG004|NOT COMPLETED|Overall Study||0
11166258|NCT01620216|12355076|FG005|NOT COMPLETED|Overall Study||0
11166259|NCT01620216|12355077|FG006|NOT COMPLETED|Overall Study||0
11166260|NCT01620255|12355098|FG000|STARTED|Overall Study||73
11166261|NCT01620255|12355099|FG001|STARTED|Overall Study||71
11166262|NCT01620255|12355100|FG002|STARTED|Overall Study||70
11166263|NCT01620255|12355101|FG003|STARTED|Overall Study||73
11166264|NCT01620255|12355102|FG004|STARTED|Overall Study||70
11166265|NCT01620255|12355098|FG000|Treated|Overall Study||73
11166266|NCT01620255|12355099|FG001|Treated|Overall Study||71
11166267|NCT01620255|12355100|FG002|Treated|Overall Study||70
11166268|NCT01620255|12355101|FG003|Treated|Overall Study||73
11166269|NCT01620255|12355102|FG004|Treated|Overall Study||70
11166270|NCT01620255|12355098|FG000|COMPLETED|Overall Study||69
11166271|NCT01620255|12355099|FG001|COMPLETED|Overall Study||65
11166272|NCT01620255|12355100|FG002|COMPLETED|Overall Study||68
11166273|NCT01620255|12355101|FG003|COMPLETED|Overall Study||70
11166274|NCT01620255|12355102|FG004|COMPLETED|Overall Study||64
11166275|NCT01620255|12355098|FG000|NOT COMPLETED|Overall Study||4
11166276|NCT01620255|12355099|FG001|NOT COMPLETED|Overall Study||6
11166277|NCT01620255|12355100|FG002|NOT COMPLETED|Overall Study||2
11166278|NCT01620255|12355101|FG003|NOT COMPLETED|Overall Study||3
11166279|NCT01620255|12355102|FG004|NOT COMPLETED|Overall Study||6
11419692|NCT04298918|12618371|FG000|STARTED|Overall Study||0
11419693|NCT04298918|12618372|FG001|STARTED|Overall Study||0
11419694|NCT04298918|12618373|FG002|STARTED|Overall Study||0
11419695|NCT04298918|12618374|FG003|STARTED|Overall Study||0
11166280|NCT01620489|12355116|FG000|STARTED|Overall Study||140
11166281|NCT01620489|12355117|FG001|STARTED|Overall Study||139
11166282|NCT01620489|12355116|FG000|Exposed|Overall Study||140
11166283|NCT01620489|12355117|FG001|Exposed|Overall Study|2 subjects did not take trial product|137
11166284|NCT01620489|12355116|FG000|COMPLETED|Overall Study||105
11166285|NCT01620489|12355117|FG001|COMPLETED|Overall Study|2 subjects did not take trial product|105
11166286|NCT01620489|12355116|FG000|NOT COMPLETED|Overall Study||35
11166287|NCT01620489|12355117|FG001|NOT COMPLETED|Overall Study||34
11166288|NCT01620528|12355126|FG000|STARTED|Treatment Period||374
11166289|NCT01620528|12355127|FG001|STARTED|Treatment Period||249
11166290|NCT01620528|12355128|FG002|STARTED|Treatment Period|1 subject did not receive study drug|249
11166291|NCT01620528|12355126|FG000|COMPLETED|Treatment Period||274
11166292|NCT01620528|12355127|FG001|COMPLETED|Treatment Period||196
11166293|NCT01620528|12355128|FG002|COMPLETED|Treatment Period||183
11419696|NCT04298918|12618371|FG000|COMPLETED|Overall Study||0
11419697|NCT04298918|12618372|FG001|COMPLETED|Overall Study||0
11166294|NCT01620528|12355126|FG000|NOT COMPLETED|Treatment Period||100
11166295|NCT01620528|12355127|FG001|NOT COMPLETED|Treatment Period||53
11166296|NCT01620528|12355128|FG002|NOT COMPLETED|Treatment Period||66
11166297|NCT01620528|12355126|FG000|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
11419698|NCT04298918|12618373|FG002|COMPLETED|Overall Study||0
11166298|NCT01620528|12355127|FG001|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
11166299|NCT01620528|12355128|FG002|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
11166300|NCT01620528|12355126|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
11166301|NCT01620528|12355127|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
11166302|NCT01620528|12355128|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
11166303|NCT01620528|12355126|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
11166304|NCT01620528|12355127|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
11166305|NCT01620528|12355128|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
11166306|NCT01620528|12355126|FG000|COMPLETED|Post-Treatment Follow-Up Period||48
11166307|NCT01620528|12355127|FG001|COMPLETED|Post-Treatment Follow-Up Period||31
11166308|NCT01620528|12355128|FG002|COMPLETED|Post-Treatment Follow-Up Period||37
11166309|NCT01620528|12355126|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||20
11166310|NCT01620528|12355127|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||17
11166311|NCT01620528|12355128|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||14
11166312|NCT01620567|12355138|FG000|STARTED|Overall Study||23
11166313|NCT01620567|12355139|FG001|STARTED|Overall Study||25
11166314|NCT01620567|12355138|FG000|COMPLETED|Overall Study||20
11166315|NCT01620567|12355139|FG001|COMPLETED|Overall Study||20
11166316|NCT01620567|12355138|FG000|NOT COMPLETED|Overall Study||3
11166317|NCT01620567|12355139|FG001|NOT COMPLETED|Overall Study||5
11166318|NCT01620593|12355150|FG000|STARTED|Overall Study||21
11166319|NCT01620593|12355151|FG001|STARTED|Overall Study||20
11166320|NCT01620593|12355150|FG000|COMPLETED|Overall Study||17
11166321|NCT01620593|12355151|FG001|COMPLETED|Overall Study||19
11166322|NCT01620593|12355150|FG000|NOT COMPLETED|Overall Study||4
11166323|NCT01620593|12355151|FG001|NOT COMPLETED|Overall Study||1
11166324|NCT01620762|12355160|FG000|STARTED|Overall Study||468
11166325|NCT01620762|12355161|FG001|STARTED|Overall Study||470
11166326|NCT01620762|12355162|FG002|STARTED|Overall Study||470
11166327|NCT01620762|12355160|FG000|COMPLETED|Overall Study||420
11166328|NCT01620762|12355161|FG001|COMPLETED|Overall Study||412
11166329|NCT01620762|12355162|FG002|COMPLETED|Overall Study||417
11166330|NCT01620762|12355160|FG000|NOT COMPLETED|Overall Study||48
11166331|NCT01620762|12355161|FG001|NOT COMPLETED|Overall Study||58
11166332|NCT01620762|12355162|FG002|NOT COMPLETED|Overall Study||53
11166333|NCT01620983|12355173|FG000|STARTED|Overall Study||130
11166334|NCT01620983|12355174|FG001|STARTED|Overall Study||135
11166335|NCT01620983|12355175|FG002|STARTED|Overall Study||137
11166336|NCT01620983|12355173|FG000|COMPLETED|Overall Study||111
11166337|NCT01620983|12355174|FG001|COMPLETED|Overall Study||113
11166338|NCT01620983|12355175|FG002|COMPLETED|Overall Study||122
11166339|NCT01620983|12355173|FG000|NOT COMPLETED|Overall Study||19
11166340|NCT01620983|12355174|FG001|NOT COMPLETED|Overall Study||22
11166341|NCT01620983|12355175|FG002|NOT COMPLETED|Overall Study||15
11166342|NCT01621009|12355187|FG000|STARTED|Overall Study||113
11166343|NCT01621009|12355188|FG001|STARTED|Overall Study||116
11166344|NCT01621009|12355189|FG002|STARTED|Overall Study||121
11166345|NCT01621009|12355190|FG003|STARTED|Overall Study||113
11166346|NCT01621009|12355187|FG000|COMPLETED|Overall Study||70
11166347|NCT01621009|12355188|FG001|COMPLETED|Overall Study||65
11166348|NCT01621009|12355189|FG002|COMPLETED|Overall Study||58
11166349|NCT01621009|12355190|FG003|COMPLETED|Overall Study||60
11166350|NCT01621009|12355187|FG000|NOT COMPLETED|Overall Study||43
11419699|NCT04298918|12618374|FG003|COMPLETED|Overall Study||0
11419700|NCT04298918|12618371|FG000|NOT COMPLETED|Overall Study||0
11166351|NCT01621009|12355188|FG001|NOT COMPLETED|Overall Study||51
11166352|NCT01621009|12355189|FG002|NOT COMPLETED|Overall Study||63
11166353|NCT01621009|12355190|FG003|NOT COMPLETED|Overall Study||53
11166354|NCT01621126|12355198|FG000|STARTED|Overall Study||40
11166355|NCT01621126|12355198|FG000|COMPLETED|Overall Study||34
11166356|NCT01621126|12355198|FG000|NOT COMPLETED|Overall Study||6
11166357|NCT01621178|12355205|FG000|STARTED|Overall Study||194
11166358|NCT01621178|12355206|FG001|STARTED|Overall Study||190
11166359|NCT01621178|12355207|FG002|STARTED|Overall Study||193
11166360|NCT01621178|12355205|FG000|Received at Least One Dose of Study Drug|Overall Study||194
11166361|NCT01621178|12355206|FG001|Received at Least One Dose of Study Drug|Overall Study||190
11166362|NCT01621178|12355207|FG002|Received at Least One Dose of Study Drug|Overall Study||192
11166363|NCT01621178|12355205|FG000|Modified Intent to Treat Population|Overall Study||186
11166364|NCT01621178|12355206|FG001|Modified Intent to Treat Population|Overall Study||180
11166365|NCT01621178|12355207|FG002|Modified Intent to Treat Population|Overall Study||183
11166366|NCT01621178|12355205|FG000|COMPLETED|Overall Study||163
11419701|NCT04298918|12618372|FG001|NOT COMPLETED|Overall Study||0
11166367|NCT01621178|12355206|FG001|COMPLETED|Overall Study||160
11166368|NCT01621178|12355207|FG002|COMPLETED|Overall Study||157
11166369|NCT01621178|12355205|FG000|NOT COMPLETED|Overall Study||31
11166370|NCT01621178|12355206|FG001|NOT COMPLETED|Overall Study||30
11166371|NCT01621178|12355207|FG002|NOT COMPLETED|Overall Study||36
11166372|NCT01621191|12355219|FG000|STARTED|Overall Study||149
11166373|NCT01621191|12355219|FG000|Received at Least 1 Dose of Study Drug|Overall Study||149
11166374|NCT01621191|12355219|FG000|Had at Least 1 Post-Baseline Observation|Overall Study||148
11166375|NCT01621191|12355219|FG000|COMPLETED|Overall Study||124
11166376|NCT01621191|12355219|FG000|NOT COMPLETED|Overall Study||25
11166377|NCT01621230|12355226|FG000|STARTED|Overall Study||154
11419702|NCT04298918|12618373|FG002|NOT COMPLETED|Overall Study||0
11166378|NCT01621230|12355227|FG001|STARTED|Overall Study||156
11166379|NCT01621230|12355226|FG000|COMPLETED|Overall Study||154
11166380|NCT01621230|12355227|FG001|COMPLETED|Overall Study||156
11166381|NCT01621230|12355226|FG000|NOT COMPLETED|Overall Study||0
11166382|NCT01621230|12355227|FG001|NOT COMPLETED|Overall Study||0
11166383|NCT01621477|12355236|FG000|STARTED|Overall Study||17
11166384|NCT01621477|12355236|FG000|COMPLETED|Overall Study||17
11166385|NCT01621477|12355236|FG000|NOT COMPLETED|Overall Study||0
11166386|NCT01621490|12355249|FG000|STARTED|Overall Study||41
11166387|NCT01621490|12355250|FG001|STARTED|Overall Study||44
11166388|NCT01621490|12355251|FG002|STARTED|Overall Study||11
11166389|NCT01621490|12355252|FG003|STARTED|Overall Study||10
11166390|NCT01621490|12355253|FG004|STARTED|Overall Study||6
11166391|NCT01621490|12355254|FG005|STARTED|Overall Study||25
11166392|NCT01621490|12355255|FG006|STARTED|Overall Study||11
11166393|NCT01621490|12355256|FG007|STARTED|Overall Study||10
11166394|NCT01621490|12355257|FG008|STARTED|Overall Study||10
11166395|NCT01621490|12355249|FG000|COMPLETED|Overall Study||0
11166396|NCT01621490|12355250|FG001|COMPLETED|Overall Study||0
11166397|NCT01621490|12355251|FG002|COMPLETED|Overall Study||0
11166398|NCT01621490|12355252|FG003|COMPLETED|Overall Study||1
11166399|NCT01621490|12355253|FG004|COMPLETED|Overall Study||0
11166400|NCT01621490|12355254|FG005|COMPLETED|Overall Study||1
11166401|NCT01621490|12355255|FG006|COMPLETED|Overall Study||0
11166402|NCT01621490|12355256|FG007|COMPLETED|Overall Study||0
11166403|NCT01621490|12355257|FG008|COMPLETED|Overall Study||2
11166404|NCT01621490|12355249|FG000|NOT COMPLETED|Overall Study||41
11166405|NCT01621490|12355250|FG001|NOT COMPLETED|Overall Study||44
11166406|NCT01621490|12355251|FG002|NOT COMPLETED|Overall Study||11
11166407|NCT01621490|12355252|FG003|NOT COMPLETED|Overall Study||9
11166408|NCT01621490|12355253|FG004|NOT COMPLETED|Overall Study||6
11166409|NCT01621490|12355254|FG005|NOT COMPLETED|Overall Study||24
11166410|NCT01621490|12355255|FG006|NOT COMPLETED|Overall Study||11
11166411|NCT01621490|12355256|FG007|NOT COMPLETED|Overall Study||10
11166412|NCT01621490|12355257|FG008|NOT COMPLETED|Overall Study||8
11166413|NCT01621542|12355376|FG000|STARTED|Overall Study||5
11166414|NCT01621542|12355377|FG001|STARTED|Overall Study||5
11166415|NCT01621542|12355378|FG002|STARTED|Overall Study||6
11166416|NCT01621542|12355379|FG003|STARTED|Overall Study||28
11166417|NCT01621542|12355380|FG004|STARTED|Overall Study||9
11166418|NCT01621542|12355381|FG005|STARTED|Overall Study||9
11166419|NCT01621542|12355376|FG000|COMPLETED|Overall Study||0
11166420|NCT01621542|12355377|FG001|COMPLETED|Overall Study||0
11166421|NCT01621542|12355378|FG002|COMPLETED|Overall Study||0
11166422|NCT01621542|12355379|FG003|COMPLETED|Overall Study||0
11166423|NCT01621542|12355380|FG004|COMPLETED|Overall Study||0
11166424|NCT01621542|12355381|FG005|COMPLETED|Overall Study||0
11166425|NCT01621542|12355376|FG000|NOT COMPLETED|Overall Study||5
11166426|NCT01621542|12355377|FG001|NOT COMPLETED|Overall Study||5
11166427|NCT01621542|12355378|FG002|NOT COMPLETED|Overall Study||6
11166428|NCT01621542|12355379|FG003|NOT COMPLETED|Overall Study||28
11166429|NCT01621542|12355380|FG004|NOT COMPLETED|Overall Study||9
11166430|NCT01621542|12355381|FG005|NOT COMPLETED|Overall Study||9
11166431|NCT01621633|12355399|FG000|STARTED|Overall Study||8
11166432|NCT01621633|12355400|FG001|STARTED|Overall Study||8
11166433|NCT01621633|12355401|FG002|STARTED|Overall Study||8
11166434|NCT01621633|12355402|FG003|STARTED|Overall Study||8
11166435|NCT01621633|12355399|FG000|COMPLETED|Overall Study||8
11166436|NCT01621633|12355400|FG001|COMPLETED|Overall Study||8
11166437|NCT01621633|12355401|FG002|COMPLETED|Overall Study||8
11166438|NCT01621633|12355402|FG003|COMPLETED|Overall Study||8
11166439|NCT01621633|12355399|FG000|NOT COMPLETED|Overall Study||0
11166440|NCT01621633|12355400|FG001|NOT COMPLETED|Overall Study||0
11166441|NCT01621633|12355401|FG002|NOT COMPLETED|Overall Study||0
11166442|NCT01621633|12355402|FG003|NOT COMPLETED|Overall Study||0
11166443|NCT01621672|12355414|FG000|STARTED|Overall Study||25
11166444|NCT01621672|12355415|FG001|STARTED|Overall Study||17
11166445|NCT01621672|12355414|FG000|COMPLETED|Overall Study||25
11166446|NCT01621672|12355415|FG001|COMPLETED|Overall Study||17
11166447|NCT01621672|12355414|FG000|NOT COMPLETED|Overall Study||0
11419703|NCT04298918|12618374|FG003|NOT COMPLETED|Overall Study||0
11419704|NCT01996371|12618392|FG000|STARTED|Overall Study||5
11166448|NCT01621672|12355415|FG001|NOT COMPLETED|Overall Study||0
11166449|NCT01621776|12355424|FG000|STARTED|Overall Study||41
11166450|NCT01621776|12355425|FG001|STARTED|Overall Study||40
11166451|NCT01621776|12355426|FG002|STARTED|Overall Study||18
11166452|NCT01621776|12355424|FG000|COMPLETED|Overall Study||41
11166453|NCT01621776|12355425|FG001|COMPLETED|Overall Study||40
11166454|NCT01621776|12355426|FG002|COMPLETED|Overall Study||18
11166455|NCT01621776|12355424|FG000|NOT COMPLETED|Overall Study||0
11166456|NCT01621776|12355425|FG001|NOT COMPLETED|Overall Study||0
11166457|NCT01621776|12355426|FG002|NOT COMPLETED|Overall Study||0
11166458|NCT01621802|12355440|FG000|STARTED|Overall Study||802
11166459|NCT01621802|12355441|FG001|STARTED|Overall Study||298
11166460|NCT01621802|12355442|FG002|STARTED|Overall Study||796
11166461|NCT01621802|12355443|FG003|STARTED|Overall Study||303
11166462|NCT01621802|12355444|FG004|STARTED|Overall Study||1319
11166463|NCT01621802|12355445|FG005|STARTED|Overall Study||489
11166464|NCT01621802|12355440|FG000|COMPLETED|Overall Study||755
11166465|NCT01621802|12355441|FG001|COMPLETED|Overall Study||275
11166466|NCT01621802|12355442|FG002|COMPLETED|Overall Study||763
11166467|NCT01621802|12355443|FG003|COMPLETED|Overall Study||292
11419705|NCT01996371|12618393|FG001|STARTED|Overall Study||4
11419706|NCT01996371|12618394|FG002|STARTED|Overall Study||6
11419707|NCT01996371|12618392|FG000|COMPLETED|Overall Study||5
11419708|NCT01996371|12618393|FG001|COMPLETED|Overall Study||4
11419709|NCT01996371|12618394|FG002|COMPLETED|Overall Study||6
11419710|NCT01996371|12618392|FG000|NOT COMPLETED|Overall Study||0
11419711|NCT01996371|12618393|FG001|NOT COMPLETED|Overall Study||0
11419712|NCT01996371|12618394|FG002|NOT COMPLETED|Overall Study||0
11419713|NCT01561378|12618407|FG000|STARTED|Overall Study||11
11419714|NCT01561378|12618408|FG001|STARTED|Overall Study||11
11419715|NCT01561378|12618407|FG000|COMPLETED|Overall Study||11
11419716|NCT01561378|12618408|FG001|COMPLETED|Overall Study||11
11419717|NCT01561378|12618407|FG000|NOT COMPLETED|Overall Study||0
11419718|NCT01561378|12618408|FG001|NOT COMPLETED|Overall Study||0
11419719|NCT00955929|12618417|FG000|STARTED|Overall Study||13
11419720|NCT00955929|12618418|FG001|STARTED|Overall Study||30
11419721|NCT00955929|12618419|FG002|STARTED|Overall Study||33
11419722|NCT00955929|12618417|FG000|COMPLETED|Overall Study||13
11419723|NCT00955929|12618418|FG001|COMPLETED|Overall Study||30
11419724|NCT00955929|12618419|FG002|COMPLETED|Overall Study||33
11419725|NCT00955929|12618417|FG000|NOT COMPLETED|Overall Study||0
11419726|NCT00955929|12618418|FG001|NOT COMPLETED|Overall Study||0
11419727|NCT00955929|12618419|FG002|NOT COMPLETED|Overall Study||0
11419728|NCT00402883|12618427|FG000|STARTED|Induction Therapy||5
11419729|NCT00402883|12618427|FG000|COMPLETED|Induction Therapy||5
11419730|NCT00402883|12618427|FG000|NOT COMPLETED|Induction Therapy||0
11166468|NCT01621802|12355444|FG004|COMPLETED|Overall Study||1284
11166469|NCT01621802|12355445|FG005|COMPLETED|Overall Study||477
11166470|NCT01621802|12355440|FG000|NOT COMPLETED|Overall Study||47
11419731|NCT00402883|12618427|FG000|STARTED|Consolidation Therapy||5
11419732|NCT00402883|12618427|FG000|COMPLETED|Consolidation Therapy||5
11419733|NCT00402883|12618427|FG000|NOT COMPLETED|Consolidation Therapy||0
11419734|NCT00402883|12618427|FG000|STARTED|Maintenance Therapy||5
11419735|NCT00402883|12618427|FG000|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
11419736|NCT00402883|12618427|FG000|NOT COMPLETED|Maintenance Therapy||0
11419737|NCT03482505|12618432|FG000|STARTED|Overall Study||10
11419738|NCT03482505|12618432|FG000|COMPLETED|Overall Study||10
11166471|NCT01621802|12355441|FG001|NOT COMPLETED|Overall Study||23
11166472|NCT01621802|12355442|FG002|NOT COMPLETED|Overall Study||33
11166473|NCT01621802|12355443|FG003|NOT COMPLETED|Overall Study||11
11166474|NCT01621802|12355444|FG004|NOT COMPLETED|Overall Study||35
11166475|NCT01621802|12355445|FG005|NOT COMPLETED|Overall Study||12
11166476|NCT01621880|12355464|FG000|STARTED|Overall Study||58
11166477|NCT01621880|12355465|FG001|STARTED|Overall Study||54
11166478|NCT01621880|12355464|FG000|COMPLETED|Overall Study||48
11166479|NCT01621880|12355465|FG001|COMPLETED|Overall Study||49
11166480|NCT01621880|12355464|FG000|NOT COMPLETED|Overall Study||10
11166481|NCT01621880|12355465|FG001|NOT COMPLETED|Overall Study||5
11166482|NCT01622010|12355474|FG000|STARTED|Overall Study||18
11166483|NCT01622010|12355475|FG001|STARTED|Overall Study||12
11166484|NCT01622010|12355474|FG000|COMPLETED|Overall Study||12
11166485|NCT01622010|12355475|FG001|COMPLETED|Overall Study||8
11166486|NCT01622010|12355474|FG000|NOT COMPLETED|Overall Study||6
11166487|NCT01622010|12355475|FG001|NOT COMPLETED|Overall Study||4
11166488|NCT01622231|12355483|FG000|STARTED|Overall Study||61
11166489|NCT01622231|12355483|FG000|COMPLETED|Overall Study||59
11166490|NCT01622231|12355483|FG000|NOT COMPLETED|Overall Study||2
11166491|NCT01622257|12355490|FG000|STARTED|Overall Study||66
11166492|NCT01622257|12355491|FG001|STARTED|Overall Study||66
11166493|NCT01622257|12355492|FG002|STARTED|Overall Study||66
11166494|NCT01622257|12355490|FG000|COMPLETED|Overall Study||66
11166495|NCT01622257|12355491|FG001|COMPLETED|Overall Study||66
11166496|NCT01622257|12355492|FG002|COMPLETED|Overall Study||66
11166497|NCT01622257|12355490|FG000|NOT COMPLETED|Overall Study||0
11166498|NCT01622257|12355491|FG001|NOT COMPLETED|Overall Study||0
11166499|NCT01622257|12355492|FG002|NOT COMPLETED|Overall Study||0
11166500|NCT01622296|12355500|FG000|STARTED|First Intervention||10
11166501|NCT01622296|12355501|FG001|STARTED|First Intervention||10
11166502|NCT01622296|12355500|FG000|COMPLETED|First Intervention||10
11166503|NCT01622296|12355501|FG001|COMPLETED|First Intervention||10
11166504|NCT01622296|12355500|FG000|NOT COMPLETED|First Intervention||0
11166505|NCT01622296|12355501|FG001|NOT COMPLETED|First Intervention||0
11166506|NCT01622296|12355500|FG000|STARTED|Washout Period of at Least 1 Week||10
11166507|NCT01622296|12355501|FG001|STARTED|Washout Period of at Least 1 Week||10
11166508|NCT01622296|12355500|FG000|COMPLETED|Washout Period of at Least 1 Week||10
11419739|NCT03482505|12618432|FG000|NOT COMPLETED|Overall Study||0
11419740|NCT02934503|12618436|FG000|STARTED|Overall Study||5
11419741|NCT02934503|12618436|FG000|COMPLETED|Overall Study||1
11419742|NCT02934503|12618436|FG000|NOT COMPLETED|Overall Study||4
11419743|NCT02137252|12618442|FG000|STARTED|Overall Study||2
11166509|NCT01622296|12355501|FG001|COMPLETED|Washout Period of at Least 1 Week||10
11166510|NCT01622296|12355500|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0
11166511|NCT01622296|12355501|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0
11166512|NCT01622296|12355500|FG000|STARTED|Second Intervention||10
11166513|NCT01622296|12355501|FG001|STARTED|Second Intervention||10
11166514|NCT01622296|12355500|FG000|COMPLETED|Second Intervention||10
11419744|NCT02137252|12618443|FG001|STARTED|Overall Study||1
11419745|NCT02137252|12618442|FG000|COMPLETED|Overall Study||0
11419746|NCT02137252|12618443|FG001|COMPLETED|Overall Study||0
11166515|NCT01622296|12355501|FG001|COMPLETED|Second Intervention||10
11166516|NCT01622296|12355500|FG000|NOT COMPLETED|Second Intervention||0
11166517|NCT01622296|12355501|FG001|NOT COMPLETED|Second Intervention||0
11166518|NCT01622348|12355509|FG000|STARTED|Overall Study||15
11166519|NCT01622348|12355510|FG001|STARTED|Overall Study||14
11166520|NCT01622348|12355511|FG002|STARTED|Overall Study||15
11166521|NCT01622348|12355509|FG000|COMPLETED|Overall Study||14
11166522|NCT01622348|12355510|FG001|COMPLETED|Overall Study||14
11166523|NCT01622348|12355511|FG002|COMPLETED|Overall Study||14
11166524|NCT01622348|12355509|FG000|NOT COMPLETED|Overall Study||1
11166525|NCT01622348|12355510|FG001|NOT COMPLETED|Overall Study||0
11166526|NCT01622348|12355511|FG002|NOT COMPLETED|Overall Study||1
11166527|NCT01622543|12355521|FG000|STARTED|Overall Study||51
11166528|NCT01622543|12355522|FG001|STARTED|Overall Study||52
11166529|NCT01622543|12355521|FG000|COMPLETED|Overall Study||51
11166530|NCT01622543|12355522|FG001|COMPLETED|Overall Study||52
11166531|NCT01622543|12355521|FG000|NOT COMPLETED|Overall Study||0
11166532|NCT01622543|12355522|FG001|NOT COMPLETED|Overall Study||0
11166533|NCT01622569|12355532|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
11166534|NCT01622569|12355533|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
11166535|NCT01622569|12355534|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
11166536|NCT01622569|12355535|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
11166537|NCT01622569|12355532|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
11166538|NCT01622569|12355533|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
11166539|NCT01622569|12355534|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
11166540|NCT01622569|12355535|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
11166541|NCT01622569|12355532|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
11166542|NCT01622569|12355533|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
11166543|NCT01622569|12355534|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
11166544|NCT01622569|12355535|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
11166545|NCT01622569|12355532|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||68
11166546|NCT01622569|12355533|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||72
11166547|NCT01622569|12355534|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||67
11166548|NCT01622569|12355535|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||75
11166549|NCT01622569|12355532|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
11166550|NCT01622569|12355533|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
11166551|NCT01622569|12355534|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
11166552|NCT01622569|12355535|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
11166553|NCT01622569|12355532|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
11166554|NCT01622569|12355533|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
11166555|NCT01622569|12355534|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
11166556|NCT01622569|12355535|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
11166557|NCT01622660|12355555|FG000|STARTED|Overall Study||2
11166558|NCT01622660|12355555|FG000|COMPLETED|Overall Study||1
11166559|NCT01622660|12355555|FG000|NOT COMPLETED|Overall Study||1
11166560|NCT01622673|12355565|FG000|STARTED|Treatment Period 1||4
11166561|NCT01622673|12355566|FG001|STARTED|Treatment Period 1||5
11166562|NCT01622673|12355567|FG002|STARTED|Treatment Period 1||4
11166563|NCT01622673|12355568|FG003|STARTED|Treatment Period 1||6
11166564|NCT01622673|12355569|FG004|STARTED|Treatment Period 1||4
11166565|NCT01622673|12355570|FG005|STARTED|Treatment Period 1||4
11166566|NCT01622673|12355565|FG000|COMPLETED|Treatment Period 1||4
11166567|NCT01622673|12355566|FG001|COMPLETED|Treatment Period 1||4
11166568|NCT01622673|12355567|FG002|COMPLETED|Treatment Period 1||4
11166569|NCT01622673|12355568|FG003|COMPLETED|Treatment Period 1||5
11166570|NCT01622673|12355569|FG004|COMPLETED|Treatment Period 1||4
11166571|NCT01622673|12355570|FG005|COMPLETED|Treatment Period 1||4
11166572|NCT01622673|12355565|FG000|NOT COMPLETED|Treatment Period 1||0
11166573|NCT01622673|12355566|FG001|NOT COMPLETED|Treatment Period 1||1
11166574|NCT01622673|12355567|FG002|NOT COMPLETED|Treatment Period 1||0
11166575|NCT01622673|12355568|FG003|NOT COMPLETED|Treatment Period 1||1
11166576|NCT01622673|12355569|FG004|NOT COMPLETED|Treatment Period 1||0
11166577|NCT01622673|12355570|FG005|NOT COMPLETED|Treatment Period 1||0
11166578|NCT01622673|12355565|FG000|STARTED|Treatment Period 2||4
11166579|NCT01622673|12355566|FG001|STARTED|Treatment Period 2||4
11166580|NCT01622673|12355567|FG002|STARTED|Treatment Period 2||4
11166581|NCT01622673|12355568|FG003|STARTED|Treatment Period 2||5
11166582|NCT01622673|12355569|FG004|STARTED|Treatment Period 2||4
11166583|NCT01622673|12355570|FG005|STARTED|Treatment Period 2||4
11166584|NCT01622673|12355565|FG000|COMPLETED|Treatment Period 2||4
11166585|NCT01622673|12355566|FG001|COMPLETED|Treatment Period 2||4
11166586|NCT01622673|12355567|FG002|COMPLETED|Treatment Period 2||4
11166587|NCT01622673|12355568|FG003|COMPLETED|Treatment Period 2||4
11166588|NCT01622673|12355569|FG004|COMPLETED|Treatment Period 2||4
11419747|NCT02137252|12618442|FG000|NOT COMPLETED|Overall Study||2
11166589|NCT01622673|12355570|FG005|COMPLETED|Treatment Period 2||4
11166590|NCT01622673|12355565|FG000|NOT COMPLETED|Treatment Period 2||0
11166591|NCT01622673|12355566|FG001|NOT COMPLETED|Treatment Period 2||0
11166592|NCT01622673|12355567|FG002|NOT COMPLETED|Treatment Period 2||0
11166593|NCT01622673|12355568|FG003|NOT COMPLETED|Treatment Period 2||1
11166594|NCT01622673|12355569|FG004|NOT COMPLETED|Treatment Period 2||0
11166595|NCT01622673|12355570|FG005|NOT COMPLETED|Treatment Period 2||0
11166596|NCT01622673|12355565|FG000|STARTED|Treatment Period 3||4
11166597|NCT01622673|12355566|FG001|STARTED|Treatment Period 3||4
11166598|NCT01622673|12355567|FG002|STARTED|Treatment Period 3||4
11166599|NCT01622673|12355568|FG003|STARTED|Treatment Period 3||4
11166600|NCT01622673|12355569|FG004|STARTED|Treatment Period 3||4
11166601|NCT01622673|12355570|FG005|STARTED|Treatment Period 3||4
11166602|NCT01622673|12355565|FG000|COMPLETED|Treatment Period 3||4
11166603|NCT01622673|12355566|FG001|COMPLETED|Treatment Period 3||3
11166604|NCT01622673|12355567|FG002|COMPLETED|Treatment Period 3||4
11166605|NCT01622673|12355568|FG003|COMPLETED|Treatment Period 3||4
11166606|NCT01622673|12355569|FG004|COMPLETED|Treatment Period 3||4
11166607|NCT01622673|12355570|FG005|COMPLETED|Treatment Period 3||4
11166608|NCT01622673|12355565|FG000|NOT COMPLETED|Treatment Period 3||0
11166609|NCT01622673|12355566|FG001|NOT COMPLETED|Treatment Period 3||1
11166610|NCT01622673|12355567|FG002|NOT COMPLETED|Treatment Period 3||0
11166611|NCT01622673|12355568|FG003|NOT COMPLETED|Treatment Period 3||0
11166612|NCT01622673|12355569|FG004|NOT COMPLETED|Treatment Period 3||0
11166613|NCT01622673|12355570|FG005|NOT COMPLETED|Treatment Period 3||0
11166614|NCT01622673|12355565|FG000|STARTED|Treatment Period 4||4
11166615|NCT01622673|12355566|FG001|STARTED|Treatment Period 4||3
11166616|NCT01622673|12355567|FG002|STARTED|Treatment Period 4||4
11166617|NCT01622673|12355568|FG003|STARTED|Treatment Period 4||4
11166618|NCT01622673|12355569|FG004|STARTED|Treatment Period 4||4
11166619|NCT01622673|12355570|FG005|STARTED|Treatment Period 4||4
11166620|NCT01622673|12355565|FG000|COMPLETED|Treatment Period 4||4
11166621|NCT01622673|12355566|FG001|COMPLETED|Treatment Period 4||3
11166622|NCT01622673|12355567|FG002|COMPLETED|Treatment Period 4||4
11166623|NCT01622673|12355568|FG003|COMPLETED|Treatment Period 4||4
11166624|NCT01622673|12355569|FG004|COMPLETED|Treatment Period 4||4
11166625|NCT01622673|12355570|FG005|COMPLETED|Treatment Period 4||4
11166626|NCT01622673|12355565|FG000|NOT COMPLETED|Treatment Period 4||0
11166627|NCT01622673|12355566|FG001|NOT COMPLETED|Treatment Period 4||0
11166628|NCT01622673|12355567|FG002|NOT COMPLETED|Treatment Period 4||0
11166629|NCT01622673|12355568|FG003|NOT COMPLETED|Treatment Period 4||0
11166630|NCT01622673|12355569|FG004|NOT COMPLETED|Treatment Period 4||0
11166631|NCT01622673|12355570|FG005|NOT COMPLETED|Treatment Period 4||0
11166632|NCT01622673|12355565|FG000|STARTED|Treatment Period 5||4
11166633|NCT01622673|12355566|FG001|STARTED|Treatment Period 5||3
11166634|NCT01622673|12355567|FG002|STARTED|Treatment Period 5||4
11166635|NCT01622673|12355568|FG003|STARTED|Treatment Period 5||4
11166636|NCT01622673|12355569|FG004|STARTED|Treatment Period 5||4
11166637|NCT01622673|12355570|FG005|STARTED|Treatment Period 5||4
11166638|NCT01622673|12355565|FG000|COMPLETED|Treatment Period 5||4
11166639|NCT01622673|12355566|FG001|COMPLETED|Treatment Period 5||3
11166640|NCT01622673|12355567|FG002|COMPLETED|Treatment Period 5||4
11166641|NCT01622673|12355568|FG003|COMPLETED|Treatment Period 5||4
11166642|NCT01622673|12355569|FG004|COMPLETED|Treatment Period 5||4
11166643|NCT01622673|12355570|FG005|COMPLETED|Treatment Period 5||4
11166644|NCT01622673|12355565|FG000|NOT COMPLETED|Treatment Period 5||0
11166645|NCT01622673|12355566|FG001|NOT COMPLETED|Treatment Period 5||0
11166646|NCT01622673|12355567|FG002|NOT COMPLETED|Treatment Period 5||0
11166647|NCT01622673|12355568|FG003|NOT COMPLETED|Treatment Period 5||0
11166648|NCT01622673|12355569|FG004|NOT COMPLETED|Treatment Period 5||0
11166649|NCT01622673|12355570|FG005|NOT COMPLETED|Treatment Period 5||0
11166650|NCT01622699|12355591|FG000|STARTED|Overall Study||213
11166651|NCT01622699|12355592|FG001|STARTED|Overall Study||217
11166652|NCT01622699|12355591|FG000|COMPLETED|Overall Study||213
11166653|NCT01622699|12355592|FG001|COMPLETED|Overall Study||217
11166654|NCT01622699|12355591|FG000|NOT COMPLETED|Overall Study||0
11166655|NCT01622699|12355592|FG001|NOT COMPLETED|Overall Study||0
11166656|NCT01623037|12355598|FG000|STARTED|Overall Study||15
11166657|NCT01623037|12355598|FG000|COMPLETED|Overall Study||15
11166658|NCT01623037|12355598|FG000|NOT COMPLETED|Overall Study||0
11166659|NCT01623050|12355604|FG000|STARTED|Overall Study||36
11166660|NCT01623050|12355604|FG000|Treated|Overall Study||34
11166661|NCT01623050|12355604|FG000|COMPLETED|Overall Study||27
11166662|NCT01623050|12355604|FG000|NOT COMPLETED|Overall Study||9
11419748|NCT02137252|12618443|FG001|NOT COMPLETED|Overall Study||1
11419749|NCT03863522|12618449|FG000|STARTED|Overall Study||116
11419750|NCT03863522|12618449|FG000|COMPLETED|Overall Study||116
11419751|NCT03863522|12618449|FG000|NOT COMPLETED|Overall Study||0
11419752|NCT01294670|12618458|FG000|STARTED|Overall Study||7
11419753|NCT01294670|12618459|FG001|STARTED|Overall Study||3
11419754|NCT01294670|12618460|FG002|STARTED|Overall Study||3
11419755|NCT01294670|12618461|FG003|STARTED|Overall Study||9
11419756|NCT01294670|12618462|FG004|STARTED|Overall Study||5
11419757|NCT01294670|12618458|FG000|COMPLETED|Overall Study||6
11419758|NCT01294670|12618459|FG001|COMPLETED|Overall Study||3
11166663|NCT01623115|12355610|FG000|STARTED|Overall Study|Randomized|163
11166664|NCT01623115|12355611|FG001|STARTED|Overall Study|Randomized|323
11419759|NCT01294670|12618460|FG002|COMPLETED|Overall Study||3
11419760|NCT01294670|12618461|FG003|COMPLETED|Overall Study||9
11419761|NCT01294670|12618462|FG004|COMPLETED|Overall Study||5
11166665|NCT01623115|12355610|FG000|Treated|Overall Study||163
11166666|NCT01623115|12355611|FG001|Treated|Overall Study||322
11166667|NCT01623115|12355610|FG000|COMPLETED|Overall Study||130
11166668|NCT01623115|12355611|FG001|COMPLETED|Overall Study||246
11166669|NCT01623115|12355610|FG000|NOT COMPLETED|Overall Study||33
11166670|NCT01623115|12355611|FG001|NOT COMPLETED|Overall Study||77
11166671|NCT01623154|12355617|FG000|STARTED|Overall Study||99
11166672|NCT01623154|12355617|FG000|Available for Analysis|Overall Study||95
11166673|NCT01623154|12355617|FG000|COMPLETED|Overall Study||95
11166674|NCT01623154|12355617|FG000|NOT COMPLETED|Overall Study||4
11419762|NCT01294670|12618458|FG000|NOT COMPLETED|Overall Study||1
11419763|NCT01294670|12618459|FG001|NOT COMPLETED|Overall Study||0
11419764|NCT01294670|12618460|FG002|NOT COMPLETED|Overall Study||0
11419765|NCT01294670|12618461|FG003|NOT COMPLETED|Overall Study||0
11419766|NCT01294670|12618462|FG004|NOT COMPLETED|Overall Study||0
11419767|NCT03095287|12618474|FG000|STARTED|Overall Study||2
11419768|NCT03095287|12618474|FG000|COMPLETED|Overall Study||0
11166675|NCT01623271|12355623|FG000|STARTED|Overall Study||5
11166676|NCT01623271|12355623|FG000|COMPLETED|Overall Study||3
11166677|NCT01623271|12355623|FG000|NOT COMPLETED|Overall Study||2
11166678|NCT01623310|12355627|FG000|STARTED|Overall Study||223
11166679|NCT01623310|12355627|FG000|COMPLETED|Overall Study||144
11166680|NCT01623310|12355627|FG000|NOT COMPLETED|Overall Study||79
11166681|NCT01623323|12355631|FG000|STARTED|Overall Study||705
11166682|NCT01623323|12355631|FG000|COMPLETED|Overall Study||601
11166683|NCT01623323|12355631|FG000|NOT COMPLETED|Overall Study||104
11166684|NCT01623466|12355637|FG000|STARTED|Overall Study||18
11166685|NCT01623466|12355638|FG001|STARTED|Overall Study||18
11166686|NCT01623466|12355637|FG000|COMPLETED|Overall Study||17
11166687|NCT01623466|12355638|FG001|COMPLETED|Overall Study||18
11166688|NCT01623466|12355637|FG000|NOT COMPLETED|Overall Study||1
11166689|NCT01623466|12355638|FG001|NOT COMPLETED|Overall Study||0
11166690|NCT01623479|12355644|FG000|STARTED|Overall Study||585
11166691|NCT01623479|12355644|FG000|COMPLETED|Overall Study||585
11166692|NCT01623479|12355644|FG000|NOT COMPLETED|Overall Study||0
11166693|NCT01623531|12355650|FG000|STARTED|Overall Study||31
11166694|NCT01623531|12355651|FG001|STARTED|Overall Study||31
11166695|NCT01623531|12355650|FG000|COMPLETED|Overall Study||27
11166696|NCT01623531|12355651|FG001|COMPLETED|Overall Study||29
11166697|NCT01623531|12355650|FG000|NOT COMPLETED|Overall Study||4
11166698|NCT01623531|12355651|FG001|NOT COMPLETED|Overall Study||2
11166699|NCT01623596|12355662|FG000|STARTED|Overall Study||436
11166700|NCT01623596|12355663|FG001|STARTED|Overall Study||439
11166701|NCT01623596|12355662|FG000|On Randomized Treatment|Overall Study||352
11166702|NCT01623596|12355663|FG001|On Randomized Treatment|Overall Study||125
11166703|NCT01623596|12355662|FG000|On Switched Treatment|Overall Study||22
11166704|NCT01623596|12355663|FG001|On Switched Treatment|Overall Study||214
11166705|NCT01623596|12355662|FG000|COMPLETED|Overall Study||374
11166706|NCT01623596|12355663|FG001|COMPLETED|Overall Study||339
11166707|NCT01623596|12355662|FG000|NOT COMPLETED|Overall Study||62
11166708|NCT01623596|12355663|FG001|NOT COMPLETED|Overall Study||100
11166709|NCT01623739|12355673|FG000|STARTED|Overall Study||19
11166710|NCT01623739|12355674|FG001|STARTED|Overall Study||19
11166711|NCT01623739|12355673|FG000|COMPLETED|Overall Study||17
11166712|NCT01623739|12355674|FG001|COMPLETED|Overall Study||15
11166713|NCT01623739|12355673|FG000|NOT COMPLETED|Overall Study||2
11166714|NCT01623739|12355674|FG001|NOT COMPLETED|Overall Study||4
11166715|NCT01623752|12355684|FG000|STARTED|Phase 1 (78 Weeks)||1378
11166716|NCT01623752|12355685|FG001|STARTED|Phase 1 (78 Weeks)||440
11166717|NCT01623752|12355686|FG002|STARTED|Phase 1 (78 Weeks)||3
11166718|NCT01623752|12355684|FG000|COMPLETED|Phase 1 (78 Weeks)||747
11166719|NCT01623752|12355685|FG001|COMPLETED|Phase 1 (78 Weeks)||233
11166720|NCT01623752|12355686|FG002|COMPLETED|Phase 1 (78 Weeks)||1
11166721|NCT01623752|12355684|FG000|NOT COMPLETED|Phase 1 (78 Weeks)||631
11166722|NCT01623752|12355685|FG001|NOT COMPLETED|Phase 1 (78 Weeks)||207
11166723|NCT01623752|12355686|FG002|NOT COMPLETED|Phase 1 (78 Weeks)||2
11166724|NCT01623752|12355684|FG000|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291
11166725|NCT01623752|12355685|FG001|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116
11166726|NCT01623752|12355686|FG002|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0
11166727|NCT01623752|12355684|FG000|COMPLETED|Phase 2 (78 Weeks)||225
11166728|NCT01623752|12355685|FG001|COMPLETED|Phase 2 (78 Weeks)||98
11166729|NCT01623752|12355686|FG002|COMPLETED|Phase 2 (78 Weeks)||0
11166730|NCT01623752|12355684|FG000|NOT COMPLETED|Phase 2 (78 Weeks)||66
11166731|NCT01623752|12355685|FG001|NOT COMPLETED|Phase 2 (78 Weeks)||18
11166732|NCT01623752|12355686|FG002|NOT COMPLETED|Phase 2 (78 Weeks)||0
11166733|NCT01623830|12355697|FG000|STARTED|Overall Study||45
11166734|NCT01623830|12355698|FG001|STARTED|Overall Study||44
11166735|NCT01623830|12355697|FG000|COMPLETED|Overall Study||38
11166736|NCT01623830|12355698|FG001|COMPLETED|Overall Study||35
11166737|NCT01623830|12355697|FG000|NOT COMPLETED|Overall Study||7
11166738|NCT01623830|12355698|FG001|NOT COMPLETED|Overall Study||9
11166739|NCT01623869|12355704|FG000|STARTED|Overall Study||16
11166740|NCT01623869|12355704|FG000|COMPLETED|Overall Study||16
11166741|NCT01623869|12355704|FG000|NOT COMPLETED|Overall Study||0
11166742|NCT01624090|12355712|FG000|STARTED|Overall Study||2
11166743|NCT01624090|12355713|FG001|STARTED|Overall Study||2
11166744|NCT01624090|12355714|FG002|STARTED|Overall Study||10
11166745|NCT01624090|12355715|FG003|STARTED|Overall Study||2
11419769|NCT03095287|12618474|FG000|NOT COMPLETED|Overall Study||2
11419770|NCT03236662|12618478|FG000|STARTED|Overall Study||2
11166746|NCT01624090|12355712|FG000|COMPLETED|Overall Study||2
11166747|NCT01624090|12355713|FG001|COMPLETED|Overall Study||0
11166748|NCT01624090|12355714|FG002|COMPLETED|Overall Study||3
11166749|NCT01624090|12355715|FG003|COMPLETED|Overall Study||2
11166750|NCT01624090|12355712|FG000|NOT COMPLETED|Overall Study||0
11166751|NCT01624090|12355713|FG001|NOT COMPLETED|Overall Study||2
11166752|NCT01624090|12355714|FG002|NOT COMPLETED|Overall Study||7
11166753|NCT01624090|12355715|FG003|NOT COMPLETED|Overall Study||0
11166754|NCT01624142|12355727|FG000|STARTED|Overall Study||106
11166755|NCT01624142|12355728|FG001|STARTED|Overall Study||194
11166756|NCT01624142|12355727|FG000|COMPLETED|Overall Study||74
11166757|NCT01624142|12355728|FG001|COMPLETED|Overall Study||178
11166758|NCT01624142|12355727|FG000|NOT COMPLETED|Overall Study||32
11166759|NCT01624142|12355728|FG001|NOT COMPLETED|Overall Study||16
11166760|NCT01624168|12355738|FG000|STARTED|Overall Study||19
11166761|NCT01624168|12355739|FG001|STARTED|Overall Study||28
11166762|NCT01624168|12355740|FG002|STARTED|Overall Study||28
11166763|NCT01624168|12355738|FG000|COMPLETED|Overall Study||15
11166764|NCT01624168|12355739|FG001|COMPLETED|Overall Study||16
11166765|NCT01624168|12355740|FG002|COMPLETED|Overall Study||22
11166766|NCT01624168|12355738|FG000|NOT COMPLETED|Overall Study||4
11166767|NCT01624168|12355739|FG001|NOT COMPLETED|Overall Study||12
11166768|NCT01624168|12355740|FG002|NOT COMPLETED|Overall Study||6
11166769|NCT01624194|12355750|FG000|STARTED|Overall Study||16
11166770|NCT01624194|12355751|FG001|STARTED|Overall Study||18
11166771|NCT01624194|12355750|FG000|COMPLETED|Overall Study||14
11166772|NCT01624194|12355751|FG001|COMPLETED|Overall Study||18
11166773|NCT01624194|12355750|FG000|NOT COMPLETED|Overall Study||2
11166774|NCT01624194|12355751|FG001|NOT COMPLETED|Overall Study||0
11166775|NCT01624233|12355758|FG000|STARTED|Period 2 - Induction||91
11166776|NCT01624233|12355758|FG000|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
11166777|NCT01624233|12355758|FG000|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
11166778|NCT01624233|12355758|FG000|Pustular Ps|Period 2 - Induction||5
11166779|NCT01624233|12355758|FG000|Plaque Ps|Period 2 - Induction||78
11166780|NCT01624233|12355758|FG000|COMPLETED|Period 2 - Induction||90
11166781|NCT01624233|12355758|FG000|NOT COMPLETED|Period 2 - Induction||1
11166782|NCT01624233|12355758|FG000|STARTED|Period 3 - Maintenance||90
11166783|NCT01624233|12355758|FG000|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
11166784|NCT01624233|12355758|FG000|COMPLETED|Period 3 - Maintenance||83
11166785|NCT01624233|12355758|FG000|NOT COMPLETED|Period 3 - Maintenance||7
11166786|NCT01624233|12355758|FG000|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
11166787|NCT01624233|12355758|FG000|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
11166788|NCT01624233|12355758|FG000|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
11166789|NCT01624233|12355758|FG000|COMPLETED|Period 4 - Drug Free Period||9
11166790|NCT01624233|12355758|FG000|NOT COMPLETED|Period 4 - Drug Free Period||61
11166791|NCT01624233|12355758|FG000|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
11166792|NCT01624233|12355758|FG000|COMPLETED|Period 5 - Retreatment Period||70
11166793|NCT01624233|12355758|FG000|NOT COMPLETED|Period 5 - Retreatment Period||10
11166794|NCT01624233|12355758|FG000|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
11166795|NCT01624233|12355758|FG000|COMPLETED|Period 6: Follow-up||79
11166796|NCT01624233|12355758|FG000|NOT COMPLETED|Period 6: Follow-up||9
11166797|NCT01624259|12355768|FG000|STARTED|Overall Study||299
11166798|NCT01624259|12355769|FG001|STARTED|Overall Study||300
11166799|NCT01624259|12355768|FG000|Received at Least One Dose of Study Drug|Overall Study||299
11166800|NCT01624259|12355769|FG001|Received at Least One Dose of Study Drug|Overall Study||300
11166801|NCT01624259|12355768|FG000|COMPLETED|Overall Study|Completed the study on study treatment|269
11166802|NCT01624259|12355769|FG001|COMPLETED|Overall Study|Completed the study on study treatment|269
11166803|NCT01624259|12355768|FG000|NOT COMPLETED|Overall Study||30
11166804|NCT01624259|12355769|FG001|NOT COMPLETED|Overall Study||31
11166805|NCT01624350|12355777|FG000|STARTED|Overall Study||100
11166806|NCT01624350|12355777|FG000|COMPLETED|Overall Study||75
11166807|NCT01624350|12355777|FG000|NOT COMPLETED|Overall Study||25
11166808|NCT01624363|12355797|FG000|STARTED|Overall Study||341
11166809|NCT01624363|12355797|FG000|COMPLETED|Overall Study||341
11166810|NCT01624363|12355797|FG000|NOT COMPLETED|Overall Study||0
11166811|NCT01624467|12355801|FG000|STARTED|Overall Study||75
11166812|NCT01624467|12355801|FG000|Received at Least One Dose of Study Drug|Overall Study||75
11166813|NCT01624467|12355801|FG000|COMPLETED|Overall Study||44
11166814|NCT01624467|12355801|FG000|NOT COMPLETED|Overall Study||31
11166815|NCT01624506|12355809|FG000|STARTED|Overall Study||530
11166816|NCT01624506|12355810|FG001|STARTED|Overall Study||230
11166817|NCT01624506|12355809|FG000|COMPLETED|Overall Study||465
11166818|NCT01624506|12355810|FG001|COMPLETED|Overall Study||213
11166819|NCT01624506|12355809|FG000|NOT COMPLETED|Overall Study||65
11166820|NCT01624506|12355810|FG001|NOT COMPLETED|Overall Study||17
11166821|NCT01624662|12355820|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
11166822|NCT01624662|12355821|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
11166823|NCT01624662|12355822|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
11166824|NCT01624662|12355823|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
11166825|NCT01624662|12355820|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
11166826|NCT01624662|12355821|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
11166827|NCT01624662|12355822|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
11166828|NCT01624662|12355823|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
11166829|NCT01624662|12355820|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
11166830|NCT01624662|12355821|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
11166831|NCT01624662|12355822|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
11166832|NCT01624662|12355823|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
11166833|NCT01624662|12355820|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||70
11323445|NCT03368664|12520706|FG000|Treated|Phase2:AlemtuzumabTreatment:Month 0 to 8||11
11166834|NCT01624662|12355821|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||78
11166835|NCT01624662|12355822|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||72
11419771|NCT03236662|12618478|FG000|COMPLETED|Overall Study||2
11419772|NCT03236662|12618478|FG000|NOT COMPLETED|Overall Study||0
11166836|NCT01624662|12355823|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||79
11166837|NCT01624662|12355820|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
11166838|NCT01624662|12355821|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
11166839|NCT01624662|12355822|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
11166840|NCT01624662|12355823|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
11166841|NCT01624662|12355820|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
11166842|NCT01624662|12355821|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
11166843|NCT01624662|12355822|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
11166844|NCT01624662|12355823|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
11166845|NCT01624870|12355844|FG000|STARTED|Overall Study|provided informed consent|200
11166846|NCT01624870|12355844|FG000|COMPLETED|Overall Study|Completed 6 month follow up|173
11166847|NCT01624870|12355844|FG000|NOT COMPLETED|Overall Study||27
11166848|NCT01624740|12355852|FG000|STARTED|First Intervention (3-4 Days)||9
11166849|NCT01624740|12355853|FG001|STARTED|First Intervention (3-4 Days)||9
11166850|NCT01624740|12355852|FG000|COMPLETED|First Intervention (3-4 Days)||9
11166851|NCT01624740|12355853|FG001|COMPLETED|First Intervention (3-4 Days)||9
11166852|NCT01624740|12355852|FG000|NOT COMPLETED|First Intervention (3-4 Days)||0
11166853|NCT01624740|12355853|FG001|NOT COMPLETED|First Intervention (3-4 Days)||0
11166854|NCT01624740|12355852|FG000|STARTED|Washout (1 Hour)||9
11166855|NCT01624740|12355853|FG001|STARTED|Washout (1 Hour)||9
11166856|NCT01624740|12355852|FG000|COMPLETED|Washout (1 Hour)||9
11166857|NCT01624740|12355853|FG001|COMPLETED|Washout (1 Hour)||9
11166858|NCT01624740|12355852|FG000|NOT COMPLETED|Washout (1 Hour)||0
11166859|NCT01624740|12355853|FG001|NOT COMPLETED|Washout (1 Hour)||0
11166860|NCT01624740|12355852|FG000|STARTED|Second Intervention (3-4 Days)||9
11166861|NCT01624740|12355853|FG001|STARTED|Second Intervention (3-4 Days)||9
11166862|NCT01624740|12355852|FG000|COMPLETED|Second Intervention (3-4 Days)||8
11166863|NCT01624740|12355853|FG001|COMPLETED|Second Intervention (3-4 Days)||9
11166864|NCT01624740|12355852|FG000|NOT COMPLETED|Second Intervention (3-4 Days)||1
11166865|NCT01624740|12355853|FG001|NOT COMPLETED|Second Intervention (3-4 Days)||0
11166866|NCT01624948|12355862|FG000|STARTED|Overall Study||20
11166867|NCT01624948|12355863|FG001|STARTED|Overall Study||20
11166868|NCT01624948|12355862|FG000|COMPLETED|Overall Study||20
11166869|NCT01624948|12355863|FG001|COMPLETED|Overall Study||20
11166870|NCT01624948|12355862|FG000|NOT COMPLETED|Overall Study||0
11166871|NCT01624948|12355863|FG001|NOT COMPLETED|Overall Study||0
11166872|NCT01624974|12355875|FG000|STARTED|Period III of Treatment (4 Weeks)||54
11166873|NCT01624974|12355876|FG001|STARTED|Period III of Treatment (4 Weeks)||53
11166874|NCT01624974|12355875|FG000|COMPLETED|Period III of Treatment (4 Weeks)||47
11166875|NCT01624974|12355876|FG001|COMPLETED|Period III of Treatment (4 Weeks)||45
11166876|NCT01624974|12355875|FG000|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
11166877|NCT01624974|12355876|FG001|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
11166878|NCT01624974|12355875|FG000|STARTED|Period IV Washout (4 Weeks)||47
11166879|NCT01624974|12355876|FG001|STARTED|Period IV Washout (4 Weeks)||45
11166880|NCT01624974|12355875|FG000|COMPLETED|Period IV Washout (4 Weeks)||44
11166881|NCT01624974|12355876|FG001|COMPLETED|Period IV Washout (4 Weeks)||42
11166882|NCT01624974|12355875|FG000|NOT COMPLETED|Period IV Washout (4 Weeks)||3
11166883|NCT01624974|12355876|FG001|NOT COMPLETED|Period IV Washout (4 Weeks)||3
11166884|NCT01624974|12355875|FG000|STARTED|Period V of Treatment (4 Weeks)||44
11166885|NCT01624974|12355876|FG001|STARTED|Period V of Treatment (4 Weeks)||42
11166886|NCT01624974|12355875|FG000|COMPLETED|Period V of Treatment (4 Weeks)||39
11166887|NCT01624974|12355876|FG001|COMPLETED|Period V of Treatment (4 Weeks)||42
11166888|NCT01624974|12355875|FG000|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
11166889|NCT01624974|12355876|FG001|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
11166890|NCT01625000|12355888|FG000|STARTED|Overall Study||126
11166891|NCT01625000|12355889|FG001|STARTED|Overall Study||133
11166892|NCT01625000|12355890|FG002|STARTED|Overall Study||67
11166893|NCT01625000|12355891|FG003|STARTED|Overall Study||56
11166894|NCT01625000|12355892|FG004|STARTED|Overall Study||126
11166895|NCT01625000|12355888|FG000|COMPLETED|Overall Study||74
11166896|NCT01625000|12355889|FG001|COMPLETED|Overall Study||81
11166897|NCT01625000|12355890|FG002|COMPLETED|Overall Study||34
11166898|NCT01625000|12355891|FG003|COMPLETED|Overall Study||37
11166899|NCT01625000|12355892|FG004|COMPLETED|Overall Study||71
11166900|NCT01625000|12355888|FG000|NOT COMPLETED|Overall Study||52
11166901|NCT01625000|12355889|FG001|NOT COMPLETED|Overall Study||52
11166902|NCT01625000|12355890|FG002|NOT COMPLETED|Overall Study||33
11323446|NCT03368664|12520706|FG000|COMPLETED|Phase2:AlemtuzumabTreatment:Month 0 to 8||11
11323447|NCT03368664|12520706|FG000|NOT COMPLETED|Phase2:AlemtuzumabTreatment:Month 0 to 8||0
11166903|NCT01625000|12355891|FG003|NOT COMPLETED|Overall Study||19
11166904|NCT01625000|12355892|FG004|NOT COMPLETED|Overall Study||55
11166905|NCT01625013|12355904|FG000|STARTED|Overall Study||51
11166906|NCT01625013|12355904|FG000|COMPLETED|Overall Study||48
11166907|NCT01625013|12355904|FG000|NOT COMPLETED|Overall Study||3
11166908|NCT01625091|12355911|FG000|STARTED|Intervention||96
11166909|NCT01625091|12355912|FG001|STARTED|Intervention||98
11166910|NCT01625091|12355911|FG000|2 Months|Intervention||90
11166911|NCT01625091|12355912|FG001|2 Months|Intervention||93
11166912|NCT01625091|12355911|FG000|4 Months|Intervention||85
11166913|NCT01625091|12355912|FG001|4 Months|Intervention||87
11166914|NCT01625091|12355911|FG000|COMPLETED|Intervention||85
11166915|NCT01625091|12355912|FG001|COMPLETED|Intervention||87
11166916|NCT01625091|12355911|FG000|NOT COMPLETED|Intervention||11
11166917|NCT01625091|12355912|FG001|NOT COMPLETED|Intervention||11
11166918|NCT01625091|12355911|FG000|STARTED|Post-intervention||85
11166919|NCT01625091|12355912|FG001|STARTED|Post-intervention||87
11166920|NCT01625091|12355911|FG000|7 Months|Post-intervention||81
11166921|NCT01625091|12355912|FG001|7 Months|Post-intervention||85
11166922|NCT01625091|12355911|FG000|COMPLETED|Post-intervention||81
11166923|NCT01625091|12355912|FG001|COMPLETED|Post-intervention||85
11166924|NCT01625091|12355911|FG000|NOT COMPLETED|Post-intervention||4
11166925|NCT01625091|12355912|FG001|NOT COMPLETED|Post-intervention||2
11166926|NCT01625104|12355920|FG000|STARTED|Overall Study||448
11166927|NCT01625104|12355921|FG001|STARTED|Overall Study||434
11166928|NCT01625104|12355920|FG000|COMPLETED|Overall Study||448
11166929|NCT01625104|12355921|FG001|COMPLETED|Overall Study||434
11166930|NCT01625104|12355920|FG000|NOT COMPLETED|Overall Study||0
11166931|NCT01625104|12355921|FG001|NOT COMPLETED|Overall Study||0
11166932|NCT01625169|12355927|FG000|STARTED|Overall Study||9
11166933|NCT01625169|12355927|FG000|COMPLETED|Overall Study||9
11166934|NCT01625169|12355927|FG000|NOT COMPLETED|Overall Study||0
11166935|NCT01625182|12355933|FG000|STARTED|Overall Study||54
11166936|NCT01625182|12355934|FG001|STARTED|Overall Study||52
11166937|NCT01625182|12355933|FG000|COMPLETED|Overall Study||34
11166938|NCT01625182|12355934|FG001|COMPLETED|Overall Study||41
11166939|NCT01625182|12355933|FG000|NOT COMPLETED|Overall Study||20
11166940|NCT01625182|12355934|FG001|NOT COMPLETED|Overall Study||11
11166941|NCT01625221|12355941|FG000|STARTED|Overall Study||35
11166942|NCT01625221|12355941|FG000|COMPLETED|Overall Study||28
11166943|NCT01625221|12355941|FG000|NOT COMPLETED|Overall Study||7
11166944|NCT01625338|12355948|FG000|STARTED|Overall Study||114
11166945|NCT01625338|12355949|FG001|STARTED|Overall Study||200
11166946|NCT01625338|12355950|FG002|STARTED|Overall Study||220
11166947|NCT01625338|12355948|FG000|COMPLETED|Overall Study||82
11166948|NCT01625338|12355949|FG001|COMPLETED|Overall Study||156
11166949|NCT01625338|12355950|FG002|COMPLETED|Overall Study||181
11166950|NCT01625338|12355948|FG000|NOT COMPLETED|Overall Study||32
11166951|NCT01625338|12355949|FG001|NOT COMPLETED|Overall Study||44
11166952|NCT01625338|12355950|FG002|NOT COMPLETED|Overall Study||39
11166953|NCT01625377|12355960|FG000|STARTED|Overall Study|"Started indicates randomized patients."|95
11166954|NCT01625377|12355961|FG001|STARTED|Overall Study||93
11166955|NCT01625377|12355960|FG000|Safety Set of Population|Overall Study||94
11166956|NCT01625377|12355961|FG001|Safety Set of Population|Overall Study||90
11166957|NCT01625377|12355960|FG000|Intent to Treat Population|Overall Study||93
11166958|NCT01625377|12355961|FG001|Intent to Treat Population|Overall Study||90
11166959|NCT01625377|12355960|FG000|COMPLETED|Overall Study||88
11166960|NCT01625377|12355961|FG001|COMPLETED|Overall Study||71
11166961|NCT01625377|12355960|FG000|NOT COMPLETED|Overall Study||7
11166962|NCT01625377|12355961|FG001|NOT COMPLETED|Overall Study||22
11419773|NCT02930122|12618484|FG000|STARTED|Overall Study||3
11419774|NCT02930122|12618485|FG001|STARTED|Overall Study||3
11419775|NCT02930122|12618484|FG000|COMPLETED|Overall Study||0
11166963|NCT01625416|12355969|FG000|STARTED|Overall Study||60
11166964|NCT01625416|12355970|FG001|STARTED|Overall Study||61
11166965|NCT01625416|12355969|FG000|COMPLETED|Overall Study||51
11166966|NCT01625416|12355970|FG001|COMPLETED|Overall Study||54
11166967|NCT01625416|12355969|FG000|NOT COMPLETED|Overall Study||9
11166968|NCT01625416|12355970|FG001|NOT COMPLETED|Overall Study||7
11166969|NCT01625455|12355979|FG000|STARTED|Overall Study||2
11166970|NCT01625455|12355980|FG001|STARTED|Overall Study||3
11166971|NCT01625455|12355979|FG000|COMPLETED|Overall Study||2
11166972|NCT01625455|12355980|FG001|COMPLETED|Overall Study||3
11166973|NCT01625455|12355979|FG000|NOT COMPLETED|Overall Study||0
11166974|NCT01625455|12355980|FG001|NOT COMPLETED|Overall Study||0
11166975|NCT01625507|12355986|FG000|STARTED|Overall Study||73
11166976|NCT01625507|12355986|FG000|COMPLETED|Overall Study||63
11166977|NCT01625507|12355986|FG000|NOT COMPLETED|Overall Study||10
11166978|NCT01625689|12355993|FG000|STARTED|Overall Study||150
11419776|NCT02930122|12618485|FG001|COMPLETED|Overall Study||0
11166979|NCT01625689|12355994|FG001|STARTED|Overall Study||150
11166980|NCT01625689|12355993|FG000|COMPLETED|Overall Study||148
11166981|NCT01625689|12355994|FG001|COMPLETED|Overall Study||149
11166982|NCT01625689|12355993|FG000|NOT COMPLETED|Overall Study||2
11166983|NCT01625689|12355994|FG001|NOT COMPLETED|Overall Study||1
11166984|NCT01625845|12356002|FG000|STARTED|Overall Study||10
11166985|NCT01625845|12356003|FG001|STARTED|Overall Study||6
11166986|NCT01625845|12356002|FG000|COMPLETED|Overall Study||5
11166987|NCT01625845|12356003|FG001|COMPLETED|Overall Study||3
11166988|NCT01625845|12356002|FG000|NOT COMPLETED|Overall Study||5
11166989|NCT01625845|12356003|FG001|NOT COMPLETED|Overall Study||3
11166990|NCT01625897|12356011|FG000|STARTED|Overall Study||83
11166991|NCT01625897|12356012|FG001|STARTED|Overall Study||42
11166992|NCT01625897|12356011|FG000|COMPLETED|Overall Study||31
11166993|NCT01625897|12356012|FG001|COMPLETED|Overall Study||28
11166994|NCT01625897|12356011|FG000|NOT COMPLETED|Overall Study||52
11166995|NCT01625897|12356012|FG001|NOT COMPLETED|Overall Study||14
11166996|NCT01625910|12356020|FG000|STARTED|Overall Study||35
11166997|NCT01625910|12356021|FG001|STARTED|Overall Study||37
11026792|NCT00830440|12205400|FG001|Completed 16 Week Follow up|Overall Study||0
11026793|NCT00830440|12205399|FG000|Completed 24 Week Follow up|Overall Study||3
11026794|NCT00830440|12205400|FG001|Completed 24 Week Follow up|Overall Study||0
11026795|NCT00830440|12205399|FG000|COMPLETED|Overall Study||24
11026796|NCT00830440|12205400|FG001|COMPLETED|Overall Study||11
11026797|NCT00830440|12205399|FG000|NOT COMPLETED|Overall Study||8
11026798|NCT00830440|12205400|FG001|NOT COMPLETED|Overall Study||0
11026799|NCT00830518|12205409|FG000|STARTED|Overall Study||46
11026800|NCT00830518|12205410|FG001|STARTED|Overall Study||11
11026801|NCT00830518|12205409|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
11026802|NCT00830518|12205410|FG001|COMPLETED|Overall Study||0
11026803|NCT00830518|12205409|FG000|NOT COMPLETED|Overall Study||46
11026804|NCT00830518|12205410|FG001|NOT COMPLETED|Overall Study||11
11026805|NCT00830596|12205420|FG000|STARTED|Overall Study||74
11026806|NCT00830596|12205421|FG001|STARTED|Overall Study||74
11026807|NCT00830596|12205422|FG002|STARTED|Overall Study||73
11026808|NCT00830596|12205420|FG000|COMPLETED|Overall Study||72
11026809|NCT00830596|12205421|FG001|COMPLETED|Overall Study||72
11026810|NCT00830596|12205422|FG002|COMPLETED|Overall Study||67
11026811|NCT00830596|12205420|FG000|NOT COMPLETED|Overall Study||2
11166998|NCT01625910|12356020|FG000|COMPLETED|Overall Study||32
11166999|NCT01625910|12356021|FG001|COMPLETED|Overall Study||33
11167000|NCT01625910|12356020|FG000|NOT COMPLETED|Overall Study||3
11167001|NCT01625910|12356021|FG001|NOT COMPLETED|Overall Study||4
11167002|NCT01625923|12356029|FG000|STARTED|Overall Study||3
11167003|NCT01625923|12356029|FG000|COMPLETED|Overall Study||3
11167004|NCT01625923|12356029|FG000|NOT COMPLETED|Overall Study||0
11167005|NCT01625988|12356036|FG000|STARTED|Overall Study|One participant was randomized inappropriately and was discontinued before start of study treatment.|108
11167006|NCT01625988|12356037|FG001|STARTED|Overall Study||110
11167007|NCT01625988|12356036|FG000|Received at Least One Dose of Study Drug|Overall Study||107
11419777|NCT02930122|12618484|FG000|NOT COMPLETED|Overall Study||3
11419778|NCT02930122|12618485|FG001|NOT COMPLETED|Overall Study||3
11419779|NCT01444209|12618492|FG000|STARTED|Overall Study||2
11419780|NCT01444209|12618492|FG000|COMPLETED|Overall Study||2
11419781|NCT01444209|12618492|FG000|NOT COMPLETED|Overall Study||0
11419782|NCT04267380|12618498|FG000|STARTED|Overall Study||149
11419783|NCT04267380|12618499|FG001|STARTED|Overall Study||149
11419784|NCT04267380|12618498|FG000|COMPLETED|Overall Study||149
11167008|NCT01625988|12356037|FG001|Received at Least One Dose of Study Drug|Overall Study||110
11167009|NCT01625988|12356036|FG000|COMPLETED|Overall Study||94
11167010|NCT01625988|12356037|FG001|COMPLETED|Overall Study||97
11167011|NCT01625988|12356036|FG000|NOT COMPLETED|Overall Study||14
11167012|NCT01625988|12356037|FG001|NOT COMPLETED|Overall Study||13
11167013|NCT01626092|12356046|FG000|STARTED|Overall Study||3
11167014|NCT01626092|12356046|FG000|COMPLETED|Overall Study||3
11167015|NCT01626092|12356046|FG000|NOT COMPLETED|Overall Study||0
11167016|NCT01626118|12356054|FG000|STARTED|Overall Study||94
11167017|NCT01626118|12356055|FG001|STARTED|Overall Study||93
11167018|NCT01626118|12356056|FG002|STARTED|Overall Study||92
11167019|NCT01626118|12356057|FG003|STARTED|Overall Study||94
11167020|NCT01626118|12356054|FG000|COMPLETED|Overall Study||92
11419785|NCT04267380|12618499|FG001|COMPLETED|Overall Study||149
11419786|NCT04267380|12618498|FG000|NOT COMPLETED|Overall Study||0
11419787|NCT04267380|12618499|FG001|NOT COMPLETED|Overall Study||0
11419788|NCT04144166|12618505|FG000|STARTED|Overall Study||60
11419789|NCT04144166|12618505|FG000|COMPLETED|Overall Study||57
11419790|NCT04144166|12618505|FG000|NOT COMPLETED|Overall Study||3
11419791|NCT04090164|12618516|FG000|STARTED|Overall Study|Number of patients retrivied from the hospital files.|650
11419792|NCT04090164|12618517|FG001|STARTED|Overall Study||145
11419793|NCT04090164|12618516|FG000|COMPLETED|Overall Study|Number of patients analyzed.|405
11167021|NCT01626118|12356055|FG001|COMPLETED|Overall Study||91
11167022|NCT01626118|12356056|FG002|COMPLETED|Overall Study||90
11167023|NCT01626118|12356057|FG003|COMPLETED|Overall Study||91
11167024|NCT01626118|12356054|FG000|NOT COMPLETED|Overall Study||2
11167025|NCT01626118|12356055|FG001|NOT COMPLETED|Overall Study||2
11167026|NCT01626118|12356056|FG002|NOT COMPLETED|Overall Study||2
11167027|NCT01626118|12356057|FG003|NOT COMPLETED|Overall Study||3
11167028|NCT01626352|12356067|FG000|STARTED|Overall Study||22
11167029|NCT01626352|12356067|FG000|COMPLETED|Overall Study||12
11167030|NCT01626352|12356067|FG000|NOT COMPLETED|Overall Study||10
11167031|NCT01626391|12356076|FG000|STARTED|Overall Study||5
11167032|NCT01626391|12356077|FG001|STARTED|Overall Study||4
11167033|NCT01626391|12356076|FG000|COMPLETED|Overall Study||3
11167034|NCT01626391|12356077|FG001|COMPLETED|Overall Study||4
11026812|NCT00830596|12205421|FG001|NOT COMPLETED|Overall Study||2
11026813|NCT00830596|12205422|FG002|NOT COMPLETED|Overall Study||6
11167035|NCT01626391|12356076|FG000|NOT COMPLETED|Overall Study||2
11167036|NCT01626391|12356077|FG001|NOT COMPLETED|Overall Study||0
11167037|NCT01626456|12356085|FG000|STARTED|Overall Study||110
11167038|NCT01626456|12356086|FG001|STARTED|Overall Study||368
11167039|NCT01626456|12356085|FG000|COMPLETED|Overall Study||75
11419794|NCT04090164|12618517|FG001|COMPLETED|Overall Study||145
11419795|NCT04090164|12618516|FG000|NOT COMPLETED|Overall Study||245
11167040|NCT01626456|12356086|FG001|COMPLETED|Overall Study||251
11167041|NCT01626456|12356085|FG000|NOT COMPLETED|Overall Study||35
11167042|NCT01626456|12356086|FG001|NOT COMPLETED|Overall Study||117
11167043|NCT01626495|12356101|FG000|STARTED|Overall Study|Number of enrolled subjects|73
11167044|NCT01626495|12356101|FG000|Intervention|Overall Study||62
11167045|NCT01626495|12356101|FG000|COMPLETED|Overall Study|Follow up phase completed as per protocol|21
11167046|NCT01626495|12356101|FG000|NOT COMPLETED|Overall Study||52
11167047|NCT01626664|12356107|FG000|STARTED|Randomization Period||47
11167048|NCT01626664|12356108|FG001|STARTED|Randomization Period||24
11167049|NCT01626664|12356109|FG002|STARTED|Randomization Period||0
11167050|NCT01626664|12356107|FG000|COMPLETED|Randomization Period||47
11167051|NCT01626664|12356108|FG001|COMPLETED|Randomization Period||24
11167052|NCT01626664|12356109|FG002|COMPLETED|Randomization Period||0
11167053|NCT01626664|12356107|FG000|NOT COMPLETED|Randomization Period||0
11167054|NCT01626664|12356108|FG001|NOT COMPLETED|Randomization Period||0
11167055|NCT01626664|12356109|FG002|NOT COMPLETED|Randomization Period||0
11167056|NCT01626664|12356107|FG000|STARTED|Crossover Period||0
11167057|NCT01626664|12356108|FG001|STARTED|Crossover Period||0
11167058|NCT01626664|12356109|FG002|STARTED|Crossover Period||18
11167059|NCT01626664|12356107|FG000|COMPLETED|Crossover Period||0
11167060|NCT01626664|12356108|FG001|COMPLETED|Crossover Period||0
11167061|NCT01626664|12356109|FG002|COMPLETED|Crossover Period||18
11167062|NCT01626664|12356107|FG000|NOT COMPLETED|Crossover Period||0
11167063|NCT01626664|12356108|FG001|NOT COMPLETED|Crossover Period||0
11167064|NCT01626664|12356109|FG002|NOT COMPLETED|Crossover Period||0
11167065|NCT01626690|12356118|FG000|STARTED|Overall Study||49
11167066|NCT01626690|12356119|FG001|STARTED|Overall Study||51
11167067|NCT01626690|12356118|FG000|COMPLETED|Overall Study||47
11167068|NCT01626690|12356119|FG001|COMPLETED|Overall Study||51
11167069|NCT01626690|12356118|FG000|NOT COMPLETED|Overall Study||2
11167070|NCT01626690|12356119|FG001|NOT COMPLETED|Overall Study||0
11167071|NCT01626820|12356129|FG000|STARTED|Overall Study||56
11167072|NCT01626820|12356130|FG001|STARTED|Overall Study||57
11167073|NCT01626820|12356129|FG000|COMPLETED|Overall Study||56
11167074|NCT01626820|12356130|FG001|COMPLETED|Overall Study||57
11167075|NCT01626820|12356129|FG000|NOT COMPLETED|Overall Study||0
11167076|NCT01626820|12356130|FG001|NOT COMPLETED|Overall Study||0
11167077|NCT01626859|12356140|FG000|STARTED|Overall Study||11
11167078|NCT01626859|12356141|FG001|STARTED|Overall Study||16
11167079|NCT01626859|12356142|FG002|STARTED|Overall Study||11
11167080|NCT01626859|12356140|FG000|COMPLETED|Overall Study||9
11167081|NCT01626859|12356141|FG001|COMPLETED|Overall Study||8
11167082|NCT01626859|12356142|FG002|COMPLETED|Overall Study||7
11167083|NCT01626859|12356140|FG000|NOT COMPLETED|Overall Study||2
11167084|NCT01626859|12356141|FG001|NOT COMPLETED|Overall Study||8
11167085|NCT01626859|12356142|FG002|NOT COMPLETED|Overall Study||4
11167086|NCT01626872|12356153|FG000|STARTED|Overall Study||81
11167087|NCT01626872|12356154|FG001|STARTED|Overall Study||109
11167088|NCT01626872|12356155|FG002|STARTED|Overall Study||58
11167089|NCT01626872|12356153|FG000|COMPLETED|Overall Study||29
11167090|NCT01626872|12356154|FG001|COMPLETED|Overall Study||43
11167091|NCT01626872|12356155|FG002|COMPLETED|Overall Study||34
11167092|NCT01626872|12356153|FG000|NOT COMPLETED|Overall Study||52
11167093|NCT01626872|12356154|FG001|NOT COMPLETED|Overall Study||66
11167094|NCT01626872|12356155|FG002|NOT COMPLETED|Overall Study||24
11167095|NCT01626885|12356163|FG000|STARTED|Overall Study||42
11167096|NCT01626885|12356163|FG000|COMPLETED|Overall Study||30
11167097|NCT01626885|12356163|FG000|NOT COMPLETED|Overall Study||12
11167098|NCT01626989|12356167|FG000|STARTED|Screening Period||44
11167099|NCT01626989|12356168|FG001|STARTED|Screening Period||0
11167100|NCT01626989|12356169|FG002|STARTED|Screening Period||0
11167101|NCT01626989|12356167|FG000|COMPLETED|Screening Period||27
11167102|NCT01626989|12356168|FG001|COMPLETED|Screening Period||0
11167103|NCT01626989|12356169|FG002|COMPLETED|Screening Period||0
11167104|NCT01626989|12356167|FG000|NOT COMPLETED|Screening Period||17
11167105|NCT01626989|12356168|FG001|NOT COMPLETED|Screening Period||0
11167106|NCT01626989|12356169|FG002|NOT COMPLETED|Screening Period||0
11167107|NCT01626989|12356167|FG000|STARTED|Fist Intervention (Night 1)||0
11167108|NCT01626989|12356168|FG001|STARTED|Fist Intervention (Night 1)||15
11167109|NCT01626989|12356169|FG002|STARTED|Fist Intervention (Night 1)||12
11167110|NCT01626989|12356167|FG000|COMPLETED|Fist Intervention (Night 1)||0
11167111|NCT01626989|12356168|FG001|COMPLETED|Fist Intervention (Night 1)||15
11167112|NCT01626989|12356169|FG002|COMPLETED|Fist Intervention (Night 1)||12
11167113|NCT01626989|12356167|FG000|NOT COMPLETED|Fist Intervention (Night 1)||0
11167114|NCT01626989|12356168|FG001|NOT COMPLETED|Fist Intervention (Night 1)||0
11167115|NCT01626989|12356169|FG002|NOT COMPLETED|Fist Intervention (Night 1)||0
11167116|NCT01626989|12356167|FG000|STARTED|Second Intervention (Night 2)||0
11167117|NCT01626989|12356168|FG001|STARTED|Second Intervention (Night 2)||15
11167118|NCT01626989|12356169|FG002|STARTED|Second Intervention (Night 2)||12
11167119|NCT01626989|12356167|FG000|COMPLETED|Second Intervention (Night 2)||0
11167120|NCT01626989|12356168|FG001|COMPLETED|Second Intervention (Night 2)||15
11167121|NCT01626989|12356169|FG002|COMPLETED|Second Intervention (Night 2)||12
11167122|NCT01626989|12356167|FG000|NOT COMPLETED|Second Intervention (Night 2)||0
11167123|NCT01626989|12356168|FG001|NOT COMPLETED|Second Intervention (Night 2)||0
11167124|NCT01626989|12356169|FG002|NOT COMPLETED|Second Intervention (Night 2)||0
11167125|NCT01627002|12356180|FG000|STARTED|Overall Study||4
11167126|NCT01627002|12356181|FG001|STARTED|Overall Study||4
11167127|NCT01627002|12356182|FG002|STARTED|Overall Study||4
11167128|NCT01627002|12356183|FG003|STARTED|Overall Study||4
11167129|NCT01627002|12356184|FG004|STARTED|Overall Study||2
11167130|NCT01627002|12356185|FG005|STARTED|Overall Study||9
11167131|NCT01627002|12356186|FG006|STARTED|Overall Study||10
11167132|NCT01627002|12356187|FG007|STARTED|Overall Study||5
11167133|NCT01627002|12356188|FG008|STARTED|Overall Study||7
11167134|NCT01627002|12356180|FG000|COMPLETED|Overall Study||4
11167135|NCT01627002|12356181|FG001|COMPLETED|Overall Study||4
11167136|NCT01627002|12356182|FG002|COMPLETED|Overall Study||4
11167137|NCT01627002|12356183|FG003|COMPLETED|Overall Study||4
11167138|NCT01627002|12356184|FG004|COMPLETED|Overall Study||2
11167139|NCT01627002|12356185|FG005|COMPLETED|Overall Study||9
11167140|NCT01627002|12356186|FG006|COMPLETED|Overall Study||10
11167141|NCT01627002|12356187|FG007|COMPLETED|Overall Study||5
11167142|NCT01627002|12356188|FG008|COMPLETED|Overall Study||7
11167143|NCT01627002|12356180|FG000|NOT COMPLETED|Overall Study||0
11167144|NCT01627002|12356181|FG001|NOT COMPLETED|Overall Study||0
11167145|NCT01627002|12356182|FG002|NOT COMPLETED|Overall Study||0
11167146|NCT01627002|12356183|FG003|NOT COMPLETED|Overall Study||0
11167147|NCT01627002|12356184|FG004|NOT COMPLETED|Overall Study||0
11167148|NCT01627002|12356185|FG005|NOT COMPLETED|Overall Study||0
11167149|NCT01627002|12356186|FG006|NOT COMPLETED|Overall Study||0
11167150|NCT01627002|12356187|FG007|NOT COMPLETED|Overall Study||0
11167151|NCT01627002|12356188|FG008|NOT COMPLETED|Overall Study||0
11203689|NCT01848353|12394184|FG003|COMPLETED|Phase 3||0
11203690|NCT01848353|12394181|FG000|NOT COMPLETED|Phase 3||1
11203691|NCT01848353|12394182|FG001|NOT COMPLETED|Phase 3||1
11203692|NCT01848353|12394183|FG002|NOT COMPLETED|Phase 3||0
11203693|NCT01848353|12394184|FG003|NOT COMPLETED|Phase 3||0
11203694|NCT01848366|12394202|FG000|STARTED|Overall Study||8
11203695|NCT01848366|12394202|FG000|COMPLETED|Overall Study||8
11203696|NCT01848366|12394202|FG000|NOT COMPLETED|Overall Study||0
11203697|NCT01848457|12394210|FG000|STARTED|Overall Study||4
11203698|NCT01848457|12394211|FG001|STARTED|Overall Study||3
11203699|NCT01848457|12394212|FG002|STARTED|Overall Study||3
11203700|NCT01848457|12394213|FG003|STARTED|Overall Study||3
11203701|NCT01848457|12394210|FG000|Baseline|Overall Study||4
11203702|NCT01848457|12394211|FG001|Baseline|Overall Study||3
11203703|NCT01848457|12394212|FG002|Baseline|Overall Study||3
11203704|NCT01848457|12394213|FG003|Baseline|Overall Study||3
11203705|NCT01848457|12394210|FG000|Cycle 1|Overall Study||4
11203706|NCT01848457|12394211|FG001|Cycle 1|Overall Study||3
11203707|NCT01848457|12394212|FG002|Cycle 1|Overall Study||3
11203708|NCT01848457|12394213|FG003|Cycle 1|Overall Study||3
11203709|NCT01848457|12394210|FG000|Cycle 2|Overall Study||3
11203710|NCT01848457|12394211|FG001|Cycle 2|Overall Study||3
11203711|NCT01848457|12394212|FG002|Cycle 2|Overall Study||3
11203712|NCT01848457|12394213|FG003|Cycle 2|Overall Study||3
11203713|NCT01848457|12394210|FG000|Cycle 3|Overall Study||3
11203714|NCT01848457|12394211|FG001|Cycle 3|Overall Study||3
11203715|NCT01848457|12394212|FG002|Cycle 3|Overall Study||3
11203716|NCT01848457|12394213|FG003|Cycle 3|Overall Study||3
11203717|NCT01848457|12394210|FG000|Cycle 4|Overall Study||3
11203718|NCT01848457|12394211|FG001|Cycle 4|Overall Study||3
11203719|NCT01848457|12394212|FG002|Cycle 4|Overall Study||3
11203720|NCT01848457|12394213|FG003|Cycle 4|Overall Study||3
11203721|NCT01848457|12394210|FG000|COMPLETED|Overall Study||3
11203722|NCT01848457|12394211|FG001|COMPLETED|Overall Study||3
11203723|NCT01848457|12394212|FG002|COMPLETED|Overall Study||3
11203724|NCT01848457|12394213|FG003|COMPLETED|Overall Study||3
11203725|NCT01848457|12394210|FG000|NOT COMPLETED|Overall Study||1
11203726|NCT01848457|12394211|FG001|NOT COMPLETED|Overall Study||0
11203727|NCT01848457|12394212|FG002|NOT COMPLETED|Overall Study||0
11203728|NCT01848457|12394213|FG003|NOT COMPLETED|Overall Study||0
11203729|NCT01848483|12394233|FG000|STARTED|Overall Study||61
11203730|NCT01848483|12394234|FG001|STARTED|Overall Study||60
11203731|NCT01848483|12394233|FG000|COMPLETED|Overall Study||50
11203732|NCT01848483|12394234|FG001|COMPLETED|Overall Study||49
11203733|NCT01848483|12394233|FG000|NOT COMPLETED|Overall Study||11
11203734|NCT01848483|12394234|FG001|NOT COMPLETED|Overall Study||11
11203735|NCT01848756|12394241|FG000|STARTED|Overall Study||15
11203736|NCT01848756|12394241|FG000|COMPLETED|Overall Study|Cycle 1|12
11203737|NCT01848756|12394241|FG000|NOT COMPLETED|Overall Study||3
11203738|NCT01848821|12394248|FG000|STARTED|Overall Study||7
11203739|NCT01848821|12394249|FG001|STARTED|Overall Study||7
11203740|NCT01848821|12394248|FG000|COMPLETED|Overall Study||7
11203741|NCT01848821|12394249|FG001|COMPLETED|Overall Study||7
11203742|NCT01848821|12394248|FG000|NOT COMPLETED|Overall Study||0
11203743|NCT01848821|12394249|FG001|NOT COMPLETED|Overall Study||0
11203744|NCT01848834|12394260|FG000|STARTED|Overall Study||32
11203745|NCT01848834|12394261|FG001|STARTED|Overall Study||61
11203746|NCT01848834|12394262|FG002|STARTED|Overall Study||33
11203747|NCT01848834|12394263|FG003|STARTED|Overall Study||39
11203748|NCT01848834|12394264|FG004|STARTED|Overall Study||132
11203749|NCT01848834|12394260|FG000|Treated|Overall Study||32
11203750|NCT01848834|12394261|FG001|Treated|Overall Study||60
11203751|NCT01848834|12394262|FG002|Treated|Overall Study||33
11203752|NCT01848834|12394263|FG003|Treated|Overall Study||39
11203753|NCT01848834|12394264|FG004|Treated|Overall Study||132
11203754|NCT01848834|12394260|FG000|COMPLETED|Overall Study|Completed means two-year treatment completed|13
11203755|NCT01848834|12394261|FG001|COMPLETED|Overall Study|Completed means two-year treatment completed|13
11203756|NCT01848834|12394262|FG002|COMPLETED|Overall Study|Completed means two-year treatment completed|9
11203757|NCT01848834|12394263|FG003|COMPLETED|Overall Study|Completed means two-year treatment completed|13
11167152|NCT01627067|12356215|FG000|STARTED|Overall Study||23
11167153|NCT01627067|12356215|FG000|COMPLETED|Overall Study||22
11167154|NCT01627067|12356215|FG000|NOT COMPLETED|Overall Study||1
11167155|NCT01627249|12356224|FG000|STARTED|Overall Study||224
11167156|NCT01627249|12356225|FG001|STARTED|Overall Study||218
11167157|NCT01627249|12356226|FG002|STARTED|Overall Study||218
11167158|NCT01627249|12356224|FG000|COMPLETED|Overall Study||208
11167159|NCT01627249|12356225|FG001|COMPLETED|Overall Study||206
11167160|NCT01627249|12356226|FG002|COMPLETED|Overall Study||206
11167161|NCT01627249|12356224|FG000|NOT COMPLETED|Overall Study||16
11167162|NCT01627249|12356225|FG001|NOT COMPLETED|Overall Study||12
11167163|NCT01627249|12356226|FG002|NOT COMPLETED|Overall Study||12
11167164|NCT01627288|12356238|FG000|STARTED|Overall Study||3
11167165|NCT01627288|12356239|FG001|STARTED|Overall Study||3
11167166|NCT01627288|12356240|FG002|STARTED|Overall Study||6
11167167|NCT01627288|12356241|FG003|STARTED|Overall Study||0
11167168|NCT01627288|12356238|FG000|COMPLETED|Overall Study||3
11167169|NCT01627288|12356239|FG001|COMPLETED|Overall Study||3
11167170|NCT01627288|12356240|FG002|COMPLETED|Overall Study||6
11167171|NCT01627288|12356241|FG003|COMPLETED|Overall Study||0
11026814|NCT00830765|12205432|FG000|STARTED|Overall Study||73
11026815|NCT00830765|12205433|FG001|STARTED|Overall Study||71
11026816|NCT00830765|12205432|FG000|COMPLETED|Overall Study||70
11323448|NCT03070600|12520716|FG000|STARTED|Overall Study||2250
11323449|NCT03070600|12520717|FG001|STARTED|Overall Study||2197
11323450|NCT03070600|12520716|FG000|COMPLETED|Overall Study||2156
11323451|NCT03070600|12520717|FG001|COMPLETED|Overall Study||2032
11323452|NCT03070600|12520716|FG000|NOT COMPLETED|Overall Study||94
11323453|NCT03070600|12520717|FG001|NOT COMPLETED|Overall Study||165
11323454|NCT02998671|12520734|FG000|STARTED|Period 1||21
11323455|NCT02998671|12520735|FG001|STARTED|Period 1||13
11323456|NCT02998671|12520736|FG002|STARTED|Period 1||6
11323457|NCT02998671|12520737|FG003|STARTED|Period 1||8
11323458|NCT02998671|12520738|FG004|STARTED|Period 1||4
11323459|NCT02998671|12520734|FG000|COMPLETED|Period 1||17
11323460|NCT02998671|12520735|FG001|COMPLETED|Period 1||10
11323461|NCT02998671|12520736|FG002|COMPLETED|Period 1||6
11323462|NCT02998671|12520737|FG003|COMPLETED|Period 1||8
11323463|NCT02998671|12520738|FG004|COMPLETED|Period 1||0
11323464|NCT02998671|12520734|FG000|NOT COMPLETED|Period 1||4
11323465|NCT02998671|12520735|FG001|NOT COMPLETED|Period 1||3
11323466|NCT02998671|12520736|FG002|NOT COMPLETED|Period 1||0
11323467|NCT02998671|12520737|FG003|NOT COMPLETED|Period 1||0
11323468|NCT02998671|12520738|FG004|NOT COMPLETED|Period 1||4
11323469|NCT02998671|12520734|FG000|STARTED|Period 2||17
11323470|NCT02998671|12520735|FG001|STARTED|Period 2||10
11323471|NCT02998671|12520736|FG002|STARTED|Period 2||6
11323472|NCT02998671|12520737|FG003|STARTED|Period 2||8
11323473|NCT02998671|12520738|FG004|STARTED|Period 2||0
11323474|NCT02998671|12520734|FG000|COMPLETED|Period 2||14
11323475|NCT02998671|12520735|FG001|COMPLETED|Period 2||3
11323476|NCT02998671|12520736|FG002|COMPLETED|Period 2||5
11323477|NCT02998671|12520737|FG003|COMPLETED|Period 2||4
11323478|NCT02998671|12520738|FG004|COMPLETED|Period 2||0
11323479|NCT02998671|12520734|FG000|NOT COMPLETED|Period 2||3
11323480|NCT02998671|12520735|FG001|NOT COMPLETED|Period 2||7
11323481|NCT02998671|12520736|FG002|NOT COMPLETED|Period 2||1
11323482|NCT02998671|12520737|FG003|NOT COMPLETED|Period 2||4
11323483|NCT02998671|12520738|FG004|NOT COMPLETED|Period 2||0
11323484|NCT02860039|12520760|FG000|STARTED|Overall Study||85
11323485|NCT02860039|12520761|FG001|STARTED|Overall Study||85
11323486|NCT02860039|12520760|FG000|Visit 1|Overall Study||85
11323487|NCT02860039|12520761|FG001|Visit 1|Overall Study||85
11323488|NCT02860039|12520760|FG000|Visit 2|Overall Study||84
11323489|NCT02860039|12520761|FG001|Visit 2|Overall Study||83
11323490|NCT02860039|12520760|FG000|Visit 3|Overall Study||78
11323491|NCT02860039|12520761|FG001|Visit 3|Overall Study||83
11323492|NCT02860039|12520760|FG000|Visit 4|Overall Study||74
11323493|NCT02860039|12520761|FG001|Visit 4|Overall Study||81
11323494|NCT02860039|12520760|FG000|Visit 1 Repeat|Overall Study||32
11323495|NCT02860039|12520761|FG001|Visit 1 Repeat|Overall Study||34
11323496|NCT02860039|12520760|FG000|Visit 2 Repeat|Overall Study||31
11323497|NCT02860039|12520761|FG001|Visit 2 Repeat|Overall Study||34
11323498|NCT02860039|12520760|FG000|Visit 3 Repeat|Overall Study||30
11323499|NCT02860039|12520761|FG001|Visit 3 Repeat|Overall Study||34
11323500|NCT02860039|12520760|FG000|Visit 4 Repeat|Overall Study||26
11323501|NCT02860039|12520761|FG001|Visit 4 Repeat|Overall Study||22
11167172|NCT01627288|12356238|FG000|NOT COMPLETED|Overall Study||0
11167173|NCT01627288|12356239|FG001|NOT COMPLETED|Overall Study||0
11167174|NCT01627288|12356240|FG002|NOT COMPLETED|Overall Study||0
11167175|NCT01627288|12356241|FG003|NOT COMPLETED|Overall Study||0
11167176|NCT01627327|12356255|FG000|STARTED|Overall Study||310
11167177|NCT01627327|12356256|FG001|STARTED|Overall Study||313
11167178|NCT01627327|12356255|FG000|COMPLETED|Overall Study||291
11167179|NCT01627327|12356256|FG001|COMPLETED|Overall Study||274
11167180|NCT01627327|12356255|FG000|NOT COMPLETED|Overall Study||19
11167181|NCT01627327|12356256|FG001|NOT COMPLETED|Overall Study||39
11167182|NCT01627340|12356264|FG000|STARTED|Overall Study||416
11167183|NCT01627340|12356265|FG001|STARTED|Overall Study||258
11167184|NCT01627340|12356264|FG000|COMPLETED|Overall Study||404
11323502|NCT02860039|12520760|FG000|COMPLETED|Overall Study||74
11323503|NCT02860039|12520761|FG001|COMPLETED|Overall Study||81
11323504|NCT02860039|12520760|FG000|NOT COMPLETED|Overall Study||11
11323505|NCT02860039|12520761|FG001|NOT COMPLETED|Overall Study||4
11323506|NCT02833805|12520767|FG000|STARTED|Overall Study||21
11323507|NCT02833805|12520767|FG000|COMPLETED|Overall Study||21
11167185|NCT01627340|12356265|FG001|COMPLETED|Overall Study||254
11167186|NCT01627340|12356264|FG000|NOT COMPLETED|Overall Study||12
11167187|NCT01627340|12356265|FG001|NOT COMPLETED|Overall Study||4
11167188|NCT01627691|12356273|FG000|STARTED|Overall Study||250
11167189|NCT01627691|12356273|FG000|Primary Endpoint (30days)|Overall Study||239
11167190|NCT01627691|12356273|FG000|COMPLETED|Overall Study||232
11026817|NCT00830765|12205433|FG001|COMPLETED|Overall Study||69
11026818|NCT00830765|12205432|FG000|NOT COMPLETED|Overall Study||3
11026819|NCT00830765|12205433|FG001|NOT COMPLETED|Overall Study||2
11167191|NCT01627691|12356273|FG000|NOT COMPLETED|Overall Study||18
11167192|NCT01627782|12356281|FG000|STARTED|Overall Study||17
11167193|NCT01627782|12356282|FG001|STARTED|Overall Study||18
11167194|NCT01627782|12356283|FG002|STARTED|Overall Study||16
11167195|NCT01627782|12356284|FG003|STARTED|Overall Study||17
11167196|NCT01627782|12356281|FG000|Treated|Overall Study||16
11167197|NCT01627782|12356282|FG001|Treated|Overall Study||18
11167198|NCT01627782|12356283|FG002|Treated|Overall Study||16
11167199|NCT01627782|12356284|FG003|Treated|Overall Study||17
11167200|NCT01627782|12356281|FG000|COMPLETED|Overall Study||1
11167201|NCT01627782|12356282|FG001|COMPLETED|Overall Study||12
11167202|NCT01627782|12356283|FG002|COMPLETED|Overall Study||1
11167203|NCT01627782|12356284|FG003|COMPLETED|Overall Study||11
11167204|NCT01627782|12356281|FG000|NOT COMPLETED|Overall Study||16
11167205|NCT01627782|12356282|FG001|NOT COMPLETED|Overall Study||6
11167206|NCT01627782|12356283|FG002|NOT COMPLETED|Overall Study||15
11167207|NCT01627782|12356284|FG003|NOT COMPLETED|Overall Study||6
11167208|NCT01627860|12356298|FG000|STARTED|Overall Study||35
11167209|NCT01627860|12356299|FG001|STARTED|Overall Study||20
11167210|NCT01627860|12356298|FG000|COMPLETED|Overall Study||23
11167211|NCT01627860|12356299|FG001|COMPLETED|Overall Study||14
11167212|NCT01627860|12356298|FG000|NOT COMPLETED|Overall Study||12
11167213|NCT01627860|12356299|FG001|NOT COMPLETED|Overall Study||6
11167214|NCT01628016|12356308|FG000|STARTED|Pretraining to Posttraining||27
11167215|NCT01628016|12356309|FG001|STARTED|Pretraining to Posttraining||27
11167216|NCT01628016|12356310|FG002|STARTED|Pretraining to Posttraining||23
11167217|NCT01628016|12356308|FG000|COMPLETED|Pretraining to Posttraining||27
11167218|NCT01628016|12356309|FG001|COMPLETED|Pretraining to Posttraining||27
11167219|NCT01628016|12356310|FG002|COMPLETED|Pretraining to Posttraining||23
11419796|NCT04090164|12618517|FG001|NOT COMPLETED|Overall Study||0
11419797|NCT04047121|12618530|FG000|STARTED|Overall Study||310
11419798|NCT04047121|12618531|FG001|STARTED|Overall Study||299
11167220|NCT01628016|12356308|FG000|NOT COMPLETED|Pretraining to Posttraining||0
11167221|NCT01628016|12356309|FG001|NOT COMPLETED|Pretraining to Posttraining||0
11167222|NCT01628016|12356310|FG002|NOT COMPLETED|Pretraining to Posttraining||0
11167223|NCT01628016|12356308|FG000|STARTED|Posttraining to 5 Follow-ups||27
11167224|NCT01628016|12356309|FG001|STARTED|Posttraining to 5 Follow-ups||27
11167225|NCT01628016|12356310|FG002|STARTED|Posttraining to 5 Follow-ups||23
11167226|NCT01628016|12356308|FG000|COMPLETED|Posttraining to 5 Follow-ups||23
11167227|NCT01628016|12356309|FG001|COMPLETED|Posttraining to 5 Follow-ups||20
11167228|NCT01628016|12356310|FG002|COMPLETED|Posttraining to 5 Follow-ups||18
11167229|NCT01628016|12356308|FG000|NOT COMPLETED|Posttraining to 5 Follow-ups||4
11167230|NCT01628016|12356309|FG001|NOT COMPLETED|Posttraining to 5 Follow-ups||7
11167231|NCT01628016|12356310|FG002|NOT COMPLETED|Posttraining to 5 Follow-ups||5
11167232|NCT01628042|12356324|FG000|STARTED|Overall Study||8
11167233|NCT01628042|12356325|FG001|STARTED|Overall Study||8
11167234|NCT01628042|12356326|FG002|STARTED|Overall Study||8
11167235|NCT01628042|12356327|FG003|STARTED|Overall Study||8
11167236|NCT01628042|12356324|FG000|COMPLETED|Overall Study||8
11419799|NCT04047121|12618532|FG002|STARTED|Overall Study||79
11419800|NCT04047121|12618533|FG003|STARTED|Overall Study||287
11419801|NCT04047121|12618534|FG004|STARTED|Overall Study||112
11419802|NCT04047121|12618535|FG005|STARTED|Overall Study||262
11419803|NCT04047121|12618530|FG000|COMPLETED|Overall Study||310
11419804|NCT04047121|12618531|FG001|COMPLETED|Overall Study||299
11419805|NCT04047121|12618532|FG002|COMPLETED|Overall Study||79
11167237|NCT01628042|12356325|FG001|COMPLETED|Overall Study||8
11167238|NCT01628042|12356326|FG002|COMPLETED|Overall Study||8
11167239|NCT01628042|12356327|FG003|COMPLETED|Overall Study||8
11167240|NCT01628042|12356324|FG000|NOT COMPLETED|Overall Study||0
11167241|NCT01628042|12356325|FG001|NOT COMPLETED|Overall Study||0
11167242|NCT01628042|12356326|FG002|NOT COMPLETED|Overall Study||0
11167243|NCT01628042|12356327|FG003|NOT COMPLETED|Overall Study||0
11167244|NCT01628107|12356337|FG000|STARTED|Overall Study||414
11167245|NCT01628107|12356337|FG000|Treated|Overall Study||406
11167246|NCT01628107|12356337|FG000|COMPLETED|Overall Study||295
11167247|NCT01628107|12356337|FG000|NOT COMPLETED|Overall Study||119
11167248|NCT01628120|12356341|FG000|STARTED|Overall Study||173
11167249|NCT01628120|12356341|FG000|Treated|Overall Study||170
11167250|NCT01628120|12356341|FG000|COMPLETED|Overall Study||129
11167251|NCT01628120|12356341|FG000|NOT COMPLETED|Overall Study||44
11167252|NCT01628159|12356345|FG000|STARTED|Overall Study||657
11167253|NCT01628159|12356345|FG000|COMPLETED|Overall Study||493
11419806|NCT04047121|12618533|FG003|COMPLETED|Overall Study||287
11419807|NCT04047121|12618534|FG004|COMPLETED|Overall Study||112
11167254|NCT01628159|12356345|FG000|NOT COMPLETED|Overall Study||164
11167255|NCT01628198|12356349|FG000|STARTED|Overall Study||38
11167256|NCT01628198|12356349|FG000|COMPLETED|Overall Study||20
11167257|NCT01628198|12356349|FG000|NOT COMPLETED|Overall Study||18
11419808|NCT04047121|12618535|FG005|COMPLETED|Overall Study||262
11419809|NCT04047121|12618530|FG000|NOT COMPLETED|Overall Study||0
11419810|NCT04047121|12618531|FG001|NOT COMPLETED|Overall Study||0
11167258|NCT01628250|12356355|FG000|STARTED|Overall Study||49
11167259|NCT01628250|12356356|FG001|STARTED|Overall Study||50
11167260|NCT01628250|12356355|FG000|COMPLETED|Overall Study||49
11167261|NCT01628250|12356356|FG001|COMPLETED|Overall Study||50
11167262|NCT01628250|12356355|FG000|NOT COMPLETED|Overall Study||0
11167263|NCT01628250|12356356|FG001|NOT COMPLETED|Overall Study||0
11167264|NCT01628367|12356364|FG000|STARTED|Overall Study||16
11167265|NCT01628367|12356365|FG001|STARTED|Overall Study||16
11167266|NCT01628367|12356364|FG000|COMPLETED|Overall Study||15
11167267|NCT01628367|12356365|FG001|COMPLETED|Overall Study||16
11167268|NCT01628367|12356364|FG000|NOT COMPLETED|Overall Study||1
11167269|NCT01628367|12356365|FG001|NOT COMPLETED|Overall Study||0
11167270|NCT01628393|12356374|FG000|STARTED|Placebo-controlled Treatment Period||88
11167271|NCT01628393|12356375|FG001|STARTED|Placebo-controlled Treatment Period||87
11167272|NCT01628393|12356376|FG002|STARTED|Placebo-controlled Treatment Period||83
11167273|NCT01628393|12356377|FG003|STARTED|Placebo-controlled Treatment Period||0
11167274|NCT01628393|12356378|FG004|STARTED|Placebo-controlled Treatment Period||0
11167275|NCT01628393|12356374|FG000|COMPLETED|Placebo-controlled Treatment Period||85
11167276|NCT01628393|12356375|FG001|COMPLETED|Placebo-controlled Treatment Period||85
11167277|NCT01628393|12356376|FG002|COMPLETED|Placebo-controlled Treatment Period||82
11167278|NCT01628393|12356377|FG003|COMPLETED|Placebo-controlled Treatment Period||0
11167279|NCT01628393|12356378|FG004|COMPLETED|Placebo-controlled Treatment Period||0
11167280|NCT01628393|12356374|FG000|NOT COMPLETED|Placebo-controlled Treatment Period||3
11167281|NCT01628393|12356375|FG001|NOT COMPLETED|Placebo-controlled Treatment Period||2
11167282|NCT01628393|12356376|FG002|NOT COMPLETED|Placebo-controlled Treatment Period||1
11167283|NCT01628393|12356377|FG003|NOT COMPLETED|Placebo-controlled Treatment Period||0
11167284|NCT01628393|12356378|FG004|NOT COMPLETED|Placebo-controlled Treatment Period||0
11167285|NCT01628393|12356374|FG000|STARTED|Blinded Active Extension Period||0
11167286|NCT01628393|12356375|FG001|STARTED|Blinded Active Extension Period||85
11167287|NCT01628393|12356376|FG002|STARTED|Blinded Active Extension Period||81
11167288|NCT01628393|12356377|FG003|STARTED|Blinded Active Extension Period||41
11167289|NCT01628393|12356378|FG004|STARTED|Blinded Active Extension Period||42
11167290|NCT01628393|12356374|FG000|COMPLETED|Blinded Active Extension Period||0
11167291|NCT01628393|12356375|FG001|COMPLETED|Blinded Active Extension Period||75
11167292|NCT01628393|12356376|FG002|COMPLETED|Blinded Active Extension Period||75
11167293|NCT01628393|12356377|FG003|COMPLETED|Blinded Active Extension Period||37
11167294|NCT01628393|12356378|FG004|COMPLETED|Blinded Active Extension Period||36
11167295|NCT01628393|12356374|FG000|NOT COMPLETED|Blinded Active Extension Period||0
11167296|NCT01628393|12356375|FG001|NOT COMPLETED|Blinded Active Extension Period||10
11167297|NCT01628393|12356376|FG002|NOT COMPLETED|Blinded Active Extension Period||6
11167298|NCT01628393|12356377|FG003|NOT COMPLETED|Blinded Active Extension Period||4
11167299|NCT01628393|12356378|FG004|NOT COMPLETED|Blinded Active Extension Period||6
11167300|NCT01628510|12356394|FG000|STARTED|Overall Study||51
11167301|NCT01628510|12356395|FG001|STARTED|Overall Study||49
11167302|NCT01628510|12356394|FG000|COMPLETED|Overall Study||48
11167303|NCT01628510|12356395|FG001|COMPLETED|Overall Study||44
11167304|NCT01628510|12356394|FG000|NOT COMPLETED|Overall Study||3
11167305|NCT01628510|12356395|FG001|NOT COMPLETED|Overall Study||5
11167306|NCT01628523|12356403|FG000|STARTED|Overall Study||219
11167307|NCT01628523|12356403|FG000|COMPLETED|Overall Study||219
11167308|NCT01628523|12356403|FG000|NOT COMPLETED|Overall Study||0
11167309|NCT01628549|12356412|FG000|STARTED|Overall Study||73
11167310|NCT01628549|12356413|FG001|STARTED|Overall Study||76
11167311|NCT01628549|12356414|FG002|STARTED|Overall Study||70
11167312|NCT01628549|12356415|FG003|STARTED|Overall Study||66
11167313|NCT01628549|12356412|FG000|COMPLETED|Overall Study||64
11167314|NCT01628549|12356413|FG001|COMPLETED|Overall Study||64
11167315|NCT01628549|12356414|FG002|COMPLETED|Overall Study||60
11167316|NCT01628549|12356415|FG003|COMPLETED|Overall Study||57
11167317|NCT01628549|12356412|FG000|NOT COMPLETED|Overall Study||9
11167318|NCT01628549|12356413|FG001|NOT COMPLETED|Overall Study||12
11167319|NCT01628549|12356414|FG002|NOT COMPLETED|Overall Study||10
11167320|NCT01628549|12356415|FG003|NOT COMPLETED|Overall Study||9
11167321|NCT01628588|12356425|FG000|STARTED|Overall Study||854
11167322|NCT01628588|12356425|FG000|COMPLETED|Overall Study||838
11026820|NCT00830791|12205445|FG000|STARTED|Overall Study||8
11026821|NCT00830791|12205446|FG001|STARTED|Overall Study||8
11026822|NCT00830791|12205447|FG002|STARTED|Overall Study||8
11026823|NCT00830791|12205448|FG003|STARTED|Overall Study||8
11026824|NCT00830791|12205449|FG004|STARTED|Overall Study||0
11026825|NCT00830791|12205450|FG005|STARTED|Overall Study||0
11026826|NCT00830791|12205445|FG000|COMPLETED|Overall Study||8
11026827|NCT00830791|12205446|FG001|COMPLETED|Overall Study||8
11026828|NCT00830791|12205447|FG002|COMPLETED|Overall Study||8
11026829|NCT00830791|12205448|FG003|COMPLETED|Overall Study||8
11026830|NCT00830791|12205449|FG004|COMPLETED|Overall Study||0
11167323|NCT01628588|12356425|FG000|NOT COMPLETED|Overall Study||16
11167324|NCT01628601|12356429|FG000|STARTED|Overall Study||392
11167325|NCT01628601|12356429|FG000|COMPLETED|Overall Study||351
11167326|NCT01628601|12356429|FG000|NOT COMPLETED|Overall Study||41
11167327|NCT01628614|12356433|FG000|STARTED|Overall Study||4812
11167328|NCT01628614|12356433|FG000|COMPLETED|Overall Study||3037
11167329|NCT01628614|12356433|FG000|NOT COMPLETED|Overall Study||1775
11026831|NCT00830791|12205450|FG005|COMPLETED|Overall Study||0
11026832|NCT00830791|12205445|FG000|NOT COMPLETED|Overall Study||0
11167330|NCT01628692|12356443|FG000|STARTED|Overall Study||53
11167331|NCT01628692|12356444|FG001|STARTED|Overall Study||23
11167332|NCT01628692|12356445|FG002|STARTED|Overall Study||51
11167333|NCT01628692|12356446|FG003|STARTED|Overall Study||20
11167334|NCT01628692|12356447|FG004|STARTED|Overall Study||12
11167335|NCT01628692|12356448|FG005|STARTED|Overall Study||9
11167336|NCT01628692|12356443|FG000|COMPLETED|Overall Study||46
11419811|NCT04047121|12618532|FG002|NOT COMPLETED|Overall Study||0
11419812|NCT04047121|12618533|FG003|NOT COMPLETED|Overall Study||0
11419813|NCT04047121|12618534|FG004|NOT COMPLETED|Overall Study||0
11167337|NCT01628692|12356444|FG001|COMPLETED|Overall Study||17
11167338|NCT01628692|12356445|FG002|COMPLETED|Overall Study||43
11167339|NCT01628692|12356446|FG003|COMPLETED|Overall Study||19
11167340|NCT01628692|12356447|FG004|COMPLETED|Overall Study||8
11167341|NCT01628692|12356448|FG005|COMPLETED|Overall Study||0
11167342|NCT01628692|12356443|FG000|NOT COMPLETED|Overall Study||7
11167343|NCT01628692|12356444|FG001|NOT COMPLETED|Overall Study||6
11167344|NCT01628692|12356445|FG002|NOT COMPLETED|Overall Study||8
11167345|NCT01628692|12356446|FG003|NOT COMPLETED|Overall Study||1
11167346|NCT01628692|12356447|FG004|NOT COMPLETED|Overall Study||4
11167347|NCT01628692|12356448|FG005|NOT COMPLETED|Overall Study||9
11167348|NCT01628718|12356467|FG000|STARTED|Overall Study||60
11167349|NCT01628718|12356468|FG001|STARTED|Overall Study||62
11167350|NCT01628718|12356467|FG000|COMPLETED|Overall Study||33
11167351|NCT01628718|12356468|FG001|COMPLETED|Overall Study||37
11167352|NCT01628718|12356467|FG000|NOT COMPLETED|Overall Study||27
11167353|NCT01628718|12356468|FG001|NOT COMPLETED|Overall Study||25
11167354|NCT01628848|12356476|FG000|STARTED|Overall Study||87
11167355|NCT01628848|12356477|FG001|STARTED|Overall Study||87
11167356|NCT01628848|12356476|FG000|COMPLETED|Overall Study||75
11167357|NCT01628848|12356477|FG001|COMPLETED|Overall Study||73
11167358|NCT01628848|12356476|FG000|NOT COMPLETED|Overall Study||12
11167359|NCT01628848|12356477|FG001|NOT COMPLETED|Overall Study||14
11167360|NCT01628874|12356485|FG000|STARTED|Overall Study||34
11167361|NCT01628874|12356486|FG001|STARTED|Overall Study||32
11167362|NCT01628874|12356485|FG000|COMPLETED|Overall Study||29
11167363|NCT01628874|12356486|FG001|COMPLETED|Overall Study||29
11167364|NCT01628874|12356485|FG000|NOT COMPLETED|Overall Study||5
11167365|NCT01628874|12356486|FG001|NOT COMPLETED|Overall Study||3
11167366|NCT01628913|12356494|FG000|STARTED|Overall Study||31
11167367|NCT01628913|12356495|FG001|STARTED|Overall Study||31
11167368|NCT01628913|12356494|FG000|COMPLETED|Overall Study||0
11167369|NCT01628913|12356495|FG001|COMPLETED|Overall Study||0
11167370|NCT01628913|12356494|FG000|NOT COMPLETED|Overall Study||31
11167371|NCT01628913|12356495|FG001|NOT COMPLETED|Overall Study||31
11167372|NCT01628926|12356504|FG000|STARTED|Overall Study||168
11167373|NCT01628926|12356505|FG001|STARTED|Overall Study||167
11167374|NCT01628926|12356506|FG002|STARTED|Overall Study||85
11167375|NCT01628926|12356504|FG000|COMPLETED|Overall Study||142
11167376|NCT01628926|12356505|FG001|COMPLETED|Overall Study||144
11167377|NCT01628926|12356506|FG002|COMPLETED|Overall Study||68
11167378|NCT01628926|12356504|FG000|NOT COMPLETED|Overall Study||26
11167379|NCT01628926|12356505|FG001|NOT COMPLETED|Overall Study||23
11167380|NCT01628926|12356506|FG002|NOT COMPLETED|Overall Study||17
11167381|NCT01628965|12356515|FG000|STARTED|Overall Study||143
11167382|NCT01628965|12356515|FG000|COMPLETED|Overall Study||94
11167383|NCT01628965|12356515|FG000|NOT COMPLETED|Overall Study||49
11167384|NCT01629134|12356519|FG000|STARTED|Overall Study||62
11167385|NCT01629134|12356519|FG000|COMPLETED|Overall Study||62
11167386|NCT01629134|12356519|FG000|NOT COMPLETED|Overall Study||0
11167387|NCT01629290|12356523|FG000|STARTED|Overall Study||15
11167388|NCT01629290|12356523|FG000|COMPLETED|Overall Study||15
11167389|NCT01629290|12356523|FG000|NOT COMPLETED|Overall Study||0
11167390|NCT01629381|12356535|FG000|STARTED|Overall Study||122
11167391|NCT01629381|12356536|FG001|STARTED|Overall Study||119
11167392|NCT01629381|12356535|FG000|COMPLETED|Overall Study||120
11167393|NCT01629381|12356536|FG001|COMPLETED|Overall Study||114
11167394|NCT01629381|12356535|FG000|NOT COMPLETED|Overall Study||2
11167395|NCT01629381|12356536|FG001|NOT COMPLETED|Overall Study||5
11167396|NCT01629563|12356548|FG000|STARTED|Overall Study||228
11167397|NCT01629563|12356549|FG001|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223
11167398|NCT01629563|12356548|FG000|Safety Population|Overall Study||230
11167399|NCT01629563|12356549|FG001|Safety Population|Overall Study||221
11167400|NCT01629563|12356548|FG000|Started Treatment Course 2|Overall Study||213
11167401|NCT01629563|12356549|FG001|Started Treatment Course 2|Overall Study||207
11167402|NCT01629563|12356548|FG000|Started Treatment Course 3|Overall Study||191
11167403|NCT01629563|12356549|FG001|Started Treatment Course 3|Overall Study||190
11167404|NCT01629563|12356548|FG000|Started Treatment Course 4|Overall Study||178
11167405|NCT01629563|12356549|FG001|Started Treatment Course 4|Overall Study||176
11167406|NCT01629563|12356548|FG000|COMPLETED|Overall Study||167
11167407|NCT01629563|12356549|FG001|COMPLETED|Overall Study||170
11167408|NCT01629563|12356548|FG000|NOT COMPLETED|Overall Study||61
11419814|NCT04047121|12618535|FG005|NOT COMPLETED|Overall Study||0
11419815|NCT04018001|12618551|FG000|STARTED|Overall Study||678
11167409|NCT01629563|12356549|FG001|NOT COMPLETED|Overall Study||53
11167410|NCT01629589|12356557|FG000|STARTED|Overall Study||212
11167411|NCT01629589|12356558|FG001|STARTED|Overall Study||211
11167412|NCT01629589|12356557|FG000|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
11167413|NCT01629589|12356558|FG001|COMPLETED|Overall Study||204
11167414|NCT01629589|12356557|FG000|NOT COMPLETED|Overall Study||8
11419816|NCT04018001|12618552|FG001|STARTED|Overall Study||379
11419817|NCT04018001|12618551|FG000|COMPLETED|Overall Study||678
11419818|NCT04018001|12618552|FG001|COMPLETED|Overall Study||379
11167415|NCT01629589|12356558|FG001|NOT COMPLETED|Overall Study||7
11167416|NCT01629615|12356564|FG000|STARTED|Overall Study||50
11167417|NCT01629615|12356564|FG000|COMPLETED|Overall Study||50
11167418|NCT01629615|12356564|FG000|NOT COMPLETED|Overall Study||0
11167419|NCT01629667|12356571|FG000|STARTED|Overall Study||59
11167420|NCT01629667|12356572|FG001|STARTED|Overall Study||58
11167421|NCT01629667|12356573|FG002|STARTED|Overall Study||59
11167422|NCT01629667|12356571|FG000|Randomized and Treated|Overall Study||57
11167423|NCT01629667|12356572|FG001|Randomized and Treated|Overall Study||57
11167424|NCT01629667|12356573|FG002|Randomized and Treated|Overall Study||59
11167425|NCT01629667|12356571|FG000|COMPLETED|Overall Study||12
11167426|NCT01629667|12356572|FG001|COMPLETED|Overall Study||17
11167427|NCT01629667|12356573|FG002|COMPLETED|Overall Study||14
11167428|NCT01629667|12356571|FG000|NOT COMPLETED|Overall Study||47
11167429|NCT01629667|12356572|FG001|NOT COMPLETED|Overall Study||41
11167430|NCT01629667|12356573|FG002|NOT COMPLETED|Overall Study||45
11167431|NCT01629693|12356585|FG000|STARTED|Overall Study||193
11167432|NCT01629693|12356586|FG001|STARTED|Overall Study||188
11167433|NCT01629693|12356585|FG000|COMPLETED|Overall Study||188
11167434|NCT01629693|12356586|FG001|COMPLETED|Overall Study||178
11167435|NCT01629693|12356585|FG000|NOT COMPLETED|Overall Study||5
11167436|NCT01629693|12356586|FG001|NOT COMPLETED|Overall Study||10
11167437|NCT01629706|12356592|FG000|STARTED|Phase 1 PureVision||44
11167438|NCT01629706|12356592|FG000|COMPLETED|Phase 1 PureVision||35
11167439|NCT01629706|12356592|FG000|NOT COMPLETED|Phase 1 PureVision||9
11167440|NCT01629706|12356592|FG000|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
11167441|NCT01629706|12356592|FG000|COMPLETED|Phase 2 Habitual||48
11167442|NCT01629706|12356592|FG000|NOT COMPLETED|Phase 2 Habitual||10
11167443|NCT01629771|12356602|FG000|STARTED|Overall Study||36
11167444|NCT01629771|12356603|FG001|STARTED|Overall Study||36
11167445|NCT01629771|12356602|FG000|COMPLETED|Overall Study||36
11167446|NCT01629771|12356603|FG001|COMPLETED|Overall Study||36
11167447|NCT01629771|12356602|FG000|NOT COMPLETED|Overall Study||0
11167448|NCT01629771|12356603|FG001|NOT COMPLETED|Overall Study||0
11167449|NCT01629784|12356609|FG000|STARTED|Overall Study||31
11167450|NCT01629784|12356609|FG000|COMPLETED|Overall Study||25
11167451|NCT01629784|12356609|FG000|NOT COMPLETED|Overall Study||6
11167452|NCT01629797|12356616|FG000|STARTED|Overall Study||100
11167453|NCT01629797|12356616|FG000|COMPLETED|Overall Study||82
11167454|NCT01629797|12356616|FG000|NOT COMPLETED|Overall Study||18
11167455|NCT01629823|12356626|FG000|STARTED|Trial Period||66
11167456|NCT01629823|12356627|FG001|STARTED|Trial Period||69
11167457|NCT01629823|12356628|FG002|STARTED|Trial Period||59
11167458|NCT01629823|12356626|FG000|COMPLETED|Trial Period||53
11167459|NCT01629823|12356627|FG001|COMPLETED|Trial Period||56
11167460|NCT01629823|12356628|FG002|COMPLETED|Trial Period||49
11167461|NCT01629823|12356626|FG000|NOT COMPLETED|Trial Period||13
11167462|NCT01629823|12356627|FG001|NOT COMPLETED|Trial Period||13
11167463|NCT01629823|12356628|FG002|NOT COMPLETED|Trial Period||10
11167464|NCT01629823|12356626|FG000|STARTED|Washout Period||54
11167465|NCT01629823|12356627|FG001|STARTED|Washout Period||57
11167466|NCT01629823|12356628|FG002|STARTED|Washout Period||50
11167467|NCT01629823|12356626|FG000|COMPLETED|Washout Period||51
11167468|NCT01629823|12356627|FG001|COMPLETED|Washout Period||51
11167469|NCT01629823|12356628|FG002|COMPLETED|Washout Period||50
11167470|NCT01629823|12356626|FG000|NOT COMPLETED|Washout Period||3
11167471|NCT01629823|12356627|FG001|NOT COMPLETED|Washout Period||6
11167472|NCT01629823|12356628|FG002|NOT COMPLETED|Washout Period||0
11167473|NCT01629862|12356638|FG000|STARTED|Overall Study||28
11167474|NCT01629862|12356639|FG001|STARTED|Overall Study||25
11167475|NCT01629862|12356638|FG000|COMPLETED|Overall Study||26
11167476|NCT01629862|12356639|FG001|COMPLETED|Overall Study||23
11167477|NCT01629862|12356638|FG000|NOT COMPLETED|Overall Study||2
11167478|NCT01629862|12356639|FG001|NOT COMPLETED|Overall Study||2
11167479|NCT01629953|12356647|FG000|STARTED|Overall Study||65
11167480|NCT01629953|12356648|FG001|STARTED|Overall Study||75
11167481|NCT01629953|12356647|FG000|COMPLETED|Overall Study||52
11167482|NCT01629953|12356648|FG001|COMPLETED|Overall Study||60
11167483|NCT01629953|12356647|FG000|NOT COMPLETED|Overall Study||13
11167484|NCT01629953|12356648|FG001|NOT COMPLETED|Overall Study||15
11167485|NCT01629966|12356657|FG000|STARTED|Overall Study||221
11167486|NCT01629966|12356658|FG001|STARTED|Overall Study||227
11167487|NCT01629966|12356659|FG002|STARTED|Overall Study||225
11167488|NCT01629966|12356657|FG000|COMPLETED|Overall Study||180
11167489|NCT01629966|12356658|FG001|COMPLETED|Overall Study||175
11419819|NCT04018001|12618551|FG000|NOT COMPLETED|Overall Study||0
11419820|NCT04018001|12618552|FG001|NOT COMPLETED|Overall Study||0
11167490|NCT01629966|12356659|FG002|COMPLETED|Overall Study||159
11167491|NCT01629966|12356657|FG000|NOT COMPLETED|Overall Study||41
11167492|NCT01629966|12356658|FG001|NOT COMPLETED|Overall Study||52
11167493|NCT01629966|12356659|FG002|NOT COMPLETED|Overall Study||66
11167494|NCT01630109|12356670|FG000|STARTED|Overall Study||1
11167495|NCT01630109|12356671|FG001|STARTED|Overall Study||1
11167496|NCT01630109|12356672|FG002|STARTED|Overall Study||3
11167497|NCT01630109|12356670|FG000|COMPLETED|Overall Study||1
11167498|NCT01630109|12356671|FG001|COMPLETED|Overall Study||1
11167499|NCT01630109|12356672|FG002|COMPLETED|Overall Study||3
11167500|NCT01630109|12356670|FG000|NOT COMPLETED|Overall Study||0
11167501|NCT01630109|12356671|FG001|NOT COMPLETED|Overall Study||0
11167502|NCT01630109|12356672|FG002|NOT COMPLETED|Overall Study||0
11167503|NCT01630135|12356688|FG000|STARTED|Overall Study||131
11167504|NCT01630135|12356689|FG001|STARTED|Overall Study||130
11167505|NCT01630135|12356688|FG000|COMPLETED|Overall Study||131
11167506|NCT01630135|12356689|FG001|COMPLETED|Overall Study||128
11167507|NCT01630135|12356688|FG000|NOT COMPLETED|Overall Study||0
11167508|NCT01630135|12356689|FG001|NOT COMPLETED|Overall Study||2
11167509|NCT01630200|12356697|FG000|STARTED|Overall Study||40
11167510|NCT01630200|12356698|FG001|STARTED|Overall Study||40
11167511|NCT01630200|12356697|FG000|COMPLETED|Overall Study||33
11167512|NCT01630200|12356698|FG001|COMPLETED|Overall Study||34
11167513|NCT01630200|12356697|FG000|NOT COMPLETED|Overall Study||7
11167514|NCT01630200|12356698|FG001|NOT COMPLETED|Overall Study||6
11167515|NCT01630616|12356710|FG000|STARTED|Overall Study||5
11167516|NCT01630616|12356711|FG001|STARTED|Overall Study||3
11167517|NCT01630616|12356712|FG002|STARTED|Overall Study||3
11167518|NCT01630616|12356713|FG003|STARTED|Overall Study||12
11167519|NCT01630616|12356714|FG004|STARTED|Overall Study||6
11167520|NCT01630616|12356715|FG005|STARTED|Overall Study||2
11167521|NCT01630616|12356710|FG000|COMPLETED|Overall Study||5
11167522|NCT01630616|12356711|FG001|COMPLETED|Overall Study||3
11167523|NCT01630616|12356712|FG002|COMPLETED|Overall Study||3
11167524|NCT01630616|12356713|FG003|COMPLETED|Overall Study||9
11167525|NCT01630616|12356714|FG004|COMPLETED|Overall Study||6
11167526|NCT01630616|12356715|FG005|COMPLETED|Overall Study||2
11167527|NCT01630616|12356710|FG000|NOT COMPLETED|Overall Study||0
11167528|NCT01630616|12356711|FG001|NOT COMPLETED|Overall Study||0
11167529|NCT01630616|12356712|FG002|NOT COMPLETED|Overall Study||0
11167530|NCT01630616|12356713|FG003|NOT COMPLETED|Overall Study||3
11167531|NCT01630616|12356714|FG004|NOT COMPLETED|Overall Study||0
11167532|NCT01630616|12356715|FG005|NOT COMPLETED|Overall Study||0
11167533|NCT01630694|12356734|FG000|STARTED|Overall Study||12
11167534|NCT01630694|12356735|FG001|STARTED|Overall Study||16
11167535|NCT01630694|12356734|FG000|COMPLETED|Overall Study||12
11167536|NCT01630694|12356735|FG001|COMPLETED|Overall Study||16
11167537|NCT01630694|12356734|FG000|NOT COMPLETED|Overall Study||0
11167538|NCT01630694|12356735|FG001|NOT COMPLETED|Overall Study||0
11167539|NCT01630811|12356741|FG000|STARTED|First Intervention (8 Weeks)||7
11167540|NCT01630811|12356742|FG001|STARTED|First Intervention (8 Weeks)||6
11167541|NCT01630811|12356741|FG000|COMPLETED|First Intervention (8 Weeks)||7
11167542|NCT01630811|12356742|FG001|COMPLETED|First Intervention (8 Weeks)||6
11167543|NCT01630811|12356741|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
11167544|NCT01630811|12356742|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
11167545|NCT01630811|12356741|FG000|STARTED|Washout (4 Weeks)||7
11167546|NCT01630811|12356742|FG001|STARTED|Washout (4 Weeks)||6
11167547|NCT01630811|12356741|FG000|COMPLETED|Washout (4 Weeks)||7
11167548|NCT01630811|12356742|FG001|COMPLETED|Washout (4 Weeks)||6
11167549|NCT01630811|12356741|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11167550|NCT01630811|12356742|FG001|NOT COMPLETED|Washout (4 Weeks)||0
11167551|NCT01630811|12356741|FG000|STARTED|Second Intervention (8 Weeks)||7
11167552|NCT01630811|12356742|FG001|STARTED|Second Intervention (8 Weeks)||6
11167553|NCT01630811|12356741|FG000|COMPLETED|Second Intervention (8 Weeks)||6
11167554|NCT01630811|12356742|FG001|COMPLETED|Second Intervention (8 Weeks)||6
11167555|NCT01630811|12356741|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||1
11167556|NCT01630811|12356742|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
11167557|NCT01630811|12356741|FG000|STARTED|Second Washout (4 Weeks)||6
11167558|NCT01630811|12356742|FG001|STARTED|Second Washout (4 Weeks)||6
11167559|NCT01630811|12356741|FG000|COMPLETED|Second Washout (4 Weeks)||6
11167560|NCT01630811|12356742|FG001|COMPLETED|Second Washout (4 Weeks)||6
11167561|NCT01630811|12356741|FG000|NOT COMPLETED|Second Washout (4 Weeks)||0
11167562|NCT01630811|12356742|FG001|NOT COMPLETED|Second Washout (4 Weeks)||0
11167563|NCT01630889|12356750|FG000|STARTED|Overall Study||15
11167564|NCT01630889|12356750|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
11167565|NCT01630889|12356750|FG000|COMPLETED|Overall Study||5
11167566|NCT01630889|12356750|FG000|NOT COMPLETED|Overall Study||10
11167567|NCT01631071|12356756|FG000|STARTED|Overall Study||55
11167568|NCT01631071|12356757|FG001|STARTED|Overall Study||55
11167569|NCT01631071|12356756|FG000|COMPLETED|Overall Study||55
11167570|NCT01631071|12356757|FG001|COMPLETED|Overall Study||55
11167571|NCT01631071|12356756|FG000|NOT COMPLETED|Overall Study||0
11167572|NCT01631071|12356757|FG001|NOT COMPLETED|Overall Study||0
11167573|NCT01631110|12356765|FG000|STARTED|Overall Study||55
11167574|NCT01631110|12356766|FG001|STARTED|Overall Study||55
11167575|NCT01631110|12356765|FG000|COMPLETED|Overall Study||55
11167576|NCT01631110|12356766|FG001|COMPLETED|Overall Study||55
11167577|NCT01631110|12356765|FG000|NOT COMPLETED|Overall Study||0
11167578|NCT01631110|12356766|FG001|NOT COMPLETED|Overall Study||0
11167579|NCT01631149|12356774|FG000|STARTED|Overall Study||12
11167580|NCT01631149|12356775|FG001|STARTED|Overall Study||12
11167581|NCT01631149|12356774|FG000|COMPLETED|Overall Study||12
11167582|NCT01631149|12356775|FG001|COMPLETED|Overall Study||12
11167583|NCT01631149|12356774|FG000|NOT COMPLETED|Overall Study||0
11167584|NCT01631149|12356775|FG001|NOT COMPLETED|Overall Study||0
11167585|NCT01631188|12356781|FG000|STARTED|Overall Study||100
11167586|NCT01631188|12356781|FG000|COMPLETED|Overall Study||25
11167587|NCT01631188|12356781|FG000|NOT COMPLETED|Overall Study||75
11167588|NCT01631214|12356787|FG000|STARTED|Overall Study||2047
11167589|NCT01631214|12356788|FG001|STARTED|Overall Study||2046
11167590|NCT01631214|12356787|FG000|Received Double-blind Treatment|Overall Study||2040
11167591|NCT01631214|12356788|FG001|Received Double-blind Treatment|Overall Study||2038
11167592|NCT01631214|12356787|FG000|Completed Double-blind Period|Overall Study||1823
11167593|NCT01631214|12356788|FG001|Completed Double-blind Period|Overall Study||1831
11167594|NCT01631214|12356787|FG000|Completed Primary Analysis Period|Overall Study||1576
11167595|NCT01631214|12356788|FG001|Completed Primary Analysis Period|Overall Study||1574
11167596|NCT01631214|12356787|FG000|COMPLETED|Overall Study||1503
11167597|NCT01631214|12356788|FG001|COMPLETED|Overall Study||1523
11167598|NCT01631214|12356787|FG000|NOT COMPLETED|Overall Study||544
11167599|NCT01631214|12356788|FG001|NOT COMPLETED|Overall Study||523
11167600|NCT01631227|12356798|FG000|STARTED|Overall Study||333
11167601|NCT01631227|12356799|FG001|STARTED|Overall Study||332
11167602|NCT01631227|12356798|FG000|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
11167603|NCT01631227|12356799|FG001|Safety Subject Sample|Overall Study||332
11167604|NCT01631227|12356798|FG000|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
11167605|NCT01631227|12356799|FG001|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
11167606|NCT01631227|12356798|FG000|COMPLETED|Overall Study||303
11167607|NCT01631227|12356799|FG001|COMPLETED|Overall Study||310
11167608|NCT01631227|12356798|FG000|NOT COMPLETED|Overall Study||30
11167609|NCT01631227|12356799|FG001|NOT COMPLETED|Overall Study||22
11167610|NCT01631331|12356805|FG000|STARTED|Overall Study||15
11167611|NCT01631331|12356805|FG000|COMPLETED|Overall Study||11
11167612|NCT01631331|12356805|FG000|NOT COMPLETED|Overall Study||4
11167613|NCT01631435|12356810|FG000|STARTED|Overall Study||75
11167614|NCT01631435|12356810|FG000|COMPLETED|Overall Study||66
11167615|NCT01631435|12356810|FG000|NOT COMPLETED|Overall Study||9
11167616|NCT01631474|12356820|FG000|STARTED|Overall Study||72
11167617|NCT01631474|12356821|FG001|STARTED|Overall Study||76
11167618|NCT01631474|12356822|FG002|STARTED|Overall Study||70
11167619|NCT01631474|12356823|FG003|STARTED|Overall Study||70
11167620|NCT01631474|12356824|FG004|STARTED|Overall Study||75
11167621|NCT01631474|12356820|FG000|COMPLETED|Overall Study||58
11167622|NCT01631474|12356821|FG001|COMPLETED|Overall Study||64
11167623|NCT01631474|12356822|FG002|COMPLETED|Overall Study||61
11167624|NCT01631474|12356823|FG003|COMPLETED|Overall Study||59
11167625|NCT01631474|12356824|FG004|COMPLETED|Overall Study||62
11167626|NCT01631474|12356820|FG000|NOT COMPLETED|Overall Study||14
11167627|NCT01631474|12356821|FG001|NOT COMPLETED|Overall Study||12
11167628|NCT01631474|12356822|FG002|NOT COMPLETED|Overall Study||9
11167629|NCT01631474|12356823|FG003|NOT COMPLETED|Overall Study||11
11167630|NCT01631474|12356824|FG004|NOT COMPLETED|Overall Study||13
11167631|NCT01631552|12356840|FG000|STARTED|Overall Study||83
11167632|NCT01631552|12356841|FG001|STARTED|Overall Study||420
11167633|NCT01631552|12356842|FG002|STARTED|Overall Study||9
11167634|NCT01631552|12356843|FG003|STARTED|Overall Study||3
11167635|NCT01631552|12356840|FG000|Enrolled and Treated|Overall Study||81
11167636|NCT01631552|12356841|FG001|Enrolled and Treated|Overall Study||402
11167637|NCT01631552|12356842|FG002|Enrolled and Treated|Overall Study||9
11167638|NCT01631552|12356843|FG003|Enrolled and Treated|Overall Study||3
11167639|NCT01631552|12356840|FG000|COMPLETED|Overall Study||81
11167640|NCT01631552|12356841|FG001|COMPLETED|Overall Study||400
11167641|NCT01631552|12356842|FG002|COMPLETED|Overall Study||9
11167642|NCT01631552|12356843|FG003|COMPLETED|Overall Study||3
11167643|NCT01631552|12356840|FG000|NOT COMPLETED|Overall Study||2
11167644|NCT01631552|12356841|FG001|NOT COMPLETED|Overall Study||20
11167645|NCT01631552|12356842|FG002|NOT COMPLETED|Overall Study||0
11167646|NCT01631552|12356843|FG003|NOT COMPLETED|Overall Study||0
11167647|NCT01631630|12356857|FG000|STARTED|Overall Study||8
11167648|NCT01631630|12356858|FG001|STARTED|Overall Study||8
11167649|NCT01631630|12356857|FG000|COMPLETED|Overall Study||5
11167650|NCT01631630|12356858|FG001|COMPLETED|Overall Study||8
11167651|NCT01631630|12356857|FG000|NOT COMPLETED|Overall Study||3
11167652|NCT01631630|12356858|FG001|NOT COMPLETED|Overall Study||0
11167653|NCT01631656|12356866|FG000|STARTED|Overall Study||5
11167654|NCT01631656|12356867|FG001|STARTED|Overall Study||5
11167655|NCT01631656|12356866|FG000|COMPLETED|Overall Study||5
11167656|NCT01631656|12356867|FG001|COMPLETED|Overall Study||5
11167657|NCT01631656|12356866|FG000|NOT COMPLETED|Overall Study||0
11167658|NCT01631656|12356867|FG001|NOT COMPLETED|Overall Study||0
11167659|NCT01631682|12356877|FG000|STARTED|Overall Study||55
11167660|NCT01631682|12356878|FG001|STARTED|Overall Study||66
11167661|NCT01631682|12356879|FG002|STARTED|Overall Study||44
11167662|NCT01631682|12356880|FG003|STARTED|Overall Study||7
11167663|NCT01631682|12356877|FG000|COMPLETED|Overall Study||24
11167664|NCT01631682|12356878|FG001|COMPLETED|Overall Study||21
11167665|NCT01631682|12356879|FG002|COMPLETED|Overall Study||13
11167666|NCT01631682|12356880|FG003|COMPLETED|Overall Study||5
11167667|NCT01631682|12356877|FG000|NOT COMPLETED|Overall Study||31
11167668|NCT01631682|12356878|FG001|NOT COMPLETED|Overall Study||45
11167669|NCT01631682|12356879|FG002|NOT COMPLETED|Overall Study||31
11167670|NCT01631682|12356880|FG003|NOT COMPLETED|Overall Study||2
11167671|NCT01631747|12356892|FG000|STARTED|Randomization Through End of Pregnancy||141
11167672|NCT01631747|12356893|FG001|STARTED|Randomization Through End of Pregnancy||140
11167673|NCT01631747|12356892|FG000|COMPLETED|Randomization Through End of Pregnancy||140
11167674|NCT01631747|12356893|FG001|COMPLETED|Randomization Through End of Pregnancy||140
11167675|NCT01631747|12356892|FG000|NOT COMPLETED|Randomization Through End of Pregnancy||1
11167676|NCT01631747|12356893|FG001|NOT COMPLETED|Randomization Through End of Pregnancy||0
11167677|NCT01631747|12356892|FG000|STARTED|Live Birth||140
11167678|NCT01631747|12356893|FG001|STARTED|Live Birth||140
11167679|NCT01631747|12356892|FG000|COMPLETED|Live Birth||136
11167680|NCT01631747|12356893|FG001|COMPLETED|Live Birth||139
11167681|NCT01631747|12356892|FG000|NOT COMPLETED|Live Birth||4
11167682|NCT01631747|12356893|FG001|NOT COMPLETED|Live Birth||1
11167683|NCT01631747|12356892|FG000|STARTED|One Year Infant Outcomes||136
11167684|NCT01631747|12356893|FG001|STARTED|One Year Infant Outcomes||139
11167685|NCT01631747|12356892|FG000|COMPLETED|One Year Infant Outcomes||123
11167686|NCT01631747|12356893|FG001|COMPLETED|One Year Infant Outcomes||130
11167687|NCT01631747|12356892|FG000|NOT COMPLETED|One Year Infant Outcomes||13
11167688|NCT01631747|12356893|FG001|NOT COMPLETED|One Year Infant Outcomes||9
11167689|NCT01631812|12356900|FG000|STARTED|Overall Study||130
11167690|NCT01631812|12356900|FG000|COMPLETED|Overall Study||93
11167691|NCT01631812|12356900|FG000|NOT COMPLETED|Overall Study||37
11167692|NCT01631825|12356904|FG000|STARTED|Overall Study||321
11167693|NCT01631825|12356904|FG000|COMPLETED|Overall Study||256
11167694|NCT01631825|12356904|FG000|NOT COMPLETED|Overall Study||65
11167695|NCT01631864|12356910|FG000|STARTED|Overall Study||50
11167696|NCT01631864|12356911|FG001|STARTED|Overall Study||48
11167697|NCT01631864|12356910|FG000|COMPLETED|Overall Study||48
11167698|NCT01631864|12356911|FG001|COMPLETED|Overall Study||44
11167699|NCT01631864|12356910|FG000|NOT COMPLETED|Overall Study||2
11167700|NCT01631864|12356911|FG001|NOT COMPLETED|Overall Study||4
11167701|NCT01631929|12356919|FG000|STARTED|Overall Study||6
11167702|NCT01631929|12356920|FG001|STARTED|Overall Study||6
11167703|NCT01631929|12356919|FG000|COMPLETED|Overall Study||6
11167704|NCT01631929|12356920|FG001|COMPLETED|Overall Study||6
11167705|NCT01631929|12356919|FG000|NOT COMPLETED|Overall Study||0
11167706|NCT01631929|12356920|FG001|NOT COMPLETED|Overall Study||0
11167707|NCT01632150|12356926|FG000|STARTED|Overall Study||40
11167708|NCT01632150|12356926|FG000|Received Cyclophosphamide|Overall Study||11
11167709|NCT01632150|12356926|FG000|COMPLETED|Overall Study|Completed=still receiving treatment|0
11167710|NCT01632150|12356926|FG000|NOT COMPLETED|Overall Study||40
11167711|NCT01632202|12356935|FG000|STARTED|Overall Study||1
11167712|NCT01632202|12356936|FG001|STARTED|Overall Study||7
11167713|NCT01632202|12356935|FG000|COMPLETED|Overall Study||1
11167714|NCT01632202|12356936|FG001|COMPLETED|Overall Study||7
11167715|NCT01632202|12356935|FG000|NOT COMPLETED|Overall Study||0
11167716|NCT01632202|12356936|FG001|NOT COMPLETED|Overall Study||0
11167717|NCT01632215|12356944|FG000|STARTED|Overall Study||20
11167718|NCT01632215|12356945|FG001|STARTED|Overall Study||20
11167719|NCT01632215|12356944|FG000|COMPLETED|Overall Study||18
11167720|NCT01632215|12356945|FG001|COMPLETED|Overall Study||19
11167721|NCT01632215|12356944|FG000|NOT COMPLETED|Overall Study||2
11026833|NCT00830791|12205446|FG001|NOT COMPLETED|Overall Study||0
11026834|NCT00830791|12205447|FG002|NOT COMPLETED|Overall Study||0
11026835|NCT00830791|12205448|FG003|NOT COMPLETED|Overall Study||0
11167722|NCT01632215|12356945|FG001|NOT COMPLETED|Overall Study||1
11167723|NCT01632241|12356953|FG000|STARTED|Double-blinded (Up to Week 52)||165
11167724|NCT01632241|12356954|FG001|STARTED|Double-blinded (Up to Week 52)||331
11167725|NCT01632241|12356953|FG000|COMPLETED|Double-blinded (Up to Week 52)||121
11167726|NCT01632241|12356954|FG001|COMPLETED|Double-blinded (Up to Week 52)||252
11167727|NCT01632241|12356953|FG000|NOT COMPLETED|Double-blinded (Up to Week 52)||44
11167728|NCT01632241|12356954|FG001|NOT COMPLETED|Double-blinded (Up to Week 52)||79
11167729|NCT01632241|12356953|FG000|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|117
11167730|NCT01632241|12356954|FG001|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|242
11167731|NCT01632241|12356953|FG000|COMPLETED|Open-label (Week 52 to Week 76)||107
11167732|NCT01632241|12356954|FG001|COMPLETED|Open-label (Week 52 to Week 76)||220
11419821|NCT04017754|12618558|FG000|STARTED|Overall Study||267
11419822|NCT04017754|12618559|FG001|STARTED|Overall Study||185
11419823|NCT04017754|12618558|FG000|COMPLETED|Overall Study||267
11419824|NCT04017754|12618559|FG001|COMPLETED|Overall Study||185
11419825|NCT04017754|12618558|FG000|NOT COMPLETED|Overall Study||0
11419826|NCT04017754|12618559|FG001|NOT COMPLETED|Overall Study||0
11419827|NCT04010370|12618602|FG000|STARTED|Overall Study||25
11419828|NCT04010370|12618602|FG000|COMPLETED|Overall Study||25
11419829|NCT04010370|12618602|FG000|NOT COMPLETED|Overall Study||0
11419830|NCT03997825|12618606|FG000|STARTED|Overall Study||117
11167733|NCT01632241|12356953|FG000|NOT COMPLETED|Open-label (Week 52 to Week 76)||10
11167734|NCT01632241|12356954|FG001|NOT COMPLETED|Open-label (Week 52 to Week 76)||22
11167735|NCT01632267|12356966|FG000|STARTED|Overall Study||104
11167736|NCT01632267|12356966|FG000|COMPLETED|Overall Study||97
11167737|NCT01632267|12356966|FG000|NOT COMPLETED|Overall Study||7
11167738|NCT01632280|12356972|FG000|STARTED|Overall Study||6
11167739|NCT01632280|12356973|FG001|STARTED|Overall Study||6
11167740|NCT01632280|12356972|FG000|COMPLETED|Overall Study||5
11167741|NCT01632280|12356973|FG001|COMPLETED|Overall Study||6
11167742|NCT01632280|12356972|FG000|NOT COMPLETED|Overall Study||1
11167743|NCT01632280|12356973|FG001|NOT COMPLETED|Overall Study||0
11167744|NCT01632306|12356981|FG000|STARTED|Overall Study||3
11167745|NCT01632306|12356982|FG001|STARTED|Overall Study||10
11167746|NCT01632306|12356983|FG002|STARTED|Overall Study||0
11167747|NCT01632306|12356981|FG000|Received at Least One Dose of Study Drug|Overall Study||3
11167748|NCT01632306|12356982|FG001|Received at Least One Dose of Study Drug|Overall Study||10
11167749|NCT01632306|12356983|FG002|Received at Least One Dose of Study Drug|Overall Study||0
11167750|NCT01632306|12356981|FG000|COMPLETED|Overall Study||2
11167751|NCT01632306|12356982|FG001|COMPLETED|Overall Study||10
11026836|NCT00830791|12205449|FG004|NOT COMPLETED|Overall Study||0
11419831|NCT03997825|12618606|FG000|COMPLETED|Overall Study||100
11419832|NCT03997825|12618606|FG000|NOT COMPLETED|Overall Study||17
11167752|NCT01632306|12356983|FG002|COMPLETED|Overall Study||0
11167753|NCT01632306|12356981|FG000|NOT COMPLETED|Overall Study||1
11167754|NCT01632306|12356982|FG001|NOT COMPLETED|Overall Study||0
11167755|NCT01632306|12356983|FG002|NOT COMPLETED|Overall Study||0
11167756|NCT01632345|12356994|FG000|STARTED|Randomized Participants||41
11167757|NCT01632345|12356995|FG001|STARTED|Randomized Participants||43
11167758|NCT01632345|12356996|FG002|STARTED|Randomized Participants||42
11167759|NCT01632345|12356997|FG003|STARTED|Randomized Participants||41
11167760|NCT01632345|12356998|FG004|STARTED|Randomized Participants||43
11167761|NCT01632345|12356999|FG005|STARTED|Randomized Participants||66
11167762|NCT01632345|12357000|FG006|STARTED|Randomized Participants||66
11167763|NCT01632345|12356994|FG000|COMPLETED|Randomized Participants||41
11167764|NCT01632345|12356995|FG001|COMPLETED|Randomized Participants||43
11167765|NCT01632345|12356996|FG002|COMPLETED|Randomized Participants||42
11167766|NCT01632345|12356997|FG003|COMPLETED|Randomized Participants||41
11167767|NCT01632345|12356998|FG004|COMPLETED|Randomized Participants||43
11167768|NCT01632345|12356999|FG005|COMPLETED|Randomized Participants||66
11167769|NCT01632345|12357000|FG006|COMPLETED|Randomized Participants||66
11167770|NCT01632345|12356994|FG000|NOT COMPLETED|Randomized Participants||0
11167771|NCT01632345|12356995|FG001|NOT COMPLETED|Randomized Participants||0
11167772|NCT01632345|12356996|FG002|NOT COMPLETED|Randomized Participants||0
11167773|NCT01632345|12356997|FG003|NOT COMPLETED|Randomized Participants||0
11167774|NCT01632345|12356998|FG004|NOT COMPLETED|Randomized Participants||0
11167775|NCT01632345|12356999|FG005|NOT COMPLETED|Randomized Participants||0
11167776|NCT01632345|12357000|FG006|NOT COMPLETED|Randomized Participants||0
11167777|NCT01632345|12356994|FG000|STARTED|Treatment: Part I||41
11167778|NCT01632345|12356995|FG001|STARTED|Treatment: Part I||43
11167779|NCT01632345|12356996|FG002|STARTED|Treatment: Part I||42
11167780|NCT01632345|12356997|FG003|STARTED|Treatment: Part I||41
11167781|NCT01632345|12356998|FG004|STARTED|Treatment: Part I||43
11167782|NCT01632345|12356999|FG005|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
11167783|NCT01632345|12357000|FG006|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
11167784|NCT01632345|12356994|FG000|Treated|Treatment: Part I||40
11167785|NCT01632345|12356995|FG001|Treated|Treatment: Part I||43
11419833|NCT03975790|12618613|FG000|STARTED|Overall Study||337
11419834|NCT03975790|12618614|FG001|STARTED|Overall Study||94
11419835|NCT03975790|12618615|FG002|STARTED|Overall Study||48
11419836|NCT03975790|12618613|FG000|COMPLETED|Overall Study||337
11167786|NCT01632345|12356996|FG002|Treated|Treatment: Part I||42
11167787|NCT01632345|12356997|FG003|Treated|Treatment: Part I||41
11167788|NCT01632345|12356998|FG004|Treated|Treatment: Part I||43
11167789|NCT01632345|12356999|FG005|Treated|Treatment: Part I||0
11167790|NCT01632345|12357000|FG006|Treated|Treatment: Part I||0
11167791|NCT01632345|12356994|FG000|COMPLETED|Treatment: Part I||29
11167792|NCT01632345|12356995|FG001|COMPLETED|Treatment: Part I||28
11167793|NCT01632345|12356996|FG002|COMPLETED|Treatment: Part I||32
11167794|NCT01632345|12356997|FG003|COMPLETED|Treatment: Part I||33
11167795|NCT01632345|12356998|FG004|COMPLETED|Treatment: Part I||30
11167796|NCT01632345|12356999|FG005|COMPLETED|Treatment: Part I||0
11167797|NCT01632345|12357000|FG006|COMPLETED|Treatment: Part I||0
11167798|NCT01632345|12356994|FG000|NOT COMPLETED|Treatment: Part I||12
11167799|NCT01632345|12356995|FG001|NOT COMPLETED|Treatment: Part I||15
11167800|NCT01632345|12356996|FG002|NOT COMPLETED|Treatment: Part I||10
11167801|NCT01632345|12356997|FG003|NOT COMPLETED|Treatment: Part I||8
11167802|NCT01632345|12356998|FG004|NOT COMPLETED|Treatment: Part I||13
11167803|NCT01632345|12356999|FG005|NOT COMPLETED|Treatment: Part I||0
11167804|NCT01632345|12357000|FG006|NOT COMPLETED|Treatment: Part I||0
11167805|NCT01632345|12356994|FG000|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
11167806|NCT01632345|12356995|FG001|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
11167807|NCT01632345|12356996|FG002|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
11167808|NCT01632345|12356997|FG003|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
11167809|NCT01632345|12356998|FG004|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
11167810|NCT01632345|12356999|FG005|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
11167811|NCT01632345|12357000|FG006|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
11167812|NCT01632345|12356994|FG000|Treated|Treatment: Part II||0
11167813|NCT01632345|12356995|FG001|Treated|Treatment: Part II||0
11167814|NCT01632345|12356996|FG002|Treated|Treatment: Part II||0
11167815|NCT01632345|12356997|FG003|Treated|Treatment: Part II||0
11167816|NCT01632345|12356998|FG004|Treated|Treatment: Part II||0
11167817|NCT01632345|12356999|FG005|Treated|Treatment: Part II||66
11167818|NCT01632345|12357000|FG006|Treated|Treatment: Part II||66
11167819|NCT01632345|12356994|FG000|COMPLETED|Treatment: Part II||0
11167820|NCT01632345|12356995|FG001|COMPLETED|Treatment: Part II||0
11167821|NCT01632345|12356996|FG002|COMPLETED|Treatment: Part II||0
11167822|NCT01632345|12356997|FG003|COMPLETED|Treatment: Part II||0
11167823|NCT01632345|12356998|FG004|COMPLETED|Treatment: Part II||0
11167824|NCT01632345|12356999|FG005|COMPLETED|Treatment: Part II||55
11167825|NCT01632345|12357000|FG006|COMPLETED|Treatment: Part II||55
11167826|NCT01632345|12356994|FG000|NOT COMPLETED|Treatment: Part II||0
11167827|NCT01632345|12356995|FG001|NOT COMPLETED|Treatment: Part II||0
11167828|NCT01632345|12356996|FG002|NOT COMPLETED|Treatment: Part II||0
11167829|NCT01632345|12356997|FG003|NOT COMPLETED|Treatment: Part II||0
11167830|NCT01632345|12356998|FG004|NOT COMPLETED|Treatment: Part II||0
11167831|NCT01632345|12356999|FG005|NOT COMPLETED|Treatment: Part II||11
11167832|NCT01632345|12357000|FG006|NOT COMPLETED|Treatment: Part II||11
11167833|NCT01632423|12357015|FG000|STARTED|Overall Study||10337
11167834|NCT01632423|12357015|FG000|COMPLETED|Overall Study||10091
11167835|NCT01632423|12357015|FG000|NOT COMPLETED|Overall Study||246
11167836|NCT01632566|12357024|FG000|STARTED|Overall Study||8
11167837|NCT01632566|12357025|FG001|STARTED|Overall Study||10
11167838|NCT01632566|12357026|FG002|STARTED|Overall Study||9
11167839|NCT01632566|12357027|FG003|STARTED|Overall Study||6
11167840|NCT01632566|12357028|FG004|STARTED|Overall Study||6
11167841|NCT01632566|12357024|FG000|Received at Least One Dose LY3031207|Overall Study||8
11167842|NCT01632566|12357025|FG001|Received at Least One Dose LY3031207|Overall Study||10
11167843|NCT01632566|12357026|FG002|Received at Least One Dose LY3031207|Overall Study||9
11167844|NCT01632566|12357027|FG003|Received at Least One Dose LY3031207|Overall Study||0
11167845|NCT01632566|12357028|FG004|Received at Least One Dose LY3031207|Overall Study||0
11167846|NCT01632566|12357024|FG000|Received at Least One Dose Simvastatin|Overall Study||0
11167847|NCT01632566|12357025|FG001|Received at Least One Dose Simvastatin|Overall Study||10
11167848|NCT01632566|12357026|FG002|Received at Least One Dose Simvastatin|Overall Study||9
11167849|NCT01632566|12357027|FG003|Received at Least One Dose Simvastatin|Overall Study||4
11167850|NCT01632566|12357028|FG004|Received at Least One Dose Simvastatin|Overall Study||4
11167851|NCT01632566|12357024|FG000|COMPLETED|Overall Study||8
11167852|NCT01632566|12357025|FG001|COMPLETED|Overall Study||7
11167853|NCT01632566|12357026|FG002|COMPLETED|Overall Study||0
11167854|NCT01632566|12357027|FG003|COMPLETED|Overall Study||4
11167855|NCT01632566|12357028|FG004|COMPLETED|Overall Study||4
11167856|NCT01632566|12357024|FG000|NOT COMPLETED|Overall Study||0
11167857|NCT01632566|12357025|FG001|NOT COMPLETED|Overall Study||3
11167858|NCT01632566|12357026|FG002|NOT COMPLETED|Overall Study||9
11167859|NCT01632566|12357027|FG003|NOT COMPLETED|Overall Study||2
11167860|NCT01632566|12357028|FG004|NOT COMPLETED|Overall Study||2
11167861|NCT01632579|12357044|FG000|STARTED|Period 1 (First Intervention)||2
11167862|NCT01632579|12357045|FG001|STARTED|Period 1 (First Intervention)||6
11167863|NCT01632579|12357046|FG002|STARTED|Period 1 (First Intervention)||2
11167864|NCT01632579|12357047|FG003|STARTED|Period 1 (First Intervention)||2
11167865|NCT01632579|12357048|FG004|STARTED|Period 1 (First Intervention)||6
11167866|NCT01632579|12357049|FG005|STARTED|Period 1 (First Intervention)||2
11167867|NCT01632579|12357050|FG006|STARTED|Period 1 (First Intervention)||2
11167868|NCT01632579|12357051|FG007|STARTED|Period 1 (First Intervention)||6
11167869|NCT01632579|12357052|FG008|STARTED|Period 1 (First Intervention)||2
11167870|NCT01632579|12357044|FG000|Received at Least 1 Dose|Period 1 (First Intervention)||2
11167871|NCT01632579|12357045|FG001|Received at Least 1 Dose|Period 1 (First Intervention)||6
11167872|NCT01632579|12357046|FG002|Received at Least 1 Dose|Period 1 (First Intervention)||2
11167873|NCT01632579|12357047|FG003|Received at Least 1 Dose|Period 1 (First Intervention)||2
11167874|NCT01632579|12357048|FG004|Received at Least 1 Dose|Period 1 (First Intervention)||6
11167875|NCT01632579|12357049|FG005|Received at Least 1 Dose|Period 1 (First Intervention)||2
11167876|NCT01632579|12357050|FG006|Received at Least 1 Dose|Period 1 (First Intervention)||2
11167877|NCT01632579|12357051|FG007|Received at Least 1 Dose|Period 1 (First Intervention)||6
11167878|NCT01632579|12357052|FG008|Received at Least 1 Dose|Period 1 (First Intervention)||2
11167879|NCT01632579|12357044|FG000|COMPLETED|Period 1 (First Intervention)||2
11167880|NCT01632579|12357045|FG001|COMPLETED|Period 1 (First Intervention)||6
11167881|NCT01632579|12357046|FG002|COMPLETED|Period 1 (First Intervention)||2
11167882|NCT01632579|12357047|FG003|COMPLETED|Period 1 (First Intervention)||2
11167883|NCT01632579|12357048|FG004|COMPLETED|Period 1 (First Intervention)||6
11167884|NCT01632579|12357049|FG005|COMPLETED|Period 1 (First Intervention)||2
11167885|NCT01632579|12357050|FG006|COMPLETED|Period 1 (First Intervention)||2
11167886|NCT01632579|12357051|FG007|COMPLETED|Period 1 (First Intervention)||6
11167887|NCT01632579|12357052|FG008|COMPLETED|Period 1 (First Intervention)||2
11167888|NCT01632579|12357044|FG000|NOT COMPLETED|Period 1 (First Intervention)||0
11167889|NCT01632579|12357045|FG001|NOT COMPLETED|Period 1 (First Intervention)||0
11167890|NCT01632579|12357046|FG002|NOT COMPLETED|Period 1 (First Intervention)||0
11167891|NCT01632579|12357047|FG003|NOT COMPLETED|Period 1 (First Intervention)||0
11167892|NCT01632579|12357048|FG004|NOT COMPLETED|Period 1 (First Intervention)||0
11167893|NCT01632579|12357049|FG005|NOT COMPLETED|Period 1 (First Intervention)||0
11167894|NCT01632579|12357050|FG006|NOT COMPLETED|Period 1 (First Intervention)||0
11167895|NCT01632579|12357051|FG007|NOT COMPLETED|Period 1 (First Intervention)||0
11167896|NCT01632579|12357052|FG008|NOT COMPLETED|Period 1 (First Intervention)||0
11167897|NCT01632579|12357044|FG000|STARTED|Washout Period||2
11167898|NCT01632579|12357045|FG001|STARTED|Washout Period||6
11167899|NCT01632579|12357046|FG002|STARTED|Washout Period||2
11167900|NCT01632579|12357047|FG003|STARTED|Washout Period||2
11167901|NCT01632579|12357048|FG004|STARTED|Washout Period||6
11167902|NCT01632579|12357049|FG005|STARTED|Washout Period||2
11167903|NCT01632579|12357050|FG006|STARTED|Washout Period||2
11167904|NCT01632579|12357051|FG007|STARTED|Washout Period||6
11167905|NCT01632579|12357052|FG008|STARTED|Washout Period||2
11167906|NCT01632579|12357044|FG000|COMPLETED|Washout Period||1
11167907|NCT01632579|12357045|FG001|COMPLETED|Washout Period||6
11167908|NCT01632579|12357046|FG002|COMPLETED|Washout Period||2
11167909|NCT01632579|12357047|FG003|COMPLETED|Washout Period||2
11167910|NCT01632579|12357048|FG004|COMPLETED|Washout Period||6
11167911|NCT01632579|12357049|FG005|COMPLETED|Washout Period||2
11167912|NCT01632579|12357050|FG006|COMPLETED|Washout Period||2
11167913|NCT01632579|12357051|FG007|COMPLETED|Washout Period||6
11167914|NCT01632579|12357052|FG008|COMPLETED|Washout Period||2
11167915|NCT01632579|12357044|FG000|NOT COMPLETED|Washout Period||1
11167916|NCT01632579|12357045|FG001|NOT COMPLETED|Washout Period||0
11167917|NCT01632579|12357046|FG002|NOT COMPLETED|Washout Period||0
11167918|NCT01632579|12357047|FG003|NOT COMPLETED|Washout Period||0
11167919|NCT01632579|12357048|FG004|NOT COMPLETED|Washout Period||0
11167920|NCT01632579|12357049|FG005|NOT COMPLETED|Washout Period||0
11167921|NCT01632579|12357050|FG006|NOT COMPLETED|Washout Period||0
11167922|NCT01632579|12357051|FG007|NOT COMPLETED|Washout Period||0
11167923|NCT01632579|12357052|FG008|NOT COMPLETED|Washout Period||0
11167924|NCT01632579|12357044|FG000|STARTED|Period 2 (Second Intervention)||1
11167925|NCT01632579|12357045|FG001|STARTED|Period 2 (Second Intervention)||6
11167926|NCT01632579|12357046|FG002|STARTED|Period 2 (Second Intervention)||2
11167927|NCT01632579|12357047|FG003|STARTED|Period 2 (Second Intervention)||2
11167928|NCT01632579|12357048|FG004|STARTED|Period 2 (Second Intervention)||6
11167929|NCT01632579|12357049|FG005|STARTED|Period 2 (Second Intervention)||2
11167930|NCT01632579|12357050|FG006|STARTED|Period 2 (Second Intervention)||2
11167931|NCT01632579|12357051|FG007|STARTED|Period 2 (Second Intervention)||6
11167932|NCT01632579|12357052|FG008|STARTED|Period 2 (Second Intervention)||2
11167933|NCT01632579|12357044|FG000|Received at Least 1 Dose|Period 2 (Second Intervention)||1
11167934|NCT01632579|12357045|FG001|Received at Least 1 Dose|Period 2 (Second Intervention)||6
11167935|NCT01632579|12357046|FG002|Received at Least 1 Dose|Period 2 (Second Intervention)||2
11167936|NCT01632579|12357047|FG003|Received at Least 1 Dose|Period 2 (Second Intervention)||2
11167937|NCT01632579|12357048|FG004|Received at Least 1 Dose|Period 2 (Second Intervention)||6
11167938|NCT01632579|12357049|FG005|Received at Least 1 Dose|Period 2 (Second Intervention)||2
11167939|NCT01632579|12357050|FG006|Received at Least 1 Dose|Period 2 (Second Intervention)||2
11167940|NCT01632579|12357051|FG007|Received at Least 1 Dose|Period 2 (Second Intervention)||6
11167941|NCT01632579|12357052|FG008|Received at Least 1 Dose|Period 2 (Second Intervention)||2
11167942|NCT01632579|12357044|FG000|COMPLETED|Period 2 (Second Intervention)||0
11167943|NCT01632579|12357045|FG001|COMPLETED|Period 2 (Second Intervention)||6
11167944|NCT01632579|12357046|FG002|COMPLETED|Period 2 (Second Intervention)||2
11167945|NCT01632579|12357047|FG003|COMPLETED|Period 2 (Second Intervention)||2
11167946|NCT01632579|12357048|FG004|COMPLETED|Period 2 (Second Intervention)||6
11167947|NCT01632579|12357049|FG005|COMPLETED|Period 2 (Second Intervention)||2
11167948|NCT01632579|12357050|FG006|COMPLETED|Period 2 (Second Intervention)||2
11167949|NCT01632579|12357051|FG007|COMPLETED|Period 2 (Second Intervention)||6
11167950|NCT01632579|12357052|FG008|COMPLETED|Period 2 (Second Intervention)||2
11167951|NCT01632579|12357044|FG000|NOT COMPLETED|Period 2 (Second Intervention)||1
11167952|NCT01632579|12357045|FG001|NOT COMPLETED|Period 2 (Second Intervention)||0
11167953|NCT01632579|12357046|FG002|NOT COMPLETED|Period 2 (Second Intervention)||0
11167954|NCT01632579|12357047|FG003|NOT COMPLETED|Period 2 (Second Intervention)||0
11167955|NCT01632579|12357048|FG004|NOT COMPLETED|Period 2 (Second Intervention)||0
11167956|NCT01632579|12357049|FG005|NOT COMPLETED|Period 2 (Second Intervention)||0
11167957|NCT01632579|12357050|FG006|NOT COMPLETED|Period 2 (Second Intervention)||0
11167958|NCT01632579|12357051|FG007|NOT COMPLETED|Period 2 (Second Intervention)||0
11167959|NCT01632579|12357052|FG008|NOT COMPLETED|Period 2 (Second Intervention)||0
11167960|NCT01632579|12357044|FG000|STARTED|Washout Period||0
11167961|NCT01632579|12357045|FG001|STARTED|Washout Period||6
11167962|NCT01632579|12357046|FG002|STARTED|Washout Period||2
11167963|NCT01632579|12357047|FG003|STARTED|Washout Period||2
11167964|NCT01632579|12357048|FG004|STARTED|Washout Period||6
11167965|NCT01632579|12357049|FG005|STARTED|Washout Period||2
11167966|NCT01632579|12357050|FG006|STARTED|Washout Period||2
11167967|NCT01632579|12357051|FG007|STARTED|Washout Period||6
11167968|NCT01632579|12357052|FG008|STARTED|Washout Period||2
11167969|NCT01632579|12357044|FG000|COMPLETED|Washout Period||0
11167970|NCT01632579|12357045|FG001|COMPLETED|Washout Period||6
11167971|NCT01632579|12357046|FG002|COMPLETED|Washout Period||2
11167972|NCT01632579|12357047|FG003|COMPLETED|Washout Period||2
11167973|NCT01632579|12357048|FG004|COMPLETED|Washout Period||6
11167974|NCT01632579|12357049|FG005|COMPLETED|Washout Period||2
11167975|NCT01632579|12357050|FG006|COMPLETED|Washout Period||2
11167976|NCT01632579|12357051|FG007|COMPLETED|Washout Period||6
11167977|NCT01632579|12357052|FG008|COMPLETED|Washout Period||2
11167978|NCT01632579|12357044|FG000|NOT COMPLETED|Washout Period||0
11167979|NCT01632579|12357045|FG001|NOT COMPLETED|Washout Period||0
11167980|NCT01632579|12357046|FG002|NOT COMPLETED|Washout Period||0
11167981|NCT01632579|12357047|FG003|NOT COMPLETED|Washout Period||0
11167982|NCT01632579|12357048|FG004|NOT COMPLETED|Washout Period||0
11167983|NCT01632579|12357049|FG005|NOT COMPLETED|Washout Period||0
11167984|NCT01632579|12357050|FG006|NOT COMPLETED|Washout Period||0
11167985|NCT01632579|12357051|FG007|NOT COMPLETED|Washout Period||0
11167986|NCT01632579|12357052|FG008|NOT COMPLETED|Washout Period||0
11167987|NCT01632579|12357044|FG000|STARTED|Period 3 (Third Intervention)||0
11167988|NCT01632579|12357045|FG001|STARTED|Period 3 (Third Intervention)||6
11167989|NCT01632579|12357046|FG002|STARTED|Period 3 (Third Intervention)||2
11167990|NCT01632579|12357047|FG003|STARTED|Period 3 (Third Intervention)||2
11167991|NCT01632579|12357048|FG004|STARTED|Period 3 (Third Intervention)||6
11167992|NCT01632579|12357049|FG005|STARTED|Period 3 (Third Intervention)||2
11167993|NCT01632579|12357050|FG006|STARTED|Period 3 (Third Intervention)||2
11167994|NCT01632579|12357051|FG007|STARTED|Period 3 (Third Intervention)||6
11167995|NCT01632579|12357052|FG008|STARTED|Period 3 (Third Intervention)||2
11167996|NCT01632579|12357044|FG000|Received at Least 1 Dose|Period 3 (Third Intervention)||0
11167997|NCT01632579|12357045|FG001|Received at Least 1 Dose|Period 3 (Third Intervention)||6
11167998|NCT01632579|12357046|FG002|Received at Least 1 Dose|Period 3 (Third Intervention)||2
11167999|NCT01632579|12357047|FG003|Received at Least 1 Dose|Period 3 (Third Intervention)||2
11168000|NCT01632579|12357048|FG004|Received at Least 1 Dose|Period 3 (Third Intervention)||6
11168001|NCT01632579|12357049|FG005|Received at Least 1 Dose|Period 3 (Third Intervention)||2
11168002|NCT01632579|12357050|FG006|Received at Least 1 Dose|Period 3 (Third Intervention)||2
11168003|NCT01632579|12357051|FG007|Received at Least 1 Dose|Period 3 (Third Intervention)||6
11168004|NCT01632579|12357052|FG008|Received at Least 1 Dose|Period 3 (Third Intervention)||2
11168005|NCT01632579|12357044|FG000|COMPLETED|Period 3 (Third Intervention)||0
11168006|NCT01632579|12357045|FG001|COMPLETED|Period 3 (Third Intervention)||6
11168007|NCT01632579|12357046|FG002|COMPLETED|Period 3 (Third Intervention)||2
11168008|NCT01632579|12357047|FG003|COMPLETED|Period 3 (Third Intervention)||2
11168009|NCT01632579|12357048|FG004|COMPLETED|Period 3 (Third Intervention)||6
11168010|NCT01632579|12357049|FG005|COMPLETED|Period 3 (Third Intervention)||2
11168011|NCT01632579|12357050|FG006|COMPLETED|Period 3 (Third Intervention)||2
11168012|NCT01632579|12357051|FG007|COMPLETED|Period 3 (Third Intervention)||6
11168013|NCT01632579|12357052|FG008|COMPLETED|Period 3 (Third Intervention)||2
11168014|NCT01632579|12357044|FG000|NOT COMPLETED|Period 3 (Third Intervention)||0
11168015|NCT01632579|12357045|FG001|NOT COMPLETED|Period 3 (Third Intervention)||0
11168016|NCT01632579|12357046|FG002|NOT COMPLETED|Period 3 (Third Intervention)||0
11168017|NCT01632579|12357047|FG003|NOT COMPLETED|Period 3 (Third Intervention)||0
11168018|NCT01632579|12357048|FG004|NOT COMPLETED|Period 3 (Third Intervention)||0
11168019|NCT01632579|12357049|FG005|NOT COMPLETED|Period 3 (Third Intervention)||0
11168020|NCT01632579|12357050|FG006|NOT COMPLETED|Period 3 (Third Intervention)||0
11168021|NCT01632579|12357051|FG007|NOT COMPLETED|Period 3 (Third Intervention)||0
11168022|NCT01632579|12357052|FG008|NOT COMPLETED|Period 3 (Third Intervention)||0
11168023|NCT01632683|12357078|FG000|STARTED|Overall Study||548
11168024|NCT01632683|12357079|FG001|STARTED|Overall Study||552
11168025|NCT01632683|12357078|FG000|COMPLETED|Overall Study||548
11168026|NCT01632683|12357079|FG001|COMPLETED|Overall Study||552
11168027|NCT01632683|12357078|FG000|NOT COMPLETED|Overall Study||0
11168028|NCT01632683|12357079|FG001|NOT COMPLETED|Overall Study||0
11168029|NCT01632709|12357089|FG000|STARTED|Overall Study||4
11168030|NCT01632709|12357090|FG001|STARTED|Overall Study||3
11168031|NCT01632709|12357091|FG002|STARTED|Overall Study||5
11168032|NCT01632709|12357092|FG003|STARTED|Overall Study||4
11168033|NCT01632709|12357089|FG000|Completed Visit 2 (Received Injection)|Overall Study||4
11168034|NCT01632709|12357090|FG001|Completed Visit 2 (Received Injection)|Overall Study||2
11168035|NCT01632709|12357091|FG002|Completed Visit 2 (Received Injection)|Overall Study||5
11168036|NCT01632709|12357092|FG003|Completed Visit 2 (Received Injection)|Overall Study||3
11168037|NCT01632709|12357089|FG000|COMPLETED|Overall Study||2
11168038|NCT01632709|12357090|FG001|COMPLETED|Overall Study||2
11168039|NCT01632709|12357091|FG002|COMPLETED|Overall Study||5
11168040|NCT01632709|12357092|FG003|COMPLETED|Overall Study||3
11168041|NCT01632709|12357089|FG000|NOT COMPLETED|Overall Study||2
11168042|NCT01632709|12357090|FG001|NOT COMPLETED|Overall Study||1
11168043|NCT01632709|12357091|FG002|NOT COMPLETED|Overall Study||0
11168044|NCT01632709|12357092|FG003|NOT COMPLETED|Overall Study||1
11168045|NCT01632735|12357102|FG000|STARTED|Overall Study||40
11168046|NCT01632735|12357103|FG001|STARTED|Overall Study||40
11168047|NCT01632735|12357102|FG000|COMPLETED|Overall Study||36
11168048|NCT01632735|12357103|FG001|COMPLETED|Overall Study||37
11168049|NCT01632735|12357102|FG000|NOT COMPLETED|Overall Study||4
11168050|NCT01632735|12357103|FG001|NOT COMPLETED|Overall Study||3
11168051|NCT01632800|12357109|FG000|STARTED|Overall Study||26
11168052|NCT01632800|12357109|FG000|COMPLETED|Overall Study||25
11168053|NCT01632800|12357109|FG000|NOT COMPLETED|Overall Study||1
11168054|NCT01632891|12357115|FG000|STARTED|Overall Study||26
11168055|NCT01632891|12357116|FG001|STARTED|Overall Study||26
11168056|NCT01632891|12357115|FG000|COMPLETED|Overall Study||25
11168057|NCT01632891|12357116|FG001|COMPLETED|Overall Study||25
11168058|NCT01632891|12357115|FG000|NOT COMPLETED|Overall Study||1
11168059|NCT01632891|12357116|FG001|NOT COMPLETED|Overall Study||1
11168060|NCT01632904|12357128|FG000|STARTED|Overall Study||54
11168061|NCT01632904|12357129|FG001|STARTED|Overall Study||56
11168062|NCT01632904|12357128|FG000|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
11168063|NCT01632904|12357129|FG001|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
11168064|NCT01632904|12357128|FG000|NOT COMPLETED|Overall Study||7
11168065|NCT01632904|12357129|FG001|NOT COMPLETED|Overall Study||6
11168066|NCT01632995|12357135|FG000|STARTED|Pre-screening to Enrollment Period||1069
11168067|NCT01632995|12357135|FG000|COMPLETED|Pre-screening to Enrollment Period||557
11168068|NCT01632995|12357135|FG000|NOT COMPLETED|Pre-screening to Enrollment Period||512
11168069|NCT01632995|12357135|FG000|STARTED|Main Study Follow-up Period||557
11168070|NCT01632995|12357135|FG000|COMPLETED|Main Study Follow-up Period||437
11168071|NCT01632995|12357135|FG000|NOT COMPLETED|Main Study Follow-up Period||120
11419837|NCT03975790|12618614|FG001|COMPLETED|Overall Study||94
11419838|NCT03975790|12618615|FG002|COMPLETED|Overall Study||48
11168072|NCT01633060|12357143|FG000|STARTED|Randomization Phase|All randomized patients|289
11168073|NCT01633060|12357144|FG001|STARTED|Randomization Phase|All randomized patients|143
11168074|NCT01633060|12357143|FG000|COMPLETED|Randomization Phase||288
11168075|NCT01633060|12357144|FG001|COMPLETED|Randomization Phase||140
11168076|NCT01633060|12357143|FG000|NOT COMPLETED|Randomization Phase||1
11419839|NCT03975790|12618613|FG000|NOT COMPLETED|Overall Study||0
11419840|NCT03975790|12618614|FG001|NOT COMPLETED|Overall Study||0
11419841|NCT03975790|12618615|FG002|NOT COMPLETED|Overall Study||0
11419842|NCT03979079|12618623|FG000|STARTED|Overall Study||2384
11419843|NCT03979079|12618623|FG000|COMPLETED|Overall Study||2384
11168077|NCT01633060|12357144|FG001|NOT COMPLETED|Randomization Phase||3
11168078|NCT01633060|12357143|FG000|STARTED|Treatment Phase||288
11168079|NCT01633060|12357144|FG001|STARTED|Treatment Phase||140
11168080|NCT01633060|12357143|FG000|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100
11168081|NCT01633060|12357144|FG001|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35
11168082|NCT01633060|12357143|FG000|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132
11168083|NCT01633060|12357144|FG001|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81
11168084|NCT01633060|12357143|FG000|Safety Set (SS)|Treatment Phase||288
11168085|NCT01633060|12357144|FG001|Safety Set (SS)|Treatment Phase||140
11168086|NCT01633060|12357143|FG000|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63
11168087|NCT01633060|12357144|FG001|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0
11168088|NCT01633060|12357143|FG000|COMPLETED|Treatment Phase||0
11168089|NCT01633060|12357144|FG001|COMPLETED|Treatment Phase||0
11168090|NCT01633060|12357143|FG000|NOT COMPLETED|Treatment Phase||288
11168091|NCT01633060|12357144|FG001|NOT COMPLETED|Treatment Phase||140
11168092|NCT01633060|12357143|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16
11168093|NCT01633060|12357144|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
11168094|NCT01633060|12357143|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11168095|NCT01633060|12357144|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11168096|NCT01633060|12357143|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16
11168097|NCT01633060|12357144|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
11168098|NCT01633112|12357154|FG000|STARTED|Overall Study||352
11168099|NCT01633112|12357155|FG001|STARTED|Overall Study||370
11168100|NCT01633112|12357156|FG002|STARTED|Overall Study||342
11168101|NCT01633112|12357154|FG000|COMPLETED|Overall Study||299
11168102|NCT01633112|12357155|FG001|COMPLETED|Overall Study||310
11168103|NCT01633112|12357156|FG002|COMPLETED|Overall Study||250
11168104|NCT01633112|12357154|FG000|NOT COMPLETED|Overall Study||53
11168105|NCT01633112|12357155|FG001|NOT COMPLETED|Overall Study||60
11168106|NCT01633112|12357156|FG002|NOT COMPLETED|Overall Study||92
11168107|NCT01633320|12357167|FG000|STARTED|Overall Study||132
11168108|NCT01633320|12357168|FG001|STARTED|Overall Study||68
11168109|NCT01633320|12357167|FG000|COMPLETED|Overall Study||132
11168110|NCT01633320|12357168|FG001|COMPLETED|Overall Study||68
11168111|NCT01633320|12357167|FG000|NOT COMPLETED|Overall Study||0
11168112|NCT01633320|12357168|FG001|NOT COMPLETED|Overall Study||0
11168113|NCT01633398|12357176|FG000|STARTED|Overall Study||4779
11168114|NCT01633398|12357177|FG001|STARTED|Overall Study||1550
11168115|NCT01633398|12357176|FG000|COMPLETED|Overall Study||4779
11168116|NCT01633398|12357177|FG001|COMPLETED|Overall Study||1550
11168117|NCT01633398|12357176|FG000|NOT COMPLETED|Overall Study||0
11168118|NCT01633398|12357177|FG001|NOT COMPLETED|Overall Study||0
11168119|NCT01633788|12357187|FG000|STARTED|Overall Study||57
11168120|NCT01633788|12357188|FG001|STARTED|Overall Study||58
11168121|NCT01633788|12357189|FG002|STARTED|Overall Study||59
11168122|NCT01633788|12357190|FG003|STARTED|Overall Study||58
11168123|NCT01633788|12357187|FG000|COMPLETED|Overall Study||50
11168124|NCT01633788|12357188|FG001|COMPLETED|Overall Study||50
11168125|NCT01633788|12357189|FG002|COMPLETED|Overall Study||49
11168126|NCT01633788|12357190|FG003|COMPLETED|Overall Study||45
11168127|NCT01633788|12357187|FG000|NOT COMPLETED|Overall Study||7
11168128|NCT01633788|12357188|FG001|NOT COMPLETED|Overall Study||8
11168129|NCT01633788|12357189|FG002|NOT COMPLETED|Overall Study||10
11168130|NCT01633788|12357190|FG003|NOT COMPLETED|Overall Study||13
11168131|NCT01633827|12357200|FG000|STARTED|First Intervention||11
11168132|NCT01633827|12357201|FG001|STARTED|First Intervention||11
11168133|NCT01633827|12357200|FG000|COMPLETED|First Intervention||11
11168134|NCT01633827|12357201|FG001|COMPLETED|First Intervention||11
11168135|NCT01633827|12357200|FG000|NOT COMPLETED|First Intervention||0
11168136|NCT01633827|12357201|FG001|NOT COMPLETED|First Intervention||0
11168137|NCT01633827|12357200|FG000|STARTED|Washout Period||11
11168138|NCT01633827|12357201|FG001|STARTED|Washout Period||11
11168139|NCT01633827|12357200|FG000|COMPLETED|Washout Period||11
11168140|NCT01633827|12357201|FG001|COMPLETED|Washout Period||11
11168141|NCT01633827|12357200|FG000|NOT COMPLETED|Washout Period||0
11168142|NCT01633827|12357201|FG001|NOT COMPLETED|Washout Period||0
11168143|NCT01633827|12357200|FG000|STARTED|Second Intervention||11
11168144|NCT01633827|12357201|FG001|STARTED|Second Intervention||11
11168145|NCT01633827|12357200|FG000|COMPLETED|Second Intervention||11
11168146|NCT01633827|12357201|FG001|COMPLETED|Second Intervention||11
11168147|NCT01633827|12357200|FG000|NOT COMPLETED|Second Intervention||0
11168148|NCT01633827|12357201|FG001|NOT COMPLETED|Second Intervention||0
11168149|NCT01633853|12357216|FG000|STARTED|Overall Study||104
11168150|NCT01633853|12357217|FG001|STARTED|Overall Study||100
11168151|NCT01633853|12357216|FG000|COMPLETED|Overall Study||104
11168152|NCT01633853|12357217|FG001|COMPLETED|Overall Study||100
11168153|NCT01633853|12357216|FG000|NOT COMPLETED|Overall Study||0
11168154|NCT01633853|12357217|FG001|NOT COMPLETED|Overall Study||0
11168155|NCT01633892|12357224|FG000|STARTED|Overall Study||5
11168156|NCT01633892|12357224|FG000|COMPLETED|Overall Study||5
11168157|NCT01633892|12357224|FG000|NOT COMPLETED|Overall Study||0
11168158|NCT01633944|12357230|FG000|STARTED|Open-label Titration Phase||752
11419844|NCT03979079|12618623|FG000|NOT COMPLETED|Overall Study||0
11168159|NCT01633944|12357231|FG001|STARTED|Open-label Titration Phase||0
11168160|NCT01633944|12357232|FG002|STARTED|Open-label Titration Phase||0
11168161|NCT01633944|12357230|FG000|COMPLETED|Open-label Titration Phase||462
11168162|NCT01633944|12357231|FG001|COMPLETED|Open-label Titration Phase||0
11168163|NCT01633944|12357232|FG002|COMPLETED|Open-label Titration Phase||0
11168164|NCT01633944|12357230|FG000|NOT COMPLETED|Open-label Titration Phase||290
11168165|NCT01633944|12357231|FG001|NOT COMPLETED|Open-label Titration Phase||0
11168166|NCT01633944|12357232|FG002|NOT COMPLETED|Open-label Titration Phase||0
11168167|NCT01633944|12357230|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
11168168|NCT01633944|12357231|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
11168169|NCT01633944|12357232|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
11168170|NCT01633944|12357230|FG000|COMPLETED|Double-blind Treatment Phase||0
11168171|NCT01633944|12357231|FG001|COMPLETED|Double-blind Treatment Phase||176
11168172|NCT01633944|12357232|FG002|COMPLETED|Double-blind Treatment Phase||174
11168173|NCT01633944|12357230|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
11168174|NCT01633944|12357231|FG001|NOT COMPLETED|Double-blind Treatment Phase||54
11168175|NCT01633944|12357232|FG002|NOT COMPLETED|Double-blind Treatment Phase||58
11168176|NCT01634100|12357240|FG000|STARTED|Overall Study||3
11168177|NCT01634100|12357241|FG001|STARTED|Overall Study||3
11168178|NCT01634100|12357242|FG002|STARTED|Overall Study||3
11168179|NCT01634100|12357243|FG003|STARTED|Overall Study||3
11168180|NCT01634100|12357244|FG004|STARTED|Overall Study||3
11168181|NCT01634100|12357245|FG005|STARTED|Overall Study||3
11168182|NCT01634100|12357240|FG000|Received Empa Alone|Overall Study||3
11168183|NCT01634100|12357241|FG001|Received Empa Alone|Overall Study||3
11168184|NCT01634100|12357242|FG002|Received Empa Alone|Overall Study||3
11168185|NCT01634100|12357243|FG003|Received Empa Alone|Overall Study||3
11168186|NCT01634100|12357244|FG004|Received Empa Alone|Overall Study||3
11168187|NCT01634100|12357245|FG005|Received Empa Alone|Overall Study||3
11168188|NCT01634100|12357240|FG000|Received Empa + Rifampicin|Overall Study||3
11168189|NCT01634100|12357241|FG001|Received Empa + Rifampicin|Overall Study||3
11168190|NCT01634100|12357242|FG002|Received Empa + Rifampicin|Overall Study||3
11168191|NCT01634100|12357243|FG003|Received Empa + Rifampicin|Overall Study||3
11168192|NCT01634100|12357244|FG004|Received Empa + Rifampicin|Overall Study||3
11323508|NCT02833805|12520767|FG000|NOT COMPLETED|Overall Study||0
11323509|NCT02499146|12520771|FG000|STARTED|Overall Study||26
11323510|NCT02499146|12520771|FG000|COMPLETED|Overall Study||0
11323511|NCT02499146|12520771|FG000|NOT COMPLETED|Overall Study||26
11323512|NCT02499120|12520777|FG000|STARTED|Overall Study||65
11323513|NCT02499120|12520778|FG001|STARTED|Overall Study||60
11323514|NCT02499120|12520777|FG000|Received Treatment|Overall Study||64
11323515|NCT02499120|12520778|FG001|Received Treatment|Overall Study||60
11323516|NCT02499120|12520777|FG000|COMPLETED|Overall Study||0
11323517|NCT02499120|12520778|FG001|COMPLETED|Overall Study||0
11323518|NCT02499120|12520777|FG000|NOT COMPLETED|Overall Study||65
11323519|NCT02499120|12520778|FG001|NOT COMPLETED|Overall Study||60
11323520|NCT02425306|12520788|FG000|STARTED|Overall Study||3
11323521|NCT02425306|12520789|FG001|STARTED|Overall Study||7
11323522|NCT02425306|12520790|FG002|STARTED|Overall Study||6
11323523|NCT02425306|12520791|FG003|STARTED|Overall Study||32
11323524|NCT02425306|12520788|FG000|COMPLETED|Overall Study||3
11323525|NCT02425306|12520789|FG001|COMPLETED|Overall Study||6
11323526|NCT02425306|12520790|FG002|COMPLETED|Overall Study||5
11323527|NCT02425306|12520791|FG003|COMPLETED|Overall Study||18
11323528|NCT02425306|12520788|FG000|NOT COMPLETED|Overall Study||0
11323529|NCT02425306|12520789|FG001|NOT COMPLETED|Overall Study||1
11323530|NCT02425306|12520790|FG002|NOT COMPLETED|Overall Study||1
11323531|NCT02425306|12520791|FG003|NOT COMPLETED|Overall Study||14
11323532|NCT02366403|12520803|FG000|STARTED|Overall Study||41
11323533|NCT02366403|12520804|FG001|STARTED|Overall Study||44
11323534|NCT02366403|12520803|FG000|COMPLETED|Overall Study||30
11323535|NCT02366403|12520804|FG001|COMPLETED|Overall Study||29
11323536|NCT02366403|12520803|FG000|NOT COMPLETED|Overall Study||11
11323537|NCT02366403|12520804|FG001|NOT COMPLETED|Overall Study||15
11323538|NCT02340221|12520812|FG000|STARTED|Overall Study||214
11323539|NCT02340221|12520813|FG001|STARTED|Overall Study||417
11323540|NCT02340221|12520812|FG000|COMPLETED|Overall Study||0
11323541|NCT02340221|12520813|FG001|COMPLETED|Overall Study||0
11419845|NCT03859622|12618628|FG000|STARTED|Overall Study||289
11419846|NCT03859622|12618628|FG000|COMPLETED|Overall Study||289
11419847|NCT03859622|12618628|FG000|NOT COMPLETED|Overall Study||0
11323542|NCT02340221|12520812|FG000|NOT COMPLETED|Overall Study||214
11323543|NCT02340221|12520813|FG001|NOT COMPLETED|Overall Study||417
11323544|NCT02332915|12520822|FG000|STARTED|Overall Study||18
11323545|NCT02332915|12520823|FG001|STARTED|Overall Study||18
11323546|NCT02332915|12520822|FG000|COMPLETED|Overall Study||12
11323547|NCT02332915|12520823|FG001|COMPLETED|Overall Study||12
11419848|NCT03764813|12618639|FG000|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving no transfusions before the age of 32 weeks|14
11419849|NCT03764813|12618640|FG001|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only cord-RBC transfusions before the age of 32 weeks|3
11323548|NCT02332915|12520822|FG000|NOT COMPLETED|Overall Study||6
11323549|NCT02332915|12520823|FG001|NOT COMPLETED|Overall Study||6
11323550|NCT02327195|12520836|FG000|STARTED|Overall Study||27
11323551|NCT02327195|12520837|FG001|STARTED|Overall Study||27
11323552|NCT02327195|12520836|FG000|COMPLETED|Overall Study||27
11323553|NCT02327195|12520837|FG001|COMPLETED|Overall Study||27
11323554|NCT02327195|12520836|FG000|NOT COMPLETED|Overall Study||0
11323555|NCT02327195|12520837|FG001|NOT COMPLETED|Overall Study||0
11419850|NCT03764813|12618641|FG002|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only adult-RBC transfusions before the age of 32 weeks|4
11323556|NCT02288247|12520843|FG000|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||688
11323557|NCT02288247|12520844|FG001|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||0
11323558|NCT02288247|12520843|FG000|Treated|Period 1: OL Treatment (Max: 315 Weeks)||687
11323559|NCT02288247|12520844|FG001|Treated|Period 1: OL Treatment (Max: 315 Weeks)||0
11323560|NCT02288247|12520843|FG000|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||41
11323561|NCT02288247|12520844|FG001|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0
11323562|NCT02288247|12520843|FG000|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||647
11168193|NCT01634100|12357245|FG005|Received Empa + Rifampicin|Overall Study||3
11168194|NCT01634100|12357240|FG000|Received Empa + Probenecid|Overall Study||2
11168195|NCT01634100|12357241|FG001|Received Empa + Probenecid|Overall Study||3
11168196|NCT01634100|12357242|FG002|Received Empa + Probenecid|Overall Study||2
11168197|NCT01634100|12357243|FG003|Received Empa + Probenecid|Overall Study||3
11168198|NCT01634100|12357244|FG004|Received Empa + Probenecid|Overall Study||3
11168199|NCT01634100|12357245|FG005|Received Empa + Probenecid|Overall Study||3
11168200|NCT01634100|12357240|FG000|COMPLETED|Overall Study||2
11168201|NCT01634100|12357241|FG001|COMPLETED|Overall Study||3
11168202|NCT01634100|12357242|FG002|COMPLETED|Overall Study||2
11168203|NCT01634100|12357243|FG003|COMPLETED|Overall Study||3
11168204|NCT01634100|12357244|FG004|COMPLETED|Overall Study||3
11168205|NCT01634100|12357245|FG005|COMPLETED|Overall Study||3
11168206|NCT01634100|12357240|FG000|NOT COMPLETED|Overall Study||1
11168207|NCT01634100|12357241|FG001|NOT COMPLETED|Overall Study||0
11168208|NCT01634100|12357242|FG002|NOT COMPLETED|Overall Study||1
11168209|NCT01634100|12357243|FG003|NOT COMPLETED|Overall Study||0
11168210|NCT01634100|12357244|FG004|NOT COMPLETED|Overall Study||0
11168211|NCT01634100|12357245|FG005|NOT COMPLETED|Overall Study||0
11168212|NCT01634113|12357256|FG000|STARTED|Overall Study||34
11168213|NCT01634113|12357257|FG001|STARTED|Overall Study||36
11168214|NCT01634113|12357258|FG002|STARTED|Overall Study||32
11168215|NCT01634113|12357256|FG000|COMPLETED|Overall Study||34
11168216|NCT01634113|12357257|FG001|COMPLETED|Overall Study||36
11168217|NCT01634113|12357258|FG002|COMPLETED|Overall Study||31
11168218|NCT01634113|12357256|FG000|NOT COMPLETED|Overall Study||0
11168219|NCT01634113|12357257|FG001|NOT COMPLETED|Overall Study||0
11168220|NCT01634113|12357258|FG002|NOT COMPLETED|Overall Study||1
11203758|NCT01848834|12394264|FG004|COMPLETED|Overall Study|Completed means two-year treatment completed|38
11203759|NCT01848834|12394260|FG000|NOT COMPLETED|Overall Study||19
11203760|NCT01848834|12394261|FG001|NOT COMPLETED|Overall Study||48
11203761|NCT01848834|12394262|FG002|NOT COMPLETED|Overall Study||24
11203762|NCT01848834|12394263|FG003|NOT COMPLETED|Overall Study||26
11203763|NCT01848834|12394264|FG004|NOT COMPLETED|Overall Study||94
11203764|NCT01848847|12394282|FG000|STARTED|Overall Study||51
11203765|NCT01848847|12394283|FG001|STARTED|Overall Study||51
11203766|NCT01848847|12394282|FG000|COMPLETED|Overall Study||49
11203767|NCT01848847|12394283|FG001|COMPLETED|Overall Study||48
11203768|NCT01848847|12394282|FG000|NOT COMPLETED|Overall Study||2
11203769|NCT01848847|12394283|FG001|NOT COMPLETED|Overall Study||3
11203770|NCT01848899|12394291|FG000|STARTED|Overall Study||50
11203771|NCT01848899|12394292|FG001|STARTED|Overall Study||50
11203772|NCT01848899|12394291|FG000|COMPLETED|Overall Study||50
11203773|NCT01848899|12394292|FG001|COMPLETED|Overall Study||50
11203774|NCT01848899|12394291|FG000|NOT COMPLETED|Overall Study||0
11203775|NCT01848899|12394292|FG001|NOT COMPLETED|Overall Study||0
11203776|NCT01848938|12394300|FG000|STARTED|Overall Study||62
11203777|NCT01848938|12394301|FG001|STARTED|Overall Study||61
11203778|NCT01848938|12394300|FG000|COMPLETED|Overall Study||61
11203779|NCT01848938|12394301|FG001|COMPLETED|Overall Study||60
11203780|NCT01848938|12394300|FG000|NOT COMPLETED|Overall Study||1
11203781|NCT01848938|12394301|FG001|NOT COMPLETED|Overall Study||1
11203782|NCT01848977|12394307|FG000|STARTED|Overall Study||20
11203783|NCT01848977|12394307|FG000|COMPLETED|Overall Study||20
11203784|NCT01848977|12394307|FG000|NOT COMPLETED|Overall Study||0
11203785|NCT01848990|12394319|FG000|STARTED|Overall Study||227
11203786|NCT01848990|12394320|FG001|STARTED|Overall Study||115
11203787|NCT01848990|12394321|FG002|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
11203788|NCT01848990|12394319|FG000|Received at Least 1 Dose of Study Drug|Overall Study||227
11203789|NCT01848990|12394320|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115
11203790|NCT01848990|12394321|FG002|Received at Least 1 Dose of Study Drug|Overall Study||113
11203791|NCT01848990|12394319|FG000|Completed Month 6|Overall Study||194
11203792|NCT01848990|12394320|FG001|Completed Month 6|Overall Study||106
11203793|NCT01848990|12394321|FG002|Completed Month 6|Overall Study||103
11203794|NCT01848990|12394319|FG000|COMPLETED|Overall Study||181
11203795|NCT01848990|12394320|FG001|COMPLETED|Overall Study||95
11203796|NCT01848990|12394321|FG002|COMPLETED|Overall Study||98
11203797|NCT01848990|12394319|FG000|NOT COMPLETED|Overall Study||46
11203798|NCT01848990|12394320|FG001|NOT COMPLETED|Overall Study||20
11203799|NCT01848990|12394321|FG002|NOT COMPLETED|Overall Study||16
11203800|NCT01849055|12394339|FG000|STARTED|Overall Study||8
11203801|NCT01849055|12394340|FG001|STARTED|Overall Study||8
11203802|NCT01849055|12394341|FG002|STARTED|Overall Study||8
11203803|NCT01849055|12394342|FG003|STARTED|Overall Study||8
11168221|NCT01634139|12357269|FG000|STARTED|Overall Study||132
11168222|NCT01634139|12357270|FG001|STARTED|Overall Study||136
11168223|NCT01634139|12357271|FG002|STARTED|Overall Study||135
11168224|NCT01634139|12357269|FG000|COMPLETED|Overall Study||122
11168225|NCT01634139|12357270|FG001|COMPLETED|Overall Study||130
11168226|NCT01634139|12357271|FG002|COMPLETED|Overall Study||130
11168227|NCT01634139|12357269|FG000|NOT COMPLETED|Overall Study||10
11168228|NCT01634139|12357270|FG001|NOT COMPLETED|Overall Study||6
11168229|NCT01634139|12357271|FG002|NOT COMPLETED|Overall Study||5
11168230|NCT01634152|12357282|FG000|STARTED|Overall Study||134
11168231|NCT01634152|12357283|FG001|STARTED|Overall Study||137
11168232|NCT01634152|12357284|FG002|STARTED|Overall Study||130
11168233|NCT01634152|12357282|FG000|COMPLETED|Overall Study||130
11168234|NCT01634152|12357283|FG001|COMPLETED|Overall Study||136
11168235|NCT01634152|12357284|FG002|COMPLETED|Overall Study||126
11168236|NCT01634152|12357282|FG000|NOT COMPLETED|Overall Study||4
11168237|NCT01634152|12357283|FG001|NOT COMPLETED|Overall Study||1
11168238|NCT01634152|12357284|FG002|NOT COMPLETED|Overall Study||4
11168239|NCT01634165|12357292|FG000|STARTED|Period 1||6
11168240|NCT01634165|12357293|FG001|STARTED|Period 1||6
11168241|NCT01634165|12357294|FG002|STARTED|Period 1||6
11168242|NCT01634165|12357295|FG003|STARTED|Period 1||6
11168243|NCT01634165|12357292|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
11168244|NCT01634165|12357293|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
11168245|NCT01634165|12357294|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
11168246|NCT01634165|12357295|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
11168247|NCT01634165|12357292|FG000|COMPLETED|Period 1||6
11168248|NCT01634165|12357293|FG001|COMPLETED|Period 1||6
11168249|NCT01634165|12357294|FG002|COMPLETED|Period 1||6
11168250|NCT01634165|12357295|FG003|COMPLETED|Period 1||6
11168251|NCT01634165|12357292|FG000|NOT COMPLETED|Period 1||0
11168252|NCT01634165|12357293|FG001|NOT COMPLETED|Period 1||0
11168253|NCT01634165|12357294|FG002|NOT COMPLETED|Period 1||0
11168254|NCT01634165|12357295|FG003|NOT COMPLETED|Period 1||0
11168255|NCT01634165|12357292|FG000|STARTED|Period 2||6
11168256|NCT01634165|12357293|FG001|STARTED|Period 2||6
11168257|NCT01634165|12357294|FG002|STARTED|Period 2||6
11168258|NCT01634165|12357295|FG003|STARTED|Period 2||6
11168259|NCT01634165|12357292|FG000|COMPLETED|Period 2||6
11168260|NCT01634165|12357293|FG001|COMPLETED|Period 2||5
11168261|NCT01634165|12357294|FG002|COMPLETED|Period 2||6
11168262|NCT01634165|12357295|FG003|COMPLETED|Period 2||6
11168263|NCT01634165|12357292|FG000|NOT COMPLETED|Period 2||0
11168264|NCT01634165|12357293|FG001|NOT COMPLETED|Period 2||1
11168265|NCT01634165|12357294|FG002|NOT COMPLETED|Period 2||0
11168266|NCT01634165|12357295|FG003|NOT COMPLETED|Period 2||0
11419851|NCT03764813|12618642|FG003|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving both adult-RBC and cord-RBCs before the age of 32 weeks|4
11419852|NCT03764813|12618639|FG000|COMPLETED|From Enrollment to the Age of 32 Weeks||14
11419853|NCT03764813|12618640|FG001|COMPLETED|From Enrollment to the Age of 32 Weeks||2
11419854|NCT03764813|12618641|FG002|COMPLETED|From Enrollment to the Age of 32 Weeks||3
11419855|NCT03764813|12618642|FG003|COMPLETED|From Enrollment to the Age of 32 Weeks||4
11419856|NCT03764813|12618639|FG000|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
11419857|NCT03764813|12618640|FG001|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
11419858|NCT03764813|12618641|FG002|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
11419859|NCT03764813|12618642|FG003|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
11419860|NCT03764813|12618639|FG000|STARTED|From Enrollment to the Last HbF Test|Patients receiving no transfusions before last HbF test (occurring at 36 weeks,discharge or death)|13
11419861|NCT03764813|12618640|FG001|STARTED|From Enrollment to the Last HbF Test|Patients receiving only cord-RBCs before last HbF test (occurring at 36 wks,discharge or death)|3
11419862|NCT03764813|12618641|FG002|STARTED|From Enrollment to the Last HbF Test|Patients receiving only adult-RBC before last HbF test (occurring at 36 wks,discharge or death)|4
11419863|NCT03764813|12618642|FG003|STARTED|From Enrollment to the Last HbF Test|Patients receiving both cord and adult-RBCs before the last HbFtest(age of 36 wk,discharge or death)|5
11419864|NCT03764813|12618639|FG000|COMPLETED|From Enrollment to the Last HbF Test||13
11419865|NCT03764813|12618640|FG001|COMPLETED|From Enrollment to the Last HbF Test||3
11419866|NCT03764813|12618641|FG002|COMPLETED|From Enrollment to the Last HbF Test||4
11168267|NCT01634165|12357292|FG000|STARTED|Period 3||6
11168268|NCT01634165|12357293|FG001|STARTED|Period 3||5
11168269|NCT01634165|12357294|FG002|STARTED|Period 3||6
11168270|NCT01634165|12357295|FG003|STARTED|Period 3||6
11168271|NCT01634165|12357292|FG000|COMPLETED|Period 3||6
11168272|NCT01634165|12357293|FG001|COMPLETED|Period 3||5
11168273|NCT01634165|12357294|FG002|COMPLETED|Period 3||6
11168274|NCT01634165|12357295|FG003|COMPLETED|Period 3||6
11168275|NCT01634165|12357292|FG000|NOT COMPLETED|Period 3||0
11168276|NCT01634165|12357293|FG001|NOT COMPLETED|Period 3||0
11168277|NCT01634165|12357294|FG002|NOT COMPLETED|Period 3||0
11168278|NCT01634165|12357295|FG003|NOT COMPLETED|Period 3||0
11168279|NCT01634165|12357292|FG000|STARTED|Period 4||6
11168280|NCT01634165|12357293|FG001|STARTED|Period 4||5
11168281|NCT01634165|12357294|FG002|STARTED|Period 4||6
11168282|NCT01634165|12357295|FG003|STARTED|Period 4||6
11168283|NCT01634165|12357292|FG000|COMPLETED|Period 4||6
11168284|NCT01634165|12357293|FG001|COMPLETED|Period 4||5
11168285|NCT01634165|12357294|FG002|COMPLETED|Period 4||6
11168286|NCT01634165|12357295|FG003|COMPLETED|Period 4||6
11168287|NCT01634165|12357292|FG000|NOT COMPLETED|Period 4||0
11168288|NCT01634165|12357293|FG001|NOT COMPLETED|Period 4||0
11168289|NCT01634165|12357294|FG002|NOT COMPLETED|Period 4||0
11419867|NCT03764813|12618642|FG003|COMPLETED|From Enrollment to the Last HbF Test||5
11419868|NCT03764813|12618639|FG000|NOT COMPLETED|From Enrollment to the Last HbF Test||0
11419869|NCT03764813|12618640|FG001|NOT COMPLETED|From Enrollment to the Last HbF Test||0
11419870|NCT03764813|12618641|FG002|NOT COMPLETED|From Enrollment to the Last HbF Test||0
11168290|NCT01634165|12357295|FG003|NOT COMPLETED|Period 4||0
11168291|NCT01634178|12357305|FG000|STARTED|Treatment Period 1||23
11168292|NCT01634178|12357306|FG001|STARTED|Treatment Period 1||23
11168293|NCT01634178|12357305|FG000|COMPLETED|Treatment Period 1||23
11168294|NCT01634178|12357306|FG001|COMPLETED|Treatment Period 1||22
11168295|NCT01634178|12357305|FG000|NOT COMPLETED|Treatment Period 1||0
11168296|NCT01634178|12357306|FG001|NOT COMPLETED|Treatment Period 1||1
11168297|NCT01634178|12357305|FG000|STARTED|Treatment Period 2||23
11168298|NCT01634178|12357306|FG001|STARTED|Treatment Period 2||22
11168299|NCT01634178|12357305|FG000|COMPLETED|Treatment Period 2||22
11168300|NCT01634178|12357306|FG001|COMPLETED|Treatment Period 2||22
11168301|NCT01634178|12357305|FG000|NOT COMPLETED|Treatment Period 2||1
11026837|NCT00830791|12205450|FG005|NOT COMPLETED|Overall Study||0
11026838|NCT00830804|12205463|FG000|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
11026839|NCT00830804|12205463|FG000|COMPLETED|Overall Study||97
11168302|NCT01634178|12357306|FG001|NOT COMPLETED|Treatment Period 2||0
11168303|NCT01634191|12357317|FG000|STARTED|Overall Study||18
11168304|NCT01634191|12357318|FG001|STARTED|Overall Study||18
11168305|NCT01634191|12357317|FG000|COMPLETED|Overall Study||18
11168306|NCT01634191|12357318|FG001|COMPLETED|Overall Study||18
11168307|NCT01634191|12357317|FG000|NOT COMPLETED|Overall Study||0
11168308|NCT01634191|12357318|FG001|NOT COMPLETED|Overall Study||0
11168309|NCT01634243|12357337|FG000|STARTED|Overall Study||21
11168310|NCT01634243|12357338|FG001|STARTED|Overall Study||43
11168311|NCT01634243|12357337|FG000|COMPLETED|Overall Study||15
11168312|NCT01634243|12357338|FG001|COMPLETED|Overall Study||38
11168313|NCT01634243|12357337|FG000|NOT COMPLETED|Overall Study||6
11168314|NCT01634243|12357338|FG001|NOT COMPLETED|Overall Study||5
11168315|NCT01634256|12357346|FG000|STARTED|Overall Study||30
11168316|NCT01634256|12357347|FG001|STARTED|Overall Study||30
11168317|NCT01634256|12357346|FG000|COMPLETED|Overall Study||26
11168318|NCT01634256|12357347|FG001|COMPLETED|Overall Study||22
11168319|NCT01634256|12357346|FG000|NOT COMPLETED|Overall Study||4
11168320|NCT01634256|12357347|FG001|NOT COMPLETED|Overall Study||8
11026840|NCT00830804|12205463|FG000|NOT COMPLETED|Overall Study||15
11168321|NCT01634269|12357353|FG000|STARTED|Overall Study||20
11168322|NCT01634269|12357353|FG000|30 Days|Overall Study||20
11168323|NCT01634269|12357353|FG000|6 Month|Overall Study||20
11168324|NCT01634269|12357353|FG000|12 Month|Overall Study||20
11168325|NCT01634269|12357353|FG000|24 Month|Overall Study||18
11168326|NCT01634269|12357353|FG000|COMPLETED|Overall Study||18
11168327|NCT01634269|12357353|FG000|NOT COMPLETED|Overall Study||2
11168328|NCT01634360|12357365|FG000|STARTED|Overall Study||49
11168329|NCT01634360|12357366|FG001|STARTED|Overall Study||136
11168330|NCT01634360|12357365|FG000|COMPLETED|Overall Study||0
11168331|NCT01634360|12357366|FG001|COMPLETED|Overall Study||0
11168332|NCT01634360|12357365|FG000|NOT COMPLETED|Overall Study||49
11168333|NCT01634360|12357366|FG001|NOT COMPLETED|Overall Study||136
11168334|NCT01634555|12357372|FG000|STARTED|Overall Study||29
11168335|NCT01634555|12357372|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29
11168336|NCT01634555|12357372|FG000|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
11168337|NCT01634555|12357372|FG000|COMPLETED|Overall Study|Completed the required treatment and assessment.|25
11168338|NCT01634555|12357372|FG000|NOT COMPLETED|Overall Study||4
11168339|NCT01634620|12357377|FG000|STARTED|Overall Study||200
11168340|NCT01634620|12357377|FG000|COMPLETED|Overall Study||200
11168341|NCT01634620|12357377|FG000|NOT COMPLETED|Overall Study||0
11168342|NCT01634659|12357388|FG000|STARTED|Period 1 - First 8 Days of Wear||155
11168343|NCT01634659|12357389|FG001|STARTED|Period 1 - First 8 Days of Wear||158
11168344|NCT01634659|12357388|FG000|COMPLETED|Period 1 - First 8 Days of Wear||155
11168345|NCT01634659|12357389|FG001|COMPLETED|Period 1 - First 8 Days of Wear||158
11168346|NCT01634659|12357388|FG000|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
11168347|NCT01634659|12357389|FG001|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
11168348|NCT01634659|12357388|FG000|STARTED|Period 2 - Second 8 Days of Wear||155
11168349|NCT01634659|12357389|FG001|STARTED|Period 2 - Second 8 Days of Wear||158
11168350|NCT01634659|12357388|FG000|COMPLETED|Period 2 - Second 8 Days of Wear||152
11168351|NCT01634659|12357389|FG001|COMPLETED|Period 2 - Second 8 Days of Wear||158
11168352|NCT01634659|12357388|FG000|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
11168353|NCT01634659|12357389|FG001|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
11168354|NCT01634854|12357397|FG000|STARTED|Overall Study||64
11168355|NCT01634854|12357398|FG001|STARTED|Overall Study||66
11168356|NCT01634854|12357397|FG000|COMPLETED|Overall Study||62
11168357|NCT01634854|12357398|FG001|COMPLETED|Overall Study||59
11168358|NCT01634854|12357397|FG000|NOT COMPLETED|Overall Study||2
11168359|NCT01634854|12357398|FG001|NOT COMPLETED|Overall Study||7
11168360|NCT01635062|12357406|FG000|STARTED|Overall Study||9
11168361|NCT01635062|12357407|FG001|STARTED|Overall Study||9
11168362|NCT01635062|12357406|FG000|Sodium Restriction Baseline Visit|Overall Study||9
11168363|NCT01635062|12357407|FG001|Sodium Restriction Baseline Visit|Overall Study||9
11168364|NCT01635062|12357406|FG000|Sodium Loading Baseline Visit|Overall Study||9
11168365|NCT01635062|12357407|FG001|Sodium Loading Baseline Visit|Overall Study||9
11168366|NCT01635062|12357406|FG000|Post-randomization Sodium Restriction|Overall Study||9
11168367|NCT01635062|12357407|FG001|Post-randomization Sodium Restriction|Overall Study||9
11168368|NCT01635062|12357406|FG000|Post-Randomization Sodium Loaded|Overall Study||9
11168369|NCT01635062|12357407|FG001|Post-Randomization Sodium Loaded|Overall Study||9
11168370|NCT01635062|12357406|FG000|COMPLETED|Overall Study||9
11168371|NCT01635062|12357407|FG001|COMPLETED|Overall Study||9
11168372|NCT01635062|12357406|FG000|NOT COMPLETED|Overall Study||0
11168373|NCT01635062|12357407|FG001|NOT COMPLETED|Overall Study||0
11168374|NCT01635101|12357420|FG000|STARTED|Overall Study||61
11168375|NCT01635101|12357421|FG001|STARTED|Overall Study||67
11168376|NCT01635101|12357422|FG002|STARTED|Overall Study||69
11168377|NCT01635101|12357420|FG000|Safety Population|Overall Study||61
11168378|NCT01635101|12357421|FG001|Safety Population|Overall Study||67
11168379|NCT01635101|12357422|FG002|Safety Population|Overall Study||69
11168380|NCT01635101|12357420|FG000|Modified Intent to Treat (mITT)|Overall Study||61
11168381|NCT01635101|12357421|FG001|Modified Intent to Treat (mITT)|Overall Study||67
11168382|NCT01635101|12357422|FG002|Modified Intent to Treat (mITT)|Overall Study||69
11168383|NCT01635101|12357420|FG000|Pharmacokinetics Evaluable Population|Overall Study||50
11168384|NCT01635101|12357421|FG001|Pharmacokinetics Evaluable Population|Overall Study||59
11168385|NCT01635101|12357422|FG002|Pharmacokinetics Evaluable Population|Overall Study||58
11168386|NCT01635101|12357420|FG000|COMPLETED|Overall Study||52
11168387|NCT01635101|12357421|FG001|COMPLETED|Overall Study||55
11168388|NCT01635101|12357422|FG002|COMPLETED|Overall Study||52
11168389|NCT01635101|12357420|FG000|NOT COMPLETED|Overall Study||9
11168390|NCT01635101|12357421|FG001|NOT COMPLETED|Overall Study||12
11168391|NCT01635101|12357422|FG002|NOT COMPLETED|Overall Study||17
11168392|NCT01635153|12357435|FG000|STARTED|Overall Study||72
11168393|NCT01635153|12357436|FG001|STARTED|Overall Study||79
11168394|NCT01635153|12357435|FG000|COMPLETED|Overall Study||32
11168395|NCT01635153|12357436|FG001|COMPLETED|Overall Study||36
11168396|NCT01635153|12357435|FG000|NOT COMPLETED|Overall Study||40
11168397|NCT01635153|12357436|FG001|NOT COMPLETED|Overall Study||43
11419871|NCT03764813|12618642|FG003|NOT COMPLETED|From Enrollment to the Last HbF Test||0
11168398|NCT01635218|12357445|FG000|STARTED|Overall Study||44
11168399|NCT01635218|12357446|FG001|STARTED|Overall Study||46
11168400|NCT01635218|12357447|FG002|STARTED|Overall Study||43
11168401|NCT01635218|12357445|FG000|COMPLETED|Overall Study||41
11168402|NCT01635218|12357446|FG001|COMPLETED|Overall Study||39
11168403|NCT01635218|12357447|FG002|COMPLETED|Overall Study||37
11168404|NCT01635218|12357445|FG000|NOT COMPLETED|Overall Study||3
11168405|NCT01635218|12357446|FG001|NOT COMPLETED|Overall Study||7
11168406|NCT01635218|12357447|FG002|NOT COMPLETED|Overall Study||6
11168407|NCT01635244|12357458|FG000|STARTED|Overall Study||18
11168408|NCT01635244|12357459|FG001|STARTED|Overall Study||22
11168409|NCT01635244|12357460|FG002|STARTED|Overall Study||20
11168410|NCT01635244|12357458|FG000|COMPLETED|Overall Study||17
11168411|NCT01635244|12357459|FG001|COMPLETED|Overall Study||21
11168412|NCT01635244|12357460|FG002|COMPLETED|Overall Study||18
11168413|NCT01635244|12357458|FG000|NOT COMPLETED|Overall Study||1
11168414|NCT01635244|12357459|FG001|NOT COMPLETED|Overall Study||1
11168415|NCT01635244|12357460|FG002|NOT COMPLETED|Overall Study||2
11168416|NCT01635283|12357468|FG000|STARTED|Overall Study||5
11168417|NCT01635283|12357468|FG000|COMPLETED|Overall Study||1
11168418|NCT01635283|12357468|FG000|NOT COMPLETED|Overall Study||4
11168419|NCT01635439|12357477|FG000|STARTED|Overall Study||100
11168420|NCT01635439|12357478|FG001|STARTED|Overall Study||100
11168421|NCT01635439|12357477|FG000|COMPLETED|Overall Study||100
11168422|NCT01635439|12357478|FG001|COMPLETED|Overall Study||100
11168423|NCT01635439|12357477|FG000|NOT COMPLETED|Overall Study||0
11168424|NCT01635439|12357478|FG001|NOT COMPLETED|Overall Study||0
11168425|NCT01635504|12357484|FG000|STARTED|Overall Study||5
11168426|NCT01635504|12357484|FG000|COMPLETED|Overall Study||5
11168427|NCT01635504|12357484|FG000|NOT COMPLETED|Overall Study||0
11168428|NCT01635764|12357493|FG000|STARTED|Overall Study||508
11168429|NCT01635764|12357493|FG000|COMPLETED|Overall Study||235
11168430|NCT01635764|12357493|FG000|NOT COMPLETED|Overall Study||273
11168431|NCT01635855|12357504|FG000|STARTED|Overall Study||117
11168432|NCT01635855|12357504|FG000|COMPLETED|Overall Study||113
11168433|NCT01635855|12357504|FG000|NOT COMPLETED|Overall Study||4
11168434|NCT01635881|12357508|FG000|STARTED|Overall Study||60
11168435|NCT01635881|12357508|FG000|COMPLETED|Overall Study||60
11168436|NCT01635881|12357508|FG000|NOT COMPLETED|Overall Study||0
11168437|NCT01635920|12357514|FG000|STARTED|Overall Study||125
11168438|NCT01635920|12357515|FG001|STARTED|Overall Study||126
11168439|NCT01635920|12357514|FG000|COMPLETED|Overall Study||122
11168440|NCT01635920|12357515|FG001|COMPLETED|Overall Study||125
11168441|NCT01635920|12357514|FG000|NOT COMPLETED|Overall Study||3
11168442|NCT01635920|12357515|FG001|NOT COMPLETED|Overall Study||1
11168443|NCT01635933|12357524|FG000|STARTED|Overall Study||178
11168444|NCT01635933|12357525|FG001|STARTED|Overall Study||185
11168445|NCT01635933|12357524|FG000|COMPLETED|Overall Study||176
11168446|NCT01635933|12357525|FG001|COMPLETED|Overall Study||177
11168447|NCT01635933|12357524|FG000|NOT COMPLETED|Overall Study||2
11168448|NCT01635933|12357525|FG001|NOT COMPLETED|Overall Study||8
11168449|NCT01635998|12357533|FG000|STARTED|Overall Study||28
11168450|NCT01635998|12357534|FG001|STARTED|Overall Study||22
11168451|NCT01635998|12357533|FG000|COMPLETED|Overall Study||24
11168452|NCT01635998|12357534|FG001|COMPLETED|Overall Study||15
11168453|NCT01635998|12357533|FG000|NOT COMPLETED|Overall Study||4
11168454|NCT01635998|12357534|FG001|NOT COMPLETED|Overall Study||7
11168455|NCT01636063|12357542|FG000|STARTED|Overall Study||21
11168456|NCT01636063|12357543|FG001|STARTED|Overall Study||21
11168457|NCT01636063|12357542|FG000|COMPLETED|Overall Study||21
11168458|NCT01636063|12357543|FG001|COMPLETED|Overall Study||21
11168459|NCT01636063|12357542|FG000|NOT COMPLETED|Overall Study||0
11168460|NCT01636063|12357543|FG001|NOT COMPLETED|Overall Study||0
11168461|NCT01636076|12357551|FG000|STARTED|Overall Study||316
11168462|NCT01636076|12357552|FG001|STARTED|Overall Study||313
11168463|NCT01636076|12357551|FG000|COMPLETED|Overall Study||299
11168464|NCT01636076|12357552|FG001|COMPLETED|Overall Study||288
11168465|NCT01636076|12357551|FG000|NOT COMPLETED|Overall Study||17
11168466|NCT01636076|12357552|FG001|NOT COMPLETED|Overall Study||25
11168467|NCT01636102|12357567|FG000|STARTED|Overall Study||63
11168468|NCT01636102|12357568|FG001|STARTED|Overall Study||63
11168469|NCT01636102|12357567|FG000|COMPLETED|Overall Study||63
11168470|NCT01636102|12357568|FG001|COMPLETED|Overall Study||63
11168471|NCT01636102|12357567|FG000|NOT COMPLETED|Overall Study||0
11168472|NCT01636102|12357568|FG001|NOT COMPLETED|Overall Study||0
11168473|NCT01636206|12357577|FG000|STARTED|Overall Study||111
11168474|NCT01636206|12357578|FG001|STARTED|Overall Study||221
11168475|NCT01636206|12357577|FG000|COMPLETED|Overall Study||92
11168476|NCT01636206|12357578|FG001|COMPLETED|Overall Study||170
11168477|NCT01636206|12357577|FG000|NOT COMPLETED|Overall Study||19
11168478|NCT01636206|12357578|FG001|NOT COMPLETED|Overall Study||51
11168479|NCT01636284|12357584|FG000|STARTED|Overall Study||16
11168480|NCT01636284|12357584|FG000|COMPLETED|Overall Study||16
11168481|NCT01636284|12357584|FG000|NOT COMPLETED|Overall Study||0
11168482|NCT01636297|12357591|FG000|STARTED|Overall Study||40
11168483|NCT01636297|12357592|FG001|STARTED|Overall Study||40
11168484|NCT01636297|12357593|FG002|STARTED|Overall Study||20
11168485|NCT01636297|12357591|FG000|COMPLETED|Overall Study||36
11168486|NCT01636297|12357592|FG001|COMPLETED|Overall Study||36
11168487|NCT01636297|12357593|FG002|COMPLETED|Overall Study||19
11168488|NCT01636297|12357591|FG000|NOT COMPLETED|Overall Study||4
11168489|NCT01636297|12357592|FG001|NOT COMPLETED|Overall Study||4
11168490|NCT01636297|12357593|FG002|NOT COMPLETED|Overall Study||1
11168491|NCT01636362|12357603|FG000|STARTED|Overall Study||45
11168492|NCT01636362|12357603|FG000|COMPLETED|Overall Study||37
11168493|NCT01636362|12357603|FG000|NOT COMPLETED|Overall Study||8
11168494|NCT01636414|12357610|FG000|STARTED|Overall Study||64
11168495|NCT01636414|12357611|FG001|STARTED|Overall Study||66
11168496|NCT01636414|12357612|FG002|STARTED|Overall Study||74
11168497|NCT01636414|12357610|FG000|COMPLETED|Overall Study||61
11168498|NCT01636414|12357611|FG001|COMPLETED|Overall Study||60
11168499|NCT01636414|12357612|FG002|COMPLETED|Overall Study||65
11168500|NCT01636414|12357610|FG000|NOT COMPLETED|Overall Study||3
11168501|NCT01636414|12357611|FG001|NOT COMPLETED|Overall Study||6
11168502|NCT01636414|12357612|FG002|NOT COMPLETED|Overall Study||9
11168503|NCT01636453|12357620|FG000|STARTED|Overall Study||120
11168504|NCT01636453|12357620|FG000|COMPLETED|Overall Study||112
11168505|NCT01636453|12357620|FG000|NOT COMPLETED|Overall Study||8
11168506|NCT01636661|12357626|FG000|STARTED|Overall Study||5
11168507|NCT01636661|12357627|FG001|STARTED|Overall Study||6
11168508|NCT01636661|12357626|FG000|COMPLETED|Overall Study||5
11168509|NCT01636661|12357627|FG001|COMPLETED|Overall Study||6
11168510|NCT01636661|12357626|FG000|NOT COMPLETED|Overall Study||0
11168511|NCT01636661|12357627|FG001|NOT COMPLETED|Overall Study||0
11168512|NCT01636687|12357636|FG000|STARTED|Induction Period||61
11168513|NCT01636687|12357637|FG001|STARTED|Induction Period||60
11168514|NCT01636687|12357638|FG002|STARTED|Induction Period||0
11168515|NCT01636687|12357639|FG003|STARTED|Induction Period||0
11168516|NCT01636687|12357640|FG004|STARTED|Induction Period||61
11168517|NCT01636687|12357636|FG000|COMPLETED|Induction Period||58
11168518|NCT01636687|12357637|FG001|COMPLETED|Induction Period||60
11168519|NCT01636687|12357638|FG002|COMPLETED|Induction Period||0
11168520|NCT01636687|12357639|FG003|COMPLETED|Induction Period||0
11168521|NCT01636687|12357640|FG004|COMPLETED|Induction Period||59
11168522|NCT01636687|12357636|FG000|NOT COMPLETED|Induction Period||3
11168523|NCT01636687|12357637|FG001|NOT COMPLETED|Induction Period||0
11168524|NCT01636687|12357638|FG002|NOT COMPLETED|Induction Period||0
11168525|NCT01636687|12357639|FG003|NOT COMPLETED|Induction Period||0
11168526|NCT01636687|12357640|FG004|NOT COMPLETED|Induction Period||2
11168527|NCT01636687|12357636|FG000|STARTED|Maintenance Period||58
11168528|NCT01636687|12357637|FG001|STARTED|Maintenance Period||60
11168529|NCT01636687|12357638|FG002|STARTED|Maintenance Period||28
11168530|NCT01636687|12357639|FG003|STARTED|Maintenance Period||28
11168531|NCT01636687|12357640|FG004|STARTED|Maintenance Period||3
11168532|NCT01636687|12357636|FG000|COMPLETED|Maintenance Period||50
11168533|NCT01636687|12357637|FG001|COMPLETED|Maintenance Period||58
11168534|NCT01636687|12357638|FG002|COMPLETED|Maintenance Period||26
11168535|NCT01636687|12357639|FG003|COMPLETED|Maintenance Period||28
11168536|NCT01636687|12357640|FG004|COMPLETED|Maintenance Period||1
11168537|NCT01636687|12357636|FG000|NOT COMPLETED|Maintenance Period||8
11168538|NCT01636687|12357637|FG001|NOT COMPLETED|Maintenance Period||2
11168539|NCT01636687|12357638|FG002|NOT COMPLETED|Maintenance Period||2
11168540|NCT01636687|12357639|FG003|NOT COMPLETED|Maintenance Period||0
11168541|NCT01636687|12357640|FG004|NOT COMPLETED|Maintenance Period||2
11168542|NCT01636687|12357636|FG000|STARTED|Extension Period||47
11168543|NCT01636687|12357637|FG001|STARTED|Extension Period||54
11168544|NCT01636687|12357638|FG002|STARTED|Extension Period||25
11168545|NCT01636687|12357639|FG003|STARTED|Extension Period||28
11168546|NCT01636687|12357640|FG004|STARTED|Extension Period||0
11168547|NCT01636687|12357636|FG000|COMPLETED|Extension Period||0
11168548|NCT01636687|12357637|FG001|COMPLETED|Extension Period||0
11168549|NCT01636687|12357638|FG002|COMPLETED|Extension Period||0
11168550|NCT01636687|12357639|FG003|COMPLETED|Extension Period||0
11168551|NCT01636687|12357640|FG004|COMPLETED|Extension Period||0
11168552|NCT01636687|12357636|FG000|NOT COMPLETED|Extension Period||47
11168553|NCT01636687|12357637|FG001|NOT COMPLETED|Extension Period||54
11168554|NCT01636687|12357638|FG002|NOT COMPLETED|Extension Period||25
11168555|NCT01636687|12357639|FG003|NOT COMPLETED|Extension Period||28
11168556|NCT01636687|12357640|FG004|NOT COMPLETED|Extension Period||0
11168557|NCT01636687|12357636|FG000|STARTED|Follow-up Period||38
11168558|NCT01636687|12357637|FG001|STARTED|Follow-up Period||45
11168559|NCT01636687|12357638|FG002|STARTED|Follow-up Period||21
11168560|NCT01636687|12357639|FG003|STARTED|Follow-up Period||20
11168561|NCT01636687|12357640|FG004|STARTED|Follow-up Period||2
11168562|NCT01636687|12357636|FG000|COMPLETED|Follow-up Period||37
11168563|NCT01636687|12357637|FG001|COMPLETED|Follow-up Period||45
11168564|NCT01636687|12357638|FG002|COMPLETED|Follow-up Period||21
11168565|NCT01636687|12357639|FG003|COMPLETED|Follow-up Period||20
11168566|NCT01636687|12357640|FG004|COMPLETED|Follow-up Period||1
11168567|NCT01636687|12357636|FG000|NOT COMPLETED|Follow-up Period||1
11168568|NCT01636687|12357637|FG001|NOT COMPLETED|Follow-up Period||0
11168569|NCT01636687|12357638|FG002|NOT COMPLETED|Follow-up Period||0
11168570|NCT01636687|12357639|FG003|NOT COMPLETED|Follow-up Period||0
11168571|NCT01636687|12357640|FG004|NOT COMPLETED|Follow-up Period||1
11168572|NCT01636713|12357661|FG000|STARTED|Overall Study||193
11168573|NCT01636713|12357662|FG001|STARTED|Overall Study||194
11168574|NCT01636713|12357663|FG002|STARTED|Overall Study||193
11168575|NCT01636713|12357661|FG000|COMPLETED|Overall Study||161
11168576|NCT01636713|12357662|FG001|COMPLETED|Overall Study||166
11168577|NCT01636713|12357663|FG002|COMPLETED|Overall Study||170
11168578|NCT01636713|12357661|FG000|NOT COMPLETED|Overall Study||32
11168579|NCT01636713|12357662|FG001|NOT COMPLETED|Overall Study||28
11168580|NCT01636713|12357663|FG002|NOT COMPLETED|Overall Study||23
11168581|NCT01636765|12357671|FG000|STARTED|Overall Study||104
11168582|NCT01636765|12357671|FG000|COMPLETED|Overall Study||104
11168583|NCT01636765|12357671|FG000|NOT COMPLETED|Overall Study||0
11168584|NCT01636778|12357675|FG000|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
11168585|NCT01636778|12357676|FG001|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
11168586|NCT01636778|12357677|FG002|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
11168587|NCT01636778|12357675|FG000|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
11168588|NCT01636778|12357676|FG001|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
11168589|NCT01636778|12357677|FG002|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
11168590|NCT01636778|12357675|FG000|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
11168591|NCT01636778|12357676|FG001|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
11168592|NCT01636778|12357677|FG002|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
11168593|NCT01636778|12357675|FG000|STARTED|Antiviral Treatment Period (Part 2)||0
11168594|NCT01636778|12357676|FG001|STARTED|Antiviral Treatment Period (Part 2)||41
11168595|NCT01636778|12357677|FG002|STARTED|Antiviral Treatment Period (Part 2)||0
11168596|NCT01636778|12357675|FG000|COMPLETED|Antiviral Treatment Period (Part 2)||0
11168597|NCT01636778|12357676|FG001|COMPLETED|Antiviral Treatment Period (Part 2)||31
11168598|NCT01636778|12357677|FG002|COMPLETED|Antiviral Treatment Period (Part 2)||0
11168599|NCT01636778|12357675|FG000|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
11168600|NCT01636778|12357676|FG001|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
11168601|NCT01636778|12357677|FG002|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
11168602|NCT01636778|12357675|FG000|STARTED|Follow-up Period After Part 2||0
11168603|NCT01636778|12357676|FG001|STARTED|Follow-up Period After Part 2||0
11168604|NCT01636778|12357677|FG002|STARTED|Follow-up Period After Part 2||41
11168605|NCT01636778|12357675|FG000|COMPLETED|Follow-up Period After Part 2||0
11168606|NCT01636778|12357676|FG001|COMPLETED|Follow-up Period After Part 2||0
11168607|NCT01636778|12357677|FG002|COMPLETED|Follow-up Period After Part 2||37
11168608|NCT01636778|12357675|FG000|NOT COMPLETED|Follow-up Period After Part 2||0
11168609|NCT01636778|12357676|FG001|NOT COMPLETED|Follow-up Period After Part 2||0
11203804|NCT01849055|12394343|FG004|STARTED|Overall Study||8
11168610|NCT01636778|12357677|FG002|NOT COMPLETED|Follow-up Period After Part 2||4
11168611|NCT01636882|12357685|FG000|STARTED|Overall Study||16
11168612|NCT01636882|12357685|FG000|COMPLETED|Overall Study||16
11168613|NCT01636882|12357685|FG000|NOT COMPLETED|Overall Study||0
11168614|NCT01636934|12357691|FG000|STARTED|Overall Study||25
11168615|NCT01636934|12357692|FG001|STARTED|Overall Study||24
11168616|NCT01636934|12357691|FG000|COMPLETED|Overall Study||19
11168617|NCT01636934|12357692|FG001|COMPLETED|Overall Study||21
11168618|NCT01636934|12357691|FG000|NOT COMPLETED|Overall Study||6
11168619|NCT01636934|12357692|FG001|NOT COMPLETED|Overall Study||3
11168620|NCT01636947|12357700|FG000|STARTED|Overall Study||244
11168621|NCT01636947|12357701|FG001|STARTED|Overall Study||250
11168622|NCT01636947|12357700|FG000|Treated|Overall Study||242
11168623|NCT01636947|12357701|FG001|Treated|Overall Study||248
11168624|NCT01636947|12357700|FG000|COMPLETED|Overall Study||232
11168625|NCT01636947|12357701|FG001|COMPLETED|Overall Study||239
11168626|NCT01636947|12357700|FG000|NOT COMPLETED|Overall Study||12
11168627|NCT01636947|12357701|FG001|NOT COMPLETED|Overall Study||11
11168628|NCT01636960|12357707|FG000|STARTED|Induction Phase||9
11168629|NCT01636960|12357707|FG000|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
11168630|NCT01636960|12357707|FG000|NOT COMPLETED|Induction Phase||2
11168631|NCT01636960|12357707|FG000|STARTED|Maintenance Phase||7
11168632|NCT01636960|12357707|FG000|COMPLETED|Maintenance Phase||0
11168633|NCT01636960|12357707|FG000|NOT COMPLETED|Maintenance Phase||7
11168634|NCT01636986|12357713|FG000|STARTED|Overall Study||30
11168635|NCT01636986|12357714|FG001|STARTED|Overall Study||32
11168636|NCT01636986|12357713|FG000|COMPLETED|Overall Study||30
11168637|NCT01636986|12357714|FG001|COMPLETED|Overall Study||30
11168638|NCT01636986|12357713|FG000|NOT COMPLETED|Overall Study||0
11168639|NCT01636986|12357714|FG001|NOT COMPLETED|Overall Study||2
11168640|NCT01637077|12357722|FG000|STARTED|Overall Study||23
11168641|NCT01637077|12357723|FG001|STARTED|Overall Study||23
11168642|NCT01637077|12357722|FG000|COMPLETED|Overall Study||19
11168643|NCT01637077|12357723|FG001|COMPLETED|Overall Study||22
11168644|NCT01637077|12357722|FG000|NOT COMPLETED|Overall Study||4
11168645|NCT01637077|12357723|FG001|NOT COMPLETED|Overall Study||1
11168646|NCT01637090|12357729|FG000|STARTED|Overall Study||3
11168647|NCT01637090|12357729|FG000|COMPLETED|Overall Study||0
11168648|NCT01637090|12357729|FG000|NOT COMPLETED|Overall Study||3
11168649|NCT01637142|12357733|FG000|STARTED|Treatment Period 1||18
11168650|NCT01637142|12357733|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||18
11168651|NCT01637142|12357733|FG000|COMPLETED|Treatment Period 1||18
11168652|NCT01637142|12357733|FG000|NOT COMPLETED|Treatment Period 1||0
11168653|NCT01637142|12357733|FG000|STARTED|Washout Period (at Least 3 Days)||18
11168654|NCT01637142|12357733|FG000|COMPLETED|Washout Period (at Least 3 Days)||17
11168655|NCT01637142|12357733|FG000|NOT COMPLETED|Washout Period (at Least 3 Days)||1
11168656|NCT01637142|12357733|FG000|STARTED|Treatment Period 2||17
11168657|NCT01637142|12357733|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||17
11168658|NCT01637142|12357733|FG000|COMPLETED|Treatment Period 2||17
11168659|NCT01637142|12357733|FG000|NOT COMPLETED|Treatment Period 2||0
11168660|NCT01637246|12357739|FG000|STARTED|Overall Study||4385
11168661|NCT01637246|12357739|FG000|COMPLETED|Overall Study||2246
11168662|NCT01637246|12357739|FG000|NOT COMPLETED|Overall Study||2139
11168663|NCT01637272|12357743|FG000|STARTED|Overall Study||43
11168664|NCT01637272|12357743|FG000|Completed sc Phase|Overall Study||33
11168665|NCT01637272|12357743|FG000|Completed Core Phase (sc + LAR)|Overall Study||31
11168666|NCT01637272|12357743|FG000|Entered Extension Phase|Overall Study||27
11168667|NCT01637272|12357743|FG000|Completed Core But Did no Enter Ext..|Overall Study||4
11168668|NCT01637272|12357743|FG000|COMPLETED|Overall Study||23
11168669|NCT01637272|12357743|FG000|NOT COMPLETED|Overall Study||20
11168670|NCT01637402|12357762|FG000|STARTED|Standard Dose Regimen||41
11168671|NCT01637402|12357763|FG001|STARTED|Standard Dose Regimen|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
11168672|NCT01637402|12357762|FG000|COMPLETED|Standard Dose Regimen||38
11168673|NCT01637402|12357763|FG001|COMPLETED|Standard Dose Regimen||0
11168674|NCT01637402|12357762|FG000|NOT COMPLETED|Standard Dose Regimen||3
11168675|NCT01637402|12357763|FG001|NOT COMPLETED|Standard Dose Regimen||0
11168676|NCT01637402|12357762|FG000|STARTED|Week 12 Evaluation||38
11168677|NCT01637402|12357763|FG001|STARTED|Week 12 Evaluation|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
11168678|NCT01637402|12357762|FG000|COMPLETED|Week 12 Evaluation||32
11168679|NCT01637402|12357763|FG001|COMPLETED|Week 12 Evaluation||0
11168680|NCT01637402|12357762|FG000|NOT COMPLETED|Week 12 Evaluation||6
11168681|NCT01637402|12357763|FG001|NOT COMPLETED|Week 12 Evaluation||0
11168682|NCT01637402|12357762|FG000|STARTED|Treatment Regiments Post Week 12|Patients continuing on standard dose|14
11168683|NCT01637402|12357763|FG001|STARTED|Treatment Regiments Post Week 12|Patients who progressed after decline on standard dose|18
11168684|NCT01637402|12357762|FG000|COMPLETED|Treatment Regiments Post Week 12||5
11168685|NCT01637402|12357763|FG001|COMPLETED|Treatment Regiments Post Week 12||14
11168686|NCT01637402|12357762|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||9
11168687|NCT01637402|12357763|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4
11168688|NCT01637584|12357790|FG000|STARTED|Overall Study||20
11168689|NCT01637584|12357791|FG001|STARTED|Overall Study||20
11168690|NCT01637584|12357790|FG000|COMPLETED|Overall Study||19
11168691|NCT01637584|12357791|FG001|COMPLETED|Overall Study||17
11168692|NCT01637584|12357790|FG000|NOT COMPLETED|Overall Study||1
11168693|NCT01637584|12357791|FG001|NOT COMPLETED|Overall Study||3
11168694|NCT01637623|12357801|FG000|STARTED|Overall Study||29
11168695|NCT01637623|12357802|FG001|STARTED|Overall Study||30
11168696|NCT01637623|12357803|FG002|STARTED|Overall Study||28
11168697|NCT01637623|12357801|FG000|Received Intervention|Overall Study||28
11168698|NCT01637623|12357802|FG001|Received Intervention|Overall Study||30
11168699|NCT01637623|12357803|FG002|Received Intervention|Overall Study||27
11168700|NCT01637623|12357801|FG000|Did Not Receive Intervention|Overall Study||1
11168701|NCT01637623|12357802|FG001|Did Not Receive Intervention|Overall Study||0
11168702|NCT01637623|12357803|FG002|Did Not Receive Intervention|Overall Study||1
11168703|NCT01637623|12357801|FG000|Analyzed|Overall Study||28
11168704|NCT01637623|12357802|FG001|Analyzed|Overall Study||30
11168705|NCT01637623|12357803|FG002|Analyzed|Overall Study||28
11168706|NCT01637623|12357801|FG000|COMPLETED|Overall Study||28
11168707|NCT01637623|12357802|FG001|COMPLETED|Overall Study||30
11168708|NCT01637623|12357803|FG002|COMPLETED|Overall Study||25
11168709|NCT01637623|12357801|FG000|NOT COMPLETED|Overall Study||1
11168710|NCT01637623|12357802|FG001|NOT COMPLETED|Overall Study||0
11168711|NCT01637623|12357803|FG002|NOT COMPLETED|Overall Study||3
11168712|NCT01637870|12357811|FG000|STARTED|Overall Study||110
11168713|NCT01637870|12357811|FG000|COMPLETED|Overall Study||110
11168714|NCT01637870|12357811|FG000|NOT COMPLETED|Overall Study||0
11168715|NCT01637922|12357817|FG000|STARTED|Overall Study||15
11168716|NCT01637922|12357818|FG001|STARTED|Overall Study||19
11168717|NCT01637922|12357817|FG000|COMPLETED|Overall Study||13
11168718|NCT01637922|12357818|FG001|COMPLETED|Overall Study||14
11168719|NCT01637922|12357817|FG000|NOT COMPLETED|Overall Study||2
11168720|NCT01637922|12357818|FG001|NOT COMPLETED|Overall Study||5
11168721|NCT01637935|12357827|FG000|STARTED|Overall Study||34181
11168722|NCT01637935|12357828|FG001|STARTED|Overall Study||158918
11168723|NCT01637935|12357827|FG000|COMPLETED|Overall Study||34181
11168724|NCT01637935|12357828|FG001|COMPLETED|Overall Study||158918
11168725|NCT01637935|12357827|FG000|NOT COMPLETED|Overall Study||0
11168726|NCT01637935|12357828|FG001|NOT COMPLETED|Overall Study||0
11168727|NCT01637961|12357834|FG000|STARTED|Overall Study||23
11168728|NCT01637961|12357834|FG000|COMPLETED|Overall Study|Eligible and treated patients.|21
11168729|NCT01637961|12357834|FG000|NOT COMPLETED|Overall Study||2
11168730|NCT01638000|12357846|FG000|STARTED|Overall Study||943
11168731|NCT01638000|12357847|FG001|STARTED|Overall Study||944
11168732|NCT01638000|12357846|FG000|Received at Least 1 Double-Blind Dose|Overall Study||936
11168733|NCT01638000|12357847|FG001|Received at Least 1 Double-Blind Dose|Overall Study||934
11168734|NCT01638000|12357846|FG000|COMPLETED|Overall Study||883
11168735|NCT01638000|12357847|FG001|COMPLETED|Overall Study||873
11168736|NCT01638000|12357846|FG000|NOT COMPLETED|Overall Study||60
11168737|NCT01638000|12357847|FG001|NOT COMPLETED|Overall Study||71
11168738|NCT01638013|12357856|FG000|STARTED|Overall Study||201
11168739|NCT01638013|12357857|FG001|STARTED|Overall Study||225
11168740|NCT01638013|12357858|FG002|STARTED|Overall Study||417
11168741|NCT01638013|12357856|FG000|COMPLETED|Overall Study||70
11168742|NCT01638013|12357857|FG001|COMPLETED|Overall Study||147
11168743|NCT01638013|12357858|FG002|COMPLETED|Overall Study||296
11168744|NCT01638013|12357856|FG000|NOT COMPLETED|Overall Study||131
11168745|NCT01638013|12357857|FG001|NOT COMPLETED|Overall Study||78
11168746|NCT01638013|12357858|FG002|NOT COMPLETED|Overall Study||121
11168747|NCT01638052|12357872|FG000|STARTED|Overall Study||28
11168748|NCT01638052|12357873|FG001|STARTED|Overall Study||28
11168749|NCT01638052|12357872|FG000|COMPLETED|Overall Study||28
11168750|NCT01638052|12357873|FG001|COMPLETED|Overall Study||28
11168751|NCT01638052|12357872|FG000|NOT COMPLETED|Overall Study||0
11168752|NCT01638052|12357873|FG001|NOT COMPLETED|Overall Study||0
11168753|NCT01638312|12357881|FG000|STARTED|Overall Study||20
11168754|NCT01638312|12357882|FG001|STARTED|Overall Study||30
11168755|NCT01638312|12357881|FG000|COMPLETED|Overall Study||20
11168756|NCT01638312|12357882|FG001|COMPLETED|Overall Study||30
11168757|NCT01638312|12357881|FG000|NOT COMPLETED|Overall Study||0
11168758|NCT01638312|12357882|FG001|NOT COMPLETED|Overall Study||0
11168759|NCT01638390|12357888|FG000|STARTED|Overall Study|enrolled|357
11168760|NCT01638390|12357888|FG000|COMPLETED|Overall Study|treated eyes|336
11168761|NCT01638390|12357888|FG000|NOT COMPLETED|Overall Study||21
11168762|NCT01638416|12357901|FG000|STARTED|Overall Study||2490
11168763|NCT01638416|12357902|FG001|STARTED|Overall Study||2504
11168764|NCT01638416|12357901|FG000|COMPLETED|Overall Study||2457
11168765|NCT01638416|12357902|FG001|COMPLETED|Overall Study||2462
11168766|NCT01638416|12357901|FG000|NOT COMPLETED|Overall Study||33
11168767|NCT01638416|12357902|FG001|NOT COMPLETED|Overall Study||42
11168768|NCT01638429|12357909|FG000|STARTED|Overall Study||12
11168769|NCT01638429|12357909|FG000|Pre-treatment Testing|Overall Study||11
11168770|NCT01638429|12357909|FG000|Antibiotic Treatment|Overall Study||11
11168771|NCT01638429|12357909|FG000|Post-treatment Testing|Overall Study||11
11168772|NCT01638429|12357909|FG000|COMPLETED|Overall Study||11
11168773|NCT01638429|12357909|FG000|NOT COMPLETED|Overall Study||1
11168774|NCT01638468|12357917|FG000|STARTED|Overall Study||7
11168775|NCT01638468|12357917|FG000|COMPLETED|Overall Study||7
11168776|NCT01638468|12357917|FG000|NOT COMPLETED|Overall Study||0
11168777|NCT01638507|12357921|FG000|STARTED|Overall Study||230
11168778|NCT01638507|12357921|FG000|COMPLETED|Overall Study||224
11168779|NCT01638507|12357921|FG000|NOT COMPLETED|Overall Study||6
11168780|NCT01638546|12357929|FG000|STARTED|Overall Study||52
11168781|NCT01638546|12357930|FG001|STARTED|Overall Study||45
11168782|NCT01638546|12357929|FG000|COMPLETED|Overall Study||51
11168783|NCT01638546|12357930|FG001|COMPLETED|Overall Study||42
11168784|NCT01638546|12357929|FG000|NOT COMPLETED|Overall Study||1
11168785|NCT01638546|12357930|FG001|NOT COMPLETED|Overall Study||3
11168786|NCT01638559|12357938|FG000|STARTED|Overall Study||88
11168787|NCT01638559|12357938|FG000|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85
11168788|NCT01638559|12357938|FG000|NOT COMPLETED|Overall Study||3
11168789|NCT01638819|12357955|FG000|STARTED|Overall Study||15
11168790|NCT01638819|12357956|FG001|STARTED|Overall Study||15
11168791|NCT01638819|12357955|FG000|First Intervention (8 Weeks)|Overall Study||15
11168792|NCT01638819|12357956|FG001|First Intervention (8 Weeks)|Overall Study||15
11168793|NCT01638819|12357955|FG000|Second Intervention (24 Weeks)|Overall Study||14
11168794|NCT01638819|12357956|FG001|Second Intervention (24 Weeks)|Overall Study||15
11168795|NCT01638819|12357955|FG000|COMPLETED|Overall Study||14
11168796|NCT01638819|12357956|FG001|COMPLETED|Overall Study||15
11168797|NCT01638819|12357955|FG000|NOT COMPLETED|Overall Study||1
11168798|NCT01638819|12357956|FG001|NOT COMPLETED|Overall Study||0
11168799|NCT01639001|12357963|FG000|STARTED|Overall Study||104
11168800|NCT01639001|12357964|FG001|STARTED|Overall Study||103
11168801|NCT01639001|12357963|FG000|Treated|Overall Study||104
11168802|NCT01639001|12357964|FG001|Treated|Overall Study||101
11168803|NCT01639001|12357963|FG000|COMPLETED|Overall Study||29
11168804|NCT01639001|12357964|FG001|COMPLETED|Overall Study||26
11168805|NCT01639001|12357963|FG000|NOT COMPLETED|Overall Study||75
11168806|NCT01639001|12357964|FG001|NOT COMPLETED|Overall Study||77
11168807|NCT01639040|12357974|FG000|STARTED|Overall Study||10
11168808|NCT01639040|12357975|FG001|STARTED|Overall Study||21
11168809|NCT01639040|12357974|FG000|COMPLETED|Overall Study||9
11168810|NCT01639040|12357975|FG001|COMPLETED|Overall Study||21
11168811|NCT01639040|12357974|FG000|NOT COMPLETED|Overall Study||1
11168812|NCT01639040|12357975|FG001|NOT COMPLETED|Overall Study||0
11168813|NCT01639144|12357986|FG000|STARTED|Overall Study||260
11168814|NCT01639144|12357987|FG001|STARTED|Overall Study||255
11168815|NCT01639144|12357986|FG000|COMPLETED|Overall Study||250
11168816|NCT01639144|12357987|FG001|COMPLETED|Overall Study||250
11168817|NCT01639144|12357986|FG000|NOT COMPLETED|Overall Study||10
11168818|NCT01639144|12357987|FG001|NOT COMPLETED|Overall Study||5
11168819|NCT01639157|12357993|FG000|STARTED|Overall Study||4
11168820|NCT01639157|12357994|FG001|STARTED|Overall Study||5
11168821|NCT01639157|12357993|FG000|COMPLETED|Overall Study||4
11168822|NCT01639157|12357994|FG001|COMPLETED|Overall Study||5
11168823|NCT01639157|12357993|FG000|NOT COMPLETED|Overall Study||0
11168824|NCT01639157|12357994|FG001|NOT COMPLETED|Overall Study||0
11168825|NCT01639222|12358000|FG000|STARTED|Overall Study||55
11168826|NCT01639222|12358000|FG000|COMPLETED|Overall Study||55
11168827|NCT01639222|12358000|FG000|NOT COMPLETED|Overall Study||0
11168828|NCT01639339|12358008|FG000|STARTED|Double-blind Period (Up to Week 104)||224
11168829|NCT01639339|12358009|FG001|STARTED|Double-blind Period (Up to Week 104)||224
11168830|NCT01639339|12358008|FG000|COMPLETED|Double-blind Period (Up to Week 104)||170
11168831|NCT01639339|12358009|FG001|COMPLETED|Double-blind Period (Up to Week 104)||186
11168832|NCT01639339|12358008|FG000|NOT COMPLETED|Double-blind Period (Up to Week 104)||54
11168833|NCT01639339|12358009|FG001|NOT COMPLETED|Double-blind Period (Up to Week 104)||38
11168834|NCT01639339|12358008|FG000|STARTED|Open-label Period (Up to Week 28)|Of the 356 participants who completed the double-blind period, 279 were eligible for open-label treatment. As enrolling into the open-label period was optional, only 257 participants enrolled, of whom 255 started open-label treatment.|123
11168835|NCT01639339|12358009|FG001|STARTED|Open-label Period (Up to Week 28)||132
11168836|NCT01639339|12358008|FG000|COMPLETED|Open-label Period (Up to Week 28)||122
11168837|NCT01639339|12358009|FG001|COMPLETED|Open-label Period (Up to Week 28)||124
11168838|NCT01639339|12358008|FG000|NOT COMPLETED|Open-label Period (Up to Week 28)||1
11168839|NCT01639339|12358009|FG001|NOT COMPLETED|Open-label Period (Up to Week 28)||8
11419872|NCT04941521|12618658|FG000|STARTED|Overall Study||3
11419873|NCT04941521|12618658|FG000|COMPLETED|Overall Study||3
11419874|NCT04941521|12618658|FG000|NOT COMPLETED|Overall Study||0
11419875|NCT04584788|12618662|FG000|STARTED|Overall Study||37
11419876|NCT04584788|12618662|FG000|COMPLETED|Overall Study||25
11419877|NCT04584788|12618662|FG000|NOT COMPLETED|Overall Study||12
11168840|NCT01639352|12358019|FG000|STARTED|Overall Study||20
11168841|NCT01639352|12358019|FG000|COMPLETED|Overall Study||20
11168842|NCT01639352|12358019|FG000|NOT COMPLETED|Overall Study||0
11168843|NCT01639443|12358025|FG000|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
11203805|NCT01849055|12394344|FG005|STARTED|Overall Study||8
11419878|NCT04219618|12618668|FG000|STARTED|Overall Study||1
11419879|NCT04219618|12618669|FG001|STARTED|Overall Study||1
11168844|NCT01639443|12358026|FG001|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
11168845|NCT01639443|12358025|FG000|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
11168846|NCT01639443|12358026|FG001|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
11168847|NCT01639443|12358025|FG000|NOT COMPLETED|Overall Study||0
11168848|NCT01639443|12358026|FG001|NOT COMPLETED|Overall Study||0
11168849|NCT01639469|12358034|FG000|STARTED|Overall Study||89
11168850|NCT01639469|12358035|FG001|STARTED|Overall Study||80
11168851|NCT01639469|12358034|FG000|COMPLETED|Overall Study||84
11168852|NCT01639469|12358035|FG001|COMPLETED|Overall Study||77
11168853|NCT01639469|12358034|FG000|NOT COMPLETED|Overall Study||5
11168854|NCT01639469|12358035|FG001|NOT COMPLETED|Overall Study||3
11168855|NCT01639495|12358041|FG000|STARTED|Overall Study|Patients who signed the informed consent.|148
11419880|NCT04219618|12618668|FG000|COMPLETED|Overall Study||1
11419881|NCT04219618|12618669|FG001|COMPLETED|Overall Study||1
11419882|NCT04219618|12618668|FG000|NOT COMPLETED|Overall Study||0
11168856|NCT01639495|12358041|FG000|Safety Cohort|Overall Study||144
11168857|NCT01639495|12358041|FG000|Primary Effectiveness Cohort|Overall Study||138
11168858|NCT01639495|12358041|FG000|COMPLETED|Overall Study||132
11168859|NCT01639495|12358041|FG000|NOT COMPLETED|Overall Study||16
11168860|NCT01639560|12358047|FG000|STARTED|Overall Study||45
11168861|NCT01639560|12358048|FG001|STARTED|Overall Study||48
11168862|NCT01639560|12358047|FG000|End of Treatment|Overall Study||28
11168863|NCT01639560|12358048|FG001|End of Treatment|Overall Study||20
11168864|NCT01639560|12358047|FG000|COMPLETED|Overall Study||26
11168865|NCT01639560|12358048|FG001|COMPLETED|Overall Study||19
11168866|NCT01639560|12358047|FG000|NOT COMPLETED|Overall Study||19
11168867|NCT01639560|12358048|FG001|NOT COMPLETED|Overall Study||29
11168868|NCT01639599|12358057|FG000|STARTED|Overall Study||50
11168869|NCT01639599|12358058|FG001|STARTED|Overall Study||50
11168870|NCT01639599|12358059|FG002|STARTED|Overall Study||50
11168871|NCT01639599|12358057|FG000|COMPLETED|Overall Study||50
11168872|NCT01639599|12358058|FG001|COMPLETED|Overall Study||49
11168873|NCT01639599|12358059|FG002|COMPLETED|Overall Study||50
11168874|NCT01639599|12358057|FG000|NOT COMPLETED|Overall Study||0
11168875|NCT01639599|12358058|FG001|NOT COMPLETED|Overall Study||1
11168876|NCT01639599|12358059|FG002|NOT COMPLETED|Overall Study||0
11168877|NCT01639664|12358069|FG000|STARTED|Overall Study||63
11168878|NCT01639664|12358070|FG001|STARTED|Overall Study||52
11168879|NCT01639664|12358069|FG000|COMPLETED|Overall Study||63
11168880|NCT01639664|12358070|FG001|COMPLETED|Overall Study||52
11168881|NCT01639664|12358069|FG000|NOT COMPLETED|Overall Study||0
11168882|NCT01639664|12358070|FG001|NOT COMPLETED|Overall Study||0
11168883|NCT01639703|12358077|FG000|STARTED|Overall Study||96
11168884|NCT01639703|12358077|FG000|COMPLETED|Overall Study||84
11168885|NCT01639703|12358077|FG000|NOT COMPLETED|Overall Study||12
11168886|NCT01639729|12358093|FG000|STARTED|Overall Study||4
11168887|NCT01639729|12358094|FG001|STARTED|Overall Study||4
11168888|NCT01639729|12358095|FG002|STARTED|Overall Study||4
11168889|NCT01639729|12358096|FG003|STARTED|Overall Study||5
11168890|NCT01639729|12358097|FG004|STARTED|Overall Study||4
11168891|NCT01639729|12358098|FG005|STARTED|Overall Study||4
11168892|NCT01639729|12358093|FG000|COMPLETED|Overall Study||3
11168893|NCT01639729|12358094|FG001|COMPLETED|Overall Study||4
11168894|NCT01639729|12358095|FG002|COMPLETED|Overall Study||3
11168895|NCT01639729|12358096|FG003|COMPLETED|Overall Study||4
11168896|NCT01639729|12358097|FG004|COMPLETED|Overall Study||4
11168897|NCT01639729|12358098|FG005|COMPLETED|Overall Study||4
11168898|NCT01639729|12358093|FG000|NOT COMPLETED|Overall Study||1
11168899|NCT01639729|12358094|FG001|NOT COMPLETED|Overall Study||0
11168900|NCT01639729|12358095|FG002|NOT COMPLETED|Overall Study||1
11168901|NCT01639729|12358096|FG003|NOT COMPLETED|Overall Study||1
11168902|NCT01639729|12358097|FG004|NOT COMPLETED|Overall Study||0
11168903|NCT01639729|12358098|FG005|NOT COMPLETED|Overall Study||0
11168904|NCT01639742|12358108|FG000|STARTED|Overall Study||18
11168905|NCT01639742|12358108|FG000|COMPLETED|Overall Study||0
11168906|NCT01639742|12358108|FG000|NOT COMPLETED|Overall Study||18
11168907|NCT01639755|12358112|FG000|STARTED|Overall Study||19
11168908|NCT01639755|12358112|FG000|COMPLETED|Overall Study||0
11168909|NCT01639755|12358112|FG000|NOT COMPLETED|Overall Study||19
11168910|NCT01639833|12358118|FG000|STARTED|Overall Study||45
11168911|NCT01639833|12358119|FG001|STARTED|Overall Study||45
11168912|NCT01639833|12358118|FG000|COMPLETED|Overall Study||39
11168913|NCT01639833|12358119|FG001|COMPLETED|Overall Study||41
11168914|NCT01639833|12358118|FG000|NOT COMPLETED|Overall Study||6
11168915|NCT01639833|12358119|FG001|NOT COMPLETED|Overall Study||4
11168916|NCT01639872|12358127|FG000|STARTED|Overall Study||24
11419883|NCT04219618|12618669|FG001|NOT COMPLETED|Overall Study||0
11419884|NCT03783923|12618677|FG000|STARTED|Placebo-Controlled Period (26 Weeks)||5
11419885|NCT03783923|12618678|FG001|STARTED|Placebo-Controlled Period (26 Weeks)||6
11168917|NCT01639872|12358128|FG001|STARTED|Overall Study||25
11168918|NCT01639872|12358127|FG000|COMPLETED|Overall Study||14
11168919|NCT01639872|12358128|FG001|COMPLETED|Overall Study||20
11168920|NCT01639872|12358127|FG000|NOT COMPLETED|Overall Study||10
11419886|NCT03783923|12618677|FG000|Safety Population|Placebo-Controlled Period (26 Weeks)||5
11168921|NCT01639872|12358128|FG001|NOT COMPLETED|Overall Study||5
11168922|NCT01640054|12358134|FG000|STARTED|Overall Study|Patients who received treatment|115
11168923|NCT01640054|12358134|FG000|Did Not Receive Treatment|Overall Study||0
11168924|NCT01640054|12358134|FG000|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
11168925|NCT01640054|12358134|FG000|NOT COMPLETED|Overall Study||6
11168926|NCT01640171|12358138|FG000|STARTED|Overall Study||57
11168927|NCT01640171|12358138|FG000|COMPLETED|Overall Study||57
11168928|NCT01640171|12358138|FG000|NOT COMPLETED|Overall Study||0
11168929|NCT01640184|12358146|FG000|STARTED|Overall Study||34
11168930|NCT01640184|12358147|FG001|STARTED|Overall Study||23
11168931|NCT01640184|12358148|FG002|STARTED|Overall Study||22
11168932|NCT01640184|12358146|FG000|COMPLETED|Overall Study||26
11168933|NCT01640184|12358147|FG001|COMPLETED|Overall Study||21
11168934|NCT01640184|12358148|FG002|COMPLETED|Overall Study||20
11168935|NCT01640184|12358146|FG000|NOT COMPLETED|Overall Study||8
11168936|NCT01640184|12358147|FG001|NOT COMPLETED|Overall Study||2
11168937|NCT01640184|12358148|FG002|NOT COMPLETED|Overall Study||2
11168938|NCT01640197|12358161|FG000|STARTED|Overall Study||30
11168939|NCT01640197|12358162|FG001|STARTED|Overall Study||30
11168940|NCT01640197|12358161|FG000|COMPLETED|Overall Study||30
11168941|NCT01640197|12358162|FG001|COMPLETED|Overall Study||30
11168942|NCT01640197|12358161|FG000|NOT COMPLETED|Overall Study||0
11168943|NCT01640197|12358162|FG001|NOT COMPLETED|Overall Study||0
11168944|NCT01640249|12358175|FG000|STARTED|Period 1||3
11168945|NCT01640249|12358176|FG001|STARTED|Period 1||2
11168946|NCT01640249|12358177|FG002|STARTED|Period 1||2
11168947|NCT01640249|12358178|FG003|STARTED|Period 1||2
11168948|NCT01640249|12358179|FG004|STARTED|Period 1||2
11168949|NCT01640249|12358180|FG005|STARTED|Period 1||5
11168950|NCT01640249|12358181|FG006|STARTED|Period 1||2
11168951|NCT01640249|12358175|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
11168952|NCT01640249|12358176|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
11168953|NCT01640249|12358177|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
11168954|NCT01640249|12358178|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
11168955|NCT01640249|12358179|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
11168956|NCT01640249|12358180|FG005|Received at Least 1 Dose of Study Drug|Period 1||5
11168957|NCT01640249|12358181|FG006|Received at Least 1 Dose of Study Drug|Period 1||2
11168958|NCT01640249|12358175|FG000|COMPLETED|Period 1||2
11168959|NCT01640249|12358176|FG001|COMPLETED|Period 1||2
11168960|NCT01640249|12358177|FG002|COMPLETED|Period 1||2
11168961|NCT01640249|12358178|FG003|COMPLETED|Period 1||2
11168962|NCT01640249|12358179|FG004|COMPLETED|Period 1||2
11168963|NCT01640249|12358180|FG005|COMPLETED|Period 1||4
11168964|NCT01640249|12358181|FG006|COMPLETED|Period 1||2
11168965|NCT01640249|12358175|FG000|NOT COMPLETED|Period 1||1
11168966|NCT01640249|12358176|FG001|NOT COMPLETED|Period 1||0
11168967|NCT01640249|12358177|FG002|NOT COMPLETED|Period 1||0
11168968|NCT01640249|12358178|FG003|NOT COMPLETED|Period 1||0
11168969|NCT01640249|12358179|FG004|NOT COMPLETED|Period 1||0
11168970|NCT01640249|12358180|FG005|NOT COMPLETED|Period 1||1
11168971|NCT01640249|12358181|FG006|NOT COMPLETED|Period 1||0
11168972|NCT01640249|12358175|FG000|STARTED|Period 2||2
11168973|NCT01640249|12358176|FG001|STARTED|Period 2||2
11168974|NCT01640249|12358177|FG002|STARTED|Period 2||2
11168975|NCT01640249|12358178|FG003|STARTED|Period 2||2
11168976|NCT01640249|12358179|FG004|STARTED|Period 2||2
11168977|NCT01640249|12358180|FG005|STARTED|Period 2||4
11168978|NCT01640249|12358181|FG006|STARTED|Period 2||2
11168979|NCT01640249|12358175|FG000|COMPLETED|Period 2||2
11168980|NCT01640249|12358176|FG001|COMPLETED|Period 2||2
11168981|NCT01640249|12358177|FG002|COMPLETED|Period 2||2
11168982|NCT01640249|12358178|FG003|COMPLETED|Period 2||2
11168983|NCT01640249|12358179|FG004|COMPLETED|Period 2||2
11168984|NCT01640249|12358180|FG005|COMPLETED|Period 2||4
11168985|NCT01640249|12358181|FG006|COMPLETED|Period 2||2
11168986|NCT01640249|12358175|FG000|NOT COMPLETED|Period 2||0
11168987|NCT01640249|12358176|FG001|NOT COMPLETED|Period 2||0
11168988|NCT01640249|12358177|FG002|NOT COMPLETED|Period 2||0
11168989|NCT01640249|12358178|FG003|NOT COMPLETED|Period 2||0
11168990|NCT01640249|12358179|FG004|NOT COMPLETED|Period 2||0
11168991|NCT01640249|12358180|FG005|NOT COMPLETED|Period 2||0
11168992|NCT01640249|12358181|FG006|NOT COMPLETED|Period 2||0
11168993|NCT01640249|12358175|FG000|STARTED|Period 3||2
11168994|NCT01640249|12358176|FG001|STARTED|Period 3||2
11168995|NCT01640249|12358177|FG002|STARTED|Period 3||2
11168996|NCT01640249|12358178|FG003|STARTED|Period 3||2
11168997|NCT01640249|12358179|FG004|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
11168998|NCT01640249|12358180|FG005|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
11168999|NCT01640249|12358181|FG006|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
11169000|NCT01640249|12358175|FG000|COMPLETED|Period 3||2
11169001|NCT01640249|12358176|FG001|COMPLETED|Period 3||2
11169002|NCT01640249|12358177|FG002|COMPLETED|Period 3||2
11169003|NCT01640249|12358178|FG003|COMPLETED|Period 3||1
11169004|NCT01640249|12358179|FG004|COMPLETED|Period 3||0
11169005|NCT01640249|12358180|FG005|COMPLETED|Period 3||0
11169006|NCT01640249|12358181|FG006|COMPLETED|Period 3||0
11169007|NCT01640249|12358175|FG000|NOT COMPLETED|Period 3||0
11169008|NCT01640249|12358176|FG001|NOT COMPLETED|Period 3||0
11169009|NCT01640249|12358177|FG002|NOT COMPLETED|Period 3||0
11169010|NCT01640249|12358178|FG003|NOT COMPLETED|Period 3||1
11169011|NCT01640249|12358179|FG004|NOT COMPLETED|Period 3||0
11169012|NCT01640249|12358180|FG005|NOT COMPLETED|Period 3||0
11169013|NCT01640249|12358181|FG006|NOT COMPLETED|Period 3||0
11169014|NCT01640288|12358202|FG000|STARTED|Overall Study||100
11169015|NCT01640288|12358203|FG001|STARTED|Overall Study||71
11203806|NCT01849055|12394339|FG000|COMPLETED|Overall Study||8
11203807|NCT01849055|12394340|FG001|COMPLETED|Overall Study||8
11169016|NCT01640288|12358202|FG000|Received Allocated Intervention|Overall Study|74 rec'd the gas (inc. 4 images were not obtained due to equipment failure = 70)|70
11169017|NCT01640288|12358203|FG001|Received Allocated Intervention|Overall Study|53 rec'd the gas (exc. 1 images not obtained due to equipment failure, 4 poor images = 48 )|48
11169018|NCT01640288|12358202|FG000|Did Not Receive Allocated Intervention|Overall Study||26
11169019|NCT01640288|12358203|FG001|Did Not Receive Allocated Intervention|Overall Study||18
11169020|NCT01640288|12358202|FG000|COMPLETED|Overall Study|One subject was lost to followup but rec'd the gas and images were obtained|70
11169021|NCT01640288|12358203|FG001|COMPLETED|Overall Study||48
11169022|NCT01640288|12358202|FG000|NOT COMPLETED|Overall Study||30
11169023|NCT01640288|12358203|FG001|NOT COMPLETED|Overall Study||23
11169024|NCT01640314|12358212|FG000|STARTED|Overall Study||63
11169025|NCT01640314|12358213|FG001|STARTED|Overall Study||63
11169026|NCT01640314|12358212|FG000|COMPLETED|Overall Study||63
11169027|NCT01640314|12358213|FG001|COMPLETED|Overall Study||62
11169028|NCT01640314|12358212|FG000|NOT COMPLETED|Overall Study||0
11169029|NCT01640314|12358213|FG001|NOT COMPLETED|Overall Study||1
11169030|NCT01640327|12358221|FG000|STARTED|Overall Study||63
11169031|NCT01640327|12358222|FG001|STARTED|Overall Study||63
11169032|NCT01640327|12358221|FG000|COMPLETED|Overall Study||63
11169033|NCT01640327|12358222|FG001|COMPLETED|Overall Study||63
11169034|NCT01640327|12358221|FG000|NOT COMPLETED|Overall Study||0
11169035|NCT01640327|12358222|FG001|NOT COMPLETED|Overall Study||0
11169036|NCT01640340|12358230|FG000|STARTED|Overall Study||20
11169037|NCT01640340|12358231|FG001|STARTED|Overall Study||20
11169038|NCT01640340|12358230|FG000|Overall Complete Response Rate|Overall Study||20
11169039|NCT01640340|12358231|FG001|Overall Complete Response Rate|Overall Study||20
11169040|NCT01640340|12358230|FG000|COMPLETED|Overall Study||20
11169041|NCT01640340|12358231|FG001|COMPLETED|Overall Study||20
11169042|NCT01640340|12358230|FG000|NOT COMPLETED|Overall Study||0
11169043|NCT01640340|12358231|FG001|NOT COMPLETED|Overall Study||0
11169044|NCT01640353|12358237|FG000|STARTED|Overall Study||194
11169045|NCT01640353|12358237|FG000|Treated|Overall Study||172
11169046|NCT01640353|12358237|FG000|Month 1|Overall Study||171
11169047|NCT01640353|12358237|FG000|Month 3|Overall Study||169
11169048|NCT01640353|12358237|FG000|Month 6|Overall Study||168
11169049|NCT01640353|12358237|FG000|Month 12|Overall Study||160
11169050|NCT01640353|12358237|FG000|Month 18|Overall Study||150
11169051|NCT01640353|12358237|FG000|COMPLETED|Overall Study||149
11169052|NCT01640353|12358237|FG000|NOT COMPLETED|Overall Study||45
11169053|NCT01640366|12358241|FG000|STARTED|Overall Study||200
11169054|NCT01640366|12358241|FG000|Day 21 Follow-up|Overall Study||185
11169055|NCT01640366|12358241|FG000|Day 42 Follow-up|Overall Study||177
11169056|NCT01640366|12358241|FG000|Day 90 Follow-up|Overall Study||178
11169057|NCT01640366|12358241|FG000|COMPLETED|Overall Study||178
11169058|NCT01640366|12358241|FG000|NOT COMPLETED|Overall Study||22
11203808|NCT01849055|12394341|FG002|COMPLETED|Overall Study||7
11203809|NCT01849055|12394342|FG003|COMPLETED|Overall Study||8
11203810|NCT01849055|12394343|FG004|COMPLETED|Overall Study||8
11203811|NCT01849055|12394344|FG005|COMPLETED|Overall Study||8
11203812|NCT01849055|12394339|FG000|NOT COMPLETED|Overall Study||0
11203813|NCT01849055|12394340|FG001|NOT COMPLETED|Overall Study||0
11203814|NCT01849055|12394341|FG002|NOT COMPLETED|Overall Study||1
11203815|NCT01849055|12394342|FG003|NOT COMPLETED|Overall Study||0
11203816|NCT01849055|12394343|FG004|NOT COMPLETED|Overall Study||0
11203817|NCT01849055|12394344|FG005|NOT COMPLETED|Overall Study||0
11203818|NCT01849068|12394364|FG000|STARTED|Overall Study||10
11203819|NCT01849068|12394365|FG001|STARTED|Overall Study||10
11203820|NCT01849068|12394364|FG000|COMPLETED|Overall Study||10
11203821|NCT01849068|12394365|FG001|COMPLETED|Overall Study||10
11203822|NCT01849068|12394364|FG000|NOT COMPLETED|Overall Study||0
11203823|NCT01849068|12394365|FG001|NOT COMPLETED|Overall Study||0
11203824|NCT01849172|12394373|FG000|STARTED|Overall Study||180
11203825|NCT01849172|12394374|FG001|STARTED|Overall Study||180
11203826|NCT01849172|12394373|FG000|COMPLETED|Overall Study||173
11203827|NCT01849172|12394374|FG001|COMPLETED|Overall Study||174
11203828|NCT01849172|12394373|FG000|NOT COMPLETED|Overall Study||7
11203829|NCT01849172|12394374|FG001|NOT COMPLETED|Overall Study||6
11203830|NCT01849276|12394380|FG000|STARTED|Registered to the Study||2
11203831|NCT01849276|12394380|FG000|COMPLETED|Registered to the Study||2
11203832|NCT01849276|12394380|FG000|NOT COMPLETED|Registered to the Study||0
11203833|NCT01849276|12394380|FG000|STARTED|Completed Treatment||2
11203834|NCT01849276|12394380|FG000|COMPLETED|Completed Treatment||2
11203835|NCT01849276|12394380|FG000|NOT COMPLETED|Completed Treatment||0
11203836|NCT01849276|12394380|FG000|STARTED|Followed for Survival for 5 Years||2
11203837|NCT01849276|12394380|FG000|COMPLETED|Followed for Survival for 5 Years||0
11203838|NCT01849276|12394380|FG000|NOT COMPLETED|Followed for Survival for 5 Years||2
11203839|NCT01849289|12394386|FG000|STARTED|Overall Study||555
11203840|NCT01849289|12394387|FG001|STARTED|Overall Study||278
11203841|NCT01849289|12394386|FG000|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
11203842|NCT01849289|12394387|FG001|Exposed|Overall Study||278
11203843|NCT01849289|12394386|FG000|COMPLETED|Overall Study||523
11203844|NCT01849289|12394387|FG001|COMPLETED|Overall Study||254
11203845|NCT01849289|12394386|FG000|NOT COMPLETED|Overall Study||32
11203846|NCT01849289|12394387|FG001|NOT COMPLETED|Overall Study||24
11203847|NCT01849419|12394393|FG000|STARTED|Overall Study||65
11203848|NCT01849419|12394393|FG000|COMPLETED|Overall Study||65
11203849|NCT01849419|12394393|FG000|NOT COMPLETED|Overall Study||0
11203850|NCT01849458|12394398|FG000|STARTED|Overall Study||50
11203851|NCT01849458|12394398|FG000|6 Months Follow-up|Overall Study||50
11169059|NCT01640379|12358249|FG000|STARTED|Overall Study||149
11169060|NCT01640379|12358250|FG001|STARTED|Overall Study||137
11169061|NCT01640379|12358249|FG000|COMPLETED|Overall Study||135
11169062|NCT01640379|12358250|FG001|COMPLETED|Overall Study||125
11169063|NCT01640379|12358249|FG000|NOT COMPLETED|Overall Study||14
11169064|NCT01640379|12358250|FG001|NOT COMPLETED|Overall Study||12
11169065|NCT01640548|12358257|FG000|STARTED|Overall Study||309
11169066|NCT01640548|12358257|FG000|COMPLETED|Overall Study||309
11169067|NCT01640548|12358257|FG000|NOT COMPLETED|Overall Study||0
11169068|NCT01640808|12358263|FG000|STARTED|Overall Study||309
11169069|NCT01640808|12358264|FG001|STARTED|Overall Study||307
11169070|NCT01640808|12358263|FG000|Subjects Received Treatment|Overall Study||305
11169071|NCT01640808|12358264|FG001|Subjects Received Treatment|Overall Study||305
11169072|NCT01640808|12358263|FG000|COMPLETED|Overall Study||251
11169073|NCT01640808|12358264|FG001|COMPLETED|Overall Study||291
11169074|NCT01640808|12358263|FG000|NOT COMPLETED|Overall Study||58
11169075|NCT01640808|12358264|FG001|NOT COMPLETED|Overall Study||16
11169076|NCT01640834|12358273|FG000|STARTED|Overall Study||8
11169077|NCT01640834|12358274|FG001|STARTED|Overall Study||8
11169078|NCT01640834|12358275|FG002|STARTED|Overall Study||4
11169079|NCT01640834|12358273|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
11169080|NCT01640834|12358274|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
11169081|NCT01640834|12358275|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
11169082|NCT01640834|12358273|FG000|COMPLETED|Overall Study||8
11169083|NCT01640834|12358274|FG001|COMPLETED|Overall Study||8
11169084|NCT01640834|12358275|FG002|COMPLETED|Overall Study||4
11169085|NCT01640834|12358273|FG000|NOT COMPLETED|Overall Study||0
11169086|NCT01640834|12358274|FG001|NOT COMPLETED|Overall Study||0
11169087|NCT01640834|12358275|FG002|NOT COMPLETED|Overall Study||0
11169088|NCT01640873|12358287|FG000|STARTED|Overall Study||22
11169089|NCT01640873|12358288|FG001|STARTED|Overall Study||11
11169090|NCT01640873|12358287|FG000|COMPLETED|Overall Study||20
11169091|NCT01640873|12358288|FG001|COMPLETED|Overall Study||10
11169092|NCT01640873|12358287|FG000|NOT COMPLETED|Overall Study||2
11169093|NCT01640873|12358288|FG001|NOT COMPLETED|Overall Study||1
11169094|NCT01640925|12358296|FG000|STARTED|Overall Study||175
11169095|NCT01640925|12358297|FG001|STARTED|Overall Study||175
11169096|NCT01640925|12358296|FG000|COMPLETED|Overall Study||161
11169097|NCT01640925|12358297|FG001|COMPLETED|Overall Study||164
11169098|NCT01640925|12358296|FG000|NOT COMPLETED|Overall Study||14
11169099|NCT01640925|12358297|FG001|NOT COMPLETED|Overall Study||11
11169100|NCT01640951|12358311|FG000|STARTED|Overall Study||77
11169101|NCT01640951|12358312|FG001|STARTED|Overall Study||75
11169102|NCT01640951|12358313|FG002|STARTED|Overall Study||168
11169103|NCT01640951|12358314|FG003|STARTED|Overall Study||55
11169104|NCT01640951|12358315|FG004|STARTED|Overall Study||95
11169105|NCT01640951|12358316|FG005|STARTED|Overall Study||60
11169106|NCT01640951|12358317|FG006|STARTED|Overall Study||112
11169107|NCT01640951|12358318|FG007|STARTED|Overall Study||33
11169108|NCT01640951|12358311|FG000|COMPLETED|Overall Study||31
11169109|NCT01640951|12358312|FG001|COMPLETED|Overall Study||60
11169110|NCT01640951|12358313|FG002|COMPLETED|Overall Study||126
11169111|NCT01640951|12358314|FG003|COMPLETED|Overall Study||10
11169112|NCT01640951|12358315|FG004|COMPLETED|Overall Study||82
11169113|NCT01640951|12358316|FG005|COMPLETED|Overall Study||13
11169114|NCT01640951|12358317|FG006|COMPLETED|Overall Study||94
11169115|NCT01640951|12358318|FG007|COMPLETED|Overall Study||17
11169116|NCT01640951|12358311|FG000|NOT COMPLETED|Overall Study||46
11169117|NCT01640951|12358312|FG001|NOT COMPLETED|Overall Study||15
11169118|NCT01640951|12358313|FG002|NOT COMPLETED|Overall Study||42
11169119|NCT01640951|12358314|FG003|NOT COMPLETED|Overall Study||45
11169120|NCT01640951|12358315|FG004|NOT COMPLETED|Overall Study||13
11169121|NCT01640951|12358316|FG005|NOT COMPLETED|Overall Study||47
11169122|NCT01640951|12358317|FG006|NOT COMPLETED|Overall Study||18
11169123|NCT01640951|12358318|FG007|NOT COMPLETED|Overall Study||16
11169124|NCT01640964|12358341|FG000|STARTED|Overall Study||20
11169125|NCT01640964|12358342|FG001|STARTED|Overall Study||20
11169126|NCT01640964|12358343|FG002|STARTED|Overall Study||6
11169127|NCT01640964|12358341|FG000|COMPLETED|Overall Study||19
11169128|NCT01640964|12358342|FG001|COMPLETED|Overall Study||19
11169129|NCT01640964|12358343|FG002|COMPLETED|Overall Study||3
11169130|NCT01640964|12358341|FG000|NOT COMPLETED|Overall Study||1
11169131|NCT01640964|12358342|FG001|NOT COMPLETED|Overall Study||1
11169132|NCT01640964|12358343|FG002|NOT COMPLETED|Overall Study||3
11169133|NCT01641042|12358354|FG000|STARTED|Overall Study||43
11169134|NCT01641042|12358355|FG001|STARTED|Overall Study||43
11169135|NCT01641042|12358354|FG000|COMPLETED|Overall Study||43
11169136|NCT01641042|12358355|FG001|COMPLETED|Overall Study||43
11169137|NCT01641042|12358354|FG000|NOT COMPLETED|Overall Study||0
11169138|NCT01641042|12358355|FG001|NOT COMPLETED|Overall Study||0
11169139|NCT01641081|12358361|FG000|STARTED|Period 1||18
11169140|NCT01641081|12358362|FG001|STARTED|Period 1||18
11169141|NCT01641081|12358363|FG002|STARTED|Period 1||15
11169142|NCT01641081|12358364|FG003|STARTED|Period 1||22
11169143|NCT01641081|12358365|FG004|STARTED|Period 1||17
11169144|NCT01641081|12358366|FG005|STARTED|Period 1||19
11169145|NCT01641081|12358367|FG006|STARTED|Period 1||19
11169146|NCT01641081|12358368|FG007|STARTED|Period 1||17
11169147|NCT01641081|12358369|FG008|STARTED|Period 1||15
11169148|NCT01641081|12358370|FG009|STARTED|Period 1||14
11169149|NCT01641081|12358361|FG000|COMPLETED|Period 1||17
11169150|NCT01641081|12358362|FG001|COMPLETED|Period 1||18
11169151|NCT01641081|12358363|FG002|COMPLETED|Period 1||15
11169152|NCT01641081|12358364|FG003|COMPLETED|Period 1||22
11169153|NCT01641081|12358365|FG004|COMPLETED|Period 1||16
11169154|NCT01641081|12358366|FG005|COMPLETED|Period 1||19
11169155|NCT01641081|12358367|FG006|COMPLETED|Period 1||18
11169156|NCT01641081|12358368|FG007|COMPLETED|Period 1||14
11169157|NCT01641081|12358369|FG008|COMPLETED|Period 1||15
11169158|NCT01641081|12358370|FG009|COMPLETED|Period 1||14
11169159|NCT01641081|12358361|FG000|NOT COMPLETED|Period 1||1
11169160|NCT01641081|12358362|FG001|NOT COMPLETED|Period 1||0
11169161|NCT01641081|12358363|FG002|NOT COMPLETED|Period 1||0
11169162|NCT01641081|12358364|FG003|NOT COMPLETED|Period 1||0
11169163|NCT01641081|12358365|FG004|NOT COMPLETED|Period 1||1
11169164|NCT01641081|12358366|FG005|NOT COMPLETED|Period 1||0
11169165|NCT01641081|12358367|FG006|NOT COMPLETED|Period 1||1
11169166|NCT01641081|12358368|FG007|NOT COMPLETED|Period 1||3
11169167|NCT01641081|12358369|FG008|NOT COMPLETED|Period 1||0
11169168|NCT01641081|12358370|FG009|NOT COMPLETED|Period 1||0
11169169|NCT01641081|12358361|FG000|STARTED|Period 2||17
11169170|NCT01641081|12358362|FG001|STARTED|Period 2||18
11169171|NCT01641081|12358363|FG002|STARTED|Period 2||15
11169172|NCT01641081|12358364|FG003|STARTED|Period 2||22
11169173|NCT01641081|12358365|FG004|STARTED|Period 2||16
11169174|NCT01641081|12358366|FG005|STARTED|Period 2||19
11169175|NCT01641081|12358367|FG006|STARTED|Period 2||18
11169176|NCT01641081|12358368|FG007|STARTED|Period 2||14
11169177|NCT01641081|12358369|FG008|STARTED|Period 2||15
11169178|NCT01641081|12358370|FG009|STARTED|Period 2||14
11169179|NCT01641081|12358361|FG000|COMPLETED|Period 2||16
11169180|NCT01641081|12358362|FG001|COMPLETED|Period 2||18
11169181|NCT01641081|12358363|FG002|COMPLETED|Period 2||15
11169182|NCT01641081|12358364|FG003|COMPLETED|Period 2||21
11169183|NCT01641081|12358365|FG004|COMPLETED|Period 2||16
11169184|NCT01641081|12358366|FG005|COMPLETED|Period 2||18
11169185|NCT01641081|12358367|FG006|COMPLETED|Period 2||16
11169186|NCT01641081|12358368|FG007|COMPLETED|Period 2||14
11169187|NCT01641081|12358369|FG008|COMPLETED|Period 2||15
11169188|NCT01641081|12358370|FG009|COMPLETED|Period 2||14
11169189|NCT01641081|12358361|FG000|NOT COMPLETED|Period 2||1
11169190|NCT01641081|12358362|FG001|NOT COMPLETED|Period 2||0
11169191|NCT01641081|12358363|FG002|NOT COMPLETED|Period 2||0
11169192|NCT01641081|12358364|FG003|NOT COMPLETED|Period 2||1
11169193|NCT01641081|12358365|FG004|NOT COMPLETED|Period 2||0
11169194|NCT01641081|12358366|FG005|NOT COMPLETED|Period 2||1
11169195|NCT01641081|12358367|FG006|NOT COMPLETED|Period 2||2
11169196|NCT01641081|12358368|FG007|NOT COMPLETED|Period 2||0
11169197|NCT01641081|12358369|FG008|NOT COMPLETED|Period 2||0
11169198|NCT01641081|12358370|FG009|NOT COMPLETED|Period 2||0
11169199|NCT01641081|12358361|FG000|STARTED|Period 3||16
11169200|NCT01641081|12358362|FG001|STARTED|Period 3||18
11169201|NCT01641081|12358363|FG002|STARTED|Period 3||15
11169202|NCT01641081|12358364|FG003|STARTED|Period 3||21
11169203|NCT01641081|12358365|FG004|STARTED|Period 3||16
11169204|NCT01641081|12358366|FG005|STARTED|Period 3||18
11169205|NCT01641081|12358367|FG006|STARTED|Period 3||16
11169206|NCT01641081|12358368|FG007|STARTED|Period 3||14
11169207|NCT01641081|12358369|FG008|STARTED|Period 3||15
11169208|NCT01641081|12358370|FG009|STARTED|Period 3||14
11169209|NCT01641081|12358361|FG000|COMPLETED|Period 3||16
11169210|NCT01641081|12358362|FG001|COMPLETED|Period 3||18
11169211|NCT01641081|12358363|FG002|COMPLETED|Period 3||14
11169212|NCT01641081|12358364|FG003|COMPLETED|Period 3||21
11169213|NCT01641081|12358365|FG004|COMPLETED|Period 3||16
11169214|NCT01641081|12358366|FG005|COMPLETED|Period 3||18
11169215|NCT01641081|12358367|FG006|COMPLETED|Period 3||16
11169216|NCT01641081|12358368|FG007|COMPLETED|Period 3||14
11169217|NCT01641081|12358369|FG008|COMPLETED|Period 3||14
11169218|NCT01641081|12358370|FG009|COMPLETED|Period 3||14
11169219|NCT01641081|12358361|FG000|NOT COMPLETED|Period 3||0
11169220|NCT01641081|12358362|FG001|NOT COMPLETED|Period 3||0
11169221|NCT01641081|12358363|FG002|NOT COMPLETED|Period 3||1
11169222|NCT01641081|12358364|FG003|NOT COMPLETED|Period 3||0
11169223|NCT01641081|12358365|FG004|NOT COMPLETED|Period 3||0
11169224|NCT01641081|12358366|FG005|NOT COMPLETED|Period 3||0
11169225|NCT01641081|12358367|FG006|NOT COMPLETED|Period 3||0
11169226|NCT01641081|12358368|FG007|NOT COMPLETED|Period 3||0
11169227|NCT01641081|12358369|FG008|NOT COMPLETED|Period 3||1
11169228|NCT01641081|12358370|FG009|NOT COMPLETED|Period 3||0
11169229|NCT01641081|12358361|FG000|STARTED|Period 4||16
11169230|NCT01641081|12358362|FG001|STARTED|Period 4||18
11169231|NCT01641081|12358363|FG002|STARTED|Period 4||14
11323563|NCT02288247|12520844|FG001|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0
11323564|NCT02288247|12520843|FG000|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|137 participants from period 1 were randomized to period 2.|137
11169232|NCT01641081|12358364|FG003|STARTED|Period 4||21
11169233|NCT01641081|12358365|FG004|STARTED|Period 4||16
11169234|NCT01641081|12358366|FG005|STARTED|Period 4||18
11169235|NCT01641081|12358367|FG006|STARTED|Period 4||16
11169236|NCT01641081|12358368|FG007|STARTED|Period 4||14
11169237|NCT01641081|12358369|FG008|STARTED|Period 4||14
11169238|NCT01641081|12358370|FG009|STARTED|Period 4||14
11169239|NCT01641081|12358361|FG000|COMPLETED|Period 4||16
11169240|NCT01641081|12358362|FG001|COMPLETED|Period 4||17
11169241|NCT01641081|12358363|FG002|COMPLETED|Period 4||14
11169242|NCT01641081|12358364|FG003|COMPLETED|Period 4||20
11169243|NCT01641081|12358365|FG004|COMPLETED|Period 4||16
11169244|NCT01641081|12358366|FG005|COMPLETED|Period 4||18
11169245|NCT01641081|12358367|FG006|COMPLETED|Period 4||16
11169246|NCT01641081|12358368|FG007|COMPLETED|Period 4||14
11169247|NCT01641081|12358369|FG008|COMPLETED|Period 4||14
11169248|NCT01641081|12358370|FG009|COMPLETED|Period 4||14
11323565|NCT02288247|12520844|FG001|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|136 participants from period 1 were randomized to period 2.|136
11323566|NCT02288247|12520843|FG000|Treated|Period 2: DB Treatment (Max: 180 Weeks)||136
11323567|NCT02288247|12520844|FG001|Treated|Period 2: DB Treatment (Max: 180 Weeks)||135
11323568|NCT02288247|12520843|FG000|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1
11323569|NCT02288247|12520844|FG001|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1
11323570|NCT02288247|12520843|FG000|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||136
11323571|NCT02288247|12520844|FG001|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||135
11323572|NCT02177175|12520854|FG000|STARTED|Overall Study||5
11323573|NCT02177175|12520855|FG001|STARTED|Overall Study||6
11323574|NCT02177175|12520854|FG000|COMPLETED|Overall Study||4
11323575|NCT02177175|12520855|FG001|COMPLETED|Overall Study||6
11323576|NCT02177175|12520854|FG000|NOT COMPLETED|Overall Study||1
11323577|NCT02177175|12520855|FG001|NOT COMPLETED|Overall Study||0
11323578|NCT02049138|12520864|FG000|STARTED|Overall Study||306
11323579|NCT02049138|12520865|FG001|STARTED|Overall Study||149
11323580|NCT02049138|12520866|FG002|STARTED|Overall Study||38
11323581|NCT02049138|12520864|FG000|Enrolled in Vaccine Sub-study|Overall Study||76
11323582|NCT02049138|12520865|FG001|Enrolled in Vaccine Sub-study|Overall Study||24
11323583|NCT02049138|12520866|FG002|Enrolled in Vaccine Sub-study|Overall Study||11
11323584|NCT02049138|12520864|FG000|COMPLETED|Overall Study||142
11323585|NCT02049138|12520865|FG001|COMPLETED|Overall Study||51
11323586|NCT02049138|12520866|FG002|COMPLETED|Overall Study||30
11323587|NCT02049138|12520864|FG000|NOT COMPLETED|Overall Study||164
11323588|NCT02049138|12520865|FG001|NOT COMPLETED|Overall Study||98
11323589|NCT02049138|12520866|FG002|NOT COMPLETED|Overall Study||8
11323590|NCT01721772|12520879|FG000|STARTED|Pre-Treatment||210
11323591|NCT01721772|12520880|FG001|STARTED|Pre-Treatment||208
11323592|NCT01721772|12520879|FG000|COMPLETED|Pre-Treatment||206
11323593|NCT01721772|12520880|FG001|COMPLETED|Pre-Treatment||205
11323594|NCT01721772|12520879|FG000|NOT COMPLETED|Pre-Treatment||4
11323595|NCT01721772|12520880|FG001|NOT COMPLETED|Pre-Treatment||3
11323596|NCT01721772|12520879|FG000|STARTED|Treatment||206
11323597|NCT01721772|12520880|FG001|STARTED|Treatment||205
11323598|NCT01721772|12520879|FG000|COMPLETED|Treatment||0
11323599|NCT01721772|12520880|FG001|COMPLETED|Treatment||0
11323600|NCT01721772|12520879|FG000|NOT COMPLETED|Treatment||206
11323601|NCT01721772|12520880|FG001|NOT COMPLETED|Treatment||205
11323602|NCT01412333|12520888|FG000|STARTED|Overall Study||418
11323603|NCT01412333|12520889|FG001|STARTED|Overall Study||417
11323604|NCT01412333|12520888|FG000|COMPLETED|Overall Study||320
11323605|NCT01412333|12520889|FG001|COMPLETED|Overall Study||360
11323606|NCT01412333|12520888|FG000|NOT COMPLETED|Overall Study||98
11323607|NCT01412333|12520889|FG001|NOT COMPLETED|Overall Study||57
11323608|NCT01306331|12520898|FG000|STARTED|Overall Study||1659
11323609|NCT01306331|12520899|FG001|STARTED|Overall Study||1665
11323610|NCT01306331|12520898|FG000|COMPLETED|Overall Study||758
11323611|NCT01306331|12520899|FG001|COMPLETED|Overall Study||788
11323612|NCT01306331|12520898|FG000|NOT COMPLETED|Overall Study||901
11323613|NCT01306331|12520899|FG001|NOT COMPLETED|Overall Study||877
11323614|NCT01247324|12520907|FG000|STARTED|Overall Study||411
11323615|NCT01247324|12520908|FG001|STARTED|Overall Study||410
11323616|NCT01247324|12520907|FG000|COMPLETED|Overall Study||340
11323617|NCT01247324|12520908|FG001|COMPLETED|Overall Study||366
11323618|NCT01247324|12520907|FG000|NOT COMPLETED|Overall Study||71
11323619|NCT01247324|12520908|FG001|NOT COMPLETED|Overall Study||44
11323620|NCT01194570|12520917|FG000|STARTED|Overall Study||244
11323621|NCT01194570|12520918|FG001|STARTED|Overall Study||488
11323622|NCT01194570|12520917|FG000|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
11323623|NCT01194570|12520918|FG001|COMPLETED|Overall Study||0
11323624|NCT01194570|12520917|FG000|NOT COMPLETED|Overall Study||244
11323625|NCT01194570|12520918|FG001|NOT COMPLETED|Overall Study||488
11323626|NCT01190930|12520926|FG000|STARTED|Induction||9298
11323627|NCT01190930|12520927|FG001|STARTED|Induction||52
11323628|NCT01190930|12520928|FG002|STARTED|Induction||0
11323629|NCT01190930|12520929|FG003|STARTED|Induction||0
11323630|NCT01190930|12520930|FG004|STARTED|Induction||0
11323631|NCT01190930|12520931|FG005|STARTED|Induction||0
11323632|NCT01190930|12520932|FG006|STARTED|Induction||0
11323633|NCT01190930|12520933|FG007|STARTED|Induction||0
11323634|NCT01190930|12520934|FG008|STARTED|Induction||0
11323635|NCT01190930|12520935|FG009|STARTED|Induction||0
11323636|NCT01190930|12520926|FG000|COMPLETED|Induction||3949
11323637|NCT01190930|12520927|FG001|COMPLETED|Induction||43
11323638|NCT01190930|12520928|FG002|COMPLETED|Induction||0
11323639|NCT01190930|12520929|FG003|COMPLETED|Induction||0
11323640|NCT01190930|12520930|FG004|COMPLETED|Induction||0
11323641|NCT01190930|12520931|FG005|COMPLETED|Induction||0
11169249|NCT01641081|12358361|FG000|NOT COMPLETED|Period 4||0
11169250|NCT01641081|12358362|FG001|NOT COMPLETED|Period 4||1
11169251|NCT01641081|12358363|FG002|NOT COMPLETED|Period 4||0
11169252|NCT01641081|12358364|FG003|NOT COMPLETED|Period 4||1
11169253|NCT01641081|12358365|FG004|NOT COMPLETED|Period 4||0
11169254|NCT01641081|12358366|FG005|NOT COMPLETED|Period 4||0
11169255|NCT01641081|12358367|FG006|NOT COMPLETED|Period 4||0
11169256|NCT01641081|12358368|FG007|NOT COMPLETED|Period 4||0
11169257|NCT01641081|12358369|FG008|NOT COMPLETED|Period 4||0
11169258|NCT01641081|12358370|FG009|NOT COMPLETED|Period 4||0
11169259|NCT01641081|12358361|FG000|STARTED|Period 5||16
11169260|NCT01641081|12358362|FG001|STARTED|Period 5||17
11323642|NCT01190930|12520932|FG006|COMPLETED|Induction||0
11323643|NCT01190930|12520933|FG007|COMPLETED|Induction||0
11323644|NCT01190930|12520934|FG008|COMPLETED|Induction||0
11169261|NCT01641081|12358363|FG002|STARTED|Period 5||14
11169262|NCT01641081|12358364|FG003|STARTED|Period 5||20
11169263|NCT01641081|12358365|FG004|STARTED|Period 5||16
11169264|NCT01641081|12358366|FG005|STARTED|Period 5||18
11169265|NCT01641081|12358367|FG006|STARTED|Period 5||16
11169266|NCT01641081|12358368|FG007|STARTED|Period 5||14
11169267|NCT01641081|12358369|FG008|STARTED|Period 5||14
11169268|NCT01641081|12358370|FG009|STARTED|Period 5||14
11169269|NCT01641081|12358361|FG000|COMPLETED|Period 5||16
11169270|NCT01641081|12358362|FG001|COMPLETED|Period 5||17
11169271|NCT01641081|12358363|FG002|COMPLETED|Period 5||12
11169272|NCT01641081|12358364|FG003|COMPLETED|Period 5||20
11169273|NCT01641081|12358365|FG004|COMPLETED|Period 5||16
11169274|NCT01641081|12358366|FG005|COMPLETED|Period 5||18
11169275|NCT01641081|12358367|FG006|COMPLETED|Period 5||16
11169276|NCT01641081|12358368|FG007|COMPLETED|Period 5||14
11169277|NCT01641081|12358369|FG008|COMPLETED|Period 5||14
11169278|NCT01641081|12358370|FG009|COMPLETED|Period 5||14
11169279|NCT01641081|12358361|FG000|NOT COMPLETED|Period 5||0
11169280|NCT01641081|12358362|FG001|NOT COMPLETED|Period 5||0
11169281|NCT01641081|12358363|FG002|NOT COMPLETED|Period 5||2
11169282|NCT01641081|12358364|FG003|NOT COMPLETED|Period 5||0
11169283|NCT01641081|12358365|FG004|NOT COMPLETED|Period 5||0
11169284|NCT01641081|12358366|FG005|NOT COMPLETED|Period 5||0
11169285|NCT01641081|12358367|FG006|NOT COMPLETED|Period 5||0
11169286|NCT01641081|12358368|FG007|NOT COMPLETED|Period 5||0
11169287|NCT01641081|12358369|FG008|NOT COMPLETED|Period 5||0
11169288|NCT01641081|12358370|FG009|NOT COMPLETED|Period 5||0
11169289|NCT01641120|12358382|FG000|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
11169290|NCT01641120|12358382|FG000|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
11169291|NCT01641120|12358382|FG000|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
11169292|NCT01641120|12358382|FG000|STARTED|30 Gauge Needle Weeks 2 and 3||20
11169293|NCT01641120|12358382|FG000|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
11169294|NCT01641120|12358382|FG000|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
11169295|NCT01641133|12358392|FG000|STARTED|Overall Study||97
11169296|NCT01641133|12358393|FG001|STARTED|Overall Study||99
11169297|NCT01641133|12358394|FG002|STARTED|Overall Study||98
11169298|NCT01641133|12358392|FG000|COMPLETED|Overall Study||87
11169299|NCT01641133|12358393|FG001|COMPLETED|Overall Study||90
11169300|NCT01641133|12358394|FG002|COMPLETED|Overall Study||90
11169301|NCT01641133|12358392|FG000|NOT COMPLETED|Overall Study||10
11169302|NCT01641133|12358393|FG001|NOT COMPLETED|Overall Study||9
11169303|NCT01641133|12358394|FG002|NOT COMPLETED|Overall Study||8
11169304|NCT01641159|12358404|FG000|STARTED|Overall Study||35
11169305|NCT01641159|12358405|FG001|STARTED|Overall Study||27
11169306|NCT01641159|12358404|FG000|COMPLETED|Overall Study||33
11169307|NCT01641159|12358405|FG001|COMPLETED|Overall Study||25
11169308|NCT01641159|12358404|FG000|NOT COMPLETED|Overall Study||2
11169309|NCT01641159|12358405|FG001|NOT COMPLETED|Overall Study||2
11169310|NCT01641198|12358414|FG000|STARTED|After 12 Months of Function||20
11169311|NCT01641198|12358415|FG001|STARTED|After 12 Months of Function||19
11169312|NCT01641198|12358416|FG002|STARTED|After 12 Months of Function||19
11169313|NCT01641198|12358414|FG000|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16
11169314|NCT01641198|12358415|FG001|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16
11169315|NCT01641198|12358416|FG002|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17
11169316|NCT01641198|12358414|FG000|NOT COMPLETED|After 12 Months of Function||4
11169317|NCT01641198|12358415|FG001|NOT COMPLETED|After 12 Months of Function||3
11169318|NCT01641198|12358416|FG002|NOT COMPLETED|After 12 Months of Function||2
11169319|NCT01641198|12358414|FG000|STARTED|After 24 Months of Function||16
11169320|NCT01641198|12358415|FG001|STARTED|After 24 Months of Function||16
11169321|NCT01641198|12358416|FG002|STARTED|After 24 Months of Function||17
11169322|NCT01641198|12358414|FG000|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12
11169323|NCT01641198|12358415|FG001|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7
11169324|NCT01641198|12358416|FG002|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11
11169325|NCT01641198|12358414|FG000|NOT COMPLETED|After 24 Months of Function||4
11169326|NCT01641198|12358415|FG001|NOT COMPLETED|After 24 Months of Function||9
11169327|NCT01641198|12358416|FG002|NOT COMPLETED|After 24 Months of Function||6
11169328|NCT01641198|12358414|FG000|STARTED|At 15-20 Years of Function||12
11169329|NCT01641198|12358415|FG001|STARTED|At 15-20 Years of Function||7
11169330|NCT01641198|12358416|FG002|STARTED|At 15-20 Years of Function||11
11169331|NCT01641198|12358414|FG000|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6
11169332|NCT01641198|12358415|FG001|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6
11169333|NCT01641198|12358416|FG002|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9
11169334|NCT01641198|12358414|FG000|NOT COMPLETED|At 15-20 Years of Function||6
11169335|NCT01641198|12358415|FG001|NOT COMPLETED|At 15-20 Years of Function||1
11169336|NCT01641198|12358416|FG002|NOT COMPLETED|At 15-20 Years of Function||2
11169337|NCT01641237|12358425|FG000|STARTED|Period I||16
11169338|NCT01641237|12358426|FG001|STARTED|Period I||16
11169339|NCT01641237|12358427|FG002|STARTED|Period I||15
11169340|NCT01641237|12358428|FG003|STARTED|Period I||15
11169341|NCT01641237|12358425|FG000|COMPLETED|Period I||16
11169342|NCT01641237|12358426|FG001|COMPLETED|Period I||16
11169343|NCT01641237|12358427|FG002|COMPLETED|Period I||15
11169344|NCT01641237|12358428|FG003|COMPLETED|Period I||15
11169345|NCT01641237|12358425|FG000|NOT COMPLETED|Period I||0
11169346|NCT01641237|12358426|FG001|NOT COMPLETED|Period I||0
11169347|NCT01641237|12358427|FG002|NOT COMPLETED|Period I||0
11169348|NCT01641237|12358428|FG003|NOT COMPLETED|Period I||0
11169349|NCT01641237|12358425|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
11169350|NCT01641237|12358426|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
11169351|NCT01641237|12358427|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
11169352|NCT01641237|12358428|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
11169353|NCT01641237|12358425|FG000|COMPLETED|Period II||14
11169354|NCT01641237|12358426|FG001|COMPLETED|Period II||16
11169355|NCT01641237|12358427|FG002|COMPLETED|Period II||16
11169356|NCT01641237|12358428|FG003|COMPLETED|Period II||15
11169357|NCT01641237|12358425|FG000|NOT COMPLETED|Period II||1
11169358|NCT01641237|12358426|FG001|NOT COMPLETED|Period II||0
11169359|NCT01641237|12358427|FG002|NOT COMPLETED|Period II||0
11169360|NCT01641237|12358428|FG003|NOT COMPLETED|Period II||0
11169361|NCT01641237|12358425|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
11169362|NCT01641237|12358426|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
11169363|NCT01641237|12358427|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
11169364|NCT01641237|12358428|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
11169365|NCT01641237|12358425|FG000|COMPLETED|Period III||15
11169366|NCT01641237|12358426|FG001|COMPLETED|Period III||14
11169367|NCT01641237|12358427|FG002|COMPLETED|Period III||15
11169368|NCT01641237|12358428|FG003|COMPLETED|Period III||16
11169369|NCT01641237|12358425|FG000|NOT COMPLETED|Period III||1
11169370|NCT01641237|12358426|FG001|NOT COMPLETED|Period III||0
11169371|NCT01641237|12358427|FG002|NOT COMPLETED|Period III||0
11169372|NCT01641237|12358428|FG003|NOT COMPLETED|Period III||0
11169373|NCT01641237|12358425|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
11169374|NCT01641237|12358426|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
11169375|NCT01641237|12358427|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
11169376|NCT01641237|12358428|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
11169377|NCT01641237|12358425|FG000|COMPLETED|Period IV||15
11169378|NCT01641237|12358426|FG001|COMPLETED|Period IV||15
11169379|NCT01641237|12358427|FG002|COMPLETED|Period IV||15
11169380|NCT01641237|12358428|FG003|COMPLETED|Period IV||15
11169381|NCT01641237|12358425|FG000|NOT COMPLETED|Period IV||0
11169382|NCT01641237|12358426|FG001|NOT COMPLETED|Period IV||0
11169383|NCT01641237|12358427|FG002|NOT COMPLETED|Period IV||0
11169384|NCT01641237|12358428|FG003|NOT COMPLETED|Period IV||0
11169385|NCT01641367|12358444|FG000|STARTED|Cohorts||287
11169386|NCT01641367|12358445|FG001|STARTED|Cohorts||74
11169387|NCT01641367|12358446|FG002|STARTED|Cohorts||72
11169388|NCT01641367|12358447|FG003|STARTED|Cohorts||8
11169389|NCT01641367|12358448|FG004|STARTED|Cohorts||70
11169390|NCT01641367|12358449|FG005|STARTED|Cohorts||34
11169391|NCT01641367|12358450|FG006|STARTED|Cohorts||0
11169392|NCT01641367|12358451|FG007|STARTED|Cohorts||0
11169393|NCT01641367|12358444|FG000|Followed 72 Weeks on Step 1/2|Cohorts||211
11169394|NCT01641367|12358445|FG001|Followed 72 Weeks on Step 1/2|Cohorts||60
11169395|NCT01641367|12358446|FG002|Followed 72 Weeks on Step 1/2|Cohorts||60
11169396|NCT01641367|12358447|FG003|Followed 72 Weeks on Step 1/2|Cohorts||6
11169397|NCT01641367|12358448|FG004|Followed 72 Weeks on Step 1/2|Cohorts||52
11169398|NCT01641367|12358449|FG005|Followed 72 Weeks on Step 1/2|Cohorts||30
11169399|NCT01641367|12358450|FG006|Followed 72 Weeks on Step 1/2|Cohorts||0
11169400|NCT01641367|12358451|FG007|Followed 72 Weeks on Step 1/2|Cohorts||0
11169401|NCT01641367|12358444|FG000|COMPLETED|Cohorts||253
11169402|NCT01641367|12358445|FG001|COMPLETED|Cohorts||73
11169403|NCT01641367|12358446|FG002|COMPLETED|Cohorts||68
11169404|NCT01641367|12358447|FG003|COMPLETED|Cohorts||8
11169405|NCT01641367|12358448|FG004|COMPLETED|Cohorts||67
11169406|NCT01641367|12358449|FG005|COMPLETED|Cohorts||33
11169407|NCT01641367|12358450|FG006|COMPLETED|Cohorts||0
11169408|NCT01641367|12358451|FG007|COMPLETED|Cohorts||0
11169409|NCT01641367|12358444|FG000|NOT COMPLETED|Cohorts||34
11169410|NCT01641367|12358445|FG001|NOT COMPLETED|Cohorts||1
11169411|NCT01641367|12358446|FG002|NOT COMPLETED|Cohorts||4
11169412|NCT01641367|12358447|FG003|NOT COMPLETED|Cohorts||0
11169413|NCT01641367|12358448|FG004|NOT COMPLETED|Cohorts||3
11169414|NCT01641367|12358449|FG005|NOT COMPLETED|Cohorts||1
11169415|NCT01641367|12358450|FG006|NOT COMPLETED|Cohorts||0
11169416|NCT01641367|12358451|FG007|NOT COMPLETED|Cohorts||0
11169417|NCT01641367|12358444|FG000|STARTED|Randomized Adherence Intervention||0
11169418|NCT01641367|12358445|FG001|STARTED|Randomized Adherence Intervention||0
11169419|NCT01641367|12358446|FG002|STARTED|Randomized Adherence Intervention||0
11169420|NCT01641367|12358447|FG003|STARTED|Randomized Adherence Intervention||0
11169421|NCT01641367|12358448|FG004|STARTED|Randomized Adherence Intervention||0
11169422|NCT01641367|12358449|FG005|STARTED|Randomized Adherence Intervention||0
11169423|NCT01641367|12358450|FG006|STARTED|Randomized Adherence Intervention||257
11169424|NCT01641367|12358451|FG007|STARTED|Randomized Adherence Intervention||264
11169425|NCT01641367|12358444|FG000|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
11169426|NCT01641367|12358445|FG001|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
11169427|NCT01641367|12358446|FG002|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
11203852|NCT01849458|12394398|FG000|COMPLETED|Overall Study||46
11169428|NCT01641367|12358447|FG003|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
11169429|NCT01641367|12358448|FG004|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
11169430|NCT01641367|12358449|FG005|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
11169431|NCT01641367|12358450|FG006|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196
11169432|NCT01641367|12358451|FG007|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202
11169433|NCT01641367|12358444|FG000|COMPLETED|Randomized Adherence Intervention||0
11169434|NCT01641367|12358445|FG001|COMPLETED|Randomized Adherence Intervention||0
11169435|NCT01641367|12358446|FG002|COMPLETED|Randomized Adherence Intervention||0
11169436|NCT01641367|12358447|FG003|COMPLETED|Randomized Adherence Intervention||0
11169437|NCT01641367|12358448|FG004|COMPLETED|Randomized Adherence Intervention||0
11169438|NCT01641367|12358449|FG005|COMPLETED|Randomized Adherence Intervention||0
11169439|NCT01641367|12358450|FG006|COMPLETED|Randomized Adherence Intervention||238
11169440|NCT01641367|12358451|FG007|COMPLETED|Randomized Adherence Intervention||240
11169441|NCT01641367|12358444|FG000|NOT COMPLETED|Randomized Adherence Intervention||0
11169442|NCT01641367|12358445|FG001|NOT COMPLETED|Randomized Adherence Intervention||0
11169443|NCT01641367|12358446|FG002|NOT COMPLETED|Randomized Adherence Intervention||0
11169444|NCT01641367|12358447|FG003|NOT COMPLETED|Randomized Adherence Intervention||0
11169445|NCT01641367|12358448|FG004|NOT COMPLETED|Randomized Adherence Intervention||0
11169446|NCT01641367|12358449|FG005|NOT COMPLETED|Randomized Adherence Intervention||0
11169447|NCT01641367|12358450|FG006|NOT COMPLETED|Randomized Adherence Intervention||19
11169448|NCT01641367|12358451|FG007|NOT COMPLETED|Randomized Adherence Intervention||24
11169449|NCT01641380|12358476|FG000|STARTED|First Injection Cycle||50
11169450|NCT01641380|12358477|FG001|STARTED|First Injection Cycle||50
11169451|NCT01641380|12358476|FG000|COMPLETED|First Injection Cycle||43
11169452|NCT01641380|12358477|FG001|COMPLETED|First Injection Cycle||44
11169453|NCT01641380|12358476|FG000|NOT COMPLETED|First Injection Cycle||7
11169454|NCT01641380|12358477|FG001|NOT COMPLETED|First Injection Cycle||6
11169455|NCT01641380|12358476|FG000|STARTED|Second Injection Cycle||43
11169456|NCT01641380|12358477|FG001|STARTED|Second Injection Cycle||44
11169457|NCT01641380|12358476|FG000|COMPLETED|Second Injection Cycle||39
11169458|NCT01641380|12358477|FG001|COMPLETED|Second Injection Cycle||38
11169459|NCT01641380|12358476|FG000|NOT COMPLETED|Second Injection Cycle||4
11169460|NCT01641380|12358477|FG001|NOT COMPLETED|Second Injection Cycle||6
11169461|NCT01641380|12358476|FG000|STARTED|Third Injection Cycle||39
11169462|NCT01641380|12358477|FG001|STARTED|Third Injection Cycle||38
11169463|NCT01641380|12358476|FG000|COMPLETED|Third Injection Cycle||36
11169464|NCT01641380|12358477|FG001|COMPLETED|Third Injection Cycle||33
11169465|NCT01641380|12358476|FG000|NOT COMPLETED|Third Injection Cycle||3
11169466|NCT01641380|12358477|FG001|NOT COMPLETED|Third Injection Cycle||5
11169467|NCT01641445|12358486|FG000|STARTED|Overall Study||41
11169468|NCT01641445|12358487|FG001|STARTED|Overall Study||41
11169469|NCT01641445|12358486|FG000|COMPLETED|Overall Study||31
11169470|NCT01641445|12358487|FG001|COMPLETED|Overall Study||36
11169471|NCT01641445|12358486|FG000|NOT COMPLETED|Overall Study||10
11169472|NCT01641445|12358487|FG001|NOT COMPLETED|Overall Study||5
11169473|NCT01641471|12358495|FG000|STARTED|Overall Study||58
11169474|NCT01641471|12358496|FG001|STARTED|Overall Study||58
11169475|NCT01641471|12358495|FG000|COMPLETED|Overall Study||35
11169476|NCT01641471|12358496|FG001|COMPLETED|Overall Study||31
11169477|NCT01641471|12358495|FG000|NOT COMPLETED|Overall Study||23
11169478|NCT01641471|12358496|FG001|NOT COMPLETED|Overall Study||27
11169479|NCT01641640|12358502|FG000|STARTED|Overall Study||328
11169480|NCT01641640|12358502|FG000|Enrolled and Treated|Overall Study||327
11169481|NCT01641640|12358502|FG000|COMPLETED|Overall Study||292
11169482|NCT01641640|12358502|FG000|NOT COMPLETED|Overall Study||36
11169483|NCT01641653|12358508|FG000|STARTED|Overall Study||30
11169484|NCT01641653|12358509|FG001|STARTED|Overall Study||30
11169485|NCT01641653|12358508|FG000|COMPLETED|Overall Study||30
11169486|NCT01641653|12358509|FG001|COMPLETED|Overall Study||30
11169487|NCT01641653|12358508|FG000|NOT COMPLETED|Overall Study||0
11169488|NCT01641653|12358509|FG001|NOT COMPLETED|Overall Study||0
11169489|NCT01641692|12358518|FG000|STARTED|Treatment Period 1||42
11169490|NCT01641692|12358519|FG001|STARTED|Treatment Period 1||45
11169491|NCT01641692|12358520|FG002|STARTED|Treatment Period 1||51
11169492|NCT01641692|12358521|FG003|STARTED|Treatment Period 1||41
11169493|NCT01641692|12358522|FG004|STARTED|Treatment Period 1||43
11169494|NCT01641692|12358523|FG005|STARTED|Treatment Period 1||39
11169495|NCT01641692|12358524|FG006|STARTED|Treatment Period 1||38
11169496|NCT01641692|12358525|FG007|STARTED|Treatment Period 1||51
11169497|NCT01641692|12358518|FG000|COMPLETED|Treatment Period 1||40
11169498|NCT01641692|12358519|FG001|COMPLETED|Treatment Period 1||45
11169499|NCT01641692|12358520|FG002|COMPLETED|Treatment Period 1||50
11169500|NCT01641692|12358521|FG003|COMPLETED|Treatment Period 1||41
11169501|NCT01641692|12358522|FG004|COMPLETED|Treatment Period 1||39
11169502|NCT01641692|12358523|FG005|COMPLETED|Treatment Period 1||37
11169503|NCT01641692|12358524|FG006|COMPLETED|Treatment Period 1||38
11169504|NCT01641692|12358525|FG007|COMPLETED|Treatment Period 1||48
11169505|NCT01641692|12358518|FG000|NOT COMPLETED|Treatment Period 1||2
11169506|NCT01641692|12358519|FG001|NOT COMPLETED|Treatment Period 1||0
11169507|NCT01641692|12358520|FG002|NOT COMPLETED|Treatment Period 1||1
11169508|NCT01641692|12358521|FG003|NOT COMPLETED|Treatment Period 1||0
11169509|NCT01641692|12358522|FG004|NOT COMPLETED|Treatment Period 1||4
11169510|NCT01641692|12358523|FG005|NOT COMPLETED|Treatment Period 1||2
11169511|NCT01641692|12358524|FG006|NOT COMPLETED|Treatment Period 1||0
11169512|NCT01641692|12358525|FG007|NOT COMPLETED|Treatment Period 1||3
11169513|NCT01641692|12358518|FG000|STARTED|Washout Period 1 (12-14 Days)||40
11169514|NCT01641692|12358519|FG001|STARTED|Washout Period 1 (12-14 Days)||45
11169515|NCT01641692|12358520|FG002|STARTED|Washout Period 1 (12-14 Days)||50
11169516|NCT01641692|12358521|FG003|STARTED|Washout Period 1 (12-14 Days)||41
11169517|NCT01641692|12358522|FG004|STARTED|Washout Period 1 (12-14 Days)||39
11169518|NCT01641692|12358523|FG005|STARTED|Washout Period 1 (12-14 Days)||37
11169519|NCT01641692|12358524|FG006|STARTED|Washout Period 1 (12-14 Days)||38
11169520|NCT01641692|12358525|FG007|STARTED|Washout Period 1 (12-14 Days)||48
11169521|NCT01641692|12358518|FG000|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
11169522|NCT01641692|12358519|FG001|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
11169523|NCT01641692|12358520|FG002|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
11169524|NCT01641692|12358521|FG003|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
11169525|NCT01641692|12358522|FG004|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
11169526|NCT01641692|12358523|FG005|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
11169527|NCT01641692|12358524|FG006|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
11169528|NCT01641692|12358525|FG007|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
11169529|NCT01641692|12358518|FG000|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
11169530|NCT01641692|12358519|FG001|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
11169531|NCT01641692|12358520|FG002|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
11169532|NCT01641692|12358521|FG003|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
11169533|NCT01641692|12358522|FG004|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
11169534|NCT01641692|12358523|FG005|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
11169535|NCT01641692|12358524|FG006|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
11169536|NCT01641692|12358525|FG007|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
11169537|NCT01641692|12358518|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
11169538|NCT01641692|12358519|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
11169539|NCT01641692|12358520|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
11169540|NCT01641692|12358521|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
11169541|NCT01641692|12358522|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
11169542|NCT01641692|12358523|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
11169543|NCT01641692|12358524|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
11169544|NCT01641692|12358525|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
11169545|NCT01641692|12358518|FG000|COMPLETED|Treatment Period 2||30
11169546|NCT01641692|12358519|FG001|COMPLETED|Treatment Period 2||46
11169547|NCT01641692|12358520|FG002|COMPLETED|Treatment Period 2||40
11169548|NCT01641692|12358521|FG003|COMPLETED|Treatment Period 2||41
11169549|NCT01641692|12358522|FG004|COMPLETED|Treatment Period 2||37
11169550|NCT01641692|12358523|FG005|COMPLETED|Treatment Period 2||43
11169551|NCT01641692|12358524|FG006|COMPLETED|Treatment Period 2||43
11169552|NCT01641692|12358525|FG007|COMPLETED|Treatment Period 2||35
11169553|NCT01641692|12358518|FG000|NOT COMPLETED|Treatment Period 2||3
11169554|NCT01641692|12358519|FG001|NOT COMPLETED|Treatment Period 2||0
11169555|NCT01641692|12358520|FG002|NOT COMPLETED|Treatment Period 2||0
11169556|NCT01641692|12358521|FG003|NOT COMPLETED|Treatment Period 2||0
11169557|NCT01641692|12358522|FG004|NOT COMPLETED|Treatment Period 2||0
11169558|NCT01641692|12358523|FG005|NOT COMPLETED|Treatment Period 2||2
11169559|NCT01641692|12358524|FG006|NOT COMPLETED|Treatment Period 2||0
11169560|NCT01641692|12358525|FG007|NOT COMPLETED|Treatment Period 2||1
11169561|NCT01641692|12358518|FG000|STARTED|Washout Period 2 (12-14 Days)||30
11169562|NCT01641692|12358519|FG001|STARTED|Washout Period 2 (12-14 Days)||46
11169563|NCT01641692|12358520|FG002|STARTED|Washout Period 2 (12-14 Days)||40
11169564|NCT01641692|12358521|FG003|STARTED|Washout Period 2 (12-14 Days)||41
11169565|NCT01641692|12358522|FG004|STARTED|Washout Period 2 (12-14 Days)||37
11169566|NCT01641692|12358523|FG005|STARTED|Washout Period 2 (12-14 Days)||43
11169567|NCT01641692|12358524|FG006|STARTED|Washout Period 2 (12-14 Days)||43
11169568|NCT01641692|12358525|FG007|STARTED|Washout Period 2 (12-14 Days)||35
11169569|NCT01641692|12358518|FG000|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
11169570|NCT01641692|12358519|FG001|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
11169571|NCT01641692|12358520|FG002|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
11169572|NCT01641692|12358521|FG003|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
11169573|NCT01641692|12358522|FG004|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
11203853|NCT01849458|12394398|FG000|NOT COMPLETED|Overall Study||4
11169574|NCT01641692|12358523|FG005|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
11169575|NCT01641692|12358524|FG006|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
11169576|NCT01641692|12358525|FG007|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
11169577|NCT01641692|12358518|FG000|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
11169578|NCT01641692|12358519|FG001|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
11169579|NCT01641692|12358520|FG002|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
11169580|NCT01641692|12358521|FG003|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
11169581|NCT01641692|12358522|FG004|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
11169582|NCT01641692|12358523|FG005|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
11169583|NCT01641692|12358524|FG006|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
11169584|NCT01641692|12358525|FG007|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
11169585|NCT01641692|12358518|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
11169586|NCT01641692|12358519|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
11169587|NCT01641692|12358520|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
11169588|NCT01641692|12358521|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
11169589|NCT01641692|12358522|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
11169590|NCT01641692|12358523|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
11169591|NCT01641692|12358524|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
11169592|NCT01641692|12358525|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
11169593|NCT01641692|12358518|FG000|COMPLETED|Treatment Period 3||43
11169594|NCT01641692|12358519|FG001|COMPLETED|Treatment Period 3||32
11169595|NCT01641692|12358520|FG002|COMPLETED|Treatment Period 3||37
11169596|NCT01641692|12358521|FG003|COMPLETED|Treatment Period 3||42
11169597|NCT01641692|12358522|FG004|COMPLETED|Treatment Period 3||40
11169598|NCT01641692|12358523|FG005|COMPLETED|Treatment Period 3||39
11169599|NCT01641692|12358524|FG006|COMPLETED|Treatment Period 3||33
11169600|NCT01641692|12358525|FG007|COMPLETED|Treatment Period 3||38
11169601|NCT01641692|12358518|FG000|NOT COMPLETED|Treatment Period 3||0
11169602|NCT01641692|12358519|FG001|NOT COMPLETED|Treatment Period 3||1
11169603|NCT01641692|12358520|FG002|NOT COMPLETED|Treatment Period 3||1
11169604|NCT01641692|12358521|FG003|NOT COMPLETED|Treatment Period 3||0
11169605|NCT01641692|12358522|FG004|NOT COMPLETED|Treatment Period 3||0
11169606|NCT01641692|12358523|FG005|NOT COMPLETED|Treatment Period 3||0
11169607|NCT01641692|12358524|FG006|NOT COMPLETED|Treatment Period 3||2
11169608|NCT01641692|12358525|FG007|NOT COMPLETED|Treatment Period 3||0
11169609|NCT01641692|12358518|FG000|STARTED|Washout Period 3 or Follow-up||43
11169610|NCT01641692|12358519|FG001|STARTED|Washout Period 3 or Follow-up||32
11169611|NCT01641692|12358520|FG002|STARTED|Washout Period 3 or Follow-up||37
11169612|NCT01641692|12358521|FG003|STARTED|Washout Period 3 or Follow-up||42
11169613|NCT01641692|12358522|FG004|STARTED|Washout Period 3 or Follow-up||40
11169614|NCT01641692|12358523|FG005|STARTED|Washout Period 3 or Follow-up||39
11169615|NCT01641692|12358524|FG006|STARTED|Washout Period 3 or Follow-up||33
11169616|NCT01641692|12358525|FG007|STARTED|Washout Period 3 or Follow-up||38
11169617|NCT01641692|12358518|FG000|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
11169618|NCT01641692|12358519|FG001|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
11169619|NCT01641692|12358520|FG002|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
11169620|NCT01641692|12358521|FG003|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
11169621|NCT01641692|12358522|FG004|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
11169622|NCT01641692|12358523|FG005|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
11169623|NCT01641692|12358524|FG006|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
11169624|NCT01641692|12358525|FG007|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
11169625|NCT01641692|12358518|FG000|NOT COMPLETED|Washout Period 3 or Follow-up||1
11169626|NCT01641692|12358519|FG001|NOT COMPLETED|Washout Period 3 or Follow-up||0
11169627|NCT01641692|12358520|FG002|NOT COMPLETED|Washout Period 3 or Follow-up||1
11169628|NCT01641692|12358521|FG003|NOT COMPLETED|Washout Period 3 or Follow-up||1
11169629|NCT01641692|12358522|FG004|NOT COMPLETED|Washout Period 3 or Follow-up||0
11169630|NCT01641692|12358523|FG005|NOT COMPLETED|Washout Period 3 or Follow-up||2
11169631|NCT01641692|12358524|FG006|NOT COMPLETED|Washout Period 3 or Follow-up||1
11169632|NCT01641692|12358525|FG007|NOT COMPLETED|Washout Period 3 or Follow-up||0
11169633|NCT01641809|12358548|FG000|STARTED|Induction Phase (Day 1 to Week 24)||60
11169634|NCT01641809|12358549|FG001|STARTED|Induction Phase (Day 1 to Week 24)||60
11169635|NCT01641809|12358550|FG002|STARTED|Induction Phase (Day 1 to Week 24)||61
11169636|NCT01641809|12358551|FG003|STARTED|Induction Phase (Day 1 to Week 24)||62
11169637|NCT01641809|12358548|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)||52
11169638|NCT01641809|12358549|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)||53
11169639|NCT01641809|12358550|FG002|COMPLETED|Induction Phase (Day 1 to Week 24)||55
11169640|NCT01641809|12358551|FG003|COMPLETED|Induction Phase (Day 1 to Week 24)||47
11169641|NCT01641809|12358548|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8
11169642|NCT01641809|12358549|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7
11169643|NCT01641809|12358550|FG002|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6
11169644|NCT01641809|12358551|FG003|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15
11169645|NCT01641809|12358548|FG000|STARTED|Maintenance Phase (Week 24 to Week 96)||52
11169646|NCT01641809|12358549|FG001|STARTED|Maintenance Phase (Week 24 to Week 96)||53
11169647|NCT01641809|12358550|FG002|STARTED|Maintenance Phase (Week 24 to Week 96)||55
11169648|NCT01641809|12358551|FG003|STARTED|Maintenance Phase (Week 24 to Week 96)||47
11169649|NCT01641809|12358548|FG000|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46
11169650|NCT01641809|12358549|FG001|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48
11169651|NCT01641809|12358550|FG002|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52
11169652|NCT01641809|12358551|FG003|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41
11169653|NCT01641809|12358548|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
11169654|NCT01641809|12358549|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5
11169655|NCT01641809|12358550|FG002|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3
11169656|NCT01641809|12358551|FG003|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
11169657|NCT01641809|12358548|FG000|STARTED|Open-label (Week 96 to Week 324)||46
11169658|NCT01641809|12358549|FG001|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|47
11169659|NCT01641809|12358550|FG002|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|51
11169660|NCT01641809|12358551|FG003|STARTED|Open-label (Week 96 to Week 324)|Participants completed study at Week 96 and did not enter open-label phase|0
11169661|NCT01641809|12358548|FG000|COMPLETED|Open-label (Week 96 to Week 324)||30
11169662|NCT01641809|12358549|FG001|COMPLETED|Open-label (Week 96 to Week 324)||35
11169663|NCT01641809|12358550|FG002|COMPLETED|Open-label (Week 96 to Week 324)||43
11419887|NCT03783923|12618678|FG001|Safety Population|Placebo-Controlled Period (26 Weeks)|2 participants who received placebo in placebo-controlled period transitioned to receive deflazacort in open-label extension.|2
11419888|NCT03783923|12618677|FG000|COMPLETED|Placebo-Controlled Period (26 Weeks)||1
11419889|NCT03783923|12618678|FG001|COMPLETED|Placebo-Controlled Period (26 Weeks)||2
11419890|NCT03783923|12618677|FG000|NOT COMPLETED|Placebo-Controlled Period (26 Weeks)||4
11169664|NCT01641809|12358551|FG003|COMPLETED|Open-label (Week 96 to Week 324)||0
11169665|NCT01641809|12358548|FG000|NOT COMPLETED|Open-label (Week 96 to Week 324)||16
11169666|NCT01641809|12358549|FG001|NOT COMPLETED|Open-label (Week 96 to Week 324)||12
11169667|NCT01641809|12358550|FG002|NOT COMPLETED|Open-label (Week 96 to Week 324)||8
11169668|NCT01641809|12358551|FG003|NOT COMPLETED|Open-label (Week 96 to Week 324)||0
11169669|NCT01641822|12358571|FG000|STARTED|Run-in Phase||107
11169670|NCT01641822|12358572|FG001|STARTED|Run-in Phase||0
11169671|NCT01641822|12358573|FG002|STARTED|Run-in Phase||0
11169672|NCT01641822|12358571|FG000|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
11169673|NCT01641822|12358572|FG001|COMPLETED|Run-in Phase||0
11169674|NCT01641822|12358573|FG002|COMPLETED|Run-in Phase||0
11169675|NCT01641822|12358571|FG000|NOT COMPLETED|Run-in Phase||14
11169676|NCT01641822|12358572|FG001|NOT COMPLETED|Run-in Phase||0
11169677|NCT01641822|12358573|FG002|NOT COMPLETED|Run-in Phase||0
11169678|NCT01641822|12358571|FG000|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
11169679|NCT01641822|12358572|FG001|STARTED|Comparative Phase||43
11169680|NCT01641822|12358573|FG002|STARTED|Comparative Phase||47
11169681|NCT01641822|12358571|FG000|Received Randomized Study Drug Treatment|Comparative Phase||0
11169682|NCT01641822|12358572|FG001|Received Randomized Study Drug Treatment|Comparative Phase||42
11169683|NCT01641822|12358573|FG002|Received Randomized Study Drug Treatment|Comparative Phase||46
11169684|NCT01641822|12358571|FG000|COMPLETED|Comparative Phase||0
11169685|NCT01641822|12358572|FG001|COMPLETED|Comparative Phase||37
11169686|NCT01641822|12358573|FG002|COMPLETED|Comparative Phase||37
11169687|NCT01641822|12358571|FG000|NOT COMPLETED|Comparative Phase||0
11169688|NCT01641822|12358572|FG001|NOT COMPLETED|Comparative Phase||6
11169689|NCT01641822|12358573|FG002|NOT COMPLETED|Comparative Phase||10
11169690|NCT01641835|12358580|FG000|STARTED|Overall Study||303
11169691|NCT01641835|12358580|FG000|COMPLETED|Overall Study||303
11169692|NCT01641835|12358580|FG000|NOT COMPLETED|Overall Study||0
11169693|NCT01641861|12358586|FG000|STARTED|Overall Study||246
11169694|NCT01641861|12358587|FG001|STARTED|Overall Study||242
11169695|NCT01641861|12358586|FG000|COMPLETED|Overall Study||211
11169696|NCT01641861|12358587|FG001|COMPLETED|Overall Study||217
11169697|NCT01641861|12358586|FG000|NOT COMPLETED|Overall Study||35
11169698|NCT01641861|12358587|FG001|NOT COMPLETED|Overall Study||25
11169699|NCT01641900|12358595|FG000|STARTED|Overall Study||28
11169700|NCT01641900|12358596|FG001|STARTED|Overall Study||31
11169701|NCT01641900|12358595|FG000|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
11169702|NCT01641900|12358596|FG001|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
11169703|NCT01641900|12358595|FG000|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
11169704|NCT01641900|12358596|FG001|Completed Drug Intervention|Overall Study||29
11169705|NCT01641900|12358595|FG000|COMPLETED|Overall Study||26
11169706|NCT01641900|12358596|FG001|COMPLETED|Overall Study||29
11169707|NCT01641900|12358595|FG000|NOT COMPLETED|Overall Study||2
11169708|NCT01641900|12358596|FG001|NOT COMPLETED|Overall Study||2
11169709|NCT01641926|12358608|FG000|STARTED|Overall Study||143
11169710|NCT01641926|12358609|FG001|STARTED|Overall Study||145
11169711|NCT01641926|12358610|FG002|STARTED|Overall Study||57
11169712|NCT01641926|12358611|FG003|STARTED|Overall Study||57
11169713|NCT01641926|12358608|FG000|Treated (All Participants as Treated)|Overall Study||142
11169714|NCT01641926|12358609|FG001|Treated (All Participants as Treated)|Overall Study||144
11169715|NCT01641926|12358610|FG002|Treated (All Participants as Treated)|Overall Study||56
11169716|NCT01641926|12358611|FG003|Treated (All Participants as Treated)|Overall Study||57
11169717|NCT01641926|12358608|FG000|COMPLETED|Overall Study||115
11169718|NCT01641926|12358609|FG001|COMPLETED|Overall Study||130
11169719|NCT01641926|12358610|FG002|COMPLETED|Overall Study||46
11169720|NCT01641926|12358611|FG003|COMPLETED|Overall Study||53
11169721|NCT01641926|12358608|FG000|NOT COMPLETED|Overall Study||28
11169722|NCT01641926|12358609|FG001|NOT COMPLETED|Overall Study||15
11169723|NCT01641926|12358610|FG002|NOT COMPLETED|Overall Study||11
11169724|NCT01641926|12358611|FG003|NOT COMPLETED|Overall Study||4
11169725|NCT01641939|12358624|FG000|STARTED|Overall Study||117
11419891|NCT03783923|12618678|FG001|NOT COMPLETED|Placebo-Controlled Period (26 Weeks)||4
11419892|NCT03783923|12618677|FG000|STARTED|Open-Label Extension (26 Weeks)||1
11419893|NCT03783923|12618678|FG001|STARTED|Open-Label Extension (26 Weeks)||2
11169726|NCT01641939|12358625|FG001|STARTED|Overall Study||228
11169727|NCT01641939|12358626|FG002|STARTED|Overall Study||70
11419894|NCT03783923|12618677|FG000|COMPLETED|Open-Label Extension (26 Weeks)||0
11169728|NCT01641939|12358624|FG000|Stage 1|Overall Study||37
11169729|NCT01641939|12358625|FG001|Stage 1|Overall Study||75
11169730|NCT01641939|12358626|FG002|Stage 1|Overall Study||70
11169731|NCT01641939|12358624|FG000|Stage 2|Overall Study||80
11169732|NCT01641939|12358625|FG001|Stage 2|Overall Study||153
11419895|NCT03783923|12618678|FG001|COMPLETED|Open-Label Extension (26 Weeks)||0
11169733|NCT01641939|12358626|FG002|Stage 2|Overall Study||0
11419896|NCT03783923|12618677|FG000|NOT COMPLETED|Open-Label Extension (26 Weeks)||1
11419897|NCT03783923|12618678|FG001|NOT COMPLETED|Open-Label Extension (26 Weeks)||2
11169734|NCT01641939|12358624|FG000|COMPLETED|Overall Study||0
11169735|NCT01641939|12358625|FG001|COMPLETED|Overall Study||0
11169736|NCT01641939|12358626|FG002|COMPLETED|Overall Study||0
11169737|NCT01641939|12358624|FG000|NOT COMPLETED|Overall Study||117
11169738|NCT01641939|12358625|FG001|NOT COMPLETED|Overall Study||228
11419898|NCT03718429|12618686|FG000|STARTED|Baseline Treatment||20
11419899|NCT03718429|12618687|FG001|STARTED|Baseline Treatment||21
11419900|NCT03718429|12618688|FG002|STARTED|Baseline Treatment||21
11419901|NCT03718429|12618689|FG003|STARTED|Baseline Treatment||20
11419902|NCT03718429|12618686|FG000|COMPLETED|Baseline Treatment||20
11419903|NCT03718429|12618687|FG001|COMPLETED|Baseline Treatment||21
11419904|NCT03718429|12618688|FG002|COMPLETED|Baseline Treatment||21
11169739|NCT01641939|12358626|FG002|NOT COMPLETED|Overall Study||70
11169740|NCT01641952|12358636|FG000|STARTED|Overall Study||505
11169741|NCT01641952|12358636|FG000|Treated|Overall Study||504
11169742|NCT01641952|12358636|FG000|COMPLETED|Overall Study||471
11169743|NCT01641952|12358636|FG000|NOT COMPLETED|Overall Study||34
11169744|NCT01641978|12358640|FG000|STARTED|Overall Study||125
11169745|NCT01641978|12358640|FG000|COMPLETED|Overall Study||125
11169746|NCT01641978|12358640|FG000|NOT COMPLETED|Overall Study||0
11169747|NCT01641991|12358652|FG000|STARTED|Overall Study||82
11169748|NCT01641991|12358653|FG001|STARTED|Overall Study||82
11169749|NCT01641991|12358654|FG002|STARTED|Overall Study||82
11169750|NCT01641991|12358655|FG003|STARTED|Overall Study||82
11169751|NCT01641991|12358652|FG000|COMPLETED|Overall Study||73
11169752|NCT01641991|12358653|FG001|COMPLETED|Overall Study||74
11169753|NCT01641991|12358654|FG002|COMPLETED|Overall Study||65
11169754|NCT01641991|12358655|FG003|COMPLETED|Overall Study||66
11169755|NCT01641991|12358652|FG000|NOT COMPLETED|Overall Study||9
11169756|NCT01641991|12358653|FG001|NOT COMPLETED|Overall Study||8
11169757|NCT01641991|12358654|FG002|NOT COMPLETED|Overall Study||17
11169758|NCT01641991|12358655|FG003|NOT COMPLETED|Overall Study||16
11169759|NCT01642056|12358670|FG000|STARTED|First Intervention||10
11169760|NCT01642056|12358671|FG001|STARTED|First Intervention||10
11169761|NCT01642056|12358670|FG000|COMPLETED|First Intervention||9
11169762|NCT01642056|12358671|FG001|COMPLETED|First Intervention||10
11169763|NCT01642056|12358670|FG000|NOT COMPLETED|First Intervention||1
11169764|NCT01642056|12358671|FG001|NOT COMPLETED|First Intervention||0
11169765|NCT01642056|12358670|FG000|STARTED|Second Intervention||9
11169766|NCT01642056|12358671|FG001|STARTED|Second Intervention||10
11169767|NCT01642056|12358670|FG000|COMPLETED|Second Intervention||8
11169768|NCT01642056|12358671|FG001|COMPLETED|Second Intervention||8
11169769|NCT01642056|12358670|FG000|NOT COMPLETED|Second Intervention||1
11169770|NCT01642056|12358671|FG001|NOT COMPLETED|Second Intervention||2
11169771|NCT01642082|12358677|FG000|STARTED|Overall Study||28
11169772|NCT01642082|12358677|FG000|COMPLETED|Overall Study||28
11169773|NCT01642082|12358677|FG000|NOT COMPLETED|Overall Study||0
11169774|NCT01642147|12358690|FG000|STARTED|Overall Study||30
11169775|NCT01642147|12358691|FG001|STARTED|Overall Study||30
11169776|NCT01642147|12358690|FG000|COMPLETED|Overall Study||30
11169777|NCT01642147|12358691|FG001|COMPLETED|Overall Study||30
11169778|NCT01642147|12358690|FG000|NOT COMPLETED|Overall Study||0
11169779|NCT01642147|12358691|FG001|NOT COMPLETED|Overall Study||0
11169780|NCT01642212|12358699|FG000|STARTED|Single-blind Baseline||119
11169781|NCT01642212|12358700|FG001|STARTED|Single-blind Baseline||0
11169782|NCT01642212|12358701|FG002|STARTED|Single-blind Baseline||0
11169783|NCT01642212|12358702|FG003|STARTED|Single-blind Baseline||0
11169784|NCT01642212|12358703|FG004|STARTED|Single-blind Baseline||0
11169785|NCT01642212|12358699|FG000|COMPLETED|Single-blind Baseline||93
11169786|NCT01642212|12358700|FG001|COMPLETED|Single-blind Baseline||0
11169787|NCT01642212|12358701|FG002|COMPLETED|Single-blind Baseline||0
11169788|NCT01642212|12358702|FG003|COMPLETED|Single-blind Baseline||0
11169789|NCT01642212|12358703|FG004|COMPLETED|Single-blind Baseline||0
11169790|NCT01642212|12358699|FG000|NOT COMPLETED|Single-blind Baseline||26
11169791|NCT01642212|12358700|FG001|NOT COMPLETED|Single-blind Baseline||0
11169792|NCT01642212|12358701|FG002|NOT COMPLETED|Single-blind Baseline||0
11169793|NCT01642212|12358702|FG003|NOT COMPLETED|Single-blind Baseline||0
11169794|NCT01642212|12358703|FG004|NOT COMPLETED|Single-blind Baseline||0
11169795|NCT01642212|12358699|FG000|STARTED|Double-blind Treatment||0
11169796|NCT01642212|12358700|FG001|STARTED|Double-blind Treatment||42
11169797|NCT01642212|12358701|FG002|STARTED|Double-blind Treatment||51
11169798|NCT01642212|12358702|FG003|STARTED|Double-blind Treatment||0
11169799|NCT01642212|12358703|FG004|STARTED|Double-blind Treatment||0
11169800|NCT01642212|12358699|FG000|COMPLETED|Double-blind Treatment||0
11169801|NCT01642212|12358700|FG001|COMPLETED|Double-blind Treatment||39
11169802|NCT01642212|12358701|FG002|COMPLETED|Double-blind Treatment||49
11169803|NCT01642212|12358702|FG003|COMPLETED|Double-blind Treatment||0
11169804|NCT01642212|12358703|FG004|COMPLETED|Double-blind Treatment||0
11169805|NCT01642212|12358699|FG000|NOT COMPLETED|Double-blind Treatment||0
11169806|NCT01642212|12358700|FG001|NOT COMPLETED|Double-blind Treatment||3
11169807|NCT01642212|12358701|FG002|NOT COMPLETED|Double-blind Treatment||2
11169808|NCT01642212|12358702|FG003|NOT COMPLETED|Double-blind Treatment||0
11169809|NCT01642212|12358703|FG004|NOT COMPLETED|Double-blind Treatment||0
11169810|NCT01642212|12358699|FG000|STARTED|Open-label Extension||0
11169811|NCT01642212|12358700|FG001|STARTED|Open-label Extension||0
11419905|NCT03718429|12618689|FG003|COMPLETED|Baseline Treatment||20
11419906|NCT03718429|12618686|FG000|NOT COMPLETED|Baseline Treatment||0
11419907|NCT03718429|12618687|FG001|NOT COMPLETED|Baseline Treatment||0
11419908|NCT03718429|12618688|FG002|NOT COMPLETED|Baseline Treatment||0
11419909|NCT03718429|12618689|FG003|NOT COMPLETED|Baseline Treatment||0
11169812|NCT01642212|12358701|FG002|STARTED|Open-label Extension||0
11169813|NCT01642212|12358702|FG003|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
11169814|NCT01642212|12358703|FG004|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
11169815|NCT01642212|12358699|FG000|COMPLETED|Open-label Extension||0
11169816|NCT01642212|12358700|FG001|COMPLETED|Open-label Extension||0
11169817|NCT01642212|12358701|FG002|COMPLETED|Open-label Extension||0
11169818|NCT01642212|12358702|FG003|COMPLETED|Open-label Extension||27
11169819|NCT01642212|12358703|FG004|COMPLETED|Open-label Extension||37
11169820|NCT01642212|12358699|FG000|NOT COMPLETED|Open-label Extension||0
11169821|NCT01642212|12358700|FG001|NOT COMPLETED|Open-label Extension||0
11169822|NCT01642212|12358701|FG002|NOT COMPLETED|Open-label Extension||0
11169823|NCT01642212|12358702|FG003|NOT COMPLETED|Open-label Extension||10
11169824|NCT01642212|12358703|FG004|NOT COMPLETED|Open-label Extension||8
11169825|NCT01642238|12358711|FG000|STARTED|First Intervention (1 Day)||7
11169826|NCT01642238|12358712|FG001|STARTED|First Intervention (1 Day)||8
11169827|NCT01642238|12358711|FG000|COMPLETED|First Intervention (1 Day)||7
11169828|NCT01642238|12358712|FG001|COMPLETED|First Intervention (1 Day)||8
11169829|NCT01642238|12358711|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11169830|NCT01642238|12358712|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11169831|NCT01642238|12358711|FG000|STARTED|Washout (1-2 Weeks)||7
11169832|NCT01642238|12358712|FG001|STARTED|Washout (1-2 Weeks)||8
11169833|NCT01642238|12358711|FG000|COMPLETED|Washout (1-2 Weeks)||7
11169834|NCT01642238|12358712|FG001|COMPLETED|Washout (1-2 Weeks)||8
11169835|NCT01642238|12358711|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0
11169836|NCT01642238|12358712|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0
11169837|NCT01642238|12358711|FG000|STARTED|Second Intervention (1 Day)||7
11169838|NCT01642238|12358712|FG001|STARTED|Second Intervention (1 Day)||8
11169839|NCT01642238|12358711|FG000|COMPLETED|Second Intervention (1 Day)||7
11169840|NCT01642238|12358712|FG001|COMPLETED|Second Intervention (1 Day)||8
11169841|NCT01642238|12358711|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11169842|NCT01642238|12358712|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11169843|NCT01642251|12358721|FG000|STARTED|Overall Study||3
11169844|NCT01642251|12358722|FG001|STARTED|Overall Study||6
11169845|NCT01642251|12358723|FG002|STARTED|Overall Study||75
11169846|NCT01642251|12358724|FG003|STARTED|Overall Study||72
11169847|NCT01642251|12358721|FG000|Started Protocol Therapy|Overall Study||3
11169848|NCT01642251|12358722|FG001|Started Protocol Therapy|Overall Study||6
11169849|NCT01642251|12358723|FG002|Started Protocol Therapy|Overall Study||66
11169850|NCT01642251|12358724|FG003|Started Protocol Therapy|Overall Study||66
11169851|NCT01642251|12358721|FG000|Eligible|Overall Study||3
11169852|NCT01642251|12358722|FG001|Eligible|Overall Study||6
11169853|NCT01642251|12358723|FG002|Eligible|Overall Study||72
11169854|NCT01642251|12358724|FG003|Eligible|Overall Study||69
11169855|NCT01642251|12358721|FG000|Eligible and Treated|Overall Study||3
11169856|NCT01642251|12358722|FG001|Eligible and Treated|Overall Study||6
11169857|NCT01642251|12358723|FG002|Eligible and Treated|Overall Study||64
11169858|NCT01642251|12358724|FG003|Eligible and Treated|Overall Study||64
11419910|NCT03718429|12618686|FG000|STARTED|Adjunctive Rivaroxaban 2.5 mg||20
11169859|NCT01642251|12358721|FG000|COMPLETED|Overall Study||3
11169860|NCT01642251|12358722|FG001|COMPLETED|Overall Study||6
11169861|NCT01642251|12358723|FG002|COMPLETED|Overall Study||53
11169862|NCT01642251|12358724|FG003|COMPLETED|Overall Study||49
11169863|NCT01642251|12358721|FG000|NOT COMPLETED|Overall Study||0
11169864|NCT01642251|12358722|FG001|NOT COMPLETED|Overall Study||0
11169865|NCT01642251|12358723|FG002|NOT COMPLETED|Overall Study||22
11169866|NCT01642251|12358724|FG003|NOT COMPLETED|Overall Study||23
11169867|NCT01642277|12358735|FG000|STARTED|Overall Study||74
11169868|NCT01642277|12358736|FG001|STARTED|Overall Study||60
11169869|NCT01642277|12358735|FG000|COMPLETED|Overall Study||50
11169870|NCT01642277|12358736|FG001|COMPLETED|Overall Study||60
11169871|NCT01642277|12358735|FG000|NOT COMPLETED|Overall Study||24
11169872|NCT01642277|12358736|FG001|NOT COMPLETED|Overall Study||0
11169873|NCT01642407|12358743|FG000|STARTED|Part 1 (Screening Till Week 16)||6
11169874|NCT01642407|12358743|FG000|COMPLETED|Part 1 (Screening Till Week 16)||3
11169875|NCT01642407|12358743|FG000|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
11169876|NCT01642407|12358743|FG000|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
11169877|NCT01642407|12358743|FG000|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
11169878|NCT01642407|12358743|FG000|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
11169879|NCT01642485|12358747|FG000|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
11169880|NCT01642485|12358748|FG001|STARTED|Period 1, Day 1||4
11169881|NCT01642485|12358749|FG002|STARTED|Period 1, Day 1||4
11169882|NCT01642485|12358750|FG003|STARTED|Period 1, Day 1||4
11169883|NCT01642485|12358751|FG004|STARTED|Period 1, Day 1||4
11169884|NCT01642485|12358752|FG005|STARTED|Period 1, Day 1||4
11169885|NCT01642485|12358753|FG006|STARTED|Period 1, Day 1||4
11169886|NCT01642485|12358754|FG007|STARTED|Period 1, Day 1||4
11169887|NCT01642485|12358747|FG000|COMPLETED|Period 1, Day 1||4
11169888|NCT01642485|12358748|FG001|COMPLETED|Period 1, Day 1||4
11169889|NCT01642485|12358749|FG002|COMPLETED|Period 1, Day 1||4
11169890|NCT01642485|12358750|FG003|COMPLETED|Period 1, Day 1||4
11169891|NCT01642485|12358751|FG004|COMPLETED|Period 1, Day 1||4
11419911|NCT03718429|12618687|FG001|STARTED|Adjunctive Rivaroxaban 2.5 mg||21
11419912|NCT03718429|12618688|FG002|STARTED|Adjunctive Rivaroxaban 2.5 mg||21
11419913|NCT03718429|12618689|FG003|STARTED|Adjunctive Rivaroxaban 2.5 mg||0
11419914|NCT03718429|12618686|FG000|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20
11419915|NCT03718429|12618687|FG001|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20
11169892|NCT01642485|12358752|FG005|COMPLETED|Period 1, Day 1||4
11169893|NCT01642485|12358753|FG006|COMPLETED|Period 1, Day 1||4
11169894|NCT01642485|12358754|FG007|COMPLETED|Period 1, Day 1||4
11169895|NCT01642485|12358747|FG000|NOT COMPLETED|Period 1, Day 1||0
11169896|NCT01642485|12358748|FG001|NOT COMPLETED|Period 1, Day 1||0
11169897|NCT01642485|12358749|FG002|NOT COMPLETED|Period 1, Day 1||0
11169898|NCT01642485|12358750|FG003|NOT COMPLETED|Period 1, Day 1||0
11169899|NCT01642485|12358751|FG004|NOT COMPLETED|Period 1, Day 1||0
11169900|NCT01642485|12358752|FG005|NOT COMPLETED|Period 1, Day 1||0
11169901|NCT01642485|12358753|FG006|NOT COMPLETED|Period 1, Day 1||0
11169902|NCT01642485|12358754|FG007|NOT COMPLETED|Period 1, Day 1||0
11169903|NCT01642485|12358747|FG000|STARTED|Period 1, Day 2||4
11169904|NCT01642485|12358748|FG001|STARTED|Period 1, Day 2||4
11169905|NCT01642485|12358749|FG002|STARTED|Period 1, Day 2||4
11169906|NCT01642485|12358750|FG003|STARTED|Period 1, Day 2||4
11169907|NCT01642485|12358751|FG004|STARTED|Period 1, Day 2||4
11169908|NCT01642485|12358752|FG005|STARTED|Period 1, Day 2||4
11169909|NCT01642485|12358753|FG006|STARTED|Period 1, Day 2||4
11169910|NCT01642485|12358754|FG007|STARTED|Period 1, Day 2||4
11169911|NCT01642485|12358747|FG000|COMPLETED|Period 1, Day 2||4
11169912|NCT01642485|12358748|FG001|COMPLETED|Period 1, Day 2||4
11169913|NCT01642485|12358749|FG002|COMPLETED|Period 1, Day 2||4
11169914|NCT01642485|12358750|FG003|COMPLETED|Period 1, Day 2||4
11169915|NCT01642485|12358751|FG004|COMPLETED|Period 1, Day 2||4
11169916|NCT01642485|12358752|FG005|COMPLETED|Period 1, Day 2||4
11169917|NCT01642485|12358753|FG006|COMPLETED|Period 1, Day 2||4
11169918|NCT01642485|12358754|FG007|COMPLETED|Period 1, Day 2||4
11169919|NCT01642485|12358747|FG000|NOT COMPLETED|Period 1, Day 2||0
11169920|NCT01642485|12358748|FG001|NOT COMPLETED|Period 1, Day 2||0
11169921|NCT01642485|12358749|FG002|NOT COMPLETED|Period 1, Day 2||0
11169922|NCT01642485|12358750|FG003|NOT COMPLETED|Period 1, Day 2||0
11419916|NCT03718429|12618688|FG002|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||20
11419917|NCT03718429|12618689|FG003|COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0
11419918|NCT03718429|12618686|FG000|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0
11169923|NCT01642485|12358751|FG004|NOT COMPLETED|Period 1, Day 2||0
11169924|NCT01642485|12358752|FG005|NOT COMPLETED|Period 1, Day 2||0
11169925|NCT01642485|12358753|FG006|NOT COMPLETED|Period 1, Day 2||0
11169926|NCT01642485|12358754|FG007|NOT COMPLETED|Period 1, Day 2||0
11169927|NCT01642485|12358747|FG000|STARTED|Period 1, Day 3||4
11169928|NCT01642485|12358748|FG001|STARTED|Period 1, Day 3||4
11169929|NCT01642485|12358749|FG002|STARTED|Period 1, Day 3||4
11169930|NCT01642485|12358750|FG003|STARTED|Period 1, Day 3||4
11169931|NCT01642485|12358751|FG004|STARTED|Period 1, Day 3||4
11169932|NCT01642485|12358752|FG005|STARTED|Period 1, Day 3||4
11169933|NCT01642485|12358753|FG006|STARTED|Period 1, Day 3||4
11169934|NCT01642485|12358754|FG007|STARTED|Period 1, Day 3||4
11169935|NCT01642485|12358747|FG000|COMPLETED|Period 1, Day 3||4
11169936|NCT01642485|12358748|FG001|COMPLETED|Period 1, Day 3||4
11169937|NCT01642485|12358749|FG002|COMPLETED|Period 1, Day 3||4
11169938|NCT01642485|12358750|FG003|COMPLETED|Period 1, Day 3||4
11169939|NCT01642485|12358751|FG004|COMPLETED|Period 1, Day 3||4
11169940|NCT01642485|12358752|FG005|COMPLETED|Period 1, Day 3||4
11169941|NCT01642485|12358753|FG006|COMPLETED|Period 1, Day 3||4
11419919|NCT03718429|12618687|FG001|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||1
11169942|NCT01642485|12358754|FG007|COMPLETED|Period 1, Day 3||4
11169943|NCT01642485|12358747|FG000|NOT COMPLETED|Period 1, Day 3||0
11169944|NCT01642485|12358748|FG001|NOT COMPLETED|Period 1, Day 3||0
11169945|NCT01642485|12358749|FG002|NOT COMPLETED|Period 1, Day 3||0
11169946|NCT01642485|12358750|FG003|NOT COMPLETED|Period 1, Day 3||0
11169947|NCT01642485|12358751|FG004|NOT COMPLETED|Period 1, Day 3||0
11169948|NCT01642485|12358752|FG005|NOT COMPLETED|Period 1, Day 3||0
11169949|NCT01642485|12358753|FG006|NOT COMPLETED|Period 1, Day 3||0
11169950|NCT01642485|12358754|FG007|NOT COMPLETED|Period 1, Day 3||0
11419920|NCT03718429|12618688|FG002|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||1
11419921|NCT03718429|12618689|FG003|NOT COMPLETED|Adjunctive Rivaroxaban 2.5 mg||0
11169951|NCT01642485|12358747|FG000|STARTED|Period 2, Day 1||4
11169952|NCT01642485|12358748|FG001|STARTED|Period 2, Day 1||4
11169953|NCT01642485|12358749|FG002|STARTED|Period 2, Day 1||4
11169954|NCT01642485|12358750|FG003|STARTED|Period 2, Day 1||4
11169955|NCT01642485|12358751|FG004|STARTED|Period 2, Day 1||4
11169956|NCT01642485|12358752|FG005|STARTED|Period 2, Day 1||4
11169957|NCT01642485|12358753|FG006|STARTED|Period 2, Day 1||4
11169958|NCT01642485|12358754|FG007|STARTED|Period 2, Day 1||4
11169959|NCT01642485|12358747|FG000|COMPLETED|Period 2, Day 1||4
11169960|NCT01642485|12358748|FG001|COMPLETED|Period 2, Day 1||4
11169961|NCT01642485|12358749|FG002|COMPLETED|Period 2, Day 1||4
11169962|NCT01642485|12358750|FG003|COMPLETED|Period 2, Day 1||4
11169963|NCT01642485|12358751|FG004|COMPLETED|Period 2, Day 1||4
11169964|NCT01642485|12358752|FG005|COMPLETED|Period 2, Day 1||4
11169965|NCT01642485|12358753|FG006|COMPLETED|Period 2, Day 1||4
11169966|NCT01642485|12358754|FG007|COMPLETED|Period 2, Day 1||4
11169967|NCT01642485|12358747|FG000|NOT COMPLETED|Period 2, Day 1||0
11169968|NCT01642485|12358748|FG001|NOT COMPLETED|Period 2, Day 1||0
11169969|NCT01642485|12358749|FG002|NOT COMPLETED|Period 2, Day 1||0
11169970|NCT01642485|12358750|FG003|NOT COMPLETED|Period 2, Day 1||0
11169971|NCT01642485|12358751|FG004|NOT COMPLETED|Period 2, Day 1||0
11169972|NCT01642485|12358752|FG005|NOT COMPLETED|Period 2, Day 1||0
11169973|NCT01642485|12358753|FG006|NOT COMPLETED|Period 2, Day 1||0
11169974|NCT01642485|12358754|FG007|NOT COMPLETED|Period 2, Day 1||0
11169975|NCT01642485|12358747|FG000|STARTED|Period 2, Day 2||4
11169976|NCT01642485|12358748|FG001|STARTED|Period 2, Day 2||4
11169977|NCT01642485|12358749|FG002|STARTED|Period 2, Day 2||4
11169978|NCT01642485|12358750|FG003|STARTED|Period 2, Day 2||4
11169979|NCT01642485|12358751|FG004|STARTED|Period 2, Day 2||4
11169980|NCT01642485|12358752|FG005|STARTED|Period 2, Day 2||4
11169981|NCT01642485|12358753|FG006|STARTED|Period 2, Day 2||4
11169982|NCT01642485|12358754|FG007|STARTED|Period 2, Day 2||4
11169983|NCT01642485|12358747|FG000|COMPLETED|Period 2, Day 2||4
11169984|NCT01642485|12358748|FG001|COMPLETED|Period 2, Day 2||4
11169985|NCT01642485|12358749|FG002|COMPLETED|Period 2, Day 2||4
11169986|NCT01642485|12358750|FG003|COMPLETED|Period 2, Day 2||4
11169987|NCT01642485|12358751|FG004|COMPLETED|Period 2, Day 2||4
11169988|NCT01642485|12358752|FG005|COMPLETED|Period 2, Day 2||4
11169989|NCT01642485|12358753|FG006|COMPLETED|Period 2, Day 2||4
11169990|NCT01642485|12358754|FG007|COMPLETED|Period 2, Day 2||4
11169991|NCT01642485|12358747|FG000|NOT COMPLETED|Period 2, Day 2||0
11169992|NCT01642485|12358748|FG001|NOT COMPLETED|Period 2, Day 2||0
11169993|NCT01642485|12358749|FG002|NOT COMPLETED|Period 2, Day 2||0
11169994|NCT01642485|12358750|FG003|NOT COMPLETED|Period 2, Day 2||0
11169995|NCT01642485|12358751|FG004|NOT COMPLETED|Period 2, Day 2||0
11169996|NCT01642485|12358752|FG005|NOT COMPLETED|Period 2, Day 2||0
11169997|NCT01642485|12358753|FG006|NOT COMPLETED|Period 2, Day 2||0
11169998|NCT01642485|12358754|FG007|NOT COMPLETED|Period 2, Day 2||0
11169999|NCT01642485|12358747|FG000|STARTED|Period 2, Day 3||4
11170000|NCT01642485|12358748|FG001|STARTED|Period 2, Day 3||4
11170001|NCT01642485|12358749|FG002|STARTED|Period 2, Day 3||4
11170002|NCT01642485|12358750|FG003|STARTED|Period 2, Day 3||4
11170003|NCT01642485|12358751|FG004|STARTED|Period 2, Day 3||4
11170004|NCT01642485|12358752|FG005|STARTED|Period 2, Day 3||4
11170005|NCT01642485|12358753|FG006|STARTED|Period 2, Day 3||4
11170006|NCT01642485|12358754|FG007|STARTED|Period 2, Day 3||4
11170007|NCT01642485|12358747|FG000|COMPLETED|Period 2, Day 3||4
11170008|NCT01642485|12358748|FG001|COMPLETED|Period 2, Day 3||4
11170009|NCT01642485|12358749|FG002|COMPLETED|Period 2, Day 3||4
11170010|NCT01642485|12358750|FG003|COMPLETED|Period 2, Day 3||4
11170011|NCT01642485|12358751|FG004|COMPLETED|Period 2, Day 3||4
11170012|NCT01642485|12358752|FG005|COMPLETED|Period 2, Day 3||4
11170013|NCT01642485|12358753|FG006|COMPLETED|Period 2, Day 3||4
11170014|NCT01642485|12358754|FG007|COMPLETED|Period 2, Day 3||4
11170015|NCT01642485|12358747|FG000|NOT COMPLETED|Period 2, Day 3||0
11170016|NCT01642485|12358748|FG001|NOT COMPLETED|Period 2, Day 3||0
11170017|NCT01642485|12358749|FG002|NOT COMPLETED|Period 2, Day 3||0
11170018|NCT01642485|12358750|FG003|NOT COMPLETED|Period 2, Day 3||0
11170019|NCT01642485|12358751|FG004|NOT COMPLETED|Period 2, Day 3||0
11170020|NCT01642485|12358752|FG005|NOT COMPLETED|Period 2, Day 3||0
11170021|NCT01642485|12358753|FG006|NOT COMPLETED|Period 2, Day 3||0
11170022|NCT01642485|12358754|FG007|NOT COMPLETED|Period 2, Day 3||0
11170023|NCT01642589|12358774|FG000|STARTED|Overall Study||200
11170024|NCT01642589|12358775|FG001|STARTED|Overall Study||100
11170025|NCT01642589|12358774|FG000|COMPLETED|Overall Study||199
11170026|NCT01642589|12358775|FG001|COMPLETED|Overall Study||99
11170027|NCT01642589|12358774|FG000|NOT COMPLETED|Overall Study||1
11170028|NCT01642589|12358775|FG001|NOT COMPLETED|Overall Study||1
11170029|NCT01642602|12358781|FG000|STARTED|Overall Study||104
11170030|NCT01642602|12358781|FG000|COMPLETED|Overall Study||102
11170031|NCT01642602|12358781|FG000|NOT COMPLETED|Overall Study||2
11170032|NCT01642615|12358785|FG000|STARTED|Open Label Maintenance Phase||63
11170033|NCT01642615|12358786|FG001|STARTED|Open Label Maintenance Phase||0
11170034|NCT01642615|12358787|FG002|STARTED|Open Label Maintenance Phase||0
11170035|NCT01642615|12358785|FG000|Safety Analysis Set|Open Label Maintenance Phase||62
11170036|NCT01642615|12358786|FG001|Safety Analysis Set|Open Label Maintenance Phase||0
11170037|NCT01642615|12358787|FG002|Safety Analysis Set|Open Label Maintenance Phase||0
11170038|NCT01642615|12358785|FG000|COMPLETED|Open Label Maintenance Phase||58
11170039|NCT01642615|12358786|FG001|COMPLETED|Open Label Maintenance Phase||0
11170040|NCT01642615|12358787|FG002|COMPLETED|Open Label Maintenance Phase||0
11170041|NCT01642615|12358785|FG000|NOT COMPLETED|Open Label Maintenance Phase||5
11170042|NCT01642615|12358786|FG001|NOT COMPLETED|Open Label Maintenance Phase||0
11170043|NCT01642615|12358787|FG002|NOT COMPLETED|Open Label Maintenance Phase||0
11170044|NCT01642615|12358785|FG000|STARTED|Double Blind Maintenance Phase||0
11170045|NCT01642615|12358786|FG001|STARTED|Double Blind Maintenance Phase||25
11170046|NCT01642615|12358787|FG002|STARTED|Double Blind Maintenance Phase||26
11170047|NCT01642615|12358785|FG000|COMPLETED|Double Blind Maintenance Phase||0
11170048|NCT01642615|12358786|FG001|COMPLETED|Double Blind Maintenance Phase||18
11170049|NCT01642615|12358787|FG002|COMPLETED|Double Blind Maintenance Phase||20
11170050|NCT01642615|12358785|FG000|NOT COMPLETED|Double Blind Maintenance Phase||0
11170051|NCT01642615|12358786|FG001|NOT COMPLETED|Double Blind Maintenance Phase||7
11170052|NCT01642615|12358787|FG002|NOT COMPLETED|Double Blind Maintenance Phase||6
11170053|NCT01642914|12358798|FG000|STARTED|Overall Study||173
11170054|NCT01642914|12358799|FG001|STARTED|Overall Study||154
11170055|NCT01642914|12358800|FG002|STARTED|Overall Study||160
11170056|NCT01642914|12358798|FG000|COMPLETED|Overall Study||127
11170057|NCT01642914|12358799|FG001|COMPLETED|Overall Study||122
11170058|NCT01642914|12358800|FG002|COMPLETED|Overall Study||120
11170059|NCT01642914|12358798|FG000|NOT COMPLETED|Overall Study||46
11170060|NCT01642914|12358799|FG001|NOT COMPLETED|Overall Study||32
11170061|NCT01642914|12358800|FG002|NOT COMPLETED|Overall Study||40
11170062|NCT01643044|12358812|FG000|STARTED|Overall Study||24
11170063|NCT01643044|12358813|FG001|STARTED|Overall Study||24
11170064|NCT01643044|12358812|FG000|COMPLETED|Overall Study||20
11170065|NCT01643044|12358813|FG001|COMPLETED|Overall Study||19
11170066|NCT01643044|12358812|FG000|NOT COMPLETED|Overall Study||4
11170067|NCT01643044|12358813|FG001|NOT COMPLETED|Overall Study||5
11170068|NCT01643213|12358821|FG000|STARTED|Overall Study||13
11170069|NCT01643213|12358822|FG001|STARTED|Overall Study||14
11170070|NCT01643213|12358821|FG000|COMPLETED|Overall Study||12
11170071|NCT01643213|12358822|FG001|COMPLETED|Overall Study||14
11170072|NCT01643213|12358821|FG000|NOT COMPLETED|Overall Study||1
11170073|NCT01643213|12358822|FG001|NOT COMPLETED|Overall Study||0
11170074|NCT01643382|12358830|FG000|STARTED|Overall Study||30
11170075|NCT01643382|12358831|FG001|STARTED|Overall Study||30
11170076|NCT01643382|12358830|FG000|COMPLETED|Overall Study||30
11170077|NCT01643382|12358831|FG001|COMPLETED|Overall Study||30
11170078|NCT01643382|12358830|FG000|NOT COMPLETED|Overall Study||0
11170079|NCT01643382|12358831|FG001|NOT COMPLETED|Overall Study||0
11170080|NCT01643408|12358837|FG000|STARTED|Overall Study||30
11170081|NCT01643408|12358837|FG000|COMPLETED|Overall Study||16
11170082|NCT01643408|12358837|FG000|NOT COMPLETED|Overall Study||14
11170083|NCT01643473|12358843|FG000|STARTED|Overall Study||21
11170084|NCT01643473|12358844|FG001|STARTED|Overall Study||21
11170085|NCT01643473|12358843|FG000|COMPLETED|Overall Study||20
11170086|NCT01643473|12358844|FG001|COMPLETED|Overall Study||21
11170087|NCT01643473|12358843|FG000|NOT COMPLETED|Overall Study||1
11170088|NCT01643473|12358844|FG001|NOT COMPLETED|Overall Study||0
11170089|NCT01643616|12358852|FG000|STARTED|Overall Study||125
11170090|NCT01643616|12358853|FG001|STARTED|Overall Study||125
11170091|NCT01643616|12358852|FG000|COMPLETED|Overall Study||125
11170092|NCT01643616|12358853|FG001|COMPLETED|Overall Study||125
11170093|NCT01643616|12358852|FG000|NOT COMPLETED|Overall Study||0
11170094|NCT01643616|12358853|FG001|NOT COMPLETED|Overall Study||0
11170095|NCT01643668|12358859|FG000|STARTED|Overall Study||34
11170096|NCT01643668|12358859|FG000|COMPLETED|Overall Study||33
11170097|NCT01643668|12358859|FG000|NOT COMPLETED|Overall Study||1
11170098|NCT01643707|12358865|FG000|STARTED|Overall Study||858
11170099|NCT01643707|12358866|FG001|STARTED|Overall Study||484
11170100|NCT01643707|12358865|FG000|COMPLETED|Overall Study||823
11170101|NCT01643707|12358866|FG001|COMPLETED|Overall Study||470
11170102|NCT01643707|12358865|FG000|NOT COMPLETED|Overall Study||35
11170103|NCT01643707|12358866|FG001|NOT COMPLETED|Overall Study||14
11170104|NCT01643772|12358879|FG000|STARTED|Overall Study||15
11170105|NCT01643772|12358880|FG001|STARTED|Overall Study||15
11170106|NCT01643772|12358881|FG002|STARTED|Overall Study||15
11170107|NCT01643772|12358882|FG003|STARTED|Overall Study||16
11170108|NCT01643772|12358879|FG000|COMPLETED|Overall Study||15
11170109|NCT01643772|12358880|FG001|COMPLETED|Overall Study||15
11170110|NCT01643772|12358881|FG002|COMPLETED|Overall Study||15
11170111|NCT01643772|12358882|FG003|COMPLETED|Overall Study||14
11170112|NCT01643772|12358879|FG000|NOT COMPLETED|Overall Study||0
11170113|NCT01643772|12358880|FG001|NOT COMPLETED|Overall Study||0
11170114|NCT01643772|12358881|FG002|NOT COMPLETED|Overall Study||0
11170115|NCT01643772|12358882|FG003|NOT COMPLETED|Overall Study||2
11170116|NCT01643798|12358894|FG000|STARTED|Pretreatment 1 and Stimulation||7
11170117|NCT01643798|12358895|FG001|STARTED|Pretreatment 1 and Stimulation||8
11170118|NCT01643798|12358894|FG000|COMPLETED|Pretreatment 1 and Stimulation||6
11170119|NCT01643798|12358895|FG001|COMPLETED|Pretreatment 1 and Stimulation||8
11170120|NCT01643798|12358894|FG000|NOT COMPLETED|Pretreatment 1 and Stimulation||1
11170121|NCT01643798|12358895|FG001|NOT COMPLETED|Pretreatment 1 and Stimulation||0
11170122|NCT01643798|12358894|FG000|STARTED|Pretreatment 2 and Stimulation||6
11170123|NCT01643798|12358895|FG001|STARTED|Pretreatment 2 and Stimulation||8
11170124|NCT01643798|12358894|FG000|COMPLETED|Pretreatment 2 and Stimulation||6
11170125|NCT01643798|12358895|FG001|COMPLETED|Pretreatment 2 and Stimulation||8
11170126|NCT01643798|12358894|FG000|NOT COMPLETED|Pretreatment 2 and Stimulation||0
11170127|NCT01643798|12358895|FG001|NOT COMPLETED|Pretreatment 2 and Stimulation||0
11170128|NCT01643850|12358915|FG000|STARTED|Overall Study||5
11170129|NCT01643850|12358916|FG001|STARTED|Overall Study||2
11170130|NCT01643850|12358917|FG002|STARTED|Overall Study||8
11170131|NCT01643850|12358918|FG003|STARTED|Overall Study||3
11170132|NCT01643850|12358919|FG004|STARTED|Overall Study||3
11170133|NCT01643850|12358920|FG005|STARTED|Overall Study||3
11170134|NCT01643850|12358921|FG006|STARTED|Overall Study||4
11170135|NCT01643850|12358922|FG007|STARTED|Overall Study||4
11170136|NCT01643850|12358923|FG008|STARTED|Overall Study||4
11170137|NCT01643850|12358915|FG000|COMPLETED|Overall Study||5
11170138|NCT01643850|12358916|FG001|COMPLETED|Overall Study||2
11170139|NCT01643850|12358917|FG002|COMPLETED|Overall Study||7
11170140|NCT01643850|12358918|FG003|COMPLETED|Overall Study||3
11170141|NCT01643850|12358919|FG004|COMPLETED|Overall Study||0
11170142|NCT01643850|12358920|FG005|COMPLETED|Overall Study||3
11170143|NCT01643850|12358921|FG006|COMPLETED|Overall Study||3
11170144|NCT01643850|12358922|FG007|COMPLETED|Overall Study||4
11419922|NCT03718429|12618686|FG000|STARTED|Stopping Aspirin||20
11419923|NCT03718429|12618687|FG001|STARTED|Stopping Aspirin||20
11419924|NCT03718429|12618688|FG002|STARTED|Stopping Aspirin||20
11419925|NCT03718429|12618689|FG003|STARTED|Stopping Aspirin||0
11419926|NCT03718429|12618686|FG000|COMPLETED|Stopping Aspirin||20
11419927|NCT03718429|12618687|FG001|COMPLETED|Stopping Aspirin||20
11419928|NCT03718429|12618688|FG002|COMPLETED|Stopping Aspirin||20
11170145|NCT01643850|12358923|FG008|COMPLETED|Overall Study||3
11170146|NCT01643850|12358915|FG000|NOT COMPLETED|Overall Study||0
11170147|NCT01643850|12358916|FG001|NOT COMPLETED|Overall Study||0
11170148|NCT01643850|12358917|FG002|NOT COMPLETED|Overall Study||1
11170149|NCT01643850|12358918|FG003|NOT COMPLETED|Overall Study||0
11170150|NCT01643850|12358919|FG004|NOT COMPLETED|Overall Study||3
11170151|NCT01643850|12358920|FG005|NOT COMPLETED|Overall Study||0
11170152|NCT01643850|12358921|FG006|NOT COMPLETED|Overall Study||1
11170153|NCT01643850|12358922|FG007|NOT COMPLETED|Overall Study||0
11170154|NCT01643850|12358923|FG008|NOT COMPLETED|Overall Study||1
11170155|NCT01643876|12358989|FG000|STARTED|Overall Study||48
11170156|NCT01643876|12358989|FG000|COMPLETED|Overall Study||48
11170157|NCT01643876|12358989|FG000|NOT COMPLETED|Overall Study||0
11170158|NCT01643902|12358993|FG000|STARTED|Overall Study||20
11170159|NCT01643902|12358993|FG000|COMPLETED|Overall Study||20
11170160|NCT01643902|12358993|FG000|NOT COMPLETED|Overall Study||0
11170161|NCT01643928|12359003|FG000|STARTED|Overall Study||58
11170162|NCT01643928|12359004|FG001|STARTED|Overall Study||32
11170163|NCT01643928|12359005|FG002|STARTED|Overall Study||33
11170164|NCT01643928|12359006|FG003|STARTED|Overall Study||30
11170165|NCT01643928|12359007|FG004|STARTED|Overall Study||30
11170166|NCT01643928|12359003|FG000|COMPLETED|Overall Study||48
11170167|NCT01643928|12359004|FG001|COMPLETED|Overall Study||30
11170168|NCT01643928|12359005|FG002|COMPLETED|Overall Study||30
11170169|NCT01643928|12359006|FG003|COMPLETED|Overall Study||27
11170170|NCT01643928|12359007|FG004|COMPLETED|Overall Study||28
11170171|NCT01643928|12359003|FG000|NOT COMPLETED|Overall Study||10
11170172|NCT01643928|12359004|FG001|NOT COMPLETED|Overall Study||2
11170173|NCT01643928|12359005|FG002|NOT COMPLETED|Overall Study||3
11170174|NCT01643928|12359006|FG003|NOT COMPLETED|Overall Study||3
11170175|NCT01643928|12359007|FG004|NOT COMPLETED|Overall Study||2
11170176|NCT01644058|12359048|FG000|STARTED|Overall Study||18
11170177|NCT01644058|12359048|FG000|COMPLETED|Overall Study||18
11170178|NCT01644058|12359048|FG000|NOT COMPLETED|Overall Study||0
11170179|NCT01644149|12359055|FG000|STARTED|Overall Study||43
11170180|NCT01644149|12359056|FG001|STARTED|Overall Study||40
11170181|NCT01644149|12359055|FG000|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39
11170182|NCT01644149|12359056|FG001|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39
11170183|NCT01644149|12359055|FG000|NOT COMPLETED|Overall Study||4
11170184|NCT01644149|12359056|FG001|NOT COMPLETED|Overall Study||1
11170185|NCT01644175|12359065|FG000|STARTED|Overall Study|Randomized|107
11170186|NCT01644175|12359066|FG001|STARTED|Overall Study|Randomized|209
11170187|NCT01644175|12359065|FG000|Treated|Overall Study||107
11170188|NCT01644175|12359066|FG001|Treated|Overall Study||207
11170189|NCT01644175|12359065|FG000|COMPLETED|Overall Study||75
11170190|NCT01644175|12359066|FG001|COMPLETED|Overall Study||156
11170191|NCT01644175|12359065|FG000|NOT COMPLETED|Overall Study||32
11170192|NCT01644175|12359066|FG001|NOT COMPLETED|Overall Study||53
11170193|NCT01644188|12359074|FG000|STARTED|Overall Study|Randomized|479
11170194|NCT01644188|12359075|FG001|STARTED|Overall Study|Randomized|241
11419929|NCT03718429|12618689|FG003|COMPLETED|Stopping Aspirin||0
11170195|NCT01644188|12359074|FG000|Treated|Overall Study||479
11170196|NCT01644188|12359075|FG001|Treated|Overall Study||241
11170197|NCT01644188|12359074|FG000|COMPLETED|Overall Study||357
11170198|NCT01644188|12359075|FG001|COMPLETED|Overall Study||166
11170199|NCT01644188|12359074|FG000|NOT COMPLETED|Overall Study||122
11419930|NCT03718429|12618686|FG000|NOT COMPLETED|Stopping Aspirin||0
11419931|NCT03718429|12618687|FG001|NOT COMPLETED|Stopping Aspirin||0
11170200|NCT01644188|12359075|FG001|NOT COMPLETED|Overall Study||75
11170201|NCT01644240|12359084|FG000|STARTED|Overall Study||6
11170202|NCT01644240|12359085|FG001|STARTED|Overall Study||4
11170203|NCT01644240|12359086|FG002|STARTED|Overall Study||6
11170204|NCT01644240|12359084|FG000|COMPLETED|Overall Study||6
11170205|NCT01644240|12359085|FG001|COMPLETED|Overall Study||4
11170206|NCT01644240|12359086|FG002|COMPLETED|Overall Study||6
11170207|NCT01644240|12359084|FG000|NOT COMPLETED|Overall Study||0
11170208|NCT01644240|12359085|FG001|NOT COMPLETED|Overall Study||0
11170209|NCT01644240|12359086|FG002|NOT COMPLETED|Overall Study||0
11170210|NCT01644292|12359094|FG000|STARTED|Overall Study||2
11170211|NCT01644292|12359094|FG000|COMPLETED|Overall Study||2
11170212|NCT01644292|12359094|FG000|NOT COMPLETED|Overall Study||0
11170213|NCT01644331|12359100|FG000|STARTED|Overall Study||129
11170214|NCT01644331|12359101|FG001|STARTED|Overall Study||128
11170215|NCT01644331|12359100|FG000|COMPLETED|Overall Study||118
11170216|NCT01644331|12359101|FG001|COMPLETED|Overall Study||118
11170217|NCT01644331|12359100|FG000|NOT COMPLETED|Overall Study||11
11170218|NCT01644331|12359101|FG001|NOT COMPLETED|Overall Study||10
11170219|NCT01644396|12359107|FG000|STARTED|Overall Study||50
11170220|NCT01644396|12359107|FG000|COMPLETED|Overall Study||50
11170221|NCT01644396|12359107|FG000|NOT COMPLETED|Overall Study||0
11170222|NCT01644474|12359114|FG000|STARTED|Overall Study|Randomized|51
11170223|NCT01644474|12359115|FG001|STARTED|Overall Study|Randomized|52
11170224|NCT01644474|12359114|FG000|Treated|Overall Study||51
11170225|NCT01644474|12359115|FG001|Treated|Overall Study||52
11170226|NCT01644474|12359114|FG000|COMPLETED|Overall Study||44
11170227|NCT01644474|12359115|FG001|COMPLETED|Overall Study||44
11170228|NCT01644474|12359114|FG000|NOT COMPLETED|Overall Study||7
11170229|NCT01644474|12359115|FG001|NOT COMPLETED|Overall Study||8
11170230|NCT01644500|12359124|FG000|STARTED|Overall Study||244
11170231|NCT01644500|12359125|FG001|STARTED|Overall Study||248
11170232|NCT01644500|12359126|FG002|STARTED|Overall Study||245
11170233|NCT01644500|12359124|FG000|Received at Least One Dose of Study Drug|Overall Study||244
11170234|NCT01644500|12359125|FG001|Received at Least One Dose of Study Drug|Overall Study||248
11170235|NCT01644500|12359126|FG002|Received at Least One Dose of Study Drug|Overall Study||243
11170236|NCT01644500|12359124|FG000|Modified Intent-to-treat Population|Overall Study||239
11170237|NCT01644500|12359125|FG001|Modified Intent-to-treat Population|Overall Study||239
11170238|NCT01644500|12359126|FG002|Modified Intent-to-treat Population|Overall Study||242
11170239|NCT01644500|12359124|FG000|COMPLETED|Overall Study||222
11170240|NCT01644500|12359125|FG001|COMPLETED|Overall Study||224
11170241|NCT01644500|12359126|FG002|COMPLETED|Overall Study||230
11170242|NCT01644500|12359124|FG000|NOT COMPLETED|Overall Study||22
11170243|NCT01644500|12359125|FG001|NOT COMPLETED|Overall Study||24
11170244|NCT01644500|12359126|FG002|NOT COMPLETED|Overall Study||15
11170245|NCT01644565|12359134|FG000|STARTED|Overall Study||5
11170246|NCT01644565|12359135|FG001|STARTED|Overall Study||5
11170247|NCT01644565|12359136|FG002|STARTED|Overall Study||5
11170248|NCT01644565|12359137|FG003|STARTED|Overall Study||5
11170249|NCT01644565|12359138|FG004|STARTED|Overall Study||5
11170250|NCT01644565|12359139|FG005|STARTED|Overall Study||7
11170251|NCT01644565|12359140|FG006|STARTED|Overall Study||7
11170252|NCT01644565|12359141|FG007|STARTED|Overall Study||10
11170253|NCT01644565|12359142|FG008|STARTED|Overall Study||8
11170254|NCT01644565|12359134|FG000|COMPLETED|Overall Study||4
11170255|NCT01644565|12359135|FG001|COMPLETED|Overall Study||5
11170256|NCT01644565|12359136|FG002|COMPLETED|Overall Study||5
11170257|NCT01644565|12359137|FG003|COMPLETED|Overall Study||4
11170258|NCT01644565|12359138|FG004|COMPLETED|Overall Study||4
11170259|NCT01644565|12359139|FG005|COMPLETED|Overall Study||7
11170260|NCT01644565|12359140|FG006|COMPLETED|Overall Study||7
11170261|NCT01644565|12359141|FG007|COMPLETED|Overall Study||8
11170262|NCT01644565|12359142|FG008|COMPLETED|Overall Study||7
11170263|NCT01644565|12359134|FG000|NOT COMPLETED|Overall Study||1
11170264|NCT01644565|12359135|FG001|NOT COMPLETED|Overall Study||0
11170265|NCT01644565|12359136|FG002|NOT COMPLETED|Overall Study||0
11170266|NCT01644565|12359137|FG003|NOT COMPLETED|Overall Study||1
11170267|NCT01644565|12359138|FG004|NOT COMPLETED|Overall Study||1
11170268|NCT01644565|12359139|FG005|NOT COMPLETED|Overall Study||0
11170269|NCT01644565|12359140|FG006|NOT COMPLETED|Overall Study||0
11170270|NCT01644565|12359141|FG007|NOT COMPLETED|Overall Study||2
11170271|NCT01644565|12359142|FG008|NOT COMPLETED|Overall Study||1
11170272|NCT01644617|12359165|FG000|STARTED|Overall Study||42
11323645|NCT01190930|12520935|FG009|COMPLETED|Induction||0
11323646|NCT01190930|12520926|FG000|NOT COMPLETED|Induction||5349
11323647|NCT01190930|12520927|FG001|NOT COMPLETED|Induction||9
11323648|NCT01190930|12520928|FG002|NOT COMPLETED|Induction||0
11323649|NCT01190930|12520929|FG003|NOT COMPLETED|Induction||0
11323650|NCT01190930|12520930|FG004|NOT COMPLETED|Induction||0
11323651|NCT01190930|12520931|FG005|NOT COMPLETED|Induction||0
11323652|NCT01190930|12520932|FG006|NOT COMPLETED|Induction||0
11323653|NCT01190930|12520933|FG007|NOT COMPLETED|Induction||0
11323654|NCT01190930|12520934|FG008|NOT COMPLETED|Induction||0
11323655|NCT01190930|12520935|FG009|NOT COMPLETED|Induction||0
11323656|NCT01190930|12520926|FG000|STARTED|Post Induction Pre-Maintenance||0
11323657|NCT01190930|12520927|FG001|STARTED|Post Induction Pre-Maintenance||43
11170273|NCT01644617|12359166|FG001|STARTED|Overall Study||41
11323658|NCT01190930|12520928|FG002|STARTED|Post Induction Pre-Maintenance||3122
11323659|NCT01190930|12520929|FG003|STARTED|Post Induction Pre-Maintenance||224
11323660|NCT01190930|12520930|FG004|STARTED|Post Induction Pre-Maintenance||301
11323661|NCT01190930|12520931|FG005|STARTED|Post Induction Pre-Maintenance||302
11323662|NCT01190930|12520932|FG006|STARTED|Post Induction Pre-Maintenance||0
11323663|NCT01190930|12520933|FG007|STARTED|Post Induction Pre-Maintenance||0
11323664|NCT01190930|12520934|FG008|STARTED|Post Induction Pre-Maintenance||0
11323665|NCT01190930|12520935|FG009|STARTED|Post Induction Pre-Maintenance||0
11323666|NCT01190930|12520926|FG000|COMPLETED|Post Induction Pre-Maintenance||0
11323667|NCT01190930|12520927|FG001|COMPLETED|Post Induction Pre-Maintenance||37
11323668|NCT01190930|12520928|FG002|COMPLETED|Post Induction Pre-Maintenance||2364
11323669|NCT01190930|12520929|FG003|COMPLETED|Post Induction Pre-Maintenance||207
11323670|NCT01190930|12520930|FG004|COMPLETED|Post Induction Pre-Maintenance||296
11170274|NCT01644617|12359167|FG002|STARTED|Overall Study||41
11170275|NCT01644617|12359165|FG000|COMPLETED|Overall Study||36
11170276|NCT01644617|12359166|FG001|COMPLETED|Overall Study||36
11170277|NCT01644617|12359167|FG002|COMPLETED|Overall Study||34
11170278|NCT01644617|12359165|FG000|NOT COMPLETED|Overall Study||6
11170279|NCT01644617|12359166|FG001|NOT COMPLETED|Overall Study||5
11170280|NCT01644617|12359167|FG002|NOT COMPLETED|Overall Study||7
11170281|NCT01644643|12359179|FG000|STARTED|Overall Study||15
11170282|NCT01644643|12359180|FG001|STARTED|Overall Study||12
11170283|NCT01644643|12359181|FG002|STARTED|Overall Study||153
11170284|NCT01644643|12359182|FG003|STARTED|Overall Study||153
11170285|NCT01644643|12359179|FG000|COMPLETED|Overall Study||13
11170286|NCT01644643|12359180|FG001|COMPLETED|Overall Study||12
11170287|NCT01644643|12359181|FG002|COMPLETED|Overall Study||148
11170288|NCT01644643|12359182|FG003|COMPLETED|Overall Study||143
11170289|NCT01644643|12359179|FG000|NOT COMPLETED|Overall Study||2
11170290|NCT01644643|12359180|FG001|NOT COMPLETED|Overall Study||0
11170291|NCT01644643|12359181|FG002|NOT COMPLETED|Overall Study||5
11170292|NCT01644643|12359182|FG003|NOT COMPLETED|Overall Study||10
11170293|NCT01644695|12359198|FG000|STARTED|Overall Study||85
11170294|NCT01644695|12359198|FG000|COMPLETED|Overall Study||85
11170295|NCT01644695|12359198|FG000|NOT COMPLETED|Overall Study||0
11170296|NCT01644734|12359202|FG000|STARTED|Overall Study|Patients with documentation of treatment.|1282
11170297|NCT01644734|12359202|FG000|COMPLETED|Overall Study||1016
11170298|NCT01644734|12359202|FG000|NOT COMPLETED|Overall Study||266
11170299|NCT01644890|12359208|FG000|STARTED|Overall Study||218
11170300|NCT01644890|12359209|FG001|STARTED|Overall Study||218
11170301|NCT01644890|12359208|FG000|COMPLETED|Overall Study||2
11170302|NCT01644890|12359209|FG001|COMPLETED|Overall Study||3
11170303|NCT01644890|12359208|FG000|NOT COMPLETED|Overall Study||216
11170304|NCT01644890|12359209|FG001|NOT COMPLETED|Overall Study||215
11170305|NCT01645059|12359215|FG000|STARTED|Overall Study||129
11170306|NCT01645059|12359215|FG000|COMPLETED|Overall Study||129
11170307|NCT01645059|12359215|FG000|NOT COMPLETED|Overall Study||0
11170308|NCT01645098|12359226|FG000|STARTED|Overall Study||24
11170309|NCT01645098|12359227|FG001|STARTED|Overall Study||29
11170310|NCT01645098|12359226|FG000|COMPLETED|Overall Study||24
11170311|NCT01645098|12359227|FG001|COMPLETED|Overall Study||29
11170312|NCT01645098|12359226|FG000|NOT COMPLETED|Overall Study||0
11170313|NCT01645098|12359227|FG001|NOT COMPLETED|Overall Study||0
11170314|NCT01645111|12359233|FG000|STARTED|Overall Study||50
11170315|NCT01645111|12359233|FG000|COMPLETED|Overall Study||35
11170316|NCT01645111|12359233|FG000|NOT COMPLETED|Overall Study||15
11170317|NCT01645176|12359237|FG000|STARTED|Overall Study||21
11170318|NCT01645176|12359237|FG000|COMPLETED|Overall Study||16
11170319|NCT01645176|12359237|FG000|NOT COMPLETED|Overall Study||5
11170320|NCT01645280|12359246|FG000|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
11170321|NCT01645280|12359247|FG001|STARTED|Overall Study||54
11170322|NCT01645280|12359248|FG002|STARTED|Overall Study||55
11170323|NCT01645280|12359249|FG003|STARTED|Overall Study||54
11170324|NCT01645280|12359250|FG004|STARTED|Overall Study||55
11170325|NCT01645280|12359246|FG000|COMPLETED|Overall Study||49
11170326|NCT01645280|12359247|FG001|COMPLETED|Overall Study||51
11170327|NCT01645280|12359248|FG002|COMPLETED|Overall Study||49
11170328|NCT01645280|12359249|FG003|COMPLETED|Overall Study||48
11170329|NCT01645280|12359250|FG004|COMPLETED|Overall Study||47
11170330|NCT01645280|12359246|FG000|NOT COMPLETED|Overall Study||6
11419932|NCT03718429|12618688|FG002|NOT COMPLETED|Stopping Aspirin||0
11419933|NCT03718429|12618689|FG003|NOT COMPLETED|Stopping Aspirin||0
11170331|NCT01645280|12359247|FG001|NOT COMPLETED|Overall Study||3
11170332|NCT01645280|12359248|FG002|NOT COMPLETED|Overall Study||6
11170333|NCT01645280|12359249|FG003|NOT COMPLETED|Overall Study||6
11170334|NCT01645280|12359250|FG004|NOT COMPLETED|Overall Study||8
11170335|NCT01645306|12359266|FG000|STARTED|Overall Study||51
11170336|NCT01645306|12359267|FG001|STARTED|Overall Study||54
11170337|NCT01645306|12359268|FG002|STARTED|Overall Study||53
11170338|NCT01645306|12359266|FG000|COMPLETED|Overall Study||49
11170339|NCT01645306|12359267|FG001|COMPLETED|Overall Study||50
11170340|NCT01645306|12359268|FG002|COMPLETED|Overall Study||48
11170341|NCT01645306|12359266|FG000|NOT COMPLETED|Overall Study||2
11170342|NCT01645306|12359267|FG001|NOT COMPLETED|Overall Study||4
11170343|NCT01645306|12359268|FG002|NOT COMPLETED|Overall Study||5
11170344|NCT01645735|12359278|FG000|STARTED|Overall Study||32
11170345|NCT01645735|12359279|FG001|STARTED|Overall Study||17
11170346|NCT01645735|12359278|FG000|COMPLETED|Overall Study||28
11170347|NCT01645735|12359279|FG001|COMPLETED|Overall Study||16
11170348|NCT01645735|12359278|FG000|NOT COMPLETED|Overall Study||4
11170349|NCT01645735|12359279|FG001|NOT COMPLETED|Overall Study||1
11170350|NCT01645930|12359286|FG000|STARTED|Overall Study||43
11170351|NCT01645930|12359286|FG000|COMPLETED|Overall Study||0
11419934|NCT03206476|12618711|FG000|STARTED|Overall Study||54
11419935|NCT03206476|12618712|FG001|STARTED|Overall Study||53
11419936|NCT03206476|12618711|FG000|Completed Short-term Evaluation (4 Months)|Overall Study||48
11419937|NCT03206476|12618712|FG001|Completed Short-term Evaluation (4 Months)|Overall Study||40
11419938|NCT03206476|12618711|FG000|COMPLETED|Overall Study||42
11419939|NCT03206476|12618712|FG001|COMPLETED|Overall Study||37
11170352|NCT01645930|12359286|FG000|NOT COMPLETED|Overall Study||43
11170353|NCT01646021|12359292|FG000|STARTED|Overall Study||139
11170354|NCT01646021|12359293|FG001|STARTED|Overall Study||141
11170355|NCT01646021|12359292|FG000|Treated|Overall Study||139
11170356|NCT01646021|12359293|FG001|Treated|Overall Study||139
11170357|NCT01646021|12359292|FG000|COMPLETED|Overall Study||0
11170358|NCT01646021|12359293|FG001|COMPLETED|Overall Study||0
11170359|NCT01646021|12359292|FG000|NOT COMPLETED|Overall Study||139
11170360|NCT01646021|12359293|FG001|NOT COMPLETED|Overall Study||141
11170361|NCT01646073|12359301|FG000|STARTED|Period A (12 Weeks)||87
11170362|NCT01646073|12359302|FG001|STARTED|Period A (12 Weeks)||338
11170363|NCT01646073|12359301|FG000|COMPLETED|Period A (12 Weeks)||85
11170364|NCT01646073|12359302|FG001|COMPLETED|Period A (12 Weeks)||333
11170365|NCT01646073|12359301|FG000|NOT COMPLETED|Period A (12 Weeks)||2
11170366|NCT01646073|12359302|FG001|NOT COMPLETED|Period A (12 Weeks)||5
11170367|NCT01646073|12359301|FG000|STARTED|Period B (12 Weeks)||85
11170368|NCT01646073|12359302|FG001|STARTED|Period B (12 Weeks)||333
11170369|NCT01646073|12359301|FG000|COMPLETED|Period B (12 Weeks)||84
11170370|NCT01646073|12359302|FG001|COMPLETED|Period B (12 Weeks)||320
11170371|NCT01646073|12359301|FG000|NOT COMPLETED|Period B (12 Weeks)||1
11170372|NCT01646073|12359302|FG001|NOT COMPLETED|Period B (12 Weeks)||13
11170373|NCT01646125|12359313|FG000|STARTED|Overall Study||31
11170374|NCT01646125|12359314|FG001|STARTED|Overall Study||28
11170375|NCT01646125|12359313|FG000|COMPLETED|Overall Study||0
11170376|NCT01646125|12359314|FG001|COMPLETED|Overall Study||0
11170377|NCT01646125|12359313|FG000|NOT COMPLETED|Overall Study||31
11170378|NCT01646125|12359314|FG001|NOT COMPLETED|Overall Study||28
11170379|NCT01646138|12359326|FG000|STARTED|Overall Study||5
11170380|NCT01646138|12359327|FG001|STARTED|Overall Study||4
11170381|NCT01646138|12359328|FG002|STARTED|Overall Study||5
11170382|NCT01646138|12359329|FG003|STARTED|Overall Study||19
11170383|NCT01646138|12359330|FG004|STARTED|Overall Study||15
11170384|NCT01646138|12359326|FG000|COMPLETED|Overall Study||5
11170385|NCT01646138|12359327|FG001|COMPLETED|Overall Study||4
11170386|NCT01646138|12359328|FG002|COMPLETED|Overall Study||5
11170387|NCT01646138|12359329|FG003|COMPLETED|Overall Study||19
11170388|NCT01646138|12359330|FG004|COMPLETED|Overall Study||13
11170389|NCT01646138|12359326|FG000|NOT COMPLETED|Overall Study||0
11170390|NCT01646138|12359327|FG001|NOT COMPLETED|Overall Study||0
11170391|NCT01646138|12359328|FG002|NOT COMPLETED|Overall Study||0
11170392|NCT01646138|12359329|FG003|NOT COMPLETED|Overall Study||0
11170393|NCT01646138|12359330|FG004|NOT COMPLETED|Overall Study||2
11170394|NCT01646151|12359342|FG000|STARTED|Overall Study||2580
11170395|NCT01646151|12359342|FG000|COMPLETED|Overall Study||2410
11170396|NCT01646151|12359342|FG000|NOT COMPLETED|Overall Study||170
11170397|NCT01646177|12359350|FG000|STARTED|Blinded Induction Dosing (Week 0-12)||193
11170398|NCT01646177|12359351|FG001|STARTED|Blinded Induction Dosing (Week 0-12)||382
11170399|NCT01646177|12359352|FG002|STARTED|Blinded Induction Dosing (Week 0-12)||386
11170400|NCT01646177|12359353|FG003|STARTED|Blinded Induction Dosing (Week 0-12)||385
11170401|NCT01646177|12359354|FG004|STARTED|Blinded Induction Dosing (Week 0-12)||0
11170402|NCT01646177|12359355|FG005|STARTED|Blinded Induction Dosing (Week 0-12)||0
11170403|NCT01646177|12359356|FG006|STARTED|Blinded Induction Dosing (Week 0-12)||0
11170404|NCT01646177|12359357|FG007|STARTED|Blinded Induction Dosing (Week 0-12)||0
11170405|NCT01646177|12359358|FG008|STARTED|Blinded Induction Dosing (Week 0-12)||0
11170406|NCT01646177|12359359|FG009|STARTED|Blinded Induction Dosing (Week 0-12)||0
11170407|NCT01646177|12359360|FG010|STARTED|Blinded Induction Dosing (Week 0-12)||0
11170408|NCT01646177|12359361|FG011|STARTED|Blinded Induction Dosing (Week 0-12)||0
11170409|NCT01646177|12359350|FG000|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||193
11170410|NCT01646177|12359351|FG001|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
11170411|NCT01646177|12359352|FG002|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
11170412|NCT01646177|12359353|FG003|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||384
11170413|NCT01646177|12359354|FG004|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
11170414|NCT01646177|12359355|FG005|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
11170415|NCT01646177|12359356|FG006|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
11170416|NCT01646177|12359357|FG007|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
11170417|NCT01646177|12359358|FG008|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
11170418|NCT01646177|12359359|FG009|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
11203854|NCT01849497|12394404|FG000|STARTED|Overall Study||75
11170419|NCT01646177|12359360|FG010|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
11170420|NCT01646177|12359361|FG011|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
11170421|NCT01646177|12359350|FG000|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
11170422|NCT01646177|12359351|FG001|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
11170423|NCT01646177|12359352|FG002|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
11170424|NCT01646177|12359353|FG003|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
11419940|NCT03206476|12618711|FG000|NOT COMPLETED|Overall Study||12
11419941|NCT03206476|12618712|FG001|NOT COMPLETED|Overall Study||16
11170425|NCT01646177|12359354|FG004|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170426|NCT01646177|12359355|FG005|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170427|NCT01646177|12359356|FG006|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170428|NCT01646177|12359357|FG007|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170429|NCT01646177|12359358|FG008|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170430|NCT01646177|12359359|FG009|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170431|NCT01646177|12359360|FG010|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170432|NCT01646177|12359361|FG011|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170433|NCT01646177|12359350|FG000|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
11170434|NCT01646177|12359351|FG001|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
11170435|NCT01646177|12359352|FG002|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
11170436|NCT01646177|12359353|FG003|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
11170437|NCT01646177|12359354|FG004|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170438|NCT01646177|12359355|FG005|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170439|NCT01646177|12359356|FG006|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170440|NCT01646177|12359357|FG007|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170441|NCT01646177|12359358|FG008|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170442|NCT01646177|12359359|FG009|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170443|NCT01646177|12359360|FG010|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170444|NCT01646177|12359361|FG011|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
11170445|NCT01646177|12359350|FG000|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
11170446|NCT01646177|12359351|FG001|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
11170447|NCT01646177|12359352|FG002|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
11170448|NCT01646177|12359353|FG003|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
11170449|NCT01646177|12359354|FG004|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|183
11170450|NCT01646177|12359355|FG005|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|369
11170451|NCT01646177|12359356|FG006|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|360
11170452|NCT01646177|12359357|FG007|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|362
11170453|NCT01646177|12359358|FG008|STARTED|Long-Term Extension Period (Week 12-264)||0
11170454|NCT01646177|12359359|FG009|STARTED|Long-Term Extension Period (Week 12-264)||0
11170455|NCT01646177|12359360|FG010|STARTED|Long-Term Extension Period (Week 12-264)||0
11170456|NCT01646177|12359361|FG011|STARTED|Long-Term Extension Period (Week 12-264)||0
11170457|NCT01646177|12359350|FG000|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
11170458|NCT01646177|12359351|FG001|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
11170459|NCT01646177|12359352|FG002|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
11170460|NCT01646177|12359353|FG003|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
11170461|NCT01646177|12359354|FG004|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||183
11170462|NCT01646177|12359355|FG005|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||369
11170463|NCT01646177|12359356|FG006|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||360
11170464|NCT01646177|12359357|FG007|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||362
11170465|NCT01646177|12359358|FG008|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
11170466|NCT01646177|12359359|FG009|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
11170467|NCT01646177|12359360|FG010|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
11170468|NCT01646177|12359361|FG011|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
11170469|NCT01646177|12359350|FG000|COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170470|NCT01646177|12359351|FG001|COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170471|NCT01646177|12359352|FG002|COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170472|NCT01646177|12359353|FG003|COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170473|NCT01646177|12359354|FG004|COMPLETED|Long-Term Extension Period (Week 12-264)||135
11170474|NCT01646177|12359355|FG005|COMPLETED|Long-Term Extension Period (Week 12-264)||256
11170475|NCT01646177|12359356|FG006|COMPLETED|Long-Term Extension Period (Week 12-264)||244
11170476|NCT01646177|12359357|FG007|COMPLETED|Long-Term Extension Period (Week 12-264)||255
11170477|NCT01646177|12359358|FG008|COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170478|NCT01646177|12359359|FG009|COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170479|NCT01646177|12359360|FG010|COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170480|NCT01646177|12359361|FG011|COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170481|NCT01646177|12359350|FG000|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170482|NCT01646177|12359351|FG001|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170483|NCT01646177|12359352|FG002|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170484|NCT01646177|12359353|FG003|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170485|NCT01646177|12359354|FG004|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||48
11170486|NCT01646177|12359355|FG005|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||113
11170487|NCT01646177|12359356|FG006|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||116
11170488|NCT01646177|12359357|FG007|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||107
11170489|NCT01646177|12359358|FG008|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170490|NCT01646177|12359359|FG009|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170491|NCT01646177|12359360|FG010|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170492|NCT01646177|12359361|FG011|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
11170493|NCT01646177|12359350|FG000|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
11170494|NCT01646177|12359351|FG001|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
11170495|NCT01646177|12359352|FG002|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
11170496|NCT01646177|12359353|FG003|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
11170497|NCT01646177|12359354|FG004|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
11170498|NCT01646177|12359355|FG005|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
11170499|NCT01646177|12359356|FG006|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
11170500|NCT01646177|12359357|FG007|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
11170501|NCT01646177|12359358|FG008|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|157
11170502|NCT01646177|12359359|FG009|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|309
11170503|NCT01646177|12359360|FG010|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|305
11170504|NCT01646177|12359361|FG011|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|313
11170505|NCT01646177|12359350|FG000|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
11170506|NCT01646177|12359351|FG001|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
11170507|NCT01646177|12359352|FG002|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
11170508|NCT01646177|12359353|FG003|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
11170509|NCT01646177|12359354|FG004|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
11170510|NCT01646177|12359355|FG005|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
11170511|NCT01646177|12359356|FG006|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
11170512|NCT01646177|12359357|FG007|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
11170513|NCT01646177|12359358|FG008|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||157
11170514|NCT01646177|12359359|FG009|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||309
11170515|NCT01646177|12359360|FG010|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||305
11170516|NCT01646177|12359361|FG011|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||313
11170517|NCT01646177|12359350|FG000|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170518|NCT01646177|12359351|FG001|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170519|NCT01646177|12359352|FG002|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170520|NCT01646177|12359353|FG003|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170521|NCT01646177|12359354|FG004|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170522|NCT01646177|12359355|FG005|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170523|NCT01646177|12359356|FG006|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170524|NCT01646177|12359357|FG007|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170525|NCT01646177|12359358|FG008|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||126
11170526|NCT01646177|12359359|FG009|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||233
11170527|NCT01646177|12359360|FG010|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||225
11170528|NCT01646177|12359361|FG011|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||230
11170529|NCT01646177|12359350|FG000|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170530|NCT01646177|12359351|FG001|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170531|NCT01646177|12359352|FG002|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170532|NCT01646177|12359353|FG003|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170533|NCT01646177|12359354|FG004|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170534|NCT01646177|12359355|FG005|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11203855|NCT01849497|12394405|FG001|STARTED|Overall Study||74
11419942|NCT03057106|12618720|FG000|STARTED|Overall Study|1 patient refused the treatment|149
11419943|NCT03057106|12618721|FG001|STARTED|Overall Study|3 patients refused the treatment|148
11419944|NCT03057106|12618720|FG000|COMPLETED|Overall Study||149
11419945|NCT03057106|12618721|FG001|COMPLETED|Overall Study||148
11419946|NCT03057106|12618720|FG000|NOT COMPLETED|Overall Study||0
11419947|NCT03057106|12618721|FG001|NOT COMPLETED|Overall Study||0
11170535|NCT01646177|12359356|FG006|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170536|NCT01646177|12359357|FG007|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
11170537|NCT01646177|12359358|FG008|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||31
11170538|NCT01646177|12359359|FG009|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||76
11419948|NCT03022461|12618727|FG000|STARTED|Overall Study||25
11419949|NCT03022461|12618727|FG000|COMPLETED|Overall Study||22
11419950|NCT03022461|12618727|FG000|NOT COMPLETED|Overall Study||3
11170539|NCT01646177|12359360|FG010|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||80
11170540|NCT01646177|12359361|FG011|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||83
11170541|NCT01646203|12359384|FG000|STARTED|Overall Study||2
11170542|NCT01646203|12359385|FG001|STARTED|Overall Study||5
11170543|NCT01646203|12359386|FG002|STARTED|Overall Study||7
11170544|NCT01646203|12359384|FG000|Received at Least One Dose of Study Drug|Overall Study||2
11170545|NCT01646203|12359385|FG001|Received at Least One Dose of Study Drug|Overall Study||5
11170546|NCT01646203|12359386|FG002|Received at Least One Dose of Study Drug|Overall Study||7
11170547|NCT01646203|12359384|FG000|COMPLETED|Overall Study||0
11170548|NCT01646203|12359385|FG001|COMPLETED|Overall Study||3
11170549|NCT01646203|12359386|FG002|COMPLETED|Overall Study||6
11170550|NCT01646203|12359384|FG000|NOT COMPLETED|Overall Study||2
11170551|NCT01646203|12359385|FG001|NOT COMPLETED|Overall Study||2
11170552|NCT01646203|12359386|FG002|NOT COMPLETED|Overall Study||1
11170553|NCT01646216|12359401|FG000|STARTED|Overall Study||17
11170554|NCT01646216|12359402|FG001|STARTED|Overall Study||17
11170555|NCT01646216|12359401|FG000|COMPLETED|Overall Study||6
11170556|NCT01646216|12359402|FG001|COMPLETED|Overall Study||4
11170557|NCT01646216|12359401|FG000|NOT COMPLETED|Overall Study||11
11170558|NCT01646216|12359402|FG001|NOT COMPLETED|Overall Study||13
11170559|NCT01646255|12359414|FG000|STARTED|Overall Study||172
11170560|NCT01646255|12359415|FG001|STARTED|Overall Study||174
11170561|NCT01646255|12359414|FG000|COMPLETED|Overall Study||151
11170562|NCT01646255|12359415|FG001|COMPLETED|Overall Study||160
11170563|NCT01646255|12359414|FG000|NOT COMPLETED|Overall Study||21
11170564|NCT01646255|12359415|FG001|NOT COMPLETED|Overall Study||14
11170565|NCT01646268|12359424|FG000|STARTED|Overall Study||124
11170566|NCT01646268|12359425|FG001|STARTED|Overall Study||123
11170567|NCT01646268|12359424|FG000|COMPLETED|Overall Study||113
11170568|NCT01646268|12359425|FG001|COMPLETED|Overall Study||107
11170569|NCT01646268|12359424|FG000|NOT COMPLETED|Overall Study||11
11170570|NCT01646268|12359425|FG001|NOT COMPLETED|Overall Study||16
11170571|NCT01646320|12359433|FG000|STARTED|Short-term Period (Day 1 to Week 24)||160
11170572|NCT01646320|12359434|FG001|STARTED|Short-term Period (Day 1 to Week 24)||160
11170573|NCT01646320|12359433|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)||148
11170574|NCT01646320|12359434|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)||153
11170575|NCT01646320|12359433|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
11170576|NCT01646320|12359434|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
11170577|NCT01646320|12359433|FG000|STARTED|Long-term Period (Weeks 24 to 52)||147
11170578|NCT01646320|12359434|FG001|STARTED|Long-term Period (Weeks 24 to 52)||147
11170579|NCT01646320|12359433|FG000|COMPLETED|Long-term Period (Weeks 24 to 52)||141
11170580|NCT01646320|12359434|FG001|COMPLETED|Long-term Period (Weeks 24 to 52)||140
11170581|NCT01646320|12359433|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
11170582|NCT01646320|12359434|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
11170583|NCT01646346|12359440|FG000|STARTED|Overall Study||46
11170584|NCT01646346|12359440|FG000|COMPLETED|Overall Study||46
11170585|NCT01646346|12359440|FG000|NOT COMPLETED|Overall Study||0
11170586|NCT01646385|12359446|FG000|STARTED|Overall Study||3529
11170587|NCT01646385|12359447|FG001|STARTED|Overall Study||2864
11170588|NCT01646385|12359446|FG000|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
11170589|NCT01646385|12359447|FG001|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
11170590|NCT01646385|12359446|FG000|NOT COMPLETED|Overall Study||838
11170591|NCT01646385|12359447|FG001|NOT COMPLETED|Overall Study||871
11170592|NCT01646398|12359455|FG000|STARTED|Overall Study||382
11170593|NCT01646398|12359456|FG001|STARTED|Overall Study||382
11170594|NCT01646398|12359455|FG000|COMPLETED|Overall Study||381
11170595|NCT01646398|12359456|FG001|COMPLETED|Overall Study||382
11170596|NCT01646398|12359455|FG000|NOT COMPLETED|Overall Study||1
11170597|NCT01646398|12359456|FG001|NOT COMPLETED|Overall Study||0
11170598|NCT01646645|12359462|FG000|STARTED|Overall Study||58
11170599|NCT01646645|12359462|FG000|COMPLETED|Overall Study||28
11170600|NCT01646645|12359462|FG000|NOT COMPLETED|Overall Study||30
11170601|NCT01646671|12359469|FG000|STARTED|Overall Study||3
11170602|NCT01646671|12359470|FG001|STARTED|Overall Study||11
11170603|NCT01646671|12359471|FG002|STARTED|Overall Study||21
11170604|NCT01646671|12359469|FG000|COMPLETED|Overall Study||3
11170605|NCT01646671|12359470|FG001|COMPLETED|Overall Study||11
11170606|NCT01646671|12359471|FG002|COMPLETED|Overall Study||21
11170607|NCT01646671|12359469|FG000|NOT COMPLETED|Overall Study||0
11170608|NCT01646671|12359470|FG001|NOT COMPLETED|Overall Study||0
11170609|NCT01646671|12359471|FG002|NOT COMPLETED|Overall Study||0
11170610|NCT01646762|12359481|FG000|STARTED|Overall Study||13
11170611|NCT01646762|12359481|FG000|COMPLETED|Overall Study||13
11170612|NCT01646762|12359481|FG000|NOT COMPLETED|Overall Study||0
11203856|NCT01849497|12394404|FG000|Received Treatment|Overall Study||75
11203857|NCT01849497|12394405|FG001|Received Treatment|Overall Study||74
11203858|NCT01849497|12394404|FG000|COMPLETED|Overall Study||74
11203859|NCT01849497|12394405|FG001|COMPLETED|Overall Study||70
11203860|NCT01849497|12394404|FG000|NOT COMPLETED|Overall Study||1
11170613|NCT01646827|12359487|FG000|STARTED|Overall Study||18
11170614|NCT01646827|12359488|FG001|STARTED|Overall Study||19
11170615|NCT01646827|12359487|FG000|COMPLETED|Overall Study||16
11170616|NCT01646827|12359488|FG001|COMPLETED|Overall Study||14
11170617|NCT01646827|12359487|FG000|NOT COMPLETED|Overall Study||2
11170618|NCT01646827|12359488|FG001|NOT COMPLETED|Overall Study||5
11170619|NCT01647217|12359496|FG000|STARTED|Overall Study||8
11170620|NCT01647217|12359497|FG001|STARTED|Overall Study||9
11170621|NCT01647217|12359496|FG000|COMPLETED|Overall Study||7
11170622|NCT01647217|12359497|FG001|COMPLETED|Overall Study||8
11170623|NCT01647217|12359496|FG000|NOT COMPLETED|Overall Study||1
11170624|NCT01647217|12359497|FG001|NOT COMPLETED|Overall Study||1
11170625|NCT01647282|12359507|FG000|STARTED|Overall Study||30
11170626|NCT01647282|12359508|FG001|STARTED|Overall Study||30
11170627|NCT01647282|12359507|FG000|COMPLETED|Overall Study||23
11170628|NCT01647282|12359508|FG001|COMPLETED|Overall Study||25
11170629|NCT01647282|12359507|FG000|NOT COMPLETED|Overall Study||7
11170630|NCT01647282|12359508|FG001|NOT COMPLETED|Overall Study||5
11170631|NCT01647438|12359516|FG000|STARTED|Overall Study||32
11170632|NCT01647438|12359517|FG001|STARTED|Overall Study||31
11419951|NCT02892955|12618732|FG000|STARTED|Overall Study||1685
11419952|NCT02892955|12618732|FG000|COMPLETED|Overall Study||1685
11419953|NCT02892955|12618732|FG000|NOT COMPLETED|Overall Study||0
11419954|NCT02689349|12618738|FG000|STARTED|Overall Study||59
11419955|NCT02689349|12618739|FG001|STARTED|Overall Study||58
11419956|NCT02689349|12618738|FG000|COMPLETED|Overall Study||46
11419957|NCT02689349|12618739|FG001|COMPLETED|Overall Study||58
11419958|NCT02689349|12618738|FG000|NOT COMPLETED|Overall Study||13
11419959|NCT02689349|12618739|FG001|NOT COMPLETED|Overall Study||0
11419960|NCT02680574|12618750|FG000|STARTED|Overall Study||862
11419961|NCT02680574|12618751|FG001|STARTED|Overall Study||863
11419962|NCT02680574|12618750|FG000|COMPLETED|Overall Study||704
11419963|NCT02680574|12618751|FG001|COMPLETED|Overall Study||711
11419964|NCT02680574|12618750|FG000|NOT COMPLETED|Overall Study||158
11419965|NCT02680574|12618751|FG001|NOT COMPLETED|Overall Study||152
11170633|NCT01647438|12359516|FG000|COMPLETED|Overall Study||32
11170634|NCT01647438|12359517|FG001|COMPLETED|Overall Study||31
11170635|NCT01647438|12359516|FG000|NOT COMPLETED|Overall Study||0
11170636|NCT01647438|12359517|FG001|NOT COMPLETED|Overall Study||0
11170637|NCT01647464|12359523|FG000|STARTED|Overall Study||10
11170638|NCT01647464|12359523|FG000|COMPLETED|Overall Study||10
11170639|NCT01647464|12359523|FG000|NOT COMPLETED|Overall Study||0
11170640|NCT01647516|12359530|FG000|STARTED|Induction Period (IP)||66
11170641|NCT01647516|12359531|FG001|STARTED|Induction Period (IP)||66
11170642|NCT01647516|12359532|FG002|STARTED|Induction Period (IP)||67
11170643|NCT01647516|12359533|FG003|STARTED|Induction Period (IP)||0
11170644|NCT01647516|12359534|FG004|STARTED|Induction Period (IP)||0
11170645|NCT01647516|12359535|FG005|STARTED|Induction Period (IP)||0
11170646|NCT01647516|12359530|FG000|Received Study Drug|Induction Period (IP)||65
11170647|NCT01647516|12359531|FG001|Received Study Drug|Induction Period (IP)||65
11170648|NCT01647516|12359532|FG002|Received Study Drug|Induction Period (IP)||67
11170649|NCT01647516|12359533|FG003|Received Study Drug|Induction Period (IP)||0
11170650|NCT01647516|12359534|FG004|Received Study Drug|Induction Period (IP)||0
11170651|NCT01647516|12359535|FG005|Received Study Drug|Induction Period (IP)||0
11170652|NCT01647516|12359530|FG000|COMPLETED|Induction Period (IP)||60
11170653|NCT01647516|12359531|FG001|COMPLETED|Induction Period (IP)||63
11170654|NCT01647516|12359532|FG002|COMPLETED|Induction Period (IP)||63
11170655|NCT01647516|12359533|FG003|COMPLETED|Induction Period (IP)||0
11170656|NCT01647516|12359534|FG004|COMPLETED|Induction Period (IP)||0
11170657|NCT01647516|12359535|FG005|COMPLETED|Induction Period (IP)||0
11170658|NCT01647516|12359530|FG000|NOT COMPLETED|Induction Period (IP)||6
11170659|NCT01647516|12359531|FG001|NOT COMPLETED|Induction Period (IP)||3
11170660|NCT01647516|12359532|FG002|NOT COMPLETED|Induction Period (IP)||4
11170661|NCT01647516|12359533|FG003|NOT COMPLETED|Induction Period (IP)||0
11170662|NCT01647516|12359534|FG004|NOT COMPLETED|Induction Period (IP)||0
11170663|NCT01647516|12359535|FG005|NOT COMPLETED|Induction Period (IP)||0
11170664|NCT01647516|12359530|FG000|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|25
11170665|NCT01647516|12359531|FG001|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|36
11170666|NCT01647516|12359532|FG002|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|42
11170667|NCT01647516|12359533|FG003|STARTED|Maintenance Period (MP)||0
11170668|NCT01647516|12359534|FG004|STARTED|Maintenance Period (MP)||0
11170669|NCT01647516|12359535|FG005|STARTED|Maintenance Period (MP)||0
11170670|NCT01647516|12359530|FG000|COMPLETED|Maintenance Period (MP)||21
11170671|NCT01647516|12359531|FG001|COMPLETED|Maintenance Period (MP)||30
11170672|NCT01647516|12359532|FG002|COMPLETED|Maintenance Period (MP)||40
11170673|NCT01647516|12359533|FG003|COMPLETED|Maintenance Period (MP)||0
11170674|NCT01647516|12359534|FG004|COMPLETED|Maintenance Period (MP)||0
11170675|NCT01647516|12359535|FG005|COMPLETED|Maintenance Period (MP)||0
11170676|NCT01647516|12359530|FG000|NOT COMPLETED|Maintenance Period (MP)||4
11170677|NCT01647516|12359531|FG001|NOT COMPLETED|Maintenance Period (MP)||6
11170678|NCT01647516|12359532|FG002|NOT COMPLETED|Maintenance Period (MP)||2
11170679|NCT01647516|12359533|FG003|NOT COMPLETED|Maintenance Period (MP)||0
11170680|NCT01647516|12359534|FG004|NOT COMPLETED|Maintenance Period (MP)||0
11419966|NCT02648347|12618759|FG000|STARTED|Overall Study||879
11419967|NCT02648347|12618760|FG001|STARTED|Overall Study||872
11419968|NCT02648347|12618759|FG000|COMPLETED|Overall Study||670
11419969|NCT02648347|12618760|FG001|COMPLETED|Overall Study||675
11419970|NCT02648347|12618759|FG000|NOT COMPLETED|Overall Study||209
11419971|NCT02648347|12618760|FG001|NOT COMPLETED|Overall Study||197
11170681|NCT01647516|12359535|FG005|NOT COMPLETED|Maintenance Period (MP)||0
11170682|NCT01647516|12359530|FG000|STARTED|Open-Label Period||0
11170683|NCT01647516|12359531|FG001|STARTED|Open-Label Period||0
11170684|NCT01647516|12359532|FG002|STARTED|Open-Label Period||0
11170685|NCT01647516|12359533|FG003|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|55
11170686|NCT01647516|12359534|FG004|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|56
11170687|NCT01647516|12359535|FG005|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|59
11170688|NCT01647516|12359530|FG000|COMPLETED|Open-Label Period||0
11170689|NCT01647516|12359531|FG001|COMPLETED|Open-Label Period||0
11170690|NCT01647516|12359532|FG002|COMPLETED|Open-Label Period||0
11170691|NCT01647516|12359533|FG003|COMPLETED|Open-Label Period||6
11170692|NCT01647516|12359534|FG004|COMPLETED|Open-Label Period||5
11170693|NCT01647516|12359535|FG005|COMPLETED|Open-Label Period||3
11170694|NCT01647516|12359530|FG000|NOT COMPLETED|Open-Label Period||0
11170695|NCT01647516|12359531|FG001|NOT COMPLETED|Open-Label Period||0
11170696|NCT01647516|12359532|FG002|NOT COMPLETED|Open-Label Period||0
11170697|NCT01647516|12359533|FG003|NOT COMPLETED|Open-Label Period||49
11170698|NCT01647516|12359534|FG004|NOT COMPLETED|Open-Label Period||51
11170699|NCT01647516|12359535|FG005|NOT COMPLETED|Open-Label Period||56
11170700|NCT01647542|12359553|FG000|STARTED|Overall Study||131
11170701|NCT01647542|12359554|FG001|STARTED|Overall Study||131
11170702|NCT01647542|12359555|FG002|STARTED|Overall Study||131
11170703|NCT01647542|12359553|FG000|COMPLETED|Overall Study||55
11170704|NCT01647542|12359554|FG001|COMPLETED|Overall Study||58
11170705|NCT01647542|12359555|FG002|COMPLETED|Overall Study||59
11170706|NCT01647542|12359553|FG000|NOT COMPLETED|Overall Study||76
11170707|NCT01647542|12359554|FG001|NOT COMPLETED|Overall Study||73
11170708|NCT01647542|12359555|FG002|NOT COMPLETED|Overall Study||72
11170709|NCT01647581|12359565|FG000|STARTED|Overall Study||547
11170710|NCT01647581|12359566|FG001|STARTED|Overall Study||551
11170711|NCT01647581|12359565|FG000|COMPLETED|Overall Study||530
11170712|NCT01647581|12359566|FG001|COMPLETED|Overall Study||520
11170713|NCT01647581|12359565|FG000|NOT COMPLETED|Overall Study||17
11170714|NCT01647581|12359566|FG001|NOT COMPLETED|Overall Study||31
11170715|NCT01647711|12359577|FG000|STARTED|Overall Study||6
11170716|NCT01647711|12359578|FG001|STARTED|Overall Study||3
11170717|NCT01647711|12359579|FG002|STARTED|Overall Study||9
11170718|NCT01647711|12359580|FG003|STARTED|Overall Study||11
11170719|NCT01647711|12359581|FG004|STARTED|Overall Study||6
11170720|NCT01647711|12359577|FG000|COMPLETED|Overall Study||0
11170721|NCT01647711|12359578|FG001|COMPLETED|Overall Study||0
11170722|NCT01647711|12359579|FG002|COMPLETED|Overall Study||0
11170723|NCT01647711|12359580|FG003|COMPLETED|Overall Study||0
11170724|NCT01647711|12359581|FG004|COMPLETED|Overall Study||0
11170725|NCT01647711|12359577|FG000|NOT COMPLETED|Overall Study||6
11170726|NCT01647711|12359578|FG001|NOT COMPLETED|Overall Study||3
11170727|NCT01647711|12359579|FG002|NOT COMPLETED|Overall Study||9
11170728|NCT01647711|12359580|FG003|NOT COMPLETED|Overall Study||11
11170729|NCT01647711|12359581|FG004|NOT COMPLETED|Overall Study||6
11170730|NCT01647737|12359597|FG000|STARTED|Overall Study||30
11170731|NCT01647737|12359598|FG001|STARTED|Overall Study||30
11170732|NCT01647737|12359597|FG000|COMPLETED|Overall Study||26
11170733|NCT01647737|12359598|FG001|COMPLETED|Overall Study||25
11170734|NCT01647737|12359597|FG000|NOT COMPLETED|Overall Study||4
11170735|NCT01647737|12359598|FG001|NOT COMPLETED|Overall Study||5
11170736|NCT01647945|12359608|FG000|STARTED|Overall Study||6
11170737|NCT01647945|12359609|FG001|STARTED|Overall Study||6
11170738|NCT01647945|12359610|FG002|STARTED|Overall Study||5
11170739|NCT01647945|12359611|FG003|STARTED|Overall Study||6
11170740|NCT01647945|12359608|FG000|COMPLETED|Overall Study||6
11170741|NCT01647945|12359609|FG001|COMPLETED|Overall Study||6
11170742|NCT01647945|12359610|FG002|COMPLETED|Overall Study||3
11170743|NCT01647945|12359611|FG003|COMPLETED|Overall Study||5
11170744|NCT01647945|12359608|FG000|NOT COMPLETED|Overall Study||0
11170745|NCT01647945|12359609|FG001|NOT COMPLETED|Overall Study||0
11170746|NCT01647945|12359610|FG002|NOT COMPLETED|Overall Study||2
11170747|NCT01647945|12359611|FG003|NOT COMPLETED|Overall Study||1
11170748|NCT01647958|12359623|FG000|STARTED|Initial Study||41
11170749|NCT01647958|12359624|FG001|STARTED|Initial Study||24
11170750|NCT01647958|12359623|FG000|COMPLETED|Initial Study||39
11170751|NCT01647958|12359624|FG001|COMPLETED|Initial Study||21
11170752|NCT01647958|12359623|FG000|NOT COMPLETED|Initial Study||2
11170753|NCT01647958|12359624|FG001|NOT COMPLETED|Initial Study||3
11170754|NCT01647958|12359623|FG000|STARTED|Continuation Phase||39
11170755|NCT01647958|12359624|FG001|STARTED|Continuation Phase||21
11170756|NCT01647958|12359623|FG000|COMPLETED|Continuation Phase|Treatment-arm patients received TIF procedure during Initial Study phase|0
11170757|NCT01647958|12359624|FG001|COMPLETED|Continuation Phase|21 Control patients received TIF crossover procedure following 6-month follow-up visit.|21
11170758|NCT01647958|12359623|FG000|NOT COMPLETED|Continuation Phase||39
11170759|NCT01647958|12359624|FG001|NOT COMPLETED|Continuation Phase||0
11170760|NCT01647958|12359623|FG000|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients were combined into 1 cohort for this follow up. 39+21=60|60
11170761|NCT01647958|12359624|FG001|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients combined into 1 cohort for this period=60, 0 under Control|0
11203861|NCT01849497|12394405|FG001|NOT COMPLETED|Overall Study||4
11170762|NCT01647958|12359623|FG000|COMPLETED|Extended Follow-up Phase|The 8 lost to follow up patients are of the combined Treatment and Control cohort of 52 patients|52
11170763|NCT01647958|12359624|FG001|COMPLETED|Extended Follow-up Phase||0
11170764|NCT01647958|12359623|FG000|NOT COMPLETED|Extended Follow-up Phase||8
11170765|NCT01647958|12359624|FG001|NOT COMPLETED|Extended Follow-up Phase||0
11170766|NCT01648101|12359642|FG000|STARTED|Titration Phase (4 Weeks)||25
11170767|NCT01648101|12359643|FG001|STARTED|Titration Phase (4 Weeks)||26
11170768|NCT01648101|12359644|FG002|STARTED|Titration Phase (4 Weeks)||24
11170769|NCT01648101|12359642|FG000|COMPLETED|Titration Phase (4 Weeks)||23
11170770|NCT01648101|12359643|FG001|COMPLETED|Titration Phase (4 Weeks)||23
11170771|NCT01648101|12359644|FG002|COMPLETED|Titration Phase (4 Weeks)||18
11170772|NCT01648101|12359642|FG000|NOT COMPLETED|Titration Phase (4 Weeks)||2
11170773|NCT01648101|12359643|FG001|NOT COMPLETED|Titration Phase (4 Weeks)||3
11170774|NCT01648101|12359644|FG002|NOT COMPLETED|Titration Phase (4 Weeks)||6
11170775|NCT01648101|12359642|FG000|STARTED|Maintenance Phase (12 Weeks)||23
11170776|NCT01648101|12359643|FG001|STARTED|Maintenance Phase (12 Weeks)||23
11170777|NCT01648101|12359644|FG002|STARTED|Maintenance Phase (12 Weeks)||18
11170778|NCT01648101|12359642|FG000|COMPLETED|Maintenance Phase (12 Weeks)||20
11170779|NCT01648101|12359643|FG001|COMPLETED|Maintenance Phase (12 Weeks)||20
11170780|NCT01648101|12359644|FG002|COMPLETED|Maintenance Phase (12 Weeks)||12
11170781|NCT01648101|12359642|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
11170782|NCT01648101|12359643|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
11170783|NCT01648101|12359644|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
11170784|NCT01648101|12359642|FG000|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
11170785|NCT01648101|12359643|FG001|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
11170786|NCT01648101|12359644|FG002|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
11170787|NCT01648101|12359642|FG000|COMPLETED|Transition Phase (4 Weeks)||12
11170788|NCT01648101|12359643|FG001|COMPLETED|Transition Phase (4 Weeks)||13
11170789|NCT01648101|12359644|FG002|COMPLETED|Transition Phase (4 Weeks)||5
11170790|NCT01648101|12359642|FG000|NOT COMPLETED|Transition Phase (4 Weeks)||5
11170791|NCT01648101|12359643|FG001|NOT COMPLETED|Transition Phase (4 Weeks)||5
11170792|NCT01648101|12359644|FG002|NOT COMPLETED|Transition Phase (4 Weeks)||4
11170793|NCT01648101|12359642|FG000|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
11170794|NCT01648101|12359643|FG001|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
11170795|NCT01648101|12359644|FG002|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
11170796|NCT01648101|12359642|FG000|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
11170797|NCT01648101|12359643|FG001|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
11170798|NCT01648101|12359644|FG002|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
11170799|NCT01648101|12359642|FG000|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
11170800|NCT01648101|12359643|FG001|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
11170801|NCT01648101|12359644|FG002|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
11170802|NCT01648140|12359660|FG000|STARTED|Overall Study||41
11170803|NCT01648140|12359661|FG001|STARTED|Overall Study||40
11170804|NCT01648140|12359662|FG002|STARTED|Overall Study||17
11170805|NCT01648140|12359663|FG003|STARTED|Overall Study||13
11170806|NCT01648140|12359660|FG000|COMPLETED|Overall Study||29
11170807|NCT01648140|12359661|FG001|COMPLETED|Overall Study||28
11170808|NCT01648140|12359662|FG002|COMPLETED|Overall Study||9
11170809|NCT01648140|12359663|FG003|COMPLETED|Overall Study||11
11170810|NCT01648140|12359660|FG000|NOT COMPLETED|Overall Study||12
11170811|NCT01648140|12359661|FG001|NOT COMPLETED|Overall Study||12
11170812|NCT01648140|12359662|FG002|NOT COMPLETED|Overall Study||8
11170813|NCT01648140|12359663|FG003|NOT COMPLETED|Overall Study||2
11170814|NCT01648166|12359684|FG000|STARTED|Overall Study||153
11170815|NCT01648166|12359685|FG001|STARTED|Overall Study||367
11170816|NCT01648166|12359684|FG000|COMPLETED|Overall Study||100
11170817|NCT01648166|12359685|FG001|COMPLETED|Overall Study||267
11170818|NCT01648166|12359684|FG000|NOT COMPLETED|Overall Study||53
11170819|NCT01648166|12359685|FG001|NOT COMPLETED|Overall Study||100
11170820|NCT01648283|12359691|FG000|STARTED|Overall Study||78
11170821|NCT01648283|12359691|FG000|COMPLETED|Overall Study||64
11170822|NCT01648283|12359691|FG000|NOT COMPLETED|Overall Study||14
11170823|NCT01648322|12359701|FG000|STARTED|Overall Study||35
11170824|NCT01648322|12359702|FG001|STARTED|Overall Study||67
11170825|NCT01648322|12359703|FG002|STARTED|Overall Study||65
11170826|NCT01648322|12359704|FG003|STARTED|Overall Study||65
11170827|NCT01648322|12359701|FG000|COMPLETED|Overall Study||33
11170828|NCT01648322|12359702|FG001|COMPLETED|Overall Study||62
11170829|NCT01648322|12359703|FG002|COMPLETED|Overall Study||60
11170830|NCT01648322|12359704|FG003|COMPLETED|Overall Study||61
11170831|NCT01648322|12359701|FG000|NOT COMPLETED|Overall Study||2
11170832|NCT01648322|12359702|FG001|NOT COMPLETED|Overall Study||5
11170833|NCT01648322|12359703|FG002|NOT COMPLETED|Overall Study||5
11170834|NCT01648322|12359704|FG003|NOT COMPLETED|Overall Study||4
11170835|NCT01648348|12359733|FG000|STARTED|Overall Study||5
11170836|NCT01648348|12359734|FG001|STARTED|Overall Study||3
11170837|NCT01648348|12359735|FG002|STARTED|Overall Study||4
11170838|NCT01648348|12359736|FG003|STARTED|Overall Study||3
11170839|NCT01648348|12359737|FG004|STARTED|Overall Study||52
11170840|NCT01648348|12359738|FG005|STARTED|Overall Study||49
11170841|NCT01648348|12359733|FG000|COMPLETED|Overall Study||3
11170842|NCT01648348|12359734|FG001|COMPLETED|Overall Study||3
11170843|NCT01648348|12359735|FG002|COMPLETED|Overall Study||3
11170844|NCT01648348|12359736|FG003|COMPLETED|Overall Study||3
11170845|NCT01648348|12359737|FG004|COMPLETED|Overall Study||49
11170846|NCT01648348|12359738|FG005|COMPLETED|Overall Study||43
11170847|NCT01648348|12359733|FG000|NOT COMPLETED|Overall Study||2
11170848|NCT01648348|12359734|FG001|NOT COMPLETED|Overall Study||0
11170849|NCT01648348|12359735|FG002|NOT COMPLETED|Overall Study||1
11170850|NCT01648348|12359736|FG003|NOT COMPLETED|Overall Study||0
11170851|NCT01648348|12359737|FG004|NOT COMPLETED|Overall Study||3
11170852|NCT01648348|12359738|FG005|NOT COMPLETED|Overall Study||6
11170853|NCT01648452|12359751|FG000|STARTED|Overall Study||5
11170854|NCT01648452|12359751|FG000|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
11170855|NCT01648452|12359751|FG000|NOT COMPLETED|Overall Study||0
11170856|NCT01648491|12359757|FG000|STARTED|Overall Study||1
11170857|NCT01648491|12359757|FG000|COMPLETED|Overall Study||1
11170858|NCT01648491|12359757|FG000|NOT COMPLETED|Overall Study||0
11170859|NCT01648530|12359762|FG000|STARTED|Overall Study||16789
11170860|NCT01648530|12359762|FG000|COMPLETED|Overall Study||5915
11170861|NCT01648530|12359762|FG000|NOT COMPLETED|Overall Study||10874
11170862|NCT01648582|12359771|FG000|STARTED|Overall Study||258
11170863|NCT01648582|12359772|FG001|STARTED|Overall Study||257
11170864|NCT01648582|12359773|FG002|STARTED|Overall Study||259
11170865|NCT01648582|12359771|FG000|Received at Least One Dose of Study Drug|Overall Study||258
11170866|NCT01648582|12359772|FG001|Received at Least One Dose of Study Drug|Overall Study||257
11170867|NCT01648582|12359773|FG002|Received at Least One Dose of Study Drug|Overall Study||259
11170868|NCT01648582|12359771|FG000|Modified Intent-to-Treat Population|Overall Study||253
11170869|NCT01648582|12359772|FG001|Modified Intent-to-Treat Population|Overall Study||252
11170870|NCT01648582|12359773|FG002|Modified Intent-to-Treat Population|Overall Study||250
11170871|NCT01648582|12359771|FG000|COMPLETED|Overall Study||226
11170872|NCT01648582|12359772|FG001|COMPLETED|Overall Study||219
11170873|NCT01648582|12359773|FG002|COMPLETED|Overall Study||227
11170874|NCT01648582|12359771|FG000|NOT COMPLETED|Overall Study||32
11170875|NCT01648582|12359772|FG001|NOT COMPLETED|Overall Study||38
11170876|NCT01648582|12359773|FG002|NOT COMPLETED|Overall Study||32
11170877|NCT01648699|12359784|FG000|STARTED|Overall Study||20
11170878|NCT01648699|12359784|FG000|COMPLETED|Overall Study||15
11170879|NCT01648699|12359784|FG000|NOT COMPLETED|Overall Study||5
11170880|NCT01648764|12359811|FG000|STARTED|Overall Study||3
11170881|NCT01648764|12359812|FG001|STARTED|Overall Study||3
11170882|NCT01648764|12359813|FG002|STARTED|Overall Study||3
11170883|NCT01648764|12359814|FG003|STARTED|Overall Study||3
11170884|NCT01648764|12359815|FG004|STARTED|Overall Study||3
11170885|NCT01648764|12359816|FG005|STARTED|Overall Study||5
11170886|NCT01648764|12359817|FG006|STARTED|Overall Study||9
11170887|NCT01648764|12359818|FG007|STARTED|Overall Study||3
11170888|NCT01648764|12359819|FG008|STARTED|Overall Study||3
11170889|NCT01648764|12359820|FG009|STARTED|Overall Study||7
11170890|NCT01648764|12359821|FG010|STARTED|Overall Study||3
11170891|NCT01648764|12359822|FG011|STARTED|Overall Study||9
11170892|NCT01648764|12359823|FG012|STARTED|Overall Study||7
11170893|NCT01648764|12359824|FG013|STARTED|Overall Study||12
11170894|NCT01648764|12359811|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11170895|NCT01648764|12359812|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
11170896|NCT01648764|12359813|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
11170897|NCT01648764|12359814|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
11170898|NCT01648764|12359815|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
11170899|NCT01648764|12359816|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
11170900|NCT01648764|12359817|FG006|Received at Least 1 Dose of Study Drug|Overall Study||9
11170901|NCT01648764|12359818|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
11170902|NCT01648764|12359819|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
11170903|NCT01648764|12359820|FG009|Received at Least 1 Dose of Study Drug|Overall Study||7
11170904|NCT01648764|12359821|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
11170905|NCT01648764|12359822|FG011|Received at Least 1 Dose of Study Drug|Overall Study||9
11170906|NCT01648764|12359823|FG012|Received at Least 1 Dose of Study Drug|Overall Study||7
11170907|NCT01648764|12359824|FG013|Received at Least 1 Dose of Study Drug|Overall Study||12
11170908|NCT01648764|12359811|FG000|COMPLETED|Overall Study||3
11170909|NCT01648764|12359812|FG001|COMPLETED|Overall Study||2
11170910|NCT01648764|12359813|FG002|COMPLETED|Overall Study||3
11170911|NCT01648764|12359814|FG003|COMPLETED|Overall Study||3
11170912|NCT01648764|12359815|FG004|COMPLETED|Overall Study||3
11170913|NCT01648764|12359816|FG005|COMPLETED|Overall Study||3
11170914|NCT01648764|12359817|FG006|COMPLETED|Overall Study||4
11170915|NCT01648764|12359818|FG007|COMPLETED|Overall Study||3
11170916|NCT01648764|12359819|FG008|COMPLETED|Overall Study||3
11170917|NCT01648764|12359820|FG009|COMPLETED|Overall Study||4
11170918|NCT01648764|12359821|FG010|COMPLETED|Overall Study||3
11170919|NCT01648764|12359822|FG011|COMPLETED|Overall Study||4
11170920|NCT01648764|12359823|FG012|COMPLETED|Overall Study||3
11170921|NCT01648764|12359824|FG013|COMPLETED|Overall Study||9
11170922|NCT01648764|12359811|FG000|NOT COMPLETED|Overall Study||0
11170923|NCT01648764|12359812|FG001|NOT COMPLETED|Overall Study||1
11170924|NCT01648764|12359813|FG002|NOT COMPLETED|Overall Study||0
11170925|NCT01648764|12359814|FG003|NOT COMPLETED|Overall Study||0
11170926|NCT01648764|12359815|FG004|NOT COMPLETED|Overall Study||0
11170927|NCT01648764|12359816|FG005|NOT COMPLETED|Overall Study||2
11170928|NCT01648764|12359817|FG006|NOT COMPLETED|Overall Study||5
11170929|NCT01648764|12359818|FG007|NOT COMPLETED|Overall Study||0
11170930|NCT01648764|12359819|FG008|NOT COMPLETED|Overall Study||0
11170931|NCT01648764|12359820|FG009|NOT COMPLETED|Overall Study||3
11170932|NCT01648764|12359821|FG010|NOT COMPLETED|Overall Study||0
11170933|NCT01648764|12359822|FG011|NOT COMPLETED|Overall Study||5
11170934|NCT01648764|12359823|FG012|NOT COMPLETED|Overall Study||4
11170935|NCT01648764|12359824|FG013|NOT COMPLETED|Overall Study||3
11170936|NCT01648790|12359858|FG000|STARTED|Treatment 1||4
11170937|NCT01648790|12359859|FG001|STARTED|Treatment 1||4
11170938|NCT01648790|12359860|FG002|STARTED|Treatment 1||4
11170939|NCT01648790|12359861|FG003|STARTED|Treatment 1||4
11170940|NCT01648790|12359862|FG004|STARTED|Treatment 1||4
11170941|NCT01648790|12359858|FG000|Received at Least 1 Dose of Study Drug|Treatment 1||4
11419972|NCT02396342|12618768|FG000|STARTED|Overall Study||5
11419973|NCT02396342|12618769|FG001|STARTED|Overall Study||5
11419974|NCT02396342|12618768|FG000|COMPLETED|Overall Study||5
11419975|NCT02396342|12618769|FG001|COMPLETED|Overall Study||5
11419976|NCT02396342|12618768|FG000|NOT COMPLETED|Overall Study||0
11419977|NCT02396342|12618769|FG001|NOT COMPLETED|Overall Study||0
11170942|NCT01648790|12359859|FG001|Received at Least 1 Dose of Study Drug|Treatment 1||4
11170943|NCT01648790|12359860|FG002|Received at Least 1 Dose of Study Drug|Treatment 1||4
11170944|NCT01648790|12359861|FG003|Received at Least 1 Dose of Study Drug|Treatment 1||4
11170945|NCT01648790|12359862|FG004|Received at Least 1 Dose of Study Drug|Treatment 1||4
11419978|NCT02307253|12618775|FG000|STARTED|Overall Study||246
11419979|NCT02307253|12618775|FG000|COMPLETED|Overall Study||246
11419980|NCT02307253|12618775|FG000|NOT COMPLETED|Overall Study||0
11419981|NCT02224755|12618781|FG000|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512
11419982|NCT02224755|12618782|FG001|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516
11419983|NCT02224755|12618781|FG000|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505
11419984|NCT02224755|12618782|FG001|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515
11170946|NCT01648790|12359858|FG000|COMPLETED|Treatment 1||4
11170947|NCT01648790|12359859|FG001|COMPLETED|Treatment 1||4
11170948|NCT01648790|12359860|FG002|COMPLETED|Treatment 1||4
11170949|NCT01648790|12359861|FG003|COMPLETED|Treatment 1||4
11170950|NCT01648790|12359862|FG004|COMPLETED|Treatment 1||4
11170951|NCT01648790|12359858|FG000|NOT COMPLETED|Treatment 1||0
11170952|NCT01648790|12359859|FG001|NOT COMPLETED|Treatment 1||0
11170953|NCT01648790|12359860|FG002|NOT COMPLETED|Treatment 1||0
11170954|NCT01648790|12359861|FG003|NOT COMPLETED|Treatment 1||0
11170955|NCT01648790|12359862|FG004|NOT COMPLETED|Treatment 1||0
11419985|NCT02224755|12618781|FG000|NOT COMPLETED|Randomization to Device Implant||7
11419986|NCT02224755|12618782|FG001|NOT COMPLETED|Randomization to Device Implant||1
11419987|NCT02224755|12618781|FG000|STARTED|Two Year Follow up Post-implant||505
11419988|NCT02224755|12618782|FG001|STARTED|Two Year Follow up Post-implant||515
11419989|NCT02224755|12618781|FG000|COMPLETED|Two Year Follow up Post-implant||247
11419990|NCT02224755|12618782|FG001|COMPLETED|Two Year Follow up Post-implant||289
11419991|NCT02224755|12618781|FG000|NOT COMPLETED|Two Year Follow up Post-implant||258
11419992|NCT02224755|12618782|FG001|NOT COMPLETED|Two Year Follow up Post-implant||226
11170956|NCT01648790|12359858|FG000|STARTED|Treatment 2||4
11170957|NCT01648790|12359859|FG001|STARTED|Treatment 2||4
11170958|NCT01648790|12359860|FG002|STARTED|Treatment 2||4
11170959|NCT01648790|12359861|FG003|STARTED|Treatment 2||4
11170960|NCT01648790|12359862|FG004|STARTED|Treatment 2||4
11170961|NCT01648790|12359858|FG000|COMPLETED|Treatment 2||4
11170962|NCT01648790|12359859|FG001|COMPLETED|Treatment 2||4
11170963|NCT01648790|12359860|FG002|COMPLETED|Treatment 2||4
11170964|NCT01648790|12359861|FG003|COMPLETED|Treatment 2||4
11170965|NCT01648790|12359862|FG004|COMPLETED|Treatment 2||4
11170966|NCT01648790|12359858|FG000|NOT COMPLETED|Treatment 2||0
11170967|NCT01648790|12359859|FG001|NOT COMPLETED|Treatment 2||0
11170968|NCT01648790|12359860|FG002|NOT COMPLETED|Treatment 2||0
11170969|NCT01648790|12359861|FG003|NOT COMPLETED|Treatment 2||0
11170970|NCT01648790|12359862|FG004|NOT COMPLETED|Treatment 2||0
11170971|NCT01648790|12359858|FG000|STARTED|Treatment 3||4
11170972|NCT01648790|12359859|FG001|STARTED|Treatment 3||4
11170973|NCT01648790|12359860|FG002|STARTED|Treatment 3||4
11170974|NCT01648790|12359861|FG003|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
11170975|NCT01648790|12359862|FG004|STARTED|Treatment 3||4
11170976|NCT01648790|12359858|FG000|COMPLETED|Treatment 3||4
11170977|NCT01648790|12359859|FG001|COMPLETED|Treatment 3||4
11170978|NCT01648790|12359860|FG002|COMPLETED|Treatment 3||4
11170979|NCT01648790|12359861|FG003|COMPLETED|Treatment 3||3
11170980|NCT01648790|12359862|FG004|COMPLETED|Treatment 3||4
11170981|NCT01648790|12359858|FG000|NOT COMPLETED|Treatment 3||0
11170982|NCT01648790|12359859|FG001|NOT COMPLETED|Treatment 3||0
11170983|NCT01648790|12359860|FG002|NOT COMPLETED|Treatment 3||0
11170984|NCT01648790|12359861|FG003|NOT COMPLETED|Treatment 3||1
11170985|NCT01648790|12359862|FG004|NOT COMPLETED|Treatment 3||0
11170986|NCT01648790|12359858|FG000|STARTED|Treatment 4||4
11170987|NCT01648790|12359859|FG001|STARTED|Treatment 4||4
11170988|NCT01648790|12359860|FG002|STARTED|Treatment 4||4
11170989|NCT01648790|12359861|FG003|STARTED|Treatment 4||3
11170990|NCT01648790|12359862|FG004|STARTED|Treatment 4||4
11170991|NCT01648790|12359858|FG000|COMPLETED|Treatment 4||4
11170992|NCT01648790|12359859|FG001|COMPLETED|Treatment 4||4
11170993|NCT01648790|12359860|FG002|COMPLETED|Treatment 4||4
11170994|NCT01648790|12359861|FG003|COMPLETED|Treatment 4||3
11170995|NCT01648790|12359862|FG004|COMPLETED|Treatment 4||4
11170996|NCT01648790|12359858|FG000|NOT COMPLETED|Treatment 4||0
11170997|NCT01648790|12359859|FG001|NOT COMPLETED|Treatment 4||0
11170998|NCT01648790|12359860|FG002|NOT COMPLETED|Treatment 4||0
11170999|NCT01648790|12359861|FG003|NOT COMPLETED|Treatment 4||0
11171000|NCT01648790|12359862|FG004|NOT COMPLETED|Treatment 4||0
11171001|NCT01648790|12359858|FG000|STARTED|Treatment 5||4
11171002|NCT01648790|12359859|FG001|STARTED|Treatment 5||4
11171003|NCT01648790|12359860|FG002|STARTED|Treatment 5||4
11171004|NCT01648790|12359861|FG003|STARTED|Treatment 5||3
11171005|NCT01648790|12359862|FG004|STARTED|Treatment 5||4
11171006|NCT01648790|12359858|FG000|COMPLETED|Treatment 5||4
11171007|NCT01648790|12359859|FG001|COMPLETED|Treatment 5||4
11171008|NCT01648790|12359860|FG002|COMPLETED|Treatment 5||4
11171009|NCT01648790|12359861|FG003|COMPLETED|Treatment 5||3
11171010|NCT01648790|12359862|FG004|COMPLETED|Treatment 5||4
11171011|NCT01648790|12359858|FG000|NOT COMPLETED|Treatment 5||0
11171012|NCT01648790|12359859|FG001|NOT COMPLETED|Treatment 5||0
11171013|NCT01648790|12359860|FG002|NOT COMPLETED|Treatment 5||0
11171014|NCT01648790|12359861|FG003|NOT COMPLETED|Treatment 5||0
11171015|NCT01648790|12359862|FG004|NOT COMPLETED|Treatment 5||0
11171016|NCT01648920|12359874|FG000|STARTED|Overall Study||50
11171017|NCT01648920|12359874|FG000|COMPLETED|Overall Study||50
11171018|NCT01648920|12359874|FG000|NOT COMPLETED|Overall Study||0
11171019|NCT01648959|12359878|FG000|STARTED|Overall Study||5
11171020|NCT01648959|12359878|FG000|COMPLETED|Overall Study||5
11171021|NCT01648959|12359878|FG000|NOT COMPLETED|Overall Study||0
11171022|NCT01649180|12359882|FG000|STARTED|Overall Study||3
11171023|NCT01649180|12359882|FG000|COMPLETED|Overall Study||3
11171024|NCT01649180|12359882|FG000|NOT COMPLETED|Overall Study||0
11171025|NCT01649232|12359888|FG000|STARTED|Overall Study||30
11419993|NCT02170363|12618792|FG000|STARTED|Overall Study||50
11419994|NCT02170363|12618792|FG000|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
11419995|NCT02170363|12618792|FG000|NOT COMPLETED|Overall Study||0
11171026|NCT01649232|12359889|FG001|STARTED|Overall Study||30
11171027|NCT01649232|12359888|FG000|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
11171028|NCT01649232|12359889|FG001|COMPLETED|Overall Study||30
11171029|NCT01649232|12359888|FG000|NOT COMPLETED|Overall Study||2
11171030|NCT01649232|12359889|FG001|NOT COMPLETED|Overall Study||0
11171031|NCT01649271|12359903|FG000|STARTED|Overall Study||6
11171032|NCT01649271|12359904|FG001|STARTED|Overall Study||7
11171033|NCT01649271|12359903|FG000|COMPLETED|Overall Study||0
11171034|NCT01649271|12359904|FG001|COMPLETED|Overall Study||0
11171035|NCT01649271|12359903|FG000|NOT COMPLETED|Overall Study||6
11171036|NCT01649271|12359904|FG001|NOT COMPLETED|Overall Study||7
11171037|NCT01649297|12359916|FG000|STARTED|Overall Study|randomised|219
11171038|NCT01649297|12359917|FG001|STARTED|Overall Study|randomised|218
11171039|NCT01649297|12359918|FG002|STARTED|Overall Study|randomised|219
11171040|NCT01649297|12359919|FG003|STARTED|Overall Study|randomised|220
11171041|NCT01649297|12359920|FG004|STARTED|Overall Study|randomised|107
11171042|NCT01649297|12359916|FG000|COMPLETED|Overall Study||205
11171043|NCT01649297|12359917|FG001|COMPLETED|Overall Study||205
11171044|NCT01649297|12359918|FG002|COMPLETED|Overall Study||202
11419996|NCT02090114|12618802|FG000|STARTED|Overall Study||30
11419997|NCT02090114|12618803|FG001|STARTED|Overall Study||29
11419998|NCT02090114|12618804|FG002|STARTED|Overall Study||29
11419999|NCT02090114|12618805|FG003|STARTED|Overall Study||8
11420000|NCT02090114|12618802|FG000|COMPLETED|Overall Study||0
11420001|NCT02090114|12618803|FG001|COMPLETED|Overall Study||0
11420002|NCT02090114|12618804|FG002|COMPLETED|Overall Study||0
11420003|NCT02090114|12618805|FG003|COMPLETED|Overall Study||0
11420004|NCT02090114|12618802|FG000|NOT COMPLETED|Overall Study||30
11420005|NCT02090114|12618803|FG001|NOT COMPLETED|Overall Study||29
11420006|NCT02090114|12618804|FG002|NOT COMPLETED|Overall Study||29
11420007|NCT02090114|12618805|FG003|NOT COMPLETED|Overall Study||8
11420008|NCT01568424|12618815|FG000|STARTED|Overall Study||25
11420009|NCT01568424|12618815|FG000|COMPLETED|Overall Study||25
11420010|NCT01568424|12618815|FG000|NOT COMPLETED|Overall Study||0
11420011|NCT00819793|12618819|FG000|STARTED|Overall Study||32
11420012|NCT00819793|12618819|FG000|COMPLETED|Overall Study||32
11171045|NCT01649297|12359919|FG003|COMPLETED|Overall Study||201
11171046|NCT01649297|12359920|FG004|COMPLETED|Overall Study||103
11171047|NCT01649297|12359916|FG000|NOT COMPLETED|Overall Study||14
11171048|NCT01649297|12359917|FG001|NOT COMPLETED|Overall Study||13
11171049|NCT01649297|12359918|FG002|NOT COMPLETED|Overall Study||17
11171050|NCT01649297|12359919|FG003|NOT COMPLETED|Overall Study||19
11171051|NCT01649297|12359920|FG004|NOT COMPLETED|Overall Study||4
11171052|NCT01649362|12359934|FG000|STARTED|Overall Study||47
11171053|NCT01649362|12359935|FG001|STARTED|Overall Study||54
11171054|NCT01649362|12359934|FG000|COMPLETED|Overall Study||46
11171055|NCT01649362|12359935|FG001|COMPLETED|Overall Study||40
11171056|NCT01649362|12359934|FG000|NOT COMPLETED|Overall Study||1
11171057|NCT01649362|12359935|FG001|NOT COMPLETED|Overall Study||14
11171058|NCT01649375|12359944|FG000|STARTED|Up to Week 16||73
11171059|NCT01649375|12359945|FG001|STARTED|Up to Week 16||72
11171060|NCT01649375|12359946|FG002|STARTED|Up to Week 16||74
11171061|NCT01649375|12359947|FG003|STARTED|Up to Week 16||0
11171062|NCT01649375|12359948|FG004|STARTED|Up to Week 16||0
11420013|NCT00819793|12618819|FG000|NOT COMPLETED|Overall Study||0
11420014|NCT00121485|12618826|FG000|STARTED|Overall Study||134
11171063|NCT01649375|12359944|FG000|COMPLETED|Up to Week 16||68
11420015|NCT00121485|12618827|FG001|STARTED|Overall Study||66
11420016|NCT00121485|12618826|FG000|COMPLETED|Overall Study||133
11420017|NCT00121485|12618827|FG001|COMPLETED|Overall Study||59
11420018|NCT00121485|12618826|FG000|NOT COMPLETED|Overall Study||1
11420019|NCT00121485|12618827|FG001|NOT COMPLETED|Overall Study||7
11420020|NCT00121472|12618834|FG000|STARTED|Overall Study||194
11420021|NCT00121472|12618834|FG000|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
11420022|NCT00121472|12618834|FG000|NOT COMPLETED|Overall Study||0
11171064|NCT01649375|12359945|FG001|COMPLETED|Up to Week 16||66
11171065|NCT01649375|12359946|FG002|COMPLETED|Up to Week 16||66
11171066|NCT01649375|12359947|FG003|COMPLETED|Up to Week 16||0
11171067|NCT01649375|12359948|FG004|COMPLETED|Up to Week 16||0
11171068|NCT01649375|12359944|FG000|NOT COMPLETED|Up to Week 16||5
11171069|NCT01649375|12359945|FG001|NOT COMPLETED|Up to Week 16||6
11171070|NCT01649375|12359946|FG002|NOT COMPLETED|Up to Week 16||8
11171071|NCT01649375|12359947|FG003|NOT COMPLETED|Up to Week 16||0
11171072|NCT01649375|12359948|FG004|NOT COMPLETED|Up to Week 16||0
11171073|NCT01649375|12359944|FG000|STARTED|Week 16 up to Week 260||68
11171074|NCT01649375|12359945|FG001|STARTED|Week 16 up to Week 260||66
11171075|NCT01649375|12359946|FG002|STARTED|Week 16 up to Week 260||0
11171076|NCT01649375|12359947|FG003|STARTED|Week 16 up to Week 260||32
11171077|NCT01649375|12359948|FG004|STARTED|Week 16 up to Week 260||34
11171078|NCT01649375|12359944|FG000|COMPLETED|Week 16 up to Week 260||48
11171079|NCT01649375|12359945|FG001|COMPLETED|Week 16 up to Week 260||53
11171080|NCT01649375|12359946|FG002|COMPLETED|Week 16 up to Week 260||0
11171081|NCT01649375|12359947|FG003|COMPLETED|Week 16 up to Week 260||20
11171082|NCT01649375|12359948|FG004|COMPLETED|Week 16 up to Week 260||29
11171083|NCT01649375|12359944|FG000|NOT COMPLETED|Week 16 up to Week 260||20
11171084|NCT01649375|12359945|FG001|NOT COMPLETED|Week 16 up to Week 260||13
11171085|NCT01649375|12359946|FG002|NOT COMPLETED|Week 16 up to Week 260||0
11171086|NCT01649375|12359947|FG003|NOT COMPLETED|Week 16 up to Week 260||12
11171087|NCT01649375|12359948|FG004|NOT COMPLETED|Week 16 up to Week 260||5
11171088|NCT01649427|12359958|FG000|STARTED|Overall Study||35
11171089|NCT01649427|12359959|FG001|STARTED|Overall Study||38
11171090|NCT01649427|12359958|FG000|COMPLETED|Overall Study||24
11171091|NCT01649427|12359959|FG001|COMPLETED|Overall Study||26
11171092|NCT01649427|12359958|FG000|NOT COMPLETED|Overall Study||11
11171093|NCT01649427|12359959|FG001|NOT COMPLETED|Overall Study||12
11171094|NCT01649557|12359968|FG000|STARTED|Overall Study||179
11171095|NCT01649557|12359969|FG001|STARTED|Overall Study||41
11171096|NCT01649557|12359970|FG002|STARTED|Overall Study||24
11171097|NCT01649557|12359968|FG000|6-week Enrollers|Overall Study||159
11171098|NCT01649557|12359969|FG001|6-week Enrollers|Overall Study||35
11171099|NCT01649557|12359970|FG002|6-week Enrollers|Overall Study||22
11171100|NCT01649557|12359968|FG000|52-week Enrollers|Overall Study||20
11171101|NCT01649557|12359969|FG001|52-week Enrollers|Overall Study||6
11171102|NCT01649557|12359970|FG002|52-week Enrollers|Overall Study||2
11171103|NCT01649557|12359968|FG000|COMPLETED|Overall Study||135
11171104|NCT01649557|12359969|FG001|COMPLETED|Overall Study||27
11171105|NCT01649557|12359970|FG002|COMPLETED|Overall Study||15
11171106|NCT01649557|12359968|FG000|NOT COMPLETED|Overall Study||44
11171107|NCT01649557|12359969|FG001|NOT COMPLETED|Overall Study||14
11171108|NCT01649557|12359970|FG002|NOT COMPLETED|Overall Study||9
11171109|NCT01649596|12359980|FG000|STARTED|Overall Study||46
11171110|NCT01649596|12359981|FG001|STARTED|Overall Study||48
11171111|NCT01649596|12359980|FG000|COMPLETED|Overall Study||46
11171112|NCT01649596|12359981|FG001|COMPLETED|Overall Study||48
11171113|NCT01649596|12359980|FG000|NOT COMPLETED|Overall Study||0
11171114|NCT01649596|12359981|FG001|NOT COMPLETED|Overall Study||0
11171115|NCT01649609|12359989|FG000|STARTED|Overall Study||20
11420023|NCT00078806|12618842|FG000|STARTED|Part 1A||19
11420024|NCT00078806|12618843|FG001|STARTED|Part 1A||0
11420025|NCT00078806|12618844|FG002|STARTED|Part 1A||0
11420026|NCT00078806|12618845|FG003|STARTED|Part 1A||0
11420027|NCT00078806|12618842|FG000|COMPLETED|Part 1A||9
11420028|NCT00078806|12618843|FG001|COMPLETED|Part 1A||0
11420029|NCT00078806|12618844|FG002|COMPLETED|Part 1A||0
11420030|NCT00078806|12618845|FG003|COMPLETED|Part 1A||0
11420031|NCT00078806|12618842|FG000|NOT COMPLETED|Part 1A||10
11420032|NCT00078806|12618843|FG001|NOT COMPLETED|Part 1A||0
11420033|NCT00078806|12618844|FG002|NOT COMPLETED|Part 1A||0
11171116|NCT01649609|12359990|FG001|STARTED|Overall Study||20
11171117|NCT01649609|12359989|FG000|COMPLETED|Overall Study||20
11171118|NCT01649609|12359990|FG001|COMPLETED|Overall Study||20
11171119|NCT01649609|12359989|FG000|NOT COMPLETED|Overall Study||0
11171120|NCT01649609|12359990|FG001|NOT COMPLETED|Overall Study||0
11171121|NCT01649765|12359998|FG000|STARTED|Overall Study||40
11171122|NCT01649765|12359999|FG001|STARTED|Overall Study||53
11171123|NCT01649765|12359998|FG000|COMPLETED|Overall Study||31
11171124|NCT01649765|12359999|FG001|COMPLETED|Overall Study||45
11171125|NCT01649765|12359998|FG000|NOT COMPLETED|Overall Study||9
11171126|NCT01649765|12359999|FG001|NOT COMPLETED|Overall Study||8
11171127|NCT01649791|12360006|FG000|STARTED|Overall Study||8
11171128|NCT01649791|12360006|FG000|COMPLETED|Overall Study||5
11171129|NCT01649791|12360006|FG000|NOT COMPLETED|Overall Study||3
11171130|NCT01649804|12360010|FG000|STARTED|Overall Study||12
11171131|NCT01649804|12360010|FG000|COMPLETED|Overall Study||4
11171132|NCT01649804|12360010|FG000|NOT COMPLETED|Overall Study||8
11171133|NCT01649856|12360016|FG000|STARTED|Overall Study||369
11171134|NCT01649856|12360017|FG001|STARTED|Overall Study||203
11171135|NCT01649856|12360016|FG000|COMPLETED|Overall Study||230
11171136|NCT01649856|12360017|FG001|COMPLETED|Overall Study||125
11171137|NCT01649856|12360016|FG000|NOT COMPLETED|Overall Study||139
11171138|NCT01649856|12360017|FG001|NOT COMPLETED|Overall Study||78
11171139|NCT01649869|12360025|FG000|STARTED|Overall Study||18
11171140|NCT01649869|12360026|FG001|STARTED|Overall Study||17
11171141|NCT01649869|12360025|FG000|COMPLETED|Overall Study||16
11171142|NCT01649869|12360026|FG001|COMPLETED|Overall Study||16
11171143|NCT01649869|12360025|FG000|NOT COMPLETED|Overall Study||2
11171144|NCT01649869|12360026|FG001|NOT COMPLETED|Overall Study||1
11171145|NCT01649947|12360036|FG000|STARTED|Overall Study||12
11171146|NCT01649947|12360037|FG001|STARTED|Overall Study||20
11171147|NCT01649947|12360036|FG000|COMPLETED|Overall Study||0
11171148|NCT01649947|12360037|FG001|COMPLETED|Overall Study||2
11171149|NCT01649947|12360036|FG000|NOT COMPLETED|Overall Study||12
11171150|NCT01649947|12360037|FG001|NOT COMPLETED|Overall Study||18
11171151|NCT01650194|12360044|FG000|STARTED|Overall Study||60
11171152|NCT01650194|12360044|FG000|Treated|Overall Study||60
11171153|NCT01650194|12360044|FG000|COMPLETED|Overall Study||13
11171154|NCT01650194|12360044|FG000|NOT COMPLETED|Overall Study||47
11171155|NCT01650246|12360049|FG000|STARTED|Overall Study||143
11171156|NCT01650246|12360049|FG000|COMPLETED|Overall Study||0
11171157|NCT01650246|12360049|FG000|NOT COMPLETED|Overall Study||143
11171158|NCT01650259|12360055|FG000|STARTED|Overall Study|Started are the registered patients|2513
11171159|NCT01650259|12360056|FG001|STARTED|Overall Study|Started are the registered patients|2363
11171160|NCT01650259|12360055|FG000|COMPLETED|Overall Study||1470
11171161|NCT01650259|12360056|FG001|COMPLETED|Overall Study||2128
11420034|NCT00078806|12618845|FG003|NOT COMPLETED|Part 1A||0
11420035|NCT00078806|12618842|FG000|STARTED|Part 1B||10
11420036|NCT00078806|12618843|FG001|STARTED|Part 1B||0
11420037|NCT00078806|12618844|FG002|STARTED|Part 1B||0
11420038|NCT00078806|12618845|FG003|STARTED|Part 1B||0
11420039|NCT00078806|12618842|FG000|COMPLETED|Part 1B||2
11420040|NCT00078806|12618843|FG001|COMPLETED|Part 1B||0
11420041|NCT00078806|12618844|FG002|COMPLETED|Part 1B||0
11420042|NCT00078806|12618845|FG003|COMPLETED|Part 1B||0
11420043|NCT00078806|12618842|FG000|NOT COMPLETED|Part 1B||8
11420044|NCT00078806|12618843|FG001|NOT COMPLETED|Part 1B||0
11420045|NCT00078806|12618844|FG002|NOT COMPLETED|Part 1B||0
11171162|NCT01650259|12360055|FG000|NOT COMPLETED|Overall Study||1043
11171163|NCT01650259|12360056|FG001|NOT COMPLETED|Overall Study||235
11171164|NCT01650298|12360062|FG000|STARTED|Overall Study||16
11171165|NCT01650298|12360063|FG001|STARTED|Overall Study||48
11171166|NCT01650298|12360062|FG000|COMPLETED|Overall Study||11
11171167|NCT01650298|12360063|FG001|COMPLETED|Overall Study||42
11171168|NCT01650298|12360062|FG000|NOT COMPLETED|Overall Study||5
11171169|NCT01650298|12360063|FG001|NOT COMPLETED|Overall Study||6
11171170|NCT01650324|12360074|FG000|STARTED|Overall Study||8
11171171|NCT01650324|12360075|FG001|STARTED|Overall Study||6
11420046|NCT00078806|12618845|FG003|NOT COMPLETED|Part 1B||0
11420047|NCT00078806|12618842|FG000|STARTED|Part 2||0
11420048|NCT00078806|12618843|FG001|STARTED|Part 2||6
11420049|NCT00078806|12618844|FG002|STARTED|Part 2||4
11420050|NCT00078806|12618845|FG003|STARTED|Part 2||0
11420051|NCT00078806|12618842|FG000|Received Study Drug|Part 2||0
11420052|NCT00078806|12618843|FG001|Received Study Drug|Part 2||5
11420053|NCT00078806|12618844|FG002|Received Study Drug|Part 2||4
11420054|NCT00078806|12618845|FG003|Received Study Drug|Part 2||0
11420055|NCT00078806|12618842|FG000|COMPLETED|Part 2||0
11420056|NCT00078806|12618843|FG001|COMPLETED|Part 2||5
11420057|NCT00078806|12618844|FG002|COMPLETED|Part 2||4
11420058|NCT00078806|12618845|FG003|COMPLETED|Part 2||0
11420059|NCT00078806|12618842|FG000|NOT COMPLETED|Part 2||0
11171172|NCT01650324|12360076|FG002|STARTED|Overall Study||6
11171173|NCT01650324|12360077|FG003|STARTED|Overall Study||6
11171174|NCT01650324|12360078|FG004|STARTED|Overall Study||6
11171175|NCT01650324|12360074|FG000|COMPLETED|Overall Study||8
11420060|NCT00078806|12618843|FG001|NOT COMPLETED|Part 2||1
11171176|NCT01650324|12360075|FG001|COMPLETED|Overall Study||6
11420061|NCT00078806|12618844|FG002|NOT COMPLETED|Part 2||0
11171177|NCT01650324|12360076|FG002|COMPLETED|Overall Study||6
11171178|NCT01650324|12360077|FG003|COMPLETED|Overall Study||6
11171179|NCT01650324|12360078|FG004|COMPLETED|Overall Study||6
11171180|NCT01650324|12360074|FG000|NOT COMPLETED|Overall Study||0
11171181|NCT01650324|12360075|FG001|NOT COMPLETED|Overall Study||0
11171182|NCT01650324|12360076|FG002|NOT COMPLETED|Overall Study||0
11171183|NCT01650324|12360077|FG003|NOT COMPLETED|Overall Study||0
11171184|NCT01650324|12360078|FG004|NOT COMPLETED|Overall Study||0
11171185|NCT01650402|12360097|FG000|STARTED|Overall Study||99
11171186|NCT01650402|12360098|FG001|STARTED|Overall Study||100
11171187|NCT01650402|12360097|FG000|COMPLETED|Overall Study||79
11171188|NCT01650402|12360098|FG001|COMPLETED|Overall Study||86
11171189|NCT01650402|12360097|FG000|NOT COMPLETED|Overall Study||20
11171190|NCT01650402|12360098|FG001|NOT COMPLETED|Overall Study||14
11171191|NCT01650519|12360106|FG000|STARTED|Overall Study||20
11171192|NCT01650519|12360107|FG001|STARTED|Overall Study||31
11171193|NCT01650519|12360106|FG000|COMPLETED|Overall Study||19
11171194|NCT01650519|12360107|FG001|COMPLETED|Overall Study||31
11171195|NCT01650519|12360106|FG000|NOT COMPLETED|Overall Study||1
11171196|NCT01650519|12360107|FG001|NOT COMPLETED|Overall Study||0
11171197|NCT01650545|12360115|FG000|STARTED|Overall Study||11
11171198|NCT01650545|12360116|FG001|STARTED|Overall Study||10
11171199|NCT01650545|12360115|FG000|COMPLETED|Overall Study||11
11171200|NCT01650545|12360116|FG001|COMPLETED|Overall Study||10
11171201|NCT01650545|12360115|FG000|NOT COMPLETED|Overall Study||0
11171202|NCT01650545|12360116|FG001|NOT COMPLETED|Overall Study||0
11171203|NCT01650584|12360126|FG000|STARTED|Overall Study|Each participant received one of 2 treatments in each eye.|35
11171204|NCT01650584|12360126|FG000|COMPLETED|Overall Study||35
11171205|NCT01650584|12360126|FG000|NOT COMPLETED|Overall Study||0
11171206|NCT01650636|12360133|FG000|STARTED|Intervention Phase||150
11171207|NCT01650636|12360134|FG001|STARTED|Intervention Phase||150
11323671|NCT01190930|12520931|FG005|COMPLETED|Post Induction Pre-Maintenance||296
11323672|NCT01190930|12520932|FG006|COMPLETED|Post Induction Pre-Maintenance||0
11323673|NCT01190930|12520933|FG007|COMPLETED|Post Induction Pre-Maintenance||0
11323674|NCT01190930|12520934|FG008|COMPLETED|Post Induction Pre-Maintenance||0
11323675|NCT01190930|12520935|FG009|COMPLETED|Post Induction Pre-Maintenance||0
11323676|NCT01190930|12520926|FG000|NOT COMPLETED|Post Induction Pre-Maintenance||0
11323677|NCT01190930|12520927|FG001|NOT COMPLETED|Post Induction Pre-Maintenance||6
11323678|NCT01190930|12520928|FG002|NOT COMPLETED|Post Induction Pre-Maintenance||758
11323679|NCT01190930|12520929|FG003|NOT COMPLETED|Post Induction Pre-Maintenance||17
11323680|NCT01190930|12520930|FG004|NOT COMPLETED|Post Induction Pre-Maintenance||5
11323681|NCT01190930|12520931|FG005|NOT COMPLETED|Post Induction Pre-Maintenance||6
11323682|NCT01190930|12520932|FG006|NOT COMPLETED|Post Induction Pre-Maintenance||0
11323683|NCT01190930|12520933|FG007|NOT COMPLETED|Post Induction Pre-Maintenance||0
11323684|NCT01190930|12520934|FG008|NOT COMPLETED|Post Induction Pre-Maintenance||0
11323685|NCT01190930|12520935|FG009|NOT COMPLETED|Post Induction Pre-Maintenance||0
11323686|NCT01190930|12520926|FG000|STARTED|Maintenance||0
11323687|NCT01190930|12520927|FG001|STARTED|Maintenance||37
11323688|NCT01190930|12520928|FG002|STARTED|Maintenance||0
11323689|NCT01190930|12520929|FG003|STARTED|Maintenance||207
11323690|NCT01190930|12520930|FG004|STARTED|Maintenance||296
11323691|NCT01190930|12520931|FG005|STARTED|Maintenance||296
11323692|NCT01190930|12520932|FG006|STARTED|Maintenance||600
11323693|NCT01190930|12520933|FG007|STARTED|Maintenance||586
11323694|NCT01190930|12520934|FG008|STARTED|Maintenance||586
11323695|NCT01190930|12520935|FG009|STARTED|Maintenance||592
11323696|NCT01190930|12520926|FG000|COMPLETED|Maintenance||0
11323697|NCT01190930|12520927|FG001|COMPLETED|Maintenance||27
11323698|NCT01190930|12520928|FG002|COMPLETED|Maintenance||0
11323699|NCT01190930|12520929|FG003|COMPLETED|Maintenance||167
11323700|NCT01190930|12520930|FG004|COMPLETED|Maintenance||287
11323701|NCT01190930|12520931|FG005|COMPLETED|Maintenance||284
11323702|NCT01190930|12520932|FG006|COMPLETED|Maintenance||574
11323703|NCT01190930|12520933|FG007|COMPLETED|Maintenance||540
11323704|NCT01190930|12520934|FG008|COMPLETED|Maintenance||540
11420062|NCT00078806|12618845|FG003|NOT COMPLETED|Part 2||0
11171208|NCT01650636|12360133|FG000|COMPLETED|Intervention Phase||150
11171209|NCT01650636|12360134|FG001|COMPLETED|Intervention Phase||150
11323705|NCT01190930|12520935|FG009|COMPLETED|Maintenance||555
11323706|NCT01190930|12520926|FG000|NOT COMPLETED|Maintenance||0
11323707|NCT01190930|12520927|FG001|NOT COMPLETED|Maintenance||10
11323708|NCT01190930|12520928|FG002|NOT COMPLETED|Maintenance||0
11323709|NCT01190930|12520929|FG003|NOT COMPLETED|Maintenance||40
11323710|NCT01190930|12520930|FG004|NOT COMPLETED|Maintenance||9
11323711|NCT01190930|12520931|FG005|NOT COMPLETED|Maintenance||12
11323712|NCT01190930|12520932|FG006|NOT COMPLETED|Maintenance||26
11323713|NCT01190930|12520933|FG007|NOT COMPLETED|Maintenance||46
11323714|NCT01190930|12520934|FG008|NOT COMPLETED|Maintenance||46
11323715|NCT01190930|12520935|FG009|NOT COMPLETED|Maintenance||37
11323716|NCT01190306|12520961|FG000|STARTED|Overall Study||61
11323717|NCT01190306|12520962|FG001|STARTED|Overall Study||66
11323718|NCT01190306|12520961|FG000|COMPLETED|Overall Study||61
11323719|NCT01190306|12520962|FG001|COMPLETED|Overall Study||66
11323720|NCT01190306|12520961|FG000|NOT COMPLETED|Overall Study||0
11171210|NCT01650636|12360133|FG000|NOT COMPLETED|Intervention Phase||0
11171211|NCT01650636|12360134|FG001|NOT COMPLETED|Intervention Phase||0
11171212|NCT01650636|12360133|FG000|STARTED|Washout up to 5 Months||150
11171213|NCT01650636|12360134|FG001|STARTED|Washout up to 5 Months||150
11171214|NCT01650636|12360133|FG000|COMPLETED|Washout up to 5 Months||141
11171215|NCT01650636|12360134|FG001|COMPLETED|Washout up to 5 Months||132
11171216|NCT01650636|12360133|FG000|NOT COMPLETED|Washout up to 5 Months||9
11171217|NCT01650636|12360134|FG001|NOT COMPLETED|Washout up to 5 Months||18
11171218|NCT01650636|12360133|FG000|STARTED|5 Month Visit||141
11171219|NCT01650636|12360134|FG001|STARTED|5 Month Visit||132
11171220|NCT01650636|12360133|FG000|COMPLETED|5 Month Visit||141
11171221|NCT01650636|12360134|FG001|COMPLETED|5 Month Visit||132
11171222|NCT01650636|12360133|FG000|NOT COMPLETED|5 Month Visit||0
11171223|NCT01650636|12360134|FG001|NOT COMPLETED|5 Month Visit||0
11171224|NCT01650636|12360133|FG000|STARTED|Washout up to 9 Months||141
11171225|NCT01650636|12360134|FG001|STARTED|Washout up to 9 Months||132
11171226|NCT01650636|12360133|FG000|COMPLETED|Washout up to 9 Months||135
11171227|NCT01650636|12360134|FG001|COMPLETED|Washout up to 9 Months||129
11171228|NCT01650636|12360133|FG000|NOT COMPLETED|Washout up to 9 Months||6
11171229|NCT01650636|12360134|FG001|NOT COMPLETED|Washout up to 9 Months||3
11171230|NCT01650636|12360133|FG000|STARTED|9 Month Visit||135
11171231|NCT01650636|12360134|FG001|STARTED|9 Month Visit||129
11171232|NCT01650636|12360133|FG000|COMPLETED|9 Month Visit||135
11171233|NCT01650636|12360134|FG001|COMPLETED|9 Month Visit||129
11171234|NCT01650636|12360133|FG000|NOT COMPLETED|9 Month Visit||0
11171235|NCT01650636|12360134|FG001|NOT COMPLETED|9 Month Visit||0
11171236|NCT01650779|12360140|FG000|STARTED|Overall Study||15
11171237|NCT01650779|12360140|FG000|COMPLETED|Overall Study||14
11171238|NCT01650779|12360140|FG000|NOT COMPLETED|Overall Study||1
11171239|NCT01650805|12360146|FG000|STARTED|Overall Study|Started means patient has been randomized.|155
11171240|NCT01650805|12360147|FG001|STARTED|Overall Study||152
11171241|NCT01650805|12360146|FG000|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
11171242|NCT01650805|12360147|FG001|COMPLETED|Overall Study||152
11171243|NCT01650805|12360146|FG000|NOT COMPLETED|Overall Study||1
11171244|NCT01650805|12360147|FG001|NOT COMPLETED|Overall Study||0
11171245|NCT01650831|12360153|FG000|STARTED|Overall Study||113
11171246|NCT01650831|12360153|FG000|COMPLETED|Overall Study||112
11171247|NCT01650831|12360153|FG000|NOT COMPLETED|Overall Study||1
11171248|NCT01650844|12360163|FG000|STARTED|Overall Study||200
11171249|NCT01650844|12360164|FG001|STARTED|Overall Study||200
11171250|NCT01650844|12360163|FG000|COMPLETED|Overall Study||199
11171251|NCT01650844|12360164|FG001|COMPLETED|Overall Study||196
11171252|NCT01650844|12360163|FG000|NOT COMPLETED|Overall Study||1
11171253|NCT01650844|12360164|FG001|NOT COMPLETED|Overall Study||4
11171254|NCT01651000|12360172|FG000|STARTED|Overall Study||72
11171255|NCT01651000|12360173|FG001|STARTED|Overall Study||141
11171256|NCT01651000|12360172|FG000|Entered Extension Study|Overall Study||50
11171257|NCT01651000|12360173|FG001|Entered Extension Study|Overall Study||93
11171258|NCT01651000|12360172|FG000|COMPLETED|Overall Study||62
11171259|NCT01651000|12360173|FG001|COMPLETED|Overall Study||113
11171260|NCT01651000|12360172|FG000|NOT COMPLETED|Overall Study||10
11171261|NCT01651000|12360173|FG001|NOT COMPLETED|Overall Study||28
11171262|NCT01651039|12360179|FG000|STARTED|Overall Study||32
11171263|NCT01651039|12360179|FG000|COMPLETED|Overall Study||2
11171264|NCT01651039|12360179|FG000|NOT COMPLETED|Overall Study||30
11171265|NCT01651052|12360183|FG000|STARTED|Overall Study||133
11171266|NCT01651052|12360183|FG000|Study Valve Group|Overall Study||133
11171267|NCT01651052|12360183|FG000|COMPLETED|Overall Study||107
11171268|NCT01651052|12360183|FG000|NOT COMPLETED|Overall Study||26
11171269|NCT01651078|12360187|FG000|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42
11171270|NCT01651078|12360187|FG000|COMPLETED|Overall Study||16
11171271|NCT01651078|12360187|FG000|NOT COMPLETED|Overall Study||26
11171272|NCT01651104|12360191|FG000|STARTED|Overall Study||63
11171273|NCT01651104|12360191|FG000|COMPLETED|Overall Study||63
11171274|NCT01651104|12360191|FG000|NOT COMPLETED|Overall Study||0
11171275|NCT01651117|12360199|FG000|STARTED|Overall Study||156
11171276|NCT01651117|12360200|FG001|STARTED|Overall Study||205
11171277|NCT01651117|12360201|FG002|STARTED|Overall Study||49
11323721|NCT01190306|12520962|FG001|NOT COMPLETED|Overall Study||0
11323722|NCT00779324|12520970|FG000|STARTED|Overall Study||82
11323723|NCT00779324|12520971|FG001|STARTED|Overall Study||86
11323724|NCT00779324|12520970|FG000|Completed 28-day Mid-point|Overall Study||80
11323725|NCT00779324|12520971|FG001|Completed 28-day Mid-point|Overall Study||81
11323726|NCT00779324|12520970|FG000|COMPLETED|Overall Study||75
11171278|NCT01651117|12360202|FG003|STARTED|Overall Study||70
11171279|NCT01651117|12360199|FG000|COMPLETED|Overall Study||154
11171280|NCT01651117|12360200|FG001|COMPLETED|Overall Study||202
11171281|NCT01651117|12360201|FG002|COMPLETED|Overall Study||47
11171282|NCT01651117|12360202|FG003|COMPLETED|Overall Study||68
11171283|NCT01651117|12360199|FG000|NOT COMPLETED|Overall Study||2
11171284|NCT01651117|12360200|FG001|NOT COMPLETED|Overall Study||3
11171285|NCT01651117|12360201|FG002|NOT COMPLETED|Overall Study||2
11171286|NCT01651117|12360202|FG003|NOT COMPLETED|Overall Study||2
11171287|NCT01651195|12360219|FG000|STARTED|Overall Study||284
11171288|NCT01651195|12360220|FG001|STARTED|Overall Study||284
11171289|NCT01651195|12360221|FG002|STARTED|Overall Study||204
11171290|NCT01651195|12360222|FG003|STARTED|Overall Study||211
11171291|NCT01651195|12360219|FG000|COMPLETED|Overall Study||63
11171292|NCT01651195|12360220|FG001|COMPLETED|Overall Study||73
11171293|NCT01651195|12360221|FG002|COMPLETED|Overall Study||121
11171294|NCT01651195|12360222|FG003|COMPLETED|Overall Study||103
11171295|NCT01651195|12360219|FG000|NOT COMPLETED|Overall Study||221
11171296|NCT01651195|12360220|FG001|NOT COMPLETED|Overall Study||211
11171297|NCT01651195|12360221|FG002|NOT COMPLETED|Overall Study||83
11171298|NCT01651195|12360222|FG003|NOT COMPLETED|Overall Study||108
11171299|NCT01651208|12360238|FG000|STARTED|Overall Study||227
11171300|NCT01651208|12360239|FG001|STARTED|Overall Study||225
11171301|NCT01651208|12360238|FG000|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
11171302|NCT01651208|12360239|FG001|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
11171303|NCT01651208|12360238|FG000|NOT COMPLETED|Overall Study||14
11171304|NCT01651208|12360239|FG001|NOT COMPLETED|Overall Study||16
11171305|NCT01651260|12360246|FG000|STARTED|Overall Study||65
11171306|NCT01651260|12360246|FG000|COMPLETED|Overall Study||62
11171307|NCT01651260|12360246|FG000|NOT COMPLETED|Overall Study||3
11171308|NCT01651351|12360253|FG000|STARTED|Overall Study||15
11171309|NCT01651351|12360254|FG001|STARTED|Overall Study||15
11171310|NCT01651351|12360253|FG000|COMPLETED|Overall Study||15
11171311|NCT01651351|12360254|FG001|COMPLETED|Overall Study||15
11171312|NCT01651351|12360253|FG000|NOT COMPLETED|Overall Study||0
11171313|NCT01651351|12360254|FG001|NOT COMPLETED|Overall Study||0
11171314|NCT01651442|12360263|FG000|STARTED|Phase I Treatment||104
11171315|NCT01651442|12360264|FG001|STARTED|Phase I Treatment||107
11171316|NCT01651442|12360265|FG002|STARTED|Phase I Treatment||0
11171317|NCT01651442|12360266|FG003|STARTED|Phase I Treatment||0
11171318|NCT01651442|12360267|FG004|STARTED|Phase I Treatment||0
11171319|NCT01651442|12360268|FG005|STARTED|Phase I Treatment||0
11171320|NCT01651442|12360263|FG000|COMPLETED|Phase I Treatment||88
11171321|NCT01651442|12360264|FG001|COMPLETED|Phase I Treatment||80
11171322|NCT01651442|12360265|FG002|COMPLETED|Phase I Treatment||0
11171323|NCT01651442|12360266|FG003|COMPLETED|Phase I Treatment||0
11171324|NCT01651442|12360267|FG004|COMPLETED|Phase I Treatment||0
11171325|NCT01651442|12360268|FG005|COMPLETED|Phase I Treatment||0
11171326|NCT01651442|12360263|FG000|NOT COMPLETED|Phase I Treatment||16
11171327|NCT01651442|12360264|FG001|NOT COMPLETED|Phase I Treatment||27
11171328|NCT01651442|12360265|FG002|NOT COMPLETED|Phase I Treatment||0
11171329|NCT01651442|12360266|FG003|NOT COMPLETED|Phase I Treatment||0
11171330|NCT01651442|12360267|FG004|NOT COMPLETED|Phase I Treatment||0
11171331|NCT01651442|12360268|FG005|NOT COMPLETED|Phase I Treatment||0
11171332|NCT01651442|12360263|FG000|STARTED|Phase II Treatment||0
11171333|NCT01651442|12360264|FG001|STARTED|Phase II Treatment||0
11171334|NCT01651442|12360265|FG002|STARTED|Phase II Treatment||27
11171335|NCT01651442|12360266|FG003|STARTED|Phase II Treatment||27
11171336|NCT01651442|12360267|FG004|STARTED|Phase II Treatment||27
11171337|NCT01651442|12360268|FG005|STARTED|Phase II Treatment||27
11171338|NCT01651442|12360263|FG000|COMPLETED|Phase II Treatment||0
11171339|NCT01651442|12360264|FG001|COMPLETED|Phase II Treatment||0
11171340|NCT01651442|12360265|FG002|COMPLETED|Phase II Treatment||25
11171341|NCT01651442|12360266|FG003|COMPLETED|Phase II Treatment||15
11171342|NCT01651442|12360267|FG004|COMPLETED|Phase II Treatment||21
11171343|NCT01651442|12360268|FG005|COMPLETED|Phase II Treatment||17
11171344|NCT01651442|12360263|FG000|NOT COMPLETED|Phase II Treatment||0
11171345|NCT01651442|12360264|FG001|NOT COMPLETED|Phase II Treatment||0
11171346|NCT01651442|12360265|FG002|NOT COMPLETED|Phase II Treatment||2
11420063|NCT00078806|12618842|FG000|STARTED|Part 3||0
11420064|NCT00078806|12618843|FG001|STARTED|Part 3||0
11420065|NCT00078806|12618844|FG002|STARTED|Part 3||0
11420066|NCT00078806|12618845|FG003|STARTED|Part 3||9
11420067|NCT00078806|12618842|FG000|COMPLETED|Part 3||0
11420068|NCT00078806|12618843|FG001|COMPLETED|Part 3||0
11420069|NCT00078806|12618844|FG002|COMPLETED|Part 3||0
11420070|NCT00078806|12618845|FG003|COMPLETED|Part 3||9
11420071|NCT00078806|12618842|FG000|NOT COMPLETED|Part 3||0
11420072|NCT00078806|12618843|FG001|NOT COMPLETED|Part 3||0
11420073|NCT00078806|12618844|FG002|NOT COMPLETED|Part 3||0
11171347|NCT01651442|12360266|FG003|NOT COMPLETED|Phase II Treatment||12
11171348|NCT01651442|12360267|FG004|NOT COMPLETED|Phase II Treatment||6
11171349|NCT01651442|12360268|FG005|NOT COMPLETED|Phase II Treatment||10
11171350|NCT01651780|12360282|FG000|STARTED|Overall Study||405
11420074|NCT00078806|12618845|FG003|NOT COMPLETED|Part 3||0
11171351|NCT01651780|12360283|FG001|STARTED|Overall Study||398
11171352|NCT01651780|12360282|FG000|Intent-To-Treat (ITT) Population|Overall Study||404
11171353|NCT01651780|12360283|FG001|Intent-To-Treat (ITT) Population|Overall Study||398
11171354|NCT01651780|12360282|FG000|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
11171355|NCT01651780|12360283|FG001|Received at Least 1 Dose of Study Drug|Overall Study||394
11171356|NCT01651780|12360282|FG000|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
11171357|NCT01651780|12360283|FG001|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
11171358|NCT01651780|12360282|FG000|COMPLETED|Overall Study||394
11171359|NCT01651780|12360283|FG001|COMPLETED|Overall Study||388
11171360|NCT01651780|12360282|FG000|NOT COMPLETED|Overall Study||11
11171361|NCT01651780|12360283|FG001|NOT COMPLETED|Overall Study||10
11171362|NCT01651793|12360293|FG000|STARTED|Overall Study||6
11171363|NCT01651793|12360294|FG001|STARTED|Overall Study||6
11171364|NCT01651793|12360295|FG002|STARTED|Overall Study||6
11171365|NCT01651793|12360296|FG003|STARTED|Overall Study||6
11171366|NCT01651793|12360293|FG000|COMPLETED|Overall Study||6
11171367|NCT01651793|12360294|FG001|COMPLETED|Overall Study||6
11171368|NCT01651793|12360295|FG002|COMPLETED|Overall Study||6
11171369|NCT01651793|12360296|FG003|COMPLETED|Overall Study||5
11171370|NCT01651793|12360293|FG000|NOT COMPLETED|Overall Study||0
11171371|NCT01651793|12360294|FG001|NOT COMPLETED|Overall Study||0
11171372|NCT01651793|12360295|FG002|NOT COMPLETED|Overall Study||0
11171373|NCT01651793|12360296|FG003|NOT COMPLETED|Overall Study||1
11171374|NCT01651806|12360315|FG000|STARTED|Overall Study||13
11171375|NCT01651806|12360316|FG001|STARTED|Overall Study||12
11171376|NCT01651806|12360317|FG002|STARTED|Overall Study||25
11171377|NCT01651806|12360318|FG003|STARTED|Overall Study||7
11171378|NCT01651806|12360319|FG004|STARTED|Overall Study||8
11171379|NCT01651806|12360315|FG000|COMPLETED|Overall Study||13
11171380|NCT01651806|12360316|FG001|COMPLETED|Overall Study||12
11171381|NCT01651806|12360317|FG002|COMPLETED|Overall Study||25
11171382|NCT01651806|12360318|FG003|COMPLETED|Overall Study||7
11171383|NCT01651806|12360319|FG004|COMPLETED|Overall Study||8
11171384|NCT01651806|12360315|FG000|NOT COMPLETED|Overall Study||0
11171385|NCT01651806|12360316|FG001|NOT COMPLETED|Overall Study||0
11171386|NCT01651806|12360317|FG002|NOT COMPLETED|Overall Study||0
11171387|NCT01651806|12360318|FG003|NOT COMPLETED|Overall Study||0
11171388|NCT01651806|12360319|FG004|NOT COMPLETED|Overall Study||0
11171389|NCT01651936|12360334|FG000|STARTED|Base Study||30
11171390|NCT01651936|12360335|FG001|STARTED|Base Study||26
11171391|NCT01651936|12360336|FG002|STARTED|Base Study||0
11171392|NCT01651936|12360334|FG000|COMPLETED|Base Study||3
11171393|NCT01651936|12360335|FG001|COMPLETED|Base Study||1
11171394|NCT01651936|12360336|FG002|COMPLETED|Base Study||0
11171395|NCT01651936|12360334|FG000|NOT COMPLETED|Base Study||27
11171396|NCT01651936|12360335|FG001|NOT COMPLETED|Base Study||25
11171397|NCT01651936|12360336|FG002|NOT COMPLETED|Base Study||0
11171398|NCT01651936|12360334|FG000|STARTED|Extension Study||0
11171399|NCT01651936|12360335|FG001|STARTED|Extension Study||0
11171400|NCT01651936|12360336|FG002|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
11171401|NCT01651936|12360334|FG000|COMPLETED|Extension Study||0
11171402|NCT01651936|12360335|FG001|COMPLETED|Extension Study||0
11171403|NCT01651936|12360336|FG002|COMPLETED|Extension Study||0
11171404|NCT01651936|12360334|FG000|NOT COMPLETED|Extension Study||0
11171405|NCT01651936|12360335|FG001|NOT COMPLETED|Extension Study||0
11171406|NCT01651936|12360336|FG002|NOT COMPLETED|Extension Study||14
11171407|NCT01651949|12360346|FG000|STARTED|Overall Study||1106
11171408|NCT01651949|12360347|FG001|STARTED|Overall Study||1101
11171409|NCT01651949|12360348|FG002|STARTED|Overall Study||313
11171410|NCT01651949|12360346|FG000|Vaccination 1|Overall Study||1103
11171411|NCT01651949|12360347|FG001|Vaccination 1|Overall Study||1099
11171412|NCT01651949|12360348|FG002|Vaccination 1|Overall Study||313
11171413|NCT01651949|12360346|FG000|Vaccination 2|Overall Study||1089
11171414|NCT01651949|12360347|FG001|Vaccination 2|Overall Study||1069
11171415|NCT01651949|12360348|FG002|Vaccination 2|Overall Study||298
11171416|NCT01651949|12360346|FG000|Vaccination 3|Overall Study||1067
11171417|NCT01651949|12360347|FG001|Vaccination 3|Overall Study||1037
11171418|NCT01651949|12360348|FG002|Vaccination 3|Overall Study||291
11171419|NCT01651949|12360346|FG000|COMPLETED|Overall Study||1053
11171420|NCT01651949|12360347|FG001|COMPLETED|Overall Study||1015
11171421|NCT01651949|12360348|FG002|COMPLETED|Overall Study||282
11171422|NCT01651949|12360346|FG000|NOT COMPLETED|Overall Study||53
11171423|NCT01651949|12360347|FG001|NOT COMPLETED|Overall Study||86
11171424|NCT01651949|12360348|FG002|NOT COMPLETED|Overall Study||31
11171425|NCT01652001|12360358|FG000|STARTED|Overall Study||100
11171426|NCT01652001|12360359|FG001|STARTED|Overall Study||85
11171427|NCT01652001|12360358|FG000|COMPLETED|Overall Study||91
11171428|NCT01652001|12360359|FG001|COMPLETED|Overall Study||79
11171429|NCT01652001|12360358|FG000|NOT COMPLETED|Overall Study||9
11171430|NCT01652001|12360359|FG001|NOT COMPLETED|Overall Study||6
11171431|NCT01652040|12360367|FG000|STARTED|Overall Study||13
11171432|NCT01652040|12360368|FG001|STARTED|Overall Study||13
11171433|NCT01652040|12360367|FG000|COMPLETED|Overall Study||11
11171434|NCT01652040|12360368|FG001|COMPLETED|Overall Study||11
11171435|NCT01652040|12360367|FG000|NOT COMPLETED|Overall Study||2
11171436|NCT01652040|12360368|FG001|NOT COMPLETED|Overall Study||2
11171437|NCT01652287|12360377|FG000|STARTED|Overall Study||31
11171438|NCT01652287|12360378|FG001|STARTED|Overall Study||31
11171439|NCT01652287|12360377|FG000|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
11171440|NCT01652287|12360378|FG001|COMPLETED|Overall Study||31
11171441|NCT01652287|12360377|FG000|NOT COMPLETED|Overall Study||2
11171442|NCT01652287|12360378|FG001|NOT COMPLETED|Overall Study||0
11171443|NCT01652495|12360386|FG000|STARTED|Overall Study||22
11171444|NCT01652495|12360387|FG001|STARTED|Overall Study||22
11171445|NCT01652495|12360386|FG000|COMPLETED|Overall Study||20
11171446|NCT01652495|12360387|FG001|COMPLETED|Overall Study||20
11171447|NCT01652495|12360386|FG000|NOT COMPLETED|Overall Study||2
11171448|NCT01652495|12360387|FG001|NOT COMPLETED|Overall Study||2
11171449|NCT01652573|12360397|FG000|STARTED|Overall Study||10
11171450|NCT01652573|12360398|FG001|STARTED|Overall Study||11
11171451|NCT01652573|12360397|FG000|COMPLETED|Overall Study||10
11171452|NCT01652573|12360398|FG001|COMPLETED|Overall Study||10
11171453|NCT01652573|12360397|FG000|NOT COMPLETED|Overall Study||0
11171454|NCT01652573|12360398|FG001|NOT COMPLETED|Overall Study||1
11171455|NCT01652664|12360406|FG000|STARTED|Overall Study||77
11171456|NCT01652664|12360407|FG001|STARTED|Overall Study||75
11171457|NCT01652664|12360406|FG000|COMPLETED|Overall Study||71
11171458|NCT01652664|12360407|FG001|COMPLETED|Overall Study||74
11171459|NCT01652664|12360406|FG000|NOT COMPLETED|Overall Study||6
11171460|NCT01652664|12360407|FG001|NOT COMPLETED|Overall Study||1
11171461|NCT01652690|12360416|FG000|STARTED|Overall Study||300
11171462|NCT01652690|12360417|FG001|STARTED|Overall Study||300
11171463|NCT01652690|12360416|FG000|COMPLETED|Overall Study||265
11171464|NCT01652690|12360417|FG001|COMPLETED|Overall Study||279
11171465|NCT01652690|12360416|FG000|NOT COMPLETED|Overall Study||35
11171466|NCT01652690|12360417|FG001|NOT COMPLETED|Overall Study||21
11171467|NCT01652703|12360429|FG000|STARTED|Overall Study||52
11171468|NCT01652703|12360430|FG001|STARTED|Overall Study||51
11171469|NCT01652703|12360431|FG002|STARTED|Overall Study||50
11171470|NCT01652703|12360432|FG003|STARTED|Overall Study||52
11171471|NCT01652703|12360433|FG004|STARTED|Overall Study||52
11171472|NCT01652703|12360434|FG005|STARTED|Overall Study||53
11171473|NCT01652703|12360429|FG000|Received Treatment|Overall Study||52
11171474|NCT01652703|12360430|FG001|Received Treatment|Overall Study||50
11171475|NCT01652703|12360431|FG002|Received Treatment|Overall Study||49
11171476|NCT01652703|12360432|FG003|Received Treatment|Overall Study||52
11171477|NCT01652703|12360433|FG004|Received Treatment|Overall Study||51
11171478|NCT01652703|12360434|FG005|Received Treatment|Overall Study||53
11171479|NCT01652703|12360429|FG000|COMPLETED|Overall Study||52
11171480|NCT01652703|12360430|FG001|COMPLETED|Overall Study||50
11171481|NCT01652703|12360431|FG002|COMPLETED|Overall Study||47
11171482|NCT01652703|12360432|FG003|COMPLETED|Overall Study||50
11171483|NCT01652703|12360433|FG004|COMPLETED|Overall Study||51
11171484|NCT01652703|12360434|FG005|COMPLETED|Overall Study||51
11171485|NCT01652703|12360429|FG000|NOT COMPLETED|Overall Study||0
11171486|NCT01652703|12360430|FG001|NOT COMPLETED|Overall Study||1
11171487|NCT01652703|12360431|FG002|NOT COMPLETED|Overall Study||3
11171488|NCT01652703|12360432|FG003|NOT COMPLETED|Overall Study||2
11171489|NCT01652703|12360433|FG004|NOT COMPLETED|Overall Study||1
11171490|NCT01652703|12360434|FG005|NOT COMPLETED|Overall Study||2
11171491|NCT01652716|12360450|FG000|STARTED|Overall Study||229
11171492|NCT01652716|12360451|FG001|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
11171493|NCT01652716|12360450|FG000|Completed 28-week|Overall Study||197
11171494|NCT01652716|12360451|FG001|Completed 28-week|Overall Study||118
11171495|NCT01652716|12360450|FG000|COMPLETED|Overall Study|* completed study|173
11171496|NCT01652716|12360451|FG001|COMPLETED|Overall Study|* completed study|102
11171497|NCT01652716|12360450|FG000|NOT COMPLETED|Overall Study||56
11171498|NCT01652716|12360451|FG001|NOT COMPLETED|Overall Study||46
11171499|NCT01652729|12360460|FG000|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
11171500|NCT01652729|12360461|FG001|STARTED|Overall Study||122
11171501|NCT01652729|12360462|FG002|STARTED|Overall Study||61
11171502|NCT01652729|12360460|FG000|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
11171503|NCT01652729|12360461|FG001|Modified Intent-to-Treat|Overall Study||122
11171504|NCT01652729|12360462|FG002|Modified Intent-to-Treat|Overall Study||61
11171505|NCT01652729|12360460|FG000|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
11171506|NCT01652729|12360461|FG001|Treated|Overall Study||122
11171507|NCT01652729|12360462|FG002|Treated|Overall Study||61
11171508|NCT01652729|12360460|FG000|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
11171509|NCT01652729|12360461|FG001|Evaluable|Overall Study||91
11171510|NCT01652729|12360462|FG002|Evaluable|Overall Study||43
11171511|NCT01652729|12360460|FG000|Meal Test Subjects|Overall Study||60
11171512|NCT01652729|12360461|FG001|Meal Test Subjects|Overall Study||41
11171513|NCT01652729|12360462|FG002|Meal Test Subjects|Overall Study||20
11171514|NCT01652729|12360460|FG000|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
11171515|NCT01652729|12360461|FG001|Meal Test Evaluable|Overall Study||31
11171516|NCT01652729|12360462|FG002|Meal Test Evaluable|Overall Study||15
11171517|NCT01652729|12360460|FG000|COMPLETED|Overall Study|The double-enrolled subject's reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
11171518|NCT01652729|12360461|FG001|COMPLETED|Overall Study||109
11171519|NCT01652729|12360462|FG002|COMPLETED|Overall Study||47
11171520|NCT01652729|12360460|FG000|NOT COMPLETED|Overall Study||27
11171521|NCT01652729|12360461|FG001|NOT COMPLETED|Overall Study||13
11171522|NCT01652729|12360462|FG002|NOT COMPLETED|Overall Study||14
11171523|NCT01652885|12360470|FG000|STARTED|Overall Study||23
11171524|NCT01652885|12360470|FG000|COMPLETED|Overall Study||22
11171525|NCT01652885|12360470|FG000|NOT COMPLETED|Overall Study||1
11171526|NCT01652976|12360474|FG000|STARTED|Overall Study||44
11171527|NCT01652976|12360474|FG000|COMPLETED|Overall Study||44
11171528|NCT01652976|12360474|FG000|NOT COMPLETED|Overall Study||0
11171529|NCT01653028|12360483|FG000|STARTED|Overall Study||12
11171530|NCT01653028|12360484|FG001|STARTED|Overall Study||10
11171531|NCT01653028|12360485|FG002|STARTED|Overall Study||11
11171532|NCT01653028|12360486|FG003|STARTED|Overall Study||10
11171533|NCT01653028|12360487|FG004|STARTED|Overall Study||29
11171534|NCT01653028|12360483|FG000|COMPLETED|Overall Study||12
11171535|NCT01653028|12360484|FG001|COMPLETED|Overall Study||10
11171536|NCT01653028|12360485|FG002|COMPLETED|Overall Study||11
11171537|NCT01653028|12360486|FG003|COMPLETED|Overall Study||10
11171538|NCT01653028|12360487|FG004|COMPLETED|Overall Study||29
11171539|NCT01653028|12360483|FG000|NOT COMPLETED|Overall Study||0
11171540|NCT01653028|12360484|FG001|NOT COMPLETED|Overall Study||0
11171541|NCT01653028|12360485|FG002|NOT COMPLETED|Overall Study||0
11171542|NCT01653028|12360486|FG003|NOT COMPLETED|Overall Study||0
11171543|NCT01653028|12360487|FG004|NOT COMPLETED|Overall Study||0
11171544|NCT01653132|12360499|FG000|STARTED|First Intervention||5
11171545|NCT01653132|12360500|FG001|STARTED|First Intervention||5
11171546|NCT01653132|12360499|FG000|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
11171547|NCT01653132|12360500|FG001|COMPLETED|First Intervention||5
11171548|NCT01653132|12360499|FG000|NOT COMPLETED|First Intervention||1
11171549|NCT01653132|12360500|FG001|NOT COMPLETED|First Intervention||0
11171550|NCT01653132|12360499|FG000|STARTED|Washout 1-2 Months||4
11171551|NCT01653132|12360500|FG001|STARTED|Washout 1-2 Months||5
11171552|NCT01653132|12360499|FG000|COMPLETED|Washout 1-2 Months||4
11171553|NCT01653132|12360500|FG001|COMPLETED|Washout 1-2 Months||5
11171554|NCT01653132|12360499|FG000|NOT COMPLETED|Washout 1-2 Months||0
11171555|NCT01653132|12360500|FG001|NOT COMPLETED|Washout 1-2 Months||0
11171556|NCT01653132|12360499|FG000|STARTED|Second Intervention||4
11171557|NCT01653132|12360500|FG001|STARTED|Second Intervention||5
11171558|NCT01653132|12360499|FG000|COMPLETED|Second Intervention||4
11171559|NCT01653132|12360500|FG001|COMPLETED|Second Intervention||5
11171560|NCT01653132|12360499|FG000|NOT COMPLETED|Second Intervention||0
11171561|NCT01653132|12360500|FG001|NOT COMPLETED|Second Intervention||0
11171562|NCT01653158|12360510|FG000|STARTED|Overall Study||3
11171563|NCT01653158|12360511|FG001|STARTED|Overall Study||3
11171564|NCT01653158|12360512|FG002|STARTED|Overall Study||3
11171565|NCT01653158|12360513|FG003|STARTED|Overall Study||3
11171566|NCT01653158|12360514|FG004|STARTED|Overall Study||3
11171567|NCT01653158|12360515|FG005|STARTED|Overall Study||3
11171568|NCT01653158|12360516|FG006|STARTED|Overall Study||9
11171569|NCT01653158|12360517|FG007|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
11171570|NCT01653158|12360510|FG000|COMPLETED|Overall Study||2
11171571|NCT01653158|12360511|FG001|COMPLETED|Overall Study||3
11171572|NCT01653158|12360512|FG002|COMPLETED|Overall Study||3
11171573|NCT01653158|12360513|FG003|COMPLETED|Overall Study||1
11171574|NCT01653158|12360514|FG004|COMPLETED|Overall Study||2
11171575|NCT01653158|12360515|FG005|COMPLETED|Overall Study||2
11171576|NCT01653158|12360516|FG006|COMPLETED|Overall Study||7
11171577|NCT01653158|12360517|FG007|COMPLETED|Overall Study||4
11171578|NCT01653158|12360510|FG000|NOT COMPLETED|Overall Study||1
11171579|NCT01653158|12360511|FG001|NOT COMPLETED|Overall Study||0
11171580|NCT01653158|12360512|FG002|NOT COMPLETED|Overall Study||0
11171581|NCT01653158|12360513|FG003|NOT COMPLETED|Overall Study||2
11171582|NCT01653158|12360514|FG004|NOT COMPLETED|Overall Study||1
11171583|NCT01653158|12360515|FG005|NOT COMPLETED|Overall Study||1
11171584|NCT01653158|12360516|FG006|NOT COMPLETED|Overall Study||2
11171585|NCT01653158|12360517|FG007|NOT COMPLETED|Overall Study||15
11171586|NCT01653210|12360540|FG000|STARTED|Overall Study||15
11171587|NCT01653210|12360540|FG000|COMPLETED|Overall Study||12
11171588|NCT01653210|12360540|FG000|NOT COMPLETED|Overall Study||3
11171589|NCT01653262|12360544|FG000|STARTED|Overall Study||29
11171590|NCT01653262|12360544|FG000|COMPLETED|Overall Study||26
11171591|NCT01653262|12360544|FG000|NOT COMPLETED|Overall Study||3
11171592|NCT01653288|12360550|FG000|STARTED|Overall Study||36
11171593|NCT01653288|12360551|FG001|STARTED|Overall Study||36
11171594|NCT01653288|12360550|FG000|COMPLETED|Overall Study||26
11171595|NCT01653288|12360551|FG001|COMPLETED|Overall Study||35
11171596|NCT01653288|12360550|FG000|NOT COMPLETED|Overall Study||10
11171597|NCT01653288|12360551|FG001|NOT COMPLETED|Overall Study||1
11171598|NCT01653327|12360559|FG000|STARTED|Overall Study||11
11171599|NCT01653327|12360559|FG000|COMPLETED|Overall Study||10
11171600|NCT01653327|12360559|FG000|NOT COMPLETED|Overall Study||1
11171601|NCT01653405|12360567|FG000|STARTED|Overall Study||11794
11171602|NCT01653405|12360568|FG001|STARTED|Overall Study||1248782
11171603|NCT01653405|12360567|FG000|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029
11171604|NCT01653405|12360568|FG001|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979
11171605|NCT01653405|12360567|FG000|NOT COMPLETED|Overall Study||3765
11171606|NCT01653405|12360568|FG001|NOT COMPLETED|Overall Study||1068803
11171607|NCT01653418|12360574|FG000|STARTED|Overall Study||10
11171608|NCT01653418|12360574|FG000|COMPLETED|Overall Study||10
11171609|NCT01653418|12360574|FG000|NOT COMPLETED|Overall Study||0
11171610|NCT01653509|12360580|FG000|STARTED|Overall Study||12
11171611|NCT01653509|12360581|FG001|STARTED|Overall Study||13
11171612|NCT01653509|12360580|FG000|COMPLETED|Overall Study||12
11171613|NCT01653509|12360581|FG001|COMPLETED|Overall Study||13
11171614|NCT01653509|12360580|FG000|NOT COMPLETED|Overall Study||0
11171615|NCT01653509|12360581|FG001|NOT COMPLETED|Overall Study||0
11171616|NCT01653587|12360591|FG000|STARTED|Overall Study||120
11171617|NCT01653587|12360592|FG001|STARTED|Overall Study||120
11171618|NCT01653587|12360591|FG000|COMPLETED|Overall Study||120
11171619|NCT01653587|12360592|FG001|COMPLETED|Overall Study||120
11171620|NCT01653587|12360591|FG000|NOT COMPLETED|Overall Study||0
11171621|NCT01653587|12360592|FG001|NOT COMPLETED|Overall Study||0
11171622|NCT01653704|12360600|FG000|STARTED|Overall Study||21
11171623|NCT01653704|12360601|FG001|STARTED|Overall Study||21
11171624|NCT01653704|12360600|FG000|COMPLETED|Overall Study||19
11171625|NCT01653704|12360601|FG001|COMPLETED|Overall Study||20
11171626|NCT01653704|12360600|FG000|NOT COMPLETED|Overall Study||2
11171627|NCT01653704|12360601|FG001|NOT COMPLETED|Overall Study||1
11171628|NCT01653743|12360609|FG000|STARTED|Overall Study||54
11171629|NCT01653743|12360610|FG001|STARTED|Overall Study||27
11171630|NCT01653743|12360609|FG000|COMPLETED|Overall Study||50
11171631|NCT01653743|12360610|FG001|COMPLETED|Overall Study||27
11171632|NCT01653743|12360609|FG000|NOT COMPLETED|Overall Study||4
11171633|NCT01653743|12360610|FG001|NOT COMPLETED|Overall Study||0
11171634|NCT01653782|12360619|FG000|STARTED|Overall Study||52
11171635|NCT01653782|12360620|FG001|STARTED|Overall Study||55
11171636|NCT01653782|12360621|FG002|STARTED|Overall Study||52
11171637|NCT01653782|12360619|FG000|COMPLETED|Overall Study||36
11171638|NCT01653782|12360620|FG001|COMPLETED|Overall Study||37
11171639|NCT01653782|12360621|FG002|COMPLETED|Overall Study||46
11171640|NCT01653782|12360619|FG000|NOT COMPLETED|Overall Study||16
11171641|NCT01653782|12360620|FG001|NOT COMPLETED|Overall Study||18
11171642|NCT01653782|12360621|FG002|NOT COMPLETED|Overall Study||6
11171643|NCT01653847|12360631|FG000|STARTED|Overall Study||20
11171644|NCT01653847|12360632|FG001|STARTED|Overall Study||20
11171645|NCT01653847|12360631|FG000|COMPLETED|Overall Study||19
11171646|NCT01653847|12360632|FG001|COMPLETED|Overall Study||20
11171647|NCT01653847|12360631|FG000|NOT COMPLETED|Overall Study||1
11171648|NCT01653847|12360632|FG001|NOT COMPLETED|Overall Study||0
11203862|NCT01849562|12394414|FG000|STARTED|Overall Study||10
11203863|NCT01849562|12394415|FG001|STARTED|Overall Study||10
11203864|NCT01849562|12394416|FG002|STARTED|Overall Study||10
11203865|NCT01849562|12394414|FG000|COMPLETED|Overall Study||8
11203866|NCT01849562|12394415|FG001|COMPLETED|Overall Study||10
11203867|NCT01849562|12394416|FG002|COMPLETED|Overall Study||10
11203868|NCT01849562|12394414|FG000|NOT COMPLETED|Overall Study||2
11203869|NCT01849562|12394415|FG001|NOT COMPLETED|Overall Study||0
11203870|NCT01849562|12394416|FG002|NOT COMPLETED|Overall Study||0
11203871|NCT01849588|12394425|FG000|STARTED|Overall Study||3
11203872|NCT01849588|12394425|FG000|COMPLETED|Overall Study||0
11203873|NCT01849588|12394425|FG000|NOT COMPLETED|Overall Study||3
11420075|NCT04377308|12618862|FG000|STARTED|Overall Study||4
11420076|NCT04377308|12618863|FG001|STARTED|Overall Study||12
11420077|NCT04377308|12618862|FG000|COMPLETED|Overall Study||4
11420078|NCT04377308|12618863|FG001|COMPLETED|Overall Study||11
11420079|NCT04377308|12618862|FG000|NOT COMPLETED|Overall Study||0
11420080|NCT04377308|12618863|FG001|NOT COMPLETED|Overall Study||1
11203874|NCT01849692|12394431|FG000|STARTED|Overall Study||10
11203875|NCT01849692|12394432|FG001|STARTED|Overall Study||3
11203876|NCT01849692|12394433|FG002|STARTED|Overall Study||10
11203877|NCT01849692|12394434|FG003|STARTED|Overall Study||3
11203878|NCT01849692|12394435|FG004|STARTED|Overall Study||10
11203879|NCT01849692|12394436|FG005|STARTED|Overall Study||3
11203880|NCT01849692|12394437|FG006|STARTED|Overall Study||10
11203881|NCT01849692|12394438|FG007|STARTED|Overall Study||3
11203882|NCT01849692|12394431|FG000|COMPLETED|Overall Study||10
11203883|NCT01849692|12394432|FG001|COMPLETED|Overall Study||3
11203884|NCT01849692|12394433|FG002|COMPLETED|Overall Study||10
11203885|NCT01849692|12394434|FG003|COMPLETED|Overall Study||3
11203886|NCT01849692|12394435|FG004|COMPLETED|Overall Study||10
11203887|NCT01849692|12394436|FG005|COMPLETED|Overall Study||3
11203888|NCT01849692|12394437|FG006|COMPLETED|Overall Study||10
11203889|NCT01849692|12394438|FG007|COMPLETED|Overall Study||3
11203890|NCT01849692|12394431|FG000|NOT COMPLETED|Overall Study||0
11203891|NCT01849692|12394432|FG001|NOT COMPLETED|Overall Study||0
11203892|NCT01849692|12394433|FG002|NOT COMPLETED|Overall Study||0
11203893|NCT01849692|12394434|FG003|NOT COMPLETED|Overall Study||0
11203894|NCT01849692|12394435|FG004|NOT COMPLETED|Overall Study||0
11203895|NCT01849692|12394436|FG005|NOT COMPLETED|Overall Study||0
11203896|NCT01849692|12394437|FG006|NOT COMPLETED|Overall Study||0
11203897|NCT01849692|12394438|FG007|NOT COMPLETED|Overall Study||0
11203898|NCT01849770|12394462|FG000|STARTED|Overall Study||20
11203899|NCT01849770|12394463|FG001|STARTED|Overall Study||19
11203900|NCT01849770|12394464|FG002|STARTED|Overall Study||20
11203901|NCT01849770|12394462|FG000|COMPLETED|Overall Study||20
11203902|NCT01849770|12394463|FG001|COMPLETED|Overall Study||15
11203903|NCT01849770|12394464|FG002|COMPLETED|Overall Study||19
11203904|NCT01849770|12394462|FG000|NOT COMPLETED|Overall Study||0
11203905|NCT01849770|12394463|FG001|NOT COMPLETED|Overall Study||4
11420081|NCT04180163|12618869|FG000|STARTED|Run-in Period (4 or up to 8 Weeks)||12
11420082|NCT04180163|12618869|FG000|COMPLETED|Run-in Period (4 or up to 8 Weeks)||12
11420083|NCT04180163|12618869|FG000|NOT COMPLETED|Run-in Period (4 or up to 8 Weeks)||0
11420084|NCT04180163|12618869|FG000|STARTED|Treatment Period A (Weeks 1 to 26)||12
11420085|NCT04180163|12618869|FG000|COMPLETED|Treatment Period A (Weeks 1 to 26)||12
11203906|NCT01849770|12394464|FG002|NOT COMPLETED|Overall Study||1
11203907|NCT01849822|12394474|FG000|STARTED|Overall Study||1
11171649|NCT01653912|12360640|FG000|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
11171650|NCT01653912|12360641|FG001|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171651|NCT01653912|12360642|FG002|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171652|NCT01653912|12360643|FG003|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11420086|NCT04180163|12618869|FG000|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||0
11420087|NCT04180163|12618869|FG000|STARTED|Treatment Period B (Weeks 27 to 52)||12
11420088|NCT04180163|12618869|FG000|COMPLETED|Treatment Period B (Weeks 27 to 52)||12
11171653|NCT01653912|12360644|FG004|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171654|NCT01653912|12360645|FG005|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171655|NCT01653912|12360640|FG000|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
11171656|NCT01653912|12360641|FG001|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171657|NCT01653912|12360642|FG002|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171658|NCT01653912|12360643|FG003|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171659|NCT01653912|12360644|FG004|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171660|NCT01653912|12360645|FG005|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171661|NCT01653912|12360640|FG000|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171662|NCT01653912|12360641|FG001|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171663|NCT01653912|12360642|FG002|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171664|NCT01653912|12360643|FG003|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171665|NCT01653912|12360644|FG004|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171666|NCT01653912|12360645|FG005|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
11171667|NCT01653912|12360640|FG000|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171668|NCT01653912|12360641|FG001|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
11171669|NCT01653912|12360642|FG002|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171670|NCT01653912|12360643|FG003|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171671|NCT01653912|12360644|FG004|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171672|NCT01653912|12360645|FG005|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171673|NCT01653912|12360640|FG000|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171674|NCT01653912|12360641|FG001|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
11171675|NCT01653912|12360642|FG002|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171676|NCT01653912|12360643|FG003|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171677|NCT01653912|12360644|FG004|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171678|NCT01653912|12360645|FG005|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171679|NCT01653912|12360640|FG000|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171680|NCT01653912|12360641|FG001|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
11171681|NCT01653912|12360642|FG002|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171682|NCT01653912|12360643|FG003|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171683|NCT01653912|12360644|FG004|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171684|NCT01653912|12360645|FG005|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
11171685|NCT01653912|12360640|FG000|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171686|NCT01653912|12360641|FG001|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171687|NCT01653912|12360642|FG002|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
11171688|NCT01653912|12360643|FG003|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171689|NCT01653912|12360644|FG004|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171690|NCT01653912|12360645|FG005|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171691|NCT01653912|12360640|FG000|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171692|NCT01653912|12360641|FG001|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171693|NCT01653912|12360642|FG002|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
11171694|NCT01653912|12360643|FG003|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171695|NCT01653912|12360644|FG004|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171696|NCT01653912|12360645|FG005|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171697|NCT01653912|12360640|FG000|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171698|NCT01653912|12360641|FG001|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171699|NCT01653912|12360642|FG002|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
11171700|NCT01653912|12360643|FG003|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171701|NCT01653912|12360644|FG004|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171702|NCT01653912|12360645|FG005|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
11171703|NCT01653912|12360640|FG000|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11171704|NCT01653912|12360641|FG001|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11171705|NCT01653912|12360642|FG002|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11420089|NCT04180163|12618869|FG000|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0
11420090|NCT04180163|12618869|FG000|STARTED|Safety Follow-up Period (Weeks 53 to 56)||12
11420091|NCT04180163|12618869|FG000|COMPLETED|Safety Follow-up Period (Weeks 53 to 56)||12
11420092|NCT04180163|12618869|FG000|NOT COMPLETED|Safety Follow-up Period (Weeks 53 to 56)||0
11420093|NCT04128007|12618888|FG000|STARTED|Overall Study||200
11171706|NCT01653912|12360643|FG003|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
11171707|NCT01653912|12360644|FG004|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11171708|NCT01653912|12360645|FG005|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11171709|NCT01653912|12360640|FG000|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11171710|NCT01653912|12360641|FG001|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11171711|NCT01653912|12360642|FG002|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11171712|NCT01653912|12360643|FG003|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
11171713|NCT01653912|12360644|FG004|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11171714|NCT01653912|12360645|FG005|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11171715|NCT01653912|12360640|FG000|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11171716|NCT01653912|12360641|FG001|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11171717|NCT01653912|12360642|FG002|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11171718|NCT01653912|12360643|FG003|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
11171719|NCT01653912|12360644|FG004|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11171720|NCT01653912|12360645|FG005|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
11171721|NCT01653912|12360640|FG000|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171722|NCT01653912|12360641|FG001|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171723|NCT01653912|12360642|FG002|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171724|NCT01653912|12360643|FG003|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171725|NCT01653912|12360644|FG004|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
11171726|NCT01653912|12360645|FG005|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171727|NCT01653912|12360640|FG000|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171728|NCT01653912|12360641|FG001|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171729|NCT01653912|12360642|FG002|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171730|NCT01653912|12360643|FG003|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171731|NCT01653912|12360644|FG004|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
11171732|NCT01653912|12360645|FG005|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171733|NCT01653912|12360640|FG000|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171734|NCT01653912|12360641|FG001|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171735|NCT01653912|12360642|FG002|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171736|NCT01653912|12360643|FG003|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171737|NCT01653912|12360644|FG004|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171738|NCT01653912|12360645|FG005|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
11171739|NCT01653912|12360640|FG000|STARTED|Phase 2: GSK2110183 125 mg||0
11171740|NCT01653912|12360641|FG001|STARTED|Phase 2: GSK2110183 125 mg||0
11171741|NCT01653912|12360642|FG002|STARTED|Phase 2: GSK2110183 125 mg||0
11171742|NCT01653912|12360643|FG003|STARTED|Phase 2: GSK2110183 125 mg||0
11171743|NCT01653912|12360644|FG004|STARTED|Phase 2: GSK2110183 125 mg||0
11171744|NCT01653912|12360645|FG005|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
11171745|NCT01653912|12360640|FG000|COMPLETED|Phase 2: GSK2110183 125 mg||0
11171746|NCT01653912|12360641|FG001|COMPLETED|Phase 2: GSK2110183 125 mg||0
11171747|NCT01653912|12360642|FG002|COMPLETED|Phase 2: GSK2110183 125 mg||0
11171748|NCT01653912|12360643|FG003|COMPLETED|Phase 2: GSK2110183 125 mg||0
11171749|NCT01653912|12360644|FG004|COMPLETED|Phase 2: GSK2110183 125 mg||0
11171750|NCT01653912|12360645|FG005|COMPLETED|Phase 2: GSK2110183 125 mg||22
11171751|NCT01653912|12360640|FG000|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
11171752|NCT01653912|12360641|FG001|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
11171753|NCT01653912|12360642|FG002|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
11171754|NCT01653912|12360643|FG003|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
11171755|NCT01653912|12360644|FG004|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
11171756|NCT01653912|12360645|FG005|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
11171757|NCT01653964|12360651|FG000|STARTED|Overall Study||82
11171758|NCT01653964|12360651|FG000|COMPLETED|Overall Study||82
11171759|NCT01653964|12360651|FG000|NOT COMPLETED|Overall Study||0
11171760|NCT01654068|12360655|FG000|STARTED|Overall Study||14
11171761|NCT01654068|12360655|FG000|COMPLETED|Overall Study||14
11171762|NCT01654068|12360655|FG000|NOT COMPLETED|Overall Study||0
11171763|NCT01654107|12360661|FG000|STARTED|Overall Study||28
11171764|NCT01654107|12360662|FG001|STARTED|Overall Study||30
11171765|NCT01654107|12360661|FG000|COMPLETED|Overall Study||25
11171766|NCT01654107|12360662|FG001|COMPLETED|Overall Study||22
11171767|NCT01654107|12360661|FG000|NOT COMPLETED|Overall Study||3
11171768|NCT01654107|12360662|FG001|NOT COMPLETED|Overall Study||8
11171769|NCT01654224|12360670|FG000|STARTED|Overall Study||95
11171770|NCT01654224|12360671|FG001|STARTED|Overall Study||110
11171771|NCT01654224|12360670|FG000|COMPLETED|Overall Study||89
11171772|NCT01654224|12360671|FG001|COMPLETED|Overall Study||98
11171773|NCT01654224|12360670|FG000|NOT COMPLETED|Overall Study||6
11171774|NCT01654224|12360671|FG001|NOT COMPLETED|Overall Study||12
11171775|NCT01654250|12360679|FG000|STARTED|Overall Study||44
11171776|NCT01654250|12360680|FG001|STARTED|Overall Study||42
11171777|NCT01654250|12360679|FG000|COMPLETED|Overall Study||43
11171778|NCT01654250|12360680|FG001|COMPLETED|Overall Study||42
11171779|NCT01654250|12360679|FG000|NOT COMPLETED|Overall Study||1
11171780|NCT01654250|12360680|FG001|NOT COMPLETED|Overall Study||0
11171781|NCT01654263|12360693|FG000|STARTED|Overall Study||164
11171782|NCT01654263|12360694|FG001|STARTED|Overall Study||147
11171783|NCT01654263|12360695|FG002|STARTED|Overall Study||139
11171784|NCT01654263|12360696|FG003|STARTED|Overall Study||145
11171785|NCT01654263|12360697|FG004|STARTED|Overall Study||140
11171786|NCT01654263|12360698|FG005|STARTED|Overall Study||149
11171787|NCT01654263|12360693|FG000|COMPLETED|Overall Study||164
11171788|NCT01654263|12360694|FG001|COMPLETED|Overall Study||147
11171789|NCT01654263|12360695|FG002|COMPLETED|Overall Study||137
11171790|NCT01654263|12360696|FG003|COMPLETED|Overall Study||144
11171791|NCT01654263|12360697|FG004|COMPLETED|Overall Study||139
11171792|NCT01654263|12360698|FG005|COMPLETED|Overall Study||148
11171793|NCT01654263|12360693|FG000|NOT COMPLETED|Overall Study||0
11171794|NCT01654263|12360694|FG001|NOT COMPLETED|Overall Study||0
11171795|NCT01654263|12360695|FG002|NOT COMPLETED|Overall Study||2
11171796|NCT01654263|12360696|FG003|NOT COMPLETED|Overall Study||1
11171797|NCT01654263|12360697|FG004|NOT COMPLETED|Overall Study||1
11171798|NCT01654263|12360698|FG005|NOT COMPLETED|Overall Study||1
11171799|NCT01654276|12360709|FG000|STARTED|Overall Study||24
11171800|NCT01654276|12360709|FG000|Visit 2 (2 Months)|Overall Study||19
11171801|NCT01654276|12360709|FG000|Visit 3 (4 Months)|Overall Study||18
11171802|NCT01654276|12360709|FG000|Visit 4 (6months)|Overall Study||18
11171803|NCT01654276|12360709|FG000|COMPLETED|Overall Study||18
11171804|NCT01654276|12360709|FG000|NOT COMPLETED|Overall Study||6
11171805|NCT01654289|12360716|FG000|STARTED|Overall Study||138
11171806|NCT01654289|12360717|FG001|STARTED|Overall Study||137
11171807|NCT01654289|12360718|FG002|STARTED|Overall Study||138
11171808|NCT01654289|12360716|FG000|COMPLETED|Overall Study||111
11171809|NCT01654289|12360717|FG001|COMPLETED|Overall Study||109
11171810|NCT01654289|12360718|FG002|COMPLETED|Overall Study||133
11171811|NCT01654289|12360716|FG000|NOT COMPLETED|Overall Study||27
11171812|NCT01654289|12360717|FG001|NOT COMPLETED|Overall Study||28
11171813|NCT01654289|12360718|FG002|NOT COMPLETED|Overall Study||5
11171814|NCT01654302|12360728|FG000|STARTED|First Intervention (Day 1)||20
11171815|NCT01654302|12360729|FG001|STARTED|First Intervention (Day 1)||20
11171816|NCT01654302|12360728|FG000|COMPLETED|First Intervention (Day 1)||20
11171817|NCT01654302|12360729|FG001|COMPLETED|First Intervention (Day 1)||20
11171818|NCT01654302|12360728|FG000|NOT COMPLETED|First Intervention (Day 1)||0
11171819|NCT01654302|12360729|FG001|NOT COMPLETED|First Intervention (Day 1)||0
11171820|NCT01654302|12360728|FG000|STARTED|Second Intervention (Day 7)||20
11171821|NCT01654302|12360729|FG001|STARTED|Second Intervention (Day 7)||20
11171822|NCT01654302|12360728|FG000|COMPLETED|Second Intervention (Day 7)||19
11171823|NCT01654302|12360729|FG001|COMPLETED|Second Intervention (Day 7)||19
11171824|NCT01654302|12360728|FG000|NOT COMPLETED|Second Intervention (Day 7)||1
11171825|NCT01654302|12360729|FG001|NOT COMPLETED|Second Intervention (Day 7)||1
11171826|NCT01654380|12360737|FG000|STARTED|Part A, Period 1||4
11171827|NCT01654380|12360738|FG001|STARTED|Part A, Period 1||4
11171828|NCT01654380|12360739|FG002|STARTED|Part A, Period 1||0
11171829|NCT01654380|12360740|FG003|STARTED|Part A, Period 1||0
11171830|NCT01654380|12360737|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
11171831|NCT01654380|12360738|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
11171832|NCT01654380|12360739|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
11171833|NCT01654380|12360740|FG003|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
11171834|NCT01654380|12360737|FG000|COMPLETED|Part A, Period 1||4
11171835|NCT01654380|12360738|FG001|COMPLETED|Part A, Period 1||4
11171836|NCT01654380|12360739|FG002|COMPLETED|Part A, Period 1||0
11171837|NCT01654380|12360740|FG003|COMPLETED|Part A, Period 1||0
11171838|NCT01654380|12360737|FG000|NOT COMPLETED|Part A, Period 1||0
11171839|NCT01654380|12360738|FG001|NOT COMPLETED|Part A, Period 1||0
11171840|NCT01654380|12360739|FG002|NOT COMPLETED|Part A, Period 1||0
11171841|NCT01654380|12360740|FG003|NOT COMPLETED|Part A, Period 1||0
11171842|NCT01654380|12360737|FG000|STARTED|Part A, Washout of at Least 6 Days||4
11171843|NCT01654380|12360738|FG001|STARTED|Part A, Washout of at Least 6 Days||4
11171844|NCT01654380|12360739|FG002|STARTED|Part A, Washout of at Least 6 Days||0
11171845|NCT01654380|12360740|FG003|STARTED|Part A, Washout of at Least 6 Days||0
11171846|NCT01654380|12360737|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
11171847|NCT01654380|12360738|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
11171848|NCT01654380|12360739|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
11171849|NCT01654380|12360740|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
11171850|NCT01654380|12360737|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
11171851|NCT01654380|12360738|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
11171852|NCT01654380|12360739|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
11171853|NCT01654380|12360740|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
11171854|NCT01654380|12360737|FG000|STARTED|Part A, Period 2||4
11171855|NCT01654380|12360738|FG001|STARTED|Part A, Period 2||4
11171856|NCT01654380|12360739|FG002|STARTED|Part A, Period 2||0
11171857|NCT01654380|12360740|FG003|STARTED|Part A, Period 2||0
11171858|NCT01654380|12360737|FG000|COMPLETED|Part A, Period 2||4
11323727|NCT00779324|12520971|FG001|COMPLETED|Overall Study||82
11171859|NCT01654380|12360738|FG001|COMPLETED|Part A, Period 2||4
11171860|NCT01654380|12360739|FG002|COMPLETED|Part A, Period 2||0
11171861|NCT01654380|12360740|FG003|COMPLETED|Part A, Period 2||0
11171862|NCT01654380|12360737|FG000|NOT COMPLETED|Part A, Period 2||0
11171863|NCT01654380|12360738|FG001|NOT COMPLETED|Part A, Period 2||0
11171864|NCT01654380|12360739|FG002|NOT COMPLETED|Part A, Period 2||0
11171865|NCT01654380|12360740|FG003|NOT COMPLETED|Part A, Period 2||0
11171866|NCT01654380|12360737|FG000|STARTED|Part A, Washout of at Least 6 Days||4
11171867|NCT01654380|12360738|FG001|STARTED|Part A, Washout of at Least 6 Days||4
11171868|NCT01654380|12360739|FG002|STARTED|Part A, Washout of at Least 6 Days||0
11171869|NCT01654380|12360740|FG003|STARTED|Part A, Washout of at Least 6 Days||0
11171870|NCT01654380|12360737|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
11171871|NCT01654380|12360738|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
11171872|NCT01654380|12360739|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
11171873|NCT01654380|12360740|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
11171874|NCT01654380|12360737|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
11171875|NCT01654380|12360738|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
11171876|NCT01654380|12360739|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
11171877|NCT01654380|12360740|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
11171878|NCT01654380|12360737|FG000|STARTED|Part A, Period 3||4
11171879|NCT01654380|12360738|FG001|STARTED|Part A, Period 3||4
11171880|NCT01654380|12360739|FG002|STARTED|Part A, Period 3||0
11171881|NCT01654380|12360740|FG003|STARTED|Part A, Period 3||0
11171882|NCT01654380|12360737|FG000|COMPLETED|Part A, Period 3||4
11171883|NCT01654380|12360738|FG001|COMPLETED|Part A, Period 3||4
11171884|NCT01654380|12360739|FG002|COMPLETED|Part A, Period 3||0
11171885|NCT01654380|12360740|FG003|COMPLETED|Part A, Period 3||0
11171886|NCT01654380|12360737|FG000|NOT COMPLETED|Part A, Period 3||0
11171887|NCT01654380|12360738|FG001|NOT COMPLETED|Part A, Period 3||0
11171888|NCT01654380|12360739|FG002|NOT COMPLETED|Part A, Period 3||0
11171889|NCT01654380|12360740|FG003|NOT COMPLETED|Part A, Period 3||0
11171890|NCT01654380|12360737|FG000|STARTED|Part A, Washout of at Least 6 Days||4
11171891|NCT01654380|12360738|FG001|STARTED|Part A, Washout of at Least 6 Days||4
11171892|NCT01654380|12360739|FG002|STARTED|Part A, Washout of at Least 6 Days||0
11171893|NCT01654380|12360740|FG003|STARTED|Part A, Washout of at Least 6 Days||0
11171894|NCT01654380|12360737|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
11171895|NCT01654380|12360738|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
11171896|NCT01654380|12360739|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
11171897|NCT01654380|12360740|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
11171898|NCT01654380|12360737|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
11171899|NCT01654380|12360738|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
11171900|NCT01654380|12360739|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
11171901|NCT01654380|12360740|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
11171902|NCT01654380|12360737|FG000|STARTED|Part A, Period 4||4
11171903|NCT01654380|12360738|FG001|STARTED|Part A, Period 4||4
11171904|NCT01654380|12360739|FG002|STARTED|Part A, Period 4||0
11171905|NCT01654380|12360740|FG003|STARTED|Part A, Period 4||0
11171906|NCT01654380|12360737|FG000|COMPLETED|Part A, Period 4||4
11171907|NCT01654380|12360738|FG001|COMPLETED|Part A, Period 4||4
11171908|NCT01654380|12360739|FG002|COMPLETED|Part A, Period 4||0
11171909|NCT01654380|12360740|FG003|COMPLETED|Part A, Period 4||0
11171910|NCT01654380|12360737|FG000|NOT COMPLETED|Part A, Period 4||0
11171911|NCT01654380|12360738|FG001|NOT COMPLETED|Part A, Period 4||0
11171912|NCT01654380|12360739|FG002|NOT COMPLETED|Part A, Period 4||0
11171913|NCT01654380|12360740|FG003|NOT COMPLETED|Part A, Period 4||0
11171914|NCT01654380|12360737|FG000|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
11171915|NCT01654380|12360738|FG001|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
11171916|NCT01654380|12360739|FG002|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
11171917|NCT01654380|12360740|FG003|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
11171918|NCT01654380|12360737|FG000|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
11171919|NCT01654380|12360738|FG001|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
11171920|NCT01654380|12360739|FG002|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
11171921|NCT01654380|12360740|FG003|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
11171922|NCT01654380|12360737|FG000|COMPLETED|Part B, Period 1||0
11171923|NCT01654380|12360738|FG001|COMPLETED|Part B, Period 1||0
11171924|NCT01654380|12360739|FG002|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6
11171925|NCT01654380|12360740|FG003|COMPLETED|Part B, Period 1||7
11171926|NCT01654380|12360737|FG000|NOT COMPLETED|Part B, Period 1||0
11171927|NCT01654380|12360738|FG001|NOT COMPLETED|Part B, Period 1||0
11171928|NCT01654380|12360739|FG002|NOT COMPLETED|Part B, Period 1||1
11171929|NCT01654380|12360740|FG003|NOT COMPLETED|Part B, Period 1||0
11171930|NCT01654380|12360737|FG000|STARTED|Part B, Washout of at Least 6 Days||0
11171931|NCT01654380|12360738|FG001|STARTED|Part B, Washout of at Least 6 Days||0
11171932|NCT01654380|12360739|FG002|STARTED|Part B, Washout of at Least 6 Days||6
11171933|NCT01654380|12360740|FG003|STARTED|Part B, Washout of at Least 6 Days||7
11171934|NCT01654380|12360737|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
11171935|NCT01654380|12360738|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
11171936|NCT01654380|12360739|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
11171937|NCT01654380|12360740|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
11171938|NCT01654380|12360737|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
11171939|NCT01654380|12360738|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
11171940|NCT01654380|12360739|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
11171941|NCT01654380|12360740|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
11171942|NCT01654380|12360737|FG000|STARTED|Part B, Period 2||0
11171943|NCT01654380|12360738|FG001|STARTED|Part B, Period 2||0
11171944|NCT01654380|12360739|FG002|STARTED|Part B, Period 2||6
11171945|NCT01654380|12360740|FG003|STARTED|Part B, Period 2||7
11171946|NCT01654380|12360737|FG000|COMPLETED|Part B, Period 2||0
11171947|NCT01654380|12360738|FG001|COMPLETED|Part B, Period 2||0
11171948|NCT01654380|12360739|FG002|COMPLETED|Part B, Period 2||6
11171949|NCT01654380|12360740|FG003|COMPLETED|Part B, Period 2||7
11171950|NCT01654380|12360737|FG000|NOT COMPLETED|Part B, Period 2||0
11171951|NCT01654380|12360738|FG001|NOT COMPLETED|Part B, Period 2||0
11171952|NCT01654380|12360739|FG002|NOT COMPLETED|Part B, Period 2||0
11171953|NCT01654380|12360740|FG003|NOT COMPLETED|Part B, Period 2||0
11171954|NCT01654380|12360737|FG000|STARTED|Part B, Washout of at Least 6 Days||0
11171955|NCT01654380|12360738|FG001|STARTED|Part B, Washout of at Least 6 Days||0
11171956|NCT01654380|12360739|FG002|STARTED|Part B, Washout of at Least 6 Days||6
11171957|NCT01654380|12360740|FG003|STARTED|Part B, Washout of at Least 6 Days||7
11171958|NCT01654380|12360737|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
11171959|NCT01654380|12360738|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
11171960|NCT01654380|12360739|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
11171961|NCT01654380|12360740|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
11171962|NCT01654380|12360737|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
11171963|NCT01654380|12360738|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
11171964|NCT01654380|12360739|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
11171965|NCT01654380|12360740|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
11171966|NCT01654380|12360737|FG000|STARTED|Part B, Period 3||0
11171967|NCT01654380|12360738|FG001|STARTED|Part B, Period 3||0
11171968|NCT01654380|12360739|FG002|STARTED|Part B, Period 3||6
11171969|NCT01654380|12360740|FG003|STARTED|Part B, Period 3||7
11171970|NCT01654380|12360737|FG000|COMPLETED|Part B, Period 3||0
11171971|NCT01654380|12360738|FG001|COMPLETED|Part B, Period 3||0
11171972|NCT01654380|12360739|FG002|COMPLETED|Part B, Period 3||6
11171973|NCT01654380|12360740|FG003|COMPLETED|Part B, Period 3||7
11171974|NCT01654380|12360737|FG000|NOT COMPLETED|Part B, Period 3||0
11420094|NCT04128007|12618889|FG001|STARTED|Overall Study||104
11420095|NCT04128007|12618888|FG000|COMPLETED|Overall Study||177
11420096|NCT04128007|12618889|FG001|COMPLETED|Overall Study||87
11420097|NCT04128007|12618888|FG000|NOT COMPLETED|Overall Study||23
11171975|NCT01654380|12360738|FG001|NOT COMPLETED|Part B, Period 3||0
11171976|NCT01654380|12360739|FG002|NOT COMPLETED|Part B, Period 3||0
11171977|NCT01654380|12360740|FG003|NOT COMPLETED|Part B, Period 3||0
11171978|NCT01654380|12360737|FG000|STARTED|Part B, Washout of at Least 6 Days||0
11171979|NCT01654380|12360738|FG001|STARTED|Part B, Washout of at Least 6 Days||0
11171980|NCT01654380|12360739|FG002|STARTED|Part B, Washout of at Least 6 Days||6
11171981|NCT01654380|12360740|FG003|STARTED|Part B, Washout of at Least 6 Days||7
11171982|NCT01654380|12360737|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
11171983|NCT01654380|12360738|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
11171984|NCT01654380|12360739|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
11171985|NCT01654380|12360740|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
11171986|NCT01654380|12360737|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
11171987|NCT01654380|12360738|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
11171988|NCT01654380|12360739|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
11171989|NCT01654380|12360740|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
11171990|NCT01654380|12360737|FG000|STARTED|Part B, Period 4||0
11171991|NCT01654380|12360738|FG001|STARTED|Part B, Period 4||0
11171992|NCT01654380|12360739|FG002|STARTED|Part B, Period 4||6
11171993|NCT01654380|12360740|FG003|STARTED|Part B, Period 4||7
11171994|NCT01654380|12360737|FG000|COMPLETED|Part B, Period 4||0
11171995|NCT01654380|12360738|FG001|COMPLETED|Part B, Period 4||0
11171996|NCT01654380|12360739|FG002|COMPLETED|Part B, Period 4||6
11171997|NCT01654380|12360740|FG003|COMPLETED|Part B, Period 4||7
11171998|NCT01654380|12360737|FG000|NOT COMPLETED|Part B, Period 4||0
11171999|NCT01654380|12360738|FG001|NOT COMPLETED|Part B, Period 4||0
11172000|NCT01654380|12360739|FG002|NOT COMPLETED|Part B, Period 4||0
11172001|NCT01654380|12360740|FG003|NOT COMPLETED|Part B, Period 4||0
11172002|NCT01654445|12360759|FG000|STARTED|Overall Study||25
11172003|NCT01654445|12360760|FG001|STARTED|Overall Study||25
11172004|NCT01654445|12360759|FG000|COMPLETED|Overall Study||25
11172005|NCT01654445|12360760|FG001|COMPLETED|Overall Study||25
11172006|NCT01654445|12360759|FG000|NOT COMPLETED|Overall Study||0
11172007|NCT01654445|12360760|FG001|NOT COMPLETED|Overall Study||0
11172008|NCT01654523|12360766|FG000|STARTED|Overall Study||20
11420098|NCT04128007|12618889|FG001|NOT COMPLETED|Overall Study||17
11172009|NCT01654523|12360766|FG000|COMPLETED|Overall Study||19
11172010|NCT01654523|12360766|FG000|NOT COMPLETED|Overall Study||1
11172011|NCT01654536|12360772|FG000|STARTED|Overall Study||368
11172012|NCT01654536|12360773|FG001|STARTED|Overall Study||369
11172013|NCT01654536|12360772|FG000|COMPLETED|Overall Study||324
11172014|NCT01654536|12360773|FG001|COMPLETED|Overall Study||331
11323728|NCT00779324|12520970|FG000|NOT COMPLETED|Overall Study||7
11323729|NCT00779324|12520971|FG001|NOT COMPLETED|Overall Study||4
11323730|NCT00554788|12520980|FG000|STARTED|Overall Study||21
11323731|NCT00554788|12520981|FG001|STARTED|Overall Study||18
11323732|NCT00554788|12520982|FG002|STARTED|Overall Study||21
11323733|NCT00554788|12520980|FG000|COMPLETED|Overall Study||14
11323734|NCT00554788|12520981|FG001|COMPLETED|Overall Study||12
11323735|NCT00554788|12520982|FG002|COMPLETED|Overall Study||7
11323736|NCT00554788|12520980|FG000|NOT COMPLETED|Overall Study||7
11323737|NCT00554788|12520981|FG001|NOT COMPLETED|Overall Study||6
11323738|NCT00554788|12520982|FG002|NOT COMPLETED|Overall Study||14
11323739|NCT00553800|12520991|FG000|STARTED|Overall Study||32
11323740|NCT00553800|12520991|FG000|COMPLETED|Overall Study||32
11323741|NCT00553800|12520991|FG000|NOT COMPLETED|Overall Study||0
11323742|NCT00336024|12520997|FG000|STARTED|Overall Study||46
11323743|NCT00336024|12520998|FG001|STARTED|Overall Study||45
11323744|NCT00336024|12520997|FG000|COMPLETED|Overall Study||26
11323745|NCT00336024|12520998|FG001|COMPLETED|Overall Study||26
11323746|NCT00336024|12520997|FG000|NOT COMPLETED|Overall Study||20
11323747|NCT00336024|12520998|FG001|NOT COMPLETED|Overall Study||19
11323748|NCT00274937|12521004|FG000|STARTED|Overall Study||111
11323749|NCT00274937|12521004|FG000|COMPLETED|Overall Study||91
11323750|NCT00274937|12521004|FG000|NOT COMPLETED|Overall Study||20
11323751|NCT02737722|12521012|FG000|STARTED|Overall Study||8
11323752|NCT02737722|12521013|FG001|STARTED|Overall Study||8
11323753|NCT02737722|12521014|FG002|STARTED|Overall Study||8
11323754|NCT02737722|12521015|FG003|STARTED|Overall Study||6
11323755|NCT02737722|12521012|FG000|COMPLETED|Overall Study||8
11323756|NCT02737722|12521013|FG001|COMPLETED|Overall Study||8
11323757|NCT02737722|12521014|FG002|COMPLETED|Overall Study||7
11323758|NCT02737722|12521015|FG003|COMPLETED|Overall Study||6
11323759|NCT02737722|12521012|FG000|NOT COMPLETED|Overall Study||0
11323760|NCT02737722|12521013|FG001|NOT COMPLETED|Overall Study||0
11323761|NCT02737722|12521014|FG002|NOT COMPLETED|Overall Study||1
11323762|NCT02737722|12521015|FG003|NOT COMPLETED|Overall Study||0
11323763|NCT02737826|12521025|FG000|STARTED|Phase I - Buprenorphine Initiation||27
11323764|NCT02737826|12521026|FG001|STARTED|Phase I - Buprenorphine Initiation||0
11323765|NCT02737826|12521027|FG002|STARTED|Phase I - Buprenorphine Initiation||0
11323766|NCT02737826|12521025|FG000|COMPLETED|Phase I - Buprenorphine Initiation||27
11323767|NCT02737826|12521026|FG001|COMPLETED|Phase I - Buprenorphine Initiation||0
11323768|NCT02737826|12521027|FG002|COMPLETED|Phase I - Buprenorphine Initiation||0
11420099|NCT04065451|12618897|FG000|STARTED|Overall Study||10
11420100|NCT04065451|12618898|FG001|STARTED|Overall Study||10
11420101|NCT04065451|12618897|FG000|COMPLETED|Overall Study||10
11420102|NCT04065451|12618898|FG001|COMPLETED|Overall Study||10
11420103|NCT04065451|12618897|FG000|NOT COMPLETED|Overall Study||0
11420104|NCT04065451|12618898|FG001|NOT COMPLETED|Overall Study||0
11420105|NCT03847896|12618909|FG000|STARTED|Overall Study||197
11420106|NCT03847896|12618910|FG001|STARTED|Overall Study||204
11420107|NCT03847896|12618911|FG002|STARTED|Overall Study||200
11420108|NCT03847896|12618912|FG003|STARTED|Overall Study||201
11420109|NCT03847896|12618913|FG004|STARTED|Overall Study||199
11172015|NCT01654536|12360772|FG000|NOT COMPLETED|Overall Study||44
11172016|NCT01654536|12360773|FG001|NOT COMPLETED|Overall Study||38
11172017|NCT01654549|12360782|FG000|STARTED|Overall Study||20
11172018|NCT01654549|12360783|FG001|STARTED|Overall Study||20
11172019|NCT01654549|12360782|FG000|COMPLETED|Overall Study||20
11172020|NCT01654549|12360783|FG001|COMPLETED|Overall Study||19
11172021|NCT01654549|12360782|FG000|NOT COMPLETED|Overall Study||0
11172022|NCT01654549|12360783|FG001|NOT COMPLETED|Overall Study||1
11172023|NCT01654601|12360795|FG000|STARTED|1st Administration||14
11172024|NCT01654601|12360796|FG001|STARTED|1st Administration||14
11172025|NCT01654601|12360795|FG000|COMPLETED|1st Administration||12
11172026|NCT01654601|12360796|FG001|COMPLETED|1st Administration||12
11172027|NCT01654601|12360795|FG000|NOT COMPLETED|1st Administration||2
11172028|NCT01654601|12360796|FG001|NOT COMPLETED|1st Administration||2
11172029|NCT01654601|12360795|FG000|STARTED|2nd Administration||12
11172030|NCT01654601|12360796|FG001|STARTED|2nd Administration||12
11172031|NCT01654601|12360795|FG000|COMPLETED|2nd Administration||11
11172032|NCT01654601|12360796|FG001|COMPLETED|2nd Administration||11
11172033|NCT01654601|12360795|FG000|NOT COMPLETED|2nd Administration||1
11172034|NCT01654601|12360796|FG001|NOT COMPLETED|2nd Administration||1
11172035|NCT01654666|12360805|FG000|STARTED|Overall Study||63
11172036|NCT01654666|12360806|FG001|STARTED|Overall Study||63
11172037|NCT01654666|12360807|FG002|STARTED|Overall Study||63
11172038|NCT01654666|12360805|FG000|Primary Analysis|Overall Study||52
11172039|NCT01654666|12360806|FG001|Primary Analysis|Overall Study||56
11172040|NCT01654666|12360807|FG002|Primary Analysis|Overall Study||54
11172041|NCT01654666|12360805|FG000|COMPLETED|Overall Study||48
11172042|NCT01654666|12360806|FG001|COMPLETED|Overall Study||50
11172043|NCT01654666|12360807|FG002|COMPLETED|Overall Study||49
11172044|NCT01654666|12360805|FG000|NOT COMPLETED|Overall Study||15
11172045|NCT01654666|12360806|FG001|NOT COMPLETED|Overall Study||13
11172046|NCT01654666|12360807|FG002|NOT COMPLETED|Overall Study||14
11172047|NCT01654796|12360818|FG000|STARTED|Overall Study||26
11172048|NCT01654796|12360819|FG001|STARTED|Overall Study||29
11172049|NCT01654796|12360820|FG002|STARTED|Overall Study||29
11172050|NCT01654796|12360818|FG000|COMPLETED|Overall Study||25
11172051|NCT01654796|12360819|FG001|COMPLETED|Overall Study||26
11172052|NCT01654796|12360820|FG002|COMPLETED|Overall Study||28
11172053|NCT01654796|12360818|FG000|NOT COMPLETED|Overall Study||1
11172054|NCT01654796|12360819|FG001|NOT COMPLETED|Overall Study||3
11172055|NCT01654796|12360820|FG002|NOT COMPLETED|Overall Study||1
11172056|NCT01654861|12360829|FG000|STARTED|Overall Study||3
11172057|NCT01654861|12360829|FG000|COMPLETED|Overall Study||3
11172058|NCT01654861|12360829|FG000|NOT COMPLETED|Overall Study||0
11172059|NCT01654887|12360835|FG000|STARTED|Overall Study||103
11172060|NCT01654887|12360836|FG001|STARTED|Overall Study||88
11172061|NCT01654887|12360835|FG000|COMPLETED|Overall Study||103
11172062|NCT01654887|12360836|FG001|COMPLETED|Overall Study||88
11172063|NCT01654887|12360835|FG000|NOT COMPLETED|Overall Study||0
11172064|NCT01654887|12360836|FG001|NOT COMPLETED|Overall Study||0
11172065|NCT01655043|12360843|FG000|STARTED|Overall Study||20
11172066|NCT01655043|12360843|FG000|COMPLETED|Overall Study||20
11172067|NCT01655043|12360843|FG000|NOT COMPLETED|Overall Study||0
11172068|NCT01655069|12360851|FG000|STARTED|Overall Study||61
11172069|NCT01655069|12360852|FG001|STARTED|Overall Study||58
11172070|NCT01655069|12360853|FG002|STARTED|Overall Study||14
11172071|NCT01655069|12360854|FG003|STARTED|Overall Study||15
11172072|NCT01655069|12360851|FG000|Safety Analysis Set (SAF)|Overall Study||61
11172073|NCT01655069|12360852|FG001|Safety Analysis Set (SAF)|Overall Study||57
11172074|NCT01655069|12360853|FG002|Safety Analysis Set (SAF)|Overall Study||14
11172075|NCT01655069|12360854|FG003|Safety Analysis Set (SAF)|Overall Study||15
11172076|NCT01655069|12360851|FG000|Full Analysis Set (FAS)|Overall Study||60
11172077|NCT01655069|12360852|FG001|Full Analysis Set (FAS)|Overall Study||57
11172078|NCT01655069|12360853|FG002|Full Analysis Set (FAS)|Overall Study||14
11172079|NCT01655069|12360854|FG003|Full Analysis Set (FAS)|Overall Study||15
11172080|NCT01655069|12360851|FG000|COMPLETED|Overall Study||53
11172081|NCT01655069|12360852|FG001|COMPLETED|Overall Study||46
11172082|NCT01655069|12360853|FG002|COMPLETED|Overall Study||12
11172083|NCT01655069|12360854|FG003|COMPLETED|Overall Study||11
11172084|NCT01655069|12360851|FG000|NOT COMPLETED|Overall Study||8
11172085|NCT01655069|12360852|FG001|NOT COMPLETED|Overall Study||12
11172086|NCT01655069|12360853|FG002|NOT COMPLETED|Overall Study||2
11420110|NCT03847896|12618909|FG000|COMPLETED|Overall Study||190
11172087|NCT01655069|12360854|FG003|NOT COMPLETED|Overall Study||4
11172088|NCT01655329|12360862|FG000|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
11172089|NCT01655329|12360862|FG000|COMPLETED|Overall Study||10
11172090|NCT01655329|12360862|FG000|NOT COMPLETED|Overall Study||0
11172091|NCT01655381|12360876|FG000|STARTED|Overall Study||15
11172092|NCT01655381|12360876|FG000|COMPLETED|Overall Study||12
11172093|NCT01655381|12360876|FG000|NOT COMPLETED|Overall Study||3
11172094|NCT01655498|12360881|FG000|STARTED|Overall Study||61
11172095|NCT01655498|12360881|FG000|COMPLETED|Overall Study||56
11172096|NCT01655498|12360881|FG000|NOT COMPLETED|Overall Study||5
11172097|NCT01655563|12360890|FG000|STARTED|Overall Study||18
11172098|NCT01655563|12360891|FG001|STARTED|Overall Study||35
11172099|NCT01655563|12360890|FG000|COMPLETED|Overall Study||18
11172100|NCT01655563|12360891|FG001|COMPLETED|Overall Study||35
11172101|NCT01655563|12360890|FG000|NOT COMPLETED|Overall Study||0
11172102|NCT01655563|12360891|FG001|NOT COMPLETED|Overall Study||0
11172103|NCT01655693|12360900|FG000|STARTED|Overall Study||130
11172104|NCT01655693|12360901|FG001|STARTED|Overall Study||133
11172105|NCT01655693|12360902|FG002|STARTED|Overall Study||134
11172106|NCT01655693|12360900|FG000|COMPLETED|Overall Study||4
11172107|NCT01655693|12360901|FG001|COMPLETED|Overall Study||7
11172108|NCT01655693|12360902|FG002|COMPLETED|Overall Study||4
11172109|NCT01655693|12360900|FG000|NOT COMPLETED|Overall Study||126
11172110|NCT01655693|12360901|FG001|NOT COMPLETED|Overall Study||126
11172111|NCT01655693|12360902|FG002|NOT COMPLETED|Overall Study||130
11172112|NCT01655719|12360920|FG000|STARTED|Overall Study||1
11172113|NCT01655719|12360920|FG000|COMPLETED|Overall Study||1
11172114|NCT01655719|12360920|FG000|NOT COMPLETED|Overall Study||0
11172115|NCT01655823|12360929|FG000|STARTED|Overall Study||25
11172116|NCT01655823|12360930|FG001|STARTED|Overall Study||25
11172117|NCT01655823|12360931|FG002|STARTED|Overall Study||24
11172118|NCT01655823|12360932|FG003|STARTED|Overall Study||25
11172119|NCT01655823|12360933|FG004|STARTED|Overall Study||26
11172120|NCT01655823|12360929|FG000|COMPLETED|Overall Study||25
11172121|NCT01655823|12360930|FG001|COMPLETED|Overall Study||23
11172122|NCT01655823|12360931|FG002|COMPLETED|Overall Study||24
11172123|NCT01655823|12360932|FG003|COMPLETED|Overall Study||24
11172124|NCT01655823|12360933|FG004|COMPLETED|Overall Study||25
11172125|NCT01655823|12360929|FG000|NOT COMPLETED|Overall Study||0
11172126|NCT01655823|12360930|FG001|NOT COMPLETED|Overall Study||2
11172127|NCT01655823|12360931|FG002|NOT COMPLETED|Overall Study||0
11172128|NCT01655823|12360932|FG003|NOT COMPLETED|Overall Study||1
11172129|NCT01655823|12360933|FG004|NOT COMPLETED|Overall Study||1
11172130|NCT01655901|12360945|FG000|STARTED|First Intervention (Hour 1)||5
11172131|NCT01655901|12360946|FG001|STARTED|First Intervention (Hour 1)||5
11172132|NCT01655901|12360947|FG002|STARTED|First Intervention (Hour 1)||5
11172133|NCT01655901|12360948|FG003|STARTED|First Intervention (Hour 1)||5
11172134|NCT01655901|12360949|FG004|STARTED|First Intervention (Hour 1)||5
11172135|NCT01655901|12360950|FG005|STARTED|First Intervention (Hour 1)||5
11172136|NCT01655901|12360945|FG000|COMPLETED|First Intervention (Hour 1)||5
11172137|NCT01655901|12360946|FG001|COMPLETED|First Intervention (Hour 1)||5
11172138|NCT01655901|12360947|FG002|COMPLETED|First Intervention (Hour 1)||5
11172139|NCT01655901|12360948|FG003|COMPLETED|First Intervention (Hour 1)||5
11172140|NCT01655901|12360949|FG004|COMPLETED|First Intervention (Hour 1)||5
11172141|NCT01655901|12360950|FG005|COMPLETED|First Intervention (Hour 1)||5
11172142|NCT01655901|12360945|FG000|NOT COMPLETED|First Intervention (Hour 1)||0
11172143|NCT01655901|12360946|FG001|NOT COMPLETED|First Intervention (Hour 1)||0
11172144|NCT01655901|12360947|FG002|NOT COMPLETED|First Intervention (Hour 1)||0
11172145|NCT01655901|12360948|FG003|NOT COMPLETED|First Intervention (Hour 1)||0
11172146|NCT01655901|12360949|FG004|NOT COMPLETED|First Intervention (Hour 1)||0
11172147|NCT01655901|12360950|FG005|NOT COMPLETED|First Intervention (Hour 1)||0
11172148|NCT01655901|12360945|FG000|STARTED|Washout (1 Week)||5
11172149|NCT01655901|12360946|FG001|STARTED|Washout (1 Week)||5
11172150|NCT01655901|12360947|FG002|STARTED|Washout (1 Week)||5
11172151|NCT01655901|12360948|FG003|STARTED|Washout (1 Week)||5
11172152|NCT01655901|12360949|FG004|STARTED|Washout (1 Week)||5
11172153|NCT01655901|12360950|FG005|STARTED|Washout (1 Week)||5
11172154|NCT01655901|12360945|FG000|COMPLETED|Washout (1 Week)||5
11172155|NCT01655901|12360946|FG001|COMPLETED|Washout (1 Week)||5
11172156|NCT01655901|12360947|FG002|COMPLETED|Washout (1 Week)||5
11172157|NCT01655901|12360948|FG003|COMPLETED|Washout (1 Week)||5
11172158|NCT01655901|12360949|FG004|COMPLETED|Washout (1 Week)||5
11172159|NCT01655901|12360950|FG005|COMPLETED|Washout (1 Week)||5
11172160|NCT01655901|12360945|FG000|NOT COMPLETED|Washout (1 Week)||0
11172161|NCT01655901|12360946|FG001|NOT COMPLETED|Washout (1 Week)||0
11172162|NCT01655901|12360947|FG002|NOT COMPLETED|Washout (1 Week)||0
11172163|NCT01655901|12360948|FG003|NOT COMPLETED|Washout (1 Week)||0
11172164|NCT01655901|12360949|FG004|NOT COMPLETED|Washout (1 Week)||0
11172165|NCT01655901|12360950|FG005|NOT COMPLETED|Washout (1 Week)||0
11172166|NCT01655901|12360945|FG000|STARTED|Second Intervention (Hour 2)||5
11172167|NCT01655901|12360946|FG001|STARTED|Second Intervention (Hour 2)||5
11172168|NCT01655901|12360947|FG002|STARTED|Second Intervention (Hour 2)||5
11172169|NCT01655901|12360948|FG003|STARTED|Second Intervention (Hour 2)||5
11172170|NCT01655901|12360949|FG004|STARTED|Second Intervention (Hour 2)||5
11172171|NCT01655901|12360950|FG005|STARTED|Second Intervention (Hour 2)||5
11172172|NCT01655901|12360945|FG000|COMPLETED|Second Intervention (Hour 2)||5
11172173|NCT01655901|12360946|FG001|COMPLETED|Second Intervention (Hour 2)||5
11172174|NCT01655901|12360947|FG002|COMPLETED|Second Intervention (Hour 2)||5
11172175|NCT01655901|12360948|FG003|COMPLETED|Second Intervention (Hour 2)||5
11172176|NCT01655901|12360949|FG004|COMPLETED|Second Intervention (Hour 2)||5
11172177|NCT01655901|12360950|FG005|COMPLETED|Second Intervention (Hour 2)||5
11172178|NCT01655901|12360945|FG000|NOT COMPLETED|Second Intervention (Hour 2)||0
11172179|NCT01655901|12360946|FG001|NOT COMPLETED|Second Intervention (Hour 2)||0
11172180|NCT01655901|12360947|FG002|NOT COMPLETED|Second Intervention (Hour 2)||0
11172181|NCT01655901|12360948|FG003|NOT COMPLETED|Second Intervention (Hour 2)||0
11172182|NCT01655901|12360949|FG004|NOT COMPLETED|Second Intervention (Hour 2)||0
11172183|NCT01655901|12360950|FG005|NOT COMPLETED|Second Intervention (Hour 2)||0
11172184|NCT01655901|12360945|FG000|STARTED|Washout (1 Week)||5
11172185|NCT01655901|12360946|FG001|STARTED|Washout (1 Week)||5
11172186|NCT01655901|12360947|FG002|STARTED|Washout (1 Week)||5
11172187|NCT01655901|12360948|FG003|STARTED|Washout (1 Week)||5
11172188|NCT01655901|12360949|FG004|STARTED|Washout (1 Week)||5
11172189|NCT01655901|12360950|FG005|STARTED|Washout (1 Week)||5
11172190|NCT01655901|12360945|FG000|COMPLETED|Washout (1 Week)||5
11172191|NCT01655901|12360946|FG001|COMPLETED|Washout (1 Week)||5
11172192|NCT01655901|12360947|FG002|COMPLETED|Washout (1 Week)||5
11172193|NCT01655901|12360948|FG003|COMPLETED|Washout (1 Week)||5
11172194|NCT01655901|12360949|FG004|COMPLETED|Washout (1 Week)||5
11172195|NCT01655901|12360950|FG005|COMPLETED|Washout (1 Week)||5
11172196|NCT01655901|12360945|FG000|NOT COMPLETED|Washout (1 Week)||0
11172197|NCT01655901|12360946|FG001|NOT COMPLETED|Washout (1 Week)||0
11172198|NCT01655901|12360947|FG002|NOT COMPLETED|Washout (1 Week)||0
11172199|NCT01655901|12360948|FG003|NOT COMPLETED|Washout (1 Week)||0
11172200|NCT01655901|12360949|FG004|NOT COMPLETED|Washout (1 Week)||0
11172201|NCT01655901|12360950|FG005|NOT COMPLETED|Washout (1 Week)||0
11172202|NCT01655901|12360945|FG000|STARTED|Third Intervention (Hour 3)||5
11172203|NCT01655901|12360946|FG001|STARTED|Third Intervention (Hour 3)||5
11172204|NCT01655901|12360947|FG002|STARTED|Third Intervention (Hour 3)||5
11172205|NCT01655901|12360948|FG003|STARTED|Third Intervention (Hour 3)||5
11172206|NCT01655901|12360949|FG004|STARTED|Third Intervention (Hour 3)||5
11172207|NCT01655901|12360950|FG005|STARTED|Third Intervention (Hour 3)||5
11172208|NCT01655901|12360945|FG000|COMPLETED|Third Intervention (Hour 3)||4
11172209|NCT01655901|12360946|FG001|COMPLETED|Third Intervention (Hour 3)||4
11172210|NCT01655901|12360947|FG002|COMPLETED|Third Intervention (Hour 3)||4
11172211|NCT01655901|12360948|FG003|COMPLETED|Third Intervention (Hour 3)||5
11172212|NCT01655901|12360949|FG004|COMPLETED|Third Intervention (Hour 3)||4
11172213|NCT01655901|12360950|FG005|COMPLETED|Third Intervention (Hour 3)||5
11172214|NCT01655901|12360945|FG000|NOT COMPLETED|Third Intervention (Hour 3)||1
11172215|NCT01655901|12360946|FG001|NOT COMPLETED|Third Intervention (Hour 3)||1
11172216|NCT01655901|12360947|FG002|NOT COMPLETED|Third Intervention (Hour 3)||1
11172217|NCT01655901|12360948|FG003|NOT COMPLETED|Third Intervention (Hour 3)||0
11172218|NCT01655901|12360949|FG004|NOT COMPLETED|Third Intervention (Hour 3)||1
11172219|NCT01655901|12360950|FG005|NOT COMPLETED|Third Intervention (Hour 3)||0
11172220|NCT01656031|12360959|FG000|STARTED|Overall Study||39
11172221|NCT01656031|12360959|FG000|COMPLETED|Overall Study||39
11172222|NCT01656031|12360959|FG000|NOT COMPLETED|Overall Study||0
11172223|NCT01656161|12360963|FG000|STARTED|Overall Study|Intention to treat analysis set|120
11172224|NCT01656161|12360963|FG000|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
11172225|NCT01656161|12360963|FG000|Received Triptorelin at Day 169|Overall Study||115
11172226|NCT01656161|12360963|FG000|COMPLETED|Overall Study|Per protocol analysis set|113
11172227|NCT01656161|12360963|FG000|NOT COMPLETED|Overall Study||7
11172228|NCT01656187|12360972|FG000|STARTED|First Intervention (24 Weeks)||20
11172229|NCT01656187|12360973|FG001|STARTED|First Intervention (24 Weeks)||26
11172230|NCT01656187|12360972|FG000|COMPLETED|First Intervention (24 Weeks)||14
11172231|NCT01656187|12360973|FG001|COMPLETED|First Intervention (24 Weeks)||23
11172232|NCT01656187|12360972|FG000|NOT COMPLETED|First Intervention (24 Weeks)||6
11172233|NCT01656187|12360973|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3
11172234|NCT01656187|12360972|FG000|STARTED|Washout (4 Weeks)||14
11172235|NCT01656187|12360973|FG001|STARTED|Washout (4 Weeks)||23
11172236|NCT01656187|12360972|FG000|COMPLETED|Washout (4 Weeks)||14
11172237|NCT01656187|12360973|FG001|COMPLETED|Washout (4 Weeks)||22
11172238|NCT01656187|12360972|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11172239|NCT01656187|12360973|FG001|NOT COMPLETED|Washout (4 Weeks)||1
11172240|NCT01656187|12360972|FG000|STARTED|Second Intervention (24 Weeks)||14
11172241|NCT01656187|12360973|FG001|STARTED|Second Intervention (24 Weeks)||22
11172242|NCT01656187|12360972|FG000|COMPLETED|Second Intervention (24 Weeks)||13
11172243|NCT01656187|12360973|FG001|COMPLETED|Second Intervention (24 Weeks)||19
11172244|NCT01656187|12360972|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||1
11172245|NCT01656187|12360973|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||3
11172246|NCT01656200|12360979|FG000|STARTED|Overall Study||17
11172247|NCT01656200|12360979|FG000|COMPLETED|Overall Study||16
11172248|NCT01656200|12360979|FG000|NOT COMPLETED|Overall Study||1
11172249|NCT01656252|12360983|FG000|STARTED|Phase I||14
11172250|NCT01656252|12360983|FG000|COMPLETED|Phase I||14
11172251|NCT01656252|12360983|FG000|NOT COMPLETED|Phase I||0
11172252|NCT01656252|12360983|FG000|STARTED|Phase II||0
11172253|NCT01656252|12360983|FG000|COMPLETED|Phase II||0
11172254|NCT01656252|12360983|FG000|NOT COMPLETED|Phase II||0
11172255|NCT01656304|12360989|FG000|STARTED|Overall Study||16
11172256|NCT01656304|12360989|FG000|COMPLETED|Overall Study||15
11172257|NCT01656304|12360989|FG000|NOT COMPLETED|Overall Study||1
11172258|NCT01656395|12360999|FG000|STARTED|Overall Study||60
11172259|NCT01656395|12361000|FG001|STARTED|Overall Study||127
11172260|NCT01656395|12361001|FG002|STARTED|Overall Study||142
11172261|NCT01656395|12361002|FG003|STARTED|Overall Study||53
11172262|NCT01656395|12361003|FG004|STARTED|Overall Study||60
11172263|NCT01656395|12361004|FG005|STARTED|Overall Study||134
11172264|NCT01656395|12361005|FG006|STARTED|Overall Study||0
11172265|NCT01656395|12361006|FG007|STARTED|Overall Study||0
11172266|NCT01656395|12360999|FG000|Treated Participants|Overall Study||58
11172267|NCT01656395|12361000|FG001|Treated Participants|Overall Study||126
11172268|NCT01656395|12361001|FG002|Treated Participants|Overall Study||135
11172269|NCT01656395|12361002|FG003|Treated Participants|Overall Study||52
11172270|NCT01656395|12361003|FG004|Treated Participants|Overall Study||60
11172271|NCT01656395|12361004|FG005|Treated Participants|Overall Study||126
11172272|NCT01656395|12361005|FG006|Treated Participants|Overall Study||0
11172273|NCT01656395|12361006|FG007|Treated Participants|Overall Study||0
11172274|NCT01656395|12360999|FG000|COMPLETED|Overall Study||43
11172275|NCT01656395|12361000|FG001|COMPLETED|Overall Study||93
11172276|NCT01656395|12361001|FG002|COMPLETED|Overall Study||106
11172277|NCT01656395|12361002|FG003|COMPLETED|Overall Study||41
11172278|NCT01656395|12361003|FG004|COMPLETED|Overall Study||46
11172279|NCT01656395|12361004|FG005|COMPLETED|Overall Study||94
11172280|NCT01656395|12361005|FG006|COMPLETED|Overall Study||0
11172281|NCT01656395|12361006|FG007|COMPLETED|Overall Study||0
11172282|NCT01656395|12360999|FG000|NOT COMPLETED|Overall Study||17
11172283|NCT01656395|12361000|FG001|NOT COMPLETED|Overall Study||34
11172284|NCT01656395|12361001|FG002|NOT COMPLETED|Overall Study||36
11172285|NCT01656395|12361002|FG003|NOT COMPLETED|Overall Study||12
11172286|NCT01656395|12361003|FG004|NOT COMPLETED|Overall Study||14
11172287|NCT01656395|12361004|FG005|NOT COMPLETED|Overall Study||40
11172288|NCT01656395|12361005|FG006|NOT COMPLETED|Overall Study||0
11172289|NCT01656395|12361006|FG007|NOT COMPLETED|Overall Study||0
11172290|NCT01656408|12361030|FG000|STARTED|Overall Study||8
11172291|NCT01656408|12361031|FG001|STARTED|Overall Study||8
11172292|NCT01656408|12361032|FG002|STARTED|Overall Study||8
11172293|NCT01656408|12361033|FG003|STARTED|Overall Study||7
11172294|NCT01656408|12361034|FG004|STARTED|Overall Study||9
11172295|NCT01656408|12361035|FG005|STARTED|Overall Study||9
11172296|NCT01656408|12361036|FG006|STARTED|Overall Study||10
11172297|NCT01656408|12361037|FG007|STARTED|Overall Study||8
11172298|NCT01656408|12361038|FG008|STARTED|Overall Study||18
11172299|NCT01656408|12361039|FG009|STARTED|Overall Study||18
11172300|NCT01656408|12361030|FG000|COMPLETED|Overall Study||7
11172301|NCT01656408|12361031|FG001|COMPLETED|Overall Study||8
11172302|NCT01656408|12361032|FG002|COMPLETED|Overall Study||6
11172303|NCT01656408|12361033|FG003|COMPLETED|Overall Study||7
11172304|NCT01656408|12361034|FG004|COMPLETED|Overall Study||8
11172305|NCT01656408|12361035|FG005|COMPLETED|Overall Study||7
11172306|NCT01656408|12361036|FG006|COMPLETED|Overall Study||9
11172307|NCT01656408|12361037|FG007|COMPLETED|Overall Study||7
11172308|NCT01656408|12361038|FG008|COMPLETED|Overall Study||16
11172309|NCT01656408|12361039|FG009|COMPLETED|Overall Study||15
11172310|NCT01656408|12361030|FG000|NOT COMPLETED|Overall Study||1
11172311|NCT01656408|12361031|FG001|NOT COMPLETED|Overall Study||0
11172312|NCT01656408|12361032|FG002|NOT COMPLETED|Overall Study||2
11172313|NCT01656408|12361033|FG003|NOT COMPLETED|Overall Study||0
11420111|NCT03847896|12618910|FG001|COMPLETED|Overall Study||188
11420112|NCT03847896|12618911|FG002|COMPLETED|Overall Study||188
11420113|NCT03847896|12618912|FG003|COMPLETED|Overall Study||184
11420114|NCT03847896|12618913|FG004|COMPLETED|Overall Study||178
11420115|NCT03847896|12618909|FG000|NOT COMPLETED|Overall Study||7
11172314|NCT01656408|12361034|FG004|NOT COMPLETED|Overall Study||1
11172315|NCT01656408|12361035|FG005|NOT COMPLETED|Overall Study||2
11172316|NCT01656408|12361036|FG006|NOT COMPLETED|Overall Study||1
11172317|NCT01656408|12361037|FG007|NOT COMPLETED|Overall Study||1
11172318|NCT01656408|12361038|FG008|NOT COMPLETED|Overall Study||2
11172319|NCT01656408|12361039|FG009|NOT COMPLETED|Overall Study||3
11172320|NCT01656460|12361085|FG000|STARTED|Overall Study||3
11172321|NCT01656460|12361086|FG001|STARTED|Overall Study||3
11172322|NCT01656460|12361087|FG002|STARTED|Overall Study||3
11172323|NCT01656460|12361088|FG003|STARTED|Overall Study||3
11172324|NCT01656460|12361085|FG000|COMPLETED|Overall Study||3
11172325|NCT01656460|12361086|FG001|COMPLETED|Overall Study||3
11172326|NCT01656460|12361087|FG002|COMPLETED|Overall Study||3
11172327|NCT01656460|12361088|FG003|COMPLETED|Overall Study||3
11172328|NCT01656460|12361085|FG000|NOT COMPLETED|Overall Study||0
11172329|NCT01656460|12361086|FG001|NOT COMPLETED|Overall Study||0
11172330|NCT01656460|12361087|FG002|NOT COMPLETED|Overall Study||0
11172331|NCT01656460|12361088|FG003|NOT COMPLETED|Overall Study||0
11172332|NCT01656629|12361101|FG000|STARTED|Overall Study||21
11172333|NCT01656629|12361102|FG001|STARTED|Overall Study||18
11172334|NCT01656629|12361103|FG002|STARTED|Overall Study||16
11172335|NCT01656629|12361101|FG000|COMPLETED|Overall Study||16
11172336|NCT01656629|12361102|FG001|COMPLETED|Overall Study||16
11172337|NCT01656629|12361103|FG002|COMPLETED|Overall Study||14
11172338|NCT01656629|12361101|FG000|NOT COMPLETED|Overall Study||5
11172339|NCT01656629|12361102|FG001|NOT COMPLETED|Overall Study||2
11172340|NCT01656629|12361103|FG002|NOT COMPLETED|Overall Study||2
11172341|NCT01656733|12361113|FG000|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67
11172342|NCT01656733|12361114|FG001|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70
11172343|NCT01656733|12361113|FG000|Visit 1 (1 Week After Quit Date)|Overall Study||45
11172344|NCT01656733|12361114|FG001|Visit 1 (1 Week After Quit Date)|Overall Study||42
11172345|NCT01656733|12361113|FG000|Visit 2 (2 Weeks After Quit Date)|Overall Study||32
11172346|NCT01656733|12361114|FG001|Visit 2 (2 Weeks After Quit Date)|Overall Study||44
11172347|NCT01656733|12361113|FG000|Visit 3 (3 Weeks After Quit Date)|Overall Study||33
11172348|NCT01656733|12361114|FG001|Visit 3 (3 Weeks After Quit Date)|Overall Study||34
11172349|NCT01656733|12361113|FG000|Visit 4 (4 Weeks After Quit Date)|Overall Study||32
11172350|NCT01656733|12361114|FG001|Visit 4 (4 Weeks After Quit Date)|Overall Study||30
11172351|NCT01656733|12361113|FG000|Visit 5 (6 Weeks After Quit Date)|Overall Study||37
11172352|NCT01656733|12361114|FG001|Visit 5 (6 Weeks After Quit Date)|Overall Study||36
11172353|NCT01656733|12361113|FG000|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39
11172354|NCT01656733|12361114|FG001|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47
11172355|NCT01656733|12361113|FG000|Participants With Perinatal Outcomes|Overall Study||67
11172356|NCT01656733|12361114|FG001|Participants With Perinatal Outcomes|Overall Study||66
11172357|NCT01656733|12361113|FG000|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47
11172358|NCT01656733|12361114|FG001|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50
11172359|NCT01656733|12361113|FG000|Visit 8 (6 Months Postpartum)|Overall Study||30
11172360|NCT01656733|12361114|FG001|Visit 8 (6 Months Postpartum)|Overall Study||28
11172361|NCT01656733|12361113|FG000|COMPLETED|Overall Study||67
11172362|NCT01656733|12361114|FG001|COMPLETED|Overall Study||66
11420116|NCT03847896|12618910|FG001|NOT COMPLETED|Overall Study||16
11420117|NCT03847896|12618911|FG002|NOT COMPLETED|Overall Study||12
11172363|NCT01656733|12361113|FG000|NOT COMPLETED|Overall Study||0
11172364|NCT01656733|12361114|FG001|NOT COMPLETED|Overall Study||4
11172365|NCT01656759|12361122|FG000|STARTED|Overall Study||27
11172366|NCT01656759|12361123|FG001|STARTED|Overall Study||25
11172367|NCT01656759|12361122|FG000|COMPLETED|Overall Study||25
11172368|NCT01656759|12361123|FG001|COMPLETED|Overall Study||22
11172369|NCT01656759|12361122|FG000|NOT COMPLETED|Overall Study||2
11172370|NCT01656759|12361123|FG001|NOT COMPLETED|Overall Study||3
11172371|NCT01656772|12361131|FG000|STARTED|Overall Study||43
11172372|NCT01656772|12361132|FG001|STARTED|Overall Study||77
11172373|NCT01656772|12361131|FG000|COMPLETED|Overall Study||43
11172374|NCT01656772|12361132|FG001|COMPLETED|Overall Study||77
11172375|NCT01656772|12361131|FG000|NOT COMPLETED|Overall Study||0
11172376|NCT01656772|12361132|FG001|NOT COMPLETED|Overall Study||0
11172377|NCT01656850|12361140|FG000|STARTED|First Intervention (3 Months)||20
11172378|NCT01656850|12361141|FG001|STARTED|First Intervention (3 Months)||20
11172379|NCT01656850|12361140|FG000|COMPLETED|First Intervention (3 Months)||17
11172380|NCT01656850|12361141|FG001|COMPLETED|First Intervention (3 Months)||16
11172381|NCT01656850|12361140|FG000|NOT COMPLETED|First Intervention (3 Months)||3
11172382|NCT01656850|12361141|FG001|NOT COMPLETED|First Intervention (3 Months)||4
11172383|NCT01656850|12361140|FG000|STARTED|Washout (2 Weeks)||17
11172384|NCT01656850|12361141|FG001|STARTED|Washout (2 Weeks)||16
11172385|NCT01656850|12361140|FG000|COMPLETED|Washout (2 Weeks)||17
11172386|NCT01656850|12361141|FG001|COMPLETED|Washout (2 Weeks)||16
11172387|NCT01656850|12361140|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11172388|NCT01656850|12361141|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11172389|NCT01656850|12361140|FG000|STARTED|Second Intervention (3 Months)||17
11172390|NCT01656850|12361141|FG001|STARTED|Second Intervention (3 Months)||16
11172391|NCT01656850|12361140|FG000|COMPLETED|Second Intervention (3 Months)||17
11172392|NCT01656850|12361141|FG001|COMPLETED|Second Intervention (3 Months)||16
11172393|NCT01656850|12361140|FG000|NOT COMPLETED|Second Intervention (3 Months)||0
11172394|NCT01656850|12361141|FG001|NOT COMPLETED|Second Intervention (3 Months)||0
11172395|NCT01656889|12361153|FG000|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
11172396|NCT01656889|12361154|FG001|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
11172397|NCT01656889|12361153|FG000|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
11172398|NCT01656889|12361154|FG001|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
11172399|NCT01656889|12361153|FG000|NOT COMPLETED|Treatment Period, 12 Weeks||12
11172400|NCT01656889|12361154|FG001|NOT COMPLETED|Treatment Period, 12 Weeks||11
11172401|NCT01656889|12361153|FG000|STARTED|Post Treatment Follow-Up, 3 Months||210
11172402|NCT01656889|12361154|FG001|STARTED|Post Treatment Follow-Up, 3 Months||213
11172403|NCT01656889|12361153|FG000|COMPLETED|Post Treatment Follow-Up, 3 Months||206
11172404|NCT01656889|12361154|FG001|COMPLETED|Post Treatment Follow-Up, 3 Months||204
11172405|NCT01656889|12361153|FG000|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
11172406|NCT01656889|12361154|FG001|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
11172407|NCT01656967|12361162|FG000|STARTED|Overall Study||33
11172408|NCT01656967|12361163|FG001|STARTED|Overall Study||33
11172409|NCT01656967|12361162|FG000|SGA Placement|Overall Study||32
11172410|NCT01656967|12361163|FG001|SGA Placement|Overall Study||33
11172411|NCT01656967|12361162|FG000|ETT Insertion|Overall Study||29
11172412|NCT01656967|12361163|FG001|ETT Insertion|Overall Study||31
11172413|NCT01656967|12361162|FG000|COMPLETED|Overall Study||29
11172414|NCT01656967|12361163|FG001|COMPLETED|Overall Study||31
11172415|NCT01656967|12361162|FG000|NOT COMPLETED|Overall Study||4
11172416|NCT01656967|12361163|FG001|NOT COMPLETED|Overall Study||2
11172417|NCT01657019|12361173|FG000|STARTED|Overall Study||604
11420118|NCT03847896|12618912|FG003|NOT COMPLETED|Overall Study||17
11420119|NCT03847896|12618913|FG004|NOT COMPLETED|Overall Study||21
11420120|NCT03257631|12618929|FG000|STARTED|Overall Study||11
11420121|NCT03257631|12618930|FG001|STARTED|Overall Study||9
11172418|NCT01657019|12361173|FG000|COMPLETED|Overall Study||369
11172419|NCT01657019|12361173|FG000|NOT COMPLETED|Overall Study||235
11172420|NCT01657032|12361179|FG000|STARTED|Overall Study||44
11172421|NCT01657032|12361180|FG001|STARTED|Overall Study||44
11172422|NCT01657032|12361179|FG000|COMPLETED|Overall Study||44
11172423|NCT01657032|12361180|FG001|COMPLETED|Overall Study||37
11172424|NCT01657032|12361179|FG000|NOT COMPLETED|Overall Study||0
11172425|NCT01657032|12361180|FG001|NOT COMPLETED|Overall Study||7
11172426|NCT01657162|12361188|FG000|STARTED|Overall Study||558
11172427|NCT01657162|12361189|FG001|STARTED|Overall Study||581
11172428|NCT01657162|12361188|FG000|Study 003 ITT Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|824
11172429|NCT01657162|12361189|FG001|Study 003 ITT Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|821
11172430|NCT01657162|12361188|FG000|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|690
11172431|NCT01657162|12361189|FG001|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|711
11172432|NCT01657162|12361188|FG000|Completed Study 003|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|606
11172433|NCT01657162|12361189|FG001|Completed Study 003|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|637
11172434|NCT01657162|12361188|FG000|Study 005 ITT Population|Overall Study||558
11172435|NCT01657162|12361189|FG001|Study 005 ITT Population|Overall Study||581
11172436|NCT01657162|12361188|FG000|Study 005 Safety Population|Overall Study||553
11172437|NCT01657162|12361189|FG001|Study 005 Safety Population|Overall Study||580
11172438|NCT01657162|12361188|FG000|Study 005 mITT Population|Overall Study||544
11172439|NCT01657162|12361189|FG001|Study 005 mITT Population|Overall Study||568
11172440|NCT01657162|12361188|FG000|COMPLETED|Overall Study||499
11172441|NCT01657162|12361189|FG001|COMPLETED|Overall Study||506
11172442|NCT01657162|12361188|FG000|NOT COMPLETED|Overall Study||59
11172443|NCT01657162|12361189|FG001|NOT COMPLETED|Overall Study||75
11420122|NCT03257631|12618931|FG002|STARTED|Overall Study||23
11172444|NCT01657253|12361197|FG000|STARTED|Overall Study||93
11172445|NCT01657253|12361198|FG001|STARTED|Overall Study||90
11172446|NCT01657253|12361197|FG000|COMPLETED|Overall Study||76
11172447|NCT01657253|12361198|FG001|COMPLETED|Overall Study||72
11172448|NCT01657253|12361197|FG000|NOT COMPLETED|Overall Study||17
11172449|NCT01657253|12361198|FG001|NOT COMPLETED|Overall Study||18
11172450|NCT01657266|12361206|FG000|STARTED|Overall Study||73
11172451|NCT01657266|12361207|FG001|STARTED|Overall Study||75
11172452|NCT01657266|12361206|FG000|COMPLETED|Overall Study||69
11172453|NCT01657266|12361207|FG001|COMPLETED|Overall Study||70
11172454|NCT01657266|12361206|FG000|NOT COMPLETED|Overall Study||4
11172455|NCT01657266|12361207|FG001|NOT COMPLETED|Overall Study||5
11172456|NCT01657292|12361213|FG000|STARTED|Overall Study||61
11172457|NCT01657292|12361213|FG000|COMPLETED|Overall Study||51
11172458|NCT01657292|12361213|FG000|NOT COMPLETED|Overall Study||10
11172459|NCT01657305|12361220|FG000|STARTED|Overall Study||107
11172460|NCT01657305|12361220|FG000|COMPLETED|Overall Study||82
11172461|NCT01657305|12361220|FG000|NOT COMPLETED|Overall Study||25
11172462|NCT01657344|12361260|FG000|STARTED|Overall Study||421622
11172463|NCT01657344|12361261|FG001|STARTED|Overall Study||409967
11172464|NCT01657344|12361262|FG002|STARTED|Overall Study||196300
11172465|NCT01657344|12361263|FG003|STARTED|Overall Study||376517
11172466|NCT01657344|12361264|FG004|STARTED|Overall Study||157802
11172467|NCT01657344|12361265|FG005|STARTED|Overall Study||316477
11172468|NCT01657344|12361266|FG006|STARTED|Overall Study||140776
11172469|NCT01657344|12361260|FG000|COMPLETED|Overall Study||421622
11172470|NCT01657344|12361261|FG001|COMPLETED|Overall Study||409967
11172471|NCT01657344|12361262|FG002|COMPLETED|Overall Study||196300
11172472|NCT01657344|12361263|FG003|COMPLETED|Overall Study||376517
11172473|NCT01657344|12361264|FG004|COMPLETED|Overall Study||157802
11172474|NCT01657344|12361265|FG005|COMPLETED|Overall Study||316477
11172475|NCT01657344|12361266|FG006|COMPLETED|Overall Study||140776
11172476|NCT01657344|12361260|FG000|NOT COMPLETED|Overall Study||0
11172477|NCT01657344|12361261|FG001|NOT COMPLETED|Overall Study||0
11172478|NCT01657344|12361262|FG002|NOT COMPLETED|Overall Study||0
11172479|NCT01657344|12361263|FG003|NOT COMPLETED|Overall Study||0
11172480|NCT01657344|12361264|FG004|NOT COMPLETED|Overall Study||0
11172481|NCT01657344|12361265|FG005|NOT COMPLETED|Overall Study||0
11172482|NCT01657344|12361266|FG006|NOT COMPLETED|Overall Study||0
11172483|NCT01657370|12361282|FG000|STARTED|Overall Study||33
11172484|NCT01657370|12361283|FG001|STARTED|Overall Study||32
11172485|NCT01657370|12361284|FG002|STARTED|Overall Study||32
11172486|NCT01657370|12361285|FG003|STARTED|Overall Study||33
11172487|NCT01657370|12361286|FG004|STARTED|Overall Study||34
11172488|NCT01657370|12361287|FG005|STARTED|Overall Study||31
11172489|NCT01657370|12361282|FG000|COMPLETED|Overall Study||27
11172490|NCT01657370|12361283|FG001|COMPLETED|Overall Study||28
11172491|NCT01657370|12361284|FG002|COMPLETED|Overall Study||25
11172492|NCT01657370|12361285|FG003|COMPLETED|Overall Study||28
11172493|NCT01657370|12361286|FG004|COMPLETED|Overall Study||27
11172494|NCT01657370|12361287|FG005|COMPLETED|Overall Study||27
11172495|NCT01657370|12361282|FG000|NOT COMPLETED|Overall Study||6
11172496|NCT01657370|12361283|FG001|NOT COMPLETED|Overall Study||4
11172497|NCT01657370|12361284|FG002|NOT COMPLETED|Overall Study||7
11172498|NCT01657370|12361285|FG003|NOT COMPLETED|Overall Study||5
11172499|NCT01657370|12361286|FG004|NOT COMPLETED|Overall Study||7
11172500|NCT01657370|12361287|FG005|NOT COMPLETED|Overall Study||4
11172501|NCT01657461|12361308|FG000|STARTED|Overall Study||98
11172502|NCT01657461|12361309|FG001|STARTED|Overall Study||98
11172503|NCT01657461|12361308|FG000|COMPLETED|Overall Study||88
11172504|NCT01657461|12361309|FG001|COMPLETED|Overall Study||78
11172505|NCT01657461|12361308|FG000|NOT COMPLETED|Overall Study||10
11172506|NCT01657461|12361309|FG001|NOT COMPLETED|Overall Study||20
11172507|NCT01657617|12361315|FG000|STARTED|Overall Study||35
11172508|NCT01657617|12361315|FG000|COMPLETED|Overall Study||35
11172509|NCT01657617|12361315|FG000|NOT COMPLETED|Overall Study||0
11172510|NCT01657760|12361321|FG000|STARTED|Overall Study||5
11172511|NCT01657760|12361322|FG001|STARTED|Overall Study||7
11172512|NCT01657760|12361323|FG002|STARTED|Overall Study||7
11172513|NCT01657760|12361324|FG003|STARTED|Overall Study||7
11172514|NCT01657760|12361321|FG000|COMPLETED|Overall Study||4
11172515|NCT01657760|12361322|FG001|COMPLETED|Overall Study||6
11172516|NCT01657760|12361323|FG002|COMPLETED|Overall Study||6
11172517|NCT01657760|12361324|FG003|COMPLETED|Overall Study||4
11172518|NCT01657760|12361321|FG000|NOT COMPLETED|Overall Study||1
11172519|NCT01657760|12361322|FG001|NOT COMPLETED|Overall Study||1
11172520|NCT01657760|12361323|FG002|NOT COMPLETED|Overall Study||1
11172521|NCT01657760|12361324|FG003|NOT COMPLETED|Overall Study||3
11172522|NCT01657799|12361339|FG000|STARTED|Overall Study||102
11172523|NCT01657799|12361340|FG001|STARTED|Overall Study||103
11172524|NCT01657799|12361341|FG002|STARTED|Overall Study||102
11172525|NCT01657799|12361339|FG000|Received Treatment|Overall Study||101
11172526|NCT01657799|12361340|FG001|Received Treatment|Overall Study||103
11172527|NCT01657799|12361341|FG002|Received Treatment|Overall Study||102
11172528|NCT01657799|12361339|FG000|COMPLETED|Overall Study||0
11172529|NCT01657799|12361340|FG001|COMPLETED|Overall Study||0
11172530|NCT01657799|12361341|FG002|COMPLETED|Overall Study||0
11172531|NCT01657799|12361339|FG000|NOT COMPLETED|Overall Study||102
11172532|NCT01657799|12361340|FG001|NOT COMPLETED|Overall Study||103
11172533|NCT01657799|12361341|FG002|NOT COMPLETED|Overall Study||102
11172534|NCT01657877|12361349|FG000|STARTED|Overall Study||79
11172535|NCT01657877|12361349|FG000|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
11172536|NCT01657877|12361349|FG000|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
11172537|NCT01657877|12361349|FG000|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
11172538|NCT01657877|12361349|FG000|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
11172539|NCT01657877|12361349|FG000|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
11172540|NCT01657877|12361349|FG000|COMPLETED|Overall Study||65
11172541|NCT01657877|12361349|FG000|NOT COMPLETED|Overall Study||14
11172542|NCT01657903|12361366|FG000|STARTED|Overall Study||56
11172543|NCT01657903|12361366|FG000|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
11172544|NCT01657903|12361366|FG000|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
11172545|NCT01657903|12361366|FG000|Received NaF/KNO3 Toothpaste 3|Overall Study||54
11172546|NCT01657903|12361366|FG000|Received NaF/KNO3 Toothpaste 2|Overall Study||55
11172547|NCT01657903|12361366|FG000|COMPLETED|Overall Study||54
11172548|NCT01657903|12361366|FG000|NOT COMPLETED|Overall Study||2
11172549|NCT01658020|12361379|FG000|STARTED|Overall Study||175
11172550|NCT01658020|12361380|FG001|STARTED|Overall Study||167
11172551|NCT01658020|12361379|FG000|COMPLETED|Overall Study||167
11172552|NCT01658020|12361380|FG001|COMPLETED|Overall Study||158
11172553|NCT01658020|12361379|FG000|NOT COMPLETED|Overall Study||8
11172554|NCT01658020|12361380|FG001|NOT COMPLETED|Overall Study||9
11172555|NCT01658059|12361387|FG000|STARTED|First Intervention- 2 Days||12
11172556|NCT01658059|12361388|FG001|STARTED|First Intervention- 2 Days||10
11172557|NCT01658059|12361387|FG000|COMPLETED|First Intervention- 2 Days||6
11172558|NCT01658059|12361388|FG001|COMPLETED|First Intervention- 2 Days||5
11172559|NCT01658059|12361387|FG000|NOT COMPLETED|First Intervention- 2 Days||6
11172560|NCT01658059|12361388|FG001|NOT COMPLETED|First Intervention- 2 Days||5
11172561|NCT01658059|12361387|FG000|STARTED|Washout Period- 14 Days||6
11172562|NCT01658059|12361388|FG001|STARTED|Washout Period- 14 Days||5
11172563|NCT01658059|12361387|FG000|COMPLETED|Washout Period- 14 Days||6
11172564|NCT01658059|12361388|FG001|COMPLETED|Washout Period- 14 Days||5
11172565|NCT01658059|12361387|FG000|NOT COMPLETED|Washout Period- 14 Days||0
11172566|NCT01658059|12361388|FG001|NOT COMPLETED|Washout Period- 14 Days||0
11172567|NCT01658059|12361387|FG000|STARTED|Second Intervention- 2 Days||6
11172568|NCT01658059|12361388|FG001|STARTED|Second Intervention- 2 Days||5
11172569|NCT01658059|12361387|FG000|COMPLETED|Second Intervention- 2 Days||6
11172570|NCT01658059|12361388|FG001|COMPLETED|Second Intervention- 2 Days||5
11172571|NCT01658059|12361387|FG000|NOT COMPLETED|Second Intervention- 2 Days||0
11172572|NCT01658059|12361388|FG001|NOT COMPLETED|Second Intervention- 2 Days||0
11172573|NCT01658072|12361396|FG000|STARTED|Overall Study||45
11172574|NCT01658072|12361397|FG001|STARTED|Overall Study||45
11172575|NCT01658072|12361396|FG000|COMPLETED|Overall Study||41
11172576|NCT01658072|12361397|FG001|COMPLETED|Overall Study||43
11172577|NCT01658072|12361396|FG000|NOT COMPLETED|Overall Study||4
11172578|NCT01658072|12361397|FG001|NOT COMPLETED|Overall Study||2
11172579|NCT01658150|12361403|FG000|STARTED|Overall Study||11
11172580|NCT01658150|12361403|FG000|COMPLETED|Overall Study||10
11172581|NCT01658150|12361403|FG000|NOT COMPLETED|Overall Study||1
11172582|NCT01658228|12361410|FG000|STARTED|Overall Study||30
11172583|NCT01658228|12361411|FG001|STARTED|Overall Study||31
11172584|NCT01658228|12361410|FG000|COMPLETED|Overall Study||23
11172585|NCT01658228|12361411|FG001|COMPLETED|Overall Study||23
11172586|NCT01658228|12361410|FG000|NOT COMPLETED|Overall Study||7
11172587|NCT01658228|12361411|FG001|NOT COMPLETED|Overall Study||8
11172588|NCT01658436|12361417|FG000|STARTED|Overall Study||20
11172589|NCT01658436|12361418|FG001|STARTED|Overall Study||11
11172590|NCT01658436|12361417|FG000|COMPLETED|Overall Study||0
11172591|NCT01658436|12361418|FG001|COMPLETED|Overall Study||0
11172592|NCT01658436|12361417|FG000|NOT COMPLETED|Overall Study||20
11172593|NCT01658436|12361418|FG001|NOT COMPLETED|Overall Study||11
11172594|NCT01658514|12361427|FG000|STARTED|Overall Study||14
11172595|NCT01658514|12361428|FG001|STARTED|Overall Study||11
11172596|NCT01658514|12361429|FG002|STARTED|Overall Study||14
11172597|NCT01658514|12361427|FG000|Completed Treatment A|Overall Study||14
11172598|NCT01658514|12361428|FG001|Completed Treatment A|Overall Study||11
11172599|NCT01658514|12361429|FG002|Completed Treatment A|Overall Study||12
11172600|NCT01658514|12361427|FG000|Completed Treatment B|Overall Study||13
11172601|NCT01658514|12361428|FG001|Completed Treatment B|Overall Study||11
11172602|NCT01658514|12361429|FG002|Completed Treatment B|Overall Study||14
11172603|NCT01658514|12361427|FG000|Completed Treatment C|Overall Study||13
11172604|NCT01658514|12361428|FG001|Completed Treatment C|Overall Study||11
11172605|NCT01658514|12361429|FG002|Completed Treatment C|Overall Study||12
11172606|NCT01658514|12361427|FG000|Started - Normal RF Cohort Only|Overall Study||3
11172607|NCT01658514|12361428|FG001|Started - Normal RF Cohort Only|Overall Study||2
11172608|NCT01658514|12361429|FG002|Started - Normal RF Cohort Only|Overall Study||3
11172609|NCT01658514|12361427|FG000|Completed - Normal RF Cohort Only|Overall Study||3
11172610|NCT01658514|12361428|FG001|Completed - Normal RF Cohort Only|Overall Study||2
11172611|NCT01658514|12361429|FG002|Completed - Normal RF Cohort Only|Overall Study||3
11172612|NCT01658514|12361427|FG000|Started - Mild RI Cohort Only|Overall Study||4
11172613|NCT01658514|12361428|FG001|Started - Mild RI Cohort Only|Overall Study||3
11172614|NCT01658514|12361429|FG002|Started - Mild RI Cohort Only|Overall Study||4
11172615|NCT01658514|12361427|FG000|Completed - Mild RI Cohort Only|Overall Study||4
11172616|NCT01658514|12361428|FG001|Completed - Mild RI Cohort Only|Overall Study||3
11172617|NCT01658514|12361429|FG002|Completed - Mild RI Cohort Only|Overall Study||4
11172618|NCT01658514|12361427|FG000|Started - Moderate RI Cohort Only|Overall Study||4
11172619|NCT01658514|12361428|FG001|Started - Moderate RI Cohort Only|Overall Study||4
11172620|NCT01658514|12361429|FG002|Started - Moderate RI Cohort Only|Overall Study||4
11172621|NCT01658514|12361427|FG000|Completed - Moderate RI Cohort Only|Overall Study||3
11172622|NCT01658514|12361428|FG001|Completed - Moderate RI Cohort Only|Overall Study||4
11172623|NCT01658514|12361429|FG002|Completed - Moderate RI Cohort Only|Overall Study||2
11172624|NCT01658514|12361427|FG000|Started - Severe RI Cohort Only|Overall Study||3
11172625|NCT01658514|12361428|FG001|Started - Severe RI Cohort Only|Overall Study||2
11172626|NCT01658514|12361429|FG002|Started - Severe RI Cohort Only|Overall Study||3
11172627|NCT01658514|12361427|FG000|Completed - Severe RI Cohort Only|Overall Study||3
11172628|NCT01658514|12361428|FG001|Completed - Severe RI Cohort Only|Overall Study||2
11172629|NCT01658514|12361429|FG002|Completed - Severe RI Cohort Only|Overall Study||3
11172630|NCT01658514|12361427|FG000|COMPLETED|Overall Study||13
11172631|NCT01658514|12361428|FG001|COMPLETED|Overall Study||11
11172632|NCT01658514|12361429|FG002|COMPLETED|Overall Study||12
11172633|NCT01658514|12361427|FG000|NOT COMPLETED|Overall Study||1
11172634|NCT01658514|12361428|FG001|NOT COMPLETED|Overall Study||0
11172635|NCT01658514|12361429|FG002|NOT COMPLETED|Overall Study||2
11420123|NCT03257631|12618932|FG003|STARTED|Overall Study||10
11420124|NCT03257631|12618929|FG000|Received Study Drug|Overall Study||11
11172636|NCT01658579|12361440|FG000|STARTED|Treatment Period A||15
11172637|NCT01658579|12361441|FG001|STARTED|Treatment Period A||15
11172638|NCT01658579|12361442|FG002|STARTED|Treatment Period A||15
11172639|NCT01658579|12361443|FG003|STARTED|Treatment Period A||14
11172640|NCT01658579|12361440|FG000|COMPLETED|Treatment Period A||14
11172641|NCT01658579|12361441|FG001|COMPLETED|Treatment Period A||15
11172642|NCT01658579|12361442|FG002|COMPLETED|Treatment Period A||14
11172643|NCT01658579|12361443|FG003|COMPLETED|Treatment Period A||13
11172644|NCT01658579|12361440|FG000|NOT COMPLETED|Treatment Period A||1
11172645|NCT01658579|12361441|FG001|NOT COMPLETED|Treatment Period A||0
11172646|NCT01658579|12361442|FG002|NOT COMPLETED|Treatment Period A||1
11172647|NCT01658579|12361443|FG003|NOT COMPLETED|Treatment Period A||1
11172648|NCT01658579|12361440|FG000|STARTED|Treatment Period B||14
11172649|NCT01658579|12361441|FG001|STARTED|Treatment Period B||15
11172650|NCT01658579|12361442|FG002|STARTED|Treatment Period B||14
11172651|NCT01658579|12361443|FG003|STARTED|Treatment Period B||13
11172652|NCT01658579|12361440|FG000|COMPLETED|Treatment Period B||14
11172653|NCT01658579|12361441|FG001|COMPLETED|Treatment Period B||15
11172654|NCT01658579|12361442|FG002|COMPLETED|Treatment Period B||14
11172655|NCT01658579|12361443|FG003|COMPLETED|Treatment Period B||12
11172656|NCT01658579|12361440|FG000|NOT COMPLETED|Treatment Period B||0
11172657|NCT01658579|12361441|FG001|NOT COMPLETED|Treatment Period B||0
11172658|NCT01658579|12361442|FG002|NOT COMPLETED|Treatment Period B||0
11172659|NCT01658579|12361443|FG003|NOT COMPLETED|Treatment Period B||1
11172660|NCT01658657|12361451|FG000|STARTED|Overall Study||7
11172661|NCT01658657|12361452|FG001|STARTED|Overall Study||10
11172662|NCT01658657|12361451|FG000|COMPLETED|Overall Study||4
11172663|NCT01658657|12361452|FG001|COMPLETED|Overall Study||7
11172664|NCT01658657|12361451|FG000|NOT COMPLETED|Overall Study||3
11172665|NCT01658657|12361452|FG001|NOT COMPLETED|Overall Study||3
11172666|NCT01658735|12361461|FG000|STARTED|Overall Study||39
11172667|NCT01658735|12361462|FG001|STARTED|Overall Study||36
11172668|NCT01658735|12361463|FG002|STARTED|Overall Study||38
11172669|NCT01658735|12361461|FG000|COMPLETED|Overall Study||34
11172670|NCT01658735|12361462|FG001|COMPLETED|Overall Study||29
11172671|NCT01658735|12361463|FG002|COMPLETED|Overall Study||34
11172672|NCT01658735|12361461|FG000|NOT COMPLETED|Overall Study||5
11172673|NCT01658735|12361462|FG001|NOT COMPLETED|Overall Study||7
11172674|NCT01658735|12361463|FG002|NOT COMPLETED|Overall Study||4
11172675|NCT01658839|12361471|FG000|STARTED|Overall Study||25
11172676|NCT01658839|12361471|FG000|COMPLETED|Overall Study||25
11172677|NCT01658839|12361471|FG000|NOT COMPLETED|Overall Study||0
11172678|NCT01658904|12361478|FG000|STARTED|Overall Study||3
11172679|NCT01658904|12361479|FG001|STARTED|Overall Study||0
11172680|NCT01658904|12361480|FG002|STARTED|Overall Study||0
11172681|NCT01658904|12361478|FG000|COMPLETED|Overall Study||1
11172682|NCT01658904|12361479|FG001|COMPLETED|Overall Study||0
11172683|NCT01658904|12361480|FG002|COMPLETED|Overall Study||0
11172684|NCT01658904|12361478|FG000|NOT COMPLETED|Overall Study||2
11172685|NCT01658904|12361479|FG001|NOT COMPLETED|Overall Study||0
11172686|NCT01658904|12361480|FG002|NOT COMPLETED|Overall Study||0
11172687|NCT01658943|12361493|FG000|STARTED|Overall Study||70
11172688|NCT01658943|12361494|FG001|STARTED|Overall Study||67
11172689|NCT01658943|12361493|FG000|Eligible|Overall Study||63
11172690|NCT01658943|12361494|FG001|Eligible|Overall Study||58
11172691|NCT01658943|12361493|FG000|Eligible and Began Protocol Therapy|Overall Study||62
11172692|NCT01658943|12361494|FG001|Eligible and Began Protocol Therapy|Overall Study||58
11172693|NCT01658943|12361493|FG000|COMPLETED|Overall Study||0
11172694|NCT01658943|12361494|FG001|COMPLETED|Overall Study||0
11172695|NCT01658943|12361493|FG000|NOT COMPLETED|Overall Study||70
11172696|NCT01658943|12361494|FG001|NOT COMPLETED|Overall Study||67
11172697|NCT01658995|12361502|FG000|STARTED|Overall Study||42
11172698|NCT01658995|12361503|FG001|STARTED|Overall Study||40
11172699|NCT01658995|12361502|FG000|COMPLETED|Overall Study||42
11172700|NCT01658995|12361503|FG001|COMPLETED|Overall Study||40
11172701|NCT01658995|12361502|FG000|NOT COMPLETED|Overall Study||0
11172702|NCT01658995|12361503|FG001|NOT COMPLETED|Overall Study||0
11172703|NCT01659021|12361511|FG000|STARTED|Main Study||174
11172704|NCT01659021|12361512|FG001|STARTED|Main Study||87
11172705|NCT01659021|12361511|FG000|Randomized and Treated|Main Study||173
11172706|NCT01659021|12361512|FG001|Randomized and Treated|Main Study||86
11172707|NCT01659021|12361511|FG000|COMPLETED|Main Study||100
11420125|NCT03257631|12618930|FG001|Received Study Drug|Overall Study||9
11172708|NCT01659021|12361512|FG001|COMPLETED|Main Study||50
11172709|NCT01659021|12361511|FG000|NOT COMPLETED|Main Study||74
11172710|NCT01659021|12361512|FG001|NOT COMPLETED|Main Study||37
11172711|NCT01659021|12361511|FG000|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138
11172712|NCT01659021|12361512|FG001|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69
11172713|NCT01659021|12361511|FG000|COMPLETED|Long-Term Follow Up||133
11172714|NCT01659021|12361512|FG001|COMPLETED|Long-Term Follow Up||65
11172715|NCT01659021|12361511|FG000|NOT COMPLETED|Long-Term Follow Up||5
11172716|NCT01659021|12361512|FG001|NOT COMPLETED|Long-Term Follow Up||4
11172717|NCT01659125|12361522|FG000|STARTED|Overall Study||26
11172718|NCT01659125|12361522|FG000|Initiated Treatment|Overall Study||24
11172719|NCT01659125|12361522|FG000|Completed the Posttreatment Assessment|Overall Study||17
11172720|NCT01659125|12361522|FG000|Completed 3-month Follow-up|Overall Study||16
11172721|NCT01659125|12361522|FG000|Completed 6-month Follow-up|Overall Study||12
11172722|NCT01659125|12361522|FG000|COMPLETED|Overall Study||12
11172723|NCT01659125|12361522|FG000|NOT COMPLETED|Overall Study||14
11172724|NCT01659255|12361543|FG000|STARTED|Overall Study||3
11172725|NCT01659255|12361544|FG001|STARTED|Overall Study||3
11172726|NCT01659255|12361545|FG002|STARTED|Overall Study||4
11172727|NCT01659255|12361546|FG003|STARTED|Overall Study||3
11172728|NCT01659255|12361547|FG004|STARTED|Overall Study||3
11172729|NCT01659255|12361548|FG005|STARTED|Overall Study||3
11172730|NCT01659255|12361549|FG006|STARTED|Overall Study||3
11172731|NCT01659255|12361550|FG007|STARTED|Overall Study||3
11172732|NCT01659255|12361551|FG008|STARTED|Overall Study||3
11172733|NCT01659255|12361552|FG009|STARTED|Overall Study||3
11172734|NCT01659255|12361553|FG010|STARTED|Overall Study||3
11172735|NCT01659255|12361554|FG011|STARTED|Overall Study||5
11172736|NCT01659255|12361555|FG012|STARTED|Overall Study||8
11172737|NCT01659255|12361556|FG013|STARTED|Overall Study||21
11172738|NCT01659255|12361557|FG014|STARTED|Overall Study||10
11172739|NCT01659255|12361558|FG015|STARTED|Overall Study||9
11172740|NCT01659255|12361559|FG016|STARTED|Overall Study||3
11172741|NCT01659255|12361543|FG000|COMPLETED|Overall Study||1
11172742|NCT01659255|12361544|FG001|COMPLETED|Overall Study||2
11172743|NCT01659255|12361545|FG002|COMPLETED|Overall Study||4
11172744|NCT01659255|12361546|FG003|COMPLETED|Overall Study||3
11172745|NCT01659255|12361547|FG004|COMPLETED|Overall Study||3
11172746|NCT01659255|12361548|FG005|COMPLETED|Overall Study||2
11172747|NCT01659255|12361549|FG006|COMPLETED|Overall Study||1
11172748|NCT01659255|12361550|FG007|COMPLETED|Overall Study||1
11172749|NCT01659255|12361551|FG008|COMPLETED|Overall Study||2
11172750|NCT01659255|12361552|FG009|COMPLETED|Overall Study||0
11172751|NCT01659255|12361553|FG010|COMPLETED|Overall Study||0
11172752|NCT01659255|12361554|FG011|COMPLETED|Overall Study||1
11172753|NCT01659255|12361555|FG012|COMPLETED|Overall Study||0
11172754|NCT01659255|12361556|FG013|COMPLETED|Overall Study||3
11172755|NCT01659255|12361557|FG014|COMPLETED|Overall Study||2
11323769|NCT02737826|12521025|FG000|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
11172756|NCT01659255|12361558|FG015|COMPLETED|Overall Study||4
11172757|NCT01659255|12361559|FG016|COMPLETED|Overall Study||0
11172758|NCT01659255|12361543|FG000|NOT COMPLETED|Overall Study||2
11172759|NCT01659255|12361544|FG001|NOT COMPLETED|Overall Study||1
11172760|NCT01659255|12361545|FG002|NOT COMPLETED|Overall Study||0
11172761|NCT01659255|12361546|FG003|NOT COMPLETED|Overall Study||0
11172762|NCT01659255|12361547|FG004|NOT COMPLETED|Overall Study||0
11172763|NCT01659255|12361548|FG005|NOT COMPLETED|Overall Study||1
11172764|NCT01659255|12361549|FG006|NOT COMPLETED|Overall Study||2
11172765|NCT01659255|12361550|FG007|NOT COMPLETED|Overall Study||2
11172766|NCT01659255|12361551|FG008|NOT COMPLETED|Overall Study||1
11172767|NCT01659255|12361552|FG009|NOT COMPLETED|Overall Study||3
11172768|NCT01659255|12361553|FG010|NOT COMPLETED|Overall Study||3
11172769|NCT01659255|12361554|FG011|NOT COMPLETED|Overall Study||4
11172770|NCT01659255|12361555|FG012|NOT COMPLETED|Overall Study||8
11172771|NCT01659255|12361556|FG013|NOT COMPLETED|Overall Study||18
11172772|NCT01659255|12361557|FG014|NOT COMPLETED|Overall Study||8
11172773|NCT01659255|12361558|FG015|NOT COMPLETED|Overall Study||5
11172774|NCT01659255|12361559|FG016|NOT COMPLETED|Overall Study||3
11172775|NCT01659268|12361599|FG000|STARTED|Overall Study||9
11172776|NCT01659268|12361600|FG001|STARTED|Overall Study||8
11172777|NCT01659268|12361599|FG000|COMPLETED|Overall Study||9
11172778|NCT01659268|12361600|FG001|COMPLETED|Overall Study||8
11172779|NCT01659268|12361599|FG000|NOT COMPLETED|Overall Study||0
11172780|NCT01659268|12361600|FG001|NOT COMPLETED|Overall Study||0
11172781|NCT01659320|12361606|FG000|STARTED|Overall Study||16
11172782|NCT01659320|12361606|FG000|COMPLETED|Overall Study||13
11172783|NCT01659320|12361606|FG000|NOT COMPLETED|Overall Study||3
11172784|NCT01659567|12361610|FG000|STARTED|Overall Study||516
11172785|NCT01659567|12361610|FG000|COMPLETED|Overall Study||393
11172786|NCT01659567|12361610|FG000|NOT COMPLETED|Overall Study||123
11172787|NCT01659736|12361616|FG000|STARTED|Treatment Period||14
11172788|NCT01659736|12361617|FG001|STARTED|Treatment Period||12
11172789|NCT01659736|12361616|FG000|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
11172790|NCT01659736|12361617|FG001|COMPLETED|Treatment Period||10
11172791|NCT01659736|12361616|FG000|NOT COMPLETED|Treatment Period||5
11172792|NCT01659736|12361617|FG001|NOT COMPLETED|Treatment Period||2
11172793|NCT01659736|12361616|FG000|STARTED|3-month Follow-up||9
11172794|NCT01659736|12361617|FG001|STARTED|3-month Follow-up||10
11172795|NCT01659736|12361616|FG000|COMPLETED|3-month Follow-up||9
11323770|NCT02737826|12521026|FG001|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
11172796|NCT01659736|12361617|FG001|COMPLETED|3-month Follow-up||9
11172797|NCT01659736|12361616|FG000|NOT COMPLETED|3-month Follow-up||0
11172798|NCT01659736|12361617|FG001|NOT COMPLETED|3-month Follow-up||1
11172799|NCT01659866|12361627|FG000|STARTED|Overall Study||430
11172800|NCT01659866|12361628|FG001|STARTED|Overall Study||80
11172801|NCT01659866|12361627|FG000|COMPLETED|Overall Study||430
11172802|NCT01659866|12361628|FG001|COMPLETED|Overall Study||80
11172803|NCT01659866|12361627|FG000|NOT COMPLETED|Overall Study||0
11172804|NCT01659866|12361628|FG001|NOT COMPLETED|Overall Study||0
11172805|NCT01659996|12361637|FG000|STARTED|Overall Study||421
11172806|NCT01659996|12361638|FG001|STARTED|Overall Study||395
11172807|NCT01659996|12361639|FG002|STARTED|Overall Study||472
11172808|NCT01659996|12361637|FG000|COMPLETED|Overall Study||413
11172809|NCT01659996|12361638|FG001|COMPLETED|Overall Study||388
11172810|NCT01659996|12361639|FG002|COMPLETED|Overall Study||461
11172811|NCT01659996|12361637|FG000|NOT COMPLETED|Overall Study||8
11172812|NCT01659996|12361638|FG001|NOT COMPLETED|Overall Study||7
11172813|NCT01659996|12361639|FG002|NOT COMPLETED|Overall Study||11
11172814|NCT01660022|12361655|FG000|STARTED|First Sequence (7 Days)||8
11172815|NCT01660022|12361656|FG001|STARTED|First Sequence (7 Days)||8
11172816|NCT01660022|12361657|FG002|STARTED|First Sequence (7 Days)||8
11172817|NCT01660022|12361658|FG003|STARTED|First Sequence (7 Days)||8
11172818|NCT01660022|12361659|FG004|STARTED|First Sequence (7 Days)||7
11172819|NCT01660022|12361660|FG005|STARTED|First Sequence (7 Days)||20
11172820|NCT01660022|12361655|FG000|COMPLETED|First Sequence (7 Days)||8
11172821|NCT01660022|12361656|FG001|COMPLETED|First Sequence (7 Days)||7
11172822|NCT01660022|12361657|FG002|COMPLETED|First Sequence (7 Days)||8
11172823|NCT01660022|12361658|FG003|COMPLETED|First Sequence (7 Days)||7
11172824|NCT01660022|12361659|FG004|COMPLETED|First Sequence (7 Days)||6
11172825|NCT01660022|12361660|FG005|COMPLETED|First Sequence (7 Days)||16
11172826|NCT01660022|12361655|FG000|NOT COMPLETED|First Sequence (7 Days)||0
11172827|NCT01660022|12361656|FG001|NOT COMPLETED|First Sequence (7 Days)||1
11172828|NCT01660022|12361657|FG002|NOT COMPLETED|First Sequence (7 Days)||0
11172829|NCT01660022|12361658|FG003|NOT COMPLETED|First Sequence (7 Days)||1
11172830|NCT01660022|12361659|FG004|NOT COMPLETED|First Sequence (7 Days)||1
11172831|NCT01660022|12361660|FG005|NOT COMPLETED|First Sequence (7 Days)||4
11172832|NCT01660022|12361655|FG000|STARTED|Second Sequence (42 Days)||8
11172833|NCT01660022|12361656|FG001|STARTED|Second Sequence (42 Days)||7
11172834|NCT01660022|12361657|FG002|STARTED|Second Sequence (42 Days)||8
11172835|NCT01660022|12361658|FG003|STARTED|Second Sequence (42 Days)||7
11172836|NCT01660022|12361659|FG004|STARTED|Second Sequence (42 Days)||6
11172837|NCT01660022|12361660|FG005|STARTED|Second Sequence (42 Days)||16
11172838|NCT01660022|12361655|FG000|COMPLETED|Second Sequence (42 Days)||8
11172839|NCT01660022|12361656|FG001|COMPLETED|Second Sequence (42 Days)||7
11172840|NCT01660022|12361657|FG002|COMPLETED|Second Sequence (42 Days)||8
11172841|NCT01660022|12361658|FG003|COMPLETED|Second Sequence (42 Days)||7
11172842|NCT01660022|12361659|FG004|COMPLETED|Second Sequence (42 Days)||6
11172843|NCT01660022|12361660|FG005|COMPLETED|Second Sequence (42 Days)||16
11172844|NCT01660022|12361655|FG000|NOT COMPLETED|Second Sequence (42 Days)||0
11172845|NCT01660022|12361656|FG001|NOT COMPLETED|Second Sequence (42 Days)||0
11172846|NCT01660022|12361657|FG002|NOT COMPLETED|Second Sequence (42 Days)||0
11172847|NCT01660022|12361658|FG003|NOT COMPLETED|Second Sequence (42 Days)||0
11172848|NCT01660022|12361659|FG004|NOT COMPLETED|Second Sequence (42 Days)||0
11172849|NCT01660022|12361660|FG005|NOT COMPLETED|Second Sequence (42 Days)||0
11172850|NCT01660191|12361689|FG000|STARTED|Enrollment and Washout||45
11172851|NCT01660191|12361690|FG001|STARTED|Enrollment and Washout||45
11172852|NCT01660191|12361691|FG002|STARTED|Enrollment and Washout||44
11172853|NCT01660191|12361689|FG000|COMPLETED|Enrollment and Washout||45
11172854|NCT01660191|12361690|FG001|COMPLETED|Enrollment and Washout||45
11172855|NCT01660191|12361691|FG002|COMPLETED|Enrollment and Washout||44
11172856|NCT01660191|12361689|FG000|NOT COMPLETED|Enrollment and Washout||0
11172857|NCT01660191|12361690|FG001|NOT COMPLETED|Enrollment and Washout||0
11172858|NCT01660191|12361691|FG002|NOT COMPLETED|Enrollment and Washout||0
11172859|NCT01660191|12361689|FG000|STARTED|Randomization||45
11172860|NCT01660191|12361690|FG001|STARTED|Randomization||45
11172861|NCT01660191|12361691|FG002|STARTED|Randomization||44
11172862|NCT01660191|12361689|FG000|COMPLETED|Randomization||45
11172863|NCT01660191|12361690|FG001|COMPLETED|Randomization||45
11026841|NCT00830869|12205480|FG000|STARTED|Period 1: Part 1||1
11026842|NCT00830869|12205481|FG001|STARTED|Period 1: Part 1||1
11026843|NCT00830869|12205482|FG002|STARTED|Period 1: Part 1||1
11026844|NCT00830869|12205483|FG003|STARTED|Period 1: Part 1||7
11172864|NCT01660191|12361691|FG002|COMPLETED|Randomization||44
11172865|NCT01660191|12361689|FG000|NOT COMPLETED|Randomization||0
11172866|NCT01660191|12361690|FG001|NOT COMPLETED|Randomization||0
11026845|NCT00830869|12205484|FG004|STARTED|Period 1: Part 1||4
11026846|NCT00830869|12205485|FG005|STARTED|Period 1: Part 1||6
11172867|NCT01660191|12361691|FG002|NOT COMPLETED|Randomization||0
11172868|NCT01660191|12361689|FG000|STARTED|End of Treatment||45
11172869|NCT01660191|12361690|FG001|STARTED|End of Treatment||45
11172870|NCT01660191|12361691|FG002|STARTED|End of Treatment||44
11172871|NCT01660191|12361689|FG000|COMPLETED|End of Treatment||44
11172872|NCT01660191|12361690|FG001|COMPLETED|End of Treatment||39
11172873|NCT01660191|12361691|FG002|COMPLETED|End of Treatment||43
11172874|NCT01660191|12361689|FG000|NOT COMPLETED|End of Treatment||1
11172875|NCT01660191|12361690|FG001|NOT COMPLETED|End of Treatment||6
11172876|NCT01660191|12361691|FG002|NOT COMPLETED|End of Treatment||1
11172877|NCT01660230|12361711|FG000|STARTED|Overall Study||4
11172878|NCT01660230|12361712|FG001|STARTED|Overall Study||4
11172879|NCT01660230|12361713|FG002|STARTED|Overall Study||4
11172880|NCT01660230|12361714|FG003|STARTED|Overall Study||4
11172881|NCT01660230|12361715|FG004|STARTED|Overall Study||4
11172882|NCT01660230|12361716|FG005|STARTED|Overall Study||2
11172883|NCT01660230|12361717|FG006|STARTED|Overall Study||4
11172884|NCT01660230|12361718|FG007|STARTED|Overall Study||6
11172885|NCT01660230|12361719|FG008|STARTED|Overall Study||6
11172886|NCT01660230|12361720|FG009|STARTED|Overall Study||6
11172887|NCT01660230|12361721|FG010|STARTED|Overall Study||6
11172888|NCT01660230|12361722|FG011|STARTED|Overall Study||14
11172889|NCT01660230|12361711|FG000|COMPLETED|Overall Study||4
11172890|NCT01660230|12361712|FG001|COMPLETED|Overall Study||4
11172891|NCT01660230|12361713|FG002|COMPLETED|Overall Study||4
11172892|NCT01660230|12361714|FG003|COMPLETED|Overall Study||4
11172893|NCT01660230|12361715|FG004|COMPLETED|Overall Study||4
11172894|NCT01660230|12361716|FG005|COMPLETED|Overall Study||2
11172895|NCT01660230|12361717|FG006|COMPLETED|Overall Study||4
11172896|NCT01660230|12361718|FG007|COMPLETED|Overall Study||6
11172897|NCT01660230|12361719|FG008|COMPLETED|Overall Study||6
11172898|NCT01660230|12361720|FG009|COMPLETED|Overall Study||6
11172899|NCT01660230|12361721|FG010|COMPLETED|Overall Study||6
11172900|NCT01660230|12361722|FG011|COMPLETED|Overall Study||14
11172901|NCT01660230|12361711|FG000|NOT COMPLETED|Overall Study||0
11172902|NCT01660230|12361712|FG001|NOT COMPLETED|Overall Study||0
11172903|NCT01660230|12361713|FG002|NOT COMPLETED|Overall Study||0
11172904|NCT01660230|12361714|FG003|NOT COMPLETED|Overall Study||0
11172905|NCT01660230|12361715|FG004|NOT COMPLETED|Overall Study||0
11172906|NCT01660230|12361716|FG005|NOT COMPLETED|Overall Study||0
11172907|NCT01660230|12361717|FG006|NOT COMPLETED|Overall Study||0
11172908|NCT01660230|12361718|FG007|NOT COMPLETED|Overall Study||0
11172909|NCT01660230|12361719|FG008|NOT COMPLETED|Overall Study||0
11172910|NCT01660230|12361720|FG009|NOT COMPLETED|Overall Study||0
11172911|NCT01660230|12361721|FG010|NOT COMPLETED|Overall Study||0
11172912|NCT01660230|12361722|FG011|NOT COMPLETED|Overall Study||0
11172913|NCT01660256|12361752|FG000|STARTED|Overall Study||84
11172914|NCT01660256|12361753|FG001|STARTED|Overall Study||83
11172915|NCT01660256|12361754|FG002|STARTED|Overall Study||42
11172916|NCT01660256|12361752|FG000|COMPLETED|Overall Study||79
11172917|NCT01660256|12361753|FG001|COMPLETED|Overall Study||83
11172918|NCT01660256|12361754|FG002|COMPLETED|Overall Study||38
11172919|NCT01660256|12361752|FG000|NOT COMPLETED|Overall Study||5
11172920|NCT01660256|12361753|FG001|NOT COMPLETED|Overall Study||0
11172921|NCT01660256|12361754|FG002|NOT COMPLETED|Overall Study||4
11172922|NCT01660321|12361762|FG000|STARTED|Overall Study||26
11172923|NCT01660321|12361762|FG000|COMPLETED|Overall Study||26
11172924|NCT01660321|12361762|FG000|NOT COMPLETED|Overall Study||0
11172925|NCT01660334|12361766|FG000|STARTED|Overall Study||13
11420126|NCT03257631|12618931|FG002|Received Study Drug|Overall Study||22
11420127|NCT03257631|12618932|FG003|Received Study Drug|Overall Study||10
11172926|NCT01660334|12361766|FG000|COMPLETED|Overall Study||12
11172927|NCT01660334|12361766|FG000|NOT COMPLETED|Overall Study||1
11172928|NCT01660412|12361770|FG000|STARTED|Overall Study||29
11172929|NCT01660412|12361771|FG001|STARTED|Overall Study||31
11172930|NCT01660412|12361770|FG000|Head|Overall Study||1
11172931|NCT01660412|12361771|FG001|Head|Overall Study||4
11172932|NCT01660412|12361770|FG000|Thorax|Overall Study||9
11172933|NCT01660412|12361771|FG001|Thorax|Overall Study||9
11172934|NCT01660412|12361770|FG000|Appendicular Structures|Overall Study||17
11172935|NCT01660412|12361771|FG001|Appendicular Structures|Overall Study||11
11172936|NCT01660412|12361770|FG000|Other|Overall Study||2
11172937|NCT01660412|12361771|FG001|Other|Overall Study||4
11172938|NCT01660412|12361770|FG000|Injection 1|Overall Study||29
11172939|NCT01660412|12361771|FG001|Injection 1|Overall Study||31
11172940|NCT01660412|12361770|FG000|Injection 2|Overall Study||29
11172941|NCT01660412|12361771|FG001|Injection 2|Overall Study||31
11172942|NCT01660412|12361770|FG000|Injection 3|Overall Study||29
11172943|NCT01660412|12361771|FG001|Injection 3|Overall Study||31
11172944|NCT01660412|12361770|FG000|Injection 4|Overall Study||29
11172945|NCT01660412|12361771|FG001|Injection 4|Overall Study||31
11172946|NCT01660412|12361770|FG000|COMPLETED|Overall Study||29
11172947|NCT01660412|12361771|FG001|COMPLETED|Overall Study||28
11172948|NCT01660412|12361770|FG000|NOT COMPLETED|Overall Study||0
11172949|NCT01660412|12361771|FG001|NOT COMPLETED|Overall Study||3
11172950|NCT01660672|12361777|FG000|STARTED|Overall Study||7
11172951|NCT01660672|12361777|FG000|COMPLETED|Overall Study||7
11172952|NCT01660672|12361777|FG000|NOT COMPLETED|Overall Study||0
11172953|NCT01660698|12361784|FG000|STARTED|Overall Study||10
11172954|NCT01660698|12361785|FG001|STARTED|Overall Study||10
11172955|NCT01660698|12361784|FG000|COMPLETED|Overall Study||10
11172956|NCT01660698|12361785|FG001|COMPLETED|Overall Study||10
11172957|NCT01660698|12361784|FG000|NOT COMPLETED|Overall Study||0
11172958|NCT01660698|12361785|FG001|NOT COMPLETED|Overall Study||0
11172959|NCT01660711|12361791|FG000|STARTED|Overall Study||22
11172960|NCT01660711|12361791|FG000|COMPLETED|Overall Study||14
11172961|NCT01660711|12361791|FG000|NOT COMPLETED|Overall Study||8
11172962|NCT01660737|12361795|FG000|STARTED|Overall Study||123
11172963|NCT01660737|12361795|FG000|COMPLETED|Overall Study||123
11172964|NCT01660737|12361795|FG000|NOT COMPLETED|Overall Study||0
11172965|NCT01660763|12361801|FG000|STARTED|Overall Study||315
11172966|NCT01660763|12361802|FG001|STARTED|Overall Study||104
11172967|NCT01660763|12361801|FG000|COMPLETED|Overall Study||215
11172968|NCT01660763|12361802|FG001|COMPLETED|Overall Study||43
11172969|NCT01660763|12361801|FG000|NOT COMPLETED|Overall Study||100
11172970|NCT01660763|12361802|FG001|NOT COMPLETED|Overall Study||61
11172971|NCT01660802|12361810|FG000|STARTED|Overall Study||130
11172972|NCT01660802|12361811|FG001|STARTED|Overall Study||132
11420128|NCT03257631|12618929|FG000|COMPLETED|Overall Study||0
11420129|NCT03257631|12618930|FG001|COMPLETED|Overall Study||0
11420130|NCT03257631|12618931|FG002|COMPLETED|Overall Study||0
11172973|NCT01660802|12361810|FG000|COMPLETED|Overall Study||126
11172974|NCT01660802|12361811|FG001|COMPLETED|Overall Study||121
11172975|NCT01660802|12361810|FG000|NOT COMPLETED|Overall Study||4
11172976|NCT01660802|12361811|FG001|NOT COMPLETED|Overall Study||11
11172977|NCT01660815|12361817|FG000|STARTED|Overall Study||7
11172978|NCT01660815|12361817|FG000|COMPLETED|Overall Study||7
11172979|NCT01660815|12361817|FG000|NOT COMPLETED|Overall Study||0
11172980|NCT01660893|12361825|FG000|STARTED|Overall Study||10
11172981|NCT01660893|12361826|FG001|STARTED|Overall Study||10
11172982|NCT01660893|12361827|FG002|STARTED|Overall Study||6
11172983|NCT01660893|12361825|FG000|COMPLETED|Overall Study||10
11172984|NCT01660893|12361826|FG001|COMPLETED|Overall Study||10
11172985|NCT01660893|12361827|FG002|COMPLETED|Overall Study||6
11172986|NCT01660893|12361825|FG000|NOT COMPLETED|Overall Study||0
11172987|NCT01660893|12361826|FG001|NOT COMPLETED|Overall Study||0
11172988|NCT01660893|12361827|FG002|NOT COMPLETED|Overall Study||0
11172989|NCT01660906|12361835|FG000|STARTED|Overall Study||39
11172990|NCT01660906|12361835|FG000|COMPLETED|Overall Study||36
11172991|NCT01660906|12361835|FG000|NOT COMPLETED|Overall Study||3
11203908|NCT01849822|12394474|FG000|COMPLETED|Overall Study||1
11203909|NCT01849822|12394474|FG000|NOT COMPLETED|Overall Study||0
11203910|NCT01849848|12394478|FG000|STARTED|Overall Study||17
11172992|NCT01661062|12361839|FG000|STARTED|Overall Study||23
11172993|NCT01661062|12361839|FG000|COMPLETED|Overall Study||18
11172994|NCT01661062|12361839|FG000|NOT COMPLETED|Overall Study||5
11172995|NCT01661088|12361843|FG000|STARTED|FOLFIRINOX||25
11172996|NCT01661088|12361843|FG000|COMPLETED|FOLFIRINOX||21
11172997|NCT01661088|12361843|FG000|NOT COMPLETED|FOLFIRINOX||4
11172998|NCT01661088|12361843|FG000|STARTED|IMRT With FDR Gemcitabine||21
11172999|NCT01661088|12361843|FG000|COMPLETED|IMRT With FDR Gemcitabine||19
11173000|NCT01661088|12361843|FG000|NOT COMPLETED|IMRT With FDR Gemcitabine||2
11173001|NCT01661114|12361847|FG000|STARTED|Overall Study||39
11173002|NCT01661114|12361847|FG000|COMPLETED|Overall Study||39
11173003|NCT01661114|12361847|FG000|NOT COMPLETED|Overall Study||0
11173004|NCT01661140|12361851|FG000|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
11173005|NCT01661140|12361852|FG001|STARTED|Open-Label Period||0
11173006|NCT01661140|12361853|FG002|STARTED|Open-Label Period||0
11173007|NCT01661140|12361851|FG000|COMPLETED|Open-Label Period||351
11173008|NCT01661140|12361852|FG001|COMPLETED|Open-Label Period||0
11173009|NCT01661140|12361853|FG002|COMPLETED|Open-Label Period||0
11173010|NCT01661140|12361851|FG000|NOT COMPLETED|Open-Label Period||76
11173011|NCT01661140|12361852|FG001|NOT COMPLETED|Open-Label Period||0
11173012|NCT01661140|12361853|FG002|NOT COMPLETED|Open-Label Period||0
11173013|NCT01661140|12361851|FG000|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
11173014|NCT01661140|12361852|FG001|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
11173015|NCT01661140|12361853|FG002|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
11173016|NCT01661140|12361851|FG000|COMPLETED|Double-Blind Period||0
11173017|NCT01661140|12361852|FG001|COMPLETED|Double-Blind Period||95
11173018|NCT01661140|12361853|FG002|COMPLETED|Double-Blind Period||86
11173019|NCT01661140|12361851|FG000|NOT COMPLETED|Double-Blind Period||0
11173020|NCT01661140|12361852|FG001|NOT COMPLETED|Double-Blind Period||41
11173021|NCT01661140|12361853|FG002|NOT COMPLETED|Double-Blind Period||50
11173022|NCT01661179|12361861|FG000|STARTED|Overall Study||14
11173023|NCT01661179|12361861|FG000|COMPLETED|Overall Study||8
11173024|NCT01661179|12361861|FG000|NOT COMPLETED|Overall Study||6
11173025|NCT01661205|12361865|FG000|STARTED|Overall Study||26
11173026|NCT01661205|12361865|FG000|COMPLETED|Overall Study||24
11173027|NCT01661205|12361865|FG000|NOT COMPLETED|Overall Study||2
11173028|NCT01661270|12361871|FG000|STARTED|Overall Study||109
11173029|NCT01661270|12361872|FG001|STARTED|Overall Study||223
11173030|NCT01661270|12361871|FG000|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
11173031|NCT01661270|12361872|FG001|Adverse Event|Overall Study|Met EOT criteria|47
11173032|NCT01661270|12361871|FG000|Disease Progression|Overall Study|Met EOT criteria|67
11173033|NCT01661270|12361872|FG001|Disease Progression|Overall Study|Met EOT criteria|118
11173034|NCT01661270|12361871|FG000|Physician Decision|Overall Study|Met EOT criteria|1
11173035|NCT01661270|12361872|FG001|Physician Decision|Overall Study|Met EOT criteria|8
11173036|NCT01661270|12361871|FG000|Participant's Request|Overall Study|Met EOT criteria|15
11173037|NCT01661270|12361872|FG001|Participant's Request|Overall Study|Met EOT criteria|48
11173038|NCT01661270|12361871|FG000|Other Reasons|Overall Study||0
11173039|NCT01661270|12361872|FG001|Other Reasons|Overall Study||2
11173040|NCT01661270|12361871|FG000|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
11173041|NCT01661270|12361872|FG001|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
11173042|NCT01661270|12361871|FG000|NOT COMPLETED|Overall Study||0
11173043|NCT01661270|12361872|FG001|NOT COMPLETED|Overall Study||0
11173044|NCT01661283|12361879|FG000|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25
11173045|NCT01661283|12361879|FG000|COMPLETED|Overall Study||25
11173046|NCT01661283|12361879|FG000|NOT COMPLETED|Overall Study||0
11173047|NCT01661595|12361887|FG000|STARTED|Phase 1: Week 0-4||5
11173048|NCT01661595|12361888|FG001|STARTED|Phase 1: Week 0-4||4
11173049|NCT01661595|12361889|FG002|STARTED|Phase 1: Week 0-4||5
11173050|NCT01661595|12361890|FG003|STARTED|Phase 1: Week 0-4||4
11173051|NCT01661595|12361887|FG000|COMPLETED|Phase 1: Week 0-4||4
11173052|NCT01661595|12361888|FG001|COMPLETED|Phase 1: Week 0-4||4
11173053|NCT01661595|12361889|FG002|COMPLETED|Phase 1: Week 0-4||5
11173054|NCT01661595|12361890|FG003|COMPLETED|Phase 1: Week 0-4||4
11173055|NCT01661595|12361887|FG000|NOT COMPLETED|Phase 1: Week 0-4||1
11173056|NCT01661595|12361888|FG001|NOT COMPLETED|Phase 1: Week 0-4||0
11173057|NCT01661595|12361889|FG002|NOT COMPLETED|Phase 1: Week 0-4||0
11173058|NCT01661595|12361890|FG003|NOT COMPLETED|Phase 1: Week 0-4||0
11173059|NCT01661595|12361887|FG000|STARTED|Phase 2: Week 5-8.||4
11173060|NCT01661595|12361888|FG001|STARTED|Phase 2: Week 5-8.||4
11173061|NCT01661595|12361889|FG002|STARTED|Phase 2: Week 5-8.||5
11173062|NCT01661595|12361890|FG003|STARTED|Phase 2: Week 5-8.||4
11173063|NCT01661595|12361887|FG000|COMPLETED|Phase 2: Week 5-8.||4
11173064|NCT01661595|12361888|FG001|COMPLETED|Phase 2: Week 5-8.||4
11173065|NCT01661595|12361889|FG002|COMPLETED|Phase 2: Week 5-8.||4
11173066|NCT01661595|12361890|FG003|COMPLETED|Phase 2: Week 5-8.||4
11173067|NCT01661595|12361887|FG000|NOT COMPLETED|Phase 2: Week 5-8.||0
11173068|NCT01661595|12361888|FG001|NOT COMPLETED|Phase 2: Week 5-8.||0
11173069|NCT01661595|12361889|FG002|NOT COMPLETED|Phase 2: Week 5-8.||1
11173070|NCT01661595|12361890|FG003|NOT COMPLETED|Phase 2: Week 5-8.||0
11173071|NCT01661621|12361909|FG000|STARTED|Overall Study||116
11173072|NCT01661621|12361910|FG001|STARTED|Overall Study||279
11173073|NCT01661621|12361909|FG000|COMPLETED|Overall Study||116
11173074|NCT01661621|12361910|FG001|COMPLETED|Overall Study||279
11173075|NCT01661621|12361909|FG000|NOT COMPLETED|Overall Study||0
11173076|NCT01661621|12361910|FG001|NOT COMPLETED|Overall Study||0
11173077|NCT01661686|12361918|FG000|STARTED|Overall Study||49
11173078|NCT01661686|12361919|FG001|STARTED|Overall Study||49
11173079|NCT01661686|12361918|FG000|COMPLETED|Overall Study||47
11173080|NCT01661686|12361919|FG001|COMPLETED|Overall Study||47
11173081|NCT01661686|12361918|FG000|NOT COMPLETED|Overall Study||2
11173082|NCT01661686|12361919|FG001|NOT COMPLETED|Overall Study||2
11173083|NCT01661712|12361927|FG000|STARTED|Overall Study|initial sham stimulation night|18
11173084|NCT01661712|12361928|FG001|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
11173085|NCT01661712|12361927|FG000|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
11173086|NCT01661712|12361928|FG001|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
11173087|NCT01661712|12361927|FG000|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
11173088|NCT01661712|12361928|FG001|COMPLETED|Overall Study|sham stimulation night|18
11173089|NCT01661712|12361927|FG000|NOT COMPLETED|Overall Study||0
11173090|NCT01661712|12361928|FG001|NOT COMPLETED|Overall Study||0
11173091|NCT01661764|12361946|FG000|STARTED|Overall Study||26
11173092|NCT01661764|12361947|FG001|STARTED|Overall Study||25
11173093|NCT01661764|12361948|FG002|STARTED|Overall Study||25
11173094|NCT01661764|12361949|FG003|STARTED|Overall Study||26
11173095|NCT01661764|12361950|FG004|STARTED|Overall Study||19
11173096|NCT01661764|12361951|FG005|STARTED|Overall Study||20
11173097|NCT01661764|12361946|FG000|COMPLETED|Overall Study||24
11173098|NCT01661764|12361947|FG001|COMPLETED|Overall Study||20
11173099|NCT01661764|12361948|FG002|COMPLETED|Overall Study||22
11173100|NCT01661764|12361949|FG003|COMPLETED|Overall Study||24
11173101|NCT01661764|12361950|FG004|COMPLETED|Overall Study||16
11173102|NCT01661764|12361951|FG005|COMPLETED|Overall Study||18
11173103|NCT01661764|12361946|FG000|NOT COMPLETED|Overall Study||2
11173104|NCT01661764|12361947|FG001|NOT COMPLETED|Overall Study||5
11173105|NCT01661764|12361948|FG002|NOT COMPLETED|Overall Study||3
11173106|NCT01661764|12361949|FG003|NOT COMPLETED|Overall Study||2
11173107|NCT01661764|12361950|FG004|NOT COMPLETED|Overall Study||3
11173108|NCT01661764|12361951|FG005|NOT COMPLETED|Overall Study||2
11173109|NCT01661790|12361967|FG000|STARTED|Overall Study||36
11173110|NCT01661790|12361968|FG001|STARTED|Overall Study||36
11173111|NCT01661790|12361967|FG000|COMPLETED|Overall Study||36
11173112|NCT01661790|12361968|FG001|COMPLETED|Overall Study||34
11323771|NCT02737826|12521027|FG002|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
11323772|NCT02737826|12521025|FG000|STARTED|Phase II - Randomization + Taper||0
11323773|NCT02737826|12521026|FG001|STARTED|Phase II - Randomization + Taper||13
11323774|NCT02737826|12521027|FG002|STARTED|Phase II - Randomization + Taper||14
11323775|NCT02737826|12521025|FG000|COMPLETED|Phase II - Randomization + Taper||0
11323776|NCT02737826|12521026|FG001|COMPLETED|Phase II - Randomization + Taper||1
11323777|NCT02737826|12521027|FG002|COMPLETED|Phase II - Randomization + Taper||0
11323778|NCT02737826|12521025|FG000|NOT COMPLETED|Phase II - Randomization + Taper||0
11323779|NCT02737826|12521026|FG001|NOT COMPLETED|Phase II - Randomization + Taper||12
11323780|NCT02737826|12521027|FG002|NOT COMPLETED|Phase II - Randomization + Taper||14
11323781|NCT02737852|12521036|FG000|STARTED|Overall Study||32
11323782|NCT02737852|12521036|FG000|COMPLETED|Overall Study||30
11323783|NCT02737852|12521036|FG000|NOT COMPLETED|Overall Study||2
11323784|NCT02737891|12521042|FG000|STARTED|Overall Study||30
11323785|NCT02737891|12521043|FG001|STARTED|Overall Study||30
11323786|NCT02737891|12521042|FG000|COMPLETED|Overall Study||30
11323787|NCT02737891|12521043|FG001|COMPLETED|Overall Study||28
11323788|NCT02737891|12521042|FG000|NOT COMPLETED|Overall Study||0
11323789|NCT02737891|12521043|FG001|NOT COMPLETED|Overall Study||2
11323790|NCT02737917|12521051|FG000|STARTED|Overall Study||103
11323791|NCT02737917|12521052|FG001|STARTED|Overall Study||103
11323792|NCT02737917|12521051|FG000|COMPLETED|Overall Study||100
11323793|NCT02737917|12521052|FG001|COMPLETED|Overall Study||100
11323794|NCT02737917|12521051|FG000|NOT COMPLETED|Overall Study||3
11323795|NCT02737917|12521052|FG001|NOT COMPLETED|Overall Study||3
11323796|NCT02737930|12521060|FG000|STARTED|Overall Study||5
11323797|NCT02737930|12521061|FG001|STARTED|Overall Study||7
11323798|NCT02737930|12521060|FG000|COMPLETED|Overall Study||5
11323799|NCT02737930|12521061|FG001|COMPLETED|Overall Study||6
11323800|NCT02737930|12521060|FG000|NOT COMPLETED|Overall Study||0
11323801|NCT02737930|12521061|FG001|NOT COMPLETED|Overall Study||1
11343133|NCT02951312|12540472|FG000|STARTED|Study Part 1||6
11343134|NCT02951312|12540473|FG001|STARTED|Study Part 1||6
11343135|NCT02951312|12540474|FG002|STARTED|Study Part 1||0
11343136|NCT02951312|12540475|FG003|STARTED|Study Part 1||0
11343137|NCT02951312|12540472|FG000|COMPLETED|Study Part 1||6
11343138|NCT02951312|12540473|FG001|COMPLETED|Study Part 1||6
11343139|NCT02951312|12540474|FG002|COMPLETED|Study Part 1||0
11343140|NCT02951312|12540475|FG003|COMPLETED|Study Part 1||0
11343141|NCT02951312|12540472|FG000|NOT COMPLETED|Study Part 1||0
11343142|NCT02951312|12540473|FG001|NOT COMPLETED|Study Part 1||0
11343143|NCT02951312|12540474|FG002|NOT COMPLETED|Study Part 1||0
11343144|NCT02951312|12540475|FG003|NOT COMPLETED|Study Part 1||0
11343145|NCT02951312|12540472|FG000|STARTED|Study Part 2||0
11343146|NCT02951312|12540473|FG001|STARTED|Study Part 2||0
11343147|NCT02951312|12540474|FG002|STARTED|Study Part 2||6
11343148|NCT02951312|12540475|FG003|STARTED|Study Part 2||6
11343149|NCT02951312|12540472|FG000|COMPLETED|Study Part 2||0
11343150|NCT02951312|12540473|FG001|COMPLETED|Study Part 2||0
11323802|NCT02738008|12521070|FG000|STARTED|Overall Study||1
11323803|NCT02738008|12521071|FG001|STARTED|Overall Study||6
11323804|NCT02738008|12521072|FG002|STARTED|Overall Study||5
11323805|NCT02738008|12521070|FG000|COMPLETED|Overall Study||0
11323806|NCT02738008|12521071|FG001|COMPLETED|Overall Study||0
11323807|NCT02738008|12521072|FG002|COMPLETED|Overall Study||0
11323808|NCT02738008|12521070|FG000|NOT COMPLETED|Overall Study||1
11323809|NCT02738008|12521071|FG001|NOT COMPLETED|Overall Study||6
11323810|NCT02738008|12521072|FG002|NOT COMPLETED|Overall Study||5
11323811|NCT02738086|12521082|FG000|STARTED|Overall Study||16
11323812|NCT02738086|12521083|FG001|STARTED|Overall Study||15
11323813|NCT02738086|12521082|FG000|COMPLETED|Overall Study||14
11323814|NCT02738086|12521083|FG001|COMPLETED|Overall Study||13
11323815|NCT02738086|12521082|FG000|NOT COMPLETED|Overall Study||2
11323816|NCT02738086|12521083|FG001|NOT COMPLETED|Overall Study||2
11323817|NCT02738138|12521094|FG000|STARTED|Overall Study||137
11323818|NCT02738138|12521095|FG001|STARTED|Overall Study||16
11323819|NCT02738138|12521094|FG000|COMPLETED|Overall Study||134
11323820|NCT02738138|12521095|FG001|COMPLETED|Overall Study||15
11323821|NCT02738138|12521094|FG000|NOT COMPLETED|Overall Study||3
11323822|NCT02738138|12521095|FG001|NOT COMPLETED|Overall Study||1
11323823|NCT02738151|12521102|FG000|STARTED|Overall Study||466
11323824|NCT02738151|12521103|FG001|STARTED|Overall Study||463
11323825|NCT02738151|12521102|FG000|Treated|Overall Study||462
11323826|NCT02738151|12521103|FG001|Treated|Overall Study||462
11323827|NCT02738151|12521102|FG000|COMPLETED|Overall Study||443
11323828|NCT02738151|12521103|FG001|COMPLETED|Overall Study||432
11323829|NCT02738151|12521102|FG000|NOT COMPLETED|Overall Study||23
11323830|NCT02738151|12521103|FG001|NOT COMPLETED|Overall Study||31
11323831|NCT02738203|12521111|FG000|STARTED|Overall Study||110
11323832|NCT02738203|12521112|FG001|STARTED|Overall Study||110
11323833|NCT02738203|12521111|FG000|COMPLETED|Overall Study||108
11323834|NCT02738203|12521112|FG001|COMPLETED|Overall Study||107
11323835|NCT02738203|12521111|FG000|NOT COMPLETED|Overall Study||2
11323836|NCT02738203|12521112|FG001|NOT COMPLETED|Overall Study||3
11323837|NCT02738333|12521121|FG000|STARTED|Overall Study||106
11323838|NCT02738333|12521122|FG001|STARTED|Overall Study||108
11323839|NCT02738333|12521123|FG002|STARTED|Overall Study||25
11323840|NCT02738333|12521121|FG000|COMPLETED|Overall Study||104
11323841|NCT02738333|12521122|FG001|COMPLETED|Overall Study||108
11323842|NCT02738333|12521123|FG002|COMPLETED|Overall Study||25
11173113|NCT01661790|12361967|FG000|NOT COMPLETED|Overall Study||0
11173114|NCT01661790|12361968|FG001|NOT COMPLETED|Overall Study||2
11173115|NCT01661933|12361974|FG000|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
11173116|NCT01661933|12361974|FG000|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
11173117|NCT01661933|12361974|FG000|NOT COMPLETED|Gluten Micro-challenge||0
11173118|NCT01661933|12361974|FG000|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
11173119|NCT01661933|12361974|FG000|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
11173120|NCT01661933|12361974|FG000|NOT COMPLETED|Low-dose Gluten Challenge||2
11173121|NCT01661933|12361974|FG000|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
11173122|NCT01661933|12361974|FG000|COMPLETED|High-dose Gluten Challenge||8
11173123|NCT01661933|12361974|FG000|NOT COMPLETED|High-dose Gluten Challenge||2
11173124|NCT01661946|12361982|FG000|STARTED|Overall Study||5
11173125|NCT01661946|12361983|FG001|STARTED|Overall Study||5
11173126|NCT01661946|12361982|FG000|COMPLETED|Overall Study||5
11173127|NCT01661946|12361983|FG001|COMPLETED|Overall Study||5
11173128|NCT01661946|12361982|FG000|NOT COMPLETED|Overall Study||0
11173129|NCT01661946|12361983|FG001|NOT COMPLETED|Overall Study||0
11173130|NCT01661972|12361991|FG000|STARTED|Overall Study||13
11173131|NCT01661972|12361992|FG001|STARTED|Overall Study||50
11173132|NCT01661972|12361991|FG000|COMPLETED|Overall Study||11
11173133|NCT01661972|12361992|FG001|COMPLETED|Overall Study||46
11173134|NCT01661972|12361991|FG000|NOT COMPLETED|Overall Study||2
11173135|NCT01661972|12361992|FG001|NOT COMPLETED|Overall Study||4
11173136|NCT01662024|12362000|FG000|STARTED|Overall Study||20
11173137|NCT01662024|12362000|FG000|COMPLETED|Overall Study||15
11173138|NCT01662024|12362000|FG000|NOT COMPLETED|Overall Study||5
11173139|NCT01662063|12362009|FG000|STARTED|Overall Study||44
11173140|NCT01662063|12362010|FG001|STARTED|Overall Study||173
11173141|NCT01662063|12362011|FG002|STARTED|Overall Study||1
11173142|NCT01662063|12362009|FG000|COMPLETED|Overall Study||39
11173143|NCT01662063|12362010|FG001|COMPLETED|Overall Study||144
11173144|NCT01662063|12362011|FG002|COMPLETED|Overall Study||0
11173145|NCT01662063|12362009|FG000|NOT COMPLETED|Overall Study||5
11173146|NCT01662063|12362010|FG001|NOT COMPLETED|Overall Study||29
11173147|NCT01662063|12362011|FG002|NOT COMPLETED|Overall Study||1
11173148|NCT01662115|12362022|FG000|STARTED|Overall Study||2
11173149|NCT01662115|12362023|FG001|STARTED|Overall Study||2
11173150|NCT01662115|12362024|FG002|STARTED|Overall Study||0
11173151|NCT01662115|12362022|FG000|COMPLETED|Overall Study||2
11173152|NCT01662115|12362023|FG001|COMPLETED|Overall Study||2
11173153|NCT01662115|12362024|FG002|COMPLETED|Overall Study||0
11173154|NCT01662115|12362022|FG000|NOT COMPLETED|Overall Study||0
11173155|NCT01662115|12362023|FG001|NOT COMPLETED|Overall Study||0
11173156|NCT01662115|12362024|FG002|NOT COMPLETED|Overall Study||0
11173157|NCT01662297|12362034|FG000|STARTED|Overall Study||0
11173158|NCT01662297|12362035|FG001|STARTED|Overall Study||1
11323843|NCT02738333|12521121|FG000|NOT COMPLETED|Overall Study||2
11173159|NCT01662297|12362034|FG000|COMPLETED|Overall Study||0
11173160|NCT01662297|12362035|FG001|COMPLETED|Overall Study||1
11173161|NCT01662297|12362034|FG000|NOT COMPLETED|Overall Study||0
11173162|NCT01662297|12362035|FG001|NOT COMPLETED|Overall Study||0
11173163|NCT01662310|12362041|FG000|STARTED|Run-In or Stabilization Phase||201
11173164|NCT01662310|12362042|FG001|STARTED|Run-In or Stabilization Phase||0
11173165|NCT01662310|12362043|FG002|STARTED|Run-In or Stabilization Phase||0
11173166|NCT01662310|12362044|FG003|STARTED|Run-In or Stabilization Phase||0
11173167|NCT01662310|12362045|FG004|STARTED|Run-In or Stabilization Phase||0
11173168|NCT01662310|12362041|FG000|COMPLETED|Run-In or Stabilization Phase||136
11173169|NCT01662310|12362042|FG001|COMPLETED|Run-In or Stabilization Phase||0
11173170|NCT01662310|12362043|FG002|COMPLETED|Run-In or Stabilization Phase||0
11173171|NCT01662310|12362044|FG003|COMPLETED|Run-In or Stabilization Phase||0
11420131|NCT03257631|12618932|FG003|COMPLETED|Overall Study||0
11420132|NCT03257631|12618929|FG000|NOT COMPLETED|Overall Study||11
11420133|NCT03257631|12618930|FG001|NOT COMPLETED|Overall Study||9
11420134|NCT03257631|12618931|FG002|NOT COMPLETED|Overall Study||23
11420135|NCT03257631|12618932|FG003|NOT COMPLETED|Overall Study||10
11420136|NCT03164616|12618945|FG000|STARTED|Overall Study||338
11420137|NCT03164616|12618946|FG001|STARTED|Overall Study||338
11420138|NCT03164616|12618947|FG002|STARTED|Overall Study||337
11173172|NCT01662310|12362045|FG004|COMPLETED|Run-In or Stabilization Phase||0
11173173|NCT01662310|12362041|FG000|NOT COMPLETED|Run-In or Stabilization Phase||65
11173174|NCT01662310|12362042|FG001|NOT COMPLETED|Run-In or Stabilization Phase||0
11173175|NCT01662310|12362043|FG002|NOT COMPLETED|Run-In or Stabilization Phase||0
11173176|NCT01662310|12362044|FG003|NOT COMPLETED|Run-In or Stabilization Phase||0
11173177|NCT01662310|12362045|FG004|NOT COMPLETED|Run-In or Stabilization Phase||0
11173178|NCT01662310|12362041|FG000|STARTED|Double-Blind Phase||0
11173179|NCT01662310|12362042|FG001|STARTED|Double-Blind Phase||65
11173180|NCT01662310|12362043|FG002|STARTED|Double-Blind Phase||71
11173181|NCT01662310|12362044|FG003|STARTED|Double-Blind Phase||0
11173182|NCT01662310|12362045|FG004|STARTED|Double-Blind Phase||0
11420139|NCT03164616|12618945|FG000|Received Treatment|Overall Study||331
11420140|NCT03164616|12618946|FG001|Received Treatment|Overall Study||335
11420141|NCT03164616|12618947|FG002|Received Treatment|Overall Study||331
11173183|NCT01662310|12362041|FG000|Treated|Double-Blind Phase||0
11173184|NCT01662310|12362042|FG001|Treated|Double-Blind Phase||64
11173185|NCT01662310|12362043|FG002|Treated|Double-Blind Phase||71
11173186|NCT01662310|12362044|FG003|Treated|Double-Blind Phase||0
11173187|NCT01662310|12362045|FG004|Treated|Double-Blind Phase||0
11173188|NCT01662310|12362041|FG000|COMPLETED|Double-Blind Phase||0
11173189|NCT01662310|12362042|FG001|COMPLETED|Double-Blind Phase||50
11173190|NCT01662310|12362043|FG002|COMPLETED|Double-Blind Phase||66
11173191|NCT01662310|12362044|FG003|COMPLETED|Double-Blind Phase||0
11173192|NCT01662310|12362045|FG004|COMPLETED|Double-Blind Phase||0
11173193|NCT01662310|12362041|FG000|NOT COMPLETED|Double-Blind Phase||0
11173194|NCT01662310|12362042|FG001|NOT COMPLETED|Double-Blind Phase||15
11173195|NCT01662310|12362043|FG002|NOT COMPLETED|Double-Blind Phase||5
11173196|NCT01662310|12362044|FG003|NOT COMPLETED|Double-Blind Phase||0
11173197|NCT01662310|12362045|FG004|NOT COMPLETED|Double-Blind Phase||0
11173198|NCT01662310|12362041|FG000|STARTED|Open-Label Extension Phase||0
11173199|NCT01662310|12362042|FG001|STARTED|Open-Label Extension Phase||0
11173200|NCT01662310|12362043|FG002|STARTED|Open-Label Extension Phase||0
11173201|NCT01662310|12362044|FG003|STARTED|Open-Label Extension Phase||47
11173202|NCT01662310|12362045|FG004|STARTED|Open-Label Extension Phase||59
11173203|NCT01662310|12362041|FG000|COMPLETED|Open-Label Extension Phase||0
11173204|NCT01662310|12362042|FG001|COMPLETED|Open-Label Extension Phase||0
11173205|NCT01662310|12362043|FG002|COMPLETED|Open-Label Extension Phase||0
11173206|NCT01662310|12362044|FG003|COMPLETED|Open-Label Extension Phase||36
11173207|NCT01662310|12362045|FG004|COMPLETED|Open-Label Extension Phase||49
11173208|NCT01662310|12362041|FG000|NOT COMPLETED|Open-Label Extension Phase||0
11173209|NCT01662310|12362042|FG001|NOT COMPLETED|Open-Label Extension Phase||0
11173210|NCT01662310|12362043|FG002|NOT COMPLETED|Open-Label Extension Phase||0
11173211|NCT01662310|12362044|FG003|NOT COMPLETED|Open-Label Extension Phase||11
11173212|NCT01662310|12362045|FG004|NOT COMPLETED|Open-Label Extension Phase||10
11173213|NCT01662336|12362057|FG000|STARTED|Overall Study||173
11173214|NCT01662336|12362057|FG000|Completed Month 6 Visit|Overall Study||142
11173215|NCT01662336|12362057|FG000|Completed Month 12 Visit|Overall Study||109
11173216|NCT01662336|12362057|FG000|COMPLETED|Overall Study||107
11173217|NCT01662336|12362057|FG000|NOT COMPLETED|Overall Study||66
11420142|NCT03164616|12618945|FG000|COMPLETED|Overall Study||80
11420143|NCT03164616|12618946|FG001|COMPLETED|Overall Study||65
11173218|NCT01662362|12362066|FG000|STARTED|Overall Study||63
11173219|NCT01662362|12362066|FG000|COMPLETED|Overall Study||25
11173220|NCT01662362|12362066|FG000|NOT COMPLETED|Overall Study||38
11173221|NCT01662440|12362075|FG000|STARTED|Overall Study||167
11173222|NCT01662440|12362076|FG001|STARTED|Overall Study||217
11173223|NCT01662440|12362077|FG002|STARTED|Overall Study||221
11173224|NCT01662440|12362078|FG003|STARTED|Overall Study||56
11173225|NCT01662440|12362075|FG000|COMPLETED|Overall Study||158
11173226|NCT01662440|12362076|FG001|COMPLETED|Overall Study||211
11173227|NCT01662440|12362077|FG002|COMPLETED|Overall Study||215
11173228|NCT01662440|12362078|FG003|COMPLETED|Overall Study||52
11173229|NCT01662440|12362075|FG000|NOT COMPLETED|Overall Study||9
11173230|NCT01662440|12362076|FG001|NOT COMPLETED|Overall Study||6
11173231|NCT01662440|12362077|FG002|NOT COMPLETED|Overall Study||6
11173232|NCT01662440|12362078|FG003|NOT COMPLETED|Overall Study||4
11173233|NCT01662492|12362101|FG000|STARTED|Overall Study||45
11173234|NCT01662492|12362102|FG001|STARTED|Overall Study||43
11173235|NCT01662492|12362103|FG002|STARTED|Overall Study||37
11173236|NCT01662492|12362101|FG000|COMPLETED|Overall Study||42
11173237|NCT01662492|12362102|FG001|COMPLETED|Overall Study||42
11173238|NCT01662492|12362103|FG002|COMPLETED|Overall Study||31
11173239|NCT01662492|12362101|FG000|NOT COMPLETED|Overall Study||3
11173240|NCT01662492|12362102|FG001|NOT COMPLETED|Overall Study||1
11173241|NCT01662492|12362103|FG002|NOT COMPLETED|Overall Study||6
11173242|NCT01662505|12362114|FG000|STARTED|Overall Study||7
11173243|NCT01662505|12362115|FG001|STARTED|Overall Study||4
11173244|NCT01662505|12362116|FG002|STARTED|Overall Study||8
11173245|NCT01662505|12362114|FG000|COMPLETED|Overall Study||0
11173246|NCT01662505|12362115|FG001|COMPLETED|Overall Study||0
11173247|NCT01662505|12362116|FG002|COMPLETED|Overall Study||0
11173248|NCT01662505|12362114|FG000|NOT COMPLETED|Overall Study||7
11173249|NCT01662505|12362115|FG001|NOT COMPLETED|Overall Study||4
11173250|NCT01662505|12362116|FG002|NOT COMPLETED|Overall Study||8
11173251|NCT01662531|12362127|FG000|STARTED|Overall Study||27
11173252|NCT01662531|12362127|FG000|COMPLETED|Overall Study||27
11173253|NCT01662531|12362127|FG000|NOT COMPLETED|Overall Study||0
11173254|NCT01662583|12362136|FG000|STARTED|Overall Study||216
11173255|NCT01662583|12362137|FG001|STARTED|Overall Study||225
11173256|NCT01662583|12362138|FG002|STARTED|Overall Study||219
11173257|NCT01662583|12362136|FG000|COMPLETED|Overall Study||216
11173258|NCT01662583|12362137|FG001|COMPLETED|Overall Study||225
11173259|NCT01662583|12362138|FG002|COMPLETED|Overall Study||219
11173260|NCT01662583|12362136|FG000|NOT COMPLETED|Overall Study||0
11173261|NCT01662583|12362137|FG001|NOT COMPLETED|Overall Study||0
11173262|NCT01662583|12362138|FG002|NOT COMPLETED|Overall Study||0
11173263|NCT01662635|12362146|FG000|STARTED|Overall Study||230
11173264|NCT01662635|12362146|FG000|COMPLETED|Overall Study||200
11173265|NCT01662635|12362146|FG000|NOT COMPLETED|Overall Study||30
11173266|NCT01662648|12362154|FG000|STARTED|Overall Study||520
11173267|NCT01662648|12362155|FG001|STARTED|Overall Study||597
11173268|NCT01662648|12362154|FG000|COMPLETED|Overall Study||373
11420144|NCT03164616|12618947|FG002|COMPLETED|Overall Study||40
11420145|NCT03164616|12618945|FG000|NOT COMPLETED|Overall Study||258
11420146|NCT03164616|12618946|FG001|NOT COMPLETED|Overall Study||273
11173269|NCT01662648|12362155|FG001|COMPLETED|Overall Study||419
11173270|NCT01662648|12362154|FG000|NOT COMPLETED|Overall Study||147
11173271|NCT01662648|12362155|FG001|NOT COMPLETED|Overall Study||178
11173272|NCT01662752|12362161|FG000|STARTED|Overall Study||30
11173273|NCT01662752|12362161|FG000|COMPLETED|Overall Study||30
11420147|NCT03164616|12618947|FG002|NOT COMPLETED|Overall Study||297
11420148|NCT03093428|12618959|FG000|STARTED|Overall Study||31
11420149|NCT03093428|12618960|FG001|STARTED|Overall Study||14
11420150|NCT03093428|12618959|FG000|COMPLETED|Overall Study||12
11420151|NCT03093428|12618960|FG001|COMPLETED|Overall Study||8
11420152|NCT03093428|12618959|FG000|NOT COMPLETED|Overall Study||19
11173274|NCT01662752|12362161|FG000|NOT COMPLETED|Overall Study||0
11420153|NCT03093428|12618960|FG001|NOT COMPLETED|Overall Study||6
11420154|NCT03067129|12618970|FG000|STARTED|Overall Study||47
11420155|NCT03067129|12618971|FG001|STARTED|Overall Study||29
11173275|NCT01662765|12362167|FG000|STARTED|Overall Study||42
11173276|NCT01662765|12362168|FG001|STARTED|Overall Study||42
11173277|NCT01662765|12362167|FG000|COMPLETED|Overall Study||41
11173278|NCT01662765|12362168|FG001|COMPLETED|Overall Study||40
11173279|NCT01662765|12362167|FG000|NOT COMPLETED|Overall Study||1
11173280|NCT01662765|12362168|FG001|NOT COMPLETED|Overall Study||2
11173281|NCT01662778|12362179|FG000|STARTED|Period 1||6
11173282|NCT01662778|12362180|FG001|STARTED|Period 1||5
11173283|NCT01662778|12362181|FG002|STARTED|Period 1||6
11173284|NCT01662778|12362182|FG003|STARTED|Period 1||4
11173285|NCT01662778|12362179|FG000|COMPLETED|Period 1||6
11173286|NCT01662778|12362180|FG001|COMPLETED|Period 1||5
11173287|NCT01662778|12362181|FG002|COMPLETED|Period 1||6
11173288|NCT01662778|12362182|FG003|COMPLETED|Period 1||4
11173289|NCT01662778|12362179|FG000|NOT COMPLETED|Period 1||0
11173290|NCT01662778|12362180|FG001|NOT COMPLETED|Period 1||0
11173291|NCT01662778|12362181|FG002|NOT COMPLETED|Period 1||0
11173292|NCT01662778|12362182|FG003|NOT COMPLETED|Period 1||0
11173293|NCT01662778|12362179|FG000|STARTED|Period 2||6
11173294|NCT01662778|12362180|FG001|STARTED|Period 2||5
11173295|NCT01662778|12362181|FG002|STARTED|Period 2||6
11173296|NCT01662778|12362182|FG003|STARTED|Period 2||4
11173297|NCT01662778|12362179|FG000|COMPLETED|Period 2||6
11173298|NCT01662778|12362180|FG001|COMPLETED|Period 2||5
11173299|NCT01662778|12362181|FG002|COMPLETED|Period 2||6
11173300|NCT01662778|12362182|FG003|COMPLETED|Period 2||4
11173301|NCT01662778|12362179|FG000|NOT COMPLETED|Period 2||0
11173302|NCT01662778|12362180|FG001|NOT COMPLETED|Period 2||0
11173303|NCT01662778|12362181|FG002|NOT COMPLETED|Period 2||0
11173304|NCT01662778|12362182|FG003|NOT COMPLETED|Period 2||0
11173305|NCT01662778|12362179|FG000|STARTED|Period 3||6
11173306|NCT01662778|12362180|FG001|STARTED|Period 3||5
11173307|NCT01662778|12362181|FG002|STARTED|Period 3||6
11173308|NCT01662778|12362182|FG003|STARTED|Period 3||4
11173309|NCT01662778|12362179|FG000|COMPLETED|Period 3||6
11173310|NCT01662778|12362180|FG001|COMPLETED|Period 3||5
11173311|NCT01662778|12362181|FG002|COMPLETED|Period 3||6
11173312|NCT01662778|12362182|FG003|COMPLETED|Period 3||4
11173313|NCT01662778|12362179|FG000|NOT COMPLETED|Period 3||0
11173314|NCT01662778|12362180|FG001|NOT COMPLETED|Period 3||0
11173315|NCT01662778|12362181|FG002|NOT COMPLETED|Period 3||0
11420156|NCT03067129|12618972|FG002|STARTED|Overall Study||27
11173316|NCT01662778|12362182|FG003|NOT COMPLETED|Period 3||0
11173317|NCT01662778|12362179|FG000|STARTED|Period 4||6
11173318|NCT01662778|12362180|FG001|STARTED|Period 4||5
11173319|NCT01662778|12362181|FG002|STARTED|Period 4||6
11173320|NCT01662778|12362182|FG003|STARTED|Period 4||4
11173321|NCT01662778|12362179|FG000|COMPLETED|Period 4||6
11173322|NCT01662778|12362180|FG001|COMPLETED|Period 4||5
11173323|NCT01662778|12362181|FG002|COMPLETED|Period 4||6
11420157|NCT03067129|12618973|FG003|STARTED|Overall Study||24
11420158|NCT03067129|12618970|FG000|COMPLETED|Overall Study||2
11420159|NCT03067129|12618971|FG001|COMPLETED|Overall Study||1
11420160|NCT03067129|12618972|FG002|COMPLETED|Overall Study||0
11420161|NCT03067129|12618973|FG003|COMPLETED|Overall Study||0
11420162|NCT03067129|12618970|FG000|NOT COMPLETED|Overall Study||45
11173324|NCT01662778|12362182|FG003|COMPLETED|Period 4||4
11173325|NCT01662778|12362179|FG000|NOT COMPLETED|Period 4||0
11173326|NCT01662778|12362180|FG001|NOT COMPLETED|Period 4||0
11173327|NCT01662778|12362181|FG002|NOT COMPLETED|Period 4||0
11173328|NCT01662778|12362182|FG003|NOT COMPLETED|Period 4||0
11173329|NCT01662791|12362198|FG000|STARTED|Part 1 - Observational||8
11173330|NCT01662791|12362199|FG001|STARTED|Part 1 - Observational||41
11173331|NCT01662791|12362198|FG000|COMPLETED|Part 1 - Observational||8
11173332|NCT01662791|12362199|FG001|COMPLETED|Part 1 - Observational||41
11173333|NCT01662791|12362198|FG000|NOT COMPLETED|Part 1 - Observational||0
11173334|NCT01662791|12362199|FG001|NOT COMPLETED|Part 1 - Observational||0
11420163|NCT03067129|12618971|FG001|NOT COMPLETED|Overall Study||28
11420164|NCT03067129|12618972|FG002|NOT COMPLETED|Overall Study||27
11420165|NCT03067129|12618973|FG003|NOT COMPLETED|Overall Study||24
11173335|NCT01662791|12362198|FG000|STARTED|Part 2 - Interventional||8
11173336|NCT01662791|12362199|FG001|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
11173337|NCT01662791|12362198|FG000|COMPLETED|Part 2 - Interventional||8
11173338|NCT01662791|12362199|FG001|COMPLETED|Part 2 - Interventional||0
11173339|NCT01662791|12362198|FG000|NOT COMPLETED|Part 2 - Interventional||0
11173340|NCT01662791|12362199|FG001|NOT COMPLETED|Part 2 - Interventional||0
11173341|NCT01662856|12362207|FG000|STARTED|Part I + Part II (Overall Study)||168
11173342|NCT01662856|12362208|FG001|STARTED|Part I + Part II (Overall Study)||57
11420166|NCT02927301|12618991|FG000|STARTED|Overall Study||181
11420167|NCT02927301|12618991|FG000|COMPLETED|Overall Study||171
11420168|NCT02927301|12618991|FG000|NOT COMPLETED|Overall Study||10
11173343|NCT01662856|12362207|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
11173344|NCT01662856|12362208|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
11173345|NCT01662856|12362207|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
11173346|NCT01662856|12362208|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
11173347|NCT01662856|12362207|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||16
11173348|NCT01662856|12362208|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||2
11173349|NCT01662856|12362207|FG000|STARTED|Primary Part II||109
11173350|NCT01662856|12362208|FG001|STARTED|Primary Part II||57
11173351|NCT01662856|12362207|FG000|Completed Study up to Week 6|Primary Part II||106
11173352|NCT01662856|12362208|FG001|Completed Study up to Week 6|Primary Part II||56
11173353|NCT01662856|12362207|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
11173354|NCT01662856|12362208|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
11173355|NCT01662856|12362207|FG000|NOT COMPLETED|Primary Part II||10
11173356|NCT01662856|12362208|FG001|NOT COMPLETED|Primary Part II||2
11173357|NCT01662882|12362217|FG000|STARTED|Overall Study||15
11173358|NCT01662882|12362218|FG001|STARTED|Overall Study||18
11173359|NCT01662882|12362219|FG002|STARTED|Overall Study||15
11173360|NCT01662882|12362217|FG000|COMPLETED|Overall Study||15
11173361|NCT01662882|12362218|FG001|COMPLETED|Overall Study||18
11173362|NCT01662882|12362219|FG002|COMPLETED|Overall Study||15
11173363|NCT01662882|12362217|FG000|NOT COMPLETED|Overall Study||0
11173364|NCT01662882|12362218|FG001|NOT COMPLETED|Overall Study||0
11173365|NCT01662882|12362219|FG002|NOT COMPLETED|Overall Study||0
11173366|NCT01662895|12362229|FG000|STARTED|Overall Study||21
11173367|NCT01662895|12362230|FG001|STARTED|Overall Study||21
11173368|NCT01662895|12362229|FG000|Initiated Study Drug|Overall Study||21
11173369|NCT01662895|12362230|FG001|Initiated Study Drug|Overall Study||21
11173370|NCT01662895|12362229|FG000|COMPLETED|Overall Study||21
11173371|NCT01662895|12362230|FG001|COMPLETED|Overall Study||20
11173372|NCT01662895|12362229|FG000|NOT COMPLETED|Overall Study||0
11173373|NCT01662895|12362230|FG001|NOT COMPLETED|Overall Study||1
11173374|NCT01662908|12362238|FG000|STARTED|Overall Study||56
11173375|NCT01662908|12362239|FG001|STARTED|Overall Study||28
11173376|NCT01662908|12362238|FG000|COMPLETED|Overall Study||50
11173377|NCT01662908|12362239|FG001|COMPLETED|Overall Study||23
11173378|NCT01662908|12362238|FG000|NOT COMPLETED|Overall Study||6
11173379|NCT01662908|12362239|FG001|NOT COMPLETED|Overall Study||5
11173380|NCT01662960|12362249|FG000|STARTED|End of 4 Week Treatment Period||25
11173381|NCT01662960|12362250|FG001|STARTED|End of 4 Week Treatment Period||23
11173382|NCT01662960|12362251|FG002|STARTED|End of 4 Week Treatment Period||9
11173383|NCT01662960|12362252|FG003|STARTED|End of 4 Week Treatment Period||15
11173384|NCT01662960|12362249|FG000|COMPLETED|End of 4 Week Treatment Period||24
11173385|NCT01662960|12362250|FG001|COMPLETED|End of 4 Week Treatment Period||19
11173386|NCT01662960|12362251|FG002|COMPLETED|End of 4 Week Treatment Period||8
11173387|NCT01662960|12362252|FG003|COMPLETED|End of 4 Week Treatment Period||15
11173388|NCT01662960|12362249|FG000|NOT COMPLETED|End of 4 Week Treatment Period||1
11173389|NCT01662960|12362250|FG001|NOT COMPLETED|End of 4 Week Treatment Period||4
11173390|NCT01662960|12362251|FG002|NOT COMPLETED|End of 4 Week Treatment Period||1
11173391|NCT01662960|12362252|FG003|NOT COMPLETED|End of 4 Week Treatment Period||0
11173392|NCT01662960|12362249|FG000|STARTED|3 Month Follow-up||24
11173393|NCT01662960|12362250|FG001|STARTED|3 Month Follow-up||19
11173394|NCT01662960|12362251|FG002|STARTED|3 Month Follow-up||8
11173395|NCT01662960|12362252|FG003|STARTED|3 Month Follow-up||15
11173396|NCT01662960|12362249|FG000|COMPLETED|3 Month Follow-up||21
11173397|NCT01662960|12362250|FG001|COMPLETED|3 Month Follow-up||16
11173398|NCT01662960|12362251|FG002|COMPLETED|3 Month Follow-up||5
11173399|NCT01662960|12362252|FG003|COMPLETED|3 Month Follow-up||13
11173400|NCT01662960|12362249|FG000|NOT COMPLETED|3 Month Follow-up||3
11173401|NCT01662960|12362250|FG001|NOT COMPLETED|3 Month Follow-up||3
11173402|NCT01662960|12362251|FG002|NOT COMPLETED|3 Month Follow-up||3
11173403|NCT01662960|12362252|FG003|NOT COMPLETED|3 Month Follow-up||2
11173404|NCT01662986|12362264|FG000|STARTED|Overall Study||40
11173405|NCT01662986|12362265|FG001|STARTED|Overall Study||39
11173406|NCT01662986|12362264|FG000|COMPLETED|Overall Study||22
11173407|NCT01662986|12362265|FG001|COMPLETED|Overall Study||26
11173408|NCT01662986|12362264|FG000|NOT COMPLETED|Overall Study||18
11173409|NCT01662986|12362265|FG001|NOT COMPLETED|Overall Study||13
11173410|NCT01662999|12362277|FG000|STARTED|Period 1||7
11420169|NCT02927262|12618997|FG000|STARTED|Overall Study||63
11420170|NCT02927262|12618998|FG001|STARTED|Overall Study||35
11420171|NCT02927262|12618997|FG000|COMPLETED|Overall Study||20
11420172|NCT02927262|12618998|FG001|COMPLETED|Overall Study||12
11420173|NCT02927262|12618997|FG000|NOT COMPLETED|Overall Study||43
11173411|NCT01662999|12362278|FG001|STARTED|Period 1||7
11173412|NCT01662999|12362279|FG002|STARTED|Period 1||7
11173413|NCT01662999|12362280|FG003|STARTED|Period 1||7
11173414|NCT01662999|12362281|FG004|STARTED|Period 1||7
11173415|NCT01662999|12362282|FG005|STARTED|Period 1||7
11173416|NCT01662999|12362277|FG000|COMPLETED|Period 1||7
11173417|NCT01662999|12362278|FG001|COMPLETED|Period 1||7
11173418|NCT01662999|12362279|FG002|COMPLETED|Period 1||7
11173419|NCT01662999|12362280|FG003|COMPLETED|Period 1||7
11173420|NCT01662999|12362281|FG004|COMPLETED|Period 1||7
11173421|NCT01662999|12362282|FG005|COMPLETED|Period 1||7
11173422|NCT01662999|12362277|FG000|NOT COMPLETED|Period 1||0
11173423|NCT01662999|12362278|FG001|NOT COMPLETED|Period 1||0
11173424|NCT01662999|12362279|FG002|NOT COMPLETED|Period 1||0
11173425|NCT01662999|12362280|FG003|NOT COMPLETED|Period 1||0
11173426|NCT01662999|12362281|FG004|NOT COMPLETED|Period 1||0
11173427|NCT01662999|12362282|FG005|NOT COMPLETED|Period 1||0
11173428|NCT01662999|12362277|FG000|STARTED|Period 2||7
11173429|NCT01662999|12362278|FG001|STARTED|Period 2||7
11173430|NCT01662999|12362279|FG002|STARTED|Period 2||7
11173431|NCT01662999|12362280|FG003|STARTED|Period 2||7
11173432|NCT01662999|12362281|FG004|STARTED|Period 2||7
11173433|NCT01662999|12362282|FG005|STARTED|Period 2||7
11173434|NCT01662999|12362277|FG000|COMPLETED|Period 2||7
11173435|NCT01662999|12362278|FG001|COMPLETED|Period 2||7
11173436|NCT01662999|12362279|FG002|COMPLETED|Period 2||7
11173437|NCT01662999|12362280|FG003|COMPLETED|Period 2||7
11173438|NCT01662999|12362281|FG004|COMPLETED|Period 2||7
11173439|NCT01662999|12362282|FG005|COMPLETED|Period 2||7
11173440|NCT01662999|12362277|FG000|NOT COMPLETED|Period 2||0
11173441|NCT01662999|12362278|FG001|NOT COMPLETED|Period 2||0
11173442|NCT01662999|12362279|FG002|NOT COMPLETED|Period 2||0
11173443|NCT01662999|12362280|FG003|NOT COMPLETED|Period 2||0
11173444|NCT01662999|12362281|FG004|NOT COMPLETED|Period 2||0
11173445|NCT01662999|12362282|FG005|NOT COMPLETED|Period 2||0
11173446|NCT01662999|12362277|FG000|STARTED|Period 3||7
11173447|NCT01662999|12362278|FG001|STARTED|Period 3||7
11173448|NCT01662999|12362279|FG002|STARTED|Period 3||7
11173449|NCT01662999|12362280|FG003|STARTED|Period 3||7
11173450|NCT01662999|12362281|FG004|STARTED|Period 3||7
11173451|NCT01662999|12362282|FG005|STARTED|Period 3||7
11173452|NCT01662999|12362277|FG000|COMPLETED|Period 3||7
11173453|NCT01662999|12362278|FG001|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
11173454|NCT01662999|12362279|FG002|COMPLETED|Period 3||7
11173455|NCT01662999|12362280|FG003|COMPLETED|Period 3||7
11173456|NCT01662999|12362281|FG004|COMPLETED|Period 3||7
11173457|NCT01662999|12362282|FG005|COMPLETED|Period 3||7
11173458|NCT01662999|12362277|FG000|NOT COMPLETED|Period 3||0
11173459|NCT01662999|12362278|FG001|NOT COMPLETED|Period 3||1
11173460|NCT01662999|12362279|FG002|NOT COMPLETED|Period 3||0
11173461|NCT01662999|12362280|FG003|NOT COMPLETED|Period 3||0
11173462|NCT01662999|12362281|FG004|NOT COMPLETED|Period 3||0
11173463|NCT01662999|12362282|FG005|NOT COMPLETED|Period 3||0
11173464|NCT01663012|12362312|FG000|STARTED|Overall Study||20
11173465|NCT01663012|12362312|FG000|COMPLETED|Overall Study||20
11173466|NCT01663012|12362312|FG000|NOT COMPLETED|Overall Study||0
11173467|NCT01663103|12362318|FG000|STARTED|Overall Study||21
11173468|NCT01663103|12362319|FG001|STARTED|Overall Study||21
11173469|NCT01663103|12362318|FG000|COMPLETED|Overall Study||18
11173470|NCT01663103|12362319|FG001|COMPLETED|Overall Study||19
11173471|NCT01663103|12362318|FG000|NOT COMPLETED|Overall Study||3
11173472|NCT01663103|12362319|FG001|NOT COMPLETED|Overall Study||2
11173473|NCT01663233|12362331|FG000|STARTED|Overall Study||130
11173474|NCT01663233|12362332|FG001|STARTED|Overall Study||136
11173475|NCT01663233|12362331|FG000|COMPLETED|Overall Study||126
11173476|NCT01663233|12362332|FG001|COMPLETED|Overall Study||129
11173477|NCT01663233|12362331|FG000|NOT COMPLETED|Overall Study||4
11420174|NCT02927262|12618998|FG001|NOT COMPLETED|Overall Study||23
11173478|NCT01663233|12362332|FG001|NOT COMPLETED|Overall Study||7
11173479|NCT01663259|12362338|FG000|STARTED|Overall Study||42
11173480|NCT01663259|12362338|FG000|COMPLETED|Overall Study||42
11173481|NCT01663259|12362338|FG000|NOT COMPLETED|Overall Study||0
11173482|NCT01663272|12362342|FG000|STARTED|Overall Study||5
11173483|NCT01663272|12362343|FG001|STARTED|Overall Study||6
11173484|NCT01663272|12362344|FG002|STARTED|Overall Study||1
11173485|NCT01663272|12362342|FG000|COMPLETED|Overall Study||5
11173486|NCT01663272|12362343|FG001|COMPLETED|Overall Study||6
11173487|NCT01663272|12362344|FG002|COMPLETED|Overall Study||1
11173488|NCT01663272|12362342|FG000|NOT COMPLETED|Overall Study||0
11173489|NCT01663272|12362343|FG001|NOT COMPLETED|Overall Study||0
11173490|NCT01663272|12362344|FG002|NOT COMPLETED|Overall Study||0
11173491|NCT01663363|12362348|FG000|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
11173492|NCT01663363|12362348|FG000|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
11173493|NCT01663363|12362348|FG000|NOT COMPLETED|Overall Study||0
11173494|NCT01663402|12362354|FG000|STARTED|Overall Study||9462
11173495|NCT01663402|12362355|FG001|STARTED|Overall Study||9462
11173496|NCT01663402|12362354|FG000|Treated|Overall Study||9443
11173497|NCT01663402|12362355|FG001|Treated|Overall Study||9451
11173498|NCT01663402|12362354|FG000|COMPLETED|Overall Study||7947
11173499|NCT01663402|12362355|FG001|COMPLETED|Overall Study||7378
11173500|NCT01663402|12362354|FG000|NOT COMPLETED|Overall Study||1515
11173501|NCT01663402|12362355|FG001|NOT COMPLETED|Overall Study||2084
11173502|NCT01663506|12362361|FG000|STARTED|Overall Study||23
11173503|NCT01663506|12362361|FG000|COMPLETED|Overall Study||15
11173504|NCT01663506|12362361|FG000|NOT COMPLETED|Overall Study||8
11173505|NCT01663532|12362367|FG000|STARTED|Overall Study||168
11173506|NCT01663532|12362368|FG001|STARTED|Overall Study||172
11173507|NCT01663532|12362367|FG000|COMPLETED|Overall Study||94
11173508|NCT01663532|12362368|FG001|COMPLETED|Overall Study||65
11173509|NCT01663532|12362367|FG000|NOT COMPLETED|Overall Study||74
11173510|NCT01663532|12362368|FG001|NOT COMPLETED|Overall Study||107
11173511|NCT01663623|12362376|FG000|STARTED|Overall Study||52
11173512|NCT01663623|12362377|FG001|STARTED|Overall Study||53
11173513|NCT01663623|12362376|FG000|COMPLETED|Overall Study||40
11173514|NCT01663623|12362377|FG001|COMPLETED|Overall Study||33
11173515|NCT01663623|12362376|FG000|NOT COMPLETED|Overall Study||12
11173516|NCT01663623|12362377|FG001|NOT COMPLETED|Overall Study||20
11173517|NCT01663636|12362385|FG000|STARTED|Infant SMS Reminder Feasibility Study||160
11173518|NCT01663636|12362386|FG001|STARTED|Infant SMS Reminder Feasibility Study||161
11173519|NCT01663636|12362385|FG000|COMPLETED|Infant SMS Reminder Feasibility Study||135
11173520|NCT01663636|12362386|FG001|COMPLETED|Infant SMS Reminder Feasibility Study||130
11173521|NCT01663636|12362385|FG000|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
11173522|NCT01663636|12362386|FG001|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
11173523|NCT01663636|12362385|FG000|STARTED|Parent SMS Acceptability Assessment||135
11173524|NCT01663636|12362386|FG001|STARTED|Parent SMS Acceptability Assessment||130
11173525|NCT01663636|12362385|FG000|COMPLETED|Parent SMS Acceptability Assessment||135
11173526|NCT01663636|12362386|FG001|COMPLETED|Parent SMS Acceptability Assessment||130
11173527|NCT01663636|12362385|FG000|NOT COMPLETED|Parent SMS Acceptability Assessment||0
11173528|NCT01663636|12362386|FG001|NOT COMPLETED|Parent SMS Acceptability Assessment||0
11173529|NCT01663714|12362392|FG000|STARTED|Dosimetric and Therapeutic Treatment||30
11173530|NCT01663714|12362392|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
11173531|NCT01663714|12362392|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
11173532|NCT01663714|12362392|FG000|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
11173533|NCT01663714|12362392|FG000|COMPLETED|Long-Term Follow-Up||16
11173534|NCT01663714|12362392|FG000|NOT COMPLETED|Long-Term Follow-Up||6
11173535|NCT01663727|12362400|FG000|STARTED|Overall Study||242
11173536|NCT01663727|12362401|FG001|STARTED|Overall Study||239
11173537|NCT01663727|12362400|FG000|COMPLETED|Overall Study||0
11173538|NCT01663727|12362401|FG001|COMPLETED|Overall Study||1
11173539|NCT01663727|12362400|FG000|NOT COMPLETED|Overall Study||242
11173540|NCT01663727|12362401|FG001|NOT COMPLETED|Overall Study||238
11173541|NCT01663740|12362409|FG000|STARTED|Overall Study|Safety Population|38
11173542|NCT01663740|12362410|FG001|STARTED|Overall Study|Safety Population|21
11173543|NCT01663740|12362409|FG000|COMPLETED|Overall Study||22
11173544|NCT01663740|12362410|FG001|COMPLETED|Overall Study||13
11173545|NCT01663740|12362409|FG000|NOT COMPLETED|Overall Study||16
11173546|NCT01663740|12362410|FG001|NOT COMPLETED|Overall Study||8
11173547|NCT01663779|12362418|FG000|STARTED|Overall Study||27
11173548|NCT01663779|12362419|FG001|STARTED|Overall Study||23
11173549|NCT01663779|12362418|FG000|COMPLETED|Overall Study||27
11173550|NCT01663779|12362419|FG001|COMPLETED|Overall Study||23
11173551|NCT01663779|12362418|FG000|NOT COMPLETED|Overall Study||0
11173552|NCT01663779|12362419|FG001|NOT COMPLETED|Overall Study||0
11173553|NCT01663857|12362429|FG000|STARTED|Overall Study||6
11173554|NCT01663857|12362430|FG001|STARTED|Overall Study||2
11173555|NCT01663857|12362431|FG002|STARTED|Overall Study||58
11173556|NCT01663857|12362432|FG003|STARTED|Overall Study||52
11173557|NCT01663857|12362429|FG000|Received at Least One Dose of Study Drug|Overall Study||6
11173558|NCT01663857|12362430|FG001|Received at Least One Dose of Study Drug|Overall Study||2
11173559|NCT01663857|12362431|FG002|Received at Least One Dose of Study Drug|Overall Study||58
11173560|NCT01663857|12362432|FG003|Received at Least One Dose of Study Drug|Overall Study||52
11173561|NCT01663857|12362429|FG000|COMPLETED|Overall Study||6
11173562|NCT01663857|12362430|FG001|COMPLETED|Overall Study||1
11173563|NCT01663857|12362431|FG002|COMPLETED|Overall Study||48
11173564|NCT01663857|12362432|FG003|COMPLETED|Overall Study||48
11173565|NCT01663857|12362429|FG000|NOT COMPLETED|Overall Study||0
11173566|NCT01663857|12362430|FG001|NOT COMPLETED|Overall Study||1
11173567|NCT01663857|12362431|FG002|NOT COMPLETED|Overall Study||10
11173568|NCT01663857|12362432|FG003|NOT COMPLETED|Overall Study||4
11173569|NCT01663896|12362448|FG000|STARTED|Overall Study||418
11173570|NCT01663896|12362448|FG000|COMPLETED|Overall Study||375
11173571|NCT01663896|12362448|FG000|NOT COMPLETED|Overall Study||43
11173572|NCT01663922|12362453|FG000|STARTED|First Intervention (14 Days or 5 Days)||8
11173573|NCT01663922|12362454|FG001|STARTED|First Intervention (14 Days or 5 Days)||9
11173574|NCT01663922|12362453|FG000|COMPLETED|First Intervention (14 Days or 5 Days)||8
11173575|NCT01663922|12362454|FG001|COMPLETED|First Intervention (14 Days or 5 Days)||9
11173576|NCT01663922|12362453|FG000|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
11173577|NCT01663922|12362454|FG001|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
11173578|NCT01663922|12362453|FG000|STARTED|Washout (7 Days)||8
11173579|NCT01663922|12362454|FG001|STARTED|Washout (7 Days)||9
11173580|NCT01663922|12362453|FG000|COMPLETED|Washout (7 Days)||8
11173581|NCT01663922|12362454|FG001|COMPLETED|Washout (7 Days)||9
11173582|NCT01663922|12362453|FG000|NOT COMPLETED|Washout (7 Days)||0
11173583|NCT01663922|12362454|FG001|NOT COMPLETED|Washout (7 Days)||0
11173584|NCT01663922|12362453|FG000|STARTED|Second Intervention (14 Days)||8
11173585|NCT01663922|12362454|FG001|STARTED|Second Intervention (14 Days)||9
11173586|NCT01663922|12362453|FG000|COMPLETED|Second Intervention (14 Days)||8
11173587|NCT01663922|12362454|FG001|COMPLETED|Second Intervention (14 Days)||9
11173588|NCT01663922|12362453|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
11173589|NCT01663922|12362454|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
11173590|NCT01663922|12362453|FG000|STARTED|Washout (7 Days)||8
11173591|NCT01663922|12362454|FG001|STARTED|Washout (7 Days)||9
11173592|NCT01663922|12362453|FG000|COMPLETED|Washout (7 Days)||8
11173593|NCT01663922|12362454|FG001|COMPLETED|Washout (7 Days)||9
11173594|NCT01663922|12362453|FG000|NOT COMPLETED|Washout (7 Days)||0
11173595|NCT01663922|12362454|FG001|NOT COMPLETED|Washout (7 Days)||0
11173596|NCT01663922|12362453|FG000|STARTED|Third Intervention (14 Days or 5 Days)||8
11173597|NCT01663922|12362454|FG001|STARTED|Third Intervention (14 Days or 5 Days)||9
11173598|NCT01663922|12362453|FG000|COMPLETED|Third Intervention (14 Days or 5 Days)||8
11173599|NCT01663922|12362454|FG001|COMPLETED|Third Intervention (14 Days or 5 Days)||9
11173600|NCT01663922|12362453|FG000|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
11173601|NCT01663922|12362454|FG001|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
11173602|NCT01663935|12362459|FG000|STARTED|Overall Study||20
11173603|NCT01663935|12362459|FG000|COMPLETED|Overall Study||20
11173604|NCT01663935|12362459|FG000|NOT COMPLETED|Overall Study||0
11173605|NCT01663987|12362465|FG000|STARTED|Overall Study||39
11173606|NCT01663987|12362466|FG001|STARTED|Overall Study||40
11173607|NCT01663987|12362465|FG000|COMPLETED|Overall Study||26
11173608|NCT01663987|12362466|FG001|COMPLETED|Overall Study||34
11173609|NCT01663987|12362465|FG000|NOT COMPLETED|Overall Study||13
11173610|NCT01663987|12362466|FG001|NOT COMPLETED|Overall Study||6
11173611|NCT01664039|12362474|FG000|STARTED|Overall Study||52
11173612|NCT01664039|12362475|FG001|STARTED|Overall Study||52
11173613|NCT01664039|12362474|FG000|COMPLETED|Overall Study||46
11173614|NCT01664039|12362475|FG001|COMPLETED|Overall Study||43
11173615|NCT01664039|12362474|FG000|NOT COMPLETED|Overall Study||6
11173616|NCT01664039|12362475|FG001|NOT COMPLETED|Overall Study||9
11173617|NCT01664052|12362483|FG000|STARTED|Phase 1|Screening and enrollment|31
11173618|NCT01664052|12362484|FG001|STARTED|Phase 1||0
11173619|NCT01664052|12362483|FG000|Insert Placed in at Least One Tube|Phase 1||25
11173620|NCT01664052|12362484|FG001|Insert Placed in at Least One Tube|Phase 1||0
11173621|NCT01664052|12362483|FG000|HSG 1 Hour Post Placement|Phase 1||24
11173622|NCT01664052|12362484|FG001|HSG 1 Hour Post Placement|Phase 1||0
11173623|NCT01664052|12362483|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
11173624|NCT01664052|12362484|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
11173625|NCT01664052|12362483|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
11173626|NCT01664052|12362484|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
11173627|NCT01664052|12362483|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
11173628|NCT01664052|12362484|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
11173629|NCT01664052|12362483|FG000|COMPLETED|Phase 1||24
11173630|NCT01664052|12362484|FG001|COMPLETED|Phase 1||0
11173631|NCT01664052|12362483|FG000|NOT COMPLETED|Phase 1||7
11173632|NCT01664052|12362484|FG001|NOT COMPLETED|Phase 1||0
11173633|NCT01664052|12362483|FG000|STARTED|Phase 2|Screened and enrolled|0
11173634|NCT01664052|12362484|FG001|STARTED|Phase 2||35
11173635|NCT01664052|12362483|FG000|Insert Placed|Phase 2||0
11173636|NCT01664052|12362484|FG001|Insert Placed|Phase 2||31
11173637|NCT01664052|12362483|FG000|HSG 1 Hour Post Placement|Phase 2||0
11173638|NCT01664052|12362484|FG001|HSG 1 Hour Post Placement|Phase 2||31
11173639|NCT01664052|12362483|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
11173640|NCT01664052|12362484|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
11173641|NCT01664052|12362483|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
11173642|NCT01664052|12362484|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
11173643|NCT01664052|12362483|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
11173644|NCT01664052|12362484|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
11173645|NCT01664052|12362483|FG000|COMPLETED|Phase 2||0
11173646|NCT01664052|12362484|FG001|COMPLETED|Phase 2||31
11173647|NCT01664052|12362483|FG000|NOT COMPLETED|Phase 2||0
11173648|NCT01664052|12362484|FG001|NOT COMPLETED|Phase 2||4
11173649|NCT01664078|12362491|FG000|STARTED|Overall Study||190
11173650|NCT01664078|12362491|FG000|COMPLETED|Overall Study||121
11173651|NCT01664078|12362491|FG000|NOT COMPLETED|Overall Study||69
11173652|NCT01664091|12362541|FG000|STARTED|Overall Study||32
11173653|NCT01664091|12362541|FG000|COMPLETED|Overall Study||26
11173654|NCT01664091|12362541|FG000|NOT COMPLETED|Overall Study||6
11173655|NCT01664104|12362546|FG000|STARTED|Overall Study||136
11173656|NCT01664104|12362546|FG000|COMPLETED|Overall Study||120
11173657|NCT01664104|12362546|FG000|NOT COMPLETED|Overall Study||16
11173658|NCT01664117|12362552|FG000|STARTED|Overall Study||209
11173659|NCT01664117|12362552|FG000|COMPLETED|Overall Study||209
11173660|NCT01664117|12362552|FG000|NOT COMPLETED|Overall Study||0
11173661|NCT01664130|12362559|FG000|STARTED|Overall Study||35
11173662|NCT01664130|12362559|FG000|COMPLETED|Overall Study||33
11173663|NCT01664130|12362559|FG000|NOT COMPLETED|Overall Study||2
11173664|NCT01664247|12362568|FG000|STARTED|Overall Study||174
11173665|NCT01664247|12362569|FG001|STARTED|Overall Study||172
11173666|NCT01664247|12362568|FG000|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
11173667|NCT01664247|12362569|FG001|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
11173668|NCT01664247|12362568|FG000|COMPLETED|Overall Study||160
11173669|NCT01664247|12362569|FG001|COMPLETED|Overall Study||131
11173670|NCT01664247|12362568|FG000|NOT COMPLETED|Overall Study||14
11173671|NCT01664247|12362569|FG001|NOT COMPLETED|Overall Study||41
11173672|NCT01664494|12362575|FG000|STARTED|Overall Study||563
11173673|NCT01664494|12362575|FG000|COMPLETED|Overall Study||370
11173674|NCT01664494|12362575|FG000|NOT COMPLETED|Overall Study||193
11173675|NCT01664533|12362579|FG000|STARTED|Overall Study||57
11173676|NCT01664533|12362579|FG000|COMPLETED|Overall Study||0
11173677|NCT01664533|12362579|FG000|NOT COMPLETED|Overall Study||57
11173678|NCT01664559|12362586|FG000|STARTED|Overall Study||34
11173679|NCT01664559|12362587|FG001|STARTED|Overall Study||33
11173680|NCT01664559|12362586|FG000|COMPLETED|Overall Study||34
11173681|NCT01664559|12362587|FG001|COMPLETED|Overall Study||33
11173682|NCT01664559|12362586|FG000|NOT COMPLETED|Overall Study||0
11173683|NCT01664559|12362587|FG001|NOT COMPLETED|Overall Study||0
11173684|NCT01664624|12362597|FG000|STARTED|Overall Study||10
11173685|NCT01664624|12362598|FG001|STARTED|Overall Study||11
11173686|NCT01664624|12362599|FG002|STARTED|Overall Study||10
11173687|NCT01664624|12362600|FG003|STARTED|Overall Study||9
11173688|NCT01664624|12362597|FG000|COMPLETED|Overall Study||10
11173689|NCT01664624|12362598|FG001|COMPLETED|Overall Study||10
11173690|NCT01664624|12362599|FG002|COMPLETED|Overall Study||10
11173691|NCT01664624|12362600|FG003|COMPLETED|Overall Study||9
11173692|NCT01664624|12362597|FG000|NOT COMPLETED|Overall Study||0
11173693|NCT01664624|12362598|FG001|NOT COMPLETED|Overall Study||1
11173694|NCT01664624|12362599|FG002|NOT COMPLETED|Overall Study||0
11173695|NCT01664624|12362600|FG003|NOT COMPLETED|Overall Study||0
11173696|NCT01664741|12362613|FG000|STARTED|Overall Study||6
11173697|NCT01664741|12362614|FG001|STARTED|Overall Study||6
11173698|NCT01664741|12362615|FG002|STARTED|Overall Study||13
11173699|NCT01664741|12362613|FG000|COMPLETED|Overall Study||6
11173700|NCT01664741|12362614|FG001|COMPLETED|Overall Study||6
11173701|NCT01664741|12362615|FG002|COMPLETED|Overall Study||13
11173702|NCT01664741|12362613|FG000|NOT COMPLETED|Overall Study||0
11173703|NCT01664741|12362614|FG001|NOT COMPLETED|Overall Study||0
11173704|NCT01664741|12362615|FG002|NOT COMPLETED|Overall Study||0
11173705|NCT01664793|12362624|FG000|STARTED|Overall Study||49039
11173706|NCT01664793|12362625|FG001|STARTED|Overall Study||38626
11173707|NCT01664793|12362624|FG000|COMPLETED|Overall Study||49039
11173708|NCT01664793|12362625|FG001|COMPLETED|Overall Study||38626
11173709|NCT01664793|12362624|FG000|NOT COMPLETED|Overall Study||0
11173710|NCT01664793|12362625|FG001|NOT COMPLETED|Overall Study||0
11173711|NCT01664806|12362635|FG000|STARTED|Overall Study||20
11173712|NCT01664806|12362636|FG001|STARTED|Overall Study||20
11173713|NCT01664806|12362635|FG000|COMPLETED|Overall Study||20
11173714|NCT01664806|12362636|FG001|COMPLETED|Overall Study||20
11173715|NCT01664806|12362635|FG000|NOT COMPLETED|Overall Study||0
11173716|NCT01664806|12362636|FG001|NOT COMPLETED|Overall Study||0
11173717|NCT01664858|12362645|FG000|STARTED|Overall Study||481
11173718|NCT01664858|12362646|FG001|STARTED|Overall Study||481
11173719|NCT01664858|12362647|FG002|STARTED|Overall Study||240
11173720|NCT01664858|12362645|FG000|COMPLETED|Overall Study||467
11173721|NCT01664858|12362646|FG001|COMPLETED|Overall Study||468
11173722|NCT01664858|12362647|FG002|COMPLETED|Overall Study||234
11173723|NCT01664858|12362645|FG000|NOT COMPLETED|Overall Study||14
11173724|NCT01664858|12362646|FG001|NOT COMPLETED|Overall Study||13
11173725|NCT01664858|12362647|FG002|NOT COMPLETED|Overall Study||6
11173726|NCT01664897|12362658|FG000|STARTED|Overall Study||29
11173727|NCT01664897|12362658|FG000|COMPLETED|Overall Study||29
11173728|NCT01664897|12362658|FG000|NOT COMPLETED|Overall Study||0
11173729|NCT01664923|12362664|FG000|STARTED|Period1:Double Blind Phase-29 Months||198
11173730|NCT01664923|12362665|FG001|STARTED|Period1:Double Blind Phase-29 Months||198
11173731|NCT01664923|12362664|FG000|Received Study Treatment|Period1:Double Blind Phase-29 Months||197
11173732|NCT01664923|12362665|FG001|Received Study Treatment|Period1:Double Blind Phase-29 Months||198
11173733|NCT01664923|12362664|FG000|COMPLETED|Period1:Double Blind Phase-29 Months||93
11173734|NCT01664923|12362665|FG001|COMPLETED|Period1:Double Blind Phase-29 Months||38
11173735|NCT01664923|12362664|FG000|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105
11173736|NCT01664923|12362665|FG001|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160
11173737|NCT01664923|12362664|FG000|STARTED|Period 2: Open-label Phase-36 Months||93
11173738|NCT01664923|12362665|FG001|STARTED|Period 2: Open-label Phase-36 Months||38
11173739|NCT01664923|12362664|FG000|Treated|Period 2: Open-label Phase-36 Months||93
11173740|NCT01664923|12362665|FG001|Treated|Period 2: Open-label Phase-36 Months||37
11173741|NCT01664923|12362664|FG000|COMPLETED|Period 2: Open-label Phase-36 Months||52
11173742|NCT01664923|12362665|FG001|COMPLETED|Period 2: Open-label Phase-36 Months||15
11173743|NCT01664923|12362664|FG000|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41
11173744|NCT01664923|12362665|FG001|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23
11173745|NCT01664949|12362677|FG000|STARTED|Overall Study||224
11173746|NCT01664949|12362678|FG001|STARTED|Overall Study||236
11173747|NCT01664949|12362677|FG000|COMPLETED|Overall Study||200
11173748|NCT01664949|12362678|FG001|COMPLETED|Overall Study||211
11173749|NCT01664949|12362677|FG000|NOT COMPLETED|Overall Study||24
11173750|NCT01664949|12362678|FG001|NOT COMPLETED|Overall Study||25
11173751|NCT01664975|12362686|FG000|STARTED|Overall Study||57
11173752|NCT01664975|12362687|FG001|STARTED|Overall Study||54
11173753|NCT01664975|12362686|FG000|COMPLETED|Overall Study||52
11173754|NCT01664975|12362687|FG001|COMPLETED|Overall Study||51
11173755|NCT01664975|12362686|FG000|NOT COMPLETED|Overall Study||5
11173756|NCT01664975|12362687|FG001|NOT COMPLETED|Overall Study||3
11173757|NCT01665040|12362693|FG000|STARTED|Overall Study||40
11173758|NCT01665040|12362693|FG000|COMPLETED|Overall Study||36
11173759|NCT01665040|12362693|FG000|NOT COMPLETED|Overall Study||4
11173760|NCT01665053|12362699|FG000|STARTED|Overall Study||838
11173761|NCT01665053|12362700|FG001|STARTED|Overall Study||846
11173762|NCT01665053|12362699|FG000|Completed 12-Month Clinical F/U|Overall Study||797
11173763|NCT01665053|12362700|FG001|Completed 12-Month Clinical F/U|Overall Study||822
11173764|NCT01665053|12362699|FG000|No 12-Month F/U|Overall Study||32
11173765|NCT01665053|12362700|FG001|No 12-Month F/U|Overall Study||15
11173766|NCT01665053|12362699|FG000|Death With No 12-month Clinical FU|Overall Study||9
11173767|NCT01665053|12362700|FG001|Death With No 12-month Clinical FU|Overall Study||9
11173768|NCT01665053|12362699|FG000|COMPLETED|Overall Study||806
11173769|NCT01665053|12362700|FG001|COMPLETED|Overall Study||831
11173770|NCT01665053|12362699|FG000|NOT COMPLETED|Overall Study||32
11173771|NCT01665053|12362700|FG001|NOT COMPLETED|Overall Study||15
11173772|NCT01665092|12362710|FG000|STARTED|Overall Study||75
11173773|NCT01665092|12362711|FG001|STARTED|Overall Study||35
11173774|NCT01665092|12362712|FG002|STARTED|Overall Study||34
11173775|NCT01665092|12362713|FG003|STARTED|Overall Study||106
11173776|NCT01665092|12362710|FG000|COMPLETED|Overall Study||75
11173777|NCT01665092|12362711|FG001|COMPLETED|Overall Study||35
11173778|NCT01665092|12362712|FG002|COMPLETED|Overall Study||32
11173779|NCT01665092|12362713|FG003|COMPLETED|Overall Study||105
11173780|NCT01665092|12362710|FG000|NOT COMPLETED|Overall Study||0
11173781|NCT01665092|12362711|FG001|NOT COMPLETED|Overall Study||0
11173782|NCT01665092|12362712|FG002|NOT COMPLETED|Overall Study||2
11173783|NCT01665092|12362713|FG003|NOT COMPLETED|Overall Study||1
11173784|NCT01665157|12362726|FG000|STARTED|Overall Study||60
11173785|NCT01665157|12362727|FG001|STARTED|Overall Study||60
11173786|NCT01665157|12362728|FG002|STARTED|Overall Study||60
11173787|NCT01665157|12362726|FG000|COMPLETED|Overall Study||60
11173788|NCT01665157|12362727|FG001|COMPLETED|Overall Study||60
11173789|NCT01665157|12362728|FG002|COMPLETED|Overall Study||60
11173790|NCT01665157|12362726|FG000|NOT COMPLETED|Overall Study||0
11173791|NCT01665157|12362727|FG001|NOT COMPLETED|Overall Study||0
11173792|NCT01665157|12362728|FG002|NOT COMPLETED|Overall Study||0
11173793|NCT01665170|12362743|FG000|STARTED|Overall Study|First patient in|30
11173794|NCT01665170|12362744|FG001|STARTED|Overall Study||30
11173795|NCT01665170|12362743|FG000|Bevore TSST|Overall Study||30
11173796|NCT01665170|12362744|FG001|Bevore TSST|Overall Study||30
11173797|NCT01665170|12362743|FG000|During TSST|Overall Study||30
11173798|NCT01665170|12362744|FG001|During TSST|Overall Study||30
11173799|NCT01665170|12362743|FG000|After TSST|Overall Study||30
11173800|NCT01665170|12362744|FG001|After TSST|Overall Study||30
11173801|NCT01665170|12362743|FG000|COMPLETED|Overall Study|Last TSST/ last patient out|30
11173802|NCT01665170|12362744|FG001|COMPLETED|Overall Study||30
11173803|NCT01665170|12362743|FG000|NOT COMPLETED|Overall Study||0
11173804|NCT01665170|12362744|FG001|NOT COMPLETED|Overall Study||0
11173805|NCT01665430|12362752|FG000|STARTED|Overall Study||38
11173806|NCT01665430|12362752|FG000|COMPLETED|Overall Study||29
11173807|NCT01665430|12362752|FG000|NOT COMPLETED|Overall Study||9
11173808|NCT01665508|12362756|FG000|STARTED|Overall Study||12
11173809|NCT01665508|12362756|FG000|COMPLETED|Overall Study||7
11173810|NCT01665508|12362756|FG000|NOT COMPLETED|Overall Study||5
11173811|NCT01665599|12362765|FG000|STARTED|Overall Study||180
11173812|NCT01665599|12362765|FG000|COMPLETED|Overall Study||172
11173813|NCT01665599|12362765|FG000|NOT COMPLETED|Overall Study||8
11173814|NCT01665768|12362769|FG000|STARTED|Overall Study||49
11173815|NCT01665768|12362769|FG000|COMPLETED|Overall Study||26
11173816|NCT01665768|12362769|FG000|NOT COMPLETED|Overall Study||23
11173817|NCT01665807|12362776|FG000|STARTED|Overall Study||411
11173818|NCT01665807|12362777|FG001|STARTED|Overall Study||58
11420175|NCT02924129|12619006|FG000|STARTED|Overall Study||67
11420176|NCT02924129|12619007|FG001|STARTED|Overall Study||67
11420177|NCT02924129|12619006|FG000|COMPLETED|Overall Study||62
11420178|NCT02924129|12619007|FG001|COMPLETED|Overall Study||63
11420179|NCT02924129|12619006|FG000|NOT COMPLETED|Overall Study||5
11420180|NCT02924129|12619007|FG001|NOT COMPLETED|Overall Study||4
11173819|NCT01665807|12362778|FG002|STARTED|Overall Study||402
11173820|NCT01665807|12362776|FG000|COMPLETED|Overall Study||409
11173821|NCT01665807|12362777|FG001|COMPLETED|Overall Study||58
11420181|NCT02674490|12619015|FG000|STARTED|Overall Study||30
11420182|NCT02674490|12619016|FG001|STARTED|Overall Study||28
11420183|NCT02674490|12619015|FG000|Received at Least One Treatment Session (Modified Intent-to-treat Sample)|Overall Study||26
11420184|NCT02674490|12619016|FG001|Received at Least One Treatment Session (Modified Intent-to-treat Sample)|Overall Study||25
11173822|NCT01665807|12362778|FG002|COMPLETED|Overall Study||401
11173823|NCT01665807|12362776|FG000|NOT COMPLETED|Overall Study||2
11173824|NCT01665807|12362777|FG001|NOT COMPLETED|Overall Study||0
11173825|NCT01665807|12362778|FG002|NOT COMPLETED|Overall Study||1
11173826|NCT01665872|12362788|FG000|STARTED|Screening||172
11173827|NCT01665872|12362789|FG001|STARTED|Screening||172
11173828|NCT01665872|12362788|FG000|COMPLETED|Screening||172
11173829|NCT01665872|12362789|FG001|COMPLETED|Screening||172
11173830|NCT01665872|12362788|FG000|NOT COMPLETED|Screening||0
11173831|NCT01665872|12362789|FG001|NOT COMPLETED|Screening||0
11173832|NCT01665872|12362788|FG000|STARTED|Treatment||87
11173833|NCT01665872|12362789|FG001|STARTED|Treatment||67
11173834|NCT01665872|12362788|FG000|COMPLETED|Treatment||72
11173835|NCT01665872|12362789|FG001|COMPLETED|Treatment||50
11173836|NCT01665872|12362788|FG000|NOT COMPLETED|Treatment||15
11173837|NCT01665872|12362789|FG001|NOT COMPLETED|Treatment||17
11173838|NCT01665872|12362788|FG000|STARTED|6 Month Follow-up||72
11173839|NCT01665872|12362789|FG001|STARTED|6 Month Follow-up||50
11420185|NCT02674490|12619015|FG000|COMPLETED|Overall Study||25
11420186|NCT02674490|12619016|FG001|COMPLETED|Overall Study||21
11173840|NCT01665872|12362788|FG000|COMPLETED|6 Month Follow-up||66
11420187|NCT02674490|12619015|FG000|NOT COMPLETED|Overall Study||5
11173841|NCT01665872|12362789|FG001|COMPLETED|6 Month Follow-up||49
11173842|NCT01665872|12362788|FG000|NOT COMPLETED|6 Month Follow-up||6
11173843|NCT01665872|12362789|FG001|NOT COMPLETED|6 Month Follow-up||1
11173844|NCT01665872|12362788|FG000|STARTED|12 Month Follow-up||72
11173845|NCT01665872|12362789|FG001|STARTED|12 Month Follow-up||50
11173846|NCT01665872|12362788|FG000|COMPLETED|12 Month Follow-up||58
11173847|NCT01665872|12362789|FG001|COMPLETED|12 Month Follow-up||47
11173848|NCT01665872|12362788|FG000|NOT COMPLETED|12 Month Follow-up||14
11173849|NCT01665872|12362789|FG001|NOT COMPLETED|12 Month Follow-up||3
11173850|NCT01665911|12362795|FG000|STARTED|Overall Study||28
11173851|NCT01665911|12362795|FG000|0 mg Fluoride in 200 ml Milk|Overall Study||22
11173852|NCT01665911|12362795|FG000|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
11173853|NCT01665911|12362795|FG000|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
11173854|NCT01665911|12362795|FG000|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
11173855|NCT01665911|12362795|FG000|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
11173856|NCT01665911|12362795|FG000|COMPLETED|Overall Study||22
11173857|NCT01665911|12362795|FG000|NOT COMPLETED|Overall Study||6
11173858|NCT01665950|12362803|FG000|STARTED|Overall Study||2
11173859|NCT01665950|12362804|FG001|STARTED|Overall Study||0
11173860|NCT01665950|12362805|FG002|STARTED|Overall Study||2
11173861|NCT01665950|12362803|FG000|COMPLETED|Overall Study||1
11173862|NCT01665950|12362804|FG001|COMPLETED|Overall Study||0
11173863|NCT01665950|12362805|FG002|COMPLETED|Overall Study||1
11173864|NCT01665950|12362803|FG000|NOT COMPLETED|Overall Study||1
11173865|NCT01665950|12362804|FG001|NOT COMPLETED|Overall Study||0
11173866|NCT01665950|12362805|FG002|NOT COMPLETED|Overall Study||1
11173867|NCT01666002|12362815|FG000|STARTED|Overall Study||17
11173868|NCT01666002|12362816|FG001|STARTED|Overall Study||10
11173869|NCT01666002|12362815|FG000|COMPLETED|Overall Study||12
11173870|NCT01666002|12362816|FG001|COMPLETED|Overall Study||10
11173871|NCT01666002|12362815|FG000|NOT COMPLETED|Overall Study||5
11173872|NCT01666002|12362816|FG001|NOT COMPLETED|Overall Study||0
11173873|NCT01666119|12362823|FG000|STARTED|Overall Study||249
11173874|NCT01666119|12362823|FG000|COMPLETED|Overall Study||197
11173875|NCT01666119|12362823|FG000|NOT COMPLETED|Overall Study||52
11173876|NCT01666197|12362829|FG000|STARTED|Overall Study||50
11173877|NCT01666197|12362830|FG001|STARTED|Overall Study||50
11173878|NCT01666197|12362829|FG000|COMPLETED|Overall Study||50
11173879|NCT01666197|12362830|FG001|COMPLETED|Overall Study||50
11173880|NCT01666197|12362829|FG000|NOT COMPLETED|Overall Study||0
11173881|NCT01666197|12362830|FG001|NOT COMPLETED|Overall Study||0
11173882|NCT01666210|12362838|FG000|STARTED|Overall Study||30
11173883|NCT01666210|12362839|FG001|STARTED|Overall Study||30
11173884|NCT01666210|12362838|FG000|COMPLETED|Overall Study||28
11173885|NCT01666210|12362839|FG001|COMPLETED|Overall Study||29
11173886|NCT01666210|12362838|FG000|NOT COMPLETED|Overall Study||2
11173887|NCT01666210|12362839|FG001|NOT COMPLETED|Overall Study||1
11173888|NCT01666314|12362853|FG000|STARTED|Overall Study||33
11173889|NCT01666314|12362854|FG001|STARTED|Overall Study||32
11173890|NCT01666314|12362855|FG002|STARTED|Overall Study||36
11173891|NCT01666314|12362856|FG003|STARTED|Overall Study||36
11173892|NCT01666314|12362853|FG000|COMPLETED|Overall Study||0
11173893|NCT01666314|12362854|FG001|COMPLETED|Overall Study||0
11173894|NCT01666314|12362855|FG002|COMPLETED|Overall Study||0
11173895|NCT01666314|12362856|FG003|COMPLETED|Overall Study||0
11173896|NCT01666314|12362853|FG000|NOT COMPLETED|Overall Study||33
11173897|NCT01666314|12362854|FG001|NOT COMPLETED|Overall Study||32
11173898|NCT01666314|12362855|FG002|NOT COMPLETED|Overall Study||36
11173899|NCT01666314|12362856|FG003|NOT COMPLETED|Overall Study||36
11203911|NCT01849848|12394478|FG000|COMPLETED|Overall Study||13
11203912|NCT01849848|12394478|FG000|NOT COMPLETED|Overall Study||4
11203913|NCT01850030|12394484|FG000|STARTED|Overall Study||520
11203914|NCT01850030|12394485|FG001|STARTED|Overall Study||511
11203915|NCT01850030|12394484|FG000|COMPLETED|Overall Study||173
11203916|NCT01850030|12394485|FG001|COMPLETED|Overall Study||142
11203917|NCT01850030|12394484|FG000|NOT COMPLETED|Overall Study||347
11173900|NCT01666444|12362879|FG000|STARTED|Overall Study||149
11173901|NCT01666444|12362880|FG001|STARTED|Overall Study||148
11173902|NCT01666444|12362879|FG000|COMPLETED|Overall Study||147
11173903|NCT01666444|12362880|FG001|COMPLETED|Overall Study||147
11173904|NCT01666444|12362879|FG000|NOT COMPLETED|Overall Study||2
11173905|NCT01666444|12362880|FG001|NOT COMPLETED|Overall Study||1
11173906|NCT01666652|12362891|FG000|STARTED|Overall Study||20
11173907|NCT01666652|12362892|FG001|STARTED|Overall Study||20
11173908|NCT01666652|12362893|FG002|STARTED|Overall Study||20
11173909|NCT01666652|12362894|FG003|STARTED|Overall Study||20
11173910|NCT01666652|12362895|FG004|STARTED|Overall Study||20
11323844|NCT02738333|12521122|FG001|NOT COMPLETED|Overall Study||0
11323845|NCT02738333|12521123|FG002|NOT COMPLETED|Overall Study||0
11323846|NCT02738450|12521135|FG000|STARTED|Overall Study||6
11323847|NCT02738450|12521136|FG001|STARTED|Overall Study||6
11323848|NCT02738450|12521137|FG002|STARTED|Overall Study||4
11323849|NCT02738450|12521135|FG000|COMPLETED|Overall Study||6
11323850|NCT02738450|12521136|FG001|COMPLETED|Overall Study||4
11323851|NCT02738450|12521137|FG002|COMPLETED|Overall Study||4
11323852|NCT02738450|12521135|FG000|NOT COMPLETED|Overall Study||0
11323853|NCT02738450|12521136|FG001|NOT COMPLETED|Overall Study||2
11323854|NCT02738450|12521137|FG002|NOT COMPLETED|Overall Study||0
11323855|NCT02738580|12521148|FG000|STARTED|Overall Study|56 patients were assigned to this arms.|56
11323856|NCT02738580|12521149|FG001|STARTED|Overall Study||56
11420188|NCT02674490|12619016|FG001|NOT COMPLETED|Overall Study||7
11323857|NCT02738580|12521148|FG000|COMPLETED|Overall Study|"3 cycles cancelled due to por response to stimullation.~1 cycle cancelled due to SAE."|52
11420189|NCT02574481|12619026|FG000|STARTED|Overall Study||309
11420190|NCT02574481|12619027|FG001|STARTED|Overall Study||156
11420191|NCT02574481|12619028|FG002|STARTED|Overall Study||50
11420192|NCT02574481|12619029|FG003|STARTED|Overall Study||13
11420193|NCT02574481|12619026|FG000|COMPLETED|Overall Study||282
11420194|NCT02574481|12619027|FG001|COMPLETED|Overall Study||142
11420195|NCT02574481|12619028|FG002|COMPLETED|Overall Study||47
11420196|NCT02574481|12619029|FG003|COMPLETED|Overall Study||13
11420197|NCT02574481|12619026|FG000|NOT COMPLETED|Overall Study||27
11420198|NCT02574481|12619027|FG001|NOT COMPLETED|Overall Study||14
11420199|NCT02574481|12619028|FG002|NOT COMPLETED|Overall Study||3
11420200|NCT02574481|12619029|FG003|NOT COMPLETED|Overall Study||0
11420201|NCT02500121|12619044|FG000|STARTED|Overall Study||53
11420202|NCT02500121|12619045|FG001|STARTED|Overall Study||55
11420203|NCT02500121|12619044|FG000|Crossover to Pembrolizumab|Overall Study|Only subjects that progressed on the control arm were eligible to participate in the crossover portion of the trial.|27
11420204|NCT02500121|12619045|FG001|Crossover to Pembrolizumab|Overall Study|Not applicable for the experimental arm.|0
11173911|NCT01666652|12362891|FG000|COMPLETED|Overall Study||18
11173912|NCT01666652|12362892|FG001|COMPLETED|Overall Study||19
11173913|NCT01666652|12362893|FG002|COMPLETED|Overall Study||19
11173914|NCT01666652|12362894|FG003|COMPLETED|Overall Study||16
11173915|NCT01666652|12362895|FG004|COMPLETED|Overall Study||19
11173916|NCT01666652|12362891|FG000|NOT COMPLETED|Overall Study||2
11173917|NCT01666652|12362892|FG001|NOT COMPLETED|Overall Study||1
11173918|NCT01666652|12362893|FG002|NOT COMPLETED|Overall Study||1
11173919|NCT01666652|12362894|FG003|NOT COMPLETED|Overall Study||4
11173920|NCT01666652|12362895|FG004|NOT COMPLETED|Overall Study||1
11173921|NCT01666730|12362907|FG000|STARTED|Overall Study||50
11173922|NCT01666730|12362907|FG000|COMPLETED|Overall Study||0
11173923|NCT01666730|12362907|FG000|NOT COMPLETED|Overall Study||50
11173924|NCT01666782|12362913|FG000|STARTED|Overall Study||54
11173925|NCT01666782|12362914|FG001|STARTED|Overall Study||51
11173926|NCT01666782|12362913|FG000|COMPLETED|Overall Study||50
11173927|NCT01666782|12362914|FG001|COMPLETED|Overall Study||50
11173928|NCT01666782|12362913|FG000|NOT COMPLETED|Overall Study||4
11173929|NCT01666782|12362914|FG001|NOT COMPLETED|Overall Study||1
11173930|NCT01666912|12362922|FG000|STARTED|Overall Study||48
11173931|NCT01666912|12362923|FG001|STARTED|Overall Study||48
11173932|NCT01666912|12362922|FG000|COMPLETED|Overall Study||27
11173933|NCT01666912|12362923|FG001|COMPLETED|Overall Study||37
11173934|NCT01666912|12362922|FG000|NOT COMPLETED|Overall Study||21
11173935|NCT01666912|12362923|FG001|NOT COMPLETED|Overall Study||11
11173936|NCT01666951|12362931|FG000|STARTED|Overall Study||18
11173937|NCT01666951|12362932|FG001|STARTED|Overall Study||18
11173938|NCT01666951|12362931|FG000|COMPLETED|Overall Study||17
11173939|NCT01666951|12362932|FG001|COMPLETED|Overall Study||17
11420205|NCT02500121|12619044|FG000|COMPLETED|Overall Study||26
11420206|NCT02500121|12619045|FG001|COMPLETED|Overall Study||29
11420207|NCT02500121|12619044|FG000|NOT COMPLETED|Overall Study||27
11420208|NCT02500121|12619045|FG001|NOT COMPLETED|Overall Study||26
11420209|NCT02258451|12619055|FG000|STARTED|Overall Study||142
11420210|NCT02258451|12619056|FG001|STARTED|Overall Study||141
11420211|NCT02258451|12619055|FG000|COMPLETED|Overall Study||0
11420212|NCT02258451|12619056|FG001|COMPLETED|Overall Study||0
11420213|NCT02258451|12619055|FG000|NOT COMPLETED|Overall Study||142
11420214|NCT02258451|12619056|FG001|NOT COMPLETED|Overall Study||141
11420215|NCT02242942|12619067|FG000|STARTED|Overall Study||216
11420216|NCT02242942|12619068|FG001|STARTED|Overall Study||216
11173940|NCT01666951|12362931|FG000|NOT COMPLETED|Overall Study||1
11173941|NCT01666951|12362932|FG001|NOT COMPLETED|Overall Study||1
11173942|NCT01667029|12362938|FG000|STARTED|Overall Study||4
11173943|NCT01667029|12362939|FG001|STARTED|Overall Study||4
11173944|NCT01667029|12362938|FG000|COMPLETED|Overall Study||3
11173945|NCT01667029|12362939|FG001|COMPLETED|Overall Study||3
11173946|NCT01667029|12362938|FG000|NOT COMPLETED|Overall Study||1
11173947|NCT01667029|12362939|FG001|NOT COMPLETED|Overall Study||1
11173948|NCT01667107|12362947|FG000|STARTED|Overall Study||8
11173949|NCT01667107|12362948|FG001|STARTED|Overall Study||18
11173950|NCT01667107|12362947|FG000|COMPLETED|Overall Study||4
11173951|NCT01667107|12362948|FG001|COMPLETED|Overall Study||11
11173952|NCT01667107|12362947|FG000|NOT COMPLETED|Overall Study||4
11420217|NCT02242942|12619069|FG002|STARTED|Overall Study||13
11420218|NCT02242942|12619067|FG000|Treated|Overall Study||214
11420219|NCT02242942|12619068|FG001|Treated|Overall Study||212
11420220|NCT02242942|12619069|FG002|Treated|Overall Study||13
11420221|NCT02242942|12619067|FG000|COMPLETED|Overall Study||0
11420222|NCT02242942|12619068|FG001|COMPLETED|Overall Study||0
11420223|NCT02242942|12619069|FG002|COMPLETED|Overall Study||0
11420224|NCT02242942|12619067|FG000|NOT COMPLETED|Overall Study||216
11420225|NCT02242942|12619068|FG001|NOT COMPLETED|Overall Study||216
11420226|NCT02242942|12619069|FG002|NOT COMPLETED|Overall Study||13
11420227|NCT02184156|12619082|FG000|STARTED|Phase 1 Safety||7
11420228|NCT02184156|12619083|FG001|STARTED|Phase 1 Safety||0
11420229|NCT02184156|12619082|FG000|COMPLETED|Phase 1 Safety||7
11420230|NCT02184156|12619083|FG001|COMPLETED|Phase 1 Safety||0
11420231|NCT02184156|12619082|FG000|NOT COMPLETED|Phase 1 Safety||0
11420232|NCT02184156|12619083|FG001|NOT COMPLETED|Phase 1 Safety||0
11420233|NCT02184156|12619082|FG000|STARTED|Phase 2 20 Week Efficacy||20
11420234|NCT02184156|12619083|FG001|STARTED|Phase 2 20 Week Efficacy||20
11420235|NCT02184156|12619082|FG000|COMPLETED|Phase 2 20 Week Efficacy||19
11420236|NCT02184156|12619083|FG001|COMPLETED|Phase 2 20 Week Efficacy||19
11420237|NCT02184156|12619082|FG000|NOT COMPLETED|Phase 2 20 Week Efficacy||1
11420238|NCT02184156|12619083|FG001|NOT COMPLETED|Phase 2 20 Week Efficacy||1
11420239|NCT02158091|12619096|FG000|STARTED|Overall Study||6
11420240|NCT02158091|12619097|FG001|STARTED|Overall Study||6
11420241|NCT02158091|12619098|FG002|STARTED|Overall Study||20
11420242|NCT02158091|12619096|FG000|COMPLETED|Overall Study||4
11420243|NCT02158091|12619097|FG001|COMPLETED|Overall Study||5
11420244|NCT02158091|12619098|FG002|COMPLETED|Overall Study||20
11420245|NCT02158091|12619096|FG000|NOT COMPLETED|Overall Study||2
11420246|NCT02158091|12619097|FG001|NOT COMPLETED|Overall Study||1
11173953|NCT01667107|12362948|FG001|NOT COMPLETED|Overall Study||7
11173954|NCT01667224|12362956|FG000|STARTED|Overall Study||40
11173955|NCT01667224|12362957|FG001|STARTED|Overall Study||40
11173956|NCT01667224|12362956|FG000|COMPLETED|Overall Study||36
11173957|NCT01667224|12362957|FG001|COMPLETED|Overall Study||38
11173958|NCT01667224|12362956|FG000|NOT COMPLETED|Overall Study||4
11173959|NCT01667224|12362957|FG001|NOT COMPLETED|Overall Study||2
11173960|NCT01667250|12362967|FG000|STARTED|Run-in (no Treatment)||0
11173961|NCT01667250|12362968|FG001|STARTED|Run-in (no Treatment)||0
11173962|NCT01667250|12362969|FG002|STARTED|Run-in (no Treatment)||73
11173963|NCT01667250|12362967|FG000|COMPLETED|Run-in (no Treatment)||0
11173964|NCT01667250|12362968|FG001|COMPLETED|Run-in (no Treatment)||0
11173965|NCT01667250|12362969|FG002|COMPLETED|Run-in (no Treatment)||59
11173966|NCT01667250|12362967|FG000|NOT COMPLETED|Run-in (no Treatment)||0
11173967|NCT01667250|12362968|FG001|NOT COMPLETED|Run-in (no Treatment)||0
11173968|NCT01667250|12362969|FG002|NOT COMPLETED|Run-in (no Treatment)||14
11173969|NCT01667250|12362967|FG000|STARTED|Randomised Period||30
11173970|NCT01667250|12362968|FG001|STARTED|Randomised Period||29
11173971|NCT01667250|12362969|FG002|STARTED|Randomised Period||0
11173972|NCT01667250|12362967|FG000|COMPLETED|Randomised Period||29
11173973|NCT01667250|12362968|FG001|COMPLETED|Randomised Period||28
11173974|NCT01667250|12362969|FG002|COMPLETED|Randomised Period||0
11173975|NCT01667250|12362967|FG000|NOT COMPLETED|Randomised Period||1
11173976|NCT01667250|12362968|FG001|NOT COMPLETED|Randomised Period||1
11173977|NCT01667250|12362969|FG002|NOT COMPLETED|Randomised Period||0
11173978|NCT01667406|12362986|FG000|STARTED|Overall Study||2
11173979|NCT01667406|12362987|FG001|STARTED|Overall Study||3
11173980|NCT01667406|12362988|FG002|STARTED|Overall Study||24
11173981|NCT01667406|12362989|FG003|STARTED|Overall Study||24
11173982|NCT01667406|12362990|FG004|STARTED|Overall Study||5
11173983|NCT01667406|12362991|FG005|STARTED|Overall Study||20
11173984|NCT01667406|12362992|FG006|STARTED|Overall Study||15
11173985|NCT01667406|12362993|FG007|STARTED|Overall Study||20
11173986|NCT01667406|12362994|FG008|STARTED|Overall Study||31
11173987|NCT01667406|12362995|FG009|STARTED|Overall Study||31
11173988|NCT01667406|12362986|FG000|COMPLETED|Overall Study||2
11173989|NCT01667406|12362987|FG001|COMPLETED|Overall Study||3
11173990|NCT01667406|12362988|FG002|COMPLETED|Overall Study||24
11173991|NCT01667406|12362989|FG003|COMPLETED|Overall Study||24
11173992|NCT01667406|12362990|FG004|COMPLETED|Overall Study||5
11173993|NCT01667406|12362991|FG005|COMPLETED|Overall Study||20
11173994|NCT01667406|12362992|FG006|COMPLETED|Overall Study||15
11173995|NCT01667406|12362993|FG007|COMPLETED|Overall Study||20
11173996|NCT01667406|12362994|FG008|COMPLETED|Overall Study||31
11173997|NCT01667406|12362995|FG009|COMPLETED|Overall Study||31
11173998|NCT01667406|12362986|FG000|NOT COMPLETED|Overall Study||0
11173999|NCT01667406|12362987|FG001|NOT COMPLETED|Overall Study||0
11174000|NCT01667406|12362988|FG002|NOT COMPLETED|Overall Study||0
11174001|NCT01667406|12362989|FG003|NOT COMPLETED|Overall Study||0
11174002|NCT01667406|12362990|FG004|NOT COMPLETED|Overall Study||0
11174003|NCT01667406|12362991|FG005|NOT COMPLETED|Overall Study||0
11174004|NCT01667406|12362992|FG006|NOT COMPLETED|Overall Study||0
11174005|NCT01667406|12362993|FG007|NOT COMPLETED|Overall Study||0
11174006|NCT01667406|12362994|FG008|NOT COMPLETED|Overall Study||0
11174007|NCT01667406|12362995|FG009|NOT COMPLETED|Overall Study||0
11174008|NCT01667419|12363051|FG000|STARTED|Overall Study||157
11174009|NCT01667419|12363052|FG001|STARTED|Overall Study||157
11174010|NCT01667419|12363053|FG002|STARTED|Overall Study||93
11174011|NCT01667419|12363054|FG003|STARTED|Overall Study||91
11174012|NCT01667419|12363051|FG000|COMPLETED|Overall Study||114
11174013|NCT01667419|12363052|FG001|COMPLETED|Overall Study||110
11174014|NCT01667419|12363053|FG002|COMPLETED|Overall Study||57
11174015|NCT01667419|12363054|FG003|COMPLETED|Overall Study||52
11174016|NCT01667419|12363051|FG000|NOT COMPLETED|Overall Study||43
11174017|NCT01667419|12363052|FG001|NOT COMPLETED|Overall Study||47
11174018|NCT01667419|12363053|FG002|NOT COMPLETED|Overall Study||36
11174019|NCT01667419|12363054|FG003|NOT COMPLETED|Overall Study||39
11174020|NCT01667432|12363065|FG000|STARTED|Overall Study||141
11174021|NCT01667432|12363065|FG000|COMPLETED|Overall Study||84
11174022|NCT01667432|12363065|FG000|NOT COMPLETED|Overall Study||57
11174023|NCT01667471|12363069|FG000|STARTED|Overall Study||7
11174024|NCT01667471|12363069|FG000|COMPLETED|Overall Study||7
11174025|NCT01667471|12363069|FG000|NOT COMPLETED|Overall Study||0
11174026|NCT01667536|12363074|FG000|STARTED|Overall Study||105
11174027|NCT01667536|12363074|FG000|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
11174028|NCT01667536|12363074|FG000|NOT COMPLETED|Overall Study||0
11420247|NCT02158091|12619098|FG002|NOT COMPLETED|Overall Study||0
11420248|NCT02086175|12619106|FG000|STARTED|Overall Study||25
11420249|NCT02086175|12619106|FG000|COMPLETED|Overall Study||25
11420250|NCT02086175|12619106|FG000|NOT COMPLETED|Overall Study||0
11174029|NCT01667549|12363086|FG000|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
11174030|NCT01667549|12363087|FG001|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
11174031|NCT01667549|12363088|FG002|STARTED|Overall Study|21 dyads=21 infants, 21 mothers|21
11174032|NCT01667549|12363089|FG003|STARTED|Overall Study|20 dyads= 20 infants, 20 mothers|20
11174033|NCT01667549|12363090|FG004|STARTED|Overall Study|16 dyads=16 infants, 16 mothers|16
11174034|NCT01667549|12363086|FG000|COMPLETED|Overall Study|17 dyads=17 infants, 17 mothers|17
11174035|NCT01667549|12363087|FG001|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
11174036|NCT01667549|12363088|FG002|COMPLETED|Overall Study|14 dyads=14 infants, 14 mothers|14
11174037|NCT01667549|12363089|FG003|COMPLETED|Overall Study|14 dyads= 14 infants, 14 mothers|14
11174038|NCT01667549|12363090|FG004|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
11174039|NCT01667549|12363086|FG000|NOT COMPLETED|Overall Study||3
11420251|NCT02065154|12619110|FG000|STARTED|Overall Study||39
11420252|NCT02065154|12619110|FG000|COMPLETED|Overall Study||39
11174040|NCT01667549|12363087|FG001|NOT COMPLETED|Overall Study||5
11174041|NCT01667549|12363088|FG002|NOT COMPLETED|Overall Study||7
11174042|NCT01667549|12363089|FG003|NOT COMPLETED|Overall Study||6
11174043|NCT01667549|12363090|FG004|NOT COMPLETED|Overall Study||1
11174044|NCT01667562|12363107|FG000|STARTED|Diagnostic Phase||375
11174045|NCT01667562|12363108|FG001|STARTED|Diagnostic Phase||0
11174046|NCT01667562|12363107|FG000|COMPLETED|Diagnostic Phase||345
11174047|NCT01667562|12363108|FG001|COMPLETED|Diagnostic Phase||0
11174048|NCT01667562|12363107|FG000|NOT COMPLETED|Diagnostic Phase||30
11174049|NCT01667562|12363108|FG001|NOT COMPLETED|Diagnostic Phase||0
11174050|NCT01667562|12363107|FG000|STARTED|Erlotinib Phase||0
11174051|NCT01667562|12363108|FG001|STARTED|Erlotinib Phase||30
11174052|NCT01667562|12363107|FG000|COMPLETED|Erlotinib Phase||0
11174053|NCT01667562|12363108|FG001|COMPLETED|Erlotinib Phase||27
11174054|NCT01667562|12363107|FG000|NOT COMPLETED|Erlotinib Phase||0
11174055|NCT01667562|12363108|FG001|NOT COMPLETED|Erlotinib Phase||3
11174056|NCT01667679|12363115|FG000|STARTED|Treatment Period 1 (<=12 Weeks)||138
11174057|NCT01667679|12363116|FG001|STARTED|Treatment Period 1 (<=12 Weeks)||137
11174058|NCT01667679|12363115|FG000|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
11174059|NCT01667679|12363116|FG001|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
11174060|NCT01667679|12363115|FG000|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
11174061|NCT01667679|12363116|FG001|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
11174062|NCT01667679|12363115|FG000|STARTED|Treatment Period 2 (<=12 Weeks)||122
11174063|NCT01667679|12363116|FG001|STARTED|Treatment Period 2 (<=12 Weeks)||107
11174064|NCT01667679|12363115|FG000|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
11174065|NCT01667679|12363116|FG001|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
11174066|NCT01667679|12363115|FG000|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
11174067|NCT01667679|12363116|FG001|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
11174068|NCT01667731|12363129|FG000|STARTED|Overall Study||26
11174069|NCT01667731|12363130|FG001|STARTED|Overall Study||42
11174070|NCT01667731|12363131|FG002|STARTED|Overall Study||24
11174071|NCT01667731|12363132|FG003|STARTED|Overall Study||17
11174072|NCT01667731|12363133|FG004|STARTED|Overall Study||115
11174073|NCT01667731|12363129|FG000|COMPLETED|Overall Study||21
11174074|NCT01667731|12363130|FG001|COMPLETED|Overall Study||26
11174075|NCT01667731|12363131|FG002|COMPLETED|Overall Study||22
11420253|NCT02065154|12619110|FG000|NOT COMPLETED|Overall Study||0
11420254|NCT02005471|12619117|FG000|STARTED|Overall Study||195
11420255|NCT02005471|12619118|FG001|STARTED|Overall Study||194
11420256|NCT02005471|12619117|FG000|Treated|Overall Study||188
11420257|NCT02005471|12619118|FG001|Treated|Overall Study||194
11420258|NCT02005471|12619117|FG000|COMPLETED|Overall Study||0
11420259|NCT02005471|12619118|FG001|COMPLETED|Overall Study||0
11420260|NCT02005471|12619117|FG000|NOT COMPLETED|Overall Study||195
11420261|NCT02005471|12619118|FG001|NOT COMPLETED|Overall Study||194
11420262|NCT01946139|12619127|FG000|STARTED|Overall Study||276
11420263|NCT01946139|12619127|FG000|COMPLETED|Overall Study||256
11420264|NCT01946139|12619127|FG000|NOT COMPLETED|Overall Study||20
11420265|NCT01828099|12619133|FG000|STARTED|Overall Study||189
11420266|NCT01828099|12619134|FG001|STARTED|Overall Study||187
11420267|NCT01828099|12619133|FG000|Untreated Patients|Overall Study||0
11420268|NCT01828099|12619134|FG001|Untreated Patients|Overall Study||12
11174076|NCT01667731|12363132|FG003|COMPLETED|Overall Study||15
11174077|NCT01667731|12363133|FG004|COMPLETED|Overall Study||87
11174078|NCT01667731|12363129|FG000|NOT COMPLETED|Overall Study||5
11174079|NCT01667731|12363130|FG001|NOT COMPLETED|Overall Study||16
11174080|NCT01667731|12363131|FG002|NOT COMPLETED|Overall Study||2
11174081|NCT01667731|12363132|FG003|NOT COMPLETED|Overall Study||2
11174082|NCT01667731|12363133|FG004|NOT COMPLETED|Overall Study||28
11174083|NCT01667796|12363148|FG000|STARTED|Overall Study||27
11174084|NCT01667796|12363149|FG001|STARTED|Overall Study||30
11174085|NCT01667796|12363148|FG000|COMPLETED|Overall Study||24
11174086|NCT01667796|12363149|FG001|COMPLETED|Overall Study||29
11174087|NCT01667796|12363148|FG000|NOT COMPLETED|Overall Study||3
11174088|NCT01667796|12363149|FG001|NOT COMPLETED|Overall Study||1
11174089|NCT01667848|12363161|FG000|STARTED|Overall Study||67
11174090|NCT01667848|12363162|FG001|STARTED|Overall Study||81
11174091|NCT01667848|12363161|FG000|COMPLETED|Overall Study||67
11174092|NCT01667848|12363162|FG001|COMPLETED|Overall Study||81
11174093|NCT01667848|12363161|FG000|NOT COMPLETED|Overall Study||0
11420269|NCT01828099|12619133|FG000|Treated|Overall Study|discontinued from treatment phase = Not completed|189
11420270|NCT01828099|12619134|FG001|Treated|Overall Study||175
11420271|NCT01828099|12619133|FG000|Discontinued From Treatment Phase|Overall Study||94
11174094|NCT01667848|12363162|FG001|NOT COMPLETED|Overall Study||0
11174095|NCT01667900|12363173|FG000|STARTED|Part A, Period 1||1
11174096|NCT01667900|12363174|FG001|STARTED|Part A, Period 1||1
11174097|NCT01667900|12363175|FG002|STARTED|Part A, Period 1||1
11174098|NCT01667900|12363176|FG003|STARTED|Part A, Period 1||1
11174099|NCT01667900|12363177|FG004|STARTED|Part A, Period 1||1
11174100|NCT01667900|12363178|FG005|STARTED|Part A, Period 1||1
11174101|NCT01667900|12363179|FG006|STARTED|Part A, Period 1||1
11174102|NCT01667900|12363180|FG007|STARTED|Part A, Period 1||1
11174103|NCT01667900|12363181|FG008|STARTED|Part A, Period 1||1
11174104|NCT01667900|12363182|FG009|STARTED|Part A, Period 1||1
11174105|NCT01667900|12363183|FG010|STARTED|Part A, Period 1||1
11174106|NCT01667900|12363184|FG011|STARTED|Part A, Period 1||1
11174107|NCT01667900|12363185|FG012|STARTED|Part A, Period 1||1
11174108|NCT01667900|12363186|FG013|STARTED|Part A, Period 1||1
11174109|NCT01667900|12363187|FG014|STARTED|Part A, Period 1||1
11174110|NCT01667900|12363188|FG015|STARTED|Part A, Period 1||1
11174111|NCT01667900|12363189|FG016|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
11174112|NCT01667900|12363190|FG017|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
11174113|NCT01667900|12363191|FG018|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
11174114|NCT01667900|12363192|FG019|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
11174115|NCT01667900|12363173|FG000|COMPLETED|Part A, Period 1||1
11174116|NCT01667900|12363174|FG001|COMPLETED|Part A, Period 1||1
11174117|NCT01667900|12363175|FG002|COMPLETED|Part A, Period 1||1
11174118|NCT01667900|12363176|FG003|COMPLETED|Part A, Period 1||1
11174119|NCT01667900|12363177|FG004|COMPLETED|Part A, Period 1||1
11174120|NCT01667900|12363178|FG005|COMPLETED|Part A, Period 1||1
11174121|NCT01667900|12363179|FG006|COMPLETED|Part A, Period 1||1
11174122|NCT01667900|12363180|FG007|COMPLETED|Part A, Period 1||1
11174123|NCT01667900|12363181|FG008|COMPLETED|Part A, Period 1||1
11174124|NCT01667900|12363182|FG009|COMPLETED|Part A, Period 1||1
11174125|NCT01667900|12363183|FG010|COMPLETED|Part A, Period 1||1
11174126|NCT01667900|12363184|FG011|COMPLETED|Part A, Period 1||1
11174127|NCT01667900|12363185|FG012|COMPLETED|Part A, Period 1||1
11174128|NCT01667900|12363186|FG013|COMPLETED|Part A, Period 1||1
11174129|NCT01667900|12363187|FG014|COMPLETED|Part A, Period 1||1
11174130|NCT01667900|12363188|FG015|COMPLETED|Part A, Period 1||1
11174131|NCT01667900|12363189|FG016|COMPLETED|Part A, Period 1||0
11174132|NCT01667900|12363190|FG017|COMPLETED|Part A, Period 1||0
11174133|NCT01667900|12363191|FG018|COMPLETED|Part A, Period 1||0
11174134|NCT01667900|12363192|FG019|COMPLETED|Part A, Period 1||0
11174135|NCT01667900|12363173|FG000|NOT COMPLETED|Part A, Period 1||0
11174136|NCT01667900|12363174|FG001|NOT COMPLETED|Part A, Period 1||0
11174137|NCT01667900|12363175|FG002|NOT COMPLETED|Part A, Period 1||0
11174138|NCT01667900|12363176|FG003|NOT COMPLETED|Part A, Period 1||0
11174139|NCT01667900|12363177|FG004|NOT COMPLETED|Part A, Period 1||0
11174140|NCT01667900|12363178|FG005|NOT COMPLETED|Part A, Period 1||0
11174141|NCT01667900|12363179|FG006|NOT COMPLETED|Part A, Period 1||0
11174142|NCT01667900|12363180|FG007|NOT COMPLETED|Part A, Period 1||0
11174143|NCT01667900|12363181|FG008|NOT COMPLETED|Part A, Period 1||0
11174144|NCT01667900|12363182|FG009|NOT COMPLETED|Part A, Period 1||0
11174145|NCT01667900|12363183|FG010|NOT COMPLETED|Part A, Period 1||0
11174146|NCT01667900|12363184|FG011|NOT COMPLETED|Part A, Period 1||0
11420272|NCT01828099|12619134|FG001|Discontinued From Treatment Phase|Overall Study||157
11420273|NCT01828099|12619133|FG000|Entered Extension-treatment Phase|Overall Study||0
11420274|NCT01828099|12619134|FG001|Entered Extension-treatment Phase|Overall Study||81
11174147|NCT01667900|12363185|FG012|NOT COMPLETED|Part A, Period 1||0
11174148|NCT01667900|12363186|FG013|NOT COMPLETED|Part A, Period 1||0
11174149|NCT01667900|12363187|FG014|NOT COMPLETED|Part A, Period 1||0
11174150|NCT01667900|12363188|FG015|NOT COMPLETED|Part A, Period 1||0
11174151|NCT01667900|12363189|FG016|NOT COMPLETED|Part A, Period 1||0
11174152|NCT01667900|12363190|FG017|NOT COMPLETED|Part A, Period 1||0
11174153|NCT01667900|12363191|FG018|NOT COMPLETED|Part A, Period 1||0
11174154|NCT01667900|12363192|FG019|NOT COMPLETED|Part A, Period 1||0
11174155|NCT01667900|12363173|FG000|STARTED|Part A, Washout 1||1
11174156|NCT01667900|12363174|FG001|STARTED|Part A, Washout 1||1
11174157|NCT01667900|12363175|FG002|STARTED|Part A, Washout 1||1
11174158|NCT01667900|12363176|FG003|STARTED|Part A, Washout 1||1
11174159|NCT01667900|12363177|FG004|STARTED|Part A, Washout 1||1
11174160|NCT01667900|12363178|FG005|STARTED|Part A, Washout 1||1
11174161|NCT01667900|12363179|FG006|STARTED|Part A, Washout 1||1
11174162|NCT01667900|12363180|FG007|STARTED|Part A, Washout 1||1
11174163|NCT01667900|12363181|FG008|STARTED|Part A, Washout 1||1
11174164|NCT01667900|12363182|FG009|STARTED|Part A, Washout 1||1
11174165|NCT01667900|12363183|FG010|STARTED|Part A, Washout 1||1
11174166|NCT01667900|12363184|FG011|STARTED|Part A, Washout 1||1
11174167|NCT01667900|12363185|FG012|STARTED|Part A, Washout 1||1
11174168|NCT01667900|12363186|FG013|STARTED|Part A, Washout 1||1
11174169|NCT01667900|12363187|FG014|STARTED|Part A, Washout 1||1
11174170|NCT01667900|12363188|FG015|STARTED|Part A, Washout 1||1
11174171|NCT01667900|12363189|FG016|STARTED|Part A, Washout 1||0
11174172|NCT01667900|12363190|FG017|STARTED|Part A, Washout 1||0
11174173|NCT01667900|12363191|FG018|STARTED|Part A, Washout 1||0
11174174|NCT01667900|12363192|FG019|STARTED|Part A, Washout 1||0
11174175|NCT01667900|12363173|FG000|COMPLETED|Part A, Washout 1||1
11174176|NCT01667900|12363174|FG001|COMPLETED|Part A, Washout 1||1
11174177|NCT01667900|12363175|FG002|COMPLETED|Part A, Washout 1||1
11174178|NCT01667900|12363176|FG003|COMPLETED|Part A, Washout 1||1
11174179|NCT01667900|12363177|FG004|COMPLETED|Part A, Washout 1||1
11174180|NCT01667900|12363178|FG005|COMPLETED|Part A, Washout 1||1
11174181|NCT01667900|12363179|FG006|COMPLETED|Part A, Washout 1||1
11174182|NCT01667900|12363180|FG007|COMPLETED|Part A, Washout 1||1
11174183|NCT01667900|12363181|FG008|COMPLETED|Part A, Washout 1||1
11174184|NCT01667900|12363182|FG009|COMPLETED|Part A, Washout 1||1
11174185|NCT01667900|12363183|FG010|COMPLETED|Part A, Washout 1||1
11174186|NCT01667900|12363184|FG011|COMPLETED|Part A, Washout 1||1
11174187|NCT01667900|12363185|FG012|COMPLETED|Part A, Washout 1||1
11174188|NCT01667900|12363186|FG013|COMPLETED|Part A, Washout 1||1
11174189|NCT01667900|12363187|FG014|COMPLETED|Part A, Washout 1||1
11174190|NCT01667900|12363188|FG015|COMPLETED|Part A, Washout 1||1
11174191|NCT01667900|12363189|FG016|COMPLETED|Part A, Washout 1||0
11174192|NCT01667900|12363190|FG017|COMPLETED|Part A, Washout 1||0
11174193|NCT01667900|12363191|FG018|COMPLETED|Part A, Washout 1||0
11174194|NCT01667900|12363192|FG019|COMPLETED|Part A, Washout 1||0
11174195|NCT01667900|12363173|FG000|NOT COMPLETED|Part A, Washout 1||0
11174196|NCT01667900|12363174|FG001|NOT COMPLETED|Part A, Washout 1||0
11174197|NCT01667900|12363175|FG002|NOT COMPLETED|Part A, Washout 1||0
11174198|NCT01667900|12363176|FG003|NOT COMPLETED|Part A, Washout 1||0
11174199|NCT01667900|12363177|FG004|NOT COMPLETED|Part A, Washout 1||0
11174200|NCT01667900|12363178|FG005|NOT COMPLETED|Part A, Washout 1||0
11174201|NCT01667900|12363179|FG006|NOT COMPLETED|Part A, Washout 1||0
11174202|NCT01667900|12363180|FG007|NOT COMPLETED|Part A, Washout 1||0
11174203|NCT01667900|12363181|FG008|NOT COMPLETED|Part A, Washout 1||0
11174204|NCT01667900|12363182|FG009|NOT COMPLETED|Part A, Washout 1||0
11174205|NCT01667900|12363183|FG010|NOT COMPLETED|Part A, Washout 1||0
11174206|NCT01667900|12363184|FG011|NOT COMPLETED|Part A, Washout 1||0
11174207|NCT01667900|12363185|FG012|NOT COMPLETED|Part A, Washout 1||0
11174208|NCT01667900|12363186|FG013|NOT COMPLETED|Part A, Washout 1||0
11174209|NCT01667900|12363187|FG014|NOT COMPLETED|Part A, Washout 1||0
11174210|NCT01667900|12363188|FG015|NOT COMPLETED|Part A, Washout 1||0
11174211|NCT01667900|12363189|FG016|NOT COMPLETED|Part A, Washout 1||0
11174212|NCT01667900|12363190|FG017|NOT COMPLETED|Part A, Washout 1||0
11174213|NCT01667900|12363191|FG018|NOT COMPLETED|Part A, Washout 1||0
11174214|NCT01667900|12363192|FG019|NOT COMPLETED|Part A, Washout 1||0
11174215|NCT01667900|12363173|FG000|STARTED|Part A, Period 2||1
11174216|NCT01667900|12363174|FG001|STARTED|Part A, Period 2||1
11174217|NCT01667900|12363175|FG002|STARTED|Part A, Period 2||1
11174218|NCT01667900|12363176|FG003|STARTED|Part A, Period 2||1
11174219|NCT01667900|12363177|FG004|STARTED|Part A, Period 2||1
11174220|NCT01667900|12363178|FG005|STARTED|Part A, Period 2||1
11174221|NCT01667900|12363179|FG006|STARTED|Part A, Period 2||1
11174222|NCT01667900|12363180|FG007|STARTED|Part A, Period 2||1
11174223|NCT01667900|12363181|FG008|STARTED|Part A, Period 2||1
11174224|NCT01667900|12363182|FG009|STARTED|Part A, Period 2||1
11174225|NCT01667900|12363183|FG010|STARTED|Part A, Period 2||1
11174226|NCT01667900|12363184|FG011|STARTED|Part A, Period 2||1
11174227|NCT01667900|12363185|FG012|STARTED|Part A, Period 2||1
11174228|NCT01667900|12363186|FG013|STARTED|Part A, Period 2||1
11174229|NCT01667900|12363187|FG014|STARTED|Part A, Period 2||1
11174230|NCT01667900|12363188|FG015|STARTED|Part A, Period 2||1
11174231|NCT01667900|12363189|FG016|STARTED|Part A, Period 2||0
11174232|NCT01667900|12363190|FG017|STARTED|Part A, Period 2||0
11174233|NCT01667900|12363191|FG018|STARTED|Part A, Period 2||0
11174234|NCT01667900|12363192|FG019|STARTED|Part A, Period 2||0
11174235|NCT01667900|12363173|FG000|COMPLETED|Part A, Period 2||1
11174236|NCT01667900|12363174|FG001|COMPLETED|Part A, Period 2||1
11174237|NCT01667900|12363175|FG002|COMPLETED|Part A, Period 2||1
11174238|NCT01667900|12363176|FG003|COMPLETED|Part A, Period 2||1
11174239|NCT01667900|12363177|FG004|COMPLETED|Part A, Period 2||1
11174240|NCT01667900|12363178|FG005|COMPLETED|Part A, Period 2||1
11174241|NCT01667900|12363179|FG006|COMPLETED|Part A, Period 2||1
11174242|NCT01667900|12363180|FG007|COMPLETED|Part A, Period 2||1
11174243|NCT01667900|12363181|FG008|COMPLETED|Part A, Period 2||1
11174244|NCT01667900|12363182|FG009|COMPLETED|Part A, Period 2||1
11174245|NCT01667900|12363183|FG010|COMPLETED|Part A, Period 2||1
11174246|NCT01667900|12363184|FG011|COMPLETED|Part A, Period 2||1
11174247|NCT01667900|12363185|FG012|COMPLETED|Part A, Period 2||1
11174248|NCT01667900|12363186|FG013|COMPLETED|Part A, Period 2||1
11174249|NCT01667900|12363187|FG014|COMPLETED|Part A, Period 2||1
11174250|NCT01667900|12363188|FG015|COMPLETED|Part A, Period 2||1
11174251|NCT01667900|12363189|FG016|COMPLETED|Part A, Period 2||0
11174252|NCT01667900|12363190|FG017|COMPLETED|Part A, Period 2||0
11174253|NCT01667900|12363191|FG018|COMPLETED|Part A, Period 2||0
11174254|NCT01667900|12363192|FG019|COMPLETED|Part A, Period 2||0
11174255|NCT01667900|12363173|FG000|NOT COMPLETED|Part A, Period 2||0
11174256|NCT01667900|12363174|FG001|NOT COMPLETED|Part A, Period 2||0
11174257|NCT01667900|12363175|FG002|NOT COMPLETED|Part A, Period 2||0
11174258|NCT01667900|12363176|FG003|NOT COMPLETED|Part A, Period 2||0
11174259|NCT01667900|12363177|FG004|NOT COMPLETED|Part A, Period 2||0
11174260|NCT01667900|12363178|FG005|NOT COMPLETED|Part A, Period 2||0
11174261|NCT01667900|12363179|FG006|NOT COMPLETED|Part A, Period 2||0
11174262|NCT01667900|12363180|FG007|NOT COMPLETED|Part A, Period 2||0
11174263|NCT01667900|12363181|FG008|NOT COMPLETED|Part A, Period 2||0
11174264|NCT01667900|12363182|FG009|NOT COMPLETED|Part A, Period 2||0
11174265|NCT01667900|12363183|FG010|NOT COMPLETED|Part A, Period 2||0
11420275|NCT01828099|12619133|FG000|Entered Post-treatment Follow-up Phase|Overall Study||10
11420276|NCT01828099|12619134|FG001|Entered Post-treatment Follow-up Phase|Overall Study||16
11174266|NCT01667900|12363184|FG011|NOT COMPLETED|Part A, Period 2||0
11174267|NCT01667900|12363185|FG012|NOT COMPLETED|Part A, Period 2||0
11174268|NCT01667900|12363186|FG013|NOT COMPLETED|Part A, Period 2||0
11174269|NCT01667900|12363187|FG014|NOT COMPLETED|Part A, Period 2||0
11174270|NCT01667900|12363188|FG015|NOT COMPLETED|Part A, Period 2||0
11174271|NCT01667900|12363189|FG016|NOT COMPLETED|Part A, Period 2||0
11174272|NCT01667900|12363190|FG017|NOT COMPLETED|Part A, Period 2||0
11174273|NCT01667900|12363191|FG018|NOT COMPLETED|Part A, Period 2||0
11174274|NCT01667900|12363192|FG019|NOT COMPLETED|Part A, Period 2||0
11174275|NCT01667900|12363173|FG000|STARTED|Part A, Washout 2||1
11174276|NCT01667900|12363174|FG001|STARTED|Part A, Washout 2||1
11174277|NCT01667900|12363175|FG002|STARTED|Part A, Washout 2||1
11174278|NCT01667900|12363176|FG003|STARTED|Part A, Washout 2||1
11174279|NCT01667900|12363177|FG004|STARTED|Part A, Washout 2||1
11174280|NCT01667900|12363178|FG005|STARTED|Part A, Washout 2||1
11174281|NCT01667900|12363179|FG006|STARTED|Part A, Washout 2||1
11174282|NCT01667900|12363180|FG007|STARTED|Part A, Washout 2||1
11174283|NCT01667900|12363181|FG008|STARTED|Part A, Washout 2||1
11174284|NCT01667900|12363182|FG009|STARTED|Part A, Washout 2||1
11174285|NCT01667900|12363183|FG010|STARTED|Part A, Washout 2||1
11174286|NCT01667900|12363184|FG011|STARTED|Part A, Washout 2||1
11174287|NCT01667900|12363185|FG012|STARTED|Part A, Washout 2||1
11174288|NCT01667900|12363186|FG013|STARTED|Part A, Washout 2||1
11174289|NCT01667900|12363187|FG014|STARTED|Part A, Washout 2||1
11174290|NCT01667900|12363188|FG015|STARTED|Part A, Washout 2||1
11174291|NCT01667900|12363189|FG016|STARTED|Part A, Washout 2||0
11174292|NCT01667900|12363190|FG017|STARTED|Part A, Washout 2||0
11174293|NCT01667900|12363191|FG018|STARTED|Part A, Washout 2||0
11174294|NCT01667900|12363192|FG019|STARTED|Part A, Washout 2||0
11174295|NCT01667900|12363173|FG000|COMPLETED|Part A, Washout 2||1
11174296|NCT01667900|12363174|FG001|COMPLETED|Part A, Washout 2||1
11174297|NCT01667900|12363175|FG002|COMPLETED|Part A, Washout 2||1
11174298|NCT01667900|12363176|FG003|COMPLETED|Part A, Washout 2||1
11174299|NCT01667900|12363177|FG004|COMPLETED|Part A, Washout 2||1
11174300|NCT01667900|12363178|FG005|COMPLETED|Part A, Washout 2||1
11174301|NCT01667900|12363179|FG006|COMPLETED|Part A, Washout 2||1
11174302|NCT01667900|12363180|FG007|COMPLETED|Part A, Washout 2||1
11174303|NCT01667900|12363181|FG008|COMPLETED|Part A, Washout 2||1
11174304|NCT01667900|12363182|FG009|COMPLETED|Part A, Washout 2||1
11174305|NCT01667900|12363183|FG010|COMPLETED|Part A, Washout 2||1
11174306|NCT01667900|12363184|FG011|COMPLETED|Part A, Washout 2||1
11174307|NCT01667900|12363185|FG012|COMPLETED|Part A, Washout 2||1
11174308|NCT01667900|12363186|FG013|COMPLETED|Part A, Washout 2||1
11174309|NCT01667900|12363187|FG014|COMPLETED|Part A, Washout 2||1
11174310|NCT01667900|12363188|FG015|COMPLETED|Part A, Washout 2||1
11174311|NCT01667900|12363189|FG016|COMPLETED|Part A, Washout 2||0
11174312|NCT01667900|12363190|FG017|COMPLETED|Part A, Washout 2||0
11174313|NCT01667900|12363191|FG018|COMPLETED|Part A, Washout 2||0
11174314|NCT01667900|12363192|FG019|COMPLETED|Part A, Washout 2||0
11174315|NCT01667900|12363173|FG000|NOT COMPLETED|Part A, Washout 2||0
11174316|NCT01667900|12363174|FG001|NOT COMPLETED|Part A, Washout 2||0
11174317|NCT01667900|12363175|FG002|NOT COMPLETED|Part A, Washout 2||0
11174318|NCT01667900|12363176|FG003|NOT COMPLETED|Part A, Washout 2||0
11174319|NCT01667900|12363177|FG004|NOT COMPLETED|Part A, Washout 2||0
11174320|NCT01667900|12363178|FG005|NOT COMPLETED|Part A, Washout 2||0
11174321|NCT01667900|12363179|FG006|NOT COMPLETED|Part A, Washout 2||0
11174322|NCT01667900|12363180|FG007|NOT COMPLETED|Part A, Washout 2||0
11174323|NCT01667900|12363181|FG008|NOT COMPLETED|Part A, Washout 2||0
11174324|NCT01667900|12363182|FG009|NOT COMPLETED|Part A, Washout 2||0
11174325|NCT01667900|12363183|FG010|NOT COMPLETED|Part A, Washout 2||0
11174326|NCT01667900|12363184|FG011|NOT COMPLETED|Part A, Washout 2||0
11174327|NCT01667900|12363185|FG012|NOT COMPLETED|Part A, Washout 2||0
11174328|NCT01667900|12363186|FG013|NOT COMPLETED|Part A, Washout 2||0
11174329|NCT01667900|12363187|FG014|NOT COMPLETED|Part A, Washout 2||0
11174330|NCT01667900|12363188|FG015|NOT COMPLETED|Part A, Washout 2||0
11174331|NCT01667900|12363189|FG016|NOT COMPLETED|Part A, Washout 2||0
11174332|NCT01667900|12363190|FG017|NOT COMPLETED|Part A, Washout 2||0
11174333|NCT01667900|12363191|FG018|NOT COMPLETED|Part A, Washout 2||0
11174334|NCT01667900|12363192|FG019|NOT COMPLETED|Part A, Washout 2||0
11174335|NCT01667900|12363173|FG000|STARTED|Part A, Period 3||1
11174336|NCT01667900|12363174|FG001|STARTED|Part A, Period 3||1
11174337|NCT01667900|12363175|FG002|STARTED|Part A, Period 3||1
11174338|NCT01667900|12363176|FG003|STARTED|Part A, Period 3||1
11174339|NCT01667900|12363177|FG004|STARTED|Part A, Period 3||1
11174340|NCT01667900|12363178|FG005|STARTED|Part A, Period 3||1
11174341|NCT01667900|12363179|FG006|STARTED|Part A, Period 3||1
11174342|NCT01667900|12363180|FG007|STARTED|Part A, Period 3||1
11174343|NCT01667900|12363181|FG008|STARTED|Part A, Period 3||1
11174344|NCT01667900|12363182|FG009|STARTED|Part A, Period 3||1
11174345|NCT01667900|12363183|FG010|STARTED|Part A, Period 3||1
11174346|NCT01667900|12363184|FG011|STARTED|Part A, Period 3||1
11174347|NCT01667900|12363185|FG012|STARTED|Part A, Period 3||1
11174348|NCT01667900|12363186|FG013|STARTED|Part A, Period 3||1
11174349|NCT01667900|12363187|FG014|STARTED|Part A, Period 3||1
11174350|NCT01667900|12363188|FG015|STARTED|Part A, Period 3||1
11174351|NCT01667900|12363189|FG016|STARTED|Part A, Period 3||0
11174352|NCT01667900|12363190|FG017|STARTED|Part A, Period 3||0
11174353|NCT01667900|12363191|FG018|STARTED|Part A, Period 3||0
11174354|NCT01667900|12363192|FG019|STARTED|Part A, Period 3||0
11174355|NCT01667900|12363173|FG000|COMPLETED|Part A, Period 3||1
11174356|NCT01667900|12363174|FG001|COMPLETED|Part A, Period 3||1
11174357|NCT01667900|12363175|FG002|COMPLETED|Part A, Period 3||1
11174358|NCT01667900|12363176|FG003|COMPLETED|Part A, Period 3||1
11174359|NCT01667900|12363177|FG004|COMPLETED|Part A, Period 3||1
11174360|NCT01667900|12363178|FG005|COMPLETED|Part A, Period 3||1
11174361|NCT01667900|12363179|FG006|COMPLETED|Part A, Period 3||1
11174362|NCT01667900|12363180|FG007|COMPLETED|Part A, Period 3||1
11174363|NCT01667900|12363181|FG008|COMPLETED|Part A, Period 3||1
11174364|NCT01667900|12363182|FG009|COMPLETED|Part A, Period 3||1
11174365|NCT01667900|12363183|FG010|COMPLETED|Part A, Period 3||1
11174366|NCT01667900|12363184|FG011|COMPLETED|Part A, Period 3||1
11174367|NCT01667900|12363185|FG012|COMPLETED|Part A, Period 3||1
11174368|NCT01667900|12363186|FG013|COMPLETED|Part A, Period 3||1
11174369|NCT01667900|12363187|FG014|COMPLETED|Part A, Period 3||1
11174370|NCT01667900|12363188|FG015|COMPLETED|Part A, Period 3||1
11174371|NCT01667900|12363189|FG016|COMPLETED|Part A, Period 3||0
11174372|NCT01667900|12363190|FG017|COMPLETED|Part A, Period 3||0
11174373|NCT01667900|12363191|FG018|COMPLETED|Part A, Period 3||0
11174374|NCT01667900|12363192|FG019|COMPLETED|Part A, Period 3||0
11174375|NCT01667900|12363173|FG000|NOT COMPLETED|Part A, Period 3||0
11174376|NCT01667900|12363174|FG001|NOT COMPLETED|Part A, Period 3||0
11174377|NCT01667900|12363175|FG002|NOT COMPLETED|Part A, Period 3||0
11174378|NCT01667900|12363176|FG003|NOT COMPLETED|Part A, Period 3||0
11174379|NCT01667900|12363177|FG004|NOT COMPLETED|Part A, Period 3||0
11174380|NCT01667900|12363178|FG005|NOT COMPLETED|Part A, Period 3||0
11174381|NCT01667900|12363179|FG006|NOT COMPLETED|Part A, Period 3||0
11174382|NCT01667900|12363180|FG007|NOT COMPLETED|Part A, Period 3||0
11174383|NCT01667900|12363181|FG008|NOT COMPLETED|Part A, Period 3||0
11174384|NCT01667900|12363182|FG009|NOT COMPLETED|Part A, Period 3||0
11174385|NCT01667900|12363183|FG010|NOT COMPLETED|Part A, Period 3||0
11174386|NCT01667900|12363184|FG011|NOT COMPLETED|Part A, Period 3||0
11174387|NCT01667900|12363185|FG012|NOT COMPLETED|Part A, Period 3||0
11174388|NCT01667900|12363186|FG013|NOT COMPLETED|Part A, Period 3||0
11174389|NCT01667900|12363187|FG014|NOT COMPLETED|Part A, Period 3||0
11174390|NCT01667900|12363188|FG015|NOT COMPLETED|Part A, Period 3||0
11174391|NCT01667900|12363189|FG016|NOT COMPLETED|Part A, Period 3||0
11174392|NCT01667900|12363190|FG017|NOT COMPLETED|Part A, Period 3||0
11174393|NCT01667900|12363191|FG018|NOT COMPLETED|Part A, Period 3||0
11174394|NCT01667900|12363192|FG019|NOT COMPLETED|Part A, Period 3||0
11174395|NCT01667900|12363173|FG000|STARTED|Part B|Part A participants did not participate in Part B.|0
11174396|NCT01667900|12363174|FG001|STARTED|Part B|Part A participants did not participate in Part B.|0
11174397|NCT01667900|12363175|FG002|STARTED|Part B|Part A participants did not participate in Part B.|0
11174398|NCT01667900|12363176|FG003|STARTED|Part B|Part A participants did not participate in Part B.|0
11174399|NCT01667900|12363177|FG004|STARTED|Part B|Part A participants did not participate in Part B.|0
11174400|NCT01667900|12363178|FG005|STARTED|Part B|Part A participants did not participate in Part B.|0
11174401|NCT01667900|12363179|FG006|STARTED|Part B|Part A participants did not participate in Part B.|0
11174402|NCT01667900|12363180|FG007|STARTED|Part B|Part A participants did not participate in Part B.|0
11174403|NCT01667900|12363181|FG008|STARTED|Part B|Part A participants did not participate in Part B.|0
11174404|NCT01667900|12363182|FG009|STARTED|Part B|Part A participants did not participate in Part B.|0
11174405|NCT01667900|12363183|FG010|STARTED|Part B|Part A participants did not participate in Part B.|0
11174406|NCT01667900|12363184|FG011|STARTED|Part B|Part A participants did not participate in Part B.|0
11174407|NCT01667900|12363185|FG012|STARTED|Part B|Part A participants did not participate in Part B.|0
11174408|NCT01667900|12363186|FG013|STARTED|Part B|Part A participants did not participate in Part B.|0
11174409|NCT01667900|12363187|FG014|STARTED|Part B|Part A participants did not participate in Part B.|0
11174410|NCT01667900|12363188|FG015|STARTED|Part B|Part A participants did not participate in Part B.|0
11174411|NCT01667900|12363189|FG016|STARTED|Part B||11
11174412|NCT01667900|12363190|FG017|STARTED|Part B||11
11174413|NCT01667900|12363191|FG018|STARTED|Part B||10
11174414|NCT01667900|12363192|FG019|STARTED|Part B||10
11174415|NCT01667900|12363173|FG000|COMPLETED|Part B||0
11174416|NCT01667900|12363174|FG001|COMPLETED|Part B||0
11174417|NCT01667900|12363175|FG002|COMPLETED|Part B||0
11174418|NCT01667900|12363176|FG003|COMPLETED|Part B||0
11174419|NCT01667900|12363177|FG004|COMPLETED|Part B||0
11174420|NCT01667900|12363178|FG005|COMPLETED|Part B||0
11174421|NCT01667900|12363179|FG006|COMPLETED|Part B||0
11174422|NCT01667900|12363180|FG007|COMPLETED|Part B||0
11174423|NCT01667900|12363181|FG008|COMPLETED|Part B||0
11174424|NCT01667900|12363182|FG009|COMPLETED|Part B||0
11174425|NCT01667900|12363183|FG010|COMPLETED|Part B||0
11174426|NCT01667900|12363184|FG011|COMPLETED|Part B||0
11174427|NCT01667900|12363185|FG012|COMPLETED|Part B||0
11174428|NCT01667900|12363186|FG013|COMPLETED|Part B||0
11174429|NCT01667900|12363187|FG014|COMPLETED|Part B||0
11174430|NCT01667900|12363188|FG015|COMPLETED|Part B||0
11174431|NCT01667900|12363189|FG016|COMPLETED|Part B||10
11174432|NCT01667900|12363190|FG017|COMPLETED|Part B||11
11174433|NCT01667900|12363191|FG018|COMPLETED|Part B||10
11174434|NCT01667900|12363192|FG019|COMPLETED|Part B||10
11174435|NCT01667900|12363173|FG000|NOT COMPLETED|Part B||0
11174436|NCT01667900|12363174|FG001|NOT COMPLETED|Part B||0
11174437|NCT01667900|12363175|FG002|NOT COMPLETED|Part B||0
11174438|NCT01667900|12363176|FG003|NOT COMPLETED|Part B||0
11174439|NCT01667900|12363177|FG004|NOT COMPLETED|Part B||0
11174440|NCT01667900|12363178|FG005|NOT COMPLETED|Part B||0
11174441|NCT01667900|12363179|FG006|NOT COMPLETED|Part B||0
11174442|NCT01667900|12363180|FG007|NOT COMPLETED|Part B||0
11174443|NCT01667900|12363181|FG008|NOT COMPLETED|Part B||0
11174444|NCT01667900|12363182|FG009|NOT COMPLETED|Part B||0
11174445|NCT01667900|12363183|FG010|NOT COMPLETED|Part B||0
11174446|NCT01667900|12363184|FG011|NOT COMPLETED|Part B||0
11174447|NCT01667900|12363185|FG012|NOT COMPLETED|Part B||0
11174448|NCT01667900|12363186|FG013|NOT COMPLETED|Part B||0
11174449|NCT01667900|12363187|FG014|NOT COMPLETED|Part B||0
11174450|NCT01667900|12363188|FG015|NOT COMPLETED|Part B||0
11174451|NCT01667900|12363189|FG016|NOT COMPLETED|Part B||1
11174452|NCT01667900|12363190|FG017|NOT COMPLETED|Part B||0
11174453|NCT01667900|12363191|FG018|NOT COMPLETED|Part B||0
11174454|NCT01667900|12363192|FG019|NOT COMPLETED|Part B||0
11174455|NCT01667926|12363214|FG000|STARTED|Overall Study||13
11174456|NCT01667926|12363215|FG001|STARTED|Overall Study||13
11174457|NCT01667926|12363216|FG002|STARTED|Overall Study||11
11174458|NCT01667926|12363214|FG000|COMPLETED|Overall Study||8
11174459|NCT01667926|12363215|FG001|COMPLETED|Overall Study||9
11026847|NCT00830869|12205486|FG006|STARTED|Period 1: Part 1||3
11026848|NCT00830869|12205487|FG007|STARTED|Period 1: Part 1||0
11026849|NCT00830869|12205488|FG008|STARTED|Period 1: Part 1||0
11026850|NCT00830869|12205489|FG009|STARTED|Period 1: Part 1||0
11026851|NCT00830869|12205490|FG010|STARTED|Period 1: Part 1||0
11026852|NCT00830869|12205491|FG011|STARTED|Period 1: Part 1||0
11026853|NCT00830869|12205480|FG000|COMPLETED|Period 1: Part 1||0
11026854|NCT00830869|12205481|FG001|COMPLETED|Period 1: Part 1||0
11174460|NCT01667926|12363216|FG002|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
11174461|NCT01667926|12363214|FG000|NOT COMPLETED|Overall Study||5
11174462|NCT01667926|12363215|FG001|NOT COMPLETED|Overall Study||4
11174463|NCT01667926|12363216|FG002|NOT COMPLETED|Overall Study||11
11174464|NCT01667978|12363224|FG000|STARTED|Overall Study||18
11174465|NCT01667978|12363225|FG001|STARTED|Overall Study||17
11174466|NCT01667978|12363224|FG000|COMPLETED|Overall Study||16
11174467|NCT01667978|12363225|FG001|COMPLETED|Overall Study||17
11174468|NCT01667978|12363224|FG000|NOT COMPLETED|Overall Study||2
11174469|NCT01667978|12363225|FG001|NOT COMPLETED|Overall Study||0
11174470|NCT01668004|12363231|FG000|STARTED|Overall Study||101
11174471|NCT01668004|12363231|FG000|Treated|Overall Study||101
11174472|NCT01668004|12363231|FG000|COMPLETED|Overall Study||76
11174473|NCT01668004|12363231|FG000|NOT COMPLETED|Overall Study||25
11174474|NCT01668017|12363242|FG000|STARTED|Overall Study||4
11420277|NCT01828099|12619133|FG000|Entered Survival Follow-up Phase|Overall Study||64
11420278|NCT01828099|12619134|FG001|Entered Survival Follow-up Phase|Overall Study||31
11420279|NCT01828099|12619133|FG000|Discontinued From Study|Overall Study||20
11420280|NCT01828099|12619134|FG001|Discontinued From Study|Overall Study||29
11420281|NCT01828099|12619133|FG000|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
11174475|NCT01668017|12363243|FG001|STARTED|Overall Study||9
11174476|NCT01668017|12363244|FG002|STARTED|Overall Study||6
11174477|NCT01668017|12363245|FG003|STARTED|Overall Study||5
11174478|NCT01668017|12363246|FG004|STARTED|Overall Study||2
11174479|NCT01668017|12363242|FG000|COMPLETED|Overall Study||4
11174480|NCT01668017|12363243|FG001|COMPLETED|Overall Study||9
11174481|NCT01668017|12363244|FG002|COMPLETED|Overall Study||6
11174482|NCT01668017|12363245|FG003|COMPLETED|Overall Study||5
11174483|NCT01668017|12363246|FG004|COMPLETED|Overall Study||2
11174484|NCT01668017|12363242|FG000|NOT COMPLETED|Overall Study||0
11174485|NCT01668017|12363243|FG001|NOT COMPLETED|Overall Study||0
11174486|NCT01668017|12363244|FG002|NOT COMPLETED|Overall Study||0
11026855|NCT00830869|12205482|FG002|COMPLETED|Period 1: Part 1||0
11026856|NCT00830869|12205483|FG003|COMPLETED|Period 1: Part 1||0
11174487|NCT01668017|12363245|FG003|NOT COMPLETED|Overall Study||0
11174488|NCT01668017|12363246|FG004|NOT COMPLETED|Overall Study||0
11174489|NCT01668030|12363273|FG000|STARTED|Overall Study||10
11174490|NCT01668030|12363274|FG001|STARTED|Overall Study||10
11174491|NCT01668030|12363273|FG000|COMPLETED|Overall Study||10
11026857|NCT00830869|12205484|FG004|COMPLETED|Period 1: Part 1||0
11174492|NCT01668030|12363274|FG001|COMPLETED|Overall Study||10
11174493|NCT01668030|12363273|FG000|NOT COMPLETED|Overall Study||0
11174494|NCT01668030|12363274|FG001|NOT COMPLETED|Overall Study||0
11174495|NCT01668173|12363279|FG000|STARTED|Overall Study||7
11174496|NCT01668173|12363279|FG000|COMPLETED|Overall Study||0
11174497|NCT01668173|12363279|FG000|NOT COMPLETED|Overall Study||7
11174498|NCT01668355|12363285|FG000|STARTED|Overall Study||164
11174499|NCT01668355|12363286|FG001|STARTED|Overall Study||167
11174500|NCT01668355|12363285|FG000|COMPLETED|Overall Study||155
11174501|NCT01668355|12363286|FG001|COMPLETED|Overall Study||165
11174502|NCT01668355|12363285|FG000|NOT COMPLETED|Overall Study||9
11174503|NCT01668355|12363286|FG001|NOT COMPLETED|Overall Study||2
11174504|NCT01668537|12363295|FG000|STARTED|Overall Study||327
11174505|NCT01668537|12363296|FG001|STARTED|Overall Study||324
11174506|NCT01668537|12363295|FG000|COMPLETED|Overall Study||305
11420282|NCT01828099|12619134|FG001|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
11420283|NCT01828099|12619133|FG000|NOT COMPLETED|Overall Study||94
11174507|NCT01668537|12363296|FG001|COMPLETED|Overall Study||314
11174508|NCT01668537|12363295|FG000|NOT COMPLETED|Overall Study||22
11174509|NCT01668537|12363296|FG001|NOT COMPLETED|Overall Study||10
11174510|NCT01668589|12363306|FG000|STARTED|Overall Study||600
11174511|NCT01668589|12363307|FG001|STARTED|Overall Study||300
11174512|NCT01668589|12363308|FG002|STARTED|Overall Study||300
11174513|NCT01668589|12363309|FG003|STARTED|Overall Study||301
11174514|NCT01668589|12363306|FG000|Received Denosumab|Overall Study||599
11174515|NCT01668589|12363307|FG001|Received Denosumab|Overall Study||300
11174516|NCT01668589|12363308|FG002|Received Denosumab|Overall Study||300
11174517|NCT01668589|12363309|FG003|Received Denosumab|Overall Study||301
11174518|NCT01668589|12363306|FG000|COMPLETED|Overall Study||461
11174519|NCT01668589|12363307|FG001|COMPLETED|Overall Study||242
11174520|NCT01668589|12363308|FG002|COMPLETED|Overall Study||265
11174521|NCT01668589|12363309|FG003|COMPLETED|Overall Study||266
11174522|NCT01668589|12363306|FG000|NOT COMPLETED|Overall Study||139
11174523|NCT01668589|12363307|FG001|NOT COMPLETED|Overall Study||58
11174524|NCT01668589|12363308|FG002|NOT COMPLETED|Overall Study||35
11174525|NCT01668589|12363309|FG003|NOT COMPLETED|Overall Study||35
11174526|NCT01668602|12363321|FG000|STARTED|Overall Study||2
11174527|NCT01668602|12363322|FG001|STARTED|Overall Study||22
11174528|NCT01668602|12363321|FG000|Cohort 2 - Began FastFES Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
11174529|NCT01668602|12363322|FG001|Cohort 2 - Began FastFES Sessions|Overall Study||20
11174530|NCT01668602|12363321|FG000|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study|This milestone does not apply to Cohort 1.|0
11174531|NCT01668602|12363322|FG001|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study||19
11174532|NCT01668602|12363321|FG000|Cohort 2 - Began Fast Walking Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
11174533|NCT01668602|12363322|FG001|Cohort 2 - Began Fast Walking Sessions|Overall Study||20
11174534|NCT01668602|12363321|FG000|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study|This milestone does not apply to Cohort 1.|0
11174535|NCT01668602|12363322|FG001|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study||18
11174536|NCT01668602|12363321|FG000|COMPLETED|Overall Study||2
11174537|NCT01668602|12363322|FG001|COMPLETED|Overall Study||18
11174538|NCT01668602|12363321|FG000|NOT COMPLETED|Overall Study||0
11174539|NCT01668602|12363322|FG001|NOT COMPLETED|Overall Study||4
11174540|NCT01668628|12363333|FG000|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
11174541|NCT01668628|12363334|FG001|STARTED|Overall Study||359
11174542|NCT01668628|12363335|FG002|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
11174543|NCT01668628|12363333|FG000|COMPLETED|Overall Study||347
11174544|NCT01668628|12363334|FG001|COMPLETED|Overall Study||359
11174545|NCT01668628|12363335|FG002|COMPLETED|Overall Study||367
11174546|NCT01668628|12363333|FG000|NOT COMPLETED|Overall Study||2
11174547|NCT01668628|12363334|FG001|NOT COMPLETED|Overall Study||0
11174548|NCT01668628|12363335|FG002|NOT COMPLETED|Overall Study||0
11174549|NCT01668654|12363347|FG000|STARTED|Overall Study||4
11174550|NCT01668654|12363347|FG000|COMPLETED|Overall Study||0
11174551|NCT01668654|12363347|FG000|NOT COMPLETED|Overall Study||4
11174552|NCT01668667|12363355|FG000|STARTED|Overall Study||126
11174553|NCT01668667|12363356|FG001|STARTED|Overall Study||125
11174554|NCT01668667|12363357|FG002|STARTED|Overall Study||125
11174555|NCT01668667|12363358|FG003|STARTED|Overall Study||125
11174556|NCT01668667|12363355|FG000|COMPLETED|Overall Study||95
11174557|NCT01668667|12363356|FG001|COMPLETED|Overall Study||99
11174558|NCT01668667|12363357|FG002|COMPLETED|Overall Study||94
11174559|NCT01668667|12363358|FG003|COMPLETED|Overall Study||102
11174560|NCT01668667|12363355|FG000|NOT COMPLETED|Overall Study||31
11174561|NCT01668667|12363356|FG001|NOT COMPLETED|Overall Study||26
11174562|NCT01668667|12363357|FG002|NOT COMPLETED|Overall Study||31
11174563|NCT01668667|12363358|FG003|NOT COMPLETED|Overall Study||23
11174564|NCT01668797|12363370|FG000|STARTED|Phase A (Conversion Phase)||406
11174565|NCT01668797|12363371|FG001|STARTED|Phase A (Conversion Phase)||0
11174566|NCT01668797|12363372|FG002|STARTED|Phase A (Conversion Phase)||0
11174567|NCT01668797|12363373|FG003|STARTED|Phase A (Conversion Phase)||0
11174568|NCT01668797|12363370|FG000|COMPLETED|Phase A (Conversion Phase)||346
11174569|NCT01668797|12363371|FG001|COMPLETED|Phase A (Conversion Phase)||0
11174570|NCT01668797|12363372|FG002|COMPLETED|Phase A (Conversion Phase)||0
11174571|NCT01668797|12363373|FG003|COMPLETED|Phase A (Conversion Phase)||0
11174572|NCT01668797|12363370|FG000|NOT COMPLETED|Phase A (Conversion Phase)||60
11174573|NCT01668797|12363371|FG001|NOT COMPLETED|Phase A (Conversion Phase)||0
11174574|NCT01668797|12363372|FG002|NOT COMPLETED|Phase A (Conversion Phase)||0
11174575|NCT01668797|12363373|FG003|NOT COMPLETED|Phase A (Conversion Phase)||0
11174576|NCT01668797|12363370|FG000|STARTED|Phase B (Stabilization Phase)||0
11174577|NCT01668797|12363371|FG001|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
11174578|NCT01668797|12363372|FG002|STARTED|Phase B (Stabilization Phase)||0
11174579|NCT01668797|12363373|FG003|STARTED|Phase B (Stabilization Phase)||0
11174580|NCT01668797|12363370|FG000|COMPLETED|Phase B (Stabilization Phase)||0
11174581|NCT01668797|12363371|FG001|COMPLETED|Phase B (Stabilization Phase)||202
11174582|NCT01668797|12363372|FG002|COMPLETED|Phase B (Stabilization Phase)||0
11174583|NCT01668797|12363373|FG003|COMPLETED|Phase B (Stabilization Phase)||0
11174584|NCT01668797|12363370|FG000|NOT COMPLETED|Phase B (Stabilization Phase)||0
11174585|NCT01668797|12363371|FG001|NOT COMPLETED|Phase B (Stabilization Phase)||262
11174586|NCT01668797|12363372|FG002|NOT COMPLETED|Phase B (Stabilization Phase)||0
11174587|NCT01668797|12363373|FG003|NOT COMPLETED|Phase B (Stabilization Phase)||0
11174588|NCT01668797|12363370|FG000|STARTED|Phase C (Double-Blind Maintenance Phase)||0
11174589|NCT01668797|12363371|FG001|STARTED|Phase C (Double-Blind Maintenance Phase)||0
11174590|NCT01668797|12363372|FG002|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
11174591|NCT01668797|12363373|FG003|STARTED|Phase C (Double-Blind Maintenance Phase)||105
11174592|NCT01668797|12363370|FG000|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
11174593|NCT01668797|12363371|FG001|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
11174594|NCT01668797|12363372|FG002|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
11174595|NCT01668797|12363373|FG003|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
11174596|NCT01668797|12363370|FG000|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
11174597|NCT01668797|12363371|FG001|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
11174598|NCT01668797|12363372|FG002|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
11174599|NCT01668797|12363373|FG003|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
11174600|NCT01668836|12363384|FG000|STARTED|Overall Study||12
11174601|NCT01668836|12363385|FG001|STARTED|Overall Study||12
11174602|NCT01668836|12363386|FG002|STARTED|Overall Study||12
11174603|NCT01668836|12363387|FG003|STARTED|Overall Study||12
11174604|NCT01668836|12363384|FG000|COMPLETED|Overall Study||12
11174605|NCT01668836|12363385|FG001|COMPLETED|Overall Study||12
11174606|NCT01668836|12363386|FG002|COMPLETED|Overall Study||12
11174607|NCT01668836|12363387|FG003|COMPLETED|Overall Study||12
11174608|NCT01668836|12363384|FG000|NOT COMPLETED|Overall Study||0
11174609|NCT01668836|12363385|FG001|NOT COMPLETED|Overall Study||0
11174610|NCT01668836|12363386|FG002|NOT COMPLETED|Overall Study||0
11174611|NCT01668836|12363387|FG003|NOT COMPLETED|Overall Study||0
11174612|NCT01668966|12363403|FG000|STARTED|Overall Study||23
11174613|NCT01668966|12363403|FG000|Treated|Overall Study||21
11174614|NCT01668966|12363403|FG000|COMPLETED|Overall Study||19
11174615|NCT01668966|12363403|FG000|NOT COMPLETED|Overall Study||4
11174616|NCT01669096|12363407|FG000|STARTED|Overall Study||20
11174617|NCT01669096|12363407|FG000|COMPLETED|Overall Study||20
11174618|NCT01669096|12363407|FG000|NOT COMPLETED|Overall Study||0
11174619|NCT01669122|12363411|FG000|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
11174620|NCT01669122|12363411|FG000|Safety Population|Period I||39
11174621|NCT01669122|12363411|FG000|COMPLETED|Period I||39
11174622|NCT01669122|12363411|FG000|NOT COMPLETED|Period I||1
11174623|NCT01669122|12363411|FG000|STARTED|Washout Period I||39
11174624|NCT01669122|12363411|FG000|COMPLETED|Washout Period I||39
11174625|NCT01669122|12363411|FG000|NOT COMPLETED|Washout Period I||0
11174626|NCT01669122|12363411|FG000|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
11174627|NCT01669122|12363411|FG000|COMPLETED|Period II||39
11174628|NCT01669122|12363411|FG000|NOT COMPLETED|Period II||0
11174629|NCT01669122|12363411|FG000|STARTED|Washout Period II||39
11174630|NCT01669122|12363411|FG000|COMPLETED|Washout Period II||37
11174631|NCT01669122|12363411|FG000|NOT COMPLETED|Washout Period II||2
11174632|NCT01669122|12363411|FG000|STARTED|Washout Period III||37
11174633|NCT01669122|12363411|FG000|COMPLETED|Washout Period III||37
11174634|NCT01669122|12363411|FG000|NOT COMPLETED|Washout Period III||0
11174635|NCT01669122|12363411|FG000|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
11174636|NCT01669122|12363411|FG000|COMPLETED|Period III||37
11174637|NCT01669122|12363411|FG000|NOT COMPLETED|Period III||0
11174638|NCT01669122|12363411|FG000|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
11174639|NCT01669122|12363411|FG000|COMPLETED|Period IV||37
11174640|NCT01669122|12363411|FG000|NOT COMPLETED|Period IV||0
11174641|NCT01669174|12363424|FG000|STARTED|Overall Study||33
11174642|NCT01669174|12363425|FG001|STARTED|Overall Study||34
11174643|NCT01669174|12363424|FG000|COMPLETED|Overall Study||27
11174644|NCT01669174|12363425|FG001|COMPLETED|Overall Study||28
11174645|NCT01669174|12363424|FG000|NOT COMPLETED|Overall Study||6
11174646|NCT01669174|12363425|FG001|NOT COMPLETED|Overall Study||6
11174647|NCT01669343|12363431|FG000|STARTED|Part A: All Patients||121
11174648|NCT01669343|12363431|FG000|COMPLETED|Part A: All Patients||112
11174649|NCT01669343|12363431|FG000|NOT COMPLETED|Part A: All Patients||9
11174650|NCT01669343|12363431|FG000|STARTED|Part B: Patients With BMI>=25||48
11174651|NCT01669343|12363431|FG000|COMPLETED|Part B: Patients With BMI>=25||31
11174652|NCT01669343|12363431|FG000|NOT COMPLETED|Part B: Patients With BMI>=25||17
11174653|NCT01669421|12363438|FG000|STARTED|Phase 1: Standard Dose Therapy||10
11174654|NCT01669421|12363438|FG000|COMPLETED|Phase 1: Standard Dose Therapy||8
11174655|NCT01669421|12363438|FG000|NOT COMPLETED|Phase 1: Standard Dose Therapy||2
11174656|NCT01669421|12363438|FG000|STARTED|Phase 2: Double Dose Therapy||8
11174657|NCT01669421|12363438|FG000|COMPLETED|Phase 2: Double Dose Therapy||8
11174658|NCT01669421|12363438|FG000|NOT COMPLETED|Phase 2: Double Dose Therapy||0
11174659|NCT01669421|12363438|FG000|STARTED|Phase 3: Standard Dose Therapy||8
11174660|NCT01669421|12363438|FG000|COMPLETED|Phase 3: Standard Dose Therapy||8
11174661|NCT01669421|12363438|FG000|NOT COMPLETED|Phase 3: Standard Dose Therapy||0
11174662|NCT01669434|12363454|FG000|STARTED|Overall Study||146
11174663|NCT01669434|12363455|FG001|STARTED|Overall Study||145
11174664|NCT01669434|12363454|FG000|COMPLETED|Overall Study||137
11174665|NCT01669434|12363455|FG001|COMPLETED|Overall Study||138
11174666|NCT01669434|12363454|FG000|NOT COMPLETED|Overall Study||9
11174667|NCT01669434|12363455|FG001|NOT COMPLETED|Overall Study||7
11174668|NCT01669538|12363463|FG000|STARTED|Overall Study||40
11174669|NCT01669538|12363464|FG001|STARTED|Overall Study||42
11174670|NCT01669538|12363463|FG000|COMPLETED|Overall Study||28
11174671|NCT01669538|12363464|FG001|COMPLETED|Overall Study||33
11174672|NCT01669538|12363463|FG000|NOT COMPLETED|Overall Study||12
11174673|NCT01669538|12363464|FG001|NOT COMPLETED|Overall Study||9
11174674|NCT01669577|12363470|FG000|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
11174675|NCT01669577|12363470|FG000|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
11174676|NCT01669577|12363470|FG000|NOT COMPLETED|Overall Study||134
11174677|NCT01669603|12363476|FG000|STARTED|Overall Study||95
11174678|NCT01669603|12363477|FG001|STARTED|Overall Study||95
11174679|NCT01669603|12363476|FG000|COMPLETED|Overall Study||58
11174680|NCT01669603|12363477|FG001|COMPLETED|Overall Study||57
11174681|NCT01669603|12363476|FG000|NOT COMPLETED|Overall Study||37
11174682|NCT01669603|12363477|FG001|NOT COMPLETED|Overall Study||38
11174683|NCT01669629|12363483|FG000|STARTED|Period 1||92
11174684|NCT01669629|12363484|FG001|STARTED|Period 1||91
11174685|NCT01669629|12363483|FG000|COMPLETED|Period 1||91
11174686|NCT01669629|12363484|FG001|COMPLETED|Period 1||89
11174687|NCT01669629|12363483|FG000|NOT COMPLETED|Period 1||1
11174688|NCT01669629|12363484|FG001|NOT COMPLETED|Period 1||2
11174689|NCT01669629|12363483|FG000|STARTED|Period 2||91
11174690|NCT01669629|12363484|FG001|STARTED|Period 2||89
11174691|NCT01669629|12363483|FG000|COMPLETED|Period 2||91
11174692|NCT01669629|12363484|FG001|COMPLETED|Period 2||89
11174693|NCT01669629|12363483|FG000|NOT COMPLETED|Period 2||0
11174694|NCT01669629|12363484|FG001|NOT COMPLETED|Period 2||0
11174695|NCT01669642|12363495|FG000|STARTED|Overall Study||20
11174696|NCT01669642|12363496|FG001|STARTED|Overall Study||20
11174697|NCT01669642|12363497|FG002|STARTED|Overall Study||20
11174698|NCT01669642|12363498|FG003|STARTED|Overall Study||21
11174699|NCT01669642|12363499|FG004|STARTED|Overall Study||20
11174700|NCT01669642|12363500|FG005|STARTED|Overall Study||10
11174701|NCT01669642|12363495|FG000|COMPLETED|Overall Study||20
11174702|NCT01669642|12363496|FG001|COMPLETED|Overall Study||20
11174703|NCT01669642|12363497|FG002|COMPLETED|Overall Study||20
11174704|NCT01669642|12363498|FG003|COMPLETED|Overall Study||20
11174705|NCT01669642|12363499|FG004|COMPLETED|Overall Study||20
11174706|NCT01669642|12363500|FG005|COMPLETED|Overall Study||0
11174707|NCT01669642|12363495|FG000|NOT COMPLETED|Overall Study||0
11174708|NCT01669642|12363496|FG001|NOT COMPLETED|Overall Study||0
11174709|NCT01669642|12363497|FG002|NOT COMPLETED|Overall Study||0
11174710|NCT01669642|12363498|FG003|NOT COMPLETED|Overall Study||1
11174711|NCT01669642|12363499|FG004|NOT COMPLETED|Overall Study||0
11174712|NCT01669642|12363500|FG005|NOT COMPLETED|Overall Study||10
11174713|NCT01669720|12363519|FG000|STARTED|Overall Study||7
11174714|NCT01669720|12363520|FG001|STARTED|Overall Study||3
11174715|NCT01669720|12363519|FG000|COMPLETED|Overall Study||7
11174716|NCT01669720|12363520|FG001|COMPLETED|Overall Study||3
11174717|NCT01669720|12363519|FG000|NOT COMPLETED|Overall Study||0
11174718|NCT01669720|12363520|FG001|NOT COMPLETED|Overall Study||0
11174719|NCT01669785|12363529|FG000|STARTED|Overall Study||45
11174720|NCT01669785|12363530|FG001|STARTED|Overall Study||48
11174721|NCT01669785|12363531|FG002|STARTED|Overall Study||46
11174722|NCT01669785|12363529|FG000|COMPLETED|Overall Study||45
11174723|NCT01669785|12363530|FG001|COMPLETED|Overall Study||48
11420284|NCT01828099|12619134|FG001|NOT COMPLETED|Overall Study||157
11420285|NCT01593254|12619142|FG000|STARTED|Treatment Period||86
11174724|NCT01669785|12363531|FG002|COMPLETED|Overall Study||46
11174725|NCT01669785|12363529|FG000|NOT COMPLETED|Overall Study||0
11174726|NCT01669785|12363530|FG001|NOT COMPLETED|Overall Study||0
11174727|NCT01669785|12363531|FG002|NOT COMPLETED|Overall Study||0
11174728|NCT01669798|12363540|FG000|STARTED|Overall Study||32
11174729|NCT01669798|12363540|FG000|COMPLETED|Overall Study||27
11174730|NCT01669798|12363540|FG000|NOT COMPLETED|Overall Study||5
11174731|NCT01669811|12363546|FG000|STARTED|Overall Study||145
11174732|NCT01669811|12363547|FG001|STARTED|Overall Study||142
11174733|NCT01669811|12363546|FG000|COMPLETED|Overall Study||142
11174734|NCT01669811|12363547|FG001|COMPLETED|Overall Study||131
11174735|NCT01669811|12363546|FG000|NOT COMPLETED|Overall Study||3
11174736|NCT01669811|12363547|FG001|NOT COMPLETED|Overall Study||11
11174737|NCT01669863|12363553|FG000|STARTED|Overall Study||6
11174738|NCT01669863|12363553|FG000|COMPLETED|Overall Study||6
11174739|NCT01669863|12363553|FG000|NOT COMPLETED|Overall Study||0
11174740|NCT01669902|12363558|FG000|STARTED|Overall Study||107
11174741|NCT01669902|12363558|FG000|COMPLETED|Overall Study||78
11174742|NCT01669902|12363558|FG000|NOT COMPLETED|Overall Study||29
11174743|NCT01669928|12363564|FG000|STARTED|First Intervention||51
11174744|NCT01669928|12363565|FG001|STARTED|First Intervention||52
11174745|NCT01669928|12363564|FG000|COMPLETED|First Intervention||48
11174746|NCT01669928|12363565|FG001|COMPLETED|First Intervention||47
11174747|NCT01669928|12363564|FG000|NOT COMPLETED|First Intervention||3
11174748|NCT01669928|12363565|FG001|NOT COMPLETED|First Intervention||5
11420286|NCT01593254|12619143|FG001|STARTED|Treatment Period||174
11174749|NCT01669928|12363564|FG000|STARTED|Second Intervention||48
11174750|NCT01669928|12363565|FG001|STARTED|Second Intervention||47
11174751|NCT01669928|12363564|FG000|COMPLETED|Second Intervention||48
11174752|NCT01669928|12363565|FG001|COMPLETED|Second Intervention||47
11174753|NCT01669928|12363564|FG000|NOT COMPLETED|Second Intervention||0
11174754|NCT01669928|12363565|FG001|NOT COMPLETED|Second Intervention||0
11174755|NCT01670019|12363575|FG000|STARTED|Overall Study||23
11420287|NCT01593254|12619142|FG000|Crossed Over to Dasatinib|Treatment Period||42
11420288|NCT01593254|12619143|FG001|Crossed Over to Dasatinib|Treatment Period||0
11420289|NCT01593254|12619142|FG000|COMPLETED|Treatment Period||72
11174756|NCT01670019|12363576|FG001|STARTED|Overall Study||23
11174757|NCT01670019|12363575|FG000|COMPLETED|Overall Study||14
11174758|NCT01670019|12363576|FG001|COMPLETED|Overall Study||23
11174759|NCT01670019|12363575|FG000|NOT COMPLETED|Overall Study||9
11174760|NCT01670019|12363576|FG001|NOT COMPLETED|Overall Study||0
11174761|NCT01670045|12363582|FG000|STARTED|Overall Study||43
11174762|NCT01670045|12363582|FG000|COMPLETED|Overall Study||27
11174763|NCT01670045|12363582|FG000|NOT COMPLETED|Overall Study||16
11174764|NCT01670097|12363588|FG000|STARTED|Overall Study||20
11174765|NCT01670097|12363589|FG001|STARTED|Overall Study||21
11174766|NCT01670097|12363588|FG000|Completed Week 1 Intervention|Overall Study||18
11174767|NCT01670097|12363589|FG001|Completed Week 1 Intervention|Overall Study||17
11174768|NCT01670097|12363588|FG000|Completed Week 2 Intervention|Overall Study||13
11174769|NCT01670097|12363589|FG001|Completed Week 2 Intervention|Overall Study||15
11174770|NCT01670097|12363588|FG000|COMPLETED|Overall Study||18
11174771|NCT01670097|12363589|FG001|COMPLETED|Overall Study||17
11174772|NCT01670097|12363588|FG000|NOT COMPLETED|Overall Study||2
11174773|NCT01670097|12363589|FG001|NOT COMPLETED|Overall Study||4
11174774|NCT01670110|12363597|FG000|STARTED|Overall Study||33
11174775|NCT01670110|12363598|FG001|STARTED|Overall Study||15
11174776|NCT01670110|12363597|FG000|COMPLETED|Overall Study||29
11174777|NCT01670110|12363598|FG001|COMPLETED|Overall Study||12
11174778|NCT01670110|12363597|FG000|NOT COMPLETED|Overall Study||4
11174779|NCT01670110|12363598|FG001|NOT COMPLETED|Overall Study||3
11174780|NCT01670188|12363606|FG000|STARTED|Overall Study||38
11174781|NCT01670188|12363607|FG001|STARTED|Overall Study||40
11174782|NCT01670188|12363606|FG000|COMPLETED|Overall Study||38
11174783|NCT01670188|12363607|FG001|COMPLETED|Overall Study||39
11174784|NCT01670188|12363606|FG000|NOT COMPLETED|Overall Study||0
11174785|NCT01670188|12363607|FG001|NOT COMPLETED|Overall Study||1
11174786|NCT01670201|12363613|FG000|STARTED|Overall Study||8
11174787|NCT01670201|12363613|FG000|COMPLETED|Overall Study||8
11174788|NCT01670201|12363613|FG000|NOT COMPLETED|Overall Study||0
11174789|NCT01670279|12363620|FG000|STARTED|Overall Study||6
11174790|NCT01670279|12363621|FG001|STARTED|Overall Study||7
11174791|NCT01670279|12363622|FG002|STARTED|Overall Study||0
11174792|NCT01670279|12363623|FG003|STARTED|Overall Study||5
11174793|NCT01670279|12363620|FG000|COMPLETED|Overall Study||6
11174794|NCT01670279|12363621|FG001|COMPLETED|Overall Study||5
11174795|NCT01670279|12363622|FG002|COMPLETED|Overall Study||0
11174796|NCT01670279|12363623|FG003|COMPLETED|Overall Study||4
11174797|NCT01670279|12363620|FG000|NOT COMPLETED|Overall Study||0
11174798|NCT01670279|12363621|FG001|NOT COMPLETED|Overall Study||2
11174799|NCT01670279|12363622|FG002|NOT COMPLETED|Overall Study||0
11174800|NCT01670279|12363623|FG003|NOT COMPLETED|Overall Study||1
11174801|NCT01670292|12363631|FG000|STARTED|Overall Study||82
11174802|NCT01670292|12363631|FG000|COMPLETED|Overall Study||68
11174803|NCT01670292|12363631|FG000|NOT COMPLETED|Overall Study||14
11174804|NCT01670487|12363645|FG000|STARTED|Overall Study||150
11174805|NCT01670487|12363646|FG001|STARTED|Overall Study||150
11174806|NCT01670487|12363645|FG000|COMPLETED|Overall Study||150
11174807|NCT01670487|12363646|FG001|COMPLETED|Overall Study||150
11174808|NCT01670487|12363645|FG000|NOT COMPLETED|Overall Study||0
11174809|NCT01670487|12363646|FG001|NOT COMPLETED|Overall Study||0
11174810|NCT01670526|12363654|FG000|STARTED|Overall Study||49
11174811|NCT01670526|12363655|FG001|STARTED|Overall Study||45
11174812|NCT01670526|12363654|FG000|COMPLETED|Overall Study||37
11174813|NCT01670526|12363655|FG001|COMPLETED|Overall Study||39
11174814|NCT01670526|12363654|FG000|NOT COMPLETED|Overall Study||12
11174815|NCT01670526|12363655|FG001|NOT COMPLETED|Overall Study||6
11174816|NCT01670721|12363661|FG000|STARTED|Overall Study||175
11174817|NCT01670721|12363661|FG000|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
11174818|NCT01670721|12363661|FG000|NOT COMPLETED|Overall Study||53
11174819|NCT01670760|12363665|FG000|STARTED|Overall Study||20
11174820|NCT01670760|12363665|FG000|COMPLETED|Overall Study||20
11174821|NCT01670760|12363665|FG000|NOT COMPLETED|Overall Study||0
11174822|NCT01670825|12363671|FG000|STARTED|Overall Study||42
11174823|NCT01670825|12363672|FG001|STARTED|Overall Study||39
11174824|NCT01670825|12363671|FG000|COMPLETED|Overall Study||42
11174825|NCT01670825|12363672|FG001|COMPLETED|Overall Study||39
11174826|NCT01670825|12363671|FG000|NOT COMPLETED|Overall Study||0
11174827|NCT01670825|12363672|FG001|NOT COMPLETED|Overall Study||0
11174828|NCT01671007|12363689|FG000|STARTED|Overall Study||2089
11174829|NCT01671007|12363690|FG001|STARTED|Overall Study||2834
11174830|NCT01671007|12363691|FG002|STARTED|Overall Study||2033
11174831|NCT01671007|12363692|FG003|STARTED|Overall Study||2214
11174832|NCT01671007|12363693|FG004|STARTED|Overall Study||180
11174833|NCT01671007|12363694|FG005|STARTED|Overall Study||513
11174834|NCT01671007|12363695|FG006|STARTED|Overall Study||80
11174835|NCT01671007|12363696|FG007|STARTED|Overall Study||526
11174836|NCT01671007|12363697|FG008|STARTED|Overall Study||2
11174837|NCT01671007|12363689|FG000|All Eligible|Overall Study||2066
11174838|NCT01671007|12363690|FG001|All Eligible|Overall Study||2758
11174839|NCT01671007|12363691|FG002|All Eligible|Overall Study||2008
11174840|NCT01671007|12363692|FG003|All Eligible|Overall Study||2197
11174841|NCT01671007|12363693|FG004|All Eligible|Overall Study||180
11174842|NCT01671007|12363694|FG005|All Eligible|Overall Study||507
11174843|NCT01671007|12363695|FG006|All Eligible|Overall Study||79
11174844|NCT01671007|12363696|FG007|All Eligible|Overall Study||507
11174845|NCT01671007|12363697|FG008|All Eligible|Overall Study||2
11174846|NCT01671007|12363689|FG000|COMPLETED|Overall Study||1768
11174847|NCT01671007|12363690|FG001|COMPLETED|Overall Study||2183
11174848|NCT01671007|12363691|FG002|COMPLETED|Overall Study||1667
11174849|NCT01671007|12363692|FG003|COMPLETED|Overall Study||1846
11174850|NCT01671007|12363693|FG004|COMPLETED|Overall Study||155
11174851|NCT01671007|12363694|FG005|COMPLETED|Overall Study||401
11174852|NCT01671007|12363695|FG006|COMPLETED|Overall Study||59
11174853|NCT01671007|12363696|FG007|COMPLETED|Overall Study||394
11174854|NCT01671007|12363697|FG008|COMPLETED|Overall Study||2
11174855|NCT01671007|12363689|FG000|NOT COMPLETED|Overall Study||321
11174856|NCT01671007|12363690|FG001|NOT COMPLETED|Overall Study||651
11174857|NCT01671007|12363691|FG002|NOT COMPLETED|Overall Study||366
11026858|NCT00830869|12205485|FG005|COMPLETED|Period 1: Part 1||0
11026859|NCT00830869|12205486|FG006|COMPLETED|Period 1: Part 1||0
11026860|NCT00830869|12205487|FG007|COMPLETED|Period 1: Part 1||0
11026861|NCT00830869|12205488|FG008|COMPLETED|Period 1: Part 1||0
11026862|NCT00830869|12205489|FG009|COMPLETED|Period 1: Part 1||0
11174858|NCT01671007|12363692|FG003|NOT COMPLETED|Overall Study||368
11174859|NCT01671007|12363693|FG004|NOT COMPLETED|Overall Study||25
11174860|NCT01671007|12363694|FG005|NOT COMPLETED|Overall Study||112
11174861|NCT01671007|12363695|FG006|NOT COMPLETED|Overall Study||21
11174862|NCT01671007|12363696|FG007|NOT COMPLETED|Overall Study||132
11174863|NCT01671007|12363697|FG008|NOT COMPLETED|Overall Study||0
11174864|NCT01671059|12363708|FG000|STARTED|Overall Study||80
11174865|NCT01671059|12363708|FG000|COMPLETED|Overall Study||75
11174866|NCT01671059|12363708|FG000|NOT COMPLETED|Overall Study||5
11174867|NCT01671085|12363715|FG000|STARTED|Overall Study|1 participant who dropped out was replaced.|11
11174868|NCT01671085|12363716|FG001|STARTED|Overall Study||2
11174869|NCT01671085|12363715|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
11174870|NCT01671085|12363716|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
11174871|NCT01671085|12363715|FG000|COMPLETED|Overall Study||10
11174872|NCT01671085|12363716|FG001|COMPLETED|Overall Study||2
11174873|NCT01671085|12363715|FG000|NOT COMPLETED|Overall Study||1
11174874|NCT01671085|12363716|FG001|NOT COMPLETED|Overall Study||0
11174875|NCT01671111|12363723|FG000|STARTED|Overall Study||30
11174876|NCT01671111|12363723|FG000|COMPLETED|Overall Study||0
11174877|NCT01671111|12363723|FG000|NOT COMPLETED|Overall Study||30
11174878|NCT01671176|12363727|FG000|STARTED|Overall Study||30
11174879|NCT01671176|12363727|FG000|COMPLETED|Overall Study||30
11174880|NCT01671176|12363727|FG000|NOT COMPLETED|Overall Study||0
11174881|NCT01671280|12363731|FG000|STARTED|Overall Study|The number is enrollment.|403
11174882|NCT01671280|12363731|FG000|COMPLETED|Overall Study||401
11174883|NCT01671280|12363731|FG000|NOT COMPLETED|Overall Study||2
11174884|NCT01671293|12363737|FG000|STARTED|Overall Study||36
11174885|NCT01671293|12363738|FG001|STARTED|Overall Study||34
11174886|NCT01671293|12363737|FG000|COMPLETED|Overall Study||33
11174887|NCT01671293|12363738|FG001|COMPLETED|Overall Study||32
11174888|NCT01671293|12363737|FG000|NOT COMPLETED|Overall Study||3
11174889|NCT01671293|12363738|FG001|NOT COMPLETED|Overall Study||2
11174890|NCT01671319|12363744|FG000|STARTED|Overall Study||42
11174891|NCT01671319|12363744|FG000|COMPLETED|Overall Study||41
11174892|NCT01671319|12363744|FG000|NOT COMPLETED|Overall Study||1
11174893|NCT01671332|12363750|FG000|STARTED|Overall Study||40
11174894|NCT01671332|12363751|FG001|STARTED|Overall Study||40
11174895|NCT01671332|12363750|FG000|Crossed Over to Docetaxel Plus Suramin|Overall Study||0
11174896|NCT01671332|12363751|FG001|Crossed Over to Docetaxel Plus Suramin|Overall Study|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|13
11174897|NCT01671332|12363750|FG000|COMPLETED|Overall Study||39
11174898|NCT01671332|12363751|FG001|COMPLETED|Overall Study||39
11174899|NCT01671332|12363750|FG000|NOT COMPLETED|Overall Study||1
11174900|NCT01671332|12363751|FG001|NOT COMPLETED|Overall Study||1
11174901|NCT01671345|12363759|FG000|STARTED|Overall Study||77
11174902|NCT01671345|12363760|FG001|STARTED|Overall Study||92
11174903|NCT01671345|12363759|FG000|COMPLETED|Overall Study||64
11174904|NCT01671345|12363760|FG001|COMPLETED|Overall Study||83
11174905|NCT01671345|12363759|FG000|NOT COMPLETED|Overall Study||13
11174906|NCT01671345|12363760|FG001|NOT COMPLETED|Overall Study||9
11174907|NCT01671423|12363771|FG000|STARTED|Overall Study||20
11174908|NCT01671423|12363772|FG001|STARTED|Overall Study||20
11174909|NCT01671423|12363771|FG000|COMPLETED|Overall Study||14
11174910|NCT01671423|12363772|FG001|COMPLETED|Overall Study||9
11174911|NCT01671423|12363771|FG000|NOT COMPLETED|Overall Study||6
11174912|NCT01671423|12363772|FG001|NOT COMPLETED|Overall Study||11
11174913|NCT01671488|12363778|FG000|STARTED|Overall Study||11
11174914|NCT01671488|12363778|FG000|COMPLETED|Overall Study||10
11174915|NCT01671488|12363778|FG000|NOT COMPLETED|Overall Study||1
11026863|NCT00830869|12205490|FG010|COMPLETED|Period 1: Part 1||0
11174916|NCT01671605|12363784|FG000|STARTED|Overall Study||72
11174917|NCT01671605|12363785|FG001|STARTED|Overall Study||31
11174918|NCT01671605|12363784|FG000|COMPLETED|Overall Study||72
11174919|NCT01671605|12363785|FG001|COMPLETED|Overall Study||31
11174920|NCT01671605|12363784|FG000|NOT COMPLETED|Overall Study||0
11174921|NCT01671605|12363785|FG001|NOT COMPLETED|Overall Study||0
11174922|NCT01671748|12363793|FG000|STARTED|4 Week run-in Phase||47
11174923|NCT01671748|12363794|FG001|STARTED|4 Week run-in Phase||0
11174924|NCT01671748|12363793|FG000|COMPLETED|4 Week run-in Phase||36
11174925|NCT01671748|12363794|FG001|COMPLETED|4 Week run-in Phase||0
11174926|NCT01671748|12363793|FG000|NOT COMPLETED|4 Week run-in Phase||11
11174927|NCT01671748|12363794|FG001|NOT COMPLETED|4 Week run-in Phase||0
11174928|NCT01671748|12363793|FG000|STARTED|12 Week Treatment Phase||19
11174929|NCT01671748|12363794|FG001|STARTED|12 Week Treatment Phase||17
11174930|NCT01671748|12363793|FG000|COMPLETED|12 Week Treatment Phase||19
11174931|NCT01671748|12363794|FG001|COMPLETED|12 Week Treatment Phase||17
11174932|NCT01671748|12363793|FG000|NOT COMPLETED|12 Week Treatment Phase||0
11174933|NCT01671748|12363794|FG001|NOT COMPLETED|12 Week Treatment Phase||0
11174934|NCT01671839|12363800|FG000|STARTED|Overall Study||55
11174935|NCT01671839|12363800|FG000|3-year Follow-up|Overall Study||45
11174936|NCT01671839|12363800|FG000|5-year Follow-up|Overall Study||37
11174937|NCT01671839|12363800|FG000|COMPLETED|Overall Study||37
11174938|NCT01671839|12363800|FG000|NOT COMPLETED|Overall Study||18
11174939|NCT01672294|12363811|FG000|STARTED|Overall Study||71
11174940|NCT01672294|12363812|FG001|STARTED|Overall Study||71
11323858|NCT02738580|12521149|FG001|COMPLETED|Overall Study|"2 cycles cancelled due to por response to stimullation~1 patient withdrawal~1 excluded"|52
11323859|NCT02738580|12521148|FG000|NOT COMPLETED|Overall Study||4
11323860|NCT02738580|12521149|FG001|NOT COMPLETED|Overall Study||4
11323861|NCT02738775|12521161|FG000|STARTED|Overall Study||8
11323862|NCT02738775|12521162|FG001|STARTED|Overall Study||8
11323863|NCT02738775|12521163|FG002|STARTED|Overall Study||8
11323864|NCT02738775|12521164|FG003|STARTED|Overall Study||9
11323865|NCT02738775|12521165|FG004|STARTED|Overall Study||8
11323866|NCT02738775|12521166|FG005|STARTED|Overall Study||8
11323867|NCT02738775|12521161|FG000|Initially Treated With Placebo|Overall Study||0
11323868|NCT02738775|12521162|FG001|Initially Treated With Placebo|Overall Study||0
11323869|NCT02738775|12521163|FG002|Initially Treated With Placebo|Overall Study||0
11323870|NCT02738775|12521164|FG003|Initially Treated With Placebo|Overall Study||1
11323871|NCT02738775|12521165|FG004|Initially Treated With Placebo|Overall Study||0
11323872|NCT02738775|12521166|FG005|Initially Treated With Placebo|Overall Study||0
11323873|NCT02738775|12521161|FG000|COMPLETED|Overall Study||8
11323874|NCT02738775|12521162|FG001|COMPLETED|Overall Study||6
11323875|NCT02738775|12521163|FG002|COMPLETED|Overall Study||8
11323876|NCT02738775|12521164|FG003|COMPLETED|Overall Study||8
11323877|NCT02738775|12521165|FG004|COMPLETED|Overall Study||8
11323878|NCT02738775|12521166|FG005|COMPLETED|Overall Study||7
11323879|NCT02738775|12521161|FG000|NOT COMPLETED|Overall Study||0
11323880|NCT02738775|12521162|FG001|NOT COMPLETED|Overall Study||2
11323881|NCT02738775|12521163|FG002|NOT COMPLETED|Overall Study||0
11323882|NCT02738775|12521164|FG003|NOT COMPLETED|Overall Study||1
11323883|NCT02738775|12521165|FG004|NOT COMPLETED|Overall Study||0
11323884|NCT02738775|12521166|FG005|NOT COMPLETED|Overall Study||1
11323885|NCT02738801|12521186|FG000|STARTED|Overall Study||6
11323886|NCT02738801|12521187|FG001|STARTED|Overall Study||17
11323887|NCT02738801|12521186|FG000|COMPLETED|Overall Study||5
11323888|NCT02738801|12521187|FG001|COMPLETED|Overall Study||15
11323889|NCT02738801|12521186|FG000|NOT COMPLETED|Overall Study||1
11323890|NCT02738801|12521187|FG001|NOT COMPLETED|Overall Study||2
11323891|NCT02738840|12521194|FG000|STARTED|Overall Study||56
11323892|NCT02738840|12521194|FG000|COMPLETED|Overall Study||48
11323893|NCT02738840|12521194|FG000|NOT COMPLETED|Overall Study||8
11323894|NCT02738879|12521200|FG000|STARTED|Overall Study||374
11323895|NCT02738879|12521201|FG001|STARTED|Overall Study||372
11323896|NCT02738879|12521200|FG000|Treated|Overall Study||373
11323897|NCT02738879|12521201|FG001|Treated|Overall Study||370
11323898|NCT02738879|12521200|FG000|COMPLETED|Overall Study||361
11323899|NCT02738879|12521201|FG001|COMPLETED|Overall Study||347
11323900|NCT02738879|12521200|FG000|NOT COMPLETED|Overall Study||13
11323901|NCT02738879|12521201|FG001|NOT COMPLETED|Overall Study||25
11323902|NCT02739100|12521207|FG000|STARTED|Overall Study||13
11323903|NCT02739100|12521207|FG000|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13
11323904|NCT02739100|12521207|FG000|Triferic 6.6 mg IV Predialyzer|Overall Study||13
11323905|NCT02739100|12521207|FG000|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13
11323906|NCT02739100|12521207|FG000|COMPLETED|Overall Study||13
11323907|NCT02739100|12521207|FG000|NOT COMPLETED|Overall Study||0
11323908|NCT02739269|12521217|FG000|STARTED|Overall Study||100
11323909|NCT02739269|12521218|FG001|STARTED|Overall Study||100
11323910|NCT02739269|12521217|FG000|COMPLETED|Overall Study||93
11323911|NCT02739269|12521218|FG001|COMPLETED|Overall Study||96
11323912|NCT02739269|12521217|FG000|NOT COMPLETED|Overall Study||7
11323913|NCT02739269|12521218|FG001|NOT COMPLETED|Overall Study||4
11323914|NCT02739321|12521226|FG000|STARTED|Overall Study||23
11323915|NCT02739321|12521227|FG001|STARTED|Overall Study||22
11323916|NCT02739321|12521226|FG000|COMPLETED|Overall Study||20
11323917|NCT02739321|12521227|FG001|COMPLETED|Overall Study||18
11323918|NCT02739321|12521226|FG000|NOT COMPLETED|Overall Study||3
11323919|NCT02739321|12521227|FG001|NOT COMPLETED|Overall Study||4
11323920|NCT02739360|12521242|FG000|STARTED|Overall Study||3
11323921|NCT02739360|12521242|FG000|COMPLETED|Overall Study||0
11323922|NCT02739360|12521242|FG000|NOT COMPLETED|Overall Study||3
11323923|NCT02739594|12521248|FG000|STARTED|Overall Study||46
11323924|NCT02739594|12521249|FG001|STARTED|Overall Study||43
11323925|NCT02739594|12521248|FG000|Completed at Week 44|Overall Study||11
11323926|NCT02739594|12521249|FG001|Completed at Week 44|Overall Study||5
11323927|NCT02739594|12521248|FG000|Completed at Week 96|Overall Study||10
11323928|NCT02739594|12521249|FG001|Completed at Week 96|Overall Study||10
11323929|NCT02739594|12521248|FG000|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
11323930|NCT02739594|12521249|FG001|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
11420290|NCT01593254|12619143|FG001|COMPLETED|Treatment Period||143
11420291|NCT01593254|12619142|FG000|NOT COMPLETED|Treatment Period||14
11174941|NCT01672294|12363813|FG002|STARTED|Overall Study||72
11174942|NCT01672294|12363814|FG003|STARTED|Overall Study||72
11174943|NCT01672294|12363811|FG000|COMPLETED|Overall Study||65
11174944|NCT01672294|12363812|FG001|COMPLETED|Overall Study||50
11174945|NCT01672294|12363813|FG002|COMPLETED|Overall Study||61
11174946|NCT01672294|12363814|FG003|COMPLETED|Overall Study||59
11174947|NCT01672294|12363811|FG000|NOT COMPLETED|Overall Study||6
11174948|NCT01672294|12363812|FG001|NOT COMPLETED|Overall Study||21
11174949|NCT01672294|12363813|FG002|NOT COMPLETED|Overall Study||11
11174950|NCT01672294|12363814|FG003|NOT COMPLETED|Overall Study||13
11174951|NCT01672658|12363826|FG000|STARTED|Overall Study||16
11174952|NCT01672658|12363827|FG001|STARTED|Overall Study||15
11174953|NCT01672658|12363826|FG000|COMPLETED|Overall Study||16
11174954|NCT01672658|12363827|FG001|COMPLETED|Overall Study||14
11174955|NCT01672658|12363826|FG000|NOT COMPLETED|Overall Study||0
11174956|NCT01672658|12363827|FG001|NOT COMPLETED|Overall Study||1
11174957|NCT01672710|12363835|FG000|STARTED|Controlled Comparison 5 Week Follow-up||22
11174958|NCT01672710|12363836|FG001|STARTED|Controlled Comparison 5 Week Follow-up||10
11174959|NCT01672710|12363835|FG000|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
11174960|NCT01672710|12363836|FG001|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
11174961|NCT01672710|12363835|FG000|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
11174962|NCT01672710|12363836|FG001|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
11174963|NCT01672710|12363835|FG000|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
11174964|NCT01672710|12363836|FG001|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
11174965|NCT01672710|12363835|FG000|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
11420292|NCT01593254|12619143|FG001|NOT COMPLETED|Treatment Period||31
11420293|NCT01593254|12619142|FG000|STARTED|Follow-Up Period||14
11420294|NCT01593254|12619143|FG001|STARTED|Follow-Up Period||28
11174966|NCT01672710|12363836|FG001|COMPLETED|Waitlist Assessed After Sauna Regimen||9
11174967|NCT01672710|12363835|FG000|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
11174968|NCT01672710|12363836|FG001|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
11174969|NCT01672710|12363835|FG000|STARTED|3 Month Follow up||22
11174970|NCT01672710|12363836|FG001|STARTED|3 Month Follow up||9
11174971|NCT01672710|12363835|FG000|COMPLETED|3 Month Follow up||16
11174972|NCT01672710|12363836|FG001|COMPLETED|3 Month Follow up||5
11174973|NCT01672710|12363835|FG000|NOT COMPLETED|3 Month Follow up||6
11174974|NCT01672710|12363836|FG001|NOT COMPLETED|3 Month Follow up||4
11174975|NCT01672723|12363842|FG000|STARTED|First Intervention||19
11174976|NCT01672723|12363843|FG001|STARTED|First Intervention||15
11174977|NCT01672723|12363842|FG000|COMPLETED|First Intervention||16
11174978|NCT01672723|12363843|FG001|COMPLETED|First Intervention||15
11174979|NCT01672723|12363842|FG000|NOT COMPLETED|First Intervention||3
11174980|NCT01672723|12363843|FG001|NOT COMPLETED|First Intervention||0
11174981|NCT01672723|12363842|FG000|STARTED|Washout Period of 10 Days||16
11174982|NCT01672723|12363843|FG001|STARTED|Washout Period of 10 Days||15
11174983|NCT01672723|12363842|FG000|COMPLETED|Washout Period of 10 Days||16
11174984|NCT01672723|12363843|FG001|COMPLETED|Washout Period of 10 Days||15
11174985|NCT01672723|12363842|FG000|NOT COMPLETED|Washout Period of 10 Days||0
11174986|NCT01672723|12363843|FG001|NOT COMPLETED|Washout Period of 10 Days||0
11174987|NCT01672723|12363842|FG000|STARTED|Second Intervention||16
11174988|NCT01672723|12363843|FG001|STARTED|Second Intervention||15
11174989|NCT01672723|12363842|FG000|COMPLETED|Second Intervention||16
11174990|NCT01672723|12363843|FG001|COMPLETED|Second Intervention||15
11174991|NCT01672723|12363842|FG000|NOT COMPLETED|Second Intervention||0
11174992|NCT01672723|12363843|FG001|NOT COMPLETED|Second Intervention||0
11174993|NCT01672736|12363849|FG000|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
11174994|NCT01672736|12363849|FG000|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
11174995|NCT01672736|12363849|FG000|NOT COMPLETED|Overall Study||3
11174996|NCT01672788|12363853|FG000|STARTED|Treatment Period 1 (3 Days)||9
11174997|NCT01672788|12363854|FG001|STARTED|Treatment Period 1 (3 Days)||9
11174998|NCT01672788|12363855|FG002|STARTED|Treatment Period 1 (3 Days)||9
11174999|NCT01672788|12363856|FG003|STARTED|Treatment Period 1 (3 Days)||9
11175000|NCT01672788|12363853|FG000|COMPLETED|Treatment Period 1 (3 Days)||9
11175001|NCT01672788|12363854|FG001|COMPLETED|Treatment Period 1 (3 Days)||9
11175002|NCT01672788|12363855|FG002|COMPLETED|Treatment Period 1 (3 Days)||9
11175003|NCT01672788|12363856|FG003|COMPLETED|Treatment Period 1 (3 Days)||9
11175004|NCT01672788|12363853|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0
11175005|NCT01672788|12363854|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
11175006|NCT01672788|12363855|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0
11175007|NCT01672788|12363856|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0
11175008|NCT01672788|12363853|FG000|STARTED|Washout Period 1 (7 Days)||9
11175009|NCT01672788|12363854|FG001|STARTED|Washout Period 1 (7 Days)||9
11420295|NCT01593254|12619142|FG000|COMPLETED|Follow-Up Period||11
11420296|NCT01593254|12619143|FG001|COMPLETED|Follow-Up Period||17
11420297|NCT01593254|12619142|FG000|NOT COMPLETED|Follow-Up Period||3
11175010|NCT01672788|12363855|FG002|STARTED|Washout Period 1 (7 Days)||9
11175011|NCT01672788|12363856|FG003|STARTED|Washout Period 1 (7 Days)||9
11175012|NCT01672788|12363853|FG000|COMPLETED|Washout Period 1 (7 Days)||9
11175013|NCT01672788|12363854|FG001|COMPLETED|Washout Period 1 (7 Days)||9
11175014|NCT01672788|12363855|FG002|COMPLETED|Washout Period 1 (7 Days)||9
11175015|NCT01672788|12363856|FG003|COMPLETED|Washout Period 1 (7 Days)||9
11175016|NCT01672788|12363853|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
11175017|NCT01672788|12363854|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
11175018|NCT01672788|12363855|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
11175019|NCT01672788|12363856|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
11175020|NCT01672788|12363853|FG000|STARTED|Treatment Period 2 (3 Days)||9
11175021|NCT01672788|12363854|FG001|STARTED|Treatment Period 2 (3 Days)||9
11175022|NCT01672788|12363855|FG002|STARTED|Treatment Period 2 (3 Days)||9
11175023|NCT01672788|12363856|FG003|STARTED|Treatment Period 2 (3 Days)||9
11175024|NCT01672788|12363853|FG000|COMPLETED|Treatment Period 2 (3 Days)||9
11175025|NCT01672788|12363854|FG001|COMPLETED|Treatment Period 2 (3 Days)||9
11175026|NCT01672788|12363855|FG002|COMPLETED|Treatment Period 2 (3 Days)||9
11175027|NCT01672788|12363856|FG003|COMPLETED|Treatment Period 2 (3 Days)||9
11175028|NCT01672788|12363853|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
11175029|NCT01672788|12363854|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0
11175030|NCT01672788|12363855|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0
11175031|NCT01672788|12363856|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0
11175032|NCT01672788|12363853|FG000|STARTED|Washout Period 2 (7 Days)||9
11175033|NCT01672788|12363854|FG001|STARTED|Washout Period 2 (7 Days)||9
11175034|NCT01672788|12363855|FG002|STARTED|Washout Period 2 (7 Days)||9
11175035|NCT01672788|12363856|FG003|STARTED|Washout Period 2 (7 Days)||9
11175036|NCT01672788|12363853|FG000|COMPLETED|Washout Period 2 (7 Days)||9
11175037|NCT01672788|12363854|FG001|COMPLETED|Washout Period 2 (7 Days)||9
11175038|NCT01672788|12363855|FG002|COMPLETED|Washout Period 2 (7 Days)||9
11175039|NCT01672788|12363856|FG003|COMPLETED|Washout Period 2 (7 Days)||8
11175040|NCT01672788|12363853|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
11175041|NCT01672788|12363854|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
11026864|NCT00830869|12205491|FG011|COMPLETED|Period 1: Part 1||0
11026865|NCT00830869|12205480|FG000|NOT COMPLETED|Period 1: Part 1||1
11175042|NCT01672788|12363855|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
11175043|NCT01672788|12363856|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1
11175044|NCT01672788|12363853|FG000|STARTED|Treatment Period 3 (3 Days)||9
11175045|NCT01672788|12363854|FG001|STARTED|Treatment Period 3 (3 Days)||9
11175046|NCT01672788|12363855|FG002|STARTED|Treatment Period 3 (3 Days)||9
11175047|NCT01672788|12363856|FG003|STARTED|Treatment Period 3 (3 Days)||8
11175048|NCT01672788|12363853|FG000|COMPLETED|Treatment Period 3 (3 Days)||9
11175049|NCT01672788|12363854|FG001|COMPLETED|Treatment Period 3 (3 Days)||9
11175050|NCT01672788|12363855|FG002|COMPLETED|Treatment Period 3 (3 Days)||9
11175051|NCT01672788|12363856|FG003|COMPLETED|Treatment Period 3 (3 Days)||8
11175052|NCT01672788|12363853|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
11175053|NCT01672788|12363854|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
11175054|NCT01672788|12363855|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
11175055|NCT01672788|12363856|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0
11175056|NCT01672788|12363853|FG000|STARTED|Washout Period 3 (7 Days)||9
11175057|NCT01672788|12363854|FG001|STARTED|Washout Period 3 (7 Days)||9
11175058|NCT01672788|12363855|FG002|STARTED|Washout Period 3 (7 Days)||9
11175059|NCT01672788|12363856|FG003|STARTED|Washout Period 3 (7 Days)||8
11175060|NCT01672788|12363853|FG000|COMPLETED|Washout Period 3 (7 Days)||9
11175061|NCT01672788|12363854|FG001|COMPLETED|Washout Period 3 (7 Days)||9
11175062|NCT01672788|12363855|FG002|COMPLETED|Washout Period 3 (7 Days)||9
11175063|NCT01672788|12363856|FG003|COMPLETED|Washout Period 3 (7 Days)||8
11175064|NCT01672788|12363853|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
11175065|NCT01672788|12363854|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
11175066|NCT01672788|12363855|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
11175067|NCT01672788|12363856|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
11175068|NCT01672788|12363853|FG000|STARTED|Treatment Period 4 (3 Days)||9
11175069|NCT01672788|12363854|FG001|STARTED|Treatment Period 4 (3 Days)||9
11175070|NCT01672788|12363855|FG002|STARTED|Treatment Period 4 (3 Days)||9
11175071|NCT01672788|12363856|FG003|STARTED|Treatment Period 4 (3 Days)||8
11175072|NCT01672788|12363853|FG000|COMPLETED|Treatment Period 4 (3 Days)||9
11175073|NCT01672788|12363854|FG001|COMPLETED|Treatment Period 4 (3 Days)||9
11175074|NCT01672788|12363855|FG002|COMPLETED|Treatment Period 4 (3 Days)||9
11175075|NCT01672788|12363856|FG003|COMPLETED|Treatment Period 4 (3 Days)||8
11175076|NCT01672788|12363853|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0
11175077|NCT01672788|12363854|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0
11420298|NCT01593254|12619143|FG001|NOT COMPLETED|Follow-Up Period||11
11420299|NCT01574274|12619152|FG000|STARTED|Overall Study||119
11026866|NCT00830869|12205481|FG001|NOT COMPLETED|Period 1: Part 1||1
11175078|NCT01672788|12363855|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0
11175079|NCT01672788|12363856|FG003|NOT COMPLETED|Treatment Period 4 (3 Days)||0
11175080|NCT01672801|12363868|FG000|STARTED|Overall Study||9
11175081|NCT01672801|12363869|FG001|STARTED|Overall Study||9
11175082|NCT01672801|12363868|FG000|COMPLETED|Overall Study||9
11420300|NCT01574274|12619153|FG001|STARTED|Overall Study||121
11175083|NCT01672801|12363869|FG001|COMPLETED|Overall Study||8
11420301|NCT01574274|12619152|FG000|Evaluable for Induction Events|Overall Study||115
11420302|NCT01574274|12619153|FG001|Evaluable for Induction Events|Overall Study||115
11175084|NCT01672801|12363868|FG000|NOT COMPLETED|Overall Study||0
11175085|NCT01672801|12363869|FG001|NOT COMPLETED|Overall Study||1
11175086|NCT01672827|12363875|FG000|STARTED|Overall Study||276
11175087|NCT01672827|12363875|FG000|COMPLETED|Overall Study||276
11175088|NCT01672827|12363875|FG000|NOT COMPLETED|Overall Study||0
11175089|NCT01672853|12363884|FG000|STARTED|Overall Study||79
11175090|NCT01672853|12363885|FG001|STARTED|Overall Study||77
11175091|NCT01672853|12363886|FG002|STARTED|Overall Study||79
11175092|NCT01672853|12363884|FG000|COMPLETED|Overall Study||69
11175093|NCT01672853|12363885|FG001|COMPLETED|Overall Study||60
11175094|NCT01672853|12363886|FG002|COMPLETED|Overall Study||65
11175095|NCT01672853|12363884|FG000|NOT COMPLETED|Overall Study||10
11175096|NCT01672853|12363885|FG001|NOT COMPLETED|Overall Study||17
11175097|NCT01672853|12363886|FG002|NOT COMPLETED|Overall Study||14
11175098|NCT01672866|12363897|FG000|STARTED|Blinded Phase (up to 240 Weeks)||74
11175099|NCT01672866|12363898|FG001|STARTED|Blinded Phase (up to 240 Weeks)||74
11175100|NCT01672866|12363899|FG002|STARTED|Blinded Phase (up to 240 Weeks)||74
11175101|NCT01672866|12363897|FG000|COMPLETED|Blinded Phase (up to 240 Weeks)||0
11175102|NCT01672866|12363898|FG001|COMPLETED|Blinded Phase (up to 240 Weeks)||0
11175103|NCT01672866|12363899|FG002|COMPLETED|Blinded Phase (up to 240 Weeks)||0
11175104|NCT01672866|12363897|FG000|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
11175105|NCT01672866|12363898|FG001|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
11175106|NCT01672866|12363899|FG002|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
11175107|NCT01672866|12363897|FG000|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11
11175108|NCT01672866|12363898|FG001|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
11175109|NCT01672866|12363899|FG002|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16
11175110|NCT01672866|12363897|FG000|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
11175111|NCT01672866|12363898|FG001|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
11175112|NCT01672866|12363899|FG002|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
11420303|NCT01574274|12619152|FG000|Achieved Complete Remission|Overall Study||109
11420304|NCT01574274|12619153|FG001|Achieved Complete Remission|Overall Study||114
11420305|NCT01574274|12619152|FG000|Received Post-induction Asparaginase|Overall Study||109
11420306|NCT01574274|12619153|FG001|Received Post-induction Asparaginase|Overall Study||114
11420307|NCT01574274|12619152|FG000|Eligible|Overall Study||119
11420308|NCT01574274|12619153|FG001|Eligible|Overall Study||120
11420309|NCT01574274|12619152|FG000|COMPLETED|Overall Study||87
11420310|NCT01574274|12619153|FG001|COMPLETED|Overall Study||99
11420311|NCT01574274|12619152|FG000|NOT COMPLETED|Overall Study||32
11175113|NCT01672866|12363897|FG000|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11
11175114|NCT01672866|12363898|FG001|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15
11175115|NCT01672866|12363899|FG002|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16
11175116|NCT01672879|12363912|FG000|STARTED|Blinded Phase (Up to 240 Weeks)||87
11175117|NCT01672879|12363913|FG001|STARTED|Blinded Phase (Up to 240 Weeks)||86
11175118|NCT01672879|12363914|FG002|STARTED|Blinded Phase (Up to 240 Weeks)||86
11175119|NCT01672879|12363912|FG000|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
11175120|NCT01672879|12363913|FG001|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
11175121|NCT01672879|12363914|FG002|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
11175122|NCT01672879|12363912|FG000|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87
11175123|NCT01672879|12363913|FG001|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
11175124|NCT01672879|12363914|FG002|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
11175125|NCT01672879|12363912|FG000|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
11175126|NCT01672879|12363913|FG001|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17
11175127|NCT01672879|12363914|FG002|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8
11175128|NCT01672879|12363912|FG000|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
11175129|NCT01672879|12363913|FG001|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
11175130|NCT01672879|12363914|FG002|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
11175131|NCT01672879|12363912|FG000|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15
11175132|NCT01672879|12363913|FG001|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17
11175133|NCT01672879|12363914|FG002|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8
11175134|NCT01672957|12363923|FG000|STARTED|Overall Study||128
11175135|NCT01672957|12363923|FG000|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
11175136|NCT01672957|12363923|FG000|COMPLETED|Overall Study||73
11175137|NCT01672957|12363923|FG000|NOT COMPLETED|Overall Study||55
11175138|NCT01672970|12363927|FG000|STARTED|Overall Study||291
11175139|NCT01672970|12363927|FG000|Treated|Overall Study||290
11175140|NCT01672970|12363927|FG000|COMPLETED|Overall Study||244
11175141|NCT01672970|12363927|FG000|NOT COMPLETED|Overall Study||47
11175142|NCT01672983|12363937|FG000|STARTED|Overall Study||18
11175143|NCT01672983|12363938|FG001|STARTED|Overall Study||18
11175144|NCT01672983|12363939|FG002|STARTED|Overall Study||19
11175145|NCT01672983|12363940|FG003|STARTED|Overall Study||18
11175146|NCT01672983|12363941|FG004|STARTED|Overall Study||19
11420312|NCT01574274|12619153|FG001|NOT COMPLETED|Overall Study||22
11420313|NCT01335399|12619161|FG000|STARTED|Pre-treatment Period||374
11175147|NCT01672983|12363942|FG005|STARTED|Overall Study||18
11175148|NCT01672983|12363937|FG000|Completed Study Drug|Overall Study||18
11175149|NCT01672983|12363938|FG001|Completed Study Drug|Overall Study||17
11175150|NCT01672983|12363939|FG002|Completed Study Drug|Overall Study||18
11175151|NCT01672983|12363940|FG003|Completed Study Drug|Overall Study||18
11175152|NCT01672983|12363941|FG004|Completed Study Drug|Overall Study||12
11175153|NCT01672983|12363942|FG005|Completed Study Drug|Overall Study||17
11175154|NCT01672983|12363937|FG000|COMPLETED|Overall Study||18
11175155|NCT01672983|12363938|FG001|COMPLETED|Overall Study||18
11175156|NCT01672983|12363939|FG002|COMPLETED|Overall Study||19
11175157|NCT01672983|12363940|FG003|COMPLETED|Overall Study||18
11175158|NCT01672983|12363941|FG004|COMPLETED|Overall Study||19
11175159|NCT01672983|12363942|FG005|COMPLETED|Overall Study||18
11175160|NCT01672983|12363937|FG000|NOT COMPLETED|Overall Study||0
11175161|NCT01672983|12363938|FG001|NOT COMPLETED|Overall Study||0
11175162|NCT01672983|12363939|FG002|NOT COMPLETED|Overall Study||0
11175163|NCT01672983|12363940|FG003|NOT COMPLETED|Overall Study||0
11175164|NCT01672983|12363941|FG004|NOT COMPLETED|Overall Study||0
11175165|NCT01672983|12363942|FG005|NOT COMPLETED|Overall Study||0
11175166|NCT01672996|12363971|FG000|STARTED|Overall Study||30
11175167|NCT01672996|12363972|FG001|STARTED|Overall Study||30
11175168|NCT01672996|12363973|FG002|STARTED|Overall Study||6
11175169|NCT01672996|12363971|FG000|COMPLETED|Overall Study||30
11175170|NCT01672996|12363972|FG001|COMPLETED|Overall Study||30
11175171|NCT01672996|12363973|FG002|COMPLETED|Overall Study||6
11175172|NCT01672996|12363971|FG000|NOT COMPLETED|Overall Study||0
11175173|NCT01672996|12363972|FG001|NOT COMPLETED|Overall Study||0
11175174|NCT01672996|12363973|FG002|NOT COMPLETED|Overall Study||0
11175175|NCT01673009|12363989|FG000|STARTED|Overall Study||36
11175176|NCT01673009|12363989|FG000|COMPLETED|Overall Study||23
11175177|NCT01673009|12363989|FG000|NOT COMPLETED|Overall Study||13
11203918|NCT01850030|12394485|FG001|NOT COMPLETED|Overall Study||369
11203919|NCT01850394|12394494|FG000|STARTED|Overall Study||45
11203920|NCT01850394|12394495|FG001|STARTED|Overall Study||45
11203921|NCT01850394|12394496|FG002|STARTED|Overall Study||45
11203922|NCT01850394|12394494|FG000|COMPLETED|Overall Study||45
11203923|NCT01850394|12394495|FG001|COMPLETED|Overall Study||45
11203924|NCT01850394|12394496|FG002|COMPLETED|Overall Study||45
11203925|NCT01850394|12394494|FG000|NOT COMPLETED|Overall Study||0
11203926|NCT01850394|12394495|FG001|NOT COMPLETED|Overall Study||0
11203927|NCT01850394|12394496|FG002|NOT COMPLETED|Overall Study||0
11203928|NCT01850446|12394506|FG000|STARTED|Overall Study||92
11203929|NCT01850446|12394507|FG001|STARTED|Overall Study||92
11203930|NCT01850446|12394506|FG000|COMPLETED|Overall Study||87
11203931|NCT01850446|12394507|FG001|COMPLETED|Overall Study||90
11203932|NCT01850446|12394506|FG000|NOT COMPLETED|Overall Study||5
11203933|NCT01850446|12394507|FG001|NOT COMPLETED|Overall Study||2
11203934|NCT01850485|12394515|FG000|STARTED|Overall Study||9
11203935|NCT01850485|12394516|FG001|STARTED|Overall Study||13
11203936|NCT01850485|12394515|FG000|COMPLETED|Overall Study||9
11203937|NCT01850485|12394516|FG001|COMPLETED|Overall Study||13
11203938|NCT01850485|12394515|FG000|NOT COMPLETED|Overall Study||0
11203939|NCT01850485|12394516|FG001|NOT COMPLETED|Overall Study||0
11203940|NCT01850550|12394524|FG000|STARTED|Overall Study||40
11203941|NCT01850550|12394525|FG001|STARTED|Overall Study||40
11203942|NCT01850550|12394524|FG000|COMPLETED|Overall Study||40
11203943|NCT01850550|12394525|FG001|COMPLETED|Overall Study||37
11203944|NCT01850550|12394524|FG000|NOT COMPLETED|Overall Study||0
11203945|NCT01850550|12394525|FG001|NOT COMPLETED|Overall Study||3
11203946|NCT01850589|12394533|FG000|STARTED|Overall Study||22
11203947|NCT01850589|12394534|FG001|STARTED|Overall Study||22
11203948|NCT01850589|12394533|FG000|COMPLETED|Overall Study||14
11203949|NCT01850589|12394534|FG001|COMPLETED|Overall Study||22
11203950|NCT01850589|12394533|FG000|NOT COMPLETED|Overall Study||8
11203951|NCT01850589|12394534|FG001|NOT COMPLETED|Overall Study||0
11203952|NCT01850602|12394542|FG000|STARTED|Overall Study||108
11203953|NCT01850602|12394543|FG001|STARTED|Overall Study||105
11203954|NCT01850602|12394542|FG000|COMPLETED|Overall Study||94
11203955|NCT01850602|12394543|FG001|COMPLETED|Overall Study||87
11203956|NCT01850602|12394542|FG000|NOT COMPLETED|Overall Study||14
11203957|NCT01850602|12394543|FG001|NOT COMPLETED|Overall Study||18
11203958|NCT01850615|12394551|FG000|STARTED|Overall Study||116
11203959|NCT01850615|12394552|FG001|STARTED|Overall Study||120
11203960|NCT01850615|12394551|FG000|Exposed|Overall Study||115
11203961|NCT01850615|12394552|FG001|Exposed|Overall Study||120
11203962|NCT01850615|12394551|FG000|COMPLETED|Overall Study||107
11203963|NCT01850615|12394552|FG001|COMPLETED|Overall Study||115
11203964|NCT01850615|12394551|FG000|NOT COMPLETED|Overall Study||9
11203965|NCT01850615|12394552|FG001|NOT COMPLETED|Overall Study||5
11203966|NCT01850641|12394558|FG000|STARTED|Overall Study||35
11203967|NCT01850641|12394558|FG000|COMPLETED|Overall Study||30
11203968|NCT01850641|12394558|FG000|NOT COMPLETED|Overall Study||5
11203969|NCT01850745|12394565|FG000|STARTED|Overall Study||147
11203970|NCT01850745|12394566|FG001|STARTED|Overall Study||169
11203971|NCT01850745|12394567|FG002|STARTED|Overall Study||131
11203972|NCT01850745|12394565|FG000|COMPLETED|Overall Study||147
11203973|NCT01850745|12394566|FG001|COMPLETED|Overall Study||169
11203974|NCT01850745|12394567|FG002|COMPLETED|Overall Study||131
11203975|NCT01850745|12394565|FG000|NOT COMPLETED|Overall Study||0
11203976|NCT01850745|12394566|FG001|NOT COMPLETED|Overall Study||0
11203977|NCT01850745|12394567|FG002|NOT COMPLETED|Overall Study||0
11203978|NCT01850823|12394578|FG000|STARTED|Overall Study||175
11203979|NCT01850823|12394579|FG001|STARTED|Overall Study||350
11175178|NCT01673022|12363993|FG000|STARTED|Overall Study||430
11175179|NCT01673022|12363993|FG000|COMPLETED|Overall Study||422
11175180|NCT01673022|12363993|FG000|NOT COMPLETED|Overall Study||8
11175181|NCT01673113|12363999|FG000|STARTED|Overall Study||11
11175182|NCT01673113|12364000|FG001|STARTED|Overall Study||11
11175183|NCT01673113|12363999|FG000|COMPLETED|Overall Study||11
11175184|NCT01673113|12364000|FG001|COMPLETED|Overall Study||11
11175185|NCT01673113|12363999|FG000|NOT COMPLETED|Overall Study||0
11175186|NCT01673113|12364000|FG001|NOT COMPLETED|Overall Study||0
11175187|NCT01673126|12364009|FG000|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
11175188|NCT01673126|12364010|FG001|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
11175189|NCT01673126|12364009|FG000|COMPLETED|Overall Study||32
11175190|NCT01673126|12364010|FG001|COMPLETED|Overall Study||23
11175191|NCT01673126|12364009|FG000|NOT COMPLETED|Overall Study||4
11175192|NCT01673126|12364010|FG001|NOT COMPLETED|Overall Study||3
11175193|NCT01673178|12364021|FG000|STARTED|Overall Study||22
11175194|NCT01673178|12364022|FG001|STARTED|Overall Study||21
11175195|NCT01673178|12364023|FG002|STARTED|Overall Study||21
11175196|NCT01673178|12364024|FG003|STARTED|Overall Study||22
11175197|NCT01673178|12364025|FG004|STARTED|Overall Study||21
11175198|NCT01673178|12364021|FG000|COMPLETED|Overall Study||19
11175199|NCT01673178|12364022|FG001|COMPLETED|Overall Study||19
11175200|NCT01673178|12364023|FG002|COMPLETED|Overall Study||18
11175201|NCT01673178|12364024|FG003|COMPLETED|Overall Study||14
11175202|NCT01673178|12364025|FG004|COMPLETED|Overall Study||19
11175203|NCT01673178|12364021|FG000|NOT COMPLETED|Overall Study||3
11175204|NCT01673178|12364022|FG001|NOT COMPLETED|Overall Study||2
11175205|NCT01673178|12364023|FG002|NOT COMPLETED|Overall Study||3
11175206|NCT01673178|12364024|FG003|NOT COMPLETED|Overall Study||8
11175207|NCT01673178|12364025|FG004|NOT COMPLETED|Overall Study||2
11175208|NCT01673191|12364043|FG000|STARTED|Overall Study||26
11175209|NCT01673191|12364044|FG001|STARTED|Overall Study||11
11175210|NCT01673191|12364043|FG000|COMPLETED|Overall Study||26
11175211|NCT01673191|12364044|FG001|COMPLETED|Overall Study||11
11175212|NCT01673191|12364043|FG000|NOT COMPLETED|Overall Study||0
11175213|NCT01673191|12364044|FG001|NOT COMPLETED|Overall Study||0
11175214|NCT01673256|12364050|FG000|STARTED|Overall Study||90
11175215|NCT01673256|12364050|FG000|COMPLETED|Overall Study||90
11175216|NCT01673256|12364050|FG000|NOT COMPLETED|Overall Study||0
11175217|NCT01673282|12364056|FG000|STARTED|Overall Study||153
11175218|NCT01673282|12364057|FG001|STARTED|Overall Study||158
11175219|NCT01673282|12364056|FG000|COMPLETED|Overall Study||120
11175220|NCT01673282|12364057|FG001|COMPLETED|Overall Study||132
11175221|NCT01673282|12364056|FG000|NOT COMPLETED|Overall Study||33
11175222|NCT01673282|12364057|FG001|NOT COMPLETED|Overall Study||26
11175223|NCT01673347|12364063|FG000|STARTED|Overall Study||24
11175224|NCT01673347|12364063|FG000|COMPLETED|Overall Study||17
11175225|NCT01673347|12364063|FG000|NOT COMPLETED|Overall Study||7
11175226|NCT01673373|12364067|FG000|STARTED|Overall Study||68
11175227|NCT01673373|12364067|FG000|COMPLETED|Overall Study|Completed primary endpoint follow up.|66
11175228|NCT01673373|12364067|FG000|NOT COMPLETED|Overall Study||2
11175229|NCT01673386|12364071|FG000|STARTED|Overall Study||27
11175230|NCT01673386|12364072|FG001|STARTED|Overall Study||31
11175231|NCT01673386|12364071|FG000|COMPLETED|Overall Study|Of 2 subjects, 1 subject discontinued tivozanib early, completed planned treatment with sunitinib.|2
11175232|NCT01673386|12364072|FG001|COMPLETED|Overall Study|Of 4 subjects, 3 subjects discontinued sunitinib early, completed planned treatment with tivozanib.|4
11175233|NCT01673386|12364071|FG000|NOT COMPLETED|Overall Study||25
11175234|NCT01673386|12364072|FG001|NOT COMPLETED|Overall Study||27
11175235|NCT01673490|12364078|FG000|STARTED|Overall Study||59
11175236|NCT01673490|12364078|FG000|COMPLETED|Overall Study||52
11175237|NCT01673490|12364078|FG000|NOT COMPLETED|Overall Study||7
11175238|NCT01673568|12364084|FG000|STARTED|Overall Study||28
11175239|NCT01673568|12364085|FG001|STARTED|Overall Study||28
11175240|NCT01673568|12364084|FG000|COMPLETED|Overall Study||28
11175241|NCT01673568|12364085|FG001|COMPLETED|Overall Study||28
11175242|NCT01673568|12364084|FG000|NOT COMPLETED|Overall Study||0
11175243|NCT01673568|12364085|FG001|NOT COMPLETED|Overall Study||0
11175244|NCT01673594|12364093|FG000|STARTED|Overall Study||18
11175245|NCT01673594|12364094|FG001|STARTED|Overall Study||19
11175246|NCT01673594|12364093|FG000|COMPLETED|Overall Study||12
11175247|NCT01673594|12364094|FG001|COMPLETED|Overall Study||13
11175248|NCT01673594|12364093|FG000|NOT COMPLETED|Overall Study||6
11175249|NCT01673594|12364094|FG001|NOT COMPLETED|Overall Study||6
11175250|NCT01673646|12364103|FG000|STARTED|Overall Study||11
11175251|NCT01673646|12364104|FG001|STARTED|Overall Study||11
11175252|NCT01673646|12364105|FG002|STARTED|Overall Study||11
11175253|NCT01673646|12364103|FG000|Entered/Treated in Core Phase|Overall Study||11
11175254|NCT01673646|12364104|FG001|Entered/Treated in Core Phase|Overall Study||11
11175255|NCT01673646|12364105|FG002|Entered/Treated in Core Phase|Overall Study||11
11175256|NCT01673646|12364103|FG000|Completed Core Phase|Overall Study||9
11175257|NCT01673646|12364104|FG001|Completed Core Phase|Overall Study||10
11175258|NCT01673646|12364105|FG002|Completed Core Phase|Overall Study||10
11175259|NCT01673646|12364103|FG000|Entered Ext. Phase|Overall Study||7
11175260|NCT01673646|12364104|FG001|Entered Ext. Phase|Overall Study||9
11175261|NCT01673646|12364105|FG002|Entered Ext. Phase|Overall Study||9
11175262|NCT01673646|12364103|FG000|Did Not Enter Ext. Phase|Overall Study||2
11175263|NCT01673646|12364104|FG001|Did Not Enter Ext. Phase|Overall Study||1
11175264|NCT01673646|12364105|FG002|Did Not Enter Ext. Phase|Overall Study||1
11175265|NCT01673646|12364103|FG000|Treated Beyond 24 Months|Overall Study||7
11175266|NCT01673646|12364104|FG001|Treated Beyond 24 Months|Overall Study||8
11175267|NCT01673646|12364105|FG002|Treated Beyond 24 Months|Overall Study||8
11175268|NCT01673646|12364103|FG000|Discontinued Beyond 24 Months|Overall Study||0
11175269|NCT01673646|12364104|FG001|Discontinued Beyond 24 Months|Overall Study||4
11175270|NCT01673646|12364105|FG002|Discontinued Beyond 24 Months|Overall Study||1
11175271|NCT01673646|12364103|FG000|COMPLETED|Overall Study||7
11175272|NCT01673646|12364104|FG001|COMPLETED|Overall Study||4
11175273|NCT01673646|12364105|FG002|COMPLETED|Overall Study||7
11175274|NCT01673646|12364103|FG000|NOT COMPLETED|Overall Study||4
11175275|NCT01673646|12364104|FG001|NOT COMPLETED|Overall Study||7
11175276|NCT01673646|12364105|FG002|NOT COMPLETED|Overall Study||4
11175277|NCT01673698|12364119|FG000|STARTED|Overall Study||187
11175278|NCT01673698|12364120|FG001|STARTED|Overall Study||139
11175279|NCT01673698|12364119|FG000|COMPLETED|Overall Study||136
11175280|NCT01673698|12364120|FG001|COMPLETED|Overall Study||126
11175281|NCT01673698|12364119|FG000|NOT COMPLETED|Overall Study||51
11175282|NCT01673698|12364120|FG001|NOT COMPLETED|Overall Study||13
11175283|NCT01673802|12364127|FG000|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
11175284|NCT01673802|12364127|FG000|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
11175285|NCT01673802|12364127|FG000|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
11175286|NCT01673802|12364127|FG000|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
11175287|NCT01673802|12364127|FG000|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
11175288|NCT01673802|12364127|FG000|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
11175289|NCT01673828|12364133|FG000|STARTED|Overall Study||7
11175290|NCT01673828|12364134|FG001|STARTED|Overall Study||6
11175291|NCT01673828|12364133|FG000|COMPLETED|Overall Study||7
11175292|NCT01673828|12364134|FG001|COMPLETED|Overall Study||6
11175293|NCT01673828|12364133|FG000|NOT COMPLETED|Overall Study||0
11175294|NCT01673828|12364134|FG001|NOT COMPLETED|Overall Study||0
11175295|NCT01673854|12364140|FG000|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
11175296|NCT01673854|12364140|FG000|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
11175297|NCT01673854|12364140|FG000|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
11175298|NCT01673854|12364140|FG000|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
11175299|NCT01673854|12364140|FG000|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
11175300|NCT01673854|12364140|FG000|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
11175301|NCT01673854|12364140|FG000|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
11175302|NCT01673854|12364140|FG000|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
11175303|NCT01673854|12364140|FG000|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
11175304|NCT01673893|12364146|FG000|STARTED|Overall Study||59
11175305|NCT01673893|12364146|FG000|COMPLETED|Overall Study||59
11175306|NCT01673893|12364146|FG000|NOT COMPLETED|Overall Study||0
11175307|NCT01673919|12364152|FG000|STARTED|Overall Study||7
11175308|NCT01673919|12364152|FG000|COMPLETED|Overall Study||7
11175309|NCT01673919|12364152|FG000|NOT COMPLETED|Overall Study||0
11175310|NCT01673984|12364158|FG000|STARTED|Overall Study||14
11175311|NCT01673984|12364159|FG001|STARTED|Overall Study||7
11175312|NCT01673984|12364158|FG000|COMPLETED|Overall Study||4
11175313|NCT01673984|12364159|FG001|COMPLETED|Overall Study||1
11175314|NCT01673984|12364158|FG000|NOT COMPLETED|Overall Study||10
11175315|NCT01673984|12364159|FG001|NOT COMPLETED|Overall Study||6
11175316|NCT01674010|12364165|FG000|STARTED|Open Treatment Phase 1||309
11175317|NCT01674010|12364166|FG001|STARTED|Open Treatment Phase 1||0
11175318|NCT01674010|12364167|FG002|STARTED|Open Treatment Phase 1||0
11175319|NCT01674010|12364165|FG000|COMPLETED|Open Treatment Phase 1||129
11175320|NCT01674010|12364166|FG001|COMPLETED|Open Treatment Phase 1||0
11175321|NCT01674010|12364167|FG002|COMPLETED|Open Treatment Phase 1||0
11175322|NCT01674010|12364165|FG000|NOT COMPLETED|Open Treatment Phase 1||180
11175323|NCT01674010|12364166|FG001|NOT COMPLETED|Open Treatment Phase 1||0
11175324|NCT01674010|12364167|FG002|NOT COMPLETED|Open Treatment Phase 1||0
11420314|NCT01335399|12619162|FG001|STARTED|Pre-treatment Period||374
11420315|NCT01335399|12619161|FG000|COMPLETED|Pre-treatment Period||371
11420316|NCT01335399|12619162|FG001|COMPLETED|Pre-treatment Period||371
11420317|NCT01335399|12619161|FG000|NOT COMPLETED|Pre-treatment Period||3
11420318|NCT01335399|12619162|FG001|NOT COMPLETED|Pre-treatment Period||3
11175325|NCT01674010|12364165|FG000|STARTED|Randomization Phase 2||0
11175326|NCT01674010|12364166|FG001|STARTED|Randomization Phase 2||65
11175327|NCT01674010|12364167|FG002|STARTED|Randomization Phase 2||64
11175328|NCT01674010|12364165|FG000|COMPLETED|Randomization Phase 2||0
11175329|NCT01674010|12364166|FG001|COMPLETED|Randomization Phase 2||3
11175330|NCT01674010|12364167|FG002|COMPLETED|Randomization Phase 2||3
11175331|NCT01674010|12364165|FG000|NOT COMPLETED|Randomization Phase 2||0
11175332|NCT01674010|12364166|FG001|NOT COMPLETED|Randomization Phase 2||62
11175333|NCT01674010|12364167|FG002|NOT COMPLETED|Randomization Phase 2||61
11175334|NCT01674062|12364177|FG000|STARTED|Overall Study||66
11175335|NCT01674062|12364178|FG001|STARTED|Overall Study||29
11175336|NCT01674062|12364177|FG000|COMPLETED|Overall Study||0
11175337|NCT01674062|12364178|FG001|COMPLETED|Overall Study||0
11175338|NCT01674062|12364177|FG000|NOT COMPLETED|Overall Study||66
11175339|NCT01674062|12364178|FG001|NOT COMPLETED|Overall Study||29
11175340|NCT01674478|12364186|FG000|STARTED|Overall Study||9
11175341|NCT01674478|12364187|FG001|STARTED|Overall Study||9
11175342|NCT01674478|12364186|FG000|COMPLETED|Overall Study||9
11175343|NCT01674478|12364187|FG001|COMPLETED|Overall Study||9
11175344|NCT01674478|12364186|FG000|NOT COMPLETED|Overall Study||0
11420319|NCT01335399|12619161|FG000|STARTED|Treatment Period||371
11175345|NCT01674478|12364187|FG001|NOT COMPLETED|Overall Study||0
11175346|NCT01674569|12364193|FG000|STARTED|Overall Study||3
11175347|NCT01674569|12364194|FG001|STARTED|Overall Study||8
11175348|NCT01674569|12364195|FG002|STARTED|Overall Study||4
11175349|NCT01674569|12364196|FG003|STARTED|Overall Study||10
11175350|NCT01674569|12364197|FG004|STARTED|Overall Study||7
11175351|NCT01674569|12364198|FG005|STARTED|Overall Study||3
11175352|NCT01674569|12364193|FG000|COMPLETED|Overall Study||3
11175353|NCT01674569|12364194|FG001|COMPLETED|Overall Study||5
11175354|NCT01674569|12364195|FG002|COMPLETED|Overall Study||2
11175355|NCT01674569|12364196|FG003|COMPLETED|Overall Study||9
11175356|NCT01674569|12364197|FG004|COMPLETED|Overall Study||5
11175357|NCT01674569|12364198|FG005|COMPLETED|Overall Study||1
11175358|NCT01674569|12364193|FG000|NOT COMPLETED|Overall Study||0
11175359|NCT01674569|12364194|FG001|NOT COMPLETED|Overall Study||3
11175360|NCT01674569|12364195|FG002|NOT COMPLETED|Overall Study||2
11175361|NCT01674569|12364196|FG003|NOT COMPLETED|Overall Study||1
11175362|NCT01674569|12364197|FG004|NOT COMPLETED|Overall Study||2
11175363|NCT01674569|12364198|FG005|NOT COMPLETED|Overall Study||2
11175364|NCT01674621|12364207|FG000|STARTED|Overall Study||50
11175365|NCT01674621|12364208|FG001|STARTED|Overall Study||51
11175366|NCT01674621|12364209|FG002|STARTED|Overall Study||48
11175367|NCT01674621|12364210|FG003|STARTED|Overall Study||51
11175368|NCT01674621|12364211|FG004|STARTED|Overall Study||50
11175369|NCT01674621|12364207|FG000|Modified Intent-to-Treat Population|Overall Study||47
11175370|NCT01674621|12364208|FG001|Modified Intent-to-Treat Population|Overall Study||46
11175371|NCT01674621|12364209|FG002|Modified Intent-to-Treat Population|Overall Study||43
11175372|NCT01674621|12364210|FG003|Modified Intent-to-Treat Population|Overall Study||49
11175373|NCT01674621|12364211|FG004|Modified Intent-to-Treat Population|Overall Study||46
11175374|NCT01674621|12364207|FG000|Safety Population|Overall Study||50
11175375|NCT01674621|12364208|FG001|Safety Population|Overall Study||51
11175376|NCT01674621|12364209|FG002|Safety Population|Overall Study||47
11175377|NCT01674621|12364210|FG003|Safety Population|Overall Study||51
11175378|NCT01674621|12364211|FG004|Safety Population|Overall Study||50
11175379|NCT01674621|12364207|FG000|COMPLETED|Overall Study||45
11175380|NCT01674621|12364208|FG001|COMPLETED|Overall Study||43
11175381|NCT01674621|12364209|FG002|COMPLETED|Overall Study||41
11175382|NCT01674621|12364210|FG003|COMPLETED|Overall Study||45
11175383|NCT01674621|12364211|FG004|COMPLETED|Overall Study||44
11175384|NCT01674621|12364207|FG000|NOT COMPLETED|Overall Study||5
11175385|NCT01674621|12364208|FG001|NOT COMPLETED|Overall Study||8
11175386|NCT01674621|12364209|FG002|NOT COMPLETED|Overall Study||7
11175387|NCT01674621|12364210|FG003|NOT COMPLETED|Overall Study||6
11175388|NCT01674621|12364211|FG004|NOT COMPLETED|Overall Study||6
11175389|NCT01674634|12364224|FG000|STARTED|Overall Study||715
11175390|NCT01674634|12364224|FG000|COMPLETED|Overall Study||709
11175391|NCT01674634|12364224|FG000|NOT COMPLETED|Overall Study||6
11175392|NCT01674647|12364234|FG000|STARTED|Treatment Period||1002
11175393|NCT01674647|12364235|FG001|STARTED|Treatment Period||502
11175394|NCT01674647|12364234|FG000|Subjects Received Treatment|Treatment Period||988
11175395|NCT01674647|12364235|FG001|Subjects Received Treatment|Treatment Period||499
11175396|NCT01674647|12364234|FG000|COMPLETED|Treatment Period||846
11175397|NCT01674647|12364235|FG001|COMPLETED|Treatment Period||400
11175398|NCT01674647|12364234|FG000|NOT COMPLETED|Treatment Period||156
11175399|NCT01674647|12364235|FG001|NOT COMPLETED|Treatment Period||102
11175400|NCT01674647|12364234|FG000|STARTED|30-day Safety Follow-up Period||982
11175401|NCT01674647|12364235|FG001|STARTED|30-day Safety Follow-up Period||487
11175402|NCT01674647|12364234|FG000|COMPLETED|30-day Safety Follow-up Period||924
11175403|NCT01674647|12364235|FG001|COMPLETED|30-day Safety Follow-up Period||446
11175404|NCT01674647|12364234|FG000|NOT COMPLETED|30-day Safety Follow-up Period||58
11175405|NCT01674647|12364235|FG001|NOT COMPLETED|30-day Safety Follow-up Period||41
11175406|NCT01674712|12364246|FG000|STARTED|Overall Study||114
11175407|NCT01674712|12364247|FG001|STARTED|Overall Study||117
11175408|NCT01674712|12364248|FG002|STARTED|Overall Study||115
11175409|NCT01674712|12364249|FG003|STARTED|Overall Study||116
11175410|NCT01674712|12364250|FG004|STARTED|Overall Study||113
11175411|NCT01674712|12364246|FG000|Full Analysis Subject Sample|Overall Study||109
11175412|NCT01674712|12364247|FG001|Full Analysis Subject Sample|Overall Study||114
11175413|NCT01674712|12364248|FG002|Full Analysis Subject Sample|Overall Study||110
11175414|NCT01674712|12364249|FG003|Full Analysis Subject Sample|Overall Study||112
11175415|NCT01674712|12364250|FG004|Full Analysis Subject Sample|Overall Study||111
11175416|NCT01674712|12364246|FG000|Safety Subject Sample|Overall Study||111
11175417|NCT01674712|12364247|FG001|Safety Subject Sample|Overall Study||117
11175418|NCT01674712|12364248|FG002|Safety Subject Sample|Overall Study||113
11175419|NCT01674712|12364249|FG003|Safety Subject Sample|Overall Study||115
11175420|NCT01674712|12364250|FG004|Safety Subject Sample|Overall Study||112
11175421|NCT01674712|12364246|FG000|COMPLETED|Overall Study||104
11175422|NCT01674712|12364247|FG001|COMPLETED|Overall Study||108
11175423|NCT01674712|12364248|FG002|COMPLETED|Overall Study||106
11175424|NCT01674712|12364249|FG003|COMPLETED|Overall Study||108
11175425|NCT01674712|12364250|FG004|COMPLETED|Overall Study||102
11175426|NCT01674712|12364246|FG000|NOT COMPLETED|Overall Study||10
11175427|NCT01674712|12364247|FG001|NOT COMPLETED|Overall Study||9
11175428|NCT01674712|12364248|FG002|NOT COMPLETED|Overall Study||9
11175429|NCT01674712|12364249|FG003|NOT COMPLETED|Overall Study||8
11175430|NCT01674712|12364250|FG004|NOT COMPLETED|Overall Study||11
11175431|NCT01674725|12364264|FG000|STARTED|Overall Study||92
11175432|NCT01674725|12364265|FG001|STARTED|Overall Study||95
11175433|NCT01674725|12364264|FG000|COMPLETED|Overall Study||89
11175434|NCT01674725|12364265|FG001|COMPLETED|Overall Study||94
11175435|NCT01674725|12364264|FG000|NOT COMPLETED|Overall Study||3
11175436|NCT01674725|12364265|FG001|NOT COMPLETED|Overall Study||1
11175437|NCT01675050|12364273|FG000|STARTED|Period One Treatment||2
11175438|NCT01675050|12364274|FG001|STARTED|Period One Treatment||2
11175439|NCT01675050|12364273|FG000|COMPLETED|Period One Treatment||1
11175440|NCT01675050|12364274|FG001|COMPLETED|Period One Treatment||2
11175441|NCT01675050|12364273|FG000|NOT COMPLETED|Period One Treatment||1
11175442|NCT01675050|12364274|FG001|NOT COMPLETED|Period One Treatment||0
11175443|NCT01675050|12364273|FG000|STARTED|Wash Out Period||1
11175444|NCT01675050|12364274|FG001|STARTED|Wash Out Period||2
11175445|NCT01675050|12364273|FG000|COMPLETED|Wash Out Period||1
11175446|NCT01675050|12364274|FG001|COMPLETED|Wash Out Period||2
11175447|NCT01675050|12364273|FG000|NOT COMPLETED|Wash Out Period||0
11175448|NCT01675050|12364274|FG001|NOT COMPLETED|Wash Out Period||0
11175449|NCT01675050|12364273|FG000|STARTED|Second Period Treatment||1
11175450|NCT01675050|12364274|FG001|STARTED|Second Period Treatment||2
11175451|NCT01675050|12364273|FG000|COMPLETED|Second Period Treatment||1
11175452|NCT01675050|12364274|FG001|COMPLETED|Second Period Treatment||2
11175453|NCT01675050|12364273|FG000|NOT COMPLETED|Second Period Treatment||0
11175454|NCT01675050|12364274|FG001|NOT COMPLETED|Second Period Treatment||0
11175455|NCT01675063|12364280|FG000|STARTED|Overall Study||77
11175456|NCT01675063|12364280|FG000|COMPLETED|Overall Study||77
11175457|NCT01675063|12364280|FG000|NOT COMPLETED|Overall Study||0
11175458|NCT01675128|12364287|FG000|STARTED|Overall Study||4
11175459|NCT01675128|12364288|FG001|STARTED|Overall Study||10
11175460|NCT01675128|12364289|FG002|STARTED|Overall Study||10
11175461|NCT01675128|12364287|FG000|COMPLETED|Overall Study||2
11175462|NCT01675128|12364288|FG001|COMPLETED|Overall Study||8
11175463|NCT01675128|12364289|FG002|COMPLETED|Overall Study||9
11175464|NCT01675128|12364287|FG000|NOT COMPLETED|Overall Study||2
11175465|NCT01675128|12364288|FG001|NOT COMPLETED|Overall Study||2
11175466|NCT01675128|12364289|FG002|NOT COMPLETED|Overall Study||1
11175467|NCT01675141|12364304|FG000|STARTED|Overall Study||11
11175468|NCT01675141|12364304|FG000|COMPLETED|Overall Study||0
11175469|NCT01675141|12364304|FG000|NOT COMPLETED|Overall Study||11
11175470|NCT01675154|12364312|FG000|STARTED|First Intervention Period (4 Weeks)||2
11175471|NCT01675154|12364313|FG001|STARTED|First Intervention Period (4 Weeks)||1
11175472|NCT01675154|12364314|FG002|STARTED|First Intervention Period (4 Weeks)||1
11175473|NCT01675154|12364315|FG003|STARTED|First Intervention Period (4 Weeks)||1
11175474|NCT01675154|12364312|FG000|COMPLETED|First Intervention Period (4 Weeks)||2
11175475|NCT01675154|12364313|FG001|COMPLETED|First Intervention Period (4 Weeks)||1
11175476|NCT01675154|12364314|FG002|COMPLETED|First Intervention Period (4 Weeks)||1
11175477|NCT01675154|12364315|FG003|COMPLETED|First Intervention Period (4 Weeks)||1
11175478|NCT01675154|12364312|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||0
11175479|NCT01675154|12364313|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||0
11175480|NCT01675154|12364314|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||0
11175481|NCT01675154|12364315|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||0
11420320|NCT01335399|12619162|FG001|STARTED|Treatment Period||371
11175482|NCT01675154|12364312|FG000|STARTED|First Washout Period (1 Week)|Subjects were enrolled Regimen 1|2
11175483|NCT01675154|12364313|FG001|STARTED|First Washout Period (1 Week)||1
11175484|NCT01675154|12364314|FG002|STARTED|First Washout Period (1 Week)||1
11175485|NCT01675154|12364315|FG003|STARTED|First Washout Period (1 Week)||1
11175486|NCT01675154|12364312|FG000|COMPLETED|First Washout Period (1 Week)||2
11175487|NCT01675154|12364313|FG001|COMPLETED|First Washout Period (1 Week)||1
11175488|NCT01675154|12364314|FG002|COMPLETED|First Washout Period (1 Week)||1
11175489|NCT01675154|12364315|FG003|COMPLETED|First Washout Period (1 Week)||1
11175490|NCT01675154|12364312|FG000|NOT COMPLETED|First Washout Period (1 Week)||0
11175491|NCT01675154|12364313|FG001|NOT COMPLETED|First Washout Period (1 Week)||0
11175492|NCT01675154|12364314|FG002|NOT COMPLETED|First Washout Period (1 Week)||0
11175493|NCT01675154|12364315|FG003|NOT COMPLETED|First Washout Period (1 Week)||0
11175494|NCT01675154|12364312|FG000|STARTED|Second Intervention Period (4 Weeks)||1
11175495|NCT01675154|12364313|FG001|STARTED|Second Intervention Period (4 Weeks)|Subjects were enrolled in Regimen 2|1
11175496|NCT01675154|12364314|FG002|STARTED|Second Intervention Period (4 Weeks)||1
11175497|NCT01675154|12364315|FG003|STARTED|Second Intervention Period (4 Weeks)||2
11175498|NCT01675154|12364312|FG000|COMPLETED|Second Intervention Period (4 Weeks)||0
11175499|NCT01675154|12364313|FG001|COMPLETED|Second Intervention Period (4 Weeks)||1
11175500|NCT01675154|12364314|FG002|COMPLETED|Second Intervention Period (4 Weeks)||1
11175501|NCT01675154|12364315|FG003|COMPLETED|Second Intervention Period (4 Weeks)||1
11175502|NCT01675154|12364312|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
11175503|NCT01675154|12364313|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
11175504|NCT01675154|12364314|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
11175505|NCT01675154|12364315|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
11175506|NCT01675154|12364312|FG000|STARTED|Second Washout Period (1 Week)||1
11175507|NCT01675154|12364313|FG001|STARTED|Second Washout Period (1 Week)||1
11175508|NCT01675154|12364314|FG002|STARTED|Second Washout Period (1 Week)||1
11175509|NCT01675154|12364315|FG003|STARTED|Second Washout Period (1 Week)||2
11175510|NCT01675154|12364312|FG000|COMPLETED|Second Washout Period (1 Week)||1
11175511|NCT01675154|12364313|FG001|COMPLETED|Second Washout Period (1 Week)||1
11175512|NCT01675154|12364314|FG002|COMPLETED|Second Washout Period (1 Week)||1
11175513|NCT01675154|12364315|FG003|COMPLETED|Second Washout Period (1 Week)||2
11175514|NCT01675154|12364312|FG000|NOT COMPLETED|Second Washout Period (1 Week)||0
11175515|NCT01675154|12364313|FG001|NOT COMPLETED|Second Washout Period (1 Week)||0
11175516|NCT01675154|12364314|FG002|NOT COMPLETED|Second Washout Period (1 Week)||0
11175517|NCT01675154|12364315|FG003|NOT COMPLETED|Second Washout Period (1 Week)||0
11175518|NCT01675154|12364312|FG000|STARTED|Third Intervention Period (4 Weeks)||1
11175519|NCT01675154|12364313|FG001|STARTED|Third Intervention Period (4 Weeks)||1
11175520|NCT01675154|12364314|FG002|STARTED|Third Intervention Period (4 Weeks)||1
11175521|NCT01675154|12364315|FG003|STARTED|Third Intervention Period (4 Weeks)||0
11175522|NCT01675154|12364312|FG000|COMPLETED|Third Intervention Period (4 Weeks)||1
11175523|NCT01675154|12364313|FG001|COMPLETED|Third Intervention Period (4 Weeks)||0
11175524|NCT01675154|12364314|FG002|COMPLETED|Third Intervention Period (4 Weeks)||1
11175525|NCT01675154|12364315|FG003|COMPLETED|Third Intervention Period (4 Weeks)||0
11175526|NCT01675154|12364312|FG000|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
11175527|NCT01675154|12364313|FG001|NOT COMPLETED|Third Intervention Period (4 Weeks)||1
11175528|NCT01675154|12364314|FG002|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
11175529|NCT01675154|12364315|FG003|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
11175530|NCT01675154|12364312|FG000|STARTED|Third Washout Period (1 Week)||1
11175531|NCT01675154|12364313|FG001|STARTED|Third Washout Period (1 Week)||0
11175532|NCT01675154|12364314|FG002|STARTED|Third Washout Period (1 Week)||1
11175533|NCT01675154|12364315|FG003|STARTED|Third Washout Period (1 Week)||0
11175534|NCT01675154|12364312|FG000|COMPLETED|Third Washout Period (1 Week)||1
11175535|NCT01675154|12364313|FG001|COMPLETED|Third Washout Period (1 Week)||0
11175536|NCT01675154|12364314|FG002|COMPLETED|Third Washout Period (1 Week)||1
11175537|NCT01675154|12364315|FG003|COMPLETED|Third Washout Period (1 Week)||0
11175538|NCT01675154|12364312|FG000|NOT COMPLETED|Third Washout Period (1 Week)||0
11175539|NCT01675154|12364313|FG001|NOT COMPLETED|Third Washout Period (1 Week)||0
11175540|NCT01675154|12364314|FG002|NOT COMPLETED|Third Washout Period (1 Week)||0
11175541|NCT01675154|12364315|FG003|NOT COMPLETED|Third Washout Period (1 Week)||0
11175542|NCT01675154|12364312|FG000|STARTED|Fourth Intervention Period (4 Weeks)||1
11175543|NCT01675154|12364313|FG001|STARTED|Fourth Intervention Period (4 Weeks)||0
11175544|NCT01675154|12364314|FG002|STARTED|Fourth Intervention Period (4 Weeks)||1
11175545|NCT01675154|12364315|FG003|STARTED|Fourth Intervention Period (4 Weeks)||0
11175546|NCT01675154|12364312|FG000|COMPLETED|Fourth Intervention Period (4 Weeks)||1
11175547|NCT01675154|12364313|FG001|COMPLETED|Fourth Intervention Period (4 Weeks)||0
11175548|NCT01675154|12364314|FG002|COMPLETED|Fourth Intervention Period (4 Weeks)||1
11175549|NCT01675154|12364315|FG003|COMPLETED|Fourth Intervention Period (4 Weeks)||0
11175550|NCT01675154|12364312|FG000|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
11175551|NCT01675154|12364313|FG001|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
11175552|NCT01675154|12364314|FG002|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
11175553|NCT01675154|12364315|FG003|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
11175554|NCT01675167|12364339|FG000|STARTED|Open-label Titration Phase||815
11175555|NCT01675167|12364340|FG001|STARTED|Open-label Titration Phase||0
11175556|NCT01675167|12364341|FG002|STARTED|Open-label Titration Phase||0
11175557|NCT01675167|12364339|FG000|COMPLETED|Open-label Titration Phase||511
11175558|NCT01675167|12364340|FG001|COMPLETED|Open-label Titration Phase||0
11175559|NCT01675167|12364341|FG002|COMPLETED|Open-label Titration Phase||0
11175560|NCT01675167|12364339|FG000|NOT COMPLETED|Open-label Titration Phase||304
11175561|NCT01675167|12364340|FG001|NOT COMPLETED|Open-label Titration Phase||0
11175562|NCT01675167|12364341|FG002|NOT COMPLETED|Open-label Titration Phase||0
11175563|NCT01675167|12364339|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
11175564|NCT01675167|12364340|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
11175565|NCT01675167|12364341|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
11175566|NCT01675167|12364339|FG000|COMPLETED|Double-blind Treatment Phase||0
11175567|NCT01675167|12364340|FG001|COMPLETED|Double-blind Treatment Phase||206
11175568|NCT01675167|12364341|FG002|COMPLETED|Double-blind Treatment Phase||147
11175569|NCT01675167|12364339|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
11175570|NCT01675167|12364340|FG001|NOT COMPLETED|Double-blind Treatment Phase||48
11175571|NCT01675167|12364341|FG002|NOT COMPLETED|Double-blind Treatment Phase||110
11175572|NCT01675297|12364351|FG000|STARTED|Overall Study||806
11175573|NCT01675297|12364352|FG001|STARTED|Overall Study||247
11175574|NCT01675297|12364351|FG000|COMPLETED|Overall Study||642
11175575|NCT01675297|12364352|FG001|COMPLETED|Overall Study||199
11175576|NCT01675297|12364351|FG000|NOT COMPLETED|Overall Study||164
11175577|NCT01675297|12364352|FG001|NOT COMPLETED|Overall Study||48
11175578|NCT01675427|12364358|FG000|STARTED|Overall Study||4766
11175579|NCT01675427|12364358|FG000|COMPLETED|Overall Study||4732
11175580|NCT01675427|12364358|FG000|NOT COMPLETED|Overall Study||34
11175581|NCT01675453|12364394|FG000|STARTED|Overall Study||20
11175582|NCT01675453|12364395|FG001|STARTED|Overall Study||20
11175583|NCT01675453|12364394|FG000|COMPLETED|Overall Study||20
11175584|NCT01675453|12364395|FG001|COMPLETED|Overall Study||20
11175585|NCT01675453|12364394|FG000|NOT COMPLETED|Overall Study||0
11175586|NCT01675453|12364395|FG001|NOT COMPLETED|Overall Study||0
11175587|NCT01675492|12364401|FG000|STARTED|Overall Study||84
11175588|NCT01675492|12364401|FG000|COMPLETED|Overall Study||42
11175589|NCT01675492|12364401|FG000|NOT COMPLETED|Overall Study||42
11175590|NCT01675531|12364406|FG000|STARTED|Overall Study||66
11175591|NCT01675531|12364406|FG000|COMPLETED|Overall Study||41
11175592|NCT01675531|12364406|FG000|NOT COMPLETED|Overall Study||25
11175593|NCT01675544|12364411|FG000|STARTED|Overall Study||46
11175594|NCT01675544|12364411|FG000|COMPLETED|Overall Study||44
11175595|NCT01675544|12364411|FG000|NOT COMPLETED|Overall Study||2
11175596|NCT01675596|12364415|FG000|STARTED|Overall Study|One patient did not receive the study device.|199
11175597|NCT01675596|12364415|FG000|COMPLETED|Overall Study||191
11175598|NCT01675596|12364415|FG000|NOT COMPLETED|Overall Study||8
11175599|NCT01675622|12364421|FG000|STARTED|Overall Study||122
11175600|NCT01675622|12364422|FG001|STARTED|Overall Study||120
11175601|NCT01675622|12364421|FG000|COMPLETED|Overall Study||96
11175602|NCT01675622|12364422|FG001|COMPLETED|Overall Study||96
11175603|NCT01675622|12364421|FG000|NOT COMPLETED|Overall Study||26
11175604|NCT01675622|12364422|FG001|NOT COMPLETED|Overall Study||24
11175605|NCT01675635|12364430|FG000|STARTED|Overall Study||117
11175606|NCT01675635|12364431|FG001|STARTED|Overall Study||117
11175607|NCT01675635|12364430|FG000|COMPLETED|Overall Study||117
11175608|NCT01675635|12364431|FG001|COMPLETED|Overall Study||117
11175609|NCT01675635|12364430|FG000|NOT COMPLETED|Overall Study||0
11175610|NCT01675635|12364431|FG001|NOT COMPLETED|Overall Study||0
11175611|NCT01675661|12364444|FG000|STARTED|Overall Study||153
11175612|NCT01675661|12364445|FG001|STARTED|Overall Study||149
11175613|NCT01675661|12364444|FG000|COMPLETED|Overall Study||113
11175614|NCT01675661|12364445|FG001|COMPLETED|Overall Study||103
11175615|NCT01675661|12364444|FG000|NOT COMPLETED|Overall Study||40
11175616|NCT01675661|12364445|FG001|NOT COMPLETED|Overall Study||46
11175617|NCT01675765|12364453|FG000|STARTED|Overall Study||38
11175618|NCT01675765|12364454|FG001|STARTED|Overall Study||22
11175619|NCT01675765|12364453|FG000|COMPLETED|Overall Study||27
11175620|NCT01675765|12364454|FG001|COMPLETED|Overall Study||14
11175621|NCT01675765|12364453|FG000|NOT COMPLETED|Overall Study||11
11175622|NCT01675765|12364454|FG001|NOT COMPLETED|Overall Study||8
11175623|NCT01675778|12364460|FG000|STARTED|Overall Study||174
11175624|NCT01675778|12364460|FG000|COMPLETED|Overall Study||174
11175625|NCT01675778|12364460|FG000|NOT COMPLETED|Overall Study||0
11175626|NCT01675830|12364465|FG000|STARTED|Overall Study||10
11175627|NCT01675830|12364465|FG000|COMPLETED|Overall Study||10
11175628|NCT01675830|12364465|FG000|NOT COMPLETED|Overall Study||0
11175629|NCT01675882|12364473|FG000|STARTED|Overall Study||53
11175630|NCT01675882|12364474|FG001|STARTED|Overall Study||56
11175631|NCT01675882|12364475|FG002|STARTED|Overall Study||56
11175632|NCT01675882|12364476|FG003|STARTED|Overall Study||56
11175633|NCT01675882|12364473|FG000|COMPLETED|Overall Study||51
11175634|NCT01675882|12364474|FG001|COMPLETED|Overall Study||49
11175635|NCT01675882|12364475|FG002|COMPLETED|Overall Study||53
11175636|NCT01675882|12364476|FG003|COMPLETED|Overall Study||54
11175637|NCT01675882|12364473|FG000|NOT COMPLETED|Overall Study||2
11175638|NCT01675882|12364474|FG001|NOT COMPLETED|Overall Study||7
11175639|NCT01675882|12364475|FG002|NOT COMPLETED|Overall Study||3
11175640|NCT01675882|12364476|FG003|NOT COMPLETED|Overall Study||2
11175641|NCT01676012|12364486|FG000|STARTED|Overall Study||32
11175642|NCT01676012|12364486|FG000|COMPLETED|Overall Study||29
11175643|NCT01676012|12364486|FG000|NOT COMPLETED|Overall Study||3
11175644|NCT01676116|12364492|FG000|STARTED|Overall Study||292
11175645|NCT01676116|12364493|FG001|STARTED|Overall Study||146
11175646|NCT01676116|12364492|FG000|COMPLETED|Overall Study||276
11175647|NCT01676116|12364493|FG001|COMPLETED|Overall Study||117
11175648|NCT01676116|12364492|FG000|NOT COMPLETED|Overall Study||16
11175649|NCT01676116|12364493|FG001|NOT COMPLETED|Overall Study||29
11175650|NCT01676220|12364501|FG000|STARTED|Overall Study||439
11175651|NCT01676220|12364502|FG001|STARTED|Overall Study||439
11175652|NCT01676220|12364501|FG000|Treated|Overall Study||435
11175653|NCT01676220|12364502|FG001|Treated|Overall Study||438
11175654|NCT01676220|12364501|FG000|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|432
11175655|NCT01676220|12364502|FG001|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|430
11175656|NCT01676220|12364501|FG000|COMPLETED|Overall Study||337
11175657|NCT01676220|12364502|FG001|COMPLETED|Overall Study||314
11175658|NCT01676220|12364501|FG000|NOT COMPLETED|Overall Study||102
11175659|NCT01676220|12364502|FG001|NOT COMPLETED|Overall Study||125
11175660|NCT01676298|12364518|FG000|STARTED|Overall Study||1
11175661|NCT01676298|12364519|FG001|STARTED|Overall Study||1
11175662|NCT01676298|12364520|FG002|STARTED|Overall Study||1
11175663|NCT01676298|12364521|FG003|STARTED|Overall Study||1
11175664|NCT01676298|12364522|FG004|STARTED|Overall Study||1
11175665|NCT01676298|12364523|FG005|STARTED|Overall Study||1
11175666|NCT01676298|12364524|FG006|STARTED|Overall Study||1
11175667|NCT01676298|12364525|FG007|STARTED|Overall Study||1
11175668|NCT01676298|12364518|FG000|All Genotypes Confirmed With Reference|Overall Study||1
11175669|NCT01676298|12364519|FG001|All Genotypes Confirmed With Reference|Overall Study||1
11175670|NCT01676298|12364520|FG002|All Genotypes Confirmed With Reference|Overall Study||1
11175671|NCT01676298|12364521|FG003|All Genotypes Confirmed With Reference|Overall Study||1
11175672|NCT01676298|12364522|FG004|All Genotypes Confirmed With Reference|Overall Study||1
11175673|NCT01676298|12364523|FG005|All Genotypes Confirmed With Reference|Overall Study||1
11175674|NCT01676298|12364524|FG006|All Genotypes Confirmed With Reference|Overall Study||1
11175675|NCT01676298|12364525|FG007|All Genotypes Confirmed With Reference|Overall Study||1
11175676|NCT01676298|12364518|FG000|Participated in All Tests|Overall Study||1
11175677|NCT01676298|12364519|FG001|Participated in All Tests|Overall Study||1
11175678|NCT01676298|12364520|FG002|Participated in All Tests|Overall Study||1
11175679|NCT01676298|12364521|FG003|Participated in All Tests|Overall Study||1
11175680|NCT01676298|12364522|FG004|Participated in All Tests|Overall Study||1
11175681|NCT01676298|12364523|FG005|Participated in All Tests|Overall Study||1
11175682|NCT01676298|12364524|FG006|Participated in All Tests|Overall Study||1
11175683|NCT01676298|12364525|FG007|Participated in All Tests|Overall Study||1
11175684|NCT01676298|12364518|FG000|COMPLETED|Overall Study||1
11175685|NCT01676298|12364519|FG001|COMPLETED|Overall Study||1
11175686|NCT01676298|12364520|FG002|COMPLETED|Overall Study||1
11175687|NCT01676298|12364521|FG003|COMPLETED|Overall Study||1
11175688|NCT01676298|12364522|FG004|COMPLETED|Overall Study||1
11175689|NCT01676298|12364523|FG005|COMPLETED|Overall Study||1
11175690|NCT01676298|12364524|FG006|COMPLETED|Overall Study||1
11175691|NCT01676298|12364525|FG007|COMPLETED|Overall Study||1
11175692|NCT01676298|12364518|FG000|NOT COMPLETED|Overall Study||0
11175693|NCT01676298|12364519|FG001|NOT COMPLETED|Overall Study||0
11175694|NCT01676298|12364520|FG002|NOT COMPLETED|Overall Study||0
11175695|NCT01676298|12364521|FG003|NOT COMPLETED|Overall Study||0
11175696|NCT01676298|12364522|FG004|NOT COMPLETED|Overall Study||0
11175697|NCT01676298|12364523|FG005|NOT COMPLETED|Overall Study||0
11175698|NCT01676298|12364524|FG006|NOT COMPLETED|Overall Study||0
11175699|NCT01676298|12364525|FG007|NOT COMPLETED|Overall Study||0
11175700|NCT01676311|12364545|FG000|STARTED|Overall Study||7
11175701|NCT01676311|12364546|FG001|STARTED|Overall Study||7
11175702|NCT01676311|12364545|FG000|COMPLETED|Overall Study||7
11175703|NCT01676311|12364546|FG001|COMPLETED|Overall Study||5
11175704|NCT01676311|12364545|FG000|NOT COMPLETED|Overall Study||0
11175705|NCT01676311|12364546|FG001|NOT COMPLETED|Overall Study||2
11175706|NCT01676415|12364554|FG000|STARTED|Overall Study||4
11175707|NCT01676415|12364555|FG001|STARTED|Overall Study||5
11175708|NCT01676415|12364554|FG000|COMPLETED|Overall Study||4
11175709|NCT01676415|12364555|FG001|COMPLETED|Overall Study||5
11175710|NCT01676415|12364554|FG000|NOT COMPLETED|Overall Study||0
11175711|NCT01676415|12364555|FG001|NOT COMPLETED|Overall Study||0
11175712|NCT01676532|12364561|FG000|STARTED|Overall Study||127
11175713|NCT01676532|12364561|FG000|COMPLETED|Overall Study||127
11175714|NCT01676532|12364561|FG000|NOT COMPLETED|Overall Study||0
11175715|NCT01676714|12364570|FG000|STARTED|Overall Study||10
11175716|NCT01676714|12364570|FG000|COMPLETED|Overall Study||10
11175717|NCT01676714|12364570|FG000|NOT COMPLETED|Overall Study||0
11175718|NCT01676727|12364575|FG000|STARTED|Overall Study||100
11175719|NCT01676727|12364575|FG000|Implanted|Overall Study||92
11175720|NCT01676727|12364575|FG000|COMPLETED|Overall Study||68
11175721|NCT01676727|12364575|FG000|NOT COMPLETED|Overall Study||32
11175722|NCT01676831|12364582|FG000|STARTED|Overall Study||8
11175723|NCT01676831|12364583|FG001|STARTED|Overall Study||5
11175724|NCT01676831|12364582|FG000|COMPLETED|Overall Study||8
11175725|NCT01676831|12364583|FG001|COMPLETED|Overall Study||4
11175726|NCT01676831|12364582|FG000|NOT COMPLETED|Overall Study||0
11175727|NCT01676831|12364583|FG001|NOT COMPLETED|Overall Study||1
11175728|NCT01676896|12364592|FG000|STARTED|Overall Study||96
11175729|NCT01676896|12364593|FG001|STARTED|Overall Study||96
11175730|NCT01676896|12364594|FG002|STARTED|Overall Study||100
11175731|NCT01676896|12364592|FG000|COMPLETED|Overall Study||84
11175732|NCT01676896|12364593|FG001|COMPLETED|Overall Study||89
11175733|NCT01676896|12364594|FG002|COMPLETED|Overall Study||81
11175734|NCT01676896|12364592|FG000|NOT COMPLETED|Overall Study||12
11175735|NCT01676896|12364593|FG001|NOT COMPLETED|Overall Study||7
11175736|NCT01676896|12364594|FG002|NOT COMPLETED|Overall Study||19
11175737|NCT01676909|12364604|FG000|STARTED|Overall Study||124
11175738|NCT01676909|12364605|FG001|STARTED|Overall Study||118
11175739|NCT01676909|12364604|FG000|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105
11175740|NCT01676909|12364605|FG001|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107
11175741|NCT01676909|12364604|FG000|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106
11175742|NCT01676909|12364605|FG001|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104
11175743|NCT01676909|12364604|FG000|NOT COMPLETED|Overall Study||18
11175744|NCT01676909|12364605|FG001|NOT COMPLETED|Overall Study||14
11175745|NCT01677182|12364616|FG000|STARTED|Overall Study||184
11175746|NCT01677182|12364617|FG001|STARTED|Overall Study||169
11175747|NCT01677182|12364618|FG002|STARTED|Overall Study||182
11175748|NCT01677182|12364616|FG000|COMPLETED|Overall Study||150
11175749|NCT01677182|12364617|FG001|COMPLETED|Overall Study||141
11175750|NCT01677182|12364618|FG002|COMPLETED|Overall Study||143
11175751|NCT01677182|12364616|FG000|NOT COMPLETED|Overall Study||34
11175752|NCT01677182|12364617|FG001|NOT COMPLETED|Overall Study||28
11175753|NCT01677182|12364618|FG002|NOT COMPLETED|Overall Study||39
11175754|NCT01677195|12364629|FG000|STARTED|Overall Study||71
11175755|NCT01677195|12364630|FG001|STARTED|Overall Study||83
11175756|NCT01677195|12364631|FG002|STARTED|Overall Study||80
11175757|NCT01677195|12364629|FG000|COMPLETED|Overall Study||42
11175758|NCT01677195|12364630|FG001|COMPLETED|Overall Study||51
11175759|NCT01677195|12364631|FG002|COMPLETED|Overall Study||50
11175760|NCT01677195|12364629|FG000|NOT COMPLETED|Overall Study||29
11175761|NCT01677195|12364630|FG001|NOT COMPLETED|Overall Study||32
11175762|NCT01677195|12364631|FG002|NOT COMPLETED|Overall Study||30
11175763|NCT01677286|12364639|FG000|STARTED|Overall Study||25
11175764|NCT01677286|12364639|FG000|COMPLETED|Overall Study||14
11175765|NCT01677286|12364639|FG000|NOT COMPLETED|Overall Study||11
11175766|NCT01677299|12364649|FG000|STARTED|Overall Study||6
11175767|NCT01677299|12364650|FG001|STARTED|Overall Study||6
11175768|NCT01677299|12364651|FG002|STARTED|Overall Study||6
11175769|NCT01677299|12364652|FG003|STARTED|Overall Study||6
11175770|NCT01677299|12364649|FG000|COMPLETED|Overall Study||6
11175771|NCT01677299|12364650|FG001|COMPLETED|Overall Study||3
11175772|NCT01677299|12364651|FG002|COMPLETED|Overall Study||5
11175773|NCT01677299|12364652|FG003|COMPLETED|Overall Study||5
11175774|NCT01677299|12364649|FG000|NOT COMPLETED|Overall Study||0
11175775|NCT01677299|12364650|FG001|NOT COMPLETED|Overall Study||3
11175776|NCT01677299|12364651|FG002|NOT COMPLETED|Overall Study||1
11175777|NCT01677299|12364652|FG003|NOT COMPLETED|Overall Study||1
11175778|NCT01677312|12364668|FG000|STARTED|Overall Study||36
11175779|NCT01677312|12364669|FG001|STARTED|Overall Study||36
11175780|NCT01677312|12364668|FG000|COMPLETED|Overall Study||36
11175781|NCT01677312|12364669|FG001|COMPLETED|Overall Study||36
11175782|NCT01677312|12364668|FG000|NOT COMPLETED|Overall Study||0
11175783|NCT01677312|12364669|FG001|NOT COMPLETED|Overall Study||0
11175784|NCT01677377|12364678|FG000|STARTED|Overall Study||15
11175785|NCT01677377|12364679|FG001|STARTED|Overall Study||15
11175786|NCT01677377|12364680|FG002|STARTED|Overall Study||15
11175787|NCT01677377|12364678|FG000|COMPLETED|Overall Study||14
11175788|NCT01677377|12364679|FG001|COMPLETED|Overall Study||14
11175789|NCT01677377|12364680|FG002|COMPLETED|Overall Study||9
11175790|NCT01677377|12364678|FG000|NOT COMPLETED|Overall Study||1
11175791|NCT01677377|12364679|FG001|NOT COMPLETED|Overall Study||1
11175792|NCT01677377|12364680|FG002|NOT COMPLETED|Overall Study||6
11175793|NCT01677507|12364688|FG000|STARTED|Initial Assignment||63
11175794|NCT01677507|12364689|FG001|STARTED|Initial Assignment||58
11175795|NCT01677507|12364688|FG000|COMPLETED|Initial Assignment||63
11175796|NCT01677507|12364689|FG001|COMPLETED|Initial Assignment||56
11175797|NCT01677507|12364688|FG000|NOT COMPLETED|Initial Assignment||0
11175798|NCT01677507|12364689|FG001|NOT COMPLETED|Initial Assignment||2
11175799|NCT01677507|12364688|FG000|STARTED|Second Assigment||63
11175800|NCT01677507|12364689|FG001|STARTED|Second Assigment||56
11175801|NCT01677507|12364688|FG000|COMPLETED|Second Assigment||60
11175802|NCT01677507|12364689|FG001|COMPLETED|Second Assigment||51
11175803|NCT01677507|12364688|FG000|NOT COMPLETED|Second Assigment||3
11175804|NCT01677507|12364689|FG001|NOT COMPLETED|Second Assigment||5
11175805|NCT01677624|12364697|FG000|STARTED|Overall Study||28
11175806|NCT01677624|12364697|FG000|COMPLETED|Overall Study||27
11175807|NCT01677624|12364697|FG000|NOT COMPLETED|Overall Study||1
11175808|NCT01677741|12364709|FG000|STARTED|Overall Study||3
11175809|NCT01677741|12364710|FG001|STARTED|Overall Study||10
11175810|NCT01677741|12364711|FG002|STARTED|Overall Study||8
11175811|NCT01677741|12364712|FG003|STARTED|Overall Study||6
11175812|NCT01677741|12364713|FG004|STARTED|Overall Study||17
11175813|NCT01677741|12364714|FG005|STARTED|Overall Study||28
11175814|NCT01677741|12364715|FG006|STARTED|Overall Study||11
11175815|NCT01677741|12364716|FG007|STARTED|Overall Study||2
11175816|NCT01677741|12364709|FG000|DLT Evaluable Population|Overall Study||3
11175817|NCT01677741|12364710|FG001|DLT Evaluable Population|Overall Study||10
11175818|NCT01677741|12364711|FG002|DLT Evaluable Population|Overall Study||8
11175819|NCT01677741|12364712|FG003|DLT Evaluable Population|Overall Study||6
11175820|NCT01677741|12364713|FG004|DLT Evaluable Population|Overall Study||0
11175821|NCT01677741|12364714|FG005|DLT Evaluable Population|Overall Study||0
11175822|NCT01677741|12364715|FG006|DLT Evaluable Population|Overall Study||0
11175823|NCT01677741|12364716|FG007|DLT Evaluable Population|Overall Study||0
11175824|NCT01677741|12364709|FG000|PK Population|Overall Study||3
11175825|NCT01677741|12364710|FG001|PK Population|Overall Study||10
11175826|NCT01677741|12364711|FG002|PK Population|Overall Study||8
11175827|NCT01677741|12364712|FG003|PK Population|Overall Study||6
11175828|NCT01677741|12364713|FG004|PK Population|Overall Study||17
11175829|NCT01677741|12364714|FG005|PK Population|Overall Study||28
11175830|NCT01677741|12364715|FG006|PK Population|Overall Study||11
11175831|NCT01677741|12364716|FG007|PK Population|Overall Study||2
11175832|NCT01677741|12364709|FG000|COMPLETED|Overall Study||0
11175833|NCT01677741|12364710|FG001|COMPLETED|Overall Study||0
11175834|NCT01677741|12364711|FG002|COMPLETED|Overall Study||0
11175835|NCT01677741|12364712|FG003|COMPLETED|Overall Study||0
11175836|NCT01677741|12364713|FG004|COMPLETED|Overall Study||0
11175837|NCT01677741|12364714|FG005|COMPLETED|Overall Study||0
11175838|NCT01677741|12364715|FG006|COMPLETED|Overall Study||0
11175839|NCT01677741|12364716|FG007|COMPLETED|Overall Study||0
11175840|NCT01677741|12364709|FG000|NOT COMPLETED|Overall Study||3
11175841|NCT01677741|12364710|FG001|NOT COMPLETED|Overall Study||10
11175842|NCT01677741|12364711|FG002|NOT COMPLETED|Overall Study||8
11175843|NCT01677741|12364712|FG003|NOT COMPLETED|Overall Study||6
11175844|NCT01677741|12364713|FG004|NOT COMPLETED|Overall Study||17
11175845|NCT01677741|12364714|FG005|NOT COMPLETED|Overall Study||28
11175846|NCT01677741|12364715|FG006|NOT COMPLETED|Overall Study||11
11175847|NCT01677741|12364716|FG007|NOT COMPLETED|Overall Study||2
11175848|NCT01677767|12364750|FG000|STARTED|Overall Study||124
11175849|NCT01677767|12364750|FG000|COMPLETED|Overall Study||102
11175850|NCT01677767|12364750|FG000|NOT COMPLETED|Overall Study||22
11175851|NCT01677910|12364759|FG000|STARTED|Double-Blind Treatment Period||45
11175852|NCT01677910|12364760|FG001|STARTED|Double-Blind Treatment Period||45
11175853|NCT01677910|12364761|FG002|STARTED|Double-Blind Treatment Period||45
11175854|NCT01677910|12364762|FG003|STARTED|Double-Blind Treatment Period||0
11175855|NCT01677910|12364759|FG000|COMPLETED|Double-Blind Treatment Period||38
11175856|NCT01677910|12364760|FG001|COMPLETED|Double-Blind Treatment Period||42
11175857|NCT01677910|12364761|FG002|COMPLETED|Double-Blind Treatment Period||38
11175858|NCT01677910|12364762|FG003|COMPLETED|Double-Blind Treatment Period||0
11175859|NCT01677910|12364759|FG000|NOT COMPLETED|Double-Blind Treatment Period||7
11175860|NCT01677910|12364760|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
11175861|NCT01677910|12364761|FG002|NOT COMPLETED|Double-Blind Treatment Period||7
11175862|NCT01677910|12364762|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
11175863|NCT01677910|12364759|FG000|STARTED|Open-Label Extension Period (OLE)||0
11175864|NCT01677910|12364760|FG001|STARTED|Open-Label Extension Period (OLE)||0
11175865|NCT01677910|12364761|FG002|STARTED|Open-Label Extension Period (OLE)||0
11175866|NCT01677910|12364762|FG003|STARTED|Open-Label Extension Period (OLE)||115
11175867|NCT01677910|12364759|FG000|COMPLETED|Open-Label Extension Period (OLE)||0
11175868|NCT01677910|12364760|FG001|COMPLETED|Open-Label Extension Period (OLE)||0
11175869|NCT01677910|12364761|FG002|COMPLETED|Open-Label Extension Period (OLE)||0
11175870|NCT01677910|12364762|FG003|COMPLETED|Open-Label Extension Period (OLE)||79
11175871|NCT01677910|12364759|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0
11175872|NCT01677910|12364760|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0
11175873|NCT01677910|12364761|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0
11175874|NCT01677910|12364762|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||36
11175875|NCT01677936|12364774|FG000|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
11175876|NCT01677936|12364775|FG001|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
11175877|NCT01677936|12364774|FG000|COMPLETED|Overall Study|Full analysis dataset completers|22
11175878|NCT01677936|12364775|FG001|COMPLETED|Overall Study|Full analysis dataset completers|15
11175879|NCT01677936|12364774|FG000|NOT COMPLETED|Overall Study||9
11175880|NCT01677936|12364775|FG001|NOT COMPLETED|Overall Study||5
11175881|NCT01677988|12364781|FG000|STARTED|Overall Study||3
11175882|NCT01677988|12364781|FG000|COMPLETED|Overall Study||1
11175883|NCT01677988|12364781|FG000|NOT COMPLETED|Overall Study||2
11175884|NCT01678144|12364786|FG000|STARTED|Stage 1: MAR Classic||7
11175885|NCT01678144|12364786|FG000|COMPLETED|Stage 1: MAR Classic||6
11175886|NCT01678144|12364786|FG000|NOT COMPLETED|Stage 1: MAR Classic||1
11175887|NCT01678144|12364786|FG000|STARTED|Stage 2: MAR Regular and MAR Expanded||5
11175888|NCT01678144|12364786|FG000|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5
11175889|NCT01678144|12364786|FG000|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0
11175890|NCT01678196|12364792|FG000|STARTED|Overall Study||34
11175891|NCT01678196|12364793|FG001|STARTED|Overall Study||32
11175892|NCT01678196|12364792|FG000|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
11323931|NCT02739594|12521248|FG000|NOT COMPLETED|Overall Study||25
11323932|NCT02739594|12521249|FG001|NOT COMPLETED|Overall Study||28
11323933|NCT02739698|12521258|FG000|STARTED|Overall Study||22
11323934|NCT02739698|12521259|FG001|STARTED|Overall Study||21
11323935|NCT02739698|12521258|FG000|COMPLETED|Overall Study||16
11323936|NCT02739698|12521259|FG001|COMPLETED|Overall Study||16
11323937|NCT02739698|12521258|FG000|NOT COMPLETED|Overall Study||6
11323938|NCT02739698|12521259|FG001|NOT COMPLETED|Overall Study||5
11323939|NCT02739789|12521267|FG000|STARTED|First fMRI Scan||9
11323940|NCT02739789|12521268|FG001|STARTED|First fMRI Scan||10
11323941|NCT02739789|12521267|FG000|COMPLETED|First fMRI Scan||9
11323942|NCT02739789|12521268|FG001|COMPLETED|First fMRI Scan||10
11323943|NCT02739789|12521267|FG000|NOT COMPLETED|First fMRI Scan||0
11323944|NCT02739789|12521268|FG001|NOT COMPLETED|First fMRI Scan||0
11323945|NCT02739789|12521267|FG000|STARTED|~1 Week Waiting Period||9
11420321|NCT01335399|12619161|FG000|COMPLETED|Treatment Period||0
11420322|NCT01335399|12619162|FG001|COMPLETED|Treatment Period||0
11420323|NCT01335399|12619161|FG000|NOT COMPLETED|Treatment Period||371
11420324|NCT01335399|12619162|FG001|NOT COMPLETED|Treatment Period||371
11420325|NCT01036087|12619168|FG000|STARTED|Overall Study||40
11420326|NCT01036087|12619168|FG000|COMPLETED|Overall Study||37
11420327|NCT01036087|12619168|FG000|NOT COMPLETED|Overall Study||3
11420328|NCT00608023|12619175|FG000|STARTED|Overall Study||92
11420329|NCT00608023|12619176|FG001|STARTED|Overall Study||85
11420330|NCT00608023|12619177|FG002|STARTED|Overall Study||86
11420331|NCT00608023|12619175|FG000|COMPLETED|Overall Study||80
11420332|NCT00608023|12619176|FG001|COMPLETED|Overall Study||63
11420333|NCT00608023|12619177|FG002|COMPLETED|Overall Study||72
11175893|NCT01678196|12364793|FG001|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
11175894|NCT01678196|12364792|FG000|NOT COMPLETED|Overall Study||0
11175895|NCT01678196|12364793|FG001|NOT COMPLETED|Overall Study||0
11175896|NCT01678209|12364802|FG000|STARTED|Overall Study||47
11175897|NCT01678209|12364803|FG001|STARTED|Overall Study||40
11175898|NCT01678209|12364804|FG002|STARTED|Overall Study||40
11175899|NCT01678209|12364802|FG000|COMPLETED|Overall Study||30
11175900|NCT01678209|12364803|FG001|COMPLETED|Overall Study||22
11175901|NCT01678209|12364804|FG002|COMPLETED|Overall Study||22
11175902|NCT01678209|12364802|FG000|NOT COMPLETED|Overall Study||17
11175903|NCT01678209|12364803|FG001|NOT COMPLETED|Overall Study||18
11175904|NCT01678209|12364804|FG002|NOT COMPLETED|Overall Study||18
11175905|NCT01678313|12364814|FG000|STARTED|Completed the 3-month Therapy||70
11175906|NCT01678313|12364815|FG001|STARTED|Completed the 3-month Therapy||70
11175907|NCT01678313|12364814|FG000|COMPLETED|Completed the 3-month Therapy||64
11175908|NCT01678313|12364815|FG001|COMPLETED|Completed the 3-month Therapy||58
11420334|NCT00608023|12619175|FG000|NOT COMPLETED|Overall Study||12
11420335|NCT00608023|12619176|FG001|NOT COMPLETED|Overall Study||22
11420336|NCT00608023|12619177|FG002|NOT COMPLETED|Overall Study||14
11175909|NCT01678313|12364814|FG000|NOT COMPLETED|Completed the 3-month Therapy||6
11175910|NCT01678313|12364815|FG001|NOT COMPLETED|Completed the 3-month Therapy||12
11175911|NCT01678313|12364814|FG000|STARTED|PSA >4 ng/dL at 3 Months||64
11175912|NCT01678313|12364815|FG001|STARTED|PSA >4 ng/dL at 3 Months||58
11175913|NCT01678313|12364814|FG000|COMPLETED|PSA >4 ng/dL at 3 Months||56
11175914|NCT01678313|12364815|FG001|COMPLETED|PSA >4 ng/dL at 3 Months||49
11175915|NCT01678313|12364814|FG000|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
11175916|NCT01678313|12364815|FG001|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
11175917|NCT01678313|12364814|FG000|STARTED|Prostate Biopsy at 3 Months||56
11175918|NCT01678313|12364815|FG001|STARTED|Prostate Biopsy at 3 Months||49
11175919|NCT01678313|12364814|FG000|COMPLETED|Prostate Biopsy at 3 Months||45
11175920|NCT01678313|12364815|FG001|COMPLETED|Prostate Biopsy at 3 Months||37
11175921|NCT01678313|12364814|FG000|NOT COMPLETED|Prostate Biopsy at 3 Months||11
11175922|NCT01678313|12364815|FG001|NOT COMPLETED|Prostate Biopsy at 3 Months||12
11175923|NCT01678443|12364821|FG000|STARTED|Overall Study||2
11175924|NCT01678443|12364821|FG000|COMPLETED|Overall Study||2
11175925|NCT01678443|12364821|FG000|NOT COMPLETED|Overall Study||0
11175926|NCT01678560|12364827|FG000|STARTED|Overall Study||26
11175927|NCT01678560|12364828|FG001|STARTED|Overall Study||26
11175928|NCT01678560|12364827|FG000|COMPLETED|Overall Study||22
11175929|NCT01678560|12364828|FG001|COMPLETED|Overall Study||20
11175930|NCT01678560|12364827|FG000|NOT COMPLETED|Overall Study||4
11175931|NCT01678560|12364828|FG001|NOT COMPLETED|Overall Study||6
11175932|NCT01678794|12364840|FG000|STARTED|Overall Study||16
11175933|NCT01678794|12364841|FG001|STARTED|Overall Study||17
11175934|NCT01678794|12364840|FG000|COMPLETED|Overall Study||16
11175935|NCT01678794|12364841|FG001|COMPLETED|Overall Study||17
11175936|NCT01678794|12364840|FG000|NOT COMPLETED|Overall Study||0
11175937|NCT01678794|12364841|FG001|NOT COMPLETED|Overall Study||0
11175938|NCT01678807|12364850|FG000|STARTED|Overall Study||65
11175939|NCT01678807|12364851|FG001|STARTED|Overall Study||65
11175940|NCT01678807|12364852|FG002|STARTED|Overall Study||65
11175941|NCT01678807|12364850|FG000|COMPLETED|Overall Study||61
11175942|NCT01678807|12364851|FG001|COMPLETED|Overall Study||60
11175943|NCT01678807|12364852|FG002|COMPLETED|Overall Study||65
11175944|NCT01678807|12364850|FG000|NOT COMPLETED|Overall Study||4
11175945|NCT01678807|12364851|FG001|NOT COMPLETED|Overall Study||5
11175946|NCT01678807|12364852|FG002|NOT COMPLETED|Overall Study||0
11175947|NCT01678820|12364863|FG000|STARTED|Overall Study||100
11175948|NCT01678820|12364864|FG001|STARTED|Overall Study||99
11175949|NCT01678820|12364865|FG002|STARTED|Overall Study||100
11175950|NCT01678820|12364863|FG000|Treated With Double-blind Study Drug|Overall Study||100
11175951|NCT01678820|12364864|FG001|Treated With Double-blind Study Drug|Overall Study||97
11175952|NCT01678820|12364865|FG002|Treated With Double-blind Study Drug|Overall Study||98
11175953|NCT01678820|12364863|FG000|COMPLETED|Overall Study||38
11175954|NCT01678820|12364864|FG001|COMPLETED|Overall Study||36
11175955|NCT01678820|12364865|FG002|COMPLETED|Overall Study||43
11175956|NCT01678820|12364863|FG000|NOT COMPLETED|Overall Study||62
11175957|NCT01678820|12364864|FG001|NOT COMPLETED|Overall Study||63
11175958|NCT01678820|12364865|FG002|NOT COMPLETED|Overall Study||57
11175959|NCT01678846|12364876|FG000|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
11175960|NCT01678846|12364877|FG001|STARTED|Overall Study||1899
11175961|NCT01678846|12364876|FG000|COMPLETED|Overall Study||1921
11175962|NCT01678846|12364877|FG001|COMPLETED|Overall Study||1899
11175963|NCT01678846|12364876|FG000|NOT COMPLETED|Overall Study||0
11175964|NCT01678846|12364877|FG001|NOT COMPLETED|Overall Study||0
11175965|NCT01678885|12364885|FG000|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
11175966|NCT01678885|12364886|FG001|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
11175967|NCT01678885|12364887|FG002|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
11175968|NCT01678885|12364888|FG003|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
11175969|NCT01678885|12364889|FG004|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
11175970|NCT01678885|12364885|FG000|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
11175971|NCT01678885|12364886|FG001|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
11175972|NCT01678885|12364887|FG002|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
11175973|NCT01678885|12364888|FG003|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
11175974|NCT01678885|12364889|FG004|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
11175975|NCT01678885|12364885|FG000|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
11175976|NCT01678885|12364886|FG001|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
11175977|NCT01678885|12364887|FG002|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
11175978|NCT01678885|12364888|FG003|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
11175979|NCT01678885|12364889|FG004|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
11175980|NCT01678885|12364885|FG000|STARTED|Phase II; 8 Week Low Calorie Diet||0
11175981|NCT01678885|12364886|FG001|STARTED|Phase II; 8 Week Low Calorie Diet||0
11175982|NCT01678885|12364887|FG002|STARTED|Phase II; 8 Week Low Calorie Diet||0
11175983|NCT01678885|12364888|FG003|STARTED|Phase II; 8 Week Low Calorie Diet||0
11175984|NCT01678885|12364889|FG004|STARTED|Phase II; 8 Week Low Calorie Diet||87
11175985|NCT01678885|12364885|FG000|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
11175986|NCT01678885|12364886|FG001|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
11175987|NCT01678885|12364887|FG002|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
11175988|NCT01678885|12364888|FG003|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
11175989|NCT01678885|12364889|FG004|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
11175990|NCT01678885|12364885|FG000|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
11175991|NCT01678885|12364886|FG001|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
11175992|NCT01678885|12364887|FG002|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
11175993|NCT01678885|12364888|FG003|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
11175994|NCT01678885|12364889|FG004|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
11175995|NCT01678898|12364900|FG000|STARTED|PB-102-F01||6
11175996|NCT01678898|12364901|FG001|STARTED|PB-102-F01||8
11175997|NCT01678898|12364902|FG002|STARTED|PB-102-F01||4
11175998|NCT01678898|12364900|FG000|COMPLETED|PB-102-F01||6
11175999|NCT01678898|12364901|FG001|COMPLETED|PB-102-F01||6
11176000|NCT01678898|12364902|FG002|COMPLETED|PB-102-F01||4
11176001|NCT01678898|12364900|FG000|NOT COMPLETED|PB-102-F01||0
11176002|NCT01678898|12364901|FG001|NOT COMPLETED|PB-102-F01||2
11176003|NCT01678898|12364902|FG002|NOT COMPLETED|PB-102-F01||0
11176004|NCT01678898|12364900|FG000|STARTED|PB-102-F02||6
11176005|NCT01678898|12364901|FG001|STARTED|PB-102-F02||6
11176006|NCT01678898|12364902|FG002|STARTED|PB-102-F02||4
11176007|NCT01678898|12364900|FG000|COMPLETED|PB-102-F02||6
11176008|NCT01678898|12364901|FG001|COMPLETED|PB-102-F02||6
11176009|NCT01678898|12364902|FG002|COMPLETED|PB-102-F02||4
11176010|NCT01678898|12364900|FG000|NOT COMPLETED|PB-102-F02||0
11176011|NCT01678898|12364901|FG001|NOT COMPLETED|PB-102-F02||0
11176012|NCT01678898|12364902|FG002|NOT COMPLETED|PB-102-F02||0
11176013|NCT01678911|12364919|FG000|STARTED|First Intervention||4
11176014|NCT01678911|12364920|FG001|STARTED|First Intervention||1
11176015|NCT01678911|12364919|FG000|Cross Over|First Intervention||4
11176016|NCT01678911|12364920|FG001|Cross Over|First Intervention||1
11176017|NCT01678911|12364919|FG000|COMPLETED|First Intervention||4
11176018|NCT01678911|12364920|FG001|COMPLETED|First Intervention||1
11176019|NCT01678911|12364919|FG000|NOT COMPLETED|First Intervention||0
11176020|NCT01678911|12364920|FG001|NOT COMPLETED|First Intervention||0
11176021|NCT01678911|12364919|FG000|STARTED|Second Intervention||4
11176022|NCT01678911|12364920|FG001|STARTED|Second Intervention||1
11176023|NCT01678911|12364919|FG000|COMPLETED|Second Intervention||2
11176024|NCT01678911|12364920|FG001|COMPLETED|Second Intervention||1
11176025|NCT01678911|12364919|FG000|NOT COMPLETED|Second Intervention||2
11176026|NCT01678911|12364920|FG001|NOT COMPLETED|Second Intervention||0
11176027|NCT01678924|12364930|FG000|STARTED|Overall Study||64
11176028|NCT01678924|12364931|FG001|STARTED|Overall Study||63
11176029|NCT01678924|12364932|FG002|STARTED|Overall Study||30
11176030|NCT01678924|12364933|FG003|STARTED|Overall Study||123
11176031|NCT01678924|12364930|FG000|COMPLETED|Overall Study||54
11176032|NCT01678924|12364931|FG001|COMPLETED|Overall Study||51
11176033|NCT01678924|12364932|FG002|COMPLETED|Overall Study||28
11176034|NCT01678924|12364933|FG003|COMPLETED|Overall Study||105
11176035|NCT01678924|12364930|FG000|NOT COMPLETED|Overall Study||10
11176036|NCT01678924|12364931|FG001|NOT COMPLETED|Overall Study||12
11176037|NCT01678924|12364932|FG002|NOT COMPLETED|Overall Study||2
11176038|NCT01678924|12364933|FG003|NOT COMPLETED|Overall Study||18
11176039|NCT01678976|12364946|FG000|STARTED|First Period||6
11176040|NCT01678976|12364947|FG001|STARTED|First Period||7
11176041|NCT01678976|12364946|FG000|COMPLETED|First Period||6
11176042|NCT01678976|12364947|FG001|COMPLETED|First Period||6
11176043|NCT01678976|12364946|FG000|NOT COMPLETED|First Period||0
11176044|NCT01678976|12364947|FG001|NOT COMPLETED|First Period||1
11176045|NCT01678976|12364946|FG000|STARTED|Second Period||6
11176046|NCT01678976|12364947|FG001|STARTED|Second Period||6
11176047|NCT01678976|12364946|FG000|COMPLETED|Second Period||6
11176048|NCT01678976|12364947|FG001|COMPLETED|Second Period||6
11176049|NCT01678976|12364946|FG000|NOT COMPLETED|Second Period||0
11176050|NCT01678976|12364947|FG001|NOT COMPLETED|Second Period||0
11176051|NCT01679002|12364959|FG000|STARTED|Overall Study||4
11176052|NCT01679002|12364960|FG001|STARTED|Overall Study||4
11176053|NCT01679002|12364961|FG002|STARTED|Overall Study||4
11176054|NCT01679002|12364959|FG000|BIA 2-093 900 mg Once-daily Period|Overall Study||4
11176055|NCT01679002|12364960|FG001|BIA 2-093 900 mg Once-daily Period|Overall Study||3
11176056|NCT01679002|12364961|FG002|BIA 2-093 900 mg Once-daily Period|Overall Study||4
11176057|NCT01679002|12364959|FG000|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
11176058|NCT01679002|12364960|FG001|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
11176059|NCT01679002|12364961|FG002|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
11176060|NCT01679002|12364959|FG000|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
11176061|NCT01679002|12364960|FG001|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
11176062|NCT01679002|12364961|FG002|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
11176063|NCT01679002|12364959|FG000|COMPLETED|Overall Study||3
11176064|NCT01679002|12364960|FG001|COMPLETED|Overall Study||3
11176065|NCT01679002|12364961|FG002|COMPLETED|Overall Study||4
11176066|NCT01679002|12364959|FG000|NOT COMPLETED|Overall Study||1
11176067|NCT01679002|12364960|FG001|NOT COMPLETED|Overall Study||1
11176068|NCT01679002|12364961|FG002|NOT COMPLETED|Overall Study||0
11176069|NCT01679028|12364975|FG000|STARTED|Overall Study||2
11176070|NCT01679028|12364976|FG001|STARTED|Overall Study||4
11176071|NCT01679028|12364977|FG002|STARTED|Overall Study||2
11176072|NCT01679028|12364978|FG003|STARTED|Overall Study||4
11176073|NCT01679028|12364979|FG004|STARTED|Overall Study||2
11176074|NCT01679028|12364980|FG005|STARTED|Overall Study||6
11176075|NCT01679028|12364975|FG000|COMPLETED|Overall Study||2
11176076|NCT01679028|12364976|FG001|COMPLETED|Overall Study||4
11176077|NCT01679028|12364977|FG002|COMPLETED|Overall Study||2
11176078|NCT01679028|12364978|FG003|COMPLETED|Overall Study||4
11176079|NCT01679028|12364979|FG004|COMPLETED|Overall Study||2
11176080|NCT01679028|12364980|FG005|COMPLETED|Overall Study||6
11176081|NCT01679028|12364975|FG000|NOT COMPLETED|Overall Study||0
11176082|NCT01679028|12364976|FG001|NOT COMPLETED|Overall Study||0
11176083|NCT01679028|12364977|FG002|NOT COMPLETED|Overall Study||0
11176084|NCT01679028|12364978|FG003|NOT COMPLETED|Overall Study||0
11176085|NCT01679028|12364979|FG004|NOT COMPLETED|Overall Study||0
11176086|NCT01679028|12364980|FG005|NOT COMPLETED|Overall Study||0
11176087|NCT01679197|12364994|FG000|STARTED|Overall Study||23
11176088|NCT01679197|12364994|FG000|COMPLETED|Overall Study||19
11176089|NCT01679197|12364994|FG000|NOT COMPLETED|Overall Study||4
11176090|NCT01679236|12365006|FG000|STARTED|Overall Study||30
11176091|NCT01679236|12365007|FG001|STARTED|Overall Study||25
11176092|NCT01679236|12365006|FG000|COMPLETED|Overall Study||15
11176093|NCT01679236|12365007|FG001|COMPLETED|Overall Study||10
11176094|NCT01679236|12365006|FG000|NOT COMPLETED|Overall Study||15
11176095|NCT01679236|12365007|FG001|NOT COMPLETED|Overall Study||15
11176096|NCT01679301|12365013|FG000|STARTED|Screening Period||11
11176097|NCT01679301|12365014|FG001|STARTED|Screening Period||0
11176098|NCT01679301|12365015|FG002|STARTED|Screening Period||0
11176099|NCT01679301|12365013|FG000|COMPLETED|Screening Period||8
11176100|NCT01679301|12365014|FG001|COMPLETED|Screening Period||0
11176101|NCT01679301|12365015|FG002|COMPLETED|Screening Period||0
11176102|NCT01679301|12365013|FG000|NOT COMPLETED|Screening Period||3
11176103|NCT01679301|12365014|FG001|NOT COMPLETED|Screening Period||0
11176104|NCT01679301|12365015|FG002|NOT COMPLETED|Screening Period||0
11176105|NCT01679301|12365013|FG000|STARTED|Study Period||0
11176106|NCT01679301|12365014|FG001|STARTED|Study Period||4
11176107|NCT01679301|12365015|FG002|STARTED|Study Period||4
11176108|NCT01679301|12365013|FG000|COMPLETED|Study Period||0
11176109|NCT01679301|12365014|FG001|COMPLETED|Study Period||4
11176110|NCT01679301|12365015|FG002|COMPLETED|Study Period||4
11176111|NCT01679301|12365013|FG000|NOT COMPLETED|Study Period||0
11176112|NCT01679301|12365014|FG001|NOT COMPLETED|Study Period||0
11176113|NCT01679301|12365015|FG002|NOT COMPLETED|Study Period||0
11176114|NCT01679314|12365023|FG000|STARTED|Overall Study||26
11176115|NCT01679314|12365024|FG001|STARTED|Overall Study||28
11176116|NCT01679314|12365023|FG000|COMPLETED|Overall Study||24
11176117|NCT01679314|12365024|FG001|COMPLETED|Overall Study||28
11176118|NCT01679314|12365023|FG000|NOT COMPLETED|Overall Study||2
11176119|NCT01679314|12365024|FG001|NOT COMPLETED|Overall Study||0
11176120|NCT01679405|12365036|FG000|STARTED|Overall Study||3
11176121|NCT01679405|12365037|FG001|STARTED|Overall Study||6
11176122|NCT01679405|12365036|FG000|COMPLETED|Overall Study||1
11176123|NCT01679405|12365037|FG001|COMPLETED|Overall Study||1
11176124|NCT01679405|12365036|FG000|NOT COMPLETED|Overall Study||2
11176125|NCT01679405|12365037|FG001|NOT COMPLETED|Overall Study||5
11176126|NCT01679600|12365045|FG000|STARTED|Overall Study||7
11176127|NCT01679600|12365046|FG001|STARTED|Overall Study||7
11176128|NCT01679600|12365045|FG000|COMPLETED|Overall Study||7
11176129|NCT01679600|12365046|FG001|COMPLETED|Overall Study||7
11176130|NCT01679600|12365045|FG000|NOT COMPLETED|Overall Study||0
11176131|NCT01679600|12365046|FG001|NOT COMPLETED|Overall Study||0
11176132|NCT01679613|12365052|FG000|STARTED|Overall Study||4
11176133|NCT01679613|12365053|FG001|STARTED|Overall Study||4
11176134|NCT01679613|12365054|FG002|STARTED|Overall Study||13
11176135|NCT01679613|12365055|FG003|STARTED|Overall Study||13
11176136|NCT01679613|12365052|FG000|Received Nintedanib (Pilot)|Overall Study||4
11176137|NCT01679613|12365053|FG001|Received Nintedanib (Pilot)|Overall Study||3
11176138|NCT01679613|12365054|FG002|Received Nintedanib (Pilot)|Overall Study||0
11176139|NCT01679613|12365055|FG003|Received Nintedanib (Pilot)|Overall Study||0
11176140|NCT01679613|12365052|FG000|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
11176141|NCT01679613|12365053|FG001|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
11176142|NCT01679613|12365054|FG002|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
11176143|NCT01679613|12365055|FG003|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
11176144|NCT01679613|12365052|FG000|Received Nintedanib (Main)|Overall Study||0
11176145|NCT01679613|12365053|FG001|Received Nintedanib (Main)|Overall Study||0
11176146|NCT01679613|12365054|FG002|Received Nintedanib (Main)|Overall Study||13
11176147|NCT01679613|12365055|FG003|Received Nintedanib (Main)|Overall Study||11
11176148|NCT01679613|12365052|FG000|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
11176149|NCT01679613|12365053|FG001|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
11176150|NCT01679613|12365054|FG002|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
11176151|NCT01679613|12365055|FG003|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
11176152|NCT01679613|12365052|FG000|COMPLETED|Overall Study||4
11176153|NCT01679613|12365053|FG001|COMPLETED|Overall Study||3
11176154|NCT01679613|12365054|FG002|COMPLETED|Overall Study||11
11176155|NCT01679613|12365055|FG003|COMPLETED|Overall Study||11
11176156|NCT01679613|12365052|FG000|NOT COMPLETED|Overall Study||0
11176157|NCT01679613|12365053|FG001|NOT COMPLETED|Overall Study||1
11176158|NCT01679613|12365054|FG002|NOT COMPLETED|Overall Study||2
11176159|NCT01679613|12365055|FG003|NOT COMPLETED|Overall Study||2
11176160|NCT01680016|12365064|FG000|STARTED|Overall Study||121
11176161|NCT01680016|12365065|FG001|STARTED|Overall Study||122
11176162|NCT01680016|12365066|FG002|STARTED|Overall Study||201
11176163|NCT01680016|12365067|FG003|STARTED|Overall Study||200
11176164|NCT01680016|12365064|FG000|COMPLETED|Overall Study||115
11176165|NCT01680016|12365065|FG001|COMPLETED|Overall Study||114
11176166|NCT01680016|12365066|FG002|COMPLETED|Overall Study||196
11176167|NCT01680016|12365067|FG003|COMPLETED|Overall Study||195
11176168|NCT01680016|12365064|FG000|NOT COMPLETED|Overall Study||6
11176169|NCT01680016|12365065|FG001|NOT COMPLETED|Overall Study||8
11176170|NCT01680016|12365066|FG002|NOT COMPLETED|Overall Study||5
11176171|NCT01680016|12365067|FG003|NOT COMPLETED|Overall Study||5
11203980|NCT01850823|12394580|FG002|STARTED|Overall Study||355
11203981|NCT01850823|12394578|FG000|COMPLETED|Overall Study||172
11203982|NCT01850823|12394579|FG001|COMPLETED|Overall Study||347
11203983|NCT01850823|12394580|FG002|COMPLETED|Overall Study||345
11203984|NCT01850823|12394578|FG000|NOT COMPLETED|Overall Study||3
11203985|NCT01850823|12394579|FG001|NOT COMPLETED|Overall Study||3
11203986|NCT01850823|12394580|FG002|NOT COMPLETED|Overall Study||10
11203987|NCT01851330|12394593|FG000|STARTED|Overall Study||215
11203988|NCT01851330|12394594|FG001|STARTED|Overall Study||216
11203989|NCT01851330|12394595|FG002|STARTED|Overall Study||216
11203990|NCT01851330|12394593|FG000|COMPLETED|Overall Study||202
11203991|NCT01851330|12394594|FG001|COMPLETED|Overall Study||200
11203992|NCT01851330|12394595|FG002|COMPLETED|Overall Study||204
11203993|NCT01851330|12394593|FG000|NOT COMPLETED|Overall Study||13
11203994|NCT01851330|12394594|FG001|NOT COMPLETED|Overall Study||16
11203995|NCT01851330|12394595|FG002|NOT COMPLETED|Overall Study||12
11203996|NCT01851590|12394606|FG000|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
11203997|NCT01851590|12394607|FG001|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
11203998|NCT01851590|12394608|FG002|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
11203999|NCT01851590|12394606|FG000|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
11204000|NCT01851590|12394607|FG001|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
11204001|NCT01851590|12394608|FG002|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
11204002|NCT01851590|12394606|FG000|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
11204003|NCT01851590|12394607|FG001|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
11204004|NCT01851590|12394608|FG002|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
11204005|NCT01851590|12394606|FG000|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
11204006|NCT01851590|12394607|FG001|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
11204007|NCT01851590|12394608|FG002|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
11204008|NCT01851590|12394606|FG000|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
11204009|NCT01851590|12394607|FG001|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
11204010|NCT01851590|12394608|FG002|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
11204011|NCT01851590|12394606|FG000|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
11204012|NCT01851590|12394607|FG001|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
11204013|NCT01851590|12394608|FG002|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
11204014|NCT01851590|12394606|FG000|NOT COMPLETED|Overall Study||0
11204015|NCT01851590|12394607|FG001|NOT COMPLETED|Overall Study||1
11204016|NCT01851590|12394608|FG002|NOT COMPLETED|Overall Study||3
11204017|NCT01851655|12394622|FG000|STARTED|Overall Study||12
11204018|NCT01851655|12394623|FG001|STARTED|Overall Study||12
11204019|NCT01851655|12394622|FG000|COMPLETED|Overall Study||12
11204020|NCT01851655|12394623|FG001|COMPLETED|Overall Study||12
11204021|NCT01851655|12394622|FG000|NOT COMPLETED|Overall Study||0
11204022|NCT01851655|12394623|FG001|NOT COMPLETED|Overall Study||0
11204023|NCT01851720|12394631|FG000|STARTED|Overall Study||0
11204024|NCT01851720|12394632|FG001|STARTED|Overall Study||1
11204025|NCT01851720|12394631|FG000|COMPLETED|Overall Study||0
11176172|NCT01680159|12365093|FG000|STARTED|Screening Period||46
11176173|NCT01680159|12365093|FG000|COMPLETED|Screening Period||39
11176174|NCT01680159|12365093|FG000|NOT COMPLETED|Screening Period||7
11176175|NCT01680159|12365093|FG000|STARTED|Increased Dose Period||51
11176176|NCT01680159|12365093|FG000|COMPLETED|Increased Dose Period||43
11176177|NCT01680159|12365093|FG000|NOT COMPLETED|Increased Dose Period||8
11176178|NCT01680172|12365115|FG000|STARTED|Overall Study||3
11176179|NCT01680172|12365116|FG001|STARTED|Overall Study||2
11176180|NCT01680172|12365115|FG000|COMPLETED|Overall Study||3
11176181|NCT01680172|12365116|FG001|COMPLETED|Overall Study||2
11176182|NCT01680172|12365115|FG000|NOT COMPLETED|Overall Study||0
11176183|NCT01680172|12365116|FG001|NOT COMPLETED|Overall Study||0
11176184|NCT01680328|12365122|FG000|STARTED|Overall Study||82
11176185|NCT01680328|12365122|FG000|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
11176186|NCT01680328|12365122|FG000|COMPLETED|Overall Study||80
11176187|NCT01680328|12365122|FG000|NOT COMPLETED|Overall Study||2
11176188|NCT01680341|12365159|FG000|STARTED|Overall Study||136
11176189|NCT01680341|12365160|FG001|STARTED|Overall Study||136
11176190|NCT01680341|12365159|FG000|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
11176191|NCT01680341|12365160|FG001|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
11176192|NCT01680341|12365159|FG000|COMPLETED|Overall Study||115
11176193|NCT01680341|12365160|FG001|COMPLETED|Overall Study||119
11176194|NCT01680341|12365159|FG000|NOT COMPLETED|Overall Study||21
11176195|NCT01680341|12365160|FG001|NOT COMPLETED|Overall Study||17
11176196|NCT01680458|12365166|FG000|STARTED|Overall Study||30
11176197|NCT01680458|12365166|FG000|COMPLETED|Overall Study||27
11176198|NCT01680458|12365166|FG000|NOT COMPLETED|Overall Study||3
11176199|NCT01680497|12365170|FG000|STARTED|Overall Study||70
11176200|NCT01680497|12365170|FG000|COMPLETED|Overall Study||68
11176201|NCT01680497|12365170|FG000|NOT COMPLETED|Overall Study||2
11176202|NCT01680549|12365176|FG000|STARTED|Overall Study||25
11176203|NCT01680549|12365177|FG001|STARTED|Overall Study||25
11176204|NCT01680549|12365176|FG000|COMPLETED|Overall Study||20
11176205|NCT01680549|12365177|FG001|COMPLETED|Overall Study||17
11176206|NCT01680549|12365176|FG000|NOT COMPLETED|Overall Study||5
11176207|NCT01680549|12365177|FG001|NOT COMPLETED|Overall Study||8
11176208|NCT01680640|12365191|FG000|STARTED|Overall Study||55
11176209|NCT01680640|12365192|FG001|STARTED|Overall Study||49
11176210|NCT01680640|12365191|FG000|COMPLETED|Overall Study||45
11176211|NCT01680640|12365192|FG001|COMPLETED|Overall Study||44
11176212|NCT01680640|12365191|FG000|NOT COMPLETED|Overall Study||10
11176213|NCT01680640|12365192|FG001|NOT COMPLETED|Overall Study||5
11176214|NCT01680653|12365198|FG000|STARTED|Overall Study||57
11176215|NCT01680653|12365198|FG000|COMPLETED|Overall Study||57
11176216|NCT01680653|12365198|FG000|NOT COMPLETED|Overall Study||0
11176217|NCT01680666|12365210|FG000|STARTED|Overall Study||84
11176218|NCT01680666|12365211|FG001|STARTED|Overall Study||66
11176219|NCT01680666|12365210|FG000|COMPLETED|Overall Study||84
11176220|NCT01680666|12365211|FG001|COMPLETED|Overall Study||66
11176221|NCT01680666|12365210|FG000|NOT COMPLETED|Overall Study||0
11176222|NCT01680666|12365211|FG001|NOT COMPLETED|Overall Study||0
11176223|NCT01680783|12365220|FG000|STARTED|Overall Study||39
11176224|NCT01680783|12365221|FG001|STARTED|Overall Study||44
11176225|NCT01680783|12365220|FG000|COMPLETED|Overall Study||39
11176226|NCT01680783|12365221|FG001|COMPLETED|Overall Study||44
11176227|NCT01680783|12365220|FG000|NOT COMPLETED|Overall Study||0
11176228|NCT01680783|12365221|FG001|NOT COMPLETED|Overall Study||0
11176229|NCT01680835|12365227|FG000|STARTED|Overall Study||108
11176230|NCT01680835|12365227|FG000|COMPLETED|Overall Study||83
11176231|NCT01680835|12365227|FG000|NOT COMPLETED|Overall Study||25
11176232|NCT01680848|12365231|FG000|STARTED|Overall Study||282
11176233|NCT01680848|12365231|FG000|COMPLETED|Overall Study||189
11176234|NCT01680848|12365231|FG000|NOT COMPLETED|Overall Study||93
11176235|NCT01680861|12365237|FG000|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
11176236|NCT01680861|12365238|FG001|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
11176237|NCT01680861|12365237|FG000|COMPLETED|Early Post-transplant Period||15
11176238|NCT01680861|12365238|FG001|COMPLETED|Early Post-transplant Period||15
11176239|NCT01680861|12365237|FG000|NOT COMPLETED|Early Post-transplant Period||1
11176240|NCT01680861|12365238|FG001|NOT COMPLETED|Early Post-transplant Period||1
11176241|NCT01680861|12365237|FG000|STARTED|First 12 Months Post-transplant||15
11176242|NCT01680861|12365238|FG001|STARTED|First 12 Months Post-transplant||15
11176243|NCT01680861|12365237|FG000|COMPLETED|First 12 Months Post-transplant||15
11176244|NCT01680861|12365238|FG001|COMPLETED|First 12 Months Post-transplant||15
11176245|NCT01680861|12365237|FG000|NOT COMPLETED|First 12 Months Post-transplant||0
11176246|NCT01680861|12365238|FG001|NOT COMPLETED|First 12 Months Post-transplant||0
11176247|NCT01680887|12365248|FG000|STARTED|Overall Study||80
11176248|NCT01680887|12365249|FG001|STARTED|Overall Study||76
11176249|NCT01680887|12365248|FG000|COMPLETED|Overall Study||51
11176250|NCT01680887|12365249|FG001|COMPLETED|Overall Study||52
11176251|NCT01680887|12365248|FG000|NOT COMPLETED|Overall Study||29
11176252|NCT01680887|12365249|FG001|NOT COMPLETED|Overall Study||24
11176253|NCT01680900|12365257|FG000|STARTED|Overall Study||24
11176254|NCT01680900|12365258|FG001|STARTED|Overall Study||12
11176255|NCT01680900|12365257|FG000|COMPLETED|Overall Study||20
11176256|NCT01680900|12365258|FG001|COMPLETED|Overall Study||11
11176257|NCT01680900|12365257|FG000|NOT COMPLETED|Overall Study||4
11176258|NCT01680900|12365258|FG001|NOT COMPLETED|Overall Study||1
11176259|NCT01680991|12365267|FG000|STARTED|Overall Study||12
11176260|NCT01680991|12365268|FG001|STARTED|Overall Study||23
11176261|NCT01680991|12365269|FG002|STARTED|Overall Study||13
11176262|NCT01680991|12365267|FG000|COMPLETED|Overall Study||4
11176263|NCT01680991|12365268|FG001|COMPLETED|Overall Study||4
11176264|NCT01680991|12365269|FG002|COMPLETED|Overall Study||9
11176265|NCT01680991|12365267|FG000|NOT COMPLETED|Overall Study||8
11176266|NCT01680991|12365268|FG001|NOT COMPLETED|Overall Study||19
11176267|NCT01680991|12365269|FG002|NOT COMPLETED|Overall Study||4
11176268|NCT01681004|12365281|FG000|STARTED|Primary Endpoint: 6 Months||102
11176269|NCT01681004|12365282|FG001|STARTED|Primary Endpoint: 6 Months||46
11176270|NCT01681004|12365281|FG000|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
11176271|NCT01681004|12365282|FG001|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
11176272|NCT01681004|12365281|FG000|COMPLETED|Primary Endpoint: 6 Months||101
11176273|NCT01681004|12365282|FG001|COMPLETED|Primary Endpoint: 6 Months||44
11176274|NCT01681004|12365281|FG000|NOT COMPLETED|Primary Endpoint: 6 Months||1
11176275|NCT01681004|12365282|FG001|NOT COMPLETED|Primary Endpoint: 6 Months||2
11176276|NCT01681004|12365281|FG000|STARTED|Study Completion||101
11176277|NCT01681004|12365282|FG001|STARTED|Study Completion||44
11176278|NCT01681004|12365281|FG000|COMPLETED|Study Completion||89
11176279|NCT01681004|12365282|FG001|COMPLETED|Study Completion||36
11176280|NCT01681004|12365281|FG000|NOT COMPLETED|Study Completion||12
11176281|NCT01681004|12365282|FG001|NOT COMPLETED|Study Completion||8
11176282|NCT01681030|12365295|FG000|STARTED|Overall Study||13
11176283|NCT01681030|12365296|FG001|STARTED|Overall Study||18
11176284|NCT01681030|12365297|FG002|STARTED|Overall Study||11
11176285|NCT01681030|12365295|FG000|COMPLETED|Overall Study||13
11176286|NCT01681030|12365296|FG001|COMPLETED|Overall Study||18
11176287|NCT01681030|12365297|FG002|COMPLETED|Overall Study||11
11176288|NCT01681030|12365295|FG000|NOT COMPLETED|Overall Study||0
11176289|NCT01681030|12365296|FG001|NOT COMPLETED|Overall Study||0
11176290|NCT01681030|12365297|FG002|NOT COMPLETED|Overall Study||0
11176291|NCT01681069|12365307|FG000|STARTED|Overall Study||60
11176292|NCT01681069|12365308|FG001|STARTED|Overall Study||60
11176293|NCT01681069|12365307|FG000|Full Analysis Set (FAS)|Overall Study||57
11176294|NCT01681069|12365308|FG001|Full Analysis Set (FAS)|Overall Study||60
11176295|NCT01681069|12365307|FG000|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
11176296|NCT01681069|12365308|FG001|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
11176297|NCT01681069|12365307|FG000|NOT COMPLETED|Overall Study||5
11176298|NCT01681069|12365308|FG001|NOT COMPLETED|Overall Study||7
11176299|NCT01681095|12365316|FG000|STARTED|Overall Study||55
11176300|NCT01681095|12365317|FG001|STARTED|Overall Study||55
11176301|NCT01681095|12365316|FG000|COMPLETED|Overall Study||55
11176302|NCT01681095|12365317|FG001|COMPLETED|Overall Study||55
11176303|NCT01681095|12365316|FG000|NOT COMPLETED|Overall Study||0
11176304|NCT01681095|12365317|FG001|NOT COMPLETED|Overall Study||0
11176305|NCT01681121|12365325|FG000|STARTED|Overall Study||44
11176306|NCT01681121|12365326|FG001|STARTED|Overall Study||49
11176307|NCT01681121|12365325|FG000|COMPLETED|Overall Study||36
11176308|NCT01681121|12365326|FG001|COMPLETED|Overall Study||38
11176309|NCT01681121|12365325|FG000|NOT COMPLETED|Overall Study||8
11176310|NCT01681121|12365326|FG001|NOT COMPLETED|Overall Study||11
11176311|NCT01681186|12365342|FG000|STARTED|First Intervention||4
11176312|NCT01681186|12365343|FG001|STARTED|First Intervention||2
11176313|NCT01681186|12365344|FG002|STARTED|First Intervention||2
11176314|NCT01681186|12365345|FG003|STARTED|First Intervention||3
11176315|NCT01681186|12365346|FG004|STARTED|First Intervention||3
11176316|NCT01681186|12365347|FG005|STARTED|First Intervention||2
11176317|NCT01681186|12365348|FG006|STARTED|First Intervention||7
11176318|NCT01681186|12365349|FG007|STARTED|First Intervention||7
11176319|NCT01681186|12365342|FG000|COMPLETED|First Intervention||4
11176320|NCT01681186|12365343|FG001|COMPLETED|First Intervention||2
11176321|NCT01681186|12365344|FG002|COMPLETED|First Intervention||2
11176322|NCT01681186|12365345|FG003|COMPLETED|First Intervention||3
11176323|NCT01681186|12365346|FG004|COMPLETED|First Intervention||3
11176324|NCT01681186|12365347|FG005|COMPLETED|First Intervention||2
11176325|NCT01681186|12365348|FG006|COMPLETED|First Intervention||7
11176326|NCT01681186|12365349|FG007|COMPLETED|First Intervention||7
11176327|NCT01681186|12365342|FG000|NOT COMPLETED|First Intervention||0
11176328|NCT01681186|12365343|FG001|NOT COMPLETED|First Intervention||0
11176329|NCT01681186|12365344|FG002|NOT COMPLETED|First Intervention||0
11176330|NCT01681186|12365345|FG003|NOT COMPLETED|First Intervention||0
11176331|NCT01681186|12365346|FG004|NOT COMPLETED|First Intervention||0
11176332|NCT01681186|12365347|FG005|NOT COMPLETED|First Intervention||0
11176333|NCT01681186|12365348|FG006|NOT COMPLETED|First Intervention||0
11176334|NCT01681186|12365349|FG007|NOT COMPLETED|First Intervention||0
11176335|NCT01681186|12365342|FG000|STARTED|Washout Period From First Intervention||4
11176336|NCT01681186|12365343|FG001|STARTED|Washout Period From First Intervention||2
11176337|NCT01681186|12365344|FG002|STARTED|Washout Period From First Intervention||2
11176338|NCT01681186|12365345|FG003|STARTED|Washout Period From First Intervention||3
11176339|NCT01681186|12365346|FG004|STARTED|Washout Period From First Intervention||3
11176340|NCT01681186|12365347|FG005|STARTED|Washout Period From First Intervention||2
11176341|NCT01681186|12365348|FG006|STARTED|Washout Period From First Intervention||7
11176342|NCT01681186|12365349|FG007|STARTED|Washout Period From First Intervention||7
11176343|NCT01681186|12365342|FG000|COMPLETED|Washout Period From First Intervention||4
11176344|NCT01681186|12365343|FG001|COMPLETED|Washout Period From First Intervention||2
11176345|NCT01681186|12365344|FG002|COMPLETED|Washout Period From First Intervention||2
11176346|NCT01681186|12365345|FG003|COMPLETED|Washout Period From First Intervention||3
11176347|NCT01681186|12365346|FG004|COMPLETED|Washout Period From First Intervention||3
11176348|NCT01681186|12365347|FG005|COMPLETED|Washout Period From First Intervention||2
11176349|NCT01681186|12365348|FG006|COMPLETED|Washout Period From First Intervention||7
11176350|NCT01681186|12365349|FG007|COMPLETED|Washout Period From First Intervention||7
11176351|NCT01681186|12365342|FG000|NOT COMPLETED|Washout Period From First Intervention||0
11176352|NCT01681186|12365343|FG001|NOT COMPLETED|Washout Period From First Intervention||0
11176353|NCT01681186|12365344|FG002|NOT COMPLETED|Washout Period From First Intervention||0
11176354|NCT01681186|12365345|FG003|NOT COMPLETED|Washout Period From First Intervention||0
11176355|NCT01681186|12365346|FG004|NOT COMPLETED|Washout Period From First Intervention||0
11176356|NCT01681186|12365347|FG005|NOT COMPLETED|Washout Period From First Intervention||0
11176357|NCT01681186|12365348|FG006|NOT COMPLETED|Washout Period From First Intervention||0
11176358|NCT01681186|12365349|FG007|NOT COMPLETED|Washout Period From First Intervention||0
11176359|NCT01681186|12365342|FG000|STARTED|Second Intervention||4
11176360|NCT01681186|12365343|FG001|STARTED|Second Intervention||2
11176361|NCT01681186|12365344|FG002|STARTED|Second Intervention||2
11176362|NCT01681186|12365345|FG003|STARTED|Second Intervention||3
11176363|NCT01681186|12365346|FG004|STARTED|Second Intervention||3
11176364|NCT01681186|12365347|FG005|STARTED|Second Intervention||2
11176365|NCT01681186|12365348|FG006|STARTED|Second Intervention||7
11176366|NCT01681186|12365349|FG007|STARTED|Second Intervention||7
11176367|NCT01681186|12365342|FG000|COMPLETED|Second Intervention||4
11176368|NCT01681186|12365343|FG001|COMPLETED|Second Intervention||2
11176369|NCT01681186|12365344|FG002|COMPLETED|Second Intervention||2
11176370|NCT01681186|12365345|FG003|COMPLETED|Second Intervention||3
11176371|NCT01681186|12365346|FG004|COMPLETED|Second Intervention||3
11176372|NCT01681186|12365347|FG005|COMPLETED|Second Intervention||2
11176373|NCT01681186|12365348|FG006|COMPLETED|Second Intervention||7
11176374|NCT01681186|12365349|FG007|COMPLETED|Second Intervention||7
11176375|NCT01681186|12365342|FG000|NOT COMPLETED|Second Intervention||0
11176376|NCT01681186|12365343|FG001|NOT COMPLETED|Second Intervention||0
11176377|NCT01681186|12365344|FG002|NOT COMPLETED|Second Intervention||0
11176378|NCT01681186|12365345|FG003|NOT COMPLETED|Second Intervention||0
11176379|NCT01681186|12365346|FG004|NOT COMPLETED|Second Intervention||0
11176380|NCT01681186|12365347|FG005|NOT COMPLETED|Second Intervention||0
11176381|NCT01681186|12365348|FG006|NOT COMPLETED|Second Intervention||0
11176382|NCT01681186|12365349|FG007|NOT COMPLETED|Second Intervention||0
11176383|NCT01681186|12365342|FG000|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
11176384|NCT01681186|12365343|FG001|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
11176385|NCT01681186|12365344|FG002|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
11176386|NCT01681186|12365345|FG003|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
11176387|NCT01681186|12365346|FG004|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
11176388|NCT01681186|12365347|FG005|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
11176389|NCT01681186|12365348|FG006|STARTED|Washout Period From Second Intervention||7
11176390|NCT01681186|12365349|FG007|STARTED|Washout Period From Second Intervention||7
11176391|NCT01681186|12365342|FG000|COMPLETED|Washout Period From Second Intervention||0
11176392|NCT01681186|12365343|FG001|COMPLETED|Washout Period From Second Intervention||0
11176393|NCT01681186|12365344|FG002|COMPLETED|Washout Period From Second Intervention||0
11176394|NCT01681186|12365345|FG003|COMPLETED|Washout Period From Second Intervention||0
11176395|NCT01681186|12365346|FG004|COMPLETED|Washout Period From Second Intervention||0
11176396|NCT01681186|12365347|FG005|COMPLETED|Washout Period From Second Intervention||0
11176397|NCT01681186|12365348|FG006|COMPLETED|Washout Period From Second Intervention||6
11176398|NCT01681186|12365349|FG007|COMPLETED|Washout Period From Second Intervention||6
11176399|NCT01681186|12365342|FG000|NOT COMPLETED|Washout Period From Second Intervention||0
11176400|NCT01681186|12365343|FG001|NOT COMPLETED|Washout Period From Second Intervention||0
11176401|NCT01681186|12365344|FG002|NOT COMPLETED|Washout Period From Second Intervention||0
11176402|NCT01681186|12365345|FG003|NOT COMPLETED|Washout Period From Second Intervention||0
11176403|NCT01681186|12365346|FG004|NOT COMPLETED|Washout Period From Second Intervention||0
11176404|NCT01681186|12365347|FG005|NOT COMPLETED|Washout Period From Second Intervention||0
11176405|NCT01681186|12365348|FG006|NOT COMPLETED|Washout Period From Second Intervention||1
11176406|NCT01681186|12365349|FG007|NOT COMPLETED|Washout Period From Second Intervention||1
11176407|NCT01681186|12365342|FG000|STARTED|Third Intervention||0
11176408|NCT01681186|12365343|FG001|STARTED|Third Intervention||0
11176409|NCT01681186|12365344|FG002|STARTED|Third Intervention||0
11176410|NCT01681186|12365345|FG003|STARTED|Third Intervention||0
11176411|NCT01681186|12365346|FG004|STARTED|Third Intervention||0
11176412|NCT01681186|12365347|FG005|STARTED|Third Intervention||0
11176413|NCT01681186|12365348|FG006|STARTED|Third Intervention||6
11176414|NCT01681186|12365349|FG007|STARTED|Third Intervention||6
11176415|NCT01681186|12365342|FG000|COMPLETED|Third Intervention||0
11176416|NCT01681186|12365343|FG001|COMPLETED|Third Intervention||0
11176417|NCT01681186|12365344|FG002|COMPLETED|Third Intervention||0
11176418|NCT01681186|12365345|FG003|COMPLETED|Third Intervention||0
11176419|NCT01681186|12365346|FG004|COMPLETED|Third Intervention||0
11176420|NCT01681186|12365347|FG005|COMPLETED|Third Intervention||0
11176421|NCT01681186|12365348|FG006|COMPLETED|Third Intervention||6
11176422|NCT01681186|12365349|FG007|COMPLETED|Third Intervention||6
11176423|NCT01681186|12365342|FG000|NOT COMPLETED|Third Intervention||0
11176424|NCT01681186|12365343|FG001|NOT COMPLETED|Third Intervention||0
11176425|NCT01681186|12365344|FG002|NOT COMPLETED|Third Intervention||0
11176426|NCT01681186|12365345|FG003|NOT COMPLETED|Third Intervention||0
11176427|NCT01681186|12365346|FG004|NOT COMPLETED|Third Intervention||0
11176428|NCT01681186|12365347|FG005|NOT COMPLETED|Third Intervention||0
11176429|NCT01681186|12365348|FG006|NOT COMPLETED|Third Intervention||0
11176430|NCT01681186|12365349|FG007|NOT COMPLETED|Third Intervention||0
11176431|NCT01681186|12365342|FG000|STARTED|Washout Period From Third Intervention||0
11176432|NCT01681186|12365343|FG001|STARTED|Washout Period From Third Intervention||0
11176433|NCT01681186|12365344|FG002|STARTED|Washout Period From Third Intervention||0
11176434|NCT01681186|12365345|FG003|STARTED|Washout Period From Third Intervention||0
11176435|NCT01681186|12365346|FG004|STARTED|Washout Period From Third Intervention||0
11176436|NCT01681186|12365347|FG005|STARTED|Washout Period From Third Intervention||0
11176437|NCT01681186|12365348|FG006|STARTED|Washout Period From Third Intervention||6
11176438|NCT01681186|12365349|FG007|STARTED|Washout Period From Third Intervention||6
11176439|NCT01681186|12365342|FG000|COMPLETED|Washout Period From Third Intervention||0
11176440|NCT01681186|12365343|FG001|COMPLETED|Washout Period From Third Intervention||0
11176441|NCT01681186|12365344|FG002|COMPLETED|Washout Period From Third Intervention||0
11176442|NCT01681186|12365345|FG003|COMPLETED|Washout Period From Third Intervention||0
11176443|NCT01681186|12365346|FG004|COMPLETED|Washout Period From Third Intervention||0
11176444|NCT01681186|12365347|FG005|COMPLETED|Washout Period From Third Intervention||0
11176445|NCT01681186|12365348|FG006|COMPLETED|Washout Period From Third Intervention||5
11176446|NCT01681186|12365349|FG007|COMPLETED|Washout Period From Third Intervention||6
11176447|NCT01681186|12365342|FG000|NOT COMPLETED|Washout Period From Third Intervention||0
11176448|NCT01681186|12365343|FG001|NOT COMPLETED|Washout Period From Third Intervention||0
11176449|NCT01681186|12365344|FG002|NOT COMPLETED|Washout Period From Third Intervention||0
11176450|NCT01681186|12365345|FG003|NOT COMPLETED|Washout Period From Third Intervention||0
11176451|NCT01681186|12365346|FG004|NOT COMPLETED|Washout Period From Third Intervention||0
11176452|NCT01681186|12365347|FG005|NOT COMPLETED|Washout Period From Third Intervention||0
11176453|NCT01681186|12365348|FG006|NOT COMPLETED|Washout Period From Third Intervention||1
11176454|NCT01681186|12365349|FG007|NOT COMPLETED|Washout Period From Third Intervention||0
11176455|NCT01681186|12365342|FG000|STARTED|Fourth Intervention||0
11176456|NCT01681186|12365343|FG001|STARTED|Fourth Intervention||0
11176457|NCT01681186|12365344|FG002|STARTED|Fourth Intervention||0
11176458|NCT01681186|12365345|FG003|STARTED|Fourth Intervention||0
11176459|NCT01681186|12365346|FG004|STARTED|Fourth Intervention||0
11176460|NCT01681186|12365347|FG005|STARTED|Fourth Intervention||0
11176461|NCT01681186|12365348|FG006|STARTED|Fourth Intervention||5
11176462|NCT01681186|12365349|FG007|STARTED|Fourth Intervention||6
11176463|NCT01681186|12365342|FG000|COMPLETED|Fourth Intervention||0
11176464|NCT01681186|12365343|FG001|COMPLETED|Fourth Intervention||0
11176465|NCT01681186|12365344|FG002|COMPLETED|Fourth Intervention||0
11176466|NCT01681186|12365345|FG003|COMPLETED|Fourth Intervention||0
11176467|NCT01681186|12365346|FG004|COMPLETED|Fourth Intervention||0
11176468|NCT01681186|12365347|FG005|COMPLETED|Fourth Intervention||0
11176469|NCT01681186|12365348|FG006|COMPLETED|Fourth Intervention||5
11176470|NCT01681186|12365349|FG007|COMPLETED|Fourth Intervention||5
11176471|NCT01681186|12365342|FG000|NOT COMPLETED|Fourth Intervention||0
11176472|NCT01681186|12365343|FG001|NOT COMPLETED|Fourth Intervention||0
11176473|NCT01681186|12365344|FG002|NOT COMPLETED|Fourth Intervention||0
11176474|NCT01681186|12365345|FG003|NOT COMPLETED|Fourth Intervention||0
11176475|NCT01681186|12365346|FG004|NOT COMPLETED|Fourth Intervention||0
11176476|NCT01681186|12365347|FG005|NOT COMPLETED|Fourth Intervention||0
11176477|NCT01681186|12365348|FG006|NOT COMPLETED|Fourth Intervention||0
11176478|NCT01681186|12365349|FG007|NOT COMPLETED|Fourth Intervention||1
11176479|NCT01681212|12365379|FG000|STARTED|Overall Study|Enrolled|21
11176480|NCT01681212|12365379|FG000|Received Treatment|Overall Study||15
11176481|NCT01681212|12365379|FG000|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
11176482|NCT01681212|12365379|FG000|NOT COMPLETED|Overall Study||6
11176483|NCT01681277|12365388|FG000|STARTED|Overall Study||12
11176484|NCT01681277|12365389|FG001|STARTED|Overall Study||9
11176485|NCT01681277|12365390|FG002|STARTED|Overall Study||9
11176486|NCT01681277|12365391|FG003|STARTED|Overall Study||9
11176487|NCT01681277|12365392|FG004|STARTED|Overall Study||9
11176488|NCT01681277|12365388|FG000|COMPLETED|Overall Study||11
11176489|NCT01681277|12365389|FG001|COMPLETED|Overall Study||9
11176490|NCT01681277|12365390|FG002|COMPLETED|Overall Study||9
11176491|NCT01681277|12365391|FG003|COMPLETED|Overall Study||9
11176492|NCT01681277|12365392|FG004|COMPLETED|Overall Study||9
11176493|NCT01681277|12365388|FG000|NOT COMPLETED|Overall Study||1
11176494|NCT01681277|12365389|FG001|NOT COMPLETED|Overall Study||0
11176495|NCT01681277|12365390|FG002|NOT COMPLETED|Overall Study||0
11176496|NCT01681277|12365391|FG003|NOT COMPLETED|Overall Study||0
11176497|NCT01681277|12365392|FG004|NOT COMPLETED|Overall Study||0
11176498|NCT01681368|12365408|FG000|STARTED|Overall Study||11
11176499|NCT01681368|12365408|FG000|COMPLETED|Overall Study||9
11176500|NCT01681368|12365408|FG000|NOT COMPLETED|Overall Study||2
11176501|NCT01681472|12365416|FG000|STARTED|Overall Study||8
11176502|NCT01681472|12365417|FG001|STARTED|Overall Study||8
11176503|NCT01681472|12365418|FG002|STARTED|Overall Study||8
11176504|NCT01681472|12365419|FG003|STARTED|Overall Study||8
11176505|NCT01681472|12365416|FG000|COMPLETED|Overall Study||8
11176506|NCT01681472|12365417|FG001|COMPLETED|Overall Study||7
11176507|NCT01681472|12365418|FG002|COMPLETED|Overall Study||8
11176508|NCT01681472|12365419|FG003|COMPLETED|Overall Study||8
11176509|NCT01681472|12365416|FG000|NOT COMPLETED|Overall Study||0
11176510|NCT01681472|12365417|FG001|NOT COMPLETED|Overall Study||1
11176511|NCT01681472|12365418|FG002|NOT COMPLETED|Overall Study||0
11176512|NCT01681472|12365419|FG003|NOT COMPLETED|Overall Study||0
11176513|NCT01681511|12365440|FG000|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
11176514|NCT01681511|12365441|FG001|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
11176515|NCT01681511|12365440|FG000|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
11176516|NCT01681511|12365441|FG001|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
11176517|NCT01681511|12365440|FG000|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
11176518|NCT01681511|12365441|FG001|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
11176519|NCT01681511|12365440|FG000|COMPLETED|Overall Study||28
11176520|NCT01681511|12365441|FG001|COMPLETED|Overall Study||35
11176521|NCT01681511|12365440|FG000|NOT COMPLETED|Overall Study||18
11176522|NCT01681511|12365441|FG001|NOT COMPLETED|Overall Study||14
11176523|NCT01681576|12365449|FG000|STARTED|Period 1||36
11176524|NCT01681576|12365450|FG001|STARTED|Period 1||36
11176525|NCT01681576|12365449|FG000|COMPLETED|Period 1||34
11176526|NCT01681576|12365450|FG001|COMPLETED|Period 1||36
11176527|NCT01681576|12365449|FG000|NOT COMPLETED|Period 1||2
11176528|NCT01681576|12365450|FG001|NOT COMPLETED|Period 1||0
11176529|NCT01681576|12365449|FG000|STARTED|Period 2|Period 2: Valsartan 320mg|34
11176530|NCT01681576|12365450|FG001|STARTED|Period 2|Period 2: LCZ696 400mg|36
11176531|NCT01681576|12365449|FG000|COMPLETED|Period 2||30
11176532|NCT01681576|12365450|FG001|COMPLETED|Period 2||35
11176533|NCT01681576|12365449|FG000|NOT COMPLETED|Period 2||4
11176534|NCT01681576|12365450|FG001|NOT COMPLETED|Period 2||1
11176535|NCT01681628|12365460|FG000|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
11176536|NCT01681628|12365461|FG001|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
11176537|NCT01681628|12365460|FG000|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
11176538|NCT01681628|12365461|FG001|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
11176539|NCT01681628|12365460|FG000|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
11176540|NCT01681628|12365461|FG001|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
11176541|NCT01681628|12365460|FG000|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
11176542|NCT01681628|12365461|FG001|STARTED|Time 2 to Time 3 (One Week Later).||122
11176543|NCT01681628|12365460|FG000|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
11176544|NCT01681628|12365461|FG001|COMPLETED|Time 2 to Time 3 (One Week Later).||107
11176545|NCT01681628|12365460|FG000|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
11176546|NCT01681628|12365461|FG001|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
11176547|NCT01681628|12365460|FG000|STARTED|19 Months Follow-up||114
11176548|NCT01681628|12365461|FG001|STARTED|19 Months Follow-up||107
11176549|NCT01681628|12365460|FG000|COMPLETED|19 Months Follow-up||52
11176550|NCT01681628|12365461|FG001|COMPLETED|19 Months Follow-up||64
11176551|NCT01681628|12365460|FG000|NOT COMPLETED|19 Months Follow-up||62
11176552|NCT01681628|12365461|FG001|NOT COMPLETED|19 Months Follow-up||43
11176553|NCT01681771|12365472|FG000|STARTED|Overall Study||25
11176554|NCT01681771|12365473|FG001|STARTED|Overall Study||25
11176555|NCT01681771|12365472|FG000|COMPLETED|Overall Study||21
11176556|NCT01681771|12365473|FG001|COMPLETED|Overall Study||23
11176557|NCT01681771|12365472|FG000|NOT COMPLETED|Overall Study||4
11176558|NCT01681771|12365473|FG001|NOT COMPLETED|Overall Study||2
11176559|NCT01681810|12365479|FG000|STARTED|Overall Study||20
11176560|NCT01681810|12365479|FG000|COMPLETED|Overall Study||20
11176561|NCT01681810|12365479|FG000|NOT COMPLETED|Overall Study||0
11176562|NCT01681836|12365483|FG000|STARTED|First Intervention||6
11176563|NCT01681836|12365484|FG001|STARTED|First Intervention||5
11176564|NCT01681836|12365483|FG000|COMPLETED|First Intervention||6
11176565|NCT01681836|12365484|FG001|COMPLETED|First Intervention||5
11176566|NCT01681836|12365483|FG000|NOT COMPLETED|First Intervention||0
11176567|NCT01681836|12365484|FG001|NOT COMPLETED|First Intervention||0
11176568|NCT01681836|12365483|FG000|STARTED|Washout Period of 3-7 Days||6
11176569|NCT01681836|12365484|FG001|STARTED|Washout Period of 3-7 Days||5
11176570|NCT01681836|12365483|FG000|COMPLETED|Washout Period of 3-7 Days||6
11176571|NCT01681836|12365484|FG001|COMPLETED|Washout Period of 3-7 Days||5
11176572|NCT01681836|12365483|FG000|NOT COMPLETED|Washout Period of 3-7 Days||0
11176573|NCT01681836|12365484|FG001|NOT COMPLETED|Washout Period of 3-7 Days||0
11176574|NCT01681836|12365483|FG000|STARTED|Second Intervention||6
11176575|NCT01681836|12365484|FG001|STARTED|Second Intervention||5
11176576|NCT01681836|12365483|FG000|COMPLETED|Second Intervention||6
11176577|NCT01681836|12365484|FG001|COMPLETED|Second Intervention||4
11176578|NCT01681836|12365483|FG000|NOT COMPLETED|Second Intervention||0
11176579|NCT01681836|12365484|FG001|NOT COMPLETED|Second Intervention||1
11176580|NCT01681849|12365493|FG000|STARTED|Overall Study||15
11176581|NCT01681849|12365494|FG001|STARTED|Overall Study||13
11176582|NCT01681849|12365495|FG002|STARTED|Overall Study||56
11176583|NCT01681849|12365493|FG000|COMPLETED|Overall Study||7
11176584|NCT01681849|12365494|FG001|COMPLETED|Overall Study||6
11176585|NCT01681849|12365495|FG002|COMPLETED|Overall Study||17
11176586|NCT01681849|12365493|FG000|NOT COMPLETED|Overall Study||8
11176587|NCT01681849|12365494|FG001|NOT COMPLETED|Overall Study||7
11176588|NCT01681849|12365495|FG002|NOT COMPLETED|Overall Study||39
11176589|NCT01681992|12365505|FG000|STARTED|Overall Study||1493
11176590|NCT01681992|12365506|FG001|STARTED|Overall Study||1497
11176591|NCT01681992|12365507|FG002|STARTED|Overall Study||1526
11176592|NCT01681992|12365505|FG000|COMPLETED|Overall Study||1427
11176593|NCT01681992|12365506|FG001|COMPLETED|Overall Study||1427
11176594|NCT01681992|12365507|FG002|COMPLETED|Overall Study||1443
11176595|NCT01681992|12365505|FG000|NOT COMPLETED|Overall Study||66
11176596|NCT01681992|12365506|FG001|NOT COMPLETED|Overall Study||70
11176597|NCT01681992|12365507|FG002|NOT COMPLETED|Overall Study||83
11176598|NCT01682031|12365517|FG000|STARTED|Overall Study||8
11176599|NCT01682031|12365518|FG001|STARTED|Overall Study||10
11176600|NCT01682031|12365517|FG000|COMPLETED|Overall Study||7
11176601|NCT01682031|12365518|FG001|COMPLETED|Overall Study||5
11176602|NCT01682031|12365517|FG000|NOT COMPLETED|Overall Study||1
11176603|NCT01682031|12365518|FG001|NOT COMPLETED|Overall Study||5
11176604|NCT01682044|12365524|FG000|STARTED|Overall Study||20
11176605|NCT01682044|12365524|FG000|COMPLETED|Overall Study||16
11176606|NCT01682044|12365524|FG000|NOT COMPLETED|Overall Study||4
11176607|NCT01682135|12365531|FG000|STARTED|Overall Study||6
11176608|NCT01682135|12365532|FG001|STARTED|Overall Study||10
11176609|NCT01682135|12365533|FG002|STARTED|Overall Study||12
11176610|NCT01682135|12365531|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
11176611|NCT01682135|12365532|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
11176612|NCT01682135|12365533|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
11176613|NCT01682135|12365531|FG000|COMPLETED|Overall Study||6
11176614|NCT01682135|12365532|FG001|COMPLETED|Overall Study||10
11176615|NCT01682135|12365533|FG002|COMPLETED|Overall Study||12
11176616|NCT01682135|12365531|FG000|NOT COMPLETED|Overall Study||0
11176617|NCT01682135|12365532|FG001|NOT COMPLETED|Overall Study||0
11176618|NCT01682135|12365533|FG002|NOT COMPLETED|Overall Study||0
11176619|NCT01682213|12365543|FG000|STARTED|Overall Study||23
11176620|NCT01682213|12365543|FG000|COMPLETED|Overall Study||21
11176621|NCT01682213|12365543|FG000|NOT COMPLETED|Overall Study||2
11176622|NCT01682460|12365548|FG000|STARTED|Overall Study||15
11176623|NCT01682460|12365548|FG000|COMPLETED|Overall Study||11
11176624|NCT01682460|12365548|FG000|NOT COMPLETED|Overall Study||4
11176625|NCT01682512|12365555|FG000|STARTED|Overall Study||116
11176626|NCT01682512|12365556|FG001|STARTED|Overall Study||111
11176627|NCT01682512|12365557|FG002|STARTED|Overall Study||66
11176628|NCT01682512|12365555|FG000|Randomized in Part-I|Overall Study||66
11176629|NCT01682512|12365556|FG001|Randomized in Part-I|Overall Study||65
11176630|NCT01682512|12365557|FG002|Randomized in Part-I|Overall Study||66
11176631|NCT01682512|12365555|FG000|Randomized in Part-II|Overall Study||50
11176632|NCT01682512|12365556|FG001|Randomized in Part-II|Overall Study||46
11176633|NCT01682512|12365557|FG002|Randomized in Part-II|Overall Study||0
11176634|NCT01682512|12365555|FG000|COMPLETED|Overall Study||44
11176635|NCT01682512|12365556|FG001|COMPLETED|Overall Study||40
11176636|NCT01682512|12365557|FG002|COMPLETED|Overall Study||48
11176637|NCT01682512|12365555|FG000|NOT COMPLETED|Overall Study||72
11176638|NCT01682512|12365556|FG001|NOT COMPLETED|Overall Study||71
11176639|NCT01682512|12365557|FG002|NOT COMPLETED|Overall Study||18
11176640|NCT01682538|12365565|FG000|STARTED|Overall Study||12
11176641|NCT01682538|12365565|FG000|COMPLETED|Overall Study||12
11176642|NCT01682538|12365565|FG000|NOT COMPLETED|Overall Study||0
11176643|NCT01682603|12365580|FG000|STARTED|Overall Study||37
11176644|NCT01682603|12365580|FG000|COMPLETED|Overall Study||34
11176645|NCT01682603|12365580|FG000|NOT COMPLETED|Overall Study||3
11176646|NCT01682642|12365588|FG000|STARTED|Overall Study||61
11176647|NCT01682642|12365589|FG001|STARTED|Overall Study||59
11176648|NCT01682642|12365588|FG000|COMPLETED|Overall Study||61
11176649|NCT01682642|12365589|FG001|COMPLETED|Overall Study||58
11176650|NCT01682642|12365588|FG000|NOT COMPLETED|Overall Study||0
11176651|NCT01682642|12365589|FG001|NOT COMPLETED|Overall Study||1
11176652|NCT01682681|12365601|FG000|STARTED|Overall Study||1234
11176653|NCT01682681|12365601|FG000|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
11176654|NCT01682681|12365601|FG000|COMPLETED|Overall Study||902
11176655|NCT01682681|12365601|FG000|NOT COMPLETED|Overall Study||332
11176656|NCT01682720|12365609|FG000|STARTED|Overall Study||85
11176657|NCT01682720|12365610|FG001|STARTED|Overall Study||74
11176658|NCT01682720|12365611|FG002|STARTED|Overall Study||12
11176659|NCT01682720|12365612|FG003|STARTED|Overall Study||250
11176660|NCT01682720|12365609|FG000|Included in Full Analysis Set|Overall Study||0
11176661|NCT01682720|12365610|FG001|Included in Full Analysis Set|Overall Study||73
11176662|NCT01682720|12365611|FG002|Included in Full Analysis Set|Overall Study||11
11176663|NCT01682720|12365612|FG003|Included in Full Analysis Set|Overall Study||250
11176664|NCT01682720|12365609|FG000|COMPLETED|Overall Study||0
11176665|NCT01682720|12365610|FG001|COMPLETED|Overall Study||69
11176666|NCT01682720|12365611|FG002|COMPLETED|Overall Study||5
11176667|NCT01682720|12365612|FG003|COMPLETED|Overall Study||211
11176668|NCT01682720|12365609|FG000|NOT COMPLETED|Overall Study||85
11176669|NCT01682720|12365610|FG001|NOT COMPLETED|Overall Study||5
11176670|NCT01682720|12365611|FG002|NOT COMPLETED|Overall Study||7
11176671|NCT01682720|12365612|FG003|NOT COMPLETED|Overall Study||39
11176672|NCT01682759|12365624|FG000|STARTED|Overall Study||376
11176673|NCT01682759|12365625|FG001|STARTED|Overall Study||375
11176674|NCT01682759|12365624|FG000|Treated|Overall Study||375
11176675|NCT01682759|12365625|FG001|Treated|Overall Study||375
11176676|NCT01682759|12365624|FG000|COMPLETED|Overall Study||307
11176677|NCT01682759|12365625|FG001|COMPLETED|Overall Study||305
11176678|NCT01682759|12365624|FG000|NOT COMPLETED|Overall Study||69
11176679|NCT01682759|12365625|FG001|NOT COMPLETED|Overall Study||70
11176680|NCT01682811|12365638|FG000|STARTED|Part 1 Levulan Injection||1
11176681|NCT01682811|12365639|FG001|STARTED|Part 1 Levulan Injection||0
11176682|NCT01682811|12365640|FG002|STARTED|Part 1 Levulan Injection||0
11176683|NCT01682811|12365641|FG003|STARTED|Part 1 Levulan Injection||0
11176684|NCT01682811|12365642|FG004|STARTED|Part 1 Levulan Injection||0
11176685|NCT01682811|12365643|FG005|STARTED|Part 1 Levulan Injection||0
11176686|NCT01682811|12365644|FG006|STARTED|Part 1 Levulan Injection||0
11176687|NCT01682811|12365638|FG000|Control|Part 1 Levulan Injection||1
11176688|NCT01682811|12365639|FG001|Control|Part 1 Levulan Injection||0
11176689|NCT01682811|12365640|FG002|Control|Part 1 Levulan Injection||0
11176690|NCT01682811|12365641|FG003|Control|Part 1 Levulan Injection||0
11176691|NCT01682811|12365642|FG004|Control|Part 1 Levulan Injection||0
11176692|NCT01682811|12365643|FG005|Control|Part 1 Levulan Injection||0
11176693|NCT01682811|12365644|FG006|Control|Part 1 Levulan Injection||0
11176694|NCT01682811|12365638|FG000|Treated 3 Hours|Part 1 Levulan Injection||1
11176695|NCT01682811|12365639|FG001|Treated 3 Hours|Part 1 Levulan Injection||0
11176696|NCT01682811|12365640|FG002|Treated 3 Hours|Part 1 Levulan Injection||0
11176697|NCT01682811|12365641|FG003|Treated 3 Hours|Part 1 Levulan Injection||0
11176698|NCT01682811|12365642|FG004|Treated 3 Hours|Part 1 Levulan Injection||0
11176699|NCT01682811|12365643|FG005|Treated 3 Hours|Part 1 Levulan Injection||0
11176700|NCT01682811|12365644|FG006|Treated 3 Hours|Part 1 Levulan Injection||0
11176701|NCT01682811|12365638|FG000|Treated 24 Hours|Part 1 Levulan Injection||1
11176702|NCT01682811|12365639|FG001|Treated 24 Hours|Part 1 Levulan Injection||0
11176703|NCT01682811|12365640|FG002|Treated 24 Hours|Part 1 Levulan Injection||0
11176704|NCT01682811|12365641|FG003|Treated 24 Hours|Part 1 Levulan Injection||0
11176705|NCT01682811|12365642|FG004|Treated 24 Hours|Part 1 Levulan Injection||0
11176706|NCT01682811|12365643|FG005|Treated 24 Hours|Part 1 Levulan Injection||0
11176707|NCT01682811|12365644|FG006|Treated 24 Hours|Part 1 Levulan Injection||0
11176708|NCT01682811|12365638|FG000|COMPLETED|Part 1 Levulan Injection||1
11176709|NCT01682811|12365639|FG001|COMPLETED|Part 1 Levulan Injection||0
11176710|NCT01682811|12365640|FG002|COMPLETED|Part 1 Levulan Injection||0
11176711|NCT01682811|12365641|FG003|COMPLETED|Part 1 Levulan Injection||0
11176712|NCT01682811|12365642|FG004|COMPLETED|Part 1 Levulan Injection||0
11176713|NCT01682811|12365643|FG005|COMPLETED|Part 1 Levulan Injection||0
11176714|NCT01682811|12365644|FG006|COMPLETED|Part 1 Levulan Injection||0
11176715|NCT01682811|12365638|FG000|NOT COMPLETED|Part 1 Levulan Injection||0
11176716|NCT01682811|12365639|FG001|NOT COMPLETED|Part 1 Levulan Injection||0
11176717|NCT01682811|12365640|FG002|NOT COMPLETED|Part 1 Levulan Injection||0
11176718|NCT01682811|12365641|FG003|NOT COMPLETED|Part 1 Levulan Injection||0
11176719|NCT01682811|12365642|FG004|NOT COMPLETED|Part 1 Levulan Injection||0
11176720|NCT01682811|12365643|FG005|NOT COMPLETED|Part 1 Levulan Injection||0
11176721|NCT01682811|12365644|FG006|NOT COMPLETED|Part 1 Levulan Injection||0
11176722|NCT01682811|12365638|FG000|STARTED|Part 1 Levulan Painting||0
11176723|NCT01682811|12365639|FG001|STARTED|Part 1 Levulan Painting||1
11176724|NCT01682811|12365640|FG002|STARTED|Part 1 Levulan Painting||0
11176725|NCT01682811|12365641|FG003|STARTED|Part 1 Levulan Painting||0
11176726|NCT01682811|12365642|FG004|STARTED|Part 1 Levulan Painting||0
11176727|NCT01682811|12365643|FG005|STARTED|Part 1 Levulan Painting||0
11176728|NCT01682811|12365644|FG006|STARTED|Part 1 Levulan Painting||0
11176729|NCT01682811|12365638|FG000|Control|Part 1 Levulan Painting||0
11176730|NCT01682811|12365639|FG001|Control|Part 1 Levulan Painting||1
11176731|NCT01682811|12365640|FG002|Control|Part 1 Levulan Painting||0
11176732|NCT01682811|12365641|FG003|Control|Part 1 Levulan Painting||0
11176733|NCT01682811|12365642|FG004|Control|Part 1 Levulan Painting||0
11176734|NCT01682811|12365643|FG005|Control|Part 1 Levulan Painting||0
11176735|NCT01682811|12365644|FG006|Control|Part 1 Levulan Painting||0
11176736|NCT01682811|12365638|FG000|Treated 3 Hours|Part 1 Levulan Painting||0
11176737|NCT01682811|12365639|FG001|Treated 3 Hours|Part 1 Levulan Painting||1
11176738|NCT01682811|12365640|FG002|Treated 3 Hours|Part 1 Levulan Painting||0
11176739|NCT01682811|12365641|FG003|Treated 3 Hours|Part 1 Levulan Painting||0
11176740|NCT01682811|12365642|FG004|Treated 3 Hours|Part 1 Levulan Painting||0
11176741|NCT01682811|12365643|FG005|Treated 3 Hours|Part 1 Levulan Painting||0
11176742|NCT01682811|12365644|FG006|Treated 3 Hours|Part 1 Levulan Painting||0
11176743|NCT01682811|12365638|FG000|Treated 24 Hours|Part 1 Levulan Painting||0
11176744|NCT01682811|12365639|FG001|Treated 24 Hours|Part 1 Levulan Painting||1
11176745|NCT01682811|12365640|FG002|Treated 24 Hours|Part 1 Levulan Painting||0
11176746|NCT01682811|12365641|FG003|Treated 24 Hours|Part 1 Levulan Painting||0
11176747|NCT01682811|12365642|FG004|Treated 24 Hours|Part 1 Levulan Painting||0
11176748|NCT01682811|12365643|FG005|Treated 24 Hours|Part 1 Levulan Painting||0
11176749|NCT01682811|12365644|FG006|Treated 24 Hours|Part 1 Levulan Painting||0
11176750|NCT01682811|12365638|FG000|COMPLETED|Part 1 Levulan Painting||0
11176751|NCT01682811|12365639|FG001|COMPLETED|Part 1 Levulan Painting||1
11176752|NCT01682811|12365640|FG002|COMPLETED|Part 1 Levulan Painting||0
11176753|NCT01682811|12365641|FG003|COMPLETED|Part 1 Levulan Painting||0
11176754|NCT01682811|12365642|FG004|COMPLETED|Part 1 Levulan Painting||0
11176755|NCT01682811|12365643|FG005|COMPLETED|Part 1 Levulan Painting||0
11176756|NCT01682811|12365644|FG006|COMPLETED|Part 1 Levulan Painting||0
11176757|NCT01682811|12365638|FG000|NOT COMPLETED|Part 1 Levulan Painting||0
11176758|NCT01682811|12365639|FG001|NOT COMPLETED|Part 1 Levulan Painting||0
11176759|NCT01682811|12365640|FG002|NOT COMPLETED|Part 1 Levulan Painting||0
11176760|NCT01682811|12365641|FG003|NOT COMPLETED|Part 1 Levulan Painting||0
11176761|NCT01682811|12365642|FG004|NOT COMPLETED|Part 1 Levulan Painting||0
11176762|NCT01682811|12365643|FG005|NOT COMPLETED|Part 1 Levulan Painting||0
11176763|NCT01682811|12365644|FG006|NOT COMPLETED|Part 1 Levulan Painting||0
11176764|NCT01682811|12365638|FG000|STARTED|Part 1 Levulan Painted Twice||0
11176765|NCT01682811|12365639|FG001|STARTED|Part 1 Levulan Painted Twice||0
11176766|NCT01682811|12365640|FG002|STARTED|Part 1 Levulan Painted Twice||2
11176767|NCT01682811|12365641|FG003|STARTED|Part 1 Levulan Painted Twice||0
11176768|NCT01682811|12365642|FG004|STARTED|Part 1 Levulan Painted Twice||0
11176769|NCT01682811|12365643|FG005|STARTED|Part 1 Levulan Painted Twice||0
11176770|NCT01682811|12365644|FG006|STARTED|Part 1 Levulan Painted Twice||0
11176771|NCT01682811|12365638|FG000|Control|Part 1 Levulan Painted Twice||0
11176772|NCT01682811|12365639|FG001|Control|Part 1 Levulan Painted Twice||0
11176773|NCT01682811|12365640|FG002|Control|Part 1 Levulan Painted Twice||2
11176774|NCT01682811|12365641|FG003|Control|Part 1 Levulan Painted Twice||0
11176775|NCT01682811|12365642|FG004|Control|Part 1 Levulan Painted Twice||0
11176776|NCT01682811|12365643|FG005|Control|Part 1 Levulan Painted Twice||0
11176777|NCT01682811|12365644|FG006|Control|Part 1 Levulan Painted Twice||0
11176778|NCT01682811|12365638|FG000|Treated 24 Hours|Part 1 Levulan Painted Twice||0
11176779|NCT01682811|12365639|FG001|Treated 24 Hours|Part 1 Levulan Painted Twice||0
11176780|NCT01682811|12365640|FG002|Treated 24 Hours|Part 1 Levulan Painted Twice||2
11176781|NCT01682811|12365641|FG003|Treated 24 Hours|Part 1 Levulan Painted Twice||0
11176782|NCT01682811|12365642|FG004|Treated 24 Hours|Part 1 Levulan Painted Twice||0
11176783|NCT01682811|12365643|FG005|Treated 24 Hours|Part 1 Levulan Painted Twice||0
11176784|NCT01682811|12365644|FG006|Treated 24 Hours|Part 1 Levulan Painted Twice||0
11176785|NCT01682811|12365638|FG000|COMPLETED|Part 1 Levulan Painted Twice||0
11176786|NCT01682811|12365639|FG001|COMPLETED|Part 1 Levulan Painted Twice||0
11176787|NCT01682811|12365640|FG002|COMPLETED|Part 1 Levulan Painted Twice||2
11176788|NCT01682811|12365641|FG003|COMPLETED|Part 1 Levulan Painted Twice||0
11176789|NCT01682811|12365642|FG004|COMPLETED|Part 1 Levulan Painted Twice||0
11176790|NCT01682811|12365643|FG005|COMPLETED|Part 1 Levulan Painted Twice||0
11176791|NCT01682811|12365644|FG006|COMPLETED|Part 1 Levulan Painted Twice||0
11176792|NCT01682811|12365638|FG000|NOT COMPLETED|Part 1 Levulan Painted Twice||0
11176793|NCT01682811|12365639|FG001|NOT COMPLETED|Part 1 Levulan Painted Twice||0
11176794|NCT01682811|12365640|FG002|NOT COMPLETED|Part 1 Levulan Painted Twice||0
11176795|NCT01682811|12365641|FG003|NOT COMPLETED|Part 1 Levulan Painted Twice||0
11176796|NCT01682811|12365642|FG004|NOT COMPLETED|Part 1 Levulan Painted Twice||0
11176797|NCT01682811|12365643|FG005|NOT COMPLETED|Part 1 Levulan Painted Twice||0
11176798|NCT01682811|12365644|FG006|NOT COMPLETED|Part 1 Levulan Painted Twice||0
11176799|NCT01682811|12365638|FG000|STARTED|Part 1 Levulan Paint Twice Microneedling||0
11176800|NCT01682811|12365639|FG001|STARTED|Part 1 Levulan Paint Twice Microneedling||0
11176801|NCT01682811|12365640|FG002|STARTED|Part 1 Levulan Paint Twice Microneedling||0
11176802|NCT01682811|12365641|FG003|STARTED|Part 1 Levulan Paint Twice Microneedling||2
11176803|NCT01682811|12365642|FG004|STARTED|Part 1 Levulan Paint Twice Microneedling||0
11176804|NCT01682811|12365643|FG005|STARTED|Part 1 Levulan Paint Twice Microneedling||0
11176805|NCT01682811|12365644|FG006|STARTED|Part 1 Levulan Paint Twice Microneedling||0
11176806|NCT01682811|12365638|FG000|Control|Part 1 Levulan Paint Twice Microneedling||0
11176807|NCT01682811|12365639|FG001|Control|Part 1 Levulan Paint Twice Microneedling||0
11176808|NCT01682811|12365640|FG002|Control|Part 1 Levulan Paint Twice Microneedling||0
11176809|NCT01682811|12365641|FG003|Control|Part 1 Levulan Paint Twice Microneedling||2
11176810|NCT01682811|12365642|FG004|Control|Part 1 Levulan Paint Twice Microneedling||0
11176811|NCT01682811|12365643|FG005|Control|Part 1 Levulan Paint Twice Microneedling||0
11176812|NCT01682811|12365644|FG006|Control|Part 1 Levulan Paint Twice Microneedling||0
11176813|NCT01682811|12365638|FG000|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
11176814|NCT01682811|12365639|FG001|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
11176815|NCT01682811|12365640|FG002|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
11176816|NCT01682811|12365641|FG003|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||2
11176817|NCT01682811|12365642|FG004|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
11176818|NCT01682811|12365643|FG005|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
11176819|NCT01682811|12365644|FG006|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
11176820|NCT01682811|12365638|FG000|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
11176821|NCT01682811|12365639|FG001|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
11176822|NCT01682811|12365640|FG002|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
11176823|NCT01682811|12365641|FG003|COMPLETED|Part 1 Levulan Paint Twice Microneedling||2
11176824|NCT01682811|12365642|FG004|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
11176825|NCT01682811|12365643|FG005|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
11176826|NCT01682811|12365644|FG006|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
11176827|NCT01682811|12365638|FG000|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
11176828|NCT01682811|12365639|FG001|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
11176829|NCT01682811|12365640|FG002|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
11176830|NCT01682811|12365641|FG003|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
11176831|NCT01682811|12365642|FG004|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
11176832|NCT01682811|12365643|FG005|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
11176833|NCT01682811|12365644|FG006|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
11176834|NCT01682811|12365638|FG000|STARTED|Part 2 Dose Level 1||0
11176835|NCT01682811|12365639|FG001|STARTED|Part 2 Dose Level 1||0
11176836|NCT01682811|12365640|FG002|STARTED|Part 2 Dose Level 1||0
11176837|NCT01682811|12365641|FG003|STARTED|Part 2 Dose Level 1||0
11176838|NCT01682811|12365642|FG004|STARTED|Part 2 Dose Level 1||11
11176839|NCT01682811|12365643|FG005|STARTED|Part 2 Dose Level 1||0
11176840|NCT01682811|12365644|FG006|STARTED|Part 2 Dose Level 1||0
11176841|NCT01682811|12365638|FG000|Control|Part 2 Dose Level 1||0
11176842|NCT01682811|12365639|FG001|Control|Part 2 Dose Level 1||0
11176843|NCT01682811|12365640|FG002|Control|Part 2 Dose Level 1||0
11176844|NCT01682811|12365641|FG003|Control|Part 2 Dose Level 1||0
11176845|NCT01682811|12365642|FG004|Control|Part 2 Dose Level 1||10
11176846|NCT01682811|12365643|FG005|Control|Part 2 Dose Level 1||0
11176847|NCT01682811|12365644|FG006|Control|Part 2 Dose Level 1||0
11176848|NCT01682811|12365638|FG000|Treated|Part 2 Dose Level 1||0
11176849|NCT01682811|12365639|FG001|Treated|Part 2 Dose Level 1||0
11176850|NCT01682811|12365640|FG002|Treated|Part 2 Dose Level 1||0
11176851|NCT01682811|12365641|FG003|Treated|Part 2 Dose Level 1||0
11176852|NCT01682811|12365642|FG004|Treated|Part 2 Dose Level 1||10
11176853|NCT01682811|12365643|FG005|Treated|Part 2 Dose Level 1||0
11176854|NCT01682811|12365644|FG006|Treated|Part 2 Dose Level 1||0
11176855|NCT01682811|12365638|FG000|COMPLETED|Part 2 Dose Level 1||0
11176856|NCT01682811|12365639|FG001|COMPLETED|Part 2 Dose Level 1||0
11176857|NCT01682811|12365640|FG002|COMPLETED|Part 2 Dose Level 1||0
11176858|NCT01682811|12365641|FG003|COMPLETED|Part 2 Dose Level 1||0
11176859|NCT01682811|12365642|FG004|COMPLETED|Part 2 Dose Level 1||0
11176860|NCT01682811|12365643|FG005|COMPLETED|Part 2 Dose Level 1||0
11176861|NCT01682811|12365644|FG006|COMPLETED|Part 2 Dose Level 1||0
11176862|NCT01682811|12365638|FG000|NOT COMPLETED|Part 2 Dose Level 1||0
11176863|NCT01682811|12365639|FG001|NOT COMPLETED|Part 2 Dose Level 1||0
11176864|NCT01682811|12365640|FG002|NOT COMPLETED|Part 2 Dose Level 1||0
11176865|NCT01682811|12365641|FG003|NOT COMPLETED|Part 2 Dose Level 1||0
11176866|NCT01682811|12365642|FG004|NOT COMPLETED|Part 2 Dose Level 1||11
11176867|NCT01682811|12365643|FG005|NOT COMPLETED|Part 2 Dose Level 1||0
11176868|NCT01682811|12365644|FG006|NOT COMPLETED|Part 2 Dose Level 1||0
11176869|NCT01682811|12365638|FG000|STARTED|Part 2 Dose Level 2||0
11176870|NCT01682811|12365639|FG001|STARTED|Part 2 Dose Level 2||0
11176871|NCT01682811|12365640|FG002|STARTED|Part 2 Dose Level 2||0
11176872|NCT01682811|12365641|FG003|STARTED|Part 2 Dose Level 2||0
11176873|NCT01682811|12365642|FG004|STARTED|Part 2 Dose Level 2||0
11176874|NCT01682811|12365643|FG005|STARTED|Part 2 Dose Level 2||3
11176875|NCT01682811|12365644|FG006|STARTED|Part 2 Dose Level 2||0
11176876|NCT01682811|12365638|FG000|Control|Part 2 Dose Level 2||0
11176877|NCT01682811|12365639|FG001|Control|Part 2 Dose Level 2||0
11176878|NCT01682811|12365640|FG002|Control|Part 2 Dose Level 2||0
11176879|NCT01682811|12365641|FG003|Control|Part 2 Dose Level 2||0
11176880|NCT01682811|12365642|FG004|Control|Part 2 Dose Level 2||0
11176881|NCT01682811|12365643|FG005|Control|Part 2 Dose Level 2||3
11176882|NCT01682811|12365644|FG006|Control|Part 2 Dose Level 2||0
11176883|NCT01682811|12365638|FG000|Treated|Part 2 Dose Level 2||0
11176884|NCT01682811|12365639|FG001|Treated|Part 2 Dose Level 2||0
11176885|NCT01682811|12365640|FG002|Treated|Part 2 Dose Level 2||0
11176886|NCT01682811|12365641|FG003|Treated|Part 2 Dose Level 2||0
11176887|NCT01682811|12365642|FG004|Treated|Part 2 Dose Level 2||0
11176888|NCT01682811|12365643|FG005|Treated|Part 2 Dose Level 2||3
11176889|NCT01682811|12365644|FG006|Treated|Part 2 Dose Level 2||0
11176890|NCT01682811|12365638|FG000|COMPLETED|Part 2 Dose Level 2||0
11176891|NCT01682811|12365639|FG001|COMPLETED|Part 2 Dose Level 2||0
11176892|NCT01682811|12365640|FG002|COMPLETED|Part 2 Dose Level 2||0
11176893|NCT01682811|12365641|FG003|COMPLETED|Part 2 Dose Level 2||0
11176894|NCT01682811|12365642|FG004|COMPLETED|Part 2 Dose Level 2||0
11176895|NCT01682811|12365643|FG005|COMPLETED|Part 2 Dose Level 2||0
11176896|NCT01682811|12365644|FG006|COMPLETED|Part 2 Dose Level 2||0
11176897|NCT01682811|12365638|FG000|NOT COMPLETED|Part 2 Dose Level 2||0
11176898|NCT01682811|12365639|FG001|NOT COMPLETED|Part 2 Dose Level 2||0
11176899|NCT01682811|12365640|FG002|NOT COMPLETED|Part 2 Dose Level 2||0
11176900|NCT01682811|12365641|FG003|NOT COMPLETED|Part 2 Dose Level 2||0
11176901|NCT01682811|12365642|FG004|NOT COMPLETED|Part 2 Dose Level 2||0
11176902|NCT01682811|12365643|FG005|NOT COMPLETED|Part 2 Dose Level 2||3
11176903|NCT01682811|12365644|FG006|NOT COMPLETED|Part 2 Dose Level 2||0
11176904|NCT01682811|12365638|FG000|STARTED|Part 2 Dose Level 3||0
11176905|NCT01682811|12365639|FG001|STARTED|Part 2 Dose Level 3||0
11176906|NCT01682811|12365640|FG002|STARTED|Part 2 Dose Level 3||0
11176907|NCT01682811|12365641|FG003|STARTED|Part 2 Dose Level 3||0
11176908|NCT01682811|12365642|FG004|STARTED|Part 2 Dose Level 3||0
11176909|NCT01682811|12365643|FG005|STARTED|Part 2 Dose Level 3||0
11176910|NCT01682811|12365644|FG006|STARTED|Part 2 Dose Level 3||0
11176911|NCT01682811|12365638|FG000|Control|Part 2 Dose Level 3||0
11176912|NCT01682811|12365639|FG001|Control|Part 2 Dose Level 3||0
11176913|NCT01682811|12365640|FG002|Control|Part 2 Dose Level 3||0
11176914|NCT01682811|12365641|FG003|Control|Part 2 Dose Level 3||0
11176915|NCT01682811|12365642|FG004|Control|Part 2 Dose Level 3||0
11176916|NCT01682811|12365643|FG005|Control|Part 2 Dose Level 3||0
11176917|NCT01682811|12365644|FG006|Control|Part 2 Dose Level 3||0
11176918|NCT01682811|12365638|FG000|Treated|Part 2 Dose Level 3||0
11176919|NCT01682811|12365639|FG001|Treated|Part 2 Dose Level 3||0
11176920|NCT01682811|12365640|FG002|Treated|Part 2 Dose Level 3||0
11176921|NCT01682811|12365641|FG003|Treated|Part 2 Dose Level 3||0
11176922|NCT01682811|12365642|FG004|Treated|Part 2 Dose Level 3||0
11176923|NCT01682811|12365643|FG005|Treated|Part 2 Dose Level 3||0
11176924|NCT01682811|12365644|FG006|Treated|Part 2 Dose Level 3||0
11176925|NCT01682811|12365638|FG000|COMPLETED|Part 2 Dose Level 3||0
11176926|NCT01682811|12365639|FG001|COMPLETED|Part 2 Dose Level 3||0
11176927|NCT01682811|12365640|FG002|COMPLETED|Part 2 Dose Level 3||0
11176928|NCT01682811|12365641|FG003|COMPLETED|Part 2 Dose Level 3||0
11176929|NCT01682811|12365642|FG004|COMPLETED|Part 2 Dose Level 3||0
11176930|NCT01682811|12365643|FG005|COMPLETED|Part 2 Dose Level 3||0
11176931|NCT01682811|12365644|FG006|COMPLETED|Part 2 Dose Level 3||0
11176932|NCT01682811|12365638|FG000|NOT COMPLETED|Part 2 Dose Level 3||0
11176933|NCT01682811|12365639|FG001|NOT COMPLETED|Part 2 Dose Level 3||0
11176934|NCT01682811|12365640|FG002|NOT COMPLETED|Part 2 Dose Level 3||0
11176935|NCT01682811|12365641|FG003|NOT COMPLETED|Part 2 Dose Level 3||0
11176936|NCT01682811|12365642|FG004|NOT COMPLETED|Part 2 Dose Level 3||0
11176937|NCT01682811|12365643|FG005|NOT COMPLETED|Part 2 Dose Level 3||0
11176938|NCT01682811|12365644|FG006|NOT COMPLETED|Part 2 Dose Level 3||0
11176939|NCT01682837|12365663|FG000|STARTED|Baseline||35
11176940|NCT01682837|12365663|FG000|COMPLETED|Baseline||30
11176941|NCT01682837|12365663|FG000|NOT COMPLETED|Baseline||5
11176942|NCT01682837|12365663|FG000|STARTED|First Intervention (4 Weeks)||30
11176943|NCT01682837|12365663|FG000|Received KMgCit|First Intervention (4 Weeks)||8
11176944|NCT01682837|12365663|FG000|Received KCit|First Intervention (4 Weeks)||8
11176945|NCT01682837|12365663|FG000|Received KCl|First Intervention (4 Weeks)||7
11176946|NCT01682837|12365663|FG000|Received Placebo|First Intervention (4 Weeks)||7
11176947|NCT01682837|12365663|FG000|COMPLETED|First Intervention (4 Weeks)||30
11176948|NCT01682837|12365663|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
11176949|NCT01682837|12365663|FG000|STARTED|Second Intervention (4 Weeks)||30
11176950|NCT01682837|12365663|FG000|Received KMgCit|Second Intervention (4 Weeks)||7
11176951|NCT01682837|12365663|FG000|Received KCit|Second Intervention (4 Weeks)||6
11176952|NCT01682837|12365663|FG000|Received KCl|Second Intervention (4 Weeks)||8
11176953|NCT01682837|12365663|FG000|Received Placebo|Second Intervention (4 Weeks)||9
11176954|NCT01682837|12365663|FG000|COMPLETED|Second Intervention (4 Weeks)||30
11176955|NCT01682837|12365663|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
11176956|NCT01682837|12365663|FG000|STARTED|Third Intervention (4 Weeks)||30
11176957|NCT01682837|12365663|FG000|Received KMgCit|Third Intervention (4 Weeks)||9
11176958|NCT01682837|12365663|FG000|Received KCit|Third Intervention (4 Weeks)||7
11176959|NCT01682837|12365663|FG000|Received KCl|Third Intervention (4 Weeks)||7
11176960|NCT01682837|12365663|FG000|Received Placebo|Third Intervention (4 Weeks)||7
11176961|NCT01682837|12365663|FG000|COMPLETED|Third Intervention (4 Weeks)||30
11176962|NCT01682837|12365663|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0
11176963|NCT01682837|12365663|FG000|STARTED|Fourth Intervention (4 Weeks)||30
11176964|NCT01682837|12365663|FG000|Received KMgCit|Fourth Intervention (4 Weeks)||6
11176965|NCT01682837|12365663|FG000|Received KCit|Fourth Intervention (4 Weeks)||9
11176966|NCT01682837|12365663|FG000|Received KCl|Fourth Intervention (4 Weeks)||8
11323946|NCT02739789|12521268|FG001|STARTED|~1 Week Waiting Period||10
11323947|NCT02739789|12521267|FG000|COMPLETED|~1 Week Waiting Period||9
11323948|NCT02739789|12521268|FG001|COMPLETED|~1 Week Waiting Period||7
11323949|NCT02739789|12521267|FG000|NOT COMPLETED|~1 Week Waiting Period||0
11323950|NCT02739789|12521268|FG001|NOT COMPLETED|~1 Week Waiting Period||3
11323951|NCT02739789|12521267|FG000|STARTED|Second fMRI Scan||9
11323952|NCT02739789|12521268|FG001|STARTED|Second fMRI Scan||7
11323953|NCT02739789|12521267|FG000|COMPLETED|Second fMRI Scan||9
11323954|NCT02739789|12521268|FG001|COMPLETED|Second fMRI Scan||7
11323955|NCT02739789|12521267|FG000|NOT COMPLETED|Second fMRI Scan||0
11323956|NCT02739789|12521268|FG001|NOT COMPLETED|Second fMRI Scan||0
11323957|NCT02739828|12521274|FG000|STARTED|Overall Study||24
11323958|NCT02739828|12521274|FG000|COMPLETED|Overall Study||19
11323959|NCT02739828|12521274|FG000|NOT COMPLETED|Overall Study||5
11323960|NCT02739984|12521280|FG000|STARTED|Overall Study||143
11323961|NCT02739984|12521281|FG001|STARTED|Overall Study||281
11323962|NCT02739984|12521280|FG000|Received Study Drug|Overall Study||141
11323963|NCT02739984|12521281|FG001|Received Study Drug|Overall Study||280
11323964|NCT02739984|12521280|FG000|COMPLETED|Overall Study||138
11323965|NCT02739984|12521281|FG001|COMPLETED|Overall Study||279
11323966|NCT02739984|12521280|FG000|NOT COMPLETED|Overall Study||5
11323967|NCT02739984|12521281|FG001|NOT COMPLETED|Overall Study||2
11323968|NCT02739997|12521287|FG000|STARTED|Overall Study||100
11323969|NCT02739997|12521287|FG000|COMPLETED|Overall Study||98
11323970|NCT02739997|12521287|FG000|NOT COMPLETED|Overall Study||2
11323971|NCT02740049|12521291|FG000|STARTED|Overall Study||9
11323972|NCT02740049|12521291|FG000|COMPLETED|Overall Study||8
11323973|NCT02740049|12521291|FG000|NOT COMPLETED|Overall Study||1
11323974|NCT02740114|12521297|FG000|STARTED|Overall Study||54
11323975|NCT02740114|12521298|FG001|STARTED|Overall Study||48
11323976|NCT02740114|12521297|FG000|COMPLETED|Overall Study||54
11323977|NCT02740114|12521298|FG001|COMPLETED|Overall Study||48
11323978|NCT02740114|12521297|FG000|NOT COMPLETED|Overall Study||0
11323979|NCT02740114|12521298|FG001|NOT COMPLETED|Overall Study||0
11323980|NCT02740153|12521306|FG000|STARTED|Overall Study||101
11323981|NCT02740153|12521307|FG001|STARTED|Overall Study||86
11323982|NCT02740153|12521306|FG000|COMPLETED|Overall Study||101
11323983|NCT02740153|12521307|FG001|COMPLETED|Overall Study||86
11323984|NCT02740153|12521306|FG000|NOT COMPLETED|Overall Study||0
11323985|NCT02740153|12521307|FG001|NOT COMPLETED|Overall Study||0
11323986|NCT02740413|12521315|FG000|STARTED|Overall Study||86
11323987|NCT02740413|12521315|FG000|COMPLETED|Overall Study||86
11323988|NCT02740413|12521315|FG000|NOT COMPLETED|Overall Study||0
11323989|NCT02740478|12521323|FG000|STARTED|Overall Study|Volunteers recruited until quantity 20 completed the study|21
11323990|NCT02740478|12521323|FG000|COMPLETED|Overall Study|One volunteer was very high BMI and uncomfortable lying still during the recordings: test stopped.|20
11323991|NCT02740478|12521323|FG000|NOT COMPLETED|Overall Study||1
11323992|NCT02740504|12521327|FG000|STARTED|Overall Study||20
11323993|NCT02740504|12521327|FG000|COMPLETED|Overall Study||20
11323994|NCT02740504|12521327|FG000|NOT COMPLETED|Overall Study||0
11323995|NCT02740517|12521334|FG000|STARTED|Overall Study||19
11323996|NCT02740517|12521335|FG001|STARTED|Overall Study||11
11176967|NCT01682837|12365663|FG000|Received Placebo|Fourth Intervention (4 Weeks)||7
11176968|NCT01682837|12365663|FG000|COMPLETED|Fourth Intervention (4 Weeks)||30
11176969|NCT01682837|12365663|FG000|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
11176970|NCT01682863|12365676|FG000|STARTED|Overall Study||204
11176971|NCT01682863|12365677|FG001|STARTED|Overall Study||204
11176972|NCT01682863|12365678|FG002|STARTED|Overall Study||207
11176973|NCT01682863|12365676|FG000|Safety Set|Overall Study||204
11176974|NCT01682863|12365677|FG001|Safety Set|Overall Study||204
11176975|NCT01682863|12365678|FG002|Safety Set|Overall Study||206
11176976|NCT01682863|12365676|FG000|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
11176977|NCT01682863|12365677|FG001|Full Analysis Set (FAS)|Overall Study||204
11176978|NCT01682863|12365678|FG002|Full Analysis Set (FAS)|Overall Study||206
11176979|NCT01682863|12365676|FG000|Randomized Set|Overall Study||204
11176980|NCT01682863|12365677|FG001|Randomized Set|Overall Study||204
11176981|NCT01682863|12365678|FG002|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
11176982|NCT01682863|12365676|FG000|COMPLETED|Overall Study||177
11176983|NCT01682863|12365677|FG001|COMPLETED|Overall Study||187
11176984|NCT01682863|12365678|FG002|COMPLETED|Overall Study||183
11323997|NCT02740517|12521336|FG002|STARTED|Overall Study||18
11176985|NCT01682863|12365676|FG000|NOT COMPLETED|Overall Study||27
11176986|NCT01682863|12365677|FG001|NOT COMPLETED|Overall Study||17
11176987|NCT01682863|12365678|FG002|NOT COMPLETED|Overall Study||24
11176988|NCT01682876|12365690|FG000|STARTED|Overall Study||176
11176989|NCT01682876|12365691|FG001|STARTED|Overall Study||183
11176990|NCT01682876|12365692|FG002|STARTED|Overall Study||180
11176991|NCT01682876|12365693|FG003|STARTED|Overall Study||176
11176992|NCT01682876|12365690|FG000|COMPLETED|Overall Study||155
11176993|NCT01682876|12365691|FG001|COMPLETED|Overall Study||163
11176994|NCT01682876|12365692|FG002|COMPLETED|Overall Study||169
11176995|NCT01682876|12365693|FG003|COMPLETED|Overall Study||157
11176996|NCT01682876|12365690|FG000|NOT COMPLETED|Overall Study||21
11176997|NCT01682876|12365691|FG001|NOT COMPLETED|Overall Study||20
11176998|NCT01682876|12365692|FG002|NOT COMPLETED|Overall Study||11
11176999|NCT01682876|12365693|FG003|NOT COMPLETED|Overall Study||19
11177000|NCT01682954|12365708|FG000|STARTED|Overall Study||40
11177001|NCT01682954|12365709|FG001|STARTED|Overall Study||38
11177002|NCT01682954|12365708|FG000|COMPLETED|Overall Study||35
11177003|NCT01682954|12365709|FG001|COMPLETED|Overall Study||33
11177004|NCT01682954|12365708|FG000|NOT COMPLETED|Overall Study||5
11177005|NCT01682954|12365709|FG001|NOT COMPLETED|Overall Study||5
11177006|NCT01683019|12365718|FG000|STARTED|Overall Study||18
11177007|NCT01683019|12365719|FG001|STARTED|Overall Study||15
11177008|NCT01683019|12365720|FG002|STARTED|Overall Study||19
11177009|NCT01683019|12365718|FG000|COMPLETED|Overall Study||16
11177010|NCT01683019|12365719|FG001|COMPLETED|Overall Study||14
11177011|NCT01683019|12365720|FG002|COMPLETED|Overall Study||15
11177012|NCT01683019|12365718|FG000|NOT COMPLETED|Overall Study||2
11177013|NCT01683019|12365719|FG001|NOT COMPLETED|Overall Study||1
11177014|NCT01683019|12365720|FG002|NOT COMPLETED|Overall Study||4
11177015|NCT01683058|12365728|FG000|STARTED|Overall Study||74
11177016|NCT01683058|12365728|FG000|COMPLETED|Overall Study||45
11177017|NCT01683058|12365728|FG000|NOT COMPLETED|Overall Study||29
11177018|NCT01683071|12365739|FG000|STARTED|Part 1||25
11177019|NCT01683071|12365740|FG001|STARTED|Part 1||26
11177020|NCT01683071|12365741|FG002|STARTED|Part 1||25
11177021|NCT01683071|12365742|FG003|STARTED|Part 1||25
11177022|NCT01683071|12365743|FG004|STARTED|Part 1||0
11177023|NCT01683071|12365744|FG005|STARTED|Part 1||0
11177024|NCT01683071|12365739|FG000|COMPLETED|Part 1||21
11177025|NCT01683071|12365740|FG001|COMPLETED|Part 1||22
11177026|NCT01683071|12365741|FG002|COMPLETED|Part 1||22
11177027|NCT01683071|12365742|FG003|COMPLETED|Part 1||20
11177028|NCT01683071|12365743|FG004|COMPLETED|Part 1||0
11177029|NCT01683071|12365744|FG005|COMPLETED|Part 1||0
11177030|NCT01683071|12365739|FG000|NOT COMPLETED|Part 1||4
11177031|NCT01683071|12365740|FG001|NOT COMPLETED|Part 1||4
11177032|NCT01683071|12365741|FG002|NOT COMPLETED|Part 1||3
11177033|NCT01683071|12365742|FG003|NOT COMPLETED|Part 1||5
11177034|NCT01683071|12365743|FG004|NOT COMPLETED|Part 1||0
11177035|NCT01683071|12365744|FG005|NOT COMPLETED|Part 1||0
11177036|NCT01683071|12365739|FG000|STARTED|Part 2||0
11177037|NCT01683071|12365740|FG001|STARTED|Part 2||0
11177038|NCT01683071|12365741|FG002|STARTED|Part 2||0
11177039|NCT01683071|12365742|FG003|STARTED|Part 2||0
11177040|NCT01683071|12365743|FG004|STARTED|Part 2||99
11177041|NCT01683071|12365744|FG005|STARTED|Part 2||97
11177042|NCT01683071|12365739|FG000|COMPLETED|Part 2||0
11177043|NCT01683071|12365740|FG001|COMPLETED|Part 2||0
11177044|NCT01683071|12365741|FG002|COMPLETED|Part 2||0
11177045|NCT01683071|12365742|FG003|COMPLETED|Part 2||0
11177046|NCT01683071|12365743|FG004|COMPLETED|Part 2||82
11177047|NCT01683071|12365744|FG005|COMPLETED|Part 2||82
11177048|NCT01683071|12365739|FG000|NOT COMPLETED|Part 2||0
11177049|NCT01683071|12365740|FG001|NOT COMPLETED|Part 2||0
11177050|NCT01683071|12365741|FG002|NOT COMPLETED|Part 2||0
11177051|NCT01683071|12365742|FG003|NOT COMPLETED|Part 2||0
11177052|NCT01683071|12365743|FG004|NOT COMPLETED|Part 2||17
11177053|NCT01683071|12365744|FG005|NOT COMPLETED|Part 2||15
11177054|NCT01683266|12365766|FG000|STARTED|Overall Study||274
11177055|NCT01683266|12365767|FG001|STARTED|Overall Study||275
11177056|NCT01683266|12365766|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
11177057|NCT01683266|12365767|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
11177058|NCT01683266|12365766|FG000|COMPLETED|Overall Study||219
11177059|NCT01683266|12365767|FG001|COMPLETED|Overall Study||225
11177060|NCT01683266|12365766|FG000|NOT COMPLETED|Overall Study||55
11177061|NCT01683266|12365767|FG001|NOT COMPLETED|Overall Study||50
11177062|NCT01683331|12365775|FG000|STARTED|Overall Study||18
11177063|NCT01683331|12365776|FG001|STARTED|Overall Study||18
11177064|NCT01683331|12365775|FG000|Began Dosage|Overall Study||18
11177065|NCT01683331|12365776|FG001|Began Dosage|Overall Study||18
11177066|NCT01683331|12365775|FG000|12 Months|Overall Study||18
11177067|NCT01683331|12365776|FG001|12 Months|Overall Study||18
11177068|NCT01683331|12365775|FG000|24 Months|Overall Study||18
11177069|NCT01683331|12365776|FG001|24 Months|Overall Study||18
11177070|NCT01683331|12365775|FG000|COMPLETED|Overall Study||18
11177071|NCT01683331|12365776|FG001|COMPLETED|Overall Study||18
11177072|NCT01683331|12365775|FG000|NOT COMPLETED|Overall Study||0
11177073|NCT01683331|12365776|FG001|NOT COMPLETED|Overall Study||0
11177074|NCT01683383|12365784|FG000|STARTED|Overall Study||50
11177075|NCT01683383|12365785|FG001|STARTED|Overall Study||51
11177076|NCT01683383|12365784|FG000|Transported and Treated|Overall Study||49
11177077|NCT01683383|12365785|FG001|Transported and Treated|Overall Study||51
11177078|NCT01683383|12365784|FG000|COMPLETED|Overall Study||49
11177079|NCT01683383|12365785|FG001|COMPLETED|Overall Study||51
11177080|NCT01683383|12365784|FG000|NOT COMPLETED|Overall Study||1
11177081|NCT01683383|12365785|FG001|NOT COMPLETED|Overall Study||0
11177082|NCT01683409|12365796|FG000|STARTED|Treatment Period (Weeks 1-24)||27
11177083|NCT01683409|12365797|FG001|STARTED|Treatment Period (Weeks 1-24)||25
11177084|NCT01683409|12365798|FG002|STARTED|Treatment Period (Weeks 1-24)||27
11177085|NCT01683409|12365799|FG003|STARTED|Treatment Period (Weeks 1-24)||26
11177086|NCT01683409|12365800|FG004|STARTED|Treatment Period (Weeks 1-24)||25
11177087|NCT01683409|12365796|FG000|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
11177088|NCT01683409|12365797|FG001|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
11177089|NCT01683409|12365798|FG002|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
11177090|NCT01683409|12365799|FG003|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
11177091|NCT01683409|12365800|FG004|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
11177092|NCT01683409|12365796|FG000|COMPLETED|Treatment Period (Weeks 1-24)||27
11177093|NCT01683409|12365797|FG001|COMPLETED|Treatment Period (Weeks 1-24)||21
11177094|NCT01683409|12365798|FG002|COMPLETED|Treatment Period (Weeks 1-24)||26
11177095|NCT01683409|12365799|FG003|COMPLETED|Treatment Period (Weeks 1-24)||24
11177096|NCT01683409|12365800|FG004|COMPLETED|Treatment Period (Weeks 1-24)||23
11177097|NCT01683409|12365796|FG000|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
11177098|NCT01683409|12365797|FG001|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
11177099|NCT01683409|12365798|FG002|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
11177100|NCT01683409|12365799|FG003|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
11177101|NCT01683409|12365800|FG004|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
11177102|NCT01683409|12365796|FG000|STARTED|Washout Period 1 (Weeks 25-28)||27
11177103|NCT01683409|12365797|FG001|STARTED|Washout Period 1 (Weeks 25-28)||21
11177104|NCT01683409|12365798|FG002|STARTED|Washout Period 1 (Weeks 25-28)||26
11177105|NCT01683409|12365799|FG003|STARTED|Washout Period 1 (Weeks 25-28)||24
11177106|NCT01683409|12365800|FG004|STARTED|Washout Period 1 (Weeks 25-28)||23
11177107|NCT01683409|12365796|FG000|COMPLETED|Washout Period 1 (Weeks 25-28)||24
11177108|NCT01683409|12365797|FG001|COMPLETED|Washout Period 1 (Weeks 25-28)||17
11177109|NCT01683409|12365798|FG002|COMPLETED|Washout Period 1 (Weeks 25-28)||25
11177110|NCT01683409|12365799|FG003|COMPLETED|Washout Period 1 (Weeks 25-28)||22
11177111|NCT01683409|12365800|FG004|COMPLETED|Washout Period 1 (Weeks 25-28)||20
11177112|NCT01683409|12365796|FG000|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
11177113|NCT01683409|12365797|FG001|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
11177114|NCT01683409|12365798|FG002|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
11177115|NCT01683409|12365799|FG003|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
11177116|NCT01683409|12365800|FG004|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
11177117|NCT01683409|12365796|FG000|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
11177118|NCT01683409|12365797|FG001|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
11177119|NCT01683409|12365798|FG002|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
11177120|NCT01683409|12365799|FG003|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
11177121|NCT01683409|12365800|FG004|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
11177122|NCT01683409|12365796|FG000|COMPLETED|Washout Period 2 (Weeks 29-32)||6
11177123|NCT01683409|12365797|FG001|COMPLETED|Washout Period 2 (Weeks 29-32)||6
11177124|NCT01683409|12365798|FG002|COMPLETED|Washout Period 2 (Weeks 29-32)||7
11177125|NCT01683409|12365799|FG003|COMPLETED|Washout Period 2 (Weeks 29-32)||6
11177126|NCT01683409|12365800|FG004|COMPLETED|Washout Period 2 (Weeks 29-32)||9
11177127|NCT01683409|12365796|FG000|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
11177128|NCT01683409|12365797|FG001|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
11177129|NCT01683409|12365798|FG002|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
11177130|NCT01683409|12365799|FG003|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
11177131|NCT01683409|12365800|FG004|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
11177132|NCT01683422|12365826|FG000|STARTED|Overall Study||9
11177133|NCT01683422|12365826|FG000|COMPLETED|Overall Study||9
11177134|NCT01683422|12365826|FG000|NOT COMPLETED|Overall Study||0
11177135|NCT01683526|12365832|FG000|STARTED|Overall Study||60
11177136|NCT01683526|12365833|FG001|STARTED|Overall Study||57
11177137|NCT01683526|12365832|FG000|COMPLETED|Overall Study||60
11177138|NCT01683526|12365833|FG001|COMPLETED|Overall Study||57
11177139|NCT01683526|12365832|FG000|NOT COMPLETED|Overall Study||0
11177140|NCT01683526|12365833|FG001|NOT COMPLETED|Overall Study||0
11177141|NCT01683565|12365841|FG000|STARTED|Overall Study||15
11177142|NCT01683565|12365842|FG001|STARTED|Overall Study||16
11177143|NCT01683565|12365841|FG000|COMPLETED|Overall Study||12
11177144|NCT01683565|12365842|FG001|COMPLETED|Overall Study||15
11177145|NCT01683565|12365841|FG000|NOT COMPLETED|Overall Study||3
11177146|NCT01683565|12365842|FG001|NOT COMPLETED|Overall Study||1
11177147|NCT01683604|12365850|FG000|STARTED|Overall Study||37
11177148|NCT01683604|12365850|FG000|COMPLETED|Overall Study||32
11177149|NCT01683604|12365850|FG000|NOT COMPLETED|Overall Study||5
11177150|NCT01683630|12365861|FG000|STARTED|Overall Study||1404
11177151|NCT01683630|12365862|FG001|STARTED|Overall Study||445
11177152|NCT01683630|12365861|FG000|COMPLETED|Overall Study||1404
11177153|NCT01683630|12365862|FG001|COMPLETED|Overall Study||445
11177154|NCT01683630|12365861|FG000|NOT COMPLETED|Overall Study||0
11177155|NCT01683630|12365862|FG001|NOT COMPLETED|Overall Study||0
11177156|NCT01683812|12365868|FG000|STARTED|Overall Study||23
11177157|NCT01683812|12365868|FG000|COMPLETED|Overall Study||23
11177158|NCT01683812|12365868|FG000|NOT COMPLETED|Overall Study||0
11177159|NCT01683838|12365874|FG000|STARTED|Overall Study||104
11177160|NCT01683838|12365875|FG001|STARTED|Overall Study||100
11177161|NCT01683838|12365874|FG000|Intent to Treat (ITT) Population|Overall Study||103
11177162|NCT01683838|12365875|FG001|Intent to Treat (ITT) Population|Overall Study||100
11177163|NCT01683838|12365874|FG000|Safety Population|Overall Study||103
11177164|NCT01683838|12365875|FG001|Safety Population|Overall Study||100
11177165|NCT01683838|12365874|FG000|Efficacy Population|Overall Study||89
11177166|NCT01683838|12365875|FG001|Efficacy Population|Overall Study||93
11177167|NCT01683838|12365874|FG000|COMPLETED|Overall Study||78
11177168|NCT01683838|12365875|FG001|COMPLETED|Overall Study||88
11177169|NCT01683838|12365874|FG000|NOT COMPLETED|Overall Study||26
11177170|NCT01683838|12365875|FG001|NOT COMPLETED|Overall Study||12
11177171|NCT01683994|12365886|FG000|STARTED|Overall Study||4
11177172|NCT01683994|12365887|FG001|STARTED|Overall Study||8
11177173|NCT01683994|12365888|FG002|STARTED|Overall Study||7
11177174|NCT01683994|12365889|FG003|STARTED|Overall Study||13
11177175|NCT01683994|12365890|FG004|STARTED|Overall Study||13
11177176|NCT01683994|12365886|FG000|# of Patients Who Received Treatment|Overall Study||4
11177177|NCT01683994|12365887|FG001|# of Patients Who Received Treatment|Overall Study||8
11177178|NCT01683994|12365888|FG002|# of Patients Who Received Treatment|Overall Study||7
11177179|NCT01683994|12365889|FG003|# of Patients Who Received Treatment|Overall Study||12
11177180|NCT01683994|12365890|FG004|# of Patients Who Received Treatment|Overall Study||13
11177181|NCT01683994|12365886|FG000|COMPLETED|Overall Study||3
11177182|NCT01683994|12365887|FG001|COMPLETED|Overall Study||8
11177183|NCT01683994|12365888|FG002|COMPLETED|Overall Study||7
11177184|NCT01683994|12365889|FG003|COMPLETED|Overall Study||10
11177185|NCT01683994|12365890|FG004|COMPLETED|Overall Study||12
11177186|NCT01683994|12365886|FG000|NOT COMPLETED|Overall Study||1
11177187|NCT01683994|12365887|FG001|NOT COMPLETED|Overall Study||0
11177188|NCT01683994|12365888|FG002|NOT COMPLETED|Overall Study||0
11177189|NCT01683994|12365889|FG003|NOT COMPLETED|Overall Study||3
11177190|NCT01683994|12365890|FG004|NOT COMPLETED|Overall Study||1
11177191|NCT01684007|12365910|FG000|STARTED|Overall Study||53
11177192|NCT01684007|12365911|FG001|STARTED|Overall Study||50
11177193|NCT01684007|12365910|FG000|COMPLETED|Overall Study||53
11177194|NCT01684007|12365911|FG001|COMPLETED|Overall Study||50
11177195|NCT01684007|12365910|FG000|NOT COMPLETED|Overall Study||0
11177196|NCT01684007|12365911|FG001|NOT COMPLETED|Overall Study||0
11177197|NCT01684020|12365919|FG000|STARTED|Overall Study||5
11177198|NCT01684020|12365920|FG001|STARTED|Overall Study||5
11177199|NCT01684020|12365919|FG000|COMPLETED|Overall Study||4
11177200|NCT01684020|12365920|FG001|COMPLETED|Overall Study||5
11177201|NCT01684020|12365919|FG000|NOT COMPLETED|Overall Study||1
11177202|NCT01684020|12365920|FG001|NOT COMPLETED|Overall Study||0
11177203|NCT01684033|12365926|FG000|STARTED|Period 1, First 30 Days||99
11177204|NCT01684033|12365927|FG001|STARTED|Period 1, First 30 Days||99
11177205|NCT01684033|12365926|FG000|COMPLETED|Period 1, First 30 Days||95
11177206|NCT01684033|12365927|FG001|COMPLETED|Period 1, First 30 Days||98
11177207|NCT01684033|12365926|FG000|NOT COMPLETED|Period 1, First 30 Days||4
11177208|NCT01684033|12365927|FG001|NOT COMPLETED|Period 1, First 30 Days||1
11177209|NCT01684033|12365926|FG000|STARTED|Period 2, Second 30 Days||95
11177210|NCT01684033|12365927|FG001|STARTED|Period 2, Second 30 Days||98
11177211|NCT01684033|12365926|FG000|COMPLETED|Period 2, Second 30 Days||94
11177212|NCT01684033|12365927|FG001|COMPLETED|Period 2, Second 30 Days||98
11177213|NCT01684033|12365926|FG000|NOT COMPLETED|Period 2, Second 30 Days||1
11177214|NCT01684033|12365927|FG001|NOT COMPLETED|Period 2, Second 30 Days||0
11177215|NCT01684046|12365933|FG000|STARTED|Period 1, First 30 Days||97
11177216|NCT01684046|12365934|FG001|STARTED|Period 1, First 30 Days||95
11177217|NCT01684046|12365933|FG000|COMPLETED|Period 1, First 30 Days||97
11177218|NCT01684046|12365934|FG001|COMPLETED|Period 1, First 30 Days||93
11177219|NCT01684046|12365933|FG000|NOT COMPLETED|Period 1, First 30 Days||0
11177220|NCT01684046|12365934|FG001|NOT COMPLETED|Period 1, First 30 Days||2
11177221|NCT01684046|12365933|FG000|STARTED|Period 2, Second 30 Days||97
11177222|NCT01684046|12365934|FG001|STARTED|Period 2, Second 30 Days||93
11177223|NCT01684046|12365933|FG000|COMPLETED|Period 2, Second 30 Days||97
11177224|NCT01684046|12365934|FG001|COMPLETED|Period 2, Second 30 Days||93
11177225|NCT01684046|12365933|FG000|NOT COMPLETED|Period 2, Second 30 Days||0
11177226|NCT01684046|12365934|FG001|NOT COMPLETED|Period 2, Second 30 Days||0
11177227|NCT01684202|12365944|FG000|STARTED|Dose-escalation Period||15
11177228|NCT01684202|12365945|FG001|STARTED|Dose-escalation Period||8
11177229|NCT01684202|12365946|FG002|STARTED|Dose-escalation Period||9
11177230|NCT01684202|12365947|FG003|STARTED|Dose-escalation Period||11
11177231|NCT01684202|12365944|FG000|COMPLETED|Dose-escalation Period||14
11177232|NCT01684202|12365945|FG001|COMPLETED|Dose-escalation Period||7
11177233|NCT01684202|12365946|FG002|COMPLETED|Dose-escalation Period||9
11177234|NCT01684202|12365947|FG003|COMPLETED|Dose-escalation Period||11
11177235|NCT01684202|12365944|FG000|NOT COMPLETED|Dose-escalation Period||1
11177236|NCT01684202|12365945|FG001|NOT COMPLETED|Dose-escalation Period||1
11177237|NCT01684202|12365946|FG002|NOT COMPLETED|Dose-escalation Period||0
11177238|NCT01684202|12365947|FG003|NOT COMPLETED|Dose-escalation Period||0
11177239|NCT01684202|12365944|FG000|STARTED|Maintenance Period||14
11177240|NCT01684202|12365945|FG001|STARTED|Maintenance Period||7
11177241|NCT01684202|12365946|FG002|STARTED|Maintenance Period||9
11177242|NCT01684202|12365947|FG003|STARTED|Maintenance Period||11
11177243|NCT01684202|12365944|FG000|COMPLETED|Maintenance Period||13
11177244|NCT01684202|12365945|FG001|COMPLETED|Maintenance Period||4
11177245|NCT01684202|12365946|FG002|COMPLETED|Maintenance Period||8
11177246|NCT01684202|12365947|FG003|COMPLETED|Maintenance Period||10
11177247|NCT01684202|12365944|FG000|NOT COMPLETED|Maintenance Period||1
11177248|NCT01684202|12365945|FG001|NOT COMPLETED|Maintenance Period||3
11177249|NCT01684202|12365946|FG002|NOT COMPLETED|Maintenance Period||1
11177250|NCT01684202|12365947|FG003|NOT COMPLETED|Maintenance Period||1
11177251|NCT01684215|12365961|FG000|STARTED|Phase 1, Part 1||6
11177252|NCT01684215|12365962|FG001|STARTED|Phase 1, Part 1||6
11177253|NCT01684215|12365963|FG002|STARTED|Phase 1, Part 1||0
11177254|NCT01684215|12365964|FG003|STARTED|Phase 1, Part 1||0
11177255|NCT01684215|12365961|FG000|Treated|Phase 1, Part 1||6
11177256|NCT01684215|12365962|FG001|Treated|Phase 1, Part 1||6
11177257|NCT01684215|12365963|FG002|Treated|Phase 1, Part 1||0
11177258|NCT01684215|12365964|FG003|Treated|Phase 1, Part 1||0
11177259|NCT01684215|12365961|FG000|COMPLETED|Phase 1, Part 1||0
11177260|NCT01684215|12365962|FG001|COMPLETED|Phase 1, Part 1||0
11177261|NCT01684215|12365963|FG002|COMPLETED|Phase 1, Part 1||0
11177262|NCT01684215|12365964|FG003|COMPLETED|Phase 1, Part 1||0
11177263|NCT01684215|12365961|FG000|NOT COMPLETED|Phase 1, Part 1||6
11177264|NCT01684215|12365962|FG001|NOT COMPLETED|Phase 1, Part 1||6
11177265|NCT01684215|12365963|FG002|NOT COMPLETED|Phase 1, Part 1||0
11177266|NCT01684215|12365964|FG003|NOT COMPLETED|Phase 1, Part 1||0
11177267|NCT01684215|12365961|FG000|STARTED|Phase 1, Part 2||0
11177268|NCT01684215|12365962|FG001|STARTED|Phase 1, Part 2||0
11177269|NCT01684215|12365963|FG002|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6
11177270|NCT01684215|12365964|FG003|STARTED|Phase 1, Part 2||0
11177271|NCT01684215|12365961|FG000|COMPLETED|Phase 1, Part 2||0
11177272|NCT01684215|12365962|FG001|COMPLETED|Phase 1, Part 2||0
11177273|NCT01684215|12365963|FG002|COMPLETED|Phase 1, Part 2||0
11177274|NCT01684215|12365964|FG003|COMPLETED|Phase 1, Part 2||0
11177275|NCT01684215|12365961|FG000|NOT COMPLETED|Phase 1, Part 2||0
11177276|NCT01684215|12365962|FG001|NOT COMPLETED|Phase 1, Part 2||0
11177277|NCT01684215|12365963|FG002|NOT COMPLETED|Phase 1, Part 2||6
11177278|NCT01684215|12365964|FG003|NOT COMPLETED|Phase 1, Part 2||0
11177279|NCT01684215|12365961|FG000|STARTED|Phase 2||0
11177280|NCT01684215|12365962|FG001|STARTED|Phase 2||0
11177281|NCT01684215|12365963|FG002|STARTED|Phase 2||0
11177282|NCT01684215|12365964|FG003|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43
11177283|NCT01684215|12365961|FG000|Treated|Phase 2||0
11177284|NCT01684215|12365962|FG001|Treated|Phase 2||0
11177285|NCT01684215|12365963|FG002|Treated|Phase 2||0
11177286|NCT01684215|12365964|FG003|Treated|Phase 2||42
11177287|NCT01684215|12365961|FG000|COMPLETED|Phase 2||0
11177288|NCT01684215|12365962|FG001|COMPLETED|Phase 2||0
11177289|NCT01684215|12365963|FG002|COMPLETED|Phase 2||0
11177290|NCT01684215|12365964|FG003|COMPLETED|Phase 2||0
11177291|NCT01684215|12365961|FG000|NOT COMPLETED|Phase 2||0
11177292|NCT01684215|12365962|FG001|NOT COMPLETED|Phase 2||0
11177293|NCT01684215|12365963|FG002|NOT COMPLETED|Phase 2||0
11177294|NCT01684215|12365964|FG003|NOT COMPLETED|Phase 2||43
11177295|NCT01684410|12365980|FG000|STARTED|Overall Study||10
11177296|NCT01684410|12365981|FG001|STARTED|Overall Study||10
11177297|NCT01684410|12365982|FG002|STARTED|Overall Study||10
11177298|NCT01684410|12365980|FG000|COMPLETED|Overall Study||10
11177299|NCT01684410|12365981|FG001|COMPLETED|Overall Study||10
11177300|NCT01684410|12365982|FG002|COMPLETED|Overall Study||10
11177301|NCT01684410|12365980|FG000|NOT COMPLETED|Overall Study||0
11177302|NCT01684410|12365981|FG001|NOT COMPLETED|Overall Study||0
11177303|NCT01684410|12365982|FG002|NOT COMPLETED|Overall Study||0
11177304|NCT01684423|12365995|FG000|STARTED|Overall Study||11
11177305|NCT01684423|12365996|FG001|STARTED|Overall Study||13
11177306|NCT01684423|12365997|FG002|STARTED|Overall Study||13
11177307|NCT01684423|12365998|FG003|STARTED|Overall Study||19
11177308|NCT01684423|12365999|FG004|STARTED|Overall Study||7
11177309|NCT01684423|12365995|FG000|COMPLETED|Overall Study||11
11177310|NCT01684423|12365996|FG001|COMPLETED|Overall Study||13
11177311|NCT01684423|12365997|FG002|COMPLETED|Overall Study||12
11177312|NCT01684423|12365998|FG003|COMPLETED|Overall Study||19
11177313|NCT01684423|12365999|FG004|COMPLETED|Overall Study||7
11177314|NCT01684423|12365995|FG000|NOT COMPLETED|Overall Study||0
11177315|NCT01684423|12365996|FG001|NOT COMPLETED|Overall Study||0
11177316|NCT01684423|12365997|FG002|NOT COMPLETED|Overall Study||1
11177317|NCT01684423|12365998|FG003|NOT COMPLETED|Overall Study||0
11177318|NCT01684423|12365999|FG004|NOT COMPLETED|Overall Study||0
11177319|NCT01684436|12366013|FG000|STARTED|Overall Study||30
11177320|NCT01684436|12366013|FG000|COMPLETED|Overall Study||29
11177321|NCT01684436|12366013|FG000|NOT COMPLETED|Overall Study||1
11177322|NCT01684566|12366019|FG000|STARTED|Overall Study||60
11177323|NCT01684566|12366020|FG001|STARTED|Overall Study||56
11177324|NCT01684566|12366019|FG000|Treated (ITT)|Overall Study||57
11177325|NCT01684566|12366020|FG001|Treated (ITT)|Overall Study||52
11177326|NCT01684566|12366019|FG000|COMPLETED|Overall Study||44
11177327|NCT01684566|12366020|FG001|COMPLETED|Overall Study||49
11177328|NCT01684566|12366019|FG000|NOT COMPLETED|Overall Study||16
11177329|NCT01684566|12366020|FG001|NOT COMPLETED|Overall Study||7
11177330|NCT01684592|12366028|FG000|STARTED|Overall Study||64
11177331|NCT01684592|12366029|FG001|STARTED|Overall Study||64
11177332|NCT01684592|12366028|FG000|COMPLETED|Overall Study||38
11177333|NCT01684592|12366029|FG001|COMPLETED|Overall Study||40
11177334|NCT01684592|12366028|FG000|NOT COMPLETED|Overall Study||26
11177335|NCT01684592|12366029|FG001|NOT COMPLETED|Overall Study||24
11177336|NCT01684748|12366037|FG000|STARTED|First Intervention - 8 Weeks||10
11177337|NCT01684748|12366038|FG001|STARTED|First Intervention - 8 Weeks||10
11177338|NCT01684748|12366037|FG000|COMPLETED|First Intervention - 8 Weeks||8
11177339|NCT01684748|12366038|FG001|COMPLETED|First Intervention - 8 Weeks||8
11177340|NCT01684748|12366037|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2
11177341|NCT01684748|12366038|FG001|NOT COMPLETED|First Intervention - 8 Weeks||2
11177342|NCT01684748|12366037|FG000|STARTED|Second Intervention - 8 Weeks||8
11177343|NCT01684748|12366038|FG001|STARTED|Second Intervention - 8 Weeks||8
11177344|NCT01684748|12366037|FG000|COMPLETED|Second Intervention - 8 Weeks||8
11177345|NCT01684748|12366038|FG001|COMPLETED|Second Intervention - 8 Weeks||8
11177346|NCT01684748|12366037|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0
11177347|NCT01684748|12366038|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0
11177348|NCT01684839|12366044|FG000|STARTED|Overall Study||9
11177349|NCT01684839|12366044|FG000|COMPLETED|Overall Study||9
11177350|NCT01684839|12366044|FG000|NOT COMPLETED|Overall Study||0
11177351|NCT01684878|12366052|FG000|STARTED|Part 1: Safety Run in Phase||22
11177352|NCT01684878|12366053|FG001|STARTED|Part 1: Safety Run in Phase||28
11177353|NCT01684878|12366054|FG002|STARTED|Part 1: Safety Run in Phase||0
11177354|NCT01684878|12366055|FG003|STARTED|Part 1: Safety Run in Phase||0
11177355|NCT01684878|12366052|FG000|COMPLETED|Part 1: Safety Run in Phase||6
11177356|NCT01684878|12366053|FG001|COMPLETED|Part 1: Safety Run in Phase||5
11177357|NCT01684878|12366054|FG002|COMPLETED|Part 1: Safety Run in Phase||0
11177358|NCT01684878|12366055|FG003|COMPLETED|Part 1: Safety Run in Phase||0
11177359|NCT01684878|12366052|FG000|NOT COMPLETED|Part 1: Safety Run in Phase||16
11177360|NCT01684878|12366053|FG001|NOT COMPLETED|Part 1: Safety Run in Phase||23
11177361|NCT01684878|12366054|FG002|NOT COMPLETED|Part 1: Safety Run in Phase||0
11177362|NCT01684878|12366055|FG003|NOT COMPLETED|Part 1: Safety Run in Phase||0
11177363|NCT01684878|12366052|FG000|STARTED|Part 2: Randomized Phase||0
11177364|NCT01684878|12366053|FG001|STARTED|Part 2: Randomized Phase||0
11177365|NCT01684878|12366054|FG002|STARTED|Part 2: Randomized Phase||78
11177366|NCT01684878|12366055|FG003|STARTED|Part 2: Randomized Phase||78
11177367|NCT01684878|12366052|FG000|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
11177368|NCT01684878|12366053|FG001|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
11177369|NCT01684878|12366054|FG002|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
11177370|NCT01684878|12366055|FG003|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
11177371|NCT01684878|12366052|FG000|Participants Mis-randomized|Part 2: Randomized Phase||0
11177372|NCT01684878|12366053|FG001|Participants Mis-randomized|Part 2: Randomized Phase||0
11177373|NCT01684878|12366054|FG002|Participants Mis-randomized|Part 2: Randomized Phase||2
11177374|NCT01684878|12366055|FG003|Participants Mis-randomized|Part 2: Randomized Phase||0
11177375|NCT01684878|12366052|FG000|COMPLETED|Part 2: Randomized Phase||0
11323998|NCT02740517|12521334|FG000|COMPLETED|Overall Study||19
11177376|NCT01684878|12366053|FG001|COMPLETED|Part 2: Randomized Phase||0
11177377|NCT01684878|12366054|FG002|COMPLETED|Part 2: Randomized Phase||0
11177378|NCT01684878|12366055|FG003|COMPLETED|Part 2: Randomized Phase||0
11177379|NCT01684878|12366052|FG000|NOT COMPLETED|Part 2: Randomized Phase||0
11177380|NCT01684878|12366053|FG001|NOT COMPLETED|Part 2: Randomized Phase||0
11177381|NCT01684878|12366054|FG002|NOT COMPLETED|Part 2: Randomized Phase||78
11177382|NCT01684878|12366055|FG003|NOT COMPLETED|Part 2: Randomized Phase||78
11177383|NCT01684917|12366069|FG000|STARTED|Overall Study||11
11177384|NCT01684917|12366070|FG001|STARTED|Overall Study||7
11177385|NCT01684917|12366071|FG002|STARTED|Overall Study||13
11177386|NCT01684917|12366072|FG003|STARTED|Overall Study||5
11177387|NCT01684917|12366069|FG000|COMPLETED|Overall Study||11
11177388|NCT01684917|12366070|FG001|COMPLETED|Overall Study||7
11177389|NCT01684917|12366071|FG002|COMPLETED|Overall Study||13
11177390|NCT01684917|12366072|FG003|COMPLETED|Overall Study||5
11177391|NCT01684917|12366069|FG000|NOT COMPLETED|Overall Study||0
11177392|NCT01684917|12366070|FG001|NOT COMPLETED|Overall Study||0
11177393|NCT01684917|12366071|FG002|NOT COMPLETED|Overall Study||0
11177394|NCT01684917|12366072|FG003|NOT COMPLETED|Overall Study||0
11177395|NCT01684930|12366084|FG000|STARTED|Overall Study||12
11177396|NCT01684930|12366085|FG001|STARTED|Overall Study||14
11177397|NCT01684930|12366084|FG000|COMPLETED|Overall Study||9
11177398|NCT01684930|12366085|FG001|COMPLETED|Overall Study||13
11177399|NCT01684930|12366084|FG000|NOT COMPLETED|Overall Study||3
11177400|NCT01684930|12366085|FG001|NOT COMPLETED|Overall Study||1
11177401|NCT01684943|12366094|FG000|STARTED|Overall Study||29
11177402|NCT01684943|12366095|FG001|STARTED|Overall Study||3
11177403|NCT01684943|12366096|FG002|STARTED|Overall Study||1
11177404|NCT01684943|12366094|FG000|COMPLETED|Overall Study||20
11177405|NCT01684943|12366095|FG001|COMPLETED|Overall Study||2
11177406|NCT01684943|12366096|FG002|COMPLETED|Overall Study||0
11177407|NCT01684943|12366094|FG000|NOT COMPLETED|Overall Study||9
11177408|NCT01684943|12366095|FG001|NOT COMPLETED|Overall Study||1
11177409|NCT01684943|12366096|FG002|NOT COMPLETED|Overall Study||1
11177410|NCT01685021|12366109|FG000|STARTED|Overall Study||22
11177411|NCT01685021|12366109|FG000|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
11177412|NCT01685021|12366109|FG000|NOT COMPLETED|Overall Study||16
11177413|NCT01685047|12366113|FG000|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481
11177414|NCT01685047|12366113|FG000|COMPLETED|Overall Study||396
11177415|NCT01685047|12366113|FG000|NOT COMPLETED|Overall Study||85
11177416|NCT01685060|12366117|FG000|STARTED|Overall Study||140
11177417|NCT01685060|12366117|FG000|Entered Post-treatment Efficacy f/u|Overall Study||7
11177418|NCT01685060|12366117|FG000|Entered Survival Follow up|Overall Study||98
11177419|NCT01685060|12366117|FG000|Discontinued From Study|Overall Study||35
11177420|NCT01685060|12366117|FG000|COMPLETED|Overall Study||0
11177421|NCT01685060|12366117|FG000|NOT COMPLETED|Overall Study||140
11177422|NCT01685073|12366123|FG000|STARTED|Overall Study|Randomized|62
11177423|NCT01685073|12366124|FG001|STARTED|Overall Study|Randomized|65
11177424|NCT01685073|12366123|FG000|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32
11177425|NCT01685073|12366124|FG001|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33
11177426|NCT01685073|12366123|FG000|NOT COMPLETED|Overall Study||30
11177427|NCT01685073|12366124|FG001|NOT COMPLETED|Overall Study||32
11177428|NCT01685138|12366130|FG000|STARTED|Overall Study||124
11177429|NCT01685138|12366130|FG000|Discontinued From Treatment Phase|Overall Study||124
11177430|NCT01685138|12366130|FG000|Entered Post-treatment Efficacy f/up|Overall Study||10
11177431|NCT01685138|12366130|FG000|Entered Survival Follow-up|Overall Study||63
11177432|NCT01685138|12366130|FG000|Discontinued From Study|Overall Study||51
11177433|NCT01685138|12366130|FG000|COMPLETED|Overall Study||32
11177434|NCT01685138|12366130|FG000|NOT COMPLETED|Overall Study||92
11177435|NCT01685203|12366141|FG000|STARTED|Overall Study||44
11177436|NCT01685203|12366142|FG001|STARTED|Overall Study||42
11177437|NCT01685203|12366143|FG002|STARTED|Overall Study||40
11177438|NCT01685203|12366144|FG003|STARTED|Overall Study||42
11177439|NCT01685203|12366145|FG004|STARTED|Overall Study||49
11177440|NCT01685203|12366146|FG005|STARTED|Overall Study||47
11177441|NCT01685203|12366147|FG006|STARTED|Overall Study||52
11177442|NCT01685203|12366141|FG000|Completed Study Drug|Overall Study||42
11177443|NCT01685203|12366142|FG001|Completed Study Drug|Overall Study||40
11177444|NCT01685203|12366143|FG002|Completed Study Drug|Overall Study||39
11177445|NCT01685203|12366144|FG003|Completed Study Drug|Overall Study||42
11177446|NCT01685203|12366145|FG004|Completed Study Drug|Overall Study||49
11177447|NCT01685203|12366146|FG005|Completed Study Drug|Overall Study||43
11177448|NCT01685203|12366147|FG006|Completed Study Drug|Overall Study||52
11177449|NCT01685203|12366141|FG000|COMPLETED|Overall Study||40
11177450|NCT01685203|12366142|FG001|COMPLETED|Overall Study||39
11177451|NCT01685203|12366143|FG002|COMPLETED|Overall Study||40
11177452|NCT01685203|12366144|FG003|COMPLETED|Overall Study||41
11177453|NCT01685203|12366145|FG004|COMPLETED|Overall Study||49
11177454|NCT01685203|12366146|FG005|COMPLETED|Overall Study||44
11177455|NCT01685203|12366147|FG006|COMPLETED|Overall Study||52
11177456|NCT01685203|12366141|FG000|NOT COMPLETED|Overall Study||4
11177457|NCT01685203|12366142|FG001|NOT COMPLETED|Overall Study||3
11177458|NCT01685203|12366143|FG002|NOT COMPLETED|Overall Study||0
11177459|NCT01685203|12366144|FG003|NOT COMPLETED|Overall Study||1
11177460|NCT01685203|12366145|FG004|NOT COMPLETED|Overall Study||0
11177461|NCT01685203|12366146|FG005|NOT COMPLETED|Overall Study||3
11177462|NCT01685203|12366147|FG006|NOT COMPLETED|Overall Study||0
11177463|NCT01685216|12366163|FG000|STARTED|Overall Study||7
11177464|NCT01685216|12366163|FG000|COMPLETED|Overall Study||6
11177465|NCT01685216|12366163|FG000|NOT COMPLETED|Overall Study||1
11177466|NCT01685229|12366169|FG000|STARTED|Overall Study||146
11177467|NCT01685229|12366170|FG001|STARTED|Overall Study||52
11177468|NCT01685229|12366169|FG000|COMPLETED|Overall Study||120
11177469|NCT01685229|12366170|FG001|COMPLETED|Overall Study||36
11177470|NCT01685229|12366169|FG000|NOT COMPLETED|Overall Study||26
11177471|NCT01685229|12366170|FG001|NOT COMPLETED|Overall Study||16
11177472|NCT01685242|12366181|FG000|STARTED|Overall Study||50
11177473|NCT01685242|12366182|FG001|STARTED|Overall Study||50
11177474|NCT01685242|12366181|FG000|COMPLETED|Overall Study||49
11177475|NCT01685242|12366182|FG001|COMPLETED|Overall Study||47
11177476|NCT01685242|12366181|FG000|NOT COMPLETED|Overall Study||1
11177477|NCT01685242|12366182|FG001|NOT COMPLETED|Overall Study||3
11177478|NCT01685320|12366190|FG000|STARTED|Overall Study||15
11177479|NCT01685320|12366191|FG001|STARTED|Overall Study||15
11177480|NCT01685320|12366190|FG000|COMPLETED|Overall Study||15
11177481|NCT01685320|12366191|FG001|COMPLETED|Overall Study||15
11177482|NCT01685320|12366190|FG000|NOT COMPLETED|Overall Study||0
11177483|NCT01685320|12366191|FG001|NOT COMPLETED|Overall Study||0
11177484|NCT01685372|12366199|FG000|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
11177485|NCT01685372|12366200|FG001|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
11177486|NCT01685372|12366199|FG000|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
11177487|NCT01685372|12366200|FG001|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
11177488|NCT01685372|12366199|FG000|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
11177489|NCT01685372|12366200|FG001|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
11177490|NCT01685372|12366199|FG000|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
11177491|NCT01685372|12366200|FG001|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
11177492|NCT01685372|12366199|FG000|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
11177493|NCT01685372|12366200|FG001|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
11177494|NCT01685372|12366199|FG000|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
11177495|NCT01685372|12366200|FG001|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
11177496|NCT01685372|12366199|FG000|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
11177497|NCT01685372|12366200|FG001|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
11177498|NCT01685372|12366199|FG000|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
11177499|NCT01685372|12366200|FG001|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
11177500|NCT01685372|12366199|FG000|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
11177501|NCT01685372|12366200|FG001|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
11177502|NCT01685411|12366206|FG000|STARTED|Overall Study||5
11177503|NCT01685411|12366206|FG000|COMPLETED|Overall Study||5
11177504|NCT01685411|12366206|FG000|NOT COMPLETED|Overall Study||0
11177505|NCT01685437|12366210|FG000|STARTED|Overall Study||189
11177506|NCT01685437|12366210|FG000|COMPLETED|Overall Study||158
11177507|NCT01685437|12366210|FG000|NOT COMPLETED|Overall Study||31
11177508|NCT01685463|12366216|FG000|STARTED|Overall Study||10
11177509|NCT01685463|12366217|FG001|STARTED|Overall Study||8
11177510|NCT01685463|12366216|FG000|COMPLETED|Overall Study||10
11177511|NCT01685463|12366217|FG001|COMPLETED|Overall Study||8
11177512|NCT01685463|12366216|FG000|NOT COMPLETED|Overall Study||0
11177513|NCT01685463|12366217|FG001|NOT COMPLETED|Overall Study||0
11177514|NCT01685567|12366223|FG000|STARTED|Overall Study||219
11177515|NCT01685567|12366223|FG000|COMPLETED|Overall Study||219
11177516|NCT01685567|12366223|FG000|NOT COMPLETED|Overall Study||0
11177517|NCT01685684|12366229|FG000|STARTED|Titration Phase||740
11177518|NCT01685684|12366230|FG001|STARTED|Titration Phase||0
11177519|NCT01685684|12366231|FG002|STARTED|Titration Phase||0
11177520|NCT01685684|12366229|FG000|COMPLETED|Titration Phase||389
11177521|NCT01685684|12366230|FG001|COMPLETED|Titration Phase||0
11177522|NCT01685684|12366231|FG002|COMPLETED|Titration Phase||0
11177523|NCT01685684|12366229|FG000|NOT COMPLETED|Titration Phase||351
11177524|NCT01685684|12366230|FG001|NOT COMPLETED|Titration Phase||0
11177525|NCT01685684|12366231|FG002|NOT COMPLETED|Titration Phase||0
11177526|NCT01685684|12366229|FG000|STARTED|Double-blind Maintenance Phase||0
11177527|NCT01685684|12366230|FG001|STARTED|Double-blind Maintenance Phase||193
11177528|NCT01685684|12366231|FG002|STARTED|Double-blind Maintenance Phase||196
11177529|NCT01685684|12366229|FG000|COMPLETED|Double-blind Maintenance Phase||0
11177530|NCT01685684|12366230|FG001|COMPLETED|Double-blind Maintenance Phase||122
11177531|NCT01685684|12366231|FG002|COMPLETED|Double-blind Maintenance Phase||100
11177532|NCT01685684|12366229|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
11177533|NCT01685684|12366230|FG001|NOT COMPLETED|Double-blind Maintenance Phase||71
11177534|NCT01685684|12366231|FG002|NOT COMPLETED|Double-blind Maintenance Phase||96
11204026|NCT01851720|12394632|FG001|COMPLETED|Overall Study||0
11204027|NCT01851720|12394631|FG000|NOT COMPLETED|Overall Study||0
11204028|NCT01851720|12394632|FG001|NOT COMPLETED|Overall Study||1
11204029|NCT01851772|12394638|FG000|STARTED|Overall Study||3
11204030|NCT01851772|12394638|FG000|COMPLETED|Overall Study||3
11204031|NCT01851772|12394638|FG000|NOT COMPLETED|Overall Study||0
11204032|NCT01851863|12394646|FG000|STARTED|Overall Study||65
11204033|NCT01851863|12394647|FG001|STARTED|Overall Study||66
11204034|NCT01851863|12394648|FG002|STARTED|Overall Study||65
11204035|NCT01851863|12394649|FG003|STARTED|Overall Study||66
11204036|NCT01851863|12394646|FG000|COMPLETED|Overall Study||60
11204037|NCT01851863|12394647|FG001|COMPLETED|Overall Study||57
11204038|NCT01851863|12394648|FG002|COMPLETED|Overall Study||60
11204039|NCT01851863|12394649|FG003|COMPLETED|Overall Study||63
11204040|NCT01851863|12394646|FG000|NOT COMPLETED|Overall Study||5
11204041|NCT01851863|12394647|FG001|NOT COMPLETED|Overall Study||9
11204042|NCT01851863|12394648|FG002|NOT COMPLETED|Overall Study||5
11204043|NCT01851863|12394649|FG003|NOT COMPLETED|Overall Study||3
11204044|NCT01851876|12394664|FG000|STARTED|Overall Study||56
11204045|NCT01851876|12394665|FG001|STARTED|Overall Study||62
11204046|NCT01851876|12394664|FG000|COMPLETED|Overall Study||56
11204047|NCT01851876|12394665|FG001|COMPLETED|Overall Study||62
11204048|NCT01851876|12394664|FG000|NOT COMPLETED|Overall Study||0
11204049|NCT01851876|12394665|FG001|NOT COMPLETED|Overall Study||0
11204050|NCT01852019|12394673|FG000|STARTED|Day 1||3
11204051|NCT01852019|12394674|FG001|STARTED|Day 1||3
11204052|NCT01852019|12394675|FG002|STARTED|Day 1||6
11204053|NCT01852019|12394676|FG003|STARTED|Day 1||0
11204054|NCT01852019|12394677|FG004|STARTED|Day 1||0
11204055|NCT01852019|12394673|FG000|COMPLETED|Day 1||3
11204056|NCT01852019|12394674|FG001|COMPLETED|Day 1||3
11204057|NCT01852019|12394675|FG002|COMPLETED|Day 1||6
11204058|NCT01852019|12394676|FG003|COMPLETED|Day 1||0
11177535|NCT01685697|12366241|FG000|STARTED|Overall Study||31
11177536|NCT01685697|12366242|FG001|STARTED|Overall Study||31
11177537|NCT01685697|12366241|FG000|COMPLETED|Overall Study||28
11177538|NCT01685697|12366242|FG001|COMPLETED|Overall Study||28
11177539|NCT01685697|12366241|FG000|NOT COMPLETED|Overall Study||3
11177540|NCT01685697|12366242|FG001|NOT COMPLETED|Overall Study||3
11177541|NCT01685801|12366252|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||5
11177542|NCT01685801|12366253|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||6
11177543|NCT01685801|12366254|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||7
11177544|NCT01685801|12366255|FG003|STARTED|Cycle 1 Period 1 (2 Weeks)||6
11177545|NCT01685801|12366252|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
11177546|NCT01685801|12366253|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
11177547|NCT01685801|12366254|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
11177548|NCT01685801|12366255|FG003|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
11177549|NCT01685801|12366252|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
11177550|NCT01685801|12366253|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
11177551|NCT01685801|12366254|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
11177552|NCT01685801|12366255|FG003|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
11177553|NCT01685801|12366252|FG000|STARTED|Cycle 1 Period 2 (2 Weeks)||5
11177554|NCT01685801|12366253|FG001|STARTED|Cycle 1 Period 2 (2 Weeks)||6
11177555|NCT01685801|12366254|FG002|STARTED|Cycle 1 Period 2 (2 Weeks)||7
11177556|NCT01685801|12366255|FG003|STARTED|Cycle 1 Period 2 (2 Weeks)||6
11177557|NCT01685801|12366252|FG000|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
11177558|NCT01685801|12366253|FG001|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
11177559|NCT01685801|12366254|FG002|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
11177560|NCT01685801|12366255|FG003|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
11177561|NCT01685801|12366252|FG000|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
11177562|NCT01685801|12366253|FG001|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
11177563|NCT01685801|12366254|FG002|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
11177564|NCT01685801|12366255|FG003|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
11177565|NCT01685801|12366252|FG000|STARTED|Washout Period 1 (4 Weeks)||5
11177566|NCT01685801|12366253|FG001|STARTED|Washout Period 1 (4 Weeks)||6
11177567|NCT01685801|12366254|FG002|STARTED|Washout Period 1 (4 Weeks)||7
11177568|NCT01685801|12366255|FG003|STARTED|Washout Period 1 (4 Weeks)||5
11177569|NCT01685801|12366252|FG000|COMPLETED|Washout Period 1 (4 Weeks)||5
11177570|NCT01685801|12366253|FG001|COMPLETED|Washout Period 1 (4 Weeks)||6
11177571|NCT01685801|12366254|FG002|COMPLETED|Washout Period 1 (4 Weeks)||7
11177572|NCT01685801|12366255|FG003|COMPLETED|Washout Period 1 (4 Weeks)||5
11177573|NCT01685801|12366252|FG000|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
11177574|NCT01685801|12366253|FG001|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
11177575|NCT01685801|12366254|FG002|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
11177576|NCT01685801|12366255|FG003|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
11177577|NCT01685801|12366252|FG000|STARTED|Cycle 2 Period 1 (2 Weeks)||5
11177578|NCT01685801|12366253|FG001|STARTED|Cycle 2 Period 1 (2 Weeks)||6
11177579|NCT01685801|12366254|FG002|STARTED|Cycle 2 Period 1 (2 Weeks)||7
11177580|NCT01685801|12366255|FG003|STARTED|Cycle 2 Period 1 (2 Weeks)||5
11177581|NCT01685801|12366252|FG000|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
11177582|NCT01685801|12366253|FG001|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
11177583|NCT01685801|12366254|FG002|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
11177584|NCT01685801|12366255|FG003|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
11177585|NCT01685801|12366252|FG000|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
11177586|NCT01685801|12366253|FG001|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
11177587|NCT01685801|12366254|FG002|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
11177588|NCT01685801|12366255|FG003|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
11177589|NCT01685801|12366252|FG000|STARTED|Cycle 2 Period 2 (2 Weeks)||5
11177590|NCT01685801|12366253|FG001|STARTED|Cycle 2 Period 2 (2 Weeks)||6
11177591|NCT01685801|12366254|FG002|STARTED|Cycle 2 Period 2 (2 Weeks)||7
11177592|NCT01685801|12366255|FG003|STARTED|Cycle 2 Period 2 (2 Weeks)||5
11177593|NCT01685801|12366252|FG000|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
11177594|NCT01685801|12366253|FG001|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
11177595|NCT01685801|12366254|FG002|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
11177596|NCT01685801|12366255|FG003|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
11177597|NCT01685801|12366252|FG000|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
11177598|NCT01685801|12366253|FG001|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
11177599|NCT01685801|12366254|FG002|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
11177600|NCT01685801|12366255|FG003|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
11177601|NCT01685801|12366252|FG000|STARTED|Washout Period 2 (4 Weeks)||5
11177602|NCT01685801|12366253|FG001|STARTED|Washout Period 2 (4 Weeks)||5
11177603|NCT01685801|12366254|FG002|STARTED|Washout Period 2 (4 Weeks)||7
11177604|NCT01685801|12366255|FG003|STARTED|Washout Period 2 (4 Weeks)||4
11177605|NCT01685801|12366252|FG000|COMPLETED|Washout Period 2 (4 Weeks)||5
11177606|NCT01685801|12366253|FG001|COMPLETED|Washout Period 2 (4 Weeks)||5
11177607|NCT01685801|12366254|FG002|COMPLETED|Washout Period 2 (4 Weeks)||7
11177608|NCT01685801|12366255|FG003|COMPLETED|Washout Period 2 (4 Weeks)||4
11177609|NCT01685801|12366252|FG000|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
11177610|NCT01685801|12366253|FG001|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
11177611|NCT01685801|12366254|FG002|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
11177612|NCT01685801|12366255|FG003|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
11177613|NCT01685801|12366252|FG000|STARTED|Open-label Period (8 Weeks)||5
11177614|NCT01685801|12366253|FG001|STARTED|Open-label Period (8 Weeks)||5
11177615|NCT01685801|12366254|FG002|STARTED|Open-label Period (8 Weeks)||7
11177616|NCT01685801|12366255|FG003|STARTED|Open-label Period (8 Weeks)||4
11177617|NCT01685801|12366252|FG000|COMPLETED|Open-label Period (8 Weeks)||5
11177618|NCT01685801|12366253|FG001|COMPLETED|Open-label Period (8 Weeks)||5
11177619|NCT01685801|12366254|FG002|COMPLETED|Open-label Period (8 Weeks)||7
11177620|NCT01685801|12366255|FG003|COMPLETED|Open-label Period (8 Weeks)||4
11177621|NCT01685801|12366252|FG000|NOT COMPLETED|Open-label Period (8 Weeks)||0
11177622|NCT01685801|12366253|FG001|NOT COMPLETED|Open-label Period (8 Weeks)||0
11177623|NCT01685801|12366254|FG002|NOT COMPLETED|Open-label Period (8 Weeks)||0
11177624|NCT01685801|12366255|FG003|NOT COMPLETED|Open-label Period (8 Weeks)||0
11177625|NCT01685840|12366274|FG000|STARTED|Overall Study||448
11177626|NCT01685840|12366275|FG001|STARTED|Overall Study||446
11177627|NCT01685840|12366274|FG000|COMPLETED|Overall Study||119
11177628|NCT01685840|12366275|FG001|COMPLETED|Overall Study||114
11177629|NCT01685840|12366274|FG000|NOT COMPLETED|Overall Study||329
11177630|NCT01685840|12366275|FG001|NOT COMPLETED|Overall Study||332
11177631|NCT01685983|12366283|FG000|STARTED|Overall Study||82
11177632|NCT01685983|12366283|FG000|COMPLETED|Overall Study||0
11177633|NCT01685983|12366283|FG000|NOT COMPLETED|Overall Study||82
11177634|NCT01685996|12366289|FG000|STARTED|Overall Study||34
11177635|NCT01685996|12366290|FG001|STARTED|Overall Study||40
11177636|NCT01685996|12366289|FG000|COMPLETED|Overall Study||18
11177637|NCT01685996|12366290|FG001|COMPLETED|Overall Study||27
11177638|NCT01685996|12366289|FG000|NOT COMPLETED|Overall Study||16
11177639|NCT01685996|12366290|FG001|NOT COMPLETED|Overall Study||13
11177640|NCT01686152|12366299|FG000|STARTED|Overall Study||252
11177641|NCT01686152|12366300|FG001|STARTED|Overall Study||253
11177642|NCT01686152|12366301|FG002|STARTED|Overall Study||84
11177643|NCT01686152|12366299|FG000|COMPLETED|Overall Study||211
11177644|NCT01686152|12366300|FG001|COMPLETED|Overall Study||218
11177645|NCT01686152|12366301|FG002|COMPLETED|Overall Study||75
11177646|NCT01686152|12366299|FG000|NOT COMPLETED|Overall Study||41
11177647|NCT01686152|12366300|FG001|NOT COMPLETED|Overall Study||35
11177648|NCT01686152|12366301|FG002|NOT COMPLETED|Overall Study||9
11177649|NCT01686165|12366309|FG000|STARTED|Overall Study||5
11177650|NCT01686165|12366309|FG000|COMPLETED|Overall Study||5
11177651|NCT01686165|12366309|FG000|NOT COMPLETED|Overall Study||0
11177652|NCT01686373|12366315|FG000|STARTED|Overall Study||34
11177653|NCT01686373|12366316|FG001|STARTED|Overall Study||40
11177654|NCT01686373|12366315|FG000|Received 15 Treatment Sessions|Overall Study||33
11177655|NCT01686373|12366316|FG001|Received 15 Treatment Sessions|Overall Study||39
11177656|NCT01686373|12366315|FG000|COMPLETED|Overall Study||31
11177657|NCT01686373|12366316|FG001|COMPLETED|Overall Study||38
11177658|NCT01686373|12366315|FG000|NOT COMPLETED|Overall Study||3
11177659|NCT01686373|12366316|FG001|NOT COMPLETED|Overall Study||2
11177660|NCT01686438|12366325|FG000|STARTED|Overall Study||15
11177661|NCT01686438|12366326|FG001|STARTED|Overall Study||35
11177662|NCT01686438|12366327|FG002|STARTED|Overall Study||37
11177663|NCT01686438|12366325|FG000|2-Week Follow Up|Overall Study||12
11177664|NCT01686438|12366326|FG001|2-Week Follow Up|Overall Study||31
11177665|NCT01686438|12366327|FG002|2-Week Follow Up|Overall Study||27
11177666|NCT01686438|12366325|FG000|3-Month Follow Up|Overall Study||7
11177667|NCT01686438|12366326|FG001|3-Month Follow Up|Overall Study||21
11177668|NCT01686438|12366327|FG002|3-Month Follow Up|Overall Study||17
11177669|NCT01686438|12366325|FG000|6-Month Follow Up|Overall Study||7
11177670|NCT01686438|12366326|FG001|6-Month Follow Up|Overall Study||26
11177671|NCT01686438|12366327|FG002|6-Month Follow Up|Overall Study||24
11177672|NCT01686438|12366325|FG000|COMPLETED|Overall Study||7
11177673|NCT01686438|12366326|FG001|COMPLETED|Overall Study||26
11177674|NCT01686438|12366327|FG002|COMPLETED|Overall Study||24
11177675|NCT01686438|12366325|FG000|NOT COMPLETED|Overall Study||8
11177676|NCT01686438|12366326|FG001|NOT COMPLETED|Overall Study||9
11177677|NCT01686438|12366327|FG002|NOT COMPLETED|Overall Study||13
11177678|NCT01686451|12366339|FG000|STARTED|Overall Study||33
11177679|NCT01686451|12366340|FG001|STARTED|Overall Study||27
11177680|NCT01686451|12366339|FG000|COMPLETED|Overall Study||33
11177681|NCT01686451|12366340|FG001|COMPLETED|Overall Study||27
11177682|NCT01686451|12366339|FG000|NOT COMPLETED|Overall Study||0
11177683|NCT01686451|12366340|FG001|NOT COMPLETED|Overall Study||0
11177684|NCT01686503|12366352|FG000|STARTED|Overall Study||66
11177685|NCT01686503|12366353|FG001|STARTED|Overall Study||66
11177686|NCT01686503|12366354|FG002|STARTED|Overall Study||66
11177687|NCT01686503|12366355|FG003|STARTED|Overall Study||33
11177688|NCT01686503|12366352|FG000|COMPLETED|Overall Study||65
11177689|NCT01686503|12366353|FG001|COMPLETED|Overall Study||63
11177690|NCT01686503|12366354|FG002|COMPLETED|Overall Study||64
11177691|NCT01686503|12366355|FG003|COMPLETED|Overall Study||32
11177692|NCT01686503|12366352|FG000|NOT COMPLETED|Overall Study||1
11177693|NCT01686503|12366353|FG001|NOT COMPLETED|Overall Study||3
11177694|NCT01686503|12366354|FG002|NOT COMPLETED|Overall Study||2
11177695|NCT01686503|12366355|FG003|NOT COMPLETED|Overall Study||1
11177696|NCT01686568|12366367|FG000|STARTED|Main Study||16
11177697|NCT01686568|12366368|FG001|STARTED|Main Study||15
11177698|NCT01686568|12366367|FG000|COMPLETED|Main Study||14
11177699|NCT01686568|12366368|FG001|COMPLETED|Main Study||11
11177700|NCT01686568|12366367|FG000|NOT COMPLETED|Main Study||2
11177701|NCT01686568|12366368|FG001|NOT COMPLETED|Main Study||4
11177702|NCT01686568|12366367|FG000|STARTED|Sub-Study||14
11177703|NCT01686568|12366368|FG001|STARTED|Sub-Study||11
11177704|NCT01686568|12366367|FG000|COMPLETED|Sub-Study||12
11177705|NCT01686568|12366368|FG001|COMPLETED|Sub-Study||9
11177706|NCT01686568|12366367|FG000|NOT COMPLETED|Sub-Study||2
11177707|NCT01686568|12366368|FG001|NOT COMPLETED|Sub-Study||2
11177708|NCT01686581|12366374|FG000|STARTED|Overall Study||641
11177709|NCT01686581|12366374|FG000|Safety Analysis Set; Received Study Drug|Overall Study||633
11177710|NCT01686581|12366374|FG000|Completed 24 Months|Overall Study||128
11177711|NCT01686581|12366374|FG000|COMPLETED|Overall Study||464
11177712|NCT01686581|12366374|FG000|NOT COMPLETED|Overall Study||177
11177713|NCT01686633|12366381|FG000|STARTED|Overall Study||347
11177714|NCT01686633|12366382|FG001|STARTED|Overall Study||346
11177715|NCT01686633|12366383|FG002|STARTED|Overall Study||346
11177716|NCT01686633|12366381|FG000|COMPLETED|Overall Study||296
11177717|NCT01686633|12366382|FG001|COMPLETED|Overall Study||314
11177718|NCT01686633|12366383|FG002|COMPLETED|Overall Study||321
11177719|NCT01686633|12366381|FG000|NOT COMPLETED|Overall Study||51
11177720|NCT01686633|12366382|FG001|NOT COMPLETED|Overall Study||32
11177721|NCT01686633|12366383|FG002|NOT COMPLETED|Overall Study||25
11177722|NCT01686646|12366395|FG000|STARTED|Overall Study||45
11177723|NCT01686646|12366396|FG001|STARTED|Overall Study||45
11177724|NCT01686646|12366397|FG002|STARTED|Overall Study||75
11177725|NCT01686646|12366398|FG003|STARTED|Overall Study||75
11177726|NCT01686646|12366395|FG000|Intent to Treat Population|Overall Study||45
11177727|NCT01686646|12366396|FG001|Intent to Treat Population|Overall Study||45
11177728|NCT01686646|12366397|FG002|Intent to Treat Population|Overall Study||75
11177729|NCT01686646|12366398|FG003|Intent to Treat Population|Overall Study||75
11177730|NCT01686646|12366395|FG000|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
11177731|NCT01686646|12366396|FG001|Safety Population|Overall Study||45
11177732|NCT01686646|12366397|FG002|Safety Population|Overall Study||74
11177733|NCT01686646|12366398|FG003|Safety Population|Overall Study||75
11177734|NCT01686646|12366395|FG000|COMPLETED|Overall Study||45
11177735|NCT01686646|12366396|FG001|COMPLETED|Overall Study||45
11177736|NCT01686646|12366397|FG002|COMPLETED|Overall Study||75
11177737|NCT01686646|12366398|FG003|COMPLETED|Overall Study||75
11177738|NCT01686646|12366395|FG000|NOT COMPLETED|Overall Study||0
11177739|NCT01686646|12366396|FG001|NOT COMPLETED|Overall Study||0
11177740|NCT01686646|12366397|FG002|NOT COMPLETED|Overall Study||0
11177741|NCT01686646|12366398|FG003|NOT COMPLETED|Overall Study||0
11177742|NCT01686750|12366410|FG000|STARTED|Overall Study||11001
11177743|NCT01686750|12366411|FG001|STARTED|Overall Study||10725
11177744|NCT01686750|12366410|FG000|COMPLETED|Overall Study||11001
11177745|NCT01686750|12366411|FG001|COMPLETED|Overall Study||10725
11177746|NCT01686750|12366410|FG000|NOT COMPLETED|Overall Study||0
11177747|NCT01686750|12366411|FG001|NOT COMPLETED|Overall Study||0
11177748|NCT01686828|12366423|FG000|STARTED|Overall Study||13
11177749|NCT01686828|12366424|FG001|STARTED|Overall Study||14
11177750|NCT01686828|12366425|FG002|STARTED|Overall Study||13
11177751|NCT01686828|12366426|FG003|STARTED|Overall Study||13
11177752|NCT01686828|12366423|FG000|COMPLETED|Overall Study||12
11177753|NCT01686828|12366424|FG001|COMPLETED|Overall Study||13
11177754|NCT01686828|12366425|FG002|COMPLETED|Overall Study||12
11177755|NCT01686828|12366426|FG003|COMPLETED|Overall Study||13
11177756|NCT01686828|12366423|FG000|NOT COMPLETED|Overall Study||1
11177757|NCT01686828|12366424|FG001|NOT COMPLETED|Overall Study||1
11177758|NCT01686828|12366425|FG002|NOT COMPLETED|Overall Study||1
11177759|NCT01686828|12366426|FG003|NOT COMPLETED|Overall Study||0
11177760|NCT01686932|12366442|FG000|STARTED|Period 1||25
11177761|NCT01686932|12366443|FG001|STARTED|Period 1||26
11177762|NCT01686932|12366442|FG000|COMPLETED|Period 1||24
11177763|NCT01686932|12366443|FG001|COMPLETED|Period 1||25
11177764|NCT01686932|12366442|FG000|NOT COMPLETED|Period 1||1
11177765|NCT01686932|12366443|FG001|NOT COMPLETED|Period 1||1
11177766|NCT01686932|12366442|FG000|STARTED|Period 2||24
11177767|NCT01686932|12366443|FG001|STARTED|Period 2||25
11177768|NCT01686932|12366442|FG000|COMPLETED|Period 2||24
11177769|NCT01686932|12366443|FG001|COMPLETED|Period 2||25
11177770|NCT01686932|12366442|FG000|NOT COMPLETED|Period 2||0
11177771|NCT01686932|12366443|FG001|NOT COMPLETED|Period 2||0
11177772|NCT01686958|12366449|FG000|STARTED|Overall Study||30
11177773|NCT01686958|12366449|FG000|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
11177774|NCT01686958|12366449|FG000|NOT COMPLETED|Overall Study||1
11177775|NCT01687036|12366454|FG000|STARTED|Overall Study||10
11177776|NCT01687036|12366454|FG000|COMPLETED|Overall Study||10
11177777|NCT01687036|12366454|FG000|NOT COMPLETED|Overall Study||0
11177778|NCT01687088|12366460|FG000|STARTED|Overall Study||50
11177779|NCT01687088|12366461|FG001|STARTED|Overall Study||50
11177780|NCT01687088|12366460|FG000|COMPLETED|Overall Study||50
11177781|NCT01687088|12366461|FG001|COMPLETED|Overall Study||50
11177782|NCT01687088|12366460|FG000|NOT COMPLETED|Overall Study||0
11177783|NCT01687088|12366461|FG001|NOT COMPLETED|Overall Study||0
11177784|NCT01687101|12366467|FG000|STARTED|Overall Study||32
11177785|NCT01687101|12366467|FG000|COMPLETED|Overall Study||25
11177786|NCT01687101|12366467|FG000|NOT COMPLETED|Overall Study||7
11177787|NCT01687114|12366471|FG000|STARTED|Overall Study||5
11177788|NCT01687114|12366471|FG000|COMPLETED|Overall Study||5
11177789|NCT01687114|12366471|FG000|NOT COMPLETED|Overall Study||0
11177790|NCT01687166|12366479|FG000|STARTED|Overall Study||167
11177791|NCT01687166|12366480|FG001|STARTED|Overall Study||172
11177792|NCT01687166|12366481|FG002|STARTED|Overall Study||56
11177793|NCT01687166|12366482|FG003|STARTED|Overall Study||3
11177794|NCT01687166|12366479|FG000|COMPLETED|Overall Study||139
11177795|NCT01687166|12366480|FG001|COMPLETED|Overall Study||145
11177796|NCT01687166|12366481|FG002|COMPLETED|Overall Study||42
11177797|NCT01687166|12366482|FG003|COMPLETED|Overall Study||1
11177798|NCT01687166|12366479|FG000|NOT COMPLETED|Overall Study||28
11177799|NCT01687166|12366480|FG001|NOT COMPLETED|Overall Study||27
11177800|NCT01687166|12366481|FG002|NOT COMPLETED|Overall Study||14
11177801|NCT01687166|12366482|FG003|NOT COMPLETED|Overall Study||2
11177802|NCT01687179|12366490|FG000|STARTED|Overall Study||3
11177803|NCT01687179|12366491|FG001|STARTED|Overall Study||10
11177804|NCT01687179|12366490|FG000|COMPLETED|Overall Study||2
11177805|NCT01687179|12366491|FG001|COMPLETED|Overall Study||6
11177806|NCT01687179|12366490|FG000|NOT COMPLETED|Overall Study||1
11177807|NCT01687179|12366491|FG001|NOT COMPLETED|Overall Study||4
11177808|NCT01687218|12366503|FG000|STARTED|Overall Study||33
11177809|NCT01687218|12366504|FG001|STARTED|Overall Study||32
11177810|NCT01687218|12366505|FG002|STARTED|Overall Study||31
11177811|NCT01687218|12366506|FG003|STARTED|Overall Study||34
11177812|NCT01687218|12366507|FG004|STARTED|Overall Study||33
11177813|NCT01687218|12366508|FG005|STARTED|Overall Study||32
11177814|NCT01687218|12366503|FG000|COMPLETED|Overall Study||30
11177815|NCT01687218|12366504|FG001|COMPLETED|Overall Study||29
11177816|NCT01687218|12366505|FG002|COMPLETED|Overall Study||30
11177817|NCT01687218|12366506|FG003|COMPLETED|Overall Study||32
11177818|NCT01687218|12366507|FG004|COMPLETED|Overall Study||32
11177819|NCT01687218|12366508|FG005|COMPLETED|Overall Study||32
11177820|NCT01687218|12366503|FG000|NOT COMPLETED|Overall Study||3
11177821|NCT01687218|12366504|FG001|NOT COMPLETED|Overall Study||3
11177822|NCT01687218|12366505|FG002|NOT COMPLETED|Overall Study||1
11177823|NCT01687218|12366506|FG003|NOT COMPLETED|Overall Study||2
11177824|NCT01687218|12366507|FG004|NOT COMPLETED|Overall Study||1
11177825|NCT01687218|12366508|FG005|NOT COMPLETED|Overall Study||0
11177826|NCT01687244|12366518|FG000|STARTED|Overall Study||21
11177827|NCT01687244|12366519|FG001|STARTED|Overall Study||19
11177828|NCT01687244|12366518|FG000|COMPLETED|Overall Study||21
11177829|NCT01687244|12366519|FG001|COMPLETED|Overall Study||19
11177830|NCT01687244|12366518|FG000|NOT COMPLETED|Overall Study||0
11177831|NCT01687244|12366519|FG001|NOT COMPLETED|Overall Study||0
11177832|NCT01687257|12366535|FG000|STARTED|Overall Study||25
11177833|NCT01687257|12366536|FG001|STARTED|Overall Study||4
11177834|NCT01687257|12366537|FG002|STARTED|Overall Study||21
11177835|NCT01687257|12366535|FG000|COMPLETED|Overall Study||17
11177836|NCT01687257|12366536|FG001|COMPLETED|Overall Study||0
11177837|NCT01687257|12366537|FG002|COMPLETED|Overall Study||15
11177838|NCT01687257|12366535|FG000|NOT COMPLETED|Overall Study||8
11177839|NCT01687257|12366536|FG001|NOT COMPLETED|Overall Study||4
11177840|NCT01687257|12366537|FG002|NOT COMPLETED|Overall Study||6
11177841|NCT01687270|12366551|FG000|STARTED|Overall Study||40
11177842|NCT01687270|12366551|FG000|COMPLETED|Overall Study||28
11177843|NCT01687270|12366551|FG000|NOT COMPLETED|Overall Study||12
11177844|NCT01687283|12366557|FG000|STARTED|Overall Study||158
11177845|NCT01687283|12366558|FG001|STARTED|Overall Study||157
11177846|NCT01687283|12366557|FG000|COMPLETED|Overall Study||123
11177847|NCT01687283|12366558|FG001|COMPLETED|Overall Study||130
11177848|NCT01687283|12366557|FG000|NOT COMPLETED|Overall Study||35
11177849|NCT01687283|12366558|FG001|NOT COMPLETED|Overall Study||27
11177850|NCT01687296|12366566|FG000|STARTED|Overall Study||123
11177851|NCT01687296|12366567|FG001|STARTED|Overall Study||128
11177852|NCT01687296|12366566|FG000|COMPLETED|Overall Study||116
11177853|NCT01687296|12366567|FG001|COMPLETED|Overall Study||123
11177854|NCT01687296|12366566|FG000|NOT COMPLETED|Overall Study||7
11177855|NCT01687296|12366567|FG001|NOT COMPLETED|Overall Study||5
11177856|NCT01687387|12366576|FG000|STARTED|Overall Study||51
11177857|NCT01687387|12366577|FG001|STARTED|Overall Study||50
11177858|NCT01687387|12366578|FG002|STARTED|Overall Study||51
11177859|NCT01687387|12366576|FG000|COMPLETED|Overall Study||10
11177860|NCT01687387|12366577|FG001|COMPLETED|Overall Study||12
11177861|NCT01687387|12366578|FG002|COMPLETED|Overall Study||13
11177862|NCT01687387|12366576|FG000|NOT COMPLETED|Overall Study||41
11177863|NCT01687387|12366577|FG001|NOT COMPLETED|Overall Study||38
11177864|NCT01687387|12366578|FG002|NOT COMPLETED|Overall Study||38
11177865|NCT01687400|12366586|FG000|STARTED|Overall Study||114
11177866|NCT01687400|12366586|FG000|COMPLETED|Overall Study||114
11177867|NCT01687400|12366586|FG000|NOT COMPLETED|Overall Study||0
11177868|NCT01687413|12366597|FG000|STARTED|Overall Study||27
11177869|NCT01687413|12366598|FG001|STARTED|Overall Study||15
11177870|NCT01687413|12366597|FG000|COMPLETED|Overall Study||26
11177871|NCT01687413|12366598|FG001|COMPLETED|Overall Study||11
11177872|NCT01687413|12366597|FG000|NOT COMPLETED|Overall Study||1
11177873|NCT01687413|12366598|FG001|NOT COMPLETED|Overall Study||4
11177874|NCT01687478|12366624|FG000|STARTED|Overall Study||88
11177875|NCT01687478|12366625|FG001|STARTED|Overall Study||88
11177876|NCT01687478|12366624|FG000|Safety Analysis Set|Overall Study||88
11177877|NCT01687478|12366625|FG001|Safety Analysis Set|Overall Study||87
11177878|NCT01687478|12366624|FG000|COMPLETED|Overall Study||56
11177879|NCT01687478|12366625|FG001|COMPLETED|Overall Study||49
11177880|NCT01687478|12366624|FG000|NOT COMPLETED|Overall Study||32
11177881|NCT01687478|12366625|FG001|NOT COMPLETED|Overall Study||39
11177882|NCT01687595|12366633|FG000|STARTED|Overall Study||70
11177883|NCT01687595|12366634|FG001|STARTED|Overall Study||10
11177884|NCT01687595|12366633|FG000|Received at Least 1 Dose of Study Drug|Overall Study||70
11177885|NCT01687595|12366634|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
11177886|NCT01687595|12366633|FG000|COMPLETED|Overall Study||0
11177887|NCT01687595|12366634|FG001|COMPLETED|Overall Study||0
11177888|NCT01687595|12366633|FG000|NOT COMPLETED|Overall Study||70
11177889|NCT01687595|12366634|FG001|NOT COMPLETED|Overall Study||10
11177890|NCT01687673|12366640|FG000|STARTED|Overall Study||29
11177891|NCT01687673|12366640|FG000|COMPLETED|Overall Study||28
11177892|NCT01687673|12366640|FG000|NOT COMPLETED|Overall Study||1
11177893|NCT01687712|12366646|FG000|STARTED|Cycle 1||549
11177894|NCT01687712|12366647|FG001|STARTED|Cycle 1||551
11177895|NCT01687712|12366646|FG000|Received hCG|Cycle 1||516
11177896|NCT01687712|12366647|FG001|Received hCG|Cycle 1||520
11177897|NCT01687712|12366646|FG000|Oocyte/Ovum Pick Up|Cycle 1||513
11177898|NCT01687712|12366647|FG001|Oocyte/Ovum Pick Up|Cycle 1||517
11177899|NCT01687712|12366646|FG000|Fertilization Performed|Cycle 1||508
11177900|NCT01687712|12366647|FG001|Fertilization Performed|Cycle 1||512
11177901|NCT01687712|12366646|FG000|Embryo Transfer|Cycle 1||466
11177902|NCT01687712|12366647|FG001|Embryo Transfer|Cycle 1||483
11177903|NCT01687712|12366646|FG000|Biochemical Pregnancy|Cycle 1||163
11177904|NCT01687712|12366647|FG001|Biochemical Pregnancy|Cycle 1||203
11177905|NCT01687712|12366646|FG000|Clinical Pregnancy|Cycle 1||114
11177906|NCT01687712|12366647|FG001|Clinical Pregnancy|Cycle 1||138
11177907|NCT01687712|12366646|FG000|COMPLETED|Cycle 1||101
11177908|NCT01687712|12366647|FG001|COMPLETED|Cycle 1||122
11177909|NCT01687712|12366646|FG000|NOT COMPLETED|Cycle 1||448
11177910|NCT01687712|12366647|FG001|NOT COMPLETED|Cycle 1||429
11177911|NCT01687712|12366646|FG000|STARTED|Cycle 2||109
11177912|NCT01687712|12366647|FG001|STARTED|Cycle 2||120
11177913|NCT01687712|12366646|FG000|Received hCG|Cycle 2||107
11177914|NCT01687712|12366647|FG001|Received hCG|Cycle 2||119
11177915|NCT01687712|12366646|FG000|Oocyte/Ovum Pick Up|Cycle 2||107
11177916|NCT01687712|12366647|FG001|Oocyte/Ovum Pick Up|Cycle 2||119
11177917|NCT01687712|12366646|FG000|Fertilization Performed|Cycle 2||106
11177918|NCT01687712|12366647|FG001|Fertilization Performed|Cycle 2||119
11177919|NCT01687712|12366646|FG000|Embryo Transfer|Cycle 2||101
11177920|NCT01687712|12366647|FG001|Embryo Transfer|Cycle 2||117
11177921|NCT01687712|12366646|FG000|Biochemical Pregnancy|Cycle 2||35
11177922|NCT01687712|12366647|FG001|Biochemical Pregnancy|Cycle 2||43
11177923|NCT01687712|12366646|FG000|Clinical Pregnancy|Cycle 2||17
11177924|NCT01687712|12366647|FG001|Clinical Pregnancy|Cycle 2||26
11177925|NCT01687712|12366646|FG000|COMPLETED|Cycle 2||16
11177926|NCT01687712|12366647|FG001|COMPLETED|Cycle 2||25
11177927|NCT01687712|12366646|FG000|NOT COMPLETED|Cycle 2||93
11177928|NCT01687712|12366647|FG001|NOT COMPLETED|Cycle 2||95
11177929|NCT01687712|12366646|FG000|STARTED|Cycle 3||28
11177930|NCT01687712|12366647|FG001|STARTED|Cycle 3||24
11177931|NCT01687712|12366646|FG000|Received hCG|Cycle 3||27
11177932|NCT01687712|12366647|FG001|Received hCG|Cycle 3||24
11177933|NCT01687712|12366646|FG000|Ooctye/Ovum Pick-Up|Cycle 3||27
11177934|NCT01687712|12366647|FG001|Ooctye/Ovum Pick-Up|Cycle 3||24
11177935|NCT01687712|12366646|FG000|Fertilization Performed|Cycle 3||27
11177936|NCT01687712|12366647|FG001|Fertilization Performed|Cycle 3||24
11177937|NCT01687712|12366646|FG000|Embryo Transfer|Cycle 3||26
11177938|NCT01687712|12366647|FG001|Embryo Transfer|Cycle 3||24
11177939|NCT01687712|12366646|FG000|Biochemically Pregnant|Cycle 3||7
11177940|NCT01687712|12366647|FG001|Biochemically Pregnant|Cycle 3||2
11177941|NCT01687712|12366646|FG000|Clinical Pregnancy|Cycle 3||5
11177942|NCT01687712|12366647|FG001|Clinical Pregnancy|Cycle 3||0
11177943|NCT01687712|12366646|FG000|COMPLETED|Cycle 3||4
11177944|NCT01687712|12366647|FG001|COMPLETED|Cycle 3||0
11177945|NCT01687712|12366646|FG000|NOT COMPLETED|Cycle 3||24
11177946|NCT01687712|12366647|FG001|NOT COMPLETED|Cycle 3||24
11177947|NCT01687790|12366657|FG000|STARTED|Overall Study||60
11177948|NCT01687790|12366657|FG000|COMPLETED|Overall Study||60
11177949|NCT01687790|12366657|FG000|NOT COMPLETED|Overall Study||0
11177950|NCT01687972|12366664|FG000|STARTED|Overall Study||44
11177951|NCT01687972|12366665|FG001|STARTED|Overall Study||44
11177952|NCT01687972|12366664|FG000|COMPLETED|Overall Study||44
11177953|NCT01687972|12366665|FG001|COMPLETED|Overall Study||44
11177954|NCT01687972|12366664|FG000|NOT COMPLETED|Overall Study||0
11177955|NCT01687972|12366665|FG001|NOT COMPLETED|Overall Study||0
11177956|NCT01687998|12366673|FG000|STARTED|Overall Study||6038
11177957|NCT01687998|12366674|FG001|STARTED|Overall Study||6054
11177958|NCT01687998|12366673|FG000|Received at Least One Dose of Study Drug|Overall Study||6036
11177959|NCT01687998|12366674|FG001|Received at Least One Dose of Study Drug|Overall Study||6052
11177960|NCT01687998|12366673|FG000|COMPLETED|Overall Study||5926
11177961|NCT01687998|12366674|FG001|COMPLETED|Overall Study||5934
11177962|NCT01687998|12366673|FG000|NOT COMPLETED|Overall Study||112
11177963|NCT01687998|12366674|FG001|NOT COMPLETED|Overall Study||120
11177964|NCT01688037|12366683|FG000|STARTED|Double-Blind Period (Week 0 to 6)||54
11177965|NCT01688037|12366684|FG001|STARTED|Double-Blind Period (Week 0 to 6)||28
11177966|NCT01688037|12366685|FG002|STARTED|Double-Blind Period (Week 0 to 6)||27
11177967|NCT01688037|12366683|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||47
11177968|NCT01688037|12366684|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||25
11177969|NCT01688037|12366685|FG002|COMPLETED|Double-Blind Period (Week 0 to 6)||21
11177970|NCT01688037|12366683|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
11177971|NCT01688037|12366684|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
11177972|NCT01688037|12366685|FG002|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
11177973|NCT01688037|12366683|FG000|STARTED|Open-Label Period (Week 6 to 12)||47
11177974|NCT01688037|12366684|FG001|STARTED|Open-Label Period (Week 6 to 12)||25
11177975|NCT01688037|12366685|FG002|STARTED|Open-Label Period (Week 6 to 12)||21
11177976|NCT01688037|12366683|FG000|COMPLETED|Open-Label Period (Week 6 to 12)||42
11177977|NCT01688037|12366684|FG001|COMPLETED|Open-Label Period (Week 6 to 12)||22
11177978|NCT01688037|12366685|FG002|COMPLETED|Open-Label Period (Week 6 to 12)||17
11177979|NCT01688037|12366683|FG000|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
11177980|NCT01688037|12366684|FG001|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
11177981|NCT01688037|12366685|FG002|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
11177982|NCT01688037|12366683|FG000|STARTED|Follow-up Period (Week 12 to 16)||42
11177983|NCT01688037|12366684|FG001|STARTED|Follow-up Period (Week 12 to 16)||22
11177984|NCT01688037|12366685|FG002|STARTED|Follow-up Period (Week 12 to 16)||17
11177985|NCT01688037|12366683|FG000|COMPLETED|Follow-up Period (Week 12 to 16)||42
11177986|NCT01688037|12366684|FG001|COMPLETED|Follow-up Period (Week 12 to 16)||21
11177987|NCT01688037|12366685|FG002|COMPLETED|Follow-up Period (Week 12 to 16)||17
11177988|NCT01688037|12366683|FG000|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
11177989|NCT01688037|12366684|FG001|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
11177990|NCT01688037|12366685|FG002|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
11177991|NCT01688050|12366697|FG000|STARTED|Overall Study||50
11177992|NCT01688050|12366697|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|22
11177993|NCT01688050|12366697|FG000|COMPLETED|Overall Study||19
11323999|NCT02740517|12521335|FG001|COMPLETED|Overall Study||11
11324000|NCT02740517|12521336|FG002|COMPLETED|Overall Study||18
11324001|NCT02740517|12521334|FG000|NOT COMPLETED|Overall Study||0
11324002|NCT02740517|12521335|FG001|NOT COMPLETED|Overall Study||0
11324003|NCT02740517|12521336|FG002|NOT COMPLETED|Overall Study||0
11324004|NCT02740543|12521346|FG000|STARTED|Overall Study||9
11324005|NCT02740543|12521347|FG001|STARTED|Overall Study||9
11324006|NCT02740543|12521346|FG000|COMPLETED|Overall Study||9
11324007|NCT02740543|12521347|FG001|COMPLETED|Overall Study||9
11324008|NCT02740543|12521346|FG000|NOT COMPLETED|Overall Study||0
11324009|NCT02740543|12521347|FG001|NOT COMPLETED|Overall Study||0
11324010|NCT02740582|12521355|FG000|STARTED|First Intervention||29
11324011|NCT02740582|12521356|FG001|STARTED|First Intervention||33
11324012|NCT02740582|12521355|FG000|COMPLETED|First Intervention||24
11324013|NCT02740582|12521356|FG001|COMPLETED|First Intervention||31
11324014|NCT02740582|12521355|FG000|NOT COMPLETED|First Intervention||5
11324015|NCT02740582|12521356|FG001|NOT COMPLETED|First Intervention||2
11324016|NCT02740582|12521355|FG000|STARTED|Washout||24
11324017|NCT02740582|12521356|FG001|STARTED|Washout||31
11324018|NCT02740582|12521355|FG000|COMPLETED|Washout||24
11324019|NCT02740582|12521356|FG001|COMPLETED|Washout||31
11324020|NCT02740582|12521355|FG000|NOT COMPLETED|Washout||0
11324021|NCT02740582|12521356|FG001|NOT COMPLETED|Washout||0
11324022|NCT02740582|12521355|FG000|STARTED|Second Intervention||24
11324023|NCT02740582|12521356|FG001|STARTED|Second Intervention||31
11324024|NCT02740582|12521355|FG000|COMPLETED|Second Intervention||23
11324025|NCT02740582|12521356|FG001|COMPLETED|Second Intervention||28
11324026|NCT02740582|12521355|FG000|NOT COMPLETED|Second Intervention||1
11324027|NCT02740582|12521356|FG001|NOT COMPLETED|Second Intervention||3
11324028|NCT02740660|12521364|FG000|STARTED|Overall Study||6
11324029|NCT02740660|12521365|FG001|STARTED|Overall Study||6
11324030|NCT02740660|12521364|FG000|COMPLETED|Overall Study||6
11324031|NCT02740660|12521365|FG001|COMPLETED|Overall Study||6
11324032|NCT02740660|12521364|FG000|NOT COMPLETED|Overall Study||0
11324033|NCT02740660|12521365|FG001|NOT COMPLETED|Overall Study||0
11324034|NCT02740920|12521371|FG000|STARTED|Overall Study||9
11324035|NCT02740920|12521371|FG000|COMPLETED|Overall Study||9
11324036|NCT02740920|12521371|FG000|NOT COMPLETED|Overall Study||0
11324037|NCT02741076|12521379|FG000|STARTED|Overall Study||13
11324038|NCT02741076|12521380|FG001|STARTED|Overall Study||12
11324039|NCT02741076|12521381|FG002|STARTED|Overall Study||3
11324040|NCT02741076|12521382|FG003|STARTED|Overall Study||4
11324041|NCT02741076|12521379|FG000|COMPLETED|Overall Study||10
11324042|NCT02741076|12521380|FG001|COMPLETED|Overall Study||7
11324043|NCT02741076|12521381|FG002|COMPLETED|Overall Study||1
11324044|NCT02741076|12521382|FG003|COMPLETED|Overall Study||2
11324045|NCT02741076|12521379|FG000|NOT COMPLETED|Overall Study||3
11324046|NCT02741076|12521380|FG001|NOT COMPLETED|Overall Study||5
11324047|NCT02741076|12521381|FG002|NOT COMPLETED|Overall Study||2
11324048|NCT02741076|12521382|FG003|NOT COMPLETED|Overall Study||2
11324049|NCT02741284|12521395|FG000|STARTED|Overall Study||57
11324050|NCT02741284|12521396|FG001|STARTED|Overall Study||57
11324051|NCT02741284|12521395|FG000|COMPLETED|Overall Study||51
11324052|NCT02741284|12521396|FG001|COMPLETED|Overall Study||48
11324053|NCT02741284|12521395|FG000|NOT COMPLETED|Overall Study||6
11324054|NCT02741284|12521396|FG001|NOT COMPLETED|Overall Study||9
11324055|NCT02741297|12521404|FG000|STARTED|Overall Study||73
11324056|NCT02741297|12521404|FG000|COMPLETED|Overall Study||59
11324057|NCT02741297|12521404|FG000|NOT COMPLETED|Overall Study||14
11324058|NCT02741310|12521410|FG000|STARTED|Overall Study||12
11324059|NCT02741310|12521411|FG001|STARTED|Overall Study||22
11324060|NCT02741310|12521410|FG000|COMPLETED|Overall Study||10
11324061|NCT02741310|12521411|FG001|COMPLETED|Overall Study||20
11324062|NCT02741310|12521410|FG000|NOT COMPLETED|Overall Study||2
11324063|NCT02741310|12521411|FG001|NOT COMPLETED|Overall Study||2
11324064|NCT02741518|12521427|FG000|STARTED|Overall Study||11
11324065|NCT02741518|12521428|FG001|STARTED|Overall Study||11
11177994|NCT01688050|12366697|FG000|NOT COMPLETED|Overall Study||31
11177995|NCT01688102|12366703|FG000|STARTED|Overall Study||60
11177996|NCT01688102|12366704|FG001|STARTED|Overall Study||58
11177997|NCT01688102|12366703|FG000|COMPLETED|Overall Study||44
11177998|NCT01688102|12366704|FG001|COMPLETED|Overall Study||40
11177999|NCT01688102|12366703|FG000|NOT COMPLETED|Overall Study||16
11178000|NCT01688102|12366704|FG001|NOT COMPLETED|Overall Study||18
11178001|NCT01688141|12366712|FG000|STARTED|Overall Study||11706
11178002|NCT01688141|12366713|FG001|STARTED|Overall Study||11651
11178003|NCT01688141|12366712|FG000|COMPLETED|Overall Study||11706
11178004|NCT01688141|12366713|FG001|COMPLETED|Overall Study||11651
11178005|NCT01688141|12366712|FG000|NOT COMPLETED|Overall Study||0
11178006|NCT01688141|12366713|FG001|NOT COMPLETED|Overall Study||0
11178007|NCT01688310|12366721|FG000|STARTED|Overall Study||100
11178008|NCT01688310|12366722|FG001|STARTED|Overall Study||100
11178009|NCT01688310|12366721|FG000|COMPLETED|Overall Study||100
11178010|NCT01688310|12366722|FG001|COMPLETED|Overall Study||100
11178011|NCT01688310|12366721|FG000|NOT COMPLETED|Overall Study||0
11178012|NCT01688310|12366722|FG001|NOT COMPLETED|Overall Study||0
11178013|NCT01688336|12366730|FG000|STARTED|Overall Study||9
11178014|NCT01688336|12366730|FG000|COMPLETED|Overall Study||9
11178015|NCT01688336|12366730|FG000|NOT COMPLETED|Overall Study||0
11178016|NCT01688466|12366737|FG000|STARTED|Overall Study||17
11178017|NCT01688466|12366738|FG001|STARTED|Overall Study||17
11178018|NCT01688466|12366737|FG000|COMPLETED|Overall Study||15
11178019|NCT01688466|12366738|FG001|COMPLETED|Overall Study||10
11178020|NCT01688466|12366737|FG000|NOT COMPLETED|Overall Study||2
11178021|NCT01688466|12366738|FG001|NOT COMPLETED|Overall Study||7
11178022|NCT01688596|12366746|FG000|STARTED|Overall Study||67
11178023|NCT01688596|12366747|FG001|STARTED|Overall Study||68
11324066|NCT02741518|12521427|FG000|COMPLETED|Overall Study||10
11324067|NCT02741518|12521428|FG001|COMPLETED|Overall Study||10
11324068|NCT02741518|12521427|FG000|NOT COMPLETED|Overall Study||1
11324069|NCT02741518|12521428|FG001|NOT COMPLETED|Overall Study||1
11324070|NCT02741596|12521436|FG000|STARTED|Overall Study||109
11324071|NCT02741596|12521437|FG001|STARTED|Overall Study||103
11324072|NCT02741596|12521436|FG000|COMPLETED|Overall Study||31
11178024|NCT01688596|12366746|FG000|COMPLETED|Overall Study||59
11178025|NCT01688596|12366747|FG001|COMPLETED|Overall Study||59
11178026|NCT01688596|12366746|FG000|NOT COMPLETED|Overall Study||8
11178027|NCT01688596|12366747|FG001|NOT COMPLETED|Overall Study||9
11178028|NCT01688609|12366753|FG000|STARTED|Overall Study||18
11178029|NCT01688609|12366753|FG000|COMPLETED|Overall Study||18
11178030|NCT01688609|12366753|FG000|NOT COMPLETED|Overall Study||0
11178031|NCT01688635|12366757|FG000|STARTED|Period 1||45
11178032|NCT01688635|12366758|FG001|STARTED|Period 1||46
11178033|NCT01688635|12366757|FG000|Received at Least 1 Dose of Study Drug|Period 1||45
11178034|NCT01688635|12366758|FG001|Received at Least 1 Dose of Study Drug|Period 1||46
11178035|NCT01688635|12366757|FG000|COMPLETED|Period 1||45
11178036|NCT01688635|12366758|FG001|COMPLETED|Period 1||46
11178037|NCT01688635|12366757|FG000|NOT COMPLETED|Period 1||0
11178038|NCT01688635|12366758|FG001|NOT COMPLETED|Period 1||0
11178039|NCT01688635|12366757|FG000|STARTED|Washout 1||45
11178040|NCT01688635|12366758|FG001|STARTED|Washout 1||46
11178041|NCT01688635|12366757|FG000|COMPLETED|Washout 1||44
11178042|NCT01688635|12366758|FG001|COMPLETED|Washout 1||44
11178043|NCT01688635|12366757|FG000|NOT COMPLETED|Washout 1||1
11178044|NCT01688635|12366758|FG001|NOT COMPLETED|Washout 1||2
11178045|NCT01688635|12366757|FG000|STARTED|Period 2||44
11178046|NCT01688635|12366758|FG001|STARTED|Period 2||44
11178047|NCT01688635|12366757|FG000|COMPLETED|Period 2||44
11178048|NCT01688635|12366758|FG001|COMPLETED|Period 2||44
11178049|NCT01688635|12366757|FG000|NOT COMPLETED|Period 2||0
11178050|NCT01688635|12366758|FG001|NOT COMPLETED|Period 2||0
11178051|NCT01688635|12366757|FG000|STARTED|Washout 2||44
11178052|NCT01688635|12366758|FG001|STARTED|Washout 2||44
11178053|NCT01688635|12366757|FG000|COMPLETED|Washout 2||41
11178054|NCT01688635|12366758|FG001|COMPLETED|Washout 2||42
11178055|NCT01688635|12366757|FG000|NOT COMPLETED|Washout 2||3
11178056|NCT01688635|12366758|FG001|NOT COMPLETED|Washout 2||2
11178057|NCT01688635|12366757|FG000|STARTED|Period 3||41
11178058|NCT01688635|12366758|FG001|STARTED|Period 3||42
11178059|NCT01688635|12366757|FG000|COMPLETED|Period 3||41
11178060|NCT01688635|12366758|FG001|COMPLETED|Period 3||42
11178061|NCT01688635|12366757|FG000|NOT COMPLETED|Period 3||0
11178062|NCT01688635|12366758|FG001|NOT COMPLETED|Period 3||0
11178063|NCT01688635|12366757|FG000|STARTED|Washout 3||41
11178064|NCT01688635|12366758|FG001|STARTED|Washout 3||42
11178065|NCT01688635|12366757|FG000|COMPLETED|Washout 3||40
11178066|NCT01688635|12366758|FG001|COMPLETED|Washout 3||42
11178067|NCT01688635|12366757|FG000|NOT COMPLETED|Washout 3||1
11178068|NCT01688635|12366758|FG001|NOT COMPLETED|Washout 3||0
11178069|NCT01688635|12366757|FG000|STARTED|Period 4||40
11178070|NCT01688635|12366758|FG001|STARTED|Period 4||42
11178071|NCT01688635|12366757|FG000|COMPLETED|Period 4||40
11178072|NCT01688635|12366758|FG001|COMPLETED|Period 4||42
11178073|NCT01688635|12366757|FG000|NOT COMPLETED|Period 4||0
11178074|NCT01688635|12366758|FG001|NOT COMPLETED|Period 4||0
11178075|NCT01688726|12366767|FG000|STARTED|Overall Study||46
11178076|NCT01688726|12366768|FG001|STARTED|Overall Study||45
11178077|NCT01688726|12366767|FG000|COMPLETED|Overall Study||45
11178078|NCT01688726|12366768|FG001|COMPLETED|Overall Study||44
11178079|NCT01688726|12366767|FG000|NOT COMPLETED|Overall Study||1
11178080|NCT01688726|12366768|FG001|NOT COMPLETED|Overall Study||1
11178081|NCT01688739|12366788|FG000|STARTED|Overall Study||13
11178082|NCT01688739|12366789|FG001|STARTED|Overall Study||3
11178083|NCT01688739|12366790|FG002|STARTED|Overall Study||3
11178084|NCT01688739|12366791|FG003|STARTED|Overall Study||6
11178085|NCT01688739|12366792|FG004|STARTED|Overall Study||6
11178086|NCT01688739|12366793|FG005|STARTED|Overall Study||6
11178087|NCT01688739|12366794|FG006|STARTED|Overall Study||6
11178088|NCT01688739|12366795|FG007|STARTED|Overall Study||6
11178089|NCT01688739|12366796|FG008|STARTED|Overall Study||6
11178090|NCT01688739|12366797|FG009|STARTED|Overall Study||6
11178091|NCT01688739|12366788|FG000|Received Study Drug|Overall Study||12
11178092|NCT01688739|12366789|FG001|Received Study Drug|Overall Study||3
11178093|NCT01688739|12366790|FG002|Received Study Drug|Overall Study||3
11178094|NCT01688739|12366791|FG003|Received Study Drug|Overall Study||6
11178095|NCT01688739|12366792|FG004|Received Study Drug|Overall Study||6
11178096|NCT01688739|12366793|FG005|Received Study Drug|Overall Study||6
11178097|NCT01688739|12366794|FG006|Received Study Drug|Overall Study||6
11178098|NCT01688739|12366795|FG007|Received Study Drug|Overall Study||6
11178099|NCT01688739|12366796|FG008|Received Study Drug|Overall Study||6
11178100|NCT01688739|12366797|FG009|Received Study Drug|Overall Study||6
11178101|NCT01688739|12366788|FG000|COMPLETED|Overall Study||12
11178102|NCT01688739|12366789|FG001|COMPLETED|Overall Study||3
11178103|NCT01688739|12366790|FG002|COMPLETED|Overall Study||3
11178104|NCT01688739|12366791|FG003|COMPLETED|Overall Study||6
11178105|NCT01688739|12366792|FG004|COMPLETED|Overall Study||6
11178106|NCT01688739|12366793|FG005|COMPLETED|Overall Study||6
11178107|NCT01688739|12366794|FG006|COMPLETED|Overall Study||6
11178108|NCT01688739|12366795|FG007|COMPLETED|Overall Study||6
11178109|NCT01688739|12366796|FG008|COMPLETED|Overall Study||6
11178110|NCT01688739|12366797|FG009|COMPLETED|Overall Study||6
11178111|NCT01688739|12366788|FG000|NOT COMPLETED|Overall Study||1
11178112|NCT01688739|12366789|FG001|NOT COMPLETED|Overall Study||0
11178113|NCT01688739|12366790|FG002|NOT COMPLETED|Overall Study||0
11178114|NCT01688739|12366791|FG003|NOT COMPLETED|Overall Study||0
11178115|NCT01688739|12366792|FG004|NOT COMPLETED|Overall Study||0
11178116|NCT01688739|12366793|FG005|NOT COMPLETED|Overall Study||0
11178117|NCT01688739|12366794|FG006|NOT COMPLETED|Overall Study||0
11178118|NCT01688739|12366795|FG007|NOT COMPLETED|Overall Study||0
11178119|NCT01688739|12366796|FG008|NOT COMPLETED|Overall Study||0
11178120|NCT01688739|12366797|FG009|NOT COMPLETED|Overall Study||0
11178121|NCT01688830|12366848|FG000|STARTED|Overall Study||21
11178122|NCT01688830|12366849|FG001|STARTED|Overall Study||6
11178123|NCT01688830|12366850|FG002|STARTED|Overall Study||6
11178124|NCT01688830|12366851|FG003|STARTED|Overall Study||6
11178125|NCT01688830|12366852|FG004|STARTED|Overall Study||5
11178126|NCT01688830|12366853|FG005|STARTED|Overall Study||6
11178127|NCT01688830|12366854|FG006|STARTED|Overall Study||12
11178128|NCT01688830|12366855|FG007|STARTED|Overall Study||6
11178129|NCT01688830|12366856|FG008|STARTED|Overall Study||6
11178130|NCT01688830|12366857|FG009|STARTED|Overall Study||6
11178131|NCT01688830|12366858|FG010|STARTED|Overall Study||6
11178132|NCT01688830|12366859|FG011|STARTED|Overall Study||6
11178133|NCT01688830|12366860|FG012|STARTED|Overall Study||6
11178134|NCT01688830|12366861|FG013|STARTED|Overall Study||6
11178135|NCT01688830|12366862|FG014|STARTED|Overall Study||6
11178136|NCT01688830|12366863|FG015|STARTED|Overall Study||9
11178137|NCT01688830|12366864|FG016|STARTED|Overall Study||9
11178138|NCT01688830|12366865|FG017|STARTED|Overall Study||9
11178139|NCT01688830|12366866|FG018|STARTED|Overall Study||8
11178140|NCT01688830|12366867|FG019|STARTED|Overall Study||3
11178141|NCT01688830|12366868|FG020|STARTED|Overall Study||9
11178142|NCT01688830|12366848|FG000|COMPLETED|Overall Study||21
11178143|NCT01688830|12366849|FG001|COMPLETED|Overall Study||6
11178144|NCT01688830|12366850|FG002|COMPLETED|Overall Study||6
11178145|NCT01688830|12366851|FG003|COMPLETED|Overall Study||6
11178146|NCT01688830|12366852|FG004|COMPLETED|Overall Study||5
11178147|NCT01688830|12366853|FG005|COMPLETED|Overall Study||6
11178148|NCT01688830|12366854|FG006|COMPLETED|Overall Study||12
11178149|NCT01688830|12366855|FG007|COMPLETED|Overall Study||6
11178150|NCT01688830|12366856|FG008|COMPLETED|Overall Study||6
11178151|NCT01688830|12366857|FG009|COMPLETED|Overall Study||6
11178152|NCT01688830|12366858|FG010|COMPLETED|Overall Study||5
11178153|NCT01688830|12366859|FG011|COMPLETED|Overall Study||6
11178154|NCT01688830|12366860|FG012|COMPLETED|Overall Study||6
11178155|NCT01688830|12366861|FG013|COMPLETED|Overall Study||6
11178156|NCT01688830|12366862|FG014|COMPLETED|Overall Study||6
11178157|NCT01688830|12366863|FG015|COMPLETED|Overall Study||9
11178158|NCT01688830|12366864|FG016|COMPLETED|Overall Study||9
11178159|NCT01688830|12366865|FG017|COMPLETED|Overall Study||9
11178160|NCT01688830|12366866|FG018|COMPLETED|Overall Study||8
11178161|NCT01688830|12366867|FG019|COMPLETED|Overall Study||3
11178162|NCT01688830|12366868|FG020|COMPLETED|Overall Study||9
11178163|NCT01688830|12366848|FG000|NOT COMPLETED|Overall Study||0
11178164|NCT01688830|12366849|FG001|NOT COMPLETED|Overall Study||0
11178165|NCT01688830|12366850|FG002|NOT COMPLETED|Overall Study||0
11178166|NCT01688830|12366851|FG003|NOT COMPLETED|Overall Study||0
11178167|NCT01688830|12366852|FG004|NOT COMPLETED|Overall Study||0
11178168|NCT01688830|12366853|FG005|NOT COMPLETED|Overall Study||0
11178169|NCT01688830|12366854|FG006|NOT COMPLETED|Overall Study||0
11178170|NCT01688830|12366855|FG007|NOT COMPLETED|Overall Study||0
11178171|NCT01688830|12366856|FG008|NOT COMPLETED|Overall Study||0
11178172|NCT01688830|12366857|FG009|NOT COMPLETED|Overall Study||0
11178173|NCT01688830|12366858|FG010|NOT COMPLETED|Overall Study||1
11178174|NCT01688830|12366859|FG011|NOT COMPLETED|Overall Study||0
11178175|NCT01688830|12366860|FG012|NOT COMPLETED|Overall Study||0
11178176|NCT01688830|12366861|FG013|NOT COMPLETED|Overall Study||0
11178177|NCT01688830|12366862|FG014|NOT COMPLETED|Overall Study||0
11178178|NCT01688830|12366863|FG015|NOT COMPLETED|Overall Study||0
11178179|NCT01688830|12366864|FG016|NOT COMPLETED|Overall Study||0
11178180|NCT01688830|12366865|FG017|NOT COMPLETED|Overall Study||0
11178181|NCT01688830|12366866|FG018|NOT COMPLETED|Overall Study||0
11178182|NCT01688830|12366867|FG019|NOT COMPLETED|Overall Study||0
11178183|NCT01688830|12366868|FG020|NOT COMPLETED|Overall Study||0
11178184|NCT01688843|12366952|FG000|STARTED|Overall Study||1060
11178185|NCT01688843|12366952|FG000|COMPLETED|Overall Study||1060
11178186|NCT01688843|12366952|FG000|NOT COMPLETED|Overall Study||0
11178187|NCT01688856|12366961|FG000|STARTED|Overall Study||28
11178188|NCT01688856|12366962|FG001|STARTED|Overall Study||28
11178189|NCT01688856|12366963|FG002|STARTED|Overall Study||11
11178190|NCT01688856|12366961|FG000|COMPLETED|Overall Study||21
11178191|NCT01688856|12366962|FG001|COMPLETED|Overall Study||24
11178192|NCT01688856|12366963|FG002|COMPLETED|Overall Study||8
11178193|NCT01688856|12366961|FG000|NOT COMPLETED|Overall Study||7
11178194|NCT01688856|12366962|FG001|NOT COMPLETED|Overall Study||4
11178195|NCT01688856|12366963|FG002|NOT COMPLETED|Overall Study||3
11178196|NCT01688882|12366973|FG000|STARTED|Overall Study||13
11178197|NCT01688882|12366974|FG001|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
11178198|NCT01688882|12366973|FG000|Safety Follow-up|Overall Study||11
11178199|NCT01688882|12366974|FG001|Safety Follow-up|Overall Study||5
11178200|NCT01688882|12366973|FG000|COMPLETED|Overall Study||10
11178201|NCT01688882|12366974|FG001|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
11178202|NCT01688882|12366973|FG000|NOT COMPLETED|Overall Study||3
11178203|NCT01688882|12366974|FG001|NOT COMPLETED|Overall Study||1
11178204|NCT01688895|12366984|FG000|STARTED|Overall Study||150
11178205|NCT01688895|12366984|FG000|COMPLETED|Overall Study||150
11178206|NCT01688895|12366984|FG000|NOT COMPLETED|Overall Study||0
11178207|NCT01688921|12366990|FG000|STARTED|Overall Study||627
11178208|NCT01688921|12366991|FG001|STARTED|Overall Study||623
11178209|NCT01688921|12366990|FG000|COMPLETED|Overall Study||611
11178210|NCT01688921|12366991|FG001|COMPLETED|Overall Study||608
11178211|NCT01688921|12366990|FG000|NOT COMPLETED|Overall Study||16
11178212|NCT01688921|12366991|FG001|NOT COMPLETED|Overall Study||15
11178213|NCT01688973|12367000|FG000|STARTED|Overall Study||27
11178214|NCT01688973|12367001|FG001|STARTED|Overall Study||28
11178215|NCT01688973|12367000|FG000|Eligible/Evaluable Patients|Overall Study||25
11178216|NCT01688973|12367001|FG001|Eligible/Evaluable Patients|Overall Study||25
11178217|NCT01688973|12367000|FG000|COMPLETED|Overall Study||25
11178218|NCT01688973|12367001|FG001|COMPLETED|Overall Study||25
11178219|NCT01688973|12367000|FG000|NOT COMPLETED|Overall Study||2
11178220|NCT01688973|12367001|FG001|NOT COMPLETED|Overall Study||3
11178221|NCT01688999|12367011|FG000|STARTED|Overall Study||50
11178222|NCT01688999|12367012|FG001|STARTED|Overall Study||6
11178223|NCT01688999|12367013|FG002|STARTED|Overall Study||13
11178224|NCT01688999|12367011|FG000|COMPLETED|Overall Study||42
11178225|NCT01688999|12367012|FG001|COMPLETED|Overall Study||5
11178226|NCT01688999|12367013|FG002|COMPLETED|Overall Study||10
11178227|NCT01688999|12367011|FG000|NOT COMPLETED|Overall Study||8
11178228|NCT01688999|12367012|FG001|NOT COMPLETED|Overall Study||1
11178229|NCT01688999|12367013|FG002|NOT COMPLETED|Overall Study||3
11178230|NCT01689155|12367020|FG000|STARTED|Overall Study||116
11178231|NCT01689155|12367020|FG000|COMPLETED|Overall Study||116
11178232|NCT01689155|12367020|FG000|NOT COMPLETED|Overall Study||0
11178233|NCT01689207|12367036|FG000|STARTED|Overall Study|Subjects randomised|4
11178234|NCT01689207|12367037|FG001|STARTED|Overall Study|Subjects randomised|8
11178235|NCT01689207|12367038|FG002|STARTED|Overall Study|Subjects randomised|16
11178236|NCT01689207|12367039|FG003|STARTED|Overall Study|Subjects randomised|8
11178237|NCT01689207|12367040|FG004|STARTED|Overall Study|Subjects randomised|4
11178238|NCT01689207|12367041|FG005|STARTED|Overall Study|Subjects randomised|8
11178239|NCT01689207|12367042|FG006|STARTED|Overall Study|Subjects randomised|10
11178240|NCT01689207|12367043|FG007|STARTED|Overall Study|Subjects randomised|10
11178241|NCT01689207|12367044|FG008|STARTED|Overall Study|Subjects randomised|6
11178242|NCT01689207|12367045|FG009|STARTED|Overall Study|Subjects randomised|10
11178243|NCT01689207|12367046|FG010|STARTED|Overall Study|Subjects randomised|8
11178244|NCT01689207|12367036|FG000|COMPLETED|Overall Study|Subjects completed study|4
11178245|NCT01689207|12367037|FG001|COMPLETED|Overall Study|Subjects completed study|7
11178246|NCT01689207|12367038|FG002|COMPLETED|Overall Study|Subjects completed study|16
11178247|NCT01689207|12367039|FG003|COMPLETED|Overall Study|Subjects completed study|8
11178248|NCT01689207|12367040|FG004|COMPLETED|Overall Study|Subjects completed study|2
11178249|NCT01689207|12367041|FG005|COMPLETED|Overall Study|Subjects completed study|7
11178250|NCT01689207|12367042|FG006|COMPLETED|Overall Study|Subjects completed study|10
11178251|NCT01689207|12367043|FG007|COMPLETED|Overall Study|Subjects completed study|10
11178252|NCT01689207|12367044|FG008|COMPLETED|Overall Study|Subjects completed study|5
11178253|NCT01689207|12367045|FG009|COMPLETED|Overall Study|Subjects completed study|10
11178254|NCT01689207|12367046|FG010|COMPLETED|Overall Study|Subjects completed study|8
11178255|NCT01689207|12367036|FG000|NOT COMPLETED|Overall Study||0
11178256|NCT01689207|12367037|FG001|NOT COMPLETED|Overall Study||1
11178257|NCT01689207|12367038|FG002|NOT COMPLETED|Overall Study||0
11178258|NCT01689207|12367039|FG003|NOT COMPLETED|Overall Study||0
11178259|NCT01689207|12367040|FG004|NOT COMPLETED|Overall Study||2
11178260|NCT01689207|12367041|FG005|NOT COMPLETED|Overall Study||1
11178261|NCT01689207|12367042|FG006|NOT COMPLETED|Overall Study||0
11178262|NCT01689207|12367043|FG007|NOT COMPLETED|Overall Study||0
11178263|NCT01689207|12367044|FG008|NOT COMPLETED|Overall Study||1
11178264|NCT01689207|12367045|FG009|NOT COMPLETED|Overall Study||0
11178265|NCT01689207|12367046|FG010|NOT COMPLETED|Overall Study||0
11178266|NCT01689324|12367076|FG000|STARTED|Overall Study||43
11178267|NCT01689324|12367076|FG000|COMPLETED|Overall Study||43
11178268|NCT01689324|12367076|FG000|NOT COMPLETED|Overall Study||0
11178269|NCT01689337|12367080|FG000|STARTED|Overall Study||1
11178270|NCT01689337|12367080|FG000|COMPLETED|Overall Study||0
11178271|NCT01689337|12367080|FG000|NOT COMPLETED|Overall Study||1
11178272|NCT01689350|12367088|FG000|STARTED|Overall Study||47
11178273|NCT01689350|12367089|FG001|STARTED|Overall Study||45
11178274|NCT01689350|12367088|FG000|COMPLETED|Overall Study||47
11178275|NCT01689350|12367089|FG001|COMPLETED|Overall Study||45
11178276|NCT01689350|12367088|FG000|NOT COMPLETED|Overall Study||0
11178277|NCT01689350|12367089|FG001|NOT COMPLETED|Overall Study||0
11178278|NCT01689363|12367095|FG000|STARTED|Overall Study||32
11178279|NCT01689363|12367096|FG001|STARTED|Overall Study||32
11178280|NCT01689363|12367097|FG002|STARTED|Overall Study||32
11178281|NCT01689363|12367098|FG003|STARTED|Overall Study||31
11178282|NCT01689363|12367099|FG004|STARTED|Overall Study||31
11178283|NCT01689363|12367100|FG005|STARTED|Overall Study||31
11178284|NCT01689363|12367101|FG006|STARTED|Overall Study||32
11178285|NCT01689363|12367102|FG007|STARTED|Overall Study||32
11178286|NCT01689363|12367095|FG000|COMPLETED|Overall Study||32
11178287|NCT01689363|12367096|FG001|COMPLETED|Overall Study||31
11178288|NCT01689363|12367097|FG002|COMPLETED|Overall Study||32
11178289|NCT01689363|12367098|FG003|COMPLETED|Overall Study||31
11178290|NCT01689363|12367099|FG004|COMPLETED|Overall Study||31
11178291|NCT01689363|12367100|FG005|COMPLETED|Overall Study||31
11178292|NCT01689363|12367101|FG006|COMPLETED|Overall Study||32
11178293|NCT01689363|12367102|FG007|COMPLETED|Overall Study||32
11178294|NCT01689363|12367095|FG000|NOT COMPLETED|Overall Study||0
11178295|NCT01689363|12367096|FG001|NOT COMPLETED|Overall Study||1
11178296|NCT01689363|12367097|FG002|NOT COMPLETED|Overall Study||0
11178297|NCT01689363|12367098|FG003|NOT COMPLETED|Overall Study||0
11178298|NCT01689363|12367099|FG004|NOT COMPLETED|Overall Study||0
11178299|NCT01689363|12367100|FG005|NOT COMPLETED|Overall Study||0
11178300|NCT01689363|12367101|FG006|NOT COMPLETED|Overall Study||0
11178301|NCT01689363|12367102|FG007|NOT COMPLETED|Overall Study||0
11178302|NCT01689441|12367115|FG000|STARTED|Overall Study||36
11178303|NCT01689441|12367116|FG001|STARTED|Overall Study||31
11178304|NCT01689441|12367115|FG000|COMPLETED|Overall Study||36
11178305|NCT01689441|12367116|FG001|COMPLETED|Overall Study||31
11178306|NCT01689441|12367115|FG000|NOT COMPLETED|Overall Study||0
11178307|NCT01689441|12367116|FG001|NOT COMPLETED|Overall Study||0
11178308|NCT01689532|12367124|FG000|STARTED|Overall Study||61
11178309|NCT01689532|12367125|FG001|STARTED|Overall Study||61
11178310|NCT01689532|12367124|FG000|COMPLETED|Overall Study||47
11178311|NCT01689532|12367125|FG001|COMPLETED|Overall Study||52
11178312|NCT01689532|12367124|FG000|NOT COMPLETED|Overall Study||14
11178313|NCT01689532|12367125|FG001|NOT COMPLETED|Overall Study||9
11178314|NCT01689649|12367131|FG000|STARTED|Overall Study||139
11178315|NCT01689649|12367131|FG000|COMPLETED|Overall Study||117
11178316|NCT01689649|12367131|FG000|NOT COMPLETED|Overall Study||22
11178317|NCT01689701|12367137|FG000|STARTED|Overall Study||27
11178318|NCT01689701|12367138|FG001|STARTED|Overall Study||27
11178319|NCT01689701|12367137|FG000|COMPLETED|Overall Study||22
11178320|NCT01689701|12367138|FG001|COMPLETED|Overall Study||21
11178321|NCT01689701|12367137|FG000|NOT COMPLETED|Overall Study||5
11178322|NCT01689701|12367138|FG001|NOT COMPLETED|Overall Study||6
11178323|NCT01689779|12367146|FG000|STARTED|Overall Study||28
11178324|NCT01689779|12367147|FG001|STARTED|Overall Study||32
11178325|NCT01689779|12367146|FG000|COMPLETED|Overall Study||28
11178326|NCT01689779|12367147|FG001|COMPLETED|Overall Study||32
11178327|NCT01689779|12367146|FG000|NOT COMPLETED|Overall Study||0
11178328|NCT01689779|12367147|FG001|NOT COMPLETED|Overall Study||0
11178329|NCT01689857|12367155|FG000|STARTED|Overall Study||20
11178330|NCT01689857|12367156|FG001|STARTED|Overall Study||20
11178331|NCT01689857|12367155|FG000|COMPLETED|Overall Study||15
11178332|NCT01689857|12367156|FG001|COMPLETED|Overall Study||18
11178333|NCT01689857|12367155|FG000|NOT COMPLETED|Overall Study||5
11178334|NCT01689857|12367156|FG001|NOT COMPLETED|Overall Study||2
11178335|NCT01690000|12367164|FG000|STARTED|Overall Study||40
11178336|NCT01690000|12367165|FG001|STARTED|Overall Study||41
11178337|NCT01690000|12367164|FG000|COMPLETED|Overall Study||37
11178338|NCT01690000|12367165|FG001|COMPLETED|Overall Study||35
11178339|NCT01690000|12367164|FG000|NOT COMPLETED|Overall Study||3
11178340|NCT01690000|12367165|FG001|NOT COMPLETED|Overall Study||6
11178341|NCT01690052|12367171|FG000|STARTED|FIRST INTERVENTION: 4 WEEKS||7
11178342|NCT01690052|12367172|FG001|STARTED|FIRST INTERVENTION: 4 WEEKS||8
11178343|NCT01690052|12367171|FG000|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
11178344|NCT01690052|12367172|FG001|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
11178345|NCT01690052|12367171|FG000|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
11178346|NCT01690052|12367172|FG001|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
11178347|NCT01690052|12367171|FG000|STARTED|Washout Period of 1 Week||6
11178348|NCT01690052|12367172|FG001|STARTED|Washout Period of 1 Week||6
11178349|NCT01690052|12367171|FG000|COMPLETED|Washout Period of 1 Week||6
11178350|NCT01690052|12367172|FG001|COMPLETED|Washout Period of 1 Week||6
11178351|NCT01690052|12367171|FG000|NOT COMPLETED|Washout Period of 1 Week||0
11178352|NCT01690052|12367172|FG001|NOT COMPLETED|Washout Period of 1 Week||0
11178353|NCT01690052|12367171|FG000|STARTED|SECOND INTERVENTION: 4 WEEKS||6
11178354|NCT01690052|12367172|FG001|STARTED|SECOND INTERVENTION: 4 WEEKS||6
11178355|NCT01690052|12367171|FG000|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
11178356|NCT01690052|12367172|FG001|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
11178357|NCT01690052|12367171|FG000|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
11178358|NCT01690052|12367172|FG001|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
11178359|NCT01690117|12367180|FG000|STARTED|Overall Study||47
11178360|NCT01690117|12367181|FG001|STARTED|Overall Study||45
11178361|NCT01690117|12367180|FG000|Post-Measurement|Overall Study||41
11178362|NCT01690117|12367181|FG001|Post-Measurement|Overall Study||40
11178363|NCT01690117|12367180|FG000|COMPLETED|Overall Study||31
11178364|NCT01690117|12367181|FG001|COMPLETED|Overall Study||31
11178365|NCT01690117|12367180|FG000|NOT COMPLETED|Overall Study||16
11178366|NCT01690117|12367181|FG001|NOT COMPLETED|Overall Study||14
11178367|NCT01690130|12367191|FG000|STARTED|Overall Study||10
11178368|NCT01690130|12367192|FG001|STARTED|Overall Study||9
11178369|NCT01690130|12367191|FG000|COMPLETED|Overall Study||9
11178370|NCT01690130|12367192|FG001|COMPLETED|Overall Study||9
11178371|NCT01690130|12367191|FG000|NOT COMPLETED|Overall Study||1
11178372|NCT01690130|12367192|FG001|NOT COMPLETED|Overall Study||0
11178373|NCT01690143|12367198|FG000|STARTED|Overall Study||45
11178374|NCT01690143|12367198|FG000|COMPLETED|Overall Study||44
11178375|NCT01690143|12367198|FG000|NOT COMPLETED|Overall Study||1
11178376|NCT01690273|12367206|FG000|STARTED|Overall Study||18
11178377|NCT01690273|12367207|FG001|STARTED|Overall Study||17
11178378|NCT01690273|12367208|FG002|STARTED|Overall Study||20
11178379|NCT01690273|12367206|FG000|COMPLETED|Overall Study||18
11178380|NCT01690273|12367207|FG001|COMPLETED|Overall Study||17
11178381|NCT01690273|12367208|FG002|COMPLETED|Overall Study||20
11178382|NCT01690273|12367206|FG000|NOT COMPLETED|Overall Study||0
11178383|NCT01690273|12367207|FG001|NOT COMPLETED|Overall Study||0
11178384|NCT01690273|12367208|FG002|NOT COMPLETED|Overall Study||0
11178385|NCT01690520|12367222|FG000|STARTED|Overall Study||78
11178386|NCT01690520|12367223|FG001|STARTED|Overall Study||82
11178387|NCT01690520|12367222|FG000|Modified Intent to Treat (mITT)|Overall Study||78
11178388|NCT01690520|12367223|FG001|Modified Intent to Treat (mITT)|Overall Study||80
11178389|NCT01690520|12367222|FG000|COMPLETED|Overall Study||27
11178390|NCT01690520|12367223|FG001|COMPLETED|Overall Study||35
11178391|NCT01690520|12367222|FG000|NOT COMPLETED|Overall Study||51
11178392|NCT01690520|12367223|FG001|NOT COMPLETED|Overall Study||47
11178393|NCT01690546|12367229|FG000|STARTED|Overall Study||35
11178394|NCT01690546|12367229|FG000|Extended Release Injectable NTX|Overall Study||27
11178395|NCT01690546|12367229|FG000|COMPLETED|Overall Study||26
11178396|NCT01690546|12367229|FG000|NOT COMPLETED|Overall Study||9
11178397|NCT01690663|12367237|FG000|STARTED|Overall Study||23
11178398|NCT01690663|12367238|FG001|STARTED|Overall Study||20
11178399|NCT01690663|12367239|FG002|STARTED|Overall Study||22
11178400|NCT01690663|12367240|FG003|STARTED|Overall Study||24
11178401|NCT01690663|12367237|FG000|COMPLETED|Overall Study||20
11178402|NCT01690663|12367238|FG001|COMPLETED|Overall Study||17
11178403|NCT01690663|12367239|FG002|COMPLETED|Overall Study||19
11178404|NCT01690663|12367240|FG003|COMPLETED|Overall Study||20
11178405|NCT01690663|12367237|FG000|NOT COMPLETED|Overall Study||3
11178406|NCT01690663|12367238|FG001|NOT COMPLETED|Overall Study||3
11178407|NCT01690663|12367239|FG002|NOT COMPLETED|Overall Study||3
11178408|NCT01690663|12367240|FG003|NOT COMPLETED|Overall Study||4
11178409|NCT01690923|12367250|FG000|STARTED|Overall Study||10
11178410|NCT01690923|12367251|FG001|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
11178411|NCT01690923|12367250|FG000|COMPLETED|Overall Study||10
11178412|NCT01690923|12367251|FG001|COMPLETED|Overall Study||10
11178413|NCT01690923|12367250|FG000|NOT COMPLETED|Overall Study||0
11178414|NCT01690923|12367251|FG001|NOT COMPLETED|Overall Study||1
11178415|NCT01690988|12367258|FG000|STARTED|Overall Study||227
11178416|NCT01690988|12367259|FG001|STARTED|Overall Study||222
11178417|NCT01690988|12367260|FG002|STARTED|Overall Study||223
11178418|NCT01690988|12367258|FG000|COMPLETED|Overall Study||221
11178419|NCT01690988|12367259|FG001|COMPLETED|Overall Study||217
11178420|NCT01690988|12367260|FG002|COMPLETED|Overall Study||216
11178421|NCT01690988|12367258|FG000|NOT COMPLETED|Overall Study||6
11178422|NCT01690988|12367259|FG001|NOT COMPLETED|Overall Study||5
11178423|NCT01690988|12367260|FG002|NOT COMPLETED|Overall Study||7
11178424|NCT01691014|12367275|FG000|STARTED|Overall Study||8
11178425|NCT01691014|12367276|FG001|STARTED|Overall Study||26
11178426|NCT01691014|12367277|FG002|STARTED|Overall Study||36
11178427|NCT01691014|12367278|FG003|STARTED|Overall Study||9
11178428|NCT01691014|12367275|FG000|COMPLETED|Overall Study||5
11178429|NCT01691014|12367276|FG001|COMPLETED|Overall Study||11
11178430|NCT01691014|12367277|FG002|COMPLETED|Overall Study||25
11178431|NCT01691014|12367278|FG003|COMPLETED|Overall Study||4
11178432|NCT01691014|12367275|FG000|NOT COMPLETED|Overall Study||3
11178433|NCT01691014|12367276|FG001|NOT COMPLETED|Overall Study||15
11178434|NCT01691014|12367277|FG002|NOT COMPLETED|Overall Study||11
11178435|NCT01691014|12367278|FG003|NOT COMPLETED|Overall Study||5
11178436|NCT01691027|12367288|FG000|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
11178437|NCT01691027|12367288|FG000|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
11178438|NCT01691027|12367288|FG000|NOT COMPLETED|Scotoma Awareness||0
11178439|NCT01691027|12367288|FG000|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
11178440|NCT01691027|12367288|FG000|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
11178441|NCT01691027|12367288|FG000|NOT COMPLETED|Line and Circle Tracing Training||0
11178442|NCT01691027|12367288|FG000|STARTED|Video Games Training|Four subjects started video game training module|4
11178443|NCT01691027|12367288|FG000|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
11178444|NCT01691027|12367288|FG000|NOT COMPLETED|Video Games Training||0
11178445|NCT01691092|12367293|FG000|STARTED|Overall Study||79
11178446|NCT01691092|12367293|FG000|COMPLETED|Overall Study||38
11178447|NCT01691092|12367293|FG000|NOT COMPLETED|Overall Study||41
11178448|NCT01691105|12367299|FG000|STARTED|Baseline||477
11178449|NCT01691105|12367300|FG001|STARTED|Baseline||567
11178450|NCT01691105|12367299|FG000|COMPLETED|Baseline||477
11178451|NCT01691105|12367300|FG001|COMPLETED|Baseline||567
11178452|NCT01691105|12367299|FG000|NOT COMPLETED|Baseline||0
11178453|NCT01691105|12367300|FG001|NOT COMPLETED|Baseline||0
11178454|NCT01691105|12367299|FG000|STARTED|1 Month Follow-up||477
11178455|NCT01691105|12367300|FG001|STARTED|1 Month Follow-up||567
11178456|NCT01691105|12367299|FG000|COMPLETED|1 Month Follow-up||434
11178457|NCT01691105|12367300|FG001|COMPLETED|1 Month Follow-up||526
11178458|NCT01691105|12367299|FG000|NOT COMPLETED|1 Month Follow-up||43
11178459|NCT01691105|12367300|FG001|NOT COMPLETED|1 Month Follow-up||41
11178460|NCT01691105|12367299|FG000|STARTED|6 Month Follow-up||477
11178461|NCT01691105|12367300|FG001|STARTED|6 Month Follow-up||567
11178462|NCT01691105|12367299|FG000|COMPLETED|6 Month Follow-up||425
11178463|NCT01691105|12367300|FG001|COMPLETED|6 Month Follow-up||496
11178464|NCT01691105|12367299|FG000|NOT COMPLETED|6 Month Follow-up||52
11178465|NCT01691105|12367300|FG001|NOT COMPLETED|6 Month Follow-up||71
11178466|NCT01691105|12367299|FG000|STARTED|12 Month Follow-up||477
11178467|NCT01691105|12367300|FG001|STARTED|12 Month Follow-up||567
11178468|NCT01691105|12367299|FG000|COMPLETED|12 Month Follow-up||405
11178469|NCT01691105|12367300|FG001|COMPLETED|12 Month Follow-up||466
11178470|NCT01691105|12367299|FG000|NOT COMPLETED|12 Month Follow-up||72
11178471|NCT01691105|12367300|FG001|NOT COMPLETED|12 Month Follow-up||101
11178472|NCT01691105|12367299|FG000|STARTED|12 Month Biochemical Verification||477
11178473|NCT01691105|12367300|FG001|STARTED|12 Month Biochemical Verification||567
11178474|NCT01691105|12367299|FG000|COMPLETED|12 Month Biochemical Verification||53
11178475|NCT01691105|12367300|FG001|COMPLETED|12 Month Biochemical Verification||65
11178476|NCT01691105|12367299|FG000|NOT COMPLETED|12 Month Biochemical Verification||424
11178477|NCT01691105|12367300|FG001|NOT COMPLETED|12 Month Biochemical Verification||502
11178478|NCT01691248|12367308|FG000|STARTED|Overall Study|Randomized|305
11178479|NCT01691248|12367309|FG001|STARTED|Overall Study|Randomized|306
11178480|NCT01691248|12367308|FG000|Treated|Overall Study|Received at least 1 dose of study drug|301
11178481|NCT01691248|12367309|FG001|Treated|Overall Study|Received at least 1 dose of study drug|299
11178482|NCT01691248|12367308|FG000|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
11178483|NCT01691248|12367309|FG001|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
11178484|NCT01691248|12367308|FG000|COMPLETED|Overall Study||194
11178485|NCT01691248|12367309|FG001|COMPLETED|Overall Study||192
11178486|NCT01691248|12367308|FG000|NOT COMPLETED|Overall Study||111
11178487|NCT01691248|12367309|FG001|NOT COMPLETED|Overall Study||114
11178488|NCT01691313|12367319|FG000|STARTED|Overall Study||22
11178489|NCT01691313|12367320|FG001|STARTED|Overall Study||32
11178490|NCT01691313|12367321|FG002|STARTED|Overall Study||25
11178491|NCT01691313|12367322|FG003|STARTED|Overall Study||25
11178492|NCT01691313|12367319|FG000|COMPLETED|Overall Study||22
11178493|NCT01691313|12367320|FG001|COMPLETED|Overall Study||32
11178494|NCT01691313|12367321|FG002|COMPLETED|Overall Study||25
11178495|NCT01691313|12367322|FG003|COMPLETED|Overall Study||25
11178496|NCT01691313|12367319|FG000|NOT COMPLETED|Overall Study||0
11178497|NCT01691313|12367320|FG001|NOT COMPLETED|Overall Study||0
11178498|NCT01691313|12367321|FG002|NOT COMPLETED|Overall Study||0
11178499|NCT01691313|12367322|FG003|NOT COMPLETED|Overall Study||0
11178500|NCT01691326|12367334|FG000|STARTED|Overall Study||30
11178501|NCT01691326|12367335|FG001|STARTED|Overall Study||30
11178502|NCT01691326|12367334|FG000|COMPLETED|Overall Study||30
11178503|NCT01691326|12367335|FG001|COMPLETED|Overall Study||30
11178504|NCT01691326|12367334|FG000|NOT COMPLETED|Overall Study||0
11178505|NCT01691326|12367335|FG001|NOT COMPLETED|Overall Study||0
11178506|NCT01691339|12367347|FG000|STARTED|Overall Study||50
11178507|NCT01691339|12367348|FG001|STARTED|Overall Study||50
11178508|NCT01691339|12367349|FG002|STARTED|Overall Study||51
11178509|NCT01691339|12367350|FG003|STARTED|Overall Study||49
11178510|NCT01691339|12367347|FG000|COMPLETED|Overall Study||50
11178511|NCT01691339|12367348|FG001|COMPLETED|Overall Study||50
11178512|NCT01691339|12367349|FG002|COMPLETED|Overall Study||51
11178513|NCT01691339|12367350|FG003|COMPLETED|Overall Study||49
11178514|NCT01691339|12367347|FG000|NOT COMPLETED|Overall Study||0
11178515|NCT01691339|12367348|FG001|NOT COMPLETED|Overall Study||0
11178516|NCT01691339|12367349|FG002|NOT COMPLETED|Overall Study||0
11178517|NCT01691339|12367350|FG003|NOT COMPLETED|Overall Study||0
11178518|NCT01691378|12367362|FG000|STARTED|Overall Study||22
11178519|NCT01691378|12367363|FG001|STARTED|Overall Study||22
11178520|NCT01691378|12367362|FG000|COMPLETED|Overall Study||15
11178521|NCT01691378|12367363|FG001|COMPLETED|Overall Study||20
11178522|NCT01691378|12367362|FG000|NOT COMPLETED|Overall Study||7
11178523|NCT01691378|12367363|FG001|NOT COMPLETED|Overall Study||2
11178524|NCT01691430|12367371|FG000|STARTED|Overall Study||92
11178525|NCT01691430|12367372|FG001|STARTED|Overall Study||93
11178526|NCT01691430|12367371|FG000|Received Medication|Overall Study||92
11178527|NCT01691430|12367372|FG001|Received Medication|Overall Study||93
11178528|NCT01691430|12367371|FG000|COMPLETED|Overall Study||70
11178529|NCT01691430|12367372|FG001|COMPLETED|Overall Study||73
11178530|NCT01691430|12367371|FG000|NOT COMPLETED|Overall Study||22
11178531|NCT01691430|12367372|FG001|NOT COMPLETED|Overall Study||20
11178532|NCT01691482|12367378|FG000|STARTED|Treatment Period 1||28
11178533|NCT01691482|12367379|FG001|STARTED|Treatment Period 1||28
11178534|NCT01691482|12367378|FG000|COMPLETED|Treatment Period 1||28
11178535|NCT01691482|12367379|FG001|COMPLETED|Treatment Period 1||28
11178536|NCT01691482|12367378|FG000|NOT COMPLETED|Treatment Period 1||0
11178537|NCT01691482|12367379|FG001|NOT COMPLETED|Treatment Period 1||0
11178538|NCT01691482|12367378|FG000|STARTED|Treatment Period 2||28
11178539|NCT01691482|12367379|FG001|STARTED|Treatment Period 2||28
11178540|NCT01691482|12367378|FG000|COMPLETED|Treatment Period 2||27
11178541|NCT01691482|12367379|FG001|COMPLETED|Treatment Period 2||26
11178542|NCT01691482|12367378|FG000|NOT COMPLETED|Treatment Period 2||1
11178543|NCT01691482|12367379|FG001|NOT COMPLETED|Treatment Period 2||2
11178544|NCT01691508|12367388|FG000|STARTED|Overall Study||66
11178545|NCT01691508|12367389|FG001|STARTED|Overall Study||69
11178546|NCT01691508|12367388|FG000|COMPLETED|Overall Study||62
11178547|NCT01691508|12367389|FG001|COMPLETED|Overall Study||66
11178548|NCT01691508|12367388|FG000|NOT COMPLETED|Overall Study||4
11178549|NCT01691508|12367389|FG001|NOT COMPLETED|Overall Study||3
11178550|NCT01691521|12367398|FG000|STARTED|Overall Study||191
11178551|NCT01691521|12367399|FG001|STARTED|Overall Study||191
11178552|NCT01691521|12367400|FG002|STARTED|Overall Study||194
11178553|NCT01691521|12367398|FG000|COMPLETED|Overall Study||179
11178554|NCT01691521|12367399|FG001|COMPLETED|Overall Study||175
11178555|NCT01691521|12367400|FG002|COMPLETED|Overall Study||185
11178556|NCT01691521|12367398|FG000|NOT COMPLETED|Overall Study||12
11178557|NCT01691521|12367399|FG001|NOT COMPLETED|Overall Study||16
11178558|NCT01691521|12367400|FG002|NOT COMPLETED|Overall Study||9
11178559|NCT01691534|12367416|FG000|STARTED|Overall Study||15
11178560|NCT01691534|12367417|FG001|STARTED|Overall Study||15
11178561|NCT01691534|12367418|FG002|STARTED|Overall Study||15
11178562|NCT01691534|12367419|FG003|STARTED|Overall Study||15
11178563|NCT01691534|12367420|FG004|STARTED|Overall Study||15
11178564|NCT01691534|12367421|FG005|STARTED|Overall Study||15
11178565|NCT01691534|12367422|FG006|STARTED|Overall Study||15
11178566|NCT01691534|12367416|FG000|COMPLETED|Overall Study||15
11178567|NCT01691534|12367417|FG001|COMPLETED|Overall Study||14
11178568|NCT01691534|12367418|FG002|COMPLETED|Overall Study||14
11178569|NCT01691534|12367419|FG003|COMPLETED|Overall Study||14
11178570|NCT01691534|12367420|FG004|COMPLETED|Overall Study||15
11178571|NCT01691534|12367421|FG005|COMPLETED|Overall Study||14
11178572|NCT01691534|12367422|FG006|COMPLETED|Overall Study||14
11178573|NCT01691534|12367416|FG000|NOT COMPLETED|Overall Study||0
11178574|NCT01691534|12367417|FG001|NOT COMPLETED|Overall Study||1
11178575|NCT01691534|12367418|FG002|NOT COMPLETED|Overall Study||1
11178576|NCT01691534|12367419|FG003|NOT COMPLETED|Overall Study||1
11178577|NCT01691534|12367420|FG004|NOT COMPLETED|Overall Study||0
11178578|NCT01691534|12367421|FG005|NOT COMPLETED|Overall Study||1
11178579|NCT01691534|12367422|FG006|NOT COMPLETED|Overall Study||1
11178580|NCT01691560|12367443|FG000|STARTED|Overall Study||34
11178581|NCT01691560|12367444|FG001|STARTED|Overall Study||33
11178582|NCT01691560|12367445|FG002|STARTED|Overall Study||34
11178583|NCT01691560|12367446|FG003|STARTED|Overall Study||33
11178584|NCT01691560|12367443|FG000|COMPLETED|Overall Study||34
11178585|NCT01691560|12367444|FG001|COMPLETED|Overall Study||33
11178586|NCT01691560|12367445|FG002|COMPLETED|Overall Study||34
11178587|NCT01691560|12367446|FG003|COMPLETED|Overall Study||33
11178588|NCT01691560|12367443|FG000|NOT COMPLETED|Overall Study||0
11178589|NCT01691560|12367444|FG001|NOT COMPLETED|Overall Study||0
11178590|NCT01691560|12367445|FG002|NOT COMPLETED|Overall Study||0
11178591|NCT01691560|12367446|FG003|NOT COMPLETED|Overall Study||0
11178592|NCT01691612|12367456|FG000|STARTED|Overall Study||14
11178593|NCT01691612|12367456|FG000|First Visit (Allergen Challenge)|Overall Study||8
11178594|NCT01691612|12367456|FG000|Second Visit (Bronchoscopy)|Overall Study||7
11178595|NCT01691612|12367456|FG000|COMPLETED|Overall Study||7
11178596|NCT01691612|12367456|FG000|NOT COMPLETED|Overall Study||7
11204059|NCT01852019|12394677|FG004|COMPLETED|Day 1||0
11204060|NCT01852019|12394673|FG000|NOT COMPLETED|Day 1||0
11204061|NCT01852019|12394674|FG001|NOT COMPLETED|Day 1||0
11204062|NCT01852019|12394675|FG002|NOT COMPLETED|Day 1||0
11204063|NCT01852019|12394676|FG003|NOT COMPLETED|Day 1||0
11204064|NCT01852019|12394677|FG004|NOT COMPLETED|Day 1||0
11204065|NCT01852019|12394673|FG000|STARTED|Day 8||0
11204066|NCT01852019|12394674|FG001|STARTED|Day 8||0
11204067|NCT01852019|12394675|FG002|STARTED|Day 8||0
11204068|NCT01852019|12394676|FG003|STARTED|Day 8||6
11204069|NCT01852019|12394677|FG004|STARTED|Day 8||6
11204070|NCT01852019|12394673|FG000|COMPLETED|Day 8||0
11204071|NCT01852019|12394674|FG001|COMPLETED|Day 8||0
11204072|NCT01852019|12394675|FG002|COMPLETED|Day 8||0
11204073|NCT01852019|12394676|FG003|COMPLETED|Day 8||6
11204074|NCT01852019|12394677|FG004|COMPLETED|Day 8||6
11204075|NCT01852019|12394673|FG000|NOT COMPLETED|Day 8||0
11204076|NCT01852019|12394674|FG001|NOT COMPLETED|Day 8||0
11204077|NCT01852019|12394675|FG002|NOT COMPLETED|Day 8||0
11204078|NCT01852019|12394676|FG003|NOT COMPLETED|Day 8||0
11204079|NCT01852019|12394677|FG004|NOT COMPLETED|Day 8||0
11204080|NCT01852032|12394690|FG000|STARTED|Overall Study||23
11204081|NCT01852032|12394690|FG000|COMPLETED|Overall Study||23
11204082|NCT01852032|12394690|FG000|NOT COMPLETED|Overall Study||0
11204083|NCT01852045|12394697|FG000|STARTED|Overall Study||39
11204084|NCT01852045|12394698|FG001|STARTED|Overall Study||45
11204085|NCT01852045|12394699|FG002|STARTED|Overall Study||30
11204086|NCT01852045|12394697|FG000|mITT Population|Overall Study||38
11204087|NCT01852045|12394698|FG001|mITT Population|Overall Study||45
11204088|NCT01852045|12394699|FG002|mITT Population|Overall Study||30
11204089|NCT01852045|12394697|FG000|Safety Population|Overall Study||38
11204090|NCT01852045|12394698|FG001|Safety Population|Overall Study||45
11204091|NCT01852045|12394699|FG002|Safety Population|Overall Study||30
11204092|NCT01852045|12394697|FG000|COMPLETED|Overall Study||33
11178597|NCT01691690|12367462|FG000|STARTED|Overall Study||125
11178598|NCT01691690|12367463|FG001|STARTED|Overall Study||125
11178599|NCT01691690|12367462|FG000|COMPLETED|Overall Study||118
11178600|NCT01691690|12367463|FG001|COMPLETED|Overall Study||121
11178601|NCT01691690|12367462|FG000|NOT COMPLETED|Overall Study||7
11178602|NCT01691690|12367463|FG001|NOT COMPLETED|Overall Study||4
11178603|NCT01691768|12367474|FG000|STARTED|Overall Study||189
11178604|NCT01691768|12367475|FG001|STARTED|Overall Study||183
11178605|NCT01691768|12367474|FG000|COMPLETED|Overall Study||174
11178606|NCT01691768|12367475|FG001|COMPLETED|Overall Study||167
11178607|NCT01691768|12367474|FG000|NOT COMPLETED|Overall Study||15
11178608|NCT01691768|12367475|FG001|NOT COMPLETED|Overall Study||16
11178609|NCT01691781|12367484|FG000|STARTED|Overall Study||19
11178610|NCT01691781|12367485|FG001|STARTED|Overall Study||22
11178611|NCT01691781|12367484|FG000|COMPLETED|Overall Study||12
11178612|NCT01691781|12367485|FG001|COMPLETED|Overall Study||15
11178613|NCT01691781|12367484|FG000|NOT COMPLETED|Overall Study||7
11178614|NCT01691781|12367485|FG001|NOT COMPLETED|Overall Study||7
11178615|NCT01691794|12367494|FG000|STARTED|Overall Study||3
11178616|NCT01691794|12367495|FG001|STARTED|Overall Study||33
11178617|NCT01691794|12367496|FG002|STARTED|Overall Study||23
11178618|NCT01691794|12367494|FG000|COMPLETED|Overall Study|Completed baseline to End of Study|2
11178619|NCT01691794|12367495|FG001|COMPLETED|Overall Study|Completed baseline to End of Study|15
11178620|NCT01691794|12367496|FG002|COMPLETED|Overall Study|Completed baseline to End of Study|13
11178621|NCT01691794|12367494|FG000|NOT COMPLETED|Overall Study||1
11178622|NCT01691794|12367495|FG001|NOT COMPLETED|Overall Study||18
11178623|NCT01691794|12367496|FG002|NOT COMPLETED|Overall Study||10
11178624|NCT01691820|12367506|FG000|STARTED|Overall Study||210
11178625|NCT01691820|12367507|FG001|STARTED|Overall Study||152
11178626|NCT01691820|12367506|FG000|COMPLETED|Overall Study||184
11178627|NCT01691820|12367507|FG001|COMPLETED|Overall Study||115
11178628|NCT01691820|12367506|FG000|NOT COMPLETED|Overall Study||26
11178629|NCT01691820|12367507|FG001|NOT COMPLETED|Overall Study||37
11178630|NCT01691859|12367517|FG000|STARTED|Overall Study||347
11178631|NCT01691859|12367517|FG000|COMPLETED|Overall Study||0
11178632|NCT01691859|12367517|FG000|NOT COMPLETED|Overall Study||347
11178633|NCT01691885|12367521|FG000|STARTED|Treatment Period 1(7-14 Days)||22
11178634|NCT01691885|12367522|FG001|STARTED|Treatment Period 1(7-14 Days)||23
11178635|NCT01691885|12367521|FG000|COMPLETED|Treatment Period 1(7-14 Days)||21
11178636|NCT01691885|12367522|FG001|COMPLETED|Treatment Period 1(7-14 Days)||22
11178637|NCT01691885|12367521|FG000|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
11178638|NCT01691885|12367522|FG001|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
11178639|NCT01691885|12367521|FG000|STARTED|Washout Period (7-9 Days)||21
11178640|NCT01691885|12367522|FG001|STARTED|Washout Period (7-9 Days)||22
11178641|NCT01691885|12367521|FG000|COMPLETED|Washout Period (7-9 Days)||21
11178642|NCT01691885|12367522|FG001|COMPLETED|Washout Period (7-9 Days)||21
11178643|NCT01691885|12367521|FG000|NOT COMPLETED|Washout Period (7-9 Days)||0
11178644|NCT01691885|12367522|FG001|NOT COMPLETED|Washout Period (7-9 Days)||1
11178645|NCT01691885|12367521|FG000|STARTED|Treatment Period 2 (7-14 Days)||21
11178646|NCT01691885|12367522|FG001|STARTED|Treatment Period 2 (7-14 Days)||21
11178647|NCT01691885|12367521|FG000|COMPLETED|Treatment Period 2 (7-14 Days)||21
11178648|NCT01691885|12367522|FG001|COMPLETED|Treatment Period 2 (7-14 Days)||21
11178649|NCT01691885|12367521|FG000|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
11178650|NCT01691885|12367522|FG001|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
11178651|NCT01691898|12367534|FG000|STARTED|Overall Study||63
11178652|NCT01691898|12367535|FG001|STARTED|Overall Study||59
11178653|NCT01691898|12367536|FG002|STARTED|Overall Study||20
11178654|NCT01691898|12367537|FG003|STARTED|Overall Study||9
11178655|NCT01691898|12367538|FG004|STARTED|Overall Study||40
11178656|NCT01691898|12367539|FG005|STARTED|Overall Study||40
11178657|NCT01691898|12367534|FG000|COMPLETED|Overall Study||16
11178658|NCT01691898|12367535|FG001|COMPLETED|Overall Study||15
11178659|NCT01691898|12367536|FG002|COMPLETED|Overall Study||11
11178660|NCT01691898|12367537|FG003|COMPLETED|Overall Study||4
11178661|NCT01691898|12367538|FG004|COMPLETED|Overall Study||26
11178662|NCT01691898|12367539|FG005|COMPLETED|Overall Study||5
11178663|NCT01691898|12367534|FG000|NOT COMPLETED|Overall Study||47
11178664|NCT01691898|12367535|FG001|NOT COMPLETED|Overall Study||44
11178665|NCT01691898|12367536|FG002|NOT COMPLETED|Overall Study||9
11178666|NCT01691898|12367537|FG003|NOT COMPLETED|Overall Study||5
11178667|NCT01691898|12367538|FG004|NOT COMPLETED|Overall Study||14
11178668|NCT01691898|12367539|FG005|NOT COMPLETED|Overall Study||35
11178669|NCT01691950|12367573|FG000|STARTED|Overall Study||20
11178670|NCT01691950|12367574|FG001|STARTED|Overall Study||10
11178671|NCT01691950|12367573|FG000|COMPLETED|Overall Study||10
11178672|NCT01691950|12367574|FG001|COMPLETED|Overall Study||10
11178673|NCT01691950|12367573|FG000|NOT COMPLETED|Overall Study||10
11178674|NCT01691950|12367574|FG001|NOT COMPLETED|Overall Study||0
11178675|NCT01692119|12367582|FG000|STARTED|Overall Study||130
11178676|NCT01692119|12367583|FG001|STARTED|Overall Study||128
11178677|NCT01692119|12367582|FG000|COMPLETED|Overall Study||110
11178678|NCT01692119|12367583|FG001|COMPLETED|Overall Study||127
11178679|NCT01692119|12367582|FG000|NOT COMPLETED|Overall Study||20
11178680|NCT01692119|12367583|FG001|NOT COMPLETED|Overall Study||1
11178681|NCT01692197|12367589|FG000|STARTED|Overall Study||43
11178682|NCT01692197|12367589|FG000|COMPLETED|Overall Study||40
11178683|NCT01692197|12367589|FG000|NOT COMPLETED|Overall Study||3
11178684|NCT01692275|12367600|FG000|STARTED|Overall Study||375
11178685|NCT01692275|12367601|FG001|STARTED|Overall Study||375
11178686|NCT01692275|12367600|FG000|COMPLETED|Overall Study||309
11178687|NCT01692275|12367601|FG001|COMPLETED|Overall Study||316
11178688|NCT01692275|12367600|FG000|NOT COMPLETED|Overall Study||66
11178689|NCT01692275|12367601|FG001|NOT COMPLETED|Overall Study||59
11178690|NCT01692301|12367621|FG000|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
11178691|NCT01692301|12367622|FG001|STARTED|Overall Study||225
11178692|NCT01692301|12367621|FG000|COMPLETED|Overall Study||184
11178693|NCT01692301|12367622|FG001|COMPLETED|Overall Study||183
11178694|NCT01692301|12367621|FG000|NOT COMPLETED|Overall Study||45
11178695|NCT01692301|12367622|FG001|NOT COMPLETED|Overall Study||42
11178696|NCT01692340|12367631|FG000|STARTED|Overall Study||8
11178697|NCT01692340|12367632|FG001|STARTED|Overall Study||4
11178698|NCT01692340|12367633|FG002|STARTED|Overall Study||0
11178699|NCT01692340|12367631|FG000|COMPLETED|Overall Study||8
11178700|NCT01692340|12367632|FG001|COMPLETED|Overall Study||4
11178701|NCT01692340|12367633|FG002|COMPLETED|Overall Study||0
11178702|NCT01692340|12367631|FG000|NOT COMPLETED|Overall Study||0
11178703|NCT01692340|12367632|FG001|NOT COMPLETED|Overall Study||0
11178704|NCT01692340|12367633|FG002|NOT COMPLETED|Overall Study||0
11178705|NCT01692496|12367642|FG000|STARTED|Overall Study||52
11178706|NCT01692496|12367642|FG000|3 Weeks Pazopanib (Per Protocol PP)|Overall Study||50
11178707|NCT01692496|12367642|FG000|COMPLETED|Overall Study||52
11178708|NCT01692496|12367642|FG000|NOT COMPLETED|Overall Study||0
11178709|NCT01692626|12367646|FG000|STARTED|Overall Study||6
11178710|NCT01692626|12367647|FG001|STARTED|Overall Study||7
11178711|NCT01692626|12367646|FG000|COMPLETED|Overall Study||2
11178712|NCT01692626|12367647|FG001|COMPLETED|Overall Study||1
11178713|NCT01692626|12367646|FG000|NOT COMPLETED|Overall Study||4
11178714|NCT01692626|12367647|FG001|NOT COMPLETED|Overall Study||6
11178715|NCT01692730|12367654|FG000|STARTED|Overall Study||723
11178716|NCT01692730|12367655|FG001|STARTED|Overall Study||729
11178717|NCT01692730|12367654|FG000|COMPLETED|Overall Study||498
11178718|NCT01692730|12367655|FG001|COMPLETED|Overall Study||502
11178719|NCT01692730|12367654|FG000|NOT COMPLETED|Overall Study||225
11178720|NCT01692730|12367655|FG001|NOT COMPLETED|Overall Study||227
11178721|NCT01692743|12367664|FG000|STARTED|Overall Study||117
11178722|NCT01692743|12367665|FG001|STARTED|Overall Study||116
11178723|NCT01692743|12367666|FG002|STARTED|Overall Study||115
11178724|NCT01692743|12367664|FG000|COMPLETED|Overall Study||90
11178725|NCT01692743|12367665|FG001|COMPLETED|Overall Study||81
11178726|NCT01692743|12367666|FG002|COMPLETED|Overall Study||88
11178727|NCT01692743|12367664|FG000|NOT COMPLETED|Overall Study||27
11178728|NCT01692743|12367665|FG001|NOT COMPLETED|Overall Study||35
11178729|NCT01692743|12367666|FG002|NOT COMPLETED|Overall Study||27
11178730|NCT01692756|12367678|FG000|STARTED|Overall Study||12
11178731|NCT01692756|12367679|FG001|STARTED|Overall Study||12
11178732|NCT01692756|12367680|FG002|STARTED|Overall Study||13
11178733|NCT01692756|12367681|FG003|STARTED|Overall Study||12
11178734|NCT01692756|12367678|FG000|COMPLETED|Overall Study||11
11178735|NCT01692756|12367679|FG001|COMPLETED|Overall Study||11
11178736|NCT01692756|12367680|FG002|COMPLETED|Overall Study||11
11178737|NCT01692756|12367681|FG003|COMPLETED|Overall Study||12
11178738|NCT01692756|12367678|FG000|NOT COMPLETED|Overall Study||1
11178739|NCT01692756|12367679|FG001|NOT COMPLETED|Overall Study||1
11178740|NCT01692756|12367680|FG002|NOT COMPLETED|Overall Study||2
11178741|NCT01692756|12367681|FG003|NOT COMPLETED|Overall Study||0
11178742|NCT01692782|12367694|FG000|STARTED|Overall Study||116
11178743|NCT01692782|12367695|FG001|STARTED|Overall Study||115
11178744|NCT01692782|12367696|FG002|STARTED|Overall Study||110
11178745|NCT01692782|12367694|FG000|COMPLETED|Overall Study||96
11178746|NCT01692782|12367695|FG001|COMPLETED|Overall Study||59
11178747|NCT01692782|12367696|FG002|COMPLETED|Overall Study||100
11178748|NCT01692782|12367694|FG000|NOT COMPLETED|Overall Study||20
11178749|NCT01692782|12367695|FG001|NOT COMPLETED|Overall Study||56
11178750|NCT01692782|12367696|FG002|NOT COMPLETED|Overall Study||10
11178751|NCT01692938|12367706|FG000|STARTED|Overall Study||16
11178752|NCT01692938|12367707|FG001|STARTED|Overall Study||16
11178753|NCT01692938|12367706|FG000|COMPLETED|Overall Study||12
11178754|NCT01692938|12367707|FG001|COMPLETED|Overall Study||12
11178755|NCT01692938|12367706|FG000|NOT COMPLETED|Overall Study||4
11178756|NCT01692938|12367707|FG001|NOT COMPLETED|Overall Study||4
11178757|NCT01692951|12367717|FG000|STARTED|Overall Study||37
11178758|NCT01692951|12367718|FG001|STARTED|Overall Study||111
11178759|NCT01692951|12367719|FG002|STARTED|Overall Study||18
11178760|NCT01692951|12367720|FG003|STARTED|Overall Study||54
11178761|NCT01692951|12367717|FG000|COMPLETED|Overall Study||37
11178762|NCT01692951|12367718|FG001|COMPLETED|Overall Study||111
11178763|NCT01692951|12367719|FG002|COMPLETED|Overall Study||18
11178764|NCT01692951|12367720|FG003|COMPLETED|Overall Study||54
11178765|NCT01692951|12367717|FG000|NOT COMPLETED|Overall Study||0
11178766|NCT01692951|12367718|FG001|NOT COMPLETED|Overall Study||0
11178767|NCT01692951|12367719|FG002|NOT COMPLETED|Overall Study||0
11178768|NCT01692951|12367720|FG003|NOT COMPLETED|Overall Study||0
11178769|NCT01692964|12367730|FG000|STARTED|Overall Study||237
11178770|NCT01692964|12367730|FG000|COMPLETED|Overall Study||237
11178771|NCT01692964|12367730|FG000|NOT COMPLETED|Overall Study||0
11178772|NCT01693029|12367737|FG000|STARTED|Overall Study||217
11178773|NCT01693029|12367738|FG001|STARTED|Overall Study||218
11178774|NCT01693029|12367737|FG000|COMPLETED|Overall Study||173
11178775|NCT01693029|12367738|FG001|COMPLETED|Overall Study||161
11178776|NCT01693029|12367737|FG000|NOT COMPLETED|Overall Study||44
11178777|NCT01693029|12367738|FG001|NOT COMPLETED|Overall Study||57
11178778|NCT01693068|12367746|FG000|STARTED|Randomization Period||64
11178779|NCT01693068|12367747|FG001|STARTED|Randomization Period||130
11178780|NCT01693068|12367748|FG002|STARTED|Randomization Period||0
11178781|NCT01693068|12367746|FG000|Treated|Randomization Period||61
11178782|NCT01693068|12367747|FG001|Treated|Randomization Period||130
11178783|NCT01693068|12367748|FG002|Treated|Randomization Period||0
11178784|NCT01693068|12367746|FG000|COMPLETED|Randomization Period||62
11178785|NCT01693068|12367747|FG001|COMPLETED|Randomization Period||125
11178786|NCT01693068|12367748|FG002|COMPLETED|Randomization Period||0
11178787|NCT01693068|12367746|FG000|NOT COMPLETED|Randomization Period||2
11178788|NCT01693068|12367747|FG001|NOT COMPLETED|Randomization Period||5
11178789|NCT01693068|12367748|FG002|NOT COMPLETED|Randomization Period||0
11178790|NCT01693068|12367746|FG000|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
11178791|NCT01693068|12367747|FG001|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
11178792|NCT01693068|12367748|FG002|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
11178793|NCT01693068|12367746|FG000|Treated|Cross-over (Dacarbazine To Pimasertib)||0
11178794|NCT01693068|12367747|FG001|Treated|Cross-over (Dacarbazine To Pimasertib)||0
11178795|NCT01693068|12367748|FG002|Treated|Cross-over (Dacarbazine To Pimasertib)||41
11178796|NCT01693068|12367746|FG000|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
11178797|NCT01693068|12367747|FG001|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
11178798|NCT01693068|12367748|FG002|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
11178799|NCT01693068|12367746|FG000|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
11178800|NCT01693068|12367747|FG001|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
11178801|NCT01693068|12367748|FG002|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
11178802|NCT01693120|12367756|FG000|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
11178803|NCT01693120|12367756|FG000|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
11178804|NCT01693120|12367756|FG000|NOT COMPLETED|Enrollment||70
11178805|NCT01693120|12367756|FG000|STARTED|Phased RF Study Procedure and Follow-up||129
11178806|NCT01693120|12367756|FG000|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
11178807|NCT01693120|12367756|FG000|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
11178808|NCT01693185|12367762|FG000|STARTED|Overall Study||27
11178809|NCT01693185|12367763|FG001|STARTED|Overall Study||33
11178810|NCT01693185|12367762|FG000|COMPLETED|Overall Study||27
11178811|NCT01693185|12367763|FG001|COMPLETED|Overall Study||27
11178812|NCT01693185|12367762|FG000|NOT COMPLETED|Overall Study||0
11178813|NCT01693185|12367763|FG001|NOT COMPLETED|Overall Study||6
11178814|NCT01693250|12367771|FG000|STARTED|Overall Study|3 months post baseline assessment|23
11178815|NCT01693250|12367772|FG001|STARTED|Overall Study|three month post baseline assessment|17
11178816|NCT01693250|12367771|FG000|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21
11178817|NCT01693250|12367772|FG001|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15
11178818|NCT01693250|12367771|FG000|NOT COMPLETED|Overall Study||2
11178819|NCT01693250|12367772|FG001|NOT COMPLETED|Overall Study||2
11178820|NCT01693523|12367783|FG000|STARTED|Overall Study||23
11178821|NCT01693523|12367784|FG001|STARTED|Overall Study||21
11178822|NCT01693523|12367785|FG002|STARTED|Overall Study||35
11178823|NCT01693523|12367783|FG000|COMPLETED|Overall Study||18
11178824|NCT01693523|12367784|FG001|COMPLETED|Overall Study||13
11178825|NCT01693523|12367785|FG002|COMPLETED|Overall Study||27
11178826|NCT01693523|12367783|FG000|NOT COMPLETED|Overall Study||5
11178827|NCT01693523|12367784|FG001|NOT COMPLETED|Overall Study||8
11178828|NCT01693523|12367785|FG002|NOT COMPLETED|Overall Study||8
11178829|NCT01693562|12367815|FG000|STARTED|Escalation Phase||4
11178830|NCT01693562|12367816|FG001|STARTED|Escalation Phase||4
11178831|NCT01693562|12367817|FG002|STARTED|Escalation Phase||3
11178832|NCT01693562|12367818|FG003|STARTED|Escalation Phase||3
11178833|NCT01693562|12367819|FG004|STARTED|Escalation Phase||6
11178834|NCT01693562|12367820|FG005|STARTED|Escalation Phase||7
11178835|NCT01693562|12367821|FG006|STARTED|Escalation Phase||0
11178836|NCT01693562|12367822|FG007|STARTED|Escalation Phase||0
11178837|NCT01693562|12367823|FG008|STARTED|Escalation Phase||0
11178838|NCT01693562|12367824|FG009|STARTED|Escalation Phase||0
11178839|NCT01693562|12367825|FG010|STARTED|Escalation Phase||0
11178840|NCT01693562|12367826|FG011|STARTED|Escalation Phase||0
11178841|NCT01693562|12367827|FG012|STARTED|Escalation Phase||0
11178842|NCT01693562|12367828|FG013|STARTED|Escalation Phase||0
11178843|NCT01693562|12367829|FG014|STARTED|Escalation Phase||0
11178844|NCT01693562|12367830|FG015|STARTED|Escalation Phase||0
11178845|NCT01693562|12367831|FG016|STARTED|Escalation Phase||0
11178846|NCT01693562|12367832|FG017|STARTED|Escalation Phase||0
11178847|NCT01693562|12367833|FG018|STARTED|Escalation Phase||0
11178848|NCT01693562|12367834|FG019|STARTED|Escalation Phase||0
11178849|NCT01693562|12367835|FG020|STARTED|Escalation Phase||0
11178850|NCT01693562|12367836|FG021|STARTED|Escalation Phase||0
11178851|NCT01693562|12367837|FG022|STARTED|Escalation Phase||0
11178852|NCT01693562|12367815|FG000|COMPLETED|Escalation Phase||0
11178853|NCT01693562|12367816|FG001|COMPLETED|Escalation Phase||0
11178854|NCT01693562|12367817|FG002|COMPLETED|Escalation Phase||0
11178855|NCT01693562|12367818|FG003|COMPLETED|Escalation Phase||0
11178856|NCT01693562|12367819|FG004|COMPLETED|Escalation Phase||0
11178857|NCT01693562|12367820|FG005|COMPLETED|Escalation Phase||0
11178858|NCT01693562|12367821|FG006|COMPLETED|Escalation Phase||0
11178859|NCT01693562|12367822|FG007|COMPLETED|Escalation Phase||0
11178860|NCT01693562|12367823|FG008|COMPLETED|Escalation Phase||0
11178861|NCT01693562|12367824|FG009|COMPLETED|Escalation Phase||0
11178862|NCT01693562|12367825|FG010|COMPLETED|Escalation Phase||0
11178863|NCT01693562|12367826|FG011|COMPLETED|Escalation Phase||0
11178864|NCT01693562|12367827|FG012|COMPLETED|Escalation Phase||0
11178865|NCT01693562|12367828|FG013|COMPLETED|Escalation Phase||0
11178866|NCT01693562|12367829|FG014|COMPLETED|Escalation Phase||0
11178867|NCT01693562|12367830|FG015|COMPLETED|Escalation Phase||0
11178868|NCT01693562|12367831|FG016|COMPLETED|Escalation Phase||0
11178869|NCT01693562|12367832|FG017|COMPLETED|Escalation Phase||0
11178870|NCT01693562|12367833|FG018|COMPLETED|Escalation Phase||0
11178871|NCT01693562|12367834|FG019|COMPLETED|Escalation Phase||0
11178872|NCT01693562|12367835|FG020|COMPLETED|Escalation Phase||0
11178873|NCT01693562|12367836|FG021|COMPLETED|Escalation Phase||0
11178874|NCT01693562|12367837|FG022|COMPLETED|Escalation Phase||0
11178875|NCT01693562|12367815|FG000|NOT COMPLETED|Escalation Phase||4
11178876|NCT01693562|12367816|FG001|NOT COMPLETED|Escalation Phase||4
11178877|NCT01693562|12367817|FG002|NOT COMPLETED|Escalation Phase||3
11178878|NCT01693562|12367818|FG003|NOT COMPLETED|Escalation Phase||3
11178879|NCT01693562|12367819|FG004|NOT COMPLETED|Escalation Phase||6
11178880|NCT01693562|12367820|FG005|NOT COMPLETED|Escalation Phase||7
11178881|NCT01693562|12367821|FG006|NOT COMPLETED|Escalation Phase||0
11178882|NCT01693562|12367822|FG007|NOT COMPLETED|Escalation Phase||0
11178883|NCT01693562|12367823|FG008|NOT COMPLETED|Escalation Phase||0
11178884|NCT01693562|12367824|FG009|NOT COMPLETED|Escalation Phase||0
11178885|NCT01693562|12367825|FG010|NOT COMPLETED|Escalation Phase||0
11178886|NCT01693562|12367826|FG011|NOT COMPLETED|Escalation Phase||0
11178887|NCT01693562|12367827|FG012|NOT COMPLETED|Escalation Phase||0
11178888|NCT01693562|12367828|FG013|NOT COMPLETED|Escalation Phase||0
11178889|NCT01693562|12367829|FG014|NOT COMPLETED|Escalation Phase||0
11178890|NCT01693562|12367830|FG015|NOT COMPLETED|Escalation Phase||0
11178891|NCT01693562|12367831|FG016|NOT COMPLETED|Escalation Phase||0
11178892|NCT01693562|12367832|FG017|NOT COMPLETED|Escalation Phase||0
11178893|NCT01693562|12367833|FG018|NOT COMPLETED|Escalation Phase||0
11178894|NCT01693562|12367834|FG019|NOT COMPLETED|Escalation Phase||0
11178895|NCT01693562|12367835|FG020|NOT COMPLETED|Escalation Phase||0
11178896|NCT01693562|12367836|FG021|NOT COMPLETED|Escalation Phase||0
11178897|NCT01693562|12367837|FG022|NOT COMPLETED|Escalation Phase||0
11178898|NCT01693562|12367815|FG000|STARTED|Exploration Phase||0
11178899|NCT01693562|12367816|FG001|STARTED|Exploration Phase||0
11178900|NCT01693562|12367817|FG002|STARTED|Exploration Phase||0
11178901|NCT01693562|12367818|FG003|STARTED|Exploration Phase||0
11178902|NCT01693562|12367819|FG004|STARTED|Exploration Phase||0
11178903|NCT01693562|12367820|FG005|STARTED|Exploration Phase||0
11178904|NCT01693562|12367821|FG006|STARTED|Exploration Phase||21
11178905|NCT01693562|12367822|FG007|STARTED|Exploration Phase||0
11178906|NCT01693562|12367823|FG008|STARTED|Exploration Phase||0
11178907|NCT01693562|12367824|FG009|STARTED|Exploration Phase||0
11178908|NCT01693562|12367825|FG010|STARTED|Exploration Phase||0
11178909|NCT01693562|12367826|FG011|STARTED|Exploration Phase||0
11178910|NCT01693562|12367827|FG012|STARTED|Exploration Phase||0
11178911|NCT01693562|12367828|FG013|STARTED|Exploration Phase||0
11178912|NCT01693562|12367829|FG014|STARTED|Exploration Phase||0
11178913|NCT01693562|12367830|FG015|STARTED|Exploration Phase||0
11178914|NCT01693562|12367831|FG016|STARTED|Exploration Phase||0
11178915|NCT01693562|12367832|FG017|STARTED|Exploration Phase||0
11178916|NCT01693562|12367833|FG018|STARTED|Exploration Phase||0
11324073|NCT02741596|12521437|FG001|COMPLETED|Overall Study||25
11324074|NCT02741596|12521436|FG000|NOT COMPLETED|Overall Study||78
11324075|NCT02741596|12521437|FG001|NOT COMPLETED|Overall Study||78
11324076|NCT02741635|12521443|FG000|STARTED|Overall Study||15
11324077|NCT02741635|12521443|FG000|COMPLETED|Overall Study||14
11324078|NCT02741635|12521443|FG000|NOT COMPLETED|Overall Study||1
11324079|NCT02741687|12521450|FG000|STARTED|Overall Study||36
11324080|NCT02741687|12521451|FG001|STARTED|Overall Study||44
11324081|NCT02741687|12521450|FG000|COMPLETED|Overall Study||36
11324082|NCT02741687|12521451|FG001|COMPLETED|Overall Study||44
11324083|NCT02741687|12521450|FG000|NOT COMPLETED|Overall Study||0
11324084|NCT02741687|12521451|FG001|NOT COMPLETED|Overall Study||0
11324085|NCT02741713|12521459|FG000|STARTED|Overall Study||20
11324086|NCT02741713|12521460|FG001|STARTED|Overall Study||20
11324087|NCT02741713|12521459|FG000|COMPLETED|Overall Study||18
11324088|NCT02741713|12521460|FG001|COMPLETED|Overall Study||19
11324089|NCT02741713|12521459|FG000|NOT COMPLETED|Overall Study||2
11324090|NCT02741713|12521460|FG001|NOT COMPLETED|Overall Study||1
11324091|NCT02742077|12521467|FG000|STARTED|Overall Study||20
11324092|NCT02742077|12521467|FG000|COMPLETED|Overall Study||20
11324093|NCT02742077|12521467|FG000|NOT COMPLETED|Overall Study||0
11324094|NCT02742103|12521473|FG000|STARTED|Overall Study||55
11324095|NCT02742103|12521474|FG001|STARTED|Overall Study||28
11324096|NCT02742103|12521473|FG000|COMPLETED|Overall Study||46
11324097|NCT02742103|12521474|FG001|COMPLETED|Overall Study||23
11324098|NCT02742103|12521473|FG000|NOT COMPLETED|Overall Study||9
11324099|NCT02742103|12521474|FG001|NOT COMPLETED|Overall Study||5
11324100|NCT02742129|12521482|FG000|STARTED|Phase 1||53
11324101|NCT02742129|12521483|FG001|STARTED|Phase 1||52
11324102|NCT02742129|12521482|FG000|COMPLETED|Phase 1||51
11324103|NCT02742129|12521483|FG001|COMPLETED|Phase 1||50
11324104|NCT02742129|12521482|FG000|NOT COMPLETED|Phase 1||2
11324105|NCT02742129|12521483|FG001|NOT COMPLETED|Phase 1||2
11324106|NCT02742129|12521482|FG000|STARTED|Phase 2||51
11324107|NCT02742129|12521483|FG001|STARTED|Phase 2||50
11324108|NCT02742129|12521482|FG000|COMPLETED|Phase 2||50
11324109|NCT02742129|12521483|FG001|COMPLETED|Phase 2||48
11324110|NCT02742129|12521482|FG000|NOT COMPLETED|Phase 2||1
11324111|NCT02742129|12521483|FG001|NOT COMPLETED|Phase 2||2
11324112|NCT02742441|12521494|FG000|STARTED|Overall Study||205
11178917|NCT01693562|12367834|FG019|STARTED|Exploration Phase||0
11178918|NCT01693562|12367835|FG020|STARTED|Exploration Phase||0
11178919|NCT01693562|12367836|FG021|STARTED|Exploration Phase||0
11178920|NCT01693562|12367837|FG022|STARTED|Exploration Phase||0
11178921|NCT01693562|12367815|FG000|COMPLETED|Exploration Phase||0
11178922|NCT01693562|12367816|FG001|COMPLETED|Exploration Phase||0
11178923|NCT01693562|12367817|FG002|COMPLETED|Exploration Phase||0
11178924|NCT01693562|12367818|FG003|COMPLETED|Exploration Phase||0
11178925|NCT01693562|12367819|FG004|COMPLETED|Exploration Phase||0
11178926|NCT01693562|12367820|FG005|COMPLETED|Exploration Phase||0
11178927|NCT01693562|12367821|FG006|COMPLETED|Exploration Phase||0
11178928|NCT01693562|12367822|FG007|COMPLETED|Exploration Phase||0
11178929|NCT01693562|12367823|FG008|COMPLETED|Exploration Phase||0
11178930|NCT01693562|12367824|FG009|COMPLETED|Exploration Phase||0
11178931|NCT01693562|12367825|FG010|COMPLETED|Exploration Phase||0
11178932|NCT01693562|12367826|FG011|COMPLETED|Exploration Phase||0
11178933|NCT01693562|12367827|FG012|COMPLETED|Exploration Phase||0
11178934|NCT01693562|12367828|FG013|COMPLETED|Exploration Phase||0
11178935|NCT01693562|12367829|FG014|COMPLETED|Exploration Phase||0
11178936|NCT01693562|12367830|FG015|COMPLETED|Exploration Phase||0
11178937|NCT01693562|12367831|FG016|COMPLETED|Exploration Phase||0
11178938|NCT01693562|12367832|FG017|COMPLETED|Exploration Phase||0
11178939|NCT01693562|12367833|FG018|COMPLETED|Exploration Phase||0
11178940|NCT01693562|12367834|FG019|COMPLETED|Exploration Phase||0
11178941|NCT01693562|12367835|FG020|COMPLETED|Exploration Phase||0
11178942|NCT01693562|12367836|FG021|COMPLETED|Exploration Phase||0
11178943|NCT01693562|12367837|FG022|COMPLETED|Exploration Phase||0
11178944|NCT01693562|12367815|FG000|NOT COMPLETED|Exploration Phase||0
11178945|NCT01693562|12367816|FG001|NOT COMPLETED|Exploration Phase||0
11178946|NCT01693562|12367817|FG002|NOT COMPLETED|Exploration Phase||0
11178947|NCT01693562|12367818|FG003|NOT COMPLETED|Exploration Phase||0
11178948|NCT01693562|12367819|FG004|NOT COMPLETED|Exploration Phase||0
11178949|NCT01693562|12367820|FG005|NOT COMPLETED|Exploration Phase||0
11178950|NCT01693562|12367821|FG006|NOT COMPLETED|Exploration Phase||21
11178951|NCT01693562|12367822|FG007|NOT COMPLETED|Exploration Phase||0
11178952|NCT01693562|12367823|FG008|NOT COMPLETED|Exploration Phase||0
11178953|NCT01693562|12367824|FG009|NOT COMPLETED|Exploration Phase||0
11178954|NCT01693562|12367825|FG010|NOT COMPLETED|Exploration Phase||0
11178955|NCT01693562|12367826|FG011|NOT COMPLETED|Exploration Phase||0
11178956|NCT01693562|12367827|FG012|NOT COMPLETED|Exploration Phase||0
11178957|NCT01693562|12367828|FG013|NOT COMPLETED|Exploration Phase||0
11178958|NCT01693562|12367829|FG014|NOT COMPLETED|Exploration Phase||0
11178959|NCT01693562|12367830|FG015|NOT COMPLETED|Exploration Phase||0
11178960|NCT01693562|12367831|FG016|NOT COMPLETED|Exploration Phase||0
11178961|NCT01693562|12367832|FG017|NOT COMPLETED|Exploration Phase||0
11178962|NCT01693562|12367833|FG018|NOT COMPLETED|Exploration Phase||0
11178963|NCT01693562|12367834|FG019|NOT COMPLETED|Exploration Phase||0
11178964|NCT01693562|12367835|FG020|NOT COMPLETED|Exploration Phase||0
11178965|NCT01693562|12367836|FG021|NOT COMPLETED|Exploration Phase||0
11178966|NCT01693562|12367837|FG022|NOT COMPLETED|Exploration Phase||0
11178967|NCT01693562|12367815|FG000|STARTED|Expansion Phase||0
11178968|NCT01693562|12367816|FG001|STARTED|Expansion Phase||0
11178969|NCT01693562|12367817|FG002|STARTED|Expansion Phase||0
11178970|NCT01693562|12367818|FG003|STARTED|Expansion Phase||0
11178971|NCT01693562|12367819|FG004|STARTED|Expansion Phase||0
11178972|NCT01693562|12367820|FG005|STARTED|Expansion Phase||0
11178973|NCT01693562|12367821|FG006|STARTED|Expansion Phase||0
11178974|NCT01693562|12367822|FG007|STARTED|Expansion Phase||62
11178975|NCT01693562|12367823|FG008|STARTED|Expansion Phase||22
11178976|NCT01693562|12367824|FG009|STARTED|Expansion Phase|2 eligible NSCLC participants from dose-escalation were added to the dose expansion summaries.|304
11178977|NCT01693562|12367825|FG010|STARTED|Expansion Phase||40
11178978|NCT01693562|12367826|FG011|STARTED|Expansion Phase||21
11178979|NCT01693562|12367827|FG012|STARTED|Expansion Phase||24
11324113|NCT02742441|12521495|FG001|STARTED|Overall Study||204
11324114|NCT02742441|12521494|FG000|COMPLETED|Overall Study||199
11178980|NCT01693562|12367828|FG013|STARTED|Expansion Phase||51
11178981|NCT01693562|12367829|FG014|STARTED|Expansion Phase||40
11178982|NCT01693562|12367830|FG015|STARTED|Expansion Phase||31
11178983|NCT01693562|12367831|FG016|STARTED|Expansion Phase||201
11178984|NCT01693562|12367832|FG017|STARTED|Expansion Phase||20
11178985|NCT01693562|12367833|FG018|STARTED|Expansion Phase||47
11178986|NCT01693562|12367834|FG019|STARTED|Expansion Phase||20
11178987|NCT01693562|12367835|FG020|STARTED|Expansion Phase||21
11178988|NCT01693562|12367836|FG021|STARTED|Expansion Phase||62
11178989|NCT01693562|12367837|FG022|STARTED|Expansion Phase||10
11178990|NCT01693562|12367815|FG000|COMPLETED|Expansion Phase||0
11178991|NCT01693562|12367816|FG001|COMPLETED|Expansion Phase||0
11178992|NCT01693562|12367817|FG002|COMPLETED|Expansion Phase||0
11178993|NCT01693562|12367818|FG003|COMPLETED|Expansion Phase||0
11178994|NCT01693562|12367819|FG004|COMPLETED|Expansion Phase||0
11178995|NCT01693562|12367820|FG005|COMPLETED|Expansion Phase||0
11178996|NCT01693562|12367821|FG006|COMPLETED|Expansion Phase||0
11178997|NCT01693562|12367822|FG007|COMPLETED|Expansion Phase||0
11178998|NCT01693562|12367823|FG008|COMPLETED|Expansion Phase||0
11178999|NCT01693562|12367824|FG009|COMPLETED|Expansion Phase||4
11179000|NCT01693562|12367825|FG010|COMPLETED|Expansion Phase||0
11179001|NCT01693562|12367826|FG011|COMPLETED|Expansion Phase||0
11179002|NCT01693562|12367827|FG012|COMPLETED|Expansion Phase||1
11179003|NCT01693562|12367828|FG013|COMPLETED|Expansion Phase||0
11179004|NCT01693562|12367829|FG014|COMPLETED|Expansion Phase||0
11179005|NCT01693562|12367830|FG015|COMPLETED|Expansion Phase||0
11179006|NCT01693562|12367831|FG016|COMPLETED|Expansion Phase||4
11179007|NCT01693562|12367832|FG017|COMPLETED|Expansion Phase||0
11179008|NCT01693562|12367833|FG018|COMPLETED|Expansion Phase||0
11179009|NCT01693562|12367834|FG019|COMPLETED|Expansion Phase||0
11179010|NCT01693562|12367835|FG020|COMPLETED|Expansion Phase||0
11179011|NCT01693562|12367836|FG021|COMPLETED|Expansion Phase||0
11179012|NCT01693562|12367837|FG022|COMPLETED|Expansion Phase||0
11179013|NCT01693562|12367815|FG000|NOT COMPLETED|Expansion Phase||0
11179014|NCT01693562|12367816|FG001|NOT COMPLETED|Expansion Phase||0
11179015|NCT01693562|12367817|FG002|NOT COMPLETED|Expansion Phase||0
11179016|NCT01693562|12367818|FG003|NOT COMPLETED|Expansion Phase||0
11179017|NCT01693562|12367819|FG004|NOT COMPLETED|Expansion Phase||0
11179018|NCT01693562|12367820|FG005|NOT COMPLETED|Expansion Phase||0
11179019|NCT01693562|12367821|FG006|NOT COMPLETED|Expansion Phase||0
11179020|NCT01693562|12367822|FG007|NOT COMPLETED|Expansion Phase||62
11179021|NCT01693562|12367823|FG008|NOT COMPLETED|Expansion Phase||22
11179022|NCT01693562|12367824|FG009|NOT COMPLETED|Expansion Phase||300
11179023|NCT01693562|12367825|FG010|NOT COMPLETED|Expansion Phase||40
11179024|NCT01693562|12367826|FG011|NOT COMPLETED|Expansion Phase||21
11179025|NCT01693562|12367827|FG012|NOT COMPLETED|Expansion Phase||23
11179026|NCT01693562|12367828|FG013|NOT COMPLETED|Expansion Phase||51
11179027|NCT01693562|12367829|FG014|NOT COMPLETED|Expansion Phase||40
11179028|NCT01693562|12367830|FG015|NOT COMPLETED|Expansion Phase||31
11179029|NCT01693562|12367831|FG016|NOT COMPLETED|Expansion Phase||197
11179030|NCT01693562|12367832|FG017|NOT COMPLETED|Expansion Phase||20
11179031|NCT01693562|12367833|FG018|NOT COMPLETED|Expansion Phase||47
11179032|NCT01693562|12367834|FG019|NOT COMPLETED|Expansion Phase||20
11179033|NCT01693562|12367835|FG020|NOT COMPLETED|Expansion Phase||21
11179034|NCT01693562|12367836|FG021|NOT COMPLETED|Expansion Phase||62
11179035|NCT01693562|12367837|FG022|NOT COMPLETED|Expansion Phase||10
11179036|NCT01693614|12367923|FG000|STARTED|Overall Study||26
11179037|NCT01693614|12367924|FG001|STARTED|Overall Study||22
11179038|NCT01693614|12367925|FG002|STARTED|Overall Study||24
11179039|NCT01693614|12367923|FG000|COMPLETED|Overall Study||0
11179040|NCT01693614|12367924|FG001|COMPLETED|Overall Study||0
11179041|NCT01693614|12367925|FG002|COMPLETED|Overall Study||0
11179042|NCT01693614|12367923|FG000|NOT COMPLETED|Overall Study||26
11179043|NCT01693614|12367924|FG001|NOT COMPLETED|Overall Study||22
11179044|NCT01693614|12367925|FG002|NOT COMPLETED|Overall Study||24
11179045|NCT01693900|12367936|FG000|STARTED|Overall Study||25
11179046|NCT01693900|12367937|FG001|STARTED|Overall Study||25
11179047|NCT01693900|12367936|FG000|COMPLETED|Overall Study||25
11179048|NCT01693900|12367937|FG001|COMPLETED|Overall Study||25
11179049|NCT01693900|12367936|FG000|NOT COMPLETED|Overall Study||0
11179050|NCT01693900|12367937|FG001|NOT COMPLETED|Overall Study||0
11179051|NCT01694108|12367945|FG000|STARTED|Overall Study||2129
11179052|NCT01694108|12367946|FG001|STARTED|Overall Study||2133
11179053|NCT01694108|12367945|FG000|COMPLETED|Overall Study|100% follow-up|2129
11179054|NCT01694108|12367946|FG001|COMPLETED|Overall Study|100% follow-up|2133
11179055|NCT01694108|12367945|FG000|NOT COMPLETED|Overall Study||0
11179056|NCT01694108|12367946|FG001|NOT COMPLETED|Overall Study||0
11179057|NCT01694121|12367961|FG000|STARTED|Overall Study||228
11179058|NCT01694121|12367962|FG001|STARTED|Overall Study||227
11179059|NCT01694121|12367961|FG000|COMPLETED|Overall Study||227
11179060|NCT01694121|12367962|FG001|COMPLETED|Overall Study||227
11179061|NCT01694121|12367961|FG000|NOT COMPLETED|Overall Study||1
11179062|NCT01694121|12367962|FG001|NOT COMPLETED|Overall Study||0
11179063|NCT01694186|12367970|FG000|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|42
11179064|NCT01694186|12367971|FG001|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|87
11179065|NCT01694186|12367970|FG000|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|36
11179066|NCT01694186|12367971|FG001|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|80
11179067|NCT01694186|12367970|FG000|NOT COMPLETED|Overall Study||6
11179068|NCT01694186|12367971|FG001|NOT COMPLETED|Overall Study||7
11179069|NCT01694199|12367979|FG000|STARTED|Overall Study||71
11179070|NCT01694199|12367980|FG001|STARTED|Overall Study||68
11179071|NCT01694199|12367979|FG000|COMPLETED|Overall Study||71
11179072|NCT01694199|12367980|FG001|COMPLETED|Overall Study||68
11179073|NCT01694199|12367979|FG000|NOT COMPLETED|Overall Study||0
11179074|NCT01694199|12367980|FG001|NOT COMPLETED|Overall Study||0
11179075|NCT01694420|12367986|FG000|STARTED|Overall Study||33
11179076|NCT01694420|12367986|FG000|COMPLETED|Overall Study||30
11179077|NCT01694420|12367986|FG000|NOT COMPLETED|Overall Study||3
11179078|NCT01694433|12367992|FG000|STARTED|Overall Study||33
11179079|NCT01694433|12367993|FG001|STARTED|Overall Study||33
11179080|NCT01694433|12367992|FG000|Baseline Visit|Overall Study||33
11179081|NCT01694433|12367993|FG001|Baseline Visit|Overall Study||32
11179082|NCT01694433|12367992|FG000|COMPLETED|Overall Study||22
11179083|NCT01694433|12367993|FG001|COMPLETED|Overall Study||29
11179084|NCT01694433|12367992|FG000|NOT COMPLETED|Overall Study||11
11179085|NCT01694433|12367993|FG001|NOT COMPLETED|Overall Study||4
11179086|NCT01694485|12368004|FG000|STARTED|Overall Study||117
11179087|NCT01694485|12368005|FG001|STARTED|Overall Study||22
11179088|NCT01694485|12368006|FG002|STARTED|Overall Study||40
11179089|NCT01694485|12368007|FG003|STARTED|Overall Study||100
11179090|NCT01694485|12368008|FG004|STARTED|Overall Study||80
11179091|NCT01694485|12368004|FG000|Received Treatment|Overall Study||116
11179092|NCT01694485|12368005|FG001|Received Treatment|Overall Study||21
11179093|NCT01694485|12368006|FG002|Received Treatment|Overall Study||40
11179094|NCT01694485|12368007|FG003|Received Treatment|Overall Study||98
11179095|NCT01694485|12368008|FG004|Received Treatment|Overall Study||79
11179096|NCT01694485|12368004|FG000|Completed Week 8 Assessment|Overall Study||106
11179097|NCT01694485|12368005|FG001|Completed Week 8 Assessment|Overall Study||18
11179098|NCT01694485|12368006|FG002|Completed Week 8 Assessment|Overall Study||38
11179099|NCT01694485|12368007|FG003|Completed Week 8 Assessment|Overall Study||94
11179100|NCT01694485|12368008|FG004|Completed Week 8 Assessment|Overall Study||76
11179101|NCT01694485|12368004|FG000|Entered Open-label Period|Overall Study||100
11179102|NCT01694485|12368005|FG001|Entered Open-label Period|Overall Study||19
11179103|NCT01694485|12368006|FG002|Entered Open-label Period|Overall Study||36
11179104|NCT01694485|12368007|FG003|Entered Open-label Period|Overall Study||88
11179105|NCT01694485|12368008|FG004|Entered Open-label Period|Overall Study||68
11179106|NCT01694485|12368004|FG000|COMPLETED|Overall Study||84
11179107|NCT01694485|12368005|FG001|COMPLETED|Overall Study||15
11179108|NCT01694485|12368006|FG002|COMPLETED|Overall Study||27
11179109|NCT01694485|12368007|FG003|COMPLETED|Overall Study||62
11179110|NCT01694485|12368008|FG004|COMPLETED|Overall Study||55
11179111|NCT01694485|12368004|FG000|NOT COMPLETED|Overall Study||33
11179112|NCT01694485|12368005|FG001|NOT COMPLETED|Overall Study||7
11179113|NCT01694485|12368006|FG002|NOT COMPLETED|Overall Study||13
11179114|NCT01694485|12368007|FG003|NOT COMPLETED|Overall Study||38
11179115|NCT01694485|12368008|FG004|NOT COMPLETED|Overall Study||25
11179116|NCT01694563|12368025|FG000|STARTED|Overall Study||365
11179117|NCT01694563|12368025|FG000|COMPLETED|Overall Study||278
11179118|NCT01694563|12368025|FG000|NOT COMPLETED|Overall Study||87
11179119|NCT01694641|12368034|FG000|STARTED|Overall Study||80
11179120|NCT01694641|12368035|FG001|STARTED|Overall Study||81
11179121|NCT01694641|12368034|FG000|COMPLETED|Overall Study||68
11179122|NCT01694641|12368035|FG001|COMPLETED|Overall Study||71
11179123|NCT01694641|12368034|FG000|NOT COMPLETED|Overall Study||12
11179124|NCT01694641|12368035|FG001|NOT COMPLETED|Overall Study||10
11179125|NCT01694667|12368044|FG000|STARTED|Overall Study||29
11179126|NCT01694667|12368045|FG001|STARTED|Overall Study||28
11179127|NCT01694667|12368044|FG000|COMPLETED|Overall Study||29
11179128|NCT01694667|12368045|FG001|COMPLETED|Overall Study||28
11179129|NCT01694667|12368044|FG000|NOT COMPLETED|Overall Study||0
11179130|NCT01694667|12368045|FG001|NOT COMPLETED|Overall Study||0
11179131|NCT01694706|12368051|FG000|STARTED|Overall Study||5
11179132|NCT01694706|12368052|FG001|STARTED|Overall Study||5
11179133|NCT01694706|12368053|FG002|STARTED|Overall Study||5
11179134|NCT01694706|12368051|FG000|Received Faldaprevir|Overall Study||5
11179135|NCT01694706|12368052|FG001|Received Faldaprevir|Overall Study||5
11179136|NCT01694706|12368053|FG002|Received Faldaprevir|Overall Study||5
11179137|NCT01694706|12368051|FG000|Received Faldaprevir +OMP|Overall Study||5
11179138|NCT01694706|12368052|FG001|Received Faldaprevir +OMP|Overall Study||5
11179139|NCT01694706|12368053|FG002|Received Faldaprevir +OMP|Overall Study||5
11179140|NCT01694706|12368051|FG000|Received Faldaprevir Fed|Overall Study||4
11179141|NCT01694706|12368052|FG001|Received Faldaprevir Fed|Overall Study||5
11179142|NCT01694706|12368053|FG002|Received Faldaprevir Fed|Overall Study||5
11179143|NCT01694706|12368051|FG000|COMPLETED|Overall Study||4
11179144|NCT01694706|12368052|FG001|COMPLETED|Overall Study||4
11179145|NCT01694706|12368053|FG002|COMPLETED|Overall Study||5
11179146|NCT01694706|12368051|FG000|NOT COMPLETED|Overall Study||1
11179147|NCT01694706|12368052|FG001|NOT COMPLETED|Overall Study||1
11179148|NCT01694706|12368053|FG002|NOT COMPLETED|Overall Study||0
11179149|NCT01694771|12368064|FG000|STARTED|Overall Study||567
11179150|NCT01694771|12368065|FG001|STARTED|Overall Study||565
11179151|NCT01694771|12368064|FG000|COMPLETED|Overall Study||527
11179152|NCT01694771|12368065|FG001|COMPLETED|Overall Study||525
11179153|NCT01694771|12368064|FG000|NOT COMPLETED|Overall Study||40
11179154|NCT01694771|12368065|FG001|NOT COMPLETED|Overall Study||40
11179155|NCT01694966|12368074|FG000|STARTED|Overall Study||504
11179156|NCT01694966|12368075|FG001|STARTED|Overall Study||247
11179157|NCT01694966|12368076|FG002|STARTED|Overall Study||498
11179158|NCT01694966|12368074|FG000|COMPLETED|Overall Study||470
11179159|NCT01694966|12368075|FG001|COMPLETED|Overall Study||232
11179160|NCT01694966|12368076|FG002|COMPLETED|Overall Study||464
11179161|NCT01694966|12368074|FG000|NOT COMPLETED|Overall Study||34
11179162|NCT01694966|12368075|FG001|NOT COMPLETED|Overall Study||15
11179163|NCT01694966|12368076|FG002|NOT COMPLETED|Overall Study||34
11179164|NCT01695044|12368086|FG000|STARTED|Overall Study||119
11179165|NCT01695044|12368086|FG000|COMPLETED|Overall Study||17
11179166|NCT01695044|12368086|FG000|NOT COMPLETED|Overall Study||102
11179167|NCT01695135|12368096|FG000|STARTED|Double-blind Treatment Phase||71
11179168|NCT01695135|12368097|FG001|STARTED|Double-blind Treatment Phase||143
11179169|NCT01695135|12368098|FG002|STARTED|Double-blind Treatment Phase||0
11179170|NCT01695135|12368099|FG003|STARTED|Double-blind Treatment Phase||0
11179171|NCT01695135|12368096|FG000|COMPLETED|Double-blind Treatment Phase||0
11179172|NCT01695135|12368097|FG001|COMPLETED|Double-blind Treatment Phase||4
11179173|NCT01695135|12368098|FG002|COMPLETED|Double-blind Treatment Phase||0
11179174|NCT01695135|12368099|FG003|COMPLETED|Double-blind Treatment Phase||0
11179175|NCT01695135|12368096|FG000|NOT COMPLETED|Double-blind Treatment Phase||71
11179176|NCT01695135|12368097|FG001|NOT COMPLETED|Double-blind Treatment Phase||139
11179177|NCT01695135|12368098|FG002|NOT COMPLETED|Double-blind Treatment Phase||0
11179178|NCT01695135|12368099|FG003|NOT COMPLETED|Double-blind Treatment Phase||0
11179179|NCT01695135|12368096|FG000|STARTED|Open Label Extension Treatment Phase||0
11179180|NCT01695135|12368097|FG001|STARTED|Open Label Extension Treatment Phase||0
11179181|NCT01695135|12368098|FG002|STARTED|Open Label Extension Treatment Phase||49
11179182|NCT01695135|12368099|FG003|STARTED|Open Label Extension Treatment Phase||80
11179183|NCT01695135|12368096|FG000|COMPLETED|Open Label Extension Treatment Phase||0
11179184|NCT01695135|12368097|FG001|COMPLETED|Open Label Extension Treatment Phase||0
11179185|NCT01695135|12368098|FG002|COMPLETED|Open Label Extension Treatment Phase||9
11179186|NCT01695135|12368099|FG003|COMPLETED|Open Label Extension Treatment Phase||10
11179187|NCT01695135|12368096|FG000|NOT COMPLETED|Open Label Extension Treatment Phase||0
11179188|NCT01695135|12368097|FG001|NOT COMPLETED|Open Label Extension Treatment Phase||0
11179189|NCT01695135|12368098|FG002|NOT COMPLETED|Open Label Extension Treatment Phase||40
11179190|NCT01695135|12368099|FG003|NOT COMPLETED|Open Label Extension Treatment Phase||70
11179191|NCT01695239|12368111|FG000|STARTED|Double-Blind (DB) Treatment Period||106
11179192|NCT01695239|12368112|FG001|STARTED|Double-Blind (DB) Treatment Period||101
11179193|NCT01695239|12368113|FG002|STARTED|Double-Blind (DB) Treatment Period||107
11179194|NCT01695239|12368114|FG003|STARTED|Double-Blind (DB) Treatment Period||103
11179195|NCT01695239|12368115|FG004|STARTED|Double-Blind (DB) Treatment Period||0
11179196|NCT01695239|12368116|FG005|STARTED|Double-Blind (DB) Treatment Period||0
11179197|NCT01695239|12368117|FG006|STARTED|Double-Blind (DB) Treatment Period||0
11179198|NCT01695239|12368118|FG007|STARTED|Double-Blind (DB) Treatment Period||0
11179199|NCT01695239|12368119|FG008|STARTED|Double-Blind (DB) Treatment Period||0
11179200|NCT01695239|12368120|FG009|STARTED|Double-Blind (DB) Treatment Period||0
11179201|NCT01695239|12368121|FG010|STARTED|Double-Blind (DB) Treatment Period||0
11179202|NCT01695239|12368122|FG011|STARTED|Double-Blind (DB) Treatment Period||0
11179203|NCT01695239|12368123|FG012|STARTED|Double-Blind (DB) Treatment Period||0
11179204|NCT01695239|12368124|FG013|STARTED|Double-Blind (DB) Treatment Period||0
11179205|NCT01695239|12368111|FG000|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106
11179206|NCT01695239|12368112|FG001|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101
11179207|NCT01695239|12368113|FG002|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107
11179208|NCT01695239|12368114|FG003|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102
11179209|NCT01695239|12368115|FG004|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
11179210|NCT01695239|12368116|FG005|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
11179211|NCT01695239|12368117|FG006|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
11179212|NCT01695239|12368118|FG007|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
11179213|NCT01695239|12368119|FG008|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
11179214|NCT01695239|12368120|FG009|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
11179215|NCT01695239|12368121|FG010|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
11179216|NCT01695239|12368122|FG011|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
11179217|NCT01695239|12368123|FG012|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
11179218|NCT01695239|12368124|FG013|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
11179219|NCT01695239|12368111|FG000|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27
11179220|NCT01695239|12368112|FG001|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9
11179221|NCT01695239|12368113|FG002|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11
11179222|NCT01695239|12368114|FG003|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10
11179223|NCT01695239|12368115|FG004|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
11179224|NCT01695239|12368116|FG005|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
11179225|NCT01695239|12368117|FG006|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
11179226|NCT01695239|12368118|FG007|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
11179227|NCT01695239|12368119|FG008|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
11179228|NCT01695239|12368120|FG009|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
11179229|NCT01695239|12368121|FG010|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
11179230|NCT01695239|12368122|FG011|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
11179231|NCT01695239|12368123|FG012|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
11179232|NCT01695239|12368124|FG013|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
11179233|NCT01695239|12368111|FG000|COMPLETED|Double-Blind (DB) Treatment Period||91
11179234|NCT01695239|12368112|FG001|COMPLETED|Double-Blind (DB) Treatment Period||97
11179235|NCT01695239|12368113|FG002|COMPLETED|Double-Blind (DB) Treatment Period||97
11179236|NCT01695239|12368114|FG003|COMPLETED|Double-Blind (DB) Treatment Period||96
11179237|NCT01695239|12368115|FG004|COMPLETED|Double-Blind (DB) Treatment Period||0
11179238|NCT01695239|12368116|FG005|COMPLETED|Double-Blind (DB) Treatment Period||0
11179239|NCT01695239|12368117|FG006|COMPLETED|Double-Blind (DB) Treatment Period||0
11179240|NCT01695239|12368118|FG007|COMPLETED|Double-Blind (DB) Treatment Period||0
11179241|NCT01695239|12368119|FG008|COMPLETED|Double-Blind (DB) Treatment Period||0
11179242|NCT01695239|12368120|FG009|COMPLETED|Double-Blind (DB) Treatment Period||0
11179243|NCT01695239|12368121|FG010|COMPLETED|Double-Blind (DB) Treatment Period||0
11179244|NCT01695239|12368122|FG011|COMPLETED|Double-Blind (DB) Treatment Period||0
11179245|NCT01695239|12368123|FG012|COMPLETED|Double-Blind (DB) Treatment Period||0
11179246|NCT01695239|12368124|FG013|COMPLETED|Double-Blind (DB) Treatment Period||0
11179247|NCT01695239|12368111|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||15
11179248|NCT01695239|12368112|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||4
11179249|NCT01695239|12368113|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||10
11179250|NCT01695239|12368114|FG003|NOT COMPLETED|Double-Blind (DB) Treatment Period||7
11179251|NCT01695239|12368115|FG004|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
11179252|NCT01695239|12368116|FG005|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
11179253|NCT01695239|12368117|FG006|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
11179254|NCT01695239|12368118|FG007|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
11179255|NCT01695239|12368119|FG008|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
11179256|NCT01695239|12368120|FG009|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
11179257|NCT01695239|12368121|FG010|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
11179258|NCT01695239|12368122|FG011|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
11179259|NCT01695239|12368123|FG012|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
11179260|NCT01695239|12368124|FG013|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
11179261|NCT01695239|12368111|FG000|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
11179262|NCT01695239|12368112|FG001|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
11179263|NCT01695239|12368113|FG002|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
11179264|NCT01695239|12368114|FG003|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
11179265|NCT01695239|12368115|FG004|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24
11179266|NCT01695239|12368116|FG005|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24
11179267|NCT01695239|12368117|FG006|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9
11179268|NCT01695239|12368118|FG007|STARTED|IR Participants (Week 16 Up To Week 24)||0
11179269|NCT01695239|12368119|FG008|STARTED|IR Participants (Week 16 Up To Week 24)||0
11179270|NCT01695239|12368120|FG009|STARTED|IR Participants (Week 16 Up To Week 24)||0
11179271|NCT01695239|12368121|FG010|STARTED|IR Participants (Week 16 Up To Week 24)||0
11179272|NCT01695239|12368122|FG011|STARTED|IR Participants (Week 16 Up To Week 24)||0
11179273|NCT01695239|12368123|FG012|STARTED|IR Participants (Week 16 Up To Week 24)||0
11179274|NCT01695239|12368124|FG013|STARTED|IR Participants (Week 16 Up To Week 24)||0
11179275|NCT01695239|12368111|FG000|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179276|NCT01695239|12368112|FG001|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179277|NCT01695239|12368113|FG002|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179278|NCT01695239|12368114|FG003|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179279|NCT01695239|12368115|FG004|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
11179280|NCT01695239|12368116|FG005|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
11179281|NCT01695239|12368117|FG006|COMPLETED|IR Participants (Week 16 Up To Week 24)||9
11179282|NCT01695239|12368118|FG007|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179283|NCT01695239|12368119|FG008|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179284|NCT01695239|12368120|FG009|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179285|NCT01695239|12368121|FG010|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179286|NCT01695239|12368122|FG011|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179287|NCT01695239|12368123|FG012|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179288|NCT01695239|12368124|FG013|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179289|NCT01695239|12368111|FG000|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179290|NCT01695239|12368112|FG001|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179291|NCT01695239|12368113|FG002|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179292|NCT01695239|12368114|FG003|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179293|NCT01695239|12368115|FG004|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179294|NCT01695239|12368116|FG005|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179295|NCT01695239|12368117|FG006|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179296|NCT01695239|12368118|FG007|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179297|NCT01695239|12368119|FG008|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179298|NCT01695239|12368120|FG009|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179299|NCT01695239|12368121|FG010|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179300|NCT01695239|12368122|FG011|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179301|NCT01695239|12368123|FG012|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179302|NCT01695239|12368124|FG013|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
11179303|NCT01695239|12368111|FG000|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
11179304|NCT01695239|12368112|FG001|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
11179305|NCT01695239|12368113|FG002|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
11179306|NCT01695239|12368114|FG003|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
11179307|NCT01695239|12368115|FG004|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
11179308|NCT01695239|12368116|FG005|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
11179309|NCT01695239|12368117|FG006|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
11179310|NCT01695239|12368118|FG007|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88
11179311|NCT01695239|12368119|FG008|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
11179312|NCT01695239|12368120|FG009|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
11179313|NCT01695239|12368121|FG010|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
11179314|NCT01695239|12368122|FG011|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
11179315|NCT01695239|12368123|FG012|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
11179316|NCT01695239|12368124|FG013|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
11179317|NCT01695239|12368111|FG000|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179318|NCT01695239|12368112|FG001|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179319|NCT01695239|12368113|FG002|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179320|NCT01695239|12368114|FG003|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179321|NCT01695239|12368115|FG004|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179322|NCT01695239|12368116|FG005|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179323|NCT01695239|12368117|FG006|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179324|NCT01695239|12368118|FG007|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77
11179325|NCT01695239|12368119|FG008|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179326|NCT01695239|12368120|FG009|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179327|NCT01695239|12368121|FG010|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179328|NCT01695239|12368122|FG011|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179329|NCT01695239|12368123|FG012|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179330|NCT01695239|12368124|FG013|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179331|NCT01695239|12368111|FG000|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179332|NCT01695239|12368112|FG001|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179333|NCT01695239|12368113|FG002|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179334|NCT01695239|12368114|FG003|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179335|NCT01695239|12368115|FG004|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179336|NCT01695239|12368116|FG005|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179337|NCT01695239|12368117|FG006|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179338|NCT01695239|12368118|FG007|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11
11179339|NCT01695239|12368119|FG008|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179340|NCT01695239|12368120|FG009|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179341|NCT01695239|12368121|FG010|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179342|NCT01695239|12368122|FG011|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179343|NCT01695239|12368123|FG012|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179344|NCT01695239|12368124|FG013|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
11179345|NCT01695239|12368111|FG000|STARTED|Extension Long-Term Extension Periods||0
11179346|NCT01695239|12368112|FG001|STARTED|Extension Long-Term Extension Periods||0
11179347|NCT01695239|12368113|FG002|STARTED|Extension Long-Term Extension Periods||0
11179348|NCT01695239|12368114|FG003|STARTED|Extension Long-Term Extension Periods||0
11179349|NCT01695239|12368115|FG004|STARTED|Extension Long-Term Extension Periods||0
11179350|NCT01695239|12368116|FG005|STARTED|Extension Long-Term Extension Periods||0
11179351|NCT01695239|12368117|FG006|STARTED|Extension Long-Term Extension Periods||0
11179352|NCT01695239|12368118|FG007|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0
11179353|NCT01695239|12368119|FG008|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187
11179354|NCT01695239|12368120|FG009|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183
11179355|NCT01695239|12368121|FG010|STARTED|Extension Long-Term Extension Periods||0
11179356|NCT01695239|12368122|FG011|STARTED|Extension Long-Term Extension Periods||0
11179357|NCT01695239|12368123|FG012|STARTED|Extension Long-Term Extension Periods||0
11179358|NCT01695239|12368124|FG013|STARTED|Extension Long-Term Extension Periods||0
11179359|NCT01695239|12368111|FG000|COMPLETED|Extension Long-Term Extension Periods||0
11179360|NCT01695239|12368112|FG001|COMPLETED|Extension Long-Term Extension Periods||0
11179361|NCT01695239|12368113|FG002|COMPLETED|Extension Long-Term Extension Periods||0
11179362|NCT01695239|12368114|FG003|COMPLETED|Extension Long-Term Extension Periods||0
11179363|NCT01695239|12368115|FG004|COMPLETED|Extension Long-Term Extension Periods||0
11179364|NCT01695239|12368116|FG005|COMPLETED|Extension Long-Term Extension Periods||0
11179365|NCT01695239|12368117|FG006|COMPLETED|Extension Long-Term Extension Periods||0
11179366|NCT01695239|12368118|FG007|COMPLETED|Extension Long-Term Extension Periods||0
11179367|NCT01695239|12368119|FG008|COMPLETED|Extension Long-Term Extension Periods||121
11179368|NCT01695239|12368120|FG009|COMPLETED|Extension Long-Term Extension Periods||122
11179369|NCT01695239|12368121|FG010|COMPLETED|Extension Long-Term Extension Periods||0
11179370|NCT01695239|12368122|FG011|COMPLETED|Extension Long-Term Extension Periods||0
11179371|NCT01695239|12368123|FG012|COMPLETED|Extension Long-Term Extension Periods||0
11179372|NCT01695239|12368124|FG013|COMPLETED|Extension Long-Term Extension Periods||0
11179373|NCT01695239|12368111|FG000|NOT COMPLETED|Extension Long-Term Extension Periods||0
11179374|NCT01695239|12368112|FG001|NOT COMPLETED|Extension Long-Term Extension Periods||0
11179375|NCT01695239|12368113|FG002|NOT COMPLETED|Extension Long-Term Extension Periods||0
11179376|NCT01695239|12368114|FG003|NOT COMPLETED|Extension Long-Term Extension Periods||0
11179377|NCT01695239|12368115|FG004|NOT COMPLETED|Extension Long-Term Extension Periods||0
11179378|NCT01695239|12368116|FG005|NOT COMPLETED|Extension Long-Term Extension Periods||0
11179379|NCT01695239|12368117|FG006|NOT COMPLETED|Extension Long-Term Extension Periods||0
11179380|NCT01695239|12368118|FG007|NOT COMPLETED|Extension Long-Term Extension Periods||0
11179381|NCT01695239|12368119|FG008|NOT COMPLETED|Extension Long-Term Extension Periods||66
11179382|NCT01695239|12368120|FG009|NOT COMPLETED|Extension Long-Term Extension Periods||61
11026867|NCT00830869|12205482|FG002|NOT COMPLETED|Period 1: Part 1||1
11026868|NCT00830869|12205483|FG003|NOT COMPLETED|Period 1: Part 1||7
11026869|NCT00830869|12205484|FG004|NOT COMPLETED|Period 1: Part 1||4
11179383|NCT01695239|12368121|FG010|NOT COMPLETED|Extension Long-Term Extension Periods||0
11179384|NCT01695239|12368122|FG011|NOT COMPLETED|Extension Long-Term Extension Periods||0
11179385|NCT01695239|12368123|FG012|NOT COMPLETED|Extension Long-Term Extension Periods||0
11179386|NCT01695239|12368124|FG013|NOT COMPLETED|Extension Long-Term Extension Periods||0
11179387|NCT01695239|12368111|FG000|STARTED|Post-Treatment Follow-Up Period||0
11179388|NCT01695239|12368112|FG001|STARTED|Post-Treatment Follow-Up Period||0
11179389|NCT01695239|12368113|FG002|STARTED|Post-Treatment Follow-Up Period||0
11179390|NCT01695239|12368114|FG003|STARTED|Post-Treatment Follow-Up Period||0
11179391|NCT01695239|12368115|FG004|STARTED|Post-Treatment Follow-Up Period||0
11179392|NCT01695239|12368116|FG005|STARTED|Post-Treatment Follow-Up Period||0
11179393|NCT01695239|12368117|FG006|STARTED|Post-Treatment Follow-Up Period||0
11179394|NCT01695239|12368118|FG007|STARTED|Post-Treatment Follow-Up Period||0
11179395|NCT01695239|12368119|FG008|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
11179396|NCT01695239|12368120|FG009|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
11179397|NCT01695239|12368121|FG010|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20
11179398|NCT01695239|12368122|FG011|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1
11179399|NCT01695239|12368123|FG012|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165
11179400|NCT01695239|12368124|FG013|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171
11179401|NCT01695239|12368111|FG000|COMPLETED|Post-Treatment Follow-Up Period||0
11179402|NCT01695239|12368112|FG001|COMPLETED|Post-Treatment Follow-Up Period||0
11179403|NCT01695239|12368113|FG002|COMPLETED|Post-Treatment Follow-Up Period||0
11179404|NCT01695239|12368114|FG003|COMPLETED|Post-Treatment Follow-Up Period||0
11179405|NCT01695239|12368115|FG004|COMPLETED|Post-Treatment Follow-Up Period||0
11179406|NCT01695239|12368116|FG005|COMPLETED|Post-Treatment Follow-Up Period||0
11179407|NCT01695239|12368117|FG006|COMPLETED|Post-Treatment Follow-Up Period||0
11179408|NCT01695239|12368118|FG007|COMPLETED|Post-Treatment Follow-Up Period||0
11179409|NCT01695239|12368119|FG008|COMPLETED|Post-Treatment Follow-Up Period||0
11179410|NCT01695239|12368120|FG009|COMPLETED|Post-Treatment Follow-Up Period||0
11179411|NCT01695239|12368121|FG010|COMPLETED|Post-Treatment Follow-Up Period||20
11179412|NCT01695239|12368122|FG011|COMPLETED|Post-Treatment Follow-Up Period||0
11179413|NCT01695239|12368123|FG012|COMPLETED|Post-Treatment Follow-Up Period||156
11179414|NCT01695239|12368124|FG013|COMPLETED|Post-Treatment Follow-Up Period||166
11179415|NCT01695239|12368111|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11179416|NCT01695239|12368112|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11179417|NCT01695239|12368113|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11179418|NCT01695239|12368114|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11179419|NCT01695239|12368115|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11179420|NCT01695239|12368116|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11179421|NCT01695239|12368117|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11179422|NCT01695239|12368118|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11179423|NCT01695239|12368119|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11179424|NCT01695239|12368120|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11179425|NCT01695239|12368121|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11179426|NCT01695239|12368122|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||1
11179427|NCT01695239|12368123|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||9
11179428|NCT01695239|12368124|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||5
11179429|NCT01695291|12368148|FG000|STARTED|Overall Study||10
11179430|NCT01695291|12368149|FG001|STARTED|Overall Study||21
11179431|NCT01695291|12368148|FG000|COMPLETED|Overall Study||8
11179432|NCT01695291|12368149|FG001|COMPLETED|Overall Study||14
11179433|NCT01695291|12368148|FG000|NOT COMPLETED|Overall Study||2
11179434|NCT01695291|12368149|FG001|NOT COMPLETED|Overall Study||7
11179435|NCT01695304|12368157|FG000|STARTED|Overall Study||120
11179436|NCT01695304|12368158|FG001|STARTED|Overall Study||120
11179437|NCT01695304|12368157|FG000|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
11179438|NCT01695304|12368158|FG001|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
11179439|NCT01695304|12368157|FG000|NOT COMPLETED|Overall Study||0
11179440|NCT01695304|12368158|FG001|NOT COMPLETED|Overall Study||0
11179441|NCT01695330|12368166|FG000|STARTED|Overall Study||52
11179442|NCT01695330|12368167|FG001|STARTED|Overall Study||0
11179443|NCT01695330|12368166|FG000|COMPLETED|Overall Study||5
11179444|NCT01695330|12368167|FG001|COMPLETED|Overall Study||0
11179445|NCT01695330|12368166|FG000|NOT COMPLETED|Overall Study||47
11179446|NCT01695330|12368167|FG001|NOT COMPLETED|Overall Study||0
11179447|NCT01695369|12368171|FG000|STARTED|Overall Study||61
11179448|NCT01695369|12368171|FG000|COMPLETED|Overall Study||61
11179449|NCT01695369|12368171|FG000|NOT COMPLETED|Overall Study||0
11179450|NCT01695473|12368177|FG000|STARTED|Overall Study||11
11179451|NCT01695473|12368177|FG000|COMPLETED|Overall Study||11
11179452|NCT01695473|12368177|FG000|NOT COMPLETED|Overall Study||0
11179453|NCT01695668|12368184|FG000|STARTED|Overall Study||38
11179454|NCT01695668|12368185|FG001|STARTED|Overall Study||37
11179455|NCT01695668|12368184|FG000|COMPLETED|Overall Study||23
11179456|NCT01695668|12368185|FG001|COMPLETED|Overall Study||20
11179457|NCT01695668|12368184|FG000|NOT COMPLETED|Overall Study||15
11179458|NCT01695668|12368185|FG001|NOT COMPLETED|Overall Study||17
11179459|NCT01695746|12368191|FG000|STARTED|Overall Study||108
11179460|NCT01695746|12368191|FG000|COMPLETED|Overall Study||96
11179461|NCT01695746|12368191|FG000|NOT COMPLETED|Overall Study||12
11179462|NCT01695772|12368196|FG000|STARTED|Overall Study||50
11179463|NCT01695772|12368196|FG000|COMPLETED|Overall Study||12
11179464|NCT01695772|12368196|FG000|NOT COMPLETED|Overall Study||38
11179465|NCT01695954|12368202|FG000|STARTED|Overall Study||18
11179466|NCT01695954|12368203|FG001|STARTED|Overall Study||16
11179467|NCT01695954|12368202|FG000|COMPLETED|Overall Study||14
11179468|NCT01695954|12368203|FG001|COMPLETED|Overall Study||14
11179469|NCT01695954|12368202|FG000|NOT COMPLETED|Overall Study||4
11179470|NCT01695954|12368203|FG001|NOT COMPLETED|Overall Study||2
11179471|NCT01695993|12368214|FG000|STARTED|Overall Study||81
11179472|NCT01695993|12368215|FG001|STARTED|Overall Study||80
11179473|NCT01695993|12368216|FG002|STARTED|Overall Study||81
11179474|NCT01695993|12368214|FG000|COMPLETED|Overall Study||76
11179475|NCT01695993|12368215|FG001|COMPLETED|Overall Study||75
11179476|NCT01695993|12368216|FG002|COMPLETED|Overall Study||75
11179477|NCT01695993|12368214|FG000|NOT COMPLETED|Overall Study||5
11179478|NCT01695993|12368215|FG001|NOT COMPLETED|Overall Study||5
11179479|NCT01695993|12368216|FG002|NOT COMPLETED|Overall Study||6
11179480|NCT01696032|12368228|FG000|STARTED|Overall Study||14
11179481|NCT01696032|12368229|FG001|STARTED|Overall Study||6
11179482|NCT01696032|12368230|FG002|STARTED|Overall Study||51
11179483|NCT01696032|12368231|FG003|STARTED|Overall Study||49
11179484|NCT01696032|12368228|FG000|COMPLETED|Overall Study||0
11179485|NCT01696032|12368229|FG001|COMPLETED|Overall Study||0
11179486|NCT01696032|12368230|FG002|COMPLETED|Overall Study||0
11179487|NCT01696032|12368231|FG003|COMPLETED|Overall Study||27
11179488|NCT01696032|12368228|FG000|NOT COMPLETED|Overall Study||14
11179489|NCT01696032|12368229|FG001|NOT COMPLETED|Overall Study||6
11179490|NCT01696032|12368230|FG002|NOT COMPLETED|Overall Study||51
11179491|NCT01696032|12368231|FG003|NOT COMPLETED|Overall Study||22
11179492|NCT01696045|12368247|FG000|STARTED|Overall Study||4
11179493|NCT01696045|12368248|FG001|STARTED|Overall Study||8
11179494|NCT01696045|12368247|FG000|COMPLETED|Overall Study||1
11179495|NCT01696045|12368248|FG001|COMPLETED|Overall Study||1
11179496|NCT01696045|12368247|FG000|NOT COMPLETED|Overall Study||3
11179497|NCT01696045|12368248|FG001|NOT COMPLETED|Overall Study||7
11179498|NCT01696058|12368256|FG000|STARTED|Overall Study||566
11179499|NCT01696058|12368257|FG001|STARTED|Overall Study||569
11179500|NCT01696058|12368256|FG000|COMPLETED|Overall Study||523
11179501|NCT01696058|12368257|FG001|COMPLETED|Overall Study||538
11179502|NCT01696058|12368256|FG000|NOT COMPLETED|Overall Study||43
11179503|NCT01696058|12368257|FG001|NOT COMPLETED|Overall Study||31
11179504|NCT01696071|12368263|FG000|STARTED|Treatment Period 1: 4 Weeks||51
11179505|NCT01696071|12368264|FG001|STARTED|Treatment Period 1: 4 Weeks||47
11179506|NCT01696071|12368263|FG000|COMPLETED|Treatment Period 1: 4 Weeks||51
11179507|NCT01696071|12368264|FG001|COMPLETED|Treatment Period 1: 4 Weeks||47
11179508|NCT01696071|12368263|FG000|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
11179509|NCT01696071|12368264|FG001|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
11179510|NCT01696071|12368263|FG000|STARTED|Treatment Period 2: 4 Weeks||51
11179511|NCT01696071|12368264|FG001|STARTED|Treatment Period 2: 4 Weeks||47
11179512|NCT01696071|12368263|FG000|COMPLETED|Treatment Period 2: 4 Weeks||50
11179513|NCT01696071|12368264|FG001|COMPLETED|Treatment Period 2: 4 Weeks||47
11179514|NCT01696071|12368263|FG000|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
11179515|NCT01696071|12368264|FG001|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
11179516|NCT01696084|12368273|FG000|STARTED|Overall Study||153
11179517|NCT01696084|12368274|FG001|STARTED|Overall Study||156
11179518|NCT01696084|12368273|FG000|COMPLETED|Overall Study||22
11179519|NCT01696084|12368274|FG001|COMPLETED|Overall Study||10
11179520|NCT01696084|12368273|FG000|NOT COMPLETED|Overall Study||131
11179521|NCT01696084|12368274|FG001|NOT COMPLETED|Overall Study||146
11179522|NCT01696188|12368282|FG000|STARTED|Overall Study||41
11179523|NCT01696188|12368283|FG001|STARTED|Overall Study||43
11179524|NCT01696188|12368282|FG000|COMPLETED|Overall Study||40
11179525|NCT01696188|12368283|FG001|COMPLETED|Overall Study||42
11179526|NCT01696188|12368282|FG000|NOT COMPLETED|Overall Study||1
11179527|NCT01696188|12368283|FG001|NOT COMPLETED|Overall Study||1
11179528|NCT01696214|12368293|FG000|STARTED|Overall Study||5
11179529|NCT01696214|12368294|FG001|STARTED|Overall Study||5
11179530|NCT01696214|12368295|FG002|STARTED|Overall Study||5
11179531|NCT01696214|12368296|FG003|STARTED|Overall Study||5
11179532|NCT01696214|12368293|FG000|COMPLETED|Overall Study||4
11179533|NCT01696214|12368294|FG001|COMPLETED|Overall Study||5
11179534|NCT01696214|12368295|FG002|COMPLETED|Overall Study||5
11179535|NCT01696214|12368296|FG003|COMPLETED|Overall Study||5
11179536|NCT01696214|12368293|FG000|NOT COMPLETED|Overall Study||1
11179537|NCT01696214|12368294|FG001|NOT COMPLETED|Overall Study||0
11179538|NCT01696214|12368295|FG002|NOT COMPLETED|Overall Study||0
11179539|NCT01696214|12368296|FG003|NOT COMPLETED|Overall Study||0
11179540|NCT01696279|12368314|FG000|STARTED|Part 1: Single Dose Lanthanum Carbonate||20
11179541|NCT01696279|12368315|FG001|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
11179542|NCT01696279|12368316|FG002|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
11179543|NCT01696279|12368317|FG003|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
11179544|NCT01696279|12368314|FG000|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20
11179545|NCT01696279|12368315|FG001|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
11179546|NCT01696279|12368316|FG002|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
11179547|NCT01696279|12368317|FG003|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
11179548|NCT01696279|12368314|FG000|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19
11179549|NCT01696279|12368315|FG001|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
11179550|NCT01696279|12368316|FG002|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
11179551|NCT01696279|12368317|FG003|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
11179552|NCT01696279|12368314|FG000|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19
11179553|NCT01696279|12368315|FG001|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
11179554|NCT01696279|12368316|FG002|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
11179555|NCT01696279|12368317|FG003|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
11179556|NCT01696279|12368314|FG000|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1
11179557|NCT01696279|12368315|FG001|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
11179558|NCT01696279|12368316|FG002|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
11179559|NCT01696279|12368317|FG003|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
11179560|NCT01696279|12368314|FG000|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
11179561|NCT01696279|12368315|FG001|STARTED|Part 2a: Calcium Carbonate + Lanthanum|19 participants enrolled from Part 1 and 34 new participants enrolled in Part 2a|53
11179562|NCT01696279|12368316|FG002|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
11179563|NCT01696279|12368317|FG003|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
11179564|NCT01696279|12368314|FG000|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
11179565|NCT01696279|12368315|FG001|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37
11179566|NCT01696279|12368316|FG002|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
11179567|NCT01696279|12368317|FG003|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
11179568|NCT01696279|12368314|FG000|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
11179569|NCT01696279|12368315|FG001|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53
11179570|NCT01696279|12368316|FG002|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
11179571|NCT01696279|12368317|FG003|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
11179572|NCT01696279|12368314|FG000|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
11179573|NCT01696279|12368315|FG001|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17
11179574|NCT01696279|12368316|FG002|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
11179575|NCT01696279|12368317|FG003|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
11179576|NCT01696279|12368314|FG000|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
11204093|NCT01852045|12394698|FG001|COMPLETED|Overall Study||41
11179577|NCT01696279|12368315|FG001|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25
11179578|NCT01696279|12368316|FG002|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
11179579|NCT01696279|12368317|FG003|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
11179580|NCT01696279|12368314|FG000|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
11179581|NCT01696279|12368315|FG001|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34
11179582|NCT01696279|12368316|FG002|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
11179583|NCT01696279|12368317|FG003|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
11179584|NCT01696279|12368314|FG000|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
11179585|NCT01696279|12368315|FG001|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34
11179586|NCT01696279|12368316|FG002|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
11179587|NCT01696279|12368317|FG003|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
11179588|NCT01696279|12368314|FG000|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
11179589|NCT01696279|12368315|FG001|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19
11179590|NCT01696279|12368316|FG002|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
11179591|NCT01696279|12368317|FG003|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
11179592|NCT01696279|12368314|FG000|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179593|NCT01696279|12368315|FG001|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179594|NCT01696279|12368316|FG002|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)|9 new participants were enrolled in Part 2b|9
11179595|NCT01696279|12368317|FG003|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179596|NCT01696279|12368314|FG000|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179597|NCT01696279|12368315|FG001|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179598|NCT01696279|12368316|FG002|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
11179599|NCT01696279|12368317|FG003|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179600|NCT01696279|12368314|FG000|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179601|NCT01696279|12368315|FG001|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179602|NCT01696279|12368316|FG002|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
11179603|NCT01696279|12368317|FG003|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179604|NCT01696279|12368314|FG000|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179605|NCT01696279|12368315|FG001|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179606|NCT01696279|12368316|FG002|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179607|NCT01696279|12368317|FG003|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179608|NCT01696279|12368314|FG000|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179609|NCT01696279|12368315|FG001|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179610|NCT01696279|12368316|FG002|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9
11179611|NCT01696279|12368317|FG003|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179612|NCT01696279|12368314|FG000|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179613|NCT01696279|12368315|FG001|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179614|NCT01696279|12368316|FG002|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8
11179615|NCT01696279|12368317|FG003|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179616|NCT01696279|12368314|FG000|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179617|NCT01696279|12368315|FG001|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179618|NCT01696279|12368316|FG002|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1
11179619|NCT01696279|12368317|FG003|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
11179620|NCT01696279|12368314|FG000|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
11179621|NCT01696279|12368315|FG001|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
11179622|NCT01696279|12368316|FG002|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
11179623|NCT01696279|12368317|FG003|STARTED|Part 3: Lanthanum Carbonate (6 Months)|34 participants from Part 2a and 8 participants from Part 2b continued to Part 3|42
11179624|NCT01696279|12368314|FG000|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
11179625|NCT01696279|12368315|FG001|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
11179626|NCT01696279|12368316|FG002|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
11179627|NCT01696279|12368317|FG003|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34
11179628|NCT01696279|12368314|FG000|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
11179629|NCT01696279|12368315|FG001|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
11179630|NCT01696279|12368316|FG002|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
11179631|NCT01696279|12368317|FG003|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8
11179632|NCT01696357|12368328|FG000|STARTED|Overall Study||42
11179633|NCT01696357|12368329|FG001|STARTED|Overall Study||42
11179634|NCT01696357|12368328|FG000|COMPLETED|Overall Study||40
11179635|NCT01696357|12368329|FG001|COMPLETED|Overall Study||41
11179636|NCT01696357|12368328|FG000|NOT COMPLETED|Overall Study||2
11179637|NCT01696357|12368329|FG001|NOT COMPLETED|Overall Study||1
11179638|NCT01696396|12368339|FG000|STARTED|Overall Study||100
11179639|NCT01696396|12368340|FG001|STARTED|Overall Study||27
11179640|NCT01696396|12368341|FG002|STARTED|Overall Study||85
11179641|NCT01696396|12368342|FG003|STARTED|Overall Study||42
11179642|NCT01696396|12368339|FG000|Received Study Drug|Overall Study||98
11179643|NCT01696396|12368340|FG001|Received Study Drug|Overall Study||26
11179644|NCT01696396|12368341|FG002|Received Study Drug|Overall Study||84
11179645|NCT01696396|12368342|FG003|Received Study Drug|Overall Study||41
11179646|NCT01696396|12368339|FG000|Entered Open-label Period|Overall Study||84
11179647|NCT01696396|12368340|FG001|Entered Open-label Period|Overall Study||21
11179648|NCT01696396|12368341|FG002|Entered Open-label Period|Overall Study||75
11179649|NCT01696396|12368342|FG003|Entered Open-label Period|Overall Study||37
11179650|NCT01696396|12368339|FG000|COMPLETED|Overall Study||69
11179651|NCT01696396|12368340|FG001|COMPLETED|Overall Study||20
11179652|NCT01696396|12368341|FG002|COMPLETED|Overall Study||59
11179653|NCT01696396|12368342|FG003|COMPLETED|Overall Study||28
11179654|NCT01696396|12368339|FG000|NOT COMPLETED|Overall Study||31
11179655|NCT01696396|12368340|FG001|NOT COMPLETED|Overall Study||7
11179656|NCT01696396|12368341|FG002|NOT COMPLETED|Overall Study||26
11179657|NCT01696396|12368342|FG003|NOT COMPLETED|Overall Study||14
11179658|NCT01696643|12368358|FG000|STARTED|Overall Study||703
11179659|NCT01696643|12368359|FG001|STARTED|Overall Study||704
11179660|NCT01696643|12368358|FG000|Received at Least 1 Dose of Study Drug|Overall Study||701
11179661|NCT01696643|12368359|FG001|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
11179662|NCT01696643|12368358|FG000|COMPLETED|Overall Study||174
11179663|NCT01696643|12368359|FG001|COMPLETED|Overall Study||169
11179664|NCT01696643|12368358|FG000|NOT COMPLETED|Overall Study||529
11179665|NCT01696643|12368359|FG001|NOT COMPLETED|Overall Study||535
11179666|NCT01696695|12368365|FG000|STARTED|Overall Study||882
11179667|NCT01696695|12368365|FG000|COMPLETED|Overall Study||0
11179668|NCT01696695|12368365|FG000|NOT COMPLETED|Overall Study||882
11179669|NCT01696760|12368371|FG000|STARTED|Overall Study||9
11179670|NCT01696760|12368372|FG001|STARTED|Overall Study||3
11179671|NCT01696760|12368371|FG000|COMPLETED|Overall Study||9
11179672|NCT01696760|12368372|FG001|COMPLETED|Overall Study||3
11179673|NCT01696760|12368371|FG000|NOT COMPLETED|Overall Study||0
11179674|NCT01696760|12368372|FG001|NOT COMPLETED|Overall Study||0
11179675|NCT01696877|12368380|FG000|STARTED|Overall Study||15
11179676|NCT01696877|12368381|FG001|STARTED|Overall Study||14
11179677|NCT01696877|12368380|FG000|COMPLETED|Overall Study||15
11179678|NCT01696877|12368381|FG001|COMPLETED|Overall Study||13
11179679|NCT01696877|12368380|FG000|NOT COMPLETED|Overall Study||0
11179680|NCT01696877|12368381|FG001|NOT COMPLETED|Overall Study||1
11179681|NCT01696929|12368389|FG000|STARTED|Overall Study||6
11179682|NCT01696929|12368389|FG000|COMPLETED|Overall Study||5
11179683|NCT01696929|12368389|FG000|NOT COMPLETED|Overall Study||1
11179684|NCT01696942|12368395|FG000|STARTED|Overall Study||5
11179685|NCT01696942|12368396|FG001|STARTED|Overall Study||5
11179686|NCT01696942|12368395|FG000|COMPLETED|Overall Study||3
11179687|NCT01696942|12368396|FG001|COMPLETED|Overall Study||2
11179688|NCT01696942|12368395|FG000|NOT COMPLETED|Overall Study||2
11179689|NCT01696942|12368396|FG001|NOT COMPLETED|Overall Study||3
11179690|NCT01696955|12368404|FG000|STARTED|Main Study||42
11179691|NCT01696955|12368405|FG001|STARTED|Main Study||39
11179692|NCT01696955|12368404|FG000|COMPLETED|Main Study||40
11179693|NCT01696955|12368405|FG001|COMPLETED|Main Study||38
11179694|NCT01696955|12368404|FG000|NOT COMPLETED|Main Study||2
11179695|NCT01696955|12368405|FG001|NOT COMPLETED|Main Study||1
11179696|NCT01696955|12368404|FG000|STARTED|Failure on Cetuximab-Received Tivantinib||0
11179697|NCT01696955|12368405|FG001|STARTED|Failure on Cetuximab-Received Tivantinib||15
11179698|NCT01696955|12368404|FG000|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
11179699|NCT01696955|12368405|FG001|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
11179700|NCT01696955|12368404|FG000|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
11179701|NCT01696955|12368405|FG001|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
11179702|NCT01697319|12368418|FG000|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
11179703|NCT01697319|12368418|FG000|COMPLETED|Primary Phase||15
11179704|NCT01697319|12368418|FG000|NOT COMPLETED|Primary Phase||1
11179705|NCT01697319|12368418|FG000|STARTED|Extension Phase||15
11179706|NCT01697319|12368418|FG000|COMPLETED|Extension Phase||0
11179707|NCT01697319|12368418|FG000|NOT COMPLETED|Extension Phase||15
11179708|NCT01697345|12368422|FG000|STARTED|Overall Study||13
11179709|NCT01697345|12368422|FG000|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
11179710|NCT01697345|12368422|FG000|NOT COMPLETED|Overall Study||1
11179711|NCT01697358|12368443|FG000|STARTED|Period I: Randomization to 6 Months||110
11179712|NCT01697358|12368444|FG001|STARTED|Period I: Randomization to 6 Months||108
11179713|NCT01697358|12368443|FG000|COMPLETED|Period I: Randomization to 6 Months||97
11179714|NCT01697358|12368444|FG001|COMPLETED|Period I: Randomization to 6 Months||107
11179715|NCT01697358|12368443|FG000|NOT COMPLETED|Period I: Randomization to 6 Months||13
11179716|NCT01697358|12368444|FG001|NOT COMPLETED|Period I: Randomization to 6 Months||1
11179717|NCT01697358|12368443|FG000|STARTED|Period II: 6-24M Long-term Follow-up||97
11179718|NCT01697358|12368444|FG001|STARTED|Period II: 6-24M Long-term Follow-up||107
11179719|NCT01697358|12368443|FG000|COMPLETED|Period II: 6-24M Long-term Follow-up||48
11179720|NCT01697358|12368444|FG001|COMPLETED|Period II: 6-24M Long-term Follow-up||52
11179721|NCT01697358|12368443|FG000|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
11179722|NCT01697358|12368444|FG001|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
11179723|NCT01697449|12368450|FG000|STARTED|Overall Study||191
11179724|NCT01697449|12368450|FG000|COMPLETED|Overall Study||101
11179725|NCT01697449|12368450|FG000|NOT COMPLETED|Overall Study||90
11179726|NCT01697462|12368457|FG000|STARTED|Overall Study||258
11179727|NCT01697462|12368457|FG000|COMPLETED|Overall Study||181
11179728|NCT01697462|12368457|FG000|NOT COMPLETED|Overall Study||77
11179729|NCT01697501|12368461|FG000|STARTED|Overall Study||88
11179730|NCT01697501|12368461|FG000|COMPLETED|Overall Study||86
11179731|NCT01697501|12368461|FG000|NOT COMPLETED|Overall Study||2
11179732|NCT01697579|12368479|FG000|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
11179733|NCT01697579|12368480|FG001|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
11179734|NCT01697579|12368481|FG002|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
11179735|NCT01697579|12368482|FG003|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
11179736|NCT01697579|12368483|FG004|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
11179737|NCT01697579|12368484|FG005|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
11179738|NCT01697579|12368485|FG006|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
11179739|NCT01697579|12368479|FG000|COMPLETED|Base Study-Cycle 1||72
11179740|NCT01697579|12368480|FG001|COMPLETED|Base Study-Cycle 1||42
11179741|NCT01697579|12368481|FG002|COMPLETED|Base Study-Cycle 1||43
11179742|NCT01697579|12368482|FG003|COMPLETED|Base Study-Cycle 1||40
11179743|NCT01697579|12368483|FG004|COMPLETED|Base Study-Cycle 1||35
11179744|NCT01697579|12368484|FG005|COMPLETED|Base Study-Cycle 1||0
11179745|NCT01697579|12368485|FG006|COMPLETED|Base Study-Cycle 1||0
11179746|NCT01697579|12368479|FG000|NOT COMPLETED|Base Study-Cycle 1||2
11179747|NCT01697579|12368480|FG001|NOT COMPLETED|Base Study-Cycle 1||1
11179748|NCT01697579|12368481|FG002|NOT COMPLETED|Base Study-Cycle 1||1
11179749|NCT01697579|12368482|FG003|NOT COMPLETED|Base Study-Cycle 1||1
11179750|NCT01697579|12368483|FG004|NOT COMPLETED|Base Study-Cycle 1||3
11179751|NCT01697579|12368484|FG005|NOT COMPLETED|Base Study-Cycle 1||0
11179752|NCT01697579|12368485|FG006|NOT COMPLETED|Base Study-Cycle 1||0
11179753|NCT01697579|12368479|FG000|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
11179754|NCT01697579|12368480|FG001|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
11179755|NCT01697579|12368481|FG002|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
11179756|NCT01697579|12368482|FG003|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
11179757|NCT01697579|12368483|FG004|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
11179758|NCT01697579|12368484|FG005|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
11179759|NCT01697579|12368485|FG006|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
11179760|NCT01697579|12368479|FG000|COMPLETED|Optional Extension-Cycles 2-6||0
11179761|NCT01697579|12368480|FG001|COMPLETED|Optional Extension-Cycles 2-6||0
11179762|NCT01697579|12368481|FG002|COMPLETED|Optional Extension-Cycles 2-6||0
11179763|NCT01697579|12368482|FG003|COMPLETED|Optional Extension-Cycles 2-6||0
11179764|NCT01697579|12368483|FG004|COMPLETED|Optional Extension-Cycles 2-6||0
11179765|NCT01697579|12368484|FG005|COMPLETED|Optional Extension-Cycles 2-6||12
11179766|NCT01697579|12368485|FG006|COMPLETED|Optional Extension-Cycles 2-6||37
11179767|NCT01697579|12368479|FG000|NOT COMPLETED|Optional Extension-Cycles 2-6||0
11179768|NCT01697579|12368480|FG001|NOT COMPLETED|Optional Extension-Cycles 2-6||0
11179769|NCT01697579|12368481|FG002|NOT COMPLETED|Optional Extension-Cycles 2-6||0
11179770|NCT01697579|12368482|FG003|NOT COMPLETED|Optional Extension-Cycles 2-6||0
11179771|NCT01697579|12368483|FG004|NOT COMPLETED|Optional Extension-Cycles 2-6||0
11179772|NCT01697579|12368484|FG005|NOT COMPLETED|Optional Extension-Cycles 2-6||35
11179773|NCT01697579|12368485|FG006|NOT COMPLETED|Optional Extension-Cycles 2-6||69
11179774|NCT01697592|12368523|FG000|STARTED|Phase A (Up to 24 Weeks)||126
11179775|NCT01697592|12368524|FG001|STARTED|Phase A (Up to 24 Weeks)||65
11179776|NCT01697592|12368525|FG002|STARTED|Phase A (Up to 24 Weeks)||66
11179777|NCT01697592|12368526|FG003|STARTED|Phase A (Up to 24 Weeks)||65
11179778|NCT01697592|12368527|FG004|STARTED|Phase A (Up to 24 Weeks)||67
11179779|NCT01697592|12368528|FG005|STARTED|Phase A (Up to 24 Weeks)||63
11179780|NCT01697592|12368529|FG006|STARTED|Phase A (Up to 24 Weeks)||34
11179781|NCT01697592|12368530|FG007|STARTED|Phase A (Up to 24 Weeks)||33
11179782|NCT01697592|12368531|FG008|STARTED|Phase A (Up to 24 Weeks)||34
11179783|NCT01697592|12368532|FG009|STARTED|Phase A (Up to 24 Weeks)||32
11179784|NCT01697592|12368523|FG000|COMPLETED|Phase A (Up to 24 Weeks)||123
11179785|NCT01697592|12368524|FG001|COMPLETED|Phase A (Up to 24 Weeks)||62
11179786|NCT01697592|12368525|FG002|COMPLETED|Phase A (Up to 24 Weeks)||65
11179787|NCT01697592|12368526|FG003|COMPLETED|Phase A (Up to 24 Weeks)||63
11179788|NCT01697592|12368527|FG004|COMPLETED|Phase A (Up to 24 Weeks)||67
11179789|NCT01697592|12368528|FG005|COMPLETED|Phase A (Up to 24 Weeks)||62
11179790|NCT01697592|12368529|FG006|COMPLETED|Phase A (Up to 24 Weeks)||32
11179791|NCT01697592|12368530|FG007|COMPLETED|Phase A (Up to 24 Weeks)||33
11179792|NCT01697592|12368531|FG008|COMPLETED|Phase A (Up to 24 Weeks)||34
11179793|NCT01697592|12368532|FG009|COMPLETED|Phase A (Up to 24 Weeks)||30
11179794|NCT01697592|12368523|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
11179795|NCT01697592|12368524|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
11179796|NCT01697592|12368525|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
11179797|NCT01697592|12368526|FG003|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
11179798|NCT01697592|12368527|FG004|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
11179799|NCT01697592|12368528|FG005|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
11179800|NCT01697592|12368529|FG006|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
11179801|NCT01697592|12368530|FG007|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
11179802|NCT01697592|12368531|FG008|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
11179803|NCT01697592|12368532|FG009|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
11179804|NCT01697592|12368523|FG000|STARTED|Phase B (Week 25 to Week 52)||123
11179805|NCT01697592|12368524|FG001|STARTED|Phase B (Week 25 to Week 52)||62
11179806|NCT01697592|12368525|FG002|STARTED|Phase B (Week 25 to Week 52)||65
11179807|NCT01697592|12368526|FG003|STARTED|Phase B (Week 25 to Week 52)||63
11179808|NCT01697592|12368527|FG004|STARTED|Phase B (Week 25 to Week 52)||67
11179809|NCT01697592|12368528|FG005|STARTED|Phase B (Week 25 to Week 52)||62
11179810|NCT01697592|12368529|FG006|STARTED|Phase B (Week 25 to Week 52)||32
11179811|NCT01697592|12368530|FG007|STARTED|Phase B (Week 25 to Week 52)||33
11179812|NCT01697592|12368531|FG008|STARTED|Phase B (Week 25 to Week 52)||34
11179813|NCT01697592|12368532|FG009|STARTED|Phase B (Week 25 to Week 52)||30
11179814|NCT01697592|12368523|FG000|COMPLETED|Phase B (Week 25 to Week 52)||118
11179815|NCT01697592|12368524|FG001|COMPLETED|Phase B (Week 25 to Week 52)||61
11179816|NCT01697592|12368525|FG002|COMPLETED|Phase B (Week 25 to Week 52)||64
11179817|NCT01697592|12368526|FG003|COMPLETED|Phase B (Week 25 to Week 52)||60
11179818|NCT01697592|12368527|FG004|COMPLETED|Phase B (Week 25 to Week 52)||67
11179819|NCT01697592|12368528|FG005|COMPLETED|Phase B (Week 25 to Week 52)||60
11179820|NCT01697592|12368529|FG006|COMPLETED|Phase B (Week 25 to Week 52)||31
11179821|NCT01697592|12368530|FG007|COMPLETED|Phase B (Week 25 to Week 52)||32
11179822|NCT01697592|12368531|FG008|COMPLETED|Phase B (Week 25 to Week 52)||32
11179823|NCT01697592|12368532|FG009|COMPLETED|Phase B (Week 25 to Week 52)||30
11179824|NCT01697592|12368523|FG000|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
11179825|NCT01697592|12368524|FG001|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
11179826|NCT01697592|12368525|FG002|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
11179827|NCT01697592|12368526|FG003|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
11179828|NCT01697592|12368527|FG004|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
11179829|NCT01697592|12368528|FG005|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
11179830|NCT01697592|12368529|FG006|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
11179831|NCT01697592|12368530|FG007|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
11179832|NCT01697592|12368531|FG008|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
11179833|NCT01697592|12368532|FG009|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
11179834|NCT01697696|12368570|FG000|STARTED|Overall Study||254
11179835|NCT01697696|12368571|FG001|STARTED|Overall Study||257
11179836|NCT01697696|12368570|FG000|Safety Set|Overall Study||251
11179837|NCT01697696|12368571|FG001|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
11179838|NCT01697696|12368570|FG000|Full Analysis Set (FAS)|Overall Study||251
11179839|NCT01697696|12368571|FG001|Full Analysis Set (FAS)|Overall Study||255
11179840|NCT01697696|12368570|FG000|COMPLETED|Overall Study||207
11179841|NCT01697696|12368571|FG001|COMPLETED|Overall Study||210
11179842|NCT01697696|12368570|FG000|NOT COMPLETED|Overall Study||47
11179843|NCT01697696|12368571|FG001|NOT COMPLETED|Overall Study||47
11179844|NCT01697709|12368579|FG000|STARTED|Overall Study||64
11179845|NCT01697709|12368580|FG001|STARTED|Overall Study||66
11179846|NCT01697709|12368579|FG000|COMPLETED|Overall Study||34
11179847|NCT01697709|12368580|FG001|COMPLETED|Overall Study||38
11179848|NCT01697709|12368579|FG000|NOT COMPLETED|Overall Study||30
11179849|NCT01697709|12368580|FG001|NOT COMPLETED|Overall Study||28
11179850|NCT01697748|12368588|FG000|STARTED|Overall Study||329
11179851|NCT01697748|12368589|FG001|STARTED|Overall Study||328
11179852|NCT01697748|12368588|FG000|COMPLETED|Overall Study||271
11179853|NCT01697748|12368589|FG001|COMPLETED|Overall Study||260
11179854|NCT01697748|12368588|FG000|NOT COMPLETED|Overall Study||58
11179855|NCT01697748|12368589|FG001|NOT COMPLETED|Overall Study||68
11179856|NCT01697956|12368597|FG000|STARTED|Overall Study|enrolled and randomized|67
11179857|NCT01697956|12368598|FG001|STARTED|Overall Study|enrolled and randomized|32
11179858|NCT01697956|12368597|FG000|Per Protocol Population|Overall Study||66
11179859|NCT01697956|12368598|FG001|Per Protocol Population|Overall Study||31
11179860|NCT01697956|12368597|FG000|COMPLETED|Overall Study||66
11179861|NCT01697956|12368598|FG001|COMPLETED|Overall Study||31
11179862|NCT01697956|12368597|FG000|NOT COMPLETED|Overall Study||1
11179863|NCT01697956|12368598|FG001|NOT COMPLETED|Overall Study||1
11179864|NCT01697969|12368610|FG000|STARTED|Overall Study||13
11179865|NCT01697969|12368610|FG000|COMPLETED|Overall Study||10
11179866|NCT01697969|12368610|FG000|NOT COMPLETED|Overall Study||3
11179867|NCT01698008|12368617|FG000|STARTED|Overall Study||3
11179868|NCT01698008|12368618|FG001|STARTED|Overall Study||2
11179869|NCT01698008|12368617|FG000|COMPLETED|Overall Study||2
11179870|NCT01698008|12368618|FG001|COMPLETED|Overall Study||0
11179871|NCT01698008|12368617|FG000|NOT COMPLETED|Overall Study||1
11179872|NCT01698008|12368618|FG001|NOT COMPLETED|Overall Study||2
11179873|NCT01698268|12368626|FG000|STARTED|Overall Study||25
11179874|NCT01698268|12368627|FG001|STARTED|Overall Study||25
11179875|NCT01698268|12368626|FG000|COMPLETED|Overall Study||23
11179876|NCT01698268|12368627|FG001|COMPLETED|Overall Study||24
11179877|NCT01698268|12368626|FG000|NOT COMPLETED|Overall Study||2
11179878|NCT01698268|12368627|FG001|NOT COMPLETED|Overall Study||1
11179879|NCT01698320|12368635|FG000|STARTED|Run-In Period (Week -1 to Day 0)||364
11179880|NCT01698320|12368636|FG001|STARTED|Run-In Period (Week -1 to Day 0)||0
11179881|NCT01698320|12368637|FG002|STARTED|Run-In Period (Week -1 to Day 0)||0
11179882|NCT01698320|12368635|FG000|COMPLETED|Run-In Period (Week -1 to Day 0)||337
11179883|NCT01698320|12368636|FG001|COMPLETED|Run-In Period (Week -1 to Day 0)||0
11179884|NCT01698320|12368637|FG002|COMPLETED|Run-In Period (Week -1 to Day 0)||0
11179885|NCT01698320|12368635|FG000|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
11179886|NCT01698320|12368636|FG001|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
11179887|NCT01698320|12368637|FG002|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
11179888|NCT01698320|12368635|FG000|STARTED|12-Week Double-Blind Period||0
11179889|NCT01698320|12368636|FG001|STARTED|12-Week Double-Blind Period||169
11179890|NCT01698320|12368637|FG002|STARTED|12-Week Double-Blind Period||168
11179891|NCT01698320|12368635|FG000|Safety Population|12-Week Double-Blind Period||0
11179892|NCT01698320|12368636|FG001|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
11179893|NCT01698320|12368637|FG002|Safety Population|12-Week Double-Blind Period||168
11179894|NCT01698320|12368635|FG000|COMPLETED|12-Week Double-Blind Period||0
11179895|NCT01698320|12368636|FG001|COMPLETED|12-Week Double-Blind Period||165
11179896|NCT01698320|12368637|FG002|COMPLETED|12-Week Double-Blind Period||156
11179897|NCT01698320|12368635|FG000|NOT COMPLETED|12-Week Double-Blind Period||0
11179898|NCT01698320|12368636|FG001|NOT COMPLETED|12-Week Double-Blind Period||4
11179899|NCT01698320|12368637|FG002|NOT COMPLETED|12-Week Double-Blind Period||12
11179900|NCT01698320|12368635|FG000|STARTED|40-Week Open-Label Period||0
11179901|NCT01698320|12368636|FG001|STARTED|40-Week Open-Label Period||165
11179902|NCT01698320|12368637|FG002|STARTED|40-Week Open-Label Period||156
11179903|NCT01698320|12368635|FG000|COMPLETED|40-Week Open-Label Period||0
11179904|NCT01698320|12368636|FG001|COMPLETED|40-Week Open-Label Period||146
11179905|NCT01698320|12368637|FG002|COMPLETED|40-Week Open-Label Period||146
11179906|NCT01698320|12368635|FG000|NOT COMPLETED|40-Week Open-Label Period||0
11179907|NCT01698320|12368636|FG001|NOT COMPLETED|40-Week Open-Label Period||19
11179908|NCT01698320|12368637|FG002|NOT COMPLETED|40-Week Open-Label Period||10
11179909|NCT01698333|12368645|FG000|STARTED|Overall Study||25
11179910|NCT01698333|12368645|FG000|COMPLETED|Overall Study||25
11179911|NCT01698333|12368645|FG000|NOT COMPLETED|Overall Study||0
11179912|NCT01698463|12368649|FG000|STARTED|Overall Study||11
11179913|NCT01698463|12368649|FG000|COMPLETED|Overall Study||11
11179914|NCT01698463|12368649|FG000|NOT COMPLETED|Overall Study||0
11179915|NCT01698502|12368655|FG000|STARTED|Overall Study||11
11179916|NCT01698502|12368656|FG001|STARTED|Overall Study||10
11179917|NCT01698502|12368655|FG000|COMPLETED|Overall Study||11
11179918|NCT01698502|12368656|FG001|COMPLETED|Overall Study||10
11179919|NCT01698502|12368655|FG000|NOT COMPLETED|Overall Study||0
11179920|NCT01698502|12368656|FG001|NOT COMPLETED|Overall Study||0
11179921|NCT01698528|12368664|FG000|STARTED|Overall Study||20
11179922|NCT01698528|12368665|FG001|STARTED|Overall Study||20
11179923|NCT01698528|12368664|FG000|COMPLETED|Overall Study||19
11179924|NCT01698528|12368665|FG001|COMPLETED|Overall Study||16
11179925|NCT01698528|12368664|FG000|NOT COMPLETED|Overall Study||1
11179926|NCT01698528|12368665|FG001|NOT COMPLETED|Overall Study||4
11179927|NCT01698554|12368675|FG000|STARTED|Overall Study||153
11179928|NCT01698554|12368676|FG001|STARTED|Overall Study||157
11179929|NCT01698554|12368677|FG002|STARTED|Overall Study||75
11179930|NCT01698554|12368678|FG003|STARTED|Overall Study||79
11179931|NCT01698554|12368675|FG000|COMPLETED|Overall Study||147
11179932|NCT01698554|12368676|FG001|COMPLETED|Overall Study||147
11179933|NCT01698554|12368677|FG002|COMPLETED|Overall Study||73
11179934|NCT01698554|12368678|FG003|COMPLETED|Overall Study||77
11179935|NCT01698554|12368675|FG000|NOT COMPLETED|Overall Study||6
11179936|NCT01698554|12368676|FG001|NOT COMPLETED|Overall Study||10
11179937|NCT01698554|12368677|FG002|NOT COMPLETED|Overall Study||2
11179938|NCT01698554|12368678|FG003|NOT COMPLETED|Overall Study||2
11179939|NCT01698684|12368691|FG000|STARTED|Overall Study||145
11179940|NCT01698684|12368692|FG001|STARTED|Overall Study||147
11179941|NCT01698684|12368693|FG002|STARTED|Overall Study||148
11179942|NCT01698684|12368691|FG000|ITT Population|Overall Study||136
11179943|NCT01698684|12368692|FG001|ITT Population|Overall Study||139
11179944|NCT01698684|12368693|FG002|ITT Population|Overall Study||139
11179945|NCT01698684|12368691|FG000|Safety Population|Overall Study||143
11179946|NCT01698684|12368692|FG001|Safety Population|Overall Study||146
11179947|NCT01698684|12368693|FG002|Safety Population|Overall Study||146
11179948|NCT01698684|12368691|FG000|COMPLETED|Overall Study||116
11179949|NCT01698684|12368692|FG001|COMPLETED|Overall Study||124
11179950|NCT01698684|12368693|FG002|COMPLETED|Overall Study||127
11179951|NCT01698684|12368691|FG000|NOT COMPLETED|Overall Study||29
11179952|NCT01698684|12368692|FG001|NOT COMPLETED|Overall Study||23
11179953|NCT01698684|12368693|FG002|NOT COMPLETED|Overall Study||21
11179954|NCT01698710|12368701|FG000|STARTED|Overall Study||5
11179955|NCT01698710|12368701|FG000|COMPLETED|Overall Study||5
11179956|NCT01698710|12368701|FG000|NOT COMPLETED|Overall Study||0
11179957|NCT01698775|12368707|FG000|STARTED|Phase A||107
11179958|NCT01698775|12368708|FG001|STARTED|Phase A||106
11179959|NCT01698775|12368707|FG000|COMPLETED|Phase A||98
11179960|NCT01698775|12368708|FG001|COMPLETED|Phase A||97
11179961|NCT01698775|12368707|FG000|NOT COMPLETED|Phase A||9
11179962|NCT01698775|12368708|FG001|NOT COMPLETED|Phase A||9
11179963|NCT01698775|12368707|FG000|STARTED|Phase B||98
11179964|NCT01698775|12368708|FG001|STARTED|Phase B||97
11179965|NCT01698775|12368707|FG000|COMPLETED|Phase B||84
11179966|NCT01698775|12368708|FG001|COMPLETED|Phase B||86
11179967|NCT01698775|12368707|FG000|NOT COMPLETED|Phase B||14
11179968|NCT01698775|12368708|FG001|NOT COMPLETED|Phase B||11
11179969|NCT01698801|12368718|FG000|STARTED|Treatment Phase||26
11179970|NCT01698801|12368718|FG000|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
11179971|NCT01698801|12368718|FG000|NOT COMPLETED|Treatment Phase||11
11179972|NCT01698801|12368718|FG000|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
11179973|NCT01698801|12368718|FG000|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
11179974|NCT01698801|12368718|FG000|NOT COMPLETED|Follow Up Phase||5
11204094|NCT01852045|12394699|FG002|COMPLETED|Overall Study||26
11204095|NCT01852045|12394697|FG000|NOT COMPLETED|Overall Study||6
11204096|NCT01852045|12394698|FG001|NOT COMPLETED|Overall Study||4
11204097|NCT01852045|12394699|FG002|NOT COMPLETED|Overall Study||4
11179975|NCT01698814|12368725|FG000|STARTED|Overall Study||331
11179976|NCT01698814|12368726|FG001|STARTED|Overall Study||169
11179977|NCT01698814|12368725|FG000|COMPLETED|Overall Study||329
11179978|NCT01698814|12368726|FG001|COMPLETED|Overall Study||166
11179979|NCT01698814|12368725|FG000|NOT COMPLETED|Overall Study||2
11179980|NCT01698814|12368726|FG001|NOT COMPLETED|Overall Study||3
11179981|NCT01698879|12368735|FG000|STARTED|Overall Study||6
11179982|NCT01698879|12368736|FG001|STARTED|Overall Study||20
11179983|NCT01698879|12368737|FG002|STARTED|Overall Study||20
11179984|NCT01698879|12368735|FG000|COMPLETED|Overall Study||5
11179985|NCT01698879|12368736|FG001|COMPLETED|Overall Study||20
11179986|NCT01698879|12368737|FG002|COMPLETED|Overall Study||20
11179987|NCT01698879|12368735|FG000|NOT COMPLETED|Overall Study||1
11179988|NCT01698879|12368736|FG001|NOT COMPLETED|Overall Study||0
11179989|NCT01698879|12368737|FG002|NOT COMPLETED|Overall Study||0
11179990|NCT01699022|12368751|FG000|STARTED|Overall Study||17
11179991|NCT01699022|12368751|FG000|COMPLETED|Overall Study||14
11179992|NCT01699022|12368751|FG000|NOT COMPLETED|Overall Study||3
11179993|NCT01699087|12368756|FG000|STARTED|Overall Study||176
11179994|NCT01699087|12368756|FG000|Treated|Overall Study||161
11179995|NCT01699087|12368756|FG000|COMPLETED|Overall Study||152
11179996|NCT01699087|12368756|FG000|NOT COMPLETED|Overall Study||24
11179997|NCT01699178|12368763|FG000|STARTED|Overall Study||88
11179998|NCT01699178|12368764|FG001|STARTED|Overall Study||94
11179999|NCT01699178|12368763|FG000|COMPLETED|Overall Study||69
11180000|NCT01699178|12368764|FG001|COMPLETED|Overall Study||62
11180001|NCT01699178|12368763|FG000|NOT COMPLETED|Overall Study||19
11180002|NCT01699178|12368764|FG001|NOT COMPLETED|Overall Study||32
11180003|NCT01699373|12368772|FG000|STARTED|Overall Study||85
11180004|NCT01699373|12368773|FG001|STARTED|Overall Study||85
11180005|NCT01699373|12368772|FG000|COMPLETED|Overall Study||85
11180006|NCT01699373|12368773|FG001|COMPLETED|Overall Study||85
11180007|NCT01699373|12368772|FG000|NOT COMPLETED|Overall Study||0
11180008|NCT01699373|12368773|FG001|NOT COMPLETED|Overall Study||0
11180009|NCT01699503|12368781|FG000|STARTED|Overall Study||2008
11180010|NCT01699503|12368782|FG001|STARTED|Overall Study||1997
11180011|NCT01699503|12368781|FG000|Baseline|Overall Study||1723
11180012|NCT01699503|12368782|FG001|Baseline|Overall Study||1693
11180013|NCT01699503|12368781|FG000|1 Month Follow-up|Overall Study||998
11180014|NCT01699503|12368782|FG001|1 Month Follow-up|Overall Study||1022
11180015|NCT01699503|12368781|FG000|6 Month Follow-up|Overall Study||903
11180016|NCT01699503|12368782|FG001|6 Month Follow-up|Overall Study||893
11180017|NCT01699503|12368781|FG000|COMPLETED|Overall Study||1008
11180018|NCT01699503|12368782|FG001|COMPLETED|Overall Study||992
11180019|NCT01699503|12368781|FG000|NOT COMPLETED|Overall Study||1000
11180020|NCT01699503|12368782|FG001|NOT COMPLETED|Overall Study||1005
11180021|NCT01699542|12368790|FG000|STARTED|Overall Study||9
11180022|NCT01699542|12368791|FG001|STARTED|Overall Study||9
11180023|NCT01699542|12368790|FG000|COMPLETED|Overall Study||9
11180024|NCT01699542|12368791|FG001|COMPLETED|Overall Study||9
11180025|NCT01699542|12368790|FG000|NOT COMPLETED|Overall Study||0
11180026|NCT01699542|12368791|FG001|NOT COMPLETED|Overall Study||0
11180027|NCT01699607|12368799|FG000|STARTED|Overall Study||6
11180028|NCT01699607|12368800|FG001|STARTED|Overall Study||4
11180029|NCT01699607|12368799|FG000|COMPLETED|Overall Study||6
11180030|NCT01699607|12368800|FG001|COMPLETED|Overall Study||4
11180031|NCT01699607|12368799|FG000|NOT COMPLETED|Overall Study||0
11180032|NCT01699607|12368800|FG001|NOT COMPLETED|Overall Study||0
11180033|NCT01699685|12368807|FG000|STARTED|Period 1||39
11180034|NCT01699685|12368808|FG001|STARTED|Period 1||39
11180035|NCT01699685|12368807|FG000|Safety Population|Period 1||39
11180036|NCT01699685|12368808|FG001|Safety Population|Period 1||38
11180037|NCT01699685|12368807|FG000|Full Analysis Population (FAS)|Period 1||38
11180038|NCT01699685|12368808|FG001|Full Analysis Population (FAS)|Period 1||38
11180039|NCT01699685|12368807|FG000|COMPLETED|Period 1||36
11180040|NCT01699685|12368808|FG001|COMPLETED|Period 1||36
11180041|NCT01699685|12368807|FG000|NOT COMPLETED|Period 1||3
11180042|NCT01699685|12368808|FG001|NOT COMPLETED|Period 1||3
11180043|NCT01699685|12368807|FG000|STARTED|Period 2||36
11180044|NCT01699685|12368808|FG001|STARTED|Period 2||36
11180045|NCT01699685|12368807|FG000|COMPLETED|Period 2||35
11180046|NCT01699685|12368808|FG001|COMPLETED|Period 2||36
11180047|NCT01699685|12368807|FG000|NOT COMPLETED|Period 2||1
11180048|NCT01699685|12368808|FG001|NOT COMPLETED|Period 2||0
11180049|NCT01699698|12368816|FG000|STARTED|Overall Study||44
11180050|NCT01699698|12368817|FG001|STARTED|Overall Study||61
11180051|NCT01699698|12368816|FG000|COMPLETED|Overall Study||42
11180052|NCT01699698|12368817|FG001|COMPLETED|Overall Study||56
11180053|NCT01699698|12368816|FG000|NOT COMPLETED|Overall Study||2
11180054|NCT01699698|12368817|FG001|NOT COMPLETED|Overall Study||5
11180055|NCT01699750|12368826|FG000|STARTED|Overall Study||34
11180056|NCT01699750|12368827|FG001|STARTED|Overall Study||36
11180057|NCT01699750|12368826|FG000|COMPLETED|Overall Study||34
11180058|NCT01699750|12368827|FG001|COMPLETED|Overall Study||33
11180059|NCT01699750|12368826|FG000|NOT COMPLETED|Overall Study||0
11180060|NCT01699750|12368827|FG001|NOT COMPLETED|Overall Study||3
11180061|NCT01699763|12368837|FG000|STARTED|Overall Study||112
11180062|NCT01699763|12368837|FG000|COMPLETED|Overall Study||112
11180063|NCT01699763|12368837|FG000|NOT COMPLETED|Overall Study||0
11180064|NCT01699789|12368843|FG000|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
11180065|NCT01699789|12368844|FG001|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
11180066|NCT01699789|12368843|FG000|Baseline|Overall Study||492
11180067|NCT01699789|12368844|FG001|Baseline|Overall Study||489
11180068|NCT01699789|12368843|FG000|6-Month Follow-Up|Overall Study||380
11180069|NCT01699789|12368844|FG001|6-Month Follow-Up|Overall Study||379
11180070|NCT01699789|12368843|FG000|12-Month Follow-Up|Overall Study||364
11180071|NCT01699789|12368844|FG001|12-Month Follow-Up|Overall Study||369
11180072|NCT01699789|12368843|FG000|3-Year Follow-up|Overall Study||293
11180073|NCT01699789|12368844|FG001|3-Year Follow-up|Overall Study||307
11180074|NCT01699789|12368843|FG000|4-Year Follow-up|Overall Study||143
11180075|NCT01699789|12368844|FG001|4-Year Follow-up|Overall Study||140
11180076|NCT01699789|12368843|FG000|COMPLETED|Overall Study|Clients in 44 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|504
11180077|NCT01699789|12368844|FG001|COMPLETED|Overall Study|Clients in 46 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|514
11180078|NCT01699789|12368843|FG000|NOT COMPLETED|Overall Study||102
11180079|NCT01699789|12368844|FG001|NOT COMPLETED|Overall Study||126
11180080|NCT01699815|12368854|FG000|STARTED|Overall Study||62
11180081|NCT01699815|12368855|FG001|STARTED|Overall Study||64
11180082|NCT01699815|12368854|FG000|COMPLETED|Overall Study||57
11180083|NCT01699815|12368855|FG001|COMPLETED|Overall Study||56
11180084|NCT01699815|12368854|FG000|NOT COMPLETED|Overall Study||5
11180085|NCT01699815|12368855|FG001|NOT COMPLETED|Overall Study||8
11180086|NCT01699867|12368861|FG000|STARTED|Overall Study||50
11180087|NCT01699867|12368861|FG000|COMPLETED|Overall Study||47
11180088|NCT01699867|12368861|FG000|NOT COMPLETED|Overall Study||3
11180089|NCT01700036|12368865|FG000|STARTED|Overall Study||40
11180090|NCT01700036|12368865|FG000|COMPLETED|Overall Study||40
11180091|NCT01700036|12368865|FG000|NOT COMPLETED|Overall Study||0
11180092|NCT01700049|12368869|FG000|STARTED|Overall Study||28
11180093|NCT01700049|12368869|FG000|COMPLETED|Overall Study||27
11180094|NCT01700049|12368869|FG000|NOT COMPLETED|Overall Study||1
11180095|NCT01700140|12368877|FG000|STARTED|Overall Study||61
11180096|NCT01700140|12368878|FG001|STARTED|Overall Study||66
11180097|NCT01700140|12368879|FG002|STARTED|Overall Study||62
11180098|NCT01700140|12368877|FG000|COMPLETED|Overall Study||55
11180099|NCT01700140|12368878|FG001|COMPLETED|Overall Study||57
11180100|NCT01700140|12368879|FG002|COMPLETED|Overall Study||61
11180101|NCT01700140|12368877|FG000|NOT COMPLETED|Overall Study||6
11180102|NCT01700140|12368878|FG001|NOT COMPLETED|Overall Study||9
11180103|NCT01700140|12368879|FG002|NOT COMPLETED|Overall Study||1
11180104|NCT01700179|12368890|FG000|STARTED|Overall Study||8
11180105|NCT01700179|12368890|FG000|COMPLETED|Overall Study||6
11180106|NCT01700179|12368890|FG000|NOT COMPLETED|Overall Study||2
11180107|NCT01700192|12368896|FG000|STARTED|Overall Study||741
11180108|NCT01700192|12368897|FG001|STARTED|Overall Study||741
11180109|NCT01700192|12368896|FG000|Treated|Overall Study||740
11180110|NCT01700192|12368897|FG001|Treated|Overall Study||741
11180111|NCT01700192|12368896|FG000|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
11180112|NCT01700192|12368897|FG001|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
11180113|NCT01700192|12368896|FG000|COMPLETED|Overall Study||561
11180114|NCT01700192|12368897|FG001|COMPLETED|Overall Study||613
11180115|NCT01700192|12368896|FG000|NOT COMPLETED|Overall Study||180
11180116|NCT01700192|12368897|FG001|NOT COMPLETED|Overall Study||128
11180117|NCT01700205|12368905|FG000|STARTED|Overall Study|Mother-Infant Dyads|59
11180118|NCT01700205|12368906|FG001|STARTED|Overall Study|Mother-Infant Dyads|54
11180119|NCT01700205|12368905|FG000|COMPLETED|Overall Study|Mother-Infant Dyads|44
11180120|NCT01700205|12368906|FG001|COMPLETED|Overall Study|Mother-Infant Dyads|39
11180121|NCT01700205|12368905|FG000|NOT COMPLETED|Overall Study||15
11180122|NCT01700205|12368906|FG001|NOT COMPLETED|Overall Study||15
11180123|NCT01700335|12368912|FG000|STARTED|Overall Study||3
11180124|NCT01700335|12368913|FG001|STARTED|Overall Study||6
11180125|NCT01700335|12368912|FG000|COMPLETED|Overall Study||2
11180126|NCT01700335|12368913|FG001|COMPLETED|Overall Study||2
11180127|NCT01700335|12368912|FG000|NOT COMPLETED|Overall Study||1
11180128|NCT01700335|12368913|FG001|NOT COMPLETED|Overall Study||4
11180129|NCT01700387|12368922|FG000|STARTED|Overall Study||10
11180130|NCT01700387|12368923|FG001|STARTED|Overall Study||10
11180131|NCT01700387|12368922|FG000|COMPLETED|Overall Study||6
11180132|NCT01700387|12368923|FG001|COMPLETED|Overall Study||6
11180133|NCT01700387|12368922|FG000|NOT COMPLETED|Overall Study||4
11180134|NCT01700387|12368923|FG001|NOT COMPLETED|Overall Study||4
11180135|NCT01700517|12368936|FG000|STARTED|Overall Study||40
11180136|NCT01700517|12368937|FG001|STARTED|Overall Study||40
11180137|NCT01700517|12368938|FG002|STARTED|Overall Study||40
11180138|NCT01700517|12368936|FG000|COMPLETED|Overall Study||40
11180139|NCT01700517|12368937|FG001|COMPLETED|Overall Study||40
11180140|NCT01700517|12368938|FG002|COMPLETED|Overall Study||40
11180141|NCT01700517|12368936|FG000|NOT COMPLETED|Overall Study||0
11180142|NCT01700517|12368937|FG001|NOT COMPLETED|Overall Study||0
11180143|NCT01700517|12368938|FG002|NOT COMPLETED|Overall Study||0
11180144|NCT01700530|12368949|FG000|STARTED|Overall Study||9
11180145|NCT01700530|12368950|FG001|STARTED|Overall Study||21
11180146|NCT01700530|12368951|FG002|STARTED|Overall Study||20
11180147|NCT01700530|12368949|FG000|COMPLETED|Overall Study||9
11180148|NCT01700530|12368950|FG001|COMPLETED|Overall Study||18
11180149|NCT01700530|12368951|FG002|COMPLETED|Overall Study||19
11180150|NCT01700530|12368949|FG000|NOT COMPLETED|Overall Study||0
11180151|NCT01700530|12368950|FG001|NOT COMPLETED|Overall Study||3
11180152|NCT01700530|12368951|FG002|NOT COMPLETED|Overall Study||1
11180153|NCT01700621|12368961|FG000|STARTED|Received Study Vaccines||240
11180154|NCT01700621|12368962|FG001|STARTED|Received Study Vaccines||240
11180155|NCT01700621|12368961|FG000|COMPLETED|Received Study Vaccines||240
11180156|NCT01700621|12368962|FG001|COMPLETED|Received Study Vaccines||240
11180157|NCT01700621|12368961|FG000|NOT COMPLETED|Received Study Vaccines||0
11180158|NCT01700621|12368962|FG001|NOT COMPLETED|Received Study Vaccines||0
11180159|NCT01700621|12368961|FG000|STARTED|Analyzed for Immunogenicity||240
11180160|NCT01700621|12368962|FG001|STARTED|Analyzed for Immunogenicity||240
11180161|NCT01700621|12368961|FG000|COMPLETED|Analyzed for Immunogenicity||227
11180162|NCT01700621|12368962|FG001|COMPLETED|Analyzed for Immunogenicity||233
11180163|NCT01700621|12368961|FG000|NOT COMPLETED|Analyzed for Immunogenicity||13
11180164|NCT01700621|12368962|FG001|NOT COMPLETED|Analyzed for Immunogenicity||7
11180165|NCT01700725|12368972|FG000|STARTED|Overall Study||14
11180166|NCT01700725|12368973|FG001|STARTED|Overall Study||14
11180167|NCT01700725|12368974|FG002|STARTED|Overall Study||12
11180168|NCT01700725|12368972|FG000|COMPLETED|Overall Study||14
11180169|NCT01700725|12368973|FG001|COMPLETED|Overall Study||14
11180170|NCT01700725|12368974|FG002|COMPLETED|Overall Study||12
11180171|NCT01700725|12368972|FG000|NOT COMPLETED|Overall Study||0
11180172|NCT01700725|12368973|FG001|NOT COMPLETED|Overall Study||0
11180173|NCT01700725|12368974|FG002|NOT COMPLETED|Overall Study||0
11180174|NCT01700816|12368984|FG000|STARTED|Overall Study||21
11180175|NCT01700816|12368985|FG001|STARTED|Overall Study||19
11180176|NCT01700816|12368984|FG000|COMPLETED|Overall Study||21
11180177|NCT01700816|12368985|FG001|COMPLETED|Overall Study||19
11180178|NCT01700816|12368984|FG000|NOT COMPLETED|Overall Study||0
11180179|NCT01700816|12368985|FG001|NOT COMPLETED|Overall Study||0
11180180|NCT01700829|12368993|FG000|STARTED|Overall Study||41
11180181|NCT01700829|12368994|FG001|STARTED|Overall Study||41
11180182|NCT01700829|12368993|FG000|COMPLETED|Overall Study||40
11180183|NCT01700829|12368994|FG001|COMPLETED|Overall Study||40
11180184|NCT01700829|12368993|FG000|NOT COMPLETED|Overall Study||1
11180185|NCT01700829|12368994|FG001|NOT COMPLETED|Overall Study||1
11180186|NCT01700907|12369002|FG000|STARTED|Overall Study||10
11180187|NCT01700907|12369003|FG001|STARTED|Overall Study||10
11180188|NCT01700907|12369002|FG000|COMPLETED|Overall Study||10
11180189|NCT01700907|12369003|FG001|COMPLETED|Overall Study||10
11180190|NCT01700907|12369002|FG000|NOT COMPLETED|Overall Study||0
11180191|NCT01700907|12369003|FG001|NOT COMPLETED|Overall Study||0
11180192|NCT01700959|12369015|FG000|STARTED|Overall Study||89
11180193|NCT01700959|12369016|FG001|STARTED|Overall Study||88
11180194|NCT01700959|12369017|FG002|STARTED|Overall Study||105
11180195|NCT01700959|12369018|FG003|STARTED|Overall Study||105
11180196|NCT01700959|12369019|FG004|STARTED|Overall Study||96
11180197|NCT01700959|12369020|FG005|STARTED|Overall Study||97
11180198|NCT01700959|12369015|FG000|COMPLETED|Overall Study||62
11180199|NCT01700959|12369016|FG001|COMPLETED|Overall Study||64
11180200|NCT01700959|12369017|FG002|COMPLETED|Overall Study||65
11180201|NCT01700959|12369018|FG003|COMPLETED|Overall Study||70
11180202|NCT01700959|12369019|FG004|COMPLETED|Overall Study||69
11180203|NCT01700959|12369020|FG005|COMPLETED|Overall Study||72
11180204|NCT01700959|12369015|FG000|NOT COMPLETED|Overall Study||27
11180205|NCT01700959|12369016|FG001|NOT COMPLETED|Overall Study||24
11180206|NCT01700959|12369017|FG002|NOT COMPLETED|Overall Study||40
11180207|NCT01700959|12369018|FG003|NOT COMPLETED|Overall Study||35
11180208|NCT01700959|12369019|FG004|NOT COMPLETED|Overall Study||27
11180209|NCT01700959|12369020|FG005|NOT COMPLETED|Overall Study||25
11180210|NCT01700985|12369038|FG000|STARTED|Overall Study||23
11180211|NCT01700985|12369039|FG001|STARTED|Overall Study||21
11180212|NCT01700985|12369038|FG000|COMPLETED|Overall Study||23
11180213|NCT01700985|12369039|FG001|COMPLETED|Overall Study||20
11180214|NCT01700985|12369038|FG000|NOT COMPLETED|Overall Study||0
11180215|NCT01700985|12369039|FG001|NOT COMPLETED|Overall Study||1
11180216|NCT01701011|12369048|FG000|STARTED|Overall Study||127
11180217|NCT01701011|12369049|FG001|STARTED|Overall Study||126
11180218|NCT01701011|12369050|FG002|STARTED|Overall Study||124
11180219|NCT01701011|12369048|FG000|COMPLETED|Overall Study||92
11180220|NCT01701011|12369049|FG001|COMPLETED|Overall Study||102
11180221|NCT01701011|12369050|FG002|COMPLETED|Overall Study||90
11180222|NCT01701011|12369048|FG000|NOT COMPLETED|Overall Study||35
11180223|NCT01701011|12369049|FG001|NOT COMPLETED|Overall Study||24
11180224|NCT01701011|12369050|FG002|NOT COMPLETED|Overall Study||34
11180225|NCT01701024|12369061|FG000|STARTED|Overall Study||253
11180226|NCT01701024|12369062|FG001|STARTED|Overall Study||245
11180227|NCT01701024|12369061|FG000|COMPLETED|Overall Study||243
11180228|NCT01701024|12369062|FG001|COMPLETED|Overall Study||236
11180229|NCT01701024|12369061|FG000|NOT COMPLETED|Overall Study||10
11180230|NCT01701024|12369062|FG001|NOT COMPLETED|Overall Study||9
11180231|NCT01701037|12369068|FG000|STARTED|Overall Study||13
11180232|NCT01701037|12369068|FG000|COMPLETED|Overall Study||13
11180233|NCT01701037|12369068|FG000|NOT COMPLETED|Overall Study||0
11180234|NCT01701063|12369076|FG000|STARTED|Overall Study||13
11180235|NCT01701063|12369077|FG001|STARTED|Overall Study||19
11180236|NCT01701063|12369078|FG002|STARTED|Overall Study||10
11180237|NCT01701063|12369076|FG000|COMPLETED|Overall Study||13
11180238|NCT01701063|12369077|FG001|COMPLETED|Overall Study||18
11180239|NCT01701063|12369078|FG002|COMPLETED|Overall Study||8
11180240|NCT01701063|12369076|FG000|NOT COMPLETED|Overall Study||0
11180241|NCT01701063|12369077|FG001|NOT COMPLETED|Overall Study||1
11180242|NCT01701063|12369078|FG002|NOT COMPLETED|Overall Study||2
11180243|NCT01701102|12369091|FG000|STARTED|Overall Study||22
11180244|NCT01701102|12369092|FG001|STARTED|Overall Study||6
11180245|NCT01701102|12369093|FG002|STARTED|Overall Study||10
11180246|NCT01701102|12369094|FG003|STARTED|Overall Study||18
11180247|NCT01701102|12369091|FG000|COMPLETED|Overall Study||22
11180248|NCT01701102|12369092|FG001|COMPLETED|Overall Study||6
11180249|NCT01701102|12369093|FG002|COMPLETED|Overall Study||10
11180250|NCT01701102|12369094|FG003|COMPLETED|Overall Study||18
11180251|NCT01701102|12369091|FG000|NOT COMPLETED|Overall Study||0
11180252|NCT01701102|12369092|FG001|NOT COMPLETED|Overall Study||0
11180253|NCT01701102|12369093|FG002|NOT COMPLETED|Overall Study||0
11180254|NCT01701102|12369094|FG003|NOT COMPLETED|Overall Study||0
11180255|NCT01701115|12369106|FG000|STARTED|Overall Study||77
11180256|NCT01701115|12369107|FG001|STARTED|Overall Study||77
11180257|NCT01701115|12369106|FG000|COMPLETED|Overall Study||75
11180258|NCT01701115|12369107|FG001|COMPLETED|Overall Study||77
11180259|NCT01701115|12369106|FG000|NOT COMPLETED|Overall Study||2
11180260|NCT01701115|12369107|FG001|NOT COMPLETED|Overall Study||0
11180261|NCT01701193|12369117|FG000|STARTED|Overall Study||18
11180262|NCT01701193|12369118|FG001|STARTED|Overall Study||19
11180263|NCT01701193|12369119|FG002|STARTED|Overall Study||5
11180264|NCT01701193|12369120|FG003|STARTED|Overall Study||5
11180265|NCT01701193|12369117|FG000|COMPLETED|Overall Study||15
11180266|NCT01701193|12369118|FG001|COMPLETED|Overall Study||17
11180267|NCT01701193|12369119|FG002|COMPLETED|Overall Study||4
11180268|NCT01701193|12369120|FG003|COMPLETED|Overall Study||3
11180269|NCT01701193|12369117|FG000|NOT COMPLETED|Overall Study||3
11180270|NCT01701193|12369118|FG001|NOT COMPLETED|Overall Study||2
11180271|NCT01701193|12369119|FG002|NOT COMPLETED|Overall Study||1
11180272|NCT01701193|12369120|FG003|NOT COMPLETED|Overall Study||2
11180273|NCT01701245|12369135|FG000|STARTED|Overall Study||49
11180274|NCT01701245|12369136|FG001|STARTED|Overall Study||48
11180275|NCT01701245|12369135|FG000|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
11180276|NCT01701245|12369136|FG001|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
11180277|NCT01701245|12369135|FG000|FAS Matched Data|Overall Study||42
11180278|NCT01701245|12369136|FG001|FAS Matched Data|Overall Study||32
11180279|NCT01701245|12369135|FG000|COMPLETED|Overall Study||37
11180280|NCT01701245|12369136|FG001|COMPLETED|Overall Study||33
11180281|NCT01701245|12369135|FG000|NOT COMPLETED|Overall Study||12
11180282|NCT01701245|12369136|FG001|NOT COMPLETED|Overall Study||15
11180283|NCT01701258|12369146|FG000|STARTED|Assessment and Scheduling||153
11180284|NCT01701258|12369147|FG001|STARTED|Assessment and Scheduling||0
11180285|NCT01701258|12369148|FG002|STARTED|Assessment and Scheduling||0
11180286|NCT01701258|12369149|FG003|STARTED|Assessment and Scheduling||0
11180287|NCT01701258|12369150|FG004|STARTED|Assessment and Scheduling||0
11180288|NCT01701258|12369151|FG005|STARTED|Assessment and Scheduling||0
11180289|NCT01701258|12369152|FG006|STARTED|Assessment and Scheduling||0
11180290|NCT01701258|12369153|FG007|STARTED|Assessment and Scheduling||0
11180291|NCT01701258|12369154|FG008|STARTED|Assessment and Scheduling||0
11180292|NCT01701258|12369155|FG009|STARTED|Assessment and Scheduling||0
11180293|NCT01701258|12369156|FG010|STARTED|Assessment and Scheduling||0
11180294|NCT01701258|12369157|FG011|STARTED|Assessment and Scheduling||0
11180295|NCT01701258|12369158|FG012|STARTED|Assessment and Scheduling||0
11180296|NCT01701258|12369146|FG000|Eligible After Screening Visit|Assessment and Scheduling||96
11180297|NCT01701258|12369147|FG001|Eligible After Screening Visit|Assessment and Scheduling||0
11180298|NCT01701258|12369148|FG002|Eligible After Screening Visit|Assessment and Scheduling||0
11180299|NCT01701258|12369149|FG003|Eligible After Screening Visit|Assessment and Scheduling||0
11180300|NCT01701258|12369150|FG004|Eligible After Screening Visit|Assessment and Scheduling||0
11180301|NCT01701258|12369151|FG005|Eligible After Screening Visit|Assessment and Scheduling||0
11180302|NCT01701258|12369152|FG006|Eligible After Screening Visit|Assessment and Scheduling||0
11180303|NCT01701258|12369153|FG007|Eligible After Screening Visit|Assessment and Scheduling||0
11180304|NCT01701258|12369154|FG008|Eligible After Screening Visit|Assessment and Scheduling||0
11180305|NCT01701258|12369155|FG009|Eligible After Screening Visit|Assessment and Scheduling||0
11026870|NCT00830869|12205485|FG005|NOT COMPLETED|Period 1: Part 1||6
11026871|NCT00830869|12205486|FG006|NOT COMPLETED|Period 1: Part 1||3
11026872|NCT00830869|12205487|FG007|NOT COMPLETED|Period 1: Part 1||0
11180306|NCT01701258|12369156|FG010|Eligible After Screening Visit|Assessment and Scheduling||0
11180307|NCT01701258|12369157|FG011|Eligible After Screening Visit|Assessment and Scheduling||0
11180308|NCT01701258|12369158|FG012|Eligible After Screening Visit|Assessment and Scheduling||0
11180309|NCT01701258|12369146|FG000|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
11180310|NCT01701258|12369147|FG001|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
11180311|NCT01701258|12369148|FG002|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
11180312|NCT01701258|12369149|FG003|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
11180313|NCT01701258|12369150|FG004|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
11180314|NCT01701258|12369151|FG005|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
11180315|NCT01701258|12369152|FG006|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
11180316|NCT01701258|12369153|FG007|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
11180317|NCT01701258|12369154|FG008|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
11180318|NCT01701258|12369155|FG009|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
11180319|NCT01701258|12369156|FG010|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
11180320|NCT01701258|12369157|FG011|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
11180321|NCT01701258|12369158|FG012|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
11180322|NCT01701258|12369146|FG000|Returned for PET (Session 3)|Assessment and Scheduling||73
11180323|NCT01701258|12369147|FG001|Returned for PET (Session 3)|Assessment and Scheduling||0
11180324|NCT01701258|12369148|FG002|Returned for PET (Session 3)|Assessment and Scheduling||0
11180325|NCT01701258|12369149|FG003|Returned for PET (Session 3)|Assessment and Scheduling||0
11026873|NCT00830869|12205488|FG008|NOT COMPLETED|Period 1: Part 1||0
11026874|NCT00830869|12205489|FG009|NOT COMPLETED|Period 1: Part 1||0
11026875|NCT00830869|12205490|FG010|NOT COMPLETED|Period 1: Part 1||0
11026876|NCT00830869|12205491|FG011|NOT COMPLETED|Period 1: Part 1||0
11026877|NCT00830869|12205480|FG000|STARTED|Period 2: Part 2||0
11026878|NCT00830869|12205481|FG001|STARTED|Period 2: Part 2||0
11026879|NCT00830869|12205482|FG002|STARTED|Period 2: Part 2||0
11026880|NCT00830869|12205483|FG003|STARTED|Period 2: Part 2||0
11026881|NCT00830869|12205484|FG004|STARTED|Period 2: Part 2||0
11026882|NCT00830869|12205485|FG005|STARTED|Period 2: Part 2||0
11026883|NCT00830869|12205486|FG006|STARTED|Period 2: Part 2||0
11026884|NCT00830869|12205487|FG007|STARTED|Period 2: Part 2||20
11180326|NCT01701258|12369150|FG004|Returned for PET (Session 3)|Assessment and Scheduling||0
11180327|NCT01701258|12369151|FG005|Returned for PET (Session 3)|Assessment and Scheduling||0
11180328|NCT01701258|12369152|FG006|Returned for PET (Session 3)|Assessment and Scheduling||0
11180329|NCT01701258|12369153|FG007|Returned for PET (Session 3)|Assessment and Scheduling||0
11180330|NCT01701258|12369154|FG008|Returned for PET (Session 3)|Assessment and Scheduling||0
11180331|NCT01701258|12369155|FG009|Returned for PET (Session 3)|Assessment and Scheduling||0
11180332|NCT01701258|12369156|FG010|Returned for PET (Session 3)|Assessment and Scheduling||0
11026885|NCT00830869|12205488|FG008|STARTED|Period 2: Part 2||22
11026886|NCT00830869|12205489|FG009|STARTED|Period 2: Part 2||20
11180333|NCT01701258|12369157|FG011|Returned for PET (Session 3)|Assessment and Scheduling||0
11180334|NCT01701258|12369158|FG012|Returned for PET (Session 3)|Assessment and Scheduling||0
11180335|NCT01701258|12369146|FG000|Returned for EEG (Session 4)|Assessment and Scheduling||66
11180336|NCT01701258|12369147|FG001|Returned for EEG (Session 4)|Assessment and Scheduling||0
11180337|NCT01701258|12369148|FG002|Returned for EEG (Session 4)|Assessment and Scheduling||0
11180338|NCT01701258|12369149|FG003|Returned for EEG (Session 4)|Assessment and Scheduling||0
11180339|NCT01701258|12369150|FG004|Returned for EEG (Session 4)|Assessment and Scheduling||0
11180340|NCT01701258|12369151|FG005|Returned for EEG (Session 4)|Assessment and Scheduling||0
11180341|NCT01701258|12369152|FG006|Returned for EEG (Session 4)|Assessment and Scheduling||0
11180342|NCT01701258|12369153|FG007|Returned for EEG (Session 4)|Assessment and Scheduling||0
11180343|NCT01701258|12369154|FG008|Returned for EEG (Session 4)|Assessment and Scheduling||0
11180344|NCT01701258|12369155|FG009|Returned for EEG (Session 4)|Assessment and Scheduling||0
11180345|NCT01701258|12369156|FG010|Returned for EEG (Session 4)|Assessment and Scheduling||0
11180346|NCT01701258|12369157|FG011|Returned for EEG (Session 4)|Assessment and Scheduling||0
11180347|NCT01701258|12369158|FG012|Returned for EEG (Session 4)|Assessment and Scheduling||0
11180348|NCT01701258|12369146|FG000|COMPLETED|Assessment and Scheduling||70
11180349|NCT01701258|12369147|FG001|COMPLETED|Assessment and Scheduling||0
11180350|NCT01701258|12369148|FG002|COMPLETED|Assessment and Scheduling||0
11180351|NCT01701258|12369149|FG003|COMPLETED|Assessment and Scheduling||0
11180352|NCT01701258|12369150|FG004|COMPLETED|Assessment and Scheduling||0
11180353|NCT01701258|12369151|FG005|COMPLETED|Assessment and Scheduling||0
11180354|NCT01701258|12369152|FG006|COMPLETED|Assessment and Scheduling||0
11180355|NCT01701258|12369153|FG007|COMPLETED|Assessment and Scheduling||0
11180356|NCT01701258|12369154|FG008|COMPLETED|Assessment and Scheduling||0
11180357|NCT01701258|12369155|FG009|COMPLETED|Assessment and Scheduling||0
11180358|NCT01701258|12369156|FG010|COMPLETED|Assessment and Scheduling||0
11180359|NCT01701258|12369157|FG011|COMPLETED|Assessment and Scheduling||0
11180360|NCT01701258|12369158|FG012|COMPLETED|Assessment and Scheduling||0
11180361|NCT01701258|12369146|FG000|NOT COMPLETED|Assessment and Scheduling||83
11180362|NCT01701258|12369147|FG001|NOT COMPLETED|Assessment and Scheduling||0
11180363|NCT01701258|12369148|FG002|NOT COMPLETED|Assessment and Scheduling||0
11180364|NCT01701258|12369149|FG003|NOT COMPLETED|Assessment and Scheduling||0
11180365|NCT01701258|12369150|FG004|NOT COMPLETED|Assessment and Scheduling||0
11180366|NCT01701258|12369151|FG005|NOT COMPLETED|Assessment and Scheduling||0
11180367|NCT01701258|12369152|FG006|NOT COMPLETED|Assessment and Scheduling||0
11180368|NCT01701258|12369153|FG007|NOT COMPLETED|Assessment and Scheduling||0
11180369|NCT01701258|12369154|FG008|NOT COMPLETED|Assessment and Scheduling||0
11180370|NCT01701258|12369155|FG009|NOT COMPLETED|Assessment and Scheduling||0
11180371|NCT01701258|12369156|FG010|NOT COMPLETED|Assessment and Scheduling||0
11180372|NCT01701258|12369157|FG011|NOT COMPLETED|Assessment and Scheduling||0
11180373|NCT01701258|12369158|FG012|NOT COMPLETED|Assessment and Scheduling||0
11180374|NCT01701258|12369146|FG000|STARTED|Drug+fMRI (Session 2)||0
11180375|NCT01701258|12369147|FG001|STARTED|Drug+fMRI (Session 2)||0
11180376|NCT01701258|12369148|FG002|STARTED|Drug+fMRI (Session 2)||11
11180377|NCT01701258|12369149|FG003|STARTED|Drug+fMRI (Session 2)||11
11180378|NCT01701258|12369150|FG004|STARTED|Drug+fMRI (Session 2)||0
11180379|NCT01701258|12369151|FG005|STARTED|Drug+fMRI (Session 2)||9
11180380|NCT01701258|12369152|FG006|STARTED|Drug+fMRI (Session 2)||8
11180381|NCT01701258|12369153|FG007|STARTED|Drug+fMRI (Session 2)||0
11180382|NCT01701258|12369154|FG008|STARTED|Drug+fMRI (Session 2)||6
11180383|NCT01701258|12369155|FG009|STARTED|Drug+fMRI (Session 2)||6
11180384|NCT01701258|12369156|FG010|STARTED|Drug+fMRI (Session 2)||0
11180385|NCT01701258|12369157|FG011|STARTED|Drug+fMRI (Session 2)||10
11180386|NCT01701258|12369158|FG012|STARTED|Drug+fMRI (Session 2)||7
11180387|NCT01701258|12369146|FG000|Received Drug Challenge|Drug+fMRI (Session 2)||0
11180388|NCT01701258|12369147|FG001|Received Drug Challenge|Drug+fMRI (Session 2)||0
11180389|NCT01701258|12369148|FG002|Received Drug Challenge|Drug+fMRI (Session 2)||11
11180390|NCT01701258|12369149|FG003|Received Drug Challenge|Drug+fMRI (Session 2)||11
11180391|NCT01701258|12369150|FG004|Received Drug Challenge|Drug+fMRI (Session 2)||0
11180392|NCT01701258|12369151|FG005|Received Drug Challenge|Drug+fMRI (Session 2)||9
11180393|NCT01701258|12369152|FG006|Received Drug Challenge|Drug+fMRI (Session 2)||8
11180394|NCT01701258|12369153|FG007|Received Drug Challenge|Drug+fMRI (Session 2)||0
11180395|NCT01701258|12369154|FG008|Received Drug Challenge|Drug+fMRI (Session 2)||6
11180396|NCT01701258|12369155|FG009|Received Drug Challenge|Drug+fMRI (Session 2)||6
11180397|NCT01701258|12369156|FG010|Received Drug Challenge|Drug+fMRI (Session 2)||0
11180398|NCT01701258|12369157|FG011|Received Drug Challenge|Drug+fMRI (Session 2)||10
11180399|NCT01701258|12369158|FG012|Received Drug Challenge|Drug+fMRI (Session 2)||7
11180400|NCT01701258|12369146|FG000|COMPLETED|Drug+fMRI (Session 2)||0
11180401|NCT01701258|12369147|FG001|COMPLETED|Drug+fMRI (Session 2)||0
11180402|NCT01701258|12369148|FG002|COMPLETED|Drug+fMRI (Session 2)||11
11180403|NCT01701258|12369149|FG003|COMPLETED|Drug+fMRI (Session 2)||11
11180404|NCT01701258|12369150|FG004|COMPLETED|Drug+fMRI (Session 2)||0
11180405|NCT01701258|12369151|FG005|COMPLETED|Drug+fMRI (Session 2)||9
11180406|NCT01701258|12369152|FG006|COMPLETED|Drug+fMRI (Session 2)||8
11180407|NCT01701258|12369153|FG007|COMPLETED|Drug+fMRI (Session 2)||0
11180408|NCT01701258|12369154|FG008|COMPLETED|Drug+fMRI (Session 2)||6
11180409|NCT01701258|12369155|FG009|COMPLETED|Drug+fMRI (Session 2)||6
11180410|NCT01701258|12369156|FG010|COMPLETED|Drug+fMRI (Session 2)||0
11180411|NCT01701258|12369157|FG011|COMPLETED|Drug+fMRI (Session 2)||10
11180412|NCT01701258|12369158|FG012|COMPLETED|Drug+fMRI (Session 2)||7
11180413|NCT01701258|12369146|FG000|NOT COMPLETED|Drug+fMRI (Session 2)||0
11180414|NCT01701258|12369147|FG001|NOT COMPLETED|Drug+fMRI (Session 2)||0
11180415|NCT01701258|12369148|FG002|NOT COMPLETED|Drug+fMRI (Session 2)||0
11180416|NCT01701258|12369149|FG003|NOT COMPLETED|Drug+fMRI (Session 2)||0
11180417|NCT01701258|12369150|FG004|NOT COMPLETED|Drug+fMRI (Session 2)||0
11180418|NCT01701258|12369151|FG005|NOT COMPLETED|Drug+fMRI (Session 2)||0
11180419|NCT01701258|12369152|FG006|NOT COMPLETED|Drug+fMRI (Session 2)||0
11180420|NCT01701258|12369153|FG007|NOT COMPLETED|Drug+fMRI (Session 2)||0
11180421|NCT01701258|12369154|FG008|NOT COMPLETED|Drug+fMRI (Session 2)||0
11180422|NCT01701258|12369155|FG009|NOT COMPLETED|Drug+fMRI (Session 2)||0
11180423|NCT01701258|12369156|FG010|NOT COMPLETED|Drug+fMRI (Session 2)||0
11180424|NCT01701258|12369157|FG011|NOT COMPLETED|Drug+fMRI (Session 2)||0
11180425|NCT01701258|12369158|FG012|NOT COMPLETED|Drug+fMRI (Session 2)||0
11180426|NCT01701258|12369146|FG000|STARTED|PET (Session 3)||0
11180427|NCT01701258|12369147|FG001|STARTED|PET (Session 3)||20
11180428|NCT01701258|12369148|FG002|STARTED|PET (Session 3)||0
11180429|NCT01701258|12369149|FG003|STARTED|PET (Session 3)||0
11180430|NCT01701258|12369150|FG004|STARTED|PET (Session 3)||16
11180431|NCT01701258|12369151|FG005|STARTED|PET (Session 3)||0
11180432|NCT01701258|12369152|FG006|STARTED|PET (Session 3)||0
11180433|NCT01701258|12369153|FG007|STARTED|PET (Session 3)||19
11180434|NCT01701258|12369154|FG008|STARTED|PET (Session 3)||0
11180435|NCT01701258|12369155|FG009|STARTED|PET (Session 3)||0
11180436|NCT01701258|12369156|FG010|STARTED|PET (Session 3)||18
11180437|NCT01701258|12369157|FG011|STARTED|PET (Session 3)||0
11180438|NCT01701258|12369158|FG012|STARTED|PET (Session 3)||0
11180439|NCT01701258|12369146|FG000|COMPLETED|PET (Session 3)||0
11180440|NCT01701258|12369147|FG001|COMPLETED|PET (Session 3)||20
11180441|NCT01701258|12369148|FG002|COMPLETED|PET (Session 3)||0
11180442|NCT01701258|12369149|FG003|COMPLETED|PET (Session 3)||0
11180443|NCT01701258|12369150|FG004|COMPLETED|PET (Session 3)||16
11180444|NCT01701258|12369151|FG005|COMPLETED|PET (Session 3)||0
11180445|NCT01701258|12369152|FG006|COMPLETED|PET (Session 3)||0
11180446|NCT01701258|12369153|FG007|COMPLETED|PET (Session 3)||19
11180447|NCT01701258|12369154|FG008|COMPLETED|PET (Session 3)||0
11180448|NCT01701258|12369155|FG009|COMPLETED|PET (Session 3)||0
11180449|NCT01701258|12369156|FG010|COMPLETED|PET (Session 3)||18
11180450|NCT01701258|12369157|FG011|COMPLETED|PET (Session 3)||0
11180451|NCT01701258|12369158|FG012|COMPLETED|PET (Session 3)||0
11180452|NCT01701258|12369146|FG000|NOT COMPLETED|PET (Session 3)||0
11180453|NCT01701258|12369147|FG001|NOT COMPLETED|PET (Session 3)||0
11180454|NCT01701258|12369148|FG002|NOT COMPLETED|PET (Session 3)||0
11180455|NCT01701258|12369149|FG003|NOT COMPLETED|PET (Session 3)||0
11180456|NCT01701258|12369150|FG004|NOT COMPLETED|PET (Session 3)||0
11180457|NCT01701258|12369151|FG005|NOT COMPLETED|PET (Session 3)||0
11180458|NCT01701258|12369152|FG006|NOT COMPLETED|PET (Session 3)||0
11180459|NCT01701258|12369153|FG007|NOT COMPLETED|PET (Session 3)||0
11180460|NCT01701258|12369154|FG008|NOT COMPLETED|PET (Session 3)||0
11180461|NCT01701258|12369155|FG009|NOT COMPLETED|PET (Session 3)||0
11180462|NCT01701258|12369156|FG010|NOT COMPLETED|PET (Session 3)||0
11180463|NCT01701258|12369157|FG011|NOT COMPLETED|PET (Session 3)||0
11180464|NCT01701258|12369158|FG012|NOT COMPLETED|PET (Session 3)||0
11180465|NCT01701258|12369146|FG000|STARTED|EEG (Session 4)||0
11180466|NCT01701258|12369147|FG001|STARTED|EEG (Session 4)||19
11180467|NCT01701258|12369148|FG002|STARTED|EEG (Session 4)||0
11180468|NCT01701258|12369149|FG003|STARTED|EEG (Session 4)||0
11180469|NCT01701258|12369150|FG004|STARTED|EEG (Session 4)||14
11180470|NCT01701258|12369151|FG005|STARTED|EEG (Session 4)||0
11180471|NCT01701258|12369152|FG006|STARTED|EEG (Session 4)||0
11180472|NCT01701258|12369153|FG007|STARTED|EEG (Session 4)||16
11180473|NCT01701258|12369154|FG008|STARTED|EEG (Session 4)||0
11180474|NCT01701258|12369155|FG009|STARTED|EEG (Session 4)||0
11180475|NCT01701258|12369156|FG010|STARTED|EEG (Session 4)||17
11180476|NCT01701258|12369157|FG011|STARTED|EEG (Session 4)||0
11180477|NCT01701258|12369158|FG012|STARTED|EEG (Session 4)||0
11180478|NCT01701258|12369146|FG000|COMPLETED|EEG (Session 4)||0
11180479|NCT01701258|12369147|FG001|COMPLETED|EEG (Session 4)||19
11324115|NCT02742441|12521495|FG001|COMPLETED|Overall Study||196
11324116|NCT02742441|12521494|FG000|NOT COMPLETED|Overall Study||6
11324117|NCT02742441|12521495|FG001|NOT COMPLETED|Overall Study||8
11324118|NCT02742519|12521503|FG000|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
11324119|NCT02742519|12521504|FG001|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
11324120|NCT02742519|12521505|FG002|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
11324121|NCT02742519|12521503|FG000|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
11324122|NCT02742519|12521504|FG001|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
11324123|NCT02742519|12521505|FG002|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
11324124|NCT02742519|12521503|FG000|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
11324125|NCT02742519|12521504|FG001|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
11324126|NCT02742519|12521505|FG002|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
11324127|NCT02742519|12521503|FG000|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
11324128|NCT02742519|12521504|FG001|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
11324129|NCT02742519|12521505|FG002|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
11324130|NCT02742519|12521503|FG000|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
11324131|NCT02742519|12521504|FG001|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
11324132|NCT02742519|12521505|FG002|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
11324133|NCT02742519|12521503|FG000|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
11324134|NCT02742519|12521504|FG001|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
11324135|NCT02742519|12521505|FG002|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
11324136|NCT02742519|12521503|FG000|STARTED|Part 2 Open Label Period (32 Weeks)||0
11324137|NCT02742519|12521504|FG001|STARTED|Part 2 Open Label Period (32 Weeks)||0
11324138|NCT02742519|12521505|FG002|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
11324139|NCT02742519|12521503|FG000|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
11324140|NCT02742519|12521504|FG001|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
11324141|NCT02742519|12521505|FG002|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
11324142|NCT02742519|12521503|FG000|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
11324143|NCT02742519|12521504|FG001|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
11324144|NCT02742519|12521505|FG002|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
11324145|NCT02742532|12521515|FG000|STARTED|Overall Study||31
11324146|NCT02742532|12521516|FG001|STARTED|Overall Study||32
11324147|NCT02742532|12521515|FG000|COMPLETED|Overall Study||28
11324148|NCT02742532|12521516|FG001|COMPLETED|Overall Study||31
11324149|NCT02742532|12521515|FG000|NOT COMPLETED|Overall Study||3
11324150|NCT02742532|12521516|FG001|NOT COMPLETED|Overall Study||1
11324151|NCT02742649|12521525|FG000|STARTED|Pre-Randomization Washout Period||55
11324152|NCT02742649|12521526|FG001|STARTED|Pre-Randomization Washout Period||0
11324153|NCT02742649|12521527|FG002|STARTED|Pre-Randomization Washout Period||0
11324154|NCT02742649|12521528|FG003|STARTED|Pre-Randomization Washout Period||0
11324155|NCT02742649|12521529|FG004|STARTED|Pre-Randomization Washout Period||0
11324156|NCT02742649|12521525|FG000|COMPLETED|Pre-Randomization Washout Period||50
11324157|NCT02742649|12521526|FG001|COMPLETED|Pre-Randomization Washout Period||0
11180480|NCT01701258|12369148|FG002|COMPLETED|EEG (Session 4)||0
11180481|NCT01701258|12369149|FG003|COMPLETED|EEG (Session 4)||0
11180482|NCT01701258|12369150|FG004|COMPLETED|EEG (Session 4)||14
11180483|NCT01701258|12369151|FG005|COMPLETED|EEG (Session 4)||0
11180484|NCT01701258|12369152|FG006|COMPLETED|EEG (Session 4)||0
11180485|NCT01701258|12369153|FG007|COMPLETED|EEG (Session 4)||16
11180486|NCT01701258|12369154|FG008|COMPLETED|EEG (Session 4)||0
11180487|NCT01701258|12369155|FG009|COMPLETED|EEG (Session 4)||0
11180488|NCT01701258|12369156|FG010|COMPLETED|EEG (Session 4)||17
11180489|NCT01701258|12369157|FG011|COMPLETED|EEG (Session 4)||0
11180490|NCT01701258|12369158|FG012|COMPLETED|EEG (Session 4)||0
11180491|NCT01701258|12369146|FG000|NOT COMPLETED|EEG (Session 4)||0
11180492|NCT01701258|12369147|FG001|NOT COMPLETED|EEG (Session 4)||0
11180493|NCT01701258|12369148|FG002|NOT COMPLETED|EEG (Session 4)||0
11180494|NCT01701258|12369149|FG003|NOT COMPLETED|EEG (Session 4)||0
11180495|NCT01701258|12369150|FG004|NOT COMPLETED|EEG (Session 4)||0
11180496|NCT01701258|12369151|FG005|NOT COMPLETED|EEG (Session 4)||0
11180497|NCT01701258|12369152|FG006|NOT COMPLETED|EEG (Session 4)||0
11180498|NCT01701258|12369153|FG007|NOT COMPLETED|EEG (Session 4)||0
11180499|NCT01701258|12369154|FG008|NOT COMPLETED|EEG (Session 4)||0
11180500|NCT01701258|12369155|FG009|NOT COMPLETED|EEG (Session 4)||0
11180501|NCT01701258|12369156|FG010|NOT COMPLETED|EEG (Session 4)||0
11180502|NCT01701258|12369157|FG011|NOT COMPLETED|EEG (Session 4)||0
11180503|NCT01701258|12369158|FG012|NOT COMPLETED|EEG (Session 4)||0
11180504|NCT01701271|12369186|FG000|STARTED|Overall Study||20
11180505|NCT01701271|12369186|FG000|COMPLETED|Overall Study||20
11180506|NCT01701271|12369186|FG000|NOT COMPLETED|Overall Study||0
11180507|NCT01701362|12369193|FG000|STARTED|Overall Study||275
11180508|NCT01701362|12369194|FG001|STARTED|Overall Study||267
11180509|NCT01701362|12369193|FG000|TREATED|Overall Study||274
11180510|NCT01701362|12369194|FG001|TREATED|Overall Study||265
11180511|NCT01701362|12369193|FG000|COMPLETED|Overall Study||233
11180512|NCT01701362|12369194|FG001|COMPLETED|Overall Study||211
11180513|NCT01701362|12369193|FG000|NOT COMPLETED|Overall Study||42
11180514|NCT01701362|12369194|FG001|NOT COMPLETED|Overall Study||56
11180515|NCT01701375|12369200|FG000|STARTED|Overall Study||2
11180516|NCT01701375|12369200|FG000|COMPLETED|Overall Study||2
11180517|NCT01701375|12369200|FG000|NOT COMPLETED|Overall Study||0
11180518|NCT01701401|12369208|FG000|STARTED|Overall Study||217
11180519|NCT01701401|12369209|FG001|STARTED|Overall Study||218
11180520|NCT01701401|12369210|FG002|STARTED|Overall Study||217
11180521|NCT01701401|12369211|FG003|STARTED|Overall Study||218
11180522|NCT01701401|12369208|FG000|COMPLETED|Overall Study||207
11180523|NCT01701401|12369209|FG001|COMPLETED|Overall Study||209
11180524|NCT01701401|12369210|FG002|COMPLETED|Overall Study||212
11180525|NCT01701401|12369211|FG003|COMPLETED|Overall Study||212
11180526|NCT01701401|12369208|FG000|NOT COMPLETED|Overall Study||10
11180527|NCT01701401|12369209|FG001|NOT COMPLETED|Overall Study||9
11180528|NCT01701401|12369210|FG002|NOT COMPLETED|Overall Study||5
11180529|NCT01701401|12369211|FG003|NOT COMPLETED|Overall Study||6
11180530|NCT01701414|12369223|FG000|STARTED|Overall Study||19
11180531|NCT01701414|12369224|FG001|STARTED|Overall Study||19
11180532|NCT01701414|12369223|FG000|COMPLETED|Overall Study||18
11180533|NCT01701414|12369224|FG001|COMPLETED|Overall Study||18
11180534|NCT01701414|12369223|FG000|NOT COMPLETED|Overall Study||1
11180535|NCT01701414|12369224|FG001|NOT COMPLETED|Overall Study||1
11180536|NCT01701505|12369236|FG000|STARTED|Overall Study||8
11180537|NCT01701505|12369237|FG001|STARTED|Overall Study||8
11180538|NCT01701505|12369238|FG002|STARTED|Overall Study||8
11180539|NCT01701505|12369239|FG003|STARTED|Overall Study||8
11180540|NCT01701505|12369240|FG004|STARTED|Overall Study||8
11180541|NCT01701505|12369241|FG005|STARTED|Overall Study||8
11180542|NCT01701505|12369236|FG000|COMPLETED|Overall Study||8
11180543|NCT01701505|12369237|FG001|COMPLETED|Overall Study||8
11180544|NCT01701505|12369238|FG002|COMPLETED|Overall Study||8
11180545|NCT01701505|12369239|FG003|COMPLETED|Overall Study||8
11180546|NCT01701505|12369240|FG004|COMPLETED|Overall Study||8
11180547|NCT01701505|12369241|FG005|COMPLETED|Overall Study||8
11180548|NCT01701505|12369236|FG000|NOT COMPLETED|Overall Study||0
11180549|NCT01701505|12369237|FG001|NOT COMPLETED|Overall Study||0
11180550|NCT01701505|12369238|FG002|NOT COMPLETED|Overall Study||0
11180551|NCT01701505|12369239|FG003|NOT COMPLETED|Overall Study||0
11180552|NCT01701505|12369240|FG004|NOT COMPLETED|Overall Study||0
11180553|NCT01701505|12369241|FG005|NOT COMPLETED|Overall Study||0
11180554|NCT01701973|12369258|FG000|STARTED|Aim 1: First Intervention (1 Day)||23
11180555|NCT01701973|12369259|FG001|STARTED|Aim 1: First Intervention (1 Day)||21
11180556|NCT01701973|12369260|FG002|STARTED|Aim 1: First Intervention (1 Day)||0
11180557|NCT01701973|12369261|FG003|STARTED|Aim 1: First Intervention (1 Day)||0
11180558|NCT01701973|12369262|FG004|STARTED|Aim 1: First Intervention (1 Day)||0
11180559|NCT01701973|12369263|FG005|STARTED|Aim 1: First Intervention (1 Day)||0
11180560|NCT01701973|12369264|FG006|STARTED|Aim 1: First Intervention (1 Day)||0
11180561|NCT01701973|12369265|FG007|STARTED|Aim 1: First Intervention (1 Day)||0
11180562|NCT01701973|12369258|FG000|COMPLETED|Aim 1: First Intervention (1 Day)||23
11180563|NCT01701973|12369259|FG001|COMPLETED|Aim 1: First Intervention (1 Day)||20
11180564|NCT01701973|12369260|FG002|COMPLETED|Aim 1: First Intervention (1 Day)||0
11180565|NCT01701973|12369261|FG003|COMPLETED|Aim 1: First Intervention (1 Day)||0
11180566|NCT01701973|12369262|FG004|COMPLETED|Aim 1: First Intervention (1 Day)||0
11180567|NCT01701973|12369263|FG005|COMPLETED|Aim 1: First Intervention (1 Day)||0
11180568|NCT01701973|12369264|FG006|COMPLETED|Aim 1: First Intervention (1 Day)||0
11180569|NCT01701973|12369265|FG007|COMPLETED|Aim 1: First Intervention (1 Day)||0
11180570|NCT01701973|12369258|FG000|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
11180571|NCT01701973|12369259|FG001|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
11180572|NCT01701973|12369260|FG002|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
11180573|NCT01701973|12369261|FG003|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
11180574|NCT01701973|12369262|FG004|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
11180575|NCT01701973|12369263|FG005|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
11180576|NCT01701973|12369264|FG006|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
11180577|NCT01701973|12369265|FG007|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
11180578|NCT01701973|12369258|FG000|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
11180579|NCT01701973|12369259|FG001|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
11180580|NCT01701973|12369260|FG002|STARTED|Aim 1: Second Intervention (1 Day)||0
11180581|NCT01701973|12369261|FG003|STARTED|Aim 1: Second Intervention (1 Day)||0
11180582|NCT01701973|12369262|FG004|STARTED|Aim 1: Second Intervention (1 Day)||0
11180583|NCT01701973|12369263|FG005|STARTED|Aim 1: Second Intervention (1 Day)||0
11180584|NCT01701973|12369264|FG006|STARTED|Aim 1: Second Intervention (1 Day)||0
11180585|NCT01701973|12369265|FG007|STARTED|Aim 1: Second Intervention (1 Day)||0
11180586|NCT01701973|12369258|FG000|COMPLETED|Aim 1: Second Intervention (1 Day)||22
11180587|NCT01701973|12369259|FG001|COMPLETED|Aim 1: Second Intervention (1 Day)||17
11180588|NCT01701973|12369260|FG002|COMPLETED|Aim 1: Second Intervention (1 Day)||0
11180589|NCT01701973|12369261|FG003|COMPLETED|Aim 1: Second Intervention (1 Day)||0
11180590|NCT01701973|12369262|FG004|COMPLETED|Aim 1: Second Intervention (1 Day)||0
11180591|NCT01701973|12369263|FG005|COMPLETED|Aim 1: Second Intervention (1 Day)||0
11180592|NCT01701973|12369264|FG006|COMPLETED|Aim 1: Second Intervention (1 Day)||0
11180593|NCT01701973|12369265|FG007|COMPLETED|Aim 1: Second Intervention (1 Day)||0
11180594|NCT01701973|12369258|FG000|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
11180595|NCT01701973|12369259|FG001|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
11180596|NCT01701973|12369260|FG002|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
11180597|NCT01701973|12369261|FG003|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
11180598|NCT01701973|12369262|FG004|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
11180599|NCT01701973|12369263|FG005|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
11180600|NCT01701973|12369264|FG006|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
11180601|NCT01701973|12369265|FG007|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
11180602|NCT01701973|12369258|FG000|STARTED|Aim 2: First Intervention (1 Day)||0
11180603|NCT01701973|12369259|FG001|STARTED|Aim 2: First Intervention (1 Day)||0
11180604|NCT01701973|12369260|FG002|STARTED|Aim 2: First Intervention (1 Day)||5
11180605|NCT01701973|12369261|FG003|STARTED|Aim 2: First Intervention (1 Day)||4
11180606|NCT01701973|12369262|FG004|STARTED|Aim 2: First Intervention (1 Day)||2
11180607|NCT01701973|12369263|FG005|STARTED|Aim 2: First Intervention (1 Day)||3
11180608|NCT01701973|12369264|FG006|STARTED|Aim 2: First Intervention (1 Day)||5
11180609|NCT01701973|12369265|FG007|STARTED|Aim 2: First Intervention (1 Day)||4
11180610|NCT01701973|12369258|FG000|COMPLETED|Aim 2: First Intervention (1 Day)||0
11180611|NCT01701973|12369259|FG001|COMPLETED|Aim 2: First Intervention (1 Day)||0
11180612|NCT01701973|12369260|FG002|COMPLETED|Aim 2: First Intervention (1 Day)||5
11180613|NCT01701973|12369261|FG003|COMPLETED|Aim 2: First Intervention (1 Day)||4
11180614|NCT01701973|12369262|FG004|COMPLETED|Aim 2: First Intervention (1 Day)||2
11180615|NCT01701973|12369263|FG005|COMPLETED|Aim 2: First Intervention (1 Day)||3
11180616|NCT01701973|12369264|FG006|COMPLETED|Aim 2: First Intervention (1 Day)||5
11180617|NCT01701973|12369265|FG007|COMPLETED|Aim 2: First Intervention (1 Day)||4
11180618|NCT01701973|12369258|FG000|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
11180619|NCT01701973|12369259|FG001|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
11180620|NCT01701973|12369260|FG002|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
11180621|NCT01701973|12369261|FG003|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
11180622|NCT01701973|12369262|FG004|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
11180623|NCT01701973|12369263|FG005|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
11180624|NCT01701973|12369264|FG006|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
11180625|NCT01701973|12369265|FG007|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
11180626|NCT01701973|12369258|FG000|STARTED|Aim 2: Second Intervention (1 Day)||0
11180627|NCT01701973|12369259|FG001|STARTED|Aim 2: Second Intervention (1 Day)||0
11180628|NCT01701973|12369260|FG002|STARTED|Aim 2: Second Intervention (1 Day)||5
11180629|NCT01701973|12369261|FG003|STARTED|Aim 2: Second Intervention (1 Day)||4
11180630|NCT01701973|12369262|FG004|STARTED|Aim 2: Second Intervention (1 Day)||2
11180631|NCT01701973|12369263|FG005|STARTED|Aim 2: Second Intervention (1 Day)||3
11180632|NCT01701973|12369264|FG006|STARTED|Aim 2: Second Intervention (1 Day)||5
11180633|NCT01701973|12369265|FG007|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
11180634|NCT01701973|12369258|FG000|COMPLETED|Aim 2: Second Intervention (1 Day)||0
11180635|NCT01701973|12369259|FG001|COMPLETED|Aim 2: Second Intervention (1 Day)||0
11180636|NCT01701973|12369260|FG002|COMPLETED|Aim 2: Second Intervention (1 Day)||5
11180637|NCT01701973|12369261|FG003|COMPLETED|Aim 2: Second Intervention (1 Day)||4
11180638|NCT01701973|12369262|FG004|COMPLETED|Aim 2: Second Intervention (1 Day)||2
11180639|NCT01701973|12369263|FG005|COMPLETED|Aim 2: Second Intervention (1 Day)||3
11180640|NCT01701973|12369264|FG006|COMPLETED|Aim 2: Second Intervention (1 Day)||5
11180641|NCT01701973|12369265|FG007|COMPLETED|Aim 2: Second Intervention (1 Day)||3
11180642|NCT01701973|12369258|FG000|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
11180643|NCT01701973|12369259|FG001|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
11180644|NCT01701973|12369260|FG002|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
11180645|NCT01701973|12369261|FG003|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
11180646|NCT01701973|12369262|FG004|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
11180647|NCT01701973|12369263|FG005|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
11180648|NCT01701973|12369264|FG006|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
11180649|NCT01701973|12369265|FG007|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
11180650|NCT01701999|12369307|FG000|STARTED|Overall Study||8
11180651|NCT01701999|12369308|FG001|STARTED|Overall Study||37
11180652|NCT01701999|12369307|FG000|COMPLETED|Overall Study||8
11180653|NCT01701999|12369308|FG001|COMPLETED|Overall Study||37
11180654|NCT01701999|12369307|FG000|NOT COMPLETED|Overall Study||0
11180655|NCT01701999|12369308|FG001|NOT COMPLETED|Overall Study||0
11180656|NCT01702025|12369318|FG000|STARTED|Overall Study||11
11180657|NCT01702025|12369319|FG001|STARTED|Overall Study||10
11180658|NCT01702025|12369320|FG002|STARTED|Overall Study||10
11180659|NCT01702025|12369321|FG003|STARTED|Overall Study||10
11180660|NCT01702025|12369318|FG000|COMPLETED|Overall Study||9
11180661|NCT01702025|12369319|FG001|COMPLETED|Overall Study||9
11180662|NCT01702025|12369320|FG002|COMPLETED|Overall Study||9
11180663|NCT01702025|12369321|FG003|COMPLETED|Overall Study||10
11180664|NCT01702025|12369318|FG000|NOT COMPLETED|Overall Study||2
11180665|NCT01702025|12369319|FG001|NOT COMPLETED|Overall Study||1
11180666|NCT01702025|12369320|FG002|NOT COMPLETED|Overall Study||1
11180667|NCT01702025|12369321|FG003|NOT COMPLETED|Overall Study||0
11180668|NCT01702233|12369338|FG000|STARTED|Overall Study||72
11180669|NCT01702233|12369339|FG001|STARTED|Overall Study||67
11180670|NCT01702233|12369340|FG002|STARTED|Overall Study||36
11180671|NCT01702233|12369338|FG000|Full Analysis Set (ITT)|Overall Study||66
11180672|NCT01702233|12369339|FG001|Full Analysis Set (ITT)|Overall Study||63
11180673|NCT01702233|12369340|FG002|Full Analysis Set (ITT)|Overall Study||31
11180674|NCT01702233|12369338|FG000|Per Protocol Set|Overall Study||58
11180675|NCT01702233|12369339|FG001|Per Protocol Set|Overall Study||58
11180676|NCT01702233|12369340|FG002|Per Protocol Set|Overall Study||27
11180677|NCT01702233|12369338|FG000|COMPLETED|Overall Study||66
11180678|NCT01702233|12369339|FG001|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
11180679|NCT01702233|12369340|FG002|COMPLETED|Overall Study||31
11180680|NCT01702233|12369338|FG000|NOT COMPLETED|Overall Study||6
11180681|NCT01702233|12369339|FG001|NOT COMPLETED|Overall Study||3
11180682|NCT01702233|12369340|FG002|NOT COMPLETED|Overall Study||5
11180683|NCT01702246|12369349|FG000|STARTED|Overall Study||24
11180684|NCT01702246|12369349|FG000|COMPLETED|Overall Study||19
11180685|NCT01702246|12369349|FG000|NOT COMPLETED|Overall Study||5
11180686|NCT01702259|12369358|FG000|STARTED|Overall Study||34
11180687|NCT01702259|12369359|FG001|STARTED|Overall Study||34
11180688|NCT01702259|12369358|FG000|COMPLETED|Overall Study||34
11180689|NCT01702259|12369359|FG001|COMPLETED|Overall Study||34
11180690|NCT01702259|12369358|FG000|NOT COMPLETED|Overall Study||0
11180691|NCT01702259|12369359|FG001|NOT COMPLETED|Overall Study||0
11180692|NCT01702298|12369365|FG000|STARTED|Overall Study||42
11180693|NCT01702298|12369365|FG000|COMPLETED|Overall Study||41
11180694|NCT01702298|12369365|FG000|NOT COMPLETED|Overall Study||1
11180695|NCT01702311|12369371|FG000|STARTED|Overall Study||122
11180696|NCT01702311|12369372|FG001|STARTED|Overall Study||113
11180697|NCT01702311|12369371|FG000|COMPLETED|Overall Study||106
11180698|NCT01702311|12369372|FG001|COMPLETED|Overall Study||100
11180699|NCT01702311|12369371|FG000|NOT COMPLETED|Overall Study||16
11180700|NCT01702311|12369372|FG001|NOT COMPLETED|Overall Study||13
11180701|NCT01702363|12369381|FG000|STARTED|Overall Study||131
11180702|NCT01702363|12369381|FG000|COMPLETED|Overall Study||111
11180703|NCT01702363|12369381|FG000|NOT COMPLETED|Overall Study||20
11180704|NCT01702428|12369390|FG000|STARTED|Overall Study||1239
11180705|NCT01702428|12369391|FG001|STARTED|Overall Study||1232
11180706|NCT01702428|12369392|FG002|STARTED|Overall Study||1243
11180707|NCT01702428|12369393|FG003|STARTED|Overall Study||1289
11180708|NCT01702428|12369390|FG000|COMPLETED|Overall Study||1175
11180709|NCT01702428|12369391|FG001|COMPLETED|Overall Study||1162
11180710|NCT01702428|12369392|FG002|COMPLETED|Overall Study||1190
11180711|NCT01702428|12369393|FG003|COMPLETED|Overall Study||1232
11180712|NCT01702428|12369390|FG000|NOT COMPLETED|Overall Study||64
11180713|NCT01702428|12369391|FG001|NOT COMPLETED|Overall Study||70
11180714|NCT01702428|12369392|FG002|NOT COMPLETED|Overall Study||53
11180715|NCT01702428|12369393|FG003|NOT COMPLETED|Overall Study||57
11180716|NCT01702454|12369412|FG000|STARTED|Overall Study||241
11180717|NCT01702454|12369413|FG001|STARTED|Overall Study||229
11180718|NCT01702454|12369412|FG000|COMPLETED|Overall Study||238
11180719|NCT01702454|12369413|FG001|COMPLETED|Overall Study||221
11180720|NCT01702454|12369412|FG000|NOT COMPLETED|Overall Study||3
11180721|NCT01702454|12369413|FG001|NOT COMPLETED|Overall Study||8
11180722|NCT01702519|12369424|FG000|STARTED|Period 1||20
11180723|NCT01702519|12369425|FG001|STARTED|Period 1||20
11180724|NCT01702519|12369424|FG000|COMPLETED|Period 1||20
11180725|NCT01702519|12369425|FG001|COMPLETED|Period 1||20
11180726|NCT01702519|12369424|FG000|NOT COMPLETED|Period 1||0
11180727|NCT01702519|12369425|FG001|NOT COMPLETED|Period 1||0
11180728|NCT01702519|12369424|FG000|STARTED|Washout Period||20
11180729|NCT01702519|12369425|FG001|STARTED|Washout Period||20
11180730|NCT01702519|12369424|FG000|COMPLETED|Washout Period||19
11180731|NCT01702519|12369425|FG001|COMPLETED|Washout Period||18
11180732|NCT01702519|12369424|FG000|NOT COMPLETED|Washout Period||1
11180733|NCT01702519|12369425|FG001|NOT COMPLETED|Washout Period||2
11324158|NCT02742649|12521527|FG002|COMPLETED|Pre-Randomization Washout Period||0
11180734|NCT01702519|12369424|FG000|STARTED|Period 2||19
11180735|NCT01702519|12369425|FG001|STARTED|Period 2||18
11180736|NCT01702519|12369424|FG000|COMPLETED|Period 2||19
11180737|NCT01702519|12369425|FG001|COMPLETED|Period 2||18
11180738|NCT01702519|12369424|FG000|NOT COMPLETED|Period 2||0
11180739|NCT01702519|12369425|FG001|NOT COMPLETED|Period 2||0
11180740|NCT01702532|12369437|FG000|STARTED|Overall Study||161
11180741|NCT01702532|12369438|FG001|STARTED|Overall Study||161
11180742|NCT01702532|12369437|FG000|Safety Population|Overall Study||161
11180743|NCT01702532|12369438|FG001|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
11180744|NCT01702532|12369437|FG000|COMPLETED|Overall Study||161
11180745|NCT01702532|12369438|FG001|COMPLETED|Overall Study||160
11180746|NCT01702532|12369437|FG000|NOT COMPLETED|Overall Study||0
11180747|NCT01702532|12369438|FG001|NOT COMPLETED|Overall Study||1
11180748|NCT01702558|12369450|FG000|STARTED|Overall Study||7
11180749|NCT01702558|12369451|FG001|STARTED|Overall Study||5
11180750|NCT01702558|12369452|FG002|STARTED|Overall Study||6
11180751|NCT01702558|12369453|FG003|STARTED|Overall Study||81
11180752|NCT01702558|12369454|FG004|STARTED|Overall Study||80
11180753|NCT01702558|12369450|FG000|COMPLETED|Overall Study||3
11180754|NCT01702558|12369451|FG001|COMPLETED|Overall Study||1
11180755|NCT01702558|12369452|FG002|COMPLETED|Overall Study||1
11180756|NCT01702558|12369453|FG003|COMPLETED|Overall Study||34
11180757|NCT01702558|12369454|FG004|COMPLETED|Overall Study||38
11180758|NCT01702558|12369450|FG000|NOT COMPLETED|Overall Study||4
11180759|NCT01702558|12369451|FG001|NOT COMPLETED|Overall Study||4
11180760|NCT01702558|12369452|FG002|NOT COMPLETED|Overall Study||5
11180761|NCT01702558|12369453|FG003|NOT COMPLETED|Overall Study||47
11180762|NCT01702558|12369454|FG004|NOT COMPLETED|Overall Study||42
11180763|NCT01702844|12369467|FG000|STARTED|Overall Study||42
11180764|NCT01702844|12369467|FG000|Disease Progression|Overall Study||23
11180765|NCT01702844|12369467|FG000|COMPLETED|Overall Study||23
11180766|NCT01702844|12369467|FG000|NOT COMPLETED|Overall Study||19
11180767|NCT01702961|12369471|FG000|STARTED|Overall Study||75
11180768|NCT01702961|12369471|FG000|COMPLETED|Overall Study||28
11180769|NCT01702961|12369471|FG000|NOT COMPLETED|Overall Study||47
11180770|NCT01702987|12369477|FG000|STARTED|Overall Study||10
11180771|NCT01702987|12369478|FG001|STARTED|Overall Study||12
11180772|NCT01702987|12369477|FG000|COMPLETED|Overall Study||9
11180773|NCT01702987|12369478|FG001|COMPLETED|Overall Study||12
11180774|NCT01702987|12369477|FG000|NOT COMPLETED|Overall Study||1
11180775|NCT01702987|12369478|FG001|NOT COMPLETED|Overall Study||0
11204098|NCT01852058|12394710|FG000|STARTED|Treatment Cycle 1, Occurred in Study 120||31
11204099|NCT01852058|12394711|FG001|STARTED|Treatment Cycle 1, Occurred in Study 120||39
11204100|NCT01852058|12394712|FG002|STARTED|Treatment Cycle 1, Occurred in Study 120||25
11204101|NCT01852058|12394713|FG003|STARTED|Treatment Cycle 1, Occurred in Study 120||0
11204102|NCT01852058|12394714|FG004|STARTED|Treatment Cycle 1, Occurred in Study 120||0
11204103|NCT01852058|12394715|FG005|STARTED|Treatment Cycle 1, Occurred in Study 120||0
11204104|NCT01852058|12394716|FG006|STARTED|Treatment Cycle 1, Occurred in Study 120||0
11204105|NCT01852058|12394717|FG007|STARTED|Treatment Cycle 1, Occurred in Study 120||0
11204106|NCT01852058|12394718|FG008|STARTED|Treatment Cycle 1, Occurred in Study 120||0
11204107|NCT01852058|12394719|FG009|STARTED|Treatment Cycle 1, Occurred in Study 120||0
11204108|NCT01852058|12394720|FG010|STARTED|Treatment Cycle 1, Occurred in Study 120||0
11204109|NCT01852058|12394721|FG011|STARTED|Treatment Cycle 1, Occurred in Study 120||0
11204110|NCT01852058|12394710|FG000|COMPLETED|Treatment Cycle 1, Occurred in Study 120||30
11204111|NCT01852058|12394711|FG001|COMPLETED|Treatment Cycle 1, Occurred in Study 120||39
11204112|NCT01852058|12394712|FG002|COMPLETED|Treatment Cycle 1, Occurred in Study 120||25
11204113|NCT01852058|12394713|FG003|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204114|NCT01852058|12394714|FG004|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204115|NCT01852058|12394715|FG005|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204116|NCT01852058|12394716|FG006|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204117|NCT01852058|12394717|FG007|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204118|NCT01852058|12394718|FG008|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204119|NCT01852058|12394719|FG009|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204120|NCT01852058|12394720|FG010|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204121|NCT01852058|12394721|FG011|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204122|NCT01852058|12394710|FG000|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||1
11204123|NCT01852058|12394711|FG001|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204124|NCT01852058|12394712|FG002|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204125|NCT01852058|12394713|FG003|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204126|NCT01852058|12394714|FG004|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204127|NCT01852058|12394715|FG005|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204128|NCT01852058|12394716|FG006|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204129|NCT01852058|12394717|FG007|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204130|NCT01852058|12394718|FG008|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204131|NCT01852058|12394719|FG009|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204132|NCT01852058|12394720|FG010|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204133|NCT01852058|12394721|FG011|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
11204134|NCT01852058|12394710|FG000|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
11204135|NCT01852058|12394711|FG001|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
11204136|NCT01852058|12394712|FG002|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
11204137|NCT01852058|12394713|FG003|STARTED|Treatment Cycle2:Retreatment 1,Study 121||9
11204138|NCT01852058|12394714|FG004|STARTED|Treatment Cycle2:Retreatment 1,Study 121||45
11204139|NCT01852058|12394715|FG005|STARTED|Treatment Cycle2:Retreatment 1,Study 121||36
11204140|NCT01852058|12394716|FG006|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
11180776|NCT01703000|12369484|FG000|STARTED|Overall Study||100
11180777|NCT01703000|12369484|FG000|COMPLETED|Overall Study||99
11180778|NCT01703000|12369484|FG000|NOT COMPLETED|Overall Study||1
11180779|NCT01703039|12369490|FG000|STARTED|Overall Study||9
11180780|NCT01703039|12369491|FG001|STARTED|Overall Study||12
11180781|NCT01703039|12369490|FG000|COMPLETED|Overall Study||6
11180782|NCT01703039|12369491|FG001|COMPLETED|Overall Study||7
11180783|NCT01703039|12369490|FG000|NOT COMPLETED|Overall Study||3
11180784|NCT01703039|12369491|FG001|NOT COMPLETED|Overall Study||5
11180785|NCT01703065|12369501|FG000|STARTED|Overall Study||9
11180786|NCT01703065|12369502|FG001|STARTED|Overall Study||0
11180787|NCT01703065|12369501|FG000|COMPLETED|Overall Study||8
11180788|NCT01703065|12369502|FG001|COMPLETED|Overall Study||0
11180789|NCT01703065|12369501|FG000|NOT COMPLETED|Overall Study||1
11180790|NCT01703065|12369502|FG001|NOT COMPLETED|Overall Study||0
11180791|NCT01703091|12369511|FG000|STARTED|Overall Study||98
11180792|NCT01703091|12369512|FG001|STARTED|Overall Study||99
11180793|NCT01703091|12369511|FG000|Received at Least One Dose of Study Drug|Overall Study||94
11180794|NCT01703091|12369512|FG001|Received at Least One Dose of Study Drug|Overall Study||98
11180795|NCT01703091|12369511|FG000|COMPLETED|Overall Study||89
11180796|NCT01703091|12369512|FG001|COMPLETED|Overall Study||95
11180797|NCT01703091|12369511|FG000|NOT COMPLETED|Overall Study||9
11180798|NCT01703091|12369512|FG001|NOT COMPLETED|Overall Study||4
11180799|NCT01703117|12369520|FG000|STARTED|Overall Study||26
11180800|NCT01703117|12369521|FG001|STARTED|Overall Study||24
11180801|NCT01703117|12369520|FG000|COMPLETED|Overall Study||22
11180802|NCT01703117|12369521|FG001|COMPLETED|Overall Study||20
11180803|NCT01703117|12369520|FG000|NOT COMPLETED|Overall Study||4
11180804|NCT01703117|12369521|FG001|NOT COMPLETED|Overall Study||4
11180805|NCT01703169|12369529|FG000|STARTED|Overall Study||13
11180806|NCT01703169|12369529|FG000|COMPLETED|Overall Study||13
11180807|NCT01703169|12369529|FG000|NOT COMPLETED|Overall Study||0
11180808|NCT01703208|12369535|FG000|STARTED|Overall Study||2100
11180809|NCT01703208|12369536|FG001|STARTED|Overall Study||2102
11180810|NCT01703208|12369535|FG000|Treated|Overall Study||2092
11180811|NCT01703208|12369536|FG001|Treated|Overall Study||2100
11180812|NCT01703208|12369535|FG000|COMPLETED|Overall Study||0
11180813|NCT01703208|12369536|FG001|COMPLETED|Overall Study||0
11180814|NCT01703208|12369535|FG000|NOT COMPLETED|Overall Study||2100
11180815|NCT01703208|12369536|FG001|NOT COMPLETED|Overall Study||2102
11180816|NCT01703221|12369545|FG000|STARTED|Phase A (Up to 24 Weeks)||166
11180817|NCT01703221|12369546|FG001|STARTED|Phase A (Up to 24 Weeks)||165
11180818|NCT01703221|12369547|FG002|STARTED|Phase A (Up to 24 Weeks)||83
11180819|NCT01703221|12369545|FG000|COMPLETED|Phase A (Up to 24 Weeks)||159
11180820|NCT01703221|12369546|FG001|COMPLETED|Phase A (Up to 24 Weeks)||161
11180821|NCT01703221|12369547|FG002|COMPLETED|Phase A (Up to 24 Weeks)||80
11180822|NCT01703221|12369545|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
11180823|NCT01703221|12369546|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
11180824|NCT01703221|12369547|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
11180825|NCT01703221|12369545|FG000|STARTED|Phase B - (Week 25 to 52)||159
11180826|NCT01703221|12369546|FG001|STARTED|Phase B - (Week 25 to 52)||161
11180827|NCT01703221|12369547|FG002|STARTED|Phase B - (Week 25 to 52)||80
11180828|NCT01703221|12369545|FG000|COMPLETED|Phase B - (Week 25 to 52)||143
11180829|NCT01703221|12369546|FG001|COMPLETED|Phase B - (Week 25 to 52)||147
11180830|NCT01703221|12369547|FG002|COMPLETED|Phase B - (Week 25 to 52)||75
11180831|NCT01703221|12369545|FG000|NOT COMPLETED|Phase B - (Week 25 to 52)||16
11180832|NCT01703221|12369546|FG001|NOT COMPLETED|Phase B - (Week 25 to 52)||14
11180833|NCT01703221|12369547|FG002|NOT COMPLETED|Phase B - (Week 25 to 52)||5
11180834|NCT01703260|12369564|FG000|STARTED|Overall Study||7
11180835|NCT01703260|12369565|FG001|STARTED|Overall Study||7
11180836|NCT01703260|12369566|FG002|STARTED|Overall Study||6
11180837|NCT01703260|12369564|FG000|COMPLETED|Overall Study||4
11180838|NCT01703260|12369565|FG001|COMPLETED|Overall Study||3
11180839|NCT01703260|12369566|FG002|COMPLETED|Overall Study||3
11180840|NCT01703260|12369564|FG000|NOT COMPLETED|Overall Study||3
11180841|NCT01703260|12369565|FG001|NOT COMPLETED|Overall Study||4
11180842|NCT01703260|12369566|FG002|NOT COMPLETED|Overall Study||3
11180843|NCT01703286|12369574|FG000|STARTED|Period 1 Including Washout||7
11180844|NCT01703286|12369575|FG001|STARTED|Period 1 Including Washout||7
11180845|NCT01703286|12369576|FG002|STARTED|Period 1 Including Washout||7
11180846|NCT01703286|12369577|FG003|STARTED|Period 1 Including Washout||7
11180847|NCT01703286|12369578|FG004|STARTED|Period 1 Including Washout||7
11180848|NCT01703286|12369579|FG005|STARTED|Period 1 Including Washout||7
11180849|NCT01703286|12369574|FG000|COMPLETED|Period 1 Including Washout||7
11180850|NCT01703286|12369575|FG001|COMPLETED|Period 1 Including Washout||7
11180851|NCT01703286|12369576|FG002|COMPLETED|Period 1 Including Washout||7
11180852|NCT01703286|12369577|FG003|COMPLETED|Period 1 Including Washout||6
11180853|NCT01703286|12369578|FG004|COMPLETED|Period 1 Including Washout||7
11180854|NCT01703286|12369579|FG005|COMPLETED|Period 1 Including Washout||6
11180855|NCT01703286|12369574|FG000|NOT COMPLETED|Period 1 Including Washout||0
11180856|NCT01703286|12369575|FG001|NOT COMPLETED|Period 1 Including Washout||0
11180857|NCT01703286|12369576|FG002|NOT COMPLETED|Period 1 Including Washout||0
11180858|NCT01703286|12369577|FG003|NOT COMPLETED|Period 1 Including Washout||1
11180859|NCT01703286|12369578|FG004|NOT COMPLETED|Period 1 Including Washout||0
11180860|NCT01703286|12369579|FG005|NOT COMPLETED|Period 1 Including Washout||1
11180861|NCT01703286|12369574|FG000|STARTED|Period 2 Including Washout||7
11180862|NCT01703286|12369575|FG001|STARTED|Period 2 Including Washout||7
11180863|NCT01703286|12369576|FG002|STARTED|Period 2 Including Washout||7
11180864|NCT01703286|12369577|FG003|STARTED|Period 2 Including Washout||6
11180865|NCT01703286|12369578|FG004|STARTED|Period 2 Including Washout||7
11180866|NCT01703286|12369579|FG005|STARTED|Period 2 Including Washout||6
11180867|NCT01703286|12369574|FG000|COMPLETED|Period 2 Including Washout||7
11180868|NCT01703286|12369575|FG001|COMPLETED|Period 2 Including Washout||7
11180869|NCT01703286|12369576|FG002|COMPLETED|Period 2 Including Washout||7
11180870|NCT01703286|12369577|FG003|COMPLETED|Period 2 Including Washout||5
11180871|NCT01703286|12369578|FG004|COMPLETED|Period 2 Including Washout||7
11180872|NCT01703286|12369579|FG005|COMPLETED|Period 2 Including Washout||6
11180873|NCT01703286|12369574|FG000|NOT COMPLETED|Period 2 Including Washout||0
11180874|NCT01703286|12369575|FG001|NOT COMPLETED|Period 2 Including Washout||0
11180875|NCT01703286|12369576|FG002|NOT COMPLETED|Period 2 Including Washout||0
11180876|NCT01703286|12369577|FG003|NOT COMPLETED|Period 2 Including Washout||1
11180877|NCT01703286|12369578|FG004|NOT COMPLETED|Period 2 Including Washout||0
11180878|NCT01703286|12369579|FG005|NOT COMPLETED|Period 2 Including Washout||0
11180879|NCT01703286|12369574|FG000|STARTED|Period 3 Including Washout||7
11180880|NCT01703286|12369575|FG001|STARTED|Period 3 Including Washout||7
11180881|NCT01703286|12369576|FG002|STARTED|Period 3 Including Washout||7
11180882|NCT01703286|12369577|FG003|STARTED|Period 3 Including Washout||5
11180883|NCT01703286|12369578|FG004|STARTED|Period 3 Including Washout||7
11180884|NCT01703286|12369579|FG005|STARTED|Period 3 Including Washout||6
11180885|NCT01703286|12369574|FG000|COMPLETED|Period 3 Including Washout||7
11180886|NCT01703286|12369575|FG001|COMPLETED|Period 3 Including Washout||7
11180887|NCT01703286|12369576|FG002|COMPLETED|Period 3 Including Washout||7
11180888|NCT01703286|12369577|FG003|COMPLETED|Period 3 Including Washout||5
11180889|NCT01703286|12369578|FG004|COMPLETED|Period 3 Including Washout||7
11180890|NCT01703286|12369579|FG005|COMPLETED|Period 3 Including Washout||6
11180891|NCT01703286|12369574|FG000|NOT COMPLETED|Period 3 Including Washout||0
11180892|NCT01703286|12369575|FG001|NOT COMPLETED|Period 3 Including Washout||0
11180893|NCT01703286|12369576|FG002|NOT COMPLETED|Period 3 Including Washout||0
11180894|NCT01703286|12369577|FG003|NOT COMPLETED|Period 3 Including Washout||0
11180895|NCT01703286|12369578|FG004|NOT COMPLETED|Period 3 Including Washout||0
11180896|NCT01703286|12369579|FG005|NOT COMPLETED|Period 3 Including Washout||0
11180897|NCT01703507|12369592|FG000|STARTED|Overall Study||6
11180898|NCT01703507|12369593|FG001|STARTED|Overall Study||11
11180899|NCT01703507|12369592|FG000|COMPLETED|Overall Study||5
11180900|NCT01703507|12369593|FG001|COMPLETED|Overall Study||11
11180901|NCT01703507|12369592|FG000|NOT COMPLETED|Overall Study||1
11180902|NCT01703507|12369593|FG001|NOT COMPLETED|Overall Study||0
11180903|NCT01703598|12369599|FG000|STARTED|Overall Study||69
11180904|NCT01703598|12369599|FG000|COMPLETED|Overall Study||69
11180905|NCT01703598|12369599|FG000|NOT COMPLETED|Overall Study||0
11180906|NCT01703663|12369603|FG000|STARTED|First Treatment Period||20
11180907|NCT01703663|12369604|FG001|STARTED|First Treatment Period||20
11180908|NCT01703663|12369603|FG000|COMPLETED|First Treatment Period||20
11180909|NCT01703663|12369604|FG001|COMPLETED|First Treatment Period||20
11180910|NCT01703663|12369603|FG000|NOT COMPLETED|First Treatment Period||0
11180911|NCT01703663|12369604|FG001|NOT COMPLETED|First Treatment Period||0
11180912|NCT01703663|12369603|FG000|STARTED|Second Treatment Period||11
11180913|NCT01703663|12369604|FG001|STARTED|Second Treatment Period||8
11180914|NCT01703663|12369603|FG000|COMPLETED|Second Treatment Period||11
11180915|NCT01703663|12369604|FG001|COMPLETED|Second Treatment Period||8
11180916|NCT01703663|12369603|FG000|NOT COMPLETED|Second Treatment Period||0
11180917|NCT01703663|12369604|FG001|NOT COMPLETED|Second Treatment Period||0
11180918|NCT01703702|12369612|FG000|STARTED|Overall Study||308
11180919|NCT01703702|12369613|FG001|STARTED|Overall Study||310
11180920|NCT01703702|12369612|FG000|COMPLETED|Overall Study||272
11180921|NCT01703702|12369613|FG001|COMPLETED|Overall Study||288
11180922|NCT01703702|12369612|FG000|NOT COMPLETED|Overall Study||36
11180923|NCT01703702|12369613|FG001|NOT COMPLETED|Overall Study||22
11180924|NCT01703741|12369624|FG000|STARTED|Overall Study||145
11180925|NCT01703741|12369624|FG000|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
11180926|NCT01703741|12369624|FG000|COMPLETED|Overall Study||127
11180927|NCT01703741|12369624|FG000|NOT COMPLETED|Overall Study||18
11180928|NCT01703819|12369630|FG000|STARTED|Overall Study||34
11180929|NCT01703819|12369631|FG001|STARTED|Overall Study||32
11180930|NCT01703819|12369630|FG000|COMPLETED|Overall Study||34
11180931|NCT01703819|12369631|FG001|COMPLETED|Overall Study||30
11180932|NCT01703819|12369630|FG000|NOT COMPLETED|Overall Study||0
11180933|NCT01703819|12369631|FG001|NOT COMPLETED|Overall Study||2
11180934|NCT01703832|12369639|FG000|STARTED|Overall Study||33
11180935|NCT01703832|12369640|FG001|STARTED|Overall Study||32
11180936|NCT01703832|12369639|FG000|COMPLETED|Overall Study||32
11180937|NCT01703832|12369640|FG001|COMPLETED|Overall Study||32
11180938|NCT01703832|12369639|FG000|NOT COMPLETED|Overall Study||1
11180939|NCT01703832|12369640|FG001|NOT COMPLETED|Overall Study||0
11180940|NCT01703845|12369648|FG000|STARTED|Overall Study|started are actually the randomized|16
11180941|NCT01703845|12369649|FG001|STARTED|Overall Study|started are actually the randomized|16
11180942|NCT01703845|12369648|FG000|COMPLETED|Overall Study||13
11180943|NCT01703845|12369649|FG001|COMPLETED|Overall Study||16
11180944|NCT01703845|12369648|FG000|NOT COMPLETED|Overall Study||3
11180945|NCT01703845|12369649|FG001|NOT COMPLETED|Overall Study||0
11180946|NCT01703858|12369660|FG000|STARTED|Overall Study||5
11180947|NCT01703858|12369661|FG001|STARTED|Overall Study||5
11180948|NCT01703858|12369662|FG002|STARTED|Overall Study||5
11180949|NCT01703858|12369660|FG000|COMPLETED|Overall Study||5
11180950|NCT01703858|12369661|FG001|COMPLETED|Overall Study||4
11180951|NCT01703858|12369662|FG002|COMPLETED|Overall Study||5
11180952|NCT01703858|12369660|FG000|NOT COMPLETED|Overall Study||0
11180953|NCT01703858|12369661|FG001|NOT COMPLETED|Overall Study||1
11180954|NCT01703858|12369662|FG002|NOT COMPLETED|Overall Study||0
11180955|NCT01703988|12369679|FG000|STARTED|Overall Study||8
11180956|NCT01703988|12369680|FG001|STARTED|Overall Study||8
11180957|NCT01703988|12369681|FG002|STARTED|Overall Study||9
11180958|NCT01703988|12369682|FG003|STARTED|Overall Study||9
11180959|NCT01703988|12369679|FG000|COMPLETED|Overall Study||8
11180960|NCT01703988|12369680|FG001|COMPLETED|Overall Study||8
11180961|NCT01703988|12369681|FG002|COMPLETED|Overall Study||9
11180962|NCT01703988|12369682|FG003|COMPLETED|Overall Study||8
11180963|NCT01703988|12369679|FG000|NOT COMPLETED|Overall Study||0
11180964|NCT01703988|12369680|FG001|NOT COMPLETED|Overall Study||0
11180965|NCT01703988|12369681|FG002|NOT COMPLETED|Overall Study||0
11180966|NCT01703988|12369682|FG003|NOT COMPLETED|Overall Study||1
11180967|NCT01704079|12369695|FG000|STARTED|Overall Study||72
11180968|NCT01704079|12369696|FG001|STARTED|Overall Study||144
11180969|NCT01704079|12369695|FG000|Entered Extension Study|Overall Study||53
11180970|NCT01704079|12369696|FG001|Entered Extension Study|Overall Study||102
11180971|NCT01704079|12369695|FG000|COMPLETED|Overall Study||58
11180972|NCT01704079|12369696|FG001|COMPLETED|Overall Study||121
11180973|NCT01704079|12369695|FG000|NOT COMPLETED|Overall Study||14
11180974|NCT01704079|12369696|FG001|NOT COMPLETED|Overall Study||23
11180975|NCT01704196|12369704|FG000|STARTED|Overall Study||90
11180976|NCT01704196|12369705|FG001|STARTED|Overall Study||89
11180977|NCT01704196|12369704|FG000|COMPLETED|Overall Study||71
11180978|NCT01704196|12369705|FG001|COMPLETED|Overall Study||65
11180979|NCT01704196|12369704|FG000|NOT COMPLETED|Overall Study||19
11180980|NCT01704196|12369705|FG001|NOT COMPLETED|Overall Study||24
11180981|NCT01704261|12369713|FG000|STARTED|Overall Study||154
11180982|NCT01704261|12369714|FG001|STARTED|Overall Study||153
11180983|NCT01704261|12369713|FG000|COMPLETED|Overall Study||141
11180984|NCT01704261|12369714|FG001|COMPLETED|Overall Study||138
11180985|NCT01704261|12369713|FG000|NOT COMPLETED|Overall Study||13
11180986|NCT01704261|12369714|FG001|NOT COMPLETED|Overall Study||15
11180987|NCT01704287|12369723|FG000|STARTED|Initial Treatment Period||180
11180988|NCT01704287|12369724|FG001|STARTED|Initial Treatment Period||181
11180989|NCT01704287|12369725|FG002|STARTED|Initial Treatment Period||179
11180990|NCT01704287|12369726|FG003|STARTED|Initial Treatment Period||0
11180991|NCT01704287|12369727|FG004|STARTED|Initial Treatment Period||0
11180992|NCT01704287|12369723|FG000|Treated|Initial Treatment Period||178
11180993|NCT01704287|12369724|FG001|Treated|Initial Treatment Period||179
11180994|NCT01704287|12369725|FG002|Treated|Initial Treatment Period||171
11180995|NCT01704287|12369726|FG003|Treated|Initial Treatment Period||0
11180996|NCT01704287|12369727|FG004|Treated|Initial Treatment Period||0
11180997|NCT01704287|12369723|FG000|COMPLETED|Initial Treatment Period||33
11180998|NCT01704287|12369724|FG001|COMPLETED|Initial Treatment Period||47
11180999|NCT01704287|12369725|FG002|COMPLETED|Initial Treatment Period||6
11181000|NCT01704287|12369726|FG003|COMPLETED|Initial Treatment Period||0
11181001|NCT01704287|12369727|FG004|COMPLETED|Initial Treatment Period||0
11181002|NCT01704287|12369723|FG000|NOT COMPLETED|Initial Treatment Period||147
11181003|NCT01704287|12369724|FG001|NOT COMPLETED|Initial Treatment Period||134
11181004|NCT01704287|12369725|FG002|NOT COMPLETED|Initial Treatment Period||173
11181005|NCT01704287|12369726|FG003|NOT COMPLETED|Initial Treatment Period||0
11181006|NCT01704287|12369727|FG004|NOT COMPLETED|Initial Treatment Period||0
11181007|NCT01704287|12369723|FG000|STARTED|Switch to Pembrolizumab Treatment Period||0
11181008|NCT01704287|12369724|FG001|STARTED|Switch to Pembrolizumab Treatment Period||0
11181009|NCT01704287|12369725|FG002|STARTED|Switch to Pembrolizumab Treatment Period||0
11181010|NCT01704287|12369726|FG003|STARTED|Switch to Pembrolizumab Treatment Period||53
11181011|NCT01704287|12369727|FG004|STARTED|Switch to Pembrolizumab Treatment Period||45
11181012|NCT01704287|12369723|FG000|COMPLETED|Switch to Pembrolizumab Treatment Period||0
11181013|NCT01704287|12369724|FG001|COMPLETED|Switch to Pembrolizumab Treatment Period||0
11181014|NCT01704287|12369725|FG002|COMPLETED|Switch to Pembrolizumab Treatment Period||0
11181015|NCT01704287|12369726|FG003|COMPLETED|Switch to Pembrolizumab Treatment Period||15
11181016|NCT01704287|12369727|FG004|COMPLETED|Switch to Pembrolizumab Treatment Period||7
11181017|NCT01704287|12369723|FG000|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
11181018|NCT01704287|12369724|FG001|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
11181019|NCT01704287|12369725|FG002|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
11181020|NCT01704287|12369726|FG003|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
11181021|NCT01704287|12369727|FG004|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
11181022|NCT01704456|12369748|FG000|STARTED|Overall Study||67
11181023|NCT01704456|12369749|FG001|STARTED|Overall Study||63
11181024|NCT01704456|12369748|FG000|COMPLETED|Overall Study||59
11181025|NCT01704456|12369749|FG001|COMPLETED|Overall Study||49
11181026|NCT01704456|12369748|FG000|NOT COMPLETED|Overall Study||8
11181027|NCT01704456|12369749|FG001|NOT COMPLETED|Overall Study||14
11181028|NCT01704495|12369759|FG000|STARTED|Subjects Randomized||162
11181029|NCT01704495|12369760|FG001|STARTED|Subjects Randomized||156
11181030|NCT01704495|12369761|FG002|STARTED|Subjects Randomized||160
11181031|NCT01704495|12369762|FG003|STARTED|Subjects Randomized||162
11181032|NCT01704495|12369759|FG000|COMPLETED|Subjects Randomized||140
11181033|NCT01704495|12369760|FG001|COMPLETED|Subjects Randomized||141
11181034|NCT01704495|12369761|FG002|COMPLETED|Subjects Randomized||144
11181035|NCT01704495|12369762|FG003|COMPLETED|Subjects Randomized||145
11181036|NCT01704495|12369759|FG000|NOT COMPLETED|Subjects Randomized||22
11181037|NCT01704495|12369760|FG001|NOT COMPLETED|Subjects Randomized||15
11181038|NCT01704495|12369761|FG002|NOT COMPLETED|Subjects Randomized||16
11181039|NCT01704495|12369762|FG003|NOT COMPLETED|Subjects Randomized||17
11181040|NCT01704495|12369759|FG000|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
11181041|NCT01704495|12369760|FG001|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
11181042|NCT01704495|12369761|FG002|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
11181043|NCT01704495|12369762|FG003|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
11181044|NCT01704495|12369759|FG000|COMPLETED|Optional Safety Extension||87
11181045|NCT01704495|12369760|FG001|COMPLETED|Optional Safety Extension||88
11181046|NCT01704495|12369761|FG002|COMPLETED|Optional Safety Extension||83
11181047|NCT01704495|12369762|FG003|COMPLETED|Optional Safety Extension||85
11181048|NCT01704495|12369759|FG000|NOT COMPLETED|Optional Safety Extension||29
11181049|NCT01704495|12369760|FG001|NOT COMPLETED|Optional Safety Extension||33
11181050|NCT01704495|12369761|FG002|NOT COMPLETED|Optional Safety Extension||31
11181051|NCT01704495|12369762|FG003|NOT COMPLETED|Optional Safety Extension||31
11181052|NCT01704521|12369774|FG000|STARTED|Overall Study||3
11181053|NCT01704521|12369775|FG001|STARTED|Overall Study||2
11181054|NCT01704521|12369774|FG000|COMPLETED|Overall Study||3
11181055|NCT01704521|12369775|FG001|COMPLETED|Overall Study||2
11181056|NCT01704521|12369774|FG000|NOT COMPLETED|Overall Study||0
11181057|NCT01704521|12369775|FG001|NOT COMPLETED|Overall Study||0
11181058|NCT01704599|12369781|FG000|STARTED|Overall Study|Study was started January 22, 2010|8
11181059|NCT01704599|12369781|FG000|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
11181060|NCT01704599|12369781|FG000|NOT COMPLETED|Overall Study||1
11181061|NCT01704651|12369810|FG000|STARTED|Overall Study||71
11181062|NCT01704651|12369811|FG001|STARTED|Overall Study||75
11181063|NCT01704651|12369810|FG000|COMPLETED|Overall Study||66
11181064|NCT01704651|12369811|FG001|COMPLETED|Overall Study||68
11181065|NCT01704651|12369810|FG000|NOT COMPLETED|Overall Study||5
11181066|NCT01704651|12369811|FG001|NOT COMPLETED|Overall Study||7
11181067|NCT01704755|12369819|FG000|STARTED|Overall Study||208
11181068|NCT01704755|12369820|FG001|STARTED|Overall Study||172
11181069|NCT01704755|12369819|FG000|Completed Study Drug|Overall Study||204
11181070|NCT01704755|12369820|FG001|Completed Study Drug|Overall Study||163
11181071|NCT01704755|12369819|FG000|COMPLETED|Overall Study||196
11181072|NCT01704755|12369820|FG001|COMPLETED|Overall Study||165
11181073|NCT01704755|12369819|FG000|NOT COMPLETED|Overall Study||12
11181074|NCT01704755|12369820|FG001|NOT COMPLETED|Overall Study||7
11181075|NCT01704781|12369831|FG000|STARTED|Overall Study||3
11181076|NCT01704781|12369832|FG001|STARTED|Overall Study||3
11181077|NCT01704781|12369833|FG002|STARTED|Overall Study||6
11181078|NCT01704781|12369834|FG003|STARTED|Overall Study||12
11181079|NCT01704781|12369835|FG004|STARTED|Overall Study||12
11181080|NCT01704781|12369831|FG000|COMPLETED|Overall Study||3
11181081|NCT01704781|12369832|FG001|COMPLETED|Overall Study||3
11181082|NCT01704781|12369833|FG002|COMPLETED|Overall Study||6
11181083|NCT01704781|12369834|FG003|COMPLETED|Overall Study||12
11181084|NCT01704781|12369835|FG004|COMPLETED|Overall Study||12
11181085|NCT01704781|12369831|FG000|NOT COMPLETED|Overall Study||0
11181086|NCT01704781|12369832|FG001|NOT COMPLETED|Overall Study||0
11181087|NCT01704781|12369833|FG002|NOT COMPLETED|Overall Study||0
11181088|NCT01704781|12369834|FG003|NOT COMPLETED|Overall Study||0
11181089|NCT01704781|12369835|FG004|NOT COMPLETED|Overall Study||0
11181090|NCT01704846|12369851|FG000|STARTED|Treatment Period 1||30
11181091|NCT01704846|12369852|FG001|STARTED|Treatment Period 1||30
11181092|NCT01704846|12369851|FG000|COMPLETED|Treatment Period 1||30
11181093|NCT01704846|12369852|FG001|COMPLETED|Treatment Period 1||30
11181094|NCT01704846|12369851|FG000|NOT COMPLETED|Treatment Period 1||0
11181095|NCT01704846|12369852|FG001|NOT COMPLETED|Treatment Period 1||0
11181096|NCT01704846|12369851|FG000|STARTED|Treatment Period 2||30
11181097|NCT01704846|12369852|FG001|STARTED|Treatment Period 2||30
11181098|NCT01704846|12369851|FG000|COMPLETED|Treatment Period 2||30
11181099|NCT01704846|12369852|FG001|COMPLETED|Treatment Period 2||29
11181100|NCT01704846|12369851|FG000|NOT COMPLETED|Treatment Period 2||0
11181101|NCT01704846|12369852|FG001|NOT COMPLETED|Treatment Period 2||1
11181102|NCT01704846|12369851|FG000|STARTED|Treatment Period 3||30
11181103|NCT01704846|12369852|FG001|STARTED|Treatment Period 3||29
11181104|NCT01704846|12369851|FG000|COMPLETED|Treatment Period 3||30
11181105|NCT01704846|12369852|FG001|COMPLETED|Treatment Period 3||29
11181106|NCT01704846|12369851|FG000|NOT COMPLETED|Treatment Period 3||0
11181107|NCT01704846|12369852|FG001|NOT COMPLETED|Treatment Period 3||0
11181108|NCT01704846|12369851|FG000|STARTED|Treatment Period 4||30
11181109|NCT01704846|12369852|FG001|STARTED|Treatment Period 4||29
11181110|NCT01704846|12369851|FG000|COMPLETED|Treatment Period 4||30
11181111|NCT01704846|12369852|FG001|COMPLETED|Treatment Period 4||29
11181112|NCT01704846|12369851|FG000|NOT COMPLETED|Treatment Period 4||0
11181113|NCT01704846|12369852|FG001|NOT COMPLETED|Treatment Period 4||0
11181114|NCT01704976|12369860|FG000|STARTED|Overall Study||14
11181115|NCT01704976|12369861|FG001|STARTED|Overall Study||13
11181116|NCT01704976|12369860|FG000|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
11181117|NCT01704976|12369861|FG001|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
11181118|NCT01704976|12369860|FG000|NOT COMPLETED|Overall Study||1
11181119|NCT01704976|12369861|FG001|NOT COMPLETED|Overall Study||2
11181120|NCT01705080|12369870|FG000|STARTED|Overall Study||147
11181121|NCT01705080|12369871|FG001|STARTED|Overall Study||101
11181122|NCT01705080|12369872|FG002|STARTED|Overall Study||28
11181123|NCT01705080|12369870|FG000|Renal Artery Ablation Procedure|Overall Study||147
11181124|NCT01705080|12369871|FG001|Renal Artery Ablation Procedure|Overall Study||101
11181125|NCT01705080|12369872|FG002|Renal Artery Ablation Procedure|Overall Study||28
11181126|NCT01705080|12369870|FG000|Discharge Following Renal Artery Ablation Procedure|Overall Study||147
11181127|NCT01705080|12369871|FG001|Discharge Following Renal Artery Ablation Procedure|Overall Study|Reason Not Completed: Withdrawal by Subject=1|100
11181128|NCT01705080|12369872|FG002|Discharge Following Renal Artery Ablation Procedure|Overall Study||28
11181129|NCT01705080|12369870|FG000|COMPLETED|Overall Study||72
11181130|NCT01705080|12369871|FG001|COMPLETED|Overall Study||49
11181131|NCT01705080|12369872|FG002|COMPLETED|Overall Study||12
11181132|NCT01705080|12369870|FG000|NOT COMPLETED|Overall Study||75
11181133|NCT01705080|12369871|FG001|NOT COMPLETED|Overall Study||52
11181134|NCT01705080|12369872|FG002|NOT COMPLETED|Overall Study||16
11181135|NCT01705145|12369880|FG000|STARTED|Part A||9
11181136|NCT01705145|12369880|FG000|COMPLETED|Part A||9
11181137|NCT01705145|12369880|FG000|NOT COMPLETED|Part A||0
11181138|NCT01705145|12369880|FG000|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
11181139|NCT01705145|12369880|FG000|COMPLETED|Part B||33
11181140|NCT01705145|12369880|FG000|NOT COMPLETED|Part B||1
11204141|NCT01852058|12394717|FG007|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
11204142|NCT01852058|12394718|FG008|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
11204143|NCT01852058|12394719|FG009|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
11204144|NCT01852058|12394720|FG010|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
11204145|NCT01852058|12394721|FG011|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
11204146|NCT01852058|12394710|FG000|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204147|NCT01852058|12394711|FG001|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204148|NCT01852058|12394712|FG002|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204149|NCT01852058|12394713|FG003|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||8
11204150|NCT01852058|12394714|FG004|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||38
11204151|NCT01852058|12394715|FG005|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||27
11204152|NCT01852058|12394716|FG006|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204153|NCT01852058|12394717|FG007|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204154|NCT01852058|12394718|FG008|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204155|NCT01852058|12394719|FG009|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204156|NCT01852058|12394720|FG010|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204157|NCT01852058|12394721|FG011|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204158|NCT01852058|12394710|FG000|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204159|NCT01852058|12394711|FG001|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204160|NCT01852058|12394712|FG002|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204161|NCT01852058|12394713|FG003|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||1
11204162|NCT01852058|12394714|FG004|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||7
11204163|NCT01852058|12394715|FG005|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||9
11204164|NCT01852058|12394716|FG006|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204165|NCT01852058|12394717|FG007|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204166|NCT01852058|12394718|FG008|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204167|NCT01852058|12394719|FG009|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204168|NCT01852058|12394720|FG010|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204169|NCT01852058|12394721|FG011|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
11204170|NCT01852058|12394710|FG000|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
11204171|NCT01852058|12394711|FG001|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
11204172|NCT01852058|12394712|FG002|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
11204173|NCT01852058|12394713|FG003|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
11204174|NCT01852058|12394714|FG004|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
11204175|NCT01852058|12394715|FG005|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
11204176|NCT01852058|12394716|FG006|STARTED|Treatment Cycle3:Retreatment 2,Study 121||5
11204177|NCT01852058|12394717|FG007|STARTED|Treatment Cycle3:Retreatment 2,Study 121||16
11204178|NCT01852058|12394718|FG008|STARTED|Treatment Cycle3:Retreatment 2,Study 121||34
11204179|NCT01852058|12394719|FG009|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
11204180|NCT01852058|12394720|FG010|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
11204181|NCT01852058|12394721|FG011|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
11204182|NCT01852058|12394710|FG000|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204183|NCT01852058|12394711|FG001|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11181141|NCT01705236|12369896|FG000|STARTED|Overall Study||87
11181142|NCT01705236|12369896|FG000|COMPLETED|Overall Study||60
11181143|NCT01705236|12369896|FG000|NOT COMPLETED|Overall Study||27
11181144|NCT01705288|12369902|FG000|STARTED|Overall Study||52
11181145|NCT01705288|12369903|FG001|STARTED|Overall Study||51
11181146|NCT01705288|12369902|FG000|COMPLETED|Overall Study||52
11181147|NCT01705288|12369903|FG001|COMPLETED|Overall Study||51
11181148|NCT01705288|12369902|FG000|NOT COMPLETED|Overall Study||0
11181149|NCT01705288|12369903|FG001|NOT COMPLETED|Overall Study||0
11181150|NCT01705496|12369909|FG000|STARTED|Overall Study||23
11181151|NCT01705496|12369909|FG000|COMPLETED|Overall Study||19
11181152|NCT01705496|12369909|FG000|NOT COMPLETED|Overall Study||4
11181153|NCT01705509|12369913|FG000|STARTED|Inclusion CPET||14
11181154|NCT01705509|12369913|FG000|COMPLETED|Inclusion CPET||7
11181155|NCT01705509|12369913|FG000|NOT COMPLETED|Inclusion CPET||7
11181156|NCT01705509|12369913|FG000|STARTED|CPET w/ Ranexa||7
11181157|NCT01705509|12369913|FG000|COMPLETED|CPET w/ Ranexa||5
11181158|NCT01705509|12369913|FG000|NOT COMPLETED|CPET w/ Ranexa||2
11181159|NCT01705574|12369919|FG000|STARTED|Double-Blind Phase||293
11181160|NCT01705574|12369920|FG001|STARTED|Double-Blind Phase||290
11181161|NCT01705574|12369921|FG002|STARTED|Double-Blind Phase||0
11181162|NCT01705574|12369922|FG003|STARTED|Double-Blind Phase||0
11181163|NCT01705574|12369919|FG000|COMPLETED|Double-Blind Phase||260
11181164|NCT01705574|12369920|FG001|COMPLETED|Double-Blind Phase||249
11181165|NCT01705574|12369921|FG002|COMPLETED|Double-Blind Phase||0
11181166|NCT01705574|12369922|FG003|COMPLETED|Double-Blind Phase||0
11181167|NCT01705574|12369919|FG000|NOT COMPLETED|Double-Blind Phase||33
11181168|NCT01705574|12369920|FG001|NOT COMPLETED|Double-Blind Phase||41
11181169|NCT01705574|12369921|FG002|NOT COMPLETED|Double-Blind Phase||0
11181170|NCT01705574|12369922|FG003|NOT COMPLETED|Double-Blind Phase||0
11181171|NCT01705574|12369919|FG000|STARTED|Open-Label Extension Phase||246
11181172|NCT01705574|12369920|FG001|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0
11181173|NCT01705574|12369921|FG002|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159
11181174|NCT01705574|12369922|FG003|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53
11181175|NCT01705574|12369919|FG000|COMPLETED|Open-Label Extension Phase||231
11181176|NCT01705574|12369920|FG001|COMPLETED|Open-Label Extension Phase||0
11181177|NCT01705574|12369921|FG002|COMPLETED|Open-Label Extension Phase||148
11181178|NCT01705574|12369922|FG003|COMPLETED|Open-Label Extension Phase||48
11181179|NCT01705574|12369919|FG000|NOT COMPLETED|Open-Label Extension Phase||15
11181180|NCT01705574|12369920|FG001|NOT COMPLETED|Open-Label Extension Phase||0
11181181|NCT01705574|12369921|FG002|NOT COMPLETED|Open-Label Extension Phase||11
11181182|NCT01705574|12369922|FG003|NOT COMPLETED|Open-Label Extension Phase||5
11181183|NCT01705587|12369940|FG000|STARTED|Overall Study||7
11181184|NCT01705587|12369941|FG001|STARTED|Overall Study||6
11181185|NCT01705587|12369940|FG000|COMPLETED|Overall Study||7
11181186|NCT01705587|12369941|FG001|COMPLETED|Overall Study||5
11181187|NCT01705587|12369940|FG000|NOT COMPLETED|Overall Study||0
11181188|NCT01705587|12369941|FG001|NOT COMPLETED|Overall Study||1
11181189|NCT01705652|12369949|FG000|STARTED|Overall Study||9
11181190|NCT01705652|12369950|FG001|STARTED|Overall Study||12
11181191|NCT01705652|12369949|FG000|COMPLETED|Overall Study||6
11181192|NCT01705652|12369950|FG001|COMPLETED|Overall Study||9
11181193|NCT01705652|12369949|FG000|NOT COMPLETED|Overall Study||3
11181194|NCT01705652|12369950|FG001|NOT COMPLETED|Overall Study||3
11181195|NCT01705691|12369958|FG000|STARTED|Overall Study||19
11181196|NCT01705691|12369959|FG001|STARTED|Overall Study||30
11181197|NCT01705691|12369958|FG000|COMPLETED|Overall Study||16
11181198|NCT01705691|12369959|FG001|COMPLETED|Overall Study||24
11181199|NCT01705691|12369958|FG000|NOT COMPLETED|Overall Study||3
11181200|NCT01705691|12369959|FG001|NOT COMPLETED|Overall Study||6
11181201|NCT01705717|12369967|FG000|STARTED|Overall Study||37
11181202|NCT01705717|12369968|FG001|STARTED|Overall Study||12
11181203|NCT01705717|12369967|FG000|COMPLETED|Overall Study||35
11181204|NCT01705717|12369968|FG001|COMPLETED|Overall Study||7
11181205|NCT01705717|12369967|FG000|NOT COMPLETED|Overall Study||2
11181206|NCT01705717|12369968|FG001|NOT COMPLETED|Overall Study||5
11181207|NCT01705730|12369973|FG000|STARTED|Overall Study|Participants who received study drug|68
11181208|NCT01705730|12369973|FG000|COMPLETED|Overall Study||59
11181209|NCT01705730|12369973|FG000|NOT COMPLETED|Overall Study||9
11181210|NCT01705964|12369979|FG000|STARTED|Overall Study||25
11181211|NCT01705964|12369980|FG001|STARTED|Overall Study||24
11181212|NCT01705964|12369979|FG000|COMPLETED|Overall Study||25
11181213|NCT01705964|12369980|FG001|COMPLETED|Overall Study||24
11181214|NCT01705964|12369979|FG000|NOT COMPLETED|Overall Study||0
11181215|NCT01705964|12369980|FG001|NOT COMPLETED|Overall Study||0
11181216|NCT01706003|12369988|FG000|STARTED|Overall Study||23
11181217|NCT01706003|12369989|FG001|STARTED|Overall Study||22
11181218|NCT01706003|12369988|FG000|COMPLETED|Overall Study||12
11181219|NCT01706003|12369989|FG001|COMPLETED|Overall Study||18
11181220|NCT01706003|12369988|FG000|NOT COMPLETED|Overall Study||11
11181221|NCT01706003|12369989|FG001|NOT COMPLETED|Overall Study||4
11181222|NCT01706081|12369997|FG000|STARTED|Overall Study||40
11181223|NCT01706081|12369998|FG001|STARTED|Overall Study||42
11181224|NCT01706081|12369997|FG000|COMPLETED|Overall Study||40
11181225|NCT01706081|12369998|FG001|COMPLETED|Overall Study||42
11181226|NCT01706081|12369997|FG000|NOT COMPLETED|Overall Study||0
11181227|NCT01706081|12369998|FG001|NOT COMPLETED|Overall Study||0
11181228|NCT01706146|12370004|FG000|STARTED|Overall Study||59
11181229|NCT01706146|12370004|FG000|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
11181230|NCT01706146|12370004|FG000|NOT COMPLETED|Overall Study||6
11181231|NCT01706159|12370010|FG000|STARTED|Overall Study||14
11181232|NCT01706159|12370011|FG001|STARTED|Overall Study||6
11181233|NCT01706159|12370010|FG000|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
11181234|NCT01706159|12370011|FG001|Exposed|Overall Study|One subject was not exposed to placebo.|5
11181235|NCT01706159|12370010|FG000|Completers (With Baron Score at Week 8)|Overall Study||6
11181236|NCT01706159|12370011|FG001|Completers (With Baron Score at Week 8)|Overall Study||3
11181237|NCT01706159|12370010|FG000|COMPLETED|Overall Study||6
11181238|NCT01706159|12370011|FG001|COMPLETED|Overall Study||4
11181239|NCT01706159|12370010|FG000|NOT COMPLETED|Overall Study||8
11181240|NCT01706159|12370011|FG001|NOT COMPLETED|Overall Study||2
11181241|NCT01706198|12370019|FG000|STARTED|Overall Study||2119
11181242|NCT01706198|12370020|FG001|STARTED|Overall Study||2114
11181243|NCT01706198|12370019|FG000|COMPLETED|Overall Study||1946
11181244|NCT01706198|12370020|FG001|COMPLETED|Overall Study||1920
11181245|NCT01706198|12370019|FG000|NOT COMPLETED|Overall Study||173
11181246|NCT01706198|12370020|FG001|NOT COMPLETED|Overall Study||194
11181247|NCT01706250|12370026|FG000|STARTED|Overall Study||20
11181248|NCT01706250|12370026|FG000|COMPLETED|Overall Study||18
11181249|NCT01706250|12370026|FG000|NOT COMPLETED|Overall Study||2
11181250|NCT01706263|12370035|FG000|STARTED|Overall Study||28
11181251|NCT01706263|12370035|FG000|COMPLETED|Overall Study||28
11181252|NCT01706263|12370035|FG000|NOT COMPLETED|Overall Study||0
11181253|NCT01706328|12370042|FG000|STARTED|2-week Run-in Period||993
11181254|NCT01706328|12370043|FG001|STARTED|2-week Run-in Period||0
11181255|NCT01706328|12370044|FG002|STARTED|2-week Run-in Period||0
11181256|NCT01706328|12370042|FG000|COMPLETED|2-week Run-in Period||828
11181257|NCT01706328|12370043|FG001|COMPLETED|2-week Run-in Period||0
11181258|NCT01706328|12370044|FG002|COMPLETED|2-week Run-in Period||0
11181259|NCT01706328|12370042|FG000|NOT COMPLETED|2-week Run-in Period||165
11181260|NCT01706328|12370043|FG001|NOT COMPLETED|2-week Run-in Period||0
11181261|NCT01706328|12370044|FG002|NOT COMPLETED|2-week Run-in Period||0
11181262|NCT01706328|12370042|FG000|STARTED|12-week Double-blind Treatment Period||0
11181263|NCT01706328|12370043|FG001|STARTED|12-week Double-blind Treatment Period||412
11181264|NCT01706328|12370044|FG002|STARTED|12-week Double-blind Treatment Period||416
11181265|NCT01706328|12370042|FG000|COMPLETED|12-week Double-blind Treatment Period||0
11181266|NCT01706328|12370043|FG001|COMPLETED|12-week Double-blind Treatment Period||366
11181267|NCT01706328|12370044|FG002|COMPLETED|12-week Double-blind Treatment Period||371
11181268|NCT01706328|12370042|FG000|NOT COMPLETED|12-week Double-blind Treatment Period||0
11181269|NCT01706328|12370043|FG001|NOT COMPLETED|12-week Double-blind Treatment Period||46
11181270|NCT01706328|12370044|FG002|NOT COMPLETED|12-week Double-blind Treatment Period||45
11181271|NCT01706458|12370052|FG000|STARTED|Overall Study||9
11181272|NCT01706458|12370053|FG001|STARTED|Overall Study||9
11181273|NCT01706458|12370052|FG000|COMPLETED|Overall Study||6
11181274|NCT01706458|12370053|FG001|COMPLETED|Overall Study||5
11181275|NCT01706458|12370052|FG000|NOT COMPLETED|Overall Study||3
11181276|NCT01706458|12370053|FG001|NOT COMPLETED|Overall Study||4
11181277|NCT01706497|12370059|FG000|STARTED|Overall Study||177
11181278|NCT01706497|12370059|FG000|COMPLETED|Overall Study||177
11181279|NCT01706497|12370059|FG000|NOT COMPLETED|Overall Study||0
11181280|NCT01706536|12370068|FG000|STARTED|Overall Study||57
11181281|NCT01706536|12370069|FG001|STARTED|Overall Study||55
11181282|NCT01706536|12370070|FG002|STARTED|Overall Study||54
11181283|NCT01706536|12370071|FG003|STARTED|Overall Study||57
11181284|NCT01706536|12370072|FG004|STARTED|Overall Study||59
11181285|NCT01706536|12370068|FG000|COMPLETED|Overall Study||53
11181286|NCT01706536|12370069|FG001|COMPLETED|Overall Study||51
11181287|NCT01706536|12370070|FG002|COMPLETED|Overall Study||49
11181288|NCT01706536|12370071|FG003|COMPLETED|Overall Study||53
11181289|NCT01706536|12370072|FG004|COMPLETED|Overall Study||57
11181290|NCT01706536|12370068|FG000|NOT COMPLETED|Overall Study||4
11181291|NCT01706536|12370069|FG001|NOT COMPLETED|Overall Study||4
11181292|NCT01706536|12370070|FG002|NOT COMPLETED|Overall Study||5
11181293|NCT01706536|12370071|FG003|NOT COMPLETED|Overall Study||4
11181294|NCT01706536|12370072|FG004|NOT COMPLETED|Overall Study||2
11181295|NCT01706549|12370085|FG000|STARTED|Overall Study||16
11181296|NCT01706549|12370085|FG000|COMPLETED|Overall Study||16
11181297|NCT01706549|12370085|FG000|NOT COMPLETED|Overall Study||0
11181298|NCT01706575|12370089|FG000|STARTED|Overall Study||76
11181299|NCT01706575|12370089|FG000|Treated|Overall Study||70
11181300|NCT01706575|12370089|FG000|COMPLETED|Overall Study||64
11181301|NCT01706575|12370089|FG000|NOT COMPLETED|Overall Study||12
11181302|NCT01706588|12370098|FG000|STARTED|Overall Study||15
11181303|NCT01706588|12370099|FG001|STARTED|Overall Study||15
11181304|NCT01706588|12370100|FG002|STARTED|Overall Study||15
11181305|NCT01706588|12370101|FG003|STARTED|Overall Study||14
11181306|NCT01706588|12370102|FG004|STARTED|Overall Study||16
11181307|NCT01706588|12370098|FG000|COMPLETED|Overall Study||15
11181308|NCT01706588|12370099|FG001|COMPLETED|Overall Study||15
11181309|NCT01706588|12370100|FG002|COMPLETED|Overall Study||15
11181310|NCT01706588|12370101|FG003|COMPLETED|Overall Study||14
11181311|NCT01706588|12370102|FG004|COMPLETED|Overall Study||16
11181312|NCT01706588|12370098|FG000|NOT COMPLETED|Overall Study||0
11181313|NCT01706588|12370099|FG001|NOT COMPLETED|Overall Study||0
11181314|NCT01706588|12370100|FG002|NOT COMPLETED|Overall Study||0
11181315|NCT01706588|12370101|FG003|NOT COMPLETED|Overall Study||0
11181316|NCT01706588|12370102|FG004|NOT COMPLETED|Overall Study||0
11181317|NCT01706666|12370117|FG000|STARTED|Overall Study||1
11181318|NCT01706666|12370118|FG001|STARTED|Overall Study||1
11181319|NCT01706666|12370119|FG002|STARTED|Overall Study||1
11181320|NCT01706666|12370117|FG000|COMPLETED|Overall Study||1
11181321|NCT01706666|12370118|FG001|COMPLETED|Overall Study||1
11181322|NCT01706666|12370119|FG002|COMPLETED|Overall Study||1
11181323|NCT01706666|12370117|FG000|NOT COMPLETED|Overall Study||0
11181324|NCT01706666|12370118|FG001|NOT COMPLETED|Overall Study||0
11181325|NCT01706666|12370119|FG002|NOT COMPLETED|Overall Study||0
11181326|NCT01706770|12370129|FG000|STARTED|Overall Study||33
11181327|NCT01706770|12370130|FG001|STARTED|Overall Study||17
11181328|NCT01706770|12370129|FG000|COMPLETED|Overall Study||31
11181329|NCT01706770|12370130|FG001|COMPLETED|Overall Study||17
11181330|NCT01706770|12370129|FG000|NOT COMPLETED|Overall Study||2
11181331|NCT01706770|12370130|FG001|NOT COMPLETED|Overall Study||0
11181332|NCT01706822|12370136|FG000|STARTED|Overall Study||8
11181333|NCT01706822|12370136|FG000|COMPLETED|Overall Study||8
11181334|NCT01706822|12370136|FG000|NOT COMPLETED|Overall Study||0
11181335|NCT01706926|12370144|FG000|STARTED|Overall Study||81
11181336|NCT01706926|12370145|FG001|STARTED|Overall Study||81
11181337|NCT01706926|12370146|FG002|STARTED|Overall Study||85
11181338|NCT01706926|12370147|FG003|STARTED|Overall Study||79
11181339|NCT01706926|12370144|FG000|COMPLETED|Overall Study||75
11181340|NCT01706926|12370145|FG001|COMPLETED|Overall Study||77
11181341|NCT01706926|12370146|FG002|COMPLETED|Overall Study||79
11181342|NCT01706926|12370147|FG003|COMPLETED|Overall Study||74
11181343|NCT01706926|12370144|FG000|NOT COMPLETED|Overall Study||6
11181344|NCT01706926|12370145|FG001|NOT COMPLETED|Overall Study||4
11181345|NCT01706926|12370146|FG002|NOT COMPLETED|Overall Study||6
11181346|NCT01706926|12370147|FG003|NOT COMPLETED|Overall Study||5
11181347|NCT01706952|12370160|FG000|STARTED|Overall Study||45
11181348|NCT01706952|12370160|FG000|COMPLETED|Overall Study||37
11181349|NCT01706952|12370160|FG000|NOT COMPLETED|Overall Study||8
11181350|NCT01706965|12370168|FG000|STARTED|Overall Study||14
11181351|NCT01706965|12370169|FG001|STARTED|Overall Study||13
11181352|NCT01706965|12370168|FG000|COMPLETED|Overall Study||13
11181353|NCT01706965|12370169|FG001|COMPLETED|Overall Study||12
11181354|NCT01706965|12370168|FG000|NOT COMPLETED|Overall Study||1
11181355|NCT01706965|12370169|FG001|NOT COMPLETED|Overall Study||1
11181356|NCT01706978|12370177|FG000|STARTED|Overall Study||47
11181357|NCT01706978|12370178|FG001|STARTED|Overall Study||41
11181358|NCT01706978|12370177|FG000|COMPLETED|Overall Study||38
11181359|NCT01706978|12370178|FG001|COMPLETED|Overall Study||35
11181360|NCT01706978|12370177|FG000|NOT COMPLETED|Overall Study||9
11181361|NCT01706978|12370178|FG001|NOT COMPLETED|Overall Study||6
11181362|NCT01707004|12370184|FG000|STARTED|Overall Study||20
11181363|NCT01707004|12370184|FG000|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17
11181364|NCT01707004|12370184|FG000|NOT COMPLETED|Overall Study||3
11181365|NCT01707030|12370191|FG000|STARTED|Overall Study||67
11181366|NCT01707030|12370192|FG001|STARTED|Overall Study||71
11181367|NCT01707030|12370191|FG000|COMPLETED|Overall Study||56
11181368|NCT01707030|12370192|FG001|COMPLETED|Overall Study||54
11181369|NCT01707030|12370191|FG000|NOT COMPLETED|Overall Study||11
11181370|NCT01707030|12370192|FG001|NOT COMPLETED|Overall Study||17
11181371|NCT01707043|12370204|FG000|STARTED|Overall Study||10
11181372|NCT01707043|12370205|FG001|STARTED|Overall Study||10
11181373|NCT01707043|12370204|FG000|COMPLETED|Overall Study||10
11181374|NCT01707043|12370205|FG001|COMPLETED|Overall Study||10
11181375|NCT01707043|12370204|FG000|NOT COMPLETED|Overall Study||0
11181376|NCT01707043|12370205|FG001|NOT COMPLETED|Overall Study||0
11181377|NCT01707095|12370213|FG000|STARTED|Overall Study||42
11181378|NCT01707095|12370214|FG001|STARTED|Overall Study||42
11181379|NCT01707095|12370213|FG000|COMPLETED|Overall Study||42
11181380|NCT01707095|12370214|FG001|COMPLETED|Overall Study||42
11181381|NCT01707095|12370213|FG000|NOT COMPLETED|Overall Study||0
11181382|NCT01707095|12370214|FG001|NOT COMPLETED|Overall Study||0
11181383|NCT01707108|12370220|FG000|STARTED|Overall Study||60
11181384|NCT01707108|12370220|FG000|1 Year|Overall Study||60
11181385|NCT01707108|12370220|FG000|COMPLETED|Overall Study||60
11181386|NCT01707108|12370220|FG000|NOT COMPLETED|Overall Study||0
11181387|NCT01707147|12370225|FG000|STARTED|Overall Study||3219
11181388|NCT01707147|12370225|FG000|COMPLETED|Overall Study||3119
11181389|NCT01707147|12370225|FG000|NOT COMPLETED|Overall Study||100
11181390|NCT01707225|12370229|FG000|STARTED|Overall Study||10
11181391|NCT01707225|12370229|FG000|COMPLETED|Overall Study||10
11181392|NCT01707225|12370229|FG000|NOT COMPLETED|Overall Study||0
11181393|NCT01707238|12370235|FG000|STARTED|Overall Study||48
11181394|NCT01707238|12370236|FG001|STARTED|Overall Study||52
11181395|NCT01707238|12370235|FG000|COMPLETED|Overall Study||48
11181396|NCT01707238|12370236|FG001|COMPLETED|Overall Study||52
11181397|NCT01707238|12370235|FG000|NOT COMPLETED|Overall Study||0
11181398|NCT01707238|12370236|FG001|NOT COMPLETED|Overall Study||0
11181399|NCT01707290|12370245|FG000|STARTED|Overall Study||121
11181400|NCT01707290|12370246|FG001|STARTED|Overall Study||4
11181401|NCT01707290|12370245|FG000|COMPLETED|Overall Study||35
11181402|NCT01707290|12370246|FG001|COMPLETED|Overall Study||3
11181403|NCT01707290|12370245|FG000|NOT COMPLETED|Overall Study||86
11181404|NCT01707290|12370246|FG001|NOT COMPLETED|Overall Study||1
11181405|NCT01707368|12370255|FG000|STARTED|Overall Study||561
11181406|NCT01707368|12370255|FG000|COMPLETED|Overall Study||393
11181407|NCT01707368|12370255|FG000|NOT COMPLETED|Overall Study||168
11181408|NCT01707381|12370259|FG000|STARTED|Period 1||12
11181409|NCT01707381|12370260|FG001|STARTED|Period 1||13
11181410|NCT01707381|12370259|FG000|COMPLETED|Period 1||10
11181411|NCT01707381|12370260|FG001|COMPLETED|Period 1||11
11181412|NCT01707381|12370259|FG000|NOT COMPLETED|Period 1||2
11181413|NCT01707381|12370260|FG001|NOT COMPLETED|Period 1||2
11181414|NCT01707381|12370259|FG000|STARTED|Period 2||10
11181415|NCT01707381|12370260|FG001|STARTED|Period 2||11
11181416|NCT01707381|12370259|FG000|COMPLETED|Period 2||10
11181417|NCT01707381|12370260|FG001|COMPLETED|Period 2||11
11181418|NCT01707381|12370259|FG000|NOT COMPLETED|Period 2||0
11181419|NCT01707381|12370260|FG001|NOT COMPLETED|Period 2||0
11181420|NCT01707420|12370268|FG000|STARTED|Overall Study||18
11181421|NCT01707420|12370269|FG001|STARTED|Overall Study||18
11181422|NCT01707420|12370268|FG000|COMPLETED|Overall Study||18
11181423|NCT01707420|12370269|FG001|COMPLETED|Overall Study||18
11181424|NCT01707420|12370268|FG000|NOT COMPLETED|Overall Study||0
11181425|NCT01707420|12370269|FG001|NOT COMPLETED|Overall Study||0
11181426|NCT01707472|12370280|FG000|STARTED|Overall Study||4
11181427|NCT01707472|12370281|FG001|STARTED|Overall Study||6
11181428|NCT01707472|12370282|FG002|STARTED|Overall Study||8
11181429|NCT01707472|12370280|FG000|COMPLETED|Overall Study||4
11181430|NCT01707472|12370281|FG001|COMPLETED|Overall Study||6
11181431|NCT01707472|12370282|FG002|COMPLETED|Overall Study||8
11181432|NCT01707472|12370280|FG000|NOT COMPLETED|Overall Study||0
11181433|NCT01707472|12370281|FG001|NOT COMPLETED|Overall Study||0
11181434|NCT01707472|12370282|FG002|NOT COMPLETED|Overall Study||0
11181435|NCT01707654|12370290|FG000|STARTED|Overall Study||9
11181436|NCT01707654|12370290|FG000|COMPLETED|Overall Study||9
11181437|NCT01707654|12370290|FG000|NOT COMPLETED|Overall Study||0
11181438|NCT01707667|12370296|FG000|STARTED|Period 1||7
11181439|NCT01707667|12370297|FG001|STARTED|Period 1||6
11181440|NCT01707667|12370296|FG000|COMPLETED|Period 1||6
11181441|NCT01707667|12370297|FG001|COMPLETED|Period 1||6
11181442|NCT01707667|12370296|FG000|NOT COMPLETED|Period 1||1
11181443|NCT01707667|12370297|FG001|NOT COMPLETED|Period 1||0
11181444|NCT01707667|12370296|FG000|STARTED|Period 2||6
11181445|NCT01707667|12370297|FG001|STARTED|Period 2||6
11181446|NCT01707667|12370296|FG000|COMPLETED|Period 2||6
11181447|NCT01707667|12370297|FG001|COMPLETED|Period 2||6
11181448|NCT01707667|12370296|FG000|NOT COMPLETED|Period 2||0
11181449|NCT01707667|12370297|FG001|NOT COMPLETED|Period 2||0
11181450|NCT01707693|12370305|FG000|STARTED|Overall Study Allocation||59
11181451|NCT01707693|12370306|FG001|STARTED|Overall Study Allocation||62
11181452|NCT01707693|12370305|FG000|COMPLETED|Overall Study Allocation||46
11181453|NCT01707693|12370306|FG001|COMPLETED|Overall Study Allocation||54
11181454|NCT01707693|12370305|FG000|NOT COMPLETED|Overall Study Allocation||13
11181455|NCT01707693|12370306|FG001|NOT COMPLETED|Overall Study Allocation||8
11181456|NCT01707693|12370305|FG000|STARTED|Time 3 Measures @ 6 Mth||46
11181457|NCT01707693|12370306|FG001|STARTED|Time 3 Measures @ 6 Mth||54
11181458|NCT01707693|12370305|FG000|COMPLETED|Time 3 Measures @ 6 Mth||46
11181459|NCT01707693|12370306|FG001|COMPLETED|Time 3 Measures @ 6 Mth||49
11181460|NCT01707693|12370305|FG000|NOT COMPLETED|Time 3 Measures @ 6 Mth||0
11181461|NCT01707693|12370306|FG001|NOT COMPLETED|Time 3 Measures @ 6 Mth||5
11181462|NCT01707992|12370316|FG000|STARTED|Placebo-Controlled Phase (24 Months)||740
11181463|NCT01707992|12370317|FG001|STARTED|Placebo-Controlled Phase (24 Months)||727
11181464|NCT01707992|12370318|FG002|STARTED|Placebo-Controlled Phase (24 Months)||732
11181465|NCT01707992|12370319|FG003|STARTED|Placebo-Controlled Phase (24 Months)||0
11181466|NCT01707992|12370320|FG004|STARTED|Placebo-Controlled Phase (24 Months)||0
11181467|NCT01707992|12370321|FG005|STARTED|Placebo-Controlled Phase (24 Months)||0
11181468|NCT01707992|12370316|FG000|COMPLETED|Placebo-Controlled Phase (24 Months)||596
11181469|NCT01707992|12370317|FG001|COMPLETED|Placebo-Controlled Phase (24 Months)||623
11181470|NCT01707992|12370318|FG002|COMPLETED|Placebo-Controlled Phase (24 Months)||532
11181471|NCT01707992|12370319|FG003|COMPLETED|Placebo-Controlled Phase (24 Months)||0
11181472|NCT01707992|12370320|FG004|COMPLETED|Placebo-Controlled Phase (24 Months)||0
11181473|NCT01707992|12370321|FG005|COMPLETED|Placebo-Controlled Phase (24 Months)||0
11181474|NCT01707992|12370316|FG000|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144
11181475|NCT01707992|12370317|FG001|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104
11181476|NCT01707992|12370318|FG002|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200
11181477|NCT01707992|12370319|FG003|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
11181478|NCT01707992|12370320|FG004|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
11181479|NCT01707992|12370321|FG005|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
11181480|NCT01707992|12370316|FG000|STARTED|Active Treatment Phase (24 Months)||0
11324159|NCT02742649|12521528|FG003|COMPLETED|Pre-Randomization Washout Period||0
11324160|NCT02742649|12521529|FG004|COMPLETED|Pre-Randomization Washout Period||0
11324161|NCT02742649|12521525|FG000|NOT COMPLETED|Pre-Randomization Washout Period||5
11324162|NCT02742649|12521526|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0
11324163|NCT02742649|12521527|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0
11324164|NCT02742649|12521528|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0
11324165|NCT02742649|12521529|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0
11324166|NCT02742649|12521525|FG000|STARTED|Double-Blind Treatment Period||0
11324167|NCT02742649|12521526|FG001|STARTED|Double-Blind Treatment Period||17
11324168|NCT02742649|12521527|FG002|STARTED|Double-Blind Treatment Period||17
11324169|NCT02742649|12521528|FG003|STARTED|Double-Blind Treatment Period||16
11324170|NCT02742649|12521529|FG004|STARTED|Double-Blind Treatment Period||0
11324171|NCT02742649|12521525|FG000|COMPLETED|Double-Blind Treatment Period||0
11324172|NCT02742649|12521526|FG001|COMPLETED|Double-Blind Treatment Period||16
11324173|NCT02742649|12521527|FG002|COMPLETED|Double-Blind Treatment Period||17
11324174|NCT02742649|12521528|FG003|COMPLETED|Double-Blind Treatment Period||16
11324175|NCT02742649|12521529|FG004|COMPLETED|Double-Blind Treatment Period||0
11324176|NCT02742649|12521525|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
11324177|NCT02742649|12521526|FG001|NOT COMPLETED|Double-Blind Treatment Period||1
11324178|NCT02742649|12521527|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
11324179|NCT02742649|12521528|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
11324180|NCT02742649|12521529|FG004|NOT COMPLETED|Double-Blind Treatment Period||0
11324181|NCT02742649|12521525|FG000|STARTED|Open-Label Period||0
11324182|NCT02742649|12521526|FG001|STARTED|Open-Label Period||0
11324183|NCT02742649|12521527|FG002|STARTED|Open-Label Period||0
11324184|NCT02742649|12521528|FG003|STARTED|Open-Label Period||0
11324185|NCT02742649|12521529|FG004|STARTED|Open-Label Period||49
11324186|NCT02742649|12521525|FG000|COMPLETED|Open-Label Period||0
11324187|NCT02742649|12521526|FG001|COMPLETED|Open-Label Period||0
11324188|NCT02742649|12521527|FG002|COMPLETED|Open-Label Period||0
11324189|NCT02742649|12521528|FG003|COMPLETED|Open-Label Period||0
11324190|NCT02742649|12521529|FG004|COMPLETED|Open-Label Period||48
11324191|NCT02742649|12521525|FG000|NOT COMPLETED|Open-Label Period||0
11324192|NCT02742649|12521526|FG001|NOT COMPLETED|Open-Label Period||0
11324193|NCT02742649|12521527|FG002|NOT COMPLETED|Open-Label Period||0
11324194|NCT02742649|12521528|FG003|NOT COMPLETED|Open-Label Period||0
11324195|NCT02742649|12521529|FG004|NOT COMPLETED|Open-Label Period||1
11324196|NCT02742766|12521559|FG000|STARTED|Part 1 (Up to 8 Days)||20
11324197|NCT02742766|12521560|FG001|STARTED|Part 1 (Up to 8 Days)||6
11324198|NCT02742766|12521561|FG002|STARTED|Part 1 (Up to 8 Days)||6
11324199|NCT02742766|12521562|FG003|STARTED|Part 1 (Up to 8 Days)||6
11324200|NCT02742766|12521563|FG004|STARTED|Part 1 (Up to 8 Days)||6
11324201|NCT02742766|12521564|FG005|STARTED|Part 1 (Up to 8 Days)||6
11324202|NCT02742766|12521565|FG006|STARTED|Part 1 (Up to 8 Days)||6
11324203|NCT02742766|12521566|FG007|STARTED|Part 1 (Up to 8 Days)||6
11324204|NCT02742766|12521567|FG008|STARTED|Part 1 (Up to 8 Days)||6
11324205|NCT02742766|12521568|FG009|STARTED|Part 1 (Up to 8 Days)||0
11324206|NCT02742766|12521569|FG010|STARTED|Part 1 (Up to 8 Days)||6
11324207|NCT02742766|12521570|FG011|STARTED|Part 1 (Up to 8 Days)||6
11324208|NCT02742766|12521571|FG012|STARTED|Part 1 (Up to 8 Days)||0
11324209|NCT02742766|12521572|FG013|STARTED|Part 1 (Up to 8 Days)||0
11324210|NCT02742766|12521573|FG014|STARTED|Part 1 (Up to 8 Days)||0
11324211|NCT02742766|12521574|FG015|STARTED|Part 1 (Up to 8 Days)||0
11324212|NCT02742766|12521575|FG016|STARTED|Part 1 (Up to 8 Days)||0
11324213|NCT02742766|12521576|FG017|STARTED|Part 1 (Up to 8 Days)||0
11324214|NCT02742766|12521577|FG018|STARTED|Part 1 (Up to 8 Days)||0
11324215|NCT02742766|12521559|FG000|COMPLETED|Part 1 (Up to 8 Days)||20
11324216|NCT02742766|12521560|FG001|COMPLETED|Part 1 (Up to 8 Days)||6
11324217|NCT02742766|12521561|FG002|COMPLETED|Part 1 (Up to 8 Days)||6
11324218|NCT02742766|12521562|FG003|COMPLETED|Part 1 (Up to 8 Days)||6
11324219|NCT02742766|12521563|FG004|COMPLETED|Part 1 (Up to 8 Days)||6
11324220|NCT02742766|12521564|FG005|COMPLETED|Part 1 (Up to 8 Days)||6
11324221|NCT02742766|12521565|FG006|COMPLETED|Part 1 (Up to 8 Days)||6
11324222|NCT02742766|12521566|FG007|COMPLETED|Part 1 (Up to 8 Days)||6
11324223|NCT02742766|12521567|FG008|COMPLETED|Part 1 (Up to 8 Days)||6
11324224|NCT02742766|12521568|FG009|COMPLETED|Part 1 (Up to 8 Days)||0
11324225|NCT02742766|12521569|FG010|COMPLETED|Part 1 (Up to 8 Days)||6
11324226|NCT02742766|12521570|FG011|COMPLETED|Part 1 (Up to 8 Days)||6
11324227|NCT02742766|12521571|FG012|COMPLETED|Part 1 (Up to 8 Days)||0
11324228|NCT02742766|12521572|FG013|COMPLETED|Part 1 (Up to 8 Days)||0
11181481|NCT01707992|12370317|FG001|STARTED|Active Treatment Phase (24 Months)||0
11181482|NCT01707992|12370318|FG002|STARTED|Active Treatment Phase (24 Months)||0
11181483|NCT01707992|12370319|FG003|STARTED|Active Treatment Phase (24 Months)||891
11181484|NCT01707992|12370320|FG004|STARTED|Active Treatment Phase (24 Months)||504
11181485|NCT01707992|12370321|FG005|STARTED|Active Treatment Phase (24 Months)||215
11181486|NCT01707992|12370316|FG000|COMPLETED|Active Treatment Phase (24 Months)||0
11181487|NCT01707992|12370317|FG001|COMPLETED|Active Treatment Phase (24 Months)||0
11181488|NCT01707992|12370318|FG002|COMPLETED|Active Treatment Phase (24 Months)||0
11181489|NCT01707992|12370319|FG003|COMPLETED|Active Treatment Phase (24 Months)||7
11181490|NCT01707992|12370320|FG004|COMPLETED|Active Treatment Phase (24 Months)||10
11181491|NCT01707992|12370321|FG005|COMPLETED|Active Treatment Phase (24 Months)||0
11181492|NCT01707992|12370316|FG000|NOT COMPLETED|Active Treatment Phase (24 Months)||0
11181493|NCT01707992|12370317|FG001|NOT COMPLETED|Active Treatment Phase (24 Months)||0
11181494|NCT01707992|12370318|FG002|NOT COMPLETED|Active Treatment Phase (24 Months)||0
11181495|NCT01707992|12370319|FG003|NOT COMPLETED|Active Treatment Phase (24 Months)||884
11181496|NCT01707992|12370320|FG004|NOT COMPLETED|Active Treatment Phase (24 Months)||494
11181497|NCT01707992|12370321|FG005|NOT COMPLETED|Active Treatment Phase (24 Months)||215
11181498|NCT01708122|12370338|FG000|STARTED|Overall Study||27
11181499|NCT01708122|12370339|FG001|STARTED|Overall Study||26
11181500|NCT01708122|12370338|FG000|COMPLETED|Overall Study||27
11181501|NCT01708122|12370339|FG001|COMPLETED|Overall Study||26
11181502|NCT01708122|12370338|FG000|NOT COMPLETED|Overall Study||0
11181503|NCT01708122|12370339|FG001|NOT COMPLETED|Overall Study||0
11181504|NCT01708161|12370351|FG000|STARTED|Overall Study||4
11181505|NCT01708161|12370352|FG001|STARTED|Overall Study||10
11181506|NCT01708161|12370353|FG002|STARTED|Overall Study||10
11181507|NCT01708161|12370354|FG003|STARTED|Overall Study||16
11181508|NCT01708161|12370355|FG004|STARTED|Overall Study||6
11181509|NCT01708161|12370356|FG005|STARTED|Overall Study||1
11181510|NCT01708161|12370351|FG000|COMPLETED|Overall Study||0
11181511|NCT01708161|12370352|FG001|COMPLETED|Overall Study||0
11181512|NCT01708161|12370353|FG002|COMPLETED|Overall Study||0
11181513|NCT01708161|12370354|FG003|COMPLETED|Overall Study||0
11181514|NCT01708161|12370355|FG004|COMPLETED|Overall Study||0
11181515|NCT01708161|12370356|FG005|COMPLETED|Overall Study||0
11181516|NCT01708161|12370351|FG000|NOT COMPLETED|Overall Study||4
11181517|NCT01708161|12370352|FG001|NOT COMPLETED|Overall Study||10
11181518|NCT01708161|12370353|FG002|NOT COMPLETED|Overall Study||10
11181519|NCT01708161|12370354|FG003|NOT COMPLETED|Overall Study||16
11181520|NCT01708161|12370355|FG004|NOT COMPLETED|Overall Study||6
11181521|NCT01708161|12370356|FG005|NOT COMPLETED|Overall Study||1
11181522|NCT01708174|12370373|FG000|STARTED|Treatment Period||2
11181523|NCT01708174|12370374|FG001|STARTED|Treatment Period||16
11181524|NCT01708174|12370375|FG002|STARTED|Treatment Period||4
11181525|NCT01708174|12370373|FG000|Pharmacokinetic Analysis Set|Treatment Period||2
11181526|NCT01708174|12370374|FG001|Pharmacokinetic Analysis Set|Treatment Period||13
11181527|NCT01708174|12370375|FG002|Pharmacokinetic Analysis Set|Treatment Period||0
11181528|NCT01708174|12370373|FG000|COMPLETED|Treatment Period||1
11181529|NCT01708174|12370374|FG001|COMPLETED|Treatment Period||14
11181530|NCT01708174|12370375|FG002|COMPLETED|Treatment Period||3
11181531|NCT01708174|12370373|FG000|NOT COMPLETED|Treatment Period||1
11181532|NCT01708174|12370374|FG001|NOT COMPLETED|Treatment Period||2
11181533|NCT01708174|12370375|FG002|NOT COMPLETED|Treatment Period||1
11181534|NCT01708174|12370373|FG000|STARTED|Survival Follow-up||1
11181535|NCT01708174|12370374|FG001|STARTED|Survival Follow-up||10
11181536|NCT01708174|12370375|FG002|STARTED|Survival Follow-up||0
11181537|NCT01708174|12370373|FG000|COMPLETED|Survival Follow-up||1
11181538|NCT01708174|12370374|FG001|COMPLETED|Survival Follow-up||10
11181539|NCT01708174|12370375|FG002|COMPLETED|Survival Follow-up||0
11181540|NCT01708174|12370373|FG000|NOT COMPLETED|Survival Follow-up||0
11181541|NCT01708174|12370374|FG001|NOT COMPLETED|Survival Follow-up||0
11181542|NCT01708174|12370375|FG002|NOT COMPLETED|Survival Follow-up||0
11181543|NCT01708187|12370386|FG000|STARTED|Overall Study||1
11181544|NCT01708187|12370387|FG001|STARTED|Overall Study||1
11181545|NCT01708187|12370386|FG000|COMPLETED|Overall Study||1
11181546|NCT01708187|12370387|FG001|COMPLETED|Overall Study||0
11181547|NCT01708187|12370386|FG000|NOT COMPLETED|Overall Study||0
11181548|NCT01708187|12370387|FG001|NOT COMPLETED|Overall Study||1
11181549|NCT01708213|12370393|FG000|STARTED|Overall Study||72
11181550|NCT01708213|12370393|FG000|COMPLETED|Overall Study||71
11181551|NCT01708213|12370393|FG000|NOT COMPLETED|Overall Study||1
11181552|NCT01708278|12370403|FG000|STARTED|Overall Study||1
11181553|NCT01708278|12370404|FG001|STARTED|Overall Study||2
11181554|NCT01708278|12370405|FG002|STARTED|Overall Study||2
11181555|NCT01708278|12370406|FG003|STARTED|Overall Study||2
11181556|NCT01708278|12370407|FG004|STARTED|Overall Study||1
11181557|NCT01708278|12370408|FG005|STARTED|Overall Study||1
11181558|NCT01708278|12370403|FG000|COMPLETED|Overall Study||1
11181559|NCT01708278|12370404|FG001|COMPLETED|Overall Study||2
11181560|NCT01708278|12370405|FG002|COMPLETED|Overall Study||2
11181561|NCT01708278|12370406|FG003|COMPLETED|Overall Study||2
11181562|NCT01708278|12370407|FG004|COMPLETED|Overall Study||1
11181563|NCT01708278|12370408|FG005|COMPLETED|Overall Study||1
11181564|NCT01708278|12370403|FG000|NOT COMPLETED|Overall Study||0
11181565|NCT01708278|12370404|FG001|NOT COMPLETED|Overall Study||0
11181566|NCT01708278|12370405|FG002|NOT COMPLETED|Overall Study||0
11181567|NCT01708278|12370406|FG003|NOT COMPLETED|Overall Study||0
11181568|NCT01708278|12370407|FG004|NOT COMPLETED|Overall Study||0
11181569|NCT01708278|12370408|FG005|NOT COMPLETED|Overall Study||0
11181570|NCT01708291|12370424|FG000|STARTED|Overall Study||21
11181571|NCT01708291|12370425|FG001|STARTED|Overall Study||21
11181572|NCT01708291|12370424|FG000|COMPLETED|Overall Study||19
11181573|NCT01708291|12370425|FG001|COMPLETED|Overall Study||20
11181574|NCT01708291|12370424|FG000|NOT COMPLETED|Overall Study||2
11181575|NCT01708291|12370425|FG001|NOT COMPLETED|Overall Study||1
11181576|NCT01708317|12370431|FG000|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
11181577|NCT01708317|12370431|FG000|COMPLETED|2010 Control Period||3929
11181578|NCT01708317|12370431|FG000|NOT COMPLETED|2010 Control Period||0
11181579|NCT01708317|12370431|FG000|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
11181580|NCT01708317|12370431|FG000|COMPLETED|Initial Education Period||982
11181581|NCT01708317|12370431|FG000|NOT COMPLETED|Initial Education Period||0
11181582|NCT01708317|12370431|FG000|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
11181583|NCT01708317|12370431|FG000|COMPLETED|ACASI + Education Period||2601
11181584|NCT01708317|12370431|FG000|NOT COMPLETED|ACASI + Education Period||0
11181585|NCT01708317|12370431|FG000|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
11181586|NCT01708317|12370431|FG000|COMPLETED|Final Education Period||909
11181587|NCT01708317|12370431|FG000|NOT COMPLETED|Final Education Period||0
11181588|NCT01708525|12370438|FG000|STARTED|Overall Study||2
11181589|NCT01708525|12370438|FG000|COMPLETED|Overall Study||2
11181590|NCT01708525|12370438|FG000|NOT COMPLETED|Overall Study||0
11181591|NCT01708590|12370446|FG000|STARTED|Induction Phase||222
11181592|NCT01708590|12370447|FG001|STARTED|Induction Phase||219
11181593|NCT01708590|12370448|FG002|STARTED|Induction Phase||220
11181594|NCT01708590|12370449|FG003|STARTED|Induction Phase||0
11181595|NCT01708590|12370450|FG004|STARTED|Induction Phase||0
11181596|NCT01708590|12370451|FG005|STARTED|Induction Phase||0
11181597|NCT01708590|12370452|FG006|STARTED|Induction Phase||0
11181598|NCT01708590|12370446|FG000|COMPLETED|Induction Phase||212
11181599|NCT01708590|12370447|FG001|COMPLETED|Induction Phase||212
11181600|NCT01708590|12370448|FG002|COMPLETED|Induction Phase||209
11181601|NCT01708590|12370449|FG003|COMPLETED|Induction Phase||0
11181602|NCT01708590|12370450|FG004|COMPLETED|Induction Phase||0
11181603|NCT01708590|12370451|FG005|COMPLETED|Induction Phase||0
11181604|NCT01708590|12370452|FG006|COMPLETED|Induction Phase||0
11181605|NCT01708590|12370446|FG000|NOT COMPLETED|Induction Phase||10
11181606|NCT01708590|12370447|FG001|NOT COMPLETED|Induction Phase||7
11181607|NCT01708590|12370448|FG002|NOT COMPLETED|Induction Phase||11
11181608|NCT01708590|12370449|FG003|NOT COMPLETED|Induction Phase||0
11181609|NCT01708590|12370450|FG004|NOT COMPLETED|Induction Phase||0
11181610|NCT01708590|12370451|FG005|NOT COMPLETED|Induction Phase||0
11181611|NCT01708590|12370452|FG006|NOT COMPLETED|Induction Phase||0
11181612|NCT01708590|12370446|FG000|STARTED|Withdrawal Phase||0
11181613|NCT01708590|12370447|FG001|STARTED|Withdrawal Phase||0
11181614|NCT01708590|12370448|FG002|STARTED|Withdrawal Phase||0
11181615|NCT01708590|12370449|FG003|STARTED|Withdrawal Phase||59
11181616|NCT01708590|12370450|FG004|STARTED|Withdrawal Phase||57
11181617|NCT01708590|12370451|FG005|STARTED|Withdrawal Phase||84
11181618|NCT01708590|12370452|FG006|STARTED|Withdrawal Phase||83
11181619|NCT01708590|12370446|FG000|COMPLETED|Withdrawal Phase||0
11181620|NCT01708590|12370447|FG001|COMPLETED|Withdrawal Phase||0
11181621|NCT01708590|12370448|FG002|COMPLETED|Withdrawal Phase||0
11181622|NCT01708590|12370449|FG003|COMPLETED|Withdrawal Phase||6
11181623|NCT01708590|12370450|FG004|COMPLETED|Withdrawal Phase||45
11181624|NCT01708590|12370451|FG005|COMPLETED|Withdrawal Phase||2
11181625|NCT01708590|12370452|FG006|COMPLETED|Withdrawal Phase||74
11181626|NCT01708590|12370446|FG000|NOT COMPLETED|Withdrawal Phase||0
11181627|NCT01708590|12370447|FG001|NOT COMPLETED|Withdrawal Phase||0
11181628|NCT01708590|12370448|FG002|NOT COMPLETED|Withdrawal Phase||0
11181629|NCT01708590|12370449|FG003|NOT COMPLETED|Withdrawal Phase||53
11181630|NCT01708590|12370450|FG004|NOT COMPLETED|Withdrawal Phase||12
11181631|NCT01708590|12370451|FG005|NOT COMPLETED|Withdrawal Phase||82
11181632|NCT01708590|12370452|FG006|NOT COMPLETED|Withdrawal Phase||9
11181633|NCT01708603|12370469|FG000|STARTED|Overall Study||612
11181634|NCT01708603|12370470|FG001|STARTED|Overall Study||610
11181635|NCT01708603|12370471|FG002|STARTED|Overall Study||300
11181636|NCT01708603|12370472|FG003|STARTED|Overall Study||309
11181637|NCT01708603|12370469|FG000|COMPLETED|Overall Study||597
11181638|NCT01708603|12370470|FG001|COMPLETED|Overall Study||588
11181639|NCT01708603|12370471|FG002|COMPLETED|Overall Study||291
11181640|NCT01708603|12370472|FG003|COMPLETED|Overall Study||300
11181641|NCT01708603|12370469|FG000|NOT COMPLETED|Overall Study||15
11181642|NCT01708603|12370470|FG001|NOT COMPLETED|Overall Study||22
11181643|NCT01708603|12370471|FG002|NOT COMPLETED|Overall Study||9
11181644|NCT01708603|12370472|FG003|NOT COMPLETED|Overall Study||9
11181645|NCT01708629|12370491|FG000|STARTED|Overall Study||624
11181646|NCT01708629|12370492|FG001|STARTED|Overall Study||629
11181647|NCT01708629|12370493|FG002|STARTED|Overall Study||313
11181648|NCT01708629|12370494|FG003|STARTED|Overall Study||315
11181649|NCT01708629|12370491|FG000|COMPLETED|Overall Study||608
11181650|NCT01708629|12370492|FG001|COMPLETED|Overall Study||604
11181651|NCT01708629|12370493|FG002|COMPLETED|Overall Study||303
11181652|NCT01708629|12370494|FG003|COMPLETED|Overall Study||301
11181653|NCT01708629|12370491|FG000|NOT COMPLETED|Overall Study||16
11181654|NCT01708629|12370492|FG001|NOT COMPLETED|Overall Study||25
11181655|NCT01708629|12370493|FG002|NOT COMPLETED|Overall Study||10
11181656|NCT01708629|12370494|FG003|NOT COMPLETED|Overall Study||14
11181657|NCT01708902|12370511|FG000|STARTED|Overall Study||147
11181658|NCT01708902|12370512|FG001|STARTED|Overall Study||145
11181659|NCT01708902|12370513|FG002|STARTED|Overall Study||144
11181660|NCT01708902|12370514|FG003|STARTED|Overall Study||147
11181661|NCT01708902|12370515|FG004|STARTED|Overall Study||147
11181662|NCT01708902|12370516|FG005|STARTED|Overall Study||71
11181663|NCT01708902|12370517|FG006|STARTED|Overall Study||72
11181664|NCT01708902|12370511|FG000|COMPLETED|Overall Study||130
11181665|NCT01708902|12370512|FG001|COMPLETED|Overall Study||137
11181666|NCT01708902|12370513|FG002|COMPLETED|Overall Study||127
11181667|NCT01708902|12370514|FG003|COMPLETED|Overall Study||137
11181668|NCT01708902|12370515|FG004|COMPLETED|Overall Study||131
11181669|NCT01708902|12370516|FG005|COMPLETED|Overall Study||64
11181670|NCT01708902|12370517|FG006|COMPLETED|Overall Study||65
11181671|NCT01708902|12370511|FG000|NOT COMPLETED|Overall Study||17
11181672|NCT01708902|12370512|FG001|NOT COMPLETED|Overall Study||8
11181673|NCT01708902|12370513|FG002|NOT COMPLETED|Overall Study||17
11181674|NCT01708902|12370514|FG003|NOT COMPLETED|Overall Study||10
11181675|NCT01708902|12370515|FG004|NOT COMPLETED|Overall Study||16
11181676|NCT01708902|12370516|FG005|NOT COMPLETED|Overall Study||7
11181677|NCT01708902|12370517|FG006|NOT COMPLETED|Overall Study||7
11181678|NCT01708915|12370540|FG000|STARTED|Overall Study||204
11181679|NCT01708915|12370541|FG001|STARTED|Overall Study||201
11181680|NCT01708915|12370542|FG002|STARTED|Overall Study||198
11181681|NCT01708915|12370543|FG003|STARTED|Overall Study||202
11181682|NCT01708915|12370540|FG000|COMPLETED|Overall Study||118
11181683|NCT01708915|12370541|FG001|COMPLETED|Overall Study||139
11181684|NCT01708915|12370542|FG002|COMPLETED|Overall Study||152
11181685|NCT01708915|12370543|FG003|COMPLETED|Overall Study||169
11181686|NCT01708915|12370540|FG000|NOT COMPLETED|Overall Study||86
11181687|NCT01708915|12370541|FG001|NOT COMPLETED|Overall Study||62
11181688|NCT01708915|12370542|FG002|NOT COMPLETED|Overall Study||46
11181689|NCT01708915|12370543|FG003|NOT COMPLETED|Overall Study||33
11181690|NCT01708967|12370555|FG000|STARTED|Overall Study||50
11181691|NCT01708967|12370556|FG001|STARTED|Overall Study||50
11181692|NCT01708967|12370555|FG000|COMPLETED|Overall Study||50
11181693|NCT01708967|12370556|FG001|COMPLETED|Overall Study||43
11181694|NCT01708967|12370555|FG000|NOT COMPLETED|Overall Study||0
11181695|NCT01708967|12370556|FG001|NOT COMPLETED|Overall Study||7
11181696|NCT01709032|12370562|FG000|STARTED|Overall Study||9
11181697|NCT01709032|12370562|FG000|COMPLETED|Overall Study||6
11181698|NCT01709032|12370562|FG000|NOT COMPLETED|Overall Study||3
11181699|NCT01709084|12370569|FG000|STARTED|Overall Study||213
11181700|NCT01709084|12370570|FG001|STARTED|Overall Study||213
11181701|NCT01709084|12370569|FG000|Treated|Overall Study||213
11181702|NCT01709084|12370570|FG001|Treated|Overall Study||211
11181703|NCT01709084|12370569|FG000|COMPLETED|Overall Study||197
11181704|NCT01709084|12370570|FG001|COMPLETED|Overall Study||198
11181705|NCT01709084|12370569|FG000|NOT COMPLETED|Overall Study||16
11181706|NCT01709084|12370570|FG001|NOT COMPLETED|Overall Study||15
11181707|NCT01709110|12370578|FG000|STARTED|Overall Study||683
11181708|NCT01709110|12370579|FG001|STARTED|Overall Study||683
11181709|NCT01709110|12370578|FG000|Received at Least One Dose of Study Drug|Overall Study||680
11181710|NCT01709110|12370579|FG001|Received at Least One Dose of Study Drug|Overall Study||680
11181711|NCT01709110|12370578|FG000|COMPLETED|Overall Study||498
11181712|NCT01709110|12370579|FG001|COMPLETED|Overall Study||515
11181713|NCT01709110|12370578|FG000|NOT COMPLETED|Overall Study||185
11181714|NCT01709110|12370579|FG001|NOT COMPLETED|Overall Study||168
11181715|NCT01709149|12370588|FG000|STARTED|Open-label Lead-in Phase||711
11181716|NCT01709149|12370589|FG001|STARTED|Open-label Lead-in Phase||0
11181717|NCT01709149|12370590|FG002|STARTED|Open-label Lead-in Phase||0
11181718|NCT01709149|12370588|FG000|COMPLETED|Open-label Lead-in Phase||596
11181719|NCT01709149|12370589|FG001|COMPLETED|Open-label Lead-in Phase||0
11181720|NCT01709149|12370590|FG002|COMPLETED|Open-label Lead-in Phase||0
11181721|NCT01709149|12370588|FG000|NOT COMPLETED|Open-label Lead-in Phase||115
11181722|NCT01709149|12370589|FG001|NOT COMPLETED|Open-label Lead-in Phase||0
11181723|NCT01709149|12370590|FG002|NOT COMPLETED|Open-label Lead-in Phase||0
11181724|NCT01709149|12370588|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
11181725|NCT01709149|12370589|FG001|STARTED|Double-blind, Placebo-controlled Phase||295
11181726|NCT01709149|12370590|FG002|STARTED|Double-blind, Placebo-controlled Phase||301
11181727|NCT01709149|12370588|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
11181728|NCT01709149|12370589|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||269
11181729|NCT01709149|12370590|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||204
11324229|NCT02742766|12521573|FG014|COMPLETED|Part 1 (Up to 8 Days)||0
11181730|NCT01709149|12370588|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
11181731|NCT01709149|12370589|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||26
11181732|NCT01709149|12370590|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||97
11181733|NCT01709162|12370599|FG000|STARTED|Overall Study|Randomized|18
11181734|NCT01709162|12370600|FG001|STARTED|Overall Study|Randomized|5
11181735|NCT01709162|12370599|FG000|Received Treatment|Overall Study||18
11181736|NCT01709162|12370600|FG001|Received Treatment|Overall Study||4
11181737|NCT01709162|12370599|FG000|Still Receiving Treatment|Overall Study||0
11181738|NCT01709162|12370600|FG001|Still Receiving Treatment|Overall Study||0
11181739|NCT01709162|12370599|FG000|COMPLETED|Overall Study|Completed treatment as per protocol|12
11181740|NCT01709162|12370600|FG001|COMPLETED|Overall Study|Completed treatment as per protocol|0
11181741|NCT01709162|12370599|FG000|NOT COMPLETED|Overall Study||6
11181742|NCT01709162|12370600|FG001|NOT COMPLETED|Overall Study||5
11181743|NCT01709227|12370608|FG000|STARTED|Overall Study||32
11181744|NCT01709227|12370609|FG001|STARTED|Overall Study||41
11181745|NCT01709227|12370608|FG000|COMPLETED|Overall Study||31
11181746|NCT01709227|12370609|FG001|COMPLETED|Overall Study||32
11181747|NCT01709227|12370608|FG000|NOT COMPLETED|Overall Study||1
11181748|NCT01709227|12370609|FG001|NOT COMPLETED|Overall Study||9
11181749|NCT01709305|12370616|FG000|STARTED|Phase 1||5570
11181750|NCT01709305|12370617|FG001|STARTED|Phase 1||0
11181751|NCT01709305|12370618|FG002|STARTED|Phase 1||0
11181752|NCT01709305|12370619|FG003|STARTED|Phase 1||0
11181753|NCT01709305|12370620|FG004|STARTED|Phase 1||0
11181754|NCT01709305|12370616|FG000|COMPLETED|Phase 1||4933
11181755|NCT01709305|12370617|FG001|COMPLETED|Phase 1||0
11181756|NCT01709305|12370618|FG002|COMPLETED|Phase 1||0
11181757|NCT01709305|12370619|FG003|COMPLETED|Phase 1||0
11181758|NCT01709305|12370620|FG004|COMPLETED|Phase 1||0
11181759|NCT01709305|12370616|FG000|NOT COMPLETED|Phase 1||637
11181760|NCT01709305|12370617|FG001|NOT COMPLETED|Phase 1||0
11181761|NCT01709305|12370618|FG002|NOT COMPLETED|Phase 1||0
11181762|NCT01709305|12370619|FG003|NOT COMPLETED|Phase 1||0
11181763|NCT01709305|12370620|FG004|NOT COMPLETED|Phase 1||0
11181764|NCT01709305|12370616|FG000|STARTED|Phase 2||0
11181765|NCT01709305|12370617|FG001|STARTED|Phase 2||552
11181766|NCT01709305|12370618|FG002|STARTED|Phase 2||550
11181767|NCT01709305|12370619|FG003|STARTED|Phase 2||556
11181768|NCT01709305|12370620|FG004|STARTED|Phase 2||554
11181769|NCT01709305|12370616|FG000|COMPLETED|Phase 2||0
11181770|NCT01709305|12370617|FG001|COMPLETED|Phase 2||500
11181771|NCT01709305|12370618|FG002|COMPLETED|Phase 2||505
11181772|NCT01709305|12370619|FG003|COMPLETED|Phase 2||508
11181773|NCT01709305|12370620|FG004|COMPLETED|Phase 2||507
11181774|NCT01709305|12370616|FG000|NOT COMPLETED|Phase 2||0
11181775|NCT01709305|12370617|FG001|NOT COMPLETED|Phase 2||52
11181776|NCT01709305|12370618|FG002|NOT COMPLETED|Phase 2||45
11181777|NCT01709305|12370619|FG003|NOT COMPLETED|Phase 2||48
11181778|NCT01709305|12370620|FG004|NOT COMPLETED|Phase 2||47
11181779|NCT01709383|12370637|FG000|STARTED|Overall Study||24
11181780|NCT01709383|12370638|FG001|STARTED|Overall Study||14
11181781|NCT01709383|12370637|FG000|Completed Treatment|Overall Study||24
11181782|NCT01709383|12370638|FG001|Completed Treatment|Overall Study||14
11181783|NCT01709383|12370637|FG000|Completed Follow-ups|Overall Study||23
11181784|NCT01709383|12370638|FG001|Completed Follow-ups|Overall Study||14
11181785|NCT01709383|12370637|FG000|Included in Analysis|Overall Study||22
11181786|NCT01709383|12370638|FG001|Included in Analysis|Overall Study||13
11181787|NCT01709383|12370637|FG000|COMPLETED|Overall Study||23
11181788|NCT01709383|12370638|FG001|COMPLETED|Overall Study||14
11181789|NCT01709383|12370637|FG000|NOT COMPLETED|Overall Study||1
11181790|NCT01709383|12370638|FG001|NOT COMPLETED|Overall Study||0
11181791|NCT01709409|12370648|FG000|STARTED|Overall Study||43
11181792|NCT01709409|12370649|FG001|STARTED|Overall Study||45
11181793|NCT01709409|12370648|FG000|COMPLETED|Overall Study||42
11181794|NCT01709409|12370649|FG001|COMPLETED|Overall Study||45
11181795|NCT01709409|12370648|FG000|NOT COMPLETED|Overall Study||1
11181796|NCT01709409|12370649|FG001|NOT COMPLETED|Overall Study||0
11181797|NCT01709422|12370657|FG000|STARTED|Overall Study||70
11181798|NCT01709422|12370658|FG001|STARTED|Overall Study||70
11181799|NCT01709422|12370657|FG000|COMPLETED|Overall Study||70
11181800|NCT01709422|12370658|FG001|COMPLETED|Overall Study||70
11181801|NCT01709422|12370657|FG000|NOT COMPLETED|Overall Study||0
11181802|NCT01709422|12370658|FG001|NOT COMPLETED|Overall Study||0
11181803|NCT01709474|12370668|FG000|STARTED|Overall Study||3
11181804|NCT01709474|12370669|FG001|STARTED|Overall Study||4
11181805|NCT01709474|12370668|FG000|COMPLETED|Overall Study||3
11181806|NCT01709474|12370669|FG001|COMPLETED|Overall Study||4
11181807|NCT01709474|12370668|FG000|NOT COMPLETED|Overall Study||0
11181808|NCT01709474|12370669|FG001|NOT COMPLETED|Overall Study||0
11181809|NCT01709500|12370677|FG000|STARTED|Overall Study||167
11181810|NCT01709500|12370678|FG001|STARTED|Overall Study||82
11181811|NCT01709500|12370677|FG000|Treated|Overall Study||167
11181812|NCT01709500|12370678|FG001|Treated|Overall Study||81
11181813|NCT01709500|12370677|FG000|COMPLETED|Overall Study||0
11181814|NCT01709500|12370678|FG001|COMPLETED|Overall Study||0
11181815|NCT01709500|12370677|FG000|NOT COMPLETED|Overall Study||167
11181816|NCT01709500|12370678|FG001|NOT COMPLETED|Overall Study||82
11181817|NCT01709513|12370687|FG000|STARTED|Overall Study||63
11181818|NCT01709513|12370688|FG001|STARTED|Overall Study||125
11181819|NCT01709513|12370689|FG002|STARTED|Overall Study||126
11181820|NCT01709513|12370687|FG000|Treated|Overall Study||63
11181821|NCT01709513|12370688|FG001|Treated|Overall Study||124
11181822|NCT01709513|12370689|FG002|Treated|Overall Study||126
11181823|NCT01709513|12370687|FG000|COMPLETED|Overall Study||42
11181824|NCT01709513|12370688|FG001|COMPLETED|Overall Study||82
11181825|NCT01709513|12370689|FG002|COMPLETED|Overall Study||96
11181826|NCT01709513|12370687|FG000|NOT COMPLETED|Overall Study||21
11181827|NCT01709513|12370688|FG001|NOT COMPLETED|Overall Study||43
11181828|NCT01709513|12370689|FG002|NOT COMPLETED|Overall Study||30
11181829|NCT01709578|12370703|FG000|STARTED|Overall Study||181
11181830|NCT01709578|12370704|FG001|STARTED|Overall Study||181
11181831|NCT01709578|12370705|FG002|STARTED|Overall Study||184
11181832|NCT01709578|12370703|FG000|COMPLETED|Overall Study||101
11181833|NCT01709578|12370704|FG001|COMPLETED|Overall Study||125
11181834|NCT01709578|12370705|FG002|COMPLETED|Overall Study||133
11181835|NCT01709578|12370703|FG000|NOT COMPLETED|Overall Study||80
11181836|NCT01709578|12370704|FG001|NOT COMPLETED|Overall Study||56
11181837|NCT01709578|12370705|FG002|NOT COMPLETED|Overall Study||51
11181838|NCT01709695|12370715|FG000|STARTED|Overall Study||13
11181839|NCT01709695|12370716|FG001|STARTED|Overall Study||14
11181840|NCT01709695|12370715|FG000|COMPLETED|Overall Study||12
11181841|NCT01709695|12370716|FG001|COMPLETED|Overall Study||13
11181842|NCT01709695|12370715|FG000|NOT COMPLETED|Overall Study||1
11181843|NCT01709695|12370716|FG001|NOT COMPLETED|Overall Study||1
11181844|NCT01709708|12370724|FG000|STARTED|Overall Study||27
11181845|NCT01709708|12370725|FG001|STARTED|Overall Study||14
11181846|NCT01709708|12370724|FG000|COMPLETED|Overall Study||26
11181847|NCT01709708|12370725|FG001|COMPLETED|Overall Study||12
11181848|NCT01709708|12370724|FG000|NOT COMPLETED|Overall Study||1
11181849|NCT01709708|12370725|FG001|NOT COMPLETED|Overall Study||2
11181850|NCT01709721|12370735|FG000|STARTED|Open Label Phase||41
11181851|NCT01709721|12370736|FG001|STARTED|Open Label Phase||40
11181852|NCT01709721|12370737|FG002|STARTED|Open Label Phase||72
11181853|NCT01709721|12370735|FG000|COMPLETED|Open Label Phase||41
11181854|NCT01709721|12370736|FG001|COMPLETED|Open Label Phase||40
11181855|NCT01709721|12370737|FG002|COMPLETED|Open Label Phase||0
11181856|NCT01709721|12370735|FG000|NOT COMPLETED|Open Label Phase||0
11181857|NCT01709721|12370736|FG001|NOT COMPLETED|Open Label Phase||0
11181858|NCT01709721|12370737|FG002|NOT COMPLETED|Open Label Phase||72
11181859|NCT01709721|12370735|FG000|STARTED|Randomized Phase||41
11181860|NCT01709721|12370736|FG001|STARTED|Randomized Phase||40
11181861|NCT01709721|12370737|FG002|STARTED|Randomized Phase||0
11181862|NCT01709721|12370735|FG000|COMPLETED|Randomized Phase||38
11181863|NCT01709721|12370736|FG001|COMPLETED|Randomized Phase||34
11181864|NCT01709721|12370737|FG002|COMPLETED|Randomized Phase||0
11181865|NCT01709721|12370735|FG000|NOT COMPLETED|Randomized Phase||3
11181866|NCT01709721|12370736|FG001|NOT COMPLETED|Randomized Phase||6
11181867|NCT01709721|12370737|FG002|NOT COMPLETED|Randomized Phase||0
11181868|NCT01709747|12370745|FG000|STARTED|Overall Study||364
11181869|NCT01709747|12370745|FG000|COMPLETED|Overall Study||287
11181870|NCT01709747|12370745|FG000|NOT COMPLETED|Overall Study||77
11181871|NCT01709786|12370750|FG000|STARTED|Overall Study||88
11181872|NCT01709786|12370750|FG000|COMPLETED|Overall Study||88
11181873|NCT01709786|12370750|FG000|NOT COMPLETED|Overall Study||0
11181874|NCT01709799|12370759|FG000|STARTED|Overall Study||25
11181875|NCT01709799|12370760|FG001|STARTED|Overall Study||21
11181876|NCT01709799|12370761|FG002|STARTED|Overall Study||18
11181877|NCT01709799|12370759|FG000|COMPLETED|Overall Study||22
11181878|NCT01709799|12370760|FG001|COMPLETED|Overall Study||18
11181879|NCT01709799|12370761|FG002|COMPLETED|Overall Study||15
11181880|NCT01709799|12370759|FG000|NOT COMPLETED|Overall Study||3
11181881|NCT01709799|12370760|FG001|NOT COMPLETED|Overall Study||3
11181882|NCT01709799|12370761|FG002|NOT COMPLETED|Overall Study||3
11181883|NCT01709838|12370769|FG000|STARTED|Overall Study||134
11181884|NCT01709838|12370769|FG000|COMPLETED|Overall Study||67
11181885|NCT01709838|12370769|FG000|NOT COMPLETED|Overall Study||67
11181886|NCT01709864|12370777|FG000|STARTED|Overall Study||222
11181887|NCT01709864|12370778|FG001|STARTED|Overall Study||219
11181888|NCT01709864|12370777|FG000|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
11181889|NCT01709864|12370778|FG001|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
11181890|NCT01709864|12370777|FG000|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
11181891|NCT01709864|12370778|FG001|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
11181892|NCT01709864|12370777|FG000|COMPLETED|Overall Study||215
11181893|NCT01709864|12370778|FG001|COMPLETED|Overall Study||208
11181894|NCT01709864|12370777|FG000|NOT COMPLETED|Overall Study||7
11181895|NCT01709864|12370778|FG001|NOT COMPLETED|Overall Study||11
11181896|NCT01709903|12370786|FG000|STARTED|Overall Study|Randomized set|372
11181897|NCT01709903|12370787|FG001|STARTED|Overall Study|Randomized set|372
11181898|NCT01709903|12370786|FG000|COMPLETED|Overall Study||343
11181899|NCT01709903|12370787|FG001|COMPLETED|Overall Study||333
11181900|NCT01709903|12370786|FG000|NOT COMPLETED|Overall Study||29
11181901|NCT01709903|12370787|FG001|NOT COMPLETED|Overall Study||39
11181902|NCT01710020|12370793|FG000|STARTED|Period 1||12
11181903|NCT01710020|12370793|FG000|COMPLETED|Period 1||11
11181904|NCT01710020|12370793|FG000|NOT COMPLETED|Period 1||1
11181905|NCT01710020|12370793|FG000|STARTED|Washout Period (at Least 14 Days)||11
11181906|NCT01710020|12370793|FG000|COMPLETED|Washout Period (at Least 14 Days)||11
11181907|NCT01710020|12370793|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11181908|NCT01710020|12370793|FG000|STARTED|Period 2||11
11181909|NCT01710020|12370793|FG000|COMPLETED|Period 2||11
11181910|NCT01710020|12370793|FG000|NOT COMPLETED|Period 2||0
11181911|NCT01710033|12370803|FG000|STARTED|Stage 1||6
11181912|NCT01710033|12370804|FG001|STARTED|Stage 1||6
11181913|NCT01710033|12370805|FG002|STARTED|Stage 1||6
11181914|NCT01710033|12370806|FG003|STARTED|Stage 1||6
11181915|NCT01710033|12370807|FG004|STARTED|Stage 1||0
11181916|NCT01710033|12370803|FG000|COMPLETED|Stage 1||6
11181917|NCT01710033|12370804|FG001|COMPLETED|Stage 1||6
11181918|NCT01710033|12370805|FG002|COMPLETED|Stage 1||6
11181919|NCT01710033|12370806|FG003|COMPLETED|Stage 1||6
11181920|NCT01710033|12370807|FG004|COMPLETED|Stage 1||0
11181921|NCT01710033|12370803|FG000|NOT COMPLETED|Stage 1||0
11181922|NCT01710033|12370804|FG001|NOT COMPLETED|Stage 1||0
11181923|NCT01710033|12370805|FG002|NOT COMPLETED|Stage 1||0
11181924|NCT01710033|12370806|FG003|NOT COMPLETED|Stage 1||0
11181925|NCT01710033|12370807|FG004|NOT COMPLETED|Stage 1||0
11181926|NCT01710033|12370803|FG000|STARTED|Stage 2||0
11181927|NCT01710033|12370804|FG001|STARTED|Stage 2||0
11181928|NCT01710033|12370805|FG002|STARTED|Stage 2||0
11181929|NCT01710033|12370806|FG003|STARTED|Stage 2||0
11181930|NCT01710033|12370807|FG004|STARTED|Stage 2||4
11181931|NCT01710033|12370803|FG000|COMPLETED|Stage 2||0
11181932|NCT01710033|12370804|FG001|COMPLETED|Stage 2||0
11181933|NCT01710033|12370805|FG002|COMPLETED|Stage 2||0
11181934|NCT01710033|12370806|FG003|COMPLETED|Stage 2||0
11181935|NCT01710033|12370807|FG004|COMPLETED|Stage 2||3
11181936|NCT01710033|12370803|FG000|NOT COMPLETED|Stage 2||0
11181937|NCT01710033|12370804|FG001|NOT COMPLETED|Stage 2||0
11181938|NCT01710033|12370805|FG002|NOT COMPLETED|Stage 2||0
11181939|NCT01710033|12370806|FG003|NOT COMPLETED|Stage 2||0
11181940|NCT01710033|12370807|FG004|NOT COMPLETED|Stage 2||1
11181941|NCT01710046|12370822|FG000|STARTED|Overall Study||9
11181942|NCT01710046|12370823|FG001|STARTED|Overall Study||3
11181943|NCT01710046|12370822|FG000|COMPLETED|Overall Study||8
11181944|NCT01710046|12370823|FG001|COMPLETED|Overall Study||3
11181945|NCT01710046|12370822|FG000|NOT COMPLETED|Overall Study||1
11181946|NCT01710046|12370823|FG001|NOT COMPLETED|Overall Study||0
11181947|NCT01710137|12370831|FG000|STARTED|Overall Study||89
11181948|NCT01710137|12370832|FG001|STARTED|Overall Study||90
11181949|NCT01710137|12370831|FG000|COMPLETED|Overall Study||65
11181950|NCT01710137|12370832|FG001|COMPLETED|Overall Study||76
11181951|NCT01710137|12370831|FG000|NOT COMPLETED|Overall Study||24
11181952|NCT01710137|12370832|FG001|NOT COMPLETED|Overall Study||14
11181953|NCT01710254|12370838|FG000|STARTED|Overall Study||30
11181954|NCT01710254|12370838|FG000|COMPLETED|Overall Study||30
11181955|NCT01710254|12370838|FG000|NOT COMPLETED|Overall Study||0
11181956|NCT01710306|12370844|FG000|STARTED|Overall Study||86
11181957|NCT01710306|12370845|FG001|STARTED|Overall Study||85
11181958|NCT01710306|12370844|FG000|COMPLETED|Overall Study||68
11181959|NCT01710306|12370845|FG001|COMPLETED|Overall Study||55
11181960|NCT01710306|12370844|FG000|NOT COMPLETED|Overall Study||18
11181961|NCT01710306|12370845|FG001|NOT COMPLETED|Overall Study||30
11181962|NCT01710332|12370854|FG000|STARTED|Overall Study||6
11181963|NCT01710332|12370855|FG001|STARTED|Overall Study||6
11181964|NCT01710332|12370854|FG000|COMPLETED|Overall Study||6
11181965|NCT01710332|12370855|FG001|COMPLETED|Overall Study||6
11181966|NCT01710332|12370854|FG000|NOT COMPLETED|Overall Study||0
11181967|NCT01710332|12370855|FG001|NOT COMPLETED|Overall Study||0
11181968|NCT01710345|12370864|FG000|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
11181969|NCT01710345|12370865|FG001|STARTED|Overall Study||40
11181970|NCT01710345|12370866|FG002|STARTED|Overall Study||20
11181971|NCT01710345|12370864|FG000|COMPLETED|Overall Study||37
11181972|NCT01710345|12370865|FG001|COMPLETED|Overall Study||35
11181973|NCT01710345|12370866|FG002|COMPLETED|Overall Study||19
11181974|NCT01710345|12370864|FG000|NOT COMPLETED|Overall Study||3
11181975|NCT01710345|12370865|FG001|NOT COMPLETED|Overall Study||5
11181976|NCT01710345|12370866|FG002|NOT COMPLETED|Overall Study||1
11181977|NCT01710358|12370877|FG000|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
11181978|NCT01710358|12370878|FG001|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
11181979|NCT01710358|12370879|FG002|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
11181980|NCT01710358|12370877|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
11181981|NCT01710358|12370878|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
11181982|NCT01710358|12370879|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
11181983|NCT01710358|12370877|FG000|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
11181984|NCT01710358|12370878|FG001|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
11181985|NCT01710358|12370879|FG002|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
11181986|NCT01710358|12370877|FG000|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
11181987|NCT01710358|12370878|FG001|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
11181988|NCT01710358|12370879|FG002|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
11181989|NCT01710358|12370877|FG000|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
11181990|NCT01710358|12370878|FG001|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
11181991|NCT01710358|12370879|FG002|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
11181992|NCT01710358|12370877|FG000|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
11181993|NCT01710358|12370878|FG001|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
11181994|NCT01710358|12370879|FG002|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
11181995|NCT01710358|12370877|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
11181996|NCT01710358|12370878|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
11181997|NCT01710358|12370879|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
11181998|NCT01710358|12370877|FG000|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
11181999|NCT01710358|12370878|FG001|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
11182000|NCT01710358|12370879|FG002|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
11182001|NCT01710358|12370877|FG000|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
11182002|NCT01710358|12370878|FG001|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
11182003|NCT01710358|12370879|FG002|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
11182004|NCT01710358|12370877|FG000|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
11182005|NCT01710358|12370878|FG001|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
11182006|NCT01710358|12370879|FG002|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
11182007|NCT01710358|12370877|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
11182008|NCT01710358|12370878|FG001|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
11182009|NCT01710358|12370879|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
11182010|NCT01710358|12370877|FG000|COMPLETED|Rescue Period||0
11182011|NCT01710358|12370878|FG001|COMPLETED|Rescue Period||196
11182012|NCT01710358|12370879|FG002|COMPLETED|Rescue Period||0
11182013|NCT01710358|12370877|FG000|NOT COMPLETED|Rescue Period||0
11182014|NCT01710358|12370878|FG001|NOT COMPLETED|Rescue Period||31
11182015|NCT01710358|12370879|FG002|NOT COMPLETED|Rescue Period||0
11182016|NCT01710358|12370877|FG000|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
11182017|NCT01710358|12370878|FG001|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
11182018|NCT01710358|12370879|FG002|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
11182019|NCT01710358|12370877|FG000|COMPLETED|Follow-up Period||33
11182020|NCT01710358|12370878|FG001|COMPLETED|Follow-up Period||76
11182021|NCT01710358|12370879|FG002|COMPLETED|Follow-up Period||20
11182022|NCT01710358|12370877|FG000|NOT COMPLETED|Follow-up Period||0
11182023|NCT01710358|12370878|FG001|NOT COMPLETED|Follow-up Period||0
11182024|NCT01710358|12370879|FG002|NOT COMPLETED|Follow-up Period||0
11182025|NCT01710501|12370903|FG000|STARTED|Overall Study||29
11182026|NCT01710501|12370904|FG001|STARTED|Overall Study||28
11182027|NCT01710501|12370905|FG002|STARTED|Overall Study||30
11182028|NCT01710501|12370903|FG000|COMPLETED|Overall Study||27
11182029|NCT01710501|12370904|FG001|COMPLETED|Overall Study||28
11182030|NCT01710501|12370905|FG002|COMPLETED|Overall Study||30
11182031|NCT01710501|12370903|FG000|NOT COMPLETED|Overall Study||2
11182032|NCT01710501|12370904|FG001|NOT COMPLETED|Overall Study||0
11182033|NCT01710501|12370905|FG002|NOT COMPLETED|Overall Study||0
11182034|NCT01710514|12370915|FG000|STARTED|Overall Study||54
11182035|NCT01710514|12370916|FG001|STARTED|Overall Study||54
11182036|NCT01710514|12370915|FG000|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
11182037|NCT01710514|12370916|FG001|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
11182038|NCT01710514|12370915|FG000|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
11182039|NCT01710514|12370916|FG001|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
11182040|NCT01710514|12370915|FG000|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
11182041|NCT01710514|12370916|FG001|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
11182042|NCT01710514|12370915|FG000|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
11182043|NCT01710514|12370916|FG001|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
11182044|NCT01710514|12370915|FG000|COMPLETED|Overall Study||47
11182045|NCT01710514|12370916|FG001|COMPLETED|Overall Study||47
11182046|NCT01710514|12370915|FG000|NOT COMPLETED|Overall Study||7
11182047|NCT01710514|12370916|FG001|NOT COMPLETED|Overall Study||7
11182048|NCT01710527|12370925|FG000|STARTED|Period 1: Intervention Period 1||16
11182049|NCT01710527|12370926|FG001|STARTED|Period 1: Intervention Period 1||16
11182050|NCT01710527|12370925|FG000|COMPLETED|Period 1: Intervention Period 1||16
11182051|NCT01710527|12370926|FG001|COMPLETED|Period 1: Intervention Period 1||16
11182052|NCT01710527|12370925|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0
11182053|NCT01710527|12370926|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0
11182054|NCT01710527|12370925|FG000|STARTED|Period 2: Washout Period (7 Days)||16
11182055|NCT01710527|12370926|FG001|STARTED|Period 2: Washout Period (7 Days)||16
11182056|NCT01710527|12370925|FG000|COMPLETED|Period 2: Washout Period (7 Days)||16
11182057|NCT01710527|12370926|FG001|COMPLETED|Period 2: Washout Period (7 Days)||15
11182058|NCT01710527|12370925|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
11182059|NCT01710527|12370926|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
11182060|NCT01710527|12370925|FG000|STARTED|Period 3: Intervention Period 2||16
11182061|NCT01710527|12370926|FG001|STARTED|Period 3: Intervention Period 2||15
11182062|NCT01710527|12370925|FG000|COMPLETED|Period 3: Intervention Period 2||16
11182063|NCT01710527|12370926|FG001|COMPLETED|Period 3: Intervention Period 2||15
11182064|NCT01710527|12370925|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
11182065|NCT01710527|12370926|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
11182066|NCT01710657|12370935|FG000|STARTED|Overall Study||184
11182067|NCT01710657|12370936|FG001|STARTED|Overall Study||183
11182068|NCT01710657|12370937|FG002|STARTED|Overall Study||180
11182069|NCT01710657|12370935|FG000|Titration Period (4 Weeks)|Overall Study||184
11182070|NCT01710657|12370936|FG001|Titration Period (4 Weeks)|Overall Study||183
11182071|NCT01710657|12370937|FG002|Titration Period (4 Weeks)|Overall Study||180
11182072|NCT01710657|12370935|FG000|Maintenance Period (12 Weeks)|Overall Study||176
11182073|NCT01710657|12370936|FG001|Maintenance Period (12 Weeks)|Overall Study||175
11182074|NCT01710657|12370937|FG002|Maintenance Period (12 Weeks)|Overall Study||168
11182075|NCT01710657|12370935|FG000|COMPLETED|Overall Study||166
11182076|NCT01710657|12370936|FG001|COMPLETED|Overall Study||171
11182077|NCT01710657|12370937|FG002|COMPLETED|Overall Study||148
11182078|NCT01710657|12370935|FG000|NOT COMPLETED|Overall Study||18
11182079|NCT01710657|12370936|FG001|NOT COMPLETED|Overall Study||12
11182080|NCT01710657|12370937|FG002|NOT COMPLETED|Overall Study||32
11204184|NCT01852058|12394712|FG002|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204185|NCT01852058|12394713|FG003|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204186|NCT01852058|12394714|FG004|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204187|NCT01852058|12394715|FG005|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204188|NCT01852058|12394716|FG006|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||5
11205202|NCT01857869|12395945|FG005|STARTED|Booster/Rechallenge Phase||2
11182081|NCT01710709|12370945|FG000|STARTED|Overall Study||464
11182082|NCT01710709|12370945|FG000|COMPLETED|Overall Study||291
11182083|NCT01710709|12370945|FG000|NOT COMPLETED|Overall Study||173
11182084|NCT01710787|12370953|FG000|STARTED|Overall Study||44
11182085|NCT01710787|12370954|FG001|STARTED|Overall Study||44
11182086|NCT01710787|12370955|FG002|STARTED|Overall Study||22
11182087|NCT01710787|12370953|FG000|COMPLETED|Overall Study||44
11182088|NCT01710787|12370954|FG001|COMPLETED|Overall Study||44
11182089|NCT01710787|12370955|FG002|COMPLETED|Overall Study||22
11182090|NCT01710787|12370953|FG000|NOT COMPLETED|Overall Study||0
11182091|NCT01710787|12370954|FG001|NOT COMPLETED|Overall Study||0
11182092|NCT01710787|12370955|FG002|NOT COMPLETED|Overall Study||0
11182093|NCT01710800|12370963|FG000|STARTED|Overall Study|63 patients consented to be part of the study|63
11182094|NCT01710800|12370963|FG000|Received PPI Intervention|Overall Study||44
11182095|NCT01710800|12370963|FG000|Received Placebo Intervention|Overall Study||45
11182096|NCT01710800|12370963|FG000|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
11182097|NCT01710800|12370963|FG000|NOT COMPLETED|Overall Study||22
11182098|NCT01710839|12370971|FG000|STARTED|Overall Study||24
11182099|NCT01710839|12370972|FG001|STARTED|Overall Study||6
11182100|NCT01710839|12370971|FG000|COMPLETED|Overall Study||23
11182101|NCT01710839|12370972|FG001|COMPLETED|Overall Study||0
11182102|NCT01710839|12370971|FG000|NOT COMPLETED|Overall Study||1
11182103|NCT01710839|12370972|FG001|NOT COMPLETED|Overall Study||6
11182104|NCT01710891|12370980|FG000|STARTED|Overall Study||95
11182105|NCT01710891|12370981|FG001|STARTED|Overall Study||103
11182106|NCT01710891|12370980|FG000|COMPLETED|Overall Study||95
11182107|NCT01710891|12370981|FG001|COMPLETED|Overall Study||103
11182108|NCT01710891|12370980|FG000|NOT COMPLETED|Overall Study||0
11182109|NCT01710891|12370981|FG001|NOT COMPLETED|Overall Study||0
11182110|NCT01711177|12370990|FG000|STARTED|Overall Study||10
11182111|NCT01711177|12370991|FG001|STARTED|Overall Study||3
11182112|NCT01711177|12370992|FG002|STARTED|Overall Study||3
11182113|NCT01711177|12370990|FG000|COMPLETED|Overall Study||10
11182114|NCT01711177|12370991|FG001|COMPLETED|Overall Study||3
11182115|NCT01711177|12370992|FG002|COMPLETED|Overall Study||3
11182116|NCT01711177|12370990|FG000|NOT COMPLETED|Overall Study||0
11182117|NCT01711177|12370991|FG001|NOT COMPLETED|Overall Study||0
11182118|NCT01711177|12370992|FG002|NOT COMPLETED|Overall Study||0
11182119|NCT01711216|12371000|FG000|STARTED|Overall Study||999
11182120|NCT01711216|12371000|FG000|COMPLETED|Overall Study||782
11182121|NCT01711216|12371000|FG000|NOT COMPLETED|Overall Study||217
11182122|NCT01711294|12371007|FG000|STARTED|Overall Study||121
11182123|NCT01711294|12371008|FG001|STARTED|Overall Study||65
11182124|NCT01711294|12371009|FG002|STARTED|Overall Study||64
11182125|NCT01711294|12371007|FG000|COMPLETED|Overall Study||121
11182126|NCT01711294|12371008|FG001|COMPLETED|Overall Study||65
11182127|NCT01711294|12371009|FG002|COMPLETED|Overall Study||64
11182128|NCT01711294|12371007|FG000|NOT COMPLETED|Overall Study||0
11182129|NCT01711294|12371008|FG001|NOT COMPLETED|Overall Study||0
11182130|NCT01711294|12371009|FG002|NOT COMPLETED|Overall Study||0
11182131|NCT01711359|12371020|FG000|STARTED|Treatment Period||213
11182132|NCT01711359|12371021|FG001|STARTED|Treatment Period||160
11182133|NCT01711359|12371022|FG002|STARTED|Treatment Period||215
11182134|NCT01711359|12371020|FG000|Received at Least One Dose of Study Drug|Treatment Period||210
11182135|NCT01711359|12371021|FG001|Received at Least One Dose of Study Drug|Treatment Period||159
11182136|NCT01711359|12371022|FG002|Received at Least One Dose of Study Drug|Treatment Period||215
11182137|NCT01711359|12371020|FG000|Rescued|Treatment Period||26
11182138|NCT01711359|12371021|FG001|Rescued|Treatment Period||7
11182139|NCT01711359|12371022|FG002|Rescued|Treatment Period||6
11182140|NCT01711359|12371020|FG000|COMPLETED|Treatment Period||161
11182141|NCT01711359|12371021|FG001|COMPLETED|Treatment Period||136
11182142|NCT01711359|12371022|FG002|COMPLETED|Treatment Period||173
11182143|NCT01711359|12371020|FG000|NOT COMPLETED|Treatment Period||52
11182144|NCT01711359|12371021|FG001|NOT COMPLETED|Treatment Period||24
11182145|NCT01711359|12371022|FG002|NOT COMPLETED|Treatment Period||42
11182146|NCT01711359|12371020|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
11182147|NCT01711359|12371021|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
11182148|NCT01711359|12371022|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
11182149|NCT01711359|12371020|FG000|COMPLETED|Follow Up||0
11182150|NCT01711359|12371021|FG001|COMPLETED|Follow Up||0
11182151|NCT01711359|12371022|FG002|COMPLETED|Follow Up||0
11182152|NCT01711359|12371020|FG000|NOT COMPLETED|Follow Up||25
11182153|NCT01711359|12371021|FG001|NOT COMPLETED|Follow Up||15
11182154|NCT01711359|12371022|FG002|NOT COMPLETED|Follow Up||28
11182155|NCT01711372|12371037|FG000|STARTED|Overall Study||66
11182156|NCT01711372|12371038|FG001|STARTED|Overall Study||47
11182157|NCT01711372|12371037|FG000|COMPLETED|Overall Study||66
11182158|NCT01711372|12371038|FG001|COMPLETED|Overall Study||47
11182159|NCT01711372|12371037|FG000|NOT COMPLETED|Overall Study||0
11182160|NCT01711372|12371038|FG001|NOT COMPLETED|Overall Study||0
11182161|NCT01711424|12371043|FG000|STARTED|Overall Study||1209
11182162|NCT01711424|12371043|FG000|COMPLETED|Overall Study||1209
11182163|NCT01711424|12371043|FG000|NOT COMPLETED|Overall Study||0
11182164|NCT01711619|12371049|FG000|STARTED|Overall Study||56
11182165|NCT01711619|12371050|FG001|STARTED|Overall Study||60
11182166|NCT01711619|12371049|FG000|COMPLETED|Overall Study||38
11182167|NCT01711619|12371050|FG001|COMPLETED|Overall Study||36
11182168|NCT01711619|12371049|FG000|NOT COMPLETED|Overall Study||18
11182169|NCT01711619|12371050|FG001|NOT COMPLETED|Overall Study||24
11182170|NCT01711645|12371056|FG000|STARTED|Overall Study||55
11182171|NCT01711645|12371056|FG000|COMPLETED|Overall Study||36
11182172|NCT01711645|12371056|FG000|NOT COMPLETED|Overall Study||19
11182173|NCT01711658|12371062|FG000|STARTED|Overall Study||64
11182174|NCT01711658|12371063|FG001|STARTED|Overall Study||63
11182175|NCT01711658|12371062|FG000|Participants Who Started Protocol Treatment|Overall Study||59
11182176|NCT01711658|12371063|FG001|Participants Who Started Protocol Treatment|Overall Study||60
11182177|NCT01711658|12371062|FG000|COMPLETED|Overall Study||64
11182178|NCT01711658|12371063|FG001|COMPLETED|Overall Study||63
11182179|NCT01711658|12371062|FG000|NOT COMPLETED|Overall Study||0
11182180|NCT01711658|12371063|FG001|NOT COMPLETED|Overall Study||0
11182181|NCT01711736|12371071|FG000|STARTED|Overall Study||299
11182182|NCT01711736|12371072|FG001|STARTED|Overall Study||302
11182183|NCT01711736|12371071|FG000|COMPLETED|Overall Study|Up to Day 180|287
11182184|NCT01711736|12371072|FG001|COMPLETED|Overall Study|Up to Day 180|294
11182185|NCT01711736|12371071|FG000|NOT COMPLETED|Overall Study||12
11182186|NCT01711736|12371072|FG001|NOT COMPLETED|Overall Study||8
11182187|NCT01711853|12371079|FG000|STARTED|Overall Study||19
11182188|NCT01711853|12371079|FG000|COMPLETED|Overall Study||16
11182189|NCT01711853|12371079|FG000|NOT COMPLETED|Overall Study||3
11182190|NCT01711866|12371083|FG000|STARTED|Overall Study||87
11182191|NCT01711866|12371083|FG000|COMPLETED|Overall Study||79
11182192|NCT01711866|12371083|FG000|NOT COMPLETED|Overall Study||8
11182193|NCT01711918|12371087|FG000|STARTED|Overall Study||9
11182194|NCT01711918|12371087|FG000|COMPLETED|Overall Study||7
11182195|NCT01711918|12371087|FG000|NOT COMPLETED|Overall Study||2
11182196|NCT01711983|12371091|FG000|STARTED|6-Month Clinical Success Evaluation||400
11182197|NCT01711983|12371091|FG000|COMPLETED|6-Month Clinical Success Evaluation||368
11182198|NCT01711983|12371091|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||32
11182199|NCT01711983|12371091|FG000|STARTED|6-Month Closure Evaluation||368
11182200|NCT01711983|12371091|FG000|COMPLETED|6-Month Closure Evaluation||342
11182201|NCT01711983|12371091|FG000|NOT COMPLETED|6-Month Closure Evaluation||26
11182202|NCT01711983|12371091|FG000|STARTED|36-Month Closure Evaluation||342
11182203|NCT01711983|12371091|FG000|COMPLETED|36-Month Closure Evaluation||278
11182204|NCT01711983|12371091|FG000|NOT COMPLETED|36-Month Closure Evaluation||64
11182205|NCT01712009|12371098|FG000|STARTED|Overall Study||198
11182206|NCT01712009|12371099|FG001|STARTED|Overall Study||200
11182207|NCT01712009|12371100|FG002|STARTED|Overall Study||202
11182208|NCT01712009|12371098|FG000|Received Pegfilgrastim|Overall Study||191
11182209|NCT01712009|12371099|FG001|Received Pegfilgrastim|Overall Study||196
11182210|NCT01712009|12371100|FG002|Received Pegfilgrastim|Overall Study||200
11182211|NCT01712009|12371098|FG000|Received Naproxen / Loratadine|Overall Study||0
11182212|NCT01712009|12371099|FG001|Received Naproxen / Loratadine|Overall Study||193
11182213|NCT01712009|12371100|FG002|Received Naproxen / Loratadine|Overall Study||198
11182214|NCT01712009|12371098|FG000|COMPLETED|Overall Study||160
11182215|NCT01712009|12371099|FG001|COMPLETED|Overall Study||171
11182216|NCT01712009|12371100|FG002|COMPLETED|Overall Study||181
11182217|NCT01712009|12371098|FG000|NOT COMPLETED|Overall Study||38
11182218|NCT01712009|12371099|FG001|NOT COMPLETED|Overall Study||29
11182219|NCT01712009|12371100|FG002|NOT COMPLETED|Overall Study||21
11182220|NCT01712061|12371110|FG000|STARTED|Overall Study||30
11182221|NCT01712061|12371111|FG001|STARTED|Overall Study||140
11182222|NCT01712061|12371112|FG002|STARTED|Overall Study||56
11182223|NCT01712061|12371110|FG000|COMPLETED|Overall Study||20
11182224|NCT01712061|12371111|FG001|COMPLETED|Overall Study||114
11182225|NCT01712061|12371112|FG002|COMPLETED|Overall Study||45
11182226|NCT01712061|12371110|FG000|NOT COMPLETED|Overall Study||10
11182227|NCT01712061|12371111|FG001|NOT COMPLETED|Overall Study||26
11182228|NCT01712061|12371112|FG002|NOT COMPLETED|Overall Study||11
11182229|NCT01712074|12371124|FG000|STARTED|Placebo Run-in Period||195
11182230|NCT01712074|12371125|FG001|STARTED|Placebo Run-in Period||0
11182231|NCT01712074|12371126|FG002|STARTED|Placebo Run-in Period||0
11182232|NCT01712074|12371124|FG000|COMPLETED|Placebo Run-in Period||185
11182233|NCT01712074|12371125|FG001|COMPLETED|Placebo Run-in Period||0
11182234|NCT01712074|12371126|FG002|COMPLETED|Placebo Run-in Period||0
11182235|NCT01712074|12371124|FG000|NOT COMPLETED|Placebo Run-in Period||10
11182236|NCT01712074|12371125|FG001|NOT COMPLETED|Placebo Run-in Period||0
11182237|NCT01712074|12371126|FG002|NOT COMPLETED|Placebo Run-in Period||0
11182238|NCT01712074|12371124|FG000|STARTED|Double Blind Period||0
11182239|NCT01712074|12371125|FG001|STARTED|Double Blind Period||91
11182240|NCT01712074|12371126|FG002|STARTED|Double Blind Period||94
11182241|NCT01712074|12371124|FG000|COMPLETED|Double Blind Period||0
11182242|NCT01712074|12371125|FG001|COMPLETED|Double Blind Period||77
11182243|NCT01712074|12371126|FG002|COMPLETED|Double Blind Period||86
11182244|NCT01712074|12371124|FG000|NOT COMPLETED|Double Blind Period||0
11182245|NCT01712074|12371125|FG001|NOT COMPLETED|Double Blind Period||14
11182246|NCT01712074|12371126|FG002|NOT COMPLETED|Double Blind Period||8
11182247|NCT01712178|12371143|FG000|STARTED|Overall Study||50
11182248|NCT01712178|12371144|FG001|STARTED|Overall Study||50
11182249|NCT01712178|12371143|FG000|COMPLETED|Overall Study||49
11182250|NCT01712178|12371144|FG001|COMPLETED|Overall Study||47
11182251|NCT01712178|12371143|FG000|NOT COMPLETED|Overall Study||1
11182252|NCT01712178|12371144|FG001|NOT COMPLETED|Overall Study||3
11182253|NCT01712204|12371152|FG000|STARTED|Overall Study||41
11182254|NCT01712204|12371153|FG001|STARTED|Overall Study||41
11182255|NCT01712204|12371152|FG000|COMPLETED|Overall Study||33
11182256|NCT01712204|12371153|FG001|COMPLETED|Overall Study||36
11182257|NCT01712204|12371152|FG000|NOT COMPLETED|Overall Study||8
11182258|NCT01712204|12371153|FG001|NOT COMPLETED|Overall Study||5
11182259|NCT01712230|12371162|FG000|STARTED|Overall Study||11
11182260|NCT01712230|12371163|FG001|STARTED|Overall Study||18
11182261|NCT01712230|12371164|FG002|STARTED|Overall Study||18
11182262|NCT01712230|12371162|FG000|COMPLETED|Overall Study||9
11182263|NCT01712230|12371163|FG001|COMPLETED|Overall Study||14
11182264|NCT01712230|12371164|FG002|COMPLETED|Overall Study||11
11182265|NCT01712230|12371162|FG000|NOT COMPLETED|Overall Study||2
11182266|NCT01712230|12371163|FG001|NOT COMPLETED|Overall Study||4
11182267|NCT01712230|12371164|FG002|NOT COMPLETED|Overall Study||7
11182268|NCT01712256|12371172|FG000|STARTED|Overall Study||33
11182269|NCT01712256|12371172|FG000|COMPLETED|Overall Study||32
11182270|NCT01712256|12371172|FG000|NOT COMPLETED|Overall Study||1
11182271|NCT01712334|12371176|FG000|STARTED|Treatment Period 1||44
11182272|NCT01712334|12371177|FG001|STARTED|Treatment Period 1||43
11182273|NCT01712334|12371176|FG000|Received Treatment|Treatment Period 1||44
11182274|NCT01712334|12371177|FG001|Received Treatment|Treatment Period 1||41
11182275|NCT01712334|12371176|FG000|COMPLETED|Treatment Period 1||44
11182276|NCT01712334|12371177|FG001|COMPLETED|Treatment Period 1||41
11182277|NCT01712334|12371176|FG000|NOT COMPLETED|Treatment Period 1||0
11182278|NCT01712334|12371177|FG001|NOT COMPLETED|Treatment Period 1||2
11182279|NCT01712334|12371176|FG000|STARTED|Treatment Period 2||44
11182280|NCT01712334|12371177|FG001|STARTED|Treatment Period 2||41
11182281|NCT01712334|12371176|FG000|COMPLETED|Treatment Period 2||44
11182282|NCT01712334|12371177|FG001|COMPLETED|Treatment Period 2||41
11182283|NCT01712334|12371176|FG000|NOT COMPLETED|Treatment Period 2||0
11182284|NCT01712334|12371177|FG001|NOT COMPLETED|Treatment Period 2||0
11182285|NCT01712360|12371187|FG000|STARTED|Overall Study||22
11182286|NCT01712360|12371188|FG001|STARTED|Overall Study||22
11182287|NCT01712360|12371189|FG002|STARTED|Overall Study||6
11182288|NCT01712360|12371190|FG003|STARTED|Overall Study||6
11182289|NCT01712360|12371187|FG000|COMPLETED|Overall Study||22
11182290|NCT01712360|12371188|FG001|COMPLETED|Overall Study||21
11182291|NCT01712360|12371189|FG002|COMPLETED|Overall Study||6
11182292|NCT01712360|12371190|FG003|COMPLETED|Overall Study||4
11182293|NCT01712360|12371187|FG000|NOT COMPLETED|Overall Study||0
11182294|NCT01712360|12371188|FG001|NOT COMPLETED|Overall Study||1
11182295|NCT01712360|12371189|FG002|NOT COMPLETED|Overall Study||0
11182296|NCT01712360|12371190|FG003|NOT COMPLETED|Overall Study||2
11182297|NCT01712399|12371206|FG000|STARTED|Overall Study||397
11182298|NCT01712399|12371206|FG000|COMPLETED|Overall Study||0
11324230|NCT02742766|12521574|FG015|COMPLETED|Part 1 (Up to 8 Days)||0
11324231|NCT02742766|12521575|FG016|COMPLETED|Part 1 (Up to 8 Days)||0
11324232|NCT02742766|12521576|FG017|COMPLETED|Part 1 (Up to 8 Days)||0
11324233|NCT02742766|12521577|FG018|COMPLETED|Part 1 (Up to 8 Days)||0
11324234|NCT02742766|12521559|FG000|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324235|NCT02742766|12521560|FG001|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324236|NCT02742766|12521561|FG002|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324237|NCT02742766|12521562|FG003|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11182299|NCT01712399|12371206|FG000|NOT COMPLETED|Overall Study||397
11182300|NCT01712438|12371210|FG000|STARTED|Overall Study||110
11182301|NCT01712438|12371210|FG000|SAF Population|Overall Study||108
11182302|NCT01712438|12371210|FG000|ITT Population|Overall Study||108
11182303|NCT01712438|12371210|FG000|PP Population|Overall Study||95
11182304|NCT01712438|12371210|FG000|PROPH Population|Overall Study||103
11182305|NCT01712438|12371210|FG000|BLEED Population|Overall Study||94
11182306|NCT01712438|12371210|FG000|SURG Population|Overall Study||24
11182307|NCT01712438|12371210|FG000|COMPLETED|Overall Study||73
11182308|NCT01712438|12371210|FG000|NOT COMPLETED|Overall Study||37
11182309|NCT01712516|12371223|FG000|STARTED|Overall Study||250
11182310|NCT01712516|12371224|FG001|STARTED|Overall Study||251
11182311|NCT01712516|12371225|FG002|STARTED|Overall Study||251
11182312|NCT01712516|12371226|FG003|STARTED|Overall Study||249
11182313|NCT01712516|12371223|FG000|Safety Set|Overall Study||250
11182314|NCT01712516|12371224|FG001|Safety Set|Overall Study||251
11182315|NCT01712516|12371225|FG002|Safety Set|Overall Study||251
11182316|NCT01712516|12371226|FG003|Safety Set|Overall Study||248
11182317|NCT01712516|12371223|FG000|Full Analysis Set|Overall Study||250
11182318|NCT01712516|12371224|FG001|Full Analysis Set|Overall Study||251
11182319|NCT01712516|12371225|FG002|Full Analysis Set|Overall Study||250
11182320|NCT01712516|12371226|FG003|Full Analysis Set|Overall Study||247
11182321|NCT01712516|12371223|FG000|COMPLETED|Overall Study||244
11182322|NCT01712516|12371224|FG001|COMPLETED|Overall Study||241
11182323|NCT01712516|12371225|FG002|COMPLETED|Overall Study||245
11182324|NCT01712516|12371226|FG003|COMPLETED|Overall Study||236
11182325|NCT01712516|12371223|FG000|NOT COMPLETED|Overall Study||6
11182326|NCT01712516|12371224|FG001|NOT COMPLETED|Overall Study||10
11182327|NCT01712516|12371225|FG002|NOT COMPLETED|Overall Study||6
11182328|NCT01712516|12371226|FG003|NOT COMPLETED|Overall Study||13
11182329|NCT01712685|12371236|FG000|STARTED|Overall Study||12
11182330|NCT01712685|12371236|FG000|COMPLETED|Overall Study||11
11182331|NCT01712685|12371236|FG000|NOT COMPLETED|Overall Study||1
11182332|NCT01712711|12371242|FG000|STARTED|Overall Study||20
11182333|NCT01712711|12371243|FG001|STARTED|Overall Study||20
11182334|NCT01712711|12371242|FG000|COMPLETED|Overall Study||20
11182335|NCT01712711|12371243|FG001|COMPLETED|Overall Study||20
11182336|NCT01712711|12371242|FG000|NOT COMPLETED|Overall Study||0
11182337|NCT01712711|12371243|FG001|NOT COMPLETED|Overall Study||0
11182338|NCT01712776|12371251|FG000|STARTED|Overall Study||50
11182339|NCT01712776|12371252|FG001|STARTED|Overall Study||50
11182340|NCT01712776|12371251|FG000|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
11182341|NCT01712776|12371252|FG001|COMPLETED|Overall Study||50
11182342|NCT01712776|12371251|FG000|NOT COMPLETED|Overall Study||0
11182343|NCT01712776|12371252|FG001|NOT COMPLETED|Overall Study||0
11182344|NCT01712984|12371261|FG000|STARTED|Overall Study||1672
11182345|NCT01712984|12371262|FG001|STARTED|Overall Study||837
11182346|NCT01712984|12371263|FG002|STARTED|Overall Study||846
11182347|NCT01712984|12371261|FG000|COMPLETED|Overall Study||1656
11182348|NCT01712984|12371262|FG001|COMPLETED|Overall Study||821
11182349|NCT01712984|12371263|FG002|COMPLETED|Overall Study||836
11182350|NCT01712984|12371261|FG000|NOT COMPLETED|Overall Study||16
11182351|NCT01712984|12371262|FG001|NOT COMPLETED|Overall Study||16
11182352|NCT01712984|12371263|FG002|NOT COMPLETED|Overall Study||10
11182353|NCT01713036|12371271|FG000|STARTED|Overall Study||6
11182354|NCT01713036|12371271|FG000|COMPLETED|Overall Study||5
11182355|NCT01713036|12371271|FG000|NOT COMPLETED|Overall Study||1
11182356|NCT01713283|12371285|FG000|STARTED|Overall Study||31
11182357|NCT01713283|12371286|FG001|STARTED|Overall Study||29
11182358|NCT01713283|12371285|FG000|COMPLETED|Overall Study||20
11182359|NCT01713283|12371286|FG001|COMPLETED|Overall Study||26
11182360|NCT01713283|12371285|FG000|NOT COMPLETED|Overall Study||11
11182361|NCT01713283|12371286|FG001|NOT COMPLETED|Overall Study||3
11182362|NCT01713348|12371300|FG000|STARTED|Overall Study||29
11182363|NCT01713348|12371301|FG001|STARTED|Overall Study||13
11182364|NCT01713348|12371302|FG002|STARTED|Overall Study||30
11182365|NCT01713348|12371303|FG003|STARTED|Overall Study||15
11182366|NCT01713348|12371300|FG000|COMPLETED|Overall Study||25
11182367|NCT01713348|12371301|FG001|COMPLETED|Overall Study||11
11182368|NCT01713348|12371302|FG002|COMPLETED|Overall Study||28
11182369|NCT01713348|12371303|FG003|COMPLETED|Overall Study||15
11182370|NCT01713348|12371300|FG000|NOT COMPLETED|Overall Study||4
11182371|NCT01713348|12371301|FG001|NOT COMPLETED|Overall Study||2
11182372|NCT01713348|12371302|FG002|NOT COMPLETED|Overall Study||2
11182373|NCT01713348|12371303|FG003|NOT COMPLETED|Overall Study||0
11182374|NCT01713400|12371315|FG000|STARTED|Overall Study||15
11182375|NCT01713400|12371316|FG001|STARTED|Overall Study||15
11182376|NCT01713400|12371315|FG000|COMPLETED|Overall Study||15
11182377|NCT01713400|12371316|FG001|COMPLETED|Overall Study||15
11182378|NCT01713400|12371315|FG000|NOT COMPLETED|Overall Study||0
11182379|NCT01713400|12371316|FG001|NOT COMPLETED|Overall Study||0
11182380|NCT01713530|12371324|FG000|STARTED|Overall Study||138
11182381|NCT01713530|12371325|FG001|STARTED|Overall Study||136
11182382|NCT01713530|12371324|FG000|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
11182383|NCT01713530|12371325|FG001|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
11182384|NCT01713530|12371324|FG000|COMPLETED|Overall Study||113
11182385|NCT01713530|12371325|FG001|COMPLETED|Overall Study||117
11182386|NCT01713530|12371324|FG000|NOT COMPLETED|Overall Study||25
11182387|NCT01713530|12371325|FG001|NOT COMPLETED|Overall Study||19
11182388|NCT01713582|12371352|FG000|STARTED|Overall Study|Number treated|3
11182389|NCT01713582|12371353|FG001|STARTED|Overall Study|Number treated|3
11182390|NCT01713582|12371354|FG002|STARTED|Overall Study|Number treated|4
11182391|NCT01713582|12371355|FG003|STARTED|Overall Study|Number treated|3
11182392|NCT01713582|12371356|FG004|STARTED|Overall Study|Number treated|4
11182393|NCT01713582|12371357|FG005|STARTED|Overall Study|Number treated|8
11182394|NCT01713582|12371358|FG006|STARTED|Overall Study|Number treated|7
11182395|NCT01713582|12371359|FG007|STARTED|Overall Study|Number treated|6
11182396|NCT01713582|12371360|FG008|STARTED|Overall Study|Number treated|6
11182397|NCT01713582|12371361|FG009|STARTED|Overall Study|Number treated|18
11182398|NCT01713582|12371362|FG010|STARTED|Overall Study|Number treated|16
11182399|NCT01713582|12371363|FG011|STARTED|Overall Study|Number treated|5
11182400|NCT01713582|12371364|FG012|STARTED|Overall Study|Number treated|3
11026887|NCT00830869|12205490|FG010|STARTED|Period 2: Part 2||11
11026888|NCT00830869|12205491|FG011|STARTED|Period 2: Part 2||20
11026889|NCT00830869|12205480|FG000|COMPLETED|Period 2: Part 2||0
11182401|NCT01713582|12371365|FG013|STARTED|Overall Study|Number treated|4
11182402|NCT01713582|12371366|FG014|STARTED|Overall Study|Number treated|7
11182403|NCT01713582|12371367|FG015|STARTED|Overall Study|Number treated|6
11026890|NCT00830869|12205481|FG001|COMPLETED|Period 2: Part 2||0
11182404|NCT01713582|12371368|FG016|STARTED|Overall Study|Number treated|7
11182405|NCT01713582|12371369|FG017|STARTED|Overall Study|Number treated|3
11182406|NCT01713582|12371370|FG018|STARTED|Overall Study|Number treated|5
11182407|NCT01713582|12371371|FG019|STARTED|Overall Study|Number treated|5
11182408|NCT01713582|12371372|FG020|STARTED|Overall Study|Number treated|15
11182409|NCT01713582|12371352|FG000|COMPLETED|Overall Study||0
11182410|NCT01713582|12371353|FG001|COMPLETED|Overall Study||0
11182411|NCT01713582|12371354|FG002|COMPLETED|Overall Study||0
11182412|NCT01713582|12371355|FG003|COMPLETED|Overall Study||0
11182413|NCT01713582|12371356|FG004|COMPLETED|Overall Study||0
11182414|NCT01713582|12371357|FG005|COMPLETED|Overall Study||0
11182415|NCT01713582|12371358|FG006|COMPLETED|Overall Study||0
11182416|NCT01713582|12371359|FG007|COMPLETED|Overall Study||0
11182417|NCT01713582|12371360|FG008|COMPLETED|Overall Study||0
11182418|NCT01713582|12371361|FG009|COMPLETED|Overall Study||0
11182419|NCT01713582|12371362|FG010|COMPLETED|Overall Study||0
11182420|NCT01713582|12371363|FG011|COMPLETED|Overall Study||0
11182421|NCT01713582|12371364|FG012|COMPLETED|Overall Study||0
11182422|NCT01713582|12371365|FG013|COMPLETED|Overall Study||0
11182423|NCT01713582|12371366|FG014|COMPLETED|Overall Study||0
11182424|NCT01713582|12371367|FG015|COMPLETED|Overall Study||0
11182425|NCT01713582|12371368|FG016|COMPLETED|Overall Study||0
11182426|NCT01713582|12371369|FG017|COMPLETED|Overall Study||0
11182427|NCT01713582|12371370|FG018|COMPLETED|Overall Study||0
11182428|NCT01713582|12371371|FG019|COMPLETED|Overall Study||0
11182429|NCT01713582|12371372|FG020|COMPLETED|Overall Study||0
11182430|NCT01713582|12371352|FG000|NOT COMPLETED|Overall Study||3
11182431|NCT01713582|12371353|FG001|NOT COMPLETED|Overall Study||3
11182432|NCT01713582|12371354|FG002|NOT COMPLETED|Overall Study||4
11182433|NCT01713582|12371355|FG003|NOT COMPLETED|Overall Study||3
11182434|NCT01713582|12371356|FG004|NOT COMPLETED|Overall Study||4
11182435|NCT01713582|12371357|FG005|NOT COMPLETED|Overall Study||8
11182436|NCT01713582|12371358|FG006|NOT COMPLETED|Overall Study||7
11182437|NCT01713582|12371359|FG007|NOT COMPLETED|Overall Study||6
11182438|NCT01713582|12371360|FG008|NOT COMPLETED|Overall Study||6
11182439|NCT01713582|12371361|FG009|NOT COMPLETED|Overall Study||18
11182440|NCT01713582|12371362|FG010|NOT COMPLETED|Overall Study||16
11182441|NCT01713582|12371363|FG011|NOT COMPLETED|Overall Study||5
11182442|NCT01713582|12371364|FG012|NOT COMPLETED|Overall Study||3
11182443|NCT01713582|12371365|FG013|NOT COMPLETED|Overall Study||4
11182444|NCT01713582|12371366|FG014|NOT COMPLETED|Overall Study||7
11182445|NCT01713582|12371367|FG015|NOT COMPLETED|Overall Study||6
11182446|NCT01713582|12371368|FG016|NOT COMPLETED|Overall Study||7
11182447|NCT01713582|12371369|FG017|NOT COMPLETED|Overall Study||3
11182448|NCT01713582|12371370|FG018|NOT COMPLETED|Overall Study||5
11182449|NCT01713582|12371371|FG019|NOT COMPLETED|Overall Study||5
11182450|NCT01713582|12371372|FG020|NOT COMPLETED|Overall Study||15
11182451|NCT01713608|12371434|FG000|STARTED|Overall Study||8
11182452|NCT01713608|12371435|FG001|STARTED|Overall Study||6
11182453|NCT01713608|12371436|FG002|STARTED|Overall Study||8
11182454|NCT01713608|12371437|FG003|STARTED|Overall Study||12
11182455|NCT01713608|12371434|FG000|COMPLETED|Overall Study||8
11182456|NCT01713608|12371435|FG001|COMPLETED|Overall Study||6
11182457|NCT01713608|12371436|FG002|COMPLETED|Overall Study||8
11182458|NCT01713608|12371437|FG003|COMPLETED|Overall Study||12
11182459|NCT01713608|12371434|FG000|NOT COMPLETED|Overall Study||0
11182460|NCT01713608|12371435|FG001|NOT COMPLETED|Overall Study||0
11182461|NCT01713608|12371436|FG002|NOT COMPLETED|Overall Study||0
11182462|NCT01713608|12371437|FG003|NOT COMPLETED|Overall Study||0
11182463|NCT01713621|12371448|FG000|STARTED|Overall Study||8
11182464|NCT01713621|12371449|FG001|STARTED|Overall Study||17
11182465|NCT01713621|12371448|FG000|COMPLETED|Overall Study||1
11182466|NCT01713621|12371449|FG001|COMPLETED|Overall Study||1
11182467|NCT01713621|12371448|FG000|NOT COMPLETED|Overall Study||7
11182468|NCT01713621|12371449|FG001|NOT COMPLETED|Overall Study||16
11182469|NCT01713660|12371455|FG000|STARTED|Overall Study||37
11182470|NCT01713660|12371455|FG000|COMPLETED|Overall Study||37
11182471|NCT01713660|12371455|FG000|NOT COMPLETED|Overall Study||0
11182472|NCT01713686|12371459|FG000|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
11182473|NCT01713686|12371459|FG000|COMPLETED|Overall Study||110
11182474|NCT01713686|12371459|FG000|NOT COMPLETED|Overall Study||15
11182475|NCT01713868|12371467|FG000|STARTED|Overall Study||400
11182476|NCT01713868|12371468|FG001|STARTED|Overall Study||400
11182477|NCT01713868|12371469|FG002|STARTED|Overall Study||400
11182478|NCT01713868|12371470|FG003|STARTED|Overall Study||400
11182479|NCT01713868|12371467|FG000|COMPLETED|Overall Study||303
11182480|NCT01713868|12371468|FG001|COMPLETED|Overall Study||335
11182481|NCT01713868|12371469|FG002|COMPLETED|Overall Study||320
11182482|NCT01713868|12371470|FG003|COMPLETED|Overall Study||305
11182483|NCT01713868|12371467|FG000|NOT COMPLETED|Overall Study||97
11182484|NCT01713868|12371468|FG001|NOT COMPLETED|Overall Study||65
11182485|NCT01713868|12371469|FG002|NOT COMPLETED|Overall Study||80
11182486|NCT01713868|12371470|FG003|NOT COMPLETED|Overall Study||95
11182487|NCT01713933|12371482|FG000|STARTED|Overall Study||37
11182488|NCT01713933|12371482|FG000|COMPLETED|Overall Study||31
11182489|NCT01713933|12371482|FG000|NOT COMPLETED|Overall Study||6
11182490|NCT01713946|12371489|FG000|STARTED|Overall Study||117
11182491|NCT01713946|12371490|FG001|STARTED|Overall Study||130
11182492|NCT01713946|12371491|FG002|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
11182493|NCT01713946|12371489|FG000|Completed Core Phase|Overall Study||110
11182494|NCT01713946|12371490|FG001|Completed Core Phase|Overall Study||122
11182495|NCT01713946|12371491|FG002|Completed Core Phase|Overall Study||114
11182496|NCT01713946|12371489|FG000|Continued in Ext. Phase|Overall Study||110
11182497|NCT01713946|12371490|FG001|Continued in Ext. Phase|Overall Study||119
11182498|NCT01713946|12371491|FG002|Continued in Ext. Phase|Overall Study||114
11182499|NCT01713946|12371489|FG000|Completed Ext. Phase|Overall Study||79
11182500|NCT01713946|12371490|FG001|Completed Ext. Phase|Overall Study||92
11182501|NCT01713946|12371491|FG002|Completed Ext. Phase|Overall Study||81
11182502|NCT01713946|12371489|FG000|Continued in Post-Ext. Phase|Overall Study||78
11182503|NCT01713946|12371490|FG001|Continued in Post-Ext. Phase|Overall Study||90
11182504|NCT01713946|12371491|FG002|Continued in Post-Ext. Phase|Overall Study||81
11182505|NCT01713946|12371489|FG000|Completed Post-Ext Phase|Overall Study||74
11182506|NCT01713946|12371490|FG001|Completed Post-Ext Phase|Overall Study||85
11182507|NCT01713946|12371491|FG002|Completed Post-Ext Phase|Overall Study||75
11182508|NCT01713946|12371489|FG000|Did Not Continue in Ext Phase|Overall Study||0
11182509|NCT01713946|12371490|FG001|Did Not Continue in Ext Phase|Overall Study||3
11182510|NCT01713946|12371491|FG002|Did Not Continue in Ext Phase|Overall Study||0
11182511|NCT01713946|12371489|FG000|Did Not Cont. in Post-Ext Phase|Overall Study||1
11182512|NCT01713946|12371490|FG001|Did Not Cont. in Post-Ext Phase|Overall Study||2
11182513|NCT01713946|12371491|FG002|Did Not Cont. in Post-Ext Phase|Overall Study||0
11182514|NCT01713946|12371489|FG000|COMPLETED|Overall Study||74
11182515|NCT01713946|12371490|FG001|COMPLETED|Overall Study||85
11182516|NCT01713946|12371491|FG002|COMPLETED|Overall Study||75
11182517|NCT01713946|12371489|FG000|NOT COMPLETED|Overall Study||43
11182518|NCT01713946|12371490|FG001|NOT COMPLETED|Overall Study||45
11182519|NCT01713946|12371491|FG002|NOT COMPLETED|Overall Study||44
11182520|NCT01713998|12371520|FG000|STARTED|Overall Study||16
11182521|NCT01713998|12371521|FG001|STARTED|Overall Study||15
11182522|NCT01713998|12371522|FG002|STARTED|Overall Study||16
11182523|NCT01713998|12371520|FG000|COMPLETED|Overall Study||13
11182524|NCT01713998|12371521|FG001|COMPLETED|Overall Study||15
11182525|NCT01713998|12371522|FG002|COMPLETED|Overall Study||14
11182526|NCT01713998|12371520|FG000|NOT COMPLETED|Overall Study||3
11182527|NCT01713998|12371521|FG001|NOT COMPLETED|Overall Study||0
11182528|NCT01713998|12371522|FG002|NOT COMPLETED|Overall Study||2
11182529|NCT01714024|12371533|FG000|STARTED|Overall Study||13
11182530|NCT01714024|12371534|FG001|STARTED|Overall Study||18
11182531|NCT01714024|12371535|FG002|STARTED|Overall Study||11
11182532|NCT01714024|12371533|FG000|COMPLETED|Overall Study||12
11182533|NCT01714024|12371534|FG001|COMPLETED|Overall Study||12
11182534|NCT01714024|12371535|FG002|COMPLETED|Overall Study||8
11182535|NCT01714024|12371533|FG000|NOT COMPLETED|Overall Study||1
11182536|NCT01714024|12371534|FG001|NOT COMPLETED|Overall Study||6
11182537|NCT01714024|12371535|FG002|NOT COMPLETED|Overall Study||3
11182538|NCT01714063|12371552|FG000|STARTED|Overall Study||34
11182539|NCT01714063|12371552|FG000|COMPLETED|Overall Study||32
11182540|NCT01714063|12371552|FG000|NOT COMPLETED|Overall Study||2
11182541|NCT01714232|12371560|FG000|STARTED|Overall Study||106
11182542|NCT01714232|12371560|FG000|COMPLETED|Overall Study||106
11182543|NCT01714232|12371560|FG000|NOT COMPLETED|Overall Study||0
11182544|NCT01714310|12371567|FG000|STARTED|Open Lisdexamfetamine Titration||0
11182545|NCT01714310|12371568|FG001|STARTED|Open Lisdexamfetamine Titration||0
11182546|NCT01714310|12371569|FG002|STARTED|Open Lisdexamfetamine Titration||34
11182547|NCT01714310|12371567|FG000|COMPLETED|Open Lisdexamfetamine Titration||0
11182548|NCT01714310|12371568|FG001|COMPLETED|Open Lisdexamfetamine Titration||0
11182549|NCT01714310|12371569|FG002|COMPLETED|Open Lisdexamfetamine Titration||30
11182550|NCT01714310|12371567|FG000|NOT COMPLETED|Open Lisdexamfetamine Titration||0
11182551|NCT01714310|12371568|FG001|NOT COMPLETED|Open Lisdexamfetamine Titration||0
11182552|NCT01714310|12371569|FG002|NOT COMPLETED|Open Lisdexamfetamine Titration||4
11182553|NCT01714310|12371567|FG000|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
11182554|NCT01714310|12371568|FG001|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
11182555|NCT01714310|12371569|FG002|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
11182556|NCT01714310|12371567|FG000|COMPLETED|Double Blind Adjunctive Treatment||10
11182557|NCT01714310|12371568|FG001|COMPLETED|Double Blind Adjunctive Treatment||11
11182558|NCT01714310|12371569|FG002|COMPLETED|Double Blind Adjunctive Treatment||0
11182559|NCT01714310|12371567|FG000|NOT COMPLETED|Double Blind Adjunctive Treatment||2
11182560|NCT01714310|12371568|FG001|NOT COMPLETED|Double Blind Adjunctive Treatment||3
11182561|NCT01714310|12371569|FG002|NOT COMPLETED|Double Blind Adjunctive Treatment||0
11182562|NCT01714323|12371589|FG000|STARTED|Overall Study||677
11182563|NCT01714323|12371590|FG001|STARTED|Overall Study||680
11182564|NCT01714323|12371589|FG000|COMPLETED|Overall Study||513
11182565|NCT01714323|12371590|FG001|COMPLETED|Overall Study||508
11182566|NCT01714323|12371589|FG000|NOT COMPLETED|Overall Study||164
11182567|NCT01714323|12371590|FG001|NOT COMPLETED|Overall Study||172
11182568|NCT01714336|12371598|FG000|STARTED|Overall Study||69
11182569|NCT01714336|12371599|FG001|STARTED|Overall Study||69
11182570|NCT01714336|12371598|FG000|COMPLETED|Overall Study||69
11182571|NCT01714336|12371599|FG001|COMPLETED|Overall Study||69
11182572|NCT01714336|12371598|FG000|NOT COMPLETED|Overall Study||0
11182573|NCT01714336|12371599|FG001|NOT COMPLETED|Overall Study||0
11182574|NCT01714492|12371605|FG000|STARTED|Overall Study||8
11182575|NCT01714492|12371605|FG000|COMPLETED|Overall Study||8
11182576|NCT01714492|12371605|FG000|NOT COMPLETED|Overall Study||0
11182577|NCT01714505|12371610|FG000|STARTED|Admission 1 (40 Hours)||10
11182578|NCT01714505|12371611|FG001|STARTED|Admission 1 (40 Hours)||10
11182579|NCT01714505|12371610|FG000|COMPLETED|Admission 1 (40 Hours)||9
11182580|NCT01714505|12371611|FG001|COMPLETED|Admission 1 (40 Hours)||9
11182581|NCT01714505|12371610|FG000|NOT COMPLETED|Admission 1 (40 Hours)||1
11182582|NCT01714505|12371611|FG001|NOT COMPLETED|Admission 1 (40 Hours)||1
11182583|NCT01714505|12371610|FG000|STARTED|Admission 2 (40 Hours)||9
11182584|NCT01714505|12371611|FG001|STARTED|Admission 2 (40 Hours)||9
11182585|NCT01714505|12371610|FG000|COMPLETED|Admission 2 (40 Hours)||9
11182586|NCT01714505|12371611|FG001|COMPLETED|Admission 2 (40 Hours)||9
11182587|NCT01714505|12371610|FG000|NOT COMPLETED|Admission 2 (40 Hours)||0
11182588|NCT01714505|12371611|FG001|NOT COMPLETED|Admission 2 (40 Hours)||0
11182589|NCT01714544|12371617|FG000|STARTED|Overall Study||60
11182590|NCT01714544|12371617|FG000|COMPLETED|Overall Study||57
11182591|NCT01714544|12371617|FG000|NOT COMPLETED|Overall Study||3
11182592|NCT01714609|12371623|FG000|STARTED|Overall Study||5
11182593|NCT01714609|12371624|FG001|STARTED|Overall Study||5
11182594|NCT01714609|12371623|FG000|COMPLETED|Overall Study||4
11182595|NCT01714609|12371624|FG001|COMPLETED|Overall Study||5
11182596|NCT01714609|12371623|FG000|NOT COMPLETED|Overall Study||1
11182597|NCT01714609|12371624|FG001|NOT COMPLETED|Overall Study||0
11182598|NCT01714635|12371633|FG000|STARTED|Overall Study||147
11182599|NCT01714635|12371634|FG001|STARTED|Overall Study||150
11182600|NCT01714635|12371635|FG002|STARTED|Overall Study||148
11182601|NCT01714635|12371633|FG000|COMPLETED|Overall Study||145
11182602|NCT01714635|12371634|FG001|COMPLETED|Overall Study||150
11182603|NCT01714635|12371635|FG002|COMPLETED|Overall Study||146
11182604|NCT01714635|12371633|FG000|NOT COMPLETED|Overall Study||2
11182605|NCT01714635|12371634|FG001|NOT COMPLETED|Overall Study||0
11182606|NCT01714635|12371635|FG002|NOT COMPLETED|Overall Study||2
11182607|NCT01714687|12371645|FG000|STARTED|Overall Study||29
11182608|NCT01714687|12371646|FG001|STARTED|Overall Study||30
11182609|NCT01714687|12371645|FG000|COMPLETED|Overall Study||26
11182610|NCT01714687|12371646|FG001|COMPLETED|Overall Study||26
11182611|NCT01714687|12371645|FG000|NOT COMPLETED|Overall Study||3
11182612|NCT01714687|12371646|FG001|NOT COMPLETED|Overall Study||4
11182613|NCT01714726|12371656|FG000|STARTED|Double-Blinded Induction Period||60
11182614|NCT01714726|12371657|FG001|STARTED|Double-Blinded Induction Period||59
11182615|NCT01714726|12371658|FG002|STARTED|Double-Blinded Induction Period||0
11182616|NCT01714726|12371659|FG003|STARTED|Double-Blinded Induction Period||0
11182617|NCT01714726|12371656|FG000|COMPLETED|Double-Blinded Induction Period||52
11182618|NCT01714726|12371657|FG001|COMPLETED|Double-Blinded Induction Period||52
11182619|NCT01714726|12371658|FG002|COMPLETED|Double-Blinded Induction Period||0
11182620|NCT01714726|12371659|FG003|COMPLETED|Double-Blinded Induction Period||0
11182621|NCT01714726|12371656|FG000|NOT COMPLETED|Double-Blinded Induction Period||8
11182622|NCT01714726|12371657|FG001|NOT COMPLETED|Double-Blinded Induction Period||7
11182623|NCT01714726|12371658|FG002|NOT COMPLETED|Double-Blinded Induction Period||0
11182624|NCT01714726|12371659|FG003|NOT COMPLETED|Double-Blinded Induction Period||0
11182625|NCT01714726|12371656|FG000|STARTED|Open-Label Period||0
11182626|NCT01714726|12371657|FG001|STARTED|Open-Label Period||0
11182627|NCT01714726|12371658|FG002|STARTED|Open-Label Period||52
11182628|NCT01714726|12371659|FG003|STARTED|Open-Label Period||52
11182629|NCT01714726|12371656|FG000|COMPLETED|Open-Label Period||0
11182630|NCT01714726|12371657|FG001|COMPLETED|Open-Label Period||0
11182631|NCT01714726|12371658|FG002|COMPLETED|Open-Label Period||33
11182632|NCT01714726|12371659|FG003|COMPLETED|Open-Label Period||24
11182633|NCT01714726|12371656|FG000|NOT COMPLETED|Open-Label Period||0
11182634|NCT01714726|12371657|FG001|NOT COMPLETED|Open-Label Period||0
11182635|NCT01714726|12371658|FG002|NOT COMPLETED|Open-Label Period||19
11182636|NCT01714726|12371659|FG003|NOT COMPLETED|Open-Label Period||28
11182637|NCT01714804|12371671|FG000|STARTED|Overall Study||30
11182638|NCT01714804|12371672|FG001|STARTED|Overall Study||30
11182639|NCT01714804|12371671|FG000|COMPLETED|Overall Study||29
11182640|NCT01714804|12371672|FG001|COMPLETED|Overall Study||30
11182641|NCT01714804|12371671|FG000|NOT COMPLETED|Overall Study||1
11182642|NCT01714804|12371672|FG001|NOT COMPLETED|Overall Study||0
11182643|NCT01714921|12371680|FG000|STARTED|Overall Study||504
11182644|NCT01714921|12371680|FG000|COMPLETED|Overall Study||311
11182645|NCT01714921|12371680|FG000|NOT COMPLETED|Overall Study||193
11182646|NCT01714947|12371685|FG000|STARTED|Part A||3
11182647|NCT01714947|12371685|FG000|COMPLETED|Part A||3
11182648|NCT01714947|12371685|FG000|NOT COMPLETED|Part A||0
11182649|NCT01714947|12371685|FG000|STARTED|Part B||3
11182650|NCT01714947|12371685|FG000|COMPLETED|Part B||0
11182651|NCT01714947|12371685|FG000|NOT COMPLETED|Part B||3
11182652|NCT01715064|12371691|FG000|STARTED|Overall Study||18
11182653|NCT01715064|12371692|FG001|STARTED|Overall Study||18
11182654|NCT01715064|12371691|FG000|COMPLETED|Overall Study||18
11182655|NCT01715064|12371692|FG001|COMPLETED|Overall Study||18
11182656|NCT01715064|12371691|FG000|NOT COMPLETED|Overall Study||0
11182657|NCT01715064|12371692|FG001|NOT COMPLETED|Overall Study||0
11182658|NCT01715129|12371698|FG000|STARTED|Overall Study||126
11182659|NCT01715129|12371698|FG000|COMPLETED|Overall Study||117
11182660|NCT01715129|12371698|FG000|NOT COMPLETED|Overall Study||9
11182661|NCT01715207|12371704|FG000|STARTED|Overall Study||15
11182662|NCT01715207|12371705|FG001|STARTED|Overall Study||15
11182663|NCT01715207|12371704|FG000|COMPLETED|Overall Study||14
11182664|NCT01715207|12371705|FG001|COMPLETED|Overall Study||14
11182665|NCT01715207|12371704|FG000|NOT COMPLETED|Overall Study||1
11182666|NCT01715207|12371705|FG001|NOT COMPLETED|Overall Study||1
11182667|NCT01715233|12371713|FG000|STARTED|Overall Study||21
11182668|NCT01715233|12371713|FG000|COMPLETED|Overall Study||21
11182669|NCT01715233|12371713|FG000|NOT COMPLETED|Overall Study||0
11182670|NCT01715298|12371720|FG000|STARTED|Overall Study||216
11182671|NCT01715298|12371721|FG001|STARTED|Overall Study||216
11182672|NCT01715298|12371720|FG000|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
11182673|NCT01715298|12371721|FG001|Full Analysis Set (FAS)|Overall Study||214
11182674|NCT01715298|12371720|FG000|COMPLETED|Overall Study||209
11182675|NCT01715298|12371721|FG001|COMPLETED|Overall Study||205
11182676|NCT01715298|12371720|FG000|NOT COMPLETED|Overall Study||7
11182677|NCT01715298|12371721|FG001|NOT COMPLETED|Overall Study||11
11182678|NCT01715415|12371729|FG000|STARTED|Double-blind Treatment||297
11182679|NCT01715415|12371730|FG001|STARTED|Double-blind Treatment||98
11182680|NCT01715415|12371729|FG000|Randomized But Not Treated|Double-blind Treatment||0
11182681|NCT01715415|12371730|FG001|Randomized But Not Treated|Double-blind Treatment||1
11182682|NCT01715415|12371729|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
11182683|NCT01715415|12371730|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
11182684|NCT01715415|12371729|FG000|NOT COMPLETED|Double-blind Treatment||5
11182685|NCT01715415|12371730|FG001|NOT COMPLETED|Double-blind Treatment||2
11182686|NCT01715415|12371729|FG000|STARTED|Open-label Treatment|not applicable to this arm|0
11182687|NCT01715415|12371730|FG001|STARTED|Open-label Treatment||96
11182688|NCT01715415|12371729|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0
11182689|NCT01715415|12371730|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
11182690|NCT01715415|12371729|FG000|NOT COMPLETED|Open-label Treatment||0
11182691|NCT01715415|12371730|FG001|NOT COMPLETED|Open-label Treatment||2
11182692|NCT01715571|12371737|FG000|STARTED|Overall Study||11
11182693|NCT01715571|12371737|FG000|COMPLETED|Overall Study||3
11182694|NCT01715571|12371737|FG000|NOT COMPLETED|Overall Study||8
11182695|NCT01715805|12371741|FG000|STARTED|Placebo + ADT Lead-in Period||1022
11182696|NCT01715805|12371742|FG001|STARTED|Placebo + ADT Lead-in Period||0
11182697|NCT01715805|12371743|FG002|STARTED|Placebo + ADT Lead-in Period||0
11182698|NCT01715805|12371744|FG003|STARTED|Placebo + ADT Lead-in Period||0
11182699|NCT01715805|12371741|FG000|COMPLETED|Placebo + ADT Lead-in Period||807
11182700|NCT01715805|12371742|FG001|COMPLETED|Placebo + ADT Lead-in Period||0
11182701|NCT01715805|12371743|FG002|COMPLETED|Placebo + ADT Lead-in Period||0
11182702|NCT01715805|12371744|FG003|COMPLETED|Placebo + ADT Lead-in Period||0
11182703|NCT01715805|12371741|FG000|NOT COMPLETED|Placebo + ADT Lead-in Period||215
11182704|NCT01715805|12371742|FG001|NOT COMPLETED|Placebo + ADT Lead-in Period||0
11182705|NCT01715805|12371743|FG002|NOT COMPLETED|Placebo + ADT Lead-in Period||0
11182706|NCT01715805|12371744|FG003|NOT COMPLETED|Placebo + ADT Lead-in Period||0
11182707|NCT01715805|12371741|FG000|STARTED|Double-Blind or Continued Treatment||0
11182708|NCT01715805|12371742|FG001|STARTED|Double-Blind or Continued Treatment||261
11182709|NCT01715805|12371743|FG002|STARTED|Double-Blind or Continued Treatment||269
11182710|NCT01715805|12371744|FG003|STARTED|Double-Blind or Continued Treatment||270
11182711|NCT01715805|12371741|FG000|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
11182712|NCT01715805|12371742|FG001|Double-Blind Safety Population|Double-Blind or Continued Treatment||258
11182713|NCT01715805|12371743|FG002|Double-Blind Safety Population|Double-Blind or Continued Treatment||269
11182714|NCT01715805|12371744|FG003|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
11182715|NCT01715805|12371741|FG000|COMPLETED|Double-Blind or Continued Treatment||0
11182716|NCT01715805|12371742|FG001|COMPLETED|Double-Blind or Continued Treatment||222
11182717|NCT01715805|12371743|FG002|COMPLETED|Double-Blind or Continued Treatment||213
11182718|NCT01715805|12371744|FG003|COMPLETED|Double-Blind or Continued Treatment||222
11182719|NCT01715805|12371741|FG000|NOT COMPLETED|Double-Blind or Continued Treatment||0
11182720|NCT01715805|12371742|FG001|NOT COMPLETED|Double-Blind or Continued Treatment||39
11182721|NCT01715805|12371743|FG002|NOT COMPLETED|Double-Blind or Continued Treatment||56
11182722|NCT01715805|12371744|FG003|NOT COMPLETED|Double-Blind or Continued Treatment||48
11182723|NCT01715831|12371752|FG000|STARTED|Overall Study||26
11182724|NCT01715831|12371752|FG000|COMPLETED|Overall Study||25
11182725|NCT01715831|12371752|FG000|NOT COMPLETED|Overall Study||1
11182726|NCT01715857|12371756|FG000|STARTED|Overall Study||4100
11182727|NCT01715857|12371756|FG000|COMPLETED|Overall Study||4004
11182728|NCT01715857|12371756|FG000|NOT COMPLETED|Overall Study||96
11182729|NCT01715883|12371760|FG000|STARTED|Overall Study||3
11182730|NCT01715883|12371760|FG000|COMPLETED|Overall Study||2
11182731|NCT01715883|12371760|FG000|NOT COMPLETED|Overall Study||1
11182732|NCT01715896|12371767|FG000|STARTED|Overall Study||68
11182733|NCT01715896|12371768|FG001|STARTED|Overall Study||70
11182734|NCT01715896|12371767|FG000|COMPLETED|Overall Study||65
11182735|NCT01715896|12371768|FG001|COMPLETED|Overall Study||59
11182736|NCT01715896|12371767|FG000|NOT COMPLETED|Overall Study||3
11182737|NCT01715896|12371768|FG001|NOT COMPLETED|Overall Study||11
11182738|NCT01715948|12371775|FG000|STARTED|Overall Study||9
11182739|NCT01715948|12371775|FG000|COMPLETED|Overall Study||8
11182740|NCT01715948|12371775|FG000|NOT COMPLETED|Overall Study||1
11182741|NCT01716013|12371796|FG000|STARTED|Overall Study||108
11182742|NCT01716013|12371797|FG001|STARTED|Overall Study||54
11182743|NCT01716013|12371796|FG000|COMPLETED|Overall Study||105
11182744|NCT01716013|12371797|FG001|COMPLETED|Overall Study||54
11182745|NCT01716013|12371796|FG000|NOT COMPLETED|Overall Study||3
11182746|NCT01716013|12371797|FG001|NOT COMPLETED|Overall Study||0
11182747|NCT01716039|12371806|FG000|STARTED|Overall Study||4
11182748|NCT01716039|12371807|FG001|STARTED|Overall Study||8
11182749|NCT01716039|12371808|FG002|STARTED|Overall Study||10
11182750|NCT01716039|12371806|FG000|COMPLETED|Overall Study||3
11182751|NCT01716039|12371807|FG001|COMPLETED|Overall Study||6
11182752|NCT01716039|12371808|FG002|COMPLETED|Overall Study||8
11182753|NCT01716039|12371806|FG000|NOT COMPLETED|Overall Study||1
11182754|NCT01716039|12371807|FG001|NOT COMPLETED|Overall Study||2
11182755|NCT01716039|12371808|FG002|NOT COMPLETED|Overall Study||2
11182756|NCT01716104|12371820|FG000|STARTED|Overall Study||125
11182757|NCT01716104|12371821|FG001|STARTED|Overall Study||124
11182758|NCT01716104|12371820|FG000|COMPLETED|Overall Study||119
11182759|NCT01716104|12371821|FG001|COMPLETED|Overall Study||117
11182760|NCT01716104|12371820|FG000|NOT COMPLETED|Overall Study||6
11182761|NCT01716104|12371821|FG001|NOT COMPLETED|Overall Study||7
11182762|NCT01716156|12371830|FG000|STARTED|Overall Study||9
11182763|NCT01716156|12371831|FG001|STARTED|Overall Study||4
11182764|NCT01716156|12371832|FG002|STARTED|Overall Study||13
11182765|NCT01716156|12371830|FG000|COMPLETED|Overall Study||7
11182766|NCT01716156|12371831|FG001|COMPLETED|Overall Study||3
11182767|NCT01716156|12371832|FG002|COMPLETED|Overall Study||11
11182768|NCT01716156|12371830|FG000|NOT COMPLETED|Overall Study||2
11182769|NCT01716156|12371831|FG001|NOT COMPLETED|Overall Study||1
11182770|NCT01716156|12371832|FG002|NOT COMPLETED|Overall Study||2
11182771|NCT01716169|12371844|FG000|STARTED|Overall Study||10
11182772|NCT01716169|12371844|FG000|Standard of Care Dressings Used|Overall Study||7
11182773|NCT01716169|12371844|FG000|COMPLETED|Overall Study||6
11182774|NCT01716169|12371844|FG000|NOT COMPLETED|Overall Study||4
11182775|NCT01716195|12371850|FG000|STARTED|Overall Study||18
11182776|NCT01716195|12371850|FG000|COMPLETED|Overall Study||17
11182777|NCT01716195|12371850|FG000|NOT COMPLETED|Overall Study||1
11182778|NCT01716208|12371854|FG000|STARTED|Overall Study||12
11182779|NCT01716208|12371854|FG000|COMPLETED|Overall Study||12
11182780|NCT01716208|12371854|FG000|NOT COMPLETED|Overall Study||0
11182781|NCT01716221|12371858|FG000|STARTED|Overall Study||1
11182782|NCT01716221|12371858|FG000|COMPLETED|Overall Study||1
11182783|NCT01716221|12371858|FG000|NOT COMPLETED|Overall Study||0
11182784|NCT01716234|12371881|FG000|STARTED|Overall Study||24
11182785|NCT01716234|12371882|FG001|STARTED|Overall Study||22
11182786|NCT01716234|12371883|FG002|STARTED|Overall Study||20
11182787|NCT01716234|12371884|FG003|STARTED|Overall Study||28
11182788|NCT01716234|12371885|FG004|STARTED|Overall Study||15
11182789|NCT01716234|12371886|FG005|STARTED|Overall Study||32
11182790|NCT01716234|12371887|FG006|STARTED|Overall Study||1
11182791|NCT01716234|12371881|FG000|Treated|Overall Study||22
11182792|NCT01716234|12371882|FG001|Treated|Overall Study||21
11182793|NCT01716234|12371883|FG002|Treated|Overall Study||19
11182794|NCT01716234|12371884|FG003|Treated|Overall Study||28
11182795|NCT01716234|12371885|FG004|Treated|Overall Study||15
11182796|NCT01716234|12371886|FG005|Treated|Overall Study||30
11182797|NCT01716234|12371887|FG006|Treated|Overall Study||1
11182798|NCT01716234|12371881|FG000|COMPLETED|Overall Study||14
11182799|NCT01716234|12371882|FG001|COMPLETED|Overall Study||12
11182800|NCT01716234|12371883|FG002|COMPLETED|Overall Study||15
11182801|NCT01716234|12371884|FG003|COMPLETED|Overall Study||16
11182802|NCT01716234|12371885|FG004|COMPLETED|Overall Study||10
11182803|NCT01716234|12371886|FG005|COMPLETED|Overall Study||18
11182804|NCT01716234|12371887|FG006|COMPLETED|Overall Study||1
11182805|NCT01716234|12371881|FG000|NOT COMPLETED|Overall Study||10
11182806|NCT01716234|12371882|FG001|NOT COMPLETED|Overall Study||10
11182807|NCT01716234|12371883|FG002|NOT COMPLETED|Overall Study||5
11182808|NCT01716234|12371884|FG003|NOT COMPLETED|Overall Study||12
11182809|NCT01716234|12371885|FG004|NOT COMPLETED|Overall Study||5
11182810|NCT01716234|12371886|FG005|NOT COMPLETED|Overall Study||14
11182811|NCT01716234|12371887|FG006|NOT COMPLETED|Overall Study||0
11182812|NCT01716455|12371909|FG000|STARTED|Overall Study||8
11182813|NCT01716455|12371910|FG001|STARTED|Overall Study||8
11182814|NCT01716455|12371911|FG002|STARTED|Overall Study||8
11182815|NCT01716455|12371912|FG003|STARTED|Overall Study||8
11182816|NCT01716455|12371913|FG004|STARTED|Overall Study||26
11182817|NCT01716455|12371914|FG005|STARTED|Overall Study||8
11182818|NCT01716455|12371909|FG000|COMPLETED|Overall Study||8
11182819|NCT01716455|12371910|FG001|COMPLETED|Overall Study||8
11182820|NCT01716455|12371911|FG002|COMPLETED|Overall Study||8
11182821|NCT01716455|12371912|FG003|COMPLETED|Overall Study||8
11182822|NCT01716455|12371913|FG004|COMPLETED|Overall Study||26
11182823|NCT01716455|12371914|FG005|COMPLETED|Overall Study||8
11182824|NCT01716455|12371909|FG000|NOT COMPLETED|Overall Study||0
11182825|NCT01716455|12371910|FG001|NOT COMPLETED|Overall Study||0
11182826|NCT01716455|12371911|FG002|NOT COMPLETED|Overall Study||0
11182827|NCT01716455|12371912|FG003|NOT COMPLETED|Overall Study||0
11182828|NCT01716455|12371913|FG004|NOT COMPLETED|Overall Study||0
11182829|NCT01716455|12371914|FG005|NOT COMPLETED|Overall Study||0
11182830|NCT01716468|12371925|FG000|STARTED|Overall Study||17
11182831|NCT01716468|12371925|FG000|COMPLETED|Overall Study||11
11182832|NCT01716468|12371925|FG000|NOT COMPLETED|Overall Study||6
11182833|NCT01716520|12371929|FG000|STARTED|Treatment Period 1 (14 Days)||31
11182834|NCT01716520|12371930|FG001|STARTED|Treatment Period 1 (14 Days)||30
11182835|NCT01716520|12371931|FG002|STARTED|Treatment Period 1 (14 Days)||30
11182836|NCT01716520|12371932|FG003|STARTED|Treatment Period 1 (14 Days)||30
11182837|NCT01716520|12371933|FG004|STARTED|Treatment Period 1 (14 Days)||31
11182838|NCT01716520|12371934|FG005|STARTED|Treatment Period 1 (14 Days)||30
11182839|NCT01716520|12371929|FG000|COMPLETED|Treatment Period 1 (14 Days)||29
11182840|NCT01716520|12371930|FG001|COMPLETED|Treatment Period 1 (14 Days)||29
11182841|NCT01716520|12371931|FG002|COMPLETED|Treatment Period 1 (14 Days)||28
11182842|NCT01716520|12371932|FG003|COMPLETED|Treatment Period 1 (14 Days)||29
11182843|NCT01716520|12371933|FG004|COMPLETED|Treatment Period 1 (14 Days)||31
11182844|NCT01716520|12371934|FG005|COMPLETED|Treatment Period 1 (14 Days)||29
11182845|NCT01716520|12371929|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
11182846|NCT01716520|12371930|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
11182847|NCT01716520|12371931|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||2
11182848|NCT01716520|12371932|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||1
11182849|NCT01716520|12371933|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0
11182850|NCT01716520|12371934|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1
11182851|NCT01716520|12371929|FG000|STARTED|Washout Period 1 (10 to 14 Days)||29
11182852|NCT01716520|12371930|FG001|STARTED|Washout Period 1 (10 to 14 Days)||29
11182853|NCT01716520|12371931|FG002|STARTED|Washout Period 1 (10 to 14 Days)||28
11182854|NCT01716520|12371932|FG003|STARTED|Washout Period 1 (10 to 14 Days)||29
11182855|NCT01716520|12371933|FG004|STARTED|Washout Period 1 (10 to 14 Days)||31
11182856|NCT01716520|12371934|FG005|STARTED|Washout Period 1 (10 to 14 Days)||29
11182857|NCT01716520|12371929|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||29
11182858|NCT01716520|12371930|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||28
11182859|NCT01716520|12371931|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||27
11182860|NCT01716520|12371932|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||29
11182861|NCT01716520|12371933|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||31
11182862|NCT01716520|12371934|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||27
11182863|NCT01716520|12371929|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
11182864|NCT01716520|12371930|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
11182865|NCT01716520|12371931|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
11182866|NCT01716520|12371932|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
11182867|NCT01716520|12371933|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
11182868|NCT01716520|12371934|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
11182869|NCT01716520|12371929|FG000|STARTED|Treatment Period 2 (14 Days)||29
11182870|NCT01716520|12371930|FG001|STARTED|Treatment Period 2 (14 Days)||28
11182871|NCT01716520|12371931|FG002|STARTED|Treatment Period 2 (14 Days)||27
11182872|NCT01716520|12371932|FG003|STARTED|Treatment Period 2 (14 Days)||29
11182873|NCT01716520|12371933|FG004|STARTED|Treatment Period 2 (14 Days)||31
11182874|NCT01716520|12371934|FG005|STARTED|Treatment Period 2 (14 Days)||27
11182875|NCT01716520|12371929|FG000|COMPLETED|Treatment Period 2 (14 Days)||29
11182876|NCT01716520|12371930|FG001|COMPLETED|Treatment Period 2 (14 Days)||28
11182877|NCT01716520|12371931|FG002|COMPLETED|Treatment Period 2 (14 Days)||27
11182878|NCT01716520|12371932|FG003|COMPLETED|Treatment Period 2 (14 Days)||28
11182879|NCT01716520|12371933|FG004|COMPLETED|Treatment Period 2 (14 Days)||29
11182880|NCT01716520|12371934|FG005|COMPLETED|Treatment Period 2 (14 Days)||27
11182881|NCT01716520|12371929|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11182882|NCT01716520|12371930|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11182883|NCT01716520|12371931|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11182884|NCT01716520|12371932|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
11182885|NCT01716520|12371933|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||2
11182886|NCT01716520|12371934|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11182887|NCT01716520|12371929|FG000|STARTED|Washout Period 2 (10 to 14 Days)||29
11182888|NCT01716520|12371930|FG001|STARTED|Washout Period 2 (10 to 14 Days)||28
11182889|NCT01716520|12371931|FG002|STARTED|Washout Period 2 (10 to 14 Days)||27
11182890|NCT01716520|12371932|FG003|STARTED|Washout Period 2 (10 to 14 Days)||28
11182891|NCT01716520|12371933|FG004|STARTED|Washout Period 2 (10 to 14 Days)||29
11182892|NCT01716520|12371934|FG005|STARTED|Washout Period 2 (10 to 14 Days)||27
11182893|NCT01716520|12371929|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||27
11182894|NCT01716520|12371930|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||27
11182895|NCT01716520|12371931|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||26
11182896|NCT01716520|12371932|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||28
11182897|NCT01716520|12371933|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||29
11182898|NCT01716520|12371934|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||25
11182899|NCT01716520|12371929|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
11182900|NCT01716520|12371930|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
11182901|NCT01716520|12371931|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
11182902|NCT01716520|12371932|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
11182903|NCT01716520|12371933|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
11182904|NCT01716520|12371934|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
11182905|NCT01716520|12371929|FG000|STARTED|Treatment Period 3 (14 Days)||27
11182906|NCT01716520|12371930|FG001|STARTED|Treatment Period 3 (14 Days)||27
11182907|NCT01716520|12371931|FG002|STARTED|Treatment Period 3 (14 Days)||26
11182908|NCT01716520|12371932|FG003|STARTED|Treatment Period 3 (14 Days)||28
11182909|NCT01716520|12371933|FG004|STARTED|Treatment Period 3 (14 Days)||29
11182910|NCT01716520|12371934|FG005|STARTED|Treatment Period 3 (14 Days)||25
11182911|NCT01716520|12371929|FG000|COMPLETED|Treatment Period 3 (14 Days)||27
11182912|NCT01716520|12371930|FG001|COMPLETED|Treatment Period 3 (14 Days)||27
11182913|NCT01716520|12371931|FG002|COMPLETED|Treatment Period 3 (14 Days)||25
11182914|NCT01716520|12371932|FG003|COMPLETED|Treatment Period 3 (14 Days)||28
11182915|NCT01716520|12371933|FG004|COMPLETED|Treatment Period 3 (14 Days)||29
11182916|NCT01716520|12371934|FG005|COMPLETED|Treatment Period 3 (14 Days)||23
11182917|NCT01716520|12371929|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11182918|NCT01716520|12371930|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11182919|NCT01716520|12371931|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
11182920|NCT01716520|12371932|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11182921|NCT01716520|12371933|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11182922|NCT01716520|12371934|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2
11182923|NCT01716533|12371946|FG000|STARTED|Overall Study||7
11182924|NCT01716533|12371947|FG001|STARTED|Overall Study||25
11182925|NCT01716533|12371948|FG002|STARTED|Overall Study||5
11182926|NCT01716533|12371949|FG003|STARTED|Overall Study||9
11182927|NCT01716533|12371946|FG000|COMPLETED|Overall Study||7
11182928|NCT01716533|12371947|FG001|COMPLETED|Overall Study||25
11182929|NCT01716533|12371948|FG002|COMPLETED|Overall Study||0
11182930|NCT01716533|12371949|FG003|COMPLETED|Overall Study||1
11182931|NCT01716533|12371946|FG000|NOT COMPLETED|Overall Study||0
11182932|NCT01716533|12371947|FG001|NOT COMPLETED|Overall Study||0
11182933|NCT01716533|12371948|FG002|NOT COMPLETED|Overall Study||5
11182934|NCT01716533|12371949|FG003|NOT COMPLETED|Overall Study||8
11182935|NCT01716559|12371963|FG000|STARTED|Overall Study||160
11182936|NCT01716559|12371963|FG000|COMPLETED|Overall Study||49
11182937|NCT01716559|12371963|FG000|NOT COMPLETED|Overall Study||111
11182938|NCT01716585|12371969|FG000|STARTED|Double-blind Treatment||477
11182939|NCT01716585|12371970|FG001|STARTED|Double-blind Treatment||159
11182940|NCT01716585|12371969|FG000|Randomized But Not Treated|Double-blind Treatment||4
11182941|NCT01716585|12371970|FG001|Randomized But Not Treated|Double-blind Treatment||1
11182942|NCT01716585|12371969|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
11182943|NCT01716585|12371970|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
11182944|NCT01716585|12371969|FG000|NOT COMPLETED|Double-blind Treatment||13
11182945|NCT01716585|12371970|FG001|NOT COMPLETED|Double-blind Treatment||2
11182946|NCT01716585|12371969|FG000|STARTED|Open-label Treatment|not applicable to this arm|0
11182947|NCT01716585|12371970|FG001|STARTED|Open-label Treatment||157
11182948|NCT01716585|12371969|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0
11182949|NCT01716585|12371970|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
11182950|NCT01716585|12371969|FG000|NOT COMPLETED|Open-label Treatment||0
11182951|NCT01716585|12371970|FG001|NOT COMPLETED|Open-label Treatment||7
11182952|NCT01716663|12371977|FG000|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
11182953|NCT01716663|12371977|FG000|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
11182954|NCT01716663|12371977|FG000|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
11182955|NCT01716663|12371977|FG000|NOT COMPLETED|Overall Study||6
11182956|NCT01716715|12371983|FG000|STARTED|Overall Study||57
11182957|NCT01716715|12371984|FG001|STARTED|Overall Study||54
11182958|NCT01716715|12371983|FG000|COMPLETED|Overall Study||55
11182959|NCT01716715|12371984|FG001|COMPLETED|Overall Study||50
11182960|NCT01716715|12371983|FG000|NOT COMPLETED|Overall Study||2
11182961|NCT01716715|12371984|FG001|NOT COMPLETED|Overall Study||4
11182962|NCT01716754|12371996|FG000|STARTED|Overall Study||199
11182963|NCT01716754|12371997|FG001|STARTED|Overall Study||40
11182964|NCT01716754|12371998|FG002|STARTED|Overall Study||135
11182965|NCT01716754|12371999|FG003|STARTED|Overall Study||97
11182966|NCT01716754|12371996|FG000|FAS|Overall Study||199
11182967|NCT01716754|12371997|FG001|FAS|Overall Study||40
11182968|NCT01716754|12371998|FG002|FAS|Overall Study||131
11182969|NCT01716754|12371999|FG003|FAS|Overall Study||96
11182970|NCT01716754|12371996|FG000|Safety Set|Overall Study||199
11182971|NCT01716754|12371997|FG001|Safety Set|Overall Study||40
11182972|NCT01716754|12371998|FG002|Safety Set|Overall Study||131
11182973|NCT01716754|12371999|FG003|Safety Set|Overall Study||96
11182974|NCT01716754|12371996|FG000|COMPLETED|Overall Study||188
11182975|NCT01716754|12371997|FG001|COMPLETED|Overall Study||36
11182976|NCT01716754|12371998|FG002|COMPLETED|Overall Study||121
11182977|NCT01716754|12371999|FG003|COMPLETED|Overall Study||89
11182978|NCT01716754|12371996|FG000|NOT COMPLETED|Overall Study||11
11182979|NCT01716754|12371997|FG001|NOT COMPLETED|Overall Study||4
11182980|NCT01716754|12371998|FG002|NOT COMPLETED|Overall Study||14
11182981|NCT01716754|12371999|FG003|NOT COMPLETED|Overall Study||8
11182982|NCT01717001|12372010|FG000|STARTED|Overall Study||38
11182983|NCT01717001|12372011|FG001|STARTED|Overall Study||28
11182984|NCT01717001|12372010|FG000|COMPLETED|Overall Study||32
11182985|NCT01717001|12372011|FG001|COMPLETED|Overall Study||24
11182986|NCT01717001|12372010|FG000|NOT COMPLETED|Overall Study||6
11182987|NCT01717001|12372011|FG001|NOT COMPLETED|Overall Study||4
11182988|NCT01717014|12372017|FG000|STARTED|Overall Study||8
11182989|NCT01717014|12372017|FG000|COMPLETED|Overall Study||8
11182990|NCT01717014|12372017|FG000|NOT COMPLETED|Overall Study||0
11182991|NCT01717040|12372023|FG000|STARTED|Overall Study||17
11182992|NCT01717040|12372024|FG001|STARTED|Overall Study||20
11182993|NCT01717040|12372023|FG000|COMPLETED|Overall Study||12
11182994|NCT01717040|12372024|FG001|COMPLETED|Overall Study||15
11182995|NCT01717040|12372023|FG000|NOT COMPLETED|Overall Study||5
11182996|NCT01717040|12372024|FG001|NOT COMPLETED|Overall Study||5
11182997|NCT01717053|12372030|FG000|STARTED|Overall Study||37
11182998|NCT01717053|12372030|FG000|COMPLETED|Overall Study||33
11182999|NCT01717053|12372030|FG000|NOT COMPLETED|Overall Study||4
11204189|NCT01852058|12394717|FG007|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||15
11204190|NCT01852058|12394718|FG008|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||33
11204191|NCT01852058|12394719|FG009|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204192|NCT01852058|12394720|FG010|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204193|NCT01852058|12394721|FG011|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204194|NCT01852058|12394710|FG000|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204195|NCT01852058|12394711|FG001|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204196|NCT01852058|12394712|FG002|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204197|NCT01852058|12394713|FG003|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204198|NCT01852058|12394714|FG004|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204199|NCT01852058|12394715|FG005|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204200|NCT01852058|12394716|FG006|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204201|NCT01852058|12394717|FG007|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
11204202|NCT01852058|12394718|FG008|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
11204203|NCT01852058|12394719|FG009|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204204|NCT01852058|12394720|FG010|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204205|NCT01852058|12394721|FG011|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
11204206|NCT01852058|12394710|FG000|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
11204207|NCT01852058|12394711|FG001|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
11204208|NCT01852058|12394712|FG002|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
11204209|NCT01852058|12394713|FG003|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
11204210|NCT01852058|12394714|FG004|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
11204211|NCT01852058|12394715|FG005|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
11204212|NCT01852058|12394716|FG006|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
11204213|NCT01852058|12394717|FG007|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
11204214|NCT01852058|12394718|FG008|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
11204215|NCT01852058|12394719|FG009|STARTED|Treatment Cycle4:Retreatment 3,Study 121||3
11204216|NCT01852058|12394720|FG010|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
11204217|NCT01852058|12394721|FG011|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
11204218|NCT01852058|12394710|FG000|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204219|NCT01852058|12394711|FG001|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204220|NCT01852058|12394712|FG002|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204221|NCT01852058|12394713|FG003|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204222|NCT01852058|12394714|FG004|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204223|NCT01852058|12394715|FG005|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204224|NCT01852058|12394716|FG006|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204225|NCT01852058|12394717|FG007|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204226|NCT01852058|12394718|FG008|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204227|NCT01852058|12394719|FG009|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||3
11204228|NCT01852058|12394720|FG010|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
11204229|NCT01852058|12394721|FG011|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
11204230|NCT01852058|12394710|FG000|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204231|NCT01852058|12394711|FG001|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204232|NCT01852058|12394712|FG002|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204233|NCT01852058|12394713|FG003|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204234|NCT01852058|12394714|FG004|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204235|NCT01852058|12394715|FG005|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204236|NCT01852058|12394716|FG006|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204237|NCT01852058|12394717|FG007|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204238|NCT01852058|12394718|FG008|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204239|NCT01852058|12394719|FG009|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204240|NCT01852058|12394720|FG010|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204241|NCT01852058|12394721|FG011|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
11204242|NCT01852084|12394760|FG000|STARTED|Overall Study||79
11204243|NCT01852084|12394761|FG001|STARTED|Overall Study||80
11204244|NCT01852084|12394762|FG002|STARTED|Overall Study||20
11204245|NCT01852084|12394763|FG003|STARTED|Overall Study||12
11204246|NCT01852084|12394760|FG000|COMPLETED|Overall Study||79
11204247|NCT01852084|12394761|FG001|COMPLETED|Overall Study||80
11204248|NCT01852084|12394762|FG002|COMPLETED|Overall Study||18
11204249|NCT01852084|12394763|FG003|COMPLETED|Overall Study||12
11204250|NCT01852084|12394760|FG000|NOT COMPLETED|Overall Study||0
11204251|NCT01852084|12394761|FG001|NOT COMPLETED|Overall Study||0
11204252|NCT01852084|12394762|FG002|NOT COMPLETED|Overall Study||2
11204253|NCT01852084|12394763|FG003|NOT COMPLETED|Overall Study||0
11204254|NCT01852110|12394775|FG000|STARTED|Overall Study||120
11204255|NCT01852110|12394776|FG001|STARTED|Overall Study||120
11204256|NCT01852110|12394777|FG002|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
11204257|NCT01852110|12394778|FG003|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
11204258|NCT01852110|12394779|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
11204259|NCT01852110|12394780|FG005|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
11183000|NCT01717209|12372034|FG000|STARTED|Overall Study||14
11183001|NCT01717209|12372034|FG000|COMPLETED|Overall Study||14
11183002|NCT01717209|12372034|FG000|NOT COMPLETED|Overall Study||0
11183003|NCT01717287|12372040|FG000|STARTED|Overall Study||4
11183004|NCT01717287|12372041|FG001|STARTED|Overall Study||28
11183005|NCT01717287|12372040|FG000|COMPLETED|Overall Study||4
11183006|NCT01717287|12372041|FG001|COMPLETED|Overall Study||25
11183007|NCT01717287|12372040|FG000|NOT COMPLETED|Overall Study||0
11183008|NCT01717287|12372041|FG001|NOT COMPLETED|Overall Study||3
11183009|NCT01717313|12372049|FG000|STARTED|Phase A (Weeks 0 to 24)||165
11183010|NCT01717313|12372050|FG001|STARTED|Phase A (Weeks 0 to 24)||164
11183011|NCT01717313|12372049|FG000|COMPLETED|Phase A (Weeks 0 to 24)||147
11183012|NCT01717313|12372050|FG001|COMPLETED|Phase A (Weeks 0 to 24)||151
11183013|NCT01717313|12372049|FG000|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
11183014|NCT01717313|12372050|FG001|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
11183015|NCT01717313|12372049|FG000|STARTED|Interphase||147
11183016|NCT01717313|12372050|FG001|STARTED|Interphase||151
11183017|NCT01717313|12372049|FG000|COMPLETED|Interphase||146
11183018|NCT01717313|12372050|FG001|COMPLETED|Interphase||151
11183019|NCT01717313|12372049|FG000|NOT COMPLETED|Interphase||1
11183020|NCT01717313|12372050|FG001|NOT COMPLETED|Interphase||0
11183021|NCT01717313|12372049|FG000|STARTED|Phase B (Weeks 24 to 54)||146
11183022|NCT01717313|12372050|FG001|STARTED|Phase B (Weeks 24 to 54)||151
11183023|NCT01717313|12372049|FG000|COMPLETED|Phase B (Weeks 24 to 54)||134
11183024|NCT01717313|12372050|FG001|COMPLETED|Phase B (Weeks 24 to 54)||135
11183025|NCT01717313|12372049|FG000|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
11183026|NCT01717313|12372050|FG001|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
11183027|NCT01717326|12372076|FG000|STARTED|Overall Study||25
11183028|NCT01717326|12372077|FG001|STARTED|Overall Study||27
11183029|NCT01717326|12372078|FG002|STARTED|Overall Study||13
11183030|NCT01717326|12372079|FG003|STARTED|Overall Study||30
11183031|NCT01717326|12372080|FG004|STARTED|Overall Study||33
11183032|NCT01717326|12372081|FG005|STARTED|Overall Study||31
11183033|NCT01717326|12372082|FG006|STARTED|Overall Study||31
11183034|NCT01717326|12372083|FG007|STARTED|Overall Study||29
11183035|NCT01717326|12372084|FG008|STARTED|Overall Study||32
11183036|NCT01717326|12372085|FG009|STARTED|Overall Study||31
11183037|NCT01717326|12372086|FG010|STARTED|Overall Study||32
11183038|NCT01717326|12372087|FG011|STARTED|Overall Study||33
11183039|NCT01717326|12372088|FG012|STARTED|Overall Study||33
11183040|NCT01717326|12372089|FG013|STARTED|Overall Study||32
11183041|NCT01717326|12372090|FG014|STARTED|Overall Study||29
11183042|NCT01717326|12372091|FG015|STARTED|Overall Study||30
11183043|NCT01717326|12372092|FG016|STARTED|Overall Study||30
11183044|NCT01717326|12372093|FG017|STARTED|Overall Study||31
11183045|NCT01717326|12372094|FG018|STARTED|Overall Study||20
11183046|NCT01717326|12372095|FG019|STARTED|Overall Study||21
11183047|NCT01717326|12372076|FG000|Treated|Overall Study||25
11183048|NCT01717326|12372077|FG001|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
11183049|NCT01717326|12372078|FG002|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
11183050|NCT01717326|12372079|FG003|Treated|Overall Study||30
11183051|NCT01717326|12372080|FG004|Treated|Overall Study||33
11183052|NCT01717326|12372081|FG005|Treated|Overall Study||31
11183053|NCT01717326|12372082|FG006|Treated|Overall Study||31
11183054|NCT01717326|12372083|FG007|Treated|Overall Study||29
11183055|NCT01717326|12372084|FG008|Treated|Overall Study||32
11183056|NCT01717326|12372085|FG009|Treated|Overall Study||31
11183057|NCT01717326|12372086|FG010|Treated|Overall Study||32
11183058|NCT01717326|12372087|FG011|Treated|Overall Study||33
11183059|NCT01717326|12372088|FG012|Treated|Overall Study||33
11183060|NCT01717326|12372089|FG013|Treated|Overall Study||32
11183061|NCT01717326|12372090|FG014|Treated|Overall Study||29
11183062|NCT01717326|12372091|FG015|Treated|Overall Study||30
11183063|NCT01717326|12372092|FG016|Treated|Overall Study||30
11183064|NCT01717326|12372093|FG017|Treated|Overall Study||31
11183065|NCT01717326|12372094|FG018|Treated|Overall Study||20
11183066|NCT01717326|12372095|FG019|Treated|Overall Study||21
11183067|NCT01717326|12372076|FG000|COMPLETED|Overall Study||22
11183068|NCT01717326|12372077|FG001|COMPLETED|Overall Study||26
11183069|NCT01717326|12372078|FG002|COMPLETED|Overall Study||13
11183070|NCT01717326|12372079|FG003|COMPLETED|Overall Study||28
11183071|NCT01717326|12372080|FG004|COMPLETED|Overall Study||31
11183072|NCT01717326|12372081|FG005|COMPLETED|Overall Study||31
11183073|NCT01717326|12372082|FG006|COMPLETED|Overall Study||30
11183074|NCT01717326|12372083|FG007|COMPLETED|Overall Study||29
11183075|NCT01717326|12372084|FG008|COMPLETED|Overall Study||32
11183076|NCT01717326|12372085|FG009|COMPLETED|Overall Study||29
11183077|NCT01717326|12372086|FG010|COMPLETED|Overall Study||30
11183078|NCT01717326|12372087|FG011|COMPLETED|Overall Study||33
11183079|NCT01717326|12372088|FG012|COMPLETED|Overall Study||32
11183080|NCT01717326|12372089|FG013|COMPLETED|Overall Study||32
11183081|NCT01717326|12372090|FG014|COMPLETED|Overall Study||29
11183082|NCT01717326|12372091|FG015|COMPLETED|Overall Study||27
11183083|NCT01717326|12372092|FG016|COMPLETED|Overall Study||29
11183084|NCT01717326|12372093|FG017|COMPLETED|Overall Study||31
11183085|NCT01717326|12372094|FG018|COMPLETED|Overall Study||16
11183086|NCT01717326|12372095|FG019|COMPLETED|Overall Study||15
11183087|NCT01717326|12372076|FG000|NOT COMPLETED|Overall Study||3
11183088|NCT01717326|12372077|FG001|NOT COMPLETED|Overall Study||1
11183089|NCT01717326|12372078|FG002|NOT COMPLETED|Overall Study||0
11183090|NCT01717326|12372079|FG003|NOT COMPLETED|Overall Study||2
11183091|NCT01717326|12372080|FG004|NOT COMPLETED|Overall Study||2
11183092|NCT01717326|12372081|FG005|NOT COMPLETED|Overall Study||0
11183093|NCT01717326|12372082|FG006|NOT COMPLETED|Overall Study||1
11183094|NCT01717326|12372083|FG007|NOT COMPLETED|Overall Study||0
11183095|NCT01717326|12372084|FG008|NOT COMPLETED|Overall Study||0
11183096|NCT01717326|12372085|FG009|NOT COMPLETED|Overall Study||2
11183097|NCT01717326|12372086|FG010|NOT COMPLETED|Overall Study||2
11183098|NCT01717326|12372087|FG011|NOT COMPLETED|Overall Study||0
11183099|NCT01717326|12372088|FG012|NOT COMPLETED|Overall Study||1
11183100|NCT01717326|12372089|FG013|NOT COMPLETED|Overall Study||0
11183101|NCT01717326|12372090|FG014|NOT COMPLETED|Overall Study||0
11183102|NCT01717326|12372091|FG015|NOT COMPLETED|Overall Study||3
11183103|NCT01717326|12372092|FG016|NOT COMPLETED|Overall Study||1
11183104|NCT01717326|12372093|FG017|NOT COMPLETED|Overall Study||0
11183105|NCT01717326|12372094|FG018|NOT COMPLETED|Overall Study||4
11183106|NCT01717326|12372095|FG019|NOT COMPLETED|Overall Study||6
11183107|NCT01717391|12372137|FG000|STARTED|Overall Study||36
11183108|NCT01717391|12372137|FG000|COMPLETED|Overall Study||27
11183109|NCT01717391|12372137|FG000|NOT COMPLETED|Overall Study||9
11183110|NCT01717456|12372145|FG000|STARTED|End of Treatment||11
11183111|NCT01717456|12372146|FG001|STARTED|End of Treatment||8
11183112|NCT01717456|12372145|FG000|COMPLETED|End of Treatment||11
11183113|NCT01717456|12372146|FG001|COMPLETED|End of Treatment||6
11183114|NCT01717456|12372145|FG000|NOT COMPLETED|End of Treatment||0
11183115|NCT01717456|12372146|FG001|NOT COMPLETED|End of Treatment||2
11183116|NCT01717456|12372145|FG000|STARTED|Follow-Up 6 Months After End of Tx||11
11183117|NCT01717456|12372146|FG001|STARTED|Follow-Up 6 Months After End of Tx||6
11183118|NCT01717456|12372145|FG000|COMPLETED|Follow-Up 6 Months After End of Tx||7
11183119|NCT01717456|12372146|FG001|COMPLETED|Follow-Up 6 Months After End of Tx||2
11183120|NCT01717456|12372145|FG000|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
11183121|NCT01717456|12372146|FG001|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
11183122|NCT01717521|12372153|FG000|STARTED|Overall Study||20
11183123|NCT01717521|12372153|FG000|COMPLETED|Overall Study||20
11183124|NCT01717521|12372153|FG000|NOT COMPLETED|Overall Study||0
11183125|NCT01717638|12372170|FG000|STARTED|Overall Study||67
11183126|NCT01717638|12372171|FG001|STARTED|Overall Study||61
11183127|NCT01717638|12372172|FG002|STARTED|Overall Study||60
11183128|NCT01717638|12372173|FG003|STARTED|Overall Study||66
11183129|NCT01717638|12372174|FG004|STARTED|Overall Study||64
11183130|NCT01717638|12372175|FG005|STARTED|Overall Study||55
11183131|NCT01717638|12372176|FG006|STARTED|Overall Study||43
11183132|NCT01717638|12372177|FG007|STARTED|Overall Study||29
11183133|NCT01717638|12372178|FG008|STARTED|Overall Study||28
11183134|NCT01717638|12372179|FG009|STARTED|Overall Study||100
11183135|NCT01717638|12372180|FG010|STARTED|Overall Study||11
11183136|NCT01717638|12372181|FG011|STARTED|Overall Study||12
11183137|NCT01717638|12372182|FG012|STARTED|Overall Study||209
11183138|NCT01717638|12372170|FG000|COMPLETED|Overall Study||67
11183139|NCT01717638|12372171|FG001|COMPLETED|Overall Study||60
11183140|NCT01717638|12372172|FG002|COMPLETED|Overall Study||59
11183141|NCT01717638|12372173|FG003|COMPLETED|Overall Study||66
11183142|NCT01717638|12372174|FG004|COMPLETED|Overall Study||63
11183143|NCT01717638|12372175|FG005|COMPLETED|Overall Study||54
11183144|NCT01717638|12372176|FG006|COMPLETED|Overall Study||41
11183145|NCT01717638|12372177|FG007|COMPLETED|Overall Study||28
11183146|NCT01717638|12372178|FG008|COMPLETED|Overall Study||26
11183147|NCT01717638|12372179|FG009|COMPLETED|Overall Study||99
11183148|NCT01717638|12372180|FG010|COMPLETED|Overall Study||11
11183149|NCT01717638|12372181|FG011|COMPLETED|Overall Study||12
11183150|NCT01717638|12372182|FG012|COMPLETED|Overall Study||190
11183151|NCT01717638|12372170|FG000|NOT COMPLETED|Overall Study||0
11183152|NCT01717638|12372171|FG001|NOT COMPLETED|Overall Study||1
11183153|NCT01717638|12372172|FG002|NOT COMPLETED|Overall Study||1
11183154|NCT01717638|12372173|FG003|NOT COMPLETED|Overall Study||0
11183155|NCT01717638|12372174|FG004|NOT COMPLETED|Overall Study||1
11183156|NCT01717638|12372175|FG005|NOT COMPLETED|Overall Study||1
11183157|NCT01717638|12372176|FG006|NOT COMPLETED|Overall Study||2
11183158|NCT01717638|12372177|FG007|NOT COMPLETED|Overall Study||1
11183159|NCT01717638|12372178|FG008|NOT COMPLETED|Overall Study||2
11183160|NCT01717638|12372179|FG009|NOT COMPLETED|Overall Study||1
11183161|NCT01717638|12372180|FG010|NOT COMPLETED|Overall Study||0
11183162|NCT01717638|12372181|FG011|NOT COMPLETED|Overall Study||0
11183163|NCT01717638|12372182|FG012|NOT COMPLETED|Overall Study||19
11183164|NCT01717742|12372218|FG000|STARTED|Overall Study||48
11183165|NCT01717742|12372219|FG001|STARTED|Overall Study||49
11183166|NCT01717742|12372218|FG000|COMPLETED|Overall Study||43
11183167|NCT01717742|12372219|FG001|COMPLETED|Overall Study||47
11183168|NCT01717742|12372218|FG000|NOT COMPLETED|Overall Study||5
11183169|NCT01717742|12372219|FG001|NOT COMPLETED|Overall Study||2
11183170|NCT01717768|12372235|FG000|STARTED|Part 1 (Duration of 15 Days)||17
11183171|NCT01717768|12372236|FG001|STARTED|Part 1 (Duration of 15 Days)||17
11183172|NCT01717768|12372237|FG002|STARTED|Part 1 (Duration of 15 Days)||0
11183173|NCT01717768|12372238|FG003|STARTED|Part 1 (Duration of 15 Days)||0
11183174|NCT01717768|12372239|FG004|STARTED|Part 1 (Duration of 15 Days)||0
11183175|NCT01717768|12372240|FG005|STARTED|Part 1 (Duration of 15 Days)||0
11183176|NCT01717768|12372241|FG006|STARTED|Part 1 (Duration of 15 Days)||0
11183177|NCT01717768|12372242|FG007|STARTED|Part 1 (Duration of 15 Days)||0
11183178|NCT01717768|12372243|FG008|STARTED|Part 1 (Duration of 15 Days)||0
11183179|NCT01717768|12372244|FG009|STARTED|Part 1 (Duration of 15 Days)||0
11183180|NCT01717768|12372245|FG010|STARTED|Part 1 (Duration of 15 Days)||0
11183181|NCT01717768|12372246|FG011|STARTED|Part 1 (Duration of 15 Days)||0
11183182|NCT01717768|12372235|FG000|COMPLETED|Part 1 (Duration of 15 Days)||17
11183183|NCT01717768|12372236|FG001|COMPLETED|Part 1 (Duration of 15 Days)||16
11183184|NCT01717768|12372237|FG002|COMPLETED|Part 1 (Duration of 15 Days)||0
11183185|NCT01717768|12372238|FG003|COMPLETED|Part 1 (Duration of 15 Days)||0
11183186|NCT01717768|12372239|FG004|COMPLETED|Part 1 (Duration of 15 Days)||0
11183187|NCT01717768|12372240|FG005|COMPLETED|Part 1 (Duration of 15 Days)||0
11183188|NCT01717768|12372241|FG006|COMPLETED|Part 1 (Duration of 15 Days)||0
11183189|NCT01717768|12372242|FG007|COMPLETED|Part 1 (Duration of 15 Days)||0
11183190|NCT01717768|12372243|FG008|COMPLETED|Part 1 (Duration of 15 Days)||0
11183191|NCT01717768|12372244|FG009|COMPLETED|Part 1 (Duration of 15 Days)||0
11183192|NCT01717768|12372245|FG010|COMPLETED|Part 1 (Duration of 15 Days)||0
11183193|NCT01717768|12372246|FG011|COMPLETED|Part 1 (Duration of 15 Days)||0
11183194|NCT01717768|12372235|FG000|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
11183195|NCT01717768|12372236|FG001|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
11183196|NCT01717768|12372237|FG002|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
11183197|NCT01717768|12372238|FG003|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
11183198|NCT01717768|12372239|FG004|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
11183199|NCT01717768|12372240|FG005|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
11183200|NCT01717768|12372241|FG006|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
11183201|NCT01717768|12372242|FG007|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
11183202|NCT01717768|12372243|FG008|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
11026891|NCT00830869|12205482|FG002|COMPLETED|Period 2: Part 2||0
11183203|NCT01717768|12372244|FG009|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
11183204|NCT01717768|12372245|FG010|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
11183205|NCT01717768|12372246|FG011|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
11183206|NCT01717768|12372235|FG000|STARTED|Part 2 (Duration of 15 Days)||0
11183207|NCT01717768|12372236|FG001|STARTED|Part 2 (Duration of 15 Days)||0
11183208|NCT01717768|12372237|FG002|STARTED|Part 2 (Duration of 15 Days)||17
11183209|NCT01717768|12372238|FG003|STARTED|Part 2 (Duration of 15 Days)||0
11183210|NCT01717768|12372239|FG004|STARTED|Part 2 (Duration of 15 Days)||0
11183211|NCT01717768|12372240|FG005|STARTED|Part 2 (Duration of 15 Days)||0
11183212|NCT01717768|12372241|FG006|STARTED|Part 2 (Duration of 15 Days)||0
11183213|NCT01717768|12372242|FG007|STARTED|Part 2 (Duration of 15 Days)||0
11183214|NCT01717768|12372243|FG008|STARTED|Part 2 (Duration of 15 Days)||0
11183215|NCT01717768|12372244|FG009|STARTED|Part 2 (Duration of 15 Days)||0
11183216|NCT01717768|12372245|FG010|STARTED|Part 2 (Duration of 15 Days)||0
11183217|NCT01717768|12372246|FG011|STARTED|Part 2 (Duration of 15 Days)||0
11183218|NCT01717768|12372235|FG000|COMPLETED|Part 2 (Duration of 15 Days)||0
11183219|NCT01717768|12372236|FG001|COMPLETED|Part 2 (Duration of 15 Days)||0
11183220|NCT01717768|12372237|FG002|COMPLETED|Part 2 (Duration of 15 Days)||17
11183221|NCT01717768|12372238|FG003|COMPLETED|Part 2 (Duration of 15 Days)||0
11183222|NCT01717768|12372239|FG004|COMPLETED|Part 2 (Duration of 15 Days)||0
11183223|NCT01717768|12372240|FG005|COMPLETED|Part 2 (Duration of 15 Days)||0
11183224|NCT01717768|12372241|FG006|COMPLETED|Part 2 (Duration of 15 Days)||0
11183225|NCT01717768|12372242|FG007|COMPLETED|Part 2 (Duration of 15 Days)||0
11183226|NCT01717768|12372243|FG008|COMPLETED|Part 2 (Duration of 15 Days)||0
11183227|NCT01717768|12372244|FG009|COMPLETED|Part 2 (Duration of 15 Days)||0
11183228|NCT01717768|12372245|FG010|COMPLETED|Part 2 (Duration of 15 Days)||0
11183229|NCT01717768|12372246|FG011|COMPLETED|Part 2 (Duration of 15 Days)||0
11183230|NCT01717768|12372235|FG000|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
11183231|NCT01717768|12372236|FG001|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
11183232|NCT01717768|12372237|FG002|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
11183233|NCT01717768|12372238|FG003|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
11183234|NCT01717768|12372239|FG004|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
11183235|NCT01717768|12372240|FG005|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
11183236|NCT01717768|12372241|FG006|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
11183237|NCT01717768|12372242|FG007|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
11183238|NCT01717768|12372243|FG008|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
11183239|NCT01717768|12372244|FG009|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
11183240|NCT01717768|12372245|FG010|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
11183241|NCT01717768|12372246|FG011|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
11183242|NCT01717768|12372235|FG000|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183243|NCT01717768|12372236|FG001|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183244|NCT01717768|12372237|FG002|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183245|NCT01717768|12372238|FG003|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
11183246|NCT01717768|12372239|FG004|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
11183247|NCT01717768|12372240|FG005|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
11183248|NCT01717768|12372241|FG006|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183249|NCT01717768|12372242|FG007|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183250|NCT01717768|12372243|FG008|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183251|NCT01717768|12372244|FG009|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183252|NCT01717768|12372245|FG010|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183253|NCT01717768|12372246|FG011|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183254|NCT01717768|12372235|FG000|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183255|NCT01717768|12372236|FG001|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183256|NCT01717768|12372237|FG002|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183257|NCT01717768|12372238|FG003|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
11183258|NCT01717768|12372239|FG004|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
11183259|NCT01717768|12372240|FG005|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
11183260|NCT01717768|12372241|FG006|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183261|NCT01717768|12372242|FG007|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183262|NCT01717768|12372243|FG008|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183263|NCT01717768|12372244|FG009|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183264|NCT01717768|12372245|FG010|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183265|NCT01717768|12372246|FG011|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183266|NCT01717768|12372235|FG000|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183267|NCT01717768|12372236|FG001|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183268|NCT01717768|12372237|FG002|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183269|NCT01717768|12372238|FG003|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183270|NCT01717768|12372239|FG004|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183271|NCT01717768|12372240|FG005|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183272|NCT01717768|12372241|FG006|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183273|NCT01717768|12372242|FG007|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183274|NCT01717768|12372243|FG008|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183275|NCT01717768|12372244|FG009|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183276|NCT01717768|12372245|FG010|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183277|NCT01717768|12372246|FG011|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
11183278|NCT01717768|12372235|FG000|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183279|NCT01717768|12372236|FG001|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183280|NCT01717768|12372237|FG002|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183281|NCT01717768|12372238|FG003|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
11183282|NCT01717768|12372239|FG004|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
11183283|NCT01717768|12372240|FG005|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
11183284|NCT01717768|12372241|FG006|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183285|NCT01717768|12372242|FG007|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183286|NCT01717768|12372243|FG008|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183287|NCT01717768|12372244|FG009|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183288|NCT01717768|12372245|FG010|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183289|NCT01717768|12372246|FG011|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183290|NCT01717768|12372235|FG000|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183291|NCT01717768|12372236|FG001|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183292|NCT01717768|12372237|FG002|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183293|NCT01717768|12372238|FG003|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
11183294|NCT01717768|12372239|FG004|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
11183295|NCT01717768|12372240|FG005|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
11183296|NCT01717768|12372241|FG006|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183297|NCT01717768|12372242|FG007|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183298|NCT01717768|12372243|FG008|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183299|NCT01717768|12372244|FG009|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183300|NCT01717768|12372245|FG010|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183301|NCT01717768|12372246|FG011|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183302|NCT01717768|12372235|FG000|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183303|NCT01717768|12372236|FG001|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183304|NCT01717768|12372237|FG002|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183305|NCT01717768|12372238|FG003|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183306|NCT01717768|12372239|FG004|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183307|NCT01717768|12372240|FG005|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183308|NCT01717768|12372241|FG006|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183309|NCT01717768|12372242|FG007|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183310|NCT01717768|12372243|FG008|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183311|NCT01717768|12372244|FG009|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183312|NCT01717768|12372245|FG010|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183313|NCT01717768|12372246|FG011|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
11183314|NCT01717768|12372235|FG000|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183315|NCT01717768|12372236|FG001|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183316|NCT01717768|12372237|FG002|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183317|NCT01717768|12372238|FG003|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
11183318|NCT01717768|12372239|FG004|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
11183319|NCT01717768|12372240|FG005|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
11183320|NCT01717768|12372241|FG006|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183321|NCT01717768|12372242|FG007|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183322|NCT01717768|12372243|FG008|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183323|NCT01717768|12372244|FG009|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183324|NCT01717768|12372245|FG010|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183325|NCT01717768|12372246|FG011|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183326|NCT01717768|12372235|FG000|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183327|NCT01717768|12372236|FG001|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183328|NCT01717768|12372237|FG002|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183329|NCT01717768|12372238|FG003|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
11183330|NCT01717768|12372239|FG004|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
11183331|NCT01717768|12372240|FG005|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
11183332|NCT01717768|12372241|FG006|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183333|NCT01717768|12372242|FG007|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183334|NCT01717768|12372243|FG008|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183335|NCT01717768|12372244|FG009|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183336|NCT01717768|12372245|FG010|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183337|NCT01717768|12372246|FG011|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183338|NCT01717768|12372235|FG000|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183339|NCT01717768|12372236|FG001|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183340|NCT01717768|12372237|FG002|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183341|NCT01717768|12372238|FG003|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183342|NCT01717768|12372239|FG004|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183343|NCT01717768|12372240|FG005|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183344|NCT01717768|12372241|FG006|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183345|NCT01717768|12372242|FG007|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183346|NCT01717768|12372243|FG008|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183347|NCT01717768|12372244|FG009|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183348|NCT01717768|12372245|FG010|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183349|NCT01717768|12372246|FG011|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
11183350|NCT01717768|12372235|FG000|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183351|NCT01717768|12372236|FG001|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183352|NCT01717768|12372237|FG002|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183353|NCT01717768|12372238|FG003|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183354|NCT01717768|12372239|FG004|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183355|NCT01717768|12372240|FG005|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183356|NCT01717768|12372241|FG006|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
11183357|NCT01717768|12372242|FG007|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183358|NCT01717768|12372243|FG008|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
11183359|NCT01717768|12372244|FG009|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183360|NCT01717768|12372245|FG010|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
11183361|NCT01717768|12372246|FG011|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
11183362|NCT01717768|12372235|FG000|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183363|NCT01717768|12372236|FG001|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183364|NCT01717768|12372237|FG002|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183365|NCT01717768|12372238|FG003|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183366|NCT01717768|12372239|FG004|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183367|NCT01717768|12372240|FG005|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183368|NCT01717768|12372241|FG006|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
11183369|NCT01717768|12372242|FG007|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183370|NCT01717768|12372243|FG008|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
11183371|NCT01717768|12372244|FG009|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183372|NCT01717768|12372245|FG010|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
11183373|NCT01717768|12372246|FG011|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
11183374|NCT01717768|12372235|FG000|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183375|NCT01717768|12372236|FG001|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183376|NCT01717768|12372237|FG002|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183377|NCT01717768|12372238|FG003|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183378|NCT01717768|12372239|FG004|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183379|NCT01717768|12372240|FG005|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183380|NCT01717768|12372241|FG006|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183381|NCT01717768|12372242|FG007|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183382|NCT01717768|12372243|FG008|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183383|NCT01717768|12372244|FG009|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183384|NCT01717768|12372245|FG010|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
11183385|NCT01717768|12372246|FG011|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
11183386|NCT01717768|12372235|FG000|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183387|NCT01717768|12372236|FG001|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183388|NCT01717768|12372237|FG002|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183389|NCT01717768|12372238|FG003|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183390|NCT01717768|12372239|FG004|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183391|NCT01717768|12372240|FG005|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183392|NCT01717768|12372241|FG006|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183393|NCT01717768|12372242|FG007|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
11183394|NCT01717768|12372243|FG008|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183395|NCT01717768|12372244|FG009|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
11183396|NCT01717768|12372245|FG010|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183397|NCT01717768|12372246|FG011|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183398|NCT01717768|12372235|FG000|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183399|NCT01717768|12372236|FG001|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183400|NCT01717768|12372237|FG002|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183401|NCT01717768|12372238|FG003|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183402|NCT01717768|12372239|FG004|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183403|NCT01717768|12372240|FG005|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183404|NCT01717768|12372241|FG006|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183405|NCT01717768|12372242|FG007|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
11183406|NCT01717768|12372243|FG008|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183407|NCT01717768|12372244|FG009|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
11183408|NCT01717768|12372245|FG010|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183409|NCT01717768|12372246|FG011|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183410|NCT01717768|12372235|FG000|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183411|NCT01717768|12372236|FG001|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183412|NCT01717768|12372237|FG002|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183413|NCT01717768|12372238|FG003|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183414|NCT01717768|12372239|FG004|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183415|NCT01717768|12372240|FG005|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183416|NCT01717768|12372241|FG006|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183417|NCT01717768|12372242|FG007|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
11183418|NCT01717768|12372243|FG008|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183419|NCT01717768|12372244|FG009|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
11183420|NCT01717768|12372245|FG010|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183421|NCT01717768|12372246|FG011|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
11183422|NCT01717859|12372272|FG000|STARTED|Overall Study||54
11183423|NCT01717859|12372272|FG000|3 Month|Overall Study||50
11183424|NCT01717859|12372272|FG000|COMPLETED|Overall Study||44
11183425|NCT01717859|12372272|FG000|NOT COMPLETED|Overall Study||10
11183426|NCT01717872|12372285|FG000|STARTED|Overall Study||25
11183427|NCT01717872|12372286|FG001|STARTED|Overall Study||25
11183428|NCT01717872|12372285|FG000|COMPLETED|Overall Study||25
11183429|NCT01717872|12372286|FG001|COMPLETED|Overall Study||25
11324238|NCT02742766|12521563|FG004|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324239|NCT02742766|12521564|FG005|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324240|NCT02742766|12521565|FG006|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324241|NCT02742766|12521566|FG007|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324242|NCT02742766|12521567|FG008|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324243|NCT02742766|12521568|FG009|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324244|NCT02742766|12521569|FG010|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324245|NCT02742766|12521570|FG011|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324246|NCT02742766|12521571|FG012|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324247|NCT02742766|12521572|FG013|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324248|NCT02742766|12521573|FG014|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324249|NCT02742766|12521574|FG015|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11026892|NCT00830869|12205483|FG003|COMPLETED|Period 2: Part 2||0
11026893|NCT00830869|12205484|FG004|COMPLETED|Period 2: Part 2||0
11324250|NCT02742766|12521575|FG016|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324251|NCT02742766|12521576|FG017|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324252|NCT02742766|12521577|FG018|NOT COMPLETED|Part 1 (Up to 8 Days)||0
11324253|NCT02742766|12521559|FG000|STARTED|Part 2 (Up to 22 Days)||0
11324254|NCT02742766|12521560|FG001|STARTED|Part 2 (Up to 22 Days)||0
11324255|NCT02742766|12521561|FG002|STARTED|Part 2 (Up to 22 Days)||0
11324256|NCT02742766|12521562|FG003|STARTED|Part 2 (Up to 22 Days)||0
11324257|NCT02742766|12521563|FG004|STARTED|Part 2 (Up to 22 Days)||0
11324258|NCT02742766|12521564|FG005|STARTED|Part 2 (Up to 22 Days)||0
11324259|NCT02742766|12521565|FG006|STARTED|Part 2 (Up to 22 Days)||0
11324260|NCT02742766|12521566|FG007|STARTED|Part 2 (Up to 22 Days)||0
11324261|NCT02742766|12521567|FG008|STARTED|Part 2 (Up to 22 Days)||0
11324262|NCT02742766|12521568|FG009|STARTED|Part 2 (Up to 22 Days)||0
11324263|NCT02742766|12521569|FG010|STARTED|Part 2 (Up to 22 Days)||0
11324264|NCT02742766|12521570|FG011|STARTED|Part 2 (Up to 22 Days)||0
11324265|NCT02742766|12521571|FG012|STARTED|Part 2 (Up to 22 Days)||6
11183430|NCT01717872|12372285|FG000|NOT COMPLETED|Overall Study||0
11183431|NCT01717872|12372286|FG001|NOT COMPLETED|Overall Study||0
11183432|NCT01717898|12372296|FG000|STARTED|Overall Study||6
11183433|NCT01717898|12372297|FG001|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
11183434|NCT01717898|12372298|FG002|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
11183435|NCT01717898|12372299|FG003|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
11183436|NCT01717898|12372296|FG000|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
11183437|NCT01717898|12372297|FG001|COMPLETED|Overall Study||0
11183438|NCT01717898|12372298|FG002|COMPLETED|Overall Study||0
11183439|NCT01717898|12372299|FG003|COMPLETED|Overall Study||0
11183440|NCT01717898|12372296|FG000|NOT COMPLETED|Overall Study||6
11183441|NCT01717898|12372297|FG001|NOT COMPLETED|Overall Study||0
11183442|NCT01717898|12372298|FG002|NOT COMPLETED|Overall Study||0
11183443|NCT01717898|12372299|FG003|NOT COMPLETED|Overall Study||0
11183444|NCT01717976|12372311|FG000|STARTED|Overall Study||257
11183445|NCT01717976|12372312|FG001|STARTED|Overall Study||257
11183446|NCT01717976|12372311|FG000|COMPLETED|Overall Study||257
11183447|NCT01717976|12372312|FG001|COMPLETED|Overall Study||256
11183448|NCT01717976|12372311|FG000|NOT COMPLETED|Overall Study||0
11183449|NCT01717976|12372312|FG001|NOT COMPLETED|Overall Study||1
11183450|NCT01717989|12372318|FG000|STARTED|Overall Study||2248
11183451|NCT01717989|12372318|FG000|COMPLETED|Overall Study||1182
11183452|NCT01717989|12372318|FG000|NOT COMPLETED|Overall Study||1066
11183453|NCT01718028|12372339|FG000|STARTED|Overall Study||25
11183454|NCT01718028|12372340|FG001|STARTED|Overall Study||24
11183455|NCT01718028|12372339|FG000|COMPLETED|Overall Study||25
11183456|NCT01718028|12372340|FG001|COMPLETED|Overall Study||24
11183457|NCT01718028|12372339|FG000|NOT COMPLETED|Overall Study||0
11183458|NCT01718028|12372340|FG001|NOT COMPLETED|Overall Study||0
11183459|NCT01718353|12372348|FG000|STARTED|Overall Study||41
11183460|NCT01718353|12372349|FG001|STARTED|Overall Study||22
11183461|NCT01718353|12372348|FG000|Treated|Overall Study||39
11183462|NCT01718353|12372349|FG001|Treated|Overall Study||22
11183463|NCT01718353|12372348|FG000|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
11183464|NCT01718353|12372349|FG001|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
11183465|NCT01718353|12372348|FG000|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
11183466|NCT01718353|12372349|FG001|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
11183467|NCT01718353|12372348|FG000|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
11183468|NCT01718353|12372349|FG001|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
11183469|NCT01718353|12372348|FG000|NOT COMPLETED|Overall Study||12
11183470|NCT01718353|12372349|FG001|NOT COMPLETED|Overall Study||5
11183471|NCT01718483|12372359|FG000|STARTED|Overall Study||191
11183472|NCT01718483|12372360|FG001|STARTED|Overall Study||192
11183473|NCT01718483|12372359|FG000|Treated|Overall Study||187
11183474|NCT01718483|12372360|FG001|Treated|Overall Study||192
11183475|NCT01718483|12372359|FG000|COMPLETED|Overall Study||157
11183476|NCT01718483|12372360|FG001|COMPLETED|Overall Study||158
11183477|NCT01718483|12372359|FG000|NOT COMPLETED|Overall Study||34
11183478|NCT01718483|12372360|FG001|NOT COMPLETED|Overall Study||34
11324266|NCT02742766|12521572|FG013|STARTED|Part 2 (Up to 22 Days)||6
11324267|NCT02742766|12521573|FG014|STARTED|Part 2 (Up to 22 Days)||6
11324268|NCT02742766|12521574|FG015|STARTED|Part 2 (Up to 22 Days)||6
11183479|NCT01718509|12372368|FG000|STARTED|Overall Study||195
11183480|NCT01718509|12372369|FG001|STARTED|Overall Study||195
11183481|NCT01718509|12372368|FG000|COMPLETED|Overall Study||147
11183482|NCT01718509|12372369|FG001|COMPLETED|Overall Study||147
11183483|NCT01718509|12372368|FG000|NOT COMPLETED|Overall Study||48
11183484|NCT01718509|12372369|FG001|NOT COMPLETED|Overall Study||48
11183485|NCT01718522|12372375|FG000|STARTED|Overall Study||75
11183486|NCT01718522|12372375|FG000|COMPLETED|Overall Study||67
11183487|NCT01718522|12372375|FG000|NOT COMPLETED|Overall Study||8
11183488|NCT01718535|12372392|FG000|STARTED|Overall Study||131
11183489|NCT01718535|12372393|FG001|STARTED|Overall Study||95
11183490|NCT01718535|12372394|FG002|STARTED|Overall Study||19
11183491|NCT01718535|12372395|FG003|STARTED|Overall Study||8
11183492|NCT01718535|12372396|FG004|STARTED|Overall Study||1
11183493|NCT01718535|12372397|FG005|STARTED|Overall Study||40
11183494|NCT01718535|12372398|FG006|STARTED|Overall Study||11
11183495|NCT01718535|12372399|FG007|STARTED|Overall Study||6
11183496|NCT01718535|12372400|FG008|STARTED|Overall Study||15
11183497|NCT01718535|12372401|FG009|STARTED|Overall Study||1
11183498|NCT01718535|12372392|FG000|First Pass|Overall Study||128
11183499|NCT01718535|12372393|FG001|First Pass|Overall Study||94
11183500|NCT01718535|12372394|FG002|First Pass|Overall Study||19
11183501|NCT01718535|12372395|FG003|First Pass|Overall Study||7
11183502|NCT01718535|12372396|FG004|First Pass|Overall Study||1
11183503|NCT01718535|12372397|FG005|First Pass|Overall Study||39
11183504|NCT01718535|12372398|FG006|First Pass|Overall Study||11
11183505|NCT01718535|12372399|FG007|First Pass|Overall Study||6
11183506|NCT01718535|12372400|FG008|First Pass|Overall Study||15
11183507|NCT01718535|12372401|FG009|First Pass|Overall Study||1
11183508|NCT01718535|12372392|FG000|COMPLETED|Overall Study||130
11183509|NCT01718535|12372393|FG001|COMPLETED|Overall Study||95
11183510|NCT01718535|12372394|FG002|COMPLETED|Overall Study||19
11183511|NCT01718535|12372395|FG003|COMPLETED|Overall Study||7
11183512|NCT01718535|12372396|FG004|COMPLETED|Overall Study||1
11183513|NCT01718535|12372397|FG005|COMPLETED|Overall Study||40
11183514|NCT01718535|12372398|FG006|COMPLETED|Overall Study||11
11183515|NCT01718535|12372399|FG007|COMPLETED|Overall Study||6
11183516|NCT01718535|12372400|FG008|COMPLETED|Overall Study||15
11183517|NCT01718535|12372401|FG009|COMPLETED|Overall Study||1
11183518|NCT01718535|12372392|FG000|NOT COMPLETED|Overall Study||1
11183519|NCT01718535|12372393|FG001|NOT COMPLETED|Overall Study||0
11183520|NCT01718535|12372394|FG002|NOT COMPLETED|Overall Study||0
11183521|NCT01718535|12372395|FG003|NOT COMPLETED|Overall Study||1
11183522|NCT01718535|12372396|FG004|NOT COMPLETED|Overall Study||0
11183523|NCT01718535|12372397|FG005|NOT COMPLETED|Overall Study||0
11183524|NCT01718535|12372398|FG006|NOT COMPLETED|Overall Study||0
11183525|NCT01718535|12372399|FG007|NOT COMPLETED|Overall Study||0
11183526|NCT01718535|12372400|FG008|NOT COMPLETED|Overall Study||0
11183527|NCT01718535|12372401|FG009|NOT COMPLETED|Overall Study||0
11183528|NCT01718691|12372425|FG000|STARTED|Overall Study||60
11183529|NCT01718691|12372426|FG001|STARTED|Overall Study||10
11183530|NCT01718691|12372425|FG000|COMPLETED|Overall Study||42
11183531|NCT01718691|12372426|FG001|COMPLETED|Overall Study||9
11183532|NCT01718691|12372425|FG000|NOT COMPLETED|Overall Study||18
11183533|NCT01718691|12372426|FG001|NOT COMPLETED|Overall Study||1
11183534|NCT01719003|12372445|FG000|STARTED|Overall Study||170
11183535|NCT01719003|12372446|FG001|STARTED|Overall Study||170
11183536|NCT01719003|12372447|FG002|STARTED|Overall Study||171
11183537|NCT01719003|12372448|FG003|STARTED|Overall Study||169
11183538|NCT01719003|12372449|FG004|STARTED|Overall Study||167
11183539|NCT01719003|12372450|FG005|STARTED|Overall Study||172
11183540|NCT01719003|12372451|FG006|STARTED|Overall Study||170
11183541|NCT01719003|12372452|FG007|STARTED|Overall Study||171
11183542|NCT01719003|12372453|FG008|STARTED|Overall Study||53
11183543|NCT01719003|12372445|FG000|COMPLETED|Overall Study||161
11183544|NCT01719003|12372446|FG001|COMPLETED|Overall Study||153
11183545|NCT01719003|12372447|FG002|COMPLETED|Overall Study||154
11183546|NCT01719003|12372448|FG003|COMPLETED|Overall Study||156
11183547|NCT01719003|12372449|FG004|COMPLETED|Overall Study||150
11183548|NCT01719003|12372450|FG005|COMPLETED|Overall Study||160
11183549|NCT01719003|12372451|FG006|COMPLETED|Overall Study||150
11183550|NCT01719003|12372452|FG007|COMPLETED|Overall Study||151
11183551|NCT01719003|12372453|FG008|COMPLETED|Overall Study||49
11183552|NCT01719003|12372445|FG000|NOT COMPLETED|Overall Study||9
11183553|NCT01719003|12372446|FG001|NOT COMPLETED|Overall Study||17
11183554|NCT01719003|12372447|FG002|NOT COMPLETED|Overall Study||17
11183555|NCT01719003|12372448|FG003|NOT COMPLETED|Overall Study||13
11183556|NCT01719003|12372449|FG004|NOT COMPLETED|Overall Study||17
11183557|NCT01719003|12372450|FG005|NOT COMPLETED|Overall Study||12
11183558|NCT01719003|12372451|FG006|NOT COMPLETED|Overall Study||20
11183559|NCT01719003|12372452|FG007|NOT COMPLETED|Overall Study||20
11183560|NCT01719003|12372453|FG008|NOT COMPLETED|Overall Study||4
11183561|NCT01719172|12372472|FG000|STARTED|Overall Study||30
11183562|NCT01719172|12372472|FG000|COMPLETED|Overall Study||28
11183563|NCT01719172|12372472|FG000|NOT COMPLETED|Overall Study||2
11183564|NCT01719224|12372476|FG000|STARTED|Intervention 1: Sleeping Position 1||18
11183565|NCT01719224|12372477|FG001|STARTED|Intervention 1: Sleeping Position 1||18
11183566|NCT01719224|12372476|FG000|COMPLETED|Intervention 1: Sleeping Position 1||14
11183567|NCT01719224|12372477|FG001|COMPLETED|Intervention 1: Sleeping Position 1||16
11204260|NCT01852110|12394775|FG000|Treated|Overall Study||119
11183568|NCT01719224|12372476|FG000|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
11183569|NCT01719224|12372477|FG001|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
11183570|NCT01719224|12372476|FG000|STARTED|Intervention 2: Position Change(At 3.5h)||14
11183571|NCT01719224|12372477|FG001|STARTED|Intervention 2: Position Change(At 3.5h)||16
11183572|NCT01719224|12372476|FG000|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
11183573|NCT01719224|12372477|FG001|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
11183574|NCT01719224|12372476|FG000|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
11183575|NCT01719224|12372477|FG001|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
11183576|NCT01719367|12372486|FG000|STARTED|Overall Study||19
11183577|NCT01719367|12372487|FG001|STARTED|Overall Study||19
11183578|NCT01719367|12372486|FG000|COMPLETED|Overall Study||19
11183579|NCT01719367|12372487|FG001|COMPLETED|Overall Study||19
11183580|NCT01719367|12372486|FG000|NOT COMPLETED|Overall Study||0
11183581|NCT01719367|12372487|FG001|NOT COMPLETED|Overall Study||0
11183582|NCT01719380|12372503|FG000|STARTED|Overall Study||2
11183583|NCT01719380|12372504|FG001|STARTED|Overall Study||7
11183584|NCT01719380|12372505|FG002|STARTED|Overall Study||9
11183585|NCT01719380|12372506|FG003|STARTED|Overall Study||8
11183586|NCT01719380|12372507|FG004|STARTED|Overall Study||3
11183587|NCT01719380|12372508|FG005|STARTED|Overall Study||8
11183588|NCT01719380|12372509|FG006|STARTED|Overall Study||10
11183589|NCT01719380|12372510|FG007|STARTED|Overall Study||7
11183590|NCT01719380|12372511|FG008|STARTED|Overall Study||50
11183591|NCT01719380|12372512|FG009|STARTED|Overall Study||52
11183592|NCT01719380|12372503|FG000|COMPLETED|Overall Study||0
11183593|NCT01719380|12372504|FG001|COMPLETED|Overall Study||0
11183594|NCT01719380|12372505|FG002|COMPLETED|Overall Study||0
11183595|NCT01719380|12372506|FG003|COMPLETED|Overall Study||0
11183596|NCT01719380|12372507|FG004|COMPLETED|Overall Study||0
11183597|NCT01719380|12372508|FG005|COMPLETED|Overall Study||0
11183598|NCT01719380|12372509|FG006|COMPLETED|Overall Study||0
11183599|NCT01719380|12372510|FG007|COMPLETED|Overall Study||0
11183600|NCT01719380|12372511|FG008|COMPLETED|Overall Study||0
11183601|NCT01719380|12372512|FG009|COMPLETED|Overall Study||1
11183602|NCT01719380|12372503|FG000|NOT COMPLETED|Overall Study||2
11183603|NCT01719380|12372504|FG001|NOT COMPLETED|Overall Study||7
11183604|NCT01719380|12372505|FG002|NOT COMPLETED|Overall Study||9
11183605|NCT01719380|12372506|FG003|NOT COMPLETED|Overall Study||8
11183606|NCT01719380|12372507|FG004|NOT COMPLETED|Overall Study||3
11183607|NCT01719380|12372508|FG005|NOT COMPLETED|Overall Study||8
11183608|NCT01719380|12372509|FG006|NOT COMPLETED|Overall Study||10
11183609|NCT01719380|12372510|FG007|NOT COMPLETED|Overall Study||7
11183610|NCT01719380|12372511|FG008|NOT COMPLETED|Overall Study||50
11183611|NCT01719380|12372512|FG009|NOT COMPLETED|Overall Study||51
11183612|NCT01719653|12372546|FG000|STARTED|Overall Study||209
11183613|NCT01719653|12372547|FG001|STARTED|Overall Study||213
11183614|NCT01719653|12372548|FG002|STARTED|Overall Study||218
11183615|NCT01719653|12372549|FG003|STARTED|Overall Study||218
11183616|NCT01719653|12372550|FG004|STARTED|Overall Study||221
11183617|NCT01719653|12372546|FG000|COMPLETED|Overall Study||200
11183618|NCT01719653|12372547|FG001|COMPLETED|Overall Study||200
11183619|NCT01719653|12372548|FG002|COMPLETED|Overall Study||200
11183620|NCT01719653|12372549|FG003|COMPLETED|Overall Study||200
11183621|NCT01719653|12372550|FG004|COMPLETED|Overall Study||200
11183622|NCT01719653|12372546|FG000|NOT COMPLETED|Overall Study||9
11183623|NCT01719653|12372547|FG001|NOT COMPLETED|Overall Study||13
11183624|NCT01719653|12372548|FG002|NOT COMPLETED|Overall Study||18
11183625|NCT01719653|12372549|FG003|NOT COMPLETED|Overall Study||18
11183626|NCT01719653|12372550|FG004|NOT COMPLETED|Overall Study||21
11183627|NCT01719757|12372562|FG000|STARTED|Overall Study||359
11183628|NCT01719757|12372562|FG000|COMPLETED|Overall Study||258
11183629|NCT01719757|12372562|FG000|NOT COMPLETED|Overall Study||101
11183630|NCT01719783|12372570|FG000|STARTED|Dose 1||30
11183631|NCT01719783|12372571|FG001|STARTED|Dose 1||10
11183632|NCT01719783|12372570|FG000|COMPLETED|Dose 1||30
11183633|NCT01719783|12372571|FG001|COMPLETED|Dose 1||10
11183634|NCT01719783|12372570|FG000|NOT COMPLETED|Dose 1||0
11183635|NCT01719783|12372571|FG001|NOT COMPLETED|Dose 1||0
11183636|NCT01719783|12372570|FG000|STARTED|Dose 2||30
11183637|NCT01719783|12372571|FG001|STARTED|Dose 2||10
11183638|NCT01719783|12372570|FG000|COMPLETED|Dose 2||29
11183639|NCT01719783|12372571|FG001|COMPLETED|Dose 2||10
11183640|NCT01719783|12372570|FG000|NOT COMPLETED|Dose 2||1
11183641|NCT01719783|12372571|FG001|NOT COMPLETED|Dose 2||0
11183642|NCT01719861|12372597|FG000|STARTED|Cycle 1||6
11183643|NCT01719861|12372597|FG000|COMPLETED|Cycle 1||2
11183644|NCT01719861|12372597|FG000|NOT COMPLETED|Cycle 1||4
11183645|NCT01719861|12372597|FG000|STARTED|Cycle 2||2
11183646|NCT01719861|12372597|FG000|COMPLETED|Cycle 2||1
11183647|NCT01719861|12372597|FG000|NOT COMPLETED|Cycle 2||1
11183648|NCT01719900|12372604|FG000|STARTED|Overall Study||29
11183649|NCT01719900|12372605|FG001|STARTED|Overall Study||24
11183650|NCT01719900|12372604|FG000|COMPLETED|Overall Study||22
11183651|NCT01719900|12372605|FG001|COMPLETED|Overall Study||22
11183652|NCT01719900|12372604|FG000|NOT COMPLETED|Overall Study||7
11183653|NCT01719900|12372605|FG001|NOT COMPLETED|Overall Study||2
11183654|NCT01720043|12372611|FG000|STARTED|Overall Study||8
11183655|NCT01720043|12372611|FG000|COMPLETED|Overall Study||7
11183656|NCT01720043|12372611|FG000|NOT COMPLETED|Overall Study||1
11183657|NCT01720069|12372618|FG000|STARTED|Overall Study||62
11183658|NCT01720069|12372619|FG001|STARTED|Overall Study||71
11183659|NCT01720069|12372620|FG002|STARTED|Overall Study||63
11183660|NCT01720069|12372618|FG000|Full Anaylsis Set|Overall Study||62
11183661|NCT01720069|12372619|FG001|Full Anaylsis Set|Overall Study||71
11183662|NCT01720069|12372620|FG002|Full Anaylsis Set|Overall Study||63
11183663|NCT01720069|12372618|FG000|COMPLETED|Overall Study||57
11183664|NCT01720069|12372619|FG001|COMPLETED|Overall Study||56
11183665|NCT01720069|12372620|FG002|COMPLETED|Overall Study||48
11183666|NCT01720069|12372618|FG000|NOT COMPLETED|Overall Study||5
11183667|NCT01720069|12372619|FG001|NOT COMPLETED|Overall Study||15
11183668|NCT01720069|12372620|FG002|NOT COMPLETED|Overall Study||15
11183669|NCT01720173|12372628|FG000|STARTED|Overall Study||30
11183670|NCT01720173|12372628|FG000|COMPLETED|Overall Study||30
11183671|NCT01720173|12372628|FG000|NOT COMPLETED|Overall Study||0
11183672|NCT01720225|12372634|FG000|STARTED|Overall Study||73
11183673|NCT01720225|12372635|FG001|STARTED|Overall Study||40
11183674|NCT01720225|12372634|FG000|COMPLETED|Overall Study||70
11183675|NCT01720225|12372635|FG001|COMPLETED|Overall Study||39
11183676|NCT01720225|12372634|FG000|NOT COMPLETED|Overall Study||3
11183677|NCT01720225|12372635|FG001|NOT COMPLETED|Overall Study||1
11183678|NCT01720251|12372644|FG000|STARTED|Overall Study||79
11183679|NCT01720251|12372645|FG001|STARTED|Overall Study||79
11183680|NCT01720251|12372646|FG002|STARTED|Overall Study||82
11183681|NCT01720251|12372644|FG000|COMPLETED|Overall Study||78
11183682|NCT01720251|12372645|FG001|COMPLETED|Overall Study||77
11183683|NCT01720251|12372646|FG002|COMPLETED|Overall Study||82
11183684|NCT01720251|12372644|FG000|NOT COMPLETED|Overall Study||1
11183685|NCT01720251|12372645|FG001|NOT COMPLETED|Overall Study||2
11183686|NCT01720251|12372646|FG002|NOT COMPLETED|Overall Study||0
11183687|NCT01720264|12372654|FG000|STARTED|Transplant With Sitagliptin for 15 Days||15
11183688|NCT01720264|12372654|FG000|COMPLETED|Transplant With Sitagliptin for 15 Days||14
11183689|NCT01720264|12372654|FG000|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1
11183690|NCT01720264|12372654|FG000|STARTED|Post-transplant (Day 16) to 1 Year||14
11183691|NCT01720264|12372654|FG000|COMPLETED|Post-transplant (Day 16) to 1 Year||2
11183692|NCT01720264|12372654|FG000|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12
11183693|NCT01720277|12372660|FG000|STARTED|Overall Study||1461
11183694|NCT01720277|12372661|FG001|STARTED|Overall Study||1496
11183695|NCT01720277|12372660|FG000|COMPLETED|Overall Study|intent-to-treat approach|958
11183696|NCT01720277|12372661|FG001|COMPLETED|Overall Study|intent-to-treat approach|938
11183697|NCT01720277|12372660|FG000|NOT COMPLETED|Overall Study||503
11183698|NCT01720277|12372661|FG001|NOT COMPLETED|Overall Study||558
11183699|NCT01720316|12372671|FG000|STARTED|Double-Blind Glycine Placebo Crossover||1
11183700|NCT01720316|12372672|FG001|STARTED|Double-Blind Glycine Placebo Crossover||1
11183701|NCT01720316|12372671|FG000|COMPLETED|Double-Blind Glycine Placebo Crossover||1
11183702|NCT01720316|12372672|FG001|COMPLETED|Double-Blind Glycine Placebo Crossover||1
11183703|NCT01720316|12372671|FG000|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
11183704|NCT01720316|12372672|FG001|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
11183705|NCT01720316|12372671|FG000|STARTED|Open-label Glycine||1
11183706|NCT01720316|12372672|FG001|STARTED|Open-label Glycine||1
11183707|NCT01720316|12372671|FG000|COMPLETED|Open-label Glycine||1
11183708|NCT01720316|12372672|FG001|COMPLETED|Open-label Glycine||1
11183709|NCT01720316|12372671|FG000|NOT COMPLETED|Open-label Glycine||0
11183710|NCT01720316|12372672|FG001|NOT COMPLETED|Open-label Glycine||0
11183711|NCT01720446|12372708|FG000|STARTED|Overall Study||826
11183712|NCT01720446|12372709|FG001|STARTED|Overall Study||822
11183713|NCT01720446|12372710|FG002|STARTED|Overall Study||824
11183714|NCT01720446|12372711|FG003|STARTED|Overall Study||825
11183715|NCT01720446|12372708|FG000|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
11183716|NCT01720446|12372709|FG001|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
11183717|NCT01720446|12372710|FG002|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
11183718|NCT01720446|12372711|FG003|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
11183719|NCT01720446|12372708|FG000|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
11183720|NCT01720446|12372709|FG001|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
11183721|NCT01720446|12372710|FG002|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
11183722|NCT01720446|12372711|FG003|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
11183723|NCT01720446|12372708|FG000|NOT COMPLETED|Overall Study||14
11183724|NCT01720446|12372709|FG001|NOT COMPLETED|Overall Study||11
11183725|NCT01720446|12372710|FG002|NOT COMPLETED|Overall Study||20
11183726|NCT01720446|12372711|FG003|NOT COMPLETED|Overall Study||20
11183727|NCT01720524|12372726|FG000|STARTED|Part A||29
11183728|NCT01720524|12372727|FG001|STARTED|Part A||30
11183729|NCT01720524|12372726|FG000|COMPLETED|Part A||22
11183730|NCT01720524|12372727|FG001|COMPLETED|Part A||18
11183731|NCT01720524|12372726|FG000|NOT COMPLETED|Part A||7
11183732|NCT01720524|12372727|FG001|NOT COMPLETED|Part A||12
11183733|NCT01720524|12372726|FG000|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|27
11183734|NCT01720524|12372727|FG001|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|26
11183735|NCT01720524|12372726|FG000|COMPLETED|Part B||22
11183736|NCT01720524|12372727|FG001|COMPLETED|Part B||17
11183737|NCT01720524|12372726|FG000|NOT COMPLETED|Part B||5
11183738|NCT01720524|12372727|FG001|NOT COMPLETED|Part B||9
11183739|NCT01720602|12372735|FG000|STARTED|Overall Study||15
11183740|NCT01720602|12372735|FG000|COMPLETED|Overall Study||10
11183741|NCT01720602|12372735|FG000|NOT COMPLETED|Overall Study||5
11183742|NCT01720667|12372741|FG000|STARTED|Overall Study||64
11183743|NCT01720667|12372742|FG001|STARTED|Overall Study||42
11183744|NCT01720667|12372741|FG000|Recieved Second Infusion of Same Drug|Overall Study||50
11183745|NCT01720667|12372742|FG001|Recieved Second Infusion of Same Drug|Overall Study||20
11183746|NCT01720667|12372741|FG000|Recieved Alternate Intervention|Overall Study||45
11183747|NCT01720667|12372742|FG001|Recieved Alternate Intervention|Overall Study||10
11183748|NCT01720667|12372741|FG000|Received 2nd Infusion of Alternate Drug|Overall Study||27
11183749|NCT01720667|12372742|FG001|Received 2nd Infusion of Alternate Drug|Overall Study||6
11183750|NCT01720667|12372741|FG000|Modified ITT|Overall Study||53
11183751|NCT01720667|12372742|FG001|Modified ITT|Overall Study||30
11183752|NCT01720667|12372741|FG000|COMPLETED|Overall Study||60
11183753|NCT01720667|12372742|FG001|COMPLETED|Overall Study||41
11183754|NCT01720667|12372741|FG000|NOT COMPLETED|Overall Study||4
11183755|NCT01720667|12372742|FG001|NOT COMPLETED|Overall Study||1
11183756|NCT01720797|12372752|FG000|STARTED|Overall Study||12
11183757|NCT01720797|12372753|FG001|STARTED|Overall Study||9
11183758|NCT01720797|12372752|FG000|COMPLETED|Overall Study||9
11183759|NCT01720797|12372753|FG001|COMPLETED|Overall Study||9
11183760|NCT01720797|12372752|FG000|NOT COMPLETED|Overall Study||3
11183761|NCT01720797|12372753|FG001|NOT COMPLETED|Overall Study||0
11183762|NCT01721044|12372762|FG000|STARTED|Treatment Period||176
11183763|NCT01721044|12372763|FG001|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
11183764|NCT01721044|12372764|FG002|STARTED|Treatment Period||177
11183765|NCT01721044|12372762|FG000|Rescue Week 16-24|Treatment Period||56
11183766|NCT01721044|12372763|FG001|Rescue Week 16-24|Treatment Period||38
11183767|NCT01721044|12372764|FG002|Rescue Week 16-24|Treatment Period||33
11183768|NCT01721044|12372762|FG000|COMPLETED|Treatment Period||144
11183769|NCT01721044|12372763|FG001|COMPLETED|Treatment Period||157
11183770|NCT01721044|12372764|FG002|COMPLETED|Treatment Period||158
11183771|NCT01721044|12372762|FG000|NOT COMPLETED|Treatment Period||32
11183772|NCT01721044|12372763|FG001|NOT COMPLETED|Treatment Period||17
11183773|NCT01721044|12372764|FG002|NOT COMPLETED|Treatment Period||19
11183774|NCT01721044|12372762|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
11183775|NCT01721044|12372763|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
11183776|NCT01721044|12372764|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
11183777|NCT01721044|12372762|FG000|COMPLETED|Follow Up||19
11183778|NCT01721044|12372763|FG001|COMPLETED|Follow Up||9
11183779|NCT01721044|12372764|FG002|COMPLETED|Follow Up||20
11183780|NCT01721044|12372762|FG000|NOT COMPLETED|Follow Up||0
11183781|NCT01721044|12372763|FG001|NOT COMPLETED|Follow Up||0
11183782|NCT01721044|12372764|FG002|NOT COMPLETED|Follow Up||0
11183783|NCT01721057|12372786|FG000|STARTED|Treatment Period||228
11183784|NCT01721057|12372787|FG001|STARTED|Treatment Period||229
11183785|NCT01721057|12372788|FG002|STARTED|Treatment Period||227
11183786|NCT01721057|12372789|FG003|STARTED|Treatment Period||0
11183787|NCT01721057|12372790|FG004|STARTED|Treatment Period||0
11183788|NCT01721057|12372791|FG005|STARTED|Treatment Period||0
11183789|NCT01721057|12372792|FG006|STARTED|Treatment Period||0
11183790|NCT01721057|12372786|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||228
11183791|NCT01721057|12372787|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||229
11183792|NCT01721057|12372788|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||227
11183793|NCT01721057|12372789|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0
11183794|NCT01721057|12372790|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0
11183795|NCT01721057|12372791|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||0
11183796|NCT01721057|12372792|FG006|Received at Least 1 Dose of Study Drug|Treatment Period||0
11183797|NCT01721057|12372786|FG000|Rescued|Treatment Period||55
11183798|NCT01721057|12372787|FG001|Rescued|Treatment Period||21
11183799|NCT01721057|12372788|FG002|Rescued|Treatment Period||15
11183800|NCT01721057|12372789|FG003|Rescued|Treatment Period||0
11183801|NCT01721057|12372790|FG004|Rescued|Treatment Period||0
11183802|NCT01721057|12372791|FG005|Rescued|Treatment Period||0
11183803|NCT01721057|12372792|FG006|Rescued|Treatment Period||0
11183804|NCT01721057|12372786|FG000|COMPLETED|Treatment Period|"Completers include rescued participants."|200
11183805|NCT01721057|12372787|FG001|COMPLETED|Treatment Period|"Completers include rescued participants."|210
11183806|NCT01721057|12372788|FG002|COMPLETED|Treatment Period|"Completers include rescued participants."|204
11183807|NCT01721057|12372789|FG003|COMPLETED|Treatment Period||0
11183808|NCT01721057|12372790|FG004|COMPLETED|Treatment Period||0
11183809|NCT01721057|12372791|FG005|COMPLETED|Treatment Period||0
11183810|NCT01721057|12372792|FG006|COMPLETED|Treatment Period||0
11183811|NCT01721057|12372786|FG000|NOT COMPLETED|Treatment Period||28
11183812|NCT01721057|12372787|FG001|NOT COMPLETED|Treatment Period||19
11183813|NCT01721057|12372788|FG002|NOT COMPLETED|Treatment Period||23
11183814|NCT01721057|12372789|FG003|NOT COMPLETED|Treatment Period||0
11183815|NCT01721057|12372790|FG004|NOT COMPLETED|Treatment Period||0
11183816|NCT01721057|12372791|FG005|NOT COMPLETED|Treatment Period||0
11183817|NCT01721057|12372792|FG006|NOT COMPLETED|Treatment Period||0
11183818|NCT01721057|12372786|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
11183819|NCT01721057|12372787|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
11183820|NCT01721057|12372788|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
11183821|NCT01721057|12372789|FG003|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
11183822|NCT01721057|12372790|FG004|STARTED|Rescue Period||0
11183823|NCT01721057|12372791|FG005|STARTED|Rescue Period||0
11183824|NCT01721057|12372792|FG006|STARTED|Rescue Period||0
11183825|NCT01721057|12372786|FG000|COMPLETED|Rescue Period||0
11183826|NCT01721057|12372787|FG001|COMPLETED|Rescue Period||0
11183827|NCT01721057|12372788|FG002|COMPLETED|Rescue Period||0
11183828|NCT01721057|12372789|FG003|COMPLETED|Rescue Period||88
11183829|NCT01721057|12372790|FG004|COMPLETED|Rescue Period||0
11183830|NCT01721057|12372791|FG005|COMPLETED|Rescue Period||0
11183831|NCT01721057|12372792|FG006|COMPLETED|Rescue Period||0
11183832|NCT01721057|12372786|FG000|NOT COMPLETED|Rescue Period||0
11183833|NCT01721057|12372787|FG001|NOT COMPLETED|Rescue Period||0
11183834|NCT01721057|12372788|FG002|NOT COMPLETED|Rescue Period||0
11183835|NCT01721057|12372789|FG003|NOT COMPLETED|Rescue Period||3
11183836|NCT01721057|12372790|FG004|NOT COMPLETED|Rescue Period||0
11183837|NCT01721057|12372791|FG005|NOT COMPLETED|Rescue Period||0
11183838|NCT01721057|12372792|FG006|NOT COMPLETED|Rescue Period||0
11183839|NCT01721057|12372786|FG000|STARTED|Follow Up||0
11183840|NCT01721057|12372787|FG001|STARTED|Follow Up||0
11183841|NCT01721057|12372788|FG002|STARTED|Follow Up||0
11183842|NCT01721057|12372789|FG003|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
11183843|NCT01721057|12372790|FG004|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
11183844|NCT01721057|12372791|FG005|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
11183845|NCT01721057|12372792|FG006|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
11183846|NCT01721057|12372786|FG000|COMPLETED|Follow Up||0
11183847|NCT01721057|12372787|FG001|COMPLETED|Follow Up||0
11183848|NCT01721057|12372788|FG002|COMPLETED|Follow Up||0
11183849|NCT01721057|12372789|FG003|COMPLETED|Follow Up||0
11183850|NCT01721057|12372790|FG004|COMPLETED|Follow Up||17
11183851|NCT01721057|12372791|FG005|COMPLETED|Follow Up||19
11183852|NCT01721057|12372792|FG006|COMPLETED|Follow Up||22
11183853|NCT01721057|12372786|FG000|NOT COMPLETED|Follow Up||0
11183854|NCT01721057|12372787|FG001|NOT COMPLETED|Follow Up||0
11183855|NCT01721057|12372788|FG002|NOT COMPLETED|Follow Up||0
11183856|NCT01721057|12372789|FG003|NOT COMPLETED|Follow Up||0
11183857|NCT01721057|12372790|FG004|NOT COMPLETED|Follow Up||0
11183858|NCT01721057|12372791|FG005|NOT COMPLETED|Follow Up||0
11183859|NCT01721057|12372792|FG006|NOT COMPLETED|Follow Up||0
11183860|NCT01721070|12372819|FG000|STARTED|SUF NT 15 mcg||19
11183861|NCT01721070|12372819|FG000|COMPLETED|SUF NT 15 mcg||19
11183862|NCT01721070|12372819|FG000|NOT COMPLETED|SUF NT 15 mcg||0
11183863|NCT01721070|12372819|FG000|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
11183864|NCT01721070|12372819|FG000|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
11183865|NCT01721070|12372819|FG000|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
11183866|NCT01721096|12372828|FG000|STARTED|Overall Study||323
11183867|NCT01721096|12372829|FG001|STARTED|Overall Study||213
11183868|NCT01721096|12372828|FG000|COMPLETED|Overall Study||3
11183869|NCT01721096|12372829|FG001|COMPLETED|Overall Study||9
11183870|NCT01721096|12372828|FG000|NOT COMPLETED|Overall Study||320
11183871|NCT01721096|12372829|FG001|NOT COMPLETED|Overall Study||204
11183872|NCT01721109|12372837|FG000|STARTED|Overall Study||50
11183873|NCT01721109|12372837|FG000|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
11183874|NCT01721109|12372837|FG000|NOT COMPLETED|Overall Study||7
11183875|NCT01721161|12372843|FG000|STARTED|Overall Study||41
11183876|NCT01721161|12372844|FG001|STARTED|Overall Study||41
11183877|NCT01721161|12372843|FG000|COMPLETED|Overall Study||37
11183878|NCT01721161|12372844|FG001|COMPLETED|Overall Study||34
11183879|NCT01721161|12372843|FG000|NOT COMPLETED|Overall Study||4
11183880|NCT01721161|12372844|FG001|NOT COMPLETED|Overall Study||7
11183881|NCT01721200|12372853|FG000|STARTED|Overall Study||62
11183882|NCT01721200|12372854|FG001|STARTED|Overall Study||63
11183883|NCT01721200|12372853|FG000|Completed 2 Week Follow-up|Overall Study||60
11183884|NCT01721200|12372854|FG001|Completed 2 Week Follow-up|Overall Study||61
11183885|NCT01721200|12372853|FG000|COMPLETED|Overall Study||59
11183886|NCT01721200|12372854|FG001|COMPLETED|Overall Study||58
11183887|NCT01721200|12372853|FG000|NOT COMPLETED|Overall Study||3
11183888|NCT01721200|12372854|FG001|NOT COMPLETED|Overall Study||5
11183889|NCT01721226|12372867|FG000|STARTED|Overall Study||55
11183890|NCT01721226|12372868|FG001|STARTED|Overall Study||57
11183891|NCT01721226|12372867|FG000|Baseline|Overall Study||53
11183892|NCT01721226|12372868|FG001|Baseline|Overall Study||57
11183893|NCT01721226|12372867|FG000|Week 12|Overall Study||48
11183894|NCT01721226|12372868|FG001|Week 12|Overall Study||53
11183895|NCT01721226|12372867|FG000|Week 24|Overall Study||50
11183896|NCT01721226|12372868|FG001|Week 24|Overall Study||50
11183897|NCT01721226|12372867|FG000|COMPLETED|Overall Study||50
11183898|NCT01721226|12372868|FG001|COMPLETED|Overall Study||50
11183899|NCT01721226|12372867|FG000|NOT COMPLETED|Overall Study||5
11183900|NCT01721226|12372868|FG001|NOT COMPLETED|Overall Study||7
11183901|NCT01721317|12372876|FG000|STARTED|Overall Study||2
11183902|NCT01721317|12372877|FG001|STARTED|Overall Study||4
11183903|NCT01721317|12372876|FG000|COMPLETED|Overall Study||0
11183904|NCT01721317|12372877|FG001|COMPLETED|Overall Study||0
11183905|NCT01721317|12372876|FG000|NOT COMPLETED|Overall Study||2
11183906|NCT01721317|12372877|FG001|NOT COMPLETED|Overall Study||4
11183907|NCT01721330|12372885|FG000|STARTED|Overall Study||1
11183908|NCT01721330|12372886|FG001|STARTED|Overall Study||2
11183909|NCT01721330|12372885|FG000|COMPLETED|Overall Study||1
11183910|NCT01721330|12372886|FG001|COMPLETED|Overall Study||1
11183911|NCT01721330|12372885|FG000|NOT COMPLETED|Overall Study||0
11183912|NCT01721330|12372886|FG001|NOT COMPLETED|Overall Study||1
11183913|NCT01721369|12372892|FG000|STARTED|Overall Study||581
11183914|NCT01721369|12372892|FG000|COMPLETED|Overall Study||569
11183915|NCT01721369|12372892|FG000|NOT COMPLETED|Overall Study||12
11183916|NCT01721408|12372898|FG000|STARTED|Overall Study|Number of participants treated.|232
11183917|NCT01721408|12372899|FG001|STARTED|Overall Study|Number of participants treated.|231
11183918|NCT01721408|12372898|FG000|COMPLETED|Overall Study||196
11183919|NCT01721408|12372899|FG001|COMPLETED|Overall Study||207
11183920|NCT01721408|12372898|FG000|NOT COMPLETED|Overall Study||36
11183921|NCT01721408|12372899|FG001|NOT COMPLETED|Overall Study||24
11183922|NCT01721447|12372905|FG000|STARTED|Overall Study||100
11183923|NCT01721447|12372905|FG000|COMPLETED|Overall Study||100
11183924|NCT01721447|12372905|FG000|NOT COMPLETED|Overall Study||0
11183925|NCT01721460|12372910|FG000|STARTED|Overall Study||6
11183926|NCT01721460|12372910|FG000|COMPLETED|Overall Study||5
11183927|NCT01721460|12372910|FG000|NOT COMPLETED|Overall Study||1
11183928|NCT01721473|12372922|FG000|STARTED|Overall Study||47
11183929|NCT01721473|12372923|FG001|STARTED|Overall Study||22
11183930|NCT01721473|12372924|FG002|STARTED|Overall Study||41
11183931|NCT01721473|12372925|FG003|STARTED|Overall Study||34
11183932|NCT01721473|12372926|FG004|STARTED|Overall Study||22
11183933|NCT01721473|12372927|FG005|STARTED|Overall Study||18
11183934|NCT01721473|12372922|FG000|COMPLETED|Overall Study||47
11183935|NCT01721473|12372923|FG001|COMPLETED|Overall Study||22
11183936|NCT01721473|12372924|FG002|COMPLETED|Overall Study||41
11183937|NCT01721473|12372925|FG003|COMPLETED|Overall Study||34
11183938|NCT01721473|12372926|FG004|COMPLETED|Overall Study||22
11183939|NCT01721473|12372927|FG005|COMPLETED|Overall Study||18
11183940|NCT01721473|12372922|FG000|NOT COMPLETED|Overall Study||0
11183941|NCT01721473|12372923|FG001|NOT COMPLETED|Overall Study||0
11183942|NCT01721473|12372924|FG002|NOT COMPLETED|Overall Study||0
11183943|NCT01721473|12372925|FG003|NOT COMPLETED|Overall Study||0
11183944|NCT01721473|12372926|FG004|NOT COMPLETED|Overall Study||0
11183945|NCT01721473|12372927|FG005|NOT COMPLETED|Overall Study||0
11183946|NCT01721486|12372938|FG000|STARTED|Overall Study||21
11183947|NCT01721486|12372939|FG001|STARTED|Overall Study||20
11183948|NCT01721486|12372938|FG000|COMPLETED|Overall Study||20
11183949|NCT01721486|12372939|FG001|COMPLETED|Overall Study||19
11183950|NCT01721486|12372938|FG000|NOT COMPLETED|Overall Study||1
11183951|NCT01721486|12372939|FG001|NOT COMPLETED|Overall Study||1
11183952|NCT01721564|12372945|FG000|STARTED|Overall Study||8
11183953|NCT01721564|12372945|FG000|COMPLETED|Overall Study||8
11183954|NCT01721564|12372945|FG000|NOT COMPLETED|Overall Study||0
11183955|NCT01721603|12372949|FG000|STARTED|Overall Study||2
11183956|NCT01721603|12372949|FG000|COMPLETED|Overall Study||2
11183957|NCT01721603|12372949|FG000|NOT COMPLETED|Overall Study||0
11183958|NCT01721681|12372953|FG000|STARTED|Overall Study||9
11183959|NCT01721681|12372953|FG000|COMPLETED|Overall Study||9
11183960|NCT01721681|12372953|FG000|NOT COMPLETED|Overall Study||0
11183961|NCT01721837|12372957|FG000|STARTED|Overall Study||2120
11183962|NCT01721837|12372957|FG000|COMPLETED|Overall Study||2120
11183963|NCT01721837|12372957|FG000|NOT COMPLETED|Overall Study||0
11183964|NCT01721876|12372963|FG000|STARTED|Overall Study||222
11183965|NCT01721876|12372964|FG001|STARTED|Overall Study||444
11183966|NCT01721876|12372963|FG000|Treated|Overall Study||221
11183967|NCT01721876|12372964|FG001|Treated|Overall Study||440
11183968|NCT01721876|12372963|FG000|COMPLETED|Overall Study||0
11183969|NCT01721876|12372964|FG001|COMPLETED|Overall Study||0
11183970|NCT01721876|12372963|FG000|NOT COMPLETED|Overall Study||222
11183971|NCT01721876|12372964|FG001|NOT COMPLETED|Overall Study||444
11183972|NCT01721954|12372972|FG000|STARTED|Overall Study||105
11183973|NCT01721954|12372973|FG001|STARTED|Overall Study||104
11183974|NCT01721954|12372972|FG000|COMPLETED|Overall Study||35
11183975|NCT01721954|12372973|FG001|COMPLETED|Overall Study||35
11183976|NCT01721954|12372972|FG000|NOT COMPLETED|Overall Study||70
11183977|NCT01721954|12372973|FG001|NOT COMPLETED|Overall Study||69
11183978|NCT01721967|12372979|FG000|STARTED|Overall Study||14
11183979|NCT01721967|12372979|FG000|COMPLETED|Overall Study||11
11183980|NCT01721967|12372979|FG000|NOT COMPLETED|Overall Study||3
11183981|NCT01722045|12372983|FG000|STARTED|Overall Study||154
11183982|NCT01722045|12372983|FG000|COMPLETED|Overall Study||126
11183983|NCT01722045|12372983|FG000|NOT COMPLETED|Overall Study||28
11183984|NCT01722071|12372987|FG000|STARTED|Overall Study||10
11183985|NCT01722071|12372988|FG001|STARTED|Overall Study||10
11183986|NCT01722071|12372987|FG000|COMPLETED|Overall Study||9
11183987|NCT01722071|12372988|FG001|COMPLETED|Overall Study||10
11183988|NCT01722071|12372987|FG000|NOT COMPLETED|Overall Study||1
11183989|NCT01722071|12372988|FG001|NOT COMPLETED|Overall Study||0
11183990|NCT01722097|12372996|FG000|STARTED|Overall Study||55
11183991|NCT01722097|12372997|FG001|STARTED|Overall Study||55
11183992|NCT01722097|12372996|FG000|COMPLETED|Overall Study||49
11183993|NCT01722097|12372997|FG001|COMPLETED|Overall Study||50
11183994|NCT01722097|12372996|FG000|NOT COMPLETED|Overall Study||6
11183995|NCT01722097|12372997|FG001|NOT COMPLETED|Overall Study||5
11183996|NCT01722162|12373005|FG000|STARTED|Overall Study||23
11183997|NCT01722162|12373006|FG001|STARTED|Overall Study||24
11183998|NCT01722162|12373005|FG000|COMPLETED|Overall Study||18
11183999|NCT01722162|12373006|FG001|COMPLETED|Overall Study||18
11184000|NCT01722162|12373005|FG000|NOT COMPLETED|Overall Study||5
11184001|NCT01722162|12373006|FG001|NOT COMPLETED|Overall Study||6
11184002|NCT01722266|12373016|FG000|STARTED|Overall Study||18
11184003|NCT01722266|12373017|FG001|STARTED|Overall Study||18
11184004|NCT01722266|12373018|FG002|STARTED|Overall Study||18
11184005|NCT01722266|12373019|FG003|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
11184006|NCT01722266|12373016|FG000|COMPLETED|Overall Study||17
11184007|NCT01722266|12373017|FG001|COMPLETED|Overall Study||15
11184008|NCT01722266|12373018|FG002|COMPLETED|Overall Study||13
11184009|NCT01722266|12373019|FG003|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
11184010|NCT01722266|12373016|FG000|NOT COMPLETED|Overall Study||1
11184011|NCT01722266|12373017|FG001|NOT COMPLETED|Overall Study||3
11184012|NCT01722266|12373018|FG002|NOT COMPLETED|Overall Study||5
11184013|NCT01722266|12373019|FG003|NOT COMPLETED|Overall Study||0
11184014|NCT01722292|12373032|FG000|STARTED|Overall Study||6
11184015|NCT01722292|12373033|FG001|STARTED|Overall Study||6
11184016|NCT01722292|12373034|FG002|STARTED|Overall Study||14
11184017|NCT01722292|12373032|FG000|Received at Least One Dose of Study Drug|Overall Study||6
11184018|NCT01722292|12373033|FG001|Received at Least One Dose of Study Drug|Overall Study||6
11184019|NCT01722292|12373034|FG002|Received at Least One Dose of Study Drug|Overall Study||14
11184020|NCT01722292|12373032|FG000|COMPLETED|Overall Study||6
11184021|NCT01722292|12373033|FG001|COMPLETED|Overall Study||6
11184022|NCT01722292|12373034|FG002|COMPLETED|Overall Study||14
11184023|NCT01722292|12373032|FG000|NOT COMPLETED|Overall Study||0
11184024|NCT01722292|12373033|FG001|NOT COMPLETED|Overall Study||0
11184025|NCT01722292|12373034|FG002|NOT COMPLETED|Overall Study||0
11184026|NCT01722318|12373064|FG000|STARTED|Overall Study||86
11184027|NCT01722318|12373065|FG001|STARTED|Overall Study||85
11184028|NCT01722318|12373066|FG002|STARTED|Overall Study||86
11184029|NCT01722318|12373067|FG003|STARTED|Overall Study||85
11184030|NCT01722318|12373068|FG004|STARTED|Overall Study||86
11184031|NCT01722318|12373064|FG000|COMPLETED|Overall Study||72
11184032|NCT01722318|12373065|FG001|COMPLETED|Overall Study||65
11184033|NCT01722318|12373066|FG002|COMPLETED|Overall Study||66
11184034|NCT01722318|12373067|FG003|COMPLETED|Overall Study||65
11184035|NCT01722318|12373068|FG004|COMPLETED|Overall Study||68
11184036|NCT01722318|12373064|FG000|NOT COMPLETED|Overall Study||14
11184037|NCT01722318|12373065|FG001|NOT COMPLETED|Overall Study||20
11184038|NCT01722318|12373066|FG002|NOT COMPLETED|Overall Study||20
11184039|NCT01722318|12373067|FG003|NOT COMPLETED|Overall Study||20
11184040|NCT01722318|12373068|FG004|NOT COMPLETED|Overall Study||18
11184041|NCT01722435|12373080|FG000|STARTED|Overall Study||78
11184042|NCT01722435|12373080|FG000|COMPLETED|Overall Study||78
11184043|NCT01722435|12373080|FG000|NOT COMPLETED|Overall Study||0
11184044|NCT01722487|12373090|FG000|STARTED|Overall Study||136
11184045|NCT01722487|12373091|FG001|STARTED|Overall Study||133
11184046|NCT01722487|12373090|FG000|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
11184047|NCT01722487|12373091|FG001|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
11184048|NCT01722487|12373090|FG000|NOT COMPLETED|Overall Study||2
11184049|NCT01722487|12373091|FG001|NOT COMPLETED|Overall Study||7
11184050|NCT01722552|12373098|FG000|STARTED|Overall Study|Number of subjects enrolled|120
11184051|NCT01722552|12373098|FG000|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
11184052|NCT01722552|12373098|FG000|NOT COMPLETED|Overall Study||4
11184053|NCT01722604|12373106|FG000|STARTED|Overall Study||129
11184054|NCT01722604|12373107|FG001|STARTED|Overall Study||129
11184055|NCT01722604|12373106|FG000|COMPLETED|Overall Study||123
11184056|NCT01722604|12373107|FG001|COMPLETED|Overall Study||120
11184057|NCT01722604|12373106|FG000|NOT COMPLETED|Overall Study||6
11184058|NCT01722604|12373107|FG001|NOT COMPLETED|Overall Study||9
11184059|NCT01722643|12373115|FG000|STARTED|Overall Study||30
11184060|NCT01722643|12373116|FG001|STARTED|Overall Study||31
11184061|NCT01722643|12373115|FG000|COMPLETED|Overall Study||30
11184062|NCT01722643|12373116|FG001|COMPLETED|Overall Study||30
11184063|NCT01722643|12373115|FG000|NOT COMPLETED|Overall Study||0
11184064|NCT01722643|12373116|FG001|NOT COMPLETED|Overall Study||1
11184065|NCT01722669|12373128|FG000|STARTED|Overall Study||5
11184066|NCT01722669|12373129|FG001|STARTED|Overall Study||5
11184067|NCT01722669|12373130|FG002|STARTED|Overall Study||5
11184068|NCT01722669|12373131|FG003|STARTED|Overall Study||5
11184069|NCT01722669|12373132|FG004|STARTED|Overall Study||10
11184070|NCT01722669|12373133|FG005|STARTED|Overall Study|Antiphospholipid Antibody (ARM D): 6 evaluable and 2 withdrew consent without any data collected|8
11184071|NCT01722669|12373128|FG000|COMPLETED|Overall Study||5
11184072|NCT01722669|12373129|FG001|COMPLETED|Overall Study||5
11184073|NCT01722669|12373130|FG002|COMPLETED|Overall Study||5
11184074|NCT01722669|12373131|FG003|COMPLETED|Overall Study||5
11184075|NCT01722669|12373132|FG004|COMPLETED|Overall Study||10
11184076|NCT01722669|12373133|FG005|COMPLETED|Overall Study||6
11184077|NCT01722669|12373128|FG000|NOT COMPLETED|Overall Study||0
11184078|NCT01722669|12373129|FG001|NOT COMPLETED|Overall Study||0
11184079|NCT01722669|12373130|FG002|NOT COMPLETED|Overall Study||0
11184080|NCT01722669|12373131|FG003|NOT COMPLETED|Overall Study||0
11184081|NCT01722669|12373132|FG004|NOT COMPLETED|Overall Study||0
11184082|NCT01722669|12373133|FG005|NOT COMPLETED|Overall Study||2
11184083|NCT01722734|12373156|FG000|STARTED|Overall Study||554
11184084|NCT01722734|12373157|FG001|STARTED|Overall Study||277
11184085|NCT01722734|12373158|FG002|STARTED|Overall Study||309
11184086|NCT01722734|12373156|FG000|COMPLETED|Overall Study||552
11184087|NCT01722734|12373157|FG001|COMPLETED|Overall Study||276
11184088|NCT01722734|12373158|FG002|COMPLETED|Overall Study||307
11184089|NCT01722734|12373156|FG000|NOT COMPLETED|Overall Study||2
11184090|NCT01722734|12373157|FG001|NOT COMPLETED|Overall Study||1
11184091|NCT01722734|12373158|FG002|NOT COMPLETED|Overall Study||2
11184092|NCT01722877|12373166|FG000|STARTED|Overall Study||29
11184093|NCT01722877|12373166|FG000|COMPLETED|Overall Study||27
11184094|NCT01722877|12373166|FG000|NOT COMPLETED|Overall Study||2
11184095|NCT01722994|12373174|FG000|STARTED|Overall Study||49
11184096|NCT01722994|12373175|FG001|STARTED|Overall Study||48
11184097|NCT01722994|12373174|FG000|COMPLETED|Overall Study||24
11184098|NCT01722994|12373175|FG001|COMPLETED|Overall Study||31
11184099|NCT01722994|12373174|FG000|NOT COMPLETED|Overall Study||25
11184100|NCT01722994|12373175|FG001|NOT COMPLETED|Overall Study||17
11184101|NCT01723072|12373185|FG000|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|44
11184102|NCT01723072|12373186|FG001|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|47
11184103|NCT01723072|12373185|FG000|COMPLETED|Overall Study||33
11184104|NCT01723072|12373186|FG001|COMPLETED|Overall Study||26
11184105|NCT01723072|12373185|FG000|NOT COMPLETED|Overall Study||11
11184106|NCT01723072|12373186|FG001|NOT COMPLETED|Overall Study||21
11184107|NCT01723163|12373194|FG000|STARTED|Baseline||156
11184108|NCT01723163|12373195|FG001|STARTED|Baseline||154
11184109|NCT01723163|12373194|FG000|COMPLETED|Baseline||156
11184110|NCT01723163|12373195|FG001|COMPLETED|Baseline||154
11184111|NCT01723163|12373194|FG000|NOT COMPLETED|Baseline||0
11184112|NCT01723163|12373195|FG001|NOT COMPLETED|Baseline||0
11184113|NCT01723163|12373194|FG000|STARTED|Treatment Phase||156
11184114|NCT01723163|12373195|FG001|STARTED|Treatment Phase||154
11184115|NCT01723163|12373194|FG000|COMPLETED|Treatment Phase||137
11184116|NCT01723163|12373195|FG001|COMPLETED|Treatment Phase||147
11184117|NCT01723163|12373194|FG000|NOT COMPLETED|Treatment Phase||19
11184118|NCT01723163|12373195|FG001|NOT COMPLETED|Treatment Phase||7
11184119|NCT01723163|12373194|FG000|STARTED|3-Month Follow-up||137
11184120|NCT01723163|12373195|FG001|STARTED|3-Month Follow-up||147
11184121|NCT01723163|12373194|FG000|COMPLETED|3-Month Follow-up||124
11184122|NCT01723163|12373195|FG001|COMPLETED|3-Month Follow-up||128
11184123|NCT01723163|12373194|FG000|NOT COMPLETED|3-Month Follow-up||13
11184124|NCT01723163|12373195|FG001|NOT COMPLETED|3-Month Follow-up||19
11184125|NCT01723163|12373194|FG000|STARTED|6-Month Follow-up||136
11184126|NCT01723163|12373195|FG001|STARTED|6-Month Follow-up||147
11184127|NCT01723163|12373194|FG000|COMPLETED|6-Month Follow-up||118
11184128|NCT01723163|12373195|FG001|COMPLETED|6-Month Follow-up||132
11184129|NCT01723163|12373194|FG000|NOT COMPLETED|6-Month Follow-up||18
11184130|NCT01723163|12373195|FG001|NOT COMPLETED|6-Month Follow-up||15
11184131|NCT01723163|12373194|FG000|STARTED|12-Month Follow-up||135
11184132|NCT01723163|12373195|FG001|STARTED|12-Month Follow-up||147
11184133|NCT01723163|12373194|FG000|COMPLETED|12-Month Follow-up||111
11184134|NCT01723163|12373195|FG001|COMPLETED|12-Month Follow-up||119
11184135|NCT01723163|12373194|FG000|NOT COMPLETED|12-Month Follow-up||24
11184136|NCT01723163|12373195|FG001|NOT COMPLETED|12-Month Follow-up||28
11184137|NCT01723228|12373203|FG000|STARTED|Overall Study||86
11184138|NCT01723228|12373204|FG001|STARTED|Overall Study||84
11184139|NCT01723228|12373203|FG000|COMPLETED|Overall Study||78
11184140|NCT01723228|12373204|FG001|COMPLETED|Overall Study||73
11184141|NCT01723228|12373203|FG000|NOT COMPLETED|Overall Study||8
11184142|NCT01723228|12373204|FG001|NOT COMPLETED|Overall Study||11
11184143|NCT01723254|12373218|FG000|STARTED|Overall Study||6
11184144|NCT01723254|12373219|FG001|STARTED|Overall Study||21
11184145|NCT01723254|12373220|FG002|STARTED|Overall Study||20
11184146|NCT01723254|12373221|FG003|STARTED|Overall Study||20
11184147|NCT01723254|12373222|FG004|STARTED|Overall Study||20
11184148|NCT01723254|12373223|FG005|STARTED|Overall Study||20
11184149|NCT01723254|12373224|FG006|STARTED|Overall Study||20
11184150|NCT01723254|12373225|FG007|STARTED|Overall Study||63
11184151|NCT01723254|12373218|FG000|COMPLETED|Overall Study||5
11184152|NCT01723254|12373219|FG001|COMPLETED|Overall Study||18
11184153|NCT01723254|12373220|FG002|COMPLETED|Overall Study||17
11184154|NCT01723254|12373221|FG003|COMPLETED|Overall Study||18
11184155|NCT01723254|12373222|FG004|COMPLETED|Overall Study||18
11184156|NCT01723254|12373223|FG005|COMPLETED|Overall Study||18
11184157|NCT01723254|12373224|FG006|COMPLETED|Overall Study||19
11184158|NCT01723254|12373225|FG007|COMPLETED|Overall Study||60
11184159|NCT01723254|12373218|FG000|NOT COMPLETED|Overall Study||1
11184160|NCT01723254|12373219|FG001|NOT COMPLETED|Overall Study||3
11184161|NCT01723254|12373220|FG002|NOT COMPLETED|Overall Study||3
11184162|NCT01723254|12373221|FG003|NOT COMPLETED|Overall Study||2
11184163|NCT01723254|12373222|FG004|NOT COMPLETED|Overall Study||2
11184164|NCT01723254|12373223|FG005|NOT COMPLETED|Overall Study||2
11184165|NCT01723254|12373224|FG006|NOT COMPLETED|Overall Study||1
11184166|NCT01723254|12373225|FG007|NOT COMPLETED|Overall Study||3
11184167|NCT01723384|12373245|FG000|STARTED|Overall Study||15
11184168|NCT01723384|12373246|FG001|STARTED|Overall Study||15
11184169|NCT01723384|12373245|FG000|COMPLETED|Overall Study||15
11184170|NCT01723384|12373246|FG001|COMPLETED|Overall Study||15
11184171|NCT01723384|12373245|FG000|NOT COMPLETED|Overall Study||0
11184172|NCT01723384|12373246|FG001|NOT COMPLETED|Overall Study||0
11184173|NCT01723397|12373254|FG000|STARTED|Study Period 1||7
11184174|NCT01723397|12373255|FG001|STARTED|Study Period 1||7
11184175|NCT01723397|12373254|FG000|COMPLETED|Study Period 1||7
11184176|NCT01723397|12373255|FG001|COMPLETED|Study Period 1||6
11184177|NCT01723397|12373254|FG000|NOT COMPLETED|Study Period 1||0
11184178|NCT01723397|12373255|FG001|NOT COMPLETED|Study Period 1||1
11184179|NCT01723397|12373254|FG000|STARTED|Washout||7
11184180|NCT01723397|12373255|FG001|STARTED|Washout||6
11184181|NCT01723397|12373254|FG000|COMPLETED|Washout||7
11184182|NCT01723397|12373255|FG001|COMPLETED|Washout||6
11184183|NCT01723397|12373254|FG000|NOT COMPLETED|Washout||0
11184184|NCT01723397|12373255|FG001|NOT COMPLETED|Washout||0
11184185|NCT01723397|12373254|FG000|STARTED|Study Period 2||7
11184186|NCT01723397|12373255|FG001|STARTED|Study Period 2||6
11184187|NCT01723397|12373254|FG000|COMPLETED|Study Period 2||7
11184188|NCT01723397|12373255|FG001|COMPLETED|Study Period 2||5
11184189|NCT01723397|12373254|FG000|NOT COMPLETED|Study Period 2||0
11184190|NCT01723397|12373255|FG001|NOT COMPLETED|Study Period 2||1
11184191|NCT01723514|12373269|FG000|STARTED|Overall Study||8
11184192|NCT01723514|12373270|FG001|STARTED|Overall Study||6
11184193|NCT01723514|12373271|FG002|STARTED|Overall Study||6
11184194|NCT01723514|12373272|FG003|STARTED|Overall Study||6
11184195|NCT01723514|12373273|FG004|STARTED|Overall Study||6
11184196|NCT01723514|12373274|FG005|STARTED|Overall Study||4
11184197|NCT01723514|12373275|FG006|STARTED|Overall Study||6
11184198|NCT01723514|12373276|FG007|STARTED|Overall Study||6
11184199|NCT01723514|12373269|FG000|COMPLETED|Overall Study||8
11184200|NCT01723514|12373270|FG001|COMPLETED|Overall Study||6
11184201|NCT01723514|12373271|FG002|COMPLETED|Overall Study||6
11184202|NCT01723514|12373272|FG003|COMPLETED|Overall Study||6
11184203|NCT01723514|12373273|FG004|COMPLETED|Overall Study||6
11184204|NCT01723514|12373274|FG005|COMPLETED|Overall Study||4
11184205|NCT01723514|12373275|FG006|COMPLETED|Overall Study||6
11184206|NCT01723514|12373276|FG007|COMPLETED|Overall Study||6
11184207|NCT01723514|12373269|FG000|NOT COMPLETED|Overall Study||0
11184208|NCT01723514|12373270|FG001|NOT COMPLETED|Overall Study||0
11184209|NCT01723514|12373271|FG002|NOT COMPLETED|Overall Study||0
11184210|NCT01723514|12373272|FG003|NOT COMPLETED|Overall Study||0
11184211|NCT01723514|12373273|FG004|NOT COMPLETED|Overall Study||0
11184212|NCT01723514|12373274|FG005|NOT COMPLETED|Overall Study||0
11184213|NCT01723514|12373275|FG006|NOT COMPLETED|Overall Study||0
11184214|NCT01723514|12373276|FG007|NOT COMPLETED|Overall Study||0
11184215|NCT01723696|12373296|FG000|STARTED|Overall Study||126
11184216|NCT01723696|12373297|FG001|STARTED|Overall Study||126
11184217|NCT01723696|12373296|FG000|COMPLETED|Overall Study||109
11184218|NCT01723696|12373297|FG001|COMPLETED|Overall Study||113
11184219|NCT01723696|12373296|FG000|NOT COMPLETED|Overall Study||17
11184220|NCT01723696|12373297|FG001|NOT COMPLETED|Overall Study||13
11184221|NCT01723722|12373307|FG000|STARTED|Overall Study||20
11184222|NCT01723722|12373308|FG001|STARTED|Overall Study||20
11184223|NCT01723722|12373307|FG000|COMPLETED|Overall Study||20
11184224|NCT01723722|12373308|FG001|COMPLETED|Overall Study||20
11184225|NCT01723722|12373307|FG000|NOT COMPLETED|Overall Study||0
11184226|NCT01723722|12373308|FG001|NOT COMPLETED|Overall Study||0
11184227|NCT01723826|12373318|FG000|STARTED|Overall Study||47
11184228|NCT01723826|12373319|FG001|STARTED|Overall Study||63
11184229|NCT01723826|12373320|FG002|STARTED|Overall Study||101
11184230|NCT01723826|12373321|FG003|STARTED|Overall Study||149
11184231|NCT01723826|12373318|FG000|COMPLETED|Overall Study||20
11184232|NCT01723826|12373319|FG001|COMPLETED|Overall Study||27
11184233|NCT01723826|12373320|FG002|COMPLETED|Overall Study||44
11184234|NCT01723826|12373321|FG003|COMPLETED|Overall Study||59
11184235|NCT01723826|12373318|FG000|NOT COMPLETED|Overall Study||27
11184236|NCT01723826|12373319|FG001|NOT COMPLETED|Overall Study||36
11184237|NCT01723826|12373320|FG002|NOT COMPLETED|Overall Study||57
11184238|NCT01723826|12373321|FG003|NOT COMPLETED|Overall Study||90
11184239|NCT01723904|12373331|FG000|STARTED|Overall Study||90
11184240|NCT01723904|12373331|FG000|COMPLETED|Overall Study||79
11184241|NCT01723904|12373331|FG000|NOT COMPLETED|Overall Study||11
11184242|NCT01724021|12373337|FG000|STARTED|Overall Study||371
11184243|NCT01724021|12373338|FG001|STARTED|Overall Study||369
11184244|NCT01724021|12373337|FG000|COMPLETED|Overall Study||244
11184245|NCT01724021|12373338|FG001|COMPLETED|Overall Study||236
11184246|NCT01724021|12373337|FG000|NOT COMPLETED|Overall Study||127
11184247|NCT01724021|12373338|FG001|NOT COMPLETED|Overall Study||133
11184248|NCT01724060|12373354|FG000|STARTED|Overall Study||10
11184249|NCT01724060|12373355|FG001|STARTED|Overall Study||10
11184250|NCT01724060|12373356|FG002|STARTED|Overall Study||10
11184251|NCT01724060|12373357|FG003|STARTED|Overall Study||10
11184252|NCT01724060|12373358|FG004|STARTED|Overall Study||10
11184253|NCT01724060|12373359|FG005|STARTED|Overall Study||10
11184254|NCT01724060|12373360|FG006|STARTED|Overall Study||10
11184255|NCT01724060|12373361|FG007|STARTED|Overall Study||10
11184256|NCT01724060|12373354|FG000|COMPLETED|Overall Study||10
11184257|NCT01724060|12373355|FG001|COMPLETED|Overall Study||10
11184258|NCT01724060|12373356|FG002|COMPLETED|Overall Study||10
11184259|NCT01724060|12373357|FG003|COMPLETED|Overall Study||10
11184260|NCT01724060|12373358|FG004|COMPLETED|Overall Study||10
11184261|NCT01724060|12373359|FG005|COMPLETED|Overall Study||10
11184262|NCT01724060|12373360|FG006|COMPLETED|Overall Study||10
11184263|NCT01724060|12373361|FG007|COMPLETED|Overall Study||10
11184264|NCT01724060|12373354|FG000|NOT COMPLETED|Overall Study||0
11184265|NCT01724060|12373355|FG001|NOT COMPLETED|Overall Study||0
11184266|NCT01724060|12373356|FG002|NOT COMPLETED|Overall Study||0
11184267|NCT01724060|12373357|FG003|NOT COMPLETED|Overall Study||0
11184268|NCT01724060|12373358|FG004|NOT COMPLETED|Overall Study||0
11184269|NCT01724060|12373359|FG005|NOT COMPLETED|Overall Study||0
11184270|NCT01724060|12373360|FG006|NOT COMPLETED|Overall Study||0
11184271|NCT01724060|12373361|FG007|NOT COMPLETED|Overall Study||0
11184272|NCT01724177|12373379|FG000|STARTED|Overall Study||26
11184273|NCT01724177|12373379|FG000|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
11184274|NCT01724177|12373379|FG000|COMPLETED|Overall Study||0
11184275|NCT01724177|12373379|FG000|NOT COMPLETED|Overall Study||26
11184276|NCT01724216|12373384|FG000|STARTED|Overall Study||11
11184277|NCT01724216|12373384|FG000|COMPLETED|Overall Study||10
11184278|NCT01724216|12373384|FG000|NOT COMPLETED|Overall Study||1
11184279|NCT01724359|12373388|FG000|STARTED|Overall Study||95
11184280|NCT01724359|12373388|FG000|COMPLETED|Overall Study||64
11184281|NCT01724359|12373388|FG000|NOT COMPLETED|Overall Study||31
11204261|NCT01852110|12394776|FG001|Treated|Overall Study||120
11204262|NCT01852110|12394777|FG002|Treated|Overall Study||0
11204263|NCT01852110|12394778|FG003|Treated|Overall Study||0
11204264|NCT01852110|12394779|FG004|Treated|Overall Study||0
11204265|NCT01852110|12394780|FG005|Treated|Overall Study||0
11204266|NCT01852110|12394775|FG000|COMPLETED|Overall Study||70
11204267|NCT01852110|12394776|FG001|COMPLETED|Overall Study||74
11204268|NCT01852110|12394777|FG002|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
11204269|NCT01852110|12394778|FG003|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
11204270|NCT01852110|12394779|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
11204271|NCT01852110|12394780|FG005|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
11204272|NCT01852110|12394775|FG000|NOT COMPLETED|Overall Study||50
11204273|NCT01852110|12394776|FG001|NOT COMPLETED|Overall Study||46
11204274|NCT01852110|12394777|FG002|NOT COMPLETED|Overall Study||0
11204275|NCT01852110|12394778|FG003|NOT COMPLETED|Overall Study||0
11204276|NCT01852110|12394779|FG004|NOT COMPLETED|Overall Study||0
11204277|NCT01852110|12394780|FG005|NOT COMPLETED|Overall Study||0
11204278|NCT01852162|12394796|FG000|STARTED|Overall Study||18
11204279|NCT01852162|12394797|FG001|STARTED|Overall Study||17
11204280|NCT01852162|12394796|FG000|COMPLETED|Overall Study||14
11204281|NCT01852162|12394797|FG001|COMPLETED|Overall Study||16
11204282|NCT01852162|12394796|FG000|NOT COMPLETED|Overall Study||4
11184282|NCT01724489|12373396|FG000|STARTED|Overall Study||39
11184283|NCT01724489|12373397|FG001|STARTED|Overall Study||38
11184284|NCT01724489|12373396|FG000|COMPLETED|Overall Study||23
11184285|NCT01724489|12373397|FG001|COMPLETED|Overall Study||26
11184286|NCT01724489|12373396|FG000|NOT COMPLETED|Overall Study||16
11184287|NCT01724489|12373397|FG001|NOT COMPLETED|Overall Study||12
11184288|NCT01724528|12373405|FG000|STARTED|Overall Study||173
11184289|NCT01724528|12373406|FG001|STARTED|Overall Study||173
11184290|NCT01724528|12373405|FG000|COMPLETED|Overall Study||169
11184291|NCT01724528|12373406|FG001|COMPLETED|Overall Study||170
11184292|NCT01724528|12373405|FG000|NOT COMPLETED|Overall Study||4
11184293|NCT01724528|12373406|FG001|NOT COMPLETED|Overall Study||3
11184294|NCT01725126|12373418|FG000|STARTED|Overall Study||4
11184295|NCT01725126|12373419|FG001|STARTED|Overall Study||11
11184296|NCT01725126|12373420|FG002|STARTED|Overall Study||6
11184297|NCT01725126|12373421|FG003|STARTED|Overall Study||14
11184298|NCT01725126|12373422|FG004|STARTED|Overall Study||6
11184299|NCT01725126|12373423|FG005|STARTED|Overall Study||12
11184300|NCT01725126|12373418|FG000|COMPLETED|Overall Study||4
11184301|NCT01725126|12373419|FG001|COMPLETED|Overall Study||10
11184302|NCT01725126|12373420|FG002|COMPLETED|Overall Study||6
11184303|NCT01725126|12373421|FG003|COMPLETED|Overall Study||13
11184304|NCT01725126|12373422|FG004|COMPLETED|Overall Study||6
11184305|NCT01725126|12373423|FG005|COMPLETED|Overall Study||12
11184306|NCT01725126|12373418|FG000|NOT COMPLETED|Overall Study||0
11184307|NCT01725126|12373419|FG001|NOT COMPLETED|Overall Study||1
11184308|NCT01725126|12373420|FG002|NOT COMPLETED|Overall Study||0
11184309|NCT01725126|12373421|FG003|NOT COMPLETED|Overall Study||1
11184310|NCT01725126|12373422|FG004|NOT COMPLETED|Overall Study||0
11184311|NCT01725126|12373423|FG005|NOT COMPLETED|Overall Study||0
11184312|NCT01725217|12373449|FG000|STARTED|Overall Study||66
11184313|NCT01725217|12373450|FG001|STARTED|Overall Study||66
11184314|NCT01725217|12373451|FG002|STARTED|Overall Study||66
11184315|NCT01725217|12373449|FG000|COMPLETED|Overall Study||65
11184316|NCT01725217|12373450|FG001|COMPLETED|Overall Study||66
11184317|NCT01725217|12373451|FG002|COMPLETED|Overall Study||66
11184318|NCT01725217|12373449|FG000|NOT COMPLETED|Overall Study||1
11184319|NCT01725217|12373450|FG001|NOT COMPLETED|Overall Study||0
11184320|NCT01725217|12373451|FG002|NOT COMPLETED|Overall Study||0
11184321|NCT01725282|12373472|FG000|STARTED|Overall Study||44
11184322|NCT01725282|12373473|FG001|STARTED|Overall Study||44
11184323|NCT01725282|12373474|FG002|STARTED|Overall Study||41
11184324|NCT01725282|12373475|FG003|STARTED|Overall Study||43
11184325|NCT01725282|12373472|FG000|COMPLETED|Overall Study||42
11184326|NCT01725282|12373473|FG001|COMPLETED|Overall Study||39
11184327|NCT01725282|12373474|FG002|COMPLETED|Overall Study||33
11184328|NCT01725282|12373475|FG003|COMPLETED|Overall Study||36
11184329|NCT01725282|12373472|FG000|NOT COMPLETED|Overall Study||2
11184330|NCT01725282|12373473|FG001|NOT COMPLETED|Overall Study||5
11184331|NCT01725282|12373474|FG002|NOT COMPLETED|Overall Study||8
11184332|NCT01725282|12373475|FG003|NOT COMPLETED|Overall Study||7
11184333|NCT01725308|12373488|FG000|STARTED|Treatment Period I||178
11184334|NCT01725308|12373489|FG001|STARTED|Treatment Period I||74
11184335|NCT01725308|12373490|FG002|STARTED|Treatment Period I||179
11184336|NCT01725308|12373488|FG000|Treated|Treatment Period I||177
11184337|NCT01725308|12373489|FG001|Treated|Treatment Period I||74
11184338|NCT01725308|12373490|FG002|Treated|Treatment Period I||179
11184339|NCT01725308|12373488|FG000|COMPLETED|Treatment Period I||134
11184340|NCT01725308|12373489|FG001|COMPLETED|Treatment Period I||60
11184341|NCT01725308|12373490|FG002|COMPLETED|Treatment Period I||138
11184342|NCT01725308|12373488|FG000|NOT COMPLETED|Treatment Period I||44
11184343|NCT01725308|12373489|FG001|NOT COMPLETED|Treatment Period I||14
11184344|NCT01725308|12373490|FG002|NOT COMPLETED|Treatment Period I||41
11184345|NCT01725308|12373488|FG000|STARTED|Treatment Period II||134
11184346|NCT01725308|12373489|FG001|STARTED|Treatment Period II||60
11184347|NCT01725308|12373490|FG002|STARTED|Treatment Period II||138
11184348|NCT01725308|12373488|FG000|Treated|Treatment Period II||120
11184349|NCT01725308|12373489|FG001|Treated|Treatment Period II||53
11184350|NCT01725308|12373490|FG002|Treated|Treatment Period II||130
11184351|NCT01725308|12373488|FG000|COMPLETED|Treatment Period II||79
11184352|NCT01725308|12373489|FG001|COMPLETED|Treatment Period II||31
11184353|NCT01725308|12373490|FG002|COMPLETED|Treatment Period II||74
11184354|NCT01725308|12373488|FG000|NOT COMPLETED|Treatment Period II||55
11184355|NCT01725308|12373489|FG001|NOT COMPLETED|Treatment Period II||29
11184356|NCT01725308|12373490|FG002|NOT COMPLETED|Treatment Period II||64
11184357|NCT01725386|12373507|FG000|STARTED|Overall Study||188
11184358|NCT01725386|12373508|FG001|STARTED|Overall Study||63
11184359|NCT01725386|12373507|FG000|COMPLETED|Overall Study||13
11184360|NCT01725386|12373508|FG001|COMPLETED|Overall Study||17
11184361|NCT01725386|12373507|FG000|NOT COMPLETED|Overall Study||175
11184362|NCT01725386|12373508|FG001|NOT COMPLETED|Overall Study||46
11184363|NCT01725451|12373514|FG000|STARTED|Period 1||8
11184364|NCT01725451|12373515|FG001|STARTED|Period 1||7
11184365|NCT01725451|12373516|FG002|STARTED|Period 1||8
11184366|NCT01725451|12373517|FG003|STARTED|Period 1||7
11184367|NCT01725451|12373514|FG000|COMPLETED|Period 1||7
11184368|NCT01725451|12373515|FG001|COMPLETED|Period 1||7
11184369|NCT01725451|12373516|FG002|COMPLETED|Period 1||8
11184370|NCT01725451|12373517|FG003|COMPLETED|Period 1||7
11184371|NCT01725451|12373514|FG000|NOT COMPLETED|Period 1||1
11184372|NCT01725451|12373515|FG001|NOT COMPLETED|Period 1||0
11184373|NCT01725451|12373516|FG002|NOT COMPLETED|Period 1||0
11184374|NCT01725451|12373517|FG003|NOT COMPLETED|Period 1||0
11184375|NCT01725451|12373514|FG000|STARTED|Washout From Period 1||7
11184376|NCT01725451|12373515|FG001|STARTED|Washout From Period 1||7
11184377|NCT01725451|12373516|FG002|STARTED|Washout From Period 1||8
11184378|NCT01725451|12373517|FG003|STARTED|Washout From Period 1||7
11184379|NCT01725451|12373514|FG000|COMPLETED|Washout From Period 1||7
11184380|NCT01725451|12373515|FG001|COMPLETED|Washout From Period 1||7
11184381|NCT01725451|12373516|FG002|COMPLETED|Washout From Period 1||8
11184382|NCT01725451|12373517|FG003|COMPLETED|Washout From Period 1||7
11184383|NCT01725451|12373514|FG000|NOT COMPLETED|Washout From Period 1||0
11184384|NCT01725451|12373515|FG001|NOT COMPLETED|Washout From Period 1||0
11184385|NCT01725451|12373516|FG002|NOT COMPLETED|Washout From Period 1||0
11184386|NCT01725451|12373517|FG003|NOT COMPLETED|Washout From Period 1||0
11184387|NCT01725451|12373514|FG000|STARTED|Period 2||7
11184388|NCT01725451|12373515|FG001|STARTED|Period 2||7
11184389|NCT01725451|12373516|FG002|STARTED|Period 2||8
11184390|NCT01725451|12373517|FG003|STARTED|Period 2||7
11184391|NCT01725451|12373514|FG000|COMPLETED|Period 2||7
11184392|NCT01725451|12373515|FG001|COMPLETED|Period 2||7
11184393|NCT01725451|12373516|FG002|COMPLETED|Period 2||8
11184394|NCT01725451|12373517|FG003|COMPLETED|Period 2||7
11184395|NCT01725451|12373514|FG000|NOT COMPLETED|Period 2||0
11184396|NCT01725451|12373515|FG001|NOT COMPLETED|Period 2||0
11184397|NCT01725451|12373516|FG002|NOT COMPLETED|Period 2||0
11184398|NCT01725451|12373517|FG003|NOT COMPLETED|Period 2||0
11184399|NCT01725451|12373514|FG000|STARTED|Washout From Period 2||7
11184400|NCT01725451|12373515|FG001|STARTED|Washout From Period 2||7
11184401|NCT01725451|12373516|FG002|STARTED|Washout From Period 2||8
11184402|NCT01725451|12373517|FG003|STARTED|Washout From Period 2||7
11184403|NCT01725451|12373514|FG000|COMPLETED|Washout From Period 2||7
11184404|NCT01725451|12373515|FG001|COMPLETED|Washout From Period 2||7
11184405|NCT01725451|12373516|FG002|COMPLETED|Washout From Period 2||8
11324269|NCT02742766|12521575|FG016|STARTED|Part 2 (Up to 22 Days)||0
11324270|NCT02742766|12521576|FG017|STARTED|Part 2 (Up to 22 Days)||0
11324271|NCT02742766|12521577|FG018|STARTED|Part 2 (Up to 22 Days)||0
11324272|NCT02742766|12521559|FG000|COMPLETED|Part 2 (Up to 22 Days)||0
11324273|NCT02742766|12521560|FG001|COMPLETED|Part 2 (Up to 22 Days)||0
11324274|NCT02742766|12521561|FG002|COMPLETED|Part 2 (Up to 22 Days)||0
11324275|NCT02742766|12521562|FG003|COMPLETED|Part 2 (Up to 22 Days)||0
11324276|NCT02742766|12521563|FG004|COMPLETED|Part 2 (Up to 22 Days)||0
11324277|NCT02742766|12521564|FG005|COMPLETED|Part 2 (Up to 22 Days)||0
11324278|NCT02742766|12521565|FG006|COMPLETED|Part 2 (Up to 22 Days)||0
11324279|NCT02742766|12521566|FG007|COMPLETED|Part 2 (Up to 22 Days)||0
11324280|NCT02742766|12521567|FG008|COMPLETED|Part 2 (Up to 22 Days)||0
11324281|NCT02742766|12521568|FG009|COMPLETED|Part 2 (Up to 22 Days)||0
11324282|NCT02742766|12521569|FG010|COMPLETED|Part 2 (Up to 22 Days)||0
11324283|NCT02742766|12521570|FG011|COMPLETED|Part 2 (Up to 22 Days)||0
11324284|NCT02742766|12521571|FG012|COMPLETED|Part 2 (Up to 22 Days)||4
11324285|NCT02742766|12521572|FG013|COMPLETED|Part 2 (Up to 22 Days)||0
11324286|NCT02742766|12521573|FG014|COMPLETED|Part 2 (Up to 22 Days)||6
11324287|NCT02742766|12521574|FG015|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5
11324288|NCT02742766|12521575|FG016|COMPLETED|Part 2 (Up to 22 Days)||0
11324289|NCT02742766|12521576|FG017|COMPLETED|Part 2 (Up to 22 Days)||0
11324290|NCT02742766|12521577|FG018|COMPLETED|Part 2 (Up to 22 Days)||0
11324291|NCT02742766|12521559|FG000|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324292|NCT02742766|12521560|FG001|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324293|NCT02742766|12521561|FG002|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324294|NCT02742766|12521562|FG003|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324295|NCT02742766|12521563|FG004|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324296|NCT02742766|12521564|FG005|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324297|NCT02742766|12521565|FG006|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324298|NCT02742766|12521566|FG007|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324299|NCT02742766|12521567|FG008|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324300|NCT02742766|12521568|FG009|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324301|NCT02742766|12521569|FG010|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324302|NCT02742766|12521570|FG011|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324303|NCT02742766|12521571|FG012|NOT COMPLETED|Part 2 (Up to 22 Days)||2
11324304|NCT02742766|12521572|FG013|NOT COMPLETED|Part 2 (Up to 22 Days)||6
11324305|NCT02742766|12521573|FG014|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324306|NCT02742766|12521574|FG015|NOT COMPLETED|Part 2 (Up to 22 Days)||1
11324307|NCT02742766|12521575|FG016|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324308|NCT02742766|12521576|FG017|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324309|NCT02742766|12521577|FG018|NOT COMPLETED|Part 2 (Up to 22 Days)||0
11324310|NCT02742766|12521559|FG000|STARTED|Part 3 (Up to 36 Days)||0
11324311|NCT02742766|12521560|FG001|STARTED|Part 3 (Up to 36 Days)||0
11324312|NCT02742766|12521561|FG002|STARTED|Part 3 (Up to 36 Days)||0
11324313|NCT02742766|12521562|FG003|STARTED|Part 3 (Up to 36 Days)||0
11324314|NCT02742766|12521563|FG004|STARTED|Part 3 (Up to 36 Days)||0
11324315|NCT02742766|12521564|FG005|STARTED|Part 3 (Up to 36 Days)||0
11324316|NCT02742766|12521565|FG006|STARTED|Part 3 (Up to 36 Days)||0
11324317|NCT02742766|12521566|FG007|STARTED|Part 3 (Up to 36 Days)||0
11324318|NCT02742766|12521567|FG008|STARTED|Part 3 (Up to 36 Days)||0
11324319|NCT02742766|12521568|FG009|STARTED|Part 3 (Up to 36 Days)||0
11324320|NCT02742766|12521569|FG010|STARTED|Part 3 (Up to 36 Days)||0
11324321|NCT02742766|12521570|FG011|STARTED|Part 3 (Up to 36 Days)||0
11324322|NCT02742766|12521571|FG012|STARTED|Part 3 (Up to 36 Days)||0
11324323|NCT02742766|12521572|FG013|STARTED|Part 3 (Up to 36 Days)||0
11184406|NCT01725451|12373517|FG003|COMPLETED|Washout From Period 2||7
11184407|NCT01725451|12373514|FG000|NOT COMPLETED|Washout From Period 2||0
11184408|NCT01725451|12373515|FG001|NOT COMPLETED|Washout From Period 2||0
11184409|NCT01725451|12373516|FG002|NOT COMPLETED|Washout From Period 2||0
11184410|NCT01725451|12373517|FG003|NOT COMPLETED|Washout From Period 2||0
11184411|NCT01725451|12373514|FG000|STARTED|Period 3||7
11184412|NCT01725451|12373515|FG001|STARTED|Period 3||7
11184413|NCT01725451|12373516|FG002|STARTED|Period 3||8
11184414|NCT01725451|12373517|FG003|STARTED|Period 3||7
11184415|NCT01725451|12373514|FG000|COMPLETED|Period 3||7
11184416|NCT01725451|12373515|FG001|COMPLETED|Period 3||7
11184417|NCT01725451|12373516|FG002|COMPLETED|Period 3||8
11184418|NCT01725451|12373517|FG003|COMPLETED|Period 3||7
11184419|NCT01725451|12373514|FG000|NOT COMPLETED|Period 3||0
11184420|NCT01725451|12373515|FG001|NOT COMPLETED|Period 3||0
11184421|NCT01725451|12373516|FG002|NOT COMPLETED|Period 3||0
11184422|NCT01725451|12373517|FG003|NOT COMPLETED|Period 3||0
11184423|NCT01725451|12373514|FG000|STARTED|Washout From Period 3||7
11184424|NCT01725451|12373515|FG001|STARTED|Washout From Period 3||7
11184425|NCT01725451|12373516|FG002|STARTED|Washout From Period 3||8
11184426|NCT01725451|12373517|FG003|STARTED|Washout From Period 3||7
11184427|NCT01725451|12373514|FG000|COMPLETED|Washout From Period 3||7
11184428|NCT01725451|12373515|FG001|COMPLETED|Washout From Period 3||6
11184429|NCT01725451|12373516|FG002|COMPLETED|Washout From Period 3||7
11184430|NCT01725451|12373517|FG003|COMPLETED|Washout From Period 3||7
11184431|NCT01725451|12373514|FG000|NOT COMPLETED|Washout From Period 3||0
11184432|NCT01725451|12373515|FG001|NOT COMPLETED|Washout From Period 3||1
11184433|NCT01725451|12373516|FG002|NOT COMPLETED|Washout From Period 3||1
11184434|NCT01725451|12373517|FG003|NOT COMPLETED|Washout From Period 3||0
11184435|NCT01725451|12373514|FG000|STARTED|Period 4||7
11184436|NCT01725451|12373515|FG001|STARTED|Period 4||6
11184437|NCT01725451|12373516|FG002|STARTED|Period 4||7
11184438|NCT01725451|12373517|FG003|STARTED|Period 4||7
11184439|NCT01725451|12373514|FG000|COMPLETED|Period 4||7
11184440|NCT01725451|12373515|FG001|COMPLETED|Period 4||6
11184441|NCT01725451|12373516|FG002|COMPLETED|Period 4||6
11184442|NCT01725451|12373517|FG003|COMPLETED|Period 4||7
11184443|NCT01725451|12373514|FG000|NOT COMPLETED|Period 4||0
11184444|NCT01725451|12373515|FG001|NOT COMPLETED|Period 4||0
11184445|NCT01725451|12373516|FG002|NOT COMPLETED|Period 4||1
11184446|NCT01725451|12373517|FG003|NOT COMPLETED|Period 4||0
11184447|NCT01725451|12373514|FG000|STARTED|Washout From Period 4||7
11184448|NCT01725451|12373515|FG001|STARTED|Washout From Period 4||6
11184449|NCT01725451|12373516|FG002|STARTED|Washout From Period 4||6
11184450|NCT01725451|12373517|FG003|STARTED|Washout From Period 4||7
11184451|NCT01725451|12373514|FG000|COMPLETED|Washout From Period 4||7
11184452|NCT01725451|12373515|FG001|COMPLETED|Washout From Period 4||6
11184453|NCT01725451|12373516|FG002|COMPLETED|Washout From Period 4||6
11184454|NCT01725451|12373517|FG003|COMPLETED|Washout From Period 4||7
11184455|NCT01725451|12373514|FG000|NOT COMPLETED|Washout From Period 4||0
11184456|NCT01725451|12373515|FG001|NOT COMPLETED|Washout From Period 4||0
11184457|NCT01725451|12373516|FG002|NOT COMPLETED|Washout From Period 4||0
11184458|NCT01725451|12373517|FG003|NOT COMPLETED|Washout From Period 4||0
11184459|NCT01725451|12373514|FG000|STARTED|Period 5||7
11184460|NCT01725451|12373515|FG001|STARTED|Period 5||6
11184461|NCT01725451|12373516|FG002|STARTED|Period 5||6
11184462|NCT01725451|12373517|FG003|STARTED|Period 5||7
11184463|NCT01725451|12373514|FG000|COMPLETED|Period 5||7
11184464|NCT01725451|12373515|FG001|COMPLETED|Period 5||6
11184465|NCT01725451|12373516|FG002|COMPLETED|Period 5||6
11184466|NCT01725451|12373517|FG003|COMPLETED|Period 5||7
11184467|NCT01725451|12373514|FG000|NOT COMPLETED|Period 5||0
11184468|NCT01725451|12373515|FG001|NOT COMPLETED|Period 5||0
11184469|NCT01725451|12373516|FG002|NOT COMPLETED|Period 5||0
11184470|NCT01725451|12373517|FG003|NOT COMPLETED|Period 5||0
11184471|NCT01725451|12373514|FG000|STARTED|Washout From Period 5||7
11184472|NCT01725451|12373515|FG001|STARTED|Washout From Period 5||6
11184473|NCT01725451|12373516|FG002|STARTED|Washout From Period 5||6
11184474|NCT01725451|12373517|FG003|STARTED|Washout From Period 5||7
11184475|NCT01725451|12373514|FG000|COMPLETED|Washout From Period 5||7
11184476|NCT01725451|12373515|FG001|COMPLETED|Washout From Period 5||6
11184477|NCT01725451|12373516|FG002|COMPLETED|Washout From Period 5||6
11184478|NCT01725451|12373517|FG003|COMPLETED|Washout From Period 5||7
11184479|NCT01725451|12373514|FG000|NOT COMPLETED|Washout From Period 5||0
11184480|NCT01725451|12373515|FG001|NOT COMPLETED|Washout From Period 5||0
11184481|NCT01725451|12373516|FG002|NOT COMPLETED|Washout From Period 5||0
11184482|NCT01725451|12373517|FG003|NOT COMPLETED|Washout From Period 5||0
11184483|NCT01725451|12373514|FG000|STARTED|Period 6||7
11184484|NCT01725451|12373515|FG001|STARTED|Period 6||6
11184485|NCT01725451|12373516|FG002|STARTED|Period 6||6
11184486|NCT01725451|12373517|FG003|STARTED|Period 6||7
11184487|NCT01725451|12373514|FG000|COMPLETED|Period 6||7
11184488|NCT01725451|12373515|FG001|COMPLETED|Period 6||6
11184489|NCT01725451|12373516|FG002|COMPLETED|Period 6||6
11184490|NCT01725451|12373517|FG003|COMPLETED|Period 6||7
11184491|NCT01725451|12373514|FG000|NOT COMPLETED|Period 6||0
11184492|NCT01725451|12373515|FG001|NOT COMPLETED|Period 6||0
11184493|NCT01725451|12373516|FG002|NOT COMPLETED|Period 6||0
11184494|NCT01725451|12373517|FG003|NOT COMPLETED|Period 6||0
11184495|NCT01725529|12373535|FG000|STARTED|Overall Study||152
11184496|NCT01725529|12373536|FG001|STARTED|Overall Study||153
11184497|NCT01725529|12373537|FG002|STARTED|Overall Study||152
11184498|NCT01725529|12373535|FG000|COMPLETED|Overall Study||137
11184499|NCT01725529|12373536|FG001|COMPLETED|Overall Study||137
11184500|NCT01725529|12373537|FG002|COMPLETED|Overall Study||142
11184501|NCT01725529|12373535|FG000|NOT COMPLETED|Overall Study||15
11184502|NCT01725529|12373536|FG001|NOT COMPLETED|Overall Study||16
11184503|NCT01725529|12373537|FG002|NOT COMPLETED|Overall Study||10
11184504|NCT01725750|12373547|FG000|STARTED|Overall Study||44
11184505|NCT01725750|12373548|FG001|STARTED|Overall Study||44
11184506|NCT01725750|12373547|FG000|COMPLETED|Overall Study||42
11184507|NCT01725750|12373548|FG001|COMPLETED|Overall Study||34
11184508|NCT01725750|12373547|FG000|NOT COMPLETED|Overall Study||2
11184509|NCT01725750|12373548|FG001|NOT COMPLETED|Overall Study||10
11184510|NCT01725815|12373558|FG000|STARTED|Overall Study||198
11184511|NCT01725815|12373559|FG001|STARTED|Overall Study||202
11184512|NCT01725815|12373558|FG000|COMPLETED|Overall Study||198
11184513|NCT01725815|12373559|FG001|COMPLETED|Overall Study||202
11184514|NCT01725815|12373558|FG000|NOT COMPLETED|Overall Study||0
11184515|NCT01725815|12373559|FG001|NOT COMPLETED|Overall Study||0
11184516|NCT01725984|12373567|FG000|STARTED|Overall Study||39
11184517|NCT01725984|12373568|FG001|STARTED|Overall Study||41
11184518|NCT01725984|12373567|FG000|COMPLETED|Overall Study||39
11184519|NCT01725984|12373568|FG001|COMPLETED|Overall Study||41
11184520|NCT01725984|12373567|FG000|NOT COMPLETED|Overall Study||0
11184521|NCT01725984|12373568|FG001|NOT COMPLETED|Overall Study||0
11184522|NCT01726023|12373576|FG000|STARTED|Overall Study||219
11184523|NCT01726023|12373577|FG001|STARTED|Overall Study||222
11184524|NCT01726023|12373576|FG000|COMPLETED|Overall Study||190
11184525|NCT01726023|12373577|FG001|COMPLETED|Overall Study||196
11184526|NCT01726023|12373576|FG000|NOT COMPLETED|Overall Study||29
11184527|NCT01726023|12373577|FG001|NOT COMPLETED|Overall Study||26
11184528|NCT01726036|12373592|FG000|STARTED|Overall Study||137
11184529|NCT01726036|12373593|FG001|STARTED|Overall Study||137
11184530|NCT01726036|12373592|FG000|COMPLETED|Overall Study||121
11184531|NCT01726036|12373593|FG001|COMPLETED|Overall Study||130
11184532|NCT01726036|12373592|FG000|NOT COMPLETED|Overall Study||16
11184533|NCT01726036|12373593|FG001|NOT COMPLETED|Overall Study||7
11184534|NCT01726049|12373601|FG000|STARTED|Overall Study||26
11184535|NCT01726049|12373602|FG001|STARTED|Overall Study||26
11184536|NCT01726049|12373601|FG000|COMPLETED|Overall Study||21
11184537|NCT01726049|12373602|FG001|COMPLETED|Overall Study||22
11184538|NCT01726049|12373601|FG000|NOT COMPLETED|Overall Study||5
11184539|NCT01726049|12373602|FG001|NOT COMPLETED|Overall Study||4
11184540|NCT01726270|12373608|FG000|STARTED|Part 1, Self-Selection Phase||689
11184541|NCT01726270|12373608|FG000|COMPLETED|Part 1, Self-Selection Phase||679
11184542|NCT01726270|12373608|FG000|NOT COMPLETED|Part 1, Self-Selection Phase||10
11184543|NCT01726270|12373608|FG000|STARTED|Eligibility for Part 2|No. of subjects potentially eligible for Part 2|389
11184544|NCT01726270|12373608|FG000|COMPLETED|Eligibility for Part 2||369
11184545|NCT01726270|12373608|FG000|NOT COMPLETED|Eligibility for Part 2||20
11184546|NCT01726270|12373608|FG000|STARTED|Part 2, Actual-Use Phase|20 subjects were eligible for Part 2 but did not enter Part 2|369
11184547|NCT01726270|12373608|FG000|COMPLETED|Part 2, Actual-Use Phase||330
11184548|NCT01726270|12373608|FG000|NOT COMPLETED|Part 2, Actual-Use Phase||39
11184549|NCT01726335|12373614|FG000|STARTED|Overall Study||53
11184550|NCT01726335|12373614|FG000|COMPLETED|Overall Study||29
11184551|NCT01726335|12373614|FG000|NOT COMPLETED|Overall Study||24
11184552|NCT01726504|12373620|FG000|STARTED|Overall Study||536
11184553|NCT01726504|12373621|FG001|STARTED|Overall Study||539
11184554|NCT01726504|12373620|FG000|COMPLETED|Overall Study||524
11184555|NCT01726504|12373621|FG001|COMPLETED|Overall Study||511
11184556|NCT01726504|12373620|FG000|NOT COMPLETED|Overall Study||12
11184557|NCT01726504|12373621|FG001|NOT COMPLETED|Overall Study||28
11184558|NCT01726517|12373632|FG000|STARTED|Overall Study||20
11184559|NCT01726517|12373633|FG001|STARTED|Overall Study||21
11184560|NCT01726517|12373634|FG002|STARTED|Overall Study||19
11184561|NCT01726517|12373635|FG003|STARTED|Overall Study||19
11184562|NCT01726517|12373636|FG004|STARTED|Overall Study||21
11184563|NCT01726517|12373632|FG000|COMPLETED|Overall Study||20
11184564|NCT01726517|12373633|FG001|COMPLETED|Overall Study||21
11184565|NCT01726517|12373634|FG002|COMPLETED|Overall Study||18
11184566|NCT01726517|12373635|FG003|COMPLETED|Overall Study||19
11184567|NCT01726517|12373636|FG004|COMPLETED|Overall Study||21
11184568|NCT01726517|12373632|FG000|NOT COMPLETED|Overall Study||0
11184569|NCT01726517|12373633|FG001|NOT COMPLETED|Overall Study||0
11184570|NCT01726517|12373634|FG002|NOT COMPLETED|Overall Study||1
11184571|NCT01726517|12373635|FG003|NOT COMPLETED|Overall Study||0
11184572|NCT01726517|12373636|FG004|NOT COMPLETED|Overall Study||0
11184573|NCT01726621|12373648|FG000|STARTED|Overall Study||55
11184574|NCT01726621|12373648|FG000|COMPLETED|Overall Study||51
11184575|NCT01726621|12373648|FG000|NOT COMPLETED|Overall Study||4
11184576|NCT01726673|12373654|FG000|STARTED|Overall Study||30
11184577|NCT01726673|12373655|FG001|STARTED|Overall Study||24
11184578|NCT01726673|12373654|FG000|COMPLETED|Overall Study||24
11184579|NCT01726673|12373655|FG001|COMPLETED|Overall Study||21
11184580|NCT01726673|12373654|FG000|NOT COMPLETED|Overall Study||6
11184581|NCT01726673|12373655|FG001|NOT COMPLETED|Overall Study||3
11184582|NCT01726738|12373661|FG000|STARTED|Overall Study||17
11184583|NCT01726738|12373661|FG000|COMPLETED|Overall Study||17
11184584|NCT01726738|12373661|FG000|NOT COMPLETED|Overall Study||0
11184585|NCT01726803|12373667|FG000|STARTED|Overall Study||112
11184586|NCT01726803|12373668|FG001|STARTED|Overall Study||108
11184587|NCT01726803|12373667|FG000|COMPLETED|Overall Study||105
11184588|NCT01726803|12373668|FG001|COMPLETED|Overall Study||107
11184589|NCT01726803|12373667|FG000|NOT COMPLETED|Overall Study||7
11184590|NCT01726803|12373668|FG001|NOT COMPLETED|Overall Study||1
11184591|NCT01727024|12373674|FG000|STARTED|Period 1||71
11184592|NCT01727024|12373675|FG001|STARTED|Period 1||68
11184593|NCT01727024|12373674|FG000|COMPLETED|Period 1||68
11184594|NCT01727024|12373675|FG001|COMPLETED|Period 1||64
11184595|NCT01727024|12373674|FG000|NOT COMPLETED|Period 1||3
11184596|NCT01727024|12373675|FG001|NOT COMPLETED|Period 1||4
11184597|NCT01727024|12373674|FG000|STARTED|Period 2||68
11184598|NCT01727024|12373675|FG001|STARTED|Period 2||64
11184599|NCT01727024|12373674|FG000|COMPLETED|Period 2||68
11184600|NCT01727024|12373675|FG001|COMPLETED|Period 2||64
11184601|NCT01727024|12373674|FG000|NOT COMPLETED|Period 2||0
11184602|NCT01727024|12373675|FG001|NOT COMPLETED|Period 2||0
11184603|NCT01727089|12373683|FG000|STARTED|Overall Study||29
11184604|NCT01727089|12373684|FG001|STARTED|Overall Study||30
11184605|NCT01727089|12373683|FG000|COMPLETED|Overall Study||29
11184606|NCT01727089|12373684|FG001|COMPLETED|Overall Study||30
11184607|NCT01727089|12373683|FG000|NOT COMPLETED|Overall Study||0
11184608|NCT01727089|12373684|FG001|NOT COMPLETED|Overall Study||0
11184609|NCT01727141|12373694|FG000|STARTED|Overall Study||260
11184610|NCT01727141|12373695|FG001|STARTED|Overall Study||260
11184611|NCT01727141|12373696|FG002|STARTED|Overall Study||261
11184612|NCT01727141|12373697|FG003|STARTED|Overall Study||261
11184613|NCT01727141|12373694|FG000|Safety Set|Overall Study||258
11184614|NCT01727141|12373695|FG001|Safety Set|Overall Study||260
11184615|NCT01727141|12373696|FG002|Safety Set|Overall Study||262
11184616|NCT01727141|12373697|FG003|Safety Set|Overall Study||260
11184617|NCT01727141|12373694|FG000|Full Analysis Set|Overall Study||258
11184618|NCT01727141|12373695|FG001|Full Analysis Set|Overall Study||260
11184619|NCT01727141|12373696|FG002|Full Analysis Set|Overall Study||261
11184620|NCT01727141|12373697|FG003|Full Analysis Set|Overall Study||261
11184621|NCT01727141|12373694|FG000|COMPLETED|Overall Study||255
11184622|NCT01727141|12373695|FG001|COMPLETED|Overall Study||251
11184623|NCT01727141|12373696|FG002|COMPLETED|Overall Study||258
11184624|NCT01727141|12373697|FG003|COMPLETED|Overall Study||246
11184625|NCT01727141|12373694|FG000|NOT COMPLETED|Overall Study||5
11184626|NCT01727141|12373695|FG001|NOT COMPLETED|Overall Study||9
11184627|NCT01727141|12373696|FG002|NOT COMPLETED|Overall Study||3
11184628|NCT01727141|12373697|FG003|NOT COMPLETED|Overall Study||15
11184629|NCT01727154|12373707|FG000|STARTED|Overall Study||139
11184630|NCT01727154|12373707|FG000|COMPLETED|Overall Study||80
11184631|NCT01727154|12373707|FG000|NOT COMPLETED|Overall Study||59
11184632|NCT01727180|12373711|FG000|STARTED|Overall Study||108
11184633|NCT01727180|12373711|FG000|COMPLETED|Overall Study||108
11184634|NCT01727180|12373711|FG000|NOT COMPLETED|Overall Study||0
11184635|NCT01727258|12373718|FG000|STARTED|Overall Study||51
11184636|NCT01727258|12373719|FG001|STARTED|Overall Study||51
11184637|NCT01727258|12373720|FG002|STARTED|Overall Study||51
11184638|NCT01727258|12373718|FG000|COMPLETED|Overall Study||49
11184639|NCT01727258|12373719|FG001|COMPLETED|Overall Study||48
11184640|NCT01727258|12373720|FG002|COMPLETED|Overall Study||50
11184641|NCT01727258|12373718|FG000|NOT COMPLETED|Overall Study||2
11184642|NCT01727258|12373719|FG001|NOT COMPLETED|Overall Study||3
11184643|NCT01727258|12373720|FG002|NOT COMPLETED|Overall Study||1
11184644|NCT01727297|12373728|FG000|STARTED|Overall Study||395
11184645|NCT01727297|12373729|FG001|STARTED|Overall Study||51
11184646|NCT01727297|12373728|FG000|COMPLETED|Overall Study||293
11184647|NCT01727297|12373729|FG001|COMPLETED|Overall Study||0
11184648|NCT01727297|12373728|FG000|NOT COMPLETED|Overall Study||102
11184649|NCT01727297|12373729|FG001|NOT COMPLETED|Overall Study||51
11184650|NCT01727336|12373748|FG000|STARTED|Part 1 Dalantercept Dose Escalation||6
11184651|NCT01727336|12373749|FG001|STARTED|Part 1 Dalantercept Dose Escalation||9
11184652|NCT01727336|12373750|FG002|STARTED|Part 1 Dalantercept Dose Escalation||14
11184653|NCT01727336|12373751|FG003|STARTED|Part 1 Dalantercept Dose Escalation||0
11184654|NCT01727336|12373752|FG004|STARTED|Part 1 Dalantercept Dose Escalation||0
11184655|NCT01727336|12373753|FG005|STARTED|Part 1 Dalantercept Dose Escalation||0
11184656|NCT01727336|12373748|FG000|COMPLETED|Part 1 Dalantercept Dose Escalation||3
11184657|NCT01727336|12373749|FG001|COMPLETED|Part 1 Dalantercept Dose Escalation||7
11184658|NCT01727336|12373750|FG002|COMPLETED|Part 1 Dalantercept Dose Escalation||6
11184659|NCT01727336|12373751|FG003|COMPLETED|Part 1 Dalantercept Dose Escalation||0
11184660|NCT01727336|12373752|FG004|COMPLETED|Part 1 Dalantercept Dose Escalation||0
11184661|NCT01727336|12373753|FG005|COMPLETED|Part 1 Dalantercept Dose Escalation||0
11184662|NCT01727336|12373748|FG000|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||3
11184663|NCT01727336|12373749|FG001|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||2
11184664|NCT01727336|12373750|FG002|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||8
11184665|NCT01727336|12373751|FG003|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
11184666|NCT01727336|12373752|FG004|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
11184667|NCT01727336|12373753|FG005|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
11184668|NCT01727336|12373748|FG000|STARTED|Part 2 Blinded||0
11184669|NCT01727336|12373749|FG001|STARTED|Part 2 Blinded||0
11184670|NCT01727336|12373750|FG002|STARTED|Part 2 Blinded||0
11184671|NCT01727336|12373751|FG003|STARTED|Part 2 Blinded||0
11184672|NCT01727336|12373752|FG004|STARTED|Part 2 Blinded||63
11184673|NCT01727336|12373753|FG005|STARTED|Part 2 Blinded||68
11184674|NCT01727336|12373748|FG000|COMPLETED|Part 2 Blinded||0
11184675|NCT01727336|12373749|FG001|COMPLETED|Part 2 Blinded||0
11184676|NCT01727336|12373750|FG002|COMPLETED|Part 2 Blinded||0
11184677|NCT01727336|12373751|FG003|COMPLETED|Part 2 Blinded||0
11184678|NCT01727336|12373752|FG004|COMPLETED|Part 2 Blinded||0
11184679|NCT01727336|12373753|FG005|COMPLETED|Part 2 Blinded||0
11184680|NCT01727336|12373748|FG000|NOT COMPLETED|Part 2 Blinded||0
11184681|NCT01727336|12373749|FG001|NOT COMPLETED|Part 2 Blinded||0
11184682|NCT01727336|12373750|FG002|NOT COMPLETED|Part 2 Blinded||0
11184683|NCT01727336|12373751|FG003|NOT COMPLETED|Part 2 Blinded||0
11184684|NCT01727336|12373752|FG004|NOT COMPLETED|Part 2 Blinded||63
11184685|NCT01727336|12373753|FG005|NOT COMPLETED|Part 2 Blinded||68
11184686|NCT01727414|12373775|FG000|STARTED|Overall Study||126
11184687|NCT01727414|12373776|FG001|STARTED|Overall Study||45
11184688|NCT01727414|12373775|FG000|COMPLETED|Overall Study||123
11184689|NCT01727414|12373776|FG001|COMPLETED|Overall Study||45
11184690|NCT01727414|12373775|FG000|NOT COMPLETED|Overall Study||3
11184691|NCT01727414|12373776|FG001|NOT COMPLETED|Overall Study||0
11184692|NCT01727505|12373782|FG000|STARTED|First 24 Hours||14
11184693|NCT01727505|12373783|FG001|STARTED|First 24 Hours||12
11184694|NCT01727505|12373782|FG000|COMPLETED|First 24 Hours||14
11184695|NCT01727505|12373783|FG001|COMPLETED|First 24 Hours||11
11184696|NCT01727505|12373782|FG000|NOT COMPLETED|First 24 Hours||0
11184697|NCT01727505|12373783|FG001|NOT COMPLETED|First 24 Hours||1
11184698|NCT01727505|12373782|FG000|STARTED|Second 24 Hours||14
11184699|NCT01727505|12373783|FG001|STARTED|Second 24 Hours||11
11184700|NCT01727505|12373782|FG000|COMPLETED|Second 24 Hours||14
11184701|NCT01727505|12373783|FG001|COMPLETED|Second 24 Hours||10
11184702|NCT01727505|12373782|FG000|NOT COMPLETED|Second 24 Hours||0
11184703|NCT01727505|12373783|FG001|NOT COMPLETED|Second 24 Hours||1
11184704|NCT01727700|12373792|FG000|STARTED|Overall Study||44
11184705|NCT01727700|12373793|FG001|STARTED|Overall Study||45
11184706|NCT01727700|12373794|FG002|STARTED|Overall Study||44
11184707|NCT01727700|12373792|FG000|COMPLETED|Overall Study||42
11184708|NCT01727700|12373793|FG001|COMPLETED|Overall Study||35
11184709|NCT01727700|12373794|FG002|COMPLETED|Overall Study||42
11184710|NCT01727700|12373792|FG000|NOT COMPLETED|Overall Study||2
11184711|NCT01727700|12373793|FG001|NOT COMPLETED|Overall Study||10
11184712|NCT01727700|12373794|FG002|NOT COMPLETED|Overall Study||2
11184713|NCT01727713|12373802|FG000|STARTED|Overall Study||110
11184714|NCT01727713|12373802|FG000|COMPLETED|Overall Study||75
11184715|NCT01727713|12373802|FG000|NOT COMPLETED|Overall Study||35
11184716|NCT01727726|12373809|FG000|STARTED|Overall Study||197
11184717|NCT01727726|12373810|FG001|STARTED|Overall Study||100
11184718|NCT01727726|12373811|FG002|STARTED|Overall Study||206
11184719|NCT01727726|12373809|FG000|COMPLETED|Overall Study||171
11184720|NCT01727726|12373810|FG001|COMPLETED|Overall Study||86
11184721|NCT01727726|12373811|FG002|COMPLETED|Overall Study||186
11184722|NCT01727726|12373809|FG000|NOT COMPLETED|Overall Study||26
11184723|NCT01727726|12373810|FG001|NOT COMPLETED|Overall Study||14
11184724|NCT01727726|12373811|FG002|NOT COMPLETED|Overall Study||20
11184725|NCT01727765|12373821|FG000|STARTED|Overall Study||8
11184726|NCT01727765|12373822|FG001|STARTED|Overall Study||8
11184727|NCT01727765|12373821|FG000|COMPLETED|Overall Study||8
11184728|NCT01727765|12373822|FG001|COMPLETED|Overall Study||8
11184729|NCT01727765|12373821|FG000|NOT COMPLETED|Overall Study||0
11184730|NCT01727765|12373822|FG001|NOT COMPLETED|Overall Study||0
11184731|NCT01727791|12373828|FG000|STARTED|Overall Study||10
11184732|NCT01727791|12373828|FG000|COMPLETED|Overall Study||10
11184733|NCT01727791|12373828|FG000|NOT COMPLETED|Overall Study||0
11184734|NCT01727895|12373834|FG000|STARTED|Overall Study||10
11184735|NCT01727895|12373835|FG001|STARTED|Overall Study||5
11184736|NCT01727895|12373834|FG000|COMPLETED|Overall Study||10
11184737|NCT01727895|12373835|FG001|COMPLETED|Overall Study||5
11184738|NCT01727895|12373834|FG000|NOT COMPLETED|Overall Study||0
11184739|NCT01727895|12373835|FG001|NOT COMPLETED|Overall Study||0
11184740|NCT01728077|12373843|FG000|STARTED|Overall Study||19
11184741|NCT01728077|12373844|FG001|STARTED|Overall Study||7
11184742|NCT01728077|12373843|FG000|COMPLETED|Overall Study||11
11184743|NCT01728077|12373844|FG001|COMPLETED|Overall Study||2
11184744|NCT01728077|12373843|FG000|NOT COMPLETED|Overall Study||8
11184745|NCT01728077|12373844|FG001|NOT COMPLETED|Overall Study||5
11184746|NCT01728116|12373853|FG000|STARTED|Overall Study|EndoBarrier mITT Subjects|213
11184747|NCT01728116|12373854|FG001|STARTED|Overall Study|Sham mITT subjects|107
11184748|NCT01728116|12373853|FG000|COMPLETED|Overall Study|Completed to Week 78|52
11184749|NCT01728116|12373854|FG001|COMPLETED|Overall Study|Completed to Week 52|60
11184750|NCT01728116|12373853|FG000|NOT COMPLETED|Overall Study||161
11184751|NCT01728116|12373854|FG001|NOT COMPLETED|Overall Study||47
11184752|NCT01728194|12373863|FG000|STARTED|Overall Study||54
11184753|NCT01728194|12373864|FG001|STARTED|Overall Study||67
11184754|NCT01728194|12373863|FG000|COMPLETED|Overall Study||34
11184755|NCT01728194|12373864|FG001|COMPLETED|Overall Study||61
11184756|NCT01728194|12373863|FG000|NOT COMPLETED|Overall Study||20
11184757|NCT01728194|12373864|FG001|NOT COMPLETED|Overall Study||6
11184758|NCT01728246|12373872|FG000|STARTED|Overall Study||242
11184759|NCT01728246|12373873|FG001|STARTED|Overall Study||231
11184760|NCT01728246|12373872|FG000|COMPLETED|Overall Study||206
11184761|NCT01728246|12373873|FG001|COMPLETED|Overall Study||195
11184762|NCT01728246|12373872|FG000|NOT COMPLETED|Overall Study||36
11184763|NCT01728246|12373873|FG001|NOT COMPLETED|Overall Study||36
11184764|NCT01728324|12373882|FG000|STARTED|Termination of DBV||211
11184765|NCT01728324|12373883|FG001|STARTED|Termination of DBV||213
11184766|NCT01728324|12373884|FG002|STARTED|Termination of DBV||72
11184767|NCT01728324|12373882|FG000|COMPLETED|Termination of DBV||173
11184768|NCT01728324|12373883|FG001|COMPLETED|Termination of DBV||177
11184769|NCT01728324|12373884|FG002|COMPLETED|Termination of DBV||58
11184770|NCT01728324|12373882|FG000|NOT COMPLETED|Termination of DBV||38
11184771|NCT01728324|12373883|FG001|NOT COMPLETED|Termination of DBV||36
11184772|NCT01728324|12373884|FG002|NOT COMPLETED|Termination of DBV||14
11184773|NCT01728324|12373882|FG000|STARTED|Termination of FDV||211
11184774|NCT01728324|12373883|FG001|STARTED|Termination of FDV||213
11184775|NCT01728324|12373884|FG002|STARTED|Termination of FDV||72
11184776|NCT01728324|12373882|FG000|COMPLETED|Termination of FDV||173
11184777|NCT01728324|12373883|FG001|COMPLETED|Termination of FDV||177
11184778|NCT01728324|12373884|FG002|COMPLETED|Termination of FDV||58
11184779|NCT01728324|12373882|FG000|NOT COMPLETED|Termination of FDV||38
11184780|NCT01728324|12373883|FG001|NOT COMPLETED|Termination of FDV||36
11184781|NCT01728324|12373884|FG002|NOT COMPLETED|Termination of FDV||14
11184782|NCT01728324|12373882|FG000|STARTED|Termination of RBV||211
11184783|NCT01728324|12373883|FG001|STARTED|Termination of RBV||213
11184784|NCT01728324|12373884|FG002|STARTED|Termination of RBV||72
11184785|NCT01728324|12373882|FG000|COMPLETED|Termination of RBV||172
11184786|NCT01728324|12373883|FG001|COMPLETED|Termination of RBV||176
11184787|NCT01728324|12373884|FG002|COMPLETED|Termination of RBV||57
11184788|NCT01728324|12373882|FG000|NOT COMPLETED|Termination of RBV||39
11184789|NCT01728324|12373883|FG001|NOT COMPLETED|Termination of RBV||37
11184790|NCT01728324|12373884|FG002|NOT COMPLETED|Termination of RBV||15
11184791|NCT01728337|12373894|FG000|STARTED|Overall Study||80
11184792|NCT01728337|12373894|FG000|COMPLETED|Overall Study||80
11184793|NCT01728337|12373894|FG000|NOT COMPLETED|Overall Study||0
11184794|NCT01728376|12373906|FG000|STARTED|Overall Study||22
11184795|NCT01728376|12373907|FG001|STARTED|Overall Study||11
11184796|NCT01728376|12373908|FG002|STARTED|Overall Study||19
11184797|NCT01728376|12373909|FG003|STARTED|Overall Study||9
11184798|NCT01728376|12373910|FG004|STARTED|Overall Study||14
11184799|NCT01728376|12373911|FG005|STARTED|Overall Study||7
11184800|NCT01728376|12373906|FG000|Treated|Overall Study||22
11184801|NCT01728376|12373907|FG001|Treated|Overall Study||10
11184802|NCT01728376|12373908|FG002|Treated|Overall Study||19
11184803|NCT01728376|12373909|FG003|Treated|Overall Study||9
11184804|NCT01728376|12373910|FG004|Treated|Overall Study||14
11184805|NCT01728376|12373911|FG005|Treated|Overall Study||7
11184806|NCT01728376|12373906|FG000|COMPLETED|Overall Study||18
11184807|NCT01728376|12373907|FG001|COMPLETED|Overall Study||9
11184808|NCT01728376|12373908|FG002|COMPLETED|Overall Study||17
11184809|NCT01728376|12373909|FG003|COMPLETED|Overall Study||7
11184810|NCT01728376|12373910|FG004|COMPLETED|Overall Study||12
11184811|NCT01728376|12373911|FG005|COMPLETED|Overall Study||5
11184812|NCT01728376|12373906|FG000|NOT COMPLETED|Overall Study||4
11184813|NCT01728376|12373907|FG001|NOT COMPLETED|Overall Study||2
11026894|NCT00830869|12205485|FG005|COMPLETED|Period 2: Part 2||0
11026895|NCT00830869|12205486|FG006|COMPLETED|Period 2: Part 2||0
11026896|NCT00830869|12205487|FG007|COMPLETED|Period 2: Part 2||0
11026897|NCT00830869|12205488|FG008|COMPLETED|Period 2: Part 2||0
11184814|NCT01728376|12373908|FG002|NOT COMPLETED|Overall Study||2
11026898|NCT00830869|12205489|FG009|COMPLETED|Period 2: Part 2||0
11184815|NCT01728376|12373909|FG003|NOT COMPLETED|Overall Study||2
11184816|NCT01728376|12373910|FG004|NOT COMPLETED|Overall Study||2
11184817|NCT01728376|12373911|FG005|NOT COMPLETED|Overall Study||2
11184818|NCT01728454|12373928|FG000|STARTED|Stage 1 and 2||17
11184819|NCT01728454|12373929|FG001|STARTED|Stage 1 and 2||20
11184820|NCT01728454|12373930|FG002|STARTED|Stage 1 and 2||23
11184821|NCT01728454|12373928|FG000|COMPLETED|Stage 1 and 2||12
11184822|NCT01728454|12373929|FG001|COMPLETED|Stage 1 and 2||16
11184823|NCT01728454|12373930|FG002|COMPLETED|Stage 1 and 2||19
11184824|NCT01728454|12373928|FG000|NOT COMPLETED|Stage 1 and 2||5
11184825|NCT01728454|12373929|FG001|NOT COMPLETED|Stage 1 and 2||4
11184826|NCT01728454|12373930|FG002|NOT COMPLETED|Stage 1 and 2||4
11184827|NCT01728454|12373928|FG000|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6
11184828|NCT01728454|12373929|FG001|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5
11184829|NCT01728454|12373930|FG002|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11
11184830|NCT01728454|12373928|FG000|COMPLETED|Stage 3||3
11184831|NCT01728454|12373929|FG001|COMPLETED|Stage 3||1
11184832|NCT01728454|12373930|FG002|COMPLETED|Stage 3||7
11184833|NCT01728454|12373928|FG000|NOT COMPLETED|Stage 3||3
11184834|NCT01728454|12373929|FG001|NOT COMPLETED|Stage 3||4
11184835|NCT01728454|12373930|FG002|NOT COMPLETED|Stage 3||4
11184836|NCT01728584|12373945|FG000|STARTED|Overall Study|Randomized|36
11184837|NCT01728584|12373946|FG001|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
11184838|NCT01728584|12373947|FG002|STARTED|Overall Study|Randomized|31
11184839|NCT01728584|12373948|FG003|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
11184840|NCT01728584|12373945|FG000|COMPLETED|Overall Study||28
11184841|NCT01728584|12373946|FG001|COMPLETED|Overall Study||30
11184842|NCT01728584|12373947|FG002|COMPLETED|Overall Study||30
11184843|NCT01728584|12373948|FG003|COMPLETED|Overall Study||29
11184844|NCT01728584|12373945|FG000|NOT COMPLETED|Overall Study||8
11184845|NCT01728584|12373946|FG001|NOT COMPLETED|Overall Study||0
11184846|NCT01728584|12373947|FG002|NOT COMPLETED|Overall Study||1
11184847|NCT01728584|12373948|FG003|NOT COMPLETED|Overall Study||1
11184848|NCT01728623|12373965|FG000|STARTED|Overall Study||51
11184849|NCT01728623|12373965|FG000|DTC|Overall Study||25
11184850|NCT01728623|12373965|FG000|MTC|Overall Study||9
11184851|NCT01728623|12373965|FG000|ATC|Overall Study||17
11184852|NCT01728623|12373965|FG000|COMPLETED|Overall Study||23
11184853|NCT01728623|12373965|FG000|NOT COMPLETED|Overall Study||28
11184854|NCT01728636|12373974|FG000|STARTED|Overall Study||31
11184855|NCT01728636|12373975|FG001|STARTED|Overall Study||30
11184856|NCT01728636|12373974|FG000|COMPLETED|Overall Study||31
11184857|NCT01728636|12373975|FG001|COMPLETED|Overall Study||30
11184858|NCT01728636|12373974|FG000|NOT COMPLETED|Overall Study||0
11184859|NCT01728636|12373975|FG001|NOT COMPLETED|Overall Study||0
11184860|NCT01728779|12373981|FG000|STARTED|Overall Study||38
11184861|NCT01728779|12373981|FG000|COMPLETED|Overall Study||37
11184862|NCT01728779|12373981|FG000|NOT COMPLETED|Overall Study||1
11184863|NCT01728792|12373990|FG000|STARTED|Overall Study||14
11184864|NCT01728792|12373991|FG001|STARTED|Overall Study||16
11184865|NCT01728792|12373992|FG002|STARTED|Overall Study||17
11184866|NCT01728792|12373993|FG003|STARTED|Overall Study||17
11184867|NCT01728792|12373994|FG004|STARTED|Overall Study||16
11184868|NCT01728792|12373990|FG000|COMPLETED|Overall Study||11
11184869|NCT01728792|12373991|FG001|COMPLETED|Overall Study||14
11184870|NCT01728792|12373992|FG002|COMPLETED|Overall Study||13
11184871|NCT01728792|12373993|FG003|COMPLETED|Overall Study||14
11184872|NCT01728792|12373994|FG004|COMPLETED|Overall Study||16
11184873|NCT01728792|12373990|FG000|NOT COMPLETED|Overall Study||3
11184874|NCT01728792|12373991|FG001|NOT COMPLETED|Overall Study||2
11184875|NCT01728792|12373992|FG002|NOT COMPLETED|Overall Study||4
11184876|NCT01728792|12373993|FG003|NOT COMPLETED|Overall Study||3
11184877|NCT01728792|12373994|FG004|NOT COMPLETED|Overall Study||0
11184878|NCT01728844|12374010|FG000|STARTED|Overall Study||22
11184879|NCT01728844|12374011|FG001|STARTED|Overall Study||21
11184880|NCT01728844|12374012|FG002|STARTED|Overall Study||22
11184881|NCT01728844|12374013|FG003|STARTED|Overall Study||23
11184882|NCT01728844|12374010|FG000|COMPLETED|Overall Study||21
11184883|NCT01728844|12374011|FG001|COMPLETED|Overall Study||21
11184884|NCT01728844|12374012|FG002|COMPLETED|Overall Study||22
11184885|NCT01728844|12374013|FG003|COMPLETED|Overall Study||21
11184886|NCT01728844|12374010|FG000|NOT COMPLETED|Overall Study||1
11184887|NCT01728844|12374011|FG001|NOT COMPLETED|Overall Study||0
11184888|NCT01728844|12374012|FG002|NOT COMPLETED|Overall Study||0
11184889|NCT01728844|12374013|FG003|NOT COMPLETED|Overall Study||2
11184890|NCT01729026|12374025|FG000|STARTED|Randomization to 3-month Follow-up||9
11184891|NCT01729026|12374026|FG001|STARTED|Randomization to 3-month Follow-up||10
11184892|NCT01729026|12374025|FG000|COMPLETED|Randomization to 3-month Follow-up||7
11184893|NCT01729026|12374026|FG001|COMPLETED|Randomization to 3-month Follow-up||8
11184894|NCT01729026|12374025|FG000|NOT COMPLETED|Randomization to 3-month Follow-up||2
11184895|NCT01729026|12374026|FG001|NOT COMPLETED|Randomization to 3-month Follow-up||2
11184896|NCT01729026|12374025|FG000|STARTED|3-month to 6-month (Final) Follow-up||7
11184897|NCT01729026|12374026|FG001|STARTED|3-month to 6-month (Final) Follow-up||8
11184898|NCT01729026|12374025|FG000|COMPLETED|3-month to 6-month (Final) Follow-up||6
11184899|NCT01729026|12374026|FG001|COMPLETED|3-month to 6-month (Final) Follow-up||6
11184900|NCT01729026|12374025|FG000|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
11184901|NCT01729026|12374026|FG001|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
11184902|NCT01729039|12374037|FG000|STARTED|Overall Study||23
11184903|NCT01729039|12374038|FG001|STARTED|Overall Study||26
11184904|NCT01729039|12374037|FG000|COMPLETED|Overall Study||13
11184905|NCT01729039|12374038|FG001|COMPLETED|Overall Study||14
11184906|NCT01729039|12374037|FG000|NOT COMPLETED|Overall Study||10
11184907|NCT01729039|12374038|FG001|NOT COMPLETED|Overall Study||12
11184908|NCT01729156|12374050|FG000|STARTED|Overall Study||12
11184909|NCT01729156|12374051|FG001|STARTED|Overall Study||12
11184910|NCT01729156|12374052|FG002|STARTED|Overall Study||12
11184911|NCT01729156|12374050|FG000|COMPLETED|Overall Study||11
11184912|NCT01729156|12374051|FG001|COMPLETED|Overall Study||12
11184913|NCT01729156|12374052|FG002|COMPLETED|Overall Study||12
11184914|NCT01729156|12374050|FG000|NOT COMPLETED|Overall Study||1
11184915|NCT01729156|12374051|FG001|NOT COMPLETED|Overall Study||0
11184916|NCT01729156|12374052|FG002|NOT COMPLETED|Overall Study||0
11184917|NCT01729208|12374063|FG000|STARTED|Baseline||70
11184918|NCT01729208|12374064|FG001|STARTED|Baseline||74
11184919|NCT01729208|12374063|FG000|COMPLETED|Baseline||65
11184920|NCT01729208|12374064|FG001|COMPLETED|Baseline||70
11184921|NCT01729208|12374063|FG000|NOT COMPLETED|Baseline||5
11184922|NCT01729208|12374064|FG001|NOT COMPLETED|Baseline||4
11184923|NCT01729208|12374063|FG000|STARTED|12 Months Follow-up||65
11184924|NCT01729208|12374064|FG001|STARTED|12 Months Follow-up||70
11184925|NCT01729208|12374063|FG000|COMPLETED|12 Months Follow-up||58
11184926|NCT01729208|12374064|FG001|COMPLETED|12 Months Follow-up||60
11184927|NCT01729208|12374063|FG000|NOT COMPLETED|12 Months Follow-up||7
11184928|NCT01729208|12374064|FG001|NOT COMPLETED|12 Months Follow-up||10
11184929|NCT01729208|12374063|FG000|STARTED|24 Months Follow-up||58
11184930|NCT01729208|12374064|FG001|STARTED|24 Months Follow-up||60
11184931|NCT01729208|12374063|FG000|COMPLETED|24 Months Follow-up||55
11184932|NCT01729208|12374064|FG001|COMPLETED|24 Months Follow-up||60
11184933|NCT01729208|12374063|FG000|NOT COMPLETED|24 Months Follow-up||3
11184934|NCT01729208|12374064|FG001|NOT COMPLETED|24 Months Follow-up||0
11184935|NCT01729208|12374063|FG000|STARTED|36 Months Follow-up||55
11184936|NCT01729208|12374064|FG001|STARTED|36 Months Follow-up||60
11184937|NCT01729208|12374063|FG000|COMPLETED|36 Months Follow-up||52
11184938|NCT01729208|12374064|FG001|COMPLETED|36 Months Follow-up||56
11184939|NCT01729208|12374063|FG000|NOT COMPLETED|36 Months Follow-up||3
11184940|NCT01729208|12374064|FG001|NOT COMPLETED|36 Months Follow-up||4
11184941|NCT01729247|12374070|FG000|STARTED|Overall Study||50
11184942|NCT01729247|12374070|FG000|COMPLETED|Overall Study||50
11184943|NCT01729247|12374070|FG000|NOT COMPLETED|Overall Study||0
11184944|NCT01729338|12374081|FG000|STARTED|Overall Study||16
11184945|NCT01729338|12374081|FG000|COMPLETED|Overall Study||14
11184946|NCT01729338|12374081|FG000|NOT COMPLETED|Overall Study||2
11184947|NCT01729494|12374088|FG000|STARTED|Overall Study||107
11184948|NCT01729494|12374089|FG001|STARTED|Overall Study||104
11184949|NCT01729494|12374090|FG002|STARTED|Overall Study||105
11184950|NCT01729494|12374088|FG000|COMPLETED|Overall Study||97
11184951|NCT01729494|12374089|FG001|COMPLETED|Overall Study||93
11184952|NCT01729494|12374090|FG002|COMPLETED|Overall Study||94
11184953|NCT01729494|12374088|FG000|NOT COMPLETED|Overall Study||10
11184954|NCT01729494|12374089|FG001|NOT COMPLETED|Overall Study||11
11184955|NCT01729494|12374090|FG002|NOT COMPLETED|Overall Study||11
11184956|NCT01729559|12374100|FG000|STARTED|Overall Study||251
11184957|NCT01729559|12374101|FG001|STARTED|Overall Study||244
11184958|NCT01729559|12374100|FG000|COMPLETED|Overall Study||220
11184959|NCT01729559|12374101|FG001|COMPLETED|Overall Study||216
11184960|NCT01729559|12374100|FG000|NOT COMPLETED|Overall Study||31
11184961|NCT01729559|12374101|FG001|NOT COMPLETED|Overall Study||28
11184962|NCT01729598|12374109|FG000|STARTED|Overall Study||10
11184963|NCT01729598|12374110|FG001|STARTED|Overall Study||4
11184964|NCT01729598|12374109|FG000|COMPLETED|Overall Study||10
11184965|NCT01729598|12374110|FG001|COMPLETED|Overall Study||4
11184966|NCT01729598|12374109|FG000|NOT COMPLETED|Overall Study||0
11184967|NCT01729598|12374110|FG001|NOT COMPLETED|Overall Study||0
11184968|NCT01729728|12374119|FG000|STARTED|Overall Study||21
11184969|NCT01729728|12374120|FG001|STARTED|Overall Study||28
11184970|NCT01729728|12374121|FG002|STARTED|Overall Study||17
11184971|NCT01729728|12374119|FG000|COMPLETED|Overall Study||20
11184972|NCT01729728|12374120|FG001|COMPLETED|Overall Study||22
11184973|NCT01729728|12374121|FG002|COMPLETED|Overall Study||16
11184974|NCT01729728|12374119|FG000|NOT COMPLETED|Overall Study||1
11184975|NCT01729728|12374120|FG001|NOT COMPLETED|Overall Study||6
11184976|NCT01729728|12374121|FG002|NOT COMPLETED|Overall Study||1
11184977|NCT01729819|12374254|FG000|STARTED|Overall Study||49
11184978|NCT01729819|12374255|FG001|STARTED|Overall Study||57
11184979|NCT01729819|12374254|FG000|COMPLETED|Overall Study||43
11184980|NCT01729819|12374255|FG001|COMPLETED|Overall Study||50
11184981|NCT01729819|12374254|FG000|NOT COMPLETED|Overall Study||6
11184982|NCT01729819|12374255|FG001|NOT COMPLETED|Overall Study||7
11184983|NCT01729845|12374267|FG000|STARTED|Safety/Tolerability of Dec/MEC||6
11324324|NCT02742766|12521573|FG014|STARTED|Part 3 (Up to 36 Days)||0
11184984|NCT01729845|12374268|FG001|STARTED|Safety/Tolerability of Dec/MEC||34
11184985|NCT01729845|12374269|FG002|STARTED|Safety/Tolerability of Dec/MEC||12
11184986|NCT01729845|12374267|FG000|COMPLETED|Safety/Tolerability of Dec/MEC||6
11184987|NCT01729845|12374268|FG001|COMPLETED|Safety/Tolerability of Dec/MEC||34
11184988|NCT01729845|12374269|FG002|COMPLETED|Safety/Tolerability of Dec/MEC||12
11184989|NCT01729845|12374267|FG000|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
11184990|NCT01729845|12374268|FG001|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
11184991|NCT01729845|12374269|FG002|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
11184992|NCT01729845|12374267|FG000|STARTED|Efficacy of Dec/MEC||0
11184993|NCT01729845|12374268|FG001|STARTED|Efficacy of Dec/MEC||22
11184994|NCT01729845|12374269|FG002|STARTED|Efficacy of Dec/MEC||0
11184995|NCT01729845|12374267|FG000|COMPLETED|Efficacy of Dec/MEC||0
11184996|NCT01729845|12374268|FG001|COMPLETED|Efficacy of Dec/MEC||22
11184997|NCT01729845|12374269|FG002|COMPLETED|Efficacy of Dec/MEC||0
11184998|NCT01729845|12374267|FG000|NOT COMPLETED|Efficacy of Dec/MEC||0
11184999|NCT01729845|12374268|FG001|NOT COMPLETED|Efficacy of Dec/MEC||0
11185000|NCT01729845|12374269|FG002|NOT COMPLETED|Efficacy of Dec/MEC||0
11185001|NCT01729871|12374281|FG000|STARTED|Overall Study||124
11185002|NCT01729871|12374282|FG001|STARTED|Overall Study||124
11185003|NCT01729871|12374281|FG000|COMPLETED|Overall Study||112
11185004|NCT01729871|12374282|FG001|COMPLETED|Overall Study||101
11185005|NCT01729871|12374281|FG000|NOT COMPLETED|Overall Study||12
11185006|NCT01729871|12374282|FG001|NOT COMPLETED|Overall Study||23
11185007|NCT01729923|12374288|FG000|STARTED|Overall Study||27
11185008|NCT01729923|12374288|FG000|COMPLETED|Overall Study||0
11185009|NCT01729923|12374288|FG000|NOT COMPLETED|Overall Study||27
11185010|NCT01730040|12374299|FG000|STARTED|Overall Study||57
11185011|NCT01730040|12374300|FG001|STARTED|Overall Study||55
11185012|NCT01730040|12374301|FG002|STARTED|Overall Study||57
11185013|NCT01730040|12374302|FG003|STARTED|Overall Study||47
11185014|NCT01730040|12374303|FG004|STARTED|Overall Study||45
11185015|NCT01730040|12374304|FG005|STARTED|Overall Study||47
11185016|NCT01730040|12374305|FG006|STARTED|Overall Study||47
11185017|NCT01730040|12374299|FG000|Treated|Overall Study||57
11185018|NCT01730040|12374300|FG001|Treated|Overall Study||55
11185019|NCT01730040|12374301|FG002|Treated|Overall Study||57
11185020|NCT01730040|12374302|FG003|Treated|Overall Study||47
11185021|NCT01730040|12374303|FG004|Treated|Overall Study||45
11185022|NCT01730040|12374304|FG005|Treated|Overall Study||46
11185023|NCT01730040|12374305|FG006|Treated|Overall Study||47
11185024|NCT01730040|12374299|FG000|COMPLETED|Overall Study||44
11185025|NCT01730040|12374300|FG001|COMPLETED|Overall Study||40
11185026|NCT01730040|12374301|FG002|COMPLETED|Overall Study||46
11185027|NCT01730040|12374302|FG003|COMPLETED|Overall Study||39
11185028|NCT01730040|12374303|FG004|COMPLETED|Overall Study||39
11185029|NCT01730040|12374304|FG005|COMPLETED|Overall Study||40
11185030|NCT01730040|12374305|FG006|COMPLETED|Overall Study||38
11185031|NCT01730040|12374299|FG000|NOT COMPLETED|Overall Study||13
11185032|NCT01730040|12374300|FG001|NOT COMPLETED|Overall Study||15
11185033|NCT01730040|12374301|FG002|NOT COMPLETED|Overall Study||11
11185034|NCT01730040|12374302|FG003|NOT COMPLETED|Overall Study||8
11185035|NCT01730040|12374303|FG004|NOT COMPLETED|Overall Study||6
11185036|NCT01730040|12374304|FG005|NOT COMPLETED|Overall Study||7
11185037|NCT01730040|12374305|FG006|NOT COMPLETED|Overall Study||9
11185038|NCT01730053|12374327|FG000|STARTED|Overall Study||48
11185039|NCT01730053|12374328|FG001|STARTED|Overall Study||48
11185040|NCT01730053|12374329|FG002|STARTED|Overall Study||49
11185041|NCT01730053|12374330|FG003|STARTED|Overall Study||53
11185042|NCT01730053|12374331|FG004|STARTED|Overall Study||53
11185043|NCT01730053|12374332|FG005|STARTED|Overall Study||54
11185044|NCT01730053|12374327|FG000|Treated|Overall Study||48
11185045|NCT01730053|12374328|FG001|Treated|Overall Study||48
11185046|NCT01730053|12374329|FG002|Treated|Overall Study||49
11185047|NCT01730053|12374330|FG003|Treated|Overall Study||53
11324325|NCT02742766|12521574|FG015|STARTED|Part 3 (Up to 36 Days)||0
11185048|NCT01730053|12374331|FG004|Treated|Overall Study||53
11185049|NCT01730053|12374332|FG005|Treated|Overall Study||54
11185050|NCT01730053|12374327|FG000|COMPLETED|Overall Study||43
11185051|NCT01730053|12374328|FG001|COMPLETED|Overall Study||34
11185052|NCT01730053|12374329|FG002|COMPLETED|Overall Study||38
11185053|NCT01730053|12374330|FG003|COMPLETED|Overall Study||45
11185054|NCT01730053|12374331|FG004|COMPLETED|Overall Study||44
11185055|NCT01730053|12374332|FG005|COMPLETED|Overall Study||41
11185056|NCT01730053|12374327|FG000|NOT COMPLETED|Overall Study||5
11185057|NCT01730053|12374328|FG001|NOT COMPLETED|Overall Study||14
11185058|NCT01730053|12374329|FG002|NOT COMPLETED|Overall Study||11
11185059|NCT01730053|12374330|FG003|NOT COMPLETED|Overall Study||8
11185060|NCT01730053|12374331|FG004|NOT COMPLETED|Overall Study||9
11185061|NCT01730053|12374332|FG005|NOT COMPLETED|Overall Study||13
11185062|NCT01730339|12374349|FG000|STARTED|Overall Study||45
11185063|NCT01730339|12374350|FG001|STARTED|Overall Study||55
11185064|NCT01730339|12374349|FG000|COMPLETED|Overall Study||40
11185065|NCT01730339|12374350|FG001|COMPLETED|Overall Study||52
11185066|NCT01730339|12374349|FG000|NOT COMPLETED|Overall Study||5
11185067|NCT01730339|12374350|FG001|NOT COMPLETED|Overall Study||3
11185068|NCT01730378|12374368|FG000|STARTED|Overall Study||84
11185069|NCT01730378|12374369|FG001|STARTED|Overall Study||47
11185070|NCT01730378|12374368|FG000|COMPLETED|Overall Study||83
11185071|NCT01730378|12374369|FG001|COMPLETED|Overall Study||47
11185072|NCT01730378|12374368|FG000|NOT COMPLETED|Overall Study||1
11185073|NCT01730378|12374369|FG001|NOT COMPLETED|Overall Study||0
11185074|NCT01730534|12374378|FG000|STARTED|Overall Study||8582
11185075|NCT01730534|12374379|FG001|STARTED|Overall Study||8578
11185076|NCT01730534|12374378|FG000|COMPLETED|Overall Study||8473
11185077|NCT01730534|12374379|FG001|COMPLETED|Overall Study||8433
11185078|NCT01730534|12374378|FG000|NOT COMPLETED|Overall Study||109
11185079|NCT01730534|12374379|FG001|NOT COMPLETED|Overall Study||145
11185080|NCT01730586|12374385|FG000|STARTED|Overall Study||34
11185081|NCT01730586|12374385|FG000|COMPLETED|Overall Study||21
11185082|NCT01730586|12374385|FG000|NOT COMPLETED|Overall Study||13
11185083|NCT01730729|12374391|FG000|STARTED|Overall Study||20
11185084|NCT01730729|12374391|FG000|Completed 2 Cycles/Reached 1st Response|Overall Study||18
11185085|NCT01730729|12374391|FG000|Treated Cycle 3 and Beyond|Overall Study||6
11185086|NCT01730729|12374391|FG000|COMPLETED|Overall Study||6
11185087|NCT01730729|12374391|FG000|NOT COMPLETED|Overall Study||14
11185088|NCT01730846|12374398|FG000|STARTED|Overall Study||11
11185089|NCT01730846|12374399|FG001|STARTED|Overall Study||11
11185090|NCT01730846|12374400|FG002|STARTED|Overall Study||13
11185091|NCT01730846|12374398|FG000|COMPLETED|Overall Study||11
11185092|NCT01730846|12374399|FG001|COMPLETED|Overall Study||11
11185093|NCT01730846|12374400|FG002|COMPLETED|Overall Study||13
11185094|NCT01730846|12374398|FG000|NOT COMPLETED|Overall Study||0
11185095|NCT01730846|12374399|FG001|NOT COMPLETED|Overall Study||0
11185096|NCT01730846|12374400|FG002|NOT COMPLETED|Overall Study||0
11185097|NCT01730872|12374411|FG000|STARTED|Overall Study||8
11185098|NCT01730872|12374412|FG001|STARTED|Overall Study||5
11185099|NCT01730872|12374413|FG002|STARTED|Overall Study||3
11185100|NCT01730872|12374411|FG000|Full Analysis Set|Overall Study||8
11185101|NCT01730872|12374412|FG001|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4
11185102|NCT01730872|12374413|FG002|Full Analysis Set|Overall Study||0
11185103|NCT01730872|12374411|FG000|COMPLETED|Overall Study||8
11185104|NCT01730872|12374412|FG001|COMPLETED|Overall Study||5
11185105|NCT01730872|12374413|FG002|COMPLETED|Overall Study||3
11185106|NCT01730872|12374411|FG000|NOT COMPLETED|Overall Study||0
11185107|NCT01730872|12374412|FG001|NOT COMPLETED|Overall Study||0
11185108|NCT01730872|12374413|FG002|NOT COMPLETED|Overall Study||0
11185109|NCT01730950|12374422|FG000|STARTED|Overall Study||90
11185110|NCT01730950|12374423|FG001|STARTED|Overall Study||92
11185111|NCT01730950|12374422|FG000|Eligible Population|Overall Study||84
11185112|NCT01730950|12374423|FG001|Eligible Population|Overall Study||86
11185113|NCT01730950|12374422|FG000|Adverse Event Population|Overall Study||76
11185114|NCT01730950|12374423|FG001|Adverse Event Population|Overall Study||83
11185115|NCT01730950|12374422|FG000|Response Population|Overall Study||78
11185116|NCT01730950|12374423|FG001|Response Population|Overall Study||77
11185117|NCT01730950|12374422|FG000|6-month Progression-free Analysis|Overall Study||79
11185118|NCT01730950|12374423|FG001|6-month Progression-free Analysis|Overall Study||81
11185119|NCT01730950|12374422|FG000|Delayed Toxicity Population|Overall Study||0
11185120|NCT01730950|12374423|FG001|Delayed Toxicity Population|Overall Study||83
11185121|NCT01730950|12374422|FG000|COMPLETED|Overall Study||84
11185122|NCT01730950|12374423|FG001|COMPLETED|Overall Study||86
11185123|NCT01730950|12374422|FG000|NOT COMPLETED|Overall Study||6
11185124|NCT01730950|12374423|FG001|NOT COMPLETED|Overall Study||6
11185125|NCT01731002|12374433|FG000|STARTED|Overall Study||75
11185126|NCT01731002|12374434|FG001|STARTED|Overall Study||72
11185127|NCT01731002|12374435|FG002|STARTED|Overall Study||77
11185128|NCT01731002|12374433|FG000|COMPLETED|Overall Study||71
11185129|NCT01731002|12374434|FG001|COMPLETED|Overall Study||68
11185130|NCT01731002|12374435|FG002|COMPLETED|Overall Study||74
11185131|NCT01731002|12374433|FG000|NOT COMPLETED|Overall Study||4
11185132|NCT01731002|12374434|FG001|NOT COMPLETED|Overall Study||4
11185133|NCT01731002|12374435|FG002|NOT COMPLETED|Overall Study||3
11185134|NCT01731041|12374445|FG000|STARTED|Overall Study||30
11185135|NCT01731041|12374446|FG001|STARTED|Overall Study||30
11185136|NCT01731041|12374445|FG000|COMPLETED|Overall Study||30
11185137|NCT01731041|12374446|FG001|COMPLETED|Overall Study||30
11185138|NCT01731041|12374445|FG000|NOT COMPLETED|Overall Study||0
11185139|NCT01731041|12374446|FG001|NOT COMPLETED|Overall Study||0
11185140|NCT01731119|12374452|FG000|STARTED|Overall Study||9
11185141|NCT01731119|12374452|FG000|COMPLETED|Overall Study||7
11185142|NCT01731119|12374452|FG000|NOT COMPLETED|Overall Study||2
11185143|NCT01731171|12374458|FG000|STARTED|Overall Study||33
11185144|NCT01731171|12374459|FG001|STARTED|Overall Study||33
11185145|NCT01731171|12374458|FG000|COMPLETED|Overall Study||26
11185146|NCT01731171|12374459|FG001|COMPLETED|Overall Study||26
11185147|NCT01731171|12374458|FG000|NOT COMPLETED|Overall Study||7
11185148|NCT01731171|12374459|FG001|NOT COMPLETED|Overall Study||7
11185149|NCT01731470|12374465|FG000|STARTED|Overall Study|Number of patients consented to participate in the study|16
11185150|NCT01731470|12374465|FG000|COMPLETED|Overall Study|Number of patients enrolled in the study|14
11185151|NCT01731470|12374465|FG000|NOT COMPLETED|Overall Study||2
11185152|NCT01731600|12374471|FG000|STARTED|Overall Study||34
11185153|NCT01731600|12374472|FG001|STARTED|Overall Study||34
11185154|NCT01731600|12374471|FG000|COMPLETED|Overall Study||28
11185155|NCT01731600|12374472|FG001|COMPLETED|Overall Study||34
11185156|NCT01731600|12374471|FG000|NOT COMPLETED|Overall Study||6
11185157|NCT01731600|12374472|FG001|NOT COMPLETED|Overall Study||0
11185158|NCT01731678|12374482|FG000|STARTED|Overall Study||39
11185159|NCT01731678|12374482|FG000|COMPLETED|Overall Study||32
11185160|NCT01731678|12374482|FG000|NOT COMPLETED|Overall Study||7
11185161|NCT01731691|12374489|FG000|STARTED|Overall Study||3
11185162|NCT01731691|12374490|FG001|STARTED|Overall Study||5
11185163|NCT01731691|12374491|FG002|STARTED|Overall Study||4
11185164|NCT01731691|12374489|FG000|COMPLETED|Overall Study||3
11185165|NCT01731691|12374490|FG001|COMPLETED|Overall Study||5
11185166|NCT01731691|12374491|FG002|COMPLETED|Overall Study||4
11185167|NCT01731691|12374489|FG000|NOT COMPLETED|Overall Study||0
11185168|NCT01731691|12374490|FG001|NOT COMPLETED|Overall Study||0
11185169|NCT01731691|12374491|FG002|NOT COMPLETED|Overall Study||0
11185170|NCT01731886|12374504|FG000|STARTED|Overall Study||31
11185171|NCT01731886|12374505|FG001|STARTED|Overall Study||29
11185172|NCT01731886|12374504|FG000|COMPLETED|Overall Study||29
11185173|NCT01731886|12374505|FG001|COMPLETED|Overall Study||28
11185174|NCT01731886|12374504|FG000|NOT COMPLETED|Overall Study||2
11185175|NCT01731886|12374505|FG001|NOT COMPLETED|Overall Study||1
11185176|NCT01731912|12374512|FG000|STARTED|Overall Study||16
11185177|NCT01731912|12374512|FG000|COMPLETED|Overall Study||14
11185178|NCT01731912|12374512|FG000|NOT COMPLETED|Overall Study||2
11185179|NCT01731938|12374520|FG000|STARTED|Preliminary Part I||51
11185180|NCT01731938|12374521|FG001|STARTED|Preliminary Part I||52
11185181|NCT01731938|12374520|FG000|COMPLETED|Preliminary Part I||48
11185182|NCT01731938|12374521|FG001|COMPLETED|Preliminary Part I||44
11185183|NCT01731938|12374520|FG000|NOT COMPLETED|Preliminary Part I||3
11185184|NCT01731938|12374521|FG001|NOT COMPLETED|Preliminary Part I||8
11185185|NCT01731938|12374520|FG000|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
11185186|NCT01731938|12374521|FG001|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
11185187|NCT01731938|12374520|FG000|COMPLETED|Primary Part II||103
11185188|NCT01731938|12374521|FG001|COMPLETED|Primary Part II||95
11185189|NCT01731938|12374520|FG000|NOT COMPLETED|Primary Part II||13
11185190|NCT01731938|12374521|FG001|NOT COMPLETED|Primary Part II||13
11185191|NCT01731951|12374534|FG000|STARTED|Overall Study||19
11185192|NCT01731951|12374535|FG001|STARTED|Overall Study||16
11185193|NCT01731951|12374536|FG002|STARTED|Overall Study||9
11185194|NCT01731951|12374537|FG003|STARTED|Overall Study||9
11185195|NCT01731951|12374538|FG004|STARTED|Overall Study||18
11185196|NCT01731951|12374539|FG005|STARTED|Overall Study||9
11185197|NCT01731951|12374534|FG000|COMPLETED|Overall Study||2
11185198|NCT01731951|12374535|FG001|COMPLETED|Overall Study||1
11185199|NCT01731951|12374536|FG002|COMPLETED|Overall Study||0
11185200|NCT01731951|12374537|FG003|COMPLETED|Overall Study||0
11185201|NCT01731951|12374538|FG004|COMPLETED|Overall Study||6
11185202|NCT01731951|12374539|FG005|COMPLETED|Overall Study||0
11185203|NCT01731951|12374534|FG000|NOT COMPLETED|Overall Study||17
11185204|NCT01731951|12374535|FG001|NOT COMPLETED|Overall Study||15
11185205|NCT01731951|12374536|FG002|NOT COMPLETED|Overall Study||9
11185206|NCT01731951|12374537|FG003|NOT COMPLETED|Overall Study||9
11185207|NCT01731951|12374538|FG004|NOT COMPLETED|Overall Study||12
11185208|NCT01731951|12374539|FG005|NOT COMPLETED|Overall Study||9
11185209|NCT01731990|12374559|FG000|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
11185210|NCT01731990|12374560|FG001|STARTED|Overall Study||20
11185211|NCT01731990|12374559|FG000|COMPLETED|Overall Study||14
11185212|NCT01731990|12374560|FG001|COMPLETED|Overall Study||12
11185213|NCT01731990|12374559|FG000|NOT COMPLETED|Overall Study||4
11185214|NCT01731990|12374560|FG001|NOT COMPLETED|Overall Study||8
11185215|NCT01732263|12374568|FG000|STARTED|Overall Study||23
11185216|NCT01732263|12374569|FG001|STARTED|Overall Study||20
11185217|NCT01732263|12374568|FG000|COMPLETED|Overall Study||23
11185218|NCT01732263|12374569|FG001|COMPLETED|Overall Study||20
11185219|NCT01732263|12374568|FG000|NOT COMPLETED|Overall Study||0
11185220|NCT01732263|12374569|FG001|NOT COMPLETED|Overall Study||0
11185221|NCT01732406|12374582|FG000|STARTED|Overall Study||31
11185222|NCT01732406|12374583|FG001|STARTED|Overall Study||60
11185223|NCT01732406|12374584|FG002|STARTED|Overall Study||35
11185224|NCT01732406|12374582|FG000|COMPLETED|Overall Study||31
11185225|NCT01732406|12374583|FG001|COMPLETED|Overall Study||60
11185226|NCT01732406|12374584|FG002|COMPLETED|Overall Study||35
11185227|NCT01732406|12374582|FG000|NOT COMPLETED|Overall Study||0
11185228|NCT01732406|12374583|FG001|NOT COMPLETED|Overall Study||0
11185229|NCT01732406|12374584|FG002|NOT COMPLETED|Overall Study||0
11185230|NCT01732419|12374598|FG000|STARTED|Overall Study||45
11185231|NCT01732419|12374599|FG001|STARTED|Overall Study||45
11185232|NCT01732419|12374598|FG000|COMPLETED|Overall Study||37
11185233|NCT01732419|12374599|FG001|COMPLETED|Overall Study||41
11185234|NCT01732419|12374598|FG000|NOT COMPLETED|Overall Study||8
11185235|NCT01732419|12374599|FG001|NOT COMPLETED|Overall Study||4
11185236|NCT01732445|12374605|FG000|STARTED|Overall Study||14
11185237|NCT01732445|12374605|FG000|COMPLETED|Overall Study||14
11185238|NCT01732445|12374605|FG000|NOT COMPLETED|Overall Study||0
11185239|NCT01732458|12374613|FG000|STARTED|Overall Study||60
11185240|NCT01732458|12374614|FG001|STARTED|Overall Study||58
11185241|NCT01732458|12374615|FG002|STARTED|Overall Study||58
11185242|NCT01732458|12374616|FG003|STARTED|Overall Study||52
11185243|NCT01732458|12374613|FG000|Treated|Overall Study||57
11185244|NCT01732458|12374614|FG001|Treated|Overall Study||55
11185245|NCT01732458|12374615|FG002|Treated|Overall Study||56
11185246|NCT01732458|12374616|FG003|Treated|Overall Study||52
11185247|NCT01732458|12374613|FG000|COMPLETED|Overall Study||57
11185248|NCT01732458|12374614|FG001|COMPLETED|Overall Study||53
11185249|NCT01732458|12374615|FG002|COMPLETED|Overall Study||55
11185250|NCT01732458|12374616|FG003|COMPLETED|Overall Study||50
11185251|NCT01732458|12374613|FG000|NOT COMPLETED|Overall Study||3
11185252|NCT01732458|12374614|FG001|NOT COMPLETED|Overall Study||5
11185253|NCT01732458|12374615|FG002|NOT COMPLETED|Overall Study||3
11185254|NCT01732458|12374616|FG003|NOT COMPLETED|Overall Study||2
11185255|NCT01732471|12374638|FG000|STARTED|Overall Study||90
11185256|NCT01732471|12374638|FG000|COMPLETED|Overall Study||89
11185257|NCT01732471|12374638|FG000|NOT COMPLETED|Overall Study||1
11185258|NCT01732484|12374642|FG000|STARTED|Overall Study||100
11185259|NCT01732484|12374642|FG000|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
11185260|NCT01732484|12374642|FG000|Allocation|Overall Study||100
11185261|NCT01732484|12374642|FG000|COMPLETED|Overall Study||74
11185262|NCT01732484|12374642|FG000|NOT COMPLETED|Overall Study||26
11185263|NCT01732510|12374655|FG000|STARTED|Overall Study||9
11185264|NCT01732510|12374656|FG001|STARTED|Overall Study||9
11185265|NCT01732510|12374657|FG002|STARTED|Overall Study||8
11185266|NCT01732510|12374658|FG003|STARTED|Overall Study||10
11185267|NCT01732510|12374659|FG004|STARTED|Overall Study||8
11185268|NCT01732510|12374660|FG005|STARTED|Overall Study||13
11185269|NCT01732510|12374661|FG006|STARTED|Overall Study||8
11185270|NCT01732510|12374655|FG000|COMPLETED|Overall Study||8
11185271|NCT01732510|12374656|FG001|COMPLETED|Overall Study||4
11185272|NCT01732510|12374657|FG002|COMPLETED|Overall Study||4
11185273|NCT01732510|12374658|FG003|COMPLETED|Overall Study||5
11185274|NCT01732510|12374659|FG004|COMPLETED|Overall Study||3
11185275|NCT01732510|12374660|FG005|COMPLETED|Overall Study||0
11185276|NCT01732510|12374661|FG006|COMPLETED|Overall Study||0
11185277|NCT01732510|12374655|FG000|NOT COMPLETED|Overall Study||1
11185278|NCT01732510|12374656|FG001|NOT COMPLETED|Overall Study||5
11185279|NCT01732510|12374657|FG002|NOT COMPLETED|Overall Study||4
11185280|NCT01732510|12374658|FG003|NOT COMPLETED|Overall Study||5
11185281|NCT01732510|12374659|FG004|NOT COMPLETED|Overall Study||5
11185282|NCT01732510|12374660|FG005|NOT COMPLETED|Overall Study||13
11185283|NCT01732510|12374661|FG006|NOT COMPLETED|Overall Study||8
11185284|NCT01732536|12374682|FG000|STARTED|Overall Study||53
11185285|NCT01732536|12374683|FG001|STARTED|Overall Study||47
11185286|NCT01732536|12374682|FG000|COMPLETED|Overall Study||52
11185287|NCT01732536|12374683|FG001|COMPLETED|Overall Study||46
11185288|NCT01732536|12374682|FG000|NOT COMPLETED|Overall Study||1
11185289|NCT01732536|12374683|FG001|NOT COMPLETED|Overall Study||1
11185290|NCT01732549|12374694|FG000|STARTED|Overall Study||71
11185291|NCT01732549|12374695|FG001|STARTED|Overall Study||73
11185292|NCT01732549|12374694|FG000|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
11185293|NCT01732549|12374695|FG001|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
11185294|NCT01732549|12374694|FG000|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
11185295|NCT01732549|12374695|FG001|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
11185296|NCT01732549|12374694|FG000|Ongoing Treatment Period:Final Analysis|Overall Study||0
11185297|NCT01732549|12374695|FG001|Ongoing Treatment Period:Final Analysis|Overall Study||0
11185298|NCT01732549|12374694|FG000|Withdrawn During Treatment:Final Analysi|Overall Study||71
11185299|NCT01732549|12374695|FG001|Withdrawn During Treatment:Final Analysi|Overall Study||73
11185300|NCT01732549|12374694|FG000|COMPLETED|Overall Study||0
11185301|NCT01732549|12374695|FG001|COMPLETED|Overall Study||0
11185302|NCT01732549|12374694|FG000|NOT COMPLETED|Overall Study||71
11185303|NCT01732549|12374695|FG001|NOT COMPLETED|Overall Study||73
11204283|NCT01852162|12394797|FG001|NOT COMPLETED|Overall Study||1
11204284|NCT01852175|12394805|FG000|STARTED|Overall Study||55
11204285|NCT01852175|12394806|FG001|STARTED|Overall Study||55
11204286|NCT01852175|12394805|FG000|COMPLETED|Overall Study||55
11204287|NCT01852175|12394806|FG001|COMPLETED|Overall Study||55
11204288|NCT01852175|12394805|FG000|NOT COMPLETED|Overall Study||0
11204289|NCT01852175|12394806|FG001|NOT COMPLETED|Overall Study||0
11204290|NCT01852201|12394814|FG000|STARTED|Overall Study||21
11204291|NCT01852201|12394815|FG001|STARTED|Overall Study||12
11204292|NCT01852201|12394814|FG000|COMPLETED|Overall Study||21
11204293|NCT01852201|12394815|FG001|COMPLETED|Overall Study||12
11204294|NCT01852201|12394814|FG000|NOT COMPLETED|Overall Study||0
11204295|NCT01852201|12394815|FG001|NOT COMPLETED|Overall Study||0
11204296|NCT01852214|12394822|FG000|STARTED|Period 1||26
11204297|NCT01852214|12394823|FG001|STARTED|Period 1||24
11204298|NCT01852214|12394822|FG000|COMPLETED|Period 1||25
11204299|NCT01852214|12394823|FG001|COMPLETED|Period 1||21
11204300|NCT01852214|12394822|FG000|NOT COMPLETED|Period 1||1
11204301|NCT01852214|12394823|FG001|NOT COMPLETED|Period 1||3
11204302|NCT01852214|12394822|FG000|STARTED|Washout Period||25
11204303|NCT01852214|12394823|FG001|STARTED|Washout Period||21
11204304|NCT01852214|12394822|FG000|COMPLETED|Washout Period||25
11204305|NCT01852214|12394823|FG001|COMPLETED|Washout Period||20
11204306|NCT01852214|12394822|FG000|NOT COMPLETED|Washout Period||0
11204307|NCT01852214|12394823|FG001|NOT COMPLETED|Washout Period||1
11204308|NCT01852214|12394822|FG000|STARTED|Period 2||25
11204309|NCT01852214|12394823|FG001|STARTED|Period 2||20
11204310|NCT01852214|12394822|FG000|COMPLETED|Period 2||25
11204311|NCT01852214|12394823|FG001|COMPLETED|Period 2||20
11204312|NCT01852214|12394822|FG000|NOT COMPLETED|Period 2||0
11204313|NCT01852214|12394823|FG001|NOT COMPLETED|Period 2||0
11204314|NCT01852292|12394832|FG000|STARTED|Overall Study||79
11204315|NCT01852292|12394833|FG001|STARTED|Overall Study||79
11204316|NCT01852292|12394832|FG000|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
11204317|NCT01852292|12394833|FG001|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
11204318|NCT01852292|12394832|FG000|NOT COMPLETED|Overall Study||79
11204319|NCT01852292|12394833|FG001|NOT COMPLETED|Overall Study||79
11204320|NCT01852344|12394843|FG000|STARTED|Overall Study||27
11204321|NCT01852344|12394844|FG001|STARTED|Overall Study||27
11204322|NCT01852344|12394845|FG002|STARTED|Overall Study||27
11204323|NCT01852344|12394846|FG003|STARTED|Overall Study||27
11204324|NCT01852344|12394843|FG000|Actual Participation in First Assignment|Overall Study||27
11204325|NCT01852344|12394844|FG001|Actual Participation in First Assignment|Overall Study||27
11204326|NCT01852344|12394845|FG002|Actual Participation in First Assignment|Overall Study||27
11204327|NCT01852344|12394846|FG003|Actual Participation in First Assignment|Overall Study||27
11204328|NCT01852344|12394843|FG000|COMPLETED|Overall Study||27
11204329|NCT01852344|12394844|FG001|COMPLETED|Overall Study||27
11204330|NCT01852344|12394845|FG002|COMPLETED|Overall Study||27
11204331|NCT01852344|12394846|FG003|COMPLETED|Overall Study||27
11204332|NCT01852344|12394843|FG000|NOT COMPLETED|Overall Study||0
11204333|NCT01852344|12394844|FG001|NOT COMPLETED|Overall Study||0
11204334|NCT01852344|12394845|FG002|NOT COMPLETED|Overall Study||0
11204335|NCT01852344|12394846|FG003|NOT COMPLETED|Overall Study||0
11205203|NCT01857869|12395946|FG006|STARTED|Booster/Rechallenge Phase||5
11205204|NCT01857869|12395947|FG007|STARTED|Booster/Rechallenge Phase||4
11205205|NCT01857869|12395948|FG008|STARTED|Booster/Rechallenge Phase||3
11205206|NCT01857869|12395949|FG009|STARTED|Booster/Rechallenge Phase||6
11205207|NCT01857869|12395940|FG000|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
11205208|NCT01857869|12395941|FG001|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
11205209|NCT01857869|12395942|FG002|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
11205210|NCT01857869|12395943|FG003|COMPLETED|Booster/Rechallenge Phase||7
11205211|NCT01857869|12395944|FG004|COMPLETED|Booster/Rechallenge Phase||10
11205212|NCT01857869|12395945|FG005|COMPLETED|Booster/Rechallenge Phase||2
11205213|NCT01857869|12395946|FG006|COMPLETED|Booster/Rechallenge Phase||5
11205214|NCT01857869|12395947|FG007|COMPLETED|Booster/Rechallenge Phase||4
11205215|NCT01857869|12395948|FG008|COMPLETED|Booster/Rechallenge Phase||3
11205216|NCT01857869|12395949|FG009|COMPLETED|Booster/Rechallenge Phase||6
11205217|NCT01857869|12395940|FG000|NOT COMPLETED|Booster/Rechallenge Phase||0
11205218|NCT01857869|12395941|FG001|NOT COMPLETED|Booster/Rechallenge Phase||0
11205219|NCT01857869|12395942|FG002|NOT COMPLETED|Booster/Rechallenge Phase||0
11205220|NCT01857869|12395943|FG003|NOT COMPLETED|Booster/Rechallenge Phase||2
11205221|NCT01857869|12395944|FG004|NOT COMPLETED|Booster/Rechallenge Phase||0
11185304|NCT01732588|12374705|FG000|STARTED|First Intervention (7 Days)||4
11185305|NCT01732588|12374706|FG001|STARTED|First Intervention (7 Days)||3
11185306|NCT01732588|12374707|FG002|STARTED|First Intervention (7 Days)||4
11185307|NCT01732588|12374705|FG000|COMPLETED|First Intervention (7 Days)||4
11185308|NCT01732588|12374706|FG001|COMPLETED|First Intervention (7 Days)||2
11185309|NCT01732588|12374707|FG002|COMPLETED|First Intervention (7 Days)||4
11185310|NCT01732588|12374705|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11185311|NCT01732588|12374706|FG001|NOT COMPLETED|First Intervention (7 Days)||1
11185312|NCT01732588|12374707|FG002|NOT COMPLETED|First Intervention (7 Days)||0
11185313|NCT01732588|12374705|FG000|STARTED|Second Intervention (7 Days)||4
11185314|NCT01732588|12374706|FG001|STARTED|Second Intervention (7 Days)||2
11185315|NCT01732588|12374707|FG002|STARTED|Second Intervention (7 Days)||4
11185316|NCT01732588|12374705|FG000|COMPLETED|Second Intervention (7 Days)||4
11185317|NCT01732588|12374706|FG001|COMPLETED|Second Intervention (7 Days)||2
11185318|NCT01732588|12374707|FG002|COMPLETED|Second Intervention (7 Days)||4
11185319|NCT01732588|12374705|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
11185320|NCT01732588|12374706|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11185321|NCT01732588|12374707|FG002|NOT COMPLETED|Second Intervention (7 Days)||0
11185322|NCT01732588|12374705|FG000|STARTED|Third Intervention (7 Days)||4
11185323|NCT01732588|12374706|FG001|STARTED|Third Intervention (7 Days)||2
11185324|NCT01732588|12374707|FG002|STARTED|Third Intervention (7 Days)||4
11185325|NCT01732588|12374705|FG000|COMPLETED|Third Intervention (7 Days)||4
11185326|NCT01732588|12374706|FG001|COMPLETED|Third Intervention (7 Days)||2
11185327|NCT01732588|12374707|FG002|COMPLETED|Third Intervention (7 Days)||4
11185328|NCT01732588|12374705|FG000|NOT COMPLETED|Third Intervention (7 Days)||0
11185329|NCT01732588|12374706|FG001|NOT COMPLETED|Third Intervention (7 Days)||0
11185330|NCT01732588|12374707|FG002|NOT COMPLETED|Third Intervention (7 Days)||0
11185331|NCT01732640|12374715|FG000|STARTED|Overall Study||6
11185332|NCT01732640|12374716|FG001|STARTED|Overall Study||3
11185333|NCT01732640|12374715|FG000|COMPLETED|Overall Study||6
11185334|NCT01732640|12374716|FG001|COMPLETED|Overall Study||1
11185335|NCT01732640|12374715|FG000|NOT COMPLETED|Overall Study||0
11185336|NCT01732640|12374716|FG001|NOT COMPLETED|Overall Study||2
11185337|NCT01732692|12374728|FG000|STARTED|Overall Study||70
11185338|NCT01732692|12374729|FG001|STARTED|Overall Study||70
11185339|NCT01732692|12374728|FG000|COMPLETED|Overall Study||70
11185340|NCT01732692|12374729|FG001|COMPLETED|Overall Study||69
11185341|NCT01732692|12374728|FG000|NOT COMPLETED|Overall Study||0
11185342|NCT01732692|12374729|FG001|NOT COMPLETED|Overall Study||1
11185343|NCT01732718|12374735|FG000|STARTED|First Intervention||7
11185344|NCT01732718|12374736|FG001|STARTED|First Intervention||6
11185345|NCT01732718|12374735|FG000|COMPLETED|First Intervention||7
11185346|NCT01732718|12374736|FG001|COMPLETED|First Intervention||6
11185347|NCT01732718|12374735|FG000|NOT COMPLETED|First Intervention||0
11185348|NCT01732718|12374736|FG001|NOT COMPLETED|First Intervention||0
11185349|NCT01732718|12374735|FG000|STARTED|Washout (4 Weeks)||7
11185350|NCT01732718|12374736|FG001|STARTED|Washout (4 Weeks)||6
11185351|NCT01732718|12374735|FG000|COMPLETED|Washout (4 Weeks)||7
11185352|NCT01732718|12374736|FG001|COMPLETED|Washout (4 Weeks)||6
11185353|NCT01732718|12374735|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11185354|NCT01732718|12374736|FG001|NOT COMPLETED|Washout (4 Weeks)||0
11185355|NCT01732718|12374735|FG000|STARTED|Second Intervention||7
11185356|NCT01732718|12374736|FG001|STARTED|Second Intervention||6
11185357|NCT01732718|12374735|FG000|COMPLETED|Second Intervention||7
11185358|NCT01732718|12374736|FG001|COMPLETED|Second Intervention||6
11185359|NCT01732718|12374735|FG000|NOT COMPLETED|Second Intervention||0
11185360|NCT01732718|12374736|FG001|NOT COMPLETED|Second Intervention||0
11185361|NCT01732757|12374751|FG000|STARTED|Overall Study||53
11185362|NCT01732757|12374752|FG001|STARTED|Overall Study||52
11185363|NCT01732757|12374753|FG002|STARTED|Overall Study||52
11185364|NCT01732757|12374751|FG000|COMPLETED|Overall Study||52
11185365|NCT01732757|12374752|FG001|COMPLETED|Overall Study||52
11185366|NCT01732757|12374753|FG002|COMPLETED|Overall Study||52
11185367|NCT01732757|12374751|FG000|NOT COMPLETED|Overall Study||1
11185368|NCT01732757|12374752|FG001|NOT COMPLETED|Overall Study||0
11185369|NCT01732757|12374753|FG002|NOT COMPLETED|Overall Study||0
11185370|NCT01732770|12374763|FG000|STARTED|Overall Study||322
11185371|NCT01732770|12374764|FG001|STARTED|Overall Study||321
11185372|NCT01732770|12374763|FG000|Received Study Treatment|Overall Study||320
11185373|NCT01732770|12374764|FG001|Received Study Treatment|Overall Study||320
11185374|NCT01732770|12374763|FG000|COMPLETED|Overall Study||312
11185375|NCT01732770|12374764|FG001|COMPLETED|Overall Study||313
11185376|NCT01732770|12374763|FG000|NOT COMPLETED|Overall Study||10
11185377|NCT01732770|12374764|FG001|NOT COMPLETED|Overall Study||8
11185378|NCT01732783|12374773|FG000|STARTED|Overall Study||164
11185379|NCT01732783|12374774|FG001|STARTED|Overall Study||37
11185380|NCT01732783|12374775|FG002|STARTED|Overall Study||12
11185381|NCT01732783|12374773|FG000|COMPLETED|Overall Study|Completed 12-month observation period.|29
11185382|NCT01732783|12374774|FG001|COMPLETED|Overall Study|Completed 12-month observation period.|5
11185383|NCT01732783|12374775|FG002|COMPLETED|Overall Study|Completed 12-month observation period.|2
11185384|NCT01732783|12374773|FG000|NOT COMPLETED|Overall Study||135
11185385|NCT01732783|12374774|FG001|NOT COMPLETED|Overall Study||32
11185386|NCT01732783|12374775|FG002|NOT COMPLETED|Overall Study||10
11185387|NCT01732796|12374786|FG000|STARTED|Overall Study||208
11185388|NCT01732796|12374787|FG001|STARTED|Overall Study||211
11185389|NCT01732796|12374788|FG002|STARTED|Overall Study||51
11185390|NCT01732796|12374786|FG000|COMPLETED|Overall Study||162
11185391|NCT01732796|12374787|FG001|COMPLETED|Overall Study||169
11185392|NCT01732796|12374788|FG002|COMPLETED|Overall Study||38
11185393|NCT01732796|12374786|FG000|NOT COMPLETED|Overall Study||46
11185394|NCT01732796|12374787|FG001|NOT COMPLETED|Overall Study||42
11185395|NCT01732796|12374788|FG002|NOT COMPLETED|Overall Study||13
11204336|NCT01852383|12394857|FG000|STARTED|Overall Study||30
11204337|NCT01852383|12394857|FG000|COMPLETED|Overall Study||19
11204338|NCT01852383|12394857|FG000|NOT COMPLETED|Overall Study||11
11204339|NCT01852513|12394864|FG000|STARTED|Overall Study||20
11204340|NCT01852513|12394865|FG001|STARTED|Overall Study||19
11204341|NCT01852513|12394864|FG000|COMPLETED|Overall Study||20
11204342|NCT01852513|12394865|FG001|COMPLETED|Overall Study||19
11204343|NCT01852513|12394864|FG000|NOT COMPLETED|Overall Study||0
11204344|NCT01852513|12394865|FG001|NOT COMPLETED|Overall Study||0
11204345|NCT01852591|12394871|FG000|STARTED|Overall Study||8
11204346|NCT01852591|12394871|FG000|COMPLETED|Overall Study||5
11204347|NCT01852591|12394871|FG000|NOT COMPLETED|Overall Study||3
11204348|NCT01852669|12394877|FG000|STARTED|Overall Study||71
11204349|NCT01852669|12394878|FG001|STARTED|Overall Study||69
11204350|NCT01852669|12394877|FG000|COMPLETED|Overall Study||71
11204351|NCT01852669|12394878|FG001|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
11204352|NCT01852669|12394877|FG000|NOT COMPLETED|Overall Study||0
11204353|NCT01852669|12394878|FG001|NOT COMPLETED|Overall Study||1
11204354|NCT01852799|12394884|FG000|STARTED|Overall Study||18
11204355|NCT01852799|12394884|FG000|COMPLETED|Overall Study||0
11204356|NCT01852799|12394884|FG000|NOT COMPLETED|Overall Study||18
11204357|NCT01852825|12394891|FG000|STARTED|Overall Study||16
11204358|NCT01852825|12394892|FG001|STARTED|Overall Study||7
11204359|NCT01852825|12394893|FG002|STARTED|Overall Study||3
11204360|NCT01852825|12394891|FG000|COMPLETED|Overall Study||14
11204361|NCT01852825|12394892|FG001|COMPLETED|Overall Study||7
11204362|NCT01852825|12394893|FG002|COMPLETED|Overall Study||3
11204363|NCT01852825|12394891|FG000|NOT COMPLETED|Overall Study||2
11204364|NCT01852825|12394892|FG001|NOT COMPLETED|Overall Study||0
11204365|NCT01852825|12394893|FG002|NOT COMPLETED|Overall Study||0
11204366|NCT01852942|12394903|FG000|STARTED|Overall Study||25
11204367|NCT01852942|12394904|FG001|STARTED|Overall Study||27
11204368|NCT01852942|12394903|FG000|COMPLETED|Overall Study||20
11204369|NCT01852942|12394904|FG001|COMPLETED|Overall Study||21
11204370|NCT01852942|12394903|FG000|NOT COMPLETED|Overall Study||5
11204371|NCT01852942|12394904|FG001|NOT COMPLETED|Overall Study||6
11204372|NCT01852955|12394913|FG000|STARTED|Overall Study||35
11204373|NCT01852955|12394914|FG001|STARTED|Overall Study||35
11204374|NCT01852955|12394913|FG000|COMPLETED|Overall Study||33
11204375|NCT01852955|12394914|FG001|COMPLETED|Overall Study||32
11204376|NCT01852955|12394913|FG000|NOT COMPLETED|Overall Study||2
11204377|NCT01852955|12394914|FG001|NOT COMPLETED|Overall Study||3
11204378|NCT01853046|12394922|FG000|STARTED|Overall Study||18
11204379|NCT01853046|12394923|FG001|STARTED|Overall Study||6
11204380|NCT01853046|12394922|FG000|Received Treatment|Overall Study||18
11204381|NCT01853046|12394923|FG001|Received Treatment|Overall Study||6
11204382|NCT01853046|12394922|FG000|COMPLETED|Overall Study||0
11204383|NCT01853046|12394923|FG001|COMPLETED|Overall Study||0
11204384|NCT01853046|12394922|FG000|NOT COMPLETED|Overall Study||18
11204385|NCT01853046|12394923|FG001|NOT COMPLETED|Overall Study||6
11204386|NCT01853072|12394932|FG000|STARTED|Overall Study||308
11204387|NCT01853072|12394933|FG001|STARTED|Overall Study||307
11204388|NCT01853072|12394932|FG000|Randomized|Overall Study||308
11204389|NCT01853072|12394933|FG001|Randomized|Overall Study||307
11204390|NCT01853072|12394932|FG000|Treated (Safety Analysis Set)|Overall Study||301
11204391|NCT01853072|12394933|FG001|Treated (Safety Analysis Set)|Overall Study||302
11204392|NCT01853072|12394932|FG000|Full Analysis Set|Overall Study||298
11204393|NCT01853072|12394933|FG001|Full Analysis Set|Overall Study||300
11204394|NCT01853072|12394932|FG000|COMPLETED|Overall Study||296
11204395|NCT01853072|12394933|FG001|COMPLETED|Overall Study||286
11204396|NCT01853072|12394932|FG000|NOT COMPLETED|Overall Study||12
11204397|NCT01853072|12394933|FG001|NOT COMPLETED|Overall Study||21
11204398|NCT01853085|12394941|FG000|STARTED|Overall Study||1830
11204399|NCT01853085|12394941|FG000|COMPLETED|Overall Study||1595
11204400|NCT01853085|12394941|FG000|NOT COMPLETED|Overall Study||235
11204401|NCT01853137|12394947|FG000|STARTED|Overall Study||25
11204402|NCT01853137|12394948|FG001|STARTED|Overall Study||18
11204403|NCT01853137|12394947|FG000|COMPLETED|Overall Study||21
11204404|NCT01853137|12394948|FG001|COMPLETED|Overall Study||17
11204405|NCT01853137|12394947|FG000|NOT COMPLETED|Overall Study||4
11204406|NCT01853137|12394948|FG001|NOT COMPLETED|Overall Study||1
11204407|NCT01853215|12394955|FG000|STARTED|Overall Study||24
11185396|NCT04537234|12374800|FG000|STARTED|Overall Study||82
11185397|NCT04537234|12374801|FG001|STARTED|Overall Study||83
11185398|NCT04537234|12374800|FG000|COMPLETED|Overall Study||80
11185399|NCT04537234|12374801|FG001|COMPLETED|Overall Study||83
11185400|NCT04537234|12374800|FG000|NOT COMPLETED|Overall Study||2
11185401|NCT04537234|12374801|FG001|NOT COMPLETED|Overall Study||0
11204408|NCT01853215|12394955|FG000|COMPLETED|Overall Study||24
11204409|NCT01853215|12394955|FG000|NOT COMPLETED|Overall Study||0
11204410|NCT01853228|12394960|FG000|STARTED|Phase 1||9
11204411|NCT01853228|12394961|FG001|STARTED|Phase 1||7
11204412|NCT01853228|12394960|FG000|COMPLETED|Phase 1||0
11204413|NCT01853228|12394961|FG001|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7
11204414|NCT01853228|12394960|FG000|NOT COMPLETED|Phase 1||9
11204415|NCT01853228|12394961|FG001|NOT COMPLETED|Phase 1||0
11204416|NCT01853228|12394960|FG000|STARTED|Phase 2||0
11204417|NCT01853228|12394961|FG001|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8
11204418|NCT01853228|12394960|FG000|COMPLETED|Phase 2||0
11204419|NCT01853228|12394961|FG001|COMPLETED|Phase 2||0
11204420|NCT01853228|12394960|FG000|NOT COMPLETED|Phase 2||0
11204421|NCT01853228|12394961|FG001|NOT COMPLETED|Phase 2||8
11204422|NCT01853254|12394966|FG000|STARTED|Overall Study||272
11204423|NCT01853254|12394966|FG000|COMPLETED|Overall Study||168
11204424|NCT01853254|12394966|FG000|NOT COMPLETED|Overall Study||104
11204425|NCT01853280|12394972|FG000|STARTED|Overall Study||22
11204426|NCT01853280|12394973|FG001|STARTED|Overall Study||22
11204427|NCT01853280|12394972|FG000|COMPLETED|Overall Study||20
11204428|NCT01853280|12394973|FG001|COMPLETED|Overall Study||16
11204429|NCT01853280|12394972|FG000|NOT COMPLETED|Overall Study||2
11204430|NCT01853280|12394973|FG001|NOT COMPLETED|Overall Study||6
11204431|NCT01853332|12394979|FG000|STARTED|Overall Study||210
11204432|NCT01853332|12394979|FG000|COMPLETED|Overall Study||151
11204433|NCT01853332|12394979|FG000|NOT COMPLETED|Overall Study||59
11204434|NCT01853371|12394986|FG000|STARTED|Overall Study||10
11204435|NCT01853371|12394987|FG001|STARTED|Overall Study||10
11204436|NCT01853371|12394986|FG000|COMPLETED|Overall Study||10
11204437|NCT01853371|12394987|FG001|COMPLETED|Overall Study||8
11204438|NCT01853371|12394986|FG000|NOT COMPLETED|Overall Study||0
11204439|NCT01853371|12394987|FG001|NOT COMPLETED|Overall Study||2
11204440|NCT01853384|12394995|FG000|STARTED|Randomized||131
11204441|NCT01853384|12394996|FG001|STARTED|Randomized||121
11204442|NCT01853384|12394995|FG000|COMPLETED|Randomized||69
11204443|NCT01853384|12394996|FG001|COMPLETED|Randomized||75
11204444|NCT01853384|12394995|FG000|NOT COMPLETED|Randomized||62
11204445|NCT01853384|12394996|FG001|NOT COMPLETED|Randomized||46
11204446|NCT01853384|12394995|FG000|STARTED|Enrolled in Follow up Period||96
11204447|NCT01853384|12394996|FG001|STARTED|Enrolled in Follow up Period||94
11204448|NCT01853384|12394995|FG000|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
11204449|NCT01853384|12394996|FG001|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
11204450|NCT01853384|12394995|FG000|COMPLETED|Enrolled in Follow up Period||96
11204451|NCT01853384|12394996|FG001|COMPLETED|Enrolled in Follow up Period||94
11204452|NCT01853384|12394995|FG000|NOT COMPLETED|Enrolled in Follow up Period||0
11204453|NCT01853384|12394996|FG001|NOT COMPLETED|Enrolled in Follow up Period||0
11204454|NCT01853384|12394995|FG000|STARTED|Completed Follow up Visit 1||96
11204455|NCT01853384|12394996|FG001|STARTED|Completed Follow up Visit 1||94
11204456|NCT01853384|12394995|FG000|COMPLETED|Completed Follow up Visit 1||82
11204457|NCT01853384|12394996|FG001|COMPLETED|Completed Follow up Visit 1||85
11204458|NCT01853384|12394995|FG000|NOT COMPLETED|Completed Follow up Visit 1||14
11204459|NCT01853384|12394996|FG001|NOT COMPLETED|Completed Follow up Visit 1||9
11204460|NCT01853384|12394995|FG000|STARTED|Completed Follow up Visit 2||96
11204461|NCT01853384|12394996|FG001|STARTED|Completed Follow up Visit 2||94
11204462|NCT01853384|12394995|FG000|COMPLETED|Completed Follow up Visit 2||93
11204463|NCT01853384|12394996|FG001|COMPLETED|Completed Follow up Visit 2||91
11204464|NCT01853384|12394995|FG000|NOT COMPLETED|Completed Follow up Visit 2||3
11204465|NCT01853384|12394996|FG001|NOT COMPLETED|Completed Follow up Visit 2||3
11204466|NCT01853397|12395006|FG000|STARTED|Overall Study||18
11204467|NCT01853397|12395007|FG001|STARTED|Overall Study||20
11204468|NCT01853397|12395008|FG002|STARTED|Overall Study||17
11204469|NCT01853397|12395009|FG003|STARTED|Overall Study||17
11204470|NCT01853397|12395006|FG000|COMPLETED|Overall Study||18
11204471|NCT01853397|12395007|FG001|COMPLETED|Overall Study||20
11204472|NCT01853397|12395008|FG002|COMPLETED|Overall Study||17
11204473|NCT01853397|12395009|FG003|COMPLETED|Overall Study||15
11204474|NCT01853397|12395006|FG000|NOT COMPLETED|Overall Study||0
11204475|NCT01853397|12395007|FG001|NOT COMPLETED|Overall Study||0
11204476|NCT01853397|12395008|FG002|NOT COMPLETED|Overall Study||0
11204477|NCT01853397|12395009|FG003|NOT COMPLETED|Overall Study||2
11204478|NCT01853462|12395021|FG000|STARTED|Overall Study||11
11204479|NCT01853462|12395022|FG001|STARTED|Overall Study||11
11204480|NCT01853462|12395021|FG000|COMPLETED|Overall Study||10
11204481|NCT01853462|12395022|FG001|COMPLETED|Overall Study||10
11204482|NCT01853462|12395021|FG000|NOT COMPLETED|Overall Study||1
11204483|NCT01853462|12395022|FG001|NOT COMPLETED|Overall Study||1
11204484|NCT01853475|12395033|FG000|STARTED|Overall Study||8
11204485|NCT01853475|12395034|FG001|STARTED|Overall Study||8
11204486|NCT01853475|12395035|FG002|STARTED|Overall Study||8
11204487|NCT01853475|12395033|FG000|COMPLETED|Overall Study||8
11204488|NCT01853475|12395034|FG001|COMPLETED|Overall Study||7
11204489|NCT01853475|12395035|FG002|COMPLETED|Overall Study||8
11204490|NCT01853475|12395033|FG000|NOT COMPLETED|Overall Study||0
11204491|NCT01853475|12395034|FG001|NOT COMPLETED|Overall Study||1
11185402|NCT04172701|12374809|FG000|STARTED|Overall Study||6352
11185403|NCT04172701|12374810|FG001|STARTED|Overall Study||2932
11185404|NCT04172701|12374809|FG000|Propensity Score (PS) Matched Population|Overall Study||2444
11185405|NCT04172701|12374810|FG001|Propensity Score (PS) Matched Population|Overall Study||2444
11185406|NCT04172701|12374809|FG000|COMPLETED|Overall Study||6352
11185407|NCT04172701|12374810|FG001|COMPLETED|Overall Study||2932
11185408|NCT04172701|12374809|FG000|NOT COMPLETED|Overall Study||0
11185409|NCT04172701|12374810|FG001|NOT COMPLETED|Overall Study||0
11185410|NCT03813199|12374819|FG000|STARTED|Overall Study||21
11185411|NCT03813199|12374820|FG001|STARTED|Overall Study||19
11185412|NCT03813199|12374821|FG002|STARTED|Overall Study||20
11185413|NCT03813199|12374819|FG000|COMPLETED|Overall Study||18
11185414|NCT03813199|12374820|FG001|COMPLETED|Overall Study||6
11185415|NCT03813199|12374821|FG002|COMPLETED|Overall Study||19
11185416|NCT03813199|12374819|FG000|NOT COMPLETED|Overall Study||3
11185417|NCT03813199|12374820|FG001|NOT COMPLETED|Overall Study||13
11185418|NCT03813199|12374821|FG002|NOT COMPLETED|Overall Study||1
11204492|NCT01853475|12395035|FG002|NOT COMPLETED|Overall Study||0
11204493|NCT01853553|12395045|FG000|STARTED|Overall Study||29
11204494|NCT01853553|12395046|FG001|STARTED|Overall Study||32
11204495|NCT01853553|12395045|FG000|COMPLETED|Overall Study||28
11204496|NCT01853553|12395046|FG001|COMPLETED|Overall Study||32
11204497|NCT01853553|12395045|FG000|NOT COMPLETED|Overall Study||1
11204498|NCT01853553|12395046|FG001|NOT COMPLETED|Overall Study||0
11204499|NCT01853605|12395056|FG000|STARTED|Overall Study||1939
11204500|NCT01853605|12395057|FG001|STARTED|Overall Study||693
11204501|NCT01853605|12395058|FG002|STARTED|Overall Study||751
11204502|NCT01853605|12395059|FG003|STARTED|Overall Study||428
11204503|NCT01853605|12395056|FG000|COMPLETED|Overall Study||1939
11204504|NCT01853605|12395057|FG001|COMPLETED|Overall Study||693
11204505|NCT01853605|12395058|FG002|COMPLETED|Overall Study||751
11204506|NCT01853605|12395059|FG003|COMPLETED|Overall Study||428
11204507|NCT01853605|12395056|FG000|NOT COMPLETED|Overall Study||0
11204508|NCT01853605|12395057|FG001|NOT COMPLETED|Overall Study||0
11204509|NCT01853605|12395058|FG002|NOT COMPLETED|Overall Study||0
11204510|NCT01853605|12395059|FG003|NOT COMPLETED|Overall Study||0
11204511|NCT01853618|12395074|FG000|STARTED|Overall Study||8
11204512|NCT01853618|12395075|FG001|STARTED|Overall Study||12
11204513|NCT01853618|12395076|FG002|STARTED|Overall Study||12
11204514|NCT01853618|12395077|FG003|STARTED|Overall Study||9
11204515|NCT01853618|12395078|FG004|STARTED|Overall Study||20
11204516|NCT01853618|12395074|FG000|COMPLETED|Overall Study||6
11204517|NCT01853618|12395075|FG001|COMPLETED|Overall Study||10
11204518|NCT01853618|12395076|FG002|COMPLETED|Overall Study||10
11204519|NCT01853618|12395077|FG003|COMPLETED|Overall Study||8
11204520|NCT01853618|12395078|FG004|COMPLETED|Overall Study||17
11204521|NCT01853618|12395074|FG000|NOT COMPLETED|Overall Study||2
11204522|NCT01853618|12395075|FG001|NOT COMPLETED|Overall Study||2
11204523|NCT01853618|12395076|FG002|NOT COMPLETED|Overall Study||2
11204524|NCT01853618|12395077|FG003|NOT COMPLETED|Overall Study||1
11204525|NCT01853618|12395078|FG004|NOT COMPLETED|Overall Study||3
11204526|NCT01853644|12395091|FG000|STARTED|Registration and Treatment Start||31
11204527|NCT01853644|12395091|FG000|Registered|Registration and Treatment Start||31
11204528|NCT01853644|12395091|FG000|Started Treatment|Registration and Treatment Start||30
11204529|NCT01853644|12395091|FG000|COMPLETED|Registration and Treatment Start||30
11204530|NCT01853644|12395091|FG000|NOT COMPLETED|Registration and Treatment Start||1
11204531|NCT01853644|12395091|FG000|STARTED|Reached First Response/Complete 2 Cycles||30
11204532|NCT01853644|12395091|FG000|COMPLETED|Reached First Response/Complete 2 Cycles||24
11204533|NCT01853644|12395091|FG000|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6
11204534|NCT01853644|12395091|FG000|STARTED|Continued Treatment After First Response||24
11204535|NCT01853644|12395091|FG000|COMPLETED|Continued Treatment After First Response||12
11204536|NCT01853644|12395091|FG000|NOT COMPLETED|Continued Treatment After First Response||12
11204537|NCT01853644|12395091|FG000|STARTED|Follow up for 3 Years or Until Death|All patients that are treated on the study go into the follow up period|30
11204538|NCT01853644|12395091|FG000|COMPLETED|Follow up for 3 Years or Until Death||30
11204539|NCT01853644|12395091|FG000|NOT COMPLETED|Follow up for 3 Years or Until Death||0
11204540|NCT01853696|12395097|FG000|STARTED|Overall Study||84
11204541|NCT01853696|12395098|FG001|STARTED|Overall Study||83
11204542|NCT01853696|12395097|FG000|COMPLETED|Overall Study||78
11204543|NCT01853696|12395098|FG001|COMPLETED|Overall Study||78
11204544|NCT01853696|12395097|FG000|NOT COMPLETED|Overall Study||6
11204545|NCT01853696|12395098|FG001|NOT COMPLETED|Overall Study||5
11204546|NCT01853774|12395106|FG000|STARTED|Overall Study||257
11204547|NCT01853774|12395107|FG001|STARTED|Overall Study||162
11204548|NCT01853774|12395106|FG000|COMPLETED|Overall Study||211
11204549|NCT01853774|12395107|FG001|COMPLETED|Overall Study||134
11204550|NCT01853774|12395106|FG000|NOT COMPLETED|Overall Study||46
11204551|NCT01853774|12395107|FG001|NOT COMPLETED|Overall Study||28
11204552|NCT01853839|12395115|FG000|STARTED|Overall Study||2092
11204553|NCT01853839|12395115|FG000|COMPLETED|Overall Study||1663
11204554|NCT01853839|12395115|FG000|NOT COMPLETED|Overall Study||429
11204555|NCT01853878|12395125|FG000|STARTED|Overall Study||86
11204556|NCT01853878|12395126|FG001|STARTED|Overall Study||47
11204557|NCT01853878|12395125|FG000|COMPLETED|Overall Study||23
11204558|NCT01853878|12395126|FG001|COMPLETED|Overall Study||3
11204559|NCT01853878|12395125|FG000|NOT COMPLETED|Overall Study||63
11204560|NCT01853878|12395126|FG001|NOT COMPLETED|Overall Study||44
11204561|NCT01853930|12395134|FG000|STARTED|Overall Study||25
11204562|NCT01853930|12395135|FG001|STARTED|Overall Study||8
11185419|NCT03478956|12374831|FG000|STARTED|Overall Study||12
11185420|NCT03478956|12374832|FG001|STARTED|Overall Study||12
11185421|NCT03478956|12374831|FG000|Received at Least One Dose of Study Drug|Overall Study||12
11185422|NCT03478956|12374832|FG001|Received at Least One Dose of Study Drug|Overall Study||12
11185423|NCT03478956|12374831|FG000|Completed Randomized Treatment Phase|Overall Study||11
11185424|NCT03478956|12374832|FG001|Completed Randomized Treatment Phase|Overall Study||10
11185425|NCT03478956|12374831|FG000|Started OLE Treatment Phase|Overall Study||11
11185426|NCT03478956|12374832|FG001|Started OLE Treatment Phase|Overall Study||10
11185427|NCT03478956|12374831|FG000|Completed OLE Treatment Phase|Overall Study||0
11185428|NCT03478956|12374832|FG001|Completed OLE Treatment Phase|Overall Study||0
11185429|NCT03478956|12374831|FG000|Started PML Safety Monitoring Phase|Overall Study||1
11185430|NCT03478956|12374832|FG001|Started PML Safety Monitoring Phase|Overall Study||2
11185431|NCT03478956|12374831|FG000|COMPLETED|Overall Study||0
11185432|NCT03478956|12374832|FG001|COMPLETED|Overall Study||0
11185433|NCT03478956|12374831|FG000|NOT COMPLETED|Overall Study||12
11185434|NCT03478956|12374832|FG001|NOT COMPLETED|Overall Study||12
11185435|NCT03348930|12374838|FG000|STARTED|First Intervention (2 Weeks)||10
11185436|NCT03348930|12374839|FG001|STARTED|First Intervention (2 Weeks)||10
11185437|NCT03348930|12374838|FG000|COMPLETED|First Intervention (2 Weeks)||10
11185438|NCT03348930|12374839|FG001|COMPLETED|First Intervention (2 Weeks)||10
11185439|NCT03348930|12374838|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
11185440|NCT03348930|12374839|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
11185441|NCT03348930|12374838|FG000|STARTED|Washout (1 Week)||10
11185442|NCT03348930|12374839|FG001|STARTED|Washout (1 Week)||10
11185443|NCT03348930|12374838|FG000|COMPLETED|Washout (1 Week)||9
11185444|NCT03348930|12374839|FG001|COMPLETED|Washout (1 Week)||9
11185445|NCT03348930|12374838|FG000|NOT COMPLETED|Washout (1 Week)||1
11185446|NCT03348930|12374839|FG001|NOT COMPLETED|Washout (1 Week)||1
11185447|NCT03348930|12374838|FG000|STARTED|Second Intervention (2 Weeks)||9
11185448|NCT03348930|12374839|FG001|STARTED|Second Intervention (2 Weeks)||9
11185449|NCT03348930|12374838|FG000|COMPLETED|Second Intervention (2 Weeks)||9
11185450|NCT03348930|12374839|FG001|COMPLETED|Second Intervention (2 Weeks)||9
11185451|NCT03348930|12374838|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
11185452|NCT03348930|12374839|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
11185453|NCT03282240|12374848|FG000|STARTED|Overall Study||1777
11185454|NCT03282240|12374849|FG001|STARTED|Overall Study||443
11185455|NCT03282240|12374850|FG002|STARTED|Overall Study||450
11185456|NCT03282240|12374848|FG000|COMPLETED|Overall Study||1767
11185457|NCT03282240|12374849|FG001|COMPLETED|Overall Study||440
11185458|NCT03282240|12374850|FG002|COMPLETED|Overall Study||447
11185459|NCT03282240|12374848|FG000|NOT COMPLETED|Overall Study||10
11185460|NCT03282240|12374849|FG001|NOT COMPLETED|Overall Study||3
11185461|NCT03282240|12374850|FG002|NOT COMPLETED|Overall Study||3
11185462|NCT03260868|12374863|FG000|STARTED|Overall Study||8
11185463|NCT03260868|12374864|FG001|STARTED|Overall Study||7
11185464|NCT03260868|12374863|FG000|Safety Population|Overall Study||8
11185465|NCT03260868|12374864|FG001|Safety Population|Overall Study||6
11185466|NCT03260868|12374863|FG000|COMPLETED|Overall Study||5
11185467|NCT03260868|12374864|FG001|COMPLETED|Overall Study||4
11185468|NCT03260868|12374863|FG000|NOT COMPLETED|Overall Study||3
11185469|NCT03260868|12374864|FG001|NOT COMPLETED|Overall Study||3
11185470|NCT03245580|12374872|FG000|STARTED|Overall Study||75
11185471|NCT03245580|12374873|FG001|STARTED|Overall Study||78
11185472|NCT03245580|12374872|FG000|COMPLETED|Overall Study||75
11185473|NCT03245580|12374873|FG001|COMPLETED|Overall Study||78
11185474|NCT03245580|12374872|FG000|NOT COMPLETED|Overall Study||0
11185475|NCT03245580|12374873|FG001|NOT COMPLETED|Overall Study||0
11185476|NCT03157037|12374879|FG000|STARTED|Overall Study||15
11185477|NCT03157037|12374879|FG000|COMPLETED|Overall Study||14
11185478|NCT03157037|12374879|FG000|NOT COMPLETED|Overall Study||1
11185479|NCT03143218|12374893|FG000|STARTED|Overall Study||1965
11185480|NCT03143218|12374894|FG001|STARTED|Overall Study||1988
11185481|NCT03143218|12374895|FG002|STARTED|Overall Study||1967
11185482|NCT03143218|12374893|FG000|COMPLETED|Overall Study||1716
11185483|NCT03143218|12374894|FG001|COMPLETED|Overall Study||1734
11185484|NCT03143218|12374895|FG002|COMPLETED|Overall Study||1740
11185485|NCT03143218|12374893|FG000|NOT COMPLETED|Overall Study||249
11185486|NCT03143218|12374894|FG001|NOT COMPLETED|Overall Study||254
11185487|NCT03143218|12374895|FG002|NOT COMPLETED|Overall Study||227
11185488|NCT03128931|12374903|FG000|STARTED|Overall Study||45
11185489|NCT03128931|12374903|FG000|COMPLETED|Overall Study||41
11185490|NCT03128931|12374903|FG000|NOT COMPLETED|Overall Study||4
11204563|NCT01853930|12395134|FG000|COMPLETED|Overall Study||25
11204564|NCT01853930|12395135|FG001|COMPLETED|Overall Study||8
11204565|NCT01853930|12395134|FG000|NOT COMPLETED|Overall Study||0
11204566|NCT01853930|12395135|FG001|NOT COMPLETED|Overall Study||0
11204567|NCT01854034|12395141|FG000|STARTED|Overall Study||29
11204568|NCT01854034|12395141|FG000|COMPLETED|Overall Study||29
11204569|NCT01854034|12395141|FG000|NOT COMPLETED|Overall Study||0
11204570|NCT01854047|12395150|FG000|STARTED|Overall Study||158
11204571|NCT01854047|12395151|FG001|STARTED|Overall Study||157
11204572|NCT01854047|12395152|FG002|STARTED|Overall Study||150
11026899|NCT00830869|12205490|FG010|COMPLETED|Period 2: Part 2||0
11026900|NCT00830869|12205491|FG011|COMPLETED|Period 2: Part 2||0
11026901|NCT00830869|12205480|FG000|NOT COMPLETED|Period 2: Part 2||0
11026902|NCT00830869|12205481|FG001|NOT COMPLETED|Period 2: Part 2||0
11204573|NCT01854047|12395153|FG003|STARTED|Overall Study||157
11204574|NCT01854047|12395154|FG004|STARTED|Overall Study||154
11185491|NCT02498392|12374909|FG000|STARTED|Double-blind(DB) Lead-in Period(3 Weeks)||160
11185492|NCT02498392|12374910|FG001|STARTED|Double-blind(DB) Lead-in Period(3 Weeks)||0
11185493|NCT02498392|12374909|FG000|Treated|Double-blind(DB) Lead-in Period(3 Weeks)||153
11185494|NCT02498392|12374910|FG001|Treated|Double-blind(DB) Lead-in Period(3 Weeks)||0
11185495|NCT02498392|12374909|FG000|COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||153
11185496|NCT02498392|12374910|FG001|COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||0
11185497|NCT02498392|12374909|FG000|NOT COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||7
11185498|NCT02498392|12374910|FG001|NOT COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||0
11185499|NCT02498392|12374909|FG000|STARTED|DB Treatment (6 Weeks)+Withdrawal Period||76
11185500|NCT02498392|12374910|FG001|STARTED|DB Treatment (6 Weeks)+Withdrawal Period||77
11185501|NCT02498392|12374909|FG000|COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||70
11185502|NCT02498392|12374910|FG001|COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||67
11185503|NCT02498392|12374909|FG000|NOT COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||6
11185504|NCT02498392|12374910|FG001|NOT COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||10
11185505|NCT02478775|12374921|FG000|STARTED|Overall Study||6
11185506|NCT02478775|12374922|FG001|STARTED|Overall Study||27
11185507|NCT02478775|12374923|FG002|STARTED|Overall Study||27
11185508|NCT02478775|12374921|FG000|COMPLETED|Overall Study||6
11185509|NCT02478775|12374922|FG001|COMPLETED|Overall Study||27
11185510|NCT02478775|12374923|FG002|COMPLETED|Overall Study||27
11185511|NCT02478775|12374921|FG000|NOT COMPLETED|Overall Study||0
11185512|NCT02478775|12374922|FG001|NOT COMPLETED|Overall Study||0
11185513|NCT02478775|12374923|FG002|NOT COMPLETED|Overall Study||0
11185514|NCT01899729|12374935|FG000|STARTED|Overall Study||9
11185515|NCT01899729|12374936|FG001|STARTED|Overall Study||9
11185516|NCT01899729|12374937|FG002|STARTED|Overall Study||8
11185517|NCT01899729|12374938|FG003|STARTED|Overall Study||9
11185518|NCT01899729|12374939|FG004|STARTED|Overall Study||11
11185519|NCT01899729|12374935|FG000|COMPLETED|Overall Study||7
11185520|NCT01899729|12374936|FG001|COMPLETED|Overall Study||7
11026903|NCT00830869|12205482|FG002|NOT COMPLETED|Period 2: Part 2||0
11026904|NCT00830869|12205483|FG003|NOT COMPLETED|Period 2: Part 2||0
11026905|NCT00830869|12205484|FG004|NOT COMPLETED|Period 2: Part 2||0
11026906|NCT00830869|12205485|FG005|NOT COMPLETED|Period 2: Part 2||0
11185521|NCT01899729|12374937|FG002|COMPLETED|Overall Study||6
11185522|NCT01899729|12374938|FG003|COMPLETED|Overall Study||9
11185523|NCT01899729|12374939|FG004|COMPLETED|Overall Study||9
11185524|NCT01899729|12374935|FG000|NOT COMPLETED|Overall Study||2
11185525|NCT01899729|12374936|FG001|NOT COMPLETED|Overall Study||2
11185526|NCT01899729|12374937|FG002|NOT COMPLETED|Overall Study||2
11185527|NCT01899729|12374938|FG003|NOT COMPLETED|Overall Study||0
11185528|NCT01899729|12374939|FG004|NOT COMPLETED|Overall Study||2
11185529|NCT01784848|12374953|FG000|STARTED|Overall Study||50
11185530|NCT01784848|12374954|FG001|STARTED|Overall Study||50
11185531|NCT01784848|12374953|FG000|COMPLETED|Overall Study||49
11185532|NCT01784848|12374954|FG001|COMPLETED|Overall Study||47
11185533|NCT01784848|12374953|FG000|NOT COMPLETED|Overall Study||1
11185534|NCT01784848|12374954|FG001|NOT COMPLETED|Overall Study||3
11185535|NCT01648205|12374960|FG000|STARTED|Placebo||25
11185536|NCT01648205|12374960|FG000|COMPLETED|Placebo||21
11185537|NCT01648205|12374960|FG000|NOT COMPLETED|Placebo||4
11185538|NCT01648205|12374960|FG000|STARTED|Ranolazine||23
11185539|NCT01648205|12374960|FG000|COMPLETED|Ranolazine||18
11185540|NCT01648205|12374960|FG000|NOT COMPLETED|Ranolazine||5
11185541|NCT01312922|12374971|FG000|STARTED|Overall Study||185
11185542|NCT01312922|12374972|FG001|STARTED|Overall Study||185
11185543|NCT01312922|12374973|FG002|STARTED|Overall Study||185
11185544|NCT01312922|12374971|FG000|COMPLETED|Overall Study||117
11185545|NCT01312922|12374972|FG001|COMPLETED|Overall Study||131
11185546|NCT01312922|12374973|FG002|COMPLETED|Overall Study||135
11185547|NCT01312922|12374971|FG000|NOT COMPLETED|Overall Study||68
11185548|NCT01312922|12374972|FG001|NOT COMPLETED|Overall Study||54
11185549|NCT01312922|12374973|FG002|NOT COMPLETED|Overall Study||50
11185550|NCT00915681|12374981|FG000|STARTED|Overall Study||148
11185551|NCT00915681|12374981|FG000|COMPLETED|Overall Study||102
11185552|NCT00915681|12374981|FG000|NOT COMPLETED|Overall Study||46
11185553|NCT00145158|12374987|FG000|STARTED|Overall Study||16
11185554|NCT00145158|12374988|FG001|STARTED|Overall Study||7
11185555|NCT00145158|12374987|FG000|COMPLETED|Overall Study||14
11185556|NCT00145158|12374988|FG001|COMPLETED|Overall Study||4
11185557|NCT00145158|12374987|FG000|NOT COMPLETED|Overall Study||2
11026907|NCT00830869|12205486|FG006|NOT COMPLETED|Period 2: Part 2||0
11185558|NCT00145158|12374988|FG001|NOT COMPLETED|Overall Study||3
11185559|NCT01732809|12374997|FG000|STARTED|Overall Study||9
11185560|NCT01732809|12374998|FG001|STARTED|Overall Study||10
11185561|NCT01732809|12374997|FG000|COMPLETED|Overall Study||9
11185562|NCT01732809|12374998|FG001|COMPLETED|Overall Study||9
11185563|NCT01732809|12374997|FG000|NOT COMPLETED|Overall Study||0
11185564|NCT01732809|12374998|FG001|NOT COMPLETED|Overall Study||1
11185565|NCT01732822|12375006|FG000|STARTED|Overall Study||6930
11185566|NCT01732822|12375007|FG001|STARTED|Overall Study||6955
11185567|NCT01732822|12375006|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
11185568|NCT01732822|12375007|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
11185569|NCT01732822|12375006|FG000|NOT COMPLETED|Overall Study||123
11185570|NCT01732822|12375007|FG001|NOT COMPLETED|Overall Study||113
11185571|NCT01732835|12375035|FG000|STARTED|6-month Primary Endpoint||68
11185572|NCT01732835|12375035|FG000|COMPLETED|6-month Primary Endpoint||44
11185573|NCT01732835|12375035|FG000|NOT COMPLETED|6-month Primary Endpoint||24
11185574|NCT01732835|12375035|FG000|STARTED|2-year Extended Follow-up||44
11185575|NCT01732835|12375035|FG000|COMPLETED|2-year Extended Follow-up||39
11185576|NCT01732835|12375035|FG000|NOT COMPLETED|2-year Extended Follow-up||5
11185577|NCT01732874|12375041|FG000|STARTED|Overall Study||16
11185578|NCT01732874|12375042|FG001|STARTED|Overall Study||11
11185579|NCT01732874|12375041|FG000|COMPLETED|Overall Study||8
11185580|NCT01732874|12375042|FG001|COMPLETED|Overall Study||8
11185581|NCT01732874|12375041|FG000|NOT COMPLETED|Overall Study||8
11185582|NCT01732874|12375042|FG001|NOT COMPLETED|Overall Study||3
11185583|NCT01733056|12375051|FG000|STARTED|Overall Study||21
11185584|NCT01733056|12375052|FG001|STARTED|Overall Study||10
11185585|NCT01733056|12375053|FG002|STARTED|Overall Study||12
11185586|NCT01733056|12375051|FG000|COMPLETED|Overall Study||21
11185587|NCT01733056|12375052|FG001|COMPLETED|Overall Study||10
11185588|NCT01733056|12375053|FG002|COMPLETED|Overall Study||12
11185589|NCT01733056|12375051|FG000|NOT COMPLETED|Overall Study||0
11185590|NCT01733056|12375052|FG001|NOT COMPLETED|Overall Study||0
11185591|NCT01733056|12375053|FG002|NOT COMPLETED|Overall Study||0
11185592|NCT01733069|12375066|FG000|STARTED|Overall Study||264
11185593|NCT01733069|12375067|FG001|STARTED|Overall Study||1598
11185594|NCT01733069|12375066|FG000|COMPLETED|Overall Study||264
11185595|NCT01733069|12375067|FG001|COMPLETED|Overall Study||1598
11185596|NCT01733069|12375066|FG000|NOT COMPLETED|Overall Study||0
11185597|NCT01733069|12375067|FG001|NOT COMPLETED|Overall Study||0
11185598|NCT01733121|12375075|FG000|STARTED|Double-Blind Period (Week 0 to 6)||51
11185599|NCT01733121|12375076|FG001|STARTED|Double-Blind Period (Week 0 to 6)||51
11185600|NCT01733121|12375075|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||44
11185601|NCT01733121|12375076|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||46
11185602|NCT01733121|12375075|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
11185603|NCT01733121|12375076|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
11185604|NCT01733121|12375075|FG000|STARTED|Follow-Up Period (Week 6 to 8)||44
11185605|NCT01733121|12375076|FG001|STARTED|Follow-Up Period (Week 6 to 8)||46
11185606|NCT01733121|12375075|FG000|COMPLETED|Follow-Up Period (Week 6 to 8)||44
11185607|NCT01733121|12375076|FG001|COMPLETED|Follow-Up Period (Week 6 to 8)||46
11185608|NCT01733121|12375075|FG000|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
11185609|NCT01733121|12375076|FG001|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
11185610|NCT01733186|12375086|FG000|STARTED|Overall Study||6
11185611|NCT01733186|12375087|FG001|STARTED|Overall Study||6
11185612|NCT01733186|12375086|FG000|COMPLETED|Overall Study||6
11185613|NCT01733186|12375087|FG001|COMPLETED|Overall Study||6
11185614|NCT01733186|12375086|FG000|NOT COMPLETED|Overall Study||0
11185615|NCT01733186|12375087|FG001|NOT COMPLETED|Overall Study||0
11185616|NCT01733212|12375095|FG000|STARTED|Overall Study||116
11185617|NCT01733212|12375096|FG001|STARTED|Overall Study||123
11185618|NCT01733212|12375095|FG000|COMPLETED|Overall Study||116
11185619|NCT01733212|12375096|FG001|COMPLETED|Overall Study||123
11185620|NCT01733212|12375095|FG000|NOT COMPLETED|Overall Study||0
11185621|NCT01733212|12375096|FG001|NOT COMPLETED|Overall Study||0
11185622|NCT01733238|12375102|FG000|STARTED|Overall Study||13
11185623|NCT01733238|12375102|FG000|COMPLETED|Overall Study|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|8
11185624|NCT01733238|12375102|FG000|NOT COMPLETED|Overall Study||5
11185625|NCT01733277|12375108|FG000|STARTED|Overall Study||25
11185626|NCT01733277|12375109|FG001|STARTED|Overall Study||25
11185627|NCT01733277|12375108|FG000|COMPLETED|Overall Study||25
11185628|NCT01733277|12375109|FG001|COMPLETED|Overall Study||25
11185629|NCT01733277|12375108|FG000|NOT COMPLETED|Overall Study||0
11185630|NCT01733277|12375109|FG001|NOT COMPLETED|Overall Study||0
11185631|NCT01733316|12375115|FG000|STARTED|Cystagon® Phase||41
11185632|NCT01733316|12375115|FG000|COMPLETED|Cystagon® Phase||41
11185633|NCT01733316|12375115|FG000|NOT COMPLETED|Cystagon® Phase||0
11185634|NCT01733316|12375115|FG000|STARTED|RP103 Phase||41
11185635|NCT01733316|12375115|FG000|COMPLETED|RP103 Phase||40
11185636|NCT01733316|12375115|FG000|NOT COMPLETED|RP103 Phase||1
11185637|NCT01733316|12375115|FG000|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
11185638|NCT01733316|12375115|FG000|COMPLETED|Long Term Extension Phase||33
11185639|NCT01733316|12375115|FG000|NOT COMPLETED|Long Term Extension Phase||5
11185640|NCT01733329|12375128|FG000|STARTED|Overall Study||62
11185641|NCT01733329|12375129|FG001|STARTED|Overall Study||61
11185642|NCT01733329|12375128|FG000|COMPLETED|Overall Study||60
11185643|NCT01733329|12375129|FG001|COMPLETED|Overall Study||60
11185644|NCT01733329|12375128|FG000|NOT COMPLETED|Overall Study||2
11185645|NCT01733329|12375129|FG001|NOT COMPLETED|Overall Study||1
11185646|NCT01733368|12375135|FG000|STARTED|Overall Study||198
11185647|NCT01733368|12375135|FG000|COMPLETED|Overall Study||167
11185648|NCT01733368|12375135|FG000|NOT COMPLETED|Overall Study||31
11185649|NCT01733407|12375143|FG000|STARTED|Overall Study||9
11185650|NCT01733407|12375144|FG001|STARTED|Overall Study||9
11185651|NCT01733407|12375143|FG000|COMPLETED|Overall Study||7
11185652|NCT01733407|12375144|FG001|COMPLETED|Overall Study||9
11185653|NCT01733407|12375143|FG000|NOT COMPLETED|Overall Study||2
11185654|NCT01733407|12375144|FG001|NOT COMPLETED|Overall Study||0
11185655|NCT01733472|12375152|FG000|STARTED|Overall Study||60
11185656|NCT01733472|12375153|FG001|STARTED|Overall Study||60
11185657|NCT01733472|12375152|FG000|COMPLETED|Overall Study||60
11185658|NCT01733472|12375153|FG001|COMPLETED|Overall Study||60
11185659|NCT01733472|12375152|FG000|NOT COMPLETED|Overall Study||0
11185660|NCT01733472|12375153|FG001|NOT COMPLETED|Overall Study||0
11185661|NCT01733628|12375160|FG000|STARTED|Overall Study||143
11185662|NCT01733628|12375160|FG000|COMPLETED|Overall Study||143
11185663|NCT01733628|12375160|FG000|NOT COMPLETED|Overall Study||0
11185664|NCT01733680|12375166|FG000|STARTED|Overall Study||2
11185665|NCT01733680|12375167|FG001|STARTED|Overall Study||1
11185666|NCT01733680|12375166|FG000|COMPLETED|Overall Study||2
11185667|NCT01733680|12375167|FG001|COMPLETED|Overall Study||0
11185668|NCT01733680|12375166|FG000|NOT COMPLETED|Overall Study||0
11185669|NCT01733680|12375167|FG001|NOT COMPLETED|Overall Study||1
11185670|NCT01733732|12375179|FG000|STARTED|Overall Study||27
11185671|NCT01733732|12375180|FG001|STARTED|Overall Study||27
11185672|NCT01733732|12375179|FG000|COMPLETED|Overall Study||25
11185673|NCT01733732|12375180|FG001|COMPLETED|Overall Study||27
11185674|NCT01733732|12375179|FG000|NOT COMPLETED|Overall Study||2
11185675|NCT01733732|12375180|FG001|NOT COMPLETED|Overall Study||0
11185676|NCT01733745|12375198|FG000|STARTED|Overall Study||13
11185677|NCT01733745|12375199|FG001|STARTED|Overall Study||13
11185678|NCT01733745|12375198|FG000|COMPLETED|Overall Study||13
11185679|NCT01733745|12375199|FG001|COMPLETED|Overall Study||13
11185680|NCT01733745|12375198|FG000|NOT COMPLETED|Overall Study||0
11185681|NCT01733745|12375199|FG001|NOT COMPLETED|Overall Study||0
11185682|NCT01733758|12375209|FG000|STARTED|Overall Study||77
11185683|NCT01733758|12375210|FG001|STARTED|Overall Study||160
11185684|NCT01733758|12375211|FG002|STARTED|Overall Study||150
11185685|NCT01733758|12375212|FG003|STARTED|Overall Study||103
11185686|NCT01733758|12375209|FG000|COMPLETED|Overall Study||62
11185687|NCT01733758|12375210|FG001|COMPLETED|Overall Study||148
11185688|NCT01733758|12375211|FG002|COMPLETED|Overall Study||135
11185689|NCT01733758|12375212|FG003|COMPLETED|Overall Study||95
11185690|NCT01733758|12375209|FG000|NOT COMPLETED|Overall Study||15
11185691|NCT01733758|12375210|FG001|NOT COMPLETED|Overall Study||12
11185692|NCT01733758|12375211|FG002|NOT COMPLETED|Overall Study||15
11185693|NCT01733758|12375212|FG003|NOT COMPLETED|Overall Study||8
11185694|NCT01733953|12375226|FG000|STARTED|Overall Study||14
11185695|NCT01733953|12375227|FG001|STARTED|Overall Study||13
11185696|NCT01733953|12375226|FG000|COMPLETED|Overall Study||9
11185697|NCT01733953|12375227|FG001|COMPLETED|Overall Study||6
11185698|NCT01733953|12375226|FG000|NOT COMPLETED|Overall Study||5
11185699|NCT01733953|12375227|FG001|NOT COMPLETED|Overall Study||7
11185700|NCT01734161|12375235|FG000|STARTED|Overall Study||61
11185701|NCT01734161|12375236|FG001|STARTED|Overall Study||61
11185702|NCT01734161|12375235|FG000|COMPLETED|Overall Study||55
11185703|NCT01734161|12375236|FG001|COMPLETED|Overall Study||53
11185704|NCT01734161|12375235|FG000|NOT COMPLETED|Overall Study||6
11185705|NCT01734161|12375236|FG001|NOT COMPLETED|Overall Study||8
11185706|NCT01734239|12375244|FG000|STARTED|Overall Study||52
11185707|NCT01734239|12375245|FG001|STARTED|Overall Study||50
11185708|NCT01734239|12375244|FG000|COMPLETED|Overall Study||52
11185709|NCT01734239|12375245|FG001|COMPLETED|Overall Study||50
11185710|NCT01734239|12375244|FG000|NOT COMPLETED|Overall Study||0
11185711|NCT01734239|12375245|FG001|NOT COMPLETED|Overall Study||0
11185712|NCT01734317|12375250|FG000|STARTED|Overall Study||10
11185713|NCT01734317|12375250|FG000|COMPLETED|Overall Study||10
11185714|NCT01734317|12375250|FG000|NOT COMPLETED|Overall Study||0
11185715|NCT01734382|12375258|FG000|STARTED|Part 1||19
11185716|NCT01734382|12375259|FG001|STARTED|Part 1||0
11185717|NCT01734382|12375260|FG002|STARTED|Part 1||0
11185718|NCT01734382|12375258|FG000|COMPLETED|Part 1||17
11185719|NCT01734382|12375259|FG001|COMPLETED|Part 1||0
11185720|NCT01734382|12375260|FG002|COMPLETED|Part 1||0
11185721|NCT01734382|12375258|FG000|NOT COMPLETED|Part 1||2
11185722|NCT01734382|12375259|FG001|NOT COMPLETED|Part 1||0
11185723|NCT01734382|12375260|FG002|NOT COMPLETED|Part 1||0
11185724|NCT01734382|12375258|FG000|STARTED|Part 2||0
11185725|NCT01734382|12375259|FG001|STARTED|Part 2||7
11185726|NCT01734382|12375260|FG002|STARTED|Part 2||15
11185727|NCT01734382|12375258|FG000|COMPLETED|Part 2||0
11185728|NCT01734382|12375259|FG001|COMPLETED|Part 2||5
11185729|NCT01734382|12375260|FG002|COMPLETED|Part 2||8
11185730|NCT01734382|12375258|FG000|NOT COMPLETED|Part 2||0
11185731|NCT01734382|12375259|FG001|NOT COMPLETED|Part 2||2
11185732|NCT01734382|12375260|FG002|NOT COMPLETED|Part 2||7
11185733|NCT01734395|12375272|FG000|STARTED|Overall Study||1882
11185734|NCT01734395|12375272|FG000|COMPLETED|Overall Study||1472
11185735|NCT01734395|12375272|FG000|NOT COMPLETED|Overall Study||410
11185736|NCT01734434|12375280|FG000|STARTED|Overall Study||500
11185737|NCT01734434|12375281|FG001|STARTED|Overall Study||500
11185738|NCT01734434|12375282|FG002|STARTED|Overall Study||1992
11185739|NCT01734434|12375283|FG003|STARTED|Overall Study||251
11185740|NCT01734434|12375280|FG000|COMPLETED|Overall Study||490
11185741|NCT01734434|12375281|FG001|COMPLETED|Overall Study||488
11185742|NCT01734434|12375282|FG002|COMPLETED|Overall Study||1863
11185743|NCT01734434|12375283|FG003|COMPLETED|Overall Study||228
11185744|NCT01734434|12375280|FG000|NOT COMPLETED|Overall Study||10
11185745|NCT01734434|12375281|FG001|NOT COMPLETED|Overall Study||12
11185746|NCT01734434|12375282|FG002|NOT COMPLETED|Overall Study||129
11185747|NCT01734434|12375283|FG003|NOT COMPLETED|Overall Study||23
11185748|NCT01734525|12375301|FG000|STARTED|Overall Study||85
11185749|NCT01734525|12375301|FG000|COMPLETED|Overall Study||85
11185750|NCT01734525|12375301|FG000|NOT COMPLETED|Overall Study||0
11185751|NCT01734551|12375307|FG000|STARTED|Overall Study||15
11185752|NCT01734551|12375308|FG001|STARTED|Overall Study||16
11185753|NCT01734551|12375307|FG000|COMPLETED|Overall Study||15
11185754|NCT01734551|12375308|FG001|COMPLETED|Overall Study||16
11185755|NCT01734551|12375307|FG000|NOT COMPLETED|Overall Study||0
11185756|NCT01734551|12375308|FG001|NOT COMPLETED|Overall Study||0
11185757|NCT01734655|12375314|FG000|STARTED|Overall Study||40
11185758|NCT01734655|12375314|FG000|COMPLETED|Overall Study||40
11185759|NCT01734655|12375314|FG000|NOT COMPLETED|Overall Study||0
11185760|NCT01734746|12375321|FG000|STARTED|Overall Study||22
11185761|NCT01734746|12375321|FG000|COMPLETED|Overall Study||21
11185762|NCT01734746|12375321|FG000|NOT COMPLETED|Overall Study||1
11185763|NCT01734772|12375328|FG000|STARTED|Overall Study||24
11185764|NCT01734772|12375329|FG001|STARTED|Overall Study||24
11185765|NCT01734772|12375328|FG000|COMPLETED|Overall Study||23
11185766|NCT01734772|12375329|FG001|COMPLETED|Overall Study||21
11185767|NCT01734772|12375328|FG000|NOT COMPLETED|Overall Study||1
11185768|NCT01734772|12375329|FG001|NOT COMPLETED|Overall Study||3
11185769|NCT01734785|12375344|FG000|STARTED|Open-Label Period||0
11185770|NCT01734785|12375345|FG001|STARTED|Open-Label Period||0
11185771|NCT01734785|12375346|FG002|STARTED|Open-Label Period||0
11185772|NCT01734785|12375347|FG003|STARTED|Open-Label Period||606
11185773|NCT01734785|12375344|FG000|COMPLETED|Open-Label Period||0
11185774|NCT01734785|12375345|FG001|COMPLETED|Open-Label Period||0
11185775|NCT01734785|12375346|FG002|COMPLETED|Open-Label Period||0
11185776|NCT01734785|12375347|FG003|COMPLETED|Open-Label Period||333
11185777|NCT01734785|12375344|FG000|NOT COMPLETED|Open-Label Period||0
11185778|NCT01734785|12375345|FG001|NOT COMPLETED|Open-Label Period||0
11185779|NCT01734785|12375346|FG002|NOT COMPLETED|Open-Label Period||0
11185780|NCT01734785|12375347|FG003|NOT COMPLETED|Open-Label Period||273
11185781|NCT01734785|12375344|FG000|STARTED|Double-Blind Period||111
11185782|NCT01734785|12375345|FG001|STARTED|Double-Blind Period||112
11185783|NCT01734785|12375346|FG002|STARTED|Double-Blind Period||110
11185784|NCT01734785|12375347|FG003|STARTED|Double-Blind Period||0
11185785|NCT01734785|12375344|FG000|COMPLETED|Double-Blind Period||106
11185786|NCT01734785|12375345|FG001|COMPLETED|Double-Blind Period||103
11185787|NCT01734785|12375346|FG002|COMPLETED|Double-Blind Period||105
11185788|NCT01734785|12375347|FG003|COMPLETED|Double-Blind Period||0
11185789|NCT01734785|12375344|FG000|NOT COMPLETED|Double-Blind Period||5
11185790|NCT01734785|12375345|FG001|NOT COMPLETED|Double-Blind Period||9
11185791|NCT01734785|12375346|FG002|NOT COMPLETED|Double-Blind Period||5
11185792|NCT01734785|12375347|FG003|NOT COMPLETED|Double-Blind Period||0
11185793|NCT01734811|12375358|FG000|STARTED|Overall Study||58
11185794|NCT01734811|12375359|FG001|STARTED|Overall Study||62
11185795|NCT01734811|12375358|FG000|COMPLETED|Overall Study||54
11185796|NCT01734811|12375359|FG001|COMPLETED|Overall Study||59
11185797|NCT01734811|12375358|FG000|NOT COMPLETED|Overall Study||4
11185798|NCT01734811|12375359|FG001|NOT COMPLETED|Overall Study||3
11185799|NCT01734850|12375368|FG000|STARTED|Overall Study||4
11185800|NCT01734850|12375369|FG001|STARTED|Overall Study||4
11185801|NCT01734850|12375370|FG002|STARTED|Overall Study||5
11185802|NCT01734850|12375368|FG000|COMPLETED|Overall Study||1
11185803|NCT01734850|12375369|FG001|COMPLETED|Overall Study||2
11185804|NCT01734850|12375370|FG002|COMPLETED|Overall Study||1
11185805|NCT01734850|12375368|FG000|NOT COMPLETED|Overall Study||3
11185806|NCT01734850|12375369|FG001|NOT COMPLETED|Overall Study||2
11185807|NCT01734850|12375370|FG002|NOT COMPLETED|Overall Study||4
11204575|NCT01854047|12395150|FG000|Treated|Overall Study||158
11204576|NCT01854047|12395151|FG001|Treated|Overall Study||156
11204577|NCT01854047|12395152|FG002|Treated|Overall Study||148
11204578|NCT01854047|12395153|FG003|Treated|Overall Study||157
11204579|NCT01854047|12395154|FG004|Treated|Overall Study||150
11204580|NCT01854047|12395150|FG000|Completed 12-week Study Treatment|Overall Study||153
11204581|NCT01854047|12395151|FG001|Completed 12-week Study Treatment|Overall Study||149
11204582|NCT01854047|12395152|FG002|Completed 12-week Study Treatment|Overall Study||141
11204583|NCT01854047|12395153|FG003|Completed 12-week Study Treatment|Overall Study||146
11204584|NCT01854047|12395154|FG004|Completed 12-week Study Treatment|Overall Study||143
11204585|NCT01854047|12395150|FG000|COMPLETED|Overall Study||146
11204586|NCT01854047|12395151|FG001|COMPLETED|Overall Study||149
11204587|NCT01854047|12395152|FG002|COMPLETED|Overall Study||137
11204588|NCT01854047|12395153|FG003|COMPLETED|Overall Study||142
11204589|NCT01854047|12395154|FG004|COMPLETED|Overall Study||135
11204590|NCT01854047|12395150|FG000|NOT COMPLETED|Overall Study||12
11204591|NCT01854047|12395151|FG001|NOT COMPLETED|Overall Study||8
11204592|NCT01854047|12395152|FG002|NOT COMPLETED|Overall Study||13
11204593|NCT01854047|12395153|FG003|NOT COMPLETED|Overall Study||15
11204594|NCT01854047|12395154|FG004|NOT COMPLETED|Overall Study||19
11204595|NCT01854138|12395168|FG000|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
11204596|NCT01854138|12395169|FG001|STARTED|Overall Study||248
11204597|NCT01854138|12395168|FG000|COMPLETED|Overall Study||400
11204598|NCT01854138|12395169|FG001|COMPLETED|Overall Study||196
11204599|NCT01854138|12395168|FG000|NOT COMPLETED|Overall Study||0
11204600|NCT01854138|12395169|FG001|NOT COMPLETED|Overall Study||52
11204601|NCT01854177|12395176|FG000|STARTED|Overall Study||10
11204602|NCT01854177|12395176|FG000|COMPLETED|Overall Study||10
11204603|NCT01854177|12395176|FG000|NOT COMPLETED|Overall Study||0
11204604|NCT01854242|12395182|FG000|STARTED|Overall Study||50
11204605|NCT01854242|12395182|FG000|COMPLETED|Overall Study||50
11204606|NCT01854242|12395182|FG000|NOT COMPLETED|Overall Study||0
11204607|NCT01854281|12395190|FG000|STARTED|Overall Study||15
11204608|NCT01854281|12395191|FG001|STARTED|Overall Study||19
11204609|NCT01854281|12395192|FG002|STARTED|Overall Study||5
11204610|NCT01854281|12395193|FG003|STARTED|Overall Study||8
11185808|NCT01734889|12375381|FG000|STARTED|Overall Study||18
11185809|NCT01734889|12375381|FG000|COMPLETED|Overall Study||18
11185810|NCT01734889|12375381|FG000|NOT COMPLETED|Overall Study||0
11185811|NCT01734902|12375388|FG000|STARTED|Overall Study||14
11185812|NCT01734902|12375389|FG001|STARTED|Overall Study||16
11185813|NCT01734902|12375388|FG000|COMPLETED|Overall Study||14
11185814|NCT01734902|12375389|FG001|COMPLETED|Overall Study||14
11185815|NCT01734902|12375388|FG000|NOT COMPLETED|Overall Study||0
11185816|NCT01734902|12375389|FG001|NOT COMPLETED|Overall Study||2
11185817|NCT01734993|12375395|FG000|STARTED|Overall Study||11
11185818|NCT01734993|12375395|FG000|COMPLETED|Overall Study||9
11185819|NCT01734993|12375395|FG000|NOT COMPLETED|Overall Study||2
11185820|NCT01735175|12375402|FG000|STARTED|Overall Study||159
11185821|NCT01735175|12375403|FG001|STARTED|Overall Study||157
11185822|NCT01735175|12375402|FG000|Completed All Cycles|Overall Study||141
11185823|NCT01735175|12375403|FG001|Completed All Cycles|Overall Study||150
11185824|NCT01735175|12375402|FG000|Completed All Treatments as Planned|Overall Study||140
11185825|NCT01735175|12375403|FG001|Completed All Treatments as Planned|Overall Study||150
11185826|NCT01735175|12375402|FG000|Completed the 6-month SFU Visit|Overall Study||120
11185827|NCT01735175|12375403|FG001|Completed the 6-month SFU Visit|Overall Study||138
11185828|NCT01735175|12375402|FG000|COMPLETED|Overall Study||130
11185829|NCT01735175|12375403|FG001|COMPLETED|Overall Study||144
11185830|NCT01735175|12375402|FG000|NOT COMPLETED|Overall Study||29
11185831|NCT01735175|12375403|FG001|NOT COMPLETED|Overall Study||13
11185832|NCT01735201|12375417|FG000|STARTED|Overall Study||45
11185833|NCT01735201|12375418|FG001|STARTED|Overall Study||44
11185834|NCT01735201|12375419|FG002|STARTED|Overall Study||44
11185835|NCT01735201|12375420|FG003|STARTED|Overall Study||44
11185836|NCT01735201|12375421|FG004|STARTED|Overall Study||45
11185837|NCT01735201|12375422|FG005|STARTED|Overall Study||45
11185838|NCT01735201|12375423|FG006|STARTED|Overall Study||45
11185839|NCT01735201|12375424|FG007|STARTED|Overall Study||44
11185840|NCT01735201|12375417|FG000|COMPLETED|Overall Study||42
11185841|NCT01735201|12375418|FG001|COMPLETED|Overall Study||43
11185842|NCT01735201|12375419|FG002|COMPLETED|Overall Study||44
11185843|NCT01735201|12375420|FG003|COMPLETED|Overall Study||42
11185844|NCT01735201|12375421|FG004|COMPLETED|Overall Study||44
11185845|NCT01735201|12375422|FG005|COMPLETED|Overall Study||40
11185846|NCT01735201|12375423|FG006|COMPLETED|Overall Study||42
11185847|NCT01735201|12375424|FG007|COMPLETED|Overall Study||42
11185848|NCT01735201|12375417|FG000|NOT COMPLETED|Overall Study||3
11185849|NCT01735201|12375418|FG001|NOT COMPLETED|Overall Study||1
11185850|NCT01735201|12375419|FG002|NOT COMPLETED|Overall Study||0
11185851|NCT01735201|12375420|FG003|NOT COMPLETED|Overall Study||2
11185852|NCT01735201|12375421|FG004|NOT COMPLETED|Overall Study||1
11185853|NCT01735201|12375422|FG005|NOT COMPLETED|Overall Study||5
11185854|NCT01735201|12375423|FG006|NOT COMPLETED|Overall Study||3
11185855|NCT01735201|12375424|FG007|NOT COMPLETED|Overall Study||2
11185856|NCT01735214|12375442|FG000|STARTED|Overall Study||358
11185857|NCT01735214|12375442|FG000|COMPLETED|Overall Study||358
11185858|NCT01735214|12375442|FG000|NOT COMPLETED|Overall Study||0
11185859|NCT01735279|12375448|FG000|STARTED|Overall Study||29
11185860|NCT01735279|12375449|FG001|STARTED|Overall Study||29
11185861|NCT01735279|12375448|FG000|COMPLETED|Overall Study||18
11185862|NCT01735279|12375449|FG001|COMPLETED|Overall Study||21
11185863|NCT01735279|12375448|FG000|NOT COMPLETED|Overall Study||11
11185864|NCT01735279|12375449|FG001|NOT COMPLETED|Overall Study||8
11185865|NCT01735396|12375455|FG000|STARTED|Overall Study||11
11185866|NCT01735396|12375455|FG000|COMPLETED|Overall Study||10
11185867|NCT01735396|12375455|FG000|NOT COMPLETED|Overall Study||1
11185868|NCT01735617|12375459|FG000|STARTED|Overall Study||16
11185869|NCT01735617|12375459|FG000|COMPLETED|Overall Study||16
11185870|NCT01735617|12375459|FG000|NOT COMPLETED|Overall Study||0
11185871|NCT01735630|12375468|FG000|STARTED|Overall Study||175
11185872|NCT01735630|12375469|FG001|STARTED|Overall Study||175
11185873|NCT01735630|12375468|FG000|COMPLETED|Overall Study||157
11185874|NCT01735630|12375469|FG001|COMPLETED|Overall Study||157
11185875|NCT01735630|12375468|FG000|NOT COMPLETED|Overall Study||18
11185876|NCT01735630|12375469|FG001|NOT COMPLETED|Overall Study||18
11185877|NCT01735877|12375477|FG000|STARTED|Overall Study||27
11185878|NCT01735877|12375478|FG001|STARTED|Overall Study||21
11185879|NCT01735877|12375477|FG000|COMPLETED|Overall Study||26
11185880|NCT01735877|12375478|FG001|COMPLETED|Overall Study||21
11185881|NCT01735877|12375477|FG000|NOT COMPLETED|Overall Study||1
11185882|NCT01735877|12375478|FG001|NOT COMPLETED|Overall Study||0
11185883|NCT01735916|12375487|FG000|STARTED|Overall Study||18
11185884|NCT01735916|12375488|FG001|STARTED|Overall Study||19
11185885|NCT01735916|12375489|FG002|STARTED|Overall Study||7
11026908|NCT00830869|12205487|FG007|NOT COMPLETED|Period 2: Part 2||20
11026909|NCT00830869|12205488|FG008|NOT COMPLETED|Period 2: Part 2||22
11026910|NCT00830869|12205489|FG009|NOT COMPLETED|Period 2: Part 2||20
11026911|NCT00830869|12205490|FG010|NOT COMPLETED|Period 2: Part 2||11
11026912|NCT00830869|12205491|FG011|NOT COMPLETED|Period 2: Part 2||20
11026913|NCT00830947|12205520|FG000|STARTED|Overall Study||23
11185886|NCT01735916|12375487|FG000|COMPLETED|Overall Study||0
11185887|NCT01735916|12375488|FG001|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
11185888|NCT01735916|12375489|FG002|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
11185889|NCT01735916|12375487|FG000|NOT COMPLETED|Overall Study||18
11185890|NCT01735916|12375488|FG001|NOT COMPLETED|Overall Study||19
11185891|NCT01735916|12375489|FG002|NOT COMPLETED|Overall Study||7
11026914|NCT00830947|12205521|FG001|STARTED|Overall Study||22
11026915|NCT00830947|12205520|FG000|COMPLETED|Overall Study||19
11026916|NCT00830947|12205521|FG001|COMPLETED|Overall Study||18
11185892|NCT01735981|12375498|FG000|STARTED|Allocated||13
11185893|NCT01735981|12375499|FG001|STARTED|Allocated||11
11185894|NCT01735981|12375498|FG000|COMPLETED|Allocated||11
11185895|NCT01735981|12375499|FG001|COMPLETED|Allocated||8
11185896|NCT01735981|12375498|FG000|NOT COMPLETED|Allocated||2
11185897|NCT01735981|12375499|FG001|NOT COMPLETED|Allocated||3
11185898|NCT01735981|12375498|FG000|STARTED|Crossed Over||11
11185899|NCT01735981|12375499|FG001|STARTED|Crossed Over|N=1 lost to cross over before DDR intervention|7
11185900|NCT01735981|12375498|FG000|COMPLETED|Crossed Over||11
11185901|NCT01735981|12375499|FG001|COMPLETED|Crossed Over||7
11185902|NCT01735981|12375498|FG000|NOT COMPLETED|Crossed Over||0
11185903|NCT01735981|12375499|FG001|NOT COMPLETED|Crossed Over||0
11185904|NCT01735994|12375509|FG000|STARTED|Overall Study||263
11185905|NCT01735994|12375510|FG001|STARTED|Overall Study||218
11185906|NCT01735994|12375509|FG000|Post Intervention (3 Weeks)|Overall Study||239
11185907|NCT01735994|12375510|FG001|Post Intervention (3 Weeks)|Overall Study||198
11185908|NCT01735994|12375509|FG000|Follow-Up #1 (6 Months)|Overall Study||213
11185909|NCT01735994|12375510|FG001|Follow-Up #1 (6 Months)|Overall Study||163
11185910|NCT01735994|12375509|FG000|Follow-Up #2 (12 Months)|Overall Study||212
11185911|NCT01735994|12375510|FG001|Follow-Up #2 (12 Months)|Overall Study||174
11185912|NCT01735994|12375509|FG000|COMPLETED|Overall Study||200
11185913|NCT01735994|12375510|FG001|COMPLETED|Overall Study||152
11185914|NCT01735994|12375509|FG000|NOT COMPLETED|Overall Study||63
11185915|NCT01735994|12375510|FG001|NOT COMPLETED|Overall Study||66
11185916|NCT01736085|12375522|FG000|STARTED|Overall Study||529
11185917|NCT01736085|12375523|FG001|STARTED|Overall Study||530
11185918|NCT01736085|12375524|FG002|STARTED|Overall Study||793
11185919|NCT01736085|12375525|FG003|STARTED|Overall Study||530
11185920|NCT01736085|12375526|FG004|STARTED|Overall Study||530
11185921|NCT01736085|12375527|FG005|STARTED|Overall Study||794
11185922|NCT01736085|12375522|FG000|COMPLETED|Overall Study||529
11185923|NCT01736085|12375523|FG001|COMPLETED|Overall Study||530
11185924|NCT01736085|12375524|FG002|COMPLETED|Overall Study||793
11185925|NCT01736085|12375525|FG003|COMPLETED|Overall Study||530
11185926|NCT01736085|12375526|FG004|COMPLETED|Overall Study||530
11185927|NCT01736085|12375527|FG005|COMPLETED|Overall Study||794
11185928|NCT01736085|12375522|FG000|NOT COMPLETED|Overall Study||0
11185929|NCT01736085|12375523|FG001|NOT COMPLETED|Overall Study||0
11185930|NCT01736085|12375524|FG002|NOT COMPLETED|Overall Study||0
11185931|NCT01736085|12375525|FG003|NOT COMPLETED|Overall Study||0
11185932|NCT01736085|12375526|FG004|NOT COMPLETED|Overall Study||0
11185933|NCT01736085|12375527|FG005|NOT COMPLETED|Overall Study||0
11185934|NCT01736124|12375540|FG000|STARTED|Baseline||90
11185935|NCT01736124|12375541|FG001|STARTED|Baseline||90
11185936|NCT01736124|12375540|FG000|COMPLETED|Baseline||90
11185937|NCT01736124|12375541|FG001|COMPLETED|Baseline||90
11185938|NCT01736124|12375540|FG000|NOT COMPLETED|Baseline||0
11185939|NCT01736124|12375541|FG001|NOT COMPLETED|Baseline||0
11185940|NCT01736124|12375540|FG000|STARTED|Post-intervention Assessment||90
11185941|NCT01736124|12375541|FG001|STARTED|Post-intervention Assessment||90
11185942|NCT01736124|12375540|FG000|COMPLETED|Post-intervention Assessment||59
11185943|NCT01736124|12375541|FG001|COMPLETED|Post-intervention Assessment||69
11185944|NCT01736124|12375540|FG000|NOT COMPLETED|Post-intervention Assessment||31
11185945|NCT01736124|12375541|FG001|NOT COMPLETED|Post-intervention Assessment||21
11185946|NCT01736124|12375540|FG000|STARTED|6 Mo. Post-Intervention Assessment|"Includes 3 who were temporarily away at Period 2 who did not permanently withdraw from the study."|62
11185947|NCT01736124|12375541|FG001|STARTED|6 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 2 but did not permanently withdraw."|70
11185948|NCT01736124|12375540|FG000|COMPLETED|6 Mo. Post-Intervention Assessment||57
11185949|NCT01736124|12375541|FG001|COMPLETED|6 Mo. Post-Intervention Assessment||58
11185950|NCT01736124|12375540|FG000|NOT COMPLETED|6 Mo. Post-Intervention Assessment||5
11185951|NCT01736124|12375541|FG001|NOT COMPLETED|6 Mo. Post-Intervention Assessment||12
11185952|NCT01736124|12375540|FG000|STARTED|12 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 3 but did not permanently withdraw."|58
11185953|NCT01736124|12375541|FG001|STARTED|12 Mo. Post-Intervention Assessment|"Includes 4 who were temporarily away at Period 3 but did not permanently withdraw."|62
11185954|NCT01736124|12375540|FG000|COMPLETED|12 Mo. Post-Intervention Assessment||46
11185955|NCT01736124|12375541|FG001|COMPLETED|12 Mo. Post-Intervention Assessment||50
11185956|NCT01736124|12375540|FG000|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
11185957|NCT01736124|12375541|FG001|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
11185958|NCT01736176|12375549|FG000|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
11185959|NCT01736176|12375549|FG000|Received LCIG|Overall Study||38
11185960|NCT01736176|12375549|FG000|COMPLETED|Overall Study||28
11185961|NCT01736176|12375549|FG000|NOT COMPLETED|Overall Study||11
11185962|NCT01736189|12375557|FG000|STARTED|Overall Study||346
11185963|NCT01736189|12375557|FG000|COMPLETED|Overall Study||300
11185964|NCT01736189|12375557|FG000|NOT COMPLETED|Overall Study||46
11185965|NCT01736215|12375561|FG000|STARTED|Overall Study||33
11185966|NCT01736215|12375561|FG000|Treated|Overall Study||25
11185967|NCT01736215|12375561|FG000|COMPLETED|Overall Study||19
11185968|NCT01736215|12375561|FG000|NOT COMPLETED|Overall Study||14
11185969|NCT01736241|12375572|FG000|STARTED|Overall Study||6
11185970|NCT01736241|12375573|FG001|STARTED|Overall Study||6
11185971|NCT01736241|12375574|FG002|STARTED|Overall Study||6
11185972|NCT01736241|12375575|FG003|STARTED|Overall Study||5
11185973|NCT01736241|12375576|FG004|STARTED|Overall Study||6
11185974|NCT01736241|12375577|FG005|STARTED|Overall Study||6
11185975|NCT01736241|12375578|FG006|STARTED|Overall Study||6
11185976|NCT01736241|12375572|FG000|Received at Least One Dose of Study Drug|Overall Study||6
11185977|NCT01736241|12375573|FG001|Received at Least One Dose of Study Drug|Overall Study||6
11185978|NCT01736241|12375574|FG002|Received at Least One Dose of Study Drug|Overall Study||6
11185979|NCT01736241|12375575|FG003|Received at Least One Dose of Study Drug|Overall Study||5
11185980|NCT01736241|12375576|FG004|Received at Least One Dose of Study Drug|Overall Study||6
11185981|NCT01736241|12375577|FG005|Received at Least One Dose of Study Drug|Overall Study||6
11185982|NCT01736241|12375578|FG006|Received at Least One Dose of Study Drug|Overall Study||6
11185983|NCT01736241|12375572|FG000|COMPLETED|Overall Study||6
11185984|NCT01736241|12375573|FG001|COMPLETED|Overall Study||6
11185985|NCT01736241|12375574|FG002|COMPLETED|Overall Study||6
11185986|NCT01736241|12375575|FG003|COMPLETED|Overall Study||5
11185987|NCT01736241|12375576|FG004|COMPLETED|Overall Study||6
11185988|NCT01736241|12375577|FG005|COMPLETED|Overall Study||6
11185989|NCT01736241|12375578|FG006|COMPLETED|Overall Study||6
11185990|NCT01736241|12375572|FG000|NOT COMPLETED|Overall Study||0
11185991|NCT01736241|12375573|FG001|NOT COMPLETED|Overall Study||0
11185992|NCT01736241|12375574|FG002|NOT COMPLETED|Overall Study||0
11185993|NCT01736241|12375575|FG003|NOT COMPLETED|Overall Study||0
11185994|NCT01736241|12375576|FG004|NOT COMPLETED|Overall Study||0
11185995|NCT01736241|12375577|FG005|NOT COMPLETED|Overall Study||0
11185996|NCT01736241|12375578|FG006|NOT COMPLETED|Overall Study||0
11185997|NCT01736254|12375595|FG000|STARTED|Period 1 (Day 1)||24
11185998|NCT01736254|12375595|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
11185999|NCT01736254|12375595|FG000|COMPLETED|Period 1 (Day 1)||24
11186000|NCT01736254|12375595|FG000|NOT COMPLETED|Period 1 (Day 1)||0
11186001|NCT01736254|12375595|FG000|STARTED|Period 2 (Days 2 to 12)||24
11186002|NCT01736254|12375595|FG000|COMPLETED|Period 2 (Days 2 to 12)||21
11186003|NCT01736254|12375595|FG000|NOT COMPLETED|Period 2 (Days 2 to 12)||3
11186004|NCT01736254|12375595|FG000|STARTED|Period 3 (Days 13 to 23)||21
11186005|NCT01736254|12375595|FG000|COMPLETED|Period 3 (Days 13 to 23)||20
11186006|NCT01736254|12375595|FG000|NOT COMPLETED|Period 3 (Days 13 to 23)||1
11186007|NCT01736267|12375603|FG000|STARTED|Overall Study||3
11186008|NCT01736267|12375603|FG000|COMPLETED|Overall Study||3
11186009|NCT01736267|12375603|FG000|NOT COMPLETED|Overall Study||0
11186010|NCT01736358|12375609|FG000|STARTED|Overall Study||25
11186011|NCT01736358|12375610|FG001|STARTED|Overall Study||25
11186012|NCT01736358|12375609|FG000|COMPLETED|Overall Study||20
11186013|NCT01736358|12375610|FG001|COMPLETED|Overall Study||23
11186014|NCT01736358|12375609|FG000|NOT COMPLETED|Overall Study||5
11186015|NCT01736358|12375610|FG001|NOT COMPLETED|Overall Study||2
11186016|NCT01736397|12375618|FG000|STARTED|Overall Study||75
11186017|NCT01736397|12375619|FG001|STARTED|Overall Study||74
11186018|NCT01736397|12375618|FG000|COMPLETED|Overall Study||61
11186019|NCT01736397|12375619|FG001|COMPLETED|Overall Study||50
11186020|NCT01736397|12375618|FG000|NOT COMPLETED|Overall Study||14
11186021|NCT01736397|12375619|FG001|NOT COMPLETED|Overall Study||24
11186022|NCT01736475|12375627|FG000|STARTED|Overall Study||121
11186023|NCT01736475|12375628|FG001|STARTED|Overall Study||17
11186024|NCT01736475|12375627|FG000|COMPLETED|Overall Study||109
11186025|NCT01736475|12375628|FG001|COMPLETED|Overall Study||17
11186026|NCT01736475|12375627|FG000|NOT COMPLETED|Overall Study||12
11186027|NCT01736475|12375628|FG001|NOT COMPLETED|Overall Study||0
11186028|NCT01736527|12375645|FG000|STARTED|Overall Study||12
11186029|NCT01736527|12375645|FG000|COMPLETED|Overall Study||12
11186030|NCT01736527|12375645|FG000|NOT COMPLETED|Overall Study||0
11186031|NCT01736540|12375649|FG000|STARTED|Overall Study||243
11186032|NCT01736540|12375649|FG000|COMPLETED|Overall Study||228
11186033|NCT01736540|12375649|FG000|NOT COMPLETED|Overall Study||15
11186034|NCT01736553|12375662|FG000|STARTED|Overall Study||26
11186035|NCT01736553|12375663|FG001|STARTED|Overall Study||27
11186036|NCT01736553|12375662|FG000|COMPLETED|Overall Study||7
11186037|NCT01736553|12375663|FG001|COMPLETED|Overall Study||23
11186038|NCT01736553|12375662|FG000|NOT COMPLETED|Overall Study||19
11186039|NCT01736553|12375663|FG001|NOT COMPLETED|Overall Study||4
11186040|NCT01736566|12375692|FG000|STARTED|Main Study||51
11186041|NCT01736566|12375693|FG001|STARTED|Main Study||50
11186042|NCT01736566|12375694|FG002|STARTED|Main Study||50
11186043|NCT01736566|12375695|FG003|STARTED|Main Study||52
11186044|NCT01736566|12375696|FG004|STARTED|Main Study||10
11186045|NCT01736566|12375692|FG000|COMPLETED|Main Study||50
11186046|NCT01736566|12375693|FG001|COMPLETED|Main Study||50
11186047|NCT01736566|12375694|FG002|COMPLETED|Main Study||49
11186048|NCT01736566|12375695|FG003|COMPLETED|Main Study||51
11186049|NCT01736566|12375696|FG004|COMPLETED|Main Study||6
11186050|NCT01736566|12375692|FG000|NOT COMPLETED|Main Study||1
11186051|NCT01736566|12375693|FG001|NOT COMPLETED|Main Study||0
11186052|NCT01736566|12375694|FG002|NOT COMPLETED|Main Study||1
11186053|NCT01736566|12375695|FG003|NOT COMPLETED|Main Study||1
11186054|NCT01736566|12375696|FG004|NOT COMPLETED|Main Study||4
11186055|NCT01736566|12375692|FG000|STARTED|Long Term Follow-up||42
11186056|NCT01736566|12375693|FG001|STARTED|Long Term Follow-up||0
11186057|NCT01736566|12375694|FG002|STARTED|Long Term Follow-up||49
11186058|NCT01736566|12375695|FG003|STARTED|Long Term Follow-up||0
11186059|NCT01736566|12375696|FG004|STARTED|Long Term Follow-up||1
11186060|NCT01736566|12375692|FG000|COMPLETED|Long Term Follow-up||0
11186061|NCT01736566|12375693|FG001|COMPLETED|Long Term Follow-up||0
11186062|NCT01736566|12375694|FG002|COMPLETED|Long Term Follow-up||0
11186063|NCT01736566|12375695|FG003|COMPLETED|Long Term Follow-up||0
11186064|NCT01736566|12375696|FG004|COMPLETED|Long Term Follow-up||0
11186065|NCT01736566|12375692|FG000|NOT COMPLETED|Long Term Follow-up||42
11186066|NCT01736566|12375693|FG001|NOT COMPLETED|Long Term Follow-up||0
11186067|NCT01736566|12375694|FG002|NOT COMPLETED|Long Term Follow-up||49
11186068|NCT01736566|12375695|FG003|NOT COMPLETED|Long Term Follow-up||0
11186069|NCT01736566|12375696|FG004|NOT COMPLETED|Long Term Follow-up||1
11186070|NCT01736579|12375723|FG000|STARTED|Overall Study||2
11186071|NCT01736579|12375724|FG001|STARTED|Overall Study||2
11186072|NCT01736579|12375723|FG000|COMPLETED|Overall Study||0
11186073|NCT01736579|12375724|FG001|COMPLETED|Overall Study||0
11186074|NCT01736579|12375723|FG000|NOT COMPLETED|Overall Study||2
11186075|NCT01736579|12375724|FG001|NOT COMPLETED|Overall Study||2
11186076|NCT01736657|12375730|FG000|STARTED|Overall Study||73
11186077|NCT01736657|12375730|FG000|COMPLETED|Overall Study||72
11186078|NCT01736657|12375730|FG000|NOT COMPLETED|Overall Study||1
11186079|NCT01736683|12375739|FG000|STARTED|Overall Study||7
11186080|NCT01736683|12375740|FG001|STARTED|Overall Study||6
11186081|NCT01736683|12375741|FG002|STARTED|Overall Study||21
11186082|NCT01736683|12375742|FG003|STARTED|Overall Study||35
11186083|NCT01736683|12375743|FG004|STARTED|Overall Study||5
11186084|NCT01736683|12375739|FG000|COMPLETED|Overall Study|# who completed treatment|0
11186085|NCT01736683|12375740|FG001|COMPLETED|Overall Study|# who completed treatment|0
11186086|NCT01736683|12375741|FG002|COMPLETED|Overall Study|# who completed treatment|0
11186087|NCT01736683|12375742|FG003|COMPLETED|Overall Study|# who completed treatment|0
11186088|NCT01736683|12375743|FG004|COMPLETED|Overall Study|# who completed treatment|0
11186089|NCT01736683|12375739|FG000|NOT COMPLETED|Overall Study||7
11186090|NCT01736683|12375740|FG001|NOT COMPLETED|Overall Study||6
11186091|NCT01736683|12375741|FG002|NOT COMPLETED|Overall Study||21
11186092|NCT01736683|12375742|FG003|NOT COMPLETED|Overall Study||35
11186093|NCT01736683|12375743|FG004|NOT COMPLETED|Overall Study||5
11186094|NCT01736696|12375764|FG000|STARTED|Overall Study||5
11186095|NCT01736696|12375765|FG001|STARTED|Overall Study||5
11186096|NCT01736696|12375766|FG002|STARTED|Overall Study||10
11186097|NCT01736696|12375767|FG003|STARTED|Overall Study||9
11186098|NCT01736696|12375768|FG004|STARTED|Overall Study||9
11186099|NCT01736696|12375769|FG005|STARTED|Overall Study||8
11186100|NCT01736696|12375770|FG006|STARTED|Overall Study||13
11186101|NCT01736696|12375764|FG000|COMPLETED|Overall Study||5
11186102|NCT01736696|12375765|FG001|COMPLETED|Overall Study||5
11186103|NCT01736696|12375766|FG002|COMPLETED|Overall Study||9
11186104|NCT01736696|12375767|FG003|COMPLETED|Overall Study||9
11186105|NCT01736696|12375768|FG004|COMPLETED|Overall Study||9
11186106|NCT01736696|12375769|FG005|COMPLETED|Overall Study||8
11186107|NCT01736696|12375770|FG006|COMPLETED|Overall Study||13
11186108|NCT01736696|12375764|FG000|NOT COMPLETED|Overall Study||0
11186109|NCT01736696|12375765|FG001|NOT COMPLETED|Overall Study||0
11186110|NCT01736696|12375766|FG002|NOT COMPLETED|Overall Study||1
11186111|NCT01736696|12375767|FG003|NOT COMPLETED|Overall Study||0
11186112|NCT01736696|12375768|FG004|NOT COMPLETED|Overall Study||0
11186113|NCT01736696|12375769|FG005|NOT COMPLETED|Overall Study||0
11186114|NCT01736696|12375770|FG006|NOT COMPLETED|Overall Study||0
11186115|NCT01736852|12375796|FG000|STARTED|Overall Study||65
11186116|NCT01736852|12375797|FG001|STARTED|Overall Study||64
11186117|NCT01736852|12375796|FG000|COMPLETED|Overall Study||63
11186118|NCT01736852|12375797|FG001|COMPLETED|Overall Study||61
11186119|NCT01736852|12375796|FG000|NOT COMPLETED|Overall Study||2
11186120|NCT01736852|12375797|FG001|NOT COMPLETED|Overall Study||3
11186121|NCT01736865|12375805|FG000|STARTED|Overall Study||61
11186122|NCT01736865|12375806|FG001|STARTED|Overall Study||66
11186123|NCT01736865|12375805|FG000|COMPLETED|Overall Study||61
11186124|NCT01736865|12375806|FG001|COMPLETED|Overall Study||66
11186125|NCT01736865|12375805|FG000|NOT COMPLETED|Overall Study||0
11186126|NCT01736865|12375806|FG001|NOT COMPLETED|Overall Study||0
11186127|NCT01736917|12375812|FG000|STARTED|Overall Study||65
11186128|NCT01736917|12375812|FG000|COMPLETED|Overall Study||54
11186129|NCT01736917|12375812|FG000|NOT COMPLETED|Overall Study||11
11186130|NCT01736930|12375818|FG000|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
11186131|NCT01736930|12375818|FG000|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
11186132|NCT01736930|12375818|FG000|NOT COMPLETED|Overall Study||1
11186133|NCT01736943|12375824|FG000|STARTED|Overall Study||25
11186134|NCT01736943|12375824|FG000|COMPLETED|Overall Study||25
11186135|NCT01736943|12375824|FG000|NOT COMPLETED|Overall Study||0
11186136|NCT01737268|12375828|FG000|STARTED|Overall Study||20
11186137|NCT01737268|12375828|FG000|Treated|Overall Study||20
11186138|NCT01737268|12375828|FG000|COMPLETED|Overall Study||11
11186139|NCT01737268|12375828|FG000|NOT COMPLETED|Overall Study||9
11186140|NCT01737281|12375835|FG000|STARTED|Overall Study||969
11186141|NCT01737281|12375836|FG001|STARTED|Overall Study||969
11186142|NCT01737281|12375835|FG000|COMPLETED|Overall Study||603
11186143|NCT01737281|12375836|FG001|COMPLETED|Overall Study||689
11186144|NCT01737281|12375835|FG000|NOT COMPLETED|Overall Study||366
11186145|NCT01737281|12375836|FG001|NOT COMPLETED|Overall Study||280
11186146|NCT01737398|12375844|FG000|STARTED|Overall Study||113
11186147|NCT01737398|12375845|FG001|STARTED|Overall Study||60
11186148|NCT01737398|12375844|FG000|Received at Least 1 Dose of Study Drug|Overall Study||112
11186149|NCT01737398|12375845|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
11186150|NCT01737398|12375844|FG000|Safety Set|Overall Study||112
11186151|NCT01737398|12375845|FG001|Safety Set|Overall Study||60
11186152|NCT01737398|12375844|FG000|COMPLETED|Overall Study||87
11186153|NCT01737398|12375845|FG001|COMPLETED|Overall Study||52
11186154|NCT01737398|12375844|FG000|NOT COMPLETED|Overall Study||26
11186155|NCT01737398|12375845|FG001|NOT COMPLETED|Overall Study||8
11186156|NCT01737593|12375857|FG000|STARTED|Overall Study||37
11186157|NCT01737593|12375858|FG001|STARTED|Overall Study||32
11186158|NCT01737593|12375859|FG002|STARTED|Overall Study||39
11186159|NCT01737593|12375857|FG000|COMPLETED|Overall Study||37
11186160|NCT01737593|12375858|FG001|COMPLETED|Overall Study||32
11186161|NCT01737593|12375859|FG002|COMPLETED|Overall Study||39
11186162|NCT01737593|12375857|FG000|NOT COMPLETED|Overall Study||0
11186163|NCT01737593|12375858|FG001|NOT COMPLETED|Overall Study||0
11186164|NCT01737593|12375859|FG002|NOT COMPLETED|Overall Study||0
11186165|NCT01737684|12375872|FG000|STARTED|Overall Study||8
11186166|NCT01737684|12375873|FG001|STARTED|Overall Study||8
11186167|NCT01737684|12375874|FG002|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
11186168|NCT01737684|12375872|FG000|COMPLETED|Overall Study||8
11186169|NCT01737684|12375873|FG001|COMPLETED|Overall Study||8
11186170|NCT01737684|12375874|FG002|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
11186171|NCT01737684|12375872|FG000|NOT COMPLETED|Overall Study||0
11186172|NCT01737684|12375873|FG001|NOT COMPLETED|Overall Study||0
11186173|NCT01737684|12375874|FG002|NOT COMPLETED|Overall Study||0
11186174|NCT01737697|12375885|FG000|STARTED|Acute Phase-Initial 48 Hours||158
11186175|NCT01737697|12375886|FG001|STARTED|Acute Phase-Initial 48 Hours||154
11186176|NCT01737697|12375887|FG002|STARTED|Acute Phase-Initial 48 Hours||141
11186177|NCT01737697|12375888|FG003|STARTED|Acute Phase-Initial 48 Hours||158
11186178|NCT01737697|12375889|FG004|STARTED|Acute Phase-Initial 48 Hours||143
11186179|NCT01737697|12375890|FG005|STARTED|Acute Phase-Initial 48 Hours||0
11186180|NCT01737697|12375891|FG006|STARTED|Acute Phase-Initial 48 Hours||0
11186181|NCT01737697|12375892|FG007|STARTED|Acute Phase-Initial 48 Hours||0
11186182|NCT01737697|12375893|FG008|STARTED|Acute Phase-Initial 48 Hours||0
11186183|NCT01737697|12375894|FG009|STARTED|Acute Phase-Initial 48 Hours||0
11186184|NCT01737697|12375895|FG010|STARTED|Acute Phase-Initial 48 Hours||0
11186185|NCT01737697|12375896|FG011|STARTED|Acute Phase-Initial 48 Hours||0
11186186|NCT01737697|12375897|FG012|STARTED|Acute Phase-Initial 48 Hours||0
11186187|NCT01737697|12375898|FG013|STARTED|Acute Phase-Initial 48 Hours||0
11186188|NCT01737697|12375899|FG014|STARTED|Acute Phase-Initial 48 Hours||0
11186189|NCT01737697|12375885|FG000|COMPLETED|Acute Phase-Initial 48 Hours||157
11186190|NCT01737697|12375886|FG001|COMPLETED|Acute Phase-Initial 48 Hours||150
11186191|NCT01737697|12375887|FG002|COMPLETED|Acute Phase-Initial 48 Hours||137
11186192|NCT01737697|12375888|FG003|COMPLETED|Acute Phase-Initial 48 Hours||152
11186193|NCT01737697|12375889|FG004|COMPLETED|Acute Phase-Initial 48 Hours||140
11186194|NCT01737697|12375890|FG005|COMPLETED|Acute Phase-Initial 48 Hours||0
11186195|NCT01737697|12375891|FG006|COMPLETED|Acute Phase-Initial 48 Hours||0
11186196|NCT01737697|12375892|FG007|COMPLETED|Acute Phase-Initial 48 Hours||0
11186197|NCT01737697|12375893|FG008|COMPLETED|Acute Phase-Initial 48 Hours||0
11186198|NCT01737697|12375894|FG009|COMPLETED|Acute Phase-Initial 48 Hours||0
11186199|NCT01737697|12375895|FG010|COMPLETED|Acute Phase-Initial 48 Hours||0
11186200|NCT01737697|12375896|FG011|COMPLETED|Acute Phase-Initial 48 Hours||0
11186201|NCT01737697|12375897|FG012|COMPLETED|Acute Phase-Initial 48 Hours||0
11186202|NCT01737697|12375898|FG013|COMPLETED|Acute Phase-Initial 48 Hours||0
11186203|NCT01737697|12375899|FG014|COMPLETED|Acute Phase-Initial 48 Hours||0
11186204|NCT01737697|12375885|FG000|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
11186205|NCT01737697|12375886|FG001|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
11186206|NCT01737697|12375887|FG002|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
11186207|NCT01737697|12375888|FG003|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
11186208|NCT01737697|12375889|FG004|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
11186209|NCT01737697|12375890|FG005|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
11186210|NCT01737697|12375891|FG006|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
11186211|NCT01737697|12375892|FG007|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
11186212|NCT01737697|12375893|FG008|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
11186213|NCT01737697|12375894|FG009|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
11186214|NCT01737697|12375895|FG010|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
11186215|NCT01737697|12375896|FG011|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
11186216|NCT01737697|12375897|FG012|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
11186217|NCT01737697|12375898|FG013|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
11186218|NCT01737697|12375899|FG014|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
11186219|NCT01737697|12375885|FG000|STARTED|Subacute Phase||0
11186220|NCT01737697|12375886|FG001|STARTED|Subacute Phase||0
11186221|NCT01737697|12375887|FG002|STARTED|Subacute Phase||0
11186222|NCT01737697|12375888|FG003|STARTED|Subacute Phase||0
11186223|NCT01737697|12375889|FG004|STARTED|Subacute Phase||0
11186224|NCT01737697|12375890|FG005|STARTED|Subacute Phase||41
11186225|NCT01737697|12375891|FG006|STARTED|Subacute Phase||49
11186226|NCT01737697|12375892|FG007|STARTED|Subacute Phase||46
11186227|NCT01737697|12375893|FG008|STARTED|Subacute Phase||54
11186228|NCT01737697|12375894|FG009|STARTED|Subacute Phase||68
11186229|NCT01737697|12375895|FG010|STARTED|Subacute Phase||65
11186230|NCT01737697|12375896|FG011|STARTED|Subacute Phase||61
11186231|NCT01737697|12375897|FG012|STARTED|Subacute Phase||63
11186232|NCT01737697|12375898|FG013|STARTED|Subacute Phase||46
11186233|NCT01737697|12375899|FG014|STARTED|Subacute Phase||50
11186234|NCT01737697|12375885|FG000|COMPLETED|Subacute Phase||0
11186235|NCT01737697|12375886|FG001|COMPLETED|Subacute Phase||0
11186236|NCT01737697|12375887|FG002|COMPLETED|Subacute Phase||0
11186237|NCT01737697|12375888|FG003|COMPLETED|Subacute Phase||0
11186238|NCT01737697|12375889|FG004|COMPLETED|Subacute Phase||0
11186239|NCT01737697|12375890|FG005|COMPLETED|Subacute Phase||38
11186240|NCT01737697|12375891|FG006|COMPLETED|Subacute Phase||48
11186241|NCT01737697|12375892|FG007|COMPLETED|Subacute Phase||43
11186242|NCT01737697|12375893|FG008|COMPLETED|Subacute Phase||52
11186243|NCT01737697|12375894|FG009|COMPLETED|Subacute Phase||66
11186244|NCT01737697|12375895|FG010|COMPLETED|Subacute Phase||59
11186245|NCT01737697|12375896|FG011|COMPLETED|Subacute Phase||58
11186246|NCT01737697|12375897|FG012|COMPLETED|Subacute Phase||61
11186247|NCT01737697|12375898|FG013|COMPLETED|Subacute Phase||44
11186248|NCT01737697|12375899|FG014|COMPLETED|Subacute Phase||49
11186249|NCT01737697|12375885|FG000|NOT COMPLETED|Subacute Phase||0
11186250|NCT01737697|12375886|FG001|NOT COMPLETED|Subacute Phase||0
11186251|NCT01737697|12375887|FG002|NOT COMPLETED|Subacute Phase||0
11186252|NCT01737697|12375888|FG003|NOT COMPLETED|Subacute Phase||0
11186253|NCT01737697|12375889|FG004|NOT COMPLETED|Subacute Phase||0
11186254|NCT01737697|12375890|FG005|NOT COMPLETED|Subacute Phase||3
11186255|NCT01737697|12375891|FG006|NOT COMPLETED|Subacute Phase||1
11186256|NCT01737697|12375892|FG007|NOT COMPLETED|Subacute Phase||3
11186257|NCT01737697|12375893|FG008|NOT COMPLETED|Subacute Phase||2
11186258|NCT01737697|12375894|FG009|NOT COMPLETED|Subacute Phase||2
11186259|NCT01737697|12375895|FG010|NOT COMPLETED|Subacute Phase||6
11186260|NCT01737697|12375896|FG011|NOT COMPLETED|Subacute Phase||3
11186261|NCT01737697|12375897|FG012|NOT COMPLETED|Subacute Phase||2
11186262|NCT01737697|12375898|FG013|NOT COMPLETED|Subacute Phase||2
11186263|NCT01737697|12375899|FG014|NOT COMPLETED|Subacute Phase||1
11186264|NCT01737710|12375937|FG000|STARTED|Overall Study||114
11186265|NCT01737710|12375938|FG001|STARTED|Overall Study||105
11186266|NCT01737710|12375939|FG002|STARTED|Overall Study||105
11186267|NCT01737710|12375940|FG003|STARTED|Overall Study||23
11186268|NCT01737710|12375941|FG004|STARTED|Overall Study||21
11186269|NCT01737710|12375937|FG000|COMPLETED|Overall Study||112
11186270|NCT01737710|12375938|FG001|COMPLETED|Overall Study||101
11186271|NCT01737710|12375939|FG002|COMPLETED|Overall Study||102
11186272|NCT01737710|12375940|FG003|COMPLETED|Overall Study||23
11186273|NCT01737710|12375941|FG004|COMPLETED|Overall Study||21
11186274|NCT01737710|12375937|FG000|NOT COMPLETED|Overall Study||2
11186275|NCT01737710|12375938|FG001|NOT COMPLETED|Overall Study||4
11186276|NCT01737710|12375939|FG002|NOT COMPLETED|Overall Study||3
11186277|NCT01737710|12375940|FG003|NOT COMPLETED|Overall Study||0
11186278|NCT01737710|12375941|FG004|NOT COMPLETED|Overall Study||0
11186279|NCT01737762|12375954|FG000|STARTED|Overall Study||77
11186280|NCT01737762|12375955|FG001|STARTED|Overall Study||78
11186281|NCT01737762|12375954|FG000|COMPLETED|Overall Study||57
11186282|NCT01737762|12375955|FG001|COMPLETED|Overall Study||61
11186283|NCT01737762|12375954|FG000|NOT COMPLETED|Overall Study||20
11186284|NCT01737762|12375955|FG001|NOT COMPLETED|Overall Study||17
11186285|NCT01737840|12375963|FG000|STARTED|Overall Study||35
11186286|NCT01737840|12375964|FG001|STARTED|Overall Study||35
11186287|NCT01737840|12375963|FG000|COMPLETED|Overall Study||33
11186288|NCT01737840|12375964|FG001|COMPLETED|Overall Study||33
11186289|NCT01737840|12375963|FG000|NOT COMPLETED|Overall Study||2
11186290|NCT01737840|12375964|FG001|NOT COMPLETED|Overall Study||2
11186291|NCT01737879|12375972|FG000|STARTED|Overall Study||41
11186292|NCT01737879|12375972|FG000|Received Peginesatide|Overall Study||34
11186293|NCT01737879|12375972|FG000|Transitioned to Epoetin Alfa|Overall Study||0
11186294|NCT01737879|12375972|FG000|COMPLETED|Overall Study||0
11186295|NCT01737879|12375972|FG000|NOT COMPLETED|Overall Study||41
11186296|NCT01737931|12375979|FG000|STARTED|Overall Study||38
11186297|NCT01737931|12375980|FG001|STARTED|Overall Study||40
11186298|NCT01737931|12375981|FG002|STARTED|Overall Study||39
11186299|NCT01737931|12375979|FG000|COMPLETED|Overall Study||38
11186300|NCT01737931|12375980|FG001|COMPLETED|Overall Study||38
11186301|NCT01737931|12375981|FG002|COMPLETED|Overall Study||38
11186302|NCT01737931|12375979|FG000|NOT COMPLETED|Overall Study||0
11186303|NCT01737931|12375980|FG001|NOT COMPLETED|Overall Study||2
11186304|NCT01737931|12375981|FG002|NOT COMPLETED|Overall Study||1
11186305|NCT01737944|12375991|FG000|STARTED|Overall Study||9
11186306|NCT01737944|12375992|FG001|STARTED|Overall Study||9
11186307|NCT01737944|12375993|FG002|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
11186308|NCT01737944|12375994|FG003|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
11186309|NCT01737944|12375991|FG000|COMPLETED|Overall Study||9
11186310|NCT01737944|12375992|FG001|COMPLETED|Overall Study||9
11186311|NCT01737944|12375993|FG002|COMPLETED|Overall Study||9
11324326|NCT02742766|12521575|FG016|STARTED|Part 3 (Up to 36 Days)||0
11324327|NCT02742766|12521576|FG017|STARTED|Part 3 (Up to 36 Days)||0
11324328|NCT02742766|12521577|FG018|STARTED|Part 3 (Up to 36 Days)||0
11324329|NCT02742766|12521559|FG000|COMPLETED|Part 3 (Up to 36 Days)||0
11324330|NCT02742766|12521560|FG001|COMPLETED|Part 3 (Up to 36 Days)||0
11186312|NCT01737944|12375994|FG003|COMPLETED|Overall Study||9
11186313|NCT01737944|12375991|FG000|NOT COMPLETED|Overall Study||0
11186314|NCT01737944|12375992|FG001|NOT COMPLETED|Overall Study||0
11186315|NCT01737944|12375993|FG002|NOT COMPLETED|Overall Study||0
11186316|NCT01737944|12375994|FG003|NOT COMPLETED|Overall Study||0
11186317|NCT01737996|12376006|FG000|STARTED|Overall Study||8
11186318|NCT01737996|12376007|FG001|STARTED|Overall Study||8
11186319|NCT01737996|12376008|FG002|STARTED|Overall Study||16
11186320|NCT01737996|12376006|FG000|COMPLETED|Overall Study||8
11186321|NCT01737996|12376007|FG001|COMPLETED|Overall Study||7
11204611|NCT01854281|12395190|FG000|COMPLETED|Overall Study||15
11186322|NCT01737996|12376008|FG002|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
11186323|NCT01737996|12376006|FG000|NOT COMPLETED|Overall Study||0
11186324|NCT01737996|12376007|FG001|NOT COMPLETED|Overall Study||1
11186325|NCT01737996|12376008|FG002|NOT COMPLETED|Overall Study||2
11186326|NCT01738191|12376018|FG000|STARTED|Overall Study||15
11186327|NCT01738191|12376019|FG001|STARTED|Overall Study||15
11186328|NCT01738191|12376018|FG000|COMPLETED|Overall Study||11
11186329|NCT01738191|12376019|FG001|COMPLETED|Overall Study||14
11186330|NCT01738191|12376018|FG000|NOT COMPLETED|Overall Study||4
11186331|NCT01738191|12376019|FG001|NOT COMPLETED|Overall Study||1
11186332|NCT01738321|12376027|FG000|STARTED|Overall Study||33
11186333|NCT01738321|12376028|FG001|STARTED|Overall Study||30
11186334|NCT01738321|12376027|FG000|COMPLETED|Overall Study||33
11186335|NCT01738321|12376028|FG001|COMPLETED|Overall Study||30
11186336|NCT01738321|12376027|FG000|NOT COMPLETED|Overall Study||0
11186337|NCT01738321|12376028|FG001|NOT COMPLETED|Overall Study||0
11186338|NCT01738438|12376034|FG000|STARTED|Overall Study||35
11186339|NCT01738438|12376034|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
11186340|NCT01738438|12376034|FG000|NOT COMPLETED|Overall Study||35
11186341|NCT01738477|12376040|FG000|STARTED|Overall Study||37
11186342|NCT01738477|12376041|FG001|STARTED|Overall Study||128
11186343|NCT01738477|12376040|FG000|COMPLETED|Overall Study||36
11186344|NCT01738477|12376041|FG001|COMPLETED|Overall Study||124
11186345|NCT01738477|12376040|FG000|NOT COMPLETED|Overall Study||1
11186346|NCT01738477|12376041|FG001|NOT COMPLETED|Overall Study||4
11186347|NCT01738503|12376055|FG000|STARTED|Induction/Stabilization (Days -14 to -1)||124
11186348|NCT01738503|12376056|FG001|STARTED|Induction/Stabilization (Days -14 to -1)||0
11186349|NCT01738503|12376057|FG002|STARTED|Induction/Stabilization (Days -14 to -1)||0
11186350|NCT01738503|12376058|FG003|STARTED|Induction/Stabilization (Days -14 to -1)||0
11186351|NCT01738503|12376059|FG004|STARTED|Induction/Stabilization (Days -14 to -1)||0
11186352|NCT01738503|12376060|FG005|STARTED|Induction/Stabilization (Days -14 to -1)||0
11186353|NCT01738503|12376061|FG006|STARTED|Induction/Stabilization (Days -14 to -1)||0
11186354|NCT01738503|12376055|FG000|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
11186355|NCT01738503|12376056|FG001|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
11186356|NCT01738503|12376057|FG002|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
11186357|NCT01738503|12376058|FG003|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
11186358|NCT01738503|12376059|FG004|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
11186359|NCT01738503|12376060|FG005|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
11186360|NCT01738503|12376061|FG006|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
11186361|NCT01738503|12376055|FG000|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
11186362|NCT01738503|12376056|FG001|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
11186363|NCT01738503|12376057|FG002|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
11186364|NCT01738503|12376058|FG003|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
11186365|NCT01738503|12376059|FG004|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
11186366|NCT01738503|12376060|FG005|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
11186367|NCT01738503|12376061|FG006|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
11186368|NCT01738503|12376055|FG000|STARTED|Treatment Period||0
11186369|NCT01738503|12376056|FG001|STARTED|Treatment Period||15
11186370|NCT01738503|12376057|FG002|STARTED|Treatment Period||15
11186371|NCT01738503|12376058|FG003|STARTED|Treatment Period||15
11186372|NCT01738503|12376059|FG004|STARTED|Treatment Period||15
11186373|NCT01738503|12376060|FG005|STARTED|Treatment Period||15
11186374|NCT01738503|12376061|FG006|STARTED|Treatment Period||14
11186375|NCT01738503|12376055|FG000|COMPLETED|Treatment Period||0
11186376|NCT01738503|12376056|FG001|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
11186377|NCT01738503|12376057|FG002|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
11186378|NCT01738503|12376058|FG003|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
11186379|NCT01738503|12376059|FG004|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
11186380|NCT01738503|12376060|FG005|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
11186381|NCT01738503|12376061|FG006|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
11186382|NCT01738503|12376055|FG000|NOT COMPLETED|Treatment Period||0
11186383|NCT01738503|12376056|FG001|NOT COMPLETED|Treatment Period||5
11186384|NCT01738503|12376057|FG002|NOT COMPLETED|Treatment Period||5
11186385|NCT01738503|12376058|FG003|NOT COMPLETED|Treatment Period||6
11186386|NCT01738503|12376059|FG004|NOT COMPLETED|Treatment Period||8
11186387|NCT01738503|12376060|FG005|NOT COMPLETED|Treatment Period||6
11186388|NCT01738503|12376061|FG006|NOT COMPLETED|Treatment Period||8
11186389|NCT01738503|12376055|FG000|STARTED|PET Imaging Sub-study||0
11186390|NCT01738503|12376056|FG001|STARTED|PET Imaging Sub-study||0
11186391|NCT01738503|12376057|FG002|STARTED|PET Imaging Sub-study||0
11186392|NCT01738503|12376058|FG003|STARTED|PET Imaging Sub-study||0
11186393|NCT01738503|12376059|FG004|STARTED|PET Imaging Sub-study||0
11186394|NCT01738503|12376060|FG005|STARTED|PET Imaging Sub-study||3
11186395|NCT01738503|12376061|FG006|STARTED|PET Imaging Sub-study||2
11186396|NCT01738503|12376055|FG000|COMPLETED|PET Imaging Sub-study||0
11186397|NCT01738503|12376056|FG001|COMPLETED|PET Imaging Sub-study||0
11186398|NCT01738503|12376057|FG002|COMPLETED|PET Imaging Sub-study||0
11186399|NCT01738503|12376058|FG003|COMPLETED|PET Imaging Sub-study||0
11186400|NCT01738503|12376059|FG004|COMPLETED|PET Imaging Sub-study||0
11186401|NCT01738503|12376060|FG005|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
11186402|NCT01738503|12376061|FG006|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
11186403|NCT01738503|12376055|FG000|NOT COMPLETED|PET Imaging Sub-study||0
11186404|NCT01738503|12376056|FG001|NOT COMPLETED|PET Imaging Sub-study||0
11186405|NCT01738503|12376057|FG002|NOT COMPLETED|PET Imaging Sub-study||0
11186406|NCT01738503|12376058|FG003|NOT COMPLETED|PET Imaging Sub-study||0
11186407|NCT01738503|12376059|FG004|NOT COMPLETED|PET Imaging Sub-study||0
11186408|NCT01738503|12376060|FG005|NOT COMPLETED|PET Imaging Sub-study||2
11186409|NCT01738503|12376061|FG006|NOT COMPLETED|PET Imaging Sub-study||1
11186410|NCT01738581|12376085|FG000|STARTED|Overall Study||5
11186411|NCT01738581|12376086|FG001|STARTED|Overall Study||4
11186412|NCT01738581|12376085|FG000|COMPLETED|Overall Study||4
11186413|NCT01738581|12376086|FG001|COMPLETED|Overall Study||4
11186414|NCT01738581|12376085|FG000|NOT COMPLETED|Overall Study||1
11186415|NCT01738581|12376086|FG001|NOT COMPLETED|Overall Study||0
11186416|NCT01738594|12376095|FG000|STARTED|Registration and Treatment Start||0
11186417|NCT01738594|12376096|FG001|STARTED|Registration and Treatment Start||3
11186418|NCT01738594|12376097|FG002|STARTED|Registration and Treatment Start||0
11186419|NCT01738594|12376098|FG003|STARTED|Registration and Treatment Start||0
11186420|NCT01738594|12376099|FG004|STARTED|Registration and Treatment Start||1
11186421|NCT01738594|12376100|FG005|STARTED|Registration and Treatment Start||3
11186422|NCT01738594|12376101|FG006|STARTED|Registration and Treatment Start||0
11186423|NCT01738594|12376102|FG007|STARTED|Registration and Treatment Start||0
11186424|NCT01738594|12376095|FG000|Registered to Study|Registration and Treatment Start||0
11186425|NCT01738594|12376096|FG001|Registered to Study|Registration and Treatment Start||3
11186426|NCT01738594|12376097|FG002|Registered to Study|Registration and Treatment Start||0
11186427|NCT01738594|12376098|FG003|Registered to Study|Registration and Treatment Start||0
11186428|NCT01738594|12376099|FG004|Registered to Study|Registration and Treatment Start||1
11186429|NCT01738594|12376100|FG005|Registered to Study|Registration and Treatment Start||3
11186430|NCT01738594|12376101|FG006|Registered to Study|Registration and Treatment Start||0
11186431|NCT01738594|12376102|FG007|Registered to Study|Registration and Treatment Start||0
11186432|NCT01738594|12376095|FG000|Treatment Started|Registration and Treatment Start||0
11186433|NCT01738594|12376096|FG001|Treatment Started|Registration and Treatment Start||2
11186434|NCT01738594|12376097|FG002|Treatment Started|Registration and Treatment Start||0
11186435|NCT01738594|12376098|FG003|Treatment Started|Registration and Treatment Start||0
11186436|NCT01738594|12376099|FG004|Treatment Started|Registration and Treatment Start||1
11186437|NCT01738594|12376100|FG005|Treatment Started|Registration and Treatment Start||3
11186438|NCT01738594|12376101|FG006|Treatment Started|Registration and Treatment Start||0
11186439|NCT01738594|12376102|FG007|Treatment Started|Registration and Treatment Start||0
11186440|NCT01738594|12376095|FG000|COMPLETED|Registration and Treatment Start||0
11186441|NCT01738594|12376096|FG001|COMPLETED|Registration and Treatment Start||2
11186442|NCT01738594|12376097|FG002|COMPLETED|Registration and Treatment Start||0
11186443|NCT01738594|12376098|FG003|COMPLETED|Registration and Treatment Start||0
11186444|NCT01738594|12376099|FG004|COMPLETED|Registration and Treatment Start||1
11186445|NCT01738594|12376100|FG005|COMPLETED|Registration and Treatment Start||3
11186446|NCT01738594|12376101|FG006|COMPLETED|Registration and Treatment Start||0
11186447|NCT01738594|12376102|FG007|COMPLETED|Registration and Treatment Start||0
11186448|NCT01738594|12376095|FG000|NOT COMPLETED|Registration and Treatment Start||0
11186449|NCT01738594|12376096|FG001|NOT COMPLETED|Registration and Treatment Start||1
11186450|NCT01738594|12376097|FG002|NOT COMPLETED|Registration and Treatment Start||0
11186451|NCT01738594|12376098|FG003|NOT COMPLETED|Registration and Treatment Start||0
11186452|NCT01738594|12376099|FG004|NOT COMPLETED|Registration and Treatment Start||0
11186453|NCT01738594|12376100|FG005|NOT COMPLETED|Registration and Treatment Start||0
11186454|NCT01738594|12376101|FG006|NOT COMPLETED|Registration and Treatment Start||0
11186455|NCT01738594|12376102|FG007|NOT COMPLETED|Registration and Treatment Start||0
11186456|NCT01738594|12376095|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||0
11186457|NCT01738594|12376096|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||2
11186458|NCT01738594|12376097|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||0
11186459|NCT01738594|12376098|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||0
11186460|NCT01738594|12376099|FG004|STARTED|Completed 2 Cycles/Reached 1st Response||1
11186461|NCT01738594|12376100|FG005|STARTED|Completed 2 Cycles/Reached 1st Response||3
11186462|NCT01738594|12376101|FG006|STARTED|Completed 2 Cycles/Reached 1st Response||0
11186463|NCT01738594|12376102|FG007|STARTED|Completed 2 Cycles/Reached 1st Response||0
11186464|NCT01738594|12376095|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
11186465|NCT01738594|12376096|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
11186466|NCT01738594|12376097|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
11186467|NCT01738594|12376098|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
11186468|NCT01738594|12376099|FG004|COMPLETED|Completed 2 Cycles/Reached 1st Response||1
11186469|NCT01738594|12376100|FG005|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
11186470|NCT01738594|12376101|FG006|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
11186471|NCT01738594|12376102|FG007|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
11186472|NCT01738594|12376095|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
11186473|NCT01738594|12376096|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
11186474|NCT01738594|12376097|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
11186475|NCT01738594|12376098|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
11186476|NCT01738594|12376099|FG004|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
11186477|NCT01738594|12376100|FG005|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
11186478|NCT01738594|12376101|FG006|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
11186479|NCT01738594|12376102|FG007|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
11186480|NCT01738594|12376095|FG000|STARTED|Completed 4 Cycles of Treatment||0
11186481|NCT01738594|12376096|FG001|STARTED|Completed 4 Cycles of Treatment||2
11186482|NCT01738594|12376097|FG002|STARTED|Completed 4 Cycles of Treatment||0
11186483|NCT01738594|12376098|FG003|STARTED|Completed 4 Cycles of Treatment||0
11186484|NCT01738594|12376099|FG004|STARTED|Completed 4 Cycles of Treatment||1
11186485|NCT01738594|12376100|FG005|STARTED|Completed 4 Cycles of Treatment||2
11186486|NCT01738594|12376101|FG006|STARTED|Completed 4 Cycles of Treatment||0
11186487|NCT01738594|12376102|FG007|STARTED|Completed 4 Cycles of Treatment||0
11186488|NCT01738594|12376095|FG000|COMPLETED|Completed 4 Cycles of Treatment||0
11186489|NCT01738594|12376096|FG001|COMPLETED|Completed 4 Cycles of Treatment||0
11186490|NCT01738594|12376097|FG002|COMPLETED|Completed 4 Cycles of Treatment||0
11186491|NCT01738594|12376098|FG003|COMPLETED|Completed 4 Cycles of Treatment||0
11186492|NCT01738594|12376099|FG004|COMPLETED|Completed 4 Cycles of Treatment||1
11186493|NCT01738594|12376100|FG005|COMPLETED|Completed 4 Cycles of Treatment||1
11186494|NCT01738594|12376101|FG006|COMPLETED|Completed 4 Cycles of Treatment||0
11186495|NCT01738594|12376102|FG007|COMPLETED|Completed 4 Cycles of Treatment||0
11186496|NCT01738594|12376095|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||0
11186497|NCT01738594|12376096|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||2
11186498|NCT01738594|12376097|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||0
11186499|NCT01738594|12376098|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||0
11186500|NCT01738594|12376099|FG004|NOT COMPLETED|Completed 4 Cycles of Treatment||0
11186501|NCT01738594|12376100|FG005|NOT COMPLETED|Completed 4 Cycles of Treatment||1
11186502|NCT01738594|12376101|FG006|NOT COMPLETED|Completed 4 Cycles of Treatment||0
11186503|NCT01738594|12376102|FG007|NOT COMPLETED|Completed 4 Cycles of Treatment||0
11186504|NCT01738594|12376095|FG000|STARTED|Went on to Continue Treatment Cycle 5||0
11186505|NCT01738594|12376096|FG001|STARTED|Went on to Continue Treatment Cycle 5||0
11186506|NCT01738594|12376097|FG002|STARTED|Went on to Continue Treatment Cycle 5||0
11186507|NCT01738594|12376098|FG003|STARTED|Went on to Continue Treatment Cycle 5||0
11186508|NCT01738594|12376099|FG004|STARTED|Went on to Continue Treatment Cycle 5||1
11186509|NCT01738594|12376100|FG005|STARTED|Went on to Continue Treatment Cycle 5||1
11186510|NCT01738594|12376101|FG006|STARTED|Went on to Continue Treatment Cycle 5||0
11186511|NCT01738594|12376102|FG007|STARTED|Went on to Continue Treatment Cycle 5||0
11186512|NCT01738594|12376095|FG000|COMPLETED|Went on to Continue Treatment Cycle 5||0
11186513|NCT01738594|12376096|FG001|COMPLETED|Went on to Continue Treatment Cycle 5||0
11186514|NCT01738594|12376097|FG002|COMPLETED|Went on to Continue Treatment Cycle 5||0
11186515|NCT01738594|12376098|FG003|COMPLETED|Went on to Continue Treatment Cycle 5||0
11186516|NCT01738594|12376099|FG004|COMPLETED|Went on to Continue Treatment Cycle 5||0
11186517|NCT01738594|12376100|FG005|COMPLETED|Went on to Continue Treatment Cycle 5||0
11186518|NCT01738594|12376101|FG006|COMPLETED|Went on to Continue Treatment Cycle 5||0
11186519|NCT01738594|12376102|FG007|COMPLETED|Went on to Continue Treatment Cycle 5||0
11186520|NCT01738594|12376095|FG000|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
11186521|NCT01738594|12376096|FG001|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
11186522|NCT01738594|12376097|FG002|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
11186523|NCT01738594|12376098|FG003|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
11186524|NCT01738594|12376099|FG004|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
11186525|NCT01738594|12376100|FG005|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
11186526|NCT01738594|12376101|FG006|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
11186527|NCT01738594|12376102|FG007|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
11186528|NCT01738594|12376095|FG000|STARTED|Follow up for 1 Year||0
11186529|NCT01738594|12376096|FG001|STARTED|Follow up for 1 Year||2
11186530|NCT01738594|12376097|FG002|STARTED|Follow up for 1 Year||0
11186531|NCT01738594|12376098|FG003|STARTED|Follow up for 1 Year||0
11186532|NCT01738594|12376099|FG004|STARTED|Follow up for 1 Year||1
11186533|NCT01738594|12376100|FG005|STARTED|Follow up for 1 Year||3
11026917|NCT00830947|12205520|FG000|NOT COMPLETED|Overall Study||4
11026918|NCT00830947|12205521|FG001|NOT COMPLETED|Overall Study||4
11026919|NCT00830960|12205533|FG000|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
11026920|NCT00830960|12205534|FG001|STARTED|Overall Study||124
11026921|NCT00830960|12205535|FG002|STARTED|Overall Study||137
11026922|NCT00830960|12205536|FG003|STARTED|Overall Study||138
11026923|NCT00830960|12205537|FG004|STARTED|Overall Study||96
11026924|NCT00830960|12205538|FG005|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
11026925|NCT00830960|12205533|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
11026926|NCT00830960|12205534|FG001|Received at Least 1 Dose of Study Drug|Overall Study||122
11026927|NCT00830960|12205535|FG002|Received at Least 1 Dose of Study Drug|Overall Study||133
11026928|NCT00830960|12205536|FG003|Received at Least 1 Dose of Study Drug|Overall Study||135
11026929|NCT00830960|12205537|FG004|Received at Least 1 Dose of Study Drug|Overall Study||91
11026930|NCT00830960|12205538|FG005|Received at Least 1 Dose of Study Drug|Overall Study||93
11026931|NCT00830960|12205533|FG000|COMPLETED|Overall Study||91
11026932|NCT00830960|12205534|FG001|COMPLETED|Overall Study||96
11026933|NCT00830960|12205535|FG002|COMPLETED|Overall Study||108
11026934|NCT00830960|12205536|FG003|COMPLETED|Overall Study||106
11026935|NCT00830960|12205537|FG004|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
11026936|NCT00830960|12205538|FG005|COMPLETED|Overall Study||63
11026937|NCT00830960|12205533|FG000|NOT COMPLETED|Overall Study||33
11026938|NCT00830960|12205534|FG001|NOT COMPLETED|Overall Study||28
11026939|NCT00830960|12205535|FG002|NOT COMPLETED|Overall Study||29
11026940|NCT00830960|12205536|FG003|NOT COMPLETED|Overall Study||32
11026941|NCT00830960|12205537|FG004|NOT COMPLETED|Overall Study||32
11026942|NCT00830960|12205538|FG005|NOT COMPLETED|Overall Study||37
11186534|NCT01738594|12376101|FG006|STARTED|Follow up for 1 Year||0
11186535|NCT01738594|12376102|FG007|STARTED|Follow up for 1 Year||0
11186536|NCT01738594|12376095|FG000|COMPLETED|Follow up for 1 Year||0
11186537|NCT01738594|12376096|FG001|COMPLETED|Follow up for 1 Year||2
11186538|NCT01738594|12376097|FG002|COMPLETED|Follow up for 1 Year||0
11186539|NCT01738594|12376098|FG003|COMPLETED|Follow up for 1 Year||0
11186540|NCT01738594|12376099|FG004|COMPLETED|Follow up for 1 Year||1
11186541|NCT01738594|12376100|FG005|COMPLETED|Follow up for 1 Year||0
11186542|NCT01738594|12376101|FG006|COMPLETED|Follow up for 1 Year||0
11186543|NCT01738594|12376102|FG007|COMPLETED|Follow up for 1 Year||0
11186544|NCT01738594|12376095|FG000|NOT COMPLETED|Follow up for 1 Year||0
11186545|NCT01738594|12376096|FG001|NOT COMPLETED|Follow up for 1 Year||0
11186546|NCT01738594|12376097|FG002|NOT COMPLETED|Follow up for 1 Year||0
11186547|NCT01738594|12376098|FG003|NOT COMPLETED|Follow up for 1 Year||0
11186548|NCT01738594|12376099|FG004|NOT COMPLETED|Follow up for 1 Year||0
11186549|NCT01738594|12376100|FG005|NOT COMPLETED|Follow up for 1 Year||3
11186550|NCT01738594|12376101|FG006|NOT COMPLETED|Follow up for 1 Year||0
11186551|NCT01738594|12376102|FG007|NOT COMPLETED|Follow up for 1 Year||0
11186552|NCT01738646|12376112|FG000|STARTED|Overall Study||40
11186553|NCT01738646|12376112|FG000|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
11186554|NCT01738646|12376112|FG000|NOT COMPLETED|Overall Study||2
11186555|NCT01738672|12376117|FG000|STARTED|Overall Study||16
11186556|NCT01738672|12376117|FG000|COMPLETED|Overall Study||11
11186557|NCT01738672|12376117|FG000|NOT COMPLETED|Overall Study||5
11186558|NCT01738737|12376126|FG000|STARTED|Overall Study||29
11186559|NCT01738737|12376127|FG001|STARTED|Overall Study||29
11186560|NCT01738737|12376128|FG002|STARTED|Overall Study||29
11186561|NCT01738737|12376129|FG003|STARTED|Overall Study||29
11186562|NCT01738737|12376130|FG004|STARTED|Overall Study||29
11186563|NCT01738737|12376126|FG000|COMPLETED|Overall Study||25
11186564|NCT01738737|12376127|FG001|COMPLETED|Overall Study||25
11186565|NCT01738737|12376128|FG002|COMPLETED|Overall Study||25
11186566|NCT01738737|12376129|FG003|COMPLETED|Overall Study||25
11186567|NCT01738737|12376130|FG004|COMPLETED|Overall Study||25
11186568|NCT01738737|12376126|FG000|NOT COMPLETED|Overall Study||4
11186569|NCT01738737|12376127|FG001|NOT COMPLETED|Overall Study||4
11186570|NCT01738737|12376128|FG002|NOT COMPLETED|Overall Study||4
11186571|NCT01738737|12376129|FG003|NOT COMPLETED|Overall Study||4
11186572|NCT01738737|12376130|FG004|NOT COMPLETED|Overall Study||4
11186573|NCT01738750|12376144|FG000|STARTED|Overall Study||49
11186574|NCT01738750|12376145|FG001|STARTED|Overall Study||51
11186575|NCT01738750|12376144|FG000|COMPLETED|Overall Study||49
11186576|NCT01738750|12376145|FG001|COMPLETED|Overall Study||51
11186577|NCT01738750|12376144|FG000|NOT COMPLETED|Overall Study||0
11186578|NCT01738750|12376145|FG001|NOT COMPLETED|Overall Study||0
11186579|NCT01738919|12376155|FG000|STARTED|Overall Study||15
11186580|NCT01738919|12376156|FG001|STARTED|Overall Study||17
11186581|NCT01738919|12376155|FG000|COMPLETED|Overall Study||14
11186582|NCT01738919|12376156|FG001|COMPLETED|Overall Study||14
11186583|NCT01738919|12376155|FG000|NOT COMPLETED|Overall Study||1
11186584|NCT01738919|12376156|FG001|NOT COMPLETED|Overall Study||3
11186585|NCT01738971|12376167|FG000|STARTED|Overall Study|54 participants recruited to this arm|54
11186586|NCT01738971|12376168|FG001|STARTED|Overall Study|58 participants recruited to this arm|58
11186587|NCT01738971|12376169|FG002|STARTED|Overall Study|56 participants recruited to this arm|56
11186588|NCT01738971|12376167|FG000|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
11186589|NCT01738971|12376168|FG001|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
11186590|NCT01738971|12376169|FG002|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
11186591|NCT01738971|12376167|FG000|NOT COMPLETED|Overall Study||19
11186592|NCT01738971|12376168|FG001|NOT COMPLETED|Overall Study||30
11186593|NCT01738971|12376169|FG002|NOT COMPLETED|Overall Study||17
11186594|NCT01738984|12376179|FG000|STARTED|Overall Study||250
11186595|NCT01738984|12376180|FG001|STARTED|Overall Study||249
11186596|NCT01738984|12376179|FG000|COMPLETED|Overall Study||186
11186597|NCT01738984|12376180|FG001|COMPLETED|Overall Study||210
11186598|NCT01738984|12376179|FG000|NOT COMPLETED|Overall Study||64
11186599|NCT01738984|12376180|FG001|NOT COMPLETED|Overall Study||39
11026943|NCT00831129|12205577|FG000|STARTED|Overall Study||20
11186600|NCT01739231|12376192|FG000|STARTED|Part A||24
11186601|NCT01739231|12376193|FG001|STARTED|Part A||24
11186602|NCT01739231|12376194|FG002|STARTED|Part A||12
11186603|NCT01739231|12376195|FG003|STARTED|Part A||0
11186604|NCT01739231|12376192|FG000|Received All 3 Vaccinations|Part A||21
11186605|NCT01739231|12376193|FG001|Received All 3 Vaccinations|Part A||20
11186606|NCT01739231|12376194|FG002|Received All 3 Vaccinations|Part A||12
11186607|NCT01739231|12376195|FG003|Received All 3 Vaccinations|Part A||0
11186608|NCT01739231|12376192|FG000|COMPLETED|Part A||20
11186609|NCT01739231|12376193|FG001|COMPLETED|Part A||17
11186610|NCT01739231|12376194|FG002|COMPLETED|Part A||12
11186611|NCT01739231|12376195|FG003|COMPLETED|Part A||0
11186612|NCT01739231|12376192|FG000|NOT COMPLETED|Part A||4
11186613|NCT01739231|12376193|FG001|NOT COMPLETED|Part A||7
11186614|NCT01739231|12376194|FG002|NOT COMPLETED|Part A||0
11186615|NCT01739231|12376195|FG003|NOT COMPLETED|Part A||0
11186616|NCT01739231|12376192|FG000|STARTED|Part B||20
11186617|NCT01739231|12376193|FG001|STARTED|Part B||17
11186618|NCT01739231|12376194|FG002|STARTED|Part B||12
11186619|NCT01739231|12376195|FG003|STARTED|Part B||21
11186620|NCT01739231|12376192|FG000|Challenged|Part B||13
11186621|NCT01739231|12376193|FG001|Challenged|Part B||13
11186622|NCT01739231|12376194|FG002|Challenged|Part B||10
11186623|NCT01739231|12376195|FG003|Challenged|Part B||21
11186624|NCT01739231|12376192|FG000|COMPLETED|Part B||13
11186625|NCT01739231|12376193|FG001|COMPLETED|Part B||12
11186626|NCT01739231|12376194|FG002|COMPLETED|Part B||10
11186627|NCT01739231|12376195|FG003|COMPLETED|Part B||19
11186628|NCT01739231|12376192|FG000|NOT COMPLETED|Part B||7
11186629|NCT01739231|12376193|FG001|NOT COMPLETED|Part B||5
11186630|NCT01739231|12376194|FG002|NOT COMPLETED|Part B||2
11186631|NCT01739231|12376195|FG003|NOT COMPLETED|Part B||2
11186632|NCT01739309|12376213|FG000|STARTED|Overall Study||28
11186633|NCT01739309|12376213|FG000|Received at Least One Dose of Study Drug|Overall Study||28
11186634|NCT01739309|12376213|FG000|Death Due to Any Cause|Overall Study||17
11186635|NCT01739309|12376213|FG000|Alive and on Study, Off Treatment|Overall Study||8
11186636|NCT01739309|12376213|FG000|COMPLETED|Overall Study||25
11186637|NCT01739309|12376213|FG000|NOT COMPLETED|Overall Study||3
11186638|NCT01739335|12376221|FG000|STARTED|Overall Study||41
11186639|NCT01739335|12376222|FG001|STARTED|Overall Study||40
11186640|NCT01739335|12376221|FG000|COMPLETED|Overall Study||34
11186641|NCT01739335|12376222|FG001|COMPLETED|Overall Study||35
11186642|NCT01739335|12376221|FG000|NOT COMPLETED|Overall Study||7
11186643|NCT01739335|12376222|FG001|NOT COMPLETED|Overall Study||5
11186644|NCT01739348|12376236|FG000|STARTED|Part I (Base Study)||703
11186645|NCT01739348|12376237|FG001|STARTED|Part I (Base Study)||700
11186646|NCT01739348|12376238|FG002|STARTED|Part I (Base Study)||103
11186647|NCT01739348|12376239|FG003|STARTED|Part I (Base Study)||705
11186648|NCT01739348|12376236|FG000|Treated|Part I (Base Study)||702
11186649|NCT01739348|12376237|FG001|Treated|Part I (Base Study)||700
11186650|NCT01739348|12376238|FG002|Treated|Part I (Base Study)||103
11186651|NCT01739348|12376239|FG003|Treated|Part I (Base Study)||705
11186652|NCT01739348|12376236|FG000|COMPLETED|Part I (Base Study)||501
11186653|NCT01739348|12376237|FG001|COMPLETED|Part I (Base Study)||497
11186654|NCT01739348|12376238|FG002|COMPLETED|Part I (Base Study)||77
11186655|NCT01739348|12376239|FG003|COMPLETED|Part I (Base Study)||516
11186656|NCT01739348|12376236|FG000|NOT COMPLETED|Part I (Base Study)||202
11186657|NCT01739348|12376237|FG001|NOT COMPLETED|Part I (Base Study)||203
11186658|NCT01739348|12376238|FG002|NOT COMPLETED|Part I (Base Study)||26
11186659|NCT01739348|12376239|FG003|NOT COMPLETED|Part I (Base Study)||189
11186660|NCT01739348|12376236|FG000|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
11186661|NCT01739348|12376237|FG001|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
11186662|NCT01739348|12376238|FG002|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
11186663|NCT01739348|12376239|FG003|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
11186664|NCT01739348|12376236|FG000|Treated|Part II (Extension Study)||379
11186665|NCT01739348|12376237|FG001|Treated|Part II (Extension Study)||365
11186666|NCT01739348|12376238|FG002|Treated|Part II (Extension Study)||61
11186667|NCT01739348|12376239|FG003|Treated|Part II (Extension Study)||394
11186668|NCT01739348|12376236|FG000|COMPLETED|Part II (Extension Study)||0
11186669|NCT01739348|12376237|FG001|COMPLETED|Part II (Extension Study)||0
11186670|NCT01739348|12376238|FG002|COMPLETED|Part II (Extension Study)||0
11186671|NCT01739348|12376239|FG003|COMPLETED|Part II (Extension Study)||0
11186672|NCT01739348|12376236|FG000|NOT COMPLETED|Part II (Extension Study)||379
11186673|NCT01739348|12376237|FG001|NOT COMPLETED|Part II (Extension Study)||366
11186674|NCT01739348|12376238|FG002|NOT COMPLETED|Part II (Extension Study)||61
11186675|NCT01739348|12376239|FG003|NOT COMPLETED|Part II (Extension Study)||396
11186676|NCT01739361|12376255|FG000|STARTED|Overall Study||21
11186677|NCT01739361|12376256|FG001|STARTED|Overall Study||23
11186678|NCT01739361|12376255|FG000|COMPLETED|Overall Study||18
11186679|NCT01739361|12376256|FG001|COMPLETED|Overall Study||22
11186680|NCT01739361|12376255|FG000|NOT COMPLETED|Overall Study||3
11186681|NCT01739361|12376256|FG001|NOT COMPLETED|Overall Study||1
11186682|NCT01739400|12376264|FG000|STARTED|Overall Study||109
11186683|NCT01739400|12376265|FG001|STARTED|Overall Study||108
11186684|NCT01739400|12376264|FG000|Treated With 10 mg Macitentan|Overall Study||109
11186685|NCT01739400|12376265|FG001|Treated With 10 mg Macitentan|Overall Study||108
11186686|NCT01739400|12376264|FG000|COMPLETED|Overall Study||92
11186687|NCT01739400|12376265|FG001|COMPLETED|Overall Study||99
11186688|NCT01739400|12376264|FG000|NOT COMPLETED|Overall Study||17
11186689|NCT01739400|12376265|FG001|NOT COMPLETED|Overall Study||9
11186690|NCT01739595|12376273|FG000|STARTED|Overall Study||112
11186691|NCT01739595|12376274|FG001|STARTED|Overall Study||22
11186692|NCT01739595|12376275|FG002|STARTED|Overall Study||47
11186693|NCT01739595|12376273|FG000|COMPLETED|Overall Study||99
11186694|NCT01739595|12376274|FG001|COMPLETED|Overall Study||21
11186695|NCT01739595|12376275|FG002|COMPLETED|Overall Study||45
11186696|NCT01739595|12376273|FG000|NOT COMPLETED|Overall Study||13
11186697|NCT01739595|12376274|FG001|NOT COMPLETED|Overall Study||1
11186698|NCT01739595|12376275|FG002|NOT COMPLETED|Overall Study||2
11186699|NCT01739699|12376284|FG000|STARTED|Overall Study||70
11186700|NCT01739699|12376285|FG001|STARTED|Overall Study||70
11186701|NCT01739699|12376284|FG000|COMPLETED|Overall Study||66
11186702|NCT01739699|12376285|FG001|COMPLETED|Overall Study||65
11186703|NCT01739699|12376284|FG000|NOT COMPLETED|Overall Study||4
11186704|NCT01739699|12376285|FG001|NOT COMPLETED|Overall Study||5
11186705|NCT01739764|12376294|FG000|STARTED|Overall Study||29
11186706|NCT01739764|12376295|FG001|STARTED|Overall Study||40
11186707|NCT01739764|12376296|FG002|STARTED|Overall Study||146
11186708|NCT01739764|12376294|FG000|COMPLETED|Overall Study||3
11186709|NCT01739764|12376295|FG001|COMPLETED|Overall Study||4
11186710|NCT01739764|12376296|FG002|COMPLETED|Overall Study||20
11186711|NCT01739764|12376294|FG000|NOT COMPLETED|Overall Study||26
11186712|NCT01739764|12376295|FG001|NOT COMPLETED|Overall Study||36
11186713|NCT01739764|12376296|FG002|NOT COMPLETED|Overall Study||126
11186714|NCT01739790|12376306|FG000|STARTED|Overall Study||24
11186715|NCT01739790|12376307|FG001|STARTED|Overall Study||27
11186716|NCT01739790|12376306|FG000|COMPLETED|Overall Study||22
11186717|NCT01739790|12376307|FG001|COMPLETED|Overall Study||23
11186718|NCT01739790|12376306|FG000|NOT COMPLETED|Overall Study||2
11186719|NCT01739790|12376307|FG001|NOT COMPLETED|Overall Study||4
11186720|NCT01739803|12376315|FG000|STARTED|Overall Study||76
11186721|NCT01739803|12376316|FG001|STARTED|Overall Study||74
11186722|NCT01739803|12376315|FG000|COMPLETED|Overall Study||67
11186723|NCT01739803|12376316|FG001|COMPLETED|Overall Study||68
11186724|NCT01739803|12376315|FG000|NOT COMPLETED|Overall Study||9
11186725|NCT01739803|12376316|FG001|NOT COMPLETED|Overall Study||6
11186726|NCT01739933|12376324|FG000|STARTED|Overall Study|Underwent randomization and received study drug|214
11186727|NCT01739933|12376325|FG001|STARTED|Overall Study|Underwent randomization and received study drug|208
11186728|NCT01739933|12376324|FG000|Discharged From Hospital and Eligible for Follow-up|Overall Study||140
11186729|NCT01739933|12376325|FG001|Discharged From Hospital and Eligible for Follow-up|Overall Study||147
11186730|NCT01739933|12376324|FG000|COMPLETED|Overall Study|97% of those eligible (alive and who did not withdraw)|108
11186731|NCT01739933|12376325|FG001|COMPLETED|Overall Study|91% of those eligible (alive and who did not withdraw)|101
11186732|NCT01739933|12376324|FG000|NOT COMPLETED|Overall Study||106
11186733|NCT01739933|12376325|FG001|NOT COMPLETED|Overall Study||107
11186734|NCT01740089|12376334|FG000|STARTED|First 12 Weeks of Treatment||50
11186735|NCT01740089|12376335|FG001|STARTED|First 12 Weeks of Treatment||50
11186736|NCT01740089|12376336|FG002|STARTED|First 12 Weeks of Treatment||50
11186737|NCT01740089|12376334|FG000|COMPLETED|First 12 Weeks of Treatment||50
11186738|NCT01740089|12376335|FG001|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
11186739|NCT01740089|12376336|FG002|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
11186740|NCT01740089|12376334|FG000|NOT COMPLETED|First 12 Weeks of Treatment||0
11186741|NCT01740089|12376335|FG001|NOT COMPLETED|First 12 Weeks of Treatment||2
11186742|NCT01740089|12376336|FG002|NOT COMPLETED|First 12 Weeks of Treatment||2
11186743|NCT01740089|12376334|FG000|STARTED|After 12 Weeks||50
11186744|NCT01740089|12376335|FG001|STARTED|After 12 Weeks||48
11186745|NCT01740089|12376336|FG002|STARTED|After 12 Weeks||48
11186746|NCT01740089|12376334|FG000|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
11186747|NCT01740089|12376335|FG001|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
11186748|NCT01740089|12376336|FG002|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
11186749|NCT01740089|12376334|FG000|NOT COMPLETED|After 12 Weeks||7
11186750|NCT01740089|12376335|FG001|NOT COMPLETED|After 12 Weeks||3
11186751|NCT01740089|12376336|FG002|NOT COMPLETED|After 12 Weeks||11
11186752|NCT01740128|12376347|FG000|STARTED|Overall Study||10
11186753|NCT01740128|12376348|FG001|STARTED|Overall Study||11
11186754|NCT01740128|12376347|FG000|COMPLETED|Overall Study||4
11186755|NCT01740128|12376348|FG001|COMPLETED|Overall Study||4
11186756|NCT01740128|12376347|FG000|NOT COMPLETED|Overall Study||6
11186757|NCT01740128|12376348|FG001|NOT COMPLETED|Overall Study||7
11186758|NCT01740206|12376356|FG000|STARTED|Overall Study||14
11186759|NCT01740206|12376357|FG001|STARTED|Overall Study||34
11186760|NCT01740206|12376356|FG000|COMPLETED|Overall Study||14
11186761|NCT01740206|12376357|FG001|COMPLETED|Overall Study||34
11186762|NCT01740206|12376356|FG000|NOT COMPLETED|Overall Study||0
11186763|NCT01740206|12376357|FG001|NOT COMPLETED|Overall Study||0
11186764|NCT01740258|12376363|FG000|STARTED|Overall Study||68
11186765|NCT01740258|12376363|FG000|Entered Part A|Overall Study||68
11186766|NCT01740258|12376363|FG000|Entered Part B|Overall Study||62
11026944|NCT00831129|12205578|FG001|STARTED|Overall Study||33
11026945|NCT00831129|12205577|FG000|COMPLETED|Overall Study||20
11026946|NCT00831129|12205578|FG001|COMPLETED|Overall Study||23
11026947|NCT00831129|12205577|FG000|NOT COMPLETED|Overall Study||0
11026948|NCT00831129|12205578|FG001|NOT COMPLETED|Overall Study||10
11026949|NCT00831181|12205584|FG000|STARTED|Overall Study||27
11026950|NCT00831181|12205584|FG000|COMPLETED|Overall Study||15
11026951|NCT00831181|12205584|FG000|NOT COMPLETED|Overall Study||12
11026952|NCT00831233|12205591|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
11186767|NCT01740258|12376363|FG000|Entered Part C|Overall Study||20
11186768|NCT01740258|12376363|FG000|Entered Part D|Overall Study||42
11186769|NCT01740258|12376363|FG000|COMPLETED|Overall Study||68
11186770|NCT01740258|12376363|FG000|NOT COMPLETED|Overall Study||0
11186771|NCT01740323|12376369|FG000|STARTED|Overall Study||15
11186772|NCT01740323|12376370|FG001|STARTED|Overall Study||15
11186773|NCT01740323|12376369|FG000|COMPLETED|Overall Study||13
11186774|NCT01740323|12376370|FG001|COMPLETED|Overall Study||15
11186775|NCT01740323|12376369|FG000|NOT COMPLETED|Overall Study||2
11186776|NCT01740323|12376370|FG001|NOT COMPLETED|Overall Study||0
11186777|NCT01740362|12376380|FG000|STARTED|Overall Study||6
11186778|NCT01740362|12376381|FG001|STARTED|Overall Study||6
11186779|NCT01740362|12376382|FG002|STARTED|Overall Study||6
11186780|NCT01740362|12376383|FG003|STARTED|Overall Study||6
11186781|NCT01740362|12376380|FG000|COMPLETED|Overall Study||6
11186782|NCT01740362|12376381|FG001|COMPLETED|Overall Study||6
11186783|NCT01740362|12376382|FG002|COMPLETED|Overall Study||6
11186784|NCT01740362|12376383|FG003|COMPLETED|Overall Study||6
11186785|NCT01740362|12376380|FG000|NOT COMPLETED|Overall Study||0
11186786|NCT01740362|12376381|FG001|NOT COMPLETED|Overall Study||0
11186787|NCT01740362|12376382|FG002|NOT COMPLETED|Overall Study||0
11026953|NCT00831233|12205592|FG001|STARTED|Overall Study|ITT population.|13
11026954|NCT00831233|12205591|FG000|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
11026955|NCT00831233|12205592|FG001|Full Analysis Set (FAS)|Overall Study||13
11026956|NCT00831233|12205591|FG000|Per Protocol (PP) Analysis Set|Overall Study||26
11026957|NCT00831233|12205592|FG001|Per Protocol (PP) Analysis Set|Overall Study||11
11026958|NCT00831233|12205591|FG000|COMPLETED|Overall Study||26
11026959|NCT00831233|12205592|FG001|COMPLETED|Overall Study||12
11026960|NCT00831233|12205591|FG000|NOT COMPLETED|Overall Study||3
11026961|NCT00831233|12205592|FG001|NOT COMPLETED|Overall Study||1
11026962|NCT00831272|12205602|FG000|STARTED|Overall Study||38
11026963|NCT00831272|12205603|FG001|STARTED|Overall Study||44
11026964|NCT00831272|12205604|FG002|STARTED|Overall Study||73
11186788|NCT01740362|12376383|FG003|NOT COMPLETED|Overall Study||0
11186789|NCT01740388|12376395|FG000|STARTED|Overall Study||64
11186790|NCT01740388|12376396|FG001|STARTED|Overall Study||72
11186791|NCT01740388|12376395|FG000|COMPLETED|Overall Study||18
11186792|NCT01740388|12376396|FG001|COMPLETED|Overall Study||28
11186793|NCT01740388|12376395|FG000|NOT COMPLETED|Overall Study||46
11186794|NCT01740388|12376396|FG001|NOT COMPLETED|Overall Study||44
11186795|NCT01740401|12376402|FG000|STARTED|Overall Study||10
11186796|NCT01740401|12376402|FG000|COMPLETED|Overall Study||0
11186797|NCT01740401|12376402|FG000|NOT COMPLETED|Overall Study||10
11186798|NCT01740414|12376408|FG000|STARTED|Overall Study||12
11186799|NCT01740414|12376409|FG001|STARTED|Overall Study||16
11186800|NCT01740414|12376408|FG000|COMPLETED|Overall Study||3
11186801|NCT01740414|12376409|FG001|COMPLETED|Overall Study||8
11186802|NCT01740414|12376408|FG000|NOT COMPLETED|Overall Study||9
11186803|NCT01740414|12376409|FG001|NOT COMPLETED|Overall Study||8
11186804|NCT01740440|12376420|FG000|STARTED|Overall Study||30
11186805|NCT01740440|12376420|FG000|COMPLETED|Overall Study||27
11186806|NCT01740440|12376420|FG000|NOT COMPLETED|Overall Study||3
11186807|NCT01740713|12376428|FG000|STARTED|Overall Study||6
11186808|NCT01740713|12376429|FG001|STARTED|Overall Study||8
11186809|NCT01740713|12376430|FG002|STARTED|Overall Study||7
11186810|NCT01740713|12376428|FG000|COMPLETED|Overall Study||6
11186811|NCT01740713|12376429|FG001|COMPLETED|Overall Study||6
11186812|NCT01740713|12376430|FG002|COMPLETED|Overall Study||6
11186813|NCT01740713|12376428|FG000|NOT COMPLETED|Overall Study||0
11186814|NCT01740713|12376429|FG001|NOT COMPLETED|Overall Study||2
11186815|NCT01740713|12376430|FG002|NOT COMPLETED|Overall Study||1
11186816|NCT01740726|12376442|FG000|STARTED|Overall Study||0
11186817|NCT01740726|12376443|FG001|STARTED|Overall Study||1
11186818|NCT01740726|12376442|FG000|COMPLETED|Overall Study||0
11186819|NCT01740726|12376443|FG001|COMPLETED|Overall Study||1
11186820|NCT01740726|12376442|FG000|NOT COMPLETED|Overall Study||0
11186821|NCT01740726|12376443|FG001|NOT COMPLETED|Overall Study||0
11186822|NCT01740791|12376455|FG000|STARTED|Overall Study||22
11186823|NCT01740791|12376456|FG001|STARTED|Overall Study||7
11186824|NCT01740791|12376457|FG002|STARTED|Overall Study||17
11186825|NCT01740791|12376458|FG003|STARTED|Overall Study||14
11186826|NCT01740791|12376459|FG004|STARTED|Overall Study||9
11186827|NCT01740791|12376460|FG005|STARTED|Overall Study||34
11186828|NCT01740791|12376455|FG000|COMPLETED|Overall Study||10
11186829|NCT01740791|12376456|FG001|COMPLETED|Overall Study||4
11186830|NCT01740791|12376457|FG002|COMPLETED|Overall Study||11
11186831|NCT01740791|12376458|FG003|COMPLETED|Overall Study||7
11186832|NCT01740791|12376459|FG004|COMPLETED|Overall Study||6
11186833|NCT01740791|12376460|FG005|COMPLETED|Overall Study||23
11186834|NCT01740791|12376455|FG000|NOT COMPLETED|Overall Study||12
11186835|NCT01740791|12376456|FG001|NOT COMPLETED|Overall Study||3
11186836|NCT01740791|12376457|FG002|NOT COMPLETED|Overall Study||6
11186837|NCT01740791|12376458|FG003|NOT COMPLETED|Overall Study||7
11186838|NCT01740791|12376459|FG004|NOT COMPLETED|Overall Study||3
11186839|NCT01740791|12376460|FG005|NOT COMPLETED|Overall Study||11
11186840|NCT01740817|12376515|FG000|STARTED|First Intervention (48 h)||8
11186841|NCT01740817|12376516|FG001|STARTED|First Intervention (48 h)||4
11186842|NCT01740817|12376515|FG000|COMPLETED|First Intervention (48 h)||8
11186843|NCT01740817|12376516|FG001|COMPLETED|First Intervention (48 h)||4
11186844|NCT01740817|12376515|FG000|NOT COMPLETED|First Intervention (48 h)||0
11186845|NCT01740817|12376516|FG001|NOT COMPLETED|First Intervention (48 h)||0
11186846|NCT01740817|12376515|FG000|STARTED|Washout (4-6 Weeks)||8
11186847|NCT01740817|12376516|FG001|STARTED|Washout (4-6 Weeks)||4
11186848|NCT01740817|12376515|FG000|COMPLETED|Washout (4-6 Weeks)||8
11186849|NCT01740817|12376516|FG001|COMPLETED|Washout (4-6 Weeks)||4
11186850|NCT01740817|12376515|FG000|NOT COMPLETED|Washout (4-6 Weeks)||0
11186851|NCT01740817|12376516|FG001|NOT COMPLETED|Washout (4-6 Weeks)||0
11186852|NCT01740817|12376515|FG000|STARTED|Second Intervention (48 h)||8
11186853|NCT01740817|12376516|FG001|STARTED|Second Intervention (48 h)||4
11186854|NCT01740817|12376515|FG000|COMPLETED|Second Intervention (48 h)||8
11186855|NCT01740817|12376516|FG001|COMPLETED|Second Intervention (48 h)||4
11186856|NCT01740817|12376515|FG000|NOT COMPLETED|Second Intervention (48 h)||0
11186857|NCT01740817|12376516|FG001|NOT COMPLETED|Second Intervention (48 h)||0
11186858|NCT01741012|12376522|FG000|STARTED|Overall Study||37
11186859|NCT01741012|12376522|FG000|COMPLETED|Overall Study||34
11186860|NCT01741012|12376522|FG000|NOT COMPLETED|Overall Study||3
11186861|NCT01741259|12376529|FG000|STARTED|Overall Study||133
11186862|NCT01741259|12376530|FG001|STARTED|Overall Study||135
11186863|NCT01741259|12376529|FG000|COMPLETED|Overall Study||127
11186864|NCT01741259|12376530|FG001|COMPLETED|Overall Study||129
11186865|NCT01741259|12376529|FG000|NOT COMPLETED|Overall Study||6
11186866|NCT01741259|12376530|FG001|NOT COMPLETED|Overall Study||6
11186867|NCT01741272|12376538|FG000|STARTED|Overall Study||92
11186868|NCT01741272|12376539|FG001|STARTED|Overall Study||97
11186869|NCT01741272|12376538|FG000|COMPLETED|Overall Study||92
11186870|NCT01741272|12376539|FG001|COMPLETED|Overall Study||97
11186871|NCT01741272|12376538|FG000|NOT COMPLETED|Overall Study||0
11186872|NCT01741272|12376539|FG001|NOT COMPLETED|Overall Study||0
11186873|NCT01741350|12376547|FG000|STARTED|Study Intervention||149
11186874|NCT01741350|12376548|FG001|STARTED|Study Intervention||155
11186875|NCT01741350|12376547|FG000|COMPLETED|Study Intervention||149
11186876|NCT01741350|12376548|FG001|COMPLETED|Study Intervention||155
11186877|NCT01741350|12376547|FG000|NOT COMPLETED|Study Intervention||0
11186878|NCT01741350|12376548|FG001|NOT COMPLETED|Study Intervention||0
11186879|NCT01741350|12376547|FG000|STARTED|Post Intervention Assessment (at Week 4)||149
11186880|NCT01741350|12376548|FG001|STARTED|Post Intervention Assessment (at Week 4)||155
11186881|NCT01741350|12376547|FG000|COMPLETED|Post Intervention Assessment (at Week 4)||135
11186882|NCT01741350|12376548|FG001|COMPLETED|Post Intervention Assessment (at Week 4)||141
11186883|NCT01741350|12376547|FG000|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
11186884|NCT01741350|12376548|FG001|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
11186885|NCT01741350|12376547|FG000|STARTED|3-Month Follow-up Assessment||135
11186886|NCT01741350|12376548|FG001|STARTED|3-Month Follow-up Assessment||141
11186887|NCT01741350|12376547|FG000|COMPLETED|3-Month Follow-up Assessment||129
11186888|NCT01741350|12376548|FG001|COMPLETED|3-Month Follow-up Assessment||119
11186889|NCT01741350|12376547|FG000|NOT COMPLETED|3-Month Follow-up Assessment||6
11186890|NCT01741350|12376548|FG001|NOT COMPLETED|3-Month Follow-up Assessment||22
11186891|NCT01741350|12376547|FG000|STARTED|6-Month Follow-up Assessment||129
11186892|NCT01741350|12376548|FG001|STARTED|6-Month Follow-up Assessment||119
11186893|NCT01741350|12376547|FG000|COMPLETED|6-Month Follow-up Assessment||114
11186894|NCT01741350|12376548|FG001|COMPLETED|6-Month Follow-up Assessment||111
11186895|NCT01741350|12376547|FG000|NOT COMPLETED|6-Month Follow-up Assessment||15
11186896|NCT01741350|12376548|FG001|NOT COMPLETED|6-Month Follow-up Assessment||8
11186897|NCT01741350|12376547|FG000|STARTED|12-Month Follow-up Assessment||114
11186898|NCT01741350|12376548|FG001|STARTED|12-Month Follow-up Assessment||111
11186899|NCT01741350|12376547|FG000|COMPLETED|12-Month Follow-up Assessment||111
11186900|NCT01741350|12376548|FG001|COMPLETED|12-Month Follow-up Assessment||109
11186901|NCT01741350|12376547|FG000|NOT COMPLETED|12-Month Follow-up Assessment||3
11186902|NCT01741350|12376548|FG001|NOT COMPLETED|12-Month Follow-up Assessment||2
11186903|NCT01741454|12376558|FG000|STARTED|Overall Study||49
11186904|NCT01741454|12376559|FG001|STARTED|Overall Study||50
11186905|NCT01741454|12376560|FG002|STARTED|Overall Study||39
11186906|NCT01741454|12376561|FG003|STARTED|Overall Study||43
11186907|NCT01741454|12376558|FG000|COMPLETED|Overall Study||36
11186908|NCT01741454|12376559|FG001|COMPLETED|Overall Study||44
11186909|NCT01741454|12376560|FG002|COMPLETED|Overall Study||22
11186910|NCT01741454|12376561|FG003|COMPLETED|Overall Study||21
11186911|NCT01741454|12376558|FG000|NOT COMPLETED|Overall Study||13
11186912|NCT01741454|12376559|FG001|NOT COMPLETED|Overall Study||6
11186913|NCT01741454|12376560|FG002|NOT COMPLETED|Overall Study||17
11186914|NCT01741454|12376561|FG003|NOT COMPLETED|Overall Study||22
11186915|NCT01741532|12376577|FG000|STARTED|Overall Study||59
11186916|NCT01741532|12376578|FG001|STARTED|Overall Study||30
11186917|NCT01741532|12376577|FG000|Exposed|Overall Study||58
11186918|NCT01741532|12376578|FG001|Exposed|Overall Study||30
11186919|NCT01741532|12376577|FG000|Provided Post-baseline Efficacy Data|Overall Study||58
11186920|NCT01741532|12376578|FG001|Provided Post-baseline Efficacy Data|Overall Study||28
11186921|NCT01741532|12376577|FG000|COMPLETED|Overall Study||49
11186922|NCT01741532|12376578|FG001|COMPLETED|Overall Study||27
11186923|NCT01741532|12376577|FG000|NOT COMPLETED|Overall Study||10
11186924|NCT01741532|12376578|FG001|NOT COMPLETED|Overall Study||3
11186925|NCT01741545|12376590|FG000|STARTED|Treatment Period||12
11186926|NCT01741545|12376591|FG001|STARTED|Treatment Period||39
11186927|NCT01741545|12376590|FG000|COMPLETED|Treatment Period||11
11186928|NCT01741545|12376591|FG001|COMPLETED|Treatment Period||35
11186929|NCT01741545|12376590|FG000|NOT COMPLETED|Treatment Period||1
11186930|NCT01741545|12376591|FG001|NOT COMPLETED|Treatment Period||4
11186931|NCT01741545|12376590|FG000|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12
11186932|NCT01741545|12376591|FG001|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39
11186933|NCT01741545|12376590|FG000|COMPLETED|Follow-up Period (24 Weeks)||11
11186934|NCT01741545|12376591|FG001|COMPLETED|Follow-up Period (24 Weeks)||37
11186935|NCT01741545|12376590|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1
11186936|NCT01741545|12376591|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||2
11186937|NCT01741688|12376597|FG000|STARTED|Overall Study||16
11186938|NCT01741688|12376597|FG000|COMPLETED|Overall Study||13
11186939|NCT01741688|12376597|FG000|NOT COMPLETED|Overall Study||3
11186940|NCT01741701|12376604|FG000|STARTED|Overall Study||18
11186941|NCT01741701|12376605|FG001|STARTED|Overall Study||15
11186942|NCT01741701|12376604|FG000|COMPLETED|Overall Study||13
11186943|NCT01741701|12376605|FG001|COMPLETED|Overall Study||13
11186944|NCT01741701|12376604|FG000|NOT COMPLETED|Overall Study||5
11186945|NCT01741701|12376605|FG001|NOT COMPLETED|Overall Study||2
11204612|NCT01854281|12395191|FG001|COMPLETED|Overall Study||19
11204613|NCT01854281|12395192|FG002|COMPLETED|Overall Study||5
11204614|NCT01854281|12395193|FG003|COMPLETED|Overall Study||8
11204615|NCT01854281|12395190|FG000|NOT COMPLETED|Overall Study||0
11204616|NCT01854281|12395191|FG001|NOT COMPLETED|Overall Study||0
11204617|NCT01854281|12395192|FG002|NOT COMPLETED|Overall Study||0
11204618|NCT01854281|12395193|FG003|NOT COMPLETED|Overall Study||0
11204619|NCT01854359|12395205|FG000|STARTED|Overall Study||31
11204620|NCT01854359|12395206|FG001|STARTED|Overall Study||30
11204621|NCT01854359|12395205|FG000|COMPLETED|Overall Study||26
11204622|NCT01854359|12395206|FG001|COMPLETED|Overall Study||22
11204623|NCT01854359|12395205|FG000|NOT COMPLETED|Overall Study||5
11204624|NCT01854359|12395206|FG001|NOT COMPLETED|Overall Study||8
11204625|NCT01854528|12395222|FG000|STARTED|Overall Study||101
11204626|NCT01854528|12395223|FG001|STARTED|Overall Study||47
11204627|NCT01854528|12395222|FG000|COMPLETED|Overall Study||101
11204628|NCT01854528|12395223|FG001|COMPLETED|Overall Study||32
11204629|NCT01854528|12395222|FG000|NOT COMPLETED|Overall Study||0
11204630|NCT01854528|12395223|FG001|NOT COMPLETED|Overall Study||15
11204631|NCT01854593|12395231|FG000|STARTED|Overall Study||34
11204632|NCT01854593|12395232|FG001|STARTED|Overall Study||35
11204633|NCT01854593|12395231|FG000|COMPLETED|Overall Study||32
11204634|NCT01854593|12395232|FG001|COMPLETED|Overall Study||34
11204635|NCT01854593|12395231|FG000|NOT COMPLETED|Overall Study||2
11204636|NCT01854593|12395232|FG001|NOT COMPLETED|Overall Study||1
11204637|NCT01854632|12395241|FG000|STARTED|Overall Study||1174
11204638|NCT01854632|12395242|FG001|STARTED|Overall Study||587
11204639|NCT01854632|12395241|FG000|COMPLETED|Overall Study||1148
11204640|NCT01854632|12395242|FG001|COMPLETED|Overall Study||574
11204641|NCT01854632|12395241|FG000|NOT COMPLETED|Overall Study||26
11204642|NCT01854632|12395242|FG001|NOT COMPLETED|Overall Study||13
11204643|NCT01854645|12395253|FG000|STARTED|Overall Study||527
11204644|NCT01854645|12395254|FG001|STARTED|Overall Study||451
11204645|NCT01854645|12395255|FG002|STARTED|Overall Study||452
11204646|NCT01854645|12395256|FG003|STARTED|Overall Study||453
11204647|NCT01854645|12395257|FG004|STARTED|Overall Study||220
11204648|NCT01854645|12395253|FG000|COMPLETED|Overall Study||429
11204649|NCT01854645|12395254|FG001|COMPLETED|Overall Study||345
11204650|NCT01854645|12395255|FG002|COMPLETED|Overall Study||370
11204651|NCT01854645|12395256|FG003|COMPLETED|Overall Study||391
11204652|NCT01854645|12395257|FG004|COMPLETED|Overall Study||160
11204653|NCT01854645|12395253|FG000|NOT COMPLETED|Overall Study||98
11204654|NCT01854645|12395254|FG001|NOT COMPLETED|Overall Study||106
11204655|NCT01854645|12395255|FG002|NOT COMPLETED|Overall Study||82
11204656|NCT01854645|12395256|FG003|NOT COMPLETED|Overall Study||62
11204657|NCT01854645|12395257|FG004|NOT COMPLETED|Overall Study||60
11204658|NCT01854658|12395273|FG000|STARTED|Overall Study||439
11204659|NCT01854658|12395274|FG001|STARTED|Overall Study||440
11204660|NCT01854658|12395275|FG002|STARTED|Overall Study||512
11204661|NCT01854658|12395276|FG003|STARTED|Overall Study||224
11204662|NCT01854658|12395273|FG000|COMPLETED|Overall Study||346
11204663|NCT01854658|12395274|FG001|COMPLETED|Overall Study||365
11204664|NCT01854658|12395275|FG002|COMPLETED|Overall Study||432
11204665|NCT01854658|12395276|FG003|COMPLETED|Overall Study||165
11204666|NCT01854658|12395273|FG000|NOT COMPLETED|Overall Study||93
11204667|NCT01854658|12395274|FG001|NOT COMPLETED|Overall Study||75
11204668|NCT01854658|12395275|FG002|NOT COMPLETED|Overall Study||80
11204669|NCT01854658|12395276|FG003|NOT COMPLETED|Overall Study||59
11204670|NCT01854697|12395291|FG000|STARTED|Overall Study||69
11204671|NCT01854697|12395292|FG001|STARTED|Overall Study||34
11204672|NCT01854697|12395293|FG002|STARTED|Overall Study||84
11204673|NCT01854697|12395294|FG003|STARTED|Overall Study||83
11204674|NCT01854697|12395295|FG004|STARTED|Overall Study||41
11204675|NCT01854697|12395291|FG000|COMPLETED|Overall Study||63
11204676|NCT01854697|12395292|FG001|COMPLETED|Overall Study||31
11204677|NCT01854697|12395293|FG002|COMPLETED|Overall Study||82
11204678|NCT01854697|12395294|FG003|COMPLETED|Overall Study||80
11204679|NCT01854697|12395295|FG004|COMPLETED|Overall Study||39
11204680|NCT01854697|12395291|FG000|NOT COMPLETED|Overall Study||6
11204681|NCT01854697|12395292|FG001|NOT COMPLETED|Overall Study||3
11204682|NCT01854697|12395293|FG002|NOT COMPLETED|Overall Study||2
11204683|NCT01854697|12395294|FG003|NOT COMPLETED|Overall Study||3
11204684|NCT01854697|12395295|FG004|NOT COMPLETED|Overall Study||2
11204685|NCT01854710|12395305|FG000|STARTED|Overall Study||10
11204686|NCT01854710|12395306|FG001|STARTED|Overall Study||10
11204687|NCT01854710|12395307|FG002|STARTED|Overall Study||10
11204688|NCT01854710|12395308|FG003|STARTED|Overall Study||10
11186946|NCT01741792|12376614|FG000|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
11186947|NCT01741792|12376615|FG001|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
11186948|NCT01741792|12376616|FG002|STARTED|Overall Study||14
11186949|NCT01741792|12376614|FG000|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
11186950|NCT01741792|12376615|FG001|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
11186951|NCT01741792|12376616|FG002|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
11186952|NCT01741792|12376614|FG000|COMPLETED|Overall Study||3
11186953|NCT01741792|12376615|FG001|COMPLETED|Overall Study||1
11186954|NCT01741792|12376616|FG002|COMPLETED|Overall Study||2
11186955|NCT01741792|12376614|FG000|NOT COMPLETED|Overall Study||6
11186956|NCT01741792|12376615|FG001|NOT COMPLETED|Overall Study||1
11186957|NCT01741792|12376616|FG002|NOT COMPLETED|Overall Study||12
11186958|NCT01742065|12376632|FG000|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
11186959|NCT01742065|12376633|FG001|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
11186960|NCT01742065|12376632|FG000|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
11186961|NCT01742065|12376633|FG001|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
11186962|NCT01742065|12376632|FG000|NOT COMPLETED|Overall Study||0
11186963|NCT01742065|12376633|FG001|NOT COMPLETED|Overall Study||0
11186964|NCT01742078|12376648|FG000|STARTED|Overall Study||6
11186965|NCT01742078|12376649|FG001|STARTED|Overall Study||6
11186966|NCT01742078|12376650|FG002|STARTED|Overall Study||6
11186967|NCT01742078|12376651|FG003|STARTED|Overall Study||6
11186968|NCT01742078|12376652|FG004|STARTED|Overall Study||6
11186969|NCT01742078|12376653|FG005|STARTED|Overall Study||6
11186970|NCT01742078|12376654|FG006|STARTED|Overall Study||6
11186971|NCT01742078|12376655|FG007|STARTED|Overall Study||6
11186972|NCT01742078|12376656|FG008|STARTED|Overall Study||12
11186973|NCT01742078|12376648|FG000|RECEIVED STUDY DRUG|Overall Study||6
11186974|NCT01742078|12376649|FG001|RECEIVED STUDY DRUG|Overall Study||6
11186975|NCT01742078|12376650|FG002|RECEIVED STUDY DRUG|Overall Study||6
11186976|NCT01742078|12376651|FG003|RECEIVED STUDY DRUG|Overall Study||6
11186977|NCT01742078|12376652|FG004|RECEIVED STUDY DRUG|Overall Study||6
11186978|NCT01742078|12376653|FG005|RECEIVED STUDY DRUG|Overall Study||6
11186979|NCT01742078|12376654|FG006|RECEIVED STUDY DRUG|Overall Study||6
11186980|NCT01742078|12376655|FG007|RECEIVED STUDY DRUG|Overall Study||6
11186981|NCT01742078|12376656|FG008|RECEIVED STUDY DRUG|Overall Study||12
11186982|NCT01742078|12376648|FG000|COMPLETED|Overall Study||6
11186983|NCT01742078|12376649|FG001|COMPLETED|Overall Study||6
11186984|NCT01742078|12376650|FG002|COMPLETED|Overall Study||6
11186985|NCT01742078|12376651|FG003|COMPLETED|Overall Study||5
11186986|NCT01742078|12376652|FG004|COMPLETED|Overall Study||6
11186987|NCT01742078|12376653|FG005|COMPLETED|Overall Study||6
11186988|NCT01742078|12376654|FG006|COMPLETED|Overall Study||6
11186989|NCT01742078|12376655|FG007|COMPLETED|Overall Study||6
11186990|NCT01742078|12376656|FG008|COMPLETED|Overall Study||12
11186991|NCT01742078|12376648|FG000|NOT COMPLETED|Overall Study||0
11186992|NCT01742078|12376649|FG001|NOT COMPLETED|Overall Study||0
11186993|NCT01742078|12376650|FG002|NOT COMPLETED|Overall Study||0
11186994|NCT01742078|12376651|FG003|NOT COMPLETED|Overall Study||1
11186995|NCT01742078|12376652|FG004|NOT COMPLETED|Overall Study||0
11186996|NCT01742078|12376653|FG005|NOT COMPLETED|Overall Study||0
11186997|NCT01742078|12376654|FG006|NOT COMPLETED|Overall Study||0
11186998|NCT01742078|12376655|FG007|NOT COMPLETED|Overall Study||0
11186999|NCT01742078|12376656|FG008|NOT COMPLETED|Overall Study||0
11187000|NCT01742091|12376684|FG000|STARTED|Overall Study||9
11187001|NCT01742091|12376685|FG001|STARTED|Overall Study||11
11187002|NCT01742091|12376686|FG002|STARTED|Overall Study||10
11187003|NCT01742091|12376687|FG003|STARTED|Overall Study||9
11187004|NCT01742091|12376688|FG004|STARTED|Overall Study||8
11187005|NCT01742091|12376689|FG005|STARTED|Overall Study||12
11187006|NCT01742091|12376684|FG000|RECEIVED STUDY DRUG|Overall Study||9
11187007|NCT01742091|12376685|FG001|RECEIVED STUDY DRUG|Overall Study||11
11187008|NCT01742091|12376686|FG002|RECEIVED STUDY DRUG|Overall Study||10
11187009|NCT01742091|12376687|FG003|RECEIVED STUDY DRUG|Overall Study||9
11187010|NCT01742091|12376688|FG004|RECEIVED STUDY DRUG|Overall Study||8
11187011|NCT01742091|12376689|FG005|RECEIVED STUDY DRUG|Overall Study||12
11187012|NCT01742091|12376684|FG000|COMPLETED|Overall Study||9
11187013|NCT01742091|12376685|FG001|COMPLETED|Overall Study||11
11187014|NCT01742091|12376686|FG002|COMPLETED|Overall Study||10
11187015|NCT01742091|12376687|FG003|COMPLETED|Overall Study||8
11187016|NCT01742091|12376688|FG004|COMPLETED|Overall Study||7
11187017|NCT01742091|12376689|FG005|COMPLETED|Overall Study||10
11187018|NCT01742091|12376684|FG000|NOT COMPLETED|Overall Study||0
11187019|NCT01742091|12376685|FG001|NOT COMPLETED|Overall Study||0
11187020|NCT01742091|12376686|FG002|NOT COMPLETED|Overall Study||0
11187021|NCT01742091|12376687|FG003|NOT COMPLETED|Overall Study||1
11187022|NCT01742091|12376688|FG004|NOT COMPLETED|Overall Study||1
11187023|NCT01742091|12376689|FG005|NOT COMPLETED|Overall Study||2
11187024|NCT01742117|12376705|FG000|STARTED|Overall Study||2641
11187025|NCT01742117|12376706|FG001|STARTED|Overall Study||2635
11187026|NCT01742117|12376705|FG000|COMPLETED|Overall Study||2641
11187027|NCT01742117|12376706|FG001|COMPLETED|Overall Study||2635
11187028|NCT01742117|12376705|FG000|NOT COMPLETED|Overall Study||0
11187029|NCT01742117|12376706|FG001|NOT COMPLETED|Overall Study||0
11187030|NCT01742208|12376715|FG000|STARTED|Overall Study||3
11187031|NCT01742208|12376716|FG001|STARTED|Overall Study||17
11187032|NCT01742208|12376717|FG002|STARTED|Overall Study||16
11187033|NCT01742208|12376715|FG000|COMPLETED|Overall Study||3
11187034|NCT01742208|12376716|FG001|COMPLETED|Overall Study||17
11187035|NCT01742208|12376717|FG002|COMPLETED|Overall Study||16
11187036|NCT01742208|12376715|FG000|NOT COMPLETED|Overall Study||0
11187037|NCT01742208|12376716|FG001|NOT COMPLETED|Overall Study||0
11187038|NCT01742208|12376717|FG002|NOT COMPLETED|Overall Study||0
11187039|NCT01742286|12376734|FG000|STARTED|Escalation Phase||5
11187040|NCT01742286|12376735|FG001|STARTED|Escalation Phase||12
11187041|NCT01742286|12376736|FG002|STARTED|Escalation Phase||6
11187042|NCT01742286|12376737|FG003|STARTED|Escalation Phase||2
11187043|NCT01742286|12376738|FG004|STARTED|Escalation Phase||4
11187044|NCT01742286|12376739|FG005|STARTED|Escalation Phase||5
11187045|NCT01742286|12376740|FG006|STARTED|Escalation Phase||6
11187046|NCT01742286|12376734|FG000|Ended Treatment = Not Completed)|Escalation Phase||5
11187047|NCT01742286|12376735|FG001|Ended Treatment = Not Completed)|Escalation Phase||12
11187048|NCT01742286|12376736|FG002|Ended Treatment = Not Completed)|Escalation Phase||6
11187049|NCT01742286|12376737|FG003|Ended Treatment = Not Completed)|Escalation Phase||2
11187050|NCT01742286|12376738|FG004|Ended Treatment = Not Completed)|Escalation Phase||4
11187051|NCT01742286|12376739|FG005|Ended Treatment = Not Completed)|Escalation Phase||5
11187052|NCT01742286|12376740|FG006|Ended Treatment = Not Completed)|Escalation Phase||6
11187053|NCT01742286|12376734|FG000|COMPLETED|Escalation Phase||0
11187054|NCT01742286|12376735|FG001|COMPLETED|Escalation Phase||0
11187055|NCT01742286|12376736|FG002|COMPLETED|Escalation Phase||0
11187056|NCT01742286|12376737|FG003|COMPLETED|Escalation Phase||0
11187057|NCT01742286|12376738|FG004|COMPLETED|Escalation Phase||0
11187058|NCT01742286|12376739|FG005|COMPLETED|Escalation Phase||0
11187059|NCT01742286|12376740|FG006|COMPLETED|Escalation Phase||0
11187060|NCT01742286|12376734|FG000|NOT COMPLETED|Escalation Phase||5
11187061|NCT01742286|12376735|FG001|NOT COMPLETED|Escalation Phase||12
11187062|NCT01742286|12376736|FG002|NOT COMPLETED|Escalation Phase||6
11187063|NCT01742286|12376737|FG003|NOT COMPLETED|Escalation Phase||2
11187064|NCT01742286|12376738|FG004|NOT COMPLETED|Escalation Phase||4
11187065|NCT01742286|12376739|FG005|NOT COMPLETED|Escalation Phase||5
11187066|NCT01742286|12376740|FG006|NOT COMPLETED|Escalation Phase||6
11187067|NCT01742286|12376734|FG000|STARTED|Expansion Phase||0
11187068|NCT01742286|12376735|FG001|STARTED|Expansion Phase||0
11187069|NCT01742286|12376736|FG002|STARTED|Expansion Phase||7
11187070|NCT01742286|12376737|FG003|STARTED|Expansion Phase||0
11187071|NCT01742286|12376738|FG004|STARTED|Expansion Phase||0
11187072|NCT01742286|12376739|FG005|STARTED|Expansion Phase||0
11187073|NCT01742286|12376740|FG006|STARTED|Expansion Phase||36
11187074|NCT01742286|12376734|FG000|End of Treatment = Not Ccompleted|Expansion Phase||0
11187075|NCT01742286|12376735|FG001|End of Treatment = Not Ccompleted|Expansion Phase||0
11187076|NCT01742286|12376736|FG002|End of Treatment = Not Ccompleted|Expansion Phase||7
11187077|NCT01742286|12376737|FG003|End of Treatment = Not Ccompleted|Expansion Phase||0
11187078|NCT01742286|12376738|FG004|End of Treatment = Not Ccompleted|Expansion Phase||0
11187079|NCT01742286|12376739|FG005|End of Treatment = Not Ccompleted|Expansion Phase||0
11187080|NCT01742286|12376740|FG006|End of Treatment = Not Ccompleted|Expansion Phase||36
11187081|NCT01742286|12376734|FG000|COMPLETED|Expansion Phase||0
11187082|NCT01742286|12376735|FG001|COMPLETED|Expansion Phase||0
11187083|NCT01742286|12376736|FG002|COMPLETED|Expansion Phase||0
11187084|NCT01742286|12376737|FG003|COMPLETED|Expansion Phase||0
11187085|NCT01742286|12376738|FG004|COMPLETED|Expansion Phase||0
11187086|NCT01742286|12376739|FG005|COMPLETED|Expansion Phase||0
11187087|NCT01742286|12376740|FG006|COMPLETED|Expansion Phase||0
11187088|NCT01742286|12376734|FG000|NOT COMPLETED|Expansion Phase||0
11187089|NCT01742286|12376735|FG001|NOT COMPLETED|Expansion Phase||0
11187090|NCT01742286|12376736|FG002|NOT COMPLETED|Expansion Phase||7
11187091|NCT01742286|12376737|FG003|NOT COMPLETED|Expansion Phase||0
11187092|NCT01742286|12376738|FG004|NOT COMPLETED|Expansion Phase||0
11187093|NCT01742286|12376739|FG005|NOT COMPLETED|Expansion Phase||0
11187094|NCT01742286|12376740|FG006|NOT COMPLETED|Expansion Phase||36
11187095|NCT01742364|12376767|FG000|STARTED|Overall Study||33
11187096|NCT01742364|12376768|FG001|STARTED|Overall Study||33
11187097|NCT01742364|12376769|FG002|STARTED|Overall Study||15
11187098|NCT01742364|12376770|FG003|STARTED|Overall Study||15
11187099|NCT01742364|12376767|FG000|COMPLETED|Overall Study||33
11187100|NCT01742364|12376768|FG001|COMPLETED|Overall Study||33
11187101|NCT01742364|12376769|FG002|COMPLETED|Overall Study||15
11187102|NCT01742364|12376770|FG003|COMPLETED|Overall Study||15
11187103|NCT01742364|12376767|FG000|NOT COMPLETED|Overall Study||0
11187104|NCT01742364|12376768|FG001|NOT COMPLETED|Overall Study||0
11187105|NCT01742364|12376769|FG002|NOT COMPLETED|Overall Study||0
11187106|NCT01742364|12376770|FG003|NOT COMPLETED|Overall Study||0
11187107|NCT01742832|12376783|FG000|STARTED|Overall Study||20
11187108|NCT01742832|12376784|FG001|STARTED|Overall Study||28
11187109|NCT01742832|12376783|FG000|COMPLETED|Overall Study||19
11187110|NCT01742832|12376784|FG001|COMPLETED|Overall Study||23
11187111|NCT01742832|12376783|FG000|NOT COMPLETED|Overall Study||1
11187112|NCT01742832|12376784|FG001|NOT COMPLETED|Overall Study||5
11187113|NCT01742897|12376790|FG000|STARTED|Overall Study||35
11187114|NCT01742897|12376790|FG000|Treated|Overall Study||33
11187115|NCT01742897|12376790|FG000|COMPLETED|Overall Study||30
11187116|NCT01742897|12376790|FG000|NOT COMPLETED|Overall Study||5
11187117|NCT01742936|12376796|FG000|STARTED|Overall Study||50
11187118|NCT01742936|12376797|FG001|STARTED|Overall Study||50
11187119|NCT01742936|12376796|FG000|COMPLETED|Overall Study||50
11187120|NCT01742936|12376797|FG001|COMPLETED|Overall Study||50
11187121|NCT01742936|12376796|FG000|NOT COMPLETED|Overall Study||0
11187122|NCT01742936|12376797|FG001|NOT COMPLETED|Overall Study||0
11187123|NCT01742949|12376803|FG000|STARTED|Overall Study||20
11187124|NCT01742949|12376804|FG001|STARTED|Overall Study||20
11187125|NCT01742949|12376803|FG000|COMPLETED|Overall Study||20
11187126|NCT01742949|12376804|FG001|COMPLETED|Overall Study||20
11187127|NCT01742949|12376803|FG000|NOT COMPLETED|Overall Study||0
11187128|NCT01742949|12376804|FG001|NOT COMPLETED|Overall Study||0
11187129|NCT01743001|12376815|FG000|STARTED|Overall Study||114
11187130|NCT01743001|12376816|FG001|STARTED|Overall Study||112
11187131|NCT01743001|12376815|FG000|COMPLETED|Overall Study||111
11187132|NCT01743001|12376816|FG001|COMPLETED|Overall Study||112
11187133|NCT01743001|12376815|FG000|NOT COMPLETED|Overall Study||3
11187134|NCT01743001|12376816|FG001|NOT COMPLETED|Overall Study||0
11187135|NCT01743027|12376826|FG000|STARTED|Overall Study||98
11187136|NCT01743027|12376827|FG001|STARTED|Overall Study||99
11187137|NCT01743027|12376828|FG002|STARTED|Overall Study||99
11187138|NCT01743027|12376829|FG003|STARTED|Overall Study||49
11187139|NCT01743027|12376826|FG000|COMPLETED|Overall Study||93
11187140|NCT01743027|12376827|FG001|COMPLETED|Overall Study||94
11187141|NCT01743027|12376828|FG002|COMPLETED|Overall Study||90
11187142|NCT01743027|12376829|FG003|COMPLETED|Overall Study||48
11187143|NCT01743027|12376826|FG000|NOT COMPLETED|Overall Study||5
11187144|NCT01743027|12376827|FG001|NOT COMPLETED|Overall Study||5
11187145|NCT01743027|12376828|FG002|NOT COMPLETED|Overall Study||9
11187146|NCT01743027|12376829|FG003|NOT COMPLETED|Overall Study||1
11187147|NCT01743040|12376839|FG000|STARTED|Overall Study||1014
11187148|NCT01743040|12376839|FG000|CADence Testing|Overall Study||1013
11187149|NCT01743040|12376839|FG000|Nuclear Stress Test|Overall Study||992
11187150|NCT01743040|12376839|FG000|CT and/or Standard Angiogram|Overall Study||785
11187151|NCT01743040|12376839|FG000|COMPLETED|Overall Study||785
11187152|NCT01743040|12376839|FG000|NOT COMPLETED|Overall Study||229
11187153|NCT01743092|12376845|FG000|STARTED|Overall Study||33
11187154|NCT01743092|12376846|FG001|STARTED|Overall Study||26
11187155|NCT01743092|12376845|FG000|COMPLETED|Overall Study||19
11187156|NCT01743092|12376846|FG001|COMPLETED|Overall Study||11
11187157|NCT01743092|12376845|FG000|NOT COMPLETED|Overall Study||14
11187158|NCT01743092|12376846|FG001|NOT COMPLETED|Overall Study||15
11187159|NCT01743131|12376856|FG000|STARTED|Overall Study||73
11187160|NCT01743131|12376857|FG001|STARTED|Overall Study||69
11187161|NCT01743131|12376858|FG002|STARTED|Overall Study||43
11187162|NCT01743131|12376859|FG003|STARTED|Overall Study||1
11187163|NCT01743131|12376860|FG004|STARTED|Overall Study||127
11187164|NCT01743131|12376856|FG000|Not Included in Analysis|Overall Study||0
11187165|NCT01743131|12376857|FG001|Not Included in Analysis|Overall Study||0
11187166|NCT01743131|12376858|FG002|Not Included in Analysis|Overall Study||0
11187167|NCT01743131|12376859|FG003|Not Included in Analysis|Overall Study||1
11187168|NCT01743131|12376860|FG004|Not Included in Analysis|Overall Study||0
11187169|NCT01743131|12376856|FG000|COMPLETED|Overall Study||73
11187170|NCT01743131|12376857|FG001|COMPLETED|Overall Study||69
11187171|NCT01743131|12376858|FG002|COMPLETED|Overall Study||43
11187172|NCT01743131|12376859|FG003|COMPLETED|Overall Study||1
11187173|NCT01743131|12376860|FG004|COMPLETED|Overall Study||127
11187174|NCT01743131|12376856|FG000|NOT COMPLETED|Overall Study||0
11187175|NCT01743131|12376857|FG001|NOT COMPLETED|Overall Study||0
11187176|NCT01743131|12376858|FG002|NOT COMPLETED|Overall Study||0
11187177|NCT01743131|12376859|FG003|NOT COMPLETED|Overall Study||0
11187178|NCT01743131|12376860|FG004|NOT COMPLETED|Overall Study||0
11187179|NCT01743469|12376873|FG000|STARTED|Active Treatment Phase||53
11187180|NCT01743469|12376874|FG001|STARTED|Active Treatment Phase||55
11187181|NCT01743469|12376875|FG002|STARTED|Active Treatment Phase||38
11187182|NCT01743469|12376876|FG003|STARTED|Active Treatment Phase||21
11187183|NCT01743469|12376873|FG000|COMPLETED|Active Treatment Phase||0
11187184|NCT01743469|12376874|FG001|COMPLETED|Active Treatment Phase||0
11187185|NCT01743469|12376875|FG002|COMPLETED|Active Treatment Phase||0
11187186|NCT01743469|12376876|FG003|COMPLETED|Active Treatment Phase||0
11187187|NCT01743469|12376873|FG000|NOT COMPLETED|Active Treatment Phase||53
11187188|NCT01743469|12376874|FG001|NOT COMPLETED|Active Treatment Phase||55
11187189|NCT01743469|12376875|FG002|NOT COMPLETED|Active Treatment Phase||38
11187190|NCT01743469|12376876|FG003|NOT COMPLETED|Active Treatment Phase||21
11187191|NCT01743469|12376873|FG000|STARTED|Follow-up Period - Post-Treatment||51
11187192|NCT01743469|12376874|FG001|STARTED|Follow-up Period - Post-Treatment||53
11187193|NCT01743469|12376875|FG002|STARTED|Follow-up Period - Post-Treatment||37
11187194|NCT01743469|12376876|FG003|STARTED|Follow-up Period - Post-Treatment||21
11187195|NCT01743469|12376873|FG000|COMPLETED|Follow-up Period - Post-Treatment||6
11187196|NCT01743469|12376874|FG001|COMPLETED|Follow-up Period - Post-Treatment||5
11187197|NCT01743469|12376875|FG002|COMPLETED|Follow-up Period - Post-Treatment||14
11187198|NCT01743469|12376876|FG003|COMPLETED|Follow-up Period - Post-Treatment||5
11187199|NCT01743469|12376873|FG000|NOT COMPLETED|Follow-up Period - Post-Treatment||45
11187200|NCT01743469|12376874|FG001|NOT COMPLETED|Follow-up Period - Post-Treatment||48
11187201|NCT01743469|12376875|FG002|NOT COMPLETED|Follow-up Period - Post-Treatment||23
11187202|NCT01743469|12376876|FG003|NOT COMPLETED|Follow-up Period - Post-Treatment||16
11187203|NCT01743521|12376890|FG000|STARTED|Overall Study||7
11187204|NCT01743521|12376891|FG001|STARTED|Overall Study||3
11187205|NCT01743521|12376892|FG002|STARTED|Overall Study||2
11187206|NCT01743521|12376893|FG003|STARTED|Overall Study||2
11187207|NCT01743521|12376890|FG000|COMPLETED|Overall Study||7
11187208|NCT01743521|12376891|FG001|COMPLETED|Overall Study||3
11187209|NCT01743521|12376892|FG002|COMPLETED|Overall Study||2
11187210|NCT01743521|12376893|FG003|COMPLETED|Overall Study||2
11187211|NCT01743521|12376890|FG000|NOT COMPLETED|Overall Study||0
11187212|NCT01743521|12376891|FG001|NOT COMPLETED|Overall Study||0
11187213|NCT01743521|12376892|FG002|NOT COMPLETED|Overall Study||0
11187214|NCT01743521|12376893|FG003|NOT COMPLETED|Overall Study||0
11187215|NCT01743560|12376901|FG000|STARTED|Overall Study||52
11187216|NCT01743560|12376901|FG000|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49
11187217|NCT01743560|12376901|FG000|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49
11187218|NCT01743560|12376901|FG000|COMPLETED|Overall Study||9
11187219|NCT01743560|12376901|FG000|NOT COMPLETED|Overall Study||43
11187220|NCT01743677|12376914|FG000|STARTED|First Intervention Period||10
11187221|NCT01743677|12376915|FG001|STARTED|First Intervention Period||10
11187222|NCT01743677|12376916|FG002|STARTED|First Intervention Period||10
11187223|NCT01743677|12376917|FG003|STARTED|First Intervention Period||10
11187224|NCT01743677|12376918|FG004|STARTED|First Intervention Period||10
11187225|NCT01743677|12376919|FG005|STARTED|First Intervention Period||10
11187226|NCT01743677|12376914|FG000|COMPLETED|First Intervention Period||10
11187227|NCT01743677|12376915|FG001|COMPLETED|First Intervention Period||10
11187228|NCT01743677|12376916|FG002|COMPLETED|First Intervention Period||10
11187229|NCT01743677|12376917|FG003|COMPLETED|First Intervention Period||10
11187230|NCT01743677|12376918|FG004|COMPLETED|First Intervention Period||10
11187231|NCT01743677|12376919|FG005|COMPLETED|First Intervention Period||10
11187232|NCT01743677|12376914|FG000|NOT COMPLETED|First Intervention Period||0
11187233|NCT01743677|12376915|FG001|NOT COMPLETED|First Intervention Period||0
11187234|NCT01743677|12376916|FG002|NOT COMPLETED|First Intervention Period||0
11187235|NCT01743677|12376917|FG003|NOT COMPLETED|First Intervention Period||0
11187236|NCT01743677|12376918|FG004|NOT COMPLETED|First Intervention Period||0
11187237|NCT01743677|12376919|FG005|NOT COMPLETED|First Intervention Period||0
11187238|NCT01743677|12376914|FG000|STARTED|Washout Period 1 (at Least 7 Days)||10
11187239|NCT01743677|12376915|FG001|STARTED|Washout Period 1 (at Least 7 Days)||10
11187240|NCT01743677|12376916|FG002|STARTED|Washout Period 1 (at Least 7 Days)||10
11187241|NCT01743677|12376917|FG003|STARTED|Washout Period 1 (at Least 7 Days)||10
11187242|NCT01743677|12376918|FG004|STARTED|Washout Period 1 (at Least 7 Days)||10
11187243|NCT01743677|12376919|FG005|STARTED|Washout Period 1 (at Least 7 Days)||10
11187244|NCT01743677|12376914|FG000|COMPLETED|Washout Period 1 (at Least 7 Days)||10
11187245|NCT01743677|12376915|FG001|COMPLETED|Washout Period 1 (at Least 7 Days)||10
11187246|NCT01743677|12376916|FG002|COMPLETED|Washout Period 1 (at Least 7 Days)||10
11187247|NCT01743677|12376917|FG003|COMPLETED|Washout Period 1 (at Least 7 Days)||10
11187248|NCT01743677|12376918|FG004|COMPLETED|Washout Period 1 (at Least 7 Days)||10
11187249|NCT01743677|12376919|FG005|COMPLETED|Washout Period 1 (at Least 7 Days)||10
11187250|NCT01743677|12376914|FG000|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
11187251|NCT01743677|12376915|FG001|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
11187252|NCT01743677|12376916|FG002|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
11187253|NCT01743677|12376917|FG003|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
11187254|NCT01743677|12376918|FG004|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
11187255|NCT01743677|12376919|FG005|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
11187256|NCT01743677|12376914|FG000|STARTED|Second Intervention Period||10
11187257|NCT01743677|12376915|FG001|STARTED|Second Intervention Period||10
11187258|NCT01743677|12376916|FG002|STARTED|Second Intervention Period||10
11187259|NCT01743677|12376917|FG003|STARTED|Second Intervention Period||10
11187260|NCT01743677|12376918|FG004|STARTED|Second Intervention Period||10
11187261|NCT01743677|12376919|FG005|STARTED|Second Intervention Period||10
11187262|NCT01743677|12376914|FG000|COMPLETED|Second Intervention Period||10
11187263|NCT01743677|12376915|FG001|COMPLETED|Second Intervention Period||10
11187264|NCT01743677|12376916|FG002|COMPLETED|Second Intervention Period||10
11187265|NCT01743677|12376917|FG003|COMPLETED|Second Intervention Period||10
11187266|NCT01743677|12376918|FG004|COMPLETED|Second Intervention Period||10
11187267|NCT01743677|12376919|FG005|COMPLETED|Second Intervention Period||10
11187268|NCT01743677|12376914|FG000|NOT COMPLETED|Second Intervention Period||0
11187269|NCT01743677|12376915|FG001|NOT COMPLETED|Second Intervention Period||0
11187270|NCT01743677|12376916|FG002|NOT COMPLETED|Second Intervention Period||0
11187271|NCT01743677|12376917|FG003|NOT COMPLETED|Second Intervention Period||0
11187272|NCT01743677|12376918|FG004|NOT COMPLETED|Second Intervention Period||0
11187273|NCT01743677|12376919|FG005|NOT COMPLETED|Second Intervention Period||0
11187274|NCT01743677|12376914|FG000|STARTED|Washout Period 2 (at Least 7 Days)||10
11187275|NCT01743677|12376915|FG001|STARTED|Washout Period 2 (at Least 7 Days)||10
11187276|NCT01743677|12376916|FG002|STARTED|Washout Period 2 (at Least 7 Days)||10
11187277|NCT01743677|12376917|FG003|STARTED|Washout Period 2 (at Least 7 Days)||10
11187278|NCT01743677|12376918|FG004|STARTED|Washout Period 2 (at Least 7 Days)||10
11187279|NCT01743677|12376919|FG005|STARTED|Washout Period 2 (at Least 7 Days)||10
11187280|NCT01743677|12376914|FG000|COMPLETED|Washout Period 2 (at Least 7 Days)||10
11187281|NCT01743677|12376915|FG001|COMPLETED|Washout Period 2 (at Least 7 Days)||10
11187282|NCT01743677|12376916|FG002|COMPLETED|Washout Period 2 (at Least 7 Days)||10
11187283|NCT01743677|12376917|FG003|COMPLETED|Washout Period 2 (at Least 7 Days)||10
11187284|NCT01743677|12376918|FG004|COMPLETED|Washout Period 2 (at Least 7 Days)||10
11187285|NCT01743677|12376919|FG005|COMPLETED|Washout Period 2 (at Least 7 Days)||10
11187286|NCT01743677|12376914|FG000|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
11187287|NCT01743677|12376915|FG001|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
11187288|NCT01743677|12376916|FG002|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
11187289|NCT01743677|12376917|FG003|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
11187290|NCT01743677|12376918|FG004|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
11187291|NCT01743677|12376919|FG005|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
11187292|NCT01743677|12376914|FG000|STARTED|Third Intervention Period||10
11187293|NCT01743677|12376915|FG001|STARTED|Third Intervention Period||10
11187294|NCT01743677|12376916|FG002|STARTED|Third Intervention Period||10
11187295|NCT01743677|12376917|FG003|STARTED|Third Intervention Period||10
11187296|NCT01743677|12376918|FG004|STARTED|Third Intervention Period||10
11324331|NCT02742766|12521561|FG002|COMPLETED|Part 3 (Up to 36 Days)||0
11324332|NCT02742766|12521562|FG003|COMPLETED|Part 3 (Up to 36 Days)||0
11324333|NCT02742766|12521563|FG004|COMPLETED|Part 3 (Up to 36 Days)||0
11324334|NCT02742766|12521564|FG005|COMPLETED|Part 3 (Up to 36 Days)||0
11324335|NCT02742766|12521565|FG006|COMPLETED|Part 3 (Up to 36 Days)||0
11324336|NCT02742766|12521566|FG007|COMPLETED|Part 3 (Up to 36 Days)||0
11324337|NCT02742766|12521567|FG008|COMPLETED|Part 3 (Up to 36 Days)||0
11324338|NCT02742766|12521568|FG009|COMPLETED|Part 3 (Up to 36 Days)||0
11324339|NCT02742766|12521569|FG010|COMPLETED|Part 3 (Up to 36 Days)||0
11324340|NCT02742766|12521570|FG011|COMPLETED|Part 3 (Up to 36 Days)||0
11324341|NCT02742766|12521571|FG012|COMPLETED|Part 3 (Up to 36 Days)||0
11324342|NCT02742766|12521572|FG013|COMPLETED|Part 3 (Up to 36 Days)||0
11324343|NCT02742766|12521573|FG014|COMPLETED|Part 3 (Up to 36 Days)||0
11324344|NCT02742766|12521574|FG015|COMPLETED|Part 3 (Up to 36 Days)||0
11324345|NCT02742766|12521575|FG016|COMPLETED|Part 3 (Up to 36 Days)||0
11324346|NCT02742766|12521576|FG017|COMPLETED|Part 3 (Up to 36 Days)||0
11324347|NCT02742766|12521577|FG018|COMPLETED|Part 3 (Up to 36 Days)||0
11324348|NCT02742766|12521559|FG000|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324349|NCT02742766|12521560|FG001|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324350|NCT02742766|12521561|FG002|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324351|NCT02742766|12521562|FG003|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324352|NCT02742766|12521563|FG004|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324353|NCT02742766|12521564|FG005|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324354|NCT02742766|12521565|FG006|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324355|NCT02742766|12521566|FG007|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324356|NCT02742766|12521567|FG008|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324357|NCT02742766|12521568|FG009|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324358|NCT02742766|12521569|FG010|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324359|NCT02742766|12521570|FG011|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324360|NCT02742766|12521571|FG012|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324361|NCT02742766|12521572|FG013|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324362|NCT02742766|12521573|FG014|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324363|NCT02742766|12521574|FG015|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324364|NCT02742766|12521575|FG016|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324365|NCT02742766|12521576|FG017|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324366|NCT02742766|12521577|FG018|NOT COMPLETED|Part 3 (Up to 36 Days)||0
11324367|NCT02742818|12521639|FG000|STARTED|Overall Study||25
11324368|NCT02742818|12521640|FG001|STARTED|Overall Study||25
11324369|NCT02742818|12521639|FG000|COMPLETED|Overall Study||25
11324370|NCT02742818|12521640|FG001|COMPLETED|Overall Study||23
11324371|NCT02742818|12521639|FG000|NOT COMPLETED|Overall Study||0
11324372|NCT02742818|12521640|FG001|NOT COMPLETED|Overall Study||2
11324373|NCT02742987|12521650|FG000|STARTED|Overall Study||21
11324374|NCT02742987|12521651|FG001|STARTED|Overall Study||21
11324375|NCT02742987|12521650|FG000|COMPLETED|Overall Study||21
11187297|NCT01743677|12376919|FG005|STARTED|Third Intervention Period||10
11187298|NCT01743677|12376914|FG000|COMPLETED|Third Intervention Period||10
11187299|NCT01743677|12376915|FG001|COMPLETED|Third Intervention Period||10
11187300|NCT01743677|12376916|FG002|COMPLETED|Third Intervention Period||10
11187301|NCT01743677|12376917|FG003|COMPLETED|Third Intervention Period||10
11187302|NCT01743677|12376918|FG004|COMPLETED|Third Intervention Period||10
11187303|NCT01743677|12376919|FG005|COMPLETED|Third Intervention Period||10
11187304|NCT01743677|12376914|FG000|NOT COMPLETED|Third Intervention Period||0
11187305|NCT01743677|12376915|FG001|NOT COMPLETED|Third Intervention Period||0
11187306|NCT01743677|12376916|FG002|NOT COMPLETED|Third Intervention Period||0
11187307|NCT01743677|12376917|FG003|NOT COMPLETED|Third Intervention Period||0
11187308|NCT01743677|12376918|FG004|NOT COMPLETED|Third Intervention Period||0
11187309|NCT01743677|12376919|FG005|NOT COMPLETED|Third Intervention Period||0
11187310|NCT01743729|12376931|FG000|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
11187311|NCT01743729|12376932|FG001|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
11187312|NCT01743729|12376931|FG000|COMPLETED|Overall Study||321
11187313|NCT01743729|12376932|FG001|COMPLETED|Overall Study||348
11187314|NCT01743729|12376931|FG000|NOT COMPLETED|Overall Study||37
11187315|NCT01743729|12376932|FG001|NOT COMPLETED|Overall Study||12
11187316|NCT01743859|12376938|FG000|STARTED|Overall Study||37
11187317|NCT01743859|12376938|FG000|COMPLETED|Overall Study||28
11187318|NCT01743859|12376938|FG000|NOT COMPLETED|Overall Study||9
11187319|NCT01743963|12376944|FG000|STARTED|Overall Study||21
11187320|NCT01743963|12376945|FG001|STARTED|Overall Study||17
11187321|NCT01743963|12376944|FG000|COMPLETED|Overall Study||21
11187322|NCT01743963|12376945|FG001|COMPLETED|Overall Study||17
11187323|NCT01743963|12376944|FG000|NOT COMPLETED|Overall Study||0
11187324|NCT01743963|12376945|FG001|NOT COMPLETED|Overall Study||0
11187325|NCT01743976|12376953|FG000|STARTED|Overall Study||2
11187326|NCT01743976|12376954|FG001|STARTED|Overall Study||3
11187327|NCT01743976|12376953|FG000|COMPLETED|Overall Study||2
11187328|NCT01743976|12376954|FG001|COMPLETED|Overall Study||3
11187329|NCT01743976|12376953|FG000|NOT COMPLETED|Overall Study||0
11187330|NCT01743976|12376954|FG001|NOT COMPLETED|Overall Study||0
11187331|NCT01743989|12376963|FG000|STARTED|Treatment Phase||120
11187332|NCT01743989|12376964|FG001|STARTED|Treatment Phase||119
11187333|NCT01743989|12376965|FG002|STARTED|Treatment Phase||381
11187334|NCT01743989|12376963|FG000|Participants Who Signed Informed Consent|Treatment Phase||120
11187335|NCT01743989|12376964|FG001|Participants Who Signed Informed Consent|Treatment Phase||118
11187336|NCT01743989|12376965|FG002|Participants Who Signed Informed Consent|Treatment Phase||381
11187337|NCT01743989|12376963|FG000|COMPLETED|Treatment Phase||119
11187338|NCT01743989|12376964|FG001|COMPLETED|Treatment Phase||104
11187339|NCT01743989|12376965|FG002|COMPLETED|Treatment Phase||0
11187340|NCT01743989|12376963|FG000|NOT COMPLETED|Treatment Phase||1
11187341|NCT01743989|12376964|FG001|NOT COMPLETED|Treatment Phase||15
11187342|NCT01743989|12376965|FG002|NOT COMPLETED|Treatment Phase||381
11187343|NCT01743989|12376963|FG000|STARTED|TFR Phase||119
11187344|NCT01743989|12376964|FG001|STARTED|TFR Phase||104
11187345|NCT01743989|12376965|FG002|STARTED|TFR Phase||0
11187346|NCT01743989|12376963|FG000|COMPLETED|TFR Phase||37
11187347|NCT01743989|12376964|FG001|COMPLETED|TFR Phase||36
11187348|NCT01743989|12376965|FG002|COMPLETED|TFR Phase||0
11187349|NCT01743989|12376963|FG000|NOT COMPLETED|TFR Phase||82
11187350|NCT01743989|12376964|FG001|NOT COMPLETED|TFR Phase||68
11187351|NCT01743989|12376965|FG002|NOT COMPLETED|TFR Phase||0
11187352|NCT01743989|12376963|FG000|STARTED|Re-treatment Phase||74
11187353|NCT01743989|12376964|FG001|STARTED|Re-treatment Phase||55
11187354|NCT01743989|12376965|FG002|STARTED|Re-treatment Phase||0
11187355|NCT01743989|12376963|FG000|COMPLETED|Re-treatment Phase||58
11187356|NCT01743989|12376964|FG001|COMPLETED|Re-treatment Phase||46
11187357|NCT01743989|12376965|FG002|COMPLETED|Re-treatment Phase||0
11187358|NCT01743989|12376963|FG000|NOT COMPLETED|Re-treatment Phase||16
11187359|NCT01743989|12376964|FG001|NOT COMPLETED|Re-treatment Phase||9
11187360|NCT01743989|12376965|FG002|NOT COMPLETED|Re-treatment Phase||0
11187361|NCT01744197|12376978|FG000|STARTED|Overall Study||32
11187362|NCT01744197|12376979|FG001|STARTED|Overall Study||29
11187363|NCT01744197|12376978|FG000|COMPLETED|Overall Study||28
11187364|NCT01744197|12376979|FG001|COMPLETED|Overall Study||26
11187365|NCT01744197|12376978|FG000|NOT COMPLETED|Overall Study||4
11187366|NCT01744197|12376979|FG001|NOT COMPLETED|Overall Study||3
11187367|NCT01744340|12376987|FG000|STARTED|Overall Study||8
11187368|NCT01744340|12376988|FG001|STARTED|Overall Study||15
11187369|NCT01744340|12376987|FG000|COMPLETED|Overall Study||8
11187370|NCT01744340|12376988|FG001|COMPLETED|Overall Study||15
11187371|NCT01744340|12376987|FG000|NOT COMPLETED|Overall Study||0
11187372|NCT01744340|12376988|FG001|NOT COMPLETED|Overall Study||0
11187373|NCT01744353|12376997|FG000|STARTED|Overall Study||6
11187374|NCT01744353|12376998|FG001|STARTED|Overall Study||26
11187375|NCT01744353|12376999|FG002|STARTED|Overall Study||3
11187376|NCT01744353|12376997|FG000|COMPLETED|Overall Study||6
11187377|NCT01744353|12376998|FG001|COMPLETED|Overall Study||26
11187378|NCT01744353|12376999|FG002|COMPLETED|Overall Study||3
11187379|NCT01744353|12376997|FG000|NOT COMPLETED|Overall Study||0
11187380|NCT01744353|12376998|FG001|NOT COMPLETED|Overall Study||0
11187381|NCT01744353|12376999|FG002|NOT COMPLETED|Overall Study||0
11187382|NCT01744392|12377005|FG000|STARTED|Overall Study||23
11187383|NCT01744392|12377005|FG000|COMPLETED|Overall Study||22
11187384|NCT01744392|12377005|FG000|NOT COMPLETED|Overall Study||1
11187385|NCT01744483|12377013|FG000|STARTED|Overall Study||44
11187386|NCT01744483|12377014|FG001|STARTED|Overall Study||35
11187387|NCT01744483|12377015|FG002|STARTED|Overall Study||38
11187388|NCT01744483|12377013|FG000|COMPLETED|Overall Study||15
11187389|NCT01744483|12377014|FG001|COMPLETED|Overall Study||13
11187390|NCT01744483|12377015|FG002|COMPLETED|Overall Study||10
11187391|NCT01744483|12377013|FG000|NOT COMPLETED|Overall Study||29
11187392|NCT01744483|12377014|FG001|NOT COMPLETED|Overall Study||22
11187393|NCT01744483|12377015|FG002|NOT COMPLETED|Overall Study||28
11187394|NCT01744496|12377025|FG000|STARTED|Titration Period||33
11187395|NCT01744496|12377026|FG001|STARTED|Titration Period||35
11187396|NCT01744496|12377025|FG000|COMPLETED|Titration Period||31
11187397|NCT01744496|12377026|FG001|COMPLETED|Titration Period||33
11187398|NCT01744496|12377025|FG000|NOT COMPLETED|Titration Period||2
11187399|NCT01744496|12377026|FG001|NOT COMPLETED|Titration Period||2
11187400|NCT01744496|12377025|FG000|STARTED|Maintenance Period||31
11187401|NCT01744496|12377026|FG001|STARTED|Maintenance Period||33
11187402|NCT01744496|12377025|FG000|COMPLETED|Maintenance Period||27
11187403|NCT01744496|12377026|FG001|COMPLETED|Maintenance Period||29
11187404|NCT01744496|12377025|FG000|NOT COMPLETED|Maintenance Period||4
11187405|NCT01744496|12377026|FG001|NOT COMPLETED|Maintenance Period||4
11187406|NCT01744574|12377036|FG000|STARTED|Overall Study||57
11187407|NCT01744574|12377037|FG001|STARTED|Overall Study||56
11187408|NCT01744574|12377038|FG002|STARTED|Overall Study||52
11187409|NCT01744574|12377039|FG003|STARTED|Overall Study||51
11187410|NCT01744574|12377036|FG000|COMPLETED|Overall Study||33
11187411|NCT01744574|12377037|FG001|COMPLETED|Overall Study||31
11187412|NCT01744574|12377038|FG002|COMPLETED|Overall Study||32
11187413|NCT01744574|12377039|FG003|COMPLETED|Overall Study||40
11187414|NCT01744574|12377036|FG000|NOT COMPLETED|Overall Study||24
11187415|NCT01744574|12377037|FG001|NOT COMPLETED|Overall Study||25
11187416|NCT01744574|12377038|FG002|NOT COMPLETED|Overall Study||20
11187417|NCT01744574|12377039|FG003|NOT COMPLETED|Overall Study||11
11187418|NCT01744665|12377049|FG000|STARTED|Monitoring Phase||59
11187419|NCT01744665|12377049|FG000|COMPLETED|Monitoring Phase||41
11187420|NCT01744665|12377049|FG000|NOT COMPLETED|Monitoring Phase||18
11187421|NCT01744665|12377049|FG000|STARTED|Consolidation Phase||41
11187422|NCT01744665|12377049|FG000|COMPLETED|Consolidation Phase||22
11187423|NCT01744665|12377049|FG000|NOT COMPLETED|Consolidation Phase||19
11187424|NCT01744665|12377049|FG000|STARTED|Treatment Free Remission Phase||32
11187425|NCT01744665|12377049|FG000|COMPLETED|Treatment Free Remission Phase||32
11187426|NCT01744665|12377049|FG000|NOT COMPLETED|Treatment Free Remission Phase||0
11187427|NCT01744665|12377049|FG000|STARTED|Re-initiation Phase||17
11187428|NCT01744665|12377049|FG000|COMPLETED|Re-initiation Phase||4
11187429|NCT01744665|12377049|FG000|NOT COMPLETED|Re-initiation Phase||13
11187430|NCT01744691|12377056|FG000|STARTED|Overall Study|Participants who received study treatment|144
11187431|NCT01744691|12377056|FG000|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
11187432|NCT01744691|12377056|FG000|NOT COMPLETED|Overall Study||43
11187433|NCT01744704|12377072|FG000|STARTED|Overall Study||3
11187434|NCT01744704|12377073|FG001|STARTED|Overall Study||3
11187435|NCT01744704|12377074|FG002|STARTED|Overall Study||3
11187436|NCT01744704|12377075|FG003|STARTED|Overall Study||6
11187437|NCT01744704|12377076|FG004|STARTED|Overall Study||6
11187438|NCT01744704|12377077|FG005|STARTED|Overall Study||7
11187439|NCT01744704|12377078|FG006|STARTED|Overall Study||6
11187440|NCT01744704|12377079|FG007|STARTED|Overall Study||9
11187441|NCT01744704|12377080|FG008|STARTED|Overall Study||3
11187442|NCT01744704|12377081|FG009|STARTED|Overall Study||9
11187443|NCT01744704|12377082|FG010|STARTED|Overall Study||9
11187444|NCT01744704|12377083|FG011|STARTED|Overall Study||10
11187445|NCT01744704|12377072|FG000|COMPLETED|Overall Study||3
11187446|NCT01744704|12377073|FG001|COMPLETED|Overall Study||3
11187447|NCT01744704|12377074|FG002|COMPLETED|Overall Study||3
11187448|NCT01744704|12377075|FG003|COMPLETED|Overall Study||6
11187449|NCT01744704|12377076|FG004|COMPLETED|Overall Study||6
11187450|NCT01744704|12377077|FG005|COMPLETED|Overall Study||7
11187451|NCT01744704|12377078|FG006|COMPLETED|Overall Study||6
11187452|NCT01744704|12377079|FG007|COMPLETED|Overall Study||9
11187453|NCT01744704|12377080|FG008|COMPLETED|Overall Study||3
11187454|NCT01744704|12377081|FG009|COMPLETED|Overall Study||9
11187455|NCT01744704|12377082|FG010|COMPLETED|Overall Study||9
11187456|NCT01744704|12377083|FG011|COMPLETED|Overall Study||10
11187457|NCT01744704|12377072|FG000|NOT COMPLETED|Overall Study||0
11187458|NCT01744704|12377073|FG001|NOT COMPLETED|Overall Study||0
11187459|NCT01744704|12377074|FG002|NOT COMPLETED|Overall Study||0
11187460|NCT01744704|12377075|FG003|NOT COMPLETED|Overall Study||0
11187461|NCT01744704|12377076|FG004|NOT COMPLETED|Overall Study||0
11187462|NCT01744704|12377077|FG005|NOT COMPLETED|Overall Study||0
11187463|NCT01744704|12377078|FG006|NOT COMPLETED|Overall Study||0
11187464|NCT01744704|12377079|FG007|NOT COMPLETED|Overall Study||0
11187465|NCT01744704|12377080|FG008|NOT COMPLETED|Overall Study||0
11187466|NCT01744704|12377081|FG009|NOT COMPLETED|Overall Study||0
11187467|NCT01744704|12377082|FG010|NOT COMPLETED|Overall Study||0
11187468|NCT01744704|12377083|FG011|NOT COMPLETED|Overall Study||0
11187469|NCT01744730|12377115|FG000|STARTED|Overall Study||4
11187470|NCT01744730|12377116|FG001|STARTED|Overall Study||3
11187471|NCT01744730|12377117|FG002|STARTED|Overall Study||4
11187472|NCT01744730|12377118|FG003|STARTED|Overall Study||11
11187473|NCT01744730|12377119|FG004|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
11187474|NCT01744730|12377115|FG000|COMPLETED|Overall Study||4
11187475|NCT01744730|12377116|FG001|COMPLETED|Overall Study||3
11187476|NCT01744730|12377117|FG002|COMPLETED|Overall Study||4
11187477|NCT01744730|12377118|FG003|COMPLETED|Overall Study||11
11187478|NCT01744730|12377119|FG004|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
11187479|NCT01744730|12377115|FG000|NOT COMPLETED|Overall Study||0
11187480|NCT01744730|12377116|FG001|NOT COMPLETED|Overall Study||0
11187481|NCT01744730|12377117|FG002|NOT COMPLETED|Overall Study||0
11187482|NCT01744730|12377118|FG003|NOT COMPLETED|Overall Study||0
11187483|NCT01744730|12377119|FG004|NOT COMPLETED|Overall Study||0
11187484|NCT01744782|12377132|FG000|STARTED|Overall Study||17
11187485|NCT01744782|12377132|FG000|COMPLETED|Overall Study||16
11187486|NCT01744782|12377132|FG000|NOT COMPLETED|Overall Study||1
11187487|NCT01744821|12377140|FG000|STARTED|Overall Study||1
11187488|NCT01744821|12377141|FG001|STARTED|Overall Study||3
11187489|NCT01744821|12377142|FG002|STARTED|Overall Study||2
11187490|NCT01744821|12377143|FG003|STARTED|Overall Study||1
11187491|NCT01744821|12377140|FG000|COMPLETED|Overall Study||1
11187492|NCT01744821|12377141|FG001|COMPLETED|Overall Study||3
11187493|NCT01744821|12377142|FG002|COMPLETED|Overall Study||2
11187494|NCT01744821|12377143|FG003|COMPLETED|Overall Study||1
11187495|NCT01744821|12377140|FG000|NOT COMPLETED|Overall Study||0
11187496|NCT01744821|12377141|FG001|NOT COMPLETED|Overall Study||0
11187497|NCT01744821|12377142|FG002|NOT COMPLETED|Overall Study||0
11187498|NCT01744821|12377143|FG003|NOT COMPLETED|Overall Study||0
11187499|NCT01744860|12377153|FG000|STARTED|Overall Study||420
11187500|NCT01744860|12377153|FG000|COMPLETED|Overall Study||420
11187501|NCT01744860|12377153|FG000|NOT COMPLETED|Overall Study||0
11187502|NCT01744977|12377167|FG000|STARTED|Overall Study||120
11187503|NCT01744977|12377168|FG001|STARTED|Overall Study||120
11187504|NCT01744977|12377167|FG000|6 Month Completed|Overall Study||113
11187505|NCT01744977|12377168|FG001|6 Month Completed|Overall Study||115
11187506|NCT01744977|12377167|FG000|COMPLETED|Overall Study||109
11187507|NCT01744977|12377168|FG001|COMPLETED|Overall Study||115
11187508|NCT01744977|12377167|FG000|NOT COMPLETED|Overall Study||11
11187509|NCT01744977|12377168|FG001|NOT COMPLETED|Overall Study||5
11187510|NCT01745055|12377174|FG000|STARTED|Overall Study||12
11187511|NCT01745055|12377174|FG000|COMPLETED|Overall Study||12
11187512|NCT01745055|12377174|FG000|NOT COMPLETED|Overall Study||0
11187513|NCT01745094|12377187|FG000|STARTED|Overall Study||35
11187514|NCT01745094|12377188|FG001|STARTED|Overall Study||37
11187515|NCT01745094|12377189|FG002|STARTED|Overall Study||58
11187516|NCT01745094|12377190|FG003|STARTED|Overall Study||93
11187517|NCT01745094|12377187|FG000|COMPLETED|Overall Study||30
11187518|NCT01745094|12377188|FG001|COMPLETED|Overall Study||37
11187519|NCT01745094|12377189|FG002|COMPLETED|Overall Study||46
11187520|NCT01745094|12377190|FG003|COMPLETED|Overall Study||90
11187521|NCT01745094|12377187|FG000|NOT COMPLETED|Overall Study||5
11187522|NCT01745094|12377188|FG001|NOT COMPLETED|Overall Study||0
11187523|NCT01745094|12377189|FG002|NOT COMPLETED|Overall Study||12
11187524|NCT01745094|12377190|FG003|NOT COMPLETED|Overall Study||3
11187525|NCT01745120|12377205|FG000|STARTED|Overall Study||11
11187526|NCT01745120|12377206|FG001|STARTED|Overall Study||8
11187527|NCT01745120|12377205|FG000|COMPLETED|Overall Study||10
11187528|NCT01745120|12377206|FG001|COMPLETED|Overall Study||8
11187529|NCT01745120|12377205|FG000|NOT COMPLETED|Overall Study||1
11187530|NCT01745120|12377206|FG001|NOT COMPLETED|Overall Study||0
11187531|NCT01745133|12377218|FG000|STARTED|Overall Study||19
11187532|NCT01745133|12377219|FG001|STARTED|Overall Study||20
11187533|NCT01745133|12377220|FG002|STARTED|Overall Study||19
11187534|NCT01745133|12377218|FG000|COMPLETED|Overall Study||13
11187535|NCT01745133|12377219|FG001|COMPLETED|Overall Study||16
11187536|NCT01745133|12377220|FG002|COMPLETED|Overall Study||15
11187537|NCT01745133|12377218|FG000|NOT COMPLETED|Overall Study||6
11187538|NCT01745133|12377219|FG001|NOT COMPLETED|Overall Study||4
11187539|NCT01745133|12377220|FG002|NOT COMPLETED|Overall Study||4
11187540|NCT01745146|12377230|FG000|STARTED|Overall Study||30
11187541|NCT01745146|12377231|FG001|STARTED|Overall Study||60
11187542|NCT01745146|12377230|FG000|Allocation to Intervention|Overall Study||30
11187543|NCT01745146|12377231|FG001|Allocation to Intervention|Overall Study||60
11187544|NCT01745146|12377230|FG000|Primary Outcome Assessment|Overall Study||27
11187545|NCT01745146|12377231|FG001|Primary Outcome Assessment|Overall Study||57
11187546|NCT01745146|12377230|FG000|Analysis|Overall Study||27
11187547|NCT01745146|12377231|FG001|Analysis|Overall Study||57
11187548|NCT01745146|12377230|FG000|COMPLETED|Overall Study||27
11187549|NCT01745146|12377231|FG001|COMPLETED|Overall Study||57
11187550|NCT01745146|12377230|FG000|NOT COMPLETED|Overall Study||3
11187551|NCT01745146|12377231|FG001|NOT COMPLETED|Overall Study||3
11187552|NCT01745211|12377238|FG000|STARTED|Overall Study||45
11187553|NCT01745211|12377238|FG000|COMPLETED|Overall Study||27
11187554|NCT01745211|12377238|FG000|NOT COMPLETED|Overall Study||18
11187555|NCT01745367|12377244|FG000|STARTED|Overall Study||8
11187556|NCT01745367|12377245|FG001|STARTED|Overall Study||22
11187557|NCT01745367|12377244|FG000|Treated|Overall Study||8
11187558|NCT01745367|12377245|FG001|Treated|Overall Study||21
11187559|NCT01745367|12377244|FG000|COMPLETED|Overall Study||0
11187560|NCT01745367|12377245|FG001|COMPLETED|Overall Study||0
11187561|NCT01745367|12377244|FG000|NOT COMPLETED|Overall Study||8
11187562|NCT01745367|12377245|FG001|NOT COMPLETED|Overall Study||22
11187563|NCT01745380|12377253|FG000|STARTED|Overall Study||100
11187564|NCT01745380|12377254|FG001|STARTED|Overall Study||50
11187565|NCT01745380|12377253|FG000|COMPLETED|Overall Study||99
11187566|NCT01745380|12377254|FG001|COMPLETED|Overall Study||49
11187567|NCT01745380|12377253|FG000|NOT COMPLETED|Overall Study||1
11187568|NCT01745380|12377254|FG001|NOT COMPLETED|Overall Study||1
11187569|NCT01745393|12377262|FG000|STARTED|Treatment to End-of-treatment Assessment||163
11187570|NCT01745393|12377263|FG001|STARTED|Treatment to End-of-treatment Assessment||164
11187571|NCT01745393|12377262|FG000|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
11187572|NCT01745393|12377263|FG001|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
11187573|NCT01745393|12377262|FG000|COMPLETED|Treatment to End-of-treatment Assessment||142
11187574|NCT01745393|12377263|FG001|COMPLETED|Treatment to End-of-treatment Assessment||156
11187575|NCT01745393|12377262|FG000|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
11187576|NCT01745393|12377263|FG001|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
11187577|NCT01745393|12377262|FG000|STARTED|12-month Follow-up||142
11187578|NCT01745393|12377263|FG001|STARTED|12-month Follow-up||156
11187579|NCT01745393|12377262|FG000|COMPLETED|12-month Follow-up||136
11187580|NCT01745393|12377263|FG001|COMPLETED|12-month Follow-up||151
11187581|NCT01745393|12377262|FG000|NOT COMPLETED|12-month Follow-up||6
11187582|NCT01745393|12377263|FG001|NOT COMPLETED|12-month Follow-up||5
11026965|NCT00831272|12205605|FG003|STARTED|Overall Study||66
11187583|NCT01745627|12377269|FG000|STARTED|Overall Study||42
11187584|NCT01745627|12377269|FG000|COMPLETED|Overall Study||20
11187585|NCT01745627|12377269|FG000|NOT COMPLETED|Overall Study||22
11187586|NCT01745822|12377275|FG000|STARTED|Overall Study|168 mothers and 163 infants|331
11187587|NCT01745822|12377276|FG001|STARTED|Overall Study|163 mothers and 160 infants|323
11187588|NCT01745822|12377275|FG000|COMPLETED|Overall Study||331
11187589|NCT01745822|12377276|FG001|COMPLETED|Overall Study||323
11187590|NCT01745822|12377275|FG000|NOT COMPLETED|Overall Study||0
11187591|NCT01745822|12377276|FG001|NOT COMPLETED|Overall Study||0
11187592|NCT01745848|12377282|FG000|STARTED|Overall Study||26
11187593|NCT01745848|12377282|FG000|COMPLETED|Overall Study||20
11187594|NCT01745848|12377282|FG000|NOT COMPLETED|Overall Study||6
11187595|NCT01745952|12377286|FG000|STARTED|Overall Study||4
11187596|NCT01745952|12377287|FG001|STARTED|Overall Study||4
11187597|NCT01745952|12377288|FG002|STARTED|Overall Study||3
11187598|NCT01745952|12377286|FG000|COMPLETED|Overall Study||3
11187599|NCT01745952|12377287|FG001|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
11187600|NCT01745952|12377288|FG002|COMPLETED|Overall Study||3
11187601|NCT01745952|12377286|FG000|NOT COMPLETED|Overall Study||1
11187602|NCT01745952|12377287|FG001|NOT COMPLETED|Overall Study||1
11187603|NCT01745952|12377288|FG002|NOT COMPLETED|Overall Study||0
11187604|NCT01746017|12377313|FG000|STARTED|Period 1||2
11187605|NCT01746017|12377314|FG001|STARTED|Period 1||2
11187606|NCT01746017|12377315|FG002|STARTED|Period 1||2
11187607|NCT01746017|12377316|FG003|STARTED|Period 1||2
11187608|NCT01746017|12377317|FG004|STARTED|Period 1||2
11187609|NCT01746017|12377318|FG005|STARTED|Period 1||2
11187610|NCT01746017|12377319|FG006|STARTED|Period 1||3
11187611|NCT01746017|12377320|FG007|STARTED|Period 1||2
11187612|NCT01746017|12377321|FG008|STARTED|Period 1||3
11187613|NCT01746017|12377322|FG009|STARTED|Period 1||3
11187614|NCT01746017|12377323|FG010|STARTED|Period 1||3
11187615|NCT01746017|12377313|FG000|Received at Least 1 Dose of Study Drug|Period 1||2
11187616|NCT01746017|12377314|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
11187617|NCT01746017|12377315|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
11187618|NCT01746017|12377316|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
11187619|NCT01746017|12377317|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
11187620|NCT01746017|12377318|FG005|Received at Least 1 Dose of Study Drug|Period 1||2
11187621|NCT01746017|12377319|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
11187622|NCT01746017|12377320|FG007|Received at Least 1 Dose of Study Drug|Period 1||2
11187623|NCT01746017|12377321|FG008|Received at Least 1 Dose of Study Drug|Period 1||3
11187624|NCT01746017|12377322|FG009|Received at Least 1 Dose of Study Drug|Period 1||3
11187625|NCT01746017|12377323|FG010|Received at Least 1 Dose of Study Drug|Period 1||3
11187626|NCT01746017|12377313|FG000|COMPLETED|Period 1||2
11187627|NCT01746017|12377314|FG001|COMPLETED|Period 1||2
11187628|NCT01746017|12377315|FG002|COMPLETED|Period 1||2
11187629|NCT01746017|12377316|FG003|COMPLETED|Period 1||2
11187630|NCT01746017|12377317|FG004|COMPLETED|Period 1||2
11187631|NCT01746017|12377318|FG005|COMPLETED|Period 1||2
11187632|NCT01746017|12377319|FG006|COMPLETED|Period 1||2
11187633|NCT01746017|12377320|FG007|COMPLETED|Period 1||2
11187634|NCT01746017|12377321|FG008|COMPLETED|Period 1||3
11187635|NCT01746017|12377322|FG009|COMPLETED|Period 1||3
11187636|NCT01746017|12377323|FG010|COMPLETED|Period 1||3
11187637|NCT01746017|12377313|FG000|NOT COMPLETED|Period 1||0
11187638|NCT01746017|12377314|FG001|NOT COMPLETED|Period 1||0
11187639|NCT01746017|12377315|FG002|NOT COMPLETED|Period 1||0
11187640|NCT01746017|12377316|FG003|NOT COMPLETED|Period 1||0
11187641|NCT01746017|12377317|FG004|NOT COMPLETED|Period 1||0
11187642|NCT01746017|12377318|FG005|NOT COMPLETED|Period 1||0
11187643|NCT01746017|12377319|FG006|NOT COMPLETED|Period 1||1
11187644|NCT01746017|12377320|FG007|NOT COMPLETED|Period 1||0
11187645|NCT01746017|12377321|FG008|NOT COMPLETED|Period 1||0
11187646|NCT01746017|12377322|FG009|NOT COMPLETED|Period 1||0
11187647|NCT01746017|12377323|FG010|NOT COMPLETED|Period 1||0
11187648|NCT01746017|12377313|FG000|STARTED|Period 2||2
11187649|NCT01746017|12377314|FG001|STARTED|Period 2||2
11187650|NCT01746017|12377315|FG002|STARTED|Period 2||2
11187651|NCT01746017|12377316|FG003|STARTED|Period 2||2
11187652|NCT01746017|12377317|FG004|STARTED|Period 2||2
11187653|NCT01746017|12377318|FG005|STARTED|Period 2||2
11187654|NCT01746017|12377319|FG006|STARTED|Period 2||2
11187655|NCT01746017|12377320|FG007|STARTED|Period 2||2
11187656|NCT01746017|12377321|FG008|STARTED|Period 2||3
11187657|NCT01746017|12377322|FG009|STARTED|Period 2||3
11187658|NCT01746017|12377323|FG010|STARTED|Period 2||3
11187659|NCT01746017|12377313|FG000|COMPLETED|Period 2||2
11187660|NCT01746017|12377314|FG001|COMPLETED|Period 2||2
11187661|NCT01746017|12377315|FG002|COMPLETED|Period 2||2
11187662|NCT01746017|12377316|FG003|COMPLETED|Period 2||2
11187663|NCT01746017|12377317|FG004|COMPLETED|Period 2||2
11187664|NCT01746017|12377318|FG005|COMPLETED|Period 2||2
11187665|NCT01746017|12377319|FG006|COMPLETED|Period 2||2
11187666|NCT01746017|12377320|FG007|COMPLETED|Period 2||2
11187667|NCT01746017|12377321|FG008|COMPLETED|Period 2||3
11187668|NCT01746017|12377322|FG009|COMPLETED|Period 2||3
11187669|NCT01746017|12377323|FG010|COMPLETED|Period 2||3
11187670|NCT01746017|12377313|FG000|NOT COMPLETED|Period 2||0
11187671|NCT01746017|12377314|FG001|NOT COMPLETED|Period 2||0
11187672|NCT01746017|12377315|FG002|NOT COMPLETED|Period 2||0
11187673|NCT01746017|12377316|FG003|NOT COMPLETED|Period 2||0
11187674|NCT01746017|12377317|FG004|NOT COMPLETED|Period 2||0
11187675|NCT01746017|12377318|FG005|NOT COMPLETED|Period 2||0
11187676|NCT01746017|12377319|FG006|NOT COMPLETED|Period 2||0
11187677|NCT01746017|12377320|FG007|NOT COMPLETED|Period 2||0
11187678|NCT01746017|12377321|FG008|NOT COMPLETED|Period 2||0
11187679|NCT01746017|12377322|FG009|NOT COMPLETED|Period 2||0
11187680|NCT01746017|12377323|FG010|NOT COMPLETED|Period 2||0
11187681|NCT01746017|12377313|FG000|STARTED|Period 3||2
11187682|NCT01746017|12377314|FG001|STARTED|Period 3||2
11187683|NCT01746017|12377315|FG002|STARTED|Period 3||2
11187684|NCT01746017|12377316|FG003|STARTED|Period 3||2
11187685|NCT01746017|12377317|FG004|STARTED|Period 3||2
11187686|NCT01746017|12377318|FG005|STARTED|Period 3||2
11187687|NCT01746017|12377319|FG006|STARTED|Period 3||2
11187688|NCT01746017|12377320|FG007|STARTED|Period 3||2
11187689|NCT01746017|12377321|FG008|STARTED|Period 3||3
11187690|NCT01746017|12377322|FG009|STARTED|Period 3||3
11187691|NCT01746017|12377323|FG010|STARTED|Period 3||3
11187692|NCT01746017|12377313|FG000|COMPLETED|Period 3||2
11187693|NCT01746017|12377314|FG001|COMPLETED|Period 3||2
11187694|NCT01746017|12377315|FG002|COMPLETED|Period 3||2
11187695|NCT01746017|12377316|FG003|COMPLETED|Period 3||2
11187696|NCT01746017|12377317|FG004|COMPLETED|Period 3||2
11187697|NCT01746017|12377318|FG005|COMPLETED|Period 3||1
11187698|NCT01746017|12377319|FG006|COMPLETED|Period 3||2
11187699|NCT01746017|12377320|FG007|COMPLETED|Period 3||2
11187700|NCT01746017|12377321|FG008|COMPLETED|Period 3||3
11187701|NCT01746017|12377322|FG009|COMPLETED|Period 3||3
11187702|NCT01746017|12377323|FG010|COMPLETED|Period 3||3
11187703|NCT01746017|12377313|FG000|NOT COMPLETED|Period 3||0
11187704|NCT01746017|12377314|FG001|NOT COMPLETED|Period 3||0
11187705|NCT01746017|12377315|FG002|NOT COMPLETED|Period 3||0
11187706|NCT01746017|12377316|FG003|NOT COMPLETED|Period 3||0
11187707|NCT01746017|12377317|FG004|NOT COMPLETED|Period 3||0
11187708|NCT01746017|12377318|FG005|NOT COMPLETED|Period 3||1
11187709|NCT01746017|12377319|FG006|NOT COMPLETED|Period 3||0
11187710|NCT01746017|12377320|FG007|NOT COMPLETED|Period 3||0
11187711|NCT01746017|12377321|FG008|NOT COMPLETED|Period 3||0
11187712|NCT01746017|12377322|FG009|NOT COMPLETED|Period 3||0
11187713|NCT01746017|12377323|FG010|NOT COMPLETED|Period 3||0
11187714|NCT01746017|12377313|FG000|STARTED|Period 4||2
11187715|NCT01746017|12377314|FG001|STARTED|Period 4||2
11187716|NCT01746017|12377315|FG002|STARTED|Period 4||2
11187717|NCT01746017|12377316|FG003|STARTED|Period 4||2
11187718|NCT01746017|12377317|FG004|STARTED|Period 4||2
11187719|NCT01746017|12377318|FG005|STARTED|Period 4||1
11187720|NCT01746017|12377319|FG006|STARTED|Period 4||2
11187721|NCT01746017|12377320|FG007|STARTED|Period 4||2
11187722|NCT01746017|12377321|FG008|STARTED|Period 4|Part B occurred only for 3 periods.|0
11187723|NCT01746017|12377322|FG009|STARTED|Period 4|Part B occurred only for 3 periods.|0
11187724|NCT01746017|12377323|FG010|STARTED|Period 4|Part B occurred only for 3 periods.|0
11187725|NCT01746017|12377313|FG000|COMPLETED|Period 4||2
11187726|NCT01746017|12377314|FG001|COMPLETED|Period 4||2
11187727|NCT01746017|12377315|FG002|COMPLETED|Period 4||2
11187728|NCT01746017|12377316|FG003|COMPLETED|Period 4||2
11187729|NCT01746017|12377317|FG004|COMPLETED|Period 4||2
11187730|NCT01746017|12377318|FG005|COMPLETED|Period 4||1
11187731|NCT01746017|12377319|FG006|COMPLETED|Period 4||2
11187732|NCT01746017|12377320|FG007|COMPLETED|Period 4||2
11187733|NCT01746017|12377321|FG008|COMPLETED|Period 4||0
11187734|NCT01746017|12377322|FG009|COMPLETED|Period 4||0
11187735|NCT01746017|12377323|FG010|COMPLETED|Period 4||0
11187736|NCT01746017|12377313|FG000|NOT COMPLETED|Period 4||0
11187737|NCT01746017|12377314|FG001|NOT COMPLETED|Period 4||0
11187738|NCT01746017|12377315|FG002|NOT COMPLETED|Period 4||0
11187739|NCT01746017|12377316|FG003|NOT COMPLETED|Period 4||0
11187740|NCT01746017|12377317|FG004|NOT COMPLETED|Period 4||0
11187741|NCT01746017|12377318|FG005|NOT COMPLETED|Period 4||0
11187742|NCT01746017|12377319|FG006|NOT COMPLETED|Period 4||0
11187743|NCT01746017|12377320|FG007|NOT COMPLETED|Period 4||0
11187744|NCT01746017|12377321|FG008|NOT COMPLETED|Period 4||0
11187745|NCT01746017|12377322|FG009|NOT COMPLETED|Period 4||0
11187746|NCT01746017|12377323|FG010|NOT COMPLETED|Period 4||0
11187747|NCT01746043|12377366|FG000|STARTED|Overall Study||5
11187748|NCT01746043|12377367|FG001|STARTED|Overall Study||4
11187749|NCT01746043|12377368|FG002|STARTED|Overall Study||5
11187750|NCT01746043|12377369|FG003|STARTED|Overall Study||5
11187751|NCT01746043|12377366|FG000|COMPLETED|Overall Study||5
11187752|NCT01746043|12377367|FG001|COMPLETED|Overall Study||4
11187753|NCT01746043|12377368|FG002|COMPLETED|Overall Study||5
11187754|NCT01746043|12377369|FG003|COMPLETED|Overall Study||5
11187755|NCT01746043|12377366|FG000|NOT COMPLETED|Overall Study||0
11187756|NCT01746043|12377367|FG001|NOT COMPLETED|Overall Study||0
11187757|NCT01746043|12377368|FG002|NOT COMPLETED|Overall Study||0
11187758|NCT01746043|12377369|FG003|NOT COMPLETED|Overall Study||0
11187759|NCT01746095|12377383|FG000|STARTED|Overall Study||20
11187760|NCT01746095|12377384|FG001|STARTED|Overall Study||20
11187761|NCT01746095|12377385|FG002|STARTED|Overall Study||24
11187762|NCT01746095|12377386|FG003|STARTED|Overall Study||23
11187763|NCT01746095|12377383|FG000|COMPLETED|Overall Study||16
11187764|NCT01746095|12377384|FG001|COMPLETED|Overall Study||16
11187765|NCT01746095|12377385|FG002|COMPLETED|Overall Study||11
11187766|NCT01746095|12377386|FG003|COMPLETED|Overall Study||15
11187767|NCT01746095|12377383|FG000|NOT COMPLETED|Overall Study||4
11187768|NCT01746095|12377384|FG001|NOT COMPLETED|Overall Study||4
11187769|NCT01746095|12377385|FG002|NOT COMPLETED|Overall Study||13
11187770|NCT01746095|12377386|FG003|NOT COMPLETED|Overall Study||8
11187771|NCT01746108|12377399|FG000|STARTED|Overall Study||18
11187772|NCT01746108|12377400|FG001|STARTED|Overall Study||28
11187773|NCT01746108|12377401|FG002|STARTED|Overall Study||6
11187774|NCT01746108|12377399|FG000|COMPLETED|Overall Study||18
11187775|NCT01746108|12377400|FG001|COMPLETED|Overall Study||24
11187776|NCT01746108|12377401|FG002|COMPLETED|Overall Study||6
11187777|NCT01746108|12377399|FG000|NOT COMPLETED|Overall Study||0
11187778|NCT01746108|12377400|FG001|NOT COMPLETED|Overall Study||4
11187779|NCT01746108|12377401|FG002|NOT COMPLETED|Overall Study||0
11187780|NCT01746225|12377420|FG000|STARTED|Overall Study||83
11187781|NCT01746225|12377421|FG001|STARTED|Overall Study||86
11187782|NCT01746225|12377422|FG002|STARTED|Overall Study||86
11187783|NCT01746225|12377420|FG000|COMPLETED|Overall Study||43
11187784|NCT01746225|12377421|FG001|COMPLETED|Overall Study||40
11187785|NCT01746225|12377422|FG002|COMPLETED|Overall Study||43
11187786|NCT01746225|12377420|FG000|NOT COMPLETED|Overall Study||40
11187787|NCT01746225|12377421|FG001|NOT COMPLETED|Overall Study||46
11187788|NCT01746225|12377422|FG002|NOT COMPLETED|Overall Study||43
11187789|NCT01746264|12377430|FG000|STARTED|Overall Study||19
11187790|NCT01746264|12377430|FG000|COMPLETED|Overall Study||19
11187791|NCT01746264|12377430|FG000|NOT COMPLETED|Overall Study||0
11187792|NCT01746368|12377436|FG000|STARTED|Overall Study||33
11187793|NCT01746368|12377437|FG001|STARTED|Overall Study||17
11187794|NCT01746368|12377436|FG000|Recieved Allocated Intervention|Overall Study||31
11187795|NCT01746368|12377437|FG001|Recieved Allocated Intervention|Overall Study||8
11187796|NCT01746368|12377436|FG000|Assessment Completed|Overall Study||31
11187797|NCT01746368|12377437|FG001|Assessment Completed|Overall Study||16
11187798|NCT01746368|12377436|FG000|Analyzed for AD Completion Rate|Overall Study||32
11187799|NCT01746368|12377437|FG001|Analyzed for AD Completion Rate|Overall Study||17
11187800|NCT01746368|12377436|FG000|Analyzed for Satisfaction|Overall Study||30
11187801|NCT01746368|12377437|FG001|Analyzed for Satisfaction|Overall Study||16
11187802|NCT01746368|12377436|FG000|COMPLETED|Overall Study||31
11187803|NCT01746368|12377437|FG001|COMPLETED|Overall Study||16
11187804|NCT01746368|12377436|FG000|NOT COMPLETED|Overall Study||2
11187805|NCT01746368|12377437|FG001|NOT COMPLETED|Overall Study||1
11187806|NCT01746420|12377448|FG000|STARTED|Overall Study||20
11187807|NCT01746420|12377449|FG001|STARTED|Overall Study||20
11187808|NCT01746420|12377450|FG002|STARTED|Overall Study||20
11187809|NCT01746420|12377451|FG003|STARTED|Overall Study||20
11187810|NCT01746420|12377452|FG004|STARTED|Overall Study||20
11187811|NCT01746420|12377448|FG000|COMPLETED|Overall Study||17
11187812|NCT01746420|12377449|FG001|COMPLETED|Overall Study||18
11187813|NCT01746420|12377450|FG002|COMPLETED|Overall Study||17
11187814|NCT01746420|12377451|FG003|COMPLETED|Overall Study||20
11187815|NCT01746420|12377452|FG004|COMPLETED|Overall Study||20
11187816|NCT01746420|12377448|FG000|NOT COMPLETED|Overall Study||3
11187817|NCT01746420|12377449|FG001|NOT COMPLETED|Overall Study||2
11187818|NCT01746420|12377450|FG002|NOT COMPLETED|Overall Study||3
11187819|NCT01746420|12377451|FG003|NOT COMPLETED|Overall Study||0
11187820|NCT01746420|12377452|FG004|NOT COMPLETED|Overall Study||0
11187821|NCT01746511|12377467|FG000|STARTED|Overall Study||40
11187822|NCT01746511|12377468|FG001|STARTED|Overall Study||39
11187823|NCT01746511|12377467|FG000|COMPLETED|Overall Study||40
11187824|NCT01746511|12377468|FG001|COMPLETED|Overall Study||39
11187825|NCT01746511|12377467|FG000|NOT COMPLETED|Overall Study||0
11187826|NCT01746511|12377468|FG001|NOT COMPLETED|Overall Study||0
11187827|NCT01746732|12377474|FG000|STARTED|Lead-In Period||23
11187828|NCT01746732|12377475|FG001|STARTED|Lead-In Period||0
11187829|NCT01746732|12377476|FG002|STARTED|Lead-In Period||0
11187830|NCT01746732|12377474|FG000|Participants Received at Least 1 Dose|Lead-In Period||22
11187831|NCT01746732|12377475|FG001|Participants Received at Least 1 Dose|Lead-In Period||0
11187832|NCT01746732|12377476|FG002|Participants Received at Least 1 Dose|Lead-In Period||0
11187833|NCT01746732|12377474|FG000|COMPLETED|Lead-In Period||22
11187834|NCT01746732|12377475|FG001|COMPLETED|Lead-In Period||0
11187835|NCT01746732|12377476|FG002|COMPLETED|Lead-In Period||0
11187836|NCT01746732|12377474|FG000|NOT COMPLETED|Lead-In Period||1
11187837|NCT01746732|12377475|FG001|NOT COMPLETED|Lead-In Period||0
11187838|NCT01746732|12377476|FG002|NOT COMPLETED|Lead-In Period||0
11187839|NCT01746732|12377474|FG000|STARTED|Period 1||0
11187840|NCT01746732|12377475|FG001|STARTED|Period 1||11
11187841|NCT01746732|12377476|FG002|STARTED|Period 1||11
11187842|NCT01746732|12377474|FG000|COMPLETED|Period 1||0
11187843|NCT01746732|12377475|FG001|COMPLETED|Period 1||10
11187844|NCT01746732|12377476|FG002|COMPLETED|Period 1||11
11187845|NCT01746732|12377474|FG000|NOT COMPLETED|Period 1||0
11187846|NCT01746732|12377475|FG001|NOT COMPLETED|Period 1||1
11187847|NCT01746732|12377476|FG002|NOT COMPLETED|Period 1||0
11187848|NCT01746732|12377474|FG000|STARTED|Period 2||0
11187849|NCT01746732|12377475|FG001|STARTED|Period 2||10
11187850|NCT01746732|12377476|FG002|STARTED|Period 2||11
11187851|NCT01746732|12377474|FG000|COMPLETED|Period 2||0
11187852|NCT01746732|12377475|FG001|COMPLETED|Period 2||10
11187853|NCT01746732|12377476|FG002|COMPLETED|Period 2||7
11187854|NCT01746732|12377474|FG000|NOT COMPLETED|Period 2||0
11187855|NCT01746732|12377475|FG001|NOT COMPLETED|Period 2||0
11187856|NCT01746732|12377476|FG002|NOT COMPLETED|Period 2||4
11187857|NCT01746745|12377484|FG000|STARTED|Overall Study||6
11187858|NCT01746745|12377484|FG000|Received Study Drug|Overall Study||6
11187859|NCT01746745|12377484|FG000|COMPLETED|Overall Study||6
11187860|NCT01746745|12377484|FG000|NOT COMPLETED|Overall Study||0
11187861|NCT01746784|12377493|FG000|STARTED|Overall Study||19
11187862|NCT01746784|12377494|FG001|STARTED|Overall Study||10
11187863|NCT01746784|12377495|FG002|STARTED|Overall Study||9
11187864|NCT01746784|12377496|FG003|STARTED|Overall Study||9
11187865|NCT01746784|12377497|FG004|STARTED|Overall Study||19
11187866|NCT01746784|12377493|FG000|Enrolled|Overall Study||19
11187867|NCT01746784|12377494|FG001|Enrolled|Overall Study||10
11187868|NCT01746784|12377495|FG002|Enrolled|Overall Study||9
11187869|NCT01746784|12377496|FG003|Enrolled|Overall Study||9
11187870|NCT01746784|12377497|FG004|Enrolled|Overall Study||19
11187871|NCT01746784|12377493|FG000|COMPLETED|Overall Study||19
11187872|NCT01746784|12377494|FG001|COMPLETED|Overall Study||10
11187873|NCT01746784|12377495|FG002|COMPLETED|Overall Study||9
11187874|NCT01746784|12377496|FG003|COMPLETED|Overall Study||9
11187875|NCT01746784|12377497|FG004|COMPLETED|Overall Study||19
11187876|NCT01746784|12377493|FG000|NOT COMPLETED|Overall Study||0
11187877|NCT01746784|12377494|FG001|NOT COMPLETED|Overall Study||0
11187878|NCT01746784|12377495|FG002|NOT COMPLETED|Overall Study||0
11187879|NCT01746784|12377496|FG003|NOT COMPLETED|Overall Study||0
11187880|NCT01746784|12377497|FG004|NOT COMPLETED|Overall Study||0
11187881|NCT01746862|12377520|FG000|STARTED|Overall Study||60
11187882|NCT01746862|12377521|FG001|STARTED|Overall Study||30
11187883|NCT01746862|12377520|FG000|Treated|Overall Study||59
11187884|NCT01746862|12377521|FG001|Treated|Overall Study||30
11187885|NCT01746862|12377520|FG000|COMPLETED|Overall Study||52
11187886|NCT01746862|12377521|FG001|COMPLETED|Overall Study||27
11187887|NCT01746862|12377520|FG000|NOT COMPLETED|Overall Study||8
11187888|NCT01746862|12377521|FG001|NOT COMPLETED|Overall Study||3
11187889|NCT01746901|12377528|FG000|STARTED|Naloxone Challenge Phase||75
11187890|NCT01746901|12377529|FG001|STARTED|Naloxone Challenge Phase||0
11187891|NCT01746901|12377530|FG002|STARTED|Naloxone Challenge Phase||0
11187892|NCT01746901|12377531|FG003|STARTED|Naloxone Challenge Phase||0
11187893|NCT01746901|12377532|FG004|STARTED|Naloxone Challenge Phase||0
11187894|NCT01746901|12377533|FG005|STARTED|Naloxone Challenge Phase||0
11187895|NCT01746901|12377534|FG006|STARTED|Naloxone Challenge Phase||0
11187896|NCT01746901|12377535|FG007|STARTED|Naloxone Challenge Phase||0
11187897|NCT01746901|12377536|FG008|STARTED|Naloxone Challenge Phase||0
11187898|NCT01746901|12377528|FG000|COMPLETED|Naloxone Challenge Phase||72
11187899|NCT01746901|12377529|FG001|COMPLETED|Naloxone Challenge Phase||0
11187900|NCT01746901|12377530|FG002|COMPLETED|Naloxone Challenge Phase||0
11187901|NCT01746901|12377531|FG003|COMPLETED|Naloxone Challenge Phase||0
11187902|NCT01746901|12377532|FG004|COMPLETED|Naloxone Challenge Phase||0
11187903|NCT01746901|12377533|FG005|COMPLETED|Naloxone Challenge Phase||0
11187904|NCT01746901|12377534|FG006|COMPLETED|Naloxone Challenge Phase||0
11187905|NCT01746901|12377535|FG007|COMPLETED|Naloxone Challenge Phase||0
11187906|NCT01746901|12377536|FG008|COMPLETED|Naloxone Challenge Phase||0
11187907|NCT01746901|12377528|FG000|NOT COMPLETED|Naloxone Challenge Phase||3
11187908|NCT01746901|12377529|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
11187909|NCT01746901|12377530|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
11187910|NCT01746901|12377531|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
11187911|NCT01746901|12377532|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
11187912|NCT01746901|12377533|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
11187913|NCT01746901|12377534|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
11187914|NCT01746901|12377535|FG007|NOT COMPLETED|Naloxone Challenge Phase||0
11187915|NCT01746901|12377536|FG008|NOT COMPLETED|Naloxone Challenge Phase||0
11187916|NCT01746901|12377528|FG000|STARTED|Drug Discrimination Phase: Day 1||0
11187917|NCT01746901|12377529|FG001|STARTED|Drug Discrimination Phase: Day 1||36
11187918|NCT01746901|12377530|FG002|STARTED|Drug Discrimination Phase: Day 1||36
11187919|NCT01746901|12377531|FG003|STARTED|Drug Discrimination Phase: Day 1||0
11187920|NCT01746901|12377532|FG004|STARTED|Drug Discrimination Phase: Day 1||0
11187921|NCT01746901|12377533|FG005|STARTED|Drug Discrimination Phase: Day 1||0
11187922|NCT01746901|12377534|FG006|STARTED|Drug Discrimination Phase: Day 1||0
11187923|NCT01746901|12377535|FG007|STARTED|Drug Discrimination Phase: Day 1||0
11187924|NCT01746901|12377536|FG008|STARTED|Drug Discrimination Phase: Day 1||0
11187925|NCT01746901|12377528|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
11187926|NCT01746901|12377529|FG001|COMPLETED|Drug Discrimination Phase: Day 1||33
11187927|NCT01746901|12377530|FG002|COMPLETED|Drug Discrimination Phase: Day 1||36
11187928|NCT01746901|12377531|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
11187929|NCT01746901|12377532|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
11187930|NCT01746901|12377533|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
11187931|NCT01746901|12377534|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
11187932|NCT01746901|12377535|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0
11187933|NCT01746901|12377536|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0
11187934|NCT01746901|12377528|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11187935|NCT01746901|12377529|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
11187936|NCT01746901|12377530|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11187937|NCT01746901|12377531|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11187938|NCT01746901|12377532|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11187939|NCT01746901|12377533|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11187940|NCT01746901|12377534|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11187941|NCT01746901|12377535|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11187942|NCT01746901|12377536|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11187943|NCT01746901|12377528|FG000|STARTED|Drug Discrimination Phase: Day 2||0
11187944|NCT01746901|12377529|FG001|STARTED|Drug Discrimination Phase: Day 2||33
11187945|NCT01746901|12377530|FG002|STARTED|Drug Discrimination Phase: Day 2||36
11187946|NCT01746901|12377531|FG003|STARTED|Drug Discrimination Phase: Day 2||0
11187947|NCT01746901|12377532|FG004|STARTED|Drug Discrimination Phase: Day 2||0
11187948|NCT01746901|12377533|FG005|STARTED|Drug Discrimination Phase: Day 2||0
11187949|NCT01746901|12377534|FG006|STARTED|Drug Discrimination Phase: Day 2||0
11187950|NCT01746901|12377535|FG007|STARTED|Drug Discrimination Phase: Day 2||0
11187951|NCT01746901|12377536|FG008|STARTED|Drug Discrimination Phase: Day 2||0
11187952|NCT01746901|12377528|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
11187953|NCT01746901|12377529|FG001|COMPLETED|Drug Discrimination Phase: Day 2||19
11187954|NCT01746901|12377530|FG002|COMPLETED|Drug Discrimination Phase: Day 2||22
11187955|NCT01746901|12377531|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
11187956|NCT01746901|12377532|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
11187957|NCT01746901|12377533|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
11187958|NCT01746901|12377534|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
11187959|NCT01746901|12377535|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0
11187960|NCT01746901|12377536|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0
11187961|NCT01746901|12377528|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11187962|NCT01746901|12377529|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
11187963|NCT01746901|12377530|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
11187964|NCT01746901|12377531|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11187965|NCT01746901|12377532|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11187966|NCT01746901|12377533|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11187967|NCT01746901|12377534|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11187968|NCT01746901|12377535|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11187969|NCT01746901|12377536|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11187970|NCT01746901|12377528|FG000|STARTED|Treatment Phase: First Intervention||0
11187971|NCT01746901|12377529|FG001|STARTED|Treatment Phase: First Intervention||0
11187972|NCT01746901|12377530|FG002|STARTED|Treatment Phase: First Intervention||0
11187973|NCT01746901|12377531|FG003|STARTED|Treatment Phase: First Intervention||6
11187974|NCT01746901|12377532|FG004|STARTED|Treatment Phase: First Intervention||6
11187975|NCT01746901|12377533|FG005|STARTED|Treatment Phase: First Intervention||7
11187976|NCT01746901|12377534|FG006|STARTED|Treatment Phase: First Intervention||8
11187977|NCT01746901|12377535|FG007|STARTED|Treatment Phase: First Intervention||7
11187978|NCT01746901|12377536|FG008|STARTED|Treatment Phase: First Intervention||7
11187979|NCT01746901|12377528|FG000|COMPLETED|Treatment Phase: First Intervention||0
11187980|NCT01746901|12377529|FG001|COMPLETED|Treatment Phase: First Intervention||0
11187981|NCT01746901|12377530|FG002|COMPLETED|Treatment Phase: First Intervention||0
11187982|NCT01746901|12377531|FG003|COMPLETED|Treatment Phase: First Intervention||6
11187983|NCT01746901|12377532|FG004|COMPLETED|Treatment Phase: First Intervention||6
11187984|NCT01746901|12377533|FG005|COMPLETED|Treatment Phase: First Intervention||7
11187985|NCT01746901|12377534|FG006|COMPLETED|Treatment Phase: First Intervention||7
11187986|NCT01746901|12377535|FG007|COMPLETED|Treatment Phase: First Intervention||7
11187987|NCT01746901|12377536|FG008|COMPLETED|Treatment Phase: First Intervention||7
11187988|NCT01746901|12377528|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
11187989|NCT01746901|12377529|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
11187990|NCT01746901|12377530|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
11187991|NCT01746901|12377531|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
11187992|NCT01746901|12377532|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
11187993|NCT01746901|12377533|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
11187994|NCT01746901|12377534|FG006|NOT COMPLETED|Treatment Phase: First Intervention||1
11187995|NCT01746901|12377535|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0
11187996|NCT01746901|12377536|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0
11187997|NCT01746901|12377528|FG000|STARTED|Treatment Phase: Washout Period 1||0
11187998|NCT01746901|12377529|FG001|STARTED|Treatment Phase: Washout Period 1||0
11187999|NCT01746901|12377530|FG002|STARTED|Treatment Phase: Washout Period 1||0
11188000|NCT01746901|12377531|FG003|STARTED|Treatment Phase: Washout Period 1||6
11188001|NCT01746901|12377532|FG004|STARTED|Treatment Phase: Washout Period 1||6
11188002|NCT01746901|12377533|FG005|STARTED|Treatment Phase: Washout Period 1||7
11188003|NCT01746901|12377534|FG006|STARTED|Treatment Phase: Washout Period 1||7
11188004|NCT01746901|12377535|FG007|STARTED|Treatment Phase: Washout Period 1||7
11188005|NCT01746901|12377536|FG008|STARTED|Treatment Phase: Washout Period 1||7
11188006|NCT01746901|12377528|FG000|COMPLETED|Treatment Phase: Washout Period 1||0
11188007|NCT01746901|12377529|FG001|COMPLETED|Treatment Phase: Washout Period 1||0
11188008|NCT01746901|12377530|FG002|COMPLETED|Treatment Phase: Washout Period 1||0
11188009|NCT01746901|12377531|FG003|COMPLETED|Treatment Phase: Washout Period 1||6
11188010|NCT01746901|12377532|FG004|COMPLETED|Treatment Phase: Washout Period 1||6
11188011|NCT01746901|12377533|FG005|COMPLETED|Treatment Phase: Washout Period 1||7
11188012|NCT01746901|12377534|FG006|COMPLETED|Treatment Phase: Washout Period 1||7
11188013|NCT01746901|12377535|FG007|COMPLETED|Treatment Phase: Washout Period 1||7
11188014|NCT01746901|12377536|FG008|COMPLETED|Treatment Phase: Washout Period 1||7
11188015|NCT01746901|12377528|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11188016|NCT01746901|12377529|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11188017|NCT01746901|12377530|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11188018|NCT01746901|12377531|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11188019|NCT01746901|12377532|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11188020|NCT01746901|12377533|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11188021|NCT01746901|12377534|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11188022|NCT01746901|12377535|FG007|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11188023|NCT01746901|12377536|FG008|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11188024|NCT01746901|12377528|FG000|STARTED|Treatment Phase: Second Intervention||0
11188025|NCT01746901|12377529|FG001|STARTED|Treatment Phase: Second Intervention||0
11188026|NCT01746901|12377530|FG002|STARTED|Treatment Phase: Second Intervention||0
11188027|NCT01746901|12377531|FG003|STARTED|Treatment Phase: Second Intervention||6
11188028|NCT01746901|12377532|FG004|STARTED|Treatment Phase: Second Intervention||6
11188029|NCT01746901|12377533|FG005|STARTED|Treatment Phase: Second Intervention||7
11188030|NCT01746901|12377534|FG006|STARTED|Treatment Phase: Second Intervention||7
11188031|NCT01746901|12377535|FG007|STARTED|Treatment Phase: Second Intervention||7
11188032|NCT01746901|12377536|FG008|STARTED|Treatment Phase: Second Intervention||7
11188033|NCT01746901|12377528|FG000|COMPLETED|Treatment Phase: Second Intervention||0
11188034|NCT01746901|12377529|FG001|COMPLETED|Treatment Phase: Second Intervention||0
11188035|NCT01746901|12377530|FG002|COMPLETED|Treatment Phase: Second Intervention||0
11188036|NCT01746901|12377531|FG003|COMPLETED|Treatment Phase: Second Intervention||6
11188037|NCT01746901|12377532|FG004|COMPLETED|Treatment Phase: Second Intervention||6
11188038|NCT01746901|12377533|FG005|COMPLETED|Treatment Phase: Second Intervention||7
11188039|NCT01746901|12377534|FG006|COMPLETED|Treatment Phase: Second Intervention||7
11188040|NCT01746901|12377535|FG007|COMPLETED|Treatment Phase: Second Intervention||6
11188041|NCT01746901|12377536|FG008|COMPLETED|Treatment Phase: Second Intervention||7
11188042|NCT01746901|12377528|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
11188043|NCT01746901|12377529|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
11188044|NCT01746901|12377530|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
11188045|NCT01746901|12377531|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0
11188046|NCT01746901|12377532|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
11188047|NCT01746901|12377533|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
11188048|NCT01746901|12377534|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
11188049|NCT01746901|12377535|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||1
11188050|NCT01746901|12377536|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0
11188051|NCT01746901|12377528|FG000|STARTED|Treatment Phase: Washout Period 2||0
11188052|NCT01746901|12377529|FG001|STARTED|Treatment Phase: Washout Period 2||0
11188053|NCT01746901|12377530|FG002|STARTED|Treatment Phase: Washout Period 2||0
11188054|NCT01746901|12377531|FG003|STARTED|Treatment Phase: Washout Period 2||6
11188055|NCT01746901|12377532|FG004|STARTED|Treatment Phase: Washout Period 2||6
11188056|NCT01746901|12377533|FG005|STARTED|Treatment Phase: Washout Period 2||7
11188057|NCT01746901|12377534|FG006|STARTED|Treatment Phase: Washout Period 2||7
11188058|NCT01746901|12377535|FG007|STARTED|Treatment Phase: Washout Period 2||6
11188059|NCT01746901|12377536|FG008|STARTED|Treatment Phase: Washout Period 2||7
11188060|NCT01746901|12377528|FG000|COMPLETED|Treatment Phase: Washout Period 2||0
11188061|NCT01746901|12377529|FG001|COMPLETED|Treatment Phase: Washout Period 2||0
11188062|NCT01746901|12377530|FG002|COMPLETED|Treatment Phase: Washout Period 2||0
11188063|NCT01746901|12377531|FG003|COMPLETED|Treatment Phase: Washout Period 2||6
11188064|NCT01746901|12377532|FG004|COMPLETED|Treatment Phase: Washout Period 2||6
11188065|NCT01746901|12377533|FG005|COMPLETED|Treatment Phase: Washout Period 2||7
11188066|NCT01746901|12377534|FG006|COMPLETED|Treatment Phase: Washout Period 2||7
11188067|NCT01746901|12377535|FG007|COMPLETED|Treatment Phase: Washout Period 2||6
11188068|NCT01746901|12377536|FG008|COMPLETED|Treatment Phase: Washout Period 2||7
11188069|NCT01746901|12377528|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11188070|NCT01746901|12377529|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11188071|NCT01746901|12377530|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11188072|NCT01746901|12377531|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11188073|NCT01746901|12377532|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11188074|NCT01746901|12377533|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11188075|NCT01746901|12377534|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11188076|NCT01746901|12377535|FG007|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11188077|NCT01746901|12377536|FG008|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11188078|NCT01746901|12377528|FG000|STARTED|Treatment Phase: Third Intervention||0
11188079|NCT01746901|12377529|FG001|STARTED|Treatment Phase: Third Intervention||0
11188080|NCT01746901|12377530|FG002|STARTED|Treatment Phase: Third Intervention||0
11188081|NCT01746901|12377531|FG003|STARTED|Treatment Phase: Third Intervention||6
11188082|NCT01746901|12377532|FG004|STARTED|Treatment Phase: Third Intervention||6
11188083|NCT01746901|12377533|FG005|STARTED|Treatment Phase: Third Intervention||7
11188084|NCT01746901|12377534|FG006|STARTED|Treatment Phase: Third Intervention||7
11188085|NCT01746901|12377535|FG007|STARTED|Treatment Phase: Third Intervention||6
11188086|NCT01746901|12377536|FG008|STARTED|Treatment Phase: Third Intervention||7
11188087|NCT01746901|12377528|FG000|COMPLETED|Treatment Phase: Third Intervention||0
11188088|NCT01746901|12377529|FG001|COMPLETED|Treatment Phase: Third Intervention||0
11188089|NCT01746901|12377530|FG002|COMPLETED|Treatment Phase: Third Intervention||0
11188090|NCT01746901|12377531|FG003|COMPLETED|Treatment Phase: Third Intervention||6
11188091|NCT01746901|12377532|FG004|COMPLETED|Treatment Phase: Third Intervention||6
11188092|NCT01746901|12377533|FG005|COMPLETED|Treatment Phase: Third Intervention||6
11188093|NCT01746901|12377534|FG006|COMPLETED|Treatment Phase: Third Intervention||6
11188094|NCT01746901|12377535|FG007|COMPLETED|Treatment Phase: Third Intervention||6
11188095|NCT01746901|12377536|FG008|COMPLETED|Treatment Phase: Third Intervention||7
11188096|NCT01746901|12377528|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
11188097|NCT01746901|12377529|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
11188098|NCT01746901|12377530|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
11188099|NCT01746901|12377531|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
11188100|NCT01746901|12377532|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
11188101|NCT01746901|12377533|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||1
11188102|NCT01746901|12377534|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||1
11188103|NCT01746901|12377535|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0
11188104|NCT01746901|12377536|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||0
11188105|NCT01746901|12377528|FG000|STARTED|Treatment Phase: Washout Period 3||0
11188106|NCT01746901|12377529|FG001|STARTED|Treatment Phase: Washout Period 3||0
11188107|NCT01746901|12377530|FG002|STARTED|Treatment Phase: Washout Period 3||0
11188108|NCT01746901|12377531|FG003|STARTED|Treatment Phase: Washout Period 3||6
11188109|NCT01746901|12377532|FG004|STARTED|Treatment Phase: Washout Period 3||6
11188110|NCT01746901|12377533|FG005|STARTED|Treatment Phase: Washout Period 3||6
11188111|NCT01746901|12377534|FG006|STARTED|Treatment Phase: Washout Period 3||6
11188112|NCT01746901|12377535|FG007|STARTED|Treatment Phase: Washout Period 3||6
11188113|NCT01746901|12377536|FG008|STARTED|Treatment Phase: Washout Period 3||7
11188114|NCT01746901|12377528|FG000|COMPLETED|Treatment Phase: Washout Period 3||0
11188115|NCT01746901|12377529|FG001|COMPLETED|Treatment Phase: Washout Period 3||0
11188116|NCT01746901|12377530|FG002|COMPLETED|Treatment Phase: Washout Period 3||0
11188117|NCT01746901|12377531|FG003|COMPLETED|Treatment Phase: Washout Period 3||6
11188118|NCT01746901|12377532|FG004|COMPLETED|Treatment Phase: Washout Period 3||6
11188119|NCT01746901|12377533|FG005|COMPLETED|Treatment Phase: Washout Period 3||6
11188120|NCT01746901|12377534|FG006|COMPLETED|Treatment Phase: Washout Period 3||6
11188121|NCT01746901|12377535|FG007|COMPLETED|Treatment Phase: Washout Period 3||6
11188122|NCT01746901|12377536|FG008|COMPLETED|Treatment Phase: Washout Period 3||7
11188123|NCT01746901|12377528|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0
11188124|NCT01746901|12377529|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0
11188125|NCT01746901|12377530|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0
11188126|NCT01746901|12377531|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||0
11188127|NCT01746901|12377532|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0
11188128|NCT01746901|12377533|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0
11188129|NCT01746901|12377534|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||0
11188130|NCT01746901|12377535|FG007|NOT COMPLETED|Treatment Phase: Washout Period 3||0
11188131|NCT01746901|12377536|FG008|NOT COMPLETED|Treatment Phase: Washout Period 3||0
11188132|NCT01746901|12377528|FG000|STARTED|Treatment Phase: Fourth Intervention||0
11188133|NCT01746901|12377529|FG001|STARTED|Treatment Phase: Fourth Intervention||0
11188134|NCT01746901|12377530|FG002|STARTED|Treatment Phase: Fourth Intervention||0
11188135|NCT01746901|12377531|FG003|STARTED|Treatment Phase: Fourth Intervention||6
11188136|NCT01746901|12377532|FG004|STARTED|Treatment Phase: Fourth Intervention||6
11188137|NCT01746901|12377533|FG005|STARTED|Treatment Phase: Fourth Intervention||6
11188138|NCT01746901|12377534|FG006|STARTED|Treatment Phase: Fourth Intervention||6
11188139|NCT01746901|12377535|FG007|STARTED|Treatment Phase: Fourth Intervention||6
11188140|NCT01746901|12377536|FG008|STARTED|Treatment Phase: Fourth Intervention||7
11188141|NCT01746901|12377528|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0
11188142|NCT01746901|12377529|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0
11188143|NCT01746901|12377530|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0
11188144|NCT01746901|12377531|FG003|COMPLETED|Treatment Phase: Fourth Intervention||5
11188145|NCT01746901|12377532|FG004|COMPLETED|Treatment Phase: Fourth Intervention||6
11188146|NCT01746901|12377533|FG005|COMPLETED|Treatment Phase: Fourth Intervention||5
11188147|NCT01746901|12377534|FG006|COMPLETED|Treatment Phase: Fourth Intervention||5
11188148|NCT01746901|12377535|FG007|COMPLETED|Treatment Phase: Fourth Intervention||6
11188149|NCT01746901|12377536|FG008|COMPLETED|Treatment Phase: Fourth Intervention||5
11188150|NCT01746901|12377528|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
11188151|NCT01746901|12377529|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
11188152|NCT01746901|12377530|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
11188153|NCT01746901|12377531|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
11188154|NCT01746901|12377532|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
11188155|NCT01746901|12377533|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
11188156|NCT01746901|12377534|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
11188157|NCT01746901|12377535|FG007|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
11188158|NCT01746901|12377536|FG008|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
11188159|NCT01746901|12377528|FG000|STARTED|Treatment Phase: Washout Period 4||0
11188160|NCT01746901|12377529|FG001|STARTED|Treatment Phase: Washout Period 4||0
11188161|NCT01746901|12377530|FG002|STARTED|Treatment Phase: Washout Period 4||0
11188162|NCT01746901|12377531|FG003|STARTED|Treatment Phase: Washout Period 4||5
11188163|NCT01746901|12377532|FG004|STARTED|Treatment Phase: Washout Period 4||6
11188164|NCT01746901|12377533|FG005|STARTED|Treatment Phase: Washout Period 4||5
11188165|NCT01746901|12377534|FG006|STARTED|Treatment Phase: Washout Period 4||5
11188166|NCT01746901|12377535|FG007|STARTED|Treatment Phase: Washout Period 4||6
11188167|NCT01746901|12377536|FG008|STARTED|Treatment Phase: Washout Period 4||5
11188168|NCT01746901|12377528|FG000|COMPLETED|Treatment Phase: Washout Period 4||0
11188169|NCT01746901|12377529|FG001|COMPLETED|Treatment Phase: Washout Period 4||0
11188170|NCT01746901|12377530|FG002|COMPLETED|Treatment Phase: Washout Period 4||0
11188171|NCT01746901|12377531|FG003|COMPLETED|Treatment Phase: Washout Period 4||5
11188172|NCT01746901|12377532|FG004|COMPLETED|Treatment Phase: Washout Period 4||6
11188173|NCT01746901|12377533|FG005|COMPLETED|Treatment Phase: Washout Period 4||5
11188174|NCT01746901|12377534|FG006|COMPLETED|Treatment Phase: Washout Period 4||5
11188175|NCT01746901|12377535|FG007|COMPLETED|Treatment Phase: Washout Period 4||6
11188176|NCT01746901|12377536|FG008|COMPLETED|Treatment Phase: Washout Period 4||5
11188177|NCT01746901|12377528|FG000|NOT COMPLETED|Treatment Phase: Washout Period 4||0
11188178|NCT01746901|12377529|FG001|NOT COMPLETED|Treatment Phase: Washout Period 4||0
11188179|NCT01746901|12377530|FG002|NOT COMPLETED|Treatment Phase: Washout Period 4||0
11188180|NCT01746901|12377531|FG003|NOT COMPLETED|Treatment Phase: Washout Period 4||0
11188181|NCT01746901|12377532|FG004|NOT COMPLETED|Treatment Phase: Washout Period 4||0
11188182|NCT01746901|12377533|FG005|NOT COMPLETED|Treatment Phase: Washout Period 4||0
11188183|NCT01746901|12377534|FG006|NOT COMPLETED|Treatment Phase: Washout Period 4||0
11188184|NCT01746901|12377535|FG007|NOT COMPLETED|Treatment Phase: Washout Period 4||0
11188185|NCT01746901|12377536|FG008|NOT COMPLETED|Treatment Phase: Washout Period 4||0
11188186|NCT01746901|12377528|FG000|STARTED|Treatment Phase: Fifth Intervention||0
11188187|NCT01746901|12377529|FG001|STARTED|Treatment Phase: Fifth Intervention||0
11188188|NCT01746901|12377530|FG002|STARTED|Treatment Phase: Fifth Intervention||0
11188189|NCT01746901|12377531|FG003|STARTED|Treatment Phase: Fifth Intervention||5
11188190|NCT01746901|12377532|FG004|STARTED|Treatment Phase: Fifth Intervention||6
11188191|NCT01746901|12377533|FG005|STARTED|Treatment Phase: Fifth Intervention||5
11188192|NCT01746901|12377534|FG006|STARTED|Treatment Phase: Fifth Intervention||5
11188193|NCT01746901|12377535|FG007|STARTED|Treatment Phase: Fifth Intervention||6
11188194|NCT01746901|12377536|FG008|STARTED|Treatment Phase: Fifth Intervention||5
11188195|NCT01746901|12377528|FG000|COMPLETED|Treatment Phase: Fifth Intervention||0
11188196|NCT01746901|12377529|FG001|COMPLETED|Treatment Phase: Fifth Intervention||0
11188197|NCT01746901|12377530|FG002|COMPLETED|Treatment Phase: Fifth Intervention||0
11188198|NCT01746901|12377531|FG003|COMPLETED|Treatment Phase: Fifth Intervention||5
11188199|NCT01746901|12377532|FG004|COMPLETED|Treatment Phase: Fifth Intervention||6
11188200|NCT01746901|12377533|FG005|COMPLETED|Treatment Phase: Fifth Intervention||5
11188201|NCT01746901|12377534|FG006|COMPLETED|Treatment Phase: Fifth Intervention||5
11188202|NCT01746901|12377535|FG007|COMPLETED|Treatment Phase: Fifth Intervention||6
11324376|NCT02742987|12521651|FG001|COMPLETED|Overall Study||21
11188203|NCT01746901|12377536|FG008|COMPLETED|Treatment Phase: Fifth Intervention||5
11188204|NCT01746901|12377528|FG000|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
11188205|NCT01746901|12377529|FG001|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
11188206|NCT01746901|12377530|FG002|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
11188207|NCT01746901|12377531|FG003|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
11188208|NCT01746901|12377532|FG004|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
11188209|NCT01746901|12377533|FG005|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
11188210|NCT01746901|12377534|FG006|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
11188211|NCT01746901|12377535|FG007|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
11188212|NCT01746901|12377536|FG008|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
11188213|NCT01746901|12377528|FG000|STARTED|Treatment Phase: Washout Period 5||0
11188214|NCT01746901|12377529|FG001|STARTED|Treatment Phase: Washout Period 5||0
11188215|NCT01746901|12377530|FG002|STARTED|Treatment Phase: Washout Period 5||0
11188216|NCT01746901|12377531|FG003|STARTED|Treatment Phase: Washout Period 5||5
11324377|NCT02742987|12521650|FG000|NOT COMPLETED|Overall Study||0
11324378|NCT02742987|12521651|FG001|NOT COMPLETED|Overall Study||0
11324379|NCT02743078|12521657|FG000|STARTED|Overall Study||3
11324380|NCT02743078|12521657|FG000|Eligible Populaton|Overall Study||3
11324381|NCT02743078|12521657|FG000|Eligible With Six-month Follow-up Data|Overall Study||3
11324382|NCT02743078|12521657|FG000|COMPLETED|Overall Study||3
11324383|NCT02743078|12521657|FG000|NOT COMPLETED|Overall Study||0
11324384|NCT02743117|12521663|FG000|STARTED|Overall Study||60
11324385|NCT02743117|12521664|FG001|STARTED|Overall Study||241
11324386|NCT02743117|12521663|FG000|Treated|Overall Study||59
11324387|NCT02743117|12521664|FG001|Treated|Overall Study||241
11324388|NCT02743117|12521663|FG000|COMPLETED|Overall Study||59
11324389|NCT02743117|12521664|FG001|COMPLETED|Overall Study||240
11324390|NCT02743117|12521663|FG000|NOT COMPLETED|Overall Study||1
11324391|NCT02743117|12521664|FG001|NOT COMPLETED|Overall Study||1
11324392|NCT02743221|12521672|FG000|STARTED|Overall Study||77
11324393|NCT02743221|12521673|FG001|STARTED|Overall Study||77
11324394|NCT02743221|12521672|FG000|COMPLETED|Overall Study||21
11324395|NCT02743221|12521673|FG001|COMPLETED|Overall Study||17
11324396|NCT02743221|12521672|FG000|NOT COMPLETED|Overall Study||56
11324397|NCT02743221|12521673|FG001|NOT COMPLETED|Overall Study||60
11324398|NCT02743312|12521681|FG000|STARTED|Overall Study||3
11324399|NCT02743312|12521682|FG001|STARTED|Overall Study||2
11324400|NCT02743312|12521681|FG000|COMPLETED|Overall Study||3
11324401|NCT02743312|12521682|FG001|COMPLETED|Overall Study||2
11324402|NCT02743312|12521681|FG000|NOT COMPLETED|Overall Study||0
11324403|NCT02743312|12521682|FG001|NOT COMPLETED|Overall Study||0
11324404|NCT02743377|12521699|FG000|STARTED|Overall Study||9
11324405|NCT02743377|12521700|FG001|STARTED|Overall Study||6
11324406|NCT02743377|12521699|FG000|Brain PET With 11C Rolipram|Overall Study||8
11324407|NCT02743377|12521700|FG001|Brain PET With 11C Rolipram|Overall Study||3
11324408|NCT02743377|12521699|FG000|Whole Body PET Baseline With 11C Rolipra|Overall Study||5
11324409|NCT02743377|12521700|FG001|Whole Body PET Baseline With 11C Rolipra|Overall Study||4
11324410|NCT02743377|12521699|FG000|Whole Body PET Baseline & Blocked|Overall Study||0
11324411|NCT02743377|12521700|FG001|Whole Body PET Baseline & Blocked|Overall Study||2
11324412|NCT02743377|12521699|FG000|COMPLETED|Overall Study||7
11324413|NCT02743377|12521700|FG001|COMPLETED|Overall Study||6
11324414|NCT02743377|12521699|FG000|NOT COMPLETED|Overall Study||2
11324415|NCT02743377|12521700|FG001|NOT COMPLETED|Overall Study||0
11324416|NCT02743442|12521707|FG000|STARTED|Overall Study||8
11324417|NCT02743442|12521707|FG000|COMPLETED|Overall Study||8
11324418|NCT02743442|12521707|FG000|NOT COMPLETED|Overall Study||0
11324419|NCT02743520|12521711|FG000|STARTED|Overall Study||86
11324420|NCT02743520|12521711|FG000|COMPLETED|Overall Study||85
11324421|NCT02743520|12521711|FG000|NOT COMPLETED|Overall Study||1
11324422|NCT02743702|12521717|FG000|STARTED|Overall Study||11
11324423|NCT02743702|12521718|FG001|STARTED|Overall Study||10
11324424|NCT02743702|12521717|FG000|COMPLETED|Overall Study||11
11324425|NCT02743702|12521718|FG001|COMPLETED|Overall Study||10
11324426|NCT02743702|12521717|FG000|NOT COMPLETED|Overall Study||0
11324427|NCT02743702|12521718|FG001|NOT COMPLETED|Overall Study||0
11324428|NCT02743780|12521729|FG000|STARTED|Part 1 (3 Days)||6
11324429|NCT02743780|12521730|FG001|STARTED|Part 1 (3 Days)||6
11324430|NCT02743780|12521731|FG002|STARTED|Part 1 (3 Days)||6
11324431|NCT02743780|12521732|FG003|STARTED|Part 1 (3 Days)||6
11324432|NCT02743780|12521733|FG004|STARTED|Part 1 (3 Days)||8
11324433|NCT02743780|12521729|FG000|COMPLETED|Part 1 (3 Days)||6
11324434|NCT02743780|12521730|FG001|COMPLETED|Part 1 (3 Days)||6
11324435|NCT02743780|12521731|FG002|COMPLETED|Part 1 (3 Days)||6
11188217|NCT01746901|12377532|FG004|STARTED|Treatment Phase: Washout Period 5||6
11188218|NCT01746901|12377533|FG005|STARTED|Treatment Phase: Washout Period 5||5
11188219|NCT01746901|12377534|FG006|STARTED|Treatment Phase: Washout Period 5||5
11188220|NCT01746901|12377535|FG007|STARTED|Treatment Phase: Washout Period 5||6
11188221|NCT01746901|12377536|FG008|STARTED|Treatment Phase: Washout Period 5||5
11188222|NCT01746901|12377528|FG000|COMPLETED|Treatment Phase: Washout Period 5||0
11188223|NCT01746901|12377529|FG001|COMPLETED|Treatment Phase: Washout Period 5||0
11188224|NCT01746901|12377530|FG002|COMPLETED|Treatment Phase: Washout Period 5||0
11188225|NCT01746901|12377531|FG003|COMPLETED|Treatment Phase: Washout Period 5||5
11188226|NCT01746901|12377532|FG004|COMPLETED|Treatment Phase: Washout Period 5||6
11188227|NCT01746901|12377533|FG005|COMPLETED|Treatment Phase: Washout Period 5||5
11188228|NCT01746901|12377534|FG006|COMPLETED|Treatment Phase: Washout Period 5||5
11188229|NCT01746901|12377535|FG007|COMPLETED|Treatment Phase: Washout Period 5||6
11188230|NCT01746901|12377536|FG008|COMPLETED|Treatment Phase: Washout Period 5||5
11188231|NCT01746901|12377528|FG000|NOT COMPLETED|Treatment Phase: Washout Period 5||0
11188232|NCT01746901|12377529|FG001|NOT COMPLETED|Treatment Phase: Washout Period 5||0
11188233|NCT01746901|12377530|FG002|NOT COMPLETED|Treatment Phase: Washout Period 5||0
11188234|NCT01746901|12377531|FG003|NOT COMPLETED|Treatment Phase: Washout Period 5||0
11188235|NCT01746901|12377532|FG004|NOT COMPLETED|Treatment Phase: Washout Period 5||0
11188236|NCT01746901|12377533|FG005|NOT COMPLETED|Treatment Phase: Washout Period 5||0
11188237|NCT01746901|12377534|FG006|NOT COMPLETED|Treatment Phase: Washout Period 5||0
11188238|NCT01746901|12377535|FG007|NOT COMPLETED|Treatment Phase: Washout Period 5||0
11188239|NCT01746901|12377536|FG008|NOT COMPLETED|Treatment Phase: Washout Period 5||0
11188240|NCT01746901|12377528|FG000|STARTED|Treatment Phase: Sixth Intervention||0
11324436|NCT02743780|12521732|FG003|COMPLETED|Part 1 (3 Days)||6
11324437|NCT02743780|12521733|FG004|COMPLETED|Part 1 (3 Days)||8
11324438|NCT02743780|12521729|FG000|NOT COMPLETED|Part 1 (3 Days)||0
11324439|NCT02743780|12521730|FG001|NOT COMPLETED|Part 1 (3 Days)||0
11324440|NCT02743780|12521731|FG002|NOT COMPLETED|Part 1 (3 Days)||0
11188241|NCT01746901|12377529|FG001|STARTED|Treatment Phase: Sixth Intervention||0
11188242|NCT01746901|12377530|FG002|STARTED|Treatment Phase: Sixth Intervention||0
11188243|NCT01746901|12377531|FG003|STARTED|Treatment Phase: Sixth Intervention||5
11188244|NCT01746901|12377532|FG004|STARTED|Treatment Phase: Sixth Intervention||6
11188245|NCT01746901|12377533|FG005|STARTED|Treatment Phase: Sixth Intervention||5
11188246|NCT01746901|12377534|FG006|STARTED|Treatment Phase: Sixth Intervention||5
11188247|NCT01746901|12377535|FG007|STARTED|Treatment Phase: Sixth Intervention||6
11188248|NCT01746901|12377536|FG008|STARTED|Treatment Phase: Sixth Intervention||5
11188249|NCT01746901|12377528|FG000|COMPLETED|Treatment Phase: Sixth Intervention||0
11188250|NCT01746901|12377529|FG001|COMPLETED|Treatment Phase: Sixth Intervention||0
11188251|NCT01746901|12377530|FG002|COMPLETED|Treatment Phase: Sixth Intervention||0
11188252|NCT01746901|12377531|FG003|COMPLETED|Treatment Phase: Sixth Intervention||5
11188253|NCT01746901|12377532|FG004|COMPLETED|Treatment Phase: Sixth Intervention||6
11188254|NCT01746901|12377533|FG005|COMPLETED|Treatment Phase: Sixth Intervention||5
11188255|NCT01746901|12377534|FG006|COMPLETED|Treatment Phase: Sixth Intervention||5
11188256|NCT01746901|12377535|FG007|COMPLETED|Treatment Phase: Sixth Intervention||6
11188257|NCT01746901|12377536|FG008|COMPLETED|Treatment Phase: Sixth Intervention||5
11188258|NCT01746901|12377528|FG000|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
11188259|NCT01746901|12377529|FG001|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
11188260|NCT01746901|12377530|FG002|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
11188261|NCT01746901|12377531|FG003|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
11188262|NCT01746901|12377532|FG004|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
11188263|NCT01746901|12377533|FG005|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
11188264|NCT01746901|12377534|FG006|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
11188265|NCT01746901|12377535|FG007|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
11188266|NCT01746901|12377536|FG008|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
11188267|NCT01746940|12377576|FG000|STARTED|Safety and Efficacy First Phase||39
11188268|NCT01746940|12377577|FG001|STARTED|Safety and Efficacy First Phase||41
11188269|NCT01746940|12377578|FG002|STARTED|Safety and Efficacy First Phase||40
11188270|NCT01746940|12377579|FG003|STARTED|Safety and Efficacy First Phase||3
11188271|NCT01746940|12377576|FG000|COMPLETED|Safety and Efficacy First Phase||39
11188272|NCT01746940|12377577|FG001|COMPLETED|Safety and Efficacy First Phase||41
11188273|NCT01746940|12377578|FG002|COMPLETED|Safety and Efficacy First Phase||40
11188274|NCT01746940|12377579|FG003|COMPLETED|Safety and Efficacy First Phase||0
11188275|NCT01746940|12377576|FG000|NOT COMPLETED|Safety and Efficacy First Phase||0
11188276|NCT01746940|12377577|FG001|NOT COMPLETED|Safety and Efficacy First Phase||0
11188277|NCT01746940|12377578|FG002|NOT COMPLETED|Safety and Efficacy First Phase||0
11188278|NCT01746940|12377579|FG003|NOT COMPLETED|Safety and Efficacy First Phase||3
11188279|NCT01746940|12377576|FG000|STARTED|Safety Second Phase||18
11188280|NCT01746940|12377577|FG001|STARTED|Safety Second Phase||18
11188281|NCT01746940|12377578|FG002|STARTED|Safety Second Phase||0
11188282|NCT01746940|12377579|FG003|STARTED|Safety Second Phase||0
11188283|NCT01746940|12377576|FG000|COMPLETED|Safety Second Phase||18
11188284|NCT01746940|12377577|FG001|COMPLETED|Safety Second Phase||18
11188285|NCT01746940|12377578|FG002|COMPLETED|Safety Second Phase||0
11188286|NCT01746940|12377579|FG003|COMPLETED|Safety Second Phase||0
11188287|NCT01746940|12377576|FG000|NOT COMPLETED|Safety Second Phase||0
11188288|NCT01746940|12377577|FG001|NOT COMPLETED|Safety Second Phase||0
11188289|NCT01746940|12377578|FG002|NOT COMPLETED|Safety Second Phase||0
11188290|NCT01746940|12377579|FG003|NOT COMPLETED|Safety Second Phase||0
11188291|NCT01746979|12377589|FG000|STARTED|Overall Study||346
11188292|NCT01746979|12377590|FG001|STARTED|Overall Study||347
11188293|NCT01746979|12377589|FG000|COMPLETED|Overall Study||0
11188294|NCT01746979|12377590|FG001|COMPLETED|Overall Study||0
11188295|NCT01746979|12377589|FG000|NOT COMPLETED|Overall Study||346
11188296|NCT01746979|12377590|FG001|NOT COMPLETED|Overall Study||347
11188297|NCT01747330|12377596|FG000|STARTED|Overall Study||40
11188298|NCT01747330|12377596|FG000|COMPLETED|Overall Study||40
11188299|NCT01747330|12377596|FG000|NOT COMPLETED|Overall Study||0
11188300|NCT01747343|12377600|FG000|STARTED|Baseline||4
11188301|NCT01747343|12377600|FG000|COMPLETED|Baseline||4
11188302|NCT01747343|12377600|FG000|NOT COMPLETED|Baseline||0
11188303|NCT01747343|12377600|FG000|STARTED|Underwear||4
11188304|NCT01747343|12377600|FG000|COMPLETED|Underwear||4
11188305|NCT01747343|12377600|FG000|NOT COMPLETED|Underwear||0
11188306|NCT01747343|12377600|FG000|STARTED|Underwear/Differential Reinforcement||4
11188307|NCT01747343|12377600|FG000|COMPLETED|Underwear/Differential Reinforcement||4
11188308|NCT01747343|12377600|FG000|NOT COMPLETED|Underwear/Differential Reinforcement||0
11188309|NCT01747486|12377606|FG000|STARTED|Stage 1||15
11188310|NCT01747486|12377607|FG001|STARTED|Stage 1||15
11188311|NCT01747486|12377606|FG000|COMPLETED|Stage 1||3
11188312|NCT01747486|12377607|FG001|COMPLETED|Stage 1||2
11188313|NCT01747486|12377606|FG000|NOT COMPLETED|Stage 1||12
11188314|NCT01747486|12377607|FG001|NOT COMPLETED|Stage 1||13
11188315|NCT01747486|12377606|FG000|STARTED|Stage 2||12
11188316|NCT01747486|12377607|FG001|STARTED|Stage 2||0
11188317|NCT01747486|12377606|FG000|COMPLETED|Stage 2||3
11188318|NCT01747486|12377607|FG001|COMPLETED|Stage 2||0
11188319|NCT01747486|12377606|FG000|NOT COMPLETED|Stage 2||9
11188320|NCT01747486|12377607|FG001|NOT COMPLETED|Stage 2||0
11188321|NCT01747499|12377618|FG000|STARTED|Overall Study||3
11188322|NCT01747499|12377619|FG001|STARTED|Overall Study||3
11188323|NCT01747499|12377620|FG002|STARTED|Overall Study||3
11188324|NCT01747499|12377621|FG003|STARTED|Overall Study||6
11188325|NCT01747499|12377622|FG004|STARTED|Overall Study||39
11188326|NCT01747499|12377618|FG000|COMPLETED|Overall Study||2
11188327|NCT01747499|12377619|FG001|COMPLETED|Overall Study||2
11188328|NCT01747499|12377620|FG002|COMPLETED|Overall Study||3
11188329|NCT01747499|12377621|FG003|COMPLETED|Overall Study||4
11188330|NCT01747499|12377622|FG004|COMPLETED|Overall Study||24
11188331|NCT01747499|12377618|FG000|NOT COMPLETED|Overall Study||1
11188332|NCT01747499|12377619|FG001|NOT COMPLETED|Overall Study||1
11188333|NCT01747499|12377620|FG002|NOT COMPLETED|Overall Study||0
11188334|NCT01747499|12377621|FG003|NOT COMPLETED|Overall Study||2
11188335|NCT01747499|12377622|FG004|NOT COMPLETED|Overall Study||15
11188336|NCT01747551|12377638|FG000|STARTED|Overall Study||43
11188337|NCT01747551|12377639|FG001|STARTED|Overall Study||21
11188338|NCT01747551|12377638|FG000|COMPLETED|Overall Study||0
11188339|NCT01747551|12377639|FG001|COMPLETED|Overall Study||0
11188340|NCT01747551|12377638|FG000|NOT COMPLETED|Overall Study||43
11188341|NCT01747551|12377639|FG001|NOT COMPLETED|Overall Study||21
11188342|NCT01747629|12377647|FG000|STARTED|Overall Study||85
11188343|NCT01747629|12377648|FG001|STARTED|Overall Study||75
11188344|NCT01747629|12377647|FG000|Treated|Overall Study|Safety set and full analysis set|84
11188345|NCT01747629|12377648|FG001|Treated|Overall Study|Safety set and full analysis set|75
11188346|NCT01747629|12377647|FG000|COMPLETED|Overall Study||77
11188347|NCT01747629|12377648|FG001|COMPLETED|Overall Study||69
11188348|NCT01747629|12377647|FG000|NOT COMPLETED|Overall Study||8
11188349|NCT01747629|12377648|FG001|NOT COMPLETED|Overall Study||6
11188350|NCT01747655|12377654|FG000|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
11188351|NCT01747655|12377655|FG001|STARTED|Temporary Naso-jejunal Tube Period||0
11188352|NCT01747655|12377654|FG000|COMPLETED|Temporary Naso-jejunal Tube Period||64
11188353|NCT01747655|12377655|FG001|COMPLETED|Temporary Naso-jejunal Tube Period||0
11188354|NCT01747655|12377654|FG000|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
11188355|NCT01747655|12377655|FG001|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
11188356|NCT01747655|12377654|FG000|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
11188357|NCT01747655|12377655|FG001|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
11188358|NCT01747655|12377654|FG000|COMPLETED|PEG-J Period (Duodopa Treatment)||44
11188359|NCT01747655|12377655|FG001|COMPLETED|PEG-J Period (Duodopa Treatment)||6
11188360|NCT01747655|12377654|FG000|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
11188361|NCT01747655|12377655|FG001|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
11188362|NCT01747655|12377654|FG000|STARTED|PEG-J Period (Continued Treatment)||41
11188363|NCT01747655|12377655|FG001|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
11188364|NCT01747655|12377654|FG000|COMPLETED|PEG-J Period (Continued Treatment)||41
11188365|NCT01747655|12377655|FG001|COMPLETED|PEG-J Period (Continued Treatment)||15
11188366|NCT01747655|12377654|FG000|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
11188367|NCT01747655|12377655|FG001|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
11188368|NCT01747772|12377661|FG000|STARTED|Overall Study||180
11188369|NCT01747772|12377661|FG000|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
11188370|NCT01747772|12377661|FG000|COMPLETED|Overall Study||171
11188371|NCT01747772|12377661|FG000|NOT COMPLETED|Overall Study||9
11188372|NCT01747811|12377671|FG000|STARTED|Overall Study||16
11188373|NCT01747811|12377672|FG001|STARTED|Overall Study||16
11188374|NCT01747811|12377671|FG000|COMPLETED|Overall Study||14
11188375|NCT01747811|12377672|FG001|COMPLETED|Overall Study||12
11188376|NCT01747811|12377671|FG000|NOT COMPLETED|Overall Study||2
11188377|NCT01747811|12377672|FG001|NOT COMPLETED|Overall Study||4
11188378|NCT01747837|12377682|FG000|STARTED|Overall Study||25
11188379|NCT01747837|12377683|FG001|STARTED|Overall Study||23
11188380|NCT01747837|12377682|FG000|COMPLETED|Overall Study||16
11188381|NCT01747837|12377683|FG001|COMPLETED|Overall Study||17
11188382|NCT01747837|12377682|FG000|NOT COMPLETED|Overall Study||9
11188383|NCT01747837|12377683|FG001|NOT COMPLETED|Overall Study||6
11188384|NCT01747850|12377692|FG000|STARTED|Overall Study||5
11188385|NCT01747850|12377693|FG001|STARTED|Overall Study||20
11188386|NCT01747850|12377694|FG002|STARTED|Overall Study||20
11188387|NCT01747850|12377692|FG000|COMPLETED|Overall Study||4
11188388|NCT01747850|12377693|FG001|COMPLETED|Overall Study||13
11188389|NCT01747850|12377694|FG002|COMPLETED|Overall Study||14
11188390|NCT01747850|12377692|FG000|NOT COMPLETED|Overall Study||1
11188391|NCT01747850|12377693|FG001|NOT COMPLETED|Overall Study||7
11188392|NCT01747850|12377694|FG002|NOT COMPLETED|Overall Study||6
11188393|NCT01747876|12377717|FG000|STARTED|Overall Study||5
11188394|NCT01747876|12377718|FG001|STARTED|Overall Study||15
11188395|NCT01747876|12377719|FG002|STARTED|Overall Study||12
11188396|NCT01747876|12377717|FG000|COMPLETED|Overall Study||0
11188397|NCT01747876|12377718|FG001|COMPLETED|Overall Study||0
11188398|NCT01747876|12377719|FG002|COMPLETED|Overall Study||0
11188399|NCT01747876|12377717|FG000|NOT COMPLETED|Overall Study||5
11188400|NCT01747876|12377718|FG001|NOT COMPLETED|Overall Study||15
11188401|NCT01747876|12377719|FG002|NOT COMPLETED|Overall Study||12
11188402|NCT01747915|12377733|FG000|STARTED|Overall Study||75
11188403|NCT01747915|12377734|FG001|STARTED|Overall Study||72
11188404|NCT01747915|12377735|FG002|STARTED|Overall Study||72
11188405|NCT01747915|12377733|FG000|COMPLETED|Overall Study||60
11188406|NCT01747915|12377734|FG001|COMPLETED|Overall Study||61
11188407|NCT01747915|12377735|FG002|COMPLETED|Overall Study||66
11188408|NCT01747915|12377733|FG000|NOT COMPLETED|Overall Study||15
11188409|NCT01747915|12377734|FG001|NOT COMPLETED|Overall Study||11
11188410|NCT01747915|12377735|FG002|NOT COMPLETED|Overall Study||6
11188411|NCT01747928|12377751|FG000|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
11188412|NCT01747928|12377752|FG001|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
11188413|NCT01747928|12377753|FG002|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
11188414|NCT01747928|12377754|FG003|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
11188415|NCT01747928|12377755|FG004|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
11188416|NCT01747928|12377756|FG005|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
11188417|NCT01747928|12377757|FG006|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
11188418|NCT01747928|12377758|FG007|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
11188419|NCT01747928|12377751|FG000|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
11188420|NCT01747928|12377752|FG001|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
11188421|NCT01747928|12377753|FG002|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
11188422|NCT01747928|12377754|FG003|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
11188423|NCT01747928|12377755|FG004|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
11188424|NCT01747928|12377756|FG005|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
11188425|NCT01747928|12377757|FG006|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
11188426|NCT01747928|12377758|FG007|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
11188427|NCT01747928|12377751|FG000|NOT COMPLETED|Overall Study||0
11188428|NCT01747928|12377752|FG001|NOT COMPLETED|Overall Study||0
11188429|NCT01747928|12377753|FG002|NOT COMPLETED|Overall Study||0
11188430|NCT01747928|12377754|FG003|NOT COMPLETED|Overall Study||0
11188431|NCT01747928|12377755|FG004|NOT COMPLETED|Overall Study||0
11188432|NCT01747928|12377756|FG005|NOT COMPLETED|Overall Study||0
11188433|NCT01747928|12377757|FG006|NOT COMPLETED|Overall Study||0
11188434|NCT01747928|12377758|FG007|NOT COMPLETED|Overall Study||0
11188435|NCT01748045|12377779|FG000|STARTED|Overall Study||2
11188436|NCT01748045|12377780|FG001|STARTED|Overall Study||1
11188437|NCT01748045|12377779|FG000|COMPLETED|Overall Study||2
11188438|NCT01748045|12377780|FG001|COMPLETED|Overall Study||1
11188439|NCT01748045|12377779|FG000|NOT COMPLETED|Overall Study||0
11188440|NCT01748045|12377780|FG001|NOT COMPLETED|Overall Study||0
11188441|NCT01748071|12377795|FG000|STARTED|Overall Study||40
11188442|NCT01748071|12377796|FG001|STARTED|Overall Study||40
11188443|NCT01748071|12377797|FG002|STARTED|Overall Study||40
11188444|NCT01748071|12377795|FG000|COMPLETED|Overall Study||38
11188445|NCT01748071|12377796|FG001|COMPLETED|Overall Study||38
11188446|NCT01748071|12377797|FG002|COMPLETED|Overall Study||40
11188447|NCT01748071|12377795|FG000|NOT COMPLETED|Overall Study||2
11188448|NCT01748071|12377796|FG001|NOT COMPLETED|Overall Study||2
11188449|NCT01748071|12377797|FG002|NOT COMPLETED|Overall Study||0
11188450|NCT01748227|12377805|FG000|STARTED|Overall Study||20
11188451|NCT01748227|12377805|FG000|COMPLETED|Overall Study||17
11188452|NCT01748227|12377805|FG000|NOT COMPLETED|Overall Study||3
11188453|NCT01748240|12377810|FG000|STARTED|Overall Study||21
11188454|NCT01748240|12377810|FG000|COMPLETED|Overall Study||21
11188455|NCT01748240|12377810|FG000|NOT COMPLETED|Overall Study||0
11188456|NCT01748292|12377816|FG000|STARTED|Overall Study||20
11188457|NCT01748292|12377817|FG001|STARTED|Overall Study||40
11188458|NCT01748292|12377816|FG000|COMPLETED|Overall Study||18
11188459|NCT01748292|12377817|FG001|COMPLETED|Overall Study||28
11188460|NCT01748292|12377816|FG000|NOT COMPLETED|Overall Study||2
11188461|NCT01748292|12377817|FG001|NOT COMPLETED|Overall Study||12
11188462|NCT01748552|12377835|FG000|STARTED|Intervention Period 1 and Washout||3
11188463|NCT01748552|12377836|FG001|STARTED|Intervention Period 1 and Washout||3
11188464|NCT01748552|12377837|FG002|STARTED|Intervention Period 1 and Washout||3
11188465|NCT01748552|12377838|FG003|STARTED|Intervention Period 1 and Washout||3
11188466|NCT01748552|12377839|FG004|STARTED|Intervention Period 1 and Washout||3
11188467|NCT01748552|12377840|FG005|STARTED|Intervention Period 1 and Washout||3
11188468|NCT01748552|12377841|FG006|STARTED|Intervention Period 1 and Washout||3
11188469|NCT01748552|12377842|FG007|STARTED|Intervention Period 1 and Washout||3
11188470|NCT01748552|12377843|FG008|STARTED|Intervention Period 1 and Washout||3
11188471|NCT01748552|12377844|FG009|STARTED|Intervention Period 1 and Washout||3
11188472|NCT01748552|12377845|FG010|STARTED|Intervention Period 1 and Washout||3
11188473|NCT01748552|12377846|FG011|STARTED|Intervention Period 1 and Washout||3
11188474|NCT01748552|12377835|FG000|COMPLETED|Intervention Period 1 and Washout||3
11188475|NCT01748552|12377836|FG001|COMPLETED|Intervention Period 1 and Washout||3
11188476|NCT01748552|12377837|FG002|COMPLETED|Intervention Period 1 and Washout||3
11188477|NCT01748552|12377838|FG003|COMPLETED|Intervention Period 1 and Washout||3
11188478|NCT01748552|12377839|FG004|COMPLETED|Intervention Period 1 and Washout||3
11188479|NCT01748552|12377840|FG005|COMPLETED|Intervention Period 1 and Washout||3
11188480|NCT01748552|12377841|FG006|COMPLETED|Intervention Period 1 and Washout||3
11188481|NCT01748552|12377842|FG007|COMPLETED|Intervention Period 1 and Washout||3
11188482|NCT01748552|12377843|FG008|COMPLETED|Intervention Period 1 and Washout||3
11188483|NCT01748552|12377844|FG009|COMPLETED|Intervention Period 1 and Washout||3
11188484|NCT01748552|12377845|FG010|COMPLETED|Intervention Period 1 and Washout||3
11188485|NCT01748552|12377846|FG011|COMPLETED|Intervention Period 1 and Washout||3
11188486|NCT01748552|12377835|FG000|NOT COMPLETED|Intervention Period 1 and Washout||0
11188487|NCT01748552|12377836|FG001|NOT COMPLETED|Intervention Period 1 and Washout||0
11188488|NCT01748552|12377837|FG002|NOT COMPLETED|Intervention Period 1 and Washout||0
11188489|NCT01748552|12377838|FG003|NOT COMPLETED|Intervention Period 1 and Washout||0
11188490|NCT01748552|12377839|FG004|NOT COMPLETED|Intervention Period 1 and Washout||0
11188491|NCT01748552|12377840|FG005|NOT COMPLETED|Intervention Period 1 and Washout||0
11188492|NCT01748552|12377841|FG006|NOT COMPLETED|Intervention Period 1 and Washout||0
11188493|NCT01748552|12377842|FG007|NOT COMPLETED|Intervention Period 1 and Washout||0
11188494|NCT01748552|12377843|FG008|NOT COMPLETED|Intervention Period 1 and Washout||0
11188495|NCT01748552|12377844|FG009|NOT COMPLETED|Intervention Period 1 and Washout||0
11188496|NCT01748552|12377845|FG010|NOT COMPLETED|Intervention Period 1 and Washout||0
11188497|NCT01748552|12377846|FG011|NOT COMPLETED|Intervention Period 1 and Washout||0
11188498|NCT01748552|12377835|FG000|STARTED|Intervention Period 2 and Washout||3
11188499|NCT01748552|12377836|FG001|STARTED|Intervention Period 2 and Washout||3
11188500|NCT01748552|12377837|FG002|STARTED|Intervention Period 2 and Washout||3
11188501|NCT01748552|12377838|FG003|STARTED|Intervention Period 2 and Washout||3
11188502|NCT01748552|12377839|FG004|STARTED|Intervention Period 2 and Washout||3
11188503|NCT01748552|12377840|FG005|STARTED|Intervention Period 2 and Washout||3
11188504|NCT01748552|12377841|FG006|STARTED|Intervention Period 2 and Washout||3
11188505|NCT01748552|12377842|FG007|STARTED|Intervention Period 2 and Washout||3
11188506|NCT01748552|12377843|FG008|STARTED|Intervention Period 2 and Washout||3
11188507|NCT01748552|12377844|FG009|STARTED|Intervention Period 2 and Washout||3
11188508|NCT01748552|12377845|FG010|STARTED|Intervention Period 2 and Washout||3
11188509|NCT01748552|12377846|FG011|STARTED|Intervention Period 2 and Washout||3
11188510|NCT01748552|12377835|FG000|COMPLETED|Intervention Period 2 and Washout||3
11188511|NCT01748552|12377836|FG001|COMPLETED|Intervention Period 2 and Washout||3
11188512|NCT01748552|12377837|FG002|COMPLETED|Intervention Period 2 and Washout||2
11188513|NCT01748552|12377838|FG003|COMPLETED|Intervention Period 2 and Washout||3
11188514|NCT01748552|12377839|FG004|COMPLETED|Intervention Period 2 and Washout||3
11188515|NCT01748552|12377840|FG005|COMPLETED|Intervention Period 2 and Washout||3
11188516|NCT01748552|12377841|FG006|COMPLETED|Intervention Period 2 and Washout||0
11188517|NCT01748552|12377842|FG007|COMPLETED|Intervention Period 2 and Washout||0
11188518|NCT01748552|12377843|FG008|COMPLETED|Intervention Period 2 and Washout||0
11188519|NCT01748552|12377844|FG009|COMPLETED|Intervention Period 2 and Washout||3
11188520|NCT01748552|12377845|FG010|COMPLETED|Intervention Period 2 and Washout||3
11188521|NCT01748552|12377846|FG011|COMPLETED|Intervention Period 2 and Washout||3
11188522|NCT01748552|12377835|FG000|NOT COMPLETED|Intervention Period 2 and Washout||0
11188523|NCT01748552|12377836|FG001|NOT COMPLETED|Intervention Period 2 and Washout||0
11188524|NCT01748552|12377837|FG002|NOT COMPLETED|Intervention Period 2 and Washout||1
11188525|NCT01748552|12377838|FG003|NOT COMPLETED|Intervention Period 2 and Washout||0
11188526|NCT01748552|12377839|FG004|NOT COMPLETED|Intervention Period 2 and Washout||0
11188527|NCT01748552|12377840|FG005|NOT COMPLETED|Intervention Period 2 and Washout||0
11188528|NCT01748552|12377841|FG006|NOT COMPLETED|Intervention Period 2 and Washout||3
11188529|NCT01748552|12377842|FG007|NOT COMPLETED|Intervention Period 2 and Washout||3
11188530|NCT01748552|12377843|FG008|NOT COMPLETED|Intervention Period 2 and Washout||3
11188531|NCT01748552|12377844|FG009|NOT COMPLETED|Intervention Period 2 and Washout||0
11188532|NCT01748552|12377845|FG010|NOT COMPLETED|Intervention Period 2 and Washout||0
11188533|NCT01748552|12377846|FG011|NOT COMPLETED|Intervention Period 2 and Washout||0
11188534|NCT01748552|12377835|FG000|STARTED|Intervention Period 3 and Washout||3
11188535|NCT01748552|12377836|FG001|STARTED|Intervention Period 3 and Washout||3
11188536|NCT01748552|12377837|FG002|STARTED|Intervention Period 3 and Washout||2
11188537|NCT01748552|12377838|FG003|STARTED|Intervention Period 3 and Washout||3
11188538|NCT01748552|12377839|FG004|STARTED|Intervention Period 3 and Washout||3
11188539|NCT01748552|12377840|FG005|STARTED|Intervention Period 3 and Washout||3
11188540|NCT01748552|12377841|FG006|STARTED|Intervention Period 3 and Washout||0
11188541|NCT01748552|12377842|FG007|STARTED|Intervention Period 3 and Washout||0
11188542|NCT01748552|12377843|FG008|STARTED|Intervention Period 3 and Washout||0
11188543|NCT01748552|12377844|FG009|STARTED|Intervention Period 3 and Washout||3
11188544|NCT01748552|12377845|FG010|STARTED|Intervention Period 3 and Washout||3
11188545|NCT01748552|12377846|FG011|STARTED|Intervention Period 3 and Washout||3
11188546|NCT01748552|12377835|FG000|COMPLETED|Intervention Period 3 and Washout||3
11188547|NCT01748552|12377836|FG001|COMPLETED|Intervention Period 3 and Washout||3
11188548|NCT01748552|12377837|FG002|COMPLETED|Intervention Period 3 and Washout||2
11188549|NCT01748552|12377838|FG003|COMPLETED|Intervention Period 3 and Washout||3
11188550|NCT01748552|12377839|FG004|COMPLETED|Intervention Period 3 and Washout||3
11188551|NCT01748552|12377840|FG005|COMPLETED|Intervention Period 3 and Washout||3
11188552|NCT01748552|12377841|FG006|COMPLETED|Intervention Period 3 and Washout||0
11188553|NCT01748552|12377842|FG007|COMPLETED|Intervention Period 3 and Washout||0
11188554|NCT01748552|12377843|FG008|COMPLETED|Intervention Period 3 and Washout||0
11188555|NCT01748552|12377844|FG009|COMPLETED|Intervention Period 3 and Washout||3
11188556|NCT01748552|12377845|FG010|COMPLETED|Intervention Period 3 and Washout||3
11188557|NCT01748552|12377846|FG011|COMPLETED|Intervention Period 3 and Washout||3
11188558|NCT01748552|12377835|FG000|NOT COMPLETED|Intervention Period 3 and Washout||0
11188559|NCT01748552|12377836|FG001|NOT COMPLETED|Intervention Period 3 and Washout||0
11188560|NCT01748552|12377837|FG002|NOT COMPLETED|Intervention Period 3 and Washout||0
11188561|NCT01748552|12377838|FG003|NOT COMPLETED|Intervention Period 3 and Washout||0
11188562|NCT01748552|12377839|FG004|NOT COMPLETED|Intervention Period 3 and Washout||0
11188563|NCT01748552|12377840|FG005|NOT COMPLETED|Intervention Period 3 and Washout||0
11188564|NCT01748552|12377841|FG006|NOT COMPLETED|Intervention Period 3 and Washout||0
11188565|NCT01748552|12377842|FG007|NOT COMPLETED|Intervention Period 3 and Washout||0
11188566|NCT01748552|12377843|FG008|NOT COMPLETED|Intervention Period 3 and Washout||0
11188567|NCT01748552|12377844|FG009|NOT COMPLETED|Intervention Period 3 and Washout||0
11188568|NCT01748552|12377845|FG010|NOT COMPLETED|Intervention Period 3 and Washout||0
11188569|NCT01748552|12377846|FG011|NOT COMPLETED|Intervention Period 3 and Washout||0
11188570|NCT01748643|12377888|FG000|STARTED|Overall Study||30
11188571|NCT01748643|12377889|FG001|STARTED|Overall Study||30
11188572|NCT01748643|12377888|FG000|COMPLETED|Overall Study||30
11188573|NCT01748643|12377889|FG001|COMPLETED|Overall Study||30
11188574|NCT01748643|12377888|FG000|NOT COMPLETED|Overall Study||0
11188575|NCT01748643|12377889|FG001|NOT COMPLETED|Overall Study||0
11188576|NCT01748695|12377895|FG000|STARTED|First Intervention (4 Weeks)||14
11188577|NCT01748695|12377896|FG001|STARTED|First Intervention (4 Weeks)||11
11188578|NCT01748695|12377895|FG000|COMPLETED|First Intervention (4 Weeks)||14
11188579|NCT01748695|12377896|FG001|COMPLETED|First Intervention (4 Weeks)||11
11188580|NCT01748695|12377895|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
11188581|NCT01748695|12377896|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
11188582|NCT01748695|12377895|FG000|STARTED|Second Intervention (4 Weeks)||14
11188583|NCT01748695|12377896|FG001|STARTED|Second Intervention (4 Weeks)||11
11188584|NCT01748695|12377895|FG000|COMPLETED|Second Intervention (4 Weeks)||14
11188585|NCT01748695|12377896|FG001|COMPLETED|Second Intervention (4 Weeks)||11
11188586|NCT01748695|12377895|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
11188587|NCT01748695|12377896|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
11188588|NCT01748760|12377904|FG000|STARTED|Overall Study||25
11188589|NCT01748760|12377905|FG001|STARTED|Overall Study||25
11188590|NCT01748760|12377904|FG000|COMPLETED|Overall Study||19
11188591|NCT01748760|12377905|FG001|COMPLETED|Overall Study||23
11188592|NCT01748760|12377904|FG000|NOT COMPLETED|Overall Study||6
11188593|NCT01748760|12377905|FG001|NOT COMPLETED|Overall Study||2
11188594|NCT01748799|12377919|FG000|STARTED|Overall Study||6
11188595|NCT01748799|12377920|FG001|STARTED|Overall Study||1
11188596|NCT01748799|12377921|FG002|STARTED|Overall Study||1
11188597|NCT01748799|12377922|FG003|STARTED|Overall Study||2
11188598|NCT01748799|12377923|FG004|STARTED|Overall Study||1
11188599|NCT01748799|12377924|FG005|STARTED|Overall Study||2
11188600|NCT01748799|12377925|FG006|STARTED|Overall Study||2
11188601|NCT01748799|12377926|FG007|STARTED|Overall Study||1
11188602|NCT01748799|12377919|FG000|Completed SAU of Fixed Dose Placebo|Overall Study||2
11188603|NCT01748799|12377920|FG001|Completed SAU of Fixed Dose Placebo|Overall Study||1
11188604|NCT01748799|12377921|FG002|Completed SAU of Fixed Dose Placebo|Overall Study||1
11188605|NCT01748799|12377922|FG003|Completed SAU of Fixed Dose Placebo|Overall Study||2
11188606|NCT01748799|12377923|FG004|Completed SAU of Fixed Dose Placebo|Overall Study||1
11188607|NCT01748799|12377924|FG005|Completed SAU of Fixed Dose Placebo|Overall Study||1
11188608|NCT01748799|12377925|FG006|Completed SAU of Fixed Dose Placebo|Overall Study||1
11188609|NCT01748799|12377926|FG007|Completed SAU of Fixed Dose Placebo|Overall Study||1
11188610|NCT01748799|12377919|FG000|Completed Fixed Dose Placebo|Overall Study||2
11188611|NCT01748799|12377920|FG001|Completed Fixed Dose Placebo|Overall Study||1
11188612|NCT01748799|12377921|FG002|Completed Fixed Dose Placebo|Overall Study||1
11188613|NCT01748799|12377922|FG003|Completed Fixed Dose Placebo|Overall Study||2
11188614|NCT01748799|12377923|FG004|Completed Fixed Dose Placebo|Overall Study||1
11188615|NCT01748799|12377924|FG005|Completed Fixed Dose Placebo|Overall Study||1
11188616|NCT01748799|12377925|FG006|Completed Fixed Dose Placebo|Overall Study||1
11188617|NCT01748799|12377926|FG007|Completed Fixed Dose Placebo|Overall Study||1
11188618|NCT01748799|12377919|FG000|Completed SAU of Fixed Dose Sativex|Overall Study||1
11188619|NCT01748799|12377920|FG001|Completed SAU of Fixed Dose Sativex|Overall Study||1
11188620|NCT01748799|12377921|FG002|Completed SAU of Fixed Dose Sativex|Overall Study||1
11188621|NCT01748799|12377922|FG003|Completed SAU of Fixed Dose Sativex|Overall Study||2
11188622|NCT01748799|12377923|FG004|Completed SAU of Fixed Dose Sativex|Overall Study||1
11188623|NCT01748799|12377924|FG005|Completed SAU of Fixed Dose Sativex|Overall Study||1
11188624|NCT01748799|12377925|FG006|Completed SAU of Fixed Dose Sativex|Overall Study||1
11188625|NCT01748799|12377926|FG007|Completed SAU of Fixed Dose Sativex|Overall Study||1
11188626|NCT01748799|12377919|FG000|Completed Fixed Dose Sativex|Overall Study||1
11188627|NCT01748799|12377920|FG001|Completed Fixed Dose Sativex|Overall Study||1
11188628|NCT01748799|12377921|FG002|Completed Fixed Dose Sativex|Overall Study||1
11188629|NCT01748799|12377922|FG003|Completed Fixed Dose Sativex|Overall Study||2
11188630|NCT01748799|12377923|FG004|Completed Fixed Dose Sativex|Overall Study||1
11188631|NCT01748799|12377924|FG005|Completed Fixed Dose Sativex|Overall Study||1
11188632|NCT01748799|12377925|FG006|Completed Fixed Dose Sativex|Overall Study||1
11188633|NCT01748799|12377926|FG007|Completed Fixed Dose Sativex|Overall Study||1
11188634|NCT01748799|12377919|FG000|Completed SAU of Self-titrated Placebo|Overall Study||5
11188635|NCT01748799|12377920|FG001|Completed SAU of Self-titrated Placebo|Overall Study||1
11188636|NCT01748799|12377921|FG002|Completed SAU of Self-titrated Placebo|Overall Study||1
11188637|NCT01748799|12377922|FG003|Completed SAU of Self-titrated Placebo|Overall Study||2
11188638|NCT01748799|12377923|FG004|Completed SAU of Self-titrated Placebo|Overall Study||1
11188639|NCT01748799|12377924|FG005|Completed SAU of Self-titrated Placebo|Overall Study||2
11188640|NCT01748799|12377925|FG006|Completed SAU of Self-titrated Placebo|Overall Study||1
11188641|NCT01748799|12377926|FG007|Completed SAU of Self-titrated Placebo|Overall Study||1
11188642|NCT01748799|12377919|FG000|Completed Self-titrated Placebo|Overall Study||4
11188643|NCT01748799|12377920|FG001|Completed Self-titrated Placebo|Overall Study||1
11188644|NCT01748799|12377921|FG002|Completed Self-titrated Placebo|Overall Study||1
11188645|NCT01748799|12377922|FG003|Completed Self-titrated Placebo|Overall Study||2
11188646|NCT01748799|12377923|FG004|Completed Self-titrated Placebo|Overall Study||1
11188647|NCT01748799|12377924|FG005|Completed Self-titrated Placebo|Overall Study||2
11188648|NCT01748799|12377925|FG006|Completed Self-titrated Placebo|Overall Study||1
11188649|NCT01748799|12377926|FG007|Completed Self-titrated Placebo|Overall Study||1
11188650|NCT01748799|12377919|FG000|Completed SAU of Self-titrated Sativex|Overall Study||2
11188651|NCT01748799|12377920|FG001|Completed SAU of Self-titrated Sativex|Overall Study||1
11188652|NCT01748799|12377921|FG002|Completed SAU of Self-titrated Sativex|Overall Study||1
11188653|NCT01748799|12377922|FG003|Completed SAU of Self-titrated Sativex|Overall Study||2
11188654|NCT01748799|12377923|FG004|Completed SAU of Self-titrated Sativex|Overall Study||1
11188655|NCT01748799|12377924|FG005|Completed SAU of Self-titrated Sativex|Overall Study||2
11188656|NCT01748799|12377925|FG006|Completed SAU of Self-titrated Sativex|Overall Study||1
11188657|NCT01748799|12377926|FG007|Completed SAU of Self-titrated Sativex|Overall Study||1
11188658|NCT01748799|12377919|FG000|Completed Self-titrated Sativex|Overall Study||1
11188659|NCT01748799|12377920|FG001|Completed Self-titrated Sativex|Overall Study||1
11188660|NCT01748799|12377921|FG002|Completed Self-titrated Sativex|Overall Study||1
11188661|NCT01748799|12377922|FG003|Completed Self-titrated Sativex|Overall Study||2
11188662|NCT01748799|12377923|FG004|Completed Self-titrated Sativex|Overall Study||1
11188663|NCT01748799|12377924|FG005|Completed Self-titrated Sativex|Overall Study||1
11188664|NCT01748799|12377925|FG006|Completed Self-titrated Sativex|Overall Study||1
11188665|NCT01748799|12377926|FG007|Completed Self-titrated Sativex|Overall Study||1
11188666|NCT01748799|12377919|FG000|COMPLETED|Overall Study||1
11188667|NCT01748799|12377920|FG001|COMPLETED|Overall Study||1
11188668|NCT01748799|12377921|FG002|COMPLETED|Overall Study||1
11188669|NCT01748799|12377922|FG003|COMPLETED|Overall Study||2
11188670|NCT01748799|12377923|FG004|COMPLETED|Overall Study||1
11188671|NCT01748799|12377924|FG005|COMPLETED|Overall Study||1
11188672|NCT01748799|12377925|FG006|COMPLETED|Overall Study||1
11188673|NCT01748799|12377926|FG007|COMPLETED|Overall Study||1
11188674|NCT01748799|12377919|FG000|NOT COMPLETED|Overall Study||5
11188675|NCT01748799|12377920|FG001|NOT COMPLETED|Overall Study||0
11188676|NCT01748799|12377921|FG002|NOT COMPLETED|Overall Study||0
11188677|NCT01748799|12377922|FG003|NOT COMPLETED|Overall Study||0
11188678|NCT01748799|12377923|FG004|NOT COMPLETED|Overall Study||0
11188679|NCT01748799|12377924|FG005|NOT COMPLETED|Overall Study||1
11188680|NCT01748799|12377925|FG006|NOT COMPLETED|Overall Study||1
11188681|NCT01748799|12377926|FG007|NOT COMPLETED|Overall Study||0
11188682|NCT01748825|12377962|FG000|STARTED|Dose Escalation||6
11188683|NCT01748825|12377963|FG001|STARTED|Dose Escalation||4
11188684|NCT01748825|12377964|FG002|STARTED|Dose Escalation||6
11188685|NCT01748825|12377965|FG003|STARTED|Dose Escalation||3
11188686|NCT01748825|12377966|FG004|STARTED|Dose Escalation||3
11188687|NCT01748825|12377967|FG005|STARTED|Dose Escalation||6
11188688|NCT01748825|12377968|FG006|STARTED|Dose Escalation||3
11188689|NCT01748825|12377969|FG007|STARTED|Dose Escalation||3
11188690|NCT01748825|12377970|FG008|STARTED|Dose Escalation||0
11188691|NCT01748825|12377971|FG009|STARTED|Dose Escalation||0
11188692|NCT01748825|12377962|FG000|COMPLETED|Dose Escalation||4
11188693|NCT01748825|12377963|FG001|COMPLETED|Dose Escalation||2
11188694|NCT01748825|12377964|FG002|COMPLETED|Dose Escalation||6
11188695|NCT01748825|12377965|FG003|COMPLETED|Dose Escalation||2
11188696|NCT01748825|12377966|FG004|COMPLETED|Dose Escalation||2
11188697|NCT01748825|12377967|FG005|COMPLETED|Dose Escalation||4
11188698|NCT01748825|12377968|FG006|COMPLETED|Dose Escalation||2
11188699|NCT01748825|12377969|FG007|COMPLETED|Dose Escalation||3
11188700|NCT01748825|12377970|FG008|COMPLETED|Dose Escalation||0
11188701|NCT01748825|12377971|FG009|COMPLETED|Dose Escalation||0
11188702|NCT01748825|12377962|FG000|NOT COMPLETED|Dose Escalation||2
11188703|NCT01748825|12377963|FG001|NOT COMPLETED|Dose Escalation||2
11188704|NCT01748825|12377964|FG002|NOT COMPLETED|Dose Escalation||0
11188705|NCT01748825|12377965|FG003|NOT COMPLETED|Dose Escalation||1
11188706|NCT01748825|12377966|FG004|NOT COMPLETED|Dose Escalation||1
11188707|NCT01748825|12377967|FG005|NOT COMPLETED|Dose Escalation||2
11188708|NCT01748825|12377968|FG006|NOT COMPLETED|Dose Escalation||1
11188709|NCT01748825|12377969|FG007|NOT COMPLETED|Dose Escalation||0
11188710|NCT01748825|12377970|FG008|NOT COMPLETED|Dose Escalation||0
11188711|NCT01748825|12377971|FG009|NOT COMPLETED|Dose Escalation||0
11188712|NCT01748825|12377962|FG000|STARTED|Dose Expansion||0
11188713|NCT01748825|12377963|FG001|STARTED|Dose Expansion||0
11188714|NCT01748825|12377964|FG002|STARTED|Dose Expansion||0
11188715|NCT01748825|12377965|FG003|STARTED|Dose Expansion||0
11188716|NCT01748825|12377966|FG004|STARTED|Dose Expansion||0
11188717|NCT01748825|12377967|FG005|STARTED|Dose Expansion||0
11188718|NCT01748825|12377968|FG006|STARTED|Dose Expansion||0
11188719|NCT01748825|12377969|FG007|STARTED|Dose Expansion||0
11188720|NCT01748825|12377970|FG008|STARTED|Dose Expansion||13
11188721|NCT01748825|12377971|FG009|STARTED|Dose Expansion||20
11188722|NCT01748825|12377962|FG000|COMPLETED|Dose Expansion||0
11188723|NCT01748825|12377963|FG001|COMPLETED|Dose Expansion||0
11188724|NCT01748825|12377964|FG002|COMPLETED|Dose Expansion||0
11188725|NCT01748825|12377965|FG003|COMPLETED|Dose Expansion||0
11188726|NCT01748825|12377966|FG004|COMPLETED|Dose Expansion||0
11188727|NCT01748825|12377967|FG005|COMPLETED|Dose Expansion||0
11188728|NCT01748825|12377968|FG006|COMPLETED|Dose Expansion||0
11188729|NCT01748825|12377969|FG007|COMPLETED|Dose Expansion||0
11188730|NCT01748825|12377970|FG008|COMPLETED|Dose Expansion||11
11188731|NCT01748825|12377971|FG009|COMPLETED|Dose Expansion||15
11188732|NCT01748825|12377962|FG000|NOT COMPLETED|Dose Expansion||0
11188733|NCT01748825|12377963|FG001|NOT COMPLETED|Dose Expansion||0
11188734|NCT01748825|12377964|FG002|NOT COMPLETED|Dose Expansion||0
11188735|NCT01748825|12377965|FG003|NOT COMPLETED|Dose Expansion||0
11188736|NCT01748825|12377966|FG004|NOT COMPLETED|Dose Expansion||0
11188737|NCT01748825|12377967|FG005|NOT COMPLETED|Dose Expansion||0
11188738|NCT01748825|12377968|FG006|NOT COMPLETED|Dose Expansion||0
11188739|NCT01748825|12377969|FG007|NOT COMPLETED|Dose Expansion||0
11188740|NCT01748825|12377970|FG008|NOT COMPLETED|Dose Expansion||2
11188741|NCT01748825|12377971|FG009|NOT COMPLETED|Dose Expansion||5
11188742|NCT01748916|12378000|FG000|STARTED|Overall Study||2
11188743|NCT01748916|12378001|FG001|STARTED|Overall Study||3
11188744|NCT01748916|12378002|FG002|STARTED|Overall Study||2
11188745|NCT01748916|12378003|FG003|STARTED|Overall Study||3
11188746|NCT01748916|12378004|FG004|STARTED|Overall Study||3
11188747|NCT01748916|12378005|FG005|STARTED|Overall Study||3
11188748|NCT01748916|12378000|FG000|COMPLETED|Overall Study||2
11188749|NCT01748916|12378001|FG001|COMPLETED|Overall Study||3
11188750|NCT01748916|12378002|FG002|COMPLETED|Overall Study||2
11188751|NCT01748916|12378003|FG003|COMPLETED|Overall Study||3
11188752|NCT01748916|12378004|FG004|COMPLETED|Overall Study||3
11188753|NCT01748916|12378005|FG005|COMPLETED|Overall Study||3
11188754|NCT01748916|12378000|FG000|NOT COMPLETED|Overall Study||0
11188755|NCT01748916|12378001|FG001|NOT COMPLETED|Overall Study||0
11188756|NCT01748916|12378002|FG002|NOT COMPLETED|Overall Study||0
11188757|NCT01748916|12378003|FG003|NOT COMPLETED|Overall Study||0
11188758|NCT01748916|12378004|FG004|NOT COMPLETED|Overall Study||0
11188759|NCT01748916|12378005|FG005|NOT COMPLETED|Overall Study||0
11188760|NCT01748942|12378015|FG000|STARTED|Overall Study||39
11188761|NCT01748942|12378016|FG001|STARTED|Overall Study||37
11188762|NCT01748942|12378015|FG000|COMPLETED|Overall Study||35
11188763|NCT01748942|12378016|FG001|COMPLETED|Overall Study||33
11188764|NCT01748942|12378015|FG000|NOT COMPLETED|Overall Study||4
11188765|NCT01748942|12378016|FG001|NOT COMPLETED|Overall Study||4
11188766|NCT01748955|12378024|FG000|STARTED|Overall Study||6
11188767|NCT01748955|12378025|FG001|STARTED|Overall Study||9
11188768|NCT01748955|12378024|FG000|COMPLETED|Overall Study||3
11188769|NCT01748955|12378025|FG001|COMPLETED|Overall Study||4
11188770|NCT01748955|12378024|FG000|NOT COMPLETED|Overall Study||3
11188771|NCT01748955|12378025|FG001|NOT COMPLETED|Overall Study||5
11188772|NCT01748994|12378033|FG000|STARTED|Overall Study||31
11188773|NCT01748994|12378034|FG001|STARTED|Overall Study||32
11188774|NCT01748994|12378033|FG000|COMPLETED|Overall Study||23
11188775|NCT01748994|12378034|FG001|COMPLETED|Overall Study||26
11188776|NCT01748994|12378033|FG000|NOT COMPLETED|Overall Study||8
11188777|NCT01748994|12378034|FG001|NOT COMPLETED|Overall Study||6
11188778|NCT01749033|12378043|FG000|STARTED|Overall Study||150
11188779|NCT01749033|12378044|FG001|STARTED|Overall Study||150
11188780|NCT01749033|12378045|FG002|STARTED|Overall Study||150
11188781|NCT01749033|12378043|FG000|COMPLETED|Overall Study||147
11188782|NCT01749033|12378044|FG001|COMPLETED|Overall Study||145
11188783|NCT01749033|12378045|FG002|COMPLETED|Overall Study||149
11188784|NCT01749033|12378043|FG000|NOT COMPLETED|Overall Study||3
11188785|NCT01749033|12378044|FG001|NOT COMPLETED|Overall Study||5
11188786|NCT01749033|12378045|FG002|NOT COMPLETED|Overall Study||1
11204689|NCT01854710|12395309|FG004|STARTED|Overall Study||10
11204690|NCT01854710|12395310|FG005|STARTED|Overall Study||10
11204691|NCT01854710|12395305|FG000|COMPLETED|Overall Study||6
11204692|NCT01854710|12395306|FG001|COMPLETED|Overall Study||7
11204693|NCT01854710|12395307|FG002|COMPLETED|Overall Study||8
11204694|NCT01854710|12395308|FG003|COMPLETED|Overall Study||8
11204695|NCT01854710|12395309|FG004|COMPLETED|Overall Study||8
11204696|NCT01854710|12395310|FG005|COMPLETED|Overall Study||8
11204697|NCT01854710|12395305|FG000|NOT COMPLETED|Overall Study||4
11204698|NCT01854710|12395306|FG001|NOT COMPLETED|Overall Study||3
11204699|NCT01854710|12395307|FG002|NOT COMPLETED|Overall Study||2
11204700|NCT01854710|12395308|FG003|NOT COMPLETED|Overall Study||2
11204701|NCT01854710|12395309|FG004|NOT COMPLETED|Overall Study||2
11204702|NCT01854710|12395310|FG005|NOT COMPLETED|Overall Study||2
11204703|NCT01854827|12395320|FG000|STARTED|Overall Study||30
11204704|NCT01854827|12395320|FG000|COMPLETED|Overall Study||29
11188787|NCT01749215|12378056|FG000|STARTED|Overall Study||72
11188788|NCT01749215|12378057|FG001|STARTED|Overall Study||79
11188789|NCT01749215|12378056|FG000|COMPLETED|Overall Study||47
11188790|NCT01749215|12378057|FG001|COMPLETED|Overall Study||53
11188791|NCT01749215|12378056|FG000|NOT COMPLETED|Overall Study||25
11188792|NCT01749215|12378057|FG001|NOT COMPLETED|Overall Study||26
11188793|NCT01749293|12378063|FG000|STARTED|Overall Study||3
11188794|NCT01749293|12378063|FG000|COMPLETED|Overall Study||3
11026966|NCT00831272|12205602|FG000|COMPLETED|Overall Study||30
11026967|NCT00831272|12205603|FG001|COMPLETED|Overall Study||37
11026968|NCT00831272|12205604|FG002|COMPLETED|Overall Study||63
11026969|NCT00831272|12205605|FG003|COMPLETED|Overall Study||56
11026970|NCT00831272|12205602|FG000|NOT COMPLETED|Overall Study||8
11026971|NCT00831272|12205603|FG001|NOT COMPLETED|Overall Study||7
11026972|NCT00831272|12205604|FG002|NOT COMPLETED|Overall Study||10
11026973|NCT00831272|12205605|FG003|NOT COMPLETED|Overall Study||10
11026974|NCT00831311|12205617|FG000|STARTED|Overall Study||312
11026975|NCT00831311|12205618|FG001|STARTED|Overall Study||312
11026976|NCT00831311|12205617|FG000|COMPLETED|Overall Study||300
11026977|NCT00831311|12205618|FG001|COMPLETED|Overall Study||304
11026978|NCT00831311|12205617|FG000|NOT COMPLETED|Overall Study||12
11026979|NCT00831311|12205618|FG001|NOT COMPLETED|Overall Study||8
11026980|NCT00831389|12205627|FG000|STARTED|Overall Study||6
11026981|NCT00831389|12205628|FG001|STARTED|Overall Study||7
11026982|NCT00831389|12205627|FG000|COMPLETED|Overall Study||6
11026983|NCT00831389|12205628|FG001|COMPLETED|Overall Study||6
11026984|NCT00831389|12205627|FG000|NOT COMPLETED|Overall Study||0
11026985|NCT00831389|12205628|FG001|NOT COMPLETED|Overall Study||1
11026986|NCT00831415|12205634|FG000|STARTED|Overall Study||304
11026987|NCT00831415|12205634|FG000|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
11026988|NCT00831415|12205634|FG000|"Study Completers"|Overall Study|"Defined as participants whose conclusion of study participation status was study completed."|227
11026989|NCT00831415|12205634|FG000|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
11026990|NCT00831415|12205634|FG000|NOT COMPLETED|Overall Study||75
11057320|NCT00996996|12238788|FG000|NOT COMPLETED|Overall Study||33
11057321|NCT00997035|12238794|FG000|STARTED|3-week Followup Visit||121
11057322|NCT00997035|12238795|FG001|STARTED|3-week Followup Visit||119
11057323|NCT00997035|12238794|FG000|COMPLETED|3-week Followup Visit||112
11057324|NCT00997035|12238795|FG001|COMPLETED|3-week Followup Visit||113
11057325|NCT00997035|12238794|FG000|NOT COMPLETED|3-week Followup Visit||9
11057326|NCT00997035|12238795|FG001|NOT COMPLETED|3-week Followup Visit||6
11057327|NCT00997035|12238794|FG000|STARTED|3-month Follow-up Visit||112
11057328|NCT00997035|12238795|FG001|STARTED|3-month Follow-up Visit||113
11057329|NCT00997035|12238794|FG000|COMPLETED|3-month Follow-up Visit||100
11057330|NCT00997035|12238795|FG001|COMPLETED|3-month Follow-up Visit||107
11057331|NCT00997035|12238794|FG000|NOT COMPLETED|3-month Follow-up Visit||12
11057332|NCT00997035|12238795|FG001|NOT COMPLETED|3-month Follow-up Visit||6
11057333|NCT00997113|12238813|FG000|STARTED|Overall Study||10
11057334|NCT00997113|12238814|FG001|STARTED|Overall Study||10
11057335|NCT00997113|12238813|FG000|COMPLETED|Overall Study||10
11057336|NCT00997113|12238814|FG001|COMPLETED|Overall Study||10
11188795|NCT01749293|12378063|FG000|NOT COMPLETED|Overall Study||0
11188796|NCT01749410|12378068|FG000|STARTED|Overall Study||33
11188797|NCT01749410|12378068|FG000|COMPLETED|Overall Study||33
11188798|NCT01749410|12378068|FG000|NOT COMPLETED|Overall Study||0
11188799|NCT01749501|12378074|FG000|STARTED|Overall Study||22
11188800|NCT01749501|12378075|FG001|STARTED|Overall Study||23
11188801|NCT01749501|12378074|FG000|COMPLETED|Overall Study||22
11188802|NCT01749501|12378075|FG001|COMPLETED|Overall Study||23
11188803|NCT01749501|12378074|FG000|NOT COMPLETED|Overall Study||0
11188804|NCT01749501|12378075|FG001|NOT COMPLETED|Overall Study||0
11188805|NCT01749605|12378083|FG000|STARTED|Overall Study||18
11188806|NCT01749605|12378084|FG001|STARTED|Overall Study||17
11188807|NCT01749605|12378083|FG000|COMPLETED|Overall Study||14
11188808|NCT01749605|12378084|FG001|COMPLETED|Overall Study||14
11188809|NCT01749605|12378083|FG000|NOT COMPLETED|Overall Study||4
11188810|NCT01749605|12378084|FG001|NOT COMPLETED|Overall Study||3
11188811|NCT01749631|12378090|FG000|STARTED|Overall Study||97
11188812|NCT01749631|12378090|FG000|COMPLETED|Overall Study||97
11188813|NCT01749631|12378090|FG000|NOT COMPLETED|Overall Study||0
11188814|NCT01749735|12378096|FG000|STARTED|Overall Study||2
11188815|NCT01749735|12378097|FG001|STARTED|Overall Study||0
11188816|NCT01749735|12378096|FG000|COMPLETED|Overall Study||1
11188817|NCT01749735|12378097|FG001|COMPLETED|Overall Study||0
11188818|NCT01749735|12378096|FG000|NOT COMPLETED|Overall Study||1
11188819|NCT01749735|12378097|FG001|NOT COMPLETED|Overall Study||0
11188820|NCT01749800|12378106|FG000|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
11188821|NCT01749800|12378107|FG001|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
11188822|NCT01749800|12378108|FG002|STARTED|Overall Study||0
11188823|NCT01749800|12378106|FG000|COMPLETED|Overall Study||3
11188824|NCT01749800|12378107|FG001|COMPLETED|Overall Study||0
11188825|NCT01749800|12378108|FG002|COMPLETED|Overall Study||0
11188826|NCT01749800|12378106|FG000|NOT COMPLETED|Overall Study||3
11188827|NCT01749800|12378107|FG001|NOT COMPLETED|Overall Study||1
11188828|NCT01749800|12378108|FG002|NOT COMPLETED|Overall Study||0
11188829|NCT01749904|12378118|FG000|STARTED|Overall Study|randomized population|286
11188830|NCT01749904|12378119|FG001|STARTED|Overall Study|randomized population|134
11188831|NCT01749904|12378118|FG000|COMPLETED|Overall Study|randomized population|264
11188832|NCT01749904|12378119|FG001|COMPLETED|Overall Study|randomized population|123
11188833|NCT01749904|12378118|FG000|NOT COMPLETED|Overall Study||22
11188834|NCT01749904|12378119|FG001|NOT COMPLETED|Overall Study||11
11188835|NCT01749930|12378131|FG000|STARTED|Overall Study|randomized population|283
11188836|NCT01749930|12378132|FG001|STARTED|Overall Study|randomized population|137
11188837|NCT01749930|12378131|FG000|COMPLETED|Overall Study|randomized population|253
11188838|NCT01749930|12378132|FG001|COMPLETED|Overall Study|randomized population|125
11188839|NCT01749930|12378131|FG000|NOT COMPLETED|Overall Study||30
11188840|NCT01749930|12378132|FG001|NOT COMPLETED|Overall Study||12
11188841|NCT01749956|12378142|FG000|STARTED|Overall Study||39
11188842|NCT01749956|12378142|FG000|COMPLETED|Overall Study||24
11188843|NCT01749956|12378142|FG000|NOT COMPLETED|Overall Study||15
11188844|NCT01749982|12378151|FG000|STARTED|Overall Study||15
11188845|NCT01749982|12378152|FG001|STARTED|Overall Study||15
11188846|NCT01749982|12378153|FG002|STARTED|Overall Study||15
11188847|NCT01749982|12378154|FG003|STARTED|Overall Study||15
11188848|NCT01749982|12378151|FG000|COMPLETED|Overall Study||15
11188849|NCT01749982|12378152|FG001|COMPLETED|Overall Study||15
11188850|NCT01749982|12378153|FG002|COMPLETED|Overall Study||15
11188851|NCT01749982|12378154|FG003|COMPLETED|Overall Study||12
11188852|NCT01749982|12378151|FG000|NOT COMPLETED|Overall Study||0
11188853|NCT01749982|12378152|FG001|NOT COMPLETED|Overall Study||0
11188854|NCT01749982|12378153|FG002|NOT COMPLETED|Overall Study||0
11188855|NCT01749982|12378154|FG003|NOT COMPLETED|Overall Study||3
11188856|NCT01749995|12378164|FG000|STARTED|Overall Study||200
11188857|NCT01749995|12378164|FG000|COMPLETED|Overall Study||196
11188858|NCT01749995|12378164|FG000|NOT COMPLETED|Overall Study||4
11188859|NCT01750086|12378170|FG000|STARTED|Overall Study||13
11188860|NCT01750086|12378171|FG001|STARTED|Overall Study||14
11188861|NCT01750086|12378170|FG000|COMPLETED|Overall Study||12
11188862|NCT01750086|12378171|FG001|COMPLETED|Overall Study||13
11188863|NCT01750086|12378170|FG000|NOT COMPLETED|Overall Study||1
11188864|NCT01750086|12378171|FG001|NOT COMPLETED|Overall Study||1
11188865|NCT01750190|12378179|FG000|STARTED|Overall Study||616
11188866|NCT01750190|12378180|FG001|STARTED|Overall Study||306
11188867|NCT01750190|12378179|FG000|Safety Population|Overall Study||611
11188868|NCT01750190|12378180|FG001|Safety Population|Overall Study||305
11188869|NCT01750190|12378179|FG000|Full Analysis Set (FAS)|Overall Study||608
11188870|NCT01750190|12378180|FG001|Full Analysis Set (FAS)|Overall Study||305
11188871|NCT01750190|12378179|FG000|COMPLETED|Overall Study||349
11188872|NCT01750190|12378180|FG001|COMPLETED|Overall Study||98
11188873|NCT01750190|12378179|FG000|NOT COMPLETED|Overall Study||267
11188874|NCT01750190|12378180|FG001|NOT COMPLETED|Overall Study||208
11188875|NCT01750229|12378186|FG000|STARTED|Randomized Crossover Phase||30
11188876|NCT01750229|12378186|FG000|Subject Received Sham|Randomized Crossover Phase||24
11188877|NCT01750229|12378186|FG000|Subjects Received 1200 Hz|Randomized Crossover Phase||24
11188878|NCT01750229|12378186|FG000|Subjects Received 3030 Hz|Randomized Crossover Phase||24
11188879|NCT01750229|12378186|FG000|Subjects Received 5882 Hz|Randomized Crossover Phase||24
11188880|NCT01750229|12378186|FG000|Protocol Violation|Randomized Crossover Phase||4
11188881|NCT01750229|12378186|FG000|COMPLETED|Randomized Crossover Phase||28
11188882|NCT01750229|12378186|FG000|NOT COMPLETED|Randomized Crossover Phase||2
11188883|NCT01750229|12378186|FG000|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
11188884|NCT01750229|12378186|FG000|COMPLETED|Long-term Follow-up Phase||25
11188885|NCT01750229|12378186|FG000|NOT COMPLETED|Long-term Follow-up Phase||3
11188886|NCT01750242|12378196|FG000|STARTED|Overall Study||23
11188887|NCT01750242|12378196|FG000|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
11188888|NCT01750242|12378196|FG000|COMPLETED|Overall Study||20
11188889|NCT01750242|12378196|FG000|NOT COMPLETED|Overall Study||3
11188890|NCT01750255|12378203|FG000|STARTED|Overall Study||49
11188891|NCT01750255|12378204|FG001|STARTED|Overall Study||43
11188892|NCT01750255|12378203|FG000|COMPLETED|Overall Study||43
11188893|NCT01750255|12378204|FG001|COMPLETED|Overall Study||38
11188894|NCT01750255|12378203|FG000|NOT COMPLETED|Overall Study||6
11188895|NCT01750255|12378204|FG001|NOT COMPLETED|Overall Study||5
11188896|NCT01750268|12378213|FG000|STARTED|Overall Study||15
11188897|NCT01750268|12378214|FG001|STARTED|Overall Study||17
11188898|NCT01750268|12378213|FG000|COMPLETED|Overall Study||13
11188899|NCT01750268|12378214|FG001|COMPLETED|Overall Study||12
11188900|NCT01750268|12378213|FG000|NOT COMPLETED|Overall Study||2
11188901|NCT01750268|12378214|FG001|NOT COMPLETED|Overall Study||5
11188902|NCT01750294|12378220|FG000|STARTED|Overall Study||14
11188903|NCT01750294|12378220|FG000|COMPLETED|Overall Study||12
11188904|NCT01750294|12378220|FG000|NOT COMPLETED|Overall Study||2
11188905|NCT01750346|12378227|FG000|STARTED|Overall Study||3
11188906|NCT01750346|12378228|FG001|STARTED|Overall Study||2
11188907|NCT01750346|12378229|FG002|STARTED|Overall Study||3
11188908|NCT01750346|12378227|FG000|COMPLETED|Overall Study||2
11188909|NCT01750346|12378228|FG001|COMPLETED|Overall Study||2
11188910|NCT01750346|12378229|FG002|COMPLETED|Overall Study||3
11188911|NCT01750346|12378227|FG000|NOT COMPLETED|Overall Study||1
11188912|NCT01750346|12378228|FG001|NOT COMPLETED|Overall Study||0
11188913|NCT01750346|12378229|FG002|NOT COMPLETED|Overall Study||0
11188914|NCT01750398|12378237|FG000|STARTED|ADT Lead In Phase||33
11188915|NCT01750398|12378237|FG000|COMPLETED|ADT Lead In Phase||29
11188916|NCT01750398|12378237|FG000|NOT COMPLETED|ADT Lead In Phase||4
11188917|NCT01750398|12378237|FG000|STARTED|Bipolar Androgen Thearpy Phase||29
11188918|NCT01750398|12378237|FG000|COMPLETED|Bipolar Androgen Thearpy Phase||26
11188919|NCT01750398|12378237|FG000|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
11188920|NCT01750502|12378243|FG000|STARTED|Overall Study||70
11188921|NCT01750502|12378244|FG001|STARTED|Overall Study||186
11188922|NCT01750502|12378243|FG000|COMPLETED|Overall Study||70
11188923|NCT01750502|12378244|FG001|COMPLETED|Overall Study||186
11188924|NCT01750502|12378243|FG000|NOT COMPLETED|Overall Study||0
11188925|NCT01750502|12378244|FG001|NOT COMPLETED|Overall Study||0
11188926|NCT01750684|12378257|FG000|STARTED|Overall Study||6
11188927|NCT01750684|12378258|FG001|STARTED|Overall Study||7
11188928|NCT01750684|12378257|FG000|COMPLETED|Overall Study||4
11188929|NCT01750684|12378258|FG001|COMPLETED|Overall Study||5
11188930|NCT01750684|12378257|FG000|NOT COMPLETED|Overall Study||2
11188931|NCT01750684|12378258|FG001|NOT COMPLETED|Overall Study||2
11188932|NCT01750697|12378265|FG000|STARTED|Overall Study||25
11188933|NCT01750697|12378265|FG000|Completed|Overall Study||25
11188934|NCT01750697|12378265|FG000|Follow-up Phase|Overall Study|Completed required follow-up|24
11188935|NCT01750697|12378265|FG000|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16
11188936|NCT01750697|12378265|FG000|NOT COMPLETED|Overall Study||9
11188937|NCT01750840|12378272|FG000|STARTED|Overall Study||8
11188938|NCT01750840|12378272|FG000|COMPLETED|Overall Study||4
11188939|NCT01750840|12378272|FG000|NOT COMPLETED|Overall Study||4
11188940|NCT01750879|12378279|FG000|STARTED|Overall Study||30
11188941|NCT01750879|12378280|FG001|STARTED|Overall Study||11
11188942|NCT01750879|12378279|FG000|DBPCFC2|Overall Study||20
11188943|NCT01750879|12378280|FG001|DBPCFC2|Overall Study||8
11188944|NCT01750879|12378279|FG000|DBPCFC3|Overall Study||20
11188945|NCT01750879|12378280|FG001|DBPCFC3|Overall Study||0
11188946|NCT01750879|12378279|FG000|COMPLETED|Overall Study||20
11188947|NCT01750879|12378280|FG001|COMPLETED|Overall Study||8
11188948|NCT01750879|12378279|FG000|NOT COMPLETED|Overall Study||10
11188949|NCT01750879|12378280|FG001|NOT COMPLETED|Overall Study||3
11188950|NCT01750918|12378307|FG000|STARTED|Overall Study||3
11188951|NCT01750918|12378308|FG001|STARTED|Overall Study||4
11324441|NCT02743780|12521732|FG003|NOT COMPLETED|Part 1 (3 Days)||0
11188952|NCT01750918|12378309|FG002|STARTED|Overall Study||36
11188953|NCT01750918|12378310|FG003|STARTED|Overall Study||50
11188954|NCT01750918|12378311|FG004|STARTED|Overall Study||13
11188955|NCT01750918|12378312|FG005|STARTED|Overall Study||20
11188956|NCT01750918|12378313|FG006|STARTED|Overall Study||20
11188957|NCT01750918|12378314|FG007|STARTED|Overall Study||20
11188958|NCT01750918|12378307|FG000|Pharmacokinetic Population|Overall Study||3
11188959|NCT01750918|12378308|FG001|Pharmacokinetic Population|Overall Study||4
11188960|NCT01750918|12378309|FG002|Pharmacokinetic Population|Overall Study||35
11188961|NCT01750918|12378310|FG003|Pharmacokinetic Population|Overall Study||48
11188962|NCT01750918|12378311|FG004|Pharmacokinetic Population|Overall Study||12
11188963|NCT01750918|12378312|FG005|Pharmacokinetic Population|Overall Study||19
11188964|NCT01750918|12378313|FG006|Pharmacokinetic Population|Overall Study||18
11188965|NCT01750918|12378314|FG007|Pharmacokinetic Population|Overall Study||20
11188966|NCT01750918|12378307|FG000|Biomarker Population|Overall Study||3
11188967|NCT01750918|12378308|FG001|Biomarker Population|Overall Study||4
11188968|NCT01750918|12378309|FG002|Biomarker Population|Overall Study||36
11188969|NCT01750918|12378310|FG003|Biomarker Population|Overall Study||50
11188970|NCT01750918|12378311|FG004|Biomarker Population|Overall Study||13
11188971|NCT01750918|12378312|FG005|Biomarker Population|Overall Study||17
11188972|NCT01750918|12378313|FG006|Biomarker Population|Overall Study||19
11188973|NCT01750918|12378314|FG007|Biomarker Population|Overall Study||20
11188974|NCT01750918|12378307|FG000|Crossover Population|Overall Study||0
11188975|NCT01750918|12378308|FG001|Crossover Population|Overall Study||0
11188976|NCT01750918|12378309|FG002|Crossover Population|Overall Study||0
11188977|NCT01750918|12378310|FG003|Crossover Population|Overall Study||0
11188978|NCT01750918|12378311|FG004|Crossover Population|Overall Study||4
11188979|NCT01750918|12378312|FG005|Crossover Population|Overall Study||2
11188980|NCT01750918|12378313|FG006|Crossover Population|Overall Study||5
11188981|NCT01750918|12378314|FG007|Crossover Population|Overall Study||5
11188982|NCT01750918|12378307|FG000|COMPLETED|Overall Study||3
11188983|NCT01750918|12378308|FG001|COMPLETED|Overall Study||4
11188984|NCT01750918|12378309|FG002|COMPLETED|Overall Study||28
11188985|NCT01750918|12378310|FG003|COMPLETED|Overall Study||44
11188986|NCT01750918|12378311|FG004|COMPLETED|Overall Study||12
11188987|NCT01750918|12378312|FG005|COMPLETED|Overall Study||17
11188988|NCT01750918|12378313|FG006|COMPLETED|Overall Study||17
11188989|NCT01750918|12378314|FG007|COMPLETED|Overall Study||16
11188990|NCT01750918|12378307|FG000|NOT COMPLETED|Overall Study||0
11188991|NCT01750918|12378308|FG001|NOT COMPLETED|Overall Study||0
11188992|NCT01750918|12378309|FG002|NOT COMPLETED|Overall Study||8
11188993|NCT01750918|12378310|FG003|NOT COMPLETED|Overall Study||6
11188994|NCT01750918|12378311|FG004|NOT COMPLETED|Overall Study||1
11188995|NCT01750918|12378312|FG005|NOT COMPLETED|Overall Study||3
11188996|NCT01750918|12378313|FG006|NOT COMPLETED|Overall Study||3
11188997|NCT01750918|12378314|FG007|NOT COMPLETED|Overall Study||4
11188998|NCT01750931|12378344|FG000|STARTED|Period 1||14
11188999|NCT01750931|12378345|FG001|STARTED|Period 1||14
11189000|NCT01750931|12378344|FG000|COMPLETED|Period 1||14
11189001|NCT01750931|12378345|FG001|COMPLETED|Period 1||14
11189002|NCT01750931|12378344|FG000|NOT COMPLETED|Period 1||0
11189003|NCT01750931|12378345|FG001|NOT COMPLETED|Period 1||0
11189004|NCT01750931|12378344|FG000|STARTED|Wash Out||14
11189005|NCT01750931|12378345|FG001|STARTED|Wash Out||14
11189006|NCT01750931|12378344|FG000|COMPLETED|Wash Out||14
11189007|NCT01750931|12378345|FG001|COMPLETED|Wash Out||14
11189008|NCT01750931|12378344|FG000|NOT COMPLETED|Wash Out||0
11189009|NCT01750931|12378345|FG001|NOT COMPLETED|Wash Out||0
11189010|NCT01750931|12378344|FG000|STARTED|Period 2||14
11189011|NCT01750931|12378345|FG001|STARTED|Period 2||14
11189012|NCT01750931|12378344|FG000|COMPLETED|Period 2||14
11189013|NCT01750931|12378345|FG001|COMPLETED|Period 2||14
11189014|NCT01750931|12378344|FG000|NOT COMPLETED|Period 2||0
11189015|NCT01750931|12378345|FG001|NOT COMPLETED|Period 2||0
11189016|NCT01751022|12378354|FG000|STARTED|Overall Study||499
11189017|NCT01751022|12378355|FG001|STARTED|Overall Study||326
11189018|NCT01751022|12378356|FG002|STARTED|Overall Study||300
11189019|NCT01751022|12378354|FG000|COMPLETED|Overall Study|6 month visit|443
11189020|NCT01751022|12378355|FG001|COMPLETED|Overall Study|6 month visit|282
11189021|NCT01751022|12378356|FG002|COMPLETED|Overall Study|6 month visit|273
11189022|NCT01751022|12378354|FG000|NOT COMPLETED|Overall Study||56
11189023|NCT01751022|12378355|FG001|NOT COMPLETED|Overall Study||44
11189024|NCT01751022|12378356|FG002|NOT COMPLETED|Overall Study||27
11189025|NCT01751061|12378385|FG000|STARTED|Overall Study||210
11189026|NCT01751061|12378386|FG001|STARTED|Overall Study||206
11189027|NCT01751061|12378385|FG000|COMPLETED|Overall Study||154
11189028|NCT01751061|12378386|FG001|COMPLETED|Overall Study||172
11189029|NCT01751061|12378385|FG000|NOT COMPLETED|Overall Study||56
11189030|NCT01751061|12378386|FG001|NOT COMPLETED|Overall Study||34
11189031|NCT01751087|12378395|FG000|STARTED|Overall Study||100
11189032|NCT01751087|12378396|FG001|STARTED|Overall Study||100
11189033|NCT01751087|12378397|FG002|STARTED|Overall Study||100
11189034|NCT01751087|12378395|FG000|COMPLETED|Overall Study||99
11189035|NCT01751087|12378396|FG001|COMPLETED|Overall Study||100
11189036|NCT01751087|12378397|FG002|COMPLETED|Overall Study||99
11189037|NCT01751087|12378395|FG000|NOT COMPLETED|Overall Study||1
11189038|NCT01751087|12378396|FG001|NOT COMPLETED|Overall Study||0
11189039|NCT01751087|12378397|FG002|NOT COMPLETED|Overall Study||1
11189040|NCT01751113|12378405|FG000|STARTED|Treatment Period 1 (4 Weeks)||8
11189041|NCT01751113|12378406|FG001|STARTED|Treatment Period 1 (4 Weeks)||8
11189042|NCT01751113|12378407|FG002|STARTED|Treatment Period 1 (4 Weeks)||9
11189043|NCT01751113|12378408|FG003|STARTED|Treatment Period 1 (4 Weeks)||9
11189044|NCT01751113|12378409|FG004|STARTED|Treatment Period 1 (4 Weeks)||9
11189045|NCT01751113|12378410|FG005|STARTED|Treatment Period 1 (4 Weeks)||10
11189046|NCT01751113|12378405|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||8
11189047|NCT01751113|12378406|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||8
11189048|NCT01751113|12378407|FG002|COMPLETED|Treatment Period 1 (4 Weeks)||9
11189049|NCT01751113|12378408|FG003|COMPLETED|Treatment Period 1 (4 Weeks)||8
11189050|NCT01751113|12378409|FG004|COMPLETED|Treatment Period 1 (4 Weeks)||8
11189051|NCT01751113|12378410|FG005|COMPLETED|Treatment Period 1 (4 Weeks)||10
11189052|NCT01751113|12378405|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
11189053|NCT01751113|12378406|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
11189054|NCT01751113|12378407|FG002|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
11189055|NCT01751113|12378408|FG003|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
11189056|NCT01751113|12378409|FG004|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
11189057|NCT01751113|12378410|FG005|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
11189058|NCT01751113|12378405|FG000|STARTED|Washout Period 1 (2 Weeks)||8
11189059|NCT01751113|12378406|FG001|STARTED|Washout Period 1 (2 Weeks)||8
11189060|NCT01751113|12378407|FG002|STARTED|Washout Period 1 (2 Weeks)||9
11189061|NCT01751113|12378408|FG003|STARTED|Washout Period 1 (2 Weeks)||8
11189062|NCT01751113|12378409|FG004|STARTED|Washout Period 1 (2 Weeks)||8
11189063|NCT01751113|12378410|FG005|STARTED|Washout Period 1 (2 Weeks)||10
11189064|NCT01751113|12378405|FG000|COMPLETED|Washout Period 1 (2 Weeks)||8
11189065|NCT01751113|12378406|FG001|COMPLETED|Washout Period 1 (2 Weeks)||8
11189066|NCT01751113|12378407|FG002|COMPLETED|Washout Period 1 (2 Weeks)||9
11189067|NCT01751113|12378408|FG003|COMPLETED|Washout Period 1 (2 Weeks)||8
11189068|NCT01751113|12378409|FG004|COMPLETED|Washout Period 1 (2 Weeks)||8
11324442|NCT02743780|12521733|FG004|NOT COMPLETED|Part 1 (3 Days)||0
11324443|NCT02743780|12521729|FG000|STARTED|Part 2 (8 Days)||0
11324444|NCT02743780|12521730|FG001|STARTED|Part 2 (8 Days)||6
11324445|NCT02743780|12521731|FG002|STARTED|Part 2 (8 Days)||6
11324446|NCT02743780|12521732|FG003|STARTED|Part 2 (8 Days)||0
11324447|NCT02743780|12521733|FG004|STARTED|Part 2 (8 Days)||4
11324448|NCT02743780|12521729|FG000|COMPLETED|Part 2 (8 Days)||0
11324449|NCT02743780|12521730|FG001|COMPLETED|Part 2 (8 Days)||6
11324450|NCT02743780|12521731|FG002|COMPLETED|Part 2 (8 Days)||6
11324451|NCT02743780|12521732|FG003|COMPLETED|Part 2 (8 Days)||0
11324452|NCT02743780|12521733|FG004|COMPLETED|Part 2 (8 Days)||4
11324453|NCT02743780|12521729|FG000|NOT COMPLETED|Part 2 (8 Days)||0
11189069|NCT01751113|12378410|FG005|COMPLETED|Washout Period 1 (2 Weeks)||10
11189070|NCT01751113|12378405|FG000|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
11189071|NCT01751113|12378406|FG001|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
11189072|NCT01751113|12378407|FG002|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
11189073|NCT01751113|12378408|FG003|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
11189074|NCT01751113|12378409|FG004|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
11189075|NCT01751113|12378410|FG005|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
11189076|NCT01751113|12378405|FG000|STARTED|Treatment Period 2 (4 Weeks)||8
11189077|NCT01751113|12378406|FG001|STARTED|Treatment Period 2 (4 Weeks)||8
11189078|NCT01751113|12378407|FG002|STARTED|Treatment Period 2 (4 Weeks)||9
11189079|NCT01751113|12378408|FG003|STARTED|Treatment Period 2 (4 Weeks)||8
11189080|NCT01751113|12378409|FG004|STARTED|Treatment Period 2 (4 Weeks)||8
11189081|NCT01751113|12378410|FG005|STARTED|Treatment Period 2 (4 Weeks)||10
11189082|NCT01751113|12378405|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||8
11189083|NCT01751113|12378406|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||8
11189084|NCT01751113|12378407|FG002|COMPLETED|Treatment Period 2 (4 Weeks)||9
11189085|NCT01751113|12378408|FG003|COMPLETED|Treatment Period 2 (4 Weeks)||8
11189086|NCT01751113|12378409|FG004|COMPLETED|Treatment Period 2 (4 Weeks)||8
11189087|NCT01751113|12378410|FG005|COMPLETED|Treatment Period 2 (4 Weeks)||10
11189088|NCT01751113|12378405|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
11189089|NCT01751113|12378406|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
11189090|NCT01751113|12378407|FG002|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
11189091|NCT01751113|12378408|FG003|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
11189092|NCT01751113|12378409|FG004|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
11189093|NCT01751113|12378410|FG005|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
11189094|NCT01751113|12378405|FG000|STARTED|Washout Period 2 (2 Weeks)||8
11189095|NCT01751113|12378406|FG001|STARTED|Washout Period 2 (2 Weeks)||8
11189096|NCT01751113|12378407|FG002|STARTED|Washout Period 2 (2 Weeks)||9
11189097|NCT01751113|12378408|FG003|STARTED|Washout Period 2 (2 Weeks)||8
11189098|NCT01751113|12378409|FG004|STARTED|Washout Period 2 (2 Weeks)||8
11189099|NCT01751113|12378410|FG005|STARTED|Washout Period 2 (2 Weeks)||10
11189100|NCT01751113|12378405|FG000|COMPLETED|Washout Period 2 (2 Weeks)||8
11189101|NCT01751113|12378406|FG001|COMPLETED|Washout Period 2 (2 Weeks)||8
11189102|NCT01751113|12378407|FG002|COMPLETED|Washout Period 2 (2 Weeks)||9
11189103|NCT01751113|12378408|FG003|COMPLETED|Washout Period 2 (2 Weeks)||8
11189104|NCT01751113|12378409|FG004|COMPLETED|Washout Period 2 (2 Weeks)||8
11189105|NCT01751113|12378410|FG005|COMPLETED|Washout Period 2 (2 Weeks)||10
11189106|NCT01751113|12378405|FG000|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
11189107|NCT01751113|12378406|FG001|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
11189108|NCT01751113|12378407|FG002|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
11189109|NCT01751113|12378408|FG003|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
11189110|NCT01751113|12378409|FG004|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
11189111|NCT01751113|12378410|FG005|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
11189112|NCT01751113|12378405|FG000|STARTED|Treatment Period 3 (4 Weeks)||8
11189113|NCT01751113|12378406|FG001|STARTED|Treatment Period 3 (4 Weeks)||8
11189114|NCT01751113|12378407|FG002|STARTED|Treatment Period 3 (4 Weeks)||9
11189115|NCT01751113|12378408|FG003|STARTED|Treatment Period 3 (4 Weeks)||8
11189116|NCT01751113|12378409|FG004|STARTED|Treatment Period 3 (4 Weeks)||8
11189117|NCT01751113|12378410|FG005|STARTED|Treatment Period 3 (4 Weeks)||10
11189118|NCT01751113|12378405|FG000|COMPLETED|Treatment Period 3 (4 Weeks)||8
11189119|NCT01751113|12378406|FG001|COMPLETED|Treatment Period 3 (4 Weeks)||8
11189120|NCT01751113|12378407|FG002|COMPLETED|Treatment Period 3 (4 Weeks)||9
11189121|NCT01751113|12378408|FG003|COMPLETED|Treatment Period 3 (4 Weeks)||8
11189122|NCT01751113|12378409|FG004|COMPLETED|Treatment Period 3 (4 Weeks)||8
11189123|NCT01751113|12378410|FG005|COMPLETED|Treatment Period 3 (4 Weeks)||9
11189124|NCT01751113|12378405|FG000|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
11189125|NCT01751113|12378406|FG001|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
11189126|NCT01751113|12378407|FG002|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
11189127|NCT01751113|12378408|FG003|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
11189128|NCT01751113|12378409|FG004|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
11189129|NCT01751113|12378410|FG005|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
11189130|NCT01751139|12378419|FG000|STARTED|Overall Study||3300
11189131|NCT01751139|12378419|FG000|COMPLETED|Overall Study||1033
11189132|NCT01751139|12378419|FG000|NOT COMPLETED|Overall Study||2267
11189133|NCT01751165|12378426|FG000|STARTED|Overall Study||119
11189134|NCT01751165|12378427|FG001|STARTED|Overall Study||119
11189135|NCT01751165|12378428|FG002|STARTED|Overall Study||116
11189136|NCT01751165|12378426|FG000|COMPLETED|Overall Study||117
11189137|NCT01751165|12378427|FG001|COMPLETED|Overall Study||116
11189138|NCT01751165|12378428|FG002|COMPLETED|Overall Study||113
11189139|NCT01751165|12378426|FG000|NOT COMPLETED|Overall Study||2
11189140|NCT01751165|12378427|FG001|NOT COMPLETED|Overall Study||3
11189141|NCT01751165|12378428|FG002|NOT COMPLETED|Overall Study||3
11189142|NCT01751178|12378441|FG000|STARTED|Overall Study||108
11189143|NCT01751178|12378442|FG001|STARTED|Overall Study||109
11189144|NCT01751178|12378443|FG002|STARTED|Overall Study||107
11189145|NCT01751178|12378441|FG000|COMPLETED|Overall Study||105
11189146|NCT01751178|12378442|FG001|COMPLETED|Overall Study||109
11189147|NCT01751178|12378443|FG002|COMPLETED|Overall Study||105
11189148|NCT01751178|12378441|FG000|NOT COMPLETED|Overall Study||3
11189149|NCT01751178|12378442|FG001|NOT COMPLETED|Overall Study||0
11189150|NCT01751178|12378443|FG002|NOT COMPLETED|Overall Study||2
11189151|NCT01751230|12378457|FG000|STARTED|Overall Study||20
11189152|NCT01751230|12378458|FG001|STARTED|Overall Study||20
11189153|NCT01751230|12378457|FG000|COMPLETED|Overall Study||19
11189154|NCT01751230|12378458|FG001|COMPLETED|Overall Study||16
11189155|NCT01751230|12378457|FG000|NOT COMPLETED|Overall Study||1
11189156|NCT01751230|12378458|FG001|NOT COMPLETED|Overall Study||4
11189157|NCT01751308|12378473|FG000|STARTED|Phase 1||6
11189158|NCT01751308|12378474|FG001|STARTED|Phase 1||3
11189159|NCT01751308|12378475|FG002|STARTED|Phase 1||7
11189160|NCT01751308|12378476|FG003|STARTED|Phase 1||7
11189161|NCT01751308|12378477|FG004|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
11189162|NCT01751308|12378473|FG000|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
11189163|NCT01751308|12378474|FG001|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
11189164|NCT01751308|12378475|FG002|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
11189165|NCT01751308|12378476|FG003|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
11189166|NCT01751308|12378477|FG004|COMPLETED|Phase 1||0
11189167|NCT01751308|12378473|FG000|NOT COMPLETED|Phase 1||0
11189168|NCT01751308|12378474|FG001|NOT COMPLETED|Phase 1||0
11189169|NCT01751308|12378475|FG002|NOT COMPLETED|Phase 1||0
11189170|NCT01751308|12378476|FG003|NOT COMPLETED|Phase 1||0
11189171|NCT01751308|12378477|FG004|NOT COMPLETED|Phase 1||0
11189172|NCT01751308|12378473|FG000|STARTED|Phase 2||0
11189173|NCT01751308|12378474|FG001|STARTED|Phase 2||0
11189174|NCT01751308|12378475|FG002|STARTED|Phase 2||0
11189175|NCT01751308|12378476|FG003|STARTED|Phase 2||0
11189176|NCT01751308|12378477|FG004|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
11189177|NCT01751308|12378473|FG000|COMPLETED|Phase 2||0
11189178|NCT01751308|12378474|FG001|COMPLETED|Phase 2||0
11189179|NCT01751308|12378475|FG002|COMPLETED|Phase 2||0
11189180|NCT01751308|12378476|FG003|COMPLETED|Phase 2||0
11189181|NCT01751308|12378477|FG004|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
11189182|NCT01751308|12378473|FG000|NOT COMPLETED|Phase 2||0
11189183|NCT01751308|12378474|FG001|NOT COMPLETED|Phase 2||0
11189184|NCT01751308|12378475|FG002|NOT COMPLETED|Phase 2||0
11189185|NCT01751308|12378476|FG003|NOT COMPLETED|Phase 2||0
11189186|NCT01751308|12378477|FG004|NOT COMPLETED|Phase 2||0
11189187|NCT01751386|12378495|FG000|STARTED|Overall Study||20
11189188|NCT01751386|12378496|FG001|STARTED|Overall Study||19
11189189|NCT01751386|12378495|FG000|COMPLETED|Overall Study||18
11189190|NCT01751386|12378496|FG001|COMPLETED|Overall Study||16
11189191|NCT01751386|12378495|FG000|NOT COMPLETED|Overall Study||2
11189192|NCT01751386|12378496|FG001|NOT COMPLETED|Overall Study||3
11189193|NCT01751399|12378506|FG000|STARTED|Overall Study||12
11189194|NCT01751399|12378507|FG001|STARTED|Overall Study||8
11189195|NCT01751399|12378508|FG002|STARTED|Overall Study||8
11189196|NCT01751399|12378509|FG003|STARTED|Overall Study||7
11189197|NCT01751399|12378506|FG000|Received 1 Dose of Study Drug|Overall Study||12
11189198|NCT01751399|12378507|FG001|Received 1 Dose of Study Drug|Overall Study||8
11189199|NCT01751399|12378508|FG002|Received 1 Dose of Study Drug|Overall Study||8
11189200|NCT01751399|12378509|FG003|Received 1 Dose of Study Drug|Overall Study||7
11189201|NCT01751399|12378506|FG000|COMPLETED|Overall Study||12
11189202|NCT01751399|12378507|FG001|COMPLETED|Overall Study||8
11189203|NCT01751399|12378508|FG002|COMPLETED|Overall Study||8
11189204|NCT01751399|12378509|FG003|COMPLETED|Overall Study||7
11189205|NCT01751399|12378506|FG000|NOT COMPLETED|Overall Study||0
11189206|NCT01751399|12378507|FG001|NOT COMPLETED|Overall Study||0
11189207|NCT01751399|12378508|FG002|NOT COMPLETED|Overall Study||0
11189208|NCT01751399|12378509|FG003|NOT COMPLETED|Overall Study||0
11189209|NCT01751412|12378519|FG000|STARTED|Overall Study||12
11189210|NCT01751412|12378519|FG000|COMPLETED|Overall Study||11
11189211|NCT01751412|12378519|FG000|NOT COMPLETED|Overall Study||1
11189212|NCT01751451|12378526|FG000|STARTED|Overall Study||42
11189213|NCT01751451|12378527|FG001|STARTED|Overall Study||40
11189214|NCT01751451|12378528|FG002|STARTED|Overall Study||42
11189215|NCT01751451|12378526|FG000|COMPLETED|Overall Study||42
11189216|NCT01751451|12378527|FG001|COMPLETED|Overall Study||40
11189217|NCT01751451|12378528|FG002|COMPLETED|Overall Study||42
11189218|NCT01751451|12378526|FG000|NOT COMPLETED|Overall Study||0
11189219|NCT01751451|12378527|FG001|NOT COMPLETED|Overall Study||0
11189220|NCT01751451|12378528|FG002|NOT COMPLETED|Overall Study||0
11189221|NCT01751568|12378539|FG000|STARTED|Overall Study||13
11189222|NCT01751568|12378540|FG001|STARTED|Overall Study||14
11189223|NCT01751568|12378541|FG002|STARTED|Overall Study||13
11189224|NCT01751568|12378539|FG000|COMPLETED|Overall Study||12
11189225|NCT01751568|12378540|FG001|COMPLETED|Overall Study||14
11189226|NCT01751568|12378541|FG002|COMPLETED|Overall Study||13
11189227|NCT01751568|12378539|FG000|NOT COMPLETED|Overall Study||1
11189228|NCT01751568|12378540|FG001|NOT COMPLETED|Overall Study||0
11189229|NCT01751568|12378541|FG002|NOT COMPLETED|Overall Study||0
11189230|NCT01751646|12378551|FG000|STARTED|Overall Study||109
11189231|NCT01751646|12378552|FG001|STARTED|Overall Study||105
11189232|NCT01751646|12378551|FG000|COMPLETED|Overall Study||98
11189233|NCT01751646|12378552|FG001|COMPLETED|Overall Study||87
11189234|NCT01751646|12378551|FG000|NOT COMPLETED|Overall Study||11
11189235|NCT01751646|12378552|FG001|NOT COMPLETED|Overall Study||18
11189236|NCT01751724|12378564|FG000|STARTED|Overall Study||42
11189237|NCT01751724|12378565|FG001|STARTED|Overall Study||44
11189238|NCT01751724|12378564|FG000|COMPLETED|Overall Study||41
11189239|NCT01751724|12378565|FG001|COMPLETED|Overall Study||42
11189240|NCT01751724|12378564|FG000|NOT COMPLETED|Overall Study||1
11189241|NCT01751724|12378565|FG001|NOT COMPLETED|Overall Study||2
11189242|NCT01751802|12378573|FG000|STARTED|Overall Study||5
11189243|NCT01751802|12378574|FG001|STARTED|Overall Study||4
11189244|NCT01751802|12378573|FG000|Completed Period 1|Overall Study||2
11189245|NCT01751802|12378574|FG001|Completed Period 1|Overall Study||4
11189246|NCT01751802|12378573|FG000|Completed Period 2|Overall Study||2
11189247|NCT01751802|12378574|FG001|Completed Period 2|Overall Study||1
11189248|NCT01751802|12378573|FG000|Completed Period 3|Overall Study||2
11189249|NCT01751802|12378574|FG001|Completed Period 3|Overall Study||1
11189250|NCT01751802|12378573|FG000|COMPLETED|Overall Study||1
11189251|NCT01751802|12378574|FG001|COMPLETED|Overall Study||2
11189252|NCT01751802|12378573|FG000|NOT COMPLETED|Overall Study||4
11189253|NCT01751802|12378574|FG001|NOT COMPLETED|Overall Study||2
11189254|NCT01751867|12378588|FG000|STARTED|Overall Study||36
11189255|NCT01751867|12378589|FG001|STARTED|Overall Study||99
11189256|NCT01751867|12378588|FG000|Treated|Overall Study||34
11189257|NCT01751867|12378589|FG001|Treated|Overall Study||98
11189258|NCT01751867|12378588|FG000|COMPLETED|Overall Study||0
11189259|NCT01751867|12378589|FG001|COMPLETED|Overall Study||0
11189260|NCT01751867|12378588|FG000|NOT COMPLETED|Overall Study||36
11189261|NCT01751867|12378589|FG001|NOT COMPLETED|Overall Study||99
11189262|NCT01751971|12378597|FG000|STARTED|Overall Study||22
11189263|NCT01751971|12378598|FG001|STARTED|Overall Study||25
11189264|NCT01751971|12378597|FG000|COMPLETED|Overall Study||20
11189265|NCT01751971|12378598|FG001|COMPLETED|Overall Study||24
11189266|NCT01751971|12378597|FG000|NOT COMPLETED|Overall Study||2
11189267|NCT01751971|12378598|FG001|NOT COMPLETED|Overall Study||1
11189268|NCT01752036|12378610|FG000|STARTED|Overall Study||33
11189269|NCT01752036|12378610|FG000|COMPLETED|Overall Study||31
11189270|NCT01752036|12378610|FG000|NOT COMPLETED|Overall Study||2
11189271|NCT01752400|12378615|FG000|STARTED|Overall Study||6
11189272|NCT01752400|12378615|FG000|COMPLETED|Overall Study||6
11189273|NCT01752400|12378615|FG000|NOT COMPLETED|Overall Study||0
11189274|NCT01752413|12378621|FG000|STARTED|Overall Study||170
11189275|NCT01752413|12378622|FG001|STARTED|Overall Study||27
11189276|NCT01752413|12378621|FG000|COMPLETED|Overall Study||58
11189277|NCT01752413|12378622|FG001|COMPLETED|Overall Study||6
11189278|NCT01752413|12378621|FG000|NOT COMPLETED|Overall Study||112
11189279|NCT01752413|12378622|FG001|NOT COMPLETED|Overall Study||21
11189280|NCT01752426|12378628|FG000|STARTED|Overall Study||30
11189281|NCT01752426|12378628|FG000|COMPLETED|Overall Study||30
11189282|NCT01752426|12378628|FG000|NOT COMPLETED|Overall Study||0
11189283|NCT01752634|12378638|FG000|STARTED|Up to Week 24 (Primary Analysis)||99
11189284|NCT01752634|12378639|FG001|STARTED|Up to Week 24 (Primary Analysis)||100
11189285|NCT01752634|12378640|FG002|STARTED|Up to Week 24 (Primary Analysis)||100
11189286|NCT01752634|12378641|FG003|STARTED|Up to Week 24 (Primary Analysis)||43
11189287|NCT01752634|12378642|FG004|STARTED|Up to Week 24 (Primary Analysis)||45
11189288|NCT01752634|12378643|FG005|STARTED|Up to Week 24 (Primary Analysis)||10
11189289|NCT01752634|12378638|FG000|COMPLETED|Up to Week 24 (Primary Analysis)||93
11189290|NCT01752634|12378639|FG001|COMPLETED|Up to Week 24 (Primary Analysis)||95
11189291|NCT01752634|12378640|FG002|COMPLETED|Up to Week 24 (Primary Analysis)||97
11189292|NCT01752634|12378641|FG003|COMPLETED|Up to Week 24 (Primary Analysis)||43
11189293|NCT01752634|12378642|FG004|COMPLETED|Up to Week 24 (Primary Analysis)||45
11189294|NCT01752634|12378643|FG005|COMPLETED|Up to Week 24 (Primary Analysis)||0
11189295|NCT01752634|12378638|FG000|NOT COMPLETED|Up to Week 24 (Primary Analysis)||6
11189296|NCT01752634|12378639|FG001|NOT COMPLETED|Up to Week 24 (Primary Analysis)||5
11189297|NCT01752634|12378640|FG002|NOT COMPLETED|Up to Week 24 (Primary Analysis)||3
11189298|NCT01752634|12378641|FG003|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
11189299|NCT01752634|12378642|FG004|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
11189300|NCT01752634|12378643|FG005|NOT COMPLETED|Up to Week 24 (Primary Analysis)||10
11189301|NCT01752634|12378638|FG000|STARTED|Week 24 to Week 260||93
11189302|NCT01752634|12378639|FG001|STARTED|Week 24 to Week 260||95
11189303|NCT01752634|12378640|FG002|STARTED|Week 24 to Week 260||97
11189304|NCT01752634|12378641|FG003|STARTED|Week 24 to Week 260||43
11189305|NCT01752634|12378642|FG004|STARTED|Week 24 to Week 260||45
11189306|NCT01752634|12378643|FG005|STARTED|Week 24 to Week 260||0
11189307|NCT01752634|12378638|FG000|COMPLETED|Week 24 to Week 260||59
11189308|NCT01752634|12378639|FG001|COMPLETED|Week 24 to Week 260||65
11189309|NCT01752634|12378640|FG002|COMPLETED|Week 24 to Week 260||64
11189310|NCT01752634|12378641|FG003|COMPLETED|Week 24 to Week 260||29
11189311|NCT01752634|12378642|FG004|COMPLETED|Week 24 to Week 260||31
11189312|NCT01752634|12378643|FG005|COMPLETED|Week 24 to Week 260||0
11189313|NCT01752634|12378638|FG000|NOT COMPLETED|Week 24 to Week 260||34
11189314|NCT01752634|12378639|FG001|NOT COMPLETED|Week 24 to Week 260||30
11189315|NCT01752634|12378640|FG002|NOT COMPLETED|Week 24 to Week 260||33
11189316|NCT01752634|12378641|FG003|NOT COMPLETED|Week 24 to Week 260||14
11189317|NCT01752634|12378642|FG004|NOT COMPLETED|Week 24 to Week 260||14
11189318|NCT01752634|12378643|FG005|NOT COMPLETED|Week 24 to Week 260||0
11189319|NCT01752712|12378655|FG000|STARTED|Overall Study||31
11189320|NCT01752712|12378656|FG001|STARTED|Overall Study||31
11189321|NCT01752712|12378655|FG000|COMPLETED|Overall Study||22
11189322|NCT01752712|12378656|FG001|COMPLETED|Overall Study||21
11189323|NCT01752712|12378655|FG000|NOT COMPLETED|Overall Study||9
11189324|NCT01752712|12378656|FG001|NOT COMPLETED|Overall Study||10
11189325|NCT01752842|12378664|FG000|STARTED|Overall Study||34
11189326|NCT01752842|12378665|FG001|STARTED|Overall Study||36
11189327|NCT01752842|12378664|FG000|COMPLETED|Overall Study||31
11189328|NCT01752842|12378665|FG001|COMPLETED|Overall Study||34
11189329|NCT01752842|12378664|FG000|NOT COMPLETED|Overall Study||3
11189330|NCT01752842|12378665|FG001|NOT COMPLETED|Overall Study||2
11189331|NCT01752855|12378673|FG000|STARTED|Overall Study||44
11189332|NCT01752855|12378674|FG001|STARTED|Overall Study||44
11189333|NCT01752855|12378673|FG000|COMPLETED|Overall Study||43
11189334|NCT01752855|12378674|FG001|COMPLETED|Overall Study||40
11189335|NCT01752855|12378673|FG000|NOT COMPLETED|Overall Study||1
11189336|NCT01752855|12378674|FG001|NOT COMPLETED|Overall Study||4
11189337|NCT01752907|12378682|FG000|STARTED|Overall Study||151
11189338|NCT01752907|12378683|FG001|STARTED|Overall Study||153
11189339|NCT01752907|12378682|FG000|Received Pegfilgrastim|Overall Study||149
11189340|NCT01752907|12378683|FG001|Received Pegfilgrastim|Overall Study||151
11189341|NCT01752907|12378682|FG000|COMPLETED|Overall Study||139
11189342|NCT01752907|12378683|FG001|COMPLETED|Overall Study||133
11189343|NCT01752907|12378682|FG000|NOT COMPLETED|Overall Study||12
11189344|NCT01752907|12378683|FG001|NOT COMPLETED|Overall Study||20
11189345|NCT01752933|12378691|FG000|STARTED|Treatment|Includes all patients who received any treatment|4
11189346|NCT01752933|12378692|FG001|STARTED|Treatment|Includes all patients who received any treatment|46
11189347|NCT01752933|12378691|FG000|COMPLETED|Treatment|Completion not applicable for this survival study|0
11189348|NCT01752933|12378692|FG001|COMPLETED|Treatment|Completion not applicable for this survival study|0
11189349|NCT01752933|12378691|FG000|NOT COMPLETED|Treatment||4
11189350|NCT01752933|12378692|FG001|NOT COMPLETED|Treatment||46
11189351|NCT01752933|12378691|FG000|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4
11189352|NCT01752933|12378692|FG001|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46
11189353|NCT01752933|12378691|FG000|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
11189354|NCT01752933|12378692|FG001|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
11189355|NCT01752933|12378691|FG000|NOT COMPLETED|Overall Study and Follow-up||4
11189356|NCT01752933|12378692|FG001|NOT COMPLETED|Overall Study and Follow-up||46
11189357|NCT01752985|12378702|FG000|STARTED|Treatment Period||29
11189358|NCT01752985|12378703|FG001|STARTED|Treatment Period||30
11189359|NCT01752985|12378704|FG002|STARTED|Treatment Period||29
11189360|NCT01752985|12378702|FG000|COMPLETED|Treatment Period||25
11189361|NCT01752985|12378703|FG001|COMPLETED|Treatment Period||27
11189362|NCT01752985|12378704|FG002|COMPLETED|Treatment Period||24
11189363|NCT01752985|12378702|FG000|NOT COMPLETED|Treatment Period||4
11189364|NCT01752985|12378703|FG001|NOT COMPLETED|Treatment Period||3
11189365|NCT01752985|12378704|FG002|NOT COMPLETED|Treatment Period||5
11189366|NCT01752985|12378702|FG000|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28
11189367|NCT01752985|12378703|FG001|STARTED|Follow-up Period||27
11189368|NCT01752985|12378704|FG002|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26
11189369|NCT01752985|12378702|FG000|COMPLETED|Follow-up Period||28
11189370|NCT01752985|12378703|FG001|COMPLETED|Follow-up Period||27
11189371|NCT01752985|12378704|FG002|COMPLETED|Follow-up Period||26
11189372|NCT01752985|12378702|FG000|NOT COMPLETED|Follow-up Period||0
11189373|NCT01752985|12378703|FG001|NOT COMPLETED|Follow-up Period||0
11189374|NCT01752985|12378704|FG002|NOT COMPLETED|Follow-up Period||0
11189375|NCT01753076|12378714|FG000|STARTED|Overall Study||151
11189376|NCT01753076|12378715|FG001|STARTED|Overall Study||152
11189377|NCT01753076|12378714|FG000|COMPLETED|Overall Study||110
11189378|NCT01753076|12378715|FG001|COMPLETED|Overall Study||106
11189379|NCT01753076|12378714|FG000|NOT COMPLETED|Overall Study||41
11189380|NCT01753076|12378715|FG001|NOT COMPLETED|Overall Study||46
11189381|NCT01753115|12378726|FG000|STARTED|Overall Study||44
11189382|NCT01753115|12378727|FG001|STARTED|Overall Study||40
11189383|NCT01753115|12378728|FG002|STARTED|Overall Study||70
11189384|NCT01753115|12378726|FG000|Treated|Overall Study||38
11189385|NCT01753115|12378727|FG001|Treated|Overall Study||39
11189386|NCT01753115|12378728|FG002|Treated|Overall Study||67
11189387|NCT01753115|12378726|FG000|COMPLETED|Overall Study||32
11189388|NCT01753115|12378727|FG001|COMPLETED|Overall Study||25
11189389|NCT01753115|12378728|FG002|COMPLETED|Overall Study||56
11189390|NCT01753115|12378726|FG000|NOT COMPLETED|Overall Study||12
11189391|NCT01753115|12378727|FG001|NOT COMPLETED|Overall Study||15
11189392|NCT01753115|12378728|FG002|NOT COMPLETED|Overall Study||14
11189393|NCT01753193|12378736|FG000|STARTED|Overall Study||218
11189394|NCT01753193|12378736|FG000|COMPLETED|Overall Study||172
11189395|NCT01753193|12378736|FG000|NOT COMPLETED|Overall Study||46
11189396|NCT01753297|12378742|FG000|STARTED|Overall Study||117
11189397|NCT01753297|12378743|FG001|STARTED|Overall Study||109
11189398|NCT01753297|12378742|FG000|Received Triptorelin Treatment|Overall Study||0
11189399|NCT01753297|12378743|FG001|Received Triptorelin Treatment|Overall Study||105
11189400|NCT01753297|12378742|FG000|COMPLETED|Overall Study||76
11189401|NCT01753297|12378743|FG001|COMPLETED|Overall Study||73
11189402|NCT01753297|12378742|FG000|NOT COMPLETED|Overall Study||41
11189403|NCT01753297|12378743|FG001|NOT COMPLETED|Overall Study||36
11189404|NCT01753310|12378753|FG000|STARTED|Overall Study||89
11189405|NCT01753310|12378754|FG001|STARTED|Overall Study||45
11189406|NCT01753310|12378753|FG000|COMPLETED|Overall Study||57
11189407|NCT01753310|12378754|FG001|COMPLETED|Overall Study||21
11189408|NCT01753310|12378753|FG000|NOT COMPLETED|Overall Study||32
11189409|NCT01753310|12378754|FG001|NOT COMPLETED|Overall Study||24
11189410|NCT01753323|12378763|FG000|STARTED|Overall Study||11
11189411|NCT01753323|12378764|FG001|STARTED|Overall Study||10
11189412|NCT01753323|12378765|FG002|STARTED|Overall Study||22
11189413|NCT01753323|12378763|FG000|Pharmacodynamic (PD) Set|Overall Study||10
11189414|NCT01753323|12378764|FG001|Pharmacodynamic (PD) Set|Overall Study||10
11189415|NCT01753323|12378765|FG002|Pharmacodynamic (PD) Set|Overall Study||21
11189416|NCT01753323|12378763|FG000|Pharmacokinetic(PK) Set|Overall Study||10
11189417|NCT01753323|12378764|FG001|Pharmacokinetic(PK) Set|Overall Study||10
11189418|NCT01753323|12378765|FG002|Pharmacokinetic(PK) Set|Overall Study||21
11189419|NCT01753323|12378763|FG000|Safety Set|Overall Study||11
11189420|NCT01753323|12378764|FG001|Safety Set|Overall Study||10
11189421|NCT01753323|12378765|FG002|Safety Set|Overall Study||22
11189422|NCT01753323|12378763|FG000|Intent-to-treat Analysis Set|Overall Study||11
11189423|NCT01753323|12378764|FG001|Intent-to-treat Analysis Set|Overall Study||10
11189424|NCT01753323|12378765|FG002|Intent-to-treat Analysis Set|Overall Study||22
11189425|NCT01753323|12378763|FG000|COMPLETED|Overall Study||10
11189426|NCT01753323|12378764|FG001|COMPLETED|Overall Study||10
11189427|NCT01753323|12378765|FG002|COMPLETED|Overall Study||13
11189428|NCT01753323|12378763|FG000|NOT COMPLETED|Overall Study||1
11189429|NCT01753323|12378764|FG001|NOT COMPLETED|Overall Study||0
11189430|NCT01753323|12378765|FG002|NOT COMPLETED|Overall Study||9
11189431|NCT01753336|12378774|FG000|STARTED|Overall Study||112
11189432|NCT01753336|12378774|FG000|Cycle 1|Overall Study||112
11189433|NCT01753336|12378774|FG000|Cycle 2|Overall Study||98
11189434|NCT01753336|12378774|FG000|Cycle 3|Overall Study||93
11189435|NCT01753336|12378774|FG000|COMPLETED|Overall Study||92
11189436|NCT01753336|12378774|FG000|NOT COMPLETED|Overall Study||20
11189437|NCT01753362|12378780|FG000|STARTED|Overall Study||36
11189438|NCT01753362|12378781|FG001|STARTED|Overall Study||48
11189439|NCT01753362|12378780|FG000|COMPLETED|Overall Study||26
11189440|NCT01753362|12378781|FG001|COMPLETED|Overall Study||40
11189441|NCT01753362|12378780|FG000|NOT COMPLETED|Overall Study||10
11189442|NCT01753362|12378781|FG001|NOT COMPLETED|Overall Study||8
11189443|NCT01753401|12378789|FG000|STARTED|Double-blind Period (8 Weeks)||12
11189444|NCT01753401|12378790|FG001|STARTED|Double-blind Period (8 Weeks)||26
11189445|NCT01753401|12378791|FG002|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
11189446|NCT01753401|12378792|FG003|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
11189447|NCT01753401|12378789|FG000|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11
11189448|NCT01753401|12378790|FG001|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25
11189449|NCT01753401|12378791|FG002|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
11189450|NCT01753401|12378792|FG003|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
11189451|NCT01753401|12378789|FG000|COMPLETED|Double-blind Period (8 Weeks)||11
11189452|NCT01753401|12378790|FG001|COMPLETED|Double-blind Period (8 Weeks)||22
11189453|NCT01753401|12378791|FG002|COMPLETED|Double-blind Period (8 Weeks)||0
11189454|NCT01753401|12378792|FG003|COMPLETED|Double-blind Period (8 Weeks)||0
11189455|NCT01753401|12378789|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||1
11189456|NCT01753401|12378790|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||4
11189457|NCT01753401|12378791|FG002|NOT COMPLETED|Double-blind Period (8 Weeks)||0
11189458|NCT01753401|12378792|FG003|NOT COMPLETED|Double-blind Period (8 Weeks)||0
11189459|NCT01753401|12378789|FG000|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
11189460|NCT01753401|12378790|FG001|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
11189461|NCT01753401|12378791|FG002|STARTED|Open Label Period (44 Weeks)||11
11189462|NCT01753401|12378792|FG003|STARTED|Open Label Period (44 Weeks)||22
11189463|NCT01753401|12378789|FG000|mITT|Open Label Period (44 Weeks)||0
11189464|NCT01753401|12378790|FG001|mITT|Open Label Period (44 Weeks)||0
11189465|NCT01753401|12378791|FG002|mITT|Open Label Period (44 Weeks)||11
11189466|NCT01753401|12378792|FG003|mITT|Open Label Period (44 Weeks)||22
11189467|NCT01753401|12378789|FG000|Safety Analysis Set|Open Label Period (44 Weeks)||0
11189468|NCT01753401|12378790|FG001|Safety Analysis Set|Open Label Period (44 Weeks)||0
11189469|NCT01753401|12378791|FG002|Safety Analysis Set|Open Label Period (44 Weeks)||11
11189470|NCT01753401|12378792|FG003|Safety Analysis Set|Open Label Period (44 Weeks)||22
11189471|NCT01753401|12378789|FG000|COMPLETED|Open Label Period (44 Weeks)||0
11189472|NCT01753401|12378790|FG001|COMPLETED|Open Label Period (44 Weeks)||0
11189473|NCT01753401|12378791|FG002|COMPLETED|Open Label Period (44 Weeks)||7
11189474|NCT01753401|12378792|FG003|COMPLETED|Open Label Period (44 Weeks)||13
11189475|NCT01753401|12378789|FG000|NOT COMPLETED|Open Label Period (44 Weeks)||0
11189476|NCT01753401|12378790|FG001|NOT COMPLETED|Open Label Period (44 Weeks)||0
11189477|NCT01753401|12378791|FG002|NOT COMPLETED|Open Label Period (44 Weeks)||4
11189478|NCT01753401|12378792|FG003|NOT COMPLETED|Open Label Period (44 Weeks)||9
11189479|NCT01753518|12378804|FG000|STARTED|Intention-to-Treat Analysis||110
11189480|NCT01753518|12378805|FG001|STARTED|Intention-to-Treat Analysis||110
11189481|NCT01753518|12378804|FG000|COMPLETED|Intention-to-Treat Analysis||103
11189482|NCT01753518|12378805|FG001|COMPLETED|Intention-to-Treat Analysis||103
11189483|NCT01753518|12378804|FG000|NOT COMPLETED|Intention-to-Treat Analysis||7
11189484|NCT01753518|12378805|FG001|NOT COMPLETED|Intention-to-Treat Analysis||7
11189485|NCT01753518|12378804|FG000|STARTED|Postpartum Follow-up||103
11189486|NCT01753518|12378805|FG001|STARTED|Postpartum Follow-up||103
11189487|NCT01753518|12378804|FG000|COMPLETED|Postpartum Follow-up||81
11189488|NCT01753518|12378805|FG001|COMPLETED|Postpartum Follow-up||88
11189489|NCT01753518|12378804|FG000|NOT COMPLETED|Postpartum Follow-up||22
11189490|NCT01753518|12378805|FG001|NOT COMPLETED|Postpartum Follow-up||15
11189491|NCT01753557|12378813|FG000|STARTED|Overall Study||35
11189492|NCT01753557|12378814|FG001|STARTED|Overall Study||19
11189493|NCT01753557|12378813|FG000|COMPLETED|Overall Study||35
11189494|NCT01753557|12378814|FG001|COMPLETED|Overall Study||19
11189495|NCT01753557|12378813|FG000|NOT COMPLETED|Overall Study||0
11189496|NCT01753557|12378814|FG001|NOT COMPLETED|Overall Study||0
11189497|NCT01753570|12378824|FG000|STARTED|Overall Study||30
11189498|NCT01753570|12378825|FG001|STARTED|Overall Study||30
11189499|NCT01753570|12378826|FG002|STARTED|Overall Study||14
11189500|NCT01753570|12378824|FG000|COMPLETED|Overall Study||28
11189501|NCT01753570|12378825|FG001|COMPLETED|Overall Study||25
11189502|NCT01753570|12378826|FG002|COMPLETED|Overall Study||13
11189503|NCT01753570|12378824|FG000|NOT COMPLETED|Overall Study||2
11189504|NCT01753570|12378825|FG001|NOT COMPLETED|Overall Study||5
11189505|NCT01753570|12378826|FG002|NOT COMPLETED|Overall Study||1
11189506|NCT01753713|12378837|FG000|STARTED|Overall Study||14
11189507|NCT01753713|12378838|FG001|STARTED|Overall Study||19
11189508|NCT01753713|12378837|FG000|COMPLETED|Overall Study||14
11189509|NCT01753713|12378838|FG001|COMPLETED|Overall Study||19
11189510|NCT01753713|12378837|FG000|NOT COMPLETED|Overall Study||0
11189511|NCT01753713|12378838|FG001|NOT COMPLETED|Overall Study||0
11189512|NCT01753739|12378849|FG000|STARTED|Overall Study||124
11189513|NCT01753739|12378850|FG001|STARTED|Overall Study||123
11189514|NCT01753739|12378851|FG002|STARTED|Overall Study||123
11189515|NCT01753739|12378852|FG003|STARTED|Overall Study||124
11189516|NCT01753739|12378853|FG004|STARTED|Overall Study||123
11189517|NCT01753739|12378849|FG000|COMPLETED|Overall Study||120
11189518|NCT01753739|12378850|FG001|COMPLETED|Overall Study||118
11189519|NCT01753739|12378851|FG002|COMPLETED|Overall Study||118
11189520|NCT01753739|12378852|FG003|COMPLETED|Overall Study||117
11189521|NCT01753739|12378853|FG004|COMPLETED|Overall Study||120
11189522|NCT01753739|12378849|FG000|NOT COMPLETED|Overall Study||4
11189523|NCT01753739|12378850|FG001|NOT COMPLETED|Overall Study||5
11189524|NCT01753739|12378851|FG002|NOT COMPLETED|Overall Study||5
11189525|NCT01753739|12378852|FG003|NOT COMPLETED|Overall Study||7
11189526|NCT01753739|12378853|FG004|NOT COMPLETED|Overall Study||3
11189527|NCT01753856|12378867|FG000|STARTED|Overall Study||33
11189528|NCT01753856|12378868|FG001|STARTED|Overall Study||36
11189529|NCT01753856|12378867|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
11189530|NCT01753856|12378868|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
11189531|NCT01753856|12378867|FG000|Completed 3-Month Bone Biopsy|Overall Study||31
11189532|NCT01753856|12378868|FG001|Completed 3-Month Bone Biopsy|Overall Study||35
11189533|NCT01753856|12378867|FG000|COMPLETED|Overall Study||30
11189534|NCT01753856|12378868|FG001|COMPLETED|Overall Study||34
11189535|NCT01753856|12378867|FG000|NOT COMPLETED|Overall Study||3
11189536|NCT01753856|12378868|FG001|NOT COMPLETED|Overall Study||2
11189537|NCT01753999|12378877|FG000|STARTED|Period 1 - Initial Assignment||155
11189538|NCT01753999|12378878|FG001|STARTED|Period 1 - Initial Assignment||162
11189539|NCT01753999|12378877|FG000|Received Intervention|Period 1 - Initial Assignment||144
11189540|NCT01753999|12378878|FG001|Received Intervention|Period 1 - Initial Assignment||146
11189541|NCT01753999|12378877|FG000|COMPLETED|Period 1 - Initial Assignment||116
11189542|NCT01753999|12378878|FG001|COMPLETED|Period 1 - Initial Assignment||112
11189543|NCT01753999|12378877|FG000|NOT COMPLETED|Period 1 - Initial Assignment||39
11189544|NCT01753999|12378878|FG001|NOT COMPLETED|Period 1 - Initial Assignment||50
11189545|NCT01753999|12378877|FG000|STARTED|Period 2 -Cross to Alternate Arm||116
11189546|NCT01753999|12378878|FG001|STARTED|Period 2 -Cross to Alternate Arm||112
11189547|NCT01753999|12378877|FG000|Received Intervention|Period 2 -Cross to Alternate Arm||103
11189548|NCT01753999|12378878|FG001|Received Intervention|Period 2 -Cross to Alternate Arm||95
11189549|NCT01753999|12378877|FG000|COMPLETED|Period 2 -Cross to Alternate Arm||99
11189550|NCT01753999|12378878|FG001|COMPLETED|Period 2 -Cross to Alternate Arm||89
11189551|NCT01753999|12378877|FG000|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
11189552|NCT01753999|12378878|FG001|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23
11189553|NCT01754129|12378889|FG000|STARTED|Overall Study||148
11189554|NCT01754129|12378889|FG000|Visit 1 (Enrollment Day)|Overall Study||145
11189555|NCT01754129|12378889|FG000|Visit 2 (Year 1)|Overall Study||129
11189556|NCT01754129|12378889|FG000|Visit 3 (Year 2)|Overall Study||115
11189557|NCT01754129|12378889|FG000|COMPLETED|Overall Study||115
11189558|NCT01754129|12378889|FG000|NOT COMPLETED|Overall Study||33
11189559|NCT01754194|12378902|FG000|STARTED|Overall Study||169
11189560|NCT01754194|12378903|FG001|STARTED|Overall Study||124
11189561|NCT01754194|12378902|FG000|COMPLETED|Overall Study||117
11189562|NCT01754194|12378903|FG001|COMPLETED|Overall Study||97
11189563|NCT01754194|12378902|FG000|NOT COMPLETED|Overall Study||52
11189564|NCT01754194|12378903|FG001|NOT COMPLETED|Overall Study||27
11189565|NCT01754207|12378911|FG000|STARTED|Overall Study||20
11189566|NCT01754207|12378911|FG000|COMPLETED|Overall Study||17
11189567|NCT01754207|12378911|FG000|NOT COMPLETED|Overall Study||3
11189568|NCT01754259|12378917|FG000|STARTED|Overall Study||23
11189569|NCT01754259|12378918|FG001|STARTED|Overall Study||24
11189570|NCT01754259|12378917|FG000|COMPLETED|Overall Study||18
11189571|NCT01754259|12378918|FG001|COMPLETED|Overall Study||18
11189572|NCT01754259|12378917|FG000|NOT COMPLETED|Overall Study||5
11189573|NCT01754259|12378918|FG001|NOT COMPLETED|Overall Study||6
11189574|NCT01754350|12378926|FG000|STARTED|Overall Study||25
11189575|NCT01754350|12378927|FG001|STARTED|Overall Study||25
11189576|NCT01754350|12378926|FG000|COMPLETED|Overall Study||20
11189577|NCT01754350|12378927|FG001|COMPLETED|Overall Study||22
11189578|NCT01754350|12378926|FG000|NOT COMPLETED|Overall Study||5
11189579|NCT01754350|12378927|FG001|NOT COMPLETED|Overall Study||3
11189580|NCT01754376|12378933|FG000|STARTED|Overall Study||6
11189581|NCT01754376|12378933|FG000|Completed 2-week Lead in of Vemurafenib|Overall Study||6
11189582|NCT01754376|12378933|FG000|COMPLETED|Overall Study||3
11189583|NCT01754376|12378933|FG000|NOT COMPLETED|Overall Study||3
11189584|NCT01754389|12378941|FG000|STARTED|Overall Study||46
11189585|NCT01754389|12378942|FG001|STARTED|Overall Study||45
11189586|NCT01754389|12378943|FG002|STARTED|Overall Study||47
11189587|NCT01754389|12378941|FG000|COMPLETED|Overall Study||46
11189588|NCT01754389|12378942|FG001|COMPLETED|Overall Study||45
11189589|NCT01754389|12378943|FG002|COMPLETED|Overall Study||47
11189590|NCT01754389|12378941|FG000|NOT COMPLETED|Overall Study||0
11189591|NCT01754389|12378942|FG001|NOT COMPLETED|Overall Study||0
11189592|NCT01754389|12378943|FG002|NOT COMPLETED|Overall Study||0
11189593|NCT01754402|12378954|FG000|STARTED|Overall Study||6
11189594|NCT01754402|12378955|FG001|STARTED|Overall Study||2
11189595|NCT01754402|12378956|FG002|STARTED|Overall Study||30
11189596|NCT01754402|12378954|FG000|COMPLETED|Overall Study||4
11189597|NCT01754402|12378955|FG001|COMPLETED|Overall Study||0
11189598|NCT01754402|12378956|FG002|COMPLETED|Overall Study||26
11189599|NCT01754402|12378954|FG000|NOT COMPLETED|Overall Study||2
11189600|NCT01754402|12378955|FG001|NOT COMPLETED|Overall Study||2
11189601|NCT01754402|12378956|FG002|NOT COMPLETED|Overall Study||4
11189602|NCT01754467|12378965|FG000|STARTED|Overall Study||9
11189603|NCT01754467|12378965|FG000|COMPLETED|Overall Study||8
11189604|NCT01754467|12378965|FG000|NOT COMPLETED|Overall Study||1
11189605|NCT01754480|12378971|FG000|STARTED|Part I + Part II (Overall Study)||163
11189606|NCT01754480|12378972|FG001|STARTED|Part I + Part II (Overall Study)||162
11189607|NCT01754480|12378971|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
11189608|NCT01754480|12378972|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
11189609|NCT01754480|12378971|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
11189610|NCT01754480|12378972|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
11189611|NCT01754480|12378971|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||25
11189612|NCT01754480|12378972|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||23
11189613|NCT01754480|12378971|FG000|STARTED|Primary Part II||111
11189614|NCT01754480|12378972|FG001|STARTED|Primary Part II||113
11189615|NCT01754480|12378971|FG000|Completed Study up to Week 6|Primary Part II||100
11189616|NCT01754480|12378972|FG001|Completed Study up to Week 6|Primary Part II||108
11189617|NCT01754480|12378971|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
11189618|NCT01754480|12378972|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
11189619|NCT01754480|12378971|FG000|NOT COMPLETED|Primary Part II||15
11189620|NCT01754480|12378972|FG001|NOT COMPLETED|Primary Part II||11
11189621|NCT01754493|12378979|FG000|STARTED|Overall Study||17
11189622|NCT01754493|12378979|FG000|COMPLETED|Overall Study||10
11189623|NCT01754493|12378979|FG000|NOT COMPLETED|Overall Study||7
11189624|NCT01754519|12378983|FG000|STARTED|Overall Study||1
11189625|NCT01754519|12378983|FG000|COMPLETED|Overall Study||1
11189626|NCT01754519|12378983|FG000|NOT COMPLETED|Overall Study||0
11189627|NCT01754623|12378987|FG000|STARTED|Overall Study||9
11189628|NCT01754623|12378987|FG000|COMPLETED|Overall Study||9
11324454|NCT02743780|12521730|FG001|NOT COMPLETED|Part 2 (8 Days)||0
11324455|NCT02743780|12521731|FG002|NOT COMPLETED|Part 2 (8 Days)||0
11324456|NCT02743780|12521732|FG003|NOT COMPLETED|Part 2 (8 Days)||0
11324457|NCT02743780|12521733|FG004|NOT COMPLETED|Part 2 (8 Days)||0
11324458|NCT02743780|12521729|FG000|STARTED|Part 3 (7 Days)||0
11324459|NCT02743780|12521730|FG001|STARTED|Part 3 (7 Days)||0
11324460|NCT02743780|12521731|FG002|STARTED|Part 3 (7 Days)||25
11324461|NCT02743780|12521732|FG003|STARTED|Part 3 (7 Days)||0
11324462|NCT02743780|12521733|FG004|STARTED|Part 3 (7 Days)||25
11324463|NCT02743780|12521729|FG000|COMPLETED|Part 3 (7 Days)||0
11324464|NCT02743780|12521730|FG001|COMPLETED|Part 3 (7 Days)||0
11324465|NCT02743780|12521731|FG002|COMPLETED|Part 3 (7 Days)||24
11324466|NCT02743780|12521732|FG003|COMPLETED|Part 3 (7 Days)||0
11324467|NCT02743780|12521733|FG004|COMPLETED|Part 3 (7 Days)||25
11324468|NCT02743780|12521729|FG000|NOT COMPLETED|Part 3 (7 Days)||0
11324469|NCT02743780|12521730|FG001|NOT COMPLETED|Part 3 (7 Days)||0
11324470|NCT02743780|12521731|FG002|NOT COMPLETED|Part 3 (7 Days)||1
11324471|NCT02743780|12521732|FG003|NOT COMPLETED|Part 3 (7 Days)||0
11324472|NCT02743780|12521733|FG004|NOT COMPLETED|Part 3 (7 Days)||0
11324473|NCT02743793|12521755|FG000|STARTED|Overall Study||5
11324474|NCT02743793|12521756|FG001|STARTED|Overall Study||36
11324475|NCT02743793|12521755|FG000|COMPLETED|Overall Study||0
11324476|NCT02743793|12521756|FG001|COMPLETED|Overall Study||0
11324477|NCT02743793|12521755|FG000|NOT COMPLETED|Overall Study||5
11324478|NCT02743793|12521756|FG001|NOT COMPLETED|Overall Study||36
11189629|NCT01754623|12378987|FG000|NOT COMPLETED|Overall Study||0
11189630|NCT01754688|12378993|FG000|STARTED|Overall Study||624
11189631|NCT01754688|12378993|FG000|COMPLETED|Overall Study||624
11189632|NCT01754688|12378993|FG000|NOT COMPLETED|Overall Study||0
11189633|NCT01754714|12379002|FG000|STARTED|Overall Study||27
11189634|NCT01754714|12379003|FG001|STARTED|Overall Study||27
11189635|NCT01754714|12379004|FG002|STARTED|Overall Study||26
11189636|NCT01754714|12379005|FG003|STARTED|Overall Study||28
11189637|NCT01754714|12379002|FG000|COMPLETED|Overall Study||27
11189638|NCT01754714|12379003|FG001|COMPLETED|Overall Study||26
11189639|NCT01754714|12379004|FG002|COMPLETED|Overall Study||24
11189640|NCT01754714|12379005|FG003|COMPLETED|Overall Study||27
11189641|NCT01754714|12379002|FG000|NOT COMPLETED|Overall Study||0
11189642|NCT01754714|12379003|FG001|NOT COMPLETED|Overall Study||1
11189643|NCT01754714|12379004|FG002|NOT COMPLETED|Overall Study||2
11189644|NCT01754714|12379005|FG003|NOT COMPLETED|Overall Study||1
11189645|NCT01754727|12379016|FG000|STARTED|Overall Study||452
11189646|NCT01754727|12379016|FG000|COMPLETED|Overall Study||450
11189647|NCT01754727|12379016|FG000|NOT COMPLETED|Overall Study||2
11189648|NCT01754753|12379022|FG000|STARTED|Overall Study||78
11189649|NCT01754753|12379023|FG001|STARTED|Overall Study||79
11189650|NCT01754753|12379022|FG000|COMPLETED|Overall Study||26
11189651|NCT01754753|12379023|FG001|COMPLETED|Overall Study||30
11189652|NCT01754753|12379022|FG000|NOT COMPLETED|Overall Study||52
11189653|NCT01754753|12379023|FG001|NOT COMPLETED|Overall Study||49
11189654|NCT01754766|12379032|FG000|STARTED|Overall Study||31
11189655|NCT01754766|12379033|FG001|STARTED|Overall Study||29
11189656|NCT01754766|12379034|FG002|STARTED|Overall Study||30
11189657|NCT01754766|12379032|FG000|COMPLETED|Overall Study||30
11189658|NCT01754766|12379033|FG001|COMPLETED|Overall Study||28
11189659|NCT01754766|12379034|FG002|COMPLETED|Overall Study||30
11189660|NCT01754766|12379032|FG000|NOT COMPLETED|Overall Study||1
11189661|NCT01754766|12379033|FG001|NOT COMPLETED|Overall Study||1
11189662|NCT01754766|12379034|FG002|NOT COMPLETED|Overall Study||0
11189663|NCT01754909|12379044|FG000|STARTED|Overall Study||20
11189664|NCT01754909|12379045|FG001|STARTED|Overall Study||23
11189665|NCT01754909|12379044|FG000|COMPLETED|Overall Study||20
11189666|NCT01754909|12379045|FG001|COMPLETED|Overall Study||23
11189667|NCT01754909|12379044|FG000|NOT COMPLETED|Overall Study||0
11189668|NCT01754909|12379045|FG001|NOT COMPLETED|Overall Study||0
11189669|NCT01754922|12379053|FG000|STARTED|Overall Study||32
11189670|NCT01754922|12379054|FG001|STARTED|Overall Study||18
11189671|NCT01754922|12379053|FG000|COMPLETED|Overall Study||32
11189672|NCT01754922|12379054|FG001|COMPLETED|Overall Study||17
11189673|NCT01754922|12379053|FG000|NOT COMPLETED|Overall Study||0
11189674|NCT01754922|12379054|FG001|NOT COMPLETED|Overall Study||1
11189675|NCT01755026|12379063|FG000|STARTED|Overall Study||11
11189676|NCT01755026|12379064|FG001|STARTED|Overall Study||12
11189677|NCT01755026|12379063|FG000|COMPLETED|Overall Study||9
11189678|NCT01755026|12379064|FG001|COMPLETED|Overall Study||11
11189679|NCT01755026|12379063|FG000|NOT COMPLETED|Overall Study||2
11324479|NCT02743936|12521763|FG000|STARTED|Overall Study||32
11189680|NCT01755026|12379064|FG001|NOT COMPLETED|Overall Study||1
11189681|NCT01755091|12379073|FG000|STARTED|Overall Study||26
11189682|NCT01755091|12379074|FG001|STARTED|Overall Study||22
11189683|NCT01755091|12379075|FG002|STARTED|Overall Study||27
11189684|NCT01755091|12379073|FG000|COMPLETED|Overall Study||17
11189685|NCT01755091|12379074|FG001|COMPLETED|Overall Study||19
11189686|NCT01755091|12379075|FG002|COMPLETED|Overall Study||20
11189687|NCT01755091|12379073|FG000|NOT COMPLETED|Overall Study||9
11189688|NCT01755091|12379074|FG001|NOT COMPLETED|Overall Study||3
11189689|NCT01755091|12379075|FG002|NOT COMPLETED|Overall Study||7
11189690|NCT01755143|12379085|FG000|STARTED|Overall Study||177
11189691|NCT01755143|12379086|FG001|STARTED|Overall Study||89
11189692|NCT01755143|12379085|FG000|COMPLETED|Overall Study||166
11189693|NCT01755143|12379086|FG001|COMPLETED|Overall Study||86
11189694|NCT01755143|12379085|FG000|NOT COMPLETED|Overall Study||11
11189695|NCT01755143|12379086|FG001|NOT COMPLETED|Overall Study||3
11189696|NCT01755156|12379094|FG000|STARTED|Phase A (Weeks 0-24)||201
11189697|NCT01755156|12379095|FG001|STARTED|Phase A (Weeks 0-24)||201
11189698|NCT01755156|12379094|FG000|COMPLETED|Phase A (Weeks 0-24)||184
11189699|NCT01755156|12379095|FG001|COMPLETED|Phase A (Weeks 0-24)||177
11189700|NCT01755156|12379094|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||17
11189701|NCT01755156|12379095|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||24
11189702|NCT01755156|12379094|FG000|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
11189703|NCT01755156|12379095|FG001|STARTED|Phase B (Weeks 24-104)||177
11189704|NCT01755156|12379094|FG000|COMPLETED|Phase B (Weeks 24-104)||144
11189705|NCT01755156|12379095|FG001|COMPLETED|Phase B (Weeks 24-104)||141
11189706|NCT01755156|12379094|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||39
11189707|NCT01755156|12379095|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||36
11189708|NCT01755169|12379109|FG000|STARTED|Overall Study||2
11189709|NCT01755169|12379110|FG001|STARTED|Overall Study||1
11189710|NCT01755169|12379111|FG002|STARTED|Overall Study||0
11189711|NCT01755169|12379112|FG003|STARTED|Overall Study||1
11189712|NCT01755169|12379109|FG000|COMPLETED|Overall Study||2
11189713|NCT01755169|12379110|FG001|COMPLETED|Overall Study||1
11189714|NCT01755169|12379111|FG002|COMPLETED|Overall Study||0
11189715|NCT01755169|12379112|FG003|COMPLETED|Overall Study||1
11189716|NCT01755169|12379109|FG000|NOT COMPLETED|Overall Study||0
11189717|NCT01755169|12379110|FG001|NOT COMPLETED|Overall Study||0
11189718|NCT01755169|12379111|FG002|NOT COMPLETED|Overall Study||0
11189719|NCT01755169|12379112|FG003|NOT COMPLETED|Overall Study||0
11204705|NCT01854827|12395320|FG000|NOT COMPLETED|Overall Study||1
11204706|NCT01854879|12395324|FG000|STARTED|Overall Study|97 consented|97
11204707|NCT01854879|12395324|FG000|COMPLETED|Overall Study|92 had matched endpoint data|92
11204708|NCT01854879|12395324|FG000|NOT COMPLETED|Overall Study||5
11204709|NCT01854905|12395328|FG000|STARTED|Overall Study||400
11204710|NCT01854905|12395328|FG000|COMPLETED|Overall Study||400
11204711|NCT01854905|12395328|FG000|NOT COMPLETED|Overall Study||0
11204712|NCT01854918|12395334|FG000|STARTED|SOC-controlled Period (Year 1)||1227
11204713|NCT01854918|12395335|FG001|STARTED|SOC-controlled Period (Year 1)||2454
11204714|NCT01854918|12395334|FG000|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5
11204715|NCT01854918|12395335|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||2452
11204716|NCT01854918|12395334|FG000|COMPLETED|SOC-controlled Period (Year 1)||1197
11204717|NCT01854918|12395335|FG001|COMPLETED|SOC-controlled Period (Year 1)||2391
11204718|NCT01854918|12395334|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||30
11204719|NCT01854918|12395335|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||63
11204720|NCT01854918|12395334|FG000|STARTED|All-IP Period (Years 2 and 3)||1197
11204721|NCT01854918|12395335|FG001|STARTED|All-IP Period (Years 2 and 3)||2391
11204722|NCT01854918|12395334|FG000|Received Evolocumab|All-IP Period (Years 2 and 3)||1152
11204723|NCT01854918|12395335|FG001|Received Evolocumab|All-IP Period (Years 2 and 3)||2291
11204724|NCT01854918|12395334|FG000|COMPLETED|All-IP Period (Years 2 and 3)||1079
11204725|NCT01854918|12395335|FG001|COMPLETED|All-IP Period (Years 2 and 3)||2196
11204726|NCT01854918|12395334|FG000|NOT COMPLETED|All-IP Period (Years 2 and 3)||118
11204727|NCT01854918|12395335|FG001|NOT COMPLETED|All-IP Period (Years 2 and 3)||195
11204728|NCT01854944|12395351|FG000|STARTED|Overall Study||4
11204729|NCT01854944|12395352|FG001|STARTED|Overall Study||4
11204730|NCT01854944|12395353|FG002|STARTED|Overall Study||4
11204731|NCT01854944|12395351|FG000|COMPLETED|Overall Study||4
11204732|NCT01854944|12395352|FG001|COMPLETED|Overall Study||4
11204733|NCT01854944|12395353|FG002|COMPLETED|Overall Study||3
11204734|NCT01854944|12395351|FG000|NOT COMPLETED|Overall Study||0
11204735|NCT01854944|12395352|FG001|NOT COMPLETED|Overall Study||0
11204736|NCT01854944|12395353|FG002|NOT COMPLETED|Overall Study||1
11204737|NCT01855048|12395381|FG000|STARTED|Overall Study||9
11204738|NCT01855048|12395382|FG001|STARTED|Overall Study||3
11204739|NCT01855048|12395383|FG002|STARTED|Overall Study||6
11204740|NCT01855048|12395384|FG003|STARTED|Overall Study||6
11204741|NCT01855048|12395385|FG004|STARTED|Overall Study||6
11204742|NCT01855048|12395386|FG005|STARTED|Overall Study||6
11204743|NCT01855048|12395381|FG000|COMPLETED|Overall Study||9
11189720|NCT01755195|12379122|FG000|STARTED|Overall Study||55
11189721|NCT01755195|12379122|FG000|COMPLETED|Overall Study||42
11189722|NCT01755195|12379122|FG000|NOT COMPLETED|Overall Study||13
11189723|NCT01755234|12379128|FG000|STARTED|Overall Study||45
11189724|NCT01755234|12379129|FG001|STARTED|Overall Study||45
11189725|NCT01755234|12379128|FG000|COMPLETED|Overall Study||30
11189726|NCT01755234|12379129|FG001|COMPLETED|Overall Study||37
11189727|NCT01755234|12379128|FG000|NOT COMPLETED|Overall Study||15
11189728|NCT01755234|12379129|FG001|NOT COMPLETED|Overall Study||8
11189729|NCT01755416|12379135|FG000|STARTED|First Intervention ( Upto 2 Days)||9
11189730|NCT01755416|12379136|FG001|STARTED|First Intervention ( Upto 2 Days)||9
11189731|NCT01755416|12379135|FG000|COMPLETED|First Intervention ( Upto 2 Days)||8
11189732|NCT01755416|12379136|FG001|COMPLETED|First Intervention ( Upto 2 Days)||7
11026991|NCT00831428|12205638|FG000|STARTED|Overall Study||97
11026992|NCT00831428|12205638|FG000|COMPLETED|Overall Study||97
11026993|NCT00831428|12205638|FG000|NOT COMPLETED|Overall Study||0
11026994|NCT00831441|12205644|FG000|STARTED|Randomized||3687
11026995|NCT00831441|12205645|FG001|STARTED|Randomized||3705
11026996|NCT00831441|12205644|FG000|Treated|Randomized||3643
11026997|NCT00831441|12205645|FG001|Treated|Randomized||3672
11026998|NCT00831441|12205644|FG000|COMPLETED|Randomized||0
11026999|NCT00831441|12205645|FG001|COMPLETED|Randomized||0
11189733|NCT01755416|12379135|FG000|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
11189734|NCT01755416|12379136|FG001|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
11189735|NCT01755416|12379135|FG000|STARTED|Second Intervention (Upto 2 Days)||8
11189736|NCT01755416|12379136|FG001|STARTED|Second Intervention (Upto 2 Days)||7
11189737|NCT01755416|12379135|FG000|COMPLETED|Second Intervention (Upto 2 Days)||8
11189738|NCT01755416|12379136|FG001|COMPLETED|Second Intervention (Upto 2 Days)||7
11189739|NCT01755416|12379135|FG000|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
11189740|NCT01755416|12379136|FG001|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
11189741|NCT01755455|12379142|FG000|STARTED|First Intervention (6 Weeks)||11
11189742|NCT01755455|12379143|FG001|STARTED|First Intervention (6 Weeks)||11
11189743|NCT01755455|12379142|FG000|COMPLETED|First Intervention (6 Weeks)||11
11189744|NCT01755455|12379143|FG001|COMPLETED|First Intervention (6 Weeks)||11
11189745|NCT01755455|12379142|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
11189746|NCT01755455|12379143|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
11189747|NCT01755455|12379142|FG000|STARTED|Washout (4 Weeks)||11
11189748|NCT01755455|12379143|FG001|STARTED|Washout (4 Weeks)||11
11189749|NCT01755455|12379142|FG000|COMPLETED|Washout (4 Weeks)||11
11189750|NCT01755455|12379143|FG001|COMPLETED|Washout (4 Weeks)||11
11189751|NCT01755455|12379142|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11189752|NCT01755455|12379143|FG001|NOT COMPLETED|Washout (4 Weeks)||0
11189753|NCT01755455|12379142|FG000|STARTED|Second Intervention (6 Weeks)||11
11189754|NCT01755455|12379143|FG001|STARTED|Second Intervention (6 Weeks)||11
11189755|NCT01755455|12379142|FG000|COMPLETED|Second Intervention (6 Weeks)||11
11189756|NCT01755455|12379143|FG001|COMPLETED|Second Intervention (6 Weeks)||11
11189757|NCT01755455|12379142|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
11189758|NCT01755455|12379143|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
11189759|NCT01755546|12379149|FG000|STARTED|Screened and Taper (Rollover and DeNovo)||304
11189760|NCT01755546|12379149|FG000|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
11189761|NCT01755546|12379149|FG000|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
11189762|NCT01755546|12379149|FG000|STARTED|Titration Phase||294
11189763|NCT01755546|12379149|FG000|COMPLETED|Titration Phase||224
11189764|NCT01755546|12379149|FG000|NOT COMPLETED|Titration Phase||70
11189765|NCT01755546|12379149|FG000|STARTED|Long Term Treatment||224
11189766|NCT01755546|12379149|FG000|COMPLETED|Long Term Treatment||103
11189767|NCT01755546|12379149|FG000|NOT COMPLETED|Long Term Treatment||121
11189768|NCT01755598|12379155|FG000|STARTED|Overall Study||1786
11189769|NCT01755598|12379156|FG001|STARTED|Overall Study||1787
11189770|NCT01755598|12379155|FG000|COMPLETED|Overall Study||1521
11189771|NCT01755598|12379156|FG001|COMPLETED|Overall Study||1504
11189772|NCT01755598|12379155|FG000|NOT COMPLETED|Overall Study||265
11189773|NCT01755598|12379156|FG001|NOT COMPLETED|Overall Study||283
11189774|NCT01755637|12379162|FG000|STARTED|Period 1||28
11189775|NCT01755637|12379163|FG001|STARTED|Period 1||28
11189776|NCT01755637|12379162|FG000|COMPLETED|Period 1||28
11189777|NCT01755637|12379163|FG001|COMPLETED|Period 1||27
11189778|NCT01755637|12379162|FG000|NOT COMPLETED|Period 1||0
11189779|NCT01755637|12379163|FG001|NOT COMPLETED|Period 1||1
11189780|NCT01755637|12379162|FG000|STARTED|Period 2||28
11189781|NCT01755637|12379163|FG001|STARTED|Period 2||27
11189782|NCT01755637|12379162|FG000|COMPLETED|Period 2||28
11189783|NCT01755637|12379163|FG001|COMPLETED|Period 2||27
11189784|NCT01755637|12379162|FG000|NOT COMPLETED|Period 2||0
11189785|NCT01755637|12379163|FG001|NOT COMPLETED|Period 2||0
11189786|NCT01755702|12379175|FG000|STARTED|Period I||66
11189787|NCT01755702|12379175|FG000|Received Paracetamol|Period I||16
11189788|NCT01755702|12379175|FG000|Received Placebo|Period I||17
11189789|NCT01755702|12379175|FG000|Received Ibuprofen|Period I||16
11189790|NCT01755702|12379175|FG000|Received Paracetamol/Caffeine|Period I||17
11189791|NCT01755702|12379175|FG000|COMPLETED|Period I||66
11189792|NCT01755702|12379175|FG000|NOT COMPLETED|Period I||0
11189793|NCT01755702|12379175|FG000|STARTED|Wash Out Period I||66
11189794|NCT01755702|12379175|FG000|COMPLETED|Wash Out Period I||63
11189795|NCT01755702|12379175|FG000|NOT COMPLETED|Wash Out Period I||3
11189796|NCT01755702|12379175|FG000|STARTED|Period II||63
11189797|NCT01755702|12379175|FG000|Received Ibuprofen|Period II||11
11189798|NCT01755702|12379175|FG000|Received Placebo|Period II||15
11189799|NCT01755702|12379175|FG000|Received Paracetamol/Caffeine|Period II||20
11189800|NCT01755702|12379175|FG000|Received Paracetamol|Period II||17
11189801|NCT01755702|12379175|FG000|COMPLETED|Period II||63
11189802|NCT01755702|12379175|FG000|NOT COMPLETED|Period II||0
11189803|NCT01755702|12379175|FG000|STARTED|Washout Period II||63
11189804|NCT01755702|12379175|FG000|COMPLETED|Washout Period II||58
11189805|NCT01755702|12379175|FG000|NOT COMPLETED|Washout Period II||5
11189806|NCT01755702|12379175|FG000|STARTED|Period III||58
11189807|NCT01755702|12379175|FG000|Received Paracetamol|Period III||17
11189808|NCT01755702|12379175|FG000|Received Placebo|Period III||13
11189809|NCT01755702|12379175|FG000|Received Paracetamol/Caffeine|Period III||10
11189810|NCT01755702|12379175|FG000|Received Ibuprofen|Period III||18
11189811|NCT01755702|12379175|FG000|COMPLETED|Period III||58
11189812|NCT01755702|12379175|FG000|NOT COMPLETED|Period III||0
11189813|NCT01755767|12379189|FG000|STARTED|Overall Study||28
11189814|NCT01755767|12379190|FG001|STARTED|Overall Study||15
11189815|NCT01755767|12379191|FG002|STARTED|Overall Study||226
11189816|NCT01755767|12379192|FG003|STARTED|Overall Study||114
11189817|NCT01755767|12379189|FG000|COMPLETED|Overall Study||0
11189818|NCT01755767|12379190|FG001|COMPLETED|Overall Study||0
11189819|NCT01755767|12379191|FG002|COMPLETED|Overall Study||0
11189820|NCT01755767|12379192|FG003|COMPLETED|Overall Study||0
11189821|NCT01755767|12379189|FG000|NOT COMPLETED|Overall Study||28
11189822|NCT01755767|12379190|FG001|NOT COMPLETED|Overall Study||15
11189823|NCT01755767|12379191|FG002|NOT COMPLETED|Overall Study||226
11189824|NCT01755767|12379192|FG003|NOT COMPLETED|Overall Study||114
11189825|NCT01755858|12379204|FG000|STARTED|Overall Study||7
11189826|NCT01755858|12379205|FG001|STARTED|Overall Study||9
11189827|NCT01755858|12379204|FG000|COMPLETED|Overall Study||6
11189828|NCT01755858|12379205|FG001|COMPLETED|Overall Study||8
11189829|NCT01755858|12379204|FG000|NOT COMPLETED|Overall Study||1
11189830|NCT01755858|12379205|FG001|NOT COMPLETED|Overall Study||1
11189831|NCT01755949|12379219|FG000|STARTED|Overall Study||5
11189832|NCT01755949|12379220|FG001|STARTED|Overall Study||5
11189833|NCT01755949|12379221|FG002|STARTED|Overall Study||4
11189834|NCT01755949|12379222|FG003|STARTED|Overall Study||5
11189835|NCT01755949|12379223|FG004|STARTED|Overall Study||4
11189836|NCT01755949|12379224|FG005|STARTED|Overall Study||3
11189837|NCT01755949|12379219|FG000|COMPLETED|Overall Study||5
11189838|NCT01755949|12379220|FG001|COMPLETED|Overall Study||5
11189839|NCT01755949|12379221|FG002|COMPLETED|Overall Study||4
11189840|NCT01755949|12379222|FG003|COMPLETED|Overall Study||5
11189841|NCT01755949|12379223|FG004|COMPLETED|Overall Study||4
11189842|NCT01755949|12379224|FG005|COMPLETED|Overall Study||3
11189843|NCT01755949|12379219|FG000|NOT COMPLETED|Overall Study||0
11189844|NCT01755949|12379220|FG001|NOT COMPLETED|Overall Study||0
11189845|NCT01755949|12379221|FG002|NOT COMPLETED|Overall Study||0
11189846|NCT01755949|12379222|FG003|NOT COMPLETED|Overall Study||0
11189847|NCT01755949|12379223|FG004|NOT COMPLETED|Overall Study||0
11189848|NCT01755949|12379224|FG005|NOT COMPLETED|Overall Study||0
11189849|NCT01756053|12379238|FG000|STARTED|Period 1 (10 Days)||8
11189850|NCT01756053|12379239|FG001|STARTED|Period 1 (10 Days)||9
11189851|NCT01756053|12379238|FG000|COMPLETED|Period 1 (10 Days)||7
11189852|NCT01756053|12379239|FG001|COMPLETED|Period 1 (10 Days)||8
11189853|NCT01756053|12379238|FG000|NOT COMPLETED|Period 1 (10 Days)||1
11189854|NCT01756053|12379239|FG001|NOT COMPLETED|Period 1 (10 Days)||1
11189855|NCT01756053|12379238|FG000|STARTED|Washout Period (~21 Days)||7
11189856|NCT01756053|12379239|FG001|STARTED|Washout Period (~21 Days)||8
11189857|NCT01756053|12379238|FG000|COMPLETED|Washout Period (~21 Days)||7
11189858|NCT01756053|12379239|FG001|COMPLETED|Washout Period (~21 Days)||8
11189859|NCT01756053|12379238|FG000|NOT COMPLETED|Washout Period (~21 Days)||0
11189860|NCT01756053|12379239|FG001|NOT COMPLETED|Washout Period (~21 Days)||0
11189861|NCT01756053|12379238|FG000|STARTED|Period 2 (10 Days)||7
11189862|NCT01756053|12379239|FG001|STARTED|Period 2 (10 Days)||8
11189863|NCT01756053|12379238|FG000|COMPLETED|Period 2 (10 Days)||7
11189864|NCT01756053|12379239|FG001|COMPLETED|Period 2 (10 Days)||6
11189865|NCT01756053|12379238|FG000|NOT COMPLETED|Period 2 (10 Days)||0
11189866|NCT01756053|12379239|FG001|NOT COMPLETED|Period 2 (10 Days)||2
11189867|NCT01756079|12379245|FG000|STARTED|Lead-in: Day 0 to Week 4||58
11189868|NCT01756079|12379245|FG000|COMPLETED|Lead-in: Day 0 to Week 4||58
11189869|NCT01756079|12379245|FG000|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
11189870|NCT01756079|12379245|FG000|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
11189871|NCT01756079|12379245|FG000|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
11189872|NCT01756079|12379245|FG000|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
11189873|NCT01756079|12379245|FG000|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
11189874|NCT01756157|12379250|FG000|STARTED|First Intervention Period||23
11189875|NCT01756157|12379251|FG001|STARTED|First Intervention Period||24
11189876|NCT01756157|12379250|FG000|COMPLETED|First Intervention Period||22
11189877|NCT01756157|12379251|FG001|COMPLETED|First Intervention Period||22
11189878|NCT01756157|12379250|FG000|NOT COMPLETED|First Intervention Period||1
11189879|NCT01756157|12379251|FG001|NOT COMPLETED|First Intervention Period||2
11189880|NCT01756157|12379250|FG000|STARTED|Washout Period (at Least 7 Days)||22
11189881|NCT01756157|12379251|FG001|STARTED|Washout Period (at Least 7 Days)||22
11189882|NCT01756157|12379250|FG000|COMPLETED|Washout Period (at Least 7 Days)||22
11189883|NCT01756157|12379251|FG001|COMPLETED|Washout Period (at Least 7 Days)||22
11189884|NCT01756157|12379250|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11189885|NCT01756157|12379251|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11189886|NCT01756157|12379250|FG000|STARTED|Second Intervention Period||22
11189887|NCT01756157|12379251|FG001|STARTED|Second Intervention Period||22
11189888|NCT01756157|12379250|FG000|COMPLETED|Second Intervention Period||22
11189889|NCT01756157|12379251|FG001|COMPLETED|Second Intervention Period||22
11189890|NCT01756157|12379250|FG000|NOT COMPLETED|Second Intervention Period||0
11189891|NCT01756157|12379251|FG001|NOT COMPLETED|Second Intervention Period||0
11189892|NCT01756209|12379261|FG000|STARTED|Overall Study||40
11189893|NCT01756209|12379262|FG001|STARTED|Overall Study||40
11189894|NCT01756209|12379263|FG002|STARTED|Overall Study||40
11189895|NCT01756209|12379264|FG003|STARTED|Overall Study||40
11189896|NCT01756209|12379261|FG000|COMPLETED|Overall Study||40
11189897|NCT01756209|12379262|FG001|COMPLETED|Overall Study||40
11189898|NCT01756209|12379263|FG002|COMPLETED|Overall Study||40
11189899|NCT01756209|12379264|FG003|COMPLETED|Overall Study||40
11189900|NCT01756209|12379261|FG000|NOT COMPLETED|Overall Study||0
11189901|NCT01756209|12379262|FG001|NOT COMPLETED|Overall Study||0
11189902|NCT01756209|12379263|FG002|NOT COMPLETED|Overall Study||0
11189903|NCT01756209|12379264|FG003|NOT COMPLETED|Overall Study||0
11189904|NCT01756235|12379274|FG000|STARTED|Overall Study||462
11189905|NCT01756235|12379274|FG000|COMPLETED|Overall Study||460
11189906|NCT01756235|12379274|FG000|NOT COMPLETED|Overall Study||2
11189907|NCT01756274|12379278|FG000|STARTED|Overall Study||162
11189908|NCT01756274|12379278|FG000|COMPLETED|Overall Study||159
11189909|NCT01756274|12379278|FG000|NOT COMPLETED|Overall Study||3
11189910|NCT01756300|12379283|FG000|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
11189911|NCT01756300|12379283|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
11189912|NCT01756300|12379283|FG000|NOT COMPLETED|Overall Study||2
11189913|NCT01756352|12379304|FG000|STARTED|Overall Study||13
11189914|NCT01756352|12379304|FG000|COMPLETED|Overall Study||12
11189915|NCT01756352|12379304|FG000|NOT COMPLETED|Overall Study||1
11189916|NCT01756391|12379308|FG000|STARTED|Overall Study||351
11189917|NCT01756391|12379308|FG000|COMPLETED|Overall Study||319
11189918|NCT01756391|12379308|FG000|NOT COMPLETED|Overall Study||32
11189919|NCT01756456|12379318|FG000|STARTED|Treatment Period: Phase I/II||7
11189920|NCT01756456|12379319|FG001|STARTED|Treatment Period: Phase I/II||7
11189921|NCT01756456|12379320|FG002|STARTED|Treatment Period: Phase I/II||4
11189922|NCT01756456|12379321|FG003|STARTED|Treatment Period: Phase I/II||52
11189923|NCT01756456|12379322|FG004|STARTED|Treatment Period: Phase I/II||52
11189924|NCT01756456|12379323|FG005|STARTED|Treatment Period: Phase I/II||52
11189925|NCT01756456|12379318|FG000|COMPLETED|Treatment Period: Phase I/II||6
11189926|NCT01756456|12379319|FG001|COMPLETED|Treatment Period: Phase I/II||6
11189927|NCT01756456|12379320|FG002|COMPLETED|Treatment Period: Phase I/II||2
11189928|NCT01756456|12379321|FG003|COMPLETED|Treatment Period: Phase I/II||45
11189929|NCT01756456|12379322|FG004|COMPLETED|Treatment Period: Phase I/II||39
11189930|NCT01756456|12379323|FG005|COMPLETED|Treatment Period: Phase I/II||48
11189931|NCT01756456|12379318|FG000|NOT COMPLETED|Treatment Period: Phase I/II||1
11189932|NCT01756456|12379319|FG001|NOT COMPLETED|Treatment Period: Phase I/II||1
11189933|NCT01756456|12379320|FG002|NOT COMPLETED|Treatment Period: Phase I/II||2
11189934|NCT01756456|12379321|FG003|NOT COMPLETED|Treatment Period: Phase I/II||7
11189935|NCT01756456|12379322|FG004|NOT COMPLETED|Treatment Period: Phase I/II||13
11189936|NCT01756456|12379323|FG005|NOT COMPLETED|Treatment Period: Phase I/II||4
11189937|NCT01756456|12379318|FG000|STARTED|Follow Up Period Phase I/II||6
11189938|NCT01756456|12379319|FG001|STARTED|Follow Up Period Phase I/II||6
11189939|NCT01756456|12379320|FG002|STARTED|Follow Up Period Phase I/II||2
11189940|NCT01756456|12379321|FG003|STARTED|Follow Up Period Phase I/II||45
11189941|NCT01756456|12379322|FG004|STARTED|Follow Up Period Phase I/II||39
11189942|NCT01756456|12379323|FG005|STARTED|Follow Up Period Phase I/II||48
11189943|NCT01756456|12379318|FG000|COMPLETED|Follow Up Period Phase I/II||5
11189944|NCT01756456|12379319|FG001|COMPLETED|Follow Up Period Phase I/II||5
11189945|NCT01756456|12379320|FG002|COMPLETED|Follow Up Period Phase I/II||1
11189946|NCT01756456|12379321|FG003|COMPLETED|Follow Up Period Phase I/II||12
11189947|NCT01756456|12379322|FG004|COMPLETED|Follow Up Period Phase I/II||13
11189948|NCT01756456|12379323|FG005|COMPLETED|Follow Up Period Phase I/II||15
11189949|NCT01756456|12379318|FG000|NOT COMPLETED|Follow Up Period Phase I/II||1
11189950|NCT01756456|12379319|FG001|NOT COMPLETED|Follow Up Period Phase I/II||1
11189951|NCT01756456|12379320|FG002|NOT COMPLETED|Follow Up Period Phase I/II||1
11189952|NCT01756456|12379321|FG003|NOT COMPLETED|Follow Up Period Phase I/II||33
11189953|NCT01756456|12379322|FG004|NOT COMPLETED|Follow Up Period Phase I/II||26
11189954|NCT01756456|12379323|FG005|NOT COMPLETED|Follow Up Period Phase I/II||33
11189955|NCT01756833|12379348|FG000|STARTED|Overall Study||133
11189956|NCT01756833|12379349|FG001|STARTED|Overall Study||128
11189957|NCT01756833|12379348|FG000|COMPLETED|Overall Study||129
11189958|NCT01756833|12379349|FG001|COMPLETED|Overall Study||125
11189959|NCT01756833|12379348|FG000|NOT COMPLETED|Overall Study||4
11189960|NCT01756833|12379349|FG001|NOT COMPLETED|Overall Study||3
11189961|NCT01756846|12379357|FG000|STARTED|Overall Study||1833
11189962|NCT01756846|12379358|FG001|STARTED|Overall Study||1833
11189963|NCT01756846|12379357|FG000|COMPLETED|Overall Study||1827
11189964|NCT01756846|12379358|FG001|COMPLETED|Overall Study||1821
11189965|NCT01756846|12379357|FG000|NOT COMPLETED|Overall Study||6
11189966|NCT01756846|12379358|FG001|NOT COMPLETED|Overall Study||12
11189967|NCT01756885|12379366|FG000|STARTED|Overall Study||102
11189968|NCT01756885|12379367|FG001|STARTED|Overall Study||105
11189969|NCT01756885|12379366|FG000|COMPLETED|Overall Study||79
11189970|NCT01756885|12379367|FG001|COMPLETED|Overall Study||79
11189971|NCT01756885|12379366|FG000|NOT COMPLETED|Overall Study||23
11189972|NCT01756885|12379367|FG001|NOT COMPLETED|Overall Study||26
11189973|NCT01756898|12379377|FG000|STARTED|Overall Study||92
11189974|NCT01756898|12379378|FG001|STARTED|Overall Study||92
11189975|NCT01756898|12379379|FG002|STARTED|Overall Study||93
11189976|NCT01756898|12379380|FG003|STARTED|Overall Study||93
11189977|NCT01756898|12379377|FG000|COMPLETED|Overall Study||73
11189978|NCT01756898|12379378|FG001|COMPLETED|Overall Study||73
11189979|NCT01756898|12379379|FG002|COMPLETED|Overall Study||76
11189980|NCT01756898|12379380|FG003|COMPLETED|Overall Study||77
11189981|NCT01756898|12379377|FG000|NOT COMPLETED|Overall Study||19
11189982|NCT01756898|12379378|FG001|NOT COMPLETED|Overall Study||19
11189983|NCT01756898|12379379|FG002|NOT COMPLETED|Overall Study||17
11189984|NCT01756898|12379380|FG003|NOT COMPLETED|Overall Study||16
11189985|NCT01756976|12379395|FG000|STARTED|Overall Study||76
11189986|NCT01756976|12379396|FG001|STARTED|Overall Study||8
11189987|NCT01756976|12379395|FG000|COMPLETED|Overall Study||73
11189988|NCT01756976|12379396|FG001|COMPLETED|Overall Study||8
11189989|NCT01756976|12379395|FG000|NOT COMPLETED|Overall Study||3
11189990|NCT01756976|12379396|FG001|NOT COMPLETED|Overall Study||0
11189991|NCT01757067|12379404|FG000|STARTED|Overall Study||2
11189992|NCT01757067|12379405|FG001|STARTED|Overall Study|The study was closed due to low enrollment.|1
11189993|NCT01757067|12379404|FG000|COMPLETED|Overall Study|The study was closed due to low enrollment.|2
11189994|NCT01757067|12379405|FG001|COMPLETED|Overall Study|The study was closed due to low enrollment.|1
11189995|NCT01757067|12379404|FG000|NOT COMPLETED|Overall Study||0
11189996|NCT01757067|12379405|FG001|NOT COMPLETED|Overall Study||0
11189997|NCT01757171|12379413|FG000|STARTED|Overall Study||61
11189998|NCT01757171|12379414|FG001|STARTED|Overall Study||24
11189999|NCT01757171|12379413|FG000|COMPLETED|Overall Study||53
11190000|NCT01757171|12379414|FG001|COMPLETED|Overall Study||23
11190001|NCT01757171|12379413|FG000|NOT COMPLETED|Overall Study||8
11190002|NCT01757171|12379414|FG001|NOT COMPLETED|Overall Study||1
11190003|NCT01757184|12379422|FG000|STARTED|Double-blind Period||36
11190004|NCT01757184|12379423|FG001|STARTED|Double-blind Period||30
11190005|NCT01757184|12379424|FG002|STARTED|Double-blind Period||0
11190006|NCT01757184|12379425|FG003|STARTED|Double-blind Period||0
11190007|NCT01757184|12379422|FG000|Received at Least 1 Dose of Study Drug|Double-blind Period||36
11190008|NCT01757184|12379423|FG001|Received at Least 1 Dose of Study Drug|Double-blind Period||30
11190009|NCT01757184|12379424|FG002|Received at Least 1 Dose of Study Drug|Double-blind Period||0
11190010|NCT01757184|12379425|FG003|Received at Least 1 Dose of Study Drug|Double-blind Period||0
11190011|NCT01757184|12379422|FG000|COMPLETED|Double-blind Period||35
11190012|NCT01757184|12379423|FG001|COMPLETED|Double-blind Period||30
11190013|NCT01757184|12379424|FG002|COMPLETED|Double-blind Period||0
11190014|NCT01757184|12379425|FG003|COMPLETED|Double-blind Period||0
11190015|NCT01757184|12379422|FG000|NOT COMPLETED|Double-blind Period||1
11190016|NCT01757184|12379423|FG001|NOT COMPLETED|Double-blind Period||0
11190017|NCT01757184|12379424|FG002|NOT COMPLETED|Double-blind Period||0
11190018|NCT01757184|12379425|FG003|NOT COMPLETED|Double-blind Period||0
11190019|NCT01757184|12379422|FG000|STARTED|Open-label Period||0
11190020|NCT01757184|12379423|FG001|STARTED|Open-label Period||0
11190021|NCT01757184|12379424|FG002|STARTED|Open-label Period|1 participant who did not complete Double-blind Period due to AE rechallenged for Open-label Period|36
11190022|NCT01757184|12379425|FG003|STARTED|Open-label Period||30
11190023|NCT01757184|12379422|FG000|Received at Least 1 Dose of Study Drug|Open-label Period||0
11190024|NCT01757184|12379423|FG001|Received at Least 1 Dose of Study Drug|Open-label Period||0
11190025|NCT01757184|12379424|FG002|Received at Least 1 Dose of Study Drug|Open-label Period||36
11190026|NCT01757184|12379425|FG003|Received at Least 1 Dose of Study Drug|Open-label Period||30
11190027|NCT01757184|12379422|FG000|COMPLETED|Open-label Period||0
11190028|NCT01757184|12379423|FG001|COMPLETED|Open-label Period||0
11190029|NCT01757184|12379424|FG002|COMPLETED|Open-label Period||32
11190030|NCT01757184|12379425|FG003|COMPLETED|Open-label Period||27
11190031|NCT01757184|12379422|FG000|NOT COMPLETED|Open-label Period||0
11190032|NCT01757184|12379423|FG001|NOT COMPLETED|Open-label Period||0
11190033|NCT01757184|12379424|FG002|NOT COMPLETED|Open-label Period||4
11190034|NCT01757184|12379425|FG003|NOT COMPLETED|Open-label Period||3
11190035|NCT01757197|12379439|FG000|STARTED|Overall Study||2
11190036|NCT01757197|12379439|FG000|COMPLETED|Overall Study||0
11190037|NCT01757197|12379439|FG000|NOT COMPLETED|Overall Study||2
11190038|NCT01757275|12379445|FG000|STARTED|Overall Study||111
11190039|NCT01757275|12379446|FG001|STARTED|Overall Study||111
11190040|NCT01757275|12379445|FG000|COMPLETED|Overall Study||102
11190041|NCT01757275|12379446|FG001|COMPLETED|Overall Study||98
11190042|NCT01757275|12379445|FG000|NOT COMPLETED|Overall Study||9
11190043|NCT01757275|12379446|FG001|NOT COMPLETED|Overall Study||13
11190044|NCT01757288|12379455|FG000|STARTED|Overall Study||6
11190045|NCT01757288|12379456|FG001|STARTED|Overall Study||46
11190046|NCT01757288|12379457|FG002|STARTED|Overall Study||46
11190047|NCT01757288|12379455|FG000|COMPLETED|Overall Study||6
11190048|NCT01757288|12379456|FG001|COMPLETED|Overall Study||38
11190049|NCT01757288|12379457|FG002|COMPLETED|Overall Study||37
11190050|NCT01757288|12379455|FG000|NOT COMPLETED|Overall Study||0
11190051|NCT01757288|12379456|FG001|NOT COMPLETED|Overall Study||8
11190052|NCT01757288|12379457|FG002|NOT COMPLETED|Overall Study||9
11190053|NCT01757301|12379468|FG000|STARTED|Overall Study||147
11190054|NCT01757301|12379469|FG001|STARTED|Overall Study||147
11190055|NCT01757301|12379468|FG000|COMPLETED|Overall Study||134
11190056|NCT01757301|12379469|FG001|COMPLETED|Overall Study||133
11190057|NCT01757301|12379468|FG000|NOT COMPLETED|Overall Study||13
11190058|NCT01757301|12379469|FG001|NOT COMPLETED|Overall Study||14
11190059|NCT01757392|12379477|FG000|STARTED|Overall Study||39
11190060|NCT01757392|12379477|FG000|COMPLETED|Overall Study||35
11190061|NCT01757392|12379477|FG000|NOT COMPLETED|Overall Study||4
11190062|NCT01757405|12379483|FG000|STARTED|Overall Study||18
11190063|NCT01757405|12379484|FG001|STARTED|Overall Study||20
11190064|NCT01757405|12379483|FG000|COMPLETED|Overall Study||17
11190065|NCT01757405|12379484|FG001|COMPLETED|Overall Study||18
11190066|NCT01757405|12379483|FG000|NOT COMPLETED|Overall Study||1
11190067|NCT01757405|12379484|FG001|NOT COMPLETED|Overall Study||2
11190068|NCT01757561|12379494|FG000|STARTED|Overall Study||38
11190069|NCT01757561|12379495|FG001|STARTED|Overall Study||34
11190070|NCT01757561|12379496|FG002|STARTED|Overall Study||38
11190071|NCT01757561|12379497|FG003|STARTED|Overall Study||34
11190072|NCT01757561|12379494|FG000|COMPLETED|Overall Study||32
11190073|NCT01757561|12379495|FG001|COMPLETED|Overall Study||28
11190074|NCT01757561|12379496|FG002|COMPLETED|Overall Study||31
11190075|NCT01757561|12379497|FG003|COMPLETED|Overall Study||25
11190076|NCT01757561|12379494|FG000|NOT COMPLETED|Overall Study||6
11190077|NCT01757561|12379495|FG001|NOT COMPLETED|Overall Study||6
11190078|NCT01757561|12379496|FG002|NOT COMPLETED|Overall Study||7
11190079|NCT01757561|12379497|FG003|NOT COMPLETED|Overall Study||9
11190080|NCT01757678|12379507|FG000|STARTED|Overall Study||276
11190081|NCT01757678|12379507|FG000|COMPLETED|Overall Study||276
11190082|NCT01757678|12379507|FG000|NOT COMPLETED|Overall Study||0
11190083|NCT01757691|12379515|FG000|STARTED|Overall Study||2
11190084|NCT01757691|12379516|FG001|STARTED|Overall Study||0
11190085|NCT01757691|12379515|FG000|COMPLETED|Overall Study||0
11190086|NCT01757691|12379516|FG001|COMPLETED|Overall Study||0
11190087|NCT01757691|12379515|FG000|NOT COMPLETED|Overall Study||2
11190088|NCT01757691|12379516|FG001|NOT COMPLETED|Overall Study||0
11190089|NCT01757704|12379524|FG000|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
11190090|NCT01757704|12379525|FG001|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
11190091|NCT01757704|12379524|FG000|COMPLETED|Overall Study||10
11190092|NCT01757704|12379525|FG001|COMPLETED|Overall Study||10
11190093|NCT01757704|12379524|FG000|NOT COMPLETED|Overall Study||1
11190094|NCT01757704|12379525|FG001|NOT COMPLETED|Overall Study||3
11190095|NCT01757717|12379531|FG000|STARTED|Overall Study||3
11190096|NCT01757717|12379531|FG000|COMPLETED|Overall Study||3
11190097|NCT01757717|12379531|FG000|NOT COMPLETED|Overall Study||0
11190098|NCT01757821|12379535|FG000|STARTED|Overall Study|11 subjects|11
11190099|NCT01757821|12379535|FG000|COMPLETED|Overall Study|10 subjects|10
11190100|NCT01757821|12379535|FG000|NOT COMPLETED|Overall Study||1
11190101|NCT01757847|12379545|FG000|STARTED|Overall Study||44
11190102|NCT01757847|12379546|FG001|STARTED|Overall Study||46
11190103|NCT01757847|12379545|FG000|COMPLETED|Overall Study||41
11190104|NCT01757847|12379546|FG001|COMPLETED|Overall Study||42
11190105|NCT01757847|12379545|FG000|NOT COMPLETED|Overall Study||3
11190106|NCT01757847|12379546|FG001|NOT COMPLETED|Overall Study||4
11190107|NCT01757964|12379554|FG000|STARTED|Overall Study||9
11190108|NCT01757964|12379555|FG001|STARTED|Overall Study||4
11190109|NCT01757964|12379554|FG000|COMPLETED|Overall Study||9
11190110|NCT01757964|12379555|FG001|COMPLETED|Overall Study||4
11190111|NCT01757964|12379554|FG000|NOT COMPLETED|Overall Study||0
11190112|NCT01757964|12379555|FG001|NOT COMPLETED|Overall Study||0
11190113|NCT01758289|12379559|FG000|STARTED|Overall Study||105
11190114|NCT01758289|12379559|FG000|COMPLETED|Overall Study||52
11190115|NCT01758289|12379559|FG000|NOT COMPLETED|Overall Study||53
11190116|NCT01758432|12379574|FG000|STARTED|Overall Study||18
11190117|NCT01758432|12379575|FG001|STARTED|Overall Study||6
11190118|NCT01758432|12379576|FG002|STARTED|Overall Study||6
11190119|NCT01758432|12379577|FG003|STARTED|Overall Study||6
11190120|NCT01758432|12379578|FG004|STARTED|Overall Study||6
11190121|NCT01758432|12379579|FG005|STARTED|Overall Study||6
11190122|NCT01758432|12379580|FG006|STARTED|Overall Study||6
11190123|NCT01758432|12379574|FG000|COMPLETED|Overall Study||18
11190124|NCT01758432|12379575|FG001|COMPLETED|Overall Study||6
11190125|NCT01758432|12379576|FG002|COMPLETED|Overall Study||6
11190126|NCT01758432|12379577|FG003|COMPLETED|Overall Study||6
11190127|NCT01758432|12379578|FG004|COMPLETED|Overall Study||6
11190128|NCT01758432|12379579|FG005|COMPLETED|Overall Study||6
11190129|NCT01758432|12379580|FG006|COMPLETED|Overall Study||6
11190130|NCT01758432|12379574|FG000|NOT COMPLETED|Overall Study||0
11190131|NCT01758432|12379575|FG001|NOT COMPLETED|Overall Study||0
11190132|NCT01758432|12379576|FG002|NOT COMPLETED|Overall Study||0
11190133|NCT01758432|12379577|FG003|NOT COMPLETED|Overall Study||0
11190134|NCT01758432|12379578|FG004|NOT COMPLETED|Overall Study||0
11190135|NCT01758432|12379579|FG005|NOT COMPLETED|Overall Study||0
11190136|NCT01758432|12379580|FG006|NOT COMPLETED|Overall Study||0
11190137|NCT01758523|12379598|FG000|STARTED|Overall Study||74
11190138|NCT01758523|12379599|FG001|STARTED|Overall Study||68
11190139|NCT01758523|12379598|FG000|Attended >/= 1 Visit Post-randomization|Overall Study||68
11190140|NCT01758523|12379599|FG001|Attended >/= 1 Visit Post-randomization|Overall Study||67
11190141|NCT01758523|12379598|FG000|COMPLETED|Overall Study||53
11190142|NCT01758523|12379599|FG001|COMPLETED|Overall Study||54
11190143|NCT01758523|12379598|FG000|NOT COMPLETED|Overall Study||21
11190144|NCT01758523|12379599|FG001|NOT COMPLETED|Overall Study||14
11190145|NCT01758588|12379611|FG000|STARTED|Overall Study||5
11190146|NCT01758588|12379612|FG001|STARTED|Overall Study||3
11190147|NCT01758588|12379611|FG000|COMPLETED|Overall Study||5
11190148|NCT01758588|12379612|FG001|COMPLETED|Overall Study||3
11190149|NCT01758588|12379611|FG000|NOT COMPLETED|Overall Study||0
11190150|NCT01758588|12379612|FG001|NOT COMPLETED|Overall Study||0
11190151|NCT01758731|12379620|FG000|STARTED|Overall Study||17
11190152|NCT01758731|12379620|FG000|COMPLETED|Overall Study||16
11190153|NCT01758731|12379620|FG000|NOT COMPLETED|Overall Study||1
11190154|NCT01758900|12379626|FG000|STARTED|Overall Study||106
11190155|NCT01758900|12379627|FG001|STARTED|Overall Study||108
11190156|NCT01758900|12379626|FG000|COMPLETED|Overall Study||99
11190157|NCT01758900|12379627|FG001|COMPLETED|Overall Study||100
11190158|NCT01758900|12379626|FG000|NOT COMPLETED|Overall Study||7
11190159|NCT01758900|12379627|FG001|NOT COMPLETED|Overall Study||8
11190160|NCT01759160|12379635|FG000|STARTED|Overall Study||30
11190161|NCT01759160|12379636|FG001|STARTED|Overall Study||30
11190162|NCT01759160|12379635|FG000|COMPLETED|Overall Study||30
11190163|NCT01759160|12379636|FG001|COMPLETED|Overall Study||30
11190164|NCT01759160|12379635|FG000|NOT COMPLETED|Overall Study||0
11190165|NCT01759160|12379636|FG001|NOT COMPLETED|Overall Study||0
11190166|NCT01759251|12379642|FG000|STARTED|30 Days Treatment Period||309
11190167|NCT01759251|12379642|FG000|COMPLETED|30 Days Treatment Period||305
11190168|NCT01759251|12379642|FG000|NOT COMPLETED|30 Days Treatment Period||4
11190169|NCT01759251|12379642|FG000|STARTED|60 Days Treatment Period||305
11190170|NCT01759251|12379642|FG000|COMPLETED|60 Days Treatment Period||305
11190171|NCT01759251|12379642|FG000|NOT COMPLETED|60 Days Treatment Period||0
11190172|NCT01759251|12379642|FG000|STARTED|Follow-up Period||305
11190173|NCT01759251|12379642|FG000|COMPLETED|Follow-up Period||305
11190174|NCT01759251|12379642|FG000|NOT COMPLETED|Follow-up Period||0
11190175|NCT01759264|12379646|FG000|STARTED|Overall Study||101
11190176|NCT01759264|12379646|FG000|COMPLETED|Overall Study||91
11190177|NCT01759264|12379646|FG000|NOT COMPLETED|Overall Study||10
11190178|NCT01759277|12379653|FG000|STARTED|Overall Study||41
11190179|NCT01759277|12379654|FG001|STARTED|Overall Study||39
11190180|NCT01759277|12379653|FG000|COMPLETED|Overall Study||41
11190181|NCT01759277|12379654|FG001|COMPLETED|Overall Study||39
11190182|NCT01759277|12379653|FG000|NOT COMPLETED|Overall Study||0
11190183|NCT01759277|12379654|FG001|NOT COMPLETED|Overall Study||0
11190184|NCT01759290|12379662|FG000|STARTED|Overall Study||1800
11190185|NCT01759290|12379662|FG000|COMPLETED|Overall Study||1719
11190186|NCT01759290|12379662|FG000|NOT COMPLETED|Overall Study||81
11190187|NCT01759368|12379668|FG000|STARTED|Overall Study||47
11190188|NCT01759368|12379669|FG001|STARTED|Overall Study||47
11190189|NCT01759368|12379668|FG000|COMPLETED|Overall Study||46
11190190|NCT01759368|12379669|FG001|COMPLETED|Overall Study||47
11190191|NCT01759368|12379668|FG000|NOT COMPLETED|Overall Study||1
11190192|NCT01759368|12379669|FG001|NOT COMPLETED|Overall Study||0
11190193|NCT01759381|12379679|FG000|STARTED|Overall Study||8
11190194|NCT01759381|12379680|FG001|STARTED|Overall Study||11
11190195|NCT01759381|12379679|FG000|COMPLETED|Overall Study||7
11190196|NCT01759381|12379680|FG001|COMPLETED|Overall Study||11
11190197|NCT01759381|12379679|FG000|NOT COMPLETED|Overall Study||1
11190198|NCT01759381|12379680|FG001|NOT COMPLETED|Overall Study||0
11190199|NCT01759407|12379688|FG000|STARTED|Overall Study||10
11190200|NCT01759407|12379689|FG001|STARTED|Overall Study||9
11190201|NCT01759407|12379688|FG000|COMPLETED|Overall Study||10
11190202|NCT01759407|12379689|FG001|COMPLETED|Overall Study||7
11190203|NCT01759407|12379688|FG000|NOT COMPLETED|Overall Study||0
11190204|NCT01759407|12379689|FG001|NOT COMPLETED|Overall Study||2
11190205|NCT01759420|12379695|FG000|STARTED|Overall Study||28
11190206|NCT01759420|12379695|FG000|COMPLETED|Overall Study||22
11190207|NCT01759420|12379695|FG000|NOT COMPLETED|Overall Study||6
11190208|NCT01759446|12379704|FG000|STARTED|Overall Study||9
11190209|NCT01759446|12379705|FG001|STARTED|Overall Study||9
11190210|NCT01759446|12379706|FG002|STARTED|Overall Study||9
11190211|NCT01759446|12379707|FG003|STARTED|Overall Study||9
11190212|NCT01759446|12379708|FG004|STARTED|Overall Study||8
11190213|NCT01759446|12379704|FG000|COMPLETED|Overall Study||8
11190214|NCT01759446|12379705|FG001|COMPLETED|Overall Study||8
11190215|NCT01759446|12379706|FG002|COMPLETED|Overall Study||8
11190216|NCT01759446|12379707|FG003|COMPLETED|Overall Study||8
11190217|NCT01759446|12379708|FG004|COMPLETED|Overall Study||8
11190218|NCT01759446|12379704|FG000|NOT COMPLETED|Overall Study||1
11190219|NCT01759446|12379705|FG001|NOT COMPLETED|Overall Study||1
11190220|NCT01759446|12379706|FG002|NOT COMPLETED|Overall Study||1
11190221|NCT01759446|12379707|FG003|NOT COMPLETED|Overall Study||1
11190222|NCT01759446|12379708|FG004|NOT COMPLETED|Overall Study||0
11190223|NCT01759511|12379720|FG000|STARTED|Overall Study||34
11190224|NCT01759511|12379720|FG000|COMPLETED|Overall Study||0
11190225|NCT01759511|12379720|FG000|NOT COMPLETED|Overall Study||34
11190226|NCT01759602|12379724|FG000|STARTED|Overall Study||10
11190227|NCT01759602|12379724|FG000|COMPLETED|Overall Study||10
11190228|NCT01759602|12379724|FG000|NOT COMPLETED|Overall Study||0
11190229|NCT01759862|12379730|FG000|STARTED|Overall Study||23
11190230|NCT01759862|12379731|FG001|STARTED|Overall Study||27
11190231|NCT01759862|12379730|FG000|COMPLETED|Overall Study||20
11190232|NCT01759862|12379731|FG001|COMPLETED|Overall Study||25
11190233|NCT01759862|12379730|FG000|NOT COMPLETED|Overall Study||3
11190234|NCT01759862|12379731|FG001|NOT COMPLETED|Overall Study||2
11190235|NCT01760187|12379747|FG000|STARTED|Overall Study||20
11190236|NCT01760187|12379748|FG001|STARTED|Overall Study||12
11190237|NCT01760187|12379749|FG002|STARTED|Overall Study||12
11190238|NCT01760187|12379750|FG003|STARTED|Overall Study||12
11190239|NCT01760187|12379751|FG004|STARTED|Overall Study||16
11190240|NCT01760187|12379747|FG000|COMPLETED|Overall Study||19
11190241|NCT01760187|12379748|FG001|COMPLETED|Overall Study||12
11190242|NCT01760187|12379749|FG002|COMPLETED|Overall Study||12
11190243|NCT01760187|12379750|FG003|COMPLETED|Overall Study||10
11190244|NCT01760187|12379751|FG004|COMPLETED|Overall Study||16
11190245|NCT01760187|12379747|FG000|NOT COMPLETED|Overall Study||1
11190246|NCT01760187|12379748|FG001|NOT COMPLETED|Overall Study||0
11190247|NCT01760187|12379749|FG002|NOT COMPLETED|Overall Study||0
11190248|NCT01760187|12379750|FG003|NOT COMPLETED|Overall Study||2
11190249|NCT01760187|12379751|FG004|NOT COMPLETED|Overall Study||0
11190250|NCT01760239|12379773|FG000|STARTED|Overall Study||17037
11190251|NCT01760239|12379774|FG001|STARTED|Overall Study||14542
11190252|NCT01760239|12379773|FG000|COMPLETED|Overall Study||296
11190253|NCT01760239|12379774|FG001|COMPLETED|Overall Study||226
11190254|NCT01760239|12379773|FG000|NOT COMPLETED|Overall Study||16741
11190255|NCT01760239|12379774|FG001|NOT COMPLETED|Overall Study||14316
11190256|NCT01760304|12379783|FG000|STARTED|Overall Study||2
11190257|NCT01760304|12379784|FG001|STARTED|Overall Study||3
11190258|NCT01760304|12379783|FG000|COMPLETED|Overall Study||2
11190259|NCT01760304|12379784|FG001|COMPLETED|Overall Study||3
11190260|NCT01760304|12379783|FG000|NOT COMPLETED|Overall Study||0
11190261|NCT01760304|12379784|FG001|NOT COMPLETED|Overall Study||0
11190262|NCT01760473|12379794|FG000|STARTED|Overall Study||27
11190263|NCT01760473|12379794|FG000|COMPLETED|Overall Study||12
11190264|NCT01760473|12379794|FG000|NOT COMPLETED|Overall Study||15
11190265|NCT01760733|12379806|FG000|STARTED|Waiting List|All patients included started in the waiting list group.|289
11190266|NCT01760733|12379806|FG000|COMPLETED|Waiting List|217 patients have been transplanted|217
11190267|NCT01760733|12379806|FG000|NOT COMPLETED|Waiting List||72
11190268|NCT01760733|12379806|FG000|STARTED|Transplanted||217
11190269|NCT01760733|12379806|FG000|COMPLETED|Transplanted||0
11190270|NCT01760733|12379806|FG000|NOT COMPLETED|Transplanted||217
11190271|NCT01760785|12379813|FG000|STARTED|Overall Study||23
11190272|NCT01760785|12379814|FG001|STARTED|Overall Study||27
11190273|NCT01760785|12379813|FG000|COMPLETED|Overall Study||23
11190274|NCT01760785|12379814|FG001|COMPLETED|Overall Study||27
11190275|NCT01760785|12379813|FG000|NOT COMPLETED|Overall Study||0
11190276|NCT01760785|12379814|FG001|NOT COMPLETED|Overall Study||0
11190277|NCT01760876|12379820|FG000|STARTED|Overall Study||106
11190278|NCT01760876|12379820|FG000|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
11190279|NCT01760876|12379820|FG000|NOT COMPLETED|Overall Study||6
11190280|NCT01760954|12379828|FG000|STARTED|Treatment Period (6 Months)||149
11190281|NCT01760954|12379829|FG001|STARTED|Treatment Period (6 Months)||138
11190282|NCT01760954|12379830|FG002|STARTED|Treatment Period (6 Months)||108
11190283|NCT01760954|12379831|FG003|STARTED|Treatment Period (6 Months)||109
11190284|NCT01760954|12379828|FG000|COMPLETED|Treatment Period (6 Months)||116
11190285|NCT01760954|12379829|FG001|COMPLETED|Treatment Period (6 Months)||110
11190286|NCT01760954|12379830|FG002|COMPLETED|Treatment Period (6 Months)||87
11190287|NCT01760954|12379831|FG003|COMPLETED|Treatment Period (6 Months)||83
11190288|NCT01760954|12379828|FG000|NOT COMPLETED|Treatment Period (6 Months)||33
11190289|NCT01760954|12379829|FG001|NOT COMPLETED|Treatment Period (6 Months)||28
11190290|NCT01760954|12379830|FG002|NOT COMPLETED|Treatment Period (6 Months)||21
11190291|NCT01760954|12379831|FG003|NOT COMPLETED|Treatment Period (6 Months)||26
11190292|NCT01760954|12379828|FG000|STARTED|Post-treatment Follow-up (12 Months)||126
11190293|NCT01760954|12379829|FG001|STARTED|Post-treatment Follow-up (12 Months)||118
11190294|NCT01760954|12379830|FG002|STARTED|Post-treatment Follow-up (12 Months)||86
11190295|NCT01760954|12379831|FG003|STARTED|Post-treatment Follow-up (12 Months)||87
11190296|NCT01760954|12379828|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||96
11190297|NCT01760954|12379829|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||83
11190298|NCT01760954|12379830|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||65
11190299|NCT01760954|12379831|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||67
11190300|NCT01760954|12379828|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
11190301|NCT01760954|12379829|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
11190302|NCT01760954|12379830|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
11190303|NCT01760954|12379831|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
11190304|NCT01761019|12379841|FG000|STARTED|Overall Study||8
11190305|NCT01761019|12379841|FG000|COMPLETED|Overall Study||8
11190306|NCT01761019|12379841|FG000|NOT COMPLETED|Overall Study||0
11190307|NCT01761084|12379847|FG000|STARTED|Overall Study||71
11190308|NCT01761084|12379848|FG001|STARTED|Overall Study||70
11190309|NCT01761084|12379847|FG000|COMPLETED|Overall Study||66
11190310|NCT01761084|12379848|FG001|COMPLETED|Overall Study||64
11190311|NCT01761084|12379847|FG000|NOT COMPLETED|Overall Study||5
11190312|NCT01761084|12379848|FG001|NOT COMPLETED|Overall Study||6
11190313|NCT01761162|12379855|FG000|STARTED|Overall Study||229
11190314|NCT01761162|12379855|FG000|COMPLETED|Overall Study||226
11190315|NCT01761162|12379855|FG000|NOT COMPLETED|Overall Study||3
11190316|NCT01761175|12379861|FG000|STARTED|Overall Study||112
11190317|NCT01761175|12379862|FG001|STARTED|Overall Study||112
11190318|NCT01761175|12379861|FG000|COMPLETED|Overall Study||112
11190319|NCT01761175|12379862|FG001|COMPLETED|Overall Study||112
11190320|NCT01761175|12379861|FG000|NOT COMPLETED|Overall Study||0
11190321|NCT01761175|12379862|FG001|NOT COMPLETED|Overall Study||0
11190322|NCT01761279|12379869|FG000|STARTED|Overall Study||84
11190323|NCT01761279|12379869|FG000|COMPLETED|Overall Study||84
11190324|NCT01761279|12379869|FG000|NOT COMPLETED|Overall Study||0
11190325|NCT01761292|12379877|FG000|STARTED|Part 1||20
11190326|NCT01761292|12379877|FG000|Patients Receiving Drug in Part 1|Part 1|One patient was enrolled in Part 1 and started treatment in Part 2.|19
11190327|NCT01761292|12379877|FG000|COMPLETED|Part 1||18
11190328|NCT01761292|12379877|FG000|NOT COMPLETED|Part 1||2
11190329|NCT01761292|12379877|FG000|STARTED|Part 2|1 pt was enrolled in Part 1 but started the treatment in Part 2. So 19 pts started Part 2.|19
11190330|NCT01761292|12379877|FG000|COMPLETED|Part 2||19
11190331|NCT01761292|12379877|FG000|NOT COMPLETED|Part 2||0
11190332|NCT01761292|12379877|FG000|STARTED|Extension 1||19
11190333|NCT01761292|12379877|FG000|COMPLETED|Extension 1||18
11190334|NCT01761292|12379877|FG000|NOT COMPLETED|Extension 1||1
11190335|NCT01761292|12379877|FG000|STARTED|Extension 2||18
11190336|NCT01761292|12379877|FG000|COMPLETED|Extension 2||18
11190337|NCT01761292|12379877|FG000|NOT COMPLETED|Extension 2||0
11190338|NCT01761292|12379877|FG000|STARTED|Extension 3||18
11190339|NCT01761292|12379877|FG000|COMPLETED|Extension 3||18
11190340|NCT01761292|12379877|FG000|NOT COMPLETED|Extension 3||0
11190341|NCT01761565|12379888|FG000|STARTED|Single Dose of SUF NT 15 mcg||40
11190342|NCT01761565|12379888|FG000|COMPLETED|Single Dose of SUF NT 15 mcg||40
11190343|NCT01761565|12379888|FG000|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
11190344|NCT01761565|12379888|FG000|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
11190345|NCT01761565|12379888|FG000|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
11190346|NCT01761565|12379888|FG000|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
11190347|NCT01761643|12379898|FG000|STARTED|Overall Study||198
11190348|NCT01761643|12379899|FG001|STARTED|Overall Study||200
11190349|NCT01761643|12379898|FG000|COMPLETED|Overall Study||166
11190350|NCT01761643|12379899|FG001|COMPLETED|Overall Study||158
11190351|NCT01761643|12379898|FG000|NOT COMPLETED|Overall Study||32
11190352|NCT01761643|12379899|FG001|NOT COMPLETED|Overall Study||42
11190353|NCT01761747|12379905|FG000|STARTED|Overall Study||3
11190354|NCT01761747|12379905|FG000|COMPLETED|Overall Study||2
11190355|NCT01761747|12379905|FG000|NOT COMPLETED|Overall Study||1
11190356|NCT01762059|12379909|FG000|STARTED|Overall Study||20
11190357|NCT01762059|12379909|FG000|COMPLETED|Overall Study||20
11190358|NCT01762059|12379909|FG000|NOT COMPLETED|Overall Study||0
11190359|NCT01762345|12379918|FG000|STARTED|Overall Study||83
11190360|NCT01762345|12379918|FG000|COMPLETED|Overall Study||76
11190361|NCT01762345|12379918|FG000|NOT COMPLETED|Overall Study||7
11190362|NCT01762501|12379925|FG000|STARTED|Overall Study||359
11190363|NCT01762501|12379926|FG001|STARTED|Overall Study||359
11190364|NCT01762501|12379925|FG000|COMPLETED|Overall Study||332
11190365|NCT01762501|12379926|FG001|COMPLETED|Overall Study||336
11190366|NCT01762501|12379925|FG000|NOT COMPLETED|Overall Study||27
11190367|NCT01762501|12379926|FG001|NOT COMPLETED|Overall Study||23
11190368|NCT01762631|12379934|FG000|STARTED|Overall Study||53
11190369|NCT01762631|12379935|FG001|STARTED|Overall Study||22
11190370|NCT01762631|12379934|FG000|COMPLETED|Overall Study||53
11190371|NCT01762631|12379935|FG001|COMPLETED|Overall Study||22
11190372|NCT01762631|12379934|FG000|NOT COMPLETED|Overall Study||0
11190373|NCT01762631|12379935|FG001|NOT COMPLETED|Overall Study||0
11190374|NCT01762722|12379943|FG000|STARTED|Overall Study||12
11190375|NCT01762722|12379944|FG001|STARTED|Overall Study||11
11190376|NCT01762722|12379943|FG000|COMPLETED|Overall Study||12
11190377|NCT01762722|12379944|FG001|COMPLETED|Overall Study||11
11190378|NCT01762722|12379943|FG000|NOT COMPLETED|Overall Study||0
11190379|NCT01762722|12379944|FG001|NOT COMPLETED|Overall Study||0
11190380|NCT01762800|12379952|FG000|STARTED|Overall Study||202
11190381|NCT01762800|12379953|FG001|STARTED|Overall Study||204
11190382|NCT01762800|12379952|FG000|COMPLETED|Overall Study||183
11190383|NCT01762800|12379953|FG001|COMPLETED|Overall Study||183
11190384|NCT01762800|12379952|FG000|NOT COMPLETED|Overall Study||19
11190385|NCT01762800|12379953|FG001|NOT COMPLETED|Overall Study||21
11190386|NCT01762904|12379965|FG000|STARTED|Overall Study|January, 2013|135
11190387|NCT01762904|12379965|FG000|COMPLETED|Overall Study|October, 2013|135
11190388|NCT01762904|12379965|FG000|NOT COMPLETED|Overall Study||0
11190389|NCT01762943|12379974|FG000|STARTED|Overall Study||19
11190390|NCT01762943|12379975|FG001|STARTED|Overall Study||17
11190391|NCT01762943|12379974|FG000|Hypogonadism|Overall Study||18
11190392|NCT01762943|12379975|FG001|Hypogonadism|Overall Study||15
11190393|NCT01762943|12379974|FG000|Addback|Overall Study||16
11190394|NCT01762943|12379975|FG001|Addback|Overall Study||15
11190395|NCT01762943|12379974|FG000|Withdrawal|Overall Study||15
11190396|NCT01762943|12379975|FG001|Withdrawal|Overall Study||15
11190397|NCT01762943|12379974|FG000|COMPLETED|Overall Study||15
11190398|NCT01762943|12379975|FG001|COMPLETED|Overall Study||15
11190399|NCT01762943|12379974|FG000|NOT COMPLETED|Overall Study||4
11190400|NCT01762943|12379975|FG001|NOT COMPLETED|Overall Study||2
11190401|NCT01762982|12379981|FG000|STARTED|Overall Study||36
11190402|NCT01762982|12379981|FG000|Received Saline Water|Overall Study||36
11190403|NCT01762982|12379981|FG000|Received Benzalkonium Chloride|Overall Study||36
11190404|NCT01762982|12379981|FG000|Received SLS|Overall Study||36
11190405|NCT01762982|12379981|FG000|Received Empty Finn Chamber|Overall Study||36
11190406|NCT01762982|12379981|FG000|COMPLETED|Overall Study||36
11190407|NCT01762982|12379981|FG000|NOT COMPLETED|Overall Study||0
11190408|NCT01763047|12379991|FG000|STARTED|Period 1||139
11190409|NCT01763047|12379992|FG001|STARTED|Period 1||137
11190410|NCT01763047|12379991|FG000|Myopes|Period 1||77
11190411|NCT01763047|12379992|FG001|Myopes|Period 1||76
11190412|NCT01763047|12379991|FG000|Hyperopes|Period 1||62
11190413|NCT01763047|12379992|FG001|Hyperopes|Period 1||61
11190414|NCT01763047|12379991|FG000|COMPLETED|Period 1||130
11190415|NCT01763047|12379992|FG001|COMPLETED|Period 1||126
11190416|NCT01763047|12379991|FG000|NOT COMPLETED|Period 1||9
11190417|NCT01763047|12379992|FG001|NOT COMPLETED|Period 1||11
11190418|NCT01763047|12379991|FG000|STARTED|Period 2||130
11190419|NCT01763047|12379992|FG001|STARTED|Period 2||126
11190420|NCT01763047|12379991|FG000|Myopes|Period 2||74
11190421|NCT01763047|12379992|FG001|Myopes|Period 2||72
11190422|NCT01763047|12379991|FG000|Hyperopes|Period 2||56
11190423|NCT01763047|12379992|FG001|Hyperopes|Period 2||54
11190424|NCT01763047|12379991|FG000|COMPLETED|Period 2||126
11190425|NCT01763047|12379992|FG001|COMPLETED|Period 2||121
11190426|NCT01763047|12379991|FG000|NOT COMPLETED|Period 2||4
11190427|NCT01763047|12379992|FG001|NOT COMPLETED|Period 2||5
11190428|NCT01763164|12380003|FG000|STARTED|Treatment Phase||269
11190429|NCT01763164|12380004|FG001|STARTED|Treatment Phase||133
11190430|NCT01763164|12380003|FG000|Treated/Safety Set|Treatment Phase||269
11190431|NCT01763164|12380004|FG001|Treated/Safety Set|Treatment Phase||114
11190432|NCT01763164|12380003|FG000|Full Analysis Set|Treatment Phase||269
11190433|NCT01763164|12380004|FG001|Full Analysis Set|Treatment Phase||133
11190434|NCT01763164|12380003|FG000|COMPLETED|Treatment Phase||0
11190435|NCT01763164|12380004|FG001|COMPLETED|Treatment Phase||0
11190436|NCT01763164|12380003|FG000|NOT COMPLETED|Treatment Phase||269
11190437|NCT01763164|12380004|FG001|NOT COMPLETED|Treatment Phase||133
11190438|NCT01763164|12380003|FG000|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|200
11190439|NCT01763164|12380004|FG001|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|78
11190440|NCT01763164|12380003|FG000|COMPLETED|Follow up Phase||3
11190441|NCT01763164|12380004|FG001|COMPLETED|Follow up Phase||3
11190442|NCT01763164|12380003|FG000|NOT COMPLETED|Follow up Phase||197
11190443|NCT01763164|12380004|FG001|NOT COMPLETED|Follow up Phase||75
11190444|NCT01763203|12380012|FG000|STARTED|Overall Study||241
11190445|NCT01763203|12380013|FG001|STARTED|Overall Study||246
11190446|NCT01763203|12380012|FG000|COMPLETED|Overall Study||208
11190447|NCT01763203|12380013|FG001|COMPLETED|Overall Study||204
11190448|NCT01763203|12380012|FG000|NOT COMPLETED|Overall Study||33
11190449|NCT01763203|12380013|FG001|NOT COMPLETED|Overall Study||42
11190450|NCT01763333|12380033|FG000|STARTED|Overall Study||6
11190451|NCT01763333|12380034|FG001|STARTED|Overall Study||6
11190452|NCT01763333|12380035|FG002|STARTED|Overall Study||6
11190453|NCT01763333|12380036|FG003|STARTED|Overall Study||6
11190454|NCT01763333|12380037|FG004|STARTED|Overall Study||4
11190455|NCT01763333|12380038|FG005|STARTED|Overall Study||6
11190456|NCT01763333|12380039|FG006|STARTED|Overall Study||5
11190457|NCT01763333|12380040|FG007|STARTED|Overall Study||6
11190458|NCT01763333|12380041|FG008|STARTED|Overall Study||5
11190459|NCT01763333|12380042|FG009|STARTED|Overall Study||18
11190460|NCT01763333|12380043|FG010|STARTED|Overall Study||3
11190461|NCT01763333|12380044|FG011|STARTED|Overall Study||3
11190462|NCT01763333|12380045|FG012|STARTED|Overall Study||3
11190463|NCT01763333|12380046|FG013|STARTED|Overall Study||3
11190464|NCT01763333|12380033|FG000|COMPLETED|Overall Study||6
11190465|NCT01763333|12380034|FG001|COMPLETED|Overall Study||6
11190466|NCT01763333|12380035|FG002|COMPLETED|Overall Study||6
11190467|NCT01763333|12380036|FG003|COMPLETED|Overall Study||6
11190468|NCT01763333|12380037|FG004|COMPLETED|Overall Study||4
11190469|NCT01763333|12380038|FG005|COMPLETED|Overall Study||6
11190470|NCT01763333|12380039|FG006|COMPLETED|Overall Study||5
11190471|NCT01763333|12380040|FG007|COMPLETED|Overall Study||6
11190472|NCT01763333|12380041|FG008|COMPLETED|Overall Study||5
11190473|NCT01763333|12380042|FG009|COMPLETED|Overall Study||18
11190474|NCT01763333|12380043|FG010|COMPLETED|Overall Study||3
11190475|NCT01763333|12380044|FG011|COMPLETED|Overall Study||3
11190476|NCT01763333|12380045|FG012|COMPLETED|Overall Study||3
11190477|NCT01763333|12380046|FG013|COMPLETED|Overall Study||3
11190478|NCT01763333|12380033|FG000|NOT COMPLETED|Overall Study||0
11190479|NCT01763333|12380034|FG001|NOT COMPLETED|Overall Study||0
11190480|NCT01763333|12380035|FG002|NOT COMPLETED|Overall Study||0
11190481|NCT01763333|12380036|FG003|NOT COMPLETED|Overall Study||0
11190482|NCT01763333|12380037|FG004|NOT COMPLETED|Overall Study||0
11190483|NCT01763333|12380038|FG005|NOT COMPLETED|Overall Study||0
11190484|NCT01763333|12380039|FG006|NOT COMPLETED|Overall Study||0
11190485|NCT01763333|12380040|FG007|NOT COMPLETED|Overall Study||0
11190486|NCT01763333|12380041|FG008|NOT COMPLETED|Overall Study||0
11190487|NCT01763333|12380042|FG009|NOT COMPLETED|Overall Study||0
11190488|NCT01763333|12380043|FG010|NOT COMPLETED|Overall Study||0
11190489|NCT01763333|12380044|FG011|NOT COMPLETED|Overall Study||0
11190490|NCT01763333|12380045|FG012|NOT COMPLETED|Overall Study||0
11190491|NCT01763333|12380046|FG013|NOT COMPLETED|Overall Study||0
11190492|NCT01763346|12380082|FG000|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44
11190493|NCT01763346|12380083|FG001|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44
11190494|NCT01763346|12380082|FG000|Received Intervention|Overall Study||39
11190495|NCT01763346|12380083|FG001|Received Intervention|Overall Study||38
11190496|NCT01763346|12380082|FG000|COMPLETED|Overall Study||34
11190497|NCT01763346|12380083|FG001|COMPLETED|Overall Study||36
11190498|NCT01763346|12380082|FG000|NOT COMPLETED|Overall Study||10
11190499|NCT01763346|12380083|FG001|NOT COMPLETED|Overall Study||8
11190500|NCT01763567|12380089|FG000|STARTED|Overall Study||19
11190501|NCT01763567|12380089|FG000|COMPLETED|Overall Study||19
11190502|NCT01763567|12380089|FG000|NOT COMPLETED|Overall Study||0
11190503|NCT01763606|12380095|FG000|STARTED|Overall Study||10
11190504|NCT01763606|12380096|FG001|STARTED|Overall Study||10
11190505|NCT01763606|12380095|FG000|COMPLETED|Overall Study||10
11190506|NCT01763606|12380096|FG001|COMPLETED|Overall Study||10
11190507|NCT01763606|12380095|FG000|NOT COMPLETED|Overall Study||0
11190508|NCT01763606|12380096|FG001|NOT COMPLETED|Overall Study||0
11190509|NCT01763645|12380105|FG000|STARTED|Overall Study||69
11190510|NCT01763645|12380106|FG001|STARTED|Overall Study||69
11190511|NCT01763645|12380105|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
11190512|NCT01763645|12380106|FG001|Received at Least 1 Dose of Study Drug|Overall Study||66
11190513|NCT01763645|12380105|FG000|COMPLETED|Overall Study|Completed the study according the protocol.|43
11190514|NCT01763645|12380106|FG001|COMPLETED|Overall Study|Completed the study according the protocol.|45
11190515|NCT01763645|12380105|FG000|NOT COMPLETED|Overall Study||26
11190516|NCT01763645|12380106|FG001|NOT COMPLETED|Overall Study||24
11324480|NCT02743936|12521764|FG001|STARTED|Overall Study||32
11324481|NCT02743936|12521763|FG000|COMPLETED|Overall Study||32
11324482|NCT02743936|12521764|FG001|COMPLETED|Overall Study||32
11324483|NCT02743936|12521763|FG000|NOT COMPLETED|Overall Study||0
11190517|NCT01763684|12380115|FG000|STARTED|Overall Study||133
11190518|NCT01763684|12380116|FG001|STARTED|Overall Study||133
11190519|NCT01763684|12380115|FG000|Completed Surgery|Overall Study||126
11190520|NCT01763684|12380116|FG001|Completed Surgery|Overall Study||127
11190521|NCT01763684|12380115|FG000|COMPLETED|Overall Study||0
11190522|NCT01763684|12380116|FG001|COMPLETED|Overall Study||0
11190523|NCT01763684|12380115|FG000|NOT COMPLETED|Overall Study||133
11190524|NCT01763684|12380116|FG001|NOT COMPLETED|Overall Study||133
11190525|NCT01763827|12380128|FG000|STARTED|Overall Study||77
11190526|NCT01763827|12380129|FG001|STARTED|Overall Study||78
11190527|NCT01763827|12380130|FG002|STARTED|Overall Study||77
11190528|NCT01763827|12380131|FG003|STARTED|Overall Study||77
11190529|NCT01763827|12380132|FG004|STARTED|Overall Study||153
11190530|NCT01763827|12380133|FG005|STARTED|Overall Study||153
11190531|NCT01763827|12380128|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
11190532|NCT01763827|12380129|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78
11190533|NCT01763827|12380130|FG002|Received at Least 1 Dose of Study Drug|Overall Study||77
11190534|NCT01763827|12380131|FG003|Received at Least 1 Dose of Study Drug|Overall Study||77
11190535|NCT01763827|12380132|FG004|Received at Least 1 Dose of Study Drug|Overall Study||153
11190536|NCT01763827|12380133|FG005|Received at Least 1 Dose of Study Drug|Overall Study||153
11190537|NCT01763827|12380128|FG000|COMPLETED|Overall Study||74
11190538|NCT01763827|12380129|FG001|COMPLETED|Overall Study||77
11190539|NCT01763827|12380130|FG002|COMPLETED|Overall Study||73
11190540|NCT01763827|12380131|FG003|COMPLETED|Overall Study||76
11190541|NCT01763827|12380132|FG004|COMPLETED|Overall Study||147
11190542|NCT01763827|12380133|FG005|COMPLETED|Overall Study||151
11190543|NCT01763827|12380128|FG000|NOT COMPLETED|Overall Study||3
11190544|NCT01763827|12380129|FG001|NOT COMPLETED|Overall Study||1
11190545|NCT01763827|12380130|FG002|NOT COMPLETED|Overall Study||4
11190546|NCT01763827|12380131|FG003|NOT COMPLETED|Overall Study||1
11190547|NCT01763827|12380132|FG004|NOT COMPLETED|Overall Study||6
11190548|NCT01763827|12380133|FG005|NOT COMPLETED|Overall Study||2
11190549|NCT01763866|12380171|FG000|STARTED|Overall Study||56
11190550|NCT01763866|12380172|FG001|STARTED|Overall Study||55
11190551|NCT01763866|12380173|FG002|STARTED|Overall Study||56
11190552|NCT01763866|12380174|FG003|STARTED|Overall Study||55
11190553|NCT01763866|12380175|FG004|STARTED|Overall Study||110
11190554|NCT01763866|12380176|FG005|STARTED|Overall Study||110
11190555|NCT01763866|12380177|FG006|STARTED|Overall Study||55
11190556|NCT01763866|12380178|FG007|STARTED|Overall Study||55
11190557|NCT01763866|12380179|FG008|STARTED|Overall Study||56
11190558|NCT01763866|12380180|FG009|STARTED|Overall Study||54
11190559|NCT01763866|12380181|FG010|STARTED|Overall Study||110
11190560|NCT01763866|12380182|FG011|STARTED|Overall Study||110
11190561|NCT01763866|12380183|FG012|STARTED|Overall Study||58
11190562|NCT01763866|12380184|FG013|STARTED|Overall Study||57
11190563|NCT01763866|12380185|FG014|STARTED|Overall Study||114
11190564|NCT01763866|12380186|FG015|STARTED|Overall Study||115
11190565|NCT01763866|12380187|FG016|STARTED|Overall Study||56
11190566|NCT01763866|12380188|FG017|STARTED|Overall Study||56
11190567|NCT01763866|12380189|FG018|STARTED|Overall Study||111
11190568|NCT01763866|12380190|FG019|STARTED|Overall Study||112
11190569|NCT01763866|12380191|FG020|STARTED|Overall Study||56
11190570|NCT01763866|12380192|FG021|STARTED|Overall Study||55
11190571|NCT01763866|12380193|FG022|STARTED|Overall Study||112
11190572|NCT01763866|12380194|FG023|STARTED|Overall Study||115
11190573|NCT01763866|12380171|FG000|Received Treatment|Overall Study||56
11190574|NCT01763866|12380172|FG001|Received Treatment|Overall Study||55
11190575|NCT01763866|12380173|FG002|Received Treatment|Overall Study||56
11190576|NCT01763866|12380174|FG003|Received Treatment|Overall Study||55
11190577|NCT01763866|12380175|FG004|Received Treatment|Overall Study||110
11190578|NCT01763866|12380176|FG005|Received Treatment|Overall Study||110
11190579|NCT01763866|12380177|FG006|Received Treatment|Overall Study||55
11190580|NCT01763866|12380178|FG007|Received Treatment|Overall Study||55
11190581|NCT01763866|12380179|FG008|Received Treatment|Overall Study||56
11190582|NCT01763866|12380180|FG009|Received Treatment|Overall Study||54
11190583|NCT01763866|12380181|FG010|Received Treatment|Overall Study||109
11190584|NCT01763866|12380182|FG011|Received Treatment|Overall Study||110
11190585|NCT01763866|12380183|FG012|Received Treatment|Overall Study||58
11190586|NCT01763866|12380184|FG013|Received Treatment|Overall Study||57
11190587|NCT01763866|12380185|FG014|Received Treatment|Overall Study||113
11190588|NCT01763866|12380186|FG015|Received Treatment|Overall Study||115
11190589|NCT01763866|12380187|FG016|Received Treatment|Overall Study||56
11190590|NCT01763866|12380188|FG017|Received Treatment|Overall Study||55
11190591|NCT01763866|12380189|FG018|Received Treatment|Overall Study||111
11190592|NCT01763866|12380190|FG019|Received Treatment|Overall Study||112
11190593|NCT01763866|12380191|FG020|Received Treatment|Overall Study||56
11190594|NCT01763866|12380192|FG021|Received Treatment|Overall Study||55
11190595|NCT01763866|12380193|FG022|Received Treatment|Overall Study||112
11190596|NCT01763866|12380194|FG023|Received Treatment|Overall Study||115
11190597|NCT01763866|12380171|FG000|COMPLETED|Overall Study||54
11190598|NCT01763866|12380172|FG001|COMPLETED|Overall Study||54
11190599|NCT01763866|12380173|FG002|COMPLETED|Overall Study||51
11190600|NCT01763866|12380174|FG003|COMPLETED|Overall Study||55
11190601|NCT01763866|12380175|FG004|COMPLETED|Overall Study||108
11190602|NCT01763866|12380176|FG005|COMPLETED|Overall Study||107
11190603|NCT01763866|12380177|FG006|COMPLETED|Overall Study||48
11190604|NCT01763866|12380178|FG007|COMPLETED|Overall Study||55
11190605|NCT01763866|12380179|FG008|COMPLETED|Overall Study||53
11190606|NCT01763866|12380180|FG009|COMPLETED|Overall Study||53
11190607|NCT01763866|12380181|FG010|COMPLETED|Overall Study||102
11190608|NCT01763866|12380182|FG011|COMPLETED|Overall Study||108
11190609|NCT01763866|12380183|FG012|COMPLETED|Overall Study||54
11190610|NCT01763866|12380184|FG013|COMPLETED|Overall Study||57
11190611|NCT01763866|12380185|FG014|COMPLETED|Overall Study||102
11190612|NCT01763866|12380186|FG015|COMPLETED|Overall Study||112
11190613|NCT01763866|12380187|FG016|COMPLETED|Overall Study||55
11190614|NCT01763866|12380188|FG017|COMPLETED|Overall Study||55
11190615|NCT01763866|12380189|FG018|COMPLETED|Overall Study||105
11190616|NCT01763866|12380190|FG019|COMPLETED|Overall Study||110
11190617|NCT01763866|12380191|FG020|COMPLETED|Overall Study||52
11190618|NCT01763866|12380192|FG021|COMPLETED|Overall Study||54
11190619|NCT01763866|12380193|FG022|COMPLETED|Overall Study||109
11190620|NCT01763866|12380194|FG023|COMPLETED|Overall Study||113
11190621|NCT01763866|12380171|FG000|NOT COMPLETED|Overall Study||2
11190622|NCT01763866|12380172|FG001|NOT COMPLETED|Overall Study||1
11190623|NCT01763866|12380173|FG002|NOT COMPLETED|Overall Study||5
11190624|NCT01763866|12380174|FG003|NOT COMPLETED|Overall Study||0
11190625|NCT01763866|12380175|FG004|NOT COMPLETED|Overall Study||2
11190626|NCT01763866|12380176|FG005|NOT COMPLETED|Overall Study||3
11190627|NCT01763866|12380177|FG006|NOT COMPLETED|Overall Study||7
11190628|NCT01763866|12380178|FG007|NOT COMPLETED|Overall Study||0
11190629|NCT01763866|12380179|FG008|NOT COMPLETED|Overall Study||3
11190630|NCT01763866|12380180|FG009|NOT COMPLETED|Overall Study||1
11190631|NCT01763866|12380181|FG010|NOT COMPLETED|Overall Study||8
11190632|NCT01763866|12380182|FG011|NOT COMPLETED|Overall Study||2
11190633|NCT01763866|12380183|FG012|NOT COMPLETED|Overall Study||4
11190634|NCT01763866|12380184|FG013|NOT COMPLETED|Overall Study||0
11190635|NCT01763866|12380185|FG014|NOT COMPLETED|Overall Study||12
11190636|NCT01763866|12380186|FG015|NOT COMPLETED|Overall Study||3
11190637|NCT01763866|12380187|FG016|NOT COMPLETED|Overall Study||1
11190638|NCT01763866|12380188|FG017|NOT COMPLETED|Overall Study||1
11190639|NCT01763866|12380189|FG018|NOT COMPLETED|Overall Study||6
11190640|NCT01763866|12380190|FG019|NOT COMPLETED|Overall Study||2
11190641|NCT01763866|12380191|FG020|NOT COMPLETED|Overall Study||4
11190642|NCT01763866|12380192|FG021|NOT COMPLETED|Overall Study||1
11190643|NCT01763866|12380193|FG022|NOT COMPLETED|Overall Study||3
11190644|NCT01763866|12380194|FG023|NOT COMPLETED|Overall Study||2
11190645|NCT01763905|12380248|FG000|STARTED|Overall Study||51
11190646|NCT01763905|12380249|FG001|STARTED|Overall Study||51
11190647|NCT01763905|12380250|FG002|STARTED|Overall Study||103
11190648|NCT01763905|12380251|FG003|STARTED|Overall Study||102
11190649|NCT01763905|12380248|FG000|COMPLETED|Overall Study||45
11190650|NCT01763905|12380249|FG001|COMPLETED|Overall Study||50
11190651|NCT01763905|12380250|FG002|COMPLETED|Overall Study||94
11190652|NCT01763905|12380251|FG003|COMPLETED|Overall Study||101
11190653|NCT01763905|12380248|FG000|NOT COMPLETED|Overall Study||6
11190654|NCT01763905|12380249|FG001|NOT COMPLETED|Overall Study||1
11190655|NCT01763905|12380250|FG002|NOT COMPLETED|Overall Study||9
11190656|NCT01763905|12380251|FG003|NOT COMPLETED|Overall Study||1
11204744|NCT01855048|12395382|FG001|COMPLETED|Overall Study||2
11204745|NCT01855048|12395383|FG002|COMPLETED|Overall Study||6
11204746|NCT01855048|12395384|FG003|COMPLETED|Overall Study||6
11204747|NCT01855048|12395385|FG004|COMPLETED|Overall Study||5
11204748|NCT01855048|12395386|FG005|COMPLETED|Overall Study||6
11204749|NCT01855048|12395381|FG000|NOT COMPLETED|Overall Study||0
11204750|NCT01855048|12395382|FG001|NOT COMPLETED|Overall Study||1
11204751|NCT01855048|12395383|FG002|NOT COMPLETED|Overall Study||0
11204752|NCT01855048|12395384|FG003|NOT COMPLETED|Overall Study||0
11204753|NCT01855048|12395385|FG004|NOT COMPLETED|Overall Study||1
11190657|NCT01763918|12380265|FG000|STARTED|Overall Study||55
11190658|NCT01763918|12380266|FG001|STARTED|Overall Study||55
11190659|NCT01763918|12380267|FG002|STARTED|Overall Study||111
11190660|NCT01763918|12380268|FG003|STARTED|Overall Study||110
11190661|NCT01763918|12380265|FG000|Received Treatment|Overall Study||54
11190662|NCT01763918|12380266|FG001|Received Treatment|Overall Study||55
11190663|NCT01763918|12380267|FG002|Received Treatment|Overall Study||110
11190664|NCT01763918|12380268|FG003|Received Treatment|Overall Study||110
11190665|NCT01763918|12380265|FG000|COMPLETED|Overall Study||49
11190666|NCT01763918|12380266|FG001|COMPLETED|Overall Study||54
11190667|NCT01763918|12380267|FG002|COMPLETED|Overall Study||101
11190668|NCT01763918|12380268|FG003|COMPLETED|Overall Study||108
11190669|NCT01763918|12380265|FG000|NOT COMPLETED|Overall Study||6
11190670|NCT01763918|12380266|FG001|NOT COMPLETED|Overall Study||1
11190671|NCT01763918|12380267|FG002|NOT COMPLETED|Overall Study||10
11190672|NCT01763918|12380268|FG003|NOT COMPLETED|Overall Study||2
11190673|NCT01763931|12380280|FG000|STARTED|Overall Study||2
11190674|NCT01763931|12380281|FG001|STARTED|Overall Study||4
11190675|NCT01763931|12380280|FG000|COMPLETED|Overall Study||2
11190676|NCT01763931|12380281|FG001|COMPLETED|Overall Study||3
11190677|NCT01763931|12380280|FG000|NOT COMPLETED|Overall Study||0
11190678|NCT01763931|12380281|FG001|NOT COMPLETED|Overall Study||1
11190679|NCT01763970|12380287|FG000|STARTED|Overall Study||14
11190680|NCT01763970|12380287|FG000|COMPLETED|Overall Study||14
11190681|NCT01763970|12380287|FG000|NOT COMPLETED|Overall Study||0
11190682|NCT01763996|12380294|FG000|STARTED|Treatment Period 1||15
11190683|NCT01763996|12380295|FG001|STARTED|Treatment Period 1||15
11190684|NCT01763996|12380294|FG000|COMPLETED|Treatment Period 1||15
11190685|NCT01763996|12380295|FG001|COMPLETED|Treatment Period 1||15
11190686|NCT01763996|12380294|FG000|NOT COMPLETED|Treatment Period 1||0
11190687|NCT01763996|12380295|FG001|NOT COMPLETED|Treatment Period 1||0
11190688|NCT01763996|12380294|FG000|STARTED|Treatment Period 2||15
11190689|NCT01763996|12380295|FG001|STARTED|Treatment Period 2||15
11190690|NCT01763996|12380294|FG000|COMPLETED|Treatment Period 2||15
11190691|NCT01763996|12380295|FG001|COMPLETED|Treatment Period 2||14
11190692|NCT01763996|12380294|FG000|NOT COMPLETED|Treatment Period 2||0
11190693|NCT01763996|12380295|FG001|NOT COMPLETED|Treatment Period 2||1
11190694|NCT01764022|12380303|FG000|STARTED|Overall Study||115
11190695|NCT01764022|12380304|FG001|STARTED|Overall Study||110
11190696|NCT01764022|12380303|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113
11190697|NCT01764022|12380304|FG001|Received at Least 1 Dose of Study Drug|Overall Study||110
11190698|NCT01764022|12380303|FG000|COMPLETED|Overall Study||107
11190699|NCT01764022|12380304|FG001|COMPLETED|Overall Study||96
11190700|NCT01764022|12380303|FG000|NOT COMPLETED|Overall Study||8
11190701|NCT01764022|12380304|FG001|NOT COMPLETED|Overall Study||14
11190702|NCT01764256|12380316|FG000|STARTED|Received All Vaccinations||12
11190703|NCT01764256|12380317|FG001|STARTED|Received All Vaccinations||12
11190704|NCT01764256|12380318|FG002|STARTED|Received All Vaccinations||12
11190705|NCT01764256|12380319|FG003|STARTED|Received All Vaccinations||12
11190706|NCT01764256|12380316|FG000|COMPLETED|Received All Vaccinations||10
11190707|NCT01764256|12380317|FG001|COMPLETED|Received All Vaccinations||11
11190708|NCT01764256|12380318|FG002|COMPLETED|Received All Vaccinations||11
11190709|NCT01764256|12380319|FG003|COMPLETED|Received All Vaccinations||12
11190710|NCT01764256|12380316|FG000|NOT COMPLETED|Received All Vaccinations||2
11190711|NCT01764256|12380317|FG001|NOT COMPLETED|Received All Vaccinations||1
11190712|NCT01764256|12380318|FG002|NOT COMPLETED|Received All Vaccinations||1
11190713|NCT01764256|12380319|FG003|NOT COMPLETED|Received All Vaccinations||0
11190714|NCT01764256|12380316|FG000|STARTED|Completed Study||10
11190715|NCT01764256|12380317|FG001|STARTED|Completed Study||11
11190716|NCT01764256|12380318|FG002|STARTED|Completed Study||11
11190717|NCT01764256|12380319|FG003|STARTED|Completed Study||12
11190718|NCT01764256|12380316|FG000|COMPLETED|Completed Study||10
11190719|NCT01764256|12380317|FG001|COMPLETED|Completed Study||11
11190720|NCT01764256|12380318|FG002|COMPLETED|Completed Study||11
11190721|NCT01764256|12380319|FG003|COMPLETED|Completed Study||11
11190722|NCT01764256|12380316|FG000|NOT COMPLETED|Completed Study||0
11190723|NCT01764256|12380317|FG001|NOT COMPLETED|Completed Study||0
11190724|NCT01764256|12380318|FG002|NOT COMPLETED|Completed Study||0
11190725|NCT01764256|12380319|FG003|NOT COMPLETED|Completed Study||1
11190726|NCT01764386|12380335|FG000|STARTED|Controlled Treatment Period (CTP)||153
11190727|NCT01764386|12380336|FG001|STARTED|Controlled Treatment Period (CTP)||89
11190728|NCT01764386|12380335|FG000|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
11190729|NCT01764386|12380336|FG001|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
11190730|NCT01764386|12380335|FG000|NOT COMPLETED|Controlled Treatment Period (CTP)||82
11190731|NCT01764386|12380336|FG001|NOT COMPLETED|Controlled Treatment Period (CTP)||7
11190732|NCT01764386|12380335|FG000|STARTED|Uncontrolled Treatment Period (UTP)||71
11190733|NCT01764386|12380336|FG001|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
11190734|NCT01764386|12380335|FG000|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
11190735|NCT01764386|12380336|FG001|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
11190736|NCT01764386|12380335|FG000|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
11190737|NCT01764386|12380336|FG001|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
11190738|NCT01764386|12380335|FG000|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
11190739|NCT01764386|12380336|FG001|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
11190740|NCT01764464|12380345|FG000|STARTED|First Intervention|Started Gralise|16
11190741|NCT01764464|12380346|FG001|STARTED|First Intervention|Started Placebo|16
11190742|NCT01764464|12380345|FG000|COMPLETED|First Intervention|Completed Gralise|14
11190743|NCT01764464|12380346|FG001|COMPLETED|First Intervention|Completed Placebo|13
11190744|NCT01764464|12380345|FG000|NOT COMPLETED|First Intervention||2
11190745|NCT01764464|12380346|FG001|NOT COMPLETED|First Intervention||3
11190746|NCT01764464|12380345|FG000|STARTED|Second Intervention (Cross-over)|Started Placebo|14
11190747|NCT01764464|12380346|FG001|STARTED|Second Intervention (Cross-over)|Started Gralise|13
11190748|NCT01764464|12380345|FG000|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12
11190749|NCT01764464|12380346|FG001|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13
11190750|NCT01764464|12380345|FG000|NOT COMPLETED|Second Intervention (Cross-over)||2
11190751|NCT01764464|12380346|FG001|NOT COMPLETED|Second Intervention (Cross-over)||0
11190752|NCT01764607|12380352|FG000|STARTED|Overall Study||1
11190753|NCT01764607|12380352|FG000|COMPLETED|Overall Study||1
11190754|NCT01764607|12380352|FG000|NOT COMPLETED|Overall Study||0
11190755|NCT01764659|12380356|FG000|STARTED|Overall Study||14
11190756|NCT01764659|12380356|FG000|COMPLETED|Overall Study||12
11190757|NCT01764659|12380356|FG000|NOT COMPLETED|Overall Study||2
11190758|NCT01764685|12380364|FG000|STARTED|Overall Study||0
11190759|NCT01764685|12380365|FG001|STARTED|Overall Study||4
11190760|NCT01764685|12380364|FG000|COMPLETED|Overall Study||0
11190761|NCT01764685|12380365|FG001|COMPLETED|Overall Study||3
11190762|NCT01764685|12380364|FG000|NOT COMPLETED|Overall Study||0
11190763|NCT01764685|12380365|FG001|NOT COMPLETED|Overall Study||1
11190764|NCT01764841|12380375|FG000|STARTED|Overall Study||141
11190765|NCT01764841|12380376|FG001|STARTED|Overall Study||137
11190766|NCT01764841|12380377|FG002|STARTED|Overall Study||70
11190767|NCT01764841|12380378|FG003|STARTED|Overall Study||68
11190768|NCT01764841|12380375|FG000|Participants Received Treatment|Overall Study|safety population|141
11190769|NCT01764841|12380376|FG001|Participants Received Treatment|Overall Study|safety population|136
11190770|NCT01764841|12380377|FG002|Participants Received Treatment|Overall Study|safety population|69
11190771|NCT01764841|12380378|FG003|Participants Received Treatment|Overall Study|safety population|68
11190772|NCT01764841|12380375|FG000|COMPLETED|Overall Study||118
11190773|NCT01764841|12380376|FG001|COMPLETED|Overall Study||111
11190774|NCT01764841|12380377|FG002|COMPLETED|Overall Study||56
11190775|NCT01764841|12380378|FG003|COMPLETED|Overall Study||49
11190776|NCT01764841|12380375|FG000|NOT COMPLETED|Overall Study||23
11190777|NCT01764841|12380376|FG001|NOT COMPLETED|Overall Study||26
11190778|NCT01764841|12380377|FG002|NOT COMPLETED|Overall Study||14
11190779|NCT01764841|12380378|FG003|NOT COMPLETED|Overall Study||19
11190780|NCT01764854|12380392|FG000|STARTED|Overall Study||8
11190781|NCT01764854|12380393|FG001|STARTED|Overall Study||8
11190782|NCT01764854|12380394|FG002|STARTED|Overall Study||37
11190783|NCT01764854|12380395|FG003|STARTED|Overall Study||35
11190784|NCT01764854|12380392|FG000|COMPLETED|Overall Study||8
11190785|NCT01764854|12380393|FG001|COMPLETED|Overall Study||8
11190786|NCT01764854|12380394|FG002|COMPLETED|Overall Study||31
11190787|NCT01764854|12380395|FG003|COMPLETED|Overall Study||33
11190788|NCT01764854|12380392|FG000|NOT COMPLETED|Overall Study||0
11190789|NCT01764854|12380393|FG001|NOT COMPLETED|Overall Study||0
11190790|NCT01764854|12380394|FG002|NOT COMPLETED|Overall Study||6
11190791|NCT01764854|12380395|FG003|NOT COMPLETED|Overall Study||2
11190792|NCT01764919|12380405|FG000|STARTED|Overall Study||4
11190793|NCT01764919|12380405|FG000|COMPLETED|Overall Study||4
11190794|NCT01764919|12380405|FG000|NOT COMPLETED|Overall Study||0
11190795|NCT01764945|12380417|FG000|STARTED|Overall Study||5
11190796|NCT01764945|12380418|FG001|STARTED|Overall Study||5
11190797|NCT01764945|12380419|FG002|STARTED|Overall Study||5
11190798|NCT01764945|12380420|FG003|STARTED|Overall Study||5
11190799|NCT01764945|12380421|FG004|STARTED|Overall Study||10
11190800|NCT01764945|12380422|FG005|STARTED|Overall Study||8
11190801|NCT01764945|12380423|FG006|STARTED|Overall Study||9
11190802|NCT01764945|12380424|FG007|STARTED|Overall Study||9
11190803|NCT01764945|12380417|FG000|COMPLETED|Overall Study||5
11190804|NCT01764945|12380418|FG001|COMPLETED|Overall Study||4
11190805|NCT01764945|12380419|FG002|COMPLETED|Overall Study||5
11190806|NCT01764945|12380420|FG003|COMPLETED|Overall Study||5
11190807|NCT01764945|12380421|FG004|COMPLETED|Overall Study||10
11190808|NCT01764945|12380422|FG005|COMPLETED|Overall Study||8
11190809|NCT01764945|12380423|FG006|COMPLETED|Overall Study||8
11190810|NCT01764945|12380424|FG007|COMPLETED|Overall Study||9
11190811|NCT01764945|12380417|FG000|NOT COMPLETED|Overall Study||0
11190812|NCT01764945|12380418|FG001|NOT COMPLETED|Overall Study||1
11190813|NCT01764945|12380419|FG002|NOT COMPLETED|Overall Study||0
11190814|NCT01764945|12380420|FG003|NOT COMPLETED|Overall Study||0
11190815|NCT01764945|12380421|FG004|NOT COMPLETED|Overall Study||0
11190816|NCT01764945|12380422|FG005|NOT COMPLETED|Overall Study||0
11190817|NCT01764945|12380423|FG006|NOT COMPLETED|Overall Study||1
11190818|NCT01764945|12380424|FG007|NOT COMPLETED|Overall Study||0
11190819|NCT01765153|12380444|FG000|STARTED|Training Phase 1||10
11190820|NCT01765153|12380445|FG001|STARTED|Training Phase 1||11
11190821|NCT01765153|12380444|FG000|COMPLETED|Training Phase 1||9
11190822|NCT01765153|12380445|FG001|COMPLETED|Training Phase 1||10
11190823|NCT01765153|12380444|FG000|NOT COMPLETED|Training Phase 1||1
11190824|NCT01765153|12380445|FG001|NOT COMPLETED|Training Phase 1||1
11190825|NCT01765153|12380444|FG000|STARTED|Rest Phase 1||9
11190826|NCT01765153|12380445|FG001|STARTED|Rest Phase 1||10
11190827|NCT01765153|12380444|FG000|COMPLETED|Rest Phase 1||9
11190828|NCT01765153|12380445|FG001|COMPLETED|Rest Phase 1||9
11190829|NCT01765153|12380444|FG000|NOT COMPLETED|Rest Phase 1||0
11190830|NCT01765153|12380445|FG001|NOT COMPLETED|Rest Phase 1||1
11190831|NCT01765153|12380444|FG000|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
11190832|NCT01765153|12380445|FG001|STARTED|Training Phase 2||9
11190833|NCT01765153|12380444|FG000|COMPLETED|Training Phase 2||10
11190834|NCT01765153|12380445|FG001|COMPLETED|Training Phase 2||8
11190835|NCT01765153|12380444|FG000|NOT COMPLETED|Training Phase 2||0
11190836|NCT01765153|12380445|FG001|NOT COMPLETED|Training Phase 2||1
11190837|NCT01765153|12380444|FG000|STARTED|Rest Phase 2||10
11190838|NCT01765153|12380445|FG001|STARTED|Rest Phase 2||8
11190839|NCT01765153|12380444|FG000|COMPLETED|Rest Phase 2||8
11190840|NCT01765153|12380445|FG001|COMPLETED|Rest Phase 2||7
11190841|NCT01765153|12380444|FG000|NOT COMPLETED|Rest Phase 2||2
11190842|NCT01765153|12380445|FG001|NOT COMPLETED|Rest Phase 2||1
11190843|NCT01765179|12380455|FG000|STARTED|Overall Study||144
11190844|NCT01765179|12380455|FG000|COMPLETED|Overall Study||117
11190845|NCT01765179|12380455|FG000|NOT COMPLETED|Overall Study||27
11190846|NCT01765192|12380461|FG000|STARTED|Treatment Period 1||32
11190847|NCT01765192|12380462|FG001|STARTED|Treatment Period 1||32
11190848|NCT01765192|12380461|FG000|COMPLETED|Treatment Period 1||32
11190849|NCT01765192|12380462|FG001|COMPLETED|Treatment Period 1||31
11190850|NCT01765192|12380461|FG000|NOT COMPLETED|Treatment Period 1||0
11190851|NCT01765192|12380462|FG001|NOT COMPLETED|Treatment Period 1||1
11190852|NCT01765192|12380461|FG000|STARTED|Washout Period||32
11190853|NCT01765192|12380462|FG001|STARTED|Washout Period||31
11190854|NCT01765192|12380461|FG000|COMPLETED|Washout Period||30
11190855|NCT01765192|12380462|FG001|COMPLETED|Washout Period||30
11190856|NCT01765192|12380461|FG000|NOT COMPLETED|Washout Period||2
11190857|NCT01765192|12380462|FG001|NOT COMPLETED|Washout Period||1
11190858|NCT01765192|12380461|FG000|STARTED|Treatment Period 2||30
11190859|NCT01765192|12380462|FG001|STARTED|Treatment Period 2||30
11190860|NCT01765192|12380461|FG000|COMPLETED|Treatment Period 2||30
11190861|NCT01765192|12380462|FG001|COMPLETED|Treatment Period 2||28
11190862|NCT01765192|12380461|FG000|NOT COMPLETED|Treatment Period 2||0
11190863|NCT01765192|12380462|FG001|NOT COMPLETED|Treatment Period 2||2
11190864|NCT01765192|12380461|FG000|STARTED|End of Treatment Period 2 to Final Visit||30
11190865|NCT01765192|12380462|FG001|STARTED|End of Treatment Period 2 to Final Visit||28
11190866|NCT01765192|12380461|FG000|COMPLETED|End of Treatment Period 2 to Final Visit||30
11190867|NCT01765192|12380462|FG001|COMPLETED|End of Treatment Period 2 to Final Visit||27
11190868|NCT01765192|12380461|FG000|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
11190869|NCT01765192|12380462|FG001|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
11190870|NCT01765270|12380470|FG000|STARTED|Overall Study||5
11190871|NCT01765270|12380471|FG001|STARTED|Overall Study||7
11190872|NCT01765270|12380470|FG000|COMPLETED|Overall Study||4
11190873|NCT01765270|12380471|FG001|COMPLETED|Overall Study||6
11190874|NCT01765270|12380470|FG000|NOT COMPLETED|Overall Study||1
11190875|NCT01765270|12380471|FG001|NOT COMPLETED|Overall Study||1
11190876|NCT01765426|12380482|FG000|STARTED|Overall Study||18
11190877|NCT01765426|12380483|FG001|STARTED|Overall Study||17
11190878|NCT01765426|12380484|FG002|STARTED|Overall Study||17
11190879|NCT01765426|12380485|FG003|STARTED|Overall Study||15
11190880|NCT01765426|12380482|FG000|Completed All Vaccinations|Overall Study||17
11190881|NCT01765426|12380483|FG001|Completed All Vaccinations|Overall Study||16
11190882|NCT01765426|12380484|FG002|Completed All Vaccinations|Overall Study||17
11190883|NCT01765426|12380485|FG003|Completed All Vaccinations|Overall Study||15
11190884|NCT01765426|12380482|FG000|COMPLETED|Overall Study||18
11190885|NCT01765426|12380483|FG001|COMPLETED|Overall Study||16
11190886|NCT01765426|12380484|FG002|COMPLETED|Overall Study||17
11190887|NCT01765426|12380485|FG003|COMPLETED|Overall Study||15
11190888|NCT01765426|12380482|FG000|NOT COMPLETED|Overall Study||0
11190889|NCT01765426|12380483|FG001|NOT COMPLETED|Overall Study||1
11190890|NCT01765426|12380484|FG002|NOT COMPLETED|Overall Study||0
11190891|NCT01765426|12380485|FG003|NOT COMPLETED|Overall Study||0
11190892|NCT01765465|12380497|FG000|STARTED|Overall Study||71
11190893|NCT01765465|12380498|FG001|STARTED|Overall Study||67
11190894|NCT01765465|12380497|FG000|COMPLETED|Overall Study||64
11190895|NCT01765465|12380498|FG001|COMPLETED|Overall Study||63
11190896|NCT01765465|12380497|FG000|NOT COMPLETED|Overall Study||7
11190897|NCT01765465|12380498|FG001|NOT COMPLETED|Overall Study||4
11190898|NCT01765530|12380508|FG000|STARTED|Overall Study||37
11190899|NCT01765530|12380509|FG001|STARTED|Overall Study||37
11190900|NCT01765530|12380508|FG000|COMPLETED|Overall Study||36
11190901|NCT01765530|12380509|FG001|COMPLETED|Overall Study||36
11190902|NCT01765530|12380508|FG000|NOT COMPLETED|Overall Study||1
11190903|NCT01765530|12380509|FG001|NOT COMPLETED|Overall Study||1
11190904|NCT01765543|12380515|FG000|STARTED|Overall Study||27
11190905|NCT01765543|12380515|FG000|COMPLETED|Overall Study||24
11190906|NCT01765543|12380515|FG000|NOT COMPLETED|Overall Study||3
11190907|NCT01765569|12380523|FG000|STARTED|Period A||29
11190908|NCT01765569|12380523|FG000|COMPLETED|Period A||29
11190909|NCT01765569|12380523|FG000|NOT COMPLETED|Period A||0
11190910|NCT01765569|12380523|FG000|STARTED|Period B||29
11190911|NCT01765569|12380523|FG000|COMPLETED|Period B||28
11190912|NCT01765569|12380523|FG000|NOT COMPLETED|Period B||1
11190913|NCT01765569|12380523|FG000|STARTED|Period C||28
11190914|NCT01765569|12380523|FG000|COMPLETED|Period C||27
11190915|NCT01765569|12380523|FG000|NOT COMPLETED|Period C||1
11190916|NCT01765582|12380533|FG000|STARTED|Overall Study||93
11190917|NCT01765582|12380534|FG001|STARTED|Overall Study||92
11190918|NCT01765582|12380535|FG002|STARTED|Overall Study||95
11190919|NCT01765582|12380533|FG000|COMPLETED|Overall Study||0
11190920|NCT01765582|12380534|FG001|COMPLETED|Overall Study||0
11190921|NCT01765582|12380535|FG002|COMPLETED|Overall Study||0
11190922|NCT01765582|12380533|FG000|NOT COMPLETED|Overall Study||93
11190923|NCT01765582|12380534|FG001|NOT COMPLETED|Overall Study||92
11190924|NCT01765582|12380535|FG002|NOT COMPLETED|Overall Study||95
11190925|NCT01765647|12380544|FG000|STARTED|Overall Study|One began the run-in period, but was withdrawn prior to beginning treatment with AGY|10
11190926|NCT01765647|12380544|FG000|COMPLETED|Overall Study|10 entered the AGY treatment phase and all 10 completed treatment.|10
11190927|NCT01765647|12380544|FG000|NOT COMPLETED|Overall Study||0
11190928|NCT01765673|12380548|FG000|STARTED|Overall Study||12
11190929|NCT01765673|12380548|FG000|COMPLETED|Overall Study||11
11190930|NCT01765673|12380548|FG000|NOT COMPLETED|Overall Study||1
11190931|NCT01765712|12380557|FG000|STARTED|Overall Study||27
11190932|NCT01765712|12380558|FG001|STARTED|Overall Study||23
11190933|NCT01765712|12380557|FG000|COMPLETED|Overall Study||27
11190934|NCT01765712|12380558|FG001|COMPLETED|Overall Study||23
11190935|NCT01765712|12380557|FG000|NOT COMPLETED|Overall Study||0
11190936|NCT01765712|12380558|FG001|NOT COMPLETED|Overall Study||0
11190937|NCT01765751|12380567|FG000|STARTED|Overall Study||16
11190938|NCT01765751|12380568|FG001|STARTED|Overall Study||16
11190939|NCT01765751|12380569|FG002|STARTED|Overall Study||16
11190940|NCT01765751|12380567|FG000|COMPLETED|Overall Study||16
11190941|NCT01765751|12380568|FG001|COMPLETED|Overall Study||14
11190942|NCT01765751|12380569|FG002|COMPLETED|Overall Study||15
11190943|NCT01765751|12380567|FG000|NOT COMPLETED|Overall Study||0
11190944|NCT01765751|12380568|FG001|NOT COMPLETED|Overall Study||2
11190945|NCT01765751|12380569|FG002|NOT COMPLETED|Overall Study||1
11190946|NCT01765764|12380583|FG000|STARTED|Treatment Period||118
11190947|NCT01765764|12380584|FG001|STARTED|Treatment Period||118
11190948|NCT01765764|12380585|FG002|STARTED|Treatment Period||121
11190949|NCT01765764|12380583|FG000|COMPLETED|Treatment Period||115
11190950|NCT01765764|12380584|FG001|COMPLETED|Treatment Period||109
11190951|NCT01765764|12380585|FG002|COMPLETED|Treatment Period||115
11190952|NCT01765764|12380583|FG000|NOT COMPLETED|Treatment Period||3
11190953|NCT01765764|12380584|FG001|NOT COMPLETED|Treatment Period||9
11190954|NCT01765764|12380585|FG002|NOT COMPLETED|Treatment Period||6
11190955|NCT01765764|12380583|FG000|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
11190956|NCT01765764|12380584|FG001|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
11190957|NCT01765764|12380585|FG002|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
11190958|NCT01765764|12380583|FG000|COMPLETED|Post-treatment Period||114
11190959|NCT01765764|12380584|FG001|COMPLETED|Post-treatment Period||107
11190960|NCT01765764|12380585|FG002|COMPLETED|Post-treatment Period||112
11190961|NCT01765764|12380583|FG000|NOT COMPLETED|Post-treatment Period||0
11190962|NCT01765764|12380584|FG001|NOT COMPLETED|Post-treatment Period||0
11190963|NCT01765764|12380585|FG002|NOT COMPLETED|Post-treatment Period||0
11190964|NCT01765803|12380593|FG000|STARTED|Overall Study||6
11190965|NCT01765803|12380593|FG000|COMPLETED|Overall Study||6
11190966|NCT01765803|12380593|FG000|NOT COMPLETED|Overall Study||0
11190967|NCT01765920|12380599|FG000|STARTED|Overall Study||169
11190968|NCT01765920|12380600|FG001|STARTED|Overall Study||173
11190969|NCT01765920|12380599|FG000|COMPLETED|Overall Study||167
11190970|NCT01765920|12380600|FG001|COMPLETED|Overall Study||167
11190971|NCT01765920|12380599|FG000|NOT COMPLETED|Overall Study||2
11190972|NCT01765920|12380600|FG001|NOT COMPLETED|Overall Study||6
11190973|NCT01765972|12380606|FG000|STARTED|Overall Study||6
11190974|NCT01765972|12380607|FG001|STARTED|Overall Study||6
11190975|NCT01765972|12380608|FG002|STARTED|Overall Study||6
11190976|NCT01765972|12380609|FG003|STARTED|Overall Study||6
11190977|NCT01765972|12380606|FG000|COMPLETED|Overall Study||6
11190978|NCT01765972|12380607|FG001|COMPLETED|Overall Study||6
11190979|NCT01765972|12380608|FG002|COMPLETED|Overall Study||6
11190980|NCT01765972|12380609|FG003|COMPLETED|Overall Study||6
11190981|NCT01765972|12380606|FG000|NOT COMPLETED|Overall Study||0
11190982|NCT01765972|12380607|FG001|NOT COMPLETED|Overall Study||0
11190983|NCT01765972|12380608|FG002|NOT COMPLETED|Overall Study||0
11190984|NCT01765972|12380609|FG003|NOT COMPLETED|Overall Study||0
11190985|NCT01766024|12380621|FG000|STARTED|Overall Study||16
11190986|NCT01766024|12380622|FG001|STARTED|Overall Study||16
11190987|NCT01766024|12380621|FG000|COMPLETED|Overall Study||16
11190988|NCT01766024|12380622|FG001|COMPLETED|Overall Study||16
11190989|NCT01766024|12380621|FG000|NOT COMPLETED|Overall Study||0
11190990|NCT01766024|12380622|FG001|NOT COMPLETED|Overall Study||0
11190991|NCT01766037|12380632|FG000|STARTED|Overall Study||111
11190992|NCT01766037|12380633|FG001|STARTED|Overall Study||60
11190993|NCT01766037|12380632|FG000|COMPLETED|Overall Study||82
11190994|NCT01766037|12380633|FG001|COMPLETED|Overall Study||31
11190995|NCT01766037|12380632|FG000|NOT COMPLETED|Overall Study||29
11190996|NCT01766037|12380633|FG001|NOT COMPLETED|Overall Study||29
11190997|NCT01766050|12380639|FG000|STARTED|Overall Study||22
11190998|NCT01766050|12380639|FG000|COMPLETED|Overall Study||18
11190999|NCT01766050|12380639|FG000|NOT COMPLETED|Overall Study||4
11191000|NCT01766076|12380659|FG000|STARTED|Overall Study||15
11191001|NCT01766076|12380660|FG001|STARTED|Overall Study||15
11191002|NCT01766076|12380659|FG000|COMPLETED|Overall Study||15
11191003|NCT01766076|12380660|FG001|COMPLETED|Overall Study||15
11191004|NCT01766076|12380659|FG000|NOT COMPLETED|Overall Study||0
11191005|NCT01766076|12380660|FG001|NOT COMPLETED|Overall Study||0
11191006|NCT01766102|12380668|FG000|STARTED|Overall Study||36
11191007|NCT01766102|12380669|FG001|STARTED|Overall Study||36
11191008|NCT01766102|12380668|FG000|COMPLETED|Overall Study||36
11191009|NCT01766102|12380669|FG001|COMPLETED|Overall Study||36
11191010|NCT01766102|12380668|FG000|NOT COMPLETED|Overall Study||0
11191011|NCT01766102|12380669|FG001|NOT COMPLETED|Overall Study||0
11191012|NCT01766206|12380675|FG000|STARTED|Overall Study||3939
11191013|NCT01766206|12380675|FG000|COMPLETED|Overall Study||3888
11191014|NCT01766206|12380675|FG000|NOT COMPLETED|Overall Study||51
11191015|NCT01766219|12380682|FG000|STARTED|Overall Study||4
11191016|NCT01766219|12380683|FG001|STARTED|Overall Study||2
11191017|NCT01766219|12380684|FG002|STARTED|Overall Study||11
11191018|NCT01766219|12380682|FG000|COMPLETED|Overall Study||4
11191019|NCT01766219|12380683|FG001|COMPLETED|Overall Study||2
11191020|NCT01766219|12380684|FG002|COMPLETED|Overall Study||11
11191021|NCT01766219|12380682|FG000|NOT COMPLETED|Overall Study||0
11191022|NCT01766219|12380683|FG001|NOT COMPLETED|Overall Study||0
11191023|NCT01766219|12380684|FG002|NOT COMPLETED|Overall Study||0
11191024|NCT01766310|12380695|FG000|STARTED|Overall Study||24
11191025|NCT01766310|12380696|FG001|STARTED|Overall Study||26
11191026|NCT01766310|12380695|FG000|COMPLETED|Overall Study||23
11191027|NCT01766310|12380696|FG001|COMPLETED|Overall Study||23
11191028|NCT01766310|12380695|FG000|NOT COMPLETED|Overall Study||1
11191029|NCT01766310|12380696|FG001|NOT COMPLETED|Overall Study||3
11191030|NCT01766336|12380704|FG000|STARTED|Overall Study||150
11191031|NCT01766336|12380705|FG001|STARTED|Overall Study||146
11191032|NCT01766336|12380704|FG000|COMPLETED|Overall Study||60
11191033|NCT01766336|12380705|FG001|COMPLETED|Overall Study||71
11191034|NCT01766336|12380704|FG000|NOT COMPLETED|Overall Study||90
11191035|NCT01766336|12380705|FG001|NOT COMPLETED|Overall Study||75
11191036|NCT01766401|12380713|FG000|STARTED|Overall Study||198
11191037|NCT01766401|12380714|FG001|STARTED|Overall Study||200
11191038|NCT01766401|12380713|FG000|COMPLETED|Overall Study||161
11191039|NCT01766401|12380714|FG001|COMPLETED|Overall Study||144
11191040|NCT01766401|12380713|FG000|NOT COMPLETED|Overall Study||37
11191041|NCT01766401|12380714|FG001|NOT COMPLETED|Overall Study||56
11191042|NCT01766440|12380720|FG000|STARTED|Overall Study||18
11191043|NCT01766440|12380720|FG000|COMPLETED|Overall Study||17
11191044|NCT01766440|12380720|FG000|NOT COMPLETED|Overall Study||1
11191045|NCT01766466|12380726|FG000|STARTED|Day 1||6
11191046|NCT01766466|12380727|FG001|STARTED|Day 1||0
11191047|NCT01766466|12380728|FG002|STARTED|Day 1||6
11191048|NCT01766466|12380729|FG003|STARTED|Day 1||0
11191049|NCT01766466|12380726|FG000|COMPLETED|Day 1||6
11191050|NCT01766466|12380727|FG001|COMPLETED|Day 1||0
11191051|NCT01766466|12380728|FG002|COMPLETED|Day 1||6
11191052|NCT01766466|12380729|FG003|COMPLETED|Day 1||0
11191053|NCT01766466|12380726|FG000|NOT COMPLETED|Day 1||0
11191054|NCT01766466|12380727|FG001|NOT COMPLETED|Day 1||0
11191055|NCT01766466|12380728|FG002|NOT COMPLETED|Day 1||0
11191056|NCT01766466|12380729|FG003|NOT COMPLETED|Day 1||0
11191057|NCT01766466|12380726|FG000|STARTED|Day 5||0
11191058|NCT01766466|12380727|FG001|STARTED|Day 5||6
11191059|NCT01766466|12380728|FG002|STARTED|Day 5||0
11191060|NCT01766466|12380729|FG003|STARTED|Day 5||6
11191061|NCT01766466|12380726|FG000|COMPLETED|Day 5||0
11191062|NCT01766466|12380727|FG001|COMPLETED|Day 5||6
11191063|NCT01766466|12380728|FG002|COMPLETED|Day 5||0
11191064|NCT01766466|12380729|FG003|COMPLETED|Day 5||6
11191065|NCT01766466|12380726|FG000|NOT COMPLETED|Day 5||0
11191066|NCT01766466|12380727|FG001|NOT COMPLETED|Day 5||0
11191067|NCT01766466|12380728|FG002|NOT COMPLETED|Day 5||0
11191068|NCT01766466|12380729|FG003|NOT COMPLETED|Day 5||0
11191069|NCT01766713|12380740|FG000|STARTED|Overall Study||25
11191070|NCT01766713|12380741|FG001|STARTED|Overall Study||25
11191071|NCT01766713|12380740|FG000|COMPLETED|Overall Study||23
11191072|NCT01766713|12380741|FG001|COMPLETED|Overall Study||22
11191073|NCT01766713|12380740|FG000|NOT COMPLETED|Overall Study||2
11191074|NCT01766713|12380741|FG001|NOT COMPLETED|Overall Study||3
11191075|NCT01766778|12380749|FG000|STARTED|Overall Study|Intent to treat population|56
11191076|NCT01766778|12380750|FG001|STARTED|Overall Study||61
11191077|NCT01766778|12380749|FG000|COMPLETED|Overall Study||51
11191078|NCT01766778|12380750|FG001|COMPLETED|Overall Study||57
11191079|NCT01766778|12380749|FG000|NOT COMPLETED|Overall Study||5
11191080|NCT01766778|12380750|FG001|NOT COMPLETED|Overall Study||4
11191081|NCT01766817|12380759|FG000|STARTED|Overall Study||48
11191082|NCT01766817|12380760|FG001|STARTED|Overall Study||48
11191083|NCT01766817|12380761|FG002|STARTED|Overall Study||47
11191084|NCT01766817|12380759|FG000|COMPLETED|Overall Study||37
11191085|NCT01766817|12380760|FG001|COMPLETED|Overall Study||37
11191086|NCT01766817|12380761|FG002|COMPLETED|Overall Study||34
11191087|NCT01766817|12380759|FG000|NOT COMPLETED|Overall Study||11
11191088|NCT01766817|12380760|FG001|NOT COMPLETED|Overall Study||11
11191089|NCT01766817|12380761|FG002|NOT COMPLETED|Overall Study||13
11191090|NCT01766921|12380771|FG000|STARTED|Overall Study||700
11191091|NCT01766921|12380772|FG001|STARTED|Overall Study||693
11191092|NCT01766921|12380771|FG000|COMPLETED|Overall Study||676
11191093|NCT01766921|12380772|FG001|COMPLETED|Overall Study||676
11191094|NCT01766921|12380771|FG000|NOT COMPLETED|Overall Study||24
11191095|NCT01766921|12380772|FG001|NOT COMPLETED|Overall Study||17
11191096|NCT01766986|12380782|FG000|STARTED|Overall Study||41
11191097|NCT01766986|12380783|FG001|STARTED|Overall Study||51
11191098|NCT01766986|12380784|FG002|STARTED|Overall Study||38
11191099|NCT01766986|12380782|FG000|COMPLETED|Overall Study||41
11191100|NCT01766986|12380783|FG001|COMPLETED|Overall Study||51
11191101|NCT01766986|12380784|FG002|COMPLETED|Overall Study||38
11191102|NCT01766986|12380782|FG000|NOT COMPLETED|Overall Study||0
11191103|NCT01766986|12380783|FG001|NOT COMPLETED|Overall Study||0
11191104|NCT01766986|12380784|FG002|NOT COMPLETED|Overall Study||0
11191105|NCT01767064|12380794|FG000|STARTED|Overall Study||7
11191106|NCT01767064|12380795|FG001|STARTED|Overall Study||7
11191107|NCT01767064|12380794|FG000|COMPLETED|Overall Study||7
11191108|NCT01767064|12380795|FG001|COMPLETED|Overall Study||7
11191109|NCT01767064|12380794|FG000|NOT COMPLETED|Overall Study||0
11191110|NCT01767064|12380795|FG001|NOT COMPLETED|Overall Study||0
11191111|NCT01767103|12380804|FG000|STARTED|Overall Study||7
11191112|NCT01767103|12380805|FG001|STARTED|Overall Study||7
11191113|NCT01767103|12380806|FG002|STARTED|Overall Study||7
11191114|NCT01767103|12380804|FG000|COMPLETED|Overall Study||7
11191115|NCT01767103|12380805|FG001|COMPLETED|Overall Study||7
11191116|NCT01767103|12380806|FG002|COMPLETED|Overall Study||7
11191117|NCT01767103|12380804|FG000|NOT COMPLETED|Overall Study||0
11191118|NCT01767103|12380805|FG001|NOT COMPLETED|Overall Study||0
11191119|NCT01767103|12380806|FG002|NOT COMPLETED|Overall Study||0
11191120|NCT01767116|12380817|FG000|STARTED|Overall Study||210
11191121|NCT01767116|12380818|FG001|STARTED|Overall Study||209
11191122|NCT01767116|12380817|FG000|COMPLETED|Overall Study||208
11191123|NCT01767116|12380818|FG001|COMPLETED|Overall Study||207
11191124|NCT01767116|12380817|FG000|NOT COMPLETED|Overall Study||2
11191125|NCT01767116|12380818|FG001|NOT COMPLETED|Overall Study||2
11191126|NCT01767142|12380824|FG000|STARTED|Overall Study|Each subject was treated on a single thigh. therefore the number of units is 40.|40
11191127|NCT01767142|12380824|FG000|COMPLETED|Overall Study||37
11191128|NCT01767142|12380824|FG000|NOT COMPLETED|Overall Study||3
11191129|NCT01767155|12380830|FG000|STARTED|Overall Study|Patients allocated to AEZS-108|256
11191130|NCT01767155|12380831|FG001|STARTED|Overall Study|Patients allocated to doxorubicin|255
11191131|NCT01767155|12380830|FG000|Modified ITT (mITT)|Overall Study||252
11191132|NCT01767155|12380831|FG001|Modified ITT (mITT)|Overall Study||249
11191133|NCT01767155|12380830|FG000|Safety Population (SAF)|Overall Study||252
11191134|NCT01767155|12380831|FG001|Safety Population (SAF)|Overall Study||249
11191135|NCT01767155|12380830|FG000|COMPLETED|Overall Study||243
11191136|NCT01767155|12380831|FG001|COMPLETED|Overall Study||240
11191137|NCT01767155|12380830|FG000|NOT COMPLETED|Overall Study||13
11191138|NCT01767155|12380831|FG001|NOT COMPLETED|Overall Study||15
11191139|NCT01767285|12380839|FG000|STARTED|Overall Study||29
11191140|NCT01767285|12380840|FG001|STARTED|Overall Study||30
11191141|NCT01767285|12380839|FG000|COMPLETED|Overall Study||22
11191142|NCT01767285|12380840|FG001|COMPLETED|Overall Study||24
11191143|NCT01767285|12380839|FG000|NOT COMPLETED|Overall Study||7
11191144|NCT01767285|12380840|FG001|NOT COMPLETED|Overall Study||6
11191145|NCT01767376|12380849|FG000|STARTED|Overall Study||231
11191146|NCT01767376|12380850|FG001|STARTED|Overall Study||228
11191147|NCT01767376|12380851|FG002|STARTED|Overall Study||232
11191148|NCT01767376|12380849|FG000|COMPLETED|Overall Study||227
11191149|NCT01767376|12380850|FG001|COMPLETED|Overall Study||225
11191150|NCT01767376|12380851|FG002|COMPLETED|Overall Study||232
11191151|NCT01767376|12380849|FG000|NOT COMPLETED|Overall Study||4
11191152|NCT01767376|12380850|FG001|NOT COMPLETED|Overall Study||3
11191153|NCT01767376|12380851|FG002|NOT COMPLETED|Overall Study||0
11191154|NCT01767415|12380861|FG000|STARTED|Overall Study||10
11191155|NCT01767415|12380861|FG000|COMPLETED|Overall Study||10
11191156|NCT01767415|12380861|FG000|NOT COMPLETED|Overall Study||0
11191157|NCT01767467|12380867|FG000|STARTED|Vaccination Phase (up to Month 2)||283
11191158|NCT01767467|12380868|FG001|STARTED|Vaccination Phase (up to Month 2)||279
11191159|NCT01767467|12380867|FG000|COMPLETED|Vaccination Phase (up to Month 2)||266
11191160|NCT01767467|12380868|FG001|COMPLETED|Vaccination Phase (up to Month 2)||259
11191161|NCT01767467|12380867|FG000|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
11191162|NCT01767467|12380868|FG001|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
11191163|NCT01767467|12380867|FG000|STARTED|End of Study Phase (up to Month 13)||283
11191164|NCT01767467|12380868|FG001|STARTED|End of Study Phase (up to Month 13)||279
11191165|NCT01767467|12380867|FG000|COMPLETED|End of Study Phase (up to Month 13)||236
11191166|NCT01767467|12380868|FG001|COMPLETED|End of Study Phase (up to Month 13)||216
11191167|NCT01767467|12380867|FG000|NOT COMPLETED|End of Study Phase (up to Month 13)||47
11191168|NCT01767467|12380868|FG001|NOT COMPLETED|End of Study Phase (up to Month 13)||63
11191169|NCT01767493|12380881|FG000|STARTED|Overall Study||19
11191170|NCT01767493|12380881|FG000|COMPLETED|Overall Study||16
11191171|NCT01767493|12380881|FG000|NOT COMPLETED|Overall Study||3
11191172|NCT01767506|12380887|FG000|STARTED|Overall Study|"26 communities were randomized to intervention group~The study was conducted at the community level."|
11191173|NCT01767506|12380888|FG001|STARTED|Overall Study|"26 communities were randomized to control group~The study was conducted at the community level."|
11191174|NCT01767506|12380887|FG000|COMPLETED|Overall Study|The study was conducted at the community level.|
11191175|NCT01767506|12380888|FG001|COMPLETED|Overall Study|The study was conducted at the community level.|
11191176|NCT01767506|12380887|FG000|NOT COMPLETED|Overall Study||
11191177|NCT01767506|12380888|FG001|NOT COMPLETED|Overall Study||
11191178|NCT01767519|12380897|FG000|STARTED|Overall Study||145
11191179|NCT01767519|12380898|FG001|STARTED|Overall Study||151
11191180|NCT01767519|12380899|FG002|STARTED|Overall Study||60
11191181|NCT01767519|12380897|FG000|COMPLETED|Overall Study||131
11191182|NCT01767519|12380898|FG001|COMPLETED|Overall Study||138
11191183|NCT01767519|12380899|FG002|COMPLETED|Overall Study||55
11191184|NCT01767519|12380897|FG000|NOT COMPLETED|Overall Study||14
11191185|NCT01767519|12380898|FG001|NOT COMPLETED|Overall Study||13
11191186|NCT01767519|12380899|FG002|NOT COMPLETED|Overall Study||5
11191187|NCT01767597|12380909|FG000|STARTED|Overall Study||500
11191188|NCT01767597|12380910|FG001|STARTED|Overall Study||500
11191189|NCT01767597|12380909|FG000|COMPLETED|Overall Study||496
11191190|NCT01767597|12380910|FG001|COMPLETED|Overall Study||499
11191191|NCT01767597|12380909|FG000|NOT COMPLETED|Overall Study||4
11191192|NCT01767597|12380910|FG001|NOT COMPLETED|Overall Study||1
11191193|NCT01767636|12380916|FG000|STARTED|Overall Study||38
11191194|NCT01767636|12380916|FG000|COMPLETED|Overall Study||35
11191195|NCT01767636|12380916|FG000|NOT COMPLETED|Overall Study||3
11191196|NCT01767688|12380922|FG000|STARTED|Overall Study||8
11191197|NCT01767688|12380923|FG001|STARTED|Overall Study||8
11191198|NCT01767688|12380922|FG000|COMPLETED|Overall Study||8
11191199|NCT01767688|12380923|FG001|COMPLETED|Overall Study||8
11191200|NCT01767688|12380922|FG000|NOT COMPLETED|Overall Study||0
11191201|NCT01767688|12380923|FG001|NOT COMPLETED|Overall Study||0
11191202|NCT01767701|12380929|FG000|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
11191203|NCT01767701|12380929|FG000|COMPLETED|Overall Study||20
11191204|NCT01767701|12380929|FG000|NOT COMPLETED|Overall Study||0
11191205|NCT01767792|12380934|FG000|STARTED|Overall Study||22
11191206|NCT01767792|12380934|FG000|COMPLETED|Overall Study||20
11191207|NCT01767792|12380934|FG000|NOT COMPLETED|Overall Study||2
11191208|NCT01767857|12380941|FG000|STARTED|Overall Study||430
11191209|NCT01767857|12380942|FG001|STARTED|Overall Study||213
11191210|NCT01767857|12380941|FG000|Treated|Overall Study||411
11191211|NCT01767857|12380942|FG001|Treated|Overall Study||200
11191212|NCT01767857|12380941|FG000|COMPLETED|Overall Study||0
11191213|NCT01767857|12380942|FG001|COMPLETED|Overall Study||0
11191214|NCT01767857|12380941|FG000|NOT COMPLETED|Overall Study||430
11191215|NCT01767857|12380942|FG001|NOT COMPLETED|Overall Study||213
11191216|NCT01767909|12380951|FG000|STARTED|Overall Study||121
11191217|NCT01767909|12380952|FG001|STARTED|Overall Study||119
11191218|NCT01767909|12380951|FG000|COMPLETED|Overall Study||108
11191219|NCT01767909|12380952|FG001|COMPLETED|Overall Study||107
11191220|NCT01767909|12380951|FG000|NOT COMPLETED|Overall Study||13
11191221|NCT01767909|12380952|FG001|NOT COMPLETED|Overall Study||12
11191222|NCT01767935|12380960|FG000|STARTED|Overall Study||1
11191223|NCT01767935|12380960|FG000|COMPLETED|Overall Study||1
11191224|NCT01767935|12380960|FG000|NOT COMPLETED|Overall Study||0
11191225|NCT01767987|12380966|FG000|STARTED|Overall Study||4
11191226|NCT01767987|12380967|FG001|STARTED|Overall Study||2
11191227|NCT01767987|12380966|FG000|COMPLETED|Overall Study||0
11191228|NCT01767987|12380967|FG001|COMPLETED|Overall Study||1
11191229|NCT01767987|12380966|FG000|NOT COMPLETED|Overall Study||4
11191230|NCT01767987|12380967|FG001|NOT COMPLETED|Overall Study||1
11191231|NCT01768000|12380977|FG000|STARTED|Overall Study||10
11191232|NCT01768000|12380978|FG001|STARTED|Overall Study||10
11191233|NCT01768000|12380979|FG002|STARTED|Overall Study||10
11191234|NCT01768000|12380980|FG003|STARTED|Overall Study||10
11191235|NCT01768000|12380977|FG000|COMPLETED|Overall Study||9
11191236|NCT01768000|12380978|FG001|COMPLETED|Overall Study||8
11191237|NCT01768000|12380979|FG002|COMPLETED|Overall Study||9
11191238|NCT01768000|12380980|FG003|COMPLETED|Overall Study||8
11191239|NCT01768000|12380977|FG000|NOT COMPLETED|Overall Study||1
11191240|NCT01768000|12380978|FG001|NOT COMPLETED|Overall Study||2
11191241|NCT01768000|12380979|FG002|NOT COMPLETED|Overall Study||1
11191242|NCT01768000|12380980|FG003|NOT COMPLETED|Overall Study||2
11191243|NCT01768013|12380992|FG000|STARTED|Overall Study||13
11191244|NCT01768013|12380992|FG000|COMPLETED|Overall Study||13
11191245|NCT01768013|12380992|FG000|NOT COMPLETED|Overall Study||0
11191246|NCT01768117|12380996|FG000|STARTED|Overall Study||13
11191247|NCT01768117|12380996|FG000|COMPLETED|Overall Study||7
11191248|NCT01768117|12380996|FG000|NOT COMPLETED|Overall Study||6
11191249|NCT01768286|12381004|FG000|STARTED|Overall Study||109
11191250|NCT01768286|12381005|FG001|STARTED|Overall Study||111
11191251|NCT01768286|12381006|FG002|STARTED|Overall Study||110
11191252|NCT01768286|12381007|FG003|STARTED|Overall Study||111
11191253|NCT01768286|12381004|FG000|COMPLETED|Overall Study||102
11191254|NCT01768286|12381005|FG001|COMPLETED|Overall Study||107
11191255|NCT01768286|12381006|FG002|COMPLETED|Overall Study||108
11191256|NCT01768286|12381007|FG003|COMPLETED|Overall Study||110
11191257|NCT01768286|12381004|FG000|NOT COMPLETED|Overall Study||7
11191258|NCT01768286|12381005|FG001|NOT COMPLETED|Overall Study||4
11191259|NCT01768286|12381006|FG002|NOT COMPLETED|Overall Study||2
11191260|NCT01768286|12381007|FG003|NOT COMPLETED|Overall Study||1
11191261|NCT01768325|12381019|FG000|STARTED|Overall Study||37
11191262|NCT01768325|12381020|FG001|STARTED|Overall Study||41
11191263|NCT01768325|12381019|FG000|COMPLETED|Overall Study||37
11191264|NCT01768325|12381020|FG001|COMPLETED|Overall Study||41
11191265|NCT01768325|12381019|FG000|NOT COMPLETED|Overall Study||0
11191266|NCT01768325|12381020|FG001|NOT COMPLETED|Overall Study||0
11191267|NCT01768520|12381031|FG000|STARTED|Overall Study||152
11191268|NCT01768520|12381032|FG001|STARTED|Overall Study||147
11191269|NCT01768520|12381033|FG002|STARTED|Overall Study||39
11191270|NCT01768520|12381031|FG000|COMPLETED|Overall Study||120
11191271|NCT01768520|12381032|FG001|COMPLETED|Overall Study||121
11191272|NCT01768520|12381033|FG002|COMPLETED|Overall Study||30
11191273|NCT01768520|12381031|FG000|NOT COMPLETED|Overall Study||32
11191274|NCT01768520|12381032|FG001|NOT COMPLETED|Overall Study||26
11191275|NCT01768520|12381033|FG002|NOT COMPLETED|Overall Study||9
11191276|NCT01768559|12381044|FG000|STARTED|Overall Study||298
11191277|NCT01768559|12381045|FG001|STARTED|Overall Study||298
11191278|NCT01768559|12381046|FG002|STARTED|Overall Study||298
11191279|NCT01768559|12381044|FG000|Treated|Overall Study||298
11191280|NCT01768559|12381045|FG001|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
11191281|NCT01768559|12381046|FG002|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
11191282|NCT01768559|12381044|FG000|COMPLETED|Overall Study||268
11191283|NCT01768559|12381045|FG001|COMPLETED|Overall Study||281
11191284|NCT01768559|12381046|FG002|COMPLETED|Overall Study||285
11191285|NCT01768559|12381044|FG000|NOT COMPLETED|Overall Study||30
11191286|NCT01768559|12381045|FG001|NOT COMPLETED|Overall Study||17
11191287|NCT01768559|12381046|FG002|NOT COMPLETED|Overall Study||13
11191288|NCT01768572|12381061|FG000|STARTED|Overall Study||49
11191289|NCT01768572|12381062|FG001|STARTED|Overall Study||51
11191290|NCT01768572|12381063|FG002|STARTED|Overall Study||102
11191291|NCT01768572|12381061|FG000|COMPLETED|Overall Study||40
11191292|NCT01768572|12381062|FG001|COMPLETED|Overall Study||39
11191293|NCT01768572|12381063|FG002|COMPLETED|Overall Study||96
11191294|NCT01768572|12381061|FG000|NOT COMPLETED|Overall Study||9
11191295|NCT01768572|12381062|FG001|NOT COMPLETED|Overall Study||12
11191296|NCT01768572|12381063|FG002|NOT COMPLETED|Overall Study||6
11191297|NCT01768637|12381073|FG000|STARTED|Overall Study||29
11191298|NCT01768637|12381074|FG001|STARTED|Overall Study||19
11191299|NCT01768637|12381073|FG000|Completed Visit 1|Overall Study||28
11191300|NCT01768637|12381074|FG001|Completed Visit 1|Overall Study||16
11191301|NCT01768637|12381073|FG000|Completed Visit 2|Overall Study||26
11191302|NCT01768637|12381074|FG001|Completed Visit 2|Overall Study||13
11191303|NCT01768637|12381073|FG000|COMPLETED|Overall Study||26
11191304|NCT01768637|12381074|FG001|COMPLETED|Overall Study||12
11191305|NCT01768637|12381073|FG000|NOT COMPLETED|Overall Study||3
11191306|NCT01768637|12381074|FG001|NOT COMPLETED|Overall Study||7
11191307|NCT01768676|12381082|FG000|STARTED|Overall Study||90
11191308|NCT01768676|12381083|FG001|STARTED|Overall Study||91
11191309|NCT01768676|12381082|FG000|COMPLETED|Overall Study||66
11191310|NCT01768676|12381083|FG001|COMPLETED|Overall Study||60
11191311|NCT01768676|12381082|FG000|NOT COMPLETED|Overall Study||24
11191312|NCT01768676|12381083|FG001|NOT COMPLETED|Overall Study||31
11191313|NCT01768832|12381092|FG000|STARTED|Overall Study||41
11191314|NCT01768832|12381093|FG001|STARTED|Overall Study||43
11191315|NCT01768832|12381094|FG002|STARTED|Overall Study||35
11191316|NCT01768832|12381092|FG000|COMPLETED|Overall Study||31
11191317|NCT01768832|12381093|FG001|COMPLETED|Overall Study||39
11191318|NCT01768832|12381094|FG002|COMPLETED|Overall Study||26
11191319|NCT01768832|12381092|FG000|NOT COMPLETED|Overall Study||10
11191320|NCT01768832|12381093|FG001|NOT COMPLETED|Overall Study||4
11191321|NCT01768832|12381094|FG002|NOT COMPLETED|Overall Study||9
11191322|NCT01768845|12381102|FG000|STARTED|Overall Study||34
11191323|NCT01768845|12381102|FG000|COMPLETED|Overall Study||11
11191324|NCT01768845|12381102|FG000|NOT COMPLETED|Overall Study||23
11191325|NCT01768858|12381106|FG000|STARTED|Overall Study||96
11191326|NCT01768858|12381106|FG000|COMPLETED|Overall Study||74
11191327|NCT01768858|12381106|FG000|NOT COMPLETED|Overall Study||22
11191328|NCT01769105|12381112|FG000|STARTED|First Intervention||16
11191329|NCT01769105|12381113|FG001|STARTED|First Intervention||19
11191330|NCT01769105|12381112|FG000|COMPLETED|First Intervention||14
11191331|NCT01769105|12381113|FG001|COMPLETED|First Intervention||17
11191332|NCT01769105|12381112|FG000|NOT COMPLETED|First Intervention||2
11191333|NCT01769105|12381113|FG001|NOT COMPLETED|First Intervention||2
11191334|NCT01769105|12381112|FG000|STARTED|Cross-over||14
11191335|NCT01769105|12381113|FG001|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
11191336|NCT01769105|12381112|FG000|COMPLETED|Cross-over||9
11191337|NCT01769105|12381113|FG001|COMPLETED|Cross-over|Was not intended by the study protocol|0
11191338|NCT01769105|12381112|FG000|NOT COMPLETED|Cross-over||5
11191339|NCT01769105|12381113|FG001|NOT COMPLETED|Cross-over||0
11191340|NCT01769170|12381123|FG000|STARTED|Overall Study||303
11191341|NCT01769170|12381124|FG001|STARTED|Overall Study||149
11191342|NCT01769170|12381123|FG000|COMPLETED|Overall Study||232
11191343|NCT01769170|12381124|FG001|COMPLETED|Overall Study||122
11191344|NCT01769170|12381123|FG000|NOT COMPLETED|Overall Study||71
11191345|NCT01769170|12381124|FG001|NOT COMPLETED|Overall Study||27
11191346|NCT01769196|12381132|FG000|STARTED|Overall Study||272
11191347|NCT01769196|12381133|FG001|STARTED|Overall Study||272
11191348|NCT01769196|12381132|FG000|COMPLETED|Overall Study||0
11191349|NCT01769196|12381133|FG001|COMPLETED|Overall Study||0
11191350|NCT01769196|12381132|FG000|NOT COMPLETED|Overall Study||272
11191351|NCT01769196|12381133|FG001|NOT COMPLETED|Overall Study||272
11191352|NCT01769209|12381139|FG000|STARTED|Overall Study||18
11191353|NCT01769209|12381139|FG000|COMPLETED|Overall Study||18
11191354|NCT01769209|12381139|FG000|NOT COMPLETED|Overall Study||0
11191355|NCT01769222|12381145|FG000|STARTED|Overall Study||3
11191356|NCT01769222|12381146|FG001|STARTED|Overall Study||0
11191357|NCT01769222|12381145|FG000|COMPLETED|Overall Study||3
11191358|NCT01769222|12381146|FG001|COMPLETED|Overall Study||0
11191359|NCT01769222|12381145|FG000|NOT COMPLETED|Overall Study||0
11191360|NCT01769222|12381146|FG001|NOT COMPLETED|Overall Study||0
11191361|NCT01769248|12381154|FG000|STARTED|Overall Study||70
11191362|NCT01769248|12381155|FG001|STARTED|Overall Study||70
11191363|NCT01769248|12381154|FG000|Participants Who Crossed-over|Overall Study||28
11191364|NCT01769248|12381155|FG001|Participants Who Crossed-over|Overall Study||12
11191365|NCT01769248|12381154|FG000|COMPLETED|Overall Study||42
11191366|NCT01769248|12381155|FG001|COMPLETED|Overall Study||58
11191367|NCT01769248|12381154|FG000|NOT COMPLETED|Overall Study||28
11191368|NCT01769248|12381155|FG001|NOT COMPLETED|Overall Study||12
11191369|NCT01769274|12381163|FG000|STARTED|Part A||5
11191370|NCT01769274|12381164|FG001|STARTED|Part A||0
11191371|NCT01769274|12381165|FG002|STARTED|Part A||0
11191372|NCT01769274|12381163|FG000|COMPLETED|Part A||5
11191373|NCT01769274|12381164|FG001|COMPLETED|Part A||0
11191374|NCT01769274|12381165|FG002|COMPLETED|Part A||0
11191375|NCT01769274|12381163|FG000|NOT COMPLETED|Part A||0
11191376|NCT01769274|12381164|FG001|NOT COMPLETED|Part A||0
11191377|NCT01769274|12381165|FG002|NOT COMPLETED|Part A||0
11191378|NCT01769274|12381163|FG000|STARTED|Part B:Treatment Session1-Period1||0
11191379|NCT01769274|12381164|FG001|STARTED|Part B:Treatment Session1-Period1||2
11191380|NCT01769274|12381165|FG002|STARTED|Part B:Treatment Session1-Period1||3
11191381|NCT01769274|12381163|FG000|COMPLETED|Part B:Treatment Session1-Period1||0
11191382|NCT01769274|12381164|FG001|COMPLETED|Part B:Treatment Session1-Period1||2
11191383|NCT01769274|12381165|FG002|COMPLETED|Part B:Treatment Session1-Period1||3
11191384|NCT01769274|12381163|FG000|NOT COMPLETED|Part B:Treatment Session1-Period1||0
11191385|NCT01769274|12381164|FG001|NOT COMPLETED|Part B:Treatment Session1-Period1||0
11191386|NCT01769274|12381165|FG002|NOT COMPLETED|Part B:Treatment Session1-Period1||0
11191387|NCT01769274|12381163|FG000|STARTED|Washout Period||0
11191388|NCT01769274|12381164|FG001|STARTED|Washout Period||2
11191389|NCT01769274|12381165|FG002|STARTED|Washout Period||3
11191390|NCT01769274|12381163|FG000|COMPLETED|Washout Period||0
11191391|NCT01769274|12381164|FG001|COMPLETED|Washout Period||2
11191392|NCT01769274|12381165|FG002|COMPLETED|Washout Period||3
11191393|NCT01769274|12381163|FG000|NOT COMPLETED|Washout Period||0
11191394|NCT01769274|12381164|FG001|NOT COMPLETED|Washout Period||0
11191395|NCT01769274|12381165|FG002|NOT COMPLETED|Washout Period||0
11191396|NCT01769274|12381163|FG000|STARTED|Part B:Treatment Session1-Period2||0
11191397|NCT01769274|12381164|FG001|STARTED|Part B:Treatment Session1-Period2||2
11191398|NCT01769274|12381165|FG002|STARTED|Part B:Treatment Session1-Period2||3
11191399|NCT01769274|12381163|FG000|COMPLETED|Part B:Treatment Session1-Period2||0
11191400|NCT01769274|12381164|FG001|COMPLETED|Part B:Treatment Session1-Period2||2
11191401|NCT01769274|12381165|FG002|COMPLETED|Part B:Treatment Session1-Period2||3
11191402|NCT01769274|12381163|FG000|NOT COMPLETED|Part B:Treatment Session1-Period2||0
11191403|NCT01769274|12381164|FG001|NOT COMPLETED|Part B:Treatment Session1-Period2||0
11191404|NCT01769274|12381165|FG002|NOT COMPLETED|Part B:Treatment Session1-Period2||0
11191405|NCT01769274|12381163|FG000|STARTED|Washout Period||0
11191406|NCT01769274|12381164|FG001|STARTED|Washout Period||2
11191407|NCT01769274|12381165|FG002|STARTED|Washout Period||3
11191408|NCT01769274|12381163|FG000|COMPLETED|Washout Period||0
11191409|NCT01769274|12381164|FG001|COMPLETED|Washout Period||2
11191410|NCT01769274|12381165|FG002|COMPLETED|Washout Period||3
11191411|NCT01769274|12381163|FG000|NOT COMPLETED|Washout Period||0
11191412|NCT01769274|12381164|FG001|NOT COMPLETED|Washout Period||0
11191413|NCT01769274|12381165|FG002|NOT COMPLETED|Washout Period||0
11191414|NCT01769274|12381163|FG000|STARTED|Part B:Treatment Session2-Period3||0
11191415|NCT01769274|12381164|FG001|STARTED|Part B:Treatment Session2-Period3||2
11191416|NCT01769274|12381165|FG002|STARTED|Part B:Treatment Session2-Period3||3
11191417|NCT01769274|12381163|FG000|COMPLETED|Part B:Treatment Session2-Period3||0
11191418|NCT01769274|12381164|FG001|COMPLETED|Part B:Treatment Session2-Period3||2
11191419|NCT01769274|12381165|FG002|COMPLETED|Part B:Treatment Session2-Period3||3
11191420|NCT01769274|12381163|FG000|NOT COMPLETED|Part B:Treatment Session2-Period3||0
11191421|NCT01769274|12381164|FG001|NOT COMPLETED|Part B:Treatment Session2-Period3||0
11191422|NCT01769274|12381165|FG002|NOT COMPLETED|Part B:Treatment Session2-Period3||0
11191423|NCT01769274|12381163|FG000|STARTED|Washout Period||0
11191424|NCT01769274|12381164|FG001|STARTED|Washout Period||2
11191425|NCT01769274|12381165|FG002|STARTED|Washout Period||3
11191426|NCT01769274|12381163|FG000|COMPLETED|Washout Period||0
11191427|NCT01769274|12381164|FG001|COMPLETED|Washout Period||2
11191428|NCT01769274|12381165|FG002|COMPLETED|Washout Period||3
11191429|NCT01769274|12381163|FG000|NOT COMPLETED|Washout Period||0
11191430|NCT01769274|12381164|FG001|NOT COMPLETED|Washout Period||0
11191431|NCT01769274|12381165|FG002|NOT COMPLETED|Washout Period||0
11191432|NCT01769274|12381163|FG000|STARTED|Part B:Treatment Session2-Period4||0
11191433|NCT01769274|12381164|FG001|STARTED|Part B:Treatment Session2-Period4||2
11191434|NCT01769274|12381165|FG002|STARTED|Part B:Treatment Session2-Period4||3
11191435|NCT01769274|12381163|FG000|COMPLETED|Part B:Treatment Session2-Period4||0
11191436|NCT01769274|12381164|FG001|COMPLETED|Part B:Treatment Session2-Period4||2
11191437|NCT01769274|12381165|FG002|COMPLETED|Part B:Treatment Session2-Period4||3
11191438|NCT01769274|12381163|FG000|NOT COMPLETED|Part B:Treatment Session2-Period4||0
11191439|NCT01769274|12381164|FG001|NOT COMPLETED|Part B:Treatment Session2-Period4||0
11191440|NCT01769274|12381165|FG002|NOT COMPLETED|Part B:Treatment Session2-Period4||0
11191441|NCT01769326|12381180|FG000|STARTED|Overall Study||11
11191442|NCT01769326|12381181|FG001|STARTED|Overall Study||12
11191443|NCT01769326|12381182|FG002|STARTED|Overall Study||9
11191444|NCT01769326|12381183|FG003|STARTED|Overall Study||8
11191445|NCT01769326|12381180|FG000|COMPLETED|Overall Study||9
11191446|NCT01769326|12381181|FG001|COMPLETED|Overall Study||8
11191447|NCT01769326|12381182|FG002|COMPLETED|Overall Study||8
11191448|NCT01769326|12381183|FG003|COMPLETED|Overall Study||8
11191449|NCT01769326|12381180|FG000|NOT COMPLETED|Overall Study||2
11191450|NCT01769326|12381181|FG001|NOT COMPLETED|Overall Study||4
11191451|NCT01769326|12381182|FG002|NOT COMPLETED|Overall Study||1
11191452|NCT01769326|12381183|FG003|NOT COMPLETED|Overall Study||0
11191453|NCT01769339|12381193|FG000|STARTED|Overall Study||115
11191454|NCT01769339|12381193|FG000|COMPLETED|Overall Study||72
11191455|NCT01769339|12381193|FG000|NOT COMPLETED|Overall Study||43
11191456|NCT01769352|12381201|FG000|STARTED|Overall Study||13
11191457|NCT01769352|12381202|FG001|STARTED|Overall Study||12
11191458|NCT01769352|12381203|FG002|STARTED|Overall Study||9
11191459|NCT01769352|12381204|FG003|STARTED|Overall Study||8
11191460|NCT01769352|12381201|FG000|COMPLETED|Overall Study||13
11191461|NCT01769352|12381202|FG001|COMPLETED|Overall Study||12
11191462|NCT01769352|12381203|FG002|COMPLETED|Overall Study||9
11191463|NCT01769352|12381204|FG003|COMPLETED|Overall Study||8
11191464|NCT01769352|12381201|FG000|NOT COMPLETED|Overall Study||0
11191465|NCT01769352|12381202|FG001|NOT COMPLETED|Overall Study||0
11191466|NCT01769352|12381203|FG002|NOT COMPLETED|Overall Study||0
11191467|NCT01769352|12381204|FG003|NOT COMPLETED|Overall Study||0
11191468|NCT01769365|12381218|FG000|STARTED|Overall Study||102
11191469|NCT01769365|12381219|FG001|STARTED|Overall Study||102
11191470|NCT01769365|12381220|FG002|STARTED|Overall Study||103
11191471|NCT01769365|12381218|FG000|COMPLETED|Overall Study||102
11191472|NCT01769365|12381219|FG001|COMPLETED|Overall Study||100
11191473|NCT01769365|12381220|FG002|COMPLETED|Overall Study||101
11191474|NCT01769365|12381218|FG000|NOT COMPLETED|Overall Study||0
11191475|NCT01769365|12381219|FG001|NOT COMPLETED|Overall Study||2
11191476|NCT01769365|12381220|FG002|NOT COMPLETED|Overall Study||2
11191477|NCT01769378|12381230|FG000|STARTED|Overall Study||240
11191478|NCT01769378|12381231|FG001|STARTED|Overall Study||60
11191479|NCT01769378|12381230|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239
11191480|NCT01769378|12381231|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
11191481|NCT01769378|12381230|FG000|COMPLETED|Overall Study|Completed the study on study treatment|215
11191482|NCT01769378|12381231|FG001|COMPLETED|Overall Study|Completed the study on study treatment|56
11191483|NCT01769378|12381230|FG000|NOT COMPLETED|Overall Study||25
11191484|NCT01769378|12381231|FG001|NOT COMPLETED|Overall Study||4
11191485|NCT01769391|12381239|FG000|STARTED|Overall Study||110
11191486|NCT01769391|12381240|FG001|STARTED|Overall Study||57
11191487|NCT01769391|12381239|FG000|Received at Least One Dose of Study Drug|Overall Study||106
11191488|NCT01769391|12381240|FG001|Received at Least One Dose of Study Drug|Overall Study||55
11191489|NCT01769391|12381239|FG000|COMPLETED|Overall Study||93
11191490|NCT01769391|12381240|FG001|COMPLETED|Overall Study||48
11191491|NCT01769391|12381239|FG000|NOT COMPLETED|Overall Study||17
11191492|NCT01769391|12381240|FG001|NOT COMPLETED|Overall Study||9
11191493|NCT01769404|12381252|FG000|STARTED|Treatment Period 1||12
11191494|NCT01769404|12381253|FG001|STARTED|Treatment Period 1||13
11191495|NCT01769404|12381252|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
11191496|NCT01769404|12381253|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||13
11191497|NCT01769404|12381252|FG000|COMPLETED|Treatment Period 1||7
11191498|NCT01769404|12381253|FG001|COMPLETED|Treatment Period 1||13
11191499|NCT01769404|12381252|FG000|NOT COMPLETED|Treatment Period 1||5
11191500|NCT01769404|12381253|FG001|NOT COMPLETED|Treatment Period 1||0
11191501|NCT01769404|12381252|FG000|STARTED|Treatment Period 2||7
11191502|NCT01769404|12381253|FG001|STARTED|Treatment Period 2||13
11191503|NCT01769404|12381252|FG000|COMPLETED|Treatment Period 2||0
11191504|NCT01769404|12381253|FG001|COMPLETED|Treatment Period 2||13
11191505|NCT01769404|12381252|FG000|NOT COMPLETED|Treatment Period 2||7
11191506|NCT01769404|12381253|FG001|NOT COMPLETED|Treatment Period 2||0
11191507|NCT01769456|12381261|FG000|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
11191508|NCT01769456|12381261|FG000|COMPLETED|Overall Study||41
11191509|NCT01769456|12381261|FG000|NOT COMPLETED|Overall Study||37
11191510|NCT01769469|12381266|FG000|STARTED|Overall Study||101
11191511|NCT01769469|12381266|FG000|COMPLETED|Overall Study||66
11191512|NCT01769469|12381266|FG000|NOT COMPLETED|Overall Study||35
11204754|NCT01855048|12395386|FG005|NOT COMPLETED|Overall Study||0
11204755|NCT01855074|12395410|FG000|STARTED|Overall Study||80
11204756|NCT01855074|12395410|FG000|Treated|Overall Study||79
11204757|NCT01855074|12395410|FG000|COMPLETED|Overall Study||66
11204758|NCT01855074|12395410|FG000|NOT COMPLETED|Overall Study||14
11204759|NCT01855126|12395416|FG000|STARTED|First Intervention (8 Weeks)||24
11204760|NCT01855126|12395417|FG001|STARTED|First Intervention (8 Weeks)||22
11204761|NCT01855126|12395416|FG000|COMPLETED|First Intervention (8 Weeks)||20
11204762|NCT01855126|12395417|FG001|COMPLETED|First Intervention (8 Weeks)||16
11204763|NCT01855126|12395416|FG000|NOT COMPLETED|First Intervention (8 Weeks)||4
11204764|NCT01855126|12395417|FG001|NOT COMPLETED|First Intervention (8 Weeks)||6
11204765|NCT01855126|12395416|FG000|STARTED|Washout Period (2 Weeks)||20
11204766|NCT01855126|12395417|FG001|STARTED|Washout Period (2 Weeks)||16
11204767|NCT01855126|12395416|FG000|COMPLETED|Washout Period (2 Weeks)||20
11204768|NCT01855126|12395417|FG001|COMPLETED|Washout Period (2 Weeks)||16
11204769|NCT01855126|12395416|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
11204770|NCT01855126|12395417|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
11204771|NCT01855126|12395416|FG000|STARTED|Second Intervention (8 Weeks)||20
11204772|NCT01855126|12395417|FG001|STARTED|Second Intervention (8 Weeks)||16
11204773|NCT01855126|12395416|FG000|COMPLETED|Second Intervention (8 Weeks)||18
11204774|NCT01855126|12395417|FG001|COMPLETED|Second Intervention (8 Weeks)||14
11204775|NCT01855126|12395416|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2
11204776|NCT01855126|12395417|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||2
11204777|NCT01855243|12395430|FG000|STARTED|Overall Study||20
11204778|NCT01855243|12395431|FG001|STARTED|Overall Study||21
11204779|NCT01855243|12395432|FG002|STARTED|Overall Study||22
11204780|NCT01855243|12395430|FG000|COMPLETED|Overall Study||19
11204781|NCT01855243|12395431|FG001|COMPLETED|Overall Study||21
11204782|NCT01855243|12395432|FG002|COMPLETED|Overall Study||22
11204783|NCT01855243|12395430|FG000|NOT COMPLETED|Overall Study||1
11204784|NCT01855243|12395431|FG001|NOT COMPLETED|Overall Study||0
11204785|NCT01855243|12395432|FG002|NOT COMPLETED|Overall Study||0
11204786|NCT01855360|12395440|FG000|STARTED|Overall Study||40
11204787|NCT01855360|12395440|FG000|COMPLETED|Overall Study||30
11204788|NCT01855360|12395440|FG000|NOT COMPLETED|Overall Study||10
11204789|NCT01855399|12395446|FG000|STARTED|6 Month||146
11204790|NCT01855399|12395447|FG001|STARTED|6 Month||144
11204791|NCT01855399|12395446|FG000|COMPLETED|6 Month||126
11204792|NCT01855399|12395447|FG001|COMPLETED|6 Month||129
11204793|NCT01855399|12395446|FG000|NOT COMPLETED|6 Month||20
11204794|NCT01855399|12395447|FG001|NOT COMPLETED|6 Month||15
11204795|NCT01855399|12395446|FG000|STARTED|12 Month||126
11204796|NCT01855399|12395447|FG001|STARTED|12 Month||129
11204797|NCT01855399|12395446|FG000|COMPLETED|12 Month||119
11191513|NCT01769508|12381272|FG000|STARTED|Overall Study||12
11191514|NCT01769508|12381272|FG000|COMPLETED|Overall Study||6
11191515|NCT01769508|12381272|FG000|NOT COMPLETED|Overall Study||6
11191516|NCT01769573|12381281|FG000|STARTED|Overall Study||10
11191517|NCT01769573|12381282|FG001|STARTED|Overall Study||6
11191518|NCT01769573|12381283|FG002|STARTED|Overall Study||10
11191519|NCT01769573|12381284|FG003|STARTED|Overall Study||0
11191520|NCT01769573|12381285|FG004|STARTED|Overall Study||10
11191521|NCT01769573|12381281|FG000|COMPLETED|Overall Study||10
11191522|NCT01769573|12381282|FG001|COMPLETED|Overall Study||6
11191523|NCT01769573|12381283|FG002|COMPLETED|Overall Study||10
11191524|NCT01769573|12381284|FG003|COMPLETED|Overall Study||0
11191525|NCT01769573|12381285|FG004|COMPLETED|Overall Study||10
11191526|NCT01769573|12381281|FG000|NOT COMPLETED|Overall Study||0
11191527|NCT01769573|12381282|FG001|NOT COMPLETED|Overall Study||0
11191528|NCT01769573|12381283|FG002|NOT COMPLETED|Overall Study||0
11191529|NCT01769573|12381284|FG003|NOT COMPLETED|Overall Study||0
11191530|NCT01769573|12381285|FG004|NOT COMPLETED|Overall Study||0
11191531|NCT01769586|12381299|FG000|STARTED|Overall Study||100
11191532|NCT01769586|12381300|FG001|STARTED|Overall Study||100
11191533|NCT01769586|12381299|FG000|COMPLETED|Overall Study||100
11191534|NCT01769586|12381300|FG001|COMPLETED|Overall Study||100
11191535|NCT01769586|12381299|FG000|NOT COMPLETED|Overall Study||0
11191536|NCT01769586|12381300|FG001|NOT COMPLETED|Overall Study||0
11191537|NCT01769612|12381306|FG000|STARTED|Overall Study||168
11191538|NCT01769612|12381306|FG000|COMPLETED|Overall Study||168
11191539|NCT01769612|12381306|FG000|NOT COMPLETED|Overall Study||0
11191540|NCT01770145|12381312|FG000|STARTED|Baseline||127
11191541|NCT01770145|12381312|FG000|COMPLETED|Baseline||101
11191542|NCT01770145|12381312|FG000|NOT COMPLETED|Baseline||26
11191543|NCT01770145|12381312|FG000|STARTED|Treatment||101
11191544|NCT01770145|12381312|FG000|COMPLETED|Treatment||97
11191545|NCT01770145|12381312|FG000|NOT COMPLETED|Treatment||4
11191546|NCT01770314|12381318|FG000|STARTED|Overall Study||86
11191547|NCT01770314|12381319|FG001|STARTED|Overall Study||90
11191548|NCT01770314|12381318|FG000|Contributed Data to Baseline|Overall Study||68
11191549|NCT01770314|12381319|FG001|Contributed Data to Baseline|Overall Study||72
11191550|NCT01770314|12381318|FG000|Contributed Data to Post-test|Overall Study||65
11191551|NCT01770314|12381319|FG001|Contributed Data to Post-test|Overall Study||67
11191552|NCT01770314|12381318|FG000|Contributed Data to One-month Follow-up|Overall Study||61
11191553|NCT01770314|12381319|FG001|Contributed Data to One-month Follow-up|Overall Study||66
11191554|NCT01770314|12381318|FG000|COMPLETED|Overall Study||86
11191555|NCT01770314|12381319|FG001|COMPLETED|Overall Study||90
11191556|NCT01770314|12381318|FG000|NOT COMPLETED|Overall Study||0
11191557|NCT01770314|12381319|FG001|NOT COMPLETED|Overall Study||0
11191558|NCT01770353|12381327|FG000|STARTED|Overall Study||15
11191559|NCT01770353|12381328|FG001|STARTED|Overall Study||30
11191560|NCT01770353|12381327|FG000|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15
11191561|NCT01770353|12381328|FG001|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30
11191562|NCT01770353|12381327|FG000|Received FMX and MM-398|Overall Study||13
11191563|NCT01770353|12381328|FG001|Received FMX and MM-398|Overall Study||29
11191564|NCT01770353|12381327|FG000|COMPLETED|Overall Study||9
11191565|NCT01770353|12381328|FG001|COMPLETED|Overall Study||18
11191566|NCT01770353|12381327|FG000|NOT COMPLETED|Overall Study||6
11191567|NCT01770353|12381328|FG001|NOT COMPLETED|Overall Study||12
11191568|NCT01770366|12381344|FG000|STARTED|Overall Study||4
11191569|NCT01770366|12381345|FG001|STARTED|Overall Study||6
11191570|NCT01770366|12381344|FG000|COMPLETED|Overall Study||2
11191571|NCT01770366|12381345|FG001|COMPLETED|Overall Study||4
11191572|NCT01770366|12381344|FG000|NOT COMPLETED|Overall Study||2
11191573|NCT01770366|12381345|FG001|NOT COMPLETED|Overall Study||2
11191574|NCT01770379|12381354|FG000|STARTED|Overall Study||80
11191575|NCT01770379|12381355|FG001|STARTED|Overall Study||81
11191576|NCT01770379|12381356|FG002|STARTED|Overall Study||81
11191577|NCT01770379|12381354|FG000|COMPLETED|Overall Study||41
11191578|NCT01770379|12381355|FG001|COMPLETED|Overall Study||37
11191579|NCT01770379|12381356|FG002|COMPLETED|Overall Study||39
11191580|NCT01770379|12381354|FG000|NOT COMPLETED|Overall Study||39
11191581|NCT01770379|12381355|FG001|NOT COMPLETED|Overall Study||44
11191582|NCT01770379|12381356|FG002|NOT COMPLETED|Overall Study||42
11191583|NCT01770392|12381366|FG000|STARTED|Nintedanib||26
11191584|NCT01770392|12381366|FG000|COMPLETED|Nintedanib||26
11191585|NCT01770392|12381366|FG000|NOT COMPLETED|Nintedanib||0
11191586|NCT01770392|12381366|FG000|STARTED|Washout Period of at Least 14 Days||26
11191587|NCT01770392|12381366|FG000|COMPLETED|Washout Period of at Least 14 Days||25
11191588|NCT01770392|12381366|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||1
11191589|NCT01770392|12381366|FG000|STARTED|Nintedanib+ Rifampicin||25
11191590|NCT01770392|12381366|FG000|COMPLETED|Nintedanib+ Rifampicin||25
11191591|NCT01770392|12381366|FG000|NOT COMPLETED|Nintedanib+ Rifampicin||0
11191592|NCT01770431|12381378|FG000|STARTED|Overall Study||696
11191593|NCT01770431|12381379|FG001|STARTED|Overall Study||348
11191594|NCT01770431|12381378|FG000|COMPLETED|Overall Study||686
11191595|NCT01770431|12381379|FG001|COMPLETED|Overall Study||316
11191596|NCT01770431|12381378|FG000|NOT COMPLETED|Overall Study||10
11191597|NCT01770431|12381379|FG001|NOT COMPLETED|Overall Study||32
11191598|NCT01770483|12381388|FG000|STARTED|Overall Study||33
11191599|NCT01770483|12381389|FG001|STARTED|Overall Study||33
11191600|NCT01770483|12381388|FG000|COMPLETED|Overall Study||33
11191601|NCT01770483|12381389|FG001|COMPLETED|Overall Study||33
11191602|NCT01770483|12381388|FG000|NOT COMPLETED|Overall Study||0
11191603|NCT01770483|12381389|FG001|NOT COMPLETED|Overall Study||0
11191604|NCT01770509|12381397|FG000|STARTED|Overall Study||12
11191605|NCT01770509|12381398|FG001|STARTED|Overall Study||17
11191606|NCT01770509|12381397|FG000|COMPLETED|Overall Study||11
11191607|NCT01770509|12381398|FG001|COMPLETED|Overall Study||14
11191608|NCT01770509|12381397|FG000|NOT COMPLETED|Overall Study||1
11191609|NCT01770509|12381398|FG001|NOT COMPLETED|Overall Study||3
11191610|NCT01770652|12381408|FG000|STARTED|Overall Study||8
11191611|NCT01770652|12381409|FG001|STARTED|Overall Study||8
11191612|NCT01770652|12381410|FG002|STARTED|Overall Study||8
11191613|NCT01770652|12381411|FG003|STARTED|Overall Study||8
11191614|NCT01770652|12381408|FG000|COMPLETED|Overall Study||8
11191615|NCT01770652|12381409|FG001|COMPLETED|Overall Study||8
11191616|NCT01770652|12381410|FG002|COMPLETED|Overall Study||8
11191617|NCT01770652|12381411|FG003|COMPLETED|Overall Study||8
11191618|NCT01770652|12381408|FG000|NOT COMPLETED|Overall Study||0
11191619|NCT01770652|12381409|FG001|NOT COMPLETED|Overall Study||0
11191620|NCT01770652|12381410|FG002|NOT COMPLETED|Overall Study||0
11191621|NCT01770652|12381411|FG003|NOT COMPLETED|Overall Study||0
11191622|NCT01770691|12381425|FG000|STARTED|Overall Study||7
11191623|NCT01770691|12381425|FG000|COMPLETED|Overall Study||7
11191624|NCT01770691|12381425|FG000|NOT COMPLETED|Overall Study||0
11191625|NCT01770743|12381437|FG000|STARTED|Overall Study||44
11191626|NCT01770743|12381438|FG001|STARTED|Overall Study||34
11191627|NCT01770743|12381439|FG002|STARTED|Overall Study||23
11191628|NCT01770743|12381440|FG003|STARTED|Overall Study||44
11191629|NCT01770743|12381441|FG004|STARTED|Overall Study||23
11191630|NCT01770743|12381437|FG000|Treated|Overall Study||44
11191631|NCT01770743|12381438|FG001|Treated|Overall Study||34
11191632|NCT01770743|12381439|FG002|Treated|Overall Study||23
11191633|NCT01770743|12381440|FG003|Treated|Overall Study||44
11191634|NCT01770743|12381441|FG004|Treated|Overall Study||23
11191635|NCT01770743|12381437|FG000|COMPLETED|Overall Study||42
11191636|NCT01770743|12381438|FG001|COMPLETED|Overall Study||31
11191637|NCT01770743|12381439|FG002|COMPLETED|Overall Study||22
11191638|NCT01770743|12381440|FG003|COMPLETED|Overall Study||42
11191639|NCT01770743|12381441|FG004|COMPLETED|Overall Study||21
11191640|NCT01770743|12381437|FG000|NOT COMPLETED|Overall Study||2
11191641|NCT01770743|12381438|FG001|NOT COMPLETED|Overall Study||3
11191642|NCT01770743|12381439|FG002|NOT COMPLETED|Overall Study||1
11191643|NCT01770743|12381440|FG003|NOT COMPLETED|Overall Study||2
11191644|NCT01770743|12381441|FG004|NOT COMPLETED|Overall Study||2
11191645|NCT01770860|12381453|FG000|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
11191646|NCT01770860|12381453|FG000|Randomization|Overall Study|One participant withdrew before randomization|45
11191647|NCT01770860|12381453|FG000|COMPLETED|Overall Study||40
11191648|NCT01770860|12381453|FG000|NOT COMPLETED|Overall Study||6
11191649|NCT01770912|12381463|FG000|STARTED|Overall Study||12
11191650|NCT01770912|12381464|FG001|STARTED|Overall Study||12
11191651|NCT01770912|12381463|FG000|COMPLETED|Overall Study||10
11191652|NCT01770912|12381464|FG001|COMPLETED|Overall Study||12
11191653|NCT01770912|12381463|FG000|NOT COMPLETED|Overall Study||2
11191654|NCT01770912|12381464|FG001|NOT COMPLETED|Overall Study||0
11191655|NCT01771055|12381472|FG000|STARTED|Overall Study||4
11191656|NCT01771055|12381473|FG001|STARTED|Overall Study||3
11191657|NCT01771055|12381472|FG000|COMPLETED|Overall Study||4
11191658|NCT01771055|12381473|FG001|COMPLETED|Overall Study||3
11191659|NCT01771055|12381472|FG000|NOT COMPLETED|Overall Study||0
11191660|NCT01771055|12381473|FG001|NOT COMPLETED|Overall Study||0
11191661|NCT01771172|12381479|FG000|STARTED|Overall Study||48
11191662|NCT01771172|12381479|FG000|COMPLETED|Overall Study||46
11191663|NCT01771172|12381479|FG000|NOT COMPLETED|Overall Study||2
11191664|NCT01771250|12381483|FG000|STARTED|Period 1||8
11191665|NCT01771250|12381484|FG001|STARTED|Period 1||7
11191666|NCT01771250|12381483|FG000|Received at Least One Dose of Study Drug|Period 1||7
11324484|NCT02743936|12521764|FG001|NOT COMPLETED|Overall Study||0
11324485|NCT02743949|12521773|FG000|STARTED|Overall Study||86
11324486|NCT02743949|12521774|FG001|STARTED|Overall Study||85
11324487|NCT02743949|12521775|FG002|STARTED|Overall Study||85
11324488|NCT02743949|12521773|FG000|COMPLETED|Overall Study||82
11324489|NCT02743949|12521774|FG001|COMPLETED|Overall Study||84
11324490|NCT02743949|12521775|FG002|COMPLETED|Overall Study||82
11324491|NCT02743949|12521773|FG000|NOT COMPLETED|Overall Study||4
11324492|NCT02743949|12521774|FG001|NOT COMPLETED|Overall Study||1
11324493|NCT02743949|12521775|FG002|NOT COMPLETED|Overall Study||3
11324494|NCT02743962|12521785|FG000|STARTED|Overall Study||5
11324495|NCT02743962|12521786|FG001|STARTED|Overall Study||5
11324496|NCT02743962|12521785|FG000|COMPLETED|Overall Study||4
11324497|NCT02743962|12521786|FG001|COMPLETED|Overall Study||5
11191667|NCT01771250|12381484|FG001|Received at Least One Dose of Study Drug|Period 1||7
11191668|NCT01771250|12381483|FG000|COMPLETED|Period 1||7
11191669|NCT01771250|12381484|FG001|COMPLETED|Period 1||7
11191670|NCT01771250|12381483|FG000|NOT COMPLETED|Period 1||1
11191671|NCT01771250|12381484|FG001|NOT COMPLETED|Period 1||0
11191672|NCT01771250|12381483|FG000|STARTED|Period 2||7
11191673|NCT01771250|12381484|FG001|STARTED|Period 2||7
11191674|NCT01771250|12381483|FG000|COMPLETED|Period 2||7
11191675|NCT01771250|12381484|FG001|COMPLETED|Period 2||7
11191676|NCT01771250|12381483|FG000|NOT COMPLETED|Period 2||0
11191677|NCT01771250|12381484|FG001|NOT COMPLETED|Period 2||0
11191678|NCT01771627|12381492|FG000|STARTED|Overall Study||200
11191679|NCT01771627|12381493|FG001|STARTED|Overall Study||100
11191680|NCT01771627|12381492|FG000|COMPLETED|Overall Study||92
11191681|NCT01771627|12381493|FG001|COMPLETED|Overall Study||50
11191682|NCT01771627|12381492|FG000|NOT COMPLETED|Overall Study||108
11191683|NCT01771627|12381493|FG001|NOT COMPLETED|Overall Study||50
11191684|NCT01771666|12381499|FG000|STARTED|Overall Study||23
11191685|NCT01771666|12381499|FG000|COMPLETED|Overall Study||23
11191686|NCT01771666|12381499|FG000|NOT COMPLETED|Overall Study||0
11191687|NCT01771731|12381505|FG000|STARTED|Overall Study||13
11191688|NCT01771731|12381506|FG001|STARTED|Overall Study||14
11191689|NCT01771731|12381505|FG000|COMPLETED|Overall Study||11
11191690|NCT01771731|12381506|FG001|COMPLETED|Overall Study||12
11191691|NCT01771731|12381505|FG000|NOT COMPLETED|Overall Study||2
11191692|NCT01771731|12381506|FG001|NOT COMPLETED|Overall Study||2
11191693|NCT01771809|12381514|FG000|STARTED|Overall Study||164
11191694|NCT01771809|12381515|FG001|STARTED|Overall Study||166
11191695|NCT01771809|12381514|FG000|COMPLETED|Overall Study||93
11191696|NCT01771809|12381515|FG001|COMPLETED|Overall Study||83
11191697|NCT01771809|12381514|FG000|NOT COMPLETED|Overall Study||71
11191698|NCT01771809|12381515|FG001|NOT COMPLETED|Overall Study||83
11191699|NCT01771913|12381523|FG000|STARTED|Overall Study||9
11191700|NCT01771913|12381524|FG001|STARTED|Overall Study||11
11191701|NCT01771913|12381523|FG000|COMPLETED|Overall Study||8
11191702|NCT01771913|12381524|FG001|COMPLETED|Overall Study||11
11191703|NCT01771913|12381523|FG000|NOT COMPLETED|Overall Study||1
11191704|NCT01771913|12381524|FG001|NOT COMPLETED|Overall Study||0
11191705|NCT01771952|12381532|FG000|STARTED|Overall Study||45
11191706|NCT01771952|12381533|FG001|STARTED|Overall Study||41
11191707|NCT01771952|12381532|FG000|COMPLETED|Overall Study||42
11191708|NCT01771952|12381533|FG001|COMPLETED|Overall Study||38
11191709|NCT01771952|12381532|FG000|NOT COMPLETED|Overall Study||3
11191710|NCT01771952|12381533|FG001|NOT COMPLETED|Overall Study||3
11191711|NCT01771965|12381541|FG000|STARTED|Overall Study||10
11191712|NCT01771965|12381542|FG001|STARTED|Overall Study||9
11191713|NCT01771965|12381541|FG000|COMPLETED|Overall Study||7
11191714|NCT01771965|12381542|FG001|COMPLETED|Overall Study||4
11191715|NCT01771965|12381541|FG000|NOT COMPLETED|Overall Study||3
11191716|NCT01771965|12381542|FG001|NOT COMPLETED|Overall Study||5
11191717|NCT01771991|12381550|FG000|STARTED|Overall Study||38
11191718|NCT01771991|12381551|FG001|STARTED|Overall Study||36
11191719|NCT01771991|12381550|FG000|Started Treatment|Overall Study||37
11191720|NCT01771991|12381551|FG001|Started Treatment|Overall Study||34
11191721|NCT01771991|12381550|FG000|COMPLETED|Overall Study||30
11191722|NCT01771991|12381551|FG001|COMPLETED|Overall Study||30
11191723|NCT01771991|12381550|FG000|NOT COMPLETED|Overall Study||8
11191724|NCT01771991|12381551|FG001|NOT COMPLETED|Overall Study||6
11191725|NCT01772134|12381561|FG000|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
11191726|NCT01772134|12381562|FG001|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
11191727|NCT01772134|12381563|FG002|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
11191728|NCT01772134|12381561|FG000|Received Randomized Study Medication|Overall Study||205
11191729|NCT01772134|12381562|FG001|Received Randomized Study Medication|Overall Study||204
11324498|NCT02743962|12521785|FG000|NOT COMPLETED|Overall Study||1
11324499|NCT02743962|12521786|FG001|NOT COMPLETED|Overall Study||0
11191730|NCT01772134|12381563|FG002|Received Randomized Study Medication|Overall Study||205
11191731|NCT01772134|12381561|FG000|COMPLETED|Overall Study||178
11191732|NCT01772134|12381562|FG001|COMPLETED|Overall Study||190
11191733|NCT01772134|12381563|FG002|COMPLETED|Overall Study||184
11191734|NCT01772134|12381561|FG000|NOT COMPLETED|Overall Study||29
11191735|NCT01772134|12381562|FG001|NOT COMPLETED|Overall Study||14
11191736|NCT01772134|12381563|FG002|NOT COMPLETED|Overall Study||22
11191737|NCT01772147|12381574|FG000|STARTED|Overall Study||201
11191738|NCT01772147|12381575|FG001|STARTED|Overall Study||203
11191739|NCT01772147|12381576|FG002|STARTED|Overall Study||202
11191740|NCT01772147|12381574|FG000|COMPLETED|Overall Study||170
11191741|NCT01772147|12381575|FG001|COMPLETED|Overall Study||178
11191742|NCT01772147|12381576|FG002|COMPLETED|Overall Study||184
11191743|NCT01772147|12381574|FG000|NOT COMPLETED|Overall Study||31
11191744|NCT01772147|12381575|FG001|NOT COMPLETED|Overall Study||25
11191745|NCT01772147|12381576|FG002|NOT COMPLETED|Overall Study||18
11191746|NCT01772160|12381584|FG000|STARTED|Overall Study||394
11191747|NCT01772160|12381584|FG000|COMPLETED|Overall Study||346
11191748|NCT01772160|12381584|FG000|NOT COMPLETED|Overall Study||48
11191749|NCT01772316|12381588|FG000|STARTED|Overall Study||47
11191750|NCT01772316|12381588|FG000|COMPLETED|Overall Study||40
11191751|NCT01772316|12381588|FG000|NOT COMPLETED|Overall Study||7
11191752|NCT01772368|12381592|FG000|STARTED|Overall Study||72
11191753|NCT01772368|12381592|FG000|Received Fp MDPI 100 mcg|Overall Study||67
11191754|NCT01772368|12381592|FG000|Received FS MDPI 100/6.25 mcg|Overall Study||68
11191755|NCT01772368|12381592|FG000|Received FS MDPI 100/12.5mcg|Overall Study||69
11191756|NCT01772368|12381592|FG000|Received FS MDPI 100/25 mcg|Overall Study||67
11191757|NCT01772368|12381592|FG000|Received FS MDPI 100/50 mcg|Overall Study||68
11191758|NCT01772368|12381592|FG000|Received Advair Diskus 100/50 mcg|Overall Study||66
11191759|NCT01772368|12381592|FG000|COMPLETED|Overall Study||65
11191760|NCT01772368|12381592|FG000|NOT COMPLETED|Overall Study||7
11191761|NCT01772537|12381611|FG000|STARTED|Overall Study||5
11191762|NCT01772537|12381612|FG001|STARTED|Overall Study||3
11191763|NCT01772537|12381613|FG002|STARTED|Overall Study||6
11191764|NCT01772537|12381611|FG000|COMPLETED|Overall Study||4
11191765|NCT01772537|12381612|FG001|COMPLETED|Overall Study||3
11191766|NCT01772537|12381613|FG002|COMPLETED|Overall Study||6
11191767|NCT01772537|12381611|FG000|NOT COMPLETED|Overall Study||1
11191768|NCT01772537|12381612|FG001|NOT COMPLETED|Overall Study||0
11191769|NCT01772537|12381613|FG002|NOT COMPLETED|Overall Study||0
11191770|NCT01772550|12381626|FG000|STARTED|Overall Study||102
11191771|NCT01772550|12381627|FG001|STARTED|Overall Study||103
11191772|NCT01772550|12381628|FG002|STARTED|Overall Study||33
11191773|NCT01772550|12381626|FG000|CT Pancreas|Overall Study||40
11191774|NCT01772550|12381627|FG001|CT Pancreas|Overall Study||36
11191775|NCT01772550|12381628|FG002|CT Pancreas|Overall Study||8
11191776|NCT01772550|12381626|FG000|CT Angiogram|Overall Study||24
11191777|NCT01772550|12381627|FG001|CT Angiogram|Overall Study||25
11191778|NCT01772550|12381628|FG002|CT Angiogram|Overall Study||4
11191779|NCT01772550|12381626|FG000|CT Liver|Overall Study||18
11191780|NCT01772550|12381627|FG001|CT Liver|Overall Study||14
11191781|NCT01772550|12381628|FG002|CT Liver|Overall Study||8
11191782|NCT01772550|12381626|FG000|CT Kidney|Overall Study||12
11191783|NCT01772550|12381627|FG001|CT Kidney|Overall Study||19
11191784|NCT01772550|12381628|FG002|CT Kidney|Overall Study||6
11191785|NCT01772550|12381626|FG000|CT Cardiac|Overall Study||7
11191786|NCT01772550|12381627|FG001|CT Cardiac|Overall Study||7
11191787|NCT01772550|12381628|FG002|CT Cardiac|Overall Study||1
11191788|NCT01772550|12381626|FG000|COMPLETED|Overall Study||101
11191789|NCT01772550|12381627|FG001|COMPLETED|Overall Study||102
11191790|NCT01772550|12381628|FG002|COMPLETED|Overall Study||27
11191791|NCT01772550|12381626|FG000|NOT COMPLETED|Overall Study||1
11191792|NCT01772550|12381627|FG001|NOT COMPLETED|Overall Study||1
11191793|NCT01772550|12381628|FG002|NOT COMPLETED|Overall Study||6
11191794|NCT01772576|12381636|FG000|STARTED|Overall Study||167
11191795|NCT01772576|12381636|FG000|COMPLETED|Overall Study||133
11191796|NCT01772576|12381636|FG000|NOT COMPLETED|Overall Study||34
11191797|NCT01772654|12381642|FG000|STARTED|Overall Study||2
11191798|NCT01772654|12381643|FG001|STARTED|Overall Study||15
11191799|NCT01772654|12381642|FG000|COMPLETED|Overall Study||2
11191800|NCT01772654|12381643|FG001|COMPLETED|Overall Study||15
11191801|NCT01772654|12381642|FG000|NOT COMPLETED|Overall Study||0
11191802|NCT01772654|12381643|FG001|NOT COMPLETED|Overall Study||0
11191803|NCT01772693|12381651|FG000|STARTED|Overall Study||20
11191804|NCT01772693|12381652|FG001|STARTED|Overall Study||7
11191805|NCT01772693|12381651|FG000|COMPLETED|Overall Study||14
11191806|NCT01772693|12381652|FG001|COMPLETED|Overall Study||6
11191807|NCT01772693|12381651|FG000|NOT COMPLETED|Overall Study||6
11191808|NCT01772693|12381652|FG001|NOT COMPLETED|Overall Study||1
11191809|NCT01772758|12381662|FG000|STARTED|Overall Study||18
11191810|NCT01772758|12381663|FG001|STARTED|Overall Study||17
11191811|NCT01772758|12381664|FG002|STARTED|Overall Study||12
11191812|NCT01772758|12381665|FG003|STARTED|Overall Study||17
11191813|NCT01772758|12381662|FG000|COMPLETED|Overall Study||18
11191814|NCT01772758|12381663|FG001|COMPLETED|Overall Study||17
11191815|NCT01772758|12381664|FG002|COMPLETED|Overall Study||12
11191816|NCT01772758|12381665|FG003|COMPLETED|Overall Study||17
11191817|NCT01772758|12381662|FG000|NOT COMPLETED|Overall Study||0
11191818|NCT01772758|12381663|FG001|NOT COMPLETED|Overall Study||0
11191819|NCT01772758|12381664|FG002|NOT COMPLETED|Overall Study||0
11191820|NCT01772758|12381665|FG003|NOT COMPLETED|Overall Study||0
11191821|NCT01772823|12381677|FG000|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
11191822|NCT01772823|12381678|FG001|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
11191823|NCT01772823|12381677|FG000|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
11191824|NCT01772823|12381678|FG001|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
11191825|NCT01772823|12381677|FG000|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
11191826|NCT01772823|12381678|FG001|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
11191827|NCT01772823|12381677|FG000|STARTED|Treatment Phase (Week 0- Week 48)||116
11191828|NCT01772823|12381678|FG001|STARTED|Treatment Phase (Week 0- Week 48)||70
11191829|NCT01772823|12381677|FG000|COMPLETED|Treatment Phase (Week 0- Week 48)||88
11191830|NCT01772823|12381678|FG001|COMPLETED|Treatment Phase (Week 0- Week 48)||52
11191831|NCT01772823|12381677|FG000|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
11191832|NCT01772823|12381678|FG001|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
11191833|NCT01772823|12381677|FG000|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
11191834|NCT01772823|12381678|FG001|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
11191835|NCT01772823|12381677|FG000|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
11191836|NCT01772823|12381678|FG001|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
11191837|NCT01772823|12381677|FG000|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
11191838|NCT01772823|12381678|FG001|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
11191839|NCT01773070|12381689|FG000|STARTED|Overall Study||478
11191840|NCT01773070|12381689|FG000|COMPLETED|Overall Study||397
11191841|NCT01773070|12381689|FG000|NOT COMPLETED|Overall Study||81
11191842|NCT01773109|12381693|FG000|STARTED|Overall Study||40
11191843|NCT01773109|12381693|FG000|COMPLETED|Overall Study||37
11191844|NCT01773109|12381693|FG000|NOT COMPLETED|Overall Study||3
11191845|NCT01773122|12381701|FG000|STARTED|Overall Study||20
11191846|NCT01773122|12381702|FG001|STARTED|Overall Study||19
11191847|NCT01773122|12381703|FG002|STARTED|Overall Study||19
11191848|NCT01773122|12381704|FG003|STARTED|Overall Study||19
11191849|NCT01773122|12381701|FG000|COMPLETED|Overall Study||17
11191850|NCT01773122|12381702|FG001|COMPLETED|Overall Study||18
11191851|NCT01773122|12381703|FG002|COMPLETED|Overall Study||19
11191852|NCT01773122|12381704|FG003|COMPLETED|Overall Study||18
11191853|NCT01773122|12381701|FG000|NOT COMPLETED|Overall Study||3
11191854|NCT01773122|12381702|FG001|NOT COMPLETED|Overall Study||1
11191855|NCT01773122|12381703|FG002|NOT COMPLETED|Overall Study||0
11191856|NCT01773122|12381704|FG003|NOT COMPLETED|Overall Study||1
11191857|NCT01773135|12381716|FG000|STARTED|Overall Study||262
11191858|NCT01773135|12381716|FG000|COMPLETED|Overall Study||262
11191859|NCT01773135|12381716|FG000|NOT COMPLETED|Overall Study||0
11191860|NCT01773187|12381723|FG000|STARTED|Overall Study||220
11191861|NCT01773187|12381724|FG001|STARTED|Overall Study||107
11191862|NCT01773187|12381723|FG000|COMPLETED|Overall Study||167
11191863|NCT01773187|12381724|FG001|COMPLETED|Overall Study||75
11191864|NCT01773187|12381723|FG000|NOT COMPLETED|Overall Study||53
11191865|NCT01773187|12381724|FG001|NOT COMPLETED|Overall Study||32
11191866|NCT01773226|12381730|FG000|STARTED|Overall Study||11
11191867|NCT01773226|12381730|FG000|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
11191868|NCT01773226|12381730|FG000|NOT COMPLETED|Overall Study||1
11191869|NCT01773291|12381737|FG000|STARTED|Overall Study||8
11191870|NCT01773291|12381738|FG001|STARTED|Overall Study||9
11191871|NCT01773291|12381739|FG002|STARTED|Overall Study||7
11191872|NCT01773291|12381737|FG000|COMPLETED|Overall Study||7
11191873|NCT01773291|12381738|FG001|COMPLETED|Overall Study||9
11191874|NCT01773291|12381739|FG002|COMPLETED|Overall Study||6
11191875|NCT01773291|12381737|FG000|NOT COMPLETED|Overall Study||1
11191876|NCT01773291|12381738|FG001|NOT COMPLETED|Overall Study||0
11191877|NCT01773291|12381739|FG002|NOT COMPLETED|Overall Study||1
11191878|NCT01773421|12381752|FG000|STARTED|Treatment Phase||7
11191879|NCT01773421|12381753|FG001|STARTED|Treatment Phase||8
11191880|NCT01773421|12381754|FG002|STARTED|Treatment Phase||19
11191881|NCT01773421|12381755|FG003|STARTED|Treatment Phase||7
11191882|NCT01773421|12381756|FG004|STARTED|Treatment Phase||0
11191883|NCT01773421|12381757|FG005|STARTED|Treatment Phase||0
11191884|NCT01773421|12381758|FG006|STARTED|Treatment Phase||0
11191885|NCT01773421|12381752|FG000|COMPLETED|Treatment Phase||7
11191886|NCT01773421|12381753|FG001|COMPLETED|Treatment Phase||8
11191887|NCT01773421|12381754|FG002|COMPLETED|Treatment Phase||13
11191888|NCT01773421|12381755|FG003|COMPLETED|Treatment Phase||5
11191889|NCT01773421|12381756|FG004|COMPLETED|Treatment Phase||0
11191890|NCT01773421|12381757|FG005|COMPLETED|Treatment Phase||0
11191891|NCT01773421|12381758|FG006|COMPLETED|Treatment Phase||0
11191892|NCT01773421|12381752|FG000|NOT COMPLETED|Treatment Phase||0
11191893|NCT01773421|12381753|FG001|NOT COMPLETED|Treatment Phase||0
11191894|NCT01773421|12381754|FG002|NOT COMPLETED|Treatment Phase||6
11191895|NCT01773421|12381755|FG003|NOT COMPLETED|Treatment Phase||2
11191896|NCT01773421|12381756|FG004|NOT COMPLETED|Treatment Phase||0
11191897|NCT01773421|12381757|FG005|NOT COMPLETED|Treatment Phase||0
11191898|NCT01773421|12381758|FG006|NOT COMPLETED|Treatment Phase||0
11191899|NCT01773421|12381752|FG000|STARTED|Extension Phase||0
11191900|NCT01773421|12381753|FG001|STARTED|Extension Phase||0
11191901|NCT01773421|12381754|FG002|STARTED|Extension Phase||0
11191902|NCT01773421|12381755|FG003|STARTED|Extension Phase||0
11191903|NCT01773421|12381756|FG004|STARTED|Extension Phase||15
11191904|NCT01773421|12381757|FG005|STARTED|Extension Phase||3
11191905|NCT01773421|12381758|FG006|STARTED|Extension Phase||0
11191906|NCT01773421|12381752|FG000|COMPLETED|Extension Phase||0
11191907|NCT01773421|12381753|FG001|COMPLETED|Extension Phase||0
11191908|NCT01773421|12381754|FG002|COMPLETED|Extension Phase||0
11191909|NCT01773421|12381755|FG003|COMPLETED|Extension Phase||0
11191910|NCT01773421|12381756|FG004|COMPLETED|Extension Phase||12
11191911|NCT01773421|12381757|FG005|COMPLETED|Extension Phase||1
11191912|NCT01773421|12381758|FG006|COMPLETED|Extension Phase||0
11191913|NCT01773421|12381752|FG000|NOT COMPLETED|Extension Phase||0
11191914|NCT01773421|12381753|FG001|NOT COMPLETED|Extension Phase||0
11191915|NCT01773421|12381754|FG002|NOT COMPLETED|Extension Phase||0
11191916|NCT01773421|12381755|FG003|NOT COMPLETED|Extension Phase||0
11191917|NCT01773421|12381756|FG004|NOT COMPLETED|Extension Phase||3
11191918|NCT01773421|12381757|FG005|NOT COMPLETED|Extension Phase||2
11191919|NCT01773421|12381758|FG006|NOT COMPLETED|Extension Phase||0
11191920|NCT01773473|12381776|FG000|STARTED|Overall Study||207
11191921|NCT01773473|12381777|FG001|STARTED|Overall Study||196
11191922|NCT01773473|12381776|FG000|Received at Least 1 Dose of Study Drug|Overall Study||207
11191923|NCT01773473|12381777|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
11191924|NCT01773473|12381776|FG000|COMPLETED|Overall Study||191
11191925|NCT01773473|12381777|FG001|COMPLETED|Overall Study||177
11191926|NCT01773473|12381776|FG000|NOT COMPLETED|Overall Study||16
11191927|NCT01773473|12381777|FG001|NOT COMPLETED|Overall Study||19
11191928|NCT01773889|12381783|FG000|STARTED|Overall Study||2
11191929|NCT01773889|12381783|FG000|COMPLETED|Overall Study||0
11191930|NCT01773889|12381783|FG000|NOT COMPLETED|Overall Study||2
11191931|NCT01773954|12381787|FG000|STARTED|Overall Study||40
11191932|NCT01773954|12381787|FG000|COMPLETED|Overall Study||31
11191933|NCT01773954|12381787|FG000|NOT COMPLETED|Overall Study||9
11191934|NCT01773967|12381793|FG000|STARTED|Overall Study||483
11191935|NCT01773967|12381794|FG001|STARTED|Overall Study||488
11191936|NCT01773967|12381793|FG000|COMPLETED|Overall Study||468
11191937|NCT01773967|12381794|FG001|COMPLETED|Overall Study||475
11191938|NCT01773967|12381793|FG000|NOT COMPLETED|Overall Study||15
11191939|NCT01773967|12381794|FG001|NOT COMPLETED|Overall Study||13
11191940|NCT01773993|12381800|FG000|STARTED|Overall Study||534
11191941|NCT01773993|12381800|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499
11191942|NCT01773993|12381800|FG000|NOT COMPLETED|Overall Study||35
11191943|NCT01774045|12381806|FG000|STARTED|Overall Study||23
11191944|NCT01774045|12381807|FG001|STARTED|Overall Study||7
11191945|NCT01774045|12381806|FG000|COMPLETED|Overall Study||23
11191946|NCT01774045|12381807|FG001|COMPLETED|Overall Study||7
11191947|NCT01774045|12381806|FG000|NOT COMPLETED|Overall Study||0
11191948|NCT01774045|12381807|FG001|NOT COMPLETED|Overall Study||0
11191949|NCT01774084|12381816|FG000|STARTED|Overall Study||11
11191950|NCT01774084|12381817|FG001|STARTED|Overall Study||12
11191951|NCT01774084|12381816|FG000|COMPLETED|Overall Study||10
11191952|NCT01774084|12381817|FG001|COMPLETED|Overall Study||12
11191953|NCT01774084|12381816|FG000|NOT COMPLETED|Overall Study||1
11191954|NCT01774084|12381817|FG001|NOT COMPLETED|Overall Study||0
11191955|NCT01774097|12381825|FG000|STARTED|Overall Study||40
11191956|NCT01774097|12381826|FG001|STARTED|Overall Study||42
11191957|NCT01774097|12381825|FG000|COMPLETED|Overall Study||38
11191958|NCT01774097|12381826|FG001|COMPLETED|Overall Study||40
11191959|NCT01774097|12381825|FG000|NOT COMPLETED|Overall Study||2
11191960|NCT01774097|12381826|FG001|NOT COMPLETED|Overall Study||2
11191961|NCT01774110|12381834|FG000|STARTED|Overall Study||12
11191962|NCT01774110|12381834|FG000|COMPLETED|Overall Study||5
11191963|NCT01774110|12381834|FG000|NOT COMPLETED|Overall Study||7
11191964|NCT01774149|12381841|FG000|STARTED|Overall Study||15
11191965|NCT01774149|12381842|FG001|STARTED|Overall Study||15
11191966|NCT01774149|12381841|FG000|COMPLETED|Overall Study||14
11191967|NCT01774149|12381842|FG001|COMPLETED|Overall Study||12
11191968|NCT01774149|12381841|FG000|NOT COMPLETED|Overall Study||1
11191969|NCT01774149|12381842|FG001|NOT COMPLETED|Overall Study||3
11191970|NCT01774305|12381850|FG000|STARTED|Overall Study||71
11191971|NCT01774305|12381851|FG001|STARTED|Overall Study||71
11191972|NCT01774305|12381850|FG000|COMPLETED|Overall Study||70
11191973|NCT01774305|12381851|FG001|COMPLETED|Overall Study||71
11191974|NCT01774305|12381850|FG000|NOT COMPLETED|Overall Study||1
11191975|NCT01774305|12381851|FG001|NOT COMPLETED|Overall Study||0
11191976|NCT01774344|12381859|FG000|STARTED|Overall Study||194
11191977|NCT01774344|12381860|FG001|STARTED|Overall Study||379
11191978|NCT01774344|12381859|FG000|Treated|Overall Study||193
11191979|NCT01774344|12381860|FG001|Treated|Overall Study||374
11191980|NCT01774344|12381859|FG000|Entered Survival FU|Overall Study||145
11191981|NCT01774344|12381860|FG001|Entered Survival FU|Overall Study||291
11191982|NCT01774344|12381859|FG000|COMPLETED|Overall Study||132
11191983|NCT01774344|12381860|FG001|COMPLETED|Overall Study||258
11191984|NCT01774344|12381859|FG000|NOT COMPLETED|Overall Study||62
11191985|NCT01774344|12381860|FG001|NOT COMPLETED|Overall Study||121
11191986|NCT01774591|12381868|FG000|STARTED|Overall Study||10
11191987|NCT01774591|12381869|FG001|STARTED|Overall Study||11
11191988|NCT01774591|12381868|FG000|COMPLETED|Overall Study||9
11191989|NCT01774591|12381869|FG001|COMPLETED|Overall Study||7
11191990|NCT01774591|12381868|FG000|NOT COMPLETED|Overall Study||1
11191991|NCT01774591|12381869|FG001|NOT COMPLETED|Overall Study||4
11191992|NCT01774604|12381877|FG000|STARTED|Overall Study||223
11191993|NCT01774604|12381878|FG001|STARTED|Overall Study||226
11191994|NCT01774604|12381877|FG000|COMPLETED|Overall Study||223
11191995|NCT01774604|12381878|FG001|COMPLETED|Overall Study||226
11191996|NCT01774604|12381877|FG000|NOT COMPLETED|Overall Study||0
11191997|NCT01774604|12381878|FG001|NOT COMPLETED|Overall Study||0
11191998|NCT01774760|12381884|FG000|STARTED|Overall Study||10
11191999|NCT01774760|12381884|FG000|COMPLETED|Overall Study||10
11192000|NCT01774760|12381884|FG000|NOT COMPLETED|Overall Study||0
11192001|NCT01774786|12381890|FG000|STARTED|Overall Study||388
11192002|NCT01774786|12381891|FG001|STARTED|Overall Study||392
11192003|NCT01774786|12381890|FG000|Did Not Receive Any Study Treatment|Overall Study|2 patients found ineligible after enrollment and 2 patients died before treatment.|4
11192004|NCT01774786|12381891|FG001|Did Not Receive Any Study Treatment|Overall Study|All 3 patients found ineligible for the study after enrollment and before treatment.|3
11192005|NCT01774786|12381890|FG000|Received at Least One Dose of Pertuzumab|Overall Study||384
11192006|NCT01774786|12381891|FG001|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
11192007|NCT01774786|12381890|FG000|Received Placebo (No Pertuzumab)|Overall Study||0
11192008|NCT01774786|12381891|FG001|Received Placebo (No Pertuzumab)|Overall Study||388
11192009|NCT01774786|12381890|FG000|COMPLETED|Overall Study||60
11192010|NCT01774786|12381891|FG001|COMPLETED|Overall Study||46
11192011|NCT01774786|12381890|FG000|NOT COMPLETED|Overall Study||328
11192012|NCT01774786|12381891|FG001|NOT COMPLETED|Overall Study||346
11192013|NCT01774799|12381901|FG000|STARTED|Overall Study||212
11192014|NCT01774799|12381902|FG001|STARTED|Overall Study||190
11192015|NCT01774799|12381903|FG002|STARTED|Overall Study||212
11192016|NCT01774799|12381904|FG003|STARTED|Overall Study||190
11192017|NCT01774799|12381901|FG000|COMPLETED|Overall Study||211
11192018|NCT01774799|12381902|FG001|COMPLETED|Overall Study||189
11192019|NCT01774799|12381903|FG002|COMPLETED|Overall Study||212
11192020|NCT01774799|12381904|FG003|COMPLETED|Overall Study||190
11192021|NCT01774799|12381901|FG000|NOT COMPLETED|Overall Study||1
11192022|NCT01774799|12381902|FG001|NOT COMPLETED|Overall Study||1
11192023|NCT01774799|12381903|FG002|NOT COMPLETED|Overall Study||0
11192024|NCT01774799|12381904|FG003|NOT COMPLETED|Overall Study||0
11192025|NCT01774851|12381912|FG000|STARTED|Overall Study||42
11192026|NCT01774851|12381913|FG001|STARTED|Overall Study||42
11192027|NCT01774851|12381912|FG000|COMPLETED|Overall Study||42
11192028|NCT01774851|12381913|FG001|COMPLETED|Overall Study||42
11192029|NCT01774851|12381912|FG000|NOT COMPLETED|Overall Study||0
11192030|NCT01774851|12381913|FG001|NOT COMPLETED|Overall Study||0
11192031|NCT01774903|12381919|FG000|STARTED|Overall Study||45
11192032|NCT01774903|12381919|FG000|COMPLETED|Overall Study||34
11192033|NCT01774903|12381919|FG000|NOT COMPLETED|Overall Study||11
11192034|NCT01774929|12381924|FG000|STARTED|Overall Study||35
11192035|NCT01774929|12381924|FG000|COMPLETED|Overall Study||32
11192036|NCT01774929|12381924|FG000|NOT COMPLETED|Overall Study||3
11192037|NCT01774968|12381930|FG000|STARTED|Overall Study||162
11192038|NCT01774968|12381931|FG001|STARTED|Overall Study||163
11192039|NCT01774968|12381930|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162
11192040|NCT01774968|12381931|FG001|Received at Least 1 Dose of Study Drug|Overall Study||161
11192041|NCT01774968|12381930|FG000|COMPLETED|Overall Study||132
11192042|NCT01774968|12381931|FG001|COMPLETED|Overall Study||128
11192043|NCT01774968|12381930|FG000|NOT COMPLETED|Overall Study||30
11192044|NCT01774968|12381931|FG001|NOT COMPLETED|Overall Study||35
11192045|NCT01774981|12381945|FG000|STARTED|Overall Study||3
11192046|NCT01774981|12381946|FG001|STARTED|Overall Study||4
11192047|NCT01774981|12381947|FG002|STARTED|Overall Study||4
11192048|NCT01774981|12381948|FG003|STARTED|Overall Study||4
11192049|NCT01774981|12381949|FG004|STARTED|Overall Study||6
11192050|NCT01774981|12381950|FG005|STARTED|Overall Study||14
11192051|NCT01774981|12381951|FG006|STARTED|Overall Study||13
11192052|NCT01774981|12381952|FG007|STARTED|Overall Study||12
11192053|NCT01774981|12381945|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11192054|NCT01774981|12381946|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
11192055|NCT01774981|12381947|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
11192056|NCT01774981|12381948|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
11192057|NCT01774981|12381949|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
11192058|NCT01774981|12381950|FG005|Received at Least 1 Dose of Study Drug|Overall Study||14
11192059|NCT01774981|12381951|FG006|Received at Least 1 Dose of Study Drug|Overall Study||13
11192060|NCT01774981|12381952|FG007|Received at Least 1 Dose of Study Drug|Overall Study||12
11192061|NCT01774981|12381945|FG000|COMPLETED|Overall Study||3
11192062|NCT01774981|12381946|FG001|COMPLETED|Overall Study||4
11192063|NCT01774981|12381947|FG002|COMPLETED|Overall Study||4
11192064|NCT01774981|12381948|FG003|COMPLETED|Overall Study||4
11192065|NCT01774981|12381949|FG004|COMPLETED|Overall Study||5
11192066|NCT01774981|12381950|FG005|COMPLETED|Overall Study||13
11192067|NCT01774981|12381951|FG006|COMPLETED|Overall Study||13
11192068|NCT01774981|12381952|FG007|COMPLETED|Overall Study||11
11192069|NCT01774981|12381945|FG000|NOT COMPLETED|Overall Study||0
11192070|NCT01774981|12381946|FG001|NOT COMPLETED|Overall Study||0
11192071|NCT01774981|12381947|FG002|NOT COMPLETED|Overall Study||0
11192072|NCT01774981|12381948|FG003|NOT COMPLETED|Overall Study||0
11192073|NCT01774981|12381949|FG004|NOT COMPLETED|Overall Study||1
11192074|NCT01774981|12381950|FG005|NOT COMPLETED|Overall Study||1
11192075|NCT01774981|12381951|FG006|NOT COMPLETED|Overall Study||0
11192076|NCT01774981|12381952|FG007|NOT COMPLETED|Overall Study||1
11192077|NCT01775124|12381977|FG000|STARTED|Core Period||168
11192078|NCT01775124|12381978|FG001|STARTED|Core Period||166
11192079|NCT01775124|12381977|FG000|Full Analysis Set|Core Period||167
11192080|NCT01775124|12381978|FG001|Full Analysis Set|Core Period||166
11192081|NCT01775124|12381977|FG000|Per Protocol Set|Core Period||157
11192082|NCT01775124|12381978|FG001|Per Protocol Set|Core Period||155
11192083|NCT01775124|12381977|FG000|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
11192084|NCT01775124|12381978|FG001|Safety Set|Core Period||166
11192085|NCT01775124|12381977|FG000|COMPLETED|Core Period||157
11192086|NCT01775124|12381978|FG001|COMPLETED|Core Period||156
11192087|NCT01775124|12381977|FG000|NOT COMPLETED|Core Period||11
11192088|NCT01775124|12381978|FG001|NOT COMPLETED|Core Period||10
11192089|NCT01775124|12381977|FG000|STARTED|Extension Period||157
11192090|NCT01775124|12381978|FG001|STARTED|Extension Period||156
11192091|NCT01775124|12381977|FG000|COMPLETED|Extension Period||145
11192092|NCT01775124|12381978|FG001|COMPLETED|Extension Period||138
11192093|NCT01775124|12381977|FG000|NOT COMPLETED|Extension Period||12
11192094|NCT01775124|12381978|FG001|NOT COMPLETED|Extension Period||18
11192095|NCT01775137|12381985|FG000|STARTED|Overall Study||45
11192096|NCT01775137|12381985|FG000|COMPLETED|Overall Study||34
11192097|NCT01775137|12381985|FG000|NOT COMPLETED|Overall Study||11
11192098|NCT01775189|12381992|FG000|STARTED|Naloxone Challenge Phase||45
11192099|NCT01775189|12381993|FG001|STARTED|Naloxone Challenge Phase||0
11192100|NCT01775189|12381994|FG002|STARTED|Naloxone Challenge Phase||0
11192101|NCT01775189|12381995|FG003|STARTED|Naloxone Challenge Phase||0
11192102|NCT01775189|12381996|FG004|STARTED|Naloxone Challenge Phase||0
11192103|NCT01775189|12381997|FG005|STARTED|Naloxone Challenge Phase||0
11192104|NCT01775189|12381998|FG006|STARTED|Naloxone Challenge Phase||0
11192105|NCT01775189|12381992|FG000|COMPLETED|Naloxone Challenge Phase||45
11192106|NCT01775189|12381993|FG001|COMPLETED|Naloxone Challenge Phase||0
11192107|NCT01775189|12381994|FG002|COMPLETED|Naloxone Challenge Phase||0
11192108|NCT01775189|12381995|FG003|COMPLETED|Naloxone Challenge Phase||0
11192109|NCT01775189|12381996|FG004|COMPLETED|Naloxone Challenge Phase||0
11192110|NCT01775189|12381997|FG005|COMPLETED|Naloxone Challenge Phase||0
11192111|NCT01775189|12381998|FG006|COMPLETED|Naloxone Challenge Phase||0
11192112|NCT01775189|12381992|FG000|NOT COMPLETED|Naloxone Challenge Phase||0
11192113|NCT01775189|12381993|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
11192114|NCT01775189|12381994|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
11192115|NCT01775189|12381995|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
11192116|NCT01775189|12381996|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
11192117|NCT01775189|12381997|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
11192118|NCT01775189|12381998|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
11192119|NCT01775189|12381992|FG000|STARTED|Drug Discrimination Phase: Day 1||0
11192120|NCT01775189|12381993|FG001|STARTED|Drug Discrimination Phase: Day 1||22
11192121|NCT01775189|12381994|FG002|STARTED|Drug Discrimination Phase: Day 1||23
11192122|NCT01775189|12381995|FG003|STARTED|Drug Discrimination Phase: Day 1||0
11192123|NCT01775189|12381996|FG004|STARTED|Drug Discrimination Phase: Day 1||0
11192124|NCT01775189|12381997|FG005|STARTED|Drug Discrimination Phase: Day 1||0
11192125|NCT01775189|12381998|FG006|STARTED|Drug Discrimination Phase: Day 1||0
11192126|NCT01775189|12381992|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
11192127|NCT01775189|12381993|FG001|COMPLETED|Drug Discrimination Phase: Day 1||19
11192128|NCT01775189|12381994|FG002|COMPLETED|Drug Discrimination Phase: Day 1||23
11192129|NCT01775189|12381995|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
11192130|NCT01775189|12381996|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
11192131|NCT01775189|12381997|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
11192132|NCT01775189|12381998|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
11192133|NCT01775189|12381992|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11192134|NCT01775189|12381993|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
11192135|NCT01775189|12381994|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11192136|NCT01775189|12381995|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11192137|NCT01775189|12381996|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11192138|NCT01775189|12381997|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11192139|NCT01775189|12381998|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
11192140|NCT01775189|12381992|FG000|STARTED|Drug Discrimination Phase: Day 2||0
11192141|NCT01775189|12381993|FG001|STARTED|Drug Discrimination Phase: Day 2||19
11192142|NCT01775189|12381994|FG002|STARTED|Drug Discrimination Phase: Day 2||23
11192143|NCT01775189|12381995|FG003|STARTED|Drug Discrimination Phase: Day 2||0
11192144|NCT01775189|12381996|FG004|STARTED|Drug Discrimination Phase: Day 2||0
11192145|NCT01775189|12381997|FG005|STARTED|Drug Discrimination Phase: Day 2||0
11192146|NCT01775189|12381998|FG006|STARTED|Drug Discrimination Phase: Day 2||0
11192147|NCT01775189|12381992|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
11192148|NCT01775189|12381993|FG001|COMPLETED|Drug Discrimination Phase: Day 2||16
11192149|NCT01775189|12381994|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16
11192150|NCT01775189|12381995|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
11192151|NCT01775189|12381996|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
11192152|NCT01775189|12381997|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
11192153|NCT01775189|12381998|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
11192154|NCT01775189|12381992|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11192155|NCT01775189|12381993|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
11192156|NCT01775189|12381994|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
11192157|NCT01775189|12381995|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11192158|NCT01775189|12381996|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11192159|NCT01775189|12381997|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11192160|NCT01775189|12381998|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
11192161|NCT01775189|12381992|FG000|STARTED|Treatment Phase: First Intervention||0
11192162|NCT01775189|12381993|FG001|STARTED|Treatment Phase: First Intervention||0
11192163|NCT01775189|12381994|FG002|STARTED|Treatment Phase: First Intervention||0
11192164|NCT01775189|12381995|FG003|STARTED|Treatment Phase: First Intervention||8
11192165|NCT01775189|12381996|FG004|STARTED|Treatment Phase: First Intervention||8
11192166|NCT01775189|12381997|FG005|STARTED|Treatment Phase: First Intervention||8
11192167|NCT01775189|12381998|FG006|STARTED|Treatment Phase: First Intervention||8
11192168|NCT01775189|12381992|FG000|COMPLETED|Treatment Phase: First Intervention||0
11192169|NCT01775189|12381993|FG001|COMPLETED|Treatment Phase: First Intervention||0
11192170|NCT01775189|12381994|FG002|COMPLETED|Treatment Phase: First Intervention||0
11192171|NCT01775189|12381995|FG003|COMPLETED|Treatment Phase: First Intervention||8
11192172|NCT01775189|12381996|FG004|COMPLETED|Treatment Phase: First Intervention||8
11192173|NCT01775189|12381997|FG005|COMPLETED|Treatment Phase: First Intervention||8
11192174|NCT01775189|12381998|FG006|COMPLETED|Treatment Phase: First Intervention||8
11192175|NCT01775189|12381992|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
11192176|NCT01775189|12381993|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
11192177|NCT01775189|12381994|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
11192178|NCT01775189|12381995|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
11192179|NCT01775189|12381996|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
11192180|NCT01775189|12381997|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
11192181|NCT01775189|12381998|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0
11192182|NCT01775189|12381992|FG000|STARTED|Treatment Phase: Washout Period 1||0
11192183|NCT01775189|12381993|FG001|STARTED|Treatment Phase: Washout Period 1||0
11192184|NCT01775189|12381994|FG002|STARTED|Treatment Phase: Washout Period 1||0
11192185|NCT01775189|12381995|FG003|STARTED|Treatment Phase: Washout Period 1||8
11192186|NCT01775189|12381996|FG004|STARTED|Treatment Phase: Washout Period 1||8
11192187|NCT01775189|12381997|FG005|STARTED|Treatment Phase: Washout Period 1||8
11192188|NCT01775189|12381998|FG006|STARTED|Treatment Phase: Washout Period 1||8
11192189|NCT01775189|12381992|FG000|COMPLETED|Treatment Phase: Washout Period 1||0
11192190|NCT01775189|12381993|FG001|COMPLETED|Treatment Phase: Washout Period 1||0
11192191|NCT01775189|12381994|FG002|COMPLETED|Treatment Phase: Washout Period 1||0
11192192|NCT01775189|12381995|FG003|COMPLETED|Treatment Phase: Washout Period 1||8
11192193|NCT01775189|12381996|FG004|COMPLETED|Treatment Phase: Washout Period 1||8
11192194|NCT01775189|12381997|FG005|COMPLETED|Treatment Phase: Washout Period 1||7
11192195|NCT01775189|12381998|FG006|COMPLETED|Treatment Phase: Washout Period 1||8
11192196|NCT01775189|12381992|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11192197|NCT01775189|12381993|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11192198|NCT01775189|12381994|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11192199|NCT01775189|12381995|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11192200|NCT01775189|12381996|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11192201|NCT01775189|12381997|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||1
11192202|NCT01775189|12381998|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0
11192203|NCT01775189|12381992|FG000|STARTED|Treatment Phase: Second Intervention||0
11192204|NCT01775189|12381993|FG001|STARTED|Treatment Phase: Second Intervention||0
11192205|NCT01775189|12381994|FG002|STARTED|Treatment Phase: Second Intervention||0
11192206|NCT01775189|12381995|FG003|STARTED|Treatment Phase: Second Intervention||8
11192207|NCT01775189|12381996|FG004|STARTED|Treatment Phase: Second Intervention||8
11192208|NCT01775189|12381997|FG005|STARTED|Treatment Phase: Second Intervention||7
11192209|NCT01775189|12381998|FG006|STARTED|Treatment Phase: Second Intervention||8
11192210|NCT01775189|12381992|FG000|COMPLETED|Treatment Phase: Second Intervention||0
11192211|NCT01775189|12381993|FG001|COMPLETED|Treatment Phase: Second Intervention||0
11192212|NCT01775189|12381994|FG002|COMPLETED|Treatment Phase: Second Intervention||0
11192213|NCT01775189|12381995|FG003|COMPLETED|Treatment Phase: Second Intervention||8
11192214|NCT01775189|12381996|FG004|COMPLETED|Treatment Phase: Second Intervention||8
11192215|NCT01775189|12381997|FG005|COMPLETED|Treatment Phase: Second Intervention||7
11192216|NCT01775189|12381998|FG006|COMPLETED|Treatment Phase: Second Intervention||8
11192217|NCT01775189|12381992|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
11192218|NCT01775189|12381993|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
11192219|NCT01775189|12381994|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
11192220|NCT01775189|12381995|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0
11192221|NCT01775189|12381996|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
11192222|NCT01775189|12381997|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
11192223|NCT01775189|12381998|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
11192224|NCT01775189|12381992|FG000|STARTED|Treatment Phase: Washout Period 2||0
11192225|NCT01775189|12381993|FG001|STARTED|Treatment Phase: Washout Period 2||0
11192226|NCT01775189|12381994|FG002|STARTED|Treatment Phase: Washout Period 2||0
11192227|NCT01775189|12381995|FG003|STARTED|Treatment Phase: Washout Period 2||8
11192228|NCT01775189|12381996|FG004|STARTED|Treatment Phase: Washout Period 2||8
11192229|NCT01775189|12381997|FG005|STARTED|Treatment Phase: Washout Period 2||7
11192230|NCT01775189|12381998|FG006|STARTED|Treatment Phase: Washout Period 2||8
11192231|NCT01775189|12381992|FG000|COMPLETED|Treatment Phase: Washout Period 2||0
11192232|NCT01775189|12381993|FG001|COMPLETED|Treatment Phase: Washout Period 2||0
11192233|NCT01775189|12381994|FG002|COMPLETED|Treatment Phase: Washout Period 2||0
11192234|NCT01775189|12381995|FG003|COMPLETED|Treatment Phase: Washout Period 2||7
11192235|NCT01775189|12381996|FG004|COMPLETED|Treatment Phase: Washout Period 2||8
11192236|NCT01775189|12381997|FG005|COMPLETED|Treatment Phase: Washout Period 2||7
11192237|NCT01775189|12381998|FG006|COMPLETED|Treatment Phase: Washout Period 2||8
11192238|NCT01775189|12381992|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11192239|NCT01775189|12381993|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11192240|NCT01775189|12381994|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11192241|NCT01775189|12381995|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||1
11192242|NCT01775189|12381996|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11192243|NCT01775189|12381997|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11192244|NCT01775189|12381998|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0
11192245|NCT01775189|12381992|FG000|STARTED|Treatment Phase: Third Intervention||0
11192246|NCT01775189|12381993|FG001|STARTED|Treatment Phase: Third Intervention||0
11192247|NCT01775189|12381994|FG002|STARTED|Treatment Phase: Third Intervention||0
11192248|NCT01775189|12381995|FG003|STARTED|Treatment Phase: Third Intervention||7
11192249|NCT01775189|12381996|FG004|STARTED|Treatment Phase: Third Intervention||8
11192250|NCT01775189|12381997|FG005|STARTED|Treatment Phase: Third Intervention||7
11192251|NCT01775189|12381998|FG006|STARTED|Treatment Phase: Third Intervention||8
11192252|NCT01775189|12381992|FG000|COMPLETED|Treatment Phase: Third Intervention||0
11192253|NCT01775189|12381993|FG001|COMPLETED|Treatment Phase: Third Intervention||0
11192254|NCT01775189|12381994|FG002|COMPLETED|Treatment Phase: Third Intervention||0
11192255|NCT01775189|12381995|FG003|COMPLETED|Treatment Phase: Third Intervention||7
11192256|NCT01775189|12381996|FG004|COMPLETED|Treatment Phase: Third Intervention||8
11192257|NCT01775189|12381997|FG005|COMPLETED|Treatment Phase: Third Intervention||7
11192258|NCT01775189|12381998|FG006|COMPLETED|Treatment Phase: Third Intervention||8
11192259|NCT01775189|12381992|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
11192260|NCT01775189|12381993|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
11192261|NCT01775189|12381994|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
11192262|NCT01775189|12381995|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
11192263|NCT01775189|12381996|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
11192264|NCT01775189|12381997|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0
11192265|NCT01775189|12381998|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0
11192266|NCT01775189|12381992|FG000|STARTED|Treatment Phase: Washout Period 3||0
11192267|NCT01775189|12381993|FG001|STARTED|Treatment Phase: Washout Period 3||0
11192268|NCT01775189|12381994|FG002|STARTED|Treatment Phase: Washout Period 3||0
11192269|NCT01775189|12381995|FG003|STARTED|Treatment Phase: Washout Period 3||7
11192270|NCT01775189|12381996|FG004|STARTED|Treatment Phase: Washout Period 3||8
11192271|NCT01775189|12381997|FG005|STARTED|Treatment Phase: Washout Period 3||7
11192272|NCT01775189|12381998|FG006|STARTED|Treatment Phase: Washout Period 3||8
11192273|NCT01775189|12381992|FG000|COMPLETED|Treatment Phase: Washout Period 3||0
11192274|NCT01775189|12381993|FG001|COMPLETED|Treatment Phase: Washout Period 3||0
11192275|NCT01775189|12381994|FG002|COMPLETED|Treatment Phase: Washout Period 3||0
11192276|NCT01775189|12381995|FG003|COMPLETED|Treatment Phase: Washout Period 3||6
11192277|NCT01775189|12381996|FG004|COMPLETED|Treatment Phase: Washout Period 3||8
11192278|NCT01775189|12381997|FG005|COMPLETED|Treatment Phase: Washout Period 3||7
11192279|NCT01775189|12381998|FG006|COMPLETED|Treatment Phase: Washout Period 3||7
11192280|NCT01775189|12381992|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0
11192281|NCT01775189|12381993|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0
11192282|NCT01775189|12381994|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0
11192283|NCT01775189|12381995|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||1
11192284|NCT01775189|12381996|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0
11192285|NCT01775189|12381997|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0
11192286|NCT01775189|12381998|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||1
11192287|NCT01775189|12381992|FG000|STARTED|Treatment Phase: Fourth Intervention||0
11192288|NCT01775189|12381993|FG001|STARTED|Treatment Phase: Fourth Intervention||0
11192289|NCT01775189|12381994|FG002|STARTED|Treatment Phase: Fourth Intervention||0
11192290|NCT01775189|12381995|FG003|STARTED|Treatment Phase: Fourth Intervention||6
11192291|NCT01775189|12381996|FG004|STARTED|Treatment Phase: Fourth Intervention||8
11192292|NCT01775189|12381997|FG005|STARTED|Treatment Phase: Fourth Intervention||7
11192293|NCT01775189|12381998|FG006|STARTED|Treatment Phase: Fourth Intervention||7
11192294|NCT01775189|12381992|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0
11192295|NCT01775189|12381993|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0
11192296|NCT01775189|12381994|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0
11192297|NCT01775189|12381995|FG003|COMPLETED|Treatment Phase: Fourth Intervention||6
11192298|NCT01775189|12381996|FG004|COMPLETED|Treatment Phase: Fourth Intervention||8
11192299|NCT01775189|12381997|FG005|COMPLETED|Treatment Phase: Fourth Intervention||7
11192300|NCT01775189|12381998|FG006|COMPLETED|Treatment Phase: Fourth Intervention||7
11192301|NCT01775189|12381992|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
11192302|NCT01775189|12381993|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
11192303|NCT01775189|12381994|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
11192304|NCT01775189|12381995|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
11192305|NCT01775189|12381996|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
11192306|NCT01775189|12381997|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
11192307|NCT01775189|12381998|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
11192308|NCT01775371|12382028|FG000|STARTED|Overall Study||306
11192309|NCT01775371|12382029|FG001|STARTED|Overall Study||330
11192310|NCT01775371|12382028|FG000|COMPLETED|Overall Study||306
11192311|NCT01775371|12382029|FG001|COMPLETED|Overall Study||330
11192312|NCT01775371|12382028|FG000|NOT COMPLETED|Overall Study||0
11192313|NCT01775371|12382029|FG001|NOT COMPLETED|Overall Study||0
11192314|NCT01775410|12382037|FG000|STARTED|Overall Study||4
11192315|NCT01775410|12382037|FG000|COMPLETED|Overall Study||4
11192316|NCT01775410|12382037|FG000|NOT COMPLETED|Overall Study||0
11192317|NCT01775501|12382041|FG000|STARTED|Overall Study||40
11192318|NCT01775501|12382041|FG000|COMPLETED|Overall Study||39
11192319|NCT01775501|12382041|FG000|NOT COMPLETED|Overall Study||1
11192320|NCT01775553|12382045|FG000|STARTED|Overall Study||13
11192321|NCT01775553|12382045|FG000|COMPLETED|Overall Study||0
11192322|NCT01775553|12382045|FG000|NOT COMPLETED|Overall Study||13
11192323|NCT01775670|12382051|FG000|STARTED|Overall Study||1
11192324|NCT01775670|12382052|FG001|STARTED|Overall Study||3
11192325|NCT01775670|12382051|FG000|COMPLETED|Overall Study||0
11192326|NCT01775670|12382052|FG001|COMPLETED|Overall Study||2
11192327|NCT01775670|12382051|FG000|NOT COMPLETED|Overall Study||1
11192328|NCT01775670|12382052|FG001|NOT COMPLETED|Overall Study||1
11192329|NCT01775722|12382058|FG000|STARTED|Overall Study||22
11192330|NCT01775722|12382058|FG000|COMPLETED|Overall Study||20
11192331|NCT01775722|12382058|FG000|NOT COMPLETED|Overall Study||2
11192332|NCT01775735|12382066|FG000|STARTED|Intervention (6 Months)||8
11192333|NCT01775735|12382067|FG001|STARTED|Intervention (6 Months)||7
11192334|NCT01775735|12382066|FG000|COMPLETED|Intervention (6 Months)||8
11192335|NCT01775735|12382067|FG001|COMPLETED|Intervention (6 Months)||7
11192336|NCT01775735|12382066|FG000|NOT COMPLETED|Intervention (6 Months)||0
11192337|NCT01775735|12382067|FG001|NOT COMPLETED|Intervention (6 Months)||0
11192338|NCT01775735|12382066|FG000|STARTED|Open Label (24 Months)||8
11192339|NCT01775735|12382067|FG001|STARTED|Open Label (24 Months)||7
11192340|NCT01775735|12382066|FG000|COMPLETED|Open Label (24 Months)||7
11192341|NCT01775735|12382067|FG001|COMPLETED|Open Label (24 Months)||3
11192342|NCT01775735|12382066|FG000|NOT COMPLETED|Open Label (24 Months)||1
11192343|NCT01775735|12382067|FG001|NOT COMPLETED|Open Label (24 Months)||4
11192344|NCT01775774|12382076|FG000|STARTED|Overall Study||3
11192345|NCT01775774|12382077|FG001|STARTED|Overall Study||3
11192346|NCT01775774|12382078|FG002|STARTED|Overall Study||3
11192347|NCT01775774|12382076|FG000|COMPLETED|Overall Study||3
11192348|NCT01775774|12382077|FG001|COMPLETED|Overall Study||3
11192349|NCT01775774|12382078|FG002|COMPLETED|Overall Study||3
11192350|NCT01775774|12382076|FG000|NOT COMPLETED|Overall Study||0
11192351|NCT01775774|12382077|FG001|NOT COMPLETED|Overall Study||0
11192352|NCT01775774|12382078|FG002|NOT COMPLETED|Overall Study||0
11192353|NCT01775787|12382086|FG000|STARTED|First 7-10 Days||13
11192354|NCT01775787|12382087|FG001|STARTED|First 7-10 Days||14
11192355|NCT01775787|12382086|FG000|COMPLETED|First 7-10 Days||12
11192356|NCT01775787|12382087|FG001|COMPLETED|First 7-10 Days||8
11192357|NCT01775787|12382086|FG000|NOT COMPLETED|First 7-10 Days||1
11192358|NCT01775787|12382087|FG001|NOT COMPLETED|First 7-10 Days||6
11192359|NCT01775787|12382086|FG000|STARTED|Second 7-10 Days||12
11192360|NCT01775787|12382087|FG001|STARTED|Second 7-10 Days||8
11192361|NCT01775787|12382086|FG000|COMPLETED|Second 7-10 Days||12
11192362|NCT01775787|12382087|FG001|COMPLETED|Second 7-10 Days||6
11192363|NCT01775787|12382086|FG000|NOT COMPLETED|Second 7-10 Days||0
11192364|NCT01775787|12382087|FG001|NOT COMPLETED|Second 7-10 Days||2
11192365|NCT01775800|12382097|FG000|STARTED|Overall Study||8
11192366|NCT01775800|12382098|FG001|STARTED|Overall Study||8
11192367|NCT01775800|12382097|FG000|COMPLETED|Overall Study||8
11192368|NCT01775800|12382098|FG001|COMPLETED|Overall Study||8
11192369|NCT01775800|12382097|FG000|NOT COMPLETED|Overall Study||0
11192370|NCT01775800|12382098|FG001|NOT COMPLETED|Overall Study||0
11192371|NCT01775852|12382107|FG000|STARTED|Overall Study||31
11192372|NCT01775852|12382108|FG001|STARTED|Overall Study||14
11192373|NCT01775852|12382107|FG000|COMPLETED|Overall Study||31
11192374|NCT01775852|12382108|FG001|COMPLETED|Overall Study||13
11192375|NCT01775852|12382107|FG000|NOT COMPLETED|Overall Study||0
11192376|NCT01775852|12382108|FG001|NOT COMPLETED|Overall Study||1
11192377|NCT01775865|12382117|FG000|STARTED|Overall Study||14
11192378|NCT01775865|12382118|FG001|STARTED|Overall Study||14
11192379|NCT01775865|12382119|FG002|STARTED|Overall Study||17
11192380|NCT01775865|12382117|FG000|COMPLETED|Overall Study||11
11192381|NCT01775865|12382118|FG001|COMPLETED|Overall Study||13
11192382|NCT01775865|12382119|FG002|COMPLETED|Overall Study||17
11192383|NCT01775865|12382117|FG000|NOT COMPLETED|Overall Study||3
11192384|NCT01775865|12382118|FG001|NOT COMPLETED|Overall Study||1
11192385|NCT01775865|12382119|FG002|NOT COMPLETED|Overall Study||0
11192386|NCT01775904|12382132|FG000|STARTED|LY2886721 ODT (no Water, Fasting)||26
11192387|NCT01775904|12382132|FG000|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26
11192388|NCT01775904|12382132|FG000|COMPLETED|LY2886721 ODT (no Water, Fasting)||26
11192389|NCT01775904|12382132|FG000|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0
11192390|NCT01775904|12382132|FG000|STARTED|First Washout (7 Days)||26
11192391|NCT01775904|12382132|FG000|COMPLETED|First Washout (7 Days)||26
11192392|NCT01775904|12382132|FG000|NOT COMPLETED|First Washout (7 Days)||0
11192393|NCT01775904|12382132|FG000|STARTED|LY2886721 Capsule (Water, Fasting)||26
11192394|NCT01775904|12382132|FG000|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26
11192395|NCT01775904|12382132|FG000|COMPLETED|LY2886721 Capsule (Water, Fasting)||25
11192396|NCT01775904|12382132|FG000|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1
11192397|NCT01775904|12382132|FG000|STARTED|Second Washout (7 Days)||25
11192398|NCT01775904|12382132|FG000|COMPLETED|Second Washout (7 Days)||25
11192399|NCT01775904|12382132|FG000|NOT COMPLETED|Second Washout (7 Days)||0
11192400|NCT01775904|12382132|FG000|STARTED|LY2886721 ODT (Water, Fed)||25
11192401|NCT01775904|12382132|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25
11192402|NCT01775904|12382132|FG000|COMPLETED|LY2886721 ODT (Water, Fed)||25
11192403|NCT01775904|12382132|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0
11192404|NCT01775904|12382132|FG000|STARTED|Third Washout (7 Days)||25
11192405|NCT01775904|12382132|FG000|COMPLETED|Third Washout (7 Days)||25
11192406|NCT01775904|12382132|FG000|NOT COMPLETED|Third Washout (7 Days)||0
11192407|NCT01775904|12382132|FG000|STARTED|LY2886721 ODT (Water, Fasting)||25
11192408|NCT01775904|12382132|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24
11192409|NCT01775904|12382132|FG000|COMPLETED|LY2886721 ODT (Water, Fasting)||24
11192410|NCT01775904|12382132|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1
11192411|NCT01775930|12382142|FG000|STARTED|Overall Study||10
11192412|NCT01775930|12382142|FG000|COMPLETED|Overall Study||9
11192413|NCT01775930|12382142|FG000|NOT COMPLETED|Overall Study||1
11192414|NCT01775995|12382148|FG000|STARTED|Overall Study||21
11192415|NCT01775995|12382149|FG001|STARTED|Overall Study||14
11192416|NCT01775995|12382148|FG000|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
11192417|NCT01775995|12382149|FG001|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
11192418|NCT01775995|12382148|FG000|NOT COMPLETED|Overall Study||1
11192419|NCT01775995|12382149|FG001|NOT COMPLETED|Overall Study||1
11192420|NCT01776008|12382155|FG000|STARTED|Overall Study||16
11192421|NCT01776008|12382155|FG000|COMPLETED|Overall Study||14
11192422|NCT01776008|12382155|FG000|NOT COMPLETED|Overall Study||2
11192423|NCT01776268|12382161|FG000|STARTED|Overall Study||48
11192424|NCT01776268|12382162|FG001|STARTED|Overall Study||51
11192425|NCT01776268|12382161|FG000|COMPLETED|Overall Study||48
11192426|NCT01776268|12382162|FG001|COMPLETED|Overall Study||51
11192427|NCT01776268|12382161|FG000|NOT COMPLETED|Overall Study||0
11192428|NCT01776268|12382162|FG001|NOT COMPLETED|Overall Study||0
11192429|NCT01776424|12382172|FG000|STARTED|Overall Study||9152
11192430|NCT01776424|12382173|FG001|STARTED|Overall Study||9117
11192431|NCT01776424|12382174|FG002|STARTED|Overall Study||9126
11192432|NCT01776424|12382172|FG000|Treated|Overall Study||9134
11192433|NCT01776424|12382173|FG001|Treated|Overall Study||9110
11192434|NCT01776424|12382174|FG002|Treated|Overall Study||9107
11192435|NCT01776424|12382172|FG000|COMPLETED|Overall Study||9132
11192436|NCT01776424|12382173|FG001|COMPLETED|Overall Study||9098
11192437|NCT01776424|12382174|FG002|COMPLETED|Overall Study||9102
11192438|NCT01776424|12382172|FG000|NOT COMPLETED|Overall Study||20
11192439|NCT01776424|12382173|FG001|NOT COMPLETED|Overall Study||19
11192440|NCT01776424|12382174|FG002|NOT COMPLETED|Overall Study||24
11192441|NCT01776541|12382184|FG000|STARTED|Overall Study||488
11192442|NCT01776541|12382185|FG001|STARTED|Overall Study||491
11192443|NCT01776541|12382184|FG000|COMPLETED|Overall Study||432
11192444|NCT01776541|12382185|FG001|COMPLETED|Overall Study||416
11192445|NCT01776541|12382184|FG000|NOT COMPLETED|Overall Study||56
11192446|NCT01776541|12382185|FG001|NOT COMPLETED|Overall Study||75
11192447|NCT01776554|12382194|FG000|STARTED|Overall Study||332
11192448|NCT01776554|12382195|FG001|STARTED|Overall Study||330
11192449|NCT01776554|12382194|FG000|COMPLETED|Overall Study||315
11192450|NCT01776554|12382195|FG001|COMPLETED|Overall Study||307
11192451|NCT01776554|12382194|FG000|NOT COMPLETED|Overall Study||17
11192452|NCT01776554|12382195|FG001|NOT COMPLETED|Overall Study||23
11192453|NCT01776632|12382204|FG000|STARTED|Overall Study||217
11192454|NCT01776632|12382205|FG001|STARTED|Overall Study||219
11192455|NCT01776632|12382204|FG000|COMPLETED|Overall Study||190
11192456|NCT01776632|12382205|FG001|COMPLETED|Overall Study||190
11192457|NCT01776632|12382204|FG000|NOT COMPLETED|Overall Study||27
11192458|NCT01776632|12382205|FG001|NOT COMPLETED|Overall Study||29
11192459|NCT01776645|12382213|FG000|STARTED|Overall Study||28
11192460|NCT01776645|12382214|FG001|STARTED|Overall Study||28
11192461|NCT01776645|12382213|FG000|COMPLETED|Overall Study||14
11192462|NCT01776645|12382214|FG001|COMPLETED|Overall Study||14
11192463|NCT01776645|12382213|FG000|NOT COMPLETED|Overall Study||14
11192464|NCT01776645|12382214|FG001|NOT COMPLETED|Overall Study||14
11192465|NCT01777126|12382221|FG000|STARTED|Overall Study||48
11192466|NCT01777126|12382222|FG001|STARTED|Overall Study||46
11192467|NCT01777126|12382221|FG000|COMPLETED|Overall Study||48
11192468|NCT01777126|12382222|FG001|COMPLETED|Overall Study||46
11192469|NCT01777126|12382221|FG000|NOT COMPLETED|Overall Study||0
11192470|NCT01777126|12382222|FG001|NOT COMPLETED|Overall Study||0
11192471|NCT01777139|12382230|FG000|STARTED|Primary Reporting Phase (Up to 4 Years)||30
11192472|NCT01777139|12382231|FG001|STARTED|Primary Reporting Phase (Up to 4 Years)||0
11192473|NCT01777139|12382230|FG000|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
11192474|NCT01777139|12382231|FG001|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
11192475|NCT01777139|12382230|FG000|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30
11192476|NCT01777139|12382231|FG001|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
11192477|NCT01777139|12382230|FG000|STARTED|SFUCP (Up to 1.4 Years)||0
11192478|NCT01777139|12382231|FG001|STARTED|SFUCP (Up to 1.4 Years)||4
11192479|NCT01777139|12382230|FG000|COMPLETED|SFUCP (Up to 1.4 Years)||0
11192480|NCT01777139|12382231|FG001|COMPLETED|SFUCP (Up to 1.4 Years)||0
11192481|NCT01777139|12382230|FG000|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0
11192482|NCT01777139|12382231|FG001|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4
11192483|NCT01777152|12382240|FG000|STARTED|Overall Study||226
11192484|NCT01777152|12382241|FG001|STARTED|Overall Study||226
11192485|NCT01777152|12382240|FG000|COMPLETED|Overall Study||131
11192486|NCT01777152|12382241|FG001|COMPLETED|Overall Study||116
11192487|NCT01777152|12382240|FG000|NOT COMPLETED|Overall Study||95
11192488|NCT01777152|12382241|FG001|NOT COMPLETED|Overall Study||110
11192489|NCT01777191|12382250|FG000|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
11192490|NCT01777191|12382251|FG001|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
11192491|NCT01777191|12382250|FG000|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
11192492|NCT01777191|12382251|FG001|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
11192493|NCT01777191|12382250|FG000|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
11192494|NCT01777191|12382251|FG001|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
11192495|NCT01777191|12382250|FG000|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
11192496|NCT01777191|12382251|FG001|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
11192497|NCT01777191|12382250|FG000|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
11192498|NCT01777191|12382251|FG001|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
11192499|NCT01777191|12382250|FG000|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
11192500|NCT01777191|12382251|FG001|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
11204798|NCT01855399|12395447|FG001|COMPLETED|12 Month||118
11204799|NCT01855399|12395446|FG000|NOT COMPLETED|12 Month||7
11204800|NCT01855399|12395447|FG001|NOT COMPLETED|12 Month||11
11204801|NCT01855425|12395453|FG000|STARTED|Overall Study||96
11204802|NCT01855425|12395453|FG000|COMPLETED|Overall Study||76
11204803|NCT01855425|12395453|FG000|NOT COMPLETED|Overall Study||20
11204804|NCT01855750|12395459|FG000|STARTED|Overall Study||419
11192501|NCT01777217|12382262|FG000|STARTED|Overall Study||4
11192502|NCT01777217|12382263|FG001|STARTED|Overall Study||4
11192503|NCT01777217|12382262|FG000|COMPLETED|Overall Study||4
11324500|NCT02744066|12521797|FG000|STARTED|Overall Study||25
11324501|NCT02744066|12521798|FG001|STARTED|Overall Study||30
11324502|NCT02744066|12521797|FG000|COMPLETED|Overall Study||25
11324503|NCT02744066|12521798|FG001|COMPLETED|Overall Study||25
11324504|NCT02744066|12521797|FG000|NOT COMPLETED|Overall Study||0
11324505|NCT02744066|12521798|FG001|NOT COMPLETED|Overall Study||5
11192504|NCT01777217|12382263|FG001|COMPLETED|Overall Study||4
11192505|NCT01777217|12382262|FG000|NOT COMPLETED|Overall Study||0
11192506|NCT01777217|12382263|FG001|NOT COMPLETED|Overall Study||0
11192507|NCT01777269|12382271|FG000|STARTED|Overall Study||246
11192508|NCT01777269|12382272|FG001|STARTED|Overall Study||243
11192509|NCT01777269|12382271|FG000|COMPLETED|Overall Study||191
11192510|NCT01777269|12382272|FG001|COMPLETED|Overall Study||184
11192511|NCT01777269|12382271|FG000|NOT COMPLETED|Overall Study||55
11192512|NCT01777269|12382272|FG001|NOT COMPLETED|Overall Study||59
11192513|NCT01777282|12382283|FG000|STARTED|Overall Study||120
11192514|NCT01777282|12382284|FG001|STARTED|Overall Study||67
11192515|NCT01777282|12382285|FG002|STARTED|Overall Study||65
11192516|NCT01777282|12382286|FG003|STARTED|Overall Study||61
11192517|NCT01777282|12382287|FG004|STARTED|Overall Study||61
11192518|NCT01777282|12382283|FG000|Completing Treatment Period|Overall Study||109
11192519|NCT01777282|12382284|FG001|Completing Treatment Period|Overall Study||63
11192520|NCT01777282|12382285|FG002|Completing Treatment Period|Overall Study||59
11192521|NCT01777282|12382286|FG003|Completing Treatment Period|Overall Study||59
11192522|NCT01777282|12382287|FG004|Completing Treatment Period|Overall Study||54
11192523|NCT01777282|12382283|FG000|Completing Follow-up Period|Overall Study||109
11192524|NCT01777282|12382284|FG001|Completing Follow-up Period|Overall Study||63
11192525|NCT01777282|12382285|FG002|Completing Follow-up Period|Overall Study||59
11192526|NCT01777282|12382286|FG003|Completing Follow-up Period|Overall Study||59
11192527|NCT01777282|12382287|FG004|Completing Follow-up Period|Overall Study||54
11192528|NCT01777282|12382283|FG000|COMPLETED|Overall Study||109
11192529|NCT01777282|12382284|FG001|COMPLETED|Overall Study||63
11192530|NCT01777282|12382285|FG002|COMPLETED|Overall Study||59
11192531|NCT01777282|12382286|FG003|COMPLETED|Overall Study||59
11192532|NCT01777282|12382287|FG004|COMPLETED|Overall Study||54
11192533|NCT01777282|12382283|FG000|NOT COMPLETED|Overall Study||11
11192534|NCT01777282|12382284|FG001|NOT COMPLETED|Overall Study||4
11192535|NCT01777282|12382285|FG002|NOT COMPLETED|Overall Study||6
11192536|NCT01777282|12382286|FG003|NOT COMPLETED|Overall Study||2
11192537|NCT01777282|12382287|FG004|NOT COMPLETED|Overall Study||7
11192538|NCT01777308|12382301|FG000|STARTED|Overall Study||119
11192539|NCT01777308|12382302|FG001|STARTED|Overall Study||37
11192540|NCT01777308|12382301|FG000|Completed up to Month 73|Overall Study||118
11192541|NCT01777308|12382302|FG001|Completed up to Month 73|Overall Study||37
11192542|NCT01777308|12382301|FG000|COMPLETED|Overall Study||105
11192543|NCT01777308|12382302|FG001|COMPLETED|Overall Study||34
11192544|NCT01777308|12382301|FG000|NOT COMPLETED|Overall Study||14
11192545|NCT01777308|12382302|FG001|NOT COMPLETED|Overall Study||3
11192546|NCT01777321|12382311|FG000|STARTED|Overall Study||30
11192547|NCT01777321|12382312|FG001|STARTED|Overall Study||30
11192548|NCT01777321|12382311|FG000|COMPLETED|Overall Study||30
11192549|NCT01777321|12382312|FG001|COMPLETED|Overall Study||29
11192550|NCT01777321|12382311|FG000|NOT COMPLETED|Overall Study||0
11192551|NCT01777321|12382312|FG001|NOT COMPLETED|Overall Study||1
11192552|NCT01777334|12382320|FG000|STARTED|Overall Study||454
11192553|NCT01777334|12382321|FG001|STARTED|Overall Study||451
11192554|NCT01777334|12382320|FG000|COMPLETED|Overall Study||401
11192555|NCT01777334|12382321|FG001|COMPLETED|Overall Study||388
11192556|NCT01777334|12382320|FG000|NOT COMPLETED|Overall Study||53
11192557|NCT01777334|12382321|FG001|NOT COMPLETED|Overall Study||63
11192558|NCT01777412|12382327|FG000|STARTED|Overall Study||10
11192559|NCT01777412|12382327|FG000|COMPLETED|Overall Study||10
11192560|NCT01777412|12382327|FG000|NOT COMPLETED|Overall Study||0
11192561|NCT01777425|12382331|FG000|STARTED|Overall Study||389
11192562|NCT01777425|12382331|FG000|COMPLETED|Overall Study||389
11192563|NCT01777425|12382331|FG000|NOT COMPLETED|Overall Study||0
11192564|NCT01777438|12382338|FG000|STARTED|Overall Study||352
11192565|NCT01777438|12382339|FG001|STARTED|Overall Study||82
11192566|NCT01777438|12382338|FG000|COMPLETED|Overall Study||352
11192567|NCT01777438|12382339|FG001|COMPLETED|Overall Study||82
11192568|NCT01777438|12382338|FG000|NOT COMPLETED|Overall Study||0
11192569|NCT01777438|12382339|FG001|NOT COMPLETED|Overall Study||0
11192570|NCT01777490|12382349|FG000|STARTED|Overall Study||123
11192571|NCT01777490|12382350|FG001|STARTED|Overall Study||123
11192572|NCT01777490|12382351|FG002|STARTED|Overall Study||119
11192573|NCT01777490|12382352|FG003|STARTED|Overall Study||119
11192574|NCT01777490|12382349|FG000|COMPLETED|Overall Study||123
11192575|NCT01777490|12382350|FG001|COMPLETED|Overall Study||123
11324506|NCT02744391|12521806|FG000|STARTED|Overall Study||47
11324507|NCT02744391|12521806|FG000|COMPLETED|Overall Study||33
11324508|NCT02744391|12521806|FG000|NOT COMPLETED|Overall Study||14
11324509|NCT02744534|12521810|FG000|STARTED|Overall Study||21
11192576|NCT01777490|12382351|FG002|COMPLETED|Overall Study||118
11192577|NCT01777490|12382352|FG003|COMPLETED|Overall Study||118
11192578|NCT01777490|12382349|FG000|NOT COMPLETED|Overall Study||0
11192579|NCT01777490|12382350|FG001|NOT COMPLETED|Overall Study||0
11192580|NCT01777490|12382351|FG002|NOT COMPLETED|Overall Study||1
11192581|NCT01777490|12382352|FG003|NOT COMPLETED|Overall Study||1
11192582|NCT01777542|12382364|FG000|STARTED|First Intervention (20 Weeks)||15
11192583|NCT01777542|12382365|FG001|STARTED|First Intervention (20 Weeks)||15
11192584|NCT01777542|12382364|FG000|COMPLETED|First Intervention (20 Weeks)||15
11192585|NCT01777542|12382365|FG001|COMPLETED|First Intervention (20 Weeks)||15
11192586|NCT01777542|12382364|FG000|NOT COMPLETED|First Intervention (20 Weeks)||0
11192587|NCT01777542|12382365|FG001|NOT COMPLETED|First Intervention (20 Weeks)||0
11192588|NCT01777542|12382364|FG000|STARTED|Washout Period (28 +/- 2 Weeks)||15
11192589|NCT01777542|12382365|FG001|STARTED|Washout Period (28 +/- 2 Weeks)||15
11192590|NCT01777542|12382364|FG000|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
11192591|NCT01777542|12382365|FG001|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
11192592|NCT01777542|12382364|FG000|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
11192593|NCT01777542|12382365|FG001|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
11192594|NCT01777542|12382364|FG000|STARTED|Second Intervention (20 Weeks)||15
11192595|NCT01777542|12382365|FG001|STARTED|Second Intervention (20 Weeks)||15
11192596|NCT01777542|12382364|FG000|COMPLETED|Second Intervention (20 Weeks)||15
11192597|NCT01777542|12382365|FG001|COMPLETED|Second Intervention (20 Weeks)||14
11192598|NCT01777542|12382364|FG000|NOT COMPLETED|Second Intervention (20 Weeks)||0
11192599|NCT01777542|12382365|FG001|NOT COMPLETED|Second Intervention (20 Weeks)||1
11192600|NCT01777568|12382374|FG000|STARTED|Overall Study||2853
11192601|NCT01777568|12382375|FG001|STARTED|Overall Study||2896
11192602|NCT01777568|12382374|FG000|COMPLETED|Overall Study||2853
11192603|NCT01777568|12382375|FG001|COMPLETED|Overall Study||2896
11192604|NCT01777568|12382374|FG000|NOT COMPLETED|Overall Study||0
11192605|NCT01777568|12382375|FG001|NOT COMPLETED|Overall Study||0
11192606|NCT01777581|12382383|FG000|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
11192607|NCT01777581|12382384|FG001|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
11192608|NCT01777581|12382383|FG000|COMPLETED|Overall Study||5
11192609|NCT01777581|12382384|FG001|COMPLETED|Overall Study||3
11192610|NCT01777581|12382383|FG000|NOT COMPLETED|Overall Study||3
11192611|NCT01777581|12382384|FG001|NOT COMPLETED|Overall Study||2
11192612|NCT01777620|12382392|FG000|STARTED|Overall Study||63
11192613|NCT01777620|12382393|FG001|STARTED|Overall Study||62
11192614|NCT01777620|12382392|FG000|COMPLETED|Overall Study||62
11192615|NCT01777620|12382393|FG001|COMPLETED|Overall Study||62
11192616|NCT01777620|12382392|FG000|NOT COMPLETED|Overall Study||1
11192617|NCT01777620|12382393|FG001|NOT COMPLETED|Overall Study||0
11192618|NCT01777763|12382401|FG000|STARTED|Overall Study||20
11192619|NCT01777763|12382402|FG001|STARTED|Overall Study||210
11192620|NCT01777763|12382401|FG000|COMPLETED|Overall Study||16
11192621|NCT01777763|12382402|FG001|COMPLETED|Overall Study||163
11192622|NCT01777763|12382401|FG000|NOT COMPLETED|Overall Study||4
11192623|NCT01777763|12382402|FG001|NOT COMPLETED|Overall Study||47
11192624|NCT01777776|12382412|FG000|STARTED|Overall Study||6
11192625|NCT01777776|12382413|FG001|STARTED|Overall Study||12
11192626|NCT01777776|12382414|FG002|STARTED|Overall Study||6
11192627|NCT01777776|12382415|FG003|STARTED|Overall Study||4
11192628|NCT01777776|12382412|FG000|COMPLETED|Overall Study||0
11192629|NCT01777776|12382413|FG001|COMPLETED|Overall Study||0
11192630|NCT01777776|12382414|FG002|COMPLETED|Overall Study||0
11192631|NCT01777776|12382415|FG003|COMPLETED|Overall Study||0
11192632|NCT01777776|12382412|FG000|NOT COMPLETED|Overall Study||6
11192633|NCT01777776|12382413|FG001|NOT COMPLETED|Overall Study||12
11192634|NCT01777776|12382414|FG002|NOT COMPLETED|Overall Study||6
11192635|NCT01777776|12382415|FG003|NOT COMPLETED|Overall Study||4
11192636|NCT01777932|12382434|FG000|STARTED|Overall Study||220
11192637|NCT01777932|12382434|FG000|COMPLETED|Overall Study||15
11192638|NCT01777932|12382434|FG000|NOT COMPLETED|Overall Study||205
11192639|NCT01777945|12382438|FG000|STARTED|Overall Study||46
11192640|NCT01777945|12382438|FG000|Evaluable Participants|Overall Study||45
11192641|NCT01777945|12382438|FG000|COMPLETED|Overall Study||46
11192642|NCT01777945|12382438|FG000|NOT COMPLETED|Overall Study||0
11192643|NCT01777997|12382442|FG000|STARTED|12 Week lead-in of no ART||38
11192644|NCT01777997|12382442|FG000|COMPLETED|12 Week lead-in of no ART||36
11192645|NCT01777997|12382442|FG000|NOT COMPLETED|12 Week lead-in of no ART||2
11192646|NCT01777997|12382442|FG000|STARTED|Weeks 0 to 24/48 on ART||36
11192647|NCT01777997|12382442|FG000|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
11192648|NCT01777997|12382442|FG000|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
11192649|NCT01777997|12382442|FG000|STARTED|Weeks 48 to 72/96 on ART||28
11192650|NCT01777997|12382442|FG000|COMPLETED|Weeks 48 to 72/96 on ART||26
11192651|NCT01777997|12382442|FG000|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
11192652|NCT01778010|12382446|FG000|STARTED|Overall Study||13
11192653|NCT01778010|12382446|FG000|COMPLETED|Overall Study||8
11192654|NCT01778010|12382446|FG000|NOT COMPLETED|Overall Study||5
11192655|NCT01778023|12382465|FG000|STARTED|Overall Study||36
11192656|NCT01778023|12382466|FG001|STARTED|Overall Study||18
11192657|NCT01778023|12382465|FG000|Exposed|Overall Study||36
11192658|NCT01778023|12382466|FG001|Exposed|Overall Study||15
11192659|NCT01778023|12382465|FG000|COMPLETED|Overall Study||36
11192660|NCT01778023|12382466|FG001|COMPLETED|Overall Study||15
11192661|NCT01778023|12382465|FG000|NOT COMPLETED|Overall Study||0
11192662|NCT01778023|12382466|FG001|NOT COMPLETED|Overall Study||3
11192663|NCT01778049|12382474|FG000|STARTED|Open Label Treatment Period||354
11192664|NCT01778049|12382475|FG001|STARTED|Open Label Treatment Period||355
11192665|NCT01778049|12382476|FG002|STARTED|Open Label Treatment Period||0
11192666|NCT01778049|12382477|FG003|STARTED|Open Label Treatment Period||0
11192667|NCT01778049|12382478|FG004|STARTED|Open Label Treatment Period||0
11192668|NCT01778049|12382479|FG005|STARTED|Open Label Treatment Period||0
11192669|NCT01778049|12382474|FG000|COMPLETED|Open Label Treatment Period||256
11192670|NCT01778049|12382475|FG001|COMPLETED|Open Label Treatment Period||226
11324510|NCT02744534|12521810|FG000|COMPLETED|Overall Study||21
11192671|NCT01778049|12382476|FG002|COMPLETED|Open Label Treatment Period||0
11192672|NCT01778049|12382477|FG003|COMPLETED|Open Label Treatment Period||0
11192673|NCT01778049|12382478|FG004|COMPLETED|Open Label Treatment Period||0
11192674|NCT01778049|12382479|FG005|COMPLETED|Open Label Treatment Period||0
11192675|NCT01778049|12382474|FG000|NOT COMPLETED|Open Label Treatment Period||98
11192676|NCT01778049|12382475|FG001|NOT COMPLETED|Open Label Treatment Period||129
11192677|NCT01778049|12382476|FG002|NOT COMPLETED|Open Label Treatment Period||0
11192678|NCT01778049|12382477|FG003|NOT COMPLETED|Open Label Treatment Period||0
11192679|NCT01778049|12382478|FG004|NOT COMPLETED|Open Label Treatment Period||0
11192680|NCT01778049|12382479|FG005|NOT COMPLETED|Open Label Treatment Period||0
11192681|NCT01778049|12382474|FG000|STARTED|Double Blind Treatment Period||0
11192682|NCT01778049|12382475|FG001|STARTED|Double Blind Treatment Period||0
11192683|NCT01778049|12382476|FG002|STARTED|Double Blind Treatment Period||126
11192684|NCT01778049|12382477|FG003|STARTED|Double Blind Treatment Period||130
11192685|NCT01778049|12382478|FG004|STARTED|Double Blind Treatment Period||114
11192686|NCT01778049|12382479|FG005|STARTED|Double Blind Treatment Period||112
11192687|NCT01778049|12382474|FG000|COMPLETED|Double Blind Treatment Period||0
11192688|NCT01778049|12382475|FG001|COMPLETED|Double Blind Treatment Period||0
11192689|NCT01778049|12382476|FG002|COMPLETED|Double Blind Treatment Period||111
11192690|NCT01778049|12382477|FG003|COMPLETED|Double Blind Treatment Period||118
11192691|NCT01778049|12382478|FG004|COMPLETED|Double Blind Treatment Period||102
11192692|NCT01778049|12382479|FG005|COMPLETED|Double Blind Treatment Period||105
11192693|NCT01778049|12382474|FG000|NOT COMPLETED|Double Blind Treatment Period||0
11192694|NCT01778049|12382475|FG001|NOT COMPLETED|Double Blind Treatment Period||0
11192695|NCT01778049|12382476|FG002|NOT COMPLETED|Double Blind Treatment Period||15
11192696|NCT01778049|12382477|FG003|NOT COMPLETED|Double Blind Treatment Period||12
11192697|NCT01778049|12382478|FG004|NOT COMPLETED|Double Blind Treatment Period||12
11192698|NCT01778049|12382479|FG005|NOT COMPLETED|Double Blind Treatment Period||7
11192699|NCT01778062|12382493|FG000|STARTED|Overall Study||68
11192700|NCT01778062|12382494|FG001|STARTED|Overall Study||68
11192701|NCT01778062|12382493|FG000|Safety Set|Overall Study||68
11192702|NCT01778062|12382494|FG001|Safety Set|Overall Study||68
11192703|NCT01778062|12382493|FG000|Intent to Treat (ITT)|Overall Study||68
11192704|NCT01778062|12382494|FG001|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
11192705|NCT01778062|12382493|FG000|COMPLETED|Overall Study||62
11192706|NCT01778062|12382494|FG001|COMPLETED|Overall Study||57
11192707|NCT01778062|12382493|FG000|NOT COMPLETED|Overall Study||6
11192708|NCT01778062|12382494|FG001|NOT COMPLETED|Overall Study||11
11192709|NCT01778127|12382503|FG000|STARTED|Overall Study||33
11192710|NCT01778127|12382504|FG001|STARTED|Overall Study||33
11192711|NCT01778127|12382505|FG002|STARTED|Overall Study||32
11192712|NCT01778127|12382503|FG000|COMPLETED|Overall Study||25
11192713|NCT01778127|12382504|FG001|COMPLETED|Overall Study||31
11192714|NCT01778127|12382505|FG002|COMPLETED|Overall Study||26
11192715|NCT01778127|12382503|FG000|NOT COMPLETED|Overall Study||8
11192716|NCT01778127|12382504|FG001|NOT COMPLETED|Overall Study||2
11192717|NCT01778127|12382505|FG002|NOT COMPLETED|Overall Study||6
11192718|NCT01778179|12382515|FG000|STARTED|Overall Study||25
11192719|NCT01778179|12382516|FG001|STARTED|Overall Study||25
11192720|NCT01778179|12382515|FG000|COMPLETED|Overall Study||23
11192721|NCT01778179|12382516|FG001|COMPLETED|Overall Study||22
11192722|NCT01778179|12382515|FG000|NOT COMPLETED|Overall Study||2
11192723|NCT01778179|12382516|FG001|NOT COMPLETED|Overall Study||3
11192724|NCT01778296|12382522|FG000|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
11192725|NCT01778296|12382522|FG000|COMPLETED|Overall Study|No patient was lost to follow-up.|12
11192726|NCT01778296|12382522|FG000|NOT COMPLETED|Overall Study||0
11192727|NCT01778426|12382528|FG000|STARTED|Overall Study - Full Analysis Set (FAS)||264
11192728|NCT01778426|12382529|FG001|STARTED|Overall Study - Full Analysis Set (FAS)||138
11192729|NCT01778426|12382528|FG000|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
11192730|NCT01778426|12382529|FG001|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
11192731|NCT01778426|12382528|FG000|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
11192732|NCT01778426|12382529|FG001|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
11192733|NCT01778426|12382528|FG000|STARTED|Intention-To-Treat (ITT) - Completer||198
11192734|NCT01778426|12382529|FG001|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
11192735|NCT01778426|12382528|FG000|COMPLETED|Intention-To-Treat (ITT) - Completer||198
11192736|NCT01778426|12382529|FG001|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
11192737|NCT01778426|12382528|FG000|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
11192738|NCT01778426|12382529|FG001|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
11192739|NCT01778465|12382538|FG000|STARTED|First Intervention (7 Days)||3
11192740|NCT01778465|12382539|FG001|STARTED|First Intervention (7 Days)||4
11192741|NCT01778465|12382538|FG000|COMPLETED|First Intervention (7 Days)||3
11192742|NCT01778465|12382539|FG001|COMPLETED|First Intervention (7 Days)||4
11192743|NCT01778465|12382538|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11192744|NCT01778465|12382539|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11192745|NCT01778465|12382538|FG000|STARTED|Second Intervention (7 Days)||3
11192746|NCT01778465|12382539|FG001|STARTED|Second Intervention (7 Days)||4
11192747|NCT01778465|12382538|FG000|COMPLETED|Second Intervention (7 Days)||3
11192748|NCT01778465|12382539|FG001|COMPLETED|Second Intervention (7 Days)||4
11192749|NCT01778465|12382538|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
11192750|NCT01778465|12382539|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11192751|NCT01778530|12382548|FG000|STARTED|Overall Study||2
11192752|NCT01778530|12382548|FG000|COMPLETED|Overall Study||0
11192753|NCT01778530|12382548|FG000|NOT COMPLETED|Overall Study||2
11192754|NCT01778556|12382554|FG000|STARTED|Intervention 1 (5 Days)||15
11192755|NCT01778556|12382555|FG001|STARTED|Intervention 1 (5 Days)||10
11192756|NCT01778556|12382554|FG000|COMPLETED|Intervention 1 (5 Days)||15
11192757|NCT01778556|12382555|FG001|COMPLETED|Intervention 1 (5 Days)||8
11192758|NCT01778556|12382554|FG000|NOT COMPLETED|Intervention 1 (5 Days)||0
11192759|NCT01778556|12382555|FG001|NOT COMPLETED|Intervention 1 (5 Days)||2
11192760|NCT01778556|12382554|FG000|STARTED|Intervention 2 (14 Days)||15
11192761|NCT01778556|12382555|FG001|STARTED|Intervention 2 (14 Days)||8
11192762|NCT01778556|12382554|FG000|COMPLETED|Intervention 2 (14 Days)||14
11192763|NCT01778556|12382555|FG001|COMPLETED|Intervention 2 (14 Days)||8
11192764|NCT01778556|12382554|FG000|NOT COMPLETED|Intervention 2 (14 Days)||1
11192765|NCT01778556|12382555|FG001|NOT COMPLETED|Intervention 2 (14 Days)||0
11192766|NCT01778556|12382554|FG000|STARTED|Long-term Follow-up||15
11192767|NCT01778556|12382555|FG001|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
11192768|NCT01778556|12382554|FG000|COMPLETED|Long-term Follow-up||14
11192769|NCT01778556|12382555|FG001|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
11192770|NCT01778556|12382554|FG000|NOT COMPLETED|Long-term Follow-up||1
11192771|NCT01778556|12382555|FG001|NOT COMPLETED|Long-term Follow-up||0
11192772|NCT01778634|12382566|FG000|STARTED|Overall Study||61
11192773|NCT01778634|12382567|FG001|STARTED|Overall Study||60
11192774|NCT01778634|12382566|FG000|COMPLETED|Overall Study||61
11192775|NCT01778634|12382567|FG001|COMPLETED|Overall Study||60
11192776|NCT01778634|12382566|FG000|NOT COMPLETED|Overall Study||0
11192777|NCT01778634|12382567|FG001|NOT COMPLETED|Overall Study||0
11192778|NCT01778751|12382576|FG000|STARTED|Overall Study||25
11192779|NCT01778751|12382577|FG001|STARTED|Overall Study||25
11192780|NCT01778751|12382576|FG000|COMPLETED|Overall Study||23
11192781|NCT01778751|12382577|FG001|COMPLETED|Overall Study||23
11192782|NCT01778751|12382576|FG000|NOT COMPLETED|Overall Study||2
11192783|NCT01778751|12382577|FG001|NOT COMPLETED|Overall Study||2
11192784|NCT01778855|12382585|FG000|STARTED|Overall Study||2
11192785|NCT01778855|12382586|FG001|STARTED|Overall Study||4
11192786|NCT01778855|12382585|FG000|COMPLETED|Overall Study||2
11192787|NCT01778855|12382586|FG001|COMPLETED|Overall Study||3
11192788|NCT01778855|12382585|FG000|NOT COMPLETED|Overall Study||0
11192789|NCT01778855|12382586|FG001|NOT COMPLETED|Overall Study||1
11192790|NCT01778985|12382594|FG000|STARTED|Overall Study||15
11192791|NCT01778985|12382595|FG001|STARTED|Overall Study||15
11192792|NCT01778985|12382594|FG000|COMPLETED|Overall Study||8
11192793|NCT01778985|12382595|FG001|COMPLETED|Overall Study||12
11192794|NCT01778985|12382594|FG000|NOT COMPLETED|Overall Study||7
11192795|NCT01778985|12382595|FG001|NOT COMPLETED|Overall Study||3
11192796|NCT01779024|12382601|FG000|STARTED|1st Visit - Alcohol Self-Administration||8
11192797|NCT01779024|12382602|FG001|STARTED|1st Visit - Alcohol Self-Administration||9
11192798|NCT01779024|12382601|FG000|COMPLETED|1st Visit - Alcohol Self-Administration||8
11192799|NCT01779024|12382602|FG001|COMPLETED|1st Visit - Alcohol Self-Administration||9
11192800|NCT01779024|12382601|FG000|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
11192801|NCT01779024|12382602|FG001|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
11192802|NCT01779024|12382601|FG000|STARTED|2nd Visit - Alcohol Self-Administration||8
11192803|NCT01779024|12382602|FG001|STARTED|2nd Visit - Alcohol Self-Administration||9
11192804|NCT01779024|12382601|FG000|COMPLETED|2nd Visit - Alcohol Self-Administration||6
11192805|NCT01779024|12382602|FG001|COMPLETED|2nd Visit - Alcohol Self-Administration||9
11192806|NCT01779024|12382601|FG000|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
11192807|NCT01779024|12382602|FG001|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
11192808|NCT01779024|12382601|FG000|STARTED|1st Visit - Functional MRI||6
11192809|NCT01779024|12382602|FG001|STARTED|1st Visit - Functional MRI||7
11192810|NCT01779024|12382601|FG000|COMPLETED|1st Visit - Functional MRI||4
11192811|NCT01779024|12382602|FG001|COMPLETED|1st Visit - Functional MRI||5
11192812|NCT01779024|12382601|FG000|NOT COMPLETED|1st Visit - Functional MRI||2
11192813|NCT01779024|12382602|FG001|NOT COMPLETED|1st Visit - Functional MRI||2
11192814|NCT01779024|12382601|FG000|STARTED|2nd Visit - Functional MRI||5
11192815|NCT01779024|12382602|FG001|STARTED|2nd Visit - Functional MRI||6
11192816|NCT01779024|12382601|FG000|COMPLETED|2nd Visit - Functional MRI||5
11192817|NCT01779024|12382602|FG001|COMPLETED|2nd Visit - Functional MRI||6
11192818|NCT01779024|12382601|FG000|NOT COMPLETED|2nd Visit - Functional MRI||0
11192819|NCT01779024|12382602|FG001|NOT COMPLETED|2nd Visit - Functional MRI||0
11192820|NCT01779141|12382608|FG000|STARTED|Overall Study||481
11192821|NCT01779141|12382608|FG000|COMPLETED|Overall Study||300
11192822|NCT01779141|12382608|FG000|NOT COMPLETED|Overall Study||181
11192823|NCT01779167|12382612|FG000|STARTED|Overall Study||4
11192824|NCT01779167|12382612|FG000|COMPLETED|Overall Study||3
11192825|NCT01779167|12382612|FG000|NOT COMPLETED|Overall Study||1
11192826|NCT01779219|12382618|FG000|STARTED|Overall Study|First interim analysis|21
11192827|NCT01779219|12382619|FG001|STARTED|Overall Study|First interim analysis|21
11192828|NCT01779219|12382618|FG000|COMPLETED|Overall Study|First interim analysis|21
11192829|NCT01779219|12382619|FG001|COMPLETED|Overall Study|First interim analysis|21
11192830|NCT01779219|12382618|FG000|NOT COMPLETED|Overall Study||0
11192831|NCT01779219|12382619|FG001|NOT COMPLETED|Overall Study||0
11192832|NCT01779375|12382627|FG000|STARTED|Overall Study||47
11192833|NCT01779375|12382628|FG001|STARTED|Overall Study||44
11192834|NCT01779375|12382627|FG000|COMPLETED|Overall Study||45
11192835|NCT01779375|12382628|FG001|COMPLETED|Overall Study||41
11192836|NCT01779375|12382627|FG000|NOT COMPLETED|Overall Study||2
11192837|NCT01779375|12382628|FG001|NOT COMPLETED|Overall Study||3
11192838|NCT01779440|12382638|FG000|STARTED|Overall Study||30
11192839|NCT01779440|12382639|FG001|STARTED|Overall Study||28
11192840|NCT01779440|12382638|FG000|COMPLETED|Overall Study||27
11192841|NCT01779440|12382639|FG001|COMPLETED|Overall Study||23
11192842|NCT01779440|12382638|FG000|NOT COMPLETED|Overall Study||3
11192843|NCT01779440|12382639|FG001|NOT COMPLETED|Overall Study||5
11192844|NCT01779648|12382647|FG000|STARTED|Overall Study||28
11192845|NCT01779648|12382648|FG001|STARTED|Overall Study||27
11192846|NCT01779648|12382647|FG000|COMPLETED|Overall Study||27
11192847|NCT01779648|12382648|FG001|COMPLETED|Overall Study||27
11192848|NCT01779648|12382647|FG000|NOT COMPLETED|Overall Study||1
11192849|NCT01779648|12382648|FG001|NOT COMPLETED|Overall Study||0
11192850|NCT01779700|12382656|FG000|STARTED|Overall Study||18
11192851|NCT01779700|12382657|FG001|STARTED|Overall Study||22
11192852|NCT01779700|12382656|FG000|COMPLETED|Overall Study||14
11192853|NCT01779700|12382657|FG001|COMPLETED|Overall Study||17
11192854|NCT01779700|12382656|FG000|NOT COMPLETED|Overall Study||4
11192855|NCT01779700|12382657|FG001|NOT COMPLETED|Overall Study||5
11192856|NCT01779856|12382663|FG000|STARTED|Overall Study||81
11192857|NCT01779856|12382663|FG000|COMPLETED|Overall Study||57
11192858|NCT01779856|12382663|FG000|NOT COMPLETED|Overall Study||24
11192859|NCT01779869|12382674|FG000|STARTED|Overall Study||16
11192860|NCT01779869|12382674|FG000|COMPLETED|Overall Study||14
11192861|NCT01779869|12382674|FG000|NOT COMPLETED|Overall Study||2
11192862|NCT01780324|12382680|FG000|STARTED|Overall Study||41
11192863|NCT01780324|12382681|FG001|STARTED|Overall Study||39
11192864|NCT01780324|12382680|FG000|COMPLETED|Overall Study||40
11192865|NCT01780324|12382681|FG001|COMPLETED|Overall Study||33
11192866|NCT01780324|12382680|FG000|NOT COMPLETED|Overall Study||1
11192867|NCT01780324|12382681|FG001|NOT COMPLETED|Overall Study||6
11192868|NCT01780337|12382689|FG000|STARTED|Overall Study||6
11192869|NCT01780337|12382690|FG001|STARTED|Overall Study||6
11192870|NCT01780337|12382689|FG000|COMPLETED|Overall Study||6
11192871|NCT01780337|12382690|FG001|COMPLETED|Overall Study||6
11192872|NCT01780337|12382689|FG000|NOT COMPLETED|Overall Study||0
11192873|NCT01780337|12382690|FG001|NOT COMPLETED|Overall Study||0
11192874|NCT01780350|12382696|FG000|STARTED|Overall Study||200
11192875|NCT01780350|12382696|FG000|COMPLETED|Overall Study||200
11192876|NCT01780350|12382696|FG000|NOT COMPLETED|Overall Study||0
11192877|NCT01780389|12382700|FG000|STARTED|Overall Study||5
11192878|NCT01780389|12382700|FG000|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
11192879|NCT01780389|12382700|FG000|NOT COMPLETED|Overall Study||1
11192880|NCT01780454|12382705|FG000|STARTED|Overall Study||2
11192881|NCT01780454|12382705|FG000|COMPLETED|Overall Study||2
11192882|NCT01780454|12382705|FG000|NOT COMPLETED|Overall Study||0
11192883|NCT01780506|12382711|FG000|STARTED|Double-Blind Phase||438
11192884|NCT01780506|12382712|FG001|STARTED|Double-Blind Phase||434
11192885|NCT01780506|12382711|FG000|COMPLETED|Double-Blind Phase||368
11192886|NCT01780506|12382712|FG001|COMPLETED|Double-Blind Phase||356
11192887|NCT01780506|12382711|FG000|NOT COMPLETED|Double-Blind Phase||70
11192888|NCT01780506|12382712|FG001|NOT COMPLETED|Double-Blind Phase||78
11192889|NCT01780506|12382711|FG000|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
11192890|NCT01780506|12382712|FG001|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
11192891|NCT01780506|12382711|FG000|COMPLETED|Open-Label Extension Phase||90
11192892|NCT01780506|12382712|FG001|COMPLETED|Open-Label Extension Phase||94
11192893|NCT01780506|12382711|FG000|NOT COMPLETED|Open-Label Extension Phase||0
11192894|NCT01780506|12382712|FG001|NOT COMPLETED|Open-Label Extension Phase||1
11192895|NCT01780584|12382723|FG000|STARTED|Overall Study||15
11192896|NCT01780584|12382724|FG001|STARTED|Overall Study||15
11192897|NCT01780584|12382725|FG002|STARTED|Overall Study||15
11192898|NCT01780584|12382723|FG000|COMPLETED|Overall Study||14
11192899|NCT01780584|12382724|FG001|COMPLETED|Overall Study||14
11192900|NCT01780584|12382725|FG002|COMPLETED|Overall Study||13
11192901|NCT01780584|12382723|FG000|NOT COMPLETED|Overall Study||1
11192902|NCT01780584|12382724|FG001|NOT COMPLETED|Overall Study||1
11192903|NCT01780584|12382725|FG002|NOT COMPLETED|Overall Study||2
11192904|NCT01780662|12382736|FG000|STARTED|Overall Study||3
11192905|NCT01780662|12382737|FG001|STARTED|Overall Study||13
11192906|NCT01780662|12382738|FG002|STARTED|Overall Study||30
11192907|NCT01780662|12382736|FG000|COMPLETED|Overall Study||2
11192908|NCT01780662|12382737|FG001|COMPLETED|Overall Study||7
11192909|NCT01780662|12382738|FG002|COMPLETED|Overall Study||20
11192910|NCT01780662|12382736|FG000|NOT COMPLETED|Overall Study||1
11192911|NCT01780662|12382737|FG001|NOT COMPLETED|Overall Study||6
11192912|NCT01780662|12382738|FG002|NOT COMPLETED|Overall Study||10
11192913|NCT01780831|12382751|FG000|STARTED|Overall Study||10
11192914|NCT01780831|12382752|FG001|STARTED|Overall Study||6
11192915|NCT01780831|12382753|FG002|STARTED|Overall Study||26
11192916|NCT01780831|12382754|FG003|STARTED|Overall Study||10
11192917|NCT01780831|12382751|FG000|COMPLETED|Overall Study||10
11192918|NCT01780831|12382752|FG001|COMPLETED|Overall Study||6
11192919|NCT01780831|12382753|FG002|COMPLETED|Overall Study||22
11192920|NCT01780831|12382754|FG003|COMPLETED|Overall Study||9
11192921|NCT01780831|12382751|FG000|NOT COMPLETED|Overall Study||0
11192922|NCT01780831|12382752|FG001|NOT COMPLETED|Overall Study||0
11192923|NCT01780831|12382753|FG002|NOT COMPLETED|Overall Study||4
11192924|NCT01780831|12382754|FG003|NOT COMPLETED|Overall Study||1
11192925|NCT01780870|12382813|FG000|STARTED|Overall Study||0
11192926|NCT01780870|12382814|FG001|STARTED|Overall Study||5
11192927|NCT01780870|12382813|FG000|COMPLETED|Overall Study||0
11192928|NCT01780870|12382814|FG001|COMPLETED|Overall Study||5
11192929|NCT01780870|12382813|FG000|NOT COMPLETED|Overall Study||0
11192930|NCT01780870|12382814|FG001|NOT COMPLETED|Overall Study||0
11192931|NCT01780922|12382820|FG000|STARTED|First Intervention (1 Day)||2
11192932|NCT01780922|12382821|FG001|STARTED|First Intervention (1 Day)||2
11192933|NCT01780922|12382822|FG002|STARTED|First Intervention (1 Day)||2
11192934|NCT01780922|12382823|FG003|STARTED|First Intervention (1 Day)||2
11192935|NCT01780922|12382824|FG004|STARTED|First Intervention (1 Day)||2
11192936|NCT01780922|12382825|FG005|STARTED|First Intervention (1 Day)||2
11192937|NCT01780922|12382820|FG000|COMPLETED|First Intervention (1 Day)||2
11192938|NCT01780922|12382821|FG001|COMPLETED|First Intervention (1 Day)||2
11192939|NCT01780922|12382822|FG002|COMPLETED|First Intervention (1 Day)||2
11192940|NCT01780922|12382823|FG003|COMPLETED|First Intervention (1 Day)||2
11192941|NCT01780922|12382824|FG004|COMPLETED|First Intervention (1 Day)||2
11192942|NCT01780922|12382825|FG005|COMPLETED|First Intervention (1 Day)||2
11192943|NCT01780922|12382820|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11192944|NCT01780922|12382821|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11192945|NCT01780922|12382822|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11192946|NCT01780922|12382823|FG003|NOT COMPLETED|First Intervention (1 Day)||0
11192947|NCT01780922|12382824|FG004|NOT COMPLETED|First Intervention (1 Day)||0
11192948|NCT01780922|12382825|FG005|NOT COMPLETED|First Intervention (1 Day)||0
11192949|NCT01780922|12382820|FG000|STARTED|Washout (7 Days)||2
11192950|NCT01780922|12382821|FG001|STARTED|Washout (7 Days)||2
11192951|NCT01780922|12382822|FG002|STARTED|Washout (7 Days)||2
11192952|NCT01780922|12382823|FG003|STARTED|Washout (7 Days)||2
11192953|NCT01780922|12382824|FG004|STARTED|Washout (7 Days)||2
11192954|NCT01780922|12382825|FG005|STARTED|Washout (7 Days)||2
11192955|NCT01780922|12382820|FG000|COMPLETED|Washout (7 Days)||2
11192956|NCT01780922|12382821|FG001|COMPLETED|Washout (7 Days)||2
11192957|NCT01780922|12382822|FG002|COMPLETED|Washout (7 Days)||2
11192958|NCT01780922|12382823|FG003|COMPLETED|Washout (7 Days)||2
11192959|NCT01780922|12382824|FG004|COMPLETED|Washout (7 Days)||2
11192960|NCT01780922|12382825|FG005|COMPLETED|Washout (7 Days)||2
11192961|NCT01780922|12382820|FG000|NOT COMPLETED|Washout (7 Days)||0
11192962|NCT01780922|12382821|FG001|NOT COMPLETED|Washout (7 Days)||0
11192963|NCT01780922|12382822|FG002|NOT COMPLETED|Washout (7 Days)||0
11192964|NCT01780922|12382823|FG003|NOT COMPLETED|Washout (7 Days)||0
11192965|NCT01780922|12382824|FG004|NOT COMPLETED|Washout (7 Days)||0
11192966|NCT01780922|12382825|FG005|NOT COMPLETED|Washout (7 Days)||0
11192967|NCT01780922|12382820|FG000|STARTED|Second Intervention (1 Day)||2
11192968|NCT01780922|12382821|FG001|STARTED|Second Intervention (1 Day)||2
11192969|NCT01780922|12382822|FG002|STARTED|Second Intervention (1 Day)||2
11192970|NCT01780922|12382823|FG003|STARTED|Second Intervention (1 Day)||2
11192971|NCT01780922|12382824|FG004|STARTED|Second Intervention (1 Day)||2
11192972|NCT01780922|12382825|FG005|STARTED|Second Intervention (1 Day)||2
11192973|NCT01780922|12382820|FG000|COMPLETED|Second Intervention (1 Day)||2
11192974|NCT01780922|12382821|FG001|COMPLETED|Second Intervention (1 Day)||2
11192975|NCT01780922|12382822|FG002|COMPLETED|Second Intervention (1 Day)||2
11192976|NCT01780922|12382823|FG003|COMPLETED|Second Intervention (1 Day)||2
11192977|NCT01780922|12382824|FG004|COMPLETED|Second Intervention (1 Day)||2
11192978|NCT01780922|12382825|FG005|COMPLETED|Second Intervention (1 Day)||2
11192979|NCT01780922|12382820|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11192980|NCT01780922|12382821|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11192981|NCT01780922|12382822|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11192982|NCT01780922|12382823|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
11192983|NCT01780922|12382824|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
11192984|NCT01780922|12382825|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
11192985|NCT01780922|12382820|FG000|STARTED|Washout (7 Days)||2
11192986|NCT01780922|12382821|FG001|STARTED|Washout (7 Days)||2
11192987|NCT01780922|12382822|FG002|STARTED|Washout (7 Days)||2
11192988|NCT01780922|12382823|FG003|STARTED|Washout (7 Days)||2
11192989|NCT01780922|12382824|FG004|STARTED|Washout (7 Days)||2
11192990|NCT01780922|12382825|FG005|STARTED|Washout (7 Days)||2
11192991|NCT01780922|12382820|FG000|COMPLETED|Washout (7 Days)||2
11192992|NCT01780922|12382821|FG001|COMPLETED|Washout (7 Days)||2
11192993|NCT01780922|12382822|FG002|COMPLETED|Washout (7 Days)||2
11192994|NCT01780922|12382823|FG003|COMPLETED|Washout (7 Days)||2
11192995|NCT01780922|12382824|FG004|COMPLETED|Washout (7 Days)||2
11192996|NCT01780922|12382825|FG005|COMPLETED|Washout (7 Days)||2
11192997|NCT01780922|12382820|FG000|NOT COMPLETED|Washout (7 Days)||0
11192998|NCT01780922|12382821|FG001|NOT COMPLETED|Washout (7 Days)||0
11192999|NCT01780922|12382822|FG002|NOT COMPLETED|Washout (7 Days)||0
11193000|NCT01780922|12382823|FG003|NOT COMPLETED|Washout (7 Days)||0
11193001|NCT01780922|12382824|FG004|NOT COMPLETED|Washout (7 Days)||0
11193002|NCT01780922|12382825|FG005|NOT COMPLETED|Washout (7 Days)||0
11193003|NCT01780922|12382820|FG000|STARTED|Third Intervention (1 Day)||2
11193004|NCT01780922|12382821|FG001|STARTED|Third Intervention (1 Day)||2
11193005|NCT01780922|12382822|FG002|STARTED|Third Intervention (1 Day)||2
11193006|NCT01780922|12382823|FG003|STARTED|Third Intervention (1 Day)||2
11193007|NCT01780922|12382824|FG004|STARTED|Third Intervention (1 Day)||2
11193008|NCT01780922|12382825|FG005|STARTED|Third Intervention (1 Day)||2
11193009|NCT01780922|12382820|FG000|COMPLETED|Third Intervention (1 Day)||2
11193010|NCT01780922|12382821|FG001|COMPLETED|Third Intervention (1 Day)||2
11193011|NCT01780922|12382822|FG002|COMPLETED|Third Intervention (1 Day)||2
11193012|NCT01780922|12382823|FG003|COMPLETED|Third Intervention (1 Day)||2
11193013|NCT01780922|12382824|FG004|COMPLETED|Third Intervention (1 Day)||2
11193014|NCT01780922|12382825|FG005|COMPLETED|Third Intervention (1 Day)||2
11193015|NCT01780922|12382820|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11193016|NCT01780922|12382821|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11193017|NCT01780922|12382822|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
11193018|NCT01780922|12382823|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
11193019|NCT01780922|12382824|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
11193020|NCT01780922|12382825|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
11193021|NCT01780935|12382835|FG000|STARTED|Overall Study||335
11193022|NCT01780935|12382836|FG001|STARTED|Overall Study||336
11193023|NCT01780935|12382835|FG000|Safety Set|Overall Study||334
11193024|NCT01780935|12382836|FG001|Safety Set|Overall Study||336
11193025|NCT01780935|12382835|FG000|COMPLETED|Overall Study||0
11193026|NCT01780935|12382836|FG001|COMPLETED|Overall Study||0
11193027|NCT01780935|12382835|FG000|NOT COMPLETED|Overall Study||335
11193028|NCT01780935|12382836|FG001|NOT COMPLETED|Overall Study||336
11193029|NCT01780974|12382844|FG000|STARTED|Overall Study||21
11193030|NCT01780974|12382845|FG001|STARTED|Overall Study||21
11193031|NCT01780974|12382844|FG000|COMPLETED|Overall Study||19
11193032|NCT01780974|12382845|FG001|COMPLETED|Overall Study||18
11193033|NCT01780974|12382844|FG000|NOT COMPLETED|Overall Study||2
11193034|NCT01780974|12382845|FG001|NOT COMPLETED|Overall Study||3
11193035|NCT01780987|12382853|FG000|STARTED|Overall Study||40
11193036|NCT01780987|12382854|FG001|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
11193037|NCT01780987|12382853|FG000|COMPLETED|Overall Study||37
11193038|NCT01780987|12382854|FG001|COMPLETED|Overall Study||34
11193039|NCT01780987|12382853|FG000|NOT COMPLETED|Overall Study||3
11193040|NCT01780987|12382854|FG001|NOT COMPLETED|Overall Study||6
11193041|NCT01781078|12382862|FG000|STARTED|Overall Study|Randomized post implantation|229
11193042|NCT01781078|12382863|FG001|STARTED|Overall Study|Randomized post implantation|118
11193043|NCT01781078|12382864|FG002|STARTED|Overall Study||16
11193044|NCT01781078|12382862|FG000|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
11193045|NCT01781078|12382863|FG001|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
11193046|NCT01781078|12382864|FG002|COMPLETED|Overall Study||0
11193047|NCT01781078|12382862|FG000|NOT COMPLETED|Overall Study||12
11193048|NCT01781078|12382863|FG001|NOT COMPLETED|Overall Study||5
11193049|NCT01781078|12382864|FG002|NOT COMPLETED|Overall Study||16
11193050|NCT01781169|12382875|FG000|STARTED|Overall Study||22
11193051|NCT01781169|12382876|FG001|STARTED|Overall Study||21
11193052|NCT01781169|12382875|FG000|COMPLETED|Overall Study||21
11193053|NCT01781169|12382876|FG001|COMPLETED|Overall Study||21
11193054|NCT01781169|12382875|FG000|NOT COMPLETED|Overall Study||1
11193055|NCT01781169|12382876|FG001|NOT COMPLETED|Overall Study||0
11193056|NCT01781208|12382882|FG000|STARTED|Overall Study||62
11193057|NCT01781208|12382882|FG000|Overall Study|Overall Study||62
11193058|NCT01781208|12382882|FG000|COMPLETED|Overall Study||62
11193059|NCT01781208|12382882|FG000|NOT COMPLETED|Overall Study||0
11193060|NCT01781234|12382889|FG000|STARTED|Overall Study||27
11193061|NCT01781234|12382890|FG001|STARTED|Overall Study||24
11193062|NCT01781234|12382889|FG000|COMPLETED|Overall Study||18
11193063|NCT01781234|12382890|FG001|COMPLETED|Overall Study||21
11193064|NCT01781234|12382889|FG000|NOT COMPLETED|Overall Study||9
11193065|NCT01781234|12382890|FG001|NOT COMPLETED|Overall Study||3
11193066|NCT01781286|12382898|FG000|STARTED|Overall Study||7
11193067|NCT01781286|12382899|FG001|STARTED|Overall Study||4
11193068|NCT01781286|12382900|FG002|STARTED|Overall Study||9
11193069|NCT01781286|12382901|FG003|STARTED|Overall Study||8
11193070|NCT01781286|12382902|FG004|STARTED|Overall Study||6
11193071|NCT01781286|12382903|FG005|STARTED|Overall Study||3
11193072|NCT01781286|12382898|FG000|Started 1st Intervention|Overall Study||6
11193073|NCT01781286|12382899|FG001|Started 1st Intervention|Overall Study||4
11193074|NCT01781286|12382900|FG002|Started 1st Intervention|Overall Study||9
11193075|NCT01781286|12382901|FG003|Started 1st Intervention|Overall Study||8
11193076|NCT01781286|12382902|FG004|Started 1st Intervention|Overall Study||6
11193077|NCT01781286|12382903|FG005|Started 1st Intervention|Overall Study||2
11193078|NCT01781286|12382898|FG000|Started 2nd Intervention|Overall Study||5
11193079|NCT01781286|12382899|FG001|Started 2nd Intervention|Overall Study||4
11193080|NCT01781286|12382900|FG002|Started 2nd Intervention|Overall Study||9
11193081|NCT01781286|12382901|FG003|Started 2nd Intervention|Overall Study||8
11193082|NCT01781286|12382902|FG004|Started 2nd Intervention|Overall Study||6
11193083|NCT01781286|12382903|FG005|Started 2nd Intervention|Overall Study||2
11193084|NCT01781286|12382898|FG000|Started 3rd Intervention|Overall Study||5
11193085|NCT01781286|12382899|FG001|Started 3rd Intervention|Overall Study||4
11193086|NCT01781286|12382900|FG002|Started 3rd Intervention|Overall Study||7
11193087|NCT01781286|12382901|FG003|Started 3rd Intervention|Overall Study||7
11193088|NCT01781286|12382902|FG004|Started 3rd Intervention|Overall Study||6
11193089|NCT01781286|12382903|FG005|Started 3rd Intervention|Overall Study||2
11193090|NCT01781286|12382898|FG000|COMPLETED|Overall Study||5
11193091|NCT01781286|12382899|FG001|COMPLETED|Overall Study||4
11193092|NCT01781286|12382900|FG002|COMPLETED|Overall Study||7
11193093|NCT01781286|12382901|FG003|COMPLETED|Overall Study||7
11193094|NCT01781286|12382902|FG004|COMPLETED|Overall Study||6
11193095|NCT01781286|12382903|FG005|COMPLETED|Overall Study||2
11193096|NCT01781286|12382898|FG000|NOT COMPLETED|Overall Study||2
11193097|NCT01781286|12382899|FG001|NOT COMPLETED|Overall Study||0
11193098|NCT01781286|12382900|FG002|NOT COMPLETED|Overall Study||2
11193099|NCT01781286|12382901|FG003|NOT COMPLETED|Overall Study||1
11193100|NCT01781286|12382902|FG004|NOT COMPLETED|Overall Study||0
11193101|NCT01781286|12382903|FG005|NOT COMPLETED|Overall Study||1
11193102|NCT01781299|12382915|FG000|STARTED|Overall Study||4
11193103|NCT01781299|12382916|FG001|STARTED|Overall Study||5
11193104|NCT01781299|12382915|FG000|COMPLETED|Overall Study||4
11193105|NCT01781299|12382916|FG001|COMPLETED|Overall Study||4
11193106|NCT01781299|12382915|FG000|NOT COMPLETED|Overall Study||0
11193107|NCT01781299|12382916|FG001|NOT COMPLETED|Overall Study||1
11193108|NCT01781403|12382922|FG000|STARTED|Overall Study||2
11193109|NCT01781403|12382923|FG001|STARTED|Overall Study||2
11193110|NCT01781403|12382924|FG002|STARTED|Overall Study||18
11193111|NCT01781403|12382922|FG000|COMPLETED|Overall Study||2
11193112|NCT01781403|12382923|FG001|COMPLETED|Overall Study||2
11193113|NCT01781403|12382924|FG002|COMPLETED|Overall Study||18
11193114|NCT01781403|12382922|FG000|NOT COMPLETED|Overall Study||0
11193115|NCT01781403|12382923|FG001|NOT COMPLETED|Overall Study||0
11193116|NCT01781403|12382924|FG002|NOT COMPLETED|Overall Study||0
11193117|NCT01781429|12382949|FG000|STARTED|Overall Study||1
11193118|NCT01781429|12382950|FG001|STARTED|Overall Study||1
11193119|NCT01781429|12382951|FG002|STARTED|Overall Study||1
11193120|NCT01781429|12382952|FG003|STARTED|Overall Study||1
11193121|NCT01781429|12382953|FG004|STARTED|Overall Study||1
11193122|NCT01781429|12382954|FG005|STARTED|Overall Study||4
11193123|NCT01781429|12382955|FG006|STARTED|Overall Study||7
11193124|NCT01781429|12382956|FG007|STARTED|Overall Study||4
11193125|NCT01781429|12382957|FG008|STARTED|Overall Study||7
11193126|NCT01781429|12382958|FG009|STARTED|Overall Study||24
11193127|NCT01781429|12382959|FG010|STARTED|Overall Study||18
11193128|NCT01781429|12382960|FG011|STARTED|Overall Study||21
11193129|NCT01781429|12382961|FG012|STARTED|Overall Study||22
11193130|NCT01781429|12382962|FG013|STARTED|Overall Study||8
11193131|NCT01781429|12382963|FG014|STARTED|Overall Study||16
11193132|NCT01781429|12382964|FG015|STARTED|Overall Study||0
11193133|NCT01781429|12382949|FG000|COMPLETED|Overall Study||0
11193134|NCT01781429|12382950|FG001|COMPLETED|Overall Study||0
11193135|NCT01781429|12382951|FG002|COMPLETED|Overall Study||0
11193136|NCT01781429|12382952|FG003|COMPLETED|Overall Study||0
11193137|NCT01781429|12382953|FG004|COMPLETED|Overall Study||0
11193138|NCT01781429|12382954|FG005|COMPLETED|Overall Study||0
11193139|NCT01781429|12382955|FG006|COMPLETED|Overall Study||0
11193140|NCT01781429|12382956|FG007|COMPLETED|Overall Study||0
11193141|NCT01781429|12382957|FG008|COMPLETED|Overall Study||0
11193142|NCT01781429|12382958|FG009|COMPLETED|Overall Study||0
11193143|NCT01781429|12382959|FG010|COMPLETED|Overall Study||0
11193144|NCT01781429|12382960|FG011|COMPLETED|Overall Study||0
11193145|NCT01781429|12382961|FG012|COMPLETED|Overall Study||0
11193146|NCT01781429|12382962|FG013|COMPLETED|Overall Study||0
11193147|NCT01781429|12382963|FG014|COMPLETED|Overall Study||0
11193148|NCT01781429|12382964|FG015|COMPLETED|Overall Study||0
11193149|NCT01781429|12382949|FG000|NOT COMPLETED|Overall Study||1
11193150|NCT01781429|12382950|FG001|NOT COMPLETED|Overall Study||1
11193151|NCT01781429|12382951|FG002|NOT COMPLETED|Overall Study||1
11193152|NCT01781429|12382952|FG003|NOT COMPLETED|Overall Study||1
11193153|NCT01781429|12382953|FG004|NOT COMPLETED|Overall Study||1
11193154|NCT01781429|12382954|FG005|NOT COMPLETED|Overall Study||4
11193155|NCT01781429|12382955|FG006|NOT COMPLETED|Overall Study||7
11193156|NCT01781429|12382956|FG007|NOT COMPLETED|Overall Study||4
11193157|NCT01781429|12382957|FG008|NOT COMPLETED|Overall Study||7
11193158|NCT01781429|12382958|FG009|NOT COMPLETED|Overall Study||24
11193159|NCT01781429|12382959|FG010|NOT COMPLETED|Overall Study||18
11193160|NCT01781429|12382960|FG011|NOT COMPLETED|Overall Study||21
11193161|NCT01781429|12382961|FG012|NOT COMPLETED|Overall Study||22
11193162|NCT01781429|12382962|FG013|NOT COMPLETED|Overall Study||8
11193163|NCT01781429|12382963|FG014|NOT COMPLETED|Overall Study||16
11193164|NCT01781429|12382964|FG015|NOT COMPLETED|Overall Study||0
11193165|NCT01781468|12383000|FG000|STARTED|Overall Study||109
11193166|NCT01781468|12383001|FG001|STARTED|Overall Study||110
11193167|NCT01781468|12383002|FG002|STARTED|Overall Study||109
11193168|NCT01781468|12383000|FG000|COMPLETED|Overall Study||103
11193169|NCT01781468|12383001|FG001|COMPLETED|Overall Study||97
11193170|NCT01781468|12383002|FG002|COMPLETED|Overall Study||97
11193171|NCT01781468|12383000|FG000|NOT COMPLETED|Overall Study||6
11193172|NCT01781468|12383001|FG001|NOT COMPLETED|Overall Study||13
11193173|NCT01781468|12383002|FG002|NOT COMPLETED|Overall Study||12
11193174|NCT01781481|12383011|FG000|STARTED|Overall Study||148
11193175|NCT01781481|12383011|FG000|COMPLETED|Overall Study||148
11193176|NCT01781481|12383011|FG000|NOT COMPLETED|Overall Study||0
11193177|NCT01781572|12383067|FG000|STARTED|MEK162 45mg BID+LEE011 200mg||16
11193178|NCT01781572|12383068|FG001|STARTED|MEK162 45mg BID+LEE011 200mg||6
11193179|NCT01781572|12383069|FG002|STARTED|MEK162 45mg BID+LEE011 200mg||41
11193180|NCT01781572|12383067|FG000|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
11193181|NCT01781572|12383068|FG001|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
11193182|NCT01781572|12383069|FG002|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
11193183|NCT01781572|12383067|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||16
11193184|NCT01781572|12383068|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||6
11193185|NCT01781572|12383069|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||41
11193186|NCT01781572|12383067|FG000|STARTED|MEK162 45mg BID+LEE011 250mg||3
11193187|NCT01781572|12383068|FG001|STARTED|MEK162 45mg BID+LEE011 250mg||0
11193188|NCT01781572|12383069|FG002|STARTED|MEK162 45mg BID+LEE011 250mg||0
11193189|NCT01781572|12383067|FG000|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
11193190|NCT01781572|12383068|FG001|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
11193191|NCT01781572|12383069|FG002|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
11193192|NCT01781572|12383067|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||3
11193193|NCT01781572|12383068|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
11193194|NCT01781572|12383069|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
11193195|NCT01781572|12383067|FG000|STARTED|MEK162 30mg BID+LEE011 300mg||4
11193196|NCT01781572|12383068|FG001|STARTED|MEK162 30mg BID+LEE011 300mg||2
11193197|NCT01781572|12383069|FG002|STARTED|MEK162 30mg BID+LEE011 300mg||0
11193198|NCT01781572|12383067|FG000|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
11193199|NCT01781572|12383068|FG001|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
11193200|NCT01781572|12383069|FG002|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
11193201|NCT01781572|12383067|FG000|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||4
11193202|NCT01781572|12383068|FG001|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||2
11193203|NCT01781572|12383069|FG002|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||0
11193204|NCT01781572|12383067|FG000|STARTED|MEK162 45mg BID+LEE011 300mg||6
11193205|NCT01781572|12383068|FG001|STARTED|MEK162 45mg BID+LEE011 300mg||4
11193206|NCT01781572|12383069|FG002|STARTED|MEK162 45mg BID+LEE011 300mg||0
11193207|NCT01781572|12383067|FG000|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
11193208|NCT01781572|12383068|FG001|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
11193209|NCT01781572|12383069|FG002|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
11193210|NCT01781572|12383067|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||6
11193211|NCT01781572|12383068|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||4
11193212|NCT01781572|12383069|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||0
11193213|NCT01781572|12383067|FG000|STARTED|MEK162 30mg LEE011 200mg||0
11193214|NCT01781572|12383068|FG001|STARTED|MEK162 30mg LEE011 200mg||5
11193215|NCT01781572|12383069|FG002|STARTED|MEK162 30mg LEE011 200mg||0
11193216|NCT01781572|12383067|FG000|COMPLETED|MEK162 30mg LEE011 200mg||0
11193217|NCT01781572|12383068|FG001|COMPLETED|MEK162 30mg LEE011 200mg||0
11193218|NCT01781572|12383069|FG002|COMPLETED|MEK162 30mg LEE011 200mg||0
11193219|NCT01781572|12383067|FG000|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
11193220|NCT01781572|12383068|FG001|NOT COMPLETED|MEK162 30mg LEE011 200mg||5
11193221|NCT01781572|12383069|FG002|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
11193222|NCT01781572|12383067|FG000|STARTED|MEK162 45mg LEE011 450mg||0
11193223|NCT01781572|12383068|FG001|STARTED|MEK162 45mg LEE011 450mg||9
11193224|NCT01781572|12383069|FG002|STARTED|MEK162 45mg LEE011 450mg||0
11193225|NCT01781572|12383067|FG000|COMPLETED|MEK162 45mg LEE011 450mg||0
11193226|NCT01781572|12383068|FG001|COMPLETED|MEK162 45mg LEE011 450mg||0
11193227|NCT01781572|12383069|FG002|COMPLETED|MEK162 45mg LEE011 450mg||0
11193228|NCT01781572|12383067|FG000|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
11193229|NCT01781572|12383068|FG001|NOT COMPLETED|MEK162 45mg LEE011 450mg||9
11193230|NCT01781572|12383069|FG002|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
11193231|NCT01781572|12383067|FG000|STARTED|MEK162 45mg LEE011 600mg||0
11193232|NCT01781572|12383068|FG001|STARTED|MEK162 45mg LEE011 600mg||6
11193233|NCT01781572|12383069|FG002|STARTED|MEK162 45mg LEE011 600mg||0
11193234|NCT01781572|12383067|FG000|COMPLETED|MEK162 45mg LEE011 600mg||0
11193235|NCT01781572|12383068|FG001|COMPLETED|MEK162 45mg LEE011 600mg||0
11193236|NCT01781572|12383069|FG002|COMPLETED|MEK162 45mg LEE011 600mg||0
11193237|NCT01781572|12383067|FG000|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
11193238|NCT01781572|12383068|FG001|NOT COMPLETED|MEK162 45mg LEE011 600mg||6
11193239|NCT01781572|12383069|FG002|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
11193240|NCT01781611|12383100|FG000|STARTED|Overall Study||13
11193241|NCT01781611|12383101|FG001|STARTED|Overall Study||5
11193242|NCT01781611|12383100|FG000|COMPLETED|Overall Study||9
11193243|NCT01781611|12383101|FG001|COMPLETED|Overall Study||5
11193244|NCT01781611|12383100|FG000|NOT COMPLETED|Overall Study||4
11193245|NCT01781611|12383101|FG001|NOT COMPLETED|Overall Study||0
11193246|NCT01781806|12383109|FG000|STARTED|Overall Study||297
11193247|NCT01781806|12383110|FG001|STARTED|Overall Study||4
11193248|NCT01781806|12383109|FG000|Week 0|Overall Study||297
11193249|NCT01781806|12383110|FG001|Week 0|Overall Study||4
11193250|NCT01781806|12383109|FG000|Week 4|Overall Study||284
11193251|NCT01781806|12383110|FG001|Week 4|Overall Study||4
11193252|NCT01781806|12383109|FG000|Week 8|Overall Study||278
11193253|NCT01781806|12383110|FG001|Week 8|Overall Study||4
11193254|NCT01781806|12383109|FG000|Week 12|Overall Study||272
11193255|NCT01781806|12383110|FG001|Week 12|Overall Study||2
11193256|NCT01781806|12383109|FG000|Week 24|Overall Study||260
11193257|NCT01781806|12383110|FG001|Week 24|Overall Study||1
11193258|NCT01781806|12383109|FG000|Week 36|Overall Study||247
11193259|NCT01781806|12383110|FG001|Week 36|Overall Study||1
11193260|NCT01781806|12383109|FG000|Week 48|Overall Study||222
11193261|NCT01781806|12383110|FG001|Week 48|Overall Study||1
11193262|NCT01781806|12383109|FG000|COMPLETED|Overall Study||218
11193263|NCT01781806|12383110|FG001|COMPLETED|Overall Study||1
11193264|NCT01781806|12383109|FG000|NOT COMPLETED|Overall Study||79
11193265|NCT01781806|12383110|FG001|NOT COMPLETED|Overall Study||3
11193266|NCT01781832|12383117|FG000|STARTED|Overall Study||26
11193267|NCT01781832|12383117|FG000|COMPLETED|Overall Study||25
11193268|NCT01781832|12383117|FG000|NOT COMPLETED|Overall Study||1
11193269|NCT01781962|12383121|FG000|STARTED|Overall Study||206
11193270|NCT01781962|12383121|FG000|COMPLETED|Overall Study||201
11193271|NCT01781962|12383121|FG000|NOT COMPLETED|Overall Study||5
11193272|NCT01781975|12383127|FG000|STARTED|Overall Study||45
11193273|NCT01781975|12383128|FG001|STARTED|Overall Study||22
11193274|NCT01781975|12383127|FG000|Treatment Period|Overall Study||44
11193275|NCT01781975|12383128|FG001|Treatment Period|Overall Study||22
11193276|NCT01781975|12383127|FG000|Follow-Up Period|Overall Study||43
11193277|NCT01781975|12383128|FG001|Follow-Up Period|Overall Study||21
11193278|NCT01781975|12383127|FG000|COMPLETED|Overall Study||43
11193279|NCT01781975|12383128|FG001|COMPLETED|Overall Study||21
11193280|NCT01781975|12383127|FG000|NOT COMPLETED|Overall Study||2
11193281|NCT01781975|12383128|FG001|NOT COMPLETED|Overall Study||1
11193282|NCT01782131|12383136|FG000|STARTED|Overall Study||293
11193283|NCT01782131|12383137|FG001|STARTED|Overall Study||292
11193284|NCT01782131|12383136|FG000|Treated|Overall Study||288
11193285|NCT01782131|12383137|FG001|Treated|Overall Study||287
11193286|NCT01782131|12383136|FG000|COMPLETED|Overall Study||184
11193287|NCT01782131|12383137|FG001|COMPLETED|Overall Study||177
11193288|NCT01782131|12383136|FG000|NOT COMPLETED|Overall Study||109
11193289|NCT01782131|12383137|FG001|NOT COMPLETED|Overall Study||115
11193290|NCT01782209|12383143|FG000|STARTED|Overall Study||335
11193291|NCT01782209|12383143|FG000|COMPLETED|Overall Study||225
11193292|NCT01782209|12383143|FG000|NOT COMPLETED|Overall Study||110
11193293|NCT01782222|12383150|FG000|STARTED|Overall Study||40
11193294|NCT01782222|12383151|FG001|STARTED|Overall Study||41
11193295|NCT01782222|12383152|FG002|STARTED|Overall Study||41
11193296|NCT01782222|12383150|FG000|COMPLETED|Overall Study||32
11193297|NCT01782222|12383151|FG001|COMPLETED|Overall Study||30
11193298|NCT01782222|12383152|FG002|COMPLETED|Overall Study||37
11193299|NCT01782222|12383150|FG000|NOT COMPLETED|Overall Study||8
11193300|NCT01782222|12383151|FG001|NOT COMPLETED|Overall Study||11
11193301|NCT01782222|12383152|FG002|NOT COMPLETED|Overall Study||4
11193302|NCT01782313|12383160|FG000|STARTED|Reached First Response/Completed 2 Cycle||58
11193303|NCT01782313|12383160|FG000|COMPLETED|Reached First Response/Completed 2 Cycle||52
11193304|NCT01782313|12383160|FG000|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
11193305|NCT01782313|12383160|FG000|STARTED|Treated Cycle 3||52
11193306|NCT01782313|12383160|FG000|COMPLETED|Treated Cycle 3||31
11193307|NCT01782313|12383160|FG000|NOT COMPLETED|Treated Cycle 3||21
11193308|NCT01782313|12383160|FG000|STARTED|Treated Cycle 4/Reached 16 Week Response||31
11193309|NCT01782313|12383160|FG000|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
11193310|NCT01782313|12383160|FG000|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
11193311|NCT01782313|12383160|FG000|STARTED|Continued Treatment After 16 Weeks||25
11193312|NCT01782313|12383160|FG000|COMPLETED|Continued Treatment After 16 Weeks||18
11193313|NCT01782313|12383160|FG000|NOT COMPLETED|Continued Treatment After 16 Weeks||7
11193314|NCT01782313|12383160|FG000|STARTED|Survival Follow up||58
11193315|NCT01782313|12383160|FG000|COMPLETED|Survival Follow up||57
11193316|NCT01782313|12383160|FG000|NOT COMPLETED|Survival Follow up||1
11193317|NCT01782326|12383166|FG000|STARTED|Planned Treatment Epoch||1680
11193318|NCT01782326|12383167|FG001|STARTED|Planned Treatment Epoch||1682
11193319|NCT01782326|12383166|FG000|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
11193320|NCT01782326|12383167|FG001|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
11193321|NCT01782326|12383166|FG000|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
11193322|NCT01782326|12383167|FG001|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
11193323|NCT01782326|12383166|FG000|Serial Spirometry Set|Planned Treatment Epoch||280
11193324|NCT01782326|12383167|FG001|Serial Spirometry Set|Planned Treatment Epoch||279
11193325|NCT01782326|12383166|FG000|Safety Set (SAF)|Planned Treatment Epoch||1678
11193326|NCT01782326|12383167|FG001|Safety Set (SAF)|Planned Treatment Epoch||1680
11193327|NCT01782326|12383166|FG000|Urine Cortisol Set|Planned Treatment Epoch||266
11193328|NCT01782326|12383167|FG001|Urine Cortisol Set|Planned Treatment Epoch||269
11193329|NCT01782326|12383166|FG000|COMPLETED|Planned Treatment Epoch||1478
11193330|NCT01782326|12383167|FG001|COMPLETED|Planned Treatment Epoch||1474
11193331|NCT01782326|12383166|FG000|NOT COMPLETED|Planned Treatment Epoch||202
11193332|NCT01782326|12383167|FG001|NOT COMPLETED|Planned Treatment Epoch||208
11193333|NCT01782326|12383166|FG000|STARTED|Double-blind Treatment||1678
11193334|NCT01782326|12383167|FG001|STARTED|Double-blind Treatment||1680
11193335|NCT01782326|12383166|FG000|COMPLETED|Double-blind Treatment||1400
11193336|NCT01782326|12383167|FG001|COMPLETED|Double-blind Treatment||1360
11193337|NCT01782326|12383166|FG000|NOT COMPLETED|Double-blind Treatment||278
11193338|NCT01782326|12383167|FG001|NOT COMPLETED|Double-blind Treatment||320
11193339|NCT01782378|12383175|FG000|STARTED|First Series||32
11193340|NCT01782378|12383176|FG001|STARTED|First Series||31
11193341|NCT01782378|12383175|FG000|COMPLETED|First Series||25
11193342|NCT01782378|12383176|FG001|COMPLETED|First Series||23
11193343|NCT01782378|12383175|FG000|NOT COMPLETED|First Series||7
11193344|NCT01782378|12383176|FG001|NOT COMPLETED|First Series||8
11193345|NCT01782378|12383175|FG000|STARTED|Second Series||31
11193346|NCT01782378|12383176|FG001|STARTED|Second Series||32
11193347|NCT01782378|12383175|FG000|COMPLETED|Second Series||5
11193348|NCT01782378|12383176|FG001|COMPLETED|Second Series||0
11193349|NCT01782378|12383175|FG000|NOT COMPLETED|Second Series||26
11193350|NCT01782378|12383176|FG001|NOT COMPLETED|Second Series||32
11193351|NCT01782469|12383182|FG000|STARTED|Overall Study||16
11193352|NCT01782469|12383182|FG000|COMPLETED|Overall Study||15
11193353|NCT01782469|12383182|FG000|NOT COMPLETED|Overall Study||1
11193354|NCT01782482|12383188|FG000|STARTED|Overall Study||281
11193355|NCT01782482|12383189|FG001|STARTED|Overall Study||280
11193356|NCT01782482|12383188|FG000|COMPLETED|Overall Study||271
11193357|NCT01782482|12383189|FG001|COMPLETED|Overall Study||270
11193358|NCT01782482|12383188|FG000|NOT COMPLETED|Overall Study||10
11193359|NCT01782482|12383189|FG001|NOT COMPLETED|Overall Study||10
11193360|NCT01782495|12383206|FG000|STARTED|Overall Study||34
11193361|NCT01782495|12383207|FG001|STARTED|Overall Study||27
11193362|NCT01782495|12383208|FG002|STARTED|Overall Study||13
11193363|NCT01782495|12383209|FG003|STARTED|Overall Study||4
11193364|NCT01782495|12383210|FG004|STARTED|Overall Study||2
11193365|NCT01782495|12383211|FG005|STARTED|Overall Study||22
11193366|NCT01782495|12383212|FG006|STARTED|Overall Study||12
11193367|NCT01782495|12383213|FG007|STARTED|Overall Study||9
11193368|NCT01782495|12383214|FG008|STARTED|Overall Study||3
11193369|NCT01782495|12383215|FG009|STARTED|Overall Study||2
11193370|NCT01782495|12383216|FG010|STARTED|Overall Study||1
11193371|NCT01782495|12383206|FG000|COMPLETED|Overall Study||34
11193372|NCT01782495|12383207|FG001|COMPLETED|Overall Study||26
11193373|NCT01782495|12383208|FG002|COMPLETED|Overall Study||13
11193374|NCT01782495|12383209|FG003|COMPLETED|Overall Study||4
11193375|NCT01782495|12383210|FG004|COMPLETED|Overall Study||2
11193376|NCT01782495|12383211|FG005|COMPLETED|Overall Study||22
11193377|NCT01782495|12383212|FG006|COMPLETED|Overall Study||12
11193378|NCT01782495|12383213|FG007|COMPLETED|Overall Study||6
11193379|NCT01782495|12383214|FG008|COMPLETED|Overall Study||3
11193380|NCT01782495|12383215|FG009|COMPLETED|Overall Study||2
11193381|NCT01782495|12383216|FG010|COMPLETED|Overall Study||1
11193382|NCT01782495|12383206|FG000|NOT COMPLETED|Overall Study||0
11193383|NCT01782495|12383207|FG001|NOT COMPLETED|Overall Study||1
11193384|NCT01782495|12383208|FG002|NOT COMPLETED|Overall Study||0
11193385|NCT01782495|12383209|FG003|NOT COMPLETED|Overall Study||0
11193386|NCT01782495|12383210|FG004|NOT COMPLETED|Overall Study||0
11193387|NCT01782495|12383211|FG005|NOT COMPLETED|Overall Study||0
11193388|NCT01782495|12383212|FG006|NOT COMPLETED|Overall Study||0
11193389|NCT01782495|12383213|FG007|NOT COMPLETED|Overall Study||3
11193390|NCT01782495|12383214|FG008|NOT COMPLETED|Overall Study||0
11193391|NCT01782495|12383215|FG009|NOT COMPLETED|Overall Study||0
11193392|NCT01782495|12383216|FG010|NOT COMPLETED|Overall Study||0
11193393|NCT01782664|12383246|FG000|STARTED|Overall Study||14
11193394|NCT01782664|12383247|FG001|STARTED|Overall Study||15
11193395|NCT01782664|12383248|FG002|STARTED|Overall Study||16
11193396|NCT01782664|12383249|FG003|STARTED|Overall Study||14
11193397|NCT01782664|12383250|FG004|STARTED|Overall Study||6
11193398|NCT01782664|12383251|FG005|STARTED|Overall Study||2
11193399|NCT01782664|12383246|FG000|COMPLETED|Overall Study||8
11193400|NCT01782664|12383247|FG001|COMPLETED|Overall Study||10
11193401|NCT01782664|12383248|FG002|COMPLETED|Overall Study||12
11193402|NCT01782664|12383249|FG003|COMPLETED|Overall Study||9
11193403|NCT01782664|12383250|FG004|COMPLETED|Overall Study||6
11193404|NCT01782664|12383251|FG005|COMPLETED|Overall Study||2
11193405|NCT01782664|12383246|FG000|NOT COMPLETED|Overall Study||6
11193406|NCT01782664|12383247|FG001|NOT COMPLETED|Overall Study||5
11193407|NCT01782664|12383248|FG002|NOT COMPLETED|Overall Study||4
11193408|NCT01782664|12383249|FG003|NOT COMPLETED|Overall Study||5
11193409|NCT01782664|12383250|FG004|NOT COMPLETED|Overall Study||0
11193410|NCT01782664|12383251|FG005|NOT COMPLETED|Overall Study||0
11193411|NCT01782690|12383265|FG000|STARTED|Overall Study||338
11193412|NCT01782690|12383265|FG000|COMPLETED|Overall Study||39
11193413|NCT01782690|12383265|FG000|NOT COMPLETED|Overall Study||299
11193414|NCT01782742|12383271|FG000|STARTED|Double-blind Treatment Phase||16
11193415|NCT01782742|12383272|FG001|STARTED|Double-blind Treatment Phase||4
11193416|NCT01782742|12383271|FG000|COMPLETED|Double-blind Treatment Phase||15
11193417|NCT01782742|12383272|FG001|COMPLETED|Double-blind Treatment Phase||4
11193418|NCT01782742|12383271|FG000|NOT COMPLETED|Double-blind Treatment Phase||1
11193419|NCT01782742|12383272|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
11193420|NCT01782742|12383271|FG000|STARTED|Open Label Phase||19
11193421|NCT01782742|12383272|FG001|STARTED|Open Label Phase||0
11193422|NCT01782742|12383271|FG000|COMPLETED|Open Label Phase||19
11193423|NCT01782742|12383272|FG001|COMPLETED|Open Label Phase||0
11193424|NCT01782742|12383271|FG000|NOT COMPLETED|Open Label Phase||0
11193425|NCT01782742|12383272|FG001|NOT COMPLETED|Open Label Phase||0
11193426|NCT01782833|12383280|FG000|STARTED|Overall Study||3635
11193427|NCT01782833|12383280|FG000|COMPLETED|Overall Study||3365
11193428|NCT01782833|12383280|FG000|NOT COMPLETED|Overall Study||270
11193429|NCT01782859|12383286|FG000|STARTED|Overall Study||20
11193430|NCT01782859|12383287|FG001|STARTED|Overall Study||20
11193431|NCT01782859|12383286|FG000|COMPLETED|Overall Study||14
11193432|NCT01782859|12383287|FG001|COMPLETED|Overall Study||13
11193433|NCT01782859|12383286|FG000|NOT COMPLETED|Overall Study||6
11193434|NCT01782859|12383287|FG001|NOT COMPLETED|Overall Study||7
11193435|NCT01782872|12383298|FG000|STARTED|Overall Study||20
11193436|NCT01782872|12383299|FG001|STARTED|Overall Study||20
11193437|NCT01782872|12383300|FG002|STARTED|Overall Study||20
11193438|NCT01782872|12383301|FG003|STARTED|Overall Study||20
11193439|NCT01782872|12383298|FG000|COMPLETED|Overall Study||20
11193440|NCT01782872|12383299|FG001|COMPLETED|Overall Study||19
11193441|NCT01782872|12383300|FG002|COMPLETED|Overall Study||20
11193442|NCT01782872|12383301|FG003|COMPLETED|Overall Study||19
11193443|NCT01782872|12383298|FG000|NOT COMPLETED|Overall Study||0
11193444|NCT01782872|12383299|FG001|NOT COMPLETED|Overall Study||1
11193445|NCT01782872|12383300|FG002|NOT COMPLETED|Overall Study||0
11193446|NCT01782872|12383301|FG003|NOT COMPLETED|Overall Study||1
11193447|NCT01782885|12383313|FG000|STARTED|Overall Study||36
11193448|NCT01782885|12383314|FG001|STARTED|Overall Study||39
11193449|NCT01782885|12383313|FG000|COMPLETED|Overall Study||32
11193450|NCT01782885|12383314|FG001|COMPLETED|Overall Study||33
11193451|NCT01782885|12383313|FG000|NOT COMPLETED|Overall Study||4
11193452|NCT01782885|12383314|FG001|NOT COMPLETED|Overall Study||6
11193453|NCT01782898|12383322|FG000|STARTED|Overall Study||35
11193454|NCT01782898|12383323|FG001|STARTED|Overall Study||35
11193455|NCT01782898|12383322|FG000|COMPLETED|Overall Study||29
11193456|NCT01782898|12383323|FG001|COMPLETED|Overall Study||29
11193457|NCT01782898|12383322|FG000|NOT COMPLETED|Overall Study||6
11193458|NCT01782898|12383323|FG001|NOT COMPLETED|Overall Study||6
11193459|NCT01782963|12383329|FG000|STARTED|Overall Study||50
11193460|NCT01782963|12383329|FG000|COMPLETED|Overall Study||50
11193461|NCT01782963|12383329|FG000|NOT COMPLETED|Overall Study||0
11193462|NCT01783054|12383337|FG000|STARTED|Overall Study||2
11193463|NCT01783054|12383337|FG000|COMPLETED|Overall Study||2
11193464|NCT01783054|12383337|FG000|NOT COMPLETED|Overall Study||0
11193465|NCT01783080|12383341|FG000|STARTED|Overall Study||16
11193466|NCT01783080|12383341|FG000|COMPLETED|Overall Study||16
11193467|NCT01783080|12383341|FG000|NOT COMPLETED|Overall Study||0
11193468|NCT01783236|12383347|FG000|STARTED|Overall Study||8
11193469|NCT01783236|12383348|FG001|STARTED|Overall Study||8
11193470|NCT01783236|12383347|FG000|COMPLETED|Overall Study||6
11193471|NCT01783236|12383348|FG001|COMPLETED|Overall Study||8
11193472|NCT01783236|12383347|FG000|NOT COMPLETED|Overall Study||2
11193473|NCT01783236|12383348|FG001|NOT COMPLETED|Overall Study||0
11193474|NCT01783418|12383356|FG000|STARTED|Overall Study||8
11193475|NCT01783418|12383357|FG001|STARTED|Overall Study||6
11193476|NCT01783418|12383356|FG000|COMPLETED|Overall Study||7
11193477|NCT01783418|12383357|FG001|COMPLETED|Overall Study||6
11193478|NCT01783418|12383356|FG000|NOT COMPLETED|Overall Study||1
11193479|NCT01783418|12383357|FG001|NOT COMPLETED|Overall Study||0
11193480|NCT01783444|12383366|FG000|STARTED|Treatment Phase||104
11193481|NCT01783444|12383367|FG001|STARTED|Treatment Phase||103
11193482|NCT01783444|12383368|FG002|STARTED|Treatment Phase||102
11193483|NCT01783444|12383366|FG000|Safety Set|Treatment Phase||104
11193484|NCT01783444|12383367|FG001|Safety Set|Treatment Phase||103
11193485|NCT01783444|12383368|FG002|Safety Set|Treatment Phase||102
11193486|NCT01783444|12383366|FG000|COMPLETED|Treatment Phase||0
11193487|NCT01783444|12383367|FG001|COMPLETED|Treatment Phase||0
11193488|NCT01783444|12383368|FG002|COMPLETED|Treatment Phase||0
11193489|NCT01783444|12383366|FG000|NOT COMPLETED|Treatment Phase||104
11193490|NCT01783444|12383367|FG001|NOT COMPLETED|Treatment Phase||103
11193491|NCT01783444|12383368|FG002|NOT COMPLETED|Treatment Phase||102
11193492|NCT01783444|12383366|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|96
11193493|NCT01783444|12383367|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|93
11193494|NCT01783444|12383368|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|91
11193495|NCT01783444|12383366|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11193496|NCT01783444|12383367|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11193497|NCT01783444|12383368|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
11193498|NCT01783444|12383366|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||96
11193499|NCT01783444|12383367|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||93
11193500|NCT01783444|12383368|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||91
11193501|NCT01783470|12383377|FG000|STARTED|Overall Study||6
11193502|NCT01783470|12383378|FG001|STARTED|Overall Study|Single-dose|6
11193503|NCT01783470|12383377|FG000|COMPLETED|Overall Study||6
11193504|NCT01783470|12383378|FG001|COMPLETED|Overall Study||6
11193505|NCT01783470|12383377|FG000|NOT COMPLETED|Overall Study||0
11193506|NCT01783470|12383378|FG001|NOT COMPLETED|Overall Study||0
11193507|NCT01783483|12383387|FG000|STARTED|Overall Study||120
11193508|NCT01783483|12383388|FG001|STARTED|Overall Study||116
11193509|NCT01783483|12383387|FG000|COMPLETED|Overall Study||100
11193510|NCT01783483|12383388|FG001|COMPLETED|Overall Study||101
11193511|NCT01783483|12383387|FG000|NOT COMPLETED|Overall Study||20
11193512|NCT01783483|12383388|FG001|NOT COMPLETED|Overall Study||15
11193513|NCT01783496|12383400|FG000|STARTED|Overall Study||10
11193514|NCT01783496|12383401|FG001|STARTED|Overall Study||10
11193515|NCT01783496|12383402|FG002|STARTED|Overall Study||10
11193516|NCT01783496|12383403|FG003|STARTED|Overall Study||10
11193517|NCT01783496|12383404|FG004|STARTED|Overall Study||5
11193518|NCT01783496|12383405|FG005|STARTED|Overall Study||5
11193519|NCT01783496|12383400|FG000|COMPLETED|Overall Study||9
11193520|NCT01783496|12383401|FG001|COMPLETED|Overall Study||10
11193521|NCT01783496|12383402|FG002|COMPLETED|Overall Study||10
11193522|NCT01783496|12383403|FG003|COMPLETED|Overall Study||8
11193523|NCT01783496|12383404|FG004|COMPLETED|Overall Study||5
11193524|NCT01783496|12383405|FG005|COMPLETED|Overall Study||4
11193525|NCT01783496|12383400|FG000|NOT COMPLETED|Overall Study||1
11193526|NCT01783496|12383401|FG001|NOT COMPLETED|Overall Study||0
11193527|NCT01783496|12383402|FG002|NOT COMPLETED|Overall Study||0
11193528|NCT01783496|12383403|FG003|NOT COMPLETED|Overall Study||2
11193529|NCT01783496|12383404|FG004|NOT COMPLETED|Overall Study||0
11193530|NCT01783496|12383405|FG005|NOT COMPLETED|Overall Study||1
11204805|NCT01855750|12395460|FG001|STARTED|Overall Study||419
11204806|NCT01855750|12395459|FG000|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416
11204807|NCT01855750|12395460|FG001|Treated|Overall Study|1 participant not treated: withdrew consent.|418
11204808|NCT01855750|12395459|FG000|COMPLETED|Overall Study||0
11204809|NCT01855750|12395460|FG001|COMPLETED|Overall Study||0
11204810|NCT01855750|12395459|FG000|NOT COMPLETED|Overall Study||419
11204811|NCT01855750|12395460|FG001|NOT COMPLETED|Overall Study||419
11204812|NCT01855789|12395466|FG000|STARTED|1) Baseline up to Week 24||718
11204813|NCT01855789|12395467|FG001|STARTED|1) Baseline up to Week 24||0
11204814|NCT01855789|12395468|FG002|STARTED|1) Baseline up to Week 24||0
11204815|NCT01855789|12395469|FG003|STARTED|1) Baseline up to Week 24||0
11204816|NCT01855789|12395466|FG000|COMPLETED|1) Baseline up to Week 24||602
11204817|NCT01855789|12395467|FG001|COMPLETED|1) Baseline up to Week 24||0
11204818|NCT01855789|12395468|FG002|COMPLETED|1) Baseline up to Week 24||0
11204819|NCT01855789|12395469|FG003|COMPLETED|1) Baseline up to Week 24||0
11204820|NCT01855789|12395466|FG000|NOT COMPLETED|1) Baseline up to Week 24||116
11204821|NCT01855789|12395467|FG001|NOT COMPLETED|1) Baseline up to Week 24||0
11204822|NCT01855789|12395468|FG002|NOT COMPLETED|1) Baseline up to Week 24||0
11204823|NCT01855789|12395469|FG003|NOT COMPLETED|1) Baseline up to Week 24||0
11204824|NCT01855789|12395466|FG000|STARTED|2) Week 24 up to End of Study||0
11204825|NCT01855789|12395467|FG001|STARTED|2) Week 24 up to End of Study||147
11204826|NCT01855789|12395468|FG002|STARTED|2) Week 24 up to End of Study||147
11204827|NCT01855789|12395469|FG003|STARTED|2) Week 24 up to End of Study||308
11204828|NCT01855789|12395466|FG000|COMPLETED|2) Week 24 up to End of Study||0
11204829|NCT01855789|12395467|FG001|COMPLETED|2) Week 24 up to End of Study||132
11204830|NCT01855789|12395468|FG002|COMPLETED|2) Week 24 up to End of Study||129
11204831|NCT01855789|12395469|FG003|COMPLETED|2) Week 24 up to End of Study||250
11204832|NCT01855789|12395466|FG000|NOT COMPLETED|2) Week 24 up to End of Study||0
11204833|NCT01855789|12395467|FG001|NOT COMPLETED|2) Week 24 up to End of Study||15
11204834|NCT01855789|12395468|FG002|NOT COMPLETED|2) Week 24 up to End of Study||18
11204835|NCT01855789|12395469|FG003|NOT COMPLETED|2) Week 24 up to End of Study||58
11204836|NCT01855828|12395475|FG000|STARTED|Overall Study||50
11204837|NCT01855828|12395475|FG000|COMPLETED|Overall Study||48
11204838|NCT01855828|12395475|FG000|NOT COMPLETED|Overall Study||2
11204839|NCT01855919|12395486|FG000|STARTED|Overall Study||232
11204840|NCT01855919|12395487|FG001|STARTED|Overall Study||226
11204841|NCT01855919|12395486|FG000|Received at Least 1 Dose of Study Drug|Overall Study||232
11204842|NCT01855919|12395487|FG001|Received at Least 1 Dose of Study Drug|Overall Study||226
11204843|NCT01855919|12395486|FG000|COMPLETED|Overall Study||209
11204844|NCT01855919|12395487|FG001|COMPLETED|Overall Study||200
11204845|NCT01855919|12395486|FG000|NOT COMPLETED|Overall Study||23
11204846|NCT01855919|12395487|FG001|NOT COMPLETED|Overall Study||26
11204847|NCT01855945|12395506|FG000|STARTED|Overall Study||54
11204848|NCT01855945|12395507|FG001|STARTED|Overall Study||55
11204849|NCT01855945|12395508|FG002|STARTED|Overall Study||51
11204850|NCT01855945|12395509|FG003|STARTED|Overall Study||53
11204851|NCT01855945|12395510|FG004|STARTED|Overall Study||51
11204852|NCT01855945|12395511|FG005|STARTED|Overall Study||53
11204853|NCT01855945|12395512|FG006|STARTED|Overall Study||53
11204854|NCT01855945|12395513|FG007|STARTED|Overall Study||55
11204855|NCT01855945|12395514|FG008|STARTED|Overall Study||48
11204856|NCT01855945|12395515|FG009|STARTED|Overall Study||51
11204857|NCT01855945|12395516|FG010|STARTED|Overall Study||51
11204858|NCT01855945|12395517|FG011|STARTED|Overall Study||52
11204859|NCT01855945|12395506|FG000|COMPLETED|Overall Study||38
11204860|NCT01855945|12395507|FG001|COMPLETED|Overall Study||44
11204861|NCT01855945|12395508|FG002|COMPLETED|Overall Study||39
11204862|NCT01855945|12395509|FG003|COMPLETED|Overall Study||49
11204863|NCT01855945|12395510|FG004|COMPLETED|Overall Study||50
11204864|NCT01855945|12395511|FG005|COMPLETED|Overall Study||50
11204865|NCT01855945|12395512|FG006|COMPLETED|Overall Study||43
11204866|NCT01855945|12395513|FG007|COMPLETED|Overall Study||47
11204867|NCT01855945|12395514|FG008|COMPLETED|Overall Study||46
11204868|NCT01855945|12395515|FG009|COMPLETED|Overall Study||49
11204869|NCT01855945|12395516|FG010|COMPLETED|Overall Study||46
11204870|NCT01855945|12395517|FG011|COMPLETED|Overall Study||49
11193531|NCT01783522|12383421|FG000|STARTED|Overall Study||4
11193532|NCT01783522|12383422|FG001|STARTED|Overall Study||5
11193533|NCT01783522|12383421|FG000|COMPLETED|Overall Study||4
11193534|NCT01783522|12383422|FG001|COMPLETED|Overall Study||5
11193535|NCT01783522|12383421|FG000|NOT COMPLETED|Overall Study||0
11193536|NCT01783522|12383422|FG001|NOT COMPLETED|Overall Study||0
11193537|NCT01783548|12383430|FG000|STARTED|Overall Study|Randomized|362
11193538|NCT01783548|12383431|FG001|STARTED|Overall Study|Randomized|185
11193539|NCT01783548|12383430|FG000|Full Analysis Set (FAS)|Overall Study||358
11193540|NCT01783548|12383431|FG001|Full Analysis Set (FAS)|Overall Study||184
11193541|NCT01783548|12383430|FG000|COMPLETED|Overall Study||328
11193542|NCT01783548|12383431|FG001|COMPLETED|Overall Study||167
11193543|NCT01783548|12383430|FG000|NOT COMPLETED|Overall Study||34
11193544|NCT01783548|12383431|FG001|NOT COMPLETED|Overall Study||18
11193545|NCT01783561|12383439|FG000|STARTED|Overall Study||11
11193546|NCT01783561|12383440|FG001|STARTED|Overall Study||10
11193547|NCT01783561|12383439|FG000|COMPLETED|Overall Study||11
11193548|NCT01783561|12383440|FG001|COMPLETED|Overall Study||10
11193549|NCT01783561|12383439|FG000|NOT COMPLETED|Overall Study||0
11193550|NCT01783561|12383440|FG001|NOT COMPLETED|Overall Study||0
11193551|NCT01783574|12383448|FG000|STARTED|Overall Study||51
11193552|NCT01783574|12383449|FG001|STARTED|Overall Study||50
11193553|NCT01783574|12383448|FG000|COMPLETED|Overall Study||46
11193554|NCT01783574|12383449|FG001|COMPLETED|Overall Study||41
11193555|NCT01783574|12383448|FG000|NOT COMPLETED|Overall Study||5
11193556|NCT01783574|12383449|FG001|NOT COMPLETED|Overall Study||9
11193557|NCT01783639|12383455|FG000|STARTED|Overall Study||120
11193558|NCT01783639|12383455|FG000|COMPLETED|Overall Study||120
11193559|NCT01783639|12383455|FG000|NOT COMPLETED|Overall Study||0
11193560|NCT01783678|12383465|FG000|STARTED|Overall Study||19
11193561|NCT01783678|12383466|FG001|STARTED|Overall Study||112
11193562|NCT01783678|12383467|FG002|STARTED|Overall Study||6
11193563|NCT01783678|12383468|FG003|STARTED|Overall Study||58
11193564|NCT01783678|12383469|FG004|STARTED|Overall Study||49
11193565|NCT01783678|12383470|FG005|STARTED|Overall Study||31
11193566|NCT01783678|12383465|FG000|COMPLETED|Overall Study||17
11193567|NCT01783678|12383466|FG001|COMPLETED|Overall Study||94
11193568|NCT01783678|12383467|FG002|COMPLETED|Overall Study||5
11193569|NCT01783678|12383468|FG003|COMPLETED|Overall Study||50
11193570|NCT01783678|12383469|FG004|COMPLETED|Overall Study||42
11193571|NCT01783678|12383470|FG005|COMPLETED|Overall Study||26
11193572|NCT01783678|12383465|FG000|NOT COMPLETED|Overall Study||2
11193573|NCT01783678|12383466|FG001|NOT COMPLETED|Overall Study||18
11193574|NCT01783678|12383467|FG002|NOT COMPLETED|Overall Study||1
11193575|NCT01783678|12383468|FG003|NOT COMPLETED|Overall Study||8
11193576|NCT01783678|12383469|FG004|NOT COMPLETED|Overall Study||7
11193577|NCT01783678|12383470|FG005|NOT COMPLETED|Overall Study||5
11193578|NCT01783730|12383485|FG000|STARTED|Overall Study||163
11193579|NCT01783730|12383485|FG000|COMPLETED|Overall Study||157
11193580|NCT01783730|12383485|FG000|NOT COMPLETED|Overall Study||6
11193581|NCT01783743|12383491|FG000|STARTED|Screening of Subjects by CTA During MDA||13509
11193582|NCT01783743|12383492|FG001|STARTED|Screening of Subjects by CTA During MDA||13964
11193583|NCT01783743|12383491|FG000|COMPLETED|Screening of Subjects by CTA During MDA||10082
11193584|NCT01783743|12383492|FG001|COMPLETED|Screening of Subjects by CTA During MDA||9525
11193585|NCT01783743|12383491|FG000|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
11193586|NCT01783743|12383492|FG001|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
11193587|NCT01783743|12383491|FG000|STARTED|Rescreening of Subjects by Senior Grader||13509
11193588|NCT01783743|12383492|FG001|STARTED|Rescreening of Subjects by Senior Grader||13964
11193589|NCT01783743|12383491|FG000|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
11193590|NCT01783743|12383492|FG001|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
11193591|NCT01783743|12383491|FG000|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
11193592|NCT01783743|12383492|FG001|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
11193593|NCT01783743|12383491|FG000|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
11193594|NCT01783743|12383492|FG001|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
11193595|NCT01783743|12383491|FG000|COMPLETED|Rescreening of Subjects by Senior Grader||2613
11193596|NCT01783743|12383492|FG001|COMPLETED|Rescreening of Subjects by Senior Grader||3044
11193597|NCT01783743|12383491|FG000|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
11193598|NCT01783743|12383492|FG001|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
11193599|NCT01783821|12383500|FG000|STARTED|Overall Study||30
11193600|NCT01783821|12383501|FG001|STARTED|Overall Study||31
11193601|NCT01783821|12383500|FG000|COMPLETED|Overall Study||29
11193602|NCT01783821|12383501|FG001|COMPLETED|Overall Study||30
11193603|NCT01783821|12383500|FG000|NOT COMPLETED|Overall Study||1
11193604|NCT01783821|12383501|FG001|NOT COMPLETED|Overall Study||1
11193605|NCT01783847|12383510|FG000|STARTED|Overall Study||85
11193606|NCT01783847|12383511|FG001|STARTED|Overall Study||16
11193607|NCT01783847|12383512|FG002|STARTED|Overall Study||16
11193608|NCT01783847|12383510|FG000|COMPLETED|Overall Study||69
11193609|NCT01783847|12383511|FG001|COMPLETED|Overall Study||15
11193610|NCT01783847|12383512|FG002|COMPLETED|Overall Study||16
11193611|NCT01783847|12383510|FG000|NOT COMPLETED|Overall Study||16
11193612|NCT01783847|12383511|FG001|NOT COMPLETED|Overall Study||1
11193613|NCT01783847|12383512|FG002|NOT COMPLETED|Overall Study||0
11193614|NCT01783860|12383525|FG000|STARTED|Overall Study||50
11193615|NCT01783860|12383526|FG001|STARTED|Overall Study||50
11193616|NCT01783860|12383525|FG000|COMPLETED|Overall Study||50
11193617|NCT01783860|12383526|FG001|COMPLETED|Overall Study||50
11193618|NCT01783860|12383525|FG000|NOT COMPLETED|Overall Study||0
11193619|NCT01783860|12383526|FG001|NOT COMPLETED|Overall Study||0
11193620|NCT01783886|12383535|FG000|STARTED|Overall Study||127
11193621|NCT01783886|12383536|FG001|STARTED|Overall Study||127
11193622|NCT01783886|12383537|FG002|STARTED|Overall Study||127
11193623|NCT01783886|12383535|FG000|Participants Received Treatment|Overall Study||127
11193624|NCT01783886|12383536|FG001|Participants Received Treatment|Overall Study||127
11193625|NCT01783886|12383537|FG002|Participants Received Treatment|Overall Study||124
11193626|NCT01783886|12383535|FG000|COMPLETED|Overall Study||122
11193627|NCT01783886|12383536|FG001|COMPLETED|Overall Study||116
11193628|NCT01783886|12383537|FG002|COMPLETED|Overall Study||117
11193629|NCT01783886|12383535|FG000|NOT COMPLETED|Overall Study||5
11193630|NCT01783886|12383536|FG001|NOT COMPLETED|Overall Study||11
11193631|NCT01783886|12383537|FG002|NOT COMPLETED|Overall Study||10
11193632|NCT01783912|12383548|FG000|STARTED|Overall Study||118
11193633|NCT01783912|12383549|FG001|STARTED|Overall Study||104
11193634|NCT01783912|12383550|FG002|STARTED|Overall Study||48
11193635|NCT01783912|12383548|FG000|COMPLETED|Overall Study||88
11193636|NCT01783912|12383549|FG001|COMPLETED|Overall Study||58
11193637|NCT01783912|12383550|FG002|COMPLETED|Overall Study||25
11193638|NCT01783912|12383548|FG000|NOT COMPLETED|Overall Study||30
11193639|NCT01783912|12383549|FG001|NOT COMPLETED|Overall Study||46
11193640|NCT01783912|12383550|FG002|NOT COMPLETED|Overall Study||23
11193641|NCT01783938|12383560|FG000|STARTED|Overall Study||68
11193642|NCT01783938|12383561|FG001|STARTED|Overall Study||70
11193643|NCT01783938|12383560|FG000|COMPLETED|Overall Study||11
11193644|NCT01783938|12383561|FG001|COMPLETED|Overall Study||9
11193645|NCT01783938|12383560|FG000|NOT COMPLETED|Overall Study||57
11193646|NCT01783938|12383561|FG001|NOT COMPLETED|Overall Study||61
11193647|NCT01783990|12383569|FG000|STARTED|Overall Study||130
11193648|NCT01783990|12383570|FG001|STARTED|Overall Study||20
11193649|NCT01783990|12383569|FG000|COMPLETED|Overall Study||125
11193650|NCT01783990|12383570|FG001|COMPLETED|Overall Study||18
11193651|NCT01783990|12383569|FG000|NOT COMPLETED|Overall Study||5
11193652|NCT01783990|12383570|FG001|NOT COMPLETED|Overall Study||2
11193653|NCT01784029|12383581|FG000|STARTED|Overall Study||61
11193654|NCT01784029|12383582|FG001|STARTED|Overall Study||59
11193655|NCT01784029|12383583|FG002|STARTED|Overall Study||63
11193656|NCT01784029|12383581|FG000|COMPLETED|Overall Study||42
11193657|NCT01784029|12383582|FG001|COMPLETED|Overall Study||39
11193658|NCT01784029|12383583|FG002|COMPLETED|Overall Study||41
11193659|NCT01784029|12383581|FG000|NOT COMPLETED|Overall Study||19
11193660|NCT01784029|12383582|FG001|NOT COMPLETED|Overall Study||20
11193661|NCT01784029|12383583|FG002|NOT COMPLETED|Overall Study||22
11193662|NCT01784055|12383591|FG000|STARTED|Overall Study||126
11193663|NCT01784055|12383591|FG000|COMPLETED|Overall Study||100
11193664|NCT01784055|12383591|FG000|NOT COMPLETED|Overall Study||26
11193665|NCT01784068|12383595|FG000|STARTED|NTCS Phase||215
11193666|NCT01784068|12383596|FG001|STARTED|NTCS Phase||0
11193667|NCT01784068|12383595|FG000|NTRI Phase|NTCS Phase||86
11193668|NCT01784068|12383596|FG001|NTRI Phase|NTCS Phase||0
11193669|NCT01784068|12383595|FG000|NTCT Phase|NTCS Phase||13
11193670|NCT01784068|12383596|FG001|NTCT Phase|NTCS Phase||0
11193671|NCT01784068|12383595|FG000|TFR-2 Phase|NTCS Phase||8
11193672|NCT01784068|12383596|FG001|TFR-2 Phase|NTCS Phase||0
11193673|NCT01784068|12383595|FG000|NTCT-P Phase|NTCS Phase||2
11193674|NCT01784068|12383596|FG001|NTCT-P Phase|NTCS Phase||0
11193675|NCT01784068|12383595|FG000|NTRI-2|NTCS Phase||0
11193676|NCT01784068|12383596|FG001|NTRI-2|NTCS Phase||0
11193677|NCT01784068|12383595|FG000|COMPLETED|NTCS Phase||0
11193678|NCT01784068|12383596|FG001|COMPLETED|NTCS Phase||0
11193679|NCT01784068|12383595|FG000|NOT COMPLETED|NTCS Phase||215
11193680|NCT01784068|12383596|FG001|NOT COMPLETED|NTCS Phase||0
11193681|NCT01784068|12383595|FG000|STARTED|TFR Phase||0
11193682|NCT01784068|12383596|FG001|STARTED|TFR Phase||190
11193683|NCT01784068|12383595|FG000|COMPLETED|TFR Phase||0
11193684|NCT01784068|12383596|FG001|COMPLETED|TFR Phase||97
11193685|NCT01784068|12383595|FG000|NOT COMPLETED|TFR Phase||0
11193686|NCT01784068|12383596|FG001|NOT COMPLETED|TFR Phase||93
11193687|NCT01784211|12383609|FG000|STARTED|Part A (Days 1-15)||38
11193688|NCT01784211|12383610|FG001|STARTED|Part A (Days 1-15)||38
11193689|NCT01784211|12383611|FG002|STARTED|Part A (Days 1-15)||0
11193690|NCT01784211|12383612|FG003|STARTED|Part A (Days 1-15)||0
11193691|NCT01784211|12383613|FG004|STARTED|Part A (Days 1-15)||0
11193692|NCT01784211|12383614|FG005|STARTED|Part A (Days 1-15)||0
11193693|NCT01784211|12383609|FG000|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37
11193694|NCT01784211|12383610|FG001|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38
11193695|NCT01784211|12383611|FG002|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
11193696|NCT01784211|12383612|FG003|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
11193697|NCT01784211|12383613|FG004|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
11193698|NCT01784211|12383614|FG005|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
11193699|NCT01784211|12383609|FG000|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19
11193700|NCT01784211|12383610|FG001|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21
11193701|NCT01784211|12383611|FG002|Entered Part B|Part A (Days 1-15)||0
11193702|NCT01784211|12383612|FG003|Entered Part B|Part A (Days 1-15)||0
11193703|NCT01784211|12383613|FG004|Entered Part B|Part A (Days 1-15)||0
11193704|NCT01784211|12383614|FG005|Entered Part B|Part A (Days 1-15)||0
11193705|NCT01784211|12383609|FG000|COMPLETED|Part A (Days 1-15)||35
11193706|NCT01784211|12383610|FG001|COMPLETED|Part A (Days 1-15)||36
11193707|NCT01784211|12383611|FG002|COMPLETED|Part A (Days 1-15)||0
11193708|NCT01784211|12383612|FG003|COMPLETED|Part A (Days 1-15)||0
11193709|NCT01784211|12383613|FG004|COMPLETED|Part A (Days 1-15)||0
11193710|NCT01784211|12383614|FG005|COMPLETED|Part A (Days 1-15)||0
11193711|NCT01784211|12383609|FG000|NOT COMPLETED|Part A (Days 1-15)||3
11193712|NCT01784211|12383610|FG001|NOT COMPLETED|Part A (Days 1-15)||2
11193713|NCT01784211|12383611|FG002|NOT COMPLETED|Part A (Days 1-15)||0
11193714|NCT01784211|12383612|FG003|NOT COMPLETED|Part A (Days 1-15)||0
11193715|NCT01784211|12383613|FG004|NOT COMPLETED|Part A (Days 1-15)||0
11193716|NCT01784211|12383614|FG005|NOT COMPLETED|Part A (Days 1-15)||0
11193717|NCT01784211|12383609|FG000|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
11193718|NCT01784211|12383610|FG001|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
11193719|NCT01784211|12383611|FG002|STARTED|Part B (Days 16-21)||10
11193720|NCT01784211|12383612|FG003|STARTED|Part B (Days 16-21)||9
11193721|NCT01784211|12383613|FG004|STARTED|Part B (Days 16-21)||11
11193722|NCT01784211|12383614|FG005|STARTED|Part B (Days 16-21)||10
11193723|NCT01784211|12383609|FG000|COMPLETED|Part B (Days 16-21)||0
11193724|NCT01784211|12383610|FG001|COMPLETED|Part B (Days 16-21)||0
11193725|NCT01784211|12383611|FG002|COMPLETED|Part B (Days 16-21)||10
11193726|NCT01784211|12383612|FG003|COMPLETED|Part B (Days 16-21)||9
11193727|NCT01784211|12383613|FG004|COMPLETED|Part B (Days 16-21)||11
11193728|NCT01784211|12383614|FG005|COMPLETED|Part B (Days 16-21)||10
11193729|NCT01784211|12383609|FG000|NOT COMPLETED|Part B (Days 16-21)||0
11193730|NCT01784211|12383610|FG001|NOT COMPLETED|Part B (Days 16-21)||0
11193731|NCT01784211|12383611|FG002|NOT COMPLETED|Part B (Days 16-21)||0
11193732|NCT01784211|12383612|FG003|NOT COMPLETED|Part B (Days 16-21)||0
11193733|NCT01784211|12383613|FG004|NOT COMPLETED|Part B (Days 16-21)||0
11193734|NCT01784211|12383614|FG005|NOT COMPLETED|Part B (Days 16-21)||0
11193735|NCT01784419|12383626|FG000|STARTED|Overall Study||10
11193736|NCT01784419|12383626|FG000|COMPLETED|Overall Study||7
11193737|NCT01784419|12383626|FG000|NOT COMPLETED|Overall Study||3
11193738|NCT01784523|12383632|FG000|STARTED|Overall Study||7
11193739|NCT01784523|12383633|FG001|STARTED|Overall Study||4
11193740|NCT01784523|12383632|FG000|COMPLETED|Overall Study||0
11193741|NCT01784523|12383633|FG001|COMPLETED|Overall Study||0
11193742|NCT01784523|12383632|FG000|NOT COMPLETED|Overall Study||7
11193743|NCT01784523|12383633|FG001|NOT COMPLETED|Overall Study||4
11193744|NCT01784588|12383641|FG000|STARTED|Overall Study||141
11193745|NCT01784588|12383642|FG001|STARTED|Overall Study||140
11193746|NCT01784588|12383641|FG000|COMPLETED|Overall Study||104
11193747|NCT01784588|12383642|FG001|COMPLETED|Overall Study||108
11193748|NCT01784588|12383641|FG000|NOT COMPLETED|Overall Study||37
11193749|NCT01784588|12383642|FG001|NOT COMPLETED|Overall Study||32
11193750|NCT01784614|12383648|FG000|STARTED|Period 1||3
11193751|NCT01784614|12383649|FG001|STARTED|Period 1||3
11193752|NCT01784614|12383650|FG002|STARTED|Period 1||3
11193753|NCT01784614|12383651|FG003|STARTED|Period 1||3
11193754|NCT01784614|12383652|FG004|STARTED|Period 1||3
11193755|NCT01784614|12383653|FG005|STARTED|Period 1||3
11193756|NCT01784614|12383654|FG006|STARTED|Period 1||3
11193757|NCT01784614|12383655|FG007|STARTED|Period 1||3
11193758|NCT01784614|12383648|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
11193759|NCT01784614|12383649|FG001|Received at Least 1 Dose of Study Drug|Period 1||3
11193760|NCT01784614|12383650|FG002|Received at Least 1 Dose of Study Drug|Period 1||3
11193761|NCT01784614|12383651|FG003|Received at Least 1 Dose of Study Drug|Period 1||3
11193762|NCT01784614|12383652|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
11193763|NCT01784614|12383653|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
11193764|NCT01784614|12383654|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
11193765|NCT01784614|12383655|FG007|Received at Least 1 Dose of Study Drug|Period 1||3
11193766|NCT01784614|12383648|FG000|COMPLETED|Period 1||3
11193767|NCT01784614|12383649|FG001|COMPLETED|Period 1||3
11193768|NCT01784614|12383650|FG002|COMPLETED|Period 1||3
11193769|NCT01784614|12383651|FG003|COMPLETED|Period 1||3
11193770|NCT01784614|12383652|FG004|COMPLETED|Period 1||3
11193771|NCT01784614|12383653|FG005|COMPLETED|Period 1||3
11193772|NCT01784614|12383654|FG006|COMPLETED|Period 1||3
11193773|NCT01784614|12383655|FG007|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
11193774|NCT01784614|12383648|FG000|NOT COMPLETED|Period 1||0
11193775|NCT01784614|12383649|FG001|NOT COMPLETED|Period 1||0
11193776|NCT01784614|12383650|FG002|NOT COMPLETED|Period 1||0
11193777|NCT01784614|12383651|FG003|NOT COMPLETED|Period 1||0
11193778|NCT01784614|12383652|FG004|NOT COMPLETED|Period 1||0
11193779|NCT01784614|12383653|FG005|NOT COMPLETED|Period 1||0
11193780|NCT01784614|12383654|FG006|NOT COMPLETED|Period 1||0
11193781|NCT01784614|12383655|FG007|NOT COMPLETED|Period 1||0
11193782|NCT01784614|12383648|FG000|STARTED|Period 2||3
11193783|NCT01784614|12383649|FG001|STARTED|Period 2||3
11193784|NCT01784614|12383650|FG002|STARTED|Period 2||3
11193785|NCT01784614|12383651|FG003|STARTED|Period 2||3
11193786|NCT01784614|12383652|FG004|STARTED|Period 2||3
11193787|NCT01784614|12383653|FG005|STARTED|Period 2||3
11193788|NCT01784614|12383654|FG006|STARTED|Period 2||3
11193789|NCT01784614|12383655|FG007|STARTED|Period 2||2
11193790|NCT01784614|12383648|FG000|COMPLETED|Period 2||3
11193791|NCT01784614|12383649|FG001|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
11193792|NCT01784614|12383650|FG002|COMPLETED|Period 2||3
11193793|NCT01784614|12383651|FG003|COMPLETED|Period 2||3
11193794|NCT01784614|12383652|FG004|COMPLETED|Period 2||3
11193795|NCT01784614|12383653|FG005|COMPLETED|Period 2||3
11193796|NCT01784614|12383654|FG006|COMPLETED|Period 2||3
11193797|NCT01784614|12383655|FG007|COMPLETED|Period 2||2
11193798|NCT01784614|12383648|FG000|NOT COMPLETED|Period 2||0
11193799|NCT01784614|12383649|FG001|NOT COMPLETED|Period 2||0
11193800|NCT01784614|12383650|FG002|NOT COMPLETED|Period 2||0
11193801|NCT01784614|12383651|FG003|NOT COMPLETED|Period 2||0
11193802|NCT01784614|12383652|FG004|NOT COMPLETED|Period 2||0
11193803|NCT01784614|12383653|FG005|NOT COMPLETED|Period 2||0
11193804|NCT01784614|12383654|FG006|NOT COMPLETED|Period 2||0
11193805|NCT01784614|12383655|FG007|NOT COMPLETED|Period 2||0
11193806|NCT01784614|12383648|FG000|STARTED|Period 3||3
11193807|NCT01784614|12383649|FG001|STARTED|Period 3||2
11193808|NCT01784614|12383650|FG002|STARTED|Period 3||3
11193809|NCT01784614|12383651|FG003|STARTED|Period 3||3
11193810|NCT01784614|12383652|FG004|STARTED|Period 3||3
11193811|NCT01784614|12383653|FG005|STARTED|Period 3||3
11193812|NCT01784614|12383654|FG006|STARTED|Period 3||3
11193813|NCT01784614|12383655|FG007|STARTED|Period 3||2
11193814|NCT01784614|12383648|FG000|COMPLETED|Period 3||3
11193815|NCT01784614|12383649|FG001|COMPLETED|Period 3||2
11193816|NCT01784614|12383650|FG002|COMPLETED|Period 3||3
11193817|NCT01784614|12383651|FG003|COMPLETED|Period 3||3
11193818|NCT01784614|12383652|FG004|COMPLETED|Period 3||3
11193819|NCT01784614|12383653|FG005|COMPLETED|Period 3||3
11193820|NCT01784614|12383654|FG006|COMPLETED|Period 3||3
11193821|NCT01784614|12383655|FG007|COMPLETED|Period 3||2
11193822|NCT01784614|12383648|FG000|NOT COMPLETED|Period 3||0
11193823|NCT01784614|12383649|FG001|NOT COMPLETED|Period 3||0
11193824|NCT01784614|12383650|FG002|NOT COMPLETED|Period 3||0
11193825|NCT01784614|12383651|FG003|NOT COMPLETED|Period 3||0
11193826|NCT01784614|12383652|FG004|NOT COMPLETED|Period 3||0
11193827|NCT01784614|12383653|FG005|NOT COMPLETED|Period 3||0
11193828|NCT01784614|12383654|FG006|NOT COMPLETED|Period 3||0
11193829|NCT01784614|12383655|FG007|NOT COMPLETED|Period 3||0
11193830|NCT01784614|12383648|FG000|STARTED|Period 4||3
11193831|NCT01784614|12383649|FG001|STARTED|Period 4||2
11193832|NCT01784614|12383650|FG002|STARTED|Period 4||3
11193833|NCT01784614|12383651|FG003|STARTED|Period 4||3
11193834|NCT01784614|12383652|FG004|STARTED|Period 4||3
11193835|NCT01784614|12383653|FG005|STARTED|Period 4||3
11193836|NCT01784614|12383654|FG006|STARTED|Period 4||3
11193837|NCT01784614|12383655|FG007|STARTED|Period 4||2
11193838|NCT01784614|12383648|FG000|COMPLETED|Period 4||3
11193839|NCT01784614|12383649|FG001|COMPLETED|Period 4||2
11193840|NCT01784614|12383650|FG002|COMPLETED|Period 4||3
11193841|NCT01784614|12383651|FG003|COMPLETED|Period 4||3
11193842|NCT01784614|12383652|FG004|COMPLETED|Period 4||3
11193843|NCT01784614|12383653|FG005|COMPLETED|Period 4||3
11193844|NCT01784614|12383654|FG006|COMPLETED|Period 4||3
11193845|NCT01784614|12383655|FG007|COMPLETED|Period 4||2
11193846|NCT01784614|12383648|FG000|NOT COMPLETED|Period 4||0
11193847|NCT01784614|12383649|FG001|NOT COMPLETED|Period 4||0
11193848|NCT01784614|12383650|FG002|NOT COMPLETED|Period 4||0
11193849|NCT01784614|12383651|FG003|NOT COMPLETED|Period 4||0
11193850|NCT01784614|12383652|FG004|NOT COMPLETED|Period 4||0
11193851|NCT01784614|12383653|FG005|NOT COMPLETED|Period 4||0
11193852|NCT01784614|12383654|FG006|NOT COMPLETED|Period 4||0
11193853|NCT01784614|12383655|FG007|NOT COMPLETED|Period 4||0
11193854|NCT01784666|12383678|FG000|STARTED|Overall Study||1
11193855|NCT01784666|12383679|FG001|STARTED|Overall Study||0
11193856|NCT01784666|12383680|FG002|STARTED|Overall Study||1
11193857|NCT01784666|12383678|FG000|COMPLETED|Overall Study||1
11193858|NCT01784666|12383679|FG001|COMPLETED|Overall Study||0
11193859|NCT01784666|12383680|FG002|COMPLETED|Overall Study||1
11193860|NCT01784666|12383678|FG000|NOT COMPLETED|Overall Study||0
11193861|NCT01784666|12383679|FG001|NOT COMPLETED|Overall Study||0
11193862|NCT01784666|12383680|FG002|NOT COMPLETED|Overall Study||0
11193863|NCT01784770|12383688|FG000|STARTED|Overall Study||21
11193864|NCT01784770|12383688|FG000|COMPLETED|Overall Study||21
11193865|NCT01784770|12383688|FG000|NOT COMPLETED|Overall Study||0
11193866|NCT01784796|12383694|FG000|STARTED|Overall Study|These are participants who provided informed consent|87
11193867|NCT01784796|12383695|FG001|STARTED|Overall Study|These are participants who provided informed consent|77
11193868|NCT01784796|12383694|FG000|Baseline Data Collected|Overall Study||75
11193869|NCT01784796|12383695|FG001|Baseline Data Collected|Overall Study||61
11193870|NCT01784796|12383694|FG000|4 Week Data Collection|Overall Study||48
11193871|NCT01784796|12383695|FG001|4 Week Data Collection|Overall Study||41
11193872|NCT01784796|12383694|FG000|8 wk Data Collection|Overall Study||50
11193873|NCT01784796|12383695|FG001|8 wk Data Collection|Overall Study||46
11193874|NCT01784796|12383694|FG000|COMPLETED|Overall Study||39
11193875|NCT01784796|12383695|FG001|COMPLETED|Overall Study||34
11193876|NCT01784796|12383694|FG000|NOT COMPLETED|Overall Study||48
11193877|NCT01784796|12383695|FG001|NOT COMPLETED|Overall Study||43
11193878|NCT01784861|12383708|FG000|STARTED|Overall Study||3
11193879|NCT01784861|12383709|FG001|STARTED|Overall Study||3
11193880|NCT01784861|12383710|FG002|STARTED|Overall Study||4
11193881|NCT01784861|12383711|FG003|STARTED|Overall Study||8
11193882|NCT01784861|12383712|FG004|STARTED|Overall Study||3
11193883|NCT01784861|12383713|FG005|STARTED|Overall Study||2
11193884|NCT01784861|12383708|FG000|COMPLETED|Overall Study||3
11193885|NCT01784861|12383709|FG001|COMPLETED|Overall Study||3
11193886|NCT01784861|12383710|FG002|COMPLETED|Overall Study||3
11193887|NCT01784861|12383711|FG003|COMPLETED|Overall Study||3
11193888|NCT01784861|12383712|FG004|COMPLETED|Overall Study||2
11193889|NCT01784861|12383713|FG005|COMPLETED|Overall Study||1
11193890|NCT01784861|12383708|FG000|NOT COMPLETED|Overall Study||0
11193891|NCT01784861|12383709|FG001|NOT COMPLETED|Overall Study||0
11193892|NCT01784861|12383710|FG002|NOT COMPLETED|Overall Study||1
11193893|NCT01784861|12383711|FG003|NOT COMPLETED|Overall Study||5
11193894|NCT01784861|12383712|FG004|NOT COMPLETED|Overall Study||1
11193895|NCT01784861|12383713|FG005|NOT COMPLETED|Overall Study||1
11193896|NCT01784926|12383731|FG000|STARTED|Overall Study||54
11193897|NCT01784926|12383732|FG001|STARTED|Overall Study||50
11193898|NCT01784926|12383731|FG000|COMPLETED|Overall Study||43
11193899|NCT01784926|12383732|FG001|COMPLETED|Overall Study||42
11193900|NCT01784926|12383731|FG000|NOT COMPLETED|Overall Study||11
11193901|NCT01784926|12383732|FG001|NOT COMPLETED|Overall Study||8
11193902|NCT01784965|12383740|FG000|STARTED|Overall Study||33
11193903|NCT01784965|12383741|FG001|STARTED|Overall Study||35
11193904|NCT01784965|12383740|FG000|COMPLETED|Overall Study||27
11193905|NCT01784965|12383741|FG001|COMPLETED|Overall Study||24
11193906|NCT01784965|12383740|FG000|NOT COMPLETED|Overall Study||6
11193907|NCT01784965|12383741|FG001|NOT COMPLETED|Overall Study||11
11193908|NCT01785069|12383753|FG000|STARTED|Overall Study||107
11193909|NCT01785069|12383754|FG001|STARTED|Overall Study||76
11193910|NCT01785069|12383755|FG002|STARTED|Overall Study||104
11193911|NCT01785069|12383756|FG003|STARTED|Overall Study||68
11193912|NCT01785069|12383753|FG000|COMPLETED|Overall Study||95
11193913|NCT01785069|12383754|FG001|COMPLETED|Overall Study||64
11193914|NCT01785069|12383755|FG002|COMPLETED|Overall Study||91
11193915|NCT01785069|12383756|FG003|COMPLETED|Overall Study||54
11193916|NCT01785069|12383753|FG000|NOT COMPLETED|Overall Study||12
11193917|NCT01785069|12383754|FG001|NOT COMPLETED|Overall Study||12
11193918|NCT01785069|12383755|FG002|NOT COMPLETED|Overall Study||13
11193919|NCT01785069|12383756|FG003|NOT COMPLETED|Overall Study||14
11193920|NCT01785095|12383766|FG000|STARTED|Overall Study||27
11193921|NCT01785095|12383766|FG000|COMPLETED|Overall Study||24
11193922|NCT01785095|12383766|FG000|NOT COMPLETED|Overall Study||3
11193923|NCT01785134|12383775|FG000|STARTED|Overall Study||41
11193924|NCT01785134|12383776|FG001|STARTED|Overall Study||40
11193925|NCT01785134|12383775|FG000|COMPLETED|Overall Study||29
11193926|NCT01785134|12383776|FG001|COMPLETED|Overall Study||33
11193927|NCT01785134|12383775|FG000|NOT COMPLETED|Overall Study||12
11193928|NCT01785134|12383776|FG001|NOT COMPLETED|Overall Study||7
11193929|NCT01785160|12383782|FG000|STARTED|Treatment Period 1: Raltegravir||25
11193930|NCT01785160|12383782|FG000|COMPLETED|Treatment Period 1: Raltegravir||24
11193931|NCT01785160|12383782|FG000|NOT COMPLETED|Treatment Period 1: Raltegravir||1
11193932|NCT01785160|12383782|FG000|STARTED|Washout Period of at Least 7 Days||24
11193933|NCT01785160|12383782|FG000|COMPLETED|Washout Period of at Least 7 Days||23
11193934|NCT01785160|12383782|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1
11193935|NCT01785160|12383782|FG000|STARTED|Treatment Period 2: Raltegravir + Faldap||23
11193936|NCT01785160|12383782|FG000|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
11193937|NCT01785160|12383782|FG000|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
11193938|NCT01785186|12383793|FG000|STARTED|Overall Study||59
11193939|NCT01785186|12383794|FG001|STARTED|Overall Study||63
11193940|NCT01785186|12383795|FG002|STARTED|Overall Study||57
11193941|NCT01785186|12383796|FG003|STARTED|Overall Study||63
11193942|NCT01785186|12383797|FG004|STARTED|Overall Study||123
11193943|NCT01785186|12383793|FG000|COMPLETED|Overall Study||53
11193944|NCT01785186|12383794|FG001|COMPLETED|Overall Study||57
11193945|NCT01785186|12383795|FG002|COMPLETED|Overall Study||52
11193946|NCT01785186|12383796|FG003|COMPLETED|Overall Study||58
11193947|NCT01785186|12383797|FG004|COMPLETED|Overall Study||117
11193948|NCT01785186|12383793|FG000|NOT COMPLETED|Overall Study||6
11193949|NCT01785186|12383794|FG001|NOT COMPLETED|Overall Study||6
11193950|NCT01785186|12383795|FG002|NOT COMPLETED|Overall Study||5
11193951|NCT01785186|12383796|FG003|NOT COMPLETED|Overall Study||5
11193952|NCT01785186|12383797|FG004|NOT COMPLETED|Overall Study||6
11193953|NCT01785472|12383814|FG000|STARTED|Overall Study||479
11193954|NCT01785472|12383815|FG001|STARTED|Overall Study||473
11193955|NCT01785472|12383816|FG002|STARTED|Overall Study||486
11193956|NCT01785472|12383814|FG000|Full Analysis Set (FAS)|Overall Study||479
11193957|NCT01785472|12383815|FG001|Full Analysis Set (FAS)|Overall Study||472
11193958|NCT01785472|12383816|FG002|Full Analysis Set (FAS)|Overall Study||484
11193959|NCT01785472|12383814|FG000|Safety Set (SAF)|Overall Study||478
11193960|NCT01785472|12383815|FG001|Safety Set (SAF)|Overall Study||472
11193961|NCT01785472|12383816|FG002|Safety Set (SAF)|Overall Study||484
11193962|NCT01785472|12383814|FG000|COMPLETED|Overall Study||455
11193963|NCT01785472|12383815|FG001|COMPLETED|Overall Study||454
11193964|NCT01785472|12383816|FG002|COMPLETED|Overall Study||464
11193965|NCT01785472|12383814|FG000|NOT COMPLETED|Overall Study||24
11193966|NCT01785472|12383815|FG001|NOT COMPLETED|Overall Study||19
11193967|NCT01785472|12383816|FG002|NOT COMPLETED|Overall Study||22
11193968|NCT01785524|12383828|FG000|STARTED|Overall Study||7
11193969|NCT01785524|12383829|FG001|STARTED|Overall Study||4
11193970|NCT01785524|12383828|FG000|COMPLETED|Overall Study||5
11193971|NCT01785524|12383829|FG001|COMPLETED|Overall Study||2
11193972|NCT01785524|12383828|FG000|NOT COMPLETED|Overall Study||2
11193973|NCT01785524|12383829|FG001|NOT COMPLETED|Overall Study||2
11193974|NCT01785602|12383837|FG000|STARTED|Overall Study||76
11193975|NCT01785602|12383838|FG001|STARTED|Overall Study||27
11193976|NCT01785602|12383837|FG000|COMPLETED|Overall Study||63
11193977|NCT01785602|12383838|FG001|COMPLETED|Overall Study||18
11193978|NCT01785602|12383837|FG000|NOT COMPLETED|Overall Study||13
11193979|NCT01785602|12383838|FG001|NOT COMPLETED|Overall Study||9
11193980|NCT01785615|12383847|FG000|STARTED|Dietary Phase||0
11193981|NCT01785615|12383848|FG001|STARTED|Dietary Phase||0
11193982|NCT01785615|12383849|FG002|STARTED|Dietary Phase||35
11193983|NCT01785615|12383850|FG003|STARTED|Dietary Phase||140
11193984|NCT01785615|12383847|FG000|COMPLETED|Dietary Phase||0
11193985|NCT01785615|12383848|FG001|COMPLETED|Dietary Phase||0
11193986|NCT01785615|12383849|FG002|COMPLETED|Dietary Phase||35
11193987|NCT01785615|12383850|FG003|COMPLETED|Dietary Phase||116
11193988|NCT01785615|12383847|FG000|NOT COMPLETED|Dietary Phase||0
11193989|NCT01785615|12383848|FG001|NOT COMPLETED|Dietary Phase||0
11193990|NCT01785615|12383849|FG002|NOT COMPLETED|Dietary Phase||0
11193991|NCT01785615|12383850|FG003|NOT COMPLETED|Dietary Phase||24
11193992|NCT01785615|12383847|FG000|STARTED|Atorvastatin Phase||44
11193993|NCT01785615|12383848|FG001|STARTED|Atorvastatin Phase||44
11193994|NCT01785615|12383849|FG002|STARTED|Atorvastatin Phase||0
11193995|NCT01785615|12383850|FG003|STARTED|Atorvastatin Phase||0
11193996|NCT01785615|12383847|FG000|COMPLETED|Atorvastatin Phase||44
11193997|NCT01785615|12383848|FG001|COMPLETED|Atorvastatin Phase||44
11193998|NCT01785615|12383849|FG002|COMPLETED|Atorvastatin Phase||0
11193999|NCT01785615|12383850|FG003|COMPLETED|Atorvastatin Phase||0
11194000|NCT01785615|12383847|FG000|NOT COMPLETED|Atorvastatin Phase||0
11194001|NCT01785615|12383848|FG001|NOT COMPLETED|Atorvastatin Phase||0
11194002|NCT01785615|12383849|FG002|NOT COMPLETED|Atorvastatin Phase||0
11194003|NCT01785615|12383850|FG003|NOT COMPLETED|Atorvastatin Phase||0
11194004|NCT01785628|12383864|FG000|STARTED|Overall Study||15
11194005|NCT01785628|12383865|FG001|STARTED|Overall Study||15
11194006|NCT01785628|12383864|FG000|COMPLETED|Overall Study||13
11194007|NCT01785628|12383865|FG001|COMPLETED|Overall Study||12
11194008|NCT01785628|12383864|FG000|NOT COMPLETED|Overall Study||2
11194009|NCT01785628|12383865|FG001|NOT COMPLETED|Overall Study||3
11194010|NCT01785680|12383873|FG000|STARTED|Overall Study||1100
11194011|NCT01785680|12383874|FG001|STARTED|Overall Study||857
11194012|NCT01785680|12383873|FG000|COMPLETED|Overall Study||1100
11194013|NCT01785680|12383874|FG001|COMPLETED|Overall Study||857
11194014|NCT01785680|12383873|FG000|NOT COMPLETED|Overall Study||0
11194015|NCT01785680|12383874|FG001|NOT COMPLETED|Overall Study||0
11194016|NCT01785810|12383880|FG000|STARTED|Overall Study||37
11194017|NCT01785810|12383880|FG000|COMPLETED|Overall Study||29
11194018|NCT01785810|12383880|FG000|NOT COMPLETED|Overall Study||8
11194019|NCT01785849|12383886|FG000|STARTED|Overall Study||254
11194020|NCT01785849|12383887|FG001|STARTED|Overall Study||254
11194021|NCT01785849|12383886|FG000|Received Treatment|Overall Study||254
11194022|NCT01785849|12383887|FG001|Received Treatment|Overall Study||251
11194023|NCT01785849|12383886|FG000|COMPLETED|Overall Study||193
11194024|NCT01785849|12383887|FG001|COMPLETED|Overall Study||220
11194025|NCT01785849|12383886|FG000|NOT COMPLETED|Overall Study||61
11194026|NCT01785849|12383887|FG001|NOT COMPLETED|Overall Study||34
11194027|NCT01785875|12383893|FG000|STARTED|Overall Study||384
11194028|NCT01785875|12383894|FG001|STARTED|Overall Study||384
11194029|NCT01785875|12383895|FG002|STARTED|Overall Study||123
11194030|NCT01785875|12383893|FG000|Received Etelcalcetide|Overall Study||383
11194031|NCT01785875|12383894|FG001|Received Etelcalcetide|Overall Study||384
11194032|NCT01785875|12383895|FG002|Received Etelcalcetide|Overall Study||123
11194033|NCT01785875|12383893|FG000|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
11194034|NCT01785875|12383894|FG001|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
11194035|NCT01785875|12383895|FG002|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
11194036|NCT01785875|12383893|FG000|NOT COMPLETED|Overall Study||294
11194037|NCT01785875|12383894|FG001|NOT COMPLETED|Overall Study||289
11194038|NCT01785875|12383895|FG002|NOT COMPLETED|Overall Study||107
11194039|NCT01786109|12383909|FG000|STARTED|Overall Study||24
11194040|NCT01786109|12383910|FG001|STARTED|Overall Study||24
11194041|NCT01786109|12383911|FG002|STARTED|Overall Study||27
11194042|NCT01786109|12383909|FG000|COMPLETED|Overall Study||23
11194043|NCT01786109|12383910|FG001|COMPLETED|Overall Study||24
11194044|NCT01786109|12383911|FG002|COMPLETED|Overall Study||25
11194045|NCT01786109|12383909|FG000|NOT COMPLETED|Overall Study||1
11194046|NCT01786109|12383910|FG001|NOT COMPLETED|Overall Study||0
11194047|NCT01786109|12383911|FG002|NOT COMPLETED|Overall Study||2
11194048|NCT01786148|12383921|FG000|STARTED|Overall Study||77
11194049|NCT01786148|12383922|FG001|STARTED|Overall Study||72
11194050|NCT01786148|12383921|FG000|COMPLETED|Overall Study||55
11194051|NCT01786148|12383922|FG001|COMPLETED|Overall Study||50
11194052|NCT01786148|12383921|FG000|NOT COMPLETED|Overall Study||22
11194053|NCT01786148|12383922|FG001|NOT COMPLETED|Overall Study||22
11194054|NCT01786161|12383930|FG000|STARTED|Overall Study||22
11194055|NCT01786161|12383931|FG001|STARTED|Overall Study||22
11194056|NCT01786161|12383930|FG000|COMPLETED|Overall Study||22
11194057|NCT01786161|12383931|FG001|COMPLETED|Overall Study||22
11194058|NCT01786161|12383930|FG000|NOT COMPLETED|Overall Study||0
11194059|NCT01786161|12383931|FG001|NOT COMPLETED|Overall Study||0
11194060|NCT01786174|12383941|FG000|STARTED|Overall Study||18
11194061|NCT01786174|12383942|FG001|STARTED|Overall Study||10
11194062|NCT01786174|12383941|FG000|Randomized|Overall Study||19
11194063|NCT01786174|12383942|FG001|Randomized|Overall Study||11
11194064|NCT01786174|12383941|FG000|COMPLETED|Overall Study||16
11194065|NCT01786174|12383942|FG001|COMPLETED|Overall Study||10
11194066|NCT01786174|12383941|FG000|NOT COMPLETED|Overall Study||2
11194067|NCT01786174|12383942|FG001|NOT COMPLETED|Overall Study||0
11194068|NCT01786187|12383950|FG000|STARTED|Overall Study||40
11194069|NCT01786187|12383951|FG001|STARTED|Overall Study||47
11194070|NCT01786187|12383950|FG000|COMPLETED|Overall Study||35
11194071|NCT01786187|12383951|FG001|COMPLETED|Overall Study||37
11324511|NCT02744534|12521810|FG000|NOT COMPLETED|Overall Study||0
11324512|NCT02744755|12521818|FG000|STARTED|Study Period 1||177
11324513|NCT02744755|12521819|FG001|STARTED|Study Period 1||176
11324514|NCT02744755|12521818|FG000|COMPLETED|Study Period 1||163
11324515|NCT02744755|12521819|FG001|COMPLETED|Study Period 1||168
11324516|NCT02744755|12521818|FG000|NOT COMPLETED|Study Period 1||14
11324517|NCT02744755|12521819|FG001|NOT COMPLETED|Study Period 1||8
11324518|NCT02744755|12521818|FG000|STARTED|Study Period 2||159
11324519|NCT02744755|12521819|FG001|STARTED|Study Period 2||166
11324520|NCT02744755|12521818|FG000|COMPLETED|Study Period 2||145
11324521|NCT02744755|12521819|FG001|COMPLETED|Study Period 2||158
11324522|NCT02744755|12521818|FG000|NOT COMPLETED|Study Period 2||14
11324523|NCT02744755|12521819|FG001|NOT COMPLETED|Study Period 2||8
11324524|NCT02744846|12521829|FG000|STARTED|5 Year Outcome Assessment||681739
11324525|NCT02744846|12521829|FG000|Excluded Ineligible Patients|5 Year Outcome Assessment|Includes lost to follow-up and patients that had not reached age 4 years by end of study period|319189
11324526|NCT02744846|12521829|FG000|COMPLETED|5 Year Outcome Assessment|Number of patients that meet eligibility criteria|362550
11324527|NCT02744846|12521829|FG000|NOT COMPLETED|5 Year Outcome Assessment||319189
11324528|NCT02744846|12521829|FG000|STARTED|10 Year Outcome Assessment||362550
11324529|NCT02744846|12521829|FG000|Exclude Ineligible Patients|10 Year Outcome Assessment|Loss to follow-up, patients not yet 9 years, or systems that only had data from 2009 to 2016 or less|305820
11324530|NCT02744846|12521829|FG000|COMPLETED|10 Year Outcome Assessment||56730
11324531|NCT02744846|12521829|FG000|NOT COMPLETED|10 Year Outcome Assessment||305820
11324532|NCT02744898|12521837|FG000|STARTED|Overall Study||23
11324533|NCT02744898|12521837|FG000|COMPLETED|Overall Study||19
11324534|NCT02744898|12521837|FG000|NOT COMPLETED|Overall Study||4
11324535|NCT02745080|12521843|FG000|STARTED|Overall Study||426
11324536|NCT02745080|12521844|FG001|STARTED|Overall Study||427
11324537|NCT02745080|12521843|FG000|COMPLETED|Overall Study||371
11324538|NCT02745080|12521844|FG001|COMPLETED|Overall Study||338
11324539|NCT02745080|12521843|FG000|NOT COMPLETED|Overall Study||55
11324540|NCT02745080|12521844|FG001|NOT COMPLETED|Overall Study||89
11324541|NCT02745119|12521855|FG000|STARTED|Overall Study||145
11324542|NCT02745119|12521856|FG001|STARTED|Overall Study||274
11324543|NCT02745119|12521857|FG002|STARTED|Overall Study||146
11324544|NCT02745119|12521858|FG003|STARTED|Overall Study||277
11324545|NCT02745119|12521855|FG000|COMPLETED|Overall Study||0
11324546|NCT02745119|12521856|FG001|COMPLETED|Overall Study||0
11324547|NCT02745119|12521857|FG002|COMPLETED|Overall Study||0
11324548|NCT02745119|12521858|FG003|COMPLETED|Overall Study||0
11324549|NCT02745119|12521855|FG000|NOT COMPLETED|Overall Study||145
11194072|NCT01786187|12383950|FG000|NOT COMPLETED|Overall Study||5
11194073|NCT01786187|12383951|FG001|NOT COMPLETED|Overall Study||10
11194074|NCT01786239|12383962|FG000|STARTED|Overall Study||25
11194075|NCT01786239|12383963|FG001|STARTED|Overall Study||25
11194076|NCT01786239|12383962|FG000|COMPLETED|Overall Study||14
11194077|NCT01786239|12383963|FG001|COMPLETED|Overall Study||14
11194078|NCT01786239|12383962|FG000|NOT COMPLETED|Overall Study||11
11194079|NCT01786239|12383963|FG001|NOT COMPLETED|Overall Study||11
11194080|NCT01786252|12383971|FG000|STARTED|Overall Study||7
11194081|NCT01786252|12383972|FG001|STARTED|Overall Study||8
11194082|NCT01786252|12383971|FG000|COMPLETED|Overall Study||7
11194083|NCT01786252|12383972|FG001|COMPLETED|Overall Study||8
11194084|NCT01786252|12383971|FG000|NOT COMPLETED|Overall Study||0
11194085|NCT01786252|12383972|FG001|NOT COMPLETED|Overall Study||0
11194086|NCT01786330|12383980|FG000|STARTED|Overall Study||30
11194087|NCT01786330|12383981|FG001|STARTED|Overall Study||30
11194088|NCT01786330|12383980|FG000|COMPLETED|Overall Study||29
11194089|NCT01786330|12383981|FG001|COMPLETED|Overall Study||27
11194090|NCT01786330|12383980|FG000|NOT COMPLETED|Overall Study||1
11194091|NCT01786330|12383981|FG001|NOT COMPLETED|Overall Study||3
11194092|NCT01786343|12383989|FG000|STARTED|Overall Study||28
11194093|NCT01786343|12383990|FG001|STARTED|Overall Study||46
11194094|NCT01786343|12383989|FG000|COMPLETED|Overall Study||28
11194095|NCT01786343|12383990|FG001|COMPLETED|Overall Study||46
11194096|NCT01786343|12383989|FG000|NOT COMPLETED|Overall Study||0
11194097|NCT01786343|12383990|FG001|NOT COMPLETED|Overall Study||0
11194098|NCT01786512|12384007|FG000|STARTED|Overall Study||11
11194099|NCT01786512|12384008|FG001|STARTED|Overall Study||11
11194100|NCT01786512|12384009|FG002|STARTED|Overall Study||14
11194101|NCT01786512|12384010|FG003|STARTED|Overall Study||13
11194102|NCT01786512|12384011|FG004|STARTED|Overall Study||10
11194103|NCT01786512|12384012|FG005|STARTED|Overall Study||11
11194104|NCT01786512|12384013|FG006|STARTED|Overall Study||12
11194105|NCT01786512|12384014|FG007|STARTED|Overall Study||14
11194106|NCT01786512|12384015|FG008|STARTED|Overall Study||149
11194107|NCT01786512|12384016|FG009|STARTED|Overall Study||150
11194108|NCT01786512|12384017|FG010|STARTED|Overall Study||149
11194109|NCT01786512|12384007|FG000|Received Study Treatment|Overall Study||11
11194110|NCT01786512|12384008|FG001|Received Study Treatment|Overall Study||10
11194111|NCT01786512|12384009|FG002|Received Study Treatment|Overall Study||14
11194112|NCT01786512|12384010|FG003|Received Study Treatment|Overall Study||13
11194113|NCT01786512|12384011|FG004|Received Study Treatment|Overall Study||10
11194114|NCT01786512|12384012|FG005|Received Study Treatment|Overall Study||11
11194115|NCT01786512|12384013|FG006|Received Study Treatment|Overall Study||11
11194116|NCT01786512|12384014|FG007|Received Study Treatment|Overall Study||14
11194117|NCT01786512|12384015|FG008|Received Study Treatment|Overall Study||149
11194118|NCT01786512|12384016|FG009|Received Study Treatment|Overall Study||150
11194119|NCT01786512|12384017|FG010|Received Study Treatment|Overall Study||146
11194120|NCT01786512|12384007|FG000|COMPLETED|Overall Study||11
11194121|NCT01786512|12384008|FG001|COMPLETED|Overall Study||10
11194122|NCT01786512|12384009|FG002|COMPLETED|Overall Study||14
11194123|NCT01786512|12384010|FG003|COMPLETED|Overall Study||13
11194124|NCT01786512|12384011|FG004|COMPLETED|Overall Study||10
11194125|NCT01786512|12384012|FG005|COMPLETED|Overall Study||11
11194126|NCT01786512|12384013|FG006|COMPLETED|Overall Study||11
11194127|NCT01786512|12384014|FG007|COMPLETED|Overall Study||14
11194128|NCT01786512|12384015|FG008|COMPLETED|Overall Study||145
11194129|NCT01786512|12384016|FG009|COMPLETED|Overall Study||145
11194130|NCT01786512|12384017|FG010|COMPLETED|Overall Study||137
11194131|NCT01786512|12384007|FG000|NOT COMPLETED|Overall Study||0
11194132|NCT01786512|12384008|FG001|NOT COMPLETED|Overall Study||1
11194133|NCT01786512|12384009|FG002|NOT COMPLETED|Overall Study||0
11194134|NCT01786512|12384010|FG003|NOT COMPLETED|Overall Study||0
11194135|NCT01786512|12384011|FG004|NOT COMPLETED|Overall Study||0
11194136|NCT01786512|12384012|FG005|NOT COMPLETED|Overall Study||0
11194137|NCT01786512|12384013|FG006|NOT COMPLETED|Overall Study||1
11194138|NCT01786512|12384014|FG007|NOT COMPLETED|Overall Study||0
11194139|NCT01786512|12384015|FG008|NOT COMPLETED|Overall Study||4
11194140|NCT01786512|12384016|FG009|NOT COMPLETED|Overall Study||5
11194141|NCT01786512|12384017|FG010|NOT COMPLETED|Overall Study||12
11194142|NCT01786551|12384049|FG000|STARTED|Overall Study||16
11194143|NCT01786551|12384049|FG000|COMPLETED|Overall Study||14
11194144|NCT01786551|12384049|FG000|NOT COMPLETED|Overall Study||2
11194145|NCT01786564|12384053|FG000|STARTED|Overall Study||120
11194146|NCT01786564|12384053|FG000|COMPLETED|Overall Study||56
11194147|NCT01786564|12384053|FG000|NOT COMPLETED|Overall Study||64
11194148|NCT01786603|12384059|FG000|STARTED|Overall Study||60
11194149|NCT01786603|12384060|FG001|STARTED|Overall Study||20
11194150|NCT01786603|12384059|FG000|COMPLETED|Overall Study||42
11194151|NCT01786603|12384060|FG001|COMPLETED|Overall Study||8
11194152|NCT01786603|12384059|FG000|NOT COMPLETED|Overall Study||18
11194153|NCT01786603|12384060|FG001|NOT COMPLETED|Overall Study||12
11194154|NCT01786629|12384068|FG000|STARTED|Overall Study||169
11194155|NCT01786629|12384069|FG001|STARTED|Overall Study||169
11194156|NCT01786629|12384068|FG000|COMPLETED|Overall Study||169
11194157|NCT01786629|12384069|FG001|COMPLETED|Overall Study||164
11194158|NCT01786629|12384068|FG000|NOT COMPLETED|Overall Study||0
11194159|NCT01786629|12384069|FG001|NOT COMPLETED|Overall Study||5
11194160|NCT01786668|12384079|FG000|STARTED|Overall Study||52
11194161|NCT01786668|12384080|FG001|STARTED|Overall Study||52
11194162|NCT01786668|12384081|FG002|STARTED|Overall Study||52
11194163|NCT01786668|12384082|FG003|STARTED|Overall Study||51
11194164|NCT01786668|12384079|FG000|COMPLETED|Overall Study||51
11194165|NCT01786668|12384080|FG001|COMPLETED|Overall Study||51
11194166|NCT01786668|12384081|FG002|COMPLETED|Overall Study||47
11194167|NCT01786668|12384082|FG003|COMPLETED|Overall Study||47
11194168|NCT01786668|12384079|FG000|NOT COMPLETED|Overall Study||1
11194169|NCT01786668|12384080|FG001|NOT COMPLETED|Overall Study||1
11194170|NCT01786668|12384081|FG002|NOT COMPLETED|Overall Study||5
11194171|NCT01786668|12384082|FG003|NOT COMPLETED|Overall Study||4
11194172|NCT01786707|12384094|FG000|STARTED|Overall Study||1
11194173|NCT01786707|12384095|FG001|STARTED|Overall Study||1
11194174|NCT01786707|12384094|FG000|COMPLETED|Overall Study||0
11194175|NCT01786707|12384095|FG001|COMPLETED|Overall Study||0
11194176|NCT01786707|12384094|FG000|NOT COMPLETED|Overall Study||1
11194177|NCT01786707|12384095|FG001|NOT COMPLETED|Overall Study||1
11194178|NCT01786876|12384101|FG000|STARTED|Overall Study||6
11194179|NCT01786876|12384101|FG000|COMPLETED|Overall Study||6
11194180|NCT01786876|12384101|FG000|NOT COMPLETED|Overall Study||0
11194181|NCT01786902|12384107|FG000|STARTED|Overall Study||36
11194182|NCT01786902|12384108|FG001|STARTED|Overall Study||34
11194183|NCT01786902|12384107|FG000|COMPLETED|Overall Study||32
11194184|NCT01786902|12384108|FG001|COMPLETED|Overall Study||31
11194185|NCT01786902|12384107|FG000|NOT COMPLETED|Overall Study||4
11194186|NCT01786902|12384108|FG001|NOT COMPLETED|Overall Study||3
11194187|NCT01786954|12384114|FG000|STARTED|Overall Study||34
11194188|NCT01786954|12384115|FG001|STARTED|Overall Study||34
11194189|NCT01786954|12384114|FG000|COMPLETED|Overall Study||34
11194190|NCT01786954|12384115|FG001|COMPLETED|Overall Study||34
11194191|NCT01786954|12384114|FG000|NOT COMPLETED|Overall Study||0
11194192|NCT01786954|12384115|FG001|NOT COMPLETED|Overall Study||0
11194193|NCT01786967|12384125|FG000|STARTED|Overall Study||61
11194194|NCT01786967|12384125|FG000|Extensive Metabolizers|Overall Study||54
11194195|NCT01786967|12384125|FG000|Poor Metabolizers|Overall Study||4
11194196|NCT01786967|12384125|FG000|Metabolizer Status Undetermined|Overall Study||3
11194197|NCT01786967|12384125|FG000|COMPLETED|Overall Study||61
11194198|NCT01786967|12384125|FG000|NOT COMPLETED|Overall Study||0
11194199|NCT01786993|12384136|FG000|STARTED|Overall Study||201
11194200|NCT01786993|12384137|FG001|STARTED|Overall Study||180
11194201|NCT01786993|12384136|FG000|Per Protocol Population at 9 Months|Overall Study||189
11194202|NCT01786993|12384137|FG001|Per Protocol Population at 9 Months|Overall Study||170
11194203|NCT01786993|12384136|FG000|COMPLETED|Overall Study||189
11194204|NCT01786993|12384137|FG001|COMPLETED|Overall Study||170
11194205|NCT01786993|12384136|FG000|NOT COMPLETED|Overall Study||12
11194206|NCT01786993|12384137|FG001|NOT COMPLETED|Overall Study||10
11194207|NCT01787006|12384146|FG000|STARTED|Overall Study||35
11194208|NCT01787006|12384147|FG001|STARTED|Overall Study||39
11194209|NCT01787006|12384146|FG000|COMPLETED|Overall Study||32
11194210|NCT01787006|12384147|FG001|COMPLETED|Overall Study||36
11194211|NCT01787006|12384146|FG000|NOT COMPLETED|Overall Study||3
11194212|NCT01787006|12384147|FG001|NOT COMPLETED|Overall Study||3
11194213|NCT01787032|12384159|FG000|STARTED|Overall Study||3
11194214|NCT01787032|12384160|FG001|STARTED|Overall Study||3
11194215|NCT01787032|12384161|FG002|STARTED|Overall Study||3
11194216|NCT01787032|12384162|FG003|STARTED|Overall Study||3
11194217|NCT01787032|12384163|FG004|STARTED|Overall Study||4
11194218|NCT01787032|12384164|FG005|STARTED|Overall Study||4
11194219|NCT01787032|12384159|FG000|Received R|Overall Study||3
11194220|NCT01787032|12384160|FG001|Received R|Overall Study||3
11194221|NCT01787032|12384161|FG002|Received R|Overall Study||3
11194222|NCT01787032|12384162|FG003|Received R|Overall Study||3
11194223|NCT01787032|12384163|FG004|Received R|Overall Study||4
11194224|NCT01787032|12384164|FG005|Received R|Overall Study||3
11194225|NCT01787032|12384159|FG000|Received T1|Overall Study||3
11194226|NCT01787032|12384160|FG001|Received T1|Overall Study||3
11194227|NCT01787032|12384161|FG002|Received T1|Overall Study||3
11194228|NCT01787032|12384162|FG003|Received T1|Overall Study||3
11194229|NCT01787032|12384163|FG004|Received T1|Overall Study||3
11194230|NCT01787032|12384164|FG005|Received T1|Overall Study||4
11194231|NCT01787032|12384159|FG000|Received T2|Overall Study||3
11194232|NCT01787032|12384160|FG001|Received T2|Overall Study||3
11194233|NCT01787032|12384161|FG002|Received T2|Overall Study||3
11194234|NCT01787032|12384162|FG003|Received T2|Overall Study||3
11194235|NCT01787032|12384163|FG004|Received T2|Overall Study||4
11194236|NCT01787032|12384164|FG005|Received T2|Overall Study||4
11194237|NCT01787032|12384159|FG000|COMPLETED|Overall Study||3
11194238|NCT01787032|12384160|FG001|COMPLETED|Overall Study||3
11194239|NCT01787032|12384161|FG002|COMPLETED|Overall Study||3
11194240|NCT01787032|12384162|FG003|COMPLETED|Overall Study||3
11194241|NCT01787032|12384163|FG004|COMPLETED|Overall Study||3
11194242|NCT01787032|12384164|FG005|COMPLETED|Overall Study||3
11194243|NCT01787032|12384159|FG000|NOT COMPLETED|Overall Study||0
11194244|NCT01787032|12384160|FG001|NOT COMPLETED|Overall Study||0
11194245|NCT01787032|12384161|FG002|NOT COMPLETED|Overall Study||0
11194246|NCT01787032|12384162|FG003|NOT COMPLETED|Overall Study||0
11194247|NCT01787032|12384163|FG004|NOT COMPLETED|Overall Study||1
11194248|NCT01787032|12384164|FG005|NOT COMPLETED|Overall Study||1
11194249|NCT01787097|12384174|FG000|STARTED|Overall Study|Study started in 2012/2013|8
11194250|NCT01787097|12384175|FG001|STARTED|Overall Study||7
11194251|NCT01787097|12384176|FG002|STARTED|Overall Study||7
11194252|NCT01787097|12384177|FG003|STARTED|Overall Study||9
11194253|NCT01787097|12384174|FG000|COMPLETED|Overall Study|Study completed|7
11194254|NCT01787097|12384175|FG001|COMPLETED|Overall Study||7
11194255|NCT01787097|12384176|FG002|COMPLETED|Overall Study||7
11194256|NCT01787097|12384177|FG003|COMPLETED|Overall Study||9
11194257|NCT01787097|12384174|FG000|NOT COMPLETED|Overall Study||1
11194258|NCT01787097|12384175|FG001|NOT COMPLETED|Overall Study||0
11194259|NCT01787097|12384176|FG002|NOT COMPLETED|Overall Study||0
11194260|NCT01787097|12384177|FG003|NOT COMPLETED|Overall Study||0
11194261|NCT01787175|12384199|FG000|STARTED|Overall Study||30
11194262|NCT01787175|12384200|FG001|STARTED|Overall Study||28
11194263|NCT01787175|12384199|FG000|COMPLETED|Overall Study||30
11324550|NCT02745119|12521856|FG001|NOT COMPLETED|Overall Study||274
11324551|NCT02745119|12521857|FG002|NOT COMPLETED|Overall Study||146
11324552|NCT02745119|12521858|FG003|NOT COMPLETED|Overall Study||277
11324553|NCT02745145|12521873|FG000|STARTED|Overall Study||10
11324554|NCT02745145|12521874|FG001|STARTED|Overall Study||5
11324555|NCT02745145|12521875|FG002|STARTED|Overall Study||9
11324556|NCT02745145|12521873|FG000|COMPLETED|Overall Study||0
11324557|NCT02745145|12521874|FG001|COMPLETED|Overall Study||0
11324558|NCT02745145|12521875|FG002|COMPLETED|Overall Study||0
11194264|NCT01787175|12384200|FG001|COMPLETED|Overall Study||28
11194265|NCT01787175|12384199|FG000|NOT COMPLETED|Overall Study||0
11194266|NCT01787175|12384200|FG001|NOT COMPLETED|Overall Study||0
11194267|NCT01787188|12384209|FG000|STARTED|Overall Study||139
11194268|NCT01787188|12384210|FG001|STARTED|Overall Study||130
11194269|NCT01787188|12384211|FG002|STARTED|Overall Study||134
11194270|NCT01787188|12384209|FG000|COMPLETED|Overall Study||122
11194271|NCT01787188|12384210|FG001|COMPLETED|Overall Study||112
11324559|NCT02745145|12521873|FG000|NOT COMPLETED|Overall Study||10
11194272|NCT01787188|12384211|FG002|COMPLETED|Overall Study||116
11194273|NCT01787188|12384209|FG000|NOT COMPLETED|Overall Study||17
11194274|NCT01787188|12384210|FG001|NOT COMPLETED|Overall Study||18
11194275|NCT01787188|12384211|FG002|NOT COMPLETED|Overall Study||18
11194276|NCT01787240|12384221|FG000|STARTED|Overall Study||15
11194277|NCT01787240|12384222|FG001|STARTED|Overall Study||5
11194278|NCT01787240|12384221|FG000|COMPLETED|Overall Study||10
11194279|NCT01787240|12384222|FG001|COMPLETED|Overall Study||4
11194280|NCT01787240|12384221|FG000|NOT COMPLETED|Overall Study||5
11194281|NCT01787240|12384222|FG001|NOT COMPLETED|Overall Study||1
11194282|NCT01787279|12384231|FG000|STARTED|Overall Study||59
11194283|NCT01787279|12384231|FG000|COMPLETED|Overall Study||56
11194284|NCT01787279|12384231|FG000|NOT COMPLETED|Overall Study||3
11194285|NCT01787292|12384235|FG000|STARTED|Crossover Exercise Interventions|Participants in this group performed aerobic training prior to cross-over to balance training.|17
11194286|NCT01787292|12384236|FG001|STARTED|Crossover Exercise Interventions|Participants in this group performed balance training prior to cross-over to aerobic training.|16
11194287|NCT01787292|12384235|FG000|COMPLETED|Crossover Exercise Interventions|Participants completed the 12-week in-house program and cross-over into the balance program.|15
11194288|NCT01787292|12384236|FG001|COMPLETED|Crossover Exercise Interventions|These participants completed the 12-week in-house program and cross-over into the balance program.|14
11194289|NCT01787292|12384235|FG000|NOT COMPLETED|Crossover Exercise Interventions||2
11194290|NCT01787292|12384236|FG001|NOT COMPLETED|Crossover Exercise Interventions||2
11194291|NCT01787292|12384235|FG000|STARTED|Home Based Exercise Program||15
11194292|NCT01787292|12384236|FG001|STARTED|Home Based Exercise Program||14
11194293|NCT01787292|12384235|FG000|COMPLETED|Home Based Exercise Program||12
11194294|NCT01787292|12384236|FG001|COMPLETED|Home Based Exercise Program||13
11194295|NCT01787292|12384235|FG000|NOT COMPLETED|Home Based Exercise Program||3
11194296|NCT01787292|12384236|FG001|NOT COMPLETED|Home Based Exercise Program||1
11194297|NCT01787331|12384247|FG000|STARTED|Overall Study||21
11194298|NCT01787331|12384247|FG000|COMPLETED|Overall Study||19
11194299|NCT01787331|12384247|FG000|NOT COMPLETED|Overall Study||2
11194300|NCT01787383|12384253|FG000|STARTED|Overall Study||101
11194301|NCT01787383|12384254|FG001|STARTED|Overall Study||98
11194302|NCT01787383|12384253|FG000|COMPLETED|Overall Study||92
11194303|NCT01787383|12384254|FG001|COMPLETED|Overall Study||76
11194304|NCT01787383|12384253|FG000|NOT COMPLETED|Overall Study||9
11194305|NCT01787383|12384254|FG001|NOT COMPLETED|Overall Study||22
11194306|NCT01787461|12384270|FG000|STARTED|Overall Study||96
11194307|NCT01787461|12384271|FG001|STARTED|Overall Study||98
11194308|NCT01787461|12384270|FG000|COMPLETED|Overall Study||82
11194309|NCT01787461|12384271|FG001|COMPLETED|Overall Study||89
11194310|NCT01787461|12384270|FG000|NOT COMPLETED|Overall Study||14
11194311|NCT01787461|12384271|FG001|NOT COMPLETED|Overall Study||9
11194312|NCT01787591|12384279|FG000|STARTED|Period 1 (Cross-over Arm 1)||5
11194313|NCT01787591|12384280|FG001|STARTED|Period 1 (Cross-over Arm 1)||5
11194314|NCT01787591|12384281|FG002|STARTED|Period 1 (Cross-over Arm 1)||5
11194315|NCT01787591|12384282|FG003|STARTED|Period 1 (Cross-over Arm 1)||6
11194316|NCT01787591|12384279|FG000|COMPLETED|Period 1 (Cross-over Arm 1)||5
11194317|NCT01787591|12384280|FG001|COMPLETED|Period 1 (Cross-over Arm 1)||5
11194318|NCT01787591|12384281|FG002|COMPLETED|Period 1 (Cross-over Arm 1)||5
11194319|NCT01787591|12384282|FG003|COMPLETED|Period 1 (Cross-over Arm 1)||5
11194320|NCT01787591|12384279|FG000|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
11194321|NCT01787591|12384280|FG001|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
11194322|NCT01787591|12384281|FG002|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
11194323|NCT01787591|12384282|FG003|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
11194324|NCT01787591|12384279|FG000|STARTED|Period 2 (Cross-over Arm 2)||5
11194325|NCT01787591|12384280|FG001|STARTED|Period 2 (Cross-over Arm 2)||5
11194326|NCT01787591|12384281|FG002|STARTED|Period 2 (Cross-over Arm 2)||5
11194327|NCT01787591|12384282|FG003|STARTED|Period 2 (Cross-over Arm 2)||5
11194328|NCT01787591|12384279|FG000|COMPLETED|Period 2 (Cross-over Arm 2)||5
11194329|NCT01787591|12384280|FG001|COMPLETED|Period 2 (Cross-over Arm 2)||5
11194330|NCT01787591|12384281|FG002|COMPLETED|Period 2 (Cross-over Arm 2)||5
11194331|NCT01787591|12384282|FG003|COMPLETED|Period 2 (Cross-over Arm 2)||5
11194332|NCT01787591|12384279|FG000|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
11194333|NCT01787591|12384280|FG001|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
11194334|NCT01787591|12384281|FG002|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
11194335|NCT01787591|12384282|FG003|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
11194336|NCT01787591|12384279|FG000|STARTED|Period 3 (Cross-over Arm 3)||5
11194337|NCT01787591|12384280|FG001|STARTED|Period 3 (Cross-over Arm 3)||5
11194338|NCT01787591|12384281|FG002|STARTED|Period 3 (Cross-over Arm 3)||5
11194339|NCT01787591|12384282|FG003|STARTED|Period 3 (Cross-over Arm 3)||5
11194340|NCT01787591|12384279|FG000|COMPLETED|Period 3 (Cross-over Arm 3)||5
11194341|NCT01787591|12384280|FG001|COMPLETED|Period 3 (Cross-over Arm 3)||5
11194342|NCT01787591|12384281|FG002|COMPLETED|Period 3 (Cross-over Arm 3)||5
11194343|NCT01787591|12384282|FG003|COMPLETED|Period 3 (Cross-over Arm 3)||5
11194344|NCT01787591|12384279|FG000|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
11194345|NCT01787591|12384280|FG001|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
11194346|NCT01787591|12384281|FG002|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
11194347|NCT01787591|12384282|FG003|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
11194348|NCT01787591|12384279|FG000|STARTED|Period 4 (Cross-over Arm 4)||5
11194349|NCT01787591|12384280|FG001|STARTED|Period 4 (Cross-over Arm 4)||5
11194350|NCT01787591|12384281|FG002|STARTED|Period 4 (Cross-over Arm 4)||5
11194351|NCT01787591|12384282|FG003|STARTED|Period 4 (Cross-over Arm 4)||5
11194352|NCT01787591|12384279|FG000|COMPLETED|Period 4 (Cross-over Arm 4)||5
11194353|NCT01787591|12384280|FG001|COMPLETED|Period 4 (Cross-over Arm 4)||5
11194354|NCT01787591|12384281|FG002|COMPLETED|Period 4 (Cross-over Arm 4)||5
11194355|NCT01787591|12384282|FG003|COMPLETED|Period 4 (Cross-over Arm 4)||5
11194356|NCT01787591|12384279|FG000|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
11194357|NCT01787591|12384280|FG001|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
11194358|NCT01787591|12384281|FG002|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
11194359|NCT01787591|12384282|FG003|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
11194360|NCT01787604|12384295|FG000|STARTED|Overall Study||32
11194361|NCT01787604|12384296|FG001|STARTED|Overall Study||32
11194362|NCT01787604|12384295|FG000|COMPLETED|Overall Study||28
11194363|NCT01787604|12384296|FG001|COMPLETED|Overall Study||28
11194364|NCT01787604|12384295|FG000|NOT COMPLETED|Overall Study||4
11194365|NCT01787604|12384296|FG001|NOT COMPLETED|Overall Study||4
11194366|NCT01787760|12384305|FG000|STARTED|Overall Study||51
11194367|NCT01787760|12384306|FG001|STARTED|Overall Study||50
11194368|NCT01787760|12384307|FG002|STARTED|Overall Study||51
11194369|NCT01787760|12384305|FG000|COMPLETED|Overall Study||25
11194370|NCT01787760|12384306|FG001|COMPLETED|Overall Study||34
11194371|NCT01787760|12384307|FG002|COMPLETED|Overall Study||46
11194372|NCT01787760|12384305|FG000|NOT COMPLETED|Overall Study||26
11194373|NCT01787760|12384306|FG001|NOT COMPLETED|Overall Study||16
11194374|NCT01787760|12384307|FG002|NOT COMPLETED|Overall Study||5
11194375|NCT01787799|12384316|FG000|STARTED|Overall Study||100
11194376|NCT01787799|12384316|FG000|COMPLETED|Overall Study||100
11194377|NCT01787799|12384316|FG000|NOT COMPLETED|Overall Study||0
11194378|NCT01787825|12384320|FG000|STARTED|Overall Study||60
11194379|NCT01787825|12384321|FG001|STARTED|Overall Study||61
11194380|NCT01787825|12384320|FG000|COMPLETED|Overall Study||54
11194381|NCT01787825|12384321|FG001|COMPLETED|Overall Study||60
11194382|NCT01787825|12384320|FG000|NOT COMPLETED|Overall Study||6
11194383|NCT01787825|12384321|FG001|NOT COMPLETED|Overall Study||1
11194384|NCT01787838|12384328|FG000|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
11194385|NCT01787838|12384328|FG000|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
11194386|NCT01787838|12384328|FG000|NOT COMPLETED|Overall Study||1413
11194387|NCT01787916|12384332|FG000|STARTED|First Intervention (24 Weeks)||8
11194388|NCT01787916|12384333|FG001|STARTED|First Intervention (24 Weeks)||7
11194389|NCT01787916|12384332|FG000|COMPLETED|First Intervention (24 Weeks)||8
11194390|NCT01787916|12384333|FG001|COMPLETED|First Intervention (24 Weeks)||7
11194391|NCT01787916|12384332|FG000|NOT COMPLETED|First Intervention (24 Weeks)||0
11194392|NCT01787916|12384333|FG001|NOT COMPLETED|First Intervention (24 Weeks)||0
11194393|NCT01787916|12384332|FG000|STARTED|Washout (4 Weeks)||8
11194394|NCT01787916|12384333|FG001|STARTED|Washout (4 Weeks)||7
11194395|NCT01787916|12384332|FG000|COMPLETED|Washout (4 Weeks)||8
11194396|NCT01787916|12384333|FG001|COMPLETED|Washout (4 Weeks)||7
11194397|NCT01787916|12384332|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11194398|NCT01787916|12384333|FG001|NOT COMPLETED|Washout (4 Weeks)||0
11194399|NCT01787916|12384332|FG000|STARTED|Second Intervention (24 Weeks)||8
11194400|NCT01787916|12384333|FG001|STARTED|Second Intervention (24 Weeks)||7
11194401|NCT01787916|12384332|FG000|COMPLETED|Second Intervention (24 Weeks)||8
11194402|NCT01787916|12384333|FG001|COMPLETED|Second Intervention (24 Weeks)||7
11194403|NCT01787916|12384332|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0
11194404|NCT01787916|12384333|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0
11194405|NCT01788046|12384341|FG000|STARTED|Overall Study||260
11194406|NCT01788046|12384342|FG001|STARTED|Overall Study||255
11194407|NCT01788046|12384341|FG000|Received Treatment|Overall Study||259
11194408|NCT01788046|12384342|FG001|Received Treatment|Overall Study||252
11194409|NCT01788046|12384341|FG000|COMPLETED|Overall Study||204
11194410|NCT01788046|12384342|FG001|COMPLETED|Overall Study||218
11194411|NCT01788046|12384341|FG000|NOT COMPLETED|Overall Study||56
11194412|NCT01788046|12384342|FG001|NOT COMPLETED|Overall Study||37
11194413|NCT01788150|12384350|FG000|STARTED|Overall Study||108
11194414|NCT01788150|12384351|FG001|STARTED|Overall Study||51
11194415|NCT01788150|12384350|FG000|COMPLETED|Overall Study||95
11194416|NCT01788150|12384351|FG001|COMPLETED|Overall Study||48
11194417|NCT01788150|12384350|FG000|NOT COMPLETED|Overall Study||13
11194418|NCT01788150|12384351|FG001|NOT COMPLETED|Overall Study||3
11194419|NCT01788163|12384366|FG000|STARTED|Overall Study||1458
11194420|NCT01788163|12384367|FG001|STARTED|Overall Study||271
11194421|NCT01788163|12384368|FG002|STARTED|Overall Study||62
11194422|NCT01788163|12384369|FG003|STARTED|Overall Study||71
11194423|NCT01788163|12384370|FG004|STARTED|Overall Study||94
11194424|NCT01788163|12384371|FG005|STARTED|Overall Study||102
11194425|NCT01788163|12384372|FG006|STARTED|Overall Study||50
11194426|NCT01788163|12384373|FG007|STARTED|Overall Study||302
11194427|NCT01788163|12384374|FG008|STARTED|Overall Study||972
11194428|NCT01788163|12384366|FG000|COMPLETED|Overall Study||1403
11194429|NCT01788163|12384367|FG001|COMPLETED|Overall Study||271
11194430|NCT01788163|12384368|FG002|COMPLETED|Overall Study||62
11194431|NCT01788163|12384369|FG003|COMPLETED|Overall Study||71
11194432|NCT01788163|12384370|FG004|COMPLETED|Overall Study||94
11194433|NCT01788163|12384371|FG005|COMPLETED|Overall Study||95
11194434|NCT01788163|12384372|FG006|COMPLETED|Overall Study||49
11194435|NCT01788163|12384373|FG007|COMPLETED|Overall Study||254
11194436|NCT01788163|12384374|FG008|COMPLETED|Overall Study||956
11194437|NCT01788163|12384366|FG000|NOT COMPLETED|Overall Study||55
11194438|NCT01788163|12384367|FG001|NOT COMPLETED|Overall Study||0
11194439|NCT01788163|12384368|FG002|NOT COMPLETED|Overall Study||0
11194440|NCT01788163|12384369|FG003|NOT COMPLETED|Overall Study||0
11194441|NCT01788163|12384370|FG004|NOT COMPLETED|Overall Study||0
11194442|NCT01788163|12384371|FG005|NOT COMPLETED|Overall Study||7
11194443|NCT01788163|12384372|FG006|NOT COMPLETED|Overall Study||1
11194444|NCT01788163|12384373|FG007|NOT COMPLETED|Overall Study||48
11194445|NCT01788163|12384374|FG008|NOT COMPLETED|Overall Study||16
11194446|NCT01788215|12384455|FG000|STARTED|Overall Study||5
11194447|NCT01788215|12384456|FG001|STARTED|Overall Study||5
11194448|NCT01788215|12384455|FG000|12 Weeks of Doxycycline or Placebo|Overall Study||5
11194449|NCT01788215|12384456|FG001|12 Weeks of Doxycycline or Placebo|Overall Study||5
11194450|NCT01788215|12384455|FG000|COMPLETED|Overall Study||3
11194451|NCT01788215|12384456|FG001|COMPLETED|Overall Study||4
11194452|NCT01788215|12384455|FG000|NOT COMPLETED|Overall Study||2
11194453|NCT01788215|12384456|FG001|NOT COMPLETED|Overall Study||1
11194454|NCT01788228|12384464|FG000|STARTED|Overall Study||49
11194455|NCT01788228|12384465|FG001|STARTED|Overall Study||1
11194456|NCT01788228|12384464|FG000|COMPLETED|Overall Study||48
11194457|NCT01788228|12384465|FG001|COMPLETED|Overall Study||1
11194458|NCT01788228|12384464|FG000|NOT COMPLETED|Overall Study||1
11194459|NCT01788228|12384465|FG001|NOT COMPLETED|Overall Study||0
11194460|NCT01788358|12384474|FG000|STARTED|Overall Study||508
11194461|NCT01788358|12384474|FG000|Treated|Overall Study||508
11194462|NCT01788358|12384474|FG000|Completed Week 28|Overall Study||417
11194463|NCT01788358|12384474|FG000|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
11194464|NCT01788358|12384474|FG000|Completed Week 52|Overall Study||193
11194465|NCT01788358|12384474|FG000|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
11194466|NCT01788358|12384474|FG000|NOT COMPLETED|Overall Study||98
11194467|NCT01788423|12384481|FG000|STARTED|Overall Study||53
11194468|NCT01788423|12384482|FG001|STARTED|Overall Study||55
11194469|NCT01788423|12384483|FG002|STARTED|Overall Study||55
11194470|NCT01788423|12384481|FG000|COMPLETED|Overall Study||53
11194471|NCT01788423|12384482|FG001|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51
11194472|NCT01788423|12384483|FG002|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50
11194473|NCT01788423|12384481|FG000|NOT COMPLETED|Overall Study||0
11194474|NCT01788423|12384482|FG001|NOT COMPLETED|Overall Study||4
11194475|NCT01788423|12384483|FG002|NOT COMPLETED|Overall Study||5
11194476|NCT01788566|12384491|FG000|STARTED|Overall Study||61
11194477|NCT01788566|12384491|FG000|COMPLETED|Overall Study||53
11194478|NCT01788566|12384491|FG000|NOT COMPLETED|Overall Study||8
11194479|NCT01788631|12384497|FG000|STARTED|Overall Study||52
11194480|NCT01788631|12384498|FG001|STARTED|Overall Study||44
11194481|NCT01788631|12384497|FG000|Randomized|Overall Study||53
11194482|NCT01788631|12384498|FG001|Randomized|Overall Study||47
11194483|NCT01788631|12384497|FG000|COMPLETED|Overall Study||49
11194484|NCT01788631|12384498|FG001|COMPLETED|Overall Study||43
11194485|NCT01788631|12384497|FG000|NOT COMPLETED|Overall Study||3
11194486|NCT01788631|12384498|FG001|NOT COMPLETED|Overall Study||1
11194487|NCT01788943|12384506|FG000|STARTED|Overall Study|Recruitment for study began.|13
11194488|NCT01788943|12384507|FG001|STARTED|Overall Study||12
11194489|NCT01788943|12384506|FG000|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
11194490|NCT01788943|12384507|FG001|COMPLETED|Overall Study||12
11194491|NCT01788943|12384506|FG000|NOT COMPLETED|Overall Study||1
11027000|NCT00831441|12205644|FG000|NOT COMPLETED|Randomized||3687
11194492|NCT01788943|12384507|FG001|NOT COMPLETED|Overall Study||0
11194493|NCT01789047|12384515|FG000|STARTED|Overall Study||21
11194494|NCT01789047|12384516|FG001|STARTED|Overall Study||21
11194495|NCT01789047|12384515|FG000|COMPLETED|Overall Study||17
11194496|NCT01789047|12384516|FG001|COMPLETED|Overall Study||17
11194497|NCT01789047|12384515|FG000|NOT COMPLETED|Overall Study||4
11194498|NCT01789047|12384516|FG001|NOT COMPLETED|Overall Study||4
11027001|NCT00831441|12205645|FG001|NOT COMPLETED|Randomized||3705
11027002|NCT00831441|12205644|FG000|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
11027003|NCT00831441|12205645|FG001|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
11027004|NCT00831441|12205644|FG000|COMPLETED|Follow Up (30 Days)||3375
11027005|NCT00831441|12205645|FG001|COMPLETED|Follow Up (30 Days)||3355
11027006|NCT00831441|12205644|FG000|NOT COMPLETED|Follow Up (30 Days)||133
11027007|NCT00831441|12205645|FG001|NOT COMPLETED|Follow Up (30 Days)||174
11027008|NCT00831480|12205652|FG000|STARTED|Overall Study||9
11027009|NCT00831480|12205652|FG000|COMPLETED|Overall Study||7
11027010|NCT00831480|12205652|FG000|NOT COMPLETED|Overall Study||2
11027011|NCT00831493|12205656|FG000|STARTED|Overall Study||3
11027012|NCT00831493|12205656|FG000|COMPLETED|Overall Study||2
11027013|NCT00831493|12205656|FG000|NOT COMPLETED|Overall Study||1
11027014|NCT00831675|12205662|FG000|STARTED|Overall Study||12
11027015|NCT00831675|12205663|FG001|STARTED|Overall Study||18
11194499|NCT01789138|12384524|FG000|STARTED|Overall Study||254
11194500|NCT01789138|12384525|FG001|STARTED|Overall Study||258
11194501|NCT01789138|12384524|FG000|COMPLETED|Overall Study||213
11194502|NCT01789138|12384525|FG001|COMPLETED|Overall Study||206
11194503|NCT01789138|12384524|FG000|NOT COMPLETED|Overall Study||41
11194504|NCT01789138|12384525|FG001|NOT COMPLETED|Overall Study||52
11194505|NCT01789203|12384533|FG000|STARTED|Overall Study||133
11194506|NCT01789203|12384534|FG001|STARTED|Overall Study||67
11194507|NCT01789203|12384533|FG000|COMPLETED|Overall Study||124
11194508|NCT01789203|12384534|FG001|COMPLETED|Overall Study||63
11194509|NCT01789203|12384533|FG000|NOT COMPLETED|Overall Study||9
11194510|NCT01789203|12384534|FG001|NOT COMPLETED|Overall Study||4
11194511|NCT01789255|12384542|FG000|STARTED|Overall Study||12
11194512|NCT01789255|12384542|FG000|COMPLETED|Overall Study||12
11194513|NCT01789255|12384542|FG000|NOT COMPLETED|Overall Study||0
11194514|NCT01789281|12384548|FG000|STARTED|Overall Study||22
11194515|NCT01789281|12384549|FG001|STARTED|Overall Study||12
11194516|NCT01789281|12384548|FG000|COMPLETED|Overall Study||0
11194517|NCT01789281|12384549|FG001|COMPLETED|Overall Study||2
11194518|NCT01789281|12384548|FG000|NOT COMPLETED|Overall Study||22
11194519|NCT01789281|12384549|FG001|NOT COMPLETED|Overall Study||10
11194520|NCT01789320|12384556|FG000|STARTED|Overall Study||11
11194521|NCT01789320|12384556|FG000|COMPLETED|Overall Study||9
11194522|NCT01789320|12384556|FG000|NOT COMPLETED|Overall Study||2
11194523|NCT01789476|12384562|FG000|STARTED|Overall Study||34
11194524|NCT01789476|12384563|FG001|STARTED|Overall Study||17
11194525|NCT01789476|12384562|FG000|COMPLETED|Overall Study||26
11194526|NCT01789476|12384563|FG001|COMPLETED|Overall Study||15
11194527|NCT01789476|12384562|FG000|NOT COMPLETED|Overall Study||8
11194528|NCT01789476|12384563|FG001|NOT COMPLETED|Overall Study||2
11194529|NCT01789567|12384569|FG000|STARTED|Overall Study||20
11194530|NCT01789567|12384569|FG000|COMPLETED|Overall Study||14
11194531|NCT01789567|12384569|FG000|NOT COMPLETED|Overall Study||6
11204871|NCT01855945|12395506|FG000|NOT COMPLETED|Overall Study||16
11204872|NCT01855945|12395507|FG001|NOT COMPLETED|Overall Study||11
11204873|NCT01855945|12395508|FG002|NOT COMPLETED|Overall Study||12
11204874|NCT01855945|12395509|FG003|NOT COMPLETED|Overall Study||4
11204875|NCT01855945|12395510|FG004|NOT COMPLETED|Overall Study||1
11204876|NCT01855945|12395511|FG005|NOT COMPLETED|Overall Study||3
11204877|NCT01855945|12395512|FG006|NOT COMPLETED|Overall Study||10
11204878|NCT01855945|12395513|FG007|NOT COMPLETED|Overall Study||8
11204879|NCT01855945|12395514|FG008|NOT COMPLETED|Overall Study||2
11204880|NCT01855945|12395515|FG009|NOT COMPLETED|Overall Study||2
11204881|NCT01855945|12395516|FG010|NOT COMPLETED|Overall Study||5
11204882|NCT01855945|12395517|FG011|NOT COMPLETED|Overall Study||3
11204883|NCT01855958|12395582|FG000|STARTED|Overall Study||13
11204884|NCT01855958|12395583|FG001|STARTED|Overall Study||13
11204885|NCT01855958|12395582|FG000|COMPLETED|Overall Study||12
11204886|NCT01855958|12395583|FG001|COMPLETED|Overall Study||13
11204887|NCT01855958|12395582|FG000|NOT COMPLETED|Overall Study||1
11204888|NCT01855958|12395583|FG001|NOT COMPLETED|Overall Study||0
11204889|NCT01855997|12395591|FG000|STARTED|Overall Study||1669
11204890|NCT01855997|12395591|FG000|COMPLETED|Overall Study||1669
11204891|NCT01855997|12395591|FG000|NOT COMPLETED|Overall Study||0
11204892|NCT01856114|12395605|FG000|STARTED|Overall Study||11
11204893|NCT01856114|12395606|FG001|STARTED|Overall Study||11
11204894|NCT01856114|12395605|FG000|COMPLETED|Overall Study||9
11204895|NCT01856114|12395606|FG001|COMPLETED|Overall Study||11
11204896|NCT01856114|12395605|FG000|NOT COMPLETED|Overall Study||2
11204897|NCT01856114|12395606|FG001|NOT COMPLETED|Overall Study||0
11204898|NCT01856218|12395612|FG000|STARTED|First Phase||3
11204899|NCT01856218|12395612|FG000|COMPLETED|First Phase||3
11204900|NCT01856218|12395612|FG000|NOT COMPLETED|First Phase||0
11204901|NCT01856218|12395612|FG000|STARTED|Long-Term Extension Phase||3
11204902|NCT01856218|12395612|FG000|COMPLETED|Long-Term Extension Phase||3
11204903|NCT01856218|12395612|FG000|NOT COMPLETED|Long-Term Extension Phase||0
11204904|NCT01856257|12395619|FG000|STARTED|Overall Study||29
11204905|NCT01856257|12395620|FG001|STARTED|Overall Study||29
11204906|NCT01856257|12395621|FG002|STARTED|Overall Study||11
11204907|NCT01856257|12395622|FG003|STARTED|Overall Study||2
11204908|NCT01856257|12395619|FG000|COMPLETED|Overall Study||26
11204909|NCT01856257|12395620|FG001|COMPLETED|Overall Study||28
11027016|NCT00831675|12205662|FG000|COMPLETED|Overall Study||12
11027017|NCT00831675|12205663|FG001|COMPLETED|Overall Study||18
11027018|NCT00831675|12205662|FG000|NOT COMPLETED|Overall Study||0
11204910|NCT01856257|12395621|FG002|COMPLETED|Overall Study||11
11204911|NCT01856257|12395622|FG003|COMPLETED|Overall Study||0
11194532|NCT01789606|12384575|FG000|STARTED|Overall Study||251
11194533|NCT01789606|12384576|FG001|STARTED|Overall Study||832
11194534|NCT01789606|12384575|FG000|COMPLETED|Overall Study||228
11194535|NCT01789606|12384576|FG001|COMPLETED|Overall Study||382
11194536|NCT01789606|12384575|FG000|NOT COMPLETED|Overall Study||23
11194537|NCT01789606|12384576|FG001|NOT COMPLETED|Overall Study||450
11194538|NCT01789775|12384583|FG000|STARTED|Overall Study||55
11194539|NCT01789775|12384584|FG001|STARTED|Overall Study||57
11194540|NCT01789775|12384583|FG000|COMPLETED|Overall Study||53
11194541|NCT01789775|12384584|FG001|COMPLETED|Overall Study||50
11194542|NCT01789775|12384583|FG000|NOT COMPLETED|Overall Study||2
11194543|NCT01789775|12384584|FG001|NOT COMPLETED|Overall Study||7
11194544|NCT01789814|12384592|FG000|STARTED|Overall Study||12
11194545|NCT01789814|12384593|FG001|STARTED|Overall Study||12
11194546|NCT01789814|12384592|FG000|COMPLETED|Overall Study||12
11194547|NCT01789814|12384593|FG001|COMPLETED|Overall Study||12
11194548|NCT01789814|12384592|FG000|NOT COMPLETED|Overall Study||0
11194549|NCT01789814|12384593|FG001|NOT COMPLETED|Overall Study||0
11194550|NCT01789840|12384601|FG000|STARTED|Overall Study||52
11194551|NCT01789840|12384602|FG001|STARTED|Overall Study||7
11194552|NCT01789840|12384601|FG000|COMPLETED|Overall Study||52
11194553|NCT01789840|12384602|FG001|COMPLETED|Overall Study||6
11194554|NCT01789840|12384601|FG000|NOT COMPLETED|Overall Study||0
11194555|NCT01789840|12384602|FG001|NOT COMPLETED|Overall Study||1
11194556|NCT01789905|12384610|FG000|STARTED|Overall Study||116
11194557|NCT01789905|12384610|FG000|COMPLETED|Overall Study||116
11194558|NCT01789905|12384610|FG000|NOT COMPLETED|Overall Study||0
11194559|NCT01789970|12384616|FG000|STARTED|Open-label Titration Period||625
11194560|NCT01789970|12384617|FG001|STARTED|Open-label Titration Period||0
11194561|NCT01789970|12384618|FG002|STARTED|Open-label Titration Period||0
11194562|NCT01789970|12384616|FG000|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
11194563|NCT01789970|12384617|FG001|Safety Analysis Set|Open-label Titration Period||0
11194564|NCT01789970|12384618|FG002|Safety Analysis Set|Open-label Titration Period||0
11194565|NCT01789970|12384616|FG000|COMPLETED|Open-label Titration Period||371
11194566|NCT01789970|12384617|FG001|COMPLETED|Open-label Titration Period||0
11194567|NCT01789970|12384618|FG002|COMPLETED|Open-label Titration Period||0
11194568|NCT01789970|12384616|FG000|NOT COMPLETED|Open-label Titration Period||254
11194569|NCT01789970|12384617|FG001|NOT COMPLETED|Open-label Titration Period||0
11194570|NCT01789970|12384618|FG002|NOT COMPLETED|Open-label Titration Period||0
11194571|NCT01789970|12384616|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0
11194572|NCT01789970|12384617|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||180
11194573|NCT01789970|12384618|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||191
11194574|NCT01789970|12384616|FG000|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
11194575|NCT01789970|12384617|FG001|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
11194576|NCT01789970|12384618|FG002|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
11194577|NCT01789970|12384616|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
11194578|NCT01789970|12384617|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
11194579|NCT01789970|12384618|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
11194580|NCT01789970|12384616|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
11194581|NCT01789970|12384617|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
11194582|NCT01789970|12384618|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
11194583|NCT01790048|12384634|FG000|STARTED|Overall Study||1156
11194584|NCT01790048|12384635|FG001|STARTED|Overall Study||1103
11194585|NCT01790048|12384634|FG000|COMPLETED|Overall Study||1144
11194586|NCT01790048|12384635|FG001|COMPLETED|Overall Study||1086
11194587|NCT01790048|12384634|FG000|NOT COMPLETED|Overall Study||12
11194588|NCT01790048|12384635|FG001|NOT COMPLETED|Overall Study||17
11194589|NCT01790113|12384645|FG000|STARTED|Overall Study||79
11194590|NCT01790113|12384646|FG001|STARTED|Overall Study||224
11194591|NCT01790113|12384645|FG000|COMPLETED|Overall Study||76
11194592|NCT01790113|12384646|FG001|COMPLETED|Overall Study||149
11194593|NCT01790113|12384645|FG000|NOT COMPLETED|Overall Study||3
11194594|NCT01790113|12384646|FG001|NOT COMPLETED|Overall Study||75
11194595|NCT01790126|12384655|FG000|STARTED|Overall Study||30
11194596|NCT01790126|12384656|FG001|STARTED|Overall Study||29
11194597|NCT01790126|12384657|FG002|STARTED|Overall Study||31
11194598|NCT01790126|12384655|FG000|Treated|Overall Study||29
11194599|NCT01790126|12384656|FG001|Treated|Overall Study||29
11194600|NCT01790126|12384657|FG002|Treated|Overall Study||31
11194601|NCT01790126|12384655|FG000|COMPLETED|Overall Study||0
11194602|NCT01790126|12384656|FG001|COMPLETED|Overall Study||0
11194603|NCT01790126|12384657|FG002|COMPLETED|Overall Study||0
11194604|NCT01790126|12384655|FG000|NOT COMPLETED|Overall Study||30
11194605|NCT01790126|12384656|FG001|NOT COMPLETED|Overall Study||29
11194606|NCT01790126|12384657|FG002|NOT COMPLETED|Overall Study||31
11194607|NCT01790178|12384668|FG000|STARTED|Overall Study||16
11194608|NCT01790178|12384669|FG001|STARTED|Overall Study||24
11194609|NCT01790178|12384668|FG000|COMPLETED|Overall Study||16
11194610|NCT01790178|12384669|FG001|COMPLETED|Overall Study||24
11194611|NCT01790178|12384668|FG000|NOT COMPLETED|Overall Study||0
11194612|NCT01790178|12384669|FG001|NOT COMPLETED|Overall Study||0
11194613|NCT01790243|12384677|FG000|STARTED|Overall Study||1029
11194614|NCT01790243|12384678|FG001|STARTED|Overall Study||160
11194615|NCT01790243|12384677|FG000|COMPLETED|Overall Study||739
11194616|NCT01790243|12384678|FG001|COMPLETED|Overall Study||117
11194617|NCT01790243|12384677|FG000|NOT COMPLETED|Overall Study||290
11194618|NCT01790243|12384678|FG001|NOT COMPLETED|Overall Study||43
11194619|NCT01790295|12384684|FG000|STARTED|Overall Study||21
11194620|NCT01790295|12384684|FG000|COMPLETED|Overall Study||10
11194621|NCT01790295|12384684|FG000|NOT COMPLETED|Overall Study||11
11194622|NCT01790438|12384691|FG000|STARTED|Overall Study||428
11194623|NCT01790438|12384692|FG001|STARTED|Overall Study||213
11194624|NCT01790438|12384691|FG000|Received at Least One Dose of Study Drug|Overall Study||427
11194625|NCT01790438|12384692|FG001|Received at Least One Dose of Study Drug|Overall Study||212
11194626|NCT01790438|12384691|FG000|COMPLETED|Overall Study||393
11194627|NCT01790438|12384692|FG001|COMPLETED|Overall Study||202
11194628|NCT01790438|12384691|FG000|NOT COMPLETED|Overall Study||35
11194629|NCT01790438|12384692|FG001|NOT COMPLETED|Overall Study||11
11194630|NCT01790490|12384703|FG000|STARTED|Overall Study||3
11194631|NCT01790490|12384704|FG001|STARTED|Overall Study||3
11194632|NCT01790490|12384705|FG002|STARTED|Overall Study||2
11194633|NCT01790490|12384703|FG000|COMPLETED|Overall Study||3
11194634|NCT01790490|12384704|FG001|COMPLETED|Overall Study||3
11194635|NCT01790490|12384705|FG002|COMPLETED|Overall Study||2
11194636|NCT01790490|12384703|FG000|NOT COMPLETED|Overall Study||0
11194637|NCT01790490|12384704|FG001|NOT COMPLETED|Overall Study||0
11194638|NCT01790490|12384705|FG002|NOT COMPLETED|Overall Study||0
11194639|NCT01790503|12384727|FG000|STARTED|Overall Study||3
11194640|NCT01790503|12384728|FG001|STARTED|Overall Study||1
11194641|NCT01790503|12384729|FG002|STARTED|Overall Study||1
11194642|NCT01790503|12384730|FG003|STARTED|Overall Study||2
11194643|NCT01790503|12384731|FG004|STARTED|Overall Study||5
11194644|NCT01790503|12384732|FG005|STARTED|Overall Study||5
11194645|NCT01790503|12384733|FG006|STARTED|Overall Study||1
11194646|NCT01790503|12384734|FG007|STARTED|Overall Study||1
11194647|NCT01790503|12384735|FG008|STARTED|Overall Study||3
11194648|NCT01790503|12384736|FG009|STARTED|Overall Study||27
11194649|NCT01790503|12384737|FG010|STARTED|Overall Study||16
11194650|NCT01790503|12384727|FG000|COMPLETED|Overall Study||0
11194651|NCT01790503|12384728|FG001|COMPLETED|Overall Study||0
11194652|NCT01790503|12384729|FG002|COMPLETED|Overall Study||0
11194653|NCT01790503|12384730|FG003|COMPLETED|Overall Study||0
11194654|NCT01790503|12384731|FG004|COMPLETED|Overall Study||0
11194655|NCT01790503|12384732|FG005|COMPLETED|Overall Study||0
11194656|NCT01790503|12384733|FG006|COMPLETED|Overall Study||0
11194657|NCT01790503|12384734|FG007|COMPLETED|Overall Study||0
11194658|NCT01790503|12384735|FG008|COMPLETED|Overall Study||0
11194659|NCT01790503|12384736|FG009|COMPLETED|Overall Study||1
11194660|NCT01790503|12384737|FG010|COMPLETED|Overall Study||0
11194661|NCT01790503|12384727|FG000|NOT COMPLETED|Overall Study||3
11194662|NCT01790503|12384728|FG001|NOT COMPLETED|Overall Study||1
11194663|NCT01790503|12384729|FG002|NOT COMPLETED|Overall Study||1
11194664|NCT01790503|12384730|FG003|NOT COMPLETED|Overall Study||2
11194665|NCT01790503|12384731|FG004|NOT COMPLETED|Overall Study||5
11194666|NCT01790503|12384732|FG005|NOT COMPLETED|Overall Study||5
11194667|NCT01790503|12384733|FG006|NOT COMPLETED|Overall Study||1
11194668|NCT01790503|12384734|FG007|NOT COMPLETED|Overall Study||1
11194669|NCT01790503|12384735|FG008|NOT COMPLETED|Overall Study||3
11194670|NCT01790503|12384736|FG009|NOT COMPLETED|Overall Study||26
11194671|NCT01790503|12384737|FG010|NOT COMPLETED|Overall Study||16
11194672|NCT01790516|12384776|FG000|STARTED|Overall Study||1
11194673|NCT01790516|12384777|FG001|STARTED|Overall Study||1
11194674|NCT01790516|12384776|FG000|COMPLETED|Overall Study||0
11194675|NCT01790516|12384777|FG001|COMPLETED|Overall Study||1
11194676|NCT01790516|12384776|FG000|NOT COMPLETED|Overall Study||1
11194677|NCT01790516|12384777|FG001|NOT COMPLETED|Overall Study||0
11194678|NCT01790568|12384783|FG000|STARTED|Overall Study||12
11194679|NCT01790568|12384784|FG001|STARTED|Overall Study||26
11194680|NCT01790568|12384783|FG000|COMPLETED|Overall Study||12
11194681|NCT01790568|12384784|FG001|COMPLETED|Overall Study||25
11194682|NCT01790568|12384783|FG000|NOT COMPLETED|Overall Study||0
11194683|NCT01790568|12384784|FG001|NOT COMPLETED|Overall Study||1
11194684|NCT01790581|12384790|FG000|STARTED|Overall Study||12
11194685|NCT01790581|12384791|FG001|STARTED|Overall Study||12
11194686|NCT01790581|12384790|FG000|COMPLETED|Overall Study||12
11194687|NCT01790581|12384791|FG001|COMPLETED|Overall Study||12
11194688|NCT01790581|12384790|FG000|NOT COMPLETED|Overall Study||0
11194689|NCT01790581|12384791|FG001|NOT COMPLETED|Overall Study||0
11194690|NCT01790594|12384799|FG000|STARTED|Overall Study||22
11194691|NCT01790594|12384800|FG001|STARTED|Overall Study||21
11194692|NCT01790594|12384801|FG002|STARTED|Overall Study||3
11194693|NCT01790594|12384799|FG000|COMPLETED|Overall Study||17
11194694|NCT01790594|12384800|FG001|COMPLETED|Overall Study||18
11194695|NCT01790594|12384801|FG002|COMPLETED|Overall Study||0
11194696|NCT01790594|12384799|FG000|NOT COMPLETED|Overall Study||5
11194697|NCT01790594|12384800|FG001|NOT COMPLETED|Overall Study||3
11194698|NCT01790594|12384801|FG002|NOT COMPLETED|Overall Study||3
11194699|NCT01790633|12384810|FG000|STARTED|Overall Study||163
11194700|NCT01790633|12384811|FG001|STARTED|Overall Study||164
11194701|NCT01790633|12384810|FG000|COMPLETED|Overall Study||115
11194702|NCT01790633|12384811|FG001|COMPLETED|Overall Study||159
11194703|NCT01790633|12384810|FG000|NOT COMPLETED|Overall Study||48
11194704|NCT01790633|12384811|FG001|NOT COMPLETED|Overall Study||5
11194705|NCT01790659|12384820|FG000|STARTED|Overall Study||201
11194706|NCT01790659|12384821|FG001|STARTED|Overall Study||198
11194707|NCT01790659|12384820|FG000|COMPLETED|Overall Study||195
11194708|NCT01790659|12384821|FG001|COMPLETED|Overall Study||192
11194709|NCT01790659|12384820|FG000|NOT COMPLETED|Overall Study||6
11194710|NCT01790659|12384821|FG001|NOT COMPLETED|Overall Study||6
11194711|NCT01790685|12384829|FG000|STARTED|Overall Study||23
11194712|NCT01790685|12384830|FG001|STARTED|Overall Study||17
11194713|NCT01790685|12384829|FG000|COMPLETED|Overall Study||23
11194714|NCT01790685|12384830|FG001|COMPLETED|Overall Study||17
11194715|NCT01790685|12384829|FG000|NOT COMPLETED|Overall Study||0
11194716|NCT01790685|12384830|FG001|NOT COMPLETED|Overall Study||0
11194717|NCT01790750|12384836|FG000|STARTED|Overall Study||50
11194718|NCT01790750|12384836|FG000|COMPLETED|Overall Study||50
11194719|NCT01790750|12384836|FG000|NOT COMPLETED|Overall Study||0
11194720|NCT01790828|12384841|FG000|STARTED|Overall Study||42
11194721|NCT01790828|12384841|FG000|COMPLETED|Overall Study||8
11194722|NCT01790828|12384841|FG000|NOT COMPLETED|Overall Study||34
11194723|NCT01790932|12384845|FG000|STARTED|Overall Study||50
11194724|NCT01790932|12384845|FG000|COMPLETED|Overall Study||0
11194725|NCT01790932|12384845|FG000|NOT COMPLETED|Overall Study||50
11194726|NCT01790984|12384851|FG000|STARTED|First Dietary Intervention (12 Weeks)||6
11194727|NCT01790984|12384852|FG001|STARTED|First Dietary Intervention (12 Weeks)||8
11194728|NCT01790984|12384853|FG002|STARTED|First Dietary Intervention (12 Weeks)||6
11194729|NCT01790984|12384854|FG003|STARTED|First Dietary Intervention (12 Weeks)||7
11194730|NCT01790984|12384851|FG000|COMPLETED|First Dietary Intervention (12 Weeks)||5
11194731|NCT01790984|12384852|FG001|COMPLETED|First Dietary Intervention (12 Weeks)||7
11194732|NCT01790984|12384853|FG002|COMPLETED|First Dietary Intervention (12 Weeks)||6
11194733|NCT01790984|12384854|FG003|COMPLETED|First Dietary Intervention (12 Weeks)||7
11194734|NCT01790984|12384851|FG000|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
11194735|NCT01790984|12384852|FG001|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
11194736|NCT01790984|12384853|FG002|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
11194737|NCT01790984|12384854|FG003|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
11194738|NCT01790984|12384851|FG000|STARTED|Wash-out (4 Weeks)||5
11194739|NCT01790984|12384852|FG001|STARTED|Wash-out (4 Weeks)||7
11194740|NCT01790984|12384853|FG002|STARTED|Wash-out (4 Weeks)||6
11194741|NCT01790984|12384854|FG003|STARTED|Wash-out (4 Weeks)||7
11194742|NCT01790984|12384851|FG000|COMPLETED|Wash-out (4 Weeks)||5
11194743|NCT01790984|12384852|FG001|COMPLETED|Wash-out (4 Weeks)||7
11194744|NCT01790984|12384853|FG002|COMPLETED|Wash-out (4 Weeks)||6
11194745|NCT01790984|12384854|FG003|COMPLETED|Wash-out (4 Weeks)||7
11194746|NCT01790984|12384851|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
11194747|NCT01790984|12384852|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
11194748|NCT01790984|12384853|FG002|NOT COMPLETED|Wash-out (4 Weeks)||0
11194749|NCT01790984|12384854|FG003|NOT COMPLETED|Wash-out (4 Weeks)||0
11194750|NCT01790984|12384851|FG000|STARTED|Second Dietary Intervention (12 Weeks)||5
11194751|NCT01790984|12384852|FG001|STARTED|Second Dietary Intervention (12 Weeks)||7
11194752|NCT01790984|12384853|FG002|STARTED|Second Dietary Intervention (12 Weeks)||6
11194753|NCT01790984|12384854|FG003|STARTED|Second Dietary Intervention (12 Weeks)||7
11194754|NCT01790984|12384851|FG000|COMPLETED|Second Dietary Intervention (12 Weeks)||5
11194755|NCT01790984|12384852|FG001|COMPLETED|Second Dietary Intervention (12 Weeks)||7
11194756|NCT01790984|12384853|FG002|COMPLETED|Second Dietary Intervention (12 Weeks)||6
11194757|NCT01790984|12384854|FG003|COMPLETED|Second Dietary Intervention (12 Weeks)||7
11194758|NCT01790984|12384851|FG000|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
11194759|NCT01790984|12384852|FG001|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
11194760|NCT01790984|12384853|FG002|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
11194761|NCT01790984|12384854|FG003|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
11194762|NCT01791127|12384877|FG000|STARTED|Overall Study||1758
11194763|NCT01791127|12384877|FG000|COMPLETED|Overall Study||286
11194764|NCT01791127|12384877|FG000|NOT COMPLETED|Overall Study||1472
11194765|NCT01791153|12384898|FG000|STARTED|Part 1: Blinded Period||100
11194766|NCT01791153|12384899|FG001|STARTED|Part 1: Blinded Period||49
11194767|NCT01791153|12384900|FG002|STARTED|Part 1: Blinded Period||50
11194768|NCT01791153|12384901|FG003|STARTED|Part 1: Blinded Period||51
11194769|NCT01791153|12384902|FG004|STARTED|Part 1: Blinded Period||0
11194770|NCT01791153|12384903|FG005|STARTED|Part 1: Blinded Period||0
11194771|NCT01791153|12384904|FG006|STARTED|Part 1: Blinded Period||0
11194772|NCT01791153|12384905|FG007|STARTED|Part 1: Blinded Period||0
11194773|NCT01791153|12384898|FG000|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85
11194774|NCT01791153|12384899|FG001|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41
11194775|NCT01791153|12384900|FG002|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44
11194776|NCT01791153|12384901|FG003|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46
11194777|NCT01791153|12384902|FG004|COMPLETED|Part 1: Blinded Period||0
11194778|NCT01791153|12384903|FG005|COMPLETED|Part 1: Blinded Period||0
11194779|NCT01791153|12384904|FG006|COMPLETED|Part 1: Blinded Period||0
11194780|NCT01791153|12384905|FG007|COMPLETED|Part 1: Blinded Period||0
11194781|NCT01791153|12384898|FG000|NOT COMPLETED|Part 1: Blinded Period||15
11194782|NCT01791153|12384899|FG001|NOT COMPLETED|Part 1: Blinded Period||8
11194783|NCT01791153|12384900|FG002|NOT COMPLETED|Part 1: Blinded Period||6
11194784|NCT01791153|12384901|FG003|NOT COMPLETED|Part 1: Blinded Period||5
11194785|NCT01791153|12384902|FG004|NOT COMPLETED|Part 1: Blinded Period||0
11194786|NCT01791153|12384903|FG005|NOT COMPLETED|Part 1: Blinded Period||0
11194787|NCT01791153|12384904|FG006|NOT COMPLETED|Part 1: Blinded Period||0
11194788|NCT01791153|12384905|FG007|NOT COMPLETED|Part 1: Blinded Period||0
11194789|NCT01791153|12384898|FG000|STARTED|Part 2: Open-label Period||0
11194790|NCT01791153|12384899|FG001|STARTED|Part 2: Open-label Period||0
11194791|NCT01791153|12384900|FG002|STARTED|Part 2: Open-label Period||0
11194792|NCT01791153|12384901|FG003|STARTED|Part 2: Open-label Period||0
11194793|NCT01791153|12384902|FG004|STARTED|Part 2: Open-label Period||40
11194794|NCT01791153|12384903|FG005|STARTED|Part 2: Open-label Period||58
11194795|NCT01791153|12384904|FG006|STARTED|Part 2: Open-label Period||50
11194796|NCT01791153|12384905|FG007|STARTED|Part 2: Open-label Period||67
11194797|NCT01791153|12384898|FG000|COMPLETED|Part 2: Open-label Period||0
11194798|NCT01791153|12384899|FG001|COMPLETED|Part 2: Open-label Period||0
11194799|NCT01791153|12384900|FG002|COMPLETED|Part 2: Open-label Period||0
11194800|NCT01791153|12384901|FG003|COMPLETED|Part 2: Open-label Period||0
11194801|NCT01791153|12384902|FG004|COMPLETED|Part 2: Open-label Period||38
11194802|NCT01791153|12384903|FG005|COMPLETED|Part 2: Open-label Period||54
11194803|NCT01791153|12384904|FG006|COMPLETED|Part 2: Open-label Period||44
11194804|NCT01791153|12384905|FG007|COMPLETED|Part 2: Open-label Period||61
11194805|NCT01791153|12384898|FG000|NOT COMPLETED|Part 2: Open-label Period||0
11194806|NCT01791153|12384899|FG001|NOT COMPLETED|Part 2: Open-label Period||0
11194807|NCT01791153|12384900|FG002|NOT COMPLETED|Part 2: Open-label Period||0
11194808|NCT01791153|12384901|FG003|NOT COMPLETED|Part 2: Open-label Period||0
11194809|NCT01791153|12384902|FG004|NOT COMPLETED|Part 2: Open-label Period||2
11194810|NCT01791153|12384903|FG005|NOT COMPLETED|Part 2: Open-label Period||4
11194811|NCT01791153|12384904|FG006|NOT COMPLETED|Part 2: Open-label Period||6
11194812|NCT01791153|12384905|FG007|NOT COMPLETED|Part 2: Open-label Period||6
11194813|NCT01791205|12384922|FG000|STARTED|Phase I||152
11194814|NCT01791205|12384923|FG001|STARTED|Phase I||152
11194815|NCT01791205|12384922|FG000|COMPLETED|Phase I||152
11194816|NCT01791205|12384923|FG001|COMPLETED|Phase I||152
11194817|NCT01791205|12384922|FG000|NOT COMPLETED|Phase I||0
11194818|NCT01791205|12384923|FG001|NOT COMPLETED|Phase I||0
11194819|NCT01791205|12384922|FG000|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
11194820|NCT01791205|12384923|FG001|STARTED|Phase II||0
11194821|NCT01791205|12384922|FG000|COMPLETED|Phase II||92
11194822|NCT01791205|12384923|FG001|COMPLETED|Phase II||0
11194823|NCT01791205|12384922|FG000|NOT COMPLETED|Phase II||12
11194824|NCT01791205|12384923|FG001|NOT COMPLETED|Phase II||0
11194825|NCT01791244|12384931|FG000|STARTED|Overall Study||46
11194826|NCT01791244|12384932|FG001|STARTED|Overall Study||47
11194827|NCT01791244|12384931|FG000|Intent to Treat (ITT)|Overall Study||38
11194828|NCT01791244|12384932|FG001|Intent to Treat (ITT)|Overall Study||39
11194829|NCT01791244|12384931|FG000|COMPLETED|Overall Study||31
11194830|NCT01791244|12384932|FG001|COMPLETED|Overall Study||29
11194831|NCT01791244|12384931|FG000|NOT COMPLETED|Overall Study||15
11194832|NCT01791244|12384932|FG001|NOT COMPLETED|Overall Study||18
11194833|NCT01791413|12384942|FG000|STARTED|Overall Study||20
11194834|NCT01791413|12384943|FG001|STARTED|Overall Study||20
11194835|NCT01791413|12384942|FG000|COMPLETED|Overall Study||15
11194836|NCT01791413|12384943|FG001|COMPLETED|Overall Study||19
11194837|NCT01791413|12384942|FG000|NOT COMPLETED|Overall Study||5
11194838|NCT01791413|12384943|FG001|NOT COMPLETED|Overall Study||1
11194839|NCT01791465|12384950|FG000|STARTED|Overall Study||6
11194840|NCT01791465|12384950|FG000|COMPLETED|Overall Study||6
11194841|NCT01791465|12384950|FG000|NOT COMPLETED|Overall Study||0
11194842|NCT01791491|12384955|FG000|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
11194843|NCT01791491|12384955|FG000|COMPLETED|Overall Study||9
11194844|NCT01791491|12384955|FG000|NOT COMPLETED|Overall Study||0
11194845|NCT01791517|12384962|FG000|STARTED|Phase I: Period 1||19
11194846|NCT01791517|12384963|FG001|STARTED|Phase I: Period 1||20
11194847|NCT01791517|12384964|FG002|STARTED|Phase I: Period 1||20
11194848|NCT01791517|12384965|FG003|STARTED|Phase I: Period 1||19
11194849|NCT01791517|12384966|FG004|STARTED|Phase I: Period 1||20
11194850|NCT01791517|12384967|FG005|STARTED|Phase I: Period 1||20
11194851|NCT01791517|12384968|FG006|STARTED|Phase I: Period 1||20
11194852|NCT01791517|12384969|FG007|STARTED|Phase I: Period 1||20
11194853|NCT01791517|12384970|FG008|STARTED|Phase I: Period 1||20
11194854|NCT01791517|12384971|FG009|STARTED|Phase I: Period 1||20
11194855|NCT01791517|12384972|FG010|STARTED|Phase I: Period 1||18
11194856|NCT01791517|12384973|FG011|STARTED|Phase I: Period 1||20
11194857|NCT01791517|12384962|FG000|COMPLETED|Phase I: Period 1||18
11194858|NCT01791517|12384963|FG001|COMPLETED|Phase I: Period 1||18
11194859|NCT01791517|12384964|FG002|COMPLETED|Phase I: Period 1||18
11194860|NCT01791517|12384965|FG003|COMPLETED|Phase I: Period 1||17
11194861|NCT01791517|12384966|FG004|COMPLETED|Phase I: Period 1||19
11194862|NCT01791517|12384967|FG005|COMPLETED|Phase I: Period 1||19
11194863|NCT01791517|12384968|FG006|COMPLETED|Phase I: Period 1||19
11194864|NCT01791517|12384969|FG007|COMPLETED|Phase I: Period 1||20
11194865|NCT01791517|12384970|FG008|COMPLETED|Phase I: Period 1||19
11194866|NCT01791517|12384971|FG009|COMPLETED|Phase I: Period 1||19
11194867|NCT01791517|12384972|FG010|COMPLETED|Phase I: Period 1||18
11194868|NCT01791517|12384973|FG011|COMPLETED|Phase I: Period 1||19
11194869|NCT01791517|12384962|FG000|NOT COMPLETED|Phase I: Period 1||1
11194870|NCT01791517|12384963|FG001|NOT COMPLETED|Phase I: Period 1||2
11194871|NCT01791517|12384964|FG002|NOT COMPLETED|Phase I: Period 1||2
11194872|NCT01791517|12384965|FG003|NOT COMPLETED|Phase I: Period 1||2
11194873|NCT01791517|12384966|FG004|NOT COMPLETED|Phase I: Period 1||1
11194874|NCT01791517|12384967|FG005|NOT COMPLETED|Phase I: Period 1||1
11194875|NCT01791517|12384968|FG006|NOT COMPLETED|Phase I: Period 1||1
11194876|NCT01791517|12384969|FG007|NOT COMPLETED|Phase I: Period 1||0
11194877|NCT01791517|12384970|FG008|NOT COMPLETED|Phase I: Period 1||1
11194878|NCT01791517|12384971|FG009|NOT COMPLETED|Phase I: Period 1||1
11194879|NCT01791517|12384972|FG010|NOT COMPLETED|Phase I: Period 1||0
11194880|NCT01791517|12384973|FG011|NOT COMPLETED|Phase I: Period 1||1
11194881|NCT01791517|12384962|FG000|STARTED|Phase I: Period 2||18
11194882|NCT01791517|12384963|FG001|STARTED|Phase I: Period 2||18
11194883|NCT01791517|12384964|FG002|STARTED|Phase I: Period 2||18
11194884|NCT01791517|12384965|FG003|STARTED|Phase I: Period 2||17
11194885|NCT01791517|12384966|FG004|STARTED|Phase I: Period 2||19
11194886|NCT01791517|12384967|FG005|STARTED|Phase I: Period 2||19
11194887|NCT01791517|12384968|FG006|STARTED|Phase I: Period 2||19
11194888|NCT01791517|12384969|FG007|STARTED|Phase I: Period 2||20
11194889|NCT01791517|12384970|FG008|STARTED|Phase I: Period 2||19
11194890|NCT01791517|12384971|FG009|STARTED|Phase I: Period 2||19
11194891|NCT01791517|12384972|FG010|STARTED|Phase I: Period 2||18
11194892|NCT01791517|12384973|FG011|STARTED|Phase I: Period 2||19
11194893|NCT01791517|12384962|FG000|COMPLETED|Phase I: Period 2||17
11194894|NCT01791517|12384963|FG001|COMPLETED|Phase I: Period 2||15
11194895|NCT01791517|12384964|FG002|COMPLETED|Phase I: Period 2||16
11194896|NCT01791517|12384965|FG003|COMPLETED|Phase I: Period 2||16
11194897|NCT01791517|12384966|FG004|COMPLETED|Phase I: Period 2||19
11194898|NCT01791517|12384967|FG005|COMPLETED|Phase I: Period 2||18
11194899|NCT01791517|12384968|FG006|COMPLETED|Phase I: Period 2||19
11194900|NCT01791517|12384969|FG007|COMPLETED|Phase I: Period 2||20
11194901|NCT01791517|12384970|FG008|COMPLETED|Phase I: Period 2||19
11194902|NCT01791517|12384971|FG009|COMPLETED|Phase I: Period 2||18
11194903|NCT01791517|12384972|FG010|COMPLETED|Phase I: Period 2||16
11194904|NCT01791517|12384973|FG011|COMPLETED|Phase I: Period 2||19
11194905|NCT01791517|12384962|FG000|NOT COMPLETED|Phase I: Period 2||1
11194906|NCT01791517|12384963|FG001|NOT COMPLETED|Phase I: Period 2||3
11194907|NCT01791517|12384964|FG002|NOT COMPLETED|Phase I: Period 2||2
11194908|NCT01791517|12384965|FG003|NOT COMPLETED|Phase I: Period 2||1
11194909|NCT01791517|12384966|FG004|NOT COMPLETED|Phase I: Period 2||0
11194910|NCT01791517|12384967|FG005|NOT COMPLETED|Phase I: Period 2||1
11194911|NCT01791517|12384968|FG006|NOT COMPLETED|Phase I: Period 2||0
11194912|NCT01791517|12384969|FG007|NOT COMPLETED|Phase I: Period 2||0
11194913|NCT01791517|12384970|FG008|NOT COMPLETED|Phase I: Period 2||0
11194914|NCT01791517|12384971|FG009|NOT COMPLETED|Phase I: Period 2||1
11194915|NCT01791517|12384972|FG010|NOT COMPLETED|Phase I: Period 2||2
11194916|NCT01791517|12384973|FG011|NOT COMPLETED|Phase I: Period 2||0
11194917|NCT01791517|12384962|FG000|STARTED|Phase I: Period 3||17
11194918|NCT01791517|12384963|FG001|STARTED|Phase I: Period 3||15
11194919|NCT01791517|12384964|FG002|STARTED|Phase I: Period 3||16
11194920|NCT01791517|12384965|FG003|STARTED|Phase I: Period 3||16
11194921|NCT01791517|12384966|FG004|STARTED|Phase I: Period 3||19
11194922|NCT01791517|12384967|FG005|STARTED|Phase I: Period 3||18
11194923|NCT01791517|12384968|FG006|STARTED|Phase I: Period 3||19
11194924|NCT01791517|12384969|FG007|STARTED|Phase I: Period 3||20
11194925|NCT01791517|12384970|FG008|STARTED|Phase I: Period 3||19
11194926|NCT01791517|12384971|FG009|STARTED|Phase I: Period 3||18
11194927|NCT01791517|12384972|FG010|STARTED|Phase I: Period 3||16
11194928|NCT01791517|12384973|FG011|STARTED|Phase I: Period 3||19
11194929|NCT01791517|12384962|FG000|COMPLETED|Phase I: Period 3||17
11194930|NCT01791517|12384963|FG001|COMPLETED|Phase I: Period 3||14
11194931|NCT01791517|12384964|FG002|COMPLETED|Phase I: Period 3||16
11194932|NCT01791517|12384965|FG003|COMPLETED|Phase I: Period 3||15
11194933|NCT01791517|12384966|FG004|COMPLETED|Phase I: Period 3||18
11194934|NCT01791517|12384967|FG005|COMPLETED|Phase I: Period 3||18
11194935|NCT01791517|12384968|FG006|COMPLETED|Phase I: Period 3||19
11194936|NCT01791517|12384969|FG007|COMPLETED|Phase I: Period 3||20
11194937|NCT01791517|12384970|FG008|COMPLETED|Phase I: Period 3||19
11194938|NCT01791517|12384971|FG009|COMPLETED|Phase I: Period 3||18
11194939|NCT01791517|12384972|FG010|COMPLETED|Phase I: Period 3||16
11194940|NCT01791517|12384973|FG011|COMPLETED|Phase I: Period 3||18
11194941|NCT01791517|12384962|FG000|NOT COMPLETED|Phase I: Period 3||0
11194942|NCT01791517|12384963|FG001|NOT COMPLETED|Phase I: Period 3||1
11194943|NCT01791517|12384964|FG002|NOT COMPLETED|Phase I: Period 3||0
11194944|NCT01791517|12384965|FG003|NOT COMPLETED|Phase I: Period 3||1
11194945|NCT01791517|12384966|FG004|NOT COMPLETED|Phase I: Period 3||1
11194946|NCT01791517|12384967|FG005|NOT COMPLETED|Phase I: Period 3||0
11194947|NCT01791517|12384968|FG006|NOT COMPLETED|Phase I: Period 3||0
11194948|NCT01791517|12384969|FG007|NOT COMPLETED|Phase I: Period 3||0
11194949|NCT01791517|12384970|FG008|NOT COMPLETED|Phase I: Period 3||0
11194950|NCT01791517|12384971|FG009|NOT COMPLETED|Phase I: Period 3||0
11194951|NCT01791517|12384972|FG010|NOT COMPLETED|Phase I: Period 3||0
11194952|NCT01791517|12384973|FG011|NOT COMPLETED|Phase I: Period 3||1
11194953|NCT01791517|12384962|FG000|STARTED|Phase I: Period 4||17
11194954|NCT01791517|12384963|FG001|STARTED|Phase I: Period 4||14
11194955|NCT01791517|12384964|FG002|STARTED|Phase I: Period 4||16
11194956|NCT01791517|12384965|FG003|STARTED|Phase I: Period 4||15
11194957|NCT01791517|12384966|FG004|STARTED|Phase I: Period 4||18
11194958|NCT01791517|12384967|FG005|STARTED|Phase I: Period 4||18
11194959|NCT01791517|12384968|FG006|STARTED|Phase I: Period 4||19
11194960|NCT01791517|12384969|FG007|STARTED|Phase I: Period 4||20
11194961|NCT01791517|12384970|FG008|STARTED|Phase I: Period 4||19
11194962|NCT01791517|12384971|FG009|STARTED|Phase I: Period 4||18
11194963|NCT01791517|12384972|FG010|STARTED|Phase I: Period 4||16
11194964|NCT01791517|12384973|FG011|STARTED|Phase I: Period 4||18
11194965|NCT01791517|12384962|FG000|COMPLETED|Phase I: Period 4||17
11194966|NCT01791517|12384963|FG001|COMPLETED|Phase I: Period 4||14
11194967|NCT01791517|12384964|FG002|COMPLETED|Phase I: Period 4||16
11194968|NCT01791517|12384965|FG003|COMPLETED|Phase I: Period 4||15
11194969|NCT01791517|12384966|FG004|COMPLETED|Phase I: Period 4||18
11194970|NCT01791517|12384967|FG005|COMPLETED|Phase I: Period 4||18
11194971|NCT01791517|12384968|FG006|COMPLETED|Phase I: Period 4||19
11194972|NCT01791517|12384969|FG007|COMPLETED|Phase I: Period 4||20
11194973|NCT01791517|12384970|FG008|COMPLETED|Phase I: Period 4||19
11194974|NCT01791517|12384971|FG009|COMPLETED|Phase I: Period 4||18
11194975|NCT01791517|12384972|FG010|COMPLETED|Phase I: Period 4||16
11194976|NCT01791517|12384973|FG011|COMPLETED|Phase I: Period 4||18
11194977|NCT01791517|12384962|FG000|NOT COMPLETED|Phase I: Period 4||0
11194978|NCT01791517|12384963|FG001|NOT COMPLETED|Phase I: Period 4||0
11194979|NCT01791517|12384964|FG002|NOT COMPLETED|Phase I: Period 4||0
11194980|NCT01791517|12384965|FG003|NOT COMPLETED|Phase I: Period 4||0
11194981|NCT01791517|12384966|FG004|NOT COMPLETED|Phase I: Period 4||0
11194982|NCT01791517|12384967|FG005|NOT COMPLETED|Phase I: Period 4||0
11194983|NCT01791517|12384968|FG006|NOT COMPLETED|Phase I: Period 4||0
11194984|NCT01791517|12384969|FG007|NOT COMPLETED|Phase I: Period 4||0
11194985|NCT01791517|12384970|FG008|NOT COMPLETED|Phase I: Period 4||0
11194986|NCT01791517|12384971|FG009|NOT COMPLETED|Phase I: Period 4||0
11194987|NCT01791517|12384972|FG010|NOT COMPLETED|Phase I: Period 4||0
11194988|NCT01791517|12384973|FG011|NOT COMPLETED|Phase I: Period 4||0
11194989|NCT01791517|12384962|FG000|STARTED|Phase II||17
11194990|NCT01791517|12384963|FG001|STARTED|Phase II||14
11194991|NCT01791517|12384964|FG002|STARTED|Phase II||16
11194992|NCT01791517|12384965|FG003|STARTED|Phase II||15
11194993|NCT01791517|12384966|FG004|STARTED|Phase II||18
11194994|NCT01791517|12384967|FG005|STARTED|Phase II||18
11194995|NCT01791517|12384968|FG006|STARTED|Phase II||19
11194996|NCT01791517|12384969|FG007|STARTED|Phase II||20
11194997|NCT01791517|12384970|FG008|STARTED|Phase II||19
11194998|NCT01791517|12384971|FG009|STARTED|Phase II||18
11194999|NCT01791517|12384972|FG010|STARTED|Phase II||16
11195000|NCT01791517|12384973|FG011|STARTED|Phase II||18
11195001|NCT01791517|12384962|FG000|COMPLETED|Phase II||15
11195002|NCT01791517|12384963|FG001|COMPLETED|Phase II||14
11195003|NCT01791517|12384964|FG002|COMPLETED|Phase II||15
11195004|NCT01791517|12384965|FG003|COMPLETED|Phase II||15
11195005|NCT01791517|12384966|FG004|COMPLETED|Phase II||16
11195006|NCT01791517|12384967|FG005|COMPLETED|Phase II||14
11195007|NCT01791517|12384968|FG006|COMPLETED|Phase II||17
11195008|NCT01791517|12384969|FG007|COMPLETED|Phase II||17
11195009|NCT01791517|12384970|FG008|COMPLETED|Phase II||17
11195010|NCT01791517|12384971|FG009|COMPLETED|Phase II||15
11195011|NCT01791517|12384972|FG010|COMPLETED|Phase II||15
11195012|NCT01791517|12384973|FG011|COMPLETED|Phase II||17
11195013|NCT01791517|12384962|FG000|NOT COMPLETED|Phase II||2
11195014|NCT01791517|12384963|FG001|NOT COMPLETED|Phase II||0
11195015|NCT01791517|12384964|FG002|NOT COMPLETED|Phase II||1
11195016|NCT01791517|12384965|FG003|NOT COMPLETED|Phase II||0
11195017|NCT01791517|12384966|FG004|NOT COMPLETED|Phase II||2
11195018|NCT01791517|12384967|FG005|NOT COMPLETED|Phase II||4
11195019|NCT01791517|12384968|FG006|NOT COMPLETED|Phase II||2
11195020|NCT01791517|12384969|FG007|NOT COMPLETED|Phase II||3
11195021|NCT01791517|12384970|FG008|NOT COMPLETED|Phase II||2
11195022|NCT01791517|12384971|FG009|NOT COMPLETED|Phase II||3
11195023|NCT01791517|12384972|FG010|NOT COMPLETED|Phase II||1
11195024|NCT01791517|12384973|FG011|NOT COMPLETED|Phase II||1
11195025|NCT01791725|12384994|FG000|STARTED|Overall Study||12
11195026|NCT01791725|12384995|FG001|STARTED|Overall Study||5
11195027|NCT01791725|12384996|FG002|STARTED|Overall Study||6
11195028|NCT01791725|12384994|FG000|COMPLETED|Overall Study||12
11195029|NCT01791725|12384995|FG001|COMPLETED|Overall Study||4
11195030|NCT01791725|12384996|FG002|COMPLETED|Overall Study||6
11195031|NCT01791725|12384994|FG000|NOT COMPLETED|Overall Study||0
11195032|NCT01791725|12384995|FG001|NOT COMPLETED|Overall Study||1
11195033|NCT01791725|12384996|FG002|NOT COMPLETED|Overall Study||0
11195034|NCT01791803|12385008|FG000|STARTED|Overall Study||41
11195035|NCT01791803|12385009|FG001|STARTED|Overall Study||41
11195036|NCT01791803|12385010|FG002|STARTED|Overall Study||40
11195037|NCT01791803|12385011|FG003|STARTED|Overall Study||42
11195038|NCT01791803|12385008|FG000|COMPLETED|Overall Study||41
11195039|NCT01791803|12385009|FG001|COMPLETED|Overall Study||39
11195040|NCT01791803|12385010|FG002|COMPLETED|Overall Study||38
11195041|NCT01791803|12385011|FG003|COMPLETED|Overall Study||37
11195042|NCT01791803|12385008|FG000|NOT COMPLETED|Overall Study||0
11195043|NCT01791803|12385009|FG001|NOT COMPLETED|Overall Study||2
11195044|NCT01791803|12385010|FG002|NOT COMPLETED|Overall Study||2
11195045|NCT01791803|12385011|FG003|NOT COMPLETED|Overall Study||5
11195046|NCT01791894|12385024|FG000|STARTED|Overall Study||5
11195047|NCT01791894|12385024|FG000|COMPLETED|Overall Study||4
11195048|NCT01791894|12385024|FG000|NOT COMPLETED|Overall Study||1
11195049|NCT01791972|12385031|FG000|STARTED|Overall Study||19
11195050|NCT01791972|12385032|FG001|STARTED|Overall Study||19
11195051|NCT01791972|12385031|FG000|COMPLETED|Overall Study||19
11195052|NCT01791972|12385032|FG001|COMPLETED|Overall Study||19
11195053|NCT01791972|12385031|FG000|NOT COMPLETED|Overall Study||0
11195054|NCT01791972|12385032|FG001|NOT COMPLETED|Overall Study||0
11195055|NCT01792024|12385038|FG000|STARTED|Overall Study||27
11195056|NCT01792024|12385038|FG000|COMPLETED|Overall Study||27
11195057|NCT01792024|12385038|FG000|NOT COMPLETED|Overall Study||0
11195058|NCT01792115|12385045|FG000|STARTED|Overall Study||7
11195059|NCT01792115|12385046|FG001|STARTED|Overall Study||7
11195060|NCT01792115|12385047|FG002|STARTED|Overall Study||8
11195061|NCT01792115|12385045|FG000|COMPLETED|Overall Study||7
11195062|NCT01792115|12385046|FG001|COMPLETED|Overall Study||6
11195063|NCT01792115|12385047|FG002|COMPLETED|Overall Study||8
11195064|NCT01792115|12385045|FG000|NOT COMPLETED|Overall Study||0
11195065|NCT01792115|12385046|FG001|NOT COMPLETED|Overall Study||1
11195066|NCT01792115|12385047|FG002|NOT COMPLETED|Overall Study||0
11195067|NCT01792284|12385055|FG000|STARTED|Lead-in Period||212
11195068|NCT01792284|12385056|FG001|STARTED|Lead-in Period||0
11195069|NCT01792284|12385057|FG002|STARTED|Lead-in Period||0
11195070|NCT01792284|12385055|FG000|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
11195071|NCT01792284|12385056|FG001|COMPLETED|Lead-in Period||0
11195072|NCT01792284|12385057|FG002|COMPLETED|Lead-in Period||0
11195073|NCT01792284|12385055|FG000|NOT COMPLETED|Lead-in Period||30
11195074|NCT01792284|12385056|FG001|NOT COMPLETED|Lead-in Period||0
11195075|NCT01792284|12385057|FG002|NOT COMPLETED|Lead-in Period||0
11195076|NCT01792284|12385055|FG000|STARTED|Randomization Period 1||0
11195077|NCT01792284|12385056|FG001|STARTED|Randomization Period 1||92
11195078|NCT01792284|12385057|FG002|STARTED|Randomization Period 1||90
11195079|NCT01792284|12385055|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
11195080|NCT01792284|12385056|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
11195081|NCT01792284|12385057|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
11195082|NCT01792284|12385055|FG000|COMPLETED|Randomization Period 1||0
11195083|NCT01792284|12385056|FG001|COMPLETED|Randomization Period 1||90
11195084|NCT01792284|12385057|FG002|COMPLETED|Randomization Period 1||85
11195085|NCT01792284|12385055|FG000|NOT COMPLETED|Randomization Period 1||0
11195086|NCT01792284|12385056|FG001|NOT COMPLETED|Randomization Period 1||2
11195087|NCT01792284|12385057|FG002|NOT COMPLETED|Randomization Period 1||5
11195088|NCT01792284|12385055|FG000|STARTED|Randomization Period 2||0
11195089|NCT01792284|12385056|FG001|STARTED|Randomization Period 2||90
11195090|NCT01792284|12385057|FG002|STARTED|Randomization Period 2||85
11195091|NCT01792284|12385055|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
11195092|NCT01792284|12385056|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
11195093|NCT01792284|12385057|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
11195094|NCT01792284|12385055|FG000|COMPLETED|Randomization Period 2||0
11195095|NCT01792284|12385056|FG001|COMPLETED|Randomization Period 2||87
11195096|NCT01792284|12385057|FG002|COMPLETED|Randomization Period 2||85
11195097|NCT01792284|12385055|FG000|NOT COMPLETED|Randomization Period 2||0
11195098|NCT01792284|12385056|FG001|NOT COMPLETED|Randomization Period 2||3
11195099|NCT01792284|12385057|FG002|NOT COMPLETED|Randomization Period 2||0
11195100|NCT01792518|12385067|FG000|STARTED|Overall Study||178
11195101|NCT01792518|12385068|FG001|STARTED|Overall Study||182
11195102|NCT01792518|12385067|FG000|COMPLETED|Overall Study||170
11195103|NCT01792518|12385068|FG001|COMPLETED|Overall Study||175
11195104|NCT01792518|12385067|FG000|NOT COMPLETED|Overall Study||8
11195105|NCT01792518|12385068|FG001|NOT COMPLETED|Overall Study||7
11195106|NCT01792635|12385077|FG000|STARTED|Part A||6
11195107|NCT01792635|12385078|FG001|STARTED|Part A||0
11195108|NCT01792635|12385079|FG002|STARTED|Part A||0
11195109|NCT01792635|12385077|FG000|COMPLETED|Part A||6
11195110|NCT01792635|12385078|FG001|COMPLETED|Part A||0
11195111|NCT01792635|12385079|FG002|COMPLETED|Part A||0
11195112|NCT01792635|12385077|FG000|NOT COMPLETED|Part A||0
11195113|NCT01792635|12385078|FG001|NOT COMPLETED|Part A||0
11195114|NCT01792635|12385079|FG002|NOT COMPLETED|Part A||0
11195115|NCT01792635|12385077|FG000|STARTED|Part B||0
11195116|NCT01792635|12385078|FG001|STARTED|Part B||6
11195117|NCT01792635|12385079|FG002|STARTED|Part B||7
11195118|NCT01792635|12385077|FG000|COMPLETED|Part B||0
11195119|NCT01792635|12385078|FG001|COMPLETED|Part B||2
11195120|NCT01792635|12385079|FG002|COMPLETED|Part B||3
11195121|NCT01792635|12385077|FG000|NOT COMPLETED|Part B||0
11195122|NCT01792635|12385078|FG001|NOT COMPLETED|Part B||4
11195123|NCT01792635|12385079|FG002|NOT COMPLETED|Part B||4
11195124|NCT01792817|12385090|FG000|STARTED|Phase 1 Double Blind Period||77
11195125|NCT01792817|12385091|FG001|STARTED|Phase 1 Double Blind Period||73
11195126|NCT01792817|12385092|FG002|STARTED|Phase 1 Double Blind Period||0
11195127|NCT01792817|12385090|FG000|COMPLETED|Phase 1 Double Blind Period||58
11195128|NCT01792817|12385091|FG001|COMPLETED|Phase 1 Double Blind Period||42
11195129|NCT01792817|12385092|FG002|COMPLETED|Phase 1 Double Blind Period||0
11195130|NCT01792817|12385090|FG000|NOT COMPLETED|Phase 1 Double Blind Period||19
11195131|NCT01792817|12385091|FG001|NOT COMPLETED|Phase 1 Double Blind Period||31
11195132|NCT01792817|12385092|FG002|NOT COMPLETED|Phase 1 Double Blind Period||0
11195133|NCT01792817|12385090|FG000|STARTED|Phase 2 Open Label||0
11195134|NCT01792817|12385091|FG001|STARTED|Phase 2 Open Label||0
11195135|NCT01792817|12385092|FG002|STARTED|Phase 2 Open Label||100
11195136|NCT01792817|12385090|FG000|COMPLETED|Phase 2 Open Label||0
11195137|NCT01792817|12385091|FG001|COMPLETED|Phase 2 Open Label||0
11195138|NCT01792817|12385092|FG002|COMPLETED|Phase 2 Open Label||74
11195139|NCT01792817|12385090|FG000|NOT COMPLETED|Phase 2 Open Label||0
11195140|NCT01792817|12385091|FG001|NOT COMPLETED|Phase 2 Open Label||0
11195141|NCT01792817|12385092|FG002|NOT COMPLETED|Phase 2 Open Label||26
11195142|NCT01792830|12385110|FG000|STARTED|Overall Study||84
11195143|NCT01792830|12385111|FG001|STARTED|Overall Study||3
11195144|NCT01792830|12385112|FG002|STARTED|Overall Study||4
11195145|NCT01792830|12385113|FG003|STARTED|Overall Study||21
11195146|NCT01792830|12385114|FG004|STARTED|Overall Study||2
11195147|NCT01792830|12385115|FG005|STARTED|Overall Study||4
11195148|NCT01792830|12385116|FG006|STARTED|Overall Study||14
11195149|NCT01792830|12385117|FG007|STARTED|Overall Study||7
11195150|NCT01792830|12385118|FG008|STARTED|Overall Study||20
11195151|NCT01792830|12385119|FG009|STARTED|Overall Study||4
11195152|NCT01792830|12385120|FG010|STARTED|Overall Study||12
11195153|NCT01792830|12385110|FG000|COMPLETED|Overall Study||59
11195154|NCT01792830|12385111|FG001|COMPLETED|Overall Study||3
11195155|NCT01792830|12385112|FG002|COMPLETED|Overall Study||4
11195156|NCT01792830|12385113|FG003|COMPLETED|Overall Study||18
11195157|NCT01792830|12385114|FG004|COMPLETED|Overall Study||1
11195158|NCT01792830|12385115|FG005|COMPLETED|Overall Study||3
11195159|NCT01792830|12385116|FG006|COMPLETED|Overall Study||12
11195160|NCT01792830|12385117|FG007|COMPLETED|Overall Study||6
11195161|NCT01792830|12385118|FG008|COMPLETED|Overall Study||11
11195162|NCT01792830|12385119|FG009|COMPLETED|Overall Study||4
11195163|NCT01792830|12385120|FG010|COMPLETED|Overall Study||9
11195164|NCT01792830|12385110|FG000|NOT COMPLETED|Overall Study||25
11195165|NCT01792830|12385111|FG001|NOT COMPLETED|Overall Study||0
11195166|NCT01792830|12385112|FG002|NOT COMPLETED|Overall Study||0
11195167|NCT01792830|12385113|FG003|NOT COMPLETED|Overall Study||3
11195168|NCT01792830|12385114|FG004|NOT COMPLETED|Overall Study||1
11195169|NCT01792830|12385115|FG005|NOT COMPLETED|Overall Study||1
11195170|NCT01792830|12385116|FG006|NOT COMPLETED|Overall Study||2
11195171|NCT01792830|12385117|FG007|NOT COMPLETED|Overall Study||1
11195172|NCT01792830|12385118|FG008|NOT COMPLETED|Overall Study||9
11195173|NCT01792830|12385119|FG009|NOT COMPLETED|Overall Study||0
11195174|NCT01792830|12385120|FG010|NOT COMPLETED|Overall Study||3
11195175|NCT01792986|12385150|FG000|STARTED|Overall Study||12
11195176|NCT01792986|12385150|FG000|COMPLETED|Overall Study||12
11195177|NCT01792986|12385150|FG000|NOT COMPLETED|Overall Study||0
11195178|NCT01793051|12385156|FG000|STARTED|Overall Study||43
11195179|NCT01793051|12385157|FG001|STARTED|Overall Study||44
11195180|NCT01793051|12385156|FG000|COMPLETED|Overall Study||33
11195181|NCT01793051|12385157|FG001|COMPLETED|Overall Study||36
11195182|NCT01793051|12385156|FG000|NOT COMPLETED|Overall Study||10
11195183|NCT01793051|12385157|FG001|NOT COMPLETED|Overall Study||8
11195184|NCT01793142|12385163|FG000|STARTED|Overall Study||3430
11195185|NCT01793142|12385163|FG000|Treated|Overall Study||3423
11195186|NCT01793142|12385163|FG000|COMPLETED|Overall Study||3423
11195187|NCT01793142|12385163|FG000|NOT COMPLETED|Overall Study||7
11195188|NCT01793285|12385167|FG000|STARTED|Overall Study||85
11195189|NCT01793285|12385167|FG000|COMPLETED|Overall Study||85
11195190|NCT01793285|12385167|FG000|NOT COMPLETED|Overall Study||0
11195191|NCT01793688|12385171|FG000|STARTED|Overall Study||982
11195192|NCT01793688|12385171|FG000|COMPLETED|Overall Study||980
11195193|NCT01793688|12385171|FG000|NOT COMPLETED|Overall Study||2
11195194|NCT01793792|12385175|FG000|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153
11195195|NCT01793792|12385175|FG000|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153
11195196|NCT01793792|12385175|FG000|COMPLETED|Overall Study||141
11195197|NCT01793792|12385175|FG000|NOT COMPLETED|Overall Study||12
11195198|NCT01793883|12385182|FG000|STARTED|Overall Study||213
11195199|NCT01793883|12385183|FG001|STARTED|Overall Study||214
11195200|NCT01793883|12385184|FG002|STARTED|Overall Study||212
11195201|NCT01793883|12385182|FG000|COMPLETED|Overall Study||201
11195202|NCT01793883|12385183|FG001|COMPLETED|Overall Study||204
11195203|NCT01793883|12385184|FG002|COMPLETED|Overall Study||204
11195204|NCT01793883|12385182|FG000|NOT COMPLETED|Overall Study||12
11195205|NCT01793883|12385183|FG001|NOT COMPLETED|Overall Study||10
11195206|NCT01793883|12385184|FG002|NOT COMPLETED|Overall Study||8
11195207|NCT01793909|12385194|FG000|STARTED|Overall Study||30
11195208|NCT01793909|12385195|FG001|STARTED|Overall Study||25
11195209|NCT01793909|12385194|FG000|COMPLETED|Overall Study||20
11195210|NCT01793909|12385195|FG001|COMPLETED|Overall Study||20
11195211|NCT01793909|12385194|FG000|NOT COMPLETED|Overall Study||10
11195212|NCT01793909|12385195|FG001|NOT COMPLETED|Overall Study||5
11195213|NCT01793935|12385203|FG000|STARTED|Overall Study||34
11195214|NCT01793935|12385204|FG001|STARTED|Overall Study||34
11195215|NCT01793935|12385203|FG000|COMPLETED|Overall Study||28
11195216|NCT01793935|12385204|FG001|COMPLETED|Overall Study||31
11195217|NCT01793935|12385203|FG000|NOT COMPLETED|Overall Study||6
11195218|NCT01793935|12385204|FG001|NOT COMPLETED|Overall Study||3
11195219|NCT01794000|12385212|FG000|STARTED|Double-Blind Phase (DBP)||171
11195220|NCT01794000|12385213|FG001|STARTED|Double-Blind Phase (DBP)||170
11195221|NCT01794000|12385212|FG000|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
11195222|NCT01794000|12385213|FG001|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
11195223|NCT01794000|12385212|FG000|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
11195224|NCT01794000|12385213|FG001|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
11195225|NCT01794000|12385212|FG000|COMPLETED|Double-Blind Phase (DBP)||2
11195226|NCT01794000|12385213|FG001|COMPLETED|Double-Blind Phase (DBP)||4
11195227|NCT01794000|12385212|FG000|NOT COMPLETED|Double-Blind Phase (DBP)||169
11195228|NCT01794000|12385213|FG001|NOT COMPLETED|Double-Blind Phase (DBP)||166
11195229|NCT01794000|12385212|FG000|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
11195230|NCT01794000|12385213|FG001|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
11195231|NCT01794000|12385212|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0
11195232|NCT01794000|12385213|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0
11195233|NCT01794000|12385212|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
11195234|NCT01794000|12385213|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
11195235|NCT01794039|12385222|FG000|STARTED|Overall Study||5
11195236|NCT01794039|12385223|FG001|STARTED|Overall Study||4
11195237|NCT01794039|12385222|FG000|COMPLETED|Overall Study||5
11195238|NCT01794039|12385223|FG001|COMPLETED|Overall Study||4
11195239|NCT01794039|12385222|FG000|NOT COMPLETED|Overall Study||0
11195240|NCT01794039|12385223|FG001|NOT COMPLETED|Overall Study||0
11195241|NCT01794117|12385235|FG000|STARTED|Overall Study||1
11195242|NCT01794117|12385236|FG001|STARTED|Overall Study||3
11195243|NCT01794117|12385237|FG002|STARTED|Overall Study||2
11195244|NCT01794117|12385238|FG003|STARTED|Overall Study||12
11195245|NCT01794117|12385235|FG000|COMPLETED|Overall Study||0
11195246|NCT01794117|12385236|FG001|COMPLETED|Overall Study||0
11195247|NCT01794117|12385237|FG002|COMPLETED|Overall Study||2
11195248|NCT01794117|12385238|FG003|COMPLETED|Overall Study||12
11195249|NCT01794117|12385235|FG000|NOT COMPLETED|Overall Study||1
11195250|NCT01794117|12385236|FG001|NOT COMPLETED|Overall Study||3
11195251|NCT01794117|12385237|FG002|NOT COMPLETED|Overall Study||0
11195252|NCT01794117|12385238|FG003|NOT COMPLETED|Overall Study||0
11195253|NCT01794299|12385249|FG000|STARTED|Overall Study||31
11195254|NCT01794299|12385249|FG000|COMPLETED|Overall Study||9
11195255|NCT01794299|12385249|FG000|NOT COMPLETED|Overall Study||22
11195256|NCT01794312|12385255|FG000|STARTED|Overall Study||74
11195257|NCT01794312|12385256|FG001|STARTED|Overall Study||78
11195258|NCT01794312|12385255|FG000|COMPLETED|Overall Study||68
11195259|NCT01794312|12385256|FG001|COMPLETED|Overall Study||67
11195260|NCT01794312|12385255|FG000|NOT COMPLETED|Overall Study||6
11195261|NCT01794312|12385256|FG001|NOT COMPLETED|Overall Study||11
11195262|NCT01794455|12385264|FG000|STARTED|Overall Study||0
11195263|NCT01794455|12385265|FG001|STARTED|Overall Study||1
11195264|NCT01794455|12385264|FG000|COMPLETED|Overall Study||0
11195265|NCT01794455|12385265|FG001|COMPLETED|Overall Study||1
11195266|NCT01794455|12385264|FG000|NOT COMPLETED|Overall Study||0
11195267|NCT01794455|12385265|FG001|NOT COMPLETED|Overall Study||0
11195268|NCT01794689|12385275|FG000|STARTED|Intervention 1 (2 Nights)||25
11195269|NCT01794689|12385276|FG001|STARTED|Intervention 1 (2 Nights)||29
11195270|NCT01794689|12385277|FG002|STARTED|Intervention 1 (2 Nights)||24
11195271|NCT01794689|12385278|FG003|STARTED|Intervention 1 (2 Nights)||22
11195272|NCT01794689|12385275|FG000|COMPLETED|Intervention 1 (2 Nights)||20
11195273|NCT01794689|12385276|FG001|COMPLETED|Intervention 1 (2 Nights)||27
11195274|NCT01794689|12385277|FG002|COMPLETED|Intervention 1 (2 Nights)||21
11195275|NCT01794689|12385278|FG003|COMPLETED|Intervention 1 (2 Nights)||18
11195276|NCT01794689|12385275|FG000|NOT COMPLETED|Intervention 1 (2 Nights)||5
11195277|NCT01794689|12385276|FG001|NOT COMPLETED|Intervention 1 (2 Nights)||2
11195278|NCT01794689|12385277|FG002|NOT COMPLETED|Intervention 1 (2 Nights)||3
11195279|NCT01794689|12385278|FG003|NOT COMPLETED|Intervention 1 (2 Nights)||4
11195280|NCT01794689|12385275|FG000|STARTED|Washout (2 Weeks)||20
11195281|NCT01794689|12385276|FG001|STARTED|Washout (2 Weeks)||27
11195282|NCT01794689|12385277|FG002|STARTED|Washout (2 Weeks)||21
11195283|NCT01794689|12385278|FG003|STARTED|Washout (2 Weeks)||18
11195284|NCT01794689|12385275|FG000|COMPLETED|Washout (2 Weeks)||20
11195285|NCT01794689|12385276|FG001|COMPLETED|Washout (2 Weeks)||27
11195286|NCT01794689|12385277|FG002|COMPLETED|Washout (2 Weeks)||21
11195287|NCT01794689|12385278|FG003|COMPLETED|Washout (2 Weeks)||18
11195288|NCT01794689|12385275|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11195289|NCT01794689|12385276|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11195290|NCT01794689|12385277|FG002|NOT COMPLETED|Washout (2 Weeks)||0
11195291|NCT01794689|12385278|FG003|NOT COMPLETED|Washout (2 Weeks)||0
11195292|NCT01794689|12385275|FG000|STARTED|Intervention 2 (2 Nights)||20
11195293|NCT01794689|12385276|FG001|STARTED|Intervention 2 (2 Nights)||27
11195294|NCT01794689|12385277|FG002|STARTED|Intervention 2 (2 Nights)||21
11195295|NCT01794689|12385278|FG003|STARTED|Intervention 2 (2 Nights)||18
11195296|NCT01794689|12385275|FG000|COMPLETED|Intervention 2 (2 Nights)||20
11195297|NCT01794689|12385276|FG001|COMPLETED|Intervention 2 (2 Nights)||27
11195298|NCT01794689|12385277|FG002|COMPLETED|Intervention 2 (2 Nights)||21
11195299|NCT01794689|12385278|FG003|COMPLETED|Intervention 2 (2 Nights)||18
11195300|NCT01794689|12385275|FG000|NOT COMPLETED|Intervention 2 (2 Nights)||0
11195301|NCT01794689|12385276|FG001|NOT COMPLETED|Intervention 2 (2 Nights)||0
11195302|NCT01794689|12385277|FG002|NOT COMPLETED|Intervention 2 (2 Nights)||0
11195303|NCT01794689|12385278|FG003|NOT COMPLETED|Intervention 2 (2 Nights)||0
11195304|NCT01794702|12385297|FG000|STARTED|Overall Study||18
11195305|NCT01794702|12385298|FG001|STARTED|Overall Study||0
11195306|NCT01794702|12385299|FG002|STARTED|Overall Study||47
11195307|NCT01794702|12385297|FG000|COMPLETED|Overall Study||18
11195308|NCT01794702|12385298|FG001|COMPLETED|Overall Study||0
11195309|NCT01794702|12385299|FG002|COMPLETED|Overall Study||47
11324560|NCT02745145|12521874|FG001|NOT COMPLETED|Overall Study||5
11324561|NCT02745145|12521875|FG002|NOT COMPLETED|Overall Study||9
11324562|NCT02745353|12521885|FG000|STARTED|First Intervention (2 Weeks)||4
11324563|NCT02745353|12521886|FG001|STARTED|First Intervention (2 Weeks)||3
11324564|NCT02745353|12521885|FG000|COMPLETED|First Intervention (2 Weeks)||1
11324565|NCT02745353|12521886|FG001|COMPLETED|First Intervention (2 Weeks)||1
11324566|NCT02745353|12521885|FG000|NOT COMPLETED|First Intervention (2 Weeks)||3
11324567|NCT02745353|12521886|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2
11324568|NCT02745353|12521885|FG000|STARTED|Washout (3 Days)||1
11324569|NCT02745353|12521886|FG001|STARTED|Washout (3 Days)||1
11324570|NCT02745353|12521885|FG000|COMPLETED|Washout (3 Days)||1
11324571|NCT02745353|12521886|FG001|COMPLETED|Washout (3 Days)||1
11324572|NCT02745353|12521885|FG000|NOT COMPLETED|Washout (3 Days)||0
11324573|NCT02745353|12521886|FG001|NOT COMPLETED|Washout (3 Days)||0
11324574|NCT02745353|12521885|FG000|STARTED|Second Intervention (2 Weeks)||1
11324575|NCT02745353|12521886|FG001|STARTED|Second Intervention (2 Weeks)||1
11324576|NCT02745353|12521885|FG000|COMPLETED|Second Intervention (2 Weeks)||1
11324577|NCT02745353|12521886|FG001|COMPLETED|Second Intervention (2 Weeks)||0
11324578|NCT02745353|12521885|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
11324579|NCT02745353|12521886|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||1
11324580|NCT02745392|12521896|FG000|STARTED|Overall Study||91
11324581|NCT02745392|12521897|FG001|STARTED|Overall Study||90
11324582|NCT02745392|12521898|FG002|STARTED|Overall Study||92
11324583|NCT02745392|12521899|FG003|STARTED|Overall Study||92
11324584|NCT02745392|12521896|FG000|COMPLETED|Overall Study||91
11324585|NCT02745392|12521897|FG001|COMPLETED|Overall Study||89
11324586|NCT02745392|12521898|FG002|COMPLETED|Overall Study||92
11324587|NCT02745392|12521899|FG003|COMPLETED|Overall Study||92
11324588|NCT02745392|12521896|FG000|NOT COMPLETED|Overall Study||0
11324589|NCT02745392|12521897|FG001|NOT COMPLETED|Overall Study||1
11324590|NCT02745392|12521898|FG002|NOT COMPLETED|Overall Study||0
11324591|NCT02745392|12521899|FG003|NOT COMPLETED|Overall Study||0
11324592|NCT02745626|12521912|FG000|STARTED|Overall Study||24
11324593|NCT02745626|12521913|FG001|STARTED|Overall Study||22
11324594|NCT02745626|12521914|FG002|STARTED|Overall Study||22
11324595|NCT02745626|12521912|FG000|COMPLETED|Overall Study||21
11324596|NCT02745626|12521913|FG001|COMPLETED|Overall Study||16
11324597|NCT02745626|12521914|FG002|COMPLETED|Overall Study||19
11324598|NCT02745626|12521912|FG000|NOT COMPLETED|Overall Study||3
11324599|NCT02745626|12521913|FG001|NOT COMPLETED|Overall Study||6
11324600|NCT02745626|12521914|FG002|NOT COMPLETED|Overall Study||3
11324601|NCT02746107|12521922|FG000|STARTED|Overall Study||968
11324602|NCT02746107|12521922|FG000|2 Diagrams DA|Overall Study||482
11324603|NCT02746107|12521922|FG000|1 Diagram DA|Overall Study||486
11324604|NCT02746107|12521922|FG000|1year Risk Estimate|Overall Study||483
11324605|NCT02746107|12521922|FG000|5year Risk Estimate|Overall Study||485
11324606|NCT02746107|12521922|FG000|Target=Patient|Overall Study||486
11324607|NCT02746107|12521922|FG000|Target=Physician|Overall Study||482
11324608|NCT02746107|12521922|FG000|CHA2DS2-VASC Score = 1|Overall Study||195
11324609|NCT02746107|12521922|FG000|CHA2DS2-VASC Score = 2|Overall Study||189
11324610|NCT02746107|12521922|FG000|CHA2DS2-VASC Score = 3|Overall Study||195
11324611|NCT02746107|12521922|FG000|CHA2DS2-VASC Score = 4|Overall Study||197
11324612|NCT02746107|12521922|FG000|CHA2DS2-VASC Score = 5|Overall Study||192
11324613|NCT02746107|12521922|FG000|COMPLETED|Overall Study||968
11324614|NCT02746107|12521922|FG000|NOT COMPLETED|Overall Study||0
11324615|NCT02746406|12521937|FG000|STARTED|Overall Study||5
11324616|NCT02746406|12521937|FG000|COMPLETED|Overall Study||5
11324617|NCT02746406|12521937|FG000|NOT COMPLETED|Overall Study||0
11324618|NCT02746575|12521941|FG000|STARTED|Overall Study||70
11324619|NCT02746575|12521941|FG000|COMPLETED|Overall Study||20
11324620|NCT02746575|12521941|FG000|NOT COMPLETED|Overall Study||50
11195310|NCT01794702|12385297|FG000|NOT COMPLETED|Overall Study||0
11195311|NCT01794702|12385298|FG001|NOT COMPLETED|Overall Study||0
11195312|NCT01794702|12385299|FG002|NOT COMPLETED|Overall Study||0
11195313|NCT01794741|12385309|FG000|STARTED|Overall Study||304
11195314|NCT01794741|12385310|FG001|STARTED|Overall Study||101
11195315|NCT01794741|12385309|FG000|COMPLETED|Overall Study||285
11195316|NCT01794741|12385310|FG001|COMPLETED|Overall Study||92
11195317|NCT01794741|12385309|FG000|NOT COMPLETED|Overall Study||19
11195318|NCT01794741|12385310|FG001|NOT COMPLETED|Overall Study||9
11195319|NCT01794780|12385324|FG000|STARTED|Overall Study||32
11195320|NCT01794780|12385325|FG001|STARTED|Overall Study||276
11195321|NCT01794780|12385326|FG002|STARTED|Overall Study||813
11195322|NCT01794780|12385327|FG003|STARTED|Overall Study||283
11195323|NCT01794780|12385328|FG004|STARTED|Overall Study||9
11195324|NCT01794780|12385329|FG005|STARTED|Overall Study||632
11195325|NCT01794780|12385330|FG006|STARTED|Overall Study||154
11195326|NCT01794780|12385331|FG007|STARTED|Overall Study||30
11195327|NCT01794780|12385324|FG000|COMPLETED|Overall Study||15
11195328|NCT01794780|12385325|FG001|COMPLETED|Overall Study||180
11195329|NCT01794780|12385326|FG002|COMPLETED|Overall Study||571
11195330|NCT01794780|12385327|FG003|COMPLETED|Overall Study||200
11195331|NCT01794780|12385328|FG004|COMPLETED|Overall Study||6
11195332|NCT01794780|12385329|FG005|COMPLETED|Overall Study||452
11195333|NCT01794780|12385330|FG006|COMPLETED|Overall Study||112
11195334|NCT01794780|12385331|FG007|COMPLETED|Overall Study||21
11195335|NCT01794780|12385324|FG000|NOT COMPLETED|Overall Study||17
11195336|NCT01794780|12385325|FG001|NOT COMPLETED|Overall Study||96
11195337|NCT01794780|12385326|FG002|NOT COMPLETED|Overall Study||242
11195338|NCT01794780|12385327|FG003|NOT COMPLETED|Overall Study||83
11195339|NCT01794780|12385328|FG004|NOT COMPLETED|Overall Study||3
11195340|NCT01794780|12385329|FG005|NOT COMPLETED|Overall Study||180
11195341|NCT01794780|12385330|FG006|NOT COMPLETED|Overall Study||42
11195342|NCT01794780|12385331|FG007|NOT COMPLETED|Overall Study||9
11195343|NCT01794806|12385358|FG000|STARTED|Overall Study||31
11195344|NCT01794806|12385359|FG001|STARTED|Overall Study||28
11195345|NCT01794806|12385358|FG000|1 Week|Overall Study||28
11195346|NCT01794806|12385359|FG001|1 Week|Overall Study||28
11195347|NCT01794806|12385358|FG000|4 Weeks|Overall Study||26
11195348|NCT01794806|12385359|FG001|4 Weeks|Overall Study||27
11195349|NCT01794806|12385358|FG000|COMPLETED|Overall Study||26
11195350|NCT01794806|12385359|FG001|COMPLETED|Overall Study||27
11195351|NCT01794806|12385358|FG000|NOT COMPLETED|Overall Study||5
11195352|NCT01794806|12385359|FG001|NOT COMPLETED|Overall Study||1
11195353|NCT01794845|12385365|FG000|STARTED|Overall Study||5
11195354|NCT01794845|12385365|FG000|COMPLETED|Overall Study||4
11195355|NCT01794845|12385365|FG000|NOT COMPLETED|Overall Study||1
11195356|NCT01794923|12385372|FG000|STARTED|Overall Study||83
11195357|NCT01794923|12385373|FG001|STARTED|Overall Study||60
11195358|NCT01794923|12385374|FG002|STARTED|Overall Study||62
11195359|NCT01794923|12385372|FG000|COMPLETED|Overall Study||83
11195360|NCT01794923|12385373|FG001|COMPLETED|Overall Study||60
11195361|NCT01794923|12385374|FG002|COMPLETED|Overall Study||61
11195362|NCT01794923|12385372|FG000|NOT COMPLETED|Overall Study||0
11195363|NCT01794923|12385373|FG001|NOT COMPLETED|Overall Study||0
11195364|NCT01794923|12385374|FG002|NOT COMPLETED|Overall Study||1
11195365|NCT01794949|12385384|FG000|STARTED|Overall Study||7
11195366|NCT01794949|12385385|FG001|STARTED|Overall Study||1
11195367|NCT01794949|12385384|FG000|6 Month Follow-up|Overall Study||6
11195368|NCT01794949|12385385|FG001|6 Month Follow-up|Overall Study||1
11195369|NCT01794949|12385384|FG000|COMPLETED|Overall Study||6
11195370|NCT01794949|12385385|FG001|COMPLETED|Overall Study||1
11195371|NCT01794949|12385384|FG000|NOT COMPLETED|Overall Study||1
11195372|NCT01794949|12385385|FG001|NOT COMPLETED|Overall Study||0
11195373|NCT01795079|12385393|FG000|STARTED|Overall Study||16
11195374|NCT01795079|12385394|FG001|STARTED|Overall Study||15
11195375|NCT01795079|12385393|FG000|COMPLETED|Overall Study||13
11195376|NCT01795079|12385394|FG001|COMPLETED|Overall Study||12
11195377|NCT01795079|12385393|FG000|NOT COMPLETED|Overall Study||3
11195378|NCT01795079|12385394|FG001|NOT COMPLETED|Overall Study||3
11195379|NCT01795105|12385400|FG000|STARTED|Overall Study||692
11195380|NCT01795105|12385400|FG000|COMPLETED|Overall Study||648
11195381|NCT01795105|12385400|FG000|NOT COMPLETED|Overall Study||44
11195382|NCT01795495|12385408|FG000|STARTED|Overall Study||20
11195383|NCT01795495|12385409|FG001|STARTED|Overall Study||22
11195384|NCT01795495|12385410|FG002|STARTED|Overall Study||21
11195385|NCT01795495|12385408|FG000|COMPLETED|Overall Study||19
11195386|NCT01795495|12385409|FG001|COMPLETED|Overall Study||22
11195387|NCT01795495|12385410|FG002|COMPLETED|Overall Study||19
11195388|NCT01795495|12385408|FG000|NOT COMPLETED|Overall Study||1
11195389|NCT01795495|12385409|FG001|NOT COMPLETED|Overall Study||0
11195390|NCT01795495|12385410|FG002|NOT COMPLETED|Overall Study||2
11195391|NCT01795534|12385418|FG000|STARTED|First Intervention (First Shot)||5
11195392|NCT01795534|12385419|FG001|STARTED|First Intervention (First Shot)||5
11195393|NCT01795534|12385418|FG000|COMPLETED|First Intervention (First Shot)||5
11195394|NCT01795534|12385419|FG001|COMPLETED|First Intervention (First Shot)||5
11195395|NCT01795534|12385418|FG000|NOT COMPLETED|First Intervention (First Shot)||0
11195396|NCT01795534|12385419|FG001|NOT COMPLETED|First Intervention (First Shot)||0
11195397|NCT01795534|12385418|FG000|STARTED|Wash Out Period (4 Days)||5
11195398|NCT01795534|12385419|FG001|STARTED|Wash Out Period (4 Days)||5
11195399|NCT01795534|12385418|FG000|COMPLETED|Wash Out Period (4 Days)||5
11195400|NCT01795534|12385419|FG001|COMPLETED|Wash Out Period (4 Days)||5
11195401|NCT01795534|12385418|FG000|NOT COMPLETED|Wash Out Period (4 Days)||0
11195402|NCT01795534|12385419|FG001|NOT COMPLETED|Wash Out Period (4 Days)||0
11195403|NCT01795534|12385418|FG000|STARTED|Second Intervention (Second Shot)||5
11195404|NCT01795534|12385419|FG001|STARTED|Second Intervention (Second Shot)||5
11195405|NCT01795534|12385418|FG000|COMPLETED|Second Intervention (Second Shot)||5
11195406|NCT01795534|12385419|FG001|COMPLETED|Second Intervention (Second Shot)||5
11195407|NCT01795534|12385418|FG000|NOT COMPLETED|Second Intervention (Second Shot)||0
11195408|NCT01795534|12385419|FG001|NOT COMPLETED|Second Intervention (Second Shot)||0
11195409|NCT01795547|12385427|FG000|STARTED|Overall Study||148
11195410|NCT01795547|12385428|FG001|STARTED|Overall Study||147
11195411|NCT01795547|12385427|FG000|COMPLETED|Overall Study||100
11195412|NCT01795547|12385428|FG001|COMPLETED|Overall Study||83
11195413|NCT01795547|12385427|FG000|NOT COMPLETED|Overall Study||48
11195414|NCT01795547|12385428|FG001|NOT COMPLETED|Overall Study||64
11195415|NCT01795638|12385438|FG000|STARTED|Overall Study||27
11195416|NCT01795638|12385439|FG001|STARTED|Overall Study||26
11195417|NCT01795638|12385438|FG000|COMPLETED|Overall Study||14
11195418|NCT01795638|12385439|FG001|COMPLETED|Overall Study||15
11195419|NCT01795638|12385438|FG000|NOT COMPLETED|Overall Study||13
11195420|NCT01795638|12385439|FG001|NOT COMPLETED|Overall Study||11
11195421|NCT01795716|12385447|FG000|STARTED|First Intervention (13 Days)||10
11195422|NCT01795716|12385448|FG001|STARTED|First Intervention (13 Days)||11
11195423|NCT01795716|12385447|FG000|COMPLETED|First Intervention (13 Days)||10
11195424|NCT01795716|12385448|FG001|COMPLETED|First Intervention (13 Days)||11
11195425|NCT01795716|12385447|FG000|NOT COMPLETED|First Intervention (13 Days)||0
11195426|NCT01795716|12385448|FG001|NOT COMPLETED|First Intervention (13 Days)||0
11195427|NCT01795716|12385447|FG000|STARTED|Washout (10 Days)||10
11195428|NCT01795716|12385448|FG001|STARTED|Washout (10 Days)||11
11195429|NCT01795716|12385447|FG000|COMPLETED|Washout (10 Days)||10
11195430|NCT01795716|12385448|FG001|COMPLETED|Washout (10 Days)||11
11195431|NCT01795716|12385447|FG000|NOT COMPLETED|Washout (10 Days)||0
11195432|NCT01795716|12385448|FG001|NOT COMPLETED|Washout (10 Days)||0
11195433|NCT01795716|12385447|FG000|STARTED|Second Intervention (13 Days)||10
11195434|NCT01795716|12385448|FG001|STARTED|Second Intervention (13 Days)||11
11195435|NCT01795716|12385447|FG000|COMPLETED|Second Intervention (13 Days)||10
11195436|NCT01795716|12385448|FG001|COMPLETED|Second Intervention (13 Days)||11
11195437|NCT01795716|12385447|FG000|NOT COMPLETED|Second Intervention (13 Days)||0
11195438|NCT01795716|12385448|FG001|NOT COMPLETED|Second Intervention (13 Days)||0
11195439|NCT01795833|12385458|FG000|STARTED|Overall Study||1031
11195440|NCT01795833|12385459|FG001|STARTED|Overall Study||1031
11195441|NCT01795833|12385458|FG000|COMPLETED|Overall Study||881
11195442|NCT01795833|12385459|FG001|COMPLETED|Overall Study||882
11195443|NCT01795833|12385458|FG000|NOT COMPLETED|Overall Study||150
11195444|NCT01795833|12385459|FG001|NOT COMPLETED|Overall Study||149
11195445|NCT01795859|12385467|FG000|STARTED|Overall Study||45
11195446|NCT01795859|12385468|FG001|STARTED|Overall Study||45
11195447|NCT01795859|12385467|FG000|COMPLETED|Overall Study||44
11195448|NCT01795859|12385468|FG001|COMPLETED|Overall Study||43
11195449|NCT01795859|12385467|FG000|NOT COMPLETED|Overall Study||1
11195450|NCT01795859|12385468|FG001|NOT COMPLETED|Overall Study||2
11195451|NCT01795898|12385474|FG000|STARTED|Overall Study||237
11195452|NCT01795898|12385474|FG000|COMPLETED|Overall Study||177
11195453|NCT01795898|12385474|FG000|NOT COMPLETED|Overall Study||60
11195454|NCT01795937|12385481|FG000|STARTED|Overall Study||18
11195455|NCT01795937|12385482|FG001|STARTED|Overall Study||16
11195456|NCT01795937|12385483|FG002|STARTED|Overall Study||17
11195457|NCT01795937|12385481|FG000|COMPLETED|Overall Study||17
11195458|NCT01795937|12385482|FG001|COMPLETED|Overall Study||15
11195459|NCT01795937|12385483|FG002|COMPLETED|Overall Study||17
11195460|NCT01795937|12385481|FG000|NOT COMPLETED|Overall Study||1
11195461|NCT01795937|12385482|FG001|NOT COMPLETED|Overall Study||1
11195462|NCT01795937|12385483|FG002|NOT COMPLETED|Overall Study||0
11195463|NCT01796236|12385501|FG000|STARTED|Overall Study||51
11195464|NCT01796236|12385502|FG001|STARTED|Overall Study||52
11195465|NCT01796236|12385501|FG000|COMPLETED|Overall Study||49
11195466|NCT01796236|12385502|FG001|COMPLETED|Overall Study||50
11195467|NCT01796236|12385501|FG000|NOT COMPLETED|Overall Study||2
11195468|NCT01796236|12385502|FG001|NOT COMPLETED|Overall Study||2
11195469|NCT01796301|12385511|FG000|STARTED|Overall Study||218
11195470|NCT01796301|12385512|FG001|STARTED|Overall Study||218
11195471|NCT01796301|12385511|FG000|Received Treatment|Overall Study||214
11195472|NCT01796301|12385512|FG001|Received Treatment|Overall Study||218
11195473|NCT01796301|12385511|FG000|COMPLETED|Overall Study||200
11195474|NCT01796301|12385512|FG001|COMPLETED|Overall Study||198
11195475|NCT01796301|12385511|FG000|NOT COMPLETED|Overall Study||18
11195476|NCT01796301|12385512|FG001|NOT COMPLETED|Overall Study||20
11195477|NCT01796392|12385520|FG000|STARTED|Overall Study||128
11195478|NCT01796392|12385521|FG001|STARTED|Overall Study||62
11195479|NCT01796392|12385520|FG000|COMPLETED|Overall Study|119 active subjects at 12-months|119
11195480|NCT01796392|12385521|FG001|COMPLETED|Overall Study|59 active subjects at 12-months|59
11195481|NCT01796392|12385520|FG000|NOT COMPLETED|Overall Study||9
11195482|NCT01796392|12385521|FG001|NOT COMPLETED|Overall Study||3
11195483|NCT01796470|12385532|FG000|STARTED|Overall Study||35
11195484|NCT01796470|12385533|FG001|STARTED|Overall Study||14
11195485|NCT01796470|12385534|FG002|STARTED|Overall Study||6
11195486|NCT01796470|12385535|FG003|STARTED|Overall Study||3
11195487|NCT01796470|12385536|FG004|STARTED|Overall Study||8
11195488|NCT01796470|12385532|FG000|Entospletinib Monotherapy|Overall Study||4
11195489|NCT01796470|12385533|FG001|Entospletinib Monotherapy|Overall Study||4
11195490|NCT01796470|12385534|FG002|Entospletinib Monotherapy|Overall Study||0
11195491|NCT01796470|12385535|FG003|Entospletinib Monotherapy|Overall Study||0
11195492|NCT01796470|12385536|FG004|Entospletinib Monotherapy|Overall Study||0
11195493|NCT01796470|12385532|FG000|COMPLETED|Overall Study||0
11195494|NCT01796470|12385533|FG001|COMPLETED|Overall Study||0
11195495|NCT01796470|12385534|FG002|COMPLETED|Overall Study||0
11195496|NCT01796470|12385535|FG003|COMPLETED|Overall Study||0
11195497|NCT01796470|12385536|FG004|COMPLETED|Overall Study||0
11195498|NCT01796470|12385532|FG000|NOT COMPLETED|Overall Study||35
11195499|NCT01796470|12385533|FG001|NOT COMPLETED|Overall Study||14
11195500|NCT01796470|12385534|FG002|NOT COMPLETED|Overall Study||6
11195501|NCT01796470|12385535|FG003|NOT COMPLETED|Overall Study||3
11195502|NCT01796470|12385536|FG004|NOT COMPLETED|Overall Study||8
11195503|NCT01796548|12385552|FG000|STARTED|Overall Study||17
11195504|NCT01796548|12385552|FG000|Treated|Overall Study||15
11195505|NCT01796548|12385552|FG000|COMPLETED|Overall Study||14
11195506|NCT01796548|12385552|FG000|NOT COMPLETED|Overall Study||3
11195507|NCT01796665|12385559|FG000|STARTED|Overall Study||474
11195508|NCT01796665|12385560|FG001|STARTED|Overall Study||469
11195509|NCT01796665|12385561|FG002|STARTED|Overall Study||237
11195510|NCT01796665|12385559|FG000|COMPLETED|Overall Study||416
11195511|NCT01796665|12385560|FG001|COMPLETED|Overall Study||396
11195512|NCT01796665|12385561|FG002|COMPLETED|Overall Study||195
11195513|NCT01796665|12385559|FG000|NOT COMPLETED|Overall Study||58
11195514|NCT01796665|12385560|FG001|NOT COMPLETED|Overall Study||73
11195515|NCT01796665|12385561|FG002|NOT COMPLETED|Overall Study||42
11195516|NCT01796860|12385569|FG000|STARTED|Overall Study||10
11195517|NCT01796860|12385569|FG000|COMPLETED|Overall Study||7
11195518|NCT01796860|12385569|FG000|NOT COMPLETED|Overall Study||3
11195519|NCT01796912|12385573|FG000|STARTED|First Intervention||10
11195520|NCT01796912|12385574|FG001|STARTED|First Intervention||10
11195521|NCT01796912|12385573|FG000|COMPLETED|First Intervention||10
11195522|NCT01796912|12385574|FG001|COMPLETED|First Intervention||10
11195523|NCT01796912|12385573|FG000|NOT COMPLETED|First Intervention||0
11195524|NCT01796912|12385574|FG001|NOT COMPLETED|First Intervention||0
11195525|NCT01796912|12385573|FG000|STARTED|Washout||10
11195526|NCT01796912|12385574|FG001|STARTED|Washout||10
11195527|NCT01796912|12385573|FG000|COMPLETED|Washout||10
11195528|NCT01796912|12385574|FG001|COMPLETED|Washout||10
11195529|NCT01796912|12385573|FG000|NOT COMPLETED|Washout||0
11195530|NCT01796912|12385574|FG001|NOT COMPLETED|Washout||0
11195531|NCT01796912|12385573|FG000|STARTED|Second Intervention||10
11195532|NCT01796912|12385574|FG001|STARTED|Second Intervention||10
11195533|NCT01796912|12385573|FG000|COMPLETED|Second Intervention||10
11195534|NCT01796912|12385574|FG001|COMPLETED|Second Intervention||10
11195535|NCT01796912|12385573|FG000|NOT COMPLETED|Second Intervention||0
11195536|NCT01796912|12385574|FG001|NOT COMPLETED|Second Intervention||0
11195537|NCT01796964|12385584|FG000|STARTED|Overall Study||44
11195538|NCT01796964|12385585|FG001|STARTED|Overall Study||45
11195539|NCT01796964|12385584|FG000|COMPLETED|Overall Study||41
11195540|NCT01796964|12385585|FG001|COMPLETED|Overall Study||42
11195541|NCT01796964|12385584|FG000|NOT COMPLETED|Overall Study||3
11195542|NCT01796964|12385585|FG001|NOT COMPLETED|Overall Study||3
11195543|NCT01796977|12385592|FG000|STARTED|Overall Study||27
11195544|NCT01796977|12385592|FG000|COMPLETED|Overall Study||27
11195545|NCT01796977|12385592|FG000|NOT COMPLETED|Overall Study||0
11195546|NCT01797029|12385603|FG000|STARTED|Overall Study||1174
11195547|NCT01797029|12385604|FG001|STARTED|Overall Study||587
11195548|NCT01797029|12385603|FG000|COMPLETED|Overall Study||1015
11195549|NCT01797029|12385604|FG001|COMPLETED|Overall Study||526
11195550|NCT01797029|12385603|FG000|NOT COMPLETED|Overall Study||159
11195551|NCT01797029|12385604|FG001|NOT COMPLETED|Overall Study||61
11195552|NCT01797081|12385614|FG000|STARTED|Overall Study||104
11195553|NCT01797081|12385615|FG001|STARTED|Overall Study||99
11195554|NCT01797081|12385616|FG002|STARTED|Overall Study||48
11195555|NCT01797081|12385617|FG003|STARTED|Overall Study||49
11195556|NCT01797081|12385614|FG000|COMPLETED|Overall Study||90
11195557|NCT01797081|12385615|FG001|COMPLETED|Overall Study||95
11195558|NCT01797081|12385616|FG002|COMPLETED|Overall Study||43
11195559|NCT01797081|12385617|FG003|COMPLETED|Overall Study||40
11195560|NCT01797081|12385614|FG000|NOT COMPLETED|Overall Study||14
11195561|NCT01797081|12385615|FG001|NOT COMPLETED|Overall Study||4
11195562|NCT01797081|12385616|FG002|NOT COMPLETED|Overall Study||5
11195563|NCT01797081|12385617|FG003|NOT COMPLETED|Overall Study||9
11195564|NCT01797094|12385627|FG000|STARTED|Overall Study||48
11195565|NCT01797094|12385628|FG001|STARTED|Overall Study||53
11195566|NCT01797094|12385627|FG000|COMPLETED|Overall Study||42
11195567|NCT01797094|12385628|FG001|COMPLETED|Overall Study||51
11195568|NCT01797094|12385627|FG000|NOT COMPLETED|Overall Study||6
11195569|NCT01797094|12385628|FG001|NOT COMPLETED|Overall Study||2
11195570|NCT01797120|12385636|FG000|STARTED|Overall Study||66
11195571|NCT01797120|12385637|FG001|STARTED|Overall Study||65
11195572|NCT01797120|12385636|FG000|COMPLETED|Overall Study||0
11195573|NCT01797120|12385637|FG001|COMPLETED|Overall Study||0
11195574|NCT01797120|12385636|FG000|NOT COMPLETED|Overall Study||66
11195575|NCT01797120|12385637|FG001|NOT COMPLETED|Overall Study||65
11195576|NCT01797159|12385643|FG000|STARTED|Overall Study||20
11195577|NCT01797159|12385643|FG000|COMPLETED|Overall Study||20
11195578|NCT01797159|12385643|FG000|NOT COMPLETED|Overall Study||0
11195579|NCT01797185|12385651|FG000|STARTED|Overall Study||162
11195580|NCT01797185|12385652|FG001|STARTED|Overall Study||163
11195581|NCT01797185|12385653|FG002|STARTED|Overall Study||50
11195582|NCT01797185|12385651|FG000|COMPLETED|Overall Study||134
11195583|NCT01797185|12385652|FG001|COMPLETED|Overall Study||125
11195584|NCT01797185|12385653|FG002|COMPLETED|Overall Study||38
11195585|NCT01797185|12385651|FG000|NOT COMPLETED|Overall Study||28
11195586|NCT01797185|12385652|FG001|NOT COMPLETED|Overall Study||38
11195587|NCT01797185|12385653|FG002|NOT COMPLETED|Overall Study||12
11195588|NCT01797263|12385663|FG000|STARTED|Overall Study||129
11195589|NCT01797263|12385664|FG001|STARTED|Overall Study||127
11195590|NCT01797263|12385663|FG000|1 Month|Overall Study||96
11195591|NCT01797263|12385664|FG001|1 Month|Overall Study||87
11195592|NCT01797263|12385663|FG000|3 Month|Overall Study||87
11195593|NCT01797263|12385664|FG001|3 Month|Overall Study||84
11195594|NCT01797263|12385663|FG000|6 Month|Overall Study||90
11195595|NCT01797263|12385664|FG001|6 Month|Overall Study||85
11195596|NCT01797263|12385663|FG000|9 Month|Overall Study||92
11195597|NCT01797263|12385664|FG001|9 Month|Overall Study||87
11195598|NCT01797263|12385663|FG000|COMPLETED|Overall Study||92
11195599|NCT01797263|12385664|FG001|COMPLETED|Overall Study||87
11195600|NCT01797263|12385663|FG000|NOT COMPLETED|Overall Study||37
11195601|NCT01797263|12385664|FG001|NOT COMPLETED|Overall Study||40
11195602|NCT01797302|12385673|FG000|STARTED|Overall Study||75
11195603|NCT01797302|12385674|FG001|STARTED|Overall Study||74
11195604|NCT01797302|12385675|FG002|STARTED|Overall Study||76
11195605|NCT01797302|12385673|FG000|3 Month Visit|Overall Study||60
11195606|NCT01797302|12385674|FG001|3 Month Visit|Overall Study||57
11195607|NCT01797302|12385675|FG002|3 Month Visit|Overall Study||57
11195608|NCT01797302|12385673|FG000|COMPLETED|Overall Study||58
11195609|NCT01797302|12385674|FG001|COMPLETED|Overall Study||48
11195610|NCT01797302|12385675|FG002|COMPLETED|Overall Study||50
11195611|NCT01797302|12385673|FG000|NOT COMPLETED|Overall Study||17
11195612|NCT01797302|12385674|FG001|NOT COMPLETED|Overall Study||26
11195613|NCT01797302|12385675|FG002|NOT COMPLETED|Overall Study||26
11195614|NCT01797328|12385685|FG000|STARTED|Overall Study||16
11195615|NCT01797328|12385686|FG001|STARTED|Overall Study||12
11195616|NCT01797328|12385685|FG000|COMPLETED|Overall Study||14
11195617|NCT01797328|12385686|FG001|COMPLETED|Overall Study||12
11195618|NCT01797328|12385685|FG000|NOT COMPLETED|Overall Study||2
11195619|NCT01797328|12385686|FG001|NOT COMPLETED|Overall Study||0
11195620|NCT01797432|12385692|FG000|STARTED|Overall Study||14
11195621|NCT01797432|12385692|FG000|COMPLETED|Overall Study||10
11195622|NCT01797432|12385692|FG000|NOT COMPLETED|Overall Study||4
11195623|NCT01797445|12385698|FG000|STARTED|Double-Blind Phase||435
11195624|NCT01797445|12385699|FG001|STARTED|Double-Blind Phase||437
11195625|NCT01797445|12385698|FG000|COMPLETED|Double-Blind Phase||348
11195626|NCT01797445|12385699|FG001|COMPLETED|Double-Blind Phase||348
11195627|NCT01797445|12385698|FG000|NOT COMPLETED|Double-Blind Phase||87
11195628|NCT01797445|12385699|FG001|NOT COMPLETED|Double-Blind Phase||89
11195629|NCT01797445|12385698|FG000|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141
11195630|NCT01797445|12385699|FG001|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119
11195631|NCT01797445|12385698|FG000|COMPLETED|Open-Label Extension Phase||140
11195632|NCT01797445|12385699|FG001|COMPLETED|Open-Label Extension Phase||119
11195633|NCT01797445|12385698|FG000|NOT COMPLETED|Open-Label Extension Phase||1
11195634|NCT01797445|12385699|FG001|NOT COMPLETED|Open-Label Extension Phase||0
11204912|NCT01856257|12395619|FG000|NOT COMPLETED|Overall Study||3
11204913|NCT01856257|12395620|FG001|NOT COMPLETED|Overall Study||1
11204914|NCT01856257|12395621|FG002|NOT COMPLETED|Overall Study||0
11204915|NCT01856257|12395622|FG003|NOT COMPLETED|Overall Study||2
11204916|NCT01856309|12395635|FG000|STARTED|Overall Study||305
11204917|NCT01856309|12395636|FG001|STARTED|Overall Study||291
11204918|NCT01856309|12395637|FG002|STARTED|Overall Study||606
11204919|NCT01856309|12395638|FG003|STARTED|Overall Study||618
11204920|NCT01856309|12395635|FG000|Participants From Study CNTO136ARA3002|Overall Study||197
11204921|NCT01856309|12395636|FG001|Participants From Study CNTO136ARA3002|Overall Study||187
11204922|NCT01856309|12395637|FG002|Participants From Study CNTO136ARA3002|Overall Study||405
11204923|NCT01856309|12395638|FG003|Participants From Study CNTO136ARA3002|Overall Study||412
11204924|NCT01856309|12395635|FG000|Participants From Study CNTO136ARA3003|Overall Study||108
11204925|NCT01856309|12395636|FG001|Participants From Study CNTO136ARA3003|Overall Study||104
11204926|NCT01856309|12395637|FG002|Participants From Study CNTO136ARA3003|Overall Study||201
11204927|NCT01856309|12395638|FG003|Participants From Study CNTO136ARA3003|Overall Study||206
11204928|NCT01856309|12395635|FG000|Treated Partcipants|Overall Study||305
11204929|NCT01856309|12395636|FG001|Treated Partcipants|Overall Study||290
11204930|NCT01856309|12395637|FG002|Treated Partcipants|Overall Study||605
11204931|NCT01856309|12395638|FG003|Treated Partcipants|Overall Study||618
11204932|NCT01856309|12395635|FG000|COMPLETED|Overall Study||6
11204933|NCT01856309|12395636|FG001|COMPLETED|Overall Study||3
11204934|NCT01856309|12395637|FG002|COMPLETED|Overall Study||11
11204935|NCT01856309|12395638|FG003|COMPLETED|Overall Study||9
11204936|NCT01856309|12395635|FG000|NOT COMPLETED|Overall Study||299
11204937|NCT01856309|12395636|FG001|NOT COMPLETED|Overall Study||288
11204938|NCT01856309|12395637|FG002|NOT COMPLETED|Overall Study||595
11204939|NCT01856309|12395638|FG003|NOT COMPLETED|Overall Study||609
11204940|NCT01856491|12395648|FG000|STARTED|Overall Study||167
11204941|NCT01856491|12395648|FG000|COMPLETED|Overall Study||152
11204942|NCT01856491|12395648|FG000|NOT COMPLETED|Overall Study||15
11204943|NCT01856530|12395654|FG000|STARTED|Overall Study||27
11204944|NCT01856530|12395655|FG001|STARTED|Overall Study||27
11204945|NCT01856530|12395654|FG000|COMPLETED|Overall Study||27
11195635|NCT01797471|12385707|FG000|STARTED|Overall Study||1
11195636|NCT01797471|12385707|FG000|COMPLETED|Overall Study||1
11195637|NCT01797471|12385707|FG000|NOT COMPLETED|Overall Study||0
11195638|NCT01797484|12385713|FG000|STARTED|Overall Study||10
11195639|NCT01797484|12385714|FG001|STARTED|Overall Study||10
11195640|NCT01797484|12385713|FG000|COMPLETED|Overall Study||10
11195641|NCT01797484|12385714|FG001|COMPLETED|Overall Study||10
11195642|NCT01797484|12385713|FG000|NOT COMPLETED|Overall Study||0
11195643|NCT01797484|12385714|FG001|NOT COMPLETED|Overall Study||0
11195644|NCT01797536|12385724|FG000|STARTED|Overall Study||8
11195645|NCT01797536|12385725|FG001|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
11195646|NCT01797536|12385726|FG002|STARTED|Overall Study||7
11195647|NCT01797536|12385727|FG003|STARTED|Overall Study||8
11195648|NCT01797536|12385724|FG000|COMPLETED|Overall Study||8
11195649|NCT01797536|12385725|FG001|COMPLETED|Overall Study||10
11195650|NCT01797536|12385726|FG002|COMPLETED|Overall Study||7
11195651|NCT01797536|12385727|FG003|COMPLETED|Overall Study||8
11195652|NCT01797536|12385724|FG000|NOT COMPLETED|Overall Study||0
11195653|NCT01797536|12385725|FG001|NOT COMPLETED|Overall Study||1
11195654|NCT01797536|12385726|FG002|NOT COMPLETED|Overall Study||0
11195655|NCT01797536|12385727|FG003|NOT COMPLETED|Overall Study||0
11195656|NCT01797562|12385737|FG000|STARTED|Overall Study||116
11195657|NCT01797562|12385737|FG000|COMPLETED|Overall Study||111
11195658|NCT01797562|12385737|FG000|NOT COMPLETED|Overall Study||5
11195659|NCT01797575|12385746|FG000|STARTED|Baseline Allocation||5
11195660|NCT01797575|12385747|FG001|STARTED|Baseline Allocation||9
11195661|NCT01797575|12385748|FG002|STARTED|Baseline Allocation||9
11195662|NCT01797575|12385749|FG003|STARTED|Baseline Allocation||15
11195663|NCT01797575|12385746|FG000|COMPLETED|Baseline Allocation||4
11195664|NCT01797575|12385747|FG001|COMPLETED|Baseline Allocation||8
11195665|NCT01797575|12385748|FG002|COMPLETED|Baseline Allocation||4
11195666|NCT01797575|12385749|FG003|COMPLETED|Baseline Allocation||8
11195667|NCT01797575|12385746|FG000|NOT COMPLETED|Baseline Allocation||1
11195668|NCT01797575|12385747|FG001|NOT COMPLETED|Baseline Allocation||1
11195669|NCT01797575|12385748|FG002|NOT COMPLETED|Baseline Allocation||5
11195670|NCT01797575|12385749|FG003|NOT COMPLETED|Baseline Allocation||7
11195671|NCT01797575|12385746|FG000|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
11195672|NCT01797575|12385747|FG001|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
11195673|NCT01797575|12385748|FG002|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
11195674|NCT01797575|12385749|FG003|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
11195675|NCT01797575|12385746|FG000|COMPLETED|Week 8 Re-Randomization||4
11195676|NCT01797575|12385747|FG001|COMPLETED|Week 8 Re-Randomization||5
11195677|NCT01797575|12385748|FG002|COMPLETED|Week 8 Re-Randomization||4
11195678|NCT01797575|12385749|FG003|COMPLETED|Week 8 Re-Randomization||7
11195679|NCT01797575|12385746|FG000|NOT COMPLETED|Week 8 Re-Randomization||0
11195680|NCT01797575|12385747|FG001|NOT COMPLETED|Week 8 Re-Randomization||0
11195681|NCT01797575|12385748|FG002|NOT COMPLETED|Week 8 Re-Randomization||1
11195682|NCT01797575|12385749|FG003|NOT COMPLETED|Week 8 Re-Randomization||3
11195683|NCT01797705|12385763|FG000|STARTED|Overall Study||33
11195684|NCT01797705|12385763|FG000|COMPLETED|Overall Study||28
11195685|NCT01797705|12385763|FG000|NOT COMPLETED|Overall Study||5
11195686|NCT01797731|12385769|FG000|STARTED|Overall Study||50
11195687|NCT01797731|12385770|FG001|STARTED|Overall Study||50
11195688|NCT01797731|12385769|FG000|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
11195689|NCT01797731|12385770|FG001|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
11195690|NCT01797731|12385769|FG000|NOT COMPLETED|Overall Study||3
11195691|NCT01797731|12385770|FG001|NOT COMPLETED|Overall Study||3
11195692|NCT01797783|12385778|FG000|STARTED|Overall Study||52
11195693|NCT01797783|12385779|FG001|STARTED|Overall Study||27
11195694|NCT01797783|12385778|FG000|COMPLETED|Overall Study||50
11195695|NCT01797783|12385779|FG001|COMPLETED|Overall Study||26
11195696|NCT01797783|12385778|FG000|NOT COMPLETED|Overall Study||2
11195697|NCT01797783|12385779|FG001|NOT COMPLETED|Overall Study||1
11195698|NCT01797822|12385793|FG000|STARTED|Overall Study||20
11195699|NCT01797822|12385793|FG000|COMPLETED|Overall Study|The protocol is now closed.|20
11195700|NCT01797822|12385793|FG000|NOT COMPLETED|Overall Study||0
11195701|NCT01797835|12385801|FG000|STARTED|Overall Study||153
11195702|NCT01797835|12385802|FG001|STARTED|Overall Study||141
11195703|NCT01797835|12385801|FG000|COMPLETED|Overall Study||122
11195704|NCT01797835|12385802|FG001|COMPLETED|Overall Study||114
11195705|NCT01797835|12385801|FG000|NOT COMPLETED|Overall Study||31
11195706|NCT01797835|12385802|FG001|NOT COMPLETED|Overall Study||27
11195707|NCT01797965|12385812|FG000|STARTED|Overall Study||597
11195708|NCT01797965|12385813|FG001|STARTED|Overall Study||607
11195709|NCT01797965|12385814|FG002|STARTED|Overall Study||70
11195710|NCT01797965|12385815|FG003|STARTED|Overall Study||227
11195711|NCT01797965|12385812|FG000|COMPLETED|Overall Study||48
11195712|NCT01797965|12385813|FG001|COMPLETED|Overall Study||38
11195713|NCT01797965|12385814|FG002|COMPLETED|Overall Study||62
11195714|NCT01797965|12385815|FG003|COMPLETED|Overall Study||154
11195715|NCT01797965|12385812|FG000|NOT COMPLETED|Overall Study||549
11195716|NCT01797965|12385813|FG001|NOT COMPLETED|Overall Study||569
11195717|NCT01797965|12385814|FG002|NOT COMPLETED|Overall Study||8
11195718|NCT01797965|12385815|FG003|NOT COMPLETED|Overall Study||73
11195719|NCT01798056|12385828|FG000|STARTED|Overall Study||117
11195720|NCT01798056|12385829|FG001|STARTED|Overall Study||115
11195721|NCT01798056|12385828|FG000|COMPLETED|Overall Study||90
11195722|NCT01798056|12385829|FG001|COMPLETED|Overall Study||90
11195723|NCT01798056|12385828|FG000|NOT COMPLETED|Overall Study||27
11195724|NCT01798056|12385829|FG001|NOT COMPLETED|Overall Study||25
11195725|NCT01798134|12385837|FG000|STARTED|Overall Study||25
11195726|NCT01798134|12385837|FG000|COMPLETED|Overall Study||9
11195727|NCT01798134|12385837|FG000|NOT COMPLETED|Overall Study||16
11195728|NCT01798186|12385845|FG000|STARTED|Overall Study||6
11195729|NCT01798186|12385846|FG001|STARTED|Overall Study||6
11195730|NCT01798186|12385847|FG002|STARTED|Overall Study||6
11195731|NCT01798186|12385848|FG003|STARTED|Overall Study||8
11195732|NCT01798186|12385845|FG000|COMPLETED|Overall Study||6
11195733|NCT01798186|12385846|FG001|COMPLETED|Overall Study||6
11195734|NCT01798186|12385847|FG002|COMPLETED|Overall Study||6
11195735|NCT01798186|12385848|FG003|COMPLETED|Overall Study||8
11195736|NCT01798186|12385845|FG000|NOT COMPLETED|Overall Study||0
11195737|NCT01798186|12385846|FG001|NOT COMPLETED|Overall Study||0
11195738|NCT01798186|12385847|FG002|NOT COMPLETED|Overall Study||0
11195739|NCT01798186|12385848|FG003|NOT COMPLETED|Overall Study||0
11195740|NCT01798225|12385863|FG000|STARTED|Overall Study||57
11195741|NCT01798225|12385864|FG001|STARTED|Overall Study||56
11195742|NCT01798225|12385863|FG000|COMPLETED|Overall Study||57
11195743|NCT01798225|12385864|FG001|COMPLETED|Overall Study||53
11195744|NCT01798225|12385863|FG000|NOT COMPLETED|Overall Study||0
11195745|NCT01798225|12385864|FG001|NOT COMPLETED|Overall Study||3
11195746|NCT01798264|12385874|FG000|STARTED|Overall Study||12
11195747|NCT01798264|12385875|FG001|STARTED|Overall Study||11
11195748|NCT01798264|12385876|FG002|STARTED|Overall Study||10
11195749|NCT01798264|12385877|FG003|STARTED|Overall Study||11
11195750|NCT01798264|12385874|FG000|COMPLETED|Overall Study||11
11195751|NCT01798264|12385875|FG001|COMPLETED|Overall Study||11
11195752|NCT01798264|12385876|FG002|COMPLETED|Overall Study||10
11195753|NCT01798264|12385877|FG003|COMPLETED|Overall Study||7
11195754|NCT01798264|12385874|FG000|NOT COMPLETED|Overall Study||1
11195755|NCT01798264|12385875|FG001|NOT COMPLETED|Overall Study||0
11195756|NCT01798264|12385876|FG002|NOT COMPLETED|Overall Study||0
11195757|NCT01798264|12385877|FG003|NOT COMPLETED|Overall Study||4
11195758|NCT01798316|12385889|FG000|STARTED|Overall Study||52
11195759|NCT01798316|12385890|FG001|STARTED|Overall Study||53
11195760|NCT01798316|12385889|FG000|COMPLETED|Overall Study||52
11195761|NCT01798316|12385890|FG001|COMPLETED|Overall Study||53
11195762|NCT01798316|12385889|FG000|NOT COMPLETED|Overall Study||0
11195763|NCT01798316|12385890|FG001|NOT COMPLETED|Overall Study||0
11195764|NCT01798394|12385900|FG000|STARTED|Overall Study||24
11195765|NCT01798394|12385901|FG001|STARTED|Overall Study||22
11195766|NCT01798394|12385900|FG000|COMPLETED|Overall Study||21
11195767|NCT01798394|12385901|FG001|COMPLETED|Overall Study||19
11195768|NCT01798394|12385900|FG000|NOT COMPLETED|Overall Study||3
11195769|NCT01798394|12385901|FG001|NOT COMPLETED|Overall Study||3
11195770|NCT01798485|12385909|FG000|STARTED|Overall Study||347
11195771|NCT01798485|12385910|FG001|STARTED|Overall Study||349
11195772|NCT01798485|12385909|FG000|Safety Population as of 23 Dec 2015|Overall Study||338
11195773|NCT01798485|12385910|FG001|Safety Population as of 23 Dec 2015|Overall Study||342
11195774|NCT01798485|12385909|FG000|Randomized as of 19 October 2015|Overall Study||335
11195775|NCT01798485|12385910|FG001|Randomized as of 19 October 2015|Overall Study||337
11195776|NCT01798485|12385909|FG000|COMPLETED|Overall Study||1
11195777|NCT01798485|12385910|FG001|COMPLETED|Overall Study||59
11195778|NCT01798485|12385909|FG000|NOT COMPLETED|Overall Study||346
11195779|NCT01798485|12385910|FG001|NOT COMPLETED|Overall Study||290
11195780|NCT01798550|12385918|FG000|STARTED|Overall Study||30
11195781|NCT01798550|12385919|FG001|STARTED|Overall Study||32
11195782|NCT01798550|12385918|FG000|COMPLETED|Overall Study||28
11195783|NCT01798550|12385919|FG001|COMPLETED|Overall Study||26
11195784|NCT01798550|12385918|FG000|NOT COMPLETED|Overall Study||2
11195785|NCT01798550|12385919|FG001|NOT COMPLETED|Overall Study||6
11195786|NCT01798589|12385925|FG000|STARTED|Overall Study||16
11195787|NCT01798589|12385925|FG000|COMPLETED|Overall Study||16
11195788|NCT01798589|12385925|FG000|NOT COMPLETED|Overall Study||0
11195789|NCT01798641|12385935|FG000|STARTED|First Intervention (6 Weeks)||19
11195790|NCT01798641|12385936|FG001|STARTED|First Intervention (6 Weeks)||19
11195791|NCT01798641|12385935|FG000|COMPLETED|First Intervention (6 Weeks)||19
11195792|NCT01798641|12385936|FG001|COMPLETED|First Intervention (6 Weeks)||19
11195793|NCT01798641|12385935|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
11195794|NCT01798641|12385936|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
11195795|NCT01798641|12385935|FG000|STARTED|Second Intervention (6 Weeks)||19
11195796|NCT01798641|12385936|FG001|STARTED|Second Intervention (6 Weeks)||19
11195797|NCT01798641|12385935|FG000|COMPLETED|Second Intervention (6 Weeks)||19
11195798|NCT01798641|12385936|FG001|COMPLETED|Second Intervention (6 Weeks)||19
11195799|NCT01798641|12385935|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
11195800|NCT01798641|12385936|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
11195801|NCT01798706|12385945|FG000|STARTED|Overall Study||176
11195802|NCT01798706|12385946|FG001|STARTED|Overall Study||174
11195803|NCT01798706|12385945|FG000|COMPLETED|Overall Study||155
11195804|NCT01798706|12385946|FG001|COMPLETED|Overall Study||153
11195805|NCT01798706|12385945|FG000|NOT COMPLETED|Overall Study||21
11195806|NCT01798706|12385946|FG001|NOT COMPLETED|Overall Study||21
11195807|NCT01798849|12385955|FG000|STARTED|Overall Study||8
11195808|NCT01798849|12385956|FG001|STARTED|Overall Study||8
11195809|NCT01798849|12385957|FG002|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9
11195810|NCT01798849|12385955|FG000|COMPLETED|Overall Study||8
11195811|NCT01798849|12385956|FG001|COMPLETED|Overall Study||8
11195812|NCT01798849|12385957|FG002|COMPLETED|Overall Study||8
11195813|NCT01798849|12385955|FG000|NOT COMPLETED|Overall Study||0
11195814|NCT01798849|12385956|FG001|NOT COMPLETED|Overall Study||0
11195815|NCT01798849|12385957|FG002|NOT COMPLETED|Overall Study||1
11195816|NCT01798927|12385994|FG000|STARTED|Overall Study||4
11195817|NCT01798927|12385994|FG000|COMPLETED|Overall Study||3
11195818|NCT01798927|12385994|FG000|NOT COMPLETED|Overall Study||1
11195819|NCT01798966|12385998|FG000|STARTED|Overall Study||10
11195820|NCT01798966|12385998|FG000|COMPLETED|Overall Study||10
11195821|NCT01798966|12385998|FG000|NOT COMPLETED|Overall Study||0
11195822|NCT01798992|12386007|FG000|STARTED|Overall Study||4
11195823|NCT01798992|12386008|FG001|STARTED|Overall Study||19
11195824|NCT01798992|12386009|FG002|STARTED|Overall Study||16
11195825|NCT01798992|12386010|FG003|STARTED|Overall Study||17
11195826|NCT01798992|12386007|FG000|COMPLETED|Overall Study||4
11195827|NCT01798992|12386008|FG001|COMPLETED|Overall Study||17
11195828|NCT01798992|12386009|FG002|COMPLETED|Overall Study||14
11195829|NCT01798992|12386010|FG003|COMPLETED|Overall Study||16
11195830|NCT01798992|12386007|FG000|NOT COMPLETED|Overall Study||0
11195831|NCT01798992|12386008|FG001|NOT COMPLETED|Overall Study||2
11195832|NCT01798992|12386009|FG002|NOT COMPLETED|Overall Study||2
11195833|NCT01798992|12386010|FG003|NOT COMPLETED|Overall Study||1
11195834|NCT01799135|12386019|FG000|STARTED|Overall Study||6
11195835|NCT01799135|12386019|FG000|COMPLETED|Overall Study||6
11195836|NCT01799135|12386019|FG000|NOT COMPLETED|Overall Study||0
11195837|NCT01799213|12386025|FG000|STARTED|Overall Study||180
11195838|NCT01799213|12386026|FG001|STARTED|Overall Study||184
11195839|NCT01799213|12386025|FG000|COMPLETED|Overall Study||173
11195840|NCT01799213|12386026|FG001|COMPLETED|Overall Study||178
11195841|NCT01799213|12386025|FG000|NOT COMPLETED|Overall Study||7
11195842|NCT01799213|12386026|FG001|NOT COMPLETED|Overall Study||6
11195843|NCT01799226|12386040|FG000|STARTED|Overall Study||16
11195844|NCT01799226|12386041|FG001|STARTED|Overall Study||16
11195845|NCT01799226|12386040|FG000|Right Stent Side|Overall Study||8
11195846|NCT01799226|12386041|FG001|Right Stent Side|Overall Study||8
11195847|NCT01799226|12386040|FG000|Left Stent Side|Overall Study||8
11195848|NCT01799226|12386041|FG001|Left Stent Side|Overall Study||8
11195849|NCT01799226|12386040|FG000|COMPLETED|Overall Study||14
11195850|NCT01799226|12386041|FG001|COMPLETED|Overall Study||16
11195851|NCT01799226|12386040|FG000|NOT COMPLETED|Overall Study||2
11195852|NCT01799226|12386041|FG001|NOT COMPLETED|Overall Study||0
11195853|NCT01799239|12386047|FG000|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
11195854|NCT01799239|12386048|FG001|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
11195855|NCT01799239|12386047|FG000|COMPLETED|Period 1 (7 Days)||12
11195856|NCT01799239|12386048|FG001|COMPLETED|Period 1 (7 Days)||15
11195857|NCT01799239|12386047|FG000|NOT COMPLETED|Period 1 (7 Days)||3
11195858|NCT01799239|12386048|FG001|NOT COMPLETED|Period 1 (7 Days)||1
11195859|NCT01799239|12386047|FG000|STARTED|Period 2 (7 Days)||13
11195860|NCT01799239|12386048|FG001|STARTED|Period 2 (7 Days)||15
11195861|NCT01799239|12386047|FG000|COMPLETED|Period 2 (7 Days)||11
11195862|NCT01799239|12386048|FG001|COMPLETED|Period 2 (7 Days)||14
11195863|NCT01799239|12386047|FG000|NOT COMPLETED|Period 2 (7 Days)||2
11195864|NCT01799239|12386048|FG001|NOT COMPLETED|Period 2 (7 Days)||1
11195865|NCT01799278|12386054|FG000|STARTED|Overall Study||60
11195866|NCT01799278|12386054|FG000|COMPLETED|Overall Study||60
11195867|NCT01799278|12386054|FG000|NOT COMPLETED|Overall Study||0
11195868|NCT01799590|12386065|FG000|STARTED|Overall Study||111
11195869|NCT01799590|12386066|FG001|STARTED|Overall Study||94
11195870|NCT01799590|12386067|FG002|STARTED|Overall Study||91
11195871|NCT01799590|12386065|FG000|COMPLETED|Overall Study||85
11195872|NCT01799590|12386066|FG001|COMPLETED|Overall Study||78
11195873|NCT01799590|12386067|FG002|COMPLETED|Overall Study||77
11195874|NCT01799590|12386065|FG000|NOT COMPLETED|Overall Study||26
11195875|NCT01799590|12386066|FG001|NOT COMPLETED|Overall Study||16
11195876|NCT01799590|12386067|FG002|NOT COMPLETED|Overall Study||14
11195877|NCT01799720|12386078|FG000|STARTED|Overall Study||20
11195878|NCT01799720|12386079|FG001|STARTED|Overall Study||18
11195879|NCT01799720|12386080|FG002|STARTED|Overall Study||19
11195880|NCT01799720|12386078|FG000|Began the Treatment|Overall Study||20
11195881|NCT01799720|12386079|FG001|Began the Treatment|Overall Study||18
11195882|NCT01799720|12386080|FG002|Began the Treatment|Overall Study||19
11195883|NCT01799720|12386078|FG000|Began the Treatment and Finished it|Overall Study||17
11195884|NCT01799720|12386079|FG001|Began the Treatment and Finished it|Overall Study||17
11195885|NCT01799720|12386080|FG002|Began the Treatment and Finished it|Overall Study||18
11195886|NCT01799720|12386078|FG000|COMPLETED|Overall Study||17
11195887|NCT01799720|12386079|FG001|COMPLETED|Overall Study||17
11195888|NCT01799720|12386080|FG002|COMPLETED|Overall Study||18
11195889|NCT01799720|12386078|FG000|NOT COMPLETED|Overall Study||3
11195890|NCT01799720|12386079|FG001|NOT COMPLETED|Overall Study||1
11195891|NCT01799720|12386080|FG002|NOT COMPLETED|Overall Study||1
11195892|NCT01799889|12386100|FG000|STARTED|Overall Study||41
11195893|NCT01799889|12386101|FG001|STARTED|Overall Study||41
11195894|NCT01799889|12386102|FG002|STARTED|Overall Study||44
11195895|NCT01799889|12386103|FG003|STARTED|Overall Study||39
11195896|NCT01799889|12386104|FG004|STARTED|Overall Study||49
11195897|NCT01799889|12386105|FG005|STARTED|Overall Study||20
11195898|NCT01799889|12386106|FG006|STARTED|Overall Study||21
11195899|NCT01799889|12386107|FG007|STARTED|Overall Study||20
11195900|NCT01799889|12386108|FG008|STARTED|Overall Study||33
11195901|NCT01799889|12386109|FG009|STARTED|Overall Study||8
11195902|NCT01799889|12386110|FG010|STARTED|Overall Study||7
11195903|NCT01799889|12386111|FG011|STARTED|Overall Study||3
11195904|NCT01799889|12386100|FG000|COMPLETED|Overall Study||0
11195905|NCT01799889|12386101|FG001|COMPLETED|Overall Study||0
11195906|NCT01799889|12386102|FG002|COMPLETED|Overall Study||0
11195907|NCT01799889|12386103|FG003|COMPLETED|Overall Study||0
11195908|NCT01799889|12386104|FG004|COMPLETED|Overall Study||0
11195909|NCT01799889|12386105|FG005|COMPLETED|Overall Study||0
11195910|NCT01799889|12386106|FG006|COMPLETED|Overall Study||0
11195911|NCT01799889|12386107|FG007|COMPLETED|Overall Study||0
11195912|NCT01799889|12386108|FG008|COMPLETED|Overall Study||0
11195913|NCT01799889|12386109|FG009|COMPLETED|Overall Study||0
11195914|NCT01799889|12386110|FG010|COMPLETED|Overall Study||0
11195915|NCT01799889|12386111|FG011|COMPLETED|Overall Study||0
11195916|NCT01799889|12386100|FG000|NOT COMPLETED|Overall Study||41
11195917|NCT01799889|12386101|FG001|NOT COMPLETED|Overall Study||41
11195918|NCT01799889|12386102|FG002|NOT COMPLETED|Overall Study||44
11195919|NCT01799889|12386103|FG003|NOT COMPLETED|Overall Study||39
11195920|NCT01799889|12386104|FG004|NOT COMPLETED|Overall Study||49
11195921|NCT01799889|12386105|FG005|NOT COMPLETED|Overall Study||20
11195922|NCT01799889|12386106|FG006|NOT COMPLETED|Overall Study||21
11195923|NCT01799889|12386107|FG007|NOT COMPLETED|Overall Study||20
11195924|NCT01799889|12386108|FG008|NOT COMPLETED|Overall Study||33
11195925|NCT01799889|12386109|FG009|NOT COMPLETED|Overall Study||8
11195926|NCT01799889|12386110|FG010|NOT COMPLETED|Overall Study||7
11195927|NCT01799889|12386111|FG011|NOT COMPLETED|Overall Study||3
11195928|NCT01799941|12386148|FG000|STARTED|Overall Study||367
11195929|NCT01799941|12386148|FG000|COMPLETED|Overall Study||271
11195930|NCT01799941|12386148|FG000|NOT COMPLETED|Overall Study||96
11195931|NCT01799993|12386160|FG000|STARTED|Overall Study||362
11195932|NCT01799993|12386161|FG001|STARTED|Overall Study||363
11195933|NCT01799993|12386160|FG000|ITT Population|Overall Study||354
11195934|NCT01799993|12386161|FG001|ITT Population|Overall Study||358
11195935|NCT01799993|12386160|FG000|mITT Population|Overall Study||255
11195936|NCT01799993|12386161|FG001|mITT Population|Overall Study||253
11195937|NCT01799993|12386160|FG000|COMPLETED|Overall Study||229
11195938|NCT01799993|12386161|FG001|COMPLETED|Overall Study||235
11195939|NCT01799993|12386160|FG000|NOT COMPLETED|Overall Study||133
11195940|NCT01799993|12386161|FG001|NOT COMPLETED|Overall Study||128
11195941|NCT01800058|12386167|FG000|STARTED|Overall Study||66
11195942|NCT01800058|12386167|FG000|COMPLETED|Overall Study||65
11195943|NCT01800058|12386167|FG000|NOT COMPLETED|Overall Study||1
11195944|NCT01800201|12386174|FG000|STARTED|Overall Study||506
11195945|NCT01800201|12386175|FG001|STARTED|Overall Study||1003
11195946|NCT01800201|12386174|FG000|COMPLETED|Overall Study||503
11195947|NCT01800201|12386175|FG001|COMPLETED|Overall Study||1000
11195948|NCT01800201|12386174|FG000|NOT COMPLETED|Overall Study||3
11195949|NCT01800201|12386175|FG001|NOT COMPLETED|Overall Study||3
11195950|NCT01800318|12386186|FG000|STARTED|Overall Study||39
11195951|NCT01800318|12386187|FG001|STARTED|Overall Study||42
11195952|NCT01800318|12386188|FG002|STARTED|Overall Study||41
11195953|NCT01800318|12386189|FG003|STARTED|Overall Study||40
11195954|NCT01800318|12386186|FG000|COMPLETED|Overall Study||37
11195955|NCT01800318|12386187|FG001|COMPLETED|Overall Study||37
11195956|NCT01800318|12386188|FG002|COMPLETED|Overall Study||40
11195957|NCT01800318|12386189|FG003|COMPLETED|Overall Study||39
11195958|NCT01800318|12386186|FG000|NOT COMPLETED|Overall Study||2
11195959|NCT01800318|12386187|FG001|NOT COMPLETED|Overall Study||5
11195960|NCT01800318|12386188|FG002|NOT COMPLETED|Overall Study||1
11195961|NCT01800318|12386189|FG003|NOT COMPLETED|Overall Study||1
11195962|NCT01800786|12386205|FG000|STARTED|Overall Study||17
11195963|NCT01800786|12386206|FG001|STARTED|Overall Study||16
11195964|NCT01800786|12386205|FG000|COMPLETED|Overall Study||15
11195965|NCT01800786|12386206|FG001|COMPLETED|Overall Study||15
11195966|NCT01800786|12386205|FG000|NOT COMPLETED|Overall Study||2
11195967|NCT01800786|12386206|FG001|NOT COMPLETED|Overall Study||1
11195968|NCT01800838|12386216|FG000|STARTED|Overall Study||1
11195969|NCT01800838|12386217|FG001|STARTED|Overall Study||1
11195970|NCT01800838|12386218|FG002|STARTED|Overall Study||7
11195971|NCT01800838|12386219|FG003|STARTED|Overall Study||2
11195972|NCT01800838|12386216|FG000|COMPLETED|Overall Study||1
11195973|NCT01800838|12386217|FG001|COMPLETED|Overall Study||1
11195974|NCT01800838|12386218|FG002|COMPLETED|Overall Study||7
11195975|NCT01800838|12386219|FG003|COMPLETED|Overall Study||2
11195976|NCT01800838|12386216|FG000|NOT COMPLETED|Overall Study||0
11195977|NCT01800838|12386217|FG001|NOT COMPLETED|Overall Study||0
11195978|NCT01800838|12386218|FG002|NOT COMPLETED|Overall Study||0
11195979|NCT01800838|12386219|FG003|NOT COMPLETED|Overall Study||0
11195980|NCT01800877|12386225|FG000|STARTED|Overall Study||60
11195981|NCT01800877|12386226|FG001|STARTED|Overall Study||60
11195982|NCT01800877|12386225|FG000|COMPLETED|Overall Study||58
11195983|NCT01800877|12386226|FG001|COMPLETED|Overall Study||60
11195984|NCT01800877|12386225|FG000|NOT COMPLETED|Overall Study||2
11195985|NCT01800877|12386226|FG001|NOT COMPLETED|Overall Study||0
11195986|NCT01800890|12386232|FG000|STARTED|Test Period 1||3
11195987|NCT01800890|12386233|FG001|STARTED|Test Period 1||3
11195988|NCT01800890|12386234|FG002|STARTED|Test Period 1||3
11195989|NCT01800890|12386235|FG003|STARTED|Test Period 1||3
11195990|NCT01800890|12386236|FG004|STARTED|Test Period 1||4
11195991|NCT01800890|12386237|FG005|STARTED|Test Period 1||4
11195992|NCT01800890|12386238|FG006|STARTED|Test Period 1||3
11195993|NCT01800890|12386239|FG007|STARTED|Test Period 1||3
11195994|NCT01800890|12386240|FG008|STARTED|Test Period 1||3
11195995|NCT01800890|12386232|FG000|COMPLETED|Test Period 1||3
11195996|NCT01800890|12386233|FG001|COMPLETED|Test Period 1||3
11195997|NCT01800890|12386234|FG002|COMPLETED|Test Period 1||3
11195998|NCT01800890|12386235|FG003|COMPLETED|Test Period 1||2
11195999|NCT01800890|12386236|FG004|COMPLETED|Test Period 1||4
11196000|NCT01800890|12386237|FG005|COMPLETED|Test Period 1||4
11196001|NCT01800890|12386238|FG006|COMPLETED|Test Period 1||3
11196002|NCT01800890|12386239|FG007|COMPLETED|Test Period 1||3
11196003|NCT01800890|12386240|FG008|COMPLETED|Test Period 1||3
11196004|NCT01800890|12386232|FG000|NOT COMPLETED|Test Period 1||0
11196005|NCT01800890|12386233|FG001|NOT COMPLETED|Test Period 1||0
11196006|NCT01800890|12386234|FG002|NOT COMPLETED|Test Period 1||0
11196007|NCT01800890|12386235|FG003|NOT COMPLETED|Test Period 1||1
11196008|NCT01800890|12386236|FG004|NOT COMPLETED|Test Period 1||0
11196009|NCT01800890|12386237|FG005|NOT COMPLETED|Test Period 1||0
11196010|NCT01800890|12386238|FG006|NOT COMPLETED|Test Period 1||0
11196011|NCT01800890|12386239|FG007|NOT COMPLETED|Test Period 1||0
11196012|NCT01800890|12386240|FG008|NOT COMPLETED|Test Period 1||0
11196013|NCT01800890|12386232|FG000|STARTED|Test Period 2||3
11196014|NCT01800890|12386233|FG001|STARTED|Test Period 2||3
11196015|NCT01800890|12386234|FG002|STARTED|Test Period 2||3
11196016|NCT01800890|12386235|FG003|STARTED|Test Period 2||2
11196017|NCT01800890|12386236|FG004|STARTED|Test Period 2||4
11196018|NCT01800890|12386237|FG005|STARTED|Test Period 2||4
11196019|NCT01800890|12386238|FG006|STARTED|Test Period 2||3
11196020|NCT01800890|12386239|FG007|STARTED|Test Period 2||3
11196021|NCT01800890|12386240|FG008|STARTED|Test Period 2||3
11196022|NCT01800890|12386232|FG000|COMPLETED|Test Period 2||3
11196023|NCT01800890|12386233|FG001|COMPLETED|Test Period 2||3
11196024|NCT01800890|12386234|FG002|COMPLETED|Test Period 2||3
11196025|NCT01800890|12386235|FG003|COMPLETED|Test Period 2||2
11196026|NCT01800890|12386236|FG004|COMPLETED|Test Period 2||4
11196027|NCT01800890|12386237|FG005|COMPLETED|Test Period 2||4
11196028|NCT01800890|12386238|FG006|COMPLETED|Test Period 2||3
11196029|NCT01800890|12386239|FG007|COMPLETED|Test Period 2||3
11196030|NCT01800890|12386240|FG008|COMPLETED|Test Period 2||3
11196031|NCT01800890|12386232|FG000|NOT COMPLETED|Test Period 2||0
11196032|NCT01800890|12386233|FG001|NOT COMPLETED|Test Period 2||0
11196033|NCT01800890|12386234|FG002|NOT COMPLETED|Test Period 2||0
11196034|NCT01800890|12386235|FG003|NOT COMPLETED|Test Period 2||0
11196035|NCT01800890|12386236|FG004|NOT COMPLETED|Test Period 2||0
11196036|NCT01800890|12386237|FG005|NOT COMPLETED|Test Period 2||0
11196037|NCT01800890|12386238|FG006|NOT COMPLETED|Test Period 2||0
11196038|NCT01800890|12386239|FG007|NOT COMPLETED|Test Period 2||0
11196039|NCT01800890|12386240|FG008|NOT COMPLETED|Test Period 2||0
11196040|NCT01800890|12386232|FG000|STARTED|Test Period 3||3
11196041|NCT01800890|12386233|FG001|STARTED|Test Period 3||3
11196042|NCT01800890|12386234|FG002|STARTED|Test Period 3||3
11196043|NCT01800890|12386235|FG003|STARTED|Test Period 3||2
11196044|NCT01800890|12386236|FG004|STARTED|Test Period 3||4
11196045|NCT01800890|12386237|FG005|STARTED|Test Period 3||4
11196046|NCT01800890|12386238|FG006|STARTED|Test Period 3||3
11196047|NCT01800890|12386239|FG007|STARTED|Test Period 3||3
11196048|NCT01800890|12386240|FG008|STARTED|Test Period 3||3
11196049|NCT01800890|12386232|FG000|COMPLETED|Test Period 3||3
11196050|NCT01800890|12386233|FG001|COMPLETED|Test Period 3||3
11196051|NCT01800890|12386234|FG002|COMPLETED|Test Period 3||3
11196052|NCT01800890|12386235|FG003|COMPLETED|Test Period 3||2
11196053|NCT01800890|12386236|FG004|COMPLETED|Test Period 3||4
11196054|NCT01800890|12386237|FG005|COMPLETED|Test Period 3||4
11196055|NCT01800890|12386238|FG006|COMPLETED|Test Period 3||3
11196056|NCT01800890|12386239|FG007|COMPLETED|Test Period 3||3
11196057|NCT01800890|12386240|FG008|COMPLETED|Test Period 3||3
11196058|NCT01800890|12386232|FG000|NOT COMPLETED|Test Period 3||0
11196059|NCT01800890|12386233|FG001|NOT COMPLETED|Test Period 3||0
11196060|NCT01800890|12386234|FG002|NOT COMPLETED|Test Period 3||0
11196061|NCT01800890|12386235|FG003|NOT COMPLETED|Test Period 3||0
11196062|NCT01800890|12386236|FG004|NOT COMPLETED|Test Period 3||0
11196063|NCT01800890|12386237|FG005|NOT COMPLETED|Test Period 3||0
11196064|NCT01800890|12386238|FG006|NOT COMPLETED|Test Period 3||0
11196065|NCT01800890|12386239|FG007|NOT COMPLETED|Test Period 3||0
11196066|NCT01800890|12386240|FG008|NOT COMPLETED|Test Period 3||0
11196067|NCT01800903|12386250|FG000|STARTED|First Test Period||7
11196068|NCT01800903|12386251|FG001|STARTED|First Test Period||6
11196069|NCT01800903|12386252|FG002|STARTED|First Test Period||4
11196070|NCT01800903|12386253|FG003|STARTED|First Test Period||7
11196071|NCT01800903|12386254|FG004|STARTED|First Test Period||6
11196072|NCT01800903|12386255|FG005|STARTED|First Test Period||6
11196073|NCT01800903|12386250|FG000|COMPLETED|First Test Period||7
11196074|NCT01800903|12386251|FG001|COMPLETED|First Test Period||6
11196075|NCT01800903|12386252|FG002|COMPLETED|First Test Period||4
11196076|NCT01800903|12386253|FG003|COMPLETED|First Test Period||7
11196077|NCT01800903|12386254|FG004|COMPLETED|First Test Period||6
11196078|NCT01800903|12386255|FG005|COMPLETED|First Test Period||6
11196079|NCT01800903|12386250|FG000|NOT COMPLETED|First Test Period||0
11196080|NCT01800903|12386251|FG001|NOT COMPLETED|First Test Period||0
11196081|NCT01800903|12386252|FG002|NOT COMPLETED|First Test Period||0
11196082|NCT01800903|12386253|FG003|NOT COMPLETED|First Test Period||0
11196083|NCT01800903|12386254|FG004|NOT COMPLETED|First Test Period||0
11196084|NCT01800903|12386255|FG005|NOT COMPLETED|First Test Period||0
11196085|NCT01800903|12386250|FG000|STARTED|Second Test Period||7
11196086|NCT01800903|12386251|FG001|STARTED|Second Test Period||6
11196087|NCT01800903|12386252|FG002|STARTED|Second Test Period||4
11196088|NCT01800903|12386253|FG003|STARTED|Second Test Period||7
11196089|NCT01800903|12386254|FG004|STARTED|Second Test Period||6
11196090|NCT01800903|12386255|FG005|STARTED|Second Test Period||6
11196091|NCT01800903|12386250|FG000|COMPLETED|Second Test Period||6
11196092|NCT01800903|12386251|FG001|COMPLETED|Second Test Period||6
11196093|NCT01800903|12386252|FG002|COMPLETED|Second Test Period||4
11196094|NCT01800903|12386253|FG003|COMPLETED|Second Test Period||7
11196095|NCT01800903|12386254|FG004|COMPLETED|Second Test Period||6
11196096|NCT01800903|12386255|FG005|COMPLETED|Second Test Period||6
11196097|NCT01800903|12386250|FG000|NOT COMPLETED|Second Test Period||1
11196098|NCT01800903|12386251|FG001|NOT COMPLETED|Second Test Period||0
11196099|NCT01800903|12386252|FG002|NOT COMPLETED|Second Test Period||0
11196100|NCT01800903|12386253|FG003|NOT COMPLETED|Second Test Period||0
11196101|NCT01800903|12386254|FG004|NOT COMPLETED|Second Test Period||0
11196102|NCT01800903|12386255|FG005|NOT COMPLETED|Second Test Period||0
11196103|NCT01800903|12386250|FG000|STARTED|Third Test Period||6
11196104|NCT01800903|12386251|FG001|STARTED|Third Test Period||6
11196105|NCT01800903|12386252|FG002|STARTED|Third Test Period||4
11196106|NCT01800903|12386253|FG003|STARTED|Third Test Period||7
11196107|NCT01800903|12386254|FG004|STARTED|Third Test Period||6
11196108|NCT01800903|12386255|FG005|STARTED|Third Test Period||6
11196109|NCT01800903|12386250|FG000|COMPLETED|Third Test Period||6
11196110|NCT01800903|12386251|FG001|COMPLETED|Third Test Period||6
11196111|NCT01800903|12386252|FG002|COMPLETED|Third Test Period||4
11196112|NCT01800903|12386253|FG003|COMPLETED|Third Test Period||7
11196113|NCT01800903|12386254|FG004|COMPLETED|Third Test Period||6
11196114|NCT01800903|12386255|FG005|COMPLETED|Third Test Period||6
11196115|NCT01800903|12386250|FG000|NOT COMPLETED|Third Test Period||0
11196116|NCT01800903|12386251|FG001|NOT COMPLETED|Third Test Period||0
11196117|NCT01800903|12386252|FG002|NOT COMPLETED|Third Test Period||0
11196118|NCT01800903|12386253|FG003|NOT COMPLETED|Third Test Period||0
11196119|NCT01800903|12386254|FG004|NOT COMPLETED|Third Test Period||0
11196120|NCT01800903|12386255|FG005|NOT COMPLETED|Third Test Period||0
11196121|NCT01800916|12386261|FG000|STARTED|Test Period 1 (1 Week)||7
11196122|NCT01800916|12386262|FG001|STARTED|Test Period 1 (1 Week)||7
11196123|NCT01800916|12386263|FG002|STARTED|Test Period 1 (1 Week)||7
11196124|NCT01800916|12386264|FG003|STARTED|Test Period 1 (1 Week)||7
11196125|NCT01800916|12386265|FG004|STARTED|Test Period 1 (1 Week)||8
11196126|NCT01800916|12386266|FG005|STARTED|Test Period 1 (1 Week)||7
11196127|NCT01800916|12386267|FG006|STARTED|Test Period 1 (1 Week)||7
11196128|NCT01800916|12386268|FG007|STARTED|Test Period 1 (1 Week)||7
11196129|NCT01800916|12386269|FG008|STARTED|Test Period 1 (1 Week)||7
11196130|NCT01800916|12386261|FG000|COMPLETED|Test Period 1 (1 Week)||7
11196131|NCT01800916|12386262|FG001|COMPLETED|Test Period 1 (1 Week)||7
11196132|NCT01800916|12386263|FG002|COMPLETED|Test Period 1 (1 Week)||7
11196133|NCT01800916|12386264|FG003|COMPLETED|Test Period 1 (1 Week)||6
11196134|NCT01800916|12386265|FG004|COMPLETED|Test Period 1 (1 Week)||7
11196135|NCT01800916|12386266|FG005|COMPLETED|Test Period 1 (1 Week)||7
11196136|NCT01800916|12386267|FG006|COMPLETED|Test Period 1 (1 Week)||7
11196137|NCT01800916|12386268|FG007|COMPLETED|Test Period 1 (1 Week)||7
11196138|NCT01800916|12386269|FG008|COMPLETED|Test Period 1 (1 Week)||7
11196139|NCT01800916|12386261|FG000|NOT COMPLETED|Test Period 1 (1 Week)||0
11196140|NCT01800916|12386262|FG001|NOT COMPLETED|Test Period 1 (1 Week)||0
11196141|NCT01800916|12386263|FG002|NOT COMPLETED|Test Period 1 (1 Week)||0
11196142|NCT01800916|12386264|FG003|NOT COMPLETED|Test Period 1 (1 Week)||1
11196143|NCT01800916|12386265|FG004|NOT COMPLETED|Test Period 1 (1 Week)||1
11196144|NCT01800916|12386266|FG005|NOT COMPLETED|Test Period 1 (1 Week)||0
11196145|NCT01800916|12386267|FG006|NOT COMPLETED|Test Period 1 (1 Week)||0
11196146|NCT01800916|12386268|FG007|NOT COMPLETED|Test Period 1 (1 Week)||0
11196147|NCT01800916|12386269|FG008|NOT COMPLETED|Test Period 1 (1 Week)||0
11196148|NCT01800916|12386261|FG000|STARTED|Test Period 2 (1 Week)||7
11196149|NCT01800916|12386262|FG001|STARTED|Test Period 2 (1 Week)||7
11196150|NCT01800916|12386263|FG002|STARTED|Test Period 2 (1 Week)||7
11196151|NCT01800916|12386264|FG003|STARTED|Test Period 2 (1 Week)||6
11196152|NCT01800916|12386265|FG004|STARTED|Test Period 2 (1 Week)||7
11196153|NCT01800916|12386266|FG005|STARTED|Test Period 2 (1 Week)||7
11196154|NCT01800916|12386267|FG006|STARTED|Test Period 2 (1 Week)||7
11196155|NCT01800916|12386268|FG007|STARTED|Test Period 2 (1 Week)||7
11196156|NCT01800916|12386269|FG008|STARTED|Test Period 2 (1 Week)||7
11196157|NCT01800916|12386261|FG000|COMPLETED|Test Period 2 (1 Week)||7
11196158|NCT01800916|12386262|FG001|COMPLETED|Test Period 2 (1 Week)||7
11196159|NCT01800916|12386263|FG002|COMPLETED|Test Period 2 (1 Week)||7
11196160|NCT01800916|12386264|FG003|COMPLETED|Test Period 2 (1 Week)||6
11196161|NCT01800916|12386265|FG004|COMPLETED|Test Period 2 (1 Week)||7
11196162|NCT01800916|12386266|FG005|COMPLETED|Test Period 2 (1 Week)||7
11196163|NCT01800916|12386267|FG006|COMPLETED|Test Period 2 (1 Week)||7
11196164|NCT01800916|12386268|FG007|COMPLETED|Test Period 2 (1 Week)||7
11196165|NCT01800916|12386269|FG008|COMPLETED|Test Period 2 (1 Week)||7
11196166|NCT01800916|12386261|FG000|NOT COMPLETED|Test Period 2 (1 Week)||0
11196167|NCT01800916|12386262|FG001|NOT COMPLETED|Test Period 2 (1 Week)||0
11196168|NCT01800916|12386263|FG002|NOT COMPLETED|Test Period 2 (1 Week)||0
11196169|NCT01800916|12386264|FG003|NOT COMPLETED|Test Period 2 (1 Week)||0
11196170|NCT01800916|12386265|FG004|NOT COMPLETED|Test Period 2 (1 Week)||0
11196171|NCT01800916|12386266|FG005|NOT COMPLETED|Test Period 2 (1 Week)||0
11196172|NCT01800916|12386267|FG006|NOT COMPLETED|Test Period 2 (1 Week)||0
11196173|NCT01800916|12386268|FG007|NOT COMPLETED|Test Period 2 (1 Week)||0
11196174|NCT01800916|12386269|FG008|NOT COMPLETED|Test Period 2 (1 Week)||0
11196175|NCT01800916|12386261|FG000|STARTED|Test Period 3 (1 Week)||7
11196176|NCT01800916|12386262|FG001|STARTED|Test Period 3 (1 Week)||7
11196177|NCT01800916|12386263|FG002|STARTED|Test Period 3 (1 Week)||7
11196178|NCT01800916|12386264|FG003|STARTED|Test Period 3 (1 Week)||6
11196179|NCT01800916|12386265|FG004|STARTED|Test Period 3 (1 Week)||7
11196180|NCT01800916|12386266|FG005|STARTED|Test Period 3 (1 Week)||7
11196181|NCT01800916|12386267|FG006|STARTED|Test Period 3 (1 Week)||7
11196182|NCT01800916|12386268|FG007|STARTED|Test Period 3 (1 Week)||7
11196183|NCT01800916|12386269|FG008|STARTED|Test Period 3 (1 Week)||7
11196184|NCT01800916|12386261|FG000|COMPLETED|Test Period 3 (1 Week)||7
11196185|NCT01800916|12386262|FG001|COMPLETED|Test Period 3 (1 Week)||7
11196186|NCT01800916|12386263|FG002|COMPLETED|Test Period 3 (1 Week)||7
11196187|NCT01800916|12386264|FG003|COMPLETED|Test Period 3 (1 Week)||6
11196188|NCT01800916|12386265|FG004|COMPLETED|Test Period 3 (1 Week)||7
11196189|NCT01800916|12386266|FG005|COMPLETED|Test Period 3 (1 Week)||7
11196190|NCT01800916|12386267|FG006|COMPLETED|Test Period 3 (1 Week)||7
11196191|NCT01800916|12386268|FG007|COMPLETED|Test Period 3 (1 Week)||7
11196192|NCT01800916|12386269|FG008|COMPLETED|Test Period 3 (1 Week)||7
11196193|NCT01800916|12386261|FG000|NOT COMPLETED|Test Period 3 (1 Week)||0
11196194|NCT01800916|12386262|FG001|NOT COMPLETED|Test Period 3 (1 Week)||0
11196195|NCT01800916|12386263|FG002|NOT COMPLETED|Test Period 3 (1 Week)||0
11196196|NCT01800916|12386264|FG003|NOT COMPLETED|Test Period 3 (1 Week)||0
11196197|NCT01800916|12386265|FG004|NOT COMPLETED|Test Period 3 (1 Week)||0
11196198|NCT01800916|12386266|FG005|NOT COMPLETED|Test Period 3 (1 Week)||0
11196199|NCT01800916|12386267|FG006|NOT COMPLETED|Test Period 3 (1 Week)||0
11196200|NCT01800916|12386268|FG007|NOT COMPLETED|Test Period 3 (1 Week)||0
11196201|NCT01800916|12386269|FG008|NOT COMPLETED|Test Period 3 (1 Week)||0
11196202|NCT01800968|12386281|FG000|STARTED|Overall Study||154
11196203|NCT01800968|12386282|FG001|STARTED|Overall Study||146
11196204|NCT01800968|12386281|FG000|COMPLETED|Overall Study||118
11196205|NCT01800968|12386282|FG001|COMPLETED|Overall Study||114
11196206|NCT01800968|12386281|FG000|NOT COMPLETED|Overall Study||36
11196207|NCT01800968|12386282|FG001|NOT COMPLETED|Overall Study||32
11196208|NCT01801007|12386288|FG000|STARTED|Overall Study||145
11196209|NCT01801007|12386288|FG000|COMPLETED|Overall Study||134
11196210|NCT01801007|12386288|FG000|NOT COMPLETED|Overall Study||11
11196211|NCT01801111|12386292|FG000|STARTED|Overall Study||138
11196212|NCT01801111|12386292|FG000|COMPLETED|Overall Study||0
11196213|NCT01801111|12386292|FG000|NOT COMPLETED|Overall Study||138
11196214|NCT01801124|12386296|FG000|STARTED|Overall Study||13
11196215|NCT01801124|12386296|FG000|COMPLETED|Overall Study||13
11196216|NCT01801124|12386296|FG000|NOT COMPLETED|Overall Study||0
11196217|NCT01801241|12386302|FG000|STARTED|Overall Study||29
11196218|NCT01801241|12386303|FG001|STARTED|Overall Study||27
11196219|NCT01801241|12386302|FG000|COMPLETED|Overall Study||21
11196220|NCT01801241|12386303|FG001|COMPLETED|Overall Study||25
11196221|NCT01801241|12386302|FG000|NOT COMPLETED|Overall Study||8
11196222|NCT01801241|12386303|FG001|NOT COMPLETED|Overall Study||2
11196223|NCT01801280|12386313|FG000|STARTED|Period 1|Each period lasted 10-14 weeks|5
11196224|NCT01801280|12386314|FG001|STARTED|Period 1||5
11196225|NCT01801280|12386315|FG002|STARTED|Period 1||5
11196226|NCT01801280|12386316|FG003|STARTED|Period 1||5
11196227|NCT01801280|12386313|FG000|COMPLETED|Period 1||5
11196228|NCT01801280|12386314|FG001|COMPLETED|Period 1||4
11196229|NCT01801280|12386315|FG002|COMPLETED|Period 1||5
11196230|NCT01801280|12386316|FG003|COMPLETED|Period 1||5
11196231|NCT01801280|12386313|FG000|NOT COMPLETED|Period 1||0
11196232|NCT01801280|12386314|FG001|NOT COMPLETED|Period 1||1
11196233|NCT01801280|12386315|FG002|NOT COMPLETED|Period 1||0
11196234|NCT01801280|12386316|FG003|NOT COMPLETED|Period 1||0
11196235|NCT01801280|12386313|FG000|STARTED|Period 2||5
11196236|NCT01801280|12386314|FG001|STARTED|Period 2||4
11196237|NCT01801280|12386315|FG002|STARTED|Period 2||5
11324621|NCT02746627|12521948|FG000|STARTED|Overall Study||60
11324622|NCT02746627|12521949|FG001|STARTED|Overall Study||30
11324623|NCT02746627|12521950|FG002|STARTED|Overall Study||30
11324624|NCT02746627|12521948|FG000|COMPLETED|Overall Study||59
11324625|NCT02746627|12521949|FG001|COMPLETED|Overall Study||29
11324626|NCT02746627|12521950|FG002|COMPLETED|Overall Study||29
11324627|NCT02746627|12521948|FG000|NOT COMPLETED|Overall Study||1
11324628|NCT02746627|12521949|FG001|NOT COMPLETED|Overall Study||1
11324629|NCT02746627|12521950|FG002|NOT COMPLETED|Overall Study||1
11324630|NCT02746679|12521960|FG000|STARTED|Overall Study||80
11324631|NCT02746679|12521961|FG001|STARTED|Overall Study||81
11324632|NCT02746679|12521960|FG000|COMPLETED|Overall Study||76
11324633|NCT02746679|12521961|FG001|COMPLETED|Overall Study||75
11324634|NCT02746679|12521960|FG000|NOT COMPLETED|Overall Study||4
11324635|NCT02746679|12521961|FG001|NOT COMPLETED|Overall Study||6
11324636|NCT02746705|12521969|FG000|STARTED|Overall Study||17
11324637|NCT02746705|12521970|FG001|STARTED|Overall Study||14
11324638|NCT02746705|12521969|FG000|COMPLETED|Overall Study||15
11324639|NCT02746705|12521970|FG001|COMPLETED|Overall Study||12
11324640|NCT02746705|12521969|FG000|NOT COMPLETED|Overall Study||2
11324641|NCT02746705|12521970|FG001|NOT COMPLETED|Overall Study||2
11324642|NCT02746874|12521978|FG000|STARTED|Overall Study||35
11324643|NCT02746874|12521979|FG001|STARTED|Overall Study||35
11324644|NCT02746874|12521978|FG000|COMPLETED|Overall Study||35
11324645|NCT02746874|12521979|FG001|COMPLETED|Overall Study||32
11324646|NCT02746874|12521978|FG000|NOT COMPLETED|Overall Study||0
11324647|NCT02746874|12521979|FG001|NOT COMPLETED|Overall Study||3
11324648|NCT02746991|12521987|FG000|STARTED|Overall Study||52
11324649|NCT02746991|12521988|FG001|STARTED|Overall Study||101
11324650|NCT02746991|12521987|FG000|COMPLETED|Overall Study||24
11324651|NCT02746991|12521988|FG001|COMPLETED|Overall Study||67
11324652|NCT02746991|12521987|FG000|NOT COMPLETED|Overall Study||28
11324653|NCT02746991|12521988|FG001|NOT COMPLETED|Overall Study||34
11324654|NCT02747108|12521998|FG000|STARTED|Overall Study||253
11324655|NCT02747108|12521999|FG001|STARTED|Overall Study||62
11324656|NCT02747108|12521998|FG000|COMPLETED|Overall Study||248
11324657|NCT02747108|12521999|FG001|COMPLETED|Overall Study||60
11324658|NCT02747108|12521998|FG000|NOT COMPLETED|Overall Study||5
11324659|NCT02747108|12521999|FG001|NOT COMPLETED|Overall Study||2
11324660|NCT02747186|12522012|FG000|STARTED|First Intervention||12
11324661|NCT02747186|12522013|FG001|STARTED|First Intervention||12
11324662|NCT02747186|12522012|FG000|COMPLETED|First Intervention||12
11324663|NCT02747186|12522013|FG001|COMPLETED|First Intervention||12
11324664|NCT02747186|12522012|FG000|NOT COMPLETED|First Intervention||0
11324665|NCT02747186|12522013|FG001|NOT COMPLETED|First Intervention||0
11324666|NCT02747186|12522012|FG000|STARTED|Washout (1 Week)||12
11324667|NCT02747186|12522013|FG001|STARTED|Washout (1 Week)||12
11324668|NCT02747186|12522012|FG000|COMPLETED|Washout (1 Week)||12
11324669|NCT02747186|12522013|FG001|COMPLETED|Washout (1 Week)||12
11324670|NCT02747186|12522012|FG000|NOT COMPLETED|Washout (1 Week)||0
11324671|NCT02747186|12522013|FG001|NOT COMPLETED|Washout (1 Week)||0
11324672|NCT02747186|12522012|FG000|STARTED|Second Intervention||12
11324673|NCT02747186|12522013|FG001|STARTED|Second Intervention||12
11324674|NCT02747186|12522012|FG000|COMPLETED|Second Intervention||12
11324675|NCT02747186|12522013|FG001|COMPLETED|Second Intervention||12
11196238|NCT01801280|12386316|FG003|STARTED|Period 2||5
11196239|NCT01801280|12386313|FG000|COMPLETED|Period 2||4
11196240|NCT01801280|12386314|FG001|COMPLETED|Period 2||4
11196241|NCT01801280|12386315|FG002|COMPLETED|Period 2||5
11196242|NCT01801280|12386316|FG003|COMPLETED|Period 2||5
11196243|NCT01801280|12386313|FG000|NOT COMPLETED|Period 2||1
11196244|NCT01801280|12386314|FG001|NOT COMPLETED|Period 2||0
11196245|NCT01801280|12386315|FG002|NOT COMPLETED|Period 2||0
11196246|NCT01801280|12386316|FG003|NOT COMPLETED|Period 2||0
11196247|NCT01801280|12386313|FG000|STARTED|Period 3||4
11196248|NCT01801280|12386314|FG001|STARTED|Period 3||4
11196249|NCT01801280|12386315|FG002|STARTED|Period 3||5
11196250|NCT01801280|12386316|FG003|STARTED|Period 3||5
11196251|NCT01801280|12386313|FG000|COMPLETED|Period 3||4
11196252|NCT01801280|12386314|FG001|COMPLETED|Period 3||4
11196253|NCT01801280|12386315|FG002|COMPLETED|Period 3||5
11196254|NCT01801280|12386316|FG003|COMPLETED|Period 3||5
11196255|NCT01801280|12386313|FG000|NOT COMPLETED|Period 3||0
11196256|NCT01801280|12386314|FG001|NOT COMPLETED|Period 3||0
11196257|NCT01801280|12386315|FG002|NOT COMPLETED|Period 3||0
11196258|NCT01801280|12386316|FG003|NOT COMPLETED|Period 3||0
11196259|NCT01801280|12386313|FG000|STARTED|Period 4||4
11196260|NCT01801280|12386314|FG001|STARTED|Period 4||4
11196261|NCT01801280|12386315|FG002|STARTED|Period 4||5
11196262|NCT01801280|12386316|FG003|STARTED|Period 4||5
11196263|NCT01801280|12386313|FG000|COMPLETED|Period 4||4
11196264|NCT01801280|12386314|FG001|COMPLETED|Period 4||4
11196265|NCT01801280|12386315|FG002|COMPLETED|Period 4||4
11196266|NCT01801280|12386316|FG003|COMPLETED|Period 4||5
11196267|NCT01801280|12386313|FG000|NOT COMPLETED|Period 4||0
11196268|NCT01801280|12386314|FG001|NOT COMPLETED|Period 4||0
11196269|NCT01801280|12386315|FG002|NOT COMPLETED|Period 4||1
11196270|NCT01801280|12386316|FG003|NOT COMPLETED|Period 4||0
11196271|NCT01801358|12386332|FG000|STARTED|Overall Study||6
11196272|NCT01801358|12386333|FG001|STARTED|Overall Study||6
11196273|NCT01801358|12386334|FG002|STARTED|Overall Study||6
11196274|NCT01801358|12386335|FG003|STARTED|Overall Study||6
11196275|NCT01801358|12386336|FG004|STARTED|Overall Study||6
11196276|NCT01801358|12386337|FG005|STARTED|Overall Study||8
11196277|NCT01801358|12386332|FG000|COMPLETED|Overall Study||0
11196278|NCT01801358|12386333|FG001|COMPLETED|Overall Study||0
11196279|NCT01801358|12386334|FG002|COMPLETED|Overall Study||0
11196280|NCT01801358|12386335|FG003|COMPLETED|Overall Study||0
11196281|NCT01801358|12386336|FG004|COMPLETED|Overall Study||0
11196282|NCT01801358|12386337|FG005|COMPLETED|Overall Study||0
11196283|NCT01801358|12386332|FG000|NOT COMPLETED|Overall Study||6
11196284|NCT01801358|12386333|FG001|NOT COMPLETED|Overall Study||6
11196285|NCT01801358|12386334|FG002|NOT COMPLETED|Overall Study||6
11196286|NCT01801358|12386335|FG003|NOT COMPLETED|Overall Study||6
11196287|NCT01801358|12386336|FG004|NOT COMPLETED|Overall Study||6
11196288|NCT01801358|12386337|FG005|NOT COMPLETED|Overall Study||8
11196289|NCT01801436|12386372|FG000|STARTED|Overall Study||14
11196290|NCT01801436|12386372|FG000|COMPLETED|Overall Study||5
11196291|NCT01801436|12386372|FG000|NOT COMPLETED|Overall Study||9
11196292|NCT01801449|12386376|FG000|STARTED|Overall Study||6
11196293|NCT01801449|12386376|FG000|COMPLETED|Overall Study||6
11196294|NCT01801449|12386376|FG000|NOT COMPLETED|Overall Study||0
11196295|NCT01801475|12386384|FG000|STARTED|Overall Study||10
11196296|NCT01801475|12386385|FG001|STARTED|Overall Study||30
11196297|NCT01801475|12386386|FG002|STARTED|Overall Study||10
11196298|NCT01801475|12386387|FG003|STARTED|Overall Study||10
11196299|NCT01801475|12386388|FG004|STARTED|Overall Study||40
11196300|NCT01801475|12386384|FG000|COMPLETED|Overall Study||10
11196301|NCT01801475|12386385|FG001|COMPLETED|Overall Study||30
11196302|NCT01801475|12386386|FG002|COMPLETED|Overall Study||10
11196303|NCT01801475|12386387|FG003|COMPLETED|Overall Study||10
11196304|NCT01801475|12386388|FG004|COMPLETED|Overall Study||39
11196305|NCT01801475|12386384|FG000|NOT COMPLETED|Overall Study||0
11196306|NCT01801475|12386385|FG001|NOT COMPLETED|Overall Study||0
11196307|NCT01801475|12386386|FG002|NOT COMPLETED|Overall Study||0
11196308|NCT01801475|12386387|FG003|NOT COMPLETED|Overall Study||0
11196309|NCT01801475|12386388|FG004|NOT COMPLETED|Overall Study||1
11196310|NCT01801735|12386397|FG000|STARTED|Overall Study||600
11196311|NCT01801735|12386397|FG000|COMPLETED|Overall Study||390
11196312|NCT01801735|12386397|FG000|NOT COMPLETED|Overall Study||210
11196313|NCT01801865|12386401|FG000|STARTED|Overall Study||657
11196314|NCT01801865|12386401|FG000|COMPLETED|Overall Study||615
11196315|NCT01801865|12386401|FG000|NOT COMPLETED|Overall Study||42
11196316|NCT01801917|12386409|FG000|STARTED|Period 1 - Randomized||7
11196317|NCT01801917|12386410|FG001|STARTED|Period 1 - Randomized||2
11196318|NCT01801917|12386411|FG002|STARTED|Period 1 - Randomized||4
11196319|NCT01801917|12386412|FG003|STARTED|Period 1 - Randomized||1
11196320|NCT01801917|12386409|FG000|COMPLETED|Period 1 - Randomized||6
11196321|NCT01801917|12386410|FG001|COMPLETED|Period 1 - Randomized||2
11196322|NCT01801917|12386411|FG002|COMPLETED|Period 1 - Randomized||3
11196323|NCT01801917|12386412|FG003|COMPLETED|Period 1 - Randomized||1
11196324|NCT01801917|12386409|FG000|NOT COMPLETED|Period 1 - Randomized||1
11196325|NCT01801917|12386410|FG001|NOT COMPLETED|Period 1 - Randomized||0
11196326|NCT01801917|12386411|FG002|NOT COMPLETED|Period 1 - Randomized||1
11196327|NCT01801917|12386412|FG003|NOT COMPLETED|Period 1 - Randomized||0
11196328|NCT01801917|12386409|FG000|STARTED|Extension - All Active||6
11196329|NCT01801917|12386410|FG001|STARTED|Extension - All Active||0
11196330|NCT01801917|12386411|FG002|STARTED|Extension - All Active||3
11196331|NCT01801917|12386412|FG003|STARTED|Extension - All Active||0
11196332|NCT01801917|12386409|FG000|COMPLETED|Extension - All Active||6
11196333|NCT01801917|12386410|FG001|COMPLETED|Extension - All Active||0
11196334|NCT01801917|12386411|FG002|COMPLETED|Extension - All Active||3
11196335|NCT01801917|12386412|FG003|COMPLETED|Extension - All Active||0
11196336|NCT01801917|12386409|FG000|NOT COMPLETED|Extension - All Active||0
11196337|NCT01801917|12386410|FG001|NOT COMPLETED|Extension - All Active||0
11196338|NCT01801917|12386411|FG002|NOT COMPLETED|Extension - All Active||0
11196339|NCT01801917|12386412|FG003|NOT COMPLETED|Extension - All Active||0
11196340|NCT01801930|12386427|FG000|STARTED|Overall Study||6
11196341|NCT01801930|12386428|FG001|STARTED|Overall Study||6
11196342|NCT01801930|12386429|FG002|STARTED|Overall Study||6
11196343|NCT01801930|12386430|FG003|STARTED|Overall Study||6
11196344|NCT01801930|12386427|FG000|COMPLETED|Overall Study||0
11196345|NCT01801930|12386428|FG001|COMPLETED|Overall Study||0
11196346|NCT01801930|12386429|FG002|COMPLETED|Overall Study||0
11196347|NCT01801930|12386430|FG003|COMPLETED|Overall Study||0
11196348|NCT01801930|12386427|FG000|NOT COMPLETED|Overall Study||6
11196349|NCT01801930|12386428|FG001|NOT COMPLETED|Overall Study||6
11196350|NCT01801930|12386429|FG002|NOT COMPLETED|Overall Study||6
11196351|NCT01801930|12386430|FG003|NOT COMPLETED|Overall Study||6
11196352|NCT01801982|12386440|FG000|STARTED|Overall Study||1
11196353|NCT01801982|12386440|FG000|COMPLETED|Overall Study||0
11196354|NCT01801982|12386440|FG000|NOT COMPLETED|Overall Study||1
11196355|NCT01802073|12386446|FG000|STARTED|Overall Study||14
11196356|NCT01802073|12386447|FG001|STARTED|Overall Study||20
11196357|NCT01802073|12386446|FG000|COMPLETED|Overall Study||9
11196358|NCT01802073|12386447|FG001|COMPLETED|Overall Study||9
11196359|NCT01802073|12386446|FG000|NOT COMPLETED|Overall Study||5
11196360|NCT01802073|12386447|FG001|NOT COMPLETED|Overall Study||11
11196361|NCT01802151|12386457|FG000|STARTED|Overall Study||20
11196362|NCT01802151|12386458|FG001|STARTED|Overall Study||21
11196363|NCT01802151|12386459|FG002|STARTED|Overall Study||22
11196364|NCT01802151|12386460|FG003|STARTED|Overall Study||20
11196365|NCT01802151|12386457|FG000|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
11196366|NCT01802151|12386458|FG001|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
11196367|NCT01802151|12386459|FG002|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
11196368|NCT01802151|12386460|FG003|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
11196369|NCT01802151|12386457|FG000|NOT COMPLETED|Overall Study||0
11196370|NCT01802151|12386458|FG001|NOT COMPLETED|Overall Study||0
11196371|NCT01802151|12386459|FG002|NOT COMPLETED|Overall Study||2
11196372|NCT01802151|12386460|FG003|NOT COMPLETED|Overall Study||0
11196373|NCT01802216|12386472|FG000|STARTED|Baseline||17
11196374|NCT01802216|12386473|FG001|STARTED|Baseline||34
11196375|NCT01802216|12386472|FG000|COMPLETED|Baseline||17
11196376|NCT01802216|12386473|FG001|COMPLETED|Baseline||34
11196377|NCT01802216|12386472|FG000|NOT COMPLETED|Baseline||0
11196378|NCT01802216|12386473|FG001|NOT COMPLETED|Baseline||0
11196379|NCT01802216|12386472|FG000|STARTED|4 Month Visit||17
11196380|NCT01802216|12386473|FG001|STARTED|4 Month Visit||34
11196381|NCT01802216|12386472|FG000|COMPLETED|4 Month Visit||14
11196382|NCT01802216|12386473|FG001|COMPLETED|4 Month Visit||30
11196383|NCT01802216|12386472|FG000|NOT COMPLETED|4 Month Visit||3
11196384|NCT01802216|12386473|FG001|NOT COMPLETED|4 Month Visit||4
11196385|NCT01802216|12386472|FG000|STARTED|8 Month Visit||17
11196386|NCT01802216|12386473|FG001|STARTED|8 Month Visit||34
11196387|NCT01802216|12386472|FG000|COMPLETED|8 Month Visit||14
11196388|NCT01802216|12386473|FG001|COMPLETED|8 Month Visit||29
11196389|NCT01802216|12386472|FG000|NOT COMPLETED|8 Month Visit||3
11196390|NCT01802216|12386473|FG001|NOT COMPLETED|8 Month Visit||5
11196391|NCT01802216|12386472|FG000|STARTED|12 Month Visit||17
11196392|NCT01802216|12386473|FG001|STARTED|12 Month Visit||34
11196393|NCT01802216|12386472|FG000|COMPLETED|12 Month Visit||14
11196394|NCT01802216|12386473|FG001|COMPLETED|12 Month Visit||30
11196395|NCT01802216|12386472|FG000|NOT COMPLETED|12 Month Visit||3
11196396|NCT01802216|12386473|FG001|NOT COMPLETED|12 Month Visit||4
11196397|NCT01802320|12386479|FG000|STARTED|Overall Study||18
11196398|NCT01802320|12386479|FG000|COMPLETED|Overall Study||16
11196399|NCT01802320|12386479|FG000|NOT COMPLETED|Overall Study||2
11196400|NCT01802333|12386486|FG000|STARTED|Overall Study||263
11196401|NCT01802333|12386487|FG001|STARTED|Overall Study||267
11196402|NCT01802333|12386488|FG002|STARTED|Overall Study||224
11196403|NCT01802333|12386486|FG000|High Risk Patients|Overall Study||60
11196404|NCT01802333|12386487|FG001|High Risk Patients|Overall Study||61
11196405|NCT01802333|12386488|FG002|High Risk Patients|Overall Study||38
11196406|NCT01802333|12386486|FG000|High Risk Patients Achieved CR/CRi|Overall Study||38
11196407|NCT01802333|12386487|FG001|High Risk Patients Achieved CR/CRi|Overall Study||40
11196408|NCT01802333|12386488|FG002|High Risk Patients Achieved CR/CRi|Overall Study||29
11196409|NCT01802333|12386486|FG000|Known NPM1 Status at Baseline|Overall Study||169
11196410|NCT01802333|12386487|FG001|Known NPM1 Status at Baseline|Overall Study||156
11196411|NCT01802333|12386488|FG002|Known NPM1 Status at Baseline|Overall Study||142
11196412|NCT01802333|12386486|FG000|Known Cytogenetic Risk at Baseline|Overall Study||252
11196413|NCT01802333|12386487|FG001|Known Cytogenetic Risk at Baseline|Overall Study||250
11196414|NCT01802333|12386488|FG002|Known Cytogenetic Risk at Baseline|Overall Study||210
11196415|NCT01802333|12386486|FG000|COMPLETED|Overall Study||214
11196416|NCT01802333|12386487|FG001|COMPLETED|Overall Study||206
11196417|NCT01802333|12386488|FG002|COMPLETED|Overall Study||161
11196418|NCT01802333|12386486|FG000|NOT COMPLETED|Overall Study||49
11196419|NCT01802333|12386487|FG001|NOT COMPLETED|Overall Study||61
11196420|NCT01802333|12386488|FG002|NOT COMPLETED|Overall Study||63
11196421|NCT01802385|12386504|FG000|STARTED|Overall Study||231
11196422|NCT01802385|12386505|FG001|STARTED|Overall Study||229
11196423|NCT01802385|12386504|FG000|COMPLETED|Overall Study||125
11196424|NCT01802385|12386505|FG001|COMPLETED|Overall Study||109
11196425|NCT01802385|12386504|FG000|NOT COMPLETED|Overall Study||106
11196426|NCT01802385|12386505|FG001|NOT COMPLETED|Overall Study||120
11196427|NCT01802411|12386513|FG000|STARTED|Overall Study||96
11196428|NCT01802411|12386514|FG001|STARTED|Overall Study||95
11196429|NCT01802411|12386513|FG000|COMPLETED|Overall Study||82
11196430|NCT01802411|12386514|FG001|COMPLETED|Overall Study||74
11196431|NCT01802411|12386513|FG000|NOT COMPLETED|Overall Study||14
11196432|NCT01802411|12386514|FG001|NOT COMPLETED|Overall Study||21
11196433|NCT01802437|12386522|FG000|STARTED|Overall Study||20
11196434|NCT01802437|12386523|FG001|STARTED|Overall Study||20
11196435|NCT01802437|12386522|FG000|COMPLETED|Overall Study||16
11196436|NCT01802437|12386523|FG001|COMPLETED|Overall Study||16
11196437|NCT01802437|12386522|FG000|NOT COMPLETED|Overall Study||4
11196438|NCT01802437|12386523|FG001|NOT COMPLETED|Overall Study||4
11196439|NCT01802515|12386532|FG000|STARTED|Overall Study||5
11196440|NCT01802515|12386533|FG001|STARTED|Overall Study||5
11196441|NCT01802515|12386534|FG002|STARTED|Overall Study||4
11196442|NCT01802515|12386532|FG000|COMPLETED|Overall Study||2
11196443|NCT01802515|12386533|FG001|COMPLETED|Overall Study||5
11196444|NCT01802515|12386534|FG002|COMPLETED|Overall Study||4
11196445|NCT01802515|12386532|FG000|NOT COMPLETED|Overall Study||3
11196446|NCT01802515|12386533|FG001|NOT COMPLETED|Overall Study||0
11196447|NCT01802515|12386534|FG002|NOT COMPLETED|Overall Study||0
11196448|NCT01802554|12386544|FG000|STARTED|Overall Study||51
11196449|NCT01802554|12386545|FG001|STARTED|Overall Study||49
11196450|NCT01802554|12386544|FG000|COMPLETED|Overall Study||43
11196451|NCT01802554|12386545|FG001|COMPLETED|Overall Study||43
11196452|NCT01802554|12386544|FG000|NOT COMPLETED|Overall Study||8
11196453|NCT01802554|12386545|FG001|NOT COMPLETED|Overall Study||6
11196454|NCT01802580|12386553|FG000|STARTED|Overall Study||20
11196455|NCT01802580|12386554|FG001|STARTED|Overall Study||20
11196456|NCT01802580|12386553|FG000|COMPLETED|Overall Study||11
11196457|NCT01802580|12386554|FG001|COMPLETED|Overall Study||9
11196458|NCT01802580|12386553|FG000|NOT COMPLETED|Overall Study||9
11196459|NCT01802580|12386554|FG001|NOT COMPLETED|Overall Study||11
11196460|NCT01802710|12386562|FG000|STARTED|From T0 to T1||76
11196461|NCT01802710|12386563|FG001|STARTED|From T0 to T1||82
11196462|NCT01802710|12386562|FG000|COMPLETED|From T0 to T1||60
11196463|NCT01802710|12386563|FG001|COMPLETED|From T0 to T1||72
11196464|NCT01802710|12386562|FG000|NOT COMPLETED|From T0 to T1||16
11196465|NCT01802710|12386563|FG001|NOT COMPLETED|From T0 to T1||10
11196466|NCT01802710|12386562|FG000|STARTED|From T1 to T2||60
11196467|NCT01802710|12386563|FG001|STARTED|From T1 to T2||72
11196468|NCT01802710|12386562|FG000|COMPLETED|From T1 to T2||58
11196469|NCT01802710|12386563|FG001|COMPLETED|From T1 to T2||70
11196470|NCT01802710|12386562|FG000|NOT COMPLETED|From T1 to T2||2
11196471|NCT01802710|12386563|FG001|NOT COMPLETED|From T1 to T2||2
11196472|NCT01802775|12386573|FG000|STARTED|Overall Study||102
11196473|NCT01802775|12386574|FG001|STARTED|Overall Study||101
11196474|NCT01802775|12386573|FG000|Received Drug (Safety Analysis Set)|Overall Study||101
11196475|NCT01802775|12386574|FG001|Received Drug (Safety Analysis Set)|Overall Study||100
11196476|NCT01802775|12386573|FG000|COMPLETED|Overall Study||96
11196477|NCT01802775|12386574|FG001|COMPLETED|Overall Study||89
11196478|NCT01802775|12386573|FG000|NOT COMPLETED|Overall Study||6
11196479|NCT01802775|12386574|FG001|NOT COMPLETED|Overall Study||12
11196480|NCT01802879|12386580|FG000|STARTED|Overall Study||8
11196481|NCT01802879|12386580|FG000|COMPLETED|Overall Study||0
11196482|NCT01802879|12386580|FG000|NOT COMPLETED|Overall Study||8
11196483|NCT01803074|12386598|FG000|STARTED|Period 1: Part A (HIV-1 Clade B)||8
11196484|NCT01803074|12386599|FG001|STARTED|Period 1: Part A (HIV-1 Clade B)||8
11196485|NCT01803074|12386600|FG002|STARTED|Period 1: Part A (HIV-1 Clade B)||8
11196486|NCT01803074|12386601|FG003|STARTED|Period 1: Part A (HIV-1 Clade B)||8
11196487|NCT01803074|12386602|FG004|STARTED|Period 1: Part A (HIV-1 Clade B)||8
11196488|NCT01803074|12386603|FG005|STARTED|Period 1: Part A (HIV-1 Clade B)||8
11196489|NCT01803074|12386604|FG006|STARTED|Period 1: Part A (HIV-1 Clade B)||12
11196490|NCT01803074|12386605|FG007|STARTED|Period 1: Part A (HIV-1 Clade B)||0
11196491|NCT01803074|12386606|FG008|STARTED|Period 1: Part A (HIV-1 Clade B)||0
11196492|NCT01803074|12386607|FG009|STARTED|Period 1: Part A (HIV-1 Clade B)||0
11196493|NCT01803074|12386608|FG010|STARTED|Period 1: Part A (HIV-1 Clade B)||0
11196494|NCT01803074|12386609|FG011|STARTED|Period 1: Part A (HIV-1 Clade B)||0
11196495|NCT01803074|12386610|FG012|STARTED|Period 1: Part A (HIV-1 Clade B)||0
11196496|NCT01803074|12386611|FG013|STARTED|Period 1: Part A (HIV-1 Clade B)||0
11196497|NCT01803074|12386598|FG000|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
11196498|NCT01803074|12386599|FG001|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
11196499|NCT01803074|12386600|FG002|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
11196500|NCT01803074|12386601|FG003|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
11196501|NCT01803074|12386602|FG004|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
11196502|NCT01803074|12386603|FG005|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
11196503|NCT01803074|12386604|FG006|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12
11196504|NCT01803074|12386605|FG007|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196505|NCT01803074|12386606|FG008|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196506|NCT01803074|12386607|FG009|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196507|NCT01803074|12386608|FG010|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196508|NCT01803074|12386609|FG011|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196509|NCT01803074|12386610|FG012|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196510|NCT01803074|12386611|FG013|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196511|NCT01803074|12386598|FG000|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196512|NCT01803074|12386599|FG001|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196513|NCT01803074|12386600|FG002|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196514|NCT01803074|12386601|FG003|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196515|NCT01803074|12386602|FG004|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196516|NCT01803074|12386603|FG005|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196517|NCT01803074|12386604|FG006|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196518|NCT01803074|12386605|FG007|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196519|NCT01803074|12386606|FG008|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196520|NCT01803074|12386607|FG009|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196521|NCT01803074|12386608|FG010|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196522|NCT01803074|12386609|FG011|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196523|NCT01803074|12386610|FG012|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196524|NCT01803074|12386611|FG013|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
11196525|NCT01803074|12386598|FG000|STARTED|Period 2: Part B (HIV-1 Clade B)||0
11196526|NCT01803074|12386599|FG001|STARTED|Period 2: Part B (HIV-1 Clade B)||0
11196527|NCT01803074|12386600|FG002|STARTED|Period 2: Part B (HIV-1 Clade B)||0
11196528|NCT01803074|12386601|FG003|STARTED|Period 2: Part B (HIV-1 Clade B)||0
11196529|NCT01803074|12386602|FG004|STARTED|Period 2: Part B (HIV-1 Clade B)||0
11196530|NCT01803074|12386603|FG005|STARTED|Period 2: Part B (HIV-1 Clade B)||0
11196531|NCT01803074|12386604|FG006|STARTED|Period 2: Part B (HIV-1 Clade B)||0
11196532|NCT01803074|12386605|FG007|STARTED|Period 2: Part B (HIV-1 Clade B)||8
11196533|NCT01803074|12386606|FG008|STARTED|Period 2: Part B (HIV-1 Clade B)||8
11196534|NCT01803074|12386607|FG009|STARTED|Period 2: Part B (HIV-1 Clade B)||4
11027019|NCT00831675|12205663|FG001|NOT COMPLETED|Overall Study||0
11027020|NCT00831701|12205671|FG000|STARTED|Overall Study||50
11027021|NCT00831701|12205672|FG001|STARTED|Overall Study||50
11027022|NCT00831701|12205671|FG000|COMPLETED|Overall Study||45
11196535|NCT01803074|12386608|FG010|STARTED|Period 2: Part B (HIV-1 Clade B)||8
11196536|NCT01803074|12386609|FG011|STARTED|Period 2: Part B (HIV-1 Clade B)||0
11196537|NCT01803074|12386610|FG012|STARTED|Period 2: Part B (HIV-1 Clade B)||0
11196538|NCT01803074|12386611|FG013|STARTED|Period 2: Part B (HIV-1 Clade B)||0
11196539|NCT01803074|12386598|FG000|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11027023|NCT00831701|12205672|FG001|COMPLETED|Overall Study||45
11027024|NCT00831701|12205671|FG000|NOT COMPLETED|Overall Study||5
11027025|NCT00831701|12205672|FG001|NOT COMPLETED|Overall Study||5
11027026|NCT00831753|12205680|FG000|STARTED|Overall Study||132
11027027|NCT00831753|12205681|FG001|STARTED|Overall Study||131
11027028|NCT00831753|12205680|FG000|COMPLETED|Overall Study||132
11027029|NCT00831753|12205681|FG001|COMPLETED|Overall Study||131
11027030|NCT00831753|12205680|FG000|NOT COMPLETED|Overall Study||0
11027031|NCT00831753|12205681|FG001|NOT COMPLETED|Overall Study||0
11027032|NCT00831766|12205689|FG000|STARTED|Overall Study||23
11196540|NCT01803074|12386599|FG001|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196541|NCT01803074|12386600|FG002|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196542|NCT01803074|12386601|FG003|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196543|NCT01803074|12386602|FG004|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196544|NCT01803074|12386603|FG005|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196545|NCT01803074|12386604|FG006|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196546|NCT01803074|12386605|FG007|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
11196547|NCT01803074|12386606|FG008|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
11196548|NCT01803074|12386607|FG009|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4
11196549|NCT01803074|12386608|FG010|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
11196550|NCT01803074|12386609|FG011|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196551|NCT01803074|12386610|FG012|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196552|NCT01803074|12386611|FG013|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196553|NCT01803074|12386598|FG000|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196554|NCT01803074|12386599|FG001|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196555|NCT01803074|12386600|FG002|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196556|NCT01803074|12386601|FG003|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196557|NCT01803074|12386602|FG004|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196558|NCT01803074|12386603|FG005|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196559|NCT01803074|12386604|FG006|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196560|NCT01803074|12386605|FG007|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196561|NCT01803074|12386606|FG008|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196562|NCT01803074|12386607|FG009|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11027033|NCT00831766|12205690|FG001|STARTED|Overall Study||28
11027034|NCT00831766|12205689|FG000|COMPLETED|Overall Study||23
11196563|NCT01803074|12386608|FG010|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196564|NCT01803074|12386609|FG011|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196565|NCT01803074|12386610|FG012|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196566|NCT01803074|12386611|FG013|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
11196567|NCT01803074|12386598|FG000|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
11196568|NCT01803074|12386599|FG001|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
11196569|NCT01803074|12386600|FG002|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
11196570|NCT01803074|12386601|FG003|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
11196571|NCT01803074|12386602|FG004|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
11196572|NCT01803074|12386603|FG005|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
11196573|NCT01803074|12386604|FG006|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
11196574|NCT01803074|12386605|FG007|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
11196575|NCT01803074|12386606|FG008|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
11196576|NCT01803074|12386607|FG009|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
11196577|NCT01803074|12386608|FG010|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
11196578|NCT01803074|12386609|FG011|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8
11196579|NCT01803074|12386610|FG012|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7
11196580|NCT01803074|12386611|FG013|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4
11196581|NCT01803074|12386598|FG000|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196582|NCT01803074|12386599|FG001|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196583|NCT01803074|12386600|FG002|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196584|NCT01803074|12386601|FG003|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196585|NCT01803074|12386602|FG004|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196586|NCT01803074|12386603|FG005|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196587|NCT01803074|12386604|FG006|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196588|NCT01803074|12386605|FG007|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196589|NCT01803074|12386606|FG008|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196590|NCT01803074|12386607|FG009|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196591|NCT01803074|12386608|FG010|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196592|NCT01803074|12386609|FG011|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8
11196593|NCT01803074|12386610|FG012|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7
11196594|NCT01803074|12386611|FG013|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4
11196595|NCT01803074|12386598|FG000|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196596|NCT01803074|12386599|FG001|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196597|NCT01803074|12386600|FG002|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196598|NCT01803074|12386601|FG003|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196599|NCT01803074|12386602|FG004|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196600|NCT01803074|12386603|FG005|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196601|NCT01803074|12386604|FG006|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196602|NCT01803074|12386605|FG007|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196603|NCT01803074|12386606|FG008|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196604|NCT01803074|12386607|FG009|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196605|NCT01803074|12386608|FG010|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196606|NCT01803074|12386609|FG011|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196607|NCT01803074|12386610|FG012|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196608|NCT01803074|12386611|FG013|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
11196609|NCT01803204|12386652|FG000|STARTED|Overall Study||20
11196610|NCT01803204|12386653|FG001|STARTED|Overall Study||20
11196611|NCT01803204|12386652|FG000|COMPLETED|Overall Study||20
11196612|NCT01803204|12386653|FG001|COMPLETED|Overall Study||20
11196613|NCT01803204|12386652|FG000|NOT COMPLETED|Overall Study||0
11196614|NCT01803204|12386653|FG001|NOT COMPLETED|Overall Study||0
11196615|NCT01803269|12386662|FG000|STARTED|Overall Study||7
11196616|NCT01803269|12386663|FG001|STARTED|Overall Study||8
11196617|NCT01803269|12386664|FG002|STARTED|Overall Study||14
11196618|NCT01803269|12386662|FG000|COMPLETED|Overall Study||4
11196619|NCT01803269|12386663|FG001|COMPLETED|Overall Study||8
11196620|NCT01803269|12386664|FG002|COMPLETED|Overall Study||14
11196621|NCT01803269|12386662|FG000|NOT COMPLETED|Overall Study||3
11196622|NCT01803269|12386663|FG001|NOT COMPLETED|Overall Study||0
11196623|NCT01803269|12386664|FG002|NOT COMPLETED|Overall Study||0
11196624|NCT01803282|12386684|FG000|STARTED|Overall Study||4
11196625|NCT01803282|12386685|FG001|STARTED|Overall Study||3
11196626|NCT01803282|12386686|FG002|STARTED|Overall Study||6
11196627|NCT01803282|12386687|FG003|STARTED|Overall Study||36
11196628|NCT01803282|12386688|FG004|STARTED|Overall Study||11
11196629|NCT01803282|12386689|FG005|STARTED|Overall Study||10
11196630|NCT01803282|12386690|FG006|STARTED|Overall Study||41
11196631|NCT01803282|12386691|FG007|STARTED|Overall Study||46
11196632|NCT01803282|12386692|FG008|STARTED|Overall Study||11
11196633|NCT01803282|12386693|FG009|STARTED|Overall Study||45
11196634|NCT01803282|12386694|FG010|STARTED|Overall Study||8
11196635|NCT01803282|12386695|FG011|STARTED|Overall Study||15
11196636|NCT01803282|12386684|FG000|COMPLETED|Overall Study||0
11196637|NCT01803282|12386685|FG001|COMPLETED|Overall Study||0
11196638|NCT01803282|12386686|FG002|COMPLETED|Overall Study||0
11196639|NCT01803282|12386687|FG003|COMPLETED|Overall Study||0
11196640|NCT01803282|12386688|FG004|COMPLETED|Overall Study||0
11196641|NCT01803282|12386689|FG005|COMPLETED|Overall Study||0
11196642|NCT01803282|12386690|FG006|COMPLETED|Overall Study||0
11196643|NCT01803282|12386691|FG007|COMPLETED|Overall Study||0
11196644|NCT01803282|12386692|FG008|COMPLETED|Overall Study||0
11196645|NCT01803282|12386693|FG009|COMPLETED|Overall Study||0
11196646|NCT01803282|12386694|FG010|COMPLETED|Overall Study||0
11196647|NCT01803282|12386695|FG011|COMPLETED|Overall Study||0
11196648|NCT01803282|12386684|FG000|NOT COMPLETED|Overall Study||4
11196649|NCT01803282|12386685|FG001|NOT COMPLETED|Overall Study||3
11196650|NCT01803282|12386686|FG002|NOT COMPLETED|Overall Study||6
11196651|NCT01803282|12386687|FG003|NOT COMPLETED|Overall Study||36
11196652|NCT01803282|12386688|FG004|NOT COMPLETED|Overall Study||11
11196653|NCT01803282|12386689|FG005|NOT COMPLETED|Overall Study||10
11196654|NCT01803282|12386690|FG006|NOT COMPLETED|Overall Study||41
11196655|NCT01803282|12386691|FG007|NOT COMPLETED|Overall Study||46
11196656|NCT01803282|12386692|FG008|NOT COMPLETED|Overall Study||11
11196657|NCT01803282|12386693|FG009|NOT COMPLETED|Overall Study||45
11196658|NCT01803282|12386694|FG010|NOT COMPLETED|Overall Study||8
11196659|NCT01803282|12386695|FG011|NOT COMPLETED|Overall Study||15
11196660|NCT01803464|12386725|FG000|STARTED|Overall Study||5
11196661|NCT01803464|12386726|FG001|STARTED|Overall Study||4
11196662|NCT01803464|12386727|FG002|STARTED|Overall Study||10
11196663|NCT01803464|12386728|FG003|STARTED|Overall Study||10
11196664|NCT01803464|12386725|FG000|COMPLETED|Overall Study||4
11196665|NCT01803464|12386726|FG001|COMPLETED|Overall Study||4
11196666|NCT01803464|12386727|FG002|COMPLETED|Overall Study||6
11196667|NCT01803464|12386728|FG003|COMPLETED|Overall Study||10
11196668|NCT01803464|12386725|FG000|NOT COMPLETED|Overall Study||1
11196669|NCT01803464|12386726|FG001|NOT COMPLETED|Overall Study||0
11196670|NCT01803464|12386727|FG002|NOT COMPLETED|Overall Study||4
11196671|NCT01803464|12386728|FG003|NOT COMPLETED|Overall Study||0
11196672|NCT01803607|12386744|FG000|STARTED|Overall Study||68
11196673|NCT01803607|12386745|FG001|STARTED|Overall Study||67
11196674|NCT01803607|12386744|FG000|COMPLETED|Overall Study||0
11196675|NCT01803607|12386745|FG001|COMPLETED|Overall Study||0
11196676|NCT01803607|12386744|FG000|NOT COMPLETED|Overall Study||68
11196677|NCT01803607|12386745|FG001|NOT COMPLETED|Overall Study||67
11196678|NCT01803646|12386753|FG000|STARTED|Overall Study||204
11196679|NCT01803646|12386754|FG001|STARTED|Overall Study||139
11196680|NCT01803646|12386753|FG000|COMPLETED|Overall Study||187
11196681|NCT01803646|12386754|FG001|COMPLETED|Overall Study||129
11196682|NCT01803646|12386753|FG000|NOT COMPLETED|Overall Study||17
11196683|NCT01803646|12386754|FG001|NOT COMPLETED|Overall Study||10
11196684|NCT01803737|12386762|FG000|STARTED|Overall Study||13
11196685|NCT01803737|12386763|FG001|STARTED|Overall Study||13
11196686|NCT01803737|12386762|FG000|COMPLETED|Overall Study||12
11196687|NCT01803737|12386763|FG001|COMPLETED|Overall Study||10
11196688|NCT01803737|12386762|FG000|NOT COMPLETED|Overall Study||1
11196689|NCT01803737|12386763|FG001|NOT COMPLETED|Overall Study||3
11196690|NCT01803880|12386772|FG000|STARTED|Overall Study||19
11196691|NCT01803880|12386773|FG001|STARTED|Overall Study||28
11196692|NCT01803880|12386774|FG002|STARTED|Overall Study||29
11196693|NCT01803880|12386772|FG000|COMPLETED|Overall Study||13
11196694|NCT01803880|12386773|FG001|COMPLETED|Overall Study||18
11196695|NCT01803880|12386774|FG002|COMPLETED|Overall Study||14
11196696|NCT01803880|12386772|FG000|NOT COMPLETED|Overall Study||6
11196697|NCT01803880|12386773|FG001|NOT COMPLETED|Overall Study||10
11196698|NCT01803880|12386774|FG002|NOT COMPLETED|Overall Study||15
11196699|NCT01804036|12386786|FG000|STARTED|Overall Study||31
11196700|NCT01804036|12386787|FG001|STARTED|Overall Study||41
11196701|NCT01804036|12386786|FG000|COMPLETED|Overall Study||18
11196702|NCT01804036|12386787|FG001|COMPLETED|Overall Study||21
11196703|NCT01804036|12386786|FG000|NOT COMPLETED|Overall Study||13
11196704|NCT01804036|12386787|FG001|NOT COMPLETED|Overall Study||20
11196705|NCT01804049|12386796|FG000|STARTED|Overall Study||43
11196706|NCT01804049|12386797|FG001|STARTED|Overall Study||77
11196707|NCT01804049|12386796|FG000|COMPLETED|Overall Study||32
11196708|NCT01804049|12386797|FG001|COMPLETED|Overall Study||45
11196709|NCT01804049|12386796|FG000|NOT COMPLETED|Overall Study||11
11196710|NCT01804049|12386797|FG001|NOT COMPLETED|Overall Study||32
11196711|NCT01804062|12386805|FG000|STARTED|Overall Study||30
11196712|NCT01804062|12386805|FG000|COMPLETED|Overall Study||30
11196713|NCT01804062|12386805|FG000|NOT COMPLETED|Overall Study||0
11196714|NCT01804075|12386811|FG000|STARTED|Overall Study||15
11196715|NCT01804075|12386812|FG001|STARTED|Overall Study||16
11196716|NCT01804075|12386811|FG000|COMPLETED|Overall Study||15
11196717|NCT01804075|12386812|FG001|COMPLETED|Overall Study||16
11196718|NCT01804075|12386811|FG000|NOT COMPLETED|Overall Study||0
11196719|NCT01804075|12386812|FG001|NOT COMPLETED|Overall Study||0
11196720|NCT01804101|12386822|FG000|STARTED|Overall Study||38
11196721|NCT01804101|12386823|FG001|STARTED|Overall Study||10
11196722|NCT01804101|12386822|FG000|COMPLETED|Overall Study||38
11196723|NCT01804101|12386823|FG001|COMPLETED|Overall Study||10
11196724|NCT01804101|12386822|FG000|NOT COMPLETED|Overall Study||0
11196725|NCT01804101|12386823|FG001|NOT COMPLETED|Overall Study||0
11196726|NCT01804114|12386833|FG000|STARTED|Overall Study||17
11196727|NCT01804114|12386834|FG001|STARTED|Overall Study||12
11196728|NCT01804114|12386833|FG000|COMPLETED|Overall Study||17
11196729|NCT01804114|12386834|FG001|COMPLETED|Overall Study||12
11196730|NCT01804114|12386833|FG000|NOT COMPLETED|Overall Study||0
11196731|NCT01804114|12386834|FG001|NOT COMPLETED|Overall Study||0
11196732|NCT01804140|12386840|FG000|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
11196733|NCT01804140|12386840|FG000|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
11196734|NCT01804140|12386840|FG000|NOT COMPLETED|Overall Study||114
11196735|NCT01804257|12386844|FG000|STARTED|Overall Study||28
11196736|NCT01804257|12386844|FG000|COMPLETED|Overall Study||27
11196737|NCT01804257|12386844|FG000|NOT COMPLETED|Overall Study||1
11196738|NCT01804465|12386850|FG000|STARTED|Overall Study||24
11196739|NCT01804465|12386851|FG001|STARTED|Overall Study||26
11196740|NCT01804465|12386850|FG000|COMPLETED|Overall Study||24
11196741|NCT01804465|12386851|FG001|COMPLETED|Overall Study||26
11196742|NCT01804465|12386850|FG000|NOT COMPLETED|Overall Study||0
11196743|NCT01804465|12386851|FG001|NOT COMPLETED|Overall Study||0
11196744|NCT01804582|12386859|FG000|STARTED|Overall Study||177
11196745|NCT01804582|12386860|FG001|STARTED|Overall Study||173
11196746|NCT01804582|12386859|FG000|COMPLETED|Overall Study||128
11196747|NCT01804582|12386860|FG001|COMPLETED|Overall Study||117
11196748|NCT01804582|12386859|FG000|NOT COMPLETED|Overall Study||49
11196749|NCT01804582|12386860|FG001|NOT COMPLETED|Overall Study||56
11196750|NCT01804673|12386867|FG000|STARTED|Overall Study||174
11196751|NCT01804673|12386867|FG000|Completed Hour 24|Overall Study||170
11196752|NCT01804673|12386867|FG000|Completed Hour 48|Overall Study||79
11196753|NCT01804673|12386867|FG000|Completed Hour 72|Overall Study||36
11196754|NCT01804673|12386867|FG000|COMPLETED|Overall Study||34
11196755|NCT01804673|12386867|FG000|NOT COMPLETED|Overall Study||140
11196756|NCT01804842|12386874|FG000|STARTED|Overall Study||9
11196757|NCT01804842|12386875|FG001|STARTED|Overall Study||8
11196758|NCT01804842|12386876|FG002|STARTED|Overall Study||9
11196759|NCT01804842|12386874|FG000|Completed Treatment A|Overall Study||9
11196760|NCT01804842|12386875|FG001|Completed Treatment A|Overall Study||6
11196761|NCT01804842|12386876|FG002|Completed Treatment A|Overall Study||8
11196762|NCT01804842|12386874|FG000|Completed Treatment B|Overall Study||8
11196763|NCT01804842|12386875|FG001|Completed Treatment B|Overall Study||8
11196764|NCT01804842|12386876|FG002|Completed Treatment B|Overall Study||8
11196765|NCT01804842|12386874|FG000|Completed Treatment C|Overall Study||7
11196766|NCT01804842|12386875|FG001|Completed Treatment C|Overall Study||7
11196767|NCT01804842|12386876|FG002|Completed Treatment C|Overall Study||9
11196768|NCT01804842|12386874|FG000|COMPLETED|Overall Study||6
11196769|NCT01804842|12386875|FG001|COMPLETED|Overall Study||6
11196770|NCT01804842|12386876|FG002|COMPLETED|Overall Study||8
11027035|NCT00831766|12205690|FG001|COMPLETED|Overall Study||28
11196771|NCT01804842|12386874|FG000|NOT COMPLETED|Overall Study||3
11196772|NCT01804842|12386875|FG001|NOT COMPLETED|Overall Study||2
11196773|NCT01804842|12386876|FG002|NOT COMPLETED|Overall Study||1
11196774|NCT01804881|12386886|FG000|STARTED|Overall Study||16
11196775|NCT01804881|12386887|FG001|STARTED|Overall Study||14
11196776|NCT01804881|12386886|FG000|COMPLETED|Overall Study||11
11196777|NCT01804881|12386887|FG001|COMPLETED|Overall Study||10
11196778|NCT01804881|12386886|FG000|NOT COMPLETED|Overall Study||5
11196779|NCT01804881|12386887|FG001|NOT COMPLETED|Overall Study||4
11196780|NCT01804946|12386897|FG000|STARTED|Overall Study||81
11196781|NCT01804946|12386898|FG001|STARTED|Overall Study||80
11196782|NCT01804946|12386897|FG000|COMPLETED|Overall Study||79
11196783|NCT01804946|12386898|FG001|COMPLETED|Overall Study||76
11196784|NCT01804946|12386897|FG000|NOT COMPLETED|Overall Study||2
11196785|NCT01804946|12386898|FG001|NOT COMPLETED|Overall Study||4
11196786|NCT01805024|12386910|FG000|STARTED|Overall Study||4
11196787|NCT01805024|12386911|FG001|STARTED|Overall Study||4
11196788|NCT01805024|12386912|FG002|STARTED|Overall Study||4
11196789|NCT01805024|12386913|FG003|STARTED|Overall Study||8
11196790|NCT01805024|12386910|FG000|COMPLETED|Overall Study||4
11196791|NCT01805024|12386911|FG001|COMPLETED|Overall Study||4
11196792|NCT01805024|12386912|FG002|COMPLETED|Overall Study||4
11196793|NCT01805024|12386913|FG003|COMPLETED|Overall Study||8
11196794|NCT01805024|12386910|FG000|NOT COMPLETED|Overall Study||0
11196795|NCT01805024|12386911|FG001|NOT COMPLETED|Overall Study||0
11196796|NCT01805024|12386912|FG002|NOT COMPLETED|Overall Study||0
11196797|NCT01805024|12386913|FG003|NOT COMPLETED|Overall Study||0
11196798|NCT01805037|12386923|FG000|STARTED|Induction (4 Weeks)||0
11196799|NCT01805037|12386924|FG001|STARTED|Induction (4 Weeks)||20
11196800|NCT01805037|12386923|FG000|Received Dose of Study Drug|Induction (4 Weeks)||0
11196801|NCT01805037|12386924|FG001|Received Dose of Study Drug|Induction (4 Weeks)||20
11196802|NCT01805037|12386923|FG000|COMPLETED|Induction (4 Weeks)||0
11196803|NCT01805037|12386924|FG001|COMPLETED|Induction (4 Weeks)||20
11196804|NCT01805037|12386923|FG000|NOT COMPLETED|Induction (4 Weeks)||0
11196805|NCT01805037|12386924|FG001|NOT COMPLETED|Induction (4 Weeks)||0
11196806|NCT01805037|12386923|FG000|STARTED|Consolidation (Optional, 4 Weeks)||0
11196807|NCT01805037|12386924|FG001|STARTED|Consolidation (Optional, 4 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction.|6
11196808|NCT01805037|12386923|FG000|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||0
11196809|NCT01805037|12386924|FG001|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||6
11196810|NCT01805037|12386923|FG000|COMPLETED|Consolidation (Optional, 4 Weeks)||0
11196811|NCT01805037|12386924|FG001|COMPLETED|Consolidation (Optional, 4 Weeks)||6
11196812|NCT01805037|12386923|FG000|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
11196813|NCT01805037|12386924|FG001|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
11196814|NCT01805037|12386923|FG000|STARTED|1st Cycle of Maintenance (3 Weeks)||0
11196815|NCT01805037|12386924|FG001|STARTED|1st Cycle of Maintenance (3 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction|20
11196816|NCT01805037|12386923|FG000|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||0
11196817|NCT01805037|12386924|FG001|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||14
11196818|NCT01805037|12386923|FG000|COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
11196819|NCT01805037|12386924|FG001|COMPLETED|1st Cycle of Maintenance (3 Weeks)||14
11196820|NCT01805037|12386923|FG000|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
11196821|NCT01805037|12386924|FG001|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||6
11196822|NCT01805037|12386923|FG000|STARTED|2nd Cycle of Maintenance and Beyond||0
11196823|NCT01805037|12386924|FG001|STARTED|2nd Cycle of Maintenance and Beyond||14
11196824|NCT01805037|12386923|FG000|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||0
11196825|NCT01805037|12386924|FG001|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||14
11196826|NCT01805037|12386923|FG000|COMPLETED|2nd Cycle of Maintenance and Beyond||0
11196827|NCT01805037|12386924|FG001|COMPLETED|2nd Cycle of Maintenance and Beyond||2
11196828|NCT01805037|12386923|FG000|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||0
11196829|NCT01805037|12386924|FG001|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||12
11196830|NCT01805037|12386923|FG000|STARTED|Follow Up (up to 3 Years)||0
11196831|NCT01805037|12386924|FG001|STARTED|Follow Up (up to 3 Years)|Patients who received at least one dose of study treatment go into follow-up.|20
11196832|NCT01805037|12386923|FG000|COMPLETED|Follow Up (up to 3 Years)||0
11196833|NCT01805037|12386924|FG001|COMPLETED|Follow Up (up to 3 Years)||14
11196834|NCT01805037|12386923|FG000|NOT COMPLETED|Follow Up (up to 3 Years)||0
11196835|NCT01805037|12386924|FG001|NOT COMPLETED|Follow Up (up to 3 Years)||6
11204946|NCT01856530|12395655|FG001|COMPLETED|Overall Study||27
11204947|NCT01856530|12395654|FG000|NOT COMPLETED|Overall Study||0
11204948|NCT01856530|12395655|FG001|NOT COMPLETED|Overall Study||0
11204949|NCT01856543|12395663|FG000|STARTED|Overall Study||73
11204950|NCT01856543|12395664|FG001|STARTED|Overall Study||70
11204951|NCT01856543|12395663|FG000|COMPLETED|Overall Study||60
11204952|NCT01856543|12395664|FG001|COMPLETED|Overall Study||64
11204953|NCT01856543|12395663|FG000|NOT COMPLETED|Overall Study||13
11204954|NCT01856543|12395664|FG001|NOT COMPLETED|Overall Study||6
11204955|NCT01856569|12395671|FG000|STARTED|Overall Study||152
11204956|NCT01856569|12395671|FG000|Full Analysis Set|Overall Study||144
11204957|NCT01856569|12395671|FG000|COMPLETED|Overall Study||139
11204958|NCT01856569|12395671|FG000|NOT COMPLETED|Overall Study||13
11204959|NCT01856582|12395675|FG000|STARTED|Overall Study||23
11204960|NCT01856582|12395675|FG000|COMPLETED|Overall Study||22
11204961|NCT01856582|12395675|FG000|NOT COMPLETED|Overall Study||1
11204962|NCT01856595|12395688|FG000|STARTED|Overall Study||18
11204963|NCT01856595|12395689|FG001|STARTED|Overall Study||12
11204964|NCT01856595|12395690|FG002|STARTED|Overall Study||12
11204965|NCT01856595|12395691|FG003|STARTED|Overall Study||12
11204966|NCT01856595|12395692|FG004|STARTED|Overall Study||14
11204967|NCT01856595|12395693|FG005|STARTED|Overall Study||12
11204968|NCT01856595|12395694|FG006|STARTED|Overall Study||13
11204969|NCT01856595|12395695|FG007|STARTED|Overall Study||10
11204970|NCT01856595|12395696|FG008|STARTED|Overall Study||14
11204971|NCT01856595|12395688|FG000|COMPLETED|Overall Study||18
11204972|NCT01856595|12395689|FG001|COMPLETED|Overall Study||11
11204973|NCT01856595|12395690|FG002|COMPLETED|Overall Study||12
11204974|NCT01856595|12395691|FG003|COMPLETED|Overall Study||12
11204975|NCT01856595|12395692|FG004|COMPLETED|Overall Study||14
11204976|NCT01856595|12395693|FG005|COMPLETED|Overall Study||12
11204977|NCT01856595|12395694|FG006|COMPLETED|Overall Study||12
11204978|NCT01856595|12395695|FG007|COMPLETED|Overall Study||10
11204979|NCT01856595|12395696|FG008|COMPLETED|Overall Study||14
11204980|NCT01856595|12395688|FG000|NOT COMPLETED|Overall Study||0
11204981|NCT01856595|12395689|FG001|NOT COMPLETED|Overall Study||1
11204982|NCT01856595|12395690|FG002|NOT COMPLETED|Overall Study||0
11204983|NCT01856595|12395691|FG003|NOT COMPLETED|Overall Study||0
11204984|NCT01856595|12395692|FG004|NOT COMPLETED|Overall Study||0
11204985|NCT01856595|12395693|FG005|NOT COMPLETED|Overall Study||0
11204986|NCT01856595|12395694|FG006|NOT COMPLETED|Overall Study||1
11204987|NCT01856595|12395695|FG007|NOT COMPLETED|Overall Study||0
11204988|NCT01856595|12395696|FG008|NOT COMPLETED|Overall Study||0
11204989|NCT01856673|12395734|FG000|STARTED|Overall Study||175
11204990|NCT01856673|12395735|FG001|STARTED|Overall Study||175
11204991|NCT01856673|12395736|FG002|STARTED|Overall Study||171
11204992|NCT01856673|12395734|FG000|Buenaventura Participants|Overall Study||92
11204993|NCT01856673|12395735|FG001|Buenaventura Participants|Overall Study||89
11204994|NCT01856673|12395736|FG002|Buenaventura Participants|Overall Study||88
11204995|NCT01856673|12395734|FG000|Quibdó Participants|Overall Study||83
11204996|NCT01856673|12395735|FG001|Quibdó Participants|Overall Study||86
11204997|NCT01856673|12395736|FG002|Quibdó Participants|Overall Study||83
11204998|NCT01856673|12395734|FG000|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|80
11204999|NCT01856673|12395735|FG001|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
11205000|NCT01856673|12395736|FG002|COMPLETED|Overall Study||137
11205001|NCT01856673|12395734|FG000|NOT COMPLETED|Overall Study||95
11205002|NCT01856673|12395735|FG001|NOT COMPLETED|Overall Study||85
11205003|NCT01856673|12395736|FG002|NOT COMPLETED|Overall Study||34
11196836|NCT01805089|12386930|FG000|STARTED|Overall Study||48
11196837|NCT01805089|12386931|FG001|STARTED|Overall Study||47
11196838|NCT01805089|12386930|FG000|COMPLETED|Overall Study||43
11196839|NCT01805089|12386931|FG001|COMPLETED|Overall Study||43
11196840|NCT01805089|12386930|FG000|NOT COMPLETED|Overall Study||5
11196841|NCT01805089|12386931|FG001|NOT COMPLETED|Overall Study||4
11196842|NCT01805154|12386937|FG000|STARTED|Overall Study||1529
11196843|NCT01805154|12386937|FG000|COMPLETED|Overall Study||1175
11196844|NCT01805154|12386937|FG000|NOT COMPLETED|Overall Study||354
11196845|NCT01805180|12386946|FG000|STARTED|Lead-in Donor Phase||7
11196846|NCT01805180|12386947|FG001|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
11196847|NCT01805180|12386948|FG002|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
11196848|NCT01805180|12386946|FG000|COMPLETED|Lead-in Donor Phase||6
11196849|NCT01805180|12386947|FG001|COMPLETED|Lead-in Donor Phase||0
11196850|NCT01805180|12386948|FG002|COMPLETED|Lead-in Donor Phase||0
11196851|NCT01805180|12386946|FG000|NOT COMPLETED|Lead-in Donor Phase||1
11196852|NCT01805180|12386947|FG001|NOT COMPLETED|Lead-in Donor Phase||0
11196853|NCT01805180|12386948|FG002|NOT COMPLETED|Lead-in Donor Phase||0
11196854|NCT01805180|12386946|FG000|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
11196855|NCT01805180|12386947|FG001|STARTED|Pivotal Randomization Through Study Exit||22
11196856|NCT01805180|12386948|FG002|STARTED|Pivotal Randomization Through Study Exit||20
11196857|NCT01805180|12386946|FG000|COMPLETED|Pivotal Randomization Through Study Exit||0
11196858|NCT01805180|12386947|FG001|COMPLETED|Pivotal Randomization Through Study Exit||17
11196859|NCT01805180|12386948|FG002|COMPLETED|Pivotal Randomization Through Study Exit||15
11196860|NCT01805180|12386946|FG000|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
11196861|NCT01805180|12386947|FG001|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
11196862|NCT01805180|12386948|FG002|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
11196863|NCT01805297|12386958|FG000|STARTED|Overall Study||6
11196864|NCT01805297|12386959|FG001|STARTED|Overall Study||6
11196865|NCT01805297|12386958|FG000|COMPLETED|Overall Study||4
11196866|NCT01805297|12386959|FG001|COMPLETED|Overall Study||3
11196867|NCT01805297|12386958|FG000|NOT COMPLETED|Overall Study||2
11196868|NCT01805297|12386959|FG001|NOT COMPLETED|Overall Study||3
11196869|NCT01805323|12386966|FG000|STARTED|Overall Study||101
11196870|NCT01805323|12386966|FG000|COMPLETED|Overall Study||101
11196871|NCT01805323|12386966|FG000|NOT COMPLETED|Overall Study||0
11196872|NCT01805440|12386973|FG000|STARTED|Overall Study||19
11196873|NCT01805440|12386974|FG001|STARTED|Overall Study||17
11196874|NCT01805440|12386975|FG002|STARTED|Overall Study||26
11196875|NCT01805440|12386973|FG000|COMPLETED|Overall Study||18
11196876|NCT01805440|12386974|FG001|COMPLETED|Overall Study||17
11196877|NCT01805440|12386975|FG002|COMPLETED|Overall Study||26
11196878|NCT01805440|12386973|FG000|NOT COMPLETED|Overall Study||1
11196879|NCT01805440|12386974|FG001|NOT COMPLETED|Overall Study||0
11196880|NCT01805440|12386975|FG002|NOT COMPLETED|Overall Study||0
11196881|NCT01805687|12386982|FG000|STARTED|Overall Study||25
11196882|NCT01805687|12386982|FG000|COMPLETED|Overall Study||25
11196883|NCT01805687|12386982|FG000|NOT COMPLETED|Overall Study||0
11196884|NCT01805791|12386989|FG000|STARTED|Overall Study||66
11196885|NCT01805791|12386990|FG001|STARTED|Overall Study||67
11196886|NCT01805791|12386991|FG002|STARTED|Overall Study||68
11196887|NCT01805791|12386989|FG000|COMPLETED|Overall Study||44
11196888|NCT01805791|12386990|FG001|COMPLETED|Overall Study||50
11196889|NCT01805791|12386991|FG002|COMPLETED|Overall Study||48
11196890|NCT01805791|12386989|FG000|NOT COMPLETED|Overall Study||22
11196891|NCT01805791|12386990|FG001|NOT COMPLETED|Overall Study||17
11196892|NCT01805791|12386991|FG002|NOT COMPLETED|Overall Study||20
11196893|NCT01805882|12387008|FG000|STARTED|Overall Study||20
11196894|NCT01805882|12387009|FG001|STARTED|Overall Study||20
11196895|NCT01805882|12387010|FG002|STARTED|Overall Study||20
11196896|NCT01805882|12387011|FG003|STARTED|Overall Study||34
11196897|NCT01805882|12387012|FG004|STARTED|Overall Study||14
11196898|NCT01805882|12387013|FG005|STARTED|Overall Study||21
11196899|NCT01805882|12387014|FG006|STARTED|Overall Study||50
11196900|NCT01805882|12387015|FG007|STARTED|Overall Study||25
11196901|NCT01805882|12387016|FG008|STARTED|Overall Study||25
11196902|NCT01805882|12387008|FG000|COMPLETED|Overall Study||20
11196903|NCT01805882|12387009|FG001|COMPLETED|Overall Study||20
11196904|NCT01805882|12387010|FG002|COMPLETED|Overall Study||19
11196905|NCT01805882|12387011|FG003|COMPLETED|Overall Study||32
11196906|NCT01805882|12387012|FG004|COMPLETED|Overall Study||14
11196907|NCT01805882|12387013|FG005|COMPLETED|Overall Study||20
11196908|NCT01805882|12387014|FG006|COMPLETED|Overall Study||48
11196909|NCT01805882|12387015|FG007|COMPLETED|Overall Study||25
11196910|NCT01805882|12387016|FG008|COMPLETED|Overall Study||24
11196911|NCT01805882|12387008|FG000|NOT COMPLETED|Overall Study||0
11196912|NCT01805882|12387009|FG001|NOT COMPLETED|Overall Study||0
11196913|NCT01805882|12387010|FG002|NOT COMPLETED|Overall Study||1
11196914|NCT01805882|12387011|FG003|NOT COMPLETED|Overall Study||2
11196915|NCT01805882|12387012|FG004|NOT COMPLETED|Overall Study||0
11196916|NCT01805882|12387013|FG005|NOT COMPLETED|Overall Study||1
11196917|NCT01805882|12387014|FG006|NOT COMPLETED|Overall Study||2
11196918|NCT01805882|12387015|FG007|NOT COMPLETED|Overall Study||0
11196919|NCT01805882|12387016|FG008|NOT COMPLETED|Overall Study||1
11196920|NCT01805895|12387038|FG000|STARTED|Overall Study||8
11196921|NCT01805895|12387039|FG001|STARTED|Overall Study||8
11196922|NCT01805895|12387038|FG000|COMPLETED|Overall Study||8
11196923|NCT01805895|12387039|FG001|COMPLETED|Overall Study||8
11196924|NCT01805895|12387038|FG000|NOT COMPLETED|Overall Study||0
11196925|NCT01805895|12387039|FG001|NOT COMPLETED|Overall Study||0
11196926|NCT01806064|12387050|FG000|STARTED|Overall Study||3
11196927|NCT01806064|12387051|FG001|STARTED|Overall Study||15
11196928|NCT01806064|12387052|FG002|STARTED|Overall Study||5
11196929|NCT01806064|12387053|FG003|STARTED|Overall Study||75
11196930|NCT01806064|12387054|FG004|STARTED|Overall Study||75
11196931|NCT01806064|12387050|FG000|COMPLETED|Overall Study||3
11196932|NCT01806064|12387051|FG001|COMPLETED|Overall Study||15
11196933|NCT01806064|12387052|FG002|COMPLETED|Overall Study||5
11196934|NCT01806064|12387053|FG003|COMPLETED|Overall Study||74
11196935|NCT01806064|12387054|FG004|COMPLETED|Overall Study||73
11196936|NCT01806064|12387050|FG000|NOT COMPLETED|Overall Study||0
11196937|NCT01806064|12387051|FG001|NOT COMPLETED|Overall Study||0
11196938|NCT01806064|12387052|FG002|NOT COMPLETED|Overall Study||0
11196939|NCT01806064|12387053|FG003|NOT COMPLETED|Overall Study||1
11196940|NCT01806064|12387054|FG004|NOT COMPLETED|Overall Study||2
11196941|NCT01806168|12387073|FG000|STARTED|Overall Study||11
11196942|NCT01806168|12387074|FG001|STARTED|Overall Study||10
11196943|NCT01806168|12387075|FG002|STARTED|Overall Study||10
11196944|NCT01806168|12387073|FG000|Received Allocated Intervention|Overall Study||11
11196945|NCT01806168|12387074|FG001|Received Allocated Intervention|Overall Study||9
11196946|NCT01806168|12387075|FG002|Received Allocated Intervention|Overall Study||9
11196947|NCT01806168|12387073|FG000|COMPLETED|Overall Study||10
11196948|NCT01806168|12387074|FG001|COMPLETED|Overall Study||9
11196949|NCT01806168|12387075|FG002|COMPLETED|Overall Study||7
11196950|NCT01806168|12387073|FG000|NOT COMPLETED|Overall Study||1
11196951|NCT01806168|12387074|FG001|NOT COMPLETED|Overall Study||1
11196952|NCT01806168|12387075|FG002|NOT COMPLETED|Overall Study||3
11196953|NCT01806259|12387088|FG000|STARTED|Overall Study||96
11196954|NCT01806259|12387089|FG001|STARTED|Overall Study||107
11196955|NCT01806259|12387088|FG000|COMPLETED|Overall Study||96
11196956|NCT01806259|12387089|FG001|COMPLETED|Overall Study||107
11196957|NCT01806259|12387088|FG000|NOT COMPLETED|Overall Study||0
11196958|NCT01806259|12387089|FG001|NOT COMPLETED|Overall Study||0
11196959|NCT01806298|12387096|FG000|STARTED|Overall Study||78
11196960|NCT01806298|12387096|FG000|COMPLETED|Overall Study||68
11196961|NCT01806298|12387096|FG000|NOT COMPLETED|Overall Study||10
11196962|NCT01806389|12387100|FG000|STARTED|Overall Study||14
11196963|NCT01806389|12387100|FG000|COMPLETED|Overall Study||10
11196964|NCT01806389|12387100|FG000|NOT COMPLETED|Overall Study||4
11196965|NCT01806506|12387116|FG000|STARTED|Overall Study||36
11196966|NCT01806506|12387117|FG001|STARTED|Overall Study||36
11196967|NCT01806506|12387116|FG000|1 Month|Overall Study||36
11196968|NCT01806506|12387117|FG001|1 Month|Overall Study||36
11196969|NCT01806506|12387116|FG000|3 Months|Overall Study|1 patient (reason - lost contact)|35
11196970|NCT01806506|12387117|FG001|3 Months|Overall Study||36
11196971|NCT01806506|12387116|FG000|6 Months|Overall Study|1 patient (reason - lost contact)|34
11196972|NCT01806506|12387117|FG001|6 Months|Overall Study||36
11196973|NCT01806506|12387116|FG000|9 Months|Overall Study||34
11196974|NCT01806506|12387117|FG001|9 Months|Overall Study|1 patient (reason - lost contact)|35
11196975|NCT01806506|12387116|FG000|COMPLETED|Overall Study||34
11196976|NCT01806506|12387117|FG001|COMPLETED|Overall Study||35
11196977|NCT01806506|12387116|FG000|NOT COMPLETED|Overall Study||2
11196978|NCT01806506|12387117|FG001|NOT COMPLETED|Overall Study||1
11196979|NCT01806545|12387125|FG000|STARTED|Overall Study||29
11196980|NCT01806545|12387126|FG001|STARTED|Overall Study||35
11196981|NCT01806545|12387125|FG000|COMPLETED|Overall Study||23
11196982|NCT01806545|12387126|FG001|COMPLETED|Overall Study||30
11196983|NCT01806545|12387125|FG000|NOT COMPLETED|Overall Study||6
11196984|NCT01806545|12387126|FG001|NOT COMPLETED|Overall Study||5
11196985|NCT01806571|12387132|FG000|STARTED|Overall Study||34
11196986|NCT01806571|12387132|FG000|COMPLETED|Overall Study||34
11196987|NCT01806571|12387132|FG000|NOT COMPLETED|Overall Study||0
11196988|NCT01806584|12387138|FG000|STARTED|Overall Study||14
11196989|NCT01806584|12387139|FG001|STARTED|Overall Study||18
11196990|NCT01806584|12387138|FG000|COMPLETED|Overall Study||0
11196991|NCT01806584|12387139|FG001|COMPLETED|Overall Study||0
11196992|NCT01806584|12387138|FG000|NOT COMPLETED|Overall Study||14
11196993|NCT01806584|12387139|FG001|NOT COMPLETED|Overall Study||18
11196994|NCT01806597|12387148|FG000|STARTED|Period 1 (Baseline to Week 16)||68
11196995|NCT01806597|12387149|FG001|STARTED|Period 1 (Baseline to Week 16)||69
11196996|NCT01806597|12387150|FG002|STARTED|Period 1 (Baseline to Week 16)||0
11196997|NCT01806597|12387151|FG003|STARTED|Period 1 (Baseline to Week 16)||0
11196998|NCT01806597|12387152|FG004|STARTED|Period 1 (Baseline to Week 16)||68
11196999|NCT01806597|12387153|FG005|STARTED|Period 1 (Baseline to Week 16)||0
11197000|NCT01806597|12387148|FG000|COMPLETED|Period 1 (Baseline to Week 16)||63
11197001|NCT01806597|12387149|FG001|COMPLETED|Period 1 (Baseline to Week 16)||64
11197002|NCT01806597|12387150|FG002|COMPLETED|Period 1 (Baseline to Week 16)||0
11197003|NCT01806597|12387151|FG003|COMPLETED|Period 1 (Baseline to Week 16)||0
11197004|NCT01806597|12387152|FG004|COMPLETED|Period 1 (Baseline to Week 16)||63
11197005|NCT01806597|12387153|FG005|COMPLETED|Period 1 (Baseline to Week 16)||0
11197006|NCT01806597|12387148|FG000|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
11197007|NCT01806597|12387149|FG001|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
11197008|NCT01806597|12387150|FG002|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
11197009|NCT01806597|12387151|FG003|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
11197010|NCT01806597|12387152|FG004|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
11197011|NCT01806597|12387153|FG005|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
11197012|NCT01806597|12387148|FG000|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
11197013|NCT01806597|12387149|FG001|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
11197014|NCT01806597|12387150|FG002|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
11197015|NCT01806597|12387151|FG003|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
11197016|NCT01806597|12387152|FG004|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
11197017|NCT01806597|12387153|FG005|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
11197018|NCT01806597|12387148|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
11197019|NCT01806597|12387149|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
11197020|NCT01806597|12387150|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
11197021|NCT01806597|12387151|FG003|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
11197022|NCT01806597|12387152|FG004|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
11197023|NCT01806597|12387153|FG005|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
11197024|NCT01806597|12387148|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
11197025|NCT01806597|12387149|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
11197026|NCT01806597|12387150|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
11197027|NCT01806597|12387151|FG003|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
11197028|NCT01806597|12387152|FG004|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
11197029|NCT01806597|12387153|FG005|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
11197030|NCT01806597|12387148|FG000|STARTED|Follow-up Period (Week 132 to Week 140)||0
11197031|NCT01806597|12387149|FG001|STARTED|Follow-up Period (Week 132 to Week 140)||0
11197032|NCT01806597|12387150|FG002|STARTED|Follow-up Period (Week 132 to Week 140)||0
11197033|NCT01806597|12387151|FG003|STARTED|Follow-up Period (Week 132 to Week 140)||0
11197034|NCT01806597|12387152|FG004|STARTED|Follow-up Period (Week 132 to Week 140)||3
11197035|NCT01806597|12387153|FG005|STARTED|Follow-up Period (Week 132 to Week 140)||161
11197036|NCT01806597|12387148|FG000|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
11197037|NCT01806597|12387149|FG001|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
11197038|NCT01806597|12387150|FG002|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
11197039|NCT01806597|12387151|FG003|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
11197040|NCT01806597|12387152|FG004|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
11197041|NCT01806597|12387153|FG005|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
11197042|NCT01806597|12387148|FG000|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
11197043|NCT01806597|12387149|FG001|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
11197044|NCT01806597|12387150|FG002|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
11197045|NCT01806597|12387151|FG003|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
11197046|NCT01806597|12387152|FG004|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
11197047|NCT01806597|12387153|FG005|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
11197048|NCT01806623|12387167|FG000|STARTED|Overall Study||157
11197049|NCT01806623|12387167|FG000|COMPLETED|Overall Study||99
11197050|NCT01806623|12387167|FG000|NOT COMPLETED|Overall Study||58
11197051|NCT01806662|12387171|FG000|STARTED|First Intervention (Weeks 0-16)||16
11197052|NCT01806662|12387172|FG001|STARTED|First Intervention (Weeks 0-16)||16
11197053|NCT01806662|12387171|FG000|Received Intervention|First Intervention (Weeks 0-16)||12
11197054|NCT01806662|12387172|FG001|Received Intervention|First Intervention (Weeks 0-16)||15
11197055|NCT01806662|12387171|FG000|COMPLETED|First Intervention (Weeks 0-16)||12
11197056|NCT01806662|12387172|FG001|COMPLETED|First Intervention (Weeks 0-16)||15
11197057|NCT01806662|12387171|FG000|NOT COMPLETED|First Intervention (Weeks 0-16)||4
11197058|NCT01806662|12387172|FG001|NOT COMPLETED|First Intervention (Weeks 0-16)||1
11197059|NCT01806662|12387171|FG000|STARTED|Second Intervention (Weeks 16-32)||12
11197060|NCT01806662|12387172|FG001|STARTED|Second Intervention (Weeks 16-32)||15
11197061|NCT01806662|12387171|FG000|COMPLETED|Second Intervention (Weeks 16-32)||10
11197062|NCT01806662|12387172|FG001|COMPLETED|Second Intervention (Weeks 16-32)||11
11197063|NCT01806662|12387171|FG000|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
11197064|NCT01806662|12387172|FG001|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
11197065|NCT01806675|12387181|FG000|STARTED|Overall Study||11
11197066|NCT01806675|12387182|FG001|STARTED|Overall Study||6
11197067|NCT01806675|12387183|FG002|STARTED|Overall Study||8
11197068|NCT01806675|12387181|FG000|COMPLETED|Overall Study||11
11197069|NCT01806675|12387182|FG001|COMPLETED|Overall Study||6
11197070|NCT01806675|12387183|FG002|COMPLETED|Overall Study||8
11197071|NCT01806675|12387181|FG000|NOT COMPLETED|Overall Study||0
11197072|NCT01806675|12387182|FG001|NOT COMPLETED|Overall Study||0
11197073|NCT01806675|12387183|FG002|NOT COMPLETED|Overall Study||0
11205004|NCT01856686|12395746|FG000|STARTED|Overall Study||31
11205005|NCT01856686|12395747|FG001|STARTED|Overall Study||33
11205006|NCT01856686|12395746|FG000|COMPLETED|Overall Study||26
11205007|NCT01856686|12395747|FG001|COMPLETED|Overall Study||22
11197074|NCT01806688|12387193|FG000|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38
11197075|NCT01806688|12387194|FG001|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0
11197076|NCT01806688|12387193|FG000|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|13
11197077|NCT01806688|12387194|FG001|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|0
11197078|NCT01806688|12387193|FG000|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|13
11197079|NCT01806688|12387194|FG001|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|0
11197080|NCT01806688|12387193|FG000|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|12
11197081|NCT01806688|12387194|FG001|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|0
11197082|NCT01806688|12387193|FG000|COMPLETED|First Intervention Seed Study||38
11197083|NCT01806688|12387194|FG001|COMPLETED|First Intervention Seed Study||0
11197084|NCT01806688|12387193|FG000|NOT COMPLETED|First Intervention Seed Study||0
11197085|NCT01806688|12387194|FG001|NOT COMPLETED|First Intervention Seed Study||0
11197086|NCT01806688|12387193|FG000|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|38
11197087|NCT01806688|12387194|FG001|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|0
11197088|NCT01806688|12387193|FG000|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|13
11324676|NCT02747186|12522012|FG000|NOT COMPLETED|Second Intervention||0
11324677|NCT02747186|12522013|FG001|NOT COMPLETED|Second Intervention||0
11324678|NCT02747238|12522021|FG000|STARTED|Overall Study||12
11324679|NCT02747238|12522022|FG001|STARTED|Overall Study||20
11324680|NCT02747238|12522021|FG000|COMPLETED|Overall Study||9
11324681|NCT02747238|12522022|FG001|COMPLETED|Overall Study||14
11027036|NCT00831766|12205689|FG000|NOT COMPLETED|Overall Study||0
11027037|NCT00831766|12205690|FG001|NOT COMPLETED|Overall Study||0
11027038|NCT00831779|12205699|FG000|STARTED|Overall Study||21
11324682|NCT02747238|12522021|FG000|NOT COMPLETED|Overall Study||3
11324683|NCT02747238|12522022|FG001|NOT COMPLETED|Overall Study||6
11324684|NCT02747420|12522030|FG000|STARTED|Overall Study||18
11324685|NCT02747420|12522031|FG001|STARTED|Overall Study||22
11324686|NCT02747420|12522030|FG000|COMPLETED|Overall Study||11
11324687|NCT02747420|12522031|FG001|COMPLETED|Overall Study||18
11324688|NCT02747420|12522030|FG000|NOT COMPLETED|Overall Study||7
11324689|NCT02747420|12522031|FG001|NOT COMPLETED|Overall Study||4
11324690|NCT02747615|12522039|FG000|STARTED|Overall Study||30
11027039|NCT00831779|12205700|FG001|STARTED|Overall Study||23
11027040|NCT00831779|12205699|FG000|COMPLETED|Overall Study||20
11027041|NCT00831779|12205700|FG001|COMPLETED|Overall Study||22
11027042|NCT00831779|12205699|FG000|NOT COMPLETED|Overall Study||1
11324691|NCT02747615|12522040|FG001|STARTED|Overall Study||30
11324692|NCT02747615|12522039|FG000|COMPLETED|Overall Study||30
11324693|NCT02747615|12522040|FG001|COMPLETED|Overall Study||30
11324694|NCT02747615|12522039|FG000|NOT COMPLETED|Overall Study||0
11324695|NCT02747615|12522040|FG001|NOT COMPLETED|Overall Study||0
11324696|NCT02747628|12522049|FG000|STARTED|Overall Study||20
11324697|NCT02747628|12522050|FG001|STARTED|Overall Study||20
11324698|NCT02747628|12522051|FG002|STARTED|Overall Study||20
11324699|NCT02747628|12522049|FG000|COMPLETED|Overall Study||20
11324700|NCT02747628|12522050|FG001|COMPLETED|Overall Study||20
11324701|NCT02747628|12522051|FG002|COMPLETED|Overall Study||20
11324702|NCT02747628|12522049|FG000|NOT COMPLETED|Overall Study||0
11324703|NCT02747628|12522050|FG001|NOT COMPLETED|Overall Study||0
11324704|NCT02747628|12522051|FG002|NOT COMPLETED|Overall Study||0
11324705|NCT02747875|12522061|FG000|STARTED|Overall Study||12
11324706|NCT02747875|12522062|FG001|STARTED|Overall Study||14
11324707|NCT02747875|12522061|FG000|COMPLETED|Overall Study||11
11324708|NCT02747875|12522062|FG001|COMPLETED|Overall Study||13
11027043|NCT00831779|12205700|FG001|NOT COMPLETED|Overall Study||1
11324709|NCT02747875|12522061|FG000|NOT COMPLETED|Overall Study||1
11324710|NCT02747875|12522062|FG001|NOT COMPLETED|Overall Study||1
11324711|NCT02748070|12522070|FG000|STARTED|Overall Study||41
11324712|NCT02748070|12522071|FG001|STARTED|Overall Study||40
11324713|NCT02748070|12522070|FG000|Randomized and Treated|Overall Study||40
11324714|NCT02748070|12522071|FG001|Randomized and Treated|Overall Study||40
11324715|NCT02748070|12522070|FG000|COMPLETED|Overall Study||33
11324716|NCT02748070|12522071|FG001|COMPLETED|Overall Study||39
11324717|NCT02748070|12522070|FG000|NOT COMPLETED|Overall Study||8
11324718|NCT02748070|12522071|FG001|NOT COMPLETED|Overall Study||1
11324719|NCT02748096|12522079|FG000|STARTED|Overall Study||23
11324720|NCT02748096|12522080|FG001|STARTED|Overall Study||22
11324721|NCT02748096|12522079|FG000|COMPLETED|Overall Study||23
11324722|NCT02748096|12522080|FG001|COMPLETED|Overall Study||22
11324723|NCT02748096|12522079|FG000|NOT COMPLETED|Overall Study||0
11324724|NCT02748096|12522080|FG001|NOT COMPLETED|Overall Study||0
11324725|NCT02748213|12522088|FG000|STARTED|Overall Study||113
11324726|NCT02748213|12522089|FG001|STARTED|Overall Study||112
11324727|NCT02748213|12522088|FG000|Treated|Overall Study||112
11324728|NCT02748213|12522089|FG001|Treated|Overall Study||110
11324729|NCT02748213|12522088|FG000|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
11324730|NCT02748213|12522089|FG001|COMPLETED|Overall Study||0
11324731|NCT02748213|12522088|FG000|NOT COMPLETED|Overall Study||113
11324732|NCT02748213|12522089|FG001|NOT COMPLETED|Overall Study||112
11324733|NCT02748317|12522095|FG000|STARTED|Overall Study||96
11324734|NCT02748317|12522095|FG000|COMPLETED|Overall Study||73
11324735|NCT02748317|12522095|FG000|NOT COMPLETED|Overall Study||23
11324736|NCT02748356|12522099|FG000|STARTED|Overall Study||7
11324737|NCT02748356|12522099|FG000|COMPLETED|Overall Study||6
11324738|NCT02748356|12522099|FG000|NOT COMPLETED|Overall Study||1
11324739|NCT02748512|12522105|FG000|STARTED|Overall Study||14
11324740|NCT02748512|12522106|FG001|STARTED|Overall Study||12
11324741|NCT02748512|12522105|FG000|COMPLETED|Overall Study||13
11324742|NCT02748512|12522106|FG001|COMPLETED|Overall Study||11
11324743|NCT02748512|12522105|FG000|NOT COMPLETED|Overall Study||1
11324744|NCT02748512|12522106|FG001|NOT COMPLETED|Overall Study||1
11324745|NCT02748525|12522112|FG000|STARTED|Overall Study||50
11324746|NCT02748525|12522112|FG000|Completed Study Intervention|Overall Study||50
11324747|NCT02748525|12522112|FG000|COMPLETED|Overall Study|Completed 6 months follow up|39
11324748|NCT02748525|12522112|FG000|NOT COMPLETED|Overall Study||11
11324749|NCT02748694|12522131|FG000|STARTED|Overall Study||10
11324750|NCT02748694|12522132|FG001|STARTED|Overall Study||6
11324751|NCT02748694|12522133|FG002|STARTED|Overall Study||6
11324752|NCT02748694|12522134|FG003|STARTED|Overall Study||6
11324753|NCT02748694|12522135|FG004|STARTED|Overall Study||6
11324754|NCT02748694|12522136|FG005|STARTED|Overall Study||6
11324755|NCT02748694|12522137|FG006|STARTED|Overall Study||8
11324756|NCT02748694|12522138|FG007|STARTED|Overall Study||6
11324757|NCT02748694|12522139|FG008|STARTED|Overall Study||6
11324758|NCT02748694|12522140|FG009|STARTED|Overall Study||6
11324759|NCT02748694|12522141|FG010|STARTED|Overall Study||6
11324760|NCT02748694|12522142|FG011|STARTED|Overall Study||9
11324761|NCT02748694|12522143|FG012|STARTED|Overall Study||9
11197089|NCT01806688|12387194|FG001|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|0
11197090|NCT01806688|12387193|FG000|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|13
11197091|NCT01806688|12387194|FG001|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|0
11197092|NCT01806688|12387193|FG000|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|12
11197093|NCT01806688|12387194|FG001|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|0
11197094|NCT01806688|12387193|FG000|COMPLETED|Second Intervention Seed Study||38
11197095|NCT01806688|12387194|FG001|COMPLETED|Second Intervention Seed Study||0
11197096|NCT01806688|12387193|FG000|NOT COMPLETED|Second Intervention Seed Study||0
11197097|NCT01806688|12387194|FG001|NOT COMPLETED|Second Intervention Seed Study||0
11197098|NCT01806688|12387193|FG000|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38
11197099|NCT01806688|12387194|FG001|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0
11197100|NCT01806688|12387193|FG000|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|12
11197101|NCT01806688|12387194|FG001|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|0
11205008|NCT01856686|12395746|FG000|NOT COMPLETED|Overall Study||5
11205009|NCT01856686|12395747|FG001|NOT COMPLETED|Overall Study||11
11324762|NCT02748694|12522144|FG013|STARTED|Overall Study||8
11324763|NCT02748694|12522145|FG014|STARTED|Overall Study||16
11324764|NCT02748694|12522131|FG000|COMPLETED|Overall Study||10
11324765|NCT02748694|12522132|FG001|COMPLETED|Overall Study||6
11197102|NCT01806688|12387193|FG000|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|12
11197103|NCT01806688|12387194|FG001|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|0
11197104|NCT01806688|12387193|FG000|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|14
11197105|NCT01806688|12387194|FG001|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|0
11197106|NCT01806688|12387193|FG000|COMPLETED|Third Intervention Seed Study||38
11197107|NCT01806688|12387194|FG001|COMPLETED|Third Intervention Seed Study||0
11197108|NCT01806688|12387193|FG000|NOT COMPLETED|Third Intervention Seed Study||0
11197109|NCT01806688|12387194|FG001|NOT COMPLETED|Third Intervention Seed Study||0
11197110|NCT01806688|12387193|FG000|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0
11197111|NCT01806688|12387194|FG001|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38
11197112|NCT01806688|12387193|FG000|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|0
11197113|NCT01806688|12387194|FG001|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|14
11197114|NCT01806688|12387193|FG000|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|0
11197115|NCT01806688|12387194|FG001|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|12
11197116|NCT01806688|12387193|FG000|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|0
11197117|NCT01806688|12387194|FG001|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|12
11197118|NCT01806688|12387193|FG000|COMPLETED|First Intervention Pita Study||0
11197119|NCT01806688|12387194|FG001|COMPLETED|First Intervention Pita Study||38
11197120|NCT01806688|12387193|FG000|NOT COMPLETED|First Intervention Pita Study||0
11197121|NCT01806688|12387194|FG001|NOT COMPLETED|First Intervention Pita Study||0
11197122|NCT01806688|12387193|FG000|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0
11197123|NCT01806688|12387194|FG001|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38
11197124|NCT01806688|12387193|FG000|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|0
11197125|NCT01806688|12387194|FG001|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|12
11197126|NCT01806688|12387193|FG000|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|0
11197127|NCT01806688|12387194|FG001|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|13
11197128|NCT01806688|12387193|FG000|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|0
11197129|NCT01806688|12387194|FG001|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|13
11197130|NCT01806688|12387193|FG000|COMPLETED|Second Intervention Pita Study||0
11197131|NCT01806688|12387194|FG001|COMPLETED|Second Intervention Pita Study||38
11197132|NCT01806688|12387193|FG000|NOT COMPLETED|Second Intervention Pita Study||0
11197133|NCT01806688|12387194|FG001|NOT COMPLETED|Second Intervention Pita Study||0
11197134|NCT01806688|12387193|FG000|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|0
11197135|NCT01806688|12387194|FG001|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|38
11205010|NCT01856712|12395755|FG000|STARTED|Overall Study||23
11205222|NCT01857869|12395945|FG005|NOT COMPLETED|Booster/Rechallenge Phase||0
11197136|NCT01806688|12387193|FG000|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|0
11197137|NCT01806688|12387194|FG001|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|12
11197138|NCT01806688|12387193|FG000|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|0
11197139|NCT01806688|12387194|FG001|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|13
11197140|NCT01806688|12387193|FG000|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|0
11197141|NCT01806688|12387194|FG001|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|13
11197142|NCT01806688|12387193|FG000|COMPLETED|Third Intervention Pita Study||0
11197143|NCT01806688|12387194|FG001|COMPLETED|Third Intervention Pita Study||38
11197144|NCT01806688|12387193|FG000|NOT COMPLETED|Third Intervention Pita Study||0
11197145|NCT01806688|12387194|FG001|NOT COMPLETED|Third Intervention Pita Study||0
11197146|NCT01806714|12387205|FG000|STARTED|Overall Study||2093
11197147|NCT01806714|12387206|FG001|STARTED|Overall Study||2089
11197148|NCT01806714|12387205|FG000|COMPLETED|Overall Study||1893
11197149|NCT01806714|12387206|FG001|COMPLETED|Overall Study||1919
11197150|NCT01806714|12387205|FG000|NOT COMPLETED|Overall Study||200
11197151|NCT01806714|12387206|FG001|NOT COMPLETED|Overall Study||170
11197152|NCT01806740|12387212|FG000|STARTED|Overall Study||37
11197153|NCT01806740|12387212|FG000|COMPLETED|Overall Study||31
11197154|NCT01806740|12387212|FG000|NOT COMPLETED|Overall Study||6
11197155|NCT01806779|12387221|FG000|STARTED|Overall Study||90
11197156|NCT01806779|12387222|FG001|STARTED|Overall Study||84
11197157|NCT01806779|12387223|FG002|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
11197158|NCT01806779|12387221|FG000|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
11197159|NCT01806779|12387222|FG001|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
11197160|NCT01806779|12387223|FG002|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
11197161|NCT01806779|12387221|FG000|Randomized at Visit 2|Overall Study||90
11197162|NCT01806779|12387222|FG001|Randomized at Visit 2|Overall Study||84
11197163|NCT01806779|12387223|FG002|Randomized at Visit 2|Overall Study||0
11197164|NCT01806779|12387221|FG000|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
11197165|NCT01806779|12387222|FG001|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
11197166|NCT01806779|12387223|FG002|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
11197167|NCT01806779|12387221|FG000|COMPLETED|Overall Study||48
11197168|NCT01806779|12387222|FG001|COMPLETED|Overall Study||40
11197169|NCT01806779|12387223|FG002|COMPLETED|Overall Study||0
11197170|NCT01806779|12387221|FG000|NOT COMPLETED|Overall Study||42
11197171|NCT01806779|12387222|FG001|NOT COMPLETED|Overall Study||44
11197172|NCT01806779|12387223|FG002|NOT COMPLETED|Overall Study||23
11197173|NCT01806857|12387230|FG000|STARTED|Overall Study||31
11197174|NCT01806857|12387231|FG001|STARTED|Overall Study||29
11197175|NCT01806857|12387230|FG000|COMPLETED|Overall Study||30
11197176|NCT01806857|12387231|FG001|COMPLETED|Overall Study||29
11197177|NCT01806857|12387230|FG000|NOT COMPLETED|Overall Study||1
11197178|NCT01806857|12387231|FG001|NOT COMPLETED|Overall Study||0
11197179|NCT01806896|12387240|FG000|STARTED|Overall Study||20
11197180|NCT01806896|12387241|FG001|STARTED|Overall Study||17
11197181|NCT01806896|12387240|FG000|Received Treatment|Overall Study||19
11197182|NCT01806896|12387241|FG001|Received Treatment|Overall Study||17
11197183|NCT01806896|12387240|FG000|COMPLETED|Overall Study||17
11197184|NCT01806896|12387241|FG001|COMPLETED|Overall Study||17
11197185|NCT01806896|12387240|FG000|NOT COMPLETED|Overall Study||3
11197186|NCT01806896|12387241|FG001|NOT COMPLETED|Overall Study||0
11197187|NCT01807000|12387247|FG000|STARTED|Overall Study||6
11197188|NCT01807000|12387247|FG000|COMPLETED|Overall Study||6
11197189|NCT01807000|12387247|FG000|NOT COMPLETED|Overall Study||0
11197190|NCT01807026|12387257|FG000|STARTED|Overall Study||10
11197191|NCT01807026|12387258|FG001|STARTED|Overall Study||2
11197192|NCT01807026|12387259|FG002|STARTED|Overall Study||10
11197193|NCT01807026|12387260|FG003|STARTED|Overall Study||2
11197194|NCT01807026|12387261|FG004|STARTED|Overall Study||9
11197195|NCT01807026|12387262|FG005|STARTED|Overall Study||3
11197196|NCT01807026|12387257|FG000|Received at Least One Dose of Study Drug|Overall Study||10
11197197|NCT01807026|12387258|FG001|Received at Least One Dose of Study Drug|Overall Study||2
11197198|NCT01807026|12387259|FG002|Received at Least One Dose of Study Drug|Overall Study||10
11197199|NCT01807026|12387260|FG003|Received at Least One Dose of Study Drug|Overall Study||2
11197200|NCT01807026|12387261|FG004|Received at Least One Dose of Study Drug|Overall Study||9
11197201|NCT01807026|12387262|FG005|Received at Least One Dose of Study Drug|Overall Study||3
11197202|NCT01807026|12387257|FG000|COMPLETED|Overall Study||10
11197203|NCT01807026|12387258|FG001|COMPLETED|Overall Study||2
11197204|NCT01807026|12387259|FG002|COMPLETED|Overall Study||10
11197205|NCT01807026|12387260|FG003|COMPLETED|Overall Study||2
11197206|NCT01807026|12387261|FG004|COMPLETED|Overall Study||9
11197207|NCT01807026|12387262|FG005|COMPLETED|Overall Study||3
11197208|NCT01807026|12387257|FG000|NOT COMPLETED|Overall Study||0
11197209|NCT01807026|12387258|FG001|NOT COMPLETED|Overall Study||0
11197210|NCT01807026|12387259|FG002|NOT COMPLETED|Overall Study||0
11197211|NCT01807026|12387260|FG003|NOT COMPLETED|Overall Study||0
11197212|NCT01807026|12387261|FG004|NOT COMPLETED|Overall Study||0
11197213|NCT01807026|12387262|FG005|NOT COMPLETED|Overall Study||0
11197214|NCT01807065|12387283|FG000|STARTED|Overall Study||25
11197215|NCT01807065|12387284|FG001|STARTED|Overall Study||26
11197216|NCT01807065|12387283|FG000|COMPLETED|Overall Study||24
11197217|NCT01807065|12387284|FG001|COMPLETED|Overall Study||25
11197218|NCT01807065|12387283|FG000|NOT COMPLETED|Overall Study||1
11197219|NCT01807065|12387284|FG001|NOT COMPLETED|Overall Study||1
11197220|NCT01807091|12387290|FG000|STARTED|Overall Study||17
11197221|NCT01807091|12387290|FG000|COMPLETED|Overall Study||17
11197222|NCT01807091|12387290|FG000|NOT COMPLETED|Overall Study||0
11197223|NCT01807104|12387296|FG000|STARTED|Overall Study||43
11197224|NCT01807104|12387297|FG001|STARTED|Overall Study||44
11197225|NCT01807104|12387296|FG000|COMPLETED|Overall Study||39
11197226|NCT01807104|12387297|FG001|COMPLETED|Overall Study||40
11197227|NCT01807104|12387296|FG000|NOT COMPLETED|Overall Study||4
11197228|NCT01807104|12387297|FG001|NOT COMPLETED|Overall Study||4
11197229|NCT01807156|12387303|FG000|STARTED|Overall Study||7
11197230|NCT01807156|12387303|FG000|COMPLETED|Overall Study||6
11197231|NCT01807156|12387303|FG000|NOT COMPLETED|Overall Study||1
11197232|NCT01807221|12387313|FG000|STARTED|Overall Study||224
11197233|NCT01807221|12387314|FG001|STARTED|Overall Study||173
11197234|NCT01807221|12387315|FG002|STARTED|Overall Study||165
11197235|NCT01807221|12387316|FG003|STARTED|Overall Study||169
11197236|NCT01807221|12387317|FG004|STARTED|Overall Study||170
11197237|NCT01807221|12387318|FG005|STARTED|Overall Study||165
11197238|NCT01807221|12387313|FG000|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||221
11197239|NCT01807221|12387314|FG001|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||172
11197240|NCT01807221|12387315|FG002|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
11197241|NCT01807221|12387316|FG003|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||167
11197242|NCT01807221|12387317|FG004|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||169
11197243|NCT01807221|12387318|FG005|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
11197244|NCT01807221|12387313|FG000|COMPLETED|Overall Study||144
11197245|NCT01807221|12387314|FG001|COMPLETED|Overall Study||121
11197246|NCT01807221|12387315|FG002|COMPLETED|Overall Study||122
11197247|NCT01807221|12387316|FG003|COMPLETED|Overall Study||123
11197248|NCT01807221|12387317|FG004|COMPLETED|Overall Study||134
11197249|NCT01807221|12387318|FG005|COMPLETED|Overall Study||124
11197250|NCT01807221|12387313|FG000|NOT COMPLETED|Overall Study||80
11197251|NCT01807221|12387314|FG001|NOT COMPLETED|Overall Study||52
11197252|NCT01807221|12387315|FG002|NOT COMPLETED|Overall Study||43
11197253|NCT01807221|12387316|FG003|NOT COMPLETED|Overall Study||46
11197254|NCT01807221|12387317|FG004|NOT COMPLETED|Overall Study||36
11197255|NCT01807221|12387318|FG005|NOT COMPLETED|Overall Study||41
11197256|NCT01807234|12387338|FG000|STARTED|Overall Study||12
11197257|NCT01807234|12387339|FG001|STARTED|Overall Study||12
11197258|NCT01807234|12387340|FG002|STARTED|Overall Study||12
11197259|NCT01807234|12387341|FG003|STARTED|Overall Study||12
11197260|NCT01807234|12387342|FG004|STARTED|Overall Study||12
11197261|NCT01807234|12387343|FG005|STARTED|Overall Study||12
11197262|NCT01807234|12387338|FG000|Randomized, But Did Not Take Drug|Overall Study||3
11197263|NCT01807234|12387339|FG001|Randomized, But Did Not Take Drug|Overall Study||5
11197264|NCT01807234|12387340|FG002|Randomized, But Did Not Take Drug|Overall Study||2
11197265|NCT01807234|12387341|FG003|Randomized, But Did Not Take Drug|Overall Study||1
11197266|NCT01807234|12387342|FG004|Randomized, But Did Not Take Drug|Overall Study||4
11197267|NCT01807234|12387343|FG005|Randomized, But Did Not Take Drug|Overall Study||3
11197268|NCT01807234|12387338|FG000|Completed Only 1 Attack|Overall Study||2
11197269|NCT01807234|12387339|FG001|Completed Only 1 Attack|Overall Study||1
11197270|NCT01807234|12387340|FG002|Completed Only 1 Attack|Overall Study||0
11197271|NCT01807234|12387341|FG003|Completed Only 1 Attack|Overall Study||1
11197272|NCT01807234|12387342|FG004|Completed Only 1 Attack|Overall Study||0
11197273|NCT01807234|12387343|FG005|Completed Only 1 Attack|Overall Study||1
11197274|NCT01807234|12387338|FG000|COMPLETED|Overall Study||7
11197275|NCT01807234|12387339|FG001|COMPLETED|Overall Study||6
11197276|NCT01807234|12387340|FG002|COMPLETED|Overall Study||10
11197277|NCT01807234|12387341|FG003|COMPLETED|Overall Study||10
11197278|NCT01807234|12387342|FG004|COMPLETED|Overall Study||8
11197279|NCT01807234|12387343|FG005|COMPLETED|Overall Study||8
11197280|NCT01807234|12387338|FG000|NOT COMPLETED|Overall Study||5
11197281|NCT01807234|12387339|FG001|NOT COMPLETED|Overall Study||6
11197282|NCT01807234|12387340|FG002|NOT COMPLETED|Overall Study||2
11197283|NCT01807234|12387341|FG003|NOT COMPLETED|Overall Study||2
11197284|NCT01807234|12387342|FG004|NOT COMPLETED|Overall Study||4
11197285|NCT01807234|12387343|FG005|NOT COMPLETED|Overall Study||4
11197286|NCT01807299|12387357|FG000|STARTED|Overall Study||14
11197287|NCT01807299|12387358|FG001|STARTED|Overall Study||14
11197288|NCT01807299|12387359|FG002|STARTED|Overall Study||12
11197289|NCT01807299|12387360|FG003|STARTED|Overall Study||13
11197290|NCT01807299|12387357|FG000|COMPLETED|Overall Study||11
11197291|NCT01807299|12387358|FG001|COMPLETED|Overall Study||13
11197292|NCT01807299|12387359|FG002|COMPLETED|Overall Study||12
11197293|NCT01807299|12387360|FG003|COMPLETED|Overall Study||11
11197294|NCT01807299|12387357|FG000|NOT COMPLETED|Overall Study||3
11197295|NCT01807299|12387358|FG001|NOT COMPLETED|Overall Study||1
11197296|NCT01807299|12387359|FG002|NOT COMPLETED|Overall Study||0
11197297|NCT01807299|12387360|FG003|NOT COMPLETED|Overall Study||2
11197298|NCT01807520|12387373|FG000|STARTED|Treatment Period 1 (0-16 Weeks)||67
11197299|NCT01807520|12387374|FG001|STARTED|Treatment Period 1 (0-16 Weeks)||66
11197300|NCT01807520|12387375|FG002|STARTED|Treatment Period 1 (0-16 Weeks)||65
11197301|NCT01807520|12387376|FG003|STARTED|Treatment Period 1 (0-16 Weeks)||0
11197302|NCT01807520|12387377|FG004|STARTED|Treatment Period 1 (0-16 Weeks)||0
11197303|NCT01807520|12387378|FG005|STARTED|Treatment Period 1 (0-16 Weeks)||0
11197304|NCT01807520|12387379|FG006|STARTED|Treatment Period 1 (0-16 Weeks)||0
11197305|NCT01807520|12387373|FG000|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
11197306|NCT01807520|12387374|FG001|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
11197307|NCT01807520|12387375|FG002|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
11197308|NCT01807520|12387376|FG003|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
11197309|NCT01807520|12387377|FG004|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
11197310|NCT01807520|12387378|FG005|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
11197311|NCT01807520|12387379|FG006|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
11197312|NCT01807520|12387373|FG000|Safety Set|Treatment Period 1 (0-16 Weeks)||67
11197313|NCT01807520|12387374|FG001|Safety Set|Treatment Period 1 (0-16 Weeks)||65
11197314|NCT01807520|12387375|FG002|Safety Set|Treatment Period 1 (0-16 Weeks)||65
11197315|NCT01807520|12387376|FG003|Safety Set|Treatment Period 1 (0-16 Weeks)||0
11197316|NCT01807520|12387377|FG004|Safety Set|Treatment Period 1 (0-16 Weeks)||0
11197317|NCT01807520|12387378|FG005|Safety Set|Treatment Period 1 (0-16 Weeks)||0
11197318|NCT01807520|12387379|FG006|Safety Set|Treatment Period 1 (0-16 Weeks)||0
11197319|NCT01807520|12387373|FG000|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
11197320|NCT01807520|12387374|FG001|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
11197321|NCT01807520|12387375|FG002|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
11197322|NCT01807520|12387376|FG003|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
11197323|NCT01807520|12387377|FG004|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
11197324|NCT01807520|12387378|FG005|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
11197325|NCT01807520|12387379|FG006|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
11197326|NCT01807520|12387373|FG000|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
11197327|NCT01807520|12387374|FG001|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
11197328|NCT01807520|12387375|FG002|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
11197329|NCT01807520|12387376|FG003|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
11197330|NCT01807520|12387377|FG004|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
11197331|NCT01807520|12387378|FG005|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
11197332|NCT01807520|12387379|FG006|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
11197333|NCT01807520|12387373|FG000|STARTED|Treatment Period 2 (16-132 Weeks)||63
11197334|NCT01807520|12387374|FG001|STARTED|Treatment Period 2 (16-132 Weeks)||65
11197335|NCT01807520|12387375|FG002|STARTED|Treatment Period 2 (16-132 Weeks)||0
11197336|NCT01807520|12387376|FG003|STARTED|Treatment Period 2 (16-132 Weeks)||29
11197337|NCT01807520|12387377|FG004|STARTED|Treatment Period 2 (16-132 Weeks)||29
11197338|NCT01807520|12387378|FG005|STARTED|Treatment Period 2 (16-132 Weeks)||0
11197339|NCT01807520|12387379|FG006|STARTED|Treatment Period 2 (16-132 Weeks)||0
11197340|NCT01807520|12387373|FG000|Safety Set|Treatment Period 2 (16-132 Weeks)||63
11197341|NCT01807520|12387374|FG001|Safety Set|Treatment Period 2 (16-132 Weeks)||65
11197342|NCT01807520|12387375|FG002|Safety Set|Treatment Period 2 (16-132 Weeks)||0
11197343|NCT01807520|12387376|FG003|Safety Set|Treatment Period 2 (16-132 Weeks)||29
11197344|NCT01807520|12387377|FG004|Safety Set|Treatment Period 2 (16-132 Weeks)||29
11197345|NCT01807520|12387378|FG005|Safety Set|Treatment Period 2 (16-132 Weeks)||0
11197346|NCT01807520|12387379|FG006|Safety Set|Treatment Period 2 (16-132 Weeks)||0
11197347|NCT01807520|12387373|FG000|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
11197348|NCT01807520|12387374|FG001|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
11197349|NCT01807520|12387375|FG002|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
11197350|NCT01807520|12387376|FG003|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
11197351|NCT01807520|12387377|FG004|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
11197352|NCT01807520|12387378|FG005|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
11197353|NCT01807520|12387379|FG006|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
11197354|NCT01807520|12387373|FG000|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
11197355|NCT01807520|12387374|FG001|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
11197356|NCT01807520|12387375|FG002|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
11197357|NCT01807520|12387376|FG003|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
11197358|NCT01807520|12387377|FG004|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
11197359|NCT01807520|12387378|FG005|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
11197360|NCT01807520|12387379|FG006|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
11197361|NCT01807520|12387373|FG000|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
11197362|NCT01807520|12387374|FG001|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
11197363|NCT01807520|12387375|FG002|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
11197364|NCT01807520|12387376|FG003|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
11197365|NCT01807520|12387377|FG004|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
11197366|NCT01807520|12387378|FG005|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
11197367|NCT01807520|12387379|FG006|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
11197368|NCT01807520|12387373|FG000|STARTED|Follow-up Period (132-140 Weeks)||0
11197369|NCT01807520|12387374|FG001|STARTED|Follow-up Period (132-140 Weeks)||0
11197370|NCT01807520|12387375|FG002|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
11197371|NCT01807520|12387376|FG003|STARTED|Follow-up Period (132-140 Weeks)||0
11197372|NCT01807520|12387377|FG004|STARTED|Follow-up Period (132-140 Weeks)||0
11197373|NCT01807520|12387378|FG005|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
11197374|NCT01807520|12387379|FG006|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
11197375|NCT01807520|12387373|FG000|COMPLETED|Follow-up Period (132-140 Weeks)||0
11197376|NCT01807520|12387374|FG001|COMPLETED|Follow-up Period (132-140 Weeks)||0
11197377|NCT01807520|12387375|FG002|COMPLETED|Follow-up Period (132-140 Weeks)||2
11197378|NCT01807520|12387376|FG003|COMPLETED|Follow-up Period (132-140 Weeks)||0
11197379|NCT01807520|12387377|FG004|COMPLETED|Follow-up Period (132-140 Weeks)||0
11197380|NCT01807520|12387378|FG005|COMPLETED|Follow-up Period (132-140 Weeks)||77
11197381|NCT01807520|12387379|FG006|COMPLETED|Follow-up Period (132-140 Weeks)||75
11197382|NCT01807520|12387373|FG000|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
11197383|NCT01807520|12387374|FG001|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
11197384|NCT01807520|12387375|FG002|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
11197385|NCT01807520|12387376|FG003|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
11197386|NCT01807520|12387377|FG004|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
11197387|NCT01807520|12387378|FG005|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
11197388|NCT01807520|12387379|FG006|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
11197389|NCT01807585|12387393|FG000|STARTED|Overall Study||20
11197390|NCT01807585|12387394|FG001|STARTED|Overall Study||108
11197391|NCT01807585|12387395|FG002|STARTED|Overall Study||114
11197392|NCT01807585|12387393|FG000|3 Mos|Overall Study||20
11197393|NCT01807585|12387394|FG001|3 Mos|Overall Study||108
11197394|NCT01807585|12387395|FG002|3 Mos|Overall Study||113
11197395|NCT01807585|12387393|FG000|COMPLETED|Overall Study||19
11197396|NCT01807585|12387394|FG001|COMPLETED|Overall Study||104
11197397|NCT01807585|12387395|FG002|COMPLETED|Overall Study||108
11197398|NCT01807585|12387393|FG000|NOT COMPLETED|Overall Study||1
11197399|NCT01807585|12387394|FG001|NOT COMPLETED|Overall Study||4
11027044|NCT00831792|12205706|FG000|STARTED|Overall Study||46
11197400|NCT01807585|12387395|FG002|NOT COMPLETED|Overall Study||6
11197401|NCT01807598|12387406|FG000|STARTED|Overall Study||10
11197402|NCT01807598|12387406|FG000|COMPLETED|Overall Study||4
11197403|NCT01807598|12387406|FG000|NOT COMPLETED|Overall Study||6
11197404|NCT01807624|12387410|FG000|STARTED|Overall Study||24
11197405|NCT01807624|12387410|FG000|COMPLETED|Overall Study||24
11197406|NCT01807624|12387410|FG000|NOT COMPLETED|Overall Study||0
11197407|NCT01807637|12387416|FG000|STARTED|Baseline||4
11197408|NCT01807637|12387417|FG001|STARTED|Baseline||2
11197409|NCT01807637|12387416|FG000|COMPLETED|Baseline||4
11197410|NCT01807637|12387417|FG001|COMPLETED|Baseline||2
11197411|NCT01807637|12387416|FG000|NOT COMPLETED|Baseline||0
11197412|NCT01807637|12387417|FG001|NOT COMPLETED|Baseline||0
11197413|NCT01807637|12387416|FG000|STARTED|One Week||4
11197414|NCT01807637|12387417|FG001|STARTED|One Week||2
11197415|NCT01807637|12387416|FG000|COMPLETED|One Week||4
11197416|NCT01807637|12387417|FG001|COMPLETED|One Week||2
11197417|NCT01807637|12387416|FG000|NOT COMPLETED|One Week||0
11197418|NCT01807637|12387417|FG001|NOT COMPLETED|One Week||0
11197419|NCT01807637|12387416|FG000|STARTED|One Month||4
11197420|NCT01807637|12387417|FG001|STARTED|One Month||2
11197421|NCT01807637|12387416|FG000|COMPLETED|One Month||4
11197422|NCT01807637|12387417|FG001|COMPLETED|One Month||2
11197423|NCT01807637|12387416|FG000|NOT COMPLETED|One Month||0
11197424|NCT01807637|12387417|FG001|NOT COMPLETED|One Month||0
11197425|NCT01807650|12387425|FG000|STARTED|Overall Study||112
11197426|NCT01807650|12387425|FG000|COMPLETED|Overall Study||92
11197427|NCT01807650|12387425|FG000|NOT COMPLETED|Overall Study||20
11197428|NCT01807871|12387468|FG000|STARTED|Overall Study||356
11197429|NCT01807871|12387469|FG001|STARTED|Overall Study||345
11197430|NCT01807871|12387468|FG000|COMPLETED|Overall Study||178
11197431|NCT01807871|12387469|FG001|COMPLETED|Overall Study||127
11197432|NCT01807871|12387468|FG000|NOT COMPLETED|Overall Study||178
11197433|NCT01807871|12387469|FG001|NOT COMPLETED|Overall Study||218
11197434|NCT01807923|12387478|FG000|STARTED|Overall Study||187
11197435|NCT01807923|12387479|FG001|STARTED|Overall Study||185
11197436|NCT01807923|12387480|FG002|STARTED|Overall Study||187
11197437|NCT01807923|12387478|FG000|COMPLETED|Overall Study||182
11197438|NCT01807923|12387479|FG001|COMPLETED|Overall Study||179
11197439|NCT01807923|12387480|FG002|COMPLETED|Overall Study||176
11197440|NCT01807923|12387478|FG000|NOT COMPLETED|Overall Study||5
11197441|NCT01807923|12387479|FG001|NOT COMPLETED|Overall Study||6
11197442|NCT01807923|12387480|FG002|NOT COMPLETED|Overall Study||11
11197443|NCT01807949|12387493|FG000|STARTED|Overall Study||187
11197444|NCT01807949|12387494|FG001|STARTED|Overall Study||187
11197445|NCT01807949|12387495|FG002|STARTED|Overall Study||189
11197446|NCT01807949|12387493|FG000|COMPLETED|Overall Study||185
11197447|NCT01807949|12387494|FG001|COMPLETED|Overall Study||180
11197448|NCT01807949|12387495|FG002|COMPLETED|Overall Study||180
11197449|NCT01807949|12387493|FG000|NOT COMPLETED|Overall Study||2
11197450|NCT01807949|12387494|FG001|NOT COMPLETED|Overall Study||7
11197451|NCT01807949|12387495|FG002|NOT COMPLETED|Overall Study||9
11197452|NCT01808066|12387505|FG000|STARTED|Overall Study||21
11197453|NCT01808066|12387505|FG000|COMPLETED|Overall Study||6
11197454|NCT01808066|12387505|FG000|NOT COMPLETED|Overall Study||15
11197455|NCT01808092|12387512|FG000|STARTED|Overall Study||409
11197456|NCT01808092|12387513|FG001|STARTED|Overall Study||408
11197457|NCT01808092|12387512|FG000|COMPLETED|Overall Study||355
11197458|NCT01808092|12387513|FG001|COMPLETED|Overall Study||363
11197459|NCT01808092|12387512|FG000|NOT COMPLETED|Overall Study||54
11197460|NCT01808092|12387513|FG001|NOT COMPLETED|Overall Study||45
11197461|NCT01808118|12387519|FG000|STARTED|Period 1||673
11197462|NCT01808118|12387520|FG001|STARTED|Period 1||0
11197463|NCT01808118|12387521|FG002|STARTED|Period 1||0
11197464|NCT01808118|12387519|FG000|COMPLETED|Period 1||305
11197465|NCT01808118|12387520|FG001|COMPLETED|Period 1||0
11197466|NCT01808118|12387521|FG002|COMPLETED|Period 1||0
11197467|NCT01808118|12387519|FG000|NOT COMPLETED|Period 1||368
11197468|NCT01808118|12387520|FG001|NOT COMPLETED|Period 1||0
11197469|NCT01808118|12387521|FG002|NOT COMPLETED|Period 1||0
11197470|NCT01808118|12387519|FG000|STARTED|Period 2||0
11197471|NCT01808118|12387520|FG001|STARTED|Period 2||153
11197472|NCT01808118|12387521|FG002|STARTED|Period 2||152
11197473|NCT01808118|12387519|FG000|COMPLETED|Period 2||0
11197474|NCT01808118|12387520|FG001|COMPLETED|Period 2||140
11197475|NCT01808118|12387521|FG002|COMPLETED|Period 2||144
11197476|NCT01808118|12387519|FG000|NOT COMPLETED|Period 2||0
11197477|NCT01808118|12387520|FG001|NOT COMPLETED|Period 2||13
11197478|NCT01808118|12387521|FG002|NOT COMPLETED|Period 2||8
11197479|NCT01808144|12387537|FG000|STARTED|Overall Study||97
11197480|NCT01808144|12387538|FG001|STARTED|Overall Study||99
11197481|NCT01808144|12387537|FG000|COMPLETED|Overall Study||57
11197482|NCT01808144|12387538|FG001|COMPLETED|Overall Study||51
11197483|NCT01808144|12387537|FG000|NOT COMPLETED|Overall Study||40
11197484|NCT01808144|12387538|FG001|NOT COMPLETED|Overall Study||48
11197485|NCT01808196|12387544|FG000|STARTED|Overall Study||6
11197486|NCT01808196|12387544|FG000|COMPLETED|Overall Study||5
11197487|NCT01808196|12387544|FG000|NOT COMPLETED|Overall Study||1
11197488|NCT01808209|12387550|FG000|STARTED|Overall Study||33
11197489|NCT01808209|12387551|FG001|STARTED|Overall Study||27
11197490|NCT01808209|12387550|FG000|COMPLETED|Overall Study||33
11197491|NCT01808209|12387551|FG001|COMPLETED|Overall Study||26
11197492|NCT01808209|12387550|FG000|NOT COMPLETED|Overall Study||0
11197493|NCT01808209|12387551|FG001|NOT COMPLETED|Overall Study||1
11197494|NCT01808222|12387561|FG000|STARTED|Overall Study||25
11197495|NCT01808222|12387561|FG000|Completed Fluciclovine PET-CT Scan|Overall Study||25
11197496|NCT01808222|12387561|FG000|Completed mpMR Scan|Overall Study||24
11197497|NCT01808222|12387561|FG000|COMPLETED|Overall Study||24
11197498|NCT01808222|12387561|FG000|NOT COMPLETED|Overall Study||1
11197499|NCT01808248|12387567|FG000|STARTED|Overall Study||47
11197500|NCT01808248|12387567|FG000|Completed Posttreatment Week 12 Visit|Overall Study||45
11197501|NCT01808248|12387567|FG000|COMPLETED|Overall Study||42
11197502|NCT01808248|12387567|FG000|NOT COMPLETED|Overall Study||5
11197503|NCT01808313|12387573|FG000|STARTED|Overall Study||133
11197504|NCT01808313|12387573|FG000|COMPLETED|Overall Study||123
11197505|NCT01808313|12387573|FG000|NOT COMPLETED|Overall Study||10
11197506|NCT01808326|12387577|FG000|STARTED|Overall Study||5
11197507|NCT01808326|12387577|FG000|COMPLETED|Overall Study||5
11197508|NCT01808326|12387577|FG000|NOT COMPLETED|Overall Study||0
11197509|NCT01808339|12387581|FG000|STARTED|Treatment Period 1 (14 Days)||4
11197510|NCT01808339|12387582|FG001|STARTED|Treatment Period 1 (14 Days)||4
11197511|NCT01808339|12387583|FG002|STARTED|Treatment Period 1 (14 Days)||4
11197512|NCT01808339|12387584|FG003|STARTED|Treatment Period 1 (14 Days)||4
11197513|NCT01808339|12387585|FG004|STARTED|Treatment Period 1 (14 Days)||6
11197514|NCT01808339|12387586|FG005|STARTED|Treatment Period 1 (14 Days)||6
11197515|NCT01808339|12387581|FG000|COMPLETED|Treatment Period 1 (14 Days)||4
11197516|NCT01808339|12387582|FG001|COMPLETED|Treatment Period 1 (14 Days)||3
11197517|NCT01808339|12387583|FG002|COMPLETED|Treatment Period 1 (14 Days)||4
11197518|NCT01808339|12387584|FG003|COMPLETED|Treatment Period 1 (14 Days)||2
11197519|NCT01808339|12387585|FG004|COMPLETED|Treatment Period 1 (14 Days)||4
11197520|NCT01808339|12387586|FG005|COMPLETED|Treatment Period 1 (14 Days)||5
11197521|NCT01808339|12387581|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
11197522|NCT01808339|12387582|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
11197523|NCT01808339|12387583|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||0
11197524|NCT01808339|12387584|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2
11197525|NCT01808339|12387585|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||2
11197526|NCT01808339|12387586|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1
11197527|NCT01808339|12387581|FG000|STARTED|Washout Period 1 (14-21 Days)||4
11197528|NCT01808339|12387582|FG001|STARTED|Washout Period 1 (14-21 Days)||3
11197529|NCT01808339|12387583|FG002|STARTED|Washout Period 1 (14-21 Days)||4
11197530|NCT01808339|12387584|FG003|STARTED|Washout Period 1 (14-21 Days)||2
11197531|NCT01808339|12387585|FG004|STARTED|Washout Period 1 (14-21 Days)||4
11197532|NCT01808339|12387586|FG005|STARTED|Washout Period 1 (14-21 Days)||5
11197533|NCT01808339|12387581|FG000|COMPLETED|Washout Period 1 (14-21 Days)||4
11197534|NCT01808339|12387582|FG001|COMPLETED|Washout Period 1 (14-21 Days)||3
11197535|NCT01808339|12387583|FG002|COMPLETED|Washout Period 1 (14-21 Days)||4
11197536|NCT01808339|12387584|FG003|COMPLETED|Washout Period 1 (14-21 Days)||2
11197537|NCT01808339|12387585|FG004|COMPLETED|Washout Period 1 (14-21 Days)||4
11197538|NCT01808339|12387586|FG005|COMPLETED|Washout Period 1 (14-21 Days)||5
11197539|NCT01808339|12387581|FG000|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
11197540|NCT01808339|12387582|FG001|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
11197541|NCT01808339|12387583|FG002|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
11197542|NCT01808339|12387584|FG003|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
11197543|NCT01808339|12387585|FG004|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
11197544|NCT01808339|12387586|FG005|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
11197545|NCT01808339|12387581|FG000|STARTED|Treatment Period 2 (14 Days)||4
11197546|NCT01808339|12387582|FG001|STARTED|Treatment Period 2 (14 Days)||3
11197547|NCT01808339|12387583|FG002|STARTED|Treatment Period 2 (14 Days)||4
11197548|NCT01808339|12387584|FG003|STARTED|Treatment Period 2 (14 Days)||2
11197549|NCT01808339|12387585|FG004|STARTED|Treatment Period 2 (14 Days)||4
11197550|NCT01808339|12387586|FG005|STARTED|Treatment Period 2 (14 Days)||5
11197551|NCT01808339|12387581|FG000|COMPLETED|Treatment Period 2 (14 Days)||4
11197552|NCT01808339|12387582|FG001|COMPLETED|Treatment Period 2 (14 Days)||3
11197553|NCT01808339|12387583|FG002|COMPLETED|Treatment Period 2 (14 Days)||4
11197554|NCT01808339|12387584|FG003|COMPLETED|Treatment Period 2 (14 Days)||2
11197555|NCT01808339|12387585|FG004|COMPLETED|Treatment Period 2 (14 Days)||4
11197556|NCT01808339|12387586|FG005|COMPLETED|Treatment Period 2 (14 Days)||5
11197557|NCT01808339|12387581|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11197558|NCT01808339|12387582|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11197559|NCT01808339|12387583|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11197560|NCT01808339|12387584|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11197561|NCT01808339|12387585|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11197562|NCT01808339|12387586|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11197563|NCT01808339|12387581|FG000|STARTED|Washout Period 2 (14-21 Days)||4
11197564|NCT01808339|12387582|FG001|STARTED|Washout Period 2 (14-21 Days)||3
11197565|NCT01808339|12387583|FG002|STARTED|Washout Period 2 (14-21 Days)||4
11197566|NCT01808339|12387584|FG003|STARTED|Washout Period 2 (14-21 Days)||2
11197567|NCT01808339|12387585|FG004|STARTED|Washout Period 2 (14-21 Days)||4
11197568|NCT01808339|12387586|FG005|STARTED|Washout Period 2 (14-21 Days)||5
11197569|NCT01808339|12387581|FG000|COMPLETED|Washout Period 2 (14-21 Days)||4
11197570|NCT01808339|12387582|FG001|COMPLETED|Washout Period 2 (14-21 Days)||3
11197571|NCT01808339|12387583|FG002|COMPLETED|Washout Period 2 (14-21 Days)||4
11197572|NCT01808339|12387584|FG003|COMPLETED|Washout Period 2 (14-21 Days)||2
11197573|NCT01808339|12387585|FG004|COMPLETED|Washout Period 2 (14-21 Days)||4
11197574|NCT01808339|12387586|FG005|COMPLETED|Washout Period 2 (14-21 Days)||5
11197575|NCT01808339|12387581|FG000|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
11197576|NCT01808339|12387582|FG001|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
11197577|NCT01808339|12387583|FG002|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
11197578|NCT01808339|12387584|FG003|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
11197579|NCT01808339|12387585|FG004|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
11197580|NCT01808339|12387586|FG005|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
11197581|NCT01808339|12387581|FG000|STARTED|Treatment Period 3 (14 Days)||4
11197582|NCT01808339|12387582|FG001|STARTED|Treatment Period 3 (14 Days)||3
11197583|NCT01808339|12387583|FG002|STARTED|Treatment Period 3 (14 Days)||4
11197584|NCT01808339|12387584|FG003|STARTED|Treatment Period 3 (14 Days)||2
11197585|NCT01808339|12387585|FG004|STARTED|Treatment Period 3 (14 Days)||4
11197586|NCT01808339|12387586|FG005|STARTED|Treatment Period 3 (14 Days)||5
11197587|NCT01808339|12387581|FG000|COMPLETED|Treatment Period 3 (14 Days)||4
11197588|NCT01808339|12387582|FG001|COMPLETED|Treatment Period 3 (14 Days)||3
11197589|NCT01808339|12387583|FG002|COMPLETED|Treatment Period 3 (14 Days)||3
11197590|NCT01808339|12387584|FG003|COMPLETED|Treatment Period 3 (14 Days)||2
11197591|NCT01808339|12387585|FG004|COMPLETED|Treatment Period 3 (14 Days)||4
11197592|NCT01808339|12387586|FG005|COMPLETED|Treatment Period 3 (14 Days)||5
11197593|NCT01808339|12387581|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11197594|NCT01808339|12387582|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11197595|NCT01808339|12387583|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
11197596|NCT01808339|12387584|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11197597|NCT01808339|12387585|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11027045|NCT00831792|12205706|FG000|COMPLETED|Overall Study||40
11027046|NCT00831792|12205706|FG000|NOT COMPLETED|Overall Study||6
11027047|NCT00831844|12205720|FG000|STARTED|Overall Study||10
11197598|NCT01808339|12387586|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11197599|NCT01808508|12387597|FG000|STARTED|Overall Study||11
11197600|NCT01808508|12387598|FG001|STARTED|Overall Study||9
11197601|NCT01808508|12387599|FG002|STARTED|Overall Study||3
11197602|NCT01808508|12387597|FG000|COMPLETED|Overall Study||10
11197603|NCT01808508|12387598|FG001|COMPLETED|Overall Study||9
11197604|NCT01808508|12387599|FG002|COMPLETED|Overall Study||3
11197605|NCT01808508|12387597|FG000|NOT COMPLETED|Overall Study||1
11197606|NCT01808508|12387598|FG001|NOT COMPLETED|Overall Study||0
11197607|NCT01808508|12387599|FG002|NOT COMPLETED|Overall Study||0
11197608|NCT01808534|12387607|FG000|STARTED|Overall Study||5
11197609|NCT01808534|12387607|FG000|COMPLETED|Overall Study||1
11197610|NCT01808534|12387607|FG000|NOT COMPLETED|Overall Study||4
11197611|NCT01808547|12387613|FG000|STARTED|Overall Study||174
11197612|NCT01808547|12387614|FG001|STARTED|Overall Study||94
11197613|NCT01808547|12387613|FG000|Safety Population|Overall Study||170
11197614|NCT01808547|12387614|FG001|Safety Population|Overall Study||85
11197615|NCT01808547|12387613|FG000|mITT Population|Overall Study||168
11197616|NCT01808547|12387614|FG001|mITT Population|Overall Study||85
11197617|NCT01808547|12387613|FG000|COMPLETED|Overall Study||137
11197618|NCT01808547|12387614|FG001|COMPLETED|Overall Study||48
11197619|NCT01808547|12387613|FG000|NOT COMPLETED|Overall Study||37
11197620|NCT01808547|12387614|FG001|NOT COMPLETED|Overall Study||46
11197621|NCT01808560|12387623|FG000|STARTED|Randomization and Treatment Allocation||18
11197622|NCT01808560|12387624|FG001|STARTED|Randomization and Treatment Allocation||16
11197623|NCT01808560|12387625|FG002|STARTED|Randomization and Treatment Allocation||0
11197624|NCT01808560|12387623|FG000|COMPLETED|Randomization and Treatment Allocation||18
11197625|NCT01808560|12387624|FG001|COMPLETED|Randomization and Treatment Allocation||16
11197626|NCT01808560|12387625|FG002|COMPLETED|Randomization and Treatment Allocation||0
11197627|NCT01808560|12387623|FG000|NOT COMPLETED|Randomization and Treatment Allocation||0
11197628|NCT01808560|12387624|FG001|NOT COMPLETED|Randomization and Treatment Allocation||0
11197629|NCT01808560|12387625|FG002|NOT COMPLETED|Randomization and Treatment Allocation||0
11197630|NCT01808560|12387623|FG000|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
11197631|NCT01808560|12387624|FG001|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
11197632|NCT01808560|12387625|FG002|STARTED|1-Month After Cataract Surgery||0
11027048|NCT00831844|12205721|FG001|STARTED|Overall Study||12
11027049|NCT00831844|12205722|FG002|STARTED|Overall Study||21
11027050|NCT00831844|12205723|FG003|STARTED|Overall Study||10
11027051|NCT00831844|12205724|FG004|STARTED|Overall Study||14
11027052|NCT00831844|12205725|FG005|STARTED|Overall Study||20
11027053|NCT00831844|12205726|FG006|STARTED|Overall Study||10
11197633|NCT01808560|12387623|FG000|COMPLETED|1-Month After Cataract Surgery||16
11197634|NCT01808560|12387624|FG001|COMPLETED|1-Month After Cataract Surgery||13
11197635|NCT01808560|12387625|FG002|COMPLETED|1-Month After Cataract Surgery||0
11197636|NCT01808560|12387623|FG000|NOT COMPLETED|1-Month After Cataract Surgery||0
11197637|NCT01808560|12387624|FG001|NOT COMPLETED|1-Month After Cataract Surgery||0
11197638|NCT01808560|12387625|FG002|NOT COMPLETED|1-Month After Cataract Surgery||0
11197639|NCT01808560|12387623|FG000|STARTED|3-Month After Cataract Surgery||17
11197640|NCT01808560|12387624|FG001|STARTED|3-Month After Cataract Surgery||13
11197641|NCT01808560|12387625|FG002|STARTED|3-Month After Cataract Surgery||0
11197642|NCT01808560|12387623|FG000|COMPLETED|3-Month After Cataract Surgery||17
11197643|NCT01808560|12387624|FG001|COMPLETED|3-Month After Cataract Surgery||13
11197644|NCT01808560|12387625|FG002|COMPLETED|3-Month After Cataract Surgery||0
11197645|NCT01808560|12387623|FG000|NOT COMPLETED|3-Month After Cataract Surgery||0
11197646|NCT01808560|12387624|FG001|NOT COMPLETED|3-Month After Cataract Surgery||0
11197647|NCT01808560|12387625|FG002|NOT COMPLETED|3-Month After Cataract Surgery||0
11197648|NCT01808560|12387623|FG000|STARTED|Crossover Treatment||0
11197649|NCT01808560|12387624|FG001|STARTED|Crossover Treatment||0
11197650|NCT01808560|12387625|FG002|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
11197651|NCT01808560|12387623|FG000|COMPLETED|Crossover Treatment||0
11197652|NCT01808560|12387624|FG001|COMPLETED|Crossover Treatment||0
11197653|NCT01808560|12387625|FG002|COMPLETED|Crossover Treatment||13
11197654|NCT01808560|12387623|FG000|NOT COMPLETED|Crossover Treatment||0
11197655|NCT01808560|12387624|FG001|NOT COMPLETED|Crossover Treatment||0
11197656|NCT01808560|12387625|FG002|NOT COMPLETED|Crossover Treatment||0
11197657|NCT01808560|12387623|FG000|STARTED|4-Month After Cataract Surgery||0
11197658|NCT01808560|12387624|FG001|STARTED|4-Month After Cataract Surgery||0
11197659|NCT01808560|12387625|FG002|STARTED|4-Month After Cataract Surgery||13
11197660|NCT01808560|12387623|FG000|COMPLETED|4-Month After Cataract Surgery||0
11197661|NCT01808560|12387624|FG001|COMPLETED|4-Month After Cataract Surgery||0
11027054|NCT00831844|12205727|FG007|STARTED|Overall Study||10
11197662|NCT01808560|12387625|FG002|COMPLETED|4-Month After Cataract Surgery||13
11197663|NCT01808560|12387623|FG000|NOT COMPLETED|4-Month After Cataract Surgery||0
11197664|NCT01808560|12387624|FG001|NOT COMPLETED|4-Month After Cataract Surgery||0
11197665|NCT01808560|12387625|FG002|NOT COMPLETED|4-Month After Cataract Surgery||0
11197666|NCT01808573|12387635|FG000|STARTED|Overall Study||307
11197667|NCT01808573|12387636|FG001|STARTED|Overall Study||314
11197668|NCT01808573|12387635|FG000|Received Treatment|Overall Study||303
11197669|NCT01808573|12387636|FG001|Received Treatment|Overall Study||311
11197670|NCT01808573|12387635|FG000|COMPLETED|Overall Study||0
11197671|NCT01808573|12387636|FG001|COMPLETED|Overall Study||0
11197672|NCT01808573|12387635|FG000|NOT COMPLETED|Overall Study||307
11197673|NCT01808573|12387636|FG001|NOT COMPLETED|Overall Study||314
11197674|NCT01808612|12387645|FG000|STARTED|Treatment Period||169
11197675|NCT01808612|12387646|FG001|STARTED|Treatment Period||84
11197676|NCT01808612|12387647|FG002|STARTED|Treatment Period||260
11197677|NCT01808612|12387645|FG000|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
11197678|NCT01808612|12387646|FG001|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
11027055|NCT00831844|12205728|FG008|STARTED|Overall Study||9
11027056|NCT00831844|12205729|FG009|STARTED|Overall Study||0
11027057|NCT00831844|12205720|FG000|COMPLETED|Overall Study||0
11197679|NCT01808612|12387647|FG002|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
11197680|NCT01808612|12387645|FG000|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
11197681|NCT01808612|12387646|FG001|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
11197682|NCT01808612|12387647|FG002|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
11197683|NCT01808612|12387645|FG000|NOT COMPLETED|Treatment Period||15
11197684|NCT01808612|12387646|FG001|NOT COMPLETED|Treatment Period||7
11197685|NCT01808612|12387647|FG002|NOT COMPLETED|Treatment Period||14
11197686|NCT01808612|12387645|FG000|STARTED|Discontinuation Period||87
11197687|NCT01808612|12387646|FG001|STARTED|Discontinuation Period||38
11197688|NCT01808612|12387647|FG002|STARTED|Discontinuation Period||145
11197689|NCT01808612|12387645|FG000|COMPLETED|Discontinuation Period||85
11197690|NCT01808612|12387646|FG001|COMPLETED|Discontinuation Period||37
11197691|NCT01808612|12387647|FG002|COMPLETED|Discontinuation Period||145
11197692|NCT01808612|12387645|FG000|NOT COMPLETED|Discontinuation Period||2
11197693|NCT01808612|12387646|FG001|NOT COMPLETED|Discontinuation Period||1
11197694|NCT01808612|12387647|FG002|NOT COMPLETED|Discontinuation Period||0
11197695|NCT01808651|12387661|FG000|STARTED|Study Period 1||99
11197696|NCT01808651|12387662|FG001|STARTED|Study Period 1||65
11197697|NCT01808651|12387663|FG002|STARTED|Study Period 1||36
11197698|NCT01808651|12387661|FG000|Received at Least One Dose of Study Drug|Study Period 1||98
11197699|NCT01808651|12387662|FG001|Received at Least One Dose of Study Drug|Study Period 1||65
11197700|NCT01808651|12387663|FG002|Received at Least One Dose of Study Drug|Study Period 1||36
11197701|NCT01808651|12387661|FG000|COMPLETED|Study Period 1||73
11197702|NCT01808651|12387662|FG001|COMPLETED|Study Period 1||48
11197703|NCT01808651|12387663|FG002|COMPLETED|Study Period 1||31
11197704|NCT01808651|12387661|FG000|NOT COMPLETED|Study Period 1||26
11197705|NCT01808651|12387662|FG001|NOT COMPLETED|Study Period 1||17
11197706|NCT01808651|12387663|FG002|NOT COMPLETED|Study Period 1||5
11197707|NCT01808651|12387661|FG000|STARTED|Study Period 2||77
11197708|NCT01808651|12387662|FG001|STARTED|Study Period 2||52
11197709|NCT01808651|12387663|FG002|STARTED|Study Period 2||33
11197710|NCT01808651|12387661|FG000|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
11197711|NCT01808651|12387662|FG001|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
11197712|NCT01808651|12387663|FG002|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
11197713|NCT01808651|12387661|FG000|NOT COMPLETED|Study Period 2||0
11197714|NCT01808651|12387662|FG001|NOT COMPLETED|Study Period 2||0
11197715|NCT01808651|12387663|FG002|NOT COMPLETED|Study Period 2||0
11197716|NCT01808690|12387676|FG000|STARTED|Overall Study||25
11197717|NCT01808690|12387677|FG001|STARTED|Overall Study||23
11197718|NCT01808690|12387676|FG000|COMPLETED|Overall Study||24
11197719|NCT01808690|12387677|FG001|COMPLETED|Overall Study||21
11197720|NCT01808690|12387676|FG000|NOT COMPLETED|Overall Study||1
11197721|NCT01808690|12387677|FG001|NOT COMPLETED|Overall Study||2
11197722|NCT01808755|12387683|FG000|STARTED|Overall Study||30
11197723|NCT01808755|12387684|FG001|STARTED|Overall Study||30
11197724|NCT01808755|12387683|FG000|COMPLETED|Overall Study||30
11197725|NCT01808755|12387684|FG001|COMPLETED|Overall Study||30
11197726|NCT01808755|12387683|FG000|NOT COMPLETED|Overall Study||0
11197727|NCT01808755|12387684|FG001|NOT COMPLETED|Overall Study||0
11197728|NCT01808963|12387689|FG000|STARTED|Overall Study||13
11197729|NCT01808963|12387689|FG000|COMPLETED|Overall Study||13
11197730|NCT01808963|12387689|FG000|NOT COMPLETED|Overall Study||0
11197731|NCT01809054|12387695|FG000|STARTED|Overall Study||27
11197732|NCT01809054|12387696|FG001|STARTED|Overall Study||22
11197733|NCT01809054|12387695|FG000|COMPLETED|Overall Study||27
11197734|NCT01809054|12387696|FG001|COMPLETED|Overall Study||22
11197735|NCT01809054|12387695|FG000|NOT COMPLETED|Overall Study||0
11197736|NCT01809054|12387696|FG001|NOT COMPLETED|Overall Study||0
11197737|NCT01809106|12387706|FG000|STARTED|Overall Study||130
11197738|NCT01809106|12387707|FG001|STARTED|Overall Study||130
11197739|NCT01809106|12387708|FG002|STARTED|Overall Study||130
11197740|NCT01809106|12387709|FG003|STARTED|Overall Study||128
11197741|NCT01809106|12387706|FG000|COMPLETED|Overall Study||122
11197742|NCT01809106|12387707|FG001|COMPLETED|Overall Study||125
11197743|NCT01809106|12387708|FG002|COMPLETED|Overall Study||127
11197744|NCT01809106|12387709|FG003|COMPLETED|Overall Study||124
11197745|NCT01809106|12387706|FG000|NOT COMPLETED|Overall Study||8
11197746|NCT01809106|12387707|FG001|NOT COMPLETED|Overall Study||5
11197747|NCT01809106|12387708|FG002|NOT COMPLETED|Overall Study||3
11197748|NCT01809106|12387709|FG003|NOT COMPLETED|Overall Study||4
11197749|NCT01809132|12387722|FG000|STARTED|Overall Study||53
11197750|NCT01809132|12387723|FG001|STARTED|Overall Study||50
11197751|NCT01809132|12387724|FG002|STARTED|Overall Study|Subject was consented but withdrew prior to randomization and initiation of treatment.|1
11197752|NCT01809132|12387722|FG000|COMPLETED|Overall Study||53
11197753|NCT01809132|12387723|FG001|COMPLETED|Overall Study||50
11197754|NCT01809132|12387724|FG002|COMPLETED|Overall Study||0
11197755|NCT01809132|12387722|FG000|NOT COMPLETED|Overall Study||0
11197756|NCT01809132|12387723|FG001|NOT COMPLETED|Overall Study||0
11197757|NCT01809132|12387724|FG002|NOT COMPLETED|Overall Study||1
11197758|NCT01809197|12387734|FG000|STARTED|Overall Study||187
11197759|NCT01809197|12387735|FG001|STARTED|Overall Study||185
11197760|NCT01809197|12387734|FG000|COMPLETED|Overall Study||177
11197761|NCT01809197|12387735|FG001|COMPLETED|Overall Study||177
11197762|NCT01809197|12387734|FG000|NOT COMPLETED|Overall Study||10
11197763|NCT01809197|12387735|FG001|NOT COMPLETED|Overall Study||8
11197764|NCT01809210|12387748|FG000|STARTED|Overall Study||3
11197765|NCT01809210|12387749|FG001|STARTED|Overall Study||9
11197766|NCT01809210|12387750|FG002|STARTED|Overall Study||7
11197767|NCT01809210|12387751|FG003|STARTED|Overall Study||3
11197768|NCT01809210|12387752|FG004|STARTED|Overall Study||6
11197769|NCT01809210|12387753|FG005|STARTED|Overall Study||15
11197770|NCT01809210|12387754|FG006|STARTED|Overall Study||12
11197771|NCT01809210|12387748|FG000|COMPLETED|Overall Study||2
11197772|NCT01809210|12387749|FG001|COMPLETED|Overall Study||8
11197773|NCT01809210|12387750|FG002|COMPLETED|Overall Study||4
11197774|NCT01809210|12387751|FG003|COMPLETED|Overall Study||2
11197775|NCT01809210|12387752|FG004|COMPLETED|Overall Study||4
11197776|NCT01809210|12387753|FG005|COMPLETED|Overall Study||12
11197777|NCT01809210|12387754|FG006|COMPLETED|Overall Study||7
11197778|NCT01809210|12387748|FG000|NOT COMPLETED|Overall Study||1
11197779|NCT01809210|12387749|FG001|NOT COMPLETED|Overall Study||1
11197780|NCT01809210|12387750|FG002|NOT COMPLETED|Overall Study||3
11197781|NCT01809210|12387751|FG003|NOT COMPLETED|Overall Study||1
11197782|NCT01809210|12387752|FG004|NOT COMPLETED|Overall Study||2
11197783|NCT01809210|12387753|FG005|NOT COMPLETED|Overall Study||3
11197784|NCT01809210|12387754|FG006|NOT COMPLETED|Overall Study||5
11197785|NCT01809262|12387770|FG000|STARTED|Period 1 (First Dose + Washout)||4
11197786|NCT01809262|12387771|FG001|STARTED|Period 1 (First Dose + Washout)||4
11197787|NCT01809262|12387772|FG002|STARTED|Period 1 (First Dose + Washout)||4
11197788|NCT01809262|12387773|FG003|STARTED|Period 1 (First Dose + Washout)||3
11197789|NCT01809262|12387774|FG004|STARTED|Period 1 (First Dose + Washout)||4
11197790|NCT01809262|12387775|FG005|STARTED|Period 1 (First Dose + Washout)||3
11197791|NCT01809262|12387776|FG006|STARTED|Period 1 (First Dose + Washout)||3
11197792|NCT01809262|12387777|FG007|STARTED|Period 1 (First Dose + Washout)||4
11197793|NCT01809262|12387778|FG008|STARTED|Period 1 (First Dose + Washout)||3
11197794|NCT01809262|12387779|FG009|STARTED|Period 1 (First Dose + Washout)||4
11197795|NCT01809262|12387770|FG000|COMPLETED|Period 1 (First Dose + Washout)||4
11197796|NCT01809262|12387771|FG001|COMPLETED|Period 1 (First Dose + Washout)||4
11197797|NCT01809262|12387772|FG002|COMPLETED|Period 1 (First Dose + Washout)||4
11197798|NCT01809262|12387773|FG003|COMPLETED|Period 1 (First Dose + Washout)||3
11197799|NCT01809262|12387774|FG004|COMPLETED|Period 1 (First Dose + Washout)||3
11197800|NCT01809262|12387775|FG005|COMPLETED|Period 1 (First Dose + Washout)||3
11197801|NCT01809262|12387776|FG006|COMPLETED|Period 1 (First Dose + Washout)||3
11197802|NCT01809262|12387777|FG007|COMPLETED|Period 1 (First Dose + Washout)||4
11197803|NCT01809262|12387778|FG008|COMPLETED|Period 1 (First Dose + Washout)||3
11197804|NCT01809262|12387779|FG009|COMPLETED|Period 1 (First Dose + Washout)||4
11197805|NCT01809262|12387770|FG000|NOT COMPLETED|Period 1 (First Dose + Washout)||0
11197806|NCT01809262|12387771|FG001|NOT COMPLETED|Period 1 (First Dose + Washout)||0
11197807|NCT01809262|12387772|FG002|NOT COMPLETED|Period 1 (First Dose + Washout)||0
11197808|NCT01809262|12387773|FG003|NOT COMPLETED|Period 1 (First Dose + Washout)||0
11197809|NCT01809262|12387774|FG004|NOT COMPLETED|Period 1 (First Dose + Washout)||1
11197810|NCT01809262|12387775|FG005|NOT COMPLETED|Period 1 (First Dose + Washout)||0
11197811|NCT01809262|12387776|FG006|NOT COMPLETED|Period 1 (First Dose + Washout)||0
11197812|NCT01809262|12387777|FG007|NOT COMPLETED|Period 1 (First Dose + Washout)||0
11197813|NCT01809262|12387778|FG008|NOT COMPLETED|Period 1 (First Dose + Washout)||0
11197814|NCT01809262|12387779|FG009|NOT COMPLETED|Period 1 (First Dose + Washout)||0
11197815|NCT01809262|12387770|FG000|STARTED|Period 2 (Second Dose + Washout)||4
11197816|NCT01809262|12387771|FG001|STARTED|Period 2 (Second Dose + Washout)||4
11197817|NCT01809262|12387772|FG002|STARTED|Period 2 (Second Dose + Washout)||4
11197818|NCT01809262|12387773|FG003|STARTED|Period 2 (Second Dose + Washout)||3
11197819|NCT01809262|12387774|FG004|STARTED|Period 2 (Second Dose + Washout)||3
11197820|NCT01809262|12387775|FG005|STARTED|Period 2 (Second Dose + Washout)||3
11197821|NCT01809262|12387776|FG006|STARTED|Period 2 (Second Dose + Washout)||3
11197822|NCT01809262|12387777|FG007|STARTED|Period 2 (Second Dose + Washout)||4
11197823|NCT01809262|12387778|FG008|STARTED|Period 2 (Second Dose + Washout)||3
11197824|NCT01809262|12387779|FG009|STARTED|Period 2 (Second Dose + Washout)||4
11197825|NCT01809262|12387770|FG000|COMPLETED|Period 2 (Second Dose + Washout)||4
11197826|NCT01809262|12387771|FG001|COMPLETED|Period 2 (Second Dose + Washout)||4
11197827|NCT01809262|12387772|FG002|COMPLETED|Period 2 (Second Dose + Washout)||4
11197828|NCT01809262|12387773|FG003|COMPLETED|Period 2 (Second Dose + Washout)||3
11197829|NCT01809262|12387774|FG004|COMPLETED|Period 2 (Second Dose + Washout)||3
11197830|NCT01809262|12387775|FG005|COMPLETED|Period 2 (Second Dose + Washout)||3
11197831|NCT01809262|12387776|FG006|COMPLETED|Period 2 (Second Dose + Washout)||3
11197832|NCT01809262|12387777|FG007|COMPLETED|Period 2 (Second Dose + Washout)||4
11197833|NCT01809262|12387778|FG008|COMPLETED|Period 2 (Second Dose + Washout)||3
11197834|NCT01809262|12387779|FG009|COMPLETED|Period 2 (Second Dose + Washout)||4
11197835|NCT01809262|12387770|FG000|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
11197836|NCT01809262|12387771|FG001|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
11197837|NCT01809262|12387772|FG002|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
11197838|NCT01809262|12387773|FG003|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
11197839|NCT01809262|12387774|FG004|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
11197840|NCT01809262|12387775|FG005|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
11197841|NCT01809262|12387776|FG006|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
11197842|NCT01809262|12387777|FG007|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
11197843|NCT01809262|12387778|FG008|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
11197844|NCT01809262|12387779|FG009|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
11197845|NCT01809262|12387770|FG000|STARTED|Period 3 (Third Dose + Washout)||4
11197846|NCT01809262|12387771|FG001|STARTED|Period 3 (Third Dose + Washout)||4
11197847|NCT01809262|12387772|FG002|STARTED|Period 3 (Third Dose + Washout)||4
11197848|NCT01809262|12387773|FG003|STARTED|Period 3 (Third Dose + Washout)||3
11197849|NCT01809262|12387774|FG004|STARTED|Period 3 (Third Dose + Washout)||3
11197850|NCT01809262|12387775|FG005|STARTED|Period 3 (Third Dose + Washout)||3
11197851|NCT01809262|12387776|FG006|STARTED|Period 3 (Third Dose + Washout)||3
11197852|NCT01809262|12387777|FG007|STARTED|Period 3 (Third Dose + Washout)||4
11197853|NCT01809262|12387778|FG008|STARTED|Period 3 (Third Dose + Washout)||3
11197854|NCT01809262|12387779|FG009|STARTED|Period 3 (Third Dose + Washout)||4
11197855|NCT01809262|12387770|FG000|COMPLETED|Period 3 (Third Dose + Washout)||4
11197856|NCT01809262|12387771|FG001|COMPLETED|Period 3 (Third Dose + Washout)||3
11197857|NCT01809262|12387772|FG002|COMPLETED|Period 3 (Third Dose + Washout)||4
11197858|NCT01809262|12387773|FG003|COMPLETED|Period 3 (Third Dose + Washout)||3
11197859|NCT01809262|12387774|FG004|COMPLETED|Period 3 (Third Dose + Washout)||3
11197860|NCT01809262|12387775|FG005|COMPLETED|Period 3 (Third Dose + Washout)||3
11197861|NCT01809262|12387776|FG006|COMPLETED|Period 3 (Third Dose + Washout)||3
11197862|NCT01809262|12387777|FG007|COMPLETED|Period 3 (Third Dose + Washout)||4
11197863|NCT01809262|12387778|FG008|COMPLETED|Period 3 (Third Dose + Washout)||3
11197864|NCT01809262|12387779|FG009|COMPLETED|Period 3 (Third Dose + Washout)||4
11197865|NCT01809262|12387770|FG000|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
11197866|NCT01809262|12387771|FG001|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
11197867|NCT01809262|12387772|FG002|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
11197868|NCT01809262|12387773|FG003|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
11197869|NCT01809262|12387774|FG004|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
11197870|NCT01809262|12387775|FG005|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
11197871|NCT01809262|12387776|FG006|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
11197872|NCT01809262|12387777|FG007|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
11197873|NCT01809262|12387778|FG008|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
11197874|NCT01809262|12387779|FG009|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
11197875|NCT01809262|12387770|FG000|STARTED|Period 4 (Fourth Dose + Washout)||4
11197876|NCT01809262|12387771|FG001|STARTED|Period 4 (Fourth Dose + Washout)||3
11197877|NCT01809262|12387772|FG002|STARTED|Period 4 (Fourth Dose + Washout)||4
11197878|NCT01809262|12387773|FG003|STARTED|Period 4 (Fourth Dose + Washout)||3
11197879|NCT01809262|12387774|FG004|STARTED|Period 4 (Fourth Dose + Washout)||3
11197880|NCT01809262|12387775|FG005|STARTED|Period 4 (Fourth Dose + Washout)||3
11197881|NCT01809262|12387776|FG006|STARTED|Period 4 (Fourth Dose + Washout)||3
11197882|NCT01809262|12387777|FG007|STARTED|Period 4 (Fourth Dose + Washout)||4
11197883|NCT01809262|12387778|FG008|STARTED|Period 4 (Fourth Dose + Washout)||3
11197884|NCT01809262|12387779|FG009|STARTED|Period 4 (Fourth Dose + Washout)||4
11197885|NCT01809262|12387770|FG000|COMPLETED|Period 4 (Fourth Dose + Washout)||4
11197886|NCT01809262|12387771|FG001|COMPLETED|Period 4 (Fourth Dose + Washout)||3
11197887|NCT01809262|12387772|FG002|COMPLETED|Period 4 (Fourth Dose + Washout)||4
11197888|NCT01809262|12387773|FG003|COMPLETED|Period 4 (Fourth Dose + Washout)||3
11197889|NCT01809262|12387774|FG004|COMPLETED|Period 4 (Fourth Dose + Washout)||3
11197890|NCT01809262|12387775|FG005|COMPLETED|Period 4 (Fourth Dose + Washout)||3
11197891|NCT01809262|12387776|FG006|COMPLETED|Period 4 (Fourth Dose + Washout)||3
11197892|NCT01809262|12387777|FG007|COMPLETED|Period 4 (Fourth Dose + Washout)||4
11197893|NCT01809262|12387778|FG008|COMPLETED|Period 4 (Fourth Dose + Washout)||3
11197894|NCT01809262|12387779|FG009|COMPLETED|Period 4 (Fourth Dose + Washout)||4
11197895|NCT01809262|12387770|FG000|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
11197896|NCT01809262|12387771|FG001|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
11197897|NCT01809262|12387772|FG002|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
11197898|NCT01809262|12387773|FG003|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
11197899|NCT01809262|12387774|FG004|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
11197900|NCT01809262|12387775|FG005|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
11197901|NCT01809262|12387776|FG006|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
11197902|NCT01809262|12387777|FG007|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
11197903|NCT01809262|12387778|FG008|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
11197904|NCT01809262|12387779|FG009|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
11197905|NCT01809262|12387770|FG000|STARTED|Period 5 (Fifth Dose + Washout)||4
11197906|NCT01809262|12387771|FG001|STARTED|Period 5 (Fifth Dose + Washout)||3
11197907|NCT01809262|12387772|FG002|STARTED|Period 5 (Fifth Dose + Washout)||4
11197908|NCT01809262|12387773|FG003|STARTED|Period 5 (Fifth Dose + Washout)||3
11197909|NCT01809262|12387774|FG004|STARTED|Period 5 (Fifth Dose + Washout)||3
11197910|NCT01809262|12387775|FG005|STARTED|Period 5 (Fifth Dose + Washout)||3
11197911|NCT01809262|12387776|FG006|STARTED|Period 5 (Fifth Dose + Washout)||3
11197912|NCT01809262|12387777|FG007|STARTED|Period 5 (Fifth Dose + Washout)||4
11197913|NCT01809262|12387778|FG008|STARTED|Period 5 (Fifth Dose + Washout)||3
11197914|NCT01809262|12387779|FG009|STARTED|Period 5 (Fifth Dose + Washout)||4
11197915|NCT01809262|12387770|FG000|COMPLETED|Period 5 (Fifth Dose + Washout)||4
11197916|NCT01809262|12387771|FG001|COMPLETED|Period 5 (Fifth Dose + Washout)||3
11197917|NCT01809262|12387772|FG002|COMPLETED|Period 5 (Fifth Dose + Washout)||4
11197918|NCT01809262|12387773|FG003|COMPLETED|Period 5 (Fifth Dose + Washout)||3
11197919|NCT01809262|12387774|FG004|COMPLETED|Period 5 (Fifth Dose + Washout)||3
11197920|NCT01809262|12387775|FG005|COMPLETED|Period 5 (Fifth Dose + Washout)||3
11197921|NCT01809262|12387776|FG006|COMPLETED|Period 5 (Fifth Dose + Washout)||3
11197922|NCT01809262|12387777|FG007|COMPLETED|Period 5 (Fifth Dose + Washout)||4
11197923|NCT01809262|12387778|FG008|COMPLETED|Period 5 (Fifth Dose + Washout)||3
11197924|NCT01809262|12387779|FG009|COMPLETED|Period 5 (Fifth Dose + Washout)||4
11197925|NCT01809262|12387770|FG000|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
11197926|NCT01809262|12387771|FG001|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
11197927|NCT01809262|12387772|FG002|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
11197928|NCT01809262|12387773|FG003|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
11197929|NCT01809262|12387774|FG004|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
11197930|NCT01809262|12387775|FG005|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
11197931|NCT01809262|12387776|FG006|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
11197932|NCT01809262|12387777|FG007|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
11197933|NCT01809262|12387778|FG008|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
11197934|NCT01809262|12387779|FG009|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
11197935|NCT01809314|12387791|FG000|STARTED|Overall Study||1167
11197936|NCT01809314|12387791|FG000|COMPLETED|Overall Study||422
11197937|NCT01809314|12387791|FG000|NOT COMPLETED|Overall Study||745
11197938|NCT01809327|12387800|FG000|STARTED|Overall Study||237
11197939|NCT01809327|12387801|FG001|STARTED|Overall Study||237
11197940|NCT01809327|12387802|FG002|STARTED|Overall Study||238
11197941|NCT01809327|12387803|FG003|STARTED|Overall Study||237
11197942|NCT01809327|12387804|FG004|STARTED|Overall Study||237
11197943|NCT01809327|12387800|FG000|COMPLETED|Overall Study||205
11197944|NCT01809327|12387801|FG001|COMPLETED|Overall Study||211
11197945|NCT01809327|12387802|FG002|COMPLETED|Overall Study||216
11197946|NCT01809327|12387803|FG003|COMPLETED|Overall Study||225
11197947|NCT01809327|12387804|FG004|COMPLETED|Overall Study||212
11197948|NCT01809327|12387800|FG000|NOT COMPLETED|Overall Study||32
11197949|NCT01809327|12387801|FG001|NOT COMPLETED|Overall Study||26
11197950|NCT01809327|12387802|FG002|NOT COMPLETED|Overall Study||22
11197951|NCT01809327|12387803|FG003|NOT COMPLETED|Overall Study||12
11197952|NCT01809327|12387804|FG004|NOT COMPLETED|Overall Study||25
11197953|NCT01809639|12387818|FG000|STARTED|Overall Study||18
11197954|NCT01809639|12387819|FG001|STARTED|Overall Study||7
11197955|NCT01809639|12387818|FG000|COMPLETED|Overall Study||18
11197956|NCT01809639|12387819|FG001|COMPLETED|Overall Study||7
11197957|NCT01809639|12387818|FG000|NOT COMPLETED|Overall Study||0
11197958|NCT01809639|12387819|FG001|NOT COMPLETED|Overall Study||0
11197959|NCT01809834|12387825|FG000|STARTED|Overall Study||44
11197960|NCT01809834|12387825|FG000|COMPLETED|Overall Study||44
11197961|NCT01809834|12387825|FG000|NOT COMPLETED|Overall Study||0
11197962|NCT01809938|12387831|FG000|STARTED|First Intervention (170 Minutes)||5
11197963|NCT01809938|12387832|FG001|STARTED|First Intervention (170 Minutes)||5
11197964|NCT01809938|12387831|FG000|COMPLETED|First Intervention (170 Minutes)||5
11197965|NCT01809938|12387832|FG001|COMPLETED|First Intervention (170 Minutes)||5
11197966|NCT01809938|12387831|FG000|NOT COMPLETED|First Intervention (170 Minutes)||0
11197967|NCT01809938|12387832|FG001|NOT COMPLETED|First Intervention (170 Minutes)||0
11197968|NCT01809938|12387831|FG000|STARTED|Washout (Not Less Than 24 Hours)||5
11197969|NCT01809938|12387832|FG001|STARTED|Washout (Not Less Than 24 Hours)||5
11197970|NCT01809938|12387831|FG000|COMPLETED|Washout (Not Less Than 24 Hours)||5
11197971|NCT01809938|12387832|FG001|COMPLETED|Washout (Not Less Than 24 Hours)||5
11197972|NCT01809938|12387831|FG000|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
11197973|NCT01809938|12387832|FG001|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
11197974|NCT01809938|12387831|FG000|STARTED|Second Intervention (170 Minutes)||5
11197975|NCT01809938|12387832|FG001|STARTED|Second Intervention (170 Minutes)||5
11197976|NCT01809938|12387831|FG000|COMPLETED|Second Intervention (170 Minutes)||5
11197977|NCT01809938|12387832|FG001|COMPLETED|Second Intervention (170 Minutes)||5
11197978|NCT01809938|12387831|FG000|NOT COMPLETED|Second Intervention (170 Minutes)||0
11197979|NCT01809938|12387832|FG001|NOT COMPLETED|Second Intervention (170 Minutes)||0
11197980|NCT01810016|12387840|FG000|STARTED|Overall Study||5
11197981|NCT01810016|12387841|FG001|STARTED|Overall Study||2
11197982|NCT01810016|12387842|FG002|STARTED|Overall Study||1
11197983|NCT01810016|12387840|FG000|COMPLETED|Overall Study||4
11197984|NCT01810016|12387841|FG001|COMPLETED|Overall Study||1
11197985|NCT01810016|12387842|FG002|COMPLETED|Overall Study||0
11197986|NCT01810016|12387840|FG000|NOT COMPLETED|Overall Study||1
11197987|NCT01810016|12387841|FG001|NOT COMPLETED|Overall Study||1
11197988|NCT01810016|12387842|FG002|NOT COMPLETED|Overall Study||1
11197989|NCT01810042|12387850|FG000|STARTED|Overall Study||49
11197990|NCT01810042|12387850|FG000|COMPLETED|Overall Study||39
11197991|NCT01810042|12387850|FG000|NOT COMPLETED|Overall Study||10
11197992|NCT01810263|12387856|FG000|STARTED|Overall Study||16
11197993|NCT01810263|12387857|FG001|STARTED|Overall Study||18
11197994|NCT01810263|12387856|FG000|COMPLETED|Overall Study|2014 July|8
11197995|NCT01810263|12387857|FG001|COMPLETED|Overall Study||11
11197996|NCT01810263|12387856|FG000|NOT COMPLETED|Overall Study||8
11197997|NCT01810263|12387857|FG001|NOT COMPLETED|Overall Study||7
11197998|NCT01810289|12387865|FG000|STARTED|Overall Study||7277
11197999|NCT01810289|12387866|FG001|STARTED|Overall Study||4747
11198000|NCT01810289|12387865|FG000|COMPLETED|Overall Study||7277
11198001|NCT01810289|12387866|FG001|COMPLETED|Overall Study||4747
11198002|NCT01810289|12387865|FG000|NOT COMPLETED|Overall Study||0
11198003|NCT01810289|12387866|FG001|NOT COMPLETED|Overall Study||0
11324766|NCT02748694|12522133|FG002|COMPLETED|Overall Study||6
11324767|NCT02748694|12522134|FG003|COMPLETED|Overall Study||6
11324768|NCT02748694|12522135|FG004|COMPLETED|Overall Study||6
11324769|NCT02748694|12522136|FG005|COMPLETED|Overall Study||6
11324770|NCT02748694|12522137|FG006|COMPLETED|Overall Study||8
11324771|NCT02748694|12522138|FG007|COMPLETED|Overall Study||6
11324772|NCT02748694|12522139|FG008|COMPLETED|Overall Study||6
11324773|NCT02748694|12522140|FG009|COMPLETED|Overall Study||6
11324774|NCT02748694|12522141|FG010|COMPLETED|Overall Study||6
11324775|NCT02748694|12522142|FG011|COMPLETED|Overall Study||9
11324776|NCT02748694|12522143|FG012|COMPLETED|Overall Study||9
11324777|NCT02748694|12522144|FG013|COMPLETED|Overall Study||8
11324778|NCT02748694|12522145|FG014|COMPLETED|Overall Study||14
11324779|NCT02748694|12522131|FG000|NOT COMPLETED|Overall Study||0
11324780|NCT02748694|12522132|FG001|NOT COMPLETED|Overall Study||0
11324781|NCT02748694|12522133|FG002|NOT COMPLETED|Overall Study||0
11324782|NCT02748694|12522134|FG003|NOT COMPLETED|Overall Study||0
11324783|NCT02748694|12522135|FG004|NOT COMPLETED|Overall Study||0
11324784|NCT02748694|12522136|FG005|NOT COMPLETED|Overall Study||0
11324785|NCT02748694|12522137|FG006|NOT COMPLETED|Overall Study||0
11324786|NCT02748694|12522138|FG007|NOT COMPLETED|Overall Study||0
11198004|NCT01810380|12387875|FG000|STARTED|Overall Study||163
11198005|NCT01810380|12387876|FG001|STARTED|Overall Study||151
11198006|NCT01810380|12387877|FG002|STARTED|Overall Study||154
11198007|NCT01810380|12387875|FG000|Treated|Overall Study||161
11198008|NCT01810380|12387876|FG001|Treated|Overall Study||150
11198009|NCT01810380|12387877|FG002|Treated|Overall Study||153
11198010|NCT01810380|12387875|FG000|COMPLETED|Overall Study||108
11198011|NCT01810380|12387876|FG001|COMPLETED|Overall Study||113
11198012|NCT01810380|12387877|FG002|COMPLETED|Overall Study||122
11198013|NCT01810380|12387875|FG000|NOT COMPLETED|Overall Study||55
11198014|NCT01810380|12387876|FG001|NOT COMPLETED|Overall Study||38
11198015|NCT01810380|12387877|FG002|NOT COMPLETED|Overall Study||32
11198016|NCT01810432|12387885|FG000|STARTED|Period 1||20
11198017|NCT01810432|12387886|FG001|STARTED|Period 1||20
11198018|NCT01810432|12387885|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
11198019|NCT01810432|12387886|FG001|Received at Least 1 Dose of Study Drug|Period 1||20
11198020|NCT01810432|12387885|FG000|COMPLETED|Period 1||20
11198021|NCT01810432|12387886|FG001|COMPLETED|Period 1||20
11198022|NCT01810432|12387885|FG000|NOT COMPLETED|Period 1||0
11198023|NCT01810432|12387886|FG001|NOT COMPLETED|Period 1||0
11198024|NCT01810432|12387885|FG000|STARTED|Washout||20
11198025|NCT01810432|12387886|FG001|STARTED|Washout||20
11198026|NCT01810432|12387885|FG000|COMPLETED|Washout||19
11198027|NCT01810432|12387886|FG001|COMPLETED|Washout||19
11198028|NCT01810432|12387885|FG000|NOT COMPLETED|Washout||1
11198029|NCT01810432|12387886|FG001|NOT COMPLETED|Washout||1
11198030|NCT01810432|12387885|FG000|STARTED|Period 2||19
11198031|NCT01810432|12387886|FG001|STARTED|Period 2||19
11198032|NCT01810432|12387885|FG000|Received at Least 1 Dose of Study Drug|Period 2||19
11198033|NCT01810432|12387886|FG001|Received at Least 1 Dose of Study Drug|Period 2||19
11198034|NCT01810432|12387885|FG000|COMPLETED|Period 2||15
11198035|NCT01810432|12387886|FG001|COMPLETED|Period 2||17
11198036|NCT01810432|12387885|FG000|NOT COMPLETED|Period 2||4
11198037|NCT01810432|12387886|FG001|NOT COMPLETED|Period 2||2
11198038|NCT01810666|12387892|FG000|STARTED|Overall Study||30
11198039|NCT01810666|12387892|FG000|COMPLETED|Overall Study||30
11198040|NCT01810666|12387892|FG000|NOT COMPLETED|Overall Study||0
11198041|NCT01810692|12387898|FG000|STARTED|Overall Study||77
11198042|NCT01810692|12387899|FG001|STARTED|Overall Study||77
11198043|NCT01810692|12387898|FG000|COMPLETED|Overall Study||77
11198044|NCT01810692|12387899|FG001|COMPLETED|Overall Study||77
11198045|NCT01810692|12387898|FG000|NOT COMPLETED|Overall Study||0
11198046|NCT01810692|12387899|FG001|NOT COMPLETED|Overall Study||0
11198047|NCT01810783|12387905|FG000|STARTED|Overall Study||210
11198048|NCT01810783|12387905|FG000|COMPLETED|Overall Study||101
11198049|NCT01810783|12387905|FG000|NOT COMPLETED|Overall Study||109
11198050|NCT01810939|12387909|FG000|STARTED|Part A Treatment Period||243
11198051|NCT01810939|12387910|FG001|STARTED|Part A Treatment Period||0
11198052|NCT01810939|12387911|FG002|STARTED|Part A Treatment Period||0
11198053|NCT01810939|12387909|FG000|COMPLETED|Part A Treatment Period||219
11198054|NCT01810939|12387910|FG001|COMPLETED|Part A Treatment Period||0
11198055|NCT01810939|12387911|FG002|COMPLETED|Part A Treatment Period||0
11198056|NCT01810939|12387909|FG000|NOT COMPLETED|Part A Treatment Period||24
11198057|NCT01810939|12387910|FG001|NOT COMPLETED|Part A Treatment Period||0
11198058|NCT01810939|12387911|FG002|NOT COMPLETED|Part A Treatment Period||0
11198059|NCT01810939|12387909|FG000|STARTED|Part B Placebo-Controlled Withdrawal||0
11198060|NCT01810939|12387910|FG001|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
11324787|NCT02748694|12522139|FG008|NOT COMPLETED|Overall Study||0
11198061|NCT01810939|12387911|FG002|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
11198062|NCT01810939|12387909|FG000|COMPLETED|Part B Placebo-Controlled Withdrawal||0
11198063|NCT01810939|12387910|FG001|COMPLETED|Part B Placebo-Controlled Withdrawal||45
11198064|NCT01810939|12387911|FG002|COMPLETED|Part B Placebo-Controlled Withdrawal||30
11198065|NCT01810939|12387909|FG000|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
11198066|NCT01810939|12387910|FG001|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
11198067|NCT01810939|12387911|FG002|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
11198068|NCT01810952|12387922|FG000|STARTED|Overall Study||20
11198069|NCT01810952|12387923|FG001|STARTED|Overall Study||17
11198070|NCT01810952|12387922|FG000|COMPLETED|Overall Study||20
11198071|NCT01810952|12387923|FG001|COMPLETED|Overall Study||17
11198072|NCT01810952|12387922|FG000|NOT COMPLETED|Overall Study||0
11198073|NCT01810952|12387923|FG001|NOT COMPLETED|Overall Study||0
11198074|NCT01810991|12387935|FG000|STARTED|Overall Study||19
11027058|NCT00831844|12205721|FG001|COMPLETED|Overall Study||0
11027059|NCT00831844|12205722|FG002|COMPLETED|Overall Study||1
11027060|NCT00831844|12205723|FG003|COMPLETED|Overall Study||0
11027061|NCT00831844|12205724|FG004|COMPLETED|Overall Study||0
11027062|NCT00831844|12205725|FG005|COMPLETED|Overall Study||1
11027063|NCT00831844|12205726|FG006|COMPLETED|Overall Study||0
11198075|NCT01810991|12387935|FG000|COMPLETED|Overall Study||17
11198076|NCT01810991|12387935|FG000|NOT COMPLETED|Overall Study||2
11198077|NCT01811004|12387941|FG000|STARTED|Overall Study||9
11198078|NCT01811004|12387942|FG001|STARTED|Overall Study||8
11198079|NCT01811004|12387941|FG000|COMPLETED|Overall Study||8
11198080|NCT01811004|12387942|FG001|COMPLETED|Overall Study||5
11198081|NCT01811004|12387941|FG000|NOT COMPLETED|Overall Study||1
11198082|NCT01811004|12387942|FG001|NOT COMPLETED|Overall Study||3
11198083|NCT01811030|12387950|FG000|STARTED|Overall Study||33
11198084|NCT01811030|12387950|FG000|COMPLETED|Overall Study||20
11198085|NCT01811030|12387950|FG000|NOT COMPLETED|Overall Study||13
11198086|NCT01811147|12387958|FG000|STARTED|Overall Study||51
11198087|NCT01811147|12387959|FG001|STARTED|Overall Study||56
11198088|NCT01811147|12387960|FG002|STARTED|Overall Study||49
11198089|NCT01811147|12387961|FG003|STARTED|Overall Study||33
11198090|NCT01811147|12387958|FG000|COMPLETED|Overall Study||15
11198091|NCT01811147|12387959|FG001|COMPLETED|Overall Study||11
11198092|NCT01811147|12387960|FG002|COMPLETED|Overall Study||6
11198093|NCT01811147|12387961|FG003|COMPLETED|Overall Study||4
11198094|NCT01811147|12387958|FG000|NOT COMPLETED|Overall Study||36
11198095|NCT01811147|12387959|FG001|NOT COMPLETED|Overall Study||45
11198096|NCT01811147|12387960|FG002|NOT COMPLETED|Overall Study||43
11198097|NCT01811147|12387961|FG003|NOT COMPLETED|Overall Study||29
11198098|NCT01811186|12387973|FG000|STARTED|Overall Study||132
11198099|NCT01811186|12387974|FG001|STARTED|Overall Study||126
11198100|NCT01811186|12387973|FG000|COMPLETED|Overall Study||61
11198101|NCT01811186|12387974|FG001|COMPLETED|Overall Study||64
11198102|NCT01811186|12387973|FG000|NOT COMPLETED|Overall Study||71
11198103|NCT01811186|12387974|FG001|NOT COMPLETED|Overall Study||62
11198104|NCT01811212|12387984|FG000|STARTED|Overall Study||25
11198105|NCT01811212|12387984|FG000|COMPLETED|Overall Study||25
11198106|NCT01811212|12387984|FG000|NOT COMPLETED|Overall Study||0
11198107|NCT01811225|12387988|FG000|STARTED|Treatment Period 1||49
11198108|NCT01811225|12387989|FG001|STARTED|Treatment Period 1||46
11198109|NCT01811225|12387988|FG000|COMPLETED|Treatment Period 1|53 completed one arm of the cross-over and 43 completed two arms of the cross-over|24
11198110|NCT01811225|12387989|FG001|COMPLETED|Treatment Period 1||29
11198111|NCT01811225|12387988|FG000|NOT COMPLETED|Treatment Period 1||25
11198112|NCT01811225|12387989|FG001|NOT COMPLETED|Treatment Period 1||17
11198113|NCT01811225|12387988|FG000|STARTED|Treatment Period 2||24
11198114|NCT01811225|12387989|FG001|STARTED|Treatment Period 2||29
11198115|NCT01811225|12387988|FG000|COMPLETED|Treatment Period 2||20
11198116|NCT01811225|12387989|FG001|COMPLETED|Treatment Period 2||23
11198117|NCT01811225|12387988|FG000|NOT COMPLETED|Treatment Period 2||4
11198118|NCT01811225|12387989|FG001|NOT COMPLETED|Treatment Period 2||6
11198119|NCT01811238|12387995|FG000|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
11198120|NCT01811238|12387995|FG000|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
11198121|NCT01811238|12387995|FG000|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
11198122|NCT01811238|12387995|FG000|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
11198123|NCT01811238|12387995|FG000|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
11198124|NCT01811238|12387995|FG000|NOT COMPLETED|Overall Study||81
11198125|NCT01811303|12388000|FG000|STARTED|First Intervention (1 Day)||4
11198126|NCT01811303|12388001|FG001|STARTED|First Intervention (1 Day)||4
11198127|NCT01811303|12388002|FG002|STARTED|First Intervention (1 Day)||4
11198128|NCT01811303|12388003|FG003|STARTED|First Intervention (1 Day)||2
11198129|NCT01811303|12388000|FG000|COMPLETED|First Intervention (1 Day)||4
11198130|NCT01811303|12388001|FG001|COMPLETED|First Intervention (1 Day)||4
11198131|NCT01811303|12388002|FG002|COMPLETED|First Intervention (1 Day)||4
11198132|NCT01811303|12388003|FG003|COMPLETED|First Intervention (1 Day)||2
11198133|NCT01811303|12388000|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11198134|NCT01811303|12388001|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11198135|NCT01811303|12388002|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11198136|NCT01811303|12388003|FG003|NOT COMPLETED|First Intervention (1 Day)||0
11027064|NCT00831844|12205727|FG007|COMPLETED|Overall Study||0
11198137|NCT01811303|12388000|FG000|STARTED|Washout (2 Days or More)||4
11198138|NCT01811303|12388001|FG001|STARTED|Washout (2 Days or More)||4
11198139|NCT01811303|12388002|FG002|STARTED|Washout (2 Days or More)||4
11198140|NCT01811303|12388003|FG003|STARTED|Washout (2 Days or More)||2
11198141|NCT01811303|12388000|FG000|COMPLETED|Washout (2 Days or More)||4
11198142|NCT01811303|12388001|FG001|COMPLETED|Washout (2 Days or More)||4
11198143|NCT01811303|12388002|FG002|COMPLETED|Washout (2 Days or More)||4
11198144|NCT01811303|12388003|FG003|COMPLETED|Washout (2 Days or More)||2
11198145|NCT01811303|12388000|FG000|NOT COMPLETED|Washout (2 Days or More)||0
11198146|NCT01811303|12388001|FG001|NOT COMPLETED|Washout (2 Days or More)||0
11198147|NCT01811303|12388002|FG002|NOT COMPLETED|Washout (2 Days or More)||0
11198148|NCT01811303|12388003|FG003|NOT COMPLETED|Washout (2 Days or More)||0
11198149|NCT01811303|12388000|FG000|STARTED|Second Intervention (1 Day)||4
11198150|NCT01811303|12388001|FG001|STARTED|Second Intervention (1 Day)||4
11198151|NCT01811303|12388002|FG002|STARTED|Second Intervention (1 Day)||4
11198152|NCT01811303|12388003|FG003|STARTED|Second Intervention (1 Day)||2
11198153|NCT01811303|12388000|FG000|COMPLETED|Second Intervention (1 Day)||4
11198154|NCT01811303|12388001|FG001|COMPLETED|Second Intervention (1 Day)||4
11198155|NCT01811303|12388002|FG002|COMPLETED|Second Intervention (1 Day)||4
11198156|NCT01811303|12388003|FG003|COMPLETED|Second Intervention (1 Day)||2
11198157|NCT01811303|12388000|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11198158|NCT01811303|12388001|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11198159|NCT01811303|12388002|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11198160|NCT01811303|12388003|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
11198161|NCT01811303|12388000|FG000|STARTED|Washout (2 Days or More)||4
11198162|NCT01811303|12388001|FG001|STARTED|Washout (2 Days or More)||4
11198163|NCT01811303|12388002|FG002|STARTED|Washout (2 Days or More)||4
11198164|NCT01811303|12388003|FG003|STARTED|Washout (2 Days or More)||2
11198165|NCT01811303|12388000|FG000|COMPLETED|Washout (2 Days or More)||4
11198166|NCT01811303|12388001|FG001|COMPLETED|Washout (2 Days or More)||4
11198167|NCT01811303|12388002|FG002|COMPLETED|Washout (2 Days or More)||4
11198168|NCT01811303|12388003|FG003|COMPLETED|Washout (2 Days or More)||2
11198169|NCT01811303|12388000|FG000|NOT COMPLETED|Washout (2 Days or More)||0
11198170|NCT01811303|12388001|FG001|NOT COMPLETED|Washout (2 Days or More)||0
11198171|NCT01811303|12388002|FG002|NOT COMPLETED|Washout (2 Days or More)||0
11198172|NCT01811303|12388003|FG003|NOT COMPLETED|Washout (2 Days or More)||0
11198173|NCT01811303|12388000|FG000|STARTED|Third Intervention (1 Day)||4
11198174|NCT01811303|12388001|FG001|STARTED|Third Intervention (1 Day)||4
11198175|NCT01811303|12388002|FG002|STARTED|Third Intervention (1 Day)||4
11198176|NCT01811303|12388003|FG003|STARTED|Third Intervention (1 Day)||2
11198177|NCT01811303|12388000|FG000|COMPLETED|Third Intervention (1 Day)||4
11198178|NCT01811303|12388001|FG001|COMPLETED|Third Intervention (1 Day)||4
11198179|NCT01811303|12388002|FG002|COMPLETED|Third Intervention (1 Day)||4
11198180|NCT01811303|12388003|FG003|COMPLETED|Third Intervention (1 Day)||2
11198181|NCT01811303|12388000|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11198182|NCT01811303|12388001|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11198183|NCT01811303|12388002|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
11198184|NCT01811303|12388003|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
11198185|NCT01811303|12388000|FG000|STARTED|Washout (2 Days or More)||4
11198186|NCT01811303|12388001|FG001|STARTED|Washout (2 Days or More)||4
11198187|NCT01811303|12388002|FG002|STARTED|Washout (2 Days or More)||4
11198188|NCT01811303|12388003|FG003|STARTED|Washout (2 Days or More)||2
11198189|NCT01811303|12388000|FG000|COMPLETED|Washout (2 Days or More)||4
11198190|NCT01811303|12388001|FG001|COMPLETED|Washout (2 Days or More)||4
11198191|NCT01811303|12388002|FG002|COMPLETED|Washout (2 Days or More)||4
11198192|NCT01811303|12388003|FG003|COMPLETED|Washout (2 Days or More)||2
11198193|NCT01811303|12388000|FG000|NOT COMPLETED|Washout (2 Days or More)||0
11198194|NCT01811303|12388001|FG001|NOT COMPLETED|Washout (2 Days or More)||0
11198195|NCT01811303|12388002|FG002|NOT COMPLETED|Washout (2 Days or More)||0
11198196|NCT01811303|12388003|FG003|NOT COMPLETED|Washout (2 Days or More)||0
11198197|NCT01811303|12388000|FG000|STARTED|Fourth Intervention (1 Day)||4
11198198|NCT01811303|12388001|FG001|STARTED|Fourth Intervention (1 Day)||4
11198199|NCT01811303|12388002|FG002|STARTED|Fourth Intervention (1 Day)||4
11198200|NCT01811303|12388003|FG003|STARTED|Fourth Intervention (1 Day)||2
11198201|NCT01811303|12388000|FG000|COMPLETED|Fourth Intervention (1 Day)||4
11198202|NCT01811303|12388001|FG001|COMPLETED|Fourth Intervention (1 Day)||4
11198203|NCT01811303|12388002|FG002|COMPLETED|Fourth Intervention (1 Day)||4
11198204|NCT01811303|12388003|FG003|COMPLETED|Fourth Intervention (1 Day)||2
11198205|NCT01811303|12388000|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
11198206|NCT01811303|12388001|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
11198207|NCT01811303|12388002|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
11198208|NCT01811303|12388003|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
11198209|NCT01811316|12388014|FG000|STARTED|Overall Study||21
11198210|NCT01811316|12388015|FG001|STARTED|Overall Study||22
11198211|NCT01811316|12388016|FG002|STARTED|Overall Study||19
11198212|NCT01811316|12388014|FG000|Visit 4 Weeks|Overall Study||19
11198213|NCT01811316|12388015|FG001|Visit 4 Weeks|Overall Study||22
11198214|NCT01811316|12388016|FG002|Visit 4 Weeks|Overall Study||19
11198215|NCT01811316|12388014|FG000|Visit 12 Weeks|Overall Study||18
11198216|NCT01811316|12388015|FG001|Visit 12 Weeks|Overall Study||22
11198217|NCT01811316|12388016|FG002|Visit 12 Weeks|Overall Study||19
11198218|NCT01811316|12388014|FG000|COMPLETED|Overall Study||18
11198219|NCT01811316|12388015|FG001|COMPLETED|Overall Study||22
11198220|NCT01811316|12388016|FG002|COMPLETED|Overall Study||19
11198221|NCT01811316|12388014|FG000|NOT COMPLETED|Overall Study||3
11198222|NCT01811316|12388015|FG001|NOT COMPLETED|Overall Study||0
11198223|NCT01811316|12388016|FG002|NOT COMPLETED|Overall Study||0
11205011|NCT01856712|12395756|FG001|STARTED|Overall Study|1 received oral in error thus randomized.|22
11205012|NCT01856712|12395755|FG000|Lost to 14 Day Follow up|Overall Study||6
11205013|NCT01856712|12395756|FG001|Lost to 14 Day Follow up|Overall Study||2
11205014|NCT01856712|12395755|FG000|Lost to 45 Day Follow up|Overall Study||1
11205015|NCT01856712|12395756|FG001|Lost to 45 Day Follow up|Overall Study||1
11205016|NCT01856712|12395755|FG000|COMPLETED|Overall Study||16
11205017|NCT01856712|12395756|FG001|COMPLETED|Overall Study||19
11205018|NCT01856712|12395755|FG000|NOT COMPLETED|Overall Study||7
11205019|NCT01856712|12395756|FG001|NOT COMPLETED|Overall Study||3
11205020|NCT01856764|12395768|FG000|STARTED|Overall Study||20
11205021|NCT01856764|12395769|FG001|STARTED|Overall Study||20
11205022|NCT01856764|12395768|FG000|COMPLETED|Overall Study||20
11205023|NCT01856764|12395769|FG001|COMPLETED|Overall Study||20
11205024|NCT01856764|12395768|FG000|NOT COMPLETED|Overall Study||0
11205025|NCT01856764|12395769|FG001|NOT COMPLETED|Overall Study||0
11205026|NCT01856790|12395775|FG000|STARTED|Closed Loop Control||15
11205027|NCT01856790|12395775|FG000|COMPLETED|Closed Loop Control||13
11205028|NCT01856790|12395775|FG000|NOT COMPLETED|Closed Loop Control||2
11205029|NCT01856790|12395775|FG000|STARTED|Closed Loop Control + Liraglutide||13
11205030|NCT01856790|12395775|FG000|COMPLETED|Closed Loop Control + Liraglutide||11
11205031|NCT01856790|12395775|FG000|NOT COMPLETED|Closed Loop Control + Liraglutide||2
11205032|NCT01856907|12395789|FG000|STARTED|Overall Study||12
11205033|NCT01856907|12395790|FG001|STARTED|Overall Study||12
11027065|NCT00831844|12205728|FG008|COMPLETED|Overall Study||0
11027066|NCT00831844|12205729|FG009|COMPLETED|Overall Study||0
11027067|NCT00831844|12205720|FG000|NOT COMPLETED|Overall Study||10
11027068|NCT00831844|12205721|FG001|NOT COMPLETED|Overall Study||12
11027069|NCT00831844|12205722|FG002|NOT COMPLETED|Overall Study||20
11027070|NCT00831844|12205723|FG003|NOT COMPLETED|Overall Study||10
11027071|NCT00831844|12205724|FG004|NOT COMPLETED|Overall Study||14
11027072|NCT00831844|12205725|FG005|NOT COMPLETED|Overall Study||19
11027073|NCT00831844|12205726|FG006|NOT COMPLETED|Overall Study||10
11027074|NCT00831844|12205727|FG007|NOT COMPLETED|Overall Study||10
11027075|NCT00831844|12205728|FG008|NOT COMPLETED|Overall Study||9
11027076|NCT00831844|12205729|FG009|NOT COMPLETED|Overall Study||0
11027077|NCT00831987|12205753|FG000|STARTED|Overall Study||60
11027078|NCT00831987|12205754|FG001|STARTED|Overall Study||60
11027079|NCT00831987|12205753|FG000|COMPLETED|Overall Study||60
11027080|NCT00831987|12205754|FG001|COMPLETED|Overall Study||60
11027081|NCT00831987|12205753|FG000|NOT COMPLETED|Overall Study||0
11205034|NCT01856907|12395791|FG002|STARTED|Overall Study||12
11205035|NCT01856907|12395789|FG000|COMPLETED|Overall Study||12
11205036|NCT01856907|12395790|FG001|COMPLETED|Overall Study||9
11205037|NCT01856907|12395791|FG002|COMPLETED|Overall Study||12
11205038|NCT01856907|12395789|FG000|NOT COMPLETED|Overall Study||0
11205039|NCT01856907|12395790|FG001|NOT COMPLETED|Overall Study||3
11205040|NCT01856907|12395791|FG002|NOT COMPLETED|Overall Study||0
11205041|NCT01856933|12395802|FG000|STARTED|Overall Study||6
11205042|NCT01856933|12395802|FG000|COMPLETED|Overall Study||6
11205043|NCT01856933|12395802|FG000|NOT COMPLETED|Overall Study||0
11205044|NCT01857102|12395806|FG000|STARTED|Period 1||58
11205045|NCT01857102|12395807|FG001|STARTED|Period 1||56
11205046|NCT01857102|12395806|FG000|Habitual Users|Period 1||51
11205047|NCT01857102|12395807|FG001|Habitual Users|Period 1||52
11205048|NCT01857102|12395806|FG000|Neophtyes|Period 1||7
11205049|NCT01857102|12395807|FG001|Neophtyes|Period 1||4
11205050|NCT01857102|12395806|FG000|COMPLETED|Period 1||55
11205051|NCT01857102|12395807|FG001|COMPLETED|Period 1||51
11205052|NCT01857102|12395806|FG000|NOT COMPLETED|Period 1||3
11205053|NCT01857102|12395807|FG001|NOT COMPLETED|Period 1||5
11205054|NCT01857102|12395806|FG000|STARTED|Period 2||55
11205055|NCT01857102|12395807|FG001|STARTED|Period 2||51
11205056|NCT01857102|12395806|FG000|Habitual Users|Period 2||48
11205057|NCT01857102|12395807|FG001|Habitual Users|Period 2||47
11205058|NCT01857102|12395806|FG000|Neophytes|Period 2||7
11205059|NCT01857102|12395807|FG001|Neophytes|Period 2||4
11205060|NCT01857102|12395806|FG000|COMPLETED|Period 2||53
11205061|NCT01857102|12395807|FG001|COMPLETED|Period 2||51
11205062|NCT01857102|12395806|FG000|NOT COMPLETED|Period 2||2
11205063|NCT01857102|12395807|FG001|NOT COMPLETED|Period 2||0
11205064|NCT01857206|12395817|FG000|STARTED|Overall Study||1372
11205065|NCT01857206|12395818|FG001|STARTED|Overall Study||683
11205066|NCT01857206|12395817|FG000|COMPLETED|Overall Study||1359
11205067|NCT01857206|12395818|FG001|COMPLETED|Overall Study||673
11205068|NCT01857206|12395817|FG000|NOT COMPLETED|Overall Study||13
11205069|NCT01857206|12395818|FG001|NOT COMPLETED|Overall Study||10
11205070|NCT01857232|12395833|FG000|STARTED|Overall Study||69
11205071|NCT01857232|12395834|FG001|STARTED|Overall Study||67
11205072|NCT01857232|12395835|FG002|STARTED|Overall Study||67
11205073|NCT01857232|12395836|FG003|STARTED|Overall Study||70
11205074|NCT01857232|12395837|FG004|STARTED|Overall Study||69
11205075|NCT01857232|12395833|FG000|Evaluable ITT|Overall Study||66
11205076|NCT01857232|12395834|FG001|Evaluable ITT|Overall Study||66
11205077|NCT01857232|12395835|FG002|Evaluable ITT|Overall Study||63
11205078|NCT01857232|12395836|FG003|Evaluable ITT|Overall Study||68
11205079|NCT01857232|12395837|FG004|Evaluable ITT|Overall Study||65
11205080|NCT01857232|12395833|FG000|COMPLETED|Overall Study||61
11205081|NCT01857232|12395834|FG001|COMPLETED|Overall Study||65
11198224|NCT01811355|12388024|FG000|STARTED|First Dose||11
11198225|NCT01811355|12388025|FG001|STARTED|First Dose||12
11198226|NCT01811355|12388024|FG000|COMPLETED|First Dose||9
11198227|NCT01811355|12388025|FG001|COMPLETED|First Dose||12
11198228|NCT01811355|12388024|FG000|NOT COMPLETED|First Dose||2
11198229|NCT01811355|12388025|FG001|NOT COMPLETED|First Dose||0
11198230|NCT01811355|12388024|FG000|STARTED|Washout||9
11198231|NCT01811355|12388025|FG001|STARTED|Washout||12
11198232|NCT01811355|12388024|FG000|COMPLETED|Washout||9
11198233|NCT01811355|12388025|FG001|COMPLETED|Washout||12
11198234|NCT01811355|12388024|FG000|NOT COMPLETED|Washout||0
11198235|NCT01811355|12388025|FG001|NOT COMPLETED|Washout||0
11198236|NCT01811355|12388024|FG000|STARTED|Second Dose||9
11198237|NCT01811355|12388025|FG001|STARTED|Second Dose||12
11198238|NCT01811355|12388024|FG000|COMPLETED|Second Dose||9
11198239|NCT01811355|12388025|FG001|COMPLETED|Second Dose||12
11198240|NCT01811355|12388024|FG000|NOT COMPLETED|Second Dose||0
11198241|NCT01811355|12388025|FG001|NOT COMPLETED|Second Dose||0
11198242|NCT01811472|12388036|FG000|STARTED|Overall Study||20
11198243|NCT01811472|12388037|FG001|STARTED|Overall Study||11
11198244|NCT01811472|12388038|FG002|STARTED|Overall Study||21
11198245|NCT01811472|12388036|FG000|COMPLETED|Overall Study||18
11198246|NCT01811472|12388037|FG001|COMPLETED|Overall Study||11
11198247|NCT01811472|12388038|FG002|COMPLETED|Overall Study||16
11198248|NCT01811472|12388036|FG000|NOT COMPLETED|Overall Study||2
11198249|NCT01811472|12388037|FG001|NOT COMPLETED|Overall Study||0
11198250|NCT01811472|12388038|FG002|NOT COMPLETED|Overall Study||5
11198251|NCT01811485|12388050|FG000|STARTED|Overall Study|"Started indicates randomized patients"|56
11198252|NCT01811485|12388051|FG001|STARTED|Overall Study||59
11198253|NCT01811485|12388052|FG002|STARTED|Overall Study||56
11198254|NCT01811485|12388050|FG000|COMPLETED|Overall Study||54
11324788|NCT02748694|12522140|FG009|NOT COMPLETED|Overall Study||0
11324789|NCT02748694|12522141|FG010|NOT COMPLETED|Overall Study||0
11198255|NCT01811485|12388051|FG001|COMPLETED|Overall Study||55
11198256|NCT01811485|12388052|FG002|COMPLETED|Overall Study||51
11198257|NCT01811485|12388050|FG000|NOT COMPLETED|Overall Study||2
11198258|NCT01811485|12388051|FG001|NOT COMPLETED|Overall Study||4
11198259|NCT01811485|12388052|FG002|NOT COMPLETED|Overall Study||5
11198260|NCT01811563|12388065|FG000|STARTED|Overall Study||25
11198261|NCT01811563|12388066|FG001|STARTED|Overall Study||23
11198262|NCT01811563|12388065|FG000|COMPLETED|Overall Study||20
11198263|NCT01811563|12388066|FG001|COMPLETED|Overall Study||20
11198264|NCT01811563|12388065|FG000|NOT COMPLETED|Overall Study||5
11198265|NCT01811563|12388066|FG001|NOT COMPLETED|Overall Study||3
11198266|NCT01811654|12388074|FG000|STARTED|Overall Study||14
11198267|NCT01811654|12388075|FG001|STARTED|Overall Study||16
11198268|NCT01811654|12388074|FG000|COMPLETED|Overall Study||14
11198269|NCT01811654|12388075|FG001|COMPLETED|Overall Study||16
11198270|NCT01811654|12388074|FG000|NOT COMPLETED|Overall Study||0
11198271|NCT01811654|12388075|FG001|NOT COMPLETED|Overall Study||0
11198272|NCT01811680|12388081|FG000|STARTED|Overall Study||10
11198273|NCT01811680|12388081|FG000|COMPLETED|Overall Study||10
11198274|NCT01811680|12388081|FG000|NOT COMPLETED|Overall Study||0
11198275|NCT01811693|12388089|FG000|STARTED|Overall Study||4
11198276|NCT01811693|12388090|FG001|STARTED|Overall Study||0
11198277|NCT01811693|12388091|FG002|STARTED|Overall Study||0
11198278|NCT01811693|12388089|FG000|COMPLETED|Overall Study||4
11198279|NCT01811693|12388090|FG001|COMPLETED|Overall Study||0
11198280|NCT01811693|12388091|FG002|COMPLETED|Overall Study||0
11198281|NCT01811693|12388089|FG000|NOT COMPLETED|Overall Study||0
11198282|NCT01811693|12388090|FG001|NOT COMPLETED|Overall Study||0
11198283|NCT01811693|12388091|FG002|NOT COMPLETED|Overall Study||0
11198284|NCT01811706|12388095|FG000|STARTED|First Intervention ( 4 Weeks)||10
11198285|NCT01811706|12388096|FG001|STARTED|First Intervention ( 4 Weeks)||10
11198286|NCT01811706|12388095|FG000|COMPLETED|First Intervention ( 4 Weeks)||9
11198287|NCT01811706|12388096|FG001|COMPLETED|First Intervention ( 4 Weeks)||10
11198288|NCT01811706|12388095|FG000|NOT COMPLETED|First Intervention ( 4 Weeks)||1
11198289|NCT01811706|12388096|FG001|NOT COMPLETED|First Intervention ( 4 Weeks)||0
11198290|NCT01811706|12388095|FG000|STARTED|Washout ( 2 Weeks)||9
11198291|NCT01811706|12388096|FG001|STARTED|Washout ( 2 Weeks)||10
11198292|NCT01811706|12388095|FG000|COMPLETED|Washout ( 2 Weeks)||9
11198293|NCT01811706|12388096|FG001|COMPLETED|Washout ( 2 Weeks)||10
11198294|NCT01811706|12388095|FG000|NOT COMPLETED|Washout ( 2 Weeks)||0
11198295|NCT01811706|12388096|FG001|NOT COMPLETED|Washout ( 2 Weeks)||0
11198296|NCT01811706|12388095|FG000|STARTED|Second Intervention (4 Weeks)||9
11198297|NCT01811706|12388096|FG001|STARTED|Second Intervention (4 Weeks)||10
11198298|NCT01811706|12388095|FG000|COMPLETED|Second Intervention (4 Weeks)||9
11198299|NCT01811706|12388096|FG001|COMPLETED|Second Intervention (4 Weeks)||10
11198300|NCT01811706|12388095|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
11198301|NCT01811706|12388096|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
11198302|NCT01811732|12388106|FG000|STARTED|Overall Study||331
11198303|NCT01811732|12388107|FG001|STARTED|Overall Study||329
11198304|NCT01811732|12388106|FG000|COMPLETED|Overall Study||276
11198305|NCT01811732|12388107|FG001|COMPLETED|Overall Study||271
11198306|NCT01811732|12388106|FG000|NOT COMPLETED|Overall Study||55
11198307|NCT01811732|12388107|FG001|NOT COMPLETED|Overall Study||58
11198308|NCT01811875|12388114|FG000|STARTED|Overall Study||7
11198309|NCT01811875|12388114|FG000|COMPLETED|Overall Study||5
11198310|NCT01811875|12388114|FG000|NOT COMPLETED|Overall Study||2
11198311|NCT01811940|12388120|FG000|STARTED|Overall Study||64
11198312|NCT01811940|12388121|FG001|STARTED|Overall Study||63
11198313|NCT01811940|12388120|FG000|COMPLETED|Overall Study||42
11198314|NCT01811940|12388121|FG001|COMPLETED|Overall Study||37
11198315|NCT01811940|12388120|FG000|NOT COMPLETED|Overall Study||22
11198316|NCT01811940|12388121|FG001|NOT COMPLETED|Overall Study||26
11198317|NCT01811953|12388133|FG000|STARTED|Overall Study||6
11198318|NCT01811953|12388134|FG001|STARTED|Overall Study||6
11198319|NCT01811953|12388135|FG002|STARTED|Overall Study||6
11198320|NCT01811953|12388136|FG003|STARTED|Overall Study||6
11198321|NCT01811953|12388137|FG004|STARTED|Overall Study||12
11198322|NCT01811953|12388138|FG005|STARTED|Overall Study||12
11198323|NCT01811953|12388133|FG000|COMPLETED|Overall Study||6
11198324|NCT01811953|12388134|FG001|COMPLETED|Overall Study||6
11198325|NCT01811953|12388135|FG002|COMPLETED|Overall Study||6
11198326|NCT01811953|12388136|FG003|COMPLETED|Overall Study||5
11198327|NCT01811953|12388137|FG004|COMPLETED|Overall Study||11
11198328|NCT01811953|12388138|FG005|COMPLETED|Overall Study||11
11198329|NCT01811953|12388133|FG000|NOT COMPLETED|Overall Study||0
11198330|NCT01811953|12388134|FG001|NOT COMPLETED|Overall Study||0
11198331|NCT01811953|12388135|FG002|NOT COMPLETED|Overall Study||0
11198332|NCT01811953|12388136|FG003|NOT COMPLETED|Overall Study||1
11198333|NCT01811953|12388137|FG004|NOT COMPLETED|Overall Study||1
11198334|NCT01811953|12388138|FG005|NOT COMPLETED|Overall Study||1
11198335|NCT01812005|12388154|FG000|STARTED|Overall Study||1
11198336|NCT01812005|12388155|FG001|STARTED|Overall Study||13
11198337|NCT01812005|12388154|FG000|COMPLETED|Overall Study||1
11198338|NCT01812005|12388155|FG001|COMPLETED|Overall Study||13
11198339|NCT01812005|12388154|FG000|NOT COMPLETED|Overall Study||0
11198340|NCT01812005|12388155|FG001|NOT COMPLETED|Overall Study||0
11198341|NCT01812044|12388164|FG000|STARTED|Overall Study||17
11198342|NCT01812044|12388165|FG001|STARTED|Overall Study||17
11198343|NCT01812044|12388166|FG002|STARTED|Overall Study||16
11198344|NCT01812044|12388164|FG000|COMPLETED|Overall Study||17
11198345|NCT01812044|12388165|FG001|COMPLETED|Overall Study||17
11198346|NCT01812044|12388166|FG002|COMPLETED|Overall Study||16
11198347|NCT01812044|12388164|FG000|NOT COMPLETED|Overall Study||0
11198348|NCT01812044|12388165|FG001|NOT COMPLETED|Overall Study||0
11198349|NCT01812044|12388166|FG002|NOT COMPLETED|Overall Study||0
11198350|NCT01812057|12388176|FG000|STARTED|Overall Study||25
11198351|NCT01812057|12388177|FG001|STARTED|Overall Study||24
11198352|NCT01812057|12388176|FG000|COMPLETED|Overall Study||23
11198353|NCT01812057|12388177|FG001|COMPLETED|Overall Study||24
11198354|NCT01812057|12388176|FG000|NOT COMPLETED|Overall Study||2
11198355|NCT01812057|12388177|FG001|NOT COMPLETED|Overall Study||0
11198356|NCT01812109|12388187|FG000|STARTED|Overall Study||154
11027082|NCT00831987|12205754|FG001|NOT COMPLETED|Overall Study||0
11027083|NCT00832000|12205760|FG000|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
11027084|NCT00832000|12205761|FG001|STARTED|Overall Study|Placebo|30
11027085|NCT00832000|12205760|FG000|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
11027086|NCT00832000|12205761|FG001|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
11027087|NCT00832000|12205760|FG000|COMPLETED|Overall Study||23
11027088|NCT00832000|12205761|FG001|COMPLETED|Overall Study||29
11027089|NCT00832000|12205760|FG000|NOT COMPLETED|Overall Study||6
11027090|NCT00832000|12205761|FG001|NOT COMPLETED|Overall Study||1
11198357|NCT01812109|12388187|FG000|With Torsion|Overall Study||36
11198358|NCT01812109|12388187|FG000|Without Torsion|Overall Study||85
11198359|NCT01812109|12388187|FG000|COMPLETED|Overall Study||121
11198360|NCT01812109|12388187|FG000|NOT COMPLETED|Overall Study||33
11198361|NCT01812473|12388193|FG000|STARTED|Overall Study||22
11198362|NCT01812473|12388194|FG001|STARTED|Overall Study||13
11198363|NCT01812473|12388193|FG000|COMPLETED|Overall Study||22
11198364|NCT01812473|12388194|FG001|COMPLETED|Overall Study||13
11198365|NCT01812473|12388193|FG000|NOT COMPLETED|Overall Study||0
11198366|NCT01812473|12388194|FG001|NOT COMPLETED|Overall Study||0
11198367|NCT01812655|12388203|FG000|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
11198368|NCT01812655|12388204|FG001|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
11198369|NCT01812655|12388205|FG002|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
11198370|NCT01812655|12388203|FG000|COMPLETED|Overall Study||8
11198371|NCT01812655|12388204|FG001|COMPLETED|Overall Study||10
11198372|NCT01812655|12388205|FG002|COMPLETED|Overall Study||10
11198373|NCT01812655|12388203|FG000|NOT COMPLETED|Overall Study||1
11198374|NCT01812655|12388204|FG001|NOT COMPLETED|Overall Study||1
11198375|NCT01812655|12388205|FG002|NOT COMPLETED|Overall Study||0
11198376|NCT01812668|12388216|FG000|STARTED|Overall Study||20
11198377|NCT01812668|12388216|FG000|COMPLETED|Overall Study||20
11198378|NCT01812668|12388216|FG000|NOT COMPLETED|Overall Study||0
11198379|NCT01812681|12388222|FG000|STARTED|Overall Study||60
11198380|NCT01812681|12388223|FG001|STARTED|Overall Study||24
11198381|NCT01812681|12388222|FG000|COMPLETED|Overall Study||57
11198382|NCT01812681|12388223|FG001|COMPLETED|Overall Study||24
11198383|NCT01812681|12388222|FG000|NOT COMPLETED|Overall Study||3
11198384|NCT01812681|12388223|FG001|NOT COMPLETED|Overall Study||0
11198385|NCT01812707|12388233|FG000|STARTED|Overall Study||25
11198386|NCT01812707|12388234|FG001|STARTED|Overall Study||25
11198387|NCT01812707|12388235|FG002|STARTED|Overall Study||25
11198388|NCT01812707|12388236|FG003|STARTED|Overall Study||25
11198389|NCT01812707|12388233|FG000|Treated|Overall Study||25
11198390|NCT01812707|12388234|FG001|Treated|Overall Study||25
11198391|NCT01812707|12388235|FG002|Treated|Overall Study||25
11198392|NCT01812707|12388236|FG003|Treated|Overall Study||25
11198393|NCT01812707|12388233|FG000|COMPLETED|Overall Study||23
11198394|NCT01812707|12388234|FG001|COMPLETED|Overall Study||25
11198395|NCT01812707|12388235|FG002|COMPLETED|Overall Study||25
11198396|NCT01812707|12388236|FG003|COMPLETED|Overall Study||23
11198397|NCT01812707|12388233|FG000|NOT COMPLETED|Overall Study||2
11198398|NCT01812707|12388234|FG001|NOT COMPLETED|Overall Study||0
11198399|NCT01812707|12388235|FG002|NOT COMPLETED|Overall Study||0
11198400|NCT01812707|12388236|FG003|NOT COMPLETED|Overall Study||2
11198401|NCT01812759|12388250|FG000|STARTED|Overall Study||1
11198402|NCT01812759|12388251|FG001|STARTED|Overall Study||1
11198403|NCT01812759|12388252|FG002|STARTED|Overall Study||1
11198404|NCT01812759|12388250|FG000|COMPLETED|Overall Study||1
11198405|NCT01812759|12388251|FG001|COMPLETED|Overall Study||1
11198406|NCT01812759|12388252|FG002|COMPLETED|Overall Study||0
11198407|NCT01812759|12388250|FG000|NOT COMPLETED|Overall Study||0
11198408|NCT01812759|12388251|FG001|NOT COMPLETED|Overall Study||0
11198409|NCT01812759|12388252|FG002|NOT COMPLETED|Overall Study||1
11198410|NCT01812837|12388263|FG000|STARTED|Overall Study||17
11198411|NCT01812837|12388264|FG001|STARTED|Overall Study||17
11198412|NCT01812837|12388265|FG002|STARTED|Overall Study||17
11198413|NCT01812837|12388263|FG000|COMPLETED|Overall Study||15
11198414|NCT01812837|12388264|FG001|COMPLETED|Overall Study||16
11198415|NCT01812837|12388265|FG002|COMPLETED|Overall Study||17
11198416|NCT01812837|12388263|FG000|NOT COMPLETED|Overall Study||2
11198417|NCT01812837|12388264|FG001|NOT COMPLETED|Overall Study||1
11198418|NCT01812837|12388265|FG002|NOT COMPLETED|Overall Study||0
11198419|NCT01813019|12388275|FG000|STARTED|Overall Study||24
11198420|NCT01813019|12388276|FG001|STARTED|Overall Study||26
11198421|NCT01813019|12388275|FG000|COMPLETED|Overall Study||17
11198422|NCT01813019|12388276|FG001|COMPLETED|Overall Study||20
11198423|NCT01813019|12388275|FG000|NOT COMPLETED|Overall Study||7
11198424|NCT01813019|12388276|FG001|NOT COMPLETED|Overall Study||6
11198425|NCT01813058|12388284|FG000|STARTED|Overall Study||60
11198426|NCT01813058|12388285|FG001|STARTED|Overall Study||60
11198427|NCT01813058|12388284|FG000|COMPLETED|Overall Study||55
11198428|NCT01813058|12388285|FG001|COMPLETED|Overall Study||56
11198429|NCT01813058|12388284|FG000|NOT COMPLETED|Overall Study||5
11198430|NCT01813058|12388285|FG001|NOT COMPLETED|Overall Study||4
11198431|NCT01813071|12388300|FG000|STARTED|Overall Study||10
11198432|NCT01813071|12388301|FG001|STARTED|Overall Study||10
11198433|NCT01813071|12388302|FG002|STARTED|Overall Study||10
11198434|NCT01813071|12388303|FG003|STARTED|Overall Study||9
11198435|NCT01813071|12388304|FG004|STARTED|Overall Study||12
11198436|NCT01813071|12388305|FG005|STARTED|Overall Study||12
11198437|NCT01813071|12388306|FG006|STARTED|Overall Study||12
11198438|NCT01813071|12388307|FG007|STARTED|Overall Study||12
11198439|NCT01813071|12388308|FG008|STARTED|Overall Study||16
11198440|NCT01813071|12388300|FG000|COMPLETED|Overall Study||10
11198441|NCT01813071|12388301|FG001|COMPLETED|Overall Study||10
11198442|NCT01813071|12388302|FG002|COMPLETED|Overall Study||10
11198443|NCT01813071|12388303|FG003|COMPLETED|Overall Study||9
11198444|NCT01813071|12388304|FG004|COMPLETED|Overall Study||11
11198445|NCT01813071|12388305|FG005|COMPLETED|Overall Study||5
11198446|NCT01813071|12388306|FG006|COMPLETED|Overall Study||9
11198447|NCT01813071|12388307|FG007|COMPLETED|Overall Study||7
11198448|NCT01813071|12388308|FG008|COMPLETED|Overall Study||13
11198449|NCT01813071|12388300|FG000|NOT COMPLETED|Overall Study||0
11198450|NCT01813071|12388301|FG001|NOT COMPLETED|Overall Study||0
11198451|NCT01813071|12388302|FG002|NOT COMPLETED|Overall Study||0
11198452|NCT01813071|12388303|FG003|NOT COMPLETED|Overall Study||0
11198453|NCT01813071|12388304|FG004|NOT COMPLETED|Overall Study||1
11198454|NCT01813071|12388305|FG005|NOT COMPLETED|Overall Study||7
11198455|NCT01813071|12388306|FG006|NOT COMPLETED|Overall Study||3
11198456|NCT01813071|12388307|FG007|NOT COMPLETED|Overall Study||5
11198457|NCT01813071|12388308|FG008|NOT COMPLETED|Overall Study||3
11198458|NCT01813110|12388342|FG000|STARTED|Overall Study||10
11198459|NCT01813110|12388343|FG001|STARTED|Overall Study||11
11198460|NCT01813110|12388342|FG000|COMPLETED|Overall Study||10
11198461|NCT01813110|12388343|FG001|COMPLETED|Overall Study||10
11198462|NCT01813110|12388342|FG000|NOT COMPLETED|Overall Study||0
11198463|NCT01813110|12388343|FG001|NOT COMPLETED|Overall Study||1
11198464|NCT01813149|12388352|FG000|STARTED|Overall Study||90
11198465|NCT01813149|12388353|FG001|STARTED|Overall Study||38
11198466|NCT01813149|12388352|FG000|COMPLETED|Overall Study||90
11198467|NCT01813149|12388353|FG001|COMPLETED|Overall Study||38
11198468|NCT01813149|12388352|FG000|NOT COMPLETED|Overall Study||0
11198469|NCT01813149|12388353|FG001|NOT COMPLETED|Overall Study||0
11198470|NCT01813214|12388366|FG000|STARTED|Overall Study||3
11198471|NCT01813214|12388367|FG001|STARTED|Overall Study||2
11198472|NCT01813214|12388366|FG000|COMPLETED|Overall Study||3
11198473|NCT01813214|12388367|FG001|COMPLETED|Overall Study||2
11198474|NCT01813214|12388366|FG000|NOT COMPLETED|Overall Study||0
11198475|NCT01813214|12388367|FG001|NOT COMPLETED|Overall Study||0
11198476|NCT01813357|12388375|FG000|STARTED|Overall Study||40
11198477|NCT01813357|12388376|FG001|STARTED|Overall Study||44
11198478|NCT01813357|12388375|FG000|COMPLETED|Overall Study||35
11198479|NCT01813357|12388376|FG001|COMPLETED|Overall Study||38
11198480|NCT01813357|12388375|FG000|NOT COMPLETED|Overall Study||5
11198481|NCT01813357|12388376|FG001|NOT COMPLETED|Overall Study||6
11198482|NCT01813422|12388384|FG000|STARTED|Overall Study||486
11198483|NCT01813422|12388385|FG001|STARTED|Overall Study||484
11198484|NCT01813422|12388384|FG000|Received Treatment|Overall Study||484
11198485|NCT01813422|12388385|FG001|Received Treatment|Overall Study||484
11198486|NCT01813422|12388384|FG000|COMPLETED|Overall Study||466
11198487|NCT01813422|12388385|FG001|COMPLETED|Overall Study||468
11198488|NCT01813422|12388384|FG000|NOT COMPLETED|Overall Study||20
11198489|NCT01813422|12388385|FG001|NOT COMPLETED|Overall Study||16
11198490|NCT01813474|12388394|FG000|STARTED|Overall Study||4
11198491|NCT01813474|12388395|FG001|STARTED|Overall Study||7
11198492|NCT01813474|12388396|FG002|STARTED|Overall Study||12
11198493|NCT01813474|12388394|FG000|COMPLETED|Overall Study|ongoing study at final data cut off|1
11198494|NCT01813474|12388395|FG001|COMPLETED|Overall Study||0
11198495|NCT01813474|12388396|FG002|COMPLETED|Overall Study|ongoing study at final data cut off|1
11198496|NCT01813474|12388394|FG000|NOT COMPLETED|Overall Study||3
11198497|NCT01813474|12388395|FG001|NOT COMPLETED|Overall Study||7
11198498|NCT01813474|12388396|FG002|NOT COMPLETED|Overall Study||11
11198499|NCT01813721|12388405|FG000|STARTED|Overall Study|Indicates number of participants enrolled|1007
11198500|NCT01813721|12388405|FG000|COMPLETED|Overall Study||943
11198501|NCT01813721|12388405|FG000|NOT COMPLETED|Overall Study||64
11198502|NCT01813734|12388427|FG000|STARTED|Overall Study||9
11198503|NCT01813734|12388427|FG000|COMPLETED|Overall Study||9
11198504|NCT01813734|12388427|FG000|NOT COMPLETED|Overall Study||0
11198505|NCT01813890|12388434|FG000|STARTED|Overall Study||20
11198506|NCT01813890|12388435|FG001|STARTED|Overall Study||21
11198507|NCT01813890|12388436|FG002|STARTED|Overall Study||19
11198508|NCT01813890|12388434|FG000|COMPLETED|Overall Study||11
11198509|NCT01813890|12388435|FG001|COMPLETED|Overall Study||17
11198510|NCT01813890|12388436|FG002|COMPLETED|Overall Study||13
11198511|NCT01813890|12388434|FG000|NOT COMPLETED|Overall Study||9
11198512|NCT01813890|12388435|FG001|NOT COMPLETED|Overall Study||4
11198513|NCT01813890|12388436|FG002|NOT COMPLETED|Overall Study||6
11198514|NCT01814007|12388444|FG000|STARTED|Overall Study||35
11198515|NCT01814007|12388444|FG000|COMPLETED|Overall Study||34
11198516|NCT01814007|12388444|FG000|NOT COMPLETED|Overall Study||1
11198517|NCT01814046|12388451|FG000|STARTED|Drug Administration||22
11198518|NCT01814046|12388452|FG001|STARTED|Drug Administration||2
11198519|NCT01814046|12388453|FG002|STARTED|Drug Administration||0
11198520|NCT01814046|12388451|FG000|COMPLETED|Drug Administration||21
11198521|NCT01814046|12388452|FG001|COMPLETED|Drug Administration||2
11198522|NCT01814046|12388453|FG002|COMPLETED|Drug Administration||0
11198523|NCT01814046|12388451|FG000|NOT COMPLETED|Drug Administration||1
11198524|NCT01814046|12388452|FG001|NOT COMPLETED|Drug Administration||0
11198525|NCT01814046|12388453|FG002|NOT COMPLETED|Drug Administration||0
11198526|NCT01814046|12388451|FG000|STARTED|Retreatment||0
11198527|NCT01814046|12388452|FG001|STARTED|Retreatment||0
11198528|NCT01814046|12388453|FG002|STARTED|Retreatment||3
11198529|NCT01814046|12388451|FG000|COMPLETED|Retreatment||0
11198530|NCT01814046|12388452|FG001|COMPLETED|Retreatment||0
11198531|NCT01814046|12388453|FG002|COMPLETED|Retreatment||3
11198532|NCT01814046|12388451|FG000|NOT COMPLETED|Retreatment||0
11198533|NCT01814046|12388452|FG001|NOT COMPLETED|Retreatment||0
11198534|NCT01814046|12388453|FG002|NOT COMPLETED|Retreatment||0
11198535|NCT01814072|12388492|FG000|STARTED|Overall Study||18
11198536|NCT01814072|12388493|FG001|STARTED|Overall Study||18
11198537|NCT01814072|12388494|FG002|STARTED|Overall Study||18
11198538|NCT01814072|12388495|FG003|STARTED|Overall Study||18
11198539|NCT01814072|12388496|FG004|STARTED|Overall Study||18
11198540|NCT01814072|12388497|FG005|STARTED|Overall Study||18
11198541|NCT01814072|12388498|FG006|STARTED|Overall Study||18
11198542|NCT01814072|12388499|FG007|STARTED|Overall Study||18
11198543|NCT01814072|12388500|FG008|STARTED|Overall Study||19
11198544|NCT01814072|12388501|FG009|STARTED|Overall Study||18
11198545|NCT01814072|12388502|FG010|STARTED|Overall Study||18
11198546|NCT01814072|12388503|FG011|STARTED|Overall Study||18
11198547|NCT01814072|12388504|FG012|STARTED|Overall Study||18
11198548|NCT01814072|12388505|FG013|STARTED|Overall Study||18
11198549|NCT01814072|12388506|FG014|STARTED|Overall Study||18
11198550|NCT01814072|12388507|FG015|STARTED|Overall Study||18
11198551|NCT01814072|12388508|FG016|STARTED|Overall Study||17
11198552|NCT01814072|12388509|FG017|STARTED|Overall Study||18
11198553|NCT01814072|12388510|FG018|STARTED|Overall Study||17
11198554|NCT01814072|12388511|FG019|STARTED|Overall Study||16
11198555|NCT01814072|12388512|FG020|STARTED|Overall Study||16
11198556|NCT01814072|12388513|FG021|STARTED|Overall Study||17
11198557|NCT01814072|12388514|FG022|STARTED|Overall Study||17
11198558|NCT01814072|12388515|FG023|STARTED|Overall Study||18
11198559|NCT01814072|12388516|FG024|STARTED|Overall Study||17
11198560|NCT01814072|12388517|FG025|STARTED|Overall Study||16
11198561|NCT01814072|12388518|FG026|STARTED|Overall Study||18
11198562|NCT01814072|12388519|FG027|STARTED|Overall Study||17
11198563|NCT01814072|12388520|FG028|STARTED|Overall Study||18
11198564|NCT01814072|12388521|FG029|STARTED|Overall Study||17
11198565|NCT01814072|12388522|FG030|STARTED|Overall Study||17
11198566|NCT01814072|12388523|FG031|STARTED|Overall Study||17
11198567|NCT01814072|12388492|FG000|3-mo Visit|Overall Study||15
11198568|NCT01814072|12388493|FG001|3-mo Visit|Overall Study||18
11198569|NCT01814072|12388494|FG002|3-mo Visit|Overall Study||16
11198570|NCT01814072|12388495|FG003|3-mo Visit|Overall Study||18
11198571|NCT01814072|12388496|FG004|3-mo Visit|Overall Study||15
11198572|NCT01814072|12388497|FG005|3-mo Visit|Overall Study||15
11198573|NCT01814072|12388498|FG006|3-mo Visit|Overall Study||16
11198574|NCT01814072|12388499|FG007|3-mo Visit|Overall Study||18
11198575|NCT01814072|12388500|FG008|3-mo Visit|Overall Study||18
11198576|NCT01814072|12388501|FG009|3-mo Visit|Overall Study||15
11198577|NCT01814072|12388502|FG010|3-mo Visit|Overall Study||18
11198578|NCT01814072|12388503|FG011|3-mo Visit|Overall Study||17
11198579|NCT01814072|12388504|FG012|3-mo Visit|Overall Study||16
11198580|NCT01814072|12388505|FG013|3-mo Visit|Overall Study||16
11198581|NCT01814072|12388506|FG014|3-mo Visit|Overall Study||16
11198582|NCT01814072|12388507|FG015|3-mo Visit|Overall Study||16
11198583|NCT01814072|12388508|FG016|3-mo Visit|Overall Study||16
11198584|NCT01814072|12388509|FG017|3-mo Visit|Overall Study||16
11198585|NCT01814072|12388510|FG018|3-mo Visit|Overall Study||14
11198586|NCT01814072|12388511|FG019|3-mo Visit|Overall Study||13
11198587|NCT01814072|12388512|FG020|3-mo Visit|Overall Study||15
11198588|NCT01814072|12388513|FG021|3-mo Visit|Overall Study||17
11198589|NCT01814072|12388514|FG022|3-mo Visit|Overall Study||15
11198590|NCT01814072|12388515|FG023|3-mo Visit|Overall Study||18
11198591|NCT01814072|12388516|FG024|3-mo Visit|Overall Study||13
11198592|NCT01814072|12388517|FG025|3-mo Visit|Overall Study||14
11198593|NCT01814072|12388518|FG026|3-mo Visit|Overall Study||17
11198594|NCT01814072|12388519|FG027|3-mo Visit|Overall Study||14
11198595|NCT01814072|12388520|FG028|3-mo Visit|Overall Study||15
11198596|NCT01814072|12388521|FG029|3-mo Visit|Overall Study||16
11198597|NCT01814072|12388522|FG030|3-mo Visit|Overall Study||16
11198598|NCT01814072|12388523|FG031|3-mo Visit|Overall Study||17
11198599|NCT01814072|12388492|FG000|Intent to Treat|Overall Study||4
11198600|NCT01814072|12388493|FG001|Intent to Treat|Overall Study||2
11198601|NCT01814072|12388494|FG002|Intent to Treat|Overall Study||3
11198602|NCT01814072|12388495|FG003|Intent to Treat|Overall Study||0
11198603|NCT01814072|12388496|FG004|Intent to Treat|Overall Study||4
11198604|NCT01814072|12388497|FG005|Intent to Treat|Overall Study||6
11198605|NCT01814072|12388498|FG006|Intent to Treat|Overall Study||4
11198606|NCT01814072|12388499|FG007|Intent to Treat|Overall Study||1
11198607|NCT01814072|12388500|FG008|Intent to Treat|Overall Study||3
11198608|NCT01814072|12388501|FG009|Intent to Treat|Overall Study||5
11198609|NCT01814072|12388502|FG010|Intent to Treat|Overall Study||1
11198610|NCT01814072|12388503|FG011|Intent to Treat|Overall Study||2
11198611|NCT01814072|12388504|FG012|Intent to Treat|Overall Study||3
11198612|NCT01814072|12388505|FG013|Intent to Treat|Overall Study||2
11198613|NCT01814072|12388506|FG014|Intent to Treat|Overall Study||3
11198614|NCT01814072|12388507|FG015|Intent to Treat|Overall Study||2
11198615|NCT01814072|12388508|FG016|Intent to Treat|Overall Study||3
11198616|NCT01814072|12388509|FG017|Intent to Treat|Overall Study||1
11198617|NCT01814072|12388510|FG018|Intent to Treat|Overall Study||3
11198618|NCT01814072|12388511|FG019|Intent to Treat|Overall Study||5
11198619|NCT01814072|12388512|FG020|Intent to Treat|Overall Study||2
11198620|NCT01814072|12388513|FG021|Intent to Treat|Overall Study||1
11198621|NCT01814072|12388514|FG022|Intent to Treat|Overall Study||4
11198622|NCT01814072|12388515|FG023|Intent to Treat|Overall Study||1
11198623|NCT01814072|12388516|FG024|Intent to Treat|Overall Study||6
11198624|NCT01814072|12388517|FG025|Intent to Treat|Overall Study||2
11198625|NCT01814072|12388518|FG026|Intent to Treat|Overall Study||2
11198626|NCT01814072|12388519|FG027|Intent to Treat|Overall Study||4
11198627|NCT01814072|12388520|FG028|Intent to Treat|Overall Study||4
11198628|NCT01814072|12388521|FG029|Intent to Treat|Overall Study||3
11198629|NCT01814072|12388522|FG030|Intent to Treat|Overall Study||2
11198630|NCT01814072|12388523|FG031|Intent to Treat|Overall Study||0
11198631|NCT01814072|12388492|FG000|COMPLETED|Overall Study||14
11198632|NCT01814072|12388493|FG001|COMPLETED|Overall Study||16
11198633|NCT01814072|12388494|FG002|COMPLETED|Overall Study||15
11198634|NCT01814072|12388495|FG003|COMPLETED|Overall Study||18
11198635|NCT01814072|12388496|FG004|COMPLETED|Overall Study||14
11198636|NCT01814072|12388497|FG005|COMPLETED|Overall Study||12
11198637|NCT01814072|12388498|FG006|COMPLETED|Overall Study||14
11198638|NCT01814072|12388499|FG007|COMPLETED|Overall Study||17
11198639|NCT01814072|12388500|FG008|COMPLETED|Overall Study||16
11198640|NCT01814072|12388501|FG009|COMPLETED|Overall Study||13
11198641|NCT01814072|12388502|FG010|COMPLETED|Overall Study||17
11198642|NCT01814072|12388503|FG011|COMPLETED|Overall Study||16
11198643|NCT01814072|12388504|FG012|COMPLETED|Overall Study||15
11198644|NCT01814072|12388505|FG013|COMPLETED|Overall Study||16
11198645|NCT01814072|12388506|FG014|COMPLETED|Overall Study||15
11198646|NCT01814072|12388507|FG015|COMPLETED|Overall Study||16
11198647|NCT01814072|12388508|FG016|COMPLETED|Overall Study||14
11198648|NCT01814072|12388509|FG017|COMPLETED|Overall Study||17
11198649|NCT01814072|12388510|FG018|COMPLETED|Overall Study||14
11198650|NCT01814072|12388511|FG019|COMPLETED|Overall Study||11
11198651|NCT01814072|12388512|FG020|COMPLETED|Overall Study||14
11198652|NCT01814072|12388513|FG021|COMPLETED|Overall Study||16
11198653|NCT01814072|12388514|FG022|COMPLETED|Overall Study||13
11198654|NCT01814072|12388515|FG023|COMPLETED|Overall Study||17
11198655|NCT01814072|12388516|FG024|COMPLETED|Overall Study||11
11198656|NCT01814072|12388517|FG025|COMPLETED|Overall Study||14
11198657|NCT01814072|12388518|FG026|COMPLETED|Overall Study||16
11198658|NCT01814072|12388519|FG027|COMPLETED|Overall Study||13
11198659|NCT01814072|12388520|FG028|COMPLETED|Overall Study||14
11198660|NCT01814072|12388521|FG029|COMPLETED|Overall Study||14
11198661|NCT01814072|12388522|FG030|COMPLETED|Overall Study||15
11198662|NCT01814072|12388523|FG031|COMPLETED|Overall Study||17
11198663|NCT01814072|12388492|FG000|NOT COMPLETED|Overall Study||4
11198664|NCT01814072|12388493|FG001|NOT COMPLETED|Overall Study||2
11198665|NCT01814072|12388494|FG002|NOT COMPLETED|Overall Study||3
11198666|NCT01814072|12388495|FG003|NOT COMPLETED|Overall Study||0
11198667|NCT01814072|12388496|FG004|NOT COMPLETED|Overall Study||4
11198668|NCT01814072|12388497|FG005|NOT COMPLETED|Overall Study||6
11198669|NCT01814072|12388498|FG006|NOT COMPLETED|Overall Study||4
11198670|NCT01814072|12388499|FG007|NOT COMPLETED|Overall Study||1
11198671|NCT01814072|12388500|FG008|NOT COMPLETED|Overall Study||3
11198672|NCT01814072|12388501|FG009|NOT COMPLETED|Overall Study||5
11198673|NCT01814072|12388502|FG010|NOT COMPLETED|Overall Study||1
11198674|NCT01814072|12388503|FG011|NOT COMPLETED|Overall Study||2
11198675|NCT01814072|12388504|FG012|NOT COMPLETED|Overall Study||3
11198676|NCT01814072|12388505|FG013|NOT COMPLETED|Overall Study||2
11198677|NCT01814072|12388506|FG014|NOT COMPLETED|Overall Study||3
11198678|NCT01814072|12388507|FG015|NOT COMPLETED|Overall Study||2
11198679|NCT01814072|12388508|FG016|NOT COMPLETED|Overall Study||3
11198680|NCT01814072|12388509|FG017|NOT COMPLETED|Overall Study||1
11198681|NCT01814072|12388510|FG018|NOT COMPLETED|Overall Study||3
11198682|NCT01814072|12388511|FG019|NOT COMPLETED|Overall Study||5
11198683|NCT01814072|12388512|FG020|NOT COMPLETED|Overall Study||2
11198684|NCT01814072|12388513|FG021|NOT COMPLETED|Overall Study||1
11198685|NCT01814072|12388514|FG022|NOT COMPLETED|Overall Study||4
11198686|NCT01814072|12388515|FG023|NOT COMPLETED|Overall Study||1
11198687|NCT01814072|12388516|FG024|NOT COMPLETED|Overall Study||6
11198688|NCT01814072|12388517|FG025|NOT COMPLETED|Overall Study||2
11198689|NCT01814072|12388518|FG026|NOT COMPLETED|Overall Study||2
11198690|NCT01814072|12388519|FG027|NOT COMPLETED|Overall Study||4
11198691|NCT01814072|12388520|FG028|NOT COMPLETED|Overall Study||4
11198692|NCT01814072|12388521|FG029|NOT COMPLETED|Overall Study||3
11198693|NCT01814072|12388522|FG030|NOT COMPLETED|Overall Study||2
11198694|NCT01814072|12388523|FG031|NOT COMPLETED|Overall Study||0
11198695|NCT01814137|12388565|FG000|STARTED|Overall Study||20
11198696|NCT01814137|12388566|FG001|STARTED|Overall Study||20
11198697|NCT01814137|12388565|FG000|COMPLETED|Overall Study||15
11198698|NCT01814137|12388566|FG001|COMPLETED|Overall Study||15
11198699|NCT01814137|12388565|FG000|NOT COMPLETED|Overall Study||5
11198700|NCT01814137|12388566|FG001|NOT COMPLETED|Overall Study||5
11198701|NCT01814241|12388572|FG000|STARTED|Overall Study||20
11198702|NCT01814241|12388572|FG000|COMPLETED|Overall Study||16
11198703|NCT01814241|12388572|FG000|NOT COMPLETED|Overall Study||4
11198704|NCT01814332|12388579|FG000|STARTED|Overall Study||63
11198705|NCT01814332|12388580|FG001|STARTED|Overall Study||65
11198706|NCT01814332|12388579|FG000|COMPLETED|Overall Study||47
11198707|NCT01814332|12388580|FG001|COMPLETED|Overall Study||49
11198708|NCT01814332|12388579|FG000|NOT COMPLETED|Overall Study||16
11198709|NCT01814332|12388580|FG001|NOT COMPLETED|Overall Study||16
11198710|NCT01814371|12388588|FG000|STARTED|Overall Study||248
11198711|NCT01814371|12388589|FG001|STARTED|Overall Study||226
11198712|NCT01814371|12388588|FG000|COMPLETED|Overall Study||218
11198713|NCT01814371|12388589|FG001|COMPLETED|Overall Study||199
11198714|NCT01814371|12388588|FG000|NOT COMPLETED|Overall Study||30
11198715|NCT01814371|12388589|FG001|NOT COMPLETED|Overall Study||27
11198716|NCT01814397|12388598|FG000|STARTED|Overall Study||50
11198717|NCT01814397|12388598|FG000|3 Month Evaluation|Overall Study||43
11198718|NCT01814397|12388598|FG000|COMPLETED|Overall Study||36
11198719|NCT01814397|12388598|FG000|NOT COMPLETED|Overall Study||14
11198720|NCT01814553|12388604|FG000|STARTED|Overall Study||18
11198721|NCT01814553|12388605|FG001|STARTED|Overall Study||22
11198722|NCT01814553|12388604|FG000|COMPLETED|Overall Study||0
11198723|NCT01814553|12388605|FG001|COMPLETED|Overall Study||0
11198724|NCT01814553|12388604|FG000|NOT COMPLETED|Overall Study||18
11198725|NCT01814553|12388605|FG001|NOT COMPLETED|Overall Study||22
11198726|NCT01814670|12388611|FG000|STARTED|Overall Study||185
11198727|NCT01814670|12388611|FG000|COMPLETED|Overall Study||173
11198728|NCT01814670|12388611|FG000|NOT COMPLETED|Overall Study||12
11198729|NCT01814696|12388617|FG000|STARTED|Overall Study||15
11198730|NCT01814696|12388618|FG001|STARTED|Overall Study||11
11198731|NCT01814696|12388617|FG000|COMPLETED|Overall Study||13
11198732|NCT01814696|12388618|FG001|COMPLETED|Overall Study||11
11198733|NCT01814696|12388617|FG000|NOT COMPLETED|Overall Study||2
11198734|NCT01814696|12388618|FG001|NOT COMPLETED|Overall Study||0
11198735|NCT01814748|12388626|FG000|STARTED|Overall Study||102
11198736|NCT01814748|12388627|FG001|STARTED|Overall Study||101
11198737|NCT01814748|12388626|FG000|COMPLETED|Overall Study||94
11198738|NCT01814748|12388627|FG001|COMPLETED|Overall Study||94
11198739|NCT01814748|12388626|FG000|NOT COMPLETED|Overall Study||8
11198740|NCT01814748|12388627|FG001|NOT COMPLETED|Overall Study||7
11198741|NCT01814761|12388635|FG000|STARTED|Overall Study||42
11198742|NCT01814761|12388636|FG001|STARTED|Overall Study||270
11198743|NCT01814761|12388635|FG000|COMPLETED|Overall Study||34
11198744|NCT01814761|12388636|FG001|COMPLETED|Overall Study||240
11198745|NCT01814761|12388635|FG000|NOT COMPLETED|Overall Study||8
11198746|NCT01814761|12388636|FG001|NOT COMPLETED|Overall Study||30
11198747|NCT01814774|12388642|FG000|STARTED|Overall Study||48
11198748|NCT01814774|12388642|FG000|COMPLETED|Overall Study||48
11198749|NCT01814774|12388642|FG000|NOT COMPLETED|Overall Study||0
11198750|NCT01814787|12388650|FG000|STARTED|Overall Study||685
11198751|NCT01814787|12388651|FG001|STARTED|Overall Study||684
11198752|NCT01814787|12388650|FG000|COMPLETED|Overall Study||685
11198753|NCT01814787|12388651|FG001|COMPLETED|Overall Study||684
11198754|NCT01814787|12388650|FG000|NOT COMPLETED|Overall Study||0
11198755|NCT01814787|12388651|FG001|NOT COMPLETED|Overall Study||0
11198756|NCT01814800|12388657|FG000|STARTED|Overall Study||59
11198757|NCT01814800|12388657|FG000|COMPLETED|Overall Study||54
11198758|NCT01814800|12388657|FG000|NOT COMPLETED|Overall Study||5
11198759|NCT01814813|12388664|FG000|STARTED|Overall Study||29
11198760|NCT01814813|12388665|FG001|STARTED|Overall Study||30
11198761|NCT01814813|12388666|FG002|STARTED|Overall Study||31
11198762|NCT01814813|12388664|FG000|COMPLETED|Overall Study||29
11198763|NCT01814813|12388665|FG001|COMPLETED|Overall Study||30
11198764|NCT01814813|12388666|FG002|COMPLETED|Overall Study||31
11198765|NCT01814813|12388664|FG000|NOT COMPLETED|Overall Study||0
11198766|NCT01814813|12388665|FG001|NOT COMPLETED|Overall Study||0
11198767|NCT01814813|12388666|FG002|NOT COMPLETED|Overall Study||0
11198768|NCT01814878|12388676|FG000|STARTED|Overall Study||162
11198769|NCT01814878|12388677|FG001|STARTED|Overall Study||158
11198770|NCT01814878|12388676|FG000|COMPLETED|Overall Study||116
11198771|NCT01814878|12388677|FG001|COMPLETED|Overall Study||128
11198772|NCT01814878|12388676|FG000|NOT COMPLETED|Overall Study||46
11198773|NCT01814878|12388677|FG001|NOT COMPLETED|Overall Study||30
11198774|NCT01815008|12388683|FG000|STARTED|Overall Study|Had difficulty in completing enrollment|19
11198775|NCT01815008|12388683|FG000|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
11198776|NCT01815008|12388683|FG000|NOT COMPLETED|Overall Study||4
11198777|NCT01815099|12388689|FG000|STARTED|Overall Study||4
11198778|NCT01815099|12388689|FG000|Began rTMS Treatment|Overall Study||3
11198779|NCT01815099|12388689|FG000|COMPLETED|Overall Study||2
11198780|NCT01815099|12388689|FG000|NOT COMPLETED|Overall Study||2
11198781|NCT01815138|12388696|FG000|STARTED|Overall Study||34
11198782|NCT01815138|12388697|FG001|STARTED|Overall Study||37
11198783|NCT01815138|12388696|FG000|COMPLETED|Overall Study||26
11198784|NCT01815138|12388697|FG001|COMPLETED|Overall Study||31
11198785|NCT01815138|12388696|FG000|NOT COMPLETED|Overall Study||8
11198786|NCT01815138|12388697|FG001|NOT COMPLETED|Overall Study||6
11198787|NCT01815229|12388706|FG000|STARTED|Overall Study||13
11198788|NCT01815229|12388707|FG001|STARTED|Overall Study||18
11198789|NCT01815229|12388708|FG002|STARTED|Overall Study||51
11198790|NCT01815229|12388706|FG000|COMPLETED|Overall Study||13
11198791|NCT01815229|12388707|FG001|COMPLETED|Overall Study||18
11198792|NCT01815229|12388708|FG002|COMPLETED|Overall Study||0
11198793|NCT01815229|12388706|FG000|NOT COMPLETED|Overall Study||0
11198794|NCT01815229|12388707|FG001|NOT COMPLETED|Overall Study||0
11198795|NCT01815229|12388708|FG002|NOT COMPLETED|Overall Study||51
11198796|NCT01815333|12388715|FG000|STARTED|Overall Study||10
11198797|NCT01815333|12388715|FG000|COMPLETED|Overall Study||10
11198798|NCT01815333|12388715|FG000|NOT COMPLETED|Overall Study||0
11198799|NCT01815424|12388722|FG000|STARTED|Week 0 to 16||90
11198800|NCT01815424|12388723|FG001|STARTED|Week 0 to 16||88
11198801|NCT01815424|12388724|FG002|STARTED|Week 0 to 16||88
11198802|NCT01815424|12388725|FG003|STARTED|Week 0 to 16||0
11198803|NCT01815424|12388726|FG004|STARTED|Week 0 to 16||0
11198804|NCT01815424|12388722|FG000|COMPLETED|Week 0 to 16||83
11198805|NCT01815424|12388723|FG001|COMPLETED|Week 0 to 16||84
11198806|NCT01815424|12388724|FG002|COMPLETED|Week 0 to 16||77
11198807|NCT01815424|12388725|FG003|COMPLETED|Week 0 to 16||0
11198808|NCT01815424|12388726|FG004|COMPLETED|Week 0 to 16||0
11198809|NCT01815424|12388722|FG000|NOT COMPLETED|Week 0 to 16||7
11198810|NCT01815424|12388723|FG001|NOT COMPLETED|Week 0 to 16||4
11198811|NCT01815424|12388724|FG002|NOT COMPLETED|Week 0 to 16||11
11198812|NCT01815424|12388725|FG003|NOT COMPLETED|Week 0 to 16||0
11198813|NCT01815424|12388726|FG004|NOT COMPLETED|Week 0 to 16||0
11198814|NCT01815424|12388722|FG000|STARTED|Week 16 to 52||83
11198815|NCT01815424|12388723|FG001|STARTED|Week 16 to 52||84
11198816|NCT01815424|12388724|FG002|STARTED|Week 16 to 52||0
11198817|NCT01815424|12388725|FG003|STARTED|Week 16 to 52||38
11198818|NCT01815424|12388726|FG004|STARTED|Week 16 to 52||39
11198819|NCT01815424|12388722|FG000|COMPLETED|Week 16 to 52||81
11198820|NCT01815424|12388723|FG001|COMPLETED|Week 16 to 52||79
11198821|NCT01815424|12388724|FG002|COMPLETED|Week 16 to 52||0
11198822|NCT01815424|12388725|FG003|COMPLETED|Week 16 to 52||35
11198823|NCT01815424|12388726|FG004|COMPLETED|Week 16 to 52||36
11198824|NCT01815424|12388722|FG000|NOT COMPLETED|Week 16 to 52||2
11198825|NCT01815424|12388723|FG001|NOT COMPLETED|Week 16 to 52||5
11198826|NCT01815424|12388724|FG002|NOT COMPLETED|Week 16 to 52||0
11198827|NCT01815424|12388725|FG003|NOT COMPLETED|Week 16 to 52||3
11198828|NCT01815424|12388726|FG004|NOT COMPLETED|Week 16 to 52||3
11198829|NCT01815502|12388741|FG000|STARTED|Overall Study||10
11198830|NCT01815502|12388742|FG001|STARTED|Overall Study||10
11198831|NCT01815502|12388741|FG000|COMPLETED|Overall Study||10
11198832|NCT01815502|12388742|FG001|COMPLETED|Overall Study||10
11198833|NCT01815502|12388741|FG000|NOT COMPLETED|Overall Study||0
11198834|NCT01815502|12388742|FG001|NOT COMPLETED|Overall Study||0
11198835|NCT01815515|12388751|FG000|STARTED|Overall Study||17
11198836|NCT01815515|12388751|FG000|COMPLETED|Overall Study||17
11198837|NCT01815515|12388751|FG000|NOT COMPLETED|Overall Study||0
11198838|NCT01815645|12388757|FG000|STARTED|Overall Study||32
11198839|NCT01815645|12388758|FG001|STARTED|Overall Study||33
11198840|NCT01815645|12388757|FG000|COMPLETED|Overall Study||32
11198841|NCT01815645|12388758|FG001|COMPLETED|Overall Study||33
11198842|NCT01815645|12388757|FG000|NOT COMPLETED|Overall Study||0
11198843|NCT01815645|12388758|FG001|NOT COMPLETED|Overall Study||0
11198844|NCT01815671|12388768|FG000|STARTED|Overall Study||88
11198845|NCT01815671|12388769|FG001|STARTED|Overall Study||85
11198846|NCT01815671|12388768|FG000|COMPLETED|Overall Study||88
11198847|NCT01815671|12388769|FG001|COMPLETED|Overall Study||85
11198848|NCT01815671|12388768|FG000|NOT COMPLETED|Overall Study||0
11198849|NCT01815671|12388769|FG001|NOT COMPLETED|Overall Study||0
11198850|NCT01815736|12388777|FG000|STARTED|Randomized Treatment Phase-Up to Week 96||963
11198851|NCT01815736|12388778|FG001|STARTED|Randomized Treatment Phase-Up to Week 96||480
11198852|NCT01815736|12388777|FG000|COMPLETED|Randomized Treatment Phase-Up to Week 96||914
11198853|NCT01815736|12388778|FG001|COMPLETED|Randomized Treatment Phase-Up to Week 96||445
11198854|NCT01815736|12388777|FG000|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||49
11198855|NCT01815736|12388778|FG001|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||35
11198856|NCT01815736|12388777|FG000|STARTED|Extension Treatment Phase- After Week 96|9 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|905
11198857|NCT01815736|12388778|FG001|STARTED|Extension Treatment Phase- After Week 96|21 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|424
11198858|NCT01815736|12388777|FG000|COMPLETED|Extension Treatment Phase- After Week 96||854
11198859|NCT01815736|12388778|FG001|COMPLETED|Extension Treatment Phase- After Week 96||398
11198860|NCT01815736|12388777|FG000|NOT COMPLETED|Extension Treatment Phase- After Week 96||51
11198861|NCT01815736|12388778|FG001|NOT COMPLETED|Extension Treatment Phase- After Week 96||26
11198862|NCT01815840|12388788|FG000|STARTED|Overall Study||116
11198863|NCT01815840|12388789|FG001|STARTED|Overall Study||113
11198864|NCT01815840|12388788|FG000|COMPLETED|Overall Study||57
11198865|NCT01815840|12388789|FG001|COMPLETED|Overall Study||50
11198866|NCT01815840|12388788|FG000|NOT COMPLETED|Overall Study||59
11198867|NCT01815840|12388789|FG001|NOT COMPLETED|Overall Study||63
11198868|NCT01815918|12388797|FG000|STARTED|Overall Study||30
11198869|NCT01815918|12388798|FG001|STARTED|Overall Study||30
11198870|NCT01815918|12388797|FG000|COMPLETED|Overall Study||12
11198871|NCT01815918|12388798|FG001|COMPLETED|Overall Study||11
11198872|NCT01815918|12388797|FG000|NOT COMPLETED|Overall Study||18
11198873|NCT01815918|12388798|FG001|NOT COMPLETED|Overall Study||19
11198874|NCT01816048|12388808|FG000|STARTED|Overall Study||8
11198875|NCT01816048|12388808|FG000|COMPLETED|Overall Study||2
11198876|NCT01816048|12388808|FG000|NOT COMPLETED|Overall Study||6
11198877|NCT01816061|12388815|FG000|STARTED|Overall Study||40
11198878|NCT01816061|12388816|FG001|STARTED|Overall Study||51
11198879|NCT01816061|12388815|FG000|COMPLETED|Overall Study||27
11198880|NCT01816061|12388816|FG001|COMPLETED|Overall Study||27
11324790|NCT02748694|12522142|FG011|NOT COMPLETED|Overall Study||0
11324791|NCT02748694|12522143|FG012|NOT COMPLETED|Overall Study||0
11324792|NCT02748694|12522144|FG013|NOT COMPLETED|Overall Study||0
11324793|NCT02748694|12522145|FG014|NOT COMPLETED|Overall Study||2
11343151|NCT02951312|12540474|FG002|COMPLETED|Study Part 2||6
11198881|NCT01816061|12388815|FG000|NOT COMPLETED|Overall Study||13
11198882|NCT01816061|12388816|FG001|NOT COMPLETED|Overall Study||24
11198883|NCT01816074|12388826|FG000|STARTED|Phase 1||11
11198884|NCT01816074|12388827|FG001|STARTED|Phase 1||9
11198885|NCT01816074|12388828|FG002|STARTED|Phase 1||11
11198886|NCT01816074|12388829|FG003|STARTED|Phase 1||10
11198887|NCT01816074|12388826|FG000|COMPLETED|Phase 1||11
11198888|NCT01816074|12388827|FG001|COMPLETED|Phase 1||9
11198889|NCT01816074|12388828|FG002|COMPLETED|Phase 1||10
11198890|NCT01816074|12388829|FG003|COMPLETED|Phase 1||10
11198891|NCT01816074|12388826|FG000|NOT COMPLETED|Phase 1||0
11198892|NCT01816074|12388827|FG001|NOT COMPLETED|Phase 1||0
11198893|NCT01816074|12388828|FG002|NOT COMPLETED|Phase 1||1
11198894|NCT01816074|12388829|FG003|NOT COMPLETED|Phase 1||0
11198895|NCT01816074|12388826|FG000|STARTED|Phase 2||11
11198896|NCT01816074|12388827|FG001|STARTED|Phase 2||9
11198897|NCT01816074|12388828|FG002|STARTED|Phase 2||10
11198898|NCT01816074|12388829|FG003|STARTED|Phase 2||10
11198899|NCT01816074|12388826|FG000|COMPLETED|Phase 2||9
11198900|NCT01816074|12388827|FG001|COMPLETED|Phase 2||7
11198901|NCT01816074|12388828|FG002|COMPLETED|Phase 2||10
11198902|NCT01816074|12388829|FG003|COMPLETED|Phase 2||9
11198903|NCT01816074|12388826|FG000|NOT COMPLETED|Phase 2||2
11198904|NCT01816074|12388827|FG001|NOT COMPLETED|Phase 2||2
11198905|NCT01816074|12388828|FG002|NOT COMPLETED|Phase 2||0
11198906|NCT01816074|12388829|FG003|NOT COMPLETED|Phase 2||1
11198907|NCT01816230|12388853|FG000|STARTED|Overall Study||36
11198908|NCT01816230|12388853|FG000|COMPLETED|Overall Study||36
11198909|NCT01816230|12388853|FG000|NOT COMPLETED|Overall Study||0
11198910|NCT01816243|12388857|FG000|STARTED|Overall Study||39
11198911|NCT01816243|12388857|FG000|COMPLETED|Overall Study||27
11198912|NCT01816243|12388857|FG000|NOT COMPLETED|Overall Study||12
11198913|NCT01816295|12388863|FG000|STARTED|Double Blind Phase||357
11198914|NCT01816295|12388864|FG001|STARTED|Double Blind Phase||358
11198915|NCT01816295|12388863|FG000|Received Study Drug|Double Blind Phase||356
11198916|NCT01816295|12388864|FG001|Received Study Drug|Double Blind Phase||354
11198917|NCT01816295|12388863|FG000|COMPLETED|Double Blind Phase||294
11198918|NCT01816295|12388864|FG001|COMPLETED|Double Blind Phase||302
11198919|NCT01816295|12388863|FG000|NOT COMPLETED|Double Blind Phase||63
11198920|NCT01816295|12388864|FG001|NOT COMPLETED|Double Blind Phase||56
11198921|NCT01816295|12388863|FG000|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
11198922|NCT01816295|12388864|FG001|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
11198923|NCT01816295|12388863|FG000|COMPLETED|OLE Phase||222
11198924|NCT01816295|12388864|FG001|COMPLETED|OLE Phase||227
11198925|NCT01816295|12388863|FG000|NOT COMPLETED|OLE Phase||53
11198926|NCT01816295|12388864|FG001|NOT COMPLETED|OLE Phase||56
11198927|NCT01816451|12388874|FG000|STARTED|Overall Study||13
11198928|NCT01816451|12388875|FG001|STARTED|Overall Study||11
11198929|NCT01816451|12388876|FG002|STARTED|Overall Study||8
11198930|NCT01816451|12388874|FG000|COMPLETED|Overall Study||13
11198931|NCT01816451|12388875|FG001|COMPLETED|Overall Study||11
11198932|NCT01816451|12388876|FG002|COMPLETED|Overall Study||8
11198933|NCT01816451|12388874|FG000|NOT COMPLETED|Overall Study||0
11198934|NCT01816451|12388875|FG001|NOT COMPLETED|Overall Study||0
11198935|NCT01816451|12388876|FG002|NOT COMPLETED|Overall Study||0
11198936|NCT01816477|12388888|FG000|STARTED|Overall Study||43
11198937|NCT01816477|12388889|FG001|STARTED|Overall Study||42
11198938|NCT01816477|12388888|FG000|COMPLETED|Overall Study||27
11198939|NCT01816477|12388889|FG001|COMPLETED|Overall Study||41
11198940|NCT01816477|12388888|FG000|NOT COMPLETED|Overall Study||16
11198941|NCT01816477|12388889|FG001|NOT COMPLETED|Overall Study||1
11198942|NCT01816594|12388897|FG000|STARTED|Overall Study||25
11198943|NCT01816594|12388898|FG001|STARTED|Overall Study||25
11198944|NCT01816594|12388897|FG000|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
11198945|NCT01816594|12388898|FG001|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
11198946|NCT01816594|12388897|FG000|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
11198947|NCT01816594|12388898|FG001|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
11198948|NCT01816594|12388897|FG000|COMPLETED|Overall Study||14
11198949|NCT01816594|12388898|FG001|COMPLETED|Overall Study||23
11198950|NCT01816594|12388897|FG000|NOT COMPLETED|Overall Study||11
11198951|NCT01816594|12388898|FG001|NOT COMPLETED|Overall Study||2
11198952|NCT01816685|12388912|FG000|STARTED|Overall Study||68
11198953|NCT01816685|12388913|FG001|STARTED|Overall Study||67
11198954|NCT01816685|12388912|FG000|COMPLETED|Overall Study||58
11198955|NCT01816685|12388913|FG001|COMPLETED|Overall Study||56
11198956|NCT01816685|12388912|FG000|NOT COMPLETED|Overall Study||10
11198957|NCT01816685|12388913|FG001|NOT COMPLETED|Overall Study||11
11198958|NCT01816711|12388921|FG000|STARTED|Overall Study||121
11198959|NCT01816711|12388922|FG001|STARTED|Overall Study||83
11198960|NCT01816711|12388921|FG000|COMPLETED|Overall Study||121
11198961|NCT01816711|12388922|FG001|COMPLETED|Overall Study||83
11198962|NCT01816711|12388921|FG000|NOT COMPLETED|Overall Study||0
11198963|NCT01816711|12388922|FG001|NOT COMPLETED|Overall Study||0
11198964|NCT01816763|12388931|FG000|STARTED|Overall Study||195
11198965|NCT01816763|12388932|FG001|STARTED|Overall Study||194
11198966|NCT01816763|12388933|FG002|STARTED|Overall Study||180
11198967|NCT01816763|12388931|FG000|COMPLETED|Overall Study||191
11198968|NCT01816763|12388932|FG001|COMPLETED|Overall Study||179
11198969|NCT01816763|12388933|FG002|COMPLETED|Overall Study||169
11198970|NCT01816763|12388931|FG000|NOT COMPLETED|Overall Study||4
11198971|NCT01816763|12388932|FG001|NOT COMPLETED|Overall Study||15
11198972|NCT01816763|12388933|FG002|NOT COMPLETED|Overall Study||11
11198973|NCT01816776|12388946|FG000|STARTED|Overall Study||73
11198974|NCT01816776|12388947|FG001|STARTED|Overall Study||78
11198975|NCT01816776|12388946|FG000|6 Month Primary Effectiveness Assessed|Overall Study||68
11198976|NCT01816776|12388947|FG001|6 Month Primary Effectiveness Assessed|Overall Study||73
11198977|NCT01816776|12388946|FG000|COMPLETED|Overall Study||60
11198978|NCT01816776|12388947|FG001|COMPLETED|Overall Study||70
11198979|NCT01816776|12388946|FG000|NOT COMPLETED|Overall Study||13
11198980|NCT01816776|12388947|FG001|NOT COMPLETED|Overall Study||8
11198981|NCT01816893|12388955|FG000|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
11198982|NCT01816893|12388956|FG001|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
11198983|NCT01816893|12388955|FG000|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
11198984|NCT01816893|12388956|FG001|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
11198985|NCT01816893|12388955|FG000|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
11198986|NCT01816893|12388956|FG001|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
11198987|NCT01816893|12388955|FG000|STARTED|Washout Period||11
11198988|NCT01816893|12388956|FG001|STARTED|Washout Period||11
11198989|NCT01816893|12388955|FG000|COMPLETED|Washout Period||9
11198990|NCT01816893|12388956|FG001|COMPLETED|Washout Period||11
11198991|NCT01816893|12388955|FG000|NOT COMPLETED|Washout Period||2
11198992|NCT01816893|12388956|FG001|NOT COMPLETED|Washout Period||0
11198993|NCT01816893|12388955|FG000|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
11198994|NCT01816893|12388956|FG001|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
11198995|NCT01816893|12388955|FG000|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
11198996|NCT01816893|12388956|FG001|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
11198997|NCT01816893|12388955|FG000|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
11198998|NCT01816893|12388956|FG001|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
11198999|NCT01816906|12388964|FG000|STARTED|Six Months||41
11199000|NCT01816906|12388965|FG001|STARTED|Six Months||41
11199001|NCT01816906|12388964|FG000|COMPLETED|Six Months||20
11199002|NCT01816906|12388965|FG001|COMPLETED|Six Months||19
11199003|NCT01816906|12388964|FG000|NOT COMPLETED|Six Months||21
11199004|NCT01816906|12388965|FG001|NOT COMPLETED|Six Months||22
11199005|NCT01816906|12388964|FG000|STARTED|12 Months||20
11199006|NCT01816906|12388965|FG001|STARTED|12 Months||19
11199007|NCT01816906|12388964|FG000|COMPLETED|12 Months||16
11199008|NCT01816906|12388965|FG001|COMPLETED|12 Months||14
11199009|NCT01816906|12388964|FG000|NOT COMPLETED|12 Months||4
11199010|NCT01816906|12388965|FG001|NOT COMPLETED|12 Months||5
11199011|NCT01816945|12388974|FG000|STARTED|Overall Study||23
11199012|NCT01816945|12388975|FG001|STARTED|Overall Study||24
11199013|NCT01816945|12388974|FG000|COMPLETED|Overall Study||21
11199014|NCT01816945|12388975|FG001|COMPLETED|Overall Study||19
11199015|NCT01816945|12388974|FG000|NOT COMPLETED|Overall Study||2
11199016|NCT01816945|12388975|FG001|NOT COMPLETED|Overall Study||5
11199017|NCT01816984|12388981|FG000|STARTED|Overall Study||12
11199018|NCT01816984|12388981|FG000|COMPLETED|Overall Study||11
11199019|NCT01816984|12388981|FG000|NOT COMPLETED|Overall Study||1
11199020|NCT01817075|12388987|FG000|STARTED|Overall Study||88
11199021|NCT01817075|12388988|FG001|STARTED|Overall Study||89
11199022|NCT01817075|12388987|FG000|COMPLETED|Overall Study||41
11199023|NCT01817075|12388988|FG001|COMPLETED|Overall Study||54
11199024|NCT01817075|12388987|FG000|NOT COMPLETED|Overall Study||47
11199025|NCT01817075|12388988|FG001|NOT COMPLETED|Overall Study||35
11199026|NCT01817374|12388994|FG000|STARTED|Overall Study||6
11199027|NCT01817374|12388994|FG000|COMPLETED|Overall Study||6
11199028|NCT01817374|12388994|FG000|NOT COMPLETED|Overall Study||0
11199029|NCT01817491|12389002|FG000|STARTED|Overall Study||32
11199030|NCT01817491|12389003|FG001|STARTED|Overall Study||28
11199031|NCT01817491|12389002|FG000|COMPLETED|Overall Study||28
11199032|NCT01817491|12389003|FG001|COMPLETED|Overall Study||28
11199033|NCT01817491|12389002|FG000|NOT COMPLETED|Overall Study||4
11199034|NCT01817491|12389003|FG001|NOT COMPLETED|Overall Study||0
11199035|NCT01817530|12389018|FG000|STARTED|Overall Study||65
11199036|NCT01817530|12389019|FG001|STARTED|Overall Study||65
11199037|NCT01817530|12389020|FG002|STARTED|Overall Study||64
11199038|NCT01817530|12389021|FG003|STARTED|Overall Study||65
11199039|NCT01817530|12389022|FG004|STARTED|Overall Study||78
11199040|NCT01817530|12389023|FG005|STARTED|Overall Study||77
11199041|NCT01817530|12389024|FG006|STARTED|Overall Study||76
11199042|NCT01817530|12389025|FG007|STARTED|Overall Study||77
11324794|NCT02748785|12522205|FG000|STARTED|Visit 1- Visit 2||69
11199043|NCT01817530|12389018|FG000|COMPLETED|Overall Study||50
11199044|NCT01817530|12389019|FG001|COMPLETED|Overall Study||52
11199045|NCT01817530|12389020|FG002|COMPLETED|Overall Study||53
11199046|NCT01817530|12389021|FG003|COMPLETED|Overall Study||52
11324795|NCT02748785|12522206|FG001|STARTED|Visit 1- Visit 2||68
11324796|NCT02748785|12522207|FG002|STARTED|Visit 1- Visit 2||71
11199047|NCT01817530|12389022|FG004|COMPLETED|Overall Study||67
11199048|NCT01817530|12389023|FG005|COMPLETED|Overall Study||58
11199049|NCT01817530|12389024|FG006|COMPLETED|Overall Study||53
11199050|NCT01817530|12389025|FG007|COMPLETED|Overall Study||53
11199051|NCT01817530|12389018|FG000|NOT COMPLETED|Overall Study||15
11199052|NCT01817530|12389019|FG001|NOT COMPLETED|Overall Study||13
11199053|NCT01817530|12389020|FG002|NOT COMPLETED|Overall Study||11
11199054|NCT01817530|12389021|FG003|NOT COMPLETED|Overall Study||13
11199055|NCT01817530|12389022|FG004|NOT COMPLETED|Overall Study||11
11199056|NCT01817530|12389023|FG005|NOT COMPLETED|Overall Study||19
11199057|NCT01817530|12389024|FG006|NOT COMPLETED|Overall Study||23
11199058|NCT01817530|12389025|FG007|NOT COMPLETED|Overall Study||24
11199059|NCT01817582|12389046|FG000|STARTED|Overall Study||33
11199060|NCT01817582|12389047|FG001|STARTED|Overall Study||36
11199061|NCT01817582|12389048|FG002|STARTED|Overall Study||33
11199062|NCT01817582|12389046|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
11199063|NCT01817582|12389047|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
11324797|NCT02748785|12522208|FG003|STARTED|Visit 1- Visit 2||69
11324798|NCT02748785|12522205|FG000|COMPLETED|Visit 1- Visit 2||59
11324799|NCT02748785|12522206|FG001|COMPLETED|Visit 1- Visit 2||49
11324800|NCT02748785|12522207|FG002|COMPLETED|Visit 1- Visit 2||57
11324801|NCT02748785|12522208|FG003|COMPLETED|Visit 1- Visit 2||63
11324802|NCT02748785|12522205|FG000|NOT COMPLETED|Visit 1- Visit 2||10
11324803|NCT02748785|12522206|FG001|NOT COMPLETED|Visit 1- Visit 2||19
11324804|NCT02748785|12522207|FG002|NOT COMPLETED|Visit 1- Visit 2||14
11324805|NCT02748785|12522208|FG003|NOT COMPLETED|Visit 1- Visit 2||6
11324806|NCT02748785|12522205|FG000|STARTED|Visit 2-Visit 3||59
11324807|NCT02748785|12522206|FG001|STARTED|Visit 2-Visit 3||49
11324808|NCT02748785|12522207|FG002|STARTED|Visit 2-Visit 3||57
11324809|NCT02748785|12522208|FG003|STARTED|Visit 2-Visit 3||63
11324810|NCT02748785|12522205|FG000|COMPLETED|Visit 2-Visit 3||54
11324811|NCT02748785|12522206|FG001|COMPLETED|Visit 2-Visit 3||44
11324812|NCT02748785|12522207|FG002|COMPLETED|Visit 2-Visit 3||49
11324813|NCT02748785|12522208|FG003|COMPLETED|Visit 2-Visit 3||52
11324814|NCT02748785|12522205|FG000|NOT COMPLETED|Visit 2-Visit 3||5
11324815|NCT02748785|12522206|FG001|NOT COMPLETED|Visit 2-Visit 3||5
11324816|NCT02748785|12522207|FG002|NOT COMPLETED|Visit 2-Visit 3||8
11324817|NCT02748785|12522208|FG003|NOT COMPLETED|Visit 2-Visit 3||11
11324818|NCT02748785|12522205|FG000|STARTED|Visit 3- Visit 4||54
11324819|NCT02748785|12522206|FG001|STARTED|Visit 3- Visit 4||44
11324820|NCT02748785|12522207|FG002|STARTED|Visit 3- Visit 4||49
11324821|NCT02748785|12522208|FG003|STARTED|Visit 3- Visit 4||52
11324822|NCT02748785|12522205|FG000|COMPLETED|Visit 3- Visit 4||53
11324823|NCT02748785|12522206|FG001|COMPLETED|Visit 3- Visit 4||43
11324824|NCT02748785|12522207|FG002|COMPLETED|Visit 3- Visit 4||47
11324825|NCT02748785|12522208|FG003|COMPLETED|Visit 3- Visit 4||50
11324826|NCT02748785|12522205|FG000|NOT COMPLETED|Visit 3- Visit 4||1
11199064|NCT01817582|12389048|FG002|Received at Least 1 Dose of Study Drug|Overall Study||33
11199065|NCT01817582|12389046|FG000|COMPLETED|Overall Study||31
11199066|NCT01817582|12389047|FG001|COMPLETED|Overall Study||35
11199067|NCT01817582|12389048|FG002|COMPLETED|Overall Study||33
11199068|NCT01817582|12389046|FG000|NOT COMPLETED|Overall Study||2
11199069|NCT01817582|12389047|FG001|NOT COMPLETED|Overall Study||1
11199070|NCT01817582|12389048|FG002|NOT COMPLETED|Overall Study||0
11199071|NCT01817712|12389058|FG000|STARTED|Overall Study||271
11199072|NCT01817712|12389059|FG001|STARTED|Overall Study||270
11199073|NCT01817712|12389058|FG000|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250
11199074|NCT01817712|12389059|FG001|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240
11199075|NCT01817712|12389058|FG000|NOT COMPLETED|Overall Study||21
11199076|NCT01817712|12389059|FG001|NOT COMPLETED|Overall Study||30
11199077|NCT01817725|12389065|FG000|STARTED|Overall Study||20
11199078|NCT01817725|12389065|FG000|COMPLETED|Overall Study||19
11199079|NCT01817725|12389065|FG000|NOT COMPLETED|Overall Study||1
11199080|NCT01817764|12389071|FG000|STARTED|Overall Study||353
11199081|NCT01817764|12389072|FG001|STARTED|Overall Study||353
11199082|NCT01817764|12389071|FG000|COMPLETED|Overall Study||319
11199083|NCT01817764|12389072|FG001|COMPLETED|Overall Study||315
11199084|NCT01817764|12389071|FG000|NOT COMPLETED|Overall Study||34
11199085|NCT01817764|12389072|FG001|NOT COMPLETED|Overall Study||38
11199086|NCT01817777|12389080|FG000|STARTED|Observational Phase (8 Weeks)||36
11199087|NCT01817777|12389081|FG001|STARTED|Observational Phase (8 Weeks)||0
11199088|NCT01817777|12389082|FG002|STARTED|Observational Phase (8 Weeks)||0
11199089|NCT01817777|12389080|FG000|COMPLETED|Observational Phase (8 Weeks)||31
11199090|NCT01817777|12389081|FG001|COMPLETED|Observational Phase (8 Weeks)||0
11199091|NCT01817777|12389082|FG002|COMPLETED|Observational Phase (8 Weeks)||0
11199092|NCT01817777|12389080|FG000|NOT COMPLETED|Observational Phase (8 Weeks)||5
11199093|NCT01817777|12389081|FG001|NOT COMPLETED|Observational Phase (8 Weeks)||0
11199094|NCT01817777|12389082|FG002|NOT COMPLETED|Observational Phase (8 Weeks)||0
11199095|NCT01817777|12389080|FG000|STARTED|Interventional Phase (20 Weeks)||0
11199096|NCT01817777|12389081|FG001|STARTED|Interventional Phase (20 Weeks)||16
11199097|NCT01817777|12389082|FG002|STARTED|Interventional Phase (20 Weeks)||15
11199098|NCT01817777|12389080|FG000|COMPLETED|Interventional Phase (20 Weeks)||0
11199099|NCT01817777|12389081|FG001|COMPLETED|Interventional Phase (20 Weeks)||11
11199100|NCT01817777|12389082|FG002|COMPLETED|Interventional Phase (20 Weeks)||10
11199101|NCT01817777|12389080|FG000|NOT COMPLETED|Interventional Phase (20 Weeks)||0
11199102|NCT01817777|12389081|FG001|NOT COMPLETED|Interventional Phase (20 Weeks)||5
11199103|NCT01817777|12389082|FG002|NOT COMPLETED|Interventional Phase (20 Weeks)||5
11199104|NCT01817790|12389090|FG000|STARTED|Overall Study||314
11199105|NCT01817790|12389091|FG001|STARTED|Overall Study||312
11199106|NCT01817790|12389090|FG000|COMPLETED|Overall Study||310
11199107|NCT01817790|12389091|FG001|COMPLETED|Overall Study||304
11199108|NCT01817790|12389090|FG000|NOT COMPLETED|Overall Study||4
11199109|NCT01817790|12389091|FG001|NOT COMPLETED|Overall Study||8
11199110|NCT01817855|12389103|FG000|STARTED|Overall Study||23
11199111|NCT01817855|12389104|FG001|STARTED|Overall Study||8
11199112|NCT01817855|12389105|FG002|STARTED|Overall Study||11
11199113|NCT01817855|12389106|FG003|STARTED|Overall Study||5
11199114|NCT01817855|12389103|FG000|COMPLETED|Overall Study||23
11199115|NCT01817855|12389104|FG001|COMPLETED|Overall Study||6
11199116|NCT01817855|12389105|FG002|COMPLETED|Overall Study||9
11199117|NCT01817855|12389106|FG003|COMPLETED|Overall Study||5
11199118|NCT01817855|12389103|FG000|NOT COMPLETED|Overall Study||0
11199119|NCT01817855|12389104|FG001|NOT COMPLETED|Overall Study||2
11199120|NCT01817855|12389105|FG002|NOT COMPLETED|Overall Study||2
11199121|NCT01817855|12389106|FG003|NOT COMPLETED|Overall Study||0
11199122|NCT01817907|12389124|FG000|STARTED|First Intervention||8
11199123|NCT01817907|12389125|FG001|STARTED|First Intervention||7
11199124|NCT01817907|12389124|FG000|COMPLETED|First Intervention||8
11199125|NCT01817907|12389125|FG001|COMPLETED|First Intervention||7
11199126|NCT01817907|12389124|FG000|NOT COMPLETED|First Intervention||0
11199127|NCT01817907|12389125|FG001|NOT COMPLETED|First Intervention||0
11199128|NCT01817907|12389124|FG000|STARTED|Washout Period||8
11199129|NCT01817907|12389125|FG001|STARTED|Washout Period||7
11199130|NCT01817907|12389124|FG000|COMPLETED|Washout Period||8
11199131|NCT01817907|12389125|FG001|COMPLETED|Washout Period||7
11199132|NCT01817907|12389124|FG000|NOT COMPLETED|Washout Period||0
11199133|NCT01817907|12389125|FG001|NOT COMPLETED|Washout Period||0
11199134|NCT01817907|12389124|FG000|STARTED|Second Intervention||8
11199135|NCT01817907|12389125|FG001|STARTED|Second Intervention||7
11199136|NCT01817907|12389124|FG000|COMPLETED|Second Intervention||8
11199137|NCT01817907|12389125|FG001|COMPLETED|Second Intervention||7
11199138|NCT01817907|12389124|FG000|NOT COMPLETED|Second Intervention||0
11199139|NCT01817907|12389125|FG001|NOT COMPLETED|Second Intervention||0
11199140|NCT01817959|12389133|FG000|STARTED|Overall Study||29
11199141|NCT01817959|12389134|FG001|STARTED|Overall Study||19
11199142|NCT01817959|12389133|FG000|COMPLETED|Overall Study||25
11199143|NCT01817959|12389134|FG001|COMPLETED|Overall Study||16
11199144|NCT01817959|12389133|FG000|NOT COMPLETED|Overall Study||4
11199145|NCT01817959|12389134|FG001|NOT COMPLETED|Overall Study||3
11199146|NCT01818063|12389142|FG000|STARTED|Overall Study||5
11199147|NCT01818063|12389143|FG001|STARTED|Overall Study||4
11199148|NCT01818063|12389142|FG000|COMPLETED|Overall Study||5
11199149|NCT01818063|12389143|FG001|COMPLETED|Overall Study||4
11199150|NCT01818063|12389142|FG000|NOT COMPLETED|Overall Study||0
11199151|NCT01818063|12389143|FG001|NOT COMPLETED|Overall Study||0
11199152|NCT01818141|12389151|FG000|STARTED|Overall Study||18
11199153|NCT01818141|12389152|FG001|STARTED|Overall Study||16
11199154|NCT01818141|12389151|FG000|COMPLETED|Overall Study||15
11199155|NCT01818141|12389152|FG001|COMPLETED|Overall Study||13
11199156|NCT01818141|12389151|FG000|NOT COMPLETED|Overall Study||3
11199157|NCT01818141|12389152|FG001|NOT COMPLETED|Overall Study||3
11199158|NCT01818245|12389160|FG000|STARTED|Intervention A||30
11199159|NCT01818245|12389161|FG001|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
11199160|NCT01818245|12389160|FG000|Received One Dose of Study Drug|Intervention A||30
11199161|NCT01818245|12389161|FG001|Received One Dose of Study Drug|Intervention A||22
11199162|NCT01818245|12389160|FG000|COMPLETED|Intervention A||30
11199163|NCT01818245|12389161|FG001|COMPLETED|Intervention A||22
11199164|NCT01818245|12389160|FG000|NOT COMPLETED|Intervention A||0
11199165|NCT01818245|12389161|FG001|NOT COMPLETED|Intervention A||0
11199166|NCT01818245|12389160|FG000|STARTED|Washout (16-28 Days)||30
11199167|NCT01818245|12389161|FG001|STARTED|Washout (16-28 Days)||0
11199168|NCT01818245|12389160|FG000|COMPLETED|Washout (16-28 Days)||30
11199169|NCT01818245|12389161|FG001|COMPLETED|Washout (16-28 Days)||0
11199170|NCT01818245|12389160|FG000|NOT COMPLETED|Washout (16-28 Days)||0
11199171|NCT01818245|12389161|FG001|NOT COMPLETED|Washout (16-28 Days)||0
11199172|NCT01818245|12389160|FG000|STARTED|Intervention B||30
11199173|NCT01818245|12389161|FG001|STARTED|Intervention B||0
11199174|NCT01818245|12389160|FG000|COMPLETED|Intervention B||30
11199175|NCT01818245|12389161|FG001|COMPLETED|Intervention B||0
11199176|NCT01818245|12389160|FG000|NOT COMPLETED|Intervention B||0
11199177|NCT01818245|12389161|FG001|NOT COMPLETED|Intervention B||0
11199178|NCT01818245|12389160|FG000|STARTED|Washout (16-28 Days)||30
11199179|NCT01818245|12389161|FG001|STARTED|Washout (16-28 Days)||0
11199180|NCT01818245|12389160|FG000|COMPLETED|Washout (16-28 Days)||30
11199181|NCT01818245|12389161|FG001|COMPLETED|Washout (16-28 Days)||0
11199182|NCT01818245|12389160|FG000|NOT COMPLETED|Washout (16-28 Days)||0
11199183|NCT01818245|12389161|FG001|NOT COMPLETED|Washout (16-28 Days)||0
11199184|NCT01818245|12389160|FG000|STARTED|Intervention C||30
11199185|NCT01818245|12389161|FG001|STARTED|Intervention C||0
11199186|NCT01818245|12389160|FG000|COMPLETED|Intervention C||30
11199187|NCT01818245|12389161|FG001|COMPLETED|Intervention C||0
11199188|NCT01818245|12389160|FG000|NOT COMPLETED|Intervention C||0
11199189|NCT01818245|12389161|FG001|NOT COMPLETED|Intervention C||0
11199190|NCT01818258|12389174|FG000|STARTED|Overall Study||25
11199191|NCT01818258|12389175|FG001|STARTED|Overall Study||27
11199192|NCT01818258|12389174|FG000|COMPLETED|Overall Study||22
11199193|NCT01818258|12389175|FG001|COMPLETED|Overall Study||24
11199194|NCT01818258|12389174|FG000|NOT COMPLETED|Overall Study||3
11199195|NCT01818258|12389175|FG001|NOT COMPLETED|Overall Study||3
11205082|NCT01857232|12395835|FG002|COMPLETED|Overall Study||63
11205083|NCT01857232|12395836|FG003|COMPLETED|Overall Study||68
11205084|NCT01857232|12395837|FG004|COMPLETED|Overall Study||63
11205085|NCT01857232|12395833|FG000|NOT COMPLETED|Overall Study||8
11205086|NCT01857232|12395834|FG001|NOT COMPLETED|Overall Study||2
11205087|NCT01857232|12395835|FG002|NOT COMPLETED|Overall Study||4
11205088|NCT01857232|12395836|FG003|NOT COMPLETED|Overall Study||2
11205089|NCT01857232|12395837|FG004|NOT COMPLETED|Overall Study||6
11205090|NCT01857258|12395852|FG000|STARTED|First Intervention (3 h Postprandially)||8
11205091|NCT01857258|12395853|FG001|STARTED|First Intervention (3 h Postprandially)||7
11205092|NCT01857258|12395852|FG000|COMPLETED|First Intervention (3 h Postprandially)||8
11205093|NCT01857258|12395853|FG001|COMPLETED|First Intervention (3 h Postprandially)||7
11205094|NCT01857258|12395852|FG000|NOT COMPLETED|First Intervention (3 h Postprandially)||0
11205095|NCT01857258|12395853|FG001|NOT COMPLETED|First Intervention (3 h Postprandially)||0
11205096|NCT01857258|12395852|FG000|STARTED|Wash-out Period (7 Days)||8
11205097|NCT01857258|12395853|FG001|STARTED|Wash-out Period (7 Days)||7
11205098|NCT01857258|12395852|FG000|COMPLETED|Wash-out Period (7 Days)||8
11205099|NCT01857258|12395853|FG001|COMPLETED|Wash-out Period (7 Days)||7
11205100|NCT01857258|12395852|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0
11205101|NCT01857258|12395853|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0
11205102|NCT01857258|12395852|FG000|STARTED|Second Intervention (3 h Postprandially)||8
11205103|NCT01857258|12395853|FG001|STARTED|Second Intervention (3 h Postprandially)||7
11205104|NCT01857258|12395852|FG000|COMPLETED|Second Intervention (3 h Postprandially)||8
11205105|NCT01857258|12395853|FG001|COMPLETED|Second Intervention (3 h Postprandially)||7
11205106|NCT01857258|12395852|FG000|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
11205107|NCT01857258|12395853|FG001|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
11205108|NCT01857297|12395863|FG000|STARTED|Overall Study||60
11205109|NCT01857297|12395864|FG001|STARTED|Overall Study||60
11205110|NCT01857297|12395863|FG000|COMPLETED|Overall Study||60
11205111|NCT01857297|12395864|FG001|COMPLETED|Overall Study||60
11205112|NCT01857297|12395863|FG000|NOT COMPLETED|Overall Study||0
11205113|NCT01857297|12395864|FG001|NOT COMPLETED|Overall Study||0
11205114|NCT01857310|12395872|FG000|STARTED|Primary Analysis: Live Birth|Male partner|1185
11205115|NCT01857310|12395873|FG001|STARTED|Primary Analysis: Live Birth|Male partner|1185
11205116|NCT01857310|12395872|FG000|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
11205223|NCT01857869|12395946|FG006|NOT COMPLETED|Booster/Rechallenge Phase||0
11199196|NCT01818284|12389184|FG000|STARTED|Overall Study||11
11199197|NCT01818284|12389185|FG001|STARTED|Overall Study||11
11199198|NCT01818284|12389184|FG000|COMPLETED|Overall Study||7
11199199|NCT01818284|12389185|FG001|COMPLETED|Overall Study||5
11199200|NCT01818284|12389184|FG000|NOT COMPLETED|Overall Study||4
11199201|NCT01818284|12389185|FG001|NOT COMPLETED|Overall Study||6
11199202|NCT01818297|12389192|FG000|STARTED|Blinded Phase (Randomization - 3 Months)||32
11199203|NCT01818297|12389193|FG001|STARTED|Blinded Phase (Randomization - 3 Months)||30
11199204|NCT01818297|12389192|FG000|Week 1|Blinded Phase (Randomization - 3 Months)||32
11199205|NCT01818297|12389193|FG001|Week 1|Blinded Phase (Randomization - 3 Months)||30
11199206|NCT01818297|12389192|FG000|Week 6|Blinded Phase (Randomization - 3 Months)||32
11199207|NCT01818297|12389193|FG001|Week 6|Blinded Phase (Randomization - 3 Months)||29
11199208|NCT01818297|12389192|FG000|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
11199209|NCT01818297|12389193|FG001|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
11199210|NCT01818297|12389192|FG000|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
11199211|NCT01818297|12389193|FG001|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
11199212|NCT01818297|12389192|FG000|STARTED|Open Label Phase (3-12 Months)||32
11199213|NCT01818297|12389193|FG001|STARTED|Open Label Phase (3-12 Months)||29
11199214|NCT01818297|12389192|FG000|COMPLETED|Open Label Phase (3-12 Months)||14
11199215|NCT01818297|12389193|FG001|COMPLETED|Open Label Phase (3-12 Months)||19
11199216|NCT01818297|12389192|FG000|NOT COMPLETED|Open Label Phase (3-12 Months)||18
11199217|NCT01818297|12389193|FG001|NOT COMPLETED|Open Label Phase (3-12 Months)||10
11199218|NCT01818336|12389199|FG000|STARTED|Overall Study||391
11199219|NCT01818336|12389200|FG001|STARTED|Overall Study||59
11199220|NCT01818336|12389199|FG000|COMPLETED|Overall Study||391
11199221|NCT01818336|12389200|FG001|COMPLETED|Overall Study||47
11199222|NCT01818336|12389199|FG000|NOT COMPLETED|Overall Study||0
11199223|NCT01818336|12389200|FG001|NOT COMPLETED|Overall Study||12
11199224|NCT01818414|12389208|FG000|STARTED|Overall Study||14
11199225|NCT01818414|12389209|FG001|STARTED|Overall Study||15
11199226|NCT01818414|12389208|FG000|COMPLETED|Overall Study||14
11199227|NCT01818414|12389209|FG001|COMPLETED|Overall Study||15
11199228|NCT01818414|12389208|FG000|NOT COMPLETED|Overall Study||0
11199229|NCT01818414|12389209|FG001|NOT COMPLETED|Overall Study||0
11199230|NCT01818427|12389219|FG000|STARTED|Overall Study||239
11199231|NCT01818427|12389220|FG001|STARTED|Overall Study||284
11199232|NCT01818427|12389219|FG000|COMPLETED|Overall Study||230
11199233|NCT01818427|12389220|FG001|COMPLETED|Overall Study||271
11199234|NCT01818427|12389219|FG000|NOT COMPLETED|Overall Study||9
11199235|NCT01818427|12389220|FG001|NOT COMPLETED|Overall Study||13
11199236|NCT01818492|12389226|FG000|STARTED|Overall Study||45
11199237|NCT01818492|12389226|FG000|COMPLETED|Overall Study||35
11199238|NCT01818492|12389226|FG000|NOT COMPLETED|Overall Study||10
11199239|NCT01818518|12389237|FG000|STARTED|Overall Study||310
11199240|NCT01818518|12389238|FG001|STARTED|Overall Study||263
11199241|NCT01818518|12389239|FG002|STARTED|Overall Study||288
11199242|NCT01818518|12389240|FG003|STARTED|Overall Study||59
11199243|NCT01818518|12389241|FG004|STARTED|Overall Study||38
11199244|NCT01818518|12389242|FG005|STARTED|Overall Study||37
11199245|NCT01818518|12389237|FG000|COMPLETED|Overall Study||310
11199246|NCT01818518|12389238|FG001|COMPLETED|Overall Study||263
11199247|NCT01818518|12389239|FG002|COMPLETED|Overall Study||288
11199248|NCT01818518|12389240|FG003|COMPLETED|Overall Study||59
11199249|NCT01818518|12389241|FG004|COMPLETED|Overall Study||38
11199250|NCT01818518|12389242|FG005|COMPLETED|Overall Study||37
11199251|NCT01818518|12389237|FG000|NOT COMPLETED|Overall Study||0
11199252|NCT01818518|12389238|FG001|NOT COMPLETED|Overall Study||0
11199253|NCT01818518|12389239|FG002|NOT COMPLETED|Overall Study||0
11199254|NCT01818518|12389240|FG003|NOT COMPLETED|Overall Study||0
11199255|NCT01818518|12389241|FG004|NOT COMPLETED|Overall Study||0
11199256|NCT01818518|12389242|FG005|NOT COMPLETED|Overall Study||0
11199257|NCT01818531|12389258|FG000|STARTED|Overall Study||75
11199258|NCT01818531|12389259|FG001|STARTED|Overall Study||75
11199259|NCT01818531|12389258|FG000|COMPLETED|Overall Study||74
11199260|NCT01818531|12389259|FG001|COMPLETED|Overall Study||73
11199261|NCT01818531|12389258|FG000|NOT COMPLETED|Overall Study||1
11199262|NCT01818531|12389259|FG001|NOT COMPLETED|Overall Study||2
11199263|NCT01818596|12389267|FG000|STARTED|Overall Study||246
11199264|NCT01818596|12389268|FG001|STARTED|Overall Study||6
11199265|NCT01818596|12389267|FG000|COMPLETED|Overall Study||215
11199266|NCT01818596|12389268|FG001|COMPLETED|Overall Study||6
11199267|NCT01818596|12389267|FG000|NOT COMPLETED|Overall Study||31
11199268|NCT01818596|12389268|FG001|NOT COMPLETED|Overall Study||0
11199269|NCT01818700|12389275|FG000|STARTED|Overall Study|The No. of enrolled patients|245
11199270|NCT01818700|12389275|FG000|Safety Set|Overall Study|4 subjects were not study drug administered.|241
11199271|NCT01818700|12389275|FG000|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
11199272|NCT01818700|12389275|FG000|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
11199273|NCT01818700|12389275|FG000|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
11199274|NCT01818700|12389275|FG000|NOT COMPLETED|Overall Study||104
11199275|NCT01818726|12389283|FG000|STARTED|Overall Study||10
11199276|NCT01818726|12389284|FG001|STARTED|Overall Study||5
11199277|NCT01818726|12389283|FG000|COMPLETED|Overall Study||4
11199278|NCT01818726|12389284|FG001|COMPLETED|Overall Study||3
11199279|NCT01818726|12389283|FG000|NOT COMPLETED|Overall Study||6
11199280|NCT01818726|12389284|FG001|NOT COMPLETED|Overall Study||2
11199281|NCT01818752|12389292|FG000|STARTED|Overall Study||477
11199282|NCT01818752|12389293|FG001|STARTED|Overall Study||478
11199283|NCT01818752|12389292|FG000|Received Treatment|Overall Study||470
11199284|NCT01818752|12389293|FG001|Received Treatment|Overall Study||474
11199285|NCT01818752|12389292|FG000|COMPLETED|Overall Study|Completed treatment|290
11199286|NCT01818752|12389293|FG001|COMPLETED|Overall Study|Completed treatment|280
11199287|NCT01818752|12389292|FG000|NOT COMPLETED|Overall Study||187
11199288|NCT01818752|12389293|FG001|NOT COMPLETED|Overall Study||198
11199289|NCT01818765|12389299|FG000|STARTED|Overall Study||20
11199290|NCT01818765|12389299|FG000|COMPLETED|Overall Study||18
11199291|NCT01818765|12389299|FG000|NOT COMPLETED|Overall Study||2
11199292|NCT01818804|12389306|FG000|STARTED|Overall Study||73
11199293|NCT01818804|12389307|FG001|STARTED|Overall Study||72
11199294|NCT01818804|12389306|FG000|COMPLETED|Overall Study||68
11199295|NCT01818804|12389307|FG001|COMPLETED|Overall Study||65
11199296|NCT01818804|12389306|FG000|NOT COMPLETED|Overall Study||5
11199297|NCT01818804|12389307|FG001|NOT COMPLETED|Overall Study||7
11199298|NCT01819129|12389315|FG000|STARTED|Overall Study||345
11199299|NCT01819129|12389316|FG001|STARTED|Overall Study||344
11199300|NCT01819129|12389315|FG000|Exposed|Overall Study||341
11199301|NCT01819129|12389316|FG001|Exposed|Overall Study||341
11199302|NCT01819129|12389315|FG000|COMPLETED|Overall Study||301
11199303|NCT01819129|12389316|FG001|COMPLETED|Overall Study||305
11199304|NCT01819129|12389315|FG000|NOT COMPLETED|Overall Study||44
11199305|NCT01819129|12389316|FG001|NOT COMPLETED|Overall Study||39
11199306|NCT01819194|12389322|FG000|STARTED|Overall Study||62
11199307|NCT01819194|12389322|FG000|COMPLETED|Overall Study||60
11199308|NCT01819194|12389322|FG000|NOT COMPLETED|Overall Study||2
11199309|NCT01819233|12389326|FG000|STARTED|Overall Study||38
11199310|NCT01819233|12389326|FG000|COMPLETED|Overall Study||32
11199311|NCT01819233|12389326|FG000|NOT COMPLETED|Overall Study||6
11199312|NCT01819272|12389336|FG000|STARTED|Overall Study||41
11199313|NCT01819272|12389337|FG001|STARTED|Overall Study||39
11199314|NCT01819272|12389338|FG002|STARTED|Overall Study||40
11199315|NCT01819272|12389339|FG003|STARTED|Overall Study||40
11199316|NCT01819272|12389340|FG004|STARTED|Overall Study||40
11199317|NCT01819272|12389341|FG005|STARTED|Overall Study||40
11199318|NCT01819272|12389336|FG000|COMPLETED|Overall Study||35
11199319|NCT01819272|12389337|FG001|COMPLETED|Overall Study||36
11199320|NCT01819272|12389338|FG002|COMPLETED|Overall Study||37
11199321|NCT01819272|12389339|FG003|COMPLETED|Overall Study||35
11199322|NCT01819272|12389340|FG004|COMPLETED|Overall Study||36
11199323|NCT01819272|12389341|FG005|COMPLETED|Overall Study||33
11199324|NCT01819272|12389336|FG000|NOT COMPLETED|Overall Study||6
11199325|NCT01819272|12389337|FG001|NOT COMPLETED|Overall Study||3
11199326|NCT01819272|12389338|FG002|NOT COMPLETED|Overall Study||3
11199327|NCT01819272|12389339|FG003|NOT COMPLETED|Overall Study||5
11199328|NCT01819272|12389340|FG004|NOT COMPLETED|Overall Study||4
11199329|NCT01819272|12389341|FG005|NOT COMPLETED|Overall Study||7
11199330|NCT01819311|12389357|FG000|STARTED|Treatment Phase (4 Weeks)||33
11199331|NCT01819311|12389358|FG001|STARTED|Treatment Phase (4 Weeks)||31
11199332|NCT01819311|12389357|FG000|COMPLETED|Treatment Phase (4 Weeks)||31
11199333|NCT01819311|12389358|FG001|COMPLETED|Treatment Phase (4 Weeks)||30
11199334|NCT01819311|12389357|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||2
11199335|NCT01819311|12389358|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||1
11199336|NCT01819311|12389357|FG000|STARTED|Follow-up Phase (8 Weeks)||31
11199337|NCT01819311|12389358|FG001|STARTED|Follow-up Phase (8 Weeks)||30
11199338|NCT01819311|12389357|FG000|COMPLETED|Follow-up Phase (8 Weeks)||24
11199339|NCT01819311|12389358|FG001|COMPLETED|Follow-up Phase (8 Weeks)||23
11199340|NCT01819311|12389357|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
11199341|NCT01819311|12389358|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
11199342|NCT01819415|12389368|FG000|STARTED|Overall Study||10
11199343|NCT01819415|12389369|FG001|STARTED|Overall Study||10
11199344|NCT01819415|12389370|FG002|STARTED|Overall Study||10
11199345|NCT01819415|12389371|FG003|STARTED|Overall Study||10
11199346|NCT01819415|12389368|FG000|COMPLETED|Overall Study||7
11199347|NCT01819415|12389369|FG001|COMPLETED|Overall Study||6
11199348|NCT01819415|12389370|FG002|COMPLETED|Overall Study||9
11199349|NCT01819415|12389371|FG003|COMPLETED|Overall Study||8
11199350|NCT01819415|12389368|FG000|NOT COMPLETED|Overall Study||3
11199351|NCT01819415|12389369|FG001|NOT COMPLETED|Overall Study||4
11199352|NCT01819415|12389370|FG002|NOT COMPLETED|Overall Study||1
11199353|NCT01819415|12389371|FG003|NOT COMPLETED|Overall Study||2
11199354|NCT01819506|12389383|FG000|STARTED|Overall Study||51
11199355|NCT01819506|12389384|FG001|STARTED|Overall Study||52
11199356|NCT01819506|12389383|FG000|COMPLETED|Overall Study||43
11199357|NCT01819506|12389384|FG001|COMPLETED|Overall Study||47
11199358|NCT01819506|12389383|FG000|NOT COMPLETED|Overall Study||8
11199359|NCT01819506|12389384|FG001|NOT COMPLETED|Overall Study||5
11199360|NCT01819597|12389390|FG000|STARTED|Overall Study||52
11199361|NCT01819597|12389390|FG000|COMPLETED|Overall Study||52
11199362|NCT01819597|12389390|FG000|NOT COMPLETED|Overall Study||0
11199363|NCT01819727|12389396|FG000|STARTED|Overall Study||131
11199364|NCT01819727|12389397|FG001|STARTED|Overall Study||130
11199365|NCT01819727|12389396|FG000|COMPLETED|Overall Study||111
11199366|NCT01819727|12389397|FG001|COMPLETED|Overall Study||102
11199367|NCT01819727|12389396|FG000|NOT COMPLETED|Overall Study||20
11199368|NCT01819727|12389397|FG001|NOT COMPLETED|Overall Study||28
11199369|NCT01819844|12389403|FG000|STARTED|Overall Study||12
11199370|NCT01819844|12389403|FG000|COMPLETED|Overall Study||12
11199371|NCT01819844|12389403|FG000|NOT COMPLETED|Overall Study||0
11199372|NCT01819883|12389410|FG000|STARTED|Overall Study||20
11199373|NCT01819883|12389411|FG001|STARTED|Overall Study||20
11199374|NCT01819883|12389410|FG000|COMPLETED|Overall Study||16
11199375|NCT01819883|12389411|FG001|COMPLETED|Overall Study||20
11199376|NCT01819883|12389410|FG000|NOT COMPLETED|Overall Study||4
11199377|NCT01819883|12389411|FG001|NOT COMPLETED|Overall Study||0
11199378|NCT01819922|12389416|FG000|STARTED|First Intervention Period (1 Day)||6
11199379|NCT01819922|12389417|FG001|STARTED|First Intervention Period (1 Day)||6
11199380|NCT01819922|12389416|FG000|COMPLETED|First Intervention Period (1 Day)||6
11199381|NCT01819922|12389417|FG001|COMPLETED|First Intervention Period (1 Day)||6
11199382|NCT01819922|12389416|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
11199383|NCT01819922|12389417|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
11199384|NCT01819922|12389416|FG000|STARTED|Washout Period (at Least 7-10 Days)||6
11199385|NCT01819922|12389417|FG001|STARTED|Washout Period (at Least 7-10 Days)||6
11199386|NCT01819922|12389416|FG000|COMPLETED|Washout Period (at Least 7-10 Days)||6
11199387|NCT01819922|12389417|FG001|COMPLETED|Washout Period (at Least 7-10 Days)||6
11199388|NCT01819922|12389416|FG000|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
11199389|NCT01819922|12389417|FG001|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
11199390|NCT01819922|12389416|FG000|STARTED|Second Intervention Period (1 Day)||6
11199391|NCT01819922|12389417|FG001|STARTED|Second Intervention Period (1 Day)||6
11199392|NCT01819922|12389416|FG000|COMPLETED|Second Intervention Period (1 Day)||6
11199393|NCT01819922|12389417|FG001|COMPLETED|Second Intervention Period (1 Day)||6
11199394|NCT01819922|12389416|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
11199395|NCT01819922|12389417|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
11199396|NCT01819935|12389425|FG000|STARTED|Overall Study||328
11199397|NCT01819935|12389426|FG001|STARTED|Overall Study||4943
11199398|NCT01819935|12389425|FG000|COMPLETED|Overall Study||328
11199399|NCT01819935|12389426|FG001|COMPLETED|Overall Study||4943
11199400|NCT01819935|12389425|FG000|NOT COMPLETED|Overall Study||0
11199401|NCT01819935|12389426|FG001|NOT COMPLETED|Overall Study||0
11199402|NCT01820260|12389446|FG000|STARTED|Phase 1 (Part 1)||3
11199403|NCT01820260|12389447|FG001|STARTED|Phase 1 (Part 1)||12
11199404|NCT01820260|12389448|FG002|STARTED|Phase 1 (Part 1)||10
11199405|NCT01820260|12389449|FG003|STARTED|Phase 1 (Part 1)||12
11199406|NCT01820260|12389450|FG004|STARTED|Phase 1 (Part 1)||12
11199407|NCT01820260|12389451|FG005|STARTED|Phase 1 (Part 1)||10
11199408|NCT01820260|12389452|FG006|STARTED|Phase 1 (Part 1)||12
11199409|NCT01820260|12389453|FG007|STARTED|Phase 1 (Part 1)||11
11199410|NCT01820260|12389454|FG008|STARTED|Phase 1 (Part 1)||0
11199411|NCT01820260|12389455|FG009|STARTED|Phase 1 (Part 1)||0
11199412|NCT01820260|12389456|FG010|STARTED|Phase 1 (Part 1)||0
11199413|NCT01820260|12389457|FG011|STARTED|Phase 1 (Part 1)||0
11199414|NCT01820260|12389458|FG012|STARTED|Phase 1 (Part 1)||0
11199415|NCT01820260|12389459|FG013|STARTED|Phase 1 (Part 1)||0
11199416|NCT01820260|12389446|FG000|COMPLETED|Phase 1 (Part 1)||3
11199417|NCT01820260|12389447|FG001|COMPLETED|Phase 1 (Part 1)||12
11199418|NCT01820260|12389448|FG002|COMPLETED|Phase 1 (Part 1)||10
11199419|NCT01820260|12389449|FG003|COMPLETED|Phase 1 (Part 1)||12
11199420|NCT01820260|12389450|FG004|COMPLETED|Phase 1 (Part 1)||12
11199421|NCT01820260|12389451|FG005|COMPLETED|Phase 1 (Part 1)||10
11199422|NCT01820260|12389452|FG006|COMPLETED|Phase 1 (Part 1)||11
11199423|NCT01820260|12389453|FG007|COMPLETED|Phase 1 (Part 1)||11
11199424|NCT01820260|12389454|FG008|COMPLETED|Phase 1 (Part 1)||0
11199425|NCT01820260|12389455|FG009|COMPLETED|Phase 1 (Part 1)||0
11199426|NCT01820260|12389456|FG010|COMPLETED|Phase 1 (Part 1)||0
11199427|NCT01820260|12389457|FG011|COMPLETED|Phase 1 (Part 1)||0
11199428|NCT01820260|12389458|FG012|COMPLETED|Phase 1 (Part 1)||0
11199429|NCT01820260|12389459|FG013|COMPLETED|Phase 1 (Part 1)||0
11199430|NCT01820260|12389446|FG000|NOT COMPLETED|Phase 1 (Part 1)||0
11199431|NCT01820260|12389447|FG001|NOT COMPLETED|Phase 1 (Part 1)||0
11199432|NCT01820260|12389448|FG002|NOT COMPLETED|Phase 1 (Part 1)||0
11199433|NCT01820260|12389449|FG003|NOT COMPLETED|Phase 1 (Part 1)||0
11199434|NCT01820260|12389450|FG004|NOT COMPLETED|Phase 1 (Part 1)||0
11199435|NCT01820260|12389451|FG005|NOT COMPLETED|Phase 1 (Part 1)||0
11199436|NCT01820260|12389452|FG006|NOT COMPLETED|Phase 1 (Part 1)||1
11199437|NCT01820260|12389453|FG007|NOT COMPLETED|Phase 1 (Part 1)||0
11199438|NCT01820260|12389454|FG008|NOT COMPLETED|Phase 1 (Part 1)||0
11199439|NCT01820260|12389455|FG009|NOT COMPLETED|Phase 1 (Part 1)||0
11199440|NCT01820260|12389456|FG010|NOT COMPLETED|Phase 1 (Part 1)||0
11199441|NCT01820260|12389457|FG011|NOT COMPLETED|Phase 1 (Part 1)||0
11199442|NCT01820260|12389458|FG012|NOT COMPLETED|Phase 1 (Part 1)||0
11199443|NCT01820260|12389459|FG013|NOT COMPLETED|Phase 1 (Part 1)||0
11199444|NCT01820260|12389446|FG000|STARTED|Phase 2 (Part 2)||0
11199445|NCT01820260|12389447|FG001|STARTED|Phase 2 (Part 2)||0
11199446|NCT01820260|12389448|FG002|STARTED|Phase 2 (Part 2)||0
11199447|NCT01820260|12389449|FG003|STARTED|Phase 2 (Part 2)||0
11199448|NCT01820260|12389450|FG004|STARTED|Phase 2 (Part 2)||0
11199449|NCT01820260|12389451|FG005|STARTED|Phase 2 (Part 2)||0
11199450|NCT01820260|12389452|FG006|STARTED|Phase 2 (Part 2)||0
11199451|NCT01820260|12389453|FG007|STARTED|Phase 2 (Part 2)||0
11199452|NCT01820260|12389454|FG008|STARTED|Phase 2 (Part 2)||64
11199453|NCT01820260|12389455|FG009|STARTED|Phase 2 (Part 2)||62
11199454|NCT01820260|12389456|FG010|STARTED|Phase 2 (Part 2)||61
11199455|NCT01820260|12389457|FG011|STARTED|Phase 2 (Part 2)||64
11199456|NCT01820260|12389458|FG012|STARTED|Phase 2 (Part 2)||31
11199457|NCT01820260|12389459|FG013|STARTED|Phase 2 (Part 2)||31
11199458|NCT01820260|12389446|FG000|COMPLETED|Phase 2 (Part 2)||0
11199459|NCT01820260|12389447|FG001|COMPLETED|Phase 2 (Part 2)||0
11199460|NCT01820260|12389448|FG002|COMPLETED|Phase 2 (Part 2)||0
11199461|NCT01820260|12389449|FG003|COMPLETED|Phase 2 (Part 2)||0
11199462|NCT01820260|12389450|FG004|COMPLETED|Phase 2 (Part 2)||0
11199463|NCT01820260|12389451|FG005|COMPLETED|Phase 2 (Part 2)||0
11199464|NCT01820260|12389452|FG006|COMPLETED|Phase 2 (Part 2)||0
11199465|NCT01820260|12389453|FG007|COMPLETED|Phase 2 (Part 2)||0
11199466|NCT01820260|12389454|FG008|COMPLETED|Phase 2 (Part 2)||64
11199467|NCT01820260|12389455|FG009|COMPLETED|Phase 2 (Part 2)||61
11199468|NCT01820260|12389456|FG010|COMPLETED|Phase 2 (Part 2)||61
11199469|NCT01820260|12389457|FG011|COMPLETED|Phase 2 (Part 2)||64
11199470|NCT01820260|12389458|FG012|COMPLETED|Phase 2 (Part 2)||31
11199471|NCT01820260|12389459|FG013|COMPLETED|Phase 2 (Part 2)||31
11199472|NCT01820260|12389446|FG000|NOT COMPLETED|Phase 2 (Part 2)||0
11199473|NCT01820260|12389447|FG001|NOT COMPLETED|Phase 2 (Part 2)||0
11199474|NCT01820260|12389448|FG002|NOT COMPLETED|Phase 2 (Part 2)||0
11199475|NCT01820260|12389449|FG003|NOT COMPLETED|Phase 2 (Part 2)||0
11199476|NCT01820260|12389450|FG004|NOT COMPLETED|Phase 2 (Part 2)||0
11199477|NCT01820260|12389451|FG005|NOT COMPLETED|Phase 2 (Part 2)||0
11199478|NCT01820260|12389452|FG006|NOT COMPLETED|Phase 2 (Part 2)||0
11199479|NCT01820260|12389453|FG007|NOT COMPLETED|Phase 2 (Part 2)||0
11199480|NCT01820260|12389454|FG008|NOT COMPLETED|Phase 2 (Part 2)||0
11199481|NCT01820260|12389455|FG009|NOT COMPLETED|Phase 2 (Part 2)||1
11199482|NCT01820260|12389456|FG010|NOT COMPLETED|Phase 2 (Part 2)||0
11199483|NCT01820260|12389457|FG011|NOT COMPLETED|Phase 2 (Part 2)||0
11199484|NCT01820260|12389458|FG012|NOT COMPLETED|Phase 2 (Part 2)||0
11199485|NCT01820260|12389459|FG013|NOT COMPLETED|Phase 2 (Part 2)||0
11199486|NCT01820364|12389495|FG000|STARTED|Part I: LGX818||15
11199487|NCT01820364|12389496|FG001|STARTED|Part I: LGX818||0
11199488|NCT01820364|12389495|FG000|COMPLETED|Part I: LGX818||1
11199489|NCT01820364|12389496|FG001|COMPLETED|Part I: LGX818||0
11199490|NCT01820364|12389495|FG000|NOT COMPLETED|Part I: LGX818||14
11199491|NCT01820364|12389496|FG001|NOT COMPLETED|Part I: LGX818||0
11199492|NCT01820364|12389495|FG000|STARTED|Part II: LGX818 + MEK162||0
11199493|NCT01820364|12389496|FG001|STARTED|Part II: LGX818 + MEK162||1
11199494|NCT01820364|12389495|FG000|COMPLETED|Part II: LGX818 + MEK162||0
11199495|NCT01820364|12389496|FG001|COMPLETED|Part II: LGX818 + MEK162||0
11199496|NCT01820364|12389495|FG000|NOT COMPLETED|Part II: LGX818 + MEK162||0
11199497|NCT01820364|12389496|FG001|NOT COMPLETED|Part II: LGX818 + MEK162||1
11199498|NCT01820416|12389505|FG000|STARTED|Overall Study||12
11199499|NCT01820416|12389506|FG001|STARTED|Overall Study||12
11199500|NCT01820416|12389507|FG002|STARTED|Overall Study||11
11199501|NCT01820416|12389505|FG000|COMPLETED|Overall Study||9
11199502|NCT01820416|12389506|FG001|COMPLETED|Overall Study||10
11199503|NCT01820416|12389507|FG002|COMPLETED|Overall Study||11
11199504|NCT01820416|12389505|FG000|NOT COMPLETED|Overall Study||3
11199505|NCT01820416|12389506|FG001|NOT COMPLETED|Overall Study||2
11199506|NCT01820416|12389507|FG002|NOT COMPLETED|Overall Study||0
11199507|NCT01820559|12389518|FG000|STARTED|Overall Study||136
11199508|NCT01820559|12389519|FG001|STARTED|Overall Study||135
11199509|NCT01820559|12389520|FG002|STARTED|Overall Study||139
11199510|NCT01820559|12389518|FG000|Randomized and Treated|Overall Study||136
11199511|NCT01820559|12389519|FG001|Randomized and Treated|Overall Study||135
11199512|NCT01820559|12389520|FG002|Randomized and Treated|Overall Study||139
11199513|NCT01820559|12389518|FG000|Completed Tutration Period|Overall Study||130
11199514|NCT01820559|12389519|FG001|Completed Tutration Period|Overall Study||134
11199515|NCT01820559|12389520|FG002|Completed Tutration Period|Overall Study||131
11199516|NCT01820559|12389518|FG000|Entered Maintenance Period|Overall Study||129
11199517|NCT01820559|12389519|FG001|Entered Maintenance Period|Overall Study||133
11199518|NCT01820559|12389520|FG002|Entered Maintenance Period|Overall Study||129
11199519|NCT01820559|12389518|FG000|Completed Maintenance Period|Overall Study||122
11199520|NCT01820559|12389519|FG001|Completed Maintenance Period|Overall Study||123
11199521|NCT01820559|12389520|FG002|Completed Maintenance Period|Overall Study||110
11199522|NCT01820559|12389518|FG000|COMPLETED|Overall Study||122
11199523|NCT01820559|12389519|FG001|COMPLETED|Overall Study||122
11199524|NCT01820559|12389520|FG002|COMPLETED|Overall Study||110
11199525|NCT01820559|12389518|FG000|NOT COMPLETED|Overall Study||14
11199526|NCT01820559|12389519|FG001|NOT COMPLETED|Overall Study||13
11199527|NCT01820559|12389520|FG002|NOT COMPLETED|Overall Study||29
11199528|NCT01820572|12389530|FG000|STARTED|Randomization||223
11199529|NCT01820572|12389531|FG001|STARTED|Randomization||223
11199530|NCT01820572|12389530|FG000|COMPLETED|Randomization||221
11199531|NCT01820572|12389531|FG001|COMPLETED|Randomization||222
11199532|NCT01820572|12389530|FG000|NOT COMPLETED|Randomization||2
11199533|NCT01820572|12389531|FG001|NOT COMPLETED|Randomization||1
11199534|NCT01820572|12389530|FG000|STARTED|Treatment Period||221
11199535|NCT01820572|12389531|FG001|STARTED|Treatment Period||222
11199536|NCT01820572|12389530|FG000|COMPLETED|Treatment Period||195
11199537|NCT01820572|12389531|FG001|COMPLETED|Treatment Period||186
11199538|NCT01820572|12389530|FG000|NOT COMPLETED|Treatment Period||26
11199539|NCT01820572|12389531|FG001|NOT COMPLETED|Treatment Period||36
11199540|NCT01820585|12389541|FG000|STARTED|Overall Study||131
11199541|NCT01820585|12389542|FG001|STARTED|Overall Study||130
11199542|NCT01820585|12389543|FG002|STARTED|Overall Study||135
11199543|NCT01820585|12389544|FG003|STARTED|Overall Study||132
11199544|NCT01820585|12389541|FG000|Randomized and Treated|Overall Study||131
11199545|NCT01820585|12389542|FG001|Randomized and Treated|Overall Study||130
11199546|NCT01820585|12389543|FG002|Randomized and Treated|Overall Study||135
11199547|NCT01820585|12389544|FG003|Randomized and Treated|Overall Study||132
11199548|NCT01820585|12389541|FG000|Full Analysis Set|Overall Study||131
11199549|NCT01820585|12389542|FG001|Full Analysis Set|Overall Study||130
11199550|NCT01820585|12389543|FG002|Full Analysis Set|Overall Study||135
11199551|NCT01820585|12389544|FG003|Full Analysis Set|Overall Study||129
11199552|NCT01820585|12389541|FG000|Completed Titration Period|Overall Study||128
11199553|NCT01820585|12389542|FG001|Completed Titration Period|Overall Study||125
11199554|NCT01820585|12389543|FG002|Completed Titration Period|Overall Study||131
11199555|NCT01820585|12389544|FG003|Completed Titration Period|Overall Study||126
11199556|NCT01820585|12389541|FG000|Entered Maintenance Period|Overall Study||128
11199557|NCT01820585|12389542|FG001|Entered Maintenance Period|Overall Study||124
11199558|NCT01820585|12389543|FG002|Entered Maintenance Period|Overall Study||131
11199559|NCT01820585|12389544|FG003|Entered Maintenance Period|Overall Study||123
11199560|NCT01820585|12389541|FG000|Completed Maintenance Period|Overall Study||105
11199561|NCT01820585|12389542|FG001|Completed Maintenance Period|Overall Study||98
11199562|NCT01820585|12389543|FG002|Completed Maintenance Period|Overall Study||101
11199563|NCT01820585|12389544|FG003|Completed Maintenance Period|Overall Study||84
11199564|NCT01820585|12389541|FG000|COMPLETED|Overall Study||104
11199565|NCT01820585|12389542|FG001|COMPLETED|Overall Study||98
11199566|NCT01820585|12389543|FG002|COMPLETED|Overall Study||101
11199567|NCT01820585|12389544|FG003|COMPLETED|Overall Study||83
11199568|NCT01820585|12389541|FG000|NOT COMPLETED|Overall Study||27
11199569|NCT01820585|12389542|FG001|NOT COMPLETED|Overall Study||32
11199570|NCT01820585|12389543|FG002|NOT COMPLETED|Overall Study||34
11199571|NCT01820585|12389544|FG003|NOT COMPLETED|Overall Study||49
11199572|NCT01820637|12389554|FG000|STARTED|Overall Study||57
11199573|NCT01820637|12389554|FG000|COMPLETED|Overall Study||54
11199574|NCT01820637|12389554|FG000|NOT COMPLETED|Overall Study||3
11199575|NCT01820754|12389558|FG000|STARTED|Overall Study||24
11199576|NCT01820754|12389558|FG000|COMPLETED|Overall Study||24
11199577|NCT01820754|12389558|FG000|NOT COMPLETED|Overall Study||0
11199578|NCT01821105|12389562|FG000|STARTED|Overall Study||21
11199579|NCT01821105|12389562|FG000|COMPLETED|Overall Study||21
11199580|NCT01821105|12389562|FG000|NOT COMPLETED|Overall Study||0
11199581|NCT01821118|12389568|FG000|STARTED|Overall Study||24
11199582|NCT01821118|12389569|FG001|STARTED|Overall Study||12
11199583|NCT01821118|12389568|FG000|COMPLETED|Overall Study||24
11199584|NCT01821118|12389569|FG001|COMPLETED|Overall Study||11
11199585|NCT01821118|12389568|FG000|NOT COMPLETED|Overall Study||0
11199586|NCT01821118|12389569|FG001|NOT COMPLETED|Overall Study||1
11199587|NCT01821300|12389577|FG000|STARTED|Overall Study||154
11199588|NCT01821300|12389578|FG001|STARTED|Overall Study||103
11199589|NCT01821300|12389577|FG000|COMPLETED|Overall Study||154
11199590|NCT01821300|12389578|FG001|COMPLETED|Overall Study||103
11199591|NCT01821300|12389577|FG000|NOT COMPLETED|Overall Study||0
11199592|NCT01821300|12389578|FG001|NOT COMPLETED|Overall Study||0
11199593|NCT01821326|12389590|FG000|STARTED|Overall Study||339
11199594|NCT01821326|12389590|FG000|COMPLETED|Overall Study||339
11199595|NCT01821326|12389590|FG000|NOT COMPLETED|Overall Study||0
11199596|NCT01821352|12389596|FG000|STARTED|Overall Study||28
11199597|NCT01821352|12389597|FG001|STARTED|Overall Study||25
11199598|NCT01821352|12389596|FG000|COMPLETED|Overall Study||28
11199599|NCT01821352|12389597|FG001|COMPLETED|Overall Study||25
11199600|NCT01821352|12389596|FG000|NOT COMPLETED|Overall Study||0
11199601|NCT01821352|12389597|FG001|NOT COMPLETED|Overall Study||0
11199602|NCT01821378|12389606|FG000|STARTED|Overall Study||101
11199603|NCT01821378|12389607|FG001|STARTED|Overall Study||199
11199604|NCT01821378|12389608|FG002|STARTED|Overall Study||112
11199605|NCT01821378|12389606|FG000|COMPLETED|Overall Study||74
11199606|NCT01821378|12389607|FG001|COMPLETED|Overall Study||145
11199607|NCT01821378|12389608|FG002|COMPLETED|Overall Study||70
11199608|NCT01821378|12389606|FG000|NOT COMPLETED|Overall Study||27
11199609|NCT01821378|12389607|FG001|NOT COMPLETED|Overall Study||54
11199610|NCT01821378|12389608|FG002|NOT COMPLETED|Overall Study||42
11199611|NCT01821391|12389623|FG000|STARTED|Overall Study||108
11199612|NCT01821391|12389624|FG001|STARTED|Overall Study||23
11199613|NCT01821391|12389623|FG000|COMPLETED|Overall Study||107
11199614|NCT01821391|12389624|FG001|COMPLETED|Overall Study||23
11199615|NCT01821391|12389623|FG000|NOT COMPLETED|Overall Study||1
11199616|NCT01821391|12389624|FG001|NOT COMPLETED|Overall Study||0
11199617|NCT01821417|12389634|FG000|STARTED|Overall Study||37
11199618|NCT01821417|12389635|FG001|STARTED|Overall Study||31
11199619|NCT01821417|12389634|FG000|COMPLETED|Overall Study||37
11199620|NCT01821417|12389635|FG001|COMPLETED|Overall Study||31
11199621|NCT01821417|12389634|FG000|NOT COMPLETED|Overall Study||0
11199622|NCT01821417|12389635|FG001|NOT COMPLETED|Overall Study||0
11199623|NCT01821534|12389641|FG000|STARTED|Overall Study||201
11199624|NCT01821534|12389641|FG000|COMPLETED|Overall Study||201
11199625|NCT01821534|12389641|FG000|NOT COMPLETED|Overall Study||0
11199626|NCT01821560|12389647|FG000|STARTED|Overall Study||22
11199627|NCT01821560|12389648|FG001|STARTED|Overall Study||22
11199628|NCT01821560|12389647|FG000|COMPLETED|Overall Study||16
11199629|NCT01821560|12389648|FG001|COMPLETED|Overall Study||15
11199630|NCT01821560|12389647|FG000|NOT COMPLETED|Overall Study||6
11199631|NCT01821560|12389648|FG001|NOT COMPLETED|Overall Study||7
11199632|NCT01821625|12389654|FG000|STARTED|Overall Study||7
11199633|NCT01821625|12389654|FG000|COMPLETED|Overall Study||1
11199634|NCT01821625|12389654|FG000|NOT COMPLETED|Overall Study||6
11199635|NCT01821729|12389658|FG000|STARTED|Overall Study||50
11199636|NCT01821729|12389658|FG000|Received Chemoradiotherapy|Overall Study||45
11199637|NCT01821729|12389658|FG000|Underwent Attempted Surgery|Overall Study||42
11199638|NCT01821729|12389658|FG000|COMPLETED|Overall Study||49
11199639|NCT01821729|12389658|FG000|NOT COMPLETED|Overall Study||1
11199640|NCT01821807|12389664|FG000|STARTED|Overall Study||150
11199641|NCT01821807|12389665|FG001|STARTED|Overall Study||110
11199642|NCT01821807|12389664|FG000|COMPLETED|Overall Study||147
11199643|NCT01821807|12389665|FG001|COMPLETED|Overall Study||109
11199644|NCT01821807|12389664|FG000|NOT COMPLETED|Overall Study||3
11199645|NCT01821807|12389665|FG001|NOT COMPLETED|Overall Study||1
11199646|NCT01821937|12389673|FG000|STARTED|Overall Study||10
11199647|NCT01821937|12389674|FG001|STARTED|Overall Study||15
11199648|NCT01821937|12389673|FG000|COMPLETED|Overall Study||10
11199649|NCT01821937|12389674|FG001|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
11199650|NCT01821937|12389673|FG000|NOT COMPLETED|Overall Study||0
11199651|NCT01821937|12389674|FG001|NOT COMPLETED|Overall Study||3
11199652|NCT01822119|12389682|FG000|STARTED|Overall Study||27
11199653|NCT01822119|12389682|FG000|COMPLETED|Overall Study||27
11199654|NCT01822119|12389682|FG000|NOT COMPLETED|Overall Study||0
11199655|NCT01822132|12389688|FG000|STARTED|Overall Study||25
11199656|NCT01822132|12389689|FG001|STARTED|Overall Study||27
11199657|NCT01822132|12389688|FG000|COMPLETED|Overall Study||21
11199658|NCT01822132|12389689|FG001|COMPLETED|Overall Study||25
11199659|NCT01822132|12389688|FG000|NOT COMPLETED|Overall Study||4
11199660|NCT01822132|12389689|FG001|NOT COMPLETED|Overall Study||2
11199661|NCT01822197|12389701|FG000|STARTED|Overall Study||30
11199662|NCT01822197|12389701|FG000|COMPLETED|Overall Study||30
11199663|NCT01822197|12389701|FG000|NOT COMPLETED|Overall Study||0
11199664|NCT01822223|12389707|FG000|STARTED|Overall Study||10
11199665|NCT01822223|12389708|FG001|STARTED|Overall Study||10
11199666|NCT01822223|12389707|FG000|COMPLETED|Overall Study||10
11199667|NCT01822223|12389708|FG001|COMPLETED|Overall Study||9
11199668|NCT01822223|12389707|FG000|NOT COMPLETED|Overall Study||0
11199669|NCT01822223|12389708|FG001|NOT COMPLETED|Overall Study||1
11199670|NCT01822301|12389716|FG000|STARTED|Overall Study||5
11199671|NCT01822301|12389716|FG000|COMPLETED|Overall Study||5
11199672|NCT01822301|12389716|FG000|NOT COMPLETED|Overall Study||0
11199673|NCT01822353|12389729|FG000|STARTED|Overall Study||10
11199674|NCT01822353|12389730|FG001|STARTED|Overall Study||9
11199675|NCT01822353|12389731|FG002|STARTED|Overall Study||4
11199676|NCT01822353|12389729|FG000|COMPLETED|Overall Study||6
11199677|NCT01822353|12389730|FG001|COMPLETED|Overall Study||4
11199678|NCT01822353|12389731|FG002|COMPLETED|Overall Study||3
11199679|NCT01822353|12389729|FG000|NOT COMPLETED|Overall Study||4
11199680|NCT01822353|12389730|FG001|NOT COMPLETED|Overall Study||5
11199681|NCT01822353|12389731|FG002|NOT COMPLETED|Overall Study||1
11199682|NCT01822366|12389746|FG000|STARTED|Overall Study||320
11199683|NCT01822366|12389747|FG001|STARTED|Overall Study||320
11199684|NCT01822366|12389748|FG002|STARTED|Overall Study||320
11199685|NCT01822366|12389749|FG003|STARTED|Overall Study||320
11199686|NCT01822366|12389746|FG000|COMPLETED|Overall Study||315
11199687|NCT01822366|12389747|FG001|COMPLETED|Overall Study||298
11199688|NCT01822366|12389748|FG002|COMPLETED|Overall Study||315
11199689|NCT01822366|12389749|FG003|COMPLETED|Overall Study||298
11199690|NCT01822366|12389746|FG000|NOT COMPLETED|Overall Study||5
11199691|NCT01822366|12389747|FG001|NOT COMPLETED|Overall Study||22
11199692|NCT01822366|12389748|FG002|NOT COMPLETED|Overall Study||5
11199693|NCT01822366|12389749|FG003|NOT COMPLETED|Overall Study||22
11199694|NCT01822457|12389779|FG000|STARTED|Overall Study||20
11199695|NCT01822457|12389780|FG001|STARTED|Overall Study||17
11199696|NCT01822457|12389779|FG000|COMPLETED|Overall Study||16
11199697|NCT01822457|12389780|FG001|COMPLETED|Overall Study||12
11199698|NCT01822457|12389779|FG000|NOT COMPLETED|Overall Study||4
11199699|NCT01822457|12389780|FG001|NOT COMPLETED|Overall Study||5
11199700|NCT01822496|12389790|FG000|STARTED|Overall Study||16
11199701|NCT01822496|12389791|FG001|STARTED|Overall Study||23
11199702|NCT01822496|12389792|FG002|STARTED|Overall Study||9
11199703|NCT01822496|12389793|FG003|STARTED|Overall Study||11
11199704|NCT01822496|12389790|FG000|Eligible|Overall Study||14
11199705|NCT01822496|12389791|FG001|Eligible|Overall Study||21
11199706|NCT01822496|12389792|FG002|Eligible|Overall Study||9
11199707|NCT01822496|12389793|FG003|Eligible|Overall Study||7
11199708|NCT01822496|12389790|FG000|Eligible With Disease Assessment|Overall Study||10
11199709|NCT01822496|12389791|FG001|Eligible With Disease Assessment|Overall Study||15
11199710|NCT01822496|12389792|FG002|Eligible With Disease Assessment|Overall Study||6
11199711|NCT01822496|12389793|FG003|Eligible With Disease Assessment|Overall Study||4
11199712|NCT01822496|12389790|FG000|Eligible and Started Study Treatment|Overall Study||14
11199713|NCT01822496|12389791|FG001|Eligible and Started Study Treatment|Overall Study||20
11199714|NCT01822496|12389792|FG002|Eligible and Started Study Treatment|Overall Study||9
11199715|NCT01822496|12389793|FG003|Eligible and Started Study Treatment|Overall Study||7
11199716|NCT01822496|12389790|FG000|COMPLETED|Overall Study||14
11199717|NCT01822496|12389791|FG001|COMPLETED|Overall Study||21
11199718|NCT01822496|12389792|FG002|COMPLETED|Overall Study||9
11199719|NCT01822496|12389793|FG003|COMPLETED|Overall Study||7
11199720|NCT01822496|12389790|FG000|NOT COMPLETED|Overall Study||2
11199721|NCT01822496|12389791|FG001|NOT COMPLETED|Overall Study||2
11199722|NCT01822496|12389792|FG002|NOT COMPLETED|Overall Study||0
11199723|NCT01822496|12389793|FG003|NOT COMPLETED|Overall Study||4
11199724|NCT01822535|12389805|FG000|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
11199725|NCT01822535|12389806|FG001|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
11199726|NCT01822535|12389805|FG000|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
11199727|NCT01822535|12389806|FG001|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
11199728|NCT01822535|12389805|FG000|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
11199729|NCT01822535|12389806|FG001|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
11199730|NCT01822535|12389805|FG000|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
11199731|NCT01822535|12389806|FG001|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
11199732|NCT01822535|12389805|FG000|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
11199733|NCT01822535|12389806|FG001|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
11199734|NCT01822535|12389805|FG000|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
11199735|NCT01822535|12389806|FG001|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
11199736|NCT01822548|12389817|FG000|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
11199737|NCT01822548|12389818|FG001|STARTED|Overall Study||24
11199738|NCT01822548|12389817|FG000|Discontinued Intervention|Overall Study||0
11199739|NCT01822548|12389818|FG001|Discontinued Intervention|Overall Study||5
11199740|NCT01822548|12389817|FG000|COMPLETED|Overall Study||40
11199741|NCT01822548|12389818|FG001|COMPLETED|Overall Study||24
11199742|NCT01822548|12389817|FG000|NOT COMPLETED|Overall Study||0
11199743|NCT01822548|12389818|FG001|NOT COMPLETED|Overall Study||0
11199744|NCT01822561|12389824|FG000|STARTED|Overall Study||15
11199745|NCT01822561|12389824|FG000|COMPLETED|Overall Study||13
11199746|NCT01822561|12389824|FG000|NOT COMPLETED|Overall Study||2
11199747|NCT01822574|12389835|FG000|STARTED|Overall Study||30
11199748|NCT01822574|12389836|FG001|STARTED|Overall Study||30
11199749|NCT01822574|12389837|FG002|STARTED|Overall Study||30
11199750|NCT01822574|12389835|FG000|COMPLETED|Overall Study||30
11199751|NCT01822574|12389836|FG001|COMPLETED|Overall Study||30
11199752|NCT01822574|12389837|FG002|COMPLETED|Overall Study||30
11199753|NCT01822574|12389835|FG000|NOT COMPLETED|Overall Study||0
11199754|NCT01822574|12389836|FG001|NOT COMPLETED|Overall Study||0
11199755|NCT01822574|12389837|FG002|NOT COMPLETED|Overall Study||0
11199756|NCT01822587|12389848|FG000|STARTED|Overall Study||59
11199757|NCT01822587|12389849|FG001|STARTED|Overall Study||60
11199758|NCT01822587|12389850|FG002|STARTED|Overall Study||62
11199759|NCT01822587|12389848|FG000|COMPLETED|Overall Study||43
11199760|NCT01822587|12389849|FG001|COMPLETED|Overall Study||45
11199761|NCT01822587|12389850|FG002|COMPLETED|Overall Study||44
11199762|NCT01822587|12389848|FG000|NOT COMPLETED|Overall Study||16
11199763|NCT01822587|12389849|FG001|NOT COMPLETED|Overall Study||15
11199764|NCT01822587|12389850|FG002|NOT COMPLETED|Overall Study||18
11199765|NCT01822665|12389858|FG000|STARTED|Overall Study||28
11199766|NCT01822665|12389858|FG000|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
11199767|NCT01822665|12389858|FG000|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
11199768|NCT01822665|12389858|FG000|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
11199769|NCT01822665|12389858|FG000|Received Paracetamol Tablet (1000 mg)|Overall Study||28
11199770|NCT01822665|12389858|FG000|COMPLETED|Overall Study||20
11199771|NCT01822665|12389858|FG000|NOT COMPLETED|Overall Study||8
11199772|NCT01822678|12389879|FG000|STARTED|Overall Study||57
11199773|NCT01822678|12389880|FG001|STARTED|Overall Study||64
11199774|NCT01822678|12389881|FG002|STARTED|Overall Study||40
11199775|NCT01822678|12389879|FG000|Treated|Overall Study||57
11199776|NCT01822678|12389880|FG001|Treated|Overall Study||64
11199777|NCT01822678|12389881|FG002|Treated|Overall Study||40
11199778|NCT01822678|12389879|FG000|Safety Population|Overall Study||57
11199779|NCT01822678|12389880|FG001|Safety Population|Overall Study||64
11199780|NCT01822678|12389881|FG002|Safety Population|Overall Study||40
11199781|NCT01822678|12389879|FG000|Intention-to-Treat Population (ITT)|Overall Study||57
11199782|NCT01822678|12389880|FG001|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
11199783|NCT01822678|12389881|FG002|Intention-to-Treat Population (ITT)|Overall Study||40
11199784|NCT01822678|12389879|FG000|Per Protocol Population|Overall Study||45
11199785|NCT01822678|12389880|FG001|Per Protocol Population|Overall Study||52
11199786|NCT01822678|12389881|FG002|Per Protocol Population|Overall Study||34
11199787|NCT01822678|12389879|FG000|COMPLETED|Overall Study||45
11199788|NCT01822678|12389880|FG001|COMPLETED|Overall Study||49
11199789|NCT01822678|12389881|FG002|COMPLETED|Overall Study||29
11199790|NCT01822678|12389879|FG000|NOT COMPLETED|Overall Study||12
11199791|NCT01822678|12389880|FG001|NOT COMPLETED|Overall Study||15
11199792|NCT01822678|12389881|FG002|NOT COMPLETED|Overall Study||11
11199793|NCT01822691|12389889|FG000|STARTED|Overall Study||15
11199794|NCT01822691|12389889|FG000|COMPLETED|Overall Study||13
11199795|NCT01822691|12389889|FG000|NOT COMPLETED|Overall Study||2
11199796|NCT01822756|12389898|FG000|STARTED|Overall Study||16
11199797|NCT01822756|12389899|FG001|STARTED|Overall Study||4
11199798|NCT01822756|12389900|FG002|STARTED|Overall Study||10
11199799|NCT01822756|12389901|FG003|STARTED|Overall Study||4
11199800|NCT01822756|12389902|FG004|STARTED|Overall Study||8
11199801|NCT01822756|12389898|FG000|Discontinued From the Study|Overall Study||16
11199802|NCT01822756|12389899|FG001|Discontinued From the Study|Overall Study||4
11199803|NCT01822756|12389900|FG002|Discontinued From the Study|Overall Study||10
11199804|NCT01822756|12389901|FG003|Discontinued From the Study|Overall Study||4
11199805|NCT01822756|12389902|FG004|Discontinued From the Study|Overall Study||7
11199806|NCT01822756|12389898|FG000|COMPLETED|Overall Study||0
11199807|NCT01822756|12389899|FG001|COMPLETED|Overall Study||0
11199808|NCT01822756|12389900|FG002|COMPLETED|Overall Study||0
11199809|NCT01822756|12389901|FG003|COMPLETED|Overall Study||0
11199810|NCT01822756|12389902|FG004|COMPLETED|Overall Study||1
11199811|NCT01822756|12389898|FG000|NOT COMPLETED|Overall Study||16
11199812|NCT01822756|12389899|FG001|NOT COMPLETED|Overall Study||4
11199813|NCT01822756|12389900|FG002|NOT COMPLETED|Overall Study||10
11199814|NCT01822756|12389901|FG003|NOT COMPLETED|Overall Study||4
11199815|NCT01822756|12389902|FG004|NOT COMPLETED|Overall Study||7
11324827|NCT02748785|12522206|FG001|NOT COMPLETED|Visit 3- Visit 4||1
11324828|NCT02748785|12522207|FG002|NOT COMPLETED|Visit 3- Visit 4||2
11324829|NCT02748785|12522208|FG003|NOT COMPLETED|Visit 3- Visit 4||2
11324830|NCT02748863|12522221|FG000|STARTED|Treatment Period 1||72
11324831|NCT02748863|12522222|FG001|STARTED|Treatment Period 1||71
11324832|NCT02748863|12522223|FG002|STARTED|Treatment Period 1||71
11324833|NCT02748863|12522224|FG003|STARTED|Treatment Period 1|Not applicable for this period|0
11324834|NCT02748863|12522225|FG004|STARTED|Treatment Period 1|Not applicable for this period|0
11324835|NCT02748863|12522221|FG000|COMPLETED|Treatment Period 1||72
11324836|NCT02748863|12522222|FG001|COMPLETED|Treatment Period 1||69
11324837|NCT02748863|12522223|FG002|COMPLETED|Treatment Period 1||69
11324838|NCT02748863|12522224|FG003|COMPLETED|Treatment Period 1||0
11324839|NCT02748863|12522225|FG004|COMPLETED|Treatment Period 1||0
11324840|NCT02748863|12522221|FG000|NOT COMPLETED|Treatment Period 1||0
11324841|NCT02748863|12522222|FG001|NOT COMPLETED|Treatment Period 1||2
11324842|NCT02748863|12522223|FG002|NOT COMPLETED|Treatment Period 1||2
11324843|NCT02748863|12522224|FG003|NOT COMPLETED|Treatment Period 1||0
11324844|NCT02748863|12522225|FG004|NOT COMPLETED|Treatment Period 1||0
11324845|NCT02748863|12522221|FG000|STARTED|Treatment Period 2||72
11324846|NCT02748863|12522222|FG001|STARTED|Treatment Period 2||69
11324847|NCT02748863|12522223|FG002|STARTED|Treatment Period 2||0
11324848|NCT02748863|12522224|FG003|STARTED|Treatment Period 2||34
11324849|NCT02748863|12522225|FG004|STARTED|Treatment Period 2||34
11324850|NCT02748863|12522221|FG000|COMPLETED|Treatment Period 2||67
11324851|NCT02748863|12522222|FG001|COMPLETED|Treatment Period 2||66
11324852|NCT02748863|12522223|FG002|COMPLETED|Treatment Period 2||0
11324853|NCT02748863|12522224|FG003|COMPLETED|Treatment Period 2||32
11324854|NCT02748863|12522225|FG004|COMPLETED|Treatment Period 2||33
11324855|NCT02748863|12522221|FG000|NOT COMPLETED|Treatment Period 2||5
11324856|NCT02748863|12522222|FG001|NOT COMPLETED|Treatment Period 2||3
11324857|NCT02748863|12522223|FG002|NOT COMPLETED|Treatment Period 2||0
11324858|NCT02748863|12522224|FG003|NOT COMPLETED|Treatment Period 2||2
11324859|NCT02748863|12522225|FG004|NOT COMPLETED|Treatment Period 2||1
11324860|NCT02748889|12522242|FG000|STARTED|Overall Study||0
11324861|NCT02748889|12522243|FG001|STARTED|Overall Study||1
11324862|NCT02748889|12522242|FG000|COMPLETED|Overall Study||0
11324863|NCT02748889|12522243|FG001|COMPLETED|Overall Study||1
11324864|NCT02748889|12522242|FG000|NOT COMPLETED|Overall Study||0
11324865|NCT02748889|12522243|FG001|NOT COMPLETED|Overall Study||0
11324866|NCT02748928|12522247|FG000|STARTED|Overall Study||62
11324867|NCT02748928|12522247|FG000|COMPLETED|Overall Study||62
11324868|NCT02748928|12522247|FG000|NOT COMPLETED|Overall Study||0
11324869|NCT02749201|12522252|FG000|STARTED|Overall Study||10
11324870|NCT02749201|12522252|FG000|COMPLETED|Overall Study||10
11324871|NCT02749201|12522252|FG000|NOT COMPLETED|Overall Study||0
11324872|NCT02749370|12522256|FG000|STARTED|Overall Study||80
11324873|NCT02749370|12522256|FG000|COMPLETED|Overall Study||66
11324874|NCT02749370|12522256|FG000|NOT COMPLETED|Overall Study||14
11324875|NCT02749721|12522260|FG000|STARTED|Screening||31
11324876|NCT02749721|12522260|FG000|COMPLETED|Screening||25
11324877|NCT02749721|12522260|FG000|NOT COMPLETED|Screening||6
11324878|NCT02749721|12522260|FG000|STARTED|8-week Open-Label Treatment Phase||25
11324879|NCT02749721|12522260|FG000|COMPLETED|8-week Open-Label Treatment Phase||22
11324880|NCT02749721|12522260|FG000|NOT COMPLETED|8-week Open-Label Treatment Phase||3
11324881|NCT02749799|12522266|FG000|STARTED|Overall Study||45
11324882|NCT02749799|12522266|FG000|COMPLETED|Overall Study||37
11324883|NCT02749799|12522266|FG000|NOT COMPLETED|Overall Study||8
11324884|NCT02749903|12522270|FG000|STARTED|Overall Study||46
11324885|NCT02749903|12522270|FG000|COMPLETED|Overall Study||46
11324886|NCT02749903|12522270|FG000|NOT COMPLETED|Overall Study||0
11324887|NCT02750267|12522276|FG000|STARTED|Overall Study||6
11324888|NCT02750267|12522277|FG001|STARTED|Overall Study||6
11324889|NCT02750267|12522276|FG000|COMPLETED|Overall Study||6
11324890|NCT02750267|12522277|FG001|COMPLETED|Overall Study||6
11324891|NCT02750267|12522276|FG000|NOT COMPLETED|Overall Study||0
11324892|NCT02750267|12522277|FG001|NOT COMPLETED|Overall Study||0
11199816|NCT01822821|12389916|FG000|STARTED|Overall Study||75
11199817|NCT01822821|12389917|FG001|STARTED|Overall Study||75
11199818|NCT01822821|12389916|FG000|COMPLETED|Overall Study||73
11199819|NCT01822821|12389917|FG001|COMPLETED|Overall Study||74
11199820|NCT01822821|12389916|FG000|NOT COMPLETED|Overall Study||2
11199821|NCT01822821|12389917|FG001|NOT COMPLETED|Overall Study||1
11199822|NCT01822886|12389923|FG000|STARTED|Overall Study||20
11199823|NCT01822886|12389923|FG000|COMPLETED|Overall Study||5
11199824|NCT01822886|12389923|FG000|NOT COMPLETED|Overall Study||15
11199825|NCT01822899|12389929|FG000|STARTED|Overall Study||358
11199826|NCT01822899|12389930|FG001|STARTED|Overall Study||358
11199827|NCT01822899|12389929|FG000|COMPLETED|Overall Study||334
11199828|NCT01822899|12389930|FG001|COMPLETED|Overall Study||340
11199829|NCT01822899|12389929|FG000|NOT COMPLETED|Overall Study||24
11199830|NCT01822899|12389930|FG001|NOT COMPLETED|Overall Study||18
11199831|NCT01822925|12389940|FG000|STARTED|Overall Study||32
11199832|NCT01822925|12389941|FG001|STARTED|Overall Study||32
11199833|NCT01822925|12389942|FG002|STARTED|Overall Study||32
11199834|NCT01822925|12389943|FG003|STARTED|Overall Study||32
11199835|NCT01822925|12389940|FG000|COMPLETED|Overall Study||26
11199836|NCT01822925|12389941|FG001|COMPLETED|Overall Study||30
11199837|NCT01822925|12389942|FG002|COMPLETED|Overall Study||29
11199838|NCT01822925|12389943|FG003|COMPLETED|Overall Study||27
11199839|NCT01822925|12389940|FG000|NOT COMPLETED|Overall Study||6
11199840|NCT01822925|12389941|FG001|NOT COMPLETED|Overall Study||2
11199841|NCT01822925|12389942|FG002|NOT COMPLETED|Overall Study||3
11199842|NCT01822925|12389943|FG003|NOT COMPLETED|Overall Study||5
11199843|NCT01823107|12389953|FG000|STARTED|Overall Study||25
11199844|NCT01823107|12389953|FG000|COMPLETED|Overall Study||24
11199845|NCT01823107|12389953|FG000|NOT COMPLETED|Overall Study||1
11199846|NCT01823146|12389959|FG000|STARTED|Overall Study||55
11199847|NCT01823146|12389960|FG001|STARTED|Overall Study||51
11199848|NCT01823146|12389959|FG000|COMPLETED|Overall Study||53
11199849|NCT01823146|12389960|FG001|COMPLETED|Overall Study||49
11199850|NCT01823146|12389959|FG000|NOT COMPLETED|Overall Study||2
11199851|NCT01823146|12389960|FG001|NOT COMPLETED|Overall Study||2
11199852|NCT01823224|12389968|FG000|STARTED|Overall Study||34
11199853|NCT01823224|12389969|FG001|STARTED|Overall Study||33
11199854|NCT01823224|12389968|FG000|COMPLETED|Overall Study||28
11199855|NCT01823224|12389969|FG001|COMPLETED|Overall Study||22
11199856|NCT01823224|12389968|FG000|NOT COMPLETED|Overall Study||6
11199857|NCT01823224|12389969|FG001|NOT COMPLETED|Overall Study||11
11199858|NCT01823289|12389977|FG000|STARTED|Overall Study||71
11199859|NCT01823289|12389977|FG000|COMPLETED|Overall Study||47
11199860|NCT01823289|12389977|FG000|NOT COMPLETED|Overall Study||24
11199861|NCT01823328|12389983|FG000|STARTED|Overall Study||70
11199862|NCT01823328|12389984|FG001|STARTED|Overall Study||73
11199863|NCT01823328|12389983|FG000|COMPLETED|Overall Study||62
11199864|NCT01823328|12389984|FG001|COMPLETED|Overall Study||67
11199865|NCT01823328|12389983|FG000|NOT COMPLETED|Overall Study||8
11199866|NCT01823328|12389984|FG001|NOT COMPLETED|Overall Study||6
11199867|NCT01823341|12389990|FG000|STARTED|Overall Study||97
11199868|NCT01823341|12389990|FG000|COMPLETED|Overall Study||82
11199869|NCT01823341|12389990|FG000|NOT COMPLETED|Overall Study||15
11199870|NCT01823497|12389999|FG000|STARTED|Overall Study||19
11199871|NCT01823497|12390000|FG001|STARTED|Overall Study||17
11199872|NCT01823497|12389999|FG000|COMPLETED|Overall Study||16
11199873|NCT01823497|12390000|FG001|COMPLETED|Overall Study||9
11199874|NCT01823497|12389999|FG000|NOT COMPLETED|Overall Study||3
11199875|NCT01823497|12390000|FG001|NOT COMPLETED|Overall Study||8
11199876|NCT01823510|12390006|FG000|STARTED|Days 1-7||10
11199877|NCT01823510|12390007|FG001|STARTED|Days 1-7||10
11199878|NCT01823510|12390006|FG000|COMPLETED|Days 1-7||10
11199879|NCT01823510|12390007|FG001|COMPLETED|Days 1-7||10
11199880|NCT01823510|12390006|FG000|NOT COMPLETED|Days 1-7||0
11199881|NCT01823510|12390007|FG001|NOT COMPLETED|Days 1-7||0
11199882|NCT01823510|12390006|FG000|STARTED|Days 8-21||10
11199883|NCT01823510|12390007|FG001|STARTED|Days 8-21||10
11199884|NCT01823510|12390006|FG000|COMPLETED|Days 8-21||10
11199885|NCT01823510|12390007|FG001|COMPLETED|Days 8-21||10
11199886|NCT01823510|12390006|FG000|NOT COMPLETED|Days 8-21||0
11199887|NCT01823510|12390007|FG001|NOT COMPLETED|Days 8-21||0
11199888|NCT01823510|12390006|FG000|STARTED|Days 22-28||10
11199889|NCT01823510|12390007|FG001|STARTED|Days 22-28||10
11199890|NCT01823510|12390006|FG000|COMPLETED|Days 22-28||10
11199891|NCT01823510|12390007|FG001|COMPLETED|Days 22-28||10
11199892|NCT01823510|12390006|FG000|NOT COMPLETED|Days 22-28||0
11199893|NCT01823510|12390007|FG001|NOT COMPLETED|Days 22-28||0
11199894|NCT01823536|12390019|FG000|STARTED|Overall Study||73
11199895|NCT01823536|12390020|FG001|STARTED|Overall Study||103
11199896|NCT01823536|12390021|FG002|STARTED|Overall Study||120
11199897|NCT01823536|12390022|FG003|STARTED|Overall Study||66
11199898|NCT01823536|12390023|FG004|STARTED|Overall Study||101
11199899|NCT01823536|12390024|FG005|STARTED|Overall Study||2
11199900|NCT01823536|12390019|FG000|COMPLETED|Overall Study||71
11199901|NCT01823536|12390020|FG001|COMPLETED|Overall Study||101
11199902|NCT01823536|12390021|FG002|COMPLETED|Overall Study||119
11199903|NCT01823536|12390022|FG003|COMPLETED|Overall Study||64
11199904|NCT01823536|12390023|FG004|COMPLETED|Overall Study||99
11199905|NCT01823536|12390024|FG005|COMPLETED|Overall Study||2
11199906|NCT01823536|12390019|FG000|NOT COMPLETED|Overall Study||2
11199907|NCT01823536|12390020|FG001|NOT COMPLETED|Overall Study||2
11199908|NCT01823536|12390021|FG002|NOT COMPLETED|Overall Study||1
11199909|NCT01823536|12390022|FG003|NOT COMPLETED|Overall Study||2
11199910|NCT01823536|12390023|FG004|NOT COMPLETED|Overall Study||2
11199911|NCT01823536|12390024|FG005|NOT COMPLETED|Overall Study||0
11199912|NCT01823614|12390043|FG000|STARTED|Overall Study||179
11199913|NCT01823614|12390044|FG001|STARTED|Overall Study||140
11199914|NCT01823614|12390045|FG002|STARTED|Overall Study||176
11199915|NCT01823614|12390046|FG003|STARTED|Overall Study||122
11199916|NCT01823614|12390047|FG004|STARTED|Overall Study||172
11199917|NCT01823614|12390048|FG005|STARTED|Overall Study||154
11199918|NCT01823614|12390043|FG000|COMPLETED|Overall Study||179
11199919|NCT01823614|12390044|FG001|COMPLETED|Overall Study||140
11199920|NCT01823614|12390045|FG002|COMPLETED|Overall Study||176
11199921|NCT01823614|12390046|FG003|COMPLETED|Overall Study||122
11199922|NCT01823614|12390047|FG004|COMPLETED|Overall Study||172
11199923|NCT01823614|12390048|FG005|COMPLETED|Overall Study||154
11199924|NCT01823614|12390043|FG000|NOT COMPLETED|Overall Study||0
11199925|NCT01823614|12390044|FG001|NOT COMPLETED|Overall Study||0
11199926|NCT01823614|12390045|FG002|NOT COMPLETED|Overall Study||0
11199927|NCT01823614|12390046|FG003|NOT COMPLETED|Overall Study||0
11199928|NCT01823614|12390047|FG004|NOT COMPLETED|Overall Study||0
11199929|NCT01823614|12390048|FG005|NOT COMPLETED|Overall Study||0
11199930|NCT01823653|12390068|FG000|STARTED|Overall Study||60
11199931|NCT01823653|12390068|FG000|COMPLETED|Overall Study||60
11199932|NCT01823653|12390068|FG000|NOT COMPLETED|Overall Study||0
11199933|NCT01823679|12390075|FG000|STARTED|Overall Study||2
11199934|NCT01823679|12390075|FG000|COMPLETED|Overall Study||1
11199935|NCT01823679|12390075|FG000|NOT COMPLETED|Overall Study||1
11199936|NCT01823835|12390095|FG000|STARTED|Overall Study||3
11199937|NCT01823835|12390096|FG001|STARTED|Overall Study||4
11199938|NCT01823835|12390097|FG002|STARTED|Overall Study||4
11199939|NCT01823835|12390098|FG003|STARTED|Overall Study||6
11199940|NCT01823835|12390099|FG004|STARTED|Overall Study||6
11199941|NCT01823835|12390100|FG005|STARTED|Overall Study||6
11199942|NCT01823835|12390101|FG006|STARTED|Overall Study||6
11199943|NCT01823835|12390102|FG007|STARTED|Overall Study||3
11199944|NCT01823835|12390103|FG008|STARTED|Overall Study||3
11199945|NCT01823835|12390104|FG009|STARTED|Overall Study||19
11199946|NCT01823835|12390105|FG010|STARTED|Overall Study||10
11199947|NCT01823835|12390106|FG011|STARTED|Overall Study||53
11199948|NCT01823835|12390107|FG012|STARTED|Overall Study||19
11199949|NCT01823835|12390108|FG013|STARTED|Overall Study||4
11199950|NCT01823835|12390109|FG014|STARTED|Overall Study||6
11199951|NCT01823835|12390095|FG000|COMPLETED|Overall Study||0
11199952|NCT01823835|12390096|FG001|COMPLETED|Overall Study||0
11199953|NCT01823835|12390097|FG002|COMPLETED|Overall Study||0
11199954|NCT01823835|12390098|FG003|COMPLETED|Overall Study||0
11199955|NCT01823835|12390099|FG004|COMPLETED|Overall Study||0
11199956|NCT01823835|12390100|FG005|COMPLETED|Overall Study||0
11199957|NCT01823835|12390101|FG006|COMPLETED|Overall Study||0
11199958|NCT01823835|12390102|FG007|COMPLETED|Overall Study||0
11199959|NCT01823835|12390103|FG008|COMPLETED|Overall Study||0
11199960|NCT01823835|12390104|FG009|COMPLETED|Overall Study||0
11199961|NCT01823835|12390105|FG010|COMPLETED|Overall Study||0
11199962|NCT01823835|12390106|FG011|COMPLETED|Overall Study||0
11199963|NCT01823835|12390107|FG012|COMPLETED|Overall Study||0
11199964|NCT01823835|12390108|FG013|COMPLETED|Overall Study||0
11199965|NCT01823835|12390109|FG014|COMPLETED|Overall Study||0
11199966|NCT01823835|12390095|FG000|NOT COMPLETED|Overall Study||3
11199967|NCT01823835|12390096|FG001|NOT COMPLETED|Overall Study||4
11199968|NCT01823835|12390097|FG002|NOT COMPLETED|Overall Study||4
11199969|NCT01823835|12390098|FG003|NOT COMPLETED|Overall Study||6
11199970|NCT01823835|12390099|FG004|NOT COMPLETED|Overall Study||6
11199971|NCT01823835|12390100|FG005|NOT COMPLETED|Overall Study||6
11199972|NCT01823835|12390101|FG006|NOT COMPLETED|Overall Study||6
11199973|NCT01823835|12390102|FG007|NOT COMPLETED|Overall Study||3
11199974|NCT01823835|12390103|FG008|NOT COMPLETED|Overall Study||3
11199975|NCT01823835|12390104|FG009|NOT COMPLETED|Overall Study||19
11199976|NCT01823835|12390105|FG010|NOT COMPLETED|Overall Study||10
11199977|NCT01823835|12390106|FG011|NOT COMPLETED|Overall Study||53
11199978|NCT01823835|12390107|FG012|NOT COMPLETED|Overall Study||19
11199979|NCT01823835|12390108|FG013|NOT COMPLETED|Overall Study||4
11199980|NCT01823835|12390109|FG014|NOT COMPLETED|Overall Study||6
11199981|NCT01823861|12390151|FG000|STARTED|4 Month Follow up||249
11199982|NCT01823861|12390152|FG001|STARTED|4 Month Follow up||251
11199983|NCT01823861|12390151|FG000|COMPLETED|4 Month Follow up||211
11199984|NCT01823861|12390152|FG001|COMPLETED|4 Month Follow up||220
11199985|NCT01823861|12390151|FG000|NOT COMPLETED|4 Month Follow up||38
11199986|NCT01823861|12390152|FG001|NOT COMPLETED|4 Month Follow up||31
11199987|NCT01823861|12390151|FG000|STARTED|12 Month Follow up||211
11199988|NCT01823861|12390152|FG001|STARTED|12 Month Follow up||220
11199989|NCT01823861|12390151|FG000|COMPLETED|12 Month Follow up||169
11199990|NCT01823861|12390152|FG001|COMPLETED|12 Month Follow up||159
11199991|NCT01823861|12390151|FG000|NOT COMPLETED|12 Month Follow up||42
11199992|NCT01823861|12390152|FG001|NOT COMPLETED|12 Month Follow up||61
11199993|NCT01823991|12390160|FG000|STARTED|Overall Study||18
11199994|NCT01823991|12390161|FG001|STARTED|Overall Study||18
11199995|NCT01823991|12390160|FG000|COMPLETED|Overall Study||10
11199996|NCT01823991|12390161|FG001|COMPLETED|Overall Study||13
11199997|NCT01823991|12390160|FG000|NOT COMPLETED|Overall Study||8
11199998|NCT01823991|12390161|FG001|NOT COMPLETED|Overall Study||5
11199999|NCT01824082|12390173|FG000|STARTED|Initial Treatment||71
11200000|NCT01824082|12390174|FG001|STARTED|Initial Treatment||73
11200001|NCT01824082|12390173|FG000|COMPLETED|Initial Treatment||71
11200002|NCT01824082|12390174|FG001|COMPLETED|Initial Treatment||73
11200003|NCT01824082|12390173|FG000|NOT COMPLETED|Initial Treatment||0
11200004|NCT01824082|12390174|FG001|NOT COMPLETED|Initial Treatment||0
11200005|NCT01824082|12390173|FG000|STARTED|Optional Crossover Treatment||40
11200006|NCT01824082|12390174|FG001|STARTED|Optional Crossover Treatment||25
11200007|NCT01824082|12390173|FG000|COMPLETED|Optional Crossover Treatment||40
11200008|NCT01824082|12390174|FG001|COMPLETED|Optional Crossover Treatment||25
11200009|NCT01824082|12390173|FG000|NOT COMPLETED|Optional Crossover Treatment||0
11200010|NCT01824082|12390174|FG001|NOT COMPLETED|Optional Crossover Treatment||0
11200011|NCT01824160|12390184|FG000|STARTED|Overall Study||50
11200012|NCT01824160|12390184|FG000|COMPLETED|Overall Study||50
11200013|NCT01824160|12390184|FG000|NOT COMPLETED|Overall Study||0
11200014|NCT01824290|12390190|FG000|STARTED|Period 1: Double Blind||18
11200015|NCT01824290|12390191|FG001|STARTED|Period 1: Double Blind||17
11200016|NCT01824290|12390192|FG002|STARTED|Period 1: Double Blind||0
11200017|NCT01824290|12390193|FG003|STARTED|Period 1: Double Blind||0
11200018|NCT01824290|12390190|FG000|Received at Least One Dose of Study Drug|Period 1: Double Blind||18
11200019|NCT01824290|12390191|FG001|Received at Least One Dose of Study Drug|Period 1: Double Blind||17
11200020|NCT01824290|12390192|FG002|Received at Least One Dose of Study Drug|Period 1: Double Blind||0
11200021|NCT01824290|12390193|FG003|Received at Least One Dose of Study Drug|Period 1: Double Blind||0
11200022|NCT01824290|12390190|FG000|Received 20 mg|Period 1: Double Blind||0
11200023|NCT01824290|12390191|FG001|Received 20 mg|Period 1: Double Blind||4
11200024|NCT01824290|12390192|FG002|Received 20 mg|Period 1: Double Blind||0
11200025|NCT01824290|12390193|FG003|Received 20 mg|Period 1: Double Blind||0
11200026|NCT01824290|12390190|FG000|Received 40 mg|Period 1: Double Blind||0
11200027|NCT01824290|12390191|FG001|Received 40 mg|Period 1: Double Blind||13
11200028|NCT01824290|12390192|FG002|Received 40 mg|Period 1: Double Blind||0
11200029|NCT01824290|12390193|FG003|Received 40 mg|Period 1: Double Blind||0
11200030|NCT01824290|12390190|FG000|COMPLETED|Period 1: Double Blind||15
11200031|NCT01824290|12390191|FG001|COMPLETED|Period 1: Double Blind||15
11200032|NCT01824290|12390192|FG002|COMPLETED|Period 1: Double Blind||0
11200033|NCT01824290|12390193|FG003|COMPLETED|Period 1: Double Blind||0
11200034|NCT01824290|12390190|FG000|NOT COMPLETED|Period 1: Double Blind||3
11200035|NCT01824290|12390191|FG001|NOT COMPLETED|Period 1: Double Blind||2
11200036|NCT01824290|12390192|FG002|NOT COMPLETED|Period 1: Double Blind||0
11200037|NCT01824290|12390193|FG003|NOT COMPLETED|Period 1: Double Blind||0
11200038|NCT01824290|12390190|FG000|STARTED|Period 2: Open-Label Treatment||0
11200039|NCT01824290|12390191|FG001|STARTED|Period 2: Open-Label Treatment||0
11200040|NCT01824290|12390192|FG002|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16
11200041|NCT01824290|12390193|FG003|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16
11200042|NCT01824290|12390190|FG000|Received 20 mg|Period 2: Open-Label Treatment||0
11200043|NCT01824290|12390191|FG001|Received 20 mg|Period 2: Open-Label Treatment||0
11200044|NCT01824290|12390192|FG002|Received 20 mg|Period 2: Open-Label Treatment||3
11200045|NCT01824290|12390193|FG003|Received 20 mg|Period 2: Open-Label Treatment||3
11200046|NCT01824290|12390190|FG000|Received 40 mg|Period 2: Open-Label Treatment||0
11200047|NCT01824290|12390191|FG001|Received 40 mg|Period 2: Open-Label Treatment||0
11200048|NCT01824290|12390192|FG002|Received 40 mg|Period 2: Open-Label Treatment||13
11200049|NCT01824290|12390193|FG003|Received 40 mg|Period 2: Open-Label Treatment||13
11200050|NCT01824290|12390190|FG000|COMPLETED|Period 2: Open-Label Treatment||0
11200051|NCT01824290|12390191|FG001|COMPLETED|Period 2: Open-Label Treatment||0
11200052|NCT01824290|12390192|FG002|COMPLETED|Period 2: Open-Label Treatment||13
11200053|NCT01824290|12390193|FG003|COMPLETED|Period 2: Open-Label Treatment||13
11200054|NCT01824290|12390190|FG000|NOT COMPLETED|Period 2: Open-Label Treatment||0
11200055|NCT01824290|12390191|FG001|NOT COMPLETED|Period 2: Open-Label Treatment||0
11200056|NCT01824290|12390192|FG002|NOT COMPLETED|Period 2: Open-Label Treatment||3
11200057|NCT01824290|12390193|FG003|NOT COMPLETED|Period 2: Open-Label Treatment||3
11200058|NCT01824303|12390207|FG000|STARTED|Randomized Study||16
11200059|NCT01824303|12390208|FG001|STARTED|Randomized Study||14
11200060|NCT01824303|12390207|FG000|COMPLETED|Randomized Study||14
11200061|NCT01824303|12390208|FG001|COMPLETED|Randomized Study||13
11200062|NCT01824303|12390207|FG000|NOT COMPLETED|Randomized Study||2
11200063|NCT01824303|12390208|FG001|NOT COMPLETED|Randomized Study||1
11200064|NCT01824303|12390207|FG000|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
11200065|NCT01824303|12390208|FG001|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
11200066|NCT01824303|12390207|FG000|COMPLETED|Open Label Extension||12
11200067|NCT01824303|12390208|FG001|COMPLETED|Open Label Extension||11
11200068|NCT01824303|12390207|FG000|NOT COMPLETED|Open Label Extension||0
11200069|NCT01824303|12390208|FG001|NOT COMPLETED|Open Label Extension||0
11200070|NCT01824342|12390218|FG000|STARTED|Overall Study||11
11200071|NCT01824342|12390219|FG001|STARTED|Overall Study||7
11200072|NCT01824342|12390218|FG000|COMPLETED|Overall Study||2
11200073|NCT01824342|12390219|FG001|COMPLETED|Overall Study||2
11200074|NCT01824342|12390218|FG000|NOT COMPLETED|Overall Study||9
11200075|NCT01824342|12390219|FG001|NOT COMPLETED|Overall Study||5
11200076|NCT01824355|12390225|FG000|STARTED|Overall Study||113
11200077|NCT01824355|12390225|FG000|COMPLETED|Overall Study||110
11200078|NCT01824355|12390225|FG000|NOT COMPLETED|Overall Study||3
11200079|NCT01824394|12390232|FG000|STARTED|Overall Study||174
11200080|NCT01824394|12390233|FG001|STARTED|Overall Study||169
11200081|NCT01824394|12390234|FG002|STARTED|Overall Study||125
11200082|NCT01824394|12390232|FG000|Intent to Treat Population|Overall Study||151
11200083|NCT01824394|12390233|FG001|Intent to Treat Population|Overall Study||149
11200084|NCT01824394|12390234|FG002|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
11200085|NCT01824394|12390232|FG000|Safety Population|Overall Study||151
11200086|NCT01824394|12390233|FG001|Safety Population|Overall Study||149
11200087|NCT01824394|12390234|FG002|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
11200088|NCT01824394|12390232|FG000|Per-Protocol Population|Overall Study||150
11200089|NCT01824394|12390233|FG001|Per-Protocol Population|Overall Study||148
11200090|NCT01824394|12390234|FG002|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
11200091|NCT01824394|12390232|FG000|COMPLETED|Overall Study||55
11200092|NCT01824394|12390233|FG001|COMPLETED|Overall Study||53
11200093|NCT01824394|12390234|FG002|COMPLETED|Overall Study||51
11200094|NCT01824394|12390232|FG000|NOT COMPLETED|Overall Study||119
11200095|NCT01824394|12390233|FG001|NOT COMPLETED|Overall Study||116
11200096|NCT01824394|12390234|FG002|NOT COMPLETED|Overall Study||74
11200097|NCT01824446|12390242|FG000|STARTED|Overall Study||6
11200098|NCT01824446|12390242|FG000|COMPLETED|Overall Study||6
11200099|NCT01824446|12390242|FG000|NOT COMPLETED|Overall Study||0
11200100|NCT01824472|12390249|FG000|STARTED|Overall Study||17
11200101|NCT01824472|12390250|FG001|STARTED|Overall Study||13
11200102|NCT01824472|12390251|FG002|STARTED|Overall Study||15
11200103|NCT01824472|12390249|FG000|COMPLETED|Overall Study||16
11200104|NCT01824472|12390250|FG001|COMPLETED|Overall Study||6
11200105|NCT01824472|12390251|FG002|COMPLETED|Overall Study||11
11200106|NCT01824472|12390249|FG000|NOT COMPLETED|Overall Study||1
11200107|NCT01824472|12390250|FG001|NOT COMPLETED|Overall Study||7
11200108|NCT01824472|12390251|FG002|NOT COMPLETED|Overall Study||4
11200109|NCT01824498|12390265|FG000|STARTED|1st Intervention (8 Weeks)||5
11200110|NCT01824498|12390266|FG001|STARTED|1st Intervention (8 Weeks)||2
11200111|NCT01824498|12390267|FG002|STARTED|1st Intervention (8 Weeks)||6
11200112|NCT01824498|12390268|FG003|STARTED|1st Intervention (8 Weeks)||3
11200113|NCT01824498|12390269|FG004|STARTED|1st Intervention (8 Weeks)||4
11200114|NCT01824498|12390270|FG005|STARTED|1st Intervention (8 Weeks)||4
11200115|NCT01824498|12390265|FG000|COMPLETED|1st Intervention (8 Weeks)||5
11200116|NCT01824498|12390266|FG001|COMPLETED|1st Intervention (8 Weeks)||2
11200117|NCT01824498|12390267|FG002|COMPLETED|1st Intervention (8 Weeks)||6
11200118|NCT01824498|12390268|FG003|COMPLETED|1st Intervention (8 Weeks)||3
11200119|NCT01824498|12390269|FG004|COMPLETED|1st Intervention (8 Weeks)||4
11200120|NCT01824498|12390270|FG005|COMPLETED|1st Intervention (8 Weeks)||4
11200121|NCT01824498|12390265|FG000|NOT COMPLETED|1st Intervention (8 Weeks)||0
11200122|NCT01824498|12390266|FG001|NOT COMPLETED|1st Intervention (8 Weeks)||0
11200123|NCT01824498|12390267|FG002|NOT COMPLETED|1st Intervention (8 Weeks)||0
11200124|NCT01824498|12390268|FG003|NOT COMPLETED|1st Intervention (8 Weeks)||0
11200125|NCT01824498|12390269|FG004|NOT COMPLETED|1st Intervention (8 Weeks)||0
11200126|NCT01824498|12390270|FG005|NOT COMPLETED|1st Intervention (8 Weeks)||0
11200127|NCT01824498|12390265|FG000|STARTED|Washout (8 Weeks)|2 dropped out|5
11200128|NCT01824498|12390266|FG001|STARTED|Washout (8 Weeks)||2
11200129|NCT01824498|12390267|FG002|STARTED|Washout (8 Weeks)|2 dropped out|6
11200130|NCT01824498|12390268|FG003|STARTED|Washout (8 Weeks)|1 dropped out|3
11200131|NCT01824498|12390269|FG004|STARTED|Washout (8 Weeks)|1 dropped out|4
11200132|NCT01824498|12390270|FG005|STARTED|Washout (8 Weeks)||4
11200133|NCT01824498|12390265|FG000|COMPLETED|Washout (8 Weeks)||3
11200134|NCT01824498|12390266|FG001|COMPLETED|Washout (8 Weeks)||2
11200135|NCT01824498|12390267|FG002|COMPLETED|Washout (8 Weeks)||4
11200136|NCT01824498|12390268|FG003|COMPLETED|Washout (8 Weeks)||2
11200137|NCT01824498|12390269|FG004|COMPLETED|Washout (8 Weeks)||3
11200138|NCT01824498|12390270|FG005|COMPLETED|Washout (8 Weeks)||4
11200139|NCT01824498|12390265|FG000|NOT COMPLETED|Washout (8 Weeks)||2
11200140|NCT01824498|12390266|FG001|NOT COMPLETED|Washout (8 Weeks)||0
11200141|NCT01824498|12390267|FG002|NOT COMPLETED|Washout (8 Weeks)||2
11200142|NCT01824498|12390268|FG003|NOT COMPLETED|Washout (8 Weeks)||1
11200143|NCT01824498|12390269|FG004|NOT COMPLETED|Washout (8 Weeks)||1
11200144|NCT01824498|12390270|FG005|NOT COMPLETED|Washout (8 Weeks)||0
11200145|NCT01824498|12390265|FG000|STARTED|2nd Intervention (8 Weeks)||3
11200146|NCT01824498|12390266|FG001|STARTED|2nd Intervention (8 Weeks)||2
11200147|NCT01824498|12390267|FG002|STARTED|2nd Intervention (8 Weeks)||4
11200148|NCT01824498|12390268|FG003|STARTED|2nd Intervention (8 Weeks)||2
11200149|NCT01824498|12390269|FG004|STARTED|2nd Intervention (8 Weeks)||3
11200150|NCT01824498|12390270|FG005|STARTED|2nd Intervention (8 Weeks)||4
11200151|NCT01824498|12390265|FG000|COMPLETED|2nd Intervention (8 Weeks)||3
11200152|NCT01824498|12390266|FG001|COMPLETED|2nd Intervention (8 Weeks)||2
11200153|NCT01824498|12390267|FG002|COMPLETED|2nd Intervention (8 Weeks)||4
11200154|NCT01824498|12390268|FG003|COMPLETED|2nd Intervention (8 Weeks)||2
11200155|NCT01824498|12390269|FG004|COMPLETED|2nd Intervention (8 Weeks)||3
11200156|NCT01824498|12390270|FG005|COMPLETED|2nd Intervention (8 Weeks)||4
11200157|NCT01824498|12390265|FG000|NOT COMPLETED|2nd Intervention (8 Weeks)||0
11200158|NCT01824498|12390266|FG001|NOT COMPLETED|2nd Intervention (8 Weeks)||0
11200159|NCT01824498|12390267|FG002|NOT COMPLETED|2nd Intervention (8 Weeks)||0
11200160|NCT01824498|12390268|FG003|NOT COMPLETED|2nd Intervention (8 Weeks)||0
11200161|NCT01824498|12390269|FG004|NOT COMPLETED|2nd Intervention (8 Weeks)||0
11200162|NCT01824498|12390270|FG005|NOT COMPLETED|2nd Intervention (8 Weeks)||0
11200163|NCT01824498|12390265|FG000|STARTED|Washout (8 Weeks)||3
11200164|NCT01824498|12390266|FG001|STARTED|Washout (8 Weeks)||2
11200165|NCT01824498|12390267|FG002|STARTED|Washout (8 Weeks)||4
11200166|NCT01824498|12390268|FG003|STARTED|Washout (8 Weeks)||2
11200167|NCT01824498|12390269|FG004|STARTED|Washout (8 Weeks)||3
11200168|NCT01824498|12390270|FG005|STARTED|Washout (8 Weeks)||4
11200169|NCT01824498|12390265|FG000|COMPLETED|Washout (8 Weeks)||3
11200170|NCT01824498|12390266|FG001|COMPLETED|Washout (8 Weeks)||2
11200171|NCT01824498|12390267|FG002|COMPLETED|Washout (8 Weeks)||4
11200172|NCT01824498|12390268|FG003|COMPLETED|Washout (8 Weeks)||2
11200173|NCT01824498|12390269|FG004|COMPLETED|Washout (8 Weeks)||3
11200174|NCT01824498|12390270|FG005|COMPLETED|Washout (8 Weeks)||4
11200175|NCT01824498|12390265|FG000|NOT COMPLETED|Washout (8 Weeks)||0
11200176|NCT01824498|12390266|FG001|NOT COMPLETED|Washout (8 Weeks)||0
11200177|NCT01824498|12390267|FG002|NOT COMPLETED|Washout (8 Weeks)||0
11200178|NCT01824498|12390268|FG003|NOT COMPLETED|Washout (8 Weeks)||0
11200179|NCT01824498|12390269|FG004|NOT COMPLETED|Washout (8 Weeks)||0
11200180|NCT01824498|12390270|FG005|NOT COMPLETED|Washout (8 Weeks)||0
11200181|NCT01824498|12390265|FG000|STARTED|3rd Intervention (8 Weeks)||3
11200182|NCT01824498|12390266|FG001|STARTED|3rd Intervention (8 Weeks)||2
11200183|NCT01824498|12390267|FG002|STARTED|3rd Intervention (8 Weeks)||4
11200184|NCT01824498|12390268|FG003|STARTED|3rd Intervention (8 Weeks)||2
11200185|NCT01824498|12390269|FG004|STARTED|3rd Intervention (8 Weeks)||3
11200186|NCT01824498|12390270|FG005|STARTED|3rd Intervention (8 Weeks)||4
11200187|NCT01824498|12390265|FG000|COMPLETED|3rd Intervention (8 Weeks)||3
11200188|NCT01824498|12390266|FG001|COMPLETED|3rd Intervention (8 Weeks)||2
11200189|NCT01824498|12390267|FG002|COMPLETED|3rd Intervention (8 Weeks)||4
11200190|NCT01824498|12390268|FG003|COMPLETED|3rd Intervention (8 Weeks)||2
11200191|NCT01824498|12390269|FG004|COMPLETED|3rd Intervention (8 Weeks)||3
11200192|NCT01824498|12390270|FG005|COMPLETED|3rd Intervention (8 Weeks)||4
11200193|NCT01824498|12390265|FG000|NOT COMPLETED|3rd Intervention (8 Weeks)||0
11200194|NCT01824498|12390266|FG001|NOT COMPLETED|3rd Intervention (8 Weeks)||0
11200195|NCT01824498|12390267|FG002|NOT COMPLETED|3rd Intervention (8 Weeks)||0
11200196|NCT01824498|12390268|FG003|NOT COMPLETED|3rd Intervention (8 Weeks)||0
11200197|NCT01824498|12390269|FG004|NOT COMPLETED|3rd Intervention (8 Weeks)||0
11200198|NCT01824498|12390270|FG005|NOT COMPLETED|3rd Intervention (8 Weeks)||0
11200199|NCT01824576|12390278|FG000|STARTED|Overall Study||9
11200200|NCT01824576|12390278|FG000|COMPLETED|Overall Study||7
11200201|NCT01824576|12390278|FG000|NOT COMPLETED|Overall Study||2
11200202|NCT01824589|12390286|FG000|STARTED|Overall Study||1
11200203|NCT01824589|12390287|FG001|STARTED|Overall Study||0
11200204|NCT01824589|12390288|FG002|STARTED|Overall Study||0
11200205|NCT01824589|12390289|FG003|STARTED|Overall Study||0
11200206|NCT01824589|12390286|FG000|COMPLETED|Overall Study||1
11200207|NCT01824589|12390287|FG001|COMPLETED|Overall Study||0
11200208|NCT01824589|12390288|FG002|COMPLETED|Overall Study||0
11200209|NCT01824589|12390289|FG003|COMPLETED|Overall Study||0
11200210|NCT01824589|12390286|FG000|NOT COMPLETED|Overall Study||0
11200211|NCT01824589|12390287|FG001|NOT COMPLETED|Overall Study||0
11200212|NCT01824589|12390288|FG002|NOT COMPLETED|Overall Study||0
11200213|NCT01824589|12390289|FG003|NOT COMPLETED|Overall Study||0
11200214|NCT01824602|12390303|FG000|STARTED|Overall Study||11
11200215|NCT01824602|12390304|FG001|STARTED|Overall Study||8
11200216|NCT01824602|12390305|FG002|STARTED|Overall Study||9
11200217|NCT01824602|12390306|FG003|STARTED|Overall Study||10
11200218|NCT01824602|12390303|FG000|Safety Population|Overall Study||11
11200219|NCT01824602|12390304|FG001|Safety Population|Overall Study||8
11200220|NCT01824602|12390305|FG002|Safety Population|Overall Study||9
11200221|NCT01824602|12390306|FG003|Safety Population|Overall Study||10
11200222|NCT01824602|12390303|FG000|Intent-to-treat Population|Overall Study||11
11200223|NCT01824602|12390304|FG001|Intent-to-treat Population|Overall Study||8
11200224|NCT01824602|12390305|FG002|Intent-to-treat Population|Overall Study||9
11200225|NCT01824602|12390306|FG003|Intent-to-treat Population|Overall Study||9
11200226|NCT01824602|12390303|FG000|COMPLETED|Overall Study||10
11200227|NCT01824602|12390304|FG001|COMPLETED|Overall Study||8
11200228|NCT01824602|12390305|FG002|COMPLETED|Overall Study||5
11200229|NCT01824602|12390306|FG003|COMPLETED|Overall Study||5
11200230|NCT01824602|12390303|FG000|NOT COMPLETED|Overall Study||1
11200231|NCT01824602|12390304|FG001|NOT COMPLETED|Overall Study||0
11200232|NCT01824602|12390305|FG002|NOT COMPLETED|Overall Study||4
11200233|NCT01824602|12390306|FG003|NOT COMPLETED|Overall Study||5
11200234|NCT01824693|12390319|FG000|STARTED|Overall Study||6
11200235|NCT01824693|12390320|FG001|STARTED|Overall Study||9
11200236|NCT01824693|12390321|FG002|STARTED|Overall Study||15
11200237|NCT01824693|12390319|FG000|COMPLETED|Overall Study||5
11200238|NCT01824693|12390320|FG001|COMPLETED|Overall Study||2
11200239|NCT01824693|12390321|FG002|COMPLETED|Overall Study||0
11200240|NCT01824693|12390319|FG000|NOT COMPLETED|Overall Study||1
11200241|NCT01824693|12390320|FG001|NOT COMPLETED|Overall Study||7
11200242|NCT01824693|12390321|FG002|NOT COMPLETED|Overall Study||15
11205117|NCT01857310|12395873|FG001|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
11205118|NCT01857310|12395872|FG000|NOT COMPLETED|Primary Analysis: Live Birth||0
11205119|NCT01857310|12395873|FG001|NOT COMPLETED|Primary Analysis: Live Birth||0
11205120|NCT01857310|12395872|FG000|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
11205121|NCT01857310|12395873|FG001|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
11205122|NCT01857310|12395872|FG000|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|870
11205123|NCT01857310|12395873|FG001|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|903
11205124|NCT01857310|12395872|FG000|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||315
11205125|NCT01857310|12395873|FG001|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||282
11205126|NCT01857323|12395879|FG000|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
11205127|NCT01857323|12395879|FG000|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
11205128|NCT01857323|12395879|FG000|COMPLETED|Overall Study||253
11205129|NCT01857323|12395879|FG000|NOT COMPLETED|Overall Study||64
11205130|NCT01857362|12395883|FG000|STARTED|Overall Study||6
11205131|NCT01857362|12395884|FG001|STARTED|Overall Study||6
11205132|NCT01857362|12395883|FG000|COMPLETED|Overall Study||6
11205133|NCT01857362|12395884|FG001|COMPLETED|Overall Study||6
11205134|NCT01857362|12395883|FG000|NOT COMPLETED|Overall Study||0
11205135|NCT01857362|12395884|FG001|NOT COMPLETED|Overall Study||0
11205136|NCT01857531|12395890|FG000|STARTED|Overall Study||16
11205137|NCT01857531|12395890|FG000|COMPLETED|Overall Study||12
11205138|NCT01857531|12395890|FG000|NOT COMPLETED|Overall Study||4
11205139|NCT01857583|12395898|FG000|STARTED|Overall Study||30
11205140|NCT01857583|12395899|FG001|STARTED|Overall Study||7
11205141|NCT01857583|12395900|FG002|STARTED|Overall Study||22
11205142|NCT01857583|12395901|FG003|STARTED|Overall Study||21
11205143|NCT01857583|12395898|FG000|Safety Analysis Population|Overall Study||30
11205144|NCT01857583|12395899|FG001|Safety Analysis Population|Overall Study||7
11205145|NCT01857583|12395900|FG002|Safety Analysis Population|Overall Study||22
11205146|NCT01857583|12395901|FG003|Safety Analysis Population|Overall Study||20
11205147|NCT01857583|12395898|FG000|COMPLETED|Overall Study||29
11205148|NCT01857583|12395899|FG001|COMPLETED|Overall Study||6
11205149|NCT01857583|12395900|FG002|COMPLETED|Overall Study||19
11205150|NCT01857583|12395901|FG003|COMPLETED|Overall Study||17
11205151|NCT01857583|12395898|FG000|NOT COMPLETED|Overall Study||1
11205152|NCT01857583|12395899|FG001|NOT COMPLETED|Overall Study||1
11205153|NCT01857583|12395900|FG002|NOT COMPLETED|Overall Study||3
11205154|NCT01857583|12395901|FG003|NOT COMPLETED|Overall Study||4
11205155|NCT01857622|12395914|FG000|STARTED|Overall Study||50
11205156|NCT01857622|12395915|FG001|STARTED|Overall Study||22
11205157|NCT01857622|12395916|FG002|STARTED|Overall Study||21
11205158|NCT01857622|12395914|FG000|COMPLETED|Overall Study||39
11205159|NCT01857622|12395915|FG001|COMPLETED|Overall Study||21
11205160|NCT01857622|12395916|FG002|COMPLETED|Overall Study||19
11205161|NCT01857622|12395914|FG000|NOT COMPLETED|Overall Study||11
11205162|NCT01857622|12395915|FG001|NOT COMPLETED|Overall Study||1
11205163|NCT01857622|12395916|FG002|NOT COMPLETED|Overall Study||2
11205164|NCT01857713|12395924|FG000|STARTED|Overall Study||95
11205165|NCT01857713|12395924|FG000|COMPLETED|Overall Study||89
11205166|NCT01857713|12395924|FG000|NOT COMPLETED|Overall Study||6
11205167|NCT01857869|12395940|FG000|STARTED|Primary/Challenge Phase||34
11205168|NCT01857869|12395941|FG001|STARTED|Primary/Challenge Phase||17
11205169|NCT01857869|12395942|FG002|STARTED|Primary/Challenge Phase||12
11205170|NCT01857869|12395943|FG003|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
11205171|NCT01857869|12395944|FG004|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
11205172|NCT01857869|12395945|FG005|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
11205173|NCT01857869|12395946|FG006|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
11205174|NCT01857869|12395947|FG007|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
11205224|NCT01857869|12395947|FG007|NOT COMPLETED|Booster/Rechallenge Phase||0
11200243|NCT01824823|12390330|FG000|STARTED|Overall Study||2
11200244|NCT01824823|12390331|FG001|STARTED|Overall Study||1
11200245|NCT01824823|12390330|FG000|COMPLETED|Overall Study||0
11200246|NCT01824823|12390331|FG001|COMPLETED|Overall Study||0
11200247|NCT01824823|12390330|FG000|NOT COMPLETED|Overall Study||2
11200248|NCT01824823|12390331|FG001|NOT COMPLETED|Overall Study||1
11200249|NCT01824901|12390337|FG000|STARTED|Overall Study||2
11200250|NCT01824901|12390338|FG001|STARTED|Overall Study||0
11200251|NCT01824901|12390339|FG002|STARTED|Overall Study||0
11200252|NCT01824901|12390340|FG003|STARTED|Overall Study||0
11200253|NCT01824901|12390337|FG000|COMPLETED|Overall Study||2
11200254|NCT01824901|12390338|FG001|COMPLETED|Overall Study||0
11200255|NCT01824901|12390339|FG002|COMPLETED|Overall Study||0
11200256|NCT01824901|12390340|FG003|COMPLETED|Overall Study||0
11200257|NCT01824901|12390337|FG000|NOT COMPLETED|Overall Study||0
11200258|NCT01824901|12390338|FG001|NOT COMPLETED|Overall Study||0
11200259|NCT01824901|12390339|FG002|NOT COMPLETED|Overall Study||0
11200260|NCT01824901|12390340|FG003|NOT COMPLETED|Overall Study||0
11200261|NCT01824979|12390346|FG000|STARTED|Overall Study||50
11200262|NCT01824979|12390347|FG001|STARTED|Overall Study||50
11200263|NCT01824979|12390346|FG000|COMPLETED|Overall Study||37
11200264|NCT01824979|12390347|FG001|COMPLETED|Overall Study||37
11200265|NCT01824979|12390346|FG000|NOT COMPLETED|Overall Study||13
11200266|NCT01824979|12390347|FG001|NOT COMPLETED|Overall Study||13
11200267|NCT01825057|12390356|FG000|STARTED|Patient Study Flow||336
11200268|NCT01825057|12390357|FG001|STARTED|Patient Study Flow||379
11200269|NCT01825057|12390358|FG002|STARTED|Patient Study Flow||458
11200270|NCT01825057|12390356|FG000|COMPLETED|Patient Study Flow||336
11200271|NCT01825057|12390357|FG001|COMPLETED|Patient Study Flow||379
11200272|NCT01825057|12390358|FG002|COMPLETED|Patient Study Flow||458
11200273|NCT01825057|12390356|FG000|NOT COMPLETED|Patient Study Flow||0
11200274|NCT01825057|12390357|FG001|NOT COMPLETED|Patient Study Flow||0
11200275|NCT01825057|12390358|FG002|NOT COMPLETED|Patient Study Flow||0
11200276|NCT01825057|12390356|FG000|STARTED|Provider Study Flow||13
11200277|NCT01825057|12390357|FG001|STARTED|Provider Study Flow||12
11200278|NCT01825057|12390358|FG002|STARTED|Provider Study Flow||13
11200279|NCT01825057|12390356|FG000|COMPLETED|Provider Study Flow||13
11200280|NCT01825057|12390357|FG001|COMPLETED|Provider Study Flow||12
11200281|NCT01825057|12390358|FG002|COMPLETED|Provider Study Flow||13
11200282|NCT01825057|12390356|FG000|NOT COMPLETED|Provider Study Flow||0
11200283|NCT01825057|12390357|FG001|NOT COMPLETED|Provider Study Flow||0
11200284|NCT01825057|12390358|FG002|NOT COMPLETED|Provider Study Flow||0
11200285|NCT01825122|12390371|FG000|STARTED|Overall Study||77
11200286|NCT01825122|12390372|FG001|STARTED|Overall Study||78
11200287|NCT01825122|12390371|FG000|COMPLETED|Overall Study||67
11200288|NCT01825122|12390372|FG001|COMPLETED|Overall Study||59
11200289|NCT01825122|12390371|FG000|NOT COMPLETED|Overall Study||10
11200290|NCT01825122|12390372|FG001|NOT COMPLETED|Overall Study||19
11200291|NCT01825200|12390380|FG000|STARTED|Overall Study||1319
11200292|NCT01825200|12390381|FG001|STARTED|Overall Study||1321
11200293|NCT01825200|12390380|FG000|COMPLETED|Overall Study||1314
11200294|NCT01825200|12390381|FG001|COMPLETED|Overall Study||1314
11200295|NCT01825200|12390380|FG000|NOT COMPLETED|Overall Study||5
11200296|NCT01825200|12390381|FG001|NOT COMPLETED|Overall Study||7
11200297|NCT01825408|12390391|FG000|STARTED|Overall Study||7
11200298|NCT01825408|12390392|FG001|STARTED|Overall Study||7
11200299|NCT01825408|12390393|FG002|STARTED|Overall Study||14
11200300|NCT01825408|12390394|FG003|STARTED|Overall Study||12
11200301|NCT01825408|12390391|FG000|COMPLETED|Overall Study||7
11200302|NCT01825408|12390392|FG001|COMPLETED|Overall Study||7
11200303|NCT01825408|12390393|FG002|COMPLETED|Overall Study||14
11200304|NCT01825408|12390394|FG003|COMPLETED|Overall Study||12
11200305|NCT01825408|12390391|FG000|NOT COMPLETED|Overall Study||0
11200306|NCT01825408|12390392|FG001|NOT COMPLETED|Overall Study||0
11200307|NCT01825408|12390393|FG002|NOT COMPLETED|Overall Study||0
11200308|NCT01825408|12390394|FG003|NOT COMPLETED|Overall Study||0
11200309|NCT01825512|12390406|FG000|STARTED|Baseline||194
11200310|NCT01825512|12390407|FG001|STARTED|Baseline||199
11200311|NCT01825512|12390406|FG000|COMPLETED|Baseline||193
11200312|NCT01825512|12390407|FG001|COMPLETED|Baseline||197
11200313|NCT01825512|12390406|FG000|NOT COMPLETED|Baseline||1
11200314|NCT01825512|12390407|FG001|NOT COMPLETED|Baseline||2
11200315|NCT01825512|12390406|FG000|STARTED|Treatment||193
11200316|NCT01825512|12390407|FG001|STARTED|Treatment||197
11200317|NCT01825512|12390406|FG000|COMPLETED|Treatment||140
11200318|NCT01825512|12390407|FG001|COMPLETED|Treatment||170
11200319|NCT01825512|12390406|FG000|NOT COMPLETED|Treatment||53
11200320|NCT01825512|12390407|FG001|NOT COMPLETED|Treatment||27
11200321|NCT01825577|12390413|FG000|STARTED|Overall Study||14
11200322|NCT01825577|12390413|FG000|COMPLETED|Overall Study||6
11200323|NCT01825577|12390413|FG000|NOT COMPLETED|Overall Study||8
11200324|NCT01825655|12390419|FG000|STARTED|Overall Study||0
11200325|NCT01825655|12390420|FG001|STARTED|Overall Study||2
11200326|NCT01825655|12390419|FG000|COMPLETED|Overall Study||0
11200327|NCT01825655|12390420|FG001|COMPLETED|Overall Study||2
11200328|NCT01825655|12390419|FG000|NOT COMPLETED|Overall Study||0
11200329|NCT01825655|12390420|FG001|NOT COMPLETED|Overall Study||0
11200330|NCT01825785|12390433|FG000|STARTED|Overall Study||12
11200331|NCT01825785|12390434|FG001|STARTED|Overall Study||6
11200332|NCT01825785|12390435|FG002|STARTED|Overall Study||6
11200333|NCT01825785|12390436|FG003|STARTED|Overall Study||6
11200334|NCT01825785|12390437|FG004|STARTED|Overall Study||6
11200335|NCT01825785|12390438|FG005|STARTED|Overall Study||6
11200336|NCT01825785|12390439|FG006|STARTED|Overall Study||6
11200337|NCT01825785|12390433|FG000|COMPLETED|Overall Study||12
11200338|NCT01825785|12390434|FG001|COMPLETED|Overall Study||6
11200339|NCT01825785|12390435|FG002|COMPLETED|Overall Study||6
11200340|NCT01825785|12390436|FG003|COMPLETED|Overall Study||6
11200341|NCT01825785|12390437|FG004|COMPLETED|Overall Study||4
11200342|NCT01825785|12390438|FG005|COMPLETED|Overall Study||5
11200343|NCT01825785|12390439|FG006|COMPLETED|Overall Study||6
11200344|NCT01825785|12390433|FG000|NOT COMPLETED|Overall Study||0
11200345|NCT01825785|12390434|FG001|NOT COMPLETED|Overall Study||0
11200346|NCT01825785|12390435|FG002|NOT COMPLETED|Overall Study||0
11200347|NCT01825785|12390436|FG003|NOT COMPLETED|Overall Study||0
11200348|NCT01825785|12390437|FG004|NOT COMPLETED|Overall Study||2
11200349|NCT01825785|12390438|FG005|NOT COMPLETED|Overall Study||1
11200350|NCT01825785|12390439|FG006|NOT COMPLETED|Overall Study||0
11200351|NCT01825798|12390463|FG000|STARTED|Overall Study||32
11200352|NCT01825798|12390464|FG001|STARTED|Overall Study||28
11200353|NCT01825798|12390463|FG000|COMPLETED|Overall Study||30
11200354|NCT01825798|12390464|FG001|COMPLETED|Overall Study||23
11200355|NCT01825798|12390463|FG000|NOT COMPLETED|Overall Study||2
11200356|NCT01825798|12390464|FG001|NOT COMPLETED|Overall Study||5
11200357|NCT01825837|12390474|FG000|STARTED|PART I||0
11200358|NCT01825837|12390475|FG001|STARTED|PART I||0
11200359|NCT01825837|12390476|FG002|STARTED|PART I||0
11200360|NCT01825837|12390477|FG003|STARTED|PART I||104
11200361|NCT01825837|12390474|FG000|Enrolled|PART I||0
11200362|NCT01825837|12390475|FG001|Enrolled|PART I||0
11200363|NCT01825837|12390476|FG002|Enrolled|PART I||0
11200364|NCT01825837|12390477|FG003|Enrolled|PART I||104
11200365|NCT01825837|12390474|FG000|Safety Population (Open-Label)|PART I||0
11200366|NCT01825837|12390475|FG001|Safety Population (Open-Label)|PART I||0
11200367|NCT01825837|12390476|FG002|Safety Population (Open-Label)|PART I||0
11200368|NCT01825837|12390477|FG003|Safety Population (Open-Label)|PART I||104
11200369|NCT01825837|12390474|FG000|COMPLETED|PART I||0
11200370|NCT01825837|12390475|FG001|COMPLETED|PART I||0
11200371|NCT01825837|12390476|FG002|COMPLETED|PART I||0
11200372|NCT01825837|12390477|FG003|COMPLETED|PART I||87
11200373|NCT01825837|12390474|FG000|NOT COMPLETED|PART I||0
11200374|NCT01825837|12390475|FG001|NOT COMPLETED|PART I||0
11200375|NCT01825837|12390476|FG002|NOT COMPLETED|PART I||0
11200376|NCT01825837|12390477|FG003|NOT COMPLETED|PART I||17
11200377|NCT01825837|12390474|FG000|STARTED|PART II||35
11200378|NCT01825837|12390475|FG001|STARTED|PART II||26
11200379|NCT01825837|12390476|FG002|STARTED|PART II||26
11200380|NCT01825837|12390477|FG003|STARTED|PART II||0
11200381|NCT01825837|12390474|FG000|Randomized Patients|PART II||35
11200382|NCT01825837|12390475|FG001|Randomized Patients|PART II||26
11200383|NCT01825837|12390476|FG002|Randomized Patients|PART II||26
11200384|NCT01825837|12390477|FG003|Randomized Patients|PART II||0
11200385|NCT01825837|12390474|FG000|Safety Population (Double-Blind)|PART II||35
11200386|NCT01825837|12390475|FG001|Safety Population (Double-Blind)|PART II||26
11200387|NCT01825837|12390476|FG002|Safety Population (Double-Blind)|PART II||26
11200388|NCT01825837|12390477|FG003|Safety Population (Double-Blind)|PART II||0
11200389|NCT01825837|12390474|FG000|Intent-to-Treat Population|PART II||34
11200390|NCT01825837|12390475|FG001|Intent-to-Treat Population|PART II||25
11200391|NCT01825837|12390476|FG002|Intent-to-Treat Population|PART II||26
11200392|NCT01825837|12390477|FG003|Intent-to-Treat Population|PART II||0
11200393|NCT01825837|12390474|FG000|Per-Protocol Population|PART II||32
11200394|NCT01825837|12390475|FG001|Per-Protocol Population|PART II||23
11200395|NCT01825837|12390476|FG002|Per-Protocol Population|PART II||24
11200396|NCT01825837|12390477|FG003|Per-Protocol Population|PART II||0
11200397|NCT01825837|12390474|FG000|COMPLETED|PART II||16
11200398|NCT01825837|12390475|FG001|COMPLETED|PART II||12
11200399|NCT01825837|12390476|FG002|COMPLETED|PART II||7
11200400|NCT01825837|12390477|FG003|COMPLETED|PART II||0
11200401|NCT01825837|12390474|FG000|NOT COMPLETED|PART II||19
11200402|NCT01825837|12390475|FG001|NOT COMPLETED|PART II||14
11200403|NCT01825837|12390476|FG002|NOT COMPLETED|PART II||19
11200404|NCT01825837|12390477|FG003|NOT COMPLETED|PART II||0
11200405|NCT01825876|12390485|FG000|STARTED|Period 1||17
11200406|NCT01825876|12390486|FG001|STARTED|Period 1||0
11200407|NCT01825876|12390485|FG000|Received 1 Dose of Study Drug|Period 1||17
11200408|NCT01825876|12390486|FG001|Received 1 Dose of Study Drug|Period 1||0
11200409|NCT01825876|12390485|FG000|COMPLETED|Period 1||17
11200410|NCT01825876|12390486|FG001|COMPLETED|Period 1||0
11200411|NCT01825876|12390485|FG000|NOT COMPLETED|Period 1||0
11200412|NCT01825876|12390486|FG001|NOT COMPLETED|Period 1||0
11200413|NCT01825876|12390485|FG000|STARTED|Period 2|Participants received a different treatment in Period 2.|0
11200414|NCT01825876|12390486|FG001|STARTED|Period 2|Participants received a different treatment in Period 1.|17
11200415|NCT01825876|12390485|FG000|Received 1 Dose of Study Drug|Period 2||0
11200416|NCT01825876|12390486|FG001|Received 1 Dose of Study Drug|Period 2||17
11200417|NCT01825876|12390485|FG000|COMPLETED|Period 2||0
11200418|NCT01825876|12390486|FG001|COMPLETED|Period 2||16
11200419|NCT01825876|12390485|FG000|NOT COMPLETED|Period 2||0
11200420|NCT01825876|12390486|FG001|NOT COMPLETED|Period 2||1
11200421|NCT01825889|12390497|FG000|STARTED|Overall Study||10
11200422|NCT01825889|12390498|FG001|STARTED|Overall Study||10
11200423|NCT01825889|12390497|FG000|Received One Dose of Study Drug|Overall Study||10
11200424|NCT01825889|12390498|FG001|Received One Dose of Study Drug|Overall Study||10
11200425|NCT01825889|12390497|FG000|COMPLETED|Overall Study||10
11200426|NCT01825889|12390498|FG001|COMPLETED|Overall Study||10
11200427|NCT01825889|12390497|FG000|NOT COMPLETED|Overall Study||0
11200428|NCT01825889|12390498|FG001|NOT COMPLETED|Overall Study||0
11200429|NCT01825941|12390506|FG000|STARTED|Overall Study||104
11200430|NCT01825941|12390507|FG001|STARTED|Overall Study||104
11200431|NCT01825941|12390506|FG000|COMPLETED|Overall Study||100
11200432|NCT01825941|12390507|FG001|COMPLETED|Overall Study||103
11200433|NCT01825941|12390506|FG000|NOT COMPLETED|Overall Study||4
11200434|NCT01825941|12390507|FG001|NOT COMPLETED|Overall Study||1
11200435|NCT01826201|12390513|FG000|STARTED|Overall Study|Subjects in each arm are same|21
11200436|NCT01826201|12390513|FG000|COMPLETED|Overall Study||17
11027091|NCT00832078|12205796|FG000|STARTED|Test Day 1- 1 Period||13
11027092|NCT00832078|12205797|FG001|STARTED|Test Day 1- 1 Period||12
11027093|NCT00832078|12205796|FG000|COMPLETED|Test Day 1- 1 Period||13
11027094|NCT00832078|12205797|FG001|COMPLETED|Test Day 1- 1 Period||12
11027095|NCT00832078|12205796|FG000|NOT COMPLETED|Test Day 1- 1 Period||0
11027096|NCT00832078|12205797|FG001|NOT COMPLETED|Test Day 1- 1 Period||0
11027097|NCT00832078|12205796|FG000|STARTED|Test Day 1-2 Period||13
11027098|NCT00832078|12205797|FG001|STARTED|Test Day 1-2 Period||12
11027099|NCT00832078|12205796|FG000|COMPLETED|Test Day 1-2 Period||13
11027100|NCT00832078|12205797|FG001|COMPLETED|Test Day 1-2 Period||10
11027101|NCT00832078|12205796|FG000|NOT COMPLETED|Test Day 1-2 Period||0
11027102|NCT00832078|12205797|FG001|NOT COMPLETED|Test Day 1-2 Period||2
11027103|NCT00832078|12205796|FG000|STARTED|Test Day 2 - 1 Period||13
11027104|NCT00832078|12205797|FG001|STARTED|Test Day 2 - 1 Period||10
11027105|NCT00832078|12205796|FG000|COMPLETED|Test Day 2 - 1 Period||13
11027106|NCT00832078|12205797|FG001|COMPLETED|Test Day 2 - 1 Period||10
11027107|NCT00832078|12205796|FG000|NOT COMPLETED|Test Day 2 - 1 Period||0
11027108|NCT00832078|12205797|FG001|NOT COMPLETED|Test Day 2 - 1 Period||0
11027109|NCT00832078|12205796|FG000|STARTED|Test Day 2 - 2 Period||13
11027110|NCT00832078|12205797|FG001|STARTED|Test Day 2 - 2 Period||10
11027111|NCT00832078|12205796|FG000|COMPLETED|Test Day 2 - 2 Period||12
11027112|NCT00832078|12205797|FG001|COMPLETED|Test Day 2 - 2 Period||10
11027113|NCT00832078|12205796|FG000|NOT COMPLETED|Test Day 2 - 2 Period||1
11027114|NCT00832078|12205797|FG001|NOT COMPLETED|Test Day 2 - 2 Period||0
11027115|NCT00832091|12205805|FG000|STARTED|Overall Study||17
11027116|NCT00832091|12205806|FG001|STARTED|Overall Study||55
11027117|NCT00832091|12205805|FG000|COMPLETED|Overall Study||12
11027118|NCT00832091|12205806|FG001|COMPLETED|Overall Study||53
11027119|NCT00832091|12205805|FG000|NOT COMPLETED|Overall Study||5
11027120|NCT00832091|12205806|FG001|NOT COMPLETED|Overall Study||2
11027121|NCT00832117|12205814|FG000|STARTED|Overall Study||29
11027122|NCT00832117|12205814|FG000|COMPLETED|Overall Study||17
11027123|NCT00832117|12205814|FG000|NOT COMPLETED|Overall Study||12
11027124|NCT00832130|12205823|FG000|STARTED|Overall Study||69
11027125|NCT00832130|12205824|FG001|STARTED|Overall Study||70
11027126|NCT00832130|12205823|FG000|COMPLETED|Overall Study||69
11027127|NCT00832130|12205824|FG001|COMPLETED|Overall Study||70
11027128|NCT00832130|12205823|FG000|NOT COMPLETED|Overall Study||0
11027129|NCT00832130|12205824|FG001|NOT COMPLETED|Overall Study||0
11027130|NCT00832260|12205830|FG000|STARTED|Overall Study||70
11027131|NCT00832260|12205830|FG000|COMPLETED|Overall Study||70
11027132|NCT00832260|12205830|FG000|NOT COMPLETED|Overall Study||0
11027133|NCT00832338|12205834|FG000|STARTED|Overall Study||23
11027134|NCT00832338|12205834|FG000|COMPLETED|Overall Study||23
11027135|NCT00832338|12205834|FG000|NOT COMPLETED|Overall Study||0
11027136|NCT00832377|12205838|FG000|STARTED|Overall Study||37
11027137|NCT00832377|12205838|FG000|COMPLETED|Overall Study||36
11027138|NCT00832377|12205838|FG000|NOT COMPLETED|Overall Study||1
11027139|NCT00832390|12205845|FG000|STARTED|Overall Study||12
11027140|NCT00832390|12205846|FG001|STARTED|Overall Study||16
11027141|NCT00832390|12205847|FG002|STARTED|Overall Study||1
11027142|NCT00832390|12205845|FG000|COMPLETED|Overall Study||12
11027143|NCT00832390|12205846|FG001|COMPLETED|Overall Study||16
11027144|NCT00832390|12205847|FG002|COMPLETED|Overall Study||1
11027145|NCT00832390|12205845|FG000|NOT COMPLETED|Overall Study||0
11027146|NCT00832390|12205846|FG001|NOT COMPLETED|Overall Study||0
11027147|NCT00832390|12205847|FG002|NOT COMPLETED|Overall Study||0
11027148|NCT00832416|12205859|FG000|STARTED|Overall Study||110
11027149|NCT00832416|12205860|FG001|STARTED|Overall Study||113
11027150|NCT00832416|12205861|FG002|STARTED|Overall Study||115
11027151|NCT00832416|12205862|FG003|STARTED|Overall Study||227
11027152|NCT00832416|12205859|FG000|COMPLETED|Overall Study||64
11027153|NCT00832416|12205860|FG001|COMPLETED|Overall Study||60
11027154|NCT00832416|12205861|FG002|COMPLETED|Overall Study||54
11027155|NCT00832416|12205862|FG003|COMPLETED|Overall Study||144
11027156|NCT00832416|12205859|FG000|NOT COMPLETED|Overall Study||46
11027157|NCT00832416|12205860|FG001|NOT COMPLETED|Overall Study||53
11027158|NCT00832416|12205861|FG002|NOT COMPLETED|Overall Study||61
11027159|NCT00832416|12205862|FG003|NOT COMPLETED|Overall Study||83
11027160|NCT00832585|12205872|FG000|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
11027161|NCT00832585|12205872|FG000|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
11027162|NCT00832585|12205872|FG000|NOT COMPLETED|Overall Study||2
11027163|NCT00832637|12205876|FG000|STARTED|Overall Study||33
11027164|NCT00832637|12205876|FG000|COMPLETED|Overall Study||33
11027165|NCT00832637|12205876|FG000|NOT COMPLETED|Overall Study||0
11027166|NCT00832650|12205883|FG000|STARTED|Overall Study||25
11027167|NCT00832650|12205884|FG001|STARTED|Overall Study||12
11027168|NCT00832650|12205885|FG002|STARTED|Overall Study||23
11027169|NCT00832650|12205883|FG000|Treated|Overall Study||25
11027170|NCT00832650|12205884|FG001|Treated|Overall Study||12
11027171|NCT00832650|12205885|FG002|Treated|Overall Study||22
11027172|NCT00832650|12205883|FG000|COMPLETED|Overall Study||25
11027173|NCT00832650|12205884|FG001|COMPLETED|Overall Study||12
11027174|NCT00832650|12205885|FG002|COMPLETED|Overall Study||22
11027175|NCT00832650|12205883|FG000|NOT COMPLETED|Overall Study||0
11027176|NCT00832650|12205884|FG001|NOT COMPLETED|Overall Study||0
11027177|NCT00832650|12205885|FG002|NOT COMPLETED|Overall Study||1
11027178|NCT00832767|12205895|FG000|STARTED|Overall Study||121
11027179|NCT00832767|12205896|FG001|STARTED|Overall Study||81
11027180|NCT00832767|12205895|FG000|COMPLETED|Overall Study||99
11027181|NCT00832767|12205896|FG001|COMPLETED|Overall Study||63
11027182|NCT00832767|12205895|FG000|NOT COMPLETED|Overall Study||22
11027183|NCT00832767|12205896|FG001|NOT COMPLETED|Overall Study||18
11027184|NCT00832780|12205904|FG000|STARTED|Overall Study||44
11027185|NCT00832780|12205904|FG000|COMPLETED|Overall Study||19
11027186|NCT00832780|12205904|FG000|NOT COMPLETED|Overall Study||25
11027187|NCT00832819|12205911|FG000|STARTED|Overall Study||6
11027188|NCT00832819|12205912|FG001|STARTED|Overall Study||6
11027189|NCT00832819|12205913|FG002|STARTED|Overall Study||16
11027190|NCT00832819|12205911|FG000|COMPLETED|Overall Study||6
11027191|NCT00832819|12205912|FG001|COMPLETED|Overall Study||5
11027192|NCT00832819|12205913|FG002|COMPLETED|Overall Study||15
11027193|NCT00832819|12205911|FG000|NOT COMPLETED|Overall Study||0
11027194|NCT00832819|12205912|FG001|NOT COMPLETED|Overall Study||1
11027195|NCT00832819|12205913|FG002|NOT COMPLETED|Overall Study||1
11027196|NCT00832871|12205919|FG000|STARTED|Overall Study||4
11027197|NCT00832871|12205919|FG000|COMPLETED|Overall Study||4
11027198|NCT00832871|12205919|FG000|NOT COMPLETED|Overall Study||0
11200437|NCT01826201|12390513|FG000|NOT COMPLETED|Overall Study||4
11200438|NCT01826214|12390521|FG000|STARTED|Overall Study||35
11200439|NCT01826214|12390522|FG001|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
11200440|NCT01826214|12390521|FG000|Untreated|Overall Study|Untreated = did not receive study drug|0
11200441|NCT01826214|12390522|FG001|Untreated|Overall Study|Untreated = did not receive study drug|1
11200442|NCT01826214|12390521|FG000|Treated|Overall Study|Treated = received at least one dose of study drug|35
11200443|NCT01826214|12390522|FG001|Treated|Overall Study|Treated = received at least one dose of study drug|34
11200444|NCT01826214|12390521|FG000|COMPLETED|Overall Study||0
11200445|NCT01826214|12390522|FG001|COMPLETED|Overall Study||0
11200446|NCT01826214|12390521|FG000|NOT COMPLETED|Overall Study||35
11200447|NCT01826214|12390522|FG001|NOT COMPLETED|Overall Study||34
11200448|NCT01826227|12390528|FG000|STARTED|Overall Study||5
11200449|NCT01826227|12390528|FG000|COMPLETED|Overall Study||5
11200450|NCT01826227|12390528|FG000|NOT COMPLETED|Overall Study||0
11200451|NCT01826370|12390532|FG000|STARTED|Overall Study||678
11200452|NCT01826370|12390532|FG000|COMPLETED|Overall Study||658
11200453|NCT01826370|12390532|FG000|NOT COMPLETED|Overall Study||20
11200454|NCT01826422|12390538|FG000|STARTED|Overall Study||18
11200455|NCT01826422|12390539|FG001|STARTED|Overall Study||22
11200456|NCT01826422|12390538|FG000|COMPLETED|Overall Study||17
11200457|NCT01826422|12390539|FG001|COMPLETED|Overall Study||19
11200458|NCT01826422|12390538|FG000|NOT COMPLETED|Overall Study||1
11200459|NCT01826422|12390539|FG001|NOT COMPLETED|Overall Study||3
11200460|NCT01826448|12390547|FG000|STARTED|Overall Study||4
11200461|NCT01826448|12390548|FG001|STARTED|Overall Study||9
11200462|NCT01826448|12390547|FG000|COMPLETED|Overall Study||0
11200463|NCT01826448|12390548|FG001|COMPLETED|Overall Study||0
11200464|NCT01826448|12390547|FG000|NOT COMPLETED|Overall Study||4
11200465|NCT01826448|12390548|FG001|NOT COMPLETED|Overall Study||9
11200466|NCT01826487|12390556|FG000|STARTED|Overall Study||115
11200467|NCT01826487|12390557|FG001|STARTED|Overall Study||115
11200468|NCT01826487|12390556|FG000|As-treated Population|Overall Study||115
11200469|NCT01826487|12390557|FG001|As-treated Population|Overall Study||115
11200470|NCT01826487|12390556|FG000|ITT Population|Overall Study||114
11200471|NCT01826487|12390557|FG001|ITT Population|Overall Study||114
11200472|NCT01826487|12390556|FG000|COMPLETED|Overall Study||111
11200473|NCT01826487|12390557|FG001|COMPLETED|Overall Study||110
11200474|NCT01826487|12390556|FG000|NOT COMPLETED|Overall Study||4
11200475|NCT01826487|12390557|FG001|NOT COMPLETED|Overall Study||5
11200476|NCT01826513|12390567|FG000|STARTED|Overall Study||5
11200477|NCT01826513|12390568|FG001|STARTED|Overall Study||10
11200478|NCT01826513|12390569|FG002|STARTED|Overall Study||10
11200479|NCT01826513|12390567|FG000|COMPLETED|Overall Study||5
11200480|NCT01826513|12390568|FG001|COMPLETED|Overall Study||10
11200481|NCT01826513|12390569|FG002|COMPLETED|Overall Study||10
11200482|NCT01826513|12390567|FG000|NOT COMPLETED|Overall Study||0
11200483|NCT01826513|12390568|FG001|NOT COMPLETED|Overall Study||0
11200484|NCT01826513|12390569|FG002|NOT COMPLETED|Overall Study||0
11200485|NCT01826604|12390578|FG000|STARTED|Overall Study||144
11200486|NCT01826604|12390579|FG001|STARTED|Overall Study||157
11200487|NCT01826604|12390578|FG000|COMPLETED|Overall Study||136
11200488|NCT01826604|12390579|FG001|COMPLETED|Overall Study||148
11200489|NCT01826604|12390578|FG000|NOT COMPLETED|Overall Study||8
11200490|NCT01826604|12390579|FG001|NOT COMPLETED|Overall Study||9
11200491|NCT01826812|12390587|FG000|STARTED|Overall Study||167
11200492|NCT01826812|12390588|FG001|STARTED|Overall Study||33
11200493|NCT01826812|12390587|FG000|COMPLETED|Overall Study||167
11200494|NCT01826812|12390588|FG001|COMPLETED|Overall Study||32
11200495|NCT01826812|12390587|FG000|NOT COMPLETED|Overall Study||0
11027199|NCT00832975|12205923|FG000|STARTED|Overall Study||157
11027200|NCT00832975|12205923|FG000|COMPLETED|Overall Study||118
11200496|NCT01826812|12390588|FG001|NOT COMPLETED|Overall Study||1
11200497|NCT01826825|12390598|FG000|STARTED|Overall Study||100
11200498|NCT01826825|12390599|FG001|STARTED|Overall Study||100
11200499|NCT01826825|12390598|FG000|COMPLETED|Overall Study||100
11200500|NCT01826825|12390599|FG001|COMPLETED|Overall Study||98
11200501|NCT01826825|12390598|FG000|NOT COMPLETED|Overall Study||0
11200502|NCT01826825|12390599|FG001|NOT COMPLETED|Overall Study||2
11200503|NCT01826851|12390609|FG000|STARTED|Overall Study||38
11200504|NCT01826851|12390610|FG001|STARTED|Overall Study||41
11200505|NCT01826851|12390609|FG000|COMPLETED|Overall Study||38
11200506|NCT01826851|12390610|FG001|COMPLETED|Overall Study||41
11200507|NCT01826851|12390609|FG000|NOT COMPLETED|Overall Study||0
11200508|NCT01826851|12390610|FG001|NOT COMPLETED|Overall Study||0
11200509|NCT01826981|12390631|FG000|STARTED|Overall Study||19
11200510|NCT01826981|12390632|FG001|STARTED|Overall Study||10
11200511|NCT01826981|12390633|FG002|STARTED|Overall Study||25
11200512|NCT01826981|12390634|FG003|STARTED|Overall Study||26
11200513|NCT01826981|12390635|FG004|STARTED|Overall Study||25
11200514|NCT01826981|12390636|FG005|STARTED|Overall Study||26
11200515|NCT01826981|12390637|FG006|STARTED|Overall Study||25
11200516|NCT01826981|12390638|FG007|STARTED|Overall Study||51
11200517|NCT01826981|12390639|FG008|STARTED|Overall Study||20
11200518|NCT01826981|12390640|FG009|STARTED|Overall Study||27
11200519|NCT01826981|12390641|FG010|STARTED|Overall Study||24
11200520|NCT01826981|12390642|FG011|STARTED|Overall Study||27
11200521|NCT01826981|12390643|FG012|STARTED|Overall Study||26
11200522|NCT01826981|12390644|FG013|STARTED|Overall Study||20
11200523|NCT01826981|12390645|FG014|STARTED|Overall Study||8
11200524|NCT01826981|12390631|FG000|COMPLETED|Overall Study||19
11200525|NCT01826981|12390632|FG001|COMPLETED|Overall Study||9
11200526|NCT01826981|12390633|FG002|COMPLETED|Overall Study||25
11200527|NCT01826981|12390634|FG003|COMPLETED|Overall Study||26
11200528|NCT01826981|12390635|FG004|COMPLETED|Overall Study||18
11200529|NCT01826981|12390636|FG005|COMPLETED|Overall Study||25
11200530|NCT01826981|12390637|FG006|COMPLETED|Overall Study||24
11200531|NCT01826981|12390638|FG007|COMPLETED|Overall Study||40
11200532|NCT01826981|12390639|FG008|COMPLETED|Overall Study||13
11200533|NCT01826981|12390640|FG009|COMPLETED|Overall Study||26
11200534|NCT01826981|12390641|FG010|COMPLETED|Overall Study||22
11200535|NCT01826981|12390642|FG011|COMPLETED|Overall Study||25
11200536|NCT01826981|12390643|FG012|COMPLETED|Overall Study||25
11200537|NCT01826981|12390644|FG013|COMPLETED|Overall Study||15
11200538|NCT01826981|12390645|FG014|COMPLETED|Overall Study||8
11200539|NCT01826981|12390631|FG000|NOT COMPLETED|Overall Study||0
11200540|NCT01826981|12390632|FG001|NOT COMPLETED|Overall Study||1
11200541|NCT01826981|12390633|FG002|NOT COMPLETED|Overall Study||0
11200542|NCT01826981|12390634|FG003|NOT COMPLETED|Overall Study||0
11200543|NCT01826981|12390635|FG004|NOT COMPLETED|Overall Study||7
11200544|NCT01826981|12390636|FG005|NOT COMPLETED|Overall Study||1
11200545|NCT01826981|12390637|FG006|NOT COMPLETED|Overall Study||1
11200546|NCT01826981|12390638|FG007|NOT COMPLETED|Overall Study||11
11200547|NCT01826981|12390639|FG008|NOT COMPLETED|Overall Study||7
11200548|NCT01826981|12390640|FG009|NOT COMPLETED|Overall Study||1
11200549|NCT01826981|12390641|FG010|NOT COMPLETED|Overall Study||2
11200550|NCT01826981|12390642|FG011|NOT COMPLETED|Overall Study||2
11200551|NCT01826981|12390643|FG012|NOT COMPLETED|Overall Study||1
11200552|NCT01826981|12390644|FG013|NOT COMPLETED|Overall Study||5
11200553|NCT01826981|12390645|FG014|NOT COMPLETED|Overall Study||0
11200554|NCT01827046|12390683|FG000|STARTED|Overall Study||250
11200555|NCT01827046|12390684|FG001|STARTED|Overall Study||249
11200556|NCT01827046|12390683|FG000|COMPLETED|Overall Study||249
11200557|NCT01827046|12390684|FG001|COMPLETED|Overall Study||240
11200558|NCT01827046|12390683|FG000|NOT COMPLETED|Overall Study||1
11200559|NCT01827046|12390684|FG001|NOT COMPLETED|Overall Study||9
11200560|NCT01827163|12390690|FG000|STARTED|Overall Study||20
11200561|NCT01827163|12390690|FG000|COMPLETED|Overall Study||9
11200562|NCT01827163|12390690|FG000|NOT COMPLETED|Overall Study||11
11200563|NCT01827254|12390694|FG000|STARTED|Overall Study||61
11200564|NCT01827254|12390694|FG000|Evaluable Population|Overall Study||52
11200565|NCT01827254|12390694|FG000|COMPLETED|Overall Study||2
11200566|NCT01827254|12390694|FG000|NOT COMPLETED|Overall Study||59
11200567|NCT01827267|12390704|FG000|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
11200568|NCT01827267|12390705|FG001|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
11200569|NCT01827267|12390704|FG000|Received Study Drug|Overall Study||17
11200570|NCT01827267|12390705|FG001|Received Study Drug|Overall Study||43
11200571|NCT01827267|12390704|FG000|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
11200572|NCT01827267|12390705|FG001|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
11200573|NCT01827267|12390704|FG000|COMPLETED|Overall Study||13
11200574|NCT01827267|12390705|FG001|COMPLETED|Overall Study||32
11200575|NCT01827267|12390704|FG000|NOT COMPLETED|Overall Study||5
11200576|NCT01827267|12390705|FG001|NOT COMPLETED|Overall Study||12
11200577|NCT01827306|12390714|FG000|STARTED|Overall Study||21
11200578|NCT01827306|12390715|FG001|STARTED|Overall Study||13
11200579|NCT01827306|12390714|FG000|COMPLETED|Overall Study||10
11200580|NCT01827306|12390715|FG001|COMPLETED|Overall Study||8
11200581|NCT01827306|12390714|FG000|NOT COMPLETED|Overall Study||11
11200582|NCT01827306|12390715|FG001|NOT COMPLETED|Overall Study||5
11200583|NCT01827319|12390721|FG000|STARTED|Overall Study||203
11200584|NCT01827319|12390721|FG000|COMPLETED|Overall Study||200
11200585|NCT01827319|12390721|FG000|NOT COMPLETED|Overall Study||3
11200586|NCT01827332|12390727|FG000|STARTED|Overall Study||8
11200587|NCT01827332|12390728|FG001|STARTED|Overall Study||8
11200588|NCT01827332|12390727|FG000|COMPLETED|Overall Study||6
11200589|NCT01827332|12390728|FG001|COMPLETED|Overall Study||7
11200590|NCT01827332|12390727|FG000|NOT COMPLETED|Overall Study||2
11200591|NCT01827332|12390728|FG001|NOT COMPLETED|Overall Study||1
11200592|NCT01827358|12390736|FG000|STARTED|Overall Study||80
11200593|NCT01827358|12390737|FG001|STARTED|Overall Study||75
11200594|NCT01827358|12390736|FG000|COMPLETED|Overall Study||45
11200595|NCT01827358|12390737|FG001|COMPLETED|Overall Study||44
11200596|NCT01827358|12390736|FG000|NOT COMPLETED|Overall Study||35
11200597|NCT01827358|12390737|FG001|NOT COMPLETED|Overall Study||31
11200598|NCT01827371|12390747|FG000|STARTED|Overall Study||115
11200599|NCT01827371|12390748|FG001|STARTED|Overall Study||96
11200600|NCT01827371|12390749|FG002|STARTED|Overall Study||104
11200601|NCT01827371|12390750|FG003|STARTED|Overall Study||120
11200602|NCT01827371|12390747|FG000|COMPLETED|Overall Study||102
11200603|NCT01827371|12390748|FG001|COMPLETED|Overall Study||89
11200604|NCT01827371|12390749|FG002|COMPLETED|Overall Study||93
11200605|NCT01827371|12390750|FG003|COMPLETED|Overall Study||97
11200606|NCT01827371|12390747|FG000|NOT COMPLETED|Overall Study||13
11200607|NCT01827371|12390748|FG001|NOT COMPLETED|Overall Study||7
11200608|NCT01827371|12390749|FG002|NOT COMPLETED|Overall Study||11
11200609|NCT01827371|12390750|FG003|NOT COMPLETED|Overall Study||23
11200610|NCT01827462|12390763|FG000|STARTED|Overall Study||59
11200611|NCT01827462|12390764|FG001|STARTED|Overall Study||37
11200612|NCT01827462|12390765|FG002|STARTED|Overall Study||40
11200613|NCT01827462|12390763|FG000|COMPLETED|Overall Study||18
11200614|NCT01827462|12390764|FG001|COMPLETED|Overall Study||19
11200615|NCT01827462|12390765|FG002|COMPLETED|Overall Study||12
11200616|NCT01827462|12390763|FG000|NOT COMPLETED|Overall Study||41
11200617|NCT01827462|12390764|FG001|NOT COMPLETED|Overall Study||18
11200618|NCT01827462|12390765|FG002|NOT COMPLETED|Overall Study||28
11200619|NCT01827475|12390779|FG000|STARTED|Overall Study||30
11200620|NCT01827475|12390780|FG001|STARTED|Overall Study||30
11200621|NCT01827475|12390781|FG002|STARTED|Overall Study||30
11200622|NCT01827475|12390779|FG000|COMPLETED|Overall Study||30
11200623|NCT01827475|12390780|FG001|COMPLETED|Overall Study||30
11200624|NCT01827475|12390781|FG002|COMPLETED|Overall Study||30
11200625|NCT01827475|12390779|FG000|NOT COMPLETED|Overall Study||0
11200626|NCT01827475|12390780|FG001|NOT COMPLETED|Overall Study||0
11200627|NCT01827475|12390781|FG002|NOT COMPLETED|Overall Study||0
11200628|NCT01827592|12390792|FG000|STARTED|Overall Study|Randomized patients.|126
11200629|NCT01827592|12390793|FG001|STARTED|Overall Study|Randomized patients.|126
11200630|NCT01827592|12390794|FG002|STARTED|Overall Study|Randomized patients.|124
11200631|NCT01827592|12390792|FG000|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
11200632|NCT01827592|12390793|FG001|Safety Analysis Set|Overall Study||126
11200633|NCT01827592|12390794|FG002|Safety Analysis Set|Overall Study||124
11200634|NCT01827592|12390792|FG000|COMPLETED|Overall Study||52
11200635|NCT01827592|12390793|FG001|COMPLETED|Overall Study||46
11200636|NCT01827592|12390794|FG002|COMPLETED|Overall Study||48
11200637|NCT01827592|12390792|FG000|NOT COMPLETED|Overall Study||74
11200638|NCT01827592|12390793|FG001|NOT COMPLETED|Overall Study||80
11200639|NCT01827592|12390794|FG002|NOT COMPLETED|Overall Study||76
11200640|NCT01827670|12390804|FG000|STARTED|Overall Study||60
11200641|NCT01827670|12390805|FG001|STARTED|Overall Study||59
11200642|NCT01827670|12390804|FG000|COMPLETED|Overall Study||57
11200643|NCT01827670|12390805|FG001|COMPLETED|Overall Study||56
11200644|NCT01827670|12390804|FG000|NOT COMPLETED|Overall Study||3
11200645|NCT01827670|12390805|FG001|NOT COMPLETED|Overall Study||3
11200646|NCT01827787|12390818|FG000|STARTED|Overall Study||45
11200647|NCT01827787|12390819|FG001|STARTED|Overall Study||38
11200648|NCT01827787|12390818|FG000|COMPLETED|Overall Study||45
11200649|NCT01827787|12390819|FG001|COMPLETED|Overall Study||38
11200650|NCT01827787|12390818|FG000|NOT COMPLETED|Overall Study||0
11200651|NCT01827787|12390819|FG001|NOT COMPLETED|Overall Study||0
11200652|NCT01827839|12390828|FG000|STARTED|Overall Study||96
11200653|NCT01827839|12390828|FG000|COMPLETED|Overall Study||93
11200654|NCT01827839|12390828|FG000|NOT COMPLETED|Overall Study||3
11200655|NCT01827930|12390842|FG000|STARTED|Overall Study||24
11200656|NCT01827930|12390843|FG001|STARTED|Overall Study||25
11200657|NCT01827930|12390844|FG002|STARTED|Overall Study||19
11200658|NCT01827930|12390842|FG000|COMPLETED|Overall Study||24
11200659|NCT01827930|12390843|FG001|COMPLETED|Overall Study||25
11324893|NCT02750306|12522287|FG000|STARTED|Overall Study||142
11324894|NCT02750306|12522288|FG001|STARTED|Overall Study||143
11324895|NCT02750306|12522287|FG000|COMPLETED|Overall Study||136
11324896|NCT02750306|12522288|FG001|COMPLETED|Overall Study||141
11324897|NCT02750306|12522287|FG000|NOT COMPLETED|Overall Study||6
11324898|NCT02750306|12522288|FG001|NOT COMPLETED|Overall Study||2
11324899|NCT02750332|12522294|FG000|STARTED|Treatment Period 1||10
11324900|NCT02750332|12522295|FG001|STARTED|Treatment Period 1||10
11324901|NCT02750332|12522294|FG000|COMPLETED|Treatment Period 1||10
11324902|NCT02750332|12522295|FG001|COMPLETED|Treatment Period 1||9
11324903|NCT02750332|12522294|FG000|NOT COMPLETED|Treatment Period 1||0
11324904|NCT02750332|12522295|FG001|NOT COMPLETED|Treatment Period 1||1
11324905|NCT02750332|12522294|FG000|STARTED|Treatment Period 2||10
11324906|NCT02750332|12522295|FG001|STARTED|Treatment Period 2||9
11324907|NCT02750332|12522294|FG000|COMPLETED|Treatment Period 2||10
11324908|NCT02750332|12522295|FG001|COMPLETED|Treatment Period 2||9
11324909|NCT02750332|12522294|FG000|NOT COMPLETED|Treatment Period 2||0
11324910|NCT02750332|12522295|FG001|NOT COMPLETED|Treatment Period 2||0
11324911|NCT02750345|12522301|FG000|STARTED|Intervention 1||4
11324912|NCT02750345|12522302|FG001|STARTED|Intervention 1||4
11324913|NCT02750345|12522303|FG002|STARTED|Intervention 1||4
11324914|NCT02750345|12522304|FG003|STARTED|Intervention 1||4
11324915|NCT02750345|12522305|FG004|STARTED|Intervention 1||4
11324916|NCT02750345|12522306|FG005|STARTED|Intervention 1||4
11324917|NCT02750345|12522301|FG000|COMPLETED|Intervention 1||4
11324918|NCT02750345|12522302|FG001|COMPLETED|Intervention 1||4
11324919|NCT02750345|12522303|FG002|COMPLETED|Intervention 1||4
11324920|NCT02750345|12522304|FG003|COMPLETED|Intervention 1||4
11324921|NCT02750345|12522305|FG004|COMPLETED|Intervention 1||3
11324922|NCT02750345|12522306|FG005|COMPLETED|Intervention 1||4
11324923|NCT02750345|12522301|FG000|NOT COMPLETED|Intervention 1||0
11324924|NCT02750345|12522302|FG001|NOT COMPLETED|Intervention 1||0
11324925|NCT02750345|12522303|FG002|NOT COMPLETED|Intervention 1||0
11324926|NCT02750345|12522304|FG003|NOT COMPLETED|Intervention 1||0
11324927|NCT02750345|12522305|FG004|NOT COMPLETED|Intervention 1||1
11324928|NCT02750345|12522306|FG005|NOT COMPLETED|Intervention 1||0
11324929|NCT02750345|12522301|FG000|STARTED|Intervention 2||4
11324930|NCT02750345|12522302|FG001|STARTED|Intervention 2||4
11324931|NCT02750345|12522303|FG002|STARTED|Intervention 2||4
11324932|NCT02750345|12522304|FG003|STARTED|Intervention 2||4
11324933|NCT02750345|12522305|FG004|STARTED|Intervention 2||3
11324934|NCT02750345|12522306|FG005|STARTED|Intervention 2||4
11324935|NCT02750345|12522301|FG000|COMPLETED|Intervention 2||4
11324936|NCT02750345|12522302|FG001|COMPLETED|Intervention 2||4
11324937|NCT02750345|12522303|FG002|COMPLETED|Intervention 2||4
11200660|NCT01827930|12390844|FG002|COMPLETED|Overall Study||19
11324938|NCT02750345|12522304|FG003|COMPLETED|Intervention 2||4
11324939|NCT02750345|12522305|FG004|COMPLETED|Intervention 2||3
11324940|NCT02750345|12522306|FG005|COMPLETED|Intervention 2||4
11324941|NCT02750345|12522301|FG000|NOT COMPLETED|Intervention 2||0
11324942|NCT02750345|12522302|FG001|NOT COMPLETED|Intervention 2||0
11324943|NCT02750345|12522303|FG002|NOT COMPLETED|Intervention 2||0
11324944|NCT02750345|12522304|FG003|NOT COMPLETED|Intervention 2||0
11324945|NCT02750345|12522305|FG004|NOT COMPLETED|Intervention 2||0
11324946|NCT02750345|12522306|FG005|NOT COMPLETED|Intervention 2||0
11324947|NCT02750345|12522301|FG000|STARTED|Intervention 3||4
11324948|NCT02750345|12522302|FG001|STARTED|Intervention 3||4
11324949|NCT02750345|12522303|FG002|STARTED|Intervention 3||4
11324950|NCT02750345|12522304|FG003|STARTED|Intervention 3||4
11324951|NCT02750345|12522305|FG004|STARTED|Intervention 3||3
11324952|NCT02750345|12522306|FG005|STARTED|Intervention 3||4
11324953|NCT02750345|12522301|FG000|COMPLETED|Intervention 3||4
11324954|NCT02750345|12522302|FG001|COMPLETED|Intervention 3||4
11324955|NCT02750345|12522303|FG002|COMPLETED|Intervention 3||4
11324956|NCT02750345|12522304|FG003|COMPLETED|Intervention 3||4
11324957|NCT02750345|12522305|FG004|COMPLETED|Intervention 3||3
11324958|NCT02750345|12522306|FG005|COMPLETED|Intervention 3||4
11324959|NCT02750345|12522301|FG000|NOT COMPLETED|Intervention 3||0
11324960|NCT02750345|12522302|FG001|NOT COMPLETED|Intervention 3||0
11324961|NCT02750345|12522303|FG002|NOT COMPLETED|Intervention 3||0
11324962|NCT02750345|12522304|FG003|NOT COMPLETED|Intervention 3||0
11324963|NCT02750345|12522305|FG004|NOT COMPLETED|Intervention 3||0
11324964|NCT02750345|12522306|FG005|NOT COMPLETED|Intervention 3||0
11324965|NCT02750410|12522318|FG000|STARTED|Double-Blind Treatment Period||39
11324966|NCT02750410|12522319|FG001|STARTED|Double-Blind Treatment Period||120
11324967|NCT02750410|12522318|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39
11324968|NCT02750410|12522319|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120
11324969|NCT02750410|12522318|FG000|COMPLETED|Double-Blind Treatment Period||37
11324970|NCT02750410|12522319|FG001|COMPLETED|Double-Blind Treatment Period||117
11324971|NCT02750410|12522318|FG000|NOT COMPLETED|Double-Blind Treatment Period||2
11324972|NCT02750410|12522319|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
11324973|NCT02750410|12522318|FG000|STARTED|Open-Label Extension Period||37
11324974|NCT02750410|12522319|FG001|STARTED|Open-Label Extension Period||117
11324975|NCT02750410|12522318|FG000|COMPLETED|Open-Label Extension Period||31
11324976|NCT02750410|12522319|FG001|COMPLETED|Open-Label Extension Period||111
11324977|NCT02750410|12522318|FG000|NOT COMPLETED|Open-Label Extension Period||6
11324978|NCT02750410|12522319|FG001|NOT COMPLETED|Open-Label Extension Period||6
11324979|NCT02750501|12522329|FG000|STARTED|Overall Study||44
11324980|NCT02750501|12522329|FG000|Enrolled|Overall Study||44
11324981|NCT02750501|12522329|FG000|Treated|Overall Study||39
11324982|NCT02750501|12522329|FG000|COMPLETED|Overall Study||36
11324983|NCT02750501|12522329|FG000|NOT COMPLETED|Overall Study||8
11324984|NCT02750514|12522342|FG000|STARTED|Track 1||40
11324985|NCT02750514|12522343|FG001|STARTED|Track 1||4
11324986|NCT02750514|12522344|FG002|STARTED|Track 1||0
11324987|NCT02750514|12522345|FG003|STARTED|Track 1||3
11324988|NCT02750514|12522346|FG004|STARTED|Track 1||0
11324989|NCT02750514|12522342|FG000|COMPLETED|Track 1|3 participants were re-randomized to track 3 (2 part.) or track 5 (1 part.)|13
11324990|NCT02750514|12522343|FG001|COMPLETED|Track 1||2
11324991|NCT02750514|12522344|FG002|COMPLETED|Track 1||0
11324992|NCT02750514|12522345|FG003|COMPLETED|Track 1||1
11324993|NCT02750514|12522346|FG004|COMPLETED|Track 1||0
11324994|NCT02750514|12522342|FG000|NOT COMPLETED|Track 1||27
11324995|NCT02750514|12522343|FG001|NOT COMPLETED|Track 1||2
11324996|NCT02750514|12522344|FG002|NOT COMPLETED|Track 1||0
11324997|NCT02750514|12522345|FG003|NOT COMPLETED|Track 1||2
11324998|NCT02750514|12522346|FG004|NOT COMPLETED|Track 1||0
11324999|NCT02750514|12522342|FG000|STARTED|Track 2||9
11325000|NCT02750514|12522343|FG001|STARTED|Track 2||8
11325001|NCT02750514|12522344|FG002|STARTED|Track 2||2
11325002|NCT02750514|12522345|FG003|STARTED|Track 2||12
11325003|NCT02750514|12522346|FG004|STARTED|Track 2||0
11325004|NCT02750514|12522342|FG000|COMPLETED|Track 2|2 participants were re-randomized to track 3 (1 part.) or track 5 (1 part.)|3
11325005|NCT02750514|12522343|FG001|COMPLETED|Track 2||0
11325006|NCT02750514|12522344|FG002|COMPLETED|Track 2||0
11325007|NCT02750514|12522345|FG003|COMPLETED|Track 2|1 participant was re-randomized to track 5|5
11325008|NCT02750514|12522346|FG004|COMPLETED|Track 2||0
11325009|NCT02750514|12522342|FG000|NOT COMPLETED|Track 2||6
11325010|NCT02750514|12522343|FG001|NOT COMPLETED|Track 2||8
11325011|NCT02750514|12522344|FG002|NOT COMPLETED|Track 2||2
11325012|NCT02750514|12522345|FG003|NOT COMPLETED|Track 2||7
11325013|NCT02750514|12522346|FG004|NOT COMPLETED|Track 2||0
11325014|NCT02750514|12522342|FG000|STARTED|Track 3||0
11325015|NCT02750514|12522343|FG001|STARTED|Track 3|2 participants had prior treatment in track 1 (1 part.) or track 2 (1 part.)|41
11325016|NCT02750514|12522344|FG002|STARTED|Track 3|1 participant had prior treatment in track 3|16
11325017|NCT02750514|12522345|FG003|STARTED|Track 3|5 participants had prior treatment in track 1 (1 part.) or track 3 (4 part.)|18
11325018|NCT02750514|12522346|FG004|STARTED|Track 3||0
11325019|NCT02750514|12522342|FG000|COMPLETED|Track 3||0
11325020|NCT02750514|12522343|FG001|COMPLETED|Track 3|6 participants were re-randomized to track 3 (5 part.) or to track 5 (1 part.)|5
11325021|NCT02750514|12522344|FG002|COMPLETED|Track 3||1
11325022|NCT02750514|12522345|FG003|COMPLETED|Track 3|1 participant was re-randomized to track 5|2
11325023|NCT02750514|12522346|FG004|COMPLETED|Track 3||0
11325024|NCT02750514|12522342|FG000|NOT COMPLETED|Track 3||0
11325025|NCT02750514|12522343|FG001|NOT COMPLETED|Track 3||36
11325026|NCT02750514|12522344|FG002|NOT COMPLETED|Track 3||15
11325027|NCT02750514|12522345|FG003|NOT COMPLETED|Track 3||16
11325028|NCT02750514|12522346|FG004|NOT COMPLETED|Track 3||0
11325029|NCT02750514|12522342|FG000|STARTED|Track 4||0
11325030|NCT02750514|12522343|FG001|STARTED|Track 4||53
11325031|NCT02750514|12522344|FG002|STARTED|Track 4||0
11325032|NCT02750514|12522345|FG003|STARTED|Track 4||60
11325033|NCT02750514|12522346|FG004|STARTED|Track 4||0
11325034|NCT02750514|12522342|FG000|COMPLETED|Track 4||0
11325035|NCT02750514|12522343|FG001|COMPLETED|Track 4|1 participant was re-randomized to track 5|2
11325036|NCT02750514|12522344|FG002|COMPLETED|Track 4||0
11325037|NCT02750514|12522345|FG003|COMPLETED|Track 4||18
11325038|NCT02750514|12522346|FG004|COMPLETED|Track 4||0
11325039|NCT02750514|12522342|FG000|NOT COMPLETED|Track 4||0
11325040|NCT02750514|12522343|FG001|NOT COMPLETED|Track 4||51
11325041|NCT02750514|12522344|FG002|NOT COMPLETED|Track 4||0
11325042|NCT02750514|12522345|FG003|NOT COMPLETED|Track 4||42
11325043|NCT02750514|12522346|FG004|NOT COMPLETED|Track 4||0
11325044|NCT02750514|12522342|FG000|STARTED|Track 5||0
11325045|NCT02750514|12522343|FG001|STARTED|Track 5||0
11325046|NCT02750514|12522344|FG002|STARTED|Track 5||0
11325047|NCT02750514|12522345|FG003|STARTED|Track 5||0
11325048|NCT02750514|12522346|FG004|STARTED|Track 5|6 participants had prior treatment in track 1 (1 part.), 2 (2 part.), 3 (2 part.) or 4 (1 part.)|43
11325049|NCT02750514|12522342|FG000|COMPLETED|Track 5||0
11325050|NCT02750514|12522343|FG001|COMPLETED|Track 5||0
11325051|NCT02750514|12522344|FG002|COMPLETED|Track 5||0
11325052|NCT02750514|12522345|FG003|COMPLETED|Track 5||0
11325053|NCT02750514|12522346|FG004|COMPLETED|Track 5||0
11325054|NCT02750514|12522342|FG000|NOT COMPLETED|Track 5||0
11325055|NCT02750514|12522343|FG001|NOT COMPLETED|Track 5||0
11325056|NCT02750514|12522344|FG002|NOT COMPLETED|Track 5||0
11325057|NCT02750514|12522345|FG003|NOT COMPLETED|Track 5||0
11325058|NCT02750514|12522346|FG004|NOT COMPLETED|Track 5||43
11325059|NCT02750592|12522366|FG000|STARTED|Overall Study||30
11325060|NCT02750592|12522366|FG000|COMPLETED|Overall Study||25
11325061|NCT02750592|12522366|FG000|NOT COMPLETED|Overall Study||5
11325062|NCT02750618|12522370|FG000|STARTED|Overall Study||13
11325063|NCT02750618|12522370|FG000|Completed Week 40|Overall Study||13
11325064|NCT02750618|12522370|FG000|Completed Week 64|Overall Study||13
11325065|NCT02750618|12522370|FG000|COMPLETED|Overall Study||12
11325066|NCT02750618|12522370|FG000|NOT COMPLETED|Overall Study||1
11325067|NCT02750709|12522374|FG000|STARTED|Treatment Period 1||4
11325068|NCT02750709|12522375|FG001|STARTED|Treatment Period 1||4
11325069|NCT02750709|12522376|FG002|STARTED|Treatment Period 1||4
11325070|NCT02750709|12522377|FG003|STARTED|Treatment Period 1||4
11325071|NCT02750709|12522378|FG004|STARTED|Treatment Period 1||4
11325072|NCT02750709|12522379|FG005|STARTED|Treatment Period 1||4
11325073|NCT02750709|12522374|FG000|COMPLETED|Treatment Period 1||4
11325074|NCT02750709|12522375|FG001|COMPLETED|Treatment Period 1||4
11325075|NCT02750709|12522376|FG002|COMPLETED|Treatment Period 1||4
11325076|NCT02750709|12522377|FG003|COMPLETED|Treatment Period 1||4
11325077|NCT02750709|12522378|FG004|COMPLETED|Treatment Period 1||4
11325078|NCT02750709|12522379|FG005|COMPLETED|Treatment Period 1||3
11325079|NCT02750709|12522374|FG000|NOT COMPLETED|Treatment Period 1||0
11325080|NCT02750709|12522375|FG001|NOT COMPLETED|Treatment Period 1||0
11325081|NCT02750709|12522376|FG002|NOT COMPLETED|Treatment Period 1||0
11325082|NCT02750709|12522377|FG003|NOT COMPLETED|Treatment Period 1||0
11325083|NCT02750709|12522378|FG004|NOT COMPLETED|Treatment Period 1||0
11325084|NCT02750709|12522379|FG005|NOT COMPLETED|Treatment Period 1||1
11325085|NCT02750709|12522374|FG000|STARTED|Treatment Period 2||4
11325086|NCT02750709|12522375|FG001|STARTED|Treatment Period 2||4
11325087|NCT02750709|12522376|FG002|STARTED|Treatment Period 2||4
11325088|NCT02750709|12522377|FG003|STARTED|Treatment Period 2||4
11325089|NCT02750709|12522378|FG004|STARTED|Treatment Period 2||4
11325090|NCT02750709|12522379|FG005|STARTED|Treatment Period 2||3
11325091|NCT02750709|12522374|FG000|COMPLETED|Treatment Period 2||4
11325092|NCT02750709|12522375|FG001|COMPLETED|Treatment Period 2||4
11325093|NCT02750709|12522376|FG002|COMPLETED|Treatment Period 2||4
11325094|NCT02750709|12522377|FG003|COMPLETED|Treatment Period 2||4
11325095|NCT02750709|12522378|FG004|COMPLETED|Treatment Period 2||4
11325096|NCT02750709|12522379|FG005|COMPLETED|Treatment Period 2||3
11325097|NCT02750709|12522374|FG000|NOT COMPLETED|Treatment Period 2||0
11325098|NCT02750709|12522375|FG001|NOT COMPLETED|Treatment Period 2||0
11325099|NCT02750709|12522376|FG002|NOT COMPLETED|Treatment Period 2||0
11325100|NCT02750709|12522377|FG003|NOT COMPLETED|Treatment Period 2||0
11325101|NCT02750709|12522378|FG004|NOT COMPLETED|Treatment Period 2||0
11325102|NCT02750709|12522379|FG005|NOT COMPLETED|Treatment Period 2||0
11325103|NCT02750709|12522374|FG000|STARTED|Treatment Period 3||4
11325104|NCT02750709|12522375|FG001|STARTED|Treatment Period 3||4
11325105|NCT02750709|12522376|FG002|STARTED|Treatment Period 3||4
11325106|NCT02750709|12522377|FG003|STARTED|Treatment Period 3||4
11325107|NCT02750709|12522378|FG004|STARTED|Treatment Period 3||4
11325108|NCT02750709|12522379|FG005|STARTED|Treatment Period 3||3
11325109|NCT02750709|12522374|FG000|COMPLETED|Treatment Period 3||4
11325110|NCT02750709|12522375|FG001|COMPLETED|Treatment Period 3||4
11325111|NCT02750709|12522376|FG002|COMPLETED|Treatment Period 3||4
11325112|NCT02750709|12522377|FG003|COMPLETED|Treatment Period 3||4
11325113|NCT02750709|12522378|FG004|COMPLETED|Treatment Period 3||4
11325114|NCT02750709|12522379|FG005|COMPLETED|Treatment Period 3||3
11325115|NCT02750709|12522374|FG000|NOT COMPLETED|Treatment Period 3||0
11325116|NCT02750709|12522375|FG001|NOT COMPLETED|Treatment Period 3||0
11325117|NCT02750709|12522376|FG002|NOT COMPLETED|Treatment Period 3||0
11325118|NCT02750709|12522377|FG003|NOT COMPLETED|Treatment Period 3||0
11325119|NCT02750709|12522378|FG004|NOT COMPLETED|Treatment Period 3||0
11325120|NCT02750709|12522379|FG005|NOT COMPLETED|Treatment Period 3||0
11325121|NCT02750761|12522393|FG000|STARTED|Overall Study||5
11325122|NCT02750761|12522394|FG001|STARTED|Overall Study||5
11325123|NCT02750761|12522395|FG002|STARTED|Overall Study||5
11325124|NCT02750761|12522396|FG003|STARTED|Overall Study||5
11325125|NCT02750761|12522397|FG004|STARTED|Overall Study||6
11325126|NCT02750761|12522398|FG005|STARTED|Overall Study||6
11325127|NCT02750761|12522393|FG000|COMPLETED|Overall Study||5
11325128|NCT02750761|12522394|FG001|COMPLETED|Overall Study||5
11325129|NCT02750761|12522395|FG002|COMPLETED|Overall Study||4
11325130|NCT02750761|12522396|FG003|COMPLETED|Overall Study||5
11325131|NCT02750761|12522397|FG004|COMPLETED|Overall Study||6
11325132|NCT02750761|12522398|FG005|COMPLETED|Overall Study||6
11325133|NCT02750761|12522393|FG000|NOT COMPLETED|Overall Study||0
11325134|NCT02750761|12522394|FG001|NOT COMPLETED|Overall Study||0
11325135|NCT02750761|12522395|FG002|NOT COMPLETED|Overall Study||1
11325136|NCT02750761|12522396|FG003|NOT COMPLETED|Overall Study||0
11325137|NCT02750761|12522397|FG004|NOT COMPLETED|Overall Study||0
11325138|NCT02750761|12522398|FG005|NOT COMPLETED|Overall Study||0
11325139|NCT02750800|12522422|FG000|STARTED|Overall Study||412
11325140|NCT02750800|12522422|FG000|COMPLETED|Overall Study||314
11325141|NCT02750800|12522422|FG000|NOT COMPLETED|Overall Study||98
11325142|NCT02750813|12522440|FG000|STARTED|Period 1, First 14 Days of Wear||125
11325143|NCT02750813|12522441|FG001|STARTED|Period 1, First 14 Days of Wear||121
11325144|NCT02750813|12522440|FG000|COMPLETED|Period 1, First 14 Days of Wear||124
11325145|NCT02750813|12522441|FG001|COMPLETED|Period 1, First 14 Days of Wear||120
11325146|NCT02750813|12522440|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||1
11325147|NCT02750813|12522441|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1
11325148|NCT02750813|12522440|FG000|STARTED|Period 2, Second 14 Days of Wear||124
11325149|NCT02750813|12522441|FG001|STARTED|Period 2, Second 14 Days of Wear||120
11325150|NCT02750813|12522440|FG000|COMPLETED|Period 2, Second 14 Days of Wear||124
11325151|NCT02750813|12522441|FG001|COMPLETED|Period 2, Second 14 Days of Wear||120
11325152|NCT02750813|12522440|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
11325153|NCT02750813|12522441|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
11325154|NCT02750930|12522448|FG000|STARTED|Overall Study||8
11325155|NCT02750930|12522448|FG000|COMPLETED|Overall Study||0
11325156|NCT02750930|12522448|FG000|NOT COMPLETED|Overall Study||8
11325157|NCT02750943|12522454|FG000|STARTED|Overall Study||125
11325158|NCT02750943|12522455|FG001|STARTED|Overall Study||128
11325159|NCT02750943|12522454|FG000|COMPLETED|Overall Study||119
11325160|NCT02750943|12522455|FG001|COMPLETED|Overall Study||119
11325161|NCT02750943|12522454|FG000|NOT COMPLETED|Overall Study||6
11325162|NCT02750943|12522455|FG001|NOT COMPLETED|Overall Study||9
11325163|NCT02751320|12522461|FG000|STARTED|Overall Study||45
11325164|NCT02751320|12522461|FG000|Received Test Product 1|Overall Study||29
11325165|NCT02751320|12522461|FG000|Received Test Prodcut 2|Overall Study||28
11325166|NCT02751320|12522461|FG000|Received Test Prodcut 3|Overall Study||28
11325167|NCT02751320|12522461|FG000|Received Reference Product 1|Overall Study||29
11325168|NCT02751320|12522461|FG000|Received Reference Product 2|Overall Study||28
11325169|NCT02751320|12522461|FG000|Received Reference Product 3|Overall Study||28
11325170|NCT02751320|12522461|FG000|COMPLETED|Overall Study||42
11325171|NCT02751320|12522461|FG000|NOT COMPLETED|Overall Study||3
11325172|NCT02751359|12522486|FG000|STARTED|Overall Study||18
11325173|NCT02751359|12522486|FG000|COMPLETED|Overall Study||17
11325174|NCT02751359|12522486|FG000|NOT COMPLETED|Overall Study||1
11325175|NCT02751385|12522496|FG000|STARTED|Period 1||2
11325176|NCT02751385|12522497|FG001|STARTED|Period 1||0
11325177|NCT02751385|12522496|FG000|COMPLETED|Period 1||2
11325178|NCT02751385|12522497|FG001|COMPLETED|Period 1||0
11325179|NCT02751385|12522496|FG000|NOT COMPLETED|Period 1||0
11325180|NCT02751385|12522497|FG001|NOT COMPLETED|Period 1||0
11325181|NCT02751385|12522496|FG000|STARTED|Period 2||0
11325182|NCT02751385|12522497|FG001|STARTED|Period 2||2
11325183|NCT02751385|12522496|FG000|COMPLETED|Period 2||0
11325184|NCT02751385|12522497|FG001|COMPLETED|Period 2||2
11325185|NCT02751385|12522496|FG000|NOT COMPLETED|Period 2||0
11325186|NCT02751385|12522497|FG001|NOT COMPLETED|Period 2||0
11325187|NCT02751424|12522514|FG000|STARTED|Part 1||6
11325188|NCT02751424|12522515|FG001|STARTED|Part 1||6
11325189|NCT02751424|12522516|FG002|STARTED|Part 1||6
11325190|NCT02751424|12522517|FG003|STARTED|Part 1||6
11325191|NCT02751424|12522518|FG004|STARTED|Part 1||6
11325192|NCT02751424|12522519|FG005|STARTED|Part 1||6
11325193|NCT02751424|12522520|FG006|STARTED|Part 1||12
11325194|NCT02751424|12522521|FG007|STARTED|Part 1||0
11325195|NCT02751424|12522522|FG008|STARTED|Part 1||0
11325196|NCT02751424|12522514|FG000|COMPLETED|Part 1||6
11325197|NCT02751424|12522515|FG001|COMPLETED|Part 1||6
11325198|NCT02751424|12522516|FG002|COMPLETED|Part 1||6
11325199|NCT02751424|12522517|FG003|COMPLETED|Part 1||6
11325200|NCT02751424|12522518|FG004|COMPLETED|Part 1||6
11325201|NCT02751424|12522519|FG005|COMPLETED|Part 1||6
11325202|NCT02751424|12522520|FG006|COMPLETED|Part 1||12
11325203|NCT02751424|12522521|FG007|COMPLETED|Part 1||0
11325204|NCT02751424|12522522|FG008|COMPLETED|Part 1||0
11325205|NCT02751424|12522514|FG000|NOT COMPLETED|Part 1||0
11325206|NCT02751424|12522515|FG001|NOT COMPLETED|Part 1||0
11325207|NCT02751424|12522516|FG002|NOT COMPLETED|Part 1||0
11325208|NCT02751424|12522517|FG003|NOT COMPLETED|Part 1||0
11325209|NCT02751424|12522518|FG004|NOT COMPLETED|Part 1||0
11325210|NCT02751424|12522519|FG005|NOT COMPLETED|Part 1||0
11325211|NCT02751424|12522520|FG006|NOT COMPLETED|Part 1||0
11325212|NCT02751424|12522521|FG007|NOT COMPLETED|Part 1||0
11325213|NCT02751424|12522522|FG008|NOT COMPLETED|Part 1||0
11325214|NCT02751424|12522514|FG000|STARTED|Part 2||0
11325215|NCT02751424|12522515|FG001|STARTED|Part 2||0
11325216|NCT02751424|12522516|FG002|STARTED|Part 2||0
11325217|NCT02751424|12522517|FG003|STARTED|Part 2||0
11325218|NCT02751424|12522518|FG004|STARTED|Part 2||0
11325219|NCT02751424|12522519|FG005|STARTED|Part 2||0
11325220|NCT02751424|12522520|FG006|STARTED|Part 2||0
11325221|NCT02751424|12522521|FG007|STARTED|Part 2||11
11325222|NCT02751424|12522522|FG008|STARTED|Part 2||3
11325223|NCT02751424|12522514|FG000|COMPLETED|Part 2||0
11325224|NCT02751424|12522515|FG001|COMPLETED|Part 2||0
11325225|NCT02751424|12522516|FG002|COMPLETED|Part 2||0
11325226|NCT02751424|12522517|FG003|COMPLETED|Part 2||0
11325227|NCT02751424|12522518|FG004|COMPLETED|Part 2||0
11325228|NCT02751424|12522519|FG005|COMPLETED|Part 2||0
11325229|NCT02751424|12522520|FG006|COMPLETED|Part 2||0
11325230|NCT02751424|12522521|FG007|COMPLETED|Part 2||6
11325231|NCT02751424|12522522|FG008|COMPLETED|Part 2||3
11325232|NCT02751424|12522514|FG000|NOT COMPLETED|Part 2||0
11325233|NCT02751424|12522515|FG001|NOT COMPLETED|Part 2||0
11325234|NCT02751424|12522516|FG002|NOT COMPLETED|Part 2||0
11325235|NCT02751424|12522517|FG003|NOT COMPLETED|Part 2||0
11325236|NCT02751424|12522518|FG004|NOT COMPLETED|Part 2||0
11325237|NCT02751424|12522519|FG005|NOT COMPLETED|Part 2||0
11325238|NCT02751424|12522520|FG006|NOT COMPLETED|Part 2||0
11325239|NCT02751424|12522521|FG007|NOT COMPLETED|Part 2||5
11325240|NCT02751424|12522522|FG008|NOT COMPLETED|Part 2||0
11325241|NCT02751450|12522547|FG000|STARTED|Overall Study||117
11325242|NCT02751450|12522548|FG001|STARTED|Overall Study||116
11325243|NCT02751450|12522547|FG000|COMPLETED|Overall Study||116
11325244|NCT02751450|12522548|FG001|COMPLETED|Overall Study||116
11325245|NCT02751450|12522547|FG000|NOT COMPLETED|Overall Study||1
11325246|NCT02751450|12522548|FG001|NOT COMPLETED|Overall Study||0
11325247|NCT02751580|12522556|FG000|STARTED|Overall Study||37
11325248|NCT02751580|12522556|FG000|COMPLETED|Overall Study||31
11325249|NCT02751580|12522556|FG000|NOT COMPLETED|Overall Study||6
11325250|NCT02751827|12522563|FG000|STARTED|Overall Study||41
11325251|NCT02751827|12522564|FG001|STARTED|Overall Study||171
11325252|NCT02751827|12522565|FG002|STARTED|Overall Study||100
11325253|NCT02751827|12522563|FG000|COMPLETED|Overall Study||41
11325254|NCT02751827|12522564|FG001|COMPLETED|Overall Study||171
11325255|NCT02751827|12522565|FG002|COMPLETED|Overall Study||99
11325256|NCT02751827|12522563|FG000|NOT COMPLETED|Overall Study||0
11325257|NCT02751827|12522564|FG001|NOT COMPLETED|Overall Study||0
11325258|NCT02751827|12522565|FG002|NOT COMPLETED|Overall Study||1
11027201|NCT00832975|12205923|FG000|NOT COMPLETED|Overall Study||39
11027202|NCT00833027|12205927|FG000|STARTED|Overall Study||608
11027203|NCT00833027|12205927|FG000|COMPLETED|Overall Study||397
11325259|NCT02751879|12522575|FG000|STARTED|Overall Study||157
11325260|NCT02751879|12522576|FG001|STARTED|Overall Study||71
11325261|NCT02751879|12522575|FG000|On Treatment at Study Completion|Overall Study||81
11325262|NCT02751879|12522576|FG001|On Treatment at Study Completion|Overall Study||41
11325263|NCT02751879|12522575|FG000|COMPLETED|Overall Study||157
11325264|NCT02751879|12522576|FG001|COMPLETED|Overall Study||71
11325265|NCT02751879|12522575|FG000|NOT COMPLETED|Overall Study||0
11325266|NCT02751879|12522576|FG001|NOT COMPLETED|Overall Study||0
11325267|NCT02751931|12522587|FG000|STARTED|Overall Study||56
11325268|NCT02751931|12522588|FG001|STARTED|Overall Study||35
11325269|NCT02751931|12522587|FG000|Treated|Overall Study||55
11325270|NCT02751931|12522588|FG001|Treated|Overall Study||31
11325271|NCT02751931|12522587|FG000|COMPLETED|Overall Study||43
11325272|NCT02751931|12522588|FG001|COMPLETED|Overall Study||27
11325273|NCT02751931|12522587|FG000|NOT COMPLETED|Overall Study||13
11325274|NCT02751931|12522588|FG001|NOT COMPLETED|Overall Study||8
11325275|NCT02751983|12522602|FG000|STARTED|Baseline and Randomization||35
11325276|NCT02751983|12522603|FG001|STARTED|Baseline and Randomization||35
11325277|NCT02751983|12522602|FG000|COMPLETED|Baseline and Randomization||35
11325278|NCT02751983|12522603|FG001|COMPLETED|Baseline and Randomization||35
11325279|NCT02751983|12522602|FG000|NOT COMPLETED|Baseline and Randomization||0
11325280|NCT02751983|12522603|FG001|NOT COMPLETED|Baseline and Randomization||0
11325281|NCT02751983|12522602|FG000|STARTED|Treatment||35
11325282|NCT02751983|12522603|FG001|STARTED|Treatment||35
11325283|NCT02751983|12522602|FG000|COMPLETED|Treatment||31
11325284|NCT02751983|12522603|FG001|COMPLETED|Treatment||35
11325285|NCT02751983|12522602|FG000|NOT COMPLETED|Treatment||4
11325286|NCT02751983|12522603|FG001|NOT COMPLETED|Treatment||0
11325287|NCT02751983|12522602|FG000|STARTED|Post-Treatment Assessment||35
11325288|NCT02751983|12522603|FG001|STARTED|Post-Treatment Assessment||0
11325289|NCT02751983|12522602|FG000|COMPLETED|Post-Treatment Assessment||30
11325290|NCT02751983|12522603|FG001|COMPLETED|Post-Treatment Assessment||0
11325291|NCT02751983|12522602|FG000|NOT COMPLETED|Post-Treatment Assessment||5
11325292|NCT02751983|12522603|FG001|NOT COMPLETED|Post-Treatment Assessment||0
11325293|NCT02751983|12522602|FG000|STARTED|One-Month Follow-Up Assessments||35
11325294|NCT02751983|12522603|FG001|STARTED|One-Month Follow-Up Assessments||35
11325295|NCT02751983|12522602|FG000|COMPLETED|One-Month Follow-Up Assessments||21
11325296|NCT02751983|12522603|FG001|COMPLETED|One-Month Follow-Up Assessments||23
11325297|NCT02751983|12522602|FG000|NOT COMPLETED|One-Month Follow-Up Assessments||14
11325298|NCT02751983|12522603|FG001|NOT COMPLETED|One-Month Follow-Up Assessments||12
11325299|NCT02751983|12522602|FG000|STARTED|Three-Month Follow-Up Assessments||35
11325300|NCT02751983|12522603|FG001|STARTED|Three-Month Follow-Up Assessments||35
11325301|NCT02751983|12522602|FG000|COMPLETED|Three-Month Follow-Up Assessments||23
11325302|NCT02751983|12522603|FG001|COMPLETED|Three-Month Follow-Up Assessments||19
11325303|NCT02751983|12522602|FG000|NOT COMPLETED|Three-Month Follow-Up Assessments||12
11325304|NCT02751983|12522603|FG001|NOT COMPLETED|Three-Month Follow-Up Assessments||16
11325305|NCT02752048|12522612|FG000|STARTED|Overall Study||11
11325306|NCT02752048|12522613|FG001|STARTED|Overall Study||12
11325307|NCT02752048|12522614|FG002|STARTED|Overall Study||13
11325308|NCT02752048|12522612|FG000|COMPLETED|Overall Study||11
11325309|NCT02752048|12522613|FG001|COMPLETED|Overall Study||12
11325310|NCT02752048|12522614|FG002|COMPLETED|Overall Study||10
11325311|NCT02752048|12522612|FG000|NOT COMPLETED|Overall Study||0
11325312|NCT02752048|12522613|FG001|NOT COMPLETED|Overall Study||0
11325313|NCT02752048|12522614|FG002|NOT COMPLETED|Overall Study||3
11325314|NCT02752074|12522624|FG000|STARTED|Overall Study||354
11325315|NCT02752074|12522625|FG001|STARTED|Overall Study||352
11325316|NCT02752074|12522624|FG000|Treated|Overall Study||353
11325317|NCT02752074|12522625|FG001|Treated|Overall Study||352
11325318|NCT02752074|12522624|FG000|COMPLETED|Overall Study||198
11325319|NCT02752074|12522625|FG001|COMPLETED|Overall Study||209
11325320|NCT02752074|12522624|FG000|NOT COMPLETED|Overall Study||156
11325321|NCT02752074|12522625|FG001|NOT COMPLETED|Overall Study||143
11325322|NCT02752087|12522631|FG000|STARTED|Study Period 1||12
11325323|NCT02752087|12522632|FG001|STARTED|Study Period 1||12
11325324|NCT02752087|12522631|FG000|Received Study Drug|Study Period 1||12
11325325|NCT02752087|12522632|FG001|Received Study Drug|Study Period 1||12
11325326|NCT02752087|12522631|FG000|COMPLETED|Study Period 1||12
11325327|NCT02752087|12522632|FG001|COMPLETED|Study Period 1||12
11325328|NCT02752087|12522631|FG000|NOT COMPLETED|Study Period 1||0
11325329|NCT02752087|12522632|FG001|NOT COMPLETED|Study Period 1||0
11325330|NCT02752087|12522631|FG000|STARTED|Washout||12
11325331|NCT02752087|12522632|FG001|STARTED|Washout||12
11325332|NCT02752087|12522631|FG000|COMPLETED|Washout||11
11325333|NCT02752087|12522632|FG001|COMPLETED|Washout||12
11325334|NCT02752087|12522631|FG000|NOT COMPLETED|Washout||1
11325335|NCT02752087|12522632|FG001|NOT COMPLETED|Washout||0
11325336|NCT02752087|12522631|FG000|STARTED|Study Period 2||11
11325337|NCT02752087|12522632|FG001|STARTED|Study Period 2||12
11325338|NCT02752087|12522631|FG000|Received Study Drug|Study Period 2||11
11325339|NCT02752087|12522632|FG001|Received Study Drug|Study Period 2||12
11325340|NCT02752087|12522631|FG000|COMPLETED|Study Period 2||11
11325341|NCT02752087|12522632|FG001|COMPLETED|Study Period 2||12
11325342|NCT02752087|12522631|FG000|NOT COMPLETED|Study Period 2||0
11325343|NCT02752087|12522632|FG001|NOT COMPLETED|Study Period 2||0
11325344|NCT02752087|12522631|FG000|STARTED|Washout||11
11325345|NCT02752087|12522632|FG001|STARTED|Washout||12
11325346|NCT02752087|12522631|FG000|COMPLETED|Washout||11
11325347|NCT02752087|12522632|FG001|COMPLETED|Washout||12
11325348|NCT02752087|12522631|FG000|NOT COMPLETED|Washout||0
11325349|NCT02752087|12522632|FG001|NOT COMPLETED|Washout||0
11325350|NCT02752087|12522631|FG000|STARTED|Study Period 3||11
11325351|NCT02752087|12522632|FG001|STARTED|Study Period 3||12
11325352|NCT02752087|12522631|FG000|Received Study Drug|Study Period 3||11
11325353|NCT02752087|12522632|FG001|Received Study Drug|Study Period 3||12
11325354|NCT02752087|12522631|FG000|COMPLETED|Study Period 3||11
11325355|NCT02752087|12522632|FG001|COMPLETED|Study Period 3||12
11325356|NCT02752087|12522631|FG000|NOT COMPLETED|Study Period 3||0
11325357|NCT02752087|12522632|FG001|NOT COMPLETED|Study Period 3||0
11027204|NCT00833027|12205927|FG000|NOT COMPLETED|Overall Study||211
11027205|NCT00833040|12205931|FG000|STARTED|Overall Study||6
11027206|NCT00833040|12205932|FG001|STARTED|Overall Study||6
11325358|NCT02752087|12522631|FG000|STARTED|Washout||11
11325359|NCT02752087|12522632|FG001|STARTED|Washout||12
11325360|NCT02752087|12522631|FG000|COMPLETED|Washout||11
11325361|NCT02752087|12522632|FG001|COMPLETED|Washout||12
11325362|NCT02752087|12522631|FG000|NOT COMPLETED|Washout||0
11325363|NCT02752087|12522632|FG001|NOT COMPLETED|Washout||0
11325364|NCT02752087|12522631|FG000|STARTED|Study Period 4||11
11325365|NCT02752087|12522632|FG001|STARTED|Study Period 4||12
11325366|NCT02752087|12522631|FG000|Received Study Drug|Study Period 4||11
11325367|NCT02752087|12522632|FG001|Received Study Drug|Study Period 4||12
11325368|NCT02752087|12522631|FG000|COMPLETED|Study Period 4||11
11325369|NCT02752087|12522632|FG001|COMPLETED|Study Period 4||12
11027207|NCT00833040|12205933|FG002|STARTED|Overall Study||6
11325370|NCT02752087|12522631|FG000|NOT COMPLETED|Study Period 4||0
11325371|NCT02752087|12522632|FG001|NOT COMPLETED|Study Period 4||0
11325372|NCT02752087|12522631|FG000|STARTED|Follow-up||11
11325373|NCT02752087|12522632|FG001|STARTED|Follow-up||12
11325374|NCT02752087|12522631|FG000|COMPLETED|Follow-up||11
11325375|NCT02752087|12522632|FG001|COMPLETED|Follow-up||12
11325376|NCT02752087|12522631|FG000|NOT COMPLETED|Follow-up||0
11325377|NCT02752087|12522632|FG001|NOT COMPLETED|Follow-up||0
11325378|NCT02752256|12522640|FG000|STARTED|Overall Study||35
11325379|NCT02752256|12522641|FG001|STARTED|Overall Study||41
11325380|NCT02752256|12522640|FG000|COMPLETED|Overall Study||35
11325381|NCT02752256|12522641|FG001|COMPLETED|Overall Study||41
11325382|NCT02752256|12522640|FG000|NOT COMPLETED|Overall Study||0
11325383|NCT02752256|12522641|FG001|NOT COMPLETED|Overall Study||0
11325384|NCT02752490|12522649|FG000|STARTED|Overall Study||409
11325385|NCT02752490|12522650|FG001|STARTED|Overall Study||435
11325386|NCT02752490|12522649|FG000|COMPLETED|Overall Study||409
11325387|NCT02752490|12522650|FG001|COMPLETED|Overall Study||435
11325388|NCT02752490|12522649|FG000|NOT COMPLETED|Overall Study||0
11325389|NCT02752490|12522650|FG001|NOT COMPLETED|Overall Study||0
11325390|NCT02752633|12522656|FG000|STARTED|Overall Study||9
11325391|NCT02752633|12522656|FG000|COMPLETED|Overall Study||8
11325392|NCT02752633|12522656|FG000|NOT COMPLETED|Overall Study||1
11325393|NCT02752776|12522663|FG000|STARTED|Overall Study||663
11325394|NCT02752776|12522664|FG001|STARTED|Overall Study||673
11325395|NCT02752776|12522665|FG002|STARTED|Overall Study||324
11325396|NCT02752776|12522663|FG000|COMPLETED|Overall Study||611
11325397|NCT02752776|12522664|FG001|COMPLETED|Overall Study||597
11325398|NCT02752776|12522665|FG002|COMPLETED|Overall Study||276
11325399|NCT02752776|12522663|FG000|NOT COMPLETED|Overall Study||52
11325400|NCT02752776|12522664|FG001|NOT COMPLETED|Overall Study||76
11325401|NCT02752776|12522665|FG002|NOT COMPLETED|Overall Study||48
11325402|NCT02752802|12522677|FG000|STARTED|Overall Study||48
11325403|NCT02752802|12522678|FG001|STARTED|Overall Study||48
11325404|NCT02752802|12522677|FG000|COMPLETED|Overall Study||47
11325405|NCT02752802|12522678|FG001|COMPLETED|Overall Study||48
11325406|NCT02752802|12522677|FG000|NOT COMPLETED|Overall Study||1
11325407|NCT02752802|12522678|FG001|NOT COMPLETED|Overall Study||0
11325408|NCT02752880|12522688|FG000|STARTED|Overall Study||23
11325409|NCT02752880|12522689|FG001|STARTED|Overall Study||23
11325410|NCT02752880|12522688|FG000|COMPLETED|Overall Study||21
11325411|NCT02752880|12522689|FG001|COMPLETED|Overall Study||20
11325412|NCT02752880|12522688|FG000|NOT COMPLETED|Overall Study||2
11325413|NCT02752880|12522689|FG001|NOT COMPLETED|Overall Study||3
11325414|NCT02752958|12522696|FG000|STARTED|Overall Study||75
11325415|NCT02752958|12522696|FG000|COMPLETED|Overall Study||66
11325416|NCT02752958|12522696|FG000|NOT COMPLETED|Overall Study||9
11325417|NCT02753075|12522705|FG000|STARTED|Overall Study||79
11325418|NCT02753075|12522706|FG001|STARTED|Overall Study||80
11325419|NCT02753075|12522707|FG002|STARTED|Overall Study||81
11325420|NCT02753075|12522705|FG000|COMPLETED|Overall Study||71
11325421|NCT02753075|12522706|FG001|COMPLETED|Overall Study||77
11325422|NCT02753075|12522707|FG002|COMPLETED|Overall Study||78
11325423|NCT02753075|12522705|FG000|NOT COMPLETED|Overall Study||8
11325424|NCT02753075|12522706|FG001|NOT COMPLETED|Overall Study||3
11325425|NCT02753075|12522707|FG002|NOT COMPLETED|Overall Study||3
11325426|NCT02753400|12522718|FG000|STARTED|Overall Study||12
11325427|NCT02753400|12522719|FG001|STARTED|Overall Study||12
11325428|NCT02753400|12522718|FG000|COMPLETED|Overall Study||7
11325429|NCT02753400|12522719|FG001|COMPLETED|Overall Study||11
11325430|NCT02753400|12522718|FG000|NOT COMPLETED|Overall Study||5
11325431|NCT02753400|12522719|FG001|NOT COMPLETED|Overall Study||1
11325432|NCT02753413|12522727|FG000|STARTED|Overall Study||49
11325433|NCT02753413|12522728|FG001|STARTED|Overall Study||51
11325434|NCT02753413|12522727|FG000|COMPLETED|Overall Study||49
11325435|NCT02753413|12522728|FG001|COMPLETED|Overall Study||51
11325436|NCT02753413|12522727|FG000|NOT COMPLETED|Overall Study||0
11325437|NCT02753413|12522728|FG001|NOT COMPLETED|Overall Study||0
11325438|NCT02753595|12522736|FG000|STARTED|Overall Study||5
11325439|NCT02753595|12522737|FG001|STARTED|Overall Study||9
11325440|NCT02753595|12522736|FG000|COMPLETED|Overall Study||3
11325441|NCT02753595|12522737|FG001|COMPLETED|Overall Study||7
11325442|NCT02753595|12522736|FG000|NOT COMPLETED|Overall Study||2
11325443|NCT02753595|12522737|FG001|NOT COMPLETED|Overall Study||2
11325444|NCT02753699|12522745|FG000|STARTED|Overall Study||164
11325445|NCT02753699|12522746|FG001|STARTED|Overall Study||397
11325446|NCT02753699|12522747|FG002|STARTED|Overall Study||162
11325447|NCT02753699|12522745|FG000|COMPLETED|Overall Study||150
11325448|NCT02753699|12522746|FG001|COMPLETED|Overall Study||354
11325449|NCT02753699|12522747|FG002|COMPLETED|Overall Study||139
11325450|NCT02753699|12522745|FG000|NOT COMPLETED|Overall Study||14
11325451|NCT02753699|12522746|FG001|NOT COMPLETED|Overall Study||43
11325452|NCT02753699|12522747|FG002|NOT COMPLETED|Overall Study||23
11325453|NCT02753816|12522760|FG000|STARTED|Overall Study||7
11325454|NCT02753816|12522761|FG001|STARTED|Overall Study||11
11325455|NCT02753816|12522762|FG002|STARTED|Overall Study||7
11325456|NCT02753816|12522760|FG000|Tranexamic Acid|Overall Study||7
11325457|NCT02753816|12522761|FG001|Tranexamic Acid|Overall Study||0
11325458|NCT02753816|12522762|FG002|Tranexamic Acid|Overall Study||7
11325459|NCT02753816|12522760|FG000|Placebo|Overall Study||0
11325460|NCT02753816|12522761|FG001|Placebo|Overall Study||11
11325461|NCT02753816|12522762|FG002|Placebo|Overall Study||7
11325462|NCT02753816|12522760|FG000|COMPLETED|Overall Study||7
11325463|NCT02753816|12522761|FG001|COMPLETED|Overall Study||10
11325464|NCT02753816|12522762|FG002|COMPLETED|Overall Study||7
11325465|NCT02753816|12522760|FG000|NOT COMPLETED|Overall Study||0
11325466|NCT02753816|12522761|FG001|NOT COMPLETED|Overall Study||1
11325467|NCT02753816|12522762|FG002|NOT COMPLETED|Overall Study||0
11325468|NCT02753842|12522774|FG000|STARTED|First Follow-Up (Set of Condoms)||85
11325469|NCT02753842|12522775|FG001|STARTED|First Follow-Up (Set of Condoms)||84
11325470|NCT02753842|12522776|FG002|STARTED|First Follow-Up (Set of Condoms)||85
11325471|NCT02753842|12522777|FG003|STARTED|First Follow-Up (Set of Condoms)||83
11325472|NCT02753842|12522778|FG004|STARTED|First Follow-Up (Set of Condoms)||83
11325473|NCT02753842|12522779|FG005|STARTED|First Follow-Up (Set of Condoms)||84
11325474|NCT02753842|12522774|FG000|COMPLETED|First Follow-Up (Set of Condoms)||75
11325475|NCT02753842|12522775|FG001|COMPLETED|First Follow-Up (Set of Condoms)||76
11325476|NCT02753842|12522776|FG002|COMPLETED|First Follow-Up (Set of Condoms)||76
11325477|NCT02753842|12522777|FG003|COMPLETED|First Follow-Up (Set of Condoms)||81
11325478|NCT02753842|12522778|FG004|COMPLETED|First Follow-Up (Set of Condoms)||76
11325479|NCT02753842|12522779|FG005|COMPLETED|First Follow-Up (Set of Condoms)||79
11325480|NCT02753842|12522774|FG000|NOT COMPLETED|First Follow-Up (Set of Condoms)||10
11325481|NCT02753842|12522775|FG001|NOT COMPLETED|First Follow-Up (Set of Condoms)||8
11325482|NCT02753842|12522776|FG002|NOT COMPLETED|First Follow-Up (Set of Condoms)||9
11325483|NCT02753842|12522777|FG003|NOT COMPLETED|First Follow-Up (Set of Condoms)||2
11325484|NCT02753842|12522778|FG004|NOT COMPLETED|First Follow-Up (Set of Condoms)||7
11325485|NCT02753842|12522779|FG005|NOT COMPLETED|First Follow-Up (Set of Condoms)||5
11325486|NCT02753842|12522774|FG000|STARTED|Second Follow-Up (Set of Condoms)||75
11325487|NCT02753842|12522775|FG001|STARTED|Second Follow-Up (Set of Condoms)||76
11325488|NCT02753842|12522776|FG002|STARTED|Second Follow-Up (Set of Condoms)||76
11325489|NCT02753842|12522777|FG003|STARTED|Second Follow-Up (Set of Condoms)||81
11325490|NCT02753842|12522778|FG004|STARTED|Second Follow-Up (Set of Condoms)||76
11325491|NCT02753842|12522779|FG005|STARTED|Second Follow-Up (Set of Condoms)||79
11325492|NCT02753842|12522774|FG000|COMPLETED|Second Follow-Up (Set of Condoms)||71
11325493|NCT02753842|12522775|FG001|COMPLETED|Second Follow-Up (Set of Condoms)||71
11325494|NCT02753842|12522776|FG002|COMPLETED|Second Follow-Up (Set of Condoms)||71
11325495|NCT02753842|12522777|FG003|COMPLETED|Second Follow-Up (Set of Condoms)||76
11325496|NCT02753842|12522778|FG004|COMPLETED|Second Follow-Up (Set of Condoms)||75
11325497|NCT02753842|12522779|FG005|COMPLETED|Second Follow-Up (Set of Condoms)||72
11325498|NCT02753842|12522774|FG000|NOT COMPLETED|Second Follow-Up (Set of Condoms)||4
11325499|NCT02753842|12522775|FG001|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
11325500|NCT02753842|12522776|FG002|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
11325501|NCT02753842|12522777|FG003|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
11325502|NCT02753842|12522778|FG004|NOT COMPLETED|Second Follow-Up (Set of Condoms)||1
11325503|NCT02753842|12522779|FG005|NOT COMPLETED|Second Follow-Up (Set of Condoms)||7
11325504|NCT02753842|12522774|FG000|STARTED|Third Follow-Up (Set of Condoms)||71
11325505|NCT02753842|12522775|FG001|STARTED|Third Follow-Up (Set of Condoms)||71
11325506|NCT02753842|12522776|FG002|STARTED|Third Follow-Up (Set of Condoms)||71
11325507|NCT02753842|12522777|FG003|STARTED|Third Follow-Up (Set of Condoms)||76
11325508|NCT02753842|12522778|FG004|STARTED|Third Follow-Up (Set of Condoms)||75
11325509|NCT02753842|12522779|FG005|STARTED|Third Follow-Up (Set of Condoms)||72
11325510|NCT02753842|12522774|FG000|COMPLETED|Third Follow-Up (Set of Condoms)||65
11325511|NCT02753842|12522775|FG001|COMPLETED|Third Follow-Up (Set of Condoms)||66
11325512|NCT02753842|12522776|FG002|COMPLETED|Third Follow-Up (Set of Condoms)||68
11325513|NCT02753842|12522777|FG003|COMPLETED|Third Follow-Up (Set of Condoms)||70
11325514|NCT02753842|12522778|FG004|COMPLETED|Third Follow-Up (Set of Condoms)||71
11325515|NCT02753842|12522779|FG005|COMPLETED|Third Follow-Up (Set of Condoms)||69
11325516|NCT02753842|12522774|FG000|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
11325517|NCT02753842|12522775|FG001|NOT COMPLETED|Third Follow-Up (Set of Condoms)||5
11325518|NCT02753842|12522776|FG002|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
11325519|NCT02753842|12522777|FG003|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
11325520|NCT02753842|12522778|FG004|NOT COMPLETED|Third Follow-Up (Set of Condoms)||4
11325521|NCT02753842|12522779|FG005|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
11325522|NCT02753881|12522796|FG000|STARTED|Overall Study||10
11325523|NCT02753881|12522797|FG001|STARTED|Overall Study||10
11325524|NCT02753881|12522798|FG002|STARTED|Overall Study||10
11325525|NCT02753881|12522796|FG000|COMPLETED|Overall Study||10
11325526|NCT02753881|12522797|FG001|COMPLETED|Overall Study||10
11325527|NCT02753881|12522798|FG002|COMPLETED|Overall Study||10
11325528|NCT02753881|12522796|FG000|NOT COMPLETED|Overall Study||0
11325529|NCT02753881|12522797|FG001|NOT COMPLETED|Overall Study||0
11325530|NCT02753881|12522798|FG002|NOT COMPLETED|Overall Study||0
11325531|NCT02753920|12522808|FG000|STARTED|Overall Study||87
11325532|NCT02753920|12522809|FG001|STARTED|Overall Study||86
11325533|NCT02753920|12522808|FG000|COMPLETED|Overall Study||87
11325534|NCT02753920|12522809|FG001|COMPLETED|Overall Study||86
11325535|NCT02753920|12522808|FG000|NOT COMPLETED|Overall Study||0
11325536|NCT02753920|12522809|FG001|NOT COMPLETED|Overall Study||0
11325537|NCT02753946|12522821|FG000|STARTED|Overall Study||233
11325538|NCT02753946|12522822|FG001|STARTED|Overall Study||231
11325539|NCT02753946|12522821|FG000|COMPLETED|Overall Study||219
11325540|NCT02753946|12522822|FG001|COMPLETED|Overall Study||222
11325541|NCT02753946|12522821|FG000|NOT COMPLETED|Overall Study||14
11325542|NCT02753946|12522822|FG001|NOT COMPLETED|Overall Study||9
11325543|NCT02754310|12522830|FG000|STARTED|Overall Study||42
11325544|NCT02754310|12522831|FG001|STARTED|Overall Study||43
11325545|NCT02754310|12522830|FG000|COMPLETED|Overall Study||42
11325546|NCT02754310|12522831|FG001|COMPLETED|Overall Study||43
11325547|NCT02754310|12522830|FG000|NOT COMPLETED|Overall Study||0
11325548|NCT02754310|12522831|FG001|NOT COMPLETED|Overall Study||0
11325549|NCT02754427|12522839|FG000|STARTED|Overall Study||21
11325550|NCT02754427|12522840|FG001|STARTED|Overall Study||20
11325551|NCT02754427|12522839|FG000|COMPLETED|Overall Study||21
11325552|NCT02754427|12522840|FG001|COMPLETED|Overall Study||19
11325553|NCT02754427|12522839|FG000|NOT COMPLETED|Overall Study||0
11325554|NCT02754427|12522840|FG001|NOT COMPLETED|Overall Study||1
11325555|NCT02754440|12522850|FG000|STARTED|Overall Study||99
11325556|NCT02754440|12522851|FG001|STARTED|Overall Study||101
11325557|NCT02754440|12522852|FG002|STARTED|Overall Study||100
11325558|NCT02754440|12522853|FG003|STARTED|Overall Study||35
11325559|NCT02754440|12522850|FG000|COMPLETED|Overall Study||93
11325560|NCT02754440|12522851|FG001|COMPLETED|Overall Study||93
11325561|NCT02754440|12522852|FG002|COMPLETED|Overall Study||93
11325562|NCT02754440|12522853|FG003|COMPLETED|Overall Study||0
11325563|NCT02754440|12522850|FG000|NOT COMPLETED|Overall Study||6
11325564|NCT02754440|12522851|FG001|NOT COMPLETED|Overall Study||8
11325565|NCT02754440|12522852|FG002|NOT COMPLETED|Overall Study||7
11325566|NCT02754440|12522853|FG003|NOT COMPLETED|Overall Study||35
11325567|NCT02754492|12522866|FG000|STARTED|Overall Study||97
11325568|NCT02754492|12522867|FG001|STARTED|Overall Study||95
11325569|NCT02754492|12522868|FG002|STARTED|Overall Study||95
11325570|NCT02754492|12522869|FG003|STARTED|Overall Study||23
11325571|NCT02754492|12522866|FG000|COMPLETED|Overall Study||93
11325572|NCT02754492|12522867|FG001|COMPLETED|Overall Study||93
11325573|NCT02754492|12522868|FG002|COMPLETED|Overall Study||93
11325574|NCT02754492|12522869|FG003|COMPLETED|Overall Study||0
11325575|NCT02754492|12522866|FG000|NOT COMPLETED|Overall Study||4
11325576|NCT02754492|12522867|FG001|NOT COMPLETED|Overall Study||2
11325577|NCT02754492|12522868|FG002|NOT COMPLETED|Overall Study||2
11325578|NCT02754492|12522869|FG003|NOT COMPLETED|Overall Study||23
11325579|NCT02754518|12522878|FG000|STARTED|Overall Study||40
11325580|NCT02754518|12522878|FG000|COMPLETED|Overall Study||40
11325581|NCT02754518|12522878|FG000|NOT COMPLETED|Overall Study||0
11325582|NCT02754570|12522882|FG000|STARTED|Overall Study||27
11325583|NCT02754570|12522882|FG000|Visits 1 and 2 (PGA Only)|Overall Study||27
11325584|NCT02754570|12522882|FG000|Visit 3 (PGA + Pilocarpine)|Overall Study||27
11325585|NCT02754570|12522882|FG000|COMPLETED|Overall Study||27
11325586|NCT02754570|12522882|FG000|NOT COMPLETED|Overall Study||0
11325587|NCT02754661|12522890|FG000|STARTED|Overall Study||160
11325588|NCT02754661|12522891|FG001|STARTED|Overall Study||160
11325589|NCT02754661|12522890|FG000|COMPLETED|Overall Study||145
11325590|NCT02754661|12522891|FG001|COMPLETED|Overall Study||141
11325591|NCT02754661|12522890|FG000|NOT COMPLETED|Overall Study||15
11325592|NCT02754661|12522891|FG001|NOT COMPLETED|Overall Study||19
11325593|NCT02754674|12522901|FG000|STARTED|Overall Study||34
11325594|NCT02754674|12522902|FG001|STARTED|Overall Study||33
11325595|NCT02754674|12522901|FG000|COMPLETED|Overall Study||28
11325596|NCT02754674|12522902|FG001|COMPLETED|Overall Study||26
11325597|NCT02754674|12522901|FG000|NOT COMPLETED|Overall Study||6
11325598|NCT02754674|12522902|FG001|NOT COMPLETED|Overall Study||7
11325599|NCT02755090|12522910|FG000|STARTED|Overall Study||19
11325600|NCT02755090|12522911|FG001|STARTED|Overall Study||20
11325601|NCT02755090|12522910|FG000|COMPLETED|Overall Study||18
11027208|NCT00833040|12205934|FG003|STARTED|Overall Study||6
11027209|NCT00833040|12205935|FG004|STARTED|Overall Study||5
11027210|NCT00833040|12205936|FG005|STARTED|Overall Study||5
11027211|NCT00833040|12205931|FG000|COMPLETED|Overall Study||6
11027212|NCT00833040|12205932|FG001|COMPLETED|Overall Study||6
11027213|NCT00833040|12205933|FG002|COMPLETED|Overall Study||6
11027214|NCT00833040|12205934|FG003|COMPLETED|Overall Study||6
11027215|NCT00833040|12205935|FG004|COMPLETED|Overall Study||5
11027216|NCT00833040|12205936|FG005|COMPLETED|Overall Study||4
11027217|NCT00833040|12205931|FG000|NOT COMPLETED|Overall Study||0
11027218|NCT00833040|12205932|FG001|NOT COMPLETED|Overall Study||0
11027219|NCT00833040|12205933|FG002|NOT COMPLETED|Overall Study||0
11027220|NCT00833040|12205934|FG003|NOT COMPLETED|Overall Study||0
11027221|NCT00833040|12205935|FG004|NOT COMPLETED|Overall Study||0
11027222|NCT00833040|12205936|FG005|NOT COMPLETED|Overall Study||1
11325602|NCT02755090|12522911|FG001|COMPLETED|Overall Study||20
11325603|NCT02755090|12522910|FG000|NOT COMPLETED|Overall Study||1
11325604|NCT02755090|12522911|FG001|NOT COMPLETED|Overall Study||0
11325605|NCT02755116|12522919|FG000|STARTED|Overall Study||74
11325606|NCT02755116|12522920|FG001|STARTED|Overall Study||70
11325607|NCT02755116|12522919|FG000|COMPLETED|Overall Study||71
11325608|NCT02755116|12522920|FG001|COMPLETED|Overall Study||69
11325609|NCT02755116|12522919|FG000|NOT COMPLETED|Overall Study||3
11325610|NCT02755116|12522920|FG001|NOT COMPLETED|Overall Study||1
11325611|NCT02755129|12522926|FG000|STARTED|Overall Study||15
11325612|NCT02755129|12522926|FG000|COMPLETED|Overall Study||15
11325613|NCT02755129|12522926|FG000|NOT COMPLETED|Overall Study||0
11325614|NCT02755285|12522933|FG000|STARTED|Overall Study||20
11325615|NCT02755285|12522933|FG000|COMPLETED|Overall Study||20
11325616|NCT02755285|12522933|FG000|NOT COMPLETED|Overall Study||0
11325617|NCT02755649|12522940|FG000|STARTED|Overall Study||108
11325618|NCT02755649|12522941|FG001|STARTED|Overall Study||107
11325619|NCT02755649|12522942|FG002|STARTED|Overall Study||110
11325620|NCT02755649|12522940|FG000|Completed Treatment (Week 16)|Overall Study||107
11325621|NCT02755649|12522941|FG001|Completed Treatment (Week 16)|Overall Study||106
11325622|NCT02755649|12522942|FG002|Completed Treatment (Week 16)|Overall Study||109
11325623|NCT02755649|12522940|FG000|Completed Study (Week 28)|Overall Study||7
11325624|NCT02755649|12522941|FG001|Completed Study (Week 28)|Overall Study||8
11325625|NCT02755649|12522942|FG002|Completed Study (Week 28)|Overall Study||8
11325626|NCT02755649|12522940|FG000|COMPLETED|Overall Study||7
11325627|NCT02755649|12522941|FG001|COMPLETED|Overall Study||8
11325628|NCT02755649|12522942|FG002|COMPLETED|Overall Study||8
11325629|NCT02755649|12522940|FG000|NOT COMPLETED|Overall Study||101
11325630|NCT02755649|12522941|FG001|NOT COMPLETED|Overall Study||99
11325631|NCT02755649|12522942|FG002|NOT COMPLETED|Overall Study||102
11325632|NCT02755805|12522952|FG000|STARTED|Overall Study||15
11325633|NCT02755805|12522953|FG001|STARTED|Overall Study||15
11325634|NCT02755805|12522952|FG000|COMPLETED|Overall Study||13
11325635|NCT02755805|12522953|FG001|COMPLETED|Overall Study||11
11325636|NCT02755805|12522952|FG000|NOT COMPLETED|Overall Study||2
11325637|NCT02755805|12522953|FG001|NOT COMPLETED|Overall Study||4
11325638|NCT02755818|12522963|FG000|STARTED|Overall Study||30
11325639|NCT02755818|12522964|FG001|STARTED|Overall Study||2
11325640|NCT02755818|12522965|FG002|STARTED|Overall Study||2
11325641|NCT02755818|12522966|FG003|STARTED|Overall Study||17
11325642|NCT02755818|12522963|FG000|COMPLETED|Overall Study||30
11325643|NCT02755818|12522964|FG001|COMPLETED|Overall Study||2
11325644|NCT02755818|12522965|FG002|COMPLETED|Overall Study||1
11325645|NCT02755818|12522966|FG003|COMPLETED|Overall Study||14
11325646|NCT02755818|12522963|FG000|NOT COMPLETED|Overall Study||0
11325647|NCT02755818|12522964|FG001|NOT COMPLETED|Overall Study||0
11325648|NCT02755818|12522965|FG002|NOT COMPLETED|Overall Study||1
11325649|NCT02755818|12522966|FG003|NOT COMPLETED|Overall Study||3
11325650|NCT02755831|12522980|FG000|STARTED|Overall Study||100
11325651|NCT02755831|12522981|FG001|STARTED|Overall Study||93
11325652|NCT02755831|12522980|FG000|COMPLETED|Overall Study||97
11325653|NCT02755831|12522981|FG001|COMPLETED|Overall Study||90
11325654|NCT02755831|12522980|FG000|NOT COMPLETED|Overall Study||3
11325655|NCT02755831|12522981|FG001|NOT COMPLETED|Overall Study||3
11325656|NCT02755935|12522987|FG000|STARTED|Overall Study||24
11325657|NCT02755935|12522987|FG000|COMPLETED|Overall Study||22
11325658|NCT02755935|12522987|FG000|NOT COMPLETED|Overall Study||2
11325659|NCT02756078|12522991|FG000|STARTED|Period 1||85
11325660|NCT02756078|12522992|FG001|STARTED|Period 1||86
11325661|NCT02756078|12522991|FG000|COMPLETED|Period 1||76
11325662|NCT02756078|12522992|FG001|COMPLETED|Period 1||64
11325663|NCT02756078|12522991|FG000|NOT COMPLETED|Period 1||9
11325664|NCT02756078|12522992|FG001|NOT COMPLETED|Period 1||22
11325665|NCT02756078|12522991|FG000|STARTED|Period 2||76
11325666|NCT02756078|12522992|FG001|STARTED|Period 2||64
11325667|NCT02756078|12522991|FG000|COMPLETED|Period 2||70
11325668|NCT02756078|12522992|FG001|COMPLETED|Period 2||57
11325669|NCT02756078|12522991|FG000|NOT COMPLETED|Period 2||6
11325670|NCT02756078|12522992|FG001|NOT COMPLETED|Period 2||7
11325671|NCT02756182|12522998|FG000|STARTED|Overall Study||25
11325672|NCT02756182|12522998|FG000|COMPLETED|Overall Study||21
11325673|NCT02756182|12522998|FG000|NOT COMPLETED|Overall Study||4
11325674|NCT02756338|12523004|FG000|STARTED|Overall Study||77
11325675|NCT02756338|12523004|FG000|COMPLETED|Overall Study||72
11325676|NCT02756338|12523004|FG000|NOT COMPLETED|Overall Study||5
11325677|NCT02756351|12523010|FG000|STARTED|Overall Study||24
11325678|NCT02756351|12523011|FG001|STARTED|Overall Study||24
11325679|NCT02756351|12523010|FG000|COMPLETED|Overall Study||24
11325680|NCT02756351|12523011|FG001|COMPLETED|Overall Study||24
11325681|NCT02756351|12523010|FG000|NOT COMPLETED|Overall Study||0
11325682|NCT02756351|12523011|FG001|NOT COMPLETED|Overall Study||0
11325683|NCT02756364|12523020|FG000|STARTED|Overall Study||46
11325684|NCT02756364|12523021|FG001|STARTED|Overall Study||47
11325685|NCT02756364|12523022|FG002|STARTED|Overall Study||48
11325686|NCT02756364|12523020|FG000|Treated Participants|Overall Study||46
11325687|NCT02756364|12523021|FG001|Treated Participants|Overall Study||47
11325688|NCT02756364|12523022|FG002|Treated Participants|Overall Study||47
11325689|NCT02756364|12523020|FG000|COMPLETED|Overall Study||0
11325690|NCT02756364|12523021|FG001|COMPLETED|Overall Study||0
11325691|NCT02756364|12523022|FG002|COMPLETED|Overall Study||0
11325692|NCT02756364|12523020|FG000|NOT COMPLETED|Overall Study||46
11325693|NCT02756364|12523021|FG001|NOT COMPLETED|Overall Study||47
11325694|NCT02756364|12523022|FG002|NOT COMPLETED|Overall Study||48
11325695|NCT02756572|12523030|FG000|STARTED|Overall Study||30
11325696|NCT02756572|12523030|FG000|COMPLETED|Overall Study||30
11325697|NCT02756572|12523030|FG000|NOT COMPLETED|Overall Study||0
11325698|NCT02756624|12523041|FG000|STARTED|Overall Study||343
11325699|NCT02756624|12523042|FG001|STARTED|Overall Study||173
11325700|NCT02756624|12523041|FG000|COMPLETED|Overall Study||327
11325701|NCT02756624|12523042|FG001|COMPLETED|Overall Study||166
11325702|NCT02756624|12523041|FG000|NOT COMPLETED|Overall Study||16
11325703|NCT02756624|12523042|FG001|NOT COMPLETED|Overall Study||7
11325704|NCT02756637|12523050|FG000|STARTED|Overall Study||317
11325705|NCT02756637|12523051|FG001|STARTED|Overall Study||317
11325706|NCT02756637|12523050|FG000|Eligible for SWOG 8710|Overall Study||307
11325707|NCT02756637|12523051|FG001|Eligible for SWOG 8710|Overall Study||307
11325708|NCT02756637|12523050|FG000|Had NLR Value|Overall Study||263
11325709|NCT02756637|12523051|FG001|Had NLR Value|Overall Study||263
11325710|NCT02756637|12523050|FG000|Completed Curative Treatment|Overall Study||230
11325711|NCT02756637|12523051|FG001|Completed Curative Treatment|Overall Study||0
11325712|NCT02756637|12523050|FG000|COMPLETED|Overall Study||230
11325713|NCT02756637|12523051|FG001|COMPLETED|Overall Study||263
11325714|NCT02756637|12523050|FG000|NOT COMPLETED|Overall Study||87
11325715|NCT02756637|12523051|FG001|NOT COMPLETED|Overall Study||54
11325716|NCT02756650|12523057|FG000|STARTED|Overall Study||8
11325717|NCT02756650|12523057|FG000|COMPLETED|Overall Study||6
11325718|NCT02756650|12523057|FG000|NOT COMPLETED|Overall Study||2
11325719|NCT02756689|12523063|FG000|STARTED|Overall Study||64
11325720|NCT02756689|12523064|FG001|STARTED|Overall Study||65
11325721|NCT02756689|12523063|FG000|COMPLETED|Overall Study||64
11325722|NCT02756689|12523064|FG001|COMPLETED|Overall Study||65
11325723|NCT02756689|12523063|FG000|NOT COMPLETED|Overall Study||0
11325724|NCT02756689|12523064|FG001|NOT COMPLETED|Overall Study||0
11325725|NCT02756819|12523104|FG000|STARTED|Overall Study||1945
11325726|NCT02756819|12523104|FG000|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724
11325727|NCT02756819|12523104|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934
11325728|NCT02756819|12523104|FG000|COMPLETED|Overall Study||1893
11325729|NCT02756819|12523104|FG000|NOT COMPLETED|Overall Study||52
11325730|NCT02756832|12523108|FG000|STARTED|Overall Study||1409
11325731|NCT02756832|12523108|FG000|Received Therapy|Overall Study||1393
11325732|NCT02756832|12523108|FG000|Included in Efficacy and Safety Analysis|Overall Study||1399
11325733|NCT02756832|12523108|FG000|COMPLETED|Overall Study||1356
11325734|NCT02756832|12523108|FG000|NOT COMPLETED|Overall Study||53
11325735|NCT02756910|12523112|FG000|STARTED|Overall Study||80
11325736|NCT02756910|12523112|FG000|COMPLETED|Overall Study||80
11325737|NCT02756910|12523112|FG000|NOT COMPLETED|Overall Study||0
11325738|NCT02756949|12523118|FG000|STARTED|Overall Study||181
11325739|NCT02756949|12523119|FG001|STARTED|Overall Study||172
11325740|NCT02756949|12523118|FG000|COMPLETED|Overall Study||181
11325741|NCT02756949|12523119|FG001|COMPLETED|Overall Study||164
11325742|NCT02756949|12523118|FG000|NOT COMPLETED|Overall Study||0
11325743|NCT02756949|12523119|FG001|NOT COMPLETED|Overall Study||8
11325744|NCT02757092|12523127|FG000|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
11325745|NCT02757092|12523128|FG001|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
11325746|NCT02757092|12523127|FG000|COMPLETED|Overall Study|All subjects completed the study|18
11325747|NCT02757092|12523128|FG001|COMPLETED|Overall Study|All subjects completed the study|18
11325748|NCT02757092|12523127|FG000|NOT COMPLETED|Overall Study||0
11325749|NCT02757092|12523128|FG001|NOT COMPLETED|Overall Study||0
11325750|NCT02757105|12523194|FG000|STARTED|Overall Study||75
11325751|NCT02757105|12523195|FG001|STARTED|Overall Study||52
11325752|NCT02757105|12523194|FG000|Treated|Overall Study||75
11325753|NCT02757105|12523195|FG001|Treated|Overall Study||51
11325754|NCT02757105|12523194|FG000|COMPLETED|Overall Study||63
11325755|NCT02757105|12523195|FG001|COMPLETED|Overall Study||41
11325756|NCT02757105|12523194|FG000|NOT COMPLETED|Overall Study||12
11325757|NCT02757105|12523195|FG001|NOT COMPLETED|Overall Study||11
11325758|NCT02757326|12523205|FG000|STARTED|Overall Study||3
11325759|NCT02757326|12523206|FG001|STARTED|Overall Study||4
11325760|NCT02757326|12523207|FG002|STARTED|Overall Study||6
11325761|NCT02757326|12523205|FG000|COMPLETED|Overall Study||3
11325762|NCT02757326|12523206|FG001|COMPLETED|Overall Study||4
11325763|NCT02757326|12523207|FG002|COMPLETED|Overall Study||6
11325764|NCT02757326|12523205|FG000|NOT COMPLETED|Overall Study||0
11325765|NCT02757326|12523206|FG001|NOT COMPLETED|Overall Study||0
11325766|NCT02757326|12523207|FG002|NOT COMPLETED|Overall Study||0
11325767|NCT02757352|12523222|FG000|STARTED|Double-Blind Period (Week 0 - Week 16)||105
11325768|NCT02757352|12523223|FG001|STARTED|Double-Blind Period (Week 0 - Week 16)||96
11325769|NCT02757352|12523224|FG002|STARTED|Double-Blind Period (Week 0 - Week 16)||102
11325770|NCT02757352|12523225|FG003|STARTED|Double-Blind Period (Week 0 - Week 16)||0
11325771|NCT02757352|12523226|FG004|STARTED|Double-Blind Period (Week 0 - Week 16)||0
11325772|NCT02757352|12523227|FG005|STARTED|Double-Blind Period (Week 0 - Week 16)||0
11325773|NCT02757352|12523228|FG006|STARTED|Double-Blind Period (Week 0 - Week 16)||0
11325774|NCT02757352|12523229|FG007|STARTED|Double-Blind Period (Week 0 - Week 16)||0
11325775|NCT02757352|12523230|FG008|STARTED|Double-Blind Period (Week 0 - Week 16)||0
11325776|NCT02757352|12523231|FG009|STARTED|Double-Blind Period (Week 0 - Week 16)||0
11325777|NCT02757352|12523222|FG000|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||104
11325778|NCT02757352|12523223|FG001|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||96
11325779|NCT02757352|12523224|FG002|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||102
11325780|NCT02757352|12523225|FG003|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
11325781|NCT02757352|12523226|FG004|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
11325782|NCT02757352|12523227|FG005|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
11325783|NCT02757352|12523228|FG006|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
11325784|NCT02757352|12523229|FG007|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
11325785|NCT02757352|12523230|FG008|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
11325786|NCT02757352|12523231|FG009|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
11325787|NCT02757352|12523222|FG000|COMPLETED|Double-Blind Period (Week 0 - Week 16)||97
11325788|NCT02757352|12523223|FG001|COMPLETED|Double-Blind Period (Week 0 - Week 16)||95
11325789|NCT02757352|12523224|FG002|COMPLETED|Double-Blind Period (Week 0 - Week 16)||98
11325790|NCT02757352|12523225|FG003|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
11325791|NCT02757352|12523226|FG004|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
11325792|NCT02757352|12523227|FG005|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
11325793|NCT02757352|12523228|FG006|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
11325794|NCT02757352|12523229|FG007|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
11325795|NCT02757352|12523230|FG008|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
11325796|NCT02757352|12523231|FG009|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
11325797|NCT02757352|12523222|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||8
11325798|NCT02757352|12523223|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||1
11325799|NCT02757352|12523224|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||4
11325800|NCT02757352|12523225|FG003|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
11325801|NCT02757352|12523226|FG004|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
11325802|NCT02757352|12523227|FG005|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
11325803|NCT02757352|12523228|FG006|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
11325804|NCT02757352|12523229|FG007|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
11325805|NCT02757352|12523230|FG008|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
11325806|NCT02757352|12523231|FG009|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
11325807|NCT02757352|12523222|FG000|STARTED|Double-Blind Period (Week 16 - Week 52)||97
11325808|NCT02757352|12523223|FG001|STARTED|Double-Blind Period (Week 16 - Week 52)||95
11325809|NCT02757352|12523224|FG002|STARTED|Double-Blind Period (Week 16 - Week 52)||98
11325810|NCT02757352|12523225|FG003|STARTED|Double-Blind Period (Week 16 - Week 52)||0
11325811|NCT02757352|12523226|FG004|STARTED|Double-Blind Period (Week 16 - Week 52)||0
11325812|NCT02757352|12523227|FG005|STARTED|Double-Blind Period (Week 16 - Week 52)||0
11325813|NCT02757352|12523228|FG006|STARTED|Double-Blind Period (Week 16 - Week 52)||0
11325814|NCT02757352|12523229|FG007|STARTED|Double-Blind Period (Week 16 - Week 52)||0
11325815|NCT02757352|12523230|FG008|STARTED|Double-Blind Period (Week 16 - Week 52)||0
11325816|NCT02757352|12523231|FG009|STARTED|Double-Blind Period (Week 16 - Week 52)||0
11325817|NCT02757352|12523222|FG000|COMPLETED|Double-Blind Period (Week 16 - Week 52)||34
11325818|NCT02757352|12523223|FG001|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
11325819|NCT02757352|12523224|FG002|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
11325820|NCT02757352|12523225|FG003|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
11325821|NCT02757352|12523226|FG004|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
11325822|NCT02757352|12523227|FG005|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
11325823|NCT02757352|12523228|FG006|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
11325824|NCT02757352|12523229|FG007|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
11325825|NCT02757352|12523230|FG008|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
11325826|NCT02757352|12523231|FG009|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
11325827|NCT02757352|12523222|FG000|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||63
11325828|NCT02757352|12523223|FG001|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||43
11325829|NCT02757352|12523224|FG002|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||46
11325830|NCT02757352|12523225|FG003|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
11325831|NCT02757352|12523226|FG004|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
11325832|NCT02757352|12523227|FG005|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
11325833|NCT02757352|12523228|FG006|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
11325834|NCT02757352|12523229|FG007|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
11325835|NCT02757352|12523230|FG008|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
11325836|NCT02757352|12523231|FG009|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
11325837|NCT02757352|12523222|FG000|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
11325838|NCT02757352|12523223|FG001|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
11325839|NCT02757352|12523224|FG002|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
11325840|NCT02757352|12523225|FG003|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|62
11325841|NCT02757352|12523226|FG004|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|40
11325842|NCT02757352|12523227|FG005|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|42
11325843|NCT02757352|12523228|FG006|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
11325844|NCT02757352|12523229|FG007|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
11325845|NCT02757352|12523230|FG008|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
11325846|NCT02757352|12523231|FG009|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
11325847|NCT02757352|12523222|FG000|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
11325848|NCT02757352|12523223|FG001|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
11325849|NCT02757352|12523224|FG002|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
11325850|NCT02757352|12523225|FG003|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||2
11325851|NCT02757352|12523226|FG004|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
11325852|NCT02757352|12523227|FG005|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||3
11325853|NCT02757352|12523228|FG006|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
11325854|NCT02757352|12523229|FG007|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
11325855|NCT02757352|12523230|FG008|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
11325856|NCT02757352|12523231|FG009|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
11325857|NCT02757352|12523222|FG000|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
11325858|NCT02757352|12523223|FG001|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
11325859|NCT02757352|12523224|FG002|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
11325860|NCT02757352|12523225|FG003|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||55
11325861|NCT02757352|12523226|FG004|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||37
11325862|NCT02757352|12523227|FG005|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||35
11325863|NCT02757352|12523228|FG006|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
11325864|NCT02757352|12523229|FG007|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
11325865|NCT02757352|12523230|FG008|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
11325866|NCT02757352|12523231|FG009|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
11325867|NCT02757352|12523222|FG000|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
11325868|NCT02757352|12523223|FG001|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
11325869|NCT02757352|12523224|FG002|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
11325870|NCT02757352|12523225|FG003|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
11325871|NCT02757352|12523226|FG004|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||3
11325872|NCT02757352|12523227|FG005|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
11325873|NCT02757352|12523228|FG006|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
11325874|NCT02757352|12523229|FG007|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
11325875|NCT02757352|12523230|FG008|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
11325876|NCT02757352|12523231|FG009|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
11325877|NCT02757352|12523222|FG000|STARTED|Follow-Up Period||0
11325878|NCT02757352|12523223|FG001|STARTED|Follow-Up Period||0
11325879|NCT02757352|12523224|FG002|STARTED|Follow-Up Period||0
11325880|NCT02757352|12523225|FG003|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
11325881|NCT02757352|12523226|FG004|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
11325882|NCT02757352|12523227|FG005|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
11325883|NCT02757352|12523228|FG006|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|3
11325884|NCT02757352|12523229|FG007|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|5
11325885|NCT02757352|12523230|FG008|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|28
11325886|NCT02757352|12523231|FG009|STARTED|Follow-Up Period||5
11325887|NCT02757352|12523222|FG000|COMPLETED|Follow-Up Period||0
11325888|NCT02757352|12523223|FG001|COMPLETED|Follow-Up Period||0
11325889|NCT02757352|12523224|FG002|COMPLETED|Follow-Up Period||0
11325890|NCT02757352|12523225|FG003|COMPLETED|Follow-Up Period||0
11325891|NCT02757352|12523226|FG004|COMPLETED|Follow-Up Period||0
11325892|NCT02757352|12523227|FG005|COMPLETED|Follow-Up Period||0
11325893|NCT02757352|12523228|FG006|COMPLETED|Follow-Up Period||2
11325894|NCT02757352|12523229|FG007|COMPLETED|Follow-Up Period||4
11325895|NCT02757352|12523230|FG008|COMPLETED|Follow-Up Period||18
11325896|NCT02757352|12523231|FG009|COMPLETED|Follow-Up Period||2
11325897|NCT02757352|12523222|FG000|NOT COMPLETED|Follow-Up Period||0
11325898|NCT02757352|12523223|FG001|NOT COMPLETED|Follow-Up Period||0
11325899|NCT02757352|12523224|FG002|NOT COMPLETED|Follow-Up Period||0
11325900|NCT02757352|12523225|FG003|NOT COMPLETED|Follow-Up Period||0
11325901|NCT02757352|12523226|FG004|NOT COMPLETED|Follow-Up Period||0
11325902|NCT02757352|12523227|FG005|NOT COMPLETED|Follow-Up Period||0
11325903|NCT02757352|12523228|FG006|NOT COMPLETED|Follow-Up Period||1
11325904|NCT02757352|12523229|FG007|NOT COMPLETED|Follow-Up Period||1
11325905|NCT02757352|12523230|FG008|NOT COMPLETED|Follow-Up Period||10
11325906|NCT02757352|12523231|FG009|NOT COMPLETED|Follow-Up Period||3
11325907|NCT02757430|12523262|FG000|STARTED|Overall Study||515
11325908|NCT02757430|12523262|FG000|Baseline Visits|Overall Study||503
11325909|NCT02757430|12523262|FG000|EP Mapping/Ablation Procedure|Overall Study||503
11325910|NCT02757430|12523262|FG000|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503
11325911|NCT02757430|12523262|FG000|NOT COMPLETED|Overall Study||12
11325912|NCT02757625|12523279|FG000|STARTED|Overall Study||14
11325913|NCT02757625|12523280|FG001|STARTED|Overall Study||18
11325914|NCT02757625|12523281|FG002|STARTED|Overall Study||19
11325915|NCT02757625|12523282|FG003|STARTED|Overall Study||12
11325916|NCT02757625|12523279|FG000|COMPLETED|Overall Study||14
11325917|NCT02757625|12523280|FG001|COMPLETED|Overall Study||18
11325918|NCT02757625|12523281|FG002|COMPLETED|Overall Study||17
11325919|NCT02757625|12523282|FG003|COMPLETED|Overall Study||12
11325920|NCT02757625|12523279|FG000|NOT COMPLETED|Overall Study||0
11325921|NCT02757625|12523280|FG001|NOT COMPLETED|Overall Study||0
11325922|NCT02757625|12523281|FG002|NOT COMPLETED|Overall Study||2
11325923|NCT02757625|12523282|FG003|NOT COMPLETED|Overall Study||0
11325924|NCT02757768|12523296|FG000|STARTED|Overall Study||356
11325925|NCT02757768|12523297|FG001|STARTED|Overall Study||359
11325926|NCT02757768|12523296|FG000|Treated|Overall Study||352
11325927|NCT02757768|12523297|FG001|Treated|Overall Study||354
11325928|NCT02757768|12523296|FG000|COMPLETED|Overall Study||323
11325929|NCT02757768|12523297|FG001|COMPLETED|Overall Study||331
11325930|NCT02757768|12523296|FG000|NOT COMPLETED|Overall Study||33
11325931|NCT02757768|12523297|FG001|NOT COMPLETED|Overall Study||28
11325932|NCT02757950|12523307|FG000|STARTED|Overall Study||1203
11325933|NCT02757950|12523308|FG001|STARTED|Overall Study||1259
11325934|NCT02757950|12523307|FG000|COMPLETED|Overall Study||1199
11325935|NCT02757950|12523308|FG001|COMPLETED|Overall Study||1248
11325936|NCT02757950|12523307|FG000|NOT COMPLETED|Overall Study||4
11325937|NCT02757950|12523308|FG001|NOT COMPLETED|Overall Study||11
11325938|NCT02757963|12523315|FG000|STARTED|Overall Study||1658
11325939|NCT02757963|12523315|FG000|COMPLETED|Overall Study||561
11325940|NCT02757963|12523315|FG000|NOT COMPLETED|Overall Study||1097
11325941|NCT02758119|12523332|FG000|STARTED|Overall Study||41
11325942|NCT02758119|12523333|FG001|STARTED|Overall Study||41
11325943|NCT02758119|12523332|FG000|COMPLETED|Overall Study||39
11325944|NCT02758119|12523333|FG001|COMPLETED|Overall Study||40
11325945|NCT02758119|12523332|FG000|NOT COMPLETED|Overall Study||2
11325946|NCT02758119|12523333|FG001|NOT COMPLETED|Overall Study||1
11325947|NCT02758171|12523343|FG000|STARTED|Treatment Period 1||28
11325948|NCT02758171|12523344|FG001|STARTED|Treatment Period 1||28
11325949|NCT02758171|12523343|FG000|COMPLETED|Treatment Period 1||28
11325950|NCT02758171|12523344|FG001|COMPLETED|Treatment Period 1||28
11325951|NCT02758171|12523343|FG000|NOT COMPLETED|Treatment Period 1||0
11325952|NCT02758171|12523344|FG001|NOT COMPLETED|Treatment Period 1||0
11325953|NCT02758171|12523343|FG000|STARTED|Wash-out||28
11325954|NCT02758171|12523344|FG001|STARTED|Wash-out||28
11325955|NCT02758171|12523343|FG000|COMPLETED|Wash-out||26
11325956|NCT02758171|12523344|FG001|COMPLETED|Wash-out||28
11325957|NCT02758171|12523343|FG000|NOT COMPLETED|Wash-out||2
11325958|NCT02758171|12523344|FG001|NOT COMPLETED|Wash-out||0
11325959|NCT02758171|12523343|FG000|STARTED|Treatment Period 2||26
11325960|NCT02758171|12523344|FG001|STARTED|Treatment Period 2||28
11325961|NCT02758171|12523343|FG000|COMPLETED|Treatment Period 2||26
11325962|NCT02758171|12523344|FG001|COMPLETED|Treatment Period 2||28
11325963|NCT02758171|12523343|FG000|NOT COMPLETED|Treatment Period 2||0
11325964|NCT02758171|12523344|FG001|NOT COMPLETED|Treatment Period 2||0
11325965|NCT02758210|12523350|FG000|STARTED|Overall Study||20
11325966|NCT02758210|12523350|FG000|COMPLETED|Overall Study||20
11325967|NCT02758210|12523350|FG000|NOT COMPLETED|Overall Study||0
11325968|NCT02758301|12523356|FG000|STARTED|Overall Study||104
11325969|NCT02758301|12523357|FG001|STARTED|Overall Study||8
11325970|NCT02758301|12523356|FG000|COMPLETED|Overall Study||70
11325971|NCT02758301|12523357|FG001|COMPLETED|Overall Study||0
11325972|NCT02758301|12523356|FG000|NOT COMPLETED|Overall Study||34
11325973|NCT02758301|12523357|FG001|NOT COMPLETED|Overall Study||8
11325974|NCT02758613|12523367|FG000|STARTED|Treatment||8
11325975|NCT02758613|12523368|FG001|STARTED|Treatment||8
11325976|NCT02758613|12523369|FG002|STARTED|Treatment||9
11325977|NCT02758613|12523370|FG003|STARTED|Treatment||8
11325978|NCT02758613|12523367|FG000|Received at Least One Dose of Study Drug|Treatment||8
11325979|NCT02758613|12523368|FG001|Received at Least One Dose of Study Drug|Treatment||8
11325980|NCT02758613|12523369|FG002|Received at Least One Dose of Study Drug|Treatment||9
11325981|NCT02758613|12523370|FG003|Received at Least One Dose of Study Drug|Treatment||8
11325982|NCT02758613|12523367|FG000|COMPLETED|Treatment||6
11325983|NCT02758613|12523368|FG001|COMPLETED|Treatment||8
11325984|NCT02758613|12523369|FG002|COMPLETED|Treatment||8
11325985|NCT02758613|12523370|FG003|COMPLETED|Treatment||8
11325986|NCT02758613|12523367|FG000|NOT COMPLETED|Treatment||2
11325987|NCT02758613|12523368|FG001|NOT COMPLETED|Treatment||0
11325988|NCT02758613|12523369|FG002|NOT COMPLETED|Treatment||1
11325989|NCT02758613|12523370|FG003|NOT COMPLETED|Treatment||0
11325990|NCT02758613|12523367|FG000|STARTED|Follow-up||6
11325991|NCT02758613|12523368|FG001|STARTED|Follow-up||8
11325992|NCT02758613|12523369|FG002|STARTED|Follow-up||8
11325993|NCT02758613|12523370|FG003|STARTED|Follow-up||8
11325994|NCT02758613|12523367|FG000|COMPLETED|Follow-up||6
11325995|NCT02758613|12523368|FG001|COMPLETED|Follow-up||8
11325996|NCT02758613|12523369|FG002|COMPLETED|Follow-up||8
11325997|NCT02758613|12523370|FG003|COMPLETED|Follow-up||8
11325998|NCT02758613|12523367|FG000|NOT COMPLETED|Follow-up||0
11325999|NCT02758613|12523368|FG001|NOT COMPLETED|Follow-up||0
11326000|NCT02758613|12523369|FG002|NOT COMPLETED|Follow-up||0
11326001|NCT02758613|12523370|FG003|NOT COMPLETED|Follow-up||0
11326002|NCT02758899|12523385|FG000|STARTED|Overall Study||11
11326003|NCT02758899|12523386|FG001|STARTED|Overall Study||10
11326004|NCT02758899|12523385|FG000|COMPLETED|Overall Study||9
11326005|NCT02758899|12523386|FG001|COMPLETED|Overall Study||9
11326006|NCT02758899|12523385|FG000|NOT COMPLETED|Overall Study||2
11326007|NCT02758899|12523386|FG001|NOT COMPLETED|Overall Study||1
11343152|NCT02951312|12540475|FG003|COMPLETED|Study Part 2||6
11343153|NCT02951312|12540472|FG000|NOT COMPLETED|Study Part 2||0
11343154|NCT02951312|12540473|FG001|NOT COMPLETED|Study Part 2||0
11343155|NCT02951312|12540474|FG002|NOT COMPLETED|Study Part 2||0
11343156|NCT02951312|12540475|FG003|NOT COMPLETED|Study Part 2||0
11343157|NCT02951351|12540497|FG000|STARTED|Overall Study||19
11343158|NCT02951351|12540498|FG001|STARTED|Overall Study||17
11343159|NCT02951351|12540497|FG000|COMPLETED|Overall Study||19
11343160|NCT02951351|12540498|FG001|COMPLETED|Overall Study||17
11343161|NCT02951351|12540497|FG000|NOT COMPLETED|Overall Study||0
11343162|NCT02951351|12540498|FG001|NOT COMPLETED|Overall Study||0
11343163|NCT02951429|12540506|FG000|STARTED|Overall Study||88
11343164|NCT02951429|12540507|FG001|STARTED|Overall Study||89
11343165|NCT02951429|12540506|FG000|COMPLETED|Overall Study||16
11343166|NCT02951429|12540507|FG001|COMPLETED|Overall Study||6
11343167|NCT02951429|12540506|FG000|NOT COMPLETED|Overall Study||72
11343168|NCT02951429|12540507|FG001|NOT COMPLETED|Overall Study||83
11343169|NCT02951533|12540515|FG000|STARTED|Part I (Week 0 Through Week 24)||60
11343170|NCT02951533|12540516|FG001|STARTED|Part I (Week 0 Through Week 24)||59
11343171|NCT02951533|12540517|FG002|STARTED|Part I (Week 0 Through Week 24)||0
11343172|NCT02951533|12540515|FG000|Treated|Part I (Week 0 Through Week 24)||60
11343173|NCT02951533|12540516|FG001|Treated|Part I (Week 0 Through Week 24)||58
11343174|NCT02951533|12540517|FG002|Treated|Part I (Week 0 Through Week 24)||0
11343175|NCT02951533|12540515|FG000|COMPLETED|Part I (Week 0 Through Week 24)||56
11343176|NCT02951533|12540516|FG001|COMPLETED|Part I (Week 0 Through Week 24)||36
11343177|NCT02951533|12540517|FG002|COMPLETED|Part I (Week 0 Through Week 24)||0
11343178|NCT02951533|12540515|FG000|NOT COMPLETED|Part I (Week 0 Through Week 24)||4
11343179|NCT02951533|12540516|FG001|NOT COMPLETED|Part I (Week 0 Through Week 24)||23
11343180|NCT02951533|12540517|FG002|NOT COMPLETED|Part I (Week 0 Through Week 24)||0
11343181|NCT02951533|12540515|FG000|STARTED|Part IIa (Week 24 Through Week 32)||56
11343182|NCT02951533|12540516|FG001|STARTED|Part IIa (Week 24 Through Week 32)|1 participant did not sign informed consent form (ICF) for Study Part II but completed Study Part I.|35
11343183|NCT02951533|12540517|FG002|STARTED|Part IIa (Week 24 Through Week 32)||0
11343184|NCT02951533|12540515|FG000|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54
11343185|NCT02951533|12540516|FG001|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14
11343186|NCT02951533|12540517|FG002|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0
11343187|NCT02951533|12540515|FG000|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1
11343188|NCT02951533|12540516|FG001|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20
11343189|NCT02951533|12540517|FG002|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0
11343190|NCT02951533|12540515|FG000|COMPLETED|Part IIa (Week 24 Through Week 32)||55
11343191|NCT02951533|12540516|FG001|COMPLETED|Part IIa (Week 24 Through Week 32)||34
11343192|NCT02951533|12540517|FG002|COMPLETED|Part IIa (Week 24 Through Week 32)||0
11343193|NCT02951533|12540515|FG000|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
11343194|NCT02951533|12540516|FG001|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
11343195|NCT02951533|12540517|FG002|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0
11343196|NCT02951533|12540515|FG000|STARTED|Part IIb (Week 32 Through Week 56)||55
11326008|NCT02759016|12523394|FG000|STARTED|Overall Study||4
11326009|NCT02759016|12523395|FG001|STARTED|Overall Study||3
11326010|NCT02759016|12523394|FG000|Treated With BI 836826 and Ibrutinib|Overall Study||3
11326011|NCT02759016|12523395|FG001|Treated With BI 836826 and Ibrutinib|Overall Study||3
11326012|NCT02759016|12523394|FG000|COMPLETED|Overall Study||0
11326013|NCT02759016|12523395|FG001|COMPLETED|Overall Study||0
11326014|NCT02759016|12523394|FG000|NOT COMPLETED|Overall Study||4
11326015|NCT02759016|12523395|FG001|NOT COMPLETED|Overall Study||3
11326016|NCT02759055|12523404|FG000|STARTED|Overall Study||12702
11326017|NCT02759055|12523405|FG001|STARTED|Overall Study||8962
11326018|NCT02759055|12523404|FG000|COMPLETED|Overall Study||10775
11326019|NCT02759055|12523405|FG001|COMPLETED|Overall Study||7454
11326020|NCT02759055|12523404|FG000|NOT COMPLETED|Overall Study||1927
11326021|NCT02759055|12523405|FG001|NOT COMPLETED|Overall Study||1508
11326022|NCT02759120|12523413|FG000|STARTED|Overall Study||254
11326023|NCT02759120|12523414|FG001|STARTED|Overall Study||259
11326024|NCT02759120|12523413|FG000|COMPLETED|Overall Study||169
11326025|NCT02759120|12523414|FG001|COMPLETED|Overall Study||180
11326026|NCT02759120|12523413|FG000|NOT COMPLETED|Overall Study||85
11326027|NCT02759120|12523414|FG001|NOT COMPLETED|Overall Study||79
11326028|NCT02759146|12523426|FG000|STARTED|Week 1-4||57
11326029|NCT02759146|12523427|FG001|STARTED|Week 1-4||36
11326030|NCT02759146|12523428|FG002|STARTED|Week 1-4||33
11326031|NCT02759146|12523429|FG003|STARTED|Week 1-4|One control participant could continue without the other after baseline.|44
11326032|NCT02759146|12523430|FG004|STARTED|Week 1-4||49
11326033|NCT02759146|12523431|FG005|STARTED|Week 1-4||30
11326034|NCT02759146|12523432|FG006|STARTED|Week 1-4||27
11326035|NCT02759146|12523426|FG000|COMPLETED|Week 1-4||56
11326036|NCT02759146|12523427|FG001|COMPLETED|Week 1-4||34
11326037|NCT02759146|12523428|FG002|COMPLETED|Week 1-4||32
11326038|NCT02759146|12523429|FG003|COMPLETED|Week 1-4||44
11326039|NCT02759146|12523430|FG004|COMPLETED|Week 1-4||49
11326040|NCT02759146|12523431|FG005|COMPLETED|Week 1-4||29
11326041|NCT02759146|12523432|FG006|COMPLETED|Week 1-4||26
11326042|NCT02759146|12523426|FG000|NOT COMPLETED|Week 1-4||1
11326043|NCT02759146|12523427|FG001|NOT COMPLETED|Week 1-4||2
11326044|NCT02759146|12523428|FG002|NOT COMPLETED|Week 1-4||1
11326045|NCT02759146|12523429|FG003|NOT COMPLETED|Week 1-4||0
11326046|NCT02759146|12523430|FG004|NOT COMPLETED|Week 1-4||0
11326047|NCT02759146|12523431|FG005|NOT COMPLETED|Week 1-4||1
11326048|NCT02759146|12523432|FG006|NOT COMPLETED|Week 1-4||1
11326049|NCT02759146|12523426|FG000|STARTED|Week 5-8||56
11326050|NCT02759146|12523427|FG001|STARTED|Week 5-8||34
11326051|NCT02759146|12523428|FG002|STARTED|Week 5-8||32
11326052|NCT02759146|12523429|FG003|STARTED|Week 5-8||44
11326053|NCT02759146|12523430|FG004|STARTED|Week 5-8||49
11326054|NCT02759146|12523431|FG005|STARTED|Week 5-8||29
11326055|NCT02759146|12523432|FG006|STARTED|Week 5-8||26
11326056|NCT02759146|12523426|FG000|COMPLETED|Week 5-8||46
11326057|NCT02759146|12523427|FG001|COMPLETED|Week 5-8||29
11326058|NCT02759146|12523428|FG002|COMPLETED|Week 5-8||22
11326059|NCT02759146|12523429|FG003|COMPLETED|Week 5-8||37
11326060|NCT02759146|12523430|FG004|COMPLETED|Week 5-8||44
11326061|NCT02759146|12523431|FG005|COMPLETED|Week 5-8||23
11326062|NCT02759146|12523432|FG006|COMPLETED|Week 5-8||20
11326063|NCT02759146|12523426|FG000|NOT COMPLETED|Week 5-8||10
11326064|NCT02759146|12523427|FG001|NOT COMPLETED|Week 5-8||5
11326065|NCT02759146|12523428|FG002|NOT COMPLETED|Week 5-8||10
11326066|NCT02759146|12523429|FG003|NOT COMPLETED|Week 5-8||7
11027223|NCT00833053|12205943|FG000|STARTED|Overall Study||19
11027224|NCT00833053|12205944|FG001|STARTED|Overall Study||20
11326067|NCT02759146|12523430|FG004|NOT COMPLETED|Week 5-8||5
11326068|NCT02759146|12523431|FG005|NOT COMPLETED|Week 5-8||6
11326069|NCT02759146|12523432|FG006|NOT COMPLETED|Week 5-8||6
11326070|NCT02759315|12523453|FG000|STARTED|Overall Study||69
11326071|NCT02759315|12523454|FG001|STARTED|Overall Study||29
11326072|NCT02759315|12523455|FG002|STARTED|Overall Study||39
11326073|NCT02759315|12523456|FG003|STARTED|Overall Study||20
11326074|NCT02759315|12523457|FG004|STARTED|Overall Study||3
11326075|NCT02759315|12523453|FG000|COMPLETED|Overall Study||65
11326076|NCT02759315|12523454|FG001|COMPLETED|Overall Study||28
11326077|NCT02759315|12523455|FG002|COMPLETED|Overall Study||29
11326078|NCT02759315|12523456|FG003|COMPLETED|Overall Study||19
11326079|NCT02759315|12523457|FG004|COMPLETED|Overall Study||2
11326080|NCT02759315|12523453|FG000|NOT COMPLETED|Overall Study||4
11326081|NCT02759315|12523454|FG001|NOT COMPLETED|Overall Study||1
11326082|NCT02759315|12523455|FG002|NOT COMPLETED|Overall Study||10
11326083|NCT02759315|12523456|FG003|NOT COMPLETED|Overall Study||1
11326084|NCT02759315|12523457|FG004|NOT COMPLETED|Overall Study||1
11326085|NCT02759354|12523475|FG000|STARTED|Overall Study||192
11326086|NCT02759354|12523476|FG001|STARTED|Overall Study||190
11326087|NCT02759354|12523477|FG002|STARTED|Overall Study||181
11326088|NCT02759354|12523478|FG003|STARTED|Overall Study||191
11326089|NCT02759354|12523475|FG000|COMPLETED|Overall Study||192
11326090|NCT02759354|12523476|FG001|COMPLETED|Overall Study||190
11326091|NCT02759354|12523477|FG002|COMPLETED|Overall Study||181
11326092|NCT02759354|12523478|FG003|COMPLETED|Overall Study||191
11326093|NCT02759354|12523475|FG000|NOT COMPLETED|Overall Study||0
11326094|NCT02759354|12523476|FG001|NOT COMPLETED|Overall Study||0
11326095|NCT02759354|12523477|FG002|NOT COMPLETED|Overall Study||0
11326096|NCT02759354|12523478|FG003|NOT COMPLETED|Overall Study||0
11326097|NCT02759471|12523490|FG000|STARTED|Overall Study||54
11326098|NCT02759471|12523490|FG000|COMPLETED|Overall Study||52
11326099|NCT02759471|12523490|FG000|NOT COMPLETED|Overall Study||2
11326100|NCT02759562|12523498|FG000|STARTED|Double-Blind Treatment Period (8 Weeks)||3
11326101|NCT02759562|12523499|FG001|STARTED|Double-Blind Treatment Period (8 Weeks)||3
11326102|NCT02759562|12523498|FG000|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
11326103|NCT02759562|12523499|FG001|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
11326104|NCT02759562|12523498|FG000|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
11326105|NCT02759562|12523499|FG001|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
11326106|NCT02759562|12523498|FG000|STARTED|Open-Label Treatment Period||2
11326107|NCT02759562|12523499|FG001|STARTED|Open-Label Treatment Period||2
11326108|NCT02759562|12523498|FG000|COMPLETED|Open-Label Treatment Period||0
11326109|NCT02759562|12523499|FG001|COMPLETED|Open-Label Treatment Period||0
11326110|NCT02759562|12523498|FG000|NOT COMPLETED|Open-Label Treatment Period||2
11326111|NCT02759562|12523499|FG001|NOT COMPLETED|Open-Label Treatment Period||2
11326112|NCT02759575|12523506|FG000|STARTED|Overall Study||9
11326113|NCT02759575|12523506|FG000|COMPLETED|Overall Study||9
11326114|NCT02759575|12523506|FG000|NOT COMPLETED|Overall Study||0
11326115|NCT02759692|12523510|FG000|STARTED|Period 1||141
11326116|NCT02759692|12523511|FG001|STARTED|Period 1||142
11326117|NCT02759692|12523510|FG000|COMPLETED|Period 1||138
11326118|NCT02759692|12523511|FG001|COMPLETED|Period 1||140
11326119|NCT02759692|12523510|FG000|NOT COMPLETED|Period 1||3
11326120|NCT02759692|12523511|FG001|NOT COMPLETED|Period 1||2
11326121|NCT02759692|12523510|FG000|STARTED|Period 2||138
11326122|NCT02759692|12523511|FG001|STARTED|Period 2||140
11326123|NCT02759692|12523510|FG000|COMPLETED|Period 2||137
11326124|NCT02759692|12523511|FG001|COMPLETED|Period 2||139
11326125|NCT02759692|12523510|FG000|NOT COMPLETED|Period 2||1
11326126|NCT02759692|12523511|FG001|NOT COMPLETED|Period 2||1
11326127|NCT02759692|12523510|FG000|STARTED|Period 3||137
11326128|NCT02759692|12523511|FG001|STARTED|Period 3||139
11326129|NCT02759692|12523510|FG000|COMPLETED|Period 3||137
11326130|NCT02759692|12523511|FG001|COMPLETED|Period 3||139
11326131|NCT02759692|12523510|FG000|NOT COMPLETED|Period 3||0
11326132|NCT02759692|12523511|FG001|NOT COMPLETED|Period 3||0
11326133|NCT02759939|12523521|FG000|STARTED|Overall Study||1256
11326134|NCT02759939|12523522|FG001|STARTED|Overall Study||1143
11326135|NCT02759939|12523523|FG002|STARTED|Overall Study||1393
11326136|NCT02759939|12523524|FG003|STARTED|Overall Study||1246
11326137|NCT02759939|12523521|FG000|Analyzed at T1|Overall Study||1245
11326138|NCT02759939|12523522|FG001|Analyzed at T1|Overall Study||1141
11326139|NCT02759939|12523523|FG002|Analyzed at T1|Overall Study||1388
11326140|NCT02759939|12523524|FG003|Analyzed at T1|Overall Study||1244
11326141|NCT02759939|12523521|FG000|Eligible for T2 and T3|Overall Study||935
11326142|NCT02759939|12523522|FG001|Eligible for T2 and T3|Overall Study||962
11326143|NCT02759939|12523523|FG002|Eligible for T2 and T3|Overall Study||1022
11326144|NCT02759939|12523524|FG003|Eligible for T2 and T3|Overall Study||853
11326145|NCT02759939|12523521|FG000|Analyzed at T2 and/or T3|Overall Study||303
11326146|NCT02759939|12523522|FG001|Analyzed at T2 and/or T3|Overall Study||278
11326147|NCT02759939|12523523|FG002|Analyzed at T2 and/or T3|Overall Study||373
11326148|NCT02759939|12523524|FG003|Analyzed at T2 and/or T3|Overall Study||304
11326149|NCT02759939|12523521|FG000|Consented to T2 and T3|Overall Study||579
11326150|NCT02759939|12523522|FG001|Consented to T2 and T3|Overall Study||626
11326151|NCT02759939|12523523|FG002|Consented to T2 and T3|Overall Study||702
11326152|NCT02759939|12523524|FG003|Consented to T2 and T3|Overall Study||564
11326153|NCT02759939|12523521|FG000|COMPLETED|Overall Study||200
11326154|NCT02759939|12523522|FG001|COMPLETED|Overall Study||171
11326155|NCT02759939|12523523|FG002|COMPLETED|Overall Study||239
11326156|NCT02759939|12523524|FG003|COMPLETED|Overall Study||203
11326157|NCT02759939|12523521|FG000|NOT COMPLETED|Overall Study||1056
11326158|NCT02759939|12523522|FG001|NOT COMPLETED|Overall Study||972
11326159|NCT02759939|12523523|FG002|NOT COMPLETED|Overall Study||1154
11326160|NCT02759939|12523524|FG003|NOT COMPLETED|Overall Study||1043
11326161|NCT02760056|12523536|FG000|STARTED|Overall Study||10
11326162|NCT02760056|12523537|FG001|STARTED|Overall Study||5
11326163|NCT02760056|12523536|FG000|COMPLETED|Overall Study||10
11326164|NCT02760056|12523537|FG001|COMPLETED|Overall Study||5
11326165|NCT02760056|12523536|FG000|NOT COMPLETED|Overall Study||0
11326166|NCT02760056|12523537|FG001|NOT COMPLETED|Overall Study||0
11326167|NCT02760069|12523547|FG000|STARTED|Overall Study||40
11326168|NCT02760069|12523548|FG001|STARTED|Overall Study||41
11326169|NCT02760069|12523549|FG002|STARTED|Overall Study||41
11326170|NCT02760069|12523547|FG000|COMPLETED|Overall Study||40
11326171|NCT02760069|12523548|FG001|COMPLETED|Overall Study||40
11326172|NCT02760069|12523549|FG002|COMPLETED|Overall Study||40
11326173|NCT02760069|12523547|FG000|NOT COMPLETED|Overall Study||0
11326174|NCT02760069|12523548|FG001|NOT COMPLETED|Overall Study||1
11326175|NCT02760069|12523549|FG002|NOT COMPLETED|Overall Study||1
11326176|NCT02760264|12523561|FG000|STARTED|0.25 mg/kg/Day||12
11326177|NCT02760264|12523562|FG001|STARTED|0.25 mg/kg/Day||0
11326178|NCT02760264|12523563|FG002|STARTED|0.25 mg/kg/Day||0
11326179|NCT02760264|12523564|FG003|STARTED|0.25 mg/kg/Day||0
11326180|NCT02760264|12523561|FG000|COMPLETED|0.25 mg/kg/Day||12
11326181|NCT02760264|12523562|FG001|COMPLETED|0.25 mg/kg/Day||0
11326182|NCT02760264|12523563|FG002|COMPLETED|0.25 mg/kg/Day||0
11326183|NCT02760264|12523564|FG003|COMPLETED|0.25 mg/kg/Day||0
11326184|NCT02760264|12523561|FG000|NOT COMPLETED|0.25 mg/kg/Day||0
11326185|NCT02760264|12523562|FG001|NOT COMPLETED|0.25 mg/kg/Day||0
11326186|NCT02760264|12523563|FG002|NOT COMPLETED|0.25 mg/kg/Day||0
11326187|NCT02760264|12523564|FG003|NOT COMPLETED|0.25 mg/kg/Day||0
11326188|NCT02760264|12523561|FG000|STARTED|0.75 mg/kg/Day||0
11326189|NCT02760264|12523562|FG001|STARTED|0.75 mg/kg/Day||12
11326190|NCT02760264|12523563|FG002|STARTED|0.75 mg/kg/Day||0
11326191|NCT02760264|12523564|FG003|STARTED|0.75 mg/kg/Day||0
11326192|NCT02760264|12523561|FG000|COMPLETED|0.75 mg/kg/Day||0
11326193|NCT02760264|12523562|FG001|COMPLETED|0.75 mg/kg/Day||12
11326194|NCT02760264|12523563|FG002|COMPLETED|0.75 mg/kg/Day||0
11326195|NCT02760264|12523564|FG003|COMPLETED|0.75 mg/kg/Day||0
11326196|NCT02760264|12523561|FG000|NOT COMPLETED|0.75 mg/kg/Day||0
11326197|NCT02760264|12523562|FG001|NOT COMPLETED|0.75 mg/kg/Day||0
11326198|NCT02760264|12523563|FG002|NOT COMPLETED|0.75 mg/kg/Day||0
11326199|NCT02760264|12523564|FG003|NOT COMPLETED|0.75 mg/kg/Day||0
11326200|NCT02760264|12523561|FG000|STARTED|2.0 mg/kg/Day||0
11326201|NCT02760264|12523562|FG001|STARTED|2.0 mg/kg/Day||0
11326202|NCT02760264|12523563|FG002|STARTED|2.0 mg/kg/Day||12
11326203|NCT02760264|12523564|FG003|STARTED|2.0 mg/kg/Day||0
11326204|NCT02760264|12523561|FG000|COMPLETED|2.0 mg/kg/Day||0
11326205|NCT02760264|12523562|FG001|COMPLETED|2.0 mg/kg/Day||0
11326206|NCT02760264|12523563|FG002|COMPLETED|2.0 mg/kg/Day||12
11326207|NCT02760264|12523564|FG003|COMPLETED|2.0 mg/kg/Day||0
11326208|NCT02760264|12523561|FG000|NOT COMPLETED|2.0 mg/kg/Day||0
11326209|NCT02760264|12523562|FG001|NOT COMPLETED|2.0 mg/kg/Day||0
11326210|NCT02760264|12523563|FG002|NOT COMPLETED|2.0 mg/kg/Day||0
11326211|NCT02760264|12523564|FG003|NOT COMPLETED|2.0 mg/kg/Day||0
11326212|NCT02760264|12523561|FG000|STARTED|6.0 mg/kg/Day||0
11326213|NCT02760264|12523562|FG001|STARTED|6.0 mg/kg/Day||0
11326214|NCT02760264|12523563|FG002|STARTED|6.0 mg/kg/Day||0
11326215|NCT02760264|12523564|FG003|STARTED|6.0 mg/kg/Day||12
11326216|NCT02760264|12523561|FG000|COMPLETED|6.0 mg/kg/Day||0
11326217|NCT02760264|12523562|FG001|COMPLETED|6.0 mg/kg/Day||0
11326218|NCT02760264|12523563|FG002|COMPLETED|6.0 mg/kg/Day||0
11326219|NCT02760264|12523564|FG003|COMPLETED|6.0 mg/kg/Day||12
11326220|NCT02760264|12523561|FG000|NOT COMPLETED|6.0 mg/kg/Day||0
11326221|NCT02760264|12523562|FG001|NOT COMPLETED|6.0 mg/kg/Day||0
11326222|NCT02760264|12523563|FG002|NOT COMPLETED|6.0 mg/kg/Day||0
11326223|NCT02760264|12523564|FG003|NOT COMPLETED|6.0 mg/kg/Day||0
11326224|NCT02760277|12523579|FG000|STARTED|Vamorolone 0.25 mg/kg/Day||12
11326225|NCT02760277|12523580|FG001|STARTED|Vamorolone 0.25 mg/kg/Day||0
11326226|NCT02760277|12523581|FG002|STARTED|Vamorolone 0.25 mg/kg/Day||0
11326227|NCT02760277|12523582|FG003|STARTED|Vamorolone 0.25 mg/kg/Day||0
11326228|NCT02760277|12523579|FG000|COMPLETED|Vamorolone 0.25 mg/kg/Day||12
11326229|NCT02760277|12523580|FG001|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
11326230|NCT02760277|12523581|FG002|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
11326231|NCT02760277|12523582|FG003|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
11326232|NCT02760277|12523579|FG000|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
11326233|NCT02760277|12523580|FG001|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
11326234|NCT02760277|12523581|FG002|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
11326235|NCT02760277|12523582|FG003|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
11326236|NCT02760277|12523579|FG000|STARTED|0.75 mg/kg/Day||0
11326237|NCT02760277|12523580|FG001|STARTED|0.75 mg/kg/Day||12
11326238|NCT02760277|12523581|FG002|STARTED|0.75 mg/kg/Day||0
11326239|NCT02760277|12523582|FG003|STARTED|0.75 mg/kg/Day||0
11326240|NCT02760277|12523579|FG000|COMPLETED|0.75 mg/kg/Day||0
11326241|NCT02760277|12523580|FG001|COMPLETED|0.75 mg/kg/Day||12
11326242|NCT02760277|12523581|FG002|COMPLETED|0.75 mg/kg/Day||0
11326243|NCT02760277|12523582|FG003|COMPLETED|0.75 mg/kg/Day||0
11326244|NCT02760277|12523579|FG000|NOT COMPLETED|0.75 mg/kg/Day||0
11326245|NCT02760277|12523580|FG001|NOT COMPLETED|0.75 mg/kg/Day||0
11326246|NCT02760277|12523581|FG002|NOT COMPLETED|0.75 mg/kg/Day||0
11326247|NCT02760277|12523582|FG003|NOT COMPLETED|0.75 mg/kg/Day||0
11326248|NCT02760277|12523579|FG000|STARTED|2.0 mg/kg/Day||0
11326249|NCT02760277|12523580|FG001|STARTED|2.0 mg/kg/Day||0
11326250|NCT02760277|12523581|FG002|STARTED|2.0 mg/kg/Day||12
11326251|NCT02760277|12523582|FG003|STARTED|2.0 mg/kg/Day||0
11326252|NCT02760277|12523579|FG000|COMPLETED|2.0 mg/kg/Day||0
11326253|NCT02760277|12523580|FG001|COMPLETED|2.0 mg/kg/Day||0
11326254|NCT02760277|12523581|FG002|COMPLETED|2.0 mg/kg/Day||12
11326255|NCT02760277|12523582|FG003|COMPLETED|2.0 mg/kg/Day||0
11326256|NCT02760277|12523579|FG000|NOT COMPLETED|2.0 mg/kg/Day||0
11326257|NCT02760277|12523580|FG001|NOT COMPLETED|2.0 mg/kg/Day||0
11326258|NCT02760277|12523581|FG002|NOT COMPLETED|2.0 mg/kg/Day||0
11326259|NCT02760277|12523582|FG003|NOT COMPLETED|2.0 mg/kg/Day||0
11326260|NCT02760277|12523579|FG000|STARTED|6.0 mg/kg/Day||0
11326261|NCT02760277|12523580|FG001|STARTED|6.0 mg/kg/Day||0
11326262|NCT02760277|12523581|FG002|STARTED|6.0 mg/kg/Day||0
11326263|NCT02760277|12523582|FG003|STARTED|6.0 mg/kg/Day||12
11326264|NCT02760277|12523579|FG000|COMPLETED|6.0 mg/kg/Day||0
11326265|NCT02760277|12523580|FG001|COMPLETED|6.0 mg/kg/Day||0
11326266|NCT02760277|12523581|FG002|COMPLETED|6.0 mg/kg/Day||0
11326267|NCT02760277|12523582|FG003|COMPLETED|6.0 mg/kg/Day||12
11326268|NCT02760277|12523579|FG000|NOT COMPLETED|6.0 mg/kg/Day||0
11326269|NCT02760277|12523580|FG001|NOT COMPLETED|6.0 mg/kg/Day||0
11326270|NCT02760277|12523581|FG002|NOT COMPLETED|6.0 mg/kg/Day||0
11326271|NCT02760277|12523582|FG003|NOT COMPLETED|6.0 mg/kg/Day||0
11326272|NCT02760368|12523595|FG000|STARTED|Overall Study||143
11326273|NCT02760368|12523596|FG001|STARTED|Overall Study||142
11326274|NCT02760368|12523597|FG002|STARTED|Overall Study||143
11326275|NCT02760368|12523595|FG000|COMPLETED|Overall Study||130
11326276|NCT02760368|12523596|FG001|COMPLETED|Overall Study||134
11326277|NCT02760368|12523597|FG002|COMPLETED|Overall Study||132
11326278|NCT02760368|12523595|FG000|NOT COMPLETED|Overall Study||13
11326279|NCT02760368|12523596|FG001|NOT COMPLETED|Overall Study||8
11326280|NCT02760368|12523597|FG002|NOT COMPLETED|Overall Study||11
11326281|NCT02760407|12523609|FG000|STARTED|Overall Study||479
11326282|NCT02760407|12523610|FG001|STARTED|Overall Study||464
11326283|NCT02760407|12523611|FG002|STARTED|Overall Study||462
11326284|NCT02760407|12523612|FG003|STARTED|Overall Study||243
11326285|NCT02760407|12523609|FG000|COMPLETED|Overall Study||443
11326286|NCT02760407|12523610|FG001|COMPLETED|Overall Study||421
11326287|NCT02760407|12523611|FG002|COMPLETED|Overall Study||412
11326288|NCT02760407|12523612|FG003|COMPLETED|Overall Study||207
11326289|NCT02760407|12523609|FG000|NOT COMPLETED|Overall Study||36
11326290|NCT02760407|12523610|FG001|NOT COMPLETED|Overall Study||43
11326291|NCT02760407|12523611|FG002|NOT COMPLETED|Overall Study||50
11326292|NCT02760407|12523612|FG003|NOT COMPLETED|Overall Study||36
11326293|NCT02760433|12523628|FG000|STARTED|Overall Study||161
11326294|NCT02760433|12523629|FG001|STARTED|Overall Study||138
11326295|NCT02760433|12523630|FG002|STARTED|Overall Study||26
11326296|NCT02760433|12523631|FG003|STARTED|Overall Study||32
11326297|NCT02760433|12523632|FG004|STARTED|Overall Study||11
11326298|NCT02760433|12523628|FG000|COMPLETED|Overall Study||134
11326299|NCT02760433|12523629|FG001|COMPLETED|Overall Study||128
11326300|NCT02760433|12523630|FG002|COMPLETED|Overall Study||25
11326301|NCT02760433|12523631|FG003|COMPLETED|Overall Study||30
11326302|NCT02760433|12523632|FG004|COMPLETED|Overall Study||1
11326303|NCT02760433|12523628|FG000|NOT COMPLETED|Overall Study||27
11326304|NCT02760433|12523629|FG001|NOT COMPLETED|Overall Study||10
11326305|NCT02760433|12523630|FG002|NOT COMPLETED|Overall Study||1
11326306|NCT02760433|12523631|FG003|NOT COMPLETED|Overall Study||2
11326307|NCT02760433|12523632|FG004|NOT COMPLETED|Overall Study||10
11326308|NCT02760654|12523651|FG000|STARTED|Overall Study||30
11326309|NCT02760654|12523652|FG001|STARTED|Overall Study||30
11326310|NCT02760654|12523651|FG000|COMPLETED|Overall Study||23
11326311|NCT02760654|12523652|FG001|COMPLETED|Overall Study||24
11326312|NCT02760654|12523651|FG000|NOT COMPLETED|Overall Study||7
11326313|NCT02760654|12523652|FG001|NOT COMPLETED|Overall Study||6
11326314|NCT02760810|12523658|FG000|STARTED|Overall Study||30
11326315|NCT02760810|12523658|FG000|COMPLETED|Overall Study||29
11326316|NCT02760810|12523658|FG000|NOT COMPLETED|Overall Study||1
11326317|NCT02760862|12523664|FG000|STARTED|Overall Study||25
11326318|NCT02760862|12523665|FG001|STARTED|Overall Study||25
11326319|NCT02760862|12523664|FG000|COMPLETED|Overall Study||25
11326320|NCT02760862|12523665|FG001|COMPLETED|Overall Study||25
11326321|NCT02760862|12523664|FG000|NOT COMPLETED|Overall Study||0
11326322|NCT02760862|12523665|FG001|NOT COMPLETED|Overall Study||0
11326323|NCT02760927|12523671|FG000|STARTED|Overall Study||4
11326324|NCT02760927|12523671|FG000|COMPLETED|Overall Study||3
11326325|NCT02760927|12523671|FG000|NOT COMPLETED|Overall Study||1
11326326|NCT02761252|12523678|FG000|STARTED|Overall Study||143
11326327|NCT02761252|12523679|FG001|STARTED|Overall Study||140
11326328|NCT02761252|12523680|FG002|STARTED|Overall Study||137
11326329|NCT02761252|12523678|FG000|COMPLETED|Overall Study||133
11326330|NCT02761252|12523679|FG001|COMPLETED|Overall Study||132
11326331|NCT02761252|12523680|FG002|COMPLETED|Overall Study||123
11326332|NCT02761252|12523678|FG000|NOT COMPLETED|Overall Study||10
11326333|NCT02761252|12523679|FG001|NOT COMPLETED|Overall Study||8
11326334|NCT02761252|12523680|FG002|NOT COMPLETED|Overall Study||14
11326335|NCT02761330|12523690|FG000|STARTED|Treatment Week 1||2
11326336|NCT02761330|12523691|FG001|STARTED|Treatment Week 1||3
11326337|NCT02761330|12523692|FG002|STARTED|Treatment Week 1||2
11326338|NCT02761330|12523693|FG003|STARTED|Treatment Week 1||3
11326339|NCT02761330|12523694|FG004|STARTED|Treatment Week 1||1
11326340|NCT02761330|12523695|FG005|STARTED|Treatment Week 1||3
11326341|NCT02761330|12523690|FG000|COMPLETED|Treatment Week 1||2
11326342|NCT02761330|12523691|FG001|COMPLETED|Treatment Week 1||3
11326343|NCT02761330|12523692|FG002|COMPLETED|Treatment Week 1||2
11326344|NCT02761330|12523693|FG003|COMPLETED|Treatment Week 1||2
11326345|NCT02761330|12523694|FG004|COMPLETED|Treatment Week 1||1
11326346|NCT02761330|12523695|FG005|COMPLETED|Treatment Week 1||2
11326347|NCT02761330|12523690|FG000|NOT COMPLETED|Treatment Week 1||0
11326348|NCT02761330|12523691|FG001|NOT COMPLETED|Treatment Week 1||0
11326349|NCT02761330|12523692|FG002|NOT COMPLETED|Treatment Week 1||0
11326350|NCT02761330|12523693|FG003|NOT COMPLETED|Treatment Week 1||1
11326351|NCT02761330|12523694|FG004|NOT COMPLETED|Treatment Week 1||0
11326352|NCT02761330|12523695|FG005|NOT COMPLETED|Treatment Week 1||1
11326353|NCT02761330|12523690|FG000|STARTED|Treatment Week 2||2
11326354|NCT02761330|12523691|FG001|STARTED|Treatment Week 2||3
11326355|NCT02761330|12523692|FG002|STARTED|Treatment Week 2||2
11326356|NCT02761330|12523693|FG003|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to withdraw.|1
11326357|NCT02761330|12523694|FG004|STARTED|Treatment Week 2||1
11326358|NCT02761330|12523695|FG005|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to cancellation of treatment.|1
11326359|NCT02761330|12523690|FG000|COMPLETED|Treatment Week 2||2
11326360|NCT02761330|12523691|FG001|COMPLETED|Treatment Week 2||3
11326361|NCT02761330|12523692|FG002|COMPLETED|Treatment Week 2||2
11326362|NCT02761330|12523693|FG003|COMPLETED|Treatment Week 2||1
11326363|NCT02761330|12523694|FG004|COMPLETED|Treatment Week 2||1
11326364|NCT02761330|12523695|FG005|COMPLETED|Treatment Week 2||1
11326365|NCT02761330|12523690|FG000|NOT COMPLETED|Treatment Week 2||0
11326366|NCT02761330|12523691|FG001|NOT COMPLETED|Treatment Week 2||0
11326367|NCT02761330|12523692|FG002|NOT COMPLETED|Treatment Week 2||0
11326368|NCT02761330|12523693|FG003|NOT COMPLETED|Treatment Week 2||0
11326369|NCT02761330|12523694|FG004|NOT COMPLETED|Treatment Week 2||0
11326370|NCT02761330|12523695|FG005|NOT COMPLETED|Treatment Week 2||0
11326371|NCT02761629|12523711|FG000|STARTED|Overall Study||90
11326372|NCT02761629|12523712|FG001|STARTED|Overall Study||90
11326373|NCT02761629|12523711|FG000|Treated|Overall Study||82
11326374|NCT02761629|12523712|FG001|Treated|Overall Study||86
11326375|NCT02761629|12523711|FG000|COMPLETED|Overall Study||63
11326376|NCT02761629|12523712|FG001|COMPLETED|Overall Study||58
11326377|NCT02761629|12523711|FG000|NOT COMPLETED|Overall Study||27
11326378|NCT02761629|12523712|FG001|NOT COMPLETED|Overall Study||32
11326379|NCT02761642|12523718|FG000|STARTED|Overall Study||200
11326380|NCT02761642|12523718|FG000|Treated|Overall Study||197
11326381|NCT02761642|12523718|FG000|COMPLETED|Overall Study||130
11326382|NCT02761642|12523718|FG000|NOT COMPLETED|Overall Study||70
11326383|NCT02761733|12523726|FG000|STARTED|Overall Study||60
11326384|NCT02761733|12523727|FG001|STARTED|Overall Study||60
11326385|NCT02761733|12523728|FG002|STARTED|Overall Study||60
11326386|NCT02761733|12523729|FG003|STARTED|Overall Study||60
11326387|NCT02761733|12523726|FG000|9/30/2014|Overall Study||53
11326388|NCT02761733|12523727|FG001|9/30/2014|Overall Study||56
11326389|NCT02761733|12523728|FG002|9/30/2014|Overall Study||48
11326390|NCT02761733|12523729|FG003|9/30/2014|Overall Study||55
11326391|NCT02761733|12523726|FG000|3/31/2015|Overall Study||48
11326392|NCT02761733|12523727|FG001|3/31/2015|Overall Study||47
11326393|NCT02761733|12523728|FG002|3/31/2015|Overall Study||43
11326394|NCT02761733|12523729|FG003|3/31/2015|Overall Study||50
11326395|NCT02761733|12523726|FG000|9/30/2015|Overall Study||40
11326396|NCT02761733|12523727|FG001|9/30/2015|Overall Study||44
11326397|NCT02761733|12523728|FG002|9/30/2015|Overall Study||33
11326398|NCT02761733|12523729|FG003|9/30/2015|Overall Study||50
11326399|NCT02761733|12523726|FG000|COMPLETED|Overall Study||30
11326400|NCT02761733|12523727|FG001|COMPLETED|Overall Study||39
11326401|NCT02761733|12523728|FG002|COMPLETED|Overall Study||33
11326402|NCT02761733|12523729|FG003|COMPLETED|Overall Study||45
11326403|NCT02761733|12523726|FG000|NOT COMPLETED|Overall Study||30
11326404|NCT02761733|12523727|FG001|NOT COMPLETED|Overall Study||21
11326405|NCT02761733|12523728|FG002|NOT COMPLETED|Overall Study||27
11326406|NCT02761733|12523729|FG003|NOT COMPLETED|Overall Study||15
11326407|NCT02761915|12523745|FG000|STARTED|Overall Study||4
11326408|NCT02761915|12523746|FG001|STARTED|Overall Study||1
11326409|NCT02761915|12523747|FG002|STARTED|Overall Study||1
11326410|NCT02761915|12523748|FG003|STARTED|Overall Study||3
11326411|NCT02761915|12523749|FG004|STARTED|Overall Study||3
11326412|NCT02761915|12523750|FG005|STARTED|Overall Study||5
11326413|NCT02761915|12523745|FG000|Underwent Leukapheresis|Overall Study||4
11326414|NCT02761915|12523746|FG001|Underwent Leukapheresis|Overall Study||1
11326415|NCT02761915|12523747|FG002|Underwent Leukapheresis|Overall Study||1
11326416|NCT02761915|12523748|FG003|Underwent Leukapheresis|Overall Study||3
11326417|NCT02761915|12523749|FG004|Underwent Leukapheresis|Overall Study||3
11326418|NCT02761915|12523750|FG005|Underwent Leukapheresis|Overall Study||5
11326419|NCT02761915|12523745|FG000|Received Investigational Medicinal Product|Overall Study||4
11326420|NCT02761915|12523746|FG001|Received Investigational Medicinal Product|Overall Study||1
11326421|NCT02761915|12523747|FG002|Received Investigational Medicinal Product|Overall Study||1
11326422|NCT02761915|12523748|FG003|Received Investigational Medicinal Product|Overall Study||3
11326423|NCT02761915|12523749|FG004|Received Investigational Medicinal Product|Overall Study||3
11326424|NCT02761915|12523750|FG005|Received Investigational Medicinal Product|Overall Study||0
11326425|NCT02761915|12523745|FG000|COMPLETED|Overall Study||0
11326426|NCT02761915|12523746|FG001|COMPLETED|Overall Study||0
11326427|NCT02761915|12523747|FG002|COMPLETED|Overall Study||0
11326428|NCT02761915|12523748|FG003|COMPLETED|Overall Study||0
11326429|NCT02761915|12523749|FG004|COMPLETED|Overall Study||0
11326430|NCT02761915|12523750|FG005|COMPLETED|Overall Study||0
11326431|NCT02761915|12523745|FG000|NOT COMPLETED|Overall Study||4
11326432|NCT02761915|12523746|FG001|NOT COMPLETED|Overall Study||1
11326433|NCT02761915|12523747|FG002|NOT COMPLETED|Overall Study||1
11326434|NCT02761915|12523748|FG003|NOT COMPLETED|Overall Study||3
11326435|NCT02761915|12523749|FG004|NOT COMPLETED|Overall Study||3
11326436|NCT02761915|12523750|FG005|NOT COMPLETED|Overall Study||5
11326437|NCT02761967|12523770|FG000|STARTED|Overall Study||70
11326438|NCT02761967|12523771|FG001|STARTED|Overall Study||70
11326439|NCT02761967|12523770|FG000|COMPLETED|Overall Study||65
11326440|NCT02761967|12523771|FG001|COMPLETED|Overall Study||64
11326441|NCT02761967|12523770|FG000|NOT COMPLETED|Overall Study||5
11326442|NCT02761967|12523771|FG001|NOT COMPLETED|Overall Study||6
11326443|NCT02761980|12523784|FG000|STARTED|Overall Study||29
11326444|NCT02761980|12523785|FG001|STARTED|Overall Study||87
11326445|NCT02761980|12523786|FG002|STARTED|Overall Study||87
11326446|NCT02761980|12523787|FG003|STARTED|Overall Study||87
11326447|NCT02761980|12523784|FG000|COMPLETED|Overall Study||25
11326448|NCT02761980|12523785|FG001|COMPLETED|Overall Study||80
11326449|NCT02761980|12523786|FG002|COMPLETED|Overall Study||81
11326450|NCT02761980|12523787|FG003|COMPLETED|Overall Study||81
11326451|NCT02761980|12523784|FG000|NOT COMPLETED|Overall Study||4
11326452|NCT02761980|12523785|FG001|NOT COMPLETED|Overall Study||7
11326453|NCT02761980|12523786|FG002|NOT COMPLETED|Overall Study||6
11326454|NCT02761980|12523787|FG003|NOT COMPLETED|Overall Study||6
11326455|NCT02761993|12523800|FG000|STARTED|Overall Study||52
11326456|NCT02761993|12523801|FG001|STARTED|Overall Study||49
11326457|NCT02761993|12523802|FG002|STARTED|Overall Study||50
11326458|NCT02761993|12523800|FG000|COMPLETED|Overall Study||50
11326459|NCT02761993|12523801|FG001|COMPLETED|Overall Study||43
11326460|NCT02761993|12523802|FG002|COMPLETED|Overall Study||46
11326461|NCT02761993|12523800|FG000|NOT COMPLETED|Overall Study||2
11326462|NCT02761993|12523801|FG001|NOT COMPLETED|Overall Study||6
11326463|NCT02761993|12523802|FG002|NOT COMPLETED|Overall Study||4
11326464|NCT02762071|12523812|FG000|STARTED|Overall Study||54
11326465|NCT02762071|12523813|FG001|STARTED|Overall Study||54
11326466|NCT02762071|12523812|FG000|COMPLETED|Overall Study||54
11326467|NCT02762071|12523813|FG001|COMPLETED|Overall Study||54
11326468|NCT02762071|12523812|FG000|NOT COMPLETED|Overall Study||0
11326469|NCT02762071|12523813|FG001|NOT COMPLETED|Overall Study||0
11326470|NCT02762084|12523823|FG000|STARTED|Overall Study||6
11326471|NCT02762084|12523824|FG001|STARTED|Overall Study||6
11326472|NCT02762084|12523825|FG002|STARTED|Overall Study||5
11326473|NCT02762084|12523823|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
11326474|NCT02762084|12523824|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
11326475|NCT02762084|12523825|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5
11326476|NCT02762084|12523823|FG000|By Tumor Per Protocol Population (PP)|Overall Study||6
11326477|NCT02762084|12523824|FG001|By Tumor Per Protocol Population (PP)|Overall Study||6
11326478|NCT02762084|12523825|FG002|By Tumor Per Protocol Population (PP)|Overall Study||4
11326479|NCT02762084|12523823|FG000|COMPLETED|Overall Study||5
11326480|NCT02762084|12523824|FG001|COMPLETED|Overall Study||6
11326481|NCT02762084|12523825|FG002|COMPLETED|Overall Study||4
11326482|NCT02762084|12523823|FG000|NOT COMPLETED|Overall Study||1
11326483|NCT02762084|12523824|FG001|NOT COMPLETED|Overall Study||0
11326484|NCT02762084|12523825|FG002|NOT COMPLETED|Overall Study||1
11326485|NCT02762331|12523837|FG000|STARTED|Overall Study||4
11326486|NCT02762331|12523838|FG001|STARTED|Overall Study||2
11326487|NCT02762331|12523837|FG000|COMPLETED|Overall Study||4
11326488|NCT02762331|12523838|FG001|COMPLETED|Overall Study||2
11326489|NCT02762331|12523837|FG000|NOT COMPLETED|Overall Study||0
11326490|NCT02762331|12523838|FG001|NOT COMPLETED|Overall Study||0
11326491|NCT02762370|12523846|FG000|STARTED|Overall Study||18
11326492|NCT02762370|12523847|FG001|STARTED|Overall Study||15
11326493|NCT02762370|12523846|FG000|COMPLETED|Overall Study||17
11326494|NCT02762370|12523847|FG001|COMPLETED|Overall Study||15
11326495|NCT02762370|12523846|FG000|NOT COMPLETED|Overall Study||1
11326496|NCT02762370|12523847|FG001|NOT COMPLETED|Overall Study||0
11326497|NCT02762500|12523857|FG000|STARTED|Overall Study||62
11326498|NCT02762500|12523858|FG001|STARTED|Overall Study||62
11326499|NCT02762500|12523857|FG000|COMPLETED|Overall Study||60
11326500|NCT02762500|12523858|FG001|COMPLETED|Overall Study||59
11326501|NCT02762500|12523857|FG000|NOT COMPLETED|Overall Study||2
11326502|NCT02762500|12523858|FG001|NOT COMPLETED|Overall Study||3
11326503|NCT02762513|12523864|FG000|STARTED|Overall Study||28
11326504|NCT02762513|12523864|FG000|COMPLETED|Overall Study||28
11326505|NCT02762513|12523864|FG000|NOT COMPLETED|Overall Study||0
11326506|NCT02762565|12523868|FG000|STARTED|Overall Study||89
11326507|NCT02762565|12523868|FG000|COMPLETED|Overall Study||78
11326508|NCT02762565|12523868|FG000|NOT COMPLETED|Overall Study||11
11326509|NCT02762578|12523874|FG000|STARTED|Overall Study||361
11326510|NCT02762578|12523875|FG001|STARTED|Overall Study||182
11326511|NCT02762578|12523874|FG000|Exposed|Overall Study||360
11326512|NCT02762578|12523875|FG001|Exposed|Overall Study||181
11326513|NCT02762578|12523874|FG000|COMPLETED|Overall Study||346
11326514|NCT02762578|12523875|FG001|COMPLETED|Overall Study||172
11326515|NCT02762578|12523874|FG000|NOT COMPLETED|Overall Study||15
11326516|NCT02762578|12523875|FG001|NOT COMPLETED|Overall Study||10
11326517|NCT02762799|12523885|FG000|STARTED|Overall Study||18
11326518|NCT02762799|12523886|FG001|STARTED|Overall Study||18
11326519|NCT02762799|12523887|FG002|STARTED|Overall Study||12
11326520|NCT02762799|12523888|FG003|STARTED|Overall Study||12
11326521|NCT02762799|12523885|FG000|COMPLETED|Overall Study||18
11326522|NCT02762799|12523886|FG001|COMPLETED|Overall Study||18
11326523|NCT02762799|12523887|FG002|COMPLETED|Overall Study||11
11326524|NCT02762799|12523888|FG003|COMPLETED|Overall Study||12
11326525|NCT02762799|12523885|FG000|NOT COMPLETED|Overall Study||0
11326526|NCT02762799|12523886|FG001|NOT COMPLETED|Overall Study||0
11326527|NCT02762799|12523887|FG002|NOT COMPLETED|Overall Study||1
11326528|NCT02762799|12523888|FG003|NOT COMPLETED|Overall Study||0
11326529|NCT02762877|12523902|FG000|STARTED|Overall Study||121
11326530|NCT02762877|12523903|FG001|STARTED|Overall Study||19
11326531|NCT02762877|12523902|FG000|COMPLETED|Overall Study||121
11326532|NCT02762877|12523903|FG001|COMPLETED|Overall Study||19
11326533|NCT02762877|12523902|FG000|NOT COMPLETED|Overall Study||0
11326534|NCT02762877|12523903|FG001|NOT COMPLETED|Overall Study||0
11326535|NCT02762994|12523914|FG000|STARTED|Overall Study||31
11326536|NCT02762994|12523915|FG001|STARTED|Overall Study||31
11326537|NCT02762994|12523916|FG002|STARTED|Overall Study||30
11326538|NCT02762994|12523917|FG003|STARTED|Overall Study||28
11326539|NCT02762994|12523914|FG000|COMPLETED|Overall Study||30
11326540|NCT02762994|12523915|FG001|COMPLETED|Overall Study||30
11326541|NCT02762994|12523916|FG002|COMPLETED|Overall Study||28
11326542|NCT02762994|12523917|FG003|COMPLETED|Overall Study||26
11326543|NCT02762994|12523914|FG000|NOT COMPLETED|Overall Study||1
11326544|NCT02762994|12523915|FG001|NOT COMPLETED|Overall Study||1
11326545|NCT02762994|12523916|FG002|NOT COMPLETED|Overall Study||2
11326546|NCT02762994|12523917|FG003|NOT COMPLETED|Overall Study||2
11326547|NCT02763046|12523934|FG000|STARTED|Overall Study||71
11326548|NCT02763046|12523935|FG001|STARTED|Overall Study||70
11326549|NCT02763046|12523936|FG002|STARTED|Overall Study||70
11326550|NCT02763046|12523934|FG000|COMPLETED|Overall Study||62
11326551|NCT02763046|12523935|FG001|COMPLETED|Overall Study||65
11326552|NCT02763046|12523936|FG002|COMPLETED|Overall Study||62
11326553|NCT02763046|12523934|FG000|NOT COMPLETED|Overall Study||9
11326554|NCT02763046|12523935|FG001|NOT COMPLETED|Overall Study||5
11326555|NCT02763046|12523936|FG002|NOT COMPLETED|Overall Study||8
11326556|NCT02763124|12523950|FG000|STARTED|Overall Study||18
11326557|NCT02763124|12523950|FG000|COMPLETED|Overall Study||18
11326558|NCT02763124|12523950|FG000|NOT COMPLETED|Overall Study||0
11326559|NCT02763215|12523954|FG000|STARTED|Overall Study||64
11326560|NCT02763215|12523954|FG000|COMPLETED|Overall Study||57
11326561|NCT02763215|12523954|FG000|NOT COMPLETED|Overall Study||7
11326562|NCT02763254|12523958|FG000|STARTED|Overall Study||1
11326563|NCT02763254|12523958|FG000|COMPLETED|Overall Study||0
11326564|NCT02763254|12523958|FG000|NOT COMPLETED|Overall Study||1
11326565|NCT02763644|12523964|FG000|STARTED|Overall Study||3
11326566|NCT02763644|12523965|FG001|STARTED|Overall Study||4
11326567|NCT02763644|12523964|FG000|COMPLETED|Overall Study||0
11326568|NCT02763644|12523965|FG001|COMPLETED|Overall Study||2
11326569|NCT02763644|12523964|FG000|NOT COMPLETED|Overall Study||3
11326570|NCT02763644|12523965|FG001|NOT COMPLETED|Overall Study||2
11326571|NCT02763826|12523980|FG000|STARTED|Part 1 Dose Escalation, 1 mA||3
11326572|NCT02763826|12523981|FG001|STARTED|Part 1 Dose Escalation, 1 mA||0
11326573|NCT02763826|12523982|FG002|STARTED|Part 1 Dose Escalation, 1 mA||0
11326574|NCT02763826|12523983|FG003|STARTED|Part 1 Dose Escalation, 1 mA||0
11326575|NCT02763826|12523984|FG004|STARTED|Part 1 Dose Escalation, 1 mA||0
11326576|NCT02763826|12523985|FG005|STARTED|Part 1 Dose Escalation, 1 mA||0
11326577|NCT02763826|12523986|FG006|STARTED|Part 1 Dose Escalation, 1 mA||0
11326578|NCT02763826|12523987|FG007|STARTED|Part 1 Dose Escalation, 1 mA||0
11326579|NCT02763826|12523980|FG000|COMPLETED|Part 1 Dose Escalation, 1 mA||3
11326580|NCT02763826|12523981|FG001|COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326581|NCT02763826|12523982|FG002|COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326582|NCT02763826|12523983|FG003|COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326583|NCT02763826|12523984|FG004|COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326584|NCT02763826|12523985|FG005|COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326585|NCT02763826|12523986|FG006|COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326586|NCT02763826|12523987|FG007|COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326587|NCT02763826|12523980|FG000|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326588|NCT02763826|12523981|FG001|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326589|NCT02763826|12523982|FG002|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326590|NCT02763826|12523983|FG003|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326591|NCT02763826|12523984|FG004|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326592|NCT02763826|12523985|FG005|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326593|NCT02763826|12523986|FG006|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326594|NCT02763826|12523987|FG007|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
11326595|NCT02763826|12523980|FG000|STARTED|Part 1 Dose Escalation, 2 mA||0
11326596|NCT02763826|12523981|FG001|STARTED|Part 1 Dose Escalation, 2 mA||3
11326597|NCT02763826|12523982|FG002|STARTED|Part 1 Dose Escalation, 2 mA||0
11326598|NCT02763826|12523983|FG003|STARTED|Part 1 Dose Escalation, 2 mA||0
11326599|NCT02763826|12523984|FG004|STARTED|Part 1 Dose Escalation, 2 mA||0
11326600|NCT02763826|12523985|FG005|STARTED|Part 1 Dose Escalation, 2 mA||0
11326601|NCT02763826|12523986|FG006|STARTED|Part 1 Dose Escalation, 2 mA||0
11326602|NCT02763826|12523987|FG007|STARTED|Part 1 Dose Escalation, 2 mA||0
11326603|NCT02763826|12523980|FG000|COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326604|NCT02763826|12523981|FG001|COMPLETED|Part 1 Dose Escalation, 2 mA||3
11326605|NCT02763826|12523982|FG002|COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326606|NCT02763826|12523983|FG003|COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326607|NCT02763826|12523984|FG004|COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326608|NCT02763826|12523985|FG005|COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326609|NCT02763826|12523986|FG006|COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326610|NCT02763826|12523987|FG007|COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326611|NCT02763826|12523980|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326612|NCT02763826|12523981|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326613|NCT02763826|12523982|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326614|NCT02763826|12523983|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326615|NCT02763826|12523984|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326616|NCT02763826|12523985|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326617|NCT02763826|12523986|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326618|NCT02763826|12523987|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
11326619|NCT02763826|12523980|FG000|STARTED|Part 1 Dose Escalation, 2.5 mA||0
11326620|NCT02763826|12523981|FG001|STARTED|Part 1 Dose Escalation, 2.5 mA||0
11326621|NCT02763826|12523982|FG002|STARTED|Part 1 Dose Escalation, 2.5 mA||3
11326622|NCT02763826|12523983|FG003|STARTED|Part 1 Dose Escalation, 2.5 mA||0
11326623|NCT02763826|12523984|FG004|STARTED|Part 1 Dose Escalation, 2.5 mA||0
11326624|NCT02763826|12523985|FG005|STARTED|Part 1 Dose Escalation, 2.5 mA||0
11326625|NCT02763826|12523986|FG006|STARTED|Part 1 Dose Escalation, 2.5 mA||0
11326626|NCT02763826|12523987|FG007|STARTED|Part 1 Dose Escalation, 2.5 mA||0
11326627|NCT02763826|12523980|FG000|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326628|NCT02763826|12523981|FG001|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326629|NCT02763826|12523982|FG002|COMPLETED|Part 1 Dose Escalation, 2.5 mA||3
11326630|NCT02763826|12523983|FG003|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326631|NCT02763826|12523984|FG004|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326632|NCT02763826|12523985|FG005|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326633|NCT02763826|12523986|FG006|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326634|NCT02763826|12523987|FG007|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326635|NCT02763826|12523980|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326636|NCT02763826|12523981|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326637|NCT02763826|12523982|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326638|NCT02763826|12523983|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326639|NCT02763826|12523984|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326640|NCT02763826|12523985|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326641|NCT02763826|12523986|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326642|NCT02763826|12523987|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
11326643|NCT02763826|12523980|FG000|STARTED|Part 1 Dose Escalation, 3 mA||0
11326644|NCT02763826|12523981|FG001|STARTED|Part 1 Dose Escalation, 3 mA||0
11326645|NCT02763826|12523982|FG002|STARTED|Part 1 Dose Escalation, 3 mA||0
11326646|NCT02763826|12523983|FG003|STARTED|Part 1 Dose Escalation, 3 mA||3
11326647|NCT02763826|12523984|FG004|STARTED|Part 1 Dose Escalation, 3 mA||0
11326648|NCT02763826|12523985|FG005|STARTED|Part 1 Dose Escalation, 3 mA||0
11326649|NCT02763826|12523986|FG006|STARTED|Part 1 Dose Escalation, 3 mA||0
11326650|NCT02763826|12523987|FG007|STARTED|Part 1 Dose Escalation, 3 mA||0
11326651|NCT02763826|12523980|FG000|COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326652|NCT02763826|12523981|FG001|COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326653|NCT02763826|12523982|FG002|COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326654|NCT02763826|12523983|FG003|COMPLETED|Part 1 Dose Escalation, 3 mA||3
11326655|NCT02763826|12523984|FG004|COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326656|NCT02763826|12523985|FG005|COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326657|NCT02763826|12523986|FG006|COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326658|NCT02763826|12523987|FG007|COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326659|NCT02763826|12523980|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326660|NCT02763826|12523981|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326661|NCT02763826|12523982|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326662|NCT02763826|12523983|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326663|NCT02763826|12523984|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326664|NCT02763826|12523985|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326665|NCT02763826|12523986|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326666|NCT02763826|12523987|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
11326667|NCT02763826|12523980|FG000|STARTED|Part 1 Dose Escalation, 3.5 mA||0
11326668|NCT02763826|12523981|FG001|STARTED|Part 1 Dose Escalation, 3.5 mA||0
11326669|NCT02763826|12523982|FG002|STARTED|Part 1 Dose Escalation, 3.5 mA||0
11326670|NCT02763826|12523983|FG003|STARTED|Part 1 Dose Escalation, 3.5 mA||0
11326671|NCT02763826|12523984|FG004|STARTED|Part 1 Dose Escalation, 3.5 mA||3
11326672|NCT02763826|12523985|FG005|STARTED|Part 1 Dose Escalation, 3.5 mA||0
11326673|NCT02763826|12523986|FG006|STARTED|Part 1 Dose Escalation, 3.5 mA||0
11326674|NCT02763826|12523987|FG007|STARTED|Part 1 Dose Escalation, 3.5 mA||0
11326675|NCT02763826|12523980|FG000|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11326676|NCT02763826|12523981|FG001|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11326677|NCT02763826|12523982|FG002|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11326678|NCT02763826|12523983|FG003|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11326679|NCT02763826|12523984|FG004|COMPLETED|Part 1 Dose Escalation, 3.5 mA||3
11326680|NCT02763826|12523985|FG005|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11326681|NCT02763826|12523986|FG006|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11326682|NCT02763826|12523987|FG007|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11326683|NCT02763826|12523980|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11326684|NCT02763826|12523981|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11326685|NCT02763826|12523982|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11326686|NCT02763826|12523983|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11326687|NCT02763826|12523984|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11326688|NCT02763826|12523985|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11027225|NCT00833053|12205943|FG000|COMPLETED|Overall Study||10
11027226|NCT00833053|12205944|FG001|COMPLETED|Overall Study||17
11027227|NCT00833053|12205943|FG000|NOT COMPLETED|Overall Study||9
11027228|NCT00833053|12205944|FG001|NOT COMPLETED|Overall Study||3
11027229|NCT00833092|12205952|FG000|STARTED|Overall Study||54
11027230|NCT00833092|12205953|FG001|STARTED|Overall Study||57
11027231|NCT00833092|12205952|FG000|COMPLETED|Overall Study||50
11326689|NCT02763826|12523986|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11326690|NCT02763826|12523987|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
11326691|NCT02763826|12523980|FG000|STARTED|Part 1 Dose Escalation, 4 mA||0
11326692|NCT02763826|12523981|FG001|STARTED|Part 1 Dose Escalation, 4 mA||0
11326693|NCT02763826|12523982|FG002|STARTED|Part 1 Dose Escalation, 4 mA||0
11326694|NCT02763826|12523983|FG003|STARTED|Part 1 Dose Escalation, 4 mA||0
11326695|NCT02763826|12523984|FG004|STARTED|Part 1 Dose Escalation, 4 mA||0
11326696|NCT02763826|12523985|FG005|STARTED|Part 1 Dose Escalation, 4 mA||3
11326697|NCT02763826|12523986|FG006|STARTED|Part 1 Dose Escalation, 4 mA||0
11326698|NCT02763826|12523987|FG007|STARTED|Part 1 Dose Escalation, 4 mA||0
11326699|NCT02763826|12523980|FG000|COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326700|NCT02763826|12523981|FG001|COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326701|NCT02763826|12523982|FG002|COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326702|NCT02763826|12523983|FG003|COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326703|NCT02763826|12523984|FG004|COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326704|NCT02763826|12523985|FG005|COMPLETED|Part 1 Dose Escalation, 4 mA||3
11326705|NCT02763826|12523986|FG006|COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326706|NCT02763826|12523987|FG007|COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326707|NCT02763826|12523980|FG000|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326708|NCT02763826|12523981|FG001|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326709|NCT02763826|12523982|FG002|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326710|NCT02763826|12523983|FG003|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326711|NCT02763826|12523984|FG004|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326712|NCT02763826|12523985|FG005|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326713|NCT02763826|12523986|FG006|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326714|NCT02763826|12523987|FG007|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
11326715|NCT02763826|12523980|FG000|STARTED|Part 2 Montage Effect, 1st Intervention||0
11326716|NCT02763826|12523981|FG001|STARTED|Part 2 Montage Effect, 1st Intervention||0
11326717|NCT02763826|12523982|FG002|STARTED|Part 2 Montage Effect, 1st Intervention||0
11326718|NCT02763826|12523983|FG003|STARTED|Part 2 Montage Effect, 1st Intervention||0
11326719|NCT02763826|12523984|FG004|STARTED|Part 2 Montage Effect, 1st Intervention||0
11326720|NCT02763826|12523985|FG005|STARTED|Part 2 Montage Effect, 1st Intervention||6
11326721|NCT02763826|12523986|FG006|STARTED|Part 2 Montage Effect, 1st Intervention||6
11326722|NCT02763826|12523987|FG007|STARTED|Part 2 Montage Effect, 1st Intervention||7
11326723|NCT02763826|12523980|FG000|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
11326724|NCT02763826|12523981|FG001|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
11326725|NCT02763826|12523982|FG002|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
11326726|NCT02763826|12523983|FG003|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
11326727|NCT02763826|12523984|FG004|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
11326728|NCT02763826|12523985|FG005|COMPLETED|Part 2 Montage Effect, 1st Intervention||6
11326729|NCT02763826|12523986|FG006|COMPLETED|Part 2 Montage Effect, 1st Intervention||6
11326730|NCT02763826|12523987|FG007|COMPLETED|Part 2 Montage Effect, 1st Intervention||7
11326731|NCT02763826|12523980|FG000|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
11326732|NCT02763826|12523981|FG001|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
11326733|NCT02763826|12523982|FG002|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
11326734|NCT02763826|12523983|FG003|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
11326735|NCT02763826|12523984|FG004|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
11326736|NCT02763826|12523985|FG005|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
11326737|NCT02763826|12523986|FG006|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
11326738|NCT02763826|12523987|FG007|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
11326739|NCT02763826|12523980|FG000|STARTED|Part 2 Montage Effect, 2nd Intervention||0
11326740|NCT02763826|12523981|FG001|STARTED|Part 2 Montage Effect, 2nd Intervention||0
11326741|NCT02763826|12523982|FG002|STARTED|Part 2 Montage Effect, 2nd Intervention||0
11326742|NCT02763826|12523983|FG003|STARTED|Part 2 Montage Effect, 2nd Intervention||0
11326743|NCT02763826|12523984|FG004|STARTED|Part 2 Montage Effect, 2nd Intervention||0
11326744|NCT02763826|12523985|FG005|STARTED|Part 2 Montage Effect, 2nd Intervention||6
11326745|NCT02763826|12523986|FG006|STARTED|Part 2 Montage Effect, 2nd Intervention||6
11326746|NCT02763826|12523987|FG007|STARTED|Part 2 Montage Effect, 2nd Intervention||6
11326747|NCT02763826|12523980|FG000|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
11326748|NCT02763826|12523981|FG001|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
11326749|NCT02763826|12523982|FG002|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
11326750|NCT02763826|12523983|FG003|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
11326751|NCT02763826|12523984|FG004|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
11326752|NCT02763826|12523985|FG005|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
11326753|NCT02763826|12523986|FG006|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
11326754|NCT02763826|12523987|FG007|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
11326755|NCT02763826|12523980|FG000|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
11326756|NCT02763826|12523981|FG001|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
11326757|NCT02763826|12523982|FG002|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
11326758|NCT02763826|12523983|FG003|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
11326759|NCT02763826|12523984|FG004|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
11326760|NCT02763826|12523985|FG005|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
11326761|NCT02763826|12523986|FG006|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
11326762|NCT02763826|12523987|FG007|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
11326763|NCT02763826|12523980|FG000|STARTED|Part 2 Montage Effect, 3rd Intervention||0
11326764|NCT02763826|12523981|FG001|STARTED|Part 2 Montage Effect, 3rd Intervention||0
11326765|NCT02763826|12523982|FG002|STARTED|Part 2 Montage Effect, 3rd Intervention||0
11326766|NCT02763826|12523983|FG003|STARTED|Part 2 Montage Effect, 3rd Intervention||0
11326767|NCT02763826|12523984|FG004|STARTED|Part 2 Montage Effect, 3rd Intervention||0
11326768|NCT02763826|12523985|FG005|STARTED|Part 2 Montage Effect, 3rd Intervention||6
11326769|NCT02763826|12523986|FG006|STARTED|Part 2 Montage Effect, 3rd Intervention||6
11326770|NCT02763826|12523987|FG007|STARTED|Part 2 Montage Effect, 3rd Intervention||6
11326771|NCT02763826|12523980|FG000|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
11326772|NCT02763826|12523981|FG001|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
11326773|NCT02763826|12523982|FG002|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
11326774|NCT02763826|12523983|FG003|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
11326775|NCT02763826|12523984|FG004|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
11326776|NCT02763826|12523985|FG005|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
11326777|NCT02763826|12523986|FG006|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
11326778|NCT02763826|12523987|FG007|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
11326779|NCT02763826|12523980|FG000|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
11326780|NCT02763826|12523981|FG001|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
11326781|NCT02763826|12523982|FG002|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
11326782|NCT02763826|12523983|FG003|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
11326783|NCT02763826|12523984|FG004|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
11326784|NCT02763826|12523985|FG005|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
11326785|NCT02763826|12523986|FG006|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
11326786|NCT02763826|12523987|FG007|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
11326787|NCT02763865|12524007|FG000|STARTED|Overall Study||5
11326788|NCT02763865|12524008|FG001|STARTED|Overall Study||5
11326789|NCT02763865|12524007|FG000|COMPLETED|Overall Study||5
11326790|NCT02763865|12524008|FG001|COMPLETED|Overall Study||5
11326791|NCT02763865|12524007|FG000|NOT COMPLETED|Overall Study||0
11326792|NCT02763865|12524008|FG001|NOT COMPLETED|Overall Study||0
11326793|NCT02764151|12524020|FG000|STARTED|Overall Study||2
11326794|NCT02764151|12524021|FG001|STARTED|Overall Study||4
11326795|NCT02764151|12524022|FG002|STARTED|Overall Study||3
11326796|NCT02764151|12524023|FG003|STARTED|Overall Study||8
11326797|NCT02764151|12524020|FG000|COMPLETED|Overall Study||2
11326798|NCT02764151|12524021|FG001|COMPLETED|Overall Study||4
11326799|NCT02764151|12524022|FG002|COMPLETED|Overall Study||3
11326800|NCT02764151|12524023|FG003|COMPLETED|Overall Study||5
11326801|NCT02764151|12524020|FG000|NOT COMPLETED|Overall Study||0
11326802|NCT02764151|12524021|FG001|NOT COMPLETED|Overall Study||0
11326803|NCT02764151|12524022|FG002|NOT COMPLETED|Overall Study||0
11326804|NCT02764151|12524023|FG003|NOT COMPLETED|Overall Study||3
11326805|NCT02764164|12524033|FG000|STARTED|Overall Study||1
11326806|NCT02764164|12524033|FG000|COMPLETED|Overall Study|Duration flexible up to 12mo, ended early (funding), 2 week time point achieved|1
11326807|NCT02764164|12524033|FG000|NOT COMPLETED|Overall Study||0
11326808|NCT02764190|12524039|FG000|STARTED|Overall Study||167
11326809|NCT02764190|12524040|FG001|STARTED|Overall Study||135
11326810|NCT02764190|12524039|FG000|1 Day Follow-up|Overall Study||161
11326811|NCT02764190|12524040|FG001|1 Day Follow-up|Overall Study||131
11326812|NCT02764190|12524039|FG000|3 Month Follow-up|Overall Study||156
11326813|NCT02764190|12524040|FG001|3 Month Follow-up|Overall Study||128
11326814|NCT02764190|12524039|FG000|6 Month Follow-up|Overall Study||155
11326815|NCT02764190|12524040|FG001|6 Month Follow-up|Overall Study||128
11326816|NCT02764190|12524039|FG000|12 Month Follow-up|Overall Study||150
11326817|NCT02764190|12524040|FG001|12 Month Follow-up|Overall Study||122
11326818|NCT02764190|12524039|FG000|COMPLETED|Overall Study||150
11326819|NCT02764190|12524040|FG001|COMPLETED|Overall Study||122
11326820|NCT02764190|12524039|FG000|NOT COMPLETED|Overall Study||17
11326821|NCT02764190|12524040|FG001|NOT COMPLETED|Overall Study||13
11326822|NCT02764229|12524046|FG000|STARTED|Overall Study||112
11326823|NCT02764229|12524046|FG000|COMPLETED|Overall Study||10
11326824|NCT02764229|12524046|FG000|NOT COMPLETED|Overall Study||102
11326825|NCT02764320|12524052|FG000|STARTED|Overall Study||361
11326826|NCT02764320|12524053|FG001|STARTED|Overall Study||359
11326827|NCT02764320|12524052|FG000|COMPLETED|Overall Study||310
11326828|NCT02764320|12524053|FG001|COMPLETED|Overall Study||310
11326829|NCT02764320|12524052|FG000|NOT COMPLETED|Overall Study||51
11326830|NCT02764320|12524053|FG001|NOT COMPLETED|Overall Study||49
11326831|NCT02764333|12524059|FG000|STARTED|Overall Study||29
11326832|NCT02764333|12524059|FG000|COMPLETED|Overall Study||28
11326833|NCT02764333|12524059|FG000|NOT COMPLETED|Overall Study||1
11326834|NCT02764385|12524065|FG000|STARTED|Overall Study||9145
11326835|NCT02764385|12524066|FG001|STARTED|Overall Study||6641
11326836|NCT02764385|12524065|FG000|COMPLETED|Overall Study||9145
11326837|NCT02764385|12524066|FG001|COMPLETED|Overall Study||6641
11326838|NCT02764385|12524065|FG000|NOT COMPLETED|Overall Study||0
11326839|NCT02764385|12524066|FG001|NOT COMPLETED|Overall Study||0
11326840|NCT02764697|12524072|FG000|STARTED|Overall Study||5
11326841|NCT02764697|12524072|FG000|COMPLETED|Overall Study||2
11326842|NCT02764697|12524072|FG000|NOT COMPLETED|Overall Study||3
11326843|NCT02764775|12524076|FG000|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14
11326844|NCT02764775|12524076|FG000|COMPLETED|Overall Study||8
11326845|NCT02764775|12524076|FG000|NOT COMPLETED|Overall Study||6
11326846|NCT02764970|12524082|FG000|STARTED|Overall Study||65
11326847|NCT02764970|12524083|FG001|STARTED|Overall Study||47
11326848|NCT02764970|12524082|FG000|COMPLETED|Overall Study||65
11326849|NCT02764970|12524083|FG001|COMPLETED|Overall Study||47
11326850|NCT02764970|12524082|FG000|NOT COMPLETED|Overall Study||0
11326851|NCT02764970|12524083|FG001|NOT COMPLETED|Overall Study||0
11326852|NCT02765035|12524091|FG000|STARTED|First Intervention (90 Days)||5
11326853|NCT02765035|12524092|FG001|STARTED|First Intervention (90 Days)||8
11326854|NCT02765035|12524091|FG000|COMPLETED|First Intervention (90 Days)||4
11326855|NCT02765035|12524092|FG001|COMPLETED|First Intervention (90 Days)||7
11326856|NCT02765035|12524091|FG000|NOT COMPLETED|First Intervention (90 Days)||1
11326857|NCT02765035|12524092|FG001|NOT COMPLETED|First Intervention (90 Days)||1
11326858|NCT02765035|12524091|FG000|STARTED|Second Intervention (30 Days)||4
11326859|NCT02765035|12524092|FG001|STARTED|Second Intervention (30 Days)||7
11326860|NCT02765035|12524091|FG000|COMPLETED|Second Intervention (30 Days)||2
11326861|NCT02765035|12524092|FG001|COMPLETED|Second Intervention (30 Days)||5
11326862|NCT02765035|12524091|FG000|NOT COMPLETED|Second Intervention (30 Days)||2
11326863|NCT02765035|12524092|FG001|NOT COMPLETED|Second Intervention (30 Days)||2
11326864|NCT02765100|12524101|FG000|STARTED|Overall Study||9
11326865|NCT02765100|12524102|FG001|STARTED|Overall Study||12
11326866|NCT02765100|12524101|FG000|COMPLETED|Overall Study||8
11326867|NCT02765100|12524102|FG001|COMPLETED|Overall Study||10
11326868|NCT02765100|12524101|FG000|NOT COMPLETED|Overall Study||1
11326869|NCT02765100|12524102|FG001|NOT COMPLETED|Overall Study||2
11326870|NCT02765165|12524115|FG000|STARTED|Treatment Period||3
11326871|NCT02765165|12524116|FG001|STARTED|Treatment Period||4
11326872|NCT02765165|12524117|FG002|STARTED|Treatment Period||3
11326873|NCT02765165|12524118|FG003|STARTED|Treatment Period||3
11326874|NCT02765165|12524119|FG004|STARTED|Treatment Period||6
11326875|NCT02765165|12524120|FG005|STARTED|Treatment Period||3
11326876|NCT02765165|12524121|FG006|STARTED|Treatment Period||4
11326877|NCT02765165|12524115|FG000|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
11326878|NCT02765165|12524116|FG001|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
11326879|NCT02765165|12524117|FG002|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
11326880|NCT02765165|12524118|FG003|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
11326881|NCT02765165|12524119|FG004|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
11326882|NCT02765165|12524120|FG005|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
11326883|NCT02765165|12524121|FG006|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
11326884|NCT02765165|12524115|FG000|NOT COMPLETED|Treatment Period||3
11326885|NCT02765165|12524116|FG001|NOT COMPLETED|Treatment Period||4
11326886|NCT02765165|12524117|FG002|NOT COMPLETED|Treatment Period||3
11326887|NCT02765165|12524118|FG003|NOT COMPLETED|Treatment Period||3
11326888|NCT02765165|12524119|FG004|NOT COMPLETED|Treatment Period||6
11326889|NCT02765165|12524120|FG005|NOT COMPLETED|Treatment Period||3
11326890|NCT02765165|12524121|FG006|NOT COMPLETED|Treatment Period||4
11326891|NCT02765165|12524115|FG000|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
11326892|NCT02765165|12524116|FG001|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
11326893|NCT02765165|12524117|FG002|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
11326894|NCT02765165|12524118|FG003|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
11326895|NCT02765165|12524119|FG004|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
11326896|NCT02765165|12524120|FG005|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
11326897|NCT02765165|12524121|FG006|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
11326898|NCT02765165|12524115|FG000|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
11326899|NCT02765165|12524116|FG001|COMPLETED|Post-treatment Follow-up||0
11326900|NCT02765165|12524117|FG002|COMPLETED|Post-treatment Follow-up||0
11326901|NCT02765165|12524118|FG003|COMPLETED|Post-treatment Follow-up||0
11326902|NCT02765165|12524119|FG004|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
11326903|NCT02765165|12524120|FG005|COMPLETED|Post-treatment Follow-up||0
11326904|NCT02765165|12524121|FG006|COMPLETED|Post-treatment Follow-up||0
11326905|NCT02765165|12524115|FG000|NOT COMPLETED|Post-treatment Follow-up||1
11326906|NCT02765165|12524116|FG001|NOT COMPLETED|Post-treatment Follow-up||3
11326907|NCT02765165|12524117|FG002|NOT COMPLETED|Post-treatment Follow-up||3
11326908|NCT02765165|12524118|FG003|NOT COMPLETED|Post-treatment Follow-up||3
11326909|NCT02765165|12524119|FG004|NOT COMPLETED|Post-treatment Follow-up||3
11326910|NCT02765165|12524120|FG005|NOT COMPLETED|Post-treatment Follow-up||3
11326911|NCT02765165|12524121|FG006|NOT COMPLETED|Post-treatment Follow-up||1
11326912|NCT02765256|12524143|FG000|STARTED|Overall Study||4
11326913|NCT02765256|12524144|FG001|STARTED|Overall Study||4
11326914|NCT02765256|12524143|FG000|COMPLETED|Overall Study||4
11326915|NCT02765256|12524144|FG001|COMPLETED|Overall Study||4
11326916|NCT02765256|12524143|FG000|NOT COMPLETED|Overall Study||0
11326917|NCT02765256|12524144|FG001|NOT COMPLETED|Overall Study||0
11326918|NCT02765269|12524152|FG000|STARTED|Overall Study||25
11326919|NCT02765269|12524153|FG001|STARTED|Overall Study||21
11326920|NCT02765269|12524152|FG000|COMPLETED|Overall Study||25
11326921|NCT02765269|12524153|FG001|COMPLETED|Overall Study||21
11326922|NCT02765269|12524152|FG000|NOT COMPLETED|Overall Study||0
11326923|NCT02765269|12524153|FG001|NOT COMPLETED|Overall Study||0
11326924|NCT02765490|12524161|FG000|STARTED|Overall Study||183
11326925|NCT02765490|12524162|FG001|STARTED|Overall Study||182
11326926|NCT02765490|12524161|FG000|COMPLETED|Overall Study||182
11326927|NCT02765490|12524162|FG001|COMPLETED|Overall Study||179
11326928|NCT02765490|12524161|FG000|NOT COMPLETED|Overall Study||1
11326929|NCT02765490|12524162|FG001|NOT COMPLETED|Overall Study||3
11326930|NCT02766023|12524170|FG000|STARTED|Overall Study||152
11326931|NCT02766023|12524171|FG001|STARTED|Overall Study||76
11326932|NCT02766023|12524170|FG000|COMPLETED|Overall Study||122
11326933|NCT02766023|12524171|FG001|COMPLETED|Overall Study||59
11326934|NCT02766023|12524170|FG000|NOT COMPLETED|Overall Study||30
11326935|NCT02766023|12524171|FG001|NOT COMPLETED|Overall Study||17
11326936|NCT02766088|12524177|FG000|STARTED|Overall Study||850
11326937|NCT02766088|12524177|FG000|COMPLETED|Overall Study||344
11326938|NCT02766088|12524177|FG000|NOT COMPLETED|Overall Study||506
11326939|NCT02766244|12524181|FG000|STARTED|Overall Study||3
11326940|NCT02766244|12524181|FG000|COMPLETED|Overall Study||3
11326941|NCT02766244|12524181|FG000|NOT COMPLETED|Overall Study||0
11326942|NCT02766283|12524190|FG000|STARTED|Overall Study||843
11326943|NCT02766283|12524190|FG000|COMPLETED|Overall Study||816
11326944|NCT02766283|12524190|FG000|NOT COMPLETED|Overall Study||27
11326945|NCT02766374|12524200|FG000|STARTED|Overall Study||35
11326946|NCT02766374|12524201|FG001|STARTED|Overall Study||33
11326947|NCT02766374|12524200|FG000|COMPLETED|Overall Study||25
11326948|NCT02766374|12524201|FG001|COMPLETED|Overall Study||30
11326949|NCT02766374|12524200|FG000|NOT COMPLETED|Overall Study||10
11326950|NCT02766374|12524201|FG001|NOT COMPLETED|Overall Study||3
11326951|NCT02766400|12524209|FG000|STARTED|Overall Study||21
11326952|NCT02766400|12524210|FG001|STARTED|Overall Study||22
11326953|NCT02766400|12524209|FG000|COMPLETED|Overall Study||19
11326954|NCT02766400|12524210|FG001|COMPLETED|Overall Study||20
11326955|NCT02766400|12524209|FG000|NOT COMPLETED|Overall Study||2
11326956|NCT02766400|12524210|FG001|NOT COMPLETED|Overall Study||2
11326957|NCT02766517|12524219|FG000|STARTED|Overall Study||19
11326958|NCT02766517|12524220|FG001|STARTED|Overall Study||9
11326959|NCT02766517|12524221|FG002|STARTED|Overall Study||9
11326960|NCT02766517|12524219|FG000|COMPLETED|Overall Study||19
11326961|NCT02766517|12524220|FG001|COMPLETED|Overall Study||9
11326962|NCT02766517|12524221|FG002|COMPLETED|Overall Study||9
11326963|NCT02766517|12524219|FG000|NOT COMPLETED|Overall Study||0
11326964|NCT02766517|12524220|FG001|NOT COMPLETED|Overall Study||0
11326965|NCT02766517|12524221|FG002|NOT COMPLETED|Overall Study||0
11326966|NCT02766608|12524234|FG000|STARTED|Overall Study||655
11326967|NCT02766608|12524235|FG001|STARTED|Overall Study||637
11326968|NCT02766608|12524236|FG002|STARTED|Overall Study||644
11326969|NCT02766608|12524237|FG003|STARTED|Overall Study||206
11326970|NCT02766608|12524238|FG004|STARTED|Overall Study||219
11326971|NCT02766608|12524234|FG000|COMPLETED|Overall Study||576
11326972|NCT02766608|12524235|FG001|COMPLETED|Overall Study||567
11326973|NCT02766608|12524236|FG002|COMPLETED|Overall Study||554
11326974|NCT02766608|12524237|FG003|COMPLETED|Overall Study||169
11326975|NCT02766608|12524238|FG004|COMPLETED|Overall Study||190
11326976|NCT02766608|12524234|FG000|NOT COMPLETED|Overall Study||79
11326977|NCT02766608|12524235|FG001|NOT COMPLETED|Overall Study||70
11326978|NCT02766608|12524236|FG002|NOT COMPLETED|Overall Study||90
11326979|NCT02766608|12524237|FG003|NOT COMPLETED|Overall Study||37
11326980|NCT02766608|12524238|FG004|NOT COMPLETED|Overall Study||29
11326981|NCT02766673|12524253|FG000|STARTED|Overall Study||4
11326982|NCT02766673|12524254|FG001|STARTED|Overall Study||4
11326983|NCT02766673|12524255|FG002|STARTED|Overall Study||4
11326984|NCT02766673|12524256|FG003|STARTED|Overall Study||4
11326985|NCT02766673|12524257|FG004|STARTED|Overall Study||4
11326986|NCT02766673|12524258|FG005|STARTED|Overall Study||4
11326987|NCT02766673|12524253|FG000|COMPLETED|Overall Study||3
11326988|NCT02766673|12524254|FG001|COMPLETED|Overall Study||4
11326989|NCT02766673|12524255|FG002|COMPLETED|Overall Study||4
11326990|NCT02766673|12524256|FG003|COMPLETED|Overall Study||4
11326991|NCT02766673|12524257|FG004|COMPLETED|Overall Study||4
11326992|NCT02766673|12524258|FG005|COMPLETED|Overall Study||3
11326993|NCT02766673|12524253|FG000|NOT COMPLETED|Overall Study||1
11326994|NCT02766673|12524254|FG001|NOT COMPLETED|Overall Study||0
11326995|NCT02766673|12524255|FG002|NOT COMPLETED|Overall Study||0
11326996|NCT02766673|12524256|FG003|NOT COMPLETED|Overall Study||0
11326997|NCT02766673|12524257|FG004|NOT COMPLETED|Overall Study||0
11326998|NCT02766673|12524258|FG005|NOT COMPLETED|Overall Study||1
11326999|NCT02766777|12524266|FG000|STARTED|Overall Study||87
11327000|NCT02766777|12524266|FG000|Treated (Safety [SAF] Population)|Overall Study||87
11327001|NCT02766777|12524266|FG000|COMPLETED|Overall Study||53
11327002|NCT02766777|12524266|FG000|NOT COMPLETED|Overall Study||34
11327003|NCT02766907|12524272|FG000|STARTED|Overall Study||10
11327004|NCT02766907|12524273|FG001|STARTED|Overall Study||10
11327005|NCT02766907|12524272|FG000|COMPLETED|Overall Study||9
11327006|NCT02766907|12524273|FG001|COMPLETED|Overall Study||9
11327007|NCT02766907|12524272|FG000|NOT COMPLETED|Overall Study||1
11327008|NCT02766907|12524273|FG001|NOT COMPLETED|Overall Study||1
11327009|NCT02767011|12524281|FG000|STARTED|Overall Study||16
11327010|NCT02767011|12524282|FG001|STARTED|Overall Study||14
11327011|NCT02767011|12524281|FG000|COMPLETED|Overall Study||16
11327012|NCT02767011|12524282|FG001|COMPLETED|Overall Study||14
11327013|NCT02767011|12524281|FG000|NOT COMPLETED|Overall Study||0
11327014|NCT02767011|12524282|FG001|NOT COMPLETED|Overall Study||0
11327015|NCT02767128|12524288|FG000|STARTED|Overall Study||14
11327016|NCT02767128|12524288|FG000|Baseline|Overall Study||14
11327017|NCT02767128|12524288|FG000|Fer-In-Sol|Overall Study||14
11327018|NCT02767128|12524288|FG000|Shohl's + Fer-In-Sol|Overall Study||14
11327019|NCT02767128|12524288|FG000|Triferic|Overall Study||14
11327020|NCT02767128|12524288|FG000|Shohl's + Triferic After 10 Min|Overall Study||14
11327021|NCT02767128|12524288|FG000|Shohl's + Triferic Immediately|Overall Study||14
11327022|NCT02767128|12524288|FG000|COMPLETED|Overall Study||14
11327023|NCT02767128|12524288|FG000|NOT COMPLETED|Overall Study||0
11327024|NCT02767271|12524304|FG000|STARTED|Overall Study||15
11327025|NCT02767271|12524305|FG001|STARTED|Overall Study||15
11327026|NCT02767271|12524304|FG000|Safety Population|Overall Study||15
11327027|NCT02767271|12524305|FG001|Safety Population|Overall Study||15
11327028|NCT02767271|12524304|FG000|Pharmacokinetic Pedis (PKP) Population|Overall Study||15
11327029|NCT02767271|12524305|FG001|Pharmacokinetic Pedis (PKP) Population|Overall Study||0
11327030|NCT02767271|12524304|FG000|Pharmacokinetic Cruris (PKC) Population|Overall Study||0
11327031|NCT02767271|12524305|FG001|Pharmacokinetic Cruris (PKC) Population|Overall Study||15
11327032|NCT02767271|12524304|FG000|COMPLETED|Overall Study||15
11327033|NCT02767271|12524305|FG001|COMPLETED|Overall Study||15
11327034|NCT02767271|12524304|FG000|NOT COMPLETED|Overall Study||0
11327035|NCT02767271|12524305|FG001|NOT COMPLETED|Overall Study||0
11327036|NCT02767323|12524315|FG000|STARTED|Overall Study||83
11327037|NCT02767323|12524316|FG001|STARTED|Overall Study||42
11327038|NCT02767323|12524317|FG002|STARTED|Overall Study||58
11327039|NCT02767323|12524318|FG003|STARTED|Overall Study||1
11327040|NCT02767323|12524315|FG000|COMPLETED|Overall Study||49
11327041|NCT02767323|12524316|FG001|COMPLETED|Overall Study||17
11327042|NCT02767323|12524317|FG002|COMPLETED|Overall Study||28
11327043|NCT02767323|12524318|FG003|COMPLETED|Overall Study||1
11327044|NCT02767323|12524315|FG000|NOT COMPLETED|Overall Study||34
11327045|NCT02767323|12524316|FG001|NOT COMPLETED|Overall Study||25
11327046|NCT02767323|12524317|FG002|NOT COMPLETED|Overall Study||30
11327047|NCT02767323|12524318|FG003|NOT COMPLETED|Overall Study||0
11327048|NCT02767388|12524334|FG000|STARTED|Overall Study||15
11327049|NCT02767388|12524335|FG001|STARTED|Overall Study||15
11327050|NCT02767388|12524336|FG002|STARTED|Overall Study||15
11327051|NCT02767388|12524334|FG000|COMPLETED|Overall Study||8
11327052|NCT02767388|12524335|FG001|COMPLETED|Overall Study||10
11327053|NCT02767388|12524336|FG002|COMPLETED|Overall Study||12
11327054|NCT02767388|12524334|FG000|NOT COMPLETED|Overall Study||7
11327055|NCT02767388|12524335|FG001|NOT COMPLETED|Overall Study||5
11327056|NCT02767388|12524336|FG002|NOT COMPLETED|Overall Study||3
11327057|NCT02767427|12524346|FG000|STARTED|Overall Study||21
11327058|NCT02767427|12524347|FG001|STARTED|Overall Study||19
11327059|NCT02767427|12524346|FG000|COMPLETED|Overall Study||21
11327060|NCT02767427|12524347|FG001|COMPLETED|Overall Study||19
11327061|NCT02767427|12524346|FG000|NOT COMPLETED|Overall Study||0
11327062|NCT02767427|12524347|FG001|NOT COMPLETED|Overall Study||0
11327063|NCT02767492|12524355|FG000|STARTED|Overall Study||45
11327064|NCT02767492|12524356|FG001|STARTED|Overall Study||45
11327065|NCT02767492|12524355|FG000|COMPLETED|Overall Study||35
11327066|NCT02767492|12524356|FG001|COMPLETED|Overall Study||35
11327067|NCT02767492|12524355|FG000|NOT COMPLETED|Overall Study||10
11327068|NCT02767492|12524356|FG001|NOT COMPLETED|Overall Study||10
11327069|NCT02767609|12524362|FG000|STARTED|Overall Study||1
11327070|NCT02767609|12524362|FG000|COMPLETED|Overall Study||1
11327071|NCT02767609|12524362|FG000|NOT COMPLETED|Overall Study||0
11327072|NCT02767765|12524366|FG000|STARTED|Overall Study||61
11327073|NCT02767765|12524366|FG000|COMPLETED|Overall Study||50
11327074|NCT02767765|12524366|FG000|NOT COMPLETED|Overall Study||11
11327075|NCT02767843|12524370|FG000|STARTED|Overall Study||4
11327076|NCT02767843|12524370|FG000|COMPLETED|Overall Study||4
11327077|NCT02767843|12524370|FG000|NOT COMPLETED|Overall Study||0
11327078|NCT02767869|12524378|FG000|STARTED|Overall Study||12
11327079|NCT02767869|12524379|FG001|STARTED|Overall Study||12
11327080|NCT02767869|12524378|FG000|COMPLETED|Overall Study||12
11327081|NCT02767869|12524379|FG001|COMPLETED|Overall Study||12
11327082|NCT02767869|12524378|FG000|NOT COMPLETED|Overall Study||0
11327083|NCT02767869|12524379|FG001|NOT COMPLETED|Overall Study||0
11327084|NCT02767934|12524385|FG000|STARTED|Overall Study||12
11327085|NCT02767934|12524385|FG000|COMPLETED|Overall Study||12
11327086|NCT02767934|12524385|FG000|NOT COMPLETED|Overall Study||0
11327087|NCT02767947|12524392|FG000|STARTED|Overall Study||60
11327088|NCT02767947|12524393|FG001|STARTED|Overall Study||15
11327089|NCT02767947|12524392|FG000|Safety Population|Overall Study||60
11327090|NCT02767947|12524393|FG001|Safety Population|Overall Study||15
11327091|NCT02767947|12524392|FG000|Pharmacokinetic (PK) Population|Overall Study||12
11327092|NCT02767947|12524393|FG001|Pharmacokinetic (PK) Population|Overall Study||3
11327093|NCT02767947|12524392|FG000|COMPLETED|Overall Study||60
11327094|NCT02767947|12524393|FG001|COMPLETED|Overall Study||15
11327095|NCT02767947|12524392|FG000|NOT COMPLETED|Overall Study||0
11327096|NCT02767947|12524393|FG001|NOT COMPLETED|Overall Study||0
11327097|NCT02768103|12524399|FG000|STARTED|Overall Study||5
11327098|NCT02768103|12524399|FG000|COMPLETED|Overall Study||4
11327099|NCT02768103|12524399|FG000|NOT COMPLETED|Overall Study||1
11327100|NCT02768129|12524405|FG000|STARTED|Overall Study||11
11327101|NCT02768129|12524406|FG001|STARTED|Overall Study||10
11327102|NCT02768129|12524405|FG000|COMPLETED|Overall Study||11
11327103|NCT02768129|12524406|FG001|COMPLETED|Overall Study||10
11327104|NCT02768129|12524405|FG000|NOT COMPLETED|Overall Study||0
11327105|NCT02768129|12524406|FG001|NOT COMPLETED|Overall Study||0
11327106|NCT02768194|12524412|FG000|STARTED|Period 1||4
11327107|NCT02768194|12524413|FG001|STARTED|Period 1||4
11327108|NCT02768194|12524414|FG002|STARTED|Period 1||4
11327109|NCT02768194|12524415|FG003|STARTED|Period 1||4
11327110|NCT02768194|12524416|FG004|STARTED|Period 1||4
11327111|NCT02768194|12524417|FG005|STARTED|Period 1||4
11327112|NCT02768194|12524412|FG000|COMPLETED|Period 1||4
11327113|NCT02768194|12524413|FG001|COMPLETED|Period 1||4
11327114|NCT02768194|12524414|FG002|COMPLETED|Period 1||4
11327115|NCT02768194|12524415|FG003|COMPLETED|Period 1||3
11327116|NCT02768194|12524416|FG004|COMPLETED|Period 1||4
11327117|NCT02768194|12524417|FG005|COMPLETED|Period 1||4
11327118|NCT02768194|12524412|FG000|NOT COMPLETED|Period 1||0
11327119|NCT02768194|12524413|FG001|NOT COMPLETED|Period 1||0
11327120|NCT02768194|12524414|FG002|NOT COMPLETED|Period 1||0
11327121|NCT02768194|12524415|FG003|NOT COMPLETED|Period 1||1
11327122|NCT02768194|12524416|FG004|NOT COMPLETED|Period 1||0
11327123|NCT02768194|12524417|FG005|NOT COMPLETED|Period 1||0
11327124|NCT02768194|12524412|FG000|STARTED|Period 2||4
11327125|NCT02768194|12524413|FG001|STARTED|Period 2||4
11327126|NCT02768194|12524414|FG002|STARTED|Period 2||4
11327127|NCT02768194|12524415|FG003|STARTED|Period 2||3
11327128|NCT02768194|12524416|FG004|STARTED|Period 2||4
11327129|NCT02768194|12524417|FG005|STARTED|Period 2||4
11327130|NCT02768194|12524412|FG000|COMPLETED|Period 2||3
11327131|NCT02768194|12524413|FG001|COMPLETED|Period 2||4
11327132|NCT02768194|12524414|FG002|COMPLETED|Period 2||4
11327133|NCT02768194|12524415|FG003|COMPLETED|Period 2||3
11327134|NCT02768194|12524416|FG004|COMPLETED|Period 2||4
11327135|NCT02768194|12524417|FG005|COMPLETED|Period 2||4
11327136|NCT02768194|12524412|FG000|NOT COMPLETED|Period 2||1
11327137|NCT02768194|12524413|FG001|NOT COMPLETED|Period 2||0
11327138|NCT02768194|12524414|FG002|NOT COMPLETED|Period 2||0
11327139|NCT02768194|12524415|FG003|NOT COMPLETED|Period 2||0
11327140|NCT02768194|12524416|FG004|NOT COMPLETED|Period 2||0
11327141|NCT02768194|12524417|FG005|NOT COMPLETED|Period 2||0
11327142|NCT02768194|12524412|FG000|STARTED|Period 3||3
11327143|NCT02768194|12524413|FG001|STARTED|Period 3||4
11327144|NCT02768194|12524414|FG002|STARTED|Period 3||4
11327145|NCT02768194|12524415|FG003|STARTED|Period 3||3
11327146|NCT02768194|12524416|FG004|STARTED|Period 3||4
11327147|NCT02768194|12524417|FG005|STARTED|Period 3||4
11327148|NCT02768194|12524412|FG000|COMPLETED|Period 3||3
11327149|NCT02768194|12524413|FG001|COMPLETED|Period 3||3
11327150|NCT02768194|12524414|FG002|COMPLETED|Period 3||4
11327151|NCT02768194|12524415|FG003|COMPLETED|Period 3||3
11327152|NCT02768194|12524416|FG004|COMPLETED|Period 3||4
11327153|NCT02768194|12524417|FG005|COMPLETED|Period 3||4
11327154|NCT02768194|12524412|FG000|NOT COMPLETED|Period 3||0
11327155|NCT02768194|12524413|FG001|NOT COMPLETED|Period 3||1
11327156|NCT02768194|12524414|FG002|NOT COMPLETED|Period 3||0
11327157|NCT02768194|12524415|FG003|NOT COMPLETED|Period 3||0
11327158|NCT02768194|12524416|FG004|NOT COMPLETED|Period 3||0
11327159|NCT02768194|12524417|FG005|NOT COMPLETED|Period 3||0
11327160|NCT02768298|12524427|FG000|STARTED|Overall Study||103
11327161|NCT02768298|12524428|FG001|STARTED|Overall Study||98
11327162|NCT02768298|12524427|FG000|COMPLETED|Overall Study||99
11327163|NCT02768298|12524428|FG001|COMPLETED|Overall Study||91
11327164|NCT02768298|12524427|FG000|NOT COMPLETED|Overall Study||4
11327165|NCT02768298|12524428|FG001|NOT COMPLETED|Overall Study||7
11327166|NCT02768558|12524436|FG000|STARTED|Overall Study||3
11327167|NCT02768558|12524437|FG001|STARTED|Overall Study||5
11327168|NCT02768558|12524436|FG000|Eligible|Overall Study||3
11327169|NCT02768558|12524437|FG001|Eligible|Overall Study||5
11327170|NCT02768558|12524436|FG000|COMPLETED|Overall Study||3
11327171|NCT02768558|12524437|FG001|COMPLETED|Overall Study||5
11327172|NCT02768558|12524436|FG000|NOT COMPLETED|Overall Study||0
11327173|NCT02768558|12524437|FG001|NOT COMPLETED|Overall Study||0
11327174|NCT02768753|12524445|FG000|STARTED|Overall Study||30
11327175|NCT02768753|12524446|FG001|STARTED|Overall Study||30
11327176|NCT02768753|12524445|FG000|COMPLETED|Overall Study||30
11327177|NCT02768753|12524446|FG001|COMPLETED|Overall Study||30
11327178|NCT02768753|12524445|FG000|NOT COMPLETED|Overall Study||0
11327179|NCT02768753|12524446|FG001|NOT COMPLETED|Overall Study||0
11327180|NCT02769065|12524482|FG000|STARTED|Overall Study||17
11327181|NCT02769065|12524483|FG001|STARTED|Overall Study||6
11327182|NCT02769065|12524484|FG002|STARTED|Overall Study||6
11327183|NCT02769065|12524485|FG003|STARTED|Overall Study||6
11327184|NCT02769065|12524486|FG004|STARTED|Overall Study||6
11327185|NCT02769065|12524487|FG005|STARTED|Overall Study||6
11327186|NCT02769065|12524488|FG006|STARTED|Overall Study||7
11327187|NCT02769065|12524489|FG007|STARTED|Overall Study||6
11327188|NCT02769065|12524490|FG008|STARTED|Overall Study||6
11327189|NCT02769065|12524491|FG009|STARTED|Overall Study||6
11327190|NCT02769065|12524492|FG010|STARTED|Overall Study||6
11327191|NCT02769065|12524493|FG011|STARTED|Overall Study||6
11327192|NCT02769065|12524494|FG012|STARTED|Overall Study||6
11327193|NCT02769065|12524495|FG013|STARTED|Overall Study||6
11327194|NCT02769065|12524496|FG014|STARTED|Overall Study||6
11327195|NCT02769065|12524497|FG015|STARTED|Overall Study||3
11327196|NCT02769065|12524498|FG016|STARTED|Overall Study||5
11327197|NCT02769065|12524499|FG017|STARTED|Overall Study||5
11327198|NCT02769065|12524500|FG018|STARTED|Overall Study||5
11327199|NCT02769065|12524501|FG019|STARTED|Overall Study||0
11327200|NCT02769065|12524502|FG020|STARTED|Overall Study||4
11327201|NCT02769065|12524503|FG021|STARTED|Overall Study||4
11327202|NCT02769065|12524504|FG022|STARTED|Overall Study||4
11327203|NCT02769065|12524505|FG023|STARTED|Overall Study||6
11327204|NCT02769065|12524506|FG024|STARTED|Overall Study||6
11327205|NCT02769065|12524507|FG025|STARTED|Overall Study||9
11327206|NCT02769065|12524508|FG026|STARTED|Overall Study||9
11327207|NCT02769065|12524509|FG027|STARTED|Overall Study||5
11327208|NCT02769065|12524510|FG028|STARTED|Overall Study||6
11327209|NCT02769065|12524511|FG029|STARTED|Overall Study||6
11327210|NCT02769065|12524482|FG000|COMPLETED|Overall Study||16
11327211|NCT02769065|12524483|FG001|COMPLETED|Overall Study||6
11327212|NCT02769065|12524484|FG002|COMPLETED|Overall Study||6
11327213|NCT02769065|12524485|FG003|COMPLETED|Overall Study||6
11327214|NCT02769065|12524486|FG004|COMPLETED|Overall Study||6
11327215|NCT02769065|12524487|FG005|COMPLETED|Overall Study||6
11327216|NCT02769065|12524488|FG006|COMPLETED|Overall Study||6
11327217|NCT02769065|12524489|FG007|COMPLETED|Overall Study||6
11327218|NCT02769065|12524490|FG008|COMPLETED|Overall Study||6
11327219|NCT02769065|12524491|FG009|COMPLETED|Overall Study||6
11327220|NCT02769065|12524492|FG010|COMPLETED|Overall Study||5
11327221|NCT02769065|12524493|FG011|COMPLETED|Overall Study||6
11327222|NCT02769065|12524494|FG012|COMPLETED|Overall Study||6
11327223|NCT02769065|12524495|FG013|COMPLETED|Overall Study||6
11327224|NCT02769065|12524496|FG014|COMPLETED|Overall Study||6
11327225|NCT02769065|12524497|FG015|COMPLETED|Overall Study||3
11327226|NCT02769065|12524498|FG016|COMPLETED|Overall Study||5
11327227|NCT02769065|12524499|FG017|COMPLETED|Overall Study||5
11327228|NCT02769065|12524500|FG018|COMPLETED|Overall Study||5
11327229|NCT02769065|12524501|FG019|COMPLETED|Overall Study||0
11327230|NCT02769065|12524502|FG020|COMPLETED|Overall Study||4
11327231|NCT02769065|12524503|FG021|COMPLETED|Overall Study||4
11327232|NCT02769065|12524504|FG022|COMPLETED|Overall Study||4
11327233|NCT02769065|12524505|FG023|COMPLETED|Overall Study||6
11327234|NCT02769065|12524506|FG024|COMPLETED|Overall Study||6
11327235|NCT02769065|12524507|FG025|COMPLETED|Overall Study||9
11327236|NCT02769065|12524508|FG026|COMPLETED|Overall Study||9
11327237|NCT02769065|12524509|FG027|COMPLETED|Overall Study||5
11327238|NCT02769065|12524510|FG028|COMPLETED|Overall Study||6
11327239|NCT02769065|12524511|FG029|COMPLETED|Overall Study||6
11327240|NCT02769065|12524482|FG000|NOT COMPLETED|Overall Study||1
11327241|NCT02769065|12524483|FG001|NOT COMPLETED|Overall Study||0
11327242|NCT02769065|12524484|FG002|NOT COMPLETED|Overall Study||0
11327243|NCT02769065|12524485|FG003|NOT COMPLETED|Overall Study||0
11327244|NCT02769065|12524486|FG004|NOT COMPLETED|Overall Study||0
11327245|NCT02769065|12524487|FG005|NOT COMPLETED|Overall Study||0
11327246|NCT02769065|12524488|FG006|NOT COMPLETED|Overall Study||1
11327247|NCT02769065|12524489|FG007|NOT COMPLETED|Overall Study||0
11327248|NCT02769065|12524490|FG008|NOT COMPLETED|Overall Study||0
11327249|NCT02769065|12524491|FG009|NOT COMPLETED|Overall Study||0
11327250|NCT02769065|12524492|FG010|NOT COMPLETED|Overall Study||1
11327251|NCT02769065|12524493|FG011|NOT COMPLETED|Overall Study||0
11327252|NCT02769065|12524494|FG012|NOT COMPLETED|Overall Study||0
11327253|NCT02769065|12524495|FG013|NOT COMPLETED|Overall Study||0
11327254|NCT02769065|12524496|FG014|NOT COMPLETED|Overall Study||0
11327255|NCT02769065|12524497|FG015|NOT COMPLETED|Overall Study||0
11327256|NCT02769065|12524498|FG016|NOT COMPLETED|Overall Study||0
11327257|NCT02769065|12524499|FG017|NOT COMPLETED|Overall Study||0
11327258|NCT02769065|12524500|FG018|NOT COMPLETED|Overall Study||0
11327259|NCT02769065|12524501|FG019|NOT COMPLETED|Overall Study||0
11327260|NCT02769065|12524502|FG020|NOT COMPLETED|Overall Study||0
11327261|NCT02769065|12524503|FG021|NOT COMPLETED|Overall Study||0
11327262|NCT02769065|12524504|FG022|NOT COMPLETED|Overall Study||0
11327263|NCT02769065|12524505|FG023|NOT COMPLETED|Overall Study||0
11327264|NCT02769065|12524506|FG024|NOT COMPLETED|Overall Study||0
11327265|NCT02769065|12524507|FG025|NOT COMPLETED|Overall Study||0
11327266|NCT02769065|12524508|FG026|NOT COMPLETED|Overall Study||0
11327267|NCT02769065|12524509|FG027|NOT COMPLETED|Overall Study||0
11327268|NCT02769065|12524510|FG028|NOT COMPLETED|Overall Study||0
11327269|NCT02769065|12524511|FG029|NOT COMPLETED|Overall Study||0
11327270|NCT02769247|12524608|FG000|STARTED|Overall Study||40
11327271|NCT02769247|12524609|FG001|STARTED|Overall Study||40
11327272|NCT02769247|12524610|FG002|STARTED|Overall Study||40
11327273|NCT02769247|12524611|FG003|STARTED|Overall Study||40
11327274|NCT02769247|12524608|FG000|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
11327275|NCT02769247|12524609|FG001|COMPLETED|Overall Study||40
11327276|NCT02769247|12524610|FG002|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
11327277|NCT02769247|12524611|FG003|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
11327278|NCT02769247|12524608|FG000|NOT COMPLETED|Overall Study||2
11327279|NCT02769247|12524609|FG001|NOT COMPLETED|Overall Study||0
11327280|NCT02769247|12524610|FG002|NOT COMPLETED|Overall Study||1
11327281|NCT02769247|12524611|FG003|NOT COMPLETED|Overall Study||1
11327282|NCT02769312|12524627|FG000|STARTED|Double-Blind (0-2 Weeks)||25
11327283|NCT02769312|12524628|FG001|STARTED|Double-Blind (0-2 Weeks)||25
11327284|NCT02769312|12524627|FG000|COMPLETED|Double-Blind (0-2 Weeks)||23
11327285|NCT02769312|12524628|FG001|COMPLETED|Double-Blind (0-2 Weeks)||24
11327286|NCT02769312|12524627|FG000|NOT COMPLETED|Double-Blind (0-2 Weeks)||2
11327287|NCT02769312|12524628|FG001|NOT COMPLETED|Double-Blind (0-2 Weeks)||1
11327288|NCT02769312|12524627|FG000|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21
11327289|NCT02769312|12524628|FG001|STARTED|Unblinded (Optional 2-4 Weeks)||24
11327290|NCT02769312|12524627|FG000|COMPLETED|Unblinded (Optional 2-4 Weeks)||20
11327291|NCT02769312|12524628|FG001|COMPLETED|Unblinded (Optional 2-4 Weeks)||23
11327292|NCT02769312|12524627|FG000|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
11327293|NCT02769312|12524628|FG001|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
11327294|NCT02769312|12524627|FG000|STARTED|Follow-up||23
11327295|NCT02769312|12524628|FG001|STARTED|Follow-up||24
11327296|NCT02769312|12524627|FG000|COMPLETED|Follow-up||22
11327297|NCT02769312|12524628|FG001|COMPLETED|Follow-up||23
11327298|NCT02769312|12524627|FG000|NOT COMPLETED|Follow-up||1
11327299|NCT02769312|12524628|FG001|NOT COMPLETED|Follow-up||1
11327300|NCT02769351|12524635|FG000|STARTED|Overall Study|SP|46
11327301|NCT02769351|12524635|FG000|COMPLETED|Overall Study|SP|4
11327302|NCT02769351|12524635|FG000|NOT COMPLETED|Overall Study||42
11327303|NCT02769442|12524642|FG000|STARTED|Overall Study||309
11327304|NCT02769442|12524643|FG001|STARTED|Overall Study||291
11327305|NCT02769442|12524642|FG000|COMPLETED|Overall Study||309
11327306|NCT02769442|12524643|FG001|COMPLETED|Overall Study||291
11327307|NCT02769442|12524642|FG000|NOT COMPLETED|Overall Study||0
11327308|NCT02769442|12524643|FG001|NOT COMPLETED|Overall Study||0
11343197|NCT02951533|12540516|FG001|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in the FAE group, 14 PASI 75 responders remained on FAE treatment.|14
11343198|NCT02951533|12540517|FG002|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in FAE group, 20 PASI 75 non-responders switched to GUS group.|20
11343199|NCT02951533|12540515|FG000|COMPLETED|Part IIb (Week 32 Through Week 56)||54
11343200|NCT02951533|12540516|FG001|COMPLETED|Part IIb (Week 32 Through Week 56)||10
11343201|NCT02951533|12540517|FG002|COMPLETED|Part IIb (Week 32 Through Week 56)||20
11343202|NCT02951533|12540515|FG000|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1
11343203|NCT02951533|12540516|FG001|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4
11343204|NCT02951533|12540517|FG002|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0
11343205|NCT02951533|12540515|FG000|STARTED|Part III (Week 64 Through Week 100)|18 participants were not eligible to enter Part III.|36
11343206|NCT02951533|12540516|FG001|STARTED|Part III (Week 64 Through Week 100)|10 participants in the FAE group were not eligible to enter Part III.|0
11343207|NCT02951533|12540517|FG002|STARTED|Part III (Week 64 Through Week 100)|8 participants were not eligible to enter Part III.|12
11343208|NCT02951533|12540515|FG000|COMPLETED|Part III (Week 64 Through Week 100)||32
11343209|NCT02951533|12540516|FG001|COMPLETED|Part III (Week 64 Through Week 100)||0
11343210|NCT02951533|12540517|FG002|COMPLETED|Part III (Week 64 Through Week 100)||10
11343211|NCT02951533|12540515|FG000|NOT COMPLETED|Part III (Week 64 Through Week 100)||4
11343212|NCT02951533|12540516|FG001|NOT COMPLETED|Part III (Week 64 Through Week 100)||0
11343213|NCT02951533|12540517|FG002|NOT COMPLETED|Part III (Week 64 Through Week 100)||2
11343214|NCT02951702|12540536|FG000|STARTED|Overall Study||34
11343215|NCT02951702|12540537|FG001|STARTED|Overall Study||17
11343216|NCT02951702|12540536|FG000|COMPLETED|Overall Study||34
11343217|NCT02951702|12540537|FG001|COMPLETED|Overall Study||17
11343218|NCT02951702|12540536|FG000|NOT COMPLETED|Overall Study||0
11343219|NCT02951702|12540537|FG001|NOT COMPLETED|Overall Study||0
11343220|NCT02951780|12540552|FG000|STARTED|Period 1||3
11343221|NCT02951780|12540553|FG001|STARTED|Period 1||2
11343222|NCT02951780|12540554|FG002|STARTED|Period 1||3
11343223|NCT02951780|12540555|FG003|STARTED|Period 1||3
11343224|NCT02951780|12540556|FG004|STARTED|Period 1||2
11343225|NCT02951780|12540557|FG005|STARTED|Period 1||3
11343226|NCT02951780|12540558|FG006|STARTED|Period 1||2
11343227|NCT02951780|12540559|FG007|STARTED|Period 1||3
11343228|NCT02951780|12540560|FG008|STARTED|Period 1||2
11343229|NCT02951780|12540552|FG000|COMPLETED|Period 1||3
11343230|NCT02951780|12540553|FG001|COMPLETED|Period 1||2
11343231|NCT02951780|12540554|FG002|COMPLETED|Period 1||3
11343232|NCT02951780|12540555|FG003|COMPLETED|Period 1||2
11343233|NCT02951780|12540556|FG004|COMPLETED|Period 1||2
11343234|NCT02951780|12540557|FG005|COMPLETED|Period 1||3
11343235|NCT02951780|12540558|FG006|COMPLETED|Period 1||2
11343236|NCT02951780|12540559|FG007|COMPLETED|Period 1||2
11343237|NCT02951780|12540560|FG008|COMPLETED|Period 1||2
11343238|NCT02951780|12540552|FG000|NOT COMPLETED|Period 1||0
11343239|NCT02951780|12540553|FG001|NOT COMPLETED|Period 1||0
11343240|NCT02951780|12540554|FG002|NOT COMPLETED|Period 1||0
11343241|NCT02951780|12540555|FG003|NOT COMPLETED|Period 1||1
11343242|NCT02951780|12540556|FG004|NOT COMPLETED|Period 1||0
11343243|NCT02951780|12540557|FG005|NOT COMPLETED|Period 1||0
11343244|NCT02951780|12540558|FG006|NOT COMPLETED|Period 1||0
11343245|NCT02951780|12540559|FG007|NOT COMPLETED|Period 1||1
11343246|NCT02951780|12540560|FG008|NOT COMPLETED|Period 1||0
11327309|NCT02769481|12524651|FG000|STARTED|Overall Study||213
11327310|NCT02769481|12524652|FG001|STARTED|Overall Study||213
11327311|NCT02769481|12524651|FG000|Study Complete at Week 60|Overall Study||193
11327312|NCT02769481|12524652|FG001|Study Complete at Week 60|Overall Study||192
11327313|NCT02769481|12524651|FG000|COMPLETED|Overall Study||180
11327314|NCT02769481|12524652|FG001|COMPLETED|Overall Study||177
11327315|NCT02769481|12524651|FG000|NOT COMPLETED|Overall Study||33
11327316|NCT02769481|12524652|FG001|NOT COMPLETED|Overall Study||36
11327317|NCT02769624|12524658|FG000|STARTED|Overall Study||7
11327318|NCT02769624|12524659|FG001|STARTED|Overall Study||8
11327319|NCT02769624|12524658|FG000|COMPLETED|Overall Study||7
11327320|NCT02769624|12524659|FG001|COMPLETED|Overall Study||7
11327321|NCT02769624|12524658|FG000|NOT COMPLETED|Overall Study||0
11327322|NCT02769624|12524659|FG001|NOT COMPLETED|Overall Study||1
11327323|NCT02769702|12524665|FG000|STARTED|Overall Study||2
11327324|NCT02769702|12524665|FG000|COMPLETED|Overall Study||2
11327325|NCT02769702|12524665|FG000|NOT COMPLETED|Overall Study||0
11327326|NCT02769858|12524669|FG000|STARTED|Overall Study||10
11327327|NCT02769858|12524669|FG000|COMPLETED|Overall Study||8
11327328|NCT02769858|12524669|FG000|NOT COMPLETED|Overall Study||2
11327329|NCT02770014|12524673|FG000|STARTED|Plasma Genotyping||43
11327330|NCT02770014|12524673|FG000|COMPLETED|Plasma Genotyping||43
11327331|NCT02770014|12524673|FG000|NOT COMPLETED|Plasma Genotyping||0
11327332|NCT02770014|12524673|FG000|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11
11327333|NCT02770014|12524673|FG000|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6
11327334|NCT02770014|12524673|FG000|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5
11327335|NCT02770170|12524682|FG000|STARTED|Overall Study||21
11327336|NCT02770170|12524683|FG001|STARTED|Overall Study||20
11327337|NCT02770170|12524684|FG002|STARTED|Overall Study||40
11327338|NCT02770170|12524685|FG003|STARTED|Overall Study||40
11327339|NCT02770170|12524682|FG000|COMPLETED|Overall Study||14
11327340|NCT02770170|12524683|FG001|COMPLETED|Overall Study||17
11327341|NCT02770170|12524684|FG002|COMPLETED|Overall Study||35
11327342|NCT02770170|12524685|FG003|COMPLETED|Overall Study||33
11327343|NCT02770170|12524682|FG000|NOT COMPLETED|Overall Study||7
11327344|NCT02770170|12524683|FG001|NOT COMPLETED|Overall Study||3
11327345|NCT02770170|12524684|FG002|NOT COMPLETED|Overall Study||5
11327346|NCT02770170|12524685|FG003|NOT COMPLETED|Overall Study||7
11327347|NCT02770248|12524697|FG000|STARTED|Overall Study||62
11327348|NCT02770248|12524698|FG001|STARTED|Overall Study||63
11327349|NCT02770248|12524697|FG000|COMPLETED|Overall Study||62
11327350|NCT02770248|12524698|FG001|COMPLETED|Overall Study||61
11327351|NCT02770248|12524697|FG000|NOT COMPLETED|Overall Study||0
11327352|NCT02770248|12524698|FG001|NOT COMPLETED|Overall Study||2
11327353|NCT02770287|12524704|FG000|STARTED|Overall Study||11
11327354|NCT02770287|12524704|FG000|COMPLETED|Overall Study||11
11327355|NCT02770287|12524704|FG000|NOT COMPLETED|Overall Study||0
11327356|NCT02770365|12524714|FG000|STARTED|Overall Study||277
11327357|NCT02770365|12524715|FG001|STARTED|Overall Study||279
11327358|NCT02770365|12524716|FG002|STARTED|Overall Study||139
11327359|NCT02770365|12524714|FG000|COMPLETED|Overall Study||272
11327360|NCT02770365|12524715|FG001|COMPLETED|Overall Study||275
11327361|NCT02770365|12524716|FG002|COMPLETED|Overall Study||139
11327362|NCT02770365|12524714|FG000|NOT COMPLETED|Overall Study||5
11327363|NCT02770365|12524715|FG001|NOT COMPLETED|Overall Study||4
11327364|NCT02770365|12524716|FG002|NOT COMPLETED|Overall Study||0
11327365|NCT02770521|12524726|FG000|STARTED|Period One||4
11327366|NCT02770521|12524727|FG001|STARTED|Period One||4
11327367|NCT02770521|12524728|FG002|STARTED|Period One||2
11327368|NCT02770521|12524729|FG003|STARTED|Period One||2
11327369|NCT02770521|12524730|FG004|STARTED|Period One||2
11327370|NCT02770521|12524731|FG005|STARTED|Period One||9
11327371|NCT02770521|12524726|FG000|Received Study Drug|Period One||4
11327372|NCT02770521|12524727|FG001|Received Study Drug|Period One||4
11327373|NCT02770521|12524728|FG002|Received Study Drug|Period One||2
11327374|NCT02770521|12524729|FG003|Received Study Drug|Period One||2
11327375|NCT02770521|12524730|FG004|Received Study Drug|Period One||2
11327376|NCT02770521|12524731|FG005|Received Study Drug|Period One||9
11327377|NCT02770521|12524726|FG000|COMPLETED|Period One||4
11327378|NCT02770521|12524727|FG001|COMPLETED|Period One||4
11327379|NCT02770521|12524728|FG002|COMPLETED|Period One||2
11327380|NCT02770521|12524729|FG003|COMPLETED|Period One||2
11327381|NCT02770521|12524730|FG004|COMPLETED|Period One||2
11327382|NCT02770521|12524731|FG005|COMPLETED|Period One||9
11327383|NCT02770521|12524726|FG000|NOT COMPLETED|Period One||0
11327384|NCT02770521|12524727|FG001|NOT COMPLETED|Period One||0
11327385|NCT02770521|12524728|FG002|NOT COMPLETED|Period One||0
11327386|NCT02770521|12524729|FG003|NOT COMPLETED|Period One||0
11327387|NCT02770521|12524730|FG004|NOT COMPLETED|Period One||0
11327388|NCT02770521|12524731|FG005|NOT COMPLETED|Period One||0
11327389|NCT02770521|12524726|FG000|STARTED|Period Two||4
11327390|NCT02770521|12524727|FG001|STARTED|Period Two||4
11327391|NCT02770521|12524728|FG002|STARTED|Period Two||2
11327392|NCT02770521|12524729|FG003|STARTED|Period Two||2
11327393|NCT02770521|12524730|FG004|STARTED|Period Two||2
11327394|NCT02770521|12524731|FG005|STARTED|Period Two||9
11327395|NCT02770521|12524726|FG000|Received Study Drug|Period Two||4
11327396|NCT02770521|12524727|FG001|Received Study Drug|Period Two||4
11327397|NCT02770521|12524728|FG002|Received Study Drug|Period Two||2
11327398|NCT02770521|12524729|FG003|Received Study Drug|Period Two||2
11327399|NCT02770521|12524730|FG004|Received Study Drug|Period Two||2
11327400|NCT02770521|12524731|FG005|Received Study Drug|Period Two||9
11327401|NCT02770521|12524726|FG000|COMPLETED|Period Two||4
11327402|NCT02770521|12524727|FG001|COMPLETED|Period Two||4
11327403|NCT02770521|12524728|FG002|COMPLETED|Period Two||2
11327404|NCT02770521|12524729|FG003|COMPLETED|Period Two||2
11327405|NCT02770521|12524730|FG004|COMPLETED|Period Two||2
11327406|NCT02770521|12524731|FG005|COMPLETED|Period Two||9
11327407|NCT02770521|12524726|FG000|NOT COMPLETED|Period Two||0
11327408|NCT02770521|12524727|FG001|NOT COMPLETED|Period Two||0
11327409|NCT02770521|12524728|FG002|NOT COMPLETED|Period Two||0
11327410|NCT02770521|12524729|FG003|NOT COMPLETED|Period Two||0
11327411|NCT02770521|12524730|FG004|NOT COMPLETED|Period Two||0
11327412|NCT02770521|12524731|FG005|NOT COMPLETED|Period Two||0
11327413|NCT02770521|12524726|FG000|STARTED|Period Three|Not applicable. Part A only had two periods.|0
11327414|NCT02770521|12524727|FG001|STARTED|Period Three|Not applicable. Part A only had two periods.|0
11327415|NCT02770521|12524728|FG002|STARTED|Period Three||2
11327416|NCT02770521|12524729|FG003|STARTED|Period Three||2
11327417|NCT02770521|12524730|FG004|STARTED|Period Three||2
11327418|NCT02770521|12524731|FG005|STARTED|Period Three||9
11327419|NCT02770521|12524726|FG000|Received Study Drug|Period Three||0
11327420|NCT02770521|12524727|FG001|Received Study Drug|Period Three||0
11327421|NCT02770521|12524728|FG002|Received Study Drug|Period Three||2
11327422|NCT02770521|12524729|FG003|Received Study Drug|Period Three||2
11327423|NCT02770521|12524730|FG004|Received Study Drug|Period Three||2
11327424|NCT02770521|12524731|FG005|Received Study Drug|Period Three||9
11327425|NCT02770521|12524726|FG000|COMPLETED|Period Three||0
11327426|NCT02770521|12524727|FG001|COMPLETED|Period Three||0
11327427|NCT02770521|12524728|FG002|COMPLETED|Period Three||2
11327428|NCT02770521|12524729|FG003|COMPLETED|Period Three||2
11327429|NCT02770521|12524730|FG004|COMPLETED|Period Three||2
11327430|NCT02770521|12524731|FG005|COMPLETED|Period Three||9
11327431|NCT02770521|12524726|FG000|NOT COMPLETED|Period Three||0
11327432|NCT02770521|12524727|FG001|NOT COMPLETED|Period Three||0
11327433|NCT02770521|12524728|FG002|NOT COMPLETED|Period Three||0
11327434|NCT02770521|12524729|FG003|NOT COMPLETED|Period Three||0
11327435|NCT02770521|12524730|FG004|NOT COMPLETED|Period Three||0
11327436|NCT02770521|12524731|FG005|NOT COMPLETED|Period Three||0
11327437|NCT02770547|12524751|FG000|STARTED|Overall Study||16
11327438|NCT02770547|12524752|FG001|STARTED|Overall Study||16
11327439|NCT02770547|12524751|FG000|COMPLETED|Overall Study||15
11327440|NCT02770547|12524752|FG001|COMPLETED|Overall Study||15
11327441|NCT02770547|12524751|FG000|NOT COMPLETED|Overall Study||1
11327442|NCT02770547|12524752|FG001|NOT COMPLETED|Overall Study||1
11327443|NCT02770612|12524758|FG000|STARTED|Overall Study||51
11327444|NCT02770612|12524758|FG000|COMPLETED|Overall Study||50
11327445|NCT02770612|12524758|FG000|NOT COMPLETED|Overall Study||1
11327446|NCT02770625|12524762|FG000|STARTED|Overall Study||8
11327447|NCT02770625|12524762|FG000|COMPLETED|Overall Study||8
11327448|NCT02770625|12524762|FG000|NOT COMPLETED|Overall Study||0
11327449|NCT02770820|12524766|FG000|STARTED|Overall Study||7
11327450|NCT02770820|12524766|FG000|COMPLETED|Overall Study||4
11327451|NCT02770820|12524766|FG000|NOT COMPLETED|Overall Study||3
11327452|NCT02770846|12524772|FG000|STARTED|Overall Study||25
11327453|NCT02770846|12524773|FG001|STARTED|Overall Study||25
11327454|NCT02770846|12524772|FG000|COMPLETED|Overall Study||25
11327455|NCT02770846|12524773|FG001|COMPLETED|Overall Study||25
11327456|NCT02770846|12524772|FG000|NOT COMPLETED|Overall Study||0
11327457|NCT02770846|12524773|FG001|NOT COMPLETED|Overall Study||0
11327458|NCT02771093|12524783|FG000|STARTED|Overall Study||13
11327459|NCT02771093|12524784|FG001|STARTED|Overall Study||14
11327460|NCT02771093|12524783|FG000|COMPLETED|Overall Study||13
11327461|NCT02771093|12524784|FG001|COMPLETED|Overall Study||14
11327462|NCT02771093|12524783|FG000|NOT COMPLETED|Overall Study||0
11327463|NCT02771093|12524784|FG001|NOT COMPLETED|Overall Study||0
11327464|NCT02771145|12524790|FG000|STARTED|Overall Study||90
11327465|NCT02771145|12524790|FG000|COMPLETED|Overall Study||86
11327466|NCT02771145|12524790|FG000|NOT COMPLETED|Overall Study||4
11327467|NCT02771210|12524812|FG000|STARTED|Period 1||102
11327468|NCT02771210|12524813|FG001|STARTED|Period 1||102
11327469|NCT02771210|12524812|FG000|COMPLETED|Period 1||91
11327470|NCT02771210|12524813|FG001|COMPLETED|Period 1||84
11327471|NCT02771210|12524812|FG000|NOT COMPLETED|Period 1||11
11327472|NCT02771210|12524813|FG001|NOT COMPLETED|Period 1||18
11327473|NCT02771210|12524812|FG000|STARTED|Period 2||91
11327474|NCT02771210|12524813|FG001|STARTED|Period 2||84
11327475|NCT02771210|12524812|FG000|COMPLETED|Period 2||89
11327476|NCT02771210|12524813|FG001|COMPLETED|Period 2||81
11327477|NCT02771210|12524812|FG000|NOT COMPLETED|Period 2||2
11327478|NCT02771210|12524813|FG001|NOT COMPLETED|Period 2||3
11327479|NCT02771340|12524822|FG000|STARTED|Overall Study||2
11327480|NCT02771340|12524823|FG001|STARTED|Overall Study||3
11327481|NCT02771340|12524824|FG002|STARTED|Overall Study||5
11327482|NCT02771340|12524822|FG000|COMPLETED|Overall Study||2
11327483|NCT02771340|12524823|FG001|COMPLETED|Overall Study||3
11327484|NCT02771340|12524824|FG002|COMPLETED|Overall Study||5
11327485|NCT02771340|12524822|FG000|NOT COMPLETED|Overall Study||0
11327486|NCT02771340|12524823|FG001|NOT COMPLETED|Overall Study||0
11327487|NCT02771340|12524824|FG002|NOT COMPLETED|Overall Study||0
11327488|NCT02771366|12524834|FG000|STARTED|Period 1||15
11327489|NCT02771366|12524835|FG001|STARTED|Period 1||15
11327490|NCT02771366|12524834|FG000|COMPLETED|Period 1||15
11327491|NCT02771366|12524835|FG001|COMPLETED|Period 1||13
11327492|NCT02771366|12524834|FG000|NOT COMPLETED|Period 1||0
11327493|NCT02771366|12524835|FG001|NOT COMPLETED|Period 1||2
11327494|NCT02771366|12524834|FG000|STARTED|Period 2 (Crossover)||15
11327495|NCT02771366|12524835|FG001|STARTED|Period 2 (Crossover)||13
11327496|NCT02771366|12524834|FG000|COMPLETED|Period 2 (Crossover)||13
11327497|NCT02771366|12524835|FG001|COMPLETED|Period 2 (Crossover)||13
11327498|NCT02771366|12524834|FG000|NOT COMPLETED|Period 2 (Crossover)||2
11327499|NCT02771366|12524835|FG001|NOT COMPLETED|Period 2 (Crossover)||0
11327500|NCT02771522|12524842|FG000|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30
11327501|NCT02771522|12524842|FG000|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22
11327502|NCT02771522|12524842|FG000|NOT COMPLETED|Overall Study||8
11327503|NCT02771574|12524856|FG000|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||3
11327504|NCT02771574|12524857|FG001|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
11327505|NCT02771574|12524858|FG002|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
11327506|NCT02771574|12524859|FG003|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
11327507|NCT02771574|12524860|FG004|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
11327508|NCT02771574|12524856|FG000|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||3
11327509|NCT02771574|12524857|FG001|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
11327510|NCT02771574|12524858|FG002|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
11327511|NCT02771574|12524859|FG003|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
11327512|NCT02771574|12524860|FG004|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
11327513|NCT02771574|12524856|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
11327514|NCT02771574|12524857|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
11327515|NCT02771574|12524858|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
11327516|NCT02771574|12524859|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
11327517|NCT02771574|12524860|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
11327518|NCT02771574|12524856|FG000|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
11327519|NCT02771574|12524857|FG001|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||5
11327520|NCT02771574|12524858|FG002|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
11327521|NCT02771574|12524859|FG003|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
11327522|NCT02771574|12524860|FG004|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
11327523|NCT02771574|12524856|FG000|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
11327524|NCT02771574|12524857|FG001|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||5
11327525|NCT02771574|12524858|FG002|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
11327526|NCT02771574|12524859|FG003|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
11327527|NCT02771574|12524860|FG004|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
11327528|NCT02771574|12524856|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
11327529|NCT02771574|12524857|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
11327530|NCT02771574|12524858|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
11327531|NCT02771574|12524859|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
11327532|NCT02771574|12524860|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
11327533|NCT02771574|12524856|FG000|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
11327534|NCT02771574|12524857|FG001|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
11327535|NCT02771574|12524858|FG002|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||3
11327536|NCT02771574|12524859|FG003|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
11327537|NCT02771574|12524860|FG004|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
11327538|NCT02771574|12524856|FG000|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
11327539|NCT02771574|12524857|FG001|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
11327540|NCT02771574|12524858|FG002|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||3
11327541|NCT02771574|12524859|FG003|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
11327542|NCT02771574|12524860|FG004|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
11327543|NCT02771574|12524856|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
11327544|NCT02771574|12524857|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
11327545|NCT02771574|12524858|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
11327546|NCT02771574|12524859|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
11327547|NCT02771574|12524860|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
11327548|NCT02771574|12524856|FG000|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
11327549|NCT02771574|12524857|FG001|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
11327550|NCT02771574|12524858|FG002|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
11327551|NCT02771574|12524859|FG003|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||3
11327552|NCT02771574|12524860|FG004|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
11327553|NCT02771574|12524856|FG000|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
11327554|NCT02771574|12524857|FG001|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
11327555|NCT02771574|12524858|FG002|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
11327556|NCT02771574|12524859|FG003|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||3
11327557|NCT02771574|12524860|FG004|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
11327558|NCT02771574|12524856|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
11327559|NCT02771574|12524857|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
11327560|NCT02771574|12524858|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
11327561|NCT02771574|12524859|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
11327562|NCT02771574|12524860|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
11327563|NCT02771574|12524856|FG000|STARTED|Liq Avexitide (3 Days)||0
11327564|NCT02771574|12524857|FG001|STARTED|Liq Avexitide (3 Days)||0
11327565|NCT02771574|12524858|FG002|STARTED|Liq Avexitide (3 Days)||0
11327566|NCT02771574|12524859|FG003|STARTED|Liq Avexitide (3 Days)||0
11327567|NCT02771574|12524860|FG004|STARTED|Liq Avexitide (3 Days)||5
11327568|NCT02771574|12524856|FG000|COMPLETED|Liq Avexitide (3 Days)||0
11327569|NCT02771574|12524857|FG001|COMPLETED|Liq Avexitide (3 Days)||0
11327570|NCT02771574|12524858|FG002|COMPLETED|Liq Avexitide (3 Days)||0
11327571|NCT02771574|12524859|FG003|COMPLETED|Liq Avexitide (3 Days)||0
11327572|NCT02771574|12524860|FG004|COMPLETED|Liq Avexitide (3 Days)||5
11327573|NCT02771574|12524856|FG000|NOT COMPLETED|Liq Avexitide (3 Days)||0
11327574|NCT02771574|12524857|FG001|NOT COMPLETED|Liq Avexitide (3 Days)||0
11327575|NCT02771574|12524858|FG002|NOT COMPLETED|Liq Avexitide (3 Days)||0
11327576|NCT02771574|12524859|FG003|NOT COMPLETED|Liq Avexitide (3 Days)||0
11327577|NCT02771574|12524860|FG004|NOT COMPLETED|Liq Avexitide (3 Days)||0
11327578|NCT02772302|12524877|FG000|STARTED|Overall Study||10
11327579|NCT02772302|12524878|FG001|STARTED|Overall Study||10
11327580|NCT02772302|12524877|FG000|COMPLETED|Overall Study||10
11327581|NCT02772302|12524878|FG001|COMPLETED|Overall Study||10
11327582|NCT02772302|12524877|FG000|NOT COMPLETED|Overall Study||0
11327583|NCT02772302|12524878|FG001|NOT COMPLETED|Overall Study||0
11327584|NCT02772432|12524886|FG000|STARTED|Overall Study||31
11327585|NCT02772432|12524887|FG001|STARTED|Overall Study||22
11327586|NCT02772432|12524886|FG000|COMPLETED|Overall Study||19
11327587|NCT02772432|12524887|FG001|COMPLETED|Overall Study||21
11327588|NCT02772432|12524886|FG000|NOT COMPLETED|Overall Study||12
11327589|NCT02772432|12524887|FG001|NOT COMPLETED|Overall Study||1
11327590|NCT02772666|12524893|FG000|STARTED|O-Glas Then SFT||44
11327591|NCT02772666|12524893|FG000|COMPLETED|O-Glas Then SFT||44
11327592|NCT02772666|12524893|FG000|NOT COMPLETED|O-Glas Then SFT||0
11327593|NCT02772666|12524893|FG000|STARTED|SFT Then O-Glass||44
11327594|NCT02772666|12524893|FG000|COMPLETED|SFT Then O-Glass||44
11327595|NCT02772666|12524893|FG000|NOT COMPLETED|SFT Then O-Glass||0
11327596|NCT02772757|12524901|FG000|STARTED|Overall Study||22
11327597|NCT02772757|12524902|FG001|STARTED|Overall Study||24
11327598|NCT02772757|12524903|FG002|STARTED|Overall Study||26
11327599|NCT02772757|12524901|FG000|COMPLETED|Overall Study||21
11327600|NCT02772757|12524902|FG001|COMPLETED|Overall Study||21
11327601|NCT02772757|12524903|FG002|COMPLETED|Overall Study||21
11327602|NCT02772757|12524901|FG000|NOT COMPLETED|Overall Study||1
11327603|NCT02772757|12524902|FG001|NOT COMPLETED|Overall Study||3
11327604|NCT02772757|12524903|FG002|NOT COMPLETED|Overall Study||5
11327605|NCT02772783|12524912|FG000|STARTED|Experimental Condition 1, 1 Day||8
11327606|NCT02772783|12524913|FG001|STARTED|Experimental Condition 1, 1 Day||7
11327607|NCT02772783|12524912|FG000|COMPLETED|Experimental Condition 1, 1 Day||8
11327608|NCT02772783|12524913|FG001|COMPLETED|Experimental Condition 1, 1 Day||7
11327609|NCT02772783|12524912|FG000|NOT COMPLETED|Experimental Condition 1, 1 Day||0
11327610|NCT02772783|12524913|FG001|NOT COMPLETED|Experimental Condition 1, 1 Day||0
11327611|NCT02772783|12524912|FG000|STARTED|Wash-out, 1 Week||8
11327612|NCT02772783|12524913|FG001|STARTED|Wash-out, 1 Week||7
11327613|NCT02772783|12524912|FG000|COMPLETED|Wash-out, 1 Week||8
11327614|NCT02772783|12524913|FG001|COMPLETED|Wash-out, 1 Week||7
11327615|NCT02772783|12524912|FG000|NOT COMPLETED|Wash-out, 1 Week||0
11327616|NCT02772783|12524913|FG001|NOT COMPLETED|Wash-out, 1 Week||0
11327617|NCT02772783|12524912|FG000|STARTED|Comparison Condition, 1 Day||8
11327618|NCT02772783|12524913|FG001|STARTED|Comparison Condition, 1 Day||7
11327619|NCT02772783|12524912|FG000|COMPLETED|Comparison Condition, 1 Day||8
11327620|NCT02772783|12524913|FG001|COMPLETED|Comparison Condition, 1 Day||7
11327621|NCT02772783|12524912|FG000|NOT COMPLETED|Comparison Condition, 1 Day||0
11327622|NCT02772783|12524913|FG001|NOT COMPLETED|Comparison Condition, 1 Day||0
11327623|NCT02772783|12524912|FG000|STARTED|Wash-out, 1 Week||8
11327624|NCT02772783|12524913|FG001|STARTED|Wash-out, 1 Week||7
11327625|NCT02772783|12524912|FG000|COMPLETED|Wash-out, 1 Week||8
11327626|NCT02772783|12524913|FG001|COMPLETED|Wash-out, 1 Week||7
11327627|NCT02772783|12524912|FG000|NOT COMPLETED|Wash-out, 1 Week||0
11327628|NCT02772783|12524913|FG001|NOT COMPLETED|Wash-out, 1 Week||0
11327629|NCT02772783|12524912|FG000|STARTED|Experimental Condition 2, 1 Day||8
11327630|NCT02772783|12524913|FG001|STARTED|Experimental Condition 2, 1 Day||7
11327631|NCT02772783|12524912|FG000|COMPLETED|Experimental Condition 2, 1 Day||8
11327632|NCT02772783|12524913|FG001|COMPLETED|Experimental Condition 2, 1 Day||7
11327633|NCT02772783|12524912|FG000|NOT COMPLETED|Experimental Condition 2, 1 Day||0
11327634|NCT02772783|12524913|FG001|NOT COMPLETED|Experimental Condition 2, 1 Day||0
11327635|NCT02772809|12524921|FG000|STARTED|Overall Study||23
11327636|NCT02772809|12524921|FG000|COMPLETED|Overall Study||17
11327637|NCT02772809|12524921|FG000|NOT COMPLETED|Overall Study||6
11327638|NCT02772978|12524930|FG000|STARTED|Overall Study|First participant enrolled|10
11327639|NCT02772978|12524931|FG001|STARTED|Overall Study||9
11327640|NCT02772978|12524930|FG000|COMPLETED|Overall Study|Last participant enrolled|9
11327641|NCT02772978|12524931|FG001|COMPLETED|Overall Study||8
11327642|NCT02772978|12524930|FG000|NOT COMPLETED|Overall Study||1
11327643|NCT02772978|12524931|FG001|NOT COMPLETED|Overall Study||1
11327644|NCT02773368|12524938|FG000|STARTED|Overall Study||210
11327645|NCT02773368|12524939|FG001|STARTED|Overall Study||210
11327646|NCT02773368|12524938|FG000|Exposed|Overall Study||209
11327647|NCT02773368|12524939|FG001|Exposed|Overall Study||210
11327648|NCT02773368|12524938|FG000|COMPLETED|Overall Study||200
11327649|NCT02773368|12524939|FG001|COMPLETED|Overall Study||206
11327650|NCT02773368|12524938|FG000|NOT COMPLETED|Overall Study||10
11327651|NCT02773368|12524939|FG001|NOT COMPLETED|Overall Study||4
11327652|NCT02773446|12524951|FG000|STARTED|First Admission||7
11327653|NCT02773446|12524952|FG001|STARTED|First Admission||7
11327654|NCT02773446|12524953|FG002|STARTED|First Admission||7
11327655|NCT02773446|12524954|FG003|STARTED|First Admission||7
11327656|NCT02773446|12524955|FG004|STARTED|First Admission||0
11327657|NCT02773446|12524956|FG005|STARTED|First Admission||0
11327658|NCT02773446|12524951|FG000|COMPLETED|First Admission||6
11327659|NCT02773446|12524952|FG001|COMPLETED|First Admission||7
11327660|NCT02773446|12524953|FG002|COMPLETED|First Admission||7
11327661|NCT02773446|12524954|FG003|COMPLETED|First Admission||6
11327662|NCT02773446|12524955|FG004|COMPLETED|First Admission||0
11327663|NCT02773446|12524956|FG005|COMPLETED|First Admission||0
11327664|NCT02773446|12524951|FG000|NOT COMPLETED|First Admission||1
11327665|NCT02773446|12524952|FG001|NOT COMPLETED|First Admission||0
11327666|NCT02773446|12524953|FG002|NOT COMPLETED|First Admission||0
11327667|NCT02773446|12524954|FG003|NOT COMPLETED|First Admission||1
11327668|NCT02773446|12524955|FG004|NOT COMPLETED|First Admission||0
11327669|NCT02773446|12524956|FG005|NOT COMPLETED|First Admission||0
11327670|NCT02773446|12524951|FG000|STARTED|Second Admission||0
11327671|NCT02773446|12524952|FG001|STARTED|Second Admission||0
11327672|NCT02773446|12524953|FG002|STARTED|Second Admission||0
11327673|NCT02773446|12524954|FG003|STARTED|Second Admission||0
11327674|NCT02773446|12524955|FG004|STARTED|Second Admission||11
11327675|NCT02773446|12524956|FG005|STARTED|Second Admission||19
11327676|NCT02773446|12524951|FG000|COMPLETED|Second Admission||0
11327677|NCT02773446|12524952|FG001|COMPLETED|Second Admission||0
11327678|NCT02773446|12524953|FG002|COMPLETED|Second Admission||0
11327679|NCT02773446|12524954|FG003|COMPLETED|Second Admission||0
11327680|NCT02773446|12524955|FG004|COMPLETED|Second Admission||11
11327681|NCT02773446|12524956|FG005|COMPLETED|Second Admission||19
11327682|NCT02773446|12524951|FG000|NOT COMPLETED|Second Admission||0
11327683|NCT02773446|12524952|FG001|NOT COMPLETED|Second Admission||0
11327684|NCT02773446|12524953|FG002|NOT COMPLETED|Second Admission||0
11327685|NCT02773446|12524954|FG003|NOT COMPLETED|Second Admission||0
11327686|NCT02773446|12524955|FG004|NOT COMPLETED|Second Admission||0
11327687|NCT02773446|12524956|FG005|NOT COMPLETED|Second Admission||0
11327688|NCT02773537|12524976|FG000|STARTED|Overall Study||25
11327689|NCT02773537|12524977|FG001|STARTED|Overall Study||25
11327690|NCT02773537|12524978|FG002|STARTED|Overall Study||25
11327691|NCT02773537|12524976|FG000|COMPLETED|Overall Study||25
11327692|NCT02773537|12524977|FG001|COMPLETED|Overall Study||24
11327693|NCT02773537|12524978|FG002|COMPLETED|Overall Study||21
11327694|NCT02773537|12524976|FG000|NOT COMPLETED|Overall Study||0
11327695|NCT02773537|12524977|FG001|NOT COMPLETED|Overall Study||1
11327696|NCT02773537|12524978|FG002|NOT COMPLETED|Overall Study||4
11327697|NCT02773758|12524988|FG000|STARTED|Overall Study||71
11327698|NCT02773758|12524989|FG001|STARTED|Overall Study||70
11327699|NCT02773758|12524988|FG000|COMPLETED|Overall Study||71
11327700|NCT02773758|12524989|FG001|COMPLETED|Overall Study||70
11327701|NCT02773758|12524988|FG000|NOT COMPLETED|Overall Study||0
11327702|NCT02773758|12524989|FG001|NOT COMPLETED|Overall Study||0
11327703|NCT02773836|12525001|FG000|STARTED|Wave 1- Pre-TPD Implementation||1000
11327704|NCT02773836|12525002|FG001|STARTED|Wave 1- Pre-TPD Implementation||1003
11327705|NCT02773836|12525003|FG002|STARTED|Wave 1- Pre-TPD Implementation||1001
11327706|NCT02773836|12525004|FG003|STARTED|Wave 1- Pre-TPD Implementation||1001
11327707|NCT02773836|12525005|FG004|STARTED|Wave 1- Pre-TPD Implementation||1000
11327708|NCT02773836|12525006|FG005|STARTED|Wave 1- Pre-TPD Implementation||1006
11327709|NCT02773836|12525001|FG000|COMPLETED|Wave 1- Pre-TPD Implementation||1000
11327710|NCT02773836|12525002|FG001|COMPLETED|Wave 1- Pre-TPD Implementation||1003
11327711|NCT02773836|12525003|FG002|COMPLETED|Wave 1- Pre-TPD Implementation||1001
11327712|NCT02773836|12525004|FG003|COMPLETED|Wave 1- Pre-TPD Implementation||1001
11327713|NCT02773836|12525005|FG004|COMPLETED|Wave 1- Pre-TPD Implementation||1000
11327714|NCT02773836|12525006|FG005|COMPLETED|Wave 1- Pre-TPD Implementation||1006
11327715|NCT02773836|12525001|FG000|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
11327716|NCT02773836|12525002|FG001|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
11327717|NCT02773836|12525003|FG002|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
11327718|NCT02773836|12525004|FG003|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
11327719|NCT02773836|12525005|FG004|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
11327720|NCT02773836|12525006|FG005|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
11327721|NCT02773836|12525001|FG000|STARTED|Wave 2- Post-TPD Implementation||1010
11327722|NCT02773836|12525002|FG001|STARTED|Wave 2- Post-TPD Implementation||1013
11327723|NCT02773836|12525003|FG002|STARTED|Wave 2- Post-TPD Implementation||1003
11327724|NCT02773836|12525004|FG003|STARTED|Wave 2- Post-TPD Implementation||1010
11327725|NCT02773836|12525005|FG004|STARTED|Wave 2- Post-TPD Implementation||1002
11327726|NCT02773836|12525006|FG005|STARTED|Wave 2- Post-TPD Implementation||998
11327727|NCT02773836|12525001|FG000|COMPLETED|Wave 2- Post-TPD Implementation||1010
11327728|NCT02773836|12525002|FG001|COMPLETED|Wave 2- Post-TPD Implementation||1013
11327729|NCT02773836|12525003|FG002|COMPLETED|Wave 2- Post-TPD Implementation||1003
11327730|NCT02773836|12525004|FG003|COMPLETED|Wave 2- Post-TPD Implementation||1010
11327731|NCT02773836|12525005|FG004|COMPLETED|Wave 2- Post-TPD Implementation||1002
11327732|NCT02773836|12525006|FG005|COMPLETED|Wave 2- Post-TPD Implementation||998
11327733|NCT02773836|12525001|FG000|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
11327734|NCT02773836|12525002|FG001|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
11327735|NCT02773836|12525003|FG002|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
11327736|NCT02773836|12525004|FG003|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
11327737|NCT02773836|12525005|FG004|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
11327738|NCT02773836|12525006|FG005|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
11327739|NCT02774213|12525026|FG000|STARTED|Overall Study||74
11327740|NCT02774213|12525026|FG000|COMPLETED|Overall Study||55
11327741|NCT02774213|12525026|FG000|NOT COMPLETED|Overall Study||19
11327742|NCT02774226|12525032|FG000|STARTED|Overall Study||8
11327743|NCT02774226|12525033|FG001|STARTED|Overall Study||7
11327744|NCT02774226|12525032|FG000|COMPLETED|Overall Study||8
11327745|NCT02774226|12525033|FG001|COMPLETED|Overall Study||7
11327746|NCT02774226|12525032|FG000|NOT COMPLETED|Overall Study||0
11327747|NCT02774226|12525033|FG001|NOT COMPLETED|Overall Study||0
11327748|NCT02774278|12525039|FG000|STARTED|Overall Study||264
11327749|NCT02774278|12525039|FG000|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
11327750|NCT02774278|12525039|FG000|COMPLETED|Overall Study||0
11327751|NCT02774278|12525039|FG000|NOT COMPLETED|Overall Study||264
11327752|NCT02774343|12525045|FG000|STARTED|Overall Study||15
11327753|NCT02774343|12525046|FG001|STARTED|Overall Study||15
11327754|NCT02774343|12525045|FG000|Received at Least One Capsule|Overall Study||12
11327755|NCT02774343|12525046|FG001|Received at Least One Capsule|Overall Study||14
11327756|NCT02774343|12525045|FG000|COMPLETED|Overall Study||9
11327757|NCT02774343|12525046|FG001|COMPLETED|Overall Study||12
11327758|NCT02774343|12525045|FG000|NOT COMPLETED|Overall Study||6
11327759|NCT02774343|12525046|FG001|NOT COMPLETED|Overall Study||3
11327760|NCT02774616|12525055|FG000|STARTED|Overall Study||95
11327761|NCT02774616|12525056|FG001|STARTED|Overall Study||167
11327762|NCT02774616|12525057|FG002|STARTED|Overall Study||16
11327763|NCT02774616|12525055|FG000|Died|Overall Study||6
11327764|NCT02774616|12525056|FG001|Died|Overall Study||3
11327765|NCT02774616|12525057|FG002|Died|Overall Study||1
11327766|NCT02774616|12525055|FG000|Withdrew Consent|Overall Study||3
11327767|NCT02774616|12525056|FG001|Withdrew Consent|Overall Study||3
11327768|NCT02774616|12525057|FG002|Withdrew Consent|Overall Study||0
11327769|NCT02774616|12525055|FG000|Lost to FU|Overall Study||2
11327770|NCT02774616|12525056|FG001|Lost to FU|Overall Study||0
11327771|NCT02774616|12525057|FG002|Lost to FU|Overall Study||0
11327772|NCT02774616|12525055|FG000|Device Explanted|Overall Study||2
11327773|NCT02774616|12525056|FG001|Device Explanted|Overall Study||1
11327774|NCT02774616|12525057|FG002|Device Explanted|Overall Study||1
11327775|NCT02774616|12525055|FG000|Other|Overall Study||2
11327776|NCT02774616|12525056|FG001|Other|Overall Study||4
11327777|NCT02774616|12525057|FG002|Other|Overall Study||1
11327778|NCT02774616|12525055|FG000|COMPLETED|Overall Study||80
11327779|NCT02774616|12525056|FG001|COMPLETED|Overall Study||156
11327780|NCT02774616|12525057|FG002|COMPLETED|Overall Study||13
11327781|NCT02774616|12525055|FG000|NOT COMPLETED|Overall Study||15
11327782|NCT02774616|12525056|FG001|NOT COMPLETED|Overall Study||11
11327783|NCT02774616|12525057|FG002|NOT COMPLETED|Overall Study||3
11327784|NCT02774681|12525067|FG000|STARTED|Treatment on Study||12
11327785|NCT02774681|12525067|FG000|Reached 1st Response/2 Cycles|Treatment on Study||10
11327786|NCT02774681|12525067|FG000|Went on to Start Cycle 3|Treatment on Study||5
11327787|NCT02774681|12525067|FG000|COMPLETED|Treatment on Study||5
11327788|NCT02774681|12525067|FG000|NOT COMPLETED|Treatment on Study||7
11327789|NCT02774681|12525067|FG000|STARTED|Follow-Up for 3 Years||12
11327790|NCT02774681|12525067|FG000|COMPLETED|Follow-Up for 3 Years||0
11327791|NCT02774681|12525067|FG000|NOT COMPLETED|Follow-Up for 3 Years||12
11327792|NCT02774798|12525074|FG000|STARTED|Overall Study||7
11327793|NCT02774798|12525075|FG001|STARTED|Overall Study||17
11327794|NCT02774798|12525076|FG002|STARTED|Overall Study||7
11327795|NCT02774798|12525074|FG000|COMPLETED|Overall Study||7
11327796|NCT02774798|12525075|FG001|COMPLETED|Overall Study||17
11327797|NCT02774798|12525076|FG002|COMPLETED|Overall Study||7
11327798|NCT02774798|12525074|FG000|NOT COMPLETED|Overall Study||0
11327799|NCT02774798|12525075|FG001|NOT COMPLETED|Overall Study||0
11327800|NCT02774798|12525076|FG002|NOT COMPLETED|Overall Study||0
11327801|NCT02774850|12525086|FG000|STARTED|Overall Study||610
11327802|NCT02774850|12525086|FG000|Induction I|Overall Study||585
11327803|NCT02774850|12525086|FG000|Early Discharge Eligible at Induction I|Overall Study|24 of these patients were managed as outpatients. 252 were managed as inpatients.|276
11327804|NCT02774850|12525086|FG000|Induction II|Overall Study||564
11327805|NCT02774850|12525086|FG000|Early Discharge Eligible at Induction II|Overall Study|114 of these patients were managed as outpatients. 379 were managed as inpatients.|493
11327806|NCT02774850|12525086|FG000|Intensification I|Overall Study||476
11327807|NCT02774850|12525086|FG000|Early Discharge Eligible at Int I|Overall Study|104 of these patients were managed as outpatients. 270 were managed as inpatients.|374
11327808|NCT02774850|12525086|FG000|Intensification II|Overall Study||342
11327809|NCT02774850|12525086|FG000|Early Discharge Eligible at Int II|Overall Study|56 of these patients were managed as outpatients. 229 were managed as inpatients.|285
11327810|NCT02774850|12525086|FG000|Intensification III|Overall Study||48
11327811|NCT02774850|12525086|FG000|Early Discharge Eligible at Int III|Overall Study|7 of these patients were managed as outpatients. 37 were managed as inpatients.|44
11327812|NCT02774850|12525086|FG000|COMPLETED|Overall Study||575
11327813|NCT02774850|12525086|FG000|NOT COMPLETED|Overall Study||35
11327814|NCT02774941|12525094|FG000|STARTED|Overall Study||110
11327815|NCT02774941|12525095|FG001|STARTED|Overall Study||110
11327816|NCT02774941|12525094|FG000|Subjects Excluded|Overall Study||1
11327817|NCT02774941|12525095|FG001|Subjects Excluded|Overall Study||2
11327818|NCT02774941|12525094|FG000|COMPLETED|Overall Study||109
11327819|NCT02774941|12525095|FG001|COMPLETED|Overall Study||108
11327820|NCT02774941|12525094|FG000|NOT COMPLETED|Overall Study||1
11327821|NCT02774941|12525095|FG001|NOT COMPLETED|Overall Study||2
11327822|NCT02775240|12525101|FG000|STARTED|Overall Study||18
11327823|NCT02775240|12525101|FG000|Started Treatment A|Overall Study||18
11327824|NCT02775240|12525101|FG000|Started Treatment B|Overall Study||17
11327825|NCT02775240|12525101|FG000|COMPLETED|Overall Study||17
11327826|NCT02775240|12525101|FG000|NOT COMPLETED|Overall Study||1
11327827|NCT02775344|12525110|FG000|STARTED|Overall Study||40
11327828|NCT02775344|12525111|FG001|STARTED|Overall Study||40
11327829|NCT02775344|12525110|FG000|COMPLETED|Overall Study||37
11327830|NCT02775344|12525111|FG001|COMPLETED|Overall Study||38
11327831|NCT02775344|12525110|FG000|NOT COMPLETED|Overall Study||3
11327832|NCT02775344|12525111|FG001|NOT COMPLETED|Overall Study||2
11327833|NCT02775617|12525119|FG000|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653
11327834|NCT02775617|12525120|FG001|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638
11327835|NCT02775617|12525119|FG000|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605
11327836|NCT02775617|12525120|FG001|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478
11327837|NCT02775617|12525119|FG000|NOT COMPLETED|Overall Study||48
11327838|NCT02775617|12525120|FG001|NOT COMPLETED|Overall Study||160
11327839|NCT02775864|12525130|FG000|STARTED|Overall Study||26014
11327840|NCT02775864|12525131|FG001|STARTED|Overall Study||31117
11327841|NCT02775864|12525132|FG002|STARTED|Overall Study||11941
11327842|NCT02775864|12525133|FG003|STARTED|Overall Study||12849
11327843|NCT02775864|12525130|FG000|COMPLETED|Overall Study||22772
11327844|NCT02775864|12525131|FG001|COMPLETED|Overall Study||26218
11327845|NCT02775864|12525132|FG002|COMPLETED|Overall Study||10081
11327846|NCT02775864|12525133|FG003|COMPLETED|Overall Study||10765
11327847|NCT02775864|12525130|FG000|NOT COMPLETED|Overall Study||3242
11327848|NCT02775864|12525131|FG001|NOT COMPLETED|Overall Study||4899
11327849|NCT02775864|12525132|FG002|NOT COMPLETED|Overall Study||1860
11327850|NCT02775864|12525133|FG003|NOT COMPLETED|Overall Study||2084
11327851|NCT02775916|12525146|FG000|STARTED|Overall Study||20
11327852|NCT02775916|12525147|FG001|STARTED|Overall Study||10
11327853|NCT02775916|12525146|FG000|COMPLETED|Overall Study||17
11327854|NCT02775916|12525147|FG001|COMPLETED|Overall Study||10
11327855|NCT02775916|12525146|FG000|NOT COMPLETED|Overall Study||3
11327856|NCT02775916|12525147|FG001|NOT COMPLETED|Overall Study||0
11327857|NCT02776033|12525156|FG000|STARTED|Overall Study||18
11327858|NCT02776033|12525157|FG001|STARTED|Overall Study||23
11327859|NCT02776033|12525158|FG002|STARTED|Overall Study||24
11327860|NCT02776033|12525156|FG000|COMPLETED|Overall Study||14
11327861|NCT02776033|12525157|FG001|COMPLETED|Overall Study||21
11327862|NCT02776033|12525158|FG002|COMPLETED|Overall Study||22
11327863|NCT02776033|12525156|FG000|NOT COMPLETED|Overall Study||4
11327864|NCT02776033|12525157|FG001|NOT COMPLETED|Overall Study||2
11327865|NCT02776033|12525158|FG002|NOT COMPLETED|Overall Study||2
11327866|NCT02776553|12525174|FG000|STARTED|Overall Study|One subject was eliminated for repeated hospitalizations.|9
11327867|NCT02776553|12525175|FG001|STARTED|Overall Study|Two subjects were eliminated for repeated hospitalizations.|8
11327868|NCT02776553|12525174|FG000|COMPLETED|Overall Study||6
11327869|NCT02776553|12525175|FG001|COMPLETED|Overall Study||5
11327870|NCT02776553|12525174|FG000|NOT COMPLETED|Overall Study||3
11327871|NCT02776553|12525175|FG001|NOT COMPLETED|Overall Study||3
11327872|NCT02776644|12525183|FG000|STARTED|Overall Study||1223
11327873|NCT02776644|12525184|FG001|STARTED|Overall Study||126
11327874|NCT02776644|12525183|FG000|COMPLETED|Overall Study||1223
11327875|NCT02776644|12525184|FG001|COMPLETED|Overall Study||126
11327876|NCT02776644|12525183|FG000|NOT COMPLETED|Overall Study||0
11327877|NCT02776644|12525184|FG001|NOT COMPLETED|Overall Study||0
11327878|NCT02776670|12525192|FG000|STARTED|Overall Study||117
11327879|NCT02776670|12525193|FG001|STARTED|Overall Study||114
11327880|NCT02776670|12525192|FG000|Full Analysis Set (FAS)|Overall Study||117
11327881|NCT02776670|12525193|FG001|Full Analysis Set (FAS)|Overall Study||114
11327882|NCT02776670|12525192|FG000|Per Protocol Analysis Set (PPS)|Overall Study||115
11327883|NCT02776670|12525193|FG001|Per Protocol Analysis Set (PPS)|Overall Study||113
11327884|NCT02776670|12525192|FG000|Safety Analysis Set|Overall Study||117
11327885|NCT02776670|12525193|FG001|Safety Analysis Set|Overall Study||114
11327886|NCT02776670|12525192|FG000|COMPLETED|Overall Study||117
11327887|NCT02776670|12525193|FG001|COMPLETED|Overall Study||108
11327888|NCT02776670|12525192|FG000|NOT COMPLETED|Overall Study||0
11327889|NCT02776670|12525193|FG001|NOT COMPLETED|Overall Study||6
11327890|NCT02776683|12525199|FG000|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123
11327891|NCT02776683|12525200|FG001|STARTED|Pre-switch Period||0
11327892|NCT02776683|12525199|FG000|COMPLETED|Pre-switch Period|Entered into Switch Set|43
11327893|NCT02776683|12525200|FG001|COMPLETED|Pre-switch Period||0
11327894|NCT02776683|12525199|FG000|NOT COMPLETED|Pre-switch Period||80
11327895|NCT02776683|12525200|FG001|NOT COMPLETED|Pre-switch Period||0
11327896|NCT02776683|12525199|FG000|STARTED|Post-switch Period||0
11327897|NCT02776683|12525200|FG001|STARTED|Post-switch Period|Entered into Switch Set|43
11327898|NCT02776683|12525199|FG000|COMPLETED|Post-switch Period||0
11327899|NCT02776683|12525200|FG001|COMPLETED|Post-switch Period||0
11327900|NCT02776683|12525199|FG000|NOT COMPLETED|Post-switch Period||0
11327901|NCT02776683|12525200|FG001|NOT COMPLETED|Post-switch Period||43
11327902|NCT02776774|12525204|FG000|STARTED|Overall Study||91
11327903|NCT02776774|12525204|FG000|COMPLETED|Overall Study|Total after data cleaning|91
11327904|NCT02776774|12525204|FG000|NOT COMPLETED|Overall Study||0
11327905|NCT02776904|12525210|FG000|STARTED|Overall Study||281
11327906|NCT02776904|12525211|FG001|STARTED|Overall Study||46
11327907|NCT02776904|12525210|FG000|Gait Assessment|Overall Study||178
11327908|NCT02776904|12525211|FG001|Gait Assessment|Overall Study||32
11327909|NCT02776904|12525210|FG000|ImPACT|Overall Study||21
11327910|NCT02776904|12525211|FG001|ImPACT|Overall Study|ImPACT testing for the concussed subjects was completed for the clinical assessment (not research).|46
11327911|NCT02776904|12525210|FG000|COMPLETED|Overall Study||281
11327912|NCT02776904|12525211|FG001|COMPLETED|Overall Study||46
11327913|NCT02776904|12525210|FG000|NOT COMPLETED|Overall Study||0
11327914|NCT02776904|12525211|FG001|NOT COMPLETED|Overall Study||0
11327915|NCT02777021|12525226|FG000|STARTED|Overall Study||60
11327916|NCT02777021|12525227|FG001|STARTED|Overall Study||94
11327917|NCT02777021|12525226|FG000|COMPLETED|Overall Study||43
11327918|NCT02777021|12525227|FG001|COMPLETED|Overall Study||77
11327919|NCT02777021|12525226|FG000|NOT COMPLETED|Overall Study||17
11327920|NCT02777021|12525227|FG001|NOT COMPLETED|Overall Study||17
11327921|NCT02777086|12525235|FG000|STARTED|Overall Study||261
11327922|NCT02777086|12525236|FG001|STARTED|Overall Study||250
11327923|NCT02777086|12525235|FG000|COMPLETED|Overall Study||165
11327924|NCT02777086|12525236|FG001|COMPLETED|Overall Study||151
11327925|NCT02777086|12525235|FG000|NOT COMPLETED|Overall Study||96
11327926|NCT02777086|12525236|FG001|NOT COMPLETED|Overall Study||99
11327927|NCT02777125|12525244|FG000|STARTED|Overall Study||488
11327928|NCT02777125|12525245|FG001|STARTED|Overall Study||492
11327929|NCT02777125|12525244|FG000|COMPLETED|Overall Study||445
11327930|NCT02777125|12525245|FG001|COMPLETED|Overall Study||445
11327931|NCT02777125|12525244|FG000|NOT COMPLETED|Overall Study||43
11327932|NCT02777125|12525245|FG001|NOT COMPLETED|Overall Study||47
11327933|NCT02777242|12525252|FG000|STARTED|Overall Study||65
11327934|NCT02777242|12525252|FG000|COMPLETED|Overall Study||59
11327935|NCT02777242|12525252|FG000|NOT COMPLETED|Overall Study||6
11327936|NCT02777268|12525256|FG000|STARTED|Overall Study||16
11327937|NCT02777268|12525256|FG000|COMPLETED|Overall Study||16
11327938|NCT02777268|12525256|FG000|NOT COMPLETED|Overall Study||0
11327939|NCT02777333|12525280|FG000|STARTED|Overall Study||15
11327940|NCT02777333|12525281|FG001|STARTED|Overall Study||15
11327941|NCT02777333|12525280|FG000|COMPLETED|Overall Study||15
11327942|NCT02777333|12525281|FG001|COMPLETED|Overall Study||13
11327943|NCT02777333|12525280|FG000|NOT COMPLETED|Overall Study||0
11327944|NCT02777333|12525281|FG001|NOT COMPLETED|Overall Study||2
11343247|NCT02951780|12540552|FG000|STARTED|Period 2||3
11343248|NCT02951780|12540553|FG001|STARTED|Period 2||2
11343249|NCT02951780|12540554|FG002|STARTED|Period 2||3
11343250|NCT02951780|12540555|FG003|STARTED|Period 2||2
11343251|NCT02951780|12540556|FG004|STARTED|Period 2||2
11343252|NCT02951780|12540557|FG005|STARTED|Period 2||3
11343253|NCT02951780|12540558|FG006|STARTED|Period 2||2
11343254|NCT02951780|12540559|FG007|STARTED|Period 2||2
11343255|NCT02951780|12540560|FG008|STARTED|Period 2||2
11343256|NCT02951780|12540552|FG000|COMPLETED|Period 2||3
11343257|NCT02951780|12540553|FG001|COMPLETED|Period 2||2
11343258|NCT02951780|12540554|FG002|COMPLETED|Period 2||3
11343259|NCT02951780|12540555|FG003|COMPLETED|Period 2||2
11343260|NCT02951780|12540556|FG004|COMPLETED|Period 2||2
11343261|NCT02951780|12540557|FG005|COMPLETED|Period 2||3
11343262|NCT02951780|12540558|FG006|COMPLETED|Period 2||2
11343263|NCT02951780|12540559|FG007|COMPLETED|Period 2||1
11343264|NCT02951780|12540560|FG008|COMPLETED|Period 2||2
11343265|NCT02951780|12540552|FG000|NOT COMPLETED|Period 2||0
11343266|NCT02951780|12540553|FG001|NOT COMPLETED|Period 2||0
11343267|NCT02951780|12540554|FG002|NOT COMPLETED|Period 2||0
11343268|NCT02951780|12540555|FG003|NOT COMPLETED|Period 2||0
11343269|NCT02951780|12540556|FG004|NOT COMPLETED|Period 2||0
11343270|NCT02951780|12540557|FG005|NOT COMPLETED|Period 2||0
11343271|NCT02951780|12540558|FG006|NOT COMPLETED|Period 2||0
11343272|NCT02951780|12540559|FG007|NOT COMPLETED|Period 2||1
11343273|NCT02951780|12540560|FG008|NOT COMPLETED|Period 2||0
11343274|NCT02951780|12540552|FG000|STARTED|Period 3||3
11343275|NCT02951780|12540553|FG001|STARTED|Period 3||2
11343276|NCT02951780|12540554|FG002|STARTED|Period 3||3
11343277|NCT02951780|12540555|FG003|STARTED|Period 3||2
11343278|NCT02951780|12540556|FG004|STARTED|Period 3||2
11343279|NCT02951780|12540557|FG005|STARTED|Period 3||3
11343280|NCT02951780|12540558|FG006|STARTED|Period 3||2
11343281|NCT02951780|12540559|FG007|STARTED|Period 3||1
11343282|NCT02951780|12540560|FG008|STARTED|Period 3||2
11343283|NCT02951780|12540552|FG000|COMPLETED|Period 3||3
11343284|NCT02951780|12540553|FG001|COMPLETED|Period 3||2
11343285|NCT02951780|12540554|FG002|COMPLETED|Period 3||3
11343286|NCT02951780|12540555|FG003|COMPLETED|Period 3||2
11343287|NCT02951780|12540556|FG004|COMPLETED|Period 3||2
11343288|NCT02951780|12540557|FG005|COMPLETED|Period 3||3
11343289|NCT02951780|12540558|FG006|COMPLETED|Period 3||2
11343290|NCT02951780|12540559|FG007|COMPLETED|Period 3||1
11343291|NCT02951780|12540560|FG008|COMPLETED|Period 3||2
11343292|NCT02951780|12540552|FG000|NOT COMPLETED|Period 3||0
11343293|NCT02951780|12540553|FG001|NOT COMPLETED|Period 3||0
11343294|NCT02951780|12540554|FG002|NOT COMPLETED|Period 3||0
11343295|NCT02951780|12540555|FG003|NOT COMPLETED|Period 3||0
11343296|NCT02951780|12540556|FG004|NOT COMPLETED|Period 3||0
11327945|NCT05283499|12525289|FG000|STARTED|Overall Study||26
11327946|NCT05283499|12525290|FG001|STARTED|Overall Study||27
11327947|NCT05283499|12525289|FG000|COMPLETED|Overall Study||25
11327948|NCT05283499|12525290|FG001|COMPLETED|Overall Study||25
11327949|NCT05283499|12525289|FG000|NOT COMPLETED|Overall Study||1
11327950|NCT05283499|12525290|FG001|NOT COMPLETED|Overall Study||2
11327951|NCT04919317|12525298|FG000|STARTED|Hospitalization and Wound Follow-up||26
11327952|NCT04919317|12525299|FG001|STARTED|Hospitalization and Wound Follow-up||30
11327953|NCT04919317|12525298|FG000|COMPLETED|Hospitalization and Wound Follow-up||26
11327954|NCT04919317|12525299|FG001|COMPLETED|Hospitalization and Wound Follow-up|5 patients completed the study but should not have been enrolled as they met pre-study exclusion criteria (chronic pain due to fibromyalgia)|25
11327955|NCT04919317|12525298|FG000|NOT COMPLETED|Hospitalization and Wound Follow-up||0
11327956|NCT04919317|12525299|FG001|NOT COMPLETED|Hospitalization and Wound Follow-up||5
11327957|NCT04919317|12525298|FG000|STARTED|SF-36 Quality of Life Survey Completion||26
11327958|NCT04919317|12525299|FG001|STARTED|SF-36 Quality of Life Survey Completion||25
11327959|NCT04919317|12525298|FG000|COMPLETED|SF-36 Quality of Life Survey Completion||14
11327960|NCT04919317|12525299|FG001|COMPLETED|SF-36 Quality of Life Survey Completion||19
11327961|NCT04919317|12525298|FG000|NOT COMPLETED|SF-36 Quality of Life Survey Completion||12
11327962|NCT04919317|12525299|FG001|NOT COMPLETED|SF-36 Quality of Life Survey Completion||6
11343297|NCT02951780|12540557|FG005|NOT COMPLETED|Period 3||0
11343298|NCT02951780|12540558|FG006|NOT COMPLETED|Period 3||0
11343299|NCT02951780|12540559|FG007|NOT COMPLETED|Period 3||0
11343300|NCT02951780|12540560|FG008|NOT COMPLETED|Period 3||0
11343301|NCT02951819|12540582|FG000|STARTED|Overall Study||87
11343302|NCT02951819|12540583|FG001|STARTED|Overall Study||14
11343303|NCT02951819|12540582|FG000|Treated|Overall Study||86
11343304|NCT02951819|12540583|FG001|Treated|Overall Study||14
11343305|NCT02951819|12540582|FG000|COMPLETED|Overall Study||59
11343306|NCT02951819|12540583|FG001|COMPLETED|Overall Study||7
11343307|NCT02951819|12540582|FG000|NOT COMPLETED|Overall Study||28
11343308|NCT02951819|12540583|FG001|NOT COMPLETED|Overall Study||7
11343309|NCT02951884|12540592|FG000|STARTED|Overall Study||0
11343310|NCT02951884|12540593|FG001|STARTED|Overall Study||1
11343311|NCT02951884|12540594|FG002|STARTED|Overall Study||1
11343312|NCT02951884|12540592|FG000|COMPLETED|Overall Study||0
11343313|NCT02951884|12540593|FG001|COMPLETED|Overall Study||1
11343314|NCT02951884|12540594|FG002|COMPLETED|Overall Study||1
11343315|NCT02951884|12540592|FG000|NOT COMPLETED|Overall Study||0
11343316|NCT02951884|12540593|FG001|NOT COMPLETED|Overall Study||0
11343317|NCT02951884|12540594|FG002|NOT COMPLETED|Overall Study||0
11343318|NCT02951988|12540605|FG000|STARTED|Open-Label Treatment Period||1304
11343319|NCT02951988|12540606|FG001|STARTED|Open-Label Treatment Period||0
11343320|NCT02951988|12540607|FG002|STARTED|Open-Label Treatment Period||0
11343321|NCT02951988|12540608|FG003|STARTED|Open-Label Treatment Period||0
11343322|NCT02951988|12540605|FG000|COMPLETED|Open-Label Treatment Period||1056
11343323|NCT02951988|12540606|FG001|COMPLETED|Open-Label Treatment Period||0
11343324|NCT02951988|12540607|FG002|COMPLETED|Open-Label Treatment Period||0
11343325|NCT02951988|12540608|FG003|COMPLETED|Open-Label Treatment Period||0
11343326|NCT02951988|12540605|FG000|NOT COMPLETED|Open-Label Treatment Period||248
11343327|NCT02951988|12540606|FG001|NOT COMPLETED|Open-Label Treatment Period||0
11343328|NCT02951988|12540607|FG002|NOT COMPLETED|Open-Label Treatment Period||0
11343329|NCT02951988|12540608|FG003|NOT COMPLETED|Open-Label Treatment Period||0
11343330|NCT02951988|12540605|FG000|STARTED|Double-Blind Treatment Period||0
11343331|NCT02951988|12540606|FG001|STARTED|Double-Blind Treatment Period||202
11343332|NCT02951988|12540607|FG002|STARTED|Double-Blind Treatment Period||202
11343333|NCT02951988|12540608|FG003|STARTED|Double-Blind Treatment Period||200
11343334|NCT02951988|12540605|FG000|COMPLETED|Double-Blind Treatment Period||0
11343335|NCT02951988|12540606|FG001|COMPLETED|Double-Blind Treatment Period||101
11343336|NCT02951988|12540607|FG002|COMPLETED|Double-Blind Treatment Period||101
11343337|NCT02951988|12540608|FG003|COMPLETED|Double-Blind Treatment Period||85
11343338|NCT02951988|12540605|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
11343339|NCT02951988|12540606|FG001|NOT COMPLETED|Double-Blind Treatment Period||101
11343340|NCT02951988|12540607|FG002|NOT COMPLETED|Double-Blind Treatment Period||101
11343341|NCT02951988|12540608|FG003|NOT COMPLETED|Double-Blind Treatment Period||115
11343342|NCT02952001|12540620|FG000|STARTED|Overall Study||28
11343343|NCT02952001|12540621|FG001|STARTED|Overall Study||5
11343344|NCT02952001|12540620|FG000|COMPLETED|Overall Study||14
11343345|NCT02952001|12540621|FG001|COMPLETED|Overall Study||2
11343346|NCT02952001|12540620|FG000|NOT COMPLETED|Overall Study||14
11343347|NCT02952001|12540621|FG001|NOT COMPLETED|Overall Study||3
11343348|NCT02952261|12540630|FG000|STARTED|Overall Study||100
11343349|NCT02952261|12540631|FG001|STARTED|Overall Study||100
11343350|NCT02952261|12540630|FG000|COMPLETED|Overall Study||95
11343351|NCT02952261|12540631|FG001|COMPLETED|Overall Study||95
11327963|NCT04647110|12525307|FG000|STARTED|Overall Study||345
11327964|NCT04647110|12525308|FG001|STARTED|Overall Study||204
11327965|NCT04647110|12525307|FG000|COMPLETED|Overall Study||345
11327966|NCT04647110|12525308|FG001|COMPLETED|Overall Study||204
11327967|NCT04647110|12525307|FG000|NOT COMPLETED|Overall Study||0
11327968|NCT04647110|12525308|FG001|NOT COMPLETED|Overall Study||0
11327969|NCT04537949|12525387|FG000|STARTED|Overall Study||12
11327970|NCT04537949|12525388|FG001|STARTED|Overall Study||12
11327971|NCT04537949|12525389|FG002|STARTED|Overall Study||12
11327972|NCT04537949|12525390|FG003|STARTED|Overall Study||12
11327973|NCT04537949|12525391|FG004|STARTED|Overall Study||12
11327974|NCT04537949|12525392|FG005|STARTED|Overall Study||12
11327975|NCT04537949|12525393|FG006|STARTED|Overall Study||12
11327976|NCT04537949|12525394|FG007|STARTED|Overall Study||12
11327977|NCT04537949|12525387|FG000|COMPLETED|Overall Study||11
11327978|NCT04537949|12525388|FG001|COMPLETED|Overall Study||12
11327979|NCT04537949|12525389|FG002|COMPLETED|Overall Study||12
11327980|NCT04537949|12525390|FG003|COMPLETED|Overall Study||12
11327981|NCT04537949|12525391|FG004|COMPLETED|Overall Study||12
11327982|NCT04537949|12525392|FG005|COMPLETED|Overall Study||12
11327983|NCT04537949|12525393|FG006|COMPLETED|Overall Study||12
11327984|NCT04537949|12525394|FG007|COMPLETED|Overall Study||12
11327985|NCT04537949|12525387|FG000|NOT COMPLETED|Overall Study||1
11327986|NCT04537949|12525388|FG001|NOT COMPLETED|Overall Study||0
11327987|NCT04537949|12525389|FG002|NOT COMPLETED|Overall Study||0
11327988|NCT04537949|12525390|FG003|NOT COMPLETED|Overall Study||0
11327989|NCT04537949|12525391|FG004|NOT COMPLETED|Overall Study||0
11327990|NCT04537949|12525392|FG005|NOT COMPLETED|Overall Study||0
11327991|NCT04537949|12525393|FG006|NOT COMPLETED|Overall Study||0
11327992|NCT04537949|12525394|FG007|NOT COMPLETED|Overall Study||0
11327993|NCT04346628|12525414|FG000|STARTED|Overall Study||74
11327994|NCT04346628|12525415|FG001|STARTED|Overall Study||75
11327995|NCT04346628|12525414|FG000|Intention-to-treat (ITT) Analysis Set|Overall Study||74
11327996|NCT04346628|12525415|FG001|Intention-to-treat (ITT) Analysis Set|Overall Study||75
11327997|NCT04346628|12525414|FG000|Symptomatic Modified ITT (smITT) Analysis Set|Overall Study||70
11327998|NCT04346628|12525415|FG001|Symptomatic Modified ITT (smITT) Analysis Set|Overall Study||65
11327999|NCT04346628|12525414|FG000|Modified ITT (mITT) Analysis|Overall Study||57
11328000|NCT04346628|12525415|FG001|Modified ITT (mITT) Analysis|Overall Study||59
11328001|NCT04346628|12525414|FG000|COMPLETED|Overall Study||68
11328002|NCT04346628|12525415|FG001|COMPLETED|Overall Study||62
11328003|NCT04346628|12525414|FG000|NOT COMPLETED|Overall Study||6
11328004|NCT04346628|12525415|FG001|NOT COMPLETED|Overall Study||13
11343352|NCT02952261|12540630|FG000|NOT COMPLETED|Overall Study||5
11343353|NCT02952261|12540631|FG001|NOT COMPLETED|Overall Study||5
11343354|NCT02952313|12540637|FG000|STARTED|Primary Endpoint||113
11343355|NCT02952313|12540637|FG000|6 Months|Primary Endpoint||106
11343356|NCT02952313|12540637|FG000|COMPLETED|Primary Endpoint||106
11343357|NCT02952313|12540637|FG000|NOT COMPLETED|Primary Endpoint||7
11343358|NCT02952313|12540637|FG000|STARTED|Long-term Follow-up||107
11343359|NCT02952313|12540637|FG000|12-Month|Long-term Follow-up||93
11343360|NCT02952313|12540637|FG000|18-Month|Long-term Follow-up||79
11343361|NCT02952313|12540637|FG000|COMPLETED|Long-term Follow-up||75
11343362|NCT02952313|12540637|FG000|NOT COMPLETED|Long-term Follow-up||32
11343363|NCT02952586|12540644|FG000|STARTED|Lead-In Phase (7 Days)||350
11343364|NCT02952586|12540645|FG001|STARTED|Lead-In Phase (7 Days)||347
11343365|NCT02952586|12540644|FG000|Safety Analysis Set|Lead-In Phase (7 Days)||348
11343366|NCT02952586|12540645|FG001|Safety Analysis Set|Lead-In Phase (7 Days)||344
11343367|NCT02952586|12540644|FG000|COMPLETED|Lead-In Phase (7 Days)||345
11343368|NCT02952586|12540645|FG001|COMPLETED|Lead-In Phase (7 Days)||343
11343369|NCT02952586|12540644|FG000|NOT COMPLETED|Lead-In Phase (7 Days)||5
11343370|NCT02952586|12540645|FG001|NOT COMPLETED|Lead-In Phase (7 Days)||4
11343371|NCT02952586|12540644|FG000|STARTED|CRT for Avelumab or Placebo (63 Days)||345
11343372|NCT02952586|12540645|FG001|STARTED|CRT for Avelumab or Placebo (63 Days)|All participants who did not withdraw from study after Lead-In phase, entered into CRT phase.|340
11343373|NCT02952586|12540644|FG000|COMPLETED|CRT for Avelumab or Placebo (63 Days)||312
11343374|NCT02952586|12540645|FG001|COMPLETED|CRT for Avelumab or Placebo (63 Days)||313
11343375|NCT02952586|12540644|FG000|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||33
11343376|NCT02952586|12540645|FG001|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||27
11343377|NCT02952586|12540644|FG000|STARTED|CRT for Cisplatin (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
11343378|NCT02952586|12540645|FG001|STARTED|CRT for Cisplatin (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
11343379|NCT02952586|12540644|FG000|COMPLETED|CRT for Cisplatin (63 Days)||234
11343380|NCT02952586|12540645|FG001|COMPLETED|CRT for Cisplatin (63 Days)||236
11343381|NCT02952586|12540644|FG000|NOT COMPLETED|CRT for Cisplatin (63 Days)||111
11343382|NCT02952586|12540645|FG001|NOT COMPLETED|CRT for Cisplatin (63 Days)||104
11343994|NCT02958345|12541296|FG001|NOT COMPLETED|Overall Study||1
11328005|NCT04114604|12525421|FG000|STARTED|Overall Study||10
11328006|NCT04114604|12525421|FG000|COMPLETED|Overall Study||10
11328007|NCT04114604|12525421|FG000|NOT COMPLETED|Overall Study||0
11328008|NCT04112940|12525429|FG000|STARTED|Overall Study||12
11328009|NCT04112940|12525429|FG000|COMPLETED|Overall Study||12
11328010|NCT04112940|12525429|FG000|NOT COMPLETED|Overall Study||0
11328011|NCT04064684|12525442|FG000|STARTED|Overall Study||1
11328012|NCT04064684|12525443|FG001|STARTED|Overall Study||1
11328013|NCT04064684|12525442|FG000|COMPLETED|Overall Study||1
11328014|NCT04064684|12525443|FG001|COMPLETED|Overall Study||1
11328015|NCT04064684|12525442|FG000|NOT COMPLETED|Overall Study||0
11328016|NCT04064684|12525443|FG001|NOT COMPLETED|Overall Study||0
11328017|NCT04040933|12525449|FG000|STARTED|Overall Study||36
11328018|NCT04040933|12525449|FG000|Treated|Overall Study||36
11328019|NCT04040933|12525449|FG000|COMPLETED|Overall Study||33
11328020|NCT04040933|12525449|FG000|NOT COMPLETED|Overall Study||3
11328021|NCT03763175|12525463|FG000|STARTED|Overall Study||20
11328022|NCT03763175|12525464|FG001|STARTED|Overall Study||19
11328023|NCT03763175|12525465|FG002|STARTED|Overall Study||20
11328024|NCT03763175|12525463|FG000|COMPLETED|Overall Study||19
11328025|NCT03763175|12525464|FG001|COMPLETED|Overall Study||17
11328026|NCT03763175|12525465|FG002|COMPLETED|Overall Study||19
11328027|NCT03763175|12525463|FG000|NOT COMPLETED|Overall Study||1
11328028|NCT03763175|12525464|FG001|NOT COMPLETED|Overall Study||2
11328029|NCT03763175|12525465|FG002|NOT COMPLETED|Overall Study||1
11328030|NCT03686514|12525475|FG000|STARTED|Overall Study||20
11328031|NCT03686514|12525476|FG001|STARTED|Overall Study||19
11328032|NCT03686514|12525475|FG000|Started 2018-2019 Vaccine Year|Overall Study||10
11328033|NCT03686514|12525476|FG001|Started 2018-2019 Vaccine Year|Overall Study||10
11328034|NCT03686514|12525475|FG000|Completed 2018-2019 Vaccine Follow up|Overall Study||10
11328035|NCT03686514|12525476|FG001|Completed 2018-2019 Vaccine Follow up|Overall Study||10
11328036|NCT03686514|12525475|FG000|Started 2019-2020 Vaccine Year|Overall Study||10
11328037|NCT03686514|12525476|FG001|Started 2019-2020 Vaccine Year|Overall Study||10
11328038|NCT03686514|12525475|FG000|Completed 2019-2020 Vaccine Follow up|Overall Study||10
11328039|NCT03686514|12525476|FG001|Completed 2019-2020 Vaccine Follow up|Overall Study||10
11328040|NCT03686514|12525475|FG000|COMPLETED|Overall Study||20
11328041|NCT03686514|12525476|FG001|COMPLETED|Overall Study||19
11328042|NCT03686514|12525475|FG000|NOT COMPLETED|Overall Study||0
11328043|NCT03686514|12525476|FG001|NOT COMPLETED|Overall Study||0
11328044|NCT03576976|12525484|FG000|STARTED|Overall Study||27
11328045|NCT03576976|12525485|FG001|STARTED|Overall Study||28
11328046|NCT03576976|12525484|FG000|COMPLETED|Overall Study||18
11328047|NCT03576976|12525485|FG001|COMPLETED|Overall Study||17
11328048|NCT03576976|12525484|FG000|NOT COMPLETED|Overall Study||9
11328049|NCT03576976|12525485|FG001|NOT COMPLETED|Overall Study||11
11328050|NCT03439670|12525497|FG000|STARTED|Overall Study||30
11328051|NCT03439670|12525498|FG001|STARTED|Overall Study||30
11328052|NCT03439670|12525499|FG002|STARTED|Overall Study||15
11328053|NCT03439670|12525500|FG003|STARTED|Overall Study||16
11328054|NCT03439670|12525501|FG004|STARTED|Overall Study||15
11328055|NCT03439670|12525502|FG005|STARTED|Overall Study||15
11328056|NCT03439670|12525497|FG000|COMPLETED|Overall Study||28
11328057|NCT03439670|12525498|FG001|COMPLETED|Overall Study||26
11328058|NCT03439670|12525499|FG002|COMPLETED|Overall Study||15
11328059|NCT03439670|12525500|FG003|COMPLETED|Overall Study||15
11328060|NCT03439670|12525501|FG004|COMPLETED|Overall Study||14
11328061|NCT03439670|12525502|FG005|COMPLETED|Overall Study||14
11328062|NCT03439670|12525497|FG000|NOT COMPLETED|Overall Study||2
11328063|NCT03439670|12525498|FG001|NOT COMPLETED|Overall Study||4
11328064|NCT03439670|12525499|FG002|NOT COMPLETED|Overall Study||0
11328065|NCT03439670|12525500|FG003|NOT COMPLETED|Overall Study||1
11328066|NCT03439670|12525501|FG004|NOT COMPLETED|Overall Study||1
11328067|NCT03439670|12525502|FG005|NOT COMPLETED|Overall Study||1
11328068|NCT03428997|12525512|FG000|STARTED|Overall Study||24
11328069|NCT03428997|12525512|FG000|COMPLETED|Overall Study||16
11328070|NCT03428997|12525512|FG000|NOT COMPLETED|Overall Study||8
11328071|NCT03385564|12525522|FG000|STARTED|Overall Study||7
11328072|NCT03385564|12525523|FG001|STARTED|Overall Study||15
11328073|NCT03385564|12525524|FG002|STARTED|Overall Study||21
11328074|NCT03385564|12525525|FG003|STARTED|Overall Study||26
11328075|NCT03385564|12525522|FG000|Intent to Treat Set|Overall Study||7
11328076|NCT03385564|12525523|FG001|Intent to Treat Set|Overall Study||15
11328077|NCT03385564|12525524|FG002|Intent to Treat Set|Overall Study||21
11328078|NCT03385564|12525525|FG003|Intent to Treat Set|Overall Study||26
11328079|NCT03385564|12525522|FG000|COMPLETED|Overall Study||7
11328080|NCT03385564|12525523|FG001|COMPLETED|Overall Study||14
11328081|NCT03385564|12525524|FG002|COMPLETED|Overall Study||16
11328082|NCT03385564|12525525|FG003|COMPLETED|Overall Study||17
11328083|NCT03385564|12525522|FG000|NOT COMPLETED|Overall Study||0
11328084|NCT03385564|12525523|FG001|NOT COMPLETED|Overall Study||1
11328085|NCT03385564|12525524|FG002|NOT COMPLETED|Overall Study||5
11328086|NCT03385564|12525525|FG003|NOT COMPLETED|Overall Study||9
11328087|NCT03335163|12525535|FG000|STARTED|Overall Study||48
11328088|NCT03335163|12525535|FG000|Completed Visit 2|Overall Study||32
11328089|NCT03335163|12525535|FG000|Completed Visit 3|Overall Study||31
11328090|NCT03335163|12525535|FG000|COMPLETED|Overall Study||27
11328091|NCT03335163|12525535|FG000|NOT COMPLETED|Overall Study||21
11343383|NCT02952586|12540644|FG000|STARTED|CRT for IMRT (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
11343384|NCT02952586|12540645|FG001|STARTED|CRT for IMRT (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
11343385|NCT02952586|12540644|FG000|COMPLETED|CRT for IMRT (63 Days)||322
11343386|NCT02952586|12540645|FG001|COMPLETED|CRT for IMRT (63 Days)||320
11343387|NCT02952586|12540644|FG000|NOT COMPLETED|CRT for IMRT (63 Days)||23
11343388|NCT02952586|12540645|FG001|NOT COMPLETED|CRT for IMRT (63 Days)||20
11343389|NCT02952586|12540644|FG000|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|291
11343390|NCT02952586|12540645|FG001|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|304
11343391|NCT02952586|12540644|FG000|COMPLETED|Maintenance Phase (12 Months)||139
11343392|NCT02952586|12540645|FG001|COMPLETED|Maintenance Phase (12 Months)||177
11343393|NCT02952586|12540644|FG000|NOT COMPLETED|Maintenance Phase (12 Months)||152
11343394|NCT02952586|12540645|FG001|NOT COMPLETED|Maintenance Phase (12 Months)||127
11343395|NCT02952586|12540644|FG000|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|266
11343396|NCT02952586|12540645|FG001|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|284
11343397|NCT02952586|12540644|FG000|COMPLETED|Follow-Up Phase (90 Days)||208
11343398|NCT02952586|12540645|FG001|COMPLETED|Follow-Up Phase (90 Days)||216
11343399|NCT02952586|12540644|FG000|NOT COMPLETED|Follow-Up Phase (90 Days)||58
11343400|NCT02952586|12540645|FG001|NOT COMPLETED|Follow-Up Phase (90 Days)||68
11343401|NCT02952586|12540644|FG000|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|247
11343402|NCT02952586|12540645|FG001|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|237
11343403|NCT02952586|12540644|FG000|COMPLETED|LT Follow-up (up to 45 Months)||0
11343404|NCT02952586|12540645|FG001|COMPLETED|LT Follow-up (up to 45 Months)||0
11343405|NCT02952586|12540644|FG000|NOT COMPLETED|LT Follow-up (up to 45 Months)||247
11343406|NCT02952586|12540645|FG001|NOT COMPLETED|LT Follow-up (up to 45 Months)||237
11343407|NCT02952820|12540655|FG000|STARTED|Placebo-Controlled Treatment (6 Months)||325
11343408|NCT02952820|12540656|FG001|STARTED|Placebo-Controlled Treatment (6 Months)||323
11343409|NCT02952820|12540657|FG002|STARTED|Placebo-Controlled Treatment (6 Months)||323
11343410|NCT02952820|12540655|FG000|Treated|Placebo-Controlled Treatment (6 Months)||321
11343411|NCT02952820|12540656|FG001|Treated|Placebo-Controlled Treatment (6 Months)||319
11343412|NCT02952820|12540657|FG002|Treated|Placebo-Controlled Treatment (6 Months)||319
11343413|NCT02952820|12540655|FG000|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319
11343414|NCT02952820|12540656|FG001|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
11343415|NCT02952820|12540657|FG002|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
11343416|NCT02952820|12540655|FG000|COMPLETED|Placebo-Controlled Treatment (6 Months)||261
11343417|NCT02952820|12540656|FG001|COMPLETED|Placebo-Controlled Treatment (6 Months)||254
11343418|NCT02952820|12540657|FG002|COMPLETED|Placebo-Controlled Treatment (6 Months)||235
11343419|NCT02952820|12540655|FG000|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64
11343420|NCT02952820|12540656|FG001|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69
11343421|NCT02952820|12540657|FG002|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88
11343422|NCT02952820|12540655|FG000|STARTED|Active Treatment Period (6 Months)|Participants from Placebo were re-randomized to Lemborexant 5 mg and Lemborexant 10 mg.|0
11343423|NCT02952820|12540656|FG001|STARTED|Active Treatment Period (6 Months)||384
11343424|NCT02952820|12540657|FG002|STARTED|Active Treatment Period (6 Months)||352
11343425|NCT02952820|12540655|FG000|COMPLETED|Active Treatment Period (6 Months)||0
11343426|NCT02952820|12540656|FG001|COMPLETED|Active Treatment Period (6 Months)||346
11343427|NCT02952820|12540657|FG002|COMPLETED|Active Treatment Period (6 Months)||321
11343428|NCT02952820|12540655|FG000|NOT COMPLETED|Active Treatment Period (6 Months)||0
11343429|NCT02952820|12540656|FG001|NOT COMPLETED|Active Treatment Period (6 Months)||38
11343430|NCT02952820|12540657|FG002|NOT COMPLETED|Active Treatment Period (6 Months)||31
11343431|NCT02952872|12540684|FG000|STARTED|Overall Study||22
11343432|NCT02952872|12540685|FG001|STARTED|Overall Study||22
11343433|NCT02952872|12540686|FG002|STARTED|Overall Study||22
11343434|NCT02952872|12540687|FG003|STARTED|Overall Study||22
11343435|NCT02952872|12540688|FG004|STARTED|Overall Study||22
11343436|NCT02952872|12540689|FG005|STARTED|Overall Study||21
11343437|NCT02952872|12540690|FG006|STARTED|Overall Study||22
11343438|NCT02952872|12540691|FG007|STARTED|Overall Study||21
11343439|NCT02952872|12540692|FG008|STARTED|Overall Study||22
11343440|NCT02952872|12540693|FG009|STARTED|Overall Study||22
11343441|NCT02952872|12540694|FG010|STARTED|Overall Study||23
11343442|NCT02952872|12540695|FG011|STARTED|Overall Study||22
11343443|NCT02952872|12540696|FG012|STARTED|Overall Study||22
11343444|NCT02952872|12540697|FG013|STARTED|Overall Study||22
11343445|NCT02952872|12540698|FG014|STARTED|Overall Study||22
11343446|NCT02952872|12540699|FG015|STARTED|Overall Study||23
11343447|NCT02952872|12540684|FG000|COMPLETED|Overall Study||22
11343448|NCT02952872|12540685|FG001|COMPLETED|Overall Study||22
11343449|NCT02952872|12540686|FG002|COMPLETED|Overall Study||22
11343450|NCT02952872|12540687|FG003|COMPLETED|Overall Study||22
11343451|NCT02952872|12540688|FG004|COMPLETED|Overall Study||22
11328092|NCT03235544|12525543|FG000|STARTED|Overall Study||12
11328093|NCT03235544|12525544|FG001|STARTED|Overall Study||41
11328094|NCT03235544|12525545|FG002|STARTED|Overall Study||31
11328095|NCT03235544|12525546|FG003|STARTED|Overall Study||77
11328096|NCT03235544|12525543|FG000|COMPLETED|Overall Study||0
11328097|NCT03235544|12525544|FG001|COMPLETED|Overall Study||0
11328098|NCT03235544|12525545|FG002|COMPLETED|Overall Study||0
11328099|NCT03235544|12525546|FG003|COMPLETED|Overall Study||0
11328100|NCT03235544|12525543|FG000|NOT COMPLETED|Overall Study||12
11328101|NCT03235544|12525544|FG001|NOT COMPLETED|Overall Study||41
11328102|NCT03235544|12525545|FG002|NOT COMPLETED|Overall Study||31
11328103|NCT03235544|12525546|FG003|NOT COMPLETED|Overall Study||77
11328104|NCT03023046|12525557|FG000|STARTED|Overall Study||54
11328105|NCT03023046|12525557|FG000|COMPLETED|Overall Study||53
11328106|NCT03023046|12525557|FG000|NOT COMPLETED|Overall Study||1
11328107|NCT03004248|12525563|FG000|STARTED|Overall Study||2691
11328108|NCT03004248|12525563|FG000|Received a Single Treatment|Overall Study||1809
11328109|NCT03004248|12525563|FG000|Received Two Treatments|Overall Study||314
11328110|NCT03004248|12525563|FG000|Received Three Treatments|Overall Study||568
11328111|NCT03004248|12525563|FG000|COMPLETED|Overall Study||2314
11328112|NCT03004248|12525563|FG000|NOT COMPLETED|Overall Study||377
11328113|NCT02947646|12525571|FG000|STARTED|Overall Study||10
11328114|NCT02947646|12525572|FG001|STARTED|Overall Study||10
11328115|NCT02947646|12525571|FG000|COMPLETED|Overall Study||10
11328116|NCT02947646|12525572|FG001|COMPLETED|Overall Study||9
11328117|NCT02947646|12525571|FG000|NOT COMPLETED|Overall Study||0
11328118|NCT02947646|12525572|FG001|NOT COMPLETED|Overall Study||1
11328119|NCT02590640|12525580|FG000|STARTED|Overall Study||40
11328120|NCT02590640|12525580|FG000|COMPLETED|Overall Study||37
11328121|NCT02590640|12525580|FG000|NOT COMPLETED|Overall Study||3
11328122|NCT02522715|12525587|FG000|STARTED|Overall Study||3
11328123|NCT02522715|12525588|FG001|STARTED|Overall Study|+1 early withdrawal|33
11328124|NCT02522715|12525587|FG000|COMPLETED|Overall Study||3
11328125|NCT02522715|12525588|FG001|COMPLETED|Overall Study||33
11328126|NCT02522715|12525587|FG000|NOT COMPLETED|Overall Study||0
11328127|NCT02522715|12525588|FG001|NOT COMPLETED|Overall Study||0
11328128|NCT02421172|12525596|FG000|STARTED|Period 1||33
11328129|NCT02421172|12525597|FG001|STARTED|Period 1||33
11328130|NCT02421172|12525598|FG002|STARTED|Period 1||0
11328131|NCT02421172|12525599|FG003|STARTED|Period 1||0
11328132|NCT02421172|12525600|FG004|STARTED|Period 1||0
11328133|NCT02421172|12525596|FG000|PD Analysis Set Period 1|Period 1||31
11328134|NCT02421172|12525597|FG001|PD Analysis Set Period 1|Period 1||33
11328135|NCT02421172|12525598|FG002|PD Analysis Set Period 1|Period 1||0
11328136|NCT02421172|12525599|FG003|PD Analysis Set Period 1|Period 1||0
11328137|NCT02421172|12525600|FG004|PD Analysis Set Period 1|Period 1||0
11328138|NCT02421172|12525596|FG000|PK Analysis Set Period 1|Period 1||33
11328139|NCT02421172|12525597|FG001|PK Analysis Set Period 1|Period 1||0
11328140|NCT02421172|12525598|FG002|PK Analysis Set Period 1|Period 1||0
11328141|NCT02421172|12525599|FG003|PK Analysis Set Period 1|Period 1||0
11328142|NCT02421172|12525600|FG004|PK Analysis Set Period 1|Period 1||0
11328143|NCT02421172|12525596|FG000|COMPLETED|Period 1||29
11328144|NCT02421172|12525597|FG001|COMPLETED|Period 1||31
11328145|NCT02421172|12525598|FG002|COMPLETED|Period 1||0
11328146|NCT02421172|12525599|FG003|COMPLETED|Period 1||0
11328147|NCT02421172|12525600|FG004|COMPLETED|Period 1||0
11328148|NCT02421172|12525596|FG000|NOT COMPLETED|Period 1||4
11328149|NCT02421172|12525597|FG001|NOT COMPLETED|Period 1||2
11328150|NCT02421172|12525598|FG002|NOT COMPLETED|Period 1||0
11328151|NCT02421172|12525599|FG003|NOT COMPLETED|Period 1||0
11328152|NCT02421172|12525600|FG004|NOT COMPLETED|Period 1||0
11328153|NCT02421172|12525596|FG000|STARTED|Period 2||0
11328154|NCT02421172|12525597|FG001|STARTED|Period 2||0
11328155|NCT02421172|12525598|FG002|STARTED|Period 2||29
11328156|NCT02421172|12525599|FG003|STARTED|Period 2||16
11328157|NCT02421172|12525600|FG004|STARTED|Period 2||15
11328158|NCT02421172|12525596|FG000|COMPLETED|Period 2||0
11328159|NCT02421172|12525597|FG001|COMPLETED|Period 2||0
11328160|NCT02421172|12525598|FG002|COMPLETED|Period 2||22
11328161|NCT02421172|12525599|FG003|COMPLETED|Period 2||13
11328162|NCT02421172|12525600|FG004|COMPLETED|Period 2||14
11328163|NCT02421172|12525596|FG000|NOT COMPLETED|Period 2||0
11328164|NCT02421172|12525597|FG001|NOT COMPLETED|Period 2||0
11328165|NCT02421172|12525598|FG002|NOT COMPLETED|Period 2||7
11328166|NCT02421172|12525599|FG003|NOT COMPLETED|Period 2||3
11328167|NCT02421172|12525600|FG004|NOT COMPLETED|Period 2||1
11328168|NCT02241967|12525615|FG000|STARTED|Overall Study||30
11328169|NCT02241967|12525616|FG001|STARTED|Overall Study||30
11328170|NCT02241967|12525617|FG002|STARTED|Overall Study||30
11328171|NCT02241967|12525618|FG003|STARTED|Overall Study||29
11328172|NCT02241967|12525615|FG000|COMPLETED|Overall Study||30
11328173|NCT02241967|12525616|FG001|COMPLETED|Overall Study||30
11328174|NCT02241967|12525617|FG002|COMPLETED|Overall Study||30
11328175|NCT02241967|12525618|FG003|COMPLETED|Overall Study||29
11328176|NCT02241967|12525615|FG000|NOT COMPLETED|Overall Study||0
11328177|NCT02241967|12525616|FG001|NOT COMPLETED|Overall Study||0
11328178|NCT02241967|12525617|FG002|NOT COMPLETED|Overall Study||0
11328179|NCT02241967|12525618|FG003|NOT COMPLETED|Overall Study||0
11328180|NCT02012296|12525635|FG000|STARTED|Overall Study||33
11328181|NCT02012296|12525636|FG001|STARTED|Overall Study||33
11328182|NCT02012296|12525637|FG002|STARTED|Overall Study||22
11328183|NCT02012296|12525635|FG000|COMPLETED|Overall Study||33
11328184|NCT02012296|12525636|FG001|COMPLETED|Overall Study||32
11328185|NCT02012296|12525637|FG002|COMPLETED|Overall Study||0
11328186|NCT02012296|12525635|FG000|NOT COMPLETED|Overall Study||0
11328187|NCT02012296|12525636|FG001|NOT COMPLETED|Overall Study||1
11328188|NCT02012296|12525637|FG002|NOT COMPLETED|Overall Study||22
11328189|NCT01915498|12525667|FG000|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
11328190|NCT01915498|12525668|FG001|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
11328191|NCT01915498|12525669|FG002|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
11328192|NCT01915498|12525670|FG003|STARTED|Main Analysis (Sept 2013 - Sept 2017)||8
11328193|NCT01915498|12525671|FG004|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
11328194|NCT01915498|12525672|FG005|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
11328195|NCT01915498|12525673|FG006|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
11328196|NCT01915498|12525674|FG007|STARTED|Main Analysis (Sept 2013 - Sept 2017)||22
11328197|NCT01915498|12525675|FG008|STARTED|Main Analysis (Sept 2013 - Sept 2017)||6
11328198|NCT01915498|12525676|FG009|STARTED|Main Analysis (Sept 2013 - Sept 2017)||14
11328199|NCT01915498|12525677|FG010|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
11328200|NCT01915498|12525678|FG011|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
11328201|NCT01915498|12525679|FG012|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
11328202|NCT01915498|12525680|FG013|STARTED|Main Analysis (Sept 2013 - Sept 2017)||49
11328203|NCT01915498|12525681|FG014|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
11328204|NCT01915498|12525682|FG015|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
11328205|NCT01915498|12525683|FG016|STARTED|Main Analysis (Sept 2013 - Sept 2017)||27
11328206|NCT01915498|12525684|FG017|STARTED|Main Analysis (Sept 2013 - Sept 2017)||106
11328207|NCT01915498|12525685|FG018|STARTED|Main Analysis (Sept 2013 - Sept 2017)||0
11328208|NCT01915498|12525667|FG000|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
11328209|NCT01915498|12525668|FG001|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
11328210|NCT01915498|12525669|FG002|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
11328211|NCT01915498|12525670|FG003|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
11328212|NCT01915498|12525671|FG004|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
11328213|NCT01915498|12525672|FG005|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
11328214|NCT01915498|12525673|FG006|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
11328215|NCT01915498|12525674|FG007|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
11328216|NCT01915498|12525675|FG008|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
11328217|NCT01915498|12525676|FG009|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
11328218|NCT01915498|12525677|FG010|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
11328219|NCT01915498|12525678|FG011|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
11328220|NCT01915498|12525679|FG012|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
11328221|NCT01915498|12525680|FG013|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
11328222|NCT01915498|12525681|FG014|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
11328223|NCT01915498|12525682|FG015|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||2
11328224|NCT01915498|12525683|FG016|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
11328225|NCT01915498|12525684|FG017|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
11328226|NCT01915498|12525685|FG018|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
11328227|NCT01915498|12525667|FG000|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
11328228|NCT01915498|12525668|FG001|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
11328229|NCT01915498|12525669|FG002|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
11328230|NCT01915498|12525670|FG003|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||8
11328231|NCT01915498|12525671|FG004|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||5
11328232|NCT01915498|12525672|FG005|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
11328233|NCT01915498|12525673|FG006|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
11328234|NCT01915498|12525674|FG007|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||21
11328235|NCT01915498|12525675|FG008|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
11328236|NCT01915498|12525676|FG009|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||14
11328237|NCT01915498|12525677|FG010|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
11328238|NCT01915498|12525678|FG011|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||4
11328239|NCT01915498|12525679|FG012|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
11328240|NCT01915498|12525680|FG013|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||46
11328241|NCT01915498|12525681|FG014|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||25
11328242|NCT01915498|12525682|FG015|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||23
11328243|NCT01915498|12525683|FG016|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||24
11328244|NCT01915498|12525684|FG017|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||100
11328245|NCT01915498|12525685|FG018|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
11328246|NCT01915498|12525667|FG000|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328247|NCT01915498|12525668|FG001|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328248|NCT01915498|12525669|FG002|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328249|NCT01915498|12525670|FG003|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328250|NCT01915498|12525671|FG004|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328251|NCT01915498|12525672|FG005|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328252|NCT01915498|12525673|FG006|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328253|NCT01915498|12525674|FG007|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328254|NCT01915498|12525675|FG008|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328255|NCT01915498|12525676|FG009|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328256|NCT01915498|12525677|FG010|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328257|NCT01915498|12525678|FG011|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328258|NCT01915498|12525679|FG012|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328259|NCT01915498|12525680|FG013|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328260|NCT01915498|12525681|FG014|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328261|NCT01915498|12525682|FG015|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328262|NCT01915498|12525683|FG016|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328263|NCT01915498|12525684|FG017|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
11328264|NCT01915498|12525685|FG018|STARTED|Safety Follow-up (Sept 2017 to July 2019||16
11328265|NCT01915498|12525667|FG000|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328266|NCT01915498|12525668|FG001|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328267|NCT01915498|12525669|FG002|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328268|NCT01915498|12525670|FG003|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328269|NCT01915498|12525671|FG004|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328270|NCT01915498|12525672|FG005|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328271|NCT01915498|12525673|FG006|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328272|NCT01915498|12525674|FG007|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328273|NCT01915498|12525675|FG008|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328274|NCT01915498|12525676|FG009|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328275|NCT01915498|12525677|FG010|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328276|NCT01915498|12525678|FG011|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328277|NCT01915498|12525679|FG012|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328278|NCT01915498|12525680|FG013|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328279|NCT01915498|12525681|FG014|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328280|NCT01915498|12525682|FG015|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328281|NCT01915498|12525683|FG016|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328282|NCT01915498|12525684|FG017|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328283|NCT01915498|12525685|FG018|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||14
11328284|NCT01915498|12525667|FG000|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328285|NCT01915498|12525668|FG001|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328286|NCT01915498|12525669|FG002|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11027232|NCT00833092|12205953|FG001|COMPLETED|Overall Study||50
11027233|NCT00833092|12205952|FG000|NOT COMPLETED|Overall Study||4
11027234|NCT00833092|12205953|FG001|NOT COMPLETED|Overall Study||7
11027235|NCT00833105|12205959|FG000|STARTED|Overall Study||13
11027236|NCT00833105|12205959|FG000|COMPLETED|Overall Study||10
11027237|NCT00833105|12205959|FG000|NOT COMPLETED|Overall Study||3
11027238|NCT00833248|12205967|FG000|STARTED|Overall Study||181
11027239|NCT00833248|12205968|FG001|STARTED|Overall Study||65
11027240|NCT00833248|12205967|FG000|Full Analysis Set (FAS)|Overall Study||180
11328287|NCT01915498|12525670|FG003|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11027241|NCT00833248|12205968|FG001|Full Analysis Set (FAS)|Overall Study||64
11027242|NCT00833248|12205967|FG000|Per Protocol (PP) Analysis Set|Overall Study||164
11027243|NCT00833248|12205968|FG001|Per Protocol (PP) Analysis Set|Overall Study||57
11027244|NCT00833248|12205967|FG000|Safety Analysis Set|Overall Study||181
11027245|NCT00833248|12205968|FG001|Safety Analysis Set|Overall Study||64
11027246|NCT00833248|12205967|FG000|COMPLETED|Overall Study||177
11027247|NCT00833248|12205968|FG001|COMPLETED|Overall Study||62
11027248|NCT00833248|12205967|FG000|NOT COMPLETED|Overall Study||4
11027249|NCT00833248|12205968|FG001|NOT COMPLETED|Overall Study||3
11027250|NCT00833261|12205974|FG000|STARTED|Overall Study||37
11027251|NCT00833261|12205974|FG000|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33
11328288|NCT01915498|12525671|FG004|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328289|NCT01915498|12525672|FG005|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328290|NCT01915498|12525673|FG006|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328291|NCT01915498|12525674|FG007|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328292|NCT01915498|12525675|FG008|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328293|NCT01915498|12525676|FG009|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328294|NCT01915498|12525677|FG010|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328295|NCT01915498|12525678|FG011|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328296|NCT01915498|12525679|FG012|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328297|NCT01915498|12525680|FG013|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328298|NCT01915498|12525681|FG014|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328299|NCT01915498|12525682|FG015|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328300|NCT01915498|12525683|FG016|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328301|NCT01915498|12525684|FG017|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
11328302|NCT01915498|12525685|FG018|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||2
11027252|NCT00833261|12205974|FG000|NOT COMPLETED|Overall Study||4
11328303|NCT00033631|12525775|FG000|STARTED|Overall Study||769
11328304|NCT00033631|12525776|FG001|STARTED|Overall Study||763
11328305|NCT00033631|12525775|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
11328306|NCT00033631|12525776|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
11328307|NCT00033631|12525775|FG000|NOT COMPLETED|Overall Study||18
11328308|NCT00033631|12525776|FG001|NOT COMPLETED|Overall Study||15
11343452|NCT02952872|12540689|FG005|COMPLETED|Overall Study||21
11343453|NCT02952872|12540690|FG006|COMPLETED|Overall Study||22
11343454|NCT02952872|12540691|FG007|COMPLETED|Overall Study||21
11343455|NCT02952872|12540692|FG008|COMPLETED|Overall Study||22
11343456|NCT02952872|12540693|FG009|COMPLETED|Overall Study||22
11343457|NCT02952872|12540694|FG010|COMPLETED|Overall Study||23
11343458|NCT02952872|12540695|FG011|COMPLETED|Overall Study||22
11343459|NCT02952872|12540696|FG012|COMPLETED|Overall Study||22
11343460|NCT02952872|12540697|FG013|COMPLETED|Overall Study||22
11343461|NCT02952872|12540698|FG014|COMPLETED|Overall Study||22
11343462|NCT02952872|12540699|FG015|COMPLETED|Overall Study||23
11343463|NCT02952872|12540684|FG000|NOT COMPLETED|Overall Study||0
11343464|NCT02952872|12540685|FG001|NOT COMPLETED|Overall Study||0
11343465|NCT02952872|12540686|FG002|NOT COMPLETED|Overall Study||0
11343466|NCT02952872|12540687|FG003|NOT COMPLETED|Overall Study||0
11343467|NCT02952872|12540688|FG004|NOT COMPLETED|Overall Study||0
11343468|NCT02952872|12540689|FG005|NOT COMPLETED|Overall Study||0
11343469|NCT02952872|12540690|FG006|NOT COMPLETED|Overall Study||0
11343470|NCT02952872|12540691|FG007|NOT COMPLETED|Overall Study||0
11343471|NCT02952872|12540692|FG008|NOT COMPLETED|Overall Study||0
11343472|NCT02952872|12540693|FG009|NOT COMPLETED|Overall Study||0
11343473|NCT02952872|12540694|FG010|NOT COMPLETED|Overall Study||0
11343474|NCT02952872|12540695|FG011|NOT COMPLETED|Overall Study||0
11343475|NCT02952872|12540696|FG012|NOT COMPLETED|Overall Study||0
11343476|NCT02952872|12540697|FG013|NOT COMPLETED|Overall Study||0
11343477|NCT02952872|12540698|FG014|NOT COMPLETED|Overall Study||0
11343478|NCT02952872|12540699|FG015|NOT COMPLETED|Overall Study||0
11343479|NCT02952898|12540736|FG000|STARTED|Overall Study||220
11343480|NCT02952898|12540737|FG001|STARTED|Overall Study||221
11343481|NCT02952898|12540738|FG002|STARTED|Overall Study||224
11343482|NCT02952898|12540736|FG000|COMPLETED|Overall Study||198
11343483|NCT02952898|12540737|FG001|COMPLETED|Overall Study||202
11343484|NCT02952898|12540738|FG002|COMPLETED|Overall Study||209
11343485|NCT02952898|12540736|FG000|NOT COMPLETED|Overall Study||22
11343486|NCT02952898|12540737|FG001|NOT COMPLETED|Overall Study||19
11343487|NCT02952898|12540738|FG002|NOT COMPLETED|Overall Study||15
11343488|NCT02953262|12540750|FG000|STARTED|Overall Study||68
11343489|NCT02953262|12540751|FG001|STARTED|Overall Study||69
11343490|NCT02953262|12540752|FG002|STARTED|Overall Study||68
11343491|NCT02953262|12540753|FG003|STARTED|Overall Study||70
11343492|NCT02953262|12540750|FG000|COMPLETED|Overall Study||65
11343493|NCT02953262|12540751|FG001|COMPLETED|Overall Study||63
11343494|NCT02953262|12540752|FG002|COMPLETED|Overall Study||65
11343495|NCT02953262|12540753|FG003|COMPLETED|Overall Study||67
11343496|NCT02953262|12540750|FG000|NOT COMPLETED|Overall Study||3
11343497|NCT02953262|12540751|FG001|NOT COMPLETED|Overall Study||6
11343498|NCT02953262|12540752|FG002|NOT COMPLETED|Overall Study||3
11343499|NCT02953262|12540753|FG003|NOT COMPLETED|Overall Study||3
11343500|NCT02953314|12540769|FG000|STARTED|Overall Study||13
11343501|NCT02953314|12540770|FG001|STARTED|Overall Study||70
11343502|NCT02953314|12540769|FG000|COMPLETED|Overall Study||13
11343503|NCT02953314|12540770|FG001|COMPLETED|Overall Study||67
11343504|NCT02953314|12540769|FG000|NOT COMPLETED|Overall Study||0
11343505|NCT02953314|12540770|FG001|NOT COMPLETED|Overall Study||3
11343506|NCT02953418|12540776|FG000|STARTED|Overall Study||34
11343507|NCT02953418|12540776|FG000|COMPLETED|Overall Study||34
11343508|NCT02953418|12540776|FG000|NOT COMPLETED|Overall Study||0
11343509|NCT02953561|12540780|FG000|STARTED|Overall Study||19
11343510|NCT02953561|12540780|FG000|COMPLETED|Overall Study||19
11343511|NCT02953561|12540780|FG000|NOT COMPLETED|Overall Study||0
11343512|NCT02953639|12540787|FG000|STARTED|Overall Study||81
11343513|NCT02953639|12540788|FG001|STARTED|Overall Study||54
11343514|NCT02953639|12540789|FG002|STARTED|Overall Study||78
11343515|NCT02953639|12540787|FG000|COMPLETED|Overall Study||61
11343516|NCT02953639|12540788|FG001|COMPLETED|Overall Study||40
11343517|NCT02953639|12540789|FG002|COMPLETED|Overall Study||62
11343518|NCT02953639|12540787|FG000|NOT COMPLETED|Overall Study||20
11343519|NCT02953639|12540788|FG001|NOT COMPLETED|Overall Study||14
11343520|NCT02953639|12540789|FG002|NOT COMPLETED|Overall Study||16
11343521|NCT02953678|12540799|FG000|STARTED|Overall Study||71
11343522|NCT02953678|12540799|FG000|COMPLETED|Overall Study||0
11343523|NCT02953678|12540799|FG000|NOT COMPLETED|Overall Study||71
11343524|NCT02953782|12540812|FG000|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
11343525|NCT02953782|12540813|FG001|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||3
11343526|NCT02953782|12540814|FG002|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||9
11343527|NCT02953782|12540815|FG003|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||8
11343528|NCT02953782|12540816|FG004|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
11343529|NCT02953782|12540817|FG005|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
11343530|NCT02953782|12540818|FG006|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
11343531|NCT02953782|12540819|FG007|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
11328309|NCT04952701|12525783|FG000|STARTED|Control Lens||63
11328310|NCT04952701|12525783|FG000|COMPLETED|Control Lens||59
11328311|NCT04952701|12525783|FG000|NOT COMPLETED|Control Lens||4
11328312|NCT04952701|12525783|FG000|STARTED|Test Lens||59
11328313|NCT04952701|12525783|FG000|COMPLETED|Test Lens||58
11328314|NCT04952701|12525783|FG000|NOT COMPLETED|Test Lens||1
11343532|NCT02953782|12540812|FG000|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
11343533|NCT02953782|12540813|FG001|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
11343534|NCT02953782|12540814|FG002|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
11343535|NCT02953782|12540815|FG003|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
11343536|NCT02953782|12540816|FG004|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
11343537|NCT02953782|12540817|FG005|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
11343538|NCT02953782|12540818|FG006|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
11343539|NCT02953782|12540819|FG007|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
11343540|NCT02953782|12540812|FG000|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
11343541|NCT02953782|12540813|FG001|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||3
11343542|NCT02953782|12540814|FG002|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||9
11343543|NCT02953782|12540815|FG003|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||8
11343544|NCT02953782|12540816|FG004|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
11343545|NCT02953782|12540817|FG005|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
11343546|NCT02953782|12540818|FG006|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
11343547|NCT02953782|12540819|FG007|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
11343548|NCT02953782|12540812|FG000|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343549|NCT02953782|12540813|FG001|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343550|NCT02953782|12540814|FG002|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343551|NCT02953782|12540815|FG003|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343552|NCT02953782|12540816|FG004|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343553|NCT02953782|12540817|FG005|STARTED|Phase 2 (Maximum Duration: 11.1 Months)|11 participants were included in safety run-in to evaluate DLT. 9 out of 11 were evaluable for DLT.|16
11343554|NCT02953782|12540818|FG006|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
11343555|NCT02953782|12540819|FG007|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
11343556|NCT02953782|12540812|FG000|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343557|NCT02953782|12540813|FG001|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343558|NCT02953782|12540814|FG002|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343559|NCT02953782|12540815|FG003|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343560|NCT02953782|12540816|FG004|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343561|NCT02953782|12540817|FG005|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343562|NCT02953782|12540818|FG006|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343563|NCT02953782|12540819|FG007|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343564|NCT02953782|12540812|FG000|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343565|NCT02953782|12540813|FG001|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343566|NCT02953782|12540814|FG002|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343567|NCT02953782|12540815|FG003|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343568|NCT02953782|12540816|FG004|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
11343569|NCT02953782|12540817|FG005|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||16
11343570|NCT02953782|12540818|FG006|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
11343571|NCT02953782|12540819|FG007|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
11343572|NCT02953821|12540842|FG000|STARTED|Overall Study||86
11343573|NCT02953821|12540843|FG001|STARTED|Overall Study||86
11343574|NCT02953821|12540842|FG000|Safety Population|Overall Study||86
11343575|NCT02953821|12540843|FG001|Safety Population|Overall Study||86
11343576|NCT02953821|12540842|FG000|Modified Intent to Treat (mITT) Populati|Overall Study||85
11343577|NCT02953821|12540843|FG001|Modified Intent to Treat (mITT) Populati|Overall Study||84
11343578|NCT02953821|12540842|FG000|Per Protocol (PP) Population|Overall Study||72
11343579|NCT02953821|12540843|FG001|Per Protocol (PP) Population|Overall Study||75
11343580|NCT02953821|12540842|FG000|Completed Week 16 Visit|Overall Study||76
11343581|NCT02953821|12540843|FG001|Completed Week 16 Visit|Overall Study||77
11343582|NCT02953821|12540842|FG000|Completed Study Treatment (Week 24)|Overall Study||73
11343583|NCT02953821|12540843|FG001|Completed Study Treatment (Week 24)|Overall Study||76
11343584|NCT02953821|12540842|FG000|COMPLETED|Overall Study||71
11343585|NCT02953821|12540843|FG001|COMPLETED|Overall Study||73
11343586|NCT02953821|12540842|FG000|NOT COMPLETED|Overall Study||15
11343587|NCT02953821|12540843|FG001|NOT COMPLETED|Overall Study||13
11343588|NCT02953860|12540851|FG000|STARTED|Overall Study||32
11343589|NCT02953860|12540851|FG000|COMPLETED|Overall Study||32
11343590|NCT02953860|12540851|FG000|NOT COMPLETED|Overall Study||0
11343591|NCT02953873|12540855|FG000|STARTED|Overall Study||25
11343592|NCT02953873|12540855|FG000|COMPLETED|Overall Study||25
11328315|NCT04350606|12525789|FG000|STARTED|Overall Study||3
11328316|NCT04350606|12525789|FG000|Treated|Overall Study||3
11328317|NCT04350606|12525789|FG000|Follow-up|Overall Study||3
11328318|NCT04350606|12525789|FG000|COMPLETED|Overall Study||3
11328319|NCT04350606|12525789|FG000|NOT COMPLETED|Overall Study||0
11343593|NCT02953873|12540855|FG000|NOT COMPLETED|Overall Study||0
11343594|NCT02953886|12540859|FG000|STARTED|Overall Study||20
11343595|NCT02953886|12540859|FG000|COMPLETED|Overall Study||20
11343596|NCT02953886|12540859|FG000|NOT COMPLETED|Overall Study||0
11343597|NCT02953938|12540865|FG000|STARTED|Overall Study||29
11343598|NCT02953938|12540866|FG001|STARTED|Overall Study||30
11343599|NCT02953938|12540865|FG000|COMPLETED|Overall Study||28
11343600|NCT02953938|12540866|FG001|COMPLETED|Overall Study||28
11343601|NCT02953938|12540865|FG000|NOT COMPLETED|Overall Study||1
11343602|NCT02953938|12540866|FG001|NOT COMPLETED|Overall Study||2
11343603|NCT02954172|12540875|FG000|STARTED|Overall Study||226
11343604|NCT02954172|12540876|FG001|STARTED|Overall Study||224
11343605|NCT02954172|12540875|FG000|COMPLETED|Overall Study||220
11343606|NCT02954172|12540876|FG001|COMPLETED|Overall Study||221
11343607|NCT02954172|12540875|FG000|NOT COMPLETED|Overall Study||6
11343608|NCT02954172|12540876|FG001|NOT COMPLETED|Overall Study||3
11343609|NCT02954198|12540885|FG000|STARTED|Overall Study||20
11343610|NCT02954198|12540886|FG001|STARTED|Overall Study||20
11343611|NCT02954198|12540885|FG000|COMPLETED|Overall Study||20
11343612|NCT02954198|12540886|FG001|COMPLETED|Overall Study||20
11343613|NCT02954198|12540885|FG000|NOT COMPLETED|Overall Study||0
11343614|NCT02954198|12540886|FG001|NOT COMPLETED|Overall Study||0
11343615|NCT02954354|12540895|FG000|STARTED|Overall Study||612
11343616|NCT02954354|12540896|FG001|STARTED|Overall Study||310
11343617|NCT02954354|12540897|FG002|STARTED|Overall Study||514
11343618|NCT02954354|12540895|FG000|Received Study Drug|Overall Study||610
11343619|NCT02954354|12540896|FG001|Received Study Drug|Overall Study||309
11343620|NCT02954354|12540897|FG002|Received Study Drug|Overall Study||513
11343621|NCT02954354|12540895|FG000|Intention to Treat Infected Population|Overall Study||456
11343622|NCT02954354|12540896|FG001|Intention to Treat Infected Population|Overall Study||231
11343623|NCT02954354|12540897|FG002|Intention to Treat Infected Population|Overall Study||377
11343624|NCT02954354|12540895|FG000|COMPLETED|Overall Study||578
11027253|NCT00833365|12205980|FG000|STARTED|Overall Study||9
11027254|NCT00833365|12205981|FG001|STARTED|Overall Study||6
11027255|NCT00833365|12205980|FG000|COMPLETED|Overall Study||9
11027256|NCT00833365|12205981|FG001|COMPLETED|Overall Study||6
11027257|NCT00833365|12205980|FG000|NOT COMPLETED|Overall Study||0
11343625|NCT02954354|12540896|FG001|COMPLETED|Overall Study||290
11343626|NCT02954354|12540897|FG002|COMPLETED|Overall Study||498
11343627|NCT02954354|12540895|FG000|NOT COMPLETED|Overall Study||34
11343628|NCT02954354|12540896|FG001|NOT COMPLETED|Overall Study||20
11343629|NCT02954354|12540897|FG002|NOT COMPLETED|Overall Study||16
11343630|NCT02954458|12540911|FG000|STARTED|Overall Study||7
11343631|NCT02954458|12540912|FG001|STARTED|Overall Study||3
11343632|NCT02954458|12540913|FG002|STARTED|Overall Study||1
11343633|NCT02954458|12540914|FG003|STARTED|Overall Study||50
11343634|NCT02954458|12540911|FG000|COMPLETED|Overall Study||6
11343635|NCT02954458|12540912|FG001|COMPLETED|Overall Study||3
11343636|NCT02954458|12540913|FG002|COMPLETED|Overall Study||0
11343637|NCT02954458|12540914|FG003|COMPLETED|Overall Study||38
11343638|NCT02954458|12540911|FG000|NOT COMPLETED|Overall Study||1
11343639|NCT02954458|12540912|FG001|NOT COMPLETED|Overall Study||0
11343640|NCT02954458|12540913|FG002|NOT COMPLETED|Overall Study||1
11343641|NCT02954458|12540914|FG003|NOT COMPLETED|Overall Study||12
11343642|NCT02954575|12540928|FG000|STARTED|Overall Study||57
11343643|NCT02954575|12540928|FG000|Received Treatment|Overall Study||55
11343644|NCT02954575|12540928|FG000|SAF Population|Overall Study||55
11343645|NCT02954575|12540928|FG000|FAS Population|Overall Study||55
11343646|NCT02954575|12540928|FG000|PP Population|Overall Study||52
11343647|NCT02954575|12540928|FG000|PK Population|Overall Study||21
11343648|NCT02954575|12540928|FG000|SURG Population|Overall Study||1
11343649|NCT02954575|12540928|FG000|COMPLETED|Overall Study||54
11343650|NCT02954575|12540928|FG000|NOT COMPLETED|Overall Study||3
11343651|NCT02954601|12540940|FG000|STARTED|First Intervention (Five Days)||11
11343652|NCT02954601|12540941|FG001|STARTED|First Intervention (Five Days)||6
11343653|NCT02954601|12540942|FG002|STARTED|First Intervention (Five Days)||8
11343654|NCT02954601|12540943|FG003|STARTED|First Intervention (Five Days)||7
11343655|NCT02954601|12540940|FG000|COMPLETED|First Intervention (Five Days)||11
11343656|NCT02954601|12540941|FG001|COMPLETED|First Intervention (Five Days)||6
11343657|NCT02954601|12540942|FG002|COMPLETED|First Intervention (Five Days)||7
11343658|NCT02954601|12540943|FG003|COMPLETED|First Intervention (Five Days)||7
11343659|NCT02954601|12540940|FG000|NOT COMPLETED|First Intervention (Five Days)||0
11343660|NCT02954601|12540941|FG001|NOT COMPLETED|First Intervention (Five Days)||0
11343661|NCT02954601|12540942|FG002|NOT COMPLETED|First Intervention (Five Days)||1
11343662|NCT02954601|12540943|FG003|NOT COMPLETED|First Intervention (Five Days)||0
11343663|NCT02954601|12540940|FG000|STARTED|Second Intervention (Five Days)||11
11343664|NCT02954601|12540941|FG001|STARTED|Second Intervention (Five Days)||6
11343665|NCT02954601|12540942|FG002|STARTED|Second Intervention (Five Days)||8
11027258|NCT00833365|12205981|FG001|NOT COMPLETED|Overall Study||0
11343666|NCT02954601|12540943|FG003|STARTED|Second Intervention (Five Days)||6
11343667|NCT02954601|12540940|FG000|COMPLETED|Second Intervention (Five Days)||11
11343668|NCT02954601|12540941|FG001|COMPLETED|Second Intervention (Five Days)||6
11343669|NCT02954601|12540942|FG002|COMPLETED|Second Intervention (Five Days)||8
11343670|NCT02954601|12540943|FG003|COMPLETED|Second Intervention (Five Days)||6
11328320|NCT04074161|12525796|FG000|STARTED|Overall Study||126
11328321|NCT04074161|12525797|FG001|STARTED|Overall Study||127
11328322|NCT04074161|12525798|FG002|STARTED|Overall Study||85
11328323|NCT04074161|12525796|FG000|Full Analysis Set|Overall Study||126
11328324|NCT04074161|12525797|FG001|Full Analysis Set|Overall Study||127
11328325|NCT04074161|12525798|FG002|Full Analysis Set|Overall Study||85
11328326|NCT04074161|12525796|FG000|Safety Analysis Set|Overall Study||126
11328327|NCT04074161|12525797|FG001|Safety Analysis Set|Overall Study||127
11328328|NCT04074161|12525798|FG002|Safety Analysis Set|Overall Study||85
11328329|NCT04074161|12525796|FG000|COMPLETED|Overall Study||120
11328330|NCT04074161|12525797|FG001|COMPLETED|Overall Study||118
11328331|NCT04074161|12525798|FG002|COMPLETED|Overall Study||81
11328332|NCT04074161|12525796|FG000|NOT COMPLETED|Overall Study||6
11328333|NCT04074161|12525797|FG001|NOT COMPLETED|Overall Study||9
11328334|NCT04074161|12525798|FG002|NOT COMPLETED|Overall Study||4
11328335|NCT04033432|12525806|FG000|STARTED|Overall Study||14
11328336|NCT04033432|12525806|FG000|Registered for Study|Overall Study||14
11328337|NCT04033432|12525806|FG000|Started Cycle 1|Overall Study||14
11328338|NCT04033432|12525806|FG000|Started Cycle 2|Overall Study||13
11328339|NCT04033432|12525806|FG000|Started Cycle 3|Overall Study||10
11328340|NCT04033432|12525806|FG000|Started Cycle 4|Overall Study||7
11328341|NCT04033432|12525806|FG000|Started Cycle 5|Overall Study||1
11328342|NCT04033432|12525806|FG000|Started Cycle 6|Overall Study||1
11328343|NCT04033432|12525806|FG000|Started Cycle 7+|Overall Study||1
11328344|NCT04033432|12525806|FG000|COMPLETED|Overall Study||1
11328345|NCT04033432|12525806|FG000|NOT COMPLETED|Overall Study||13
11328346|NCT04030247|12525811|FG000|STARTED|Overall Study||50
11328347|NCT04030247|12525811|FG000|COMPLETED|Overall Study||33
11328348|NCT04030247|12525811|FG000|NOT COMPLETED|Overall Study||17
11328349|NCT03893565|12525820|FG000|STARTED|Double-blind Induction Phase (10 Weeks)||27
11328350|NCT03893565|12525821|FG001|STARTED|Double-blind Induction Phase (10 Weeks)||48
11328351|NCT03893565|12525822|FG002|STARTED|Double-blind Induction Phase (10 Weeks)||11
11328352|NCT03893565|12525823|FG003|STARTED|Double-blind Induction Phase (10 Weeks)||10
11328353|NCT03893565|12525824|FG004|STARTED|Double-blind Induction Phase (10 Weeks)||8
11328354|NCT03893565|12525825|FG005|STARTED|Double-blind Induction Phase (10 Weeks)||0
11328355|NCT03893565|12525826|FG006|STARTED|Double-blind Induction Phase (10 Weeks)||0
11328356|NCT03893565|12525827|FG007|STARTED|Double-blind Induction Phase (10 Weeks)||0
11328357|NCT03893565|12525828|FG008|STARTED|Double-blind Induction Phase (10 Weeks)||0
11328358|NCT03893565|12525820|FG000|COMPLETED|Double-blind Induction Phase (10 Weeks)||21
11328359|NCT03893565|12525821|FG001|COMPLETED|Double-blind Induction Phase (10 Weeks)||32
11328360|NCT03893565|12525822|FG002|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
11328361|NCT03893565|12525823|FG003|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
11328362|NCT03893565|12525824|FG004|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
11328363|NCT03893565|12525825|FG005|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
11328364|NCT03893565|12525826|FG006|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
11328365|NCT03893565|12525827|FG007|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
11328366|NCT03893565|12525828|FG008|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
11328367|NCT03893565|12525820|FG000|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||6
11328368|NCT03893565|12525821|FG001|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||16
11328369|NCT03893565|12525822|FG002|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||10
11328370|NCT03893565|12525823|FG003|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||9
11328371|NCT03893565|12525824|FG004|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||7
11328372|NCT03893565|12525825|FG005|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
11328373|NCT03893565|12525826|FG006|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
11328374|NCT03893565|12525827|FG007|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
11328375|NCT03893565|12525828|FG008|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
11328376|NCT03893565|12525820|FG000|STARTED|Double-blind Extended Treatment(20weeks)||0
11328377|NCT03893565|12525821|FG001|STARTED|Double-blind Extended Treatment(20weeks)||0
11328378|NCT03893565|12525822|FG002|STARTED|Double-blind Extended Treatment(20weeks)||0
11328379|NCT03893565|12525823|FG003|STARTED|Double-blind Extended Treatment(20weeks)||0
11328380|NCT03893565|12525824|FG004|STARTED|Double-blind Extended Treatment(20weeks)||0
11328381|NCT03893565|12525825|FG005|STARTED|Double-blind Extended Treatment(20weeks)||5
11328382|NCT03893565|12525826|FG006|STARTED|Double-blind Extended Treatment(20weeks)||8
11328383|NCT03893565|12525827|FG007|STARTED|Double-blind Extended Treatment(20weeks)||0
11328384|NCT03893565|12525828|FG008|STARTED|Double-blind Extended Treatment(20weeks)||0
11328385|NCT03893565|12525820|FG000|COMPLETED|Double-blind Extended Treatment(20weeks)||0
11328386|NCT03893565|12525821|FG001|COMPLETED|Double-blind Extended Treatment(20weeks)||0
11328387|NCT03893565|12525822|FG002|COMPLETED|Double-blind Extended Treatment(20weeks)||0
11328388|NCT03893565|12525823|FG003|COMPLETED|Double-blind Extended Treatment(20weeks)||0
11328389|NCT03893565|12525824|FG004|COMPLETED|Double-blind Extended Treatment(20weeks)||0
11328390|NCT03893565|12525825|FG005|COMPLETED|Double-blind Extended Treatment(20weeks)||2
11328391|NCT03893565|12525826|FG006|COMPLETED|Double-blind Extended Treatment(20weeks)||4
11328392|NCT03893565|12525827|FG007|COMPLETED|Double-blind Extended Treatment(20weeks)||0
11328393|NCT03893565|12525828|FG008|COMPLETED|Double-blind Extended Treatment(20weeks)||0
11328394|NCT03893565|12525820|FG000|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
11328395|NCT03893565|12525821|FG001|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
11328396|NCT03893565|12525822|FG002|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
11328397|NCT03893565|12525823|FG003|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
11328398|NCT03893565|12525824|FG004|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
11328399|NCT03893565|12525825|FG005|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||3
11328400|NCT03893565|12525826|FG006|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||4
11328401|NCT03893565|12525827|FG007|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
11328402|NCT03893565|12525828|FG008|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
11328403|NCT03893565|12525820|FG000|STARTED|Open-label Induction Phase (10 Weeks)||0
11328404|NCT03893565|12525821|FG001|STARTED|Open-label Induction Phase (10 Weeks)||0
11328405|NCT03893565|12525822|FG002|STARTED|Open-label Induction Phase (10 Weeks)||0
11328406|NCT03893565|12525823|FG003|STARTED|Open-label Induction Phase (10 Weeks)||0
11328407|NCT03893565|12525824|FG004|STARTED|Open-label Induction Phase (10 Weeks)||0
11328408|NCT03893565|12525825|FG005|STARTED|Open-label Induction Phase (10 Weeks)||0
11328409|NCT03893565|12525826|FG006|STARTED|Open-label Induction Phase (10 Weeks)||0
11328410|NCT03893565|12525827|FG007|STARTED|Open-label Induction Phase (10 Weeks)||42
11328411|NCT03893565|12525828|FG008|STARTED|Open-label Induction Phase (10 Weeks)||0
11328412|NCT03893565|12525820|FG000|COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328413|NCT03893565|12525821|FG001|COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328414|NCT03893565|12525822|FG002|COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328415|NCT03893565|12525823|FG003|COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328416|NCT03893565|12525824|FG004|COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328417|NCT03893565|12525825|FG005|COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328418|NCT03893565|12525826|FG006|COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328419|NCT03893565|12525827|FG007|COMPLETED|Open-label Induction Phase (10 Weeks)||12
11328420|NCT03893565|12525828|FG008|COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328421|NCT03893565|12525820|FG000|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328422|NCT03893565|12525821|FG001|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328423|NCT03893565|12525822|FG002|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328424|NCT03893565|12525823|FG003|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328425|NCT03893565|12525824|FG004|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328426|NCT03893565|12525825|FG005|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328427|NCT03893565|12525826|FG006|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328428|NCT03893565|12525827|FG007|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||30
11328429|NCT03893565|12525828|FG008|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
11328430|NCT03893565|12525820|FG000|STARTED|Open-label Extended Treatment (20 Weeks)||0
11328431|NCT03893565|12525821|FG001|STARTED|Open-label Extended Treatment (20 Weeks)||0
11328432|NCT03893565|12525822|FG002|STARTED|Open-label Extended Treatment (20 Weeks)||0
11328433|NCT03893565|12525823|FG003|STARTED|Open-label Extended Treatment (20 Weeks)||0
11328434|NCT03893565|12525824|FG004|STARTED|Open-label Extended Treatment (20 Weeks)||0
11328435|NCT03893565|12525825|FG005|STARTED|Open-label Extended Treatment (20 Weeks)||0
11328436|NCT03893565|12525826|FG006|STARTED|Open-label Extended Treatment (20 Weeks)||0
11328437|NCT03893565|12525827|FG007|STARTED|Open-label Extended Treatment (20 Weeks)||0
11328438|NCT03893565|12525828|FG008|STARTED|Open-label Extended Treatment (20 Weeks)||7
11328439|NCT03893565|12525820|FG000|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328440|NCT03893565|12525821|FG001|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328441|NCT03893565|12525822|FG002|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328442|NCT03893565|12525823|FG003|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328443|NCT03893565|12525824|FG004|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328444|NCT03893565|12525825|FG005|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328445|NCT03893565|12525826|FG006|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328446|NCT03893565|12525827|FG007|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328447|NCT03893565|12525828|FG008|COMPLETED|Open-label Extended Treatment (20 Weeks)||3
11328448|NCT03893565|12525820|FG000|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328449|NCT03893565|12525821|FG001|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328450|NCT03893565|12525822|FG002|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328451|NCT03893565|12525823|FG003|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328452|NCT03893565|12525824|FG004|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328453|NCT03893565|12525825|FG005|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328454|NCT03893565|12525826|FG006|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328455|NCT03893565|12525827|FG007|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
11328456|NCT03893565|12525828|FG008|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||4
11328457|NCT03701516|12525847|FG000|STARTED|Period 1||131
11328458|NCT03701516|12525848|FG001|STARTED|Period 1||132
11328459|NCT03701516|12525847|FG000|COMPLETED|Period 1||127
11328460|NCT03701516|12525848|FG001|COMPLETED|Period 1||127
11328461|NCT03701516|12525847|FG000|NOT COMPLETED|Period 1||4
11027259|NCT00833417|12205989|FG000|STARTED|Overall Study||33
11027260|NCT00833417|12205990|FG001|STARTED|Overall Study||71
11027261|NCT00833417|12205989|FG000|COMPLETED|Overall Study||0
11027262|NCT00833417|12205990|FG001|COMPLETED|Overall Study||0
11027263|NCT00833417|12205989|FG000|NOT COMPLETED|Overall Study||33
11027264|NCT00833417|12205990|FG001|NOT COMPLETED|Overall Study||71
11027265|NCT00833443|12205999|FG000|STARTED|Overall Study||41
11027266|NCT00833443|12206000|FG001|STARTED|Overall Study||43
11027267|NCT00833443|12205999|FG000|COMPLETED|Overall Study||21
11027268|NCT00833443|12206000|FG001|COMPLETED|Overall Study||15
11027269|NCT00833443|12205999|FG000|NOT COMPLETED|Overall Study||20
11027270|NCT00833443|12206000|FG001|NOT COMPLETED|Overall Study||28
11027271|NCT00833469|12206008|FG000|STARTED|Overall Study||5
11027272|NCT00833469|12206008|FG000|COMPLETED|Overall Study||3
11027273|NCT00833469|12206008|FG000|NOT COMPLETED|Overall Study||2
11027274|NCT00833482|12206014|FG000|STARTED|Days 1-3|Participants who received treatment|24
11027275|NCT00833482|12206015|FG001|STARTED|Days 1-3|Participants who received treatment|0
11027276|NCT00833482|12206016|FG002|STARTED|Days 1-3||0
11027277|NCT00833482|12206017|FG003|STARTED|Days 1-3||8
11027278|NCT00833482|12206018|FG004|STARTED|Days 1-3||0
11027279|NCT00833482|12206019|FG005|STARTED|Days 1-3||0
11027280|NCT00833482|12206014|FG000|COMPLETED|Days 1-3||24
11027281|NCT00833482|12206015|FG001|COMPLETED|Days 1-3||0
11027282|NCT00833482|12206016|FG002|COMPLETED|Days 1-3||0
11027283|NCT00833482|12206017|FG003|COMPLETED|Days 1-3||8
11027284|NCT00833482|12206018|FG004|COMPLETED|Days 1-3||0
11328462|NCT03701516|12525848|FG001|NOT COMPLETED|Period 1||5
11328463|NCT03701516|12525847|FG000|STARTED|Period 2||127
11328464|NCT03701516|12525848|FG001|STARTED|Period 2||127
11328465|NCT03701516|12525847|FG000|COMPLETED|Period 2||126
11328466|NCT03701516|12525848|FG001|COMPLETED|Period 2||126
11328467|NCT03701516|12525847|FG000|NOT COMPLETED|Period 2||1
11328468|NCT03701516|12525848|FG001|NOT COMPLETED|Period 2||1
11328469|NCT03650556|12525854|FG000|STARTED|Overall Study||224
11328470|NCT03650556|12525854|FG000|Ablation Procedure|Overall Study||223
11328471|NCT03650556|12525854|FG000|Pre-Discharge|Overall Study||223
11328472|NCT03650556|12525854|FG000|7-day Follow-Up|Overall Study||223
11328473|NCT03650556|12525854|FG000|3-month Follow-Up|Overall Study||210
11328474|NCT03650556|12525854|FG000|6-month Follow-up|Overall Study||197
11328475|NCT03650556|12525854|FG000|12-month Follow-Up|Overall Study||189
11328476|NCT03650556|12525854|FG000|15-month Follow-Up|Overall Study||187
11328477|NCT03650556|12525854|FG000|COMPLETED|Overall Study||187
11328478|NCT03650556|12525854|FG000|NOT COMPLETED|Overall Study||37
11328479|NCT03628716|12525861|FG000|STARTED|Overall Study||19
11328480|NCT03628716|12525862|FG001|STARTED|Overall Study||24
11328481|NCT03628716|12525861|FG000|COMPLETED|Overall Study||0
11328482|NCT03628716|12525862|FG001|COMPLETED|Overall Study||1
11328483|NCT03628716|12525861|FG000|NOT COMPLETED|Overall Study||19
11328484|NCT03628716|12525862|FG001|NOT COMPLETED|Overall Study||23
11343671|NCT02954601|12540940|FG000|NOT COMPLETED|Second Intervention (Five Days)||0
11343672|NCT02954601|12540941|FG001|NOT COMPLETED|Second Intervention (Five Days)||0
11343673|NCT02954601|12540942|FG002|NOT COMPLETED|Second Intervention (Five Days)||0
11343674|NCT02954601|12540943|FG003|NOT COMPLETED|Second Intervention (Five Days)||0
11343675|NCT02954601|12540940|FG000|STARTED|Third Intervention (Five Days)||9
11343676|NCT02954601|12540941|FG001|STARTED|Third Intervention (Five Days)||8
11343677|NCT02954601|12540942|FG002|STARTED|Third Intervention (Five Days)||6
11343678|NCT02954601|12540943|FG003|STARTED|Third Intervention (Five Days)||8
11343679|NCT02954601|12540940|FG000|COMPLETED|Third Intervention (Five Days)||9
11343680|NCT02954601|12540941|FG001|COMPLETED|Third Intervention (Five Days)||8
11343681|NCT02954601|12540942|FG002|COMPLETED|Third Intervention (Five Days)||6
11343682|NCT02954601|12540943|FG003|COMPLETED|Third Intervention (Five Days)||8
11343683|NCT02954601|12540940|FG000|NOT COMPLETED|Third Intervention (Five Days)||0
11343684|NCT02954601|12540941|FG001|NOT COMPLETED|Third Intervention (Five Days)||0
11343685|NCT02954601|12540942|FG002|NOT COMPLETED|Third Intervention (Five Days)||0
11343686|NCT02954601|12540943|FG003|NOT COMPLETED|Third Intervention (Five Days)||0
11343687|NCT02954653|12540955|FG000|STARTED|Overall Study||4
11343688|NCT02954653|12540956|FG001|STARTED|Overall Study||4
11343689|NCT02954653|12540957|FG002|STARTED|Overall Study|No participants were enrolled in this arm.|0
11343690|NCT02954653|12540958|FG003|STARTED|Overall Study|No participants were enrolled in this arm.|0
11343691|NCT02954653|12540959|FG004|STARTED|Overall Study|No participants were enrolled in this arm.|0
11343692|NCT02954653|12540960|FG005|STARTED|Overall Study|No participants were enrolled in this arm.|0
11343693|NCT02954653|12540961|FG006|STARTED|Overall Study|No participants were enrolled in this arm.|0
11343694|NCT02954653|12540962|FG007|STARTED|Overall Study|No participants were enrolled in this arm.|0
11343695|NCT02954653|12540963|FG008|STARTED|Overall Study|No participants were enrolled in this arm.|0
11343696|NCT02954653|12540955|FG000|Received Treatment|Overall Study||3
11343697|NCT02954653|12540956|FG001|Received Treatment|Overall Study||4
11343698|NCT02954653|12540957|FG002|Received Treatment|Overall Study||0
11343699|NCT02954653|12540958|FG003|Received Treatment|Overall Study||0
11343700|NCT02954653|12540959|FG004|Received Treatment|Overall Study||0
11343701|NCT02954653|12540960|FG005|Received Treatment|Overall Study||0
11343702|NCT02954653|12540961|FG006|Received Treatment|Overall Study||0
11343703|NCT02954653|12540962|FG007|Received Treatment|Overall Study||0
11343704|NCT02954653|12540963|FG008|Received Treatment|Overall Study||0
11343705|NCT02954653|12540955|FG000|COMPLETED|Overall Study||0
11343706|NCT02954653|12540956|FG001|COMPLETED|Overall Study||1
11343707|NCT02954653|12540957|FG002|COMPLETED|Overall Study||0
11343708|NCT02954653|12540958|FG003|COMPLETED|Overall Study||0
11343709|NCT02954653|12540959|FG004|COMPLETED|Overall Study||0
11343710|NCT02954653|12540960|FG005|COMPLETED|Overall Study||0
11343711|NCT02954653|12540961|FG006|COMPLETED|Overall Study||0
11343712|NCT02954653|12540962|FG007|COMPLETED|Overall Study||0
11343713|NCT02954653|12540963|FG008|COMPLETED|Overall Study||0
11343714|NCT02954653|12540955|FG000|NOT COMPLETED|Overall Study||4
11343715|NCT02954653|12540956|FG001|NOT COMPLETED|Overall Study||3
11343716|NCT02954653|12540957|FG002|NOT COMPLETED|Overall Study||0
11343717|NCT02954653|12540958|FG003|NOT COMPLETED|Overall Study||0
11343718|NCT02954653|12540959|FG004|NOT COMPLETED|Overall Study||0
11343719|NCT02954653|12540960|FG005|NOT COMPLETED|Overall Study||0
11027285|NCT00833482|12206019|FG005|COMPLETED|Days 1-3||0
11328485|NCT03377699|12525872|FG000|STARTED|Overall Study||111
11328486|NCT03377699|12525873|FG001|STARTED|Overall Study||114
11328487|NCT03377699|12525872|FG000|Treated|Overall Study||110
11328488|NCT03377699|12525873|FG001|Treated|Overall Study||112
11328489|NCT03377699|12525872|FG000|SASpregnant|Overall Study||91
11328490|NCT03377699|12525873|FG001|SASpregnant|Overall Study||94
11328491|NCT03377699|12525872|FG000|FASpregnant|Overall Study||92
11328492|NCT03377699|12525873|FG001|FASpregnant|Overall Study||96
11328493|NCT03377699|12525872|FG000|COMPLETED|Overall Study||89
11328494|NCT03377699|12525873|FG001|COMPLETED|Overall Study||89
11328495|NCT03377699|12525872|FG000|NOT COMPLETED|Overall Study||22
11328496|NCT03377699|12525873|FG001|NOT COMPLETED|Overall Study||25
11328497|NCT03275350|12525883|FG000|STARTED|Overall Study||55
11328498|NCT03275350|12525884|FG001|STARTED|Overall Study||59
11328499|NCT03275350|12525883|FG000|COMPLETED|Overall Study||47
11328500|NCT03275350|12525884|FG001|COMPLETED|Overall Study||51
11328501|NCT03275350|12525883|FG000|NOT COMPLETED|Overall Study||8
11328502|NCT03275350|12525884|FG001|NOT COMPLETED|Overall Study||8
11328503|NCT03272347|12525895|FG000|STARTED|Overall Study||31
11328504|NCT03272347|12525896|FG001|STARTED|Overall Study||30
11328505|NCT03272347|12525897|FG002|STARTED|Overall Study||31
11328506|NCT03272347|12525898|FG003|STARTED|Overall Study||31
11328507|NCT03272347|12525895|FG000|Treated|Overall Study||29
11328508|NCT03272347|12525896|FG001|Treated|Overall Study||30
11328509|NCT03272347|12525897|FG002|Treated|Overall Study||31
11328510|NCT03272347|12525898|FG003|Treated|Overall Study||31
11328511|NCT03272347|12525895|FG000|COMPLETED|Overall Study||0
11328512|NCT03272347|12525896|FG001|COMPLETED|Overall Study||1
11328513|NCT03272347|12525897|FG002|COMPLETED|Overall Study||0
11328514|NCT03272347|12525898|FG003|COMPLETED|Overall Study||2
11328515|NCT03272347|12525895|FG000|NOT COMPLETED|Overall Study||31
11328516|NCT03272347|12525896|FG001|NOT COMPLETED|Overall Study||29
11328517|NCT03272347|12525897|FG002|NOT COMPLETED|Overall Study||31
11328518|NCT03272347|12525898|FG003|NOT COMPLETED|Overall Study||29
11328519|NCT03138369|12525910|FG000|STARTED|Overall Study||11
11328520|NCT03138369|12525911|FG001|STARTED|Overall Study||11
11328521|NCT03138369|12525910|FG000|COMPLETED|Overall Study||8
11328522|NCT03138369|12525911|FG001|COMPLETED|Overall Study||3
11328523|NCT03138369|12525910|FG000|NOT COMPLETED|Overall Study||3
11328524|NCT03138369|12525911|FG001|NOT COMPLETED|Overall Study||8
11328525|NCT02758184|12525920|FG000|STARTED|Overall Study||11
11328526|NCT02758184|12525921|FG001|STARTED|Overall Study||10
11328527|NCT02758184|12525920|FG000|COMPLETED|Overall Study||11
11328528|NCT02758184|12525921|FG001|COMPLETED|Overall Study||10
11328529|NCT02758184|12525920|FG000|NOT COMPLETED|Overall Study||0
11328530|NCT02758184|12525921|FG001|NOT COMPLETED|Overall Study||0
11328531|NCT02677870|12525927|FG000|STARTED|Diet Treatment (4 Weeks)||4
11328532|NCT02677870|12525928|FG001|STARTED|Diet Treatment (4 Weeks)||3
11328533|NCT02677870|12525927|FG000|COMPLETED|Diet Treatment (4 Weeks)||4
11328534|NCT02677870|12525928|FG001|COMPLETED|Diet Treatment (4 Weeks)||3
11328535|NCT02677870|12525927|FG000|NOT COMPLETED|Diet Treatment (4 Weeks)||0
11328536|NCT02677870|12525928|FG001|NOT COMPLETED|Diet Treatment (4 Weeks)||0
11328537|NCT02677870|12525927|FG000|STARTED|First Saproterin Dihydrochloride tx||4
11328538|NCT02677870|12525928|FG001|STARTED|First Saproterin Dihydrochloride tx||3
11328539|NCT02677870|12525927|FG000|COMPLETED|First Saproterin Dihydrochloride tx||4
11328540|NCT02677870|12525928|FG001|COMPLETED|First Saproterin Dihydrochloride tx||3
11328541|NCT02677870|12525927|FG000|NOT COMPLETED|First Saproterin Dihydrochloride tx||0
11328542|NCT02677870|12525928|FG001|NOT COMPLETED|First Saproterin Dihydrochloride tx||0
11328543|NCT02677870|12525927|FG000|STARTED|Washout (2 Weeks)||4
11328544|NCT02677870|12525928|FG001|STARTED|Washout (2 Weeks)||3
11328545|NCT02677870|12525927|FG000|COMPLETED|Washout (2 Weeks)||4
11328546|NCT02677870|12525928|FG001|COMPLETED|Washout (2 Weeks)||3
11328547|NCT02677870|12525927|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11328548|NCT02677870|12525928|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11328549|NCT02677870|12525927|FG000|STARTED|Second Saproterin Dihydrochloride tx||4
11328550|NCT02677870|12525928|FG001|STARTED|Second Saproterin Dihydrochloride tx||3
11328551|NCT02677870|12525927|FG000|COMPLETED|Second Saproterin Dihydrochloride tx||4
11328552|NCT02677870|12525928|FG001|COMPLETED|Second Saproterin Dihydrochloride tx||3
11328553|NCT02677870|12525927|FG000|NOT COMPLETED|Second Saproterin Dihydrochloride tx||0
11328554|NCT02677870|12525928|FG001|NOT COMPLETED|Second Saproterin Dihydrochloride tx||0
11328555|NCT02674750|12525939|FG000|STARTED|Overall Study||5
11328556|NCT02674750|12525940|FG001|STARTED|Overall Study||49
11328557|NCT02674750|12525941|FG002|STARTED|Overall Study||16
11328558|NCT02674750|12525939|FG000|COMPLETED|Overall Study||0
11328559|NCT02674750|12525940|FG001|COMPLETED|Overall Study||4
11328560|NCT02674750|12525941|FG002|COMPLETED|Overall Study||4
11328561|NCT02674750|12525939|FG000|NOT COMPLETED|Overall Study||5
11328562|NCT02674750|12525940|FG001|NOT COMPLETED|Overall Study||45
11328563|NCT02674750|12525941|FG002|NOT COMPLETED|Overall Study||12
11328564|NCT02440854|12525948|FG000|STARTED|Overall Study||80
11328565|NCT02440854|12525948|FG000|Analyzed|Overall Study||77
11328566|NCT02440854|12525948|FG000|COMPLETED|Overall Study||0
11328567|NCT02440854|12525948|FG000|NOT COMPLETED|Overall Study||80
11343720|NCT02954653|12540961|FG006|NOT COMPLETED|Overall Study||0
11343721|NCT02954653|12540962|FG007|NOT COMPLETED|Overall Study||0
11343722|NCT02954653|12540963|FG008|NOT COMPLETED|Overall Study||0
11328568|NCT02278185|12525954|FG000|STARTED|Overall Study||10
11328569|NCT02278185|12525955|FG001|STARTED|Overall Study||9
11328570|NCT02278185|12525954|FG000|COMPLETED|Overall Study||7
11328571|NCT02278185|12525955|FG001|COMPLETED|Overall Study||7
11328572|NCT02278185|12525954|FG000|NOT COMPLETED|Overall Study||3
11328573|NCT02278185|12525955|FG001|NOT COMPLETED|Overall Study||2
11328574|NCT02154529|12525967|FG000|STARTED|Overall Study||4
11328575|NCT02154529|12525968|FG001|STARTED|Overall Study||3
11328576|NCT02154529|12525969|FG002|STARTED|Overall Study||8
11328577|NCT02154529|12525970|FG003|STARTED|Overall Study||2
11328578|NCT02154529|12525967|FG000|COMPLETED|Overall Study|Study terminated by sponsor|0
11328579|NCT02154529|12525968|FG001|COMPLETED|Overall Study|Study terminated by sponsor|0
11328580|NCT02154529|12525969|FG002|COMPLETED|Overall Study|Study terminated by sponsor|0
11328581|NCT02154529|12525970|FG003|COMPLETED|Overall Study|Study terminated by sponsor|0
11328582|NCT02154529|12525967|FG000|NOT COMPLETED|Overall Study||4
11328583|NCT02154529|12525968|FG001|NOT COMPLETED|Overall Study||3
11328584|NCT02154529|12525969|FG002|NOT COMPLETED|Overall Study||8
11328585|NCT02154529|12525970|FG003|NOT COMPLETED|Overall Study||2
11328586|NCT00788125|12525982|FG000|STARTED|Overall Study||7
11328587|NCT00788125|12525982|FG000|COMPLETED|Overall Study||1
11328588|NCT00788125|12525982|FG000|NOT COMPLETED|Overall Study||6
11328589|NCT02777554|12525988|FG000|STARTED|Overall Study||62
11328590|NCT02777554|12525989|FG001|STARTED|Overall Study||62
11328591|NCT02777554|12525990|FG002|STARTED|Overall Study||5
11328592|NCT02777554|12525991|FG003|STARTED|Overall Study||5
11328593|NCT02777554|12525992|FG004|STARTED|Overall Study||5
11328594|NCT02777554|12525993|FG005|STARTED|Overall Study||5
11328595|NCT02777554|12525988|FG000|COMPLETED|Overall Study||32
11328596|NCT02777554|12525989|FG001|COMPLETED|Overall Study||37
11328597|NCT02777554|12525990|FG002|COMPLETED|Overall Study||4
11328598|NCT02777554|12525991|FG003|COMPLETED|Overall Study||4
11328599|NCT02777554|12525992|FG004|COMPLETED|Overall Study||5
11328600|NCT02777554|12525993|FG005|COMPLETED|Overall Study||5
11328601|NCT02777554|12525988|FG000|NOT COMPLETED|Overall Study||30
11328602|NCT02777554|12525989|FG001|NOT COMPLETED|Overall Study||25
11328603|NCT02777554|12525990|FG002|NOT COMPLETED|Overall Study||1
11328604|NCT02777554|12525991|FG003|NOT COMPLETED|Overall Study||1
11328605|NCT02777554|12525992|FG004|NOT COMPLETED|Overall Study||0
11328606|NCT02777554|12525993|FG005|NOT COMPLETED|Overall Study||0
11328607|NCT02777749|12526016|FG000|STARTED|Overall Study||53
11328608|NCT02777749|12526017|FG001|STARTED|Overall Study||51
11328609|NCT02777749|12526018|FG002|STARTED|Overall Study||51
11328610|NCT02777749|12526016|FG000|COMPLETED|Overall Study||53
11328611|NCT02777749|12526017|FG001|COMPLETED|Overall Study||51
11328612|NCT02777749|12526018|FG002|COMPLETED|Overall Study||51
11328613|NCT02777749|12526016|FG000|NOT COMPLETED|Overall Study||0
11328614|NCT02777749|12526017|FG001|NOT COMPLETED|Overall Study||0
11328615|NCT02777749|12526018|FG002|NOT COMPLETED|Overall Study||0
11328616|NCT02777827|12526030|FG000|STARTED|Treatment Period 1||5
11328617|NCT02777827|12526031|FG001|STARTED|Treatment Period 1||5
11328618|NCT02777827|12526032|FG002|STARTED|Treatment Period 1||5
11328619|NCT02777827|12526033|FG003|STARTED|Treatment Period 1||5
11328620|NCT02777827|12526034|FG004|STARTED|Treatment Period 1||4
11328621|NCT02777827|12526035|FG005|STARTED|Treatment Period 1||6
11328622|NCT02777827|12526030|FG000|COMPLETED|Treatment Period 1||5
11328623|NCT02777827|12526031|FG001|COMPLETED|Treatment Period 1||5
11328624|NCT02777827|12526032|FG002|COMPLETED|Treatment Period 1||5
11328625|NCT02777827|12526033|FG003|COMPLETED|Treatment Period 1||5
11328626|NCT02777827|12526034|FG004|COMPLETED|Treatment Period 1||4
11328627|NCT02777827|12526035|FG005|COMPLETED|Treatment Period 1||6
11328628|NCT02777827|12526030|FG000|NOT COMPLETED|Treatment Period 1||0
11328629|NCT02777827|12526031|FG001|NOT COMPLETED|Treatment Period 1||0
11328630|NCT02777827|12526032|FG002|NOT COMPLETED|Treatment Period 1||0
11328631|NCT02777827|12526033|FG003|NOT COMPLETED|Treatment Period 1||0
11328632|NCT02777827|12526034|FG004|NOT COMPLETED|Treatment Period 1||0
11328633|NCT02777827|12526035|FG005|NOT COMPLETED|Treatment Period 1||0
11328634|NCT02777827|12526030|FG000|STARTED|Washout Between Periods 1 and 2||5
11328635|NCT02777827|12526031|FG001|STARTED|Washout Between Periods 1 and 2||5
11328636|NCT02777827|12526032|FG002|STARTED|Washout Between Periods 1 and 2||5
11328637|NCT02777827|12526033|FG003|STARTED|Washout Between Periods 1 and 2||5
11328638|NCT02777827|12526034|FG004|STARTED|Washout Between Periods 1 and 2||4
11328639|NCT02777827|12526035|FG005|STARTED|Washout Between Periods 1 and 2||6
11328640|NCT02777827|12526030|FG000|COMPLETED|Washout Between Periods 1 and 2||5
11328641|NCT02777827|12526031|FG001|COMPLETED|Washout Between Periods 1 and 2||5
11328642|NCT02777827|12526032|FG002|COMPLETED|Washout Between Periods 1 and 2||5
11328643|NCT02777827|12526033|FG003|COMPLETED|Washout Between Periods 1 and 2||5
11328644|NCT02777827|12526034|FG004|COMPLETED|Washout Between Periods 1 and 2||4
11328645|NCT02777827|12526035|FG005|COMPLETED|Washout Between Periods 1 and 2||6
11328646|NCT02777827|12526030|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0
11328647|NCT02777827|12526031|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0
11328648|NCT02777827|12526032|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0
11328649|NCT02777827|12526033|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0
11328650|NCT02777827|12526034|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0
11328651|NCT02777827|12526035|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0
11328652|NCT02777827|12526030|FG000|STARTED|Treatment Period 2||5
11328653|NCT02777827|12526031|FG001|STARTED|Treatment Period 2||5
11328654|NCT02777827|12526032|FG002|STARTED|Treatment Period 2||5
11328655|NCT02777827|12526033|FG003|STARTED|Treatment Period 2||5
11328656|NCT02777827|12526034|FG004|STARTED|Treatment Period 2||4
11328657|NCT02777827|12526035|FG005|STARTED|Treatment Period 2||6
11328658|NCT02777827|12526030|FG000|COMPLETED|Treatment Period 2||5
11328659|NCT02777827|12526031|FG001|COMPLETED|Treatment Period 2||5
11328660|NCT02777827|12526032|FG002|COMPLETED|Treatment Period 2||5
11328661|NCT02777827|12526033|FG003|COMPLETED|Treatment Period 2||5
11328662|NCT02777827|12526034|FG004|COMPLETED|Treatment Period 2||4
11328663|NCT02777827|12526035|FG005|COMPLETED|Treatment Period 2||6
11328664|NCT02777827|12526030|FG000|NOT COMPLETED|Treatment Period 2||0
11328665|NCT02777827|12526031|FG001|NOT COMPLETED|Treatment Period 2||0
11328666|NCT02777827|12526032|FG002|NOT COMPLETED|Treatment Period 2||0
11328667|NCT02777827|12526033|FG003|NOT COMPLETED|Treatment Period 2||0
11328668|NCT02777827|12526034|FG004|NOT COMPLETED|Treatment Period 2||0
11328669|NCT02777827|12526035|FG005|NOT COMPLETED|Treatment Period 2||0
11328670|NCT02777827|12526030|FG000|STARTED|Washout Between Periods 2 and 3||5
11328671|NCT02777827|12526031|FG001|STARTED|Washout Between Periods 2 and 3||5
11328672|NCT02777827|12526032|FG002|STARTED|Washout Between Periods 2 and 3||5
11328673|NCT02777827|12526033|FG003|STARTED|Washout Between Periods 2 and 3||5
11328674|NCT02777827|12526034|FG004|STARTED|Washout Between Periods 2 and 3||4
11328675|NCT02777827|12526035|FG005|STARTED|Washout Between Periods 2 and 3||6
11328676|NCT02777827|12526030|FG000|COMPLETED|Washout Between Periods 2 and 3||5
11328677|NCT02777827|12526031|FG001|COMPLETED|Washout Between Periods 2 and 3||5
11328678|NCT02777827|12526032|FG002|COMPLETED|Washout Between Periods 2 and 3||5
11328679|NCT02777827|12526033|FG003|COMPLETED|Washout Between Periods 2 and 3||5
11328680|NCT02777827|12526034|FG004|COMPLETED|Washout Between Periods 2 and 3||4
11328681|NCT02777827|12526035|FG005|COMPLETED|Washout Between Periods 2 and 3||6
11328682|NCT02777827|12526030|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0
11328683|NCT02777827|12526031|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0
11328684|NCT02777827|12526032|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0
11328685|NCT02777827|12526033|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0
11328686|NCT02777827|12526034|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0
11328687|NCT02777827|12526035|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0
11328688|NCT02777827|12526030|FG000|STARTED|Treatment Period 3||5
11328689|NCT02777827|12526031|FG001|STARTED|Treatment Period 3||5
11328690|NCT02777827|12526032|FG002|STARTED|Treatment Period 3||5
11328691|NCT02777827|12526033|FG003|STARTED|Treatment Period 3||5
11328692|NCT02777827|12526034|FG004|STARTED|Treatment Period 3||4
11328693|NCT02777827|12526035|FG005|STARTED|Treatment Period 3||6
11328694|NCT02777827|12526030|FG000|COMPLETED|Treatment Period 3||5
11328695|NCT02777827|12526031|FG001|COMPLETED|Treatment Period 3||5
11328696|NCT02777827|12526032|FG002|COMPLETED|Treatment Period 3||5
11328697|NCT02777827|12526033|FG003|COMPLETED|Treatment Period 3||5
11328698|NCT02777827|12526034|FG004|COMPLETED|Treatment Period 3||4
11328699|NCT02777827|12526035|FG005|COMPLETED|Treatment Period 3||6
11328700|NCT02777827|12526030|FG000|NOT COMPLETED|Treatment Period 3||0
11328701|NCT02777827|12526031|FG001|NOT COMPLETED|Treatment Period 3||0
11328702|NCT02777827|12526032|FG002|NOT COMPLETED|Treatment Period 3||0
11328703|NCT02777827|12526033|FG003|NOT COMPLETED|Treatment Period 3||0
11328704|NCT02777827|12526034|FG004|NOT COMPLETED|Treatment Period 3||0
11328705|NCT02777827|12526035|FG005|NOT COMPLETED|Treatment Period 3||0
11328706|NCT02777827|12526030|FG000|STARTED|Washout Between Periods 3 and 4||5
11328707|NCT02777827|12526031|FG001|STARTED|Washout Between Periods 3 and 4||5
11328708|NCT02777827|12526032|FG002|STARTED|Washout Between Periods 3 and 4||5
11328709|NCT02777827|12526033|FG003|STARTED|Washout Between Periods 3 and 4||5
11328710|NCT02777827|12526034|FG004|STARTED|Washout Between Periods 3 and 4||4
11328711|NCT02777827|12526035|FG005|STARTED|Washout Between Periods 3 and 4||6
11328712|NCT02777827|12526030|FG000|COMPLETED|Washout Between Periods 3 and 4||5
11328713|NCT02777827|12526031|FG001|COMPLETED|Washout Between Periods 3 and 4||5
11328714|NCT02777827|12526032|FG002|COMPLETED|Washout Between Periods 3 and 4||4
11328715|NCT02777827|12526033|FG003|COMPLETED|Washout Between Periods 3 and 4||5
11328716|NCT02777827|12526034|FG004|COMPLETED|Washout Between Periods 3 and 4||4
11328717|NCT02777827|12526035|FG005|COMPLETED|Washout Between Periods 3 and 4||6
11328718|NCT02777827|12526030|FG000|NOT COMPLETED|Washout Between Periods 3 and 4||0
11328719|NCT02777827|12526031|FG001|NOT COMPLETED|Washout Between Periods 3 and 4||0
11328720|NCT02777827|12526032|FG002|NOT COMPLETED|Washout Between Periods 3 and 4||1
11328721|NCT02777827|12526033|FG003|NOT COMPLETED|Washout Between Periods 3 and 4||0
11328722|NCT02777827|12526034|FG004|NOT COMPLETED|Washout Between Periods 3 and 4||0
11328723|NCT02777827|12526035|FG005|NOT COMPLETED|Washout Between Periods 3 and 4||0
11328724|NCT02777827|12526030|FG000|STARTED|Treatment Period 4||5
11328725|NCT02777827|12526031|FG001|STARTED|Treatment Period 4||5
11328726|NCT02777827|12526032|FG002|STARTED|Treatment Period 4||4
11328727|NCT02777827|12526033|FG003|STARTED|Treatment Period 4||5
11328728|NCT02777827|12526034|FG004|STARTED|Treatment Period 4||4
11328729|NCT02777827|12526035|FG005|STARTED|Treatment Period 4||6
11328730|NCT02777827|12526030|FG000|COMPLETED|Treatment Period 4||5
11328731|NCT02777827|12526031|FG001|COMPLETED|Treatment Period 4||5
11328732|NCT02777827|12526032|FG002|COMPLETED|Treatment Period 4||4
11328733|NCT02777827|12526033|FG003|COMPLETED|Treatment Period 4||5
11328734|NCT02777827|12526034|FG004|COMPLETED|Treatment Period 4||4
11328735|NCT02777827|12526035|FG005|COMPLETED|Treatment Period 4||6
11328736|NCT02777827|12526030|FG000|NOT COMPLETED|Treatment Period 4||0
11328737|NCT02777827|12526031|FG001|NOT COMPLETED|Treatment Period 4||0
11328738|NCT02777827|12526032|FG002|NOT COMPLETED|Treatment Period 4||0
11328739|NCT02777827|12526033|FG003|NOT COMPLETED|Treatment Period 4||0
11328740|NCT02777827|12526034|FG004|NOT COMPLETED|Treatment Period 4||0
11328741|NCT02777827|12526035|FG005|NOT COMPLETED|Treatment Period 4||0
11328742|NCT02777827|12526030|FG000|STARTED|Washout Between Periods 4 and 5||5
11328743|NCT02777827|12526031|FG001|STARTED|Washout Between Periods 4 and 5||5
11328744|NCT02777827|12526032|FG002|STARTED|Washout Between Periods 4 and 5||4
11328745|NCT02777827|12526033|FG003|STARTED|Washout Between Periods 4 and 5||5
11328746|NCT02777827|12526034|FG004|STARTED|Washout Between Periods 4 and 5||4
11328747|NCT02777827|12526035|FG005|STARTED|Washout Between Periods 4 and 5||6
11328748|NCT02777827|12526030|FG000|COMPLETED|Washout Between Periods 4 and 5||5
11328749|NCT02777827|12526031|FG001|COMPLETED|Washout Between Periods 4 and 5||5
11328750|NCT02777827|12526032|FG002|COMPLETED|Washout Between Periods 4 and 5||4
11328751|NCT02777827|12526033|FG003|COMPLETED|Washout Between Periods 4 and 5||5
11328752|NCT02777827|12526034|FG004|COMPLETED|Washout Between Periods 4 and 5||4
11328753|NCT02777827|12526035|FG005|COMPLETED|Washout Between Periods 4 and 5||6
11328754|NCT02777827|12526030|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0
11328755|NCT02777827|12526031|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0
11328756|NCT02777827|12526032|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0
11328757|NCT02777827|12526033|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0
11328758|NCT02777827|12526034|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0
11328759|NCT02777827|12526035|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0
11328760|NCT02777827|12526030|FG000|STARTED|Treatment Period 5||5
11328761|NCT02777827|12526031|FG001|STARTED|Treatment Period 5||5
11328762|NCT02777827|12526032|FG002|STARTED|Treatment Period 5||4
11328763|NCT02777827|12526033|FG003|STARTED|Treatment Period 5||5
11328764|NCT02777827|12526034|FG004|STARTED|Treatment Period 5||4
11328765|NCT02777827|12526035|FG005|STARTED|Treatment Period 5||6
11328766|NCT02777827|12526030|FG000|COMPLETED|Treatment Period 5||5
11328767|NCT02777827|12526031|FG001|COMPLETED|Treatment Period 5||5
11328768|NCT02777827|12526032|FG002|COMPLETED|Treatment Period 5||4
11328769|NCT02777827|12526033|FG003|COMPLETED|Treatment Period 5||5
11328770|NCT02777827|12526034|FG004|COMPLETED|Treatment Period 5||4
11328771|NCT02777827|12526035|FG005|COMPLETED|Treatment Period 5||6
11328772|NCT02777827|12526030|FG000|NOT COMPLETED|Treatment Period 5||0
11328773|NCT02777827|12526031|FG001|NOT COMPLETED|Treatment Period 5||0
11328774|NCT02777827|12526032|FG002|NOT COMPLETED|Treatment Period 5||0
11328775|NCT02777827|12526033|FG003|NOT COMPLETED|Treatment Period 5||0
11328776|NCT02777827|12526034|FG004|NOT COMPLETED|Treatment Period 5||0
11328777|NCT02777827|12526035|FG005|NOT COMPLETED|Treatment Period 5||0
11328778|NCT02777827|12526030|FG000|STARTED|Washout Between Periods 5 and 6||5
11328779|NCT02777827|12526031|FG001|STARTED|Washout Between Periods 5 and 6||5
11328780|NCT02777827|12526032|FG002|STARTED|Washout Between Periods 5 and 6||4
11328781|NCT02777827|12526033|FG003|STARTED|Washout Between Periods 5 and 6||5
11328782|NCT02777827|12526034|FG004|STARTED|Washout Between Periods 5 and 6||4
11328783|NCT02777827|12526035|FG005|STARTED|Washout Between Periods 5 and 6||6
11328784|NCT02777827|12526030|FG000|COMPLETED|Washout Between Periods 5 and 6||5
11328785|NCT02777827|12526031|FG001|COMPLETED|Washout Between Periods 5 and 6||5
11328786|NCT02777827|12526032|FG002|COMPLETED|Washout Between Periods 5 and 6||4
11328787|NCT02777827|12526033|FG003|COMPLETED|Washout Between Periods 5 and 6||5
11328788|NCT02777827|12526034|FG004|COMPLETED|Washout Between Periods 5 and 6||4
11328789|NCT02777827|12526035|FG005|COMPLETED|Washout Between Periods 5 and 6||6
11328790|NCT02777827|12526030|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0
11328791|NCT02777827|12526031|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0
11328792|NCT02777827|12526032|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0
11328793|NCT02777827|12526033|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0
11328794|NCT02777827|12526034|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0
11328795|NCT02777827|12526035|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0
11328796|NCT02777827|12526030|FG000|STARTED|Treatment Period 6||5
11328797|NCT02777827|12526031|FG001|STARTED|Treatment Period 6||5
11328798|NCT02777827|12526032|FG002|STARTED|Treatment Period 6||4
11328799|NCT02777827|12526033|FG003|STARTED|Treatment Period 6||5
11328800|NCT02777827|12526034|FG004|STARTED|Treatment Period 6||4
11328801|NCT02777827|12526035|FG005|STARTED|Treatment Period 6||6
11328802|NCT02777827|12526030|FG000|COMPLETED|Treatment Period 6||5
11328803|NCT02777827|12526031|FG001|COMPLETED|Treatment Period 6||5
11328804|NCT02777827|12526032|FG002|COMPLETED|Treatment Period 6||4
11328805|NCT02777827|12526033|FG003|COMPLETED|Treatment Period 6||5
11328806|NCT02777827|12526034|FG004|COMPLETED|Treatment Period 6||4
11328807|NCT02777827|12526035|FG005|COMPLETED|Treatment Period 6||6
11328808|NCT02777827|12526030|FG000|NOT COMPLETED|Treatment Period 6||0
11328809|NCT02777827|12526031|FG001|NOT COMPLETED|Treatment Period 6||0
11328810|NCT02777827|12526032|FG002|NOT COMPLETED|Treatment Period 6||0
11328811|NCT02777827|12526033|FG003|NOT COMPLETED|Treatment Period 6||0
11328812|NCT02777827|12526034|FG004|NOT COMPLETED|Treatment Period 6||0
11328813|NCT02777827|12526035|FG005|NOT COMPLETED|Treatment Period 6||0
11328814|NCT02777918|12526051|FG000|STARTED|Overall Study||53
11328815|NCT02777918|12526052|FG001|STARTED|Overall Study||47
11328816|NCT02777918|12526051|FG000|COMPLETED|Overall Study||50
11328817|NCT02777918|12526052|FG001|COMPLETED|Overall Study||43
11328818|NCT02777918|12526051|FG000|NOT COMPLETED|Overall Study||3
11328819|NCT02777918|12526052|FG001|NOT COMPLETED|Overall Study||4
11328820|NCT02777931|12526060|FG000|STARTED|Overall Study||49
11328821|NCT02777931|12526061|FG001|STARTED|Overall Study||52
11328822|NCT02777931|12526060|FG000|Safety Population|Overall Study||47
11328823|NCT02777931|12526061|FG001|Safety Population|Overall Study||50
11328824|NCT02777931|12526060|FG000|Modified Intent to Treat Population|Overall Study||46
11328825|NCT02777931|12526061|FG001|Modified Intent to Treat Population|Overall Study||50
11328826|NCT02777931|12526060|FG000|COMPLETED|Overall Study||37
11328827|NCT02777931|12526061|FG001|COMPLETED|Overall Study||39
11328828|NCT02777931|12526060|FG000|NOT COMPLETED|Overall Study||12
11328829|NCT02777931|12526061|FG001|NOT COMPLETED|Overall Study||13
11328830|NCT02777944|12526069|FG000|STARTED|Overall Study||157
11328831|NCT02777944|12526070|FG001|STARTED|Overall Study||156
11328832|NCT02777944|12526069|FG000|COMPLETED|Overall Study||157
11328833|NCT02777944|12526070|FG001|COMPLETED|Overall Study||156
11328834|NCT02777944|12526069|FG000|NOT COMPLETED|Overall Study||0
11328835|NCT02777944|12526070|FG001|NOT COMPLETED|Overall Study||0
11328836|NCT02777970|12526079|FG000|STARTED|Overall Study||261
11328837|NCT02777970|12526080|FG001|STARTED|Overall Study||262
11328838|NCT02777970|12526081|FG002|STARTED|Overall Study||131
11328839|NCT02777970|12526079|FG000|COMPLETED|Overall Study||260
11328840|NCT02777970|12526080|FG001|COMPLETED|Overall Study||261
11328841|NCT02777970|12526081|FG002|COMPLETED|Overall Study||131
11328842|NCT02777970|12526079|FG000|NOT COMPLETED|Overall Study||1
11328843|NCT02777970|12526080|FG001|NOT COMPLETED|Overall Study||1
11328844|NCT02777970|12526081|FG002|NOT COMPLETED|Overall Study||0
11328845|NCT02778074|12526093|FG000|STARTED|Overall Study||72
11328846|NCT02778074|12526094|FG001|STARTED|Overall Study||72
11328847|NCT02778074|12526093|FG000|COMPLETED|Overall Study||65
11328848|NCT02778074|12526094|FG001|COMPLETED|Overall Study||62
11328849|NCT02778074|12526093|FG000|NOT COMPLETED|Overall Study||7
11328850|NCT02778074|12526094|FG001|NOT COMPLETED|Overall Study||10
11328851|NCT02778100|12526102|FG000|STARTED|Period 1 (Common Cold)||18
11328852|NCT02778100|12526103|FG001|STARTED|Period 1 (Common Cold)||18
11328853|NCT02778100|12526102|FG000|COMPLETED|Period 1 (Common Cold)||17
11328854|NCT02778100|12526103|FG001|COMPLETED|Period 1 (Common Cold)||18
11328855|NCT02778100|12526102|FG000|NOT COMPLETED|Period 1 (Common Cold)||1
11328856|NCT02778100|12526103|FG001|NOT COMPLETED|Period 1 (Common Cold)||0
11328857|NCT02778100|12526102|FG000|STARTED|Period 2 (No Cold Symptoms)||17
11328858|NCT02778100|12526103|FG001|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0
11328859|NCT02778100|12526102|FG000|COMPLETED|Period 2 (No Cold Symptoms)||17
11328860|NCT02778100|12526103|FG001|COMPLETED|Period 2 (No Cold Symptoms)||0
11328861|NCT02778100|12526102|FG000|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
11328862|NCT02778100|12526103|FG001|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
11328863|NCT02778113|12526111|FG000|STARTED|Study Period One||4
11328864|NCT02778113|12526112|FG001|STARTED|Study Period One||4
11328865|NCT02778113|12526113|FG002|STARTED|Study Period One||4
11328866|NCT02778113|12526114|FG003|STARTED|Study Period One||4
11328867|NCT02778113|12526111|FG000|Received Study Drug|Study Period One||4
11328868|NCT02778113|12526112|FG001|Received Study Drug|Study Period One||4
11328869|NCT02778113|12526113|FG002|Received Study Drug|Study Period One||4
11328870|NCT02778113|12526114|FG003|Received Study Drug|Study Period One||4
11328871|NCT02778113|12526111|FG000|COMPLETED|Study Period One||4
11328872|NCT02778113|12526112|FG001|COMPLETED|Study Period One||4
11328873|NCT02778113|12526113|FG002|COMPLETED|Study Period One||4
11328874|NCT02778113|12526114|FG003|COMPLETED|Study Period One||4
11328875|NCT02778113|12526111|FG000|NOT COMPLETED|Study Period One||0
11328876|NCT02778113|12526112|FG001|NOT COMPLETED|Study Period One||0
11328877|NCT02778113|12526113|FG002|NOT COMPLETED|Study Period One||0
11328878|NCT02778113|12526114|FG003|NOT COMPLETED|Study Period One||0
11328879|NCT02778113|12526111|FG000|STARTED|Study Period Two||4
11328880|NCT02778113|12526112|FG001|STARTED|Study Period Two||4
11328881|NCT02778113|12526113|FG002|STARTED|Study Period Two||4
11328882|NCT02778113|12526114|FG003|STARTED|Study Period Two||4
11328883|NCT02778113|12526111|FG000|Received Study Drug|Study Period Two||4
11328884|NCT02778113|12526112|FG001|Received Study Drug|Study Period Two||4
11328885|NCT02778113|12526113|FG002|Received Study Drug|Study Period Two||4
11328886|NCT02778113|12526114|FG003|Received Study Drug|Study Period Two||4
11328887|NCT02778113|12526111|FG000|COMPLETED|Study Period Two||4
11328888|NCT02778113|12526112|FG001|COMPLETED|Study Period Two||4
11328889|NCT02778113|12526113|FG002|COMPLETED|Study Period Two||4
11328890|NCT02778113|12526114|FG003|COMPLETED|Study Period Two||4
11328891|NCT02778113|12526111|FG000|NOT COMPLETED|Study Period Two||0
11328892|NCT02778113|12526112|FG001|NOT COMPLETED|Study Period Two||0
11328893|NCT02778113|12526113|FG002|NOT COMPLETED|Study Period Two||0
11328894|NCT02778113|12526114|FG003|NOT COMPLETED|Study Period Two||0
11328895|NCT02778113|12526111|FG000|STARTED|Study Period Three||4
11328896|NCT02778113|12526112|FG001|STARTED|Study Period Three||4
11328897|NCT02778113|12526113|FG002|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3
11328898|NCT02778113|12526114|FG003|STARTED|Study Period Three||4
11328899|NCT02778113|12526111|FG000|Received Study Drug|Study Period Three||4
11328900|NCT02778113|12526112|FG001|Received Study Drug|Study Period Three||4
11328901|NCT02778113|12526113|FG002|Received Study Drug|Study Period Three||3
11328902|NCT02778113|12526114|FG003|Received Study Drug|Study Period Three||4
11328903|NCT02778113|12526111|FG000|COMPLETED|Study Period Three||4
11328904|NCT02778113|12526112|FG001|COMPLETED|Study Period Three||4
11328905|NCT02778113|12526113|FG002|COMPLETED|Study Period Three||3
11328906|NCT02778113|12526114|FG003|COMPLETED|Study Period Three||4
11328907|NCT02778113|12526111|FG000|NOT COMPLETED|Study Period Three||0
11328908|NCT02778113|12526112|FG001|NOT COMPLETED|Study Period Three||0
11328909|NCT02778113|12526113|FG002|NOT COMPLETED|Study Period Three||0
11328910|NCT02778113|12526114|FG003|NOT COMPLETED|Study Period Three||0
11328911|NCT02778113|12526111|FG000|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3
11328912|NCT02778113|12526112|FG001|STARTED|Study Period Four||4
11328913|NCT02778113|12526113|FG002|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2
11328914|NCT02778113|12526114|FG003|STARTED|Study Period Four||4
11328915|NCT02778113|12526111|FG000|Received Study Drug|Study Period Four||3
11328916|NCT02778113|12526112|FG001|Received Study Drug|Study Period Four||4
11328917|NCT02778113|12526113|FG002|Received Study Drug|Study Period Four||2
11328918|NCT02778113|12526114|FG003|Received Study Drug|Study Period Four||4
11328919|NCT02778113|12526111|FG000|COMPLETED|Study Period Four||3
11328920|NCT02778113|12526112|FG001|COMPLETED|Study Period Four||4
11328921|NCT02778113|12526113|FG002|COMPLETED|Study Period Four||2
11328922|NCT02778113|12526114|FG003|COMPLETED|Study Period Four||4
11328923|NCT02778113|12526111|FG000|NOT COMPLETED|Study Period Four||0
11328924|NCT02778113|12526112|FG001|NOT COMPLETED|Study Period Four||0
11328925|NCT02778113|12526113|FG002|NOT COMPLETED|Study Period Four||0
11328926|NCT02778113|12526114|FG003|NOT COMPLETED|Study Period Four||0
11328927|NCT02778152|12526126|FG000|STARTED|Overall Study||13
11328928|NCT02778152|12526126|FG000|COMPLETED|Overall Study||13
11328929|NCT02778152|12526126|FG000|NOT COMPLETED|Overall Study||0
11328930|NCT02778555|12526133|FG000|STARTED|Overall Study||186
11328931|NCT02778555|12526134|FG001|STARTED|Overall Study||209
11328932|NCT02778555|12526135|FG002|STARTED|Overall Study||318
11328933|NCT02778555|12526133|FG000|COMPLETED|Overall Study||131
11328934|NCT02778555|12526134|FG001|COMPLETED|Overall Study||177
11328935|NCT02778555|12526135|FG002|COMPLETED|Overall Study||211
11328936|NCT02778555|12526133|FG000|NOT COMPLETED|Overall Study||55
11328937|NCT02778555|12526134|FG001|NOT COMPLETED|Overall Study||32
11328938|NCT02778555|12526135|FG002|NOT COMPLETED|Overall Study||107
11328939|NCT02778867|12526145|FG000|STARTED|Phase 1||67
11328940|NCT02778867|12526146|FG001|STARTED|Phase 1||62
11328941|NCT02778867|12526147|FG002|STARTED|Phase 1||0
11328942|NCT02778867|12526148|FG003|STARTED|Phase 1||0
11328943|NCT02778867|12526145|FG000|COMPLETED|Phase 1||65
11328944|NCT02778867|12526146|FG001|COMPLETED|Phase 1||59
11328945|NCT02778867|12526147|FG002|COMPLETED|Phase 1||0
11328946|NCT02778867|12526148|FG003|COMPLETED|Phase 1||0
11328947|NCT02778867|12526145|FG000|NOT COMPLETED|Phase 1||2
11328948|NCT02778867|12526146|FG001|NOT COMPLETED|Phase 1||3
11328949|NCT02778867|12526147|FG002|NOT COMPLETED|Phase 1||0
11328950|NCT02778867|12526148|FG003|NOT COMPLETED|Phase 1||0
11328951|NCT02778867|12526145|FG000|STARTED|Phase 2|1FED non-responders from Phase 1 have the option to undergo 6FED in Phase 2|0
11328952|NCT02778867|12526146|FG001|STARTED|Phase 2|6FED non-responders from Phase 1 have the option to undergo SGC in Phase 2|0
11328953|NCT02778867|12526147|FG002|STARTED|Phase 2|Optional phase for 1FED non-responders|21
11328954|NCT02778867|12526148|FG003|STARTED|Phase 2|Optional phase for 6FED non-responders|11
11328955|NCT02778867|12526145|FG000|COMPLETED|Phase 2||0
11328956|NCT02778867|12526146|FG001|COMPLETED|Phase 2||0
11328957|NCT02778867|12526147|FG002|COMPLETED|Phase 2||20
11328958|NCT02778867|12526148|FG003|COMPLETED|Phase 2||9
11328959|NCT02778867|12526145|FG000|NOT COMPLETED|Phase 2||0
11328960|NCT02778867|12526146|FG001|NOT COMPLETED|Phase 2||0
11328961|NCT02778867|12526147|FG002|NOT COMPLETED|Phase 2||1
11328962|NCT02778867|12526148|FG003|NOT COMPLETED|Phase 2||2
11328963|NCT02778880|12526160|FG000|STARTED|Overall Study||45
11328964|NCT02778880|12526161|FG001|STARTED|Overall Study||45
11328965|NCT02778880|12526160|FG000|COMPLETED|Overall Study||44
11328966|NCT02778880|12526161|FG001|COMPLETED|Overall Study||42
11328967|NCT02778880|12526160|FG000|NOT COMPLETED|Overall Study||1
11328968|NCT02778880|12526161|FG001|NOT COMPLETED|Overall Study||3
11328969|NCT02778932|12526169|FG000|STARTED|Overall Study||74
11328970|NCT02778932|12526170|FG001|STARTED|Overall Study||74
11328971|NCT02778932|12526169|FG000|COMPLETED|Overall Study||74
11328972|NCT02778932|12526170|FG001|COMPLETED|Overall Study||74
11328973|NCT02778932|12526169|FG000|NOT COMPLETED|Overall Study||0
11328974|NCT02778932|12526170|FG001|NOT COMPLETED|Overall Study||0
11328975|NCT02779075|12526178|FG000|STARTED|Overall Study||16
11328976|NCT02779075|12526179|FG001|STARTED|Overall Study||13
11328977|NCT02779075|12526178|FG000|COMPLETED|Overall Study||14
11328978|NCT02779075|12526179|FG001|COMPLETED|Overall Study||10
11328979|NCT02779075|12526178|FG000|NOT COMPLETED|Overall Study||2
11328980|NCT02779075|12526179|FG001|NOT COMPLETED|Overall Study||3
11328981|NCT02779166|12526187|FG000|STARTED|Overall Study||50
11328982|NCT02779166|12526188|FG001|STARTED|Overall Study||48
11328983|NCT02779166|12526187|FG000|COMPLETED|Overall Study||50
11328984|NCT02779166|12526188|FG001|COMPLETED|Overall Study||48
11328985|NCT02779166|12526187|FG000|NOT COMPLETED|Overall Study||0
11328986|NCT02779166|12526188|FG001|NOT COMPLETED|Overall Study||0
11328987|NCT02779491|12526198|FG000|STARTED|Overall Study||32
11328988|NCT02779491|12526199|FG001|STARTED|Overall Study||27
11328989|NCT02779491|12526200|FG002|STARTED|Overall Study||18
11328990|NCT02779491|12526201|FG003|STARTED|Overall Study||17
11328991|NCT02779491|12526198|FG000|COMPLETED|Overall Study||32
11328992|NCT02779491|12526199|FG001|COMPLETED|Overall Study||26
11328993|NCT02779491|12526200|FG002|COMPLETED|Overall Study||17
11328994|NCT02779491|12526201|FG003|COMPLETED|Overall Study||15
11328995|NCT02779491|12526198|FG000|NOT COMPLETED|Overall Study||0
11328996|NCT02779491|12526199|FG001|NOT COMPLETED|Overall Study||1
11328997|NCT02779491|12526200|FG002|NOT COMPLETED|Overall Study||1
11328998|NCT02779491|12526201|FG003|NOT COMPLETED|Overall Study||2
11328999|NCT02779543|12526213|FG000|STARTED|Overall Study||100
11329000|NCT02779543|12526214|FG001|STARTED|Overall Study||100
11329001|NCT02779543|12526213|FG000|COMPLETED|Overall Study||100
11329002|NCT02779543|12526214|FG001|COMPLETED|Overall Study||100
11329003|NCT02779543|12526213|FG000|NOT COMPLETED|Overall Study||0
11329004|NCT02779543|12526214|FG001|NOT COMPLETED|Overall Study||0
11329005|NCT02780115|12526226|FG000|STARTED|Overall Study||28
11329006|NCT02780115|12526227|FG001|STARTED|Overall Study||30
11329007|NCT02780115|12526228|FG002|STARTED|Overall Study||30
11329008|NCT02780115|12526229|FG003|STARTED|Overall Study||32
11329009|NCT02780115|12526230|FG004|STARTED|Overall Study||31
11329010|NCT02780115|12526226|FG000|COMPLETED|Overall Study||28
11329011|NCT02780115|12526227|FG001|COMPLETED|Overall Study||29
11329012|NCT02780115|12526228|FG002|COMPLETED|Overall Study||29
11329013|NCT02780115|12526229|FG003|COMPLETED|Overall Study||31
11329014|NCT02780115|12526230|FG004|COMPLETED|Overall Study||30
11329015|NCT02780115|12526226|FG000|NOT COMPLETED|Overall Study||0
11329016|NCT02780115|12526227|FG001|NOT COMPLETED|Overall Study||1
11329017|NCT02780115|12526228|FG002|NOT COMPLETED|Overall Study||1
11329018|NCT02780115|12526229|FG003|NOT COMPLETED|Overall Study||1
11329019|NCT02780115|12526230|FG004|NOT COMPLETED|Overall Study||1
11329020|NCT02780167|12526247|FG000|STARTED|Overall Study||56
11329021|NCT02780167|12526248|FG001|STARTED|Overall Study||49
11329022|NCT02780167|12526249|FG002|STARTED|Overall Study||51
11329023|NCT02780167|12526250|FG003|STARTED|Overall Study||56
11329024|NCT02780167|12526251|FG004|STARTED|Overall Study||55
11329025|NCT02780167|12526247|FG000|COMPLETED|Overall Study||28
11329026|NCT02780167|12526248|FG001|COMPLETED|Overall Study||27
11329027|NCT02780167|12526249|FG002|COMPLETED|Overall Study||27
11329028|NCT02780167|12526250|FG003|COMPLETED|Overall Study||37
11329029|NCT02780167|12526251|FG004|COMPLETED|Overall Study||38
11329030|NCT02780167|12526247|FG000|NOT COMPLETED|Overall Study||28
11329031|NCT02780167|12526248|FG001|NOT COMPLETED|Overall Study||22
11329032|NCT02780167|12526249|FG002|NOT COMPLETED|Overall Study||24
11329033|NCT02780167|12526250|FG003|NOT COMPLETED|Overall Study||19
11329034|NCT02780167|12526251|FG004|NOT COMPLETED|Overall Study||17
11329035|NCT02780349|12526263|FG000|STARTED|Overall Study||103
11329036|NCT02780349|12526263|FG000|COMPLETED|Overall Study||101
11329037|NCT02780349|12526263|FG000|NOT COMPLETED|Overall Study||2
11329038|NCT02780388|12526272|FG000|STARTED|Overall Study||15
11329039|NCT02780388|12526273|FG001|STARTED|Overall Study||8
11329040|NCT02780388|12526274|FG002|STARTED|Overall Study||10
11329041|NCT02780388|12526275|FG003|STARTED|Overall Study||12
11329042|NCT02780388|12526276|FG004|STARTED|Overall Study||12
11329043|NCT02780388|12526272|FG000|COMPLETED|Overall Study||14
11329044|NCT02780388|12526273|FG001|COMPLETED|Overall Study||6
11329045|NCT02780388|12526274|FG002|COMPLETED|Overall Study||10
11329046|NCT02780388|12526275|FG003|COMPLETED|Overall Study||12
11329047|NCT02780388|12526276|FG004|COMPLETED|Overall Study||12
11329048|NCT02780388|12526272|FG000|NOT COMPLETED|Overall Study||1
11329049|NCT02780388|12526273|FG001|NOT COMPLETED|Overall Study||2
11329050|NCT02780388|12526274|FG002|NOT COMPLETED|Overall Study||0
11329051|NCT02780388|12526275|FG003|NOT COMPLETED|Overall Study||0
11329052|NCT02780388|12526276|FG004|NOT COMPLETED|Overall Study||0
11329053|NCT02780622|12526292|FG000|STARTED|Treatment Period 1||10
11329054|NCT02780622|12526293|FG001|STARTED|Treatment Period 1||10
11329055|NCT02780622|12526292|FG000|COMPLETED|Treatment Period 1||10
11329056|NCT02780622|12526293|FG001|COMPLETED|Treatment Period 1||10
11329057|NCT02780622|12526292|FG000|NOT COMPLETED|Treatment Period 1||0
11329058|NCT02780622|12526293|FG001|NOT COMPLETED|Treatment Period 1||0
11329059|NCT02780622|12526292|FG000|STARTED|Treatment Period 2||10
11329060|NCT02780622|12526293|FG001|STARTED|Treatment Period 2||10
11329061|NCT02780622|12526292|FG000|COMPLETED|Treatment Period 2||10
11329062|NCT02780622|12526293|FG001|COMPLETED|Treatment Period 2||10
11329063|NCT02780622|12526292|FG000|NOT COMPLETED|Treatment Period 2||0
11329064|NCT02780622|12526293|FG001|NOT COMPLETED|Treatment Period 2||0
11329065|NCT02780661|12526300|FG000|STARTED|Period 1||10
11329066|NCT02780661|12526301|FG001|STARTED|Period 1||9
11329067|NCT02780661|12526300|FG000|COMPLETED|Period 1||10
11329068|NCT02780661|12526301|FG001|COMPLETED|Period 1||9
11329069|NCT02780661|12526300|FG000|NOT COMPLETED|Period 1||0
11329070|NCT02780661|12526301|FG001|NOT COMPLETED|Period 1||0
11329071|NCT02780661|12526300|FG000|STARTED|Wash Out Period||10
11329072|NCT02780661|12526301|FG001|STARTED|Wash Out Period||9
11329073|NCT02780661|12526300|FG000|COMPLETED|Wash Out Period||10
11329074|NCT02780661|12526301|FG001|COMPLETED|Wash Out Period||9
11329075|NCT02780661|12526300|FG000|NOT COMPLETED|Wash Out Period||0
11329076|NCT02780661|12526301|FG001|NOT COMPLETED|Wash Out Period||0
11329077|NCT02780661|12526300|FG000|STARTED|Period 2||10
11329078|NCT02780661|12526301|FG001|STARTED|Period 2||9
11329079|NCT02780661|12526300|FG000|COMPLETED|Period 2||10
11329080|NCT02780661|12526301|FG001|COMPLETED|Period 2||9
11329081|NCT02780661|12526300|FG000|NOT COMPLETED|Period 2||0
11329082|NCT02780661|12526301|FG001|NOT COMPLETED|Period 2||0
11329083|NCT02780687|12526310|FG000|STARTED|Overall Study||34
11329084|NCT02780687|12526311|FG001|STARTED|Overall Study||8
11329085|NCT02780687|12526310|FG000|COMPLETED|Overall Study||0
11329086|NCT02780687|12526311|FG001|COMPLETED|Overall Study||0
11329087|NCT02780687|12526310|FG000|NOT COMPLETED|Overall Study||34
11329088|NCT02780687|12526311|FG001|NOT COMPLETED|Overall Study||8
11329089|NCT02780700|12526316|FG000|STARTED|Overall Study||1
11329090|NCT02780700|12526316|FG000|COMPLETED|Overall Study||0
11329091|NCT02780700|12526316|FG000|NOT COMPLETED|Overall Study||1
11329092|NCT02780713|12526320|FG000|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 2.|14
11329093|NCT02780713|12526321|FG001|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 3.|0
11329094|NCT02780713|12526322|FG002|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 4.|0
11329095|NCT02780713|12526323|FG003|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 5.|0
11329096|NCT02780713|12526324|FG004|STARTED|Period 1: Variant A (100mg)||0
11329097|NCT02780713|12526320|FG000|COMPLETED|Period 1: Variant A (100mg)||14
11329098|NCT02780713|12526321|FG001|COMPLETED|Period 1: Variant A (100mg)||0
11329099|NCT02780713|12526322|FG002|COMPLETED|Period 1: Variant A (100mg)||0
11329100|NCT02780713|12526323|FG003|COMPLETED|Period 1: Variant A (100mg)||0
11329101|NCT02780713|12526324|FG004|COMPLETED|Period 1: Variant A (100mg)||0
11329102|NCT02780713|12526320|FG000|NOT COMPLETED|Period 1: Variant A (100mg)||0
11329103|NCT02780713|12526321|FG001|NOT COMPLETED|Period 1: Variant A (100mg)||0
11329104|NCT02780713|12526322|FG002|NOT COMPLETED|Period 1: Variant A (100mg)||0
11329105|NCT02780713|12526323|FG003|NOT COMPLETED|Period 1: Variant A (100mg)||0
11329106|NCT02780713|12526324|FG004|NOT COMPLETED|Period 1: Variant A (100mg)||0
11329107|NCT02780713|12526320|FG000|STARTED|Period 2: Reference (100mg)||0
11329108|NCT02780713|12526321|FG001|STARTED|Period 2: Reference (100mg)||14
11329109|NCT02780713|12526322|FG002|STARTED|Period 2: Reference (100mg)||0
11329110|NCT02780713|12526323|FG003|STARTED|Period 2: Reference (100mg)||0
11329111|NCT02780713|12526324|FG004|STARTED|Period 2: Reference (100mg)||0
11329112|NCT02780713|12526320|FG000|COMPLETED|Period 2: Reference (100mg)||0
11329113|NCT02780713|12526321|FG001|COMPLETED|Period 2: Reference (100mg)||14
11329114|NCT02780713|12526322|FG002|COMPLETED|Period 2: Reference (100mg)||0
11329115|NCT02780713|12526323|FG003|COMPLETED|Period 2: Reference (100mg)||0
11329116|NCT02780713|12526324|FG004|COMPLETED|Period 2: Reference (100mg)||0
11329117|NCT02780713|12526320|FG000|NOT COMPLETED|Period 2: Reference (100mg)||0
11329118|NCT02780713|12526321|FG001|NOT COMPLETED|Period 2: Reference (100mg)||0
11027286|NCT00833482|12206014|FG000|NOT COMPLETED|Days 1-3||0
11027287|NCT00833482|12206015|FG001|NOT COMPLETED|Days 1-3||0
11027288|NCT00833482|12206016|FG002|NOT COMPLETED|Days 1-3||0
11027289|NCT00833482|12206017|FG003|NOT COMPLETED|Days 1-3||0
11027290|NCT00833482|12206018|FG004|NOT COMPLETED|Days 1-3||0
11027291|NCT00833482|12206019|FG005|NOT COMPLETED|Days 1-3||0
11027292|NCT00833482|12206014|FG000|STARTED|Days 11-20||0
11027293|NCT00833482|12206015|FG001|STARTED|Days 11-20|Participants who received treatment.|24
11027294|NCT00833482|12206016|FG002|STARTED|Days 11-20||0
11027295|NCT00833482|12206017|FG003|STARTED|Days 11-20||0
11027296|NCT00833482|12206018|FG004|STARTED|Days 11-20||0
11027297|NCT00833482|12206019|FG005|STARTED|Days 11-20|Participants who received treatment.|8
11329119|NCT02780713|12526322|FG002|NOT COMPLETED|Period 2: Reference (100mg)||0
11329120|NCT02780713|12526323|FG003|NOT COMPLETED|Period 2: Reference (100mg)||0
11329121|NCT02780713|12526324|FG004|NOT COMPLETED|Period 2: Reference (100mg)||0
11329122|NCT02780713|12526320|FG000|STARTED|Period 3: Variant B (100mg)||0
11329123|NCT02780713|12526321|FG001|STARTED|Period 3: Variant B (100mg)||0
11329124|NCT02780713|12526322|FG002|STARTED|Period 3: Variant B (100mg)||14
11329125|NCT02780713|12526323|FG003|STARTED|Period 3: Variant B (100mg)||0
11329126|NCT02780713|12526324|FG004|STARTED|Period 3: Variant B (100mg)||0
11329127|NCT02780713|12526320|FG000|COMPLETED|Period 3: Variant B (100mg)||0
11329128|NCT02780713|12526321|FG001|COMPLETED|Period 3: Variant B (100mg)||0
11329129|NCT02780713|12526322|FG002|COMPLETED|Period 3: Variant B (100mg)||12
11329130|NCT02780713|12526323|FG003|COMPLETED|Period 3: Variant B (100mg)||0
11329131|NCT02780713|12526324|FG004|COMPLETED|Period 3: Variant B (100mg)||0
11329132|NCT02780713|12526320|FG000|NOT COMPLETED|Period 3: Variant B (100mg)||0
11329133|NCT02780713|12526321|FG001|NOT COMPLETED|Period 3: Variant B (100mg)||0
11329134|NCT02780713|12526322|FG002|NOT COMPLETED|Period 3: Variant B (100mg)||2
11329135|NCT02780713|12526323|FG003|NOT COMPLETED|Period 3: Variant B (100mg)||0
11329136|NCT02780713|12526324|FG004|NOT COMPLETED|Period 3: Variant B (100mg)||0
11329137|NCT02780713|12526320|FG000|STARTED|Period 4: Variant C (100mg)||0
11329138|NCT02780713|12526321|FG001|STARTED|Period 4: Variant C (100mg)||0
11329139|NCT02780713|12526322|FG002|STARTED|Period 4: Variant C (100mg)||0
11329140|NCT02780713|12526323|FG003|STARTED|Period 4: Variant C (100mg)||12
11329141|NCT02780713|12526324|FG004|STARTED|Period 4: Variant C (100mg)||0
11329142|NCT02780713|12526320|FG000|COMPLETED|Period 4: Variant C (100mg)||0
11329143|NCT02780713|12526321|FG001|COMPLETED|Period 4: Variant C (100mg)||0
11329144|NCT02780713|12526322|FG002|COMPLETED|Period 4: Variant C (100mg)||0
11329145|NCT02780713|12526323|FG003|COMPLETED|Period 4: Variant C (100mg)||12
11329146|NCT02780713|12526324|FG004|COMPLETED|Period 4: Variant C (100mg)||0
11329147|NCT02780713|12526320|FG000|NOT COMPLETED|Period 4: Variant C (100mg)||0
11329148|NCT02780713|12526321|FG001|NOT COMPLETED|Period 4: Variant C (100mg)||0
11329149|NCT02780713|12526322|FG002|NOT COMPLETED|Period 4: Variant C (100mg)||0
11329150|NCT02780713|12526323|FG003|NOT COMPLETED|Period 4: Variant C (100mg)||0
11329151|NCT02780713|12526324|FG004|NOT COMPLETED|Period 4: Variant C (100mg)||0
11329152|NCT02780713|12526320|FG000|STARTED|Period 5: Variant B (300mg)||0
11329153|NCT02780713|12526321|FG001|STARTED|Period 5: Variant B (300mg)||0
11329154|NCT02780713|12526322|FG002|STARTED|Period 5: Variant B (300mg)||0
11329155|NCT02780713|12526323|FG003|STARTED|Period 5: Variant B (300mg)||0
11329156|NCT02780713|12526324|FG004|STARTED|Period 5: Variant B (300mg)||12
11329157|NCT02780713|12526320|FG000|COMPLETED|Period 5: Variant B (300mg)||0
11329158|NCT02780713|12526321|FG001|COMPLETED|Period 5: Variant B (300mg)||0
11329159|NCT02780713|12526322|FG002|COMPLETED|Period 5: Variant B (300mg)||0
11329160|NCT02780713|12526323|FG003|COMPLETED|Period 5: Variant B (300mg)||0
11329161|NCT02780713|12526324|FG004|COMPLETED|Period 5: Variant B (300mg)||12
11329162|NCT02780713|12526320|FG000|NOT COMPLETED|Period 5: Variant B (300mg)||0
11329163|NCT02780713|12526321|FG001|NOT COMPLETED|Period 5: Variant B (300mg)||0
11329164|NCT02780713|12526322|FG002|NOT COMPLETED|Period 5: Variant B (300mg)||0
11329165|NCT02780713|12526323|FG003|NOT COMPLETED|Period 5: Variant B (300mg)||0
11329166|NCT02780713|12526324|FG004|NOT COMPLETED|Period 5: Variant B (300mg)||0
11329167|NCT02780765|12526345|FG000|STARTED|Overall Study||30
11329168|NCT02780765|12526346|FG001|STARTED|Overall Study||30
11329169|NCT02780765|12526345|FG000|COMPLETED|Overall Study||30
11329170|NCT02780765|12526346|FG001|COMPLETED|Overall Study||30
11329171|NCT02780765|12526345|FG000|NOT COMPLETED|Overall Study||0
11329172|NCT02780765|12526346|FG001|NOT COMPLETED|Overall Study||0
11329173|NCT02780856|12526352|FG000|STARTED|Overall Study||110
11329174|NCT02780856|12526352|FG000|COMPLETED|Overall Study||109
11329175|NCT02780856|12526352|FG000|NOT COMPLETED|Overall Study||1
11329176|NCT02780869|12526361|FG000|STARTED|Overall Study||175
11329177|NCT02780869|12526362|FG001|STARTED|Overall Study||83
11329178|NCT02780869|12526361|FG000|COMPLETED|Overall Study||162
11329179|NCT02780869|12526362|FG001|COMPLETED|Overall Study||74
11329180|NCT02780869|12526361|FG000|NOT COMPLETED|Overall Study||13
11329181|NCT02780869|12526362|FG001|NOT COMPLETED|Overall Study||9
11329182|NCT02781051|12526368|FG000|STARTED|Overall Study||16
11329183|NCT02781051|12526368|FG000|COMPLETED|Overall Study||14
11329184|NCT02781051|12526368|FG000|NOT COMPLETED|Overall Study||2
11329185|NCT02781311|12526376|FG000|STARTED|Overall Study||74
11329186|NCT02781311|12526377|FG001|STARTED|Overall Study||83
11329187|NCT02781311|12526378|FG002|STARTED|Overall Study||12
11329188|NCT02781311|12526376|FG000|Safety Population (Treated)|Overall Study||73
11329189|NCT02781311|12526377|FG001|Safety Population (Treated)|Overall Study||81
11329190|NCT02781311|12526378|FG002|Safety Population (Treated)|Overall Study||12
11329191|NCT02781311|12526376|FG000|mITT Population|Overall Study||70
11329192|NCT02781311|12526377|FG001|mITT Population|Overall Study||78
11329193|NCT02781311|12526378|FG002|mITT Population|Overall Study||11
11329194|NCT02781311|12526376|FG000|COMPLETED|Overall Study||48
11329195|NCT02781311|12526377|FG001|COMPLETED|Overall Study||57
11329196|NCT02781311|12526378|FG002|COMPLETED|Overall Study||8
11329197|NCT02781311|12526376|FG000|NOT COMPLETED|Overall Study||26
11329198|NCT02781311|12526377|FG001|NOT COMPLETED|Overall Study||26
11329199|NCT02781311|12526378|FG002|NOT COMPLETED|Overall Study||4
11343723|NCT02954848|12540977|FG000|STARTED|Overall Study||245
11343724|NCT02954848|12540978|FG001|STARTED|Overall Study||239
11343725|NCT02954848|12540977|FG000|Treated|Overall Study||245
11343726|NCT02954848|12540978|FG001|Treated|Overall Study||238
11343727|NCT02954848|12540977|FG000|COMPLETED|Overall Study||243
11343728|NCT02954848|12540978|FG001|COMPLETED|Overall Study||234
11343729|NCT02954848|12540977|FG000|NOT COMPLETED|Overall Study||2
11343730|NCT02954848|12540978|FG001|NOT COMPLETED|Overall Study||5
11343731|NCT02955069|12540986|FG000|STARTED|Overall Study||95
11343732|NCT02955069|12540987|FG001|STARTED|Overall Study||21
11343733|NCT02955069|12540986|FG000|Full Analysis Set (FAS)|Overall Study||95
11343734|NCT02955069|12540987|FG001|Full Analysis Set (FAS)|Overall Study||21
11343735|NCT02955069|12540986|FG000|Safety Set|Overall Study||95
11343736|NCT02955069|12540987|FG001|Safety Set|Overall Study||21
11343737|NCT02955069|12540986|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||94
11343738|NCT02955069|12540987|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||18
11343739|NCT02955069|12540986|FG000|Immunogenicity (IG) Prevalence Set|Overall Study||94
11343740|NCT02955069|12540987|FG001|Immunogenicity (IG) Prevalence Set|Overall Study||21
11343741|NCT02955069|12540986|FG000|IG Incidence Set|Overall Study||84
11343742|NCT02955069|12540987|FG001|IG Incidence Set|Overall Study||17
11343743|NCT02955069|12540986|FG000|COMPLETED|Overall Study||0
11343744|NCT02955069|12540987|FG001|COMPLETED|Overall Study||0
11343745|NCT02955069|12540986|FG000|NOT COMPLETED|Overall Study||95
11343746|NCT02955069|12540987|FG001|NOT COMPLETED|Overall Study||21
11343747|NCT02955147|12540995|FG000|STARTED|Overall Study||13
11343748|NCT02955147|12540995|FG000|COMPLETED|Overall Study||13
11343749|NCT02955147|12540995|FG000|NOT COMPLETED|Overall Study||0
11343750|NCT02955186|12541001|FG000|STARTED|Overall Study||33
11343751|NCT02955186|12541002|FG001|STARTED|Overall Study||17
11343752|NCT02955186|12541001|FG000|COMPLETED|Overall Study||26
11343753|NCT02955186|12541002|FG001|COMPLETED|Overall Study||15
11343754|NCT02955186|12541001|FG000|NOT COMPLETED|Overall Study||7
11343755|NCT02955186|12541002|FG001|NOT COMPLETED|Overall Study||2
11343756|NCT02955212|12541010|FG000|STARTED|Period 1: Double-blind Treatment Period||169
11343757|NCT02955212|12541011|FG001|STARTED|Period 1: Double-blind Treatment Period||169
11343758|NCT02955212|12541010|FG000|COMPLETED|Period 1: Double-blind Treatment Period||153
11343759|NCT02955212|12541011|FG001|COMPLETED|Period 1: Double-blind Treatment Period||157
11343760|NCT02955212|12541010|FG000|NOT COMPLETED|Period 1: Double-blind Treatment Period||16
11343761|NCT02955212|12541011|FG001|NOT COMPLETED|Period 1: Double-blind Treatment Period||12
11343762|NCT02955212|12541010|FG000|STARTED|Period 2: Open-label Extension||153
11343763|NCT02955212|12541011|FG001|STARTED|Period 2: Open-label Extension||157
11343764|NCT02955212|12541010|FG000|COMPLETED|Period 2: Open-label Extension||136
11343765|NCT02955212|12541011|FG001|COMPLETED|Period 2: Open-label Extension||139
11343766|NCT02955212|12541010|FG000|NOT COMPLETED|Period 2: Open-label Extension||17
11343767|NCT02955212|12541011|FG001|NOT COMPLETED|Period 2: Open-label Extension||18
11343768|NCT02955329|12541018|FG000|STARTED|Tobacco Arm||8
11343769|NCT02955329|12541018|FG000|COMPLETED|Tobacco Arm||8
11343770|NCT02955329|12541018|FG000|NOT COMPLETED|Tobacco Arm||0
11343771|NCT02955329|12541018|FG000|STARTED|Cannabis Arm||8
11343772|NCT02955329|12541018|FG000|COMPLETED|Cannabis Arm||8
11343773|NCT02955329|12541018|FG000|NOT COMPLETED|Cannabis Arm||0
11343774|NCT02955329|12541018|FG000|STARTED|Combined Cannabis and Tobacco Arm||8
11343775|NCT02955329|12541018|FG000|COMPLETED|Combined Cannabis and Tobacco Arm||8
11343776|NCT02955329|12541018|FG000|NOT COMPLETED|Combined Cannabis and Tobacco Arm||0
11343777|NCT02956044|12541029|FG000|STARTED|Overall Study||18
11343778|NCT02956044|12541030|FG001|STARTED|Overall Study||18
11329200|NCT02781324|12526387|FG000|STARTED|Overall Study||33
11329201|NCT02781324|12526388|FG001|STARTED|Overall Study||33
11329202|NCT02781324|12526387|FG000|COMPLETED|Overall Study||31
11329203|NCT02781324|12526388|FG001|COMPLETED|Overall Study||31
11329204|NCT02781324|12526387|FG000|NOT COMPLETED|Overall Study||2
11329205|NCT02781324|12526388|FG001|NOT COMPLETED|Overall Study||2
11329206|NCT02781454|12526399|FG000|STARTED|Overall Study||8
11329207|NCT02781454|12526400|FG001|STARTED|Overall Study||6
11329208|NCT02781454|12526401|FG002|STARTED|Overall Study||6
11329209|NCT02781454|12526399|FG000|COMPLETED|Overall Study||8
11329210|NCT02781454|12526400|FG001|COMPLETED|Overall Study||6
11329211|NCT02781454|12526401|FG002|COMPLETED|Overall Study||5
11329212|NCT02781454|12526399|FG000|NOT COMPLETED|Overall Study||0
11329213|NCT02781454|12526400|FG001|NOT COMPLETED|Overall Study||0
11329214|NCT02781454|12526401|FG002|NOT COMPLETED|Overall Study||1
11329215|NCT02781480|12526412|FG000|STARTED|Overall Study||9
11329216|NCT02781480|12526413|FG001|STARTED|Overall Study||3
11329217|NCT02781480|12526414|FG002|STARTED|Overall Study||3
11329218|NCT02781480|12526412|FG000|COMPLETED|Overall Study||9
11329219|NCT02781480|12526413|FG001|COMPLETED|Overall Study||3
11329220|NCT02781480|12526414|FG002|COMPLETED|Overall Study||3
11329221|NCT02781480|12526412|FG000|NOT COMPLETED|Overall Study||0
11329222|NCT02781480|12526413|FG001|NOT COMPLETED|Overall Study||0
11329223|NCT02781480|12526414|FG002|NOT COMPLETED|Overall Study||0
11329224|NCT02781558|12526424|FG000|STARTED|Overall Study||101
11329225|NCT02781558|12526425|FG001|STARTED|Overall Study||103
11329226|NCT02781558|12526424|FG000|COMPLETED|Overall Study||98
11329227|NCT02781558|12526425|FG001|COMPLETED|Overall Study||101
11329228|NCT02781558|12526424|FG000|NOT COMPLETED|Overall Study||3
11329229|NCT02781558|12526425|FG001|NOT COMPLETED|Overall Study||2
11329230|NCT02781571|12526432|FG000|STARTED|Overall Study||79
11329231|NCT02781571|12526432|FG000|COMPLETED|Overall Study||79
11329232|NCT02781571|12526432|FG000|NOT COMPLETED|Overall Study||0
11329233|NCT02781610|12526440|FG000|STARTED|Overall Study||140
11329234|NCT02781610|12526441|FG001|STARTED|Overall Study||137
11329235|NCT02781610|12526442|FG002|STARTED|Overall Study||353
11329236|NCT02781610|12526443|FG003|STARTED|Overall Study||352
11329237|NCT02781610|12526440|FG000|COMPLETED|Overall Study||134
11329238|NCT02781610|12526441|FG001|COMPLETED|Overall Study||130
11329239|NCT02781610|12526442|FG002|COMPLETED|Overall Study||336
11329240|NCT02781610|12526443|FG003|COMPLETED|Overall Study||323
11329241|NCT02781610|12526440|FG000|NOT COMPLETED|Overall Study||6
11329242|NCT02781610|12526441|FG001|NOT COMPLETED|Overall Study||7
11329243|NCT02781610|12526442|FG002|NOT COMPLETED|Overall Study||17
11329244|NCT02781610|12526443|FG003|NOT COMPLETED|Overall Study||29
11329245|NCT02781649|12526456|FG000|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
11329246|NCT02781649|12526457|FG001|STARTED|Overall Study||0
11329247|NCT02781649|12526458|FG002|STARTED|Overall Study||3
11329248|NCT02781649|12526456|FG000|COMPLETED|Overall Study||7
11329249|NCT02781649|12526457|FG001|COMPLETED|Overall Study||0
11329250|NCT02781649|12526458|FG002|COMPLETED|Overall Study||3
11329251|NCT02781649|12526456|FG000|NOT COMPLETED|Overall Study||0
11329252|NCT02781649|12526457|FG001|NOT COMPLETED|Overall Study||0
11329253|NCT02781649|12526458|FG002|NOT COMPLETED|Overall Study||0
11329254|NCT02781818|12526469|FG000|STARTED|Overall Study||20
11329255|NCT02781818|12526470|FG001|STARTED|Overall Study||18
11329256|NCT02781818|12526471|FG002|STARTED|Overall Study||17
11329257|NCT02781818|12526469|FG000|COMPLETED|Overall Study||16
11329258|NCT02781818|12526470|FG001|COMPLETED|Overall Study||16
11329259|NCT02781818|12526471|FG002|COMPLETED|Overall Study||16
11329260|NCT02781818|12526469|FG000|NOT COMPLETED|Overall Study||4
11329261|NCT02781818|12526470|FG001|NOT COMPLETED|Overall Study||2
11329262|NCT02781818|12526471|FG002|NOT COMPLETED|Overall Study||1
11329263|NCT02781844|12526483|FG000|STARTED|Treatment Period 1||5
11329264|NCT02781844|12526484|FG001|STARTED|Treatment Period 1||4
11329265|NCT02781844|12526485|FG002|STARTED|Treatment Period 1||4
11329266|NCT02781844|12526486|FG003|STARTED|Treatment Period 1||4
11329267|NCT02781844|12526487|FG004|STARTED|Treatment Period 1||4
11329268|NCT02781844|12526488|FG005|STARTED|Treatment Period 1||5
11329269|NCT02781844|12526489|FG006|STARTED|Treatment Period 1||4
11329270|NCT02781844|12526490|FG007|STARTED|Treatment Period 1||4
11329271|NCT02781844|12526483|FG000|COMPLETED|Treatment Period 1||5
11329272|NCT02781844|12526484|FG001|COMPLETED|Treatment Period 1||4
11329273|NCT02781844|12526485|FG002|COMPLETED|Treatment Period 1||4
11329274|NCT02781844|12526486|FG003|COMPLETED|Treatment Period 1||4
11329275|NCT02781844|12526487|FG004|COMPLETED|Treatment Period 1||4
11329276|NCT02781844|12526488|FG005|COMPLETED|Treatment Period 1||4
11329277|NCT02781844|12526489|FG006|COMPLETED|Treatment Period 1||4
11329278|NCT02781844|12526490|FG007|COMPLETED|Treatment Period 1||4
11329279|NCT02781844|12526483|FG000|NOT COMPLETED|Treatment Period 1||0
11329280|NCT02781844|12526484|FG001|NOT COMPLETED|Treatment Period 1||0
11329281|NCT02781844|12526485|FG002|NOT COMPLETED|Treatment Period 1||0
11329282|NCT02781844|12526486|FG003|NOT COMPLETED|Treatment Period 1||0
11329283|NCT02781844|12526487|FG004|NOT COMPLETED|Treatment Period 1||0
11329284|NCT02781844|12526488|FG005|NOT COMPLETED|Treatment Period 1||1
11329285|NCT02781844|12526489|FG006|NOT COMPLETED|Treatment Period 1||0
11329286|NCT02781844|12526490|FG007|NOT COMPLETED|Treatment Period 1||0
11329287|NCT02781844|12526483|FG000|STARTED|Treatment Period 2||5
11329288|NCT02781844|12526484|FG001|STARTED|Treatment Period 2||4
11329289|NCT02781844|12526485|FG002|STARTED|Treatment Period 2||4
11329290|NCT02781844|12526486|FG003|STARTED|Treatment Period 2||4
11329291|NCT02781844|12526487|FG004|STARTED|Treatment Period 2||4
11329292|NCT02781844|12526488|FG005|STARTED|Treatment Period 2||4
11329293|NCT02781844|12526489|FG006|STARTED|Treatment Period 2||4
11329294|NCT02781844|12526490|FG007|STARTED|Treatment Period 2||4
11329295|NCT02781844|12526483|FG000|COMPLETED|Treatment Period 2||5
11329296|NCT02781844|12526484|FG001|COMPLETED|Treatment Period 2||4
11329297|NCT02781844|12526485|FG002|COMPLETED|Treatment Period 2||4
11329298|NCT02781844|12526486|FG003|COMPLETED|Treatment Period 2||4
11329299|NCT02781844|12526487|FG004|COMPLETED|Treatment Period 2||4
11329300|NCT02781844|12526488|FG005|COMPLETED|Treatment Period 2||4
11329301|NCT02781844|12526489|FG006|COMPLETED|Treatment Period 2||4
11329302|NCT02781844|12526490|FG007|COMPLETED|Treatment Period 2||4
11329303|NCT02781844|12526483|FG000|NOT COMPLETED|Treatment Period 2||0
11329304|NCT02781844|12526484|FG001|NOT COMPLETED|Treatment Period 2||0
11329305|NCT02781844|12526485|FG002|NOT COMPLETED|Treatment Period 2||0
11329306|NCT02781844|12526486|FG003|NOT COMPLETED|Treatment Period 2||0
11329307|NCT02781844|12526487|FG004|NOT COMPLETED|Treatment Period 2||0
11329308|NCT02781844|12526488|FG005|NOT COMPLETED|Treatment Period 2||0
11329309|NCT02781844|12526489|FG006|NOT COMPLETED|Treatment Period 2||0
11329310|NCT02781844|12526490|FG007|NOT COMPLETED|Treatment Period 2||0
11329311|NCT02782065|12526506|FG000|STARTED|Overall Study||58
11329312|NCT02782065|12526506|FG000|COMPLETED|Overall Study||58
11329313|NCT02782065|12526506|FG000|NOT COMPLETED|Overall Study||0
11329314|NCT02782169|12526513|FG000|STARTED|Overall Study||56
11329315|NCT02782169|12526514|FG001|STARTED|Overall Study||54
11329316|NCT02782169|12526513|FG000|COMPLETED|Overall Study||55
11329317|NCT02782169|12526514|FG001|COMPLETED|Overall Study||52
11329318|NCT02782169|12526513|FG000|NOT COMPLETED|Overall Study||1
11329319|NCT02782169|12526514|FG001|NOT COMPLETED|Overall Study||2
11329320|NCT02782325|12526522|FG000|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4
11329321|NCT02782325|12526523|FG001|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2
11329322|NCT02782325|12526524|FG002|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0
11329323|NCT02782325|12526522|FG000|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
11329324|NCT02782325|12526523|FG001|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
11329325|NCT02782325|12526524|FG002|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
11329326|NCT02782325|12526522|FG000|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4
11329327|NCT02782325|12526523|FG001|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2
11329328|NCT02782325|12526524|FG002|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
11329329|NCT02782325|12526522|FG000|STARTED|Open Label FMT Period (up to 24 Weeks)||0
11329330|NCT02782325|12526523|FG001|STARTED|Open Label FMT Period (up to 24 Weeks)||0
11329331|NCT02782325|12526524|FG002|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5
11329332|NCT02782325|12526522|FG000|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
11329333|NCT02782325|12526523|FG001|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
11329334|NCT02782325|12526524|FG002|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1
11329335|NCT02782325|12526522|FG000|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
11329336|NCT02782325|12526523|FG001|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
11329337|NCT02782325|12526524|FG002|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4
11329338|NCT02782364|12526532|FG000|STARTED|Overall Study||18
11329339|NCT02782364|12526533|FG001|STARTED|Overall Study||18
11329340|NCT02782364|12526532|FG000|COMPLETED|Overall Study||18
11329341|NCT02782364|12526533|FG001|COMPLETED|Overall Study||18
11329342|NCT02782364|12526532|FG000|NOT COMPLETED|Overall Study||0
11329343|NCT02782364|12526533|FG001|NOT COMPLETED|Overall Study||0
11329344|NCT02782377|12526540|FG000|STARTED|Overall Study||40
11329345|NCT02782377|12526540|FG000|COMPLETED|Overall Study|data from five of the patients were excluded due to interpretation difficulties|35
11329346|NCT02782377|12526540|FG000|NOT COMPLETED|Overall Study||5
11329347|NCT02782676|12526545|FG000|STARTED|Overall Study||211
11329348|NCT02782676|12526546|FG001|STARTED|Overall Study||210
11329349|NCT02782676|12526545|FG000|COMPLETED|Overall Study||211
11329350|NCT02782676|12526546|FG001|COMPLETED|Overall Study||209
11329351|NCT02782676|12526545|FG000|NOT COMPLETED|Overall Study||0
11329352|NCT02782676|12526546|FG001|NOT COMPLETED|Overall Study||1
11329353|NCT02782780|12526554|FG000|STARTED|Overall Study||46
11329354|NCT02782780|12526555|FG001|STARTED|Overall Study||39
11329355|NCT02782780|12526554|FG000|COMPLETED|Overall Study||39
11329356|NCT02782780|12526555|FG001|COMPLETED|Overall Study||32
11329357|NCT02782780|12526554|FG000|NOT COMPLETED|Overall Study||7
11329358|NCT02782780|12526555|FG001|NOT COMPLETED|Overall Study||7
11329359|NCT02782923|12526561|FG000|STARTED|Overall Study||19
11329360|NCT02782923|12526561|FG000|COMPLETED|Overall Study||4
11329361|NCT02782923|12526561|FG000|NOT COMPLETED|Overall Study||15
11329362|NCT02783027|12526567|FG000|STARTED|Overall Study||39
11329363|NCT02783027|12526568|FG001|STARTED|Overall Study||44
11329364|NCT02783027|12526567|FG000|COMPLETED|Overall Study||16
11329365|NCT02783027|12526568|FG001|COMPLETED|Overall Study||27
11329366|NCT02783027|12526567|FG000|NOT COMPLETED|Overall Study||23
11329367|NCT02783027|12526568|FG001|NOT COMPLETED|Overall Study||17
11329368|NCT02783066|12526574|FG000|STARTED|Overall Study||16
11329369|NCT02783066|12526574|FG000|COMPLETED|Overall Study|complete 4-week pulseflow offloading wearing test|3
11329370|NCT02783066|12526574|FG000|NOT COMPLETED|Overall Study||13
11329371|NCT02783170|12526581|FG000|STARTED|Overall Study||43
11329372|NCT02783170|12526582|FG001|STARTED|Overall Study||38
11329373|NCT02783170|12526581|FG000|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42
11329374|NCT02783170|12526582|FG001|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38
11329375|NCT02783170|12526581|FG000|COMPLETED|Overall Study||42
11329376|NCT02783170|12526582|FG001|COMPLETED|Overall Study||38
11329377|NCT02783170|12526581|FG000|NOT COMPLETED|Overall Study||1
11329378|NCT02783170|12526582|FG001|NOT COMPLETED|Overall Study||0
11329379|NCT02783443|12526591|FG000|STARTED|Overall Study||30
11329380|NCT02783443|12526592|FG001|STARTED|Overall Study||30
11329381|NCT02783443|12526591|FG000|COMPLETED|Overall Study||30
11329382|NCT02783443|12526592|FG001|COMPLETED|Overall Study||30
11329383|NCT02783443|12526591|FG000|NOT COMPLETED|Overall Study||0
11329384|NCT02783443|12526592|FG001|NOT COMPLETED|Overall Study||0
11329385|NCT02783469|12526598|FG000|STARTED|Overall Study||1915
11329386|NCT02783469|12526598|FG000|COMPLETED|Overall Study||1915
11329387|NCT02783469|12526598|FG000|NOT COMPLETED|Overall Study||0
11329388|NCT02783573|12526605|FG000|STARTED|Placebo-Controlled Treatment Period||562
11329389|NCT02783573|12526606|FG001|STARTED|Placebo-Controlled Treatment Period||590
11329390|NCT02783573|12526607|FG002|STARTED|Placebo-Controlled Treatment Period||570
11329391|NCT02783573|12526605|FG000|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558
11329392|NCT02783573|12526606|FG001|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588
11329393|NCT02783573|12526607|FG002|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568
11329394|NCT02783573|12526605|FG000|COMPLETED|Placebo-Controlled Treatment Period||26
11329395|NCT02783573|12526606|FG001|COMPLETED|Placebo-Controlled Treatment Period||28
11329396|NCT02783573|12526607|FG002|COMPLETED|Placebo-Controlled Treatment Period||22
11329397|NCT02783573|12526605|FG000|NOT COMPLETED|Placebo-Controlled Treatment Period||536
11329398|NCT02783573|12526606|FG001|NOT COMPLETED|Placebo-Controlled Treatment Period||562
11329399|NCT02783573|12526607|FG002|NOT COMPLETED|Placebo-Controlled Treatment Period||548
11329400|NCT02783573|12526605|FG000|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0
11329401|NCT02783573|12526606|FG001|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17
11329402|NCT02783573|12526607|FG002|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12
11329403|NCT02783573|12526605|FG000|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0
11329404|NCT02783573|12526606|FG001|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14
11329405|NCT02783573|12526607|FG002|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12
11329406|NCT02783573|12526605|FG000|COMPLETED|Delayed-Start Period||0
11329407|NCT02783573|12526606|FG001|COMPLETED|Delayed-Start Period||0
11329408|NCT02783573|12526607|FG002|COMPLETED|Delayed-Start Period||0
11329409|NCT02783573|12526605|FG000|NOT COMPLETED|Delayed-Start Period||0
11329410|NCT02783573|12526606|FG001|NOT COMPLETED|Delayed-Start Period||17
11329411|NCT02783573|12526607|FG002|NOT COMPLETED|Delayed-Start Period||12
11329412|NCT02783599|12526618|FG000|STARTED|Overall Study||51
11329413|NCT02783599|12526618|FG000|Received At Least One Dose of Study Drug|Overall Study||51
11329414|NCT02783599|12526618|FG000|COMPLETED|Overall Study||11
11329415|NCT02783599|12526618|FG000|NOT COMPLETED|Overall Study||40
11329416|NCT02783729|12526633|FG000|STARTED|Overall Study||208
11329417|NCT02783729|12526634|FG001|STARTED|Overall Study||263
11329418|NCT02783729|12526635|FG002|STARTED|Overall Study||266
11329419|NCT02783729|12526636|FG003|STARTED|Overall Study||269
11329420|NCT02783729|12526633|FG000|COMPLETED|Overall Study||198
11329421|NCT02783729|12526634|FG001|COMPLETED|Overall Study||246
11329422|NCT02783729|12526635|FG002|COMPLETED|Overall Study||258
11329423|NCT02783729|12526636|FG003|COMPLETED|Overall Study||260
11329424|NCT02783729|12526633|FG000|NOT COMPLETED|Overall Study||10
11329425|NCT02783729|12526634|FG001|NOT COMPLETED|Overall Study||17
11329426|NCT02783729|12526635|FG002|NOT COMPLETED|Overall Study||8
11329427|NCT02783729|12526636|FG003|NOT COMPLETED|Overall Study||9
11329428|NCT02783768|12526651|FG000|STARTED|Overall Study||6
11329429|NCT02783768|12526652|FG001|STARTED|Overall Study||5
11329430|NCT02783768|12526651|FG000|COMPLETED|Overall Study||5
11329431|NCT02783768|12526652|FG001|COMPLETED|Overall Study||5
11329432|NCT02783768|12526651|FG000|NOT COMPLETED|Overall Study||1
11329433|NCT02783768|12526652|FG001|NOT COMPLETED|Overall Study||0
11329434|NCT02783820|12526662|FG000|STARTED|Overall Study||6
11329435|NCT02783820|12526663|FG001|STARTED|Overall Study||6
11329436|NCT02783820|12526664|FG002|STARTED|Overall Study||6
11329437|NCT02783820|12526665|FG003|STARTED|Overall Study||6
11329438|NCT02783820|12526662|FG000|COMPLETED|Overall Study||6
11329439|NCT02783820|12526663|FG001|COMPLETED|Overall Study||6
11329440|NCT02783820|12526664|FG002|COMPLETED|Overall Study||6
11329441|NCT02783820|12526665|FG003|COMPLETED|Overall Study||6
11329442|NCT02783820|12526662|FG000|NOT COMPLETED|Overall Study||0
11329443|NCT02783820|12526663|FG001|NOT COMPLETED|Overall Study||0
11329444|NCT02783820|12526664|FG002|NOT COMPLETED|Overall Study||0
11329445|NCT02783820|12526665|FG003|NOT COMPLETED|Overall Study||0
11329446|NCT02783898|12526677|FG000|STARTED|Overall Study||125
11329447|NCT02783898|12526678|FG001|STARTED|Overall Study||117
11329448|NCT02783898|12526677|FG000|COMPLETED|Overall Study||124
11329449|NCT02783898|12526678|FG001|COMPLETED|Overall Study||116
11329450|NCT02783898|12526677|FG000|NOT COMPLETED|Overall Study||1
11329451|NCT02783898|12526678|FG001|NOT COMPLETED|Overall Study||1
11329452|NCT02783911|12526688|FG000|STARTED|Overall Study||11
11329453|NCT02783911|12526689|FG001|STARTED|Overall Study||46
11027298|NCT00833482|12206014|FG000|COMPLETED|Days 11-20||0
11027299|NCT00833482|12206015|FG001|COMPLETED|Days 11-20||21
11027300|NCT00833482|12206016|FG002|COMPLETED|Days 11-20||0
11027301|NCT00833482|12206017|FG003|COMPLETED|Days 11-20||0
11027302|NCT00833482|12206018|FG004|COMPLETED|Days 11-20||0
11027303|NCT00833482|12206019|FG005|COMPLETED|Days 11-20||8
11027304|NCT00833482|12206014|FG000|NOT COMPLETED|Days 11-20||0
11027305|NCT00833482|12206015|FG001|NOT COMPLETED|Days 11-20||3
11027306|NCT00833482|12206016|FG002|NOT COMPLETED|Days 11-20||0
11027307|NCT00833482|12206017|FG003|NOT COMPLETED|Days 11-20||0
11027308|NCT00833482|12206018|FG004|NOT COMPLETED|Days 11-20||0
11027309|NCT00833482|12206019|FG005|NOT COMPLETED|Days 11-20||0
11027310|NCT00833482|12206014|FG000|STARTED|Days 21-30||0
11027311|NCT00833482|12206015|FG001|STARTED|Days 21-30||0
11027312|NCT00833482|12206016|FG002|STARTED|Days 21-30||21
11027313|NCT00833482|12206017|FG003|STARTED|Days 21-30||0
11027314|NCT00833482|12206018|FG004|STARTED|Days 21-30||8
11027315|NCT00833482|12206019|FG005|STARTED|Days 21-30||0
11027316|NCT00833482|12206014|FG000|COMPLETED|Days 21-30||0
11027317|NCT00833482|12206015|FG001|COMPLETED|Days 21-30||0
11027318|NCT00833482|12206016|FG002|COMPLETED|Days 21-30||20
11027319|NCT00833482|12206017|FG003|COMPLETED|Days 21-30||0
11027320|NCT00833482|12206018|FG004|COMPLETED|Days 21-30||7
11027321|NCT00833482|12206019|FG005|COMPLETED|Days 21-30||0
11027322|NCT00833482|12206014|FG000|NOT COMPLETED|Days 21-30||0
11027323|NCT00833482|12206015|FG001|NOT COMPLETED|Days 21-30||0
11027324|NCT00833482|12206016|FG002|NOT COMPLETED|Days 21-30||1
11027325|NCT00833482|12206017|FG003|NOT COMPLETED|Days 21-30||0
11027326|NCT00833482|12206018|FG004|NOT COMPLETED|Days 21-30||1
11027327|NCT00833482|12206019|FG005|NOT COMPLETED|Days 21-30||0
11027328|NCT00833547|12206043|FG000|STARTED|Overall Study||13
11027329|NCT00833547|12206044|FG001|STARTED|Overall Study||12
11329454|NCT02783911|12526688|FG000|COMPLETED|Overall Study||8
11329455|NCT02783911|12526689|FG001|COMPLETED|Overall Study||14
11329456|NCT02783911|12526688|FG000|NOT COMPLETED|Overall Study||3
11329457|NCT02783911|12526689|FG001|NOT COMPLETED|Overall Study||32
11329458|NCT02784106|12526697|FG000|STARTED|Double-Blind Treatment Period (12 Weeks)||32
11329459|NCT02784106|12526698|FG001|STARTED|Double-Blind Treatment Period (12 Weeks)||33
11329460|NCT02784106|12526699|FG002|STARTED|Double-Blind Treatment Period (12 Weeks)||0
11329461|NCT02784106|12526700|FG003|STARTED|Double-Blind Treatment Period (12 Weeks)||0
11329462|NCT02784106|12526697|FG000|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
11329463|NCT02784106|12526698|FG001|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
11329464|NCT02784106|12526699|FG002|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
11329465|NCT02784106|12526700|FG003|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
11027330|NCT00833547|12206043|FG000|COMPLETED|Overall Study||11
11027331|NCT00833547|12206044|FG001|COMPLETED|Overall Study||10
11027332|NCT00833547|12206043|FG000|NOT COMPLETED|Overall Study||2
11027333|NCT00833547|12206044|FG001|NOT COMPLETED|Overall Study||2
11027334|NCT00833560|12206050|FG000|STARTED|Overall Study||395
11329466|NCT02784106|12526697|FG000|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
11329467|NCT02784106|12526698|FG001|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
11329468|NCT02784106|12526699|FG002|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
11329469|NCT02784106|12526700|FG003|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
11329470|NCT02784106|12526697|FG000|STARTED|Open-Label Extension Period (26 Weeks)||0
11329471|NCT02784106|12526698|FG001|STARTED|Open-Label Extension Period (26 Weeks)||0
11329472|NCT02784106|12526699|FG002|STARTED|Open-Label Extension Period (26 Weeks)||18
11329473|NCT02784106|12526700|FG003|STARTED|Open-Label Extension Period (26 Weeks)||21
11329474|NCT02784106|12526697|FG000|COMPLETED|Open-Label Extension Period (26 Weeks)||0
11329475|NCT02784106|12526698|FG001|COMPLETED|Open-Label Extension Period (26 Weeks)||0
11329476|NCT02784106|12526699|FG002|COMPLETED|Open-Label Extension Period (26 Weeks)||15
11329477|NCT02784106|12526700|FG003|COMPLETED|Open-Label Extension Period (26 Weeks)||19
11329478|NCT02784106|12526697|FG000|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
11329479|NCT02784106|12526698|FG001|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
11329480|NCT02784106|12526699|FG002|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
11329481|NCT02784106|12526700|FG003|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
11329482|NCT02784275|12526713|FG000|STARTED|Overall Study||16
11329483|NCT02784275|12526714|FG001|STARTED|Overall Study||16
11329484|NCT02784275|12526715|FG002|STARTED|Overall Study||17
11329485|NCT02784275|12526716|FG003|STARTED|Overall Study||15
11329486|NCT02784275|12526713|FG000|COMPLETED|Overall Study||15
11329487|NCT02784275|12526714|FG001|COMPLETED|Overall Study||16
11329488|NCT02784275|12526715|FG002|COMPLETED|Overall Study||16
11329489|NCT02784275|12526716|FG003|COMPLETED|Overall Study||14
11329490|NCT02784275|12526713|FG000|NOT COMPLETED|Overall Study||1
11329491|NCT02784275|12526714|FG001|NOT COMPLETED|Overall Study||0
11329492|NCT02784275|12526715|FG002|NOT COMPLETED|Overall Study||1
11329493|NCT02784275|12526716|FG003|NOT COMPLETED|Overall Study||1
11329494|NCT02784444|12526730|FG000|STARTED|Overall Study||94
11329495|NCT02784444|12526731|FG001|STARTED|Overall Study||99
11329496|NCT02784444|12526732|FG002|STARTED|Overall Study||98
11329497|NCT02784444|12526733|FG003|STARTED|Overall Study||101
11329498|NCT02784444|12526730|FG000|COMPLETED|Overall Study||78
11329499|NCT02784444|12526731|FG001|COMPLETED|Overall Study||90
11329500|NCT02784444|12526732|FG002|COMPLETED|Overall Study||86
11329501|NCT02784444|12526733|FG003|COMPLETED|Overall Study||88
11329502|NCT02784444|12526730|FG000|NOT COMPLETED|Overall Study||16
11329503|NCT02784444|12526731|FG001|NOT COMPLETED|Overall Study||9
11329504|NCT02784444|12526732|FG002|NOT COMPLETED|Overall Study||12
11329505|NCT02784444|12526733|FG003|NOT COMPLETED|Overall Study||13
11329506|NCT02784548|12526743|FG000|STARTED|Overall Study||15
11329507|NCT02784548|12526743|FG000|COMPLETED|Overall Study||15
11329508|NCT02784548|12526743|FG000|NOT COMPLETED|Overall Study||0
11329509|NCT02784587|12526748|FG000|STARTED|Overall Study||25
11329510|NCT02784587|12526748|FG000|COMPLETED|Overall Study||25
11329511|NCT02784587|12526748|FG000|NOT COMPLETED|Overall Study||0
11329512|NCT02784613|12526752|FG000|STARTED|Overall Study||10
11329513|NCT02784613|12526752|FG000|COMPLETED|Overall Study||8
11329514|NCT02784613|12526752|FG000|NOT COMPLETED|Overall Study||2
11329515|NCT02784834|12526756|FG000|STARTED|Overall Study||2
11329516|NCT02784834|12526756|FG000|COMPLETED|Overall Study||1
11329517|NCT02784834|12526756|FG000|NOT COMPLETED|Overall Study||1
11329518|NCT02784925|12526760|FG000|STARTED|Overall Study||30
11329519|NCT02784925|12526760|FG000|COMPLETED|Overall Study||30
11329520|NCT02784925|12526760|FG000|NOT COMPLETED|Overall Study||0
11329521|NCT02785159|12526768|FG000|STARTED|Overall Study||62
11329522|NCT02785159|12526769|FG001|STARTED|Overall Study||58
11329523|NCT02785159|12526770|FG002|STARTED|Overall Study||15
11329524|NCT02785159|12526771|FG003|STARTED|Overall Study||17
11329525|NCT02785159|12526768|FG000|COMPLETED|Overall Study||51
11329526|NCT02785159|12526769|FG001|COMPLETED|Overall Study||45
11329527|NCT02785159|12526770|FG002|COMPLETED|Overall Study||12
11329528|NCT02785159|12526771|FG003|COMPLETED|Overall Study||14
11329529|NCT02785159|12526768|FG000|NOT COMPLETED|Overall Study||11
11329530|NCT02785159|12526769|FG001|NOT COMPLETED|Overall Study||13
11329531|NCT02785159|12526770|FG002|NOT COMPLETED|Overall Study||3
11329532|NCT02785159|12526771|FG003|NOT COMPLETED|Overall Study||3
11329533|NCT02785172|12526785|FG000|STARTED|Overall Study||61
11329534|NCT02785172|12526786|FG001|STARTED|Overall Study||63
11329535|NCT02785172|12526787|FG002|STARTED|Overall Study||16
11329536|NCT02785172|12526788|FG003|STARTED|Overall Study||14
11329537|NCT02785172|12526785|FG000|COMPLETED|Overall Study||61
11329538|NCT02785172|12526786|FG001|COMPLETED|Overall Study||62
11329539|NCT02785172|12526787|FG002|COMPLETED|Overall Study||15
11329540|NCT02785172|12526788|FG003|COMPLETED|Overall Study||14
11329541|NCT02785172|12526785|FG000|NOT COMPLETED|Overall Study||0
11329542|NCT02785172|12526786|FG001|NOT COMPLETED|Overall Study||1
11329543|NCT02785172|12526787|FG002|NOT COMPLETED|Overall Study||1
11329544|NCT02785172|12526788|FG003|NOT COMPLETED|Overall Study||0
11329545|NCT02785185|12526802|FG000|STARTED|Overall Study||60
11329546|NCT02785185|12526803|FG001|STARTED|Overall Study||57
11329547|NCT02785185|12526804|FG002|STARTED|Overall Study||17
11329548|NCT02785185|12526805|FG003|STARTED|Overall Study||16
11329549|NCT02785185|12526802|FG000|COMPLETED|Overall Study||59
11329550|NCT02785185|12526803|FG001|COMPLETED|Overall Study||56
11329551|NCT02785185|12526804|FG002|COMPLETED|Overall Study||15
11329552|NCT02785185|12526805|FG003|COMPLETED|Overall Study||16
11329553|NCT02785185|12526802|FG000|NOT COMPLETED|Overall Study||1
11329554|NCT02785185|12526803|FG001|NOT COMPLETED|Overall Study||1
11329555|NCT02785185|12526804|FG002|NOT COMPLETED|Overall Study||2
11329556|NCT02785185|12526805|FG003|NOT COMPLETED|Overall Study||0
11329557|NCT02785354|12526818|FG000|STARTED|Overall Study||27060
11329558|NCT02785354|12526819|FG001|STARTED|Overall Study||31388
11329559|NCT02785354|12526820|FG002|STARTED|Overall Study||44653
11329560|NCT02785354|12526818|FG000|COMPLETED|Overall Study||27060
11329561|NCT02785354|12526819|FG001|COMPLETED|Overall Study||31388
11329562|NCT02785354|12526820|FG002|COMPLETED|Overall Study||44653
11329563|NCT02785354|12526818|FG000|NOT COMPLETED|Overall Study||0
11329564|NCT02785354|12526819|FG001|NOT COMPLETED|Overall Study||0
11329565|NCT02785354|12526820|FG002|NOT COMPLETED|Overall Study||0
11329566|NCT02785406|12526831|FG000|STARTED|Overall Study||10
11329567|NCT02785406|12526832|FG001|STARTED|Overall Study||10
11329568|NCT02785406|12526831|FG000|Completed First Week|Overall Study||10
11329569|NCT02785406|12526832|FG001|Completed First Week|Overall Study||10
11329570|NCT02785406|12526831|FG000|Completed Second Week|Overall Study||10
11329571|NCT02785406|12526832|FG001|Completed Second Week|Overall Study||10
11329572|NCT02785406|12526831|FG000|COMPLETED|Overall Study||10
11329573|NCT02785406|12526832|FG001|COMPLETED|Overall Study||10
11329574|NCT02785406|12526831|FG000|NOT COMPLETED|Overall Study||0
11329575|NCT02785406|12526832|FG001|NOT COMPLETED|Overall Study||0
11329576|NCT02785432|12526840|FG000|STARTED|Overall Study||4
11329577|NCT02785432|12526841|FG001|STARTED|Overall Study||7
11329578|NCT02785432|12526840|FG000|COMPLETED|Overall Study||4
11329579|NCT02785432|12526841|FG001|COMPLETED|Overall Study||7
11329580|NCT02785432|12526840|FG000|NOT COMPLETED|Overall Study||0
11329581|NCT02785432|12526841|FG001|NOT COMPLETED|Overall Study||0
11329582|NCT02785458|12526849|FG000|STARTED|Baseline||526
11329583|NCT02785458|12526850|FG001|STARTED|Baseline||479
11329584|NCT02785458|12526849|FG000|COMPLETED|Baseline||526
11329585|NCT02785458|12526850|FG001|COMPLETED|Baseline||479
11329586|NCT02785458|12526849|FG000|NOT COMPLETED|Baseline||0
11329587|NCT02785458|12526850|FG001|NOT COMPLETED|Baseline||0
11329588|NCT02785458|12526849|FG000|STARTED|1 Month||526
11329589|NCT02785458|12526850|FG001|STARTED|1 Month||479
11329590|NCT02785458|12526849|FG000|COMPLETED|1 Month||443
11329591|NCT02785458|12526850|FG001|COMPLETED|1 Month||404
11329592|NCT02785458|12526849|FG000|NOT COMPLETED|1 Month||83
11329593|NCT02785458|12526850|FG001|NOT COMPLETED|1 Month||75
11329594|NCT02785458|12526849|FG000|STARTED|3 Months||443
11329595|NCT02785458|12526850|FG001|STARTED|3 Months||404
11329596|NCT02785458|12526849|FG000|COMPLETED|3 Months||315
11329597|NCT02785458|12526850|FG001|COMPLETED|3 Months||293
11329598|NCT02785458|12526849|FG000|NOT COMPLETED|3 Months||128
11329599|NCT02785458|12526850|FG001|NOT COMPLETED|3 Months||111
11329600|NCT02785588|12526856|FG000|STARTED|Phase 1: Initial Feasibility Assessment||49
11329601|NCT02785588|12526856|FG000|COMPLETED|Phase 1: Initial Feasibility Assessment||47
11329602|NCT02785588|12526856|FG000|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2
11329603|NCT02785588|12526856|FG000|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5
11329604|NCT02785588|12526856|FG000|COMPLETED|Phase2 Controlled Image &Data Collection||5
11329605|NCT02785588|12526856|FG000|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0
11329606|NCT02785770|12526860|FG000|STARTED|Intervention Period 1 (1 Day)||11
11329607|NCT02785770|12526861|FG001|STARTED|Intervention Period 1 (1 Day)||11
11329608|NCT02785770|12526862|FG002|STARTED|Intervention Period 1 (1 Day)||11
11329609|NCT02785770|12526863|FG003|STARTED|Intervention Period 1 (1 Day)||11
11329610|NCT02785770|12526860|FG000|COMPLETED|Intervention Period 1 (1 Day)||11
11329611|NCT02785770|12526861|FG001|COMPLETED|Intervention Period 1 (1 Day)||11
11329612|NCT02785770|12526862|FG002|COMPLETED|Intervention Period 1 (1 Day)||11
11329613|NCT02785770|12526863|FG003|COMPLETED|Intervention Period 1 (1 Day)||11
11329614|NCT02785770|12526860|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0
11329615|NCT02785770|12526861|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0
11329616|NCT02785770|12526862|FG002|NOT COMPLETED|Intervention Period 1 (1 Day)||0
11329617|NCT02785770|12526863|FG003|NOT COMPLETED|Intervention Period 1 (1 Day)||0
11329618|NCT02785770|12526860|FG000|STARTED|Washout Period 1 (7 Days)||11
11329619|NCT02785770|12526861|FG001|STARTED|Washout Period 1 (7 Days)||11
11329620|NCT02785770|12526862|FG002|STARTED|Washout Period 1 (7 Days)||11
11329621|NCT02785770|12526863|FG003|STARTED|Washout Period 1 (7 Days)||11
11329622|NCT02785770|12526860|FG000|COMPLETED|Washout Period 1 (7 Days)||11
11329623|NCT02785770|12526861|FG001|COMPLETED|Washout Period 1 (7 Days)||11
11329624|NCT02785770|12526862|FG002|COMPLETED|Washout Period 1 (7 Days)||11
11329625|NCT02785770|12526863|FG003|COMPLETED|Washout Period 1 (7 Days)||11
11329626|NCT02785770|12526860|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
11329627|NCT02785770|12526861|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
11329628|NCT02785770|12526862|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
11329629|NCT02785770|12526863|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
11329630|NCT02785770|12526860|FG000|STARTED|Intervention Period 2 (1 Day)||11
11329631|NCT02785770|12526861|FG001|STARTED|Intervention Period 2 (1 Day)||11
11329632|NCT02785770|12526862|FG002|STARTED|Intervention Period 2 (1 Day)||11
11329633|NCT02785770|12526863|FG003|STARTED|Intervention Period 2 (1 Day)||11
11329634|NCT02785770|12526860|FG000|COMPLETED|Intervention Period 2 (1 Day)||11
11329635|NCT02785770|12526861|FG001|COMPLETED|Intervention Period 2 (1 Day)||10
11329636|NCT02785770|12526862|FG002|COMPLETED|Intervention Period 2 (1 Day)||10
11329637|NCT02785770|12526863|FG003|COMPLETED|Intervention Period 2 (1 Day)||11
11329638|NCT02785770|12526860|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0
11329639|NCT02785770|12526861|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||1
11329640|NCT02785770|12526862|FG002|NOT COMPLETED|Intervention Period 2 (1 Day)||1
11329641|NCT02785770|12526863|FG003|NOT COMPLETED|Intervention Period 2 (1 Day)||0
11329642|NCT02785770|12526860|FG000|STARTED|Washout Period 2 (7 Days)||11
11329643|NCT02785770|12526861|FG001|STARTED|Washout Period 2 (7 Days)||10
11329644|NCT02785770|12526862|FG002|STARTED|Washout Period 2 (7 Days)||10
11329645|NCT02785770|12526863|FG003|STARTED|Washout Period 2 (7 Days)||11
11329646|NCT02785770|12526860|FG000|COMPLETED|Washout Period 2 (7 Days)||11
11329647|NCT02785770|12526861|FG001|COMPLETED|Washout Period 2 (7 Days)||10
11329648|NCT02785770|12526862|FG002|COMPLETED|Washout Period 2 (7 Days)||10
11329649|NCT02785770|12526863|FG003|COMPLETED|Washout Period 2 (7 Days)||11
11329650|NCT02785770|12526860|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
11329651|NCT02785770|12526861|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
11329652|NCT02785770|12526862|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
11329653|NCT02785770|12526863|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
11329654|NCT02785770|12526860|FG000|STARTED|Intervention Period 3 (1 Day)||11
11329655|NCT02785770|12526861|FG001|STARTED|Intervention Period 3 (1 Day)||10
11329656|NCT02785770|12526862|FG002|STARTED|Intervention Period 3 (1 Day)||10
11329657|NCT02785770|12526863|FG003|STARTED|Intervention Period 3 (1 Day)||11
11329658|NCT02785770|12526860|FG000|COMPLETED|Intervention Period 3 (1 Day)||11
11329659|NCT02785770|12526861|FG001|COMPLETED|Intervention Period 3 (1 Day)||10
11329660|NCT02785770|12526862|FG002|COMPLETED|Intervention Period 3 (1 Day)||10
11329661|NCT02785770|12526863|FG003|COMPLETED|Intervention Period 3 (1 Day)||10
11329662|NCT02785770|12526860|FG000|NOT COMPLETED|Intervention Period 3 (1 Day)||0
11329663|NCT02785770|12526861|FG001|NOT COMPLETED|Intervention Period 3 (1 Day)||0
11329664|NCT02785770|12526862|FG002|NOT COMPLETED|Intervention Period 3 (1 Day)||0
11329665|NCT02785770|12526863|FG003|NOT COMPLETED|Intervention Period 3 (1 Day)||1
11329666|NCT02785770|12526860|FG000|STARTED|Washout Period 3 (7 Days)||11
11329667|NCT02785770|12526861|FG001|STARTED|Washout Period 3 (7 Days)||10
11329668|NCT02785770|12526862|FG002|STARTED|Washout Period 3 (7 Days)||10
11329669|NCT02785770|12526863|FG003|STARTED|Washout Period 3 (7 Days)||10
11329670|NCT02785770|12526860|FG000|COMPLETED|Washout Period 3 (7 Days)||11
11329671|NCT02785770|12526861|FG001|COMPLETED|Washout Period 3 (7 Days)||10
11329672|NCT02785770|12526862|FG002|COMPLETED|Washout Period 3 (7 Days)||10
11329673|NCT02785770|12526863|FG003|COMPLETED|Washout Period 3 (7 Days)||10
11329674|NCT02785770|12526860|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
11329675|NCT02785770|12526861|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
11329676|NCT02785770|12526862|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
11329677|NCT02785770|12526863|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
11329678|NCT02785770|12526860|FG000|STARTED|Intervention Period 4 (1 Day)||11
11329679|NCT02785770|12526861|FG001|STARTED|Intervention Period 4 (1 Day)||10
11329680|NCT02785770|12526862|FG002|STARTED|Intervention Period 4 (1 Day)||10
11329681|NCT02785770|12526863|FG003|STARTED|Intervention Period 4 (1 Day)||10
11329682|NCT02785770|12526860|FG000|COMPLETED|Intervention Period 4 (1 Day)||11
11329683|NCT02785770|12526861|FG001|COMPLETED|Intervention Period 4 (1 Day)||10
11329684|NCT02785770|12526862|FG002|COMPLETED|Intervention Period 4 (1 Day)||10
11329685|NCT02785770|12526863|FG003|COMPLETED|Intervention Period 4 (1 Day)||10
11329686|NCT02785770|12526860|FG000|NOT COMPLETED|Intervention Period 4 (1 Day)||0
11329687|NCT02785770|12526861|FG001|NOT COMPLETED|Intervention Period 4 (1 Day)||0
11329688|NCT02785770|12526862|FG002|NOT COMPLETED|Intervention Period 4 (1 Day)||0
11329689|NCT02785770|12526863|FG003|NOT COMPLETED|Intervention Period 4 (1 Day)||0
11329690|NCT02785900|12526878|FG000|STARTED|Overall Study||117
11329691|NCT02785900|12526879|FG001|STARTED|Overall Study||123
11329692|NCT02785900|12526878|FG000|COMPLETED|Overall Study||0
11329693|NCT02785900|12526879|FG001|COMPLETED|Overall Study||0
11329694|NCT02785900|12526878|FG000|NOT COMPLETED|Overall Study||117
11329695|NCT02785900|12526879|FG001|NOT COMPLETED|Overall Study||123
11329696|NCT02785913|12526885|FG000|STARTED|Overall Study||26
11329697|NCT02785913|12526885|FG000|COMPLETED|Overall Study||0
11329698|NCT02785913|12526885|FG000|NOT COMPLETED|Overall Study||26
11329699|NCT02785939|12526892|FG000|STARTED|Overall Study||31
11329700|NCT02785939|12526893|FG001|STARTED|Overall Study||10
11329701|NCT02785939|12526892|FG000|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||0
11329702|NCT02785939|12526893|FG001|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||1
11329703|NCT02785939|12526892|FG000|COMPLETED|Overall Study||0
11329704|NCT02785939|12526893|FG001|COMPLETED|Overall Study||0
11329705|NCT02785939|12526892|FG000|NOT COMPLETED|Overall Study||31
11329706|NCT02785939|12526893|FG001|NOT COMPLETED|Overall Study||10
11329707|NCT02786004|12526901|FG000|STARTED|Overall Study||14
11329708|NCT02786004|12526902|FG001|STARTED|Overall Study||10
11329709|NCT02786004|12526901|FG000|COMPLETED|Overall Study||14
11329710|NCT02786004|12526902|FG001|COMPLETED|Overall Study||9
11329711|NCT02786004|12526901|FG000|NOT COMPLETED|Overall Study||0
11329712|NCT02786004|12526902|FG001|NOT COMPLETED|Overall Study||1
11329713|NCT02786134|12526912|FG000|STARTED|Overall Study||25
11329714|NCT02786134|12526913|FG001|STARTED|Overall Study||25
11329715|NCT02786134|12526912|FG000|COMPLETED|Overall Study||25
11329716|NCT02786134|12526913|FG001|COMPLETED|Overall Study||25
11329717|NCT02786134|12526912|FG000|NOT COMPLETED|Overall Study||0
11329718|NCT02786134|12526913|FG001|NOT COMPLETED|Overall Study||0
11329719|NCT02786355|12526919|FG000|STARTED|Overall Study||35
11329720|NCT02786355|12526919|FG000|COMPLETED|Overall Study||35
11329721|NCT02786355|12526919|FG000|NOT COMPLETED|Overall Study||0
11329722|NCT02786719|12526926|FG000|STARTED|Overall Study||13
11329723|NCT02786719|12526926|FG000|COMPLETED|Overall Study||12
11329724|NCT02786719|12526926|FG000|NOT COMPLETED|Overall Study||1
11329725|NCT02786771|12526932|FG000|STARTED|Overall Study||63
11329726|NCT02786771|12526933|FG001|STARTED|Overall Study||62
11329727|NCT02786771|12526932|FG000|COMPLETED|Overall Study||53
11329728|NCT02786771|12526933|FG001|COMPLETED|Overall Study||56
11329729|NCT02786771|12526932|FG000|NOT COMPLETED|Overall Study||10
11329730|NCT02786771|12526933|FG001|NOT COMPLETED|Overall Study||6
11329731|NCT02786810|12526939|FG000|STARTED|Overall Study||10
11329732|NCT02786810|12526939|FG000|COMPLETED|Overall Study||10
11329733|NCT02786810|12526939|FG000|NOT COMPLETED|Overall Study||0
11329734|NCT02786836|12526943|FG000|STARTED|Overall Study||76
11329735|NCT02786836|12526943|FG000|Eligible Patients Enrolled Into the Stud|Overall Study||76
11329736|NCT02786836|12526943|FG000|COMPLETED|Overall Study||62
11329737|NCT02786836|12526943|FG000|NOT COMPLETED|Overall Study||14
11329738|NCT02786901|12526951|FG000|STARTED|Overall Study||199
11329739|NCT02786901|12526952|FG001|STARTED|Overall Study||201
11329740|NCT02786901|12526953|FG002|STARTED|Overall Study||200
11329741|NCT02786901|12526951|FG000|COMPLETED|Overall Study||122
11329742|NCT02786901|12526952|FG001|COMPLETED|Overall Study||145
11329743|NCT02786901|12526953|FG002|COMPLETED|Overall Study||159
11329744|NCT02786901|12526951|FG000|NOT COMPLETED|Overall Study||77
11329745|NCT02786901|12526952|FG001|NOT COMPLETED|Overall Study||56
11329746|NCT02786901|12526953|FG002|NOT COMPLETED|Overall Study||41
11329747|NCT02786927|12526961|FG000|STARTED|Overall Study||212
11329748|NCT02786927|12526961|FG000|COMPLETED|Overall Study||207
11329749|NCT02786927|12526961|FG000|NOT COMPLETED|Overall Study||5
11329750|NCT02786953|12526968|FG000|STARTED|Overall Study||20
11329751|NCT02786953|12526969|FG001|STARTED|Overall Study||19
11329752|NCT02786953|12526968|FG000|Baseline Teen Survey Data Completed|Overall Study||20
11329753|NCT02786953|12526969|FG001|Baseline Teen Survey Data Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
11329754|NCT02786953|12526968|FG000|Baseline Parent Survey Completed|Overall Study||20
11329755|NCT02786953|12526969|FG001|Baseline Parent Survey Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
11329756|NCT02786953|12526968|FG000|Actigraph Data Complete|Overall Study||14
11329757|NCT02786953|12526969|FG001|Actigraph Data Complete|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|17
11329758|NCT02786953|12526968|FG000|A1C Data Baseline|Overall Study||20
11329759|NCT02786953|12526969|FG001|A1C Data Baseline|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
11329760|NCT02786953|12526968|FG000|Session 1 Completed|Overall Study||17
11329761|NCT02786953|12526969|FG001|Session 1 Completed|Overall Study||0
11329762|NCT02786953|12526968|FG000|Session 2 Completed|Overall Study||16
11329763|NCT02786953|12526969|FG001|Session 2 Completed|Overall Study||0
11329764|NCT02786953|12526968|FG000|Session 3 Completed|Overall Study||16
11329765|NCT02786953|12526969|FG001|Session 3 Completed|Overall Study||0
11329766|NCT02786953|12526968|FG000|3 Month Teen Survey Completed|Overall Study||17
11329767|NCT02786953|12526969|FG001|3 Month Teen Survey Completed|Overall Study||18
11329768|NCT02786953|12526968|FG000|3 Month Parent Survey Completed|Overall Study||17
11329769|NCT02786953|12526969|FG001|3 Month Parent Survey Completed|Overall Study||18
11329770|NCT02786953|12526968|FG000|A1C 3 Month|Overall Study||15
11329771|NCT02786953|12526969|FG001|A1C 3 Month|Overall Study||17
11329772|NCT02786953|12526968|FG000|COMPLETED|Overall Study||17
11329773|NCT02786953|12526969|FG001|COMPLETED|Overall Study||18
11329774|NCT02786953|12526968|FG000|NOT COMPLETED|Overall Study||3
11329775|NCT02786953|12526969|FG001|NOT COMPLETED|Overall Study||1
11329776|NCT02787057|12526977|FG000|STARTED|Overall Study||40
11329777|NCT02787057|12526978|FG001|STARTED|Overall Study||40
11329778|NCT02787057|12526977|FG000|COMPLETED|Overall Study||40
11329779|NCT02787057|12526978|FG001|COMPLETED|Overall Study||40
11329780|NCT02787057|12526977|FG000|NOT COMPLETED|Overall Study||0
11329781|NCT02787057|12526978|FG001|NOT COMPLETED|Overall Study||0
11329782|NCT02787083|12526986|FG000|STARTED|Overall Study||4
11329783|NCT02787083|12526987|FG001|STARTED|Overall Study||5
11329784|NCT02787083|12526986|FG000|COMPLETED|Overall Study||1
11329785|NCT02787083|12526987|FG001|COMPLETED|Overall Study||3
11329786|NCT02787083|12526986|FG000|NOT COMPLETED|Overall Study||3
11329787|NCT02787083|12526987|FG001|NOT COMPLETED|Overall Study||2
11329788|NCT02787291|12526993|FG000|STARTED|Overall Study||227
11329789|NCT02787291|12526993|FG000|COMPLETED|Overall Study||227
11329790|NCT02787291|12526993|FG000|NOT COMPLETED|Overall Study||0
11329791|NCT02787304|12527001|FG000|STARTED|Overall Study||49
11343779|NCT02956044|12541031|FG002|STARTED|Overall Study||18
11329792|NCT02787304|12527002|FG001|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50
11329793|NCT02787304|12527003|FG002|STARTED|Overall Study||49
11329794|NCT02787304|12527004|FG003|STARTED|Overall Study||49
11329795|NCT02787304|12527001|FG000|COMPLETED|Overall Study||13
11329796|NCT02787304|12527002|FG001|COMPLETED|Overall Study||12
11329797|NCT02787304|12527003|FG002|COMPLETED|Overall Study||8
11329798|NCT02787304|12527004|FG003|COMPLETED|Overall Study||15
11329799|NCT02787304|12527001|FG000|NOT COMPLETED|Overall Study||36
11329800|NCT02787304|12527002|FG001|NOT COMPLETED|Overall Study||38
11329801|NCT02787304|12527003|FG002|NOT COMPLETED|Overall Study||41
11329802|NCT02787304|12527004|FG003|NOT COMPLETED|Overall Study||34
11329803|NCT02787564|12527016|FG000|STARTED|Overall Study||32
11329804|NCT02787564|12527017|FG001|STARTED|Overall Study||29
11329805|NCT02787564|12527016|FG000|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
11329806|NCT02787564|12527017|FG001|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
11329807|NCT02787564|12527016|FG000|NOT COMPLETED|Overall Study||7
11329808|NCT02787564|12527017|FG001|NOT COMPLETED|Overall Study||2
11329809|NCT02787655|12527025|FG000|STARTED|Overall Study||40
11329810|NCT02787655|12527026|FG001|STARTED|Overall Study||38
11329811|NCT02787655|12527025|FG000|COMPLETED|Overall Study||29
11329812|NCT02787655|12527026|FG001|COMPLETED|Overall Study||26
11329813|NCT02787655|12527025|FG000|NOT COMPLETED|Overall Study||11
11329814|NCT02787655|12527026|FG001|NOT COMPLETED|Overall Study||12
11329815|NCT02787681|12527032|FG000|STARTED|Overall Study||71
11329816|NCT02787681|12527032|FG000|COMPLETED|Overall Study||69
11329817|NCT02787681|12527032|FG000|NOT COMPLETED|Overall Study||2
11329818|NCT02787694|12527036|FG000|STARTED|Overall Study||22
11329819|NCT02787694|12527036|FG000|COMPLETED|Overall Study||17
11329820|NCT02787694|12527036|FG000|NOT COMPLETED|Overall Study||5
11329821|NCT02787863|12527048|FG000|STARTED|Overall Study||33
11329822|NCT02787863|12527049|FG001|STARTED|Overall Study||34
11329823|NCT02787863|12527050|FG002|STARTED|Overall Study||25
11329824|NCT02787863|12527051|FG003|STARTED|Overall Study||25
11329825|NCT02787863|12527052|FG004|STARTED|Overall Study||32
11329826|NCT02787863|12527053|FG005|STARTED|Overall Study||18
11329827|NCT02787863|12527054|FG006|STARTED|Overall Study||25
11329828|NCT02787863|12527055|FG007|STARTED|Overall Study||27
11329829|NCT02787863|12527048|FG000|1 Year After Vaccination|Overall Study||32
11329830|NCT02787863|12527049|FG001|1 Year After Vaccination|Overall Study||33
11329831|NCT02787863|12527050|FG002|1 Year After Vaccination|Overall Study||23
11329832|NCT02787863|12527051|FG003|1 Year After Vaccination|Overall Study||25
11329833|NCT02787863|12527052|FG004|1 Year After Vaccination|Overall Study||32
11329834|NCT02787863|12527053|FG005|1 Year After Vaccination|Overall Study||18
11329835|NCT02787863|12527054|FG006|1 Year After Vaccination|Overall Study||25
11329836|NCT02787863|12527055|FG007|1 Year After Vaccination|Overall Study||27
11329837|NCT02787863|12527048|FG000|4 Years After Vaccination|Overall Study||32
11329838|NCT02787863|12527049|FG001|4 Years After Vaccination|Overall Study||33
11329839|NCT02787863|12527050|FG002|4 Years After Vaccination|Overall Study||23
11329840|NCT02787863|12527051|FG003|4 Years After Vaccination|Overall Study||25
11329841|NCT02787863|12527052|FG004|4 Years After Vaccination|Overall Study||32
11329842|NCT02787863|12527053|FG005|4 Years After Vaccination|Overall Study||18
11329843|NCT02787863|12527054|FG006|4 Years After Vaccination|Overall Study||25
11329844|NCT02787863|12527055|FG007|4 Years After Vaccination|Overall Study||27
11329845|NCT02787863|12527048|FG000|COMPLETED|Overall Study||32
11329846|NCT02787863|12527049|FG001|COMPLETED|Overall Study||33
11329847|NCT02787863|12527050|FG002|COMPLETED|Overall Study||23
11329848|NCT02787863|12527051|FG003|COMPLETED|Overall Study||25
11329849|NCT02787863|12527052|FG004|COMPLETED|Overall Study||32
11329850|NCT02787863|12527053|FG005|COMPLETED|Overall Study||18
11329851|NCT02787863|12527054|FG006|COMPLETED|Overall Study||25
11329852|NCT02787863|12527055|FG007|COMPLETED|Overall Study||27
11329853|NCT02787863|12527048|FG000|NOT COMPLETED|Overall Study||1
11329854|NCT02787863|12527049|FG001|NOT COMPLETED|Overall Study||1
11329855|NCT02787863|12527050|FG002|NOT COMPLETED|Overall Study||2
11329856|NCT02787863|12527051|FG003|NOT COMPLETED|Overall Study||0
11329857|NCT02787863|12527052|FG004|NOT COMPLETED|Overall Study||0
11329858|NCT02787863|12527053|FG005|NOT COMPLETED|Overall Study||0
11329859|NCT02787863|12527054|FG006|NOT COMPLETED|Overall Study||0
11329860|NCT02787863|12527055|FG007|NOT COMPLETED|Overall Study||0
11329861|NCT02788019|12527098|FG000|STARTED|Overall Study||27
11329862|NCT02788019|12527099|FG001|STARTED|Overall Study||25
11329863|NCT02788019|12527098|FG000|COMPLETED|Overall Study||23
11329864|NCT02788019|12527099|FG001|COMPLETED|Overall Study||20
11329865|NCT02788019|12527098|FG000|NOT COMPLETED|Overall Study||4
11329866|NCT02788019|12527099|FG001|NOT COMPLETED|Overall Study||5
11329867|NCT02788097|12527107|FG000|STARTED|Overall Study||61
11329868|NCT02788097|12527108|FG001|STARTED|Overall Study||69
11329869|NCT02788097|12527107|FG000|COMPLETED|Overall Study||61
11329870|NCT02788097|12527108|FG001|COMPLETED|Overall Study||69
11329871|NCT02788097|12527107|FG000|NOT COMPLETED|Overall Study||0
11329872|NCT02788097|12527108|FG001|NOT COMPLETED|Overall Study||0
11329873|NCT02788175|12527114|FG000|STARTED|Overall Study||26
11329874|NCT02788175|12527114|FG000|Received Study Agent|Overall Study||20
11329875|NCT02788175|12527114|FG000|COMPLETED|Overall Study||13
11329876|NCT02788175|12527114|FG000|NOT COMPLETED|Overall Study||13
11343780|NCT02956044|12541029|FG000|COMPLETED|Overall Study||18
11343781|NCT02956044|12541030|FG001|COMPLETED|Overall Study||18
11343782|NCT02956044|12541031|FG002|COMPLETED|Overall Study||18
11343783|NCT02956044|12541029|FG000|NOT COMPLETED|Overall Study||0
11329877|NCT02788188|12527125|FG000|STARTED|Overall Study||2
11329878|NCT02788188|12527126|FG001|STARTED|Overall Study||2
11329879|NCT02788188|12527127|FG002|STARTED|Overall Study||4
11329880|NCT02788188|12527128|FG003|STARTED|Overall Study||4
11027335|NCT00833560|12206050|FG000|COMPLETED|Overall Study||353
11027336|NCT00833560|12206050|FG000|NOT COMPLETED|Overall Study||42
11027337|NCT00833638|12206057|FG000|STARTED|Phase 2: Double-blind Treatment Phase||121
11027338|NCT00833638|12206058|FG001|STARTED|Phase 2: Double-blind Treatment Phase||118
11027339|NCT00833638|12206059|FG002|STARTED|Phase 2: Double-blind Treatment Phase||133
11329881|NCT02788188|12527129|FG004|STARTED|Overall Study||8
11329882|NCT02788188|12527130|FG005|STARTED|Overall Study||8
11329883|NCT02788188|12527131|FG006|STARTED|Overall Study||10
11329884|NCT02788188|12527125|FG000|COMPLETED|Overall Study||2
11329885|NCT02788188|12527126|FG001|COMPLETED|Overall Study||2
11329886|NCT02788188|12527127|FG002|COMPLETED|Overall Study||4
11329887|NCT02788188|12527128|FG003|COMPLETED|Overall Study||4
11329888|NCT02788188|12527129|FG004|COMPLETED|Overall Study||8
11329889|NCT02788188|12527130|FG005|COMPLETED|Overall Study||8
11329890|NCT02788188|12527131|FG006|COMPLETED|Overall Study||10
11329891|NCT02788188|12527125|FG000|NOT COMPLETED|Overall Study||0
11329892|NCT02788188|12527126|FG001|NOT COMPLETED|Overall Study||0
11329893|NCT02788188|12527127|FG002|NOT COMPLETED|Overall Study||0
11329894|NCT02788188|12527128|FG003|NOT COMPLETED|Overall Study||0
11329895|NCT02788188|12527129|FG004|NOT COMPLETED|Overall Study||0
11329896|NCT02788188|12527130|FG005|NOT COMPLETED|Overall Study||0
11329897|NCT02788188|12527131|FG006|NOT COMPLETED|Overall Study||0
11329898|NCT02788201|12527153|FG000|STARTED|Overall Study||1
11329899|NCT02788201|12527154|FG001|STARTED|Overall Study||1
11329900|NCT02788201|12527155|FG002|STARTED|Overall Study||1
11329901|NCT02788201|12527156|FG003|STARTED|Overall Study||1
11329902|NCT02788201|12527157|FG004|STARTED|Overall Study||1
11329903|NCT02788201|12527158|FG005|STARTED|Overall Study||3
11329904|NCT02788201|12527153|FG000|Did Not Start Treatment|Overall Study||0
11329905|NCT02788201|12527154|FG001|Did Not Start Treatment|Overall Study||0
11329906|NCT02788201|12527155|FG002|Did Not Start Treatment|Overall Study||0
11329907|NCT02788201|12527156|FG003|Did Not Start Treatment|Overall Study||0
11329908|NCT02788201|12527157|FG004|Did Not Start Treatment|Overall Study||0
11329909|NCT02788201|12527158|FG005|Did Not Start Treatment|Overall Study||3
11329910|NCT02788201|12527153|FG000|COMPLETED|Overall Study||0
11329911|NCT02788201|12527154|FG001|COMPLETED|Overall Study||0
11329912|NCT02788201|12527155|FG002|COMPLETED|Overall Study||0
11329913|NCT02788201|12527156|FG003|COMPLETED|Overall Study||0
11329914|NCT02788201|12527157|FG004|COMPLETED|Overall Study||1
11329915|NCT02788201|12527158|FG005|COMPLETED|Overall Study||0
11329916|NCT02788201|12527153|FG000|NOT COMPLETED|Overall Study||1
11329917|NCT02788201|12527154|FG001|NOT COMPLETED|Overall Study||1
11329918|NCT02788201|12527155|FG002|NOT COMPLETED|Overall Study||1
11329919|NCT02788201|12527156|FG003|NOT COMPLETED|Overall Study||1
11329920|NCT02788201|12527157|FG004|NOT COMPLETED|Overall Study||0
11329921|NCT02788201|12527158|FG005|NOT COMPLETED|Overall Study||3
11329922|NCT02788279|12527177|FG000|STARTED|Overall Study||90
11329923|NCT02788279|12527178|FG001|STARTED|Overall Study||183
11329924|NCT02788279|12527179|FG002|STARTED|Overall Study||90
11329925|NCT02788279|12527177|FG000|Received Treatment (Safety Population)|Overall Study||80
11329926|NCT02788279|12527178|FG001|Received Treatment (Safety Population)|Overall Study||179
11329927|NCT02788279|12527179|FG002|Received Treatment (Safety Population)|Overall Study||90
11329928|NCT02788279|12527177|FG000|Modified ITT Population|Overall Study||57
11329929|NCT02788279|12527178|FG001|Modified ITT Population|Overall Study||125
11329930|NCT02788279|12527179|FG002|Modified ITT Population|Overall Study||61
11329931|NCT02788279|12527177|FG000|COMPLETED|Overall Study||0
11329932|NCT02788279|12527178|FG001|COMPLETED|Overall Study||0
11329933|NCT02788279|12527179|FG002|COMPLETED|Overall Study||0
11329934|NCT02788279|12527177|FG000|NOT COMPLETED|Overall Study||90
11329935|NCT02788279|12527178|FG001|NOT COMPLETED|Overall Study||183
11329936|NCT02788279|12527179|FG002|NOT COMPLETED|Overall Study||90
11329937|NCT02788357|12527192|FG000|STARTED|Overall Study||6
11329938|NCT02788357|12527193|FG001|STARTED|Overall Study||6
11329939|NCT02788357|12527192|FG000|COMPLETED|Overall Study||3
11329940|NCT02788357|12527193|FG001|COMPLETED|Overall Study||6
11329941|NCT02788357|12527192|FG000|NOT COMPLETED|Overall Study||3
11329942|NCT02788357|12527193|FG001|NOT COMPLETED|Overall Study||0
11329943|NCT02788474|12527201|FG000|STARTED|Double Blind Treatment Period||231
11329944|NCT02788474|12527202|FG001|STARTED|Double Blind Treatment Period||116
11329945|NCT02788474|12527201|FG000|Treated|Double Blind Treatment Period||230
11329946|NCT02788474|12527202|FG001|Treated|Double Blind Treatment Period||116
11329947|NCT02788474|12527201|FG000|COMPLETED|Double Blind Treatment Period||221
11329948|NCT02788474|12527202|FG001|COMPLETED|Double Blind Treatment Period||112
11329949|NCT02788474|12527201|FG000|NOT COMPLETED|Double Blind Treatment Period||10
11329950|NCT02788474|12527202|FG001|NOT COMPLETED|Double Blind Treatment Period||4
11329951|NCT02788474|12527201|FG000|STARTED|Open Label Treatment Period||221
11329952|NCT02788474|12527202|FG001|STARTED|Open Label Treatment Period||112
11329953|NCT02788474|12527201|FG000|COMPLETED|Open Label Treatment Period||189
11329954|NCT02788474|12527202|FG001|COMPLETED|Open Label Treatment Period||100
11329955|NCT02788474|12527201|FG000|NOT COMPLETED|Open Label Treatment Period||32
11329956|NCT02788474|12527202|FG001|NOT COMPLETED|Open Label Treatment Period||12
11329957|NCT02788513|12527214|FG000|STARTED|Overall Study||123
11329958|NCT02788513|12527215|FG001|STARTED|Overall Study||122
11329959|NCT02788513|12527216|FG002|STARTED|Overall Study||122
11329960|NCT02788513|12527217|FG003|STARTED|Overall Study||123
11329961|NCT02788513|12527218|FG004|STARTED|Overall Study||120
11329962|NCT02788513|12527214|FG000|COMPLETED|Overall Study||114
11329963|NCT02788513|12527215|FG001|COMPLETED|Overall Study||114
11329964|NCT02788513|12527216|FG002|COMPLETED|Overall Study||114
11329965|NCT02788513|12527217|FG003|COMPLETED|Overall Study||117
11329966|NCT02788513|12527218|FG004|COMPLETED|Overall Study||115
11329967|NCT02788513|12527214|FG000|NOT COMPLETED|Overall Study||9
11329968|NCT02788513|12527215|FG001|NOT COMPLETED|Overall Study||8
11329969|NCT02788513|12527216|FG002|NOT COMPLETED|Overall Study||8
11329970|NCT02788513|12527217|FG003|NOT COMPLETED|Overall Study||6
11329971|NCT02788513|12527218|FG004|NOT COMPLETED|Overall Study||5
11329972|NCT02788656|12527232|FG000|STARTED|Overall Study||2
11329973|NCT02788656|12527233|FG001|STARTED|Overall Study||2
11329974|NCT02788656|12527232|FG000|COMPLETED|Overall Study||1
11329975|NCT02788656|12527233|FG001|COMPLETED|Overall Study||2
11329976|NCT02788656|12527232|FG000|NOT COMPLETED|Overall Study||1
11329977|NCT02788656|12527233|FG001|NOT COMPLETED|Overall Study||0
11329978|NCT02788747|12527242|FG000|STARTED|Overall Study||23
11329979|NCT02788747|12527243|FG001|STARTED|Overall Study||24
11329980|NCT02788747|12527244|FG002|STARTED|Overall Study||24
11329981|NCT02788747|12527242|FG000|COMPLETED|Overall Study||22
11329982|NCT02788747|12527243|FG001|COMPLETED|Overall Study||24
11329983|NCT02788747|12527244|FG002|COMPLETED|Overall Study||24
11329984|NCT02788747|12527242|FG000|NOT COMPLETED|Overall Study||1
11329985|NCT02788747|12527243|FG001|NOT COMPLETED|Overall Study||0
11329986|NCT02788747|12527244|FG002|NOT COMPLETED|Overall Study||0
11329987|NCT02788903|12527257|FG000|STARTED|Overall Study||567908
11329988|NCT02788903|12527258|FG001|STARTED|Overall Study||2054256
11329989|NCT02788903|12527257|FG000|COMPLETED|Overall Study||567908
11329990|NCT02788903|12527258|FG001|COMPLETED|Overall Study||2054256
11329991|NCT02788903|12527257|FG000|NOT COMPLETED|Overall Study||0
11329992|NCT02788903|12527258|FG001|NOT COMPLETED|Overall Study||0
11329993|NCT02789033|12527270|FG000|STARTED|Overall Study||17
11329994|NCT02789033|12527271|FG001|STARTED|Overall Study||17
11329995|NCT02789033|12527272|FG002|STARTED|Overall Study||17
11329996|NCT02789033|12527273|FG003|STARTED|Overall Study||17
11329997|NCT02789033|12527270|FG000|COMPLETED|Overall Study||15
11329998|NCT02789033|12527271|FG001|COMPLETED|Overall Study||15
11329999|NCT02789033|12527272|FG002|COMPLETED|Overall Study||16
11330000|NCT02789033|12527273|FG003|COMPLETED|Overall Study||15
11330001|NCT02789033|12527270|FG000|NOT COMPLETED|Overall Study||2
11330002|NCT02789033|12527271|FG001|NOT COMPLETED|Overall Study||2
11330003|NCT02789033|12527272|FG002|NOT COMPLETED|Overall Study||1
11330004|NCT02789033|12527273|FG003|NOT COMPLETED|Overall Study||2
11330005|NCT02789111|12527285|FG000|STARTED|Overall Study||24
11330006|NCT02789111|12527286|FG001|STARTED|Overall Study||25
11330007|NCT02789111|12527285|FG000|COMPLETED|Overall Study||23
11330008|NCT02789111|12527286|FG001|COMPLETED|Overall Study||21
11330009|NCT02789111|12527285|FG000|NOT COMPLETED|Overall Study||1
11330010|NCT02789111|12527286|FG001|NOT COMPLETED|Overall Study||4
11330011|NCT02789137|12527294|FG000|STARTED|Overall Study||111
11330012|NCT02789137|12527294|FG000|COMPLETED|Overall Study||53
11330013|NCT02789137|12527294|FG000|NOT COMPLETED|Overall Study||58
11330014|NCT02789176|12527303|FG000|STARTED|Overall Study||99
11330015|NCT02789176|12527304|FG001|STARTED|Overall Study||55
11330016|NCT02789176|12527305|FG002|STARTED|Overall Study||95
11330017|NCT02789176|12527306|FG003|STARTED|Overall Study||54
11330018|NCT02789176|12527303|FG000|COMPLETED|Overall Study||91
11330019|NCT02789176|12527304|FG001|COMPLETED|Overall Study||53
11330020|NCT02789176|12527305|FG002|COMPLETED|Overall Study||85
11330021|NCT02789176|12527306|FG003|COMPLETED|Overall Study||53
11330022|NCT02789176|12527303|FG000|NOT COMPLETED|Overall Study||8
11330023|NCT02789176|12527304|FG001|NOT COMPLETED|Overall Study||2
11330024|NCT02789176|12527305|FG002|NOT COMPLETED|Overall Study||10
11330025|NCT02789176|12527306|FG003|NOT COMPLETED|Overall Study||1
11330026|NCT02789410|12527318|FG000|STARTED|Overall Study||66
11330027|NCT02789410|12527319|FG001|STARTED|Overall Study||68
11330028|NCT02789410|12527318|FG000|COMPLETED|Overall Study||66
11330029|NCT02789410|12527319|FG001|COMPLETED|Overall Study||68
11330030|NCT02789410|12527318|FG000|NOT COMPLETED|Overall Study||0
11330031|NCT02789410|12527319|FG001|NOT COMPLETED|Overall Study||0
11330032|NCT02790073|12527325|FG000|STARTED|Overall Study||14
11330033|NCT02790073|12527325|FG000|COMPLETED|Overall Study||11
11330034|NCT02790073|12527325|FG000|NOT COMPLETED|Overall Study||3
11330035|NCT02790281|12527329|FG000|STARTED|Overall Study||33
11330036|NCT02790281|12527329|FG000|COMPLETED|Overall Study||33
11330037|NCT02790281|12527329|FG000|NOT COMPLETED|Overall Study||0
11330038|NCT02790437|12527335|FG000|STARTED|Overall Study||16
11330039|NCT02790437|12527336|FG001|STARTED|Overall Study||3
11330040|NCT02790437|12527335|FG000|COMPLETED|Overall Study||13
11330041|NCT02790437|12527336|FG001|COMPLETED|Overall Study||3
11330042|NCT02790437|12527335|FG000|NOT COMPLETED|Overall Study||3
11330043|NCT02790437|12527336|FG001|NOT COMPLETED|Overall Study||0
11330044|NCT02790463|12527351|FG000|STARTED|Overall Study||782
11330045|NCT02790463|12527352|FG001|STARTED|Overall Study||681
11330046|NCT02790463|12527351|FG000|COMPLETED|Overall Study||782
11330047|NCT02790463|12527352|FG001|COMPLETED|Overall Study||372
11330048|NCT02790463|12527351|FG000|NOT COMPLETED|Overall Study||0
11330049|NCT02790463|12527352|FG001|NOT COMPLETED|Overall Study||309
11330050|NCT02790606|12527358|FG000|STARTED|Overall Study||110
11330051|NCT02790606|12527358|FG000|COMPLETED|Overall Study||75
11330052|NCT02790606|12527358|FG000|NOT COMPLETED|Overall Study||35
11330053|NCT02790736|12527364|FG000|STARTED|Overall Study||5
11330054|NCT02790736|12527365|FG001|STARTED|Overall Study||1
11330055|NCT02790736|12527364|FG000|COMPLETED|Overall Study||5
11330056|NCT02790736|12527365|FG001|COMPLETED|Overall Study||1
11330057|NCT02790736|12527364|FG000|NOT COMPLETED|Overall Study||0
11330058|NCT02790736|12527365|FG001|NOT COMPLETED|Overall Study||0
11330059|NCT02790788|12527373|FG000|STARTED|Overall Study||46
11330060|NCT02790788|12527374|FG001|STARTED|Overall Study||54
11330061|NCT02790788|12527373|FG000|COMPLETED|Overall Study||46
11330062|NCT02790788|12527374|FG001|COMPLETED|Overall Study||54
11330063|NCT02790788|12527373|FG000|NOT COMPLETED|Overall Study||0
11330064|NCT02790788|12527374|FG001|NOT COMPLETED|Overall Study||0
11330065|NCT02791191|12527385|FG000|STARTED|Overall Study||55
11330066|NCT02791191|12527386|FG001|STARTED|Overall Study||128
11330067|NCT02791191|12527387|FG002|STARTED|Overall Study||133
11330068|NCT02791191|12527385|FG000|Received One Dose of Study Drug|Overall Study||55
11330069|NCT02791191|12527386|FG001|Received One Dose of Study Drug|Overall Study||127
11330070|NCT02791191|12527387|FG002|Received One Dose of Study Drug|Overall Study||133
11330071|NCT02791191|12527385|FG000|COMPLETED|Overall Study||17
11330072|NCT02791191|12527386|FG001|COMPLETED|Overall Study||17
11330073|NCT02791191|12527387|FG002|COMPLETED|Overall Study||13
11330074|NCT02791191|12527385|FG000|NOT COMPLETED|Overall Study||38
11330075|NCT02791191|12527386|FG001|NOT COMPLETED|Overall Study||111
11330076|NCT02791191|12527387|FG002|NOT COMPLETED|Overall Study||120
11330077|NCT02791269|12527397|FG000|STARTED|Overall Study||4
11330078|NCT02791269|12527398|FG001|STARTED|Overall Study||20
11330079|NCT02791269|12527397|FG000|COMPLETED|Overall Study||4
11330080|NCT02791269|12527398|FG001|COMPLETED|Overall Study||19
11330081|NCT02791269|12527397|FG000|NOT COMPLETED|Overall Study||0
11330082|NCT02791269|12527398|FG001|NOT COMPLETED|Overall Study||1
11330083|NCT02791308|12527409|FG000|STARTED|Overall Study||195
11330084|NCT02791308|12527410|FG001|STARTED|Overall Study||196
11330085|NCT02791308|12527411|FG002|STARTED|Overall Study||196
11330086|NCT02791308|12527409|FG000|COMPLETED|Overall Study||185
11330087|NCT02791308|12527410|FG001|COMPLETED|Overall Study||187
11330088|NCT02791308|12527411|FG002|COMPLETED|Overall Study||179
11330089|NCT02791308|12527409|FG000|NOT COMPLETED|Overall Study||10
11330090|NCT02791308|12527410|FG001|NOT COMPLETED|Overall Study||9
11330091|NCT02791308|12527411|FG002|NOT COMPLETED|Overall Study||17
11330092|NCT02791399|12527421|FG000|STARTED|Overall Study||136
11330093|NCT02791399|12527422|FG001|STARTED|Overall Study||150
11330094|NCT02791399|12527421|FG000|COMPLETED|Overall Study||123
11330095|NCT02791399|12527422|FG001|COMPLETED|Overall Study||135
11330096|NCT02791399|12527421|FG000|NOT COMPLETED|Overall Study||13
11330097|NCT02791399|12527422|FG001|NOT COMPLETED|Overall Study||15
11330098|NCT02791438|12527430|FG000|STARTED|Run-In Period||22
11330099|NCT02791438|12527431|FG001|STARTED|Run-In Period||5
11330100|NCT02791438|12527430|FG000|COMPLETED|Run-In Period||22
11330101|NCT02791438|12527431|FG001|COMPLETED|Run-In Period||5
11330102|NCT02791438|12527430|FG000|NOT COMPLETED|Run-In Period||0
11330103|NCT02791438|12527431|FG001|NOT COMPLETED|Run-In Period||0
11330104|NCT02791438|12527430|FG000|STARTED|Treatment Period||22
11330105|NCT02791438|12527431|FG001|STARTED|Treatment Period||5
11330106|NCT02791438|12527430|FG000|COMPLETED|Treatment Period||19
11330107|NCT02791438|12527431|FG001|COMPLETED|Treatment Period||4
11330108|NCT02791438|12527430|FG000|NOT COMPLETED|Treatment Period||3
11330109|NCT02791438|12527431|FG001|NOT COMPLETED|Treatment Period||1
11330110|NCT02791490|12527439|FG000|STARTED|Overall Study||229
11330111|NCT02791490|12527440|FG001|STARTED|Overall Study||229
11330112|NCT02791490|12527439|FG000|COMPLETED|Overall Study||226
11330113|NCT02791490|12527440|FG001|COMPLETED|Overall Study||221
11330114|NCT02791490|12527439|FG000|NOT COMPLETED|Overall Study||3
11330115|NCT02791490|12527440|FG001|NOT COMPLETED|Overall Study||8
11330116|NCT02791516|12527448|FG000|STARTED|Overall Study||33
11330117|NCT02791516|12527449|FG001|STARTED|Overall Study||34
11330118|NCT02791516|12527448|FG000|Completed 6-month Treatment Period|Overall Study||33
11330119|NCT02791516|12527449|FG001|Completed 6-month Treatment Period|Overall Study||33
11330120|NCT02791516|12527448|FG000|COMPLETED|Overall Study||32
11330121|NCT02791516|12527449|FG001|COMPLETED|Overall Study||33
11330122|NCT02791516|12527448|FG000|NOT COMPLETED|Overall Study||1
11330123|NCT02791516|12527449|FG001|NOT COMPLETED|Overall Study||1
11330124|NCT02791659|12527457|FG000|STARTED|Overall Study||27
11330125|NCT02791659|12527458|FG001|STARTED|Overall Study||28
11330126|NCT02791659|12527457|FG000|COMPLETED|Overall Study||27
11330127|NCT02791659|12527458|FG001|COMPLETED|Overall Study||27
11330128|NCT02791659|12527457|FG000|NOT COMPLETED|Overall Study||0
11330129|NCT02791659|12527458|FG001|NOT COMPLETED|Overall Study||1
11343784|NCT02956044|12541030|FG001|NOT COMPLETED|Overall Study||0
11343785|NCT02956044|12541031|FG002|NOT COMPLETED|Overall Study||0
11343786|NCT02956057|12541059|FG000|STARTED|Overall Study||174
11343787|NCT02956057|12541060|FG001|STARTED|Overall Study||174
11343788|NCT02956057|12541061|FG002|STARTED|Overall Study||174
11343789|NCT02956057|12541062|FG003|STARTED|Overall Study||174
11343790|NCT02956057|12541063|FG004|STARTED|Overall Study||174
11343791|NCT02956057|12541064|FG005|STARTED|Overall Study||174
11343792|NCT02956057|12541059|FG000|COMPLETED|Overall Study||160
11343793|NCT02956057|12541060|FG001|COMPLETED|Overall Study||162
11343794|NCT02956057|12541061|FG002|COMPLETED|Overall Study||166
11343795|NCT02956057|12541062|FG003|COMPLETED|Overall Study||159
11343796|NCT02956057|12541063|FG004|COMPLETED|Overall Study||169
11343797|NCT02956057|12541064|FG005|COMPLETED|Overall Study||157
11343798|NCT02956057|12541059|FG000|NOT COMPLETED|Overall Study||14
11343799|NCT02956057|12541060|FG001|NOT COMPLETED|Overall Study||12
11330130|NCT02791763|12527467|FG000|STARTED|Overall Study||149
11330131|NCT02791763|12527468|FG001|STARTED|Overall Study||150
11330132|NCT02791763|12527469|FG002|STARTED|Overall Study||56
11330133|NCT02791763|12527467|FG000|COMPLETED|Overall Study||111
11330134|NCT02791763|12527468|FG001|COMPLETED|Overall Study||113
11330135|NCT02791763|12527469|FG002|COMPLETED|Overall Study||43
11330136|NCT02791763|12527467|FG000|NOT COMPLETED|Overall Study||38
11330137|NCT02791763|12527468|FG001|NOT COMPLETED|Overall Study||37
11330138|NCT02791763|12527469|FG002|NOT COMPLETED|Overall Study||13
11330139|NCT02791893|12527488|FG000|STARTED|Blinded Phase||13
11330140|NCT02791893|12527489|FG001|STARTED|Blinded Phase||14
11330141|NCT02791893|12527488|FG000|COMPLETED|Blinded Phase||10
11330142|NCT02791893|12527489|FG001|COMPLETED|Blinded Phase||10
11330143|NCT02791893|12527488|FG000|NOT COMPLETED|Blinded Phase||3
11330144|NCT02791893|12527489|FG001|NOT COMPLETED|Blinded Phase||4
11330145|NCT02791893|12527488|FG000|STARTED|Open Label Phase||10
11330146|NCT02791893|12527489|FG001|STARTED|Open Label Phase||10
11330147|NCT02791893|12527488|FG000|COMPLETED|Open Label Phase||7
11330148|NCT02791893|12527489|FG001|COMPLETED|Open Label Phase||8
11330149|NCT02791893|12527488|FG000|NOT COMPLETED|Open Label Phase||3
11330150|NCT02791893|12527489|FG001|NOT COMPLETED|Open Label Phase||2
11330151|NCT02791906|12527497|FG000|STARTED|Overall Study||4
11330152|NCT02791906|12527498|FG001|STARTED|Overall Study||3
11330153|NCT02791906|12527497|FG000|COMPLETED|Overall Study||2
11330154|NCT02791906|12527498|FG001|COMPLETED|Overall Study||2
11330155|NCT02791906|12527497|FG000|NOT COMPLETED|Overall Study||2
11330156|NCT02791906|12527498|FG001|NOT COMPLETED|Overall Study||1
11330157|NCT02791945|12527508|FG000|STARTED|Overall Study||14
11330158|NCT02791945|12527509|FG001|STARTED|Overall Study||16
11330159|NCT02791945|12527508|FG000|COMPLETED|Overall Study||12
11330160|NCT02791945|12527509|FG001|COMPLETED|Overall Study||14
11330161|NCT02791945|12527508|FG000|NOT COMPLETED|Overall Study||2
11330162|NCT02791945|12527509|FG001|NOT COMPLETED|Overall Study||2
11330163|NCT02792049|12527517|FG000|STARTED|Overall Study||35
11330164|NCT02792049|12527518|FG001|STARTED|Overall Study||35
11330165|NCT02792049|12527517|FG000|COMPLETED|Overall Study||35
11330166|NCT02792049|12527518|FG001|COMPLETED|Overall Study||35
11330167|NCT02792049|12527517|FG000|NOT COMPLETED|Overall Study||0
11330168|NCT02792049|12527518|FG001|NOT COMPLETED|Overall Study||0
11330169|NCT02792062|12527532|FG000|STARTED|Intervention Period 1 (6 Days)||2
11330170|NCT02792062|12527533|FG001|STARTED|Intervention Period 1 (6 Days)||2
11330171|NCT02792062|12527534|FG002|STARTED|Intervention Period 1 (6 Days)||2
11330172|NCT02792062|12527535|FG003|STARTED|Intervention Period 1 (6 Days)||2
11330173|NCT02792062|12527536|FG004|STARTED|Intervention Period 1 (6 Days)||2
11330174|NCT02792062|12527537|FG005|STARTED|Intervention Period 1 (6 Days)||2
11330175|NCT02792062|12527532|FG000|COMPLETED|Intervention Period 1 (6 Days)||2
11330176|NCT02792062|12527533|FG001|COMPLETED|Intervention Period 1 (6 Days)||2
11330177|NCT02792062|12527534|FG002|COMPLETED|Intervention Period 1 (6 Days)||2
11330178|NCT02792062|12527535|FG003|COMPLETED|Intervention Period 1 (6 Days)||2
11330179|NCT02792062|12527536|FG004|COMPLETED|Intervention Period 1 (6 Days)||2
11330180|NCT02792062|12527537|FG005|COMPLETED|Intervention Period 1 (6 Days)||2
11330181|NCT02792062|12527532|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
11330182|NCT02792062|12527533|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
11330183|NCT02792062|12527534|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0
11330184|NCT02792062|12527535|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0
11330185|NCT02792062|12527536|FG004|NOT COMPLETED|Intervention Period 1 (6 Days)||0
11330186|NCT02792062|12527537|FG005|NOT COMPLETED|Intervention Period 1 (6 Days)||0
11330187|NCT02792062|12527532|FG000|STARTED|Washout Period (at Least 14 Days)||2
11330188|NCT02792062|12527533|FG001|STARTED|Washout Period (at Least 14 Days)||2
11330189|NCT02792062|12527534|FG002|STARTED|Washout Period (at Least 14 Days)||2
11330190|NCT02792062|12527535|FG003|STARTED|Washout Period (at Least 14 Days)||2
11330191|NCT02792062|12527536|FG004|STARTED|Washout Period (at Least 14 Days)||2
11330192|NCT02792062|12527537|FG005|STARTED|Washout Period (at Least 14 Days)||2
11330193|NCT02792062|12527532|FG000|COMPLETED|Washout Period (at Least 14 Days)||2
11330194|NCT02792062|12527533|FG001|COMPLETED|Washout Period (at Least 14 Days)||2
11330195|NCT02792062|12527534|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
11330196|NCT02792062|12527535|FG003|COMPLETED|Washout Period (at Least 14 Days)||2
11330197|NCT02792062|12527536|FG004|COMPLETED|Washout Period (at Least 14 Days)||2
11330198|NCT02792062|12527537|FG005|COMPLETED|Washout Period (at Least 14 Days)||2
11330199|NCT02792062|12527532|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11330200|NCT02792062|12527533|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11330201|NCT02792062|12527534|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11330202|NCT02792062|12527535|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11330203|NCT02792062|12527536|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11330204|NCT02792062|12527537|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11330205|NCT02792062|12527532|FG000|STARTED|Intervention Period 2 (6 Days)||2
11330206|NCT02792062|12527533|FG001|STARTED|Intervention Period 2 (6 Days)||2
11330207|NCT02792062|12527534|FG002|STARTED|Intervention Period 2 (6 Days)||2
11330208|NCT02792062|12527535|FG003|STARTED|Intervention Period 2 (6 Days)||2
11330209|NCT02792062|12527536|FG004|STARTED|Intervention Period 2 (6 Days)||2
11330210|NCT02792062|12527537|FG005|STARTED|Intervention Period 2 (6 Days)||2
11330211|NCT02792062|12527532|FG000|COMPLETED|Intervention Period 2 (6 Days)||2
11330212|NCT02792062|12527533|FG001|COMPLETED|Intervention Period 2 (6 Days)||2
11330213|NCT02792062|12527534|FG002|COMPLETED|Intervention Period 2 (6 Days)||2
11330214|NCT02792062|12527535|FG003|COMPLETED|Intervention Period 2 (6 Days)||2
11330215|NCT02792062|12527536|FG004|COMPLETED|Intervention Period 2 (6 Days)||2
11330216|NCT02792062|12527537|FG005|COMPLETED|Intervention Period 2 (6 Days)||2
11330217|NCT02792062|12527532|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
11330218|NCT02792062|12527533|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
11330219|NCT02792062|12527534|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0
11330220|NCT02792062|12527535|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0
11330221|NCT02792062|12527536|FG004|NOT COMPLETED|Intervention Period 2 (6 Days)||0
11330222|NCT02792062|12527537|FG005|NOT COMPLETED|Intervention Period 2 (6 Days)||0
11330223|NCT02792062|12527532|FG000|STARTED|Washout Period (at Least 14 Days)||2
11330224|NCT02792062|12527533|FG001|STARTED|Washout Period (at Least 14 Days)||2
11330225|NCT02792062|12527534|FG002|STARTED|Washout Period (at Least 14 Days)||2
11330226|NCT02792062|12527535|FG003|STARTED|Washout Period (at Least 14 Days)||2
11330227|NCT02792062|12527536|FG004|STARTED|Washout Period (at Least 14 Days)||2
11330228|NCT02792062|12527537|FG005|STARTED|Washout Period (at Least 14 Days)||2
11330229|NCT02792062|12527532|FG000|COMPLETED|Washout Period (at Least 14 Days)||1
11330230|NCT02792062|12527533|FG001|COMPLETED|Washout Period (at Least 14 Days)||2
11330231|NCT02792062|12527534|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
11330232|NCT02792062|12527535|FG003|COMPLETED|Washout Period (at Least 14 Days)||2
11330233|NCT02792062|12527536|FG004|COMPLETED|Washout Period (at Least 14 Days)||2
11330234|NCT02792062|12527537|FG005|COMPLETED|Washout Period (at Least 14 Days)||2
11330235|NCT02792062|12527532|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||1
11330236|NCT02792062|12527533|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11330237|NCT02792062|12527534|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11330238|NCT02792062|12527535|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11330239|NCT02792062|12527536|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11330240|NCT02792062|12527537|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11330241|NCT02792062|12527532|FG000|STARTED|Intervention Period 3 (6 Days)||1
11330242|NCT02792062|12527533|FG001|STARTED|Intervention Period 3 (6 Days)||2
11330243|NCT02792062|12527534|FG002|STARTED|Intervention Period 3 (6 Days)||2
11330244|NCT02792062|12527535|FG003|STARTED|Intervention Period 3 (6 Days)||2
11330245|NCT02792062|12527536|FG004|STARTED|Intervention Period 3 (6 Days)||2
11330246|NCT02792062|12527537|FG005|STARTED|Intervention Period 3 (6 Days)||2
11330247|NCT02792062|12527532|FG000|COMPLETED|Intervention Period 3 (6 Days)||1
11330248|NCT02792062|12527533|FG001|COMPLETED|Intervention Period 3 (6 Days)||2
11330249|NCT02792062|12527534|FG002|COMPLETED|Intervention Period 3 (6 Days)||2
11330250|NCT02792062|12527535|FG003|COMPLETED|Intervention Period 3 (6 Days)||2
11330251|NCT02792062|12527536|FG004|COMPLETED|Intervention Period 3 (6 Days)||2
11330252|NCT02792062|12527537|FG005|COMPLETED|Intervention Period 3 (6 Days)||2
11330253|NCT02792062|12527532|FG000|NOT COMPLETED|Intervention Period 3 (6 Days)||0
11330254|NCT02792062|12527533|FG001|NOT COMPLETED|Intervention Period 3 (6 Days)||0
11330255|NCT02792062|12527534|FG002|NOT COMPLETED|Intervention Period 3 (6 Days)||0
11330256|NCT02792062|12527535|FG003|NOT COMPLETED|Intervention Period 3 (6 Days)||0
11330257|NCT02792062|12527536|FG004|NOT COMPLETED|Intervention Period 3 (6 Days)||0
11330258|NCT02792062|12527537|FG005|NOT COMPLETED|Intervention Period 3 (6 Days)||0
11330259|NCT02792192|12527549|FG000|STARTED|Overall Study||12
11330260|NCT02792192|12527550|FG001|STARTED|Overall Study||12
11330261|NCT02792192|12527551|FG002|STARTED|Overall Study||0
11330262|NCT02792192|12527552|FG003|STARTED|Overall Study||0
11330263|NCT02792192|12527549|FG000|COMPLETED|Overall Study||0
11330264|NCT02792192|12527550|FG001|COMPLETED|Overall Study||1
11330265|NCT02792192|12527551|FG002|COMPLETED|Overall Study||0
11330266|NCT02792192|12527552|FG003|COMPLETED|Overall Study||0
11330267|NCT02792192|12527549|FG000|NOT COMPLETED|Overall Study||12
11330268|NCT02792192|12527550|FG001|NOT COMPLETED|Overall Study||11
11330269|NCT02792192|12527551|FG002|NOT COMPLETED|Overall Study||0
11330270|NCT02792192|12527552|FG003|NOT COMPLETED|Overall Study||0
11330271|NCT02792218|12527565|FG000|STARTED|Overall Study||465
11330272|NCT02792218|12527566|FG001|STARTED|Overall Study||462
11330273|NCT02792218|12527565|FG000|COMPLETED|Overall Study||416
11330274|NCT02792218|12527566|FG001|COMPLETED|Overall Study||381
11330275|NCT02792218|12527565|FG000|NOT COMPLETED|Overall Study||49
11330276|NCT02792218|12527566|FG001|NOT COMPLETED|Overall Study||81
11330277|NCT02792231|12527574|FG000|STARTED|Overall Study||481
11330278|NCT02792231|12527575|FG001|STARTED|Overall Study||474
11330279|NCT02792231|12527574|FG000|COMPLETED|Overall Study||399
11330280|NCT02792231|12527575|FG001|COMPLETED|Overall Study||390
11330281|NCT02792231|12527574|FG000|NOT COMPLETED|Overall Study||82
11330282|NCT02792231|12527575|FG001|NOT COMPLETED|Overall Study||84
11330283|NCT02792504|12527581|FG000|STARTED|Overall Study||669
11330284|NCT02792504|12527581|FG000|Safety Analysis Set|Overall Study||639
11330285|NCT02792504|12527581|FG000|Efficacy Analysis Set|Overall Study||390
11330286|NCT02792504|12527581|FG000|COMPLETED|Overall Study||639
11330287|NCT02792504|12527581|FG000|NOT COMPLETED|Overall Study||30
11330288|NCT02792517|12527585|FG000|STARTED|Overall Study||41
11330289|NCT02792517|12527585|FG000|Received Erenumab|Overall Study||24
11330290|NCT02792517|12527585|FG000|COMPLETED|Overall Study||21
11330291|NCT02792517|12527585|FG000|NOT COMPLETED|Overall Study||20
11330292|NCT02792699|12527592|FG000|STARTED|Overall Study||104
11330293|NCT02792699|12527593|FG001|STARTED|Overall Study||104
11330294|NCT02792699|12527594|FG002|STARTED|Overall Study||103
11330295|NCT02792699|12527592|FG000|Received First Infusion of First Dose|Overall Study||104
11330296|NCT02792699|12527593|FG001|Received First Infusion of First Dose|Overall Study||104
11330297|NCT02792699|12527594|FG002|Received First Infusion of First Dose|Overall Study||103
11330298|NCT02792699|12527592|FG000|Received Second Infusion of First Dose|Overall Study||102
11330299|NCT02792699|12527593|FG001|Received Second Infusion of First Dose|Overall Study||103
11330300|NCT02792699|12527594|FG002|Received Second Infusion of First Dose|Overall Study||99
11330301|NCT02792699|12527592|FG000|Received First Infusion of Second Dose|Overall Study||97
11330302|NCT02792699|12527593|FG001|Received First Infusion of Second Dose|Overall Study||99
11330303|NCT02792699|12527594|FG002|Received First Infusion of Second Dose|Overall Study||95
11330304|NCT02792699|12527592|FG000|Received Second Infusion of Second Dose|Overall Study||97
11330305|NCT02792699|12527593|FG001|Received Second Infusion of Second Dose|Overall Study||99
11330306|NCT02792699|12527594|FG002|Received Second Infusion of Second Dose|Overall Study||93
11330307|NCT02792699|12527592|FG000|COMPLETED|Overall Study||95
11330308|NCT02792699|12527593|FG001|COMPLETED|Overall Study||94
11330309|NCT02792699|12527594|FG002|COMPLETED|Overall Study||93
11330310|NCT02792699|12527592|FG000|NOT COMPLETED|Overall Study||9
11330311|NCT02792699|12527593|FG001|NOT COMPLETED|Overall Study||10
11330312|NCT02792699|12527594|FG002|NOT COMPLETED|Overall Study||10
11330313|NCT02792777|12527611|FG000|STARTED|Overall Study||96
11330314|NCT02792777|12527612|FG001|STARTED|Overall Study||52
11330315|NCT02792777|12527611|FG000|COMPLETED|Overall Study||89
11330316|NCT02792777|12527612|FG001|COMPLETED|Overall Study||52
11330317|NCT02792777|12527611|FG000|NOT COMPLETED|Overall Study||7
11330318|NCT02792777|12527612|FG001|NOT COMPLETED|Overall Study||0
11330319|NCT02792829|12527627|FG000|STARTED|Treatment Period 1||10
11330320|NCT02792829|12527628|FG001|STARTED|Treatment Period 1||10
11330321|NCT02792829|12527629|FG002|STARTED|Treatment Period 1||5
11330322|NCT02792829|12527630|FG003|STARTED|Treatment Period 1||5
11330323|NCT02792829|12527631|FG004|STARTED|Treatment Period 1||5
11330324|NCT02792829|12527632|FG005|STARTED|Treatment Period 1||5
11330325|NCT02792829|12527633|FG006|STARTED|Treatment Period 1||10
11330326|NCT02792829|12527634|FG007|STARTED|Treatment Period 1||10
11330327|NCT02792829|12527627|FG000|COMPLETED|Treatment Period 1||10
11330328|NCT02792829|12527628|FG001|COMPLETED|Treatment Period 1||10
11330329|NCT02792829|12527629|FG002|COMPLETED|Treatment Period 1||5
11330330|NCT02792829|12527630|FG003|COMPLETED|Treatment Period 1||5
11330331|NCT02792829|12527631|FG004|COMPLETED|Treatment Period 1||5
11330332|NCT02792829|12527632|FG005|COMPLETED|Treatment Period 1||5
11330333|NCT02792829|12527633|FG006|COMPLETED|Treatment Period 1||10
11330334|NCT02792829|12527634|FG007|COMPLETED|Treatment Period 1||10
11330335|NCT02792829|12527627|FG000|NOT COMPLETED|Treatment Period 1||0
11330336|NCT02792829|12527628|FG001|NOT COMPLETED|Treatment Period 1||0
11330337|NCT02792829|12527629|FG002|NOT COMPLETED|Treatment Period 1||0
11330338|NCT02792829|12527630|FG003|NOT COMPLETED|Treatment Period 1||0
11330339|NCT02792829|12527631|FG004|NOT COMPLETED|Treatment Period 1||0
11330340|NCT02792829|12527632|FG005|NOT COMPLETED|Treatment Period 1||0
11330341|NCT02792829|12527633|FG006|NOT COMPLETED|Treatment Period 1||0
11330342|NCT02792829|12527634|FG007|NOT COMPLETED|Treatment Period 1||0
11330343|NCT02792829|12527627|FG000|STARTED|Wash Out Period||10
11330344|NCT02792829|12527628|FG001|STARTED|Wash Out Period||10
11330345|NCT02792829|12527629|FG002|STARTED|Wash Out Period||5
11330346|NCT02792829|12527630|FG003|STARTED|Wash Out Period||5
11330347|NCT02792829|12527631|FG004|STARTED|Wash Out Period||5
11330348|NCT02792829|12527632|FG005|STARTED|Wash Out Period||5
11330349|NCT02792829|12527633|FG006|STARTED|Wash Out Period||10
11330350|NCT02792829|12527634|FG007|STARTED|Wash Out Period||10
11330351|NCT02792829|12527627|FG000|COMPLETED|Wash Out Period||10
11330352|NCT02792829|12527628|FG001|COMPLETED|Wash Out Period||10
11330353|NCT02792829|12527629|FG002|COMPLETED|Wash Out Period||5
11330354|NCT02792829|12527630|FG003|COMPLETED|Wash Out Period||5
11330355|NCT02792829|12527631|FG004|COMPLETED|Wash Out Period||5
11330356|NCT02792829|12527632|FG005|COMPLETED|Wash Out Period||5
11330357|NCT02792829|12527633|FG006|COMPLETED|Wash Out Period||10
11330358|NCT02792829|12527634|FG007|COMPLETED|Wash Out Period||10
11330359|NCT02792829|12527627|FG000|NOT COMPLETED|Wash Out Period||0
11330360|NCT02792829|12527628|FG001|NOT COMPLETED|Wash Out Period||0
11330361|NCT02792829|12527629|FG002|NOT COMPLETED|Wash Out Period||0
11330362|NCT02792829|12527630|FG003|NOT COMPLETED|Wash Out Period||0
11330363|NCT02792829|12527631|FG004|NOT COMPLETED|Wash Out Period||0
11330364|NCT02792829|12527632|FG005|NOT COMPLETED|Wash Out Period||0
11330365|NCT02792829|12527633|FG006|NOT COMPLETED|Wash Out Period||0
11330366|NCT02792829|12527634|FG007|NOT COMPLETED|Wash Out Period||0
11330367|NCT02792829|12527627|FG000|STARTED|Treatment Period 2||10
11330368|NCT02792829|12527628|FG001|STARTED|Treatment Period 2||10
11330369|NCT02792829|12527629|FG002|STARTED|Treatment Period 2||5
11330370|NCT02792829|12527630|FG003|STARTED|Treatment Period 2||5
11330371|NCT02792829|12527631|FG004|STARTED|Treatment Period 2||5
11330372|NCT02792829|12527632|FG005|STARTED|Treatment Period 2||5
11330373|NCT02792829|12527633|FG006|STARTED|Treatment Period 2||10
11330374|NCT02792829|12527634|FG007|STARTED|Treatment Period 2||10
11330375|NCT02792829|12527627|FG000|COMPLETED|Treatment Period 2||10
11330376|NCT02792829|12527628|FG001|COMPLETED|Treatment Period 2||9
11330377|NCT02792829|12527629|FG002|COMPLETED|Treatment Period 2||5
11330378|NCT02792829|12527630|FG003|COMPLETED|Treatment Period 2||5
11330379|NCT02792829|12527631|FG004|COMPLETED|Treatment Period 2||4
11330380|NCT02792829|12527632|FG005|COMPLETED|Treatment Period 2||5
11330381|NCT02792829|12527633|FG006|COMPLETED|Treatment Period 2||9
11330382|NCT02792829|12527634|FG007|COMPLETED|Treatment Period 2||8
11330383|NCT02792829|12527627|FG000|NOT COMPLETED|Treatment Period 2||0
11330384|NCT02792829|12527628|FG001|NOT COMPLETED|Treatment Period 2||1
11330385|NCT02792829|12527629|FG002|NOT COMPLETED|Treatment Period 2||0
11330386|NCT02792829|12527630|FG003|NOT COMPLETED|Treatment Period 2||0
11330387|NCT02792829|12527631|FG004|NOT COMPLETED|Treatment Period 2||1
11330388|NCT02792829|12527632|FG005|NOT COMPLETED|Treatment Period 2||0
11330389|NCT02792829|12527633|FG006|NOT COMPLETED|Treatment Period 2||1
11330390|NCT02792829|12527634|FG007|NOT COMPLETED|Treatment Period 2||2
11330391|NCT02792959|12527660|FG000|STARTED|Overall Study||11
11330392|NCT02792959|12527660|FG000|COMPLETED|Overall Study||10
11330393|NCT02792959|12527660|FG000|NOT COMPLETED|Overall Study||1
11330394|NCT02793128|12527664|FG000|STARTED|Overall Study||71
11330395|NCT02793128|12527664|FG000|COMPLETED|Overall Study||62
11330396|NCT02793128|12527664|FG000|NOT COMPLETED|Overall Study||9
11330397|NCT02793154|12527679|FG000|STARTED|Part A (Single Group-up to 12 Days)||4
11330398|NCT02793154|12527680|FG001|STARTED|Part A (Single Group-up to 12 Days)||0
11330399|NCT02793154|12527681|FG002|STARTED|Part A (Single Group-up to 12 Days)||0
11330400|NCT02793154|12527679|FG000|COMPLETED|Part A (Single Group-up to 12 Days)||4
11330401|NCT02793154|12527680|FG001|COMPLETED|Part A (Single Group-up to 12 Days)||0
11330402|NCT02793154|12527681|FG002|COMPLETED|Part A (Single Group-up to 12 Days)||0
11330403|NCT02793154|12527679|FG000|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
11330404|NCT02793154|12527680|FG001|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
11330405|NCT02793154|12527681|FG002|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
11330406|NCT02793154|12527679|FG000|STARTED|Part B (Parallel Group-up to 84 Days)||0
11330407|NCT02793154|12527680|FG001|STARTED|Part B (Parallel Group-up to 84 Days)||0
11330408|NCT02793154|12527681|FG002|STARTED|Part B (Parallel Group-up to 84 Days)||0
11330409|NCT02793154|12527679|FG000|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
11330410|NCT02793154|12527680|FG001|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
11330411|NCT02793154|12527681|FG002|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
11330412|NCT02793154|12527679|FG000|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
11330413|NCT02793154|12527680|FG001|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
11330414|NCT02793154|12527681|FG002|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
11330415|NCT02793232|12527698|FG000|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
11330416|NCT02793232|12527699|FG001|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
11330417|NCT02793232|12527700|FG002|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
11330418|NCT02793232|12527701|FG003|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
11330419|NCT02793232|12527702|FG004|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
11330420|NCT02793232|12527703|FG005|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
11330421|NCT02793232|12527704|FG006|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
11330422|NCT02793232|12527705|FG007|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
11330423|NCT02793232|12527706|FG008|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
11330424|NCT02793232|12527698|FG000|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
11330425|NCT02793232|12527699|FG001|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
11330426|NCT02793232|12527700|FG002|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
11330427|NCT02793232|12527701|FG003|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
11330428|NCT02793232|12527702|FG004|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
11330429|NCT02793232|12527703|FG005|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
11330430|NCT02793232|12527704|FG006|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
11330431|NCT02793232|12527705|FG007|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
11330432|NCT02793232|12527706|FG008|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
11330433|NCT02793232|12527698|FG000|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
11330434|NCT02793232|12527699|FG001|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
11330435|NCT02793232|12527700|FG002|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
11330436|NCT02793232|12527701|FG003|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
11330437|NCT02793232|12527702|FG004|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
11330438|NCT02793232|12527703|FG005|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
11330439|NCT02793232|12527704|FG006|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
11330440|NCT02793232|12527705|FG007|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
11330441|NCT02793232|12527706|FG008|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
11330442|NCT02793232|12527698|FG000|STARTED|Washout Period 1(Part A:at Least 10days)||2
11330443|NCT02793232|12527699|FG001|STARTED|Washout Period 1(Part A:at Least 10days)||2
11330444|NCT02793232|12527700|FG002|STARTED|Washout Period 1(Part A:at Least 10days)||2
11330445|NCT02793232|12527701|FG003|STARTED|Washout Period 1(Part A:at Least 10days)||2
11330446|NCT02793232|12527702|FG004|STARTED|Washout Period 1(Part A:at Least 10days)||0
11330447|NCT02793232|12527703|FG005|STARTED|Washout Period 1(Part A:at Least 10days)||0
11330448|NCT02793232|12527704|FG006|STARTED|Washout Period 1(Part A:at Least 10days)||0
11330449|NCT02793232|12527705|FG007|STARTED|Washout Period 1(Part A:at Least 10days)||0
11330450|NCT02793232|12527706|FG008|STARTED|Washout Period 1(Part A:at Least 10days)||0
11330451|NCT02793232|12527698|FG000|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
11330452|NCT02793232|12527699|FG001|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
11330453|NCT02793232|12527700|FG002|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
11330454|NCT02793232|12527701|FG003|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
11330455|NCT02793232|12527702|FG004|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
11330456|NCT02793232|12527703|FG005|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
11330457|NCT02793232|12527704|FG006|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
11330458|NCT02793232|12527705|FG007|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
11330459|NCT02793232|12527706|FG008|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
11330460|NCT02793232|12527698|FG000|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
11330461|NCT02793232|12527699|FG001|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
11330462|NCT02793232|12527700|FG002|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
11330463|NCT02793232|12527701|FG003|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
11330464|NCT02793232|12527702|FG004|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
11330465|NCT02793232|12527703|FG005|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
11330466|NCT02793232|12527704|FG006|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
11330467|NCT02793232|12527705|FG007|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
11330468|NCT02793232|12527706|FG008|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
11330469|NCT02793232|12527698|FG000|STARTED|Period 2 (Part A: 5 Days)||2
11330470|NCT02793232|12527699|FG001|STARTED|Period 2 (Part A: 5 Days)||2
11330471|NCT02793232|12527700|FG002|STARTED|Period 2 (Part A: 5 Days)||2
11330472|NCT02793232|12527701|FG003|STARTED|Period 2 (Part A: 5 Days)||2
11330473|NCT02793232|12527702|FG004|STARTED|Period 2 (Part A: 5 Days)||0
11330474|NCT02793232|12527703|FG005|STARTED|Period 2 (Part A: 5 Days)||0
11330475|NCT02793232|12527704|FG006|STARTED|Period 2 (Part A: 5 Days)||0
11330476|NCT02793232|12527705|FG007|STARTED|Period 2 (Part A: 5 Days)||0
11330477|NCT02793232|12527706|FG008|STARTED|Period 2 (Part A: 5 Days)||0
11330478|NCT02793232|12527698|FG000|COMPLETED|Period 2 (Part A: 5 Days)||2
11330479|NCT02793232|12527699|FG001|COMPLETED|Period 2 (Part A: 5 Days)||2
11330480|NCT02793232|12527700|FG002|COMPLETED|Period 2 (Part A: 5 Days)||2
11330481|NCT02793232|12527701|FG003|COMPLETED|Period 2 (Part A: 5 Days)||2
11330482|NCT02793232|12527702|FG004|COMPLETED|Period 2 (Part A: 5 Days)||0
11330483|NCT02793232|12527703|FG005|COMPLETED|Period 2 (Part A: 5 Days)||0
11330484|NCT02793232|12527704|FG006|COMPLETED|Period 2 (Part A: 5 Days)||0
11330485|NCT02793232|12527705|FG007|COMPLETED|Period 2 (Part A: 5 Days)||0
11330486|NCT02793232|12527706|FG008|COMPLETED|Period 2 (Part A: 5 Days)||0
11330487|NCT02793232|12527698|FG000|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
11330488|NCT02793232|12527699|FG001|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
11330489|NCT02793232|12527700|FG002|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
11330490|NCT02793232|12527701|FG003|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
11330491|NCT02793232|12527702|FG004|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
11330492|NCT02793232|12527703|FG005|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
11330493|NCT02793232|12527704|FG006|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
11330494|NCT02793232|12527705|FG007|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
11330495|NCT02793232|12527706|FG008|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
11330496|NCT02793232|12527698|FG000|STARTED|Washout Period 2(Part A:at Least 10days)||2
11330497|NCT02793232|12527699|FG001|STARTED|Washout Period 2(Part A:at Least 10days)||2
11330498|NCT02793232|12527700|FG002|STARTED|Washout Period 2(Part A:at Least 10days)||2
11330499|NCT02793232|12527701|FG003|STARTED|Washout Period 2(Part A:at Least 10days)||2
11330500|NCT02793232|12527702|FG004|STARTED|Washout Period 2(Part A:at Least 10days)||0
11330501|NCT02793232|12527703|FG005|STARTED|Washout Period 2(Part A:at Least 10days)||0
11330502|NCT02793232|12527704|FG006|STARTED|Washout Period 2(Part A:at Least 10days)||0
11330503|NCT02793232|12527705|FG007|STARTED|Washout Period 2(Part A:at Least 10days)||0
11330504|NCT02793232|12527706|FG008|STARTED|Washout Period 2(Part A:at Least 10days)||0
11330505|NCT02793232|12527698|FG000|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
11330506|NCT02793232|12527699|FG001|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
11330507|NCT02793232|12527700|FG002|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
11330508|NCT02793232|12527701|FG003|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
11330509|NCT02793232|12527702|FG004|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
11330510|NCT02793232|12527703|FG005|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
11330511|NCT02793232|12527704|FG006|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
11330512|NCT02793232|12527705|FG007|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
11330513|NCT02793232|12527706|FG008|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
11330514|NCT02793232|12527698|FG000|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
11330515|NCT02793232|12527699|FG001|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
11330516|NCT02793232|12527700|FG002|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
11330517|NCT02793232|12527701|FG003|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
11330518|NCT02793232|12527702|FG004|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
11330519|NCT02793232|12527703|FG005|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
11330520|NCT02793232|12527704|FG006|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
11330521|NCT02793232|12527705|FG007|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
11330522|NCT02793232|12527706|FG008|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
11330523|NCT02793232|12527698|FG000|STARTED|Period 3 (Part A: 5 Days)||2
11330524|NCT02793232|12527699|FG001|STARTED|Period 3 (Part A: 5 Days)||2
11330525|NCT02793232|12527700|FG002|STARTED|Period 3 (Part A: 5 Days)||2
11330526|NCT02793232|12527701|FG003|STARTED|Period 3 (Part A: 5 Days)||2
11330527|NCT02793232|12527702|FG004|STARTED|Period 3 (Part A: 5 Days)||0
11330528|NCT02793232|12527703|FG005|STARTED|Period 3 (Part A: 5 Days)||0
11330529|NCT02793232|12527704|FG006|STARTED|Period 3 (Part A: 5 Days)||0
11330530|NCT02793232|12527705|FG007|STARTED|Period 3 (Part A: 5 Days)||0
11330531|NCT02793232|12527706|FG008|STARTED|Period 3 (Part A: 5 Days)||0
11330532|NCT02793232|12527698|FG000|COMPLETED|Period 3 (Part A: 5 Days)||2
11330533|NCT02793232|12527699|FG001|COMPLETED|Period 3 (Part A: 5 Days)||2
11330534|NCT02793232|12527700|FG002|COMPLETED|Period 3 (Part A: 5 Days)||2
11330535|NCT02793232|12527701|FG003|COMPLETED|Period 3 (Part A: 5 Days)||2
11330536|NCT02793232|12527702|FG004|COMPLETED|Period 3 (Part A: 5 Days)||0
11330537|NCT02793232|12527703|FG005|COMPLETED|Period 3 (Part A: 5 Days)||0
11330538|NCT02793232|12527704|FG006|COMPLETED|Period 3 (Part A: 5 Days)||0
11330539|NCT02793232|12527705|FG007|COMPLETED|Period 3 (Part A: 5 Days)||0
11330540|NCT02793232|12527706|FG008|COMPLETED|Period 3 (Part A: 5 Days)||0
11330541|NCT02793232|12527698|FG000|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
11330542|NCT02793232|12527699|FG001|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
11330543|NCT02793232|12527700|FG002|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
11330544|NCT02793232|12527701|FG003|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
11330545|NCT02793232|12527702|FG004|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
11330546|NCT02793232|12527703|FG005|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
11330547|NCT02793232|12527704|FG006|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
11330548|NCT02793232|12527705|FG007|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
11330549|NCT02793232|12527706|FG008|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
11330550|NCT02793232|12527698|FG000|STARTED|Washout Period 3(Part A:at Least 10days)||2
11330551|NCT02793232|12527699|FG001|STARTED|Washout Period 3(Part A:at Least 10days)||2
11330552|NCT02793232|12527700|FG002|STARTED|Washout Period 3(Part A:at Least 10days)||2
11330553|NCT02793232|12527701|FG003|STARTED|Washout Period 3(Part A:at Least 10days)||2
11330554|NCT02793232|12527702|FG004|STARTED|Washout Period 3(Part A:at Least 10days)||0
11330555|NCT02793232|12527703|FG005|STARTED|Washout Period 3(Part A:at Least 10days)||0
11330556|NCT02793232|12527704|FG006|STARTED|Washout Period 3(Part A:at Least 10days)||0
11330557|NCT02793232|12527705|FG007|STARTED|Washout Period 3(Part A:at Least 10days)||0
11330558|NCT02793232|12527706|FG008|STARTED|Washout Period 3(Part A:at Least 10days)||0
11330559|NCT02793232|12527698|FG000|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
11330560|NCT02793232|12527699|FG001|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
11330561|NCT02793232|12527700|FG002|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
11330562|NCT02793232|12527701|FG003|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
11330563|NCT02793232|12527702|FG004|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
11330564|NCT02793232|12527703|FG005|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
11330565|NCT02793232|12527704|FG006|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
11330566|NCT02793232|12527705|FG007|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
11330567|NCT02793232|12527706|FG008|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
11330568|NCT02793232|12527698|FG000|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
11330569|NCT02793232|12527699|FG001|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
11330570|NCT02793232|12527700|FG002|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
11330571|NCT02793232|12527701|FG003|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
11330572|NCT02793232|12527702|FG004|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
11330573|NCT02793232|12527703|FG005|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
11330574|NCT02793232|12527704|FG006|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
11330575|NCT02793232|12527705|FG007|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
11330576|NCT02793232|12527706|FG008|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
11330577|NCT02793232|12527698|FG000|STARTED|Period 4 (Part A: 5 Days)||2
11330578|NCT02793232|12527699|FG001|STARTED|Period 4 (Part A: 5 Days)||2
11330579|NCT02793232|12527700|FG002|STARTED|Period 4 (Part A: 5 Days)||2
11330580|NCT02793232|12527701|FG003|STARTED|Period 4 (Part A: 5 Days)||2
11330581|NCT02793232|12527702|FG004|STARTED|Period 4 (Part A: 5 Days)||0
11330582|NCT02793232|12527703|FG005|STARTED|Period 4 (Part A: 5 Days)||0
11330583|NCT02793232|12527704|FG006|STARTED|Period 4 (Part A: 5 Days)||0
11330584|NCT02793232|12527705|FG007|STARTED|Period 4 (Part A: 5 Days)||0
11330585|NCT02793232|12527706|FG008|STARTED|Period 4 (Part A: 5 Days)||0
11330586|NCT02793232|12527698|FG000|COMPLETED|Period 4 (Part A: 5 Days)||2
11330587|NCT02793232|12527699|FG001|COMPLETED|Period 4 (Part A: 5 Days)||2
11330588|NCT02793232|12527700|FG002|COMPLETED|Period 4 (Part A: 5 Days)||2
11330589|NCT02793232|12527701|FG003|COMPLETED|Period 4 (Part A: 5 Days)||2
11330590|NCT02793232|12527702|FG004|COMPLETED|Period 4 (Part A: 5 Days)||0
11330591|NCT02793232|12527703|FG005|COMPLETED|Period 4 (Part A: 5 Days)||0
11330592|NCT02793232|12527704|FG006|COMPLETED|Period 4 (Part A: 5 Days)||0
11330593|NCT02793232|12527705|FG007|COMPLETED|Period 4 (Part A: 5 Days)||0
11330594|NCT02793232|12527706|FG008|COMPLETED|Period 4 (Part A: 5 Days)||0
11330595|NCT02793232|12527698|FG000|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
11330596|NCT02793232|12527699|FG001|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
11330597|NCT02793232|12527700|FG002|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
11330598|NCT02793232|12527701|FG003|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
11330599|NCT02793232|12527702|FG004|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
11330600|NCT02793232|12527703|FG005|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
11330601|NCT02793232|12527704|FG006|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
11330602|NCT02793232|12527705|FG007|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
11330603|NCT02793232|12527706|FG008|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
11330604|NCT02793622|12527742|FG000|STARTED|Overall Study||391
11330605|NCT02793622|12527743|FG001|STARTED|Overall Study||391
11330606|NCT02793622|12527742|FG000|COMPLETED|Overall Study||338
11330607|NCT02793622|12527743|FG001|COMPLETED|Overall Study||349
11330608|NCT02793622|12527742|FG000|NOT COMPLETED|Overall Study||53
11330609|NCT02793622|12527743|FG001|NOT COMPLETED|Overall Study||42
11330610|NCT02793674|12527751|FG000|STARTED|Overall Study||9
11330611|NCT02793674|12527752|FG001|STARTED|Overall Study||12
11330612|NCT02793674|12527751|FG000|COMPLETED|Overall Study||9
11330613|NCT02793674|12527752|FG001|COMPLETED|Overall Study||12
11330614|NCT02793674|12527751|FG000|NOT COMPLETED|Overall Study||0
11330615|NCT02793674|12527752|FG001|NOT COMPLETED|Overall Study||0
11330616|NCT02793817|12527766|FG000|STARTED|Overall Study||261
11330617|NCT02793817|12527767|FG001|STARTED|Overall Study||259
11330618|NCT02793817|12527766|FG000|COMPLETED|Overall Study||258
11330619|NCT02793817|12527767|FG001|COMPLETED|Overall Study||254
11330620|NCT02793817|12527766|FG000|NOT COMPLETED|Overall Study||3
11330621|NCT02793817|12527767|FG001|NOT COMPLETED|Overall Study||5
11330622|NCT02793856|12527777|FG000|STARTED|Overall Study||2
11330623|NCT02793856|12527778|FG001|STARTED|Overall Study||4
11330624|NCT02793856|12527779|FG002|STARTED|Overall Study||3
11330625|NCT02793856|12527780|FG003|STARTED|Overall Study||3
11330626|NCT02793856|12527777|FG000|COMPLETED|Overall Study||2
11330627|NCT02793856|12527778|FG001|COMPLETED|Overall Study||4
11330628|NCT02793856|12527779|FG002|COMPLETED|Overall Study||3
11330629|NCT02793856|12527780|FG003|COMPLETED|Overall Study||3
11330630|NCT02793856|12527777|FG000|NOT COMPLETED|Overall Study||0
11330631|NCT02793856|12527778|FG001|NOT COMPLETED|Overall Study||0
11330632|NCT02793856|12527779|FG002|NOT COMPLETED|Overall Study||0
11330633|NCT02793856|12527780|FG003|NOT COMPLETED|Overall Study||0
11330634|NCT02793947|12527820|FG000|STARTED|Overall Study||47
11330635|NCT02793947|12527821|FG001|STARTED|Overall Study||55
11330636|NCT02793947|12527820|FG000|COMPLETED|Overall Study||45
11330637|NCT02793947|12527821|FG001|COMPLETED|Overall Study||50
11330638|NCT02793947|12527820|FG000|NOT COMPLETED|Overall Study||2
11330639|NCT02793947|12527821|FG001|NOT COMPLETED|Overall Study||5
11330640|NCT02794103|12527827|FG000|STARTED|Overall Study||18
11330641|NCT02794103|12527827|FG000|COMPLETED|Overall Study||15
11330642|NCT02794103|12527827|FG000|NOT COMPLETED|Overall Study||3
11330643|NCT02794207|12527833|FG000|STARTED|Overall Study||32
11330644|NCT02794207|12527834|FG001|STARTED|Overall Study||54
11330645|NCT02794207|12527833|FG000|COMPLETED|Overall Study||32
11330646|NCT02794207|12527834|FG001|COMPLETED|Overall Study||54
11330647|NCT02794207|12527833|FG000|NOT COMPLETED|Overall Study||0
11330648|NCT02794207|12527834|FG001|NOT COMPLETED|Overall Study||0
11330649|NCT02794246|12527839|FG000|STARTED|Overall Study||6
11330650|NCT02794246|12527839|FG000|Treated|Overall Study||3
11330651|NCT02794246|12527839|FG000|COMPLETED|Overall Study||0
11330652|NCT02794246|12527839|FG000|NOT COMPLETED|Overall Study||6
11330653|NCT02794441|12527845|FG000|STARTED|Overall Study||7
11330654|NCT02794441|12527846|FG001|STARTED|Overall Study||5
11330655|NCT02794441|12527845|FG000|COMPLETED|Overall Study||6
11330656|NCT02794441|12527846|FG001|COMPLETED|Overall Study||5
11330657|NCT02794441|12527845|FG000|NOT COMPLETED|Overall Study||1
11330658|NCT02794441|12527846|FG001|NOT COMPLETED|Overall Study||0
11330659|NCT02794480|12527854|FG000|STARTED|Period 1: Treatment Period 1 (28 Days)||80
11330660|NCT02794480|12527855|FG001|STARTED|Period 1: Treatment Period 1 (28 Days)||82
11330661|NCT02794480|12527856|FG002|STARTED|Period 1: Treatment Period 1 (28 Days)||81
11330662|NCT02794480|12527857|FG003|STARTED|Period 1: Treatment Period 1 (28 Days)||81
11330663|NCT02794480|12527854|FG000|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
11330664|NCT02794480|12527855|FG001|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
11330665|NCT02794480|12527856|FG002|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
11330666|NCT02794480|12527857|FG003|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
11330667|NCT02794480|12527854|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
11330668|NCT02794480|12527855|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
11330669|NCT02794480|12527856|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
11330670|NCT02794480|12527857|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
11027340|NCT00833638|12206057|FG000|COMPLETED|Phase 2: Double-blind Treatment Phase||111
11027341|NCT00833638|12206058|FG001|COMPLETED|Phase 2: Double-blind Treatment Phase||108
11027342|NCT00833638|12206059|FG002|COMPLETED|Phase 2: Double-blind Treatment Phase||124
11330671|NCT02794480|12527854|FG000|STARTED|Period 2: Treatment Period 2 (28 Days)||80
11330672|NCT02794480|12527855|FG001|STARTED|Period 2: Treatment Period 2 (28 Days)||80
11330673|NCT02794480|12527856|FG002|STARTED|Period 2: Treatment Period 2 (28 Days)||79
11330674|NCT02794480|12527857|FG003|STARTED|Period 2: Treatment Period 2 (28 Days)||78
11330675|NCT02794480|12527854|FG000|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
11330676|NCT02794480|12527855|FG001|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
11330677|NCT02794480|12527856|FG002|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
11330678|NCT02794480|12527857|FG003|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
11330679|NCT02794480|12527854|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
11330680|NCT02794480|12527855|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
11330681|NCT02794480|12527856|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
11330682|NCT02794480|12527857|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
11330683|NCT02794597|12527867|FG000|STARTED|Overall Study||63
11330684|NCT02794597|12527868|FG001|STARTED|Overall Study||56
11330685|NCT02794597|12527867|FG000|COMPLETED|Overall Study||63
11330686|NCT02794597|12527868|FG001|COMPLETED|Overall Study||56
11330687|NCT02794597|12527867|FG000|NOT COMPLETED|Overall Study||0
11330688|NCT02794597|12527868|FG001|NOT COMPLETED|Overall Study||0
11330689|NCT02794727|12527877|FG000|STARTED|Overall Study||44
11330690|NCT02794727|12527878|FG001|STARTED|Overall Study||46
11330691|NCT02794727|12527879|FG002|STARTED|Overall Study||45
11330692|NCT02794727|12527877|FG000|COMPLETED|Overall Study||44
11330693|NCT02794727|12527878|FG001|COMPLETED|Overall Study||46
11330694|NCT02794727|12527879|FG002|COMPLETED|Overall Study||44
11330695|NCT02794727|12527877|FG000|NOT COMPLETED|Overall Study||0
11330696|NCT02794727|12527878|FG001|NOT COMPLETED|Overall Study||0
11330697|NCT02794727|12527879|FG002|NOT COMPLETED|Overall Study||1
11330698|NCT02794766|12527889|FG000|STARTED|Overall Study||15
11330699|NCT02794766|12527890|FG001|STARTED|Overall Study||15
11330700|NCT02794766|12527891|FG002|STARTED|Overall Study||15
11330701|NCT02794766|12527889|FG000|COMPLETED|Overall Study||15
11330702|NCT02794766|12527890|FG001|COMPLETED|Overall Study||15
11330703|NCT02794766|12527891|FG002|COMPLETED|Overall Study||14
11330704|NCT02794766|12527889|FG000|NOT COMPLETED|Overall Study||0
11330705|NCT02794766|12527890|FG001|NOT COMPLETED|Overall Study||0
11330706|NCT02794766|12527891|FG002|NOT COMPLETED|Overall Study||1
11330707|NCT02794844|12527899|FG000|STARTED|Overall Study||28
11330708|NCT02794844|12527899|FG000|COMPLETED|Overall Study||23
11330709|NCT02794844|12527899|FG000|NOT COMPLETED|Overall Study||5
11330710|NCT02794870|12527905|FG000|STARTED|Overall Study||22
11330711|NCT02794870|12527906|FG001|STARTED|Overall Study||11
11330712|NCT02794870|12527905|FG000|Received Inoculation|Overall Study||21
11330713|NCT02794870|12527906|FG001|Received Inoculation|Overall Study||11
11330714|NCT02794870|12527905|FG000|COMPLETED|Overall Study||20
11330715|NCT02794870|12527906|FG001|COMPLETED|Overall Study||11
11330716|NCT02794870|12527905|FG000|NOT COMPLETED|Overall Study||2
11330717|NCT02794870|12527906|FG001|NOT COMPLETED|Overall Study||0
11330718|NCT02794974|12527914|FG000|STARTED|Overall Study||14
11330719|NCT02794974|12527915|FG001|STARTED|Overall Study||15
11330720|NCT02794974|12527914|FG000|COMPLETED|Overall Study||14
11330721|NCT02794974|12527915|FG001|COMPLETED|Overall Study||14
11330722|NCT02794974|12527914|FG000|NOT COMPLETED|Overall Study||0
11330723|NCT02794974|12527915|FG001|NOT COMPLETED|Overall Study||1
11330724|NCT02795117|12527924|FG000|STARTED|Overall Study||193
11330725|NCT02795117|12527925|FG001|STARTED|Overall Study||193
11330726|NCT02795117|12527926|FG002|STARTED|Overall Study||100
11330727|NCT02795117|12527924|FG000|COMPLETED|Overall Study||175
11330728|NCT02795117|12527925|FG001|COMPLETED|Overall Study||166
11330729|NCT02795117|12527926|FG002|COMPLETED|Overall Study||88
11330730|NCT02795117|12527924|FG000|NOT COMPLETED|Overall Study||18
11330731|NCT02795117|12527925|FG001|NOT COMPLETED|Overall Study||27
11330732|NCT02795117|12527926|FG002|NOT COMPLETED|Overall Study||12
11330733|NCT02795767|12527937|FG000|STARTED|Overall Study||68
11330734|NCT02795767|12527938|FG001|STARTED|Overall Study||10
11330735|NCT02795767|12527939|FG002|STARTED|Overall Study||10
11330736|NCT02795767|12527937|FG000|Received at Least One Dose of Emicizumab|Overall Study||68
11330737|NCT02795767|12527938|FG001|Received at Least One Dose of Emicizumab|Overall Study||10
11330738|NCT02795767|12527939|FG002|Received at Least One Dose of Emicizumab|Overall Study||10
11330739|NCT02795767|12527937|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
11330740|NCT02795767|12527938|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
11330741|NCT02795767|12527939|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
11330742|NCT02795767|12527937|FG000|Completed 52 Weeks in Study|Overall Study||67
11330743|NCT02795767|12527938|FG001|Completed 52 Weeks in Study|Overall Study||10
11330744|NCT02795767|12527939|FG002|Completed 52 Weeks in Study|Overall Study||9
11330745|NCT02795767|12527937|FG000|COMPLETED|Overall Study||67
11330746|NCT02795767|12527938|FG001|COMPLETED|Overall Study||10
11330747|NCT02795767|12527939|FG002|COMPLETED|Overall Study||10
11330748|NCT02795767|12527937|FG000|NOT COMPLETED|Overall Study||1
11330749|NCT02795767|12527938|FG001|NOT COMPLETED|Overall Study||0
11330750|NCT02795767|12527939|FG002|NOT COMPLETED|Overall Study||0
11330751|NCT02795780|12527953|FG000|STARTED|Overall Study||25
11330752|NCT02795780|12527954|FG001|STARTED|Overall Study||54
11330753|NCT02795780|12527953|FG000|COMPLETED|Overall Study||25
11330754|NCT02795780|12527954|FG001|COMPLETED|Overall Study||54
11330755|NCT02795780|12527953|FG000|NOT COMPLETED|Overall Study||0
11330756|NCT02795780|12527954|FG001|NOT COMPLETED|Overall Study||0
11330757|NCT02795819|12527962|FG000|STARTED|Overall Study||0
11330758|NCT02795819|12527963|FG001|STARTED|Overall Study||6
11330759|NCT02795819|12527964|FG002|STARTED|Overall Study||0
11330760|NCT02795819|12527965|FG003|STARTED|Overall Study||0
11330761|NCT02795819|12527966|FG004|STARTED|Overall Study||0
11330762|NCT02795819|12527967|FG005|STARTED|Overall Study||0
11330763|NCT02795819|12527968|FG006|STARTED|Overall Study||0
11330764|NCT02795819|12527962|FG000|COMPLETED|Overall Study||0
11330765|NCT02795819|12527963|FG001|COMPLETED|Overall Study||6
11330766|NCT02795819|12527964|FG002|COMPLETED|Overall Study||0
11330767|NCT02795819|12527965|FG003|COMPLETED|Overall Study||0
11330768|NCT02795819|12527966|FG004|COMPLETED|Overall Study||0
11330769|NCT02795819|12527967|FG005|COMPLETED|Overall Study||0
11330770|NCT02795819|12527968|FG006|COMPLETED|Overall Study||0
11330771|NCT02795819|12527962|FG000|NOT COMPLETED|Overall Study||0
11330772|NCT02795819|12527963|FG001|NOT COMPLETED|Overall Study||0
11330773|NCT02795819|12527964|FG002|NOT COMPLETED|Overall Study||0
11330774|NCT02795819|12527965|FG003|NOT COMPLETED|Overall Study||0
11330775|NCT02795819|12527966|FG004|NOT COMPLETED|Overall Study||0
11330776|NCT02795819|12527967|FG005|NOT COMPLETED|Overall Study||0
11330777|NCT02795819|12527968|FG006|NOT COMPLETED|Overall Study||0
11330778|NCT02795832|12527984|FG000|STARTED|Overall Study||8
11330779|NCT02795832|12527985|FG001|STARTED|Overall Study||4
11330780|NCT02795832|12527986|FG002|STARTED|Overall Study||8
11330781|NCT02795832|12527987|FG003|STARTED|Overall Study||3
11330782|NCT02795832|12527988|FG004|STARTED|Overall Study||20
11330783|NCT02795832|12527989|FG005|STARTED|Overall Study||10
11330784|NCT02795832|12527984|FG000|COMPLETED|Overall Study||8
11330785|NCT02795832|12527985|FG001|COMPLETED|Overall Study||4
11330786|NCT02795832|12527986|FG002|COMPLETED|Overall Study||8
11330787|NCT02795832|12527987|FG003|COMPLETED|Overall Study||3
11330788|NCT02795832|12527988|FG004|COMPLETED|Overall Study||20
11330789|NCT02795832|12527989|FG005|COMPLETED|Overall Study||7
11330790|NCT02795832|12527984|FG000|NOT COMPLETED|Overall Study||0
11330791|NCT02795832|12527985|FG001|NOT COMPLETED|Overall Study||0
11330792|NCT02795832|12527986|FG002|NOT COMPLETED|Overall Study||0
11330793|NCT02795832|12527987|FG003|NOT COMPLETED|Overall Study||0
11330794|NCT02795832|12527988|FG004|NOT COMPLETED|Overall Study||0
11330795|NCT02795832|12527989|FG005|NOT COMPLETED|Overall Study||3
11330796|NCT02796092|12528013|FG000|STARTED|Overall Study||50
11330797|NCT02796092|12528014|FG001|STARTED|Overall Study||50
11330798|NCT02796092|12528013|FG000|COMPLETED|Overall Study||50
11330799|NCT02796092|12528014|FG001|COMPLETED|Overall Study||50
11330800|NCT02796092|12528013|FG000|NOT COMPLETED|Overall Study||0
11330801|NCT02796092|12528014|FG001|NOT COMPLETED|Overall Study||0
11330802|NCT02796144|12528023|FG000|STARTED|Overall Study||23
11330803|NCT02796144|12528024|FG001|STARTED|Overall Study||24
11330804|NCT02796144|12528025|FG002|STARTED|Overall Study||24
11330805|NCT02796144|12528023|FG000|COMPLETED|Overall Study||18
11330806|NCT02796144|12528024|FG001|COMPLETED|Overall Study||21
11330807|NCT02796144|12528025|FG002|COMPLETED|Overall Study||18
11330808|NCT02796144|12528023|FG000|NOT COMPLETED|Overall Study||5
11330809|NCT02796144|12528024|FG001|NOT COMPLETED|Overall Study||3
11330810|NCT02796144|12528025|FG002|NOT COMPLETED|Overall Study||6
11330811|NCT02796274|12528035|FG000|STARTED|Overall Study||219
11330812|NCT02796274|12528035|FG000|COMPLETED|Overall Study||219
11330813|NCT02796274|12528035|FG000|NOT COMPLETED|Overall Study||0
11330814|NCT02796300|12528041|FG000|STARTED|Overall Study||10
11330815|NCT02796300|12528042|FG001|STARTED|Overall Study||22
11330816|NCT02796300|12528041|FG000|COMPLETED|Overall Study||10
11330817|NCT02796300|12528042|FG001|COMPLETED|Overall Study||22
11330818|NCT02796300|12528041|FG000|NOT COMPLETED|Overall Study||0
11330819|NCT02796300|12528042|FG001|NOT COMPLETED|Overall Study||0
11330820|NCT02796352|12528048|FG000|STARTED|Overall Study||1
11330821|NCT02796352|12528048|FG000|COMPLETED|Overall Study||1
11330822|NCT02796352|12528048|FG000|NOT COMPLETED|Overall Study||0
11330823|NCT02796560|12528054|FG000|STARTED|Overall Study||38
11330824|NCT02796560|12528055|FG001|STARTED|Overall Study||38
11330825|NCT02796560|12528054|FG000|COMPLETED|Overall Study||34
11330826|NCT02796560|12528055|FG001|COMPLETED|Overall Study||36
11330827|NCT02796560|12528054|FG000|NOT COMPLETED|Overall Study||4
11330828|NCT02796560|12528055|FG001|NOT COMPLETED|Overall Study||2
11330829|NCT02796625|12528061|FG000|STARTED|Overall Study||80
11330830|NCT02796625|12528061|FG000|COMPLETED|Overall Study||61
11330831|NCT02796625|12528061|FG000|NOT COMPLETED|Overall Study||19
11330832|NCT02796651|12528065|FG000|STARTED|Overall Study||132
11330833|NCT02796651|12528065|FG000|Formoterol Fumarate (FF) 6 μg|Overall Study||107
11330834|NCT02796651|12528065|FG000|Formoterol Fumarate (FF) 12 μg|Overall Study||121
11330835|NCT02796651|12528065|FG000|Formoterol Fumarate (FF) 24 μg|Overall Study||105
11330836|NCT02796651|12528065|FG000|Perforomist 20 μg|Overall Study||118
11330837|NCT02796651|12528065|FG000|Perforomist 40 μg|Overall Study||108
11330838|NCT02796651|12528065|FG000|Placebo (Lactose Monohydrate)|Overall Study||38
11330839|NCT02796651|12528065|FG000|COMPLETED|Overall Study||106
11330840|NCT02796651|12528065|FG000|NOT COMPLETED|Overall Study||26
11330841|NCT02796664|12528082|FG000|STARTED|Overall Study||29
11330842|NCT02796664|12528083|FG001|STARTED|Overall Study||29
11330843|NCT02796664|12528082|FG000|COMPLETED|Overall Study||28
11330844|NCT02796664|12528083|FG001|COMPLETED|Overall Study||24
11330845|NCT02796664|12528082|FG000|NOT COMPLETED|Overall Study||1
11330846|NCT02796664|12528083|FG001|NOT COMPLETED|Overall Study||5
11330847|NCT02796677|12528095|FG000|STARTED|Overall Study||317
11330848|NCT02796677|12528096|FG001|STARTED|Overall Study||478
11330849|NCT02796677|12528097|FG002|STARTED|Overall Study||320
11330850|NCT02796677|12528098|FG003|STARTED|Overall Study||479
11330851|NCT02796677|12528095|FG000|Completed Treatment and Follow-up|Overall Study||279
11330852|NCT02796677|12528096|FG001|Completed Treatment and Follow-up|Overall Study||405
11330853|NCT02796677|12528097|FG002|Completed Treatment and Follow-up|Overall Study||267
11330854|NCT02796677|12528098|FG003|Completed Treatment and Follow-up|Overall Study||403
11330855|NCT02796677|12528095|FG000|COMPLETED|Overall Study||279
11330856|NCT02796677|12528096|FG001|COMPLETED|Overall Study||405
11330857|NCT02796677|12528097|FG002|COMPLETED|Overall Study||267
11330858|NCT02796677|12528098|FG003|COMPLETED|Overall Study||405
11330859|NCT02796677|12528095|FG000|NOT COMPLETED|Overall Study||38
11330860|NCT02796677|12528096|FG001|NOT COMPLETED|Overall Study||73
11330861|NCT02796677|12528097|FG002|NOT COMPLETED|Overall Study||53
11330862|NCT02796677|12528098|FG003|NOT COMPLETED|Overall Study||74
11330863|NCT02796755|12528112|FG000|STARTED|Overall Study||15
11330864|NCT02796755|12528113|FG001|STARTED|Overall Study||15
11330865|NCT02796755|12528112|FG000|COMPLETED|Overall Study||13
11330866|NCT02796755|12528113|FG001|COMPLETED|Overall Study||15
11330867|NCT02796755|12528112|FG000|NOT COMPLETED|Overall Study||2
11330868|NCT02796755|12528113|FG001|NOT COMPLETED|Overall Study||0
11330869|NCT02796924|12528119|FG000|STARTED|Overall Study||10
11330870|NCT02796924|12528119|FG000|COMPLETED|Overall Study||10
11330871|NCT02796924|12528119|FG000|NOT COMPLETED|Overall Study||0
11330872|NCT02796963|12528127|FG000|STARTED|Overall Study||383
11330873|NCT02796963|12528128|FG001|STARTED|Overall Study||328
11330874|NCT02796963|12528129|FG002|STARTED|Overall Study||316
11330875|NCT02796963|12528130|FG003|STARTED|Overall Study||354
11330876|NCT02796963|12528127|FG000|First Follow up|Overall Study||293
11330877|NCT02796963|12528128|FG001|First Follow up|Overall Study||279
11330878|NCT02796963|12528129|FG002|First Follow up|Overall Study||257
11330879|NCT02796963|12528130|FG003|First Follow up|Overall Study||291
11330880|NCT02796963|12528127|FG000|Second Follow up|Overall Study||280
11330881|NCT02796963|12528128|FG001|Second Follow up|Overall Study||260
11330882|NCT02796963|12528129|FG002|Second Follow up|Overall Study||255
11330883|NCT02796963|12528130|FG003|Second Follow up|Overall Study||293
11330884|NCT02796963|12528127|FG000|Third Follow up|Overall Study||276
11330885|NCT02796963|12528128|FG001|Third Follow up|Overall Study||237
11330886|NCT02796963|12528129|FG002|Third Follow up|Overall Study||245
11330887|NCT02796963|12528130|FG003|Third Follow up|Overall Study||286
11330888|NCT02796963|12528127|FG000|Fourth Follow up|Overall Study||275
11330889|NCT02796963|12528128|FG001|Fourth Follow up|Overall Study||233
11330890|NCT02796963|12528129|FG002|Fourth Follow up|Overall Study||236
11330891|NCT02796963|12528130|FG003|Fourth Follow up|Overall Study||263
11330892|NCT02796963|12528127|FG000|HIV Sero Converted|Overall Study||19
11330893|NCT02796963|12528128|FG001|HIV Sero Converted|Overall Study||19
11330894|NCT02796963|12528129|FG002|HIV Sero Converted|Overall Study||11
11330895|NCT02796963|12528130|FG003|HIV Sero Converted|Overall Study||19
11330896|NCT02796963|12528127|FG000|COMPLETED|Overall Study||294
11330897|NCT02796963|12528128|FG001|COMPLETED|Overall Study||252
11330898|NCT02796963|12528129|FG002|COMPLETED|Overall Study||247
11330899|NCT02796963|12528130|FG003|COMPLETED|Overall Study||282
11330900|NCT02796963|12528127|FG000|NOT COMPLETED|Overall Study||89
11330901|NCT02796963|12528128|FG001|NOT COMPLETED|Overall Study||76
11330902|NCT02796963|12528129|FG002|NOT COMPLETED|Overall Study||69
11330903|NCT02796963|12528130|FG003|NOT COMPLETED|Overall Study||72
11330904|NCT02797054|12528143|FG000|STARTED|Post-test||387
11330905|NCT02797054|12528144|FG001|STARTED|Post-test||383
11330906|NCT02797054|12528145|FG002|STARTED|Post-test||435
11330907|NCT02797054|12528143|FG000|COMPLETED|Post-test||380
11330908|NCT02797054|12528144|FG001|COMPLETED|Post-test||372
11330909|NCT02797054|12528145|FG002|COMPLETED|Post-test||87
11330910|NCT02797054|12528143|FG000|NOT COMPLETED|Post-test||7
11330911|NCT02797054|12528144|FG001|NOT COMPLETED|Post-test||11
11330912|NCT02797054|12528145|FG002|NOT COMPLETED|Post-test||348
11330913|NCT02797054|12528143|FG000|STARTED|Follow-up||387
11330914|NCT02797054|12528144|FG001|STARTED|Follow-up||383
11330915|NCT02797054|12528145|FG002|STARTED|Follow-up||435
11330916|NCT02797054|12528143|FG000|COMPLETED|Follow-up||178
11330917|NCT02797054|12528144|FG001|COMPLETED|Follow-up||155
11330918|NCT02797054|12528145|FG002|COMPLETED|Follow-up||150
11330919|NCT02797054|12528143|FG000|NOT COMPLETED|Follow-up||209
11330920|NCT02797054|12528144|FG001|NOT COMPLETED|Follow-up||228
11330921|NCT02797054|12528145|FG002|NOT COMPLETED|Follow-up||285
11330922|NCT02797080|12528153|FG000|STARTED|Overall Study||38
11330923|NCT02797080|12528153|FG000|COMPLETED|Overall Study||36
11330924|NCT02797080|12528153|FG000|NOT COMPLETED|Overall Study||2
11330925|NCT02797132|12528157|FG000|STARTED|Part A (15 Days)||12
11330926|NCT02797132|12528157|FG000|Part A (<14 kg Weight)|Part A (15 Days)||4
11330927|NCT02797132|12528157|FG000|Part A (>=14 kg Weight)|Part A (15 Days)||8
11330928|NCT02797132|12528157|FG000|COMPLETED|Part A (15 Days)||11
11330929|NCT02797132|12528157|FG000|NOT COMPLETED|Part A (15 Days)||1
11330930|NCT02797132|12528157|FG000|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
11330931|NCT02797132|12528157|FG000|Part B (<14 kg Weight)|Part B (24 Weeks)||19
11330932|NCT02797132|12528157|FG000|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
11330933|NCT02797132|12528157|FG000|COMPLETED|Part B (24 Weeks)||57
11330934|NCT02797132|12528157|FG000|NOT COMPLETED|Part B (24 Weeks)||3
11330935|NCT02797171|12528176|FG000|STARTED|Overall Study||23
11330936|NCT02797171|12528177|FG001|STARTED|Overall Study||23
11330937|NCT02797171|12528178|FG002|STARTED|Overall Study||7
11330938|NCT02797171|12528179|FG003|STARTED|Overall Study||16
11330939|NCT02797171|12528180|FG004|STARTED|Overall Study||10
11330940|NCT02797171|12528181|FG005|STARTED|Overall Study||1
11330941|NCT02797171|12528176|FG000|Safety Population|Overall Study||23
11330942|NCT02797171|12528177|FG001|Safety Population|Overall Study||23
11330943|NCT02797171|12528178|FG002|Safety Population|Overall Study||7
11330944|NCT02797171|12528179|FG003|Safety Population|Overall Study||16
11330945|NCT02797171|12528180|FG004|Safety Population|Overall Study||10
11330946|NCT02797171|12528181|FG005|Safety Population|Overall Study||1
11330947|NCT02797171|12528176|FG000|COMPLETED|Overall Study||19
11330948|NCT02797171|12528177|FG001|COMPLETED|Overall Study||21
11330949|NCT02797171|12528178|FG002|COMPLETED|Overall Study||5
11330950|NCT02797171|12528179|FG003|COMPLETED|Overall Study||15
11330951|NCT02797171|12528180|FG004|COMPLETED|Overall Study||8
11330952|NCT02797171|12528181|FG005|COMPLETED|Overall Study||0
11330953|NCT02797171|12528176|FG000|NOT COMPLETED|Overall Study||4
11330954|NCT02797171|12528177|FG001|NOT COMPLETED|Overall Study||2
11330955|NCT02797171|12528178|FG002|NOT COMPLETED|Overall Study||2
11330956|NCT02797171|12528179|FG003|NOT COMPLETED|Overall Study||1
11330957|NCT02797171|12528180|FG004|NOT COMPLETED|Overall Study||2
11330958|NCT02797171|12528181|FG005|NOT COMPLETED|Overall Study||1
11330959|NCT02797522|12528206|FG000|STARTED|Overall Study||4
11330960|NCT02797522|12528207|FG001|STARTED|Overall Study||4
11330961|NCT02797522|12528208|FG002|STARTED|Overall Study||4
11330962|NCT02797522|12528209|FG003|STARTED|Overall Study||4
11330963|NCT02797522|12528210|FG004|STARTED|Overall Study||4
11330964|NCT02797522|12528211|FG005|STARTED|Overall Study||4
11330965|NCT02797522|12528212|FG006|STARTED|Overall Study||12
11330966|NCT02797522|12528213|FG007|STARTED|Overall Study||4
11330967|NCT02797522|12528214|FG008|STARTED|Overall Study||2
11330968|NCT02797522|12528215|FG009|STARTED|Overall Study||4
11330969|NCT02797522|12528216|FG010|STARTED|Overall Study||1
11330970|NCT02797522|12528206|FG000|COMPLETED|Overall Study||4
11330971|NCT02797522|12528207|FG001|COMPLETED|Overall Study||4
11330972|NCT02797522|12528208|FG002|COMPLETED|Overall Study||4
11330973|NCT02797522|12528209|FG003|COMPLETED|Overall Study||4
11330974|NCT02797522|12528210|FG004|COMPLETED|Overall Study||4
11330975|NCT02797522|12528211|FG005|COMPLETED|Overall Study||4
11330976|NCT02797522|12528212|FG006|COMPLETED|Overall Study||12
11330977|NCT02797522|12528213|FG007|COMPLETED|Overall Study||0
11330978|NCT02797522|12528214|FG008|COMPLETED|Overall Study||0
11330979|NCT02797522|12528215|FG009|COMPLETED|Overall Study||0
11330980|NCT02797522|12528216|FG010|COMPLETED|Overall Study||0
11330981|NCT02797522|12528206|FG000|NOT COMPLETED|Overall Study||0
11330982|NCT02797522|12528207|FG001|NOT COMPLETED|Overall Study||0
11330983|NCT02797522|12528208|FG002|NOT COMPLETED|Overall Study||0
11330984|NCT02797522|12528209|FG003|NOT COMPLETED|Overall Study||0
11330985|NCT02797522|12528210|FG004|NOT COMPLETED|Overall Study||0
11330986|NCT02797522|12528211|FG005|NOT COMPLETED|Overall Study||0
11330987|NCT02797522|12528212|FG006|NOT COMPLETED|Overall Study||0
11330988|NCT02797522|12528213|FG007|NOT COMPLETED|Overall Study||4
11330989|NCT02797522|12528214|FG008|NOT COMPLETED|Overall Study||2
11330990|NCT02797522|12528215|FG009|NOT COMPLETED|Overall Study||4
11330991|NCT02797522|12528216|FG010|NOT COMPLETED|Overall Study||1
11330992|NCT02797613|12528246|FG000|STARTED|Overall Study||55
11330993|NCT02797613|12528247|FG001|STARTED|Overall Study||55
11330994|NCT02797613|12528246|FG000|COMPLETED|Overall Study||55
11330995|NCT02797613|12528247|FG001|COMPLETED|Overall Study||55
11330996|NCT02797613|12528246|FG000|NOT COMPLETED|Overall Study||0
11330997|NCT02797613|12528247|FG001|NOT COMPLETED|Overall Study||0
11330998|NCT02797678|12528253|FG000|STARTED|Screening Phase||62
11330999|NCT02797678|12528254|FG001|STARTED|Screening Phase||0
11331000|NCT02797678|12528255|FG002|STARTED|Screening Phase||0
11331001|NCT02797678|12528256|FG003|STARTED|Screening Phase||0
11331002|NCT02797678|12528253|FG000|COMPLETED|Screening Phase||37
11331003|NCT02797678|12528254|FG001|COMPLETED|Screening Phase||0
11331004|NCT02797678|12528255|FG002|COMPLETED|Screening Phase||0
11331005|NCT02797678|12528256|FG003|COMPLETED|Screening Phase||0
11331006|NCT02797678|12528253|FG000|NOT COMPLETED|Screening Phase||25
11331007|NCT02797678|12528254|FG001|NOT COMPLETED|Screening Phase||0
11331008|NCT02797678|12528255|FG002|NOT COMPLETED|Screening Phase||0
11331009|NCT02797678|12528256|FG003|NOT COMPLETED|Screening Phase||0
11331010|NCT02797678|12528253|FG000|STARTED|First Intervention (5 Nights)||0
11331011|NCT02797678|12528254|FG001|STARTED|First Intervention (5 Nights)||20
11331012|NCT02797678|12528255|FG002|STARTED|First Intervention (5 Nights)||17
11331013|NCT02797678|12528256|FG003|STARTED|First Intervention (5 Nights)||0
11331014|NCT02797678|12528253|FG000|COMPLETED|First Intervention (5 Nights)||0
11331015|NCT02797678|12528254|FG001|COMPLETED|First Intervention (5 Nights)||19
11331016|NCT02797678|12528255|FG002|COMPLETED|First Intervention (5 Nights)||17
11331017|NCT02797678|12528256|FG003|COMPLETED|First Intervention (5 Nights)||0
11331018|NCT02797678|12528253|FG000|NOT COMPLETED|First Intervention (5 Nights)||0
11331019|NCT02797678|12528254|FG001|NOT COMPLETED|First Intervention (5 Nights)||1
11331020|NCT02797678|12528255|FG002|NOT COMPLETED|First Intervention (5 Nights)||0
11331021|NCT02797678|12528256|FG003|NOT COMPLETED|First Intervention (5 Nights)||0
11331022|NCT02797678|12528253|FG000|STARTED|Washout||0
11331023|NCT02797678|12528254|FG001|STARTED|Washout||19
11331024|NCT02797678|12528255|FG002|STARTED|Washout||17
11331025|NCT02797678|12528256|FG003|STARTED|Washout||0
11331026|NCT02797678|12528253|FG000|COMPLETED|Washout||0
11331027|NCT02797678|12528254|FG001|COMPLETED|Washout||19
11331028|NCT02797678|12528255|FG002|COMPLETED|Washout||17
11331029|NCT02797678|12528256|FG003|COMPLETED|Washout||0
11331030|NCT02797678|12528253|FG000|NOT COMPLETED|Washout||0
11331031|NCT02797678|12528254|FG001|NOT COMPLETED|Washout||0
11331032|NCT02797678|12528255|FG002|NOT COMPLETED|Washout||0
11331033|NCT02797678|12528256|FG003|NOT COMPLETED|Washout||0
11331034|NCT02797678|12528253|FG000|STARTED|Second Intervention (5 Nights)||0
11331035|NCT02797678|12528254|FG001|STARTED|Second Intervention (5 Nights)||19
11331036|NCT02797678|12528255|FG002|STARTED|Second Intervention (5 Nights)||17
11331037|NCT02797678|12528256|FG003|STARTED|Second Intervention (5 Nights)||0
11331038|NCT02797678|12528253|FG000|COMPLETED|Second Intervention (5 Nights)||0
11331039|NCT02797678|12528254|FG001|COMPLETED|Second Intervention (5 Nights)||19
11331040|NCT02797678|12528255|FG002|COMPLETED|Second Intervention (5 Nights)||16
11331041|NCT02797678|12528256|FG003|COMPLETED|Second Intervention (5 Nights)||0
11331042|NCT02797678|12528253|FG000|NOT COMPLETED|Second Intervention (5 Nights)||0
11331043|NCT02797678|12528254|FG001|NOT COMPLETED|Second Intervention (5 Nights)||0
11331044|NCT02797678|12528255|FG002|NOT COMPLETED|Second Intervention (5 Nights)||1
11331045|NCT02797678|12528256|FG003|NOT COMPLETED|Second Intervention (5 Nights)||0
11331046|NCT02797678|12528253|FG000|STARTED|Sub-Study||0
11331047|NCT02797678|12528254|FG001|STARTED|Sub-Study||0
11331048|NCT02797678|12528255|FG002|STARTED|Sub-Study||0
11331049|NCT02797678|12528256|FG003|STARTED|Sub-Study||9
11331050|NCT02797678|12528253|FG000|COMPLETED|Sub-Study||0
11331051|NCT02797678|12528254|FG001|COMPLETED|Sub-Study||0
11331052|NCT02797678|12528255|FG002|COMPLETED|Sub-Study||0
11331053|NCT02797678|12528256|FG003|COMPLETED|Sub-Study||9
11331054|NCT02797678|12528253|FG000|NOT COMPLETED|Sub-Study||0
11331055|NCT02797678|12528254|FG001|NOT COMPLETED|Sub-Study||0
11331056|NCT02797678|12528255|FG002|NOT COMPLETED|Sub-Study||0
11331057|NCT02797678|12528256|FG003|NOT COMPLETED|Sub-Study||0
11331058|NCT02797808|12528271|FG000|STARTED|Overall Study||23
11331059|NCT02797808|12528272|FG001|STARTED|Overall Study||18
11331060|NCT02797808|12528271|FG000|COMPLETED|Overall Study||16
11331061|NCT02797808|12528272|FG001|COMPLETED|Overall Study||15
11331062|NCT02797808|12528271|FG000|NOT COMPLETED|Overall Study||7
11331063|NCT02797808|12528272|FG001|NOT COMPLETED|Overall Study||3
11331064|NCT02797821|12528281|FG000|STARTED|Overall Study||8
11331065|NCT02797821|12528282|FG001|STARTED|Overall Study||10
11331066|NCT02797821|12528283|FG002|STARTED|Overall Study||9
11331067|NCT02797821|12528281|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
11331068|NCT02797821|12528282|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
11331069|NCT02797821|12528283|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
11331070|NCT02797821|12528281|FG000|COMPLETED|Overall Study||8
11331071|NCT02797821|12528282|FG001|COMPLETED|Overall Study||10
11331072|NCT02797821|12528283|FG002|COMPLETED|Overall Study||9
11331073|NCT02797821|12528281|FG000|NOT COMPLETED|Overall Study||0
11331074|NCT02797821|12528282|FG001|NOT COMPLETED|Overall Study||0
11331075|NCT02797821|12528283|FG002|NOT COMPLETED|Overall Study||0
11331076|NCT02798211|12528294|FG000|STARTED|Period 1||103
11331077|NCT02798211|12528295|FG001|STARTED|Period 1||103
11331078|NCT02798211|12528296|FG002|STARTED|Period 1||52
11331079|NCT02798211|12528297|FG003|STARTED|Period 1||0
11331080|NCT02798211|12528298|FG004|STARTED|Period 1||0
11331081|NCT02798211|12528299|FG005|STARTED|Period 1||0
11331082|NCT02798211|12528294|FG000|COMPLETED|Period 1||97
11331083|NCT02798211|12528295|FG001|COMPLETED|Period 1||93
11331084|NCT02798211|12528296|FG002|COMPLETED|Period 1||46
11331085|NCT02798211|12528297|FG003|COMPLETED|Period 1||0
11331086|NCT02798211|12528298|FG004|COMPLETED|Period 1||0
11331087|NCT02798211|12528299|FG005|COMPLETED|Period 1||0
11331088|NCT02798211|12528294|FG000|NOT COMPLETED|Period 1||6
11331089|NCT02798211|12528295|FG001|NOT COMPLETED|Period 1||10
11331090|NCT02798211|12528296|FG002|NOT COMPLETED|Period 1||6
11331091|NCT02798211|12528297|FG003|NOT COMPLETED|Period 1||0
11331092|NCT02798211|12528298|FG004|NOT COMPLETED|Period 1||0
11331093|NCT02798211|12528299|FG005|NOT COMPLETED|Period 1||0
11331094|NCT02798211|12528294|FG000|STARTED|Period 2||97
11331095|NCT02798211|12528295|FG001|STARTED|Period 2||0
11331096|NCT02798211|12528296|FG002|STARTED|Period 2||0
11331097|NCT02798211|12528297|FG003|STARTED|Period 2||50
11331098|NCT02798211|12528298|FG004|STARTED|Period 2||42
11331099|NCT02798211|12528299|FG005|STARTED|Period 2||46
11331100|NCT02798211|12528294|FG000|COMPLETED|Period 2||83
11331101|NCT02798211|12528295|FG001|COMPLETED|Period 2||0
11331102|NCT02798211|12528296|FG002|COMPLETED|Period 2||0
11331103|NCT02798211|12528297|FG003|COMPLETED|Period 2||43
11331104|NCT02798211|12528298|FG004|COMPLETED|Period 2||34
11331105|NCT02798211|12528299|FG005|COMPLETED|Period 2||40
11331106|NCT02798211|12528294|FG000|NOT COMPLETED|Period 2||14
11331107|NCT02798211|12528295|FG001|NOT COMPLETED|Period 2||0
11331108|NCT02798211|12528296|FG002|NOT COMPLETED|Period 2||0
11331109|NCT02798211|12528297|FG003|NOT COMPLETED|Period 2||7
11331110|NCT02798211|12528298|FG004|NOT COMPLETED|Period 2||8
11331111|NCT02798211|12528299|FG005|NOT COMPLETED|Period 2||6
11331112|NCT02798289|12528311|FG000|STARTED|Overall Study||55
11331113|NCT02798289|12528311|FG000|COMPLETED|Overall Study||55
11331114|NCT02798289|12528311|FG000|NOT COMPLETED|Overall Study||0
11331115|NCT02798315|12528315|FG000|STARTED|Overall Study||40
11331116|NCT02798315|12528315|FG000|COMPLETED|Overall Study||39
11331117|NCT02798315|12528315|FG000|NOT COMPLETED|Overall Study||1
11331118|NCT02798354|12528322|FG000|STARTED|First Intervention Period||1184
11331119|NCT02798354|12528323|FG001|STARTED|First Intervention Period||2176
11331120|NCT02798354|12528324|FG002|STARTED|First Intervention Period||990
11331121|NCT02798354|12528322|FG000|Control Data Error 1|First Intervention Period||440
11331122|NCT02798354|12528323|FG001|Control Data Error 1|First Intervention Period||549
11331123|NCT02798354|12528324|FG002|Control Data Error 1|First Intervention Period||345
11331124|NCT02798354|12528322|FG000|Intervention Data Error 1|First Intervention Period||744
11331125|NCT02798354|12528323|FG001|Intervention Data Error 1|First Intervention Period||1627
11331126|NCT02798354|12528324|FG002|Intervention Data Error 1|First Intervention Period||645
11331127|NCT02798354|12528322|FG000|COMPLETED|First Intervention Period||1184
11331128|NCT02798354|12528323|FG001|COMPLETED|First Intervention Period||2176
11331129|NCT02798354|12528324|FG002|COMPLETED|First Intervention Period||990
11331130|NCT02798354|12528322|FG000|NOT COMPLETED|First Intervention Period||0
11331131|NCT02798354|12528323|FG001|NOT COMPLETED|First Intervention Period||0
11331132|NCT02798354|12528324|FG002|NOT COMPLETED|First Intervention Period||0
11331133|NCT02798354|12528322|FG000|STARTED|Second Intervention Period||2617
11331134|NCT02798354|12528323|FG001|STARTED|Second Intervention Period||1047
11331135|NCT02798354|12528324|FG002|STARTED|Second Intervention Period||1368
11331136|NCT02798354|12528322|FG000|Control Data Error 2|Second Intervention Period||1378
11331137|NCT02798354|12528323|FG001|Control Data Error 2|Second Intervention Period||593
11331138|NCT02798354|12528324|FG002|Control Data Error 2|Second Intervention Period||668
11331139|NCT02798354|12528322|FG000|Intervention Data Error 2|Second Intervention Period||1239
11331140|NCT02798354|12528323|FG001|Intervention Data Error 2|Second Intervention Period||454
11331141|NCT02798354|12528324|FG002|Intervention Data Error 2|Second Intervention Period||700
11331142|NCT02798354|12528322|FG000|COMPLETED|Second Intervention Period||2617
11331143|NCT02798354|12528323|FG001|COMPLETED|Second Intervention Period||1047
11331144|NCT02798354|12528324|FG002|COMPLETED|Second Intervention Period||1368
11331145|NCT02798354|12528322|FG000|NOT COMPLETED|Second Intervention Period||0
11331146|NCT02798354|12528323|FG001|NOT COMPLETED|Second Intervention Period||0
11331147|NCT02798354|12528324|FG002|NOT COMPLETED|Second Intervention Period||0
11331148|NCT02798354|12528322|FG000|STARTED|Third Intervention Period||746
11331149|NCT02798354|12528323|FG001|STARTED|Third Intervention Period||1010
11331150|NCT02798354|12528324|FG002|STARTED|Third Intervention Period||2715
11331151|NCT02798354|12528322|FG000|Control Data Error 3|Third Intervention Period||419
11331152|NCT02798354|12528323|FG001|Control Data Error 3|Third Intervention Period||620
11331153|NCT02798354|12528324|FG002|Control Data Error 3|Third Intervention Period||1467
11331154|NCT02798354|12528322|FG000|Intervention Data Error 3|Third Intervention Period||327
11331155|NCT02798354|12528323|FG001|Intervention Data Error 3|Third Intervention Period||390
11331156|NCT02798354|12528324|FG002|Intervention Data Error 3|Third Intervention Period||1248
11331157|NCT02798354|12528322|FG000|COMPLETED|Third Intervention Period||746
11331158|NCT02798354|12528323|FG001|COMPLETED|Third Intervention Period||1010
11331159|NCT02798354|12528324|FG002|COMPLETED|Third Intervention Period||2715
11331160|NCT02798354|12528322|FG000|NOT COMPLETED|Third Intervention Period||0
11331161|NCT02798354|12528323|FG001|NOT COMPLETED|Third Intervention Period||0
11331162|NCT02798354|12528324|FG002|NOT COMPLETED|Third Intervention Period||0
11331163|NCT02798380|12528338|FG000|STARTED|Overall Study||30
11331164|NCT02798380|12528338|FG000|COMPLETED|Overall Study||30
11331165|NCT02798380|12528338|FG000|NOT COMPLETED|Overall Study||0
11331166|NCT02798627|12528344|FG000|STARTED|Overall Study||27
11331167|NCT02798627|12528345|FG001|STARTED|Overall Study||28
11331168|NCT02798627|12528344|FG000|COMPLETED|Overall Study||27
11331169|NCT02798627|12528345|FG001|COMPLETED|Overall Study||28
11331170|NCT02798627|12528344|FG000|NOT COMPLETED|Overall Study||0
11331171|NCT02798627|12528345|FG001|NOT COMPLETED|Overall Study||0
11331172|NCT02798835|12528354|FG000|STARTED|Overall Study||60
11331173|NCT02798835|12528355|FG001|STARTED|Overall Study||60
11331174|NCT02798835|12528356|FG002|STARTED|Overall Study||60
11331175|NCT02798835|12528354|FG000|COMPLETED|Overall Study||60
11331176|NCT02798835|12528355|FG001|COMPLETED|Overall Study||60
11331177|NCT02798835|12528356|FG002|COMPLETED|Overall Study||57
11331178|NCT02798835|12528354|FG000|NOT COMPLETED|Overall Study||0
11331179|NCT02798835|12528355|FG001|NOT COMPLETED|Overall Study||0
11331180|NCT02798835|12528356|FG002|NOT COMPLETED|Overall Study||3
11331181|NCT02798861|12528364|FG000|STARTED|Overall Study||160
11331182|NCT02798861|12528364|FG000|COMPLETED|Overall Study||137
11331183|NCT02798861|12528364|FG000|NOT COMPLETED|Overall Study||23
11331184|NCT02798952|12528368|FG000|STARTED|Overall Study||302
11331185|NCT02798952|12528368|FG000|COMPLETED|Overall Study||302
11331186|NCT02798952|12528368|FG000|NOT COMPLETED|Overall Study||0
11331187|NCT02798978|12528379|FG000|STARTED|Part 1 (30 Days)||10
11331188|NCT02798978|12528380|FG001|STARTED|Part 1 (30 Days)||6
11331189|NCT02798978|12528381|FG002|STARTED|Part 1 (30 Days)||6
11331190|NCT02798978|12528382|FG003|STARTED|Part 1 (30 Days)||6
11331191|NCT02798978|12528383|FG004|STARTED|Part 1 (30 Days)||6
11331192|NCT02798978|12528384|FG005|STARTED|Part 1 (30 Days)||6
11331193|NCT02798978|12528385|FG006|STARTED|Part 1 (30 Days)||0
11331194|NCT02798978|12528379|FG000|COMPLETED|Part 1 (30 Days)||10
11331195|NCT02798978|12528380|FG001|COMPLETED|Part 1 (30 Days)||6
11331196|NCT02798978|12528381|FG002|COMPLETED|Part 1 (30 Days)||6
11331197|NCT02798978|12528382|FG003|COMPLETED|Part 1 (30 Days)||6
11331198|NCT02798978|12528383|FG004|COMPLETED|Part 1 (30 Days)||6
11331199|NCT02798978|12528384|FG005|COMPLETED|Part 1 (30 Days)||6
11331200|NCT02798978|12528385|FG006|COMPLETED|Part 1 (30 Days)||0
11331201|NCT02798978|12528379|FG000|NOT COMPLETED|Part 1 (30 Days)||0
11331202|NCT02798978|12528380|FG001|NOT COMPLETED|Part 1 (30 Days)||0
11331203|NCT02798978|12528381|FG002|NOT COMPLETED|Part 1 (30 Days)||0
11331204|NCT02798978|12528382|FG003|NOT COMPLETED|Part 1 (30 Days)||0
11331205|NCT02798978|12528383|FG004|NOT COMPLETED|Part 1 (30 Days)||0
11331206|NCT02798978|12528384|FG005|NOT COMPLETED|Part 1 (30 Days)||0
11331207|NCT02798978|12528385|FG006|NOT COMPLETED|Part 1 (30 Days)||0
11331208|NCT02798978|12528379|FG000|STARTED|Part 2 (45 Days)||0
11331209|NCT02798978|12528380|FG001|STARTED|Part 2 (45 Days)||0
11331210|NCT02798978|12528381|FG002|STARTED|Part 2 (45 Days)||0
11331211|NCT02798978|12528382|FG003|STARTED|Part 2 (45 Days)||0
11331212|NCT02798978|12528383|FG004|STARTED|Part 2 (45 Days)||0
11331213|NCT02798978|12528384|FG005|STARTED|Part 2 (45 Days)||0
11331214|NCT02798978|12528385|FG006|STARTED|Part 2 (45 Days)||0
11331215|NCT02798978|12528379|FG000|COMPLETED|Part 2 (45 Days)||0
11331216|NCT02798978|12528380|FG001|COMPLETED|Part 2 (45 Days)||0
11331217|NCT02798978|12528381|FG002|COMPLETED|Part 2 (45 Days)||0
11331218|NCT02798978|12528382|FG003|COMPLETED|Part 2 (45 Days)||0
11331219|NCT02798978|12528383|FG004|COMPLETED|Part 2 (45 Days)||0
11331220|NCT02798978|12528384|FG005|COMPLETED|Part 2 (45 Days)||0
11331221|NCT02798978|12528385|FG006|COMPLETED|Part 2 (45 Days)||0
11331222|NCT02798978|12528379|FG000|NOT COMPLETED|Part 2 (45 Days)||0
11331223|NCT02798978|12528380|FG001|NOT COMPLETED|Part 2 (45 Days)||0
11331224|NCT02798978|12528381|FG002|NOT COMPLETED|Part 2 (45 Days)||0
11331225|NCT02798978|12528382|FG003|NOT COMPLETED|Part 2 (45 Days)||0
11331226|NCT02798978|12528383|FG004|NOT COMPLETED|Part 2 (45 Days)||0
11331227|NCT02798978|12528384|FG005|NOT COMPLETED|Part 2 (45 Days)||0
11331228|NCT02798978|12528385|FG006|NOT COMPLETED|Part 2 (45 Days)||0
11331229|NCT02799069|12528410|FG000|STARTED|Overall Study||76
11331230|NCT02799069|12528411|FG001|STARTED|Overall Study||248
11331231|NCT02799069|12528412|FG002|STARTED|Overall Study||247
11331232|NCT02799069|12528410|FG000|ITT/Safety|Overall Study||76
11331233|NCT02799069|12528411|FG001|ITT/Safety|Overall Study||248
11331234|NCT02799069|12528412|FG002|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
11331235|NCT02799069|12528410|FG000|COMPLETED|Overall Study||68
11331236|NCT02799069|12528411|FG001|COMPLETED|Overall Study||241
11331237|NCT02799069|12528412|FG002|COMPLETED|Overall Study||240
11331238|NCT02799069|12528410|FG000|NOT COMPLETED|Overall Study||8
11331239|NCT02799069|12528411|FG001|NOT COMPLETED|Overall Study||7
11331240|NCT02799069|12528412|FG002|NOT COMPLETED|Overall Study||7
11331241|NCT02799082|12528422|FG000|STARTED|Overall Study||41
11331242|NCT02799082|12528423|FG001|STARTED|Overall Study||81
11331243|NCT02799082|12528422|FG000|COMPLETED|Overall Study||37
11331244|NCT02799082|12528423|FG001|COMPLETED|Overall Study||77
11331245|NCT02799082|12528422|FG000|NOT COMPLETED|Overall Study||4
11331246|NCT02799082|12528423|FG001|NOT COMPLETED|Overall Study||4
11331247|NCT02799290|12528432|FG000|STARTED|Overall Study||24
11331248|NCT02799290|12528433|FG001|STARTED|Overall Study||13
11331249|NCT02799290|12528434|FG002|STARTED|Overall Study||11
11331250|NCT02799290|12528432|FG000|COMPLETED|Overall Study||24
11331251|NCT02799290|12528433|FG001|COMPLETED|Overall Study||13
11331252|NCT02799290|12528434|FG002|COMPLETED|Overall Study||11
11331253|NCT02799290|12528432|FG000|NOT COMPLETED|Overall Study||0
11331254|NCT02799290|12528433|FG001|NOT COMPLETED|Overall Study||0
11331255|NCT02799290|12528434|FG002|NOT COMPLETED|Overall Study||0
11331256|NCT02799381|12528448|FG000|STARTED|Overall Study||33
11331257|NCT02799381|12528449|FG001|STARTED|Overall Study||28
11331258|NCT02799381|12528448|FG000|COMPLETED|Overall Study||29
11331259|NCT02799381|12528449|FG001|COMPLETED|Overall Study||25
11331260|NCT02799381|12528448|FG000|NOT COMPLETED|Overall Study||4
11331261|NCT02799381|12528449|FG001|NOT COMPLETED|Overall Study||3
11331262|NCT02799472|12528457|FG000|STARTED|Overall Study||11
11331263|NCT02799472|12528458|FG001|STARTED|Overall Study||28
11331264|NCT02799472|12528457|FG000|COMPLETED|Overall Study||7
11331265|NCT02799472|12528458|FG001|COMPLETED|Overall Study||23
11331266|NCT02799472|12528457|FG000|NOT COMPLETED|Overall Study||4
11331267|NCT02799472|12528458|FG001|NOT COMPLETED|Overall Study||5
11331268|NCT02799667|12528466|FG000|STARTED|Overall Study||55
11331269|NCT02799667|12528467|FG001|STARTED|Overall Study||55
11331270|NCT02799667|12528466|FG000|COMPLETED|Overall Study||54
11331271|NCT02799667|12528467|FG001|COMPLETED|Overall Study||54
11331272|NCT02799667|12528466|FG000|NOT COMPLETED|Overall Study||1
11331273|NCT02799667|12528467|FG001|NOT COMPLETED|Overall Study||1
11331274|NCT02799745|12528475|FG000|STARTED|Overall Study||114
11331275|NCT02799745|12528476|FG001|STARTED|Overall Study||113
11331276|NCT02799745|12528475|FG000|Treated|Overall Study||112
11331277|NCT02799745|12528476|FG001|Treated|Overall Study||113
11331278|NCT02799745|12528475|FG000|COMPLETED|Overall Study||58
11331279|NCT02799745|12528476|FG001|COMPLETED|Overall Study||42
11331280|NCT02799745|12528475|FG000|NOT COMPLETED|Overall Study||56
11331281|NCT02799745|12528476|FG001|NOT COMPLETED|Overall Study||71
11331282|NCT02799784|12528482|FG000|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
11331283|NCT02799784|12528483|FG001|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
11331284|NCT02799784|12528482|FG000|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
11331285|NCT02799784|12528483|FG001|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
11331286|NCT02799784|12528482|FG000|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
11331287|NCT02799784|12528483|FG001|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
11331288|NCT02799784|12528482|FG000|STARTED|Washout Period (3 Weeks)||111
11331289|NCT02799784|12528483|FG001|STARTED|Washout Period (3 Weeks)||118
11331290|NCT02799784|12528482|FG000|COMPLETED|Washout Period (3 Weeks)||111
11331291|NCT02799784|12528483|FG001|COMPLETED|Washout Period (3 Weeks)||118
11331292|NCT02799784|12528482|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
11331293|NCT02799784|12528483|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
11331294|NCT02799784|12528482|FG000|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
11331295|NCT02799784|12528483|FG001|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
11331296|NCT02799784|12528482|FG000|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
11331297|NCT02799784|12528483|FG001|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
11331298|NCT02799784|12528482|FG000|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
11331299|NCT02799784|12528483|FG001|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
11331300|NCT02800148|12528492|FG000|STARTED|Overall Study||224
11331301|NCT02800148|12528493|FG001|STARTED|Overall Study||224
11331302|NCT02800148|12528494|FG002|STARTED|Overall Study||219
11331303|NCT02800148|12528492|FG000|COMPLETED|Overall Study||199
11331304|NCT02800148|12528493|FG001|COMPLETED|Overall Study||204
11331305|NCT02800148|12528494|FG002|COMPLETED|Overall Study||194
11331306|NCT02800148|12528492|FG000|NOT COMPLETED|Overall Study||25
11331307|NCT02800148|12528493|FG001|NOT COMPLETED|Overall Study||20
11331308|NCT02800148|12528494|FG002|NOT COMPLETED|Overall Study||25
11331309|NCT02800213|12528504|FG000|STARTED|First Intervention||35
11331310|NCT02800213|12528505|FG001|STARTED|First Intervention||35
11331311|NCT02800213|12528504|FG000|COMPLETED|First Intervention||35
11331312|NCT02800213|12528505|FG001|COMPLETED|First Intervention||35
11331313|NCT02800213|12528504|FG000|NOT COMPLETED|First Intervention||0
11331314|NCT02800213|12528505|FG001|NOT COMPLETED|First Intervention||0
11331315|NCT02800213|12528504|FG000|STARTED|Second Intervention||35
11331316|NCT02800213|12528505|FG001|STARTED|Second Intervention||35
11331317|NCT02800213|12528504|FG000|COMPLETED|Second Intervention||35
11331318|NCT02800213|12528505|FG001|COMPLETED|Second Intervention||35
11331319|NCT02800213|12528504|FG000|NOT COMPLETED|Second Intervention||0
11331320|NCT02800213|12528505|FG001|NOT COMPLETED|Second Intervention||0
11331321|NCT02800356|12528511|FG000|STARTED|Overall Study||20
11331322|NCT02800356|12528511|FG000|COMPLETED|Overall Study||20
11331323|NCT02800356|12528511|FG000|NOT COMPLETED|Overall Study||0
11331324|NCT02800642|12528515|FG000|STARTED|Overall Study||162
11331325|NCT02800642|12528515|FG000|COMPLETED|Overall Study||137
11331326|NCT02800642|12528515|FG000|NOT COMPLETED|Overall Study||25
11331327|NCT02800928|12528519|FG000|STARTED|Overall Study||9
11027343|NCT00833638|12206057|FG000|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
11027344|NCT00833638|12206058|FG001|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
11331328|NCT02800928|12528520|FG001|STARTED|Overall Study||8
11331329|NCT02800928|12528519|FG000|COMPLETED|Overall Study||7
11331330|NCT02800928|12528520|FG001|COMPLETED|Overall Study||6
11027345|NCT00833638|12206059|FG002|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
11027346|NCT00833638|12206057|FG000|STARTED|Phase 3: Open-label Extension Phase||111
11331331|NCT02800928|12528519|FG000|NOT COMPLETED|Overall Study||2
11331332|NCT02800928|12528520|FG001|NOT COMPLETED|Overall Study||2
11331333|NCT02801006|12528526|FG000|STARTED|Lens 1||22
11331334|NCT02801006|12528527|FG001|STARTED|Lens 1||19
11331335|NCT02801006|12528526|FG000|COMPLETED|Lens 1||22
11331336|NCT02801006|12528527|FG001|COMPLETED|Lens 1||19
11331337|NCT02801006|12528526|FG000|NOT COMPLETED|Lens 1||0
11331338|NCT02801006|12528527|FG001|NOT COMPLETED|Lens 1||0
11331339|NCT02801006|12528526|FG000|STARTED|Lens 2||22
11331340|NCT02801006|12528527|FG001|STARTED|Lens 2||19
11331341|NCT02801006|12528526|FG000|COMPLETED|Lens 2||22
11331342|NCT02801006|12528527|FG001|COMPLETED|Lens 2||19
11331343|NCT02801006|12528526|FG000|NOT COMPLETED|Lens 2||0
11331344|NCT02801006|12528527|FG001|NOT COMPLETED|Lens 2||0
11331345|NCT02801370|12528537|FG000|STARTED|Overall Study||130
11331346|NCT02801370|12528538|FG001|STARTED|Overall Study||132
11331347|NCT02801370|12528537|FG000|COMPLETED|Overall Study||123
11331348|NCT02801370|12528538|FG001|COMPLETED|Overall Study||132
11331349|NCT02801370|12528537|FG000|NOT COMPLETED|Overall Study||7
11331350|NCT02801370|12528538|FG001|NOT COMPLETED|Overall Study||0
11331351|NCT02801396|12528545|FG000|STARTED|Period 1||17
11331352|NCT02801396|12528546|FG001|STARTED|Period 1||17
11331353|NCT02801396|12528547|FG002|STARTED|Period 1||17
11331354|NCT02801396|12528548|FG003|STARTED|Period 1||16
11331355|NCT02801396|12528549|FG004|STARTED|Period 1||17
11331356|NCT02801396|12528550|FG005|STARTED|Period 1||17
11331357|NCT02801396|12528545|FG000|COMPLETED|Period 1||17
11331358|NCT02801396|12528546|FG001|COMPLETED|Period 1||17
11331359|NCT02801396|12528547|FG002|COMPLETED|Period 1||17
11331360|NCT02801396|12528548|FG003|COMPLETED|Period 1||16
11331361|NCT02801396|12528549|FG004|COMPLETED|Period 1||16
11331362|NCT02801396|12528550|FG005|COMPLETED|Period 1||17
11331363|NCT02801396|12528545|FG000|NOT COMPLETED|Period 1||0
11331364|NCT02801396|12528546|FG001|NOT COMPLETED|Period 1||0
11331365|NCT02801396|12528547|FG002|NOT COMPLETED|Period 1||0
11331366|NCT02801396|12528548|FG003|NOT COMPLETED|Period 1||0
11331367|NCT02801396|12528549|FG004|NOT COMPLETED|Period 1||1
11331368|NCT02801396|12528550|FG005|NOT COMPLETED|Period 1||0
11331369|NCT02801396|12528545|FG000|STARTED|Period 2||17
11331370|NCT02801396|12528546|FG001|STARTED|Period 2||17
11331371|NCT02801396|12528547|FG002|STARTED|Period 2||17
11331372|NCT02801396|12528548|FG003|STARTED|Period 2||16
11331373|NCT02801396|12528549|FG004|STARTED|Period 2||16
11331374|NCT02801396|12528550|FG005|STARTED|Period 2||17
11331375|NCT02801396|12528545|FG000|COMPLETED|Period 2||17
11331376|NCT02801396|12528546|FG001|COMPLETED|Period 2||17
11331377|NCT02801396|12528547|FG002|COMPLETED|Period 2||17
11331378|NCT02801396|12528548|FG003|COMPLETED|Period 2||16
11331379|NCT02801396|12528549|FG004|COMPLETED|Period 2||16
11331380|NCT02801396|12528550|FG005|COMPLETED|Period 2||17
11331381|NCT02801396|12528545|FG000|NOT COMPLETED|Period 2||0
11331382|NCT02801396|12528546|FG001|NOT COMPLETED|Period 2||0
11331383|NCT02801396|12528547|FG002|NOT COMPLETED|Period 2||0
11331384|NCT02801396|12528548|FG003|NOT COMPLETED|Period 2||0
11331385|NCT02801396|12528549|FG004|NOT COMPLETED|Period 2||0
11331386|NCT02801396|12528550|FG005|NOT COMPLETED|Period 2||0
11331387|NCT02801396|12528545|FG000|STARTED|Period 3||17
11331388|NCT02801396|12528546|FG001|STARTED|Period 3||17
11331389|NCT02801396|12528547|FG002|STARTED|Period 3||17
11331390|NCT02801396|12528548|FG003|STARTED|Period 3||16
11331391|NCT02801396|12528549|FG004|STARTED|Period 3||16
11331392|NCT02801396|12528550|FG005|STARTED|Period 3||17
11331393|NCT02801396|12528545|FG000|COMPLETED|Period 3||17
11331394|NCT02801396|12528546|FG001|COMPLETED|Period 3||17
11331395|NCT02801396|12528547|FG002|COMPLETED|Period 3||17
11331396|NCT02801396|12528548|FG003|COMPLETED|Period 3||16
11331397|NCT02801396|12528549|FG004|COMPLETED|Period 3||16
11331398|NCT02801396|12528550|FG005|COMPLETED|Period 3||17
11331399|NCT02801396|12528545|FG000|NOT COMPLETED|Period 3||0
11331400|NCT02801396|12528546|FG001|NOT COMPLETED|Period 3||0
11331401|NCT02801396|12528547|FG002|NOT COMPLETED|Period 3||0
11331402|NCT02801396|12528548|FG003|NOT COMPLETED|Period 3||0
11331403|NCT02801396|12528549|FG004|NOT COMPLETED|Period 3||0
11331404|NCT02801396|12528550|FG005|NOT COMPLETED|Period 3||0
11331405|NCT02801578|12528558|FG000|STARTED|Overall Study||11
11331406|NCT02801578|12528558|FG000|COMPLETED|Overall Study||9
11331407|NCT02801578|12528558|FG000|NOT COMPLETED|Overall Study||2
11331408|NCT02801617|12528564|FG000|STARTED|Overall Study||51
11331409|NCT02801617|12528565|FG001|STARTED|Overall Study||56
11331410|NCT02801617|12528564|FG000|COMPLETED|Overall Study||49
11331411|NCT02801617|12528565|FG001|COMPLETED|Overall Study||50
11331412|NCT02801617|12528564|FG000|NOT COMPLETED|Overall Study||2
11331413|NCT02801617|12528565|FG001|NOT COMPLETED|Overall Study||6
11331414|NCT02801669|12528577|FG000|STARTED|Overall Study||492
11331415|NCT02801669|12528578|FG001|STARTED|Overall Study||492
11331416|NCT02801669|12528577|FG000|Received at Least 1 Dose of Study Drug|Overall Study||492
11331417|NCT02801669|12528578|FG001|Received at Least 1 Dose of Study Drug|Overall Study||490
11331418|NCT02801669|12528577|FG000|COMPLETED|Overall Study||341
11331419|NCT02801669|12528578|FG001|COMPLETED|Overall Study||340
11331420|NCT02801669|12528577|FG000|NOT COMPLETED|Overall Study||151
11331421|NCT02801669|12528578|FG001|NOT COMPLETED|Overall Study||152
11331422|NCT02801877|12528588|FG000|STARTED|Overall Study||74
11331423|NCT02801877|12528589|FG001|STARTED|Overall Study||75
11331424|NCT02801877|12528590|FG002|STARTED|Overall Study||76
11331425|NCT02801877|12528591|FG003|STARTED|Overall Study||76
11331426|NCT02801877|12528588|FG000|COMPLETED|Overall Study||71
11331427|NCT02801877|12528589|FG001|COMPLETED|Overall Study||74
11331428|NCT02801877|12528590|FG002|COMPLETED|Overall Study||70
11331429|NCT02801877|12528591|FG003|COMPLETED|Overall Study||76
11331430|NCT02801877|12528588|FG000|NOT COMPLETED|Overall Study||3
11331431|NCT02801877|12528589|FG001|NOT COMPLETED|Overall Study||1
11331432|NCT02801877|12528590|FG002|NOT COMPLETED|Overall Study||6
11331433|NCT02801877|12528591|FG003|NOT COMPLETED|Overall Study||0
11331434|NCT02801942|12528603|FG000|STARTED|Overall Study||12
11331435|NCT02801942|12528604|FG001|STARTED|Overall Study||10
11331436|NCT02801942|12528603|FG000|COMPLETED|Overall Study||12
11331437|NCT02801942|12528604|FG001|COMPLETED|Overall Study||10
11331438|NCT02801942|12528603|FG000|NOT COMPLETED|Overall Study||0
11331439|NCT02801942|12528604|FG001|NOT COMPLETED|Overall Study||0
11331440|NCT02802111|12528612|FG000|STARTED|First Intervention (5 Min of Drug)||12
11331441|NCT02802111|12528613|FG001|STARTED|First Intervention (5 Min of Drug)||12
11331442|NCT02802111|12528612|FG000|COMPLETED|First Intervention (5 Min of Drug)||12
11331443|NCT02802111|12528613|FG001|COMPLETED|First Intervention (5 Min of Drug)||12
11331444|NCT02802111|12528612|FG000|NOT COMPLETED|First Intervention (5 Min of Drug)||0
11331445|NCT02802111|12528613|FG001|NOT COMPLETED|First Intervention (5 Min of Drug)||0
11331446|NCT02802111|12528612|FG000|STARTED|Washout (4 Hours)||12
11331447|NCT02802111|12528613|FG001|STARTED|Washout (4 Hours)||12
11331448|NCT02802111|12528612|FG000|COMPLETED|Washout (4 Hours)||12
11331449|NCT02802111|12528613|FG001|COMPLETED|Washout (4 Hours)||12
11331450|NCT02802111|12528612|FG000|NOT COMPLETED|Washout (4 Hours)||0
11331451|NCT02802111|12528613|FG001|NOT COMPLETED|Washout (4 Hours)||0
11331452|NCT02802111|12528612|FG000|STARTED|Second Intervention (5 Min of Drug)||12
11331453|NCT02802111|12528613|FG001|STARTED|Second Intervention (5 Min of Drug)||12
11331454|NCT02802111|12528612|FG000|COMPLETED|Second Intervention (5 Min of Drug)||12
11331455|NCT02802111|12528613|FG001|COMPLETED|Second Intervention (5 Min of Drug)||12
11331456|NCT02802111|12528612|FG000|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
11331457|NCT02802111|12528613|FG001|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
11331458|NCT02802241|12528623|FG000|STARTED|Overall Study||97
11331459|NCT02802241|12528624|FG001|STARTED|Overall Study||97
11331460|NCT02802241|12528625|FG002|STARTED|Overall Study||48
11331461|NCT02802241|12528626|FG003|STARTED|Overall Study||98
11331462|NCT02802241|12528623|FG000|Planned Analysis|Overall Study||89
11331463|NCT02802241|12528624|FG001|Planned Analysis|Overall Study||86
11331464|NCT02802241|12528625|FG002|Planned Analysis|Overall Study|Not included in primary analysis|0
11331465|NCT02802241|12528626|FG003|Planned Analysis|Overall Study||87
11331466|NCT02802241|12528623|FG000|COMPLETED|Overall Study||68
11331467|NCT02802241|12528624|FG001|COMPLETED|Overall Study||71
11331468|NCT02802241|12528625|FG002|COMPLETED|Overall Study|Not included in primary analysis|0
11331469|NCT02802241|12528626|FG003|COMPLETED|Overall Study||72
11331470|NCT02802241|12528623|FG000|NOT COMPLETED|Overall Study||29
11331471|NCT02802241|12528624|FG001|NOT COMPLETED|Overall Study||26
11331472|NCT02802241|12528625|FG002|NOT COMPLETED|Overall Study||48
11331473|NCT02802241|12528626|FG003|NOT COMPLETED|Overall Study||26
11331474|NCT02802319|12528638|FG000|STARTED|Overall Study||22
11331475|NCT02802319|12528639|FG001|STARTED|Overall Study||22
11331476|NCT02802319|12528638|FG000|COMPLETED|Overall Study||20
11331477|NCT02802319|12528639|FG001|COMPLETED|Overall Study||17
11331478|NCT02802319|12528638|FG000|NOT COMPLETED|Overall Study||2
11331479|NCT02802319|12528639|FG001|NOT COMPLETED|Overall Study||5
11331480|NCT02802345|12528647|FG000|STARTED|Overall Study||136
11331481|NCT02802345|12528648|FG001|STARTED|Overall Study||138
11331482|NCT02802345|12528647|FG000|Treated|Overall Study||136
11331483|NCT02802345|12528648|FG001|Treated|Overall Study||137
11331484|NCT02802345|12528647|FG000|COMPLETED|Overall Study||104
11331485|NCT02802345|12528648|FG001|COMPLETED|Overall Study||108
11331486|NCT02802345|12528647|FG000|NOT COMPLETED|Overall Study||32
11331487|NCT02802345|12528648|FG001|NOT COMPLETED|Overall Study||30
11331488|NCT02802449|12528656|FG000|STARTED|Overall Study||111
11331489|NCT02802449|12528657|FG001|STARTED|Overall Study||219
11331490|NCT02802449|12528656|FG000|COMPLETED|Overall Study||102
11331491|NCT02802449|12528657|FG001|COMPLETED|Overall Study||202
11331492|NCT02802449|12528656|FG000|NOT COMPLETED|Overall Study||9
11331493|NCT02802449|12528657|FG001|NOT COMPLETED|Overall Study||17
11331494|NCT02802501|12528666|FG000|STARTED|Double-blind (Up to Day 180)||50
11331495|NCT02802501|12528667|FG001|STARTED|Double-blind (Up to Day 180)||50
11331496|NCT02802501|12528668|FG002|STARTED|Double-blind (Up to Day 180)||50
11331497|NCT02802501|12528666|FG000|COMPLETED|Double-blind (Up to Day 180)||50
11331498|NCT02802501|12528667|FG001|COMPLETED|Double-blind (Up to Day 180)||50
11331499|NCT02802501|12528668|FG002|COMPLETED|Double-blind (Up to Day 180)||50
11343800|NCT02956057|12541061|FG002|NOT COMPLETED|Overall Study||8
11331500|NCT02802501|12528666|FG000|NOT COMPLETED|Double-blind (Up to Day 180)||0
11331501|NCT02802501|12528667|FG001|NOT COMPLETED|Double-blind (Up to Day 180)||0
11331502|NCT02802501|12528668|FG002|NOT COMPLETED|Double-blind (Up to Day 180)||0
11331503|NCT02802501|12528666|FG000|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|6
11331504|NCT02802501|12528667|FG001|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|12
11331505|NCT02802501|12528668|FG002|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|26
11331506|NCT02802501|12528666|FG000|COMPLETED|Open-Label (Day 180 to Day 195)||6
11331507|NCT02802501|12528667|FG001|COMPLETED|Open-Label (Day 180 to Day 195)||12
11331508|NCT02802501|12528668|FG002|COMPLETED|Open-Label (Day 180 to Day 195)||26
11331509|NCT02802501|12528666|FG000|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
11331510|NCT02802501|12528667|FG001|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
11331511|NCT02802501|12528668|FG002|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
11331512|NCT02802514|12528681|FG000|STARTED|Session 1 (up to Day 8)||1
11331513|NCT02802514|12528682|FG001|STARTED|Session 1 (up to Day 8)||1
11331514|NCT02802514|12528683|FG002|STARTED|Session 1 (up to Day 8)||1
11331515|NCT02802514|12528684|FG003|STARTED|Session 1 (up to Day 8)||1
11331516|NCT02802514|12528681|FG000|COMPLETED|Session 1 (up to Day 8)||1
11331517|NCT02802514|12528682|FG001|COMPLETED|Session 1 (up to Day 8)||1
11331518|NCT02802514|12528683|FG002|COMPLETED|Session 1 (up to Day 8)||1
11331519|NCT02802514|12528684|FG003|COMPLETED|Session 1 (up to Day 8)||1
11331520|NCT02802514|12528681|FG000|NOT COMPLETED|Session 1 (up to Day 8)||0
11331521|NCT02802514|12528682|FG001|NOT COMPLETED|Session 1 (up to Day 8)||0
11331522|NCT02802514|12528683|FG002|NOT COMPLETED|Session 1 (up to Day 8)||0
11331523|NCT02802514|12528684|FG003|NOT COMPLETED|Session 1 (up to Day 8)||0
11331524|NCT02802514|12528681|FG000|STARTED|Wash Out Period (up to Week 9)||1
11331525|NCT02802514|12528682|FG001|STARTED|Wash Out Period (up to Week 9)||1
11331526|NCT02802514|12528683|FG002|STARTED|Wash Out Period (up to Week 9)||1
11331527|NCT02802514|12528684|FG003|STARTED|Wash Out Period (up to Week 9)||1
11331528|NCT02802514|12528681|FG000|COMPLETED|Wash Out Period (up to Week 9)||1
11331529|NCT02802514|12528682|FG001|COMPLETED|Wash Out Period (up to Week 9)||1
11331530|NCT02802514|12528683|FG002|COMPLETED|Wash Out Period (up to Week 9)||1
11331531|NCT02802514|12528684|FG003|COMPLETED|Wash Out Period (up to Week 9)||1
11331532|NCT02802514|12528681|FG000|NOT COMPLETED|Wash Out Period (up to Week 9)||0
11331533|NCT02802514|12528682|FG001|NOT COMPLETED|Wash Out Period (up to Week 9)||0
11331534|NCT02802514|12528683|FG002|NOT COMPLETED|Wash Out Period (up to Week 9)||0
11331535|NCT02802514|12528684|FG003|NOT COMPLETED|Wash Out Period (up to Week 9)||0
11331536|NCT02802514|12528681|FG000|STARTED|Session 2 (Up to Day 8)||1
11331537|NCT02802514|12528682|FG001|STARTED|Session 2 (Up to Day 8)||1
11331538|NCT02802514|12528683|FG002|STARTED|Session 2 (Up to Day 8)||1
11331539|NCT02802514|12528684|FG003|STARTED|Session 2 (Up to Day 8)||1
11331540|NCT02802514|12528681|FG000|COMPLETED|Session 2 (Up to Day 8)||1
11331541|NCT02802514|12528682|FG001|COMPLETED|Session 2 (Up to Day 8)||1
11331542|NCT02802514|12528683|FG002|COMPLETED|Session 2 (Up to Day 8)||1
11331543|NCT02802514|12528684|FG003|COMPLETED|Session 2 (Up to Day 8)||1
11331544|NCT02802514|12528681|FG000|NOT COMPLETED|Session 2 (Up to Day 8)||0
11331545|NCT02802514|12528682|FG001|NOT COMPLETED|Session 2 (Up to Day 8)||0
11331546|NCT02802514|12528683|FG002|NOT COMPLETED|Session 2 (Up to Day 8)||0
11331547|NCT02802514|12528684|FG003|NOT COMPLETED|Session 2 (Up to Day 8)||0
11331548|NCT02802735|12528700|FG000|STARTED|Overall Study||4
11331549|NCT02802735|12528701|FG001|STARTED|Overall Study||4
11331550|NCT02802735|12528702|FG002|STARTED|Overall Study||4
11331551|NCT02802735|12528703|FG003|STARTED|Overall Study||12
11331552|NCT02802735|12528704|FG004|STARTED|Overall Study||4
11331553|NCT02802735|12528700|FG000|COMPLETED|Overall Study||4
11331554|NCT02802735|12528701|FG001|COMPLETED|Overall Study||3
11331555|NCT02802735|12528702|FG002|COMPLETED|Overall Study||4
11331556|NCT02802735|12528703|FG003|COMPLETED|Overall Study||12
11331557|NCT02802735|12528704|FG004|COMPLETED|Overall Study||4
11331558|NCT02802735|12528700|FG000|NOT COMPLETED|Overall Study||0
11331559|NCT02802735|12528701|FG001|NOT COMPLETED|Overall Study||1
11331560|NCT02802735|12528702|FG002|NOT COMPLETED|Overall Study||0
11331561|NCT02802735|12528703|FG003|NOT COMPLETED|Overall Study||0
11331562|NCT02802735|12528704|FG004|NOT COMPLETED|Overall Study||0
11343801|NCT02956057|12541062|FG003|NOT COMPLETED|Overall Study||15
11343802|NCT02956057|12541063|FG004|NOT COMPLETED|Overall Study||5
11343803|NCT02956057|12541064|FG005|NOT COMPLETED|Overall Study||17
11343804|NCT02956070|12541080|FG000|STARTED|Overall Study||35
11343805|NCT02956070|12541081|FG001|STARTED|Overall Study||35
11343806|NCT02956070|12541080|FG000|COMPLETED|Overall Study||35
11343807|NCT02956070|12541081|FG001|COMPLETED|Overall Study||35
11343808|NCT02956070|12541080|FG000|NOT COMPLETED|Overall Study||0
11343809|NCT02956070|12541081|FG001|NOT COMPLETED|Overall Study||0
11343810|NCT02956122|12541087|FG000|STARTED|Overall Study||1
11343811|NCT02956122|12541087|FG000|COMPLETED|Overall Study||1
11343812|NCT02956122|12541087|FG000|NOT COMPLETED|Overall Study||0
11343813|NCT02956278|12541101|FG000|STARTED|Overall Study||15
11343814|NCT02956278|12541102|FG001|STARTED|Overall Study||9
11343815|NCT02956278|12541103|FG002|STARTED|Overall Study||3
11343816|NCT02956278|12541101|FG000|COMPLETED|Overall Study||9
11343817|NCT02956278|12541102|FG001|COMPLETED|Overall Study||7
11343818|NCT02956278|12541103|FG002|COMPLETED|Overall Study||3
11343819|NCT02956278|12541101|FG000|NOT COMPLETED|Overall Study||6
11343820|NCT02956278|12541102|FG001|NOT COMPLETED|Overall Study||2
11343821|NCT02956278|12541103|FG002|NOT COMPLETED|Overall Study||0
11331563|NCT02802865|12528721|FG000|STARTED|Overall Study||35
11331564|NCT02802865|12528722|FG001|STARTED|Overall Study||35
11331565|NCT02802865|12528721|FG000|COMPLETED|Overall Study||34
11331566|NCT02802865|12528722|FG001|COMPLETED|Overall Study||33
11331567|NCT02802865|12528721|FG000|NOT COMPLETED|Overall Study||1
11331568|NCT02802865|12528722|FG001|NOT COMPLETED|Overall Study||2
11057337|NCT00997113|12238813|FG000|NOT COMPLETED|Overall Study||0
11331569|NCT02802878|12528730|FG000|STARTED|Overall Study||21
11331570|NCT02802878|12528731|FG001|STARTED|Overall Study||21
11331571|NCT02802878|12528730|FG000|COMPLETED|Overall Study||17
11331572|NCT02802878|12528731|FG001|COMPLETED|Overall Study||18
11331573|NCT02802878|12528730|FG000|NOT COMPLETED|Overall Study||4
11331574|NCT02802878|12528731|FG001|NOT COMPLETED|Overall Study||3
11331575|NCT02803138|12528737|FG000|STARTED|Overall Study||236
11331576|NCT02803138|12528737|FG000|COMPLETED|Overall Study||166
11331577|NCT02803138|12528737|FG000|NOT COMPLETED|Overall Study||70
11331578|NCT02803164|12528745|FG000|STARTED|Overall Study||10
11331579|NCT02803164|12528746|FG001|STARTED|Overall Study||11
11331580|NCT02803164|12528745|FG000|COMPLETED|Overall Study||10
11331581|NCT02803164|12528746|FG001|COMPLETED|Overall Study||11
11331582|NCT02803164|12528745|FG000|NOT COMPLETED|Overall Study||0
11331583|NCT02803164|12528746|FG001|NOT COMPLETED|Overall Study||0
11331584|NCT02803229|12528756|FG000|STARTED|Overall Study||15
11331585|NCT02803229|12528757|FG001|STARTED|Overall Study||13
11331586|NCT02803229|12528756|FG000|COMPLETED|Overall Study||11
11331587|NCT02803229|12528757|FG001|COMPLETED|Overall Study||7
11331588|NCT02803229|12528756|FG000|NOT COMPLETED|Overall Study||4
11331589|NCT02803229|12528757|FG001|NOT COMPLETED|Overall Study||6
11331590|NCT02803580|12528763|FG000|STARTED|Overall Study||209
11331591|NCT02803580|12528763|FG000|COMPLETED|Overall Study||173
11331592|NCT02803580|12528763|FG000|NOT COMPLETED|Overall Study||36
11331593|NCT02803749|12528769|FG000|STARTED|Overall Study||17
11331594|NCT02803749|12528770|FG001|STARTED|Overall Study||4
11331595|NCT02803749|12528769|FG000|COMPLETED|Overall Study||12
11331596|NCT02803749|12528770|FG001|COMPLETED|Overall Study||4
11331597|NCT02803749|12528769|FG000|NOT COMPLETED|Overall Study||5
11331598|NCT02803749|12528770|FG001|NOT COMPLETED|Overall Study||0
11331599|NCT02804178|12528776|FG000|STARTED|Overall Study||10
11331600|NCT02804178|12528776|FG000|COMPLETED|Overall Study||9
11331601|NCT02804178|12528776|FG000|NOT COMPLETED|Overall Study||1
11331602|NCT02804399|12528780|FG000|STARTED|Period 1||12
11331603|NCT02804399|12528781|FG001|STARTED|Period 1||0
11331604|NCT02804399|12528780|FG000|COMPLETED|Period 1||12
11331605|NCT02804399|12528781|FG001|COMPLETED|Period 1||0
11331606|NCT02804399|12528780|FG000|NOT COMPLETED|Period 1||0
11331607|NCT02804399|12528781|FG001|NOT COMPLETED|Period 1||0
11331608|NCT02804399|12528780|FG000|STARTED|Washout Period at Least 10 Days||12
11331609|NCT02804399|12528781|FG001|STARTED|Washout Period at Least 10 Days||0
11331610|NCT02804399|12528780|FG000|COMPLETED|Washout Period at Least 10 Days||12
11331611|NCT02804399|12528781|FG001|COMPLETED|Washout Period at Least 10 Days||0
11331612|NCT02804399|12528780|FG000|NOT COMPLETED|Washout Period at Least 10 Days||0
11331613|NCT02804399|12528781|FG001|NOT COMPLETED|Washout Period at Least 10 Days||0
11331614|NCT02804399|12528780|FG000|STARTED|Period 2||0
11331615|NCT02804399|12528781|FG001|STARTED|Period 2||12
11331616|NCT02804399|12528780|FG000|COMPLETED|Period 2||0
11331617|NCT02804399|12528781|FG001|COMPLETED|Period 2||11
11331618|NCT02804399|12528780|FG000|NOT COMPLETED|Period 2||0
11331619|NCT02804399|12528781|FG001|NOT COMPLETED|Period 2||1
11331620|NCT02804594|12528792|FG000|STARTED|Overall Study||10
11331621|NCT02804594|12528793|FG001|STARTED|Overall Study||5
11331622|NCT02804594|12528792|FG000|COMPLETED|Overall Study||10
11331623|NCT02804594|12528793|FG001|COMPLETED|Overall Study||5
11331624|NCT02804594|12528792|FG000|NOT COMPLETED|Overall Study||0
11331625|NCT02804594|12528793|FG001|NOT COMPLETED|Overall Study||0
11331626|NCT02804750|12528801|FG000|STARTED|Period 1||17
11331627|NCT02804750|12528802|FG001|STARTED|Period 1||18
11331628|NCT02804750|12528801|FG000|COMPLETED|Period 1||17
11331629|NCT02804750|12528802|FG001|COMPLETED|Period 1||15
11331630|NCT02804750|12528801|FG000|NOT COMPLETED|Period 1||0
11331631|NCT02804750|12528802|FG001|NOT COMPLETED|Period 1||3
11331632|NCT02804750|12528801|FG000|STARTED|Period 2||17
11331633|NCT02804750|12528802|FG001|STARTED|Period 2||15
11331634|NCT02804750|12528801|FG000|COMPLETED|Period 2||16
11331635|NCT02804750|12528802|FG001|COMPLETED|Period 2||15
11331636|NCT02804750|12528801|FG000|NOT COMPLETED|Period 2||1
11331637|NCT02804750|12528802|FG001|NOT COMPLETED|Period 2||0
11331638|NCT02804750|12528801|FG000|STARTED|Period 3||16
11331639|NCT02804750|12528802|FG001|STARTED|Period 3||15
11331640|NCT02804750|12528801|FG000|COMPLETED|Period 3||16
11331641|NCT02804750|12528802|FG001|COMPLETED|Period 3||13
11331642|NCT02804750|12528801|FG000|NOT COMPLETED|Period 3||0
11331643|NCT02804750|12528802|FG001|NOT COMPLETED|Period 3||2
11331644|NCT02804750|12528801|FG000|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0
11331645|NCT02804750|12528802|FG001|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12
11331646|NCT02804750|12528801|FG000|COMPLETED|Period 4||0
11331647|NCT02804750|12528802|FG001|COMPLETED|Period 4||7
11331648|NCT02804750|12528801|FG000|NOT COMPLETED|Period 4||0
11331649|NCT02804750|12528802|FG001|NOT COMPLETED|Period 4||5
11331650|NCT02804763|12528814|FG000|STARTED|Double-Blind Period (Week 1 to Week 24)||45
11331651|NCT02804763|12528815|FG001|STARTED|Double-Blind Period (Week 1 to Week 24)||45
11331652|NCT02804763|12528816|FG002|STARTED|Double-Blind Period (Week 1 to Week 24)||45
11331653|NCT02804763|12528817|FG003|STARTED|Double-Blind Period (Week 1 to Week 24)||47
11331654|NCT02804763|12528814|FG000|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
11331655|NCT02804763|12528815|FG001|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
11331656|NCT02804763|12528816|FG002|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
11331657|NCT02804763|12528817|FG003|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
11331658|NCT02804763|12528814|FG000|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
11331659|NCT02804763|12528815|FG001|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
11331660|NCT02804763|12528816|FG002|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
11331661|NCT02804763|12528817|FG003|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||45
11331662|NCT02804763|12528814|FG000|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
11331663|NCT02804763|12528815|FG001|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
11331664|NCT02804763|12528816|FG002|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
11331665|NCT02804763|12528817|FG003|COMPLETED|Double-Blind Period (Week 1 to Week 24)||45
11331666|NCT02804763|12528814|FG000|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
11331667|NCT02804763|12528815|FG001|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
11331668|NCT02804763|12528816|FG002|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
11331669|NCT02804763|12528817|FG003|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||2
11331670|NCT02804763|12528814|FG000|STARTED|Observational Period (Wk 24 to Wk 48)||44
11331671|NCT02804763|12528815|FG001|STARTED|Observational Period (Wk 24 to Wk 48)||44
11331672|NCT02804763|12528816|FG002|STARTED|Observational Period (Wk 24 to Wk 48)||44
11331673|NCT02804763|12528817|FG003|STARTED|Observational Period (Wk 24 to Wk 48)||45
11331674|NCT02804763|12528814|FG000|COMPLETED|Observational Period (Wk 24 to Wk 48)||38
11331675|NCT02804763|12528815|FG001|COMPLETED|Observational Period (Wk 24 to Wk 48)||43
11331676|NCT02804763|12528816|FG002|COMPLETED|Observational Period (Wk 24 to Wk 48)||41
11331677|NCT02804763|12528817|FG003|COMPLETED|Observational Period (Wk 24 to Wk 48)||42
11331678|NCT02804763|12528814|FG000|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||6
11331679|NCT02804763|12528815|FG001|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||1
11331680|NCT02804763|12528816|FG002|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
11331681|NCT02804763|12528817|FG003|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
11331682|NCT02805179|12528831|FG000|STARTED|Overall Study||26
11331683|NCT02805179|12528831|FG000|Eligible Patients That Started Dose-intensified Chemo-radiation|Overall Study||23
11331684|NCT02805179|12528831|FG000|Subset of Participants, Boosted to Both High B-value Diffusion and Perfusion|Overall Study||13
11331685|NCT02805179|12528831|FG000|COMPLETED|Overall Study||23
11331686|NCT02805179|12528831|FG000|NOT COMPLETED|Overall Study||3
11331687|NCT02805309|12528838|FG000|STARTED|Overall Study||18
11331688|NCT02805309|12528839|FG001|STARTED|Overall Study||17
11331689|NCT02805309|12528840|FG002|STARTED|Overall Study||19
11331690|NCT02805309|12528838|FG000|COMPLETED|Overall Study||16
11331691|NCT02805309|12528839|FG001|COMPLETED|Overall Study||13
11331692|NCT02805309|12528840|FG002|COMPLETED|Overall Study||16
11331693|NCT02805309|12528838|FG000|NOT COMPLETED|Overall Study||2
11331694|NCT02805309|12528839|FG001|NOT COMPLETED|Overall Study||4
11331695|NCT02805309|12528840|FG002|NOT COMPLETED|Overall Study||3
11331696|NCT02805647|12528850|FG000|STARTED|Overall Study|at the moment of submision|100
11331697|NCT02805647|12528851|FG001|STARTED|Overall Study|at the moment of submision|122
11331698|NCT02805647|12528850|FG000|COMPLETED|Overall Study|after laboratory tests|100
11331699|NCT02805647|12528851|FG001|COMPLETED|Overall Study|after laboratory tests|122
11331700|NCT02805647|12528850|FG000|NOT COMPLETED|Overall Study||0
11331701|NCT02805647|12528851|FG001|NOT COMPLETED|Overall Study||0
11331702|NCT02805660|12528864|FG000|STARTED|Overall Study||5
11331703|NCT02805660|12528865|FG001|STARTED|Overall Study||4
11331704|NCT02805660|12528866|FG002|STARTED|Overall Study||11
11331705|NCT02805660|12528867|FG003|STARTED|Overall Study||18
11331706|NCT02805660|12528868|FG004|STARTED|Overall Study||3
11331707|NCT02805660|12528869|FG005|STARTED|Overall Study||23
11331708|NCT02805660|12528870|FG006|STARTED|Overall Study||19
11331709|NCT02805660|12528864|FG000|COMPLETED|Overall Study||0
11331710|NCT02805660|12528865|FG001|COMPLETED|Overall Study||0
11331711|NCT02805660|12528866|FG002|COMPLETED|Overall Study||0
11331712|NCT02805660|12528867|FG003|COMPLETED|Overall Study||0
11331713|NCT02805660|12528868|FG004|COMPLETED|Overall Study||0
11331714|NCT02805660|12528869|FG005|COMPLETED|Overall Study||0
11331715|NCT02805660|12528870|FG006|COMPLETED|Overall Study||0
11331716|NCT02805660|12528864|FG000|NOT COMPLETED|Overall Study||5
11331717|NCT02805660|12528865|FG001|NOT COMPLETED|Overall Study||4
11331718|NCT02805660|12528866|FG002|NOT COMPLETED|Overall Study||11
11331719|NCT02805660|12528867|FG003|NOT COMPLETED|Overall Study||18
11331720|NCT02805660|12528868|FG004|NOT COMPLETED|Overall Study||3
11331721|NCT02805660|12528869|FG005|NOT COMPLETED|Overall Study||23
11331722|NCT02805660|12528870|FG006|NOT COMPLETED|Overall Study||19
11331723|NCT02805790|12528901|FG000|STARTED|First Intervention (4 Weeks)||14
11331724|NCT02805790|12528902|FG001|STARTED|First Intervention (4 Weeks)||16
11331725|NCT02805790|12528901|FG000|COMPLETED|First Intervention (4 Weeks)||14
11331726|NCT02805790|12528902|FG001|COMPLETED|First Intervention (4 Weeks)||16
11331727|NCT02805790|12528901|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
11331728|NCT02805790|12528902|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
11331729|NCT02805790|12528901|FG000|STARTED|Washout (4 Weeks)||14
11331730|NCT02805790|12528902|FG001|STARTED|Washout (4 Weeks)||16
11331731|NCT02805790|12528901|FG000|COMPLETED|Washout (4 Weeks)||14
11331732|NCT02805790|12528902|FG001|COMPLETED|Washout (4 Weeks)||16
11331733|NCT02805790|12528901|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11331734|NCT02805790|12528902|FG001|NOT COMPLETED|Washout (4 Weeks)||0
11331735|NCT02805790|12528901|FG000|STARTED|Second Intervention (4 Weeks)||14
11331736|NCT02805790|12528902|FG001|STARTED|Second Intervention (4 Weeks)||16
11331737|NCT02805790|12528901|FG000|COMPLETED|Second Intervention (4 Weeks)||14
11331738|NCT02805790|12528902|FG001|COMPLETED|Second Intervention (4 Weeks)||15
11331739|NCT02805790|12528901|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
11331740|NCT02805790|12528902|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
11331741|NCT02805907|12528910|FG000|STARTED|Overall Study||56
11331742|NCT02805907|12528911|FG001|STARTED|Overall Study||56
11331743|NCT02805907|12528910|FG000|COMPLETED|Overall Study||53
11331744|NCT02805907|12528911|FG001|COMPLETED|Overall Study||53
11331745|NCT02805907|12528910|FG000|NOT COMPLETED|Overall Study||3
11331746|NCT02805907|12528911|FG001|NOT COMPLETED|Overall Study||3
11331747|NCT02805972|12528919|FG000|STARTED|Intervention Visit 1||23
11331748|NCT02805972|12528920|FG001|STARTED|Intervention Visit 1||18
11331749|NCT02805972|12528919|FG000|COMPLETED|Intervention Visit 1||23
11331750|NCT02805972|12528920|FG001|COMPLETED|Intervention Visit 1||18
11331751|NCT02805972|12528919|FG000|NOT COMPLETED|Intervention Visit 1||0
11331752|NCT02805972|12528920|FG001|NOT COMPLETED|Intervention Visit 1||0
11331753|NCT02805972|12528919|FG000|STARTED|Washout Period||23
11331754|NCT02805972|12528920|FG001|STARTED|Washout Period||18
11331755|NCT02805972|12528919|FG000|COMPLETED|Washout Period||20
11331756|NCT02805972|12528920|FG001|COMPLETED|Washout Period||18
11331757|NCT02805972|12528919|FG000|NOT COMPLETED|Washout Period||3
11331758|NCT02805972|12528920|FG001|NOT COMPLETED|Washout Period||0
11331759|NCT02805972|12528919|FG000|STARTED|Intervention Visit 2||20
11331760|NCT02805972|12528920|FG001|STARTED|Intervention Visit 2||18
11331761|NCT02805972|12528919|FG000|COMPLETED|Intervention Visit 2||20
11331762|NCT02805972|12528920|FG001|COMPLETED|Intervention Visit 2||18
11331763|NCT02805972|12528919|FG000|NOT COMPLETED|Intervention Visit 2||0
11331764|NCT02805972|12528920|FG001|NOT COMPLETED|Intervention Visit 2||0
11331765|NCT02806024|12528938|FG000|STARTED|Overall Study||7
11331766|NCT02806024|12528939|FG001|STARTED|Overall Study||7
11331767|NCT02806024|12528938|FG000|COMPLETED|Overall Study||6
11331768|NCT02806024|12528939|FG001|COMPLETED|Overall Study||5
11331769|NCT02806024|12528938|FG000|NOT COMPLETED|Overall Study||1
11331770|NCT02806024|12528939|FG001|NOT COMPLETED|Overall Study||2
11331771|NCT02806232|12528954|FG000|STARTED|Overall Study||60
11331772|NCT02806232|12528955|FG001|STARTED|Overall Study||60
11331773|NCT02806232|12528956|FG002|STARTED|Overall Study||60
11331774|NCT02806232|12528957|FG003|STARTED|Overall Study||60
11331775|NCT02806232|12528958|FG004|STARTED|Overall Study||60
11331776|NCT02806232|12528959|FG005|STARTED|Overall Study||60
11331777|NCT02806232|12528960|FG006|STARTED|Overall Study||60
11331778|NCT02806232|12528961|FG007|STARTED|Overall Study||20
11331779|NCT02806232|12528962|FG008|STARTED|Overall Study||4
11331780|NCT02806232|12528954|FG000|COMPLETED|Overall Study||59
11331781|NCT02806232|12528955|FG001|COMPLETED|Overall Study||56
11331782|NCT02806232|12528956|FG002|COMPLETED|Overall Study||59
11331783|NCT02806232|12528957|FG003|COMPLETED|Overall Study||60
11331784|NCT02806232|12528958|FG004|COMPLETED|Overall Study||58
11331785|NCT02806232|12528959|FG005|COMPLETED|Overall Study||58
11331786|NCT02806232|12528960|FG006|COMPLETED|Overall Study||60
11331787|NCT02806232|12528961|FG007|COMPLETED|Overall Study||20
11331788|NCT02806232|12528962|FG008|COMPLETED|Overall Study||4
11331789|NCT02806232|12528954|FG000|NOT COMPLETED|Overall Study||1
11331790|NCT02806232|12528955|FG001|NOT COMPLETED|Overall Study||4
11331791|NCT02806232|12528956|FG002|NOT COMPLETED|Overall Study||1
11331792|NCT02806232|12528957|FG003|NOT COMPLETED|Overall Study||0
11331793|NCT02806232|12528958|FG004|NOT COMPLETED|Overall Study||2
11331794|NCT02806232|12528959|FG005|NOT COMPLETED|Overall Study||2
11331795|NCT02806232|12528960|FG006|NOT COMPLETED|Overall Study||0
11331796|NCT02806232|12528961|FG007|NOT COMPLETED|Overall Study||0
11331797|NCT02806232|12528962|FG008|NOT COMPLETED|Overall Study||0
11331798|NCT02806414|12528982|FG000|STARTED|Overall Study||25
11331799|NCT02806414|12528982|FG000|COMPLETED|Overall Study||23
11331800|NCT02806414|12528982|FG000|NOT COMPLETED|Overall Study||2
11331801|NCT02806505|12528988|FG000|STARTED|Overall Study||38
11331802|NCT02806505|12528989|FG001|STARTED|Overall Study||43
11331803|NCT02806505|12528988|FG000|COMPLETED|Overall Study||28
11331804|NCT02806505|12528989|FG001|COMPLETED|Overall Study||32
11331805|NCT02806505|12528988|FG000|NOT COMPLETED|Overall Study||10
11331806|NCT02806505|12528989|FG001|NOT COMPLETED|Overall Study||11
11331807|NCT02806544|12528995|FG000|STARTED|Overall Study||35
11331808|NCT02806544|12528995|FG000|COMPLETED|Overall Study||31
11331809|NCT02806544|12528995|FG000|NOT COMPLETED|Overall Study||4
11331810|NCT02806713|12529001|FG000|STARTED|Overall Study||46
11331811|NCT02806713|12529002|FG001|STARTED|Overall Study||46
11331812|NCT02806713|12529001|FG000|COMPLETED|Overall Study||44
11331813|NCT02806713|12529002|FG001|COMPLETED|Overall Study||44
11331814|NCT02806713|12529001|FG000|NOT COMPLETED|Overall Study||2
11331815|NCT02806713|12529002|FG001|NOT COMPLETED|Overall Study||2
11331816|NCT02806726|12529008|FG000|STARTED|Overall Study|Subjects were treated contralaterally|7
11331817|NCT02806726|12529008|FG000|COMPLETED|Overall Study|Subjects were treated contralaterally|6
11331818|NCT02806726|12529008|FG000|NOT COMPLETED|Overall Study||1
11331819|NCT02806869|12529015|FG000|STARTED|First Intervention (1 Day)||24
11331820|NCT02806869|12529016|FG001|STARTED|First Intervention (1 Day)||24
11331821|NCT02806869|12529015|FG000|COMPLETED|First Intervention (1 Day)||13
11331822|NCT02806869|12529016|FG001|COMPLETED|First Intervention (1 Day)||12
11331823|NCT02806869|12529015|FG000|NOT COMPLETED|First Intervention (1 Day)||11
11331824|NCT02806869|12529016|FG001|NOT COMPLETED|First Intervention (1 Day)||12
11331825|NCT02806869|12529015|FG000|STARTED|Washout (7 Days)||7
11331826|NCT02806869|12529016|FG001|STARTED|Washout (7 Days)||7
11331827|NCT02806869|12529015|FG000|COMPLETED|Washout (7 Days)||7
11331828|NCT02806869|12529016|FG001|COMPLETED|Washout (7 Days)||7
11331829|NCT02806869|12529015|FG000|NOT COMPLETED|Washout (7 Days)||0
11331830|NCT02806869|12529016|FG001|NOT COMPLETED|Washout (7 Days)||0
11331831|NCT02806869|12529015|FG000|STARTED|Second Intervention (1 Day)||7
11331832|NCT02806869|12529016|FG001|STARTED|Second Intervention (1 Day)||7
11331833|NCT02806869|12529015|FG000|COMPLETED|Second Intervention (1 Day)||7
11331834|NCT02806869|12529016|FG001|COMPLETED|Second Intervention (1 Day)||5
11331835|NCT02806869|12529015|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11331836|NCT02806869|12529016|FG001|NOT COMPLETED|Second Intervention (1 Day)||2
11331837|NCT02806895|12529024|FG000|STARTED|Overall Study||17
11331838|NCT02806895|12529025|FG001|STARTED|Overall Study||17
11331839|NCT02806895|12529024|FG000|COMPLETED|Overall Study||16
11331840|NCT02806895|12529025|FG001|COMPLETED|Overall Study||17
11331841|NCT02806895|12529024|FG000|NOT COMPLETED|Overall Study||1
11331842|NCT02806895|12529025|FG001|NOT COMPLETED|Overall Study||0
11331843|NCT02806908|12529034|FG000|STARTED|Overall Study||11
11331844|NCT02806908|12529035|FG001|STARTED|Overall Study||13
11331845|NCT02806908|12529034|FG000|COMPLETED|Overall Study||10
11331846|NCT02806908|12529035|FG001|COMPLETED|Overall Study||12
11331847|NCT02806908|12529034|FG000|NOT COMPLETED|Overall Study||1
11331848|NCT02806908|12529035|FG001|NOT COMPLETED|Overall Study||1
11331849|NCT02806947|12529044|FG000|STARTED|Overall Study||58
11331850|NCT02806947|12529045|FG001|STARTED|Overall Study||64
11331851|NCT02806947|12529044|FG000|COMPLETED|Overall Study||53
11331852|NCT02806947|12529045|FG001|COMPLETED|Overall Study||63
11331853|NCT02806947|12529044|FG000|NOT COMPLETED|Overall Study||5
11331854|NCT02806947|12529045|FG001|NOT COMPLETED|Overall Study||1
11331855|NCT02806973|12529051|FG000|STARTED|Period 1||8
11331856|NCT02806973|12529052|FG001|STARTED|Period 1||8
11331857|NCT02806973|12529053|FG002|STARTED|Period 1||8
11331858|NCT02806973|12529054|FG003|STARTED|Period 1||8
11331859|NCT02806973|12529051|FG000|COMPLETED|Period 1||8
11331860|NCT02806973|12529052|FG001|COMPLETED|Period 1||6
11331861|NCT02806973|12529053|FG002|COMPLETED|Period 1||7
11331862|NCT02806973|12529054|FG003|COMPLETED|Period 1||6
11331863|NCT02806973|12529051|FG000|NOT COMPLETED|Period 1||0
11331864|NCT02806973|12529052|FG001|NOT COMPLETED|Period 1||2
11331865|NCT02806973|12529053|FG002|NOT COMPLETED|Period 1||1
11331866|NCT02806973|12529054|FG003|NOT COMPLETED|Period 1||2
11331867|NCT02806973|12529051|FG000|STARTED|Period 2||8
11331868|NCT02806973|12529052|FG001|STARTED|Period 2||6
11331869|NCT02806973|12529053|FG002|STARTED|Period 2||7
11331870|NCT02806973|12529054|FG003|STARTED|Period 2||6
11331871|NCT02806973|12529051|FG000|COMPLETED|Period 2||8
11331872|NCT02806973|12529052|FG001|COMPLETED|Period 2||6
11331873|NCT02806973|12529053|FG002|COMPLETED|Period 2||7
11331874|NCT02806973|12529054|FG003|COMPLETED|Period 2||6
11331875|NCT02806973|12529051|FG000|NOT COMPLETED|Period 2||0
11331876|NCT02806973|12529052|FG001|NOT COMPLETED|Period 2||0
11331877|NCT02806973|12529053|FG002|NOT COMPLETED|Period 2||0
11331878|NCT02806973|12529054|FG003|NOT COMPLETED|Period 2||0
11331879|NCT02806973|12529051|FG000|STARTED|Period 3||8
11331880|NCT02806973|12529052|FG001|STARTED|Period 3||6
11331881|NCT02806973|12529053|FG002|STARTED|Period 3||7
11331882|NCT02806973|12529054|FG003|STARTED|Period 3||6
11331883|NCT02806973|12529051|FG000|COMPLETED|Period 3||8
11331884|NCT02806973|12529052|FG001|COMPLETED|Period 3||6
11331885|NCT02806973|12529053|FG002|COMPLETED|Period 3||6
11331886|NCT02806973|12529054|FG003|COMPLETED|Period 3||3
11331887|NCT02806973|12529051|FG000|NOT COMPLETED|Period 3||0
11331888|NCT02806973|12529052|FG001|NOT COMPLETED|Period 3||0
11331889|NCT02806973|12529053|FG002|NOT COMPLETED|Period 3||1
11331890|NCT02806973|12529054|FG003|NOT COMPLETED|Period 3||3
11331891|NCT02806973|12529051|FG000|STARTED|Period 4||8
11331892|NCT02806973|12529052|FG001|STARTED|Period 4||6
11331893|NCT02806973|12529053|FG002|STARTED|Period 4||6
11331894|NCT02806973|12529054|FG003|STARTED|Period 4||3
11331895|NCT02806973|12529051|FG000|COMPLETED|Period 4||8
11331896|NCT02806973|12529052|FG001|COMPLETED|Period 4||6
11331897|NCT02806973|12529053|FG002|COMPLETED|Period 4||6
11331898|NCT02806973|12529054|FG003|COMPLETED|Period 4||3
11331899|NCT02806973|12529051|FG000|NOT COMPLETED|Period 4||0
11331900|NCT02806973|12529052|FG001|NOT COMPLETED|Period 4||0
11331901|NCT02806973|12529053|FG002|NOT COMPLETED|Period 4||0
11331902|NCT02806973|12529054|FG003|NOT COMPLETED|Period 4||0
11331903|NCT02806986|12529064|FG000|STARTED|Treatment Stage 1||61
11331904|NCT02806986|12529064|FG000|COMPLETED|Treatment Stage 1||60
11331905|NCT02806986|12529064|FG000|NOT COMPLETED|Treatment Stage 1||1
11331906|NCT02806986|12529064|FG000|STARTED|Treatment Stage 2||60
11331907|NCT02806986|12529064|FG000|COMPLETED|Treatment Stage 2||55
11331908|NCT02806986|12529064|FG000|NOT COMPLETED|Treatment Stage 2||5
11331909|NCT02807259|12529074|FG000|STARTED|Baseline (3 Months)||405
11331910|NCT02807259|12529075|FG001|STARTED|Baseline (3 Months)||404
11331911|NCT02807259|12529074|FG000|COMPLETED|Baseline (3 Months)||328
11331912|NCT02807259|12529075|FG001|COMPLETED|Baseline (3 Months)||292
11331913|NCT02807259|12529074|FG000|NOT COMPLETED|Baseline (3 Months)||77
11331914|NCT02807259|12529075|FG001|NOT COMPLETED|Baseline (3 Months)||112
11331915|NCT02807259|12529074|FG000|STARTED|Midline (3 Months)||352
11331916|NCT02807259|12529075|FG001|STARTED|Midline (3 Months)||223
11331917|NCT02807259|12529074|FG000|COMPLETED|Midline (3 Months)||322
11331918|NCT02807259|12529075|FG001|COMPLETED|Midline (3 Months)||189
11331919|NCT02807259|12529074|FG000|NOT COMPLETED|Midline (3 Months)||30
11331920|NCT02807259|12529075|FG001|NOT COMPLETED|Midline (3 Months)||34
11331921|NCT02807259|12529074|FG000|STARTED|Endline (3 Months)||323
11331922|NCT02807259|12529075|FG001|STARTED|Endline (3 Months)||346
11331923|NCT02807259|12529074|FG000|COMPLETED|Endline (3 Months)||288
11331924|NCT02807259|12529075|FG001|COMPLETED|Endline (3 Months)||259
11331925|NCT02807259|12529074|FG000|NOT COMPLETED|Endline (3 Months)||35
11331926|NCT02807259|12529075|FG001|NOT COMPLETED|Endline (3 Months)||87
11331927|NCT02807376|12529085|FG000|STARTED|Overall Study||139
11331928|NCT02807376|12529086|FG001|STARTED|Overall Study||131
11331929|NCT02807376|12529085|FG000|COMPLETED|Overall Study||136
11331930|NCT02807376|12529086|FG001|COMPLETED|Overall Study||130
11331931|NCT02807376|12529085|FG000|NOT COMPLETED|Overall Study||3
11331932|NCT02807376|12529086|FG001|NOT COMPLETED|Overall Study||1
11331933|NCT02807402|12529092|FG000|STARTED|Overall Study||522
11331934|NCT02807402|12529092|FG000|COMPLETED|Overall Study||516
11331935|NCT02807402|12529092|FG000|NOT COMPLETED|Overall Study||6
11331936|NCT02807623|12529107|FG000|STARTED|Overall Study||98
11331937|NCT02807623|12529108|FG001|STARTED|Overall Study||100
11331938|NCT02807623|12529109|FG002|STARTED|Overall Study||102
11331939|NCT02807623|12529107|FG000|COMPLETED|Overall Study||75
11331940|NCT02807623|12529108|FG001|COMPLETED|Overall Study||79
11331941|NCT02807623|12529109|FG002|COMPLETED|Overall Study||79
11331942|NCT02807623|12529107|FG000|NOT COMPLETED|Overall Study||23
11331943|NCT02807623|12529108|FG001|NOT COMPLETED|Overall Study||21
11331944|NCT02807623|12529109|FG002|NOT COMPLETED|Overall Study||23
11331945|NCT02807844|12529136|FG000|STARTED|Overall Study||6
11331946|NCT02807844|12529137|FG001|STARTED|Overall Study||12
11331947|NCT02807844|12529138|FG002|STARTED|Overall Study||12
11331948|NCT02807844|12529139|FG003|STARTED|Overall Study||13
11331949|NCT02807844|12529140|FG004|STARTED|Overall Study||6
11331950|NCT02807844|12529141|FG005|STARTED|Overall Study||11
11331951|NCT02807844|12529142|FG006|STARTED|Overall Study||20
11331952|NCT02807844|12529143|FG007|STARTED|Overall Study||20
11331953|NCT02807844|12529144|FG008|STARTED|Overall Study||21
11331954|NCT02807844|12529145|FG009|STARTED|Overall Study||20
11331955|NCT02807844|12529136|FG000|COMPLETED|Overall Study||0
11331956|NCT02807844|12529137|FG001|COMPLETED|Overall Study||0
11331957|NCT02807844|12529138|FG002|COMPLETED|Overall Study||0
11331958|NCT02807844|12529139|FG003|COMPLETED|Overall Study||0
11331959|NCT02807844|12529140|FG004|COMPLETED|Overall Study||0
11331960|NCT02807844|12529141|FG005|COMPLETED|Overall Study||0
11331961|NCT02807844|12529142|FG006|COMPLETED|Overall Study||0
11331962|NCT02807844|12529143|FG007|COMPLETED|Overall Study||0
11331963|NCT02807844|12529144|FG008|COMPLETED|Overall Study||0
11331964|NCT02807844|12529145|FG009|COMPLETED|Overall Study||0
11331965|NCT02807844|12529136|FG000|NOT COMPLETED|Overall Study||6
11331966|NCT02807844|12529137|FG001|NOT COMPLETED|Overall Study||12
11331967|NCT02807844|12529138|FG002|NOT COMPLETED|Overall Study||12
11331968|NCT02807844|12529139|FG003|NOT COMPLETED|Overall Study||13
11331969|NCT02807844|12529140|FG004|NOT COMPLETED|Overall Study||6
11331970|NCT02807844|12529141|FG005|NOT COMPLETED|Overall Study||11
11331971|NCT02807844|12529142|FG006|NOT COMPLETED|Overall Study||20
11331972|NCT02807844|12529143|FG007|NOT COMPLETED|Overall Study||20
11331973|NCT02807844|12529144|FG008|NOT COMPLETED|Overall Study||21
11331974|NCT02807844|12529145|FG009|NOT COMPLETED|Overall Study||20
11331975|NCT02807857|12529171|FG000|STARTED|Enrolled Set||1415
11331976|NCT02807857|12529171|FG000|COMPLETED|Enrolled Set||864
11331977|NCT02807857|12529171|FG000|NOT COMPLETED|Enrolled Set||551
11331978|NCT02807857|12529171|FG000|STARTED|Follow-Up Set||864
11331979|NCT02807857|12529171|FG000|COMPLETED|Follow-Up Set||680
11331980|NCT02807857|12529171|FG000|NOT COMPLETED|Follow-Up Set||184
11331981|NCT02807948|12529181|FG000|STARTED|Overall Study||132
11331982|NCT02807948|12529182|FG001|STARTED|Overall Study||57
11331983|NCT02807948|12529181|FG000|COMPLETED|Overall Study||131
11331984|NCT02807948|12529182|FG001|COMPLETED|Overall Study||57
11331985|NCT02807948|12529181|FG000|NOT COMPLETED|Overall Study||1
11331986|NCT02807948|12529182|FG001|NOT COMPLETED|Overall Study||0
11331987|NCT02808052|12529190|FG000|STARTED|Overall Study||4
11331988|NCT02808052|12529191|FG001|STARTED|Overall Study||3
11331989|NCT02808052|12529192|FG002|STARTED|Overall Study||2
11331990|NCT02808052|12529190|FG000|COMPLETED|Overall Study||4
11331991|NCT02808052|12529191|FG001|COMPLETED|Overall Study||3
11331992|NCT02808052|12529192|FG002|COMPLETED|Overall Study||2
11331993|NCT02808052|12529190|FG000|NOT COMPLETED|Overall Study||0
11331994|NCT02808052|12529191|FG001|NOT COMPLETED|Overall Study||0
11331995|NCT02808052|12529192|FG002|NOT COMPLETED|Overall Study||0
11331996|NCT02808130|12529206|FG000|STARTED|Overall Study||15
11331997|NCT02808130|12529207|FG001|STARTED|Overall Study||15
11331998|NCT02808130|12529208|FG002|STARTED|Overall Study||15
11331999|NCT02808130|12529209|FG003|STARTED|Overall Study||15
11332000|NCT02808130|12529210|FG004|STARTED|Overall Study||15
11332001|NCT02808130|12529211|FG005|STARTED|Overall Study||15
11332002|NCT02808130|12529206|FG000|COMPLETED|Overall Study||15
11332003|NCT02808130|12529207|FG001|COMPLETED|Overall Study||15
11332004|NCT02808130|12529208|FG002|COMPLETED|Overall Study||15
11332005|NCT02808130|12529209|FG003|COMPLETED|Overall Study||15
11332006|NCT02808130|12529210|FG004|COMPLETED|Overall Study||15
11332007|NCT02808130|12529211|FG005|COMPLETED|Overall Study||15
11332008|NCT02808130|12529206|FG000|NOT COMPLETED|Overall Study||0
11332009|NCT02808130|12529207|FG001|NOT COMPLETED|Overall Study||0
11332010|NCT02808130|12529208|FG002|NOT COMPLETED|Overall Study||0
11332011|NCT02808130|12529209|FG003|NOT COMPLETED|Overall Study||0
11332012|NCT02808130|12529210|FG004|NOT COMPLETED|Overall Study||0
11332013|NCT02808130|12529211|FG005|NOT COMPLETED|Overall Study||0
11332014|NCT02808312|12529233|FG000|STARTED|Overall Study||10
11332015|NCT02808312|12529234|FG001|STARTED|Overall Study||10
11332016|NCT02808312|12529235|FG002|STARTED|Overall Study||17
11332017|NCT02808312|12529236|FG003|STARTED|Overall Study||10
11332018|NCT02808312|12529237|FG004|STARTED|Overall Study||10
11332019|NCT02808312|12529233|FG000|COMPLETED|Overall Study||10
11332020|NCT02808312|12529234|FG001|COMPLETED|Overall Study||10
11332021|NCT02808312|12529235|FG002|COMPLETED|Overall Study||16
11332022|NCT02808312|12529236|FG003|COMPLETED|Overall Study||10
11332023|NCT02808312|12529237|FG004|COMPLETED|Overall Study||10
11332024|NCT02808312|12529233|FG000|NOT COMPLETED|Overall Study||0
11332025|NCT02808312|12529234|FG001|NOT COMPLETED|Overall Study||0
11332026|NCT02808312|12529235|FG002|NOT COMPLETED|Overall Study||1
11332027|NCT02808312|12529236|FG003|NOT COMPLETED|Overall Study||0
11332028|NCT02808312|12529237|FG004|NOT COMPLETED|Overall Study||0
11332029|NCT02808338|12529254|FG000|STARTED|Screening||25
11332030|NCT02808338|12529254|FG000|COMPLETED|Screening||15
11332031|NCT02808338|12529254|FG000|NOT COMPLETED|Screening||10
11332032|NCT02808338|12529254|FG000|STARTED|Overnight In-lab Polysomonography||15
11332033|NCT02808338|12529254|FG000|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13
11332034|NCT02808338|12529254|FG000|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13
11332035|NCT02808338|12529254|FG000|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12
11332036|NCT02808338|12529254|FG000|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12
11332037|NCT02808338|12529254|FG000|COMPLETED|Overnight In-lab Polysomonography||13
11332038|NCT02808338|12529254|FG000|NOT COMPLETED|Overnight In-lab Polysomonography||2
11332039|NCT02808338|12529254|FG000|STARTED|Take Home Period||13
11332040|NCT02808338|12529254|FG000|COMPLETED|Take Home Period||13
11332041|NCT02808338|12529254|FG000|NOT COMPLETED|Take Home Period||0
11332042|NCT02808429|12529268|FG000|STARTED|Overall Study||5
11332043|NCT02808429|12529269|FG001|STARTED|Overall Study||6
11332044|NCT02808429|12529270|FG002|STARTED|Overall Study||5
11332045|NCT02808429|12529268|FG000|COMPLETED|Overall Study||2
11332046|NCT02808429|12529269|FG001|COMPLETED|Overall Study||5
11332047|NCT02808429|12529270|FG002|COMPLETED|Overall Study||3
11332048|NCT02808429|12529268|FG000|NOT COMPLETED|Overall Study||3
11332049|NCT02808429|12529269|FG001|NOT COMPLETED|Overall Study||1
11332050|NCT02808429|12529270|FG002|NOT COMPLETED|Overall Study||2
11332051|NCT02808819|12529280|FG000|STARTED|Overall Study||220
11332052|NCT02808819|12529281|FG001|STARTED|Overall Study||226
11332053|NCT02808819|12529280|FG000|Treated|Overall Study||220
11332054|NCT02808819|12529281|FG001|Treated|Overall Study||226
11332055|NCT02808819|12529280|FG000|COMPLETED|Overall Study||189
11332056|NCT02808819|12529281|FG001|COMPLETED|Overall Study||195
11332057|NCT02808819|12529280|FG000|NOT COMPLETED|Overall Study||31
11332058|NCT02808819|12529281|FG001|NOT COMPLETED|Overall Study||31
11332059|NCT02808975|12529290|FG000|STARTED|Overall Study||103
11332060|NCT02808975|12529291|FG001|STARTED|Overall Study||103
11332061|NCT02808975|12529290|FG000|COMPLETED|Overall Study||81
11332062|NCT02808975|12529291|FG001|COMPLETED|Overall Study||84
11332063|NCT02808975|12529290|FG000|NOT COMPLETED|Overall Study||22
11332064|NCT02808975|12529291|FG001|NOT COMPLETED|Overall Study||19
11332065|NCT02809053|12529299|FG000|STARTED|Overall Study||157
11332066|NCT02809053|12529300|FG001|STARTED|Overall Study||158
11332067|NCT02809053|12529299|FG000|Completed Treatment|Overall Study||156
11332068|NCT02809053|12529300|FG001|Completed Treatment|Overall Study||156
11332069|NCT02809053|12529299|FG000|COMPLETED|Overall Study||150
11332070|NCT02809053|12529300|FG001|COMPLETED|Overall Study||152
11332071|NCT02809053|12529299|FG000|NOT COMPLETED|Overall Study||7
11332072|NCT02809053|12529300|FG001|NOT COMPLETED|Overall Study||6
11332073|NCT02809183|12529311|FG000|STARTED|Overall Study||25
11332074|NCT02809183|12529312|FG001|STARTED|Overall Study||25
11332075|NCT02809183|12529313|FG002|STARTED|Overall Study||25
11332076|NCT02809183|12529314|FG003|STARTED|Overall Study||26
11332077|NCT02809183|12529315|FG004|STARTED|Overall Study||6
11332078|NCT02809183|12529316|FG005|STARTED|Overall Study||28
11332079|NCT02809183|12529311|FG000|COMPLETED|Overall Study||25
11332080|NCT02809183|12529312|FG001|COMPLETED|Overall Study||25
11332081|NCT02809183|12529313|FG002|COMPLETED|Overall Study||25
11332082|NCT02809183|12529314|FG003|COMPLETED|Overall Study||26
11332083|NCT02809183|12529315|FG004|COMPLETED|Overall Study||6
11332084|NCT02809183|12529316|FG005|COMPLETED|Overall Study||28
11332085|NCT02809183|12529311|FG000|NOT COMPLETED|Overall Study||0
11332086|NCT02809183|12529312|FG001|NOT COMPLETED|Overall Study||0
11332087|NCT02809183|12529313|FG002|NOT COMPLETED|Overall Study||0
11332088|NCT02809183|12529314|FG003|NOT COMPLETED|Overall Study||0
11332089|NCT02809183|12529315|FG004|NOT COMPLETED|Overall Study||0
11332090|NCT02809183|12529316|FG005|NOT COMPLETED|Overall Study||0
11332091|NCT02809430|12529333|FG000|STARTED|Overall Study||90
11332092|NCT02809430|12529333|FG000|Failed 3-night run-in Because no Evidence of Obstructive Sleep Apnea|Overall Study|14 with CPAP < 3 hours, 5 without evidence of OSA, 9 with evidence of central or complex sleep apnea|28
11332093|NCT02809430|12529333|FG000|Stopped CPAP During Inpatient Rehabilitation|Overall Study|10 of 62 participants stopped CPAP after the run-in and prior to discharge from IPR|10
11332094|NCT02809430|12529333|FG000|COMPLETED|Overall Study||52
11332095|NCT02809430|12529333|FG000|NOT COMPLETED|Overall Study||38
11027347|NCT00833638|12206058|FG001|STARTED|Phase 3: Open-label Extension Phase||108
11027348|NCT00833638|12206059|FG002|STARTED|Phase 3: Open-label Extension Phase||124
11027349|NCT00833638|12206057|FG000|COMPLETED|Phase 3: Open-label Extension Phase||110
11027350|NCT00833638|12206058|FG001|COMPLETED|Phase 3: Open-label Extension Phase||105
11027351|NCT00833638|12206059|FG002|COMPLETED|Phase 3: Open-label Extension Phase||122
11027352|NCT00833638|12206057|FG000|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
11332096|NCT02809833|12529340|FG000|STARTED|Overall Study||850
11332097|NCT02809833|12529340|FG000|COMPLETED|Overall Study||550
11332098|NCT02809833|12529340|FG000|NOT COMPLETED|Overall Study||300
11332099|NCT02809846|12529346|FG000|STARTED|Overall Study||17
11332100|NCT02809846|12529347|FG001|STARTED|Overall Study||16
11332101|NCT02809846|12529346|FG000|COMPLETED|Overall Study||8
11332102|NCT02809846|12529347|FG001|COMPLETED|Overall Study||9
11332103|NCT02809846|12529346|FG000|NOT COMPLETED|Overall Study||9
11332104|NCT02809846|12529347|FG001|NOT COMPLETED|Overall Study||7
11332105|NCT02809859|12529353|FG000|STARTED|Overall Study||139
11332106|NCT02809859|12529353|FG000|COMPLETED|Overall Study||125
11332107|NCT02809859|12529353|FG000|NOT COMPLETED|Overall Study||14
11332108|NCT02809911|12529359|FG000|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
11332109|NCT02809911|12529360|FG001|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
11332110|NCT02809911|12529359|FG000|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
11332111|NCT02809911|12529360|FG001|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
11332112|NCT02809911|12529359|FG000|NOT COMPLETED|Overall Study||0
11332113|NCT02809911|12529360|FG001|NOT COMPLETED|Overall Study||0
11332114|NCT02809976|12529366|FG000|STARTED|Overall Study||11
11332115|NCT02809976|12529366|FG000|COMPLETED|Overall Study||9
11332116|NCT02809976|12529366|FG000|NOT COMPLETED|Overall Study||2
11332117|NCT02810327|12529372|FG000|STARTED|Overall Study||76
11332118|NCT02810327|12529373|FG001|STARTED|Overall Study||41
11332119|NCT02810327|12529372|FG000|COMPLETED|Overall Study||69
11332120|NCT02810327|12529373|FG001|COMPLETED|Overall Study||34
11332121|NCT02810327|12529372|FG000|NOT COMPLETED|Overall Study||7
11332122|NCT02810327|12529373|FG001|NOT COMPLETED|Overall Study||7
11332123|NCT02810340|12529382|FG000|STARTED|Overall Study||20
11332124|NCT02810340|12529383|FG001|STARTED|Overall Study||20
11332125|NCT02810340|12529384|FG002|STARTED|Overall Study||20
11332126|NCT02810340|12529382|FG000|COMPLETED|Overall Study||19
11332127|NCT02810340|12529383|FG001|COMPLETED|Overall Study||19
11332128|NCT02810340|12529384|FG002|COMPLETED|Overall Study||19
11332129|NCT02810340|12529382|FG000|NOT COMPLETED|Overall Study||1
11332130|NCT02810340|12529383|FG001|NOT COMPLETED|Overall Study||1
11332131|NCT02810340|12529384|FG002|NOT COMPLETED|Overall Study||1
11332132|NCT02810392|12529394|FG000|STARTED|Overall Study||9
11332133|NCT02810392|12529395|FG001|STARTED|Overall Study||10
11332134|NCT02810392|12529394|FG000|COMPLETED|Overall Study||8
11332135|NCT02810392|12529395|FG001|COMPLETED|Overall Study||9
11332136|NCT02810392|12529394|FG000|NOT COMPLETED|Overall Study||1
11332137|NCT02810392|12529395|FG001|NOT COMPLETED|Overall Study||1
11332138|NCT02810509|12529403|FG000|STARTED|Overall Study||584
11332139|NCT02810509|12529404|FG001|STARTED|Overall Study||1230
11332140|NCT02810509|12529403|FG000|COMPLETED|Overall Study||584
11332141|NCT02810509|12529404|FG001|COMPLETED|Overall Study||1230
11332142|NCT02810509|12529403|FG000|NOT COMPLETED|Overall Study||0
11332143|NCT02810509|12529404|FG001|NOT COMPLETED|Overall Study||0
11332144|NCT02810873|12529414|FG000|STARTED|Overall Study||6
11332145|NCT02810873|12529415|FG001|STARTED|Overall Study||13
11332146|NCT02810873|12529414|FG000|COMPLETED|Overall Study||6
11332147|NCT02810873|12529415|FG001|COMPLETED|Overall Study||13
11332148|NCT02810873|12529414|FG000|NOT COMPLETED|Overall Study||0
11332149|NCT02810873|12529415|FG001|NOT COMPLETED|Overall Study||0
11332150|NCT02810951|12529422|FG000|STARTED|Overall Study||6
11332151|NCT02810951|12529422|FG000|FCX-007 Injection|Overall Study||6
11332152|NCT02810951|12529422|FG000|No FCX-007 Injection|Overall Study||6
11332153|NCT02810951|12529422|FG000|COMPLETED|Overall Study||5
11332154|NCT02810951|12529422|FG000|NOT COMPLETED|Overall Study||1
11332155|NCT02810964|12529430|FG000|STARTED|Placebo Run-In Phase (2 Weeks)||32
11332156|NCT02810964|12529431|FG001|STARTED|Placebo Run-In Phase (2 Weeks)||32
11332157|NCT02810964|12529430|FG000|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
11332158|NCT02810964|12529431|FG001|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
11332159|NCT02810964|12529430|FG000|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
11332160|NCT02810964|12529431|FG001|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
11332161|NCT02810964|12529430|FG000|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
11332162|NCT02810964|12529431|FG001|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
11332163|NCT02810964|12529430|FG000|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
11332164|NCT02810964|12529431|FG001|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
11332165|NCT02810964|12529430|FG000|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
11332166|NCT02810964|12529431|FG001|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
11332167|NCT02811159|12529437|FG000|STARTED|Treatment Course 1||20
11332168|NCT02811159|12529437|FG000|COMPLETED|Treatment Course 1||19
11332169|NCT02811159|12529437|FG000|NOT COMPLETED|Treatment Course 1||1
11332170|NCT02811159|12529437|FG000|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4
11332171|NCT02811159|12529437|FG000|COMPLETED|Treatment Course 2||4
11332172|NCT02811159|12529437|FG000|NOT COMPLETED|Treatment Course 2||0
11332173|NCT02811302|12529441|FG000|STARTED|Overall Study||1495
11332174|NCT02811302|12529441|FG000|COMPLETED|Overall Study||1282
11332175|NCT02811302|12529441|FG000|NOT COMPLETED|Overall Study||213
11332176|NCT02811419|12529448|FG000|STARTED|Overall Study||369
11332177|NCT02811419|12529449|FG001|STARTED|Overall Study||371
11332178|NCT02811419|12529448|FG000|COMPLETED|Overall Study||357
11332179|NCT02811419|12529449|FG001|COMPLETED|Overall Study||358
11332180|NCT02811419|12529448|FG000|NOT COMPLETED|Overall Study||12
11332181|NCT02811419|12529449|FG001|NOT COMPLETED|Overall Study||13
11332182|NCT02811445|12529457|FG000|STARTED|Overall Study||18
11332183|NCT02811445|12529458|FG001|STARTED|Overall Study||11
11332184|NCT02811445|12529457|FG000|COMPLETED|Overall Study||18
11332185|NCT02811445|12529458|FG001|COMPLETED|Overall Study||11
11332186|NCT02811445|12529457|FG000|NOT COMPLETED|Overall Study||0
11332187|NCT02811445|12529458|FG001|NOT COMPLETED|Overall Study||0
11332188|NCT02811640|12529464|FG000|STARTED|Overall Study||12
11332189|NCT02811640|12529464|FG000|COMPLETED|Overall Study||10
11332190|NCT02811640|12529464|FG000|NOT COMPLETED|Overall Study||2
11332191|NCT02811965|12529468|FG000|STARTED|Overall Study||21
11332192|NCT02811965|12529468|FG000|COMPLETED|Overall Study||21
11332193|NCT02811965|12529468|FG000|NOT COMPLETED|Overall Study||0
11332194|NCT02812160|12529486|FG000|STARTED|Overall Study||187
11332195|NCT02812160|12529487|FG001|STARTED|Overall Study||101
11332196|NCT02812160|12529486|FG000|COMPLETED|Overall Study||187
11332197|NCT02812160|12529487|FG001|COMPLETED|Overall Study||101
11332198|NCT02812160|12529486|FG000|NOT COMPLETED|Overall Study||0
11332199|NCT02812160|12529487|FG001|NOT COMPLETED|Overall Study||0
11332200|NCT02812186|12529495|FG000|STARTED|Period 1||40
11332201|NCT02812186|12529496|FG001|STARTED|Period 1||39
11332202|NCT02812186|12529495|FG000|COMPLETED|Period 1||29
11332203|NCT02812186|12529496|FG001|COMPLETED|Period 1||24
11332204|NCT02812186|12529495|FG000|NOT COMPLETED|Period 1||11
11332205|NCT02812186|12529496|FG001|NOT COMPLETED|Period 1||15
11332206|NCT02812186|12529495|FG000|STARTED|Period 2||29
11332207|NCT02812186|12529496|FG001|STARTED|Period 2||24
11332208|NCT02812186|12529495|FG000|COMPLETED|Period 2||29
11332209|NCT02812186|12529496|FG001|COMPLETED|Period 2||24
11332210|NCT02812186|12529495|FG000|NOT COMPLETED|Period 2||0
11332211|NCT02812186|12529496|FG001|NOT COMPLETED|Period 2||0
11332212|NCT02812238|12529505|FG000|STARTED|First Intervention||19
11332213|NCT02812238|12529506|FG001|STARTED|First Intervention||19
11332214|NCT02812238|12529505|FG000|COMPLETED|First Intervention||18
11332215|NCT02812238|12529506|FG001|COMPLETED|First Intervention||19
11332216|NCT02812238|12529505|FG000|NOT COMPLETED|First Intervention||1
11332217|NCT02812238|12529506|FG001|NOT COMPLETED|First Intervention||0
11332218|NCT02812238|12529505|FG000|STARTED|Second Intervention||18
11332219|NCT02812238|12529506|FG001|STARTED|Second Intervention||19
11332220|NCT02812238|12529505|FG000|COMPLETED|Second Intervention||18
11332221|NCT02812238|12529506|FG001|COMPLETED|Second Intervention||18
11332222|NCT02812238|12529505|FG000|NOT COMPLETED|Second Intervention||0
11332223|NCT02812238|12529506|FG001|NOT COMPLETED|Second Intervention||1
11332224|NCT02812342|12529512|FG000|STARTED|Overall Study||10
11332225|NCT02812342|12529512|FG000|COMPLETED|Overall Study||10
11332226|NCT02812342|12529512|FG000|NOT COMPLETED|Overall Study||0
11332227|NCT02812771|12529516|FG000|STARTED|Overall Study||62
11332228|NCT02812771|12529516|FG000|COMPLETED|Overall Study||50
11332229|NCT02812771|12529516|FG000|NOT COMPLETED|Overall Study||12
11332230|NCT02813070|12529523|FG000|STARTED|Overall Study||28
11332231|NCT02813070|12529524|FG001|STARTED|Overall Study||23
11332232|NCT02813070|12529525|FG002|STARTED|Overall Study||36
11332233|NCT02813070|12529523|FG000|Treated (Safety Population)|Overall Study||25
11332234|NCT02813070|12529524|FG001|Treated (Safety Population)|Overall Study||20
11332235|NCT02813070|12529525|FG002|Treated (Safety Population)|Overall Study||25
11332236|NCT02813070|12529523|FG000|COMPLETED|Overall Study||25
11332237|NCT02813070|12529524|FG001|COMPLETED|Overall Study||20
11332238|NCT02813070|12529525|FG002|COMPLETED|Overall Study||25
11332239|NCT02813070|12529523|FG000|NOT COMPLETED|Overall Study||3
11332240|NCT02813070|12529524|FG001|NOT COMPLETED|Overall Study||3
11332241|NCT02813070|12529525|FG002|NOT COMPLETED|Overall Study||11
11332242|NCT02813265|12529534|FG000|STARTED|Overall Study||459
11332243|NCT02813265|12529535|FG001|STARTED|Overall Study||456
11332244|NCT02813265|12529534|FG000|COMPLETED|Overall Study||455
11332245|NCT02813265|12529535|FG001|COMPLETED|Overall Study||453
11332246|NCT02813265|12529534|FG000|NOT COMPLETED|Overall Study||4
11332247|NCT02813265|12529535|FG001|NOT COMPLETED|Overall Study||3
11332248|NCT02813421|12529543|FG000|STARTED|Overall Study||5
11332249|NCT02813421|12529544|FG001|STARTED|Overall Study||6
11332250|NCT02813421|12529543|FG000|COMPLETED|Overall Study||3
11332251|NCT02813421|12529544|FG001|COMPLETED|Overall Study||3
11057338|NCT00997113|12238814|FG001|NOT COMPLETED|Overall Study||0
11027353|NCT00833638|12206058|FG001|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
11027354|NCT00833638|12206059|FG002|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
11027355|NCT00833690|12206078|FG000|STARTED|Overall Study||25
11027356|NCT00833690|12206079|FG001|STARTED|Overall Study||24
11027357|NCT00833690|12206080|FG002|STARTED|Overall Study||26
11027358|NCT00833690|12206078|FG000|COMPLETED|Overall Study||21
11027359|NCT00833690|12206079|FG001|COMPLETED|Overall Study||22
11027360|NCT00833690|12206080|FG002|COMPLETED|Overall Study||26
11027361|NCT00833690|12206078|FG000|NOT COMPLETED|Overall Study||4
11027362|NCT00833690|12206079|FG001|NOT COMPLETED|Overall Study||2
11027363|NCT00833690|12206080|FG002|NOT COMPLETED|Overall Study||0
11027364|NCT00833703|12206090|FG000|STARTED|Overall Study|Included|23
11027365|NCT00833703|12206091|FG001|STARTED|Overall Study|Included|26
11027366|NCT00833703|12206090|FG000|Treated|Overall Study||23
11027367|NCT00833703|12206091|FG001|Treated|Overall Study||26
11027368|NCT00833703|12206090|FG000|Completed Treatment|Overall Study||22
11027369|NCT00833703|12206091|FG001|Completed Treatment|Overall Study||24
11027370|NCT00833703|12206090|FG000|COMPLETED|Overall Study|Completed follow-up|23
11027371|NCT00833703|12206091|FG001|COMPLETED|Overall Study|Completed follow-up|25
11027372|NCT00833703|12206090|FG000|NOT COMPLETED|Overall Study||0
11027373|NCT00833703|12206091|FG001|NOT COMPLETED|Overall Study||1
11027374|NCT00833755|12206101|FG000|STARTED|Overall Study||16
11027375|NCT00833755|12206102|FG001|STARTED|Overall Study||18
11027376|NCT00833755|12206103|FG002|STARTED|Overall Study||22
11027377|NCT00833755|12206104|FG003|STARTED|Overall Study||23
11027378|NCT00833755|12206101|FG000|COMPLETED|Overall Study||12
11027379|NCT00833755|12206102|FG001|COMPLETED|Overall Study||13
11027380|NCT00833755|12206103|FG002|COMPLETED|Overall Study||20
11027381|NCT00833755|12206104|FG003|COMPLETED|Overall Study||17
11027382|NCT00833755|12206101|FG000|NOT COMPLETED|Overall Study||4
11027383|NCT00833755|12206102|FG001|NOT COMPLETED|Overall Study||5
11027384|NCT00833755|12206103|FG002|NOT COMPLETED|Overall Study||2
11027385|NCT00833755|12206104|FG003|NOT COMPLETED|Overall Study||6
11027386|NCT00833781|12206117|FG000|STARTED|Overall Study||10
11027387|NCT00833781|12206118|FG001|STARTED|Overall Study||5
11027388|NCT00833781|12206117|FG000|COMPLETED|Overall Study||10
11027389|NCT00833781|12206118|FG001|COMPLETED|Overall Study||5
11027390|NCT00833781|12206117|FG000|NOT COMPLETED|Overall Study||0
11027391|NCT00833781|12206118|FG001|NOT COMPLETED|Overall Study||0
11027392|NCT00833794|12206125|FG000|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
11027393|NCT00833794|12206126|FG001|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
11027394|NCT00833794|12206125|FG000|Entered run-in Period|Open-label Phase||1027
11027395|NCT00833794|12206126|FG001|Entered run-in Period|Open-label Phase||0
11027396|NCT00833794|12206125|FG000|Received Open-Label Treatment|Open-label Phase||1023
11027397|NCT00833794|12206126|FG001|Received Open-Label Treatment|Open-label Phase||0
11027398|NCT00833794|12206125|FG000|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
11027399|NCT00833794|12206126|FG001|COMPLETED|Open-label Phase||0
11027400|NCT00833794|12206125|FG000|NOT COMPLETED|Open-label Phase||382
11027401|NCT00833794|12206126|FG001|NOT COMPLETED|Open-label Phase||0
11027402|NCT00833794|12206125|FG000|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
11027403|NCT00833794|12206126|FG001|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
11027404|NCT00833794|12206125|FG000|COMPLETED|Double-blind Phase||326
11027405|NCT00833794|12206126|FG001|COMPLETED|Double-blind Phase||165
11027406|NCT00833794|12206125|FG000|NOT COMPLETED|Double-blind Phase||106
11027407|NCT00833794|12206126|FG001|NOT COMPLETED|Double-blind Phase||49
11027408|NCT00833833|12206140|FG000|STARTED|Phase 1 (as of 01 April 2011)||6
11027409|NCT00833833|12206141|FG001|STARTED|Phase 1 (as of 01 April 2011)||8
11027410|NCT00833833|12206142|FG002|STARTED|Phase 1 (as of 01 April 2011)||14
11027411|NCT00833833|12206143|FG003|STARTED|Phase 1 (as of 01 April 2011)||10
11027412|NCT00833833|12206144|FG004|STARTED|Phase 1 (as of 01 April 2011)||0
11027413|NCT00833833|12206145|FG005|STARTED|Phase 1 (as of 01 April 2011)||0
11057339|NCT00997126|12238822|FG000|STARTED|Overall Study||63
11027414|NCT00833833|12206140|FG000|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
11027415|NCT00833833|12206141|FG001|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
11027416|NCT00833833|12206142|FG002|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
11027417|NCT00833833|12206143|FG003|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
11027418|NCT00833833|12206144|FG004|COMPLETED|Phase 1 (as of 01 April 2011)||0
11027419|NCT00833833|12206145|FG005|COMPLETED|Phase 1 (as of 01 April 2011)||0
11027420|NCT00833833|12206140|FG000|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
11027421|NCT00833833|12206141|FG001|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
11027422|NCT00833833|12206142|FG002|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
11027423|NCT00833833|12206143|FG003|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
11027424|NCT00833833|12206144|FG004|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
11027425|NCT00833833|12206145|FG005|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
11027426|NCT00833833|12206140|FG000|STARTED|Phase 2 (as of 01 April 2011)||0
11027427|NCT00833833|12206141|FG001|STARTED|Phase 2 (as of 01 April 2011)||0
11027428|NCT00833833|12206142|FG002|STARTED|Phase 2 (as of 01 April 2011)||0
11027429|NCT00833833|12206143|FG003|STARTED|Phase 2 (as of 01 April 2011)||0
11027430|NCT00833833|12206144|FG004|STARTED|Phase 2 (as of 01 April 2011)||113
11027431|NCT00833833|12206145|FG005|STARTED|Phase 2 (as of 01 April 2011)||108
11027432|NCT00833833|12206140|FG000|Safety Population|Phase 2 (as of 01 April 2011)||0
11027433|NCT00833833|12206141|FG001|Safety Population|Phase 2 (as of 01 April 2011)||0
11027434|NCT00833833|12206142|FG002|Safety Population|Phase 2 (as of 01 April 2011)||0
11027435|NCT00833833|12206143|FG003|Safety Population|Phase 2 (as of 01 April 2011)||0
11027436|NCT00833833|12206144|FG004|Safety Population|Phase 2 (as of 01 April 2011)||112
11027437|NCT00833833|12206145|FG005|Safety Population|Phase 2 (as of 01 April 2011)||107
11027438|NCT00833833|12206140|FG000|COMPLETED|Phase 2 (as of 01 April 2011)||0
11027439|NCT00833833|12206141|FG001|COMPLETED|Phase 2 (as of 01 April 2011)||0
11027440|NCT00833833|12206142|FG002|COMPLETED|Phase 2 (as of 01 April 2011)||0
11027441|NCT00833833|12206143|FG003|COMPLETED|Phase 2 (as of 01 April 2011)||0
11027442|NCT00833833|12206144|FG004|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
11027443|NCT00833833|12206145|FG005|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
11027444|NCT00833833|12206140|FG000|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
11027445|NCT00833833|12206141|FG001|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
11027446|NCT00833833|12206142|FG002|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
11027447|NCT00833833|12206143|FG003|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
11027448|NCT00833833|12206144|FG004|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
11027449|NCT00833833|12206145|FG005|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
11027450|NCT00833898|12206167|FG000|STARTED|Overall Study||74
11027451|NCT00833898|12206168|FG001|STARTED|Overall Study||74
11027452|NCT00833898|12206167|FG000|Month 1 (Post Transplantation)|Overall Study||72
11027453|NCT00833898|12206168|FG001|Month 1 (Post Transplantation)|Overall Study||74
11027454|NCT00833898|12206167|FG000|Month 3 (Post Transplantation)|Overall Study||66
11027455|NCT00833898|12206168|FG001|Month 3 (Post Transplantation)|Overall Study||64
11027456|NCT00833898|12206167|FG000|Month 6 (Post Transplantation)|Overall Study||59
11027457|NCT00833898|12206168|FG001|Month 6 (Post Transplantation)|Overall Study||54
11027458|NCT00833898|12206167|FG000|Month 12 (Post Transplantation)|Overall Study||50
11027459|NCT00833898|12206168|FG001|Month 12 (Post Transplantation)|Overall Study||50
11027460|NCT00833898|12206167|FG000|COMPLETED|Overall Study||34
11027461|NCT00833898|12206168|FG001|COMPLETED|Overall Study||38
11027462|NCT00833898|12206167|FG000|NOT COMPLETED|Overall Study||40
11027463|NCT00833898|12206168|FG001|NOT COMPLETED|Overall Study||36
11027464|NCT00833911|12206174|FG000|STARTED|Titration||392
11027465|NCT00833911|12206174|FG000|COMPLETED|Titration||371
11027466|NCT00833911|12206174|FG000|NOT COMPLETED|Titration||21
11027467|NCT00833911|12206174|FG000|STARTED|Maintenance Phase I||371
11027468|NCT00833911|12206174|FG000|COMPLETED|Maintenance Phase I||273
11027469|NCT00833911|12206174|FG000|NOT COMPLETED|Maintenance Phase I||98
11027470|NCT00833911|12206174|FG000|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
11027471|NCT00833911|12206174|FG000|COMPLETED|Maintenance Phase II||166
11027472|NCT00833911|12206174|FG000|NOT COMPLETED|Maintenance Phase II||10
11027473|NCT00833924|12206182|FG000|STARTED|Overall Study||120
11027474|NCT00833924|12206182|FG000|30-day|Overall Study||120
11027475|NCT00833924|12206182|FG000|12-month|Overall Study||113
11027476|NCT00833924|12206182|FG000|COMPLETED|Overall Study||11
11027477|NCT00833924|12206182|FG000|NOT COMPLETED|Overall Study||109
11027478|NCT00833976|12206186|FG000|STARTED|Overall Study||65
11027479|NCT00833976|12206186|FG000|COMPLETED|Overall Study||14
11027480|NCT00833976|12206186|FG000|NOT COMPLETED|Overall Study||51
11027481|NCT00833989|12206194|FG000|STARTED|Overall Study||17
11027482|NCT00833989|12206195|FG001|STARTED|Overall Study||8
11027483|NCT00833989|12206196|FG002|STARTED|Overall Study||9
11027484|NCT00833989|12206197|FG003|STARTED|Overall Study||8
11027485|NCT00833989|12206194|FG000|COMPLETED|Overall Study||14
11027486|NCT00833989|12206195|FG001|COMPLETED|Overall Study||8
11027487|NCT00833989|12206196|FG002|COMPLETED|Overall Study||8
11027488|NCT00833989|12206197|FG003|COMPLETED|Overall Study||6
11027489|NCT00833989|12206194|FG000|NOT COMPLETED|Overall Study||3
11027490|NCT00833989|12206195|FG001|NOT COMPLETED|Overall Study||0
11027491|NCT00833989|12206196|FG002|NOT COMPLETED|Overall Study||1
11027492|NCT00833989|12206197|FG003|NOT COMPLETED|Overall Study||2
11027493|NCT00834041|12206212|FG000|STARTED|Overall Study||19
11027494|NCT00834041|12206213|FG001|STARTED|Overall Study||20
11027495|NCT00834041|12206212|FG000|COMPLETED|Overall Study||18
11027496|NCT00834041|12206213|FG001|COMPLETED|Overall Study||19
11027497|NCT00834041|12206212|FG000|NOT COMPLETED|Overall Study||1
11027498|NCT00834041|12206213|FG001|NOT COMPLETED|Overall Study||1
11027499|NCT00834080|12206219|FG000|STARTED|Overall Study||38
11027500|NCT00834080|12206219|FG000|COMPLETED|Overall Study||15
11027501|NCT00834080|12206219|FG000|NOT COMPLETED|Overall Study||23
11027502|NCT00834106|12206225|FG000|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
11027503|NCT00834106|12206226|FG001|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
11027504|NCT00834106|12206225|FG000|Vaccinated|Base Study (Day 1 to Month 30)||1503
11027505|NCT00834106|12206226|FG001|Vaccinated|Base Study (Day 1 to Month 30)||1503
11027506|NCT00834106|12206225|FG000|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
11027507|NCT00834106|12206226|FG001|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
11027508|NCT00834106|12206225|FG000|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
11027509|NCT00834106|12206226|FG001|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
11027510|NCT00834106|12206225|FG000|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
11027511|NCT00834106|12206226|FG001|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
11027512|NCT00834106|12206225|FG000|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
11027513|NCT00834106|12206226|FG001|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
11027514|NCT00834106|12206225|FG000|COMPLETED|Extension Study (Month 42 to Month 90)||1308
11027515|NCT00834106|12206226|FG001|COMPLETED|Extension Study (Month 42 to Month 90)||1294
11027516|NCT00834106|12206225|FG000|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
11027517|NCT00834106|12206226|FG001|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
11027518|NCT00834171|12206234|FG000|STARTED|Overall Study||43
11027519|NCT00834171|12206235|FG001|STARTED|Overall Study||7
11027520|NCT00834171|12206234|FG000|COMPLETED|Overall Study||43
11027521|NCT00834171|12206235|FG001|COMPLETED|Overall Study||7
11027522|NCT00834171|12206234|FG000|NOT COMPLETED|Overall Study||0
11027523|NCT00834171|12206235|FG001|NOT COMPLETED|Overall Study||0
11027524|NCT00834210|12206243|FG000|STARTED|Overall Study||86
11027525|NCT00834210|12206244|FG001|STARTED|Overall Study||85
11027526|NCT00834210|12206243|FG000|COMPLETED|Overall Study||83
11027527|NCT00834210|12206244|FG001|COMPLETED|Overall Study||77
11027528|NCT00834210|12206243|FG000|NOT COMPLETED|Overall Study||3
11027529|NCT00834210|12206244|FG001|NOT COMPLETED|Overall Study||8
11027530|NCT00834236|12206252|FG000|STARTED|Overall Study||29
11027531|NCT00834236|12206253|FG001|STARTED|Overall Study||47
11027532|NCT00834236|12206252|FG000|COMPLETED|Overall Study||29
11027533|NCT00834236|12206253|FG001|COMPLETED|Overall Study||47
11027534|NCT00834236|12206252|FG000|NOT COMPLETED|Overall Study||0
11027535|NCT00834236|12206253|FG001|NOT COMPLETED|Overall Study||0
11027536|NCT00834288|12206261|FG000|STARTED|Treatment Phase I||13
11027537|NCT00834288|12206262|FG001|STARTED|Treatment Phase I||13
11027538|NCT00834288|12206261|FG000|COMPLETED|Treatment Phase I||13
11027539|NCT00834288|12206262|FG001|COMPLETED|Treatment Phase I||13
11027540|NCT00834288|12206261|FG000|NOT COMPLETED|Treatment Phase I||0
11027541|NCT00834288|12206262|FG001|NOT COMPLETED|Treatment Phase I||0
11027542|NCT00834288|12206261|FG000|STARTED|Treatment Phase II||13
11027543|NCT00834288|12206262|FG001|STARTED|Treatment Phase II||13
11027544|NCT00834288|12206261|FG000|COMPLETED|Treatment Phase II||13
11027545|NCT00834288|12206262|FG001|COMPLETED|Treatment Phase II||13
11027546|NCT00834288|12206261|FG000|NOT COMPLETED|Treatment Phase II||0
11027547|NCT00834288|12206262|FG001|NOT COMPLETED|Treatment Phase II||0
11027548|NCT00834366|12206270|FG000|STARTED|Treatment Period 1||13
11027549|NCT00834366|12206271|FG001|STARTED|Treatment Period 1||13
11027550|NCT00834366|12206270|FG000|COMPLETED|Treatment Period 1||12
11027551|NCT00834366|12206271|FG001|COMPLETED|Treatment Period 1||12
11027552|NCT00834366|12206270|FG000|NOT COMPLETED|Treatment Period 1||1
11027553|NCT00834366|12206271|FG001|NOT COMPLETED|Treatment Period 1||1
11027554|NCT00834366|12206270|FG000|STARTED|Treatment Period 2||12
11027555|NCT00834366|12206271|FG001|STARTED|Treatment Period 2||12
11027556|NCT00834366|12206270|FG000|COMPLETED|Treatment Period 2||12
11027557|NCT00834366|12206271|FG001|COMPLETED|Treatment Period 2||12
11027558|NCT00834366|12206270|FG000|NOT COMPLETED|Treatment Period 2||0
11027559|NCT00834366|12206271|FG001|NOT COMPLETED|Treatment Period 2||0
11027560|NCT00834483|12206279|FG000|STARTED|Overall Study||31
11027561|NCT00834483|12206280|FG001|STARTED|Overall Study||29
11027562|NCT00834483|12206279|FG000|COMPLETED|Overall Study||31
11332252|NCT02813421|12529543|FG000|NOT COMPLETED|Overall Study||2
11332253|NCT02813421|12529544|FG001|NOT COMPLETED|Overall Study||3
11332254|NCT02813473|12529550|FG000|STARTED|Overall Study||223
11027563|NCT00834483|12206280|FG001|COMPLETED|Overall Study||29
11027564|NCT00834483|12206279|FG000|NOT COMPLETED|Overall Study||0
11027565|NCT00834483|12206280|FG001|NOT COMPLETED|Overall Study||0
11027566|NCT00834626|12206286|FG000|STARTED|Overall Study||30
11332255|NCT02813473|12529550|FG000|COMPLETED|Overall Study||223
11332256|NCT02813473|12529550|FG000|NOT COMPLETED|Overall Study||0
11332257|NCT02813551|12529556|FG000|STARTED|Overall Study||59
11332258|NCT02813551|12529557|FG001|STARTED|Overall Study||59
11332259|NCT02813551|12529556|FG000|COMPLETED|Overall Study||58
11332260|NCT02813551|12529557|FG001|COMPLETED|Overall Study||57
11332261|NCT02813551|12529556|FG000|NOT COMPLETED|Overall Study||1
11332262|NCT02813551|12529557|FG001|NOT COMPLETED|Overall Study||2
11332263|NCT02813577|12529563|FG000|STARTED|Overall Study||4
11343822|NCT02956460|12541113|FG000|STARTED|Lens 1||30
11027567|NCT00834626|12206286|FG000|1 Year Follow-up|Overall Study||30
11027568|NCT00834626|12206286|FG000|COMPLETED|Overall Study||30
11027569|NCT00834626|12206286|FG000|NOT COMPLETED|Overall Study||0
11027570|NCT00834652|12206293|FG000|STARTED|Overall Study||104
11027571|NCT00834652|12206294|FG001|STARTED|Overall Study||102
11027572|NCT00834652|12206293|FG000|COMPLETED|Overall Study||66
11027573|NCT00834652|12206294|FG001|COMPLETED|Overall Study||62
11027574|NCT00834652|12206293|FG000|NOT COMPLETED|Overall Study||38
11027575|NCT00834652|12206294|FG001|NOT COMPLETED|Overall Study||40
11027576|NCT00834678|12206300|FG000|STARTED|Overall Study||11
11027577|NCT00834678|12206300|FG000|COMPLETED|Overall Study||11
11027578|NCT00834678|12206300|FG000|NOT COMPLETED|Overall Study||0
11027579|NCT00834808|12206309|FG000|STARTED|Treatment Period 1 (Day 1)||9
11027580|NCT00834808|12206310|FG001|STARTED|Treatment Period 1 (Day 1)||9
11027581|NCT00834808|12206311|FG002|STARTED|Treatment Period 1 (Day 1)||9
11027582|NCT00834808|12206309|FG000|COMPLETED|Treatment Period 1 (Day 1)||9
11027583|NCT00834808|12206310|FG001|COMPLETED|Treatment Period 1 (Day 1)||9
11027584|NCT00834808|12206311|FG002|COMPLETED|Treatment Period 1 (Day 1)||9
11027585|NCT00834808|12206309|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11027586|NCT00834808|12206310|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11027587|NCT00834808|12206311|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
11027588|NCT00834808|12206309|FG000|STARTED|Treatment Period 2 (Day 8)||9
11027589|NCT00834808|12206310|FG001|STARTED|Treatment Period 2 (Day 8)||9
11027590|NCT00834808|12206311|FG002|STARTED|Treatment Period 2 (Day 8)||9
11027591|NCT00834808|12206309|FG000|COMPLETED|Treatment Period 2 (Day 8)||9
11027592|NCT00834808|12206310|FG001|COMPLETED|Treatment Period 2 (Day 8)||9
11027593|NCT00834808|12206311|FG002|COMPLETED|Treatment Period 2 (Day 8)||9
11027594|NCT00834808|12206309|FG000|NOT COMPLETED|Treatment Period 2 (Day 8)||0
11027595|NCT00834808|12206310|FG001|NOT COMPLETED|Treatment Period 2 (Day 8)||0
11027596|NCT00834808|12206311|FG002|NOT COMPLETED|Treatment Period 2 (Day 8)||0
11027597|NCT00834808|12206309|FG000|STARTED|Treatment Period 3 (Day 15)||9
11027598|NCT00834808|12206310|FG001|STARTED|Treatment Period 3 (Day 15)||9
11027599|NCT00834808|12206311|FG002|STARTED|Treatment Period 3 (Day 15)||9
11027600|NCT00834808|12206309|FG000|COMPLETED|Treatment Period 3 (Day 15)||9
11027601|NCT00834808|12206310|FG001|COMPLETED|Treatment Period 3 (Day 15)||9
11027602|NCT00834808|12206311|FG002|COMPLETED|Treatment Period 3 (Day 15)||9
11027603|NCT00834808|12206309|FG000|NOT COMPLETED|Treatment Period 3 (Day 15)||0
11027604|NCT00834808|12206310|FG001|NOT COMPLETED|Treatment Period 3 (Day 15)||0
11027605|NCT00834808|12206311|FG002|NOT COMPLETED|Treatment Period 3 (Day 15)||0
11027606|NCT00834834|12206321|FG000|STARTED|Overall Study||42
11027607|NCT00834834|12206322|FG001|STARTED|Overall Study||42
11027608|NCT00834834|12206321|FG000|COMPLETED|Overall Study||38
11027609|NCT00834834|12206322|FG001|COMPLETED|Overall Study||39
11027610|NCT00834834|12206321|FG000|NOT COMPLETED|Overall Study||4
11027611|NCT00834834|12206322|FG001|NOT COMPLETED|Overall Study||3
11027612|NCT00834886|12206332|FG000|STARTED|Overall Study||10
11027613|NCT00834886|12206333|FG001|STARTED|Overall Study||10
11027614|NCT00834886|12206334|FG002|STARTED|Overall Study||10
11027615|NCT00834886|12206335|FG003|STARTED|Overall Study||10
11027616|NCT00834886|12206332|FG000|COMPLETED|Overall Study||10
11027617|NCT00834886|12206333|FG001|COMPLETED|Overall Study||9
11027618|NCT00834886|12206334|FG002|COMPLETED|Overall Study||9
11027619|NCT00834886|12206335|FG003|COMPLETED|Overall Study||10
11027620|NCT00834886|12206332|FG000|NOT COMPLETED|Overall Study||0
11027621|NCT00834886|12206333|FG001|NOT COMPLETED|Overall Study||1
11027622|NCT00834886|12206334|FG002|NOT COMPLETED|Overall Study||1
11027623|NCT00834886|12206335|FG003|NOT COMPLETED|Overall Study||0
11027624|NCT00834899|12206347|FG000|STARTED|Overall Study||9
11027625|NCT00834899|12206348|FG001|STARTED|Overall Study||4
11027626|NCT00834899|12206347|FG000|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
11027627|NCT00834899|12206348|FG001|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
11027628|NCT00834899|12206347|FG000|NOT COMPLETED|Overall Study||1
11027629|NCT00834899|12206348|FG001|NOT COMPLETED|Overall Study||1
11027630|NCT00834912|12206360|FG000|STARTED|Treatment Period 1||6
11027631|NCT00834912|12206361|FG001|STARTED|Treatment Period 1||6
11027632|NCT00834912|12206362|FG002|STARTED|Treatment Period 1||6
11027633|NCT00834912|12206363|FG003|STARTED|Treatment Period 1||6
11027634|NCT00834912|12206364|FG004|STARTED|Treatment Period 1||6
11027635|NCT00834912|12206365|FG005|STARTED|Treatment Period 1||6
11027636|NCT00834912|12206360|FG000|COMPLETED|Treatment Period 1||6
11027637|NCT00834912|12206361|FG001|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
11027638|NCT00834912|12206362|FG002|COMPLETED|Treatment Period 1||6
11027639|NCT00834912|12206363|FG003|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
11027640|NCT00834912|12206364|FG004|COMPLETED|Treatment Period 1||6
11027641|NCT00834912|12206365|FG005|COMPLETED|Treatment Period 1||6
11027642|NCT00834912|12206360|FG000|NOT COMPLETED|Treatment Period 1||0
11027643|NCT00834912|12206361|FG001|NOT COMPLETED|Treatment Period 1||1
11027644|NCT00834912|12206362|FG002|NOT COMPLETED|Treatment Period 1||0
11027645|NCT00834912|12206363|FG003|NOT COMPLETED|Treatment Period 1||1
11027646|NCT00834912|12206364|FG004|NOT COMPLETED|Treatment Period 1||0
11027647|NCT00834912|12206365|FG005|NOT COMPLETED|Treatment Period 1||0
11332264|NCT02813577|12529563|FG000|COMPLETED|Overall Study|Study was terminated and only some results at 1 month follow up are available.|0
11332265|NCT02813577|12529563|FG000|NOT COMPLETED|Overall Study||4
11027648|NCT00834912|12206360|FG000|STARTED|Treatment Period 2||6
11027649|NCT00834912|12206361|FG001|STARTED|Treatment Period 2||5
11027650|NCT00834912|12206362|FG002|STARTED|Treatment Period 2||6
11027651|NCT00834912|12206363|FG003|STARTED|Treatment Period 2||5
11027652|NCT00834912|12206364|FG004|STARTED|Treatment Period 2||6
11027653|NCT00834912|12206365|FG005|STARTED|Treatment Period 2||6
11027654|NCT00834912|12206360|FG000|COMPLETED|Treatment Period 2||6
11027655|NCT00834912|12206361|FG001|COMPLETED|Treatment Period 2||5
11027656|NCT00834912|12206362|FG002|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
11027657|NCT00834912|12206363|FG003|COMPLETED|Treatment Period 2||5
11027658|NCT00834912|12206364|FG004|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
11027659|NCT00834912|12206365|FG005|COMPLETED|Treatment Period 2||6
11027660|NCT00834912|12206360|FG000|NOT COMPLETED|Treatment Period 2||0
11027661|NCT00834912|12206361|FG001|NOT COMPLETED|Treatment Period 2||0
11027662|NCT00834912|12206362|FG002|NOT COMPLETED|Treatment Period 2||1
11027663|NCT00834912|12206363|FG003|NOT COMPLETED|Treatment Period 2||0
11027664|NCT00834912|12206364|FG004|NOT COMPLETED|Treatment Period 2||1
11027665|NCT00834912|12206365|FG005|NOT COMPLETED|Treatment Period 2||0
11027666|NCT00834912|12206360|FG000|STARTED|Treatment Period 3||6
11027667|NCT00834912|12206361|FG001|STARTED|Treatment Period 3||5
11027668|NCT00834912|12206362|FG002|STARTED|Treatment Period 3||5
11027669|NCT00834912|12206363|FG003|STARTED|Treatment Period 3||5
11027670|NCT00834912|12206364|FG004|STARTED|Treatment Period 3||5
11027671|NCT00834912|12206365|FG005|STARTED|Treatment Period 3||6
11027672|NCT00834912|12206360|FG000|COMPLETED|Treatment Period 3||6
11027673|NCT00834912|12206361|FG001|COMPLETED|Treatment Period 3||5
11027674|NCT00834912|12206362|FG002|COMPLETED|Treatment Period 3||5
11027675|NCT00834912|12206363|FG003|COMPLETED|Treatment Period 3||5
11027676|NCT00834912|12206364|FG004|COMPLETED|Treatment Period 3||5
11027677|NCT00834912|12206365|FG005|COMPLETED|Treatment Period 3||6
11027678|NCT00834912|12206360|FG000|NOT COMPLETED|Treatment Period 3||0
11027679|NCT00834912|12206361|FG001|NOT COMPLETED|Treatment Period 3||0
11027680|NCT00834912|12206362|FG002|NOT COMPLETED|Treatment Period 3||0
11027681|NCT00834912|12206363|FG003|NOT COMPLETED|Treatment Period 3||0
11027682|NCT00834912|12206364|FG004|NOT COMPLETED|Treatment Period 3||0
11027683|NCT00834912|12206365|FG005|NOT COMPLETED|Treatment Period 3||0
11027684|NCT00835003|12206375|FG000|STARTED|Overall Study||636
11027685|NCT00835003|12206376|FG001|STARTED|Overall Study||638
11027686|NCT00835003|12206375|FG000|COMPLETED|Overall Study||636
11027687|NCT00835003|12206376|FG001|COMPLETED|Overall Study||638
11027688|NCT00835003|12206375|FG000|NOT COMPLETED|Overall Study||0
11027689|NCT00835003|12206376|FG001|NOT COMPLETED|Overall Study||0
11027690|NCT00835068|12206384|FG000|STARTED|Overall Study||57
11027691|NCT00835068|12206385|FG001|STARTED|Overall Study||1
11027692|NCT00835068|12206384|FG000|COMPLETED|Overall Study||47
11027693|NCT00835068|12206385|FG001|COMPLETED|Overall Study||0
11027694|NCT00835068|12206384|FG000|NOT COMPLETED|Overall Study||10
11027695|NCT00835068|12206385|FG001|NOT COMPLETED|Overall Study||1
11027696|NCT00835120|12206391|FG000|STARTED|Overall Study||34
11027697|NCT00835120|12206391|FG000|COMPLETED|Overall Study||26
11027698|NCT00835120|12206391|FG000|NOT COMPLETED|Overall Study||8
11027699|NCT00835159|12206397|FG000|STARTED|Overall Study||11
11027700|NCT00835159|12206398|FG001|STARTED|Overall Study||17
11027701|NCT00835159|12206397|FG000|COMPLETED|Overall Study||11
11027702|NCT00835159|12206398|FG001|COMPLETED|Overall Study||17
11027703|NCT00835159|12206397|FG000|NOT COMPLETED|Overall Study||0
11332266|NCT02813681|12529570|FG000|STARTED|Overall Study||27
11332267|NCT02813681|12529571|FG001|STARTED|Overall Study||34
11332268|NCT02813681|12529572|FG002|STARTED|Overall Study||19
11027704|NCT00835159|12206398|FG001|NOT COMPLETED|Overall Study||0
11027705|NCT00835185|12206404|FG000|STARTED|Overall Study||44
11027706|NCT00835185|12206404|FG000|Received at Least 1 Dose of Study Drug|Overall Study||44
11027707|NCT00835185|12206404|FG000|COMPLETED|Overall Study||44
11027708|NCT00835185|12206404|FG000|NOT COMPLETED|Overall Study||0
11027709|NCT00835198|12206411|FG000|STARTED|Overall Study||82
11027710|NCT00835198|12206412|FG001|STARTED|Overall Study||81
11027711|NCT00835198|12206411|FG000|COMPLETED|Overall Study||74
11027712|NCT00835198|12206412|FG001|COMPLETED|Overall Study||74
11027713|NCT00835198|12206411|FG000|NOT COMPLETED|Overall Study||8
11027714|NCT00835198|12206412|FG001|NOT COMPLETED|Overall Study||7
11027715|NCT00835224|12206418|FG000|STARTED|Overall Study||34
11027716|NCT00835224|12206418|FG000|COMPLETED|Overall Study||24
11027717|NCT00835224|12206418|FG000|NOT COMPLETED|Overall Study||10
11027718|NCT00835237|12206434|FG000|STARTED|Overall Study||887
11027719|NCT00835237|12206435|FG001|STARTED|Overall Study||445
11027720|NCT00835237|12206434|FG000|COMPLETED|Overall Study||881
11027721|NCT00835237|12206435|FG001|COMPLETED|Overall Study||445
11027722|NCT00835237|12206434|FG000|NOT COMPLETED|Overall Study||6
11332269|NCT02813681|12529570|FG000|COMPLETED|Overall Study||22
11332270|NCT02813681|12529571|FG001|COMPLETED|Overall Study||28
11332271|NCT02813681|12529572|FG002|COMPLETED|Overall Study||19
11027723|NCT00835237|12206435|FG001|NOT COMPLETED|Overall Study||0
11027724|NCT00835341|12206443|FG000|STARTED|Overall Study||35
11027725|NCT00835341|12206444|FG001|STARTED|Overall Study||58
11027726|NCT00835341|12206443|FG000|COMPLETED|Overall Study||32
11027727|NCT00835341|12206444|FG001|COMPLETED|Overall Study||46
11027728|NCT00835341|12206443|FG000|NOT COMPLETED|Overall Study||3
11027729|NCT00835341|12206444|FG001|NOT COMPLETED|Overall Study||12
11027730|NCT00835380|12206450|FG000|STARTED|Overall Study||80
11027731|NCT00835380|12206450|FG000|COMPLETED|Overall Study||78
11332272|NCT02813681|12529570|FG000|NOT COMPLETED|Overall Study||5
11332273|NCT02813681|12529571|FG001|NOT COMPLETED|Overall Study||6
11332274|NCT02813681|12529572|FG002|NOT COMPLETED|Overall Study||0
11332275|NCT02813694|12529584|FG000|STARTED|Overall Study|Intent to Treat Analysis Set|370
11332276|NCT02813694|12529585|FG001|STARTED|Overall Study|Intent to Treat Analysis Set|368
11332277|NCT02813694|12529584|FG000|COMPLETED|Overall Study||353
11332278|NCT02813694|12529585|FG001|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354
11332279|NCT02813694|12529584|FG000|NOT COMPLETED|Overall Study||17
11332280|NCT02813694|12529585|FG001|NOT COMPLETED|Overall Study||14
11332281|NCT02814175|12529593|FG000|STARTED|Part 1||122
11332282|NCT02814175|12529594|FG001|STARTED|Part 1||123
11332283|NCT02814175|12529595|FG002|STARTED|Part 1||0
11332284|NCT02814175|12529596|FG003|STARTED|Part 1||0
11332285|NCT02814175|12529597|FG004|STARTED|Part 1||0
11332286|NCT02814175|12529598|FG005|STARTED|Part 1||0
11332287|NCT02814175|12529593|FG000|COMPLETED|Part 1||110
11332288|NCT02814175|12529594|FG001|COMPLETED|Part 1||117
11332289|NCT02814175|12529595|FG002|COMPLETED|Part 1||0
11332290|NCT02814175|12529596|FG003|COMPLETED|Part 1||0
11332291|NCT02814175|12529597|FG004|COMPLETED|Part 1||0
11332292|NCT02814175|12529598|FG005|COMPLETED|Part 1||0
11332293|NCT02814175|12529593|FG000|NOT COMPLETED|Part 1||12
11332294|NCT02814175|12529594|FG001|NOT COMPLETED|Part 1||6
11332295|NCT02814175|12529595|FG002|NOT COMPLETED|Part 1||0
11332296|NCT02814175|12529596|FG003|NOT COMPLETED|Part 1||0
11332297|NCT02814175|12529597|FG004|NOT COMPLETED|Part 1||0
11332298|NCT02814175|12529598|FG005|NOT COMPLETED|Part 1||0
11332299|NCT02814175|12529593|FG000|STARTED|Part 2||0
11332300|NCT02814175|12529594|FG001|STARTED|Part 2||0
11332301|NCT02814175|12529595|FG002|STARTED|Part 2||15
11332302|NCT02814175|12529596|FG003|STARTED|Part 2||95
11332303|NCT02814175|12529597|FG004|STARTED|Part 2||54
11332304|NCT02814175|12529598|FG005|STARTED|Part 2||63
11332305|NCT02814175|12529593|FG000|COMPLETED|Part 2||0
11332306|NCT02814175|12529594|FG001|COMPLETED|Part 2||0
11332307|NCT02814175|12529595|FG002|COMPLETED|Part 2||15
11332308|NCT02814175|12529596|FG003|COMPLETED|Part 2||91
11332309|NCT02814175|12529597|FG004|COMPLETED|Part 2||52
11332310|NCT02814175|12529598|FG005|COMPLETED|Part 2||57
11332311|NCT02814175|12529593|FG000|NOT COMPLETED|Part 2||0
11332312|NCT02814175|12529594|FG001|NOT COMPLETED|Part 2||0
11332313|NCT02814175|12529595|FG002|NOT COMPLETED|Part 2||0
11332314|NCT02814175|12529596|FG003|NOT COMPLETED|Part 2||4
11332315|NCT02814175|12529597|FG004|NOT COMPLETED|Part 2||2
11332316|NCT02814175|12529598|FG005|NOT COMPLETED|Part 2||6
11332317|NCT02814227|12529612|FG000|STARTED|Overall Study||52
11332318|NCT02814227|12529612|FG000|COMPLETED|Overall Study||52
11332319|NCT02814227|12529612|FG000|NOT COMPLETED|Overall Study||0
11332320|NCT02814279|12529618|FG000|STARTED|Overall Study||21
11332321|NCT02814279|12529619|FG001|STARTED|Overall Study||21
11332322|NCT02814279|12529618|FG000|COMPLETED|Overall Study||21
11332323|NCT02814279|12529619|FG001|COMPLETED|Overall Study||21
11332324|NCT02814279|12529618|FG000|NOT COMPLETED|Overall Study||0
11332325|NCT02814279|12529619|FG001|NOT COMPLETED|Overall Study||0
11332326|NCT02814448|12529630|FG000|STARTED|Overall Study||27
11332327|NCT02814448|12529631|FG001|STARTED|Overall Study||24
11332328|NCT02814448|12529632|FG002|STARTED|Overall Study||26
11332329|NCT02814448|12529633|FG003|STARTED|Overall Study||25
11332330|NCT02814448|12529634|FG004|STARTED|Overall Study||28
11332331|NCT02814448|12529630|FG000|COMPLETED|Overall Study||27
11332332|NCT02814448|12529631|FG001|COMPLETED|Overall Study||24
11332333|NCT02814448|12529632|FG002|COMPLETED|Overall Study||25
11332334|NCT02814448|12529633|FG003|COMPLETED|Overall Study||25
11027732|NCT00835380|12206450|FG000|NOT COMPLETED|Overall Study||2
11027733|NCT00835510|12206457|FG000|STARTED|Overall Study||219
11027734|NCT00835510|12206458|FG001|STARTED|Overall Study||221
11027735|NCT00835510|12206459|FG002|STARTED|Overall Study||108
11332335|NCT02814448|12529634|FG004|COMPLETED|Overall Study||26
11332336|NCT02814448|12529630|FG000|NOT COMPLETED|Overall Study||0
11332337|NCT02814448|12529631|FG001|NOT COMPLETED|Overall Study||0
11332338|NCT02814448|12529632|FG002|NOT COMPLETED|Overall Study||1
11332339|NCT02814448|12529633|FG003|NOT COMPLETED|Overall Study||0
11332340|NCT02814448|12529634|FG004|NOT COMPLETED|Overall Study||2
11332341|NCT02814565|12529648|FG000|STARTED|Overall Study||90
11332342|NCT02814565|12529649|FG001|STARTED|Overall Study||90
11332343|NCT02814565|12529648|FG000|COMPLETED|Overall Study||89
11332344|NCT02814565|12529649|FG001|COMPLETED|Overall Study||88
11332345|NCT02814565|12529648|FG000|NOT COMPLETED|Overall Study||1
11332346|NCT02814565|12529649|FG001|NOT COMPLETED|Overall Study||2
11332347|NCT02814643|12529657|FG000|STARTED|Overall Study||51
11332348|NCT02814643|12529658|FG001|STARTED|Overall Study||52
11332349|NCT02814643|12529657|FG000|COMPLETED|Overall Study||50
11332350|NCT02814643|12529658|FG001|COMPLETED|Overall Study||49
11332351|NCT02814643|12529657|FG000|NOT COMPLETED|Overall Study||1
11332352|NCT02814643|12529658|FG001|NOT COMPLETED|Overall Study||3
11332353|NCT02814656|12529668|FG000|STARTED|Overall Study||6
11332354|NCT02814656|12529669|FG001|STARTED|Overall Study||6
11332355|NCT02814656|12529670|FG002|STARTED|Overall Study||6
11332356|NCT02814656|12529671|FG003|STARTED|Overall Study||6
11332357|NCT02814656|12529668|FG000|COMPLETED|Overall Study||6
11332358|NCT02814656|12529669|FG001|COMPLETED|Overall Study||6
11332359|NCT02814656|12529670|FG002|COMPLETED|Overall Study||6
11332360|NCT02814656|12529671|FG003|COMPLETED|Overall Study||6
11332361|NCT02814656|12529668|FG000|NOT COMPLETED|Overall Study||0
11332362|NCT02814656|12529669|FG001|NOT COMPLETED|Overall Study||0
11332363|NCT02814656|12529670|FG002|NOT COMPLETED|Overall Study||0
11332364|NCT02814656|12529671|FG003|NOT COMPLETED|Overall Study||0
11332365|NCT02814838|12529683|FG000|STARTED|Overall Study||50
11332366|NCT02814838|12529684|FG001|STARTED|Overall Study||26
11332367|NCT02814838|12529683|FG000|COMPLETED|Overall Study||48
11332368|NCT02814838|12529684|FG001|COMPLETED|Overall Study||25
11332369|NCT02814838|12529683|FG000|NOT COMPLETED|Overall Study||2
11332370|NCT02814838|12529684|FG001|NOT COMPLETED|Overall Study||1
11332371|NCT02814890|12529692|FG000|STARTED|Overall Study||33
11027736|NCT00835510|12206457|FG000|Positive Fungal Culture|Overall Study||149
11027737|NCT00835510|12206458|FG001|Positive Fungal Culture|Overall Study||155
11027738|NCT00835510|12206459|FG002|Positive Fungal Culture|Overall Study||71
11027739|NCT00835510|12206457|FG000|COMPLETED|Overall Study||143
11027740|NCT00835510|12206458|FG001|COMPLETED|Overall Study||152
11027741|NCT00835510|12206459|FG002|COMPLETED|Overall Study||70
11027742|NCT00835510|12206457|FG000|NOT COMPLETED|Overall Study||76
11027743|NCT00835510|12206458|FG001|NOT COMPLETED|Overall Study||69
11027744|NCT00835510|12206459|FG002|NOT COMPLETED|Overall Study||38
11027745|NCT00835731|12206469|FG000|STARTED|Overall Study||64
11027746|NCT00835731|12206470|FG001|STARTED|Overall Study||61
11027747|NCT00835731|12206469|FG000|COMPLETED|Overall Study||62
11027748|NCT00835731|12206470|FG001|COMPLETED|Overall Study||60
11027749|NCT00835731|12206469|FG000|NOT COMPLETED|Overall Study||2
11027750|NCT00835731|12206470|FG001|NOT COMPLETED|Overall Study||1
11027751|NCT00835770|12206478|FG000|STARTED|Overall Study||868
11027752|NCT00835770|12206479|FG001|STARTED|Overall Study||868
11027753|NCT00835770|12206478|FG000|COMPLETED|Overall Study||384
11027754|NCT00835770|12206479|FG001|COMPLETED|Overall Study||375
11027755|NCT00835770|12206478|FG000|NOT COMPLETED|Overall Study||484
11027756|NCT00835770|12206479|FG001|NOT COMPLETED|Overall Study||493
11027757|NCT00835861|12206493|FG000|STARTED|Overall Study||15
11027758|NCT00835861|12206494|FG001|STARTED|Overall Study||16
11027759|NCT00835861|12206493|FG000|COMPLETED|Overall Study||14
11027760|NCT00835861|12206494|FG001|COMPLETED|Overall Study||14
11027761|NCT00835861|12206493|FG000|NOT COMPLETED|Overall Study||1
11027762|NCT00835861|12206494|FG001|NOT COMPLETED|Overall Study||2
11027763|NCT00835900|12206502|FG000|STARTED|Overall Study||32
11027764|NCT00835900|12206503|FG001|STARTED|Overall Study||28
11027765|NCT00835900|12206502|FG000|COMPLETED|Overall Study||27
11027766|NCT00835900|12206503|FG001|COMPLETED|Overall Study||22
11027767|NCT00835900|12206502|FG000|NOT COMPLETED|Overall Study||5
11027768|NCT00835900|12206503|FG001|NOT COMPLETED|Overall Study||6
11027769|NCT00835926|12206511|FG000|STARTED|Overall Study||61
11027770|NCT00835926|12206512|FG001|STARTED|Overall Study||60
11027771|NCT00835926|12206511|FG000|COMPLETED|Overall Study||61
11027772|NCT00835926|12206512|FG001|COMPLETED|Overall Study||60
11027773|NCT00835926|12206511|FG000|NOT COMPLETED|Overall Study||0
11027774|NCT00835926|12206512|FG001|NOT COMPLETED|Overall Study||0
11027775|NCT00835978|12206522|FG000|STARTED|Overall Study||56
11027776|NCT00835978|12206523|FG001|STARTED|Overall Study||56
11027777|NCT00835978|12206524|FG002|STARTED|Overall Study||91
11027778|NCT00835978|12206525|FG003|STARTED|Overall Study||10
11027779|NCT00835978|12206522|FG000|Treated|Overall Study||56
11027780|NCT00835978|12206523|FG001|Treated|Overall Study||56
11027781|NCT00835978|12206524|FG002|Treated|Overall Study||91
11027782|NCT00835978|12206525|FG003|Treated|Overall Study||10
11332372|NCT02814890|12529693|FG001|STARTED|Overall Study||32
11027783|NCT00835978|12206522|FG000|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
11027784|NCT00835978|12206523|FG001|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
11027785|NCT00835978|12206524|FG002|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
11027786|NCT00835978|12206525|FG003|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
11027787|NCT00835978|12206522|FG000|NOT COMPLETED|Overall Study||56
11027788|NCT00835978|12206523|FG001|NOT COMPLETED|Overall Study||56
11027789|NCT00835978|12206524|FG002|NOT COMPLETED|Overall Study||91
11027790|NCT00835978|12206525|FG003|NOT COMPLETED|Overall Study||10
11027791|NCT00836017|12206540|FG000|STARTED|Overall Study||1046
11027792|NCT00836017|12206540|FG000|COMPLETED|Overall Study||502
11027793|NCT00836017|12206540|FG000|NOT COMPLETED|Overall Study||544
11027794|NCT00836095|12206546|FG000|STARTED|Overall Study||22
11332373|NCT02814890|12529692|FG000|COMPLETED|Overall Study||30
11332374|NCT02814890|12529693|FG001|COMPLETED|Overall Study||30
11332375|NCT02814890|12529692|FG000|NOT COMPLETED|Overall Study||3
11332376|NCT02814890|12529693|FG001|NOT COMPLETED|Overall Study||2
11332377|NCT02815293|12529708|FG000|STARTED|Overall Study||10
11332378|NCT02815293|12529709|FG001|STARTED|Overall Study||8
11332379|NCT02815293|12529710|FG002|STARTED|Overall Study||18
11332380|NCT02815293|12529708|FG000|COMPLETED|Overall Study||0
11332381|NCT02815293|12529709|FG001|COMPLETED|Overall Study||0
11332382|NCT02815293|12529710|FG002|COMPLETED|Overall Study||0
11332383|NCT02815293|12529708|FG000|NOT COMPLETED|Overall Study||10
11332384|NCT02815293|12529709|FG001|NOT COMPLETED|Overall Study||8
11332385|NCT02815293|12529710|FG002|NOT COMPLETED|Overall Study||18
11332386|NCT02815644|12529718|FG000|STARTED|Treatment Period 1 + Washout||11
11332387|NCT02815644|12529719|FG001|STARTED|Treatment Period 1 + Washout||11
11027795|NCT00836095|12206547|FG001|STARTED|Overall Study||30
11027796|NCT00836095|12206546|FG000|COMPLETED|Overall Study||22
11027797|NCT00836095|12206547|FG001|COMPLETED|Overall Study||27
11027798|NCT00836095|12206546|FG000|NOT COMPLETED|Overall Study||0
11027799|NCT00836095|12206547|FG001|NOT COMPLETED|Overall Study||3
11027800|NCT00836186|12206553|FG000|STARTED|Overall Study||82
11027801|NCT00836186|12206553|FG000|COMPLETED|Overall Study||81
11027802|NCT00836186|12206553|FG000|NOT COMPLETED|Overall Study||1
11027803|NCT00836277|12206558|FG000|STARTED|Overall Study||24
11027804|NCT00836277|12206558|FG000|COMPLETED|Overall Study||18
11027805|NCT00836277|12206558|FG000|NOT COMPLETED|Overall Study||6
11027806|NCT00836342|12206565|FG000|STARTED|Overall Study||22
11027807|NCT00836342|12206566|FG001|STARTED|Overall Study||23
11027808|NCT00836342|12206567|FG002|STARTED|Overall Study||36
11027809|NCT00836342|12206565|FG000|COMPLETED|Overall Study||22
11027810|NCT00836342|12206566|FG001|COMPLETED|Overall Study||23
11027811|NCT00836342|12206567|FG002|COMPLETED|Overall Study||36
11027812|NCT00836342|12206565|FG000|NOT COMPLETED|Overall Study||0
11027813|NCT00836342|12206566|FG001|NOT COMPLETED|Overall Study||0
11027814|NCT00836342|12206567|FG002|NOT COMPLETED|Overall Study||0
11027815|NCT00836407|12206579|FG000|STARTED|Overall Study||15
11027816|NCT00836407|12206580|FG001|STARTED|Overall Study||15
11027817|NCT00836407|12206579|FG000|COMPLETED|Overall Study||4
11027818|NCT00836407|12206580|FG001|COMPLETED|Overall Study||7
11027819|NCT00836407|12206579|FG000|NOT COMPLETED|Overall Study||11
11027820|NCT00836407|12206580|FG001|NOT COMPLETED|Overall Study||8
11027821|NCT00836433|12206588|FG000|STARTED|Overall Study||361
11027822|NCT00836433|12206589|FG001|STARTED|Overall Study||328
11027823|NCT00836433|12206588|FG000|COMPLETED|Overall Study||349
11027824|NCT00836433|12206589|FG001|COMPLETED|Overall Study||321
11027825|NCT00836433|12206588|FG000|NOT COMPLETED|Overall Study||12
11027826|NCT00836433|12206589|FG001|NOT COMPLETED|Overall Study||7
11027827|NCT00836498|12206599|FG000|STARTED|Overall Study||44
11027828|NCT00836498|12206600|FG001|STARTED|Overall Study||22
11027829|NCT00836498|12206599|FG000|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
11027830|NCT00836498|12206600|FG001|COMPLETED|Overall Study||21
11027831|NCT00836498|12206599|FG000|NOT COMPLETED|Overall Study||4
11027832|NCT00836498|12206600|FG001|NOT COMPLETED|Overall Study||1
11027833|NCT00836589|12206607|FG000|STARTED|Overall Study||1997
11332388|NCT02815644|12529718|FG000|COMPLETED|Treatment Period 1 + Washout||11
11332389|NCT02815644|12529719|FG001|COMPLETED|Treatment Period 1 + Washout||11
11332390|NCT02815644|12529718|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0
11332391|NCT02815644|12529719|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0
11332392|NCT02815644|12529718|FG000|STARTED|Treatment Period 2||11
11332393|NCT02815644|12529719|FG001|STARTED|Treatment Period 2||11
11332394|NCT02815644|12529718|FG000|COMPLETED|Treatment Period 2||11
11332395|NCT02815644|12529719|FG001|COMPLETED|Treatment Period 2||11
11332396|NCT02815644|12529718|FG000|NOT COMPLETED|Treatment Period 2||0
11332397|NCT02815644|12529719|FG001|NOT COMPLETED|Treatment Period 2||0
11332398|NCT02815670|12529725|FG000|STARTED|Overall Study||1
11332399|NCT02815670|12529725|FG000|COMPLETED|Overall Study||0
11332400|NCT02815670|12529725|FG000|NOT COMPLETED|Overall Study||1
11332401|NCT02815709|12529734|FG000|STARTED|Overall Study||82
11332402|NCT02815709|12529735|FG001|STARTED|Overall Study||86
11332403|NCT02815709|12529736|FG002|STARTED|Overall Study||82
11332404|NCT02815709|12529737|FG003|STARTED|Overall Study||84
11332405|NCT02815709|12529738|FG004|STARTED|Overall Study||84
11332406|NCT02815709|12529734|FG000|Treated With Study Medication|Overall Study||76
11332407|NCT02815709|12529735|FG001|Treated With Study Medication|Overall Study||79
11332408|NCT02815709|12529736|FG002|Treated With Study Medication|Overall Study||79
11332409|NCT02815709|12529737|FG003|Treated With Study Medication|Overall Study||79
11332410|NCT02815709|12529738|FG004|Treated With Study Medication|Overall Study||76
11332411|NCT02815709|12529734|FG000|COMPLETED|Overall Study|Completed Study|75
11332412|NCT02815709|12529735|FG001|COMPLETED|Overall Study|Completed Study|78
11332413|NCT02815709|12529736|FG002|COMPLETED|Overall Study|Completed Study|75
11332414|NCT02815709|12529737|FG003|COMPLETED|Overall Study|Completed Study|76
11332415|NCT02815709|12529738|FG004|COMPLETED|Overall Study|Completed Study|74
11332416|NCT02815709|12529734|FG000|NOT COMPLETED|Overall Study||7
11332417|NCT02815709|12529735|FG001|NOT COMPLETED|Overall Study||8
11332418|NCT02815709|12529736|FG002|NOT COMPLETED|Overall Study||7
11332419|NCT02815709|12529737|FG003|NOT COMPLETED|Overall Study||8
11332420|NCT02815709|12529738|FG004|NOT COMPLETED|Overall Study||10
11332421|NCT02815735|12529751|FG000|STARTED|First Intervention (4 Weeks)||36
11332422|NCT02815735|12529752|FG001|STARTED|First Intervention (4 Weeks)||38
11332423|NCT02815735|12529751|FG000|COMPLETED|First Intervention (4 Weeks)||34
11332424|NCT02815735|12529752|FG001|COMPLETED|First Intervention (4 Weeks)||37
11332425|NCT02815735|12529751|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
11332426|NCT02815735|12529752|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
11332427|NCT02815735|12529751|FG000|STARTED|Second Intervention (4 Weeks)||34
11332428|NCT02815735|12529752|FG001|STARTED|Second Intervention (4 Weeks)||37
11332429|NCT02815735|12529751|FG000|COMPLETED|Second Intervention (4 Weeks)||33
11332430|NCT02815735|12529752|FG001|COMPLETED|Second Intervention (4 Weeks)||37
11027834|NCT00836589|12206607|FG000|COMPLETED|Overall Study||731
11027835|NCT00836589|12206607|FG000|NOT COMPLETED|Overall Study||1266
11027836|NCT00836641|12206621|FG000|STARTED|Overall Study||36
11027837|NCT00836641|12206622|FG001|STARTED|Overall Study||34
11027838|NCT00836641|12206621|FG000|COMPLETED|Overall Study||36
11027839|NCT00836641|12206622|FG001|COMPLETED|Overall Study||34
11027840|NCT00836641|12206621|FG000|NOT COMPLETED|Overall Study||0
11027841|NCT00836641|12206622|FG001|NOT COMPLETED|Overall Study||0
11057340|NCT00997126|12238823|FG001|STARTED|Overall Study||63
11057341|NCT00997126|12238822|FG000|COMPLETED|Overall Study||56
11057342|NCT00997126|12238823|FG001|COMPLETED|Overall Study||52
11057343|NCT00997126|12238822|FG000|NOT COMPLETED|Overall Study||7
11057344|NCT00997126|12238823|FG001|NOT COMPLETED|Overall Study||11
11057345|NCT00997139|12238829|FG000|STARTED|Overall Study||216
11057346|NCT00997139|12238829|FG000|Treated for Positive Baseline Culture|Overall Study||30
11057347|NCT00997139|12238829|FG000|COMPLETED|Overall Study||30
11057348|NCT00997139|12238829|FG000|NOT COMPLETED|Overall Study||186
11057349|NCT00997204|12238837|FG000|STARTED|Naive Treatment Phase||25
11057350|NCT00997204|12238838|FG001|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
11057351|NCT00997204|12238837|FG000|COMPLETED|Naive Treatment Phase||19
11027842|NCT00836693|12206629|FG000|STARTED|Overall Study||147
11027843|NCT00836693|12206630|FG001|STARTED|Overall Study||70
11027844|NCT00836693|12206629|FG000|COMPLETED|Overall Study||130
11027845|NCT00836693|12206630|FG001|COMPLETED|Overall Study||64
11027846|NCT00836693|12206629|FG000|NOT COMPLETED|Overall Study||17
11027847|NCT00836693|12206630|FG001|NOT COMPLETED|Overall Study||6
11027848|NCT00836719|12206636|FG000|STARTED|Overall Study||10
11027849|NCT00836719|12206636|FG000|COMPLETED|Overall Study||10
11027850|NCT00836719|12206636|FG000|NOT COMPLETED|Overall Study||0
11027851|NCT00836745|12206640|FG000|STARTED|Overall Study||36
11027852|NCT00836745|12206640|FG000|COMPLETED|Overall Study||15
11027853|NCT00836745|12206640|FG000|NOT COMPLETED|Overall Study||21
11027854|NCT00836758|12206644|FG000|STARTED|Overall Study||115
11027855|NCT00836758|12206644|FG000|COMPLETED|Overall Study||115
11027856|NCT00836758|12206644|FG000|NOT COMPLETED|Overall Study||0
11027857|NCT00836875|12206652|FG000|STARTED|Overall Study||11
11027858|NCT00836875|12206653|FG001|STARTED|Overall Study||20
11027859|NCT00836875|12206652|FG000|COMPLETED|Overall Study||8
11027860|NCT00836875|12206653|FG001|COMPLETED|Overall Study||17
11027861|NCT00836875|12206652|FG000|NOT COMPLETED|Overall Study||3
11027862|NCT00836875|12206653|FG001|NOT COMPLETED|Overall Study||3
11027863|NCT00836888|12206663|FG000|STARTED|Overall Study||3
11027864|NCT00836888|12206664|FG001|STARTED|Overall Study||5
11027865|NCT00836888|12206665|FG002|STARTED|Overall Study||6
11027866|NCT00836888|12206666|FG003|STARTED|Overall Study||3
11027867|NCT00836888|12206663|FG000|COMPLETED|Overall Study||0
11027868|NCT00836888|12206664|FG001|COMPLETED|Overall Study||2
11027869|NCT00836888|12206665|FG002|COMPLETED|Overall Study||0
11332431|NCT02815735|12529751|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
11332432|NCT02815735|12529752|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
11332433|NCT02815982|12529771|FG000|STARTED|Overall Study||27
11332434|NCT02815982|12529772|FG001|STARTED|Overall Study||26
11332435|NCT02815982|12529773|FG002|STARTED|Overall Study||27
11332436|NCT02815982|12529774|FG003|STARTED|Overall Study||26
11027870|NCT00836888|12206666|FG003|COMPLETED|Overall Study||0
11027871|NCT00836888|12206663|FG000|NOT COMPLETED|Overall Study||3
11027872|NCT00836888|12206664|FG001|NOT COMPLETED|Overall Study||3
11027873|NCT00836888|12206665|FG002|NOT COMPLETED|Overall Study||6
11027874|NCT00836888|12206666|FG003|NOT COMPLETED|Overall Study||3
11027875|NCT00836927|12206681|FG000|STARTED|Overall Study||3
11027876|NCT00836927|12206682|FG001|STARTED|Overall Study||1
11332437|NCT02815982|12529771|FG000|COMPLETED|Overall Study||27
11332438|NCT02815982|12529772|FG001|COMPLETED|Overall Study||26
11332439|NCT02815982|12529773|FG002|COMPLETED|Overall Study||27
11332440|NCT02815982|12529774|FG003|COMPLETED|Overall Study||26
11332441|NCT02815982|12529771|FG000|NOT COMPLETED|Overall Study||0
11332442|NCT02815982|12529772|FG001|NOT COMPLETED|Overall Study||0
11332443|NCT02815982|12529773|FG002|NOT COMPLETED|Overall Study||0
11332444|NCT02815982|12529774|FG003|NOT COMPLETED|Overall Study||0
11332445|NCT02816138|12529786|FG000|STARTED|Overall Study||15
11332446|NCT02816138|12529786|FG000|COMPLETED|Overall Study||14
11332447|NCT02816138|12529786|FG000|NOT COMPLETED|Overall Study||1
11332448|NCT02816346|12529795|FG000|STARTED|Overall Study||10
11332449|NCT02816346|12529796|FG001|STARTED|Overall Study||10
11332450|NCT02816346|12529797|FG002|STARTED|Overall Study||10
11332451|NCT02816346|12529798|FG003|STARTED|Overall Study||10
11332452|NCT02816346|12529799|FG004|STARTED|Overall Study||16
11332453|NCT02816346|12529795|FG000|COMPLETED|Overall Study||10
11332454|NCT02816346|12529796|FG001|COMPLETED|Overall Study||10
11332455|NCT02816346|12529797|FG002|COMPLETED|Overall Study||10
11332456|NCT02816346|12529798|FG003|COMPLETED|Overall Study||10
11332457|NCT02816346|12529799|FG004|COMPLETED|Overall Study||16
11332458|NCT02816346|12529795|FG000|NOT COMPLETED|Overall Study||0
11332459|NCT02816346|12529796|FG001|NOT COMPLETED|Overall Study||0
11332460|NCT02816346|12529797|FG002|NOT COMPLETED|Overall Study||0
11332461|NCT02816346|12529798|FG003|NOT COMPLETED|Overall Study||0
11332462|NCT02816346|12529799|FG004|NOT COMPLETED|Overall Study||0
11332463|NCT02816398|12529811|FG000|STARTED|Overall Study||26
11332464|NCT02816398|12529811|FG000|COMPLETED|Overall Study||12
11332465|NCT02816398|12529811|FG000|NOT COMPLETED|Overall Study||14
11332466|NCT02816710|12529818|FG000|STARTED|Overall Study||38
11027877|NCT00836927|12206683|FG002|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
11027878|NCT00836927|12206684|FG003|STARTED|Overall Study||1
11027879|NCT00836927|12206685|FG004|STARTED|Overall Study||1
11027880|NCT00836927|12206681|FG000|Completed Dosing Through 03 Apr 2017|Overall Study||0
11027881|NCT00836927|12206682|FG001|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
11027882|NCT00836927|12206683|FG002|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
11332467|NCT02816710|12529819|FG001|STARTED|Overall Study||38
11332468|NCT02816710|12529820|FG002|STARTED|Overall Study||36
11332469|NCT02816710|12529818|FG000|COMPLETED|Overall Study||34
11332470|NCT02816710|12529819|FG001|COMPLETED|Overall Study||35
11332471|NCT02816710|12529820|FG002|COMPLETED|Overall Study||29
11027883|NCT00836927|12206684|FG003|Completed Dosing Through 03 Apr 2017|Overall Study||0
11027884|NCT00836927|12206685|FG004|Completed Dosing Through 03 Apr 2017|Overall Study||0
11027885|NCT00836927|12206681|FG000|COMPLETED|Overall Study||0
11027886|NCT00836927|12206682|FG001|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
11027887|NCT00836927|12206683|FG002|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
11027888|NCT00836927|12206684|FG003|COMPLETED|Overall Study||0
11027889|NCT00836927|12206685|FG004|COMPLETED|Overall Study||0
11027890|NCT00836927|12206681|FG000|NOT COMPLETED|Overall Study||3
11027891|NCT00836927|12206682|FG001|NOT COMPLETED|Overall Study||0
11027892|NCT00836927|12206683|FG002|NOT COMPLETED|Overall Study||0
11027893|NCT00836927|12206684|FG003|NOT COMPLETED|Overall Study||1
11027894|NCT00836927|12206685|FG004|NOT COMPLETED|Overall Study||1
11027895|NCT00836953|12206699|FG000|STARTED|Overall Study||33
11027896|NCT00836953|12206699|FG000|COMPLETED|Overall Study||31
11027897|NCT00836953|12206699|FG000|NOT COMPLETED|Overall Study||2
11027898|NCT00837031|12206703|FG000|STARTED|Overall Study||72
11027899|NCT00837031|12206703|FG000|COMPLETED|Overall Study||72
11027900|NCT00837031|12206703|FG000|NOT COMPLETED|Overall Study||0
11027901|NCT00837148|12206707|FG000|STARTED|Overall Study||37
11027902|NCT00837148|12206707|FG000|COMPLETED|Overall Study||35
11027903|NCT00837148|12206707|FG000|NOT COMPLETED|Overall Study||2
11027904|NCT00837161|12206711|FG000|STARTED|Overall Study||11
11027905|NCT00837161|12206711|FG000|COMPLETED|Overall Study||9
11027906|NCT00837161|12206711|FG000|NOT COMPLETED|Overall Study||2
11027907|NCT00837200|12206715|FG000|STARTED|Overall Study||13
11027908|NCT00837200|12206715|FG000|COMPLETED|Overall Study||13
11027909|NCT00837200|12206715|FG000|NOT COMPLETED|Overall Study||0
11027910|NCT00837213|12206721|FG000|STARTED|Overall Study||16
11332472|NCT02816710|12529818|FG000|NOT COMPLETED|Overall Study||4
11332473|NCT02816710|12529819|FG001|NOT COMPLETED|Overall Study||3
11332474|NCT02816710|12529820|FG002|NOT COMPLETED|Overall Study||7
11332475|NCT02816723|12529833|FG000|STARTED|Overall Study||30
11027911|NCT00837213|12206722|FG001|STARTED|Overall Study||17
11027912|NCT00837213|12206721|FG000|COMPLETED|Overall Study||10
11027913|NCT00837213|12206722|FG001|COMPLETED|Overall Study||12
11027914|NCT00837213|12206721|FG000|NOT COMPLETED|Overall Study||6
11332476|NCT02816723|12529834|FG001|STARTED|Overall Study||30
11332477|NCT02816723|12529833|FG000|COMPLETED|Overall Study||24
11332478|NCT02816723|12529834|FG001|COMPLETED|Overall Study||28
11332479|NCT02816723|12529833|FG000|NOT COMPLETED|Overall Study||6
11332480|NCT02816723|12529834|FG001|NOT COMPLETED|Overall Study||2
11343823|NCT02956460|12541114|FG001|STARTED|Lens 1||34
11343824|NCT02956460|12541113|FG000|COMPLETED|Lens 1||29
11332481|NCT02817087|12529842|FG000|STARTED|Overall Study||16
11332482|NCT02817087|12529843|FG001|STARTED|Overall Study||15
11332483|NCT02817087|12529842|FG000|COMPLETED|Overall Study|1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns|14
11027915|NCT00837213|12206722|FG001|NOT COMPLETED|Overall Study||5
11332484|NCT02817087|12529843|FG001|COMPLETED|Overall Study||15
11332485|NCT02817087|12529842|FG000|NOT COMPLETED|Overall Study||2
11332486|NCT02817087|12529843|FG001|NOT COMPLETED|Overall Study||0
11332487|NCT02817516|12529853|FG000|STARTED|Overall Study||6
11332488|NCT02817516|12529854|FG001|STARTED|Overall Study||6
11332489|NCT02817516|12529855|FG002|STARTED|Overall Study||6
11332490|NCT02817516|12529856|FG003|STARTED|Overall Study||6
11332491|NCT02817516|12529853|FG000|COMPLETED|Overall Study||6
11332492|NCT02817516|12529854|FG001|COMPLETED|Overall Study||6
11027916|NCT00837252|12206728|FG000|STARTED|Overall Study||5
11027917|NCT00837252|12206728|FG000|COMPLETED|Overall Study||5
11027918|NCT00837252|12206728|FG000|NOT COMPLETED|Overall Study||0
11027919|NCT00837330|12206734|FG000|STARTED|Overall Study||10
11027920|NCT00837330|12206735|FG001|STARTED|Overall Study||10
11027921|NCT00837330|12206734|FG000|COMPLETED|Overall Study||9
11027922|NCT00837330|12206735|FG001|COMPLETED|Overall Study||7
11332493|NCT02817516|12529855|FG002|COMPLETED|Overall Study||5
11027923|NCT00837330|12206734|FG000|NOT COMPLETED|Overall Study||1
11027924|NCT00837330|12206735|FG001|NOT COMPLETED|Overall Study||3
11027925|NCT00837434|12206743|FG000|STARTED|Overall Study||43
11027926|NCT00837434|12206744|FG001|STARTED|Overall Study||20
11027927|NCT00837434|12206743|FG000|COMPLETED|Overall Study||34
11027928|NCT00837434|12206744|FG001|COMPLETED|Overall Study||19
11027929|NCT00837434|12206743|FG000|NOT COMPLETED|Overall Study||9
11332494|NCT02817516|12529856|FG003|COMPLETED|Overall Study||6
11332495|NCT02817516|12529853|FG000|NOT COMPLETED|Overall Study||0
11332496|NCT02817516|12529854|FG001|NOT COMPLETED|Overall Study||0
11332497|NCT02817516|12529855|FG002|NOT COMPLETED|Overall Study||1
11332498|NCT02817516|12529856|FG003|NOT COMPLETED|Overall Study||0
11332499|NCT02817555|12529871|FG000|STARTED|Overall Study||24
11332500|NCT02817555|12529872|FG001|STARTED|Overall Study||26
11332501|NCT02817555|12529871|FG000|COMPLETED|Overall Study||21
11332502|NCT02817555|12529872|FG001|COMPLETED|Overall Study||21
11332503|NCT02817555|12529871|FG000|NOT COMPLETED|Overall Study||3
11332504|NCT02817555|12529872|FG001|NOT COMPLETED|Overall Study||5
11332505|NCT02817594|12529878|FG000|STARTED|Overall Study||51
11332506|NCT02817594|12529878|FG000|Received Treatment|Overall Study||50
11332507|NCT02817594|12529878|FG000|COMPLETED|Overall Study||48
11332508|NCT02817594|12529878|FG000|NOT COMPLETED|Overall Study||3
11332509|NCT02817763|12529888|FG000|STARTED|Overall Study||20
11332510|NCT02817763|12529889|FG001|STARTED|Overall Study||20
11332511|NCT02817763|12529888|FG000|COMPLETED|Overall Study||20
11332512|NCT02817763|12529889|FG001|COMPLETED|Overall Study||20
11332513|NCT02817763|12529888|FG000|NOT COMPLETED|Overall Study||0
11332514|NCT02817763|12529889|FG001|NOT COMPLETED|Overall Study||0
11332515|NCT02817776|12529895|FG000|STARTED|Overall Study|33 excluded prior to procedure. 348 had study catheter inserted (Safety Population)|381
11332516|NCT02817776|12529895|FG000|COMPLETED|Overall Study||293
11332517|NCT02817776|12529895|FG000|NOT COMPLETED|Overall Study||88
11332518|NCT02817828|12529899|FG000|STARTED|Overall Study||1553
11332519|NCT02817828|12529899|FG000|COMPLETED|Overall Study||1218
11332520|NCT02817828|12529899|FG000|NOT COMPLETED|Overall Study||335
11332521|NCT02817841|12529908|FG000|STARTED|Overall Study||1864
11332522|NCT02817841|12529908|FG000|COMPLETED|Overall Study||1016
11332523|NCT02817841|12529908|FG000|NOT COMPLETED|Overall Study||848
11332524|NCT02817906|12529918|FG000|STARTED|Overall Study|87 patients were randomized but only 86 received study drug. The number completed and discontinued is based on the 86 patients that received study drug.|86
11332525|NCT02817906|12529919|FG001|STARTED|Overall Study|90 patients were randomized but only 89 received study drug. The number completed and discontinued is based on 89 patients that received study drug.|89
11332526|NCT02817906|12529918|FG000|COMPLETED|Overall Study||70
11332527|NCT02817906|12529919|FG001|COMPLETED|Overall Study||84
11027930|NCT00837434|12206744|FG001|NOT COMPLETED|Overall Study||1
11332528|NCT02817906|12529918|FG000|NOT COMPLETED|Overall Study||16
11332529|NCT02817906|12529919|FG001|NOT COMPLETED|Overall Study||5
11332530|NCT02818036|12529927|FG000|STARTED|Overall Study||42
11332531|NCT02818036|12529928|FG001|STARTED|Overall Study||40
11332532|NCT02818036|12529927|FG000|COMPLETED|Overall Study||40
11332533|NCT02818036|12529928|FG001|COMPLETED|Overall Study||40
11332534|NCT02818036|12529927|FG000|NOT COMPLETED|Overall Study||2
11332535|NCT02818036|12529928|FG001|NOT COMPLETED|Overall Study||0
11332536|NCT02818114|12529934|FG000|STARTED|Overall Study||8
11332537|NCT02818114|12529934|FG000|COMPLETED|Overall Study||7
11332538|NCT02818114|12529934|FG000|NOT COMPLETED|Overall Study||1
11332539|NCT02818244|12529943|FG000|STARTED|Overall Study||25
11332540|NCT02818244|12529944|FG001|STARTED|Overall Study||25
11332541|NCT02818244|12529945|FG002|STARTED|Overall Study||25
11332542|NCT02818244|12529946|FG003|STARTED|Overall Study||25
11332543|NCT02818244|12529943|FG000|COMPLETED|Overall Study||25
11332544|NCT02818244|12529944|FG001|COMPLETED|Overall Study||25
11332545|NCT02818244|12529945|FG002|COMPLETED|Overall Study||25
11332546|NCT02818244|12529946|FG003|COMPLETED|Overall Study||25
11332547|NCT02818244|12529943|FG000|NOT COMPLETED|Overall Study||0
11027931|NCT00837447|12206750|FG000|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
11027932|NCT00837447|12206750|FG000|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
11027933|NCT00837447|12206750|FG000|NOT COMPLETED|Overall Study||0
11027934|NCT00837473|12206755|FG000|STARTED|Overall Study||15
11027935|NCT00837473|12206755|FG000|COMPLETED|Overall Study||12
11027936|NCT00837473|12206755|FG000|NOT COMPLETED|Overall Study||3
11027937|NCT00837486|12206761|FG000|STARTED|Blinded-treatment Phase||16
11027938|NCT00837486|12206762|FG001|STARTED|Blinded-treatment Phase||14
11027939|NCT00837486|12206761|FG000|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
11027940|NCT00837486|12206762|FG001|COMPLETED|Blinded-treatment Phase||14
11027941|NCT00837486|12206761|FG000|NOT COMPLETED|Blinded-treatment Phase||1
11027942|NCT00837486|12206762|FG001|NOT COMPLETED|Blinded-treatment Phase||0
11027943|NCT00837486|12206761|FG000|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
11027944|NCT00837486|12206762|FG001|STARTED|Long-term Follow-up Phase - Open Label||0
11027945|NCT00837486|12206761|FG000|COMPLETED|Long-term Follow-up Phase - Open Label||24
11027946|NCT00837486|12206762|FG001|COMPLETED|Long-term Follow-up Phase - Open Label||0
11027947|NCT00837486|12206761|FG000|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
11027948|NCT00837486|12206762|FG001|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
11027949|NCT00837512|12206770|FG000|STARTED|First Intervention (6hrs) - RANDOMIZED||8
11027950|NCT00837512|12206771|FG001|STARTED|First Intervention (6hrs) - RANDOMIZED||8
11027951|NCT00837512|12206770|FG000|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
11027952|NCT00837512|12206771|FG001|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
11027953|NCT00837512|12206770|FG000|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
11027954|NCT00837512|12206771|FG001|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
11027955|NCT00837512|12206770|FG000|STARTED|Both Arms: Washout (7-28 Days)||8
11027956|NCT00837512|12206771|FG001|STARTED|Both Arms: Washout (7-28 Days)||8
11332548|NCT02818244|12529944|FG001|NOT COMPLETED|Overall Study||0
11332549|NCT02818244|12529945|FG002|NOT COMPLETED|Overall Study||0
11332550|NCT02818244|12529946|FG003|NOT COMPLETED|Overall Study||0
11027957|NCT00837512|12206770|FG000|COMPLETED|Both Arms: Washout (7-28 Days)||8
11027958|NCT00837512|12206771|FG001|COMPLETED|Both Arms: Washout (7-28 Days)||8
11027959|NCT00837512|12206770|FG000|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
11027960|NCT00837512|12206771|FG001|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
11027961|NCT00837512|12206770|FG000|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
11027962|NCT00837512|12206771|FG001|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
11027963|NCT00837512|12206770|FG000|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
11332551|NCT02818569|12529956|FG000|STARTED|Overall Study||8
11027964|NCT00837512|12206771|FG001|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
11027965|NCT00837512|12206770|FG000|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
11027966|NCT00837512|12206771|FG001|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
11027967|NCT00837577|12206779|FG000|STARTED|Double-blind Period||70
11027968|NCT00837577|12206780|FG001|STARTED|Double-blind Period||63
11027969|NCT00837577|12206779|FG000|COMPLETED|Double-blind Period||68
11027970|NCT00837577|12206780|FG001|COMPLETED|Double-blind Period||63
11027971|NCT00837577|12206779|FG000|NOT COMPLETED|Double-blind Period||2
11027972|NCT00837577|12206780|FG001|NOT COMPLETED|Double-blind Period||0
11027973|NCT00837577|12206779|FG000|STARTED|Open-label Period||68
11027974|NCT00837577|12206780|FG001|STARTED|Open-label Period||63
11027975|NCT00837577|12206779|FG000|COMPLETED|Open-label Period||60
11027976|NCT00837577|12206780|FG001|COMPLETED|Open-label Period||54
11027977|NCT00837577|12206779|FG000|NOT COMPLETED|Open-label Period||8
11027978|NCT00837577|12206780|FG001|NOT COMPLETED|Open-label Period||9
11027979|NCT00837590|12206790|FG000|STARTED|Overall Study||6
11027980|NCT00837590|12206791|FG001|STARTED|Overall Study||5
11027981|NCT00837590|12206792|FG002|STARTED|Overall Study||5
11027982|NCT00837590|12206790|FG000|COMPLETED|Overall Study||6
11027983|NCT00837590|12206791|FG001|COMPLETED|Overall Study||4
11027984|NCT00837590|12206792|FG002|COMPLETED|Overall Study||4
11027985|NCT00837590|12206790|FG000|NOT COMPLETED|Overall Study||0
11027986|NCT00837590|12206791|FG001|NOT COMPLETED|Overall Study||1
11027987|NCT00837590|12206792|FG002|NOT COMPLETED|Overall Study||1
11027988|NCT00837616|12206802|FG000|STARTED|Overall Study||20
11027989|NCT00837616|12206803|FG001|STARTED|Overall Study||21
11027990|NCT00837616|12206802|FG000|COMPLETED|Overall Study||20
11027991|NCT00837616|12206803|FG001|COMPLETED|Overall Study||20
11027992|NCT00837616|12206802|FG000|NOT COMPLETED|Overall Study||0
11027993|NCT00837616|12206803|FG001|NOT COMPLETED|Overall Study||1
11027994|NCT00837694|12206815|FG000|STARTED|Overall Study||10
11027995|NCT00837694|12206816|FG001|STARTED|Overall Study||11
11027996|NCT00837694|12206817|FG002|STARTED|Overall Study||10
11332552|NCT02818569|12529957|FG001|STARTED|Overall Study||7
11332553|NCT02818569|12529956|FG000|COMPLETED|Overall Study||8
11332554|NCT02818569|12529957|FG001|COMPLETED|Overall Study||7
11332555|NCT02818569|12529956|FG000|NOT COMPLETED|Overall Study||0
11332556|NCT02818569|12529957|FG001|NOT COMPLETED|Overall Study||0
11332557|NCT02818777|12529966|FG000|STARTED|Overall Study|The number of baseline participants was 13.|13
11332558|NCT02818777|12529966|FG000|COMPLETED|Overall Study||10
11332559|NCT02818777|12529966|FG000|NOT COMPLETED|Overall Study||3
11332560|NCT02818998|12529979|FG000|STARTED|Overall Study||155
11332561|NCT02818998|12529980|FG001|STARTED|Overall Study||154
11332562|NCT02818998|12529981|FG002|STARTED|Overall Study||154
11332563|NCT02818998|12529979|FG000|Completed Week 52 Visit|Overall Study||144
11332564|NCT02818998|12529980|FG001|Completed Week 52 Visit|Overall Study||146
11332565|NCT02818998|12529981|FG002|Completed Week 52 Visit|Overall Study||140
11332566|NCT02818998|12529979|FG000|COMPLETED|Overall Study||137
11332567|NCT02818998|12529980|FG001|COMPLETED|Overall Study||138
11332568|NCT02818998|12529981|FG002|COMPLETED|Overall Study||136
11332569|NCT02818998|12529979|FG000|NOT COMPLETED|Overall Study||18
11332570|NCT02818998|12529980|FG001|NOT COMPLETED|Overall Study||16
11332571|NCT02818998|12529981|FG002|NOT COMPLETED|Overall Study||18
11332572|NCT02819011|12529991|FG000|STARTED|Overall Study||22
11332573|NCT02819011|12529992|FG001|STARTED|Overall Study||22
11332574|NCT02819011|12529991|FG000|COMPLETED|Overall Study||15
11332575|NCT02819011|12529992|FG001|COMPLETED|Overall Study||17
11332576|NCT02819011|12529991|FG000|NOT COMPLETED|Overall Study||7
11332577|NCT02819011|12529992|FG001|NOT COMPLETED|Overall Study||5
11332578|NCT02819284|12530001|FG000|STARTED|Overall Study||452
11332579|NCT02819284|12530002|FG001|STARTED|Overall Study||453
11332580|NCT02819284|12530001|FG000|COMPLETED|Overall Study||447
11332581|NCT02819284|12530002|FG001|COMPLETED|Overall Study||448
11332582|NCT02819284|12530001|FG000|NOT COMPLETED|Overall Study||5
11332583|NCT02819284|12530002|FG001|NOT COMPLETED|Overall Study||5
11332584|NCT02819297|12530010|FG000|STARTED|Overall Study||299
11332585|NCT02819297|12530011|FG001|STARTED|Overall Study||304
11332586|NCT02819297|12530010|FG000|COMPLETED|Overall Study||239
11332587|NCT02819297|12530011|FG001|COMPLETED|Overall Study||252
11332588|NCT02819297|12530010|FG000|NOT COMPLETED|Overall Study||60
11332589|NCT02819297|12530011|FG001|NOT COMPLETED|Overall Study||52
11332590|NCT02819310|12530017|FG000|STARTED|Overall Study||330
11332591|NCT02819310|12530017|FG000|COMPLETED|Overall Study||221
11332592|NCT02819310|12530017|FG000|NOT COMPLETED|Overall Study||109
11332593|NCT02819323|12530024|FG000|STARTED|Overall Study||31
11332594|NCT02819323|12530025|FG001|STARTED|Overall Study||28
11332595|NCT02819323|12530026|FG002|STARTED|Overall Study||32
11332596|NCT02819323|12530024|FG000|COMPLETED|Overall Study||26
11332597|NCT02819323|12530025|FG001|COMPLETED|Overall Study||26
11332598|NCT02819323|12530026|FG002|COMPLETED|Overall Study||31
11332599|NCT02819323|12530024|FG000|NOT COMPLETED|Overall Study||5
11332600|NCT02819323|12530025|FG001|NOT COMPLETED|Overall Study||2
11332601|NCT02819323|12530026|FG002|NOT COMPLETED|Overall Study||1
11332602|NCT02819557|12530034|FG000|STARTED|Overall Study||14
11332603|NCT02819557|12530034|FG000|Safety Population|Overall Study||14
11332604|NCT02819557|12530034|FG000|Pharmacokinetics (PK) Population|Overall Study||14
11332605|NCT02819557|12530034|FG000|Evaluable Population|Overall Study||14
11332606|NCT02819557|12530034|FG000|COMPLETED|Overall Study||14
11332607|NCT02819557|12530034|FG000|NOT COMPLETED|Overall Study||0
11332608|NCT02819726|12530041|FG000|STARTED|Part A (All Participants)||98
11332609|NCT02819726|12530042|FG001|STARTED|Part A (All Participants)||98
11332610|NCT02819726|12530043|FG002|STARTED|Part A (All Participants)||98
11332611|NCT02819726|12530044|FG003|STARTED|Part A (All Participants)||0
11332612|NCT02819726|12530041|FG000|COMPLETED|Part A (All Participants)||92
11332613|NCT02819726|12530042|FG001|COMPLETED|Part A (All Participants)||88
11332614|NCT02819726|12530043|FG002|COMPLETED|Part A (All Participants)||87
11332615|NCT02819726|12530044|FG003|COMPLETED|Part A (All Participants)||0
11332616|NCT02819726|12530041|FG000|NOT COMPLETED|Part A (All Participants)||6
11332617|NCT02819726|12530042|FG001|NOT COMPLETED|Part A (All Participants)||10
11332618|NCT02819726|12530043|FG002|NOT COMPLETED|Part A (All Participants)||11
11332619|NCT02819726|12530044|FG003|NOT COMPLETED|Part A (All Participants)||0
11332620|NCT02819726|12530041|FG000|STARTED|Part B (All Participants)|19 participants who completed Part A were not eligible for Part B|73
11332621|NCT02819726|12530042|FG001|STARTED|Part B (All Participants)|18 participants completing Part A were not eligible for Part B|70
11332622|NCT02819726|12530043|FG002|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|39
11332623|NCT02819726|12530044|FG003|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|38
11332624|NCT02819726|12530041|FG000|COMPLETED|Part B (All Participants)||70
11332625|NCT02819726|12530042|FG001|COMPLETED|Part B (All Participants)||68
11332626|NCT02819726|12530043|FG002|COMPLETED|Part B (All Participants)||35
11332627|NCT02819726|12530044|FG003|COMPLETED|Part B (All Participants)||36
11332628|NCT02819726|12530041|FG000|NOT COMPLETED|Part B (All Participants)||3
11332629|NCT02819726|12530042|FG001|NOT COMPLETED|Part B (All Participants)||2
11027997|NCT00837694|12206818|FG003|STARTED|Overall Study||11
11027998|NCT00837694|12206819|FG004|STARTED|Overall Study||12
11027999|NCT00837694|12206820|FG005|STARTED|Overall Study||11
11028000|NCT00837694|12206815|FG000|COMPLETED|Overall Study||8
11028001|NCT00837694|12206816|FG001|COMPLETED|Overall Study||11
11028002|NCT00837694|12206817|FG002|COMPLETED|Overall Study||8
11028003|NCT00837694|12206818|FG003|COMPLETED|Overall Study||10
11028004|NCT00837694|12206819|FG004|COMPLETED|Overall Study||11
11028005|NCT00837694|12206820|FG005|COMPLETED|Overall Study||10
11028006|NCT00837694|12206815|FG000|NOT COMPLETED|Overall Study||2
11028007|NCT00837694|12206816|FG001|NOT COMPLETED|Overall Study||0
11028008|NCT00837694|12206817|FG002|NOT COMPLETED|Overall Study||2
11028009|NCT00837694|12206818|FG003|NOT COMPLETED|Overall Study||1
11028010|NCT00837694|12206819|FG004|NOT COMPLETED|Overall Study||1
11028011|NCT00837694|12206820|FG005|NOT COMPLETED|Overall Study||1
11332630|NCT02819726|12530043|FG002|NOT COMPLETED|Part B (All Participants)||4
11332631|NCT02819726|12530044|FG003|NOT COMPLETED|Part B (All Participants)||2
11332632|NCT02819973|12530055|FG000|STARTED|Overall Study||114
11332633|NCT02819973|12530056|FG001|STARTED|Overall Study||114
11332634|NCT02819973|12530057|FG002|STARTED|Overall Study||115
11332635|NCT02819973|12530055|FG000|COMPLETED|Overall Study|2 withdrawn by request, 4 determined after randomization to be not eligible|108
11332636|NCT02819973|12530056|FG001|COMPLETED|Overall Study|3 determined after randomization to be not eligible|111
11332637|NCT02819973|12530057|FG002|COMPLETED|Overall Study|2 withdrawn by request, 2 determined after randomization to be not eligible|111
11332638|NCT02819973|12530055|FG000|NOT COMPLETED|Overall Study||6
11332639|NCT02819973|12530056|FG001|NOT COMPLETED|Overall Study||3
11332640|NCT02819973|12530057|FG002|NOT COMPLETED|Overall Study||4
11332641|NCT02820038|12530075|FG000|STARTED|Overall Study||78
11332642|NCT02820038|12530076|FG001|STARTED|Overall Study||77
11332643|NCT02820038|12530077|FG002|STARTED|Overall Study||65
11332644|NCT02820038|12530078|FG003|STARTED|Overall Study||66
11332645|NCT02820038|12530075|FG000|COMPLETED|Overall Study||68
11332646|NCT02820038|12530076|FG001|COMPLETED|Overall Study||52
11332647|NCT02820038|12530077|FG002|COMPLETED|Overall Study||60
11332648|NCT02820038|12530078|FG003|COMPLETED|Overall Study||44
11332649|NCT02820038|12530075|FG000|NOT COMPLETED|Overall Study||10
11332650|NCT02820038|12530076|FG001|NOT COMPLETED|Overall Study||25
11332651|NCT02820038|12530077|FG002|NOT COMPLETED|Overall Study||5
11332652|NCT02820038|12530078|FG003|NOT COMPLETED|Overall Study||22
11332653|NCT02820181|12530091|FG000|STARTED|Overall Study||30
11332654|NCT02820181|12530092|FG001|STARTED|Overall Study||30
11332655|NCT02820181|12530091|FG000|COMPLETED|Overall Study||30
11332656|NCT02820181|12530092|FG001|COMPLETED|Overall Study||30
11332657|NCT02820181|12530091|FG000|NOT COMPLETED|Overall Study||0
11332658|NCT02820181|12530092|FG001|NOT COMPLETED|Overall Study||0
11332659|NCT02820298|12530100|FG000|STARTED|Overall Study||13
11332660|NCT02820298|12530101|FG001|STARTED|Overall Study||12
11332661|NCT02820298|12530100|FG000|COMPLETED|Overall Study||12
11332662|NCT02820298|12530101|FG001|COMPLETED|Overall Study||10
11332663|NCT02820298|12530100|FG000|NOT COMPLETED|Overall Study||1
11332664|NCT02820298|12530101|FG001|NOT COMPLETED|Overall Study||2
11332665|NCT02820324|12530118|FG000|STARTED|Overall Study||78
11332666|NCT02820324|12530119|FG001|STARTED|Overall Study||82
11332667|NCT02820324|12530120|FG002|STARTED|Overall Study||82
11332668|NCT02820324|12530121|FG003|STARTED|Overall Study||82
11332669|NCT02820324|12530122|FG004|STARTED|Overall Study||83
11332670|NCT02820324|12530118|FG000|Treated With Study Medication|Overall Study||77
11332671|NCT02820324|12530119|FG001|Treated With Study Medication|Overall Study||80
11332672|NCT02820324|12530120|FG002|Treated With Study Medication|Overall Study||80
11028012|NCT00837759|12206834|FG000|STARTED|Overall Study||7
11028013|NCT00837759|12206834|FG000|COMPLETED|Overall Study||3
11332673|NCT02820324|12530121|FG003|Treated With Study Medication|Overall Study||81
11332674|NCT02820324|12530122|FG004|Treated With Study Medication|Overall Study||83
11332675|NCT02820324|12530118|FG000|COMPLETED|Overall Study||76
11332676|NCT02820324|12530119|FG001|COMPLETED|Overall Study||79
11332677|NCT02820324|12530120|FG002|COMPLETED|Overall Study||79
11332678|NCT02820324|12530121|FG003|COMPLETED|Overall Study||79
11332679|NCT02820324|12530122|FG004|COMPLETED|Overall Study||80
11332680|NCT02820324|12530118|FG000|NOT COMPLETED|Overall Study||2
11332681|NCT02820324|12530119|FG001|NOT COMPLETED|Overall Study||3
11332682|NCT02820324|12530120|FG002|NOT COMPLETED|Overall Study||3
11332683|NCT02820324|12530121|FG003|NOT COMPLETED|Overall Study||3
11332684|NCT02820324|12530122|FG004|NOT COMPLETED|Overall Study||3
11332685|NCT02820597|12530134|FG000|STARTED|Overall Study||27
11332686|NCT02820597|12530134|FG000|1-day Post Treatment|Overall Study||27
11332687|NCT02820597|12530134|FG000|7-day Post Treatment|Overall Study||27
11332688|NCT02820597|12530134|FG000|30-day Post Treatment|Overall Study||27
11332689|NCT02820597|12530134|FG000|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24
11332690|NCT02820597|12530134|FG000|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21
11332691|NCT02820597|12530134|FG000|COMPLETED|Overall Study|12 participants were lost to follow-up.|15
11028014|NCT00837759|12206834|FG000|NOT COMPLETED|Overall Study||4
11332692|NCT02820597|12530134|FG000|NOT COMPLETED|Overall Study||12
11028015|NCT00837811|12206841|FG000|STARTED|Overall Study||60
11028016|NCT00837811|12206842|FG001|STARTED|Overall Study||121
11028017|NCT00837811|12206843|FG002|STARTED|Overall Study||1
11028018|NCT00837811|12206841|FG000|Received Any Amount of Study Drug|Overall Study||60
11028019|NCT00837811|12206842|FG001|Received Any Amount of Study Drug|Overall Study||121
11028020|NCT00837811|12206843|FG002|Received Any Amount of Study Drug|Overall Study||1
11028021|NCT00837811|12206841|FG000|Had at Least 1 Efficacy Assessment|Overall Study||59
11028022|NCT00837811|12206842|FG001|Had at Least 1 Efficacy Assessment|Overall Study||121
11028023|NCT00837811|12206843|FG002|Had at Least 1 Efficacy Assessment|Overall Study||1
11028024|NCT00837811|12206841|FG000|Included in Efficacy Analyses|Overall Study||59
11028025|NCT00837811|12206842|FG001|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
11028026|NCT00837811|12206843|FG002|Included in Efficacy Analyses|Overall Study||1
11028027|NCT00837811|12206841|FG000|COMPLETED|Overall Study||53
11028028|NCT00837811|12206842|FG001|COMPLETED|Overall Study||87
11028029|NCT00837811|12206843|FG002|COMPLETED|Overall Study||0
11028030|NCT00837811|12206841|FG000|NOT COMPLETED|Overall Study||7
11028031|NCT00837811|12206842|FG001|NOT COMPLETED|Overall Study||34
11028032|NCT00837811|12206843|FG002|NOT COMPLETED|Overall Study||1
11028033|NCT00837824|12206862|FG000|STARTED|Overall Study||11
11028034|NCT00837824|12206863|FG001|STARTED|Overall Study||9
11028035|NCT00837824|12206862|FG000|COMPLETED|Overall Study||11
11028036|NCT00837824|12206863|FG001|COMPLETED|Overall Study||9
11028037|NCT00837824|12206862|FG000|NOT COMPLETED|Overall Study||0
11028038|NCT00837824|12206863|FG001|NOT COMPLETED|Overall Study||0
11028039|NCT00837876|12206870|FG000|STARTED|Overall Study||37
11028040|NCT00837876|12206870|FG000|COMPLETED|Overall Study||0
11028041|NCT00837876|12206870|FG000|NOT COMPLETED|Overall Study||37
11028042|NCT00837902|12206876|FG000|STARTED|Overall Study||85
11028043|NCT00837902|12206877|FG001|STARTED|Overall Study||69
11028044|NCT00837902|12206876|FG000|COMPLETED|Overall Study||85
11028045|NCT00837902|12206877|FG001|COMPLETED|Overall Study||69
11028046|NCT00837902|12206876|FG000|NOT COMPLETED|Overall Study||0
11028047|NCT00837902|12206877|FG001|NOT COMPLETED|Overall Study||0
11028048|NCT00837967|12206884|FG000|STARTED|First Intervention||13
11028049|NCT00837967|12206885|FG001|STARTED|First Intervention||12
11028050|NCT00837967|12206884|FG000|COMPLETED|First Intervention||13
11028051|NCT00837967|12206885|FG001|COMPLETED|First Intervention||12
11028052|NCT00837967|12206884|FG000|NOT COMPLETED|First Intervention||0
11028053|NCT00837967|12206885|FG001|NOT COMPLETED|First Intervention||0
11028054|NCT00837967|12206884|FG000|STARTED|Washout Period of 7 - 14 Days||13
11028055|NCT00837967|12206885|FG001|STARTED|Washout Period of 7 - 14 Days||12
11028056|NCT00837967|12206884|FG000|COMPLETED|Washout Period of 7 - 14 Days||11
11028057|NCT00837967|12206885|FG001|COMPLETED|Washout Period of 7 - 14 Days||12
11028058|NCT00837967|12206884|FG000|NOT COMPLETED|Washout Period of 7 - 14 Days||2
11028059|NCT00837967|12206885|FG001|NOT COMPLETED|Washout Period of 7 - 14 Days||0
11028060|NCT00837967|12206884|FG000|STARTED|Second Intervention||11
11028061|NCT00837967|12206885|FG001|STARTED|Second Intervention||12
11028062|NCT00837967|12206884|FG000|COMPLETED|Second Intervention||11
11028063|NCT00837967|12206885|FG001|COMPLETED|Second Intervention||12
11028064|NCT00837967|12206884|FG000|NOT COMPLETED|Second Intervention||0
11028065|NCT00837967|12206885|FG001|NOT COMPLETED|Second Intervention||0
11028066|NCT00838006|12206894|FG000|STARTED|Overall Study||102
11028067|NCT00838006|12206895|FG001|STARTED|Overall Study||98
11028068|NCT00838006|12206896|FG002|STARTED|Overall Study||142
11028069|NCT00838006|12206894|FG000|3-month Post-deployment Follow-up|Overall Study||92
11028070|NCT00838006|12206895|FG001|3-month Post-deployment Follow-up|Overall Study||80
11028071|NCT00838006|12206896|FG002|3-month Post-deployment Follow-up|Overall Study||135
11028072|NCT00838006|12206894|FG000|COMPLETED|Overall Study||68
11028073|NCT00838006|12206895|FG001|COMPLETED|Overall Study||72
11028074|NCT00838006|12206896|FG002|COMPLETED|Overall Study||94
11028075|NCT00838006|12206894|FG000|NOT COMPLETED|Overall Study||34
11028076|NCT00838006|12206895|FG001|NOT COMPLETED|Overall Study||26
11028077|NCT00838006|12206896|FG002|NOT COMPLETED|Overall Study||48
11028078|NCT00838097|12206906|FG000|STARTED|Overall Study||321
11028079|NCT00838097|12206906|FG000|Received Darbepoetin Alfa|Overall Study||319
11028080|NCT00838097|12206906|FG000|COMPLETED|Overall Study||145
11028081|NCT00838097|12206906|FG000|NOT COMPLETED|Overall Study||176
11028082|NCT00838110|12206912|FG000|STARTED|Overall Study||127
11028083|NCT00838110|12206913|FG001|STARTED|Overall Study||128
11028084|NCT00838110|12206914|FG002|STARTED|Overall Study||243
11028085|NCT00838110|12206915|FG003|STARTED|Overall Study||244
11028086|NCT00838110|12206912|FG000|Treated|Overall Study||127
11028087|NCT00838110|12206913|FG001|Treated|Overall Study||127
11028088|NCT00838110|12206914|FG002|Treated|Overall Study||243
11028089|NCT00838110|12206915|FG003|Treated|Overall Study||244
11028090|NCT00838110|12206912|FG000|COMPLETED|Overall Study||105
11028091|NCT00838110|12206913|FG001|COMPLETED|Overall Study||106
11028092|NCT00838110|12206914|FG002|COMPLETED|Overall Study||226
11028093|NCT00838110|12206915|FG003|COMPLETED|Overall Study||226
11028094|NCT00838110|12206912|FG000|NOT COMPLETED|Overall Study||22
11028095|NCT00838110|12206913|FG001|NOT COMPLETED|Overall Study||22
11028096|NCT00838110|12206914|FG002|NOT COMPLETED|Overall Study||17
11028097|NCT00838110|12206915|FG003|NOT COMPLETED|Overall Study||18
11028098|NCT00838162|12206929|FG000|STARTED|Overall Study||9
11028099|NCT00838162|12206930|FG001|STARTED|Overall Study||8
11028100|NCT00838162|12206931|FG002|STARTED|Overall Study||8
11028101|NCT00838162|12206932|FG003|STARTED|Overall Study||8
11028102|NCT00838162|12206929|FG000|COMPLETED|Overall Study||9
11028103|NCT00838162|12206930|FG001|COMPLETED|Overall Study||8
11028104|NCT00838162|12206931|FG002|COMPLETED|Overall Study||8
11028105|NCT00838162|12206932|FG003|COMPLETED|Overall Study||8
11028106|NCT00838162|12206929|FG000|NOT COMPLETED|Overall Study||0
11028107|NCT00838162|12206930|FG001|NOT COMPLETED|Overall Study||0
11028108|NCT00838162|12206931|FG002|NOT COMPLETED|Overall Study||0
11028109|NCT00838162|12206932|FG003|NOT COMPLETED|Overall Study||0
11028110|NCT00838201|12206944|FG000|STARTED|Overall Study||186
11028111|NCT00838201|12206945|FG001|STARTED|Overall Study||198
11028112|NCT00838201|12206944|FG000|COMPLETED|Overall Study||144
11028113|NCT00838201|12206945|FG001|COMPLETED|Overall Study||145
11028114|NCT00838201|12206944|FG000|NOT COMPLETED|Overall Study||42
11028115|NCT00838201|12206945|FG001|NOT COMPLETED|Overall Study||53
11028116|NCT00838331|12206951|FG000|STARTED|Fresh Blood Transfusion||17
11028117|NCT00838331|12206951|FG000|COMPLETED|Fresh Blood Transfusion||17
11028118|NCT00838331|12206951|FG000|NOT COMPLETED|Fresh Blood Transfusion||0
11028119|NCT00838331|12206951|FG000|STARTED|Aged Blood Transfusion||17
11028120|NCT00838331|12206951|FG000|COMPLETED|Aged Blood Transfusion||8
11028121|NCT00838331|12206951|FG000|NOT COMPLETED|Aged Blood Transfusion||9
11028122|NCT00838435|12206955|FG000|STARTED|Part 1 (4 Weeks)||95
11028123|NCT00838435|12206955|FG000|COMPLETED|Part 1 (4 Weeks)||95
11028124|NCT00838435|12206955|FG000|NOT COMPLETED|Part 1 (4 Weeks)||0
11028125|NCT00838435|12206955|FG000|STARTED|PK Sub-Study 2 (4 Weeks)|1 subject declined participation in the PK Sub-Study.|94
11028126|NCT00838435|12206955|FG000|COMPLETED|PK Sub-Study 2 (4 Weeks)||93
11028127|NCT00838435|12206955|FG000|NOT COMPLETED|PK Sub-Study 2 (4 Weeks)||1
11028128|NCT00838435|12206955|FG000|STARTED|Safety/Efficacy Sub-Study 1 (6 Months)|65 of 95 subjects in Part 1 were determined responders & eligible for the Safety/Efficacy Sub-study.|65
11028129|NCT00838435|12206955|FG000|COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||63
11028130|NCT00838435|12206955|FG000|NOT COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||2
11028131|NCT00838435|12206955|FG000|STARTED|Part 2 (7 Years)|65 of 95 subjects in Part 1 were determined responders & eligible for the Part 2 of the study.|65
11028132|NCT00838435|12206955|FG000|COMPLETED|Part 2 (7 Years)||49
11028133|NCT00838435|12206955|FG000|NOT COMPLETED|Part 2 (7 Years)||16
11028134|NCT00838513|12206962|FG000|STARTED|Screening Period||23
11028135|NCT00838513|12206962|FG000|COMPLETED|Screening Period||20
11028136|NCT00838513|12206962|FG000|NOT COMPLETED|Screening Period||3
11028137|NCT00838513|12206962|FG000|STARTED|Observation Period (8 Weeks)||20
11028138|NCT00838513|12206962|FG000|COMPLETED|Observation Period (8 Weeks)||20
11028139|NCT00838513|12206962|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0
11028140|NCT00838513|12206962|FG000|STARTED|Treatment Period (26 Weeks)||20
11028141|NCT00838513|12206962|FG000|COMPLETED|Treatment Period (26 Weeks)||20
11028142|NCT00838513|12206962|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0
11028143|NCT00838513|12206962|FG000|STARTED|Extension Treatment Period||19
11028144|NCT00838513|12206962|FG000|COMPLETED|Extension Treatment Period||18
11332693|NCT02820844|12530140|FG000|STARTED|Double-blinded (Up to 48 Weeks)||124
11332694|NCT02820844|12530141|FG001|STARTED|Double-blinded (Up to 48 Weeks)||124
11332695|NCT02820844|12530142|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0
11332696|NCT02820844|12530143|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0
11332697|NCT02820844|12530144|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0
11332698|NCT02820844|12530145|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0
11332699|NCT02820844|12530140|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||119
11332700|NCT02820844|12530141|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||115
11332701|NCT02820844|12530142|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0
11332702|NCT02820844|12530143|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0
11332703|NCT02820844|12530144|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0
11332704|NCT02820844|12530145|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0
11332705|NCT02820844|12530140|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5
11332706|NCT02820844|12530141|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9
11332707|NCT02820844|12530142|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
11332708|NCT02820844|12530143|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
11332709|NCT02820844|12530144|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
11332710|NCT02820844|12530145|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
11332711|NCT02820844|12530140|FG000|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
11332712|NCT02820844|12530141|FG001|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
11332713|NCT02820844|12530142|FG002|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108
11332714|NCT02820844|12530143|FG003|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88
11332715|NCT02820844|12530144|FG004|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
11332716|NCT02820844|12530145|FG005|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
11332717|NCT02820844|12530140|FG000|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
11332718|NCT02820844|12530141|FG001|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
11332719|NCT02820844|12530142|FG002|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99
11332720|NCT02820844|12530143|FG003|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84
11332721|NCT02820844|12530144|FG004|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
11332722|NCT02820844|12530145|FG005|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
11332723|NCT02820844|12530140|FG000|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
11332724|NCT02820844|12530141|FG001|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
11332725|NCT02820844|12530142|FG002|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9
11332726|NCT02820844|12530143|FG003|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4
11028145|NCT00838513|12206962|FG000|NOT COMPLETED|Extension Treatment Period||1
11028146|NCT00838513|12206962|FG000|STARTED|Post Treatment Period (Patients Who Disc||5
11028147|NCT00838513|12206962|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4
11028148|NCT00838513|12206962|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
11028149|NCT00838539|12206978|FG000|STARTED|Overall Study||3
11028150|NCT00838539|12206979|FG001|STARTED|Overall Study||6
11028151|NCT00838539|12206980|FG002|STARTED|Overall Study||5
11028152|NCT00838539|12206981|FG003|STARTED|Overall Study||4
11028153|NCT00838539|12206982|FG004|STARTED|Overall Study||6
11028154|NCT00838539|12206983|FG005|STARTED|Overall Study||4
11028155|NCT00838539|12206984|FG006|STARTED|Overall Study||7
11028156|NCT00838539|12206985|FG007|STARTED|Overall Study||6
11028157|NCT00838539|12206986|FG008|STARTED|Overall Study||5
11028158|NCT00838539|12206987|FG009|STARTED|Overall Study||8
11028159|NCT00838539|12206988|FG010|STARTED|Overall Study||5
11028160|NCT00838539|12206989|FG011|STARTED|Overall Study||4
11028161|NCT00838539|12206978|FG000|Received Treatment|Overall Study||3
11028162|NCT00838539|12206979|FG001|Received Treatment|Overall Study||5
11028163|NCT00838539|12206980|FG002|Received Treatment|Overall Study||5
11028164|NCT00838539|12206981|FG003|Received Treatment|Overall Study||4
11028165|NCT00838539|12206982|FG004|Received Treatment|Overall Study||4
11028166|NCT00838539|12206983|FG005|Received Treatment|Overall Study||4
11028167|NCT00838539|12206984|FG006|Received Treatment|Overall Study||7
11028168|NCT00838539|12206985|FG007|Received Treatment|Overall Study||6
11028169|NCT00838539|12206986|FG008|Received Treatment|Overall Study||5
11028170|NCT00838539|12206987|FG009|Received Treatment|Overall Study||8
11028171|NCT00838539|12206988|FG010|Received Treatment|Overall Study||5
11028172|NCT00838539|12206989|FG011|Received Treatment|Overall Study||4
11028173|NCT00838539|12206978|FG000|COMPLETED|Overall Study||0
11028174|NCT00838539|12206979|FG001|COMPLETED|Overall Study||0
11028175|NCT00838539|12206980|FG002|COMPLETED|Overall Study||0
11028176|NCT00838539|12206981|FG003|COMPLETED|Overall Study||0
11028177|NCT00838539|12206982|FG004|COMPLETED|Overall Study||0
11028178|NCT00838539|12206983|FG005|COMPLETED|Overall Study||0
11028179|NCT00838539|12206984|FG006|COMPLETED|Overall Study||2
11028180|NCT00838539|12206985|FG007|COMPLETED|Overall Study||0
11028181|NCT00838539|12206986|FG008|COMPLETED|Overall Study||0
11028182|NCT00838539|12206987|FG009|COMPLETED|Overall Study||0
11028183|NCT00838539|12206988|FG010|COMPLETED|Overall Study||0
11028184|NCT00838539|12206989|FG011|COMPLETED|Overall Study||0
11028185|NCT00838539|12206978|FG000|NOT COMPLETED|Overall Study||3
11028186|NCT00838539|12206979|FG001|NOT COMPLETED|Overall Study||6
11028187|NCT00838539|12206980|FG002|NOT COMPLETED|Overall Study||5
11028188|NCT00838539|12206981|FG003|NOT COMPLETED|Overall Study||4
11028189|NCT00838539|12206982|FG004|NOT COMPLETED|Overall Study||6
11028190|NCT00838539|12206983|FG005|NOT COMPLETED|Overall Study||4
11028191|NCT00838539|12206984|FG006|NOT COMPLETED|Overall Study||5
11028192|NCT00838539|12206985|FG007|NOT COMPLETED|Overall Study||6
11028193|NCT00838539|12206986|FG008|NOT COMPLETED|Overall Study||5
11028194|NCT00838539|12206987|FG009|NOT COMPLETED|Overall Study||8
11028195|NCT00838539|12206988|FG010|NOT COMPLETED|Overall Study||5
11028196|NCT00838539|12206989|FG011|NOT COMPLETED|Overall Study||4
11028197|NCT00838565|12207035|FG000|STARTED|Overall Study||9
11028198|NCT00838565|12207036|FG001|STARTED|Overall Study||7
11028199|NCT00838565|12207037|FG002|STARTED|Overall Study||6
11028200|NCT00838565|12207038|FG003|STARTED|Overall Study||6
11028201|NCT00838565|12207039|FG004|STARTED|Overall Study||6
11332727|NCT02820844|12530144|FG004|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
11332728|NCT02820844|12530145|FG005|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
11332729|NCT02820844|12530140|FG000|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
11332730|NCT02820844|12530141|FG001|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
11332731|NCT02820844|12530142|FG002|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
11332732|NCT02820844|12530143|FG003|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
11028202|NCT00838565|12207040|FG005|STARTED|Overall Study||7
11028203|NCT00838565|12207035|FG000|Treated|Overall Study||9
11028204|NCT00838565|12207036|FG001|Treated|Overall Study||6
11028205|NCT00838565|12207037|FG002|Treated|Overall Study||6
11028206|NCT00838565|12207038|FG003|Treated|Overall Study||6
11028207|NCT00838565|12207039|FG004|Treated|Overall Study||6
11028208|NCT00838565|12207040|FG005|Treated|Overall Study||7
11028209|NCT00838565|12207035|FG000|COMPLETED|Overall Study||9
11332733|NCT02820844|12530144|FG004|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56
11332734|NCT02820844|12530145|FG005|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43
11332735|NCT02820844|12530140|FG000|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
11332736|NCT02820844|12530141|FG001|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
11028210|NCT00838565|12207036|FG001|COMPLETED|Overall Study||4
11028211|NCT00838565|12207037|FG002|COMPLETED|Overall Study||5
11028212|NCT00838565|12207038|FG003|COMPLETED|Overall Study||6
11028213|NCT00838565|12207039|FG004|COMPLETED|Overall Study||6
11028214|NCT00838565|12207040|FG005|COMPLETED|Overall Study||5
11028215|NCT00838565|12207035|FG000|NOT COMPLETED|Overall Study||0
11028216|NCT00838565|12207036|FG001|NOT COMPLETED|Overall Study||3
11028217|NCT00838565|12207037|FG002|NOT COMPLETED|Overall Study||1
11028218|NCT00838565|12207038|FG003|NOT COMPLETED|Overall Study||0
11028219|NCT00838565|12207039|FG004|NOT COMPLETED|Overall Study||0
11028220|NCT00838565|12207040|FG005|NOT COMPLETED|Overall Study||2
11028221|NCT00838578|12207059|FG000|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
11028222|NCT00838578|12207059|FG000|COMPLETED|Overall Study||63
11028223|NCT00838578|12207059|FG000|NOT COMPLETED|Overall Study||2
11028224|NCT00838682|12207069|FG000|STARTED|Overall Study||54
11028225|NCT00838682|12207070|FG001|STARTED|Overall Study||52
11028226|NCT00838682|12207069|FG000|COMPLETED|Overall Study||29
11028227|NCT00838682|12207070|FG001|COMPLETED|Overall Study||33
11028228|NCT00838682|12207069|FG000|NOT COMPLETED|Overall Study||25
11028229|NCT00838682|12207070|FG001|NOT COMPLETED|Overall Study||19
11028230|NCT00838695|12207078|FG000|STARTED|Overall Study||42
11028231|NCT00838695|12207079|FG001|STARTED|Overall Study||64
11028232|NCT00838695|12207078|FG000|COMPLETED|Overall Study||42
11028233|NCT00838695|12207079|FG001|COMPLETED|Overall Study||64
11028234|NCT00838695|12207078|FG000|NOT COMPLETED|Overall Study||0
11028235|NCT00838695|12207079|FG001|NOT COMPLETED|Overall Study||0
11028236|NCT00838903|12207089|FG000|STARTED|Treatment Period (156 Weeks)||101
11028237|NCT00838903|12207090|FG001|STARTED|Treatment Period (156 Weeks)||302
11028238|NCT00838903|12207091|FG002|STARTED|Treatment Period (156 Weeks)||307
11028239|NCT00838903|12207092|FG003|STARTED|Treatment Period (156 Weeks)||302
11028240|NCT00838903|12207089|FG000|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
11028241|NCT00838903|12207090|FG001|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
11028242|NCT00838903|12207091|FG002|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
11028243|NCT00838903|12207092|FG003|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
11028244|NCT00838903|12207089|FG000|COMPLETED|Treatment Period (156 Weeks)||55
11028245|NCT00838903|12207090|FG001|COMPLETED|Treatment Period (156 Weeks)||190
11028246|NCT00838903|12207091|FG002|COMPLETED|Treatment Period (156 Weeks)||191
11028247|NCT00838903|12207092|FG003|COMPLETED|Treatment Period (156 Weeks)||192
11028248|NCT00838903|12207089|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||46
11028249|NCT00838903|12207090|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||112
11028250|NCT00838903|12207091|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||116
11028251|NCT00838903|12207092|FG003|NOT COMPLETED|Treatment Period (156 Weeks)||110
11028252|NCT00838903|12207089|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
11028253|NCT00838903|12207090|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
11028254|NCT00838903|12207091|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
11057352|NCT00997204|12238838|FG001|COMPLETED|Naive Treatment Phase||0
11332737|NCT02820844|12530142|FG002|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
11332738|NCT02820844|12530143|FG003|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
11332739|NCT02820844|12530144|FG004|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54
11332740|NCT02820844|12530145|FG005|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42
11332741|NCT02820844|12530140|FG000|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
11332742|NCT02820844|12530141|FG001|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
11332743|NCT02820844|12530142|FG002|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
11332744|NCT02820844|12530143|FG003|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
11332745|NCT02820844|12530144|FG004|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2
11332746|NCT02820844|12530145|FG005|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1
11332747|NCT02820870|12530164|FG000|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
11332748|NCT02820870|12530165|FG001|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
11332749|NCT02820870|12530164|FG000|COMPLETED|Before Intervention||15
11332750|NCT02820870|12530165|FG001|COMPLETED|Before Intervention||28
11332751|NCT02820870|12530164|FG000|NOT COMPLETED|Before Intervention||0
11332752|NCT02820870|12530165|FG001|NOT COMPLETED|Before Intervention||0
11332753|NCT02820870|12530164|FG000|STARTED|Intervention||15
11332754|NCT02820870|12530165|FG001|STARTED|Intervention||28
11332755|NCT02820870|12530164|FG000|COMPLETED|Intervention||15
11332756|NCT02820870|12530165|FG001|COMPLETED|Intervention||28
11332757|NCT02820870|12530164|FG000|NOT COMPLETED|Intervention||0
11332758|NCT02820870|12530165|FG001|NOT COMPLETED|Intervention||0
11332759|NCT02820870|12530164|FG000|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
11028255|NCT00838903|12207092|FG003|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
11028256|NCT00838903|12207089|FG000|COMPLETED|Follow-up Period (8 Weeks)||75
11028257|NCT00838903|12207090|FG001|COMPLETED|Follow-up Period (8 Weeks)||237
11028258|NCT00838903|12207091|FG002|COMPLETED|Follow-up Period (8 Weeks)||243
11028259|NCT00838903|12207092|FG003|COMPLETED|Follow-up Period (8 Weeks)||244
11028260|NCT00838903|12207089|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||26
11028261|NCT00838903|12207090|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||65
11028262|NCT00838903|12207091|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||64
11028263|NCT00838903|12207092|FG003|NOT COMPLETED|Follow-up Period (8 Weeks)||58
11028264|NCT00838916|12207104|FG000|STARTED|Treatment Period (156 Weeks)||504
11028265|NCT00838916|12207105|FG001|STARTED|Treatment Period (156 Weeks)||241
11028266|NCT00838916|12207104|FG000|COMPLETED|Treatment Period (156 Weeks)||308
11028267|NCT00838916|12207105|FG001|COMPLETED|Treatment Period (156 Weeks)||164
11028268|NCT00838916|12207104|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||196
11028269|NCT00838916|12207105|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||77
11028270|NCT00838916|12207104|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
11057353|NCT00997204|12238837|FG000|NOT COMPLETED|Naive Treatment Phase||6
11343825|NCT02956460|12541114|FG001|COMPLETED|Lens 1||34
11028271|NCT00838916|12207105|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
11028272|NCT00838916|12207104|FG000|COMPLETED|Follow-up Period (8 Weeks)||408
11028273|NCT00838916|12207105|FG001|COMPLETED|Follow-up Period (8 Weeks)||190
11028274|NCT00838916|12207104|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||96
11028275|NCT00838916|12207105|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||51
11028276|NCT00838929|12207114|FG000|STARTED|Overall Study||3
11028277|NCT00838929|12207115|FG001|STARTED|Overall Study||8
11028278|NCT00838929|12207116|FG002|STARTED|Overall Study||6
11028279|NCT00838929|12207114|FG000|COMPLETED|Overall Study||3
11028280|NCT00838929|12207115|FG001|COMPLETED|Overall Study||5
11028281|NCT00838929|12207116|FG002|COMPLETED|Overall Study||5
11028282|NCT00838929|12207114|FG000|NOT COMPLETED|Overall Study||0
11028283|NCT00838929|12207115|FG001|NOT COMPLETED|Overall Study||3
11028284|NCT00838929|12207116|FG002|NOT COMPLETED|Overall Study||1
11028285|NCT00839072|12207122|FG000|STARTED|First Intervention Period||12
11028286|NCT00839072|12207123|FG001|STARTED|First Intervention Period||12
11028287|NCT00839072|12207122|FG000|COMPLETED|First Intervention Period||10
11028288|NCT00839072|12207123|FG001|COMPLETED|First Intervention Period||11
11028289|NCT00839072|12207122|FG000|NOT COMPLETED|First Intervention Period||2
11028290|NCT00839072|12207123|FG001|NOT COMPLETED|First Intervention Period||1
11028291|NCT00839072|12207122|FG000|STARTED|Washout Period of 7 Days||10
11028292|NCT00839072|12207123|FG001|STARTED|Washout Period of 7 Days||11
11028293|NCT00839072|12207122|FG000|COMPLETED|Washout Period of 7 Days||10
11028294|NCT00839072|12207123|FG001|COMPLETED|Washout Period of 7 Days||11
11200661|NCT01827930|12390842|FG000|NOT COMPLETED|Overall Study||0
11200662|NCT01827930|12390843|FG001|NOT COMPLETED|Overall Study||0
11200663|NCT01827930|12390844|FG002|NOT COMPLETED|Overall Study||0
11200664|NCT01827943|12390852|FG000|STARTED|Overall Study||54
11200665|NCT01827943|12390852|FG000|Safety Population|Overall Study||53
11200666|NCT01827943|12390852|FG000|COMPLETED|Overall Study||45
11200667|NCT01827943|12390852|FG000|NOT COMPLETED|Overall Study||9
11200668|NCT01828034|12390860|FG000|STARTED|Overall Study||3
11200669|NCT01828034|12390861|FG001|STARTED|Overall Study||6
11200670|NCT01828034|12390862|FG002|STARTED|Overall Study||3
11200671|NCT01828034|12390863|FG003|STARTED|Overall Study||30
11200672|NCT01828034|12390860|FG000|COMPLETED|Overall Study||3
11200673|NCT01828034|12390861|FG001|COMPLETED|Overall Study||6
11200674|NCT01828034|12390862|FG002|COMPLETED|Overall Study||3
11200675|NCT01828034|12390863|FG003|COMPLETED|Overall Study||29
11200676|NCT01828034|12390860|FG000|NOT COMPLETED|Overall Study||0
11200677|NCT01828034|12390861|FG001|NOT COMPLETED|Overall Study||0
11200678|NCT01828034|12390862|FG002|NOT COMPLETED|Overall Study||0
11200679|NCT01828034|12390863|FG003|NOT COMPLETED|Overall Study||1
11200680|NCT01828073|12390872|FG000|STARTED|Overall Study||22
11200681|NCT01828073|12390873|FG001|STARTED|Overall Study||18
11200682|NCT01828073|12390872|FG000|COMPLETED|Overall Study||21
11200683|NCT01828073|12390873|FG001|COMPLETED|Overall Study||16
11200684|NCT01828073|12390872|FG000|NOT COMPLETED|Overall Study||1
11200685|NCT01828073|12390873|FG001|NOT COMPLETED|Overall Study||2
11200686|NCT01828164|12390885|FG000|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
11200687|NCT01828164|12390885|FG000|COMPLETED|Overall Study||32
11200688|NCT01828164|12390885|FG000|NOT COMPLETED|Overall Study||17
11200689|NCT01828216|12390895|FG000|STARTED|Overall Study||159
11332760|NCT02820870|12530165|FG001|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
11332761|NCT02820870|12530164|FG000|COMPLETED|Post Intervention||15
11332762|NCT02820870|12530165|FG001|COMPLETED|Post Intervention||28
11332763|NCT02820870|12530164|FG000|NOT COMPLETED|Post Intervention||0
11332764|NCT02820870|12530165|FG001|NOT COMPLETED|Post Intervention||0
11028295|NCT00839072|12207122|FG000|NOT COMPLETED|Washout Period of 7 Days||0
11332765|NCT02821104|12530173|FG000|STARTED|Overall Study||77
11332766|NCT02821104|12530173|FG000|COMPLETED|Overall Study||77
11332767|NCT02821104|12530173|FG000|NOT COMPLETED|Overall Study||0
11028296|NCT00839072|12207123|FG001|NOT COMPLETED|Washout Period of 7 Days||0
11332768|NCT02821338|12530180|FG000|STARTED|Overall Study||15
11332769|NCT02821338|12530181|FG001|STARTED|Overall Study||15
11028297|NCT00839072|12207122|FG000|STARTED|Second Intervention Period||10
11332770|NCT02821338|12530180|FG000|COMPLETED|Overall Study|12 out of 15 subjects assigned to Sequence 1 completed the study, and provided two data points.|12
11332771|NCT02821338|12530181|FG001|COMPLETED|Overall Study|13 out of 15 subjects assigned to Sequence 2 completed the study, and provided two data points.|13
11332772|NCT02821338|12530180|FG000|NOT COMPLETED|Overall Study||3
11332773|NCT02821338|12530181|FG001|NOT COMPLETED|Overall Study||2
11332774|NCT02821403|12530189|FG000|STARTED|"First Intervention (1 Month)"||40
11332775|NCT02821403|12530190|FG001|STARTED|"First Intervention (1 Month)"||40
11028298|NCT00839072|12207123|FG001|STARTED|Second Intervention Period||11
11028299|NCT00839072|12207122|FG000|COMPLETED|Second Intervention Period||9
11028300|NCT00839072|12207123|FG001|COMPLETED|Second Intervention Period||11
11028301|NCT00839072|12207122|FG000|NOT COMPLETED|Second Intervention Period||1
11028302|NCT00839072|12207123|FG001|NOT COMPLETED|Second Intervention Period||0
11332776|NCT02821403|12530189|FG000|Used Clear Lens|"First Intervention (1 Month)"||13
11332777|NCT02821403|12530190|FG001|Used Clear Lens|"First Intervention (1 Month)"||13
11332778|NCT02821403|12530189|FG000|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
11332779|NCT02821403|12530190|FG001|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
11332780|NCT02821403|12530189|FG000|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
11332781|NCT02821403|12530190|FG001|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
11332782|NCT02821403|12530189|FG000|COMPLETED|"First Intervention (1 Month)"||40
11028303|NCT00839098|12207132|FG000|STARTED|Overall Study||3
11028304|NCT00839098|12207133|FG001|STARTED|Overall Study||12
11028305|NCT00839098|12207134|FG002|STARTED|Overall Study||13
11028306|NCT00839098|12207132|FG000|COMPLETED|Overall Study||1
11028307|NCT00839098|12207133|FG001|COMPLETED|Overall Study||11
11028308|NCT00839098|12207134|FG002|COMPLETED|Overall Study||6
11028309|NCT00839098|12207132|FG000|NOT COMPLETED|Overall Study||2
11028310|NCT00839098|12207133|FG001|NOT COMPLETED|Overall Study||1
11028311|NCT00839098|12207134|FG002|NOT COMPLETED|Overall Study||7
11028312|NCT00839241|12207144|FG000|STARTED|Overall Study||20
11028313|NCT00839241|12207145|FG001|STARTED|Overall Study||25
11028314|NCT00839241|12207144|FG000|COMPLETED|Overall Study||15
11028315|NCT00839241|12207145|FG001|COMPLETED|Overall Study||8
11028316|NCT00839241|12207144|FG000|NOT COMPLETED|Overall Study||5
11028317|NCT00839241|12207145|FG001|NOT COMPLETED|Overall Study||17
11028318|NCT00839254|12207159|FG000|STARTED|Overall Study||1849
11028319|NCT00839254|12207160|FG001|STARTED|Overall Study||1316
11028320|NCT00839254|12207161|FG002|STARTED|Overall Study||1069
11028321|NCT00839254|12207162|FG003|STARTED|Overall Study||859
11028322|NCT00839254|12207163|FG004|STARTED|Overall Study||241
11028323|NCT00839254|12207164|FG005|STARTED|Overall Study||204
11028324|NCT00839254|12207165|FG006|STARTED|Overall Study||368
11028325|NCT00839254|12207166|FG007|STARTED|Overall Study||271
11028326|NCT00839254|12207159|FG000|COMPLETED|Overall Study||1696
11028327|NCT00839254|12207160|FG001|COMPLETED|Overall Study||1224
11028328|NCT00839254|12207161|FG002|COMPLETED|Overall Study||979
11028329|NCT00839254|12207162|FG003|COMPLETED|Overall Study||797
11028330|NCT00839254|12207163|FG004|COMPLETED|Overall Study||204
11028331|NCT00839254|12207164|FG005|COMPLETED|Overall Study||178
11028332|NCT00839254|12207165|FG006|COMPLETED|Overall Study||340
11028333|NCT00839254|12207166|FG007|COMPLETED|Overall Study||256
11028334|NCT00839254|12207159|FG000|NOT COMPLETED|Overall Study||153
11028335|NCT00839254|12207160|FG001|NOT COMPLETED|Overall Study||92
11028336|NCT00839254|12207161|FG002|NOT COMPLETED|Overall Study||90
11028337|NCT00839254|12207162|FG003|NOT COMPLETED|Overall Study||62
11028338|NCT00839254|12207163|FG004|NOT COMPLETED|Overall Study||37
11028339|NCT00839254|12207164|FG005|NOT COMPLETED|Overall Study||26
11028340|NCT00839254|12207165|FG006|NOT COMPLETED|Overall Study||28
11028341|NCT00839254|12207166|FG007|NOT COMPLETED|Overall Study||15
11028342|NCT00839306|12207217|FG000|STARTED|Overall Study|Treated|60
11028343|NCT00839306|12207218|FG001|STARTED|Overall Study|Treated|177
11028344|NCT00839306|12207217|FG000|COMPLETED|Overall Study||35
11028345|NCT00839306|12207218|FG001|COMPLETED|Overall Study||134
11028346|NCT00839306|12207217|FG000|NOT COMPLETED|Overall Study||25
11028347|NCT00839306|12207218|FG001|NOT COMPLETED|Overall Study||43
11028348|NCT00839319|12207230|FG000|STARTED|Overall Study||8
11028349|NCT00839319|12207231|FG001|STARTED|Overall Study||8
11028350|NCT00839319|12207232|FG002|STARTED|Overall Study||8
11028351|NCT00839319|12207233|FG003|STARTED|Overall Study||8
11028352|NCT00839319|12207234|FG004|STARTED|Overall Study||8
11028353|NCT00839319|12207230|FG000|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
11028354|NCT00839319|12207231|FG001|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
11028355|NCT00839319|12207232|FG002|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
11028356|NCT00839319|12207233|FG003|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
11028357|NCT00839319|12207234|FG004|COMPLETED|Overall Study||8
11028358|NCT00839319|12207230|FG000|NOT COMPLETED|Overall Study||2
11028359|NCT00839319|12207231|FG001|NOT COMPLETED|Overall Study||1
11028360|NCT00839319|12207232|FG002|NOT COMPLETED|Overall Study||3
11028361|NCT00839319|12207233|FG003|NOT COMPLETED|Overall Study||3
11028362|NCT00839319|12207234|FG004|NOT COMPLETED|Overall Study||0
11028363|NCT00839332|12207249|FG000|STARTED|Phase 1||50
11028364|NCT00839332|12207250|FG001|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
11057354|NCT00997204|12238838|FG001|NOT COMPLETED|Naive Treatment Phase||79
11332783|NCT02821403|12530190|FG001|COMPLETED|"First Intervention (1 Month)"||40
11332784|NCT02821403|12530189|FG000|NOT COMPLETED|"First Intervention (1 Month)"||0
11332785|NCT02821403|12530190|FG001|NOT COMPLETED|"First Intervention (1 Month)"||0
11332786|NCT02821403|12530189|FG000|STARTED|"Second Intervention (1 Month)"||40
11332787|NCT02821403|12530190|FG001|STARTED|"Second Intervention (1 Month)"||40
11332788|NCT02821403|12530189|FG000|Used Clear Lens|"Second Intervention (1 Month)"||13
11332789|NCT02821403|12530190|FG001|Used Clear Lens|"Second Intervention (1 Month)"||14
11332790|NCT02821403|12530189|FG000|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
11332791|NCT02821403|12530190|FG001|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
11332792|NCT02821403|12530189|FG000|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
11332793|NCT02821403|12530190|FG001|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
11332794|NCT02821403|12530189|FG000|COMPLETED|"Second Intervention (1 Month)"||40
11332795|NCT02821403|12530190|FG001|COMPLETED|"Second Intervention (1 Month)"||40
11332796|NCT02821403|12530189|FG000|NOT COMPLETED|"Second Intervention (1 Month)"||0
11332797|NCT02821403|12530190|FG001|NOT COMPLETED|"Second Intervention (1 Month)"||0
11332798|NCT02821403|12530189|FG000|STARTED|"Third Intervention (1 Month)"||40
11332799|NCT02821403|12530190|FG001|STARTED|"Third Intervention (1 Month)"||40
11332800|NCT02821403|12530189|FG000|Used Clear Lens|"Third Intervention (1 Month)"||14
11332801|NCT02821403|12530190|FG001|Used Clear Lens|"Third Intervention (1 Month)"||13
11332802|NCT02821403|12530189|FG000|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
11332803|NCT02821403|12530190|FG001|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
11332804|NCT02821403|12530189|FG000|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
11332805|NCT02821403|12530190|FG001|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
11332806|NCT02821403|12530189|FG000|COMPLETED|"Third Intervention (1 Month)"||40
11332807|NCT02821403|12530190|FG001|COMPLETED|"Third Intervention (1 Month)"||40
11332808|NCT02821403|12530189|FG000|NOT COMPLETED|"Third Intervention (1 Month)"||0
11332809|NCT02821403|12530190|FG001|NOT COMPLETED|"Third Intervention (1 Month)"||0
11332810|NCT02821416|12530204|FG000|STARTED|Overall Study||23
11332811|NCT02821416|12530205|FG001|STARTED|Overall Study||23
11332812|NCT02821416|12530204|FG000|COMPLETED|Overall Study||20
11332813|NCT02821416|12530205|FG001|COMPLETED|Overall Study||22
11332814|NCT02821416|12530204|FG000|NOT COMPLETED|Overall Study||3
11332815|NCT02821416|12530205|FG001|NOT COMPLETED|Overall Study||1
11332816|NCT02821455|12530212|FG000|STARTED|Overall Study||19
11332817|NCT02821455|12530212|FG000|COMPLETED|Overall Study||19
11332818|NCT02821455|12530212|FG000|NOT COMPLETED|Overall Study||0
11332819|NCT02821715|12530216|FG000|STARTED|Overall Study||8
11332820|NCT02821715|12530217|FG001|STARTED|Overall Study||8
11332821|NCT02821715|12530218|FG002|STARTED|Overall Study||8
11332822|NCT02821715|12530219|FG003|STARTED|Overall Study||9
11332823|NCT02821715|12530220|FG004|STARTED|Overall Study||6
11332824|NCT02821715|12530221|FG005|STARTED|Overall Study||9
11332825|NCT02821715|12530216|FG000|COMPLETED|Overall Study||7
11332826|NCT02821715|12530217|FG001|COMPLETED|Overall Study||8
11332827|NCT02821715|12530218|FG002|COMPLETED|Overall Study||8
11332828|NCT02821715|12530219|FG003|COMPLETED|Overall Study||9
11332829|NCT02821715|12530220|FG004|COMPLETED|Overall Study||6
11332830|NCT02821715|12530221|FG005|COMPLETED|Overall Study||9
11332831|NCT02821715|12530216|FG000|NOT COMPLETED|Overall Study||1
11332832|NCT02821715|12530217|FG001|NOT COMPLETED|Overall Study||0
11332833|NCT02821715|12530218|FG002|NOT COMPLETED|Overall Study||0
11332834|NCT02821715|12530219|FG003|NOT COMPLETED|Overall Study||0
11332835|NCT02821715|12530220|FG004|NOT COMPLETED|Overall Study||0
11028365|NCT00839332|12207251|FG002|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
11028366|NCT00839332|12207249|FG000|Received at Least 1 Dose of Study Drug|Phase 1||50
11028367|NCT00839332|12207250|FG001|Received at Least 1 Dose of Study Drug|Phase 1||0
11028368|NCT00839332|12207251|FG002|Received at Least 1 Dose of Study Drug|Phase 1||0
11028369|NCT00839332|12207249|FG000|COMPLETED|Phase 1||0
11028370|NCT00839332|12207250|FG001|COMPLETED|Phase 1||0
11028371|NCT00839332|12207251|FG002|COMPLETED|Phase 1||0
11028372|NCT00839332|12207249|FG000|NOT COMPLETED|Phase 1||50
11028373|NCT00839332|12207250|FG001|NOT COMPLETED|Phase 1||0
11028374|NCT00839332|12207251|FG002|NOT COMPLETED|Phase 1||0
11028375|NCT00839332|12207249|FG000|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
11028376|NCT00839332|12207250|FG001|STARTED|Phase 2||68
11028377|NCT00839332|12207251|FG002|STARTED|Phase 2||39
11028378|NCT00839332|12207249|FG000|Received at Least 1 Dose of Study Drug|Phase 2||0
11028379|NCT00839332|12207250|FG001|Received at Least 1 Dose of Study Drug|Phase 2||65
11028380|NCT00839332|12207251|FG002|Received at Least 1 Dose of Study Drug|Phase 2||34
11028381|NCT00839332|12207249|FG000|COMPLETED|Phase 2||0
11028382|NCT00839332|12207250|FG001|COMPLETED|Phase 2||0
11028383|NCT00839332|12207251|FG002|COMPLETED|Phase 2||0
11028384|NCT00839332|12207249|FG000|NOT COMPLETED|Phase 2||0
11028385|NCT00839332|12207250|FG001|NOT COMPLETED|Phase 2||68
11028386|NCT00839332|12207251|FG002|NOT COMPLETED|Phase 2||39
11028387|NCT00839423|12207264|FG000|STARTED|Overall Study||105
11028388|NCT00839423|12207265|FG001|STARTED|Overall Study||108
11028389|NCT00839423|12207266|FG002|STARTED|Overall Study||100
11028390|NCT00839423|12207267|FG003|STARTED|Overall Study||113
11028391|NCT00839423|12207264|FG000|COMPLETED|Overall Study||87
11028392|NCT00839423|12207265|FG001|COMPLETED|Overall Study||98
11028393|NCT00839423|12207266|FG002|COMPLETED|Overall Study||82
11028394|NCT00839423|12207267|FG003|COMPLETED|Overall Study||93
11028395|NCT00839423|12207264|FG000|NOT COMPLETED|Overall Study||18
11028396|NCT00839423|12207265|FG001|NOT COMPLETED|Overall Study||10
11028397|NCT00839423|12207266|FG002|NOT COMPLETED|Overall Study||18
11028398|NCT00839423|12207267|FG003|NOT COMPLETED|Overall Study||20
11028399|NCT00839436|12207280|FG000|STARTED|Overall Study||3
11028400|NCT00839436|12207281|FG001|STARTED|Overall Study||5
11028401|NCT00839436|12207282|FG002|STARTED|Overall Study||1
11028402|NCT00839436|12207280|FG000|COMPLETED|Overall Study||2
11028403|NCT00839436|12207281|FG001|COMPLETED|Overall Study||4
11028404|NCT00839436|12207282|FG002|COMPLETED|Overall Study||0
11028405|NCT00839436|12207280|FG000|NOT COMPLETED|Overall Study||1
11028406|NCT00839436|12207281|FG001|NOT COMPLETED|Overall Study||1
11028407|NCT00839436|12207282|FG002|NOT COMPLETED|Overall Study||1
11028408|NCT00839527|12207293|FG000|STARTED|Treatment Period (TP) (156 Weeks)||115
11028409|NCT00839527|12207294|FG001|STARTED|Treatment Period (TP) (156 Weeks)||277
11028410|NCT00839527|12207295|FG002|STARTED|Treatment Period (TP) (156 Weeks)||271
11028411|NCT00839527|12207293|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||55
11028412|NCT00839527|12207294|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||159
11028413|NCT00839527|12207295|FG002|COMPLETED|Treatment Period (TP) (156 Weeks)||152
11028414|NCT00839527|12207293|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
11028415|NCT00839527|12207294|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
11028416|NCT00839527|12207295|FG002|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
11028417|NCT00839527|12207293|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
11028418|NCT00839527|12207294|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
11028419|NCT00839527|12207295|FG002|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
11028420|NCT00839527|12207293|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
11028421|NCT00839527|12207294|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
11028422|NCT00839527|12207295|FG002|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
11028423|NCT00839527|12207293|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
11028424|NCT00839527|12207294|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
11028425|NCT00839527|12207295|FG002|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
11028426|NCT00839540|12207308|FG000|STARTED|Overall Study||8
11028427|NCT00839540|12207309|FG001|STARTED|Overall Study||8
11028428|NCT00839540|12207310|FG002|STARTED|Overall Study||5
11028429|NCT00839540|12207308|FG000|COMPLETED|Overall Study||8
11028430|NCT00839540|12207309|FG001|COMPLETED|Overall Study||8
11028431|NCT00839540|12207310|FG002|COMPLETED|Overall Study||5
11028432|NCT00839540|12207308|FG000|NOT COMPLETED|Overall Study||0
11028433|NCT00839540|12207309|FG001|NOT COMPLETED|Overall Study||0
11028434|NCT00839540|12207310|FG002|NOT COMPLETED|Overall Study||0
11028435|NCT00839800|12207320|FG000|STARTED|Overall Study||1049
11028436|NCT00839800|12207321|FG001|STARTED|Overall Study||1042
11028437|NCT00839800|12207320|FG000|COMPLETED|Overall Study||956
11028438|NCT00839800|12207321|FG001|COMPLETED|Overall Study||932
11028439|NCT00839800|12207320|FG000|NOT COMPLETED|Overall Study||93
11028440|NCT00839800|12207321|FG001|NOT COMPLETED|Overall Study||110
11028441|NCT00839852|12207327|FG000|STARTED|Overall Study||93
11028442|NCT00839852|12207327|FG000|COMPLETED|Overall Study||46
11028443|NCT00839852|12207327|FG000|NOT COMPLETED|Overall Study||47
11028444|NCT00839917|12207333|FG000|STARTED|Overall Study||13
11028445|NCT00839917|12207334|FG001|STARTED|Overall Study||17
11028446|NCT00839917|12207333|FG000|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
11028447|NCT00839917|12207334|FG001|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
11028448|NCT00839917|12207333|FG000|NOT COMPLETED|Overall Study||1
11028449|NCT00839917|12207334|FG001|NOT COMPLETED|Overall Study||1
11028450|NCT00839956|12207340|FG000|STARTED|Overall Study||31
11028451|NCT00839956|12207340|FG000|COMPLETED|Overall Study||19
11028452|NCT00839956|12207340|FG000|NOT COMPLETED|Overall Study||12
11028453|NCT00839982|12207344|FG000|STARTED|Overall Study||4
11028454|NCT00839982|12207345|FG001|STARTED|Overall Study||26
11028455|NCT00839982|12207346|FG002|STARTED|Overall Study||2
11028456|NCT00839982|12207347|FG003|STARTED|Overall Study||3
11028457|NCT00839982|12207344|FG000|COMPLETED|Overall Study||4
11028458|NCT00839982|12207345|FG001|COMPLETED|Overall Study||26
11028459|NCT00839982|12207346|FG002|COMPLETED|Overall Study||2
11028460|NCT00839982|12207347|FG003|COMPLETED|Overall Study||3
11028461|NCT00839982|12207344|FG000|NOT COMPLETED|Overall Study||0
11028462|NCT00839982|12207345|FG001|NOT COMPLETED|Overall Study||0
11028463|NCT00839982|12207346|FG002|NOT COMPLETED|Overall Study||0
11028464|NCT00839982|12207347|FG003|NOT COMPLETED|Overall Study||0
11028465|NCT00840034|12207357|FG000|STARTED|Acute Treatment Phase||111
11028466|NCT00840034|12207358|FG001|STARTED|Acute Treatment Phase||116
11028467|NCT00840034|12207357|FG000|COMPLETED|Acute Treatment Phase||90
11028468|NCT00840034|12207358|FG001|COMPLETED|Acute Treatment Phase||80
11028469|NCT00840034|12207357|FG000|NOT COMPLETED|Acute Treatment Phase||21
11028470|NCT00840034|12207358|FG001|NOT COMPLETED|Acute Treatment Phase||36
11028471|NCT00840034|12207357|FG000|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
11028472|NCT00840034|12207358|FG001|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
11028473|NCT00840034|12207357|FG000|COMPLETED|Taper Phase||87
11028474|NCT00840034|12207358|FG001|COMPLETED|Taper Phase||80
11028475|NCT00840034|12207357|FG000|NOT COMPLETED|Taper Phase||3
11028476|NCT00840034|12207358|FG001|NOT COMPLETED|Taper Phase||2
11028477|NCT00840060|12207368|FG000|STARTED|Overall Study||20
11028478|NCT00840060|12207369|FG001|STARTED|Overall Study||20
11028479|NCT00840060|12207368|FG000|COMPLETED|Overall Study||19
11028480|NCT00840060|12207369|FG001|COMPLETED|Overall Study||19
11028481|NCT00840060|12207368|FG000|NOT COMPLETED|Overall Study||1
11028482|NCT00840060|12207369|FG001|NOT COMPLETED|Overall Study||1
11028483|NCT00840086|12207375|FG000|STARTED|Overall Study||150
11028484|NCT00840086|12207375|FG000|COMPLETED|Overall Study||146
11028485|NCT00840086|12207375|FG000|NOT COMPLETED|Overall Study||4
11028486|NCT00840294|12207384|FG000|STARTED|Overall Study||42
11028487|NCT00840294|12207385|FG001|STARTED|Overall Study||43
11028488|NCT00840294|12207384|FG000|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
11028489|NCT00840294|12207385|FG001|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
11028490|NCT00840294|12207384|FG000|NOT COMPLETED|Overall Study||3
11028491|NCT00840294|12207385|FG001|NOT COMPLETED|Overall Study||5
11028492|NCT00840307|12207391|FG000|STARTED|Overall Study||20
11028493|NCT00840307|12207391|FG000|COMPLETED|Overall Study||16
11028494|NCT00840307|12207391|FG000|NOT COMPLETED|Overall Study||4
11028495|NCT00840450|12207395|FG000|STARTED|Overall Study||12
11028496|NCT00840450|12207395|FG000|COMPLETED|Overall Study||9
11028497|NCT00840450|12207395|FG000|NOT COMPLETED|Overall Study||3
11028498|NCT00840463|12207401|FG000|STARTED|Overall Study||3
11028499|NCT00840463|12207402|FG001|STARTED|Overall Study||1
11028500|NCT00840463|12207401|FG000|COMPLETED|Overall Study||2
11028501|NCT00840463|12207402|FG001|COMPLETED|Overall Study||1
11028502|NCT00840463|12207401|FG000|NOT COMPLETED|Overall Study||1
11028503|NCT00840463|12207402|FG001|NOT COMPLETED|Overall Study||0
11028504|NCT00840658|12207412|FG000|STARTED|Overall Study||144
11028505|NCT00840658|12207413|FG001|STARTED|Overall Study||146
11028506|NCT00840658|12207414|FG002|STARTED|Overall Study||148
11028507|NCT00840658|12207415|FG003|STARTED|Overall Study||146
11028508|NCT00840658|12207412|FG000|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
11057355|NCT00997204|12238837|FG000|STARTED|Self-administration Phase||19
11028509|NCT00840658|12207413|FG001|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
11028510|NCT00840658|12207414|FG002|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
11028511|NCT00840658|12207415|FG003|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
11028512|NCT00840658|12207412|FG000|NOT COMPLETED|Overall Study||5
11028513|NCT00840658|12207413|FG001|NOT COMPLETED|Overall Study||3
11028514|NCT00840658|12207414|FG002|NOT COMPLETED|Overall Study||5
11028515|NCT00840658|12207415|FG003|NOT COMPLETED|Overall Study||4
11028516|NCT00840749|12207431|FG000|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|31
11028517|NCT00840749|12207432|FG001|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|27
11028518|NCT00840749|12207431|FG000|Treatment|Overall Study||20
11028519|NCT00840749|12207432|FG001|Treatment|Overall Study||16
11028520|NCT00840749|12207431|FG000|1 Month Post tx|Overall Study||19
11028521|NCT00840749|12207432|FG001|1 Month Post tx|Overall Study||15
11028522|NCT00840749|12207431|FG000|6 Months Post tx|Overall Study||16
11028523|NCT00840749|12207432|FG001|6 Months Post tx|Overall Study||10
11028524|NCT00840749|12207431|FG000|12 Months Post tx|Overall Study||14
11028525|NCT00840749|12207432|FG001|12 Months Post tx|Overall Study||7
11028526|NCT00840749|12207431|FG000|18 Months Post tx|Overall Study||12
11028527|NCT00840749|12207432|FG001|18 Months Post tx|Overall Study||6
11028528|NCT00840749|12207431|FG000|24 Months Post tx|Overall Study||9
11028529|NCT00840749|12207432|FG001|24 Months Post tx|Overall Study||3
11028530|NCT00840749|12207431|FG000|36 Months Post tx|Overall Study||1
11028531|NCT00840749|12207432|FG001|36 Months Post tx|Overall Study||0
11028532|NCT00840749|12207431|FG000|COMPLETED|Overall Study||0
11028533|NCT00840749|12207432|FG001|COMPLETED|Overall Study||0
11028534|NCT00840749|12207431|FG000|NOT COMPLETED|Overall Study||31
11028535|NCT00840749|12207432|FG001|NOT COMPLETED|Overall Study||27
11028536|NCT00840970|12207438|FG000|STARTED|Overall Study||7
11028537|NCT00840970|12207439|FG001|STARTED|Overall Study||38
11028538|NCT00840970|12207440|FG002|STARTED|Overall Study||5
11028539|NCT00840970|12207438|FG000|COMPLETED|Overall Study||7
11028540|NCT00840970|12207439|FG001|COMPLETED|Overall Study||38
11028541|NCT00840970|12207440|FG002|COMPLETED|Overall Study||4
11028542|NCT00840970|12207438|FG000|NOT COMPLETED|Overall Study||0
11028543|NCT00840970|12207439|FG001|NOT COMPLETED|Overall Study||0
11332836|NCT02821715|12530221|FG005|NOT COMPLETED|Overall Study||0
11332837|NCT02821819|12530229|FG000|STARTED|Overall Study||15
11332838|NCT02821819|12530229|FG000|COMPLETED|Overall Study||14
11332839|NCT02821819|12530229|FG000|NOT COMPLETED|Overall Study||1
11332840|NCT02821910|12530239|FG000|STARTED|Overall Study||7
11332841|NCT02821910|12530240|FG001|STARTED|Overall Study||8
11332842|NCT02821910|12530241|FG002|STARTED|Overall Study||10
11332843|NCT02821910|12530242|FG003|STARTED|Overall Study||10
11332844|NCT02821910|12530243|FG004|STARTED|Overall Study||7
11332845|NCT02821910|12530244|FG005|STARTED|Overall Study||8
11332846|NCT02821910|12530239|FG000|COMPLETED|Overall Study||6
11332847|NCT02821910|12530240|FG001|COMPLETED|Overall Study||8
11332848|NCT02821910|12530241|FG002|COMPLETED|Overall Study||8
11332849|NCT02821910|12530242|FG003|COMPLETED|Overall Study||10
11332850|NCT02821910|12530243|FG004|COMPLETED|Overall Study||7
11332851|NCT02821910|12530244|FG005|COMPLETED|Overall Study||7
11332852|NCT02821910|12530239|FG000|NOT COMPLETED|Overall Study||1
11332853|NCT02821910|12530240|FG001|NOT COMPLETED|Overall Study||0
11332854|NCT02821910|12530241|FG002|NOT COMPLETED|Overall Study||2
11332855|NCT02821910|12530242|FG003|NOT COMPLETED|Overall Study||0
11332856|NCT02821910|12530243|FG004|NOT COMPLETED|Overall Study||0
11332857|NCT02821910|12530244|FG005|NOT COMPLETED|Overall Study||1
11332858|NCT02821962|12530260|FG000|STARTED|Overall Study||19
11332859|NCT02821962|12530261|FG001|STARTED|Overall Study||21
11332860|NCT02821962|12530260|FG000|COMPLETED|Overall Study||17
11332861|NCT02821962|12530261|FG001|COMPLETED|Overall Study||21
11332862|NCT02821962|12530260|FG000|NOT COMPLETED|Overall Study||2
11332863|NCT02821962|12530261|FG001|NOT COMPLETED|Overall Study||0
11332864|NCT02822222|12530269|FG000|STARTED|Overall Study||16
11332865|NCT02822222|12530270|FG001|STARTED|Overall Study||6
11332866|NCT02822222|12530269|FG000|COMPLETED|Overall Study||15
11332867|NCT02822222|12530270|FG001|COMPLETED|Overall Study||6
11332868|NCT02822222|12530269|FG000|NOT COMPLETED|Overall Study||1
11332869|NCT02822222|12530270|FG001|NOT COMPLETED|Overall Study||0
11332870|NCT02822235|12530278|FG000|STARTED|Cross-sectional Phase (Day 1)||264
11332871|NCT02822235|12530279|FG001|STARTED|Cross-sectional Phase (Day 1)||143
11332872|NCT02822235|12530278|FG000|COMPLETED|Cross-sectional Phase (Day 1)||118
11332873|NCT02822235|12530279|FG001|COMPLETED|Cross-sectional Phase (Day 1)||36
11332874|NCT02822235|12530278|FG000|NOT COMPLETED|Cross-sectional Phase (Day 1)||146
11028544|NCT00840970|12207440|FG002|NOT COMPLETED|Overall Study||1
11028545|NCT00840996|12207452|FG000|STARTED|Overall Study||58
11028546|NCT00840996|12207453|FG001|STARTED|Overall Study||58
11028547|NCT00840996|12207452|FG000|COMPLETED|Overall Study||57
11028548|NCT00840996|12207453|FG001|COMPLETED|Overall Study||58
11028549|NCT00840996|12207452|FG000|NOT COMPLETED|Overall Study||1
11028550|NCT00840996|12207453|FG001|NOT COMPLETED|Overall Study||0
11332875|NCT02822235|12530279|FG001|NOT COMPLETED|Cross-sectional Phase (Day 1)||107
11332876|NCT02822235|12530278|FG000|STARTED|Prospective Phase (Day 1 up to Month 12)||118
11332877|NCT02822235|12530279|FG001|STARTED|Prospective Phase (Day 1 up to Month 12)||36
11332878|NCT02822235|12530278|FG000|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107
11332879|NCT02822235|12530279|FG001|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34
11332880|NCT02822235|12530278|FG000|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11
11332881|NCT02822235|12530279|FG001|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2
11332882|NCT02822287|12530292|FG000|STARTED|Overall Study||57
11332883|NCT02822287|12530292|FG000|COMPLETED|Overall Study||57
11332884|NCT02822287|12530292|FG000|NOT COMPLETED|Overall Study||0
11332885|NCT02822599|12530298|FG000|STARTED|Overall Study|First subject enrolled on 6-1-17.|15
11332886|NCT02822599|12530299|FG001|STARTED|Overall Study|First subject enrolled on 6-1-17.|15
11332887|NCT02822599|12530298|FG000|COMPLETED|Overall Study||15
11332888|NCT02822599|12530299|FG001|COMPLETED|Overall Study||15
11332889|NCT02822599|12530298|FG000|NOT COMPLETED|Overall Study||0
11332890|NCT02822599|12530299|FG001|NOT COMPLETED|Overall Study||0
11332891|NCT02822612|12530310|FG000|STARTED|Overall Study||14
11332892|NCT02822612|12530311|FG001|STARTED|Overall Study||13
11332893|NCT02822612|12530312|FG002|STARTED|Overall Study||14
11332894|NCT02822612|12530313|FG003|STARTED|Overall Study||4
11332895|NCT02822612|12530314|FG004|STARTED|Overall Study||15
11332896|NCT02822612|12530310|FG000|COMPLETED|Overall Study||14
11332897|NCT02822612|12530311|FG001|COMPLETED|Overall Study||13
11332898|NCT02822612|12530312|FG002|COMPLETED|Overall Study||14
11332899|NCT02822612|12530313|FG003|COMPLETED|Overall Study||4
11332900|NCT02822612|12530314|FG004|COMPLETED|Overall Study||15
11332901|NCT02822612|12530310|FG000|NOT COMPLETED|Overall Study||0
11332902|NCT02822612|12530311|FG001|NOT COMPLETED|Overall Study||0
11028551|NCT00841087|12207461|FG000|STARTED|Overall Study||33
11028552|NCT00841087|12207462|FG001|STARTED|Overall Study||32
11028553|NCT00841087|12207461|FG000|COMPLETED|Overall Study||33
11028554|NCT00841087|12207462|FG001|COMPLETED|Overall Study||32
11028555|NCT00841087|12207461|FG000|NOT COMPLETED|Overall Study||0
11028556|NCT00841087|12207462|FG001|NOT COMPLETED|Overall Study||0
11028557|NCT00841100|12207468|FG000|STARTED|Acute Component (24 Hours)||21
11028558|NCT00841100|12207468|FG000|COMPLETED|Acute Component (24 Hours)||21
11028559|NCT00841100|12207468|FG000|NOT COMPLETED|Acute Component (24 Hours)||0
11028560|NCT00841100|12207468|FG000|STARTED|Phase 1 (28 Days)|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18
11028561|NCT00841100|12207468|FG000|COMPLETED|Phase 1 (28 Days)||15
11028562|NCT00841100|12207468|FG000|NOT COMPLETED|Phase 1 (28 Days)||3
11028563|NCT00841100|12207468|FG000|STARTED|Phase 2 (2 Weeks)|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5
11028564|NCT00841100|12207468|FG000|COMPLETED|Phase 2 (2 Weeks)||5
11028565|NCT00841100|12207468|FG000|NOT COMPLETED|Phase 2 (2 Weeks)||0
11028566|NCT00841100|12207468|FG000|STARTED|Phase 3 (28 Days)|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4
11028567|NCT00841100|12207468|FG000|COMPLETED|Phase 3 (28 Days)||4
11028568|NCT00841100|12207468|FG000|NOT COMPLETED|Phase 3 (28 Days)||0
11028569|NCT00841204|12207474|FG000|STARTED|Overall Study||25
11028570|NCT00841204|12207475|FG001|STARTED|Overall Study||25
11028571|NCT00841204|12207474|FG000|COMPLETED|Overall Study||25
11028572|NCT00841204|12207475|FG001|COMPLETED|Overall Study||25
11028573|NCT00841204|12207474|FG000|NOT COMPLETED|Overall Study||0
11028574|NCT00841204|12207475|FG001|NOT COMPLETED|Overall Study||0
11332903|NCT02822612|12530312|FG002|NOT COMPLETED|Overall Study||0
11028575|NCT00841269|12207485|FG000|STARTED|Overall Study||20
11028576|NCT00841269|12207486|FG001|STARTED|Overall Study||22
11028577|NCT00841269|12207485|FG000|COMPLETED|Overall Study||12
11028578|NCT00841269|12207486|FG001|COMPLETED|Overall Study||13
11028579|NCT00841269|12207485|FG000|NOT COMPLETED|Overall Study||8
11028580|NCT00841269|12207486|FG001|NOT COMPLETED|Overall Study||9
11028581|NCT00841321|12207493|FG000|STARTED|Overall Study||59
11028582|NCT00841321|12207494|FG001|STARTED|Overall Study||61
11028583|NCT00841321|12207493|FG000|COMPLETED|Overall Study||58
11028584|NCT00841321|12207494|FG001|COMPLETED|Overall Study||58
11028585|NCT00841321|12207493|FG000|NOT COMPLETED|Overall Study||1
11028586|NCT00841321|12207494|FG001|NOT COMPLETED|Overall Study||3
11028587|NCT00841412|12207502|FG000|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
11028588|NCT00841412|12207503|FG001|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
11028589|NCT00841412|12207502|FG000|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
11028590|NCT00841412|12207503|FG001|COMPLETED|Overall Study||50
11028591|NCT00841412|12207502|FG000|NOT COMPLETED|Overall Study||40
11028592|NCT00841412|12207503|FG001|NOT COMPLETED|Overall Study||30
11028593|NCT00841555|12207510|FG000|STARTED|Overall Study||3
11028594|NCT00841555|12207511|FG001|STARTED|Overall Study||3
11028595|NCT00841555|12207512|FG002|STARTED|Overall Study||3
11028596|NCT00841555|12207510|FG000|COMPLETED|Overall Study||3
11028597|NCT00841555|12207511|FG001|COMPLETED|Overall Study||3
11028598|NCT00841555|12207512|FG002|COMPLETED|Overall Study||3
11028599|NCT00841555|12207510|FG000|NOT COMPLETED|Overall Study||0
11028600|NCT00841555|12207511|FG001|NOT COMPLETED|Overall Study||0
11028601|NCT00841555|12207512|FG002|NOT COMPLETED|Overall Study||0
11028602|NCT00841568|12207518|FG000|STARTED|Overall Study||17
11028603|NCT00841568|12207518|FG000|COMPLETED|Overall Study||12
11028604|NCT00841568|12207518|FG000|NOT COMPLETED|Overall Study||5
11028605|NCT00841672|12207528|FG000|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
11332904|NCT02822612|12530313|FG003|NOT COMPLETED|Overall Study||0
11332905|NCT02822612|12530314|FG004|NOT COMPLETED|Overall Study||0
11332906|NCT02822794|12530330|FG000|STARTED|Overall Study||57
11332907|NCT02822794|12530331|FG001|STARTED|Overall Study||60
11028606|NCT00841672|12207529|FG001|STARTED|Overall Study||241
11028607|NCT00841672|12207528|FG000|COMPLETED|Overall Study||224
11028608|NCT00841672|12207529|FG001|COMPLETED|Overall Study||209
11028609|NCT00841672|12207528|FG000|NOT COMPLETED|Overall Study||20
11028610|NCT00841672|12207529|FG001|NOT COMPLETED|Overall Study||32
11028611|NCT00841763|12207537|FG000|STARTED|Overall Study||2691
11028612|NCT00841763|12207538|FG001|STARTED|Overall Study||681
11028613|NCT00841763|12207539|FG002|STARTED|Overall Study||219
11028614|NCT00841763|12207540|FG003|STARTED|Overall Study||56
11028615|NCT00841763|12207537|FG000|COMPLETED|Overall Study||2529
11028616|NCT00841763|12207538|FG001|COMPLETED|Overall Study||624
11028617|NCT00841763|12207539|FG002|COMPLETED|Overall Study||211
11332908|NCT02822794|12530330|FG000|COMPLETED|Overall Study||56
11332909|NCT02822794|12530331|FG001|COMPLETED|Overall Study||60
11332910|NCT02822794|12530330|FG000|NOT COMPLETED|Overall Study||1
11332911|NCT02822794|12530331|FG001|NOT COMPLETED|Overall Study||0
11332912|NCT02822885|12530344|FG000|STARTED|Overall Study||70
11028618|NCT00841763|12207540|FG003|COMPLETED|Overall Study||53
11028619|NCT00841763|12207537|FG000|NOT COMPLETED|Overall Study||162
11028620|NCT00841763|12207538|FG001|NOT COMPLETED|Overall Study||57
11028621|NCT00841763|12207539|FG002|NOT COMPLETED|Overall Study||8
11028622|NCT00841763|12207540|FG003|NOT COMPLETED|Overall Study||3
11028623|NCT00841776|12207587|FG000|STARTED|Overall Study||27
11028624|NCT00841776|12207588|FG001|STARTED|Overall Study||27
11028625|NCT00841776|12207587|FG000|COMPLETED|Overall Study||25
11028626|NCT00841776|12207588|FG001|COMPLETED|Overall Study||24
11028627|NCT00841776|12207587|FG000|NOT COMPLETED|Overall Study||2
11028628|NCT00841776|12207588|FG001|NOT COMPLETED|Overall Study||3
11028629|NCT00841828|12207596|FG000|STARTED|Overall Study||52
11028630|NCT00841828|12207597|FG001|STARTED|Overall Study||50
11028631|NCT00841828|12207596|FG000|COMPLETED|Overall Study||42
11332913|NCT02822885|12530344|FG000|COMPLETED|Overall Study||70
11332914|NCT02822885|12530344|FG000|NOT COMPLETED|Overall Study||0
11332915|NCT02822950|12530348|FG000|STARTED|Overall Study||10
11332916|NCT02822950|12530348|FG000|COMPLETED|Overall Study||10
11332917|NCT02822950|12530348|FG000|NOT COMPLETED|Overall Study||0
11332918|NCT02823080|12530354|FG000|STARTED|Overall Study||24
11332919|NCT02823080|12530355|FG001|STARTED|Overall Study||24
11332920|NCT02823080|12530354|FG000|COMPLETED|Overall Study||24
11332921|NCT02823080|12530355|FG001|COMPLETED|Overall Study||24
11332922|NCT02823080|12530354|FG000|NOT COMPLETED|Overall Study||0
11332923|NCT02823080|12530355|FG001|NOT COMPLETED|Overall Study||0
11332924|NCT02823431|12530364|FG000|STARTED|Overall Study||11
11332925|NCT02823431|12530365|FG001|STARTED|Overall Study||12
11332926|NCT02823431|12530364|FG000|COMPLETED|Overall Study||11
11332927|NCT02823431|12530365|FG001|COMPLETED|Overall Study||12
11332928|NCT02823431|12530364|FG000|NOT COMPLETED|Overall Study||0
11332929|NCT02823431|12530365|FG001|NOT COMPLETED|Overall Study||0
11332930|NCT02823470|12530373|FG000|STARTED|Overall Study||9
11332931|NCT02823470|12530374|FG001|STARTED|Overall Study||15
11332932|NCT02823470|12530373|FG000|COMPLETED|Overall Study||0
11332933|NCT02823470|12530374|FG001|COMPLETED|Overall Study||0
11332934|NCT02823470|12530373|FG000|NOT COMPLETED|Overall Study||9
11332935|NCT02823470|12530374|FG001|NOT COMPLETED|Overall Study||15
11332936|NCT02823600|12530383|FG000|STARTED|Overall Study||68
11332937|NCT02823600|12530383|FG000|COMPLETED|Overall Study||68
11332938|NCT02823600|12530383|FG000|NOT COMPLETED|Overall Study||0
11332939|NCT02823964|12530389|FG000|STARTED|Overall Study||25
11332940|NCT02823964|12530389|FG000|COMPLETED|Overall Study||20
11332941|NCT02823964|12530389|FG000|NOT COMPLETED|Overall Study||5
11332942|NCT02824224|12530395|FG000|STARTED|Overall Study||19
11332943|NCT02824224|12530396|FG001|STARTED|Overall Study||18
11332944|NCT02824224|12530395|FG000|COMPLETED|Overall Study||17
11332945|NCT02824224|12530396|FG001|COMPLETED|Overall Study||17
11332946|NCT02824224|12530395|FG000|NOT COMPLETED|Overall Study||2
11332947|NCT02824224|12530396|FG001|NOT COMPLETED|Overall Study||1
11332948|NCT02824432|12530404|FG000|STARTED|Overall Study||18
11332949|NCT02824432|12530405|FG001|STARTED|Overall Study||19
11332950|NCT02824432|12530404|FG000|COMPLETED|Overall Study||17
11332951|NCT02824432|12530405|FG001|COMPLETED|Overall Study||19
11332952|NCT02824432|12530404|FG000|NOT COMPLETED|Overall Study||1
11332953|NCT02824432|12530405|FG001|NOT COMPLETED|Overall Study||0
11332954|NCT02824562|12530413|FG000|STARTED|Overall Study||22
11332955|NCT02824562|12530414|FG001|STARTED|Overall Study||22
11332956|NCT02824562|12530413|FG000|COMPLETED|Overall Study||19
11332957|NCT02824562|12530414|FG001|COMPLETED|Overall Study||17
11332958|NCT02824562|12530413|FG000|NOT COMPLETED|Overall Study||3
11332959|NCT02824562|12530414|FG001|NOT COMPLETED|Overall Study||5
11332960|NCT02824913|12530422|FG000|STARTED|First Intervention (1 Day)||1
11332961|NCT02824913|12530423|FG001|STARTED|First Intervention (1 Day)||0
11332962|NCT02824913|12530422|FG000|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
11332963|NCT02824913|12530423|FG001|COMPLETED|First Intervention (1 Day)||0
11332964|NCT02824913|12530422|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11332965|NCT02824913|12530423|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11332966|NCT02824913|12530422|FG000|STARTED|Washout (7-14 Days)||1
11028632|NCT00841828|12207597|FG001|COMPLETED|Overall Study||48
11332967|NCT02824913|12530423|FG001|STARTED|Washout (7-14 Days)||0
11332968|NCT02824913|12530422|FG000|COMPLETED|Washout (7-14 Days)||1
11332969|NCT02824913|12530423|FG001|COMPLETED|Washout (7-14 Days)||0
11332970|NCT02824913|12530422|FG000|NOT COMPLETED|Washout (7-14 Days)||0
11332971|NCT02824913|12530423|FG001|NOT COMPLETED|Washout (7-14 Days)||0
11332972|NCT02824913|12530422|FG000|STARTED|Second Intervention (1 Day)||1
11332973|NCT02824913|12530423|FG001|STARTED|Second Intervention (1 Day)||0
11332974|NCT02824913|12530422|FG000|COMPLETED|Second Intervention (1 Day)||1
11332975|NCT02824913|12530423|FG001|COMPLETED|Second Intervention (1 Day)||0
11332976|NCT02824913|12530422|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11332977|NCT02824913|12530423|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11332978|NCT02825212|12530431|FG000|STARTED|Overall Study||10
11332979|NCT02825212|12530431|FG000|COMPLETED|Overall Study||10
11332980|NCT02825212|12530431|FG000|NOT COMPLETED|Overall Study||0
11332981|NCT02825251|12530437|FG000|STARTED|Overall Study||236
11332982|NCT02825251|12530438|FG001|STARTED|Overall Study||236
11332983|NCT02825251|12530437|FG000|COMPLETED|Overall Study||233
11028633|NCT00841828|12207596|FG000|NOT COMPLETED|Overall Study||10
11028634|NCT00841828|12207597|FG001|NOT COMPLETED|Overall Study||2
11028635|NCT00841906|12207607|FG000|STARTED|Overall Study||18
11028636|NCT00841906|12207608|FG001|STARTED|Overall Study||14
11028637|NCT00841906|12207607|FG000|COMPLETED|Overall Study||16
11028638|NCT00841906|12207608|FG001|COMPLETED|Overall Study||14
11028639|NCT00841906|12207607|FG000|NOT COMPLETED|Overall Study||2
11028640|NCT00841906|12207608|FG001|NOT COMPLETED|Overall Study||0
11028641|NCT00841971|12207618|FG000|STARTED|Overall Study||100
11028642|NCT00841971|12207619|FG001|STARTED|Overall Study||100
11028643|NCT00841971|12207618|FG000|COMPLETED|Overall Study||98
11028644|NCT00841971|12207619|FG001|COMPLETED|Overall Study||99
11028645|NCT00841971|12207618|FG000|NOT COMPLETED|Overall Study||2
11028646|NCT00841971|12207619|FG001|NOT COMPLETED|Overall Study||1
11028647|NCT00842023|12207627|FG000|STARTED|Overall Study||45
11028648|NCT00842023|12207628|FG001|STARTED|Overall Study||44
11028649|NCT00842023|12207627|FG000|COMPLETED|Overall Study||45
11028650|NCT00842023|12207628|FG001|COMPLETED|Overall Study||44
11028651|NCT00842023|12207627|FG000|NOT COMPLETED|Overall Study||0
11028652|NCT00842023|12207628|FG001|NOT COMPLETED|Overall Study||0
11028653|NCT00842075|12207639|FG000|STARTED|Overall Study||5
11028654|NCT00842075|12207640|FG001|STARTED|Overall Study||5
11028655|NCT00842075|12207639|FG000|COMPLETED|Overall Study||5
11028656|NCT00842075|12207640|FG001|COMPLETED|Overall Study||5
11028657|NCT00842075|12207639|FG000|NOT COMPLETED|Overall Study||0
11028658|NCT00842075|12207640|FG001|NOT COMPLETED|Overall Study||0
11028659|NCT00842153|12207648|FG000|STARTED|Overall Study||28
11028660|NCT00842153|12207649|FG001|STARTED|Overall Study||30
11028661|NCT00842153|12207648|FG000|COMPLETED|Overall Study||27
11028662|NCT00842153|12207649|FG001|COMPLETED|Overall Study||27
11028663|NCT00842153|12207648|FG000|NOT COMPLETED|Overall Study||1
11028664|NCT00842153|12207649|FG001|NOT COMPLETED|Overall Study||3
11028665|NCT00842231|12207655|FG000|STARTED|Overall Study||40
11028666|NCT00842231|12207655|FG000|COMPLETED|Overall Study||40
11028667|NCT00842231|12207655|FG000|NOT COMPLETED|Overall Study||0
11028668|NCT00842244|12207659|FG000|STARTED|Overall Study||22
11028669|NCT00842244|12207659|FG000|COMPLETED|Overall Study||1
11028670|NCT00842244|12207659|FG000|NOT COMPLETED|Overall Study||21
11028671|NCT00842257|12207666|FG000|STARTED|Overall Study||20
11028672|NCT00842257|12207666|FG000|COMPLETED|Overall Study||19
11028673|NCT00842257|12207666|FG000|NOT COMPLETED|Overall Study||1
11028674|NCT00842296|12207670|FG000|STARTED|Overall Study||326
11028675|NCT00842296|12207670|FG000|COMPLETED|Overall Study||326
11028676|NCT00842296|12207670|FG000|NOT COMPLETED|Overall Study||0
11028677|NCT00842309|12207676|FG000|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14
11028678|NCT00842309|12207677|FG001|STARTED|Overall Study||14
11028679|NCT00842309|12207676|FG000|COMPLETED|Overall Study||11
11028680|NCT00842309|12207677|FG001|COMPLETED|Overall Study||13
11028681|NCT00842309|12207676|FG000|NOT COMPLETED|Overall Study||3
11028682|NCT00842309|12207677|FG001|NOT COMPLETED|Overall Study||1
11028683|NCT00842335|12207683|FG000|STARTED|Overall Study||18
11028684|NCT00842335|12207683|FG000|COMPLETED|Overall Study||18
11028685|NCT00842335|12207683|FG000|NOT COMPLETED|Overall Study||0
11028686|NCT00842348|12207691|FG000|STARTED|Patients Randomised in Study 726||101
11028687|NCT00842348|12207692|FG001|STARTED|Patients Randomised in Study 726||103
11028688|NCT00842348|12207691|FG000|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
11028689|NCT00842348|12207692|FG001|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
11028690|NCT00842348|12207691|FG000|NOT COMPLETED|Patients Randomised in Study 726||59
11028691|NCT00842348|12207692|FG001|NOT COMPLETED|Patients Randomised in Study 726||56
11028692|NCT00842348|12207691|FG000|STARTED|Study 729||42
11028693|NCT00842348|12207692|FG001|STARTED|Study 729||47
11028694|NCT00842348|12207691|FG000|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
11028695|NCT00842348|12207692|FG001|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
11028696|NCT00842348|12207691|FG000|NOT COMPLETED|Study 729||26
11028697|NCT00842348|12207692|FG001|NOT COMPLETED|Study 729||38
11028698|NCT00842361|12207704|FG000|STARTED|Overall Study||33
11028699|NCT00842361|12207705|FG001|STARTED|Overall Study||33
11028700|NCT00842361|12207704|FG000|Exposed|Overall Study||33
11028701|NCT00842361|12207705|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
11028702|NCT00842361|12207704|FG000|COMPLETED|Overall Study||32
11028703|NCT00842361|12207705|FG001|COMPLETED|Overall Study||31
11028704|NCT00842361|12207704|FG000|NOT COMPLETED|Overall Study||1
11028705|NCT00842361|12207705|FG001|NOT COMPLETED|Overall Study||2
11028706|NCT00842543|12207715|FG000|STARTED|Overall Study||13
11028707|NCT00842543|12207716|FG001|STARTED|Overall Study||5
11028708|NCT00842543|12207717|FG002|STARTED|Overall Study||13
11028709|NCT00842543|12207718|FG003|STARTED|Overall Study||8
11028710|NCT00842543|12207715|FG000|COMPLETED|Overall Study||11
11028711|NCT00842543|12207716|FG001|COMPLETED|Overall Study||5
11028712|NCT00842543|12207717|FG002|COMPLETED|Overall Study||10
11028713|NCT00842543|12207718|FG003|COMPLETED|Overall Study||4
11028714|NCT00842543|12207715|FG000|NOT COMPLETED|Overall Study||2
11028715|NCT00842543|12207716|FG001|NOT COMPLETED|Overall Study||0
11028716|NCT00842543|12207717|FG002|NOT COMPLETED|Overall Study||3
11028717|NCT00842543|12207718|FG003|NOT COMPLETED|Overall Study||4
11028718|NCT00842608|12207734|FG000|STARTED|Overall Study||174
11028719|NCT00842608|12207735|FG001|STARTED|Overall Study||177
11028720|NCT00842608|12207736|FG002|STARTED|Overall Study||99
11028721|NCT00842608|12207737|FG003|STARTED|Overall Study||101
11028722|NCT00842608|12207734|FG000|COMPLETED|Overall Study||170
11028723|NCT00842608|12207735|FG001|COMPLETED|Overall Study||176
11028724|NCT00842608|12207736|FG002|COMPLETED|Overall Study||99
11028725|NCT00842608|12207737|FG003|COMPLETED|Overall Study||100
11028726|NCT00842608|12207734|FG000|NOT COMPLETED|Overall Study||4
11028727|NCT00842608|12207735|FG001|NOT COMPLETED|Overall Study||1
11028728|NCT00842608|12207736|FG002|NOT COMPLETED|Overall Study||0
11028729|NCT00842608|12207737|FG003|NOT COMPLETED|Overall Study||1
11057356|NCT00997204|12238838|FG001|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
11057357|NCT00997204|12238837|FG000|COMPLETED|Self-administration Phase||19
11057358|NCT00997204|12238838|FG001|COMPLETED|Self-administration Phase||77
11332984|NCT02825251|12530438|FG001|COMPLETED|Overall Study||230
11332985|NCT02825251|12530437|FG000|NOT COMPLETED|Overall Study||3
11332986|NCT02825251|12530438|FG001|NOT COMPLETED|Overall Study||6
11332987|NCT02825420|12530446|FG000|STARTED|Overall Study||131
11332988|NCT02825420|12530447|FG001|STARTED|Overall Study||89
11332989|NCT02825420|12530446|FG000|COMPLETED|Overall Study||88
11057359|NCT00997204|12238837|FG000|NOT COMPLETED|Self-administration Phase||0
11057360|NCT00997204|12238838|FG001|NOT COMPLETED|Self-administration Phase||1
11057361|NCT00997243|12238848|FG000|STARTED|Overall Study||7
11057362|NCT00997243|12238848|FG000|COMPLETED|Overall Study||0
11057363|NCT00997243|12238848|FG000|NOT COMPLETED|Overall Study||7
11057364|NCT00997321|12238854|FG000|STARTED|Overall Study||50
11057365|NCT00997321|12238855|FG001|STARTED|Overall Study||50
11057366|NCT00997321|12238854|FG000|COMPLETED|Overall Study||50
11057367|NCT00997321|12238855|FG001|COMPLETED|Overall Study||47
11057368|NCT00997321|12238854|FG000|NOT COMPLETED|Overall Study||0
11057369|NCT00997321|12238855|FG001|NOT COMPLETED|Overall Study||3
11058431|NCT01004003|12240272|FG004|NOT COMPLETED|Overall Study||4
11058432|NCT01004003|12240273|FG005|NOT COMPLETED|Overall Study||4
11058433|NCT01004003|12240274|FG006|NOT COMPLETED|Overall Study||8
11058434|NCT01004003|12240275|FG007|NOT COMPLETED|Overall Study||60
11058435|NCT01004003|12240276|FG008|NOT COMPLETED|Overall Study||30
11058436|NCT01004042|12240300|FG000|STARTED|Overall Study||25
11058437|NCT01004042|12240301|FG001|STARTED|Overall Study||25
11058438|NCT01004042|12240300|FG000|COMPLETED|Overall Study||21
11058439|NCT01004042|12240301|FG001|COMPLETED|Overall Study||25
11058440|NCT01004042|12240300|FG000|NOT COMPLETED|Overall Study||4
11058441|NCT01004042|12240301|FG001|NOT COMPLETED|Overall Study||0
11058442|NCT01004107|12240309|FG000|STARTED|Overall Study||76
11058443|NCT01004107|12240310|FG001|STARTED|Overall Study||25
11058444|NCT01004107|12240309|FG000|COMPLETED|Overall Study||75
11058445|NCT01004107|12240310|FG001|COMPLETED|Overall Study||23
11058446|NCT01004107|12240309|FG000|NOT COMPLETED|Overall Study||1
11058447|NCT01004107|12240310|FG001|NOT COMPLETED|Overall Study||2
11058448|NCT01004146|12240337|FG000|STARTED|Overall Study||25
11058449|NCT01004146|12240338|FG001|STARTED|Overall Study||25
11058450|NCT01004146|12240337|FG000|Have Incentive Spirometry Data|Overall Study||21
11058451|NCT01004146|12240338|FG001|Have Incentive Spirometry Data|Overall Study||20
11058452|NCT01004146|12240337|FG000|COMPLETED|Overall Study||21
11058453|NCT01004146|12240338|FG001|COMPLETED|Overall Study||20
11058454|NCT01004146|12240337|FG000|NOT COMPLETED|Overall Study||4
11058455|NCT01004146|12240338|FG001|NOT COMPLETED|Overall Study||5
11058456|NCT01004159|12240344|FG000|STARTED|Overall Study||20
11058457|NCT01004159|12240344|FG000|COMPLETED|Overall Study||0
11332990|NCT02825420|12530447|FG001|COMPLETED|Overall Study||72
11332991|NCT02825420|12530446|FG000|NOT COMPLETED|Overall Study||43
11332992|NCT02825420|12530447|FG001|NOT COMPLETED|Overall Study||17
11332993|NCT02825550|12530458|FG000|STARTED|Overall Study||13
11332994|NCT02825550|12530458|FG000|COMPLETED|Overall Study||12
11332995|NCT02825550|12530458|FG000|NOT COMPLETED|Overall Study||1
11332996|NCT02825680|12530466|FG000|STARTED|Overall Study||82
11332997|NCT02825680|12530467|FG001|STARTED|Overall Study||55
11332998|NCT02825680|12530466|FG000|COMPLETED|Overall Study||82
11332999|NCT02825680|12530467|FG001|COMPLETED|Overall Study||39
11333000|NCT02825680|12530466|FG000|NOT COMPLETED|Overall Study||0
11028730|NCT00842712|12207754|FG000|STARTED|Safety Run-in Part||3
11028731|NCT00842712|12207755|FG001|STARTED|Safety Run-in Part||3
11028732|NCT00842712|12207756|FG002|STARTED|Safety Run-in Part||3
11028733|NCT00842712|12207757|FG003|STARTED|Safety Run-in Part||3
11028734|NCT00842712|12207758|FG004|STARTED|Safety Run-in Part||0
11028735|NCT00842712|12207759|FG005|STARTED|Safety Run-in Part||0
11028736|NCT00842712|12207760|FG006|STARTED|Safety Run-in Part||0
11028737|NCT00842712|12207754|FG000|COMPLETED|Safety Run-in Part||0
11028738|NCT00842712|12207755|FG001|COMPLETED|Safety Run-in Part||1
11028739|NCT00842712|12207756|FG002|COMPLETED|Safety Run-in Part||3
11028740|NCT00842712|12207757|FG003|COMPLETED|Safety Run-in Part||2
11028741|NCT00842712|12207758|FG004|COMPLETED|Safety Run-in Part||0
11028742|NCT00842712|12207759|FG005|COMPLETED|Safety Run-in Part||0
11028743|NCT00842712|12207760|FG006|COMPLETED|Safety Run-in Part||0
11028744|NCT00842712|12207754|FG000|NOT COMPLETED|Safety Run-in Part||3
11028745|NCT00842712|12207755|FG001|NOT COMPLETED|Safety Run-in Part||2
11028746|NCT00842712|12207756|FG002|NOT COMPLETED|Safety Run-in Part||0
11028747|NCT00842712|12207757|FG003|NOT COMPLETED|Safety Run-in Part||1
11028748|NCT00842712|12207758|FG004|NOT COMPLETED|Safety Run-in Part||0
11028749|NCT00842712|12207759|FG005|NOT COMPLETED|Safety Run-in Part||0
11028750|NCT00842712|12207760|FG006|NOT COMPLETED|Safety Run-in Part||0
11028751|NCT00842712|12207754|FG000|STARTED|Randomized Part||0
11028752|NCT00842712|12207755|FG001|STARTED|Randomized Part||0
11028753|NCT00842712|12207756|FG002|STARTED|Randomized Part||0
11028754|NCT00842712|12207757|FG003|STARTED|Randomized Part||0
11028755|NCT00842712|12207758|FG004|STARTED|Randomized Part||85
11028756|NCT00842712|12207759|FG005|STARTED|Randomized Part||51
11028757|NCT00842712|12207760|FG006|STARTED|Randomized Part||84
11028758|NCT00842712|12207754|FG000|Treated|Randomized Part||0
11028759|NCT00842712|12207755|FG001|Treated|Randomized Part||0
11028760|NCT00842712|12207756|FG002|Treated|Randomized Part||0
11028761|NCT00842712|12207757|FG003|Treated|Randomized Part||0
11028762|NCT00842712|12207758|FG004|Treated|Randomized Part||85
11333001|NCT02825680|12530467|FG001|NOT COMPLETED|Overall Study||16
11333002|NCT02825849|12530475|FG000|STARTED|Overall Study||22
11333003|NCT02825849|12530476|FG001|STARTED|Overall Study||5
11333004|NCT02825849|12530475|FG000|COMPLETED|Overall Study||22
11028763|NCT00842712|12207759|FG005|Treated|Randomized Part||50
11028764|NCT00842712|12207760|FG006|Treated|Randomized Part||80
11028765|NCT00842712|12207754|FG000|COMPLETED|Randomized Part||0
11333005|NCT02825849|12530476|FG001|COMPLETED|Overall Study||5
11333006|NCT02825849|12530475|FG000|NOT COMPLETED|Overall Study||0
11333007|NCT02825849|12530476|FG001|NOT COMPLETED|Overall Study||0
11333008|NCT02825966|12530482|FG000|STARTED|Overall Study||35
11028766|NCT00842712|12207755|FG001|COMPLETED|Randomized Part||0
11028767|NCT00842712|12207756|FG002|COMPLETED|Randomized Part||0
11028768|NCT00842712|12207757|FG003|COMPLETED|Randomized Part||0
11028769|NCT00842712|12207758|FG004|COMPLETED|Randomized Part||85
11028770|NCT00842712|12207759|FG005|COMPLETED|Randomized Part||50
11028771|NCT00842712|12207760|FG006|COMPLETED|Randomized Part||78
11028772|NCT00842712|12207754|FG000|NOT COMPLETED|Randomized Part||0
11028773|NCT00842712|12207755|FG001|NOT COMPLETED|Randomized Part||0
11028774|NCT00842712|12207756|FG002|NOT COMPLETED|Randomized Part||0
11333009|NCT02825966|12530482|FG000|COMPLETED|Overall Study||35
11333010|NCT02825966|12530482|FG000|NOT COMPLETED|Overall Study||0
11343826|NCT02956460|12541113|FG000|NOT COMPLETED|Lens 1||1
11343827|NCT02956460|12541114|FG001|NOT COMPLETED|Lens 1||0
11028775|NCT00842712|12207757|FG003|NOT COMPLETED|Randomized Part||0
11028776|NCT00842712|12207758|FG004|NOT COMPLETED|Randomized Part||0
11028777|NCT00842712|12207759|FG005|NOT COMPLETED|Randomized Part||1
11343828|NCT02956460|12541113|FG000|STARTED|Lens 2||29
11028778|NCT00842712|12207760|FG006|NOT COMPLETED|Randomized Part||6
11028779|NCT00842751|12207776|FG000|STARTED|Overall Study||11
11028780|NCT00842751|12207776|FG000|COMPLETED|Overall Study||11
11028781|NCT00842751|12207776|FG000|NOT COMPLETED|Overall Study||0
11028782|NCT00842764|12207789|FG000|STARTED|Overall Study||7
11028783|NCT00842764|12207789|FG000|COMPLETED|Overall Study||5
11028784|NCT00842764|12207789|FG000|NOT COMPLETED|Overall Study||2
11028785|NCT00842829|12207795|FG000|STARTED|Dose Titration Period||156
11028786|NCT00842829|12207796|FG001|STARTED|Dose Titration Period||174
11028787|NCT00842829|12207797|FG002|STARTED|Dose Titration Period||0
11028788|NCT00842829|12207795|FG000|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
11028789|NCT00842829|12207796|FG001|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
11028790|NCT00842829|12207797|FG002|Titration Safety Analysis Set|Dose Titration Period||0
11028791|NCT00842829|12207795|FG000|COMPLETED|Dose Titration Period||130
11028792|NCT00842829|12207796|FG001|COMPLETED|Dose Titration Period||151
11028793|NCT00842829|12207797|FG002|COMPLETED|Dose Titration Period||0
11028794|NCT00842829|12207795|FG000|NOT COMPLETED|Dose Titration Period||26
11028795|NCT00842829|12207796|FG001|NOT COMPLETED|Dose Titration Period||23
11028796|NCT00842829|12207797|FG002|NOT COMPLETED|Dose Titration Period||0
11028797|NCT00842829|12207795|FG000|STARTED|Treatment Period||0
11028798|NCT00842829|12207796|FG001|STARTED|Treatment Period||0
11028799|NCT00842829|12207797|FG002|STARTED|Treatment Period||281
11028800|NCT00842829|12207795|FG000|Safety Analysis Set|Treatment Period||0
11028801|NCT00842829|12207796|FG001|Safety Analysis Set|Treatment Period||0
11028802|NCT00842829|12207797|FG002|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
11028803|NCT00842829|12207795|FG000|COMPLETED|Treatment Period||0
11028804|NCT00842829|12207796|FG001|COMPLETED|Treatment Period||0
11028805|NCT00842829|12207797|FG002|COMPLETED|Treatment Period||218
11028806|NCT00842829|12207795|FG000|NOT COMPLETED|Treatment Period||0
11028807|NCT00842829|12207796|FG001|NOT COMPLETED|Treatment Period||0
11028808|NCT00842829|12207797|FG002|NOT COMPLETED|Treatment Period||63
11028809|NCT00842829|12207795|FG000|STARTED|Continuation Period||0
11028810|NCT00842829|12207796|FG001|STARTED|Continuation Period||0
11028811|NCT00842829|12207797|FG002|STARTED|Continuation Period|Eligible for Continuation Period|88
11028812|NCT00842829|12207795|FG000|Continuation Safety Analysis Set|Continuation Period||0
11028813|NCT00842829|12207796|FG001|Continuation Safety Analysis Set|Continuation Period||0
11028814|NCT00842829|12207797|FG002|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
11028815|NCT00842829|12207795|FG000|COMPLETED|Continuation Period||0
11028816|NCT00842829|12207796|FG001|COMPLETED|Continuation Period||0
11028817|NCT00842829|12207797|FG002|COMPLETED|Continuation Period||27
11028818|NCT00842829|12207795|FG000|NOT COMPLETED|Continuation Period||0
11028819|NCT00842829|12207796|FG001|NOT COMPLETED|Continuation Period||0
11028820|NCT00842829|12207797|FG002|NOT COMPLETED|Continuation Period||61
11028821|NCT00842946|12207811|FG000|STARTED|Overall Study||21
11028822|NCT00842946|12207812|FG001|STARTED|Overall Study||24
11028823|NCT00842946|12207811|FG000|COMPLETED|Overall Study||16
11028824|NCT00842946|12207812|FG001|COMPLETED|Overall Study||19
11028825|NCT00842946|12207811|FG000|NOT COMPLETED|Overall Study||5
11028826|NCT00842946|12207812|FG001|NOT COMPLETED|Overall Study||5
11028827|NCT00842985|12207818|FG000|STARTED|Screening||53
11028828|NCT00842985|12207818|FG000|COMPLETED|Screening||26
11028829|NCT00842985|12207818|FG000|NOT COMPLETED|Screening||27
11028830|NCT00842985|12207818|FG000|STARTED|First Intervention|Signed Consent|26
11028831|NCT00842985|12207818|FG000|COMPLETED|First Intervention|Completed 1st Intervention|20
11028832|NCT00842985|12207818|FG000|NOT COMPLETED|First Intervention||6
11028833|NCT00842985|12207818|FG000|STARTED|Washout Period of GE 4 Days||20
11028834|NCT00842985|12207818|FG000|COMPLETED|Washout Period of GE 4 Days||18
11028835|NCT00842985|12207818|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2
11028836|NCT00842985|12207818|FG000|STARTED|Second Intervention||18
11028837|NCT00842985|12207818|FG000|COMPLETED|Second Intervention||17
11028838|NCT00842985|12207818|FG000|NOT COMPLETED|Second Intervention||1
11028839|NCT00842985|12207818|FG000|STARTED|Washout Period of GE 4 Days||17
11028840|NCT00842985|12207818|FG000|COMPLETED|Washout Period of GE 4 Days||15
11028841|NCT00842985|12207818|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2
11028842|NCT00842985|12207818|FG000|STARTED|Third Intervention||15
11028843|NCT00842985|12207818|FG000|COMPLETED|Third Intervention||15
11028844|NCT00842985|12207818|FG000|NOT COMPLETED|Third Intervention||0
11028845|NCT00842985|12207818|FG000|STARTED|Washout Period of GE 4 Days||15
11028846|NCT00842985|12207818|FG000|COMPLETED|Washout Period of GE 4 Days||15
11028847|NCT00842985|12207818|FG000|NOT COMPLETED|Washout Period of GE 4 Days||0
11028848|NCT00842985|12207818|FG000|STARTED|Fourth Intervention||15
11343829|NCT02956460|12541114|FG001|STARTED|Lens 2||34
11343830|NCT02956460|12541113|FG000|COMPLETED|Lens 2||29
11343831|NCT02956460|12541114|FG001|COMPLETED|Lens 2||34
11343832|NCT02956460|12541113|FG000|NOT COMPLETED|Lens 2||0
11343833|NCT02956460|12541114|FG001|NOT COMPLETED|Lens 2||0
11343995|NCT02958527|12541302|FG000|STARTED|Overall Study||1408
11343996|NCT02958527|12541302|FG000|COMPLETED|Overall Study||1396
11028849|NCT00842985|12207818|FG000|COMPLETED|Fourth Intervention||15
11028850|NCT00842985|12207818|FG000|NOT COMPLETED|Fourth Intervention||0
11028851|NCT00843024|12207829|FG000|STARTED|Single-blind Placebo Run-In Phase||408
11028852|NCT00843024|12207830|FG001|STARTED|Single-blind Placebo Run-In Phase||457
11028853|NCT00843024|12207831|FG002|STARTED|Single-blind Placebo Run-In Phase||0
11028854|NCT00843024|12207832|FG003|STARTED|Single-blind Placebo Run-In Phase||0
11028855|NCT00843024|12207833|FG004|STARTED|Single-blind Placebo Run-In Phase||0
11028856|NCT00843024|12207834|FG005|STARTED|Single-blind Placebo Run-In Phase||0
11028857|NCT00843024|12207829|FG000|COMPLETED|Single-blind Placebo Run-In Phase||268
11028858|NCT00843024|12207830|FG001|COMPLETED|Single-blind Placebo Run-In Phase||321
11028859|NCT00843024|12207831|FG002|COMPLETED|Single-blind Placebo Run-In Phase||0
11028860|NCT00843024|12207832|FG003|COMPLETED|Single-blind Placebo Run-In Phase||0
11028861|NCT00843024|12207833|FG004|COMPLETED|Single-blind Placebo Run-In Phase||0
11028862|NCT00843024|12207834|FG005|COMPLETED|Single-blind Placebo Run-In Phase||0
11028863|NCT00843024|12207829|FG000|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
11028864|NCT00843024|12207830|FG001|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
11028865|NCT00843024|12207831|FG002|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
11028866|NCT00843024|12207832|FG003|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
11028867|NCT00843024|12207833|FG004|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
11028868|NCT00843024|12207834|FG005|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
11028869|NCT00843024|12207829|FG000|STARTED|Double-blind Treatment Phase||0
11028870|NCT00843024|12207830|FG001|STARTED|Double-blind Treatment Phase||0
11028871|NCT00843024|12207831|FG002|STARTED|Double-blind Treatment Phase||176
11028872|NCT00843024|12207832|FG003|STARTED|Double-blind Treatment Phase||119
11028873|NCT00843024|12207833|FG004|STARTED|Double-blind Treatment Phase||117
11028874|NCT00843024|12207834|FG005|STARTED|Double-blind Treatment Phase||177
11028875|NCT00843024|12207829|FG000|COMPLETED|Double-blind Treatment Phase||0
11028876|NCT00843024|12207830|FG001|COMPLETED|Double-blind Treatment Phase||0
11028877|NCT00843024|12207831|FG002|COMPLETED|Double-blind Treatment Phase||145
11028878|NCT00843024|12207832|FG003|COMPLETED|Double-blind Treatment Phase||96
11028879|NCT00843024|12207833|FG004|COMPLETED|Double-blind Treatment Phase||97
11028880|NCT00843024|12207834|FG005|COMPLETED|Double-blind Treatment Phase||152
11028881|NCT00843024|12207829|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
11028882|NCT00843024|12207830|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
11028883|NCT00843024|12207831|FG002|NOT COMPLETED|Double-blind Treatment Phase||31
11028884|NCT00843024|12207832|FG003|NOT COMPLETED|Double-blind Treatment Phase||23
11028885|NCT00843024|12207833|FG004|NOT COMPLETED|Double-blind Treatment Phase||20
11028886|NCT00843024|12207834|FG005|NOT COMPLETED|Double-blind Treatment Phase||25
11028887|NCT00843115|12207847|FG000|STARTED|Overall Study||370
11028888|NCT00843115|12207847|FG000|COMPLETED|Overall Study||304
11028889|NCT00843115|12207847|FG000|NOT COMPLETED|Overall Study||66
11028890|NCT00843167|12207853|FG000|STARTED|Treatment Period||27
11028891|NCT00843167|12207854|FG001|STARTED|Treatment Period||27
11028892|NCT00843167|12207853|FG000|COMPLETED|Treatment Period||24
11028893|NCT00843167|12207854|FG001|COMPLETED|Treatment Period||19
11028894|NCT00843167|12207853|FG000|NOT COMPLETED|Treatment Period||3
11028895|NCT00843167|12207854|FG001|NOT COMPLETED|Treatment Period||8
11028896|NCT00843167|12207853|FG000|STARTED|Follow-up||24
11028897|NCT00843167|12207854|FG001|STARTED|Follow-up||24
11028898|NCT00843167|12207853|FG000|Completed Final Visit|Follow-up||24
11028899|NCT00843167|12207854|FG001|Completed Final Visit|Follow-up||24
11028900|NCT00843167|12207853|FG000|COMPLETED|Follow-up||24
11028901|NCT00843167|12207854|FG001|COMPLETED|Follow-up||24
11028902|NCT00843167|12207853|FG000|NOT COMPLETED|Follow-up||0
11028903|NCT00843167|12207854|FG001|NOT COMPLETED|Follow-up||0
11028904|NCT00843180|12207866|FG000|STARTED|Overall Study||16
11028905|NCT00843180|12207867|FG001|STARTED|Overall Study||7
11028906|NCT00843180|12207866|FG000|COMPLETED|Overall Study||16
11028907|NCT00843180|12207867|FG001|COMPLETED|Overall Study||7
11028908|NCT00843180|12207866|FG000|NOT COMPLETED|Overall Study||0
11028909|NCT00843180|12207867|FG001|NOT COMPLETED|Overall Study||0
11028910|NCT00843193|12207875|FG000|STARTED|Overall Study||99
11028911|NCT00843193|12207876|FG001|STARTED|Overall Study||99
11028912|NCT00843193|12207875|FG000|COMPLETED|Overall Study||91
11028913|NCT00843193|12207876|FG001|COMPLETED|Overall Study||88
11028914|NCT00843193|12207875|FG000|NOT COMPLETED|Overall Study||8
11028915|NCT00843193|12207876|FG001|NOT COMPLETED|Overall Study||11
11028916|NCT00843284|12207883|FG000|STARTED|Overall Study||691
11028917|NCT00843284|12207883|FG000|COMPLETED|Overall Study||619
11028918|NCT00843284|12207883|FG000|NOT COMPLETED|Overall Study||72
11028919|NCT00843349|12207891|FG000|STARTED|Overall Study||11
11028920|NCT00843349|12207892|FG001|STARTED|Overall Study||11
11028921|NCT00843349|12207893|FG002|STARTED|Overall Study||10
11028922|NCT00843349|12207894|FG003|STARTED|Overall Study||11
11028923|NCT00843349|12207891|FG000|COMPLETED|Overall Study||8
11028924|NCT00843349|12207892|FG001|COMPLETED|Overall Study||11
11028925|NCT00843349|12207893|FG002|COMPLETED|Overall Study||10
11028926|NCT00843349|12207894|FG003|COMPLETED|Overall Study||10
11028927|NCT00843349|12207891|FG000|NOT COMPLETED|Overall Study||3
11028928|NCT00843349|12207892|FG001|NOT COMPLETED|Overall Study||0
11028929|NCT00843349|12207893|FG002|NOT COMPLETED|Overall Study||0
11028930|NCT00843349|12207894|FG003|NOT COMPLETED|Overall Study||1
11028931|NCT00843466|12207906|FG000|STARTED|Overall Study||24
11028932|NCT00843466|12207907|FG001|STARTED|Overall Study||18
11028933|NCT00843466|12207906|FG000|COMPLETED|Overall Study||24
11028934|NCT00843466|12207907|FG001|COMPLETED|Overall Study||18
11028935|NCT00843466|12207906|FG000|NOT COMPLETED|Overall Study||0
11028936|NCT00843466|12207907|FG001|NOT COMPLETED|Overall Study||0
11028937|NCT00843479|12207915|FG000|STARTED|Overall Study||12
11028938|NCT00843479|12207916|FG001|STARTED|Overall Study||12
11028939|NCT00843479|12207915|FG000|COMPLETED|Overall Study||12
11028940|NCT00843479|12207916|FG001|COMPLETED|Overall Study||12
11028941|NCT00843479|12207915|FG000|NOT COMPLETED|Overall Study||0
11028942|NCT00843479|12207916|FG001|NOT COMPLETED|Overall Study||0
11028943|NCT00843492|12207926|FG000|STARTED|Overall Study||622
11028944|NCT00843492|12207927|FG001|STARTED|Overall Study||621
11028945|NCT00843492|12207926|FG000|COMPLETED|Overall Study||614
11028946|NCT00843492|12207927|FG001|COMPLETED|Overall Study||607
11028947|NCT00843492|12207926|FG000|NOT COMPLETED|Overall Study||8
11028948|NCT00843492|12207927|FG001|NOT COMPLETED|Overall Study||14
11028949|NCT00843518|12207935|FG000|STARTED|Period 2 (Double-blind Treatment)||63
11028950|NCT00843518|12207936|FG001|STARTED|Period 2 (Double-blind Treatment)||69
11028951|NCT00843518|12207935|FG000|COMPLETED|Period 2 (Double-blind Treatment)||43
11028952|NCT00843518|12207936|FG001|COMPLETED|Period 2 (Double-blind Treatment)||49
11028953|NCT00843518|12207935|FG000|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
11028954|NCT00843518|12207936|FG001|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
11028955|NCT00843518|12207935|FG000|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
11028956|NCT00843518|12207936|FG001|STARTED|Period 3 (Single-blind Washout)||49
11028957|NCT00843518|12207935|FG000|COMPLETED|Period 3 (Single-blind Washout)||42
11028958|NCT00843518|12207936|FG001|COMPLETED|Period 3 (Single-blind Washout)||49
11028959|NCT00843518|12207935|FG000|NOT COMPLETED|Period 3 (Single-blind Washout)||0
11333011|NCT02825992|12530489|FG000|STARTED|Overall Study|The procedure was terminated for clinical reasons in 2 patients, therefore only 127 were treated.|129
11333012|NCT02825992|12530489|FG000|COMPLETED|Overall Study||121
11333013|NCT02825992|12530489|FG000|NOT COMPLETED|Overall Study||8
11333014|NCT02826421|12530503|FG000|STARTED|Overall Study||22
11333015|NCT02826421|12530504|FG001|STARTED|Overall Study||29
11333016|NCT02826421|12530505|FG002|STARTED|Overall Study||28
11333017|NCT02826421|12530506|FG003|STARTED|Overall Study||30
11333018|NCT02826421|12530503|FG000|Treated|Overall Study||19
11333019|NCT02826421|12530504|FG001|Treated|Overall Study||26
11333020|NCT02826421|12530505|FG002|Treated|Overall Study||26
11333021|NCT02826421|12530506|FG003|Treated|Overall Study||28
11333022|NCT02826421|12530503|FG000|COMPLETED|Overall Study||19
11333023|NCT02826421|12530504|FG001|COMPLETED|Overall Study||26
11333024|NCT02826421|12530505|FG002|COMPLETED|Overall Study||26
11028960|NCT00843518|12207936|FG001|NOT COMPLETED|Period 3 (Single-blind Washout)||0
11028961|NCT00843531|12207946|FG000|STARTED|Overall Study||17
11028962|NCT00843531|12207946|FG000|COMPLETED|Overall Study||17
11028963|NCT00843531|12207946|FG000|NOT COMPLETED|Overall Study||0
11028964|NCT00843622|12207956|FG000|STARTED|Overall Study||125
11028965|NCT00843622|12207957|FG001|STARTED|Overall Study||125
11333025|NCT02826421|12530506|FG003|COMPLETED|Overall Study||28
11028966|NCT00843622|12207956|FG000|COMPLETED|Overall Study||82
11028967|NCT00843622|12207957|FG001|COMPLETED|Overall Study||70
11028968|NCT00843622|12207956|FG000|NOT COMPLETED|Overall Study||43
11028969|NCT00843622|12207957|FG001|NOT COMPLETED|Overall Study||55
11028970|NCT00843635|12207966|FG000|STARTED|Overall Study||15
11028971|NCT00843635|12207967|FG001|STARTED|Overall Study||15
11028972|NCT00843635|12207968|FG002|STARTED|Overall Study||5
11028973|NCT00843635|12207966|FG000|COMPLETED|Overall Study||13
11028974|NCT00843635|12207967|FG001|COMPLETED|Overall Study||13
11028975|NCT00843635|12207968|FG002|COMPLETED|Overall Study||5
11028976|NCT00843635|12207966|FG000|NOT COMPLETED|Overall Study||2
11028977|NCT00843635|12207967|FG001|NOT COMPLETED|Overall Study||2
11028978|NCT00843635|12207968|FG002|NOT COMPLETED|Overall Study||0
11028979|NCT00843713|12207982|FG000|STARTED|Overall Study||30
11028980|NCT00843713|12207983|FG001|STARTED|Overall Study||26
11028981|NCT00843713|12207982|FG000|COMPLETED|Overall Study||30
11028982|NCT00843713|12207983|FG001|COMPLETED|Overall Study||26
11028983|NCT00843713|12207982|FG000|NOT COMPLETED|Overall Study||0
11028984|NCT00843713|12207983|FG001|NOT COMPLETED|Overall Study||0
11028985|NCT00843726|12207991|FG000|STARTED|Overall Study||49
11028986|NCT00843726|12207992|FG001|STARTED|Overall Study||49
11028987|NCT00843726|12207991|FG000|COMPLETED|Overall Study||48
11028988|NCT00843726|12207992|FG001|COMPLETED|Overall Study||48
11028989|NCT00843726|12207991|FG000|NOT COMPLETED|Overall Study||1
11028990|NCT00843726|12207992|FG001|NOT COMPLETED|Overall Study||1
11028991|NCT00843778|12207999|FG000|STARTED|Overall Study||131
11028992|NCT00843778|12207999|FG000|COMPLETED|Overall Study||96
11028993|NCT00843778|12207999|FG000|NOT COMPLETED|Overall Study||35
11028994|NCT00843843|12208005|FG000|STARTED|Overall Study||8
11028995|NCT00843843|12208006|FG001|STARTED|Overall Study||8
11028996|NCT00843843|12208005|FG000|COMPLETED|Overall Study||6
11028997|NCT00843843|12208006|FG001|COMPLETED|Overall Study||6
11028998|NCT00843843|12208005|FG000|NOT COMPLETED|Overall Study||2
11028999|NCT00843843|12208006|FG001|NOT COMPLETED|Overall Study||2
11029000|NCT00843856|12208014|FG000|STARTED|Overall Study||20
11029001|NCT00843856|12208015|FG001|STARTED|Overall Study||20
11029002|NCT00843856|12208014|FG000|COMPLETED|Overall Study||19
11029003|NCT00843856|12208015|FG001|COMPLETED|Overall Study||18
11029004|NCT00843856|12208014|FG000|NOT COMPLETED|Overall Study||1
11029005|NCT00843856|12208015|FG001|NOT COMPLETED|Overall Study||2
11029006|NCT00844051|12208023|FG000|STARTED|Overall Study||2087
11029007|NCT00844051|12208024|FG001|STARTED|Overall Study||2368
11029008|NCT00844051|12208023|FG000|COMPLETED|Overall Study||2087
11333026|NCT02826421|12530503|FG000|NOT COMPLETED|Overall Study||3
11333027|NCT02826421|12530504|FG001|NOT COMPLETED|Overall Study||3
11029009|NCT00844051|12208024|FG001|COMPLETED|Overall Study||2368
11029010|NCT00844051|12208023|FG000|NOT COMPLETED|Overall Study||0
11029011|NCT00844051|12208024|FG001|NOT COMPLETED|Overall Study||0
11029012|NCT00844090|12208032|FG000|STARTED|Overall Study||52
11029013|NCT00844090|12208033|FG001|STARTED|Overall Study||54
11029014|NCT00844090|12208032|FG000|COMPLETED|Overall Study||46
11029015|NCT00844090|12208033|FG001|COMPLETED|Overall Study||46
11029016|NCT00844090|12208032|FG000|NOT COMPLETED|Overall Study||6
11029017|NCT00844090|12208033|FG001|NOT COMPLETED|Overall Study||8
11029018|NCT00844194|12208041|FG000|STARTED|Overall Study||78
11029019|NCT00844194|12208042|FG001|STARTED|Overall Study||30
11029020|NCT00844194|12208041|FG000|COMPLETED|Overall Study||53
11029021|NCT00844194|12208042|FG001|COMPLETED|Overall Study||22
11333028|NCT02826421|12530505|FG002|NOT COMPLETED|Overall Study||2
11333029|NCT02826421|12530506|FG003|NOT COMPLETED|Overall Study||2
11333030|NCT02826603|12530519|FG000|STARTED|Overall Study||550
11333031|NCT02826603|12530520|FG001|STARTED|Overall Study||552
11333032|NCT02826603|12530519|FG000|COMPLETED|Overall Study||489
11333033|NCT02826603|12530520|FG001|COMPLETED|Overall Study||488
11333034|NCT02826603|12530519|FG000|NOT COMPLETED|Overall Study||61
11333035|NCT02826603|12530520|FG001|NOT COMPLETED|Overall Study||64
11333036|NCT02826694|12530529|FG000|STARTED|Overall Study||61
11333037|NCT02826694|12530530|FG001|STARTED|Overall Study||45
11333038|NCT02826694|12530529|FG000|Decision Group|Overall Study||41
11333039|NCT02826694|12530530|FG001|Decision Group|Overall Study||30
11333040|NCT02826694|12530529|FG000|Control Group|Overall Study||20
11333041|NCT02826694|12530530|FG001|Control Group|Overall Study||15
11029022|NCT00844194|12208041|FG000|NOT COMPLETED|Overall Study||25
11029023|NCT00844194|12208042|FG001|NOT COMPLETED|Overall Study||8
11029024|NCT00844298|12208052|FG000|STARTED|Overall Study||91
11029025|NCT00844298|12208052|FG000|COMPLETED|Overall Study||91
11029026|NCT00844298|12208052|FG000|NOT COMPLETED|Overall Study||0
11029027|NCT00844376|12208056|FG000|STARTED|Period 1: First Intervention||6
11029028|NCT00844376|12208057|FG001|STARTED|Period 1: First Intervention||6
11029029|NCT00844376|12208056|FG000|COMPLETED|Period 1: First Intervention||5
11029030|NCT00844376|12208057|FG001|COMPLETED|Period 1: First Intervention||6
11029031|NCT00844376|12208056|FG000|NOT COMPLETED|Period 1: First Intervention||1
11029032|NCT00844376|12208057|FG001|NOT COMPLETED|Period 1: First Intervention||0
11029033|NCT00844376|12208056|FG000|STARTED|Period 2: Second Intervention||5
11029034|NCT00844376|12208057|FG001|STARTED|Period 2: Second Intervention||6
11029035|NCT00844376|12208056|FG000|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
11029036|NCT00844376|12208057|FG001|COMPLETED|Period 2: Second Intervention||6
11029037|NCT00844376|12208056|FG000|NOT COMPLETED|Period 2: Second Intervention||0
11029038|NCT00844376|12208057|FG001|NOT COMPLETED|Period 2: Second Intervention||0
11029039|NCT00844415|12208063|FG000|STARTED|Overall Study|Entered and treated.|9
11029040|NCT00844415|12208063|FG000|Pat. Received 75mg Followed by 100mg|Overall Study||3
11029041|NCT00844415|12208063|FG000|Pat. Received 100mg Followed by 125mg|Overall Study||3
11029042|NCT00844415|12208063|FG000|Pat. Received 125mg Followed by 150mg|Overall Study||2
11029043|NCT00844415|12208063|FG000|Pat. Received Single Dose 75mg|Overall Study||1
11029044|NCT00844415|12208063|FG000|COMPLETED|Overall Study|Completed.|8
11029045|NCT00844415|12208063|FG000|NOT COMPLETED|Overall Study||1
11029046|NCT00844428|12208068|FG000|STARTED|Screening Period||23
11029047|NCT00844428|12208068|FG000|COMPLETED|Screening Period||20
11029048|NCT00844428|12208068|FG000|NOT COMPLETED|Screening Period||3
11029049|NCT00844428|12208068|FG000|STARTED|Observation Period (8 Weeks)||20
11029050|NCT00844428|12208068|FG000|COMPLETED|Observation Period (8 Weeks)||20
11029051|NCT00844428|12208068|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0
11029052|NCT00844428|12208068|FG000|STARTED|Treatment Period (26 Weeks)||20
11029053|NCT00844428|12208068|FG000|COMPLETED|Treatment Period (26 Weeks)||20
11029054|NCT00844428|12208068|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0
11029055|NCT00844428|12208068|FG000|STARTED|Extension Treatment Period||19
11029056|NCT00844428|12208068|FG000|COMPLETED|Extension Treatment Period||18
11029057|NCT00844428|12208068|FG000|NOT COMPLETED|Extension Treatment Period||1
11029058|NCT00844428|12208068|FG000|STARTED|Post Treatment Period (Patients Who Disc||5
11333042|NCT02826694|12530529|FG000|COMPLETED|Overall Study||61
11333043|NCT02826694|12530530|FG001|COMPLETED|Overall Study||45
11333044|NCT02826694|12530529|FG000|NOT COMPLETED|Overall Study||0
11333045|NCT02826694|12530530|FG001|NOT COMPLETED|Overall Study||0
11029059|NCT00844428|12208068|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4
11029060|NCT00844428|12208068|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
11029061|NCT00844519|12208074|FG000|STARTED|Overall Study||26
11029062|NCT00844519|12208075|FG001|STARTED|Overall Study||26
11029063|NCT00844519|12208074|FG000|COMPLETED|Overall Study||24
11029064|NCT00844519|12208075|FG001|COMPLETED|Overall Study||25
11029065|NCT00844519|12208074|FG000|NOT COMPLETED|Overall Study||2
11029066|NCT00844519|12208075|FG001|NOT COMPLETED|Overall Study||1
11029067|NCT00844532|12208081|FG000|STARTED|Overall Study||151
11029068|NCT00844532|12208081|FG000|COMPLETED|Overall Study||112
11029069|NCT00844532|12208081|FG000|NOT COMPLETED|Overall Study||39
11029070|NCT00844545|12208085|FG000|STARTED|Screening Period||17
11029071|NCT00844545|12208085|FG000|COMPLETED|Screening Period||17
11029072|NCT00844545|12208085|FG000|NOT COMPLETED|Screening Period||0
11029073|NCT00844545|12208085|FG000|STARTED|Treatment Period (26 Weeks)||17
11029074|NCT00844545|12208085|FG000|COMPLETED|Treatment Period (26 Weeks)||15
11029075|NCT00844545|12208085|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2
11029076|NCT00844545|12208085|FG000|STARTED|Extension Treatment Period||13
11029077|NCT00844545|12208085|FG000|COMPLETED|Extension Treatment Period||11
11029078|NCT00844545|12208085|FG000|NOT COMPLETED|Extension Treatment Period||2
11029079|NCT00844545|12208085|FG000|STARTED|Post Treatment Period||6
11029080|NCT00844545|12208085|FG000|COMPLETED|Post Treatment Period||5
11333046|NCT02826798|12530543|FG000|STARTED|Overall Study||25
11333047|NCT02826798|12530544|FG001|STARTED|Overall Study||26
11029081|NCT00844545|12208085|FG000|NOT COMPLETED|Post Treatment Period||1
11029082|NCT00844558|12208092|FG000|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
11029083|NCT00844558|12208093|FG001|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
11029084|NCT00844558|12208092|FG000|Received Allocated Intervention|Overall Study||33
11029085|NCT00844558|12208093|FG001|Received Allocated Intervention|Overall Study||21
11029086|NCT00844558|12208092|FG000|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
11029087|NCT00844558|12208093|FG001|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
11029088|NCT00844558|12208092|FG000|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
11029089|NCT00844558|12208093|FG001|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
11029090|NCT00844558|12208092|FG000|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
11029091|NCT00844558|12208093|FG001|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
11029092|NCT00844558|12208092|FG000|COMPLETED|Overall Study||24
11029093|NCT00844558|12208093|FG001|COMPLETED|Overall Study||18
11029094|NCT00844558|12208092|FG000|NOT COMPLETED|Overall Study||12
11029095|NCT00844558|12208093|FG001|NOT COMPLETED|Overall Study||4
11029096|NCT00844597|12208110|FG000|STARTED|Overall Study||4
11029097|NCT00844597|12208111|FG001|STARTED|Overall Study||2
11029098|NCT00844597|12208112|FG002|STARTED|Overall Study||2
11029099|NCT00844597|12208113|FG003|STARTED|Overall Study||3
11029100|NCT00844597|12208114|FG004|STARTED|Overall Study||4
11029101|NCT00844597|12208115|FG005|STARTED|Overall Study||4
11029102|NCT00844597|12208110|FG000|COMPLETED|Overall Study||4
11029103|NCT00844597|12208111|FG001|COMPLETED|Overall Study||2
11029104|NCT00844597|12208112|FG002|COMPLETED|Overall Study||2
11029105|NCT00844597|12208113|FG003|COMPLETED|Overall Study||2
11029106|NCT00844597|12208114|FG004|COMPLETED|Overall Study||4
11029107|NCT00844597|12208115|FG005|COMPLETED|Overall Study||4
11029108|NCT00844597|12208110|FG000|NOT COMPLETED|Overall Study||0
11029109|NCT00844597|12208111|FG001|NOT COMPLETED|Overall Study||0
11029110|NCT00844597|12208112|FG002|NOT COMPLETED|Overall Study||0
11029111|NCT00844597|12208113|FG003|NOT COMPLETED|Overall Study||1
11029112|NCT00844597|12208114|FG004|NOT COMPLETED|Overall Study||0
11029113|NCT00844597|12208115|FG005|NOT COMPLETED|Overall Study||0
11029114|NCT00844649|12208133|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
11333048|NCT02826798|12530545|FG002|STARTED|Overall Study||26
11333049|NCT02826798|12530546|FG003|STARTED|Overall Study||25
11333050|NCT02826798|12530547|FG004|STARTED|Overall Study||26
11333051|NCT02826798|12530543|FG000|COMPLETED|Overall Study||25
11333052|NCT02826798|12530544|FG001|COMPLETED|Overall Study||25
11333053|NCT02826798|12530545|FG002|COMPLETED|Overall Study||26
11333054|NCT02826798|12530546|FG003|COMPLETED|Overall Study||24
11333055|NCT02826798|12530547|FG004|COMPLETED|Overall Study||26
11333056|NCT02826798|12530543|FG000|NOT COMPLETED|Overall Study||0
11333057|NCT02826798|12530544|FG001|NOT COMPLETED|Overall Study||1
11333058|NCT02826798|12530545|FG002|NOT COMPLETED|Overall Study||0
11333059|NCT02826798|12530546|FG003|NOT COMPLETED|Overall Study||1
11333060|NCT02826798|12530547|FG004|NOT COMPLETED|Overall Study||0
11333061|NCT02827500|12530561|FG000|STARTED|Overall Study||52
11333062|NCT02827500|12530562|FG001|STARTED|Overall Study||52
11333063|NCT02827500|12530561|FG000|COMPLETED|Overall Study||33
11333064|NCT02827500|12530562|FG001|COMPLETED|Overall Study||45
11333065|NCT02827500|12530561|FG000|NOT COMPLETED|Overall Study||19
11333066|NCT02827500|12530562|FG001|NOT COMPLETED|Overall Study||7
11333067|NCT02827708|12530570|FG000|STARTED|Overall Study||163
11333068|NCT02827708|12530571|FG001|STARTED|Overall Study||161
11333069|NCT02827708|12530570|FG000|Full Analysis Set (FAS)|Overall Study||163
11333070|NCT02827708|12530571|FG001|Full Analysis Set (FAS)|Overall Study||161
11333071|NCT02827708|12530570|FG000|Safety Analysis Set (SAS)|Overall Study||163
11333072|NCT02827708|12530571|FG001|Safety Analysis Set (SAS)|Overall Study||161
11333073|NCT02827708|12530570|FG000|COMPLETED|Overall Study||158
11333074|NCT02827708|12530571|FG001|COMPLETED|Overall Study||156
11333075|NCT02827708|12530570|FG000|NOT COMPLETED|Overall Study||5
11333076|NCT02827708|12530571|FG001|NOT COMPLETED|Overall Study||5
11333077|NCT02828020|12530580|FG000|STARTED|Treatment Period||559
11029115|NCT00844649|12208134|FG001|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
11333078|NCT02828020|12530581|FG001|STARTED|Treatment Period||556
11333079|NCT02828020|12530582|FG002|STARTED|Treatment Period||557
11333080|NCT02828020|12530580|FG000|Safety Population: Received Study Drug|Treatment Period||485
11029116|NCT00844649|12208133|FG000|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
11029117|NCT00844649|12208134|FG001|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
11029118|NCT00844649|12208133|FG000|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
11029119|NCT00844649|12208134|FG001|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
11029120|NCT00844649|12208133|FG000|NOT COMPLETED|Overall Study||405
11029121|NCT00844649|12208134|FG001|NOT COMPLETED|Overall Study||418
11029122|NCT00844714|12208142|FG000|STARTED|Overall Study||20
11029123|NCT00844714|12208142|FG000|COMPLETED|Overall Study||20
11029124|NCT00844714|12208142|FG000|NOT COMPLETED|Overall Study||0
11029125|NCT00844753|12208150|FG000|STARTED|Overall Study||32
11029126|NCT00844753|12208151|FG001|STARTED|Overall Study||32
11029127|NCT00844753|12208152|FG002|STARTED|Overall Study||32
11029128|NCT00844753|12208153|FG003|STARTED|Overall Study||32
11029129|NCT00844753|12208150|FG000|COMPLETED|Overall Study||24
11029130|NCT00844753|12208151|FG001|COMPLETED|Overall Study||29
11029131|NCT00844753|12208152|FG002|COMPLETED|Overall Study||25
11029132|NCT00844753|12208153|FG003|COMPLETED|Overall Study||21
11029133|NCT00844753|12208150|FG000|NOT COMPLETED|Overall Study||8
11029134|NCT00844753|12208151|FG001|NOT COMPLETED|Overall Study||3
11029135|NCT00844753|12208152|FG002|NOT COMPLETED|Overall Study||7
11029136|NCT00844753|12208153|FG003|NOT COMPLETED|Overall Study||11
11029137|NCT00844805|12208163|FG000|STARTED|Treatment Phase||106
11029138|NCT00844805|12208164|FG001|STARTED|Treatment Phase||52
11029139|NCT00844805|12208165|FG002|STARTED|Treatment Phase||0
11029140|NCT00844805|12208166|FG003|STARTED|Treatment Phase||0
11029141|NCT00844805|12208163|FG000|COMPLETED|Treatment Phase||96
11029142|NCT00844805|12208164|FG001|COMPLETED|Treatment Phase||45
11029143|NCT00844805|12208165|FG002|COMPLETED|Treatment Phase||0
11029144|NCT00844805|12208166|FG003|COMPLETED|Treatment Phase||0
11029145|NCT00844805|12208163|FG000|NOT COMPLETED|Treatment Phase||10
11029146|NCT00844805|12208164|FG001|NOT COMPLETED|Treatment Phase||7
11029147|NCT00844805|12208165|FG002|NOT COMPLETED|Treatment Phase||0
11029148|NCT00844805|12208166|FG003|NOT COMPLETED|Treatment Phase||0
11029149|NCT00844805|12208163|FG000|STARTED|Follow-Up Phase||0
11029150|NCT00844805|12208164|FG001|STARTED|Follow-Up Phase||0
11029151|NCT00844805|12208165|FG002|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
11029152|NCT00844805|12208166|FG003|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
11029153|NCT00844805|12208163|FG000|COMPLETED|Follow-Up Phase||0
11029154|NCT00844805|12208164|FG001|COMPLETED|Follow-Up Phase||0
11333081|NCT02828020|12530581|FG001|Safety Population: Received Study Drug|Treatment Period||466
11333082|NCT02828020|12530582|FG002|Safety Population: Received Study Drug|Treatment Period||485
11333083|NCT02828020|12530580|FG000|COMPLETED|Treatment Period||479
11333084|NCT02828020|12530581|FG001|COMPLETED|Treatment Period||457
11333085|NCT02828020|12530582|FG002|COMPLETED|Treatment Period||479
11333086|NCT02828020|12530580|FG000|NOT COMPLETED|Treatment Period||80
11029155|NCT00844805|12208165|FG002|COMPLETED|Follow-Up Phase||32
11029156|NCT00844805|12208166|FG003|COMPLETED|Follow-Up Phase||32
11029157|NCT00844805|12208163|FG000|NOT COMPLETED|Follow-Up Phase||0
11029158|NCT00844805|12208164|FG001|NOT COMPLETED|Follow-Up Phase||0
11029159|NCT00844805|12208165|FG002|NOT COMPLETED|Follow-Up Phase||9
11333087|NCT02828020|12530581|FG001|NOT COMPLETED|Treatment Period||99
11333088|NCT02828020|12530582|FG002|NOT COMPLETED|Treatment Period||78
11333089|NCT02828020|12530580|FG000|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
11333090|NCT02828020|12530581|FG001|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458
11333091|NCT02828020|12530582|FG002|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
11333092|NCT02828020|12530580|FG000|COMPLETED|Safety Follow-up Period||460
11333093|NCT02828020|12530581|FG001|COMPLETED|Safety Follow-up Period||440
11333094|NCT02828020|12530582|FG002|COMPLETED|Safety Follow-up Period||461
11333095|NCT02828020|12530580|FG000|NOT COMPLETED|Safety Follow-up Period||20
11333096|NCT02828020|12530581|FG001|NOT COMPLETED|Safety Follow-up Period||18
11029160|NCT00844805|12208166|FG003|NOT COMPLETED|Follow-Up Phase||9
11029161|NCT00844831|12208177|FG000|STARTED|Overall Study||25
11029162|NCT00844831|12208177|FG000|COMPLETED|Overall Study||19
11029163|NCT00844831|12208177|FG000|NOT COMPLETED|Overall Study||6
11029164|NCT00844844|12208185|FG000|STARTED|Screening Period||17
11029165|NCT00844844|12208185|FG000|COMPLETED|Screening Period||17
11029166|NCT00844844|12208185|FG000|NOT COMPLETED|Screening Period||0
11029167|NCT00844844|12208185|FG000|STARTED|Treatment Period (26 Weeks)||17
11029168|NCT00844844|12208185|FG000|COMPLETED|Treatment Period (26 Weeks)||15
11029169|NCT00844844|12208185|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2
11029170|NCT00844844|12208185|FG000|STARTED|Extension Treatment Period||13
11029171|NCT00844844|12208185|FG000|COMPLETED|Extension Treatment Period||11
11029172|NCT00844844|12208185|FG000|NOT COMPLETED|Extension Treatment Period||2
11333097|NCT02828020|12530582|FG002|NOT COMPLETED|Safety Follow-up Period||19
11333098|NCT02828111|12530595|FG000|STARTED|Overall Study||6
11333099|NCT02828111|12530596|FG001|STARTED|Overall Study||6
11333100|NCT02828111|12530597|FG002|STARTED|Overall Study||6
11029173|NCT00844844|12208185|FG000|STARTED|Post Treatment Period||6
11029174|NCT00844844|12208185|FG000|COMPLETED|Post Treatment Period||5
11029175|NCT00844844|12208185|FG000|NOT COMPLETED|Post Treatment Period||1
11029176|NCT00844857|12208191|FG000|STARTED|Overall Study||194
11029177|NCT00844857|12208192|FG001|STARTED|Overall Study||97
11029178|NCT00844857|12208191|FG000|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
11029179|NCT00844857|12208192|FG001|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
11029180|NCT00844857|12208191|FG000|COMPLETED|Overall Study||116
11029181|NCT00844857|12208192|FG001|COMPLETED|Overall Study||60
11029182|NCT00844857|12208191|FG000|NOT COMPLETED|Overall Study||78
11029183|NCT00844857|12208192|FG001|NOT COMPLETED|Overall Study||37
11029184|NCT00844883|12208201|FG000|STARTED|Overall Study||50
11029185|NCT00844883|12208201|FG000|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
11029186|NCT00844883|12208201|FG000|COMPLETED|Overall Study||46
11029187|NCT00844883|12208201|FG000|NOT COMPLETED|Overall Study||4
11029188|NCT00844896|12208207|FG000|STARTED|Overall Study||29
11029189|NCT00844896|12208208|FG001|STARTED|Overall Study||28
11029190|NCT00844896|12208207|FG000|COMPLETED|Overall Study||17
11029191|NCT00844896|12208208|FG001|COMPLETED|Overall Study||11
11029192|NCT00844896|12208207|FG000|NOT COMPLETED|Overall Study||12
11029193|NCT00844896|12208208|FG001|NOT COMPLETED|Overall Study||17
11029194|NCT00845000|12208221|FG000|STARTED|Period 1||2
11029195|NCT00845000|12208222|FG001|STARTED|Period 1||2
11029196|NCT00845000|12208223|FG002|STARTED|Period 1||2
11029197|NCT00845000|12208224|FG003|STARTED|Period 1||2
11029198|NCT00845000|12208225|FG004|STARTED|Period 1||2
11029199|NCT00845000|12208226|FG005|STARTED|Period 1||2
11029200|NCT00845000|12208221|FG000|COMPLETED|Period 1||2
11029201|NCT00845000|12208222|FG001|COMPLETED|Period 1||2
11029202|NCT00845000|12208223|FG002|COMPLETED|Period 1||2
11029203|NCT00845000|12208224|FG003|COMPLETED|Period 1||2
11029204|NCT00845000|12208225|FG004|COMPLETED|Period 1||2
11029205|NCT00845000|12208226|FG005|COMPLETED|Period 1||2
11029206|NCT00845000|12208221|FG000|NOT COMPLETED|Period 1||0
11029207|NCT00845000|12208222|FG001|NOT COMPLETED|Period 1||0
11029208|NCT00845000|12208223|FG002|NOT COMPLETED|Period 1||0
11029209|NCT00845000|12208224|FG003|NOT COMPLETED|Period 1||0
11029210|NCT00845000|12208225|FG004|NOT COMPLETED|Period 1||0
11029211|NCT00845000|12208226|FG005|NOT COMPLETED|Period 1||0
11029212|NCT00845000|12208221|FG000|STARTED|Period 2||2
11029213|NCT00845000|12208222|FG001|STARTED|Period 2||2
11029214|NCT00845000|12208223|FG002|STARTED|Period 2||2
11029215|NCT00845000|12208224|FG003|STARTED|Period 2||2
11029216|NCT00845000|12208225|FG004|STARTED|Period 2||2
11029217|NCT00845000|12208226|FG005|STARTED|Period 2||2
11029218|NCT00845000|12208221|FG000|COMPLETED|Period 2||2
11029219|NCT00845000|12208222|FG001|COMPLETED|Period 2||2
11029220|NCT00845000|12208223|FG002|COMPLETED|Period 2||2
11029221|NCT00845000|12208224|FG003|COMPLETED|Period 2||2
11029222|NCT00845000|12208225|FG004|COMPLETED|Period 2||2
11029223|NCT00845000|12208226|FG005|COMPLETED|Period 2||2
11029224|NCT00845000|12208221|FG000|NOT COMPLETED|Period 2||0
11029225|NCT00845000|12208222|FG001|NOT COMPLETED|Period 2||0
11029226|NCT00845000|12208223|FG002|NOT COMPLETED|Period 2||0
11029227|NCT00845000|12208224|FG003|NOT COMPLETED|Period 2||0
11029228|NCT00845000|12208225|FG004|NOT COMPLETED|Period 2||0
11029229|NCT00845000|12208226|FG005|NOT COMPLETED|Period 2||0
11029230|NCT00845000|12208221|FG000|STARTED|Period 3||2
11029231|NCT00845000|12208222|FG001|STARTED|Period 3||2
11029232|NCT00845000|12208223|FG002|STARTED|Period 3||2
11029233|NCT00845000|12208224|FG003|STARTED|Period 3||2
11029234|NCT00845000|12208225|FG004|STARTED|Period 3||2
11029235|NCT00845000|12208226|FG005|STARTED|Period 3||2
11029236|NCT00845000|12208221|FG000|COMPLETED|Period 3||2
11029237|NCT00845000|12208222|FG001|COMPLETED|Period 3||2
11029238|NCT00845000|12208223|FG002|COMPLETED|Period 3||2
11029239|NCT00845000|12208224|FG003|COMPLETED|Period 3||2
11029240|NCT00845000|12208225|FG004|COMPLETED|Period 3||2
11029241|NCT00845000|12208226|FG005|COMPLETED|Period 3||2
11029242|NCT00845000|12208221|FG000|NOT COMPLETED|Period 3||0
11029243|NCT00845000|12208222|FG001|NOT COMPLETED|Period 3||0
11029244|NCT00845000|12208223|FG002|NOT COMPLETED|Period 3||0
11029245|NCT00845000|12208224|FG003|NOT COMPLETED|Period 3||0
11029246|NCT00845000|12208225|FG004|NOT COMPLETED|Period 3||0
11029247|NCT00845000|12208226|FG005|NOT COMPLETED|Period 3||0
11029248|NCT00845039|12208236|FG000|STARTED|Overall Study||2
11029249|NCT00845039|12208237|FG001|STARTED|Overall Study||2
11029250|NCT00845039|12208236|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
11029251|NCT00845039|12208237|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
11029252|NCT00845039|12208236|FG000|COMPLETED|Overall Study||2
11029253|NCT00845039|12208237|FG001|COMPLETED|Overall Study||2
11029254|NCT00845039|12208236|FG000|NOT COMPLETED|Overall Study||0
11029255|NCT00845039|12208237|FG001|NOT COMPLETED|Overall Study||0
11029256|NCT00845065|12208247|FG000|STARTED|Overall Study||67
11029257|NCT00845065|12208248|FG001|STARTED|Overall Study||134
11029258|NCT00845065|12208247|FG000|COMPLETED|Overall Study||20
11029259|NCT00845065|12208248|FG001|COMPLETED|Overall Study||79
11029260|NCT00845065|12208247|FG000|NOT COMPLETED|Overall Study||47
11029261|NCT00845065|12208248|FG001|NOT COMPLETED|Overall Study||55
11029262|NCT00845130|12208256|FG000|STARTED|Overall Study||20
11029263|NCT00845130|12208257|FG001|STARTED|Overall Study||22
11029264|NCT00845130|12208256|FG000|COMPLETED|Overall Study||16
11029265|NCT00845130|12208257|FG001|COMPLETED|Overall Study||19
11029266|NCT00845130|12208256|FG000|NOT COMPLETED|Overall Study||4
11029267|NCT00845130|12208257|FG001|NOT COMPLETED|Overall Study||3
11029268|NCT00845182|12208268|FG000|STARTED|Overall Study||13
11029269|NCT00845182|12208269|FG001|STARTED|Overall Study||15
11029270|NCT00845182|12208270|FG002|STARTED|Overall Study||15
11029271|NCT00845182|12208268|FG000|COMPLETED|Overall Study||10
11029272|NCT00845182|12208269|FG001|COMPLETED|Overall Study||11
11029273|NCT00845182|12208270|FG002|COMPLETED|Overall Study||9
11029274|NCT00845182|12208268|FG000|NOT COMPLETED|Overall Study||3
11029275|NCT00845182|12208269|FG001|NOT COMPLETED|Overall Study||4
11029276|NCT00845182|12208270|FG002|NOT COMPLETED|Overall Study||6
11029277|NCT00845195|12208284|FG000|STARTED|Overall Study||75
11029278|NCT00845195|12208285|FG001|STARTED|Overall Study||75
11029279|NCT00845195|12208284|FG000|COMPLETED|Overall Study||75
11029280|NCT00845195|12208285|FG001|COMPLETED|Overall Study||75
11029281|NCT00845195|12208284|FG000|NOT COMPLETED|Overall Study||0
11029282|NCT00845195|12208285|FG001|NOT COMPLETED|Overall Study||0
11029283|NCT00845429|12208294|FG000|STARTED|Overall Study||244
11029284|NCT00845429|12208295|FG001|STARTED|Overall Study||241
11029285|NCT00845429|12208296|FG002|STARTED|Overall Study||244
11029286|NCT00845429|12208294|FG000|COMPLETED|Overall Study||230
11029287|NCT00845429|12208295|FG001|COMPLETED|Overall Study||226
11029288|NCT00845429|12208296|FG002|COMPLETED|Overall Study||224
11029289|NCT00845429|12208294|FG000|NOT COMPLETED|Overall Study||14
11029290|NCT00845429|12208295|FG001|NOT COMPLETED|Overall Study||15
11029291|NCT00845429|12208296|FG002|NOT COMPLETED|Overall Study||20
11029292|NCT00845481|12208304|FG000|STARTED|Overall Study||24
11029293|NCT00845481|12208304|FG000|COMPLETED|Overall Study||24
11029294|NCT00845481|12208304|FG000|NOT COMPLETED|Overall Study||0
11029295|NCT00845507|12208315|FG000|STARTED|Overall Study||24
11029296|NCT00845507|12208316|FG001|STARTED|Overall Study||30
11029297|NCT00845507|12208315|FG000|COMPLETED|Overall Study||22
11029298|NCT00845507|12208316|FG001|COMPLETED|Overall Study||29
11029299|NCT00845507|12208315|FG000|NOT COMPLETED|Overall Study||2
11029300|NCT00845507|12208316|FG001|NOT COMPLETED|Overall Study||1
11029301|NCT00845520|12208325|FG000|STARTED|Overall Study||25
11029302|NCT00845520|12208326|FG001|STARTED|Overall Study||25
11029303|NCT00845520|12208327|FG002|STARTED|Overall Study||24
11029304|NCT00845520|12208325|FG000|COMPLETED|Overall Study||23
11029305|NCT00845520|12208326|FG001|COMPLETED|Overall Study||23
11029306|NCT00845520|12208327|FG002|COMPLETED|Overall Study||23
11029307|NCT00845520|12208325|FG000|NOT COMPLETED|Overall Study||2
11029308|NCT00845520|12208326|FG001|NOT COMPLETED|Overall Study||2
11029309|NCT00845520|12208327|FG002|NOT COMPLETED|Overall Study||1
11029310|NCT00845650|12208347|FG000|STARTED|Overall Study|1 subject not dosed|31
11029311|NCT00845650|12208348|FG001|STARTED|Overall Study||5
11029312|NCT00845650|12208349|FG002|STARTED|Overall Study||31
11029313|NCT00845650|12208350|FG003|STARTED|Overall Study||14
11029314|NCT00845650|12208351|FG004|STARTED|Overall Study|2 subjects not dosed|31
11029315|NCT00845650|12208352|FG005|STARTED|Overall Study|1 subject not dosed|17
11029316|NCT00845650|12208347|FG000|COMPLETED|Overall Study||30
11029317|NCT00845650|12208348|FG001|COMPLETED|Overall Study||5
11029318|NCT00845650|12208349|FG002|COMPLETED|Overall Study||28
11029319|NCT00845650|12208350|FG003|COMPLETED|Overall Study||13
11029320|NCT00845650|12208351|FG004|COMPLETED|Overall Study||28
11029321|NCT00845650|12208352|FG005|COMPLETED|Overall Study||15
11029322|NCT00845650|12208347|FG000|NOT COMPLETED|Overall Study||1
11029323|NCT00845650|12208348|FG001|NOT COMPLETED|Overall Study||0
11029324|NCT00845650|12208349|FG002|NOT COMPLETED|Overall Study||3
11029325|NCT00845650|12208350|FG003|NOT COMPLETED|Overall Study||1
11029326|NCT00845650|12208351|FG004|NOT COMPLETED|Overall Study||3
11029327|NCT00845650|12208352|FG005|NOT COMPLETED|Overall Study||2
11029328|NCT00845663|12208370|FG000|STARTED|Overall Study||49
11029329|NCT00845663|12208371|FG001|STARTED|Overall Study||49
11029330|NCT00845663|12208370|FG000|COMPLETED|Overall Study||49
11029331|NCT00845663|12208371|FG001|COMPLETED|Overall Study||49
11029332|NCT00845663|12208370|FG000|NOT COMPLETED|Overall Study||0
11029333|NCT00845663|12208371|FG001|NOT COMPLETED|Overall Study||0
11029334|NCT00845676|12208377|FG000|STARTED|Overall Study||21
11029335|NCT00845676|12208377|FG000|COMPLETED|Overall Study||19
11029336|NCT00845676|12208377|FG000|NOT COMPLETED|Overall Study||2
11029337|NCT00845728|12208384|FG000|STARTED|Overall Study||1723
11029338|NCT00845728|12208385|FG001|STARTED|Overall Study||1721
11029339|NCT00845728|12208384|FG000|Exposed|Overall Study||1721
11029340|NCT00845728|12208385|FG001|Exposed|Overall Study||1718
11029341|NCT00845728|12208384|FG000|COMPLETED|Overall Study||1337
11333101|NCT02828111|12530598|FG003|STARTED|Overall Study||6
11333102|NCT02828111|12530599|FG004|STARTED|Overall Study||12
11333103|NCT02828111|12530595|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
11333104|NCT02828111|12530596|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
11333105|NCT02828111|12530597|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11333106|NCT02828111|12530598|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
11333107|NCT02828111|12530599|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
11333108|NCT02828111|12530595|FG000|COMPLETED|Overall Study||6
11333109|NCT02828111|12530596|FG001|COMPLETED|Overall Study||6
11333110|NCT02828111|12530597|FG002|COMPLETED|Overall Study||4
11333111|NCT02828111|12530598|FG003|COMPLETED|Overall Study||5
11333112|NCT02828111|12530599|FG004|COMPLETED|Overall Study||11
11333113|NCT02828111|12530595|FG000|NOT COMPLETED|Overall Study||0
11333114|NCT02828111|12530596|FG001|NOT COMPLETED|Overall Study||0
11333115|NCT02828111|12530597|FG002|NOT COMPLETED|Overall Study||2
11333116|NCT02828111|12530598|FG003|NOT COMPLETED|Overall Study||1
11333117|NCT02828111|12530599|FG004|NOT COMPLETED|Overall Study||1
11333118|NCT02828137|12530623|FG000|STARTED|Overall Study||41
11333119|NCT02828137|12530624|FG001|STARTED|Overall Study||41
11333120|NCT02828137|12530625|FG002|STARTED|Overall Study||41
11333121|NCT02828137|12530623|FG000|COMPLETED|Overall Study||41
11333122|NCT02828137|12530624|FG001|COMPLETED|Overall Study||41
11333123|NCT02828137|12530625|FG002|COMPLETED|Overall Study||41
11333124|NCT02828137|12530623|FG000|NOT COMPLETED|Overall Study||0
11333125|NCT02828137|12530624|FG001|NOT COMPLETED|Overall Study||0
11333126|NCT02828137|12530625|FG002|NOT COMPLETED|Overall Study||0
11333127|NCT02828241|12530635|FG000|STARTED|Overall Study||38
11333128|NCT02828241|12530636|FG001|STARTED|Overall Study||23
11029342|NCT00845728|12208385|FG001|COMPLETED|Overall Study||1379
11333129|NCT02828241|12530635|FG000|COMPLETED|Overall Study||30
11333130|NCT02828241|12530636|FG001|COMPLETED|Overall Study||21
11333131|NCT02828241|12530635|FG000|NOT COMPLETED|Overall Study||8
11333132|NCT02828241|12530636|FG001|NOT COMPLETED|Overall Study||2
11333133|NCT02828267|12530647|FG000|STARTED|Overall Study||10
11333134|NCT02828267|12530648|FG001|STARTED|Overall Study||21
11333135|NCT02828267|12530649|FG002|STARTED|Overall Study||24
11333136|NCT02828267|12530650|FG003|STARTED|Overall Study||20
11333137|NCT02828267|12530647|FG000|COMPLETED|Overall Study||10
11333138|NCT02828267|12530648|FG001|COMPLETED|Overall Study||21
11333139|NCT02828267|12530649|FG002|COMPLETED|Overall Study||24
11333140|NCT02828267|12530650|FG003|COMPLETED|Overall Study||20
11029343|NCT00845728|12208384|FG000|NOT COMPLETED|Overall Study||386
11029344|NCT00845728|12208385|FG001|NOT COMPLETED|Overall Study||342
11029345|NCT00845832|12208394|FG000|STARTED|Treatment Period||4
11029346|NCT00845832|12208395|FG001|STARTED|Treatment Period||10
11029347|NCT00845832|12208396|FG002|STARTED|Treatment Period||10
11029348|NCT00845832|12208394|FG000|COMPLETED|Treatment Period||3
11029349|NCT00845832|12208395|FG001|COMPLETED|Treatment Period||7
11029350|NCT00845832|12208396|FG002|COMPLETED|Treatment Period||10
11029351|NCT00845832|12208394|FG000|NOT COMPLETED|Treatment Period||1
11029352|NCT00845832|12208395|FG001|NOT COMPLETED|Treatment Period||3
11029353|NCT00845832|12208396|FG002|NOT COMPLETED|Treatment Period||0
11029354|NCT00845832|12208394|FG000|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
11029355|NCT00845832|12208395|FG001|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
11029356|NCT00845832|12208396|FG002|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
11029357|NCT00845832|12208394|FG000|COMPLETED|Safety Follow-Up||2
11029358|NCT00845832|12208395|FG001|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
11029359|NCT00845832|12208396|FG002|COMPLETED|Safety Follow-Up||12
11029360|NCT00845832|12208394|FG000|NOT COMPLETED|Safety Follow-Up||1
11029361|NCT00845832|12208395|FG001|NOT COMPLETED|Safety Follow-Up||0
11029362|NCT00845832|12208396|FG002|NOT COMPLETED|Safety Follow-Up||0
11029363|NCT00845832|12208394|FG000|STARTED|Extended Safety Follow-Up||2
11029364|NCT00845832|12208395|FG001|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
11029365|NCT00845832|12208396|FG002|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
11029366|NCT00845832|12208394|FG000|COMPLETED|Extended Safety Follow-Up||2
11029367|NCT00845832|12208395|FG001|COMPLETED|Extended Safety Follow-Up||5
11029368|NCT00845832|12208396|FG002|COMPLETED|Extended Safety Follow-Up||0
11029369|NCT00845832|12208394|FG000|NOT COMPLETED|Extended Safety Follow-Up||0
11029370|NCT00845832|12208395|FG001|NOT COMPLETED|Extended Safety Follow-Up||0
11029371|NCT00845832|12208396|FG002|NOT COMPLETED|Extended Safety Follow-Up||7
11029372|NCT00845858|12208407|FG000|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
11029373|NCT00845858|12208408|FG001|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
11029374|NCT00845858|12208409|FG002|STARTED|Overall Study||95
11029375|NCT00845858|12208407|FG000|COMPLETED|Overall Study||88
11029376|NCT00845858|12208408|FG001|COMPLETED|Overall Study||84
11029377|NCT00845858|12208409|FG002|COMPLETED|Overall Study||87
11029378|NCT00845858|12208407|FG000|NOT COMPLETED|Overall Study||8
11029379|NCT00845858|12208408|FG001|NOT COMPLETED|Overall Study||12
11029380|NCT00845858|12208409|FG002|NOT COMPLETED|Overall Study||8
11029381|NCT00845871|12208420|FG000|STARTED|Run-in Period||65
11029382|NCT00845871|12208420|FG000|COMPLETED|Run-in Period||65
11029383|NCT00845871|12208420|FG000|NOT COMPLETED|Run-in Period||0
11029384|NCT00845871|12208420|FG000|STARTED|Assessment Period||65
11029385|NCT00845871|12208420|FG000|COMPLETED|Assessment Period||58
11029386|NCT00845871|12208420|FG000|NOT COMPLETED|Assessment Period||7
11029387|NCT00845897|12208447|FG000|STARTED|Overall Study||5
11029388|NCT00845897|12208448|FG001|STARTED|Overall Study||7
11029389|NCT00845897|12208449|FG002|STARTED|Overall Study||5
11029390|NCT00845897|12208447|FG000|COMPLETED|Overall Study||3
11029391|NCT00845897|12208448|FG001|COMPLETED|Overall Study||2
11029392|NCT00845897|12208449|FG002|COMPLETED|Overall Study||2
11029393|NCT00845897|12208447|FG000|NOT COMPLETED|Overall Study||2
11029394|NCT00845897|12208448|FG001|NOT COMPLETED|Overall Study||5
11029395|NCT00845897|12208449|FG002|NOT COMPLETED|Overall Study||3
11029396|NCT00845975|12208459|FG000|STARTED|Overall Study||9
11029397|NCT00845975|12208460|FG001|STARTED|Overall Study||9
11029398|NCT00845975|12208459|FG000|COMPLETED|Overall Study||9
11333141|NCT02828267|12530647|FG000|NOT COMPLETED|Overall Study||0
11333142|NCT02828267|12530648|FG001|NOT COMPLETED|Overall Study||0
11333143|NCT02828267|12530649|FG002|NOT COMPLETED|Overall Study||0
11333144|NCT02828267|12530650|FG003|NOT COMPLETED|Overall Study||0
11333145|NCT02828358|12530664|FG000|STARTED|Overall Study||56
11333146|NCT02828358|12530665|FG001|STARTED|Overall Study||22
11333147|NCT02828358|12530664|FG000|COMPLETED|Overall Study||11
11333148|NCT02828358|12530665|FG001|COMPLETED|Overall Study||0
11333149|NCT02828358|12530664|FG000|NOT COMPLETED|Overall Study||45
11333150|NCT02828358|12530665|FG001|NOT COMPLETED|Overall Study||22
11333151|NCT02828436|12530670|FG000|STARTED|Period 1||0
11333152|NCT02828436|12530671|FG001|STARTED|Period 1||9
11029399|NCT00845975|12208460|FG001|COMPLETED|Overall Study||9
11029400|NCT00845975|12208459|FG000|NOT COMPLETED|Overall Study||0
11029401|NCT00845975|12208460|FG001|NOT COMPLETED|Overall Study||0
11029402|NCT00846027|12208466|FG000|STARTED|Overall Study||90
11029403|NCT00846027|12208466|FG000|Received Treatment|Overall Study||83
11029404|NCT00846027|12208466|FG000|COMPLETED|Overall Study||0
11029405|NCT00846027|12208466|FG000|NOT COMPLETED|Overall Study||90
11029406|NCT00846040|12208473|FG000|STARTED|Baseline: Days 1-5||10
11029407|NCT00846040|12208474|FG001|STARTED|Baseline: Days 1-5||10
11029408|NCT00846040|12208475|FG002|STARTED|Baseline: Days 1-5||23
11029409|NCT00846040|12208473|FG000|COMPLETED|Baseline: Days 1-5||9
11029410|NCT00846040|12208474|FG001|COMPLETED|Baseline: Days 1-5||10
11029411|NCT00846040|12208475|FG002|COMPLETED|Baseline: Days 1-5||23
11029412|NCT00846040|12208473|FG000|NOT COMPLETED|Baseline: Days 1-5||1
11029413|NCT00846040|12208474|FG001|NOT COMPLETED|Baseline: Days 1-5||0
11029414|NCT00846040|12208475|FG002|NOT COMPLETED|Baseline: Days 1-5||0
11029415|NCT00846040|12208473|FG000|STARTED|First Treatment Period: Days 6-14||9
11029416|NCT00846040|12208474|FG001|STARTED|First Treatment Period: Days 6-14||10
11029417|NCT00846040|12208475|FG002|STARTED|First Treatment Period: Days 6-14|This group participated in only the baseline period|0
11029418|NCT00846040|12208473|FG000|COMPLETED|First Treatment Period: Days 6-14||9
11029419|NCT00846040|12208474|FG001|COMPLETED|First Treatment Period: Days 6-14||10
11029420|NCT00846040|12208475|FG002|COMPLETED|First Treatment Period: Days 6-14||0
11029421|NCT00846040|12208473|FG000|NOT COMPLETED|First Treatment Period: Days 6-14||0
11029422|NCT00846040|12208474|FG001|NOT COMPLETED|First Treatment Period: Days 6-14||0
11029423|NCT00846040|12208475|FG002|NOT COMPLETED|First Treatment Period: Days 6-14||0
11029424|NCT00846040|12208473|FG000|STARTED|Washout: 2 Weeks to 10 Weeks||9
11029425|NCT00846040|12208474|FG001|STARTED|Washout: 2 Weeks to 10 Weeks||10
11029426|NCT00846040|12208475|FG002|STARTED|Washout: 2 Weeks to 10 Weeks||0
11029427|NCT00846040|12208473|FG000|COMPLETED|Washout: 2 Weeks to 10 Weeks||9
11029428|NCT00846040|12208474|FG001|COMPLETED|Washout: 2 Weeks to 10 Weeks||8
11029429|NCT00846040|12208475|FG002|COMPLETED|Washout: 2 Weeks to 10 Weeks||0
11029430|NCT00846040|12208473|FG000|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
11029431|NCT00846040|12208474|FG001|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||2
11029432|NCT00846040|12208475|FG002|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
11029433|NCT00846040|12208473|FG000|STARTED|Second Treatment: After Washout, 14 Day||9
11029434|NCT00846040|12208474|FG001|STARTED|Second Treatment: After Washout, 14 Day||8
11029435|NCT00846040|12208475|FG002|STARTED|Second Treatment: After Washout, 14 Day||0
11029436|NCT00846040|12208473|FG000|COMPLETED|Second Treatment: After Washout, 14 Day||9
11029437|NCT00846040|12208474|FG001|COMPLETED|Second Treatment: After Washout, 14 Day||8
11029438|NCT00846040|12208475|FG002|COMPLETED|Second Treatment: After Washout, 14 Day||0
11029439|NCT00846040|12208473|FG000|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
11029440|NCT00846040|12208474|FG001|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
11029441|NCT00846040|12208475|FG002|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
11029442|NCT00846053|12208486|FG000|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
11029443|NCT00846053|12208487|FG001|STARTED|Overall Study||8
11029444|NCT00846053|12208486|FG000|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
11029445|NCT00846053|12208487|FG001|COMPLETED|Overall Study||8
11029446|NCT00846053|12208486|FG000|NOT COMPLETED|Overall Study||3
11029447|NCT00846053|12208487|FG001|NOT COMPLETED|Overall Study||0
11029448|NCT00846066|12208497|FG000|STARTED|Overall Study||27
11029449|NCT00846066|12208498|FG001|STARTED|Overall Study||29
11029450|NCT00846066|12208497|FG000|COMPLETED|Overall Study||27
11029451|NCT00846066|12208498|FG001|COMPLETED|Overall Study||29
11029452|NCT00846066|12208497|FG000|NOT COMPLETED|Overall Study||0
11029453|NCT00846066|12208498|FG001|NOT COMPLETED|Overall Study||0
11029454|NCT00846287|12208507|FG000|STARTED|Overall Study||16
11029455|NCT00846287|12208508|FG001|STARTED|Overall Study||15
11029456|NCT00846287|12208507|FG000|COMPLETED|Overall Study||6
11029457|NCT00846287|12208508|FG001|COMPLETED|Overall Study||10
11029458|NCT00846287|12208507|FG000|NOT COMPLETED|Overall Study||10
11029459|NCT00846287|12208508|FG001|NOT COMPLETED|Overall Study||5
11029460|NCT00846365|12208517|FG000|STARTED|Overall Study||372
11029461|NCT00846365|12208518|FG001|STARTED|Overall Study||357
11029462|NCT00846365|12208519|FG002|STARTED|Overall Study||356
11029463|NCT00846365|12208517|FG000|COMPLETED|Overall Study||317
11029464|NCT00846365|12208518|FG001|COMPLETED|Overall Study||308
11029465|NCT00846365|12208519|FG002|COMPLETED|Overall Study||323
11029466|NCT00846365|12208517|FG000|NOT COMPLETED|Overall Study||55
11029467|NCT00846365|12208518|FG001|NOT COMPLETED|Overall Study||49
11029468|NCT00846365|12208519|FG002|NOT COMPLETED|Overall Study||33
11029469|NCT00846391|12208530|FG000|STARTED|Overall Study||4
11029470|NCT00846391|12208531|FG001|STARTED|Overall Study||4
11029471|NCT00846391|12208532|FG002|STARTED|Overall Study||6
11029472|NCT00846391|12208530|FG000|COMPLETED|Overall Study||3
11029473|NCT00846391|12208531|FG001|COMPLETED|Overall Study||2
11029474|NCT00846391|12208532|FG002|COMPLETED|Overall Study||3
11029475|NCT00846391|12208530|FG000|NOT COMPLETED|Overall Study||1
11029476|NCT00846391|12208531|FG001|NOT COMPLETED|Overall Study||2
11029477|NCT00846391|12208532|FG002|NOT COMPLETED|Overall Study||3
11029478|NCT00846482|12208540|FG000|STARTED|Overall Study||64
11029479|NCT00846482|12208540|FG000|COMPLETED|Overall Study||54
11029480|NCT00846482|12208540|FG000|NOT COMPLETED|Overall Study||10
11029481|NCT00846495|12208547|FG000|STARTED|Overall Study||28
11029482|NCT00846495|12208548|FG001|STARTED|Overall Study||27
11029483|NCT00846495|12208547|FG000|COMPLETED|Overall Study||20
11029484|NCT00846495|12208548|FG001|COMPLETED|Overall Study||24
11029485|NCT00846495|12208547|FG000|NOT COMPLETED|Overall Study||8
11029486|NCT00846495|12208548|FG001|NOT COMPLETED|Overall Study||3
11029487|NCT00846521|12208554|FG000|STARTED|Overall Study||23
11029488|NCT00846521|12208554|FG000|COMPLETED|Overall Study||12
11029489|NCT00846521|12208554|FG000|NOT COMPLETED|Overall Study||11
11029490|NCT00846547|12208558|FG000|STARTED|Overall Study||32
11029491|NCT00846547|12208558|FG000|COMPLETED|Overall Study||25
11029492|NCT00846547|12208558|FG000|NOT COMPLETED|Overall Study||7
11029493|NCT00846573|12208565|FG000|STARTED|Overall Study||5
11029494|NCT00846573|12208566|FG001|STARTED|Overall Study||2
11029495|NCT00846573|12208567|FG002|STARTED|Overall Study||7
11029496|NCT00846573|12208568|FG003|STARTED|Overall Study||0
11029497|NCT00846573|12208565|FG000|COMPLETED|Overall Study||5
11029498|NCT00846573|12208566|FG001|COMPLETED|Overall Study||2
11029499|NCT00846573|12208567|FG002|COMPLETED|Overall Study||7
11029500|NCT00846573|12208568|FG003|COMPLETED|Overall Study||0
11029501|NCT00846573|12208565|FG000|NOT COMPLETED|Overall Study||0
11029502|NCT00846573|12208566|FG001|NOT COMPLETED|Overall Study||0
11029503|NCT00846573|12208567|FG002|NOT COMPLETED|Overall Study||0
11029504|NCT00846573|12208568|FG003|NOT COMPLETED|Overall Study||0
11029505|NCT00846586|12208578|FG000|STARTED|Overall Study||570
11029506|NCT00846586|12208579|FG001|STARTED|Overall Study||564
11029507|NCT00846586|12208578|FG000|Received Study Drug|Overall Study||570
11029508|NCT00846586|12208579|FG001|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
11029509|NCT00846586|12208578|FG000|COMPLETED|Overall Study||531
11029510|NCT00846586|12208579|FG001|COMPLETED|Overall Study||529
11029511|NCT00846586|12208578|FG000|NOT COMPLETED|Overall Study||39
11029512|NCT00846586|12208579|FG001|NOT COMPLETED|Overall Study||35
11029513|NCT00846651|12208587|FG000|STARTED|Overall Study||41
11029514|NCT00846651|12208588|FG001|STARTED|Overall Study||41
11029515|NCT00846651|12208587|FG000|COMPLETED|Overall Study||37
11029516|NCT00846651|12208588|FG001|COMPLETED|Overall Study||37
11029517|NCT00846651|12208587|FG000|NOT COMPLETED|Overall Study||4
11029518|NCT00846651|12208588|FG001|NOT COMPLETED|Overall Study||4
11029519|NCT00846768|12208596|FG000|STARTED|Overall Study||11
11029520|NCT00846768|12208597|FG001|STARTED|Overall Study||12
11029521|NCT00846768|12208598|FG002|STARTED|Overall Study||12
11029522|NCT00846768|12208599|FG003|STARTED|Overall Study||12
11029523|NCT00846768|12208596|FG000|COMPLETED|Overall Study||11
11029524|NCT00846768|12208597|FG001|COMPLETED|Overall Study||11
11029525|NCT00846768|12208598|FG002|COMPLETED|Overall Study||12
11029526|NCT00846768|12208599|FG003|COMPLETED|Overall Study||12
11029527|NCT00846768|12208596|FG000|NOT COMPLETED|Overall Study||0
11029528|NCT00846768|12208597|FG001|NOT COMPLETED|Overall Study||1
11029529|NCT00846768|12208598|FG002|NOT COMPLETED|Overall Study||0
11029530|NCT00846768|12208599|FG003|NOT COMPLETED|Overall Study||0
11029531|NCT00846807|12208609|FG000|STARTED|Overall Study|Entered and treated.|5292
11029532|NCT00846807|12208609|FG000|COMPLETED|Overall Study|Completed treatment.|4660
11029533|NCT00846807|12208609|FG000|NOT COMPLETED|Overall Study||632
11029534|NCT00846846|12208613|FG000|STARTED|Overall Study||1018
11029535|NCT00846846|12208613|FG000|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
11029536|NCT00846846|12208613|FG000|NOT COMPLETED|Overall Study||75
11029537|NCT00847015|12208617|FG000|STARTED|Overall Study||18
11029538|NCT00847015|12208617|FG000|COMPLETED|Overall Study||15
11029539|NCT00847015|12208617|FG000|NOT COMPLETED|Overall Study||3
11029540|NCT00847132|12208623|FG000|STARTED|Overall Study||90
11029541|NCT00847132|12208624|FG001|STARTED|Overall Study||85
11029542|NCT00847132|12208623|FG000|COMPLETED|Overall Study||89
11029543|NCT00847132|12208624|FG001|COMPLETED|Overall Study||84
11029544|NCT00847132|12208623|FG000|NOT COMPLETED|Overall Study||1
11029545|NCT00847132|12208624|FG001|NOT COMPLETED|Overall Study||1
11029546|NCT00847145|12208638|FG000|STARTED|Overall Study||629
11029547|NCT00847145|12208639|FG001|STARTED|Overall Study||633
11029548|NCT00847145|12208640|FG002|STARTED|Overall Study||285
11029549|NCT00847145|12208641|FG003|STARTED|Overall Study||117
11029550|NCT00847145|12208642|FG004|STARTED|Overall Study||137
11029551|NCT00847145|12208643|FG005|STARTED|Overall Study||156
11029552|NCT00847145|12208644|FG006|STARTED|Overall Study||152
11029553|NCT00847145|12208645|FG007|STARTED|Overall Study||140
11029554|NCT00847145|12208638|FG000|COMPLETED|Overall Study||623
11029555|NCT00847145|12208639|FG001|COMPLETED|Overall Study||627
11029556|NCT00847145|12208640|FG002|COMPLETED|Overall Study||274
11029557|NCT00847145|12208641|FG003|COMPLETED|Overall Study||116
11029558|NCT00847145|12208642|FG004|COMPLETED|Overall Study||131
11029559|NCT00847145|12208643|FG005|COMPLETED|Overall Study||152
11029560|NCT00847145|12208644|FG006|COMPLETED|Overall Study||143
11029561|NCT00847145|12208645|FG007|COMPLETED|Overall Study||136
11029562|NCT00847145|12208638|FG000|NOT COMPLETED|Overall Study||6
11029563|NCT00847145|12208639|FG001|NOT COMPLETED|Overall Study||6
11029564|NCT00847145|12208640|FG002|NOT COMPLETED|Overall Study||11
11029565|NCT00847145|12208641|FG003|NOT COMPLETED|Overall Study||1
11029566|NCT00847145|12208642|FG004|NOT COMPLETED|Overall Study||6
11029567|NCT00847145|12208643|FG005|NOT COMPLETED|Overall Study||4
11029568|NCT00847145|12208644|FG006|NOT COMPLETED|Overall Study||9
11029569|NCT00847145|12208645|FG007|NOT COMPLETED|Overall Study||4
11029570|NCT00847171|12208672|FG000|STARTED|Overall Study||20
11029571|NCT00847171|12208672|FG000|COMPLETED|Overall Study||20
11029572|NCT00847171|12208672|FG000|NOT COMPLETED|Overall Study||0
11029573|NCT00847197|12208679|FG000|STARTED|Overall Study||116
11029574|NCT00847197|12208680|FG001|STARTED|Overall Study||75
11029575|NCT00847197|12208679|FG000|COMPLETED|Overall Study||92
11029576|NCT00847197|12208680|FG001|COMPLETED|Overall Study||70
11029577|NCT00847197|12208679|FG000|NOT COMPLETED|Overall Study||24
11029578|NCT00847197|12208680|FG001|NOT COMPLETED|Overall Study||5
11029579|NCT00847210|12208688|FG000|STARTED|Overall Study||18
11029580|NCT00847210|12208689|FG001|STARTED|Overall Study||18
11029581|NCT00847210|12208688|FG000|COMPLETED|Overall Study||18
11029582|NCT00847210|12208689|FG001|COMPLETED|Overall Study||18
11029583|NCT00847210|12208688|FG000|NOT COMPLETED|Overall Study||0
11029584|NCT00847210|12208689|FG001|NOT COMPLETED|Overall Study||0
11029585|NCT00847288|12208697|FG000|STARTED|Overall Study||841
11029586|NCT00847288|12208698|FG001|STARTED|Overall Study||827
11029587|NCT00847288|12208697|FG000|COMPLETED|Overall Study||811
11029588|NCT00847288|12208698|FG001|COMPLETED|Overall Study||780
11029589|NCT00847288|12208697|FG000|NOT COMPLETED|Overall Study||30
11029590|NCT00847288|12208698|FG001|NOT COMPLETED|Overall Study||47
11029591|NCT00847301|12208704|FG000|STARTED|Overall Study||428
11029592|NCT00847301|12208704|FG000|COMPLETED|Overall Study||374
11029593|NCT00847301|12208704|FG000|NOT COMPLETED|Overall Study||54
11029594|NCT00847379|12208711|FG000|STARTED|Overall Study||59
11029595|NCT00847379|12208712|FG001|STARTED|Overall Study||57
11029596|NCT00847379|12208713|FG002|STARTED|Overall Study||57
11029597|NCT00847379|12208711|FG000|As-treated Population|Overall Study||59
11029598|NCT00847379|12208712|FG001|As-treated Population|Overall Study||57
11029599|NCT00847379|12208713|FG002|As-treated Population|Overall Study||57
11029600|NCT00847379|12208711|FG000|COMPLETED|Overall Study||0
11029601|NCT00847379|12208712|FG001|COMPLETED|Overall Study||0
11029602|NCT00847379|12208713|FG002|COMPLETED|Overall Study||0
11029603|NCT00847379|12208711|FG000|NOT COMPLETED|Overall Study||59
11029604|NCT00847379|12208712|FG001|NOT COMPLETED|Overall Study||57
11333153|NCT02828436|12530670|FG000|COMPLETED|Period 1||0
11333154|NCT02828436|12530671|FG001|COMPLETED|Period 1||5
11333155|NCT02828436|12530670|FG000|NOT COMPLETED|Period 1||0
11333156|NCT02828436|12530671|FG001|NOT COMPLETED|Period 1||4
11333157|NCT02828436|12530670|FG000|STARTED|Period 2||9
11333158|NCT02828436|12530671|FG001|STARTED|Period 2||0
11029605|NCT00847379|12208713|FG002|NOT COMPLETED|Overall Study||57
11029606|NCT00847522|12208723|FG000|STARTED|Overall Study||90
11029607|NCT00847522|12208723|FG000|Phase I|Overall Study||10
11029608|NCT00847522|12208723|FG000|Phase II|Overall Study||80
11029609|NCT00847522|12208723|FG000|COMPLETED|Overall Study||90
11029610|NCT00847522|12208723|FG000|NOT COMPLETED|Overall Study||0
11029611|NCT00847535|12208727|FG000|STARTED|Overall Study||24
11029612|NCT00847535|12208728|FG001|STARTED|Overall Study||24
11029613|NCT00847535|12208729|FG002|STARTED|Overall Study||16
11333159|NCT02828436|12530670|FG000|COMPLETED|Period 2||1
11333160|NCT02828436|12530671|FG001|COMPLETED|Period 2||0
11333161|NCT02828436|12530670|FG000|NOT COMPLETED|Period 2||8
11333162|NCT02828436|12530671|FG001|NOT COMPLETED|Period 2||0
11333163|NCT02828644|12530679|FG000|STARTED|Overall Study||88
11333164|NCT02828644|12530680|FG001|STARTED|Overall Study||87
11333165|NCT02828644|12530679|FG000|COMPLETED|Overall Study||65
11333166|NCT02828644|12530680|FG001|COMPLETED|Overall Study||65
11333167|NCT02828644|12530679|FG000|NOT COMPLETED|Overall Study||23
11333168|NCT02828644|12530680|FG001|NOT COMPLETED|Overall Study||22
11333169|NCT02829034|12530689|FG000|STARTED|Overall Study||14
11333170|NCT02829034|12530690|FG001|STARTED|Overall Study||8
11333171|NCT02829034|12530689|FG000|COMPLETED|Overall Study||9
11333172|NCT02829034|12530690|FG001|COMPLETED|Overall Study||6
11029614|NCT00847535|12208727|FG000|10 Million AMDC|Overall Study||8
11029615|NCT00847535|12208728|FG001|10 Million AMDC|Overall Study||8
11029616|NCT00847535|12208729|FG002|10 Million AMDC|Overall Study||0
11029617|NCT00847535|12208727|FG000|50 Million AMDC|Overall Study||8
11029618|NCT00847535|12208728|FG001|50 Million AMDC|Overall Study||8
11029619|NCT00847535|12208729|FG002|50 Million AMDC|Overall Study||0
11029620|NCT00847535|12208727|FG000|100 Million AMDC|Overall Study||8
11029621|NCT00847535|12208728|FG001|100 Million AMDC|Overall Study||8
11029622|NCT00847535|12208729|FG002|100 Million AMDC|Overall Study||8
11029623|NCT00847535|12208727|FG000|200 Million AMDC|Overall Study||0
11333173|NCT02829034|12530689|FG000|NOT COMPLETED|Overall Study||5
11333174|NCT02829034|12530690|FG001|NOT COMPLETED|Overall Study||2
11333175|NCT02829138|12530698|FG000|STARTED|Overall Study||29
11333176|NCT02829138|12530699|FG001|STARTED|Overall Study||28
11333177|NCT02829138|12530698|FG000|COMPLETED|Overall Study||28
11333178|NCT02829138|12530699|FG001|COMPLETED|Overall Study||28
11333179|NCT02829138|12530698|FG000|NOT COMPLETED|Overall Study||1
11333180|NCT02829138|12530699|FG001|NOT COMPLETED|Overall Study||0
11333181|NCT02829294|12530705|FG000|STARTED|Overall Study||19
11333182|NCT02829294|12530705|FG000|COMPLETED|Overall Study||19
11333183|NCT02829294|12530705|FG000|NOT COMPLETED|Overall Study||0
11333184|NCT02829307|12530711|FG000|STARTED|Overall Study||8
11333185|NCT02829307|12530711|FG000|COMPLETED|Overall Study||8
11333186|NCT02829307|12530711|FG000|NOT COMPLETED|Overall Study||0
11333187|NCT02829320|12530715|FG000|STARTED|Overall Study||28
11333188|NCT02829320|12530715|FG000|COMPLETED|Overall Study||28
11333189|NCT02829320|12530715|FG000|NOT COMPLETED|Overall Study||0
11333190|NCT02829463|12530728|FG000|STARTED|Overall Study||59
11333191|NCT02829463|12530729|FG001|STARTED|Overall Study||62
11333192|NCT02829463|12530728|FG000|COMPLETED|Overall Study||59
11029624|NCT00847535|12208728|FG001|200 Million AMDC|Overall Study||0
11029625|NCT00847535|12208729|FG002|200 Million AMDC|Overall Study||8
11029626|NCT00847535|12208727|FG000|COMPLETED|Overall Study||22
11029627|NCT00847535|12208728|FG001|COMPLETED|Overall Study||22
11029628|NCT00847535|12208729|FG002|COMPLETED|Overall Study||15
11029629|NCT00847535|12208727|FG000|NOT COMPLETED|Overall Study||2
11029630|NCT00847535|12208728|FG001|NOT COMPLETED|Overall Study||2
11333193|NCT02829463|12530729|FG001|COMPLETED|Overall Study||62
11333194|NCT02829463|12530728|FG000|NOT COMPLETED|Overall Study||0
11333195|NCT02829463|12530729|FG001|NOT COMPLETED|Overall Study||0
11333196|NCT02829775|12530735|FG000|STARTED|Overall Study||9
11333197|NCT02829775|12530735|FG000|COMPLETED|Overall Study||4
11029631|NCT00847535|12208729|FG002|NOT COMPLETED|Overall Study||1
11029632|NCT00847561|12208736|FG000|STARTED|Overall Study||70
11029633|NCT00847561|12208737|FG001|STARTED|Overall Study||66
11029634|NCT00847561|12208736|FG000|COMPLETED|Overall Study||57
11333198|NCT02829775|12530735|FG000|NOT COMPLETED|Overall Study||5
11029635|NCT00847561|12208737|FG001|COMPLETED|Overall Study||62
11029636|NCT00847561|12208736|FG000|NOT COMPLETED|Overall Study||13
11333199|NCT02829944|12530742|FG000|STARTED|Overall Study||44
11333200|NCT02829944|12530743|FG001|STARTED|Overall Study||40
11333201|NCT02829944|12530742|FG000|COMPLETED|Overall Study||38
11333202|NCT02829944|12530743|FG001|COMPLETED|Overall Study||33
11333203|NCT02829944|12530742|FG000|NOT COMPLETED|Overall Study||6
11029637|NCT00847561|12208737|FG001|NOT COMPLETED|Overall Study||4
11029638|NCT00847587|12208745|FG000|STARTED|Overall Study||35
11029639|NCT00847587|12208746|FG001|STARTED|Overall Study||34
11029640|NCT00847587|12208745|FG000|COMPLETED|Overall Study|Patient declined study after randomization.|34
11029641|NCT00847587|12208746|FG001|COMPLETED|Overall Study||34
11029642|NCT00847587|12208745|FG000|NOT COMPLETED|Overall Study||1
11029643|NCT00847587|12208746|FG001|NOT COMPLETED|Overall Study||0
11029644|NCT00847613|12208756|FG000|STARTED|Overall Study||321
11029645|NCT00847613|12208757|FG001|STARTED|Overall Study||319
11029646|NCT00847613|12208758|FG002|STARTED|Overall Study||81
11029647|NCT00847613|12208759|FG003|STARTED|Overall Study||79
11029648|NCT00847613|12208756|FG000|Treated|Overall Study||321
11029649|NCT00847613|12208757|FG001|Treated|Overall Study||316
11029650|NCT00847613|12208758|FG002|Treated|Overall Study||81
11029651|NCT00847613|12208759|FG003|Treated|Overall Study||79
11029652|NCT00847613|12208756|FG000|COMPLETED|Overall Study||0
11029653|NCT00847613|12208757|FG001|COMPLETED|Overall Study||0
11029654|NCT00847613|12208758|FG002|COMPLETED|Overall Study||0
11029655|NCT00847613|12208759|FG003|COMPLETED|Overall Study||0
11333204|NCT02829944|12530743|FG001|NOT COMPLETED|Overall Study||7
11029656|NCT00847613|12208756|FG000|NOT COMPLETED|Overall Study||321
11029657|NCT00847613|12208757|FG001|NOT COMPLETED|Overall Study||319
11029658|NCT00847613|12208758|FG002|NOT COMPLETED|Overall Study||81
11029659|NCT00847613|12208759|FG003|NOT COMPLETED|Overall Study||79
11029660|NCT00847626|12208787|FG000|STARTED|Overall Study||156
11029661|NCT00847626|12208788|FG001|STARTED|Overall Study||154
11029662|NCT00847626|12208789|FG002|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
11029663|NCT00847626|12208790|FG003|STARTED|Overall Study||156
11029664|NCT00847626|12208791|FG004|STARTED|Overall Study||153
11029665|NCT00847626|12208792|FG005|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
11029666|NCT00847626|12208793|FG006|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
11029667|NCT00847626|12208794|FG007|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
11029668|NCT00847626|12208795|FG008|STARTED|Overall Study||155
11029669|NCT00847626|12208796|FG009|STARTED|Overall Study||153
11029670|NCT00847626|12208797|FG010|STARTED|Overall Study||162
11029671|NCT00847626|12208787|FG000|COMPLETED|Overall Study||135
11029672|NCT00847626|12208788|FG001|COMPLETED|Overall Study||131
11029673|NCT00847626|12208789|FG002|COMPLETED|Overall Study||131
11029674|NCT00847626|12208790|FG003|COMPLETED|Overall Study||125
11029675|NCT00847626|12208791|FG004|COMPLETED|Overall Study||125
11029676|NCT00847626|12208792|FG005|COMPLETED|Overall Study||125
11029677|NCT00847626|12208793|FG006|COMPLETED|Overall Study||135
11029678|NCT00847626|12208794|FG007|COMPLETED|Overall Study||141
11029679|NCT00847626|12208795|FG008|COMPLETED|Overall Study||141
11029680|NCT00847626|12208796|FG009|COMPLETED|Overall Study||139
11029681|NCT00847626|12208797|FG010|COMPLETED|Overall Study||142
11029682|NCT00847626|12208787|FG000|NOT COMPLETED|Overall Study||21
11029683|NCT00847626|12208788|FG001|NOT COMPLETED|Overall Study||23
11029684|NCT00847626|12208789|FG002|NOT COMPLETED|Overall Study||16
11029685|NCT00847626|12208790|FG003|NOT COMPLETED|Overall Study||31
11029686|NCT00847626|12208791|FG004|NOT COMPLETED|Overall Study||28
11029687|NCT00847626|12208792|FG005|NOT COMPLETED|Overall Study||37
11029688|NCT00847626|12208793|FG006|NOT COMPLETED|Overall Study||22
11029689|NCT00847626|12208794|FG007|NOT COMPLETED|Overall Study||19
11029690|NCT00847626|12208795|FG008|NOT COMPLETED|Overall Study||14
11029691|NCT00847626|12208796|FG009|NOT COMPLETED|Overall Study||14
11029692|NCT00847626|12208797|FG010|NOT COMPLETED|Overall Study||20
11029693|NCT00847665|12208826|FG000|STARTED|Overall Study||165
11029694|NCT00847665|12208827|FG001|STARTED|Overall Study||165
11029695|NCT00847665|12208826|FG000|COMPLETED|Overall Study||164
11029696|NCT00847665|12208827|FG001|COMPLETED|Overall Study||165
11029697|NCT00847665|12208826|FG000|NOT COMPLETED|Overall Study||1
11333205|NCT02829983|12530751|FG000|STARTED|Overall Study||20
11333206|NCT02829983|12530752|FG001|STARTED|Overall Study||20
11333207|NCT02829983|12530751|FG000|COMPLETED|Overall Study||20
11029698|NCT00847665|12208827|FG001|NOT COMPLETED|Overall Study||0
11029699|NCT00847704|12208833|FG000|STARTED|Overall Study||3
11029700|NCT00847704|12208833|FG000|COMPLETED|Overall Study||2
11029701|NCT00847704|12208833|FG000|NOT COMPLETED|Overall Study||1
11029702|NCT00847808|12208837|FG000|STARTED|Overall Study||178
11029703|NCT00847808|12208837|FG000|COMPLETED|Overall Study||163
11029704|NCT00847808|12208837|FG000|NOT COMPLETED|Overall Study||15
11057370|NCT00997334|12238867|FG000|STARTED|Overall Study||60
11057371|NCT00997334|12238867|FG000|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
11057372|NCT00997334|12238867|FG000|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
11057373|NCT00997334|12238867|FG000|COMPLETED|Overall Study||35
11057374|NCT00997334|12238867|FG000|NOT COMPLETED|Overall Study||25
11057375|NCT00997373|12238873|FG000|STARTED|Overall Study||28
11057376|NCT00997373|12238874|FG001|STARTED|Overall Study||15
11057377|NCT00997373|12238873|FG000|Received Letrozole|Overall Study||23
11057378|NCT00997373|12238874|FG001|Received Letrozole|Overall Study||0
11057379|NCT00997373|12238873|FG000|Completed Hysterectomy|Overall Study||17
11057380|NCT00997373|12238874|FG001|Completed Hysterectomy|Overall Study||15
11057381|NCT00997373|12238873|FG000|COMPLETED|Overall Study||13
11057382|NCT00997373|12238874|FG001|COMPLETED|Overall Study||15
11057383|NCT00997373|12238873|FG000|NOT COMPLETED|Overall Study||15
11057384|NCT00997373|12238874|FG001|NOT COMPLETED|Overall Study||0
11057385|NCT00997425|12238880|FG000|STARTED|Overall Study||19
11057386|NCT00997425|12238880|FG000|COMPLETED|Overall Study||19
11057387|NCT00997425|12238880|FG000|NOT COMPLETED|Overall Study||0
11057388|NCT00997438|12238888|FG000|STARTED|Overall Study||21
11057389|NCT00997438|12238889|FG001|STARTED|Overall Study||24
11057390|NCT00997438|12238890|FG002|STARTED|Overall Study||24
11057391|NCT00997438|12238888|FG000|COMPLETED|Overall Study||16
11057392|NCT00997438|12238889|FG001|COMPLETED|Overall Study||21
11057393|NCT00997438|12238890|FG002|COMPLETED|Overall Study||20
11057394|NCT00997438|12238888|FG000|NOT COMPLETED|Overall Study||5
11057395|NCT00997438|12238889|FG001|NOT COMPLETED|Overall Study||3
11057396|NCT00997438|12238890|FG002|NOT COMPLETED|Overall Study||4
11057397|NCT00997503|12238899|FG000|STARTED|Overall Study||4199
11057398|NCT00997503|12238899|FG000|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
11057399|NCT00997503|12238899|FG000|COMPLETED|Overall Study||3926
11057400|NCT00997503|12238899|FG000|NOT COMPLETED|Overall Study||273
11057401|NCT00997516|12238908|FG000|STARTED|Short-term Follow-up (Post Operative)||37
11057402|NCT00997516|12238909|FG001|STARTED|Short-term Follow-up (Post Operative)||38
11057403|NCT00997516|12238908|FG000|COMPLETED|Short-term Follow-up (Post Operative)||37
11057404|NCT00997516|12238909|FG001|COMPLETED|Short-term Follow-up (Post Operative)||38
11057405|NCT00997516|12238908|FG000|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
11057406|NCT00997516|12238909|FG001|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
11057407|NCT00997516|12238908|FG000|STARTED|Long-term Follow-up (After 6 Months)||37
11057408|NCT00997516|12238909|FG001|STARTED|Long-term Follow-up (After 6 Months)||38
11057409|NCT00997516|12238908|FG000|COMPLETED|Long-term Follow-up (After 6 Months)||31
11057410|NCT00997516|12238909|FG001|COMPLETED|Long-term Follow-up (After 6 Months)||36
11057411|NCT00997516|12238908|FG000|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
11057412|NCT00997516|12238909|FG001|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
11057413|NCT00997555|12238917|FG000|STARTED|Overall Study||13
11057414|NCT00997555|12238918|FG001|STARTED|Overall Study||15
11057415|NCT00997555|12238917|FG000|COMPLETED|Overall Study||13
11057416|NCT00997555|12238918|FG001|COMPLETED|Overall Study||15
11057417|NCT00997555|12238917|FG000|NOT COMPLETED|Overall Study||0
11057418|NCT00997555|12238918|FG001|NOT COMPLETED|Overall Study||0
11057419|NCT00997594|12238926|FG000|STARTED|Overall Study||9
11057420|NCT00997594|12238927|FG001|STARTED|Overall Study||9
11057421|NCT00997594|12238926|FG000|Completion of Ablation Procedure|Overall Study||9
11057422|NCT00997594|12238927|FG001|Completion of Ablation Procedure|Overall Study||9
11057423|NCT00997594|12238926|FG000|COMPLETED|Overall Study||9
11057424|NCT00997594|12238927|FG001|COMPLETED|Overall Study||9
11057425|NCT00997594|12238926|FG000|NOT COMPLETED|Overall Study||0
11057426|NCT00997594|12238927|FG001|NOT COMPLETED|Overall Study||0
11057427|NCT00997620|12238935|FG000|STARTED|Overall Study||19
11057428|NCT00997620|12238936|FG001|STARTED|Overall Study||21
11057429|NCT00997620|12238935|FG000|COMPLETED|Overall Study||19
11333208|NCT02829983|12530752|FG001|COMPLETED|Overall Study||20
11333209|NCT02829983|12530751|FG000|NOT COMPLETED|Overall Study||0
11333210|NCT02829983|12530752|FG001|NOT COMPLETED|Overall Study||0
11333211|NCT02829996|12530763|FG000|STARTED|Overall Study||39
11333212|NCT02829996|12530764|FG001|STARTED|Overall Study||39
11333213|NCT02829996|12530765|FG002|STARTED|Overall Study||40
11333214|NCT02829996|12530766|FG003|STARTED|Overall Study||41
11333215|NCT02829996|12530767|FG004|STARTED|Overall Study||42
11333216|NCT02829996|12530763|FG000|COMPLETED|Overall Study||38
11333217|NCT02829996|12530764|FG001|COMPLETED|Overall Study||39
11333218|NCT02829996|12530765|FG002|COMPLETED|Overall Study||40
11333219|NCT02829996|12530766|FG003|COMPLETED|Overall Study||41
11333220|NCT02829996|12530767|FG004|COMPLETED|Overall Study||42
11333221|NCT02829996|12530763|FG000|NOT COMPLETED|Overall Study||1
11333222|NCT02829996|12530764|FG001|NOT COMPLETED|Overall Study||0
11333223|NCT02829996|12530765|FG002|NOT COMPLETED|Overall Study||0
11333224|NCT02829996|12530766|FG003|NOT COMPLETED|Overall Study||0
11333225|NCT02829996|12530767|FG004|NOT COMPLETED|Overall Study||0
11333226|NCT02830074|12530781|FG000|STARTED|Overall Study||32
11333227|NCT02830074|12530782|FG001|STARTED|Overall Study||31
11333228|NCT02830074|12530781|FG000|COMPLETED|Overall Study||32
11029705|NCT00847886|12208843|FG000|STARTED|Overall Study||12
11029706|NCT00847886|12208844|FG001|STARTED|Overall Study||4
11029707|NCT00847886|12208843|FG000|COMPLETED|Overall Study||12
11029708|NCT00847886|12208844|FG001|COMPLETED|Overall Study||3
11029709|NCT00847886|12208843|FG000|NOT COMPLETED|Overall Study||0
11200690|NCT01828216|12390896|FG001|STARTED|Overall Study||157
11029710|NCT00847886|12208844|FG001|NOT COMPLETED|Overall Study||1
11200691|NCT01828216|12390895|FG000|COMPLETED|Overall Study||159
11200692|NCT01828216|12390896|FG001|COMPLETED|Overall Study||157
11200693|NCT01828216|12390895|FG000|NOT COMPLETED|Overall Study||0
11200694|NCT01828216|12390896|FG001|NOT COMPLETED|Overall Study||0
11200695|NCT01828255|12390906|FG000|STARTED|Overall Study||20
11200696|NCT01828255|12390907|FG001|STARTED|Overall Study||20
11200697|NCT01828255|12390906|FG000|COMPLETED|Overall Study||20
11200698|NCT01828255|12390907|FG001|COMPLETED|Overall Study||20
11200699|NCT01828255|12390906|FG000|NOT COMPLETED|Overall Study||0
11200700|NCT01828255|12390907|FG001|NOT COMPLETED|Overall Study||0
11200701|NCT01828281|12390917|FG000|STARTED|Overall Study||45
11200702|NCT01828281|12390918|FG001|STARTED|Overall Study||45
11200703|NCT01828281|12390917|FG000|COMPLETED|Overall Study||44
11200704|NCT01828281|12390918|FG001|COMPLETED|Overall Study||45
11200705|NCT01828281|12390917|FG000|NOT COMPLETED|Overall Study||1
11200706|NCT01828281|12390918|FG001|NOT COMPLETED|Overall Study||0
11200707|NCT01828476|12390927|FG000|STARTED|Overall Study||13
11200708|NCT01828476|12390928|FG001|STARTED|Overall Study||0
11200709|NCT01828476|12390927|FG000|COMPLETED|Overall Study||13
11200710|NCT01828476|12390928|FG001|COMPLETED|Overall Study||0
11029711|NCT00847912|12208852|FG000|STARTED|Overall Study||477
11029712|NCT00847912|12208853|FG001|STARTED|Overall Study||477
11029713|NCT00847912|12208852|FG000|COMPLETED|Overall Study||468
11029714|NCT00847912|12208853|FG001|COMPLETED|Overall Study||464
11029715|NCT00847912|12208852|FG000|NOT COMPLETED|Overall Study||9
11029716|NCT00847912|12208853|FG001|NOT COMPLETED|Overall Study||13
11029717|NCT00847938|12208864|FG000|STARTED|Overall Study||16
11029718|NCT00847938|12208865|FG001|STARTED|Overall Study||15
11029719|NCT00847938|12208866|FG002|STARTED|Overall Study||16
11029720|NCT00847938|12208867|FG003|STARTED|Overall Study||15
11029721|NCT00847938|12208864|FG000|COMPLETED|Overall Study||16
11029722|NCT00847938|12208865|FG001|COMPLETED|Overall Study||14
11029723|NCT00847938|12208866|FG002|COMPLETED|Overall Study||15
11029724|NCT00847938|12208867|FG003|COMPLETED|Overall Study||15
11029725|NCT00847938|12208864|FG000|NOT COMPLETED|Overall Study||0
11029726|NCT00847938|12208865|FG001|NOT COMPLETED|Overall Study||1
11029727|NCT00847938|12208866|FG002|NOT COMPLETED|Overall Study||1
11029728|NCT00847938|12208867|FG003|NOT COMPLETED|Overall Study||0
11029729|NCT00848016|12208877|FG000|STARTED|Overall Study||29
11029730|NCT00848016|12208877|FG000|COMPLETED|Overall Study||29
11029731|NCT00848016|12208877|FG000|NOT COMPLETED|Overall Study||0
11029732|NCT00848042|12208884|FG000|STARTED|Overall Study||5
11029733|NCT00848042|12208885|FG001|STARTED|Overall Study||5
11029734|NCT00848042|12208886|FG002|STARTED|Overall Study||1
11029735|NCT00848042|12208884|FG000|Day 1|Overall Study||5
11029736|NCT00848042|12208885|FG001|Day 1|Overall Study||5
11029737|NCT00848042|12208886|FG002|Day 1|Overall Study||1
11029738|NCT00848042|12208884|FG000|Day 2|Overall Study||5
11029739|NCT00848042|12208885|FG001|Day 2|Overall Study||5
11029740|NCT00848042|12208886|FG002|Day 2|Overall Study||1
11029741|NCT00848042|12208884|FG000|Day 3|Overall Study||5
11029742|NCT00848042|12208885|FG001|Day 3|Overall Study||5
11029743|NCT00848042|12208886|FG002|Day 3|Overall Study||1
11029744|NCT00848042|12208884|FG000|Day 8|Overall Study||5
11029745|NCT00848042|12208885|FG001|Day 8|Overall Study||5
11029746|NCT00848042|12208886|FG002|Day 8|Overall Study||1
11029747|NCT00848042|12208884|FG000|Day 15|Overall Study||4
11029748|NCT00848042|12208885|FG001|Day 15|Overall Study||5
11029749|NCT00848042|12208886|FG002|Day 15|Overall Study||1
11029750|NCT00848042|12208884|FG000|Month 1|Overall Study||4
11029751|NCT00848042|12208885|FG001|Month 1|Overall Study||5
11029752|NCT00848042|12208886|FG002|Month 1|Overall Study||1
11029753|NCT00848042|12208884|FG000|Month 2|Overall Study||1
11029754|NCT00848042|12208885|FG001|Month 2|Overall Study||5
11029755|NCT00848042|12208886|FG002|Month 2|Overall Study||1
11029756|NCT00848042|12208884|FG000|Month 3|Overall Study||1
11029757|NCT00848042|12208885|FG001|Month 3|Overall Study||4
11029758|NCT00848042|12208886|FG002|Month 3|Overall Study||1
11029759|NCT00848042|12208884|FG000|Month 4|Overall Study||1
11029760|NCT00848042|12208885|FG001|Month 4|Overall Study||4
11029761|NCT00848042|12208886|FG002|Month 4|Overall Study||1
11029762|NCT00848042|12208884|FG000|Month 5|Overall Study||1
11029763|NCT00848042|12208885|FG001|Month 5|Overall Study||3
11029764|NCT00848042|12208886|FG002|Month 5|Overall Study||1
11029765|NCT00848042|12208884|FG000|Month 6|Overall Study||1
11029766|NCT00848042|12208885|FG001|Month 6|Overall Study||3
11029767|NCT00848042|12208886|FG002|Month 6|Overall Study||1
11029768|NCT00848042|12208884|FG000|COMPLETED|Overall Study||1
11029769|NCT00848042|12208885|FG001|COMPLETED|Overall Study||3
11029770|NCT00848042|12208886|FG002|COMPLETED|Overall Study||1
11029771|NCT00848042|12208884|FG000|NOT COMPLETED|Overall Study||4
11029772|NCT00848042|12208885|FG001|NOT COMPLETED|Overall Study||2
11029773|NCT00848042|12208886|FG002|NOT COMPLETED|Overall Study||0
11029774|NCT00848081|12208896|FG000|STARTED|Overall Study||160
11029775|NCT00848081|12208897|FG001|STARTED|Overall Study||158
11029776|NCT00848081|12208896|FG000|COMPLETED|Overall Study||140
11029777|NCT00848081|12208897|FG001|COMPLETED|Overall Study||140
11029778|NCT00848081|12208896|FG000|NOT COMPLETED|Overall Study||20
11029779|NCT00848081|12208897|FG001|NOT COMPLETED|Overall Study||18
11029780|NCT00848107|12208903|FG000|STARTED|Overall Study||115
11029781|NCT00848107|12208903|FG000|COMPLETED|Overall Study||94
11029782|NCT00848107|12208903|FG000|NOT COMPLETED|Overall Study||21
11029783|NCT00848120|12208907|FG000|STARTED|Overall Study||29
11029784|NCT00848120|12208907|FG000|COMPLETED|Overall Study||28
11029785|NCT00848120|12208907|FG000|NOT COMPLETED|Overall Study||1
11029786|NCT00848172|12208913|FG000|STARTED|Visit 2 - Drug Administration||10
11029787|NCT00848172|12208914|FG001|STARTED|Visit 2 - Drug Administration||9
11029788|NCT00848172|12208913|FG000|COMPLETED|Visit 2 - Drug Administration||10
11029789|NCT00848172|12208914|FG001|COMPLETED|Visit 2 - Drug Administration||8
11029790|NCT00848172|12208913|FG000|NOT COMPLETED|Visit 2 - Drug Administration||0
11029791|NCT00848172|12208914|FG001|NOT COMPLETED|Visit 2 - Drug Administration||1
11029792|NCT00848172|12208913|FG000|STARTED|Visit 3 - Follow Up||10
11029793|NCT00848172|12208914|FG001|STARTED|Visit 3 - Follow Up||8
11029794|NCT00848172|12208913|FG000|COMPLETED|Visit 3 - Follow Up||10
11029795|NCT00848172|12208914|FG001|COMPLETED|Visit 3 - Follow Up||8
11029796|NCT00848172|12208913|FG000|NOT COMPLETED|Visit 3 - Follow Up||0
11029797|NCT00848172|12208914|FG001|NOT COMPLETED|Visit 3 - Follow Up||0
11029798|NCT00848185|12208926|FG000|STARTED|Overall Study||32
11029799|NCT00848185|12208927|FG001|STARTED|Overall Study||32
11029800|NCT00848185|12208928|FG002|STARTED|Overall Study||32
11029801|NCT00848185|12208926|FG000|COMPLETED|Overall Study||32
11029802|NCT00848185|12208927|FG001|COMPLETED|Overall Study||32
11029803|NCT00848185|12208928|FG002|COMPLETED|Overall Study||32
11029804|NCT00848185|12208926|FG000|NOT COMPLETED|Overall Study||0
11029805|NCT00848185|12208927|FG001|NOT COMPLETED|Overall Study||0
11029806|NCT00848185|12208928|FG002|NOT COMPLETED|Overall Study||0
11029807|NCT00848198|12208936|FG000|STARTED|Overall Study||314
11029808|NCT00848198|12208936|FG000|COMPLETED|Overall Study||299
11029809|NCT00848198|12208936|FG000|NOT COMPLETED|Overall Study||15
11029810|NCT00848211|12208948|FG000|STARTED|Overall Study||6
11029811|NCT00848211|12208949|FG001|STARTED|Overall Study||7
11029812|NCT00848211|12208950|FG002|STARTED|Overall Study||6
11029813|NCT00848211|12208951|FG003|STARTED|Overall Study||5
11029814|NCT00848211|12208948|FG000|COMPLETED|Overall Study||6
11029815|NCT00848211|12208949|FG001|COMPLETED|Overall Study||6
11029816|NCT00848211|12208950|FG002|COMPLETED|Overall Study||5
11029817|NCT00848211|12208951|FG003|COMPLETED|Overall Study||5
11029818|NCT00848211|12208948|FG000|NOT COMPLETED|Overall Study||0
11029819|NCT00848211|12208949|FG001|NOT COMPLETED|Overall Study||1
11029820|NCT00848211|12208950|FG002|NOT COMPLETED|Overall Study||1
11029821|NCT00848211|12208951|FG003|NOT COMPLETED|Overall Study||0
11029822|NCT00848237|12208961|FG000|STARTED|Overall Study||5521
11029823|NCT00848237|12208961|FG000|COMPLETED|Overall Study||4982
11029824|NCT00848237|12208961|FG000|NOT COMPLETED|Overall Study||539
11029825|NCT00848250|12208967|FG000|STARTED|Overall Study||11
11029826|NCT00848250|12208968|FG001|STARTED|Overall Study||10
11029827|NCT00848250|12208967|FG000|COMPLETED|Overall Study||11
11029828|NCT00848250|12208968|FG001|COMPLETED|Overall Study||9
11029829|NCT00848250|12208967|FG000|NOT COMPLETED|Overall Study||0
11029830|NCT00848250|12208968|FG001|NOT COMPLETED|Overall Study||1
11029831|NCT00848354|12208977|FG000|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
11029832|NCT00848354|12208978|FG001|STARTED|Phase 1||143
11029833|NCT00848354|12208977|FG000|COMPLETED|Phase 1||269
11029834|NCT00848354|12208978|FG001|COMPLETED|Phase 1||129
11029835|NCT00848354|12208977|FG000|NOT COMPLETED|Phase 1||12
11029836|NCT00848354|12208978|FG001|NOT COMPLETED|Phase 1||14
11029837|NCT00848354|12208977|FG000|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
11029838|NCT00848354|12208978|FG001|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
11029839|NCT00848354|12208977|FG000|COMPLETED|Phase 2 Year 1||242
11029840|NCT00848354|12208978|FG001|COMPLETED|Phase 2 Year 1||120
11029841|NCT00848354|12208977|FG000|NOT COMPLETED|Phase 2 Year 1||18
11029842|NCT00848354|12208978|FG001|NOT COMPLETED|Phase 2 Year 1||6
11029843|NCT00848354|12208977|FG000|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
11029844|NCT00848354|12208978|FG001|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
11029845|NCT00848354|12208977|FG000|COMPLETED|Phase 2 Year 2||218
11029846|NCT00848354|12208978|FG001|COMPLETED|Phase 2 Year 2||113
11029847|NCT00848354|12208977|FG000|NOT COMPLETED|Phase 2 Year 2||23
11029848|NCT00848354|12208978|FG001|NOT COMPLETED|Phase 2 Year 2||7
11029849|NCT00848367|12208990|FG000|STARTED|Overall Study||52
11029850|NCT00848367|12208991|FG001|STARTED|Overall Study||50
11029851|NCT00848367|12208990|FG000|COMPLETED|Overall Study||43
11029852|NCT00848367|12208991|FG001|COMPLETED|Overall Study||41
11029853|NCT00848367|12208990|FG000|NOT COMPLETED|Overall Study||9
11029854|NCT00848367|12208991|FG001|NOT COMPLETED|Overall Study||9
11029855|NCT00848393|12209002|FG000|STARTED|Overall Study||17
11029856|NCT00848393|12209003|FG001|STARTED|Overall Study||16
11029857|NCT00848393|12209004|FG002|STARTED|Overall Study||18
11029858|NCT00848393|12209002|FG000|COMPLETED|Overall Study||17
11029859|NCT00848393|12209003|FG001|COMPLETED|Overall Study||16
11029860|NCT00848393|12209004|FG002|COMPLETED|Overall Study||15
11029861|NCT00848393|12209002|FG000|NOT COMPLETED|Overall Study||0
11029862|NCT00848393|12209003|FG001|NOT COMPLETED|Overall Study||0
11029863|NCT00848393|12209004|FG002|NOT COMPLETED|Overall Study||3
11029864|NCT00848484|12209018|FG000|STARTED|First Intervention (Treatment Period 1)||27
11029865|NCT00848484|12209019|FG001|STARTED|First Intervention (Treatment Period 1)||27
11029866|NCT00848484|12209018|FG000|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
11029867|NCT00848484|12209019|FG001|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
11029868|NCT00848484|12209018|FG000|COMPLETED|First Intervention (Treatment Period 1)||25
11029869|NCT00848484|12209019|FG001|COMPLETED|First Intervention (Treatment Period 1)||24
11029870|NCT00848484|12209018|FG000|NOT COMPLETED|First Intervention (Treatment Period 1)||2
11333229|NCT02830074|12530782|FG001|COMPLETED|Overall Study||31
11333230|NCT02830074|12530781|FG000|NOT COMPLETED|Overall Study||0
11333231|NCT02830074|12530782|FG001|NOT COMPLETED|Overall Study||0
11333232|NCT02830087|12530795|FG000|STARTED|Overall Study||4
11333233|NCT02830087|12530796|FG001|STARTED|Overall Study||4
11333234|NCT02830087|12530797|FG002|STARTED|Overall Study||4
11333235|NCT02830087|12530798|FG003|STARTED|Overall Study||3
11029871|NCT00848484|12209019|FG001|NOT COMPLETED|First Intervention (Treatment Period 1)||3
11029872|NCT00848484|12209018|FG000|STARTED|Washout Period of Two Weeks||25
11029873|NCT00848484|12209019|FG001|STARTED|Washout Period of Two Weeks||24
11029874|NCT00848484|12209018|FG000|COMPLETED|Washout Period of Two Weeks||25
11029875|NCT00848484|12209019|FG001|COMPLETED|Washout Period of Two Weeks||21
11029876|NCT00848484|12209018|FG000|NOT COMPLETED|Washout Period of Two Weeks||0
11029877|NCT00848484|12209019|FG001|NOT COMPLETED|Washout Period of Two Weeks||3
11029878|NCT00848484|12209018|FG000|STARTED|Second Intervention (Treatment Period 2)||25
11029879|NCT00848484|12209019|FG001|STARTED|Second Intervention (Treatment Period 2)||21
11029880|NCT00848484|12209018|FG000|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
11029881|NCT00848484|12209019|FG001|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
11029882|NCT00848484|12209018|FG000|COMPLETED|Second Intervention (Treatment Period 2)||25
11029883|NCT00848484|12209019|FG001|COMPLETED|Second Intervention (Treatment Period 2)||20
11029884|NCT00848484|12209018|FG000|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
11029885|NCT00848484|12209019|FG001|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
11029886|NCT00848497|12209027|FG000|STARTED|Overall Study||2
11029887|NCT00848497|12209028|FG001|STARTED|Overall Study|Completed Visit 4|1
11029888|NCT00848497|12209027|FG000|COMPLETED|Overall Study||0
11029889|NCT00848497|12209028|FG001|COMPLETED|Overall Study||0
11029890|NCT00848497|12209027|FG000|NOT COMPLETED|Overall Study||2
11029891|NCT00848497|12209028|FG001|NOT COMPLETED|Overall Study||1
11029892|NCT00848510|12209040|FG000|STARTED|Overall Study||10
11029893|NCT00848510|12209041|FG001|STARTED|Overall Study||13
11029894|NCT00848510|12209042|FG002|STARTED|Overall Study||8
11029895|NCT00848510|12209043|FG003|STARTED|Overall Study||10
11029896|NCT00848510|12209040|FG000|COMPLETED|Overall Study||10
11029897|NCT00848510|12209041|FG001|COMPLETED|Overall Study||13
11029898|NCT00848510|12209042|FG002|COMPLETED|Overall Study||8
11029899|NCT00848510|12209043|FG003|COMPLETED|Overall Study||10
11029900|NCT00848510|12209040|FG000|NOT COMPLETED|Overall Study||0
11029901|NCT00848510|12209041|FG001|NOT COMPLETED|Overall Study||0
11333236|NCT02830087|12530799|FG004|STARTED|Overall Study||3
11333237|NCT02830087|12530800|FG005|STARTED|Overall Study||3
11333238|NCT02830087|12530795|FG000|COMPLETED|Overall Study||0
11029902|NCT00848510|12209042|FG002|NOT COMPLETED|Overall Study||0
11029903|NCT00848510|12209043|FG003|NOT COMPLETED|Overall Study||0
11029904|NCT00848536|12209055|FG000|STARTED|Overall Study||185
11029905|NCT00848536|12209056|FG001|STARTED|Overall Study||186
11029906|NCT00848536|12209055|FG000|COMPLETED|Overall Study||181
11029907|NCT00848536|12209056|FG001|COMPLETED|Overall Study||179
11029908|NCT00848536|12209055|FG000|NOT COMPLETED|Overall Study||4
11029909|NCT00848536|12209056|FG001|NOT COMPLETED|Overall Study||7
11029910|NCT00848549|12209064|FG000|STARTED|E2090-E044-310 (Base Study) Disposition||282
11029911|NCT00848549|12209065|FG001|STARTED|E2090-E044-310 (Base Study) Disposition||301
11029912|NCT00848549|12209064|FG000|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
11029913|NCT00848549|12209065|FG001|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
11029914|NCT00848549|12209064|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
11029915|NCT00848549|12209065|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
11029916|NCT00848549|12209064|FG000|STARTED|E2090-E044-310 (Base Study) Transition||161
11029917|NCT00848549|12209065|FG001|STARTED|E2090-E044-310 (Base Study) Transition||192
11029918|NCT00848549|12209064|FG000|COMPLETED|E2090-E044-310 (Base Study) Transition||137
11029919|NCT00848549|12209065|FG001|COMPLETED|E2090-E044-310 (Base Study) Transition||158
11029920|NCT00848549|12209064|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
11029921|NCT00848549|12209065|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
11029922|NCT00848549|12209064|FG000|STARTED|E2090-E044-314 (Extension Study)||137
11029923|NCT00848549|12209065|FG001|STARTED|E2090-E044-314 (Extension Study)||158
11029924|NCT00848549|12209064|FG000|COMPLETED|E2090-E044-314 (Extension Study)||120
11029925|NCT00848549|12209065|FG001|COMPLETED|E2090-E044-314 (Extension Study)||134
11029926|NCT00848549|12209064|FG000|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
11029927|NCT00848549|12209065|FG001|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
11029928|NCT00848718|12209086|FG000|STARTED|Overall Study||7
11029929|NCT00848718|12209087|FG001|STARTED|Overall Study||9
11029930|NCT00848718|12209088|FG002|STARTED|Overall Study||6
11029931|NCT00848718|12209089|FG003|STARTED|Overall Study||5
11029932|NCT00848718|12209090|FG004|STARTED|Overall Study||6
11029933|NCT00848718|12209091|FG005|STARTED|Overall Study||5
11029934|NCT00848718|12209092|FG006|STARTED|Overall Study||3
11029935|NCT00848718|12209093|FG007|STARTED|Overall Study||5
11029936|NCT00848718|12209094|FG008|STARTED|Overall Study||4
11029937|NCT00848718|12209095|FG009|STARTED|Overall Study||9
11029938|NCT00848718|12209096|FG010|STARTED|Overall Study||4
11029939|NCT00848718|12209097|FG011|STARTED|Overall Study||6
11029940|NCT00848718|12209098|FG012|STARTED|Overall Study||8
11333239|NCT02830087|12530796|FG001|COMPLETED|Overall Study||0
11333240|NCT02830087|12530797|FG002|COMPLETED|Overall Study||0
11333241|NCT02830087|12530798|FG003|COMPLETED|Overall Study||0
11333242|NCT02830087|12530799|FG004|COMPLETED|Overall Study||0
11333243|NCT02830087|12530800|FG005|COMPLETED|Overall Study||0
11029941|NCT00848718|12209086|FG000|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6
11029942|NCT00848718|12209087|FG001|Treated|Overall Study||9
11029943|NCT00848718|12209088|FG002|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5
11333244|NCT02830087|12530795|FG000|NOT COMPLETED|Overall Study||4
11333245|NCT02830087|12530796|FG001|NOT COMPLETED|Overall Study||4
11029944|NCT00848718|12209089|FG003|Treated|Overall Study||5
11029945|NCT00848718|12209090|FG004|Treated|Overall Study||6
11029946|NCT00848718|12209091|FG005|Treated|Overall Study||5
11029947|NCT00848718|12209092|FG006|Treated|Overall Study||3
11057430|NCT00997620|12238936|FG001|COMPLETED|Overall Study||21
11029948|NCT00848718|12209093|FG007|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4
11029949|NCT00848718|12209094|FG008|Treated|Overall Study||4
11029950|NCT00848718|12209095|FG009|Treated|Overall Study||9
11029951|NCT00848718|12209096|FG010|Treated|Overall Study||4
11029952|NCT00848718|12209097|FG011|Treated|Overall Study||6
11029953|NCT00848718|12209098|FG012|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6
11029954|NCT00848718|12209086|FG000|COMPLETED|Overall Study||0
11029955|NCT00848718|12209087|FG001|COMPLETED|Overall Study||0
11029956|NCT00848718|12209088|FG002|COMPLETED|Overall Study||0
11029957|NCT00848718|12209089|FG003|COMPLETED|Overall Study||0
11029958|NCT00848718|12209090|FG004|COMPLETED|Overall Study||0
11029959|NCT00848718|12209091|FG005|COMPLETED|Overall Study||0
11029960|NCT00848718|12209092|FG006|COMPLETED|Overall Study||0
11029961|NCT00848718|12209093|FG007|COMPLETED|Overall Study||0
11029962|NCT00848718|12209094|FG008|COMPLETED|Overall Study||0
11029963|NCT00848718|12209095|FG009|COMPLETED|Overall Study||0
11029964|NCT00848718|12209096|FG010|COMPLETED|Overall Study||0
11029965|NCT00848718|12209097|FG011|COMPLETED|Overall Study||0
11029966|NCT00848718|12209098|FG012|COMPLETED|Overall Study||0
11029967|NCT00848718|12209086|FG000|NOT COMPLETED|Overall Study||7
11029968|NCT00848718|12209087|FG001|NOT COMPLETED|Overall Study||9
11029969|NCT00848718|12209088|FG002|NOT COMPLETED|Overall Study||6
11029970|NCT00848718|12209089|FG003|NOT COMPLETED|Overall Study||5
11029971|NCT00848718|12209090|FG004|NOT COMPLETED|Overall Study||6
11029972|NCT00848718|12209091|FG005|NOT COMPLETED|Overall Study||5
11029973|NCT00848718|12209092|FG006|NOT COMPLETED|Overall Study||3
11029974|NCT00848718|12209093|FG007|NOT COMPLETED|Overall Study||5
11029975|NCT00848718|12209094|FG008|NOT COMPLETED|Overall Study||4
11029976|NCT00848718|12209095|FG009|NOT COMPLETED|Overall Study||9
11029977|NCT00848718|12209096|FG010|NOT COMPLETED|Overall Study||4
11200711|NCT01828476|12390927|FG000|NOT COMPLETED|Overall Study||0
11029978|NCT00848718|12209097|FG011|NOT COMPLETED|Overall Study||6
11029979|NCT00848718|12209098|FG012|NOT COMPLETED|Overall Study||8
11029980|NCT00848744|12209132|FG000|STARTED|Overall Study||10
11029981|NCT00848744|12209132|FG000|COMPLETED|Overall Study||10
11029982|NCT00848744|12209132|FG000|NOT COMPLETED|Overall Study||0
11029983|NCT00848783|12209140|FG000|STARTED|Overall Study||4
11029984|NCT00848783|12209141|FG001|STARTED|Overall Study||3
11029985|NCT00848783|12209142|FG002|STARTED|Overall Study||1
11029986|NCT00848783|12209140|FG000|COMPLETED|Overall Study||1
11333246|NCT02830087|12530797|FG002|NOT COMPLETED|Overall Study||4
11333247|NCT02830087|12530798|FG003|NOT COMPLETED|Overall Study||3
11333248|NCT02830087|12530799|FG004|NOT COMPLETED|Overall Study||3
11029987|NCT00848783|12209141|FG001|COMPLETED|Overall Study||1
11029988|NCT00848783|12209142|FG002|COMPLETED|Overall Study||1
11029989|NCT00848783|12209140|FG000|NOT COMPLETED|Overall Study||3
11029990|NCT00848783|12209141|FG001|NOT COMPLETED|Overall Study||2
11029991|NCT00848783|12209142|FG002|NOT COMPLETED|Overall Study||0
11029992|NCT00848926|12209149|FG000|STARTED|Treatment Period||102
11029993|NCT00848926|12209149|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
11029994|NCT00848926|12209149|FG000|NOT COMPLETED|Treatment Period||84
11029995|NCT00848926|12209149|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|102
11029996|NCT00848926|12209149|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
11029997|NCT00848926|12209149|FG000|NOT COMPLETED|Follow-up Period||12
11029998|NCT00848965|12209153|FG000|STARTED|Overall Study||59
11029999|NCT00848965|12209153|FG000|COMPLETED|Overall Study||57
11030000|NCT00848965|12209153|FG000|NOT COMPLETED|Overall Study||2
11030001|NCT00849017|12209168|FG000|STARTED|Treatment Period (156 Weeks)||101
11030002|NCT00849017|12209169|FG001|STARTED|Treatment Period (156 Weeks)||101
11030003|NCT00849017|12209170|FG002|STARTED|Treatment Period (156 Weeks)||99
11030004|NCT00849017|12209168|FG000|COMPLETED|Treatment Period (156 Weeks)||58
11030005|NCT00849017|12209169|FG001|COMPLETED|Treatment Period (156 Weeks)||68
11030006|NCT00849017|12209170|FG002|COMPLETED|Treatment Period (156 Weeks)||57
11030007|NCT00849017|12209168|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||43
11030008|NCT00849017|12209169|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||33
11030009|NCT00849017|12209170|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||42
11030010|NCT00849017|12209168|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
11030011|NCT00849017|12209169|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
11030012|NCT00849017|12209170|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
11030013|NCT00849017|12209168|FG000|COMPLETED|Follow-up Period (8 Weeks)||76
11030014|NCT00849017|12209169|FG001|COMPLETED|Follow-up Period (8 Weeks)||83
11030015|NCT00849017|12209170|FG002|COMPLETED|Follow-up Period (8 Weeks)||74
11030016|NCT00849017|12209168|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||25
11030017|NCT00849017|12209169|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||18
11030018|NCT00849017|12209170|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||25
11030019|NCT00849056|12209184|FG000|STARTED|Treatment Period (TP) (156 Weeks)||151
11030020|NCT00849056|12209185|FG001|STARTED|Treatment Period (TP) (156 Weeks)||150
11030021|NCT00849056|12209184|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||88
11030022|NCT00849056|12209185|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||100
11030023|NCT00849056|12209184|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
11030024|NCT00849056|12209185|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
11030025|NCT00849056|12209184|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
11030026|NCT00849056|12209185|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
11030027|NCT00849056|12209184|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
11030028|NCT00849056|12209185|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
11030029|NCT00849056|12209184|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
11030030|NCT00849056|12209185|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
11030031|NCT00849108|12209194|FG000|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
11030032|NCT00849108|12209195|FG001|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
11030033|NCT00849108|12209194|FG000|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
11030034|NCT00849108|12209195|FG001|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
11030035|NCT00849108|12209194|FG000|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
11030036|NCT00849108|12209195|FG001|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
11030037|NCT00849108|12209194|FG000|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
11030038|NCT00849108|12209195|FG001|STARTED|Cohort 2 Efficacy||143
11030039|NCT00849108|12209194|FG000|COMPLETED|Cohort 2 Efficacy||0
11030040|NCT00849108|12209195|FG001|COMPLETED|Cohort 2 Efficacy||133
11030041|NCT00849108|12209194|FG000|NOT COMPLETED|Cohort 2 Efficacy||0
11030042|NCT00849108|12209195|FG001|NOT COMPLETED|Cohort 2 Efficacy||10
11030043|NCT00849121|12209205|FG000|STARTED|Overall Study||8
11030044|NCT00849121|12209206|FG001|STARTED|Overall Study||9
11030045|NCT00849121|12209205|FG000|COMPLETED|Overall Study||8
11030046|NCT00849121|12209206|FG001|COMPLETED|Overall Study||9
11030047|NCT00849121|12209205|FG000|NOT COMPLETED|Overall Study||0
11030048|NCT00849121|12209206|FG001|NOT COMPLETED|Overall Study||0
11030049|NCT00849147|12209212|FG000|STARTED|Overall Study||55
11030050|NCT00849147|12209212|FG000|COMPLETED|Overall Study||50
11030051|NCT00849147|12209212|FG000|NOT COMPLETED|Overall Study||5
11030052|NCT00849186|12209216|FG000|STARTED|Overall Study||26
11030053|NCT00849186|12209216|FG000|COMPLETED|Overall Study||16
11030054|NCT00849186|12209216|FG000|NOT COMPLETED|Overall Study||10
11030055|NCT00849212|12209221|FG000|STARTED|Overall Study||30
11030056|NCT00849212|12209221|FG000|COMPLETED|Overall Study||23
11030057|NCT00849212|12209221|FG000|NOT COMPLETED|Overall Study||7
11030058|NCT00849251|12209225|FG000|STARTED|Overall Study||6
11030059|NCT00849251|12209226|FG001|STARTED|Overall Study||25
11030060|NCT00849251|12209225|FG000|COMPLETED|Overall Study||5
11030061|NCT00849251|12209226|FG001|COMPLETED|Overall Study||24
11030062|NCT00849251|12209225|FG000|NOT COMPLETED|Overall Study||1
11030063|NCT00849251|12209226|FG001|NOT COMPLETED|Overall Study||1
11030064|NCT00849290|12209232|FG000|STARTED|Overall Study||113
11030065|NCT00849290|12209232|FG000|COMPLETED|Overall Study||58
11030066|NCT00849290|12209232|FG000|NOT COMPLETED|Overall Study||55
11030067|NCT00849381|12209236|FG000|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
11030068|NCT00849381|12209236|FG000|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
11030069|NCT00849381|12209236|FG000|NOT COMPLETED|Overall Study||145
11030070|NCT00849472|12209240|FG000|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
11030071|NCT00849472|12209240|FG000|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
11030072|NCT00849472|12209240|FG000|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
11030073|NCT00849472|12209240|FG000|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
11030074|NCT00849472|12209240|FG000|COMPLETED|Weekly Paclitaxel||78
11030075|NCT00849472|12209240|FG000|NOT COMPLETED|Weekly Paclitaxel||16
11030076|NCT00849472|12209240|FG000|STARTED|Pazopanib Presurgery Treatment (PPT)||94
11030077|NCT00849472|12209240|FG000|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
11030078|NCT00849472|12209240|FG000|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
11030079|NCT00849472|12209240|FG000|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
11030080|NCT00849472|12209240|FG000|COMPLETED|Pazopanib Postsurgery Treatment||16
11030081|NCT00849472|12209240|FG000|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
11030082|NCT00849680|12209253|FG000|STARTED|Overall Study||27
11030083|NCT00849680|12209254|FG001|STARTED|Overall Study||13
11030084|NCT00849680|12209255|FG002|STARTED|Overall Study||42
11030085|NCT00849680|12209256|FG003|STARTED|Overall Study||42
11030086|NCT00849680|12209257|FG004|STARTED|Overall Study||42
11030087|NCT00849680|12209258|FG005|STARTED|Overall Study||42
11030088|NCT00849680|12209259|FG006|STARTED|Overall Study||78
11030089|NCT00849680|12209260|FG007|STARTED|Overall Study||31
11030090|NCT00849680|12209253|FG000|COMPLETED|Overall Study||16
11030091|NCT00849680|12209254|FG001|COMPLETED|Overall Study||10
11030092|NCT00849680|12209255|FG002|COMPLETED|Overall Study||27
11030093|NCT00849680|12209256|FG003|COMPLETED|Overall Study||28
11030094|NCT00849680|12209257|FG004|COMPLETED|Overall Study||32
11030095|NCT00849680|12209258|FG005|COMPLETED|Overall Study||27
11030096|NCT00849680|12209259|FG006|COMPLETED|Overall Study||61
11030097|NCT00849680|12209260|FG007|COMPLETED|Overall Study||23
11030098|NCT00849680|12209253|FG000|NOT COMPLETED|Overall Study||11
11030099|NCT00849680|12209254|FG001|NOT COMPLETED|Overall Study||3
11030100|NCT00849680|12209255|FG002|NOT COMPLETED|Overall Study||15
11030101|NCT00849680|12209256|FG003|NOT COMPLETED|Overall Study||14
11030102|NCT00849680|12209257|FG004|NOT COMPLETED|Overall Study||10
11030103|NCT00849680|12209258|FG005|NOT COMPLETED|Overall Study||15
11030104|NCT00849680|12209259|FG006|NOT COMPLETED|Overall Study||17
11030105|NCT00849680|12209260|FG007|NOT COMPLETED|Overall Study||8
11030106|NCT00849693|12209282|FG000|STARTED|Acute Treatment Phase||108
11030107|NCT00849693|12209283|FG001|STARTED|Acute Treatment Phase||116
11030108|NCT00849693|12209284|FG002|STARTED|Acute Treatment Phase||117
11030109|NCT00849693|12209285|FG003|STARTED|Acute Treatment Phase||122
11030110|NCT00849693|12209282|FG000|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
11030111|NCT00849693|12209283|FG001|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
11030112|NCT00849693|12209284|FG002|COMPLETED|Acute Treatment Phase||84
11030113|NCT00849693|12209285|FG003|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
11030114|NCT00849693|12209282|FG000|NOT COMPLETED|Acute Treatment Phase||33
11030115|NCT00849693|12209283|FG001|NOT COMPLETED|Acute Treatment Phase||35
11030116|NCT00849693|12209284|FG002|NOT COMPLETED|Acute Treatment Phase||33
11030117|NCT00849693|12209285|FG003|NOT COMPLETED|Acute Treatment Phase||37
11030118|NCT00849693|12209282|FG000|STARTED|Extension Phase||73
11030119|NCT00849693|12209283|FG001|STARTED|Extension Phase||80
11030120|NCT00849693|12209284|FG002|STARTED|Extension Phase||84
11030121|NCT00849693|12209285|FG003|STARTED|Extension Phase||82
11030122|NCT00849693|12209282|FG000|COMPLETED|Extension Phase||43
11030123|NCT00849693|12209283|FG001|COMPLETED|Extension Phase||50
11030124|NCT00849693|12209284|FG002|COMPLETED|Extension Phase||49
11030125|NCT00849693|12209285|FG003|COMPLETED|Extension Phase||44
11030126|NCT00849693|12209282|FG000|NOT COMPLETED|Extension Phase||30
11030127|NCT00849693|12209283|FG001|NOT COMPLETED|Extension Phase||30
11030128|NCT00849693|12209284|FG002|NOT COMPLETED|Extension Phase||35
11030129|NCT00849693|12209285|FG003|NOT COMPLETED|Extension Phase||38
11030130|NCT00849810|12209307|FG000|STARTED|Overall Study||1
11030131|NCT00849810|12209307|FG000|COMPLETED|Overall Study||1
11030132|NCT00849810|12209307|FG000|NOT COMPLETED|Overall Study||0
11030133|NCT00849875|12209314|FG000|STARTED|Overall Study||48
11030134|NCT00849875|12209314|FG000|COMPLETED|Overall Study||1
11030135|NCT00849875|12209314|FG000|NOT COMPLETED|Overall Study||47
11030136|NCT00849901|12209328|FG000|STARTED|Acute Treatment Phase||117
11030137|NCT00849901|12209329|FG001|STARTED|Acute Treatment Phase||117
11030138|NCT00849901|12209330|FG002|STARTED|Acute Treatment Phase||103
11030139|NCT00849901|12209328|FG000|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
11030140|NCT00849901|12209329|FG001|COMPLETED|Acute Treatment Phase||91
11030141|NCT00849901|12209330|FG002|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
11030142|NCT00849901|12209328|FG000|NOT COMPLETED|Acute Treatment Phase||30
11030143|NCT00849901|12209329|FG001|NOT COMPLETED|Acute Treatment Phase||26
11030144|NCT00849901|12209330|FG002|NOT COMPLETED|Acute Treatment Phase||16
11030145|NCT00849901|12209328|FG000|STARTED|Extension Phase||83
11030146|NCT00849901|12209329|FG001|STARTED|Extension Phase||91
11030147|NCT00849901|12209330|FG002|STARTED|Extension Phase||86
11030148|NCT00849901|12209328|FG000|COMPLETED|Extension Phase||56
11030149|NCT00849901|12209329|FG001|COMPLETED|Extension Phase||65
11030150|NCT00849901|12209330|FG002|COMPLETED|Extension Phase||69
11030151|NCT00849901|12209328|FG000|NOT COMPLETED|Extension Phase||27
11030152|NCT00849901|12209329|FG001|NOT COMPLETED|Extension Phase||26
11030153|NCT00849901|12209330|FG002|NOT COMPLETED|Extension Phase||17
11030154|NCT00849940|12209344|FG000|STARTED|Overall Study||72
11030155|NCT00849940|12209344|FG000|COMPLETED|Overall Study||68
11030156|NCT00849940|12209344|FG000|NOT COMPLETED|Overall Study||4
11030157|NCT00850031|12209348|FG000|STARTED|Overall Study||118
11030158|NCT00850031|12209348|FG000|COMPLETED|Overall Study||101
11030159|NCT00850031|12209348|FG000|NOT COMPLETED|Overall Study||17
11030160|NCT00850070|12209354|FG000|STARTED|Overall Study||23
11030161|NCT00850070|12209355|FG001|STARTED|Overall Study||23
11030162|NCT00850070|12209354|FG000|COMPLETED|Overall Study||20
11030163|NCT00850070|12209355|FG001|COMPLETED|Overall Study||22
11030164|NCT00850070|12209354|FG000|NOT COMPLETED|Overall Study||3
11030165|NCT00850070|12209355|FG001|NOT COMPLETED|Overall Study||1
11030166|NCT00850096|12209368|FG000|STARTED|Overall Study||47
11030167|NCT00850096|12209369|FG001|STARTED|Overall Study||47
11030168|NCT00850096|12209368|FG000|COMPLETED|Overall Study||44
11030169|NCT00850096|12209369|FG001|COMPLETED|Overall Study||45
11030170|NCT00850096|12209368|FG000|NOT COMPLETED|Overall Study||3
11030171|NCT00850096|12209369|FG001|NOT COMPLETED|Overall Study||2
11030172|NCT00850135|12209375|FG000|STARTED|Overall Study||57
11030173|NCT00850135|12209375|FG000|COMPLETED|Overall Study||56
11030174|NCT00850135|12209375|FG000|NOT COMPLETED|Overall Study||1
11030175|NCT00850200|12209381|FG000|STARTED|Overall Study||20
11030176|NCT00850200|12209381|FG000|COMPLETED|Overall Study||15
11030177|NCT00850200|12209381|FG000|NOT COMPLETED|Overall Study||5
11030178|NCT00850343|12209392|FG000|STARTED|Overall Study||110
11333249|NCT02830087|12530800|FG005|NOT COMPLETED|Overall Study||3
11333250|NCT02830438|12530814|FG000|STARTED|Overall Study||8
11333251|NCT02830438|12530814|FG000|COMPLETED|Overall Study||8
11333252|NCT02830438|12530814|FG000|NOT COMPLETED|Overall Study||0
11333253|NCT02830776|12530818|FG000|STARTED|Overall Study||15
11030179|NCT00850343|12209393|FG001|STARTED|Overall Study||12
11030180|NCT00850343|12209394|FG002|STARTED|Overall Study||43
11030181|NCT00850343|12209395|FG003|STARTED|Overall Study||43
11030182|NCT00850343|12209392|FG000|Completed Week 24|Overall Study||94
11030183|NCT00850343|12209393|FG001|Completed Week 24|Overall Study||12
11030184|NCT00850343|12209394|FG002|Completed Week 24|Overall Study||39
11030185|NCT00850343|12209395|FG003|Completed Week 24|Overall Study||39
11030186|NCT00850343|12209392|FG000|Completed Week 52|Overall Study||88
11030187|NCT00850343|12209393|FG001|Completed Week 52|Overall Study||11
11030188|NCT00850343|12209394|FG002|Completed Week 52|Overall Study||37
11030189|NCT00850343|12209395|FG003|Completed Week 52|Overall Study||37
11030190|NCT00850343|12209392|FG000|COMPLETED|Overall Study||64
11030191|NCT00850343|12209393|FG001|COMPLETED|Overall Study||9
11030192|NCT00850343|12209394|FG002|COMPLETED|Overall Study||29
11030193|NCT00850343|12209395|FG003|COMPLETED|Overall Study||30
11030194|NCT00850343|12209392|FG000|NOT COMPLETED|Overall Study||46
11030195|NCT00850343|12209393|FG001|NOT COMPLETED|Overall Study||3
11030196|NCT00850343|12209394|FG002|NOT COMPLETED|Overall Study||14
11030197|NCT00850343|12209395|FG003|NOT COMPLETED|Overall Study||13
11030198|NCT00850395|12209405|FG000|STARTED|Overall Study||79
11333254|NCT02830776|12530818|FG000|COMPLETED|Overall Study||14
11333255|NCT02830776|12530818|FG000|NOT COMPLETED|Overall Study||1
11333256|NCT02830880|12530823|FG000|STARTED|Overall Study||7
11030199|NCT00850395|12209405|FG000|COMPLETED|Overall Study||69
11030200|NCT00850395|12209405|FG000|NOT COMPLETED|Overall Study||10
11030201|NCT00850460|12209411|FG000|STARTED|Overall Study||7
11030202|NCT00850460|12209412|FG001|STARTED|Overall Study||7
11030203|NCT00850460|12209411|FG000|Started - Week 0|Overall Study||7
11030204|NCT00850460|12209412|FG001|Started - Week 0|Overall Study||7
11030205|NCT00850460|12209411|FG000|Completion - Week 8|Overall Study||3
11030206|NCT00850460|12209412|FG001|Completion - Week 8|Overall Study||3
11030207|NCT00850460|12209411|FG000|COMPLETED|Overall Study||3
11030208|NCT00850460|12209412|FG001|COMPLETED|Overall Study||3
11030209|NCT00850460|12209411|FG000|NOT COMPLETED|Overall Study||4
11030210|NCT00850460|12209412|FG001|NOT COMPLETED|Overall Study||4
11030211|NCT00850473|12209418|FG000|STARTED|Overall Study||3
11030212|NCT00850473|12209418|FG000|COMPLETED|Overall Study||3
11030213|NCT00850473|12209418|FG000|NOT COMPLETED|Overall Study||0
11030214|NCT00850499|12209424|FG000|STARTED|Overall Study||4
11030215|NCT00850499|12209425|FG001|STARTED|Overall Study||8
11333257|NCT02830880|12530823|FG000|Completed Visit After Cyle 1|Overall Study||7
11333258|NCT02830880|12530823|FG000|COMPLETED|Overall Study||4
11333259|NCT02830880|12530823|FG000|NOT COMPLETED|Overall Study||3
11333260|NCT02830893|12530829|FG000|STARTED|Overall Study||12
11333261|NCT02830893|12530830|FG001|STARTED|Overall Study||11
11333262|NCT02830893|12530829|FG000|COMPLETED|Overall Study||11
11333263|NCT02830893|12530830|FG001|COMPLETED|Overall Study||8
11333264|NCT02830893|12530829|FG000|NOT COMPLETED|Overall Study||1
11333265|NCT02830893|12530830|FG001|NOT COMPLETED|Overall Study||3
11333266|NCT02831387|12530838|FG000|STARTED|Overall Study||23
11333267|NCT02831387|12530839|FG001|STARTED|Overall Study||24
11333268|NCT02831387|12530838|FG000|COMPLETED|Overall Study||22
11333269|NCT02831387|12530839|FG001|COMPLETED|Overall Study||22
11333270|NCT02831387|12530838|FG000|NOT COMPLETED|Overall Study||1
11030216|NCT00850499|12209424|FG000|COMPLETED|Overall Study||1
11030217|NCT00850499|12209425|FG001|COMPLETED|Overall Study||6
11030218|NCT00850499|12209424|FG000|NOT COMPLETED|Overall Study||3
11030219|NCT00850499|12209425|FG001|NOT COMPLETED|Overall Study||2
11030220|NCT00850538|12209431|FG000|STARTED|Overall Study||101
11030221|NCT00850538|12209431|FG000|COMPLETED|Overall Study||60
11030222|NCT00850538|12209431|FG000|NOT COMPLETED|Overall Study||41
11030223|NCT00850564|12209435|FG000|STARTED|Overall Study||15
11030224|NCT00850564|12209435|FG000|COMPLETED|Overall Study||13
11333271|NCT02831387|12530839|FG001|NOT COMPLETED|Overall Study||2
11333272|NCT02831569|12530845|FG000|STARTED|Overall Study||80
11333273|NCT02831569|12530845|FG000|COMPLETED|Overall Study||80
11333274|NCT02831569|12530845|FG000|NOT COMPLETED|Overall Study||0
11333275|NCT02831660|12530849|FG000|STARTED|Overall Study||1
11333276|NCT02831660|12530849|FG000|COMPLETED|Overall Study||1
11333277|NCT02831660|12530849|FG000|NOT COMPLETED|Overall Study||0
11333278|NCT02831816|12530853|FG000|STARTED|Overall Study||640
11333279|NCT02831816|12530853|FG000|ZP|Overall Study||589
11333280|NCT02831816|12530853|FG000|CP|Overall Study||590
11333281|NCT02831816|12530853|FG000|Vehicle|Overall Study||131
11333282|NCT02831816|12530853|FG000|COMPLETED|Overall Study||640
11333283|NCT02831816|12530853|FG000|NOT COMPLETED|Overall Study||0
11333284|NCT02831855|12530864|FG000|STARTED|Open Label Phase (24 Weeks)||694
11333285|NCT02831855|12530865|FG001|STARTED|Open Label Phase (24 Weeks)||0
11333286|NCT02831855|12530866|FG002|STARTED|Open Label Phase (24 Weeks)||0
11333287|NCT02831855|12530864|FG000|COMPLETED|Open Label Phase (24 Weeks)||623
11333288|NCT02831855|12530865|FG001|COMPLETED|Open Label Phase (24 Weeks)||0
11333289|NCT02831855|12530866|FG002|COMPLETED|Open Label Phase (24 Weeks)||0
11333290|NCT02831855|12530864|FG000|NOT COMPLETED|Open Label Phase (24 Weeks)||71
11333291|NCT02831855|12530865|FG001|NOT COMPLETED|Open Label Phase (24 Weeks)||0
11333292|NCT02831855|12530866|FG002|NOT COMPLETED|Open Label Phase (24 Weeks)||0
11333293|NCT02831855|12530864|FG000|STARTED|Double Blind Phase (24 Weeks)||0
11333294|NCT02831855|12530865|FG001|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase.|267
11333295|NCT02831855|12530866|FG002|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase. .|266
11333296|NCT02831855|12530864|FG000|Treated|Double Blind Phase (24 Weeks)||0
11333297|NCT02831855|12530865|FG001|Treated|Double Blind Phase (24 Weeks)||264
11333298|NCT02831855|12530866|FG002|Treated|Double Blind Phase (24 Weeks)||266
11333299|NCT02831855|12530864|FG000|COMPLETED|Double Blind Phase (24 Weeks)||0
11333300|NCT02831855|12530865|FG001|COMPLETED|Double Blind Phase (24 Weeks)||238
11333301|NCT02831855|12530866|FG002|COMPLETED|Double Blind Phase (24 Weeks)||247
11333302|NCT02831855|12530864|FG000|NOT COMPLETED|Double Blind Phase (24 Weeks)||0
11333303|NCT02831855|12530865|FG001|NOT COMPLETED|Double Blind Phase (24 Weeks)||29
11333304|NCT02831855|12530866|FG002|NOT COMPLETED|Double Blind Phase (24 Weeks)||19
11333305|NCT02831998|12530876|FG000|STARTED|Overall Study||440
11030225|NCT00850564|12209435|FG000|NOT COMPLETED|Overall Study||2
11030226|NCT00850603|12209444|FG000|STARTED|Overall Study||34
11030227|NCT00850603|12209445|FG001|STARTED|Overall Study||34
11030228|NCT00850603|12209446|FG002|STARTED|Overall Study||34
11030229|NCT00850603|12209447|FG003|STARTED|Overall Study||34
11030230|NCT00850603|12209448|FG004|STARTED|Overall Study||34
11030231|NCT00850603|12209444|FG000|COMPLETED|Overall Study||34
11030232|NCT00850603|12209445|FG001|COMPLETED|Overall Study||34
11030233|NCT00850603|12209446|FG002|COMPLETED|Overall Study||34
11030234|NCT00850603|12209447|FG003|COMPLETED|Overall Study||34
11030235|NCT00850603|12209448|FG004|COMPLETED|Overall Study||34
11030236|NCT00850603|12209444|FG000|NOT COMPLETED|Overall Study||0
11030237|NCT00850603|12209445|FG001|NOT COMPLETED|Overall Study||0
11030238|NCT00850603|12209446|FG002|NOT COMPLETED|Overall Study||0
11030239|NCT00850603|12209447|FG003|NOT COMPLETED|Overall Study||0
11030240|NCT00850603|12209448|FG004|NOT COMPLETED|Overall Study||0
11030241|NCT00850642|12209462|FG000|STARTED|Overall Study||3
11030242|NCT00850642|12209463|FG001|STARTED|Overall Study||4
11030243|NCT00850642|12209462|FG000|COMPLETED|Overall Study||3
11030244|NCT00850642|12209463|FG001|COMPLETED|Overall Study||4
11030245|NCT00850642|12209462|FG000|NOT COMPLETED|Overall Study||0
11030246|NCT00850642|12209463|FG001|NOT COMPLETED|Overall Study||0
11030247|NCT00850759|12209478|FG000|STARTED|Overall Study||59
11030248|NCT00850759|12209479|FG001|STARTED|Overall Study||57
11030249|NCT00850759|12209480|FG002|STARTED|Overall Study||57
11030250|NCT00850759|12209481|FG003|STARTED|Overall Study||58
11030251|NCT00850759|12209478|FG000|COMPLETED|Overall Study||52
11030252|NCT00850759|12209479|FG001|COMPLETED|Overall Study||52
11030253|NCT00850759|12209480|FG002|COMPLETED|Overall Study||52
11030254|NCT00850759|12209481|FG003|COMPLETED|Overall Study||55
11030255|NCT00850759|12209478|FG000|NOT COMPLETED|Overall Study||7
11030256|NCT00850759|12209479|FG001|NOT COMPLETED|Overall Study||5
11030257|NCT00850759|12209480|FG002|NOT COMPLETED|Overall Study||5
11030258|NCT00850759|12209481|FG003|NOT COMPLETED|Overall Study||3
11030259|NCT00850889|12209491|FG000|STARTED|Overall Study||32
11030260|NCT00850889|12209491|FG000|COMPLETED|Overall Study||32
11030261|NCT00850889|12209491|FG000|NOT COMPLETED|Overall Study||0
11030262|NCT00850993|12209502|FG000|STARTED|Overall Study||17
11030263|NCT00850993|12209503|FG001|STARTED|Overall Study||18
11030264|NCT00850993|12209504|FG002|STARTED|Overall Study||8
11030265|NCT00850993|12209505|FG003|STARTED|Overall Study||15
11030266|NCT00850993|12209502|FG000|Safety|Overall Study||17
11030267|NCT00850993|12209503|FG001|Safety|Overall Study||18
11030268|NCT00850993|12209504|FG002|Safety|Overall Study||8
11030269|NCT00850993|12209505|FG003|Safety|Overall Study||15
11030270|NCT00850993|12209502|FG000|Intent-to-treat|Overall Study||17
11030271|NCT00850993|12209503|FG001|Intent-to-treat|Overall Study||18
11030272|NCT00850993|12209504|FG002|Intent-to-treat|Overall Study||8
11030273|NCT00850993|12209505|FG003|Intent-to-treat|Overall Study||15
11030274|NCT00850993|12209502|FG000|Received Phototherapy|Overall Study||3
11030275|NCT00850993|12209503|FG001|Received Phototherapy|Overall Study||6
11030276|NCT00850993|12209504|FG002|Received Phototherapy|Overall Study||2
11030277|NCT00850993|12209505|FG003|Received Phototherapy|Overall Study||8
11030278|NCT00850993|12209502|FG000|Per Protocol|Overall Study||10
11030279|NCT00850993|12209503|FG001|Per Protocol|Overall Study||13
11030280|NCT00850993|12209504|FG002|Per Protocol|Overall Study||5
11030281|NCT00850993|12209505|FG003|Per Protocol|Overall Study||13
11030282|NCT00850993|12209502|FG000|COMPLETED|Overall Study||16
11030283|NCT00850993|12209503|FG001|COMPLETED|Overall Study||18
11030284|NCT00850993|12209504|FG002|COMPLETED|Overall Study||8
11030285|NCT00850993|12209505|FG003|COMPLETED|Overall Study||14
11030286|NCT00850993|12209502|FG000|NOT COMPLETED|Overall Study||1
11030287|NCT00850993|12209503|FG001|NOT COMPLETED|Overall Study||0
11030288|NCT00850993|12209504|FG002|NOT COMPLETED|Overall Study||0
11030289|NCT00850993|12209505|FG003|NOT COMPLETED|Overall Study||1
11030290|NCT00851006|12209515|FG000|STARTED|Overall Study||7
11030291|NCT00851006|12209516|FG001|STARTED|Overall Study||6
11030292|NCT00851006|12209515|FG000|COMPLETED|Overall Study||7
11030293|NCT00851006|12209516|FG001|COMPLETED|Overall Study||6
11030294|NCT00851006|12209515|FG000|NOT COMPLETED|Overall Study||0
11030295|NCT00851006|12209516|FG001|NOT COMPLETED|Overall Study||0
11030296|NCT00851084|12209525|FG000|STARTED|Overall Study||117
11030297|NCT00851084|12209526|FG001|STARTED|Overall Study||119
11030298|NCT00851084|12209525|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
11030299|NCT00851084|12209526|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
11030300|NCT00851084|12209525|FG000|NOT COMPLETED|Overall Study||117
11030301|NCT00851084|12209526|FG001|NOT COMPLETED|Overall Study||119
11030302|NCT00851253|12209536|FG000|STARTED|Overall Study||2
11030303|NCT00851253|12209537|FG001|STARTED|Overall Study||10
11030304|NCT00851253|12209536|FG000|COMPLETED|Overall Study||1
11030305|NCT00851253|12209537|FG001|COMPLETED|Overall Study||10
11030306|NCT00851253|12209536|FG000|NOT COMPLETED|Overall Study||1
11030307|NCT00851253|12209537|FG001|NOT COMPLETED|Overall Study||0
11030308|NCT00851279|12209543|FG000|STARTED|Overall Study||53
11030309|NCT00851279|12209543|FG000|COMPLETED|Overall Study||53
11030310|NCT00851279|12209543|FG000|NOT COMPLETED|Overall Study||0
11030311|NCT00851318|12209551|FG000|STARTED|Overall Study||81
11030312|NCT00851318|12209552|FG001|STARTED|Overall Study||19
11030313|NCT00851318|12209553|FG002|STARTED|Overall Study||93
11030314|NCT00851318|12209554|FG003|STARTED|Overall Study||92
11030315|NCT00851318|12209551|FG000|Completed Week 24|Overall Study||69
11030316|NCT00851318|12209552|FG001|Completed Week 24|Overall Study||17
11030317|NCT00851318|12209553|FG002|Completed Week 24|Overall Study||90
11030318|NCT00851318|12209554|FG003|Completed Week 24|Overall Study||87
11030319|NCT00851318|12209551|FG000|Completed Week 52|Overall Study||64
11030320|NCT00851318|12209552|FG001|Completed Week 52|Overall Study||16
11030321|NCT00851318|12209553|FG002|Completed Week 52|Overall Study||87
11030322|NCT00851318|12209554|FG003|Completed Week 52|Overall Study||85
11030323|NCT00851318|12209551|FG000|COMPLETED|Overall Study||51
11030324|NCT00851318|12209552|FG001|COMPLETED|Overall Study||14
11030325|NCT00851318|12209553|FG002|COMPLETED|Overall Study||72
11030326|NCT00851318|12209554|FG003|COMPLETED|Overall Study||73
11030327|NCT00851318|12209551|FG000|NOT COMPLETED|Overall Study||30
11030328|NCT00851318|12209552|FG001|NOT COMPLETED|Overall Study||5
11030329|NCT00851318|12209553|FG002|NOT COMPLETED|Overall Study||21
11030330|NCT00851318|12209554|FG003|NOT COMPLETED|Overall Study||19
11030331|NCT00851357|12209567|FG000|STARTED|Overall Study||1200
11030332|NCT00851357|12209568|FG001|STARTED|Overall Study||1201
11030333|NCT00851357|12209569|FG002|STARTED|Overall Study||1799
11030334|NCT00851357|12209567|FG000|COMPLETED|Overall Study||1200
11030335|NCT00851357|12209568|FG001|COMPLETED|Overall Study||1201
11030336|NCT00851357|12209569|FG002|COMPLETED|Overall Study||1799
11030337|NCT00851357|12209567|FG000|NOT COMPLETED|Overall Study||0
11030338|NCT00851357|12209568|FG001|NOT COMPLETED|Overall Study||0
11030339|NCT00851357|12209569|FG002|NOT COMPLETED|Overall Study||0
11030340|NCT00851409|12209577|FG000|STARTED|Overall Study||25
11333306|NCT02831998|12530876|FG000|ZP|Overall Study||400
11333307|NCT02831998|12530876|FG000|CP|Overall Study||400
11333308|NCT02831998|12530876|FG000|Vehicle|Overall Study||80
11030341|NCT00851409|12209577|FG000|COMPLETED|Overall Study||25
11030342|NCT00851409|12209577|FG000|NOT COMPLETED|Overall Study||0
11030343|NCT00851630|12209584|FG000|STARTED|Overall Study||35
11030344|NCT00851630|12209585|FG001|STARTED|Overall Study||35
11030345|NCT00851630|12209584|FG000|COMPLETED|Overall Study||33
11030346|NCT00851630|12209585|FG001|COMPLETED|Overall Study||33
11030347|NCT00851630|12209584|FG000|NOT COMPLETED|Overall Study||2
11030348|NCT00851630|12209585|FG001|NOT COMPLETED|Overall Study||2
11030349|NCT00851643|12209597|FG000|STARTED|Base Study (Up to 12 Months)||15
11030350|NCT00851643|12209598|FG001|STARTED|Base Study (Up to 12 Months)||30
11030351|NCT00851643|12209599|FG002|STARTED|Base Study (Up to 12 Months)||30
11030352|NCT00851643|12209600|FG003|STARTED|Base Study (Up to 12 Months)||15
11030353|NCT00851643|12209601|FG004|STARTED|Base Study (Up to 12 Months)||30
11030354|NCT00851643|12209602|FG005|STARTED|Base Study (Up to 12 Months)||30
11030355|NCT00851643|12209597|FG000|COMPLETED|Base Study (Up to 12 Months)||14
11030356|NCT00851643|12209598|FG001|COMPLETED|Base Study (Up to 12 Months)||30
11030357|NCT00851643|12209599|FG002|COMPLETED|Base Study (Up to 12 Months)||30
11030358|NCT00851643|12209600|FG003|COMPLETED|Base Study (Up to 12 Months)||15
11030359|NCT00851643|12209601|FG004|COMPLETED|Base Study (Up to 12 Months)||30
11030360|NCT00851643|12209602|FG005|COMPLETED|Base Study (Up to 12 Months)||29
11030361|NCT00851643|12209597|FG000|NOT COMPLETED|Base Study (Up to 12 Months)||1
11030362|NCT00851643|12209598|FG001|NOT COMPLETED|Base Study (Up to 12 Months)||0
11030363|NCT00851643|12209599|FG002|NOT COMPLETED|Base Study (Up to 12 Months)||0
11030364|NCT00851643|12209600|FG003|NOT COMPLETED|Base Study (Up to 12 Months)||0
11030365|NCT00851643|12209601|FG004|NOT COMPLETED|Base Study (Up to 12 Months)||0
11030366|NCT00851643|12209602|FG005|NOT COMPLETED|Base Study (Up to 12 Months)||1
11030367|NCT00851643|12209597|FG000|STARTED|Extension Study (Up to 36 Months)||10
11030368|NCT00851643|12209598|FG001|STARTED|Extension Study (Up to 36 Months)||19
11030369|NCT00851643|12209599|FG002|STARTED|Extension Study (Up to 36 Months)||19
11030370|NCT00851643|12209600|FG003|STARTED|Extension Study (Up to 36 Months)||7
11030371|NCT00851643|12209601|FG004|STARTED|Extension Study (Up to 36 Months)||21
11333309|NCT02831998|12530876|FG000|COMPLETED|Overall Study||440
11333310|NCT02831998|12530876|FG000|NOT COMPLETED|Overall Study||0
11343834|NCT02956486|12541122|FG000|STARTED|Core Phase||1108
11343835|NCT02956486|12541123|FG001|STARTED|Core Phase||1104
11343836|NCT02956486|12541124|FG002|STARTED|Core Phase||0
11343837|NCT02956486|12541122|FG000|Treated|Core Phase||1108
11343838|NCT02956486|12541123|FG001|Treated|Core Phase||1101
11030372|NCT00851643|12209602|FG005|STARTED|Extension Study (Up to 36 Months)||15
11030373|NCT00851643|12209597|FG000|COMPLETED|Extension Study (Up to 36 Months)||6
11343839|NCT02956486|12541124|FG002|Treated|Core Phase||0
11030374|NCT00851643|12209598|FG001|COMPLETED|Extension Study (Up to 36 Months)||15
11030375|NCT00851643|12209599|FG002|COMPLETED|Extension Study (Up to 36 Months)||14
11030376|NCT00851643|12209600|FG003|COMPLETED|Extension Study (Up to 36 Months)||5
11030377|NCT00851643|12209601|FG004|COMPLETED|Extension Study (Up to 36 Months)||19
11030378|NCT00851643|12209602|FG005|COMPLETED|Extension Study (Up to 36 Months)||14
11200712|NCT01828476|12390928|FG001|NOT COMPLETED|Overall Study||0
11200713|NCT01828515|12390936|FG000|STARTED|First Intervention (19 Days)||13
11343840|NCT02956486|12541122|FG000|Safety Analysis Set (SAS)|Core Phase||1105
11343841|NCT02956486|12541123|FG001|Safety Analysis Set (SAS)|Core Phase||1099
11343842|NCT02956486|12541124|FG002|Safety Analysis Set (SAS)|Core Phase||0
11200714|NCT01828515|12390937|FG001|STARTED|First Intervention (19 Days)||11
11200715|NCT01828515|12390936|FG000|COMPLETED|First Intervention (19 Days)||11
11200716|NCT01828515|12390937|FG001|COMPLETED|First Intervention (19 Days)||9
11200717|NCT01828515|12390936|FG000|NOT COMPLETED|First Intervention (19 Days)||2
11200718|NCT01828515|12390937|FG001|NOT COMPLETED|First Intervention (19 Days)||2
11200719|NCT01828515|12390936|FG000|STARTED|Washout (23 Days)||11
11200720|NCT01828515|12390937|FG001|STARTED|Washout (23 Days)||9
11200721|NCT01828515|12390936|FG000|COMPLETED|Washout (23 Days)||6
11200722|NCT01828515|12390937|FG001|COMPLETED|Washout (23 Days)||8
11200723|NCT01828515|12390936|FG000|NOT COMPLETED|Washout (23 Days)||5
11200724|NCT01828515|12390937|FG001|NOT COMPLETED|Washout (23 Days)||1
11200725|NCT01828515|12390936|FG000|STARTED|Second Intervention (19 Days)||6
11200726|NCT01828515|12390937|FG001|STARTED|Second Intervention (19 Days)||8
11200727|NCT01828515|12390936|FG000|COMPLETED|Second Intervention (19 Days)||6
11200728|NCT01828515|12390937|FG001|COMPLETED|Second Intervention (19 Days)||5
11200729|NCT01828515|12390936|FG000|NOT COMPLETED|Second Intervention (19 Days)||0
11200730|NCT01828515|12390937|FG001|NOT COMPLETED|Second Intervention (19 Days)||3
11200731|NCT01828554|12390943|FG000|STARTED|Overall Study||8
11200732|NCT01828554|12390943|FG000|COMPLETED|Overall Study||8
11200733|NCT01828554|12390943|FG000|NOT COMPLETED|Overall Study||0
11200734|NCT01828567|12390949|FG000|STARTED|Overall Study||208
11200735|NCT01828567|12390950|FG001|STARTED|Overall Study||209
11200736|NCT01828567|12390949|FG000|1 Month|Overall Study||172
11200737|NCT01828567|12390950|FG001|1 Month|Overall Study||192
11200738|NCT01828567|12390949|FG000|COMPLETED|Overall Study||177
11200739|NCT01828567|12390950|FG001|COMPLETED|Overall Study||199
11200740|NCT01828567|12390949|FG000|NOT COMPLETED|Overall Study||31
11200741|NCT01828567|12390950|FG001|NOT COMPLETED|Overall Study||10
11200742|NCT01828593|12390959|FG000|STARTED|Placebo-Controlled Phase||36
11200743|NCT01828593|12390960|FG001|STARTED|Placebo-Controlled Phase||34
11200744|NCT01828593|12390961|FG002|STARTED|Placebo-Controlled Phase||33
11030379|NCT00851643|12209597|FG000|NOT COMPLETED|Extension Study (Up to 36 Months)||4
11030380|NCT00851643|12209598|FG001|NOT COMPLETED|Extension Study (Up to 36 Months)||4
11030381|NCT00851643|12209599|FG002|NOT COMPLETED|Extension Study (Up to 36 Months)||5
11030382|NCT00851643|12209600|FG003|NOT COMPLETED|Extension Study (Up to 36 Months)||2
11030383|NCT00851643|12209601|FG004|NOT COMPLETED|Extension Study (Up to 36 Months)||2
11030384|NCT00851643|12209602|FG005|NOT COMPLETED|Extension Study (Up to 36 Months)||1
11030385|NCT00851721|12209617|FG000|STARTED|Overall Study||19
11030386|NCT00851721|12209618|FG001|STARTED|Overall Study||17
11030387|NCT00851721|12209617|FG000|COMPLETED|Overall Study||17
11030388|NCT00851721|12209618|FG001|COMPLETED|Overall Study||16
11030389|NCT00851721|12209617|FG000|NOT COMPLETED|Overall Study||2
11030390|NCT00851721|12209618|FG001|NOT COMPLETED|Overall Study||1
11030391|NCT00851786|12209632|FG000|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
11030392|NCT00851786|12209633|FG001|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
11030393|NCT00851786|12209632|FG000|COMPLETED|Overall Study||291
11030394|NCT00851786|12209633|FG001|COMPLETED|Overall Study||97
11030395|NCT00851786|12209632|FG000|NOT COMPLETED|Overall Study||5
11030396|NCT00851786|12209633|FG001|NOT COMPLETED|Overall Study||2
11030397|NCT00851799|12209642|FG000|STARTED|Overall Study||109
11030398|NCT00851799|12209643|FG001|STARTED|Overall Study||106
11030399|NCT00851799|12209644|FG002|STARTED|Overall Study||113
11030400|NCT00851799|12209642|FG000|COMPLETED|Overall Study||93
11030401|NCT00851799|12209643|FG001|COMPLETED|Overall Study||93
11030402|NCT00851799|12209644|FG002|COMPLETED|Overall Study||89
11030403|NCT00851799|12209642|FG000|NOT COMPLETED|Overall Study||16
11030404|NCT00851799|12209643|FG001|NOT COMPLETED|Overall Study||13
11030405|NCT00851799|12209644|FG002|NOT COMPLETED|Overall Study||24
11030406|NCT00851877|12209652|FG000|STARTED|Phase I-1||7
11030407|NCT00851877|12209653|FG001|STARTED|Phase I-1||0
11030408|NCT00851877|12209654|FG002|STARTED|Phase I-1||0
11030409|NCT00851877|12209652|FG000|COMPLETED|Phase I-1||6
11030410|NCT00851877|12209653|FG001|COMPLETED|Phase I-1||0
11030411|NCT00851877|12209654|FG002|COMPLETED|Phase I-1||0
11030412|NCT00851877|12209652|FG000|NOT COMPLETED|Phase I-1||1
11030413|NCT00851877|12209653|FG001|NOT COMPLETED|Phase I-1||0
11030414|NCT00851877|12209654|FG002|NOT COMPLETED|Phase I-1||0
11030415|NCT00851877|12209652|FG000|STARTED|Phase I-2||0
11030416|NCT00851877|12209653|FG001|STARTED|Phase I-2||5
11030417|NCT00851877|12209654|FG002|STARTED|Phase I-2||0
11030418|NCT00851877|12209652|FG000|COMPLETED|Phase I-2||0
11030419|NCT00851877|12209653|FG001|COMPLETED|Phase I-2||5
11030420|NCT00851877|12209654|FG002|COMPLETED|Phase I-2||0
11030421|NCT00851877|12209652|FG000|NOT COMPLETED|Phase I-2||0
11030422|NCT00851877|12209653|FG001|NOT COMPLETED|Phase I-2||0
11030423|NCT00851877|12209654|FG002|NOT COMPLETED|Phase I-2||0
11030424|NCT00851877|12209652|FG000|STARTED|Phase II||0
11030425|NCT00851877|12209653|FG001|STARTED|Phase II||0
11030426|NCT00851877|12209654|FG002|STARTED|Phase II||25
11030427|NCT00851877|12209652|FG000|COMPLETED|Phase II||0
11030428|NCT00851877|12209653|FG001|COMPLETED|Phase II||0
11030429|NCT00851877|12209654|FG002|COMPLETED|Phase II||22
11030430|NCT00851877|12209652|FG000|NOT COMPLETED|Phase II||0
11030431|NCT00851877|12209653|FG001|NOT COMPLETED|Phase II||0
11030432|NCT00851877|12209654|FG002|NOT COMPLETED|Phase II||3
11030433|NCT00851890|12209664|FG000|STARTED|Overall Study||8
11030434|NCT00851890|12209665|FG001|STARTED|Overall Study||8
11030435|NCT00851890|12209666|FG002|STARTED|Overall Study||8
11030436|NCT00851890|12209667|FG003|STARTED|Overall Study||6
11030437|NCT00851890|12209664|FG000|COMPLETED|Overall Study||8
11030438|NCT00851890|12209665|FG001|COMPLETED|Overall Study||7
11030439|NCT00851890|12209666|FG002|COMPLETED|Overall Study||8
11030440|NCT00851890|12209667|FG003|COMPLETED|Overall Study||5
11030441|NCT00851890|12209664|FG000|NOT COMPLETED|Overall Study||0
11030442|NCT00851890|12209665|FG001|NOT COMPLETED|Overall Study||1
11030443|NCT00851890|12209666|FG002|NOT COMPLETED|Overall Study||0
11030444|NCT00851890|12209667|FG003|NOT COMPLETED|Overall Study||1
11030445|NCT00851903|12209677|FG000|STARTED|Overall Study||112
11057431|NCT00997620|12238935|FG000|NOT COMPLETED|Overall Study||0
11030446|NCT00851903|12209677|FG000|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
11030447|NCT00851903|12209677|FG000|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
11030448|NCT00851903|12209677|FG000|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
11030449|NCT00851903|12209677|FG000|COMPLETED|Overall Study||110
11030450|NCT00851903|12209677|FG000|NOT COMPLETED|Overall Study||2
11030451|NCT00852137|12209683|FG000|STARTED|Overall Study||13
11030452|NCT00852137|12209684|FG001|STARTED|Overall Study||3
11030453|NCT00852137|12209683|FG000|COMPLETED|Overall Study||13
11333311|NCT02832037|12530892|FG000|STARTED|Overall Study||85
11333312|NCT02832037|12530893|FG001|STARTED|Overall Study||84
11333313|NCT02832037|12530894|FG002|STARTED|Overall Study||85
11333314|NCT02832037|12530895|FG003|STARTED|Overall Study||85
11333315|NCT02832037|12530896|FG004|STARTED|Overall Study||170
11333316|NCT02832037|12530892|FG000|COMPLETED|Overall Study||66
11333317|NCT02832037|12530893|FG001|COMPLETED|Overall Study||72
11333318|NCT02832037|12530894|FG002|COMPLETED|Overall Study||77
11333319|NCT02832037|12530895|FG003|COMPLETED|Overall Study||78
11333320|NCT02832037|12530896|FG004|COMPLETED|Overall Study||151
11333321|NCT02832037|12530892|FG000|NOT COMPLETED|Overall Study||19
11333322|NCT02832037|12530893|FG001|NOT COMPLETED|Overall Study||12
11333323|NCT02832037|12530894|FG002|NOT COMPLETED|Overall Study||8
11333324|NCT02832037|12530895|FG003|NOT COMPLETED|Overall Study||7
11333325|NCT02832037|12530896|FG004|NOT COMPLETED|Overall Study||19
11333326|NCT02832115|12530910|FG000|STARTED|Overall Study||48
11333327|NCT02832115|12530911|FG001|STARTED|Overall Study||52
11333328|NCT02832115|12530910|FG000|COMPLETED|Overall Study||48
11333329|NCT02832115|12530911|FG001|COMPLETED|Overall Study||52
11333330|NCT02832115|12530910|FG000|NOT COMPLETED|Overall Study||0
11333331|NCT02832115|12530911|FG001|NOT COMPLETED|Overall Study||0
11333332|NCT02832154|12530917|FG000|STARTED|Overall Study||43
11333333|NCT02832154|12530917|FG000|COMPLETED|Overall Study||43
11333334|NCT02832154|12530917|FG000|NOT COMPLETED|Overall Study||0
11333335|NCT02832284|12530921|FG000|STARTED|Overall Study||23
11333336|NCT02832284|12530921|FG000|COMPLETED|Overall Study||23
11333337|NCT02832284|12530921|FG000|NOT COMPLETED|Overall Study||0
11333338|NCT02832375|12530927|FG000|STARTED|Overall Study||121
11333339|NCT02832375|12530928|FG001|STARTED|Overall Study||121
11333340|NCT02832375|12530927|FG000|COMPLETED|Overall Study||119
11333341|NCT02832375|12530928|FG001|COMPLETED|Overall Study||121
11333342|NCT02832375|12530927|FG000|NOT COMPLETED|Overall Study||2
11333343|NCT02832375|12530928|FG001|NOT COMPLETED|Overall Study||0
11333344|NCT02832622|12530935|FG000|STARTED|Overall Study||2169
11333345|NCT02832622|12530935|FG000|COMPLETED|Overall Study||433
11333346|NCT02832622|12530935|FG000|NOT COMPLETED|Overall Study||1736
11333347|NCT02832674|12530940|FG000|STARTED|Overall Study||72
11333348|NCT02832674|12530940|FG000|COMPLETED|Overall Study||67
11333349|NCT02832674|12530940|FG000|NOT COMPLETED|Overall Study||5
11333350|NCT02833077|12530946|FG000|STARTED|Overall Study||144
11333351|NCT02833077|12530947|FG001|STARTED|Overall Study||48
11333352|NCT02833077|12530946|FG000|Participants Treated|Overall Study||144
11333353|NCT02833077|12530947|FG001|Participants Treated|Overall Study||38
11333354|NCT02833077|12530946|FG000|COMPLETED|Overall Study||127
11333355|NCT02833077|12530947|FG001|COMPLETED|Overall Study|Includes participants who completed the study but did not receive the optional treatment.|40
11333356|NCT02833077|12530946|FG000|NOT COMPLETED|Overall Study||17
11333357|NCT02833077|12530947|FG001|NOT COMPLETED|Overall Study||8
11333358|NCT02833337|12530954|FG000|STARTED|Overall Study||180
11333359|NCT02833337|12530954|FG000|COMPLETED|Overall Study||180
11333360|NCT02833337|12530954|FG000|NOT COMPLETED|Overall Study||0
11333361|NCT02833350|12530965|FG000|STARTED|Overall Study||40
11333362|NCT02833350|12530966|FG001|STARTED|Overall Study||109
11333363|NCT02833350|12530967|FG002|STARTED|Overall Study||110
11333364|NCT02833350|12530968|FG003|STARTED|Overall Study||110
11333365|NCT02833350|12530969|FG004|STARTED|Overall Study||111
11333366|NCT02833350|12530970|FG005|STARTED|Overall Study||49
11333367|NCT02833350|12530971|FG006|STARTED|Overall Study||49
11333368|NCT02833350|12530965|FG000|Randomized|Overall Study||40
11333369|NCT02833350|12530966|FG001|Randomized|Overall Study||109
11333370|NCT02833350|12530967|FG002|Randomized|Overall Study||110
11333371|NCT02833350|12530968|FG003|Randomized|Overall Study||110
11333372|NCT02833350|12530969|FG004|Randomized|Overall Study||111
11333373|NCT02833350|12530970|FG005|Randomized|Overall Study||48
11333374|NCT02833350|12530971|FG006|Randomized|Overall Study||50
11333375|NCT02833350|12530965|FG000|COMPLETED|Overall Study||37
11333376|NCT02833350|12530966|FG001|COMPLETED|Overall Study||100
11333377|NCT02833350|12530967|FG002|COMPLETED|Overall Study||102
11333378|NCT02833350|12530968|FG003|COMPLETED|Overall Study||102
11333379|NCT02833350|12530969|FG004|COMPLETED|Overall Study||108
11333380|NCT02833350|12530970|FG005|COMPLETED|Overall Study||48
11333381|NCT02833350|12530971|FG006|COMPLETED|Overall Study||44
11333382|NCT02833350|12530965|FG000|NOT COMPLETED|Overall Study||3
11333383|NCT02833350|12530966|FG001|NOT COMPLETED|Overall Study||9
11333384|NCT02833350|12530967|FG002|NOT COMPLETED|Overall Study||8
11030454|NCT00852137|12209684|FG001|COMPLETED|Overall Study||3
11030455|NCT00852137|12209683|FG000|NOT COMPLETED|Overall Study||0
11030456|NCT00852137|12209684|FG001|NOT COMPLETED|Overall Study||0
11030457|NCT00852202|12209693|FG000|STARTED|Overall Study||77
11030458|NCT00852202|12209694|FG001|STARTED|Overall Study||75
11030459|NCT00852202|12209695|FG002|STARTED|Overall Study||75
11030460|NCT00852202|12209693|FG000|COMPLETED|Overall Study||60
11030461|NCT00852202|12209694|FG001|COMPLETED|Overall Study||63
11030462|NCT00852202|12209695|FG002|COMPLETED|Overall Study||49
11030463|NCT00852202|12209693|FG000|NOT COMPLETED|Overall Study||17
11030464|NCT00852202|12209694|FG001|NOT COMPLETED|Overall Study||12
11030465|NCT00852202|12209695|FG002|NOT COMPLETED|Overall Study||26
11030466|NCT00852397|12209707|FG000|STARTED|Overall Study||52
11030467|NCT00852397|12209708|FG001|STARTED|Overall Study||49
11030468|NCT00852397|12209709|FG002|STARTED|Overall Study||50
11030469|NCT00852397|12209707|FG000|Treated Participants|Overall Study||51
11030470|NCT00852397|12209708|FG001|Treated Participants|Overall Study||49
11030471|NCT00852397|12209709|FG002|Treated Participants|Overall Study||49
11030472|NCT00852397|12209707|FG000|COMPLETED|Overall Study||41
11030473|NCT00852397|12209708|FG001|COMPLETED|Overall Study||41
11030474|NCT00852397|12209709|FG002|COMPLETED|Overall Study||36
11030475|NCT00852397|12209707|FG000|NOT COMPLETED|Overall Study||11
11030476|NCT00852397|12209708|FG001|NOT COMPLETED|Overall Study||8
11030477|NCT00852397|12209709|FG002|NOT COMPLETED|Overall Study||14
11030478|NCT00852475|12209719|FG000|STARTED|Overall Study||26
11030479|NCT00852475|12209720|FG001|STARTED|Overall Study||20
11030480|NCT00852475|12209719|FG000|COMPLETED|Overall Study||23
11030481|NCT00852475|12209720|FG001|COMPLETED|Overall Study||16
11030482|NCT00852475|12209719|FG000|NOT COMPLETED|Overall Study||3
11030483|NCT00852475|12209720|FG001|NOT COMPLETED|Overall Study||4
11030484|NCT00852527|12209728|FG000|STARTED|Overall Study||196
11030485|NCT00852527|12209729|FG001|STARTED|Overall Study||242
11030486|NCT00852527|12209728|FG000|COMPLETED|Overall Study||196
11030487|NCT00852527|12209729|FG001|COMPLETED|Overall Study||242
11030488|NCT00852527|12209728|FG000|NOT COMPLETED|Overall Study||0
11030489|NCT00852527|12209729|FG001|NOT COMPLETED|Overall Study||0
11030490|NCT00852540|12209736|FG000|STARTED|Overall Study||270
11030491|NCT00852540|12209737|FG001|STARTED|Overall Study||140
11030492|NCT00852540|12209736|FG000|COMPLETED|Overall Study||234
11030493|NCT00852540|12209737|FG001|COMPLETED|Overall Study||122
11030494|NCT00852540|12209736|FG000|NOT COMPLETED|Overall Study||36
11030495|NCT00852540|12209737|FG001|NOT COMPLETED|Overall Study||18
11030496|NCT00852592|12209746|FG000|STARTED|Overall Study||23
11030497|NCT00852592|12209747|FG001|STARTED|Overall Study||23
11030498|NCT00852592|12209746|FG000|COMPLETED|Overall Study||20
11030499|NCT00852592|12209747|FG001|COMPLETED|Overall Study||19
11030500|NCT00852592|12209746|FG000|NOT COMPLETED|Overall Study||3
11030501|NCT00852592|12209747|FG001|NOT COMPLETED|Overall Study||4
11030502|NCT00852631|12209753|FG000|STARTED|Overall Study||28
11030503|NCT00852631|12209753|FG000|COMPLETED|Overall Study||17
11030504|NCT00852631|12209753|FG000|NOT COMPLETED|Overall Study||11
11030505|NCT00852644|12209757|FG000|STARTED|Overall Study||3
11030506|NCT00852644|12209758|FG001|STARTED|Overall Study||3
11030507|NCT00852644|12209759|FG002|STARTED|Overall Study||0
11030508|NCT00852644|12209760|FG003|STARTED|Overall Study||3
11030509|NCT00852644|12209761|FG004|STARTED|Overall Study||0
11030510|NCT00852644|12209762|FG005|STARTED|Overall Study||0
11030511|NCT00852644|12209757|FG000|COMPLETED|Overall Study||3
11030512|NCT00852644|12209758|FG001|COMPLETED|Overall Study||3
11030513|NCT00852644|12209759|FG002|COMPLETED|Overall Study||0
11030514|NCT00852644|12209760|FG003|COMPLETED|Overall Study||3
11030515|NCT00852644|12209761|FG004|COMPLETED|Overall Study||0
11030516|NCT00852644|12209762|FG005|COMPLETED|Overall Study||0
11030517|NCT00852644|12209757|FG000|NOT COMPLETED|Overall Study||0
11030518|NCT00852644|12209758|FG001|NOT COMPLETED|Overall Study||0
11030519|NCT00852644|12209759|FG002|NOT COMPLETED|Overall Study||0
11030520|NCT00852644|12209760|FG003|NOT COMPLETED|Overall Study||0
11030521|NCT00852644|12209761|FG004|NOT COMPLETED|Overall Study||0
11030522|NCT00852644|12209762|FG005|NOT COMPLETED|Overall Study||0
11030523|NCT00852761|12209779|FG000|STARTED|Overall Study||17
11030524|NCT00852761|12209780|FG001|STARTED|Overall Study||17
11030525|NCT00852761|12209779|FG000|COMPLETED|Overall Study||17
11030526|NCT00852761|12209780|FG001|COMPLETED|Overall Study||17
11030527|NCT00852761|12209779|FG000|NOT COMPLETED|Overall Study||0
11030528|NCT00852761|12209780|FG001|NOT COMPLETED|Overall Study||0
11030529|NCT00852917|12209790|FG000|STARTED|Overall Study||106
11030530|NCT00852917|12209791|FG001|STARTED|Overall Study||111
11030531|NCT00852917|12209792|FG002|STARTED|Overall Study||108
11030532|NCT00852917|12209793|FG003|STARTED|Overall Study||227
11030533|NCT00852917|12209790|FG000|COMPLETED|Overall Study||62
11030534|NCT00852917|12209791|FG001|COMPLETED|Overall Study||65
11030535|NCT00852917|12209792|FG002|COMPLETED|Overall Study||50
11030536|NCT00852917|12209793|FG003|COMPLETED|Overall Study||134
11030537|NCT00852917|12209790|FG000|NOT COMPLETED|Overall Study||44
11030538|NCT00852917|12209791|FG001|NOT COMPLETED|Overall Study||46
11030539|NCT00852917|12209792|FG002|NOT COMPLETED|Overall Study||58
11030540|NCT00852917|12209793|FG003|NOT COMPLETED|Overall Study||93
11030541|NCT00852930|12209806|FG000|STARTED|Overall Study||16
11030542|NCT00852930|12209807|FG001|STARTED|Overall Study||17
11030543|NCT00852930|12209808|FG002|STARTED|Overall Study||17
11030544|NCT00852930|12209806|FG000|COMPLETED|Overall Study||15
11030545|NCT00852930|12209807|FG001|COMPLETED|Overall Study||16
11030546|NCT00852930|12209808|FG002|COMPLETED|Overall Study||15
11030547|NCT00852930|12209806|FG000|NOT COMPLETED|Overall Study||1
11030548|NCT00852930|12209807|FG001|NOT COMPLETED|Overall Study||1
11030549|NCT00852930|12209808|FG002|NOT COMPLETED|Overall Study||2
11030550|NCT00852969|12209819|FG000|STARTED|Overall Study||15
11030551|NCT00852969|12209820|FG001|STARTED|Overall Study||15
11030552|NCT00852969|12209819|FG000|COMPLETED|Overall Study||15
11030553|NCT00852969|12209820|FG001|COMPLETED|Overall Study||13
11030554|NCT00852969|12209819|FG000|NOT COMPLETED|Overall Study||0
11030555|NCT00852969|12209820|FG001|NOT COMPLETED|Overall Study||2
11030556|NCT00852995|12209831|FG000|STARTED|Overall Study||46
11030557|NCT00852995|12209832|FG001|STARTED|Overall Study||43
11030558|NCT00852995|12209833|FG002|STARTED|Overall Study||44
11030559|NCT00852995|12209834|FG003|STARTED|Overall Study||45
11030560|NCT00852995|12209835|FG004|STARTED|Overall Study||50
11030561|NCT00852995|12209831|FG000|COMPLETED|Overall Study||38
11333385|NCT02833350|12530968|FG003|NOT COMPLETED|Overall Study||8
11333386|NCT02833350|12530969|FG004|NOT COMPLETED|Overall Study||3
11333387|NCT02833350|12530970|FG005|NOT COMPLETED|Overall Study||1
11333388|NCT02833350|12530971|FG006|NOT COMPLETED|Overall Study||5
11333389|NCT02833415|12530992|FG000|STARTED|Overall Study||20
11333390|NCT02833415|12530993|FG001|STARTED|Overall Study||20
11030562|NCT00852995|12209832|FG001|COMPLETED|Overall Study||42
11030563|NCT00852995|12209833|FG002|COMPLETED|Overall Study||39
11030564|NCT00852995|12209834|FG003|COMPLETED|Overall Study||40
11030565|NCT00852995|12209835|FG004|COMPLETED|Overall Study||46
11030566|NCT00852995|12209831|FG000|NOT COMPLETED|Overall Study||8
11030567|NCT00852995|12209832|FG001|NOT COMPLETED|Overall Study||1
11030568|NCT00852995|12209833|FG002|NOT COMPLETED|Overall Study||5
11030569|NCT00852995|12209834|FG003|NOT COMPLETED|Overall Study||5
11030570|NCT00852995|12209835|FG004|NOT COMPLETED|Overall Study||4
11030571|NCT00853021|12209852|FG000|STARTED|Overall Study||26
11030572|NCT00853021|12209852|FG000|COMPLETED|Overall Study||21
11030573|NCT00853021|12209852|FG000|NOT COMPLETED|Overall Study||5
11030574|NCT00853047|12209861|FG000|STARTED|Core Phase||5
11030575|NCT00853047|12209862|FG001|STARTED|Core Phase||3
11030576|NCT00853047|12209863|FG002|STARTED|Core Phase||3
11030577|NCT00853047|12209864|FG003|STARTED|Core Phase||3
11030578|NCT00853047|12209865|FG004|STARTED|Core Phase||9
11030579|NCT00853047|12209866|FG005|STARTED|Core Phase||0
11030580|NCT00853047|12209861|FG000|COMPLETED|Core Phase||5
11030581|NCT00853047|12209862|FG001|COMPLETED|Core Phase||3
11030582|NCT00853047|12209863|FG002|COMPLETED|Core Phase||3
11030583|NCT00853047|12209864|FG003|COMPLETED|Core Phase||2
11030584|NCT00853047|12209865|FG004|COMPLETED|Core Phase||9
11030585|NCT00853047|12209866|FG005|COMPLETED|Core Phase||0
11030586|NCT00853047|12209861|FG000|NOT COMPLETED|Core Phase||0
11030587|NCT00853047|12209862|FG001|NOT COMPLETED|Core Phase||0
11030588|NCT00853047|12209863|FG002|NOT COMPLETED|Core Phase||0
11030589|NCT00853047|12209864|FG003|NOT COMPLETED|Core Phase||1
11030590|NCT00853047|12209865|FG004|NOT COMPLETED|Core Phase||0
11030591|NCT00853047|12209866|FG005|NOT COMPLETED|Core Phase||0
11030592|NCT00853047|12209861|FG000|STARTED|Open-Label Extension Phase||0
11030593|NCT00853047|12209862|FG001|STARTED|Open-Label Extension Phase||0
11030594|NCT00853047|12209863|FG002|STARTED|Open-Label Extension Phase||0
11030595|NCT00853047|12209864|FG003|STARTED|Open-Label Extension Phase||0
11030596|NCT00853047|12209865|FG004|STARTED|Open-Label Extension Phase||0
11030597|NCT00853047|12209866|FG005|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
11030598|NCT00853047|12209861|FG000|Completed 8-week Extension Period|Open-Label Extension Phase||0
11030599|NCT00853047|12209862|FG001|Completed 8-week Extension Period|Open-Label Extension Phase||0
11030600|NCT00853047|12209863|FG002|Completed 8-week Extension Period|Open-Label Extension Phase||0
11030601|NCT00853047|12209864|FG003|Completed 8-week Extension Period|Open-Label Extension Phase||0
11030602|NCT00853047|12209865|FG004|Completed 8-week Extension Period|Open-Label Extension Phase||0
11030603|NCT00853047|12209866|FG005|Completed 8-week Extension Period|Open-Label Extension Phase||16
11030604|NCT00853047|12209861|FG000|COMPLETED|Open-Label Extension Phase||0
11030605|NCT00853047|12209862|FG001|COMPLETED|Open-Label Extension Phase||0
11030606|NCT00853047|12209863|FG002|COMPLETED|Open-Label Extension Phase||0
11030607|NCT00853047|12209864|FG003|COMPLETED|Open-Label Extension Phase||0
11030608|NCT00853047|12209865|FG004|COMPLETED|Open-Label Extension Phase||0
11333391|NCT02833415|12530992|FG000|COMPLETED|Overall Study||18
11333392|NCT02833415|12530993|FG001|COMPLETED|Overall Study||17
11333393|NCT02833415|12530992|FG000|NOT COMPLETED|Overall Study||2
11333394|NCT02833415|12530993|FG001|NOT COMPLETED|Overall Study||3
11333395|NCT02833857|12530999|FG000|STARTED|Overall Study||11
11333396|NCT02833857|12530999|FG000|COMPLETED|Overall Study||11
11333397|NCT02833857|12530999|FG000|NOT COMPLETED|Overall Study||0
11333398|NCT02833922|12531003|FG000|STARTED|Overall Study||718
11333399|NCT02833922|12531003|FG000|COMPLETED|Overall Study||336
11333400|NCT02833922|12531003|FG000|NOT COMPLETED|Overall Study||382
11333401|NCT02833948|12531009|FG000|STARTED|Overall Study||116
11333402|NCT02833948|12531010|FG001|STARTED|Overall Study||115
11333403|NCT02833948|12531009|FG000|COMPLETED|Overall Study||101
11333404|NCT02833948|12531010|FG001|COMPLETED|Overall Study||97
11333405|NCT02833948|12531009|FG000|NOT COMPLETED|Overall Study||15
11333406|NCT02833948|12531010|FG001|NOT COMPLETED|Overall Study||18
11333407|NCT02833974|12531022|FG000|STARTED|Overall Study||14
11333408|NCT02833974|12531023|FG001|STARTED|Overall Study||22
11333409|NCT02833974|12531022|FG000|COMPLETED|Overall Study||13
11333410|NCT02833974|12531023|FG001|COMPLETED|Overall Study||19
11333411|NCT02833974|12531022|FG000|NOT COMPLETED|Overall Study||1
11333412|NCT02833974|12531023|FG001|NOT COMPLETED|Overall Study||3
11333413|NCT02834247|12531033|FG000|STARTED|Dose Escalation Phase||8
11333414|NCT02834247|12531034|FG001|STARTED|Dose Escalation Phase||11
11030609|NCT00853047|12209866|FG005|COMPLETED|Open-Label Extension Phase||2
11030610|NCT00853047|12209861|FG000|NOT COMPLETED|Open-Label Extension Phase||0
11030611|NCT00853047|12209862|FG001|NOT COMPLETED|Open-Label Extension Phase||0
11030612|NCT00853047|12209863|FG002|NOT COMPLETED|Open-Label Extension Phase||0
11030613|NCT00853047|12209864|FG003|NOT COMPLETED|Open-Label Extension Phase||0
11030614|NCT00853047|12209865|FG004|NOT COMPLETED|Open-Label Extension Phase||0
11030615|NCT00853047|12209866|FG005|NOT COMPLETED|Open-Label Extension Phase||17
11030616|NCT00853073|12209883|FG000|STARTED|Overall Study||32
11030617|NCT00853073|12209884|FG001|STARTED|Overall Study||31
11030618|NCT00853073|12209883|FG000|COMPLETED|Overall Study||29
11030619|NCT00853073|12209884|FG001|COMPLETED|Overall Study||29
11030620|NCT00853073|12209883|FG000|NOT COMPLETED|Overall Study||3
11030621|NCT00853073|12209884|FG001|NOT COMPLETED|Overall Study||2
11030622|NCT00853099|12209893|FG000|STARTED|Double-blind Period||96
11333415|NCT02834247|12531035|FG002|STARTED|Dose Escalation Phase||5
11030623|NCT00853099|12209894|FG001|STARTED|Double-blind Period||87
11030624|NCT00853099|12209895|FG002|STARTED|Double-blind Period||91
11030625|NCT00853099|12209896|FG003|STARTED|Double-blind Period||0
11030626|NCT00853099|12209893|FG000|Treated|Double-blind Period||96
11030627|NCT00853099|12209894|FG001|Treated|Double-blind Period||87
11030628|NCT00853099|12209895|FG002|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
11030629|NCT00853099|12209896|FG003|Treated|Double-blind Period||0
11030630|NCT00853099|12209893|FG000|Completed Week 8|Double-blind Period||92
11030631|NCT00853099|12209894|FG001|Completed Week 8|Double-blind Period||85
11030632|NCT00853099|12209895|FG002|Completed Week 8|Double-blind Period||86
11030633|NCT00853099|12209896|FG003|Completed Week 8|Double-blind Period||0
11030634|NCT00853099|12209893|FG000|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
11030635|NCT00853099|12209894|FG001|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
11030636|NCT00853099|12209895|FG002|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
11030637|NCT00853099|12209896|FG003|COMPLETED|Double-blind Period||0
11030638|NCT00853099|12209893|FG000|NOT COMPLETED|Double-blind Period||23
11030639|NCT00853099|12209894|FG001|NOT COMPLETED|Double-blind Period||29
11030640|NCT00853099|12209895|FG002|NOT COMPLETED|Double-blind Period||31
11030641|NCT00853099|12209896|FG003|NOT COMPLETED|Double-blind Period||0
11030642|NCT00853099|12209893|FG000|STARTED|Double-blind + Open-label Periods||0
11030643|NCT00853099|12209894|FG001|STARTED|Double-blind + Open-label Periods||0
11030644|NCT00853099|12209895|FG002|STARTED|Double-blind + Open-label Periods||0
11030645|NCT00853099|12209896|FG003|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
11030646|NCT00853099|12209893|FG000|COMPLETED|Double-blind + Open-label Periods||0
11030647|NCT00853099|12209894|FG001|COMPLETED|Double-blind + Open-label Periods||0
11030648|NCT00853099|12209895|FG002|COMPLETED|Double-blind + Open-label Periods||0
11030649|NCT00853099|12209896|FG003|COMPLETED|Double-blind + Open-label Periods||119
11030650|NCT00853099|12209893|FG000|NOT COMPLETED|Double-blind + Open-label Periods||0
11333416|NCT02834247|12531036|FG003|STARTED|Dose Escalation Phase||0
11333417|NCT02834247|12531033|FG000|COMPLETED|Dose Escalation Phase||0
11333418|NCT02834247|12531034|FG001|COMPLETED|Dose Escalation Phase||0
11333419|NCT02834247|12531035|FG002|COMPLETED|Dose Escalation Phase||0
11333420|NCT02834247|12531036|FG003|COMPLETED|Dose Escalation Phase||0
11333421|NCT02834247|12531033|FG000|NOT COMPLETED|Dose Escalation Phase||8
11333422|NCT02834247|12531034|FG001|NOT COMPLETED|Dose Escalation Phase||11
11333423|NCT02834247|12531035|FG002|NOT COMPLETED|Dose Escalation Phase||5
11333424|NCT02834247|12531036|FG003|NOT COMPLETED|Dose Escalation Phase||0
11333425|NCT02834247|12531033|FG000|STARTED|Dose Expansion Phase||0
11333426|NCT02834247|12531034|FG001|STARTED|Dose Expansion Phase||0
11333427|NCT02834247|12531035|FG002|STARTED|Dose Expansion Phase||0
11333428|NCT02834247|12531036|FG003|STARTED|Dose Expansion Phase||17
11333429|NCT02834247|12531033|FG000|COMPLETED|Dose Expansion Phase||0
11333430|NCT02834247|12531034|FG001|COMPLETED|Dose Expansion Phase||0
11333431|NCT02834247|12531035|FG002|COMPLETED|Dose Expansion Phase||0
11333432|NCT02834247|12531036|FG003|COMPLETED|Dose Expansion Phase||0
11333433|NCT02834247|12531033|FG000|NOT COMPLETED|Dose Expansion Phase||0
11333434|NCT02834247|12531034|FG001|NOT COMPLETED|Dose Expansion Phase||0
11333435|NCT02834247|12531035|FG002|NOT COMPLETED|Dose Expansion Phase||0
11333436|NCT02834247|12531036|FG003|NOT COMPLETED|Dose Expansion Phase||17
11333437|NCT02834390|12531050|FG000|STARTED|Induction Phase||4
11333438|NCT02834390|12531051|FG001|STARTED|Induction Phase||3
11333439|NCT02834390|12531050|FG000|COMPLETED|Induction Phase||2
11333440|NCT02834390|12531051|FG001|COMPLETED|Induction Phase||1
11333441|NCT02834390|12531050|FG000|NOT COMPLETED|Induction Phase||2
11333442|NCT02834390|12531051|FG001|NOT COMPLETED|Induction Phase||2
11333443|NCT02834390|12531050|FG000|STARTED|Consolidation Phase||2
11333444|NCT02834390|12531051|FG001|STARTED|Consolidation Phase||1
11333445|NCT02834390|12531050|FG000|COMPLETED|Consolidation Phase||1
11333446|NCT02834390|12531051|FG001|COMPLETED|Consolidation Phase||0
11333447|NCT02834390|12531050|FG000|NOT COMPLETED|Consolidation Phase||1
11333448|NCT02834390|12531051|FG001|NOT COMPLETED|Consolidation Phase||1
11333449|NCT02834624|12531059|FG000|STARTED|Overall Study||15
11333450|NCT02834624|12531060|FG001|STARTED|Overall Study||15
11333451|NCT02834624|12531059|FG000|COMPLETED|Overall Study||15
11333452|NCT02834624|12531060|FG001|COMPLETED|Overall Study||15
11030651|NCT00853099|12209894|FG001|NOT COMPLETED|Double-blind + Open-label Periods||0
11030652|NCT00853099|12209895|FG002|NOT COMPLETED|Double-blind + Open-label Periods||0
11030653|NCT00853099|12209896|FG003|NOT COMPLETED|Double-blind + Open-label Periods||147
11030654|NCT00853112|12209913|FG000|STARTED|Overall Study||6
11333453|NCT02834624|12531059|FG000|NOT COMPLETED|Overall Study||0
11333454|NCT02834624|12531060|FG001|NOT COMPLETED|Overall Study||0
11333455|NCT02834663|12531067|FG000|STARTED|Overall Study|Unit means the eye. One eye was included per patient|25
11333456|NCT02834663|12531067|FG000|COMPLETED|Overall Study|Unit means the eye. One eye was included per patient|25
11333457|NCT02834663|12531067|FG000|NOT COMPLETED|Overall Study||0
11333458|NCT02834806|12531085|FG000|STARTED|Overall Study||58
11333459|NCT02834806|12531085|FG000|COMPLETED|Overall Study||58
11333460|NCT02834806|12531085|FG000|NOT COMPLETED|Overall Study||0
11333461|NCT02834819|12531091|FG000|STARTED|Overall Study||9
11333462|NCT02834819|12531092|FG001|STARTED|Overall Study||9
11333463|NCT02834819|12531091|FG000|COMPLETED|Overall Study||4
11333464|NCT02834819|12531092|FG001|COMPLETED|Overall Study||9
11333465|NCT02834819|12531091|FG000|NOT COMPLETED|Overall Study||5
11333466|NCT02834819|12531092|FG001|NOT COMPLETED|Overall Study||0
11333467|NCT02835092|12531101|FG000|STARTED|Overall Study||66
11333468|NCT02835092|12531102|FG001|STARTED|Overall Study||65
11333469|NCT02835092|12531103|FG002|STARTED|Overall Study||67
11333470|NCT02835092|12531101|FG000|COMPLETED|Overall Study||63
11333471|NCT02835092|12531102|FG001|COMPLETED|Overall Study||57
11333472|NCT02835092|12531103|FG002|COMPLETED|Overall Study||64
11333473|NCT02835092|12531101|FG000|NOT COMPLETED|Overall Study||3
11333474|NCT02835092|12531102|FG001|NOT COMPLETED|Overall Study||8
11333475|NCT02835092|12531103|FG002|NOT COMPLETED|Overall Study||3
11333476|NCT02835274|12531113|FG000|STARTED|Overall Study||6
11333477|NCT02835274|12531114|FG001|STARTED|Overall Study||6
11333478|NCT02835274|12531113|FG000|COMPLETED|Overall Study||6
11333479|NCT02835274|12531114|FG001|COMPLETED|Overall Study||6
11333480|NCT02835274|12531113|FG000|NOT COMPLETED|Overall Study||0
11333481|NCT02835274|12531114|FG001|NOT COMPLETED|Overall Study||0
11333482|NCT02835339|12531122|FG000|STARTED|Overall Study||31
11333483|NCT02835339|12531123|FG001|STARTED|Overall Study||35
11333484|NCT02835339|12531122|FG000|COMPLETED|Overall Study||18
11333485|NCT02835339|12531123|FG001|COMPLETED|Overall Study||19
11333486|NCT02835339|12531122|FG000|NOT COMPLETED|Overall Study||13
11333487|NCT02835339|12531123|FG001|NOT COMPLETED|Overall Study||16
11333488|NCT02835495|12531131|FG000|STARTED|Overall Study|26 randomized, however, one had to withdraw pre-intervention initiation due to cancer diagnosis.|26
11030655|NCT00853112|12209914|FG001|STARTED|Overall Study||7
11030656|NCT00853112|12209915|FG002|STARTED|Overall Study||7
11030657|NCT00853112|12209916|FG003|STARTED|Overall Study||8
11030658|NCT00853112|12209917|FG004|STARTED|Overall Study||6
11030659|NCT00853112|12209918|FG005|STARTED|Overall Study||7
11030660|NCT00853112|12209919|FG006|STARTED|Overall Study||7
11333489|NCT02835495|12531132|FG001|STARTED|Overall Study||25
11333490|NCT02835495|12531131|FG000|Intervention Start|Overall Study||25
11333491|NCT02835495|12531132|FG001|Intervention Start|Overall Study||25
11333492|NCT02835495|12531131|FG000|COMPLETED|Overall Study||21
11333493|NCT02835495|12531132|FG001|COMPLETED|Overall Study||23
11333494|NCT02835495|12531131|FG000|NOT COMPLETED|Overall Study||5
11030661|NCT00853112|12209913|FG000|Treated|Overall Study||6
11030662|NCT00853112|12209914|FG001|Treated|Overall Study||6
11030663|NCT00853112|12209915|FG002|Treated|Overall Study||7
11030664|NCT00853112|12209916|FG003|Treated|Overall Study||6
11030665|NCT00853112|12209917|FG004|Treated|Overall Study||6
11030666|NCT00853112|12209918|FG005|Treated|Overall Study||7
11030667|NCT00853112|12209919|FG006|Treated|Overall Study||6
11030668|NCT00853112|12209913|FG000|COMPLETED|Overall Study||6
11030669|NCT00853112|12209914|FG001|COMPLETED|Overall Study||6
11030670|NCT00853112|12209915|FG002|COMPLETED|Overall Study||7
11030671|NCT00853112|12209916|FG003|COMPLETED|Overall Study||6
11030672|NCT00853112|12209917|FG004|COMPLETED|Overall Study||6
11030673|NCT00853112|12209918|FG005|COMPLETED|Overall Study||7
11030674|NCT00853112|12209919|FG006|COMPLETED|Overall Study||6
11030675|NCT00853112|12209913|FG000|NOT COMPLETED|Overall Study||0
11030676|NCT00853112|12209914|FG001|NOT COMPLETED|Overall Study||1
11030677|NCT00853112|12209915|FG002|NOT COMPLETED|Overall Study||0
11030678|NCT00853112|12209916|FG003|NOT COMPLETED|Overall Study||2
11030679|NCT00853112|12209917|FG004|NOT COMPLETED|Overall Study||0
11030680|NCT00853112|12209918|FG005|NOT COMPLETED|Overall Study||0
11030681|NCT00853112|12209919|FG006|NOT COMPLETED|Overall Study||1
11030682|NCT00853125|12209935|FG000|STARTED|Overall Study||10
11030683|NCT00853125|12209935|FG000|COMPLETED|Overall Study||9
11030684|NCT00853125|12209935|FG000|NOT COMPLETED|Overall Study||1
11030685|NCT00853151|12209944|FG000|STARTED|Overall Study||38
11030686|NCT00853151|12209945|FG001|STARTED|Overall Study||37
11030687|NCT00853151|12209946|FG002|STARTED|Overall Study||38
11030688|NCT00853151|12209947|FG003|STARTED|Overall Study||18
11030689|NCT00853151|12209944|FG000|COMPLETED|Overall Study||28
11030690|NCT00853151|12209945|FG001|COMPLETED|Overall Study||24
11030691|NCT00853151|12209946|FG002|COMPLETED|Overall Study||30
11030692|NCT00853151|12209947|FG003|COMPLETED|Overall Study||15
11030693|NCT00853151|12209944|FG000|NOT COMPLETED|Overall Study||10
11030694|NCT00853151|12209945|FG001|NOT COMPLETED|Overall Study||13
11030695|NCT00853151|12209946|FG002|NOT COMPLETED|Overall Study||8
11030696|NCT00853151|12209947|FG003|NOT COMPLETED|Overall Study||3
11030697|NCT00853242|12209967|FG000|STARTED|Overall Study||50
11030698|NCT00853242|12209968|FG001|STARTED|Overall Study||50
11030699|NCT00853242|12209969|FG002|STARTED|Overall Study||49
11030700|NCT00853242|12209970|FG003|STARTED|Overall Study||50
11030701|NCT00853242|12209971|FG004|STARTED|Overall Study||50
11030702|NCT00853242|12209972|FG005|STARTED|Overall Study||51
11030703|NCT00853242|12209973|FG006|STARTED|Overall Study||49
11030704|NCT00853242|12209967|FG000|Treated|Overall Study||50
11030705|NCT00853242|12209968|FG001|Treated|Overall Study||49
11030706|NCT00853242|12209969|FG002|Treated|Overall Study||48
11030707|NCT00853242|12209970|FG003|Treated|Overall Study||50
11030708|NCT00853242|12209971|FG004|Treated|Overall Study||50
11030709|NCT00853242|12209972|FG005|Treated|Overall Study||51
11030710|NCT00853242|12209973|FG006|Treated|Overall Study||48
11030711|NCT00853242|12209967|FG000|COMPLETED|Overall Study||47
11030712|NCT00853242|12209968|FG001|COMPLETED|Overall Study||47
11030713|NCT00853242|12209969|FG002|COMPLETED|Overall Study||46
11030714|NCT00853242|12209970|FG003|COMPLETED|Overall Study||46
11030715|NCT00853242|12209971|FG004|COMPLETED|Overall Study||46
11030716|NCT00853242|12209972|FG005|COMPLETED|Overall Study||49
11030717|NCT00853242|12209973|FG006|COMPLETED|Overall Study||44
11030718|NCT00853242|12209967|FG000|NOT COMPLETED|Overall Study||3
11030719|NCT00853242|12209968|FG001|NOT COMPLETED|Overall Study||3
11030720|NCT00853242|12209969|FG002|NOT COMPLETED|Overall Study||3
11030721|NCT00853242|12209970|FG003|NOT COMPLETED|Overall Study||4
11030722|NCT00853242|12209971|FG004|NOT COMPLETED|Overall Study||4
11030723|NCT00853242|12209972|FG005|NOT COMPLETED|Overall Study||2
11030724|NCT00853242|12209973|FG006|NOT COMPLETED|Overall Study||5
11030725|NCT00853333|12209998|FG000|STARTED|Overall Study||28
11030726|NCT00853333|12209999|FG001|STARTED|Overall Study||27
11030727|NCT00853333|12210000|FG002|STARTED|Overall Study||31
11030728|NCT00853333|12209998|FG000|COMPLETED|Overall Study||28
11030729|NCT00853333|12209999|FG001|COMPLETED|Overall Study||27
11030730|NCT00853333|12210000|FG002|COMPLETED|Overall Study||31
11030731|NCT00853333|12209998|FG000|NOT COMPLETED|Overall Study||0
11030732|NCT00853333|12209999|FG001|NOT COMPLETED|Overall Study||0
11030733|NCT00853333|12210000|FG002|NOT COMPLETED|Overall Study||0
11030734|NCT00853372|12210010|FG000|STARTED|Overall Study||43
11030735|NCT00853372|12210011|FG001|STARTED|Overall Study||42
11030736|NCT00853372|12210010|FG000|COMPLETED|Overall Study||11
11030737|NCT00853372|12210011|FG001|COMPLETED|Overall Study||13
11030738|NCT00853372|12210010|FG000|NOT COMPLETED|Overall Study||32
11030739|NCT00853372|12210011|FG001|NOT COMPLETED|Overall Study||29
11057432|NCT00997620|12238936|FG001|NOT COMPLETED|Overall Study||0
11057433|NCT00997672|12238947|FG000|STARTED|Overall Study||4
11057434|NCT00997672|12238948|FG001|STARTED|Overall Study||5
11333495|NCT02835495|12531132|FG001|NOT COMPLETED|Overall Study||2
11057435|NCT00997672|12238947|FG000|COMPLETED|Overall Study||0
11057436|NCT00997672|12238948|FG001|COMPLETED|Overall Study||1
11057437|NCT00997672|12238947|FG000|NOT COMPLETED|Overall Study||4
11057438|NCT00997672|12238948|FG001|NOT COMPLETED|Overall Study||4
11057439|NCT00997893|12238957|FG000|STARTED|Overall Study||14
11057440|NCT00997893|12238958|FG001|STARTED|Overall Study||13
11030740|NCT00853385|12210022|FG000|STARTED|Overall Study||204
11030741|NCT00853385|12210023|FG001|STARTED|Overall Study||201
11030742|NCT00853385|12210024|FG002|STARTED|Overall Study||56
11030743|NCT00853385|12210025|FG003|STARTED|Overall Study||52
11030744|NCT00853385|12210026|FG004|STARTED|Overall Study||204
11030745|NCT00853385|12210022|FG000|COMPLETED|Overall Study||150
11030746|NCT00853385|12210023|FG001|COMPLETED|Overall Study||158
11030747|NCT00853385|12210024|FG002|COMPLETED|Overall Study||47
11030748|NCT00853385|12210025|FG003|COMPLETED|Overall Study||39
11030749|NCT00853385|12210026|FG004|COMPLETED|Overall Study||162
11030750|NCT00853385|12210022|FG000|NOT COMPLETED|Overall Study||54
11030751|NCT00853385|12210023|FG001|NOT COMPLETED|Overall Study||43
11030752|NCT00853385|12210024|FG002|NOT COMPLETED|Overall Study||9
11030753|NCT00853385|12210025|FG003|NOT COMPLETED|Overall Study||13
11030754|NCT00853385|12210026|FG004|NOT COMPLETED|Overall Study||42
11030755|NCT00853489|12210050|FG000|STARTED|Overall Study||16
11030756|NCT00853489|12210051|FG001|STARTED|Overall Study||14
11030757|NCT00853489|12210050|FG000|COMPLETED|Overall Study||11
11030758|NCT00853489|12210051|FG001|COMPLETED|Overall Study||12
11030759|NCT00853489|12210050|FG000|NOT COMPLETED|Overall Study||5
11030760|NCT00853489|12210051|FG001|NOT COMPLETED|Overall Study||2
11030761|NCT00853580|12210059|FG000|STARTED|Overall Study||74
11030762|NCT00853580|12210060|FG001|STARTED|Overall Study||72
11030763|NCT00853580|12210059|FG000|COMPLETED|Overall Study||67
11030764|NCT00853580|12210060|FG001|COMPLETED|Overall Study||56
11030765|NCT00853580|12210059|FG000|NOT COMPLETED|Overall Study||7
11030766|NCT00853580|12210060|FG001|NOT COMPLETED|Overall Study||16
11030767|NCT00853593|12210066|FG000|STARTED|Overall Study||197
11030768|NCT00853593|12210066|FG000|Implant Attempted|Overall Study||193
11333496|NCT02835625|12531142|FG000|STARTED|Overall Study||14734
11333497|NCT02835625|12531143|FG001|STARTED|Overall Study||14719
11333498|NCT02835625|12531142|FG000|COMPLETED|Overall Study||14734
11333499|NCT02835625|12531143|FG001|COMPLETED|Overall Study||14719
11333500|NCT02835625|12531142|FG000|NOT COMPLETED|Overall Study||0
11333501|NCT02835625|12531143|FG001|NOT COMPLETED|Overall Study||0
11333502|NCT02835677|12531150|FG000|STARTED|Overall Study||25
11333503|NCT02835677|12531150|FG000|COMPLETED|Overall Study||25
11333504|NCT02835677|12531150|FG000|NOT COMPLETED|Overall Study||0
11333505|NCT02835820|12531156|FG000|STARTED|Overall Study||7
11333506|NCT02835820|12531157|FG001|STARTED|Overall Study||10
11333507|NCT02835820|12531156|FG000|Baseline Screen (OGTT)|Overall Study||7
11333508|NCT02835820|12531157|FG001|Baseline Screen (OGTT)|Overall Study||7
11333509|NCT02835820|12531156|FG000|COMPLETED|Overall Study||7
11333510|NCT02835820|12531157|FG001|COMPLETED|Overall Study||7
11333511|NCT02835820|12531156|FG000|NOT COMPLETED|Overall Study||0
11333512|NCT02835820|12531157|FG001|NOT COMPLETED|Overall Study||3
11333513|NCT02835846|12531163|FG000|STARTED|Overall Study||35
11333514|NCT02835846|12531163|FG000|COMPLETED|Overall Study||24
11333515|NCT02835846|12531163|FG000|NOT COMPLETED|Overall Study||11
11333516|NCT02836496|12531169|FG000|STARTED|Overall Study||54
11333517|NCT02836496|12531170|FG001|STARTED|Overall Study||54
11333518|NCT02836496|12531169|FG000|COMPLETED|Overall Study||52
11333519|NCT02836496|12531170|FG001|COMPLETED|Overall Study||52
11333520|NCT02836496|12531169|FG000|NOT COMPLETED|Overall Study||2
11333521|NCT02836496|12531170|FG001|NOT COMPLETED|Overall Study||2
11333522|NCT02836613|12531178|FG000|STARTED|Overall Study||80
11333523|NCT02836613|12531179|FG001|STARTED|Overall Study||80
11333524|NCT02836613|12531178|FG000|COMPLETED|Overall Study||79
11333525|NCT02836613|12531179|FG001|COMPLETED|Overall Study||77
11333526|NCT02836613|12531178|FG000|NOT COMPLETED|Overall Study||1
11333527|NCT02836613|12531179|FG001|NOT COMPLETED|Overall Study||3
11333528|NCT02836652|12531187|FG000|STARTED|Overall Study||35
11333529|NCT02836652|12531188|FG001|STARTED|Overall Study||37
11030769|NCT00853593|12210066|FG000|Model 4396 Lead Attempted|Overall Study||164
11333530|NCT02836652|12531187|FG000|As-treated Population|Overall Study||31
11333531|NCT02836652|12531188|FG001|As-treated Population|Overall Study||34
11333532|NCT02836652|12531187|FG000|COMPLETED|Overall Study||17
11333533|NCT02836652|12531188|FG001|COMPLETED|Overall Study||18
11333534|NCT02836652|12531187|FG000|NOT COMPLETED|Overall Study||18
11333535|NCT02836652|12531188|FG001|NOT COMPLETED|Overall Study||19
11333536|NCT02836769|12531194|FG000|STARTED|Overall Study||35
11333537|NCT02836769|12531194|FG000|Received Intervention|Overall Study||30
11333538|NCT02836769|12531194|FG000|Completed Post-test Assessment|Overall Study||21
11333539|NCT02836769|12531194|FG000|COMPLETED|Overall Study||20
11333540|NCT02836769|12531194|FG000|NOT COMPLETED|Overall Study||15
11333541|NCT02836873|12531200|FG000|STARTED|Overall Study||157
11333542|NCT02836873|12531201|FG001|STARTED|Overall Study||155
11333543|NCT02836873|12531200|FG000|COMPLETED|Overall Study||152
11333544|NCT02836873|12531201|FG001|COMPLETED|Overall Study||144
11333545|NCT02836873|12531200|FG000|NOT COMPLETED|Overall Study||5
11333546|NCT02836873|12531201|FG001|NOT COMPLETED|Overall Study||11
11333547|NCT02836990|12531209|FG000|STARTED|Overall Study||50
11333548|NCT02836990|12531210|FG001|STARTED|Overall Study||55
11333549|NCT02836990|12531209|FG000|COMPLETED|Overall Study||50
11333550|NCT02836990|12531210|FG001|COMPLETED|Overall Study||55
11333551|NCT02836990|12531209|FG000|NOT COMPLETED|Overall Study||0
11333552|NCT02836990|12531210|FG001|NOT COMPLETED|Overall Study||0
11030770|NCT00853593|12210066|FG000|COMPLETED|Overall Study||152
11030771|NCT00853593|12210066|FG000|NOT COMPLETED|Overall Study||45
11030772|NCT00853606|12210087|FG000|STARTED|Overall Study||712
11030773|NCT00853606|12210087|FG000|COMPLETED|Overall Study||492
11030774|NCT00853606|12210087|FG000|NOT COMPLETED|Overall Study||220
11030775|NCT00853645|12210091|FG000|STARTED|Overall Study||6
11333553|NCT02837237|12531218|FG000|STARTED|Overall Study||11
11333554|NCT02837237|12531218|FG000|COMPLETED|Overall Study||11
11333555|NCT02837237|12531218|FG000|NOT COMPLETED|Overall Study||0
11333556|NCT02837328|12531224|FG000|STARTED|Overall Study||29
11333557|NCT02837328|12531225|FG001|STARTED|Overall Study||30
11333558|NCT02837328|12531224|FG000|COMPLETED|Overall Study||29
11333559|NCT02837328|12531225|FG001|COMPLETED|Overall Study||30
11333560|NCT02837328|12531224|FG000|NOT COMPLETED|Overall Study||0
11030776|NCT00853645|12210091|FG000|COMPLETED|Overall Study||6
11030777|NCT00853645|12210091|FG000|NOT COMPLETED|Overall Study||0
11030778|NCT00853658|12210098|FG000|STARTED|Overall Study||2354
11030779|NCT00853658|12210099|FG001|STARTED|Overall Study||2356
11030780|NCT00853658|12210100|FG002|STARTED|Overall Study||2354
11030781|NCT00853658|12210098|FG000|Full Analysis Set (FAS)|Overall Study||2340
11030782|NCT00853658|12210099|FG001|Full Analysis Set (FAS)|Overall Study||2340
11030783|NCT00853658|12210100|FG002|Full Analysis Set (FAS)|Overall Study||2336
11030784|NCT00853658|12210098|FG000|Safety Set|Overall Study||2347
11030785|NCT00853658|12210099|FG001|Safety Set|Overall Study||2348
11030786|NCT00853658|12210100|FG002|Safety Set|Overall Study||2345
11030787|NCT00853658|12210098|FG000|COMPLETED|Overall Study||1567
11030788|NCT00853658|12210099|FG001|COMPLETED|Overall Study||1524
11030789|NCT00853658|12210100|FG002|COMPLETED|Overall Study||1539
11030790|NCT00853658|12210098|FG000|NOT COMPLETED|Overall Study||787
11030791|NCT00853658|12210099|FG001|NOT COMPLETED|Overall Study||832
11030792|NCT00853658|12210100|FG002|NOT COMPLETED|Overall Study||815
11030793|NCT00853671|12210108|FG000|STARTED|Overall Study||50
11030794|NCT00853671|12210108|FG000|COMPLETED|Overall Study||50
11030795|NCT00853671|12210108|FG000|NOT COMPLETED|Overall Study||0
11030796|NCT00853723|12210115|FG000|STARTED|Overall Study||35
11030797|NCT00853723|12210116|FG001|STARTED|Overall Study||35
11030798|NCT00853723|12210117|FG002|STARTED|Overall Study||35
11030799|NCT00853723|12210115|FG000|COMPLETED|Overall Study||29
11030800|NCT00853723|12210116|FG001|COMPLETED|Overall Study||28
11030801|NCT00853723|12210117|FG002|COMPLETED|Overall Study||33
11030802|NCT00853723|12210115|FG000|NOT COMPLETED|Overall Study||6
11030803|NCT00853723|12210116|FG001|NOT COMPLETED|Overall Study||7
11030804|NCT00853723|12210117|FG002|NOT COMPLETED|Overall Study||2
11030805|NCT00853749|12210130|FG000|STARTED|Overall Study||50
11030806|NCT00853749|12210131|FG001|STARTED|Overall Study||39
11030807|NCT00853749|12210130|FG000|Vaccinated|Overall Study||50
11030808|NCT00853749|12210131|FG001|Vaccinated|Overall Study||39
11030809|NCT00853749|12210130|FG000|COMPLETED|Overall Study||50
11030810|NCT00853749|12210131|FG001|COMPLETED|Overall Study||38
11030811|NCT00853749|12210130|FG000|NOT COMPLETED|Overall Study||0
11030812|NCT00853749|12210131|FG001|NOT COMPLETED|Overall Study||1
11030813|NCT00853762|12210141|FG000|STARTED|Overall Study||16
11030814|NCT00853762|12210142|FG001|STARTED|Overall Study||19
11030815|NCT00853762|12210143|FG002|STARTED|Overall Study||17
11030816|NCT00853762|12210144|FG003|STARTED|Overall Study||22
11030817|NCT00853762|12210141|FG000|COMPLETED|Overall Study||0
11030818|NCT00853762|12210142|FG001|COMPLETED|Overall Study||0
11030819|NCT00853762|12210143|FG002|COMPLETED|Overall Study||0
11030820|NCT00853762|12210144|FG003|COMPLETED|Overall Study||0
11030821|NCT00853762|12210141|FG000|NOT COMPLETED|Overall Study||16
11030822|NCT00853762|12210142|FG001|NOT COMPLETED|Overall Study||19
11030823|NCT00853762|12210143|FG002|NOT COMPLETED|Overall Study||17
11030824|NCT00853762|12210144|FG003|NOT COMPLETED|Overall Study||22
11030825|NCT00853827|12210156|FG000|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
11030826|NCT00853827|12210157|FG001|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
11030827|NCT00853827|12210156|FG000|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
11030828|NCT00853827|12210157|FG001|COMPLETED|Single Blind Period (1 Week)||0
11030829|NCT00853827|12210156|FG000|NOT COMPLETED|Single Blind Period (1 Week)||39
11030830|NCT00853827|12210157|FG001|NOT COMPLETED|Single Blind Period (1 Week)||0
11030831|NCT00853827|12210156|FG000|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
11030832|NCT00853827|12210157|FG001|STARTED|Double Blind Period (103 Weeks)||308
11030833|NCT00853827|12210156|FG000|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
11030834|NCT00853827|12210157|FG001|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
11030835|NCT00853827|12210156|FG000|COMPLETED|Double Blind Period (103 Weeks)||201
11030836|NCT00853827|12210157|FG001|COMPLETED|Double Blind Period (103 Weeks)||199
11030837|NCT00853827|12210156|FG000|NOT COMPLETED|Double Blind Period (103 Weeks)||104
11030838|NCT00853827|12210157|FG001|NOT COMPLETED|Double Blind Period (103 Weeks)||109
11030839|NCT00853840|12210163|FG000|STARTED|Period 1||9
11030840|NCT00853840|12210164|FG001|STARTED|Period 1||9
11030841|NCT00853840|12210163|FG000|Maraviroc (Days 1 - 4)|Period 1||9
11030842|NCT00853840|12210164|FG001|Maraviroc (Days 1 - 4)|Period 1||9
11030843|NCT00853840|12210163|FG000|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
11030844|NCT00853840|12210164|FG001|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
11030845|NCT00853840|12210163|FG000|COMPLETED|Period 1||9
11030846|NCT00853840|12210164|FG001|COMPLETED|Period 1||9
11030847|NCT00853840|12210163|FG000|NOT COMPLETED|Period 1||0
11030848|NCT00853840|12210164|FG001|NOT COMPLETED|Period 1||0
11030849|NCT00853840|12210163|FG000|STARTED|Period 2||9
11030850|NCT00853840|12210164|FG001|STARTED|Period 2||9
11030851|NCT00853840|12210163|FG000|Maraviroc (Days 1 - 3)|Period 2||9
11030852|NCT00853840|12210164|FG001|Maraviroc (Days 1 - 3)|Period 2||9
11030853|NCT00853840|12210163|FG000|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
11030854|NCT00853840|12210164|FG001|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
11030855|NCT00853840|12210163|FG000|COMPLETED|Period 2||9
11030856|NCT00853840|12210164|FG001|COMPLETED|Period 2||9
11030857|NCT00853840|12210163|FG000|NOT COMPLETED|Period 2||0
11030858|NCT00853840|12210164|FG001|NOT COMPLETED|Period 2||0
11030859|NCT00853905|12210173|FG000|STARTED|Overall Study||37
11030860|NCT00853905|12210174|FG001|STARTED|Overall Study||40
11030861|NCT00853905|12210173|FG000|COMPLETED|Overall Study||35
11030862|NCT00853905|12210174|FG001|COMPLETED|Overall Study||36
11030863|NCT00853905|12210173|FG000|NOT COMPLETED|Overall Study||2
11030864|NCT00853905|12210174|FG001|NOT COMPLETED|Overall Study||4
11030865|NCT00853957|12210185|FG000|STARTED|Overall Study||220
11030866|NCT00853957|12210186|FG001|STARTED|Overall Study||223
11030867|NCT00853957|12210185|FG000|COMPLETED|Overall Study||206
11030868|NCT00853957|12210186|FG001|COMPLETED|Overall Study||204
11030869|NCT00853957|12210185|FG000|NOT COMPLETED|Overall Study||14
11030870|NCT00853957|12210186|FG001|NOT COMPLETED|Overall Study||19
11030871|NCT00853970|12210194|FG000|STARTED|Overall Study||152
11030872|NCT00853970|12210195|FG001|STARTED|Overall Study||147
11030873|NCT00853970|12210194|FG000|COMPLETED|Overall Study||146
11030874|NCT00853970|12210195|FG001|COMPLETED|Overall Study||144
11030875|NCT00853970|12210194|FG000|NOT COMPLETED|Overall Study||6
11030876|NCT00853970|12210195|FG001|NOT COMPLETED|Overall Study||3
11030877|NCT00853996|12210201|FG000|STARTED|Overall Study||25
11030878|NCT00853996|12210201|FG000|COMPLETED|Overall Study||25
11030879|NCT00853996|12210201|FG000|NOT COMPLETED|Overall Study||0
11030880|NCT00854061|12210205|FG000|STARTED|Overall Study||172
11030881|NCT00854061|12210205|FG000|Completed 1st Surgery (T-PRED in One Eye and Pred Forte in the Other Eye)|Overall Study||162
11333561|NCT02837328|12531225|FG001|NOT COMPLETED|Overall Study||0
11333562|NCT02837731|12531233|FG000|STARTED|Allocation||102
11333563|NCT02837731|12531234|FG001|STARTED|Allocation||48
11333564|NCT02837731|12531233|FG000|COMPLETED|Allocation||83
11333565|NCT02837731|12531234|FG001|COMPLETED|Allocation||41
11333566|NCT02837731|12531233|FG000|NOT COMPLETED|Allocation||19
11333567|NCT02837731|12531234|FG001|NOT COMPLETED|Allocation||7
11333568|NCT02837731|12531233|FG000|STARTED|Follow-up||83
11333569|NCT02837731|12531234|FG001|STARTED|Follow-up||41
11333570|NCT02837731|12531233|FG000|COMPLETED|Follow-up||83
11333571|NCT02837731|12531234|FG001|COMPLETED|Follow-up||41
11333572|NCT02837731|12531233|FG000|NOT COMPLETED|Follow-up||0
11333573|NCT02837731|12531234|FG001|NOT COMPLETED|Follow-up||0
11333574|NCT02837731|12531233|FG000|STARTED|Analysis||83
11333575|NCT02837731|12531234|FG001|STARTED|Analysis||41
11333576|NCT02837731|12531233|FG000|COMPLETED|Analysis||83
11333577|NCT02837731|12531234|FG001|COMPLETED|Analysis||41
11333578|NCT02837731|12531233|FG000|NOT COMPLETED|Analysis||0
11333579|NCT02837731|12531234|FG001|NOT COMPLETED|Analysis||0
11333580|NCT02837744|12531240|FG000|STARTED|Overall Study||70
11333581|NCT02837744|12531240|FG000|COMPLETED|Overall Study||70
11333582|NCT02837744|12531240|FG000|NOT COMPLETED|Overall Study||0
11333583|NCT02837913|12531246|FG000|STARTED|Overall Study||10
11333584|NCT02837913|12531247|FG001|STARTED|Overall Study||9
11333585|NCT02837913|12531246|FG000|COMPLETED|Overall Study||10
11333586|NCT02837913|12531247|FG001|COMPLETED|Overall Study||9
11333587|NCT02837913|12531246|FG000|NOT COMPLETED|Overall Study||0
11333588|NCT02837913|12531247|FG001|NOT COMPLETED|Overall Study||0
11333589|NCT02837952|12531255|FG000|STARTED|Overall Study||41
11333590|NCT02837952|12531256|FG001|STARTED|Overall Study||82
11333591|NCT02837952|12531255|FG000|COMPLETED|Overall Study||36
11333592|NCT02837952|12531256|FG001|COMPLETED|Overall Study||76
11333593|NCT02837952|12531255|FG000|NOT COMPLETED|Overall Study||5
11333594|NCT02837952|12531256|FG001|NOT COMPLETED|Overall Study||6
11030882|NCT00854061|12210205|FG000|Completed 2nd Surgery (T-PRED and Pred Forte in Opposite Eyes Compared to 1st Surgery)|Overall Study||149
11030883|NCT00854061|12210205|FG000|COMPLETED|Overall Study||149
11030884|NCT00854061|12210205|FG000|NOT COMPLETED|Overall Study||23
11030885|NCT00854087|12210213|FG000|STARTED|Overall Study||59
11030886|NCT00854087|12210214|FG001|STARTED|Overall Study||59
11030887|NCT00854087|12210213|FG000|COMPLETED|Overall Study||40
11030888|NCT00854087|12210214|FG001|COMPLETED|Overall Study||40
11030889|NCT00854087|12210213|FG000|NOT COMPLETED|Overall Study||19
11030890|NCT00854087|12210214|FG001|NOT COMPLETED|Overall Study||19
11030891|NCT00854100|12210223|FG000|STARTED|Overall Study||81
11030892|NCT00854100|12210224|FG001|STARTED|Overall Study||76
11030893|NCT00854100|12210225|FG002|STARTED|Overall Study||74
11030894|NCT00854100|12210223|FG000|COMPLETED|Overall Study||72
11030895|NCT00854100|12210224|FG001|COMPLETED|Overall Study||70
11030896|NCT00854100|12210225|FG002|COMPLETED|Overall Study||63
11030897|NCT00854100|12210223|FG000|NOT COMPLETED|Overall Study||9
11030898|NCT00854100|12210224|FG001|NOT COMPLETED|Overall Study||6
11030899|NCT00854100|12210225|FG002|NOT COMPLETED|Overall Study||11
11030900|NCT00854113|12210245|FG000|STARTED|Overall Study||6
11030901|NCT00854113|12210246|FG001|STARTED|Overall Study||6
11030902|NCT00854113|12210247|FG002|STARTED|Overall Study||6
11030903|NCT00854113|12210248|FG003|STARTED|Overall Study||6
11030904|NCT00854113|12210249|FG004|STARTED|Overall Study||6
11030905|NCT00854113|12210250|FG005|STARTED|Overall Study||6
11030906|NCT00854113|12210251|FG006|STARTED|Overall Study||12
11030907|NCT00854113|12210252|FG007|STARTED|Overall Study||8
11030908|NCT00854113|12210253|FG008|STARTED|Overall Study||8
11030909|NCT00854113|12210254|FG009|STARTED|Overall Study||8
11030910|NCT00854113|12210255|FG010|STARTED|Overall Study||6
11030911|NCT00854113|12210245|FG000|COMPLETED|Overall Study||6
11333595|NCT02838017|12531264|FG000|STARTED|Overall Study||252
11030912|NCT00854113|12210246|FG001|COMPLETED|Overall Study||6
11030913|NCT00854113|12210247|FG002|COMPLETED|Overall Study||6
11030914|NCT00854113|12210248|FG003|COMPLETED|Overall Study||6
11030915|NCT00854113|12210249|FG004|COMPLETED|Overall Study||6
11030916|NCT00854113|12210250|FG005|COMPLETED|Overall Study||6
11030917|NCT00854113|12210251|FG006|COMPLETED|Overall Study||12
11030918|NCT00854113|12210252|FG007|COMPLETED|Overall Study||5
11030919|NCT00854113|12210253|FG008|COMPLETED|Overall Study||7
11030920|NCT00854113|12210254|FG009|COMPLETED|Overall Study||8
11030921|NCT00854113|12210255|FG010|COMPLETED|Overall Study||6
11030922|NCT00854113|12210245|FG000|NOT COMPLETED|Overall Study||0
11030923|NCT00854113|12210246|FG001|NOT COMPLETED|Overall Study||0
11030924|NCT00854113|12210247|FG002|NOT COMPLETED|Overall Study||0
11030925|NCT00854113|12210248|FG003|NOT COMPLETED|Overall Study||0
11030926|NCT00854113|12210249|FG004|NOT COMPLETED|Overall Study||0
11030927|NCT00854113|12210250|FG005|NOT COMPLETED|Overall Study||0
11030928|NCT00854113|12210251|FG006|NOT COMPLETED|Overall Study||0
11030929|NCT00854113|12210252|FG007|NOT COMPLETED|Overall Study||3
11030930|NCT00854113|12210253|FG008|NOT COMPLETED|Overall Study||1
11030931|NCT00854113|12210254|FG009|NOT COMPLETED|Overall Study||0
11030932|NCT00854113|12210255|FG010|NOT COMPLETED|Overall Study||0
11030933|NCT00854308|12210281|FG000|STARTED|Overall Study||69
11030934|NCT00854308|12210282|FG001|STARTED|Overall Study||68
11030935|NCT00854308|12210281|FG000|Received Study Drug|Overall Study||69
11030936|NCT00854308|12210282|FG001|Received Study Drug|Overall Study||67
11030937|NCT00854308|12210281|FG000|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
11030938|NCT00854308|12210282|FG001|COMPLETED|Overall Study||1
11030939|NCT00854308|12210281|FG000|NOT COMPLETED|Overall Study||62
11030940|NCT00854308|12210282|FG001|NOT COMPLETED|Overall Study||67
11030941|NCT00854360|12210292|FG000|STARTED|Overall Study||118
11030942|NCT00854360|12210293|FG001|STARTED|Overall Study||123
11030943|NCT00854360|12210294|FG002|STARTED|Overall Study||122
11030944|NCT00854360|12210295|FG003|STARTED|Overall Study||124
11030945|NCT00854360|12210292|FG000|Intent to Treat / Safety Population|Overall Study||118
11030946|NCT00854360|12210293|FG001|Intent to Treat / Safety Population|Overall Study||123
11030947|NCT00854360|12210294|FG002|Intent to Treat / Safety Population|Overall Study||122
11030948|NCT00854360|12210295|FG003|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
11030949|NCT00854360|12210292|FG000|COMPLETED|Overall Study||116
11030950|NCT00854360|12210293|FG001|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
11030951|NCT00854360|12210294|FG002|COMPLETED|Overall Study||120
11030952|NCT00854360|12210295|FG003|COMPLETED|Overall Study||114
11030953|NCT00854360|12210292|FG000|NOT COMPLETED|Overall Study||2
11030954|NCT00854360|12210293|FG001|NOT COMPLETED|Overall Study||3
11030955|NCT00854360|12210294|FG002|NOT COMPLETED|Overall Study||2
11030956|NCT00854360|12210295|FG003|NOT COMPLETED|Overall Study||10
11030957|NCT00854373|12210307|FG000|STARTED|Overall Study||95
11030958|NCT00854373|12210308|FG001|STARTED|Overall Study||93
11030959|NCT00854373|12210307|FG000|COMPLETED|Overall Study||93
11030960|NCT00854373|12210308|FG001|COMPLETED|Overall Study||89
11030961|NCT00854373|12210307|FG000|NOT COMPLETED|Overall Study||2
11030962|NCT00854373|12210308|FG001|NOT COMPLETED|Overall Study||4
11030963|NCT00854581|12210314|FG000|STARTED|Induction (Up to Day 21)||13
11030964|NCT00854581|12210314|FG000|COMPLETED|Induction (Up to Day 21)||7
11030965|NCT00854581|12210314|FG000|NOT COMPLETED|Induction (Up to Day 21)||6
11030966|NCT00854581|12210314|FG000|STARTED|Part 1 Maintenance (Up to Day 60)||7
11030967|NCT00854581|12210314|FG000|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
11030968|NCT00854581|12210314|FG000|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
11030969|NCT00854581|12210314|FG000|STARTED|Part 2 Maintenance (Up to 12 Months)||5
11030970|NCT00854581|12210314|FG000|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
11030971|NCT00854581|12210314|FG000|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
11030972|NCT00854594|12210325|FG000|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
11030973|NCT00854594|12210326|FG001|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
11030974|NCT00854594|12210325|FG000|COMPLETED|Overall Study||48
11030975|NCT00854594|12210326|FG001|COMPLETED|Overall Study||69
11030976|NCT00854594|12210325|FG000|NOT COMPLETED|Overall Study||0
11030977|NCT00854594|12210326|FG001|NOT COMPLETED|Overall Study||0
11030978|NCT00854607|12210332|FG000|STARTED|Enrollment||116
11030979|NCT00854607|12210332|FG000|COMPLETED|Enrollment||116
11030980|NCT00854607|12210332|FG000|NOT COMPLETED|Enrollment||0
11030981|NCT00854607|12210332|FG000|STARTED|2 Weeks After Start Anti-fungal Therapy||116
11030982|NCT00854607|12210332|FG000|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
11030983|NCT00854607|12210332|FG000|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
11030984|NCT00854620|12210343|FG000|STARTED|Overall Study||9
11030985|NCT00854620|12210343|FG000|COMPLETED|Overall Study||8
11030986|NCT00854620|12210343|FG000|NOT COMPLETED|Overall Study||1
11030987|NCT00854724|12210349|FG000|STARTED|First Intervention||8
11030988|NCT00854724|12210350|FG001|STARTED|First Intervention||8
11030989|NCT00854724|12210349|FG000|COMPLETED|First Intervention||7
11030990|NCT00854724|12210350|FG001|COMPLETED|First Intervention||7
11030991|NCT00854724|12210349|FG000|NOT COMPLETED|First Intervention||1
11030992|NCT00854724|12210350|FG001|NOT COMPLETED|First Intervention||1
11030993|NCT00854724|12210349|FG000|STARTED|Washout||7
11030994|NCT00854724|12210350|FG001|STARTED|Washout||7
11030995|NCT00854724|12210349|FG000|COMPLETED|Washout||6
11030996|NCT00854724|12210350|FG001|COMPLETED|Washout||6
11030997|NCT00854724|12210349|FG000|NOT COMPLETED|Washout||1
11030998|NCT00854724|12210350|FG001|NOT COMPLETED|Washout||1
11030999|NCT00854724|12210349|FG000|STARTED|Second Intervention||6
11031000|NCT00854724|12210350|FG001|STARTED|Second Intervention||6
11031001|NCT00854724|12210349|FG000|COMPLETED|Second Intervention||5
11031002|NCT00854724|12210350|FG001|COMPLETED|Second Intervention||5
11031003|NCT00854724|12210349|FG000|NOT COMPLETED|Second Intervention||1
11031004|NCT00854724|12210350|FG001|NOT COMPLETED|Second Intervention||1
11031005|NCT00854828|12210360|FG000|STARTED|Overall Study|6 patients crossed over to non-operative intervention.|30
11031006|NCT00854828|12210361|FG001|STARTED|Overall Study||33
11031007|NCT00854828|12210362|FG002|STARTED|Overall Study||112
11031008|NCT00854828|12210363|FG003|STARTED|Overall Study||111
11031009|NCT00854828|12210360|FG000|3 Months Post Intervention|Overall Study|6 missed visits|24
11031010|NCT00854828|12210361|FG001|3 Months Post Intervention|Overall Study|1 missed visit|32
11031011|NCT00854828|12210362|FG002|3 Months Post Intervention|Overall Study|112 (100%) of patients underwent operative treatment.|112
11031012|NCT00854828|12210363|FG003|3 Months Post Intervention|Overall Study|2 missed visits. 3 withdrew.|106
11031013|NCT00854828|12210360|FG000|12 Months Post Intervention|Overall Study|"2 missed visits.~1 withdrew.~1 deceased."|26
11031014|NCT00854828|12210361|FG001|12 Months Post Intervention|Overall Study|1 withdrew. 15 (45%) crossed over to operative treatment.|32
11031015|NCT00854828|12210362|FG002|12 Months Post Intervention|Overall Study||112
11031016|NCT00854828|12210363|FG003|12 Months Post Intervention|Overall Study|4 missed visits. 6 withdrew. 6 (5%) crossed over to operative treatment.|101
11031017|NCT00854828|12210360|FG000|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew.~1 deceased. 24 patients (80%) underwent surgery."|27
11031018|NCT00854828|12210361|FG001|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew. 21 (64%) crossed over to operative treatment."|31
11031019|NCT00854828|12210362|FG002|24 Months Post Intervention|Overall Study|8 missed visits.|104
11031020|NCT00854828|12210363|FG003|24 Months Post Intervention|Overall Study|8 missed visits. 9 withdrew. 14 (13%) crossed over to operative treatment.|94
11031021|NCT00854828|12210360|FG000|COMPLETED|Overall Study||27
11031022|NCT00854828|12210361|FG001|COMPLETED|Overall Study||31
11031023|NCT00854828|12210362|FG002|COMPLETED|Overall Study||104
11031024|NCT00854828|12210363|FG003|COMPLETED|Overall Study||94
11031025|NCT00854828|12210360|FG000|NOT COMPLETED|Overall Study||3
11031026|NCT00854828|12210361|FG001|NOT COMPLETED|Overall Study||2
11031027|NCT00854828|12210362|FG002|NOT COMPLETED|Overall Study||8
11031028|NCT00854828|12210363|FG003|NOT COMPLETED|Overall Study||17
11031029|NCT00854906|12210373|FG000|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
11031030|NCT00854906|12210373|FG000|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
11031031|NCT00854906|12210373|FG000|NOT COMPLETED|Overall Study||1
11031032|NCT00855010|12210382|FG000|STARTED|Overall Study||23
11031033|NCT00855010|12210383|FG001|STARTED|Overall Study||19
11031034|NCT00855010|12210382|FG000|COMPLETED|Overall Study||19
11031035|NCT00855010|12210383|FG001|COMPLETED|Overall Study||18
11031036|NCT00855010|12210382|FG000|NOT COMPLETED|Overall Study||4
11031037|NCT00855010|12210383|FG001|NOT COMPLETED|Overall Study||1
11031038|NCT00855062|12210395|FG000|STARTED|Step1||36
11031039|NCT00855062|12210396|FG001|STARTED|Step1||37
11031040|NCT00855062|12210395|FG000|COMPLETED|Step1||26
11031041|NCT00855062|12210396|FG001|COMPLETED|Step1||26
11031042|NCT00855062|12210395|FG000|NOT COMPLETED|Step1||10
11031043|NCT00855062|12210396|FG001|NOT COMPLETED|Step1||11
11031044|NCT00855062|12210395|FG000|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
11031045|NCT00855062|12210396|FG001|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
11031046|NCT00855062|12210395|FG000|COMPLETED|Step2||13
11031047|NCT00855062|12210396|FG001|COMPLETED|Step2||15
11031048|NCT00855062|12210395|FG000|NOT COMPLETED|Step2||6
11031049|NCT00855062|12210396|FG001|NOT COMPLETED|Step2||6
11031050|NCT00855166|12210404|FG000|STARTED|Overall Study||91
11031051|NCT00855166|12210405|FG001|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
11031052|NCT00855166|12210404|FG000|COMPLETED|Overall Study||86
11031053|NCT00855166|12210405|FG001|COMPLETED|Overall Study||83
11031054|NCT00855166|12210404|FG000|NOT COMPLETED|Overall Study||5
11031055|NCT00855166|12210405|FG001|NOT COMPLETED|Overall Study||8
11031056|NCT00855218|12210415|FG000|STARTED|Overall Study||154
11031057|NCT00855218|12210416|FG001|STARTED|Overall Study||153
11031058|NCT00855218|12210415|FG000|Participants Received Treatment|Overall Study||153
11031059|NCT00855218|12210416|FG001|Participants Received Treatment|Overall Study||151
11031060|NCT00855218|12210415|FG000|COMPLETED|Overall Study||0
11031061|NCT00855218|12210416|FG001|COMPLETED|Overall Study||0
11031062|NCT00855218|12210415|FG000|NOT COMPLETED|Overall Study||154
11031063|NCT00855218|12210416|FG001|NOT COMPLETED|Overall Study||153
11031064|NCT00855309|12210424|FG000|STARTED|Overall Study||57
11031065|NCT00855309|12210425|FG001|STARTED|Overall Study||55
11031066|NCT00855309|12210424|FG000|COMPLETED|Overall Study||56
11031067|NCT00855309|12210425|FG001|COMPLETED|Overall Study||55
11031068|NCT00855309|12210424|FG000|NOT COMPLETED|Overall Study||1
11031069|NCT00855309|12210425|FG001|NOT COMPLETED|Overall Study||0
11031070|NCT00855335|12210436|FG000|STARTED|Overall Study||18
11031071|NCT00855335|12210437|FG001|STARTED|Overall Study||18
11031072|NCT00855335|12210438|FG002|STARTED|Overall Study||15
11031073|NCT00855335|12210439|FG003|STARTED|Overall Study||19
11031074|NCT00855335|12210440|FG004|STARTED|Overall Study||7
11031075|NCT00855335|12210436|FG000|COMPLETED|Overall Study||13
11031076|NCT00855335|12210437|FG001|COMPLETED|Overall Study||16
11031077|NCT00855335|12210438|FG002|COMPLETED|Overall Study||10
11031078|NCT00855335|12210439|FG003|COMPLETED|Overall Study||12
11031079|NCT00855335|12210440|FG004|COMPLETED|Overall Study||6
11333596|NCT02838017|12531265|FG001|STARTED|Overall Study||252
11333597|NCT02838017|12531264|FG000|COMPLETED|Overall Study||238
11333598|NCT02838017|12531265|FG001|COMPLETED|Overall Study||241
11031080|NCT00855335|12210436|FG000|NOT COMPLETED|Overall Study||5
11031081|NCT00855335|12210437|FG001|NOT COMPLETED|Overall Study||2
11031082|NCT00855335|12210438|FG002|NOT COMPLETED|Overall Study||5
11031083|NCT00855335|12210439|FG003|NOT COMPLETED|Overall Study||7
11031084|NCT00855335|12210440|FG004|NOT COMPLETED|Overall Study||1
11031085|NCT00855413|12210465|FG000|STARTED|Overall Study||15
11031086|NCT00855413|12210465|FG000|COMPLETED|Overall Study||15
11031087|NCT00855413|12210465|FG000|NOT COMPLETED|Overall Study||0
11031088|NCT00855439|12210471|FG000|STARTED|Overall Study||22
11031089|NCT00855439|12210472|FG001|STARTED|Overall Study||24
11031090|NCT00855439|12210471|FG000|COMPLETED|Overall Study||19
11031091|NCT00855439|12210472|FG001|COMPLETED|Overall Study||24
11031092|NCT00855439|12210471|FG000|NOT COMPLETED|Overall Study||3
11031093|NCT00855439|12210472|FG001|NOT COMPLETED|Overall Study||0
11031094|NCT00855465|12210480|FG000|STARTED|Treatment Period||174
11031095|NCT00855465|12210481|FG001|STARTED|Treatment Period||88
11031096|NCT00855465|12210480|FG000|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
11031097|NCT00855465|12210481|FG001|Participants Received Treatment|Treatment Period||88
11031098|NCT00855465|12210480|FG000|COMPLETED|Treatment Period||160
11031099|NCT00855465|12210481|FG001|COMPLETED|Treatment Period||83
11031100|NCT00855465|12210480|FG000|NOT COMPLETED|Treatment Period||14
11031101|NCT00855465|12210481|FG001|NOT COMPLETED|Treatment Period||5
11031102|NCT00855465|12210480|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
11031103|NCT00855465|12210481|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
11031104|NCT00855465|12210480|FG000|COMPLETED|Follow-up Period (FUP)||9
11333599|NCT02838017|12531264|FG000|NOT COMPLETED|Overall Study||14
11333600|NCT02838017|12531265|FG001|NOT COMPLETED|Overall Study||11
11031105|NCT00855465|12210481|FG001|COMPLETED|Follow-up Period (FUP)||2
11031106|NCT00855465|12210480|FG000|NOT COMPLETED|Follow-up Period (FUP)||8
11031107|NCT00855465|12210481|FG001|NOT COMPLETED|Follow-up Period (FUP)||2
11031108|NCT00855582|12210490|FG000|STARTED|Overall Study||198
11031109|NCT00855582|12210491|FG001|STARTED|Overall Study||208
11031110|NCT00855582|12210492|FG002|STARTED|Overall Study||200
11031111|NCT00855582|12210490|FG000|COMPLETED|Overall Study||172
11031112|NCT00855582|12210491|FG001|COMPLETED|Overall Study||184
11031113|NCT00855582|12210492|FG002|COMPLETED|Overall Study||170
11031114|NCT00855582|12210490|FG000|NOT COMPLETED|Overall Study||26
11031115|NCT00855582|12210491|FG001|NOT COMPLETED|Overall Study||24
11031116|NCT00855582|12210492|FG002|NOT COMPLETED|Overall Study||30
11031117|NCT00855595|12210505|FG000|STARTED|Overall Study||106
11031118|NCT00855595|12210506|FG001|STARTED|Overall Study||101
11031119|NCT00855595|12210505|FG000|COMPLETED|Overall Study||100
11031120|NCT00855595|12210506|FG001|COMPLETED|Overall Study||94
11031121|NCT00855595|12210505|FG000|NOT COMPLETED|Overall Study||6
11031122|NCT00855595|12210506|FG001|NOT COMPLETED|Overall Study||7
11031123|NCT00855738|12210512|FG000|STARTED|Overall Study||111
11031124|NCT00855738|12210512|FG000|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
11031125|NCT00855738|12210512|FG000|COMPLETED|Overall Study||106
11031126|NCT00855738|12210512|FG000|NOT COMPLETED|Overall Study||5
11031127|NCT00855816|12210520|FG000|STARTED|Overall Study||47
11031128|NCT00855816|12210521|FG001|STARTED|Overall Study||33
11031129|NCT00855816|12210520|FG000|COMPLETED|Overall Study||21
11031130|NCT00855816|12210521|FG001|COMPLETED|Overall Study||12
11031131|NCT00855816|12210520|FG000|NOT COMPLETED|Overall Study||26
11031132|NCT00855816|12210521|FG001|NOT COMPLETED|Overall Study||21
11031133|NCT00855842|12210527|FG000|STARTED|Overall Study||4
11031134|NCT00855842|12210527|FG000|COMPLETED|Overall Study||4
11031135|NCT00855842|12210527|FG000|NOT COMPLETED|Overall Study||0
11031136|NCT00855868|12210533|FG000|STARTED|Overall Study||13
11031137|NCT00855868|12210534|FG001|STARTED|Overall Study||15
11031138|NCT00855868|12210533|FG000|COMPLETED|Overall Study||12
11031139|NCT00855868|12210534|FG001|COMPLETED|Overall Study||14
11031140|NCT00855868|12210533|FG000|NOT COMPLETED|Overall Study||1
11031141|NCT00855868|12210534|FG001|NOT COMPLETED|Overall Study||1
11031142|NCT00855894|12210540|FG000|STARTED|Overall Study||41
11031143|NCT00855894|12210540|FG000|COMPLETED|Overall Study||8
11031144|NCT00855894|12210540|FG000|NOT COMPLETED|Overall Study||33
11031145|NCT00855920|12210547|FG000|STARTED|Overall Study||76
11031146|NCT00855920|12210548|FG001|STARTED|Overall Study||74
11031147|NCT00855920|12210549|FG002|STARTED|Overall Study||75
11031148|NCT00855920|12210547|FG000|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
11031149|NCT00855920|12210548|FG001|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
11031150|NCT00855920|12210549|FG002|Safety Population|Overall Study||75
11031151|NCT00855920|12210547|FG000|COMPLETED|Overall Study||68
11031152|NCT00855920|12210548|FG001|COMPLETED|Overall Study||65
11031153|NCT00855920|12210549|FG002|COMPLETED|Overall Study||64
11031154|NCT00855920|12210547|FG000|NOT COMPLETED|Overall Study||8
11031155|NCT00855920|12210548|FG001|NOT COMPLETED|Overall Study||9
11031156|NCT00855920|12210549|FG002|NOT COMPLETED|Overall Study||11
11031157|NCT00855933|12210559|FG000|STARTED|Overall Study||30
11031158|NCT00855933|12210560|FG001|STARTED|Overall Study||30
11031159|NCT00855933|12210559|FG000|COMPLETED|Overall Study||30
11031160|NCT00855933|12210560|FG001|COMPLETED|Overall Study||29
11031161|NCT00855933|12210559|FG000|NOT COMPLETED|Overall Study||0
11031162|NCT00855933|12210560|FG001|NOT COMPLETED|Overall Study||1
11031163|NCT00855959|12210566|FG000|STARTED|Overall Study||108
11031164|NCT00855959|12210566|FG000|Patients Who Received Pulmicort Respules|Overall Study||105
11031165|NCT00855959|12210566|FG000|COMPLETED|Overall Study||99
11031166|NCT00855959|12210566|FG000|NOT COMPLETED|Overall Study||9
11031167|NCT00856024|12210570|FG000|STARTED|Overall Study||902
11031168|NCT00856024|12210570|FG000|COMPLETED|Overall Study||902
11031169|NCT00856024|12210570|FG000|NOT COMPLETED|Overall Study||0
11031170|NCT00856050|12210576|FG000|STARTED|Overall Study||26
11031171|NCT00856050|12210576|FG000|COMPLETED|Overall Study||26
11031172|NCT00856050|12210576|FG000|NOT COMPLETED|Overall Study||0
11031173|NCT00856180|12210580|FG000|STARTED|Overall Study||20
11031174|NCT00856180|12210580|FG000|COMPLETED|Overall Study||0
11031175|NCT00856180|12210580|FG000|NOT COMPLETED|Overall Study||20
11031176|NCT00856193|12210586|FG000|STARTED|Period 1||16
11031177|NCT00856193|12210587|FG001|STARTED|Period 1||17
11031178|NCT00856193|12210586|FG000|COMPLETED|Period 1||16
11031179|NCT00856193|12210587|FG001|COMPLETED|Period 1||17
11031180|NCT00856193|12210586|FG000|NOT COMPLETED|Period 1||0
11031181|NCT00856193|12210587|FG001|NOT COMPLETED|Period 1||0
11031182|NCT00856193|12210586|FG000|STARTED|Period 2||16
11031183|NCT00856193|12210587|FG001|STARTED|Period 2||17
11031184|NCT00856193|12210586|FG000|COMPLETED|Period 2||16
11031185|NCT00856193|12210587|FG001|COMPLETED|Period 2||15
11031186|NCT00856193|12210586|FG000|NOT COMPLETED|Period 2||0
11031187|NCT00856193|12210587|FG001|NOT COMPLETED|Period 2||2
11031188|NCT00856206|12210595|FG000|STARTED|Overall Study||330
11031189|NCT00856206|12210596|FG001|STARTED|Overall Study||985
11031190|NCT00856206|12210595|FG000|COMPLETED|Overall Study||276
11031191|NCT00856206|12210596|FG001|COMPLETED|Overall Study||824
11031192|NCT00856206|12210595|FG000|NOT COMPLETED|Overall Study||54
11031193|NCT00856206|12210596|FG001|NOT COMPLETED|Overall Study||161
11031194|NCT00856232|12210605|FG000|STARTED|Overall Study||26
11031195|NCT00856232|12210606|FG001|STARTED|Overall Study||29
11031196|NCT00856232|12210607|FG002|STARTED|Overall Study||36
11031197|NCT00856232|12210605|FG000|COMPLETED|Overall Study||26
11031198|NCT00856232|12210606|FG001|COMPLETED|Overall Study||29
11031199|NCT00856232|12210607|FG002|COMPLETED|Overall Study||36
11031200|NCT00856232|12210605|FG000|NOT COMPLETED|Overall Study||0
11031201|NCT00856232|12210606|FG001|NOT COMPLETED|Overall Study||0
11031202|NCT00856232|12210607|FG002|NOT COMPLETED|Overall Study||0
11031203|NCT00856245|12210617|FG000|STARTED|Overall Study||19
11031204|NCT00856245|12210617|FG000|COMPLETED|Overall Study||14
11031205|NCT00856245|12210617|FG000|NOT COMPLETED|Overall Study||5
11031206|NCT00856284|12210624|FG000|STARTED|Overall Study||880
11031207|NCT00856284|12210625|FG001|STARTED|Overall Study||885
11031208|NCT00856284|12210626|FG002|STARTED|Overall Study||874
11031209|NCT00856284|12210624|FG000|Received Study Drug|Overall Study||873
11031210|NCT00856284|12210625|FG001|Received Study Drug|Overall Study||878
11031211|NCT00856284|12210626|FG002|Received Study Drug|Overall Study||869
11031212|NCT00856284|12210624|FG000|COMPLETED|Overall Study||472
11031213|NCT00856284|12210625|FG001|COMPLETED|Overall Study||493
11031214|NCT00856284|12210626|FG002|COMPLETED|Overall Study||427
11031215|NCT00856284|12210624|FG000|NOT COMPLETED|Overall Study||408
11031216|NCT00856284|12210625|FG001|NOT COMPLETED|Overall Study||392
11031217|NCT00856284|12210626|FG002|NOT COMPLETED|Overall Study||447
11031218|NCT00856297|12210639|FG000|STARTED|Overall Study||131
11031219|NCT00856297|12210640|FG001|STARTED|Overall Study||76
11031220|NCT00856297|12210641|FG002|STARTED|Overall Study||107
11031221|NCT00856297|12210642|FG003|STARTED|Overall Study||44
11031222|NCT00856297|12210643|FG004|STARTED|Overall Study||31
11031223|NCT00856297|12210639|FG000|COMPLETED|Overall Study||129
11031224|NCT00856297|12210640|FG001|COMPLETED|Overall Study||76
11031225|NCT00856297|12210641|FG002|COMPLETED|Overall Study||107
11031226|NCT00856297|12210642|FG003|COMPLETED|Overall Study||44
11031227|NCT00856297|12210643|FG004|COMPLETED|Overall Study||31
11031228|NCT00856297|12210639|FG000|NOT COMPLETED|Overall Study||2
11031229|NCT00856297|12210640|FG001|NOT COMPLETED|Overall Study||0
11031230|NCT00856297|12210641|FG002|NOT COMPLETED|Overall Study||0
11031231|NCT00856297|12210642|FG003|NOT COMPLETED|Overall Study||0
11031232|NCT00856297|12210643|FG004|NOT COMPLETED|Overall Study||0
11031233|NCT00856323|12210660|FG000|STARTED|Overall Study||53
11031234|NCT00856323|12210660|FG000|COMPLETED|Overall Study||51
11031235|NCT00856323|12210660|FG000|NOT COMPLETED|Overall Study||2
11031236|NCT00856349|12210664|FG000|STARTED|Overall Study||4132
11031237|NCT00856349|12210664|FG000|12 Month Follow-up|Overall Study||3228
11031238|NCT00856349|12210664|FG000|18 Month Follow-up|Overall Study||2467
11031239|NCT00856349|12210664|FG000|24 Month Follow-up|Overall Study||1698
11031240|NCT00856349|12210664|FG000|COMPLETED|Overall Study||3111
11031241|NCT00856349|12210664|FG000|NOT COMPLETED|Overall Study||1021
11031242|NCT00856375|12210672|FG000|STARTED|Overall Study||42
11031243|NCT00856375|12210673|FG001|STARTED|Overall Study||41
11031244|NCT00856375|12210672|FG000|COMPLETED|Overall Study||0
11031245|NCT00856375|12210673|FG001|COMPLETED|Overall Study||0
11031246|NCT00856375|12210672|FG000|NOT COMPLETED|Overall Study||42
11031247|NCT00856375|12210673|FG001|NOT COMPLETED|Overall Study||41
11031248|NCT00856388|12210679|FG000|STARTED|Overall Study||62
11031249|NCT00856388|12210679|FG000|COMPLETED|Overall Study||61
11031250|NCT00856388|12210679|FG000|NOT COMPLETED|Overall Study||1
11031251|NCT00856414|12210684|FG000|STARTED|Overall Study||45
11031252|NCT00856414|12210684|FG000|COMPLETED|Overall Study||45
11031253|NCT00856414|12210684|FG000|NOT COMPLETED|Overall Study||0
11031254|NCT00856492|12210691|FG000|STARTED|Overall Study||99
11031255|NCT00856492|12210692|FG001|STARTED|Overall Study||63
11031256|NCT00856492|12210693|FG002|STARTED|Overall Study||53
11031257|NCT00856492|12210691|FG000|Toxicity Eval|Overall Study||96
11031258|NCT00856492|12210692|FG001|Toxicity Eval|Overall Study||60
11031259|NCT00856492|12210693|FG002|Toxicity Eval|Overall Study||51
11031260|NCT00856492|12210691|FG000|COMPLETED|Overall Study||98
11031261|NCT00856492|12210692|FG001|COMPLETED|Overall Study||62
11031262|NCT00856492|12210693|FG002|COMPLETED|Overall Study||51
11031263|NCT00856492|12210691|FG000|NOT COMPLETED|Overall Study||1
11031264|NCT00856492|12210692|FG001|NOT COMPLETED|Overall Study||1
11031265|NCT00856492|12210693|FG002|NOT COMPLETED|Overall Study||2
11031266|NCT00856518|12210706|FG000|STARTED|Overall Study||24
11031267|NCT00856518|12210707|FG001|STARTED|Overall Study||18
11031268|NCT00856518|12210706|FG000|COMPLETED|Overall Study||20
11031269|NCT00856518|12210707|FG001|COMPLETED|Overall Study||16
11031270|NCT00856518|12210706|FG000|NOT COMPLETED|Overall Study||4
11031271|NCT00856518|12210707|FG001|NOT COMPLETED|Overall Study||2
11031272|NCT00856544|12210719|FG000|STARTED|Overall Study||318
11031273|NCT00856544|12210720|FG001|STARTED|Overall Study||318
11031274|NCT00856544|12210721|FG002|STARTED|Overall Study||79
11031275|NCT00856544|12210722|FG003|STARTED|Overall Study||80
11031276|NCT00856544|12210719|FG000|Treated|Overall Study||315
11031277|NCT00856544|12210720|FG001|Treated|Overall Study||318
11031278|NCT00856544|12210721|FG002|Treated|Overall Study||79
11031279|NCT00856544|12210722|FG003|Treated|Overall Study||80
11031280|NCT00856544|12210719|FG000|COMPLETED|Overall Study||261
11031281|NCT00856544|12210720|FG001|COMPLETED|Overall Study||252
11031282|NCT00856544|12210721|FG002|COMPLETED|Overall Study||71
11031283|NCT00856544|12210722|FG003|COMPLETED|Overall Study||67
11031284|NCT00856544|12210719|FG000|NOT COMPLETED|Overall Study||57
11031285|NCT00856544|12210720|FG001|NOT COMPLETED|Overall Study||66
11031286|NCT00856544|12210721|FG002|NOT COMPLETED|Overall Study||8
11031287|NCT00856544|12210722|FG003|NOT COMPLETED|Overall Study||13
11031288|NCT00856557|12210746|FG000|STARTED|Overall Study||62
11031289|NCT00856557|12210747|FG001|STARTED|Overall Study||76
11031290|NCT00856557|12210746|FG000|Received Intervention/Control|Overall Study||62
11031291|NCT00856557|12210747|FG001|Received Intervention/Control|Overall Study||76
11333601|NCT02838134|12531273|FG000|STARTED|Overall Study||50
11333602|NCT02838134|12531274|FG001|STARTED|Overall Study||51
11333603|NCT02838134|12531273|FG000|COMPLETED|Overall Study||48
11333604|NCT02838134|12531274|FG001|COMPLETED|Overall Study||48
11333605|NCT02838134|12531273|FG000|NOT COMPLETED|Overall Study||2
11333606|NCT02838134|12531274|FG001|NOT COMPLETED|Overall Study||3
11333607|NCT02838407|12531280|FG000|STARTED|Overall Study||197
11333608|NCT02838407|12531280|FG000|COMPLETED|Overall Study||197
11333609|NCT02838407|12531280|FG000|NOT COMPLETED|Overall Study||0
11333610|NCT02838420|12531286|FG000|STARTED|Overall Study||125
11333611|NCT02838420|12531287|FG001|STARTED|Overall Study||62
11333612|NCT02838420|12531286|FG000|COMPLETED|Overall Study||0
11333613|NCT02838420|12531287|FG001|COMPLETED|Overall Study||0
11333614|NCT02838420|12531286|FG000|NOT COMPLETED|Overall Study||125
11333615|NCT02838420|12531287|FG001|NOT COMPLETED|Overall Study||62
11333616|NCT02838628|12531295|FG000|STARTED|Treatment and Follow-up Period||84
11031292|NCT00856557|12210746|FG000|Tested With Standardized Patients|Overall Study||62
11031293|NCT00856557|12210747|FG001|Tested With Standardized Patients|Overall Study||76
11031294|NCT00856557|12210746|FG000|With Patients With Contextual Flags|Overall Study||50
11031295|NCT00856557|12210747|FG001|With Patients With Contextual Flags|Overall Study||60
11031296|NCT00856557|12210746|FG000|COMPLETED|Overall Study||50
11031297|NCT00856557|12210747|FG001|COMPLETED|Overall Study||60
11031298|NCT00856557|12210746|FG000|NOT COMPLETED|Overall Study||12
11031299|NCT00856557|12210747|FG001|NOT COMPLETED|Overall Study||16
11031300|NCT00856583|12210755|FG000|STARTED|Overall Study|Patients treated|4905
11031301|NCT00856583|12210756|FG001|STARTED|Overall Study|Patients treated|4904
11333617|NCT02838628|12531296|FG001|STARTED|Treatment and Follow-up Period||84
11333618|NCT02838628|12531295|FG000|COMPLETED|Treatment and Follow-up Period||84
11333619|NCT02838628|12531296|FG001|COMPLETED|Treatment and Follow-up Period||84
11333620|NCT02838628|12531295|FG000|NOT COMPLETED|Treatment and Follow-up Period||0
11333621|NCT02838628|12531296|FG001|NOT COMPLETED|Treatment and Follow-up Period||0
11333622|NCT02838628|12531295|FG000|STARTED|Recurrence Follow-up Period||36
11333623|NCT02838628|12531296|FG001|STARTED|Recurrence Follow-up Period||27
11333624|NCT02838628|12531295|FG000|COMPLETED|Recurrence Follow-up Period||16
11333625|NCT02838628|12531296|FG001|COMPLETED|Recurrence Follow-up Period||10
11333626|NCT02838628|12531295|FG000|NOT COMPLETED|Recurrence Follow-up Period||20
11333627|NCT02838628|12531296|FG001|NOT COMPLETED|Recurrence Follow-up Period||17
11333628|NCT02838901|12531305|FG000|STARTED|Overall Study||9
11333629|NCT02838901|12531306|FG001|STARTED|Overall Study||9
11333630|NCT02838901|12531305|FG000|COMPLETED|Overall Study||7
11333631|NCT02838901|12531306|FG001|COMPLETED|Overall Study||7
11333632|NCT02838901|12531305|FG000|NOT COMPLETED|Overall Study||2
11333633|NCT02838901|12531306|FG001|NOT COMPLETED|Overall Study||2
11333634|NCT02839200|12531320|FG000|STARTED|Overall Study||60
11333635|NCT02839200|12531321|FG001|STARTED|Overall Study||59
11031302|NCT00856583|12210755|FG000|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
11031303|NCT00856583|12210756|FG001|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
11031304|NCT00856583|12210755|FG000|NOT COMPLETED|Overall Study||3137
11031305|NCT00856583|12210756|FG001|NOT COMPLETED|Overall Study||2597
11031306|NCT00856609|12210764|FG000|STARTED|Overall Study||41
11031307|NCT00856609|12210765|FG001|STARTED|Overall Study||39
11031308|NCT00856609|12210764|FG000|COMPLETED|Overall Study||40
11031309|NCT00856609|12210765|FG001|COMPLETED|Overall Study||39
11031310|NCT00856609|12210764|FG000|NOT COMPLETED|Overall Study||1
11031311|NCT00856609|12210765|FG001|NOT COMPLETED|Overall Study||0
11031312|NCT00856635|12210773|FG000|STARTED|Overall Study||22
11031313|NCT00856635|12210774|FG001|STARTED|Overall Study||22
11031314|NCT00856635|12210773|FG000|Received Study Drug|Overall Study||20
11031315|NCT00856635|12210774|FG001|Received Study Drug|Overall Study||20
11031316|NCT00856635|12210773|FG000|COMPLETED|Overall Study||12
11031317|NCT00856635|12210774|FG001|COMPLETED|Overall Study||14
11031318|NCT00856635|12210773|FG000|NOT COMPLETED|Overall Study||10
11031319|NCT00856635|12210774|FG001|NOT COMPLETED|Overall Study||8
11031320|NCT00856661|12210784|FG000|STARTED|Overall Study|Randomised|135
11031321|NCT00856661|12210785|FG001|STARTED|Overall Study|Randomised|135
11031322|NCT00856661|12210784|FG000|Treated|Overall Study||126
11031323|NCT00856661|12210785|FG001|Treated|Overall Study||131
11031324|NCT00856661|12210784|FG000|Randomized Not Treated|Overall Study||9
11333636|NCT02839200|12531322|FG002|STARTED|Overall Study||60
11333637|NCT02839200|12531323|FG003|STARTED|Overall Study||61
11333638|NCT02839200|12531324|FG004|STARTED|Overall Study||60
11031325|NCT00856661|12210785|FG001|Randomized Not Treated|Overall Study||4
11031326|NCT00856661|12210784|FG000|COMPLETED|Overall Study||108
11031327|NCT00856661|12210785|FG001|COMPLETED|Overall Study||106
11031328|NCT00856661|12210784|FG000|NOT COMPLETED|Overall Study||27
11031329|NCT00856661|12210785|FG001|NOT COMPLETED|Overall Study||29
11031330|NCT00856726|12210791|FG000|STARTED|Overall Study||26
11031331|NCT00856726|12210791|FG000|COMPLETED|Overall Study||26
11031332|NCT00856726|12210791|FG000|NOT COMPLETED|Overall Study||0
11031333|NCT00856739|12210798|FG000|STARTED|Overall Study||70
11031334|NCT00856739|12210799|FG001|STARTED|Overall Study||52
11031335|NCT00856739|12210800|FG002|STARTED|Overall Study||55
11031336|NCT00856739|12210798|FG000|COMPLETED|Overall Study||70
11031337|NCT00856739|12210799|FG001|COMPLETED|Overall Study||52
11031338|NCT00856739|12210800|FG002|COMPLETED|Overall Study||55
11031339|NCT00856739|12210798|FG000|NOT COMPLETED|Overall Study||0
11031340|NCT00856739|12210799|FG001|NOT COMPLETED|Overall Study||0
11031341|NCT00856739|12210800|FG002|NOT COMPLETED|Overall Study||0
11031342|NCT00856778|12210811|FG000|STARTED|Overall Study||98
11031343|NCT00856778|12210811|FG000|COMPLETED|Overall Study||74
11031344|NCT00856778|12210811|FG000|NOT COMPLETED|Overall Study||24
11031345|NCT00856791|12210815|FG000|STARTED|Overall Study||1
11031346|NCT00856791|12210815|FG000|COMPLETED|Overall Study||1
11031347|NCT00856791|12210815|FG000|NOT COMPLETED|Overall Study||0
11031348|NCT00856830|12210823|FG000|STARTED|Irinotecan & Bendamustine||3
11031349|NCT00856830|12210824|FG001|STARTED|Irinotecan & Bendamustine||6
11031350|NCT00856830|12210825|FG002|STARTED|Irinotecan & Bendamustine||6
11031351|NCT00856830|12210826|FG003|STARTED|Irinotecan & Bendamustine||15
11031352|NCT00856830|12210823|FG000|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
11031353|NCT00856830|12210824|FG001|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
11031354|NCT00856830|12210825|FG002|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
11333639|NCT02839200|12531325|FG005|STARTED|Overall Study||60
11031355|NCT00856830|12210826|FG003|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
11031356|NCT00856830|12210823|FG000|COMPLETED|Irinotecan & Bendamustine||3
11031357|NCT00856830|12210824|FG001|COMPLETED|Irinotecan & Bendamustine||6
11031358|NCT00856830|12210825|FG002|COMPLETED|Irinotecan & Bendamustine||6
11031359|NCT00856830|12210826|FG003|COMPLETED|Irinotecan & Bendamustine||12
11031360|NCT00856830|12210823|FG000|NOT COMPLETED|Irinotecan & Bendamustine||0
11031361|NCT00856830|12210824|FG001|NOT COMPLETED|Irinotecan & Bendamustine||0
11031362|NCT00856830|12210825|FG002|NOT COMPLETED|Irinotecan & Bendamustine||0
11031363|NCT00856830|12210826|FG003|NOT COMPLETED|Irinotecan & Bendamustine||3
11031364|NCT00856830|12210823|FG000|STARTED|Regimen - B (Carboplatin & Etoposide)||3
11031365|NCT00856830|12210824|FG001|STARTED|Regimen - B (Carboplatin & Etoposide)||6
11031366|NCT00856830|12210825|FG002|STARTED|Regimen - B (Carboplatin & Etoposide)||6
11031367|NCT00856830|12210826|FG003|STARTED|Regimen - B (Carboplatin & Etoposide)||12
11031368|NCT00856830|12210823|FG000|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
11031369|NCT00856830|12210824|FG001|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
11200745|NCT01828593|12390959|FG000|COMPLETED|Placebo-Controlled Phase||36
11031370|NCT00856830|12210825|FG002|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
11031371|NCT00856830|12210826|FG003|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
11031372|NCT00856830|12210823|FG000|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
11031373|NCT00856830|12210824|FG001|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
11031374|NCT00856830|12210825|FG002|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
11031375|NCT00856830|12210826|FG003|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
11031376|NCT00856843|12210833|FG000|STARTED|Overall Study||68
11031377|NCT00856843|12210834|FG001|STARTED|Overall Study||68
11031378|NCT00856843|12210833|FG000|COMPLETED|Overall Study||66
11031379|NCT00856843|12210834|FG001|COMPLETED|Overall Study||63
11031380|NCT00856843|12210833|FG000|NOT COMPLETED|Overall Study||2
11031381|NCT00856843|12210834|FG001|NOT COMPLETED|Overall Study||5
11031382|NCT00856856|12210840|FG000|STARTED|Baseline||101
11031383|NCT00856856|12210840|FG000|COMPLETED|Baseline||101
11031384|NCT00856856|12210840|FG000|NOT COMPLETED|Baseline||0
11031385|NCT00856856|12210840|FG000|STARTED|30-day Clinical Follow-up||101
11031386|NCT00856856|12210840|FG000|COMPLETED|30-day Clinical Follow-up||101
11031387|NCT00856856|12210840|FG000|NOT COMPLETED|30-day Clinical Follow-up||0
11031388|NCT00856856|12210840|FG000|STARTED|180-day Clinical Follow-up||101
11031389|NCT00856856|12210840|FG000|COMPLETED|180-day Clinical Follow-up||101
11031390|NCT00856856|12210840|FG000|NOT COMPLETED|180-day Clinical Follow-up||0
11031391|NCT00856856|12210840|FG000|STARTED|270-day Clinical Follow-up||101
11031392|NCT00856856|12210840|FG000|COMPLETED|270-day Clinical Follow-up||101
11031393|NCT00856856|12210840|FG000|NOT COMPLETED|270-day Clinical Follow-up||0
11031394|NCT00856856|12210840|FG000|STARTED|1-year Clinical Follow-up||101
11031395|NCT00856856|12210840|FG000|COMPLETED|1-year Clinical Follow-up||101
11031396|NCT00856856|12210840|FG000|NOT COMPLETED|1-year Clinical Follow-up||0
11031397|NCT00856856|12210840|FG000|STARTED|2-year Clinical Follow-up||101
11031398|NCT00856856|12210840|FG000|COMPLETED|2-year Clinical Follow-up||100
11031399|NCT00856856|12210840|FG000|NOT COMPLETED|2-year Clinical Follow-up||1
11031400|NCT00856856|12210840|FG000|STARTED|3-year Clinical Follow-up||100
11031401|NCT00856856|12210840|FG000|COMPLETED|3-year Clinical Follow-up||100
11031402|NCT00856856|12210840|FG000|NOT COMPLETED|3-year Clinical Follow-up||0
11031403|NCT00856856|12210840|FG000|STARTED|4-year Clinical Follow-up||100
11333640|NCT02839200|12531320|FG000|COMPLETED|Overall Study||56
11333641|NCT02839200|12531321|FG001|COMPLETED|Overall Study||58
11031404|NCT00856856|12210840|FG000|COMPLETED|4-year Clinical Follow-up||99
11031405|NCT00856856|12210840|FG000|NOT COMPLETED|4-year Clinical Follow-up||1
11031406|NCT00856856|12210840|FG000|STARTED|5-year Clinical Follow-up||100
11057441|NCT00997893|12238959|FG002|STARTED|Overall Study||13
11200746|NCT01828593|12390960|FG001|COMPLETED|Placebo-Controlled Phase||34
11200747|NCT01828593|12390961|FG002|COMPLETED|Placebo-Controlled Phase||32
11200748|NCT01828593|12390959|FG000|NOT COMPLETED|Placebo-Controlled Phase||0
11200749|NCT01828593|12390960|FG001|NOT COMPLETED|Placebo-Controlled Phase||0
11200750|NCT01828593|12390961|FG002|NOT COMPLETED|Placebo-Controlled Phase||1
11200751|NCT01828593|12390959|FG000|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
11200752|NCT01828593|12390960|FG001|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
11200753|NCT01828593|12390961|FG002|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
11200754|NCT01828593|12390959|FG000|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
11200755|NCT01828593|12390960|FG001|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
11200756|NCT01828593|12390961|FG002|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
11200757|NCT01828593|12390959|FG000|NOT COMPLETED|Placebo-Free Phase||0
11200758|NCT01828593|12390960|FG001|NOT COMPLETED|Placebo-Free Phase||6
11200759|NCT01828593|12390961|FG002|NOT COMPLETED|Placebo-Free Phase||6
11200760|NCT01828983|12390974|FG000|STARTED|Overall Study||80
11333642|NCT02839200|12531322|FG002|COMPLETED|Overall Study||59
11333643|NCT02839200|12531323|FG003|COMPLETED|Overall Study||61
11333644|NCT02839200|12531324|FG004|COMPLETED|Overall Study||58
11333645|NCT02839200|12531325|FG005|COMPLETED|Overall Study||59
11333646|NCT02839200|12531320|FG000|NOT COMPLETED|Overall Study||4
11333647|NCT02839200|12531321|FG001|NOT COMPLETED|Overall Study||1
11333648|NCT02839200|12531322|FG002|NOT COMPLETED|Overall Study||1
11333649|NCT02839200|12531323|FG003|NOT COMPLETED|Overall Study||0
11333650|NCT02839200|12531324|FG004|NOT COMPLETED|Overall Study||2
11333651|NCT02839200|12531325|FG005|NOT COMPLETED|Overall Study||1
11333652|NCT02839330|12531343|FG000|STARTED|Overall Study||804
11333653|NCT02839330|12531344|FG001|STARTED|Overall Study||799
11333654|NCT02839330|12531345|FG002|STARTED|Overall Study||795
11333655|NCT02839330|12531346|FG003|STARTED|Overall Study||798
11333656|NCT02839330|12531343|FG000|Exposed|Overall Study||804
11333657|NCT02839330|12531344|FG001|Exposed|Overall Study||797
11333658|NCT02839330|12531345|FG002|Exposed|Overall Study||793
11333659|NCT02839330|12531346|FG003|Exposed|Overall Study||797
11333660|NCT02839330|12531343|FG000|COMPLETED|Overall Study||746
11333661|NCT02839330|12531344|FG001|COMPLETED|Overall Study||741
11333662|NCT02839330|12531345|FG002|COMPLETED|Overall Study||747
11333663|NCT02839330|12531346|FG003|COMPLETED|Overall Study||747
11333664|NCT02839330|12531343|FG000|NOT COMPLETED|Overall Study||58
11333665|NCT02839330|12531344|FG001|NOT COMPLETED|Overall Study||58
11333666|NCT02839330|12531345|FG002|NOT COMPLETED|Overall Study||48
11333667|NCT02839330|12531346|FG003|NOT COMPLETED|Overall Study||51
11333668|NCT02839681|12531357|FG000|STARTED|Overall Study||2
11333669|NCT02839681|12531357|FG000|COMPLETED|Overall Study||0
11333670|NCT02839681|12531357|FG000|NOT COMPLETED|Overall Study||2
11333671|NCT02839746|12531361|FG000|STARTED|Overall Study||671
11333672|NCT02839746|12531361|FG000|COMPLETED|Overall Study||659
11333673|NCT02839746|12531361|FG000|NOT COMPLETED|Overall Study||12
11333674|NCT02839772|12531367|FG000|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
11333675|NCT02839772|12531368|FG001|STARTED|Overall Study||96
11333676|NCT02839772|12531367|FG000|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
11333677|NCT02839772|12531368|FG001|COMPLETED|Overall Study||96
11333678|NCT02839772|12531367|FG000|NOT COMPLETED|Overall Study||1
11333679|NCT02839772|12531368|FG001|NOT COMPLETED|Overall Study||0
11333680|NCT02839798|12531388|FG000|STARTED|Overall Study||6
11333681|NCT02839798|12531388|FG000|COMPLETED|Overall Study||4
11333682|NCT02839798|12531388|FG000|NOT COMPLETED|Overall Study||2
11333683|NCT02839876|12531394|FG000|STARTED|Overall Study||41
11333684|NCT02839876|12531395|FG001|STARTED|Overall Study||40
11333685|NCT02839876|12531394|FG000|COMPLETED|Overall Study||31
11333686|NCT02839876|12531395|FG001|COMPLETED|Overall Study||29
11333687|NCT02839876|12531394|FG000|NOT COMPLETED|Overall Study||10
11333688|NCT02839876|12531395|FG001|NOT COMPLETED|Overall Study||11
11333689|NCT02839889|12531403|FG000|STARTED|Randomization Period||2
11333690|NCT02839889|12531404|FG001|STARTED|Randomization Period||3
11333691|NCT02839889|12531403|FG000|COMPLETED|Randomization Period||2
11333692|NCT02839889|12531404|FG001|COMPLETED|Randomization Period||3
11333693|NCT02839889|12531403|FG000|NOT COMPLETED|Randomization Period||0
11333694|NCT02839889|12531404|FG001|NOT COMPLETED|Randomization Period||0
11333695|NCT02839889|12531403|FG000|STARTED|Open-Label Period||0
11031407|NCT00856856|12210840|FG000|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100
11031408|NCT00856856|12210840|FG000|NOT COMPLETED|5-year Clinical Follow-up||0
11333696|NCT02839889|12531404|FG001|STARTED|Open-Label Period||5
11031409|NCT00856908|12210851|FG000|STARTED|Overall Study||15
11031410|NCT00856908|12210852|FG001|STARTED|Overall Study||5
11031411|NCT00856908|12210851|FG000|COMPLETED|Overall Study||14
11031412|NCT00856908|12210852|FG001|COMPLETED|Overall Study||5
11031413|NCT00856908|12210851|FG000|NOT COMPLETED|Overall Study||1
11031414|NCT00856908|12210852|FG001|NOT COMPLETED|Overall Study||0
11031415|NCT00856973|12210861|FG000|STARTED|Overall Study||162
11031416|NCT00856973|12210862|FG001|STARTED|Overall Study||163
11031417|NCT00856973|12210863|FG002|STARTED|Overall Study||161
11031418|NCT00856973|12210861|FG000|COMPLETED|Overall Study||126
11031419|NCT00856973|12210862|FG001|COMPLETED|Overall Study||122
11031420|NCT00856973|12210863|FG002|COMPLETED|Overall Study||123
11031421|NCT00856973|12210861|FG000|NOT COMPLETED|Overall Study||36
11031422|NCT00856973|12210862|FG001|NOT COMPLETED|Overall Study||41
11031423|NCT00856973|12210863|FG002|NOT COMPLETED|Overall Study||38
11031424|NCT00856986|12210880|FG000|STARTED|Run-in Period, Weeks -12-0||161
11031425|NCT00856986|12210881|FG001|STARTED|Run-in Period, Weeks -12-0||162
11333697|NCT02839889|12531403|FG000|COMPLETED|Open-Label Period||0
11031426|NCT00856986|12210882|FG002|STARTED|Run-in Period, Weeks -12-0||498
11031427|NCT00856986|12210883|FG003|STARTED|Run-in Period, Weeks -12-0||167
11031428|NCT00856986|12210884|FG004|STARTED|Run-in Period, Weeks -12-0||0
11031429|NCT00856986|12210880|FG000|COMPLETED|Run-in Period, Weeks -12-0||161
11031430|NCT00856986|12210881|FG001|COMPLETED|Run-in Period, Weeks -12-0||162
11031431|NCT00856986|12210882|FG002|COMPLETED|Run-in Period, Weeks -12-0||498
11031432|NCT00856986|12210883|FG003|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
11031433|NCT00856986|12210884|FG004|COMPLETED|Run-in Period, Weeks -12-0||0
11031434|NCT00856986|12210880|FG000|NOT COMPLETED|Run-in Period, Weeks -12-0||0
11031435|NCT00856986|12210881|FG001|NOT COMPLETED|Run-in Period, Weeks -12-0||0
11031436|NCT00856986|12210882|FG002|NOT COMPLETED|Run-in Period, Weeks -12-0||0
11031437|NCT00856986|12210883|FG003|NOT COMPLETED|Run-in Period, Weeks -12-0||167
11031438|NCT00856986|12210884|FG004|NOT COMPLETED|Run-in Period, Weeks -12-0||0
11031439|NCT00856986|12210880|FG000|STARTED|Main Period, Weeks 0-26||161
11031440|NCT00856986|12210881|FG001|STARTED|Main Period, Weeks 0-26||162
11031441|NCT00856986|12210882|FG002|STARTED|Main Period, Weeks 0-26||498
11031442|NCT00856986|12210883|FG003|STARTED|Main Period, Weeks 0-26||0
11031443|NCT00856986|12210884|FG004|STARTED|Main Period, Weeks 0-26||0
11031444|NCT00856986|12210880|FG000|COMPLETED|Main Period, Weeks 0-26||127
11031445|NCT00856986|12210881|FG001|COMPLETED|Main Period, Weeks 0-26||144
11031446|NCT00856986|12210882|FG002|COMPLETED|Main Period, Weeks 0-26||470
11031447|NCT00856986|12210883|FG003|COMPLETED|Main Period, Weeks 0-26||0
11031448|NCT00856986|12210884|FG004|COMPLETED|Main Period, Weeks 0-26||0
11031449|NCT00856986|12210880|FG000|NOT COMPLETED|Main Period, Weeks 0-26||34
11031450|NCT00856986|12210881|FG001|NOT COMPLETED|Main Period, Weeks 0-26||18
11031451|NCT00856986|12210882|FG002|NOT COMPLETED|Main Period, Weeks 0-26||28
11031452|NCT00856986|12210883|FG003|NOT COMPLETED|Main Period, Weeks 0-26||0
11031453|NCT00856986|12210884|FG004|NOT COMPLETED|Main Period, Weeks 0-26||0
11031454|NCT00856986|12210880|FG000|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
11031455|NCT00856986|12210881|FG001|STARTED|Extension Period, Weeks 26-52||144
11031456|NCT00856986|12210882|FG002|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
11031457|NCT00856986|12210883|FG003|STARTED|Extension Period, Weeks 26-52||0
11031458|NCT00856986|12210884|FG004|STARTED|Extension Period, Weeks 26-52||0
11031459|NCT00856986|12210880|FG000|Enrolled in Extension|Extension Period, Weeks 26-52||122
11031460|NCT00856986|12210881|FG001|Enrolled in Extension|Extension Period, Weeks 26-52||140
11031461|NCT00856986|12210882|FG002|Enrolled in Extension|Extension Period, Weeks 26-52||461
11031462|NCT00856986|12210883|FG003|Enrolled in Extension|Extension Period, Weeks 26-52||0
11031463|NCT00856986|12210884|FG004|Enrolled in Extension|Extension Period, Weeks 26-52||0
11031464|NCT00856986|12210880|FG000|COMPLETED|Extension Period, Weeks 26-52||108
11031465|NCT00856986|12210881|FG001|COMPLETED|Extension Period, Weeks 26-52||130
11031466|NCT00856986|12210882|FG002|COMPLETED|Extension Period, Weeks 26-52||432
11031467|NCT00856986|12210883|FG003|COMPLETED|Extension Period, Weeks 26-52||0
11031468|NCT00856986|12210884|FG004|COMPLETED|Extension Period, Weeks 26-52||0
11031469|NCT00856986|12210880|FG000|NOT COMPLETED|Extension Period, Weeks 26-52||19
11031470|NCT00856986|12210881|FG001|NOT COMPLETED|Extension Period, Weeks 26-52||14
11031471|NCT00856986|12210882|FG002|NOT COMPLETED|Extension Period, Weeks 26-52||38
11031472|NCT00856986|12210883|FG003|NOT COMPLETED|Extension Period, Weeks 26-52||0
11031473|NCT00856986|12210884|FG004|NOT COMPLETED|Extension Period, Weeks 26-52||0
11031474|NCT00856999|12210896|FG000|STARTED|Overall Study||50
11031475|NCT00856999|12210896|FG000|COMPLETED|Overall Study||45
11031476|NCT00856999|12210896|FG000|NOT COMPLETED|Overall Study||5
11031477|NCT00857207|12210903|FG000|STARTED|Overall Study||48
11031478|NCT00857207|12210904|FG001|STARTED|Overall Study||3
11031479|NCT00857207|12210903|FG000|COMPLETED|Overall Study||14
11031480|NCT00857207|12210904|FG001|COMPLETED|Overall Study||3
11031481|NCT00857207|12210903|FG000|NOT COMPLETED|Overall Study||34
11031482|NCT00857207|12210904|FG001|NOT COMPLETED|Overall Study||0
11031483|NCT00857220|12210911|FG000|STARTED|Overall Study||304
11031484|NCT00857220|12210911|FG000|COMPLETED|Overall Study||121
11031485|NCT00857220|12210911|FG000|NOT COMPLETED|Overall Study||183
11031486|NCT00857233|12210915|FG000|STARTED|Overall Study||297
11031487|NCT00857233|12210915|FG000|COMPLETED|Overall Study||242
11031488|NCT00857233|12210915|FG000|NOT COMPLETED|Overall Study||55
11031489|NCT00857246|12210919|FG000|STARTED|Induction Regimen||30
11031490|NCT00857246|12210919|FG000|COMPLETED|Induction Regimen||27
11031491|NCT00857246|12210919|FG000|NOT COMPLETED|Induction Regimen||3
11031492|NCT00857246|12210919|FG000|STARTED|Surgery (Curative)||27
11031493|NCT00857246|12210919|FG000|COMPLETED|Surgery (Curative)||21
11031494|NCT00857246|12210919|FG000|NOT COMPLETED|Surgery (Curative)||6
11031495|NCT00857246|12210919|FG000|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
11031496|NCT00857246|12210919|FG000|COMPLETED|ChemoRT||12
11031497|NCT00857246|12210919|FG000|NOT COMPLETED|ChemoRT||3
11200761|NCT01828983|12390975|FG001|STARTED|Overall Study||81
11200762|NCT01828983|12390974|FG000|COMPLETED|Overall Study||80
11200763|NCT01828983|12390975|FG001|COMPLETED|Overall Study||81
11200764|NCT01828983|12390974|FG000|NOT COMPLETED|Overall Study||0
11200765|NCT01828983|12390975|FG001|NOT COMPLETED|Overall Study||0
11200766|NCT01829048|12390986|FG000|STARTED|Overall Study||6
11200767|NCT01829048|12390987|FG001|STARTED|Overall Study||8
11200768|NCT01829048|12390988|FG002|STARTED|Overall Study||7
11200769|NCT01829048|12390989|FG003|STARTED|Overall Study||14
11200770|NCT01829048|12390990|FG004|STARTED|Overall Study||2
11200771|NCT01829048|12390986|FG000|COMPLETED|Overall Study||6
11200772|NCT01829048|12390987|FG001|COMPLETED|Overall Study||8
11200773|NCT01829048|12390988|FG002|COMPLETED|Overall Study||7
11200774|NCT01829048|12390989|FG003|COMPLETED|Overall Study||12
11200775|NCT01829048|12390990|FG004|COMPLETED|Overall Study||2
11200776|NCT01829048|12390986|FG000|NOT COMPLETED|Overall Study||0
11200777|NCT01829048|12390987|FG001|NOT COMPLETED|Overall Study||0
11200778|NCT01829048|12390988|FG002|NOT COMPLETED|Overall Study||0
11200779|NCT01829048|12390989|FG003|NOT COMPLETED|Overall Study||2
11200780|NCT01829048|12390990|FG004|NOT COMPLETED|Overall Study||0
11200781|NCT01829113|12391005|FG000|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
11200782|NCT01829113|12391006|FG001|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
11200783|NCT01829113|12391005|FG000|COMPLETED|Overall Study||0
11200784|NCT01829113|12391006|FG001|COMPLETED|Overall Study||0
11200785|NCT01829113|12391005|FG000|NOT COMPLETED|Overall Study||77
11200786|NCT01829113|12391006|FG001|NOT COMPLETED|Overall Study||78
11200787|NCT01829165|12391016|FG000|STARTED|Overall Study||20
11200788|NCT01829165|12391017|FG001|STARTED|Overall Study||13
11200789|NCT01829165|12391016|FG000|COMPLETED|Overall Study||18
11200790|NCT01829165|12391017|FG001|COMPLETED|Overall Study||13
11200791|NCT01829165|12391016|FG000|NOT COMPLETED|Overall Study||2
11200792|NCT01829165|12391017|FG001|NOT COMPLETED|Overall Study||0
11200793|NCT01829191|12391025|FG000|STARTED|Overall Study||63
11200794|NCT01829191|12391026|FG001|STARTED|Overall Study||64
11200795|NCT01829191|12391025|FG000|COMPLETED|Overall Study||56
11200796|NCT01829191|12391026|FG001|COMPLETED|Overall Study||50
11200797|NCT01829191|12391025|FG000|NOT COMPLETED|Overall Study||7
11200798|NCT01829191|12391026|FG001|NOT COMPLETED|Overall Study||14
11200799|NCT01829217|12391031|FG000|STARTED|Overall Study||13
11200800|NCT01829217|12391031|FG000|COMPLETED|Overall Study||13
11200801|NCT01829217|12391031|FG000|NOT COMPLETED|Overall Study||0
11200802|NCT01829230|12391037|FG000|STARTED|Overall Study||40
11200803|NCT01829230|12391038|FG001|STARTED|Overall Study||42
11200804|NCT01829230|12391037|FG000|COMPLETED|Overall Study||39
11200805|NCT01829230|12391038|FG001|COMPLETED|Overall Study||38
11200806|NCT01829230|12391037|FG000|NOT COMPLETED|Overall Study||1
11200807|NCT01829230|12391038|FG001|NOT COMPLETED|Overall Study||4
11200808|NCT01829243|12391044|FG000|STARTED|First Intervention||11
11200809|NCT01829243|12391045|FG001|STARTED|First Intervention||15
11200810|NCT01829243|12391044|FG000|COMPLETED|First Intervention||7
11200811|NCT01829243|12391045|FG001|COMPLETED|First Intervention||13
11200812|NCT01829243|12391044|FG000|NOT COMPLETED|First Intervention||4
11200813|NCT01829243|12391045|FG001|NOT COMPLETED|First Intervention||2
11200814|NCT01829243|12391044|FG000|STARTED|Washout Period of 1 Week||7
11200815|NCT01829243|12391045|FG001|STARTED|Washout Period of 1 Week||13
11200816|NCT01829243|12391044|FG000|COMPLETED|Washout Period of 1 Week||7
11200817|NCT01829243|12391045|FG001|COMPLETED|Washout Period of 1 Week||13
11200818|NCT01829243|12391044|FG000|NOT COMPLETED|Washout Period of 1 Week||0
11200819|NCT01829243|12391045|FG001|NOT COMPLETED|Washout Period of 1 Week||0
11200820|NCT01829243|12391044|FG000|STARTED|Second Intervention||7
11200821|NCT01829243|12391045|FG001|STARTED|Second Intervention||13
11200822|NCT01829243|12391044|FG000|COMPLETED|Second Intervention||7
11200823|NCT01829243|12391045|FG001|COMPLETED|Second Intervention||13
11200824|NCT01829243|12391044|FG000|NOT COMPLETED|Second Intervention||0
11200825|NCT01829243|12391045|FG001|NOT COMPLETED|Second Intervention||0
11200826|NCT01829295|12391055|FG000|STARTED|0-6 Months||107
11200827|NCT01829295|12391056|FG001|STARTED|0-6 Months||109
11200828|NCT01829295|12391057|FG002|STARTED|0-6 Months||0
11031498|NCT00857259|12210929|FG000|STARTED|Overall Study||8
11031499|NCT00857259|12210930|FG001|STARTED|Overall Study||1
11031500|NCT00857259|12210931|FG002|STARTED|Overall Study||7
11031501|NCT00857259|12210929|FG000|COMPLETED|Overall Study||7
11031502|NCT00857259|12210930|FG001|COMPLETED|Overall Study||1
11031503|NCT00857259|12210931|FG002|COMPLETED|Overall Study||6
11031504|NCT00857259|12210929|FG000|NOT COMPLETED|Overall Study||1
11031505|NCT00857259|12210930|FG001|NOT COMPLETED|Overall Study||0
11031506|NCT00857259|12210931|FG002|NOT COMPLETED|Overall Study||1
11031507|NCT00857272|12210943|FG000|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
11031508|NCT00857272|12210944|FG001|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
11031509|NCT00857272|12210943|FG000|COMPLETED|Overall Study||145
11031510|NCT00857272|12210944|FG001|COMPLETED|Overall Study||145
11031511|NCT00857272|12210943|FG000|NOT COMPLETED|Overall Study||9
11031512|NCT00857272|12210944|FG001|NOT COMPLETED|Overall Study||9
11031513|NCT00857311|12210954|FG000|STARTED|Overall Study||9
11200829|NCT01829295|12391058|FG003|STARTED|0-6 Months||0
11031514|NCT00857311|12210955|FG001|STARTED|Overall Study||0
11031515|NCT00857311|12210956|FG002|STARTED|Overall Study||8
11031516|NCT00857311|12210957|FG003|STARTED|Overall Study||0
11031517|NCT00857311|12210954|FG000|COMPLETED|Overall Study||8
11031518|NCT00857311|12210955|FG001|COMPLETED|Overall Study||0
11031519|NCT00857311|12210956|FG002|COMPLETED|Overall Study||8
11031520|NCT00857311|12210957|FG003|COMPLETED|Overall Study||0
11031521|NCT00857311|12210954|FG000|NOT COMPLETED|Overall Study||1
11031522|NCT00857311|12210955|FG001|NOT COMPLETED|Overall Study||0
11031523|NCT00857311|12210956|FG002|NOT COMPLETED|Overall Study||0
11031524|NCT00857311|12210957|FG003|NOT COMPLETED|Overall Study||0
11031525|NCT00857389|12210963|FG000|STARTED|Overall Study||60
11031526|NCT00857389|12210963|FG000|COMPLETED|Overall Study||58
11031527|NCT00857389|12210963|FG000|NOT COMPLETED|Overall Study||2
11031528|NCT00857415|12210969|FG000|STARTED|Overall Study||152
11333698|NCT02839889|12531404|FG001|COMPLETED|Open-Label Period||4
11333699|NCT02839889|12531403|FG000|NOT COMPLETED|Open-Label Period||0
11333700|NCT02839889|12531404|FG001|NOT COMPLETED|Open-Label Period||1
11333701|NCT02839902|12531412|FG000|STARTED|Overall Study||24
11031529|NCT00857415|12210970|FG001|STARTED|Overall Study||74
11031530|NCT00857415|12210969|FG000|Deceased Within One Year of AV-45 Scan|Overall Study||37
11031531|NCT00857415|12210970|FG001|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
11031532|NCT00857415|12210969|FG000|COMPLETED|Overall Study||35
11031533|NCT00857415|12210970|FG001|COMPLETED|Overall Study||74
11333702|NCT02839902|12531413|FG001|STARTED|Overall Study||29
11333703|NCT02839902|12531412|FG000|COMPLETED|Overall Study||24
11031534|NCT00857415|12210969|FG000|NOT COMPLETED|Overall Study||117
11031535|NCT00857415|12210970|FG001|NOT COMPLETED|Overall Study||0
11031536|NCT00857454|12210976|FG000|STARTED|Overall Study||71
11031537|NCT00857454|12210976|FG000|COMPLETED|Overall Study||51
11031538|NCT00857454|12210976|FG000|NOT COMPLETED|Overall Study||20
11031539|NCT00857493|12210982|FG000|STARTED|Overall Study||62
11031540|NCT00857493|12210983|FG001|STARTED|Overall Study||58
11333704|NCT02839902|12531413|FG001|COMPLETED|Overall Study||29
11031541|NCT00857493|12210982|FG000|COMPLETED|Overall Study||59
11031542|NCT00857493|12210983|FG001|COMPLETED|Overall Study||58
11031543|NCT00857493|12210982|FG000|NOT COMPLETED|Overall Study||3
11031544|NCT00857493|12210983|FG001|NOT COMPLETED|Overall Study||0
11031545|NCT00857506|12210992|FG000|STARTED|Overall Study||31
11333705|NCT02839902|12531412|FG000|NOT COMPLETED|Overall Study||0
11333706|NCT02839902|12531413|FG001|NOT COMPLETED|Overall Study||0
11031546|NCT00857506|12210993|FG001|STARTED|Overall Study||52
11333707|NCT02840097|12531422|FG000|STARTED|Overall Study||9
11333708|NCT02840097|12531423|FG001|STARTED|Overall Study||10
11333709|NCT02840097|12531424|FG002|STARTED|Overall Study||12
11333710|NCT02840097|12531422|FG000|COMPLETED|Overall Study||9
11333711|NCT02840097|12531423|FG001|COMPLETED|Overall Study||10
11333712|NCT02840097|12531424|FG002|COMPLETED|Overall Study||12
11333713|NCT02840097|12531422|FG000|NOT COMPLETED|Overall Study||0
11333714|NCT02840097|12531423|FG001|NOT COMPLETED|Overall Study||0
11333715|NCT02840097|12531424|FG002|NOT COMPLETED|Overall Study||0
11333716|NCT02840253|12531435|FG000|STARTED|Overall Study||23
11333717|NCT02840253|12531435|FG000|COMPLETED|Overall Study||19
11333718|NCT02840253|12531435|FG000|NOT COMPLETED|Overall Study||4
11333719|NCT02840461|12531442|FG000|STARTED|Overall Study||259
11333720|NCT02840461|12531443|FG001|STARTED|Overall Study||257
11333721|NCT02840461|12531444|FG002|STARTED|Overall Study||114
11333722|NCT02840461|12531442|FG000|COMPLETED|Overall Study||236
11333723|NCT02840461|12531443|FG001|COMPLETED|Overall Study||235
11333724|NCT02840461|12531444|FG002|COMPLETED|Overall Study||100
11333725|NCT02840461|12531442|FG000|NOT COMPLETED|Overall Study||23
11333726|NCT02840461|12531443|FG001|NOT COMPLETED|Overall Study||22
11333727|NCT02840461|12531444|FG002|NOT COMPLETED|Overall Study||14
11333728|NCT02840474|12531455|FG000|STARTED|Overall Study||7
11333729|NCT02840474|12531456|FG001|STARTED|Overall Study||9
11031547|NCT00857506|12210994|FG002|STARTED|Overall Study||69
11031548|NCT00857506|12210992|FG000|COMPLETED|Overall Study||16
11031549|NCT00857506|12210993|FG001|COMPLETED|Overall Study||37
11031550|NCT00857506|12210994|FG002|COMPLETED|Overall Study||51
11333730|NCT02840474|12531455|FG000|Received Study Product|Overall Study||7
11333731|NCT02840474|12531456|FG001|Received Study Product|Overall Study||9
11333732|NCT02840474|12531455|FG000|COMPLETED|Overall Study||6
11333733|NCT02840474|12531456|FG001|COMPLETED|Overall Study||9
11333734|NCT02840474|12531455|FG000|NOT COMPLETED|Overall Study||1
11333735|NCT02840474|12531456|FG001|NOT COMPLETED|Overall Study||0
11031551|NCT00857506|12210992|FG000|NOT COMPLETED|Overall Study||15
11031552|NCT00857506|12210993|FG001|NOT COMPLETED|Overall Study||15
11031553|NCT00857506|12210994|FG002|NOT COMPLETED|Overall Study||18
11031554|NCT00857532|12211014|FG000|STARTED|Overall Study||31
11031555|NCT00857532|12211014|FG000|COMPLETED|Overall Study||31
11031556|NCT00857532|12211014|FG000|NOT COMPLETED|Overall Study||0
11031557|NCT00857545|12211023|FG000|STARTED|Overall Study||86
11031558|NCT00857545|12211024|FG001|STARTED|Overall Study||85
11031559|NCT00857545|12211023|FG000|COMPLETED|Overall Study|Enrolled and randomized participants.|86
11031560|NCT00857545|12211024|FG001|COMPLETED|Overall Study||85
11031561|NCT00857545|12211023|FG000|NOT COMPLETED|Overall Study||0
11031562|NCT00857545|12211024|FG001|NOT COMPLETED|Overall Study||0
11031563|NCT00857584|12211032|FG000|STARTED|Overall Study||14
11031564|NCT00857584|12211033|FG001|STARTED|Overall Study||13
11031565|NCT00857584|12211032|FG000|Week 1|Overall Study||14
11031566|NCT00857584|12211033|FG001|Week 1|Overall Study||13
11031567|NCT00857584|12211032|FG000|Week 2|Overall Study||14
11031568|NCT00857584|12211033|FG001|Week 2|Overall Study||11
11031569|NCT00857584|12211032|FG000|Week 4|Overall Study||11
11031570|NCT00857584|12211033|FG001|Week 4|Overall Study||9
11031571|NCT00857584|12211032|FG000|Week 8|Overall Study||10
11031572|NCT00857584|12211033|FG001|Week 8|Overall Study||8
11031573|NCT00857584|12211032|FG000|COMPLETED|Overall Study||10
11031574|NCT00857584|12211033|FG001|COMPLETED|Overall Study||8
11031575|NCT00857584|12211032|FG000|NOT COMPLETED|Overall Study||4
11031576|NCT00857584|12211033|FG001|NOT COMPLETED|Overall Study||5
11031577|NCT00857623|12211041|FG000|STARTED|Overall Study||62
11031578|NCT00857623|12211042|FG001|STARTED|Overall Study||65
11031579|NCT00857623|12211041|FG000|COMPLETED|Overall Study||48
11031580|NCT00857623|12211042|FG001|COMPLETED|Overall Study||55
11031581|NCT00857623|12211041|FG000|NOT COMPLETED|Overall Study||14
11031582|NCT00857623|12211042|FG001|NOT COMPLETED|Overall Study||10
11031583|NCT00857649|12211050|FG000|STARTED|Overall Study||182
11031584|NCT00857649|12211051|FG001|STARTED|Overall Study||187
11031585|NCT00857649|12211050|FG000|COMPLETED|Overall Study||151
11031586|NCT00857649|12211051|FG001|COMPLETED|Overall Study||155
11031587|NCT00857649|12211050|FG000|NOT COMPLETED|Overall Study||31
11031588|NCT00857649|12211051|FG001|NOT COMPLETED|Overall Study||32
11057442|NCT00997893|12238957|FG000|COMPLETED|Overall Study||12
11057443|NCT00997893|12238958|FG001|COMPLETED|Overall Study||12
11057444|NCT00997893|12238959|FG002|COMPLETED|Overall Study||13
11057445|NCT00997893|12238957|FG000|NOT COMPLETED|Overall Study||2
11057446|NCT00997893|12238958|FG001|NOT COMPLETED|Overall Study||1
11057447|NCT00997893|12238959|FG002|NOT COMPLETED|Overall Study||0
11057448|NCT00997932|12238967|FG000|STARTED|Overall Study||29
11057449|NCT00997932|12238967|FG000|COMPLETED|Overall Study||27
11057450|NCT00997932|12238967|FG000|NOT COMPLETED|Overall Study||2
11057451|NCT00997984|12238975|FG000|STARTED|Overall Study||113
11057452|NCT00997984|12238976|FG001|STARTED|Overall Study||113
11057453|NCT00997984|12238977|FG002|STARTED|Overall Study||114
11057454|NCT00997984|12238975|FG000|COMPLETED|Overall Study||76
11057455|NCT00997984|12238976|FG001|COMPLETED|Overall Study||79
11057456|NCT00997984|12238977|FG002|COMPLETED|Overall Study||88
11057457|NCT00997984|12238975|FG000|NOT COMPLETED|Overall Study||37
11057458|NCT00997984|12238976|FG001|NOT COMPLETED|Overall Study||34
11057459|NCT00997984|12238977|FG002|NOT COMPLETED|Overall Study||26
11057460|NCT00998010|12238987|FG000|STARTED|Overall Study||24
11057461|NCT00998010|12238987|FG000|COMPLETED|Overall Study||24
11057462|NCT00998010|12238987|FG000|NOT COMPLETED|Overall Study||0
11057463|NCT00998023|12238993|FG000|STARTED|Overall Study||32
11057464|NCT00998023|12238994|FG001|STARTED|Overall Study||32
11057465|NCT00998023|12238993|FG000|COMPLETED|Overall Study||32
11057466|NCT00998023|12238994|FG001|COMPLETED|Overall Study||32
11057467|NCT00998023|12238993|FG000|NOT COMPLETED|Overall Study||0
11057468|NCT00998023|12238994|FG001|NOT COMPLETED|Overall Study||0
11057469|NCT00998049|12239000|FG000|STARTED|Overall Study||39
11057470|NCT00998049|12239000|FG000|COMPLETED|Overall Study||39
11057471|NCT00998049|12239000|FG000|NOT COMPLETED|Overall Study||0
11057472|NCT00998205|12239004|FG000|STARTED|Overall Study||16
11057473|NCT00998205|12239004|FG000|COMPLETED|Overall Study||16
11057474|NCT00998205|12239004|FG000|NOT COMPLETED|Overall Study||0
11057475|NCT00998296|12239020|FG000|STARTED|Overall Study||6
11057476|NCT00998296|12239021|FG001|STARTED|Overall Study||3
11057477|NCT00998296|12239022|FG002|STARTED|Overall Study||3
11057478|NCT00998296|12239023|FG003|STARTED|Overall Study||3
11057479|NCT00998296|12239024|FG004|STARTED|Overall Study||8
11057480|NCT00998296|12239025|FG005|STARTED|Overall Study||3
11057481|NCT00998296|12239026|FG006|STARTED|Overall Study||7
11057482|NCT00998296|12239027|FG007|STARTED|Overall Study||6
11057483|NCT00998296|12239028|FG008|STARTED|Overall Study||6
11333736|NCT02840721|12531462|FG000|STARTED|Treatment Period||50
11333737|NCT02840721|12531462|FG000|COMPLETED|Treatment Period||49
11333738|NCT02840721|12531462|FG000|NOT COMPLETED|Treatment Period||1
11333739|NCT02840721|12531462|FG000|STARTED|Follow-Up||49
11333740|NCT02840721|12531462|FG000|COMPLETED|Follow-Up||42
11333741|NCT02840721|12531462|FG000|NOT COMPLETED|Follow-Up||7
11031589|NCT00857714|12211057|FG000|STARTED|Overall Study||1
11031590|NCT00857714|12211057|FG000|COMPLETED|Overall Study||1
11333742|NCT02840916|12531468|FG000|STARTED|Overall Study||33
11333743|NCT02840916|12531469|FG001|STARTED|Overall Study||33
11333744|NCT02840916|12531468|FG000|COMPLETED|Overall Study||32
11333745|NCT02840916|12531469|FG001|COMPLETED|Overall Study||30
11333746|NCT02840916|12531468|FG000|NOT COMPLETED|Overall Study||1
11333747|NCT02840916|12531469|FG001|NOT COMPLETED|Overall Study||3
11031591|NCT00857714|12211057|FG000|NOT COMPLETED|Overall Study||0
11031592|NCT00857727|12211063|FG000|STARTED|Overall Study||14
11031593|NCT00857727|12211064|FG001|STARTED|Overall Study||14
11031594|NCT00857727|12211063|FG000|COMPLETED|Overall Study||14
11031595|NCT00857727|12211064|FG001|COMPLETED|Overall Study||14
11031596|NCT00857727|12211063|FG000|NOT COMPLETED|Overall Study||0
11031597|NCT00857727|12211064|FG001|NOT COMPLETED|Overall Study||0
11031598|NCT00857766|12211072|FG000|STARTED|Overall Study||123
11031599|NCT00857766|12211073|FG001|STARTED|Overall Study||126
11031600|NCT00857766|12211072|FG000|COMPLETED|Overall Study||92
11031601|NCT00857766|12211073|FG001|COMPLETED|Overall Study||96
11031602|NCT00857766|12211072|FG000|NOT COMPLETED|Overall Study||31
11031603|NCT00857766|12211073|FG001|NOT COMPLETED|Overall Study||30
11031604|NCT00857792|12211079|FG000|STARTED|Overall Study||120
11031605|NCT00857792|12211079|FG000|COMPLETED|Overall Study||108
11031606|NCT00857792|12211079|FG000|NOT COMPLETED|Overall Study||12
11031607|NCT00857818|12211085|FG000|STARTED|Overall Study||14
11031608|NCT00857818|12211086|FG001|STARTED|Overall Study||14
11031609|NCT00857818|12211085|FG000|Received Treatment|Overall Study||14
11031610|NCT00857818|12211086|FG001|Received Treatment|Overall Study||12
11031611|NCT00857818|12211085|FG000|COMPLETED|Overall Study||3
11031612|NCT00857818|12211086|FG001|COMPLETED|Overall Study||6
11031613|NCT00857818|12211085|FG000|NOT COMPLETED|Overall Study||11
11031614|NCT00857818|12211086|FG001|NOT COMPLETED|Overall Study||8
11333748|NCT02841033|12531475|FG000|STARTED|Overall Study||22
11333749|NCT02841033|12531475|FG000|COMPLETED|Overall Study||22
11333750|NCT02841033|12531475|FG000|NOT COMPLETED|Overall Study||0
11333751|NCT02841046|12531481|FG000|STARTED|Overall Study||25
11333752|NCT02841046|12531482|FG001|STARTED|Overall Study||25
11333753|NCT02841046|12531481|FG000|COMPLETED|Overall Study||25
11333754|NCT02841046|12531482|FG001|COMPLETED|Overall Study||25
11333755|NCT02841046|12531481|FG000|NOT COMPLETED|Overall Study||0
11333756|NCT02841046|12531482|FG001|NOT COMPLETED|Overall Study||0
11333757|NCT02841189|12531488|FG000|STARTED|Overall Study||100
11333758|NCT02841189|12531488|FG000|COMPLETED|Overall Study||65
11333759|NCT02841189|12531488|FG000|NOT COMPLETED|Overall Study||35
11333760|NCT02841241|12531492|FG000|STARTED|Overall Study||7
11333761|NCT02841241|12531492|FG000|COMPLETED|Overall Study||7
11333762|NCT02841241|12531492|FG000|NOT COMPLETED|Overall Study||0
11031615|NCT00857857|12211092|FG000|STARTED|Overall Study||24
11031616|NCT00857857|12211092|FG000|COMPLETED|Overall Study||24
11031617|NCT00857857|12211092|FG000|NOT COMPLETED|Overall Study||0
11031618|NCT00857896|12211104|FG000|STARTED|Baseline to Week 4||21
11031619|NCT00857896|12211104|FG000|COMPLETED|Baseline to Week 4||20
11031620|NCT00857896|12211104|FG000|NOT COMPLETED|Baseline to Week 4||1
11031621|NCT00857896|12211104|FG000|STARTED|Week 5 to Week 8||20
11031622|NCT00857896|12211104|FG000|COMPLETED|Week 5 to Week 8||20
11031623|NCT00857896|12211104|FG000|NOT COMPLETED|Week 5 to Week 8||0
11031624|NCT00857948|12211113|FG000|STARTED|Overall Study||18
11031625|NCT00857948|12211114|FG001|STARTED|Overall Study||18
11031626|NCT00857948|12211115|FG002|STARTED|Overall Study||19
11333763|NCT02841267|12531499|FG000|STARTED|Lead-in (Untreated)||4
11333764|NCT02841267|12531500|FG001|STARTED|Lead-in (Untreated)||7
11333765|NCT02841267|12531501|FG002|STARTED|Lead-in (Untreated)||8
11333766|NCT02841267|12531499|FG000|COMPLETED|Lead-in (Untreated)||4
11333767|NCT02841267|12531500|FG001|COMPLETED|Lead-in (Untreated)||7
11333768|NCT02841267|12531501|FG002|COMPLETED|Lead-in (Untreated)||8
11333769|NCT02841267|12531499|FG000|NOT COMPLETED|Lead-in (Untreated)||0
11333770|NCT02841267|12531500|FG001|NOT COMPLETED|Lead-in (Untreated)||0
11333771|NCT02841267|12531501|FG002|NOT COMPLETED|Lead-in (Untreated)||0
11333772|NCT02841267|12531499|FG000|STARTED|Treatment Period|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
11333773|NCT02841267|12531500|FG001|STARTED|Treatment Period||7
11333774|NCT02841267|12531501|FG002|STARTED|Treatment Period||8
11333775|NCT02841267|12531499|FG000|COMPLETED|Treatment Period||4
11333776|NCT02841267|12531500|FG001|COMPLETED|Treatment Period||7
11333777|NCT02841267|12531501|FG002|COMPLETED|Treatment Period||8
11333778|NCT02841267|12531499|FG000|NOT COMPLETED|Treatment Period||0
11333779|NCT02841267|12531500|FG001|NOT COMPLETED|Treatment Period||0
11333780|NCT02841267|12531501|FG002|NOT COMPLETED|Treatment Period||0
11333781|NCT02841267|12531499|FG000|STARTED|Extension Study|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
11333782|NCT02841267|12531500|FG001|STARTED|Extension Study|Cohort 2 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 40 weeks.|6
11333783|NCT02841267|12531501|FG002|STARTED|Extension Study|Cohort 3 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 24 weeks.|6
11333784|NCT02841267|12531499|FG000|COMPLETED|Extension Study||4
11333785|NCT02841267|12531500|FG001|COMPLETED|Extension Study||6
11333786|NCT02841267|12531501|FG002|COMPLETED|Extension Study||6
11333787|NCT02841267|12531499|FG000|NOT COMPLETED|Extension Study||0
11333788|NCT02841267|12531500|FG001|NOT COMPLETED|Extension Study||0
11333789|NCT02841267|12531501|FG002|NOT COMPLETED|Extension Study||0
11333790|NCT02841397|12531517|FG000|STARTED|Overall Study||50
11333791|NCT02841397|12531517|FG000|COMPLETED|Overall Study||48
11333792|NCT02841397|12531517|FG000|NOT COMPLETED|Overall Study||2
11333793|NCT02841449|12531523|FG000|STARTED|Overall Study||7
11333794|NCT02841449|12531524|FG001|STARTED|Overall Study||9
11333795|NCT02841449|12531523|FG000|COMPLETED|Overall Study||7
11333796|NCT02841449|12531524|FG001|COMPLETED|Overall Study||9
11333797|NCT02841449|12531523|FG000|NOT COMPLETED|Overall Study||0
11333798|NCT02841449|12531524|FG001|NOT COMPLETED|Overall Study||0
11333799|NCT02841709|12531530|FG000|STARTED|1st Intervention||12
11333800|NCT02841709|12531531|FG001|STARTED|1st Intervention||11
11333801|NCT02841709|12531532|FG002|STARTED|1st Intervention||12
11333802|NCT02841709|12531533|FG003|STARTED|1st Intervention||12
11333803|NCT02841709|12531534|FG004|STARTED|1st Intervention||11
11333804|NCT02841709|12531530|FG000|COMPLETED|1st Intervention||12
11333805|NCT02841709|12531531|FG001|COMPLETED|1st Intervention||11
11333806|NCT02841709|12531532|FG002|COMPLETED|1st Intervention||12
11333807|NCT02841709|12531533|FG003|COMPLETED|1st Intervention||12
11333808|NCT02841709|12531534|FG004|COMPLETED|1st Intervention||11
11333809|NCT02841709|12531530|FG000|NOT COMPLETED|1st Intervention||0
11333810|NCT02841709|12531531|FG001|NOT COMPLETED|1st Intervention||0
11333811|NCT02841709|12531532|FG002|NOT COMPLETED|1st Intervention||0
11333812|NCT02841709|12531533|FG003|NOT COMPLETED|1st Intervention||0
11333813|NCT02841709|12531534|FG004|NOT COMPLETED|1st Intervention||0
11333814|NCT02841709|12531530|FG000|STARTED|Washout Period 1||12
11333815|NCT02841709|12531531|FG001|STARTED|Washout Period 1||11
11333816|NCT02841709|12531532|FG002|STARTED|Washout Period 1||12
11333817|NCT02841709|12531533|FG003|STARTED|Washout Period 1||12
11333818|NCT02841709|12531534|FG004|STARTED|Washout Period 1||11
11333819|NCT02841709|12531530|FG000|COMPLETED|Washout Period 1||12
11333820|NCT02841709|12531531|FG001|COMPLETED|Washout Period 1||11
11333821|NCT02841709|12531532|FG002|COMPLETED|Washout Period 1||12
11333822|NCT02841709|12531533|FG003|COMPLETED|Washout Period 1||12
11333823|NCT02841709|12531534|FG004|COMPLETED|Washout Period 1||11
11333824|NCT02841709|12531530|FG000|NOT COMPLETED|Washout Period 1||0
11333825|NCT02841709|12531531|FG001|NOT COMPLETED|Washout Period 1||0
11333826|NCT02841709|12531532|FG002|NOT COMPLETED|Washout Period 1||0
11333827|NCT02841709|12531533|FG003|NOT COMPLETED|Washout Period 1||0
11333828|NCT02841709|12531534|FG004|NOT COMPLETED|Washout Period 1||0
11333829|NCT02841709|12531530|FG000|STARTED|2nd Intervention||12
11333830|NCT02841709|12531531|FG001|STARTED|2nd Intervention||11
11333831|NCT02841709|12531532|FG002|STARTED|2nd Intervention||12
11333832|NCT02841709|12531533|FG003|STARTED|2nd Intervention||12
11333833|NCT02841709|12531534|FG004|STARTED|2nd Intervention||11
11333834|NCT02841709|12531530|FG000|COMPLETED|2nd Intervention||12
11333835|NCT02841709|12531531|FG001|COMPLETED|2nd Intervention||11
11333836|NCT02841709|12531532|FG002|COMPLETED|2nd Intervention||12
11333837|NCT02841709|12531533|FG003|COMPLETED|2nd Intervention||12
11031627|NCT00857948|12211116|FG003|STARTED|Overall Study||23
11031628|NCT00857948|12211113|FG000|COMPLETED|Overall Study||15
11031629|NCT00857948|12211114|FG001|COMPLETED|Overall Study||18
11031630|NCT00857948|12211115|FG002|COMPLETED|Overall Study||18
11031631|NCT00857948|12211116|FG003|COMPLETED|Overall Study||23
11031632|NCT00857948|12211113|FG000|NOT COMPLETED|Overall Study||3
11031633|NCT00857948|12211114|FG001|NOT COMPLETED|Overall Study||0
11031634|NCT00857948|12211115|FG002|NOT COMPLETED|Overall Study||1
11031635|NCT00857948|12211116|FG003|NOT COMPLETED|Overall Study||0
11031636|NCT00857961|12211126|FG000|STARTED|Overall Study||21
11031637|NCT00857961|12211126|FG000|COMPLETED|Overall Study||21
11031638|NCT00857961|12211126|FG000|NOT COMPLETED|Overall Study||0
11031639|NCT00858013|12211138|FG000|STARTED|Overall Study||46
11031640|NCT00858013|12211139|FG001|STARTED|Overall Study||42
11031641|NCT00858013|12211138|FG000|COMPLETED|Overall Study||24
11031642|NCT00858013|12211139|FG001|COMPLETED|Overall Study||23
11031643|NCT00858013|12211138|FG000|NOT COMPLETED|Overall Study||22
11031644|NCT00858013|12211139|FG001|NOT COMPLETED|Overall Study||19
11031645|NCT00858117|12211145|FG000|STARTED|Treatment on Study||30
11031646|NCT00858117|12211145|FG000|Completed 18 Weeks of Treatment|Treatment on Study||28
11031647|NCT00858117|12211145|FG000|COMPLETED|Treatment on Study||28
11031648|NCT00858117|12211145|FG000|NOT COMPLETED|Treatment on Study||2
11031649|NCT00858117|12211145|FG000|STARTED|Follow up for 5 Years|All patients who receive at least one dose of drug under the protocol go into follow up for survival|30
11031650|NCT00858117|12211145|FG000|COMPLETED|Follow up for 5 Years||17
11031651|NCT00858117|12211145|FG000|NOT COMPLETED|Follow up for 5 Years||13
11031652|NCT00858130|12211149|FG000|STARTED|Overall Study||12
11031653|NCT00858130|12211149|FG000|COMPLETED|Overall Study||12
11031654|NCT00858130|12211149|FG000|NOT COMPLETED|Overall Study||0
11031655|NCT00858143|12211154|FG000|STARTED|Overall Study|Baseline|311
11031656|NCT00858143|12211154|FG000|COMPLETED|Overall Study||261
11031657|NCT00858143|12211154|FG000|NOT COMPLETED|Overall Study||50
11057484|NCT00998296|12239029|FG009|STARTED|Overall Study||18
11057485|NCT00998296|12239030|FG010|STARTED|Overall Study||7
11057486|NCT00998296|12239020|FG000|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
11057487|NCT00998296|12239021|FG001|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
11057488|NCT00998296|12239022|FG002|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
11057489|NCT00998296|12239023|FG003|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
11057490|NCT00998296|12239024|FG004|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
11057491|NCT00998296|12239025|FG005|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
11057492|NCT00998296|12239026|FG006|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
11057493|NCT00998296|12239027|FG007|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
11057494|NCT00998296|12239028|FG008|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
11057495|NCT00998296|12239029|FG009|COMPLETED|Overall Study||0
11057496|NCT00998296|12239030|FG010|COMPLETED|Overall Study||0
11057497|NCT00998296|12239020|FG000|NOT COMPLETED|Overall Study||0
11057498|NCT00998296|12239021|FG001|NOT COMPLETED|Overall Study||1
11057499|NCT00998296|12239022|FG002|NOT COMPLETED|Overall Study||0
11057500|NCT00998296|12239023|FG003|NOT COMPLETED|Overall Study||0
11057501|NCT00998296|12239024|FG004|NOT COMPLETED|Overall Study||2
11057502|NCT00998296|12239025|FG005|NOT COMPLETED|Overall Study||0
11057503|NCT00998296|12239026|FG006|NOT COMPLETED|Overall Study||1
11057504|NCT00998296|12239027|FG007|NOT COMPLETED|Overall Study||2
11057505|NCT00998296|12239028|FG008|NOT COMPLETED|Overall Study||2
11057506|NCT00998296|12239029|FG009|NOT COMPLETED|Overall Study||18
11057507|NCT00998296|12239030|FG010|NOT COMPLETED|Overall Study||7
11057508|NCT00998309|12239059|FG000|STARTED|Overall Study||502
11057509|NCT00998309|12239059|FG000|COMPLETED|Overall Study||498
11057510|NCT00998309|12239059|FG000|NOT COMPLETED|Overall Study||4
11057511|NCT00998335|12239113|FG000|STARTED|Initial Treatment (Months 0 - 3)||30
11057512|NCT00998335|12239114|FG001|STARTED|Initial Treatment (Months 0 - 3)||0
11057513|NCT00998335|12239113|FG000|COMPLETED|Initial Treatment (Months 0 - 3)||30
11057514|NCT00998335|12239114|FG001|COMPLETED|Initial Treatment (Months 0 - 3)||0
11057515|NCT00998335|12239113|FG000|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
11057516|NCT00998335|12239114|FG001|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
11057517|NCT00998335|12239113|FG000|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
11057518|NCT00998335|12239114|FG001|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
11057519|NCT00998335|12239113|FG000|COMPLETED|Randomized Period (Months 3 to 6)||8
11057520|NCT00998335|12239114|FG001|COMPLETED|Randomized Period (Months 3 to 6)||20
11057521|NCT00998335|12239113|FG000|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
11057522|NCT00998335|12239114|FG001|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
11057523|NCT00998374|12239128|FG000|STARTED|Overall Study||39
11057524|NCT00998374|12239129|FG001|STARTED|Overall Study||23
11057525|NCT00998374|12239128|FG000|COMPLETED|Overall Study||27
11057526|NCT00998374|12239129|FG001|COMPLETED|Overall Study||12
11057527|NCT00998374|12239128|FG000|NOT COMPLETED|Overall Study||12
11057528|NCT00998374|12239129|FG001|NOT COMPLETED|Overall Study||11
11057529|NCT00998400|12239139|FG000|STARTED|Overall Study||50
11031658|NCT00858208|12211158|FG000|STARTED|Overall Study||85
11031659|NCT00858208|12211158|FG000|COMPLETED|Overall Study||6
11031660|NCT00858208|12211158|FG000|NOT COMPLETED|Overall Study||79
11031661|NCT00858234|12211162|FG000|STARTED|Overall Study||9
11031662|NCT00858234|12211162|FG000|COMPLETED|Overall Study||0
11031663|NCT00858234|12211162|FG000|NOT COMPLETED|Overall Study||9
11031664|NCT00858247|12211168|FG000|STARTED|Baseline Assessment||25
11031665|NCT00858247|12211169|FG001|STARTED|Baseline Assessment||26
11031666|NCT00858247|12211168|FG000|COMPLETED|Baseline Assessment||23
11031667|NCT00858247|12211169|FG001|COMPLETED|Baseline Assessment||24
11031668|NCT00858247|12211168|FG000|NOT COMPLETED|Baseline Assessment||2
11031669|NCT00858247|12211169|FG001|NOT COMPLETED|Baseline Assessment||2
11031670|NCT00858247|12211168|FG000|STARTED|Week 12 Follow-up||23
11031671|NCT00858247|12211169|FG001|STARTED|Week 12 Follow-up||24
11031672|NCT00858247|12211168|FG000|COMPLETED|Week 12 Follow-up||23
11031673|NCT00858247|12211169|FG001|COMPLETED|Week 12 Follow-up||23
11031674|NCT00858247|12211168|FG000|NOT COMPLETED|Week 12 Follow-up||0
11031675|NCT00858247|12211169|FG001|NOT COMPLETED|Week 12 Follow-up||1
11031676|NCT00858364|12211177|FG000|STARTED|Overall Study||846
11031677|NCT00858364|12211178|FG001|STARTED|Overall Study||1703
11031678|NCT00858364|12211177|FG000|Received Study Drug|Overall Study||837
11031679|NCT00858364|12211178|FG001|Received Study Drug|Overall Study||1681
11031680|NCT00858364|12211177|FG000|COMPLETED|Overall Study||642
11031681|NCT00858364|12211178|FG001|COMPLETED|Overall Study||1246
11031682|NCT00858364|12211177|FG000|NOT COMPLETED|Overall Study||204
11031683|NCT00858364|12211178|FG001|NOT COMPLETED|Overall Study||457
11031684|NCT00858390|12211186|FG000|STARTED|Overall Study||18
11031685|NCT00858390|12211187|FG001|STARTED|Overall Study||18
11031686|NCT00858390|12211186|FG000|COMPLETED|Overall Study||18
11031687|NCT00858390|12211187|FG001|COMPLETED|Overall Study||18
11031688|NCT00858390|12211186|FG000|NOT COMPLETED|Overall Study||0
11031689|NCT00858390|12211187|FG001|NOT COMPLETED|Overall Study||0
11031690|NCT00858403|12211193|FG000|STARTED|Overall Study||7
11031691|NCT00858403|12211193|FG000|COMPLETED|Overall Study||2
11031692|NCT00858403|12211193|FG000|NOT COMPLETED|Overall Study||5
11031693|NCT00858442|12211199|FG000|STARTED|From Surgery to Start Compression;||21
11031694|NCT00858442|12211200|FG001|STARTED|From Surgery to Start Compression;||23
11031695|NCT00858442|12211199|FG000|COMPLETED|From Surgery to Start Compression;||21
11031696|NCT00858442|12211200|FG001|COMPLETED|From Surgery to Start Compression;||23
11031697|NCT00858442|12211199|FG000|NOT COMPLETED|From Surgery to Start Compression;||0
11031698|NCT00858442|12211200|FG001|NOT COMPLETED|From Surgery to Start Compression;||0
11031699|NCT00858442|12211199|FG000|STARTED|Compression:Start to Finish||21
11031700|NCT00858442|12211200|FG001|STARTED|Compression:Start to Finish||23
11031701|NCT00858442|12211199|FG000|COMPLETED|Compression:Start to Finish||20
11031702|NCT00858442|12211200|FG001|COMPLETED|Compression:Start to Finish||20
11031703|NCT00858442|12211199|FG000|NOT COMPLETED|Compression:Start to Finish||1
11031704|NCT00858442|12211200|FG001|NOT COMPLETED|Compression:Start to Finish||3
11031705|NCT00858468|12211209|FG000|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
11031706|NCT00858468|12211210|FG001|STARTED|Overall Study||192
11031707|NCT00858468|12211209|FG000|COMPLETED|Overall Study||201
11031708|NCT00858468|12211210|FG001|COMPLETED|Overall Study||192
11031709|NCT00858468|12211209|FG000|NOT COMPLETED|Overall Study||0
11031710|NCT00858468|12211210|FG001|NOT COMPLETED|Overall Study||0
11031711|NCT00858494|12211216|FG000|STARTED|Overall Study||49
11031712|NCT00858494|12211216|FG000|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
11031713|NCT00858494|12211216|FG000|NOT COMPLETED|Overall Study||4
11031714|NCT00858507|12211222|FG000|STARTED|Overall Study||105
11031715|NCT00858507|12211223|FG001|STARTED|Overall Study||116
11031716|NCT00858507|12211222|FG000|COMPLETED|Overall Study||83
11031717|NCT00858507|12211223|FG001|COMPLETED|Overall Study||101
11031718|NCT00858507|12211222|FG000|NOT COMPLETED|Overall Study||22
11031719|NCT00858507|12211223|FG001|NOT COMPLETED|Overall Study||15
11031720|NCT00858637|12211231|FG000|STARTED|Active Comparison Phase||127
11031721|NCT00858637|12211232|FG001|STARTED|Active Comparison Phase||0
11031722|NCT00858637|12211233|FG002|STARTED|Active Comparison Phase||0
11031723|NCT00858637|12211234|FG003|STARTED|Active Comparison Phase||133
11031724|NCT00858637|12211235|FG004|STARTED|Active Comparison Phase||0
11031725|NCT00858637|12211236|FG005|STARTED|Active Comparison Phase||0
11031726|NCT00858637|12211231|FG000|COMPLETED|Active Comparison Phase||103
11031727|NCT00858637|12211232|FG001|COMPLETED|Active Comparison Phase||0
11031728|NCT00858637|12211233|FG002|COMPLETED|Active Comparison Phase||0
11031729|NCT00858637|12211234|FG003|COMPLETED|Active Comparison Phase||115
11031730|NCT00858637|12211235|FG004|COMPLETED|Active Comparison Phase||0
11031731|NCT00858637|12211236|FG005|COMPLETED|Active Comparison Phase||0
11031732|NCT00858637|12211231|FG000|NOT COMPLETED|Active Comparison Phase||24
11031733|NCT00858637|12211232|FG001|NOT COMPLETED|Active Comparison Phase||0
11031734|NCT00858637|12211233|FG002|NOT COMPLETED|Active Comparison Phase||0
11031735|NCT00858637|12211234|FG003|NOT COMPLETED|Active Comparison Phase||18
11031736|NCT00858637|12211235|FG004|NOT COMPLETED|Active Comparison Phase||0
11031737|NCT00858637|12211236|FG005|NOT COMPLETED|Active Comparison Phase||0
11031738|NCT00858637|12211231|FG000|STARTED|Placebo-controlled Withdrawal Phase||0
11031739|NCT00858637|12211232|FG001|STARTED|Placebo-controlled Withdrawal Phase||49
11031740|NCT00858637|12211233|FG002|STARTED|Placebo-controlled Withdrawal Phase||54
11031741|NCT00858637|12211234|FG003|STARTED|Placebo-controlled Withdrawal Phase||0
11031742|NCT00858637|12211235|FG004|STARTED|Placebo-controlled Withdrawal Phase||56
11031743|NCT00858637|12211236|FG005|STARTED|Placebo-controlled Withdrawal Phase||59
11031744|NCT00858637|12211231|FG000|COMPLETED|Placebo-controlled Withdrawal Phase||0
11031745|NCT00858637|12211232|FG001|COMPLETED|Placebo-controlled Withdrawal Phase||49
11031746|NCT00858637|12211233|FG002|COMPLETED|Placebo-controlled Withdrawal Phase||53
11031747|NCT00858637|12211234|FG003|COMPLETED|Placebo-controlled Withdrawal Phase||0
11031748|NCT00858637|12211235|FG004|COMPLETED|Placebo-controlled Withdrawal Phase||55
11031749|NCT00858637|12211236|FG005|COMPLETED|Placebo-controlled Withdrawal Phase||58
11031750|NCT00858637|12211231|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
11031751|NCT00858637|12211232|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
11031752|NCT00858637|12211233|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
11031753|NCT00858637|12211234|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
11031754|NCT00858637|12211235|FG004|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
11031755|NCT00858637|12211236|FG005|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
11031756|NCT00858689|12211246|FG000|STARTED|Overall Study||20
11031757|NCT00858689|12211246|FG000|COMPLETED|Overall Study||19
11031758|NCT00858689|12211246|FG000|NOT COMPLETED|Overall Study||1
11031759|NCT00858780|12211250|FG000|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
11031760|NCT00858780|12211251|FG001|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
11031761|NCT00858780|12211252|FG002|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
11031762|NCT00858780|12211253|FG003|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
11031763|NCT00858780|12211254|FG004|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
11031764|NCT00858780|12211250|FG000|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
11031765|NCT00858780|12211251|FG001|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
11031766|NCT00858780|12211252|FG002|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
11031767|NCT00858780|12211253|FG003|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
11031768|NCT00858780|12211254|FG004|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
11031769|NCT00858780|12211250|FG000|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
11031770|NCT00858780|12211251|FG001|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
11031771|NCT00858780|12211252|FG002|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
11031772|NCT00858780|12211253|FG003|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
11031773|NCT00858780|12211254|FG004|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
11031774|NCT00858780|12211250|FG000|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
11031775|NCT00858780|12211251|FG001|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
11031776|NCT00858780|12211252|FG002|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
11031777|NCT00858780|12211253|FG003|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
11031778|NCT00858780|12211254|FG004|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
11031779|NCT00858780|12211250|FG000|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
11031780|NCT00858780|12211251|FG001|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
11031781|NCT00858780|12211252|FG002|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
11031782|NCT00858780|12211253|FG003|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
11031783|NCT00858780|12211254|FG004|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
11031784|NCT00858780|12211250|FG000|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
11031785|NCT00858780|12211251|FG001|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
11031786|NCT00858780|12211252|FG002|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
11031787|NCT00858780|12211253|FG003|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
11031788|NCT00858780|12211254|FG004|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
11031789|NCT00858780|12211250|FG000|STARTED|OL Re-Treatment (Failure to Week 48)||0
11031790|NCT00858780|12211251|FG001|STARTED|OL Re-Treatment (Failure to Week 48)||0
11031791|NCT00858780|12211252|FG002|STARTED|OL Re-Treatment (Failure to Week 48)||0
11031792|NCT00858780|12211253|FG003|STARTED|OL Re-Treatment (Failure to Week 48)||0
11031793|NCT00858780|12211254|FG004|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
11031794|NCT00858780|12211250|FG000|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
11031795|NCT00858780|12211251|FG001|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
11031796|NCT00858780|12211252|FG002|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
11031797|NCT00858780|12211253|FG003|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
11031798|NCT00858780|12211254|FG004|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
11031799|NCT00858780|12211250|FG000|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
11031800|NCT00858780|12211251|FG001|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
11031801|NCT00858780|12211252|FG002|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
11031802|NCT00858780|12211253|FG003|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
11031803|NCT00858780|12211254|FG004|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
11031804|NCT00858832|12211266|FG000|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
11031805|NCT00858832|12211267|FG001|STARTED|Overall Study||23
11031806|NCT00858832|12211266|FG000|COMPLETED|Overall Study||20
11031807|NCT00858832|12211267|FG001|COMPLETED|Overall Study||22
11031808|NCT00858832|12211266|FG000|NOT COMPLETED|Overall Study||1
11031809|NCT00858832|12211267|FG001|NOT COMPLETED|Overall Study||1
11031810|NCT00858845|12211275|FG000|STARTED|Overall Study||5
11031811|NCT00858845|12211276|FG001|STARTED|Overall Study||6
11031812|NCT00858845|12211275|FG000|COMPLETED|Overall Study||5
11031813|NCT00858845|12211276|FG001|COMPLETED|Overall Study||5
11031814|NCT00858845|12211275|FG000|NOT COMPLETED|Overall Study||0
11031815|NCT00858845|12211276|FG001|NOT COMPLETED|Overall Study||1
11031816|NCT00858858|12211282|FG000|STARTED|Overall Study||60
11031817|NCT00858858|12211282|FG000|COMPLETED|Overall Study||42
11031818|NCT00858858|12211282|FG000|NOT COMPLETED|Overall Study||18
11031819|NCT00858962|12211286|FG000|STARTED|Overall Study||12
11031820|NCT00858962|12211286|FG000|COMPLETED|Overall Study||12
11031821|NCT00858962|12211286|FG000|NOT COMPLETED|Overall Study||0
11031822|NCT00858988|12211292|FG000|STARTED|Randomized and Allocation||74
11031823|NCT00858988|12211293|FG001|STARTED|Randomized and Allocation||73
11031824|NCT00858988|12211292|FG000|COMPLETED|Randomized and Allocation||74
11031825|NCT00858988|12211293|FG001|COMPLETED|Randomized and Allocation||73
11031826|NCT00858988|12211292|FG000|NOT COMPLETED|Randomized and Allocation||0
11031827|NCT00858988|12211293|FG001|NOT COMPLETED|Randomized and Allocation||0
11031828|NCT00858988|12211292|FG000|STARTED|Analysis||74
11031829|NCT00858988|12211293|FG001|STARTED|Analysis||73
11031830|NCT00858988|12211292|FG000|COMPLETED|Analysis||72
11031831|NCT00858988|12211293|FG001|COMPLETED|Analysis||72
11031832|NCT00858988|12211292|FG000|NOT COMPLETED|Analysis||2
11031833|NCT00858988|12211293|FG001|NOT COMPLETED|Analysis||1
11031834|NCT00859014|12211299|FG000|STARTED|Overall Study||25
11031835|NCT00859014|12211299|FG000|COMPLETED|Overall Study||20
11031836|NCT00859014|12211299|FG000|NOT COMPLETED|Overall Study||5
11031837|NCT00859027|12211305|FG000|STARTED|Overall Study||25
11031838|NCT00859027|12211306|FG001|STARTED|Overall Study||25
11031839|NCT00859027|12211305|FG000|COMPLETED|Overall Study||20
11031840|NCT00859027|12211306|FG001|COMPLETED|Overall Study||20
11031841|NCT00859027|12211305|FG000|NOT COMPLETED|Overall Study||5
11031842|NCT00859027|12211306|FG001|NOT COMPLETED|Overall Study||5
11031843|NCT00859040|12211314|FG000|STARTED|Overall Study||18
11031844|NCT00859040|12211315|FG001|STARTED|Overall Study||16
11031845|NCT00859040|12211314|FG000|COMPLETED|Overall Study||18
11031846|NCT00859040|12211315|FG001|COMPLETED|Overall Study||16
11031847|NCT00859040|12211314|FG000|NOT COMPLETED|Overall Study||0
11031848|NCT00859040|12211315|FG001|NOT COMPLETED|Overall Study||0
11031849|NCT00859053|12211325|FG000|STARTED|Overall Study||6
11031850|NCT00859053|12211326|FG001|STARTED|Overall Study||6
11031851|NCT00859053|12211327|FG002|STARTED|Overall Study||6
11031852|NCT00859053|12211328|FG003|STARTED|Overall Study||12
11031853|NCT00859053|12211325|FG000|COMPLETED|Overall Study||6
11031854|NCT00859053|12211326|FG001|COMPLETED|Overall Study||6
11031855|NCT00859053|12211327|FG002|COMPLETED|Overall Study||6
11031856|NCT00859053|12211328|FG003|COMPLETED|Overall Study||12
11031857|NCT00859053|12211325|FG000|NOT COMPLETED|Overall Study||0
11031858|NCT00859053|12211326|FG001|NOT COMPLETED|Overall Study||0
11031859|NCT00859053|12211327|FG002|NOT COMPLETED|Overall Study||0
11031860|NCT00859053|12211328|FG003|NOT COMPLETED|Overall Study||0
11031861|NCT00859131|12211340|FG000|STARTED|Overall Study||102
11031862|NCT00859131|12211341|FG001|STARTED|Overall Study||98
11031863|NCT00859131|12211340|FG000|COMPLETED|Overall Study||102
11031864|NCT00859131|12211341|FG001|COMPLETED|Overall Study||98
11031865|NCT00859131|12211340|FG000|NOT COMPLETED|Overall Study||0
11031866|NCT00859131|12211341|FG001|NOT COMPLETED|Overall Study||0
11031867|NCT00859222|12211350|FG000|STARTED|Overall Study||3
11031868|NCT00859222|12211351|FG001|STARTED|Overall Study||3
11031869|NCT00859222|12211352|FG002|STARTED|Overall Study||6
11031870|NCT00859222|12211353|FG003|STARTED|Overall Study||24
11031871|NCT00859222|12211354|FG004|STARTED|Overall Study||15
11031872|NCT00859222|12211350|FG000|COMPLETED|Overall Study||0
11031873|NCT00859222|12211351|FG001|COMPLETED|Overall Study||0
11031874|NCT00859222|12211352|FG002|COMPLETED|Overall Study||0
11031875|NCT00859222|12211353|FG003|COMPLETED|Overall Study||0
11031876|NCT00859222|12211354|FG004|COMPLETED|Overall Study||0
11031877|NCT00859222|12211350|FG000|NOT COMPLETED|Overall Study||3
11031878|NCT00859222|12211351|FG001|NOT COMPLETED|Overall Study||3
11031879|NCT00859222|12211352|FG002|NOT COMPLETED|Overall Study||6
11031880|NCT00859222|12211353|FG003|NOT COMPLETED|Overall Study||24
11031881|NCT00859222|12211354|FG004|NOT COMPLETED|Overall Study||15
11031882|NCT00859313|12211369|FG000|STARTED|Overall Study||30
11031883|NCT00859313|12211369|FG000|COMPLETED|Overall Study||26
11031884|NCT00859313|12211369|FG000|NOT COMPLETED|Overall Study||4
11031885|NCT00859339|12211373|FG000|STARTED|Overall Study||9
11031886|NCT00859339|12211373|FG000|COMPLETED|Overall Study||9
11031887|NCT00859339|12211373|FG000|NOT COMPLETED|Overall Study||0
11031888|NCT00859456|12211377|FG000|STARTED|Overall Study||9
11031889|NCT00859456|12211377|FG000|COMPLETED|Overall Study||1
11031890|NCT00859456|12211377|FG000|NOT COMPLETED|Overall Study||8
11031891|NCT00859469|12211381|FG000|STARTED|Overall Study||29
11031892|NCT00859469|12211381|FG000|6 Cycles|Overall Study||16
11031893|NCT00859469|12211381|FG000|COMPLETED|Overall Study||1
11031894|NCT00859469|12211381|FG000|NOT COMPLETED|Overall Study||28
11031895|NCT00859495|12211385|FG000|STARTED|Overall Study||9
11031896|NCT00859495|12211385|FG000|COMPLETED|Overall Study||9
11031897|NCT00859495|12211385|FG000|NOT COMPLETED|Overall Study||0
11031898|NCT00859508|12211391|FG000|STARTED|Overall Study||68
11333838|NCT02841709|12531534|FG004|COMPLETED|2nd Intervention||11
11333839|NCT02841709|12531530|FG000|NOT COMPLETED|2nd Intervention||0
11333840|NCT02841709|12531531|FG001|NOT COMPLETED|2nd Intervention||0
11333841|NCT02841709|12531532|FG002|NOT COMPLETED|2nd Intervention||0
11333842|NCT02841709|12531533|FG003|NOT COMPLETED|2nd Intervention||0
11333843|NCT02841709|12531534|FG004|NOT COMPLETED|2nd Intervention||0
11333844|NCT02841709|12531530|FG000|STARTED|Washout Period 2||12
11031899|NCT00859508|12211392|FG001|STARTED|Overall Study||37
11031900|NCT00859508|12211391|FG000|COMPLETED|Overall Study||62
11031901|NCT00859508|12211392|FG001|COMPLETED|Overall Study||37
11031902|NCT00859508|12211391|FG000|NOT COMPLETED|Overall Study||6
11031903|NCT00859508|12211392|FG001|NOT COMPLETED|Overall Study||0
11031904|NCT00859547|12211398|FG000|STARTED|Overall Study||30
11031905|NCT00859547|12211398|FG000|COMPLETED|Overall Study||28
11031906|NCT00859547|12211398|FG000|NOT COMPLETED|Overall Study||2
11031907|NCT00859573|12211404|FG000|STARTED|Overall Study||6
11031908|NCT00859573|12211405|FG001|STARTED|Overall Study||3
11031909|NCT00859573|12211404|FG000|COMPLETED|Overall Study||1
11031910|NCT00859573|12211405|FG001|COMPLETED|Overall Study||1
11031911|NCT00859573|12211404|FG000|NOT COMPLETED|Overall Study||5
11031912|NCT00859573|12211405|FG001|NOT COMPLETED|Overall Study||2
11333845|NCT02841709|12531531|FG001|STARTED|Washout Period 2||11
11333846|NCT02841709|12531532|FG002|STARTED|Washout Period 2||12
11333847|NCT02841709|12531533|FG003|STARTED|Washout Period 2||12
11333848|NCT02841709|12531534|FG004|STARTED|Washout Period 2||11
11031913|NCT00859586|12211411|FG000|STARTED|Overall Study||8
11031914|NCT00859586|12211411|FG000|COMPLETED|Overall Study||4
11031915|NCT00859586|12211411|FG000|NOT COMPLETED|Overall Study||4
11031916|NCT00859638|12211417|FG000|STARTED|Overall Study||65
11031917|NCT00859638|12211418|FG001|STARTED|Overall Study||59
11031918|NCT00859638|12211417|FG000|COMPLETED|Overall Study||55
11031919|NCT00859638|12211418|FG001|COMPLETED|Overall Study||55
11031920|NCT00859638|12211417|FG000|NOT COMPLETED|Overall Study||10
11031921|NCT00859638|12211418|FG001|NOT COMPLETED|Overall Study||4
11031922|NCT00859651|12211426|FG000|STARTED|Overall Study||18
11031923|NCT00859651|12211427|FG001|STARTED|Overall Study||22
11031924|NCT00859651|12211426|FG000|COMPLETED|Overall Study||18
11031925|NCT00859651|12211427|FG001|COMPLETED|Overall Study||22
11031926|NCT00859651|12211426|FG000|NOT COMPLETED|Overall Study||0
11031927|NCT00859651|12211427|FG001|NOT COMPLETED|Overall Study||0
11031928|NCT00859833|12211433|FG000|STARTED|Overall Study||30
11031929|NCT00859833|12211433|FG000|COMPLETED|Overall Study||30
11031930|NCT00859833|12211433|FG000|NOT COMPLETED|Overall Study||0
11031931|NCT00859898|12211441|FG000|STARTED|Overall Study||211
11031932|NCT00859898|12211442|FG001|STARTED|Overall Study||219
11031933|NCT00859898|12211443|FG002|STARTED|Overall Study||208
11031934|NCT00859898|12211441|FG000|COMPLETED|Overall Study||183
11031935|NCT00859898|12211442|FG001|COMPLETED|Overall Study||188
11031936|NCT00859898|12211443|FG002|COMPLETED|Overall Study||181
11031937|NCT00859898|12211441|FG000|NOT COMPLETED|Overall Study||28
11031938|NCT00859898|12211442|FG001|NOT COMPLETED|Overall Study||31
11031939|NCT00859898|12211443|FG002|NOT COMPLETED|Overall Study||27
11031940|NCT00859937|12211454|FG000|STARTED|Overall Study||41
11031941|NCT00859937|12211455|FG001|STARTED|Overall Study||14
11031942|NCT00859937|12211454|FG000|COMPLETED|Overall Study||40
11031943|NCT00859937|12211455|FG001|COMPLETED|Overall Study||14
11031944|NCT00859937|12211454|FG000|NOT COMPLETED|Overall Study||1
11031945|NCT00859937|12211455|FG001|NOT COMPLETED|Overall Study||0
11031946|NCT00859950|12211463|FG000|STARTED|Overall Study||49
11031947|NCT00859950|12211464|FG001|STARTED|Overall Study||21
11031948|NCT00859950|12211463|FG000|COMPLETED|Overall Study||49
11031949|NCT00859950|12211464|FG001|COMPLETED|Overall Study||21
11031950|NCT00859950|12211463|FG000|NOT COMPLETED|Overall Study||0
11031951|NCT00859950|12211464|FG001|NOT COMPLETED|Overall Study||0
11031952|NCT00859976|12211472|FG000|STARTED|Overall Study||82
11031953|NCT00859976|12211473|FG001|STARTED|Overall Study||85
11031954|NCT00859976|12211472|FG000|COMPLETED|Overall Study||66
11031955|NCT00859976|12211473|FG001|COMPLETED|Overall Study||67
11031956|NCT00859976|12211472|FG000|NOT COMPLETED|Overall Study||16
11031957|NCT00859976|12211473|FG001|NOT COMPLETED|Overall Study||18
11031958|NCT00860015|12211479|FG000|STARTED|Overall Study||12
11031959|NCT00860015|12211479|FG000|COMPLETED|Overall Study||12
11031960|NCT00860015|12211479|FG000|NOT COMPLETED|Overall Study||0
11031961|NCT00860028|12211485|FG000|STARTED|Placebo Controlled Pretreatment Period||15
11031962|NCT00860028|12211486|FG001|STARTED|Placebo Controlled Pretreatment Period||15
11031963|NCT00860028|12211485|FG000|COMPLETED|Placebo Controlled Pretreatment Period||13
11031964|NCT00860028|12211486|FG001|COMPLETED|Placebo Controlled Pretreatment Period||14
11031965|NCT00860028|12211485|FG000|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
11031966|NCT00860028|12211486|FG001|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
11031967|NCT00860028|12211485|FG000|STARTED|Smoking Cessation Phase||13
11031968|NCT00860028|12211486|FG001|STARTED|Smoking Cessation Phase||14
11031969|NCT00860028|12211485|FG000|COMPLETED|Smoking Cessation Phase||13
11031970|NCT00860028|12211486|FG001|COMPLETED|Smoking Cessation Phase||12
11031971|NCT00860028|12211485|FG000|NOT COMPLETED|Smoking Cessation Phase||0
11031972|NCT00860028|12211486|FG001|NOT COMPLETED|Smoking Cessation Phase||2
11200830|NCT01829295|12391055|FG000|COMPLETED|0-6 Months||96
11200831|NCT01829295|12391056|FG001|COMPLETED|0-6 Months||98
11333849|NCT02841709|12531530|FG000|COMPLETED|Washout Period 2||12
11333850|NCT02841709|12531531|FG001|COMPLETED|Washout Period 2||11
11333851|NCT02841709|12531532|FG002|COMPLETED|Washout Period 2||12
11333852|NCT02841709|12531533|FG003|COMPLETED|Washout Period 2||12
11333853|NCT02841709|12531534|FG004|COMPLETED|Washout Period 2||11
11333854|NCT02841709|12531530|FG000|NOT COMPLETED|Washout Period 2||0
11333855|NCT02841709|12531531|FG001|NOT COMPLETED|Washout Period 2||0
11333856|NCT02841709|12531532|FG002|NOT COMPLETED|Washout Period 2||0
11333857|NCT02841709|12531533|FG003|NOT COMPLETED|Washout Period 2||0
11333858|NCT02841709|12531534|FG004|NOT COMPLETED|Washout Period 2||0
11333859|NCT02841709|12531530|FG000|STARTED|3rd Intervention||12
11333860|NCT02841709|12531531|FG001|STARTED|3rd Intervention||11
11333861|NCT02841709|12531532|FG002|STARTED|3rd Intervention||12
11333862|NCT02841709|12531533|FG003|STARTED|3rd Intervention||12
11333863|NCT02841709|12531534|FG004|STARTED|3rd Intervention||11
11333864|NCT02841709|12531530|FG000|COMPLETED|3rd Intervention||12
11333865|NCT02841709|12531531|FG001|COMPLETED|3rd Intervention||11
11333866|NCT02841709|12531532|FG002|COMPLETED|3rd Intervention||12
11333867|NCT02841709|12531533|FG003|COMPLETED|3rd Intervention||12
11333868|NCT02841709|12531534|FG004|COMPLETED|3rd Intervention||11
11333869|NCT02841709|12531530|FG000|NOT COMPLETED|3rd Intervention||0
11333870|NCT02841709|12531531|FG001|NOT COMPLETED|3rd Intervention||0
11333871|NCT02841709|12531532|FG002|NOT COMPLETED|3rd Intervention||0
11333872|NCT02841709|12531533|FG003|NOT COMPLETED|3rd Intervention||0
11333873|NCT02841709|12531534|FG004|NOT COMPLETED|3rd Intervention||0
11333874|NCT02841709|12531530|FG000|STARTED|Washout Period 3||12
11333875|NCT02841709|12531531|FG001|STARTED|Washout Period 3||11
11333876|NCT02841709|12531532|FG002|STARTED|Washout Period 3||12
11333877|NCT02841709|12531533|FG003|STARTED|Washout Period 3||12
11333878|NCT02841709|12531534|FG004|STARTED|Washout Period 3||11
11333879|NCT02841709|12531530|FG000|COMPLETED|Washout Period 3||12
11333880|NCT02841709|12531531|FG001|COMPLETED|Washout Period 3||11
11333881|NCT02841709|12531532|FG002|COMPLETED|Washout Period 3||12
11333882|NCT02841709|12531533|FG003|COMPLETED|Washout Period 3||12
11333883|NCT02841709|12531534|FG004|COMPLETED|Washout Period 3||11
11333884|NCT02841709|12531530|FG000|NOT COMPLETED|Washout Period 3||0
11333885|NCT02841709|12531531|FG001|NOT COMPLETED|Washout Period 3||0
11333886|NCT02841709|12531532|FG002|NOT COMPLETED|Washout Period 3||0
11333887|NCT02841709|12531533|FG003|NOT COMPLETED|Washout Period 3||0
11333888|NCT02841709|12531534|FG004|NOT COMPLETED|Washout Period 3||0
11031973|NCT00860067|12211497|FG000|STARTED|Overall Study||1200
11031974|NCT00860067|12211498|FG001|STARTED|Overall Study||299
11031975|NCT00860067|12211499|FG002|STARTED|Overall Study||301
11031976|NCT00860067|12211497|FG000|COMPLETED|Overall Study||1149
11031977|NCT00860067|12211498|FG001|COMPLETED|Overall Study||290
11031978|NCT00860067|12211499|FG002|COMPLETED|Overall Study||292
11031979|NCT00860067|12211497|FG000|NOT COMPLETED|Overall Study||51
11031980|NCT00860067|12211498|FG001|NOT COMPLETED|Overall Study||9
11031981|NCT00860067|12211499|FG002|NOT COMPLETED|Overall Study||9
11031982|NCT00860171|12211510|FG000|STARTED|Overall Study||16
11031983|NCT00860171|12211510|FG000|COMPLETED|Overall Study||16
11031984|NCT00860171|12211510|FG000|NOT COMPLETED|Overall Study||0
11031985|NCT00860262|12211517|FG000|STARTED|Overall Study||421
11031986|NCT00860262|12211518|FG001|STARTED|Overall Study||217
11031987|NCT00860262|12211519|FG002|STARTED|Overall Study||220
11031988|NCT00860262|12211517|FG000|COMPLETED|Overall Study||401
11031989|NCT00860262|12211518|FG001|COMPLETED|Overall Study||195
11031990|NCT00860262|12211519|FG002|COMPLETED|Overall Study||202
11031991|NCT00860262|12211517|FG000|NOT COMPLETED|Overall Study||20
11031992|NCT00860262|12211518|FG001|NOT COMPLETED|Overall Study||22
11031993|NCT00860262|12211519|FG002|NOT COMPLETED|Overall Study||18
11031994|NCT00860314|12211531|FG000|STARTED|Overall Study||48
11031995|NCT00860314|12211532|FG001|STARTED|Overall Study||48
11031996|NCT00860314|12211531|FG000|COMPLETED|Overall Study||48
11031997|NCT00860314|12211532|FG001|COMPLETED|Overall Study||48
11031998|NCT00860314|12211531|FG000|NOT COMPLETED|Overall Study||0
11031999|NCT00860314|12211532|FG001|NOT COMPLETED|Overall Study||0
11032000|NCT00860379|12211541|FG000|STARTED|Overall Study||4
11032001|NCT00860379|12211542|FG001|STARTED|Overall Study||6
11032002|NCT00860379|12211543|FG002|STARTED|Overall Study||4
11032003|NCT00860379|12211541|FG000|COMPLETED|Overall Study||4
11032004|NCT00860379|12211542|FG001|COMPLETED|Overall Study||6
11032005|NCT00860379|12211543|FG002|COMPLETED|Overall Study||4
11200832|NCT01829295|12391057|FG002|COMPLETED|0-6 Months||0
11200833|NCT01829295|12391058|FG003|COMPLETED|0-6 Months||0
11200834|NCT01829295|12391055|FG000|NOT COMPLETED|0-6 Months||11
11200835|NCT01829295|12391056|FG001|NOT COMPLETED|0-6 Months||11
11200836|NCT01829295|12391057|FG002|NOT COMPLETED|0-6 Months||0
11200837|NCT01829295|12391058|FG003|NOT COMPLETED|0-6 Months||0
11200838|NCT01829295|12391055|FG000|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64
11032006|NCT00860379|12211541|FG000|NOT COMPLETED|Overall Study||0
11032007|NCT00860379|12211542|FG001|NOT COMPLETED|Overall Study||0
11032008|NCT00860379|12211543|FG002|NOT COMPLETED|Overall Study||0
11032009|NCT00860405|12211553|FG000|STARTED|Overall Study||31
11032010|NCT00860405|12211554|FG001|STARTED|Overall Study||30
11032011|NCT00860405|12211553|FG000|Completed Treatment|Overall Study||31
11032012|NCT00860405|12211554|FG001|Completed Treatment|Overall Study||29
11032013|NCT00860405|12211553|FG000|Day 28 Follow-up Performed|Overall Study||31
11032014|NCT00860405|12211554|FG001|Day 28 Follow-up Performed|Overall Study||29
11032015|NCT00860405|12211553|FG000|COMPLETED|Overall Study|completed overall study|26
11032016|NCT00860405|12211554|FG001|COMPLETED|Overall Study||26
11032017|NCT00860405|12211553|FG000|NOT COMPLETED|Overall Study||5
11032018|NCT00860405|12211554|FG001|NOT COMPLETED|Overall Study||4
11032019|NCT00860457|12211560|FG000|STARTED|Overall Study||22
11032020|NCT00860457|12211560|FG000|COMPLETED|Overall Study||11
11032021|NCT00860457|12211560|FG000|NOT COMPLETED|Overall Study||11
11032022|NCT00860470|12211566|FG000|STARTED|Overall Study||22162
11032023|NCT00860470|12211567|FG001|STARTED|Overall Study||22405
11032024|NCT00860470|12211566|FG000|COMPLETED|Overall Study||22114
11032025|NCT00860470|12211567|FG001|COMPLETED|Overall Study||22346
11032026|NCT00860470|12211566|FG000|NOT COMPLETED|Overall Study||48
11032027|NCT00860470|12211567|FG001|NOT COMPLETED|Overall Study||59
11032028|NCT00860535|12211573|FG000|STARTED|Overall Study||9
11032029|NCT00860535|12211573|FG000|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
11032030|NCT00860535|12211573|FG000|COMPLETED|Overall Study||8
11032031|NCT00860535|12211573|FG000|NOT COMPLETED|Overall Study||1
11032032|NCT00860574|12211577|FG000|STARTED|Overall Study||96
11032033|NCT00860574|12211577|FG000|COMPLETED|Overall Study||93
11032034|NCT00860574|12211577|FG000|NOT COMPLETED|Overall Study||3
11032035|NCT00860743|12211587|FG000|STARTED|Overall Study||40
11032036|NCT00860743|12211588|FG001|STARTED|Overall Study||23
11032037|NCT00860743|12211587|FG000|COMPLETED|Overall Study||37
11032038|NCT00860743|12211588|FG001|COMPLETED|Overall Study||23
11032039|NCT00860743|12211587|FG000|NOT COMPLETED|Overall Study||3
11032040|NCT00860743|12211588|FG001|NOT COMPLETED|Overall Study||0
11032041|NCT00860795|12211596|FG000|STARTED|Overall Study||10
11032042|NCT00860795|12211597|FG001|STARTED|Overall Study||10
11032043|NCT00860795|12211596|FG000|Number to Complete Study Medication|Overall Study||9
11032044|NCT00860795|12211597|FG001|Number to Complete Study Medication|Overall Study||10
11032045|NCT00860795|12211596|FG000|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
11032046|NCT00860795|12211597|FG001|COMPLETED|Overall Study||10
11032047|NCT00860795|12211596|FG000|NOT COMPLETED|Overall Study||0
11032048|NCT00860795|12211597|FG001|NOT COMPLETED|Overall Study||0
11032049|NCT00860847|12211605|FG000|STARTED|Overall Study||32
11032050|NCT00860847|12211606|FG001|STARTED|Overall Study||33
11032051|NCT00860847|12211605|FG000|COMPLETED|Overall Study||28
11032052|NCT00860847|12211606|FG001|COMPLETED|Overall Study||28
11032053|NCT00860847|12211605|FG000|NOT COMPLETED|Overall Study||4
11032054|NCT00860847|12211606|FG001|NOT COMPLETED|Overall Study||5
11032055|NCT00860938|12211614|FG000|STARTED|Overall Study||45
11032056|NCT00860938|12211615|FG001|STARTED|Overall Study||45
11032057|NCT00860938|12211614|FG000|COMPLETED|Overall Study||31
11032058|NCT00860938|12211615|FG001|COMPLETED|Overall Study||37
11032059|NCT00860938|12211614|FG000|NOT COMPLETED|Overall Study||14
11032060|NCT00860938|12211615|FG001|NOT COMPLETED|Overall Study||8
11032061|NCT00860951|12211621|FG000|STARTED|Overall Study||29
11032062|NCT00860951|12211621|FG000|COMPLETED|Overall Study||22
11032063|NCT00860951|12211621|FG000|NOT COMPLETED|Overall Study||7
11032064|NCT00861146|12211629|FG000|STARTED|Overall Study||105
11032065|NCT00861146|12211630|FG001|STARTED|Overall Study||46
11333889|NCT02841709|12531530|FG000|STARTED|4th Intervention||12
11333890|NCT02841709|12531531|FG001|STARTED|4th Intervention||11
11333891|NCT02841709|12531532|FG002|STARTED|4th Intervention||12
11333892|NCT02841709|12531533|FG003|STARTED|4th Intervention||12
11333893|NCT02841709|12531534|FG004|STARTED|4th Intervention||11
11333894|NCT02841709|12531530|FG000|COMPLETED|4th Intervention||12
11333895|NCT02841709|12531531|FG001|COMPLETED|4th Intervention||11
11333896|NCT02841709|12531532|FG002|COMPLETED|4th Intervention||12
11333897|NCT02841709|12531533|FG003|COMPLETED|4th Intervention||12
11333898|NCT02841709|12531534|FG004|COMPLETED|4th Intervention||11
11333899|NCT02841709|12531530|FG000|NOT COMPLETED|4th Intervention||0
11333900|NCT02841709|12531531|FG001|NOT COMPLETED|4th Intervention||0
11333901|NCT02841709|12531532|FG002|NOT COMPLETED|4th Intervention||0
11333902|NCT02841709|12531533|FG003|NOT COMPLETED|4th Intervention||0
11333903|NCT02841709|12531534|FG004|NOT COMPLETED|4th Intervention||0
11333904|NCT02841709|12531530|FG000|STARTED|Washout Period 4||12
11333905|NCT02841709|12531531|FG001|STARTED|Washout Period 4||11
11333906|NCT02841709|12531532|FG002|STARTED|Washout Period 4||12
11032066|NCT00861146|12211629|FG000|Week 2 Assessment|Overall Study||97
11032067|NCT00861146|12211630|FG001|Week 2 Assessment|Overall Study||45
11032068|NCT00861146|12211629|FG000|Week 13 Assessment|Overall Study||85
11333907|NCT02841709|12531533|FG003|STARTED|Washout Period 4||12
11333908|NCT02841709|12531534|FG004|STARTED|Washout Period 4||11
11333909|NCT02841709|12531530|FG000|COMPLETED|Washout Period 4||12
11333910|NCT02841709|12531531|FG001|COMPLETED|Washout Period 4||11
11333911|NCT02841709|12531532|FG002|COMPLETED|Washout Period 4||12
11333912|NCT02841709|12531533|FG003|COMPLETED|Washout Period 4||12
11333913|NCT02841709|12531534|FG004|COMPLETED|Washout Period 4||11
11333914|NCT02841709|12531530|FG000|NOT COMPLETED|Washout Period 4||0
11333915|NCT02841709|12531531|FG001|NOT COMPLETED|Washout Period 4||0
11333916|NCT02841709|12531532|FG002|NOT COMPLETED|Washout Period 4||0
11333917|NCT02841709|12531533|FG003|NOT COMPLETED|Washout Period 4||0
11333918|NCT02841709|12531534|FG004|NOT COMPLETED|Washout Period 4||0
11333919|NCT02841709|12531530|FG000|STARTED|5th Intervention||12
11333920|NCT02841709|12531531|FG001|STARTED|5th Intervention||11
11333921|NCT02841709|12531532|FG002|STARTED|5th Intervention||12
11333922|NCT02841709|12531533|FG003|STARTED|5th Intervention||12
11333923|NCT02841709|12531534|FG004|STARTED|5th Intervention||11
11333924|NCT02841709|12531530|FG000|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 1.|10
11333925|NCT02841709|12531531|FG001|COMPLETED|5th Intervention||11
11333926|NCT02841709|12531532|FG002|COMPLETED|5th Intervention||12
11333927|NCT02841709|12531533|FG003|COMPLETED|5th Intervention||12
11333928|NCT02841709|12531534|FG004|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 5.|9
11333929|NCT02841709|12531530|FG000|NOT COMPLETED|5th Intervention||2
11333930|NCT02841709|12531531|FG001|NOT COMPLETED|5th Intervention||0
11333931|NCT02841709|12531532|FG002|NOT COMPLETED|5th Intervention||0
11333932|NCT02841709|12531533|FG003|NOT COMPLETED|5th Intervention||0
11333933|NCT02841709|12531534|FG004|NOT COMPLETED|5th Intervention||2
11333934|NCT02841787|12531550|FG000|STARTED|Overall Study||12
11333935|NCT02841787|12531551|FG001|STARTED|Overall Study||23
11333936|NCT02841787|12531552|FG002|STARTED|Overall Study||12
11333937|NCT02841787|12531550|FG000|COMPLETED|Overall Study||9
11333938|NCT02841787|12531551|FG001|COMPLETED|Overall Study||19
11333939|NCT02841787|12531552|FG002|COMPLETED|Overall Study||12
11333940|NCT02841787|12531550|FG000|NOT COMPLETED|Overall Study||3
11333941|NCT02841787|12531551|FG001|NOT COMPLETED|Overall Study||4
11333942|NCT02841787|12531552|FG002|NOT COMPLETED|Overall Study||0
11333943|NCT02842060|12531562|FG000|STARTED|Overall Study||120
11333944|NCT02842060|12531563|FG001|STARTED|Overall Study||60
11333945|NCT02842060|12531562|FG000|COMPLETED|Overall Study||120
11333946|NCT02842060|12531563|FG001|COMPLETED|Overall Study||60
11333947|NCT02842060|12531562|FG000|NOT COMPLETED|Overall Study||0
11333948|NCT02842060|12531563|FG001|NOT COMPLETED|Overall Study||0
11333949|NCT02842073|12531569|FG000|STARTED|Overall Study||12
11333950|NCT02842073|12531569|FG000|COMPLETED|Overall Study||11
11333951|NCT02842073|12531569|FG000|NOT COMPLETED|Overall Study||1
11333952|NCT02842151|12531573|FG000|STARTED|Overall Study||150
11333953|NCT02842151|12531573|FG000|COMPLETED|Overall Study||148
11333954|NCT02842151|12531573|FG000|NOT COMPLETED|Overall Study||2
11333955|NCT02842242|12531581|FG000|STARTED|Overall Study||11
11333956|NCT02842242|12531582|FG001|STARTED|Overall Study||10
11333957|NCT02842242|12531581|FG000|COMPLETED|Overall Study||10
11333958|NCT02842242|12531582|FG001|COMPLETED|Overall Study||10
11333959|NCT02842242|12531581|FG000|NOT COMPLETED|Overall Study||1
11333960|NCT02842242|12531582|FG001|NOT COMPLETED|Overall Study||0
11333961|NCT02842736|12531588|FG000|STARTED|Overall Study|Treated|242
11333962|NCT02842736|12531588|FG000|Known Month 12 Outcome|Overall Study||230
11333963|NCT02842736|12531588|FG000|24 Month Visit Performed|Overall Study||210
11333964|NCT02842736|12531588|FG000|COMPLETED|Overall Study|36 Month Visit Completed|201
11333965|NCT02842736|12531588|FG000|NOT COMPLETED|Overall Study||41
11333966|NCT02843178|12531596|FG000|STARTED|Overall Study||86
11333967|NCT02843178|12531597|FG001|STARTED|Overall Study||90
11333968|NCT02843178|12531598|FG002|STARTED|Overall Study||92
11333969|NCT02843178|12531599|FG003|STARTED|Overall Study||91
11333970|NCT02843178|12531596|FG000|COMPLETED|Overall Study||78
11333971|NCT02843178|12531597|FG001|COMPLETED|Overall Study||82
11333972|NCT02843178|12531598|FG002|COMPLETED|Overall Study||85
11333973|NCT02843178|12531599|FG003|COMPLETED|Overall Study||87
11333974|NCT02843178|12531596|FG000|NOT COMPLETED|Overall Study||8
11333975|NCT02843178|12531597|FG001|NOT COMPLETED|Overall Study||8
11333976|NCT02843178|12531598|FG002|NOT COMPLETED|Overall Study||7
11333977|NCT02843178|12531599|FG003|NOT COMPLETED|Overall Study||4
11333978|NCT02843529|12531611|FG000|STARTED|Overall Study||244
11333979|NCT02843529|12531612|FG001|STARTED|Overall Study||304
11333980|NCT02843529|12531611|FG000|COMPLETED|Overall Study||213
11333981|NCT02843529|12531612|FG001|COMPLETED|Overall Study||283
11333982|NCT02843529|12531611|FG000|NOT COMPLETED|Overall Study||31
11333983|NCT02843529|12531612|FG001|NOT COMPLETED|Overall Study||21
11333984|NCT02843659|12531621|FG000|STARTED|Overall Study||5
11333985|NCT02843659|12531622|FG001|STARTED|Overall Study||6
11333986|NCT02843659|12531623|FG002|STARTED|Overall Study||7
11032069|NCT00861146|12211630|FG001|Week 13 Assessment|Overall Study||38
11032070|NCT00861146|12211629|FG000|COMPLETED|Overall Study||85
11032071|NCT00861146|12211630|FG001|COMPLETED|Overall Study||38
11333987|NCT02843659|12531621|FG000|COMPLETED|Overall Study||1
11333988|NCT02843659|12531622|FG001|COMPLETED|Overall Study||0
11333989|NCT02843659|12531623|FG002|COMPLETED|Overall Study||2
11333990|NCT02843659|12531621|FG000|NOT COMPLETED|Overall Study||4
11333991|NCT02843659|12531622|FG001|NOT COMPLETED|Overall Study||6
11333992|NCT02843659|12531623|FG002|NOT COMPLETED|Overall Study||5
11333993|NCT02844439|12531631|FG000|STARTED|Overall Study|"All Subjects with Glioblastoma:~24 subjects with EGFR-gene amplified + 16 subjects without EGFR gene-amplified nor EGFRvIII^pos"|40
11032072|NCT00861146|12211629|FG000|NOT COMPLETED|Overall Study||20
11032073|NCT00861146|12211630|FG001|NOT COMPLETED|Overall Study||8
11032074|NCT00861198|12211636|FG000|STARTED|Overall Study||75
11032075|NCT00861198|12211636|FG000|COMPLETED|Overall Study||70
11032076|NCT00861198|12211636|FG000|NOT COMPLETED|Overall Study||5
11032077|NCT00861263|12211640|FG000|STARTED|Overall Study||193
11032078|NCT00861263|12211640|FG000|COMPLETED|Overall Study||193
11032079|NCT00861263|12211640|FG000|NOT COMPLETED|Overall Study||0
11032080|NCT00861341|12211644|FG000|STARTED|Overall Study||40
11032081|NCT00861341|12211644|FG000|COMPLETED|Overall Study||38
11032082|NCT00861341|12211644|FG000|NOT COMPLETED|Overall Study||2
11032083|NCT00861380|12211655|FG000|STARTED|Overall Study||8427
11032084|NCT00861380|12211656|FG001|STARTED|Overall Study||9112
11032085|NCT00861380|12211657|FG002|STARTED|Overall Study||8872
11032086|NCT00861380|12211658|FG003|STARTED|Overall Study||3689
11032087|NCT00861380|12211659|FG004|STARTED|Overall Study||1812
11032088|NCT00861380|12211660|FG005|STARTED|Overall Study||6249
11032089|NCT00861380|12211661|FG006|STARTED|Overall Study||3020
11032090|NCT00861380|12211655|FG000|COMPLETED|Overall Study||0
11032091|NCT00861380|12211656|FG001|COMPLETED|Overall Study||0
11032092|NCT00861380|12211657|FG002|COMPLETED|Overall Study||0
11032093|NCT00861380|12211658|FG003|COMPLETED|Overall Study||0
11032094|NCT00861380|12211659|FG004|COMPLETED|Overall Study||0
11032095|NCT00861380|12211660|FG005|COMPLETED|Overall Study||0
11032096|NCT00861380|12211661|FG006|COMPLETED|Overall Study||0
11032097|NCT00861380|12211655|FG000|NOT COMPLETED|Overall Study||8427
11032098|NCT00861380|12211656|FG001|NOT COMPLETED|Overall Study||9112
11032099|NCT00861380|12211657|FG002|NOT COMPLETED|Overall Study||8872
11032100|NCT00861380|12211658|FG003|NOT COMPLETED|Overall Study||3689
11032101|NCT00861380|12211659|FG004|NOT COMPLETED|Overall Study||1812
11032102|NCT00861380|12211660|FG005|NOT COMPLETED|Overall Study||6249
11032103|NCT00861380|12211661|FG006|NOT COMPLETED|Overall Study||3020
11032104|NCT00861471|12211694|FG000|STARTED|Overall Study||12
11032105|NCT00861471|12211694|FG000|COMPLETED|Overall Study||3
11032106|NCT00861471|12211694|FG000|NOT COMPLETED|Overall Study||9
11032107|NCT00861601|12211701|FG000|STARTED|Overall Study||12
11032108|NCT00861601|12211702|FG001|STARTED|Overall Study||14
11032109|NCT00861601|12211703|FG002|STARTED|Overall Study||12
11032110|NCT00861601|12211701|FG000|COMPLETED|Overall Study||12
11032111|NCT00861601|12211702|FG001|COMPLETED|Overall Study||14
11032112|NCT00861601|12211703|FG002|COMPLETED|Overall Study||12
11032113|NCT00861601|12211701|FG000|NOT COMPLETED|Overall Study||0
11032114|NCT00861601|12211702|FG001|NOT COMPLETED|Overall Study||0
11032115|NCT00861601|12211703|FG002|NOT COMPLETED|Overall Study||0
11032116|NCT00861614|12211716|FG000|STARTED|Overall Study||393
11032117|NCT00861614|12211717|FG001|STARTED|Overall Study||396
11032118|NCT00861614|12211716|FG000|COMPLETED|Overall Study||22
11032119|NCT00861614|12211717|FG001|COMPLETED|Overall Study||28
11032120|NCT00861614|12211716|FG000|NOT COMPLETED|Overall Study||371
11032121|NCT00861614|12211717|FG001|NOT COMPLETED|Overall Study||368
11032122|NCT00861692|12211723|FG000|STARTED|Overall Study||20
11032123|NCT00861692|12211723|FG000|COMPLETED|Overall Study||14
11032124|NCT00861692|12211723|FG000|NOT COMPLETED|Overall Study||6
11032125|NCT00861744|12211731|FG000|STARTED|Overall Study||304
11032126|NCT00861744|12211732|FG001|STARTED|Overall Study||304
11032127|NCT00861744|12211733|FG002|STARTED|Overall Study||304
11032128|NCT00861744|12211734|FG003|STARTED|Overall Study||308
11032129|NCT00861744|12211731|FG000|COMPLETED|Overall Study||287
11032130|NCT00861744|12211732|FG001|COMPLETED|Overall Study||275
11032131|NCT00861744|12211733|FG002|COMPLETED|Overall Study||280
11032132|NCT00861744|12211734|FG003|COMPLETED|Overall Study||275
11032133|NCT00861744|12211731|FG000|NOT COMPLETED|Overall Study||17
11032134|NCT00861744|12211732|FG001|NOT COMPLETED|Overall Study||29
11032135|NCT00861744|12211733|FG002|NOT COMPLETED|Overall Study||24
11032136|NCT00861744|12211734|FG003|NOT COMPLETED|Overall Study||33
11032137|NCT00861757|12211748|FG000|STARTED|Overall Study||154
11032138|NCT00861757|12211749|FG001|STARTED|Overall Study||151
11032139|NCT00861757|12211750|FG002|STARTED|Overall Study||155
11032140|NCT00861757|12211751|FG003|STARTED|Overall Study||152
11032141|NCT00861757|12211748|FG000|COMPLETED|Overall Study||145
11032142|NCT00861757|12211749|FG001|COMPLETED|Overall Study||136
11032143|NCT00861757|12211750|FG002|COMPLETED|Overall Study||137
11032144|NCT00861757|12211751|FG003|COMPLETED|Overall Study||143
11032145|NCT00861757|12211748|FG000|NOT COMPLETED|Overall Study||9
11032146|NCT00861757|12211749|FG001|NOT COMPLETED|Overall Study||15
11032147|NCT00861757|12211750|FG002|NOT COMPLETED|Overall Study||18
11032148|NCT00861757|12211751|FG003|NOT COMPLETED|Overall Study||9
11032149|NCT00861913|12211765|FG000|STARTED|Overall Study||13
11032150|NCT00861913|12211765|FG000|COMPLETED|Overall Study||13
11032151|NCT00861913|12211765|FG000|NOT COMPLETED|Overall Study||0
11032152|NCT00862082|12211771|FG000|STARTED|Overall Study||8
11032153|NCT00862082|12211772|FG001|STARTED|Overall Study||6
11032154|NCT00862082|12211771|FG000|COMPLETED|Overall Study||3
11032155|NCT00862082|12211772|FG001|COMPLETED|Overall Study||5
11032156|NCT00862082|12211771|FG000|NOT COMPLETED|Overall Study||5
11032157|NCT00862082|12211772|FG001|NOT COMPLETED|Overall Study||1
11032158|NCT00862121|12211787|FG000|STARTED|Overall Study||8
11032159|NCT00862121|12211788|FG001|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
11032160|NCT00862121|12211787|FG000|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
11032161|NCT00862121|12211788|FG001|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
11057530|NCT00998400|12239140|FG001|STARTED|Overall Study||50
11057531|NCT00998400|12239139|FG000|COMPLETED|Overall Study||48
11032162|NCT00862121|12211787|FG000|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
11032163|NCT00862121|12211788|FG001|Safety Analysis Set|Overall Study||11
11032164|NCT00862121|12211787|FG000|COMPLETED|Overall Study||7
11032165|NCT00862121|12211788|FG001|COMPLETED|Overall Study||4
11032166|NCT00862121|12211787|FG000|NOT COMPLETED|Overall Study||1
11032167|NCT00862121|12211788|FG001|NOT COMPLETED|Overall Study||8
11032168|NCT00862134|12211796|FG000|STARTED|Overall Study||19
11032169|NCT00862134|12211797|FG001|STARTED|Overall Study||23
11032170|NCT00862134|12211796|FG000|COMPLETED|Overall Study||8
11032171|NCT00862134|12211797|FG001|COMPLETED|Overall Study||11
11032172|NCT00862134|12211796|FG000|NOT COMPLETED|Overall Study||11
11032173|NCT00862134|12211797|FG001|NOT COMPLETED|Overall Study||12
11032174|NCT00862186|12211803|FG000|STARTED|Overall Study||15
11032175|NCT00862186|12211803|FG000|COMPLETED|Overall Study||15
11032176|NCT00862186|12211803|FG000|NOT COMPLETED|Overall Study||0
11032177|NCT00862277|12211811|FG000|STARTED|Overall Study||561
11032178|NCT00862277|12211812|FG001|STARTED|Overall Study||96
11032179|NCT00862277|12211813|FG002|STARTED|Overall Study||105
11032180|NCT00862277|12211811|FG000|COMPLETED|Overall Study||560
11032181|NCT00862277|12211812|FG001|COMPLETED|Overall Study||94
11032182|NCT00862277|12211813|FG002|COMPLETED|Overall Study||100
11032183|NCT00862277|12211811|FG000|NOT COMPLETED|Overall Study||1
11032184|NCT00862277|12211812|FG001|NOT COMPLETED|Overall Study||2
11032185|NCT00862277|12211813|FG002|NOT COMPLETED|Overall Study||5
11032186|NCT00862446|12211821|FG000|STARTED|Overall Study||48
11032187|NCT00862446|12211821|FG000|COMPLETED|Overall Study||48
11032188|NCT00862446|12211821|FG000|NOT COMPLETED|Overall Study||0
11032189|NCT00862459|12211828|FG000|STARTED|Overall Study||72
11032190|NCT00862459|12211829|FG001|STARTED|Overall Study||93
11032191|NCT00862459|12211830|FG002|STARTED|Overall Study||72
11032192|NCT00862459|12211828|FG000|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
11032193|NCT00862459|12211829|FG001|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
11032194|NCT00862459|12211830|FG002|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
11032195|NCT00862459|12211828|FG000|COMPLETED|Overall Study||66
11032196|NCT00862459|12211829|FG001|COMPLETED|Overall Study||85
11032197|NCT00862459|12211830|FG002|COMPLETED|Overall Study||66
11032198|NCT00862459|12211828|FG000|NOT COMPLETED|Overall Study||6
11032199|NCT00862459|12211829|FG001|NOT COMPLETED|Overall Study||8
11032200|NCT00862459|12211830|FG002|NOT COMPLETED|Overall Study||6
11032201|NCT00862537|12211839|FG000|STARTED|Overall Study||18
11032202|NCT00862537|12211839|FG000|COMPLETED|Overall Study||11
11032203|NCT00862537|12211839|FG000|NOT COMPLETED|Overall Study||7
11032204|NCT00862563|12211847|FG000|STARTED|Overall Study||19
11032205|NCT00862563|12211848|FG001|STARTED|Overall Study||21
11032206|NCT00862563|12211849|FG002|STARTED|Overall Study||21
11032207|NCT00862563|12211850|FG003|STARTED|Overall Study||24
11032208|NCT00862563|12211847|FG000|COMPLETED|Overall Study||15
11032209|NCT00862563|12211848|FG001|COMPLETED|Overall Study||17
11032210|NCT00862563|12211849|FG002|COMPLETED|Overall Study||15
11032211|NCT00862563|12211850|FG003|COMPLETED|Overall Study||19
11032212|NCT00862563|12211847|FG000|NOT COMPLETED|Overall Study||4
11333994|NCT02844439|12531631|FG000|Subpopulation A (EGFR Gene Amplified Glioblastoma)|Overall Study||24
11333995|NCT02844439|12531631|FG000|Subpopulation B (EGFRvIII^Pos Glioblastoma)|Overall Study||11
11333996|NCT02844439|12531631|FG000|COMPLETED|Overall Study||0
11333997|NCT02844439|12531631|FG000|NOT COMPLETED|Overall Study||40
11333998|NCT02844543|12531642|FG000|STARTED|Overall Study||155
11333999|NCT02844543|12531642|FG000|COMPLETED|Overall Study||150
11334000|NCT02844543|12531642|FG000|NOT COMPLETED|Overall Study||5
11334001|NCT02844569|12531648|FG000|STARTED|Overall Study||12
11334002|NCT02844569|12531649|FG001|STARTED|Overall Study||12
11032213|NCT00862563|12211848|FG001|NOT COMPLETED|Overall Study||4
11032214|NCT00862563|12211849|FG002|NOT COMPLETED|Overall Study||6
11032215|NCT00862563|12211850|FG003|NOT COMPLETED|Overall Study||5
11032216|NCT00862641|12211873|FG000|STARTED|Overall Study||177
11032217|NCT00862641|12211874|FG001|STARTED|Overall Study||360
11032218|NCT00862641|12211875|FG002|STARTED|Overall Study||152
11032219|NCT00862641|12211876|FG003|STARTED|Overall Study||320
11032220|NCT00862641|12211873|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
11032221|NCT00862641|12211874|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
11032222|NCT00862641|12211875|FG002|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
11032223|NCT00862641|12211876|FG003|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
11032224|NCT00862641|12211873|FG000|NOT COMPLETED|Overall Study||1
11032225|NCT00862641|12211874|FG001|NOT COMPLETED|Overall Study||4
11032226|NCT00862641|12211875|FG002|NOT COMPLETED|Overall Study||1
11032227|NCT00862641|12211876|FG003|NOT COMPLETED|Overall Study||4
11032228|NCT00862654|12211890|FG000|STARTED|Overall Study||82
11032229|NCT00862654|12211891|FG001|STARTED|Overall Study||82
11032230|NCT00862654|12211892|FG002|STARTED|Overall Study||82
11032231|NCT00862654|12211893|FG003|STARTED|Overall Study||80
11032232|NCT00862654|12211890|FG000|COMPLETED|Overall Study||76
11032233|NCT00862654|12211891|FG001|COMPLETED|Overall Study||74
11032234|NCT00862654|12211892|FG002|COMPLETED|Overall Study||76
11032235|NCT00862654|12211893|FG003|COMPLETED|Overall Study||74
11032236|NCT00862654|12211890|FG000|NOT COMPLETED|Overall Study||6
11334003|NCT02844569|12531648|FG000|COMPLETED|Overall Study||12
11032237|NCT00862654|12211891|FG001|NOT COMPLETED|Overall Study||8
11032238|NCT00862654|12211892|FG002|NOT COMPLETED|Overall Study||6
11032239|NCT00862654|12211893|FG003|NOT COMPLETED|Overall Study||6
11032240|NCT00862719|12211907|FG000|STARTED|Overall Study||17
11032241|NCT00862719|12211908|FG001|STARTED|Overall Study||7
11032242|NCT00862719|12211909|FG002|STARTED|Overall Study||4
11032243|NCT00862719|12211910|FG003|STARTED|Overall Study||1
11032244|NCT00862719|12211907|FG000|COMPLETED|Overall Study||7
11032245|NCT00862719|12211908|FG001|COMPLETED|Overall Study||1
11032246|NCT00862719|12211909|FG002|COMPLETED|Overall Study||0
11032247|NCT00862719|12211910|FG003|COMPLETED|Overall Study||0
11032248|NCT00862719|12211907|FG000|NOT COMPLETED|Overall Study||10
11032249|NCT00862719|12211908|FG001|NOT COMPLETED|Overall Study||6
11032250|NCT00862719|12211909|FG002|NOT COMPLETED|Overall Study||4
11032251|NCT00862719|12211910|FG003|NOT COMPLETED|Overall Study||1
11032252|NCT00862745|12211922|FG000|STARTED|Randomized Control Trial||322
11032253|NCT00862745|12211923|FG001|STARTED|Randomized Control Trial||323
11032254|NCT00862745|12211922|FG000|COMPLETED|Randomized Control Trial||284
11032255|NCT00862745|12211923|FG001|COMPLETED|Randomized Control Trial||284
11032256|NCT00862745|12211922|FG000|NOT COMPLETED|Randomized Control Trial||38
11032257|NCT00862745|12211923|FG001|NOT COMPLETED|Randomized Control Trial||39
11032258|NCT00862745|12211922|FG000|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
11032259|NCT00862745|12211923|FG001|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
11032260|NCT00862745|12211922|FG000|COMPLETED|Open-label Follow-up||229
11032261|NCT00862745|12211923|FG001|COMPLETED|Open-label Follow-up||225
11032262|NCT00862745|12211922|FG000|NOT COMPLETED|Open-label Follow-up||39
11032263|NCT00862745|12211923|FG001|NOT COMPLETED|Open-label Follow-up||49
11032264|NCT00862784|12211929|FG000|STARTED|Overall Study||48
11032265|NCT00862784|12211929|FG000|Received Any Amount of Study Drug|Overall Study||48
11032266|NCT00862784|12211929|FG000|COMPLETED|Overall Study||48
11032267|NCT00862784|12211929|FG000|NOT COMPLETED|Overall Study||0
11032268|NCT00862810|12211935|FG000|STARTED|Overall Study||33
11032269|NCT00862810|12211936|FG001|STARTED|Overall Study||39
11032270|NCT00862810|12211935|FG000|COMPLETED|Overall Study||29
11032271|NCT00862810|12211936|FG001|COMPLETED|Overall Study||35
11032272|NCT00862810|12211935|FG000|NOT COMPLETED|Overall Study||4
11032273|NCT00862810|12211936|FG001|NOT COMPLETED|Overall Study||4
11032274|NCT00862823|12211942|FG000|STARTED|First Intervention||6
11032275|NCT00862823|12211943|FG001|STARTED|First Intervention||10
11032276|NCT00862823|12211942|FG000|COMPLETED|First Intervention||5
11032277|NCT00862823|12211943|FG001|COMPLETED|First Intervention||9
11032278|NCT00862823|12211942|FG000|NOT COMPLETED|First Intervention||1
11032279|NCT00862823|12211943|FG001|NOT COMPLETED|First Intervention||1
11032280|NCT00862823|12211942|FG000|STARTED|Washout Period of 2 Weeks||5
11032281|NCT00862823|12211943|FG001|STARTED|Washout Period of 2 Weeks||9
11032282|NCT00862823|12211942|FG000|COMPLETED|Washout Period of 2 Weeks||5
11032283|NCT00862823|12211943|FG001|COMPLETED|Washout Period of 2 Weeks||9
11032284|NCT00862823|12211942|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
11032285|NCT00862823|12211943|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
11032286|NCT00862823|12211942|FG000|STARTED|Second Intervention||5
11032287|NCT00862823|12211943|FG001|STARTED|Second Intervention||9
11032288|NCT00862823|12211942|FG000|COMPLETED|Second Intervention||5
11032289|NCT00862823|12211943|FG001|COMPLETED|Second Intervention||9
11032290|NCT00862823|12211942|FG000|NOT COMPLETED|Second Intervention||0
11032291|NCT00862823|12211943|FG001|NOT COMPLETED|Second Intervention||0
11032292|NCT00862836|12211948|FG000|STARTED|Overall Study||15
11032293|NCT00862836|12211948|FG000|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
11032294|NCT00862836|12211948|FG000|Evaluable for Activity (Tumour Response)|Overall Study||10
11032295|NCT00862836|12211948|FG000|COMPLETED|Overall Study||14
11032296|NCT00862836|12211948|FG000|NOT COMPLETED|Overall Study||1
11032297|NCT00862849|12211952|FG000|STARTED|Intervention 1||3
11334004|NCT02844569|12531649|FG001|COMPLETED|Overall Study||12
11334005|NCT02844569|12531648|FG000|NOT COMPLETED|Overall Study||0
11032298|NCT00862849|12211953|FG001|STARTED|Intervention 1||5
11032299|NCT00862849|12211954|FG002|STARTED|Intervention 1||3
11032300|NCT00862849|12211955|FG003|STARTED|Intervention 1||4
11032301|NCT00862849|12211956|FG004|STARTED|Intervention 1||4
11032302|NCT00862849|12211957|FG005|STARTED|Intervention 1||3
11032303|NCT00862849|12211952|FG000|Received at Least One Dose of Study Drug|Intervention 1||3
11032304|NCT00862849|12211953|FG001|Received at Least One Dose of Study Drug|Intervention 1||5
11032305|NCT00862849|12211954|FG002|Received at Least One Dose of Study Drug|Intervention 1||3
11032306|NCT00862849|12211955|FG003|Received at Least One Dose of Study Drug|Intervention 1||4
11032307|NCT00862849|12211956|FG004|Received at Least One Dose of Study Drug|Intervention 1||4
11032308|NCT00862849|12211957|FG005|Received at Least One Dose of Study Drug|Intervention 1||3
11032309|NCT00862849|12211952|FG000|COMPLETED|Intervention 1||3
11032310|NCT00862849|12211953|FG001|COMPLETED|Intervention 1||5
11032311|NCT00862849|12211954|FG002|COMPLETED|Intervention 1||3
11032312|NCT00862849|12211955|FG003|COMPLETED|Intervention 1||4
11032313|NCT00862849|12211956|FG004|COMPLETED|Intervention 1||4
11032314|NCT00862849|12211957|FG005|COMPLETED|Intervention 1||3
11032315|NCT00862849|12211952|FG000|NOT COMPLETED|Intervention 1||0
11032316|NCT00862849|12211953|FG001|NOT COMPLETED|Intervention 1||0
11032317|NCT00862849|12211954|FG002|NOT COMPLETED|Intervention 1||0
11032318|NCT00862849|12211955|FG003|NOT COMPLETED|Intervention 1||0
11032319|NCT00862849|12211956|FG004|NOT COMPLETED|Intervention 1||0
11032320|NCT00862849|12211957|FG005|NOT COMPLETED|Intervention 1||0
11032321|NCT00862849|12211952|FG000|STARTED|Washout 1 (3 to 14 Days)||3
11032322|NCT00862849|12211953|FG001|STARTED|Washout 1 (3 to 14 Days)||5
11032323|NCT00862849|12211954|FG002|STARTED|Washout 1 (3 to 14 Days)||3
11032324|NCT00862849|12211955|FG003|STARTED|Washout 1 (3 to 14 Days)||4
11032325|NCT00862849|12211956|FG004|STARTED|Washout 1 (3 to 14 Days)||4
11032326|NCT00862849|12211957|FG005|STARTED|Washout 1 (3 to 14 Days)||3
11032327|NCT00862849|12211952|FG000|COMPLETED|Washout 1 (3 to 14 Days)||3
11032328|NCT00862849|12211953|FG001|COMPLETED|Washout 1 (3 to 14 Days)||4
11032329|NCT00862849|12211954|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3
11032330|NCT00862849|12211955|FG003|COMPLETED|Washout 1 (3 to 14 Days)||4
11032331|NCT00862849|12211956|FG004|COMPLETED|Washout 1 (3 to 14 Days)||4
11032332|NCT00862849|12211957|FG005|COMPLETED|Washout 1 (3 to 14 Days)||3
11032333|NCT00862849|12211952|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
11032334|NCT00862849|12211953|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
11032335|NCT00862849|12211954|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
11032336|NCT00862849|12211955|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
11032337|NCT00862849|12211956|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
11032338|NCT00862849|12211957|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
11032339|NCT00862849|12211952|FG000|STARTED|Intervention 2||3
11032340|NCT00862849|12211953|FG001|STARTED|Intervention 2||4
11032341|NCT00862849|12211954|FG002|STARTED|Intervention 2||3
11032342|NCT00862849|12211955|FG003|STARTED|Intervention 2||4
11032343|NCT00862849|12211956|FG004|STARTED|Intervention 2||4
11032344|NCT00862849|12211957|FG005|STARTED|Intervention 2||3
11032345|NCT00862849|12211952|FG000|COMPLETED|Intervention 2||3
11032346|NCT00862849|12211953|FG001|COMPLETED|Intervention 2||4
11032347|NCT00862849|12211954|FG002|COMPLETED|Intervention 2||3
11032348|NCT00862849|12211955|FG003|COMPLETED|Intervention 2||4
11032349|NCT00862849|12211956|FG004|COMPLETED|Intervention 2||4
11032350|NCT00862849|12211957|FG005|COMPLETED|Intervention 2||3
11032351|NCT00862849|12211952|FG000|NOT COMPLETED|Intervention 2||0
11032352|NCT00862849|12211953|FG001|NOT COMPLETED|Intervention 2||0
11032353|NCT00862849|12211954|FG002|NOT COMPLETED|Intervention 2||0
11032354|NCT00862849|12211955|FG003|NOT COMPLETED|Intervention 2||0
11032355|NCT00862849|12211956|FG004|NOT COMPLETED|Intervention 2||0
11032356|NCT00862849|12211957|FG005|NOT COMPLETED|Intervention 2||0
11032357|NCT00862849|12211952|FG000|STARTED|Washout 2 (3 to 14 Days)||3
11032358|NCT00862849|12211953|FG001|STARTED|Washout 2 (3 to 14 Days)||4
11032359|NCT00862849|12211954|FG002|STARTED|Washout 2 (3 to 14 Days)||3
11032360|NCT00862849|12211955|FG003|STARTED|Washout 2 (3 to 14 Days)||4
11032361|NCT00862849|12211956|FG004|STARTED|Washout 2 (3 to 14 Days)||4
11032362|NCT00862849|12211957|FG005|STARTED|Washout 2 (3 to 14 Days)||3
11032363|NCT00862849|12211952|FG000|COMPLETED|Washout 2 (3 to 14 Days)||3
11334006|NCT02844569|12531649|FG001|NOT COMPLETED|Overall Study||0
11334007|NCT02844582|12531655|FG000|STARTED|Overall Study||2
11334008|NCT02844582|12531655|FG000|COMPLETED|Overall Study||2
11334009|NCT02844582|12531655|FG000|NOT COMPLETED|Overall Study||0
11334010|NCT02844920|12531659|FG000|STARTED|Overall Study||37
11334011|NCT02844920|12531659|FG000|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1
11334012|NCT02844920|12531659|FG000|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34
11032364|NCT00862849|12211953|FG001|COMPLETED|Washout 2 (3 to 14 Days)||3
11032365|NCT00862849|12211954|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3
11032366|NCT00862849|12211955|FG003|COMPLETED|Washout 2 (3 to 14 Days)||4
11032367|NCT00862849|12211956|FG004|COMPLETED|Washout 2 (3 to 14 Days)||4
11032368|NCT00862849|12211957|FG005|COMPLETED|Washout 2 (3 to 14 Days)||3
11032369|NCT00862849|12211952|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
11032370|NCT00862849|12211953|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
11032371|NCT00862849|12211954|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
11032372|NCT00862849|12211955|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
11032373|NCT00862849|12211956|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
11032374|NCT00862849|12211957|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
11032375|NCT00862849|12211952|FG000|STARTED|Intervention 3||3
11032376|NCT00862849|12211953|FG001|STARTED|Intervention 3||3
11032377|NCT00862849|12211954|FG002|STARTED|Intervention 3||3
11032378|NCT00862849|12211955|FG003|STARTED|Intervention 3||4
11032379|NCT00862849|12211956|FG004|STARTED|Intervention 3||4
11032380|NCT00862849|12211957|FG005|STARTED|Intervention 3||3
11032381|NCT00862849|12211952|FG000|COMPLETED|Intervention 3||3
11032382|NCT00862849|12211953|FG001|COMPLETED|Intervention 3||3
11032383|NCT00862849|12211954|FG002|COMPLETED|Intervention 3||3
11032384|NCT00862849|12211955|FG003|COMPLETED|Intervention 3||4
11032385|NCT00862849|12211956|FG004|COMPLETED|Intervention 3||4
11032386|NCT00862849|12211957|FG005|COMPLETED|Intervention 3||3
11032387|NCT00862849|12211952|FG000|NOT COMPLETED|Intervention 3||0
11032388|NCT00862849|12211953|FG001|NOT COMPLETED|Intervention 3||0
11032389|NCT00862849|12211954|FG002|NOT COMPLETED|Intervention 3||0
11032390|NCT00862849|12211955|FG003|NOT COMPLETED|Intervention 3||0
11032391|NCT00862849|12211956|FG004|NOT COMPLETED|Intervention 3||0
11032392|NCT00862849|12211957|FG005|NOT COMPLETED|Intervention 3||0
11032393|NCT00862849|12211952|FG000|STARTED|Washout 3 (3 to 14 Days)||3
11032394|NCT00862849|12211953|FG001|STARTED|Washout 3 (3 to 14 Days)||3
11032395|NCT00862849|12211954|FG002|STARTED|Washout 3 (3 to 14 Days)||3
11032396|NCT00862849|12211955|FG003|STARTED|Washout 3 (3 to 14 Days)||4
11032397|NCT00862849|12211956|FG004|STARTED|Washout 3 (3 to 14 Days)||4
11032398|NCT00862849|12211957|FG005|STARTED|Washout 3 (3 to 14 Days)||3
11032399|NCT00862849|12211952|FG000|COMPLETED|Washout 3 (3 to 14 Days)||3
11032400|NCT00862849|12211953|FG001|COMPLETED|Washout 3 (3 to 14 Days)||3
11032401|NCT00862849|12211954|FG002|COMPLETED|Washout 3 (3 to 14 Days)||3
11032402|NCT00862849|12211955|FG003|COMPLETED|Washout 3 (3 to 14 Days)||4
11032403|NCT00862849|12211956|FG004|COMPLETED|Washout 3 (3 to 14 Days)||4
11032404|NCT00862849|12211957|FG005|COMPLETED|Washout 3 (3 to 14 Days)||3
11032405|NCT00862849|12211952|FG000|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
11032406|NCT00862849|12211953|FG001|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
11032407|NCT00862849|12211954|FG002|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
11032408|NCT00862849|12211955|FG003|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
11032409|NCT00862849|12211956|FG004|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
11032410|NCT00862849|12211957|FG005|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
11032411|NCT00862849|12211952|FG000|STARTED|Intervention 4||3
11032412|NCT00862849|12211953|FG001|STARTED|Intervention 4||3
11032413|NCT00862849|12211954|FG002|STARTED|Intervention 4||3
11032414|NCT00862849|12211955|FG003|STARTED|Intervention 4||4
11032415|NCT00862849|12211956|FG004|STARTED|Intervention 4||4
11032416|NCT00862849|12211957|FG005|STARTED|Intervention 4||3
11032417|NCT00862849|12211952|FG000|COMPLETED|Intervention 4||3
11032418|NCT00862849|12211953|FG001|COMPLETED|Intervention 4||3
11032419|NCT00862849|12211954|FG002|COMPLETED|Intervention 4||3
11032420|NCT00862849|12211955|FG003|COMPLETED|Intervention 4||4
11032421|NCT00862849|12211956|FG004|COMPLETED|Intervention 4||4
11032422|NCT00862849|12211957|FG005|COMPLETED|Intervention 4||3
11032423|NCT00862849|12211952|FG000|NOT COMPLETED|Intervention 4||0
11032424|NCT00862849|12211953|FG001|NOT COMPLETED|Intervention 4||0
11032425|NCT00862849|12211954|FG002|NOT COMPLETED|Intervention 4||0
11032426|NCT00862849|12211955|FG003|NOT COMPLETED|Intervention 4||0
11032427|NCT00862849|12211956|FG004|NOT COMPLETED|Intervention 4||0
11032428|NCT00862849|12211957|FG005|NOT COMPLETED|Intervention 4||0
11032429|NCT00862849|12211952|FG000|STARTED|Washout 4 (3 to 14 Days)||3
11032430|NCT00862849|12211953|FG001|STARTED|Washout 4 (3 to 14 Days)||3
11032431|NCT00862849|12211954|FG002|STARTED|Washout 4 (3 to 14 Days)||3
11032432|NCT00862849|12211955|FG003|STARTED|Washout 4 (3 to 14 Days)||4
11032433|NCT00862849|12211956|FG004|STARTED|Washout 4 (3 to 14 Days)||4
11032434|NCT00862849|12211957|FG005|STARTED|Washout 4 (3 to 14 Days)||3
11032435|NCT00862849|12211952|FG000|COMPLETED|Washout 4 (3 to 14 Days)||3
11032436|NCT00862849|12211953|FG001|COMPLETED|Washout 4 (3 to 14 Days)||3
11032437|NCT00862849|12211954|FG002|COMPLETED|Washout 4 (3 to 14 Days)||3
11032438|NCT00862849|12211955|FG003|COMPLETED|Washout 4 (3 to 14 Days)||4
11032439|NCT00862849|12211956|FG004|COMPLETED|Washout 4 (3 to 14 Days)||4
11032440|NCT00862849|12211957|FG005|COMPLETED|Washout 4 (3 to 14 Days)||3
11032441|NCT00862849|12211952|FG000|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
11334013|NCT02844920|12531659|FG000|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6
11334014|NCT02844920|12531659|FG000|COMPLETED|Overall Study|Participants with completed the follow-up|35
11334015|NCT02844920|12531659|FG000|NOT COMPLETED|Overall Study||2
11032442|NCT00862849|12211953|FG001|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
11032443|NCT00862849|12211954|FG002|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
11032444|NCT00862849|12211955|FG003|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
11032445|NCT00862849|12211956|FG004|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
11032446|NCT00862849|12211957|FG005|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
11032447|NCT00862849|12211952|FG000|STARTED|Intervention 5||3
11032448|NCT00862849|12211953|FG001|STARTED|Intervention 5||3
11032449|NCT00862849|12211954|FG002|STARTED|Intervention 5||3
11032450|NCT00862849|12211955|FG003|STARTED|Intervention 5||4
11032451|NCT00862849|12211956|FG004|STARTED|Intervention 5||4
11032452|NCT00862849|12211957|FG005|STARTED|Intervention 5||3
11032453|NCT00862849|12211952|FG000|COMPLETED|Intervention 5||3
11032454|NCT00862849|12211953|FG001|COMPLETED|Intervention 5||3
11032455|NCT00862849|12211954|FG002|COMPLETED|Intervention 5||3
11032456|NCT00862849|12211955|FG003|COMPLETED|Intervention 5||4
11032457|NCT00862849|12211956|FG004|COMPLETED|Intervention 5||4
11032458|NCT00862849|12211957|FG005|COMPLETED|Intervention 5||3
11032459|NCT00862849|12211952|FG000|NOT COMPLETED|Intervention 5||0
11032460|NCT00862849|12211953|FG001|NOT COMPLETED|Intervention 5||0
11032461|NCT00862849|12211954|FG002|NOT COMPLETED|Intervention 5||0
11032462|NCT00862849|12211955|FG003|NOT COMPLETED|Intervention 5||0
11032463|NCT00862849|12211956|FG004|NOT COMPLETED|Intervention 5||0
11032464|NCT00862849|12211957|FG005|NOT COMPLETED|Intervention 5||0
11032465|NCT00862849|12211952|FG000|STARTED|Washout 5 (3 to 14 Days)||3
11032466|NCT00862849|12211953|FG001|STARTED|Washout 5 (3 to 14 Days)||3
11032467|NCT00862849|12211954|FG002|STARTED|Washout 5 (3 to 14 Days)||3
11032468|NCT00862849|12211955|FG003|STARTED|Washout 5 (3 to 14 Days)||4
11032469|NCT00862849|12211956|FG004|STARTED|Washout 5 (3 to 14 Days)||4
11032470|NCT00862849|12211957|FG005|STARTED|Washout 5 (3 to 14 Days)||3
11032471|NCT00862849|12211952|FG000|COMPLETED|Washout 5 (3 to 14 Days)||3
11032472|NCT00862849|12211953|FG001|COMPLETED|Washout 5 (3 to 14 Days)||3
11032473|NCT00862849|12211954|FG002|COMPLETED|Washout 5 (3 to 14 Days)||3
11032474|NCT00862849|12211955|FG003|COMPLETED|Washout 5 (3 to 14 Days)||4
11032475|NCT00862849|12211956|FG004|COMPLETED|Washout 5 (3 to 14 Days)||4
11032476|NCT00862849|12211957|FG005|COMPLETED|Washout 5 (3 to 14 Days)||3
11032477|NCT00862849|12211952|FG000|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
11032478|NCT00862849|12211953|FG001|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
11032479|NCT00862849|12211954|FG002|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
11032480|NCT00862849|12211955|FG003|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
11032481|NCT00862849|12211956|FG004|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
11032482|NCT00862849|12211957|FG005|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
11032483|NCT00862849|12211952|FG000|STARTED|Intervention 6||3
11032484|NCT00862849|12211953|FG001|STARTED|Intervention 6||3
11032485|NCT00862849|12211954|FG002|STARTED|Intervention 6||3
11032486|NCT00862849|12211955|FG003|STARTED|Intervention 6||4
11032487|NCT00862849|12211956|FG004|STARTED|Intervention 6||4
11032488|NCT00862849|12211957|FG005|STARTED|Intervention 6||3
11032489|NCT00862849|12211952|FG000|COMPLETED|Intervention 6||3
11032490|NCT00862849|12211953|FG001|COMPLETED|Intervention 6||3
11032491|NCT00862849|12211954|FG002|COMPLETED|Intervention 6||3
11032492|NCT00862849|12211955|FG003|COMPLETED|Intervention 6||4
11032493|NCT00862849|12211956|FG004|COMPLETED|Intervention 6||4
11032494|NCT00862849|12211957|FG005|COMPLETED|Intervention 6||3
11032495|NCT00862849|12211952|FG000|NOT COMPLETED|Intervention 6||0
11032496|NCT00862849|12211953|FG001|NOT COMPLETED|Intervention 6||0
11032497|NCT00862849|12211954|FG002|NOT COMPLETED|Intervention 6||0
11032498|NCT00862849|12211955|FG003|NOT COMPLETED|Intervention 6||0
11032499|NCT00862849|12211956|FG004|NOT COMPLETED|Intervention 6||0
11032500|NCT00862849|12211957|FG005|NOT COMPLETED|Intervention 6||0
11057532|NCT00998400|12239140|FG001|COMPLETED|Overall Study||48
11057533|NCT00998400|12239139|FG000|NOT COMPLETED|Overall Study||2
11057534|NCT00998400|12239140|FG001|NOT COMPLETED|Overall Study||2
11057535|NCT00998426|12239147|FG000|STARTED|Overall Study||5
11057536|NCT00998426|12239147|FG000|Blood Glucose Monitoring|Overall Study||5
11057537|NCT00998426|12239147|FG000|COMPLETED|Overall Study||5
11057538|NCT00998426|12239147|FG000|NOT COMPLETED|Overall Study||0
11057539|NCT00998517|12239155|FG000|STARTED|Overall Study||888
11334016|NCT02844998|12531666|FG000|STARTED|Overall Study||42
11334017|NCT02844998|12531667|FG001|STARTED|Overall Study||39
11334018|NCT02844998|12531668|FG002|STARTED|Overall Study||39
11334019|NCT02844998|12531666|FG000|COMPLETED|Overall Study||35
11334020|NCT02844998|12531667|FG001|COMPLETED|Overall Study||35
11334021|NCT02844998|12531668|FG002|COMPLETED|Overall Study||35
11334022|NCT02844998|12531666|FG000|NOT COMPLETED|Overall Study||7
11334023|NCT02844998|12531667|FG001|NOT COMPLETED|Overall Study||4
11334024|NCT02844998|12531668|FG002|NOT COMPLETED|Overall Study||4
11334025|NCT02845336|12531678|FG000|STARTED|Overall Study||6
11334026|NCT02845336|12531679|FG001|STARTED|Overall Study||1
11334027|NCT02845336|12531678|FG000|COMPLETED|Overall Study||1
11334028|NCT02845336|12531679|FG001|COMPLETED|Overall Study||0
11334029|NCT02845336|12531678|FG000|NOT COMPLETED|Overall Study||5
11334030|NCT02845336|12531679|FG001|NOT COMPLETED|Overall Study||1
11334031|NCT02845375|12531688|FG000|STARTED|Overall Study||13
11334032|NCT02845375|12531689|FG001|STARTED|Overall Study||14
11057540|NCT00998517|12239156|FG001|STARTED|Overall Study||906
11057541|NCT00998517|12239157|FG002|STARTED|Overall Study||918
11057542|NCT00998517|12239155|FG000|COMPLETED|Overall Study||888
11334033|NCT02845375|12531690|FG002|STARTED|Overall Study||13
11334034|NCT02845375|12531688|FG000|COMPLETED|Overall Study||12
11334035|NCT02845375|12531689|FG001|COMPLETED|Overall Study||12
11334036|NCT02845375|12531690|FG002|COMPLETED|Overall Study||12
11032501|NCT00862940|12211967|FG000|STARTED|Overall Study||133
11032502|NCT00862940|12211968|FG001|STARTED|Overall Study||144
11032503|NCT00862940|12211967|FG000|COMPLETED|Overall Study||103
11032504|NCT00862940|12211968|FG001|COMPLETED|Overall Study||114
11032505|NCT00862940|12211967|FG000|NOT COMPLETED|Overall Study||30
11032506|NCT00862940|12211968|FG001|NOT COMPLETED|Overall Study||30
11032507|NCT00862979|12211976|FG000|STARTED|Overall Study||84
11032508|NCT00862979|12211977|FG001|STARTED|Overall Study||78
11032509|NCT00862979|12211976|FG000|Full Analysis Set (FAS)|Overall Study||74
11032510|NCT00862979|12211977|FG001|Full Analysis Set (FAS)|Overall Study||71
11032511|NCT00862979|12211976|FG000|COMPLETED|Overall Study||76
11032512|NCT00862979|12211977|FG001|COMPLETED|Overall Study||71
11032513|NCT00862979|12211976|FG000|NOT COMPLETED|Overall Study||8
11032514|NCT00862979|12211977|FG001|NOT COMPLETED|Overall Study||7
11032515|NCT00862992|12211986|FG000|STARTED|Overall Study||12
11032516|NCT00862992|12211987|FG001|STARTED|Overall Study||10
11032517|NCT00862992|12211988|FG002|STARTED|Overall Study||12
11032518|NCT00862992|12211986|FG000|COMPLETED|Overall Study||9
11032519|NCT00862992|12211987|FG001|COMPLETED|Overall Study||9
11032520|NCT00862992|12211988|FG002|COMPLETED|Overall Study||9
11032521|NCT00862992|12211986|FG000|NOT COMPLETED|Overall Study||3
11032522|NCT00862992|12211987|FG001|NOT COMPLETED|Overall Study||1
11032523|NCT00862992|12211988|FG002|NOT COMPLETED|Overall Study||3
11032524|NCT00863057|12212000|FG000|STARTED|Milestones Period 1 (Weeks 0-5)||4
11032525|NCT00863057|12212001|FG001|STARTED|Milestones Period 1 (Weeks 0-5)||4
11032526|NCT00863057|12212002|FG002|STARTED|Milestones Period 1 (Weeks 0-5)||3
11032527|NCT00863057|12212003|FG003|STARTED|Milestones Period 1 (Weeks 0-5)||4
11032528|NCT00863057|12212000|FG000|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
11032529|NCT00863057|12212001|FG001|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
11032530|NCT00863057|12212002|FG002|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
11032531|NCT00863057|12212003|FG003|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
11032532|NCT00863057|12212000|FG000|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
11032533|NCT00863057|12212001|FG001|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
11032534|NCT00863057|12212002|FG002|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
11032535|NCT00863057|12212003|FG003|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
11032536|NCT00863057|12212000|FG000|STARTED|Period 2 (Weeks 6-10)||3
11032537|NCT00863057|12212001|FG001|STARTED|Period 2 (Weeks 6-10)||2
11032538|NCT00863057|12212002|FG002|STARTED|Period 2 (Weeks 6-10)||3
11032539|NCT00863057|12212003|FG003|STARTED|Period 2 (Weeks 6-10)||3
11032540|NCT00863057|12212000|FG000|COMPLETED|Period 2 (Weeks 6-10)||3
11032541|NCT00863057|12212001|FG001|COMPLETED|Period 2 (Weeks 6-10)||1
11032542|NCT00863057|12212002|FG002|COMPLETED|Period 2 (Weeks 6-10)||2
11032543|NCT00863057|12212003|FG003|COMPLETED|Period 2 (Weeks 6-10)||2
11032544|NCT00863057|12212000|FG000|NOT COMPLETED|Period 2 (Weeks 6-10)||0
11032545|NCT00863057|12212001|FG001|NOT COMPLETED|Period 2 (Weeks 6-10)||1
11032546|NCT00863057|12212002|FG002|NOT COMPLETED|Period 2 (Weeks 6-10)||1
11032547|NCT00863057|12212003|FG003|NOT COMPLETED|Period 2 (Weeks 6-10)||1
11032548|NCT00863057|12212000|FG000|STARTED|Period 3 (Weeks 11-15)||3
11032549|NCT00863057|12212001|FG001|STARTED|Period 3 (Weeks 11-15)||1
11032550|NCT00863057|12212002|FG002|STARTED|Period 3 (Weeks 11-15)||2
11032551|NCT00863057|12212003|FG003|STARTED|Period 3 (Weeks 11-15)||2
11032552|NCT00863057|12212000|FG000|COMPLETED|Period 3 (Weeks 11-15)||3
11032553|NCT00863057|12212001|FG001|COMPLETED|Period 3 (Weeks 11-15)||1
11032554|NCT00863057|12212002|FG002|COMPLETED|Period 3 (Weeks 11-15)||2
11032555|NCT00863057|12212003|FG003|COMPLETED|Period 3 (Weeks 11-15)||2
11032556|NCT00863057|12212000|FG000|NOT COMPLETED|Period 3 (Weeks 11-15)||0
11032557|NCT00863057|12212001|FG001|NOT COMPLETED|Period 3 (Weeks 11-15)||0
11032558|NCT00863057|12212002|FG002|NOT COMPLETED|Period 3 (Weeks 11-15)||0
11032559|NCT00863057|12212003|FG003|NOT COMPLETED|Period 3 (Weeks 11-15)||0
11032560|NCT00863057|12212000|FG000|STARTED|Period 4 (Weeks 16-20)||3
11032561|NCT00863057|12212001|FG001|STARTED|Period 4 (Weeks 16-20)||1
11032562|NCT00863057|12212002|FG002|STARTED|Period 4 (Weeks 16-20)||2
11032563|NCT00863057|12212003|FG003|STARTED|Period 4 (Weeks 16-20)||2
11032564|NCT00863057|12212000|FG000|COMPLETED|Period 4 (Weeks 16-20)||3
11032565|NCT00863057|12212001|FG001|COMPLETED|Period 4 (Weeks 16-20)||1
11032566|NCT00863057|12212002|FG002|COMPLETED|Period 4 (Weeks 16-20)||2
11032567|NCT00863057|12212003|FG003|COMPLETED|Period 4 (Weeks 16-20)||2
11032568|NCT00863057|12212000|FG000|NOT COMPLETED|Period 4 (Weeks 16-20)||0
11032569|NCT00863057|12212001|FG001|NOT COMPLETED|Period 4 (Weeks 16-20)||0
11032570|NCT00863057|12212002|FG002|NOT COMPLETED|Period 4 (Weeks 16-20)||0
11032571|NCT00863057|12212003|FG003|NOT COMPLETED|Period 4 (Weeks 16-20)||0
11032572|NCT00863109|12212019|FG000|STARTED|Treatment Period||130
11032573|NCT00863109|12212019|FG000|COMPLETED|Treatment Period||53
11032574|NCT00863109|12212019|FG000|NOT COMPLETED|Treatment Period||77
11032575|NCT00863109|12212019|FG000|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
11032576|NCT00863109|12212019|FG000|COMPLETED|Follow-up Period||48
11032577|NCT00863109|12212019|FG000|NOT COMPLETED|Follow-up Period||11
11032578|NCT00863122|12212027|FG000|STARTED|Overall Study||19
11032579|NCT00863122|12212028|FG001|STARTED|Overall Study||7
11032580|NCT00863122|12212027|FG000|COMPLETED|Overall Study||19
11032581|NCT00863122|12212028|FG001|COMPLETED|Overall Study||7
11032582|NCT00863122|12212027|FG000|NOT COMPLETED|Overall Study||0
11032583|NCT00863122|12212028|FG001|NOT COMPLETED|Overall Study||0
11032584|NCT00863265|12212038|FG000|STARTED|Overall Study||4
11032585|NCT00863265|12212039|FG001|STARTED|Overall Study||3
11032586|NCT00863265|12212040|FG002|STARTED|Overall Study||4
11032587|NCT00863265|12212041|FG003|STARTED|Overall Study||4
11032588|NCT00863265|12212042|FG004|STARTED|Overall Study||4
11032589|NCT00863265|12212043|FG005|STARTED|Overall Study||3
11032590|NCT00863265|12212038|FG000|COMPLETED|Overall Study||4
11032591|NCT00863265|12212039|FG001|COMPLETED|Overall Study||3
11032592|NCT00863265|12212040|FG002|COMPLETED|Overall Study||4
11032593|NCT00863265|12212041|FG003|COMPLETED|Overall Study||4
11032594|NCT00863265|12212042|FG004|COMPLETED|Overall Study||3
11032595|NCT00863265|12212043|FG005|COMPLETED|Overall Study||3
11032596|NCT00863265|12212038|FG000|NOT COMPLETED|Overall Study||0
11032597|NCT00863265|12212039|FG001|NOT COMPLETED|Overall Study||0
11032598|NCT00863265|12212040|FG002|NOT COMPLETED|Overall Study||0
11032599|NCT00863265|12212041|FG003|NOT COMPLETED|Overall Study||0
11032600|NCT00863265|12212042|FG004|NOT COMPLETED|Overall Study||1
11032601|NCT00863265|12212043|FG005|NOT COMPLETED|Overall Study||0
11032602|NCT00863304|12212061|FG000|STARTED|Overall Study||212
11032603|NCT00863304|12212062|FG001|STARTED|Overall Study||212
11032604|NCT00863304|12212063|FG002|STARTED|Overall Study||213
11032605|NCT00863304|12212064|FG003|STARTED|Overall Study||212
11032606|NCT00863304|12212061|FG000|Treated|Overall Study||209
11032607|NCT00863304|12212062|FG001|Treated|Overall Study||211
11032608|NCT00863304|12212063|FG002|Treated|Overall Study||209
11032609|NCT00863304|12212064|FG003|Treated|Overall Study||211
11032610|NCT00863304|12212061|FG000|COMPLETED|Overall Study||18
11032611|NCT00863304|12212062|FG001|COMPLETED|Overall Study||27
11032612|NCT00863304|12212063|FG002|COMPLETED|Overall Study||26
11032613|NCT00863304|12212064|FG003|COMPLETED|Overall Study||21
11032614|NCT00863304|12212061|FG000|NOT COMPLETED|Overall Study||194
11032615|NCT00863304|12212062|FG001|NOT COMPLETED|Overall Study||185
11032616|NCT00863304|12212063|FG002|NOT COMPLETED|Overall Study||187
11032617|NCT00863304|12212064|FG003|NOT COMPLETED|Overall Study||191
11032618|NCT00863317|12212078|FG000|STARTED|Overall Study||68
11032619|NCT00863317|12212079|FG001|STARTED|Overall Study||73
11032620|NCT00863317|12212078|FG000|COMPLETED|Overall Study||60
11032621|NCT00863317|12212079|FG001|COMPLETED|Overall Study||64
11032622|NCT00863317|12212078|FG000|NOT COMPLETED|Overall Study||8
11032623|NCT00863317|12212079|FG001|NOT COMPLETED|Overall Study||9
11032624|NCT00863343|12212087|FG000|STARTED|Overall Study||17
11032625|NCT00863343|12212088|FG001|STARTED|Overall Study||374
11032626|NCT00863343|12212087|FG000|COMPLETED|Overall Study||17
11032627|NCT00863343|12212088|FG001|COMPLETED|Overall Study||374
11032628|NCT00863343|12212087|FG000|NOT COMPLETED|Overall Study||0
11032629|NCT00863343|12212088|FG001|NOT COMPLETED|Overall Study||0
11032630|NCT00863356|12212096|FG000|STARTED|Overall Study||20
11032631|NCT00863356|12212096|FG000|COMPLETED|Overall Study||20
11032632|NCT00863356|12212096|FG000|NOT COMPLETED|Overall Study||0
11032633|NCT00863434|12212100|FG000|STARTED|Overall Study||2
11032634|NCT00863434|12212100|FG000|COMPLETED|Overall Study||2
11032635|NCT00863434|12212100|FG000|NOT COMPLETED|Overall Study||0
11032636|NCT00863551|12212104|FG000|STARTED|Overall Study||12
11032637|NCT00863551|12212104|FG000|COMPLETED|Overall Study||12
11032638|NCT00863551|12212104|FG000|NOT COMPLETED|Overall Study||0
11032639|NCT00863655|12212110|FG000|STARTED|Overall Study||485
11032640|NCT00863655|12212111|FG001|STARTED|Overall Study||239
11032641|NCT00863655|12212110|FG000|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
11032642|NCT00863655|12212111|FG001|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
11032643|NCT00863655|12212110|FG000|NOT COMPLETED|Overall Study||485
11032644|NCT00863655|12212111|FG001|NOT COMPLETED|Overall Study||239
11032645|NCT00863681|12212120|FG000|STARTED|Overall Study||231
11032646|NCT00863681|12212121|FG001|STARTED|Overall Study||109
11032647|NCT00863681|12212122|FG002|STARTED|Overall Study||56
11032648|NCT00863681|12212120|FG000|COMPLETED|Overall Study|Completed treatment|140
11032649|NCT00863681|12212121|FG001|COMPLETED|Overall Study|Completed treatment|66
11032650|NCT00863681|12212122|FG002|COMPLETED|Overall Study|Completed treatment|38
11032651|NCT00863681|12212120|FG000|NOT COMPLETED|Overall Study||91
11032652|NCT00863681|12212121|FG001|NOT COMPLETED|Overall Study||43
11032653|NCT00863681|12212122|FG002|NOT COMPLETED|Overall Study||18
11032654|NCT00863707|12212132|FG000|STARTED|Overall Study||174
11032655|NCT00863707|12212133|FG001|STARTED|Overall Study||337
11032656|NCT00863707|12212132|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
11032657|NCT00863707|12212133|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
11032658|NCT00863707|12212132|FG000|NOT COMPLETED|Overall Study||4
11032659|NCT00863707|12212133|FG001|NOT COMPLETED|Overall Study||3
11032660|NCT00863746|12212141|FG000|STARTED|Treatment||350
11032661|NCT00863746|12212142|FG001|STARTED|Treatment||353
11032662|NCT00863746|12212141|FG000|Participants Received Treatment|Treatment|Safety population|346
11032663|NCT00863746|12212142|FG001|Participants Received Treatment|Treatment|Safety population|351
11032664|NCT00863746|12212141|FG000|COMPLETED|Treatment||279
11032665|NCT00863746|12212142|FG001|COMPLETED|Treatment||318
11032666|NCT00863746|12212141|FG000|NOT COMPLETED|Treatment||71
11032667|NCT00863746|12212142|FG001|NOT COMPLETED|Treatment||35
11032668|NCT00863746|12212141|FG000|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
11032669|NCT00863746|12212142|FG001|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
11032670|NCT00863746|12212141|FG000|COMPLETED|Survival Follow up||45
11032671|NCT00863746|12212142|FG001|COMPLETED|Survival Follow up||51
11032672|NCT00863746|12212141|FG000|NOT COMPLETED|Survival Follow up||253
11032673|NCT00863746|12212142|FG001|NOT COMPLETED|Survival Follow up||280
11032674|NCT00863772|12212151|FG000|STARTED|Overall Study||74
11032675|NCT00863772|12212152|FG001|STARTED|Overall Study||74
11032676|NCT00863772|12212153|FG002|STARTED|Overall Study||72
11032677|NCT00863772|12212151|FG000|Treated|Overall Study||73
11032678|NCT00863772|12212152|FG001|Treated|Overall Study||74
11032679|NCT00863772|12212153|FG002|Treated|Overall Study||72
11032680|NCT00863772|12212151|FG000|COMPLETED|Overall Study||6
11032681|NCT00863772|12212152|FG001|COMPLETED|Overall Study||9
11032682|NCT00863772|12212153|FG002|COMPLETED|Overall Study||11
11032683|NCT00863772|12212151|FG000|NOT COMPLETED|Overall Study||68
11032684|NCT00863772|12212152|FG001|NOT COMPLETED|Overall Study||65
11032685|NCT00863772|12212153|FG002|NOT COMPLETED|Overall Study||61
11032686|NCT00863798|12212164|FG000|STARTED|Overall Study||227
11032687|NCT00863798|12212165|FG001|STARTED|Overall Study||228
11032688|NCT00863798|12212166|FG002|STARTED|Overall Study||227
11032689|NCT00863798|12212164|FG000|Treated|Overall Study||223
11032690|NCT00863798|12212165|FG001|Treated|Overall Study||226
11032691|NCT00863798|12212166|FG002|Treated|Overall Study||224
11032692|NCT00863798|12212164|FG000|COMPLETED|Overall Study||195
11032693|NCT00863798|12212165|FG001|COMPLETED|Overall Study||198
11032694|NCT00863798|12212166|FG002|COMPLETED|Overall Study||202
11032695|NCT00863798|12212164|FG000|NOT COMPLETED|Overall Study||32
11032696|NCT00863798|12212165|FG001|NOT COMPLETED|Overall Study||30
11032697|NCT00863798|12212166|FG002|NOT COMPLETED|Overall Study||25
11032698|NCT00863928|12212176|FG000|STARTED|Overall Study||94
11032699|NCT00863928|12212177|FG001|STARTED|Overall Study||41
11032700|NCT00863928|12212176|FG000|COMPLETED|Overall Study||58
11032701|NCT00863928|12212177|FG001|COMPLETED|Overall Study||41
11032702|NCT00863928|12212176|FG000|NOT COMPLETED|Overall Study||36
11032703|NCT00863928|12212177|FG001|NOT COMPLETED|Overall Study||0
11032704|NCT00864032|12212183|FG000|STARTED|Overall Study||3
11032705|NCT00864032|12212184|FG001|STARTED|Overall Study||5
11032706|NCT00864032|12212185|FG002|STARTED|Overall Study||0
11032707|NCT00864032|12212183|FG000|COMPLETED|Overall Study||3
11032708|NCT00864032|12212184|FG001|COMPLETED|Overall Study||5
11032709|NCT00864032|12212185|FG002|COMPLETED|Overall Study||0
11032710|NCT00864032|12212183|FG000|NOT COMPLETED|Overall Study||0
11032711|NCT00864032|12212184|FG001|NOT COMPLETED|Overall Study||0
11032712|NCT00864032|12212185|FG002|NOT COMPLETED|Overall Study||0
11032713|NCT00864084|12212191|FG000|STARTED|Overall Study||14
11032714|NCT00864084|12212191|FG000|COMPLETED|Overall Study||11
11032715|NCT00864084|12212191|FG000|NOT COMPLETED|Overall Study||3
11032716|NCT00864097|12212204|FG000|STARTED|Overall Study||154
11032717|NCT00864097|12212205|FG001|STARTED|Overall Study||157
11032718|NCT00864097|12212206|FG002|STARTED|Overall Study||151
11032719|NCT00864097|12212207|FG003|STARTED|Overall Study||145
11032720|NCT00864097|12212204|FG000|Treated|Overall Study||152
11032721|NCT00864097|12212205|FG001|Treated|Overall Study||157
11032722|NCT00864097|12212206|FG002|Treated|Overall Study||150
11032723|NCT00864097|12212207|FG003|Treated|Overall Study||145
11032724|NCT00864097|12212204|FG000|COMPLETED|Overall Study||15
11032725|NCT00864097|12212205|FG001|COMPLETED|Overall Study||20
11032726|NCT00864097|12212206|FG002|COMPLETED|Overall Study||19
11032727|NCT00864097|12212207|FG003|COMPLETED|Overall Study||20
11032728|NCT00864097|12212204|FG000|NOT COMPLETED|Overall Study||139
11032729|NCT00864097|12212205|FG001|NOT COMPLETED|Overall Study||137
11032730|NCT00864097|12212206|FG002|NOT COMPLETED|Overall Study||132
11032731|NCT00864097|12212207|FG003|NOT COMPLETED|Overall Study||125
11032732|NCT00864123|12212219|FG000|STARTED|Overall Study||15
11032733|NCT00864123|12212220|FG001|STARTED|Overall Study||15
11032734|NCT00864123|12212219|FG000|COMPLETED|Overall Study||15
11032735|NCT00864123|12212220|FG001|COMPLETED|Overall Study||15
11032736|NCT00864123|12212219|FG000|NOT COMPLETED|Overall Study||0
11032737|NCT00864123|12212220|FG001|NOT COMPLETED|Overall Study||0
11032738|NCT00864253|12212228|FG000|STARTED|Overall Study||264
11032739|NCT00864253|12212229|FG001|STARTED|Overall Study||265
11032740|NCT00864253|12212228|FG000|Treated|Overall Study||257
11032741|NCT00864253|12212229|FG001|Treated|Overall Study||258
11032742|NCT00864253|12212228|FG000|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
11032743|NCT00864253|12212229|FG001|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
11032744|NCT00864253|12212228|FG000|NOT COMPLETED|Overall Study||99
11032745|NCT00864253|12212229|FG001|NOT COMPLETED|Overall Study||58
11032746|NCT00864383|12212240|FG000|STARTED|Per- Protocol||640
11032747|NCT00864383|12212241|FG001|STARTED|Per- Protocol||655
11032748|NCT00864383|12212242|FG002|STARTED|Per- Protocol||636
11032749|NCT00864383|12212240|FG000|COMPLETED|Per- Protocol||510
11032750|NCT00864383|12212241|FG001|COMPLETED|Per- Protocol||514
11032751|NCT00864383|12212242|FG002|COMPLETED|Per- Protocol||524
11032752|NCT00864383|12212240|FG000|NOT COMPLETED|Per- Protocol||130
11032753|NCT00864383|12212241|FG001|NOT COMPLETED|Per- Protocol||141
11032754|NCT00864383|12212242|FG002|NOT COMPLETED|Per- Protocol||112
11032755|NCT00864383|12212240|FG000|STARTED|Modified Intent to Treat||640
11032756|NCT00864383|12212241|FG001|STARTED|Modified Intent to Treat||655
11032757|NCT00864383|12212242|FG002|STARTED|Modified Intent to Treat||636
11032758|NCT00864383|12212240|FG000|COMPLETED|Modified Intent to Treat||555
11032759|NCT00864383|12212241|FG001|COMPLETED|Modified Intent to Treat||568
11032760|NCT00864383|12212242|FG002|COMPLETED|Modified Intent to Treat||551
11032761|NCT00864383|12212240|FG000|NOT COMPLETED|Modified Intent to Treat||85
11032762|NCT00864383|12212241|FG001|NOT COMPLETED|Modified Intent to Treat||87
11032763|NCT00864383|12212242|FG002|NOT COMPLETED|Modified Intent to Treat||85
11032764|NCT00864513|12212250|FG000|STARTED|Overall Study||15
11032765|NCT00864513|12212250|FG000|COMPLETED|Overall Study||12
11032766|NCT00864513|12212250|FG000|NOT COMPLETED|Overall Study||3
11032767|NCT00864539|12212260|FG000|STARTED|Overall Study||104
11032768|NCT00864539|12212261|FG001|STARTED|Overall Study||95
11032769|NCT00864539|12212262|FG002|STARTED|Overall Study||102
11032770|NCT00864539|12212263|FG003|STARTED|Overall Study||96
11032771|NCT00864539|12212264|FG004|STARTED|Overall Study||103
11032772|NCT00864539|12212265|FG005|STARTED|Overall Study||85
11032773|NCT00864539|12212260|FG000|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
11032774|NCT00864539|12212261|FG001|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
11032775|NCT00864539|12212262|FG002|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
11032776|NCT00864539|12212263|FG003|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
11032777|NCT00864539|12212264|FG004|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
11032778|NCT00864539|12212265|FG005|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
11032779|NCT00864539|12212260|FG000|NOT COMPLETED|Overall Study||9
11032780|NCT00864539|12212261|FG001|NOT COMPLETED|Overall Study||23
11032781|NCT00864539|12212262|FG002|NOT COMPLETED|Overall Study||10
11032782|NCT00864539|12212263|FG003|NOT COMPLETED|Overall Study||7
11032783|NCT00864539|12212264|FG004|NOT COMPLETED|Overall Study||22
11032784|NCT00864539|12212265|FG005|NOT COMPLETED|Overall Study||14
11032785|NCT00864682|12212282|FG000|STARTED|Overall Study||52
11032786|NCT00864682|12212283|FG001|STARTED|Overall Study||51
11032787|NCT00864682|12212284|FG002|STARTED|Overall Study||53
11032788|NCT00864682|12212282|FG000|COMPLETED|Overall Study||50
11032789|NCT00864682|12212283|FG001|COMPLETED|Overall Study||50
11032790|NCT00864682|12212284|FG002|COMPLETED|Overall Study||51
11032791|NCT00864682|12212282|FG000|NOT COMPLETED|Overall Study||2
11032792|NCT00864682|12212283|FG001|NOT COMPLETED|Overall Study||1
11032793|NCT00864682|12212284|FG002|NOT COMPLETED|Overall Study||2
11032794|NCT00864708|12212292|FG000|STARTED|Overall Study||1
11032795|NCT00864708|12212292|FG000|COMPLETED|Overall Study||1
11032796|NCT00864708|12212292|FG000|NOT COMPLETED|Overall Study||0
11032797|NCT00864721|12212298|FG000|STARTED|Overall Study||63
11032798|NCT00864721|12212298|FG000|COMPLETED|Overall Study||29
11032799|NCT00864721|12212298|FG000|NOT COMPLETED|Overall Study||34
11032800|NCT00864851|12212305|FG000|STARTED|Overall Study||20
11032801|NCT00864851|12212306|FG001|STARTED|Overall Study||19
11032802|NCT00864851|12212307|FG002|STARTED|Overall Study||5
11032803|NCT00864851|12212305|FG000|COMPLETED|Overall Study||17
11032804|NCT00864851|12212306|FG001|COMPLETED|Overall Study||18
11032805|NCT00864851|12212307|FG002|COMPLETED|Overall Study||5
11032806|NCT00864851|12212305|FG000|NOT COMPLETED|Overall Study||3
11032807|NCT00864851|12212306|FG001|NOT COMPLETED|Overall Study||1
11032808|NCT00864851|12212307|FG002|NOT COMPLETED|Overall Study||0
11032809|NCT00864916|12212319|FG000|STARTED|Overall Study||10
11032810|NCT00864916|12212320|FG001|STARTED|Overall Study||9
11032811|NCT00864916|12212319|FG000|COMPLETED|Overall Study||4
11032812|NCT00864916|12212320|FG001|COMPLETED|Overall Study||5
11032813|NCT00864916|12212319|FG000|NOT COMPLETED|Overall Study||6
11032814|NCT00864916|12212320|FG001|NOT COMPLETED|Overall Study||4
11032815|NCT00865020|12212328|FG000|STARTED|Overall Study||414
11032816|NCT00865020|12212329|FG001|STARTED|Overall Study||408
11032817|NCT00865020|12212328|FG000|COMPLETED|Overall Study||365
11032818|NCT00865020|12212329|FG001|COMPLETED|Overall Study||357
11032819|NCT00865020|12212328|FG000|NOT COMPLETED|Overall Study||49
11032820|NCT00865020|12212329|FG001|NOT COMPLETED|Overall Study||51
11032821|NCT00865046|12212338|FG000|STARTED|Overall Study||63
11032822|NCT00865046|12212339|FG001|STARTED|Overall Study||64
11032823|NCT00865046|12212340|FG002|STARTED|Overall Study||63
11032824|NCT00865046|12212338|FG000|COMPLETED|Overall Study||57
11032825|NCT00865046|12212339|FG001|COMPLETED|Overall Study||59
11032826|NCT00865046|12212340|FG002|COMPLETED|Overall Study||62
11032827|NCT00865046|12212338|FG000|NOT COMPLETED|Overall Study||6
11032828|NCT00865046|12212339|FG001|NOT COMPLETED|Overall Study||5
11032829|NCT00865046|12212340|FG002|NOT COMPLETED|Overall Study||1
11032830|NCT00865098|12212348|FG000|STARTED|Overall Study||22
11032831|NCT00865098|12212348|FG000|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
11032832|NCT00865098|12212348|FG000|NOT COMPLETED|Overall Study||1
11032833|NCT00865124|12212355|FG000|STARTED|Overall Study||27
11032834|NCT00865124|12212356|FG001|STARTED|Overall Study||25
11032835|NCT00865124|12212357|FG002|STARTED|Overall Study||17
11032836|NCT00865124|12212355|FG000|COMPLETED|Overall Study||23
11032837|NCT00865124|12212356|FG001|COMPLETED|Overall Study||24
11032838|NCT00865124|12212357|FG002|COMPLETED|Overall Study||17
11032839|NCT00865124|12212355|FG000|NOT COMPLETED|Overall Study||4
11032840|NCT00865124|12212356|FG001|NOT COMPLETED|Overall Study||1
11032841|NCT00865124|12212357|FG002|NOT COMPLETED|Overall Study||0
11032842|NCT00865189|12212367|FG000|STARTED|Overall Study||46
11032843|NCT00865189|12212368|FG001|STARTED|Overall Study||45
11032844|NCT00865189|12212367|FG000|COMPLETED|Overall Study||34
11032845|NCT00865189|12212368|FG001|COMPLETED|Overall Study||26
11032846|NCT00865189|12212367|FG000|NOT COMPLETED|Overall Study||12
11032847|NCT00865189|12212368|FG001|NOT COMPLETED|Overall Study||19
11032848|NCT00865202|12212376|FG000|STARTED|Overall Study||152
11032849|NCT00865202|12212377|FG001|STARTED|Overall Study||149
11032850|NCT00865202|12212376|FG000|COMPLETED|Overall Study||152
11032851|NCT00865202|12212377|FG001|COMPLETED|Overall Study||149
11334037|NCT02845375|12531688|FG000|NOT COMPLETED|Overall Study||1
11032852|NCT00865202|12212376|FG000|NOT COMPLETED|Overall Study||0
11032853|NCT00865202|12212377|FG001|NOT COMPLETED|Overall Study||0
11032854|NCT00865280|12212386|FG000|STARTED|Overall Study||70
11032855|NCT00865280|12212387|FG001|STARTED|Overall Study||73
11032856|NCT00865280|12212386|FG000|COMPLETED|Overall Study||64
11032857|NCT00865280|12212387|FG001|COMPLETED|Overall Study||70
11032858|NCT00865280|12212386|FG000|NOT COMPLETED|Overall Study||6
11032859|NCT00865280|12212387|FG001|NOT COMPLETED|Overall Study||3
11032860|NCT00865306|12212395|FG000|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
11032861|NCT00865306|12212396|FG001|STARTED|Controlled Trial||30
11032862|NCT00865306|12212395|FG000|COMPLETED|Controlled Trial||29
11032863|NCT00865306|12212396|FG001|COMPLETED|Controlled Trial||28
11032864|NCT00865306|12212395|FG000|NOT COMPLETED|Controlled Trial||5
11032865|NCT00865306|12212396|FG001|NOT COMPLETED|Controlled Trial||2
11032866|NCT00865306|12212395|FG000|STARTED|One-Year Follow-Up||29
11032867|NCT00865306|12212396|FG001|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
11032868|NCT00865306|12212395|FG000|COMPLETED|One-Year Follow-Up||29
11032869|NCT00865306|12212396|FG001|COMPLETED|One-Year Follow-Up||15
11032870|NCT00865306|12212395|FG000|NOT COMPLETED|One-Year Follow-Up||0
11032871|NCT00865306|12212396|FG001|NOT COMPLETED|One-Year Follow-Up||0
11032872|NCT00865345|12212402|FG000|STARTED|Overall Study||63
11032873|NCT00865345|12212402|FG000|COMPLETED|Overall Study||61
11032874|NCT00865345|12212402|FG000|NOT COMPLETED|Overall Study||2
11032875|NCT00865566|12212408|FG000|STARTED|Overall Study||1253
11032876|NCT00865566|12212409|FG001|STARTED|Overall Study||1251
11032877|NCT00865566|12212408|FG000|Modified Intent-to-Treat Population|Overall Study||1251
11032878|NCT00865566|12212409|FG001|Modified Intent-to-Treat Population|Overall Study||1245
11032879|NCT00865566|12212408|FG000|COMPLETED|Overall Study||629
11032880|NCT00865566|12212409|FG001|COMPLETED|Overall Study||564
11032881|NCT00865566|12212408|FG000|NOT COMPLETED|Overall Study||624
11032882|NCT00865566|12212409|FG001|NOT COMPLETED|Overall Study||687
11032883|NCT00865709|12212417|FG000|STARTED|Treatment||97
11032884|NCT00865709|12212418|FG001|STARTED|Treatment||101
11032885|NCT00865709|12212417|FG000|Received Treatment|Treatment|Safety population|97
11032886|NCT00865709|12212418|FG001|Received Treatment|Treatment|Safety population|101
11032887|NCT00865709|12212417|FG000|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
11032888|NCT00865709|12212418|FG001|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
11032889|NCT00865709|12212417|FG000|NOT COMPLETED|Treatment||30
11032890|NCT00865709|12212418|FG001|NOT COMPLETED|Treatment||18
11032891|NCT00865709|12212417|FG000|STARTED|Active Follow-up||25
11032892|NCT00865709|12212418|FG001|STARTED|Active Follow-up||16
11032893|NCT00865709|12212417|FG000|COMPLETED|Active Follow-up||17
11032894|NCT00865709|12212418|FG001|COMPLETED|Active Follow-up||15
11032895|NCT00865709|12212417|FG000|NOT COMPLETED|Active Follow-up||8
11032896|NCT00865709|12212418|FG001|NOT COMPLETED|Active Follow-up||1
11032897|NCT00865709|12212417|FG000|STARTED|Long Term Follow-up||70
11032898|NCT00865709|12212418|FG001|STARTED|Long Term Follow-up||82
11032899|NCT00865709|12212417|FG000|COMPLETED|Long Term Follow-up||24
11032900|NCT00865709|12212418|FG001|COMPLETED|Long Term Follow-up||33
11032901|NCT00865709|12212417|FG000|NOT COMPLETED|Long Term Follow-up||46
11032902|NCT00865709|12212418|FG001|NOT COMPLETED|Long Term Follow-up||49
11032903|NCT00865904|12212431|FG000|STARTED|Overall Study|Randomized.|19
11032904|NCT00865904|12212432|FG001|STARTED|Overall Study|Randomized.|18
11032905|NCT00865904|12212433|FG002|STARTED|Overall Study|Randomized.|18
11032906|NCT00865904|12212434|FG003|STARTED|Overall Study|Randomized.|18
11032907|NCT00865904|12212435|FG004|STARTED|Overall Study|Randomized.|20
11032908|NCT00865904|12212431|FG000|COMPLETED|Overall Study|Completed 14-day follow-up.|17
11032909|NCT00865904|12212432|FG001|COMPLETED|Overall Study|Completed 14-day follow-up.|18
11032910|NCT00865904|12212433|FG002|COMPLETED|Overall Study|Completed 14-day follow-up.|18
11032911|NCT00865904|12212434|FG003|COMPLETED|Overall Study|Completed 14-day follow-up.|17
11032912|NCT00865904|12212435|FG004|COMPLETED|Overall Study|Completed 14-day follow-up.|19
11032913|NCT00865904|12212431|FG000|NOT COMPLETED|Overall Study||2
11032914|NCT00865904|12212432|FG001|NOT COMPLETED|Overall Study||0
11032915|NCT00865904|12212433|FG002|NOT COMPLETED|Overall Study||0
11032916|NCT00865904|12212434|FG003|NOT COMPLETED|Overall Study||1
11032917|NCT00865904|12212435|FG004|NOT COMPLETED|Overall Study||1
11032918|NCT00865969|12212451|FG000|STARTED|Overall Study||129
11032919|NCT00865969|12212451|FG000|COMPLETED|Overall Study||129
11032920|NCT00865969|12212451|FG000|NOT COMPLETED|Overall Study||0
11032921|NCT00866034|12212457|FG000|STARTED|Overall Study||308
11032922|NCT00866034|12212458|FG001|STARTED|Overall Study||309
11032923|NCT00866034|12212457|FG000|COMPLETED|Overall Study||292
11032924|NCT00866034|12212458|FG001|COMPLETED|Overall Study||301
11334038|NCT02845375|12531689|FG001|NOT COMPLETED|Overall Study||2
11334039|NCT02845375|12531690|FG002|NOT COMPLETED|Overall Study||1
11334040|NCT02845674|12531700|FG000|STARTED|Overall Study||129
11334041|NCT02845674|12531701|FG001|STARTED|Overall Study||129
11334042|NCT02845674|12531700|FG000|COMPLETED|Overall Study||111
11334043|NCT02845674|12531701|FG001|COMPLETED|Overall Study||79
11334044|NCT02845674|12531700|FG000|NOT COMPLETED|Overall Study||18
11032925|NCT00866034|12212457|FG000|NOT COMPLETED|Overall Study||16
11032926|NCT00866034|12212458|FG001|NOT COMPLETED|Overall Study||8
11032927|NCT00866047|12212464|FG000|STARTED|Treatment Period||58
11032928|NCT00866047|12212464|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
11032929|NCT00866047|12212464|FG000|NOT COMPLETED|Treatment Period||48
11334045|NCT02845674|12531701|FG001|NOT COMPLETED|Overall Study||50
11334046|NCT02845700|12531709|FG000|STARTED|Baseline Appointment||6
11334047|NCT02845700|12531710|FG001|STARTED|Baseline Appointment||7
11334048|NCT02845700|12531709|FG000|COMPLETED|Baseline Appointment||6
11032930|NCT00866047|12212464|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|58
11032931|NCT00866047|12212464|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
11032932|NCT00866047|12212464|FG000|NOT COMPLETED|Follow-up Period||5
11032933|NCT00866177|12212468|FG000|STARTED|Overall Study||167
11032934|NCT00866177|12212468|FG000|COMPLETED|Overall Study||15
11032935|NCT00866177|12212468|FG000|NOT COMPLETED|Overall Study||152
11032936|NCT00866281|12212474|FG000|STARTED|Overall Study||7
11032937|NCT00866281|12212475|FG001|STARTED|Overall Study||15
11032938|NCT00866281|12212474|FG000|COMPLETED|Overall Study||0
11032939|NCT00866281|12212475|FG001|COMPLETED|Overall Study||0
11032940|NCT00866281|12212474|FG000|NOT COMPLETED|Overall Study||7
11032941|NCT00866281|12212475|FG001|NOT COMPLETED|Overall Study||15
11032942|NCT00866294|12212487|FG000|STARTED|Overall Study||172
11032943|NCT00866294|12212488|FG001|STARTED|Overall Study||161
11032944|NCT00866294|12212489|FG002|STARTED|Overall Study||83
11032945|NCT00866294|12212487|FG000|COMPLETED|Overall Study||139
11032946|NCT00866294|12212488|FG001|COMPLETED|Overall Study||141
11032947|NCT00866294|12212489|FG002|COMPLETED|Overall Study||72
11032948|NCT00866294|12212487|FG000|NOT COMPLETED|Overall Study||33
11032949|NCT00866294|12212488|FG001|NOT COMPLETED|Overall Study||20
11032950|NCT00866294|12212489|FG002|NOT COMPLETED|Overall Study||11
11032951|NCT00866307|12212505|FG000|STARTED|Induction||104
11032952|NCT00866307|12212506|FG001|STARTED|Induction||0
11032953|NCT00866307|12212507|FG002|STARTED|Induction||0
11032954|NCT00866307|12212505|FG000|COMPLETED|Induction||84
11032955|NCT00866307|12212506|FG001|COMPLETED|Induction||0
11032956|NCT00866307|12212507|FG002|COMPLETED|Induction||0
11032957|NCT00866307|12212505|FG000|NOT COMPLETED|Induction||20
11032958|NCT00866307|12212506|FG001|NOT COMPLETED|Induction||0
11032959|NCT00866307|12212507|FG002|NOT COMPLETED|Induction||0
11032960|NCT00866307|12212505|FG000|STARTED|Consolidation/Maintenance||0
11032961|NCT00866307|12212506|FG001|STARTED|Consolidation/Maintenance||54
11032962|NCT00866307|12212507|FG002|STARTED|Consolidation/Maintenance||30
11032963|NCT00866307|12212505|FG000|COMPLETED|Consolidation/Maintenance||0
11032964|NCT00866307|12212506|FG001|COMPLETED|Consolidation/Maintenance||45
11032965|NCT00866307|12212507|FG002|COMPLETED|Consolidation/Maintenance||14
11032966|NCT00866307|12212505|FG000|NOT COMPLETED|Consolidation/Maintenance||0
11032967|NCT00866307|12212506|FG001|NOT COMPLETED|Consolidation/Maintenance||9
11032968|NCT00866307|12212507|FG002|NOT COMPLETED|Consolidation/Maintenance||16
11032969|NCT00866320|12212513|FG000|STARTED|Overall Study||49
11032970|NCT00866320|12212513|FG000|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
11032971|NCT00866320|12212513|FG000|NOT COMPLETED|Overall Study||6
11032972|NCT00866333|12212522|FG000|STARTED|Overall Study||16
11032973|NCT00866333|12212523|FG001|STARTED|Overall Study||17
11032974|NCT00866333|12212524|FG002|STARTED|Overall Study||16
11032975|NCT00866333|12212522|FG000|COMPLETED|Overall Study||11
11032976|NCT00866333|12212523|FG001|COMPLETED|Overall Study||10
11032977|NCT00866333|12212524|FG002|COMPLETED|Overall Study||4
11032978|NCT00866333|12212522|FG000|NOT COMPLETED|Overall Study||5
11032979|NCT00866333|12212523|FG001|NOT COMPLETED|Overall Study||7
11032980|NCT00866333|12212524|FG002|NOT COMPLETED|Overall Study||12
11032981|NCT00866359|12212534|FG000|STARTED|Treatment Phase (Days 1 to 85)||56
11032982|NCT00866359|12212535|FG001|STARTED|Treatment Phase (Days 1 to 85)||55
11032983|NCT00866359|12212536|FG002|STARTED|Treatment Phase (Days 1 to 85)||0
11032984|NCT00866359|12212537|FG003|STARTED|Treatment Phase (Days 1 to 85)||0
11032985|NCT00866359|12212534|FG000|COMPLETED|Treatment Phase (Days 1 to 85)||45
11032986|NCT00866359|12212535|FG001|COMPLETED|Treatment Phase (Days 1 to 85)||50
11032987|NCT00866359|12212536|FG002|COMPLETED|Treatment Phase (Days 1 to 85)||0
11032988|NCT00866359|12212537|FG003|COMPLETED|Treatment Phase (Days 1 to 85)||0
11032989|NCT00866359|12212534|FG000|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
11032990|NCT00866359|12212535|FG001|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
11032991|NCT00866359|12212536|FG002|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
11032992|NCT00866359|12212537|FG003|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
11032993|NCT00866359|12212534|FG000|STARTED|Extension Phase (Day 86 to 169)||0
11032994|NCT00866359|12212535|FG001|STARTED|Extension Phase (Day 86 to 169)||0
11032995|NCT00866359|12212536|FG002|STARTED|Extension Phase (Day 86 to 169)||45
11032996|NCT00866359|12212537|FG003|STARTED|Extension Phase (Day 86 to 169)||50
11032997|NCT00866359|12212534|FG000|COMPLETED|Extension Phase (Day 86 to 169)||0
11032998|NCT00866359|12212535|FG001|COMPLETED|Extension Phase (Day 86 to 169)||0
11032999|NCT00866359|12212536|FG002|COMPLETED|Extension Phase (Day 86 to 169)||44
11033000|NCT00866359|12212537|FG003|COMPLETED|Extension Phase (Day 86 to 169)||47
11033001|NCT00866359|12212534|FG000|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
11033002|NCT00866359|12212535|FG001|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
11033003|NCT00866359|12212536|FG002|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
11033004|NCT00866359|12212537|FG003|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
11033005|NCT00866359|12212534|FG000|STARTED|Observational Follow-Up Phase||0
11033006|NCT00866359|12212535|FG001|STARTED|Observational Follow-Up Phase||0
11033007|NCT00866359|12212536|FG002|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
11057543|NCT00998517|12239156|FG001|COMPLETED|Overall Study||906
11033008|NCT00866359|12212537|FG003|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
11033009|NCT00866359|12212534|FG000|COMPLETED|Observational Follow-Up Phase||0
11033010|NCT00866359|12212535|FG001|COMPLETED|Observational Follow-Up Phase||0
11033011|NCT00866359|12212536|FG002|COMPLETED|Observational Follow-Up Phase||54
11033012|NCT00866359|12212537|FG003|COMPLETED|Observational Follow-Up Phase||54
11033013|NCT00866359|12212534|FG000|NOT COMPLETED|Observational Follow-Up Phase||0
11033014|NCT00866359|12212535|FG001|NOT COMPLETED|Observational Follow-Up Phase||0
11033015|NCT00866359|12212536|FG002|NOT COMPLETED|Observational Follow-Up Phase||0
11033016|NCT00866359|12212537|FG003|NOT COMPLETED|Observational Follow-Up Phase||0
11033017|NCT00866606|12212564|FG000|STARTED|Overall Study||35
11033018|NCT00866606|12212564|FG000|COMPLETED|Overall Study||31
11033019|NCT00866606|12212564|FG000|NOT COMPLETED|Overall Study||4
11033020|NCT00866619|12212572|FG000|STARTED|Overall Study||5948
11033021|NCT00866619|12212573|FG001|STARTED|Overall Study||4358
11033022|NCT00866619|12212574|FG002|STARTED|Overall Study||2974
11033023|NCT00866619|12212575|FG003|STARTED|Overall Study||2179
11033024|NCT00866619|12212572|FG000|COMPLETED|Overall Study||4102
11033025|NCT00866619|12212573|FG001|COMPLETED|Overall Study||3088
11033026|NCT00866619|12212574|FG002|COMPLETED|Overall Study||2085
11033027|NCT00866619|12212575|FG003|COMPLETED|Overall Study||1549
11033028|NCT00866619|12212572|FG000|NOT COMPLETED|Overall Study||1846
11033029|NCT00866619|12212573|FG001|NOT COMPLETED|Overall Study||1270
11033030|NCT00866619|12212574|FG002|NOT COMPLETED|Overall Study||889
11033031|NCT00866619|12212575|FG003|NOT COMPLETED|Overall Study||630
11033032|NCT00866658|12212612|FG000|STARTED|Overall Study|Randomized.|157
11033033|NCT00866658|12212613|FG001|STARTED|Overall Study||154
11057544|NCT00998517|12239157|FG002|COMPLETED|Overall Study||918
11033034|NCT00866658|12212612|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
11033035|NCT00866658|12212613|FG001|Safety Population|Overall Study||154
11033036|NCT00866658|12212612|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
11033037|NCT00866658|12212613|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||154
11033038|NCT00866658|12212612|FG000|COMPLETED|Overall Study||144
11033039|NCT00866658|12212613|FG001|COMPLETED|Overall Study||133
11033040|NCT00866658|12212612|FG000|NOT COMPLETED|Overall Study||13
11033041|NCT00866658|12212613|FG001|NOT COMPLETED|Overall Study||21
11033042|NCT00866697|12212621|FG000|STARTED|Overall Study||468
11033043|NCT00866697|12212622|FG001|STARTED|Overall Study||472
11033044|NCT00866697|12212621|FG000|COMPLETED|Overall Study||254
11033045|NCT00866697|12212622|FG001|COMPLETED|Overall Study||244
11033046|NCT00866697|12212621|FG000|NOT COMPLETED|Overall Study||214
11033047|NCT00866697|12212622|FG001|NOT COMPLETED|Overall Study||228
11033048|NCT00866723|12212628|FG000|STARTED|Overall Study||5
11033049|NCT00866723|12212628|FG000|COMPLETED|Overall Study||0
11033050|NCT00866723|12212628|FG000|NOT COMPLETED|Overall Study||5
11033051|NCT00866749|12212632|FG000|STARTED|Overall Study||120
11033052|NCT00866749|12212632|FG000|COMPLETED|Overall Study||120
11033053|NCT00866749|12212632|FG000|NOT COMPLETED|Overall Study||0
11033054|NCT00866775|12212638|FG000|STARTED|Overall Study||65
11033055|NCT00866775|12212639|FG001|STARTED|Overall Study||128
11033056|NCT00866775|12212638|FG000|COMPLETED|Overall Study||29
11033057|NCT00866775|12212639|FG001|COMPLETED|Overall Study||76
11033058|NCT00866775|12212638|FG000|NOT COMPLETED|Overall Study||36
11033059|NCT00866775|12212639|FG001|NOT COMPLETED|Overall Study||52
11033060|NCT00866788|12212651|FG000|STARTED|Overall Study||21
11033061|NCT00866788|12212652|FG001|STARTED|Overall Study||23
11033062|NCT00866788|12212653|FG002|STARTED|Overall Study||25
11033063|NCT00866788|12212654|FG003|STARTED|Overall Study||21
11033064|NCT00866788|12212651|FG000|COMPLETED|Overall Study||15
11033065|NCT00866788|12212652|FG001|COMPLETED|Overall Study||17
11033066|NCT00866788|12212653|FG002|COMPLETED|Overall Study||23
11033067|NCT00866788|12212654|FG003|COMPLETED|Overall Study||16
11033068|NCT00866788|12212651|FG000|NOT COMPLETED|Overall Study||6
11033069|NCT00866788|12212652|FG001|NOT COMPLETED|Overall Study||6
11033070|NCT00866788|12212653|FG002|NOT COMPLETED|Overall Study||2
11033071|NCT00866788|12212654|FG003|NOT COMPLETED|Overall Study||5
11033072|NCT00866814|12212667|FG000|STARTED|Overall Study||119
11033073|NCT00866814|12212667|FG000|COMPLETED|Overall Study||99
11033074|NCT00866814|12212667|FG000|NOT COMPLETED|Overall Study||20
11033075|NCT00866879|12212673|FG000|STARTED|Overall Study||90
11033076|NCT00866879|12212674|FG001|STARTED|Overall Study||185
11033077|NCT00866879|12212673|FG000|COMPLETED|Overall Study||90
11033078|NCT00866879|12212674|FG001|COMPLETED|Overall Study||185
11033079|NCT00866879|12212673|FG000|NOT COMPLETED|Overall Study||0
11033080|NCT00866879|12212674|FG001|NOT COMPLETED|Overall Study||0
11033081|NCT00866905|12212680|FG000|STARTED|Overall Study||168
11033082|NCT00866905|12212680|FG000|COMPLETED|Overall Study||135
11033083|NCT00866905|12212680|FG000|NOT COMPLETED|Overall Study||33
11033084|NCT00867009|12212686|FG000|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
11033085|NCT00867009|12212686|FG000|Received at Least 1 Dose of Study Drug|Induction Period||113
11033086|NCT00867009|12212686|FG000|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
11033087|NCT00867009|12212686|FG000|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
11033088|NCT00867009|12212686|FG000|NOT COMPLETED|Induction Period||62
11033089|NCT00867009|12212686|FG000|STARTED|Maintenance Period||51
11033090|NCT00867009|12212686|FG000|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
11033091|NCT00867009|12212686|FG000|NOT COMPLETED|Maintenance Period||4
11033092|NCT00867035|12212692|FG000|STARTED|Baseline to 1 Hour||13
11033093|NCT00867035|12212693|FG001|STARTED|Baseline to 1 Hour||9
11033094|NCT00867035|12212692|FG000|COMPLETED|Baseline to 1 Hour||12
11033095|NCT00867035|12212693|FG001|COMPLETED|Baseline to 1 Hour||8
11033096|NCT00867035|12212692|FG000|NOT COMPLETED|Baseline to 1 Hour||1
11033097|NCT00867035|12212693|FG001|NOT COMPLETED|Baseline to 1 Hour||1
11033098|NCT00867035|12212692|FG000|STARTED|Baseline to 2 Hours||12
11033099|NCT00867035|12212693|FG001|STARTED|Baseline to 2 Hours||8
11033100|NCT00867035|12212692|FG000|COMPLETED|Baseline to 2 Hours||12
11033101|NCT00867035|12212693|FG001|COMPLETED|Baseline to 2 Hours||8
11033102|NCT00867035|12212692|FG000|NOT COMPLETED|Baseline to 2 Hours||0
11033103|NCT00867035|12212693|FG001|NOT COMPLETED|Baseline to 2 Hours||0
11033104|NCT00867035|12212692|FG000|STARTED|Baseline to 4 Hours||12
11033105|NCT00867035|12212693|FG001|STARTED|Baseline to 4 Hours||8
11033106|NCT00867035|12212692|FG000|COMPLETED|Baseline to 4 Hours||12
11033107|NCT00867035|12212693|FG001|COMPLETED|Baseline to 4 Hours||8
11033108|NCT00867035|12212692|FG000|NOT COMPLETED|Baseline to 4 Hours||0
11033109|NCT00867035|12212693|FG001|NOT COMPLETED|Baseline to 4 Hours||0
11033110|NCT00867035|12212692|FG000|STARTED|Baseline to 1 Week||12
11033111|NCT00867035|12212693|FG001|STARTED|Baseline to 1 Week||8
11033112|NCT00867035|12212692|FG000|COMPLETED|Baseline to 1 Week||11
11033113|NCT00867035|12212693|FG001|COMPLETED|Baseline to 1 Week||8
11033114|NCT00867035|12212692|FG000|NOT COMPLETED|Baseline to 1 Week||1
11033115|NCT00867035|12212693|FG001|NOT COMPLETED|Baseline to 1 Week||0
11033116|NCT00867087|12212699|FG000|STARTED|Overall Study||63
11033117|NCT00867087|12212699|FG000|COMPLETED|Overall Study||21
11033118|NCT00867087|12212699|FG000|NOT COMPLETED|Overall Study||42
11033119|NCT00867100|12212716|FG000|STARTED|Overall Study||5
11033120|NCT00867100|12212717|FG001|STARTED|Overall Study||5
11033121|NCT00867100|12212718|FG002|STARTED|Overall Study||8
11033122|NCT00867100|12212719|FG003|STARTED|Overall Study||8
11033123|NCT00867100|12212720|FG004|STARTED|Overall Study||14
11033124|NCT00867100|12212721|FG005|STARTED|Overall Study||6
11033125|NCT00867100|12212722|FG006|STARTED|Overall Study||7
11033126|NCT00867100|12212723|FG007|STARTED|Overall Study||3
11033127|NCT00867100|12212724|FG008|STARTED|Overall Study||6
11033128|NCT00867100|12212725|FG009|STARTED|Overall Study||6
11033129|NCT00867100|12212726|FG010|STARTED|Overall Study||4
11334049|NCT02845700|12531710|FG001|COMPLETED|Baseline Appointment||7
11334050|NCT02845700|12531709|FG000|NOT COMPLETED|Baseline Appointment||0
11334051|NCT02845700|12531710|FG001|NOT COMPLETED|Baseline Appointment||0
11334052|NCT02845700|12531709|FG000|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5
11334053|NCT02845700|12531710|FG001|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6
11334054|NCT02845700|12531709|FG000|COMPLETED|Intervention Session 1||5
11334055|NCT02845700|12531710|FG001|COMPLETED|Intervention Session 1||6
11334056|NCT02845700|12531709|FG000|NOT COMPLETED|Intervention Session 1||0
11334057|NCT02845700|12531710|FG001|NOT COMPLETED|Intervention Session 1||0
11334058|NCT02845700|12531709|FG000|STARTED|Intervention Session 2||5
11334059|NCT02845700|12531710|FG001|STARTED|Intervention Session 2||6
11334060|NCT02845700|12531709|FG000|COMPLETED|Intervention Session 2||5
11334061|NCT02845700|12531710|FG001|COMPLETED|Intervention Session 2||6
11334062|NCT02845700|12531709|FG000|NOT COMPLETED|Intervention Session 2||0
11033130|NCT00867100|12212727|FG011|STARTED|Overall Study||6
11033131|NCT00867100|12212728|FG012|STARTED|Overall Study||6
11033132|NCT00867100|12212716|FG000|COMPLETED|Overall Study||5
11033133|NCT00867100|12212717|FG001|COMPLETED|Overall Study||4
11033134|NCT00867100|12212718|FG002|COMPLETED|Overall Study||8
11033135|NCT00867100|12212719|FG003|COMPLETED|Overall Study||8
11033136|NCT00867100|12212720|FG004|COMPLETED|Overall Study||14
11334063|NCT02845700|12531710|FG001|NOT COMPLETED|Intervention Session 2||0
11334064|NCT02845700|12531709|FG000|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2
11334065|NCT02845700|12531710|FG001|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4
11334066|NCT02845700|12531709|FG000|COMPLETED|Month 1 Follow-Up||2
11334067|NCT02845700|12531710|FG001|COMPLETED|Month 1 Follow-Up||4
11033137|NCT00867100|12212721|FG005|COMPLETED|Overall Study||6
11033138|NCT00867100|12212722|FG006|COMPLETED|Overall Study||6
11033139|NCT00867100|12212723|FG007|COMPLETED|Overall Study||3
11033140|NCT00867100|12212724|FG008|COMPLETED|Overall Study||6
11033141|NCT00867100|12212725|FG009|COMPLETED|Overall Study||6
11033142|NCT00867100|12212726|FG010|COMPLETED|Overall Study||3
11033143|NCT00867100|12212727|FG011|COMPLETED|Overall Study||6
11033144|NCT00867100|12212728|FG012|COMPLETED|Overall Study||6
11033145|NCT00867100|12212716|FG000|NOT COMPLETED|Overall Study||0
11033146|NCT00867100|12212717|FG001|NOT COMPLETED|Overall Study||1
11033147|NCT00867100|12212718|FG002|NOT COMPLETED|Overall Study||0
11033148|NCT00867100|12212719|FG003|NOT COMPLETED|Overall Study||0
11033149|NCT00867100|12212720|FG004|NOT COMPLETED|Overall Study||0
11033150|NCT00867100|12212721|FG005|NOT COMPLETED|Overall Study||0
11033151|NCT00867100|12212722|FG006|NOT COMPLETED|Overall Study||1
11033152|NCT00867100|12212723|FG007|NOT COMPLETED|Overall Study||0
11033153|NCT00867100|12212724|FG008|NOT COMPLETED|Overall Study||0
11033154|NCT00867100|12212725|FG009|NOT COMPLETED|Overall Study||0
11033155|NCT00867100|12212726|FG010|NOT COMPLETED|Overall Study||1
11033156|NCT00867100|12212727|FG011|NOT COMPLETED|Overall Study||0
11033157|NCT00867100|12212728|FG012|NOT COMPLETED|Overall Study||0
11033158|NCT00867113|12212760|FG000|STARTED|Treatment Period||91
11033159|NCT00867113|12212760|FG000|Safety Set|Treatment Period||91
11033160|NCT00867113|12212760|FG000|Full Analysis Set (FAS)|Treatment Period||91
11033161|NCT00867113|12212760|FG000|COMPLETED|Treatment Period||46
11033162|NCT00867113|12212760|FG000|NOT COMPLETED|Treatment Period||45
11033163|NCT00867113|12212760|FG000|STARTED|Post Treatment After Survival Follow-up||68
11033164|NCT00867113|12212760|FG000|COMPLETED|Post Treatment After Survival Follow-up||57
11033165|NCT00867113|12212760|FG000|NOT COMPLETED|Post Treatment After Survival Follow-up||11
11200839|NCT01829295|12391056|FG001|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56
11200840|NCT01829295|12391057|FG002|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32
11334068|NCT02845700|12531709|FG000|NOT COMPLETED|Month 1 Follow-Up||0
11033166|NCT00867139|12212767|FG000|STARTED|Overall Study||2
11033167|NCT00867139|12212768|FG001|STARTED|Overall Study||1
11033168|NCT00867139|12212769|FG002|STARTED|Overall Study||4
11033169|NCT00867139|12212767|FG000|COMPLETED|Overall Study||2
11033170|NCT00867139|12212768|FG001|COMPLETED|Overall Study||1
11033171|NCT00867139|12212769|FG002|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
11033172|NCT00867139|12212767|FG000|NOT COMPLETED|Overall Study||0
11033173|NCT00867139|12212768|FG001|NOT COMPLETED|Overall Study||0
11033174|NCT00867139|12212769|FG002|NOT COMPLETED|Overall Study||1
11033175|NCT00867217|12212787|FG000|STARTED|Overall Study||80
11033176|NCT00867217|12212788|FG001|STARTED|Overall Study||80
11033177|NCT00867217|12212787|FG000|COMPLETED|Overall Study||77
11033178|NCT00867217|12212788|FG001|COMPLETED|Overall Study||70
11033179|NCT00867217|12212787|FG000|NOT COMPLETED|Overall Study||3
11033180|NCT00867217|12212788|FG001|NOT COMPLETED|Overall Study||10
11033181|NCT00867308|12212796|FG000|STARTED|Overall Study||9
11033182|NCT00867308|12212797|FG001|STARTED|Overall Study||18
11033183|NCT00867308|12212796|FG000|COMPLETED|Overall Study||0
11033184|NCT00867308|12212797|FG001|COMPLETED|Overall Study||0
11033185|NCT00867308|12212796|FG000|NOT COMPLETED|Overall Study||9
11033186|NCT00867308|12212797|FG001|NOT COMPLETED|Overall Study||18
11033187|NCT00867334|12212805|FG000|STARTED|Overall Study||6
11033188|NCT00867334|12212806|FG001|STARTED|Overall Study||1
11033189|NCT00867334|12212805|FG000|COMPLETED|Overall Study||4
11033190|NCT00867334|12212806|FG001|COMPLETED|Overall Study||0
11033191|NCT00867334|12212805|FG000|NOT COMPLETED|Overall Study||2
11033192|NCT00867334|12212806|FG001|NOT COMPLETED|Overall Study||1
11033193|NCT00867360|12212814|FG000|STARTED|Overall Study||4
11033194|NCT00867360|12212815|FG001|STARTED|Overall Study||6
11033195|NCT00867360|12212814|FG000|COMPLETED|Overall Study||3
11334069|NCT02845700|12531710|FG001|NOT COMPLETED|Month 1 Follow-Up||0
11334070|NCT02845752|12531718|FG000|STARTED|First Intervention (7 Days)||7
11033196|NCT00867360|12212815|FG001|COMPLETED|Overall Study||5
11334071|NCT02845752|12531719|FG001|STARTED|First Intervention (7 Days)||7
11334072|NCT02845752|12531718|FG000|COMPLETED|First Intervention (7 Days)||7
11334073|NCT02845752|12531719|FG001|COMPLETED|First Intervention (7 Days)||7
11334074|NCT02845752|12531718|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11334075|NCT02845752|12531719|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11334076|NCT02845752|12531718|FG000|STARTED|Washout (14 Days)||7
11334077|NCT02845752|12531719|FG001|STARTED|Washout (14 Days)||7
11334078|NCT02845752|12531718|FG000|COMPLETED|Washout (14 Days)||7
11334079|NCT02845752|12531719|FG001|COMPLETED|Washout (14 Days)||7
11334080|NCT02845752|12531718|FG000|NOT COMPLETED|Washout (14 Days)||0
11334081|NCT02845752|12531719|FG001|NOT COMPLETED|Washout (14 Days)||0
11334082|NCT02845752|12531718|FG000|STARTED|Second Intervention (7 Days)||7
11334083|NCT02845752|12531719|FG001|STARTED|Second Intervention (7 Days)||7
11334084|NCT02845752|12531718|FG000|COMPLETED|Second Intervention (7 Days)||7
11334085|NCT02845752|12531719|FG001|COMPLETED|Second Intervention (7 Days)||7
11334086|NCT02845752|12531718|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
11334087|NCT02845752|12531719|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11334088|NCT02846233|12531727|FG000|STARTED|Overall Study||12
11334089|NCT02846233|12531728|FG001|STARTED|Overall Study||10
11334090|NCT02846233|12531727|FG000|COMPLETED|Overall Study||10
11334091|NCT02846233|12531728|FG001|COMPLETED|Overall Study||8
11334092|NCT02846233|12531727|FG000|NOT COMPLETED|Overall Study||2
11334093|NCT02846233|12531728|FG001|NOT COMPLETED|Overall Study||2
11334094|NCT02846324|12531738|FG000|STARTED|Overall Study||9
11334095|NCT02846324|12531739|FG001|STARTED|Overall Study||6
11334096|NCT02846324|12531740|FG002|STARTED|Overall Study||14
11334097|NCT02846324|12531741|FG003|STARTED|Overall Study||10
11334098|NCT02846324|12531738|FG000|Completed Study Treatment|Overall Study||7
11334099|NCT02846324|12531739|FG001|Completed Study Treatment|Overall Study||5
11334100|NCT02846324|12531740|FG002|Completed Study Treatment|Overall Study||11
11334101|NCT02846324|12531741|FG003|Completed Study Treatment|Overall Study||10
11334102|NCT02846324|12531738|FG000|COMPLETED|Overall Study||7
11334103|NCT02846324|12531739|FG001|COMPLETED|Overall Study||6
11334104|NCT02846324|12531740|FG002|COMPLETED|Overall Study||10
11334105|NCT02846324|12531741|FG003|COMPLETED|Overall Study||10
11334106|NCT02846324|12531738|FG000|NOT COMPLETED|Overall Study||2
11334107|NCT02846324|12531739|FG001|NOT COMPLETED|Overall Study||0
11334108|NCT02846324|12531740|FG002|NOT COMPLETED|Overall Study||4
11334109|NCT02846324|12531741|FG003|NOT COMPLETED|Overall Study||0
11334110|NCT02846415|12531762|FG000|STARTED|Overall Study||18
11334111|NCT02846415|12531763|FG001|STARTED|Overall Study||12
11334112|NCT02846415|12531762|FG000|COMPLETED|Overall Study||15
11334113|NCT02846415|12531763|FG001|COMPLETED|Overall Study||11
11033197|NCT00867360|12212814|FG000|NOT COMPLETED|Overall Study||1
11033198|NCT00867360|12212815|FG001|NOT COMPLETED|Overall Study||1
11033199|NCT00867451|12212824|FG000|STARTED|Overall Study||4
11033200|NCT00867451|12212825|FG001|STARTED|Overall Study||4
11033201|NCT00867451|12212824|FG000|COMPLETED|Overall Study||4
11033202|NCT00867451|12212825|FG001|COMPLETED|Overall Study||4
11033203|NCT00867451|12212824|FG000|NOT COMPLETED|Overall Study||0
11033204|NCT00867451|12212825|FG001|NOT COMPLETED|Overall Study||0
11033205|NCT00867490|12212835|FG000|STARTED|Phase 1 - Candesartan+HCTZ||186
11033206|NCT00867490|12212835|FG000|COMPLETED|Phase 1 - Candesartan+HCTZ||176
11033207|NCT00867490|12212835|FG000|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
11033208|NCT00867490|12212835|FG000|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
11033209|NCT00867490|12212835|FG000|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
11033210|NCT00867490|12212835|FG000|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
11033211|NCT00867490|12212835|FG000|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
11033212|NCT00867490|12212835|FG000|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
11033213|NCT00867490|12212835|FG000|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
11033214|NCT00867503|12212842|FG000|STARTED|Overall Study||10
11033215|NCT00867503|12212842|FG000|COMPLETED|Overall Study||9
11033216|NCT00867503|12212842|FG000|NOT COMPLETED|Overall Study||1
11033217|NCT00867529|12212848|FG000|STARTED|Overall Study||63
11033218|NCT00867529|12212848|FG000|COMPLETED|Overall Study||63
11033219|NCT00867529|12212848|FG000|NOT COMPLETED|Overall Study||0
11033220|NCT00867659|12212852|FG000|STARTED|Overall Study|October 2009|20
11033221|NCT00867659|12212852|FG000|COMPLETED|Overall Study|January 2010|20
11033222|NCT00867659|12212852|FG000|NOT COMPLETED|Overall Study||0
11033223|NCT00867789|12212859|FG000|STARTED|Overall Study||70
11033224|NCT00867789|12212860|FG001|STARTED|Overall Study||70
11033225|NCT00867789|12212859|FG000|COMPLETED|Overall Study||68
11033226|NCT00867789|12212860|FG001|COMPLETED|Overall Study||70
11033227|NCT00867789|12212859|FG000|NOT COMPLETED|Overall Study||2
11033228|NCT00867789|12212860|FG001|NOT COMPLETED|Overall Study||0
11033229|NCT00867815|12212866|FG000|STARTED|Overall Study||10
11033230|NCT00867815|12212866|FG000|COMPLETED|Overall Study||9
11033231|NCT00867815|12212866|FG000|NOT COMPLETED|Overall Study||1
11033232|NCT00867932|12212870|FG000|STARTED|Overall Study||7
11033233|NCT00867932|12212870|FG000|Induction Phase|Overall Study||7
11033234|NCT00867932|12212870|FG000|Maintenance Phase|Overall Study||7
11033235|NCT00867932|12212870|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
11033236|NCT00867932|12212870|FG000|Intent-to-Treat (ITT) Population|Overall Study||7
11033237|NCT00867932|12212870|FG000|COMPLETED|Overall Study||7
11334114|NCT02846415|12531762|FG000|NOT COMPLETED|Overall Study||3
11334115|NCT02846415|12531763|FG001|NOT COMPLETED|Overall Study||1
11033238|NCT00867932|12212870|FG000|NOT COMPLETED|Overall Study||0
11033239|NCT00868101|12212876|FG000|STARTED|Overall Study||12
11033240|NCT00868101|12212877|FG001|STARTED|Overall Study||10
11033241|NCT00868101|12212876|FG000|COMPLETED|Overall Study||12
11033242|NCT00868101|12212877|FG001|COMPLETED|Overall Study||10
11033243|NCT00868101|12212876|FG000|NOT COMPLETED|Overall Study||0
11033244|NCT00868101|12212877|FG001|NOT COMPLETED|Overall Study||0
11033245|NCT00868140|12212887|FG000|STARTED|Overall Study||26
11033246|NCT00868140|12212888|FG001|STARTED|Overall Study||25
11033247|NCT00868140|12212887|FG000|COMPLETED|Overall Study||26
11033248|NCT00868140|12212888|FG001|COMPLETED|Overall Study||25
11033249|NCT00868140|12212887|FG000|NOT COMPLETED|Overall Study||0
11033250|NCT00868140|12212888|FG001|NOT COMPLETED|Overall Study||0
11033251|NCT00868166|12212898|FG000|STARTED|Overall Study||259
11033252|NCT00868166|12212899|FG001|STARTED|Overall Study||253
11033253|NCT00868166|12212898|FG000|COMPLETED|Overall Study||147
11033254|NCT00868166|12212899|FG001|COMPLETED|Overall Study||139
11033255|NCT00868166|12212898|FG000|NOT COMPLETED|Overall Study||112
11033256|NCT00868166|12212899|FG001|NOT COMPLETED|Overall Study||114
11033257|NCT00868192|12212905|FG000|STARTED|Overall Study||38
11334116|NCT02846558|12531773|FG000|STARTED|Overall Study||15
11334117|NCT02846558|12531774|FG001|STARTED|Overall Study||12
11334118|NCT02846558|12531775|FG002|STARTED|Overall Study||14
11334119|NCT02846558|12531776|FG003|STARTED|Overall Study||13
11334120|NCT02846558|12531773|FG000|Baseline Study Visit|Overall Study||10
11334121|NCT02846558|12531774|FG001|Baseline Study Visit|Overall Study||9
11334122|NCT02846558|12531775|FG002|Baseline Study Visit|Overall Study||14
11334123|NCT02846558|12531776|FG003|Baseline Study Visit|Overall Study||12
11334124|NCT02846558|12531773|FG000|3 Month Study Visit|Overall Study||7
11334125|NCT02846558|12531774|FG001|3 Month Study Visit|Overall Study||8
11334126|NCT02846558|12531775|FG002|3 Month Study Visit|Overall Study||12
11334127|NCT02846558|12531776|FG003|3 Month Study Visit|Overall Study||11
11334128|NCT02846558|12531773|FG000|COMPLETED|Overall Study||7
11334129|NCT02846558|12531774|FG001|COMPLETED|Overall Study||8
11334130|NCT02846558|12531775|FG002|COMPLETED|Overall Study||12
11334131|NCT02846558|12531776|FG003|COMPLETED|Overall Study||11
11334132|NCT02846558|12531773|FG000|NOT COMPLETED|Overall Study||8
11334133|NCT02846558|12531774|FG001|NOT COMPLETED|Overall Study||4
11334134|NCT02846558|12531775|FG002|NOT COMPLETED|Overall Study||2
11334135|NCT02846558|12531776|FG003|NOT COMPLETED|Overall Study||2
11334136|NCT02846714|12531793|FG000|STARTED|Overall Study||42
11334137|NCT02846714|12531793|FG000|COMPLETED|Overall Study||36
11334138|NCT02846714|12531793|FG000|NOT COMPLETED|Overall Study||6
11334139|NCT02846740|12531799|FG000|STARTED|Overall Study||15
11334140|NCT02846740|12531800|FG001|STARTED|Overall Study||15
11334141|NCT02846740|12531799|FG000|COMPLETED|Overall Study||15
11334142|NCT02846740|12531800|FG001|COMPLETED|Overall Study||14
11334143|NCT02846740|12531799|FG000|NOT COMPLETED|Overall Study||0
11334144|NCT02846740|12531800|FG001|NOT COMPLETED|Overall Study||1
11334145|NCT02846779|12531809|FG000|STARTED|Overall Study||2000
11334146|NCT02846779|12531810|FG001|STARTED|Overall Study||2000
11334147|NCT02846779|12531811|FG002|STARTED|Overall Study||2000
11334148|NCT02846779|12531809|FG000|COMPLETED|Overall Study||1861
11334149|NCT02846779|12531810|FG001|COMPLETED|Overall Study||1873
11334150|NCT02846779|12531811|FG002|COMPLETED|Overall Study||1862
11334151|NCT02846779|12531809|FG000|NOT COMPLETED|Overall Study||139
11334152|NCT02846779|12531810|FG001|NOT COMPLETED|Overall Study||127
11334153|NCT02846779|12531811|FG002|NOT COMPLETED|Overall Study||138
11334154|NCT02846792|12531819|FG000|STARTED|Overall Study||5
11334155|NCT02846792|12531819|FG000|COMPLETED|Overall Study||5
11334156|NCT02846792|12531819|FG000|NOT COMPLETED|Overall Study||0
11334157|NCT02847169|12531823|FG000|STARTED|First Intervention (1 Week)||15
11334158|NCT02847169|12531824|FG001|STARTED|First Intervention (1 Week)||15
11334159|NCT02847169|12531823|FG000|COMPLETED|First Intervention (1 Week)||15
11334160|NCT02847169|12531824|FG001|COMPLETED|First Intervention (1 Week)||15
11334161|NCT02847169|12531823|FG000|NOT COMPLETED|First Intervention (1 Week)||0
11334162|NCT02847169|12531824|FG001|NOT COMPLETED|First Intervention (1 Week)||0
11334163|NCT02847169|12531823|FG000|STARTED|Second Intervention (1 Week)||15
11334164|NCT02847169|12531824|FG001|STARTED|Second Intervention (1 Week)||15
11334165|NCT02847169|12531823|FG000|COMPLETED|Second Intervention (1 Week)||15
11334166|NCT02847169|12531824|FG001|COMPLETED|Second Intervention (1 Week)||15
11334167|NCT02847169|12531823|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
11334168|NCT02847169|12531824|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
11334169|NCT02847182|12531847|FG000|STARTED|Overall Study||119
11033258|NCT00868192|12212905|FG000|COMPLETED|Overall Study||34
11033259|NCT00868192|12212905|FG000|NOT COMPLETED|Overall Study||4
11033260|NCT00868218|12212913|FG000|STARTED|Overall Study||15
11033261|NCT00868218|12212914|FG001|STARTED|Overall Study||15
11033262|NCT00868218|12212915|FG002|STARTED|Overall Study||15
11033263|NCT00868218|12212916|FG003|STARTED|Overall Study||15
11033264|NCT00868218|12212913|FG000|COMPLETED|Overall Study||15
11033265|NCT00868218|12212914|FG001|COMPLETED|Overall Study||15
11334170|NCT02847182|12531848|FG001|STARTED|Overall Study||61
11334171|NCT02847182|12531847|FG000|First Intervention (6 Months)|Overall Study||119
11334172|NCT02847182|12531848|FG001|First Intervention (6 Months)|Overall Study||61
11334173|NCT02847182|12531847|FG000|Second Intervention (6 Months)|Overall Study||61
11334174|NCT02847182|12531848|FG001|Second Intervention (6 Months)|Overall Study||119
11033266|NCT00868218|12212915|FG002|COMPLETED|Overall Study||15
11033267|NCT00868218|12212916|FG003|COMPLETED|Overall Study||15
11033268|NCT00868218|12212913|FG000|NOT COMPLETED|Overall Study||0
11033269|NCT00868218|12212914|FG001|NOT COMPLETED|Overall Study||0
11033270|NCT00868218|12212915|FG002|NOT COMPLETED|Overall Study||0
11033271|NCT00868218|12212916|FG003|NOT COMPLETED|Overall Study||0
11033272|NCT00868231|12212930|FG000|STARTED|Treatment Period 1||5
11033273|NCT00868231|12212931|FG001|STARTED|Treatment Period 1||5
11033274|NCT00868231|12212932|FG002|STARTED|Treatment Period 1||5
11033275|NCT00868231|12212933|FG003|STARTED|Treatment Period 1||5
11033276|NCT00868231|12212934|FG004|STARTED|Treatment Period 1||5
11033277|NCT00868231|12212935|FG005|STARTED|Treatment Period 1||5
11033278|NCT00868231|12212930|FG000|COMPLETED|Treatment Period 1||5
11033279|NCT00868231|12212931|FG001|COMPLETED|Treatment Period 1||5
11033280|NCT00868231|12212932|FG002|COMPLETED|Treatment Period 1||5
11033281|NCT00868231|12212933|FG003|COMPLETED|Treatment Period 1||5
11033282|NCT00868231|12212934|FG004|COMPLETED|Treatment Period 1||4
11033283|NCT00868231|12212935|FG005|COMPLETED|Treatment Period 1||5
11033284|NCT00868231|12212930|FG000|NOT COMPLETED|Treatment Period 1||0
11033285|NCT00868231|12212931|FG001|NOT COMPLETED|Treatment Period 1||0
11033286|NCT00868231|12212932|FG002|NOT COMPLETED|Treatment Period 1||0
11033287|NCT00868231|12212933|FG003|NOT COMPLETED|Treatment Period 1||0
11033288|NCT00868231|12212934|FG004|NOT COMPLETED|Treatment Period 1||1
11033289|NCT00868231|12212935|FG005|NOT COMPLETED|Treatment Period 1||0
11033290|NCT00868231|12212930|FG000|STARTED|Treatment Period 2||5
11033291|NCT00868231|12212931|FG001|STARTED|Treatment Period 2||5
11033292|NCT00868231|12212932|FG002|STARTED|Treatment Period 2||5
11033293|NCT00868231|12212933|FG003|STARTED|Treatment Period 2||5
11033294|NCT00868231|12212934|FG004|STARTED|Treatment Period 2||4
11033295|NCT00868231|12212935|FG005|STARTED|Treatment Period 2||5
11033296|NCT00868231|12212930|FG000|COMPLETED|Treatment Period 2||4
11033297|NCT00868231|12212931|FG001|COMPLETED|Treatment Period 2||5
11033298|NCT00868231|12212932|FG002|COMPLETED|Treatment Period 2||5
11033299|NCT00868231|12212933|FG003|COMPLETED|Treatment Period 2||5
11033300|NCT00868231|12212934|FG004|COMPLETED|Treatment Period 2||4
11033301|NCT00868231|12212935|FG005|COMPLETED|Treatment Period 2||5
11033302|NCT00868231|12212930|FG000|NOT COMPLETED|Treatment Period 2||1
11033303|NCT00868231|12212931|FG001|NOT COMPLETED|Treatment Period 2||0
11033304|NCT00868231|12212932|FG002|NOT COMPLETED|Treatment Period 2||0
11033305|NCT00868231|12212933|FG003|NOT COMPLETED|Treatment Period 2||0
11033306|NCT00868231|12212934|FG004|NOT COMPLETED|Treatment Period 2||0
11033307|NCT00868231|12212935|FG005|NOT COMPLETED|Treatment Period 2||0
11033308|NCT00868231|12212930|FG000|STARTED|Treatment Period 3||4
11033309|NCT00868231|12212931|FG001|STARTED|Treatment Period 3||5
11033310|NCT00868231|12212932|FG002|STARTED|Treatment Period 3||5
11033311|NCT00868231|12212933|FG003|STARTED|Treatment Period 3||5
11033312|NCT00868231|12212934|FG004|STARTED|Treatment Period 3||4
11033313|NCT00868231|12212935|FG005|STARTED|Treatment Period 3||5
11033314|NCT00868231|12212930|FG000|COMPLETED|Treatment Period 3||4
11033315|NCT00868231|12212931|FG001|COMPLETED|Treatment Period 3||5
11033316|NCT00868231|12212932|FG002|COMPLETED|Treatment Period 3||4
11033317|NCT00868231|12212933|FG003|COMPLETED|Treatment Period 3||5
11033318|NCT00868231|12212934|FG004|COMPLETED|Treatment Period 3||4
11033319|NCT00868231|12212935|FG005|COMPLETED|Treatment Period 3||5
11033320|NCT00868231|12212930|FG000|NOT COMPLETED|Treatment Period 3||0
11033321|NCT00868231|12212931|FG001|NOT COMPLETED|Treatment Period 3||0
11033322|NCT00868231|12212932|FG002|NOT COMPLETED|Treatment Period 3||1
11033323|NCT00868231|12212933|FG003|NOT COMPLETED|Treatment Period 3||0
11033324|NCT00868231|12212934|FG004|NOT COMPLETED|Treatment Period 3||0
11033325|NCT00868231|12212935|FG005|NOT COMPLETED|Treatment Period 3||0
11033326|NCT00868296|12212945|FG000|STARTED|Overall Study||12
11033327|NCT00868296|12212946|FG001|STARTED|Overall Study||46
11033328|NCT00868296|12212945|FG000|COMPLETED|Overall Study||12
11033329|NCT00868296|12212946|FG001|COMPLETED|Overall Study||43
11033330|NCT00868296|12212945|FG000|NOT COMPLETED|Overall Study||0
11033331|NCT00868296|12212946|FG001|NOT COMPLETED|Overall Study||3
11033332|NCT00868309|12212954|FG000|STARTED|Overall Study||6
11033333|NCT00868309|12212955|FG001|STARTED|Overall Study||6
11033334|NCT00868309|12212954|FG000|COMPLETED|Overall Study||6
11033335|NCT00868309|12212955|FG001|COMPLETED|Overall Study||6
11033336|NCT00868309|12212954|FG000|NOT COMPLETED|Overall Study||0
11033337|NCT00868309|12212955|FG001|NOT COMPLETED|Overall Study||0
11033338|NCT00868348|12212963|FG000|STARTED|Overall Study||30
11033339|NCT00868348|12212964|FG001|STARTED|Overall Study||30
11033340|NCT00868348|12212963|FG000|COMPLETED|Overall Study||30
11033341|NCT00868348|12212964|FG001|COMPLETED|Overall Study||30
11033342|NCT00868348|12212963|FG000|NOT COMPLETED|Overall Study||0
11033343|NCT00868348|12212964|FG001|NOT COMPLETED|Overall Study||0
11033344|NCT00868374|12212972|FG000|STARTED|Overall Study||12
11033345|NCT00868374|12212973|FG001|STARTED|Overall Study||11
11033346|NCT00868374|12212972|FG000|COMPLETED|Overall Study||5
11033347|NCT00868374|12212973|FG001|COMPLETED|Overall Study||4
11033348|NCT00868374|12212972|FG000|NOT COMPLETED|Overall Study||7
11033349|NCT00868374|12212973|FG001|NOT COMPLETED|Overall Study||7
11033350|NCT00868439|12212981|FG000|STARTED|Overall Study||56
11033351|NCT00868439|12212982|FG001|STARTED|Overall Study||49
11033352|NCT00868439|12212981|FG000|COMPLETED|Overall Study||48
11033353|NCT00868439|12212982|FG001|COMPLETED|Overall Study||40
11033354|NCT00868439|12212981|FG000|NOT COMPLETED|Overall Study||8
11033355|NCT00868439|12212982|FG001|NOT COMPLETED|Overall Study||9
11033356|NCT00868452|12212990|FG000|STARTED|Overall Study||183
11033357|NCT00868452|12212991|FG001|STARTED|Overall Study||165
11033358|NCT00868452|12212990|FG000|COMPLETED|Overall Study||143
11033359|NCT00868452|12212991|FG001|COMPLETED|Overall Study||136
11033360|NCT00868452|12212990|FG000|NOT COMPLETED|Overall Study||40
11033361|NCT00868452|12212991|FG001|NOT COMPLETED|Overall Study||29
11033362|NCT00868517|12213001|FG000|STARTED|Overall Study||12
11033363|NCT00868517|12213002|FG001|STARTED|Overall Study||12
11033364|NCT00868517|12213003|FG002|STARTED|Overall Study||11
11033365|NCT00868517|12213001|FG000|COMPLETED|Overall Study||8
11033366|NCT00868517|12213002|FG001|COMPLETED|Overall Study||8
11033367|NCT00868517|12213003|FG002|COMPLETED|Overall Study||9
11033368|NCT00868517|12213001|FG000|NOT COMPLETED|Overall Study||4
11033369|NCT00868517|12213002|FG001|NOT COMPLETED|Overall Study||4
11033370|NCT00868517|12213003|FG002|NOT COMPLETED|Overall Study||2
11033371|NCT00868530|12213011|FG000|STARTED|Overall Study||53
11033372|NCT00868530|12213011|FG000|COMPLETED|Overall Study||49
11033373|NCT00868530|12213011|FG000|NOT COMPLETED|Overall Study||4
11033374|NCT00868608|12213018|FG000|STARTED|Overall Study||72
11033375|NCT00868608|12213019|FG001|STARTED|Overall Study||4
11334175|NCT02847182|12531847|FG000|COMPLETED|Overall Study||119
11334176|NCT02847182|12531848|FG001|COMPLETED|Overall Study||60
11334177|NCT02847182|12531847|FG000|NOT COMPLETED|Overall Study||0
11334178|NCT02847182|12531848|FG001|NOT COMPLETED|Overall Study||1
11343843|NCT02956486|12541122|FG000|Full Analysis Set (FAS)|Core Phase||1084
11343844|NCT02956486|12541123|FG001|Full Analysis Set (FAS)|Core Phase||1062
11343845|NCT02956486|12541124|FG002|Full Analysis Set (FAS)|Core Phase||0
11343846|NCT02956486|12541122|FG000|COMPLETED|Core Phase||29
11343847|NCT02956486|12541123|FG001|COMPLETED|Core Phase||32
11033376|NCT00868608|12213020|FG002|STARTED|Overall Study||5
11033377|NCT00868608|12213018|FG000|COMPLETED|Overall Study||49
11033378|NCT00868608|12213019|FG001|COMPLETED|Overall Study||1
11033379|NCT00868608|12213020|FG002|COMPLETED|Overall Study||0
11033380|NCT00868608|12213018|FG000|NOT COMPLETED|Overall Study||23
11033381|NCT00868608|12213019|FG001|NOT COMPLETED|Overall Study||3
11033382|NCT00868608|12213020|FG002|NOT COMPLETED|Overall Study||5
11033383|NCT00868699|12213031|FG000|STARTED|Overall Study||170
11033384|NCT00868699|12213032|FG001|STARTED|Overall Study||169
11033385|NCT00868699|12213033|FG002|STARTED|Overall Study||166
11033386|NCT00868699|12213031|FG000|Intent-to-Treat Population|Overall Study||162
11033387|NCT00868699|12213032|FG001|Intent-to-Treat Population|Overall Study||162
11033388|NCT00868699|12213033|FG002|Intent-to-Treat Population|Overall Study||161
11033389|NCT00868699|12213031|FG000|Safety Population|Overall Study||168
11033390|NCT00868699|12213032|FG001|Safety Population|Overall Study||167
11033391|NCT00868699|12213033|FG002|Safety Population|Overall Study||164
11033392|NCT00868699|12213031|FG000|COMPLETED|Overall Study||127
11033393|NCT00868699|12213032|FG001|COMPLETED|Overall Study||124
11033394|NCT00868699|12213033|FG002|COMPLETED|Overall Study||123
11033395|NCT00868699|12213031|FG000|NOT COMPLETED|Overall Study||43
11033396|NCT00868699|12213032|FG001|NOT COMPLETED|Overall Study||45
11033397|NCT00868699|12213033|FG002|NOT COMPLETED|Overall Study||43
11057545|NCT00998517|12239155|FG000|NOT COMPLETED|Overall Study||0
11057546|NCT00998517|12239156|FG001|NOT COMPLETED|Overall Study||0
11057547|NCT00998517|12239157|FG002|NOT COMPLETED|Overall Study||0
11057548|NCT00998582|12239167|FG000|STARTED|Overall Study||13
11057549|NCT00998582|12239168|FG001|STARTED|Overall Study||14
11057550|NCT00998582|12239167|FG000|COMPLETED|Overall Study||13
11057551|NCT00998582|12239168|FG001|COMPLETED|Overall Study||14
11057552|NCT00998582|12239167|FG000|NOT COMPLETED|Overall Study||0
11057553|NCT00998582|12239168|FG001|NOT COMPLETED|Overall Study||0
11057554|NCT00998660|12239177|FG000|STARTED|Overall Study||100
11057555|NCT00998660|12239177|FG000|Implanted|Overall Study||93
11057556|NCT00998660|12239177|FG000|Month 3 Visit|Overall Study||87
11057557|NCT00998660|12239177|FG000|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
11057558|NCT00998660|12239177|FG000|NOT COMPLETED|Overall Study||13
11057559|NCT00998764|12239183|FG000|STARTED|Overall Study||216
11057560|NCT00998764|12239184|FG001|STARTED|Overall Study||276
11057561|NCT00998764|12239183|FG000|Treated|Overall Study||215
11057562|NCT00998764|12239184|FG001|Treated|Overall Study||275
11057563|NCT00998764|12239183|FG000|COMPLETED|Overall Study||0
11057564|NCT00998764|12239184|FG001|COMPLETED|Overall Study||2
11057565|NCT00998764|12239183|FG000|NOT COMPLETED|Overall Study||216
11057566|NCT00998764|12239184|FG001|NOT COMPLETED|Overall Study||274
11343848|NCT02956486|12541124|FG002|COMPLETED|Core Phase||0
11033398|NCT00868712|12213044|FG000|STARTED|Overall Study||31
11033399|NCT00868712|12213045|FG001|STARTED|Overall Study||11
11033400|NCT00868712|12213046|FG002|STARTED|Overall Study||28
11033401|NCT00868712|12213044|FG000|COMPLETED|Overall Study||31
11033402|NCT00868712|12213045|FG001|COMPLETED|Overall Study||11
11033403|NCT00868712|12213046|FG002|COMPLETED|Overall Study||28
11033404|NCT00868712|12213044|FG000|NOT COMPLETED|Overall Study||0
11033405|NCT00868712|12213045|FG001|NOT COMPLETED|Overall Study||0
11033406|NCT00868712|12213046|FG002|NOT COMPLETED|Overall Study||0
11033407|NCT00868751|12213054|FG000|STARTED|Overall Study||1
11033408|NCT00868751|12213054|FG000|COMPLETED|Overall Study||0
11033409|NCT00868751|12213054|FG000|NOT COMPLETED|Overall Study||1
11033410|NCT00868790|12213058|FG000|STARTED|Period 1||11
11033411|NCT00868790|12213059|FG001|STARTED|Period 1||8
11033412|NCT00868790|12213060|FG002|STARTED|Period 1||4
11033413|NCT00868790|12213061|FG003|STARTED|Period 1||4
11033414|NCT00868790|12213062|FG004|STARTED|Period 1||19
11033415|NCT00868790|12213063|FG005|STARTED|Period 1||3
11033416|NCT00868790|12213064|FG006|STARTED|Period 1||4
11033417|NCT00868790|12213065|FG007|STARTED|Period 1||20
11033418|NCT00868790|12213066|FG008|STARTED|Period 1||11
11033419|NCT00868790|12213067|FG009|STARTED|Period 1||3
11033420|NCT00868790|12213068|FG010|STARTED|Period 1||9
11033421|NCT00868790|12213069|FG011|STARTED|Period 1||4
11033422|NCT00868790|12213070|FG012|STARTED|Period 1||7
11033423|NCT00868790|12213071|FG013|STARTED|Period 1||11
11033424|NCT00868790|12213058|FG000|COMPLETED|Period 1||9
11033425|NCT00868790|12213059|FG001|COMPLETED|Period 1||7
11033426|NCT00868790|12213060|FG002|COMPLETED|Period 1||4
11033427|NCT00868790|12213061|FG003|COMPLETED|Period 1||4
11033428|NCT00868790|12213062|FG004|COMPLETED|Period 1||18
11033429|NCT00868790|12213063|FG005|COMPLETED|Period 1||2
11033430|NCT00868790|12213064|FG006|COMPLETED|Period 1||4
11033431|NCT00868790|12213065|FG007|COMPLETED|Period 1||17
11033432|NCT00868790|12213066|FG008|COMPLETED|Period 1||10
11033433|NCT00868790|12213067|FG009|COMPLETED|Period 1||3
11033434|NCT00868790|12213068|FG010|COMPLETED|Period 1||9
11033435|NCT00868790|12213069|FG011|COMPLETED|Period 1||4
11033436|NCT00868790|12213070|FG012|COMPLETED|Period 1||7
11033437|NCT00868790|12213071|FG013|COMPLETED|Period 1||9
11033438|NCT00868790|12213058|FG000|NOT COMPLETED|Period 1||2
11033439|NCT00868790|12213059|FG001|NOT COMPLETED|Period 1||1
11033440|NCT00868790|12213060|FG002|NOT COMPLETED|Period 1||0
11033441|NCT00868790|12213061|FG003|NOT COMPLETED|Period 1||0
11033442|NCT00868790|12213062|FG004|NOT COMPLETED|Period 1||1
11033443|NCT00868790|12213063|FG005|NOT COMPLETED|Period 1||1
11033444|NCT00868790|12213064|FG006|NOT COMPLETED|Period 1||0
11033445|NCT00868790|12213065|FG007|NOT COMPLETED|Period 1||3
11033446|NCT00868790|12213066|FG008|NOT COMPLETED|Period 1||1
11033447|NCT00868790|12213067|FG009|NOT COMPLETED|Period 1||0
11033448|NCT00868790|12213068|FG010|NOT COMPLETED|Period 1||0
11033449|NCT00868790|12213069|FG011|NOT COMPLETED|Period 1||0
11033450|NCT00868790|12213070|FG012|NOT COMPLETED|Period 1||0
11033451|NCT00868790|12213071|FG013|NOT COMPLETED|Period 1||2
11033452|NCT00868790|12213058|FG000|STARTED|Period 2||9
11033453|NCT00868790|12213059|FG001|STARTED|Period 2||7
11033454|NCT00868790|12213060|FG002|STARTED|Period 2||4
11033455|NCT00868790|12213061|FG003|STARTED|Period 2||4
11033456|NCT00868790|12213062|FG004|STARTED|Period 2||18
11033457|NCT00868790|12213063|FG005|STARTED|Period 2||2
11033458|NCT00868790|12213064|FG006|STARTED|Period 2||4
11033459|NCT00868790|12213065|FG007|STARTED|Period 2||17
11033460|NCT00868790|12213066|FG008|STARTED|Period 2||10
11033461|NCT00868790|12213067|FG009|STARTED|Period 2||3
11033462|NCT00868790|12213068|FG010|STARTED|Period 2||9
11033463|NCT00868790|12213069|FG011|STARTED|Period 2||4
11033464|NCT00868790|12213070|FG012|STARTED|Period 2||7
11033465|NCT00868790|12213071|FG013|STARTED|Period 2||9
11033466|NCT00868790|12213058|FG000|COMPLETED|Period 2||9
11033467|NCT00868790|12213059|FG001|COMPLETED|Period 2||6
11033468|NCT00868790|12213060|FG002|COMPLETED|Period 2||4
11033469|NCT00868790|12213061|FG003|COMPLETED|Period 2||4
11334179|NCT02847260|12531860|FG000|STARTED|Overall Study||39
11334180|NCT02847260|12531860|FG000|COMPLETED|Overall Study||32
11334181|NCT02847260|12531860|FG000|NOT COMPLETED|Overall Study||7
11334182|NCT02847494|12531866|FG000|STARTED|Overall Study||109
11033470|NCT00868790|12213062|FG004|COMPLETED|Period 2||18
11033471|NCT00868790|12213063|FG005|COMPLETED|Period 2||1
11033472|NCT00868790|12213064|FG006|COMPLETED|Period 2||4
11033473|NCT00868790|12213065|FG007|COMPLETED|Period 2||17
11033474|NCT00868790|12213066|FG008|COMPLETED|Period 2||8
11033475|NCT00868790|12213067|FG009|COMPLETED|Period 2||3
11033476|NCT00868790|12213068|FG010|COMPLETED|Period 2||9
11033477|NCT00868790|12213069|FG011|COMPLETED|Period 2||4
11033478|NCT00868790|12213070|FG012|COMPLETED|Period 2||7
11033479|NCT00868790|12213071|FG013|COMPLETED|Period 2||8
11033480|NCT00868790|12213058|FG000|NOT COMPLETED|Period 2||0
11033481|NCT00868790|12213059|FG001|NOT COMPLETED|Period 2||1
11033482|NCT00868790|12213060|FG002|NOT COMPLETED|Period 2||0
11033483|NCT00868790|12213061|FG003|NOT COMPLETED|Period 2||0
11033484|NCT00868790|12213062|FG004|NOT COMPLETED|Period 2||0
11334183|NCT02847494|12531867|FG001|STARTED|Overall Study||111
11334184|NCT02847494|12531866|FG000|COMPLETED|Overall Study||101
11334185|NCT02847494|12531867|FG001|COMPLETED|Overall Study||106
11334186|NCT02847494|12531866|FG000|NOT COMPLETED|Overall Study||8
11334187|NCT02847494|12531867|FG001|NOT COMPLETED|Overall Study||5
11334188|NCT02847650|12531875|FG000|STARTED|Overall Study||29
11334189|NCT02847650|12531876|FG001|STARTED|Overall Study||28
11334190|NCT02847650|12531875|FG000|COMPLETED|Overall Study||25
11334191|NCT02847650|12531876|FG001|COMPLETED|Overall Study||22
11334192|NCT02847650|12531875|FG000|NOT COMPLETED|Overall Study||4
11334193|NCT02847650|12531876|FG001|NOT COMPLETED|Overall Study||6
11334194|NCT02847858|12531884|FG000|STARTED|Overall Study||693
11334195|NCT02847858|12531885|FG001|STARTED|Overall Study||667
11334196|NCT02847858|12531884|FG000|COMPLETED|Overall Study||292
11334197|NCT02847858|12531885|FG001|COMPLETED|Overall Study||398
11334198|NCT02847858|12531884|FG000|NOT COMPLETED|Overall Study||401
11334199|NCT02847858|12531885|FG001|NOT COMPLETED|Overall Study||269
11334200|NCT02848079|12531896|FG000|STARTED|Overall Study||41
11033485|NCT00868790|12213063|FG005|NOT COMPLETED|Period 2||1
11033486|NCT00868790|12213064|FG006|NOT COMPLETED|Period 2||0
11033487|NCT00868790|12213065|FG007|NOT COMPLETED|Period 2||0
11033488|NCT00868790|12213066|FG008|NOT COMPLETED|Period 2||2
11033489|NCT00868790|12213067|FG009|NOT COMPLETED|Period 2||0
11033490|NCT00868790|12213068|FG010|NOT COMPLETED|Period 2||0
11033491|NCT00868790|12213069|FG011|NOT COMPLETED|Period 2||0
11033492|NCT00868790|12213070|FG012|NOT COMPLETED|Period 2||0
11033493|NCT00868790|12213071|FG013|NOT COMPLETED|Period 2||1
11033494|NCT00868790|12213058|FG000|STARTED|Period 3||9
11033495|NCT00868790|12213059|FG001|STARTED|Period 3||6
11033496|NCT00868790|12213060|FG002|STARTED|Period 3||4
11033497|NCT00868790|12213061|FG003|STARTED|Period 3||4
11033498|NCT00868790|12213062|FG004|STARTED|Period 3||18
11033499|NCT00868790|12213063|FG005|STARTED|Period 3||1
11033500|NCT00868790|12213064|FG006|STARTED|Period 3||4
11033501|NCT00868790|12213065|FG007|STARTED|Period 3||17
11033502|NCT00868790|12213066|FG008|STARTED|Period 3||8
11033503|NCT00868790|12213067|FG009|STARTED|Period 3||3
11033504|NCT00868790|12213068|FG010|STARTED|Period 3||9
11033505|NCT00868790|12213069|FG011|STARTED|Period 3||4
11334201|NCT02848079|12531896|FG000|Receieved Study Treatment|Overall Study||41
11334202|NCT02848079|12531896|FG000|Discontinued|Overall Study||41
11033506|NCT00868790|12213070|FG012|STARTED|Period 3||7
11033507|NCT00868790|12213071|FG013|STARTED|Period 3||8
11033508|NCT00868790|12213058|FG000|COMPLETED|Period 3||9
11033509|NCT00868790|12213059|FG001|COMPLETED|Period 3||6
11033510|NCT00868790|12213060|FG002|COMPLETED|Period 3||4
11033511|NCT00868790|12213061|FG003|COMPLETED|Period 3||3
11033512|NCT00868790|12213062|FG004|COMPLETED|Period 3||18
11033513|NCT00868790|12213063|FG005|COMPLETED|Period 3||1
11033514|NCT00868790|12213064|FG006|COMPLETED|Period 3||4
11033515|NCT00868790|12213065|FG007|COMPLETED|Period 3||17
11033516|NCT00868790|12213066|FG008|COMPLETED|Period 3||8
11033517|NCT00868790|12213067|FG009|COMPLETED|Period 3||2
11033518|NCT00868790|12213068|FG010|COMPLETED|Period 3||8
11033519|NCT00868790|12213069|FG011|COMPLETED|Period 3||4
11033520|NCT00868790|12213070|FG012|COMPLETED|Period 3||7
11033521|NCT00868790|12213071|FG013|COMPLETED|Period 3||8
11033522|NCT00868790|12213058|FG000|NOT COMPLETED|Period 3||0
11033523|NCT00868790|12213059|FG001|NOT COMPLETED|Period 3||0
11033524|NCT00868790|12213060|FG002|NOT COMPLETED|Period 3||0
11033525|NCT00868790|12213061|FG003|NOT COMPLETED|Period 3||1
11033526|NCT00868790|12213062|FG004|NOT COMPLETED|Period 3||0
11033527|NCT00868790|12213063|FG005|NOT COMPLETED|Period 3||0
11033528|NCT00868790|12213064|FG006|NOT COMPLETED|Period 3||0
11033529|NCT00868790|12213065|FG007|NOT COMPLETED|Period 3||0
11033530|NCT00868790|12213066|FG008|NOT COMPLETED|Period 3||0
11033531|NCT00868790|12213067|FG009|NOT COMPLETED|Period 3||1
11033532|NCT00868790|12213068|FG010|NOT COMPLETED|Period 3||1
11033533|NCT00868790|12213069|FG011|NOT COMPLETED|Period 3||0
11033534|NCT00868790|12213070|FG012|NOT COMPLETED|Period 3||0
11033535|NCT00868790|12213071|FG013|NOT COMPLETED|Period 3||0
11033536|NCT00868790|12213058|FG000|STARTED|Period 4||9
11033537|NCT00868790|12213059|FG001|STARTED|Period 4||6
11033538|NCT00868790|12213060|FG002|STARTED|Period 4||4
11033539|NCT00868790|12213061|FG003|STARTED|Period 4||3
11033540|NCT00868790|12213062|FG004|STARTED|Period 4||18
11033541|NCT00868790|12213063|FG005|STARTED|Period 4||1
11033542|NCT00868790|12213064|FG006|STARTED|Period 4||4
11033543|NCT00868790|12213065|FG007|STARTED|Period 4||17
11205225|NCT01857869|12395948|FG008|NOT COMPLETED|Booster/Rechallenge Phase||0
11033544|NCT00868790|12213066|FG008|STARTED|Period 4||8
11033545|NCT00868790|12213067|FG009|STARTED|Period 4||2
11033546|NCT00868790|12213068|FG010|STARTED|Period 4||8
11033547|NCT00868790|12213069|FG011|STARTED|Period 4||4
11033548|NCT00868790|12213070|FG012|STARTED|Period 4||7
11033549|NCT00868790|12213071|FG013|STARTED|Period 4||8
11033550|NCT00868790|12213058|FG000|COMPLETED|Period 4||7
11033551|NCT00868790|12213059|FG001|COMPLETED|Period 4||6
11033552|NCT00868790|12213060|FG002|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
11033553|NCT00868790|12213061|FG003|COMPLETED|Period 4||3
11033554|NCT00868790|12213062|FG004|COMPLETED|Period 4||18
11033555|NCT00868790|12213063|FG005|COMPLETED|Period 4||1
11033556|NCT00868790|12213064|FG006|COMPLETED|Period 4||4
11033557|NCT00868790|12213065|FG007|COMPLETED|Period 4||14
11033558|NCT00868790|12213066|FG008|COMPLETED|Period 4||6
11033559|NCT00868790|12213067|FG009|COMPLETED|Period 4||2
11033560|NCT00868790|12213068|FG010|COMPLETED|Period 4||5
11033561|NCT00868790|12213069|FG011|COMPLETED|Period 4||3
11033562|NCT00868790|12213070|FG012|COMPLETED|Period 4||6
11033563|NCT00868790|12213071|FG013|COMPLETED|Period 4||7
11033564|NCT00868790|12213058|FG000|NOT COMPLETED|Period 4||2
11033565|NCT00868790|12213059|FG001|NOT COMPLETED|Period 4||0
11033566|NCT00868790|12213060|FG002|NOT COMPLETED|Period 4||1
11033567|NCT00868790|12213061|FG003|NOT COMPLETED|Period 4||0
11033568|NCT00868790|12213062|FG004|NOT COMPLETED|Period 4||0
11033569|NCT00868790|12213063|FG005|NOT COMPLETED|Period 4||0
11033570|NCT00868790|12213064|FG006|NOT COMPLETED|Period 4||0
11033571|NCT00868790|12213065|FG007|NOT COMPLETED|Period 4||3
11033572|NCT00868790|12213066|FG008|NOT COMPLETED|Period 4||2
11033573|NCT00868790|12213067|FG009|NOT COMPLETED|Period 4||0
11033574|NCT00868790|12213068|FG010|NOT COMPLETED|Period 4||3
11033575|NCT00868790|12213069|FG011|NOT COMPLETED|Period 4||1
11033576|NCT00868790|12213070|FG012|NOT COMPLETED|Period 4||1
11033577|NCT00868790|12213071|FG013|NOT COMPLETED|Period 4||1
11033578|NCT00868790|12213058|FG000|STARTED|Post-study||7
11033579|NCT00868790|12213059|FG001|STARTED|Post-study||6
11033580|NCT00868790|12213060|FG002|STARTED|Post-study||3
11033581|NCT00868790|12213061|FG003|STARTED|Post-study||3
11033582|NCT00868790|12213062|FG004|STARTED|Post-study||18
11033583|NCT00868790|12213063|FG005|STARTED|Post-study||1
11033584|NCT00868790|12213064|FG006|STARTED|Post-study||4
11033585|NCT00868790|12213065|FG007|STARTED|Post-study||14
11033586|NCT00868790|12213066|FG008|STARTED|Post-study||6
11033587|NCT00868790|12213067|FG009|STARTED|Post-study||2
11033588|NCT00868790|12213068|FG010|STARTED|Post-study||5
11033589|NCT00868790|12213069|FG011|STARTED|Post-study||3
11033590|NCT00868790|12213070|FG012|STARTED|Post-study||6
11033591|NCT00868790|12213071|FG013|STARTED|Post-study||7
11033592|NCT00868790|12213058|FG000|COMPLETED|Post-study||7
11033593|NCT00868790|12213059|FG001|COMPLETED|Post-study||6
11033594|NCT00868790|12213060|FG002|COMPLETED|Post-study||3
11033595|NCT00868790|12213061|FG003|COMPLETED|Post-study||3
11033596|NCT00868790|12213062|FG004|COMPLETED|Post-study||17
11033597|NCT00868790|12213063|FG005|COMPLETED|Post-study||1
11033598|NCT00868790|12213064|FG006|COMPLETED|Post-study||4
11033599|NCT00868790|12213065|FG007|COMPLETED|Post-study||12
11033600|NCT00868790|12213066|FG008|COMPLETED|Post-study||6
11033601|NCT00868790|12213067|FG009|COMPLETED|Post-study||1
11033602|NCT00868790|12213068|FG010|COMPLETED|Post-study||5
11033603|NCT00868790|12213069|FG011|COMPLETED|Post-study||3
11033604|NCT00868790|12213070|FG012|COMPLETED|Post-study||6
11033605|NCT00868790|12213071|FG013|COMPLETED|Post-study||7
11033606|NCT00868790|12213058|FG000|NOT COMPLETED|Post-study||0
11033607|NCT00868790|12213059|FG001|NOT COMPLETED|Post-study||0
11033608|NCT00868790|12213060|FG002|NOT COMPLETED|Post-study||0
11033609|NCT00868790|12213061|FG003|NOT COMPLETED|Post-study||0
11033610|NCT00868790|12213062|FG004|NOT COMPLETED|Post-study||1
11033611|NCT00868790|12213063|FG005|NOT COMPLETED|Post-study||0
11033612|NCT00868790|12213064|FG006|NOT COMPLETED|Post-study||0
11033613|NCT00868790|12213065|FG007|NOT COMPLETED|Post-study||2
11033614|NCT00868790|12213066|FG008|NOT COMPLETED|Post-study||0
11033615|NCT00868790|12213067|FG009|NOT COMPLETED|Post-study||1
11033616|NCT00868790|12213068|FG010|NOT COMPLETED|Post-study||0
11033617|NCT00868790|12213069|FG011|NOT COMPLETED|Post-study||0
11033618|NCT00868790|12213070|FG012|NOT COMPLETED|Post-study||0
11033619|NCT00868790|12213071|FG013|NOT COMPLETED|Post-study||0
11033620|NCT00868959|12213087|FG000|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
11033621|NCT00868959|12213087|FG000|COMPLETED|Overall Study||559
11033622|NCT00868959|12213087|FG000|NOT COMPLETED|Overall Study||258
11334203|NCT02848079|12531896|FG000|COMPLETED|Overall Study||41
11334204|NCT02848079|12531896|FG000|NOT COMPLETED|Overall Study||0
11334205|NCT02848222|12531903|FG000|STARTED|Overall Study||25
11334206|NCT02848222|12531904|FG001|STARTED|Overall Study||18
11334207|NCT02848222|12531905|FG002|STARTED|Overall Study||17
11334208|NCT02848222|12531903|FG000|COMPLETED|Overall Study||18
11334209|NCT02848222|12531904|FG001|COMPLETED|Overall Study||17
11334210|NCT02848222|12531905|FG002|COMPLETED|Overall Study||17
11334211|NCT02848222|12531903|FG000|NOT COMPLETED|Overall Study||7
11334212|NCT02848222|12531904|FG001|NOT COMPLETED|Overall Study||1
11334213|NCT02848222|12531905|FG002|NOT COMPLETED|Overall Study||0
11334214|NCT02848313|12531915|FG000|STARTED|Overall Study||21
11334215|NCT02848313|12531916|FG001|STARTED|Overall Study||19
11334216|NCT02848313|12531915|FG000|COMPLETED|Overall Study||18
11334217|NCT02848313|12531916|FG001|COMPLETED|Overall Study||15
11334218|NCT02848313|12531915|FG000|NOT COMPLETED|Overall Study||3
11334219|NCT02848313|12531916|FG001|NOT COMPLETED|Overall Study||4
11334220|NCT02848326|12531928|FG000|STARTED|Treatment Period||186
11334221|NCT02848326|12531929|FG001|STARTED|Treatment Period||94
11334222|NCT02848326|12531930|FG002|STARTED|Treatment Period||185
11334223|NCT02848326|12531931|FG003|STARTED|Treatment Period||187
11334224|NCT02848326|12531932|FG004|STARTED|Treatment Period||89
11334225|NCT02848326|12531933|FG005|STARTED|Treatment Period||93
11334226|NCT02848326|12531928|FG000|Safety Population: Received Study Drug|Treatment Period||186
11334227|NCT02848326|12531929|FG001|Safety Population: Received Study Drug|Treatment Period||93
11334228|NCT02848326|12531930|FG002|Safety Population: Received Study Drug|Treatment Period||183
11334229|NCT02848326|12531931|FG003|Safety Population: Received Study Drug|Treatment Period||186
11334230|NCT02848326|12531932|FG004|Safety Population: Received Study Drug|Treatment Period||86
11334231|NCT02848326|12531933|FG005|Safety Population: Received Study Drug|Treatment Period||91
11334232|NCT02848326|12531928|FG000|COMPLETED|Treatment Period||148
11334233|NCT02848326|12531929|FG001|COMPLETED|Treatment Period||80
11334234|NCT02848326|12531930|FG002|COMPLETED|Treatment Period||149
11334235|NCT02848326|12531931|FG003|COMPLETED|Treatment Period||164
11334236|NCT02848326|12531932|FG004|COMPLETED|Treatment Period||70
11334237|NCT02848326|12531933|FG005|COMPLETED|Treatment Period||73
11334238|NCT02848326|12531928|FG000|NOT COMPLETED|Treatment Period||38
11334239|NCT02848326|12531929|FG001|NOT COMPLETED|Treatment Period||14
11334240|NCT02848326|12531930|FG002|NOT COMPLETED|Treatment Period||36
11334241|NCT02848326|12531931|FG003|NOT COMPLETED|Treatment Period||23
11334242|NCT02848326|12531932|FG004|NOT COMPLETED|Treatment Period||19
11334243|NCT02848326|12531933|FG005|NOT COMPLETED|Treatment Period||20
11334244|NCT02848326|12531928|FG000|STARTED|Safety Follow-up Period||161
11334245|NCT02848326|12531929|FG001|STARTED|Safety Follow-up Period||84
11334246|NCT02848326|12531930|FG002|STARTED|Safety Follow-up Period||156
11334247|NCT02848326|12531931|FG003|STARTED|Safety Follow-up Period||169
11334248|NCT02848326|12531932|FG004|STARTED|Safety Follow-up Period||77
11334249|NCT02848326|12531933|FG005|STARTED|Safety Follow-up Period||82
11334250|NCT02848326|12531928|FG000|COMPLETED|Safety Follow-up Period||157
11334251|NCT02848326|12531929|FG001|COMPLETED|Safety Follow-up Period||83
11033623|NCT00869024|12213093|FG000|STARTED|Overall Study||16
11033624|NCT00869024|12213094|FG001|STARTED|Overall Study|One patient intent to treat, did not receive study product|9
11334252|NCT02848326|12531930|FG002|COMPLETED|Safety Follow-up Period||153
11334253|NCT02848326|12531931|FG003|COMPLETED|Safety Follow-up Period||169
11334254|NCT02848326|12531932|FG004|COMPLETED|Safety Follow-up Period||76
11334255|NCT02848326|12531933|FG005|COMPLETED|Safety Follow-up Period||77
11334256|NCT02848326|12531928|FG000|NOT COMPLETED|Safety Follow-up Period||4
11334257|NCT02848326|12531929|FG001|NOT COMPLETED|Safety Follow-up Period||1
11334258|NCT02848326|12531930|FG002|NOT COMPLETED|Safety Follow-up Period||3
11334259|NCT02848326|12531931|FG003|NOT COMPLETED|Safety Follow-up Period||0
11334260|NCT02848326|12531932|FG004|NOT COMPLETED|Safety Follow-up Period||1
11334261|NCT02848326|12531933|FG005|NOT COMPLETED|Safety Follow-up Period||5
11334262|NCT02848599|12531949|FG000|STARTED|Overall Study||42
11334263|NCT02848599|12531950|FG001|STARTED|Overall Study||44
11334264|NCT02848599|12531949|FG000|COMPLETED|Overall Study||35
11334265|NCT02848599|12531950|FG001|COMPLETED|Overall Study||35
11334266|NCT02848599|12531949|FG000|NOT COMPLETED|Overall Study||7
11334267|NCT02848599|12531950|FG001|NOT COMPLETED|Overall Study||9
11334268|NCT02848651|12531958|FG000|STARTED|Overall Study||153
11334269|NCT02848651|12531958|FG000|Received Treatment|Overall Study||152
11334270|NCT02848651|12531958|FG000|COMPLETED|Overall Study||47
11334271|NCT02848651|12531958|FG000|NOT COMPLETED|Overall Study||106
11334272|NCT02848664|12531978|FG000|STARTED|Overall Study||11
11334273|NCT02848664|12531978|FG000|COMPLETED|Overall Study||7
11334274|NCT02848664|12531978|FG000|NOT COMPLETED|Overall Study||4
11334275|NCT02848729|12531988|FG000|STARTED|Overall Study||27
11334276|NCT02848729|12531989|FG001|STARTED|Overall Study||23
11334277|NCT02848729|12531988|FG000|Per Protocol Population|Overall Study||11
11334278|NCT02848729|12531989|FG001|Per Protocol Population|Overall Study||11
11334279|NCT02848729|12531988|FG000|Safety Population|Overall Study||27
11334280|NCT02848729|12531989|FG001|Safety Population|Overall Study||23
11334281|NCT02848729|12531988|FG000|COMPLETED|Overall Study||11
11334282|NCT02848729|12531989|FG001|COMPLETED|Overall Study||12
11334283|NCT02848729|12531988|FG000|NOT COMPLETED|Overall Study||16
11334284|NCT02848729|12531989|FG001|NOT COMPLETED|Overall Study||11
11334285|NCT02848833|12532002|FG000|STARTED|Overall Study||3368
11334286|NCT02848833|12532002|FG000|COMPLETED|Overall Study||3231
11334287|NCT02848833|12532002|FG000|NOT COMPLETED|Overall Study||137
11334288|NCT02849184|12532008|FG000|STARTED|Overall Study||40
11334289|NCT02849184|12532009|FG001|STARTED|Overall Study||42
11334290|NCT02849184|12532008|FG000|COMPLETED|Overall Study||40
11334291|NCT02849184|12532009|FG001|COMPLETED|Overall Study||42
11334292|NCT02849184|12532008|FG000|NOT COMPLETED|Overall Study||0
11334293|NCT02849184|12532009|FG001|NOT COMPLETED|Overall Study||0
11334294|NCT02849418|12532017|FG000|STARTED|Double-blinded (Up to 48 Weeks)||10
11334295|NCT02849418|12532018|FG001|STARTED|Double-blinded (Up to 48 Weeks)||11
11334296|NCT02849418|12532019|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0
11334297|NCT02849418|12532020|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0
11334298|NCT02849418|12532021|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0
11334299|NCT02849418|12532022|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0
11334300|NCT02849418|12532017|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||10
11334301|NCT02849418|12532018|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||11
11334302|NCT02849418|12532019|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0
11334303|NCT02849418|12532020|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0
11334304|NCT02849418|12532021|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0
11334305|NCT02849418|12532022|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0
11334306|NCT02849418|12532017|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
11334307|NCT02849418|12532018|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
11334308|NCT02849418|12532019|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
11334309|NCT02849418|12532020|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
11334310|NCT02849418|12532021|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
11334311|NCT02849418|12532022|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
11334312|NCT02849418|12532017|FG000|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
11334313|NCT02849418|12532018|FG001|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
11334314|NCT02849418|12532019|FG002|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10
11334315|NCT02849418|12532020|FG003|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6
11334316|NCT02849418|12532021|FG004|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
11334317|NCT02849418|12532022|FG005|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
11334318|NCT02849418|12532017|FG000|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
11334319|NCT02849418|12532018|FG001|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
11334320|NCT02849418|12532019|FG002|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10
11334321|NCT02849418|12532020|FG003|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6
11334322|NCT02849418|12532021|FG004|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
11334323|NCT02849418|12532022|FG005|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
11334324|NCT02849418|12532017|FG000|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
11334325|NCT02849418|12532018|FG001|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
11334326|NCT02849418|12532019|FG002|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
11334327|NCT02849418|12532020|FG003|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
11334328|NCT02849418|12532021|FG004|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
11334329|NCT02849418|12532022|FG005|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
11334330|NCT02849418|12532017|FG000|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
11334331|NCT02849418|12532018|FG001|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
11334332|NCT02849418|12532019|FG002|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
11334333|NCT02849418|12532020|FG003|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
11334334|NCT02849418|12532021|FG004|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5
11334335|NCT02849418|12532022|FG005|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3
11334336|NCT02849418|12532017|FG000|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
11334337|NCT02849418|12532018|FG001|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
11334338|NCT02849418|12532019|FG002|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
11334339|NCT02849418|12532020|FG003|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
11334340|NCT02849418|12532021|FG004|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5
11334341|NCT02849418|12532022|FG005|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3
11334342|NCT02849418|12532017|FG000|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
11334343|NCT02849418|12532018|FG001|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
11334344|NCT02849418|12532019|FG002|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
11334345|NCT02849418|12532020|FG003|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
11334346|NCT02849418|12532021|FG004|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
11334347|NCT02849418|12532022|FG005|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
11334348|NCT02849509|12532041|FG000|STARTED|Overall Study||379
11334349|NCT02849509|12532042|FG001|STARTED|Overall Study||591
11334350|NCT02849509|12532043|FG002|STARTED|Overall Study||343
11334351|NCT02849509|12532041|FG000|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289
11334352|NCT02849509|12532042|FG001|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425
11334353|NCT02849509|12532043|FG002|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258
11334354|NCT02849509|12532041|FG000|NOT COMPLETED|Overall Study||90
11334355|NCT02849509|12532042|FG001|NOT COMPLETED|Overall Study||166
11334356|NCT02849509|12532043|FG002|NOT COMPLETED|Overall Study||85
11334357|NCT02849678|12532055|FG000|STARTED|Overall Study||20
11334358|NCT02849678|12532056|FG001|STARTED|Overall Study||24
11334359|NCT02849678|12532055|FG000|COMPLETED|Overall Study||17
11334360|NCT02849678|12532056|FG001|COMPLETED|Overall Study||18
11334361|NCT02849678|12532055|FG000|NOT COMPLETED|Overall Study||3
11334362|NCT02849678|12532056|FG001|NOT COMPLETED|Overall Study||6
11334363|NCT02849704|12532064|FG000|STARTED|Washout Period - CP Subj on PERT - 3days||11
11334364|NCT02849704|12532065|FG001|STARTED|Washout Period - CP Subj on PERT - 3days||0
11334365|NCT02849704|12532064|FG000|COMPLETED|Washout Period - CP Subj on PERT - 3days||11
11334366|NCT02849704|12532065|FG001|COMPLETED|Washout Period - CP Subj on PERT - 3days||0
11334367|NCT02849704|12532064|FG000|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
11334368|NCT02849704|12532065|FG001|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
11334369|NCT02849704|12532064|FG000|STARTED|Baseline Assessments - All Subj - 7 Days||24
11334370|NCT02849704|12532065|FG001|STARTED|Baseline Assessments - All Subj - 7 Days||24
11334371|NCT02849704|12532064|FG000|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
11334372|NCT02849704|12532065|FG001|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
11334373|NCT02849704|12532064|FG000|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
11334374|NCT02849704|12532065|FG001|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
11334375|NCT02849704|12532064|FG000|STARTED|Assessment on PERT - CP Subj - 16 Days||24
11334376|NCT02849704|12532065|FG001|STARTED|Assessment on PERT - CP Subj - 16 Days||0
11334377|NCT02849704|12532064|FG000|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21
11334378|NCT02849704|12532065|FG001|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
11334379|NCT02849704|12532064|FG000|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3
11334380|NCT02849704|12532065|FG001|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
11334381|NCT02849938|12532077|FG000|STARTED|Overall Study||9
11334382|NCT02849938|12532078|FG001|STARTED|Overall Study||15
11334383|NCT02849938|12532077|FG000|COMPLETED|Overall Study||9
11334384|NCT02849938|12532078|FG001|COMPLETED|Overall Study||15
11334385|NCT02849938|12532077|FG000|NOT COMPLETED|Overall Study||0
11334386|NCT02849938|12532078|FG001|NOT COMPLETED|Overall Study||0
11334387|NCT02850068|12532084|FG000|STARTED|Overall Study||20
11334388|NCT02850068|12532084|FG000|COMPLETED|Overall Study||0
11334389|NCT02850068|12532084|FG000|NOT COMPLETED|Overall Study||20
11334390|NCT02850159|12532090|FG000|STARTED|Overall Study||16
11334391|NCT02850159|12532091|FG001|STARTED|Overall Study||16
11334392|NCT02850159|12532090|FG000|COMPLETED|Overall Study||16
11334393|NCT02850159|12532091|FG001|COMPLETED|Overall Study||16
11334394|NCT02850159|12532090|FG000|NOT COMPLETED|Overall Study||0
11334395|NCT02850159|12532091|FG001|NOT COMPLETED|Overall Study||0
11334396|NCT02850276|12532097|FG000|STARTED|Overall Study||76
11334397|NCT02850276|12532097|FG000|COMPLETED|Overall Study||15
11334398|NCT02850276|12532097|FG000|NOT COMPLETED|Overall Study||61
11334399|NCT02850601|12532104|FG000|STARTED|Overall Study||12
11334400|NCT02850601|12532105|FG001|STARTED|Overall Study||12
11334401|NCT02850601|12532104|FG000|COMPLETED|Overall Study||12
11334402|NCT02850601|12532105|FG001|COMPLETED|Overall Study||12
11334403|NCT02850601|12532104|FG000|NOT COMPLETED|Overall Study||0
11334404|NCT02850601|12532105|FG001|NOT COMPLETED|Overall Study||0
11334405|NCT02850965|12532113|FG000|STARTED|Overall Study||159
11334406|NCT02850965|12532114|FG001|STARTED|Overall Study||159
11334407|NCT02850965|12532113|FG000|Treated|Overall Study||159
11334408|NCT02850965|12532114|FG001|Treated|Overall Study||158
11334409|NCT02850965|12532113|FG000|COMPLETED|Overall Study||141
11334410|NCT02850965|12532114|FG001|COMPLETED|Overall Study||134
11334411|NCT02850965|12532113|FG000|NOT COMPLETED|Overall Study||18
11334412|NCT02850965|12532114|FG001|NOT COMPLETED|Overall Study||25
11334413|NCT02850978|12532120|FG000|STARTED|Overall Study||1335
11334414|NCT02850978|12532120|FG000|Case Report Form (CRF) Collected|Overall Study||1308
11334415|NCT02850978|12532120|FG000|Treated|Overall Study||1308
11334416|NCT02850978|12532120|FG000|COMPLETED|Overall Study||909
11334417|NCT02850978|12532120|FG000|NOT COMPLETED|Overall Study||426
11334418|NCT02851069|12532124|FG000|STARTED|Overall Study||65
11334419|NCT02851069|12532124|FG000|COMPLETED|Overall Study||59
11334420|NCT02851069|12532124|FG000|NOT COMPLETED|Overall Study||6
11334421|NCT02851108|12532131|FG000|STARTED|Overall Study||50
11334422|NCT02851108|12532132|FG001|STARTED|Overall Study||50
11334423|NCT02851108|12532131|FG000|COMPLETED|Overall Study||42
11033625|NCT00869024|12213093|FG000|COMPLETED|Overall Study||14
11033626|NCT00869024|12213094|FG001|COMPLETED|Overall Study||4
11033627|NCT00869024|12213093|FG000|NOT COMPLETED|Overall Study||2
11033628|NCT00869024|12213094|FG001|NOT COMPLETED|Overall Study||5
11033629|NCT00869050|12213100|FG000|STARTED|Overall Study||41
11033630|NCT00869050|12213100|FG000|COMPLETED|Overall Study||38
11033631|NCT00869050|12213100|FG000|NOT COMPLETED|Overall Study||3
11033632|NCT00869089|12213104|FG000|STARTED|Overall Study||5
11033633|NCT00869089|12213104|FG000|COMPLETED|Overall Study||2
11033634|NCT00869089|12213104|FG000|NOT COMPLETED|Overall Study||3
11033635|NCT00869141|12213110|FG000|STARTED|Overall Study||26
11033636|NCT00869141|12213111|FG001|STARTED|Overall Study||26
11033637|NCT00869141|12213110|FG000|COMPLETED|Overall Study||26
11033638|NCT00869141|12213111|FG001|COMPLETED|Overall Study||26
11033639|NCT00869141|12213110|FG000|NOT COMPLETED|Overall Study||0
11033640|NCT00869141|12213111|FG001|NOT COMPLETED|Overall Study||0
11033641|NCT00869167|12213121|FG000|STARTED|Overall Study||2
11033642|NCT00869167|12213122|FG001|STARTED|Overall Study||1
11033643|NCT00869167|12213121|FG000|COMPLETED|Overall Study||2
11033644|NCT00869167|12213122|FG001|COMPLETED|Overall Study||0
11033645|NCT00869167|12213121|FG000|NOT COMPLETED|Overall Study||0
11033646|NCT00869167|12213122|FG001|NOT COMPLETED|Overall Study||1
11033647|NCT00869206|12213132|FG000|STARTED|Overall Study||911
11033648|NCT00869206|12213133|FG001|STARTED|Overall Study||911
11033649|NCT00869206|12213132|FG000|COMPLETED|Overall Study||882
11033650|NCT00869206|12213133|FG001|COMPLETED|Overall Study||884
11334424|NCT02851108|12532132|FG001|COMPLETED|Overall Study||49
11334425|NCT02851108|12532131|FG000|NOT COMPLETED|Overall Study||8
11334426|NCT02851108|12532132|FG001|NOT COMPLETED|Overall Study||1
11334427|NCT02851615|12532140|FG000|STARTED|Overall Study||27
11334428|NCT02851615|12532141|FG001|STARTED|Overall Study||31
11334429|NCT02851615|12532140|FG000|COMPLETED|Overall Study||26
11334430|NCT02851615|12532141|FG001|COMPLETED|Overall Study||27
11334431|NCT02851615|12532140|FG000|NOT COMPLETED|Overall Study||1
11033651|NCT00869206|12213132|FG000|NOT COMPLETED|Overall Study||29
11033652|NCT00869206|12213133|FG001|NOT COMPLETED|Overall Study||27
11334432|NCT02851615|12532141|FG001|NOT COMPLETED|Overall Study||4
11334433|NCT02851823|12532148|FG000|STARTED|Overall Study||25
11334434|NCT02851823|12532148|FG000|1 Month|Overall Study||25
11334435|NCT02851823|12532148|FG000|3 Months|Overall Study||25
11334436|NCT02851823|12532148|FG000|COMPLETED|Overall Study||25
11334437|NCT02851823|12532148|FG000|NOT COMPLETED|Overall Study||0
11334438|NCT02852265|12532156|FG000|STARTED|1-month Follow-up||10
11334439|NCT02852265|12532157|FG001|STARTED|1-month Follow-up||10
11033653|NCT00869323|12213145|FG000|STARTED|Induction Therapy||3
11033654|NCT00869323|12213145|FG000|COMPLETED|Induction Therapy||3
11033655|NCT00869323|12213145|FG000|NOT COMPLETED|Induction Therapy||0
11334440|NCT02852265|12532156|FG000|COMPLETED|1-month Follow-up||10
11334441|NCT02852265|12532157|FG001|COMPLETED|1-month Follow-up||10
11334442|NCT02852265|12532156|FG000|NOT COMPLETED|1-month Follow-up||0
11334443|NCT02852265|12532157|FG001|NOT COMPLETED|1-month Follow-up||0
11334444|NCT02852265|12532156|FG000|STARTED|3-month Follow-up||10
11334445|NCT02852265|12532157|FG001|STARTED|3-month Follow-up||10
11334446|NCT02852265|12532156|FG000|COMPLETED|3-month Follow-up||9
11334447|NCT02852265|12532157|FG001|COMPLETED|3-month Follow-up||9
11334448|NCT02852265|12532156|FG000|NOT COMPLETED|3-month Follow-up||1
11334449|NCT02852265|12532157|FG001|NOT COMPLETED|3-month Follow-up||1
11334450|NCT02852265|12532156|FG000|STARTED|6-month Follow-up||9
11334451|NCT02852265|12532157|FG001|STARTED|6-month Follow-up||9
11334452|NCT02852265|12532156|FG000|COMPLETED|6-month Follow-up||9
11334453|NCT02852265|12532157|FG001|COMPLETED|6-month Follow-up||9
11334454|NCT02852265|12532156|FG000|NOT COMPLETED|6-month Follow-up||0
11334455|NCT02852265|12532157|FG001|NOT COMPLETED|6-month Follow-up||0
11334456|NCT02852330|12532167|FG000|STARTED|Overall Study||20
11334457|NCT02852330|12532167|FG000|COMPLETED|Overall Study||20
11334458|NCT02852330|12532167|FG000|NOT COMPLETED|Overall Study||0
11334459|NCT02852434|12532173|FG000|STARTED|Overall Study||36
11334460|NCT02852434|12532174|FG001|STARTED|Overall Study||36
11334461|NCT02852434|12532173|FG000|COMPLETED|Overall Study||34
11334462|NCT02852434|12532174|FG001|COMPLETED|Overall Study||35
11334463|NCT02852434|12532173|FG000|NOT COMPLETED|Overall Study||2
11334464|NCT02852434|12532174|FG001|NOT COMPLETED|Overall Study||1
11334465|NCT02853032|12532182|FG000|STARTED|Overall Study||60
11334466|NCT02853032|12532183|FG001|STARTED|Overall Study||59
11334467|NCT02853032|12532182|FG000|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|51
11334468|NCT02853032|12532183|FG001|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|56
11334469|NCT02853032|12532182|FG000|NOT COMPLETED|Overall Study||9
11334470|NCT02853032|12532183|FG001|NOT COMPLETED|Overall Study||3
11334471|NCT02853123|12532191|FG000|STARTED|Treatment Period 1||52
11334472|NCT02853123|12532192|FG001|STARTED|Treatment Period 1||54
11334473|NCT02853123|12532191|FG000|COMPLETED|Treatment Period 1||52
11334474|NCT02853123|12532192|FG001|COMPLETED|Treatment Period 1||51
11334475|NCT02853123|12532191|FG000|NOT COMPLETED|Treatment Period 1||0
11334476|NCT02853123|12532192|FG001|NOT COMPLETED|Treatment Period 1||3
11334477|NCT02853123|12532191|FG000|STARTED|Washout Period||52
11334478|NCT02853123|12532192|FG001|STARTED|Washout Period||51
11334479|NCT02853123|12532191|FG000|COMPLETED|Washout Period||51
11334480|NCT02853123|12532192|FG001|COMPLETED|Washout Period||48
11334481|NCT02853123|12532191|FG000|NOT COMPLETED|Washout Period||1
11334482|NCT02853123|12532192|FG001|NOT COMPLETED|Washout Period||3
11334483|NCT02853123|12532191|FG000|STARTED|Treatment Period 2||51
11334484|NCT02853123|12532192|FG001|STARTED|Treatment Period 2||48
11334485|NCT02853123|12532191|FG000|COMPLETED|Treatment Period 2||51
11334486|NCT02853123|12532192|FG001|COMPLETED|Treatment Period 2||48
11334487|NCT02853123|12532191|FG000|NOT COMPLETED|Treatment Period 2||0
11334488|NCT02853123|12532192|FG001|NOT COMPLETED|Treatment Period 2||0
11334489|NCT02853318|12532199|FG000|STARTED|Overall Study||40
11334490|NCT02853318|12532199|FG000|COMPLETED|Overall Study||39
11334491|NCT02853318|12532199|FG000|NOT COMPLETED|Overall Study||1
11334492|NCT02853435|12532206|FG000|STARTED|Part 1a, Period 1 (3 Days)||9
11334493|NCT02853435|12532207|FG001|STARTED|Part 1a, Period 1 (3 Days)||9
11334494|NCT02853435|12532208|FG002|STARTED|Part 1a, Period 1 (3 Days)||8
11334495|NCT02853435|12532209|FG003|STARTED|Part 1a, Period 1 (3 Days)||0
11334496|NCT02853435|12532210|FG004|STARTED|Part 1a, Period 1 (3 Days)||0
11334497|NCT02853435|12532211|FG005|STARTED|Part 1a, Period 1 (3 Days)||0
11334498|NCT02853435|12532206|FG000|COMPLETED|Part 1a, Period 1 (3 Days)||9
11334499|NCT02853435|12532207|FG001|COMPLETED|Part 1a, Period 1 (3 Days)||9
11334500|NCT02853435|12532208|FG002|COMPLETED|Part 1a, Period 1 (3 Days)||8
11334501|NCT02853435|12532209|FG003|COMPLETED|Part 1a, Period 1 (3 Days)||0
11334502|NCT02853435|12532210|FG004|COMPLETED|Part 1a, Period 1 (3 Days)||0
11334503|NCT02853435|12532211|FG005|COMPLETED|Part 1a, Period 1 (3 Days)||0
11334504|NCT02853435|12532206|FG000|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
11334505|NCT02853435|12532207|FG001|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
11334506|NCT02853435|12532208|FG002|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
11334507|NCT02853435|12532209|FG003|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
11334508|NCT02853435|12532210|FG004|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
11334509|NCT02853435|12532211|FG005|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
11334510|NCT02853435|12532206|FG000|STARTED|Part 1a, Washout Period 1 (3 Days)||9
11334511|NCT02853435|12532207|FG001|STARTED|Part 1a, Washout Period 1 (3 Days)||9
11334512|NCT02853435|12532208|FG002|STARTED|Part 1a, Washout Period 1 (3 Days)||8
11334513|NCT02853435|12532209|FG003|STARTED|Part 1a, Washout Period 1 (3 Days)||0
11334514|NCT02853435|12532210|FG004|STARTED|Part 1a, Washout Period 1 (3 Days)||0
11334515|NCT02853435|12532211|FG005|STARTED|Part 1a, Washout Period 1 (3 Days)||0
11334516|NCT02853435|12532206|FG000|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
11334517|NCT02853435|12532207|FG001|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
11334518|NCT02853435|12532208|FG002|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
11334519|NCT02853435|12532209|FG003|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
11334520|NCT02853435|12532210|FG004|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
11334521|NCT02853435|12532211|FG005|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
11334522|NCT02853435|12532206|FG000|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
11334523|NCT02853435|12532207|FG001|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
11334524|NCT02853435|12532208|FG002|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
11334525|NCT02853435|12532209|FG003|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
11334526|NCT02853435|12532210|FG004|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
11334527|NCT02853435|12532211|FG005|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
11334528|NCT02853435|12532206|FG000|STARTED|Part 1a, Period 2 (3 Days)||9
11334529|NCT02853435|12532207|FG001|STARTED|Part 1a, Period 2 (3 Days)||9
11334530|NCT02853435|12532208|FG002|STARTED|Part 1a, Period 2 (3 Days)||8
11334531|NCT02853435|12532209|FG003|STARTED|Part 1a, Period 2 (3 Days)||0
11334532|NCT02853435|12532210|FG004|STARTED|Part 1a, Period 2 (3 Days)||0
11334533|NCT02853435|12532211|FG005|STARTED|Part 1a, Period 2 (3 Days)||0
11334534|NCT02853435|12532206|FG000|COMPLETED|Part 1a, Period 2 (3 Days)||9
11334535|NCT02853435|12532207|FG001|COMPLETED|Part 1a, Period 2 (3 Days)||9
11334536|NCT02853435|12532208|FG002|COMPLETED|Part 1a, Period 2 (3 Days)||8
11334537|NCT02853435|12532209|FG003|COMPLETED|Part 1a, Period 2 (3 Days)||0
11334538|NCT02853435|12532210|FG004|COMPLETED|Part 1a, Period 2 (3 Days)||0
11334539|NCT02853435|12532211|FG005|COMPLETED|Part 1a, Period 2 (3 Days)||0
11334540|NCT02853435|12532206|FG000|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
11334541|NCT02853435|12532207|FG001|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
11334542|NCT02853435|12532208|FG002|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
11334543|NCT02853435|12532209|FG003|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
11334544|NCT02853435|12532210|FG004|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
11334545|NCT02853435|12532211|FG005|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
11334546|NCT02853435|12532206|FG000|STARTED|Part 1a, Washout Period 2 (3 Days)||9
11334547|NCT02853435|12532207|FG001|STARTED|Part 1a, Washout Period 2 (3 Days)||9
11334548|NCT02853435|12532208|FG002|STARTED|Part 1a, Washout Period 2 (3 Days)||8
11334549|NCT02853435|12532209|FG003|STARTED|Part 1a, Washout Period 2 (3 Days)||0
11334550|NCT02853435|12532210|FG004|STARTED|Part 1a, Washout Period 2 (3 Days)||0
11334551|NCT02853435|12532211|FG005|STARTED|Part 1a, Washout Period 2 (3 Days)||0
11334552|NCT02853435|12532206|FG000|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
11334553|NCT02853435|12532207|FG001|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
11334554|NCT02853435|12532208|FG002|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
11334555|NCT02853435|12532209|FG003|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
11334556|NCT02853435|12532210|FG004|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
11334557|NCT02853435|12532211|FG005|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
11334558|NCT02853435|12532206|FG000|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
11334559|NCT02853435|12532207|FG001|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
11334560|NCT02853435|12532208|FG002|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
11334561|NCT02853435|12532209|FG003|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
11334562|NCT02853435|12532210|FG004|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
11334563|NCT02853435|12532211|FG005|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
11334564|NCT02853435|12532206|FG000|STARTED|Part 1a, Period 3 (3 Days)||9
11334565|NCT02853435|12532207|FG001|STARTED|Part 1a, Period 3 (3 Days)||9
11334566|NCT02853435|12532208|FG002|STARTED|Part 1a, Period 3 (3 Days)||8
11334567|NCT02853435|12532209|FG003|STARTED|Part 1a, Period 3 (3 Days)||0
11334568|NCT02853435|12532210|FG004|STARTED|Part 1a, Period 3 (3 Days)||0
11334569|NCT02853435|12532211|FG005|STARTED|Part 1a, Period 3 (3 Days)||0
11334570|NCT02853435|12532206|FG000|COMPLETED|Part 1a, Period 3 (3 Days)||9
11334571|NCT02853435|12532207|FG001|COMPLETED|Part 1a, Period 3 (3 Days)||9
11334572|NCT02853435|12532208|FG002|COMPLETED|Part 1a, Period 3 (3 Days)||8
11334573|NCT02853435|12532209|FG003|COMPLETED|Part 1a, Period 3 (3 Days)||0
11334574|NCT02853435|12532210|FG004|COMPLETED|Part 1a, Period 3 (3 Days)||0
11057567|NCT00998790|12239192|FG000|STARTED|Overall Study||114
11334575|NCT02853435|12532211|FG005|COMPLETED|Part 1a, Period 3 (3 Days)||0
11334576|NCT02853435|12532206|FG000|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
11334577|NCT02853435|12532207|FG001|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
11334578|NCT02853435|12532208|FG002|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
11334579|NCT02853435|12532209|FG003|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
11334580|NCT02853435|12532210|FG004|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
11334581|NCT02853435|12532211|FG005|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
11033656|NCT00869323|12213145|FG000|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
11033657|NCT00869323|12213145|FG000|COMPLETED|Maintenance Therapy||1
11033658|NCT00869323|12213145|FG000|NOT COMPLETED|Maintenance Therapy||1
11033659|NCT00869349|12213151|FG000|STARTED|Overall Study||39
11033660|NCT00869349|12213152|FG001|STARTED|Overall Study||40
11033661|NCT00869349|12213151|FG000|COMPLETED|Overall Study||32
11033662|NCT00869349|12213152|FG001|COMPLETED|Overall Study||36
11033663|NCT00869349|12213151|FG000|NOT COMPLETED|Overall Study||7
11033664|NCT00869349|12213152|FG001|NOT COMPLETED|Overall Study||4
11033665|NCT00869362|12213160|FG000|STARTED|Overall Study||15
11033666|NCT00869362|12213161|FG001|STARTED|Overall Study||16
11033667|NCT00869362|12213160|FG000|COMPLETED|Overall Study||14
11033668|NCT00869362|12213161|FG001|COMPLETED|Overall Study||11
11033669|NCT00869362|12213160|FG000|NOT COMPLETED|Overall Study||1
11033670|NCT00869362|12213161|FG001|NOT COMPLETED|Overall Study||5
11033671|NCT00869375|12213170|FG000|STARTED|Overall Study||3
11033672|NCT00869375|12213171|FG001|STARTED|Overall Study||3
11033673|NCT00869375|12213170|FG000|COMPLETED|Overall Study||3
11033674|NCT00869375|12213171|FG001|COMPLETED|Overall Study||3
11033675|NCT00869375|12213170|FG000|NOT COMPLETED|Overall Study||0
11033676|NCT00869375|12213171|FG001|NOT COMPLETED|Overall Study||0
11033677|NCT00869401|12213182|FG000|STARTED|Overall Study||3
11033678|NCT00869401|12213183|FG001|STARTED|Overall Study||3
11033679|NCT00869401|12213184|FG002|STARTED|Overall Study||7
11033680|NCT00869401|12213185|FG003|STARTED|Overall Study||138
11033681|NCT00869401|12213186|FG004|STARTED|Overall Study||66
11033682|NCT00869401|12213182|FG000|COMPLETED|Overall Study||3
11033683|NCT00869401|12213183|FG001|COMPLETED|Overall Study||3
11033684|NCT00869401|12213184|FG002|COMPLETED|Overall Study||7
11033685|NCT00869401|12213185|FG003|COMPLETED|Overall Study||133
11334582|NCT02853435|12532206|FG000|STARTED|Part 2, Period 1 (3 Days)||0
11334583|NCT02853435|12532207|FG001|STARTED|Part 2, Period 1 (3 Days)||0
11334584|NCT02853435|12532208|FG002|STARTED|Part 2, Period 1 (3 Days)||0
11334585|NCT02853435|12532209|FG003|STARTED|Part 2, Period 1 (3 Days)||10
11334586|NCT02853435|12532210|FG004|STARTED|Part 2, Period 1 (3 Days)||0
11334587|NCT02853435|12532211|FG005|STARTED|Part 2, Period 1 (3 Days)||0
11334588|NCT02853435|12532206|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0
11334589|NCT02853435|12532207|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0
11334590|NCT02853435|12532208|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0
11334591|NCT02853435|12532209|FG003|COMPLETED|Part 2, Period 1 (3 Days)||10
11334592|NCT02853435|12532210|FG004|COMPLETED|Part 2, Period 1 (3 Days)||0
11334593|NCT02853435|12532211|FG005|COMPLETED|Part 2, Period 1 (3 Days)||0
11334594|NCT02853435|12532206|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11334595|NCT02853435|12532207|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11334596|NCT02853435|12532208|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11334597|NCT02853435|12532209|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11334598|NCT02853435|12532210|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11334599|NCT02853435|12532211|FG005|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
11334600|NCT02853435|12532206|FG000|STARTED|Part 2, Washout Period 1 (3 Days)||0
11334601|NCT02853435|12532207|FG001|STARTED|Part 2, Washout Period 1 (3 Days)||0
11334602|NCT02853435|12532208|FG002|STARTED|Part 2, Washout Period 1 (3 Days)||0
11334603|NCT02853435|12532209|FG003|STARTED|Part 2, Washout Period 1 (3 Days)||10
11334604|NCT02853435|12532210|FG004|STARTED|Part 2, Washout Period 1 (3 Days)||0
11334605|NCT02853435|12532211|FG005|STARTED|Part 2, Washout Period 1 (3 Days)||0
11334606|NCT02853435|12532206|FG000|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
11334607|NCT02853435|12532207|FG001|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
11334608|NCT02853435|12532208|FG002|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
11334609|NCT02853435|12532209|FG003|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
11334610|NCT02853435|12532210|FG004|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
11334611|NCT02853435|12532211|FG005|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
11334612|NCT02853435|12532206|FG000|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
11334613|NCT02853435|12532207|FG001|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
11334614|NCT02853435|12532208|FG002|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
11334615|NCT02853435|12532209|FG003|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
11334616|NCT02853435|12532210|FG004|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
11334617|NCT02853435|12532211|FG005|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
11334618|NCT02853435|12532206|FG000|STARTED|Part 2, Period 2 (3 Days)||0
11334619|NCT02853435|12532207|FG001|STARTED|Part 2, Period 2 (3 Days)||0
11334620|NCT02853435|12532208|FG002|STARTED|Part 2, Period 2 (3 Days)||0
11334621|NCT02853435|12532209|FG003|STARTED|Part 2, Period 2 (3 Days)||10
11334622|NCT02853435|12532210|FG004|STARTED|Part 2, Period 2 (3 Days)||0
11334623|NCT02853435|12532211|FG005|STARTED|Part 2, Period 2 (3 Days)||0
11334624|NCT02853435|12532206|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0
11334625|NCT02853435|12532207|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0
11334626|NCT02853435|12532208|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0
11033686|NCT00869401|12213186|FG004|COMPLETED|Overall Study||63
11334627|NCT02853435|12532209|FG003|COMPLETED|Part 2, Period 2 (3 Days)||10
11334628|NCT02853435|12532210|FG004|COMPLETED|Part 2, Period 2 (3 Days)||0
11334629|NCT02853435|12532211|FG005|COMPLETED|Part 2, Period 2 (3 Days)||0
11334630|NCT02853435|12532206|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11334631|NCT02853435|12532207|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11334632|NCT02853435|12532208|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11334633|NCT02853435|12532209|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11334634|NCT02853435|12532210|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11334635|NCT02853435|12532211|FG005|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
11334636|NCT02853435|12532206|FG000|STARTED|Part 3, Period 1 (3 Days)||0
11334637|NCT02853435|12532207|FG001|STARTED|Part 3, Period 1 (3 Days)||0
11334638|NCT02853435|12532208|FG002|STARTED|Part 3, Period 1 (3 Days)||0
11334639|NCT02853435|12532209|FG003|STARTED|Part 3, Period 1 (3 Days)||0
11033687|NCT00869401|12213182|FG000|NOT COMPLETED|Overall Study||0
11033688|NCT00869401|12213183|FG001|NOT COMPLETED|Overall Study||0
11033689|NCT00869401|12213184|FG002|NOT COMPLETED|Overall Study||0
11033690|NCT00869401|12213185|FG003|NOT COMPLETED|Overall Study||5
11033691|NCT00869401|12213186|FG004|NOT COMPLETED|Overall Study||3
11033692|NCT00869440|12213202|FG000|STARTED|Overall Study||25
11033693|NCT00869440|12213203|FG001|STARTED|Overall Study||25
11033694|NCT00869440|12213204|FG002|STARTED|Overall Study||25
11033695|NCT00869440|12213205|FG003|STARTED|Overall Study||25
11033696|NCT00869440|12213202|FG000|COMPLETED|Overall Study||23
11033697|NCT00869440|12213203|FG001|COMPLETED|Overall Study||24
11033698|NCT00869440|12213204|FG002|COMPLETED|Overall Study||25
11033699|NCT00869440|12213205|FG003|COMPLETED|Overall Study||25
11033700|NCT00869440|12213202|FG000|NOT COMPLETED|Overall Study||2
11033701|NCT00869440|12213203|FG001|NOT COMPLETED|Overall Study||1
11033702|NCT00869440|12213204|FG002|NOT COMPLETED|Overall Study||0
11033703|NCT00869440|12213205|FG003|NOT COMPLETED|Overall Study||0
11033704|NCT00869518|12213217|FG000|STARTED|Overall Study||6
11033705|NCT00869518|12213218|FG001|STARTED|Overall Study||6
11033706|NCT00869518|12213217|FG000|COMPLETED|Overall Study||5
11033707|NCT00869518|12213218|FG001|COMPLETED|Overall Study||5
11033708|NCT00869518|12213217|FG000|NOT COMPLETED|Overall Study||1
11033709|NCT00869518|12213218|FG001|NOT COMPLETED|Overall Study||1
11033710|NCT00869557|12213226|FG000|STARTED|Randomized Phase||48
11033711|NCT00869557|12213227|FG001|STARTED|Randomized Phase||23
11033712|NCT00869557|12213226|FG000|COMPLETED|Randomized Phase||45
11033713|NCT00869557|12213227|FG001|COMPLETED|Randomized Phase||21
11033714|NCT00869557|12213226|FG000|NOT COMPLETED|Randomized Phase||3
11334640|NCT02853435|12532210|FG004|STARTED|Part 3, Period 1 (3 Days)||10
11334641|NCT02853435|12532211|FG005|STARTED|Part 3, Period 1 (3 Days)||2
11334642|NCT02853435|12532206|FG000|COMPLETED|Part 3, Period 1 (3 Days)||0
11334643|NCT02853435|12532207|FG001|COMPLETED|Part 3, Period 1 (3 Days)||0
11334644|NCT02853435|12532208|FG002|COMPLETED|Part 3, Period 1 (3 Days)||0
11334645|NCT02853435|12532209|FG003|COMPLETED|Part 3, Period 1 (3 Days)||0
11334646|NCT02853435|12532210|FG004|COMPLETED|Part 3, Period 1 (3 Days)||10
11334647|NCT02853435|12532211|FG005|COMPLETED|Part 3, Period 1 (3 Days)||2
11334648|NCT02853435|12532206|FG000|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
11334649|NCT02853435|12532207|FG001|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
11334650|NCT02853435|12532208|FG002|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
11334651|NCT02853435|12532209|FG003|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
11334652|NCT02853435|12532210|FG004|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
11334653|NCT02853435|12532211|FG005|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
11334654|NCT02853435|12532206|FG000|STARTED|Part 3, Washout Period 1 (3 Days)||0
11334655|NCT02853435|12532207|FG001|STARTED|Part 3, Washout Period 1 (3 Days)||0
11334656|NCT02853435|12532208|FG002|STARTED|Part 3, Washout Period 1 (3 Days)||0
11334657|NCT02853435|12532209|FG003|STARTED|Part 3, Washout Period 1 (3 Days)||0
11334658|NCT02853435|12532210|FG004|STARTED|Part 3, Washout Period 1 (3 Days)||10
11334659|NCT02853435|12532211|FG005|STARTED|Part 3, Washout Period 1 (3 Days)||2
11334660|NCT02853435|12532206|FG000|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
11334661|NCT02853435|12532207|FG001|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
11334662|NCT02853435|12532208|FG002|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
11334663|NCT02853435|12532209|FG003|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
11334664|NCT02853435|12532210|FG004|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
11334665|NCT02853435|12532211|FG005|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
11334666|NCT02853435|12532206|FG000|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
11334667|NCT02853435|12532207|FG001|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
11334668|NCT02853435|12532208|FG002|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
11334669|NCT02853435|12532209|FG003|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
11334670|NCT02853435|12532210|FG004|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
11334671|NCT02853435|12532211|FG005|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
11334672|NCT02853435|12532206|FG000|STARTED|Part 3, Period 2 (3 Days)||0
11334673|NCT02853435|12532207|FG001|STARTED|Part 3, Period 2 (3 Days)||0
11334674|NCT02853435|12532208|FG002|STARTED|Part 3, Period 2 (3 Days)||0
11334675|NCT02853435|12532209|FG003|STARTED|Part 3, Period 2 (3 Days)||0
11334676|NCT02853435|12532210|FG004|STARTED|Part 3, Period 2 (3 Days)||10
11334677|NCT02853435|12532211|FG005|STARTED|Part 3, Period 2 (3 Days)||2
11334678|NCT02853435|12532206|FG000|COMPLETED|Part 3, Period 2 (3 Days)||0
11334679|NCT02853435|12532207|FG001|COMPLETED|Part 3, Period 2 (3 Days)||0
11334680|NCT02853435|12532208|FG002|COMPLETED|Part 3, Period 2 (3 Days)||0
11334681|NCT02853435|12532209|FG003|COMPLETED|Part 3, Period 2 (3 Days)||0
11334682|NCT02853435|12532210|FG004|COMPLETED|Part 3, Period 2 (3 Days)||10
11334683|NCT02853435|12532211|FG005|COMPLETED|Part 3, Period 2 (3 Days)||2
11334684|NCT02853435|12532206|FG000|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
11334685|NCT02853435|12532207|FG001|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
11334686|NCT02853435|12532208|FG002|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
11334687|NCT02853435|12532209|FG003|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
11334688|NCT02853435|12532210|FG004|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
11334689|NCT02853435|12532211|FG005|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
11334690|NCT02853435|12532206|FG000|STARTED|Part 3, Washout Period 2 (3 Days)||0
11334691|NCT02853435|12532207|FG001|STARTED|Part 3, Washout Period 2 (3 Days)||0
11334692|NCT02853435|12532208|FG002|STARTED|Part 3, Washout Period 2 (3 Days)||0
11334693|NCT02853435|12532209|FG003|STARTED|Part 3, Washout Period 2 (3 Days)||0
11334694|NCT02853435|12532210|FG004|STARTED|Part 3, Washout Period 2 (3 Days)||10
11334695|NCT02853435|12532211|FG005|STARTED|Part 3, Washout Period 2 (3 Days)||2
11334696|NCT02853435|12532206|FG000|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
11334697|NCT02853435|12532207|FG001|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
11334698|NCT02853435|12532208|FG002|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
11334699|NCT02853435|12532209|FG003|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
11334700|NCT02853435|12532210|FG004|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
11334701|NCT02853435|12532211|FG005|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
11033715|NCT00869557|12213227|FG001|NOT COMPLETED|Randomized Phase||2
11033716|NCT00869557|12213226|FG000|STARTED|Extension Phase||45
11033717|NCT00869557|12213227|FG001|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
11033718|NCT00869557|12213226|FG000|COMPLETED|Extension Phase||35
11033719|NCT00869557|12213227|FG001|COMPLETED|Extension Phase||11
11033720|NCT00869557|12213226|FG000|NOT COMPLETED|Extension Phase||10
11033721|NCT00869557|12213227|FG001|NOT COMPLETED|Extension Phase||3
11033722|NCT00869609|12213236|FG000|STARTED|Overall Study||31
11033723|NCT00869609|12213237|FG001|STARTED|Overall Study||29
11033724|NCT00869609|12213236|FG000|COMPLETED|Overall Study||25
11033725|NCT00869609|12213237|FG001|COMPLETED|Overall Study||26
11033726|NCT00869609|12213236|FG000|NOT COMPLETED|Overall Study||6
11033727|NCT00869609|12213237|FG001|NOT COMPLETED|Overall Study||3
11033728|NCT00869622|12213245|FG000|STARTED|Overall Study||40
11033729|NCT00869622|12213246|FG001|STARTED|Overall Study||40
11033730|NCT00869622|12213245|FG000|COMPLETED|Overall Study||27
11033731|NCT00869622|12213246|FG001|COMPLETED|Overall Study||26
11033732|NCT00869622|12213245|FG000|NOT COMPLETED|Overall Study||13
11033733|NCT00869622|12213246|FG001|NOT COMPLETED|Overall Study||14
11033734|NCT00869778|12213256|FG000|STARTED|Overall Study||120
11033735|NCT00869778|12213257|FG001|STARTED|Overall Study||120
11033736|NCT00869778|12213258|FG002|STARTED|Overall Study||120
11033737|NCT00869778|12213256|FG000|COMPLETED|Overall Study||108
11033738|NCT00869778|12213257|FG001|COMPLETED|Overall Study||113
11033739|NCT00869778|12213258|FG002|COMPLETED|Overall Study||110
11033740|NCT00869778|12213256|FG000|NOT COMPLETED|Overall Study||12
11033741|NCT00869778|12213257|FG001|NOT COMPLETED|Overall Study||7
11033742|NCT00869778|12213258|FG002|NOT COMPLETED|Overall Study||10
11033743|NCT00869791|12213269|FG000|STARTED|Period 1 Treatment for 7 Days||14
11033744|NCT00869791|12213270|FG001|STARTED|Period 1 Treatment for 7 Days||13
11033745|NCT00869791|12213269|FG000|COMPLETED|Period 1 Treatment for 7 Days||14
11033746|NCT00869791|12213270|FG001|COMPLETED|Period 1 Treatment for 7 Days||13
11033747|NCT00869791|12213269|FG000|NOT COMPLETED|Period 1 Treatment for 7 Days||0
11033748|NCT00869791|12213270|FG001|NOT COMPLETED|Period 1 Treatment for 7 Days||0
11033749|NCT00869791|12213269|FG000|STARTED|Period 2 Treatment for 7 Days||14
11033750|NCT00869791|12213270|FG001|STARTED|Period 2 Treatment for 7 Days||13
11033751|NCT00869791|12213269|FG000|COMPLETED|Period 2 Treatment for 7 Days||14
11033752|NCT00869791|12213270|FG001|COMPLETED|Period 2 Treatment for 7 Days||13
11033753|NCT00869791|12213269|FG000|NOT COMPLETED|Period 2 Treatment for 7 Days||0
11033754|NCT00869791|12213270|FG001|NOT COMPLETED|Period 2 Treatment for 7 Days||0
11033755|NCT00869947|12213278|FG000|STARTED|Overall Study||8
11033756|NCT00869947|12213279|FG001|STARTED|Overall Study||8
11033757|NCT00869947|12213278|FG000|COMPLETED|Overall Study||8
11033758|NCT00869947|12213279|FG001|COMPLETED|Overall Study||8
11033759|NCT00869947|12213278|FG000|NOT COMPLETED|Overall Study||0
11033760|NCT00869947|12213279|FG001|NOT COMPLETED|Overall Study||0
11033761|NCT00869960|12213287|FG000|STARTED|Overall Study||24
11033762|NCT00869960|12213287|FG000|COMPLETED|Overall Study||22
11033763|NCT00869960|12213287|FG000|NOT COMPLETED|Overall Study||2
11033764|NCT00869999|12213291|FG000|STARTED|Overall Study||26
11033765|NCT00869999|12213291|FG000|COMPLETED|Overall Study||24
11033766|NCT00869999|12213291|FG000|NOT COMPLETED|Overall Study||2
11033767|NCT00870103|12213295|FG000|STARTED|Overall Study||64
11033768|NCT00870103|12213295|FG000|COMPLETED|Overall Study||60
11033769|NCT00870103|12213295|FG000|NOT COMPLETED|Overall Study||4
11033770|NCT00870194|12213301|FG000|STARTED|Overall Study||127
11033771|NCT00870194|12213302|FG001|STARTED|Overall Study||128
11033772|NCT00870194|12213301|FG000|Per Protocol Set|Overall Study||97
11033773|NCT00870194|12213302|FG001|Per Protocol Set|Overall Study||111
11033774|NCT00870194|12213301|FG000|COMPLETED|Overall Study||101
11033775|NCT00870194|12213302|FG001|COMPLETED|Overall Study||114
11033776|NCT00870194|12213301|FG000|NOT COMPLETED|Overall Study||26
11033777|NCT00870194|12213302|FG001|NOT COMPLETED|Overall Study||14
11033778|NCT00870233|12213308|FG000|STARTED|Overall Study||120
11033779|NCT00870233|12213308|FG000|COMPLETED|Overall Study||96
11033780|NCT00870233|12213308|FG000|NOT COMPLETED|Overall Study||24
11033781|NCT00870363|12213317|FG000|STARTED|Overall Study||10
11033782|NCT00870363|12213318|FG001|STARTED|Overall Study||11
11033783|NCT00870363|12213319|FG002|STARTED|Overall Study||11
11033784|NCT00870363|12213320|FG003|STARTED|Overall Study||12
11033785|NCT00870363|12213317|FG000|COMPLETED|Overall Study||10
11033786|NCT00870363|12213318|FG001|COMPLETED|Overall Study||8
11033787|NCT00870363|12213319|FG002|COMPLETED|Overall Study||8
11033788|NCT00870363|12213320|FG003|COMPLETED|Overall Study||12
11033789|NCT00870363|12213317|FG000|NOT COMPLETED|Overall Study||0
11033790|NCT00870363|12213318|FG001|NOT COMPLETED|Overall Study||3
11033791|NCT00870363|12213319|FG002|NOT COMPLETED|Overall Study||3
11033792|NCT00870363|12213320|FG003|NOT COMPLETED|Overall Study||0
11033793|NCT00870467|12213332|FG000|STARTED|Double-blind||171
11033794|NCT00870467|12213333|FG001|STARTED|Double-blind||163
11033795|NCT00870467|12213334|FG002|STARTED|Double-blind||0
11033796|NCT00870467|12213335|FG003|STARTED|Double-blind||0
11033797|NCT00870467|12213336|FG004|STARTED|Double-blind||0
11033798|NCT00870467|12213337|FG005|STARTED|Double-blind||0
11033799|NCT00870467|12213332|FG000|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
11033800|NCT00870467|12213333|FG001|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
11033801|NCT00870467|12213334|FG002|COMPLETED|Double-blind||0
11033802|NCT00870467|12213335|FG003|COMPLETED|Double-blind||0
11033803|NCT00870467|12213336|FG004|COMPLETED|Double-blind||0
11033804|NCT00870467|12213337|FG005|COMPLETED|Double-blind||0
11033805|NCT00870467|12213332|FG000|NOT COMPLETED|Double-blind||16
11033806|NCT00870467|12213333|FG001|NOT COMPLETED|Double-blind||12
11033807|NCT00870467|12213334|FG002|NOT COMPLETED|Double-blind||0
11033808|NCT00870467|12213335|FG003|NOT COMPLETED|Double-blind||0
11033809|NCT00870467|12213336|FG004|NOT COMPLETED|Double-blind||0
11033810|NCT00870467|12213337|FG005|NOT COMPLETED|Double-blind||0
11033811|NCT00870467|12213332|FG000|STARTED|Open-label||0
11033812|NCT00870467|12213333|FG001|STARTED|Open-label||0
11033813|NCT00870467|12213334|FG002|STARTED|Open-label||145
11033814|NCT00870467|12213335|FG003|STARTED|Open-label||127
11033815|NCT00870467|12213336|FG004|STARTED|Open-label||10
11033816|NCT00870467|12213337|FG005|STARTED|Open-label||24
11033817|NCT00870467|12213332|FG000|COMPLETED|Open-label||0
11033818|NCT00870467|12213333|FG001|COMPLETED|Open-label||0
11033819|NCT00870467|12213334|FG002|COMPLETED|Open-label||132
11033820|NCT00870467|12213335|FG003|COMPLETED|Open-label||120
11033821|NCT00870467|12213336|FG004|COMPLETED|Open-label||5
11033822|NCT00870467|12213337|FG005|COMPLETED|Open-label||21
11033823|NCT00870467|12213332|FG000|NOT COMPLETED|Open-label||0
11033824|NCT00870467|12213333|FG001|NOT COMPLETED|Open-label||0
11033825|NCT00870467|12213334|FG002|NOT COMPLETED|Open-label||13
11033826|NCT00870467|12213335|FG003|NOT COMPLETED|Open-label||7
11033827|NCT00870467|12213336|FG004|NOT COMPLETED|Open-label||5
11033828|NCT00870467|12213337|FG005|NOT COMPLETED|Open-label||3
11033829|NCT00870545|12213349|FG000|STARTED|Overall Study||86
11033830|NCT00870545|12213349|FG000|COMPLETED|Overall Study||69
11033831|NCT00870545|12213349|FG000|NOT COMPLETED|Overall Study||17
11033832|NCT00870584|12213355|FG000|STARTED|Overall Study||136
11033833|NCT00870584|12213356|FG001|STARTED|Overall Study||135
11033834|NCT00870584|12213355|FG000|COMPLETED|Overall Study||120
11033835|NCT00870584|12213356|FG001|COMPLETED|Overall Study||122
11033836|NCT00870584|12213355|FG000|NOT COMPLETED|Overall Study||16
11033837|NCT00870584|12213356|FG001|NOT COMPLETED|Overall Study||13
11033838|NCT00870727|12213364|FG000|STARTED|Overall Study||17
11033839|NCT00870727|12213365|FG001|STARTED|Overall Study||16
11033840|NCT00870727|12213364|FG000|COMPLETED|Overall Study||16
11033841|NCT00870727|12213365|FG001|COMPLETED|Overall Study||11
11033842|NCT00870727|12213364|FG000|NOT COMPLETED|Overall Study||1
11033843|NCT00870727|12213365|FG001|NOT COMPLETED|Overall Study||5
11033844|NCT00870740|12213377|FG000|STARTED|Overall Study|number randomized and dosed|86
11033845|NCT00870740|12213378|FG001|STARTED|Overall Study|number randomized and dosed|84
11033846|NCT00870740|12213379|FG002|STARTED|Overall Study|number randomized and dosed|86
11033847|NCT00870740|12213380|FG003|STARTED|Overall Study|number randomized and dosed|86
11033848|NCT00870740|12213381|FG004|STARTED|Overall Study|number randomized and dosed|88
11033849|NCT00870740|12213382|FG005|STARTED|Overall Study|number randomized and dosed|87
11033850|NCT00870740|12213377|FG000|COMPLETED|Overall Study||74
11033851|NCT00870740|12213378|FG001|COMPLETED|Overall Study||75
11033852|NCT00870740|12213379|FG002|COMPLETED|Overall Study||76
11033853|NCT00870740|12213380|FG003|COMPLETED|Overall Study||74
11033854|NCT00870740|12213381|FG004|COMPLETED|Overall Study||77
11033855|NCT00870740|12213382|FG005|COMPLETED|Overall Study||70
11033856|NCT00870740|12213377|FG000|NOT COMPLETED|Overall Study||12
11033857|NCT00870740|12213378|FG001|NOT COMPLETED|Overall Study||9
11033858|NCT00870740|12213379|FG002|NOT COMPLETED|Overall Study||10
11033859|NCT00870740|12213380|FG003|NOT COMPLETED|Overall Study||12
11033860|NCT00870740|12213381|FG004|NOT COMPLETED|Overall Study||11
11033861|NCT00870740|12213382|FG005|NOT COMPLETED|Overall Study||17
11033862|NCT00870870|12213411|FG000|STARTED|Overall Study||4
11033863|NCT00870870|12213412|FG001|STARTED|Overall Study||6
11033864|NCT00870870|12213413|FG002|STARTED|Overall Study||29
11033865|NCT00870870|12213414|FG003|STARTED|Overall Study||25
11033866|NCT00870870|12213411|FG000|COMPLETED|Overall Study||4
11033867|NCT00870870|12213412|FG001|COMPLETED|Overall Study||5
11033868|NCT00870870|12213413|FG002|COMPLETED|Overall Study||26
11033869|NCT00870870|12213414|FG003|COMPLETED|Overall Study||20
11033870|NCT00870870|12213411|FG000|NOT COMPLETED|Overall Study||0
11033871|NCT00870870|12213412|FG001|NOT COMPLETED|Overall Study||1
11033872|NCT00870870|12213413|FG002|NOT COMPLETED|Overall Study||3
11033873|NCT00870870|12213414|FG003|NOT COMPLETED|Overall Study||5
11033874|NCT00870896|12213429|FG000|STARTED|Overall Study||5
11033875|NCT00870896|12213429|FG000|COMPLETED|Overall Study||5
11033876|NCT00870896|12213429|FG000|NOT COMPLETED|Overall Study||0
11033877|NCT00871000|12213437|FG000|STARTED|Overall Study||151
11033878|NCT00871000|12213438|FG001|STARTED|Overall Study||152
11033879|NCT00871000|12213437|FG000|COMPLETED|Overall Study||150
11033880|NCT00871000|12213438|FG001|COMPLETED|Overall Study||152
11033881|NCT00871000|12213437|FG000|NOT COMPLETED|Overall Study||1
11033882|NCT00871000|12213438|FG001|NOT COMPLETED|Overall Study||0
11033883|NCT00871117|12213446|FG000|STARTED|Overall Study||239
11033884|NCT00871117|12213447|FG001|STARTED|Overall Study||237
11033885|NCT00871117|12213446|FG000|COMPLETED|Overall Study||234
11033886|NCT00871117|12213447|FG001|COMPLETED|Overall Study||227
11033887|NCT00871117|12213446|FG000|NOT COMPLETED|Overall Study||5
11033888|NCT00871117|12213447|FG001|NOT COMPLETED|Overall Study||10
11033889|NCT00871143|12213456|FG000|STARTED|Overall Study||21
11033890|NCT00871143|12213457|FG001|STARTED|Overall Study||25
11033891|NCT00871143|12213456|FG000|COMPLETED|Overall Study||21
11033892|NCT00871143|12213457|FG001|COMPLETED|Overall Study||25
11033893|NCT00871143|12213456|FG000|NOT COMPLETED|Overall Study||0
11033894|NCT00871143|12213457|FG001|NOT COMPLETED|Overall Study||0
11033895|NCT00871169|12213463|FG000|STARTED|Overall Study||61
11033896|NCT00871169|12213463|FG000|COMPLETED|Overall Study||58
11033897|NCT00871169|12213463|FG000|NOT COMPLETED|Overall Study||3
11033898|NCT00871234|12213467|FG000|STARTED|Overall Study||28
11033899|NCT00871234|12213467|FG000|COMPLETED|Overall Study||23
11033900|NCT00871234|12213467|FG000|NOT COMPLETED|Overall Study||5
11033901|NCT00871260|12213471|FG000|STARTED|Overall Study||20
11033902|NCT00871260|12213471|FG000|COMPLETED|Overall Study||20
11033903|NCT00871260|12213471|FG000|NOT COMPLETED|Overall Study||0
11033904|NCT00871286|12213477|FG000|STARTED|Overall Study||20
11033905|NCT00871286|12213478|FG001|STARTED|Overall Study||20
11033906|NCT00871286|12213477|FG000|COMPLETED|Overall Study||20
11033907|NCT00871286|12213478|FG001|COMPLETED|Overall Study||14
11033908|NCT00871286|12213477|FG000|NOT COMPLETED|Overall Study||0
11033909|NCT00871286|12213478|FG001|NOT COMPLETED|Overall Study||6
11033910|NCT00871338|12213486|FG000|STARTED|Prior to Booster||142
11033911|NCT00871338|12213487|FG001|STARTED|Prior to Booster||142
11033912|NCT00871338|12213486|FG000|COMPLETED|Prior to Booster||140
11033913|NCT00871338|12213487|FG001|COMPLETED|Prior to Booster||139
11033914|NCT00871338|12213486|FG000|NOT COMPLETED|Prior to Booster||2
11033915|NCT00871338|12213487|FG001|NOT COMPLETED|Prior to Booster||3
11033916|NCT00871338|12213486|FG000|STARTED|After Booster||139
11033917|NCT00871338|12213487|FG001|STARTED|After Booster||135
11033918|NCT00871338|12213486|FG000|COMPLETED|After Booster||139
11033919|NCT00871338|12213487|FG001|COMPLETED|After Booster||135
11033920|NCT00871338|12213486|FG000|NOT COMPLETED|After Booster||0
11033921|NCT00871338|12213487|FG001|NOT COMPLETED|After Booster||0
11033922|NCT00871377|12213493|FG000|STARTED|First Intervention (10 Weeks)||3
11033923|NCT00871377|12213494|FG001|STARTED|First Intervention (10 Weeks)||4
11033924|NCT00871377|12213495|FG002|STARTED|First Intervention (10 Weeks)||4
11033925|NCT00871377|12213496|FG003|STARTED|First Intervention (10 Weeks)||4
11033926|NCT00871377|12213497|FG004|STARTED|First Intervention (10 Weeks)||4
11033927|NCT00871377|12213498|FG005|STARTED|First Intervention (10 Weeks)||5
11033928|NCT00871377|12213493|FG000|COMPLETED|First Intervention (10 Weeks)||3
11033929|NCT00871377|12213494|FG001|COMPLETED|First Intervention (10 Weeks)||4
11033930|NCT00871377|12213495|FG002|COMPLETED|First Intervention (10 Weeks)||3
11033931|NCT00871377|12213496|FG003|COMPLETED|First Intervention (10 Weeks)||4
11033932|NCT00871377|12213497|FG004|COMPLETED|First Intervention (10 Weeks)||4
11033933|NCT00871377|12213498|FG005|COMPLETED|First Intervention (10 Weeks)||4
11033934|NCT00871377|12213493|FG000|NOT COMPLETED|First Intervention (10 Weeks)||0
11033935|NCT00871377|12213494|FG001|NOT COMPLETED|First Intervention (10 Weeks)||0
11033936|NCT00871377|12213495|FG002|NOT COMPLETED|First Intervention (10 Weeks)||1
11033937|NCT00871377|12213496|FG003|NOT COMPLETED|First Intervention (10 Weeks)||0
11033938|NCT00871377|12213497|FG004|NOT COMPLETED|First Intervention (10 Weeks)||0
11033939|NCT00871377|12213498|FG005|NOT COMPLETED|First Intervention (10 Weeks)||1
11033940|NCT00871377|12213493|FG000|STARTED|Washout (6 Weeks)||3
11033941|NCT00871377|12213494|FG001|STARTED|Washout (6 Weeks)||4
11033942|NCT00871377|12213495|FG002|STARTED|Washout (6 Weeks)||3
11033943|NCT00871377|12213496|FG003|STARTED|Washout (6 Weeks)||4
11033944|NCT00871377|12213497|FG004|STARTED|Washout (6 Weeks)||4
11033945|NCT00871377|12213498|FG005|STARTED|Washout (6 Weeks)||4
11033946|NCT00871377|12213493|FG000|COMPLETED|Washout (6 Weeks)||2
11033947|NCT00871377|12213494|FG001|COMPLETED|Washout (6 Weeks)||4
11033948|NCT00871377|12213495|FG002|COMPLETED|Washout (6 Weeks)||3
11033949|NCT00871377|12213496|FG003|COMPLETED|Washout (6 Weeks)||4
11033950|NCT00871377|12213497|FG004|COMPLETED|Washout (6 Weeks)||4
11033951|NCT00871377|12213498|FG005|COMPLETED|Washout (6 Weeks)||4
11033952|NCT00871377|12213493|FG000|NOT COMPLETED|Washout (6 Weeks)||1
11033953|NCT00871377|12213494|FG001|NOT COMPLETED|Washout (6 Weeks)||0
11033954|NCT00871377|12213495|FG002|NOT COMPLETED|Washout (6 Weeks)||0
11033955|NCT00871377|12213496|FG003|NOT COMPLETED|Washout (6 Weeks)||0
11033956|NCT00871377|12213497|FG004|NOT COMPLETED|Washout (6 Weeks)||0
11033957|NCT00871377|12213498|FG005|NOT COMPLETED|Washout (6 Weeks)||0
11033958|NCT00871377|12213493|FG000|STARTED|Second Intervention (10 Weeks)||2
11033959|NCT00871377|12213494|FG001|STARTED|Second Intervention (10 Weeks)||4
11033960|NCT00871377|12213495|FG002|STARTED|Second Intervention (10 Weeks)||3
11033961|NCT00871377|12213496|FG003|STARTED|Second Intervention (10 Weeks)||4
11033962|NCT00871377|12213497|FG004|STARTED|Second Intervention (10 Weeks)||4
11033963|NCT00871377|12213498|FG005|STARTED|Second Intervention (10 Weeks)||4
11033964|NCT00871377|12213493|FG000|COMPLETED|Second Intervention (10 Weeks)||2
11033965|NCT00871377|12213494|FG001|COMPLETED|Second Intervention (10 Weeks)||4
11033966|NCT00871377|12213495|FG002|COMPLETED|Second Intervention (10 Weeks)||3
11033967|NCT00871377|12213496|FG003|COMPLETED|Second Intervention (10 Weeks)||4
11033968|NCT00871377|12213497|FG004|COMPLETED|Second Intervention (10 Weeks)||4
11033969|NCT00871377|12213498|FG005|COMPLETED|Second Intervention (10 Weeks)||4
11033970|NCT00871377|12213493|FG000|NOT COMPLETED|Second Intervention (10 Weeks)||0
11033971|NCT00871377|12213494|FG001|NOT COMPLETED|Second Intervention (10 Weeks)||0
11033972|NCT00871377|12213495|FG002|NOT COMPLETED|Second Intervention (10 Weeks)||0
11033973|NCT00871377|12213496|FG003|NOT COMPLETED|Second Intervention (10 Weeks)||0
11033974|NCT00871377|12213497|FG004|NOT COMPLETED|Second Intervention (10 Weeks)||0
11033975|NCT00871377|12213498|FG005|NOT COMPLETED|Second Intervention (10 Weeks)||0
11033976|NCT00871377|12213493|FG000|STARTED|Washout (6 Weeks)||2
11033977|NCT00871377|12213494|FG001|STARTED|Washout (6 Weeks)||4
11033978|NCT00871377|12213495|FG002|STARTED|Washout (6 Weeks)||3
11033979|NCT00871377|12213496|FG003|STARTED|Washout (6 Weeks)||4
11033980|NCT00871377|12213497|FG004|STARTED|Washout (6 Weeks)||4
11033981|NCT00871377|12213498|FG005|STARTED|Washout (6 Weeks)||4
11033982|NCT00871377|12213493|FG000|COMPLETED|Washout (6 Weeks)||2
11033983|NCT00871377|12213494|FG001|COMPLETED|Washout (6 Weeks)||4
11033984|NCT00871377|12213495|FG002|COMPLETED|Washout (6 Weeks)||3
11033985|NCT00871377|12213496|FG003|COMPLETED|Washout (6 Weeks)||4
11334702|NCT02853435|12532206|FG000|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
11334703|NCT02853435|12532207|FG001|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
11334704|NCT02853435|12532208|FG002|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
11334705|NCT02853435|12532209|FG003|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
11334706|NCT02853435|12532210|FG004|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
11334707|NCT02853435|12532211|FG005|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
11334708|NCT02853435|12532206|FG000|STARTED|Part 3, Period 3 (3 Days)||0
11334709|NCT02853435|12532207|FG001|STARTED|Part 3, Period 3 (3 Days)||0
11334710|NCT02853435|12532208|FG002|STARTED|Part 3, Period 3 (3 Days)||0
11334711|NCT02853435|12532209|FG003|STARTED|Part 3, Period 3 (3 Days)||0
11334712|NCT02853435|12532210|FG004|STARTED|Part 3, Period 3 (3 Days)||9
11334713|NCT02853435|12532211|FG005|STARTED|Part 3, Period 3 (3 Days)||2
11334714|NCT02853435|12532206|FG000|COMPLETED|Part 3, Period 3 (3 Days)||0
11334715|NCT02853435|12532207|FG001|COMPLETED|Part 3, Period 3 (3 Days)||0
11334716|NCT02853435|12532208|FG002|COMPLETED|Part 3, Period 3 (3 Days)||0
11033986|NCT00871377|12213497|FG004|COMPLETED|Washout (6 Weeks)||4
11033987|NCT00871377|12213498|FG005|COMPLETED|Washout (6 Weeks)||3
11033988|NCT00871377|12213493|FG000|NOT COMPLETED|Washout (6 Weeks)||0
11033989|NCT00871377|12213494|FG001|NOT COMPLETED|Washout (6 Weeks)||0
11033990|NCT00871377|12213495|FG002|NOT COMPLETED|Washout (6 Weeks)||0
11033991|NCT00871377|12213496|FG003|NOT COMPLETED|Washout (6 Weeks)||0
11033992|NCT00871377|12213497|FG004|NOT COMPLETED|Washout (6 Weeks)||0
11033993|NCT00871377|12213498|FG005|NOT COMPLETED|Washout (6 Weeks)||1
11033994|NCT00871377|12213493|FG000|STARTED|Third Intervention (10 Weeks)||2
11033995|NCT00871377|12213494|FG001|STARTED|Third Intervention (10 Weeks)||4
11033996|NCT00871377|12213495|FG002|STARTED|Third Intervention (10 Weeks)||3
11033997|NCT00871377|12213496|FG003|STARTED|Third Intervention (10 Weeks)||4
11033998|NCT00871377|12213497|FG004|STARTED|Third Intervention (10 Weeks)||4
11033999|NCT00871377|12213498|FG005|STARTED|Third Intervention (10 Weeks)||3
11034000|NCT00871377|12213493|FG000|COMPLETED|Third Intervention (10 Weeks)||2
11034001|NCT00871377|12213494|FG001|COMPLETED|Third Intervention (10 Weeks)||4
11034002|NCT00871377|12213495|FG002|COMPLETED|Third Intervention (10 Weeks)||3
11034003|NCT00871377|12213496|FG003|COMPLETED|Third Intervention (10 Weeks)||3
11034004|NCT00871377|12213497|FG004|COMPLETED|Third Intervention (10 Weeks)||4
11034005|NCT00871377|12213498|FG005|COMPLETED|Third Intervention (10 Weeks)||3
11034006|NCT00871377|12213493|FG000|NOT COMPLETED|Third Intervention (10 Weeks)||0
11034007|NCT00871377|12213494|FG001|NOT COMPLETED|Third Intervention (10 Weeks)||0
11034008|NCT00871377|12213495|FG002|NOT COMPLETED|Third Intervention (10 Weeks)||0
11034009|NCT00871377|12213496|FG003|NOT COMPLETED|Third Intervention (10 Weeks)||1
11034010|NCT00871377|12213497|FG004|NOT COMPLETED|Third Intervention (10 Weeks)||0
11034011|NCT00871377|12213498|FG005|NOT COMPLETED|Third Intervention (10 Weeks)||0
11034012|NCT00871403|12213509|FG000|STARTED|Combination Treatment Phase||9
11034013|NCT00871403|12213510|FG001|STARTED|Combination Treatment Phase||62
11034014|NCT00871403|12213511|FG002|STARTED|Combination Treatment Phase||35
11034015|NCT00871403|12213509|FG000|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
11034016|NCT00871403|12213510|FG001|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
11034017|NCT00871403|12213511|FG002|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
11034018|NCT00871403|12213509|FG000|NOT COMPLETED|Combination Treatment Phase||9
11034019|NCT00871403|12213510|FG001|NOT COMPLETED|Combination Treatment Phase||49
11034020|NCT00871403|12213511|FG002|NOT COMPLETED|Combination Treatment Phase||12
11034021|NCT00871403|12213509|FG000|STARTED|Monotherapy Treatment Phase||0
11034022|NCT00871403|12213510|FG001|STARTED|Monotherapy Treatment Phase||13
11034023|NCT00871403|12213511|FG002|STARTED|Monotherapy Treatment Phase||1
11034024|NCT00871403|12213509|FG000|COMPLETED|Monotherapy Treatment Phase||0
11034025|NCT00871403|12213510|FG001|COMPLETED|Monotherapy Treatment Phase||0
11034026|NCT00871403|12213511|FG002|COMPLETED|Monotherapy Treatment Phase||0
11034027|NCT00871403|12213509|FG000|NOT COMPLETED|Monotherapy Treatment Phase||0
11034028|NCT00871403|12213510|FG001|NOT COMPLETED|Monotherapy Treatment Phase||13
11034029|NCT00871403|12213511|FG002|NOT COMPLETED|Monotherapy Treatment Phase||1
11034030|NCT00871429|12213518|FG000|STARTED|Overall Study||99
11034031|NCT00871429|12213518|FG000|COMPLETED|Overall Study||75
11034032|NCT00871429|12213518|FG000|NOT COMPLETED|Overall Study||24
11034033|NCT00871494|12213526|FG000|STARTED|Overall Study||76
11034034|NCT00871494|12213526|FG000|COMPLETED|Overall Study||62
11034035|NCT00871494|12213526|FG000|NOT COMPLETED|Overall Study||14
11034036|NCT00871572|12213534|FG000|STARTED|Overall Study||10
11034037|NCT00871572|12213535|FG001|STARTED|Overall Study||17
11034038|NCT00871572|12213536|FG002|STARTED|Overall Study||34
11034039|NCT00871572|12213537|FG003|STARTED|Overall Study||26
11034040|NCT00871572|12213534|FG000|≥1 Post Baseline Value by Assigned Group|Overall Study||9
11034041|NCT00871572|12213535|FG001|≥1 Post Baseline Value by Assigned Group|Overall Study||17
11034042|NCT00871572|12213536|FG002|≥1 Post Baseline Value by Assigned Group|Overall Study||34
11034043|NCT00871572|12213537|FG003|≥1 Post Baseline Value by Assigned Group|Overall Study||25
11034044|NCT00871572|12213534|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9
11034045|NCT00871572|12213535|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
11034046|NCT00871572|12213536|FG002|Received at Least 1 Dose of Study Drug|Overall Study||34
11034047|NCT00871572|12213537|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25
11034048|NCT00871572|12213534|FG000|COMPLETED|Overall Study||8
11034049|NCT00871572|12213535|FG001|COMPLETED|Overall Study||11
11034050|NCT00871572|12213536|FG002|COMPLETED|Overall Study||30
11034051|NCT00871572|12213537|FG003|COMPLETED|Overall Study||19
11034052|NCT00871572|12213534|FG000|NOT COMPLETED|Overall Study||2
11034053|NCT00871572|12213535|FG001|NOT COMPLETED|Overall Study||6
11034054|NCT00871572|12213536|FG002|NOT COMPLETED|Overall Study||4
11034055|NCT00871572|12213537|FG003|NOT COMPLETED|Overall Study||7
11034056|NCT00871624|12213549|FG000|STARTED|Overall Study||18
11034057|NCT00871624|12213550|FG001|STARTED|Overall Study||18
11034058|NCT00871624|12213549|FG000|COMPLETED|Overall Study||16
11034059|NCT00871624|12213550|FG001|COMPLETED|Overall Study||17
11034060|NCT00871624|12213549|FG000|NOT COMPLETED|Overall Study||2
11034061|NCT00871624|12213550|FG001|NOT COMPLETED|Overall Study||1
11034062|NCT00871689|12213558|FG000|STARTED|Overall Study||2
11034063|NCT00871689|12213558|FG000|COMPLETED|Overall Study||2
11034064|NCT00871689|12213558|FG000|NOT COMPLETED|Overall Study||0
11034065|NCT00871715|12213565|FG000|STARTED|Overall Study||119
11034066|NCT00871715|12213566|FG001|STARTED|Overall Study||120
11034067|NCT00871715|12213567|FG002|STARTED|Overall Study||122
11034068|NCT00871715|12213565|FG000|Post-Intervention|Overall Study||112
11034069|NCT00871715|12213566|FG001|Post-Intervention|Overall Study||115
11034070|NCT00871715|12213567|FG002|Post-Intervention|Overall Study||115
11034071|NCT00871715|12213565|FG000|6-mo Follow-up|Overall Study||110
11034072|NCT00871715|12213566|FG001|6-mo Follow-up|Overall Study||113
11034073|NCT00871715|12213567|FG002|6-mo Follow-up|Overall Study||112
11034074|NCT00871715|12213565|FG000|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
11034075|NCT00871715|12213566|FG001|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
11034076|NCT00871715|12213567|FG002|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
11034077|NCT00871715|12213565|FG000|NOT COMPLETED|Overall Study||15
11034078|NCT00871715|12213566|FG001|NOT COMPLETED|Overall Study||16
11034079|NCT00871715|12213567|FG002|NOT COMPLETED|Overall Study||26
11034080|NCT00871728|12213576|FG000|STARTED|Overall Study||132
11034081|NCT00871728|12213576|FG000|Treated|Overall Study||130
11034082|NCT00871728|12213576|FG000|COMPLETED|Overall Study||112
11034083|NCT00871728|12213576|FG000|NOT COMPLETED|Overall Study||20
11034084|NCT00871741|12213582|FG000|STARTED|Overall Study||9
11034085|NCT00871741|12213583|FG001|STARTED|Overall Study||7
11034086|NCT00871741|12213582|FG000|COMPLETED|Overall Study||0
11334717|NCT02853435|12532209|FG003|COMPLETED|Part 3, Period 3 (3 Days)||0
11334718|NCT02853435|12532210|FG004|COMPLETED|Part 3, Period 3 (3 Days)||9
11334719|NCT02853435|12532211|FG005|COMPLETED|Part 3, Period 3 (3 Days)||2
11334720|NCT02853435|12532206|FG000|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
11334721|NCT02853435|12532207|FG001|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
11334722|NCT02853435|12532208|FG002|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
11334723|NCT02853435|12532209|FG003|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
11334724|NCT02853435|12532210|FG004|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
11334725|NCT02853435|12532211|FG005|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
11334726|NCT02853929|12532243|FG000|STARTED|Overall Study||270
11334727|NCT02853929|12532244|FG001|STARTED|Overall Study||281
11334728|NCT02853929|12532243|FG000|Vaccinated|Overall Study||263
11334729|NCT02853929|12532244|FG001|Vaccinated|Overall Study||277
11334730|NCT02853929|12532243|FG000|COMPLETED|Overall Study||259
11034087|NCT00871741|12213583|FG001|COMPLETED|Overall Study||0
11034088|NCT00871741|12213582|FG000|NOT COMPLETED|Overall Study||9
11034089|NCT00871741|12213583|FG001|NOT COMPLETED|Overall Study||7
11034090|NCT00871780|12213589|FG000|STARTED|Overall Study|number enrolled|224
11334731|NCT02853929|12532244|FG001|COMPLETED|Overall Study||277
11334732|NCT02853929|12532243|FG000|NOT COMPLETED|Overall Study||11
11334733|NCT02853929|12532244|FG001|NOT COMPLETED|Overall Study||4
11334734|NCT02854059|12532252|FG000|STARTED|Overall Study||2
11334735|NCT02854059|12532253|FG001|STARTED|Overall Study||0
11334736|NCT02854059|12532252|FG000|COMPLETED|Overall Study||2
11034091|NCT00871780|12213589|FG000|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
11034092|NCT00871780|12213589|FG000|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
11034093|NCT00871780|12213589|FG000|COMPLETED|Overall Study||197
11034094|NCT00871780|12213589|FG000|NOT COMPLETED|Overall Study||27
11034095|NCT00871819|12213596|FG000|STARTED|Overall Study||20
11034096|NCT00871819|12213596|FG000|COMPLETED|Overall Study||20
11034097|NCT00871819|12213596|FG000|NOT COMPLETED|Overall Study||0
11034098|NCT00871845|12213602|FG000|STARTED|Overall Study||11
11034099|NCT00871845|12213603|FG001|STARTED|Overall Study||25
11034100|NCT00871845|12213602|FG000|COMPLETED|Overall Study||11
11034101|NCT00871845|12213603|FG001|COMPLETED|Overall Study||25
11034102|NCT00871845|12213602|FG000|NOT COMPLETED|Overall Study||0
11034103|NCT00871845|12213603|FG001|NOT COMPLETED|Overall Study||0
11034104|NCT00871858|12213615|FG000|STARTED|Overall Study||61
11034105|NCT00871858|12213616|FG001|STARTED|Overall Study||59
11034106|NCT00871858|12213615|FG000|Evaluable for Safety|Overall Study|1 patient refused to continue study and therefore did not received treatment.|60
11034107|NCT00871858|12213616|FG001|Evaluable for Safety|Overall Study|1 patient refused to continue study after randomization and therefore did not received treatment.|58
11034108|NCT00871858|12213615|FG000|COMPLETED|Overall Study||56
11034109|NCT00871858|12213616|FG001|COMPLETED|Overall Study||52
11034110|NCT00871858|12213615|FG000|NOT COMPLETED|Overall Study||5
11034111|NCT00871858|12213616|FG001|NOT COMPLETED|Overall Study||7
11034112|NCT00871871|12213624|FG000|STARTED|Part I||18
11034113|NCT00871871|12213625|FG001|STARTED|Part I||18
11034114|NCT00871871|12213626|FG002|STARTED|Part I||0
11034115|NCT00871871|12213627|FG003|STARTED|Part I||0
11034116|NCT00871871|12213624|FG000|COMPLETED|Part I||15
11034117|NCT00871871|12213625|FG001|COMPLETED|Part I||15
11034118|NCT00871871|12213626|FG002|COMPLETED|Part I||0
11034119|NCT00871871|12213627|FG003|COMPLETED|Part I||0
11034120|NCT00871871|12213624|FG000|NOT COMPLETED|Part I||3
11034121|NCT00871871|12213625|FG001|NOT COMPLETED|Part I||3
11034122|NCT00871871|12213626|FG002|NOT COMPLETED|Part I||0
11034123|NCT00871871|12213627|FG003|NOT COMPLETED|Part I||0
11034124|NCT00871871|12213624|FG000|STARTED|Part II||0
11034125|NCT00871871|12213625|FG001|STARTED|Part II||0
11034126|NCT00871871|12213626|FG002|STARTED|Part II||13
11034127|NCT00871871|12213627|FG003|STARTED|Part II||15
11034128|NCT00871871|12213624|FG000|COMPLETED|Part II||0
11034129|NCT00871871|12213625|FG001|COMPLETED|Part II||0
11034130|NCT00871871|12213626|FG002|COMPLETED|Part II||9
11034131|NCT00871871|12213627|FG003|COMPLETED|Part II||11
11034132|NCT00871871|12213624|FG000|NOT COMPLETED|Part II||0
11034133|NCT00871871|12213625|FG001|NOT COMPLETED|Part II||0
11034134|NCT00871871|12213626|FG002|NOT COMPLETED|Part II||4
11034135|NCT00871871|12213627|FG003|NOT COMPLETED|Part II||4
11034136|NCT00871923|12213637|FG000|STARTED|Overall Study||44
11034137|NCT00871923|12213637|FG000|COMPLETED|Overall Study||42
11034138|NCT00871923|12213637|FG000|NOT COMPLETED|Overall Study||2
11034139|NCT00871975|12213641|FG000|STARTED|Overall Study||155
11034140|NCT00871975|12213641|FG000|COMPLETED|Overall Study||133
11034141|NCT00871975|12213641|FG000|NOT COMPLETED|Overall Study||22
11034142|NCT00872001|12213647|FG000|STARTED|Overall Study||1536
11034143|NCT00872001|12213648|FG001|STARTED|Overall Study||1544
11034144|NCT00872001|12213647|FG000|COMPLETED|Overall Study||1400
11034145|NCT00872001|12213648|FG001|COMPLETED|Overall Study||1413
11034146|NCT00872001|12213647|FG000|NOT COMPLETED|Overall Study||136
11034147|NCT00872001|12213648|FG001|NOT COMPLETED|Overall Study||131
11034148|NCT00872027|12213658|FG000|STARTED|Overall Study||7
11034149|NCT00872027|12213659|FG001|STARTED|Overall Study||8
11034150|NCT00872027|12213658|FG000|COMPLETED|Overall Study||7
11034151|NCT00872027|12213659|FG001|COMPLETED|Overall Study||8
11034152|NCT00872027|12213658|FG000|NOT COMPLETED|Overall Study||0
11034153|NCT00872027|12213659|FG001|NOT COMPLETED|Overall Study||0
11034154|NCT00872079|12213665|FG000|STARTED|Overall Study||175
11034155|NCT00872079|12213665|FG000|COMPLETED|Overall Study||175
11034156|NCT00872079|12213665|FG000|NOT COMPLETED|Overall Study||0
11034157|NCT00872170|12213671|FG000|STARTED|Overall Study||14
11034158|NCT00872170|12213672|FG001|STARTED|Overall Study||13
11034159|NCT00872170|12213671|FG000|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
11034160|NCT00872170|12213672|FG001|COMPLETED|Overall Study||13
11034161|NCT00872170|12213671|FG000|NOT COMPLETED|Overall Study||1
11034162|NCT00872170|12213672|FG001|NOT COMPLETED|Overall Study||0
11034163|NCT00872339|12213680|FG000|STARTED|Overall Study||201
11034164|NCT00872339|12213681|FG001|STARTED|Overall Study||14
11034165|NCT00872339|12213682|FG002|STARTED|Overall Study||37
11034166|NCT00872339|12213680|FG000|COMPLETED|Overall Study||201
11034167|NCT00872339|12213681|FG001|COMPLETED|Overall Study||14
11034168|NCT00872339|12213682|FG002|COMPLETED|Overall Study||37
11034169|NCT00872339|12213680|FG000|NOT COMPLETED|Overall Study||0
11034170|NCT00872339|12213681|FG001|NOT COMPLETED|Overall Study||0
11034171|NCT00872339|12213682|FG002|NOT COMPLETED|Overall Study||0
11034172|NCT00872521|12213693|FG000|STARTED|Completed PAD Induction|Received allocated treatment|26
11034173|NCT00872521|12213694|FG001|STARTED|Completed PAD Induction|Received allocated treatment|72
11034174|NCT00872521|12213695|FG002|STARTED|Completed PAD Induction|Received allocated treatment|9
11034175|NCT00872521|12213693|FG000|COMPLETED|Completed PAD Induction|Completed PAD induction|21
11034176|NCT00872521|12213694|FG001|COMPLETED|Completed PAD Induction|Completed PAD induction|68
11034177|NCT00872521|12213695|FG002|COMPLETED|Completed PAD Induction|Completed PAD induction|9
11034178|NCT00872521|12213693|FG000|NOT COMPLETED|Completed PAD Induction||5
11034179|NCT00872521|12213694|FG001|NOT COMPLETED|Completed PAD Induction||4
11034180|NCT00872521|12213695|FG002|NOT COMPLETED|Completed PAD Induction||0
11034181|NCT00872521|12213693|FG000|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
11034182|NCT00872521|12213694|FG001|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
11034183|NCT00872521|12213695|FG002|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
11034184|NCT00872521|12213693|FG000|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
11034185|NCT00872521|12213694|FG001|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
11034186|NCT00872521|12213695|FG002|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
11034187|NCT00872521|12213693|FG000|NOT COMPLETED|Primary Endpoint Analysis||1
11034188|NCT00872521|12213694|FG001|NOT COMPLETED|Primary Endpoint Analysis||5
11034189|NCT00872521|12213695|FG002|NOT COMPLETED|Primary Endpoint Analysis||1
11034190|NCT00872521|12213693|FG000|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
11034191|NCT00872521|12213694|FG001|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
11034192|NCT00872521|12213695|FG002|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
11034193|NCT00872521|12213693|FG000|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
11034194|NCT00872521|12213694|FG001|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
11034195|NCT00872521|12213695|FG002|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
11034196|NCT00872521|12213693|FG000|NOT COMPLETED|Completed 3-month Follow up||0
11034197|NCT00872521|12213694|FG001|NOT COMPLETED|Completed 3-month Follow up||3
11034198|NCT00872521|12213695|FG002|NOT COMPLETED|Completed 3-month Follow up||0
11034199|NCT00872521|12213693|FG000|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
11034200|NCT00872521|12213694|FG001|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
11034201|NCT00872521|12213695|FG002|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
11034202|NCT00872521|12213693|FG000|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
11034203|NCT00872521|12213694|FG001|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
11034204|NCT00872521|12213695|FG002|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
11034205|NCT00872521|12213693|FG000|NOT COMPLETED|Secondary Endpoint Analysis||0
11034206|NCT00872521|12213694|FG001|NOT COMPLETED|Secondary Endpoint Analysis||2
11034207|NCT00872521|12213695|FG002|NOT COMPLETED|Secondary Endpoint Analysis||1
11034208|NCT00872534|12213716|FG000|STARTED|Overall Study||100
11034209|NCT00872534|12213717|FG001|STARTED|Overall Study||104
11034210|NCT00872534|12213716|FG000|COMPLETED|Overall Study||97
11034211|NCT00872534|12213717|FG001|COMPLETED|Overall Study||101
11034212|NCT00872534|12213716|FG000|NOT COMPLETED|Overall Study||3
11034213|NCT00872534|12213717|FG001|NOT COMPLETED|Overall Study||3
11034214|NCT00872599|12213723|FG000|STARTED|First Washout Period After Low Salt||16
11034215|NCT00872599|12213724|FG001|STARTED|First Washout Period After Low Salt||17
11034216|NCT00872599|12213723|FG000|COMPLETED|First Washout Period After Low Salt||16
11034217|NCT00872599|12213724|FG001|COMPLETED|First Washout Period After Low Salt||17
11034218|NCT00872599|12213723|FG000|NOT COMPLETED|First Washout Period After Low Salt||0
11034219|NCT00872599|12213724|FG001|NOT COMPLETED|First Washout Period After Low Salt||0
11034220|NCT00872599|12213723|FG000|STARTED|First Drug During High Salt Intake||16
11034221|NCT00872599|12213724|FG001|STARTED|First Drug During High Salt Intake||17
11034222|NCT00872599|12213723|FG000|COMPLETED|First Drug During High Salt Intake||16
11034223|NCT00872599|12213724|FG001|COMPLETED|First Drug During High Salt Intake||17
11034224|NCT00872599|12213723|FG000|NOT COMPLETED|First Drug During High Salt Intake||0
11034225|NCT00872599|12213724|FG001|NOT COMPLETED|First Drug During High Salt Intake||0
11034226|NCT00872599|12213723|FG000|STARTED|Second Washout Period||16
11034227|NCT00872599|12213724|FG001|STARTED|Second Washout Period||17
11034228|NCT00872599|12213723|FG000|COMPLETED|Second Washout Period||15
11034229|NCT00872599|12213724|FG001|COMPLETED|Second Washout Period||16
11034230|NCT00872599|12213723|FG000|NOT COMPLETED|Second Washout Period||1
11034231|NCT00872599|12213724|FG001|NOT COMPLETED|Second Washout Period||1
11034232|NCT00872599|12213723|FG000|STARTED|Second Drug During High Salt Intake||15
11034233|NCT00872599|12213724|FG001|STARTED|Second Drug During High Salt Intake||16
11034234|NCT00872599|12213723|FG000|COMPLETED|Second Drug During High Salt Intake||15
11034235|NCT00872599|12213724|FG001|COMPLETED|Second Drug During High Salt Intake||16
11034236|NCT00872599|12213723|FG000|NOT COMPLETED|Second Drug During High Salt Intake||0
11034237|NCT00872599|12213724|FG001|NOT COMPLETED|Second Drug During High Salt Intake||0
11034238|NCT00872729|12213730|FG000|STARTED|Overall Study||9
11034239|NCT00872729|12213730|FG000|COMPLETED|Overall Study||9
11034240|NCT00872729|12213730|FG000|NOT COMPLETED|Overall Study||0
11034241|NCT00872833|12213756|FG000|STARTED|Overall Study||15
11034242|NCT00872833|12213757|FG001|STARTED|Overall Study||17
11034243|NCT00872833|12213756|FG000|COMPLETED|Overall Study||15
11034244|NCT00872833|12213757|FG001|COMPLETED|Overall Study||17
11034245|NCT00872833|12213756|FG000|NOT COMPLETED|Overall Study||0
11034246|NCT00872833|12213757|FG001|NOT COMPLETED|Overall Study||0
11034247|NCT00872898|12213769|FG000|STARTED|Part One - Open Label, Pharmacokinetics||0
11034248|NCT00872898|12213770|FG001|STARTED|Part One - Open Label, Pharmacokinetics||4
11034249|NCT00872898|12213769|FG000|COMPLETED|Part One - Open Label, Pharmacokinetics||0
11034250|NCT00872898|12213770|FG001|COMPLETED|Part One - Open Label, Pharmacokinetics||4
11034251|NCT00872898|12213769|FG000|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
11034252|NCT00872898|12213770|FG001|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
11034253|NCT00872898|12213769|FG000|STARTED|Part Two - Double Blind||61
11034254|NCT00872898|12213770|FG001|STARTED|Part Two - Double Blind||60
11034255|NCT00872898|12213769|FG000|COMPLETED|Part Two - Double Blind||50
11034256|NCT00872898|12213770|FG001|COMPLETED|Part Two - Double Blind||54
11034257|NCT00872898|12213769|FG000|NOT COMPLETED|Part Two - Double Blind||11
11034258|NCT00872898|12213770|FG001|NOT COMPLETED|Part Two - Double Blind||6
11034259|NCT00872989|12213781|FG000|STARTED|Overall Study||66
11034260|NCT00872989|12213782|FG001|STARTED|Overall Study||63
11034261|NCT00872989|12213781|FG000|COMPLETED|Overall Study||1
11034262|NCT00872989|12213782|FG001|COMPLETED|Overall Study||0
11034263|NCT00872989|12213781|FG000|NOT COMPLETED|Overall Study||65
11034264|NCT00872989|12213782|FG001|NOT COMPLETED|Overall Study||63
11034265|NCT00873015|12213798|FG000|STARTED|Overall Study||9
11034266|NCT00873015|12213799|FG001|STARTED|Overall Study||4
11034267|NCT00873015|12213800|FG002|STARTED|Overall Study||3
11034268|NCT00873015|12213801|FG003|STARTED|Overall Study||3
11034269|NCT00873015|12213798|FG000|COMPLETED|Overall Study||9
11034270|NCT00873015|12213799|FG001|COMPLETED|Overall Study||3
11034271|NCT00873015|12213800|FG002|COMPLETED|Overall Study||3
11034272|NCT00873015|12213801|FG003|COMPLETED|Overall Study||3
11034273|NCT00873015|12213798|FG000|NOT COMPLETED|Overall Study||0
11034274|NCT00873015|12213799|FG001|NOT COMPLETED|Overall Study||1
11034275|NCT00873015|12213800|FG002|NOT COMPLETED|Overall Study||0
11034276|NCT00873015|12213801|FG003|NOT COMPLETED|Overall Study||0
11034277|NCT00873041|12213813|FG000|STARTED|Core Study||55
11034278|NCT00873041|12213814|FG001|STARTED|Core Study||55
11034279|NCT00873041|12213815|FG002|STARTED|Core Study||56
11034280|NCT00873041|12213813|FG000|COMPLETED|Core Study||48
11034281|NCT00873041|12213814|FG001|COMPLETED|Core Study||49
11034282|NCT00873041|12213815|FG002|COMPLETED|Core Study||51
11034283|NCT00873041|12213813|FG000|NOT COMPLETED|Core Study||7
11034284|NCT00873041|12213814|FG001|NOT COMPLETED|Core Study||6
11034285|NCT00873041|12213815|FG002|NOT COMPLETED|Core Study||5
11034286|NCT00873041|12213813|FG000|STARTED|Extension Study||41
11034287|NCT00873041|12213814|FG001|STARTED|Extension Study||44
11034288|NCT00873041|12213815|FG002|STARTED|Extension Study||48
11034289|NCT00873041|12213813|FG000|COMPLETED|Extension Study||40
11034290|NCT00873041|12213814|FG001|COMPLETED|Extension Study||44
11034291|NCT00873041|12213815|FG002|COMPLETED|Extension Study||46
11034292|NCT00873041|12213813|FG000|NOT COMPLETED|Extension Study||1
11034293|NCT00873041|12213814|FG001|NOT COMPLETED|Extension Study||0
11034294|NCT00873041|12213815|FG002|NOT COMPLETED|Extension Study||2
11034295|NCT00873093|12213835|FG000|STARTED|Overall Study||4
11034296|NCT00873093|12213836|FG001|STARTED|Overall Study||62
11034297|NCT00873093|12213837|FG002|STARTED|Overall Study||49
11034298|NCT00873093|12213838|FG003|STARTED|Overall Study||23
11034299|NCT00873093|12213839|FG004|STARTED|Overall Study||10
11034300|NCT00873093|12213835|FG000|COMPLETED|Overall Study||3
11034301|NCT00873093|12213836|FG001|COMPLETED|Overall Study||35
11034302|NCT00873093|12213837|FG002|COMPLETED|Overall Study||33
11034303|NCT00873093|12213838|FG003|COMPLETED|Overall Study||12
11034304|NCT00873093|12213839|FG004|COMPLETED|Overall Study||8
11034305|NCT00873093|12213835|FG000|NOT COMPLETED|Overall Study||1
11034306|NCT00873093|12213836|FG001|NOT COMPLETED|Overall Study||27
11034307|NCT00873093|12213837|FG002|NOT COMPLETED|Overall Study||16
11034308|NCT00873093|12213838|FG003|NOT COMPLETED|Overall Study||11
11034309|NCT00873093|12213839|FG004|NOT COMPLETED|Overall Study||2
11034310|NCT00873119|12213863|FG000|STARTED|Overall Study||44
11034311|NCT00873119|12213864|FG001|STARTED|Overall Study||45
11034312|NCT00873119|12213863|FG000|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
11034313|NCT00873119|12213864|FG001|COMPLETED|Overall Study||19
11034314|NCT00873119|12213863|FG000|NOT COMPLETED|Overall Study||44
11034315|NCT00873119|12213864|FG001|NOT COMPLETED|Overall Study||26
11034316|NCT00873327|12213870|FG000|STARTED|Overall Study||32
11034317|NCT00873327|12213870|FG000|COMPLETED|Overall Study||32
11034318|NCT00873327|12213870|FG000|NOT COMPLETED|Overall Study||0
11034319|NCT00873457|12213874|FG000|STARTED|Overall Study||16
11034320|NCT00873457|12213874|FG000|COMPLETED|Overall Study||16
11034321|NCT00873457|12213874|FG000|NOT COMPLETED|Overall Study||0
11034322|NCT00873730|12213880|FG000|STARTED|Overall Study||54
11034323|NCT00873730|12213881|FG001|STARTED|Overall Study||54
11034324|NCT00873730|12213880|FG000|COMPLETED|Overall Study||48
11034325|NCT00873730|12213881|FG001|COMPLETED|Overall Study||49
11034326|NCT00873730|12213880|FG000|NOT COMPLETED|Overall Study||6
11034327|NCT00873730|12213881|FG001|NOT COMPLETED|Overall Study||5
11034328|NCT00873782|12213887|FG000|STARTED|Overall Study||16
11034329|NCT00873782|12213887|FG000|COMPLETED|Overall Study||16
11034330|NCT00873782|12213887|FG000|NOT COMPLETED|Overall Study||0
11034331|NCT00873821|12213893|FG000|STARTED|Overall Study||22
11034332|NCT00873821|12213894|FG001|STARTED|Overall Study||22
11034333|NCT00873821|12213893|FG000|COMPLETED|Overall Study||22
11034334|NCT00873821|12213894|FG001|COMPLETED|Overall Study||22
11034335|NCT00873821|12213893|FG000|NOT COMPLETED|Overall Study||0
11034336|NCT00873821|12213894|FG001|NOT COMPLETED|Overall Study||0
11034337|NCT00873860|12213904|FG000|STARTED|Overall Study||48
11034338|NCT00873860|12213905|FG001|STARTED|Overall Study||47
11034339|NCT00873860|12213906|FG002|STARTED|Overall Study||51
11034340|NCT00873860|12213907|FG003|STARTED|Overall Study||48
11034341|NCT00873860|12213904|FG000|Treated|Overall Study||47
11034342|NCT00873860|12213905|FG001|Treated|Overall Study||47
11034343|NCT00873860|12213906|FG002|Treated|Overall Study||51
11034344|NCT00873860|12213907|FG003|Treated|Overall Study||48
11034345|NCT00873860|12213904|FG000|COMPLETED|Overall Study||44
11034346|NCT00873860|12213905|FG001|COMPLETED|Overall Study||47
11034347|NCT00873860|12213906|FG002|COMPLETED|Overall Study||48
11034348|NCT00873860|12213907|FG003|COMPLETED|Overall Study||47
11034349|NCT00873860|12213904|FG000|NOT COMPLETED|Overall Study||4
11034350|NCT00873860|12213905|FG001|NOT COMPLETED|Overall Study||0
11034351|NCT00873860|12213906|FG002|NOT COMPLETED|Overall Study||3
11034352|NCT00873860|12213907|FG003|NOT COMPLETED|Overall Study||1
11034353|NCT00873873|12213924|FG000|STARTED|Overall Study||20
11034354|NCT00873873|12213925|FG001|STARTED|Overall Study||8
11034355|NCT00873873|12213926|FG002|STARTED|Overall Study||9
11034356|NCT00873873|12213927|FG003|STARTED|Overall Study||18
11034357|NCT00873873|12213924|FG000|COMPLETED|Overall Study||20
11034358|NCT00873873|12213925|FG001|COMPLETED|Overall Study||8
11034359|NCT00873873|12213926|FG002|COMPLETED|Overall Study||9
11034360|NCT00873873|12213927|FG003|COMPLETED|Overall Study||18
11034361|NCT00873873|12213924|FG000|NOT COMPLETED|Overall Study||0
11034362|NCT00873873|12213925|FG001|NOT COMPLETED|Overall Study||0
11034363|NCT00873873|12213926|FG002|NOT COMPLETED|Overall Study||0
11034364|NCT00873873|12213927|FG003|NOT COMPLETED|Overall Study||0
11034365|NCT00873912|12213939|FG000|STARTED|Overall Study||240
11034366|NCT00873912|12213940|FG001|STARTED|Overall Study||60
11034367|NCT00873912|12213939|FG000|COMPLETED|Overall Study||237
11034368|NCT00873912|12213940|FG001|COMPLETED|Overall Study||60
11034369|NCT00873912|12213939|FG000|NOT COMPLETED|Overall Study||3
11034370|NCT00873912|12213940|FG001|NOT COMPLETED|Overall Study||0
11334737|NCT02854059|12532253|FG001|COMPLETED|Overall Study||0
11334738|NCT02854059|12532252|FG000|NOT COMPLETED|Overall Study||0
11334739|NCT02854059|12532253|FG001|NOT COMPLETED|Overall Study||0
11334740|NCT02854527|12532269|FG000|STARTED|Overall Study||3
11334741|NCT02854527|12532270|FG001|STARTED|Overall Study||3
11334742|NCT02854527|12532271|FG002|STARTED|Overall Study||3
11334743|NCT02854527|12532272|FG003|STARTED|Overall Study||3
11334744|NCT02854527|12532273|FG004|STARTED|Overall Study||3
11334745|NCT02854527|12532274|FG005|STARTED|Overall Study||3
11334746|NCT02854527|12532275|FG006|STARTED|Overall Study||3
11334747|NCT02854527|12532276|FG007|STARTED|Overall Study||3
11334748|NCT02854527|12532277|FG008|STARTED|Overall Study||3
11334749|NCT02854527|12532278|FG009|STARTED|Overall Study||3
11334750|NCT02854527|12532269|FG000|Received R1|Overall Study||3
11334751|NCT02854527|12532270|FG001|Received R1|Overall Study||3
11334752|NCT02854527|12532271|FG002|Received R1|Overall Study||3
11334753|NCT02854527|12532272|FG003|Received R1|Overall Study||2
11034371|NCT00874029|12213946|FG000|STARTED|Overall Study||137
11034372|NCT00874029|12213946|FG000|COMPLETED|Overall Study||116
11034373|NCT00874029|12213946|FG000|NOT COMPLETED|Overall Study||21
11034374|NCT00874094|12213960|FG000|STARTED|Overall Study||15
11034375|NCT00874094|12213960|FG000|COMPLETED|Overall Study||15
11034376|NCT00874094|12213960|FG000|NOT COMPLETED|Overall Study||0
11334754|NCT02854527|12532273|FG004|Received R1|Overall Study||2
11334755|NCT02854527|12532274|FG005|Received R1|Overall Study||3
11334756|NCT02854527|12532275|FG006|Received R1|Overall Study||3
11034377|NCT00874120|12213966|FG000|STARTED|First Intervention||58
11034378|NCT00874120|12213967|FG001|STARTED|First Intervention||58
11034379|NCT00874120|12213966|FG000|COMPLETED|First Intervention||52
11034380|NCT00874120|12213967|FG001|COMPLETED|First Intervention||56
11034381|NCT00874120|12213966|FG000|NOT COMPLETED|First Intervention||6
11034382|NCT00874120|12213967|FG001|NOT COMPLETED|First Intervention||2
11034383|NCT00874120|12213966|FG000|STARTED|Wash-out Period||52
11034384|NCT00874120|12213967|FG001|STARTED|Wash-out Period||56
11034385|NCT00874120|12213966|FG000|COMPLETED|Wash-out Period||52
11034386|NCT00874120|12213967|FG001|COMPLETED|Wash-out Period||56
11034387|NCT00874120|12213966|FG000|NOT COMPLETED|Wash-out Period||0
11034388|NCT00874120|12213967|FG001|NOT COMPLETED|Wash-out Period||0
11034389|NCT00874120|12213966|FG000|STARTED|Second Intervention||52
11034390|NCT00874120|12213967|FG001|STARTED|Second Intervention||56
11034391|NCT00874120|12213966|FG000|COMPLETED|Second Intervention||50
11034392|NCT00874120|12213967|FG001|COMPLETED|Second Intervention||56
11034393|NCT00874120|12213966|FG000|NOT COMPLETED|Second Intervention||2
11034394|NCT00874120|12213967|FG001|NOT COMPLETED|Second Intervention||0
11034395|NCT00874237|12213973|FG000|STARTED|Overall Study||8
11034396|NCT00874237|12213974|FG001|STARTED|Overall Study||8
11034397|NCT00874237|12213975|FG002|STARTED|Overall Study||8
11334757|NCT02854527|12532276|FG007|Received R1|Overall Study||3
11034398|NCT00874237|12213976|FG003|STARTED|Overall Study||8
11034399|NCT00874237|12213977|FG004|STARTED|Overall Study||8
11034400|NCT00874237|12213978|FG005|STARTED|Overall Study||8
11034401|NCT00874237|12213973|FG000|COMPLETED|Overall Study||8
11034402|NCT00874237|12213974|FG001|COMPLETED|Overall Study||7
11034403|NCT00874237|12213975|FG002|COMPLETED|Overall Study||7
11034404|NCT00874237|12213976|FG003|COMPLETED|Overall Study||8
11034405|NCT00874237|12213977|FG004|COMPLETED|Overall Study||8
11034406|NCT00874237|12213978|FG005|COMPLETED|Overall Study||8
11034407|NCT00874237|12213973|FG000|NOT COMPLETED|Overall Study||0
11034408|NCT00874237|12213974|FG001|NOT COMPLETED|Overall Study||1
11034409|NCT00874237|12213975|FG002|NOT COMPLETED|Overall Study||1
11034410|NCT00874237|12213976|FG003|NOT COMPLETED|Overall Study||0
11034411|NCT00874237|12213977|FG004|NOT COMPLETED|Overall Study||0
11034412|NCT00874237|12213978|FG005|NOT COMPLETED|Overall Study||0
11034413|NCT00874250|12213988|FG000|STARTED|Overall Study||51
11034414|NCT00874250|12213988|FG000|COMPLETED|Overall Study||0
11034415|NCT00874250|12213988|FG000|NOT COMPLETED|Overall Study||51
11034416|NCT00874276|12213995|FG000|STARTED|Overall Study||6
11034417|NCT00874276|12213996|FG001|STARTED|Overall Study||8
11034418|NCT00874276|12213995|FG000|COMPLETED|Overall Study||5
11034419|NCT00874276|12213996|FG001|COMPLETED|Overall Study||7
11034420|NCT00874276|12213995|FG000|NOT COMPLETED|Overall Study||1
11034421|NCT00874276|12213996|FG001|NOT COMPLETED|Overall Study||1
11034422|NCT00874432|12214008|FG000|STARTED|Overall Study||8
11034423|NCT00874432|12214009|FG001|STARTED|Overall Study||4
11034424|NCT00874432|12214010|FG002|STARTED|Overall Study||17
11034425|NCT00874432|12214011|FG003|STARTED|Overall Study||14
11034426|NCT00874432|12214008|FG000|COMPLETED|Overall Study||5
11034427|NCT00874432|12214009|FG001|COMPLETED|Overall Study||2
11034428|NCT00874432|12214010|FG002|COMPLETED|Overall Study||9
11034429|NCT00874432|12214011|FG003|COMPLETED|Overall Study||11
11034430|NCT00874432|12214008|FG000|NOT COMPLETED|Overall Study||3
11034431|NCT00874432|12214009|FG001|NOT COMPLETED|Overall Study||2
11034432|NCT00874432|12214010|FG002|NOT COMPLETED|Overall Study||8
11034433|NCT00874432|12214011|FG003|NOT COMPLETED|Overall Study||3
11034434|NCT00874497|12214025|FG000|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
11034435|NCT00874497|12214026|FG001|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
11034436|NCT00874497|12214025|FG000|COMPLETED|Overall Study||23
11034437|NCT00874497|12214026|FG001|COMPLETED|Overall Study||15
11034438|NCT00874497|12214025|FG000|NOT COMPLETED|Overall Study||28
11034439|NCT00874497|12214026|FG001|NOT COMPLETED|Overall Study||18
11034440|NCT00874510|12214034|FG000|STARTED|Year 1||88
11034441|NCT00874510|12214035|FG001|STARTED|Year 1||85
11034442|NCT00874510|12214034|FG000|COMPLETED|Year 1||88
11034443|NCT00874510|12214035|FG001|COMPLETED|Year 1||85
11034444|NCT00874510|12214034|FG000|NOT COMPLETED|Year 1||0
11034445|NCT00874510|12214035|FG001|NOT COMPLETED|Year 1||0
11034446|NCT00874510|12214034|FG000|STARTED|Year 2||92
11034447|NCT00874510|12214035|FG001|STARTED|Year 2||87
11034448|NCT00874510|12214034|FG000|COMPLETED|Year 2||92
11034449|NCT00874510|12214035|FG001|COMPLETED|Year 2||87
11034450|NCT00874510|12214034|FG000|NOT COMPLETED|Year 2||0
11034451|NCT00874510|12214035|FG001|NOT COMPLETED|Year 2||0
11034452|NCT00874549|12214045|FG000|STARTED|Overall Study||51
11034453|NCT00874549|12214046|FG001|STARTED|Overall Study||56
11034454|NCT00874549|12214047|FG002|STARTED|Overall Study||51
11034455|NCT00874549|12214048|FG003|STARTED|Overall Study||58
11034456|NCT00874549|12214045|FG000|COMPLETED|Overall Study||50
11034457|NCT00874549|12214046|FG001|COMPLETED|Overall Study||55
11034458|NCT00874549|12214047|FG002|COMPLETED|Overall Study||47
11034459|NCT00874549|12214048|FG003|COMPLETED|Overall Study||56
11034460|NCT00874549|12214045|FG000|NOT COMPLETED|Overall Study||1
11034461|NCT00874549|12214046|FG001|NOT COMPLETED|Overall Study||1
11034462|NCT00874549|12214047|FG002|NOT COMPLETED|Overall Study||4
11034463|NCT00874549|12214048|FG003|NOT COMPLETED|Overall Study||2
11034464|NCT00874614|12214058|FG000|STARTED|Overall Study||74
11034465|NCT00874614|12214058|FG000|Received at Least One Therapeutic Dose|Overall Study||68
11034466|NCT00874614|12214058|FG000|Received Two Therapeutic Doses|Overall Study||50
11034467|NCT00874614|12214058|FG000|COMPLETED|Overall Study|As of December 2017|16
11034468|NCT00874614|12214058|FG000|NOT COMPLETED|Overall Study||58
11034469|NCT00874731|12214064|FG000|STARTED|Part 1, Day 1: Placebo||23
11034470|NCT00874731|12214065|FG001|STARTED|Part 1, Day 1: Placebo||0
11034471|NCT00874731|12214066|FG002|STARTED|Part 1, Day 1: Placebo||0
11034472|NCT00874731|12214064|FG000|COMPLETED|Part 1, Day 1: Placebo||22
11034473|NCT00874731|12214065|FG001|COMPLETED|Part 1, Day 1: Placebo||0
11034474|NCT00874731|12214066|FG002|COMPLETED|Part 1, Day 1: Placebo||0
11034475|NCT00874731|12214064|FG000|NOT COMPLETED|Part 1, Day 1: Placebo||1
11034476|NCT00874731|12214065|FG001|NOT COMPLETED|Part 1, Day 1: Placebo||0
11034477|NCT00874731|12214066|FG002|NOT COMPLETED|Part 1, Day 1: Placebo||0
11034478|NCT00874731|12214064|FG000|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, enter into the Pt 1, Day 2. Ridaforolimus 100 mg arm."|0
11034479|NCT00874731|12214065|FG001|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, started this period in Pt 1, Day 2. Ridaforolimus 100 mg arm."|22
11034480|NCT00874731|12214066|FG002|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0
11034481|NCT00874731|12214064|FG000|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
11034482|NCT00874731|12214065|FG001|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22
11034483|NCT00874731|12214066|FG002|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
11034484|NCT00874731|12214064|FG000|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
11034485|NCT00874731|12214065|FG001|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
11034486|NCT00874731|12214066|FG002|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
11034487|NCT00874731|12214064|FG000|STARTED|Washout Period||0
11034488|NCT00874731|12214065|FG001|STARTED|Washout Period||22
11034489|NCT00874731|12214066|FG002|STARTED|Washout Period||0
11034490|NCT00874731|12214064|FG000|COMPLETED|Washout Period||0
11034491|NCT00874731|12214065|FG001|COMPLETED|Washout Period||22
11034492|NCT00874731|12214066|FG002|COMPLETED|Washout Period||0
11034493|NCT00874731|12214064|FG000|NOT COMPLETED|Washout Period||0
11334758|NCT02854527|12532277|FG008|Received R1|Overall Study||3
11334759|NCT02854527|12532278|FG009|Received R1|Overall Study||3
11334760|NCT02854527|12532269|FG000|Received R2|Overall Study||3
11334761|NCT02854527|12532270|FG001|Received R2|Overall Study||3
11334762|NCT02854527|12532271|FG002|Received R2|Overall Study||3
11334763|NCT02854527|12532272|FG003|Received R2|Overall Study||3
11334764|NCT02854527|12532273|FG004|Received R2|Overall Study||3
11334765|NCT02854527|12532274|FG005|Received R2|Overall Study||3
11334766|NCT02854527|12532275|FG006|Received R2|Overall Study||3
11034494|NCT00874731|12214065|FG001|NOT COMPLETED|Washout Period||0
11034495|NCT00874731|12214066|FG002|NOT COMPLETED|Washout Period||0
11034496|NCT00874731|12214064|FG000|STARTED|Part 2: Ridaforolimus 40 mg||0
11034497|NCT00874731|12214065|FG001|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, enter into the Pt 2. Ridaforolimus 40 mg arm."|0
11034498|NCT00874731|12214066|FG002|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, started this period in Pt 2. Ridaforolimus 40 mg arm."|22
11334767|NCT02854527|12532276|FG007|Received R2|Overall Study||3
11334768|NCT02854527|12532277|FG008|Received R2|Overall Study||3
11334769|NCT02854527|12532278|FG009|Received R2|Overall Study||3
11334770|NCT02854527|12532269|FG000|Received R3|Overall Study||3
11334771|NCT02854527|12532270|FG001|Received R3|Overall Study||3
11334772|NCT02854527|12532271|FG002|Received R3|Overall Study||3
11334773|NCT02854527|12532272|FG003|Received R3|Overall Study||2
11334774|NCT02854527|12532273|FG004|Received R3|Overall Study||3
11334775|NCT02854527|12532274|FG005|Received R3|Overall Study||3
11334776|NCT02854527|12532275|FG006|Received R3|Overall Study||3
11334777|NCT02854527|12532276|FG007|Received R3|Overall Study||3
11334778|NCT02854527|12532277|FG008|Received R3|Overall Study||3
11334779|NCT02854527|12532278|FG009|Received R3|Overall Study||3
11334780|NCT02854527|12532269|FG000|Received R4|Overall Study||3
11334781|NCT02854527|12532270|FG001|Received R4|Overall Study||3
11334782|NCT02854527|12532271|FG002|Received R4|Overall Study||3
11334783|NCT02854527|12532272|FG003|Received R4|Overall Study||2
11334784|NCT02854527|12532273|FG004|Received R4|Overall Study||3
11334785|NCT02854527|12532274|FG005|Received R4|Overall Study||3
11334786|NCT02854527|12532275|FG006|Received R4|Overall Study||3
11334787|NCT02854527|12532276|FG007|Received R4|Overall Study||3
11334788|NCT02854527|12532277|FG008|Received R4|Overall Study||3
11334789|NCT02854527|12532278|FG009|Received R4|Overall Study||3
11334790|NCT02854527|12532269|FG000|Received T|Overall Study||3
11334791|NCT02854527|12532270|FG001|Received T|Overall Study||3
11334792|NCT02854527|12532271|FG002|Received T|Overall Study||3
11334793|NCT02854527|12532272|FG003|Received T|Overall Study||2
11334794|NCT02854527|12532273|FG004|Received T|Overall Study||2
11334795|NCT02854527|12532274|FG005|Received T|Overall Study||3
11334796|NCT02854527|12532275|FG006|Received T|Overall Study||3
11334797|NCT02854527|12532276|FG007|Received T|Overall Study||3
11334798|NCT02854527|12532277|FG008|Received T|Overall Study||3
11334799|NCT02854527|12532278|FG009|Received T|Overall Study||3
11334800|NCT02854527|12532269|FG000|COMPLETED|Overall Study||3
11334801|NCT02854527|12532270|FG001|COMPLETED|Overall Study||3
11334802|NCT02854527|12532271|FG002|COMPLETED|Overall Study||3
11334803|NCT02854527|12532272|FG003|COMPLETED|Overall Study||2
11334804|NCT02854527|12532273|FG004|COMPLETED|Overall Study||2
11334805|NCT02854527|12532274|FG005|COMPLETED|Overall Study||3
11334806|NCT02854527|12532275|FG006|COMPLETED|Overall Study||3
11334807|NCT02854527|12532276|FG007|COMPLETED|Overall Study||3
11334808|NCT02854527|12532277|FG008|COMPLETED|Overall Study||3
11334809|NCT02854527|12532278|FG009|COMPLETED|Overall Study||3
11334810|NCT02854527|12532269|FG000|NOT COMPLETED|Overall Study||0
11334811|NCT02854527|12532270|FG001|NOT COMPLETED|Overall Study||0
11334812|NCT02854527|12532271|FG002|NOT COMPLETED|Overall Study||0
11334813|NCT02854527|12532272|FG003|NOT COMPLETED|Overall Study||1
11334814|NCT02854527|12532273|FG004|NOT COMPLETED|Overall Study||1
11334815|NCT02854527|12532274|FG005|NOT COMPLETED|Overall Study||0
11334816|NCT02854527|12532275|FG006|NOT COMPLETED|Overall Study||0
11334817|NCT02854527|12532276|FG007|NOT COMPLETED|Overall Study||0
11334818|NCT02854527|12532277|FG008|NOT COMPLETED|Overall Study||0
11334819|NCT02854527|12532278|FG009|NOT COMPLETED|Overall Study||0
11334820|NCT02854540|12532290|FG000|STARTED|Overall Study||13
11334821|NCT02854540|12532290|FG000|COMPLETED|Overall Study||11
11334822|NCT02854540|12532290|FG000|NOT COMPLETED|Overall Study||2
11334823|NCT02854605|12532299|FG000|STARTED|Overall Study||56
11334824|NCT02854605|12532300|FG001|STARTED|Overall Study||56
11334825|NCT02854605|12532301|FG002|STARTED|Overall Study||28
11334826|NCT02854605|12532299|FG000|COMPLETED|Overall Study||53
11334827|NCT02854605|12532300|FG001|COMPLETED|Overall Study||49
11334828|NCT02854605|12532301|FG002|COMPLETED|Overall Study||24
11334829|NCT02854605|12532299|FG000|NOT COMPLETED|Overall Study||3
11334830|NCT02854605|12532300|FG001|NOT COMPLETED|Overall Study||7
11334831|NCT02854605|12532301|FG002|NOT COMPLETED|Overall Study||4
11334832|NCT02854631|12532311|FG000|STARTED|Overall Study||52
11334833|NCT02854631|12532312|FG001|STARTED|Overall Study||52
11334834|NCT02854631|12532311|FG000|COMPLETED|Overall Study||26
11334835|NCT02854631|12532312|FG001|COMPLETED|Overall Study||37
11334836|NCT02854631|12532311|FG000|NOT COMPLETED|Overall Study||26
11334837|NCT02854631|12532312|FG001|NOT COMPLETED|Overall Study||15
11334838|NCT02854800|12532321|FG000|STARTED|Overall Study||32
11334839|NCT02854800|12532322|FG001|STARTED|Overall Study||28
11334840|NCT02854800|12532323|FG002|STARTED|Overall Study||14
11334841|NCT02854800|12532321|FG000|COMPLETED|Overall Study||12
11334842|NCT02854800|12532322|FG001|COMPLETED|Overall Study||15
11334843|NCT02854800|12532323|FG002|COMPLETED|Overall Study||8
11334844|NCT02854800|12532321|FG000|NOT COMPLETED|Overall Study||20
11334845|NCT02854800|12532322|FG001|NOT COMPLETED|Overall Study||13
11334846|NCT02854800|12532323|FG002|NOT COMPLETED|Overall Study||6
11334847|NCT02855086|12532336|FG000|STARTED|Overall Study||2
11334848|NCT02855086|12532337|FG001|STARTED|Overall Study||1
11334849|NCT02855086|12532336|FG000|COMPLETED|Overall Study||2
11334850|NCT02855086|12532337|FG001|COMPLETED|Overall Study||1
11334851|NCT02855086|12532336|FG000|NOT COMPLETED|Overall Study||0
11034499|NCT00874731|12214064|FG000|COMPLETED|Part 2: Ridaforolimus 40 mg||0
11034500|NCT00874731|12214065|FG001|COMPLETED|Part 2: Ridaforolimus 40 mg||0
11034501|NCT00874731|12214066|FG002|COMPLETED|Part 2: Ridaforolimus 40 mg||0
11034502|NCT00874731|12214064|FG000|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
11034503|NCT00874731|12214065|FG001|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
11034504|NCT00874731|12214066|FG002|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22
11034505|NCT00874770|12214078|FG000|STARTED|Overall Study||12
11034506|NCT00874770|12214079|FG001|STARTED|Overall Study||12
11034507|NCT00874770|12214080|FG002|STARTED|Overall Study||12
11034508|NCT00874770|12214081|FG003|STARTED|Overall Study||12
11034509|NCT00874770|12214078|FG000|COMPLETED|Overall Study||7
11034510|NCT00874770|12214079|FG001|COMPLETED|Overall Study||11
11034511|NCT00874770|12214080|FG002|COMPLETED|Overall Study||8
11034512|NCT00874770|12214081|FG003|COMPLETED|Overall Study||7
11034513|NCT00874770|12214078|FG000|NOT COMPLETED|Overall Study||5
11034514|NCT00874770|12214079|FG001|NOT COMPLETED|Overall Study||1
11034515|NCT00874770|12214080|FG002|NOT COMPLETED|Overall Study||4
11034516|NCT00874770|12214081|FG003|NOT COMPLETED|Overall Study||5
11034517|NCT00874822|12214101|FG000|STARTED|Overall Study||216
11034518|NCT00874822|12214101|FG000|COMPLETED|Overall Study||208
11034519|NCT00874822|12214101|FG000|NOT COMPLETED|Overall Study||8
11034520|NCT00874848|12214107|FG000|STARTED|Overall Study||59
11034521|NCT00874848|12214108|FG001|STARTED|Overall Study||29
11034522|NCT00874848|12214107|FG000|Discontinued|Overall Study||59
11034523|NCT00874848|12214108|FG001|Discontinued|Overall Study||28
11034524|NCT00874848|12214107|FG000|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
11034525|NCT00874848|12214108|FG001|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
11034526|NCT00874848|12214107|FG000|NOT COMPLETED|Overall Study||59
11034527|NCT00874848|12214108|FG001|NOT COMPLETED|Overall Study||28
11057568|NCT00998790|12239192|FG000|Participants Who Were Treated|Overall Study||113
11057569|NCT00998790|12239192|FG000|COMPLETED|Overall Study||93
11057570|NCT00998790|12239192|FG000|NOT COMPLETED|Overall Study||21
11057571|NCT00998868|12239196|FG000|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
11057572|NCT00998868|12239196|FG000|COMPLETED|Overall Study||51
11057573|NCT00998868|12239196|FG000|NOT COMPLETED|Overall Study||0
11057574|NCT00998881|12239202|FG000|STARTED|Overall Study||104
11057575|NCT00998881|12239203|FG001|STARTED|Overall Study||99
11057576|NCT00998881|12239202|FG000|COMPLETED|Overall Study||96
11057577|NCT00998881|12239203|FG001|COMPLETED|Overall Study||97
11057578|NCT00998881|12239202|FG000|NOT COMPLETED|Overall Study||8
11057579|NCT00998881|12239203|FG001|NOT COMPLETED|Overall Study||2
11057580|NCT00998946|12239209|FG000|STARTED|Overall Study||29
11057581|NCT00998946|12239209|FG000|Safety Population|Overall Study|Safety population included all participants who received at least 1 dose of the study drug.|27
11057582|NCT00998946|12239209|FG000|COMPLETED|Overall Study||20
11057583|NCT00998946|12239209|FG000|NOT COMPLETED|Overall Study||9
11057584|NCT00998985|12239227|FG000|STARTED|Overall Study||5
11334852|NCT02855086|12532337|FG001|NOT COMPLETED|Overall Study||0
11334853|NCT02855164|12532351|FG000|STARTED|Parts A + B (Randomized Set)||14
11034528|NCT00874887|12214116|FG000|STARTED|Overall Study||32
11034529|NCT00874887|12214117|FG001|STARTED|Overall Study||34
11034530|NCT00874887|12214116|FG000|COMPLETED|Overall Study||32
11034531|NCT00874887|12214117|FG001|COMPLETED|Overall Study||34
11034532|NCT00874887|12214116|FG000|NOT COMPLETED|Overall Study||0
11034533|NCT00874887|12214117|FG001|NOT COMPLETED|Overall Study||0
11034534|NCT00875017|12214129|FG000|STARTED|First Intervention||5
11034535|NCT00875017|12214130|FG001|STARTED|First Intervention||5
11034536|NCT00875017|12214131|FG002|STARTED|First Intervention||5
11034537|NCT00875017|12214132|FG003|STARTED|First Intervention||6
11034538|NCT00875017|12214133|FG004|STARTED|First Intervention||5
11034539|NCT00875017|12214134|FG005|STARTED|First Intervention||5
11034540|NCT00875017|12214129|FG000|COMPLETED|First Intervention||3
11034541|NCT00875017|12214130|FG001|COMPLETED|First Intervention||5
11034542|NCT00875017|12214131|FG002|COMPLETED|First Intervention||4
11034543|NCT00875017|12214132|FG003|COMPLETED|First Intervention||5
11034544|NCT00875017|12214133|FG004|COMPLETED|First Intervention||4
11034545|NCT00875017|12214134|FG005|COMPLETED|First Intervention||5
11034546|NCT00875017|12214129|FG000|NOT COMPLETED|First Intervention||2
11034547|NCT00875017|12214130|FG001|NOT COMPLETED|First Intervention||0
11034548|NCT00875017|12214131|FG002|NOT COMPLETED|First Intervention||1
11034549|NCT00875017|12214132|FG003|NOT COMPLETED|First Intervention||1
11034550|NCT00875017|12214133|FG004|NOT COMPLETED|First Intervention||1
11034551|NCT00875017|12214134|FG005|NOT COMPLETED|First Intervention||0
11034552|NCT00875017|12214129|FG000|STARTED|Washout||3
11034553|NCT00875017|12214130|FG001|STARTED|Washout||5
11034554|NCT00875017|12214131|FG002|STARTED|Washout||4
11034555|NCT00875017|12214132|FG003|STARTED|Washout||5
11034556|NCT00875017|12214133|FG004|STARTED|Washout||4
11034557|NCT00875017|12214134|FG005|STARTED|Washout||5
11034558|NCT00875017|12214129|FG000|COMPLETED|Washout||3
11034559|NCT00875017|12214130|FG001|COMPLETED|Washout||5
11034560|NCT00875017|12214131|FG002|COMPLETED|Washout||3
11034561|NCT00875017|12214132|FG003|COMPLETED|Washout||5
11034562|NCT00875017|12214133|FG004|COMPLETED|Washout||4
11034563|NCT00875017|12214134|FG005|COMPLETED|Washout||5
11034564|NCT00875017|12214129|FG000|NOT COMPLETED|Washout||0
11034565|NCT00875017|12214130|FG001|NOT COMPLETED|Washout||0
11034566|NCT00875017|12214131|FG002|NOT COMPLETED|Washout||1
11034567|NCT00875017|12214132|FG003|NOT COMPLETED|Washout||0
11034568|NCT00875017|12214133|FG004|NOT COMPLETED|Washout||0
11034569|NCT00875017|12214134|FG005|NOT COMPLETED|Washout||0
11034570|NCT00875017|12214129|FG000|STARTED|Second Intervention||3
11034571|NCT00875017|12214130|FG001|STARTED|Second Intervention||5
11034572|NCT00875017|12214131|FG002|STARTED|Second Intervention||3
11034573|NCT00875017|12214132|FG003|STARTED|Second Intervention||5
11034574|NCT00875017|12214133|FG004|STARTED|Second Intervention||4
11034575|NCT00875017|12214134|FG005|STARTED|Second Intervention||5
11034576|NCT00875017|12214129|FG000|COMPLETED|Second Intervention||3
11034577|NCT00875017|12214130|FG001|COMPLETED|Second Intervention||5
11034578|NCT00875017|12214131|FG002|COMPLETED|Second Intervention||3
11034579|NCT00875017|12214132|FG003|COMPLETED|Second Intervention||4
11034580|NCT00875017|12214133|FG004|COMPLETED|Second Intervention||4
11034581|NCT00875017|12214134|FG005|COMPLETED|Second Intervention||5
11034582|NCT00875017|12214129|FG000|NOT COMPLETED|Second Intervention||0
11034583|NCT00875017|12214130|FG001|NOT COMPLETED|Second Intervention||0
11034584|NCT00875017|12214131|FG002|NOT COMPLETED|Second Intervention||0
11034585|NCT00875017|12214132|FG003|NOT COMPLETED|Second Intervention||1
11034586|NCT00875017|12214133|FG004|NOT COMPLETED|Second Intervention||0
11034587|NCT00875017|12214134|FG005|NOT COMPLETED|Second Intervention||0
11034588|NCT00875017|12214129|FG000|STARTED|Washout||3
11034589|NCT00875017|12214130|FG001|STARTED|Washout||5
11034590|NCT00875017|12214131|FG002|STARTED|Washout||3
11034591|NCT00875017|12214132|FG003|STARTED|Washout||4
11034592|NCT00875017|12214133|FG004|STARTED|Washout||4
11034593|NCT00875017|12214134|FG005|STARTED|Washout||5
11034594|NCT00875017|12214129|FG000|COMPLETED|Washout||3
11034595|NCT00875017|12214130|FG001|COMPLETED|Washout||4
11034596|NCT00875017|12214131|FG002|COMPLETED|Washout||3
11034597|NCT00875017|12214132|FG003|COMPLETED|Washout||4
11034598|NCT00875017|12214133|FG004|COMPLETED|Washout||4
11034599|NCT00875017|12214134|FG005|COMPLETED|Washout||5
11034600|NCT00875017|12214129|FG000|NOT COMPLETED|Washout||0
11034601|NCT00875017|12214130|FG001|NOT COMPLETED|Washout||1
11034602|NCT00875017|12214131|FG002|NOT COMPLETED|Washout||0
11034603|NCT00875017|12214132|FG003|NOT COMPLETED|Washout||0
11034604|NCT00875017|12214133|FG004|NOT COMPLETED|Washout||0
11034605|NCT00875017|12214134|FG005|NOT COMPLETED|Washout||0
11034606|NCT00875017|12214129|FG000|STARTED|Third Intervention||3
11034607|NCT00875017|12214130|FG001|STARTED|Third Intervention||4
11034608|NCT00875017|12214131|FG002|STARTED|Third Intervention||3
11034609|NCT00875017|12214132|FG003|STARTED|Third Intervention||4
11034610|NCT00875017|12214133|FG004|STARTED|Third Intervention||4
11034611|NCT00875017|12214134|FG005|STARTED|Third Intervention||5
11034612|NCT00875017|12214129|FG000|COMPLETED|Third Intervention||3
11034613|NCT00875017|12214130|FG001|COMPLETED|Third Intervention||3
11034614|NCT00875017|12214131|FG002|COMPLETED|Third Intervention||2
11034615|NCT00875017|12214132|FG003|COMPLETED|Third Intervention||4
11034616|NCT00875017|12214133|FG004|COMPLETED|Third Intervention||4
11034617|NCT00875017|12214134|FG005|COMPLETED|Third Intervention||5
11034618|NCT00875017|12214129|FG000|NOT COMPLETED|Third Intervention||0
11034619|NCT00875017|12214130|FG001|NOT COMPLETED|Third Intervention||1
11034620|NCT00875017|12214131|FG002|NOT COMPLETED|Third Intervention||1
11034621|NCT00875017|12214132|FG003|NOT COMPLETED|Third Intervention||0
11034622|NCT00875017|12214133|FG004|NOT COMPLETED|Third Intervention||0
11034623|NCT00875017|12214134|FG005|NOT COMPLETED|Third Intervention||0
11034624|NCT00875017|12214129|FG000|STARTED|Washout||3
11034625|NCT00875017|12214130|FG001|STARTED|Washout||3
11034626|NCT00875017|12214131|FG002|STARTED|Washout||2
11034627|NCT00875017|12214132|FG003|STARTED|Washout||4
11034628|NCT00875017|12214133|FG004|STARTED|Washout||4
11034629|NCT00875017|12214134|FG005|STARTED|Washout||5
11034630|NCT00875017|12214129|FG000|COMPLETED|Washout||3
11034631|NCT00875017|12214130|FG001|COMPLETED|Washout||3
11034632|NCT00875017|12214131|FG002|COMPLETED|Washout||2
11034633|NCT00875017|12214132|FG003|COMPLETED|Washout||4
11034634|NCT00875017|12214133|FG004|COMPLETED|Washout||3
11034635|NCT00875017|12214134|FG005|COMPLETED|Washout||5
11034636|NCT00875017|12214129|FG000|NOT COMPLETED|Washout||0
11034637|NCT00875017|12214130|FG001|NOT COMPLETED|Washout||0
11034638|NCT00875017|12214131|FG002|NOT COMPLETED|Washout||0
11034639|NCT00875017|12214132|FG003|NOT COMPLETED|Washout||0
11034640|NCT00875017|12214133|FG004|NOT COMPLETED|Washout||1
11034641|NCT00875017|12214134|FG005|NOT COMPLETED|Washout||0
11034642|NCT00875017|12214129|FG000|STARTED|Fourth Intervention||3
11034643|NCT00875017|12214130|FG001|STARTED|Fourth Intervention||3
11034644|NCT00875017|12214131|FG002|STARTED|Fourth Intervention||2
11034645|NCT00875017|12214132|FG003|STARTED|Fourth Intervention||4
11034646|NCT00875017|12214133|FG004|STARTED|Fourth Intervention||3
11034647|NCT00875017|12214134|FG005|STARTED|Fourth Intervention||5
11034648|NCT00875017|12214129|FG000|COMPLETED|Fourth Intervention||3
11034649|NCT00875017|12214130|FG001|COMPLETED|Fourth Intervention||3
11034650|NCT00875017|12214131|FG002|COMPLETED|Fourth Intervention||2
11034651|NCT00875017|12214132|FG003|COMPLETED|Fourth Intervention||4
11034652|NCT00875017|12214133|FG004|COMPLETED|Fourth Intervention||3
11034653|NCT00875017|12214134|FG005|COMPLETED|Fourth Intervention||4
11034654|NCT00875017|12214129|FG000|NOT COMPLETED|Fourth Intervention||0
11034655|NCT00875017|12214130|FG001|NOT COMPLETED|Fourth Intervention||0
11034656|NCT00875017|12214131|FG002|NOT COMPLETED|Fourth Intervention||0
11034657|NCT00875017|12214132|FG003|NOT COMPLETED|Fourth Intervention||0
11034658|NCT00875017|12214133|FG004|NOT COMPLETED|Fourth Intervention||0
11034659|NCT00875017|12214134|FG005|NOT COMPLETED|Fourth Intervention||1
11034660|NCT00875056|12214150|FG000|STARTED|Overall Study||39
11034661|NCT00875056|12214151|FG001|STARTED|Overall Study||11
11034662|NCT00875056|12214152|FG002|STARTED|Overall Study||6
11034663|NCT00875056|12214150|FG000|COMPLETED|Overall Study||16
11034664|NCT00875056|12214151|FG001|COMPLETED|Overall Study||2
11034665|NCT00875056|12214152|FG002|COMPLETED|Overall Study||0
11034666|NCT00875056|12214150|FG000|NOT COMPLETED|Overall Study||23
11034667|NCT00875056|12214151|FG001|NOT COMPLETED|Overall Study||9
11034668|NCT00875056|12214152|FG002|NOT COMPLETED|Overall Study||6
11034669|NCT00875212|12214160|FG000|STARTED|Placebo Dentifrice||12
11034670|NCT00875212|12214160|FG000|COMPLETED|Placebo Dentifrice|all participants completed this group|12
11034671|NCT00875212|12214160|FG000|NOT COMPLETED|Placebo Dentifrice||0
11034672|NCT00875212|12214160|FG000|STARTED|CaGP Only Dentifrice||12
11034673|NCT00875212|12214160|FG000|COMPLETED|CaGP Only Dentifrice||12
11034674|NCT00875212|12214160|FG000|NOT COMPLETED|CaGP Only Dentifrice||0
11034675|NCT00875212|12214160|FG000|STARTED|Fluoride Only Dentifrice||12
11034676|NCT00875212|12214160|FG000|COMPLETED|Fluoride Only Dentifrice||12
11034677|NCT00875212|12214160|FG000|NOT COMPLETED|Fluoride Only Dentifrice||0
11034678|NCT00875212|12214160|FG000|STARTED|CaGP and Fluoride Dentifrice||12
11034679|NCT00875212|12214160|FG000|COMPLETED|CaGP and Fluoride Dentifrice||12
11034680|NCT00875212|12214160|FG000|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
11034681|NCT00875277|12214171|FG000|STARTED|Overall Study||24
11034682|NCT00875277|12214171|FG000|COMPLETED|Overall Study||24
11034683|NCT00875277|12214171|FG000|NOT COMPLETED|Overall Study||0
11034684|NCT00875329|12214182|FG000|STARTED|Overall Study||97
11034685|NCT00875329|12214182|FG000|COMPLETED|Overall Study||97
11034686|NCT00875329|12214182|FG000|NOT COMPLETED|Overall Study||0
11034687|NCT00875342|12214188|FG000|STARTED|Overall Study||20
11034688|NCT00875342|12214189|FG001|STARTED|Overall Study||21
11034689|NCT00875342|12214188|FG000|COMPLETED|Overall Study||16
11034690|NCT00875342|12214189|FG001|COMPLETED|Overall Study||16
11034691|NCT00875342|12214188|FG000|NOT COMPLETED|Overall Study||4
11034692|NCT00875342|12214189|FG001|NOT COMPLETED|Overall Study||5
11034693|NCT00875420|12214200|FG000|STARTED|Overall Study||22
11034694|NCT00875420|12214201|FG001|STARTED|Overall Study||20
11034695|NCT00875420|12214202|FG002|STARTED|Overall Study||21
11034696|NCT00875420|12214203|FG003|STARTED|Overall Study||18
11034697|NCT00875420|12214204|FG004|STARTED|Overall Study||19
11034698|NCT00875420|12214200|FG000|COMPLETED|Overall Study||20
11034699|NCT00875420|12214201|FG001|COMPLETED|Overall Study||18
11034700|NCT00875420|12214202|FG002|COMPLETED|Overall Study||18
11034701|NCT00875420|12214203|FG003|COMPLETED|Overall Study||16
11034702|NCT00875420|12214204|FG004|COMPLETED|Overall Study||17
11034703|NCT00875420|12214200|FG000|NOT COMPLETED|Overall Study||2
11034704|NCT00875420|12214201|FG001|NOT COMPLETED|Overall Study||2
11034705|NCT00875420|12214202|FG002|NOT COMPLETED|Overall Study||3
11034706|NCT00875420|12214203|FG003|NOT COMPLETED|Overall Study||2
11034707|NCT00875420|12214204|FG004|NOT COMPLETED|Overall Study||2
11034708|NCT00875433|12214216|FG000|STARTED|Overall Study|Treated|60
11034709|NCT00875433|12214216|FG000|COMPLETED|Overall Study||0
11034710|NCT00875433|12214216|FG000|NOT COMPLETED|Overall Study||60
11034711|NCT00875485|12214222|FG000|STARTED|Year 11||99
11034712|NCT00875485|12214223|FG001|STARTED|Year 11||111
11034713|NCT00875485|12214222|FG000|COMPLETED|Year 11||99
11034714|NCT00875485|12214223|FG001|COMPLETED|Year 11||111
11034715|NCT00875485|12214222|FG000|NOT COMPLETED|Year 11||0
11034716|NCT00875485|12214223|FG001|NOT COMPLETED|Year 11||0
11034717|NCT00875485|12214222|FG000|STARTED|Year 12||101
11034718|NCT00875485|12214223|FG001|STARTED|Year 12||109
11034719|NCT00875485|12214222|FG000|COMPLETED|Year 12||101
11034720|NCT00875485|12214223|FG001|COMPLETED|Year 12||109
11034721|NCT00875485|12214222|FG000|NOT COMPLETED|Year 12||0
11034722|NCT00875485|12214223|FG001|NOT COMPLETED|Year 12||0
11034723|NCT00875485|12214222|FG000|STARTED|Year 13||102
11034724|NCT00875485|12214223|FG001|STARTED|Year 13||113
11034725|NCT00875485|12214222|FG000|COMPLETED|Year 13||102
11034726|NCT00875485|12214223|FG001|COMPLETED|Year 13||113
11034727|NCT00875485|12214222|FG000|NOT COMPLETED|Year 13||0
11034728|NCT00875485|12214223|FG001|NOT COMPLETED|Year 13||0
11034729|NCT00875485|12214222|FG000|STARTED|Year 14||100
11034730|NCT00875485|12214223|FG001|STARTED|Year 14||113
11034731|NCT00875485|12214222|FG000|COMPLETED|Year 14||100
11034732|NCT00875485|12214223|FG001|COMPLETED|Year 14||113
11034733|NCT00875485|12214222|FG000|NOT COMPLETED|Year 14||0
11034734|NCT00875485|12214223|FG001|NOT COMPLETED|Year 14||0
11034735|NCT00875485|12214222|FG000|STARTED|Year 15||98
11034736|NCT00875485|12214223|FG001|STARTED|Year 15||111
11034737|NCT00875485|12214222|FG000|COMPLETED|Year 15||98
11034738|NCT00875485|12214223|FG001|COMPLETED|Year 15||111
11034739|NCT00875485|12214222|FG000|NOT COMPLETED|Year 15||0
11034740|NCT00875485|12214223|FG001|NOT COMPLETED|Year 15||0
11034741|NCT00875485|12214222|FG000|STARTED|Challenge Dose Epoch||8
11034742|NCT00875485|12214223|FG001|STARTED|Challenge Dose Epoch||11
11034743|NCT00875485|12214222|FG000|COMPLETED|Challenge Dose Epoch||7
11034744|NCT00875485|12214223|FG001|COMPLETED|Challenge Dose Epoch||11
11034745|NCT00875485|12214222|FG000|NOT COMPLETED|Challenge Dose Epoch||1
11034746|NCT00875485|12214223|FG001|NOT COMPLETED|Challenge Dose Epoch||0
11034747|NCT00875550|12214231|FG000|STARTED|Overall Study||89
11034748|NCT00875550|12214232|FG001|STARTED|Overall Study||86
11034749|NCT00875550|12214231|FG000|COMPLETED|Overall Study||77
11034750|NCT00875550|12214232|FG001|COMPLETED|Overall Study||76
11034751|NCT00875550|12214231|FG000|NOT COMPLETED|Overall Study||12
11034752|NCT00875550|12214232|FG001|NOT COMPLETED|Overall Study||10
11034753|NCT00875563|12214240|FG000|STARTED|Overall Study||42
11034754|NCT00875563|12214240|FG000|COMPLETED|Overall Study||18
11034755|NCT00875563|12214240|FG000|NOT COMPLETED|Overall Study||24
11034756|NCT00875589|12214246|FG000|STARTED|Overall Study||15
11034757|NCT00875589|12214247|FG001|STARTED|Overall Study||11
11034758|NCT00875589|12214246|FG000|COMPLETED|Overall Study||15
11034759|NCT00875589|12214247|FG001|COMPLETED|Overall Study||11
11034760|NCT00875589|12214246|FG000|NOT COMPLETED|Overall Study||0
11034761|NCT00875589|12214247|FG001|NOT COMPLETED|Overall Study||0
11034762|NCT00875615|12214253|FG000|STARTED|Overall Study||11
11034763|NCT00875615|12214253|FG000|COMPLETED|Overall Study||10
11034764|NCT00875615|12214253|FG000|NOT COMPLETED|Overall Study||1
11034765|NCT00875641|12214260|FG000|STARTED|Overall Study||57931
11034766|NCT00875641|12214261|FG001|STARTED|Overall Study||173384
11034767|NCT00875641|12214262|FG002|STARTED|Overall Study||159344
11034768|NCT00875641|12214260|FG000|COMPLETED|Overall Study||57931
11034769|NCT00875641|12214261|FG001|COMPLETED|Overall Study||173384
11034770|NCT00875641|12214262|FG002|COMPLETED|Overall Study||159344
11034771|NCT00875641|12214260|FG000|NOT COMPLETED|Overall Study||0
11034772|NCT00875641|12214261|FG001|NOT COMPLETED|Overall Study||0
11034773|NCT00875641|12214262|FG002|NOT COMPLETED|Overall Study||0
11334854|NCT02855164|12532352|FG001|STARTED|Parts A + B (Randomized Set)||16
11334855|NCT02855164|12532353|FG002|STARTED|Parts A + B (Randomized Set)||37
11334856|NCT02855164|12532354|FG003|STARTED|Parts A + B (Randomized Set)||85
11334857|NCT02855164|12532355|FG004|STARTED|Parts A + B (Randomized Set)||46
11334858|NCT02855164|12532356|FG005|STARTED|Parts A + B (Randomized Set)||0
11334859|NCT02855164|12532357|FG006|STARTED|Parts A + B (Randomized Set)||0
11334860|NCT02855164|12532358|FG007|STARTED|Parts A + B (Randomized Set)||0
11334861|NCT02855164|12532351|FG000|COMPLETED|Parts A + B (Randomized Set)||14
11334862|NCT02855164|12532352|FG001|COMPLETED|Parts A + B (Randomized Set)||16
11334863|NCT02855164|12532353|FG002|COMPLETED|Parts A + B (Randomized Set)||36
11334864|NCT02855164|12532354|FG003|COMPLETED|Parts A + B (Randomized Set)||77
11334865|NCT02855164|12532355|FG004|COMPLETED|Parts A + B (Randomized Set)||45
11334866|NCT02855164|12532356|FG005|COMPLETED|Parts A + B (Randomized Set)||0
11334867|NCT02855164|12532357|FG006|COMPLETED|Parts A + B (Randomized Set)||0
11334868|NCT02855164|12532358|FG007|COMPLETED|Parts A + B (Randomized Set)||0
11334869|NCT02855164|12532351|FG000|NOT COMPLETED|Parts A + B (Randomized Set)||0
11334870|NCT02855164|12532352|FG001|NOT COMPLETED|Parts A + B (Randomized Set)||0
11334871|NCT02855164|12532353|FG002|NOT COMPLETED|Parts A + B (Randomized Set)||1
11334872|NCT02855164|12532354|FG003|NOT COMPLETED|Parts A + B (Randomized Set)||8
11334873|NCT02855164|12532355|FG004|NOT COMPLETED|Parts A + B (Randomized Set)||1
11034774|NCT00875667|12214272|FG000|STARTED|Overall Study||170
11034775|NCT00875667|12214273|FG001|STARTED|Overall Study||84
11034776|NCT00875667|12214272|FG000|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0
11034777|NCT00875667|12214273|FG001|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40
11034778|NCT00875667|12214272|FG000|Participants Treated|Overall Study||167
11034779|NCT00875667|12214273|FG001|Participants Treated|Overall Study||83
11034780|NCT00875667|12214272|FG000|COMPLETED|Overall Study||0
11034781|NCT00875667|12214273|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11
11034782|NCT00875667|12214272|FG000|NOT COMPLETED|Overall Study||170
11034783|NCT00875667|12214273|FG001|NOT COMPLETED|Overall Study||73
11034784|NCT00875706|12214282|FG000|STARTED|Overall Study||8
11034785|NCT00875706|12214283|FG001|STARTED|Overall Study||24
11034786|NCT00875706|12214284|FG002|STARTED|Overall Study||13
11034787|NCT00875706|12214282|FG000|COMPLETED|Overall Study||7
11034788|NCT00875706|12214283|FG001|COMPLETED|Overall Study||24
11034789|NCT00875706|12214284|FG002|COMPLETED|Overall Study||13
11034790|NCT00875706|12214282|FG000|NOT COMPLETED|Overall Study||1
11034791|NCT00875706|12214283|FG001|NOT COMPLETED|Overall Study||0
11034792|NCT00875706|12214284|FG002|NOT COMPLETED|Overall Study||0
11034793|NCT00875797|12214294|FG000|STARTED|Overall Study||45
11034794|NCT00875797|12214295|FG001|STARTED|Overall Study||45
11034795|NCT00875797|12214294|FG000|COMPLETED|Overall Study||39
11034796|NCT00875797|12214295|FG001|COMPLETED|Overall Study||42
11034797|NCT00875797|12214294|FG000|NOT COMPLETED|Overall Study||6
11034798|NCT00875797|12214295|FG001|NOT COMPLETED|Overall Study||3
11034799|NCT00875810|12214304|FG000|STARTED|Overall Study||194
11034800|NCT00875810|12214304|FG000|Implanted|Overall Study||190
11034801|NCT00875810|12214304|FG000|Discharged|Overall Study||177
11034802|NCT00875810|12214304|FG000|3 Months Follow up|Overall Study||175
11034803|NCT00875810|12214304|FG000|6 Months Follow up|Overall Study||80
11034804|NCT00875810|12214304|FG000|12 Months Follow up|Overall Study||112
11034805|NCT00875810|12214304|FG000|24 Months Follow up|Overall Study||148
11034806|NCT00875810|12214304|FG000|COMPLETED|Overall Study||148
11034807|NCT00875810|12214304|FG000|NOT COMPLETED|Overall Study||46
11034808|NCT00875836|12214310|FG000|STARTED|Overall Study||88
11034809|NCT00875836|12214311|FG001|STARTED|Overall Study||87
11034810|NCT00875836|12214310|FG000|COMPLETED|Overall Study||45
11034811|NCT00875836|12214311|FG001|COMPLETED|Overall Study||47
11034812|NCT00875836|12214310|FG000|NOT COMPLETED|Overall Study||43
11034813|NCT00875836|12214311|FG001|NOT COMPLETED|Overall Study||40
11034814|NCT00875979|12214319|FG000|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
11034815|NCT00875979|12214320|FG001|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
11034816|NCT00875979|12214319|FG000|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
11034817|NCT00875979|12214320|FG001|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
11034818|NCT00875979|12214319|FG000|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
11034819|NCT00875979|12214320|FG001|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
11034820|NCT00875979|12214319|FG000|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
11034821|NCT00875979|12214320|FG001|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
11034822|NCT00875979|12214319|FG000|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
11034823|NCT00875979|12214320|FG001|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
11034824|NCT00875979|12214319|FG000|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
11034825|NCT00875979|12214320|FG001|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
11034826|NCT00875979|12214319|FG000|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
11034827|NCT00875979|12214320|FG001|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
11034828|NCT00875979|12214319|FG000|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
11034829|NCT00875979|12214320|FG001|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
11034830|NCT00875979|12214319|FG000|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
11034831|NCT00875979|12214320|FG001|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
11034832|NCT00876018|12214329|FG000|STARTED|Overall Study||100
11034833|NCT00876018|12214330|FG001|STARTED|Overall Study||100
11034834|NCT00876018|12214331|FG002|STARTED|Overall Study||100
11034835|NCT00876018|12214329|FG000|COMPLETED|Overall Study||95
11034836|NCT00876018|12214330|FG001|COMPLETED|Overall Study||95
11034837|NCT00876018|12214331|FG002|COMPLETED|Overall Study||97
11034838|NCT00876018|12214329|FG000|NOT COMPLETED|Overall Study||5
11034839|NCT00876018|12214330|FG001|NOT COMPLETED|Overall Study||5
11034840|NCT00876018|12214331|FG002|NOT COMPLETED|Overall Study||3
11034841|NCT00876187|12214346|FG000|STARTED|Overall Study||233
11034842|NCT00876187|12214347|FG001|STARTED|Overall Study||233
11034843|NCT00876187|12214348|FG002|STARTED|Overall Study||298
11034844|NCT00876187|12214349|FG003|STARTED|Overall Study||297
11034845|NCT00876187|12214350|FG004|STARTED|Overall Study||298
11034846|NCT00876187|12214346|FG000|Treated|Overall Study||230
11034847|NCT00876187|12214347|FG001|Treated|Overall Study||232
11034848|NCT00876187|12214348|FG002|Treated|Overall Study||295
11034849|NCT00876187|12214349|FG003|Treated|Overall Study||295
11034850|NCT00876187|12214350|FG004|Treated|Overall Study||295
11034851|NCT00876187|12214346|FG000|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|128
11034852|NCT00876187|12214347|FG001|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|146
11034853|NCT00876187|12214348|FG002|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|193
11034854|NCT00876187|12214349|FG003|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|188
11034855|NCT00876187|12214350|FG004|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|185
11034856|NCT00876187|12214346|FG000|COMPLETED|Overall Study||23
11034857|NCT00876187|12214347|FG001|COMPLETED|Overall Study||18
11034858|NCT00876187|12214348|FG002|COMPLETED|Overall Study||19
11034859|NCT00876187|12214349|FG003|COMPLETED|Overall Study||22
11034860|NCT00876187|12214350|FG004|COMPLETED|Overall Study||27
11034861|NCT00876187|12214346|FG000|NOT COMPLETED|Overall Study||210
11034862|NCT00876187|12214347|FG001|NOT COMPLETED|Overall Study||215
11034863|NCT00876187|12214348|FG002|NOT COMPLETED|Overall Study||279
11034864|NCT00876187|12214349|FG003|NOT COMPLETED|Overall Study||275
11034865|NCT00876187|12214350|FG004|NOT COMPLETED|Overall Study||271
11034866|NCT00876200|12214367|FG000|STARTED|Overall Study||9
11034867|NCT00876200|12214368|FG001|STARTED|Overall Study||12
11034868|NCT00876200|12214367|FG000|COMPLETED|Overall Study||8
11034869|NCT00876200|12214368|FG001|COMPLETED|Overall Study||9
11034870|NCT00876200|12214367|FG000|NOT COMPLETED|Overall Study||1
11034871|NCT00876200|12214368|FG001|NOT COMPLETED|Overall Study||3
11034872|NCT00876265|12214374|FG000|STARTED|Overall Study||118
11034873|NCT00876265|12214374|FG000|COMPLETED|Overall Study||106
11034874|NCT00876265|12214374|FG000|NOT COMPLETED|Overall Study||12
11034875|NCT00876343|12214383|FG000|STARTED|Overall Study||194
11034876|NCT00876343|12214384|FG001|STARTED|Overall Study||197
11034877|NCT00876343|12214385|FG002|STARTED|Overall Study||195
11034878|NCT00876343|12214383|FG000|COMPLETED|Overall Study||177
11034879|NCT00876343|12214384|FG001|COMPLETED|Overall Study||180
11034880|NCT00876343|12214385|FG002|COMPLETED|Overall Study||183
11034881|NCT00876343|12214383|FG000|NOT COMPLETED|Overall Study||17
11034882|NCT00876343|12214384|FG001|NOT COMPLETED|Overall Study||17
11034883|NCT00876343|12214385|FG002|NOT COMPLETED|Overall Study||12
11034884|NCT00876395|12214395|FG000|STARTED|Overall Study||480
11034885|NCT00876395|12214396|FG001|STARTED|Overall Study||239
11034886|NCT00876395|12214395|FG000|Untreated|Overall Study||8
11034887|NCT00876395|12214396|FG001|Untreated|Overall Study||1
11034888|NCT00876395|12214395|FG000|COMPLETED|Overall Study||0
11034889|NCT00876395|12214396|FG001|COMPLETED|Overall Study||0
11034890|NCT00876395|12214395|FG000|NOT COMPLETED|Overall Study||480
11034891|NCT00876395|12214396|FG001|NOT COMPLETED|Overall Study||239
11034892|NCT00876447|12214409|FG000|STARTED|Overall Study||185
11034893|NCT00876447|12214410|FG001|STARTED|Overall Study||203
11034894|NCT00876447|12214409|FG000|COMPLETED|Overall Study||105
11343849|NCT02956486|12541122|FG000|NOT COMPLETED|Core Phase||1079
11034895|NCT00876447|12214410|FG001|COMPLETED|Overall Study||122
11034896|NCT00876447|12214409|FG000|NOT COMPLETED|Overall Study||80
11034897|NCT00876447|12214410|FG001|NOT COMPLETED|Overall Study||81
11034898|NCT00876460|12214448|FG000|STARTED|Combination Therapy Phase||3
11034899|NCT00876460|12214449|FG001|STARTED|Combination Therapy Phase||7
11034900|NCT00876460|12214450|FG002|STARTED|Combination Therapy Phase||3
11034901|NCT00876460|12214451|FG003|STARTED|Combination Therapy Phase||6
11034902|NCT00876460|12214452|FG004|STARTED|Combination Therapy Phase||7
11034903|NCT00876460|12214453|FG005|STARTED|Combination Therapy Phase||3
11034904|NCT00876460|12214454|FG006|STARTED|Combination Therapy Phase||8
11034905|NCT00876460|12214455|FG007|STARTED|Combination Therapy Phase||6
11034906|NCT00876460|12214448|FG000|COMPLETED|Combination Therapy Phase||0
11034907|NCT00876460|12214449|FG001|COMPLETED|Combination Therapy Phase||0
11034908|NCT00876460|12214450|FG002|COMPLETED|Combination Therapy Phase||0
11034909|NCT00876460|12214451|FG003|COMPLETED|Combination Therapy Phase||0
11034910|NCT00876460|12214452|FG004|COMPLETED|Combination Therapy Phase||0
11034911|NCT00876460|12214453|FG005|COMPLETED|Combination Therapy Phase||0
11034912|NCT00876460|12214454|FG006|COMPLETED|Combination Therapy Phase||0
11034913|NCT00876460|12214455|FG007|COMPLETED|Combination Therapy Phase||0
11034914|NCT00876460|12214448|FG000|NOT COMPLETED|Combination Therapy Phase||3
11034915|NCT00876460|12214449|FG001|NOT COMPLETED|Combination Therapy Phase||7
11034916|NCT00876460|12214450|FG002|NOT COMPLETED|Combination Therapy Phase||3
11034917|NCT00876460|12214451|FG003|NOT COMPLETED|Combination Therapy Phase||6
11034918|NCT00876460|12214452|FG004|NOT COMPLETED|Combination Therapy Phase||7
11034919|NCT00876460|12214453|FG005|NOT COMPLETED|Combination Therapy Phase||3
11034920|NCT00876460|12214454|FG006|NOT COMPLETED|Combination Therapy Phase||8
11034921|NCT00876460|12214455|FG007|NOT COMPLETED|Combination Therapy Phase||6
11034922|NCT00876460|12214448|FG000|STARTED|Mono Therapy Phase||0
11034923|NCT00876460|12214449|FG001|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
11034924|NCT00876460|12214450|FG002|STARTED|Mono Therapy Phase||0
11034925|NCT00876460|12214451|FG003|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
11034926|NCT00876460|12214452|FG004|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
11034927|NCT00876460|12214453|FG005|STARTED|Mono Therapy Phase||0
11034928|NCT00876460|12214454|FG006|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
11205226|NCT01857869|12395949|FG009|NOT COMPLETED|Booster/Rechallenge Phase||0
11034929|NCT00876460|12214455|FG007|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
11034930|NCT00876460|12214448|FG000|COMPLETED|Mono Therapy Phase||0
11034931|NCT00876460|12214449|FG001|COMPLETED|Mono Therapy Phase||0
11034932|NCT00876460|12214450|FG002|COMPLETED|Mono Therapy Phase||0
11034933|NCT00876460|12214451|FG003|COMPLETED|Mono Therapy Phase||0
11034934|NCT00876460|12214452|FG004|COMPLETED|Mono Therapy Phase||0
11034935|NCT00876460|12214453|FG005|COMPLETED|Mono Therapy Phase||0
11034936|NCT00876460|12214454|FG006|COMPLETED|Mono Therapy Phase||0
11034937|NCT00876460|12214455|FG007|COMPLETED|Mono Therapy Phase||0
11034938|NCT00876460|12214448|FG000|NOT COMPLETED|Mono Therapy Phase||0
11034939|NCT00876460|12214449|FG001|NOT COMPLETED|Mono Therapy Phase||1
11034940|NCT00876460|12214450|FG002|NOT COMPLETED|Mono Therapy Phase||0
11034941|NCT00876460|12214451|FG003|NOT COMPLETED|Mono Therapy Phase||1
11034942|NCT00876460|12214452|FG004|NOT COMPLETED|Mono Therapy Phase||2
11034943|NCT00876460|12214453|FG005|NOT COMPLETED|Mono Therapy Phase||0
11034944|NCT00876460|12214454|FG006|NOT COMPLETED|Mono Therapy Phase||1
11034945|NCT00876460|12214455|FG007|NOT COMPLETED|Mono Therapy Phase||3
11034946|NCT00876694|12214487|FG000|STARTED|Overall Study||125
11034947|NCT00876694|12214488|FG001|STARTED|Overall Study||61
11034948|NCT00876694|12214487|FG000|COMPLETED|Overall Study||104
11034949|NCT00876694|12214488|FG001|COMPLETED|Overall Study||49
11034950|NCT00876694|12214487|FG000|NOT COMPLETED|Overall Study||21
11034951|NCT00876694|12214488|FG001|NOT COMPLETED|Overall Study||12
11034952|NCT00876733|12214498|FG000|STARTED|Overall Study||288
11034953|NCT00876733|12214499|FG001|STARTED|Overall Study||203
11034954|NCT00876733|12214500|FG002|STARTED|Overall Study||93
11034955|NCT00876733|12214501|FG003|STARTED|Overall Study||21
11034956|NCT00876733|12214498|FG000|COMPLETED|Overall Study||197
11034957|NCT00876733|12214499|FG001|COMPLETED|Overall Study||161
11034958|NCT00876733|12214500|FG002|COMPLETED|Overall Study||63
11034959|NCT00876733|12214501|FG003|COMPLETED|Overall Study||14
11034960|NCT00876733|12214498|FG000|NOT COMPLETED|Overall Study||91
11334874|NCT02855164|12532356|FG005|NOT COMPLETED|Parts A + B (Randomized Set)||0
11334875|NCT02855164|12532357|FG006|NOT COMPLETED|Parts A + B (Randomized Set)||0
11334876|NCT02855164|12532358|FG007|NOT COMPLETED|Parts A + B (Randomized Set)||0
11334877|NCT02855164|12532351|FG000|STARTED|Part C (Randomized Set)||0
11334878|NCT02855164|12532352|FG001|STARTED|Part C (Randomized Set)||0
11334879|NCT02855164|12532353|FG002|STARTED|Part C (Randomized Set)||0
11334880|NCT02855164|12532354|FG003|STARTED|Part C (Randomized Set)||0
11334881|NCT02855164|12532355|FG004|STARTED|Part C (Randomized Set)||0
11334882|NCT02855164|12532356|FG005|STARTED|Part C (Randomized Set)||50
11034961|NCT00876733|12214499|FG001|NOT COMPLETED|Overall Study||42
11034962|NCT00876733|12214500|FG002|NOT COMPLETED|Overall Study||30
11034963|NCT00876733|12214501|FG003|NOT COMPLETED|Overall Study||7
11034964|NCT00876915|12214514|FG000|STARTED|Overall Study||50
11034965|NCT00876915|12214515|FG001|STARTED|Overall Study||48
11034966|NCT00876915|12214516|FG002|STARTED|Overall Study||101
11034967|NCT00876915|12214514|FG000|Week 4|Overall Study||38
11334883|NCT02855164|12532357|FG006|STARTED|Part C (Randomized Set)||51
11334884|NCT02855164|12532358|FG007|STARTED|Part C (Randomized Set)||51
11334885|NCT02855164|12532351|FG000|COMPLETED|Part C (Randomized Set)||0
11334886|NCT02855164|12532352|FG001|COMPLETED|Part C (Randomized Set)||0
11334887|NCT02855164|12532353|FG002|COMPLETED|Part C (Randomized Set)||0
11334888|NCT02855164|12532354|FG003|COMPLETED|Part C (Randomized Set)||0
11334889|NCT02855164|12532355|FG004|COMPLETED|Part C (Randomized Set)||0
11334890|NCT02855164|12532356|FG005|COMPLETED|Part C (Randomized Set)||38
11334891|NCT02855164|12532357|FG006|COMPLETED|Part C (Randomized Set)||37
11334892|NCT02855164|12532358|FG007|COMPLETED|Part C (Randomized Set)||44
11334893|NCT02855164|12532351|FG000|NOT COMPLETED|Part C (Randomized Set)||0
11334894|NCT02855164|12532352|FG001|NOT COMPLETED|Part C (Randomized Set)||0
11334895|NCT02855164|12532353|FG002|NOT COMPLETED|Part C (Randomized Set)||0
11034968|NCT00876915|12214515|FG001|Week 4|Overall Study||45
11034969|NCT00876915|12214516|FG002|Week 4|Overall Study||0
11034970|NCT00876915|12214514|FG000|Week 8|Overall Study||33
11034971|NCT00876915|12214515|FG001|Week 8|Overall Study||36
11034972|NCT00876915|12214516|FG002|Week 8|Overall Study||0
11034973|NCT00876915|12214514|FG000|COMPLETED|Overall Study||31
11034974|NCT00876915|12214515|FG001|COMPLETED|Overall Study||34
11034975|NCT00876915|12214516|FG002|COMPLETED|Overall Study||101
11034976|NCT00876915|12214514|FG000|NOT COMPLETED|Overall Study||19
11034977|NCT00876915|12214515|FG001|NOT COMPLETED|Overall Study||14
11034978|NCT00876915|12214516|FG002|NOT COMPLETED|Overall Study||0
11034979|NCT00876928|12214526|FG000|STARTED|Overall Study||56
11034980|NCT00876928|12214527|FG001|STARTED|Overall Study||61
11034981|NCT00876928|12214526|FG000|COMPLETED|Overall Study||53
11034982|NCT00876928|12214527|FG001|COMPLETED|Overall Study||56
11034983|NCT00876928|12214526|FG000|NOT COMPLETED|Overall Study||3
11034984|NCT00876928|12214527|FG001|NOT COMPLETED|Overall Study||5
11034985|NCT00876993|12214538|FG000|STARTED|Overall Study||5
11034986|NCT00876993|12214539|FG001|STARTED|Overall Study||6
11034987|NCT00876993|12214540|FG002|STARTED|Overall Study||5
11034988|NCT00876993|12214541|FG003|STARTED|Overall Study||5
11034989|NCT00876993|12214542|FG004|STARTED|Overall Study||5
11034990|NCT00876993|12214538|FG000|COMPLETED|Overall Study||4
11034991|NCT00876993|12214539|FG001|COMPLETED|Overall Study||6
11034992|NCT00876993|12214540|FG002|COMPLETED|Overall Study||3
11034993|NCT00876993|12214541|FG003|COMPLETED|Overall Study||5
11034994|NCT00876993|12214542|FG004|COMPLETED|Overall Study||3
11034995|NCT00876993|12214538|FG000|NOT COMPLETED|Overall Study||1
11034996|NCT00876993|12214539|FG001|NOT COMPLETED|Overall Study||0
11034997|NCT00876993|12214540|FG002|NOT COMPLETED|Overall Study||2
11034998|NCT00876993|12214541|FG003|NOT COMPLETED|Overall Study||0
11034999|NCT00876993|12214542|FG004|NOT COMPLETED|Overall Study||2
11035000|NCT00877006|12214558|FG000|STARTED|Treatment Period||224
11035001|NCT00877006|12214559|FG001|STARTED|Treatment Period||223
11035002|NCT00877006|12214558|FG000|COMPLETED|Treatment Period||199
11035003|NCT00877006|12214559|FG001|COMPLETED|Treatment Period||196
11035004|NCT00877006|12214558|FG000|NOT COMPLETED|Treatment Period||25
11334896|NCT02855164|12532354|FG003|NOT COMPLETED|Part C (Randomized Set)||0
11334897|NCT02855164|12532355|FG004|NOT COMPLETED|Part C (Randomized Set)||0
11334898|NCT02855164|12532356|FG005|NOT COMPLETED|Part C (Randomized Set)||12
11035005|NCT00877006|12214559|FG001|NOT COMPLETED|Treatment Period||27
11035006|NCT00877006|12214558|FG000|STARTED|Long-Term Follow-up Period||210
11035007|NCT00877006|12214559|FG001|STARTED|Long-Term Follow-up Period||209
11035008|NCT00877006|12214558|FG000|COMPLETED|Long-Term Follow-up Period||157
11035009|NCT00877006|12214559|FG001|COMPLETED|Long-Term Follow-up Period||154
11035010|NCT00877006|12214558|FG000|NOT COMPLETED|Long-Term Follow-up Period||53
11035011|NCT00877006|12214559|FG001|NOT COMPLETED|Long-Term Follow-up Period||55
11035012|NCT00877032|12214574|FG000|STARTED|Overall Study||6
11035013|NCT00877032|12214575|FG001|STARTED|Overall Study||6
11035014|NCT00877032|12214576|FG002|STARTED|Overall Study||6
11035015|NCT00877032|12214577|FG003|STARTED|Overall Study||7
11035016|NCT00877032|12214578|FG004|STARTED|Overall Study||6
11035017|NCT00877032|12214579|FG005|STARTED|Overall Study||6
11035018|NCT00877032|12214580|FG006|STARTED|Overall Study||20
11035019|NCT00877032|12214574|FG000|Treated|Overall Study||6
11035020|NCT00877032|12214575|FG001|Treated|Overall Study||6
11035021|NCT00877032|12214576|FG002|Treated|Overall Study||6
11035022|NCT00877032|12214577|FG003|Treated|Overall Study||6
11035023|NCT00877032|12214578|FG004|Treated|Overall Study||6
11035024|NCT00877032|12214579|FG005|Treated|Overall Study||6
11035025|NCT00877032|12214580|FG006|Treated|Overall Study||18
11035026|NCT00877032|12214574|FG000|COMPLETED|Overall Study||6
11035027|NCT00877032|12214575|FG001|COMPLETED|Overall Study||6
11035028|NCT00877032|12214576|FG002|COMPLETED|Overall Study||6
11035029|NCT00877032|12214577|FG003|COMPLETED|Overall Study||6
11334899|NCT02855164|12532357|FG006|NOT COMPLETED|Part C (Randomized Set)||14
11334900|NCT02855164|12532358|FG007|NOT COMPLETED|Part C (Randomized Set)||7
11334901|NCT02855281|12532396|FG000|STARTED|Overall Study||50
11334902|NCT02855281|12532396|FG000|COMPLETED|Overall Study||50
11035030|NCT00877032|12214578|FG004|COMPLETED|Overall Study||6
11035031|NCT00877032|12214579|FG005|COMPLETED|Overall Study||6
11035032|NCT00877032|12214580|FG006|COMPLETED|Overall Study||18
11035033|NCT00877032|12214574|FG000|NOT COMPLETED|Overall Study||0
11035034|NCT00877032|12214575|FG001|NOT COMPLETED|Overall Study||0
11035035|NCT00877032|12214576|FG002|NOT COMPLETED|Overall Study||0
11035036|NCT00877032|12214577|FG003|NOT COMPLETED|Overall Study||1
11035037|NCT00877032|12214578|FG004|NOT COMPLETED|Overall Study||0
11035038|NCT00877032|12214579|FG005|NOT COMPLETED|Overall Study||0
11035039|NCT00877032|12214580|FG006|NOT COMPLETED|Overall Study||2
11035040|NCT00877058|12214599|FG000|STARTED|Overall Study||174
11035041|NCT00877058|12214600|FG001|STARTED|Overall Study||171
11035042|NCT00877058|12214601|FG002|STARTED|Overall Study||114
11035043|NCT00877058|12214599|FG000|COMPLETED|Overall Study||137
11035044|NCT00877058|12214600|FG001|COMPLETED|Overall Study||131
11035045|NCT00877058|12214601|FG002|COMPLETED|Overall Study||75
11035046|NCT00877058|12214599|FG000|NOT COMPLETED|Overall Study||37
11035047|NCT00877058|12214600|FG001|NOT COMPLETED|Overall Study||40
11035048|NCT00877058|12214601|FG002|NOT COMPLETED|Overall Study||39
11035049|NCT00877370|12214609|FG000|STARTED|Overall Study||8
11035050|NCT00877370|12214609|FG000|COMPLETED|Overall Study||8
11035051|NCT00877370|12214609|FG000|NOT COMPLETED|Overall Study||0
11035052|NCT00877383|12214615|FG000|STARTED|Overall Study||572
11035053|NCT00877383|12214616|FG001|STARTED|Overall Study||570
11035054|NCT00877383|12214615|FG000|COMPLETED|Overall Study||543
11035055|NCT00877383|12214616|FG001|COMPLETED|Overall Study||533
11035056|NCT00877383|12214615|FG000|NOT COMPLETED|Overall Study||29
11035057|NCT00877383|12214616|FG001|NOT COMPLETED|Overall Study||37
11035058|NCT00877448|12214629|FG000|STARTED|Overall Study||10
11035059|NCT00877448|12214630|FG001|STARTED|Overall Study||10
11035060|NCT00877448|12214631|FG002|STARTED|Overall Study||10
11035061|NCT00877448|12214632|FG003|STARTED|Overall Study||10
11035062|NCT00877448|12214633|FG004|STARTED|Overall Study||10
11035063|NCT00877448|12214634|FG005|STARTED|Overall Study||10
11035064|NCT00877448|12214635|FG006|STARTED|Overall Study||3
11035065|NCT00877448|12214629|FG000|COMPLETED|Overall Study||10
11035066|NCT00877448|12214630|FG001|COMPLETED|Overall Study||9
11035067|NCT00877448|12214631|FG002|COMPLETED|Overall Study||10
11035068|NCT00877448|12214632|FG003|COMPLETED|Overall Study||9
11035069|NCT00877448|12214633|FG004|COMPLETED|Overall Study||10
11035070|NCT00877448|12214634|FG005|COMPLETED|Overall Study||9
11035071|NCT00877448|12214635|FG006|COMPLETED|Overall Study||3
11035072|NCT00877448|12214629|FG000|NOT COMPLETED|Overall Study||0
11035073|NCT00877448|12214630|FG001|NOT COMPLETED|Overall Study||1
11035074|NCT00877448|12214631|FG002|NOT COMPLETED|Overall Study||0
11035075|NCT00877448|12214632|FG003|NOT COMPLETED|Overall Study||1
11035076|NCT00877448|12214633|FG004|NOT COMPLETED|Overall Study||0
11035077|NCT00877448|12214634|FG005|NOT COMPLETED|Overall Study||1
11200841|NCT01829295|12391058|FG003|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42
11200842|NCT01829295|12391055|FG000|COMPLETED|6-12 Months||60
11200843|NCT01829295|12391056|FG001|COMPLETED|6-12 Months||54
11200844|NCT01829295|12391057|FG002|COMPLETED|6-12 Months||20
11200845|NCT01829295|12391058|FG003|COMPLETED|6-12 Months||29
11200846|NCT01829295|12391055|FG000|NOT COMPLETED|6-12 Months||4
11200847|NCT01829295|12391056|FG001|NOT COMPLETED|6-12 Months||2
11200848|NCT01829295|12391057|FG002|NOT COMPLETED|6-12 Months||12
11200849|NCT01829295|12391058|FG003|NOT COMPLETED|6-12 Months||13
11200850|NCT01829347|12391070|FG000|STARTED|VTI-210||9
11200851|NCT01829347|12391071|FG001|STARTED|VTI-210||9
11200852|NCT01829347|12391070|FG000|COMPLETED|VTI-210||3
11200853|NCT01829347|12391071|FG001|COMPLETED|VTI-210||6
11200854|NCT01829347|12391070|FG000|NOT COMPLETED|VTI-210||6
11200855|NCT01829347|12391071|FG001|NOT COMPLETED|VTI-210||3
11200856|NCT01829347|12391070|FG000|STARTED|VTI-210E||3
11200857|NCT01829347|12391071|FG001|STARTED|VTI-210E||6
11200858|NCT01829347|12391070|FG000|COMPLETED|VTI-210E||0
11200859|NCT01829347|12391071|FG001|COMPLETED|VTI-210E||0
11200860|NCT01829347|12391070|FG000|NOT COMPLETED|VTI-210E||3
11200861|NCT01829347|12391071|FG001|NOT COMPLETED|VTI-210E||6
11200862|NCT01829360|12391081|FG000|STARTED|Overall Study||8
11200863|NCT01829360|12391082|FG001|STARTED|Overall Study||9
11334903|NCT02855281|12532396|FG000|NOT COMPLETED|Overall Study||0
11334904|NCT02855359|12532406|FG000|STARTED|Overall Study||11
11200864|NCT01829360|12391083|FG002|STARTED|Overall Study||10
11200865|NCT01829360|12391084|FG003|STARTED|Overall Study||8
11035078|NCT00877448|12214635|FG006|NOT COMPLETED|Overall Study||0
11035079|NCT00877487|12214651|FG000|STARTED|Open-label Treatment Phase||123
11035080|NCT00877487|12214652|FG001|STARTED|Open-label Treatment Phase||0
11035081|NCT00877487|12214651|FG000|COMPLETED|Open-label Treatment Phase||116
11035082|NCT00877487|12214652|FG001|COMPLETED|Open-label Treatment Phase||0
11035083|NCT00877487|12214651|FG000|NOT COMPLETED|Open-label Treatment Phase||7
11035084|NCT00877487|12214652|FG001|NOT COMPLETED|Open-label Treatment Phase||0
11035085|NCT00877487|12214651|FG000|STARTED|Double-blind Randomized Withdrawal Phase||56
11334905|NCT02855359|12532407|FG001|STARTED|Overall Study||13
11334906|NCT02855359|12532408|FG002|STARTED|Overall Study||0
11334907|NCT02855359|12532409|FG003|STARTED|Overall Study||0
11334908|NCT02855359|12532406|FG000|COMPLETED|Overall Study||0
11334909|NCT02855359|12532407|FG001|COMPLETED|Overall Study||0
11200866|NCT01829360|12391081|FG000|COMPLETED|Overall Study||8
11334910|NCT02855359|12532408|FG002|COMPLETED|Overall Study||0
11334911|NCT02855359|12532409|FG003|COMPLETED|Overall Study||0
11334912|NCT02855359|12532406|FG000|NOT COMPLETED|Overall Study||11
11334913|NCT02855359|12532407|FG001|NOT COMPLETED|Overall Study||13
11334914|NCT02855359|12532408|FG002|NOT COMPLETED|Overall Study||0
11334915|NCT02855359|12532409|FG003|NOT COMPLETED|Overall Study||0
11334916|NCT02855437|12532417|FG000|STARTED|Phase 1||23
11334917|NCT02855437|12532418|FG001|STARTED|Phase 1||21
11334918|NCT02855437|12532417|FG000|COMPLETED|Phase 1||21
11334919|NCT02855437|12532418|FG001|COMPLETED|Phase 1||19
11035086|NCT00877487|12214652|FG001|STARTED|Double-blind Randomized Withdrawal Phase||60
11035087|NCT00877487|12214651|FG000|COMPLETED|Double-blind Randomized Withdrawal Phase||50
11035088|NCT00877487|12214652|FG001|COMPLETED|Double-blind Randomized Withdrawal Phase||13
11035089|NCT00877487|12214651|FG000|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
11035090|NCT00877487|12214652|FG001|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
11035091|NCT00877604|12214660|FG000|STARTED|Overall Study||17
11035092|NCT00877604|12214661|FG001|STARTED|Overall Study||17
11035093|NCT00877604|12214660|FG000|COMPLETED|Overall Study||15
11035094|NCT00877604|12214661|FG001|COMPLETED|Overall Study||14
11035095|NCT00877604|12214660|FG000|NOT COMPLETED|Overall Study||2
11035096|NCT00877604|12214661|FG001|NOT COMPLETED|Overall Study||3
11035097|NCT00877773|12214667|FG000|STARTED|Overall Study||44
11035098|NCT00877773|12214667|FG000|COMPLETED|Overall Study|No participant reached to first restaging.|0
11035099|NCT00877773|12214667|FG000|NOT COMPLETED|Overall Study||44
11035100|NCT00877799|12214676|FG000|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
11035101|NCT00877799|12214677|FG001|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
11035102|NCT00877799|12214678|FG002|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
11035103|NCT00877799|12214679|FG003|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
11035104|NCT00877799|12214680|FG004|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
11035105|NCT00877799|12214676|FG000|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
11035106|NCT00877799|12214677|FG001|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
11035107|NCT00877799|12214678|FG002|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
11035108|NCT00877799|12214679|FG003|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
11035109|NCT00877799|12214680|FG004|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
11035110|NCT00877799|12214676|FG000|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
11035111|NCT00877799|12214677|FG001|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
11035112|NCT00877799|12214678|FG002|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
11035113|NCT00877799|12214679|FG003|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
11035114|NCT00877799|12214680|FG004|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
11035115|NCT00877799|12214676|FG000|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
11035116|NCT00877799|12214677|FG001|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
11035117|NCT00877799|12214678|FG002|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
11035118|NCT00877799|12214679|FG003|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
11035119|NCT00877799|12214680|FG004|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
11035120|NCT00877799|12214676|FG000|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
11035121|NCT00877799|12214677|FG001|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
11035122|NCT00877799|12214678|FG002|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
11035123|NCT00877799|12214679|FG003|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
11035124|NCT00877799|12214680|FG004|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
11035125|NCT00877799|12214676|FG000|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
11035126|NCT00877799|12214677|FG001|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
11035127|NCT00877799|12214678|FG002|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
11035128|NCT00877799|12214679|FG003|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
11035129|NCT00877799|12214680|FG004|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
11035130|NCT00877877|12214691|FG000|STARTED|Year 5||397
11035131|NCT00877877|12214691|FG000|COMPLETED|Year 5||397
11035132|NCT00877877|12214691|FG000|NOT COMPLETED|Year 5||0
11035133|NCT00877877|12214691|FG000|STARTED|Year 6||529
11035134|NCT00877877|12214691|FG000|COMPLETED|Year 6||529
11035135|NCT00877877|12214691|FG000|NOT COMPLETED|Year 6||0
11035136|NCT00877877|12214691|FG000|STARTED|Year 7||523
11035137|NCT00877877|12214691|FG000|COMPLETED|Year 7||523
11035138|NCT00877877|12214691|FG000|NOT COMPLETED|Year 7||0
11035139|NCT00877877|12214691|FG000|STARTED|Year 8||522
11035140|NCT00877877|12214691|FG000|COMPLETED|Year 8||522
11035141|NCT00877877|12214691|FG000|NOT COMPLETED|Year 8||0
11035142|NCT00877877|12214691|FG000|STARTED|Year 9||507
11035143|NCT00877877|12214691|FG000|COMPLETED|Year 9||507
11035144|NCT00877877|12214691|FG000|NOT COMPLETED|Year 9||0
11035145|NCT00877877|12214691|FG000|STARTED|Year 10||495
11035146|NCT00877877|12214691|FG000|COMPLETED|Year 10||495
11035147|NCT00877877|12214691|FG000|NOT COMPLETED|Year 10||0
11035148|NCT00877890|12214702|FG000|STARTED|Overall Study||129
11035149|NCT00877890|12214703|FG001|STARTED|Overall Study||125
11035150|NCT00877890|12214702|FG000|Intent to Treat (ITT)|Overall Study||129
11035151|NCT00877890|12214703|FG001|Intent to Treat (ITT)|Overall Study||123
11035152|NCT00877890|12214702|FG000|COMPLETED|Overall Study||109
11334920|NCT02855437|12532417|FG000|NOT COMPLETED|Phase 1||2
11334921|NCT02855437|12532418|FG001|NOT COMPLETED|Phase 1||2
11334922|NCT02855437|12532417|FG000|STARTED|Crossover Period (Same Day)||21
11334923|NCT02855437|12532418|FG001|STARTED|Crossover Period (Same Day)||19
11035153|NCT00877890|12214703|FG001|COMPLETED|Overall Study||95
11334924|NCT02855437|12532417|FG000|COMPLETED|Crossover Period (Same Day)||21
11334925|NCT02855437|12532418|FG001|COMPLETED|Crossover Period (Same Day)||19
11334926|NCT02855437|12532417|FG000|NOT COMPLETED|Crossover Period (Same Day)||0
11334927|NCT02855437|12532418|FG001|NOT COMPLETED|Crossover Period (Same Day)||0
11334928|NCT02855437|12532417|FG000|STARTED|Phase 2||21
11334929|NCT02855437|12532418|FG001|STARTED|Phase 2||19
11334930|NCT02855437|12532417|FG000|COMPLETED|Phase 2||20
11334931|NCT02855437|12532418|FG001|COMPLETED|Phase 2||18
11334932|NCT02855437|12532417|FG000|NOT COMPLETED|Phase 2||1
11334933|NCT02855437|12532418|FG001|NOT COMPLETED|Phase 2||1
11334934|NCT02855450|12532427|FG000|STARTED|Overall Study||40
11334935|NCT02855450|12532428|FG001|STARTED|Overall Study||20
11334936|NCT02855450|12532427|FG000|COMPLETED|Overall Study||35
11334937|NCT02855450|12532428|FG001|COMPLETED|Overall Study||20
11334938|NCT02855450|12532427|FG000|NOT COMPLETED|Overall Study||5
11334939|NCT02855450|12532428|FG001|NOT COMPLETED|Overall Study||0
11035154|NCT00877890|12214702|FG000|NOT COMPLETED|Overall Study||20
11035155|NCT00877890|12214703|FG001|NOT COMPLETED|Overall Study||30
11035156|NCT00877929|12214715|FG000|STARTED|Overall Study||352
11035157|NCT00877929|12214716|FG001|STARTED|Overall Study||354
11035158|NCT00877929|12214715|FG000|COMPLETED|Overall Study||332
11035159|NCT00877929|12214716|FG001|COMPLETED|Overall Study||319
11035160|NCT00877929|12214715|FG000|NOT COMPLETED|Overall Study||20
11035161|NCT00877929|12214716|FG001|NOT COMPLETED|Overall Study||35
11035162|NCT00878072|12214726|FG000|STARTED|Overall Study||53
11035163|NCT00878072|12214726|FG000|COMPLETED|Overall Study||51
11035164|NCT00878072|12214726|FG000|NOT COMPLETED|Overall Study||2
11035165|NCT00878189|12214737|FG000|STARTED|Overall Study||3
11035166|NCT00878189|12214738|FG001|STARTED|Overall Study||3
11035167|NCT00878189|12214739|FG002|STARTED|Overall Study||4
11035168|NCT00878189|12214740|FG003|STARTED|Overall Study||8
11035169|NCT00878189|12214741|FG004|STARTED|Overall Study||4
11035170|NCT00878189|12214742|FG005|STARTED|Overall Study||23
11035171|NCT00878189|12214743|FG006|STARTED|Overall Study||16
11035172|NCT00878189|12214744|FG007|STARTED|Overall Study||3
11035173|NCT00878189|12214745|FG008|STARTED|Overall Study||8
11035174|NCT00878189|12214737|FG000|COMPLETED|Overall Study||0
11035175|NCT00878189|12214738|FG001|COMPLETED|Overall Study||0
11035176|NCT00878189|12214739|FG002|COMPLETED|Overall Study||0
11035177|NCT00878189|12214740|FG003|COMPLETED|Overall Study||0
11035178|NCT00878189|12214741|FG004|COMPLETED|Overall Study||0
11035179|NCT00878189|12214742|FG005|COMPLETED|Overall Study||0
11035180|NCT00878189|12214743|FG006|COMPLETED|Overall Study||0
11035181|NCT00878189|12214744|FG007|COMPLETED|Overall Study||0
11035182|NCT00878189|12214745|FG008|COMPLETED|Overall Study||0
11035183|NCT00878189|12214737|FG000|NOT COMPLETED|Overall Study||3
11035184|NCT00878189|12214738|FG001|NOT COMPLETED|Overall Study||3
11035185|NCT00878189|12214739|FG002|NOT COMPLETED|Overall Study||4
11035186|NCT00878189|12214740|FG003|NOT COMPLETED|Overall Study||8
11035187|NCT00878189|12214741|FG004|NOT COMPLETED|Overall Study||4
11035188|NCT00878189|12214742|FG005|NOT COMPLETED|Overall Study||23
11035189|NCT00878189|12214743|FG006|NOT COMPLETED|Overall Study||16
11035190|NCT00878189|12214744|FG007|NOT COMPLETED|Overall Study||3
11035191|NCT00878189|12214745|FG008|NOT COMPLETED|Overall Study||8
11035192|NCT00878215|12214783|FG000|STARTED|Overall Study||21
11035193|NCT00878215|12214784|FG001|STARTED|Overall Study||19
11035194|NCT00878215|12214785|FG002|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
11035195|NCT00878215|12214786|FG003|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
11035196|NCT00878215|12214783|FG000|COMPLETED|Overall Study||21
11035197|NCT00878215|12214784|FG001|COMPLETED|Overall Study||9
11035198|NCT00878215|12214785|FG002|COMPLETED|Overall Study||0
11035199|NCT00878215|12214786|FG003|COMPLETED|Overall Study||0
11035200|NCT00878215|12214783|FG000|NOT COMPLETED|Overall Study||0
11035201|NCT00878215|12214784|FG001|NOT COMPLETED|Overall Study||10
11035202|NCT00878215|12214785|FG002|NOT COMPLETED|Overall Study||0
11035203|NCT00878215|12214786|FG003|NOT COMPLETED|Overall Study||0
11035204|NCT00878228|12214798|FG000|STARTED|Overall Study||49
11035205|NCT00878228|12214799|FG001|STARTED|Overall Study||49
11035206|NCT00878228|12214798|FG000|COMPLETED|Overall Study||39
11035207|NCT00878228|12214799|FG001|COMPLETED|Overall Study||37
11035208|NCT00878228|12214798|FG000|NOT COMPLETED|Overall Study||10
11035209|NCT00878228|12214799|FG001|NOT COMPLETED|Overall Study||12
11035210|NCT00878436|12214807|FG000|STARTED|Overall Study||28
11035211|NCT00878436|12214808|FG001|STARTED|Overall Study||24
11035212|NCT00878436|12214807|FG000|Completed 2 Cycles|Overall Study||21
11035213|NCT00878436|12214808|FG001|Completed 2 Cycles|Overall Study||20
11035214|NCT00878436|12214807|FG000|6 Months|Overall Study||8
11035215|NCT00878436|12214808|FG001|6 Months|Overall Study||0
11035216|NCT00878436|12214807|FG000|COMPLETED|Overall Study||5
11035217|NCT00878436|12214808|FG001|COMPLETED|Overall Study||0
11035218|NCT00878436|12214807|FG000|NOT COMPLETED|Overall Study||23
11035219|NCT00878436|12214808|FG001|NOT COMPLETED|Overall Study||24
11057585|NCT00998985|12239228|FG001|STARTED|Overall Study||5
11334940|NCT02855541|12532434|FG000|STARTED|Overall Study||25
11334941|NCT02855541|12532434|FG000|COMPLETED|Overall Study||21
11334942|NCT02855541|12532434|FG000|NOT COMPLETED|Overall Study||4
11334943|NCT02855567|12532440|FG000|STARTED|Overall Study||54
11334944|NCT02855567|12532441|FG001|STARTED|Overall Study||56
11035220|NCT00878501|12214817|FG000|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
11035221|NCT00878501|12214818|FG001|STARTED|Overall Study||44
11035222|NCT00878501|12214819|FG002|STARTED|Overall Study||93
11035223|NCT00878501|12214817|FG000|Interim Analysis|Overall Study||83
11035224|NCT00878501|12214818|FG001|Interim Analysis|Overall Study||37
11035225|NCT00878501|12214819|FG002|Interim Analysis|Overall Study||81
11035226|NCT00878501|12214817|FG000|COMPLETED|Overall Study||87
11035227|NCT00878501|12214818|FG001|COMPLETED|Overall Study||37
11035228|NCT00878501|12214819|FG002|COMPLETED|Overall Study||85
11035229|NCT00878501|12214817|FG000|NOT COMPLETED|Overall Study||17
11035230|NCT00878501|12214818|FG001|NOT COMPLETED|Overall Study||7
11035231|NCT00878501|12214819|FG002|NOT COMPLETED|Overall Study||8
11035232|NCT00878553|12214831|FG000|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
11035233|NCT00878553|12214832|FG001|STARTED|Sleep Study||0
11035234|NCT00878553|12214833|FG002|STARTED|Sleep Study||0
11035235|NCT00878553|12214834|FG003|STARTED|Sleep Study||0
11035236|NCT00878553|12214835|FG004|STARTED|Sleep Study||0
11035237|NCT00878553|12214831|FG000|Number of Patients Receiving Placebo|Sleep Study||66
11035238|NCT00878553|12214832|FG001|Number of Patients Receiving Placebo|Sleep Study||0
11035239|NCT00878553|12214833|FG002|Number of Patients Receiving Placebo|Sleep Study||0
11035240|NCT00878553|12214834|FG003|Number of Patients Receiving Placebo|Sleep Study||0
11035241|NCT00878553|12214835|FG004|Number of Patients Receiving Placebo|Sleep Study||0
11035242|NCT00878553|12214831|FG000|Number of Patients Receiving 10mg|Sleep Study||65
11035243|NCT00878553|12214832|FG001|Number of Patients Receiving 10mg|Sleep Study||0
11035244|NCT00878553|12214833|FG002|Number of Patients Receiving 10mg|Sleep Study||0
11035245|NCT00878553|12214834|FG003|Number of Patients Receiving 10mg|Sleep Study||0
11035246|NCT00878553|12214835|FG004|Number of Patients Receiving 10mg|Sleep Study||0
11035247|NCT00878553|12214831|FG000|Number of Patients Receiving 15mg|Sleep Study||65
11035248|NCT00878553|12214832|FG001|Number of Patients Receiving 15mg|Sleep Study||0
11035249|NCT00878553|12214833|FG002|Number of Patients Receiving 15mg|Sleep Study||0
11035250|NCT00878553|12214834|FG003|Number of Patients Receiving 15mg|Sleep Study||0
11035251|NCT00878553|12214835|FG004|Number of Patients Receiving 15mg|Sleep Study||0
11035252|NCT00878553|12214831|FG000|Number of Patients Receiving 20mg|Sleep Study||65
11035253|NCT00878553|12214832|FG001|Number of Patients Receiving 20mg|Sleep Study||0
11035254|NCT00878553|12214833|FG002|Number of Patients Receiving 20mg|Sleep Study||0
11035255|NCT00878553|12214834|FG003|Number of Patients Receiving 20mg|Sleep Study||0
11035256|NCT00878553|12214835|FG004|Number of Patients Receiving 20mg|Sleep Study||0
11035257|NCT00878553|12214831|FG000|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
11035258|NCT00878553|12214832|FG001|COMPLETED|Sleep Study||0
11035259|NCT00878553|12214833|FG002|COMPLETED|Sleep Study||0
11035260|NCT00878553|12214834|FG003|COMPLETED|Sleep Study||0
11334945|NCT02855567|12532440|FG000|COMPLETED|Overall Study||54
11334946|NCT02855567|12532441|FG001|COMPLETED|Overall Study||56
11334947|NCT02855567|12532440|FG000|NOT COMPLETED|Overall Study||0
11334948|NCT02855567|12532441|FG001|NOT COMPLETED|Overall Study||0
11334949|NCT02856035|12532447|FG000|STARTED|Overall Study||4
11334950|NCT02856035|12532447|FG000|COMPLETED|Overall Study||4
11334951|NCT02856035|12532447|FG000|NOT COMPLETED|Overall Study||0
11334952|NCT02856282|12532451|FG000|STARTED|Overall Study||46
11334953|NCT02856282|12532451|FG000|COMPLETED|Overall Study||45
11334954|NCT02856282|12532451|FG000|NOT COMPLETED|Overall Study||1
11334955|NCT02856490|12532458|FG000|STARTED|Overall Study||2
11334956|NCT02856490|12532459|FG001|STARTED|Overall Study||2
11334957|NCT02856490|12532460|FG002|STARTED|Overall Study||2
11334958|NCT02856490|12532458|FG000|COMPLETED|Overall Study||2
11334959|NCT02856490|12532459|FG001|COMPLETED|Overall Study||2
11035261|NCT00878553|12214835|FG004|COMPLETED|Sleep Study||0
11035262|NCT00878553|12214831|FG000|NOT COMPLETED|Sleep Study||5
11035263|NCT00878553|12214832|FG001|NOT COMPLETED|Sleep Study||0
11035264|NCT00878553|12214833|FG002|NOT COMPLETED|Sleep Study||0
11035265|NCT00878553|12214834|FG003|NOT COMPLETED|Sleep Study||0
11035266|NCT00878553|12214835|FG004|NOT COMPLETED|Sleep Study||0
11035267|NCT00878553|12214831|FG000|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
11035268|NCT00878553|12214832|FG001|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
11035269|NCT00878553|12214833|FG002|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
11035270|NCT00878553|12214834|FG003|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
11035271|NCT00878553|12214835|FG004|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
11035272|NCT00878553|12214831|FG000|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
11035273|NCT00878553|12214832|FG001|COMPLETED|PK Study||16
11035274|NCT00878553|12214833|FG002|COMPLETED|PK Study||17
11035275|NCT00878553|12214834|FG003|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
11035276|NCT00878553|12214835|FG004|COMPLETED|PK Study||15
11035277|NCT00878553|12214831|FG000|NOT COMPLETED|PK Study||0
11035278|NCT00878553|12214832|FG001|NOT COMPLETED|PK Study||0
11035279|NCT00878553|12214833|FG002|NOT COMPLETED|PK Study||0
11035280|NCT00878553|12214834|FG003|NOT COMPLETED|PK Study||1
11035281|NCT00878553|12214835|FG004|NOT COMPLETED|PK Study||0
11334960|NCT02856490|12532460|FG002|COMPLETED|Overall Study||2
11334961|NCT02856490|12532458|FG000|NOT COMPLETED|Overall Study||0
11035282|NCT00878644|12214854|FG000|STARTED|Overall Study||155
11035283|NCT00878644|12214855|FG001|STARTED|Overall Study||140
11035284|NCT00878644|12214854|FG000|COMPLETED|Overall Study||151
11035285|NCT00878644|12214855|FG001|COMPLETED|Overall Study||136
11035286|NCT00878644|12214854|FG000|NOT COMPLETED|Overall Study||4
11035287|NCT00878644|12214855|FG001|NOT COMPLETED|Overall Study||4
11035288|NCT00878709|12214863|FG000|STARTED|Overall Study||1420
11035289|NCT00878709|12214864|FG001|STARTED|Overall Study||1420
11035290|NCT00878709|12214863|FG000|COMPLETED|Overall Study||1095
11035291|NCT00878709|12214864|FG001|COMPLETED|Overall Study||1183
11035292|NCT00878709|12214863|FG000|NOT COMPLETED|Overall Study||325
11035293|NCT00878709|12214864|FG001|NOT COMPLETED|Overall Study||237
11035294|NCT00878722|12214879|FG000|STARTED|Overall Study||3
11035295|NCT00878722|12214880|FG001|STARTED|Overall Study||3
11035296|NCT00878722|12214881|FG002|STARTED|Overall Study||3
11035297|NCT00878722|12214882|FG003|STARTED|Overall Study||9
11035298|NCT00878722|12214883|FG004|STARTED|Overall Study||7
11035299|NCT00878722|12214884|FG005|STARTED|Overall Study||3
11035300|NCT00878722|12214885|FG006|STARTED|Overall Study||6
11200867|NCT01829360|12391082|FG001|COMPLETED|Overall Study||9
11035301|NCT00878722|12214886|FG007|STARTED|Overall Study||7
11035302|NCT00878722|12214879|FG000|COMPLETED|Overall Study||0
11035303|NCT00878722|12214880|FG001|COMPLETED|Overall Study||0
11035304|NCT00878722|12214881|FG002|COMPLETED|Overall Study||0
11035305|NCT00878722|12214882|FG003|COMPLETED|Overall Study||0
11035306|NCT00878722|12214883|FG004|COMPLETED|Overall Study||0
11035307|NCT00878722|12214884|FG005|COMPLETED|Overall Study||1
11035308|NCT00878722|12214885|FG006|COMPLETED|Overall Study||0
11035309|NCT00878722|12214886|FG007|COMPLETED|Overall Study||0
11035310|NCT00878722|12214879|FG000|NOT COMPLETED|Overall Study||3
11035311|NCT00878722|12214880|FG001|NOT COMPLETED|Overall Study||3
11035312|NCT00878722|12214881|FG002|NOT COMPLETED|Overall Study||3
11035313|NCT00878722|12214882|FG003|NOT COMPLETED|Overall Study||9
11035314|NCT00878722|12214883|FG004|NOT COMPLETED|Overall Study||7
11035315|NCT00878722|12214884|FG005|NOT COMPLETED|Overall Study||2
11035316|NCT00878722|12214885|FG006|NOT COMPLETED|Overall Study||6
11035317|NCT00878722|12214886|FG007|NOT COMPLETED|Overall Study||7
11035318|NCT00878800|12214912|FG000|STARTED|Overall Study||3
11035319|NCT00878800|12214913|FG001|STARTED|Overall Study||7
11035320|NCT00878800|12214914|FG002|STARTED|Overall Study||9
11035321|NCT00878800|12214915|FG003|STARTED|Overall Study||6
11035322|NCT00878800|12214916|FG004|STARTED|Overall Study||16
11035323|NCT00878800|12214912|FG000|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
11035324|NCT00878800|12214913|FG001|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
11035325|NCT00878800|12214914|FG002|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
11035326|NCT00878800|12214915|FG003|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
11035327|NCT00878800|12214916|FG004|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
11035328|NCT00878800|12214912|FG000|NOT COMPLETED|Overall Study||3
11035329|NCT00878800|12214913|FG001|NOT COMPLETED|Overall Study||7
11035330|NCT00878800|12214914|FG002|NOT COMPLETED|Overall Study||9
11035331|NCT00878800|12214915|FG003|NOT COMPLETED|Overall Study||6
11035332|NCT00878800|12214916|FG004|NOT COMPLETED|Overall Study||16
11035333|NCT00878826|12214930|FG000|STARTED|Overall Study||3
11035334|NCT00878826|12214931|FG001|STARTED|Overall Study||6
11035335|NCT00878826|12214932|FG002|STARTED|Overall Study||2
11035336|NCT00878826|12214930|FG000|COMPLETED|Overall Study||3
11035337|NCT00878826|12214931|FG001|COMPLETED|Overall Study||6
11035338|NCT00878826|12214932|FG002|COMPLETED|Overall Study||2
11035339|NCT00878826|12214930|FG000|NOT COMPLETED|Overall Study||0
11035340|NCT00878826|12214931|FG001|NOT COMPLETED|Overall Study||0
11035341|NCT00878826|12214932|FG002|NOT COMPLETED|Overall Study||0
11035342|NCT00878878|12214942|FG000|STARTED|Overall Study||15
11035343|NCT00878878|12214943|FG001|STARTED|Overall Study||15
11035344|NCT00878878|12214942|FG000|COMPLETED|Overall Study||15
11035345|NCT00878878|12214943|FG001|COMPLETED|Overall Study||15
11035346|NCT00878878|12214942|FG000|NOT COMPLETED|Overall Study||0
11035347|NCT00878878|12214943|FG001|NOT COMPLETED|Overall Study||0
11035348|NCT00878995|12214953|FG000|STARTED|Baseline Study - Midpoint Study||12
11035349|NCT00878995|12214954|FG001|STARTED|Baseline Study - Midpoint Study||12
11035350|NCT00878995|12214953|FG000|Baseline Study|Baseline Study - Midpoint Study||12
11035351|NCT00878995|12214954|FG001|Baseline Study|Baseline Study - Midpoint Study||12
11035352|NCT00878995|12214953|FG000|COMPLETED|Baseline Study - Midpoint Study||12
11035353|NCT00878995|12214954|FG001|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
11035354|NCT00878995|12214953|FG000|NOT COMPLETED|Baseline Study - Midpoint Study||0
11035355|NCT00878995|12214954|FG001|NOT COMPLETED|Baseline Study - Midpoint Study||2
11035356|NCT00878995|12214953|FG000|STARTED|Midpoint Study - Post Study||12
11035357|NCT00878995|12214954|FG001|STARTED|Midpoint Study - Post Study||10
11035358|NCT00878995|12214953|FG000|COMPLETED|Midpoint Study - Post Study||12
11035359|NCT00878995|12214954|FG001|COMPLETED|Midpoint Study - Post Study||10
11035360|NCT00878995|12214953|FG000|NOT COMPLETED|Midpoint Study - Post Study||0
11035361|NCT00878995|12214954|FG001|NOT COMPLETED|Midpoint Study - Post Study||0
11035362|NCT00879034|12214960|FG000|STARTED|Overall Study||5
11035363|NCT00879034|12214960|FG000|Received Treatment|Overall Study||4
11035364|NCT00879034|12214960|FG000|COMPLETED|Overall Study||5
11035365|NCT00879034|12214960|FG000|NOT COMPLETED|Overall Study||0
11035366|NCT00879060|12214966|FG000|STARTED|Overall Study||26
11035367|NCT00879060|12214967|FG001|STARTED|Overall Study||27
11035368|NCT00879060|12214966|FG000|COMPLETED|Overall Study||26
11035369|NCT00879060|12214967|FG001|COMPLETED|Overall Study||27
11035370|NCT00879060|12214966|FG000|NOT COMPLETED|Overall Study||0
11035371|NCT00879060|12214967|FG001|NOT COMPLETED|Overall Study||0
11035372|NCT00879190|12214978|FG000|STARTED|Overall Study||43
11035373|NCT00879190|12214979|FG001|STARTED|Overall Study||49
11035374|NCT00879190|12214978|FG000|COMPLETED|Overall Study||43
11035375|NCT00879190|12214979|FG001|COMPLETED|Overall Study||49
11035376|NCT00879190|12214978|FG000|NOT COMPLETED|Overall Study||0
11035377|NCT00879190|12214979|FG001|NOT COMPLETED|Overall Study||0
11035378|NCT00879229|12214987|FG000|STARTED|Overall Study||25
11035379|NCT00879229|12214988|FG001|STARTED|Overall Study||15
11035380|NCT00879229|12214987|FG000|COMPLETED|Overall Study||3
11035381|NCT00879229|12214988|FG001|COMPLETED|Overall Study||1
11035382|NCT00879229|12214987|FG000|NOT COMPLETED|Overall Study||22
11035383|NCT00879229|12214988|FG001|NOT COMPLETED|Overall Study||14
11035384|NCT00879255|12214996|FG000|STARTED|Overall Study||61
11035385|NCT00879255|12214997|FG001|STARTED|Overall Study||64
11035386|NCT00879255|12214996|FG000|Received Allocated Intervention:|Overall Study||51
11035387|NCT00879255|12214997|FG001|Received Allocated Intervention:|Overall Study||56
11035388|NCT00879255|12214996|FG000|Completed Posttreatment Follow-up|Overall Study||50
11035389|NCT00879255|12214997|FG001|Completed Posttreatment Follow-up|Overall Study||55
11035390|NCT00879255|12214996|FG000|Completed 3-mo Follow-up|Overall Study||48
11035391|NCT00879255|12214997|FG001|Completed 3-mo Follow-up|Overall Study||49
11035392|NCT00879255|12214996|FG000|COMPLETED|Overall Study|Completed 6-mo follow-up|45
11035393|NCT00879255|12214997|FG001|COMPLETED|Overall Study|Completed 6-mo follow-up|45
11035394|NCT00879255|12214996|FG000|NOT COMPLETED|Overall Study||16
11035395|NCT00879255|12214997|FG001|NOT COMPLETED|Overall Study||19
11035396|NCT00879333|12215005|FG000|STARTED|Overall Study||439
11035397|NCT00879333|12215006|FG001|STARTED|Overall Study||217
11035398|NCT00879333|12215005|FG000|Discontinued Study Treatment|Overall Study||428
11035399|NCT00879333|12215006|FG001|Discontinued Study Treatment|Overall Study||217
11035400|NCT00879333|12215005|FG000|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
11035401|NCT00879333|12215006|FG001|COMPLETED|Overall Study||0
11035402|NCT00879333|12215005|FG000|NOT COMPLETED|Overall Study||428
11035403|NCT00879333|12215006|FG001|NOT COMPLETED|Overall Study||217
11035404|NCT00879359|12215014|FG000|STARTED|Overall Study||15
11035405|NCT00879359|12215014|FG000|COMPLETED|Overall Study||15
11035406|NCT00879359|12215014|FG000|NOT COMPLETED|Overall Study||0
11035407|NCT00879398|12215019|FG000|STARTED|Overall Study||3109
11035408|NCT00879398|12215019|FG000|COMPLETED|Overall Study||2434
11035409|NCT00879398|12215019|FG000|NOT COMPLETED|Overall Study||675
11035410|NCT00879411|12215023|FG000|STARTED|Overall Study||701
11035411|NCT00879411|12215023|FG000|COMPLETED|Overall Study||539
11035412|NCT00879411|12215023|FG000|NOT COMPLETED|Overall Study||162
11035413|NCT00879437|12215027|FG000|STARTED|Overall Study||20
11035414|NCT00879437|12215028|FG001|STARTED|Overall Study||18
11035415|NCT00879437|12215027|FG000|COMPLETED|Overall Study||19
11035416|NCT00879437|12215028|FG001|COMPLETED|Overall Study||17
11035417|NCT00879437|12215027|FG000|NOT COMPLETED|Overall Study||1
11035418|NCT00879437|12215028|FG001|NOT COMPLETED|Overall Study||1
11035419|NCT00879645|12215040|FG000|STARTED|Overall Study||9
11035420|NCT00879645|12215041|FG001|STARTED|Overall Study||6
11035421|NCT00879645|12215042|FG002|STARTED|Overall Study||6
11035422|NCT00879645|12215043|FG003|STARTED|Overall Study||7
11035423|NCT00879645|12215040|FG000|COMPLETED|Overall Study||8
11035424|NCT00879645|12215041|FG001|COMPLETED|Overall Study||6
11035425|NCT00879645|12215042|FG002|COMPLETED|Overall Study||6
11035426|NCT00879645|12215043|FG003|COMPLETED|Overall Study||7
11035427|NCT00879645|12215040|FG000|NOT COMPLETED|Overall Study||1
11035428|NCT00879645|12215041|FG001|NOT COMPLETED|Overall Study||0
11035429|NCT00879645|12215042|FG002|NOT COMPLETED|Overall Study||0
11035430|NCT00879645|12215043|FG003|NOT COMPLETED|Overall Study||0
11035431|NCT00879658|12215060|FG000|STARTED|Overall Study||50
11035432|NCT00879658|12215061|FG001|STARTED|Overall Study||49
11035433|NCT00879658|12215062|FG002|STARTED|Overall Study||43
11035434|NCT00879658|12215063|FG003|STARTED|Overall Study||46
11035435|NCT00879658|12215064|FG004|STARTED|Overall Study||42
11035436|NCT00879658|12215065|FG005|STARTED|Overall Study||51
11035437|NCT00879658|12215066|FG006|STARTED|Overall Study||16
11035438|NCT00879658|12215060|FG000|COMPLETED|Overall Study||35
11035439|NCT00879658|12215061|FG001|COMPLETED|Overall Study||44
11035440|NCT00879658|12215062|FG002|COMPLETED|Overall Study||36
11035441|NCT00879658|12215063|FG003|COMPLETED|Overall Study||42
11035442|NCT00879658|12215064|FG004|COMPLETED|Overall Study||40
11035443|NCT00879658|12215065|FG005|COMPLETED|Overall Study||50
11035444|NCT00879658|12215066|FG006|COMPLETED|Overall Study||16
11035445|NCT00879658|12215060|FG000|NOT COMPLETED|Overall Study||15
11035446|NCT00879658|12215061|FG001|NOT COMPLETED|Overall Study||5
11035447|NCT00879658|12215062|FG002|NOT COMPLETED|Overall Study||7
11035448|NCT00879658|12215063|FG003|NOT COMPLETED|Overall Study||4
11035449|NCT00879658|12215064|FG004|NOT COMPLETED|Overall Study||2
11035450|NCT00879658|12215065|FG005|NOT COMPLETED|Overall Study||1
11035451|NCT00879658|12215066|FG006|NOT COMPLETED|Overall Study||0
11035452|NCT00879684|12215088|FG000|STARTED|Stage 1: Dose Escalation||3
11035453|NCT00879684|12215089|FG001|STARTED|Stage 1: Dose Escalation||3
11035454|NCT00879684|12215090|FG002|STARTED|Stage 1: Dose Escalation||3
11035455|NCT00879684|12215091|FG003|STARTED|Stage 1: Dose Escalation||6
11035456|NCT00879684|12215092|FG004|STARTED|Stage 1: Dose Escalation||3
11035457|NCT00879684|12215093|FG005|STARTED|Stage 1: Dose Escalation||3
11035458|NCT00879684|12215094|FG006|STARTED|Stage 1: Dose Escalation||0
11035459|NCT00879684|12215088|FG000|COMPLETED|Stage 1: Dose Escalation||0
11035460|NCT00879684|12215089|FG001|COMPLETED|Stage 1: Dose Escalation||0
11035461|NCT00879684|12215090|FG002|COMPLETED|Stage 1: Dose Escalation||0
11035462|NCT00879684|12215091|FG003|COMPLETED|Stage 1: Dose Escalation||0
11035463|NCT00879684|12215092|FG004|COMPLETED|Stage 1: Dose Escalation||0
11035464|NCT00879684|12215093|FG005|COMPLETED|Stage 1: Dose Escalation||0
11035465|NCT00879684|12215094|FG006|COMPLETED|Stage 1: Dose Escalation||0
11035466|NCT00879684|12215088|FG000|NOT COMPLETED|Stage 1: Dose Escalation||3
11035467|NCT00879684|12215089|FG001|NOT COMPLETED|Stage 1: Dose Escalation||3
11035468|NCT00879684|12215090|FG002|NOT COMPLETED|Stage 1: Dose Escalation||3
11035469|NCT00879684|12215091|FG003|NOT COMPLETED|Stage 1: Dose Escalation||6
11035470|NCT00879684|12215092|FG004|NOT COMPLETED|Stage 1: Dose Escalation||3
11035471|NCT00879684|12215093|FG005|NOT COMPLETED|Stage 1: Dose Escalation||3
11035472|NCT00879684|12215094|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0
11035473|NCT00879684|12215088|FG000|STARTED|Stage 2: Expanded Cohort||0
11035474|NCT00879684|12215089|FG001|STARTED|Stage 2: Expanded Cohort||0
11035475|NCT00879684|12215090|FG002|STARTED|Stage 2: Expanded Cohort||0
11035476|NCT00879684|12215091|FG003|STARTED|Stage 2: Expanded Cohort||0
11035477|NCT00879684|12215092|FG004|STARTED|Stage 2: Expanded Cohort||0
11035478|NCT00879684|12215093|FG005|STARTED|Stage 2: Expanded Cohort||0
11035479|NCT00879684|12215094|FG006|STARTED|Stage 2: Expanded Cohort||13
11035480|NCT00879684|12215088|FG000|COMPLETED|Stage 2: Expanded Cohort||0
11035481|NCT00879684|12215089|FG001|COMPLETED|Stage 2: Expanded Cohort||0
11035482|NCT00879684|12215090|FG002|COMPLETED|Stage 2: Expanded Cohort||0
11035483|NCT00879684|12215091|FG003|COMPLETED|Stage 2: Expanded Cohort||0
11035484|NCT00879684|12215092|FG004|COMPLETED|Stage 2: Expanded Cohort||0
11035485|NCT00879684|12215093|FG005|COMPLETED|Stage 2: Expanded Cohort||0
11035486|NCT00879684|12215094|FG006|COMPLETED|Stage 2: Expanded Cohort||0
11035487|NCT00879684|12215088|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0
11035488|NCT00879684|12215089|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0
11334962|NCT02856490|12532459|FG001|NOT COMPLETED|Overall Study||0
11334963|NCT02856490|12532460|FG002|NOT COMPLETED|Overall Study||0
11334964|NCT02856555|12532471|FG000|STARTED|Overall Study||51
11334965|NCT02856555|12532472|FG001|STARTED|Overall Study||50
11334966|NCT02856555|12532473|FG002|STARTED|Overall Study||26
11334967|NCT02856555|12532471|FG000|COMPLETED|Overall Study||46
11334968|NCT02856555|12532472|FG001|COMPLETED|Overall Study||46
11334969|NCT02856555|12532473|FG002|COMPLETED|Overall Study||26
11334970|NCT02856555|12532471|FG000|NOT COMPLETED|Overall Study||5
11334971|NCT02856555|12532472|FG001|NOT COMPLETED|Overall Study||4
11334972|NCT02856555|12532473|FG002|NOT COMPLETED|Overall Study||0
11334973|NCT02856802|12532483|FG000|STARTED|Double-Blind Treatment Period 1|4 of 54 randomized subjects did not start; 2 had no migraines, 1 withdrew, 1 lost to follow-up.|50
11334974|NCT02856802|12532484|FG001|STARTED|Double-Blind Treatment Period 1|10 of 53 randomized subjects did not start; 6 had no migraines, 3 withdrew, 1 sponsor terminated.|43
11334975|NCT02856802|12532483|FG000|COMPLETED|Double-Blind Treatment Period 1||48
11334976|NCT02856802|12532484|FG001|COMPLETED|Double-Blind Treatment Period 1||38
11334977|NCT02856802|12532483|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||2
11334978|NCT02856802|12532484|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||5
11334979|NCT02856802|12532483|FG000|STARTED|Double-Blind Treatment Period 2|6 of 43 re-randomized subjects did not start; 5 had no migraines, for 1 protocol deviation.|37
11334980|NCT02856802|12532484|FG001|STARTED|Double-Blind Treatment Period 2|5 of 43 re-randomized subjects did not start; 4 had no migraines, for 1 prohibited drug use.|38
11334981|NCT02856802|12532483|FG000|COMPLETED|Double-Blind Treatment Period 2||36
11334982|NCT02856802|12532484|FG001|COMPLETED|Double-Blind Treatment Period 2||38
11035489|NCT00879684|12215090|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0
11035490|NCT00879684|12215091|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||0
11035491|NCT00879684|12215092|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||0
11035492|NCT00879684|12215093|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||0
11035493|NCT00879684|12215094|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||13
11035494|NCT00879697|12215115|FG000|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
11035495|NCT00879697|12215116|FG001|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
11035496|NCT00879697|12215115|FG000|COMPLETED|Overall Study|Two patients did not finish the trial|15
11035497|NCT00879697|12215116|FG001|COMPLETED|Overall Study|Two patients did not finish the trial|15
11035498|NCT00879697|12215115|FG000|NOT COMPLETED|Overall Study||2
11035499|NCT00879697|12215116|FG001|NOT COMPLETED|Overall Study||2
11035500|NCT00879710|12215124|FG000|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
11035501|NCT00879710|12215125|FG001|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
11035502|NCT00879710|12215126|FG002|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
11035503|NCT00879710|12215127|FG003|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
11035504|NCT00879710|12215124|FG000|COMPLETED|Phase 1 - 6 Weeks||10
11035505|NCT00879710|12215125|FG001|COMPLETED|Phase 1 - 6 Weeks||14
11035506|NCT00879710|12215126|FG002|COMPLETED|Phase 1 - 6 Weeks||9
11035507|NCT00879710|12215127|FG003|COMPLETED|Phase 1 - 6 Weeks||13
11035508|NCT00879710|12215124|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||2
11035509|NCT00879710|12215125|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||3
11035510|NCT00879710|12215126|FG002|NOT COMPLETED|Phase 1 - 6 Weeks||2
11035511|NCT00879710|12215127|FG003|NOT COMPLETED|Phase 1 - 6 Weeks||4
11035512|NCT00879710|12215124|FG000|STARTED|Wash Out Period of 4 Weeks||10
11035513|NCT00879710|12215125|FG001|STARTED|Wash Out Period of 4 Weeks||14
11035514|NCT00879710|12215126|FG002|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
11035515|NCT00879710|12215127|FG003|STARTED|Wash Out Period of 4 Weeks||13
11035516|NCT00879710|12215124|FG000|COMPLETED|Wash Out Period of 4 Weeks||10
11035517|NCT00879710|12215125|FG001|COMPLETED|Wash Out Period of 4 Weeks||14
11035518|NCT00879710|12215126|FG002|COMPLETED|Wash Out Period of 4 Weeks||10
11035519|NCT00879710|12215127|FG003|COMPLETED|Wash Out Period of 4 Weeks||13
11035520|NCT00879710|12215124|FG000|NOT COMPLETED|Wash Out Period of 4 Weeks||0
11035521|NCT00879710|12215125|FG001|NOT COMPLETED|Wash Out Period of 4 Weeks||0
11035522|NCT00879710|12215126|FG002|NOT COMPLETED|Wash Out Period of 4 Weeks||0
11035523|NCT00879710|12215127|FG003|NOT COMPLETED|Wash Out Period of 4 Weeks||0
11035524|NCT00879710|12215124|FG000|STARTED|Phase 2 6 Weeks||10
11035525|NCT00879710|12215125|FG001|STARTED|Phase 2 6 Weeks||14
11035526|NCT00879710|12215126|FG002|STARTED|Phase 2 6 Weeks||10
11035527|NCT00879710|12215127|FG003|STARTED|Phase 2 6 Weeks||13
11035528|NCT00879710|12215124|FG000|COMPLETED|Phase 2 6 Weeks||10
11035529|NCT00879710|12215125|FG001|COMPLETED|Phase 2 6 Weeks||14
11035530|NCT00879710|12215126|FG002|COMPLETED|Phase 2 6 Weeks||10
11035531|NCT00879710|12215127|FG003|COMPLETED|Phase 2 6 Weeks||13
11035532|NCT00879710|12215124|FG000|NOT COMPLETED|Phase 2 6 Weeks||0
11035533|NCT00879710|12215125|FG001|NOT COMPLETED|Phase 2 6 Weeks||0
11035534|NCT00879710|12215126|FG002|NOT COMPLETED|Phase 2 6 Weeks||0
11035535|NCT00879710|12215127|FG003|NOT COMPLETED|Phase 2 6 Weeks||0
11035536|NCT00879775|12215137|FG000|STARTED|Overall Study||20
11035537|NCT00879775|12215138|FG001|STARTED|Overall Study||21
11035538|NCT00879775|12215137|FG000|COMPLETED|Overall Study||18
11035539|NCT00879775|12215138|FG001|COMPLETED|Overall Study||20
11035540|NCT00879775|12215137|FG000|NOT COMPLETED|Overall Study||2
11035541|NCT00879775|12215138|FG001|NOT COMPLETED|Overall Study||1
11035542|NCT00879814|12215148|FG000|STARTED|Overall Study||12
11035543|NCT00879814|12215149|FG001|STARTED|Overall Study||12
11035544|NCT00879814|12215150|FG002|STARTED|Overall Study||12
11035545|NCT00879814|12215151|FG003|STARTED|Overall Study||12
11035546|NCT00879814|12215148|FG000|COMPLETED|Overall Study||8
11035547|NCT00879814|12215149|FG001|COMPLETED|Overall Study||10
11035548|NCT00879814|12215150|FG002|COMPLETED|Overall Study||9
11035549|NCT00879814|12215151|FG003|COMPLETED|Overall Study||7
11035550|NCT00879814|12215148|FG000|NOT COMPLETED|Overall Study||4
11035551|NCT00879814|12215149|FG001|NOT COMPLETED|Overall Study||2
11035552|NCT00879814|12215150|FG002|NOT COMPLETED|Overall Study||3
11035553|NCT00879814|12215151|FG003|NOT COMPLETED|Overall Study||5
11035554|NCT00879879|12215161|FG000|STARTED|Overall Study||20
11035555|NCT00879879|12215161|FG000|COMPLETED|Overall Study||17
11035556|NCT00879879|12215161|FG000|NOT COMPLETED|Overall Study||3
11035557|NCT00879970|12215170|FG000|STARTED|Period 1 TZD Randomization||541
11035558|NCT00879970|12215171|FG001|STARTED|Period 1 TZD Randomization||392
11035559|NCT00879970|12215172|FG002|STARTED|Period 1 TZD Randomization||399
11035560|NCT00879970|12215173|FG003|STARTED|Period 1 TZD Randomization||0
11035561|NCT00879970|12215174|FG004|STARTED|Period 1 TZD Randomization||0
11035562|NCT00879970|12215170|FG000|COMPLETED|Period 1 TZD Randomization||533
11035563|NCT00879970|12215171|FG001|COMPLETED|Period 1 TZD Randomization||388
11035564|NCT00879970|12215172|FG002|COMPLETED|Period 1 TZD Randomization||393
11035565|NCT00879970|12215173|FG003|COMPLETED|Period 1 TZD Randomization||0
11035566|NCT00879970|12215174|FG004|COMPLETED|Period 1 TZD Randomization||0
11035567|NCT00879970|12215170|FG000|NOT COMPLETED|Period 1 TZD Randomization||8
11035568|NCT00879970|12215171|FG001|NOT COMPLETED|Period 1 TZD Randomization||4
11035569|NCT00879970|12215172|FG002|NOT COMPLETED|Period 1 TZD Randomization||6
11035570|NCT00879970|12215173|FG003|NOT COMPLETED|Period 1 TZD Randomization||0
11035571|NCT00879970|12215174|FG004|NOT COMPLETED|Period 1 TZD Randomization||0
11035572|NCT00879970|12215170|FG000|STARTED|Period 2 Vitamin D Randomization||0
11035573|NCT00879970|12215171|FG001|STARTED|Period 2 Vitamin D Randomization||0
11035574|NCT00879970|12215172|FG002|STARTED|Period 2 Vitamin D Randomization||0
11035575|NCT00879970|12215173|FG003|STARTED|Period 2 Vitamin D Randomization||614
11035576|NCT00879970|12215174|FG004|STARTED|Period 2 Vitamin D Randomization||607
11035577|NCT00879970|12215170|FG000|COMPLETED|Period 2 Vitamin D Randomization||0
11035578|NCT00879970|12215171|FG001|COMPLETED|Period 2 Vitamin D Randomization||0
11035579|NCT00879970|12215172|FG002|COMPLETED|Period 2 Vitamin D Randomization||0
11035580|NCT00879970|12215173|FG003|COMPLETED|Period 2 Vitamin D Randomization||610
11035581|NCT00879970|12215174|FG004|COMPLETED|Period 2 Vitamin D Randomization||600
11035582|NCT00879970|12215170|FG000|NOT COMPLETED|Period 2 Vitamin D Randomization||0
11035583|NCT00879970|12215171|FG001|NOT COMPLETED|Period 2 Vitamin D Randomization||0
11035584|NCT00879970|12215172|FG002|NOT COMPLETED|Period 2 Vitamin D Randomization||0
11035585|NCT00879970|12215173|FG003|NOT COMPLETED|Period 2 Vitamin D Randomization||4
11035586|NCT00879970|12215174|FG004|NOT COMPLETED|Period 2 Vitamin D Randomization||7
11035587|NCT00879996|12215194|FG000|STARTED|Overall Study||28
11035588|NCT00879996|12215195|FG001|STARTED|Overall Study||26
11035589|NCT00879996|12215194|FG000|COMPLETED|Overall Study||13
11035590|NCT00879996|12215195|FG001|COMPLETED|Overall Study||13
11035591|NCT00879996|12215194|FG000|NOT COMPLETED|Overall Study||15
11035592|NCT00879996|12215195|FG001|NOT COMPLETED|Overall Study||13
11035593|NCT00880009|12215203|FG000|STARTED|Overall Study||16
11334983|NCT02856802|12532483|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1
11334984|NCT02856802|12532484|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||0
11334985|NCT02856828|12532496|FG000|STARTED|Overall Study||2
11334986|NCT02856828|12532497|FG001|STARTED|Overall Study||3
11334987|NCT02856828|12532496|FG000|COMPLETED|Overall Study||2
11334988|NCT02856828|12532497|FG001|COMPLETED|Overall Study||3
11334989|NCT02856828|12532496|FG000|NOT COMPLETED|Overall Study||0
11334990|NCT02856828|12532497|FG001|NOT COMPLETED|Overall Study||0
11334991|NCT02856880|12532511|FG000|STARTED|Overall Study||45
11334992|NCT02856880|12532511|FG000|Received Test Zinc-IPMP|Overall Study||44
11334993|NCT02856880|12532511|FG000|Received Test Zinc Non-IPMP|Overall Study||44
11334994|NCT02856880|12532511|FG000|Received Positive Control|Overall Study||45
11334995|NCT02856880|12532511|FG000|Received Non-SLS Negative Control|Overall Study||44
11334996|NCT02856880|12532511|FG000|Received SLS Negative Control|Overall Study||44
11035594|NCT00880009|12215203|FG000|COMPLETED|Overall Study||0
11035595|NCT00880009|12215203|FG000|NOT COMPLETED|Overall Study||16
11035596|NCT00880022|12215212|FG000|STARTED|Overall Study||23
11035597|NCT00880022|12215213|FG001|STARTED|Overall Study||24
11035598|NCT00880022|12215212|FG000|COMPLETED|Overall Study||21
11035599|NCT00880022|12215213|FG001|COMPLETED|Overall Study||21
11035600|NCT00880022|12215212|FG000|NOT COMPLETED|Overall Study||2
11035601|NCT00880022|12215213|FG001|NOT COMPLETED|Overall Study||3
11035602|NCT00880048|12215224|FG000|STARTED|Overall Study||116
11035603|NCT00880048|12215225|FG001|STARTED|Overall Study||115
11035604|NCT00880048|12215226|FG002|STARTED|Overall Study||112
11035605|NCT00880048|12215224|FG000|COMPLETED|Overall Study||88
11035606|NCT00880048|12215225|FG001|COMPLETED|Overall Study||82
11035607|NCT00880048|12215226|FG002|COMPLETED|Overall Study||77
11334997|NCT02856880|12532511|FG000|COMPLETED|Overall Study||44
11334998|NCT02856880|12532511|FG000|NOT COMPLETED|Overall Study||1
11334999|NCT02857283|12532532|FG000|STARTED|First Exposure||8
11335000|NCT02857283|12532533|FG001|STARTED|First Exposure||7
11335001|NCT02857283|12532532|FG000|COMPLETED|First Exposure||7
11335002|NCT02857283|12532533|FG001|COMPLETED|First Exposure||7
11335003|NCT02857283|12532532|FG000|NOT COMPLETED|First Exposure||1
11335004|NCT02857283|12532533|FG001|NOT COMPLETED|First Exposure||0
11335005|NCT02857283|12532532|FG000|STARTED|Washout (2 Weeks)||7
11335006|NCT02857283|12532533|FG001|STARTED|Washout (2 Weeks)||7
11335007|NCT02857283|12532532|FG000|COMPLETED|Washout (2 Weeks)||7
11335008|NCT02857283|12532533|FG001|COMPLETED|Washout (2 Weeks)||7
11335009|NCT02857283|12532532|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11335010|NCT02857283|12532533|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11335011|NCT02857283|12532532|FG000|STARTED|Second Exposure||7
11335012|NCT02857283|12532533|FG001|STARTED|Second Exposure||7
11335013|NCT02857283|12532532|FG000|COMPLETED|Second Exposure||7
11335014|NCT02857283|12532533|FG001|COMPLETED|Second Exposure||7
11335015|NCT02857283|12532532|FG000|NOT COMPLETED|Second Exposure||0
11335016|NCT02857283|12532533|FG001|NOT COMPLETED|Second Exposure||0
11335017|NCT02857816|12532540|FG000|STARTED|Overall Study||154
11335018|NCT02857816|12532540|FG000|Subjects Qualified and Treated With PTNM|Overall Study||120
11335019|NCT02857816|12532540|FG000|COMPLETED|Overall Study||116
11335020|NCT02857816|12532540|FG000|NOT COMPLETED|Overall Study||38
11035608|NCT00880048|12215224|FG000|NOT COMPLETED|Overall Study||28
11035609|NCT00880048|12215225|FG001|NOT COMPLETED|Overall Study||33
11035610|NCT00880048|12215226|FG002|NOT COMPLETED|Overall Study||35
11035611|NCT00880087|12215236|FG000|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
11035612|NCT00880087|12215237|FG001|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
11035613|NCT00880087|12215236|FG000|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
11335021|NCT02858050|12532547|FG000|STARTED|Overall Study||20
11035614|NCT00880087|12215237|FG001|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
11335022|NCT02858050|12532548|FG001|STARTED|Overall Study||20
11335023|NCT02858050|12532547|FG000|COMPLETED|Overall Study||20
11335024|NCT02858050|12532548|FG001|COMPLETED|Overall Study||20
11035615|NCT00880087|12215236|FG000|NOT COMPLETED|Overall Study||0
11035616|NCT00880087|12215237|FG001|NOT COMPLETED|Overall Study||2
11035617|NCT00880100|12215243|FG000|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
11035618|NCT00880100|12215243|FG000|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
11035619|NCT00880100|12215243|FG000|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
11035620|NCT00880100|12215243|FG000|STARTED|Treatment Phase With Ultrase® MT12||48
11035621|NCT00880100|12215243|FG000|COMPLETED|Treatment Phase With Ultrase® MT12||45
11035622|NCT00880100|12215243|FG000|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
11035623|NCT00880165|12215249|FG000|STARTED|Overall Study||148
11035624|NCT00880165|12215250|FG001|STARTED|Overall Study||148
11035625|NCT00880165|12215249|FG000|COMPLETED|Overall Study||86
11035626|NCT00880165|12215250|FG001|COMPLETED|Overall Study||98
11035627|NCT00880165|12215249|FG000|NOT COMPLETED|Overall Study||62
11035628|NCT00880165|12215250|FG001|NOT COMPLETED|Overall Study||50
11035629|NCT00880191|12215258|FG000|STARTED|Overall Study||207
11035630|NCT00880191|12215259|FG001|STARTED|Overall Study||206
11035631|NCT00880191|12215258|FG000|Available for Primary Endpoint Analysis|Overall Study||207
11035632|NCT00880191|12215259|FG001|Available for Primary Endpoint Analysis|Overall Study||206
11335025|NCT02858050|12532547|FG000|NOT COMPLETED|Overall Study||0
11335026|NCT02858050|12532548|FG001|NOT COMPLETED|Overall Study||0
11335027|NCT02858076|12532556|FG000|STARTED|Overall Study||100
11035633|NCT00880191|12215258|FG000|COMPLETED|Overall Study||194
11035634|NCT00880191|12215259|FG001|COMPLETED|Overall Study||198
11035635|NCT00880191|12215258|FG000|NOT COMPLETED|Overall Study||13
11035636|NCT00880191|12215259|FG001|NOT COMPLETED|Overall Study||8
11035637|NCT00880230|12215265|FG000|STARTED|Overall Study||141
11035638|NCT00880230|12215265|FG000|COMPLETED|Overall Study||134
11035639|NCT00880230|12215265|FG000|NOT COMPLETED|Overall Study||7
11035640|NCT00880256|12215269|FG000|STARTED|Overall Study||93
11035641|NCT00880256|12215269|FG000|COMPLETED|Overall Study||65
11035642|NCT00880256|12215269|FG000|NOT COMPLETED|Overall Study||28
11035643|NCT00880269|12215275|FG000|STARTED|Overall Study||32
11035644|NCT00880269|12215276|FG001|STARTED|Overall Study||27
11035645|NCT00880269|12215275|FG000|Discontinued Treatment|Overall Study||32
11035646|NCT00880269|12215276|FG001|Discontinued Treatment|Overall Study||27
11035647|NCT00880269|12215275|FG000|COMPLETED|Overall Study||0
11035648|NCT00880269|12215276|FG001|COMPLETED|Overall Study||0
11035649|NCT00880269|12215275|FG000|NOT COMPLETED|Overall Study||32
11035650|NCT00880269|12215276|FG001|NOT COMPLETED|Overall Study||27
11035651|NCT00880334|12215284|FG000|STARTED|Randomized Phase||74
11035652|NCT00880334|12215285|FG001|STARTED|Randomized Phase||75
11035653|NCT00880334|12215284|FG000|Eligible & Treated|Randomized Phase||70
11035654|NCT00880334|12215285|FG001|Eligible & Treated|Randomized Phase||72
11035655|NCT00880334|12215284|FG000|COMPLETED|Randomized Phase||70
11035656|NCT00880334|12215285|FG001|COMPLETED|Randomized Phase||35
11035657|NCT00880334|12215284|FG000|NOT COMPLETED|Randomized Phase||4
11035658|NCT00880334|12215285|FG001|NOT COMPLETED|Randomized Phase||40
11035659|NCT00880334|12215284|FG000|STARTED|Crossover Phase||0
11035660|NCT00880334|12215285|FG001|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
11035661|NCT00880334|12215284|FG000|COMPLETED|Crossover Phase||0
11035662|NCT00880334|12215285|FG001|COMPLETED|Crossover Phase||37
11035663|NCT00880334|12215284|FG000|NOT COMPLETED|Crossover Phase||0
11035664|NCT00880334|12215285|FG001|NOT COMPLETED|Crossover Phase||0
11035665|NCT00880360|12215295|FG000|STARTED|Overall Study||19
11035666|NCT00880360|12215295|FG000|COMPLETED|Overall Study||19
11035667|NCT00880360|12215295|FG000|NOT COMPLETED|Overall Study||0
11035668|NCT00880399|12215303|FG000|STARTED|Overall Study||108
11035669|NCT00880399|12215304|FG001|STARTED|Overall Study||113
11035670|NCT00880399|12215305|FG002|STARTED|Overall Study||107
11035671|NCT00880399|12215303|FG000|COMPLETED|Overall Study||77
11035672|NCT00880399|12215304|FG001|COMPLETED|Overall Study||84
11035673|NCT00880399|12215305|FG002|COMPLETED|Overall Study||81
11035674|NCT00880399|12215303|FG000|NOT COMPLETED|Overall Study||31
11035675|NCT00880399|12215304|FG001|NOT COMPLETED|Overall Study||29
11035676|NCT00880399|12215305|FG002|NOT COMPLETED|Overall Study||26
11035677|NCT00880425|12215313|FG000|STARTED|Overall Study||18
11035678|NCT00880425|12215314|FG001|STARTED|Overall Study||27
11035679|NCT00880425|12215313|FG000|COMPLETED|Overall Study||18
11035680|NCT00880425|12215314|FG001|COMPLETED|Overall Study||27
11035681|NCT00880425|12215313|FG000|NOT COMPLETED|Overall Study||0
11035682|NCT00880425|12215314|FG001|NOT COMPLETED|Overall Study||0
11035683|NCT00880464|12215320|FG000|STARTED|Overall Study||7
11035684|NCT00880464|12215320|FG000|COMPLETED|Overall Study||7
11035685|NCT00880464|12215320|FG000|NOT COMPLETED|Overall Study||0
11035686|NCT00880555|12215327|FG000|STARTED|Overall Study||23
11035687|NCT00880555|12215328|FG001|STARTED|Overall Study||40
11035688|NCT00880555|12215329|FG002|STARTED|Overall Study||11
11035689|NCT00880555|12215330|FG003|STARTED|Overall Study||2
11035690|NCT00880555|12215331|FG004|STARTED|Overall Study||1
11035691|NCT00880555|12215332|FG005|STARTED|Overall Study||1
11035692|NCT00880555|12215327|FG000|COMPLETED|Overall Study||13
11035693|NCT00880555|12215328|FG001|COMPLETED|Overall Study||23
11035694|NCT00880555|12215329|FG002|COMPLETED|Overall Study||6
11035695|NCT00880555|12215330|FG003|COMPLETED|Overall Study||0
11035696|NCT00880555|12215331|FG004|COMPLETED|Overall Study||0
11035697|NCT00880555|12215332|FG005|COMPLETED|Overall Study||0
11035698|NCT00880555|12215327|FG000|NOT COMPLETED|Overall Study||10
11035699|NCT00880555|12215328|FG001|NOT COMPLETED|Overall Study||17
11035700|NCT00880555|12215329|FG002|NOT COMPLETED|Overall Study||5
11035701|NCT00880555|12215330|FG003|NOT COMPLETED|Overall Study||2
11035702|NCT00880555|12215331|FG004|NOT COMPLETED|Overall Study||1
11035703|NCT00880555|12215332|FG005|NOT COMPLETED|Overall Study||1
11035704|NCT00880568|12215352|FG000|STARTED|Overall Study||3
11035705|NCT00880568|12215353|FG001|STARTED|Overall Study||3
11035706|NCT00880568|12215354|FG002|STARTED|Overall Study||3
11035707|NCT00880568|12215355|FG003|STARTED|Overall Study||1
11035708|NCT00880568|12215356|FG004|STARTED|Overall Study||3
11035709|NCT00880568|12215357|FG005|STARTED|Overall Study||3
11035710|NCT00880568|12215358|FG006|STARTED|Overall Study||6
11035711|NCT00880568|12215359|FG007|STARTED|Overall Study||2
11035712|NCT00880568|12215360|FG008|STARTED|Overall Study||3
11035713|NCT00880568|12215352|FG000|COMPLETED|Overall Study||0
11035714|NCT00880568|12215353|FG001|COMPLETED|Overall Study||0
11035715|NCT00880568|12215354|FG002|COMPLETED|Overall Study||0
11035716|NCT00880568|12215355|FG003|COMPLETED|Overall Study||0
11035717|NCT00880568|12215356|FG004|COMPLETED|Overall Study||0
11035718|NCT00880568|12215357|FG005|COMPLETED|Overall Study||0
11035719|NCT00880568|12215358|FG006|COMPLETED|Overall Study||0
11035720|NCT00880568|12215359|FG007|COMPLETED|Overall Study||0
11035721|NCT00880568|12215360|FG008|COMPLETED|Overall Study||0
11035722|NCT00880568|12215352|FG000|NOT COMPLETED|Overall Study||3
11035723|NCT00880568|12215353|FG001|NOT COMPLETED|Overall Study||3
11035724|NCT00880568|12215354|FG002|NOT COMPLETED|Overall Study||3
11035725|NCT00880568|12215355|FG003|NOT COMPLETED|Overall Study||1
11035726|NCT00880568|12215356|FG004|NOT COMPLETED|Overall Study||3
11035727|NCT00880568|12215357|FG005|NOT COMPLETED|Overall Study||3
11035728|NCT00880568|12215358|FG006|NOT COMPLETED|Overall Study||6
11035729|NCT00880568|12215359|FG007|NOT COMPLETED|Overall Study||2
11035730|NCT00880568|12215360|FG008|NOT COMPLETED|Overall Study||3
11035731|NCT00880581|12215385|FG000|STARTED|Cycle 1||30
11035732|NCT00880581|12215385|FG000|COMPLETED|Cycle 1||30
11035733|NCT00880581|12215385|FG000|NOT COMPLETED|Cycle 1||0
11035734|NCT00880581|12215385|FG000|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
11035735|NCT00880581|12215385|FG000|COMPLETED|Cycle 2 Re-treatment||24
11035736|NCT00880581|12215385|FG000|NOT COMPLETED|Cycle 2 Re-treatment||0
11035737|NCT00880607|12215391|FG000|STARTED|Overall Study||44
11035738|NCT00880607|12215392|FG001|STARTED|Overall Study||37
11035739|NCT00880607|12215391|FG000|Observation After Receiving Medication|Overall Study||42
11035740|NCT00880607|12215392|FG001|Observation After Receiving Medication|Overall Study||35
11035741|NCT00880607|12215391|FG000|COMPLETED|Overall Study||37
11035742|NCT00880607|12215392|FG001|COMPLETED|Overall Study||34
11035743|NCT00880607|12215391|FG000|NOT COMPLETED|Overall Study||7
11035744|NCT00880607|12215392|FG001|NOT COMPLETED|Overall Study||3
11057586|NCT00998985|12239229|FG002|STARTED|Overall Study||15
11057587|NCT00998985|12239230|FG003|STARTED|Overall Study||5
11057588|NCT00998985|12239231|FG004|STARTED|Overall Study||5
11057589|NCT00998985|12239232|FG005|STARTED|Overall Study||5
11057590|NCT00998985|12239233|FG006|STARTED|Overall Study||5
11057591|NCT00998985|12239234|FG007|STARTED|Overall Study||5
11057592|NCT00998985|12239235|FG008|STARTED|Overall Study||6
11057593|NCT00998985|12239236|FG009|STARTED|Overall Study||5
11057594|NCT00998985|12239237|FG010|STARTED|Overall Study||5
11057595|NCT00998985|12239238|FG011|STARTED|Overall Study||5
11057596|NCT00998985|12239239|FG012|STARTED|Overall Study||5
11057597|NCT00998985|12239240|FG013|STARTED|Overall Study||15
11057598|NCT00998985|12239227|FG000|COMPLETED|Overall Study||5
11057599|NCT00998985|12239228|FG001|COMPLETED|Overall Study||5
11057600|NCT00998985|12239229|FG002|COMPLETED|Overall Study||15
11057601|NCT00998985|12239230|FG003|COMPLETED|Overall Study||5
11057602|NCT00998985|12239231|FG004|COMPLETED|Overall Study||5
11057603|NCT00998985|12239232|FG005|COMPLETED|Overall Study||4
11057604|NCT00998985|12239233|FG006|COMPLETED|Overall Study||5
11057605|NCT00998985|12239234|FG007|COMPLETED|Overall Study||5
11057606|NCT00998985|12239235|FG008|COMPLETED|Overall Study||5
11057607|NCT00998985|12239236|FG009|COMPLETED|Overall Study||5
11057608|NCT00998985|12239237|FG010|COMPLETED|Overall Study||5
11057609|NCT00998985|12239238|FG011|COMPLETED|Overall Study||5
11057610|NCT00998985|12239239|FG012|COMPLETED|Overall Study||5
11057611|NCT00998985|12239240|FG013|COMPLETED|Overall Study||15
11057612|NCT00998985|12239227|FG000|NOT COMPLETED|Overall Study||0
11057613|NCT00998985|12239228|FG001|NOT COMPLETED|Overall Study||0
11057614|NCT00998985|12239229|FG002|NOT COMPLETED|Overall Study||0
11057615|NCT00998985|12239230|FG003|NOT COMPLETED|Overall Study||0
11057616|NCT00998985|12239231|FG004|NOT COMPLETED|Overall Study||0
11057617|NCT00998985|12239232|FG005|NOT COMPLETED|Overall Study||1
11057618|NCT00998985|12239233|FG006|NOT COMPLETED|Overall Study||0
11057619|NCT00998985|12239234|FG007|NOT COMPLETED|Overall Study||0
11057620|NCT00998985|12239235|FG008|NOT COMPLETED|Overall Study||1
11057621|NCT00998985|12239236|FG009|NOT COMPLETED|Overall Study||0
11057622|NCT00998985|12239237|FG010|NOT COMPLETED|Overall Study||0
11057623|NCT00998985|12239238|FG011|NOT COMPLETED|Overall Study||0
11057624|NCT00998985|12239239|FG012|NOT COMPLETED|Overall Study||0
11057625|NCT00998985|12239240|FG013|NOT COMPLETED|Overall Study||0
11057626|NCT00999037|12239287|FG000|STARTED|Overall Study||9
11057627|NCT00999037|12239288|FG001|STARTED|Overall Study|20|9
11057628|NCT00999037|12239287|FG000|COMPLETED|Overall Study||9
11057629|NCT00999037|12239288|FG001|COMPLETED|Overall Study||9
11057630|NCT00999037|12239287|FG000|NOT COMPLETED|Overall Study||0
11057631|NCT00999037|12239288|FG001|NOT COMPLETED|Overall Study||0
11057632|NCT00999102|12239296|FG000|STARTED|4 Weeks at Lower Dose of First Drug||16
11057633|NCT00999102|12239297|FG001|STARTED|4 Weeks at Lower Dose of First Drug||17
11057634|NCT00999102|12239296|FG000|COMPLETED|4 Weeks at Lower Dose of First Drug||15
11057635|NCT00999102|12239297|FG001|COMPLETED|4 Weeks at Lower Dose of First Drug||16
11057636|NCT00999102|12239296|FG000|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
11057637|NCT00999102|12239297|FG001|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
11057638|NCT00999102|12239296|FG000|STARTED|4 Weeks at Higher Dose of First Drug||15
11035745|NCT00880620|12215404|FG000|STARTED|Overall Study||92
11035746|NCT00880620|12215405|FG001|STARTED|Overall Study||87
11035747|NCT00880620|12215406|FG002|STARTED|Overall Study||104
11035748|NCT00880620|12215407|FG003|STARTED|Overall Study||98
11035749|NCT00880620|12215404|FG000|Week 4|Overall Study||88
11035750|NCT00880620|12215405|FG001|Week 4|Overall Study||79
11035751|NCT00880620|12215406|FG002|Week 4|Overall Study||94
11035752|NCT00880620|12215407|FG003|Week 4|Overall Study||86
11035753|NCT00880620|12215404|FG000|Week 9|Overall Study||80
11035754|NCT00880620|12215405|FG001|Week 9|Overall Study||73
11035755|NCT00880620|12215406|FG002|Week 9|Overall Study||88
11035756|NCT00880620|12215407|FG003|Week 9|Overall Study||78
11035757|NCT00880620|12215404|FG000|Week 16|Overall Study||74
11035758|NCT00880620|12215405|FG001|Week 16|Overall Study||73
11035759|NCT00880620|12215406|FG002|Week 16|Overall Study||87
11035760|NCT00880620|12215407|FG003|Week 16|Overall Study||74
11035761|NCT00880620|12215404|FG000|Week 23|Overall Study||71
11035762|NCT00880620|12215405|FG001|Week 23|Overall Study||72
11035763|NCT00880620|12215406|FG002|Week 23|Overall Study||85
11035764|NCT00880620|12215407|FG003|Week 23|Overall Study||74
11035765|NCT00880620|12215404|FG000|COMPLETED|Overall Study||71
11035766|NCT00880620|12215405|FG001|COMPLETED|Overall Study||72
11035767|NCT00880620|12215406|FG002|COMPLETED|Overall Study||83
11035768|NCT00880620|12215407|FG003|COMPLETED|Overall Study||74
11035769|NCT00880620|12215404|FG000|NOT COMPLETED|Overall Study||21
11035770|NCT00880620|12215405|FG001|NOT COMPLETED|Overall Study||15
11035771|NCT00880620|12215406|FG002|NOT COMPLETED|Overall Study||21
11035772|NCT00880620|12215407|FG003|NOT COMPLETED|Overall Study||24
11035773|NCT00880685|12215421|FG000|STARTED|Memantine 10mg||12
11035774|NCT00880685|12215421|FG000|COMPLETED|Memantine 10mg||10
11035775|NCT00880685|12215421|FG000|NOT COMPLETED|Memantine 10mg||2
11035776|NCT00880685|12215421|FG000|STARTED|Memantine 20mg||10
11035777|NCT00880685|12215421|FG000|COMPLETED|Memantine 20mg||9
11035778|NCT00880685|12215421|FG000|NOT COMPLETED|Memantine 20mg||1
11035779|NCT00880685|12215421|FG000|STARTED|Memantine 30mg||9
11035780|NCT00880685|12215421|FG000|COMPLETED|Memantine 30mg||9
11035781|NCT00880685|12215421|FG000|NOT COMPLETED|Memantine 30mg||0
11035782|NCT00880698|12215432|FG000|STARTED|Overall Study||62
11035783|NCT00880698|12215433|FG001|STARTED|Overall Study||64
11035784|NCT00880698|12215434|FG002|STARTED|Overall Study||37
11035785|NCT00880698|12215435|FG003|STARTED|Overall Study||39
11035786|NCT00880698|12215432|FG000|COMPLETED|Overall Study||61
11035787|NCT00880698|12215433|FG001|COMPLETED|Overall Study||61
11035788|NCT00880698|12215434|FG002|COMPLETED|Overall Study||36
11035789|NCT00880698|12215435|FG003|COMPLETED|Overall Study||36
11035790|NCT00880698|12215432|FG000|NOT COMPLETED|Overall Study||1
11035791|NCT00880698|12215433|FG001|NOT COMPLETED|Overall Study||3
11035792|NCT00880698|12215434|FG002|NOT COMPLETED|Overall Study||1
11035793|NCT00880698|12215435|FG003|NOT COMPLETED|Overall Study||3
11035794|NCT00880750|12215449|FG000|STARTED|First Intervention||39
11035795|NCT00880750|12215450|FG001|STARTED|First Intervention||33
11035796|NCT00880750|12215449|FG000|COMPLETED|First Intervention||30
11035797|NCT00880750|12215450|FG001|COMPLETED|First Intervention||32
11035798|NCT00880750|12215449|FG000|NOT COMPLETED|First Intervention||9
11035799|NCT00880750|12215450|FG001|NOT COMPLETED|First Intervention||1
11035800|NCT00880750|12215449|FG000|STARTED|Washout Period||30
11035801|NCT00880750|12215450|FG001|STARTED|Washout Period||32
11035802|NCT00880750|12215449|FG000|COMPLETED|Washout Period||30
11035803|NCT00880750|12215450|FG001|COMPLETED|Washout Period||32
11035804|NCT00880750|12215449|FG000|NOT COMPLETED|Washout Period||0
11035805|NCT00880750|12215450|FG001|NOT COMPLETED|Washout Period||0
11035806|NCT00880750|12215449|FG000|STARTED|Second Intervention||30
11035807|NCT00880750|12215450|FG001|STARTED|Second Intervention||32
11035808|NCT00880750|12215449|FG000|COMPLETED|Second Intervention||26
11035809|NCT00880750|12215450|FG001|COMPLETED|Second Intervention||30
11035810|NCT00880750|12215449|FG000|NOT COMPLETED|Second Intervention||4
11035811|NCT00880750|12215450|FG001|NOT COMPLETED|Second Intervention||2
11035812|NCT00880763|12215460|FG000|STARTED|Initial Treatment Period (Part 1)||23
11035813|NCT00880763|12215461|FG001|STARTED|Initial Treatment Period (Part 1)||22
11035814|NCT00880763|12215462|FG002|STARTED|Initial Treatment Period (Part 1)||23
11035815|NCT00880763|12215463|FG003|STARTED|Initial Treatment Period (Part 1)||22
11035816|NCT00880763|12215460|FG000|COMPLETED|Initial Treatment Period (Part 1)||23
11035817|NCT00880763|12215461|FG001|COMPLETED|Initial Treatment Period (Part 1)||22
11035818|NCT00880763|12215462|FG002|COMPLETED|Initial Treatment Period (Part 1)||23
11035819|NCT00880763|12215463|FG003|COMPLETED|Initial Treatment Period (Part 1)||22
11035820|NCT00880763|12215460|FG000|NOT COMPLETED|Initial Treatment Period (Part 1)||0
11035821|NCT00880763|12215461|FG001|NOT COMPLETED|Initial Treatment Period (Part 1)||0
11035822|NCT00880763|12215462|FG002|NOT COMPLETED|Initial Treatment Period (Part 1)||0
11035823|NCT00880763|12215463|FG003|NOT COMPLETED|Initial Treatment Period (Part 1)||0
11035824|NCT00880763|12215460|FG000|STARTED|Extension Period (Part 2)||23
11035825|NCT00880763|12215461|FG001|STARTED|Extension Period (Part 2)||22
11035826|NCT00880763|12215462|FG002|STARTED|Extension Period (Part 2)||23
11035827|NCT00880763|12215463|FG003|STARTED|Extension Period (Part 2)||22
11035828|NCT00880763|12215460|FG000|COMPLETED|Extension Period (Part 2)||23
11035829|NCT00880763|12215461|FG001|COMPLETED|Extension Period (Part 2)||19
11035830|NCT00880763|12215462|FG002|COMPLETED|Extension Period (Part 2)||20
11035831|NCT00880763|12215463|FG003|COMPLETED|Extension Period (Part 2)||19
11035832|NCT00880763|12215460|FG000|NOT COMPLETED|Extension Period (Part 2)||0
11035833|NCT00880763|12215461|FG001|NOT COMPLETED|Extension Period (Part 2)||3
11035834|NCT00880763|12215462|FG002|NOT COMPLETED|Extension Period (Part 2)||3
11035835|NCT00880763|12215463|FG003|NOT COMPLETED|Extension Period (Part 2)||3
11035836|NCT00880906|12215475|FG000|STARTED|Overall Study||29
11035837|NCT00880906|12215476|FG001|STARTED|Overall Study||21
11035838|NCT00880906|12215475|FG000|COMPLETED|Overall Study||17
11035839|NCT00880906|12215476|FG001|COMPLETED|Overall Study||14
11035840|NCT00880906|12215475|FG000|NOT COMPLETED|Overall Study||12
11035841|NCT00880906|12215476|FG001|NOT COMPLETED|Overall Study||7
11035842|NCT00880919|12215485|FG000|STARTED|Overall Study||33
11335028|NCT02858076|12532557|FG001|STARTED|Overall Study||105
11335029|NCT02858076|12532556|FG000|COMPLETED|Overall Study||90
11335030|NCT02858076|12532557|FG001|COMPLETED|Overall Study||87
11335031|NCT02858076|12532556|FG000|NOT COMPLETED|Overall Study||10
11335032|NCT02858076|12532557|FG001|NOT COMPLETED|Overall Study||18
11335033|NCT02858180|12532567|FG000|STARTED|Overall Study||10
11335034|NCT02858180|12532568|FG001|STARTED|Overall Study||5
11335035|NCT02858180|12532567|FG000|COMPLETED|Overall Study|Completed a 12-week course of therapy.|10
11335036|NCT02858180|12532568|FG001|COMPLETED|Overall Study|Completed a 12-week course of therapy.|3
11335037|NCT02858180|12532567|FG000|NOT COMPLETED|Overall Study||0
11335038|NCT02858180|12532568|FG001|NOT COMPLETED|Overall Study||2
11335039|NCT02858349|12532574|FG000|STARTED|Overall Study||10
11335040|NCT02858349|12532574|FG000|COMPLETED|Overall Study||10
11335041|NCT02858349|12532574|FG000|NOT COMPLETED|Overall Study||0
11335042|NCT02858362|12532581|FG000|STARTED|Overall Study||30
11335043|NCT02858362|12532582|FG001|STARTED|Overall Study||10
11335044|NCT02858362|12532583|FG002|STARTED|Overall Study||3
11335045|NCT02858362|12532581|FG000|Did Not Enter Extension Phase|Overall Study||1
11335046|NCT02858362|12532582|FG001|Did Not Enter Extension Phase|Overall Study||2
11335047|NCT02858362|12532583|FG002|Did Not Enter Extension Phase|Overall Study||0
11335048|NCT02858362|12532581|FG000|COMPLETED|Overall Study||28
11335049|NCT02858362|12532582|FG001|COMPLETED|Overall Study||9
11335050|NCT02858362|12532583|FG002|COMPLETED|Overall Study||0
11335051|NCT02858362|12532581|FG000|NOT COMPLETED|Overall Study||2
11335052|NCT02858362|12532582|FG001|NOT COMPLETED|Overall Study||1
11335053|NCT02858362|12532583|FG002|NOT COMPLETED|Overall Study||3
11335054|NCT02858401|12532603|FG000|STARTED|Overall Study||6
11335055|NCT02858401|12532604|FG001|STARTED|Overall Study||6
11335056|NCT02858401|12532605|FG002|STARTED|Overall Study||6
11335057|NCT02858401|12532606|FG003|STARTED|Overall Study||6
11335058|NCT02858401|12532607|FG004|STARTED|Overall Study||6
11335059|NCT02858401|12532608|FG005|STARTED|Overall Study||6
11335060|NCT02858401|12532609|FG006|STARTED|Overall Study||12
11335061|NCT02858401|12532603|FG000|COMPLETED|Overall Study||6
11335062|NCT02858401|12532604|FG001|COMPLETED|Overall Study||5
11335063|NCT02858401|12532605|FG002|COMPLETED|Overall Study||6
11335064|NCT02858401|12532606|FG003|COMPLETED|Overall Study||6
11335065|NCT02858401|12532607|FG004|COMPLETED|Overall Study||6
11035843|NCT00880919|12215486|FG001|STARTED|Overall Study||33
11035844|NCT00880919|12215487|FG002|STARTED|Overall Study||29
11035845|NCT00880919|12215485|FG000|COMPLETED|Overall Study||18
11035846|NCT00880919|12215486|FG001|COMPLETED|Overall Study||19
11035847|NCT00880919|12215487|FG002|COMPLETED|Overall Study||23
11035848|NCT00880919|12215485|FG000|NOT COMPLETED|Overall Study||15
11035849|NCT00880919|12215486|FG001|NOT COMPLETED|Overall Study||14
11035850|NCT00880919|12215487|FG002|NOT COMPLETED|Overall Study||6
11035851|NCT00880997|12215501|FG000|STARTED|Overall Study||9
11035852|NCT00880997|12215502|FG001|STARTED|Overall Study||8
11335066|NCT02858401|12532608|FG005|COMPLETED|Overall Study||5
11335067|NCT02858401|12532609|FG006|COMPLETED|Overall Study||12
11335068|NCT02858401|12532603|FG000|NOT COMPLETED|Overall Study||0
11035853|NCT00880997|12215503|FG002|STARTED|Overall Study||13
11035854|NCT00880997|12215501|FG000|COMPLETED|Overall Study||6
11035855|NCT00880997|12215502|FG001|COMPLETED|Overall Study||6
11035856|NCT00880997|12215503|FG002|COMPLETED|Overall Study||5
11035857|NCT00880997|12215501|FG000|NOT COMPLETED|Overall Study||3
11035858|NCT00880997|12215502|FG001|NOT COMPLETED|Overall Study||2
11035859|NCT00880997|12215503|FG002|NOT COMPLETED|Overall Study||8
11035860|NCT00881335|12215513|FG000|STARTED|Overall Study||30
11035861|NCT00881335|12215514|FG001|STARTED|Overall Study||30
11035862|NCT00881335|12215513|FG000|COMPLETED|Overall Study|3 participants did not complete the period|27
11035863|NCT00881335|12215514|FG001|COMPLETED|Overall Study|2 participants did not complete the period|28
11035864|NCT00881335|12215513|FG000|NOT COMPLETED|Overall Study||3
11035865|NCT00881335|12215514|FG001|NOT COMPLETED|Overall Study||2
11035866|NCT00881361|12215522|FG000|STARTED|Overall Study||707
11035867|NCT00881361|12215523|FG001|STARTED|Overall Study||47
11035868|NCT00881361|12215524|FG002|STARTED|Overall Study||2
11035869|NCT00881361|12215522|FG000|COMPLETED|Overall Study||663
11035870|NCT00881361|12215523|FG001|COMPLETED|Overall Study||38
11035871|NCT00881361|12215524|FG002|COMPLETED|Overall Study||0
11035872|NCT00881361|12215522|FG000|NOT COMPLETED|Overall Study||44
11035873|NCT00881361|12215523|FG001|NOT COMPLETED|Overall Study||9
11035874|NCT00881361|12215524|FG002|NOT COMPLETED|Overall Study||2
11035875|NCT00881465|12215535|FG000|STARTED|Overall Study||16
11035876|NCT00881465|12215536|FG001|STARTED|Overall Study||15
11035877|NCT00881465|12215535|FG000|COMPLETED|Overall Study||14
11035878|NCT00881465|12215536|FG001|COMPLETED|Overall Study||15
11035879|NCT00881465|12215535|FG000|NOT COMPLETED|Overall Study||2
11035880|NCT00881465|12215536|FG001|NOT COMPLETED|Overall Study||0
11035881|NCT00881504|12215542|FG000|STARTED|Overall Study||9
11035882|NCT00881504|12215542|FG000|COMPLETED|Overall Study||8
11035883|NCT00881504|12215542|FG000|NOT COMPLETED|Overall Study||1
11035884|NCT00881530|12215552|FG000|STARTED|Overall Study||106
11035885|NCT00881530|12215553|FG001|STARTED|Overall Study||109
11035886|NCT00881530|12215554|FG002|STARTED|Overall Study||56
11035887|NCT00881530|12215555|FG003|STARTED|Overall Study||166
11035888|NCT00881530|12215556|FG004|STARTED|Overall Study||166
11035889|NCT00881530|12215557|FG005|STARTED|Overall Study||56
11035890|NCT00881530|12215552|FG000|COMPLETED|Overall Study||92
11035891|NCT00881530|12215553|FG001|COMPLETED|Overall Study||104
11035892|NCT00881530|12215554|FG002|COMPLETED|Overall Study||51
11035893|NCT00881530|12215555|FG003|COMPLETED|Overall Study||157
11035894|NCT00881530|12215556|FG004|COMPLETED|Overall Study||152
11035895|NCT00881530|12215557|FG005|COMPLETED|Overall Study||51
11035896|NCT00881530|12215552|FG000|NOT COMPLETED|Overall Study||14
11035897|NCT00881530|12215553|FG001|NOT COMPLETED|Overall Study||5
11035898|NCT00881530|12215554|FG002|NOT COMPLETED|Overall Study||5
11035899|NCT00881530|12215555|FG003|NOT COMPLETED|Overall Study||9
11035900|NCT00881530|12215556|FG004|NOT COMPLETED|Overall Study||14
11035901|NCT00881530|12215557|FG005|NOT COMPLETED|Overall Study||5
11035902|NCT00881569|12215573|FG000|STARTED|Overall Study||1
11035903|NCT00881569|12215574|FG001|STARTED|Overall Study||1
11035904|NCT00881569|12215573|FG000|COMPLETED|Overall Study||0
11035905|NCT00881569|12215574|FG001|COMPLETED|Overall Study||0
11035906|NCT00881569|12215573|FG000|NOT COMPLETED|Overall Study||1
11035907|NCT00881569|12215574|FG001|NOT COMPLETED|Overall Study||1
11035908|NCT00881621|12215580|FG000|STARTED|Overall Study||51
11035909|NCT00881621|12215580|FG000|COMPLETED|Overall Study||17
11035910|NCT00881621|12215580|FG000|NOT COMPLETED|Overall Study||34
11035911|NCT00881647|12215586|FG000|STARTED|Overall Study||29
11035912|NCT00881647|12215587|FG001|STARTED|Overall Study||16
11035913|NCT00881647|12215586|FG000|COMPLETED|Overall Study||27
11035914|NCT00881647|12215587|FG001|COMPLETED|Overall Study||15
11035915|NCT00881647|12215586|FG000|NOT COMPLETED|Overall Study||2
11035916|NCT00881647|12215587|FG001|NOT COMPLETED|Overall Study||1
11035917|NCT00881712|12215596|FG000|STARTED|Overall Study||15
11035918|NCT00881712|12215597|FG001|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
11035919|NCT00881712|12215598|FG002|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
11035920|NCT00881712|12215596|FG000|COMPLETED|Overall Study||13
11035921|NCT00881712|12215597|FG001|COMPLETED|Overall Study||0
11035922|NCT00881712|12215598|FG002|COMPLETED|Overall Study||0
11035923|NCT00881712|12215596|FG000|NOT COMPLETED|Overall Study||2
11035924|NCT00881712|12215597|FG001|NOT COMPLETED|Overall Study||0
11035925|NCT00881712|12215598|FG002|NOT COMPLETED|Overall Study||0
11035926|NCT00881751|12215608|FG000|STARTED|Overall Study||47
11035927|NCT00881751|12215609|FG001|STARTED|Overall Study||48
11035928|NCT00881751|12215608|FG000|COMPLETED|Overall Study||47
11035929|NCT00881751|12215609|FG001|COMPLETED|Overall Study||43
11035930|NCT00881751|12215608|FG000|NOT COMPLETED|Overall Study||0
11035931|NCT00881751|12215609|FG001|NOT COMPLETED|Overall Study||5
11035932|NCT00881894|12215617|FG000|STARTED|Overall Study||26
11035933|NCT00881894|12215618|FG001|STARTED|Overall Study||26
11035934|NCT00881894|12215617|FG000|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
11035935|NCT00881894|12215618|FG001|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
11035936|NCT00881894|12215617|FG000|COMPLETED|Overall Study||25
11035937|NCT00881894|12215618|FG001|COMPLETED|Overall Study||23
11035938|NCT00881894|12215617|FG000|NOT COMPLETED|Overall Study||1
11035939|NCT00881894|12215618|FG001|NOT COMPLETED|Overall Study||3
11035940|NCT00881959|12215626|FG000|STARTED|Overall Study||38
11035941|NCT00881959|12215627|FG001|STARTED|Overall Study||42
11335069|NCT02858401|12532604|FG001|NOT COMPLETED|Overall Study||1
11335070|NCT02858401|12532605|FG002|NOT COMPLETED|Overall Study||0
11335071|NCT02858401|12532606|FG003|NOT COMPLETED|Overall Study||0
11335072|NCT02858401|12532607|FG004|NOT COMPLETED|Overall Study||0
11335073|NCT02858401|12532608|FG005|NOT COMPLETED|Overall Study||1
11335074|NCT02858401|12532609|FG006|NOT COMPLETED|Overall Study||0
11335075|NCT02858440|12532634|FG000|STARTED|Overall Study||235
11335076|NCT02858440|12532634|FG000|COMPLETED|Overall Study||223
11335077|NCT02858440|12532634|FG000|NOT COMPLETED|Overall Study||12
11335078|NCT02858492|12532642|FG000|STARTED|Overall Study||3
11335079|NCT02858492|12532643|FG001|STARTED|Overall Study||15
11335080|NCT02858492|12532644|FG002|STARTED|Overall Study||5
11335081|NCT02858492|12532645|FG003|STARTED|Overall Study||28
11335082|NCT02858492|12532642|FG000|COMPLETED|Overall Study||3
11335083|NCT02858492|12532643|FG001|COMPLETED|Overall Study||14
11335084|NCT02858492|12532644|FG002|COMPLETED|Overall Study||5
11335085|NCT02858492|12532645|FG003|COMPLETED|Overall Study||22
11335086|NCT02858492|12532642|FG000|NOT COMPLETED|Overall Study||0
11335087|NCT02858492|12532643|FG001|NOT COMPLETED|Overall Study||1
11335088|NCT02858492|12532644|FG002|NOT COMPLETED|Overall Study||0
11335089|NCT02858492|12532645|FG003|NOT COMPLETED|Overall Study||6
11335090|NCT02858713|12532659|FG000|STARTED|Overall Study||68
11335091|NCT02858713|12532660|FG001|STARTED|Overall Study||66
11335092|NCT02858713|12532659|FG000|COMPLETED|Overall Study||61
11335093|NCT02858713|12532660|FG001|COMPLETED|Overall Study||61
11335094|NCT02858713|12532659|FG000|NOT COMPLETED|Overall Study||7
11335095|NCT02858713|12532660|FG001|NOT COMPLETED|Overall Study||5
11335096|NCT02858726|12532674|FG000|STARTED|Overall Study||44
11335097|NCT02858726|12532675|FG001|STARTED|Overall Study||42
11335098|NCT02858726|12532676|FG002|STARTED|Overall Study||44
11335099|NCT02858726|12532677|FG003|STARTED|Overall Study||45
11335100|NCT02858726|12532674|FG000|COMPLETED|Overall Study||39
11335101|NCT02858726|12532675|FG001|COMPLETED|Overall Study||35
11335102|NCT02858726|12532676|FG002|COMPLETED|Overall Study||33
11335103|NCT02858726|12532677|FG003|COMPLETED|Overall Study||42
11335104|NCT02858726|12532674|FG000|NOT COMPLETED|Overall Study||5
11335105|NCT02858726|12532675|FG001|NOT COMPLETED|Overall Study||7
11335106|NCT02858726|12532676|FG002|NOT COMPLETED|Overall Study||11
11335107|NCT02858726|12532677|FG003|NOT COMPLETED|Overall Study||3
11335108|NCT02859142|12532693|FG000|STARTED|Overall Study||61
11335109|NCT02859142|12532694|FG001|STARTED|Overall Study||61
11335110|NCT02859142|12532693|FG000|COMPLETED|Overall Study||57
11335111|NCT02859142|12532694|FG001|COMPLETED|Overall Study||52
11335112|NCT02859142|12532693|FG000|NOT COMPLETED|Overall Study||4
11335113|NCT02859142|12532694|FG001|NOT COMPLETED|Overall Study||9
11335114|NCT02859246|12532700|FG000|STARTED|Overall Study|15 subjects were enrolled into study|15
11335115|NCT02859246|12532700|FG000|COMPLETED|Overall Study|10 subjects completed the study|10
11335116|NCT02859246|12532700|FG000|NOT COMPLETED|Overall Study||5
11335117|NCT02859324|12532708|FG000|STARTED|Overall Study||7
11335118|NCT02859324|12532709|FG001|STARTED|Overall Study||9
11335119|NCT02859324|12532710|FG002|STARTED|Overall Study||5
11335120|NCT02859324|12532708|FG000|COMPLETED|Overall Study||0
11335121|NCT02859324|12532709|FG001|COMPLETED|Overall Study||0
11335122|NCT02859324|12532710|FG002|COMPLETED|Overall Study||0
11335123|NCT02859324|12532708|FG000|NOT COMPLETED|Overall Study||7
11335124|NCT02859324|12532709|FG001|NOT COMPLETED|Overall Study||9
11335125|NCT02859324|12532710|FG002|NOT COMPLETED|Overall Study||5
11335126|NCT02859441|12532718|FG000|STARTED|Overall Study||3
11335127|NCT02859441|12532718|FG000|COMPLETED|Overall Study||3
11035942|NCT00881959|12215626|FG000|COMPLETED|Overall Study||36
11335128|NCT02859441|12532718|FG000|NOT COMPLETED|Overall Study||0
11335129|NCT02859454|12532739|FG000|STARTED|Overall Study||13
11335130|NCT02859454|12532739|FG000|COMPLETED|Overall Study||12
11335131|NCT02859454|12532739|FG000|NOT COMPLETED|Overall Study||1
11335132|NCT02859597|12532748|FG000|STARTED|Overall Study|started Dec 2016|22
11335133|NCT02859597|12532749|FG001|STARTED|Overall Study|Started Dec 2016|19
11035943|NCT00881959|12215627|FG001|COMPLETED|Overall Study||38
11035944|NCT00881959|12215626|FG000|NOT COMPLETED|Overall Study||2
11035945|NCT00881959|12215627|FG001|NOT COMPLETED|Overall Study||4
11035946|NCT00882102|12215633|FG000|STARTED|Overall Study||40
11035947|NCT00882102|12215633|FG000|COMPLETED|Overall Study||40
11035948|NCT00882102|12215633|FG000|NOT COMPLETED|Overall Study||0
11035949|NCT00882115|12215637|FG000|STARTED|Overall Study||38
11035950|NCT00882115|12215637|FG000|COMPLETED|Overall Study||29
11035951|NCT00882115|12215637|FG000|NOT COMPLETED|Overall Study||9
11035952|NCT00882206|12215641|FG000|STARTED|Overall Study||13
11035953|NCT00882206|12215641|FG000|COMPLETED|Overall Study||13
11035954|NCT00882206|12215641|FG000|NOT COMPLETED|Overall Study||0
11035955|NCT00882362|12215648|FG000|STARTED|Overall Study||122
11035956|NCT00882362|12215649|FG001|STARTED|Overall Study||33
11035957|NCT00882362|12215648|FG000|COMPLETED|Overall Study||73
11035958|NCT00882362|12215649|FG001|COMPLETED|Overall Study||10
11035959|NCT00882362|12215648|FG000|NOT COMPLETED|Overall Study||49
11035960|NCT00882362|12215649|FG001|NOT COMPLETED|Overall Study||23
11035961|NCT00882518|12215657|FG000|STARTED|Overall Study||196
11035962|NCT00882518|12215658|FG001|STARTED|Overall Study||192
11035963|NCT00882518|12215657|FG000|COMPLETED|Overall Study||158
11035964|NCT00882518|12215658|FG001|COMPLETED|Overall Study||148
11035965|NCT00882518|12215657|FG000|NOT COMPLETED|Overall Study||38
11035966|NCT00882518|12215658|FG001|NOT COMPLETED|Overall Study||44
11035967|NCT00882557|12215666|FG000|STARTED|Overall Study||8
11035968|NCT00882557|12215667|FG001|STARTED|Overall Study||8
11035969|NCT00882557|12215666|FG000|Completed Dose 1|Overall Study||8
11035970|NCT00882557|12215667|FG001|Completed Dose 1|Overall Study||7
11035971|NCT00882557|12215666|FG000|Completed Dose 2|Overall Study||6
11035972|NCT00882557|12215667|FG001|Completed Dose 2|Overall Study||7
11035973|NCT00882557|12215666|FG000|COMPLETED|Overall Study||6
11035974|NCT00882557|12215667|FG001|COMPLETED|Overall Study||7
11335134|NCT02859597|12532748|FG000|COMPLETED|Overall Study|September 2018|22
11035975|NCT00882557|12215666|FG000|NOT COMPLETED|Overall Study||2
11035976|NCT00882557|12215667|FG001|NOT COMPLETED|Overall Study||1
11035977|NCT00882583|12215675|FG000|STARTED|Overall Study||7
11035978|NCT00882583|12215676|FG001|STARTED|Overall Study||12
11035979|NCT00882583|12215675|FG000|COMPLETED|Overall Study||6
11035980|NCT00882583|12215676|FG001|COMPLETED|Overall Study||11
11035981|NCT00882583|12215675|FG000|NOT COMPLETED|Overall Study||1
11035982|NCT00882583|12215676|FG001|NOT COMPLETED|Overall Study||1
11035983|NCT00882661|12215685|FG000|STARTED|Investigational Training||89
11035984|NCT00882661|12215686|FG001|STARTED|Investigational Training||0
11035985|NCT00882661|12215685|FG000|COMPLETED|Investigational Training||79
11035986|NCT00882661|12215686|FG001|COMPLETED|Investigational Training||0
11035987|NCT00882661|12215685|FG000|NOT COMPLETED|Investigational Training||10
11035988|NCT00882661|12215686|FG001|NOT COMPLETED|Investigational Training||0
11035989|NCT00882661|12215685|FG000|STARTED|Treatment||151
11035990|NCT00882661|12215686|FG001|STARTED|Treatment||140
11035991|NCT00882661|12215685|FG000|COMPLETED|Treatment||141
11035992|NCT00882661|12215686|FG001|COMPLETED|Treatment||114
11035993|NCT00882661|12215685|FG000|NOT COMPLETED|Treatment||10
11035994|NCT00882661|12215686|FG001|NOT COMPLETED|Treatment||26
11035995|NCT00882687|12215698|FG000|STARTED|Overall Study||15
11035996|NCT00882687|12215699|FG001|STARTED|Overall Study||15
11035997|NCT00882687|12215700|FG002|STARTED|Overall Study||15
11035998|NCT00882687|12215701|FG003|STARTED|Overall Study||15
11035999|NCT00882687|12215698|FG000|COMPLETED|Overall Study||13
11036000|NCT00882687|12215699|FG001|COMPLETED|Overall Study||13
11036001|NCT00882687|12215700|FG002|COMPLETED|Overall Study||12
11036002|NCT00882687|12215701|FG003|COMPLETED|Overall Study||13
11036003|NCT00882687|12215698|FG000|NOT COMPLETED|Overall Study||2
11036004|NCT00882687|12215699|FG001|NOT COMPLETED|Overall Study||2
11036005|NCT00882687|12215700|FG002|NOT COMPLETED|Overall Study||3
11036006|NCT00882687|12215701|FG003|NOT COMPLETED|Overall Study||2
11036007|NCT00882713|12215711|FG000|STARTED|Overall Study||194
11036008|NCT00882713|12215711|FG000|COMPLETED|Overall Study||172
11036009|NCT00882713|12215711|FG000|NOT COMPLETED|Overall Study||22
11335135|NCT02859597|12532749|FG001|COMPLETED|Overall Study|September 2018|19
11335136|NCT02859597|12532748|FG000|NOT COMPLETED|Overall Study||0
11335137|NCT02859597|12532749|FG001|NOT COMPLETED|Overall Study||0
11335138|NCT02860130|12532759|FG000|STARTED|Overall Study||17
11335139|NCT02860130|12532760|FG001|STARTED|Overall Study||17
11335140|NCT02860130|12532759|FG000|COMPLETED|Overall Study||10
11335141|NCT02860130|12532760|FG001|COMPLETED|Overall Study||8
11335142|NCT02860130|12532759|FG000|NOT COMPLETED|Overall Study||7
11335143|NCT02860130|12532760|FG001|NOT COMPLETED|Overall Study||9
11335144|NCT02860286|12532768|FG000|STARTED|Overall Study||13
11335145|NCT02860286|12532769|FG001|STARTED|Overall Study||61
11335146|NCT02860286|12532768|FG000|COMPLETED|Overall Study||13
11036010|NCT00882778|12215716|FG000|STARTED|Overall Study||86
11036011|NCT00882778|12215716|FG000|COMPLETED|Overall Study||86
11036012|NCT00882778|12215716|FG000|NOT COMPLETED|Overall Study||0
11036013|NCT00882908|12215725|FG000|STARTED|Overall Study||78
11335147|NCT02860286|12532769|FG001|COMPLETED|Overall Study||61
11335148|NCT02860286|12532768|FG000|NOT COMPLETED|Overall Study||0
11335149|NCT02860286|12532769|FG001|NOT COMPLETED|Overall Study||0
11335150|NCT02860507|12532786|FG000|STARTED|Overall Study||25
11036014|NCT00882908|12215726|FG001|STARTED|Overall Study||75
11036015|NCT00882908|12215727|FG002|STARTED|Overall Study||77
11036016|NCT00882908|12215728|FG003|STARTED|Overall Study||79
11036017|NCT00882908|12215729|FG004|STARTED|Overall Study||77
11036018|NCT00882908|12215725|FG000|COMPLETED|Overall Study||75
11036019|NCT00882908|12215726|FG001|COMPLETED|Overall Study||69
11036020|NCT00882908|12215727|FG002|COMPLETED|Overall Study||70
11036021|NCT00882908|12215728|FG003|COMPLETED|Overall Study||72
11036022|NCT00882908|12215729|FG004|COMPLETED|Overall Study||71
11036023|NCT00882908|12215725|FG000|NOT COMPLETED|Overall Study||3
11036024|NCT00882908|12215726|FG001|NOT COMPLETED|Overall Study||6
11036025|NCT00882908|12215727|FG002|NOT COMPLETED|Overall Study||7
11036026|NCT00882908|12215728|FG003|NOT COMPLETED|Overall Study||7
11036027|NCT00882908|12215729|FG004|NOT COMPLETED|Overall Study||6
11036028|NCT00882921|12215742|FG000|STARTED|Overall Study||26
11036029|NCT00882921|12215742|FG000|COMPLETED|Overall Study||15
11036030|NCT00882921|12215742|FG000|NOT COMPLETED|Overall Study||11
11036031|NCT00882999|12215754|FG000|STARTED|Overall Study||35
11036032|NCT00882999|12215755|FG001|STARTED|Overall Study||34
11335151|NCT02860507|12532787|FG001|STARTED|Overall Study||25
11335152|NCT02860507|12532786|FG000|COMPLETED|Overall Study||25
11335153|NCT02860507|12532787|FG001|COMPLETED|Overall Study||25
11335154|NCT02860507|12532786|FG000|NOT COMPLETED|Overall Study||0
11036033|NCT00882999|12215756|FG002|STARTED|Overall Study||34
11036034|NCT00882999|12215757|FG003|STARTED|Overall Study||36
11036035|NCT00882999|12215758|FG004|STARTED|Overall Study||36
11036036|NCT00882999|12215759|FG005|STARTED|Overall Study||35
11036037|NCT00882999|12215760|FG006|STARTED|Overall Study||35
11036038|NCT00882999|12215754|FG000|Received Any Amount of Study Drug|Overall Study||35
11036039|NCT00882999|12215755|FG001|Received Any Amount of Study Drug|Overall Study||34
11036040|NCT00882999|12215756|FG002|Received Any Amount of Study Drug|Overall Study||34
11036041|NCT00882999|12215757|FG003|Received Any Amount of Study Drug|Overall Study||36
11036042|NCT00882999|12215758|FG004|Received Any Amount of Study Drug|Overall Study||36
11036043|NCT00882999|12215759|FG005|Received Any Amount of Study Drug|Overall Study||35
11036044|NCT00882999|12215760|FG006|Received Any Amount of Study Drug|Overall Study||35
11036045|NCT00882999|12215754|FG000|Completed Study Treatment|Overall Study||29
11036046|NCT00882999|12215755|FG001|Completed Study Treatment|Overall Study||29
11036047|NCT00882999|12215756|FG002|Completed Study Treatment|Overall Study||31
11036048|NCT00882999|12215757|FG003|Completed Study Treatment|Overall Study||33
11036049|NCT00882999|12215758|FG004|Completed Study Treatment|Overall Study||29
11036050|NCT00882999|12215759|FG005|Completed Study Treatment|Overall Study||30
11036051|NCT00882999|12215760|FG006|Completed Study Treatment|Overall Study||31
11036052|NCT00882999|12215754|FG000|COMPLETED|Overall Study||27
11036053|NCT00882999|12215755|FG001|COMPLETED|Overall Study||26
11036054|NCT00882999|12215756|FG002|COMPLETED|Overall Study||30
11036055|NCT00882999|12215757|FG003|COMPLETED|Overall Study||31
11036056|NCT00882999|12215758|FG004|COMPLETED|Overall Study||28
11036057|NCT00882999|12215759|FG005|COMPLETED|Overall Study||28
11036058|NCT00882999|12215760|FG006|COMPLETED|Overall Study||27
11036059|NCT00882999|12215754|FG000|NOT COMPLETED|Overall Study||8
11036060|NCT00882999|12215755|FG001|NOT COMPLETED|Overall Study||8
11036061|NCT00882999|12215756|FG002|NOT COMPLETED|Overall Study||4
11036062|NCT00882999|12215757|FG003|NOT COMPLETED|Overall Study||5
11036063|NCT00882999|12215758|FG004|NOT COMPLETED|Overall Study||8
11036064|NCT00882999|12215759|FG005|NOT COMPLETED|Overall Study||7
11036065|NCT00882999|12215760|FG006|NOT COMPLETED|Overall Study||8
11036066|NCT00883051|12215788|FG000|STARTED|Overall Study||106
11036067|NCT00883051|12215789|FG001|STARTED|Overall Study||104
11036068|NCT00883051|12215790|FG002|STARTED|Overall Study||100
11036069|NCT00883051|12215791|FG003|STARTED|Overall Study||99
11036070|NCT00883051|12215792|FG004|STARTED|Overall Study||103
11036071|NCT00883051|12215788|FG000|No Study Medication Used|Overall Study||24
11036072|NCT00883051|12215789|FG001|No Study Medication Used|Overall Study||22
11036073|NCT00883051|12215790|FG002|No Study Medication Used|Overall Study||29
11036074|NCT00883051|12215791|FG003|No Study Medication Used|Overall Study||29
11036075|NCT00883051|12215792|FG004|No Study Medication Used|Overall Study||17
11036076|NCT00883051|12215788|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
11036077|NCT00883051|12215789|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82
11036078|NCT00883051|12215790|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71
11036079|NCT00883051|12215791|FG003|Received at Least 1 Dose of Study Drug|Overall Study||70
11036080|NCT00883051|12215792|FG004|Received at Least 1 Dose of Study Drug|Overall Study||86
11036081|NCT00883051|12215788|FG000|COMPLETED|Overall Study||82
11036082|NCT00883051|12215789|FG001|COMPLETED|Overall Study||82
11036083|NCT00883051|12215790|FG002|COMPLETED|Overall Study||71
11036084|NCT00883051|12215791|FG003|COMPLETED|Overall Study||70
11036085|NCT00883051|12215792|FG004|COMPLETED|Overall Study|One participant was lost to follow up and did not provide adverse event data.|85
11036086|NCT00883051|12215788|FG000|NOT COMPLETED|Overall Study||24
11036087|NCT00883051|12215789|FG001|NOT COMPLETED|Overall Study||22
11036088|NCT00883051|12215790|FG002|NOT COMPLETED|Overall Study||29
11036089|NCT00883051|12215791|FG003|NOT COMPLETED|Overall Study||29
11036090|NCT00883051|12215792|FG004|NOT COMPLETED|Overall Study||18
11036091|NCT00883090|12215804|FG000|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
11036092|NCT00883090|12215804|FG000|COMPLETED|Overall Study||13
11036093|NCT00883090|12215804|FG000|NOT COMPLETED|Overall Study||2
11036094|NCT00883103|12215810|FG000|STARTED|Overall Study||69
11036095|NCT00883103|12215811|FG001|STARTED|Overall Study||68
11036096|NCT00883103|12215810|FG000|COMPLETED|Overall Study||69
11036097|NCT00883103|12215811|FG001|COMPLETED|Overall Study||68
11036098|NCT00883103|12215810|FG000|NOT COMPLETED|Overall Study||0
11335155|NCT02860507|12532787|FG001|NOT COMPLETED|Overall Study||0
11335156|NCT02860546|12532793|FG000|STARTED|Overall Study||18
11036099|NCT00883103|12215811|FG001|NOT COMPLETED|Overall Study||0
11036100|NCT00883116|12215819|FG000|STARTED|Overall Study||248
11036101|NCT00883116|12215820|FG001|STARTED|Overall Study||248
11036102|NCT00883116|12215819|FG000|Received Treatment|Overall Study||248
11036103|NCT00883116|12215820|FG001|Received Treatment|Overall Study||239
11036104|NCT00883116|12215819|FG000|COMPLETED|Overall Study||39
11036105|NCT00883116|12215820|FG001|COMPLETED|Overall Study||29
11036106|NCT00883116|12215819|FG000|NOT COMPLETED|Overall Study||209
11036107|NCT00883116|12215820|FG001|NOT COMPLETED|Overall Study||219
11036108|NCT00883129|12215830|FG000|STARTED|Overall Study||69
11036109|NCT00883129|12215831|FG001|STARTED|Overall Study||73
11036110|NCT00883129|12215830|FG000|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
11036111|NCT00883129|12215831|FG001|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
11036112|NCT00883129|12215830|FG000|NOT COMPLETED|Overall Study||20
11036113|NCT00883129|12215831|FG001|NOT COMPLETED|Overall Study||36
11036114|NCT00883168|12215841|FG000|STARTED|Overall Study||448
11036115|NCT00883168|12215842|FG001|STARTED|Overall Study||445
11036116|NCT00883168|12215843|FG002|STARTED|Overall Study||450
11036117|NCT00883168|12215844|FG003|STARTED|Overall Study||448
11036118|NCT00883168|12215841|FG000|COMPLETED|Overall Study||434
11036119|NCT00883168|12215842|FG001|COMPLETED|Overall Study||430
11036120|NCT00883168|12215843|FG002|COMPLETED|Overall Study||431
11036121|NCT00883168|12215844|FG003|COMPLETED|Overall Study||433
11036122|NCT00883168|12215841|FG000|NOT COMPLETED|Overall Study||14
11036123|NCT00883168|12215842|FG001|NOT COMPLETED|Overall Study||15
11036124|NCT00883168|12215843|FG002|NOT COMPLETED|Overall Study||19
11036125|NCT00883168|12215844|FG003|NOT COMPLETED|Overall Study||15
11036126|NCT00883181|12215854|FG000|STARTED|Overall Study|Full analysis set|1347
11036127|NCT00883181|12215854|FG000|COMPLETED|Overall Study|Completed planned chemotherapy|1069
11335157|NCT02860546|12532793|FG000|COMPLETED|Overall Study||0
11036128|NCT00883181|12215854|FG000|NOT COMPLETED|Overall Study||278
11036129|NCT00883233|12215875|FG000|STARTED|Overall Study||32
11036130|NCT00883233|12215876|FG001|STARTED|Overall Study||32
11036131|NCT00883233|12215877|FG002|STARTED|Overall Study||29
11036132|NCT00883233|12215878|FG003|STARTED|Overall Study||30
11036133|NCT00883233|12215875|FG000|COMPLETED|Overall Study||27
11036134|NCT00883233|12215876|FG001|COMPLETED|Overall Study||28
11036135|NCT00883233|12215877|FG002|COMPLETED|Overall Study||25
11036136|NCT00883233|12215878|FG003|COMPLETED|Overall Study||25
11036137|NCT00883233|12215875|FG000|NOT COMPLETED|Overall Study||5
11036138|NCT00883233|12215876|FG001|NOT COMPLETED|Overall Study||4
11036139|NCT00883233|12215877|FG002|NOT COMPLETED|Overall Study||4
11036140|NCT00883233|12215878|FG003|NOT COMPLETED|Overall Study||5
11036141|NCT00883246|12215888|FG000|STARTED|Overall Study||799
11036142|NCT00883246|12215888|FG000|COMPLETED|Overall Study||626
11036143|NCT00883246|12215888|FG000|NOT COMPLETED|Overall Study||173
11036144|NCT00883337|12215901|FG000|STARTED|Core Treatment Period||109
11036145|NCT00883337|12215902|FG001|STARTED|Core Treatment Period||111
11036146|NCT00883337|12215903|FG002|STARTED|Core Treatment Period||104
11036147|NCT00883337|12215901|FG000|Treated|Core Treatment Period||109
11036148|NCT00883337|12215902|FG001|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
11036149|NCT00883337|12215903|FG002|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
11036150|NCT00883337|12215901|FG000|COMPLETED|Core Treatment Period||89
11036151|NCT00883337|12215902|FG001|COMPLETED|Core Treatment Period||89
11036152|NCT00883337|12215903|FG002|COMPLETED|Core Treatment Period||71
11036153|NCT00883337|12215901|FG000|NOT COMPLETED|Core Treatment Period||20
11036154|NCT00883337|12215902|FG001|NOT COMPLETED|Core Treatment Period||22
11036155|NCT00883337|12215903|FG002|NOT COMPLETED|Core Treatment Period||33
11036156|NCT00883337|12215901|FG000|STARTED|Extension Treatment Period||89
11036157|NCT00883337|12215902|FG001|STARTED|Extension Treatment Period||89
11036158|NCT00883337|12215903|FG002|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
11036159|NCT00883337|12215901|FG000|COMPLETED|Extension Treatment Period||61
11036160|NCT00883337|12215902|FG001|COMPLETED|Extension Treatment Period||66
11036161|NCT00883337|12215903|FG002|COMPLETED|Extension Treatment Period||40
11036162|NCT00883337|12215901|FG000|NOT COMPLETED|Extension Treatment Period||28
11036163|NCT00883337|12215902|FG001|NOT COMPLETED|Extension Treatment Period||23
11036164|NCT00883337|12215903|FG002|NOT COMPLETED|Extension Treatment Period||19
11036165|NCT00883389|12215917|FG000|STARTED|Overall Study||26
11036166|NCT00883389|12215917|FG000|COMPLETED|Overall Study||26
11036167|NCT00883389|12215917|FG000|NOT COMPLETED|Overall Study||0
11036168|NCT00883415|12215921|FG000|STARTED|Overall Study||20
11036169|NCT00883415|12215921|FG000|COMPLETED|Overall Study||18
11036170|NCT00883415|12215921|FG000|NOT COMPLETED|Overall Study||2
11036171|NCT00883493|12215927|FG000|STARTED|Overall Study||212
11036172|NCT00883493|12215928|FG001|STARTED|Overall Study||209
11036173|NCT00883493|12215927|FG000|Intention To Treat Analysis Population|Overall Study||204
11036174|NCT00883493|12215928|FG001|Intention To Treat Analysis Population|Overall Study||195
11036175|NCT00883493|12215927|FG000|Per Protocol Analysis Population|Overall Study||162
11036176|NCT00883493|12215928|FG001|Per Protocol Analysis Population|Overall Study||155
11036177|NCT00883493|12215927|FG000|COMPLETED|Overall Study||166
11036178|NCT00883493|12215928|FG001|COMPLETED|Overall Study||159
11036179|NCT00883493|12215927|FG000|NOT COMPLETED|Overall Study||46
11036180|NCT00883493|12215928|FG001|NOT COMPLETED|Overall Study||50
11036181|NCT00883558|12215934|FG000|STARTED|Titration Period (Weeks 0 to 4)||48
11036182|NCT00883558|12215935|FG001|STARTED|Titration Period (Weeks 0 to 4)||0
11036183|NCT00883558|12215936|FG002|STARTED|Titration Period (Weeks 0 to 4)||0
11036184|NCT00883558|12215934|FG000|COMPLETED|Titration Period (Weeks 0 to 4)||46
11036185|NCT00883558|12215935|FG001|COMPLETED|Titration Period (Weeks 0 to 4)||0
11036186|NCT00883558|12215936|FG002|COMPLETED|Titration Period (Weeks 0 to 4)||0
11036187|NCT00883558|12215934|FG000|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
11036188|NCT00883558|12215935|FG001|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
11036189|NCT00883558|12215936|FG002|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
11036190|NCT00883558|12215934|FG000|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
11036191|NCT00883558|12215935|FG001|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
11036192|NCT00883558|12215936|FG002|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
11036193|NCT00883558|12215934|FG000|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
11036194|NCT00883558|12215935|FG001|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
11036195|NCT00883558|12215936|FG002|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
11036196|NCT00883558|12215934|FG000|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
11036197|NCT00883558|12215935|FG001|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
11036198|NCT00883558|12215936|FG002|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
11036199|NCT00883558|12215934|FG000|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
11036200|NCT00883558|12215935|FG001|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
11036201|NCT00883558|12215936|FG002|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
11036202|NCT00883558|12215934|FG000|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
11036203|NCT00883558|12215935|FG001|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
11036204|NCT00883558|12215936|FG002|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
11036205|NCT00883558|12215934|FG000|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
11036206|NCT00883558|12215935|FG001|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
11036207|NCT00883558|12215936|FG002|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
11036208|NCT00883558|12215934|FG000|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
11036209|NCT00883558|12215935|FG001|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
11036210|NCT00883558|12215936|FG002|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
11036211|NCT00883558|12215934|FG000|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
11036212|NCT00883558|12215935|FG001|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
11036213|NCT00883558|12215936|FG002|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
11036214|NCT00883675|12215942|FG000|STARTED|Overall Study||133
11036215|NCT00883675|12215942|FG000|COMPLETED|Overall Study||133
11036216|NCT00883675|12215942|FG000|NOT COMPLETED|Overall Study||0
11036217|NCT00883688|12215946|FG000|STARTED|Overall Study||24
11036218|NCT00883688|12215946|FG000|COMPLETED|Overall Study||22
11036219|NCT00883688|12215946|FG000|NOT COMPLETED|Overall Study||2
11036220|NCT00883740|12215950|FG000|STARTED|First Intervention||60
11036221|NCT00883740|12215951|FG001|STARTED|First Intervention||59
11036222|NCT00883740|12215950|FG000|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
11036223|NCT00883740|12215951|FG001|COMPLETED|First Intervention||51
11036224|NCT00883740|12215950|FG000|NOT COMPLETED|First Intervention||7
11036225|NCT00883740|12215951|FG001|NOT COMPLETED|First Intervention||8
11036226|NCT00883740|12215950|FG000|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
11036227|NCT00883740|12215951|FG001|STARTED|Taper and Washout Period (2 Weeks)||51
11036228|NCT00883740|12215950|FG000|COMPLETED|Taper and Washout Period (2 Weeks)||54
11036229|NCT00883740|12215951|FG001|COMPLETED|Taper and Washout Period (2 Weeks)||51
11036230|NCT00883740|12215950|FG000|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
11036231|NCT00883740|12215951|FG001|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
11036232|NCT00883740|12215950|FG000|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
11036233|NCT00883740|12215951|FG001|STARTED|Second Intervention||51
11036234|NCT00883740|12215950|FG000|COMPLETED|Second Intervention||52
11036235|NCT00883740|12215951|FG001|COMPLETED|Second Intervention||50
11036236|NCT00883740|12215950|FG000|NOT COMPLETED|Second Intervention||1
11036237|NCT00883740|12215951|FG001|NOT COMPLETED|Second Intervention||1
11036238|NCT00883753|12215957|FG000|STARTED|Overall Study||934
11036239|NCT00883753|12215957|FG000|COMPLETED|Overall Study||827
11036240|NCT00883753|12215957|FG000|NOT COMPLETED|Overall Study||107
11036241|NCT00883779|12215966|FG000|STARTED|Primary Study Treatment Phase||225
11335158|NCT02860546|12532793|FG000|NOT COMPLETED|Overall Study||18
11335159|NCT02860845|12532799|FG000|STARTED|Overall Study||24
11036242|NCT00883779|12215967|FG001|STARTED|Primary Study Treatment Phase||226
11036243|NCT00883779|12215966|FG000|COMPLETED|Primary Study Treatment Phase||120
11036244|NCT00883779|12215967|FG001|COMPLETED|Primary Study Treatment Phase||140
11036245|NCT00883779|12215966|FG000|NOT COMPLETED|Primary Study Treatment Phase||105
11036246|NCT00883779|12215967|FG001|NOT COMPLETED|Primary Study Treatment Phase||86
11036247|NCT00883779|12215966|FG000|STARTED|Post-Study Treatment Phase||112
11036248|NCT00883779|12215967|FG001|STARTED|Post-Study Treatment Phase||135
11036249|NCT00883779|12215966|FG000|COMPLETED|Post-Study Treatment Phase||0
11335160|NCT02860845|12532800|FG001|STARTED|Overall Study||24
11335161|NCT02860845|12532799|FG000|Analyzed Patients|Overall Study||22
11335162|NCT02860845|12532800|FG001|Analyzed Patients|Overall Study||23
11335163|NCT02860845|12532799|FG000|COMPLETED|Overall Study||22
11335164|NCT02860845|12532800|FG001|COMPLETED|Overall Study||23
11335165|NCT02860845|12532799|FG000|NOT COMPLETED|Overall Study||2
11335166|NCT02860845|12532800|FG001|NOT COMPLETED|Overall Study||1
11335167|NCT02860988|12532812|FG000|STARTED|Overall Study||201
11335168|NCT02860988|12532813|FG001|STARTED|Overall Study||200
11335169|NCT02860988|12532812|FG000|COMPLETED|Overall Study||117
11335170|NCT02860988|12532813|FG001|COMPLETED|Overall Study||94
11036250|NCT00883779|12215967|FG001|COMPLETED|Post-Study Treatment Phase||0
11036251|NCT00883779|12215966|FG000|NOT COMPLETED|Post-Study Treatment Phase||112
11036252|NCT00883779|12215967|FG001|NOT COMPLETED|Post-Study Treatment Phase||135
11036253|NCT00883779|12215966|FG000|STARTED|Off-study Phase||209
11036254|NCT00883779|12215967|FG001|STARTED|Off-study Phase||202
11036255|NCT00883779|12215966|FG000|COMPLETED|Off-study Phase||0
11036256|NCT00883779|12215967|FG001|COMPLETED|Off-study Phase||0
11036257|NCT00883779|12215966|FG000|NOT COMPLETED|Off-study Phase||209
11036258|NCT00883779|12215967|FG001|NOT COMPLETED|Off-study Phase||202
11036259|NCT00884039|12215975|FG000|STARTED|Overall Study||5
11036260|NCT00884039|12215976|FG001|STARTED|Overall Study||2
11036261|NCT00884039|12215975|FG000|COMPLETED|Overall Study||3
11036262|NCT00884039|12215976|FG001|COMPLETED|Overall Study||1
11036263|NCT00884039|12215975|FG000|NOT COMPLETED|Overall Study||2
11036264|NCT00884039|12215976|FG001|NOT COMPLETED|Overall Study||1
11036265|NCT00884052|12215982|FG000|STARTED|Overall Study||6
11036266|NCT00884052|12215983|FG001|STARTED|Overall Study||12
11036267|NCT00884052|12215982|FG000|COMPLETED|Overall Study||6
11036268|NCT00884052|12215983|FG001|COMPLETED|Overall Study||12
11036269|NCT00884052|12215982|FG000|NOT COMPLETED|Overall Study||0
11036270|NCT00884052|12215983|FG001|NOT COMPLETED|Overall Study||0
11036271|NCT00884065|12215991|FG000|STARTED|Overall Study||25
11036272|NCT00884065|12215992|FG001|STARTED|Overall Study||25
11036273|NCT00884065|12215991|FG000|COMPLETED|Overall Study||25
11036274|NCT00884065|12215992|FG001|COMPLETED|Overall Study||25
11036275|NCT00884065|12215991|FG000|NOT COMPLETED|Overall Study||0
11036276|NCT00884065|12215992|FG001|NOT COMPLETED|Overall Study||0
11036277|NCT00884117|12215998|FG000|STARTED|Overall Study||4561
11036278|NCT00884117|12215998|FG000|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
11036279|NCT00884117|12215998|FG000|NOT COMPLETED|Overall Study||249
11036280|NCT00884221|12216017|FG000|STARTED|Overall Study||374
11036281|NCT00884221|12216018|FG001|STARTED|Overall Study||375
11036282|NCT00884221|12216017|FG000|COMPLETED|Overall Study||340
11036283|NCT00884221|12216018|FG001|COMPLETED|Overall Study||343
11036284|NCT00884221|12216017|FG000|NOT COMPLETED|Overall Study||34
11036285|NCT00884221|12216018|FG001|NOT COMPLETED|Overall Study||32
11036286|NCT00884273|12216028|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
11200868|NCT01829360|12391083|FG002|COMPLETED|Overall Study||9
11200869|NCT01829360|12391084|FG003|COMPLETED|Overall Study||8
11200870|NCT01829360|12391081|FG000|NOT COMPLETED|Overall Study||0
11200871|NCT01829360|12391082|FG001|NOT COMPLETED|Overall Study||0
11200872|NCT01829360|12391083|FG002|NOT COMPLETED|Overall Study||1
11200873|NCT01829360|12391084|FG003|NOT COMPLETED|Overall Study||0
11200874|NCT01829399|12391100|FG000|STARTED|Visit 1||12
11200875|NCT01829399|12391101|FG001|STARTED|Visit 1||12
11200876|NCT01829399|12391100|FG000|COMPLETED|Visit 1||12
11200877|NCT01829399|12391101|FG001|COMPLETED|Visit 1||12
11200878|NCT01829399|12391100|FG000|NOT COMPLETED|Visit 1||0
11200879|NCT01829399|12391101|FG001|NOT COMPLETED|Visit 1||0
11200880|NCT01829399|12391100|FG000|STARTED|Visit 2 (One Month Later)||12
11200881|NCT01829399|12391101|FG001|STARTED|Visit 2 (One Month Later)||12
11200882|NCT01829399|12391100|FG000|COMPLETED|Visit 2 (One Month Later)||12
11200883|NCT01829399|12391101|FG001|COMPLETED|Visit 2 (One Month Later)||12
11200884|NCT01829399|12391100|FG000|NOT COMPLETED|Visit 2 (One Month Later)||0
11200885|NCT01829399|12391101|FG001|NOT COMPLETED|Visit 2 (One Month Later)||0
11200886|NCT01829425|12391111|FG000|STARTED|Overall Study||78
11200887|NCT01829425|12391112|FG001|STARTED|Overall Study||74
11200888|NCT01829425|12391111|FG000|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72
11200889|NCT01829425|12391112|FG001|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70
11200890|NCT01829425|12391111|FG000|NOT COMPLETED|Overall Study||6
11200891|NCT01829425|12391112|FG001|NOT COMPLETED|Overall Study||4
11200892|NCT01829464|12391121|FG000|STARTED|Overall Study||30
11200893|NCT01829464|12391122|FG001|STARTED|Overall Study||31
11200894|NCT01829464|12391123|FG002|STARTED|Overall Study||29
11200895|NCT01829464|12391121|FG000|COMPLETED|Overall Study||2
11200896|NCT01829464|12391122|FG001|COMPLETED|Overall Study||2
11200897|NCT01829464|12391123|FG002|COMPLETED|Overall Study||3
11200898|NCT01829464|12391121|FG000|NOT COMPLETED|Overall Study||28
11200899|NCT01829464|12391122|FG001|NOT COMPLETED|Overall Study||29
11200900|NCT01829464|12391123|FG002|NOT COMPLETED|Overall Study||26
11200901|NCT01829503|12391131|FG000|STARTED|Overall Study||44
11200902|NCT01829503|12391131|FG000|COMPLETED|Overall Study||44
11200903|NCT01829503|12391131|FG000|NOT COMPLETED|Overall Study||0
11200904|NCT01829516|12391137|FG000|STARTED|First Intervention||18
11200905|NCT01829516|12391138|FG001|STARTED|First Intervention||14
11200906|NCT01829516|12391137|FG000|COMPLETED|First Intervention||18
11200907|NCT01829516|12391138|FG001|COMPLETED|First Intervention||14
11200908|NCT01829516|12391137|FG000|NOT COMPLETED|First Intervention||0
11200909|NCT01829516|12391138|FG001|NOT COMPLETED|First Intervention||0
11200910|NCT01829516|12391137|FG000|STARTED|Washout Period - 1 Week||18
11200911|NCT01829516|12391138|FG001|STARTED|Washout Period - 1 Week||14
11200912|NCT01829516|12391137|FG000|COMPLETED|Washout Period - 1 Week||18
11200913|NCT01829516|12391138|FG001|COMPLETED|Washout Period - 1 Week||14
11200914|NCT01829516|12391137|FG000|NOT COMPLETED|Washout Period - 1 Week||0
11200915|NCT01829516|12391138|FG001|NOT COMPLETED|Washout Period - 1 Week||0
11200916|NCT01829516|12391137|FG000|STARTED|2nd Intervention||18
11200917|NCT01829516|12391138|FG001|STARTED|2nd Intervention||14
11335171|NCT02860988|12532812|FG000|NOT COMPLETED|Overall Study||84
11335172|NCT02860988|12532813|FG001|NOT COMPLETED|Overall Study||106
11335173|NCT02861118|12532821|FG000|STARTED|Overall Study||194
11335174|NCT02861118|12532822|FG001|STARTED|Overall Study||116
11036287|NCT00884273|12216029|FG001|STARTED|Overall Study|ITT population.|98
11036288|NCT00884273|12216028|FG000|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
11036289|NCT00884273|12216029|FG001|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
11036290|NCT00884273|12216028|FG000|Per Protocol (PP) Analysis Set|Overall Study||81
11036291|NCT00884273|12216029|FG001|Per Protocol (PP) Analysis Set|Overall Study||92
11036292|NCT00884273|12216028|FG000|Safety Analysis Set|Overall Study||84
11036293|NCT00884273|12216029|FG001|Safety Analysis Set|Overall Study||98
11036294|NCT00884273|12216028|FG000|COMPLETED|Overall Study||82
11036295|NCT00884273|12216029|FG001|COMPLETED|Overall Study||93
11036296|NCT00884273|12216028|FG000|NOT COMPLETED|Overall Study||2
11036297|NCT00884273|12216029|FG001|NOT COMPLETED|Overall Study||5
11036298|NCT00884286|12216037|FG000|STARTED|Overall Study||34
11036299|NCT00884286|12216038|FG001|STARTED|Overall Study||33
11036300|NCT00884286|12216037|FG000|COMPLETED|Overall Study||2
11036301|NCT00884286|12216038|FG001|COMPLETED|Overall Study||0
11036302|NCT00884286|12216037|FG000|NOT COMPLETED|Overall Study||32
11036303|NCT00884286|12216038|FG001|NOT COMPLETED|Overall Study||33
11036304|NCT00884312|12216047|FG000|STARTED|Overall Study||9
11036305|NCT00884312|12216048|FG001|STARTED|Overall Study||92
11036306|NCT00884312|12216047|FG000|Received Treatment|Overall Study||9
11036307|NCT00884312|12216048|FG001|Received Treatment|Overall Study||91
11036308|NCT00884312|12216047|FG000|COMPLETED|Overall Study||7
11036309|NCT00884312|12216048|FG001|COMPLETED|Overall Study||67
11036310|NCT00884312|12216047|FG000|NOT COMPLETED|Overall Study||2
11335175|NCT02861118|12532821|FG000|COMPLETED|Overall Study||194
11335176|NCT02861118|12532822|FG001|COMPLETED|Overall Study||116
11335177|NCT02861118|12532821|FG000|NOT COMPLETED|Overall Study||0
11335178|NCT02861118|12532822|FG001|NOT COMPLETED|Overall Study||0
11335179|NCT02861131|12532832|FG000|STARTED|Overall Study||100
11335180|NCT02861131|12532833|FG001|STARTED|Overall Study||100
11335181|NCT02861131|12532832|FG000|COMPLETED|Overall Study||100
11335182|NCT02861131|12532833|FG001|COMPLETED|Overall Study||100
11335183|NCT02861131|12532832|FG000|NOT COMPLETED|Overall Study||0
11335184|NCT02861131|12532833|FG001|NOT COMPLETED|Overall Study||0
11335185|NCT02861534|12532841|FG000|STARTED|Overall Study||2526
11335186|NCT02861534|12532842|FG001|STARTED|Overall Study||2524
11335187|NCT02861534|12532841|FG000|Treated|Overall Study||2519
11335188|NCT02861534|12532842|FG001|Treated|Overall Study||2515
11335189|NCT02861534|12532841|FG000|COMPLETED|Overall Study||1952
11335190|NCT02861534|12532842|FG001|COMPLETED|Overall Study||1937
11335191|NCT02861534|12532841|FG000|NOT COMPLETED|Overall Study||574
11335192|NCT02861534|12532842|FG001|NOT COMPLETED|Overall Study||587
11335193|NCT02861586|12532856|FG000|STARTED|Overall Study||51
11335194|NCT02861586|12532857|FG001|STARTED|Overall Study||18
11335195|NCT02861586|12532858|FG002|STARTED|Overall Study||47
11335196|NCT02861586|12532859|FG003|STARTED|Overall Study||16
11335197|NCT02861586|12532860|FG004|STARTED|Overall Study||47
11335198|NCT02861586|12532861|FG005|STARTED|Overall Study||50
11335199|NCT02861586|12532862|FG006|STARTED|Overall Study||18
11036311|NCT00884312|12216048|FG001|NOT COMPLETED|Overall Study||25
11036312|NCT00884325|12216056|FG000|STARTED|Overall Study||20
11036313|NCT00884325|12216057|FG001|STARTED|Overall Study||20
11036314|NCT00884325|12216056|FG000|COMPLETED|Overall Study||17
11036315|NCT00884325|12216057|FG001|COMPLETED|Overall Study||16
11200918|NCT01829516|12391137|FG000|COMPLETED|2nd Intervention||18
11036316|NCT00884325|12216056|FG000|NOT COMPLETED|Overall Study||3
11036317|NCT00884325|12216057|FG001|NOT COMPLETED|Overall Study||4
11036318|NCT00884377|12216065|FG000|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
11036319|NCT00884377|12216066|FG001|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
11036320|NCT00884377|12216065|FG000|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
11036321|NCT00884377|12216066|FG001|COMPLETED|Overall Study||27
11036322|NCT00884377|12216065|FG000|NOT COMPLETED|Overall Study||2
11036323|NCT00884377|12216066|FG001|NOT COMPLETED|Overall Study||1
11036324|NCT00884390|12216080|FG000|STARTED|Overall Study||146
11036325|NCT00884390|12216081|FG001|STARTED|Overall Study||62
11036326|NCT00884390|12216080|FG000|COMPLETED|Overall Study||123
11036327|NCT00884390|12216081|FG001|COMPLETED|Overall Study||54
11036328|NCT00884390|12216080|FG000|NOT COMPLETED|Overall Study||23
11036329|NCT00884390|12216081|FG001|NOT COMPLETED|Overall Study||8
11036330|NCT00884585|12216097|FG000|STARTED|Double-Masked Phase (Day 1-Month 3)||89
11036331|NCT00884585|12216098|FG001|STARTED|Double-Masked Phase (Day 1-Month 3)||87
11036332|NCT00884585|12216097|FG000|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
11036333|NCT00884585|12216098|FG001|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
11036334|NCT00884585|12216097|FG000|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
11036335|NCT00884585|12216098|FG001|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
11036336|NCT00884585|12216097|FG000|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
11036337|NCT00884585|12216098|FG001|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
11036338|NCT00884585|12216097|FG000|COMPLETED|Open-Label Phase (Months 3-9)||147
11036339|NCT00884585|12216098|FG001|COMPLETED|Open-Label Phase (Months 3-9)||0
11036340|NCT00884585|12216097|FG000|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
11036341|NCT00884585|12216098|FG001|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
11036342|NCT00884585|12216097|FG000|STARTED|Open-Label Maintenance (Months 9-12)||147
11036343|NCT00884585|12216098|FG001|STARTED|Open-Label Maintenance (Months 9-12)||0
11036344|NCT00884585|12216097|FG000|COMPLETED|Open-Label Maintenance (Months 9-12)||144
11036345|NCT00884585|12216098|FG001|COMPLETED|Open-Label Maintenance (Months 9-12)||0
11036346|NCT00884585|12216097|FG000|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
11036347|NCT00884585|12216098|FG001|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
11036348|NCT00884611|12216104|FG000|STARTED|Overall Study||20
11036349|NCT00884611|12216104|FG000|Enrolled, Not Treated|Overall Study||1
11036350|NCT00884611|12216104|FG000|COMPLETED|Overall Study||19
11036351|NCT00884611|12216104|FG000|NOT COMPLETED|Overall Study||1
11036352|NCT00884650|12216116|FG000|STARTED|Overall Study||25
11036353|NCT00884650|12216117|FG001|STARTED|Overall Study||29
11200919|NCT01829516|12391138|FG001|COMPLETED|2nd Intervention||14
11200920|NCT01829516|12391137|FG000|NOT COMPLETED|2nd Intervention||0
11200921|NCT01829516|12391138|FG001|NOT COMPLETED|2nd Intervention||0
11200922|NCT01829919|12391146|FG000|STARTED|Overall Study||24
11200923|NCT01829919|12391146|FG000|COMPLETED|Overall Study||24
11200924|NCT01829919|12391146|FG000|NOT COMPLETED|Overall Study||0
11200925|NCT01829997|12391150|FG000|STARTED|Overall Study||22
11200926|NCT01829997|12391150|FG000|COMPLETED|Overall Study||16
11200927|NCT01829997|12391150|FG000|NOT COMPLETED|Overall Study||6
11200928|NCT01830127|12391156|FG000|STARTED|Overall Study||18
11200929|NCT01830127|12391157|FG001|STARTED|Overall Study||17
11200930|NCT01830127|12391156|FG000|COMPLETED|Overall Study||13
11200931|NCT01830127|12391157|FG001|COMPLETED|Overall Study||8
11200932|NCT01830127|12391156|FG000|NOT COMPLETED|Overall Study||5
11200933|NCT01830127|12391157|FG001|NOT COMPLETED|Overall Study||9
11200934|NCT01830140|12391165|FG000|STARTED|Overall Study||233
11200935|NCT01830140|12391166|FG001|STARTED|Overall Study||233
11200936|NCT01830140|12391165|FG000|COMPLETED|Overall Study||226
11200937|NCT01830140|12391166|FG001|COMPLETED|Overall Study||229
11200938|NCT01830140|12391165|FG000|NOT COMPLETED|Overall Study||7
11200939|NCT01830140|12391166|FG001|NOT COMPLETED|Overall Study||4
11200940|NCT01830205|12391176|FG000|STARTED|Overall Study||12
11200941|NCT01830205|12391177|FG001|STARTED|Overall Study||6
11200942|NCT01830205|12391178|FG002|STARTED|Overall Study||6
11200943|NCT01830205|12391179|FG003|STARTED|Overall Study||12
11200944|NCT01830205|12391176|FG000|COMPLETED|Overall Study||12
11200945|NCT01830205|12391177|FG001|COMPLETED|Overall Study||6
11200946|NCT01830205|12391178|FG002|COMPLETED|Overall Study||6
11036354|NCT00884650|12216116|FG000|COMPLETED|Overall Study||16
11036355|NCT00884650|12216117|FG001|COMPLETED|Overall Study||21
11036356|NCT00884650|12216116|FG000|NOT COMPLETED|Overall Study||9
11036357|NCT00884650|12216117|FG001|NOT COMPLETED|Overall Study||8
11036358|NCT00884741|12216127|FG000|STARTED|Step 1 Registration: Tissue Screening||978
11036359|NCT00884741|12216128|FG001|STARTED|Step 1 Registration: Tissue Screening||0
11036360|NCT00884741|12216129|FG002|STARTED|Step 1 Registration: Tissue Screening||0
11036361|NCT00884741|12216130|FG003|STARTED|Step 1 Registration: Tissue Screening||0
11036362|NCT00884741|12216127|FG000|COMPLETED|Step 1 Registration: Tissue Screening||666
11036363|NCT00884741|12216128|FG001|COMPLETED|Step 1 Registration: Tissue Screening||0
11036364|NCT00884741|12216129|FG002|COMPLETED|Step 1 Registration: Tissue Screening||0
11036365|NCT00884741|12216130|FG003|COMPLETED|Step 1 Registration: Tissue Screening||0
11036366|NCT00884741|12216127|FG000|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
11036367|NCT00884741|12216128|FG001|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
11036368|NCT00884741|12216129|FG002|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
11036369|NCT00884741|12216130|FG003|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
11036370|NCT00884741|12216127|FG000|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
11036371|NCT00884741|12216128|FG001|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
11036372|NCT00884741|12216129|FG002|STARTED|Step 2 Registration: Tissue Analysis||0
11036373|NCT00884741|12216130|FG003|STARTED|Step 2 Registration: Tissue Analysis||0
11036374|NCT00884741|12216127|FG000|COMPLETED|Step 2 Registration: Tissue Analysis||0
11036375|NCT00884741|12216128|FG001|COMPLETED|Step 2 Registration: Tissue Analysis||637
11036376|NCT00884741|12216129|FG002|COMPLETED|Step 2 Registration: Tissue Analysis||0
11036377|NCT00884741|12216130|FG003|COMPLETED|Step 2 Registration: Tissue Analysis||0
11036378|NCT00884741|12216127|FG000|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
11036379|NCT00884741|12216128|FG001|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
11036380|NCT00884741|12216129|FG002|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
11036381|NCT00884741|12216130|FG003|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
11036382|NCT00884741|12216127|FG000|STARTED|Randomization||0
11036383|NCT00884741|12216128|FG001|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
11036384|NCT00884741|12216129|FG002|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
11036385|NCT00884741|12216130|FG003|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
11036386|NCT00884741|12216127|FG000|COMPLETED|Randomization||0
11036387|NCT00884741|12216128|FG001|COMPLETED|Randomization||0
11036388|NCT00884741|12216129|FG002|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
11036389|NCT00884741|12216130|FG003|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
11036390|NCT00884741|12216127|FG000|NOT COMPLETED|Randomization||0
11036391|NCT00884741|12216128|FG001|NOT COMPLETED|Randomization||0
11036392|NCT00884741|12216129|FG002|NOT COMPLETED|Randomization||8
11036393|NCT00884741|12216130|FG003|NOT COMPLETED|Randomization||8
11036394|NCT00884754|12216139|FG000|STARTED|Overall Study||30
11036395|NCT00884754|12216140|FG001|STARTED|Overall Study||30
11036396|NCT00884754|12216139|FG000|COMPLETED|Overall Study||30
11036397|NCT00884754|12216140|FG001|COMPLETED|Overall Study||30
11036398|NCT00884754|12216139|FG000|NOT COMPLETED|Overall Study||0
11036399|NCT00884754|12216140|FG001|NOT COMPLETED|Overall Study||0
11036400|NCT00884793|12216146|FG000|STARTED|Overall Study||8
11036401|NCT00884793|12216146|FG000|COMPLETED|Overall Study||7
11036402|NCT00884793|12216146|FG000|NOT COMPLETED|Overall Study||1
11036403|NCT00884806|12216150|FG000|STARTED|Overall Study||110
11036404|NCT00884806|12216150|FG000|COMPLETED|Overall Study||110
11036405|NCT00884806|12216150|FG000|NOT COMPLETED|Overall Study||0
11036406|NCT00884832|12216156|FG000|STARTED|Overall Study||22
11036407|NCT00884832|12216157|FG001|STARTED|Overall Study||22
11036408|NCT00884832|12216156|FG000|COMPLETED|Overall Study||22
11036409|NCT00884832|12216157|FG001|COMPLETED|Overall Study||21
11036410|NCT00884832|12216156|FG000|NOT COMPLETED|Overall Study||0
11036411|NCT00884832|12216157|FG001|NOT COMPLETED|Overall Study||1
11036412|NCT00884897|12216165|FG000|STARTED|Overall Study||13
11036413|NCT00884897|12216166|FG001|STARTED|Overall Study||15
11036414|NCT00884897|12216165|FG000|COMPLETED|Overall Study||13
11036415|NCT00884897|12216166|FG001|COMPLETED|Overall Study||15
11036416|NCT00884897|12216165|FG000|NOT COMPLETED|Overall Study||0
11036417|NCT00884897|12216166|FG001|NOT COMPLETED|Overall Study||0
11036418|NCT00884910|12216172|FG000|STARTED|Overall Study||33
11036419|NCT00884910|12216172|FG000|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
11036420|NCT00884910|12216172|FG000|NOT COMPLETED|Overall Study||1
11036421|NCT00884949|12216176|FG000|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
11036422|NCT00884949|12216176|FG000|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
11036423|NCT00884949|12216176|FG000|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
11036424|NCT00884949|12216176|FG000|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
11036425|NCT00884949|12216176|FG000|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
11036426|NCT00884949|12216176|FG000|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
11036427|NCT00884949|12216176|FG000|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
11036428|NCT00884949|12216176|FG000|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
11036429|NCT00884949|12216176|FG000|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
11036430|NCT00884949|12216176|FG000|STARTED|Continuation Period||18
11036431|NCT00884949|12216176|FG000|COMPLETED|Continuation Period||18
11036432|NCT00884949|12216176|FG000|NOT COMPLETED|Continuation Period||0
11036433|NCT00885079|12216191|FG000|STARTED|Overall Study||93
11036434|NCT00885079|12216192|FG001|STARTED|Overall Study||95
11036435|NCT00885079|12216191|FG000|COMPLETED|Overall Study||91
11036436|NCT00885079|12216192|FG001|COMPLETED|Overall Study||91
11036437|NCT00885079|12216191|FG000|NOT COMPLETED|Overall Study||2
11036438|NCT00885079|12216192|FG001|NOT COMPLETED|Overall Study||4
11036439|NCT00885092|12216200|FG000|STARTED|Period 1, 7 Days||20
11036440|NCT00885092|12216201|FG001|STARTED|Period 1, 7 Days||20
11036441|NCT00885092|12216200|FG000|COMPLETED|Period 1, 7 Days||20
11036442|NCT00885092|12216201|FG001|COMPLETED|Period 1, 7 Days||20
11036443|NCT00885092|12216200|FG000|NOT COMPLETED|Period 1, 7 Days||0
11036444|NCT00885092|12216201|FG001|NOT COMPLETED|Period 1, 7 Days||0
11036445|NCT00885092|12216200|FG000|STARTED|Period 2, 7 Days||20
11036446|NCT00885092|12216201|FG001|STARTED|Period 2, 7 Days||20
11036447|NCT00885092|12216200|FG000|COMPLETED|Period 2, 7 Days||20
11036448|NCT00885092|12216201|FG001|COMPLETED|Period 2, 7 Days||20
11036449|NCT00885092|12216200|FG000|NOT COMPLETED|Period 2, 7 Days||0
11036450|NCT00885092|12216201|FG001|NOT COMPLETED|Period 2, 7 Days||0
11036451|NCT00885105|12216209|FG000|STARTED|Overall Study||112
11036452|NCT00885105|12216210|FG001|STARTED|Overall Study||130
11036453|NCT00885105|12216209|FG000|COMPLETED|Overall Study||111
11036454|NCT00885105|12216210|FG001|COMPLETED|Overall Study||120
11036455|NCT00885105|12216209|FG000|NOT COMPLETED|Overall Study||1
11036456|NCT00885105|12216210|FG001|NOT COMPLETED|Overall Study||10
11036457|NCT00885118|12216221|FG000|STARTED|Overall Study||21
11036458|NCT00885118|12216222|FG001|STARTED|Overall Study||19
11036459|NCT00885118|12216223|FG002|STARTED|Overall Study||21
11036460|NCT00885118|12216224|FG003|STARTED|Overall Study||20
11036461|NCT00885118|12216225|FG004|STARTED|Overall Study||19
11036462|NCT00885118|12216221|FG000|COMPLETED|Overall Study||20
11036463|NCT00885118|12216222|FG001|COMPLETED|Overall Study||19
11036464|NCT00885118|12216223|FG002|COMPLETED|Overall Study||20
11036465|NCT00885118|12216224|FG003|COMPLETED|Overall Study||20
11036466|NCT00885118|12216225|FG004|COMPLETED|Overall Study||18
11036467|NCT00885118|12216221|FG000|NOT COMPLETED|Overall Study||1
11036468|NCT00885118|12216222|FG001|NOT COMPLETED|Overall Study||0
11036469|NCT00885118|12216223|FG002|NOT COMPLETED|Overall Study||1
11036470|NCT00885118|12216224|FG003|NOT COMPLETED|Overall Study||0
11036471|NCT00885118|12216225|FG004|NOT COMPLETED|Overall Study||1
11036472|NCT00885170|12216243|FG000|STARTED|Overall Study||124
11036473|NCT00885170|12216244|FG001|STARTED|Overall Study||122
11036474|NCT00885170|12216243|FG000|Treated|Overall Study||122
11036475|NCT00885170|12216244|FG001|Treated|Overall Study||121
11036476|NCT00885170|12216243|FG000|COMPLETED|Overall Study||86
11036477|NCT00885170|12216244|FG001|COMPLETED|Overall Study||99
11036478|NCT00885170|12216243|FG000|NOT COMPLETED|Overall Study||38
11036479|NCT00885170|12216244|FG001|NOT COMPLETED|Overall Study||23
11036480|NCT00885352|12216252|FG000|STARTED|Overall Study||157
11036481|NCT00885352|12216253|FG001|STARTED|Overall Study||156
11036482|NCT00885352|12216252|FG000|COMPLETED|Overall Study||149
11036483|NCT00885352|12216253|FG001|COMPLETED|Overall Study||136
11036484|NCT00885352|12216252|FG000|NOT COMPLETED|Overall Study||8
11036485|NCT00885352|12216253|FG001|NOT COMPLETED|Overall Study||20
11036486|NCT00885365|12216261|FG000|STARTED|4 Weeks ON Treatment||159
11036487|NCT00885365|12216262|FG001|STARTED|4 Weeks ON Treatment||165
11036488|NCT00885365|12216261|FG000|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
11036489|NCT00885365|12216262|FG001|Intent-to-Treat Population|4 Weeks ON Treatment||163
11036490|NCT00885365|12216261|FG000|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
11036491|NCT00885365|12216262|FG001|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
11036492|NCT00885365|12216261|FG000|COMPLETED|4 Weeks ON Treatment||155
11036493|NCT00885365|12216262|FG001|COMPLETED|4 Weeks ON Treatment||159
11036494|NCT00885365|12216261|FG000|NOT COMPLETED|4 Weeks ON Treatment||4
11036495|NCT00885365|12216262|FG001|NOT COMPLETED|4 Weeks ON Treatment||6
11036496|NCT00885365|12216261|FG000|STARTED|4 Weeks OFF Treatment||155
11036497|NCT00885365|12216262|FG001|STARTED|4 Weeks OFF Treatment||159
11036498|NCT00885365|12216261|FG000|COMPLETED|4 Weeks OFF Treatment||155
11036499|NCT00885365|12216262|FG001|COMPLETED|4 Weeks OFF Treatment||159
11036500|NCT00885365|12216261|FG000|NOT COMPLETED|4 Weeks OFF Treatment||0
11036501|NCT00885365|12216262|FG001|NOT COMPLETED|4 Weeks OFF Treatment||0
11036502|NCT00885378|12216270|FG000|STARTED|Overall Study|Number randomized.|74
11036503|NCT00885378|12216271|FG001|STARTED|Overall Study|Number randomized.|86
11036504|NCT00885378|12216270|FG000|COMPLETED|Overall Study||66
11036505|NCT00885378|12216271|FG001|COMPLETED|Overall Study||78
11036506|NCT00885378|12216270|FG000|NOT COMPLETED|Overall Study||8
11036507|NCT00885378|12216271|FG001|NOT COMPLETED|Overall Study||8
11036508|NCT00885482|12216277|FG000|STARTED|Overall Study||40
11036509|NCT00885482|12216277|FG000|COMPLETED|Overall Study||36
11036510|NCT00885482|12216277|FG000|NOT COMPLETED|Overall Study||4
11036511|NCT00885534|12216281|FG000|STARTED|Overall Study||7
11036512|NCT00885534|12216281|FG000|COMPLETED|Overall Study||6
11036513|NCT00885534|12216281|FG000|NOT COMPLETED|Overall Study||1
11036514|NCT00885638|12216285|FG000|STARTED|Overall Study||6
11036515|NCT00885638|12216286|FG001|STARTED|Overall Study||6
11036516|NCT00885638|12216285|FG000|COMPLETED|Overall Study||6
11036517|NCT00885638|12216286|FG001|COMPLETED|Overall Study||6
11036518|NCT00885638|12216285|FG000|NOT COMPLETED|Overall Study||0
11036519|NCT00885638|12216286|FG001|NOT COMPLETED|Overall Study||0
11036520|NCT00885677|12216295|FG000|STARTED|Overall Study||462
11036521|NCT00885677|12216296|FG001|STARTED|Overall Study||455
11036522|NCT00885677|12216295|FG000|Intention To Treat|Overall Study||437
11036523|NCT00885677|12216296|FG001|Intention To Treat|Overall Study||428
11036524|NCT00885677|12216295|FG000|COMPLETED|Overall Study||279
11036525|NCT00885677|12216296|FG001|COMPLETED|Overall Study||277
11036526|NCT00885677|12216295|FG000|NOT COMPLETED|Overall Study||183
11036527|NCT00885677|12216296|FG001|NOT COMPLETED|Overall Study||178
11036528|NCT00885703|12216309|FG000|STARTED|Overall Study||22
11036529|NCT00885703|12216310|FG001|STARTED|Overall Study||26
11036530|NCT00885703|12216311|FG002|STARTED|Overall Study||24
11036531|NCT00885703|12216312|FG003|STARTED|Overall Study||24
11036532|NCT00885703|12216313|FG004|STARTED|Overall Study||24
11036533|NCT00885703|12216314|FG005|STARTED|Overall Study||24
11036534|NCT00885703|12216315|FG006|STARTED|Overall Study||24
11036535|NCT00885703|12216309|FG000|COMPLETED|Overall Study||12
11036536|NCT00885703|12216310|FG001|COMPLETED|Overall Study||16
11036537|NCT00885703|12216311|FG002|COMPLETED|Overall Study||13
11036538|NCT00885703|12216312|FG003|COMPLETED|Overall Study||15
11036539|NCT00885703|12216313|FG004|COMPLETED|Overall Study||12
11036540|NCT00885703|12216314|FG005|COMPLETED|Overall Study||11
11036541|NCT00885703|12216315|FG006|COMPLETED|Overall Study||18
11036542|NCT00885703|12216309|FG000|NOT COMPLETED|Overall Study||10
11036543|NCT00885703|12216310|FG001|NOT COMPLETED|Overall Study||10
11036544|NCT00885703|12216311|FG002|NOT COMPLETED|Overall Study||11
11036545|NCT00885703|12216312|FG003|NOT COMPLETED|Overall Study||9
11036546|NCT00885703|12216313|FG004|NOT COMPLETED|Overall Study||12
11036547|NCT00885703|12216314|FG005|NOT COMPLETED|Overall Study||13
11036548|NCT00885703|12216315|FG006|NOT COMPLETED|Overall Study||6
11036549|NCT00885742|12216335|FG000|STARTED|Overall Study||41
11036550|NCT00885742|12216335|FG000|COMPLETED|Overall Study||41
11036551|NCT00885742|12216335|FG000|NOT COMPLETED|Overall Study||0
11036552|NCT00885755|12216342|FG000|STARTED|Part I: Trastuzumab+Taxane||31
11036553|NCT00885755|12216343|FG001|STARTED|Part I: Trastuzumab+Taxane||1
11036554|NCT00885755|12216344|FG002|STARTED|Part I: Trastuzumab+Taxane||1
11036555|NCT00885755|12216342|FG000|COMPLETED|Part I: Trastuzumab+Taxane||13
11036556|NCT00885755|12216343|FG001|COMPLETED|Part I: Trastuzumab+Taxane||1
11036557|NCT00885755|12216344|FG002|COMPLETED|Part I: Trastuzumab+Taxane||0
11036558|NCT00885755|12216342|FG000|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
11036559|NCT00885755|12216343|FG001|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
11036560|NCT00885755|12216344|FG002|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
11036561|NCT00885755|12216342|FG000|STARTED|Part II: Trastuzumab + Capecitabine.||13
11036562|NCT00885755|12216343|FG001|STARTED|Part II: Trastuzumab + Capecitabine.||1
11036563|NCT00885755|12216344|FG002|STARTED|Part II: Trastuzumab + Capecitabine.||0
11036564|NCT00885755|12216342|FG000|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
11036565|NCT00885755|12216343|FG001|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
11036566|NCT00885755|12216344|FG002|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
11036567|NCT00885755|12216342|FG000|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
11036568|NCT00885755|12216343|FG001|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
11036569|NCT00885755|12216344|FG002|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
11036570|NCT00885768|12216352|FG000|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
11036571|NCT00885768|12216352|FG000|COMPLETED|Overall Study|all patients with including criteria completed the study|146
11036572|NCT00885768|12216352|FG000|NOT COMPLETED|Overall Study||0
11036573|NCT00885846|12216359|FG000|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
11036574|NCT00885846|12216360|FG001|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
11036575|NCT00885846|12216361|FG002|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
11036576|NCT00885846|12216359|FG000|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
11036577|NCT00885846|12216360|FG001|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
11036578|NCT00885846|12216361|FG002|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
11036579|NCT00885846|12216359|FG000|NOT COMPLETED|Overall Study||2
11036580|NCT00885846|12216360|FG001|NOT COMPLETED|Overall Study||5
11036581|NCT00885846|12216361|FG002|NOT COMPLETED|Overall Study||2
11036582|NCT00886015|12216371|FG000|STARTED|Overall Study|1674 eyes; 960 participants|1674
11036583|NCT00886015|12216372|FG001|STARTED|Overall Study|1671 eyes; 957 participants|1671
11036584|NCT00886015|12216371|FG000|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
11036585|NCT00886015|12216372|FG001|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
11036586|NCT00886015|12216371|FG000|NOT COMPLETED|Overall Study||0
11036587|NCT00886015|12216372|FG001|NOT COMPLETED|Overall Study||2
11036588|NCT00886119|12216378|FG000|STARTED|Period 1||24
11036589|NCT00886119|12216379|FG001|STARTED|Period 1||22
11036590|NCT00886119|12216378|FG000|COMPLETED|Period 1||23
11036591|NCT00886119|12216379|FG001|COMPLETED|Period 1||22
11036592|NCT00886119|12216378|FG000|NOT COMPLETED|Period 1||1
11036593|NCT00886119|12216379|FG001|NOT COMPLETED|Period 1||0
11036594|NCT00886119|12216378|FG000|STARTED|Period 2||23
11036595|NCT00886119|12216379|FG001|STARTED|Period 2||22
11036596|NCT00886119|12216378|FG000|COMPLETED|Period 2||23
11036597|NCT00886119|12216379|FG001|COMPLETED|Period 2||22
11036598|NCT00886119|12216378|FG000|NOT COMPLETED|Period 2||0
11036599|NCT00886119|12216379|FG001|NOT COMPLETED|Period 2||0
11036600|NCT00886145|12216385|FG000|STARTED|Overall Study||1
11335200|NCT02861586|12532863|FG007|STARTED|Overall Study||16
11335201|NCT02861586|12532856|FG000|COMPLETED|Overall Study||47
11036601|NCT00886145|12216385|FG000|COMPLETED|Overall Study||1
11036602|NCT00886145|12216385|FG000|NOT COMPLETED|Overall Study||0
11036603|NCT00886236|12216394|FG000|STARTED|Overall Study||20
11036604|NCT00886236|12216395|FG001|STARTED|Overall Study||21
11036605|NCT00886236|12216396|FG002|STARTED|Overall Study||21
11036606|NCT00886236|12216394|FG000|COMPLETED|Overall Study||18
11036607|NCT00886236|12216395|FG001|COMPLETED|Overall Study||17
11036608|NCT00886236|12216396|FG002|COMPLETED|Overall Study||17
11335202|NCT02861586|12532857|FG001|COMPLETED|Overall Study||15
11036609|NCT00886236|12216394|FG000|NOT COMPLETED|Overall Study||2
11036610|NCT00886236|12216395|FG001|NOT COMPLETED|Overall Study||4
11036611|NCT00886236|12216396|FG002|NOT COMPLETED|Overall Study||4
11036612|NCT00886262|12216406|FG000|STARTED|Overall Study||8
11036613|NCT00886262|12216407|FG001|STARTED|Overall Study||10
11036614|NCT00886262|12216406|FG000|COMPLETED|Overall Study||8
11036615|NCT00886262|12216407|FG001|COMPLETED|Overall Study||7
11036616|NCT00886262|12216406|FG000|NOT COMPLETED|Overall Study||0
11036617|NCT00886262|12216407|FG001|NOT COMPLETED|Overall Study||3
11036618|NCT00886288|12216415|FG000|STARTED|Overall Study|Baseline Population|2027
11036619|NCT00886288|12216416|FG001|STARTED|Overall Study|Baseline Population|684
11036620|NCT00886288|12216415|FG000|COMPLETED|Overall Study||1284
11036621|NCT00886288|12216416|FG001|COMPLETED|Overall Study||457
11036622|NCT00886288|12216415|FG000|NOT COMPLETED|Overall Study||743
11036623|NCT00886288|12216416|FG001|NOT COMPLETED|Overall Study||227
11036624|NCT00886340|12216426|FG000|STARTED|Overall Study||27
11036625|NCT00886340|12216427|FG001|STARTED|Overall Study||31
11036626|NCT00886340|12216426|FG000|COMPLETED|Overall Study||27
11036627|NCT00886340|12216427|FG001|COMPLETED|Overall Study||24
11036628|NCT00886340|12216426|FG000|NOT COMPLETED|Overall Study||0
11036629|NCT00886340|12216427|FG001|NOT COMPLETED|Overall Study||7
11036630|NCT00886379|12216438|FG000|STARTED|Overall Study||104
11036631|NCT00886379|12216439|FG001|STARTED|Overall Study||143
11036632|NCT00886379|12216440|FG002|STARTED|Overall Study||143
11036633|NCT00886379|12216441|FG003|STARTED|Overall Study||112
11036634|NCT00886379|12216442|FG004|STARTED|Overall Study||95
11036635|NCT00886379|12216438|FG000|COMPLETED|Overall Study||101
11036636|NCT00886379|12216439|FG001|COMPLETED|Overall Study||140
11036637|NCT00886379|12216440|FG002|COMPLETED|Overall Study||137
11036638|NCT00886379|12216441|FG003|COMPLETED|Overall Study||109
11036639|NCT00886379|12216442|FG004|COMPLETED|Overall Study||92
11036640|NCT00886379|12216438|FG000|NOT COMPLETED|Overall Study||3
11036641|NCT00886379|12216439|FG001|NOT COMPLETED|Overall Study||3
11036642|NCT00886379|12216440|FG002|NOT COMPLETED|Overall Study||6
11036643|NCT00886379|12216441|FG003|NOT COMPLETED|Overall Study||3
11036644|NCT00886379|12216442|FG004|NOT COMPLETED|Overall Study||3
11057639|NCT00999102|12239297|FG001|STARTED|4 Weeks at Higher Dose of First Drug||16
11057640|NCT00999102|12239296|FG000|COMPLETED|4 Weeks at Higher Dose of First Drug||15
11057641|NCT00999102|12239297|FG001|COMPLETED|4 Weeks at Higher Dose of First Drug||16
11335203|NCT02861586|12532858|FG002|COMPLETED|Overall Study||46
11335204|NCT02861586|12532859|FG003|COMPLETED|Overall Study||16
11335205|NCT02861586|12532860|FG004|COMPLETED|Overall Study||47
11335206|NCT02861586|12532861|FG005|COMPLETED|Overall Study||45
11335207|NCT02861586|12532862|FG006|COMPLETED|Overall Study||17
11335208|NCT02861586|12532863|FG007|COMPLETED|Overall Study||16
11335209|NCT02861586|12532856|FG000|NOT COMPLETED|Overall Study||4
11335210|NCT02861586|12532857|FG001|NOT COMPLETED|Overall Study||3
11335211|NCT02861586|12532858|FG002|NOT COMPLETED|Overall Study||1
11335212|NCT02861586|12532859|FG003|NOT COMPLETED|Overall Study||0
11335213|NCT02861586|12532860|FG004|NOT COMPLETED|Overall Study||0
11335214|NCT02861586|12532861|FG005|NOT COMPLETED|Overall Study||5
11335215|NCT02861586|12532862|FG006|NOT COMPLETED|Overall Study||1
11335216|NCT02861586|12532863|FG007|NOT COMPLETED|Overall Study||0
11335217|NCT02861664|12532888|FG000|STARTED|Overall Study||67
11335218|NCT02861664|12532889|FG001|STARTED|Overall Study||68
11335219|NCT02861664|12532888|FG000|COMPLETED|Overall Study||67
11335220|NCT02861664|12532889|FG001|COMPLETED|Overall Study||67
11335221|NCT02861664|12532888|FG000|NOT COMPLETED|Overall Study||0
11057642|NCT00999102|12239296|FG000|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
11057643|NCT00999102|12239297|FG001|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
11057644|NCT00999102|12239296|FG000|STARTED|4 Weeks at Lower Dose of Second Drug||15
11335222|NCT02861664|12532889|FG001|NOT COMPLETED|Overall Study||1
11335223|NCT02861807|12532897|FG000|STARTED|Overall Study||47
11335224|NCT02861807|12532898|FG001|STARTED|Overall Study||37
11335225|NCT02861807|12532897|FG000|Attended Post-treatment Assessment|Overall Study||34
11335226|NCT02861807|12532898|FG001|Attended Post-treatment Assessment|Overall Study||18
11335227|NCT02861807|12532897|FG000|Attended 2-month Follow-up|Overall Study||32
11335228|NCT02861807|12532898|FG001|Attended 2-month Follow-up|Overall Study||20
11335229|NCT02861807|12532897|FG000|COMPLETED|Overall Study||35
11335230|NCT02861807|12532898|FG001|COMPLETED|Overall Study||23
11335231|NCT02861807|12532897|FG000|NOT COMPLETED|Overall Study||12
11036645|NCT00886483|12216456|FG000|STARTED|Overall Study||26
11036646|NCT00886483|12216457|FG001|STARTED|Overall Study||13
11036647|NCT00886483|12216456|FG000|Completed 20 Treatments|Overall Study||25
11036648|NCT00886483|12216457|FG001|Completed 20 Treatments|Overall Study||11
11036649|NCT00886483|12216456|FG000|COMPLETED|Overall Study||24
11036650|NCT00886483|12216457|FG001|COMPLETED|Overall Study||10
11036651|NCT00886483|12216456|FG000|NOT COMPLETED|Overall Study||2
11036652|NCT00886483|12216457|FG001|NOT COMPLETED|Overall Study||3
11036653|NCT00886587|12216473|FG000|STARTED|Overall Study||41
11036654|NCT00886587|12216474|FG001|STARTED|Overall Study||41
11036655|NCT00886587|12216473|FG000|COMPLETED|Overall Study||37
11036656|NCT00886587|12216474|FG001|COMPLETED|Overall Study||39
11036657|NCT00886587|12216473|FG000|NOT COMPLETED|Overall Study||4
11036658|NCT00886587|12216474|FG001|NOT COMPLETED|Overall Study||2
11036659|NCT00886613|12216483|FG000|STARTED|Overall Study||41
11036660|NCT00886613|12216484|FG001|STARTED|Overall Study||39
11036661|NCT00886613|12216485|FG002|STARTED|Overall Study||40
11036662|NCT00886613|12216483|FG000|COMPLETED|Overall Study||39
11036663|NCT00886613|12216484|FG001|COMPLETED|Overall Study||39
11036664|NCT00886613|12216485|FG002|COMPLETED|Overall Study||37
11036665|NCT00886613|12216483|FG000|NOT COMPLETED|Overall Study||2
11036666|NCT00886613|12216484|FG001|NOT COMPLETED|Overall Study||0
11036667|NCT00886613|12216485|FG002|NOT COMPLETED|Overall Study||3
11036668|NCT00886626|12216496|FG000|STARTED|Period 1 (90 Days)||6
11036669|NCT00886626|12216497|FG001|STARTED|Period 1 (90 Days)||6
11036670|NCT00886626|12216496|FG000|COMPLETED|Period 1 (90 Days)||5
11036671|NCT00886626|12216497|FG001|COMPLETED|Period 1 (90 Days)||6
11036672|NCT00886626|12216496|FG000|NOT COMPLETED|Period 1 (90 Days)||1
11036673|NCT00886626|12216497|FG001|NOT COMPLETED|Period 1 (90 Days)||0
11036674|NCT00886626|12216496|FG000|STARTED|Period 2 (90 Days)||5
11036675|NCT00886626|12216497|FG001|STARTED|Period 2 (90 Days)||6
11036676|NCT00886626|12216496|FG000|COMPLETED|Period 2 (90 Days)||5
11036677|NCT00886626|12216497|FG001|COMPLETED|Period 2 (90 Days)||6
11036678|NCT00886626|12216496|FG000|NOT COMPLETED|Period 2 (90 Days)||0
11036679|NCT00886626|12216497|FG001|NOT COMPLETED|Period 2 (90 Days)||0
11036680|NCT00886639|12216503|FG000|STARTED|Overall Study||127
11036681|NCT00886639|12216503|FG000|COMPLETED|Overall Study||111
11036682|NCT00886639|12216503|FG000|NOT COMPLETED|Overall Study||16
11036683|NCT00886704|12216509|FG000|STARTED|Overall Study||40
11036684|NCT00886704|12216510|FG001|STARTED|Overall Study||10
11036685|NCT00886704|12216509|FG000|COMPLETED|Overall Study||40
11036686|NCT00886704|12216510|FG001|COMPLETED|Overall Study||10
11036687|NCT00886704|12216509|FG000|NOT COMPLETED|Overall Study||0
11036688|NCT00886704|12216510|FG001|NOT COMPLETED|Overall Study||0
11036689|NCT00886743|12216518|FG000|STARTED|Overall Study|Received treatment|19
11036690|NCT00886743|12216518|FG000|COMPLETED|Overall Study||15
11036691|NCT00886743|12216518|FG000|NOT COMPLETED|Overall Study||4
11036692|NCT00886769|12216524|FG000|STARTED|Overall Study||43
11036693|NCT00886769|12216525|FG001|STARTED|Overall Study||41
11036694|NCT00886769|12216524|FG000|COMPLETED|Overall Study||37
11036695|NCT00886769|12216525|FG001|COMPLETED|Overall Study||4
11036696|NCT00886769|12216524|FG000|NOT COMPLETED|Overall Study||6
11036697|NCT00886769|12216525|FG001|NOT COMPLETED|Overall Study||37
11036698|NCT00886795|12216531|FG000|STARTED|Overall Study||4
11036699|NCT00886795|12216531|FG000|COMPLETED|Overall Study||3
11036700|NCT00886795|12216531|FG000|NOT COMPLETED|Overall Study||1
11036701|NCT00886821|12216550|FG000|STARTED|Stage 1||7
11036702|NCT00886821|12216551|FG001|STARTED|Stage 1||6
11036703|NCT00886821|12216552|FG002|STARTED|Stage 1||6
11036704|NCT00886821|12216553|FG003|STARTED|Stage 1||7
11036705|NCT00886821|12216554|FG004|STARTED|Stage 1||6
11036706|NCT00886821|12216555|FG005|STARTED|Stage 1||6
11036707|NCT00886821|12216556|FG006|STARTED|Stage 1||6
11036708|NCT00886821|12216557|FG007|STARTED|Stage 1||6
11036709|NCT00886821|12216558|FG008|STARTED|Stage 1||6
11036710|NCT00886821|12216559|FG009|STARTED|Stage 1||18
11036711|NCT00886821|12216560|FG010|STARTED|Stage 1||0
11036712|NCT00886821|12216561|FG011|STARTED|Stage 1||0
11036713|NCT00886821|12216562|FG012|STARTED|Stage 1||0
11036714|NCT00886821|12216563|FG013|STARTED|Stage 1||0
11036715|NCT00886821|12216550|FG000|COMPLETED|Stage 1||7
11036716|NCT00886821|12216551|FG001|COMPLETED|Stage 1||6
11036717|NCT00886821|12216552|FG002|COMPLETED|Stage 1||6
11036718|NCT00886821|12216553|FG003|COMPLETED|Stage 1||7
11036719|NCT00886821|12216554|FG004|COMPLETED|Stage 1||6
11036720|NCT00886821|12216555|FG005|COMPLETED|Stage 1||6
11036721|NCT00886821|12216556|FG006|COMPLETED|Stage 1||6
11036722|NCT00886821|12216557|FG007|COMPLETED|Stage 1||6
11036723|NCT00886821|12216558|FG008|COMPLETED|Stage 1||6
11036724|NCT00886821|12216559|FG009|COMPLETED|Stage 1||18
11036725|NCT00886821|12216560|FG010|COMPLETED|Stage 1||0
11036726|NCT00886821|12216561|FG011|COMPLETED|Stage 1||0
11335232|NCT02861807|12532898|FG001|NOT COMPLETED|Overall Study||14
11335233|NCT02861937|12532907|FG000|STARTED|Overall Study||10
11335234|NCT02861937|12532908|FG001|STARTED|Overall Study||12
11335235|NCT02861937|12532909|FG002|STARTED|Overall Study||12
11335236|NCT02861937|12532907|FG000|COMPLETED|Overall Study||10
11335237|NCT02861937|12532908|FG001|COMPLETED|Overall Study||12
11036727|NCT00886821|12216562|FG012|COMPLETED|Stage 1||0
11036728|NCT00886821|12216563|FG013|COMPLETED|Stage 1||0
11036729|NCT00886821|12216550|FG000|NOT COMPLETED|Stage 1||0
11036730|NCT00886821|12216551|FG001|NOT COMPLETED|Stage 1||0
11036731|NCT00886821|12216552|FG002|NOT COMPLETED|Stage 1||0
11036732|NCT00886821|12216553|FG003|NOT COMPLETED|Stage 1||0
11036733|NCT00886821|12216554|FG004|NOT COMPLETED|Stage 1||0
11036734|NCT00886821|12216555|FG005|NOT COMPLETED|Stage 1||0
11036735|NCT00886821|12216556|FG006|NOT COMPLETED|Stage 1||0
11036736|NCT00886821|12216557|FG007|NOT COMPLETED|Stage 1||0
11036737|NCT00886821|12216558|FG008|NOT COMPLETED|Stage 1||0
11036738|NCT00886821|12216559|FG009|NOT COMPLETED|Stage 1||0
11036739|NCT00886821|12216560|FG010|NOT COMPLETED|Stage 1||0
11036740|NCT00886821|12216561|FG011|NOT COMPLETED|Stage 1||0
11036741|NCT00886821|12216562|FG012|NOT COMPLETED|Stage 1||0
11036742|NCT00886821|12216563|FG013|NOT COMPLETED|Stage 1||0
11036743|NCT00886821|12216550|FG000|STARTED|Stage 2||0
11036744|NCT00886821|12216551|FG001|STARTED|Stage 2||0
11036745|NCT00886821|12216552|FG002|STARTED|Stage 2||0
11036746|NCT00886821|12216553|FG003|STARTED|Stage 2||0
11036747|NCT00886821|12216554|FG004|STARTED|Stage 2||0
11036748|NCT00886821|12216555|FG005|STARTED|Stage 2||0
11036749|NCT00886821|12216556|FG006|STARTED|Stage 2||0
11036750|NCT00886821|12216557|FG007|STARTED|Stage 2||0
11036751|NCT00886821|12216558|FG008|STARTED|Stage 2||0
11036752|NCT00886821|12216559|FG009|STARTED|Stage 2||0
11036753|NCT00886821|12216560|FG010|STARTED|Stage 2||9
11036754|NCT00886821|12216561|FG011|STARTED|Stage 2||9
11036755|NCT00886821|12216562|FG012|STARTED|Stage 2||13
11036756|NCT00886821|12216563|FG013|STARTED|Stage 2||9
11036757|NCT00886821|12216550|FG000|COMPLETED|Stage 2||0
11036758|NCT00886821|12216551|FG001|COMPLETED|Stage 2||0
11036759|NCT00886821|12216552|FG002|COMPLETED|Stage 2||0
11036760|NCT00886821|12216553|FG003|COMPLETED|Stage 2||0
11036761|NCT00886821|12216554|FG004|COMPLETED|Stage 2||0
11036762|NCT00886821|12216555|FG005|COMPLETED|Stage 2||0
11036763|NCT00886821|12216556|FG006|COMPLETED|Stage 2||0
11036764|NCT00886821|12216557|FG007|COMPLETED|Stage 2||0
11036765|NCT00886821|12216558|FG008|COMPLETED|Stage 2||0
11036766|NCT00886821|12216559|FG009|COMPLETED|Stage 2||0
11036767|NCT00886821|12216560|FG010|COMPLETED|Stage 2||9
11036768|NCT00886821|12216561|FG011|COMPLETED|Stage 2||8
11036769|NCT00886821|12216562|FG012|COMPLETED|Stage 2||8
11036770|NCT00886821|12216563|FG013|COMPLETED|Stage 2||8
11036771|NCT00886821|12216550|FG000|NOT COMPLETED|Stage 2||0
11036772|NCT00886821|12216551|FG001|NOT COMPLETED|Stage 2||0
11036773|NCT00886821|12216552|FG002|NOT COMPLETED|Stage 2||0
11036774|NCT00886821|12216553|FG003|NOT COMPLETED|Stage 2||0
11036775|NCT00886821|12216554|FG004|NOT COMPLETED|Stage 2||0
11036776|NCT00886821|12216555|FG005|NOT COMPLETED|Stage 2||0
11036777|NCT00886821|12216556|FG006|NOT COMPLETED|Stage 2||0
11036778|NCT00886821|12216557|FG007|NOT COMPLETED|Stage 2||0
11036779|NCT00886821|12216558|FG008|NOT COMPLETED|Stage 2||0
11036780|NCT00886821|12216559|FG009|NOT COMPLETED|Stage 2||0
11036781|NCT00886821|12216560|FG010|NOT COMPLETED|Stage 2||0
11036782|NCT00886821|12216561|FG011|NOT COMPLETED|Stage 2||1
11036783|NCT00886821|12216562|FG012|NOT COMPLETED|Stage 2||5
11036784|NCT00886821|12216563|FG013|NOT COMPLETED|Stage 2||1
11036785|NCT00886834|12216609|FG000|STARTED|Overall Study||54
11036786|NCT00886834|12216610|FG001|STARTED|Overall Study||54
11036787|NCT00886834|12216609|FG000|COMPLETED|Overall Study||54
11036788|NCT00886834|12216610|FG001|COMPLETED|Overall Study||51
11036789|NCT00886834|12216609|FG000|NOT COMPLETED|Overall Study||0
11036790|NCT00886834|12216610|FG001|NOT COMPLETED|Overall Study||3
11036791|NCT00886899|12216616|FG000|STARTED|Overall Study||147
11036792|NCT00886899|12216616|FG000|COMPLETED|Overall Study||147
11036793|NCT00886899|12216616|FG000|NOT COMPLETED|Overall Study||0
11036794|NCT00886938|12216620|FG000|STARTED|Overall Study||12
11036795|NCT00886938|12216620|FG000|COMPLETED|Overall Study||10
11036796|NCT00886938|12216620|FG000|NOT COMPLETED|Overall Study||2
11036797|NCT00887068|12216626|FG000|STARTED|Overall Study||93
11036798|NCT00887068|12216627|FG001|STARTED|Overall Study||94
11036799|NCT00887068|12216626|FG000|COMPLETED|Overall Study||87
11036800|NCT00887068|12216627|FG001|COMPLETED|Overall Study||94
11036801|NCT00887068|12216626|FG000|NOT COMPLETED|Overall Study||6
11036802|NCT00887068|12216627|FG001|NOT COMPLETED|Overall Study||0
11036803|NCT00887159|12216636|FG000|STARTED|Overall Study||56
11036804|NCT00887159|12216637|FG001|STARTED|Overall Study||56
11036805|NCT00887159|12216638|FG002|STARTED|Overall Study||56
11036806|NCT00887159|12216636|FG000|Patients Who Started Assigned Treatment|Overall Study||53
11036807|NCT00887159|12216637|FG001|Patients Who Started Assigned Treatment|Overall Study||53
11036808|NCT00887159|12216638|FG002|Patients Who Started Assigned Treatment|Overall Study||52
11036809|NCT00887159|12216636|FG000|Eligible and Treated Patients|Overall Study||48
11036810|NCT00887159|12216637|FG001|Eligible and Treated Patients|Overall Study||52
11036811|NCT00887159|12216638|FG002|Eligible and Treated Patients|Overall Study||52
11036812|NCT00887159|12216636|FG000|Eligible/Treated Pts With CTCs Results|Overall Study||40
11036813|NCT00887159|12216637|FG001|Eligible/Treated Pts With CTCs Results|Overall Study||42
11036814|NCT00887159|12216638|FG002|Eligible/Treated Pts With CTCs Results|Overall Study||38
11036815|NCT00887159|12216636|FG000|COMPLETED|Overall Study||27
11036816|NCT00887159|12216637|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
11036817|NCT00887159|12216638|FG002|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
11036818|NCT00887159|12216636|FG000|NOT COMPLETED|Overall Study||29
11036819|NCT00887159|12216637|FG001|NOT COMPLETED|Overall Study||56
11036820|NCT00887159|12216638|FG002|NOT COMPLETED|Overall Study||56
11036821|NCT00887198|12216650|FG000|STARTED|Randomized Period||546
11036822|NCT00887198|12216651|FG001|STARTED|Randomized Period||542
11036823|NCT00887198|12216652|FG002|STARTED|Randomized Period||0
11036824|NCT00887198|12216650|FG000|Treated|Randomized Period||542
11036825|NCT00887198|12216651|FG001|Treated|Randomized Period||540
11036826|NCT00887198|12216652|FG002|Treated|Randomized Period||0
11036827|NCT00887198|12216650|FG000|COMPLETED|Randomized Period||0
11036828|NCT00887198|12216651|FG001|COMPLETED|Randomized Period||0
11036829|NCT00887198|12216652|FG002|COMPLETED|Randomized Period||0
11036830|NCT00887198|12216650|FG000|NOT COMPLETED|Randomized Period||546
11036831|NCT00887198|12216651|FG001|NOT COMPLETED|Randomized Period||542
11036832|NCT00887198|12216652|FG002|NOT COMPLETED|Randomized Period||0
11036833|NCT00887198|12216650|FG000|STARTED|Cross Over (Placebo to AA)||0
11036834|NCT00887198|12216651|FG001|STARTED|Cross Over (Placebo to AA)||0
11036835|NCT00887198|12216652|FG002|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
11036836|NCT00887198|12216650|FG000|COMPLETED|Cross Over (Placebo to AA)||0
11036837|NCT00887198|12216651|FG001|COMPLETED|Cross Over (Placebo to AA)||0
11036838|NCT00887198|12216652|FG002|COMPLETED|Cross Over (Placebo to AA)||0
11036839|NCT00887198|12216650|FG000|NOT COMPLETED|Cross Over (Placebo to AA)||0
11036840|NCT00887198|12216651|FG001|NOT COMPLETED|Cross Over (Placebo to AA)||0
11036841|NCT00887198|12216652|FG002|NOT COMPLETED|Cross Over (Placebo to AA)||93
11036842|NCT00887224|12216663|FG000|STARTED|Open-label Response (OLR) Phase||874
11036843|NCT00887224|12216664|FG001|STARTED|Open-label Response (OLR) Phase||0
11036844|NCT00887224|12216665|FG002|STARTED|Open-label Response (OLR) Phase||0
11036845|NCT00887224|12216663|FG000|COMPLETED|Open-label Response (OLR) Phase||752
11036846|NCT00887224|12216664|FG001|COMPLETED|Open-label Response (OLR) Phase||0
11036847|NCT00887224|12216665|FG002|COMPLETED|Open-label Response (OLR) Phase||0
11036848|NCT00887224|12216663|FG000|NOT COMPLETED|Open-label Response (OLR) Phase||122
11036849|NCT00887224|12216664|FG001|NOT COMPLETED|Open-label Response (OLR) Phase||0
11036850|NCT00887224|12216665|FG002|NOT COMPLETED|Open-label Response (OLR) Phase||0
11036851|NCT00887224|12216663|FG000|STARTED|Between OLR and OLS Phases||752
11036852|NCT00887224|12216664|FG001|STARTED|Between OLR and OLS Phases||0
11036853|NCT00887224|12216665|FG002|STARTED|Between OLR and OLS Phases||0
11036854|NCT00887224|12216663|FG000|COMPLETED|Between OLR and OLS Phases||659
11036855|NCT00887224|12216664|FG001|COMPLETED|Between OLR and OLS Phases||0
11200947|NCT01830205|12391179|FG003|COMPLETED|Overall Study||12
11335238|NCT02861937|12532909|FG002|COMPLETED|Overall Study||12
11335239|NCT02861937|12532907|FG000|NOT COMPLETED|Overall Study||0
11036856|NCT00887224|12216665|FG002|COMPLETED|Between OLR and OLS Phases||0
11036857|NCT00887224|12216663|FG000|NOT COMPLETED|Between OLR and OLS Phases||93
11036858|NCT00887224|12216664|FG001|NOT COMPLETED|Between OLR and OLS Phases||0
11036859|NCT00887224|12216665|FG002|NOT COMPLETED|Between OLR and OLS Phases||0
11036860|NCT00887224|12216663|FG000|STARTED|Open-label Stability (OLS) Phase||659
11036861|NCT00887224|12216664|FG001|STARTED|Open-label Stability (OLS) Phase||0
11200948|NCT01830205|12391176|FG000|NOT COMPLETED|Overall Study||0
11200949|NCT01830205|12391177|FG001|NOT COMPLETED|Overall Study||0
11200950|NCT01830205|12391178|FG002|NOT COMPLETED|Overall Study||0
11200951|NCT01830205|12391179|FG003|NOT COMPLETED|Overall Study||0
11200952|NCT01830543|12391203|FG000|STARTED|Overall Study||709
11200953|NCT01830543|12391204|FG001|STARTED|Overall Study||709
11200954|NCT01830543|12391205|FG002|STARTED|Overall Study||706
11200955|NCT01830543|12391203|FG000|Treated|Overall Study||696
11200956|NCT01830543|12391204|FG001|Treated|Overall Study||706
11200957|NCT01830543|12391205|FG002|Treated|Overall Study||697
11200958|NCT01830543|12391203|FG000|COMPLETED|Overall Study||550
11036862|NCT00887224|12216665|FG002|STARTED|Open-label Stability (OLS) Phase||0
11036863|NCT00887224|12216663|FG000|COMPLETED|Open-label Stability (OLS) Phase||576
11036864|NCT00887224|12216664|FG001|COMPLETED|Open-label Stability (OLS) Phase||0
11036865|NCT00887224|12216665|FG002|COMPLETED|Open-label Stability (OLS) Phase||0
11036866|NCT00887224|12216663|FG000|NOT COMPLETED|Open-label Stability (OLS) Phase||83
11036867|NCT00887224|12216664|FG001|NOT COMPLETED|Open-label Stability (OLS) Phase||0
11036868|NCT00887224|12216665|FG002|NOT COMPLETED|Open-label Stability (OLS) Phase||0
11036869|NCT00887224|12216663|FG000|STARTED|Between OLS and DB Phases||576
11036870|NCT00887224|12216664|FG001|STARTED|Between OLS and DB Phases||0
11036871|NCT00887224|12216665|FG002|STARTED|Between OLS and DB Phases||0
11036872|NCT00887224|12216663|FG000|COMPLETED|Between OLS and DB Phases||548
11036873|NCT00887224|12216664|FG001|COMPLETED|Between OLS and DB Phases||0
11036874|NCT00887224|12216665|FG002|COMPLETED|Between OLS and DB Phases||0
11036875|NCT00887224|12216663|FG000|NOT COMPLETED|Between OLS and DB Phases||28
11036876|NCT00887224|12216664|FG001|NOT COMPLETED|Between OLS and DB Phases||0
11036877|NCT00887224|12216665|FG002|NOT COMPLETED|Between OLS and DB Phases||0
11036878|NCT00887224|12216663|FG000|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
11036879|NCT00887224|12216664|FG001|STARTED|OL Taper Phase / OL Follow Up||0
11036880|NCT00887224|12216665|FG002|STARTED|OL Taper Phase / OL Follow Up||0
11335240|NCT02861937|12532908|FG001|NOT COMPLETED|Overall Study||0
11335241|NCT02861937|12532909|FG002|NOT COMPLETED|Overall Study||0
11335242|NCT02862080|12532920|FG000|STARTED|7 Days Before Any Intervention||1
11335243|NCT02862080|12532921|FG001|STARTED|7 Days Before Any Intervention||1
11335244|NCT02862080|12532922|FG002|STARTED|7 Days Before Any Intervention||1
11335245|NCT02862080|12532923|FG003|STARTED|7 Days Before Any Intervention||1
11335246|NCT02862080|12532920|FG000|COMPLETED|7 Days Before Any Intervention||1
11335247|NCT02862080|12532921|FG001|COMPLETED|7 Days Before Any Intervention||1
11335248|NCT02862080|12532922|FG002|COMPLETED|7 Days Before Any Intervention||1
11335249|NCT02862080|12532923|FG003|COMPLETED|7 Days Before Any Intervention||1
11335250|NCT02862080|12532920|FG000|NOT COMPLETED|7 Days Before Any Intervention||0
11335251|NCT02862080|12532921|FG001|NOT COMPLETED|7 Days Before Any Intervention||0
11335252|NCT02862080|12532922|FG002|NOT COMPLETED|7 Days Before Any Intervention||0
11335253|NCT02862080|12532923|FG003|NOT COMPLETED|7 Days Before Any Intervention||0
11335254|NCT02862080|12532920|FG000|STARTED|3 Days Before Any Intervention||1
11335255|NCT02862080|12532921|FG001|STARTED|3 Days Before Any Intervention||1
11335256|NCT02862080|12532922|FG002|STARTED|3 Days Before Any Intervention||1
11335257|NCT02862080|12532923|FG003|STARTED|3 Days Before Any Intervention||1
11335258|NCT02862080|12532920|FG000|COMPLETED|3 Days Before Any Intervention||1
11335259|NCT02862080|12532921|FG001|COMPLETED|3 Days Before Any Intervention||1
11335260|NCT02862080|12532922|FG002|COMPLETED|3 Days Before Any Intervention||1
11335261|NCT02862080|12532923|FG003|COMPLETED|3 Days Before Any Intervention||1
11335262|NCT02862080|12532920|FG000|NOT COMPLETED|3 Days Before Any Intervention||0
11335263|NCT02862080|12532921|FG001|NOT COMPLETED|3 Days Before Any Intervention||0
11335264|NCT02862080|12532922|FG002|NOT COMPLETED|3 Days Before Any Intervention||0
11335265|NCT02862080|12532923|FG003|NOT COMPLETED|3 Days Before Any Intervention||0
11335266|NCT02862080|12532920|FG000|STARTED|Intervention 1 (1 Week)||1
11335267|NCT02862080|12532921|FG001|STARTED|Intervention 1 (1 Week)||1
11335268|NCT02862080|12532922|FG002|STARTED|Intervention 1 (1 Week)||1
11335269|NCT02862080|12532923|FG003|STARTED|Intervention 1 (1 Week)||1
11335270|NCT02862080|12532920|FG000|COMPLETED|Intervention 1 (1 Week)||1
11335271|NCT02862080|12532921|FG001|COMPLETED|Intervention 1 (1 Week)||1
11335272|NCT02862080|12532922|FG002|COMPLETED|Intervention 1 (1 Week)||1
11335273|NCT02862080|12532923|FG003|COMPLETED|Intervention 1 (1 Week)||1
11335274|NCT02862080|12532920|FG000|NOT COMPLETED|Intervention 1 (1 Week)||0
11058458|NCT01004159|12240344|FG000|NOT COMPLETED|Overall Study||20
11335275|NCT02862080|12532921|FG001|NOT COMPLETED|Intervention 1 (1 Week)||0
11335276|NCT02862080|12532922|FG002|NOT COMPLETED|Intervention 1 (1 Week)||0
11335277|NCT02862080|12532923|FG003|NOT COMPLETED|Intervention 1 (1 Week)||0
11335278|NCT02862080|12532920|FG000|STARTED|Washout (1 Week)||1
11335279|NCT02862080|12532921|FG001|STARTED|Washout (1 Week)||1
11335280|NCT02862080|12532922|FG002|STARTED|Washout (1 Week)||1
11335281|NCT02862080|12532923|FG003|STARTED|Washout (1 Week)||1
11335282|NCT02862080|12532920|FG000|COMPLETED|Washout (1 Week)||1
11335283|NCT02862080|12532921|FG001|COMPLETED|Washout (1 Week)||1
11335284|NCT02862080|12532922|FG002|COMPLETED|Washout (1 Week)||1
11335285|NCT02862080|12532923|FG003|COMPLETED|Washout (1 Week)||1
11335286|NCT02862080|12532920|FG000|NOT COMPLETED|Washout (1 Week)||0
11335287|NCT02862080|12532921|FG001|NOT COMPLETED|Washout (1 Week)||0
11335288|NCT02862080|12532922|FG002|NOT COMPLETED|Washout (1 Week)||0
11335289|NCT02862080|12532923|FG003|NOT COMPLETED|Washout (1 Week)||0
11335290|NCT02862080|12532920|FG000|STARTED|Intervention 2 (1 Week)||1
11335291|NCT02862080|12532921|FG001|STARTED|Intervention 2 (1 Week)||1
11335292|NCT02862080|12532922|FG002|STARTED|Intervention 2 (1 Week)||1
11335293|NCT02862080|12532923|FG003|STARTED|Intervention 2 (1 Week)||1
11335294|NCT02862080|12532920|FG000|COMPLETED|Intervention 2 (1 Week)||1
11335295|NCT02862080|12532921|FG001|COMPLETED|Intervention 2 (1 Week)||1
11335296|NCT02862080|12532922|FG002|COMPLETED|Intervention 2 (1 Week)||1
11335297|NCT02862080|12532923|FG003|COMPLETED|Intervention 2 (1 Week)||1
11335298|NCT02862080|12532920|FG000|NOT COMPLETED|Intervention 2 (1 Week)||0
11335299|NCT02862080|12532921|FG001|NOT COMPLETED|Intervention 2 (1 Week)||0
11036881|NCT00887224|12216663|FG000|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
11036882|NCT00887224|12216664|FG001|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
11036883|NCT00887224|12216665|FG002|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
11036884|NCT00887224|12216663|FG000|COMPLETED|OL Taper Phase / OL Follow Up||163
11036885|NCT00887224|12216664|FG001|COMPLETED|OL Taper Phase / OL Follow Up||0
11036886|NCT00887224|12216665|FG002|COMPLETED|OL Taper Phase / OL Follow Up||0
11036887|NCT00887224|12216663|FG000|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
11036888|NCT00887224|12216664|FG001|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
11036889|NCT00887224|12216665|FG002|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
11036890|NCT00887224|12216663|FG000|STARTED|Double-blind (DB) Phase||0
11036891|NCT00887224|12216664|FG001|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
11036892|NCT00887224|12216665|FG002|STARTED|Double-blind (DB) Phase||272
11036893|NCT00887224|12216663|FG000|COMPLETED|Double-blind (DB) Phase||0
11036894|NCT00887224|12216664|FG001|COMPLETED|Double-blind (DB) Phase||176
11036895|NCT00887224|12216665|FG002|COMPLETED|Double-blind (DB) Phase||210
11036896|NCT00887224|12216663|FG000|NOT COMPLETED|Double-blind (DB) Phase||0
11036897|NCT00887224|12216664|FG001|NOT COMPLETED|Double-blind (DB) Phase||100
11036898|NCT00887224|12216665|FG002|NOT COMPLETED|Double-blind (DB) Phase||62
11036899|NCT00887224|12216663|FG000|STARTED|DB Taper Phase / Post Study Follow Up||0
11036900|NCT00887224|12216664|FG001|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
11335300|NCT02862080|12532922|FG002|NOT COMPLETED|Intervention 2 (1 Week)||0
11335301|NCT02862080|12532923|FG003|NOT COMPLETED|Intervention 2 (1 Week)||0
11335302|NCT02862080|12532920|FG000|STARTED|Washout (1 Week)||1
11335303|NCT02862080|12532921|FG001|STARTED|Washout (1 Week)||1
11335304|NCT02862080|12532922|FG002|STARTED|Washout (1 Week)||1
11335305|NCT02862080|12532923|FG003|STARTED|Washout (1 Week)||1
11335306|NCT02862080|12532920|FG000|COMPLETED|Washout (1 Week)||1
11335307|NCT02862080|12532921|FG001|COMPLETED|Washout (1 Week)||1
11335308|NCT02862080|12532922|FG002|COMPLETED|Washout (1 Week)||1
11335309|NCT02862080|12532923|FG003|COMPLETED|Washout (1 Week)||1
11335310|NCT02862080|12532920|FG000|NOT COMPLETED|Washout (1 Week)||0
11335311|NCT02862080|12532921|FG001|NOT COMPLETED|Washout (1 Week)||0
11335312|NCT02862080|12532922|FG002|NOT COMPLETED|Washout (1 Week)||0
11335313|NCT02862080|12532923|FG003|NOT COMPLETED|Washout (1 Week)||0
11335314|NCT02862080|12532920|FG000|STARTED|Intervention 1 Again (1 Week)||1
11335315|NCT02862080|12532921|FG001|STARTED|Intervention 1 Again (1 Week)||1
11335316|NCT02862080|12532922|FG002|STARTED|Intervention 1 Again (1 Week)||1
11335317|NCT02862080|12532923|FG003|STARTED|Intervention 1 Again (1 Week)||1
11335318|NCT02862080|12532920|FG000|COMPLETED|Intervention 1 Again (1 Week)||1
11335319|NCT02862080|12532921|FG001|COMPLETED|Intervention 1 Again (1 Week)||1
11335320|NCT02862080|12532922|FG002|COMPLETED|Intervention 1 Again (1 Week)||1
11335321|NCT02862080|12532923|FG003|COMPLETED|Intervention 1 Again (1 Week)||1
11335322|NCT02862080|12532920|FG000|NOT COMPLETED|Intervention 1 Again (1 Week)||0
11335323|NCT02862080|12532921|FG001|NOT COMPLETED|Intervention 1 Again (1 Week)||0
11335324|NCT02862080|12532922|FG002|NOT COMPLETED|Intervention 1 Again (1 Week)||0
11335325|NCT02862080|12532923|FG003|NOT COMPLETED|Intervention 1 Again (1 Week)||0
11335326|NCT02862106|12532939|FG000|STARTED|Overall Study||183
11335327|NCT02862106|12532940|FG001|STARTED|Overall Study||26
11335328|NCT02862106|12532939|FG000|COMPLETED|Overall Study||145
11335329|NCT02862106|12532940|FG001|COMPLETED|Overall Study||20
11036901|NCT00887224|12216665|FG002|STARTED|DB Taper Phase / Post Study Follow Up||265
11036902|NCT00887224|12216663|FG000|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
11036903|NCT00887224|12216664|FG001|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
11335330|NCT02862106|12532939|FG000|NOT COMPLETED|Overall Study||38
11335331|NCT02862106|12532940|FG001|NOT COMPLETED|Overall Study||6
11335332|NCT02862535|12532956|FG000|STARTED|Overall Study||9
11335333|NCT02862535|12532957|FG001|STARTED|Overall Study||6
11335334|NCT02862535|12532958|FG002|STARTED|Overall Study||10
11335335|NCT02862535|12532959|FG003|STARTED|Overall Study||11
11335336|NCT02862535|12532956|FG000|COMPLETED|Overall Study||0
11335337|NCT02862535|12532957|FG001|COMPLETED|Overall Study||0
11335338|NCT02862535|12532958|FG002|COMPLETED|Overall Study||0
11335339|NCT02862535|12532959|FG003|COMPLETED|Overall Study||0
11036904|NCT00887224|12216665|FG002|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
11036905|NCT00887224|12216663|FG000|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
11036906|NCT00887224|12216664|FG001|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
11036907|NCT00887224|12216665|FG002|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
11036908|NCT00887224|12216663|FG000|COMPLETED|DB Taper Phase / Post Study Follow Up||0
11036909|NCT00887224|12216664|FG001|COMPLETED|DB Taper Phase / Post Study Follow Up||226
11036910|NCT00887224|12216665|FG002|COMPLETED|DB Taper Phase / Post Study Follow Up||235
11036911|NCT00887224|12216663|FG000|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
11036912|NCT00887224|12216664|FG001|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
11036913|NCT00887224|12216665|FG002|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
11036914|NCT00887289|12216677|FG000|STARTED|Overall Study||1504
11036915|NCT00887289|12216677|FG000|COMPLETED|Overall Study||1409
11036916|NCT00887289|12216677|FG000|NOT COMPLETED|Overall Study||95
11036917|NCT00887341|12216683|FG000|STARTED|Overall Study||37
11036918|NCT00887341|12216684|FG001|STARTED|Overall Study||39
11036919|NCT00887341|12216683|FG000|COMPLETED|Overall Study||35
11036920|NCT00887341|12216684|FG001|COMPLETED|Overall Study||36
11036921|NCT00887341|12216683|FG000|NOT COMPLETED|Overall Study||2
11036922|NCT00887341|12216684|FG001|NOT COMPLETED|Overall Study||3
11036923|NCT00887354|12216692|FG000|STARTED|Treatment Phase (Week 0 to Week 26)||111
11036924|NCT00887354|12216693|FG001|STARTED|Treatment Phase (Week 0 to Week 26)||113
11036925|NCT00887354|12216692|FG000|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
11036926|NCT00887354|12216693|FG001|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
11036927|NCT00887354|12216692|FG000|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
11036928|NCT00887354|12216693|FG001|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
11036929|NCT00887354|12216692|FG000|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
11036930|NCT00887354|12216693|FG001|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
11036931|NCT00887354|12216692|FG000|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
11036932|NCT00887354|12216693|FG001|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
11036933|NCT00887354|12216692|FG000|STARTED|Open Label Phase (Week 26 to Week 78)||60
11036934|NCT00887354|12216693|FG001|STARTED|Open Label Phase (Week 26 to Week 78)||65
11036935|NCT00887354|12216692|FG000|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
11036936|NCT00887354|12216693|FG001|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
11036937|NCT00887354|12216692|FG000|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
11036938|NCT00887354|12216693|FG001|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
11036939|NCT00887432|12216702|FG000|STARTED|Overall Study||58
11036940|NCT00887432|12216703|FG001|STARTED|Overall Study||74
11036941|NCT00887432|12216702|FG000|COMPLETED|Overall Study||43
11036942|NCT00887432|12216703|FG001|COMPLETED|Overall Study||60
11036943|NCT00887432|12216702|FG000|NOT COMPLETED|Overall Study||15
11036944|NCT00887432|12216703|FG001|NOT COMPLETED|Overall Study||14
11036945|NCT00887458|12216711|FG000|STARTED|Overall Study||17
11036946|NCT00887458|12216712|FG001|STARTED|Overall Study||29
11036947|NCT00887458|12216711|FG000|COMPLETED|Overall Study||17
11036948|NCT00887458|12216712|FG001|COMPLETED|Overall Study||25
11036949|NCT00887458|12216711|FG000|NOT COMPLETED|Overall Study||0
11036950|NCT00887458|12216712|FG001|NOT COMPLETED|Overall Study||4
11036951|NCT00887471|12216722|FG000|STARTED|Overall Study||15
11036952|NCT00887471|12216723|FG001|STARTED|Overall Study||15
11036953|NCT00887471|12216722|FG000|COMPLETED|Overall Study||15
11036954|NCT00887471|12216723|FG001|COMPLETED|Overall Study||15
11036955|NCT00887471|12216722|FG000|NOT COMPLETED|Overall Study||0
11036956|NCT00887471|12216723|FG001|NOT COMPLETED|Overall Study||0
11036957|NCT00887484|12216729|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||48
11335340|NCT02862535|12532956|FG000|NOT COMPLETED|Overall Study||9
11036958|NCT00887484|12216729|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
11036959|NCT00887484|12216729|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
11036960|NCT00887484|12216729|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||48
11036961|NCT00887484|12216729|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
11036962|NCT00887484|12216729|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
11036963|NCT00887510|12216740|FG000|STARTED|Overall Study||12
11036964|NCT00887510|12216741|FG001|STARTED|Overall Study||12
11036965|NCT00887510|12216740|FG000|COMPLETED|Overall Study||12
11036966|NCT00887510|12216741|FG001|COMPLETED|Overall Study||12
11036967|NCT00887510|12216740|FG000|NOT COMPLETED|Overall Study||0
11036968|NCT00887510|12216741|FG001|NOT COMPLETED|Overall Study||0
11036969|NCT00887549|12216747|FG000|STARTED|Induction Therapy||70
11036970|NCT00887549|12216747|FG000|COMPLETED|Induction Therapy||43
11036971|NCT00887549|12216747|FG000|NOT COMPLETED|Induction Therapy||27
11036972|NCT00887549|12216747|FG000|STARTED|Maintenance Therapy||43
11036973|NCT00887549|12216747|FG000|COMPLETED|Maintenance Therapy||0
11036974|NCT00887549|12216747|FG000|NOT COMPLETED|Maintenance Therapy||43
11036975|NCT00887562|12216754|FG000|STARTED|Overall Study||10
11036976|NCT00887562|12216755|FG001|STARTED|Overall Study||9
11036977|NCT00887562|12216756|FG002|STARTED|Overall Study||8
11036978|NCT00887562|12216754|FG000|COMPLETED|Overall Study||7
11036979|NCT00887562|12216755|FG001|COMPLETED|Overall Study||7
11036980|NCT00887562|12216756|FG002|COMPLETED|Overall Study||7
11036981|NCT00887562|12216754|FG000|NOT COMPLETED|Overall Study||3
11036982|NCT00887562|12216755|FG001|NOT COMPLETED|Overall Study||2
11036983|NCT00887562|12216756|FG002|NOT COMPLETED|Overall Study||1
11036984|NCT00887575|12216766|FG000|STARTED|Phase I||6
11036985|NCT00887575|12216767|FG001|STARTED|Phase I||6
11036986|NCT00887575|12216768|FG002|STARTED|Phase I||3
11036987|NCT00887575|12216766|FG000|COMPLETED|Phase I||6
11036988|NCT00887575|12216767|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
11036989|NCT00887575|12216768|FG002|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
11036990|NCT00887575|12216766|FG000|NOT COMPLETED|Phase I||0
11036991|NCT00887575|12216767|FG001|NOT COMPLETED|Phase I||6
11036992|NCT00887575|12216768|FG002|NOT COMPLETED|Phase I||3
11036993|NCT00887575|12216766|FG000|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
11036994|NCT00887575|12216767|FG001|STARTED|Phase II - Neoadjuvant Therapy||0
11036995|NCT00887575|12216768|FG002|STARTED|Phase II - Neoadjuvant Therapy||0
11036996|NCT00887575|12216766|FG000|COMPLETED|Phase II - Neoadjuvant Therapy||16
11036997|NCT00887575|12216767|FG001|COMPLETED|Phase II - Neoadjuvant Therapy||0
11036998|NCT00887575|12216768|FG002|COMPLETED|Phase II - Neoadjuvant Therapy||0
11036999|NCT00887575|12216766|FG000|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
11037000|NCT00887575|12216767|FG001|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
11037001|NCT00887575|12216768|FG002|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
11037002|NCT00887575|12216766|FG000|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
11037003|NCT00887575|12216767|FG001|STARTED|Phase II - Maintenance Therapy||0
11037004|NCT00887575|12216768|FG002|STARTED|Phase II - Maintenance Therapy||0
11037005|NCT00887575|12216766|FG000|COMPLETED|Phase II - Maintenance Therapy||6
11037006|NCT00887575|12216767|FG001|COMPLETED|Phase II - Maintenance Therapy||0
11037007|NCT00887575|12216768|FG002|COMPLETED|Phase II - Maintenance Therapy||0
11037008|NCT00887575|12216766|FG000|NOT COMPLETED|Phase II - Maintenance Therapy||2
11037009|NCT00887575|12216767|FG001|NOT COMPLETED|Phase II - Maintenance Therapy||0
11037010|NCT00887575|12216768|FG002|NOT COMPLETED|Phase II - Maintenance Therapy||0
11037011|NCT00887588|12216775|FG000|STARTED|Core Period||149
11037012|NCT00887588|12216776|FG001|STARTED|Core Period||152
11037013|NCT00887588|12216775|FG000|Extension Efficacy Set|Core Period||127
11037014|NCT00887588|12216776|FG001|Extension Efficacy Set|Core Period||125
11037015|NCT00887588|12216775|FG000|Full Analysis Set|Core Period||148
11037016|NCT00887588|12216776|FG001|Full Analysis Set|Core Period||146
11037017|NCT00887588|12216775|FG000|Arterial Stiffness Set|Core Period||86
11037018|NCT00887588|12216776|FG001|Arterial Stiffness Set|Core Period||94
11037019|NCT00887588|12216775|FG000|COMPLETED|Core Period||130
11037020|NCT00887588|12216776|FG001|COMPLETED|Core Period||131
11037021|NCT00887588|12216775|FG000|NOT COMPLETED|Core Period||19
11037022|NCT00887588|12216776|FG001|NOT COMPLETED|Core Period||21
11037023|NCT00887588|12216775|FG000|STARTED|Extension Period||127
11037024|NCT00887588|12216776|FG001|STARTED|Extension Period||125
11037025|NCT00887588|12216775|FG000|Arterial Stiffness Set|Extension Period||86
11037026|NCT00887588|12216776|FG001|Arterial Stiffness Set|Extension Period||94
11037027|NCT00887588|12216775|FG000|COMPLETED|Extension Period||121
11037028|NCT00887588|12216776|FG001|COMPLETED|Extension Period||120
11037029|NCT00887588|12216775|FG000|NOT COMPLETED|Extension Period||6
11037030|NCT00887588|12216776|FG001|NOT COMPLETED|Extension Period||5
11037031|NCT00887640|12216782|FG000|STARTED|Overall Study||11
11037032|NCT00887640|12216782|FG000|COMPLETED|Overall Study||11
11037033|NCT00887640|12216782|FG000|NOT COMPLETED|Overall Study||0
11037034|NCT00887653|12216786|FG000|STARTED|Overall Study||20
11037035|NCT00887653|12216786|FG000|COMPLETED|Overall Study||20
11037036|NCT00887653|12216786|FG000|NOT COMPLETED|Overall Study||0
11037037|NCT00887679|12216790|FG000|STARTED|Overall Study||30
11037038|NCT00887679|12216790|FG000|COMPLETED|Overall Study|20 subjects completed the study.|20
11037039|NCT00887679|12216790|FG000|NOT COMPLETED|Overall Study||10
11037040|NCT00887744|12216795|FG000|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
11037041|NCT00887744|12216795|FG000|COMPLETED|Overall Study||128
11200959|NCT01830543|12391204|FG001|COMPLETED|Overall Study||557
11037042|NCT00887744|12216795|FG000|NOT COMPLETED|Overall Study||34
11037043|NCT00887809|12216801|FG000|STARTED|Overall Study||37
11037044|NCT00887809|12216802|FG001|STARTED|Overall Study||10
11037045|NCT00887809|12216801|FG000|COMPLETED|Overall Study||33
11037046|NCT00887809|12216802|FG001|COMPLETED|Overall Study||10
11037047|NCT00887809|12216801|FG000|NOT COMPLETED|Overall Study||4
11037048|NCT00887809|12216802|FG001|NOT COMPLETED|Overall Study||0
11037049|NCT00887822|12216810|FG000|STARTED|Overall Study||100
11037050|NCT00887822|12216811|FG001|STARTED|Overall Study||102
11037051|NCT00887822|12216810|FG000|Treated (Safety Population)|Overall Study||100
11037052|NCT00887822|12216811|FG001|Treated (Safety Population)|Overall Study||101
11037053|NCT00887822|12216810|FG000|COMPLETED|Overall Study||3
11037054|NCT00887822|12216811|FG001|COMPLETED|Overall Study||0
11037055|NCT00887822|12216810|FG000|NOT COMPLETED|Overall Study||97
11037056|NCT00887822|12216811|FG001|NOT COMPLETED|Overall Study||102
11037057|NCT00887913|12216817|FG000|STARTED|Overall Study||69
11037058|NCT00887913|12216817|FG000|COMPLETED|Overall Study||63
11037059|NCT00887913|12216817|FG000|NOT COMPLETED|Overall Study||6
11037060|NCT00887926|12216825|FG000|STARTED|Overall Study||3
11037061|NCT00887926|12216826|FG001|STARTED|Overall Study||14
11037062|NCT00887926|12216827|FG002|STARTED|Overall Study||3
11037063|NCT00887926|12216828|FG003|STARTED|Overall Study||5
11037064|NCT00887926|12216825|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11037065|NCT00887926|12216826|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
11037066|NCT00887926|12216827|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
11037067|NCT00887926|12216828|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
11037068|NCT00887926|12216825|FG000|COMPLETED|Overall Study||3
11037069|NCT00887926|12216826|FG001|COMPLETED|Overall Study||13
11037070|NCT00887926|12216827|FG002|COMPLETED|Overall Study||3
11037071|NCT00887926|12216828|FG003|COMPLETED|Overall Study||5
11037072|NCT00887926|12216825|FG000|NOT COMPLETED|Overall Study||0
11037073|NCT00887926|12216826|FG001|NOT COMPLETED|Overall Study||1
11037074|NCT00887926|12216827|FG002|NOT COMPLETED|Overall Study||0
11037075|NCT00887926|12216828|FG003|NOT COMPLETED|Overall Study||0
11037076|NCT00887965|12216840|FG000|STARTED|Overall Study||15
11037077|NCT00887965|12216840|FG000|COMPLETED|Overall Study||15
11037078|NCT00887965|12216840|FG000|NOT COMPLETED|Overall Study||0
11037079|NCT00887978|12216846|FG000|STARTED|Overall Study||157
11037080|NCT00887978|12216847|FG001|STARTED|Overall Study||153
11037081|NCT00887978|12216846|FG000|COMPLETED|Overall Study||132
11037082|NCT00887978|12216847|FG001|COMPLETED|Overall Study||138
11037083|NCT00887978|12216846|FG000|NOT COMPLETED|Overall Study||25
11037084|NCT00887978|12216847|FG001|NOT COMPLETED|Overall Study||15
11037085|NCT00888134|12216853|FG000|STARTED|Treatment With Study Drug||28
11037086|NCT00888134|12216853|FG000|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
11037087|NCT00888134|12216853|FG000|NOT COMPLETED|Treatment With Study Drug||1
11037088|NCT00888134|12216853|FG000|STARTED|Follow-up||27
11037089|NCT00888134|12216853|FG000|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
11037090|NCT00888134|12216853|FG000|NOT COMPLETED|Follow-up||1
11037091|NCT00888173|12216858|FG000|STARTED|Overall Study||45
11037092|NCT00888173|12216858|FG000|COMPLETED|Overall Study||43
11037093|NCT00888173|12216858|FG000|NOT COMPLETED|Overall Study||2
11037094|NCT00888238|12216862|FG000|STARTED|First Period of Treatment Intervention||4
11037095|NCT00888238|12216863|FG001|STARTED|First Period of Treatment Intervention||4
11037096|NCT00888238|12216864|FG002|STARTED|First Period of Treatment Intervention||4
11037097|NCT00888238|12216862|FG000|COMPLETED|First Period of Treatment Intervention||4
11037098|NCT00888238|12216863|FG001|COMPLETED|First Period of Treatment Intervention||4
11037099|NCT00888238|12216864|FG002|COMPLETED|First Period of Treatment Intervention||4
11037100|NCT00888238|12216862|FG000|NOT COMPLETED|First Period of Treatment Intervention||0
11037101|NCT00888238|12216863|FG001|NOT COMPLETED|First Period of Treatment Intervention||0
11037102|NCT00888238|12216864|FG002|NOT COMPLETED|First Period of Treatment Intervention||0
11037103|NCT00888238|12216862|FG000|STARTED|Washout Period After Period 1||4
11037104|NCT00888238|12216863|FG001|STARTED|Washout Period After Period 1||4
11037105|NCT00888238|12216864|FG002|STARTED|Washout Period After Period 1||4
11037106|NCT00888238|12216862|FG000|COMPLETED|Washout Period After Period 1||4
11037107|NCT00888238|12216863|FG001|COMPLETED|Washout Period After Period 1||4
11037108|NCT00888238|12216864|FG002|COMPLETED|Washout Period After Period 1||4
11037109|NCT00888238|12216862|FG000|NOT COMPLETED|Washout Period After Period 1||0
11037110|NCT00888238|12216863|FG001|NOT COMPLETED|Washout Period After Period 1||0
11037111|NCT00888238|12216864|FG002|NOT COMPLETED|Washout Period After Period 1||0
11037112|NCT00888238|12216862|FG000|STARTED|Second Period of Treatment Intervention||4
11037113|NCT00888238|12216863|FG001|STARTED|Second Period of Treatment Intervention||4
11037114|NCT00888238|12216864|FG002|STARTED|Second Period of Treatment Intervention||4
11037115|NCT00888238|12216862|FG000|COMPLETED|Second Period of Treatment Intervention||4
11037116|NCT00888238|12216863|FG001|COMPLETED|Second Period of Treatment Intervention||4
11037117|NCT00888238|12216864|FG002|COMPLETED|Second Period of Treatment Intervention||4
11037118|NCT00888238|12216862|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0
11037119|NCT00888238|12216863|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0
11037120|NCT00888238|12216864|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0
11037121|NCT00888238|12216862|FG000|STARTED|Washout Period After Period 2||4
11037122|NCT00888238|12216863|FG001|STARTED|Washout Period After Period 2||4
11037123|NCT00888238|12216864|FG002|STARTED|Washout Period After Period 2||4
11037124|NCT00888238|12216862|FG000|COMPLETED|Washout Period After Period 2||4
11037125|NCT00888238|12216863|FG001|COMPLETED|Washout Period After Period 2||4
11037126|NCT00888238|12216864|FG002|COMPLETED|Washout Period After Period 2||3
11037127|NCT00888238|12216862|FG000|NOT COMPLETED|Washout Period After Period 2||0
11037128|NCT00888238|12216863|FG001|NOT COMPLETED|Washout Period After Period 2||0
11037129|NCT00888238|12216864|FG002|NOT COMPLETED|Washout Period After Period 2||1
11037130|NCT00888238|12216862|FG000|STARTED|Third Period of Treatment Intervention||4
11037131|NCT00888238|12216863|FG001|STARTED|Third Period of Treatment Intervention||4
11037132|NCT00888238|12216864|FG002|STARTED|Third Period of Treatment Intervention||3
11037133|NCT00888238|12216862|FG000|COMPLETED|Third Period of Treatment Intervention||4
11037134|NCT00888238|12216863|FG001|COMPLETED|Third Period of Treatment Intervention||4
11037135|NCT00888238|12216864|FG002|COMPLETED|Third Period of Treatment Intervention||3
11037136|NCT00888238|12216862|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0
11037137|NCT00888238|12216863|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0
11037138|NCT00888238|12216864|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0
11037139|NCT00888329|12216872|FG000|STARTED|Overall Study||125
11037140|NCT00888329|12216873|FG001|STARTED|Overall Study||131
11037141|NCT00888329|12216872|FG000|COMPLETED|Overall Study||119
11037142|NCT00888329|12216873|FG001|COMPLETED|Overall Study||122
11037143|NCT00888329|12216872|FG000|NOT COMPLETED|Overall Study||6
11037144|NCT00888329|12216873|FG001|NOT COMPLETED|Overall Study||9
11037145|NCT00888381|12216881|FG000|STARTED|Overall Study||60
11037146|NCT00888381|12216882|FG001|STARTED|Overall Study||60
11037147|NCT00888381|12216881|FG000|COMPLETED|Overall Study||60
11037148|NCT00888381|12216882|FG001|COMPLETED|Overall Study||59
11037149|NCT00888381|12216881|FG000|NOT COMPLETED|Overall Study||0
11037150|NCT00888381|12216882|FG001|NOT COMPLETED|Overall Study||1
11037151|NCT00888433|12216890|FG000|STARTED|Overall Study||52
11037152|NCT00888433|12216891|FG001|STARTED|Overall Study||54
11037153|NCT00888433|12216890|FG000|COMPLETED|Overall Study||49
11037154|NCT00888433|12216891|FG001|COMPLETED|Overall Study||51
11037155|NCT00888433|12216890|FG000|NOT COMPLETED|Overall Study||3
11037156|NCT00888433|12216891|FG001|NOT COMPLETED|Overall Study||3
11037157|NCT00888459|12216899|FG000|STARTED|Overall Study||30
11037158|NCT00888459|12216900|FG001|STARTED|Overall Study||30
11037159|NCT00888459|12216899|FG000|COMPLETED|Overall Study||30
11037160|NCT00888459|12216900|FG001|COMPLETED|Overall Study||30
11037161|NCT00888459|12216899|FG000|NOT COMPLETED|Overall Study||0
11037162|NCT00888459|12216900|FG001|NOT COMPLETED|Overall Study||0
11037163|NCT00888511|12216906|FG000|STARTED|Overall Study||15
11037164|NCT00888511|12216906|FG000|COMPLETED|Overall Study||15
11037165|NCT00888511|12216906|FG000|NOT COMPLETED|Overall Study||0
11037166|NCT00888615|12216910|FG000|STARTED|Overall Study||58
11037167|NCT00888615|12216910|FG000|COMPLETED|Overall Study||56
11037168|NCT00888615|12216910|FG000|NOT COMPLETED|Overall Study||2
11037169|NCT00888628|12216914|FG000|STARTED|Overall Study||7
11037170|NCT00888628|12216914|FG000|Enrolled|Overall Study||7
11037171|NCT00888628|12216914|FG000|Screen Failure|Overall Study||2
11037172|NCT00888628|12216914|FG000|Withdrawn|Overall Study||1
11037173|NCT00888628|12216914|FG000|Transplanted|Overall Study||4
11037174|NCT00888628|12216914|FG000|COMPLETED|Overall Study||4
11037175|NCT00888628|12216914|FG000|NOT COMPLETED|Overall Study||3
11037176|NCT00888654|12216918|FG000|STARTED|Overall Study||41
11037177|NCT00888654|12216918|FG000|COMPLETED|Overall Study||31
11037178|NCT00888654|12216918|FG000|NOT COMPLETED|Overall Study||10
11037179|NCT00888849|12216924|FG000|STARTED|Overall Study||142
11037180|NCT00888849|12216925|FG001|STARTED|Overall Study||138
11037181|NCT00888849|12216924|FG000|COMPLETED|Overall Study||137
11037182|NCT00888849|12216925|FG001|COMPLETED|Overall Study||129
11037183|NCT00888849|12216924|FG000|NOT COMPLETED|Overall Study||5
11037184|NCT00888849|12216925|FG001|NOT COMPLETED|Overall Study||9
11037185|NCT00888927|12216935|FG000|STARTED|Overall Study||3
11037186|NCT00888927|12216936|FG001|STARTED|Overall Study||3
11037187|NCT00888927|12216937|FG002|STARTED|Overall Study||3
11037188|NCT00888927|12216938|FG003|STARTED|Overall Study||33
11037189|NCT00888927|12216935|FG000|COMPLETED|Overall Study||3
11037190|NCT00888927|12216936|FG001|COMPLETED|Overall Study||3
11037191|NCT00888927|12216937|FG002|COMPLETED|Overall Study||3
11037192|NCT00888927|12216938|FG003|COMPLETED|Overall Study||31
11037193|NCT00888927|12216935|FG000|NOT COMPLETED|Overall Study||0
11037194|NCT00888927|12216936|FG001|NOT COMPLETED|Overall Study||0
11037195|NCT00888927|12216937|FG002|NOT COMPLETED|Overall Study||0
11037196|NCT00888927|12216938|FG003|NOT COMPLETED|Overall Study||2
11037197|NCT00888940|12216950|FG000|STARTED|Overall Study||120
11037198|NCT00888940|12216951|FG001|STARTED|Overall Study||122
11037199|NCT00888940|12216950|FG000|Completed Therapy|Overall Study||107
11037200|NCT00888940|12216951|FG001|Completed Therapy|Overall Study||106
11037201|NCT00888940|12216950|FG000|COMPLETED|Overall Study||92
11037202|NCT00888940|12216951|FG001|COMPLETED|Overall Study||101
11037203|NCT00888940|12216950|FG000|NOT COMPLETED|Overall Study||28
11037204|NCT00888940|12216951|FG001|NOT COMPLETED|Overall Study||21
11037205|NCT00888979|12216957|FG000|STARTED|Overall Study||10
11037206|NCT00888979|12216957|FG000|Received the Inhaler/Counseling|Overall Study||8
11037207|NCT00888979|12216957|FG000|COMPLETED|Overall Study||6
11037208|NCT00888979|12216957|FG000|NOT COMPLETED|Overall Study||4
11037209|NCT00889005|12216963|FG000|STARTED|Overall Study||65
11037210|NCT00889005|12216964|FG001|STARTED|Overall Study||74
11037211|NCT00889005|12216963|FG000|COMPLETED|Overall Study||57
11037212|NCT00889005|12216964|FG001|COMPLETED|Overall Study||72
11037213|NCT00889005|12216963|FG000|NOT COMPLETED|Overall Study||8
11037214|NCT00889005|12216964|FG001|NOT COMPLETED|Overall Study||2
11037215|NCT00889187|12216970|FG000|STARTED|Overall Study||3
11037216|NCT00889187|12216971|FG001|STARTED|Overall Study||3
11037217|NCT00889187|12216972|FG002|STARTED|Overall Study||4
11037218|NCT00889187|12216973|FG003|STARTED|Overall Study||0
11037219|NCT00889187|12216970|FG000|COMPLETED|Overall Study||3
11037220|NCT00889187|12216971|FG001|COMPLETED|Overall Study||3
11037221|NCT00889187|12216972|FG002|COMPLETED|Overall Study||4
11037222|NCT00889187|12216973|FG003|COMPLETED|Overall Study||0
11037223|NCT00889187|12216970|FG000|NOT COMPLETED|Overall Study||0
11037224|NCT00889187|12216971|FG001|NOT COMPLETED|Overall Study||0
11037225|NCT00889187|12216972|FG002|NOT COMPLETED|Overall Study||0
11037226|NCT00889187|12216973|FG003|NOT COMPLETED|Overall Study||0
11037227|NCT00889200|12216983|FG000|STARTED|Overall Study||12
11037228|NCT00889200|12216983|FG000|COMPLETED|Overall Study||12
11037229|NCT00889200|12216983|FG000|NOT COMPLETED|Overall Study||0
11037230|NCT00889226|12216989|FG000|STARTED|Overall Study||83
11037231|NCT00889226|12216990|FG001|STARTED|Overall Study||78
11037232|NCT00889226|12216989|FG000|COMPLETED|Overall Study||58
11037233|NCT00889226|12216990|FG001|COMPLETED|Overall Study||43
11037234|NCT00889226|12216989|FG000|NOT COMPLETED|Overall Study||25
11037235|NCT00889226|12216990|FG001|NOT COMPLETED|Overall Study||35
11037236|NCT00889252|12216998|FG000|STARTED|Overall Study||168
11037237|NCT00889252|12216999|FG001|STARTED|Overall Study||82
11037238|NCT00889252|12216998|FG000|COMPLETED|Overall Study||161
11037239|NCT00889252|12216999|FG001|COMPLETED|Overall Study||78
11037240|NCT00889252|12216998|FG000|NOT COMPLETED|Overall Study||7
11037241|NCT00889252|12216999|FG001|NOT COMPLETED|Overall Study||4
11037242|NCT00889265|12217005|FG000|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
11037243|NCT00889265|12217005|FG000|COMPLETED|Overall Study||44
11037244|NCT00889265|12217005|FG000|NOT COMPLETED|Overall Study||7
11037245|NCT00889330|12217011|FG000|STARTED|Overall Study||30
11037246|NCT00889330|12217012|FG001|STARTED|Overall Study||30
11037247|NCT00889330|12217011|FG000|COMPLETED|Overall Study||30
11037248|NCT00889330|12217012|FG001|COMPLETED|Overall Study||30
11037249|NCT00889330|12217011|FG000|NOT COMPLETED|Overall Study||0
11037250|NCT00889330|12217012|FG001|NOT COMPLETED|Overall Study||0
11037251|NCT00889512|12217020|FG000|STARTED|Overall Study||5
11037252|NCT00889512|12217021|FG001|STARTED|Overall Study||9
11037253|NCT00889512|12217020|FG000|COMPLETED|Overall Study||5
11037254|NCT00889512|12217021|FG001|COMPLETED|Overall Study||9
11037255|NCT00889512|12217020|FG000|NOT COMPLETED|Overall Study||0
11037256|NCT00889512|12217021|FG001|NOT COMPLETED|Overall Study||0
11037257|NCT00889603|12217027|FG000|STARTED|Overall Study||370
11037258|NCT00889603|12217027|FG000|COMPLETED|Overall Study||333
11037259|NCT00889603|12217027|FG000|NOT COMPLETED|Overall Study||37
11037260|NCT00889681|12217031|FG000|STARTED|Overall Study||81
11037261|NCT00889681|12217031|FG000|Received Treatment|Overall Study||78
11037262|NCT00889681|12217031|FG000|COMPLETED|Overall Study||78
11037263|NCT00889681|12217031|FG000|NOT COMPLETED|Overall Study||3
11037264|NCT00889707|12217037|FG000|STARTED|Overall Study||61
11037265|NCT00889707|12217038|FG001|STARTED|Overall Study||31
11037266|NCT00889707|12217037|FG000|COMPLETED|Overall Study||54
11037267|NCT00889707|12217038|FG001|COMPLETED|Overall Study||21
11037268|NCT00889707|12217037|FG000|NOT COMPLETED|Overall Study||7
11037269|NCT00889707|12217038|FG001|NOT COMPLETED|Overall Study||10
11037270|NCT00889720|12217044|FG000|STARTED|Overall Study||16
11037271|NCT00889720|12217044|FG000|Surgical Population|Overall Study||12
11037272|NCT00889720|12217044|FG000|COMPLETED|Overall Study||8
11037273|NCT00889720|12217044|FG000|NOT COMPLETED|Overall Study||8
11037274|NCT00889824|12217048|FG000|STARTED|Overall Study||5
11037275|NCT00889824|12217048|FG000|COMPLETED|Overall Study||5
11037276|NCT00889824|12217048|FG000|NOT COMPLETED|Overall Study||0
11037277|NCT00889863|12217052|FG000|STARTED|Part I: Open Label||177
11037278|NCT00889863|12217053|FG001|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
11037279|NCT00889863|12217052|FG000|Entered Part Ia|Part I: Open Label||145
11037280|NCT00889863|12217053|FG001|Entered Part Ia|Part I: Open Label||0
11037281|NCT00889863|12217052|FG000|Entered Part Ib|Part I: Open Label||142
11037282|NCT00889863|12217053|FG001|Entered Part Ib|Part I: Open Label||0
11037283|NCT00889863|12217052|FG000|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
11037284|NCT00889863|12217053|FG001|Entered Part Ic|Part I: Open Label||0
11037285|NCT00889863|12217052|FG000|Entered Part 1d|Part I: Open Label||103
11037286|NCT00889863|12217053|FG001|Entered Part 1d|Part I: Open Label||0
11037287|NCT00889863|12217052|FG000|COMPLETED|Part I: Open Label||100
11037288|NCT00889863|12217053|FG001|COMPLETED|Part I: Open Label||0
11037289|NCT00889863|12217052|FG000|NOT COMPLETED|Part I: Open Label||77
11037290|NCT00889863|12217053|FG001|NOT COMPLETED|Part I: Open Label||0
11037291|NCT00889863|12217052|FG000|STARTED|Part II: Randomized Double Blind||50
11037292|NCT00889863|12217053|FG001|STARTED|Part II: Randomized Double Blind||50
11037293|NCT00889863|12217052|FG000|COMPLETED|Part II: Randomized Double Blind||39
11037294|NCT00889863|12217053|FG001|COMPLETED|Part II: Randomized Double Blind||24
11037295|NCT00889863|12217052|FG000|NOT COMPLETED|Part II: Randomized Double Blind||11
11037296|NCT00889863|12217053|FG001|NOT COMPLETED|Part II: Randomized Double Blind||26
11037297|NCT00889915|12217065|FG000|STARTED|Overall Study||37
11037298|NCT00889915|12217066|FG001|STARTED|Overall Study||76
11037299|NCT00889915|12217067|FG002|STARTED|Overall Study||67
11037300|NCT00889915|12217068|FG003|STARTED|Overall Study||48
11037301|NCT00889915|12217065|FG000|COMPLETED|Overall Study||35
11037302|NCT00889915|12217066|FG001|COMPLETED|Overall Study||71
11037303|NCT00889915|12217067|FG002|COMPLETED|Overall Study||54
11037304|NCT00889915|12217068|FG003|COMPLETED|Overall Study||40
11037305|NCT00889915|12217065|FG000|NOT COMPLETED|Overall Study||2
11037306|NCT00889915|12217066|FG001|NOT COMPLETED|Overall Study||5
11037307|NCT00889915|12217067|FG002|NOT COMPLETED|Overall Study||13
11037308|NCT00889915|12217068|FG003|NOT COMPLETED|Overall Study||8
11037309|NCT00889928|12217078|FG000|STARTED|Overall Study||7
11037310|NCT00889928|12217078|FG000|COMPLETED|Overall Study||7
11037311|NCT00889928|12217078|FG000|NOT COMPLETED|Overall Study||0
11037312|NCT00890045|12217084|FG000|STARTED|Overall Study||20
11037313|NCT00890045|12217085|FG001|STARTED|Overall Study|Of the 52 subjects randomized to the HeRO Graft, two implants were abandoned.|52
11037314|NCT00890045|12217084|FG000|COMPLETED|Overall Study||15
11037315|NCT00890045|12217085|FG001|COMPLETED|Overall Study||42
11037316|NCT00890045|12217084|FG000|NOT COMPLETED|Overall Study||5
11037317|NCT00890045|12217085|FG001|NOT COMPLETED|Overall Study||10
11037318|NCT00890084|12217091|FG000|STARTED|Overall Study||2913
11037319|NCT00890084|12217091|FG000|COMPLETED|Overall Study||2771
11037320|NCT00890084|12217091|FG000|NOT COMPLETED|Overall Study||142
11037321|NCT00890097|12217098|FG000|STARTED|Overall Study||252
11037322|NCT00890097|12217099|FG001|STARTED|Overall Study||259
11037323|NCT00890097|12217100|FG002|STARTED|Overall Study||261
11037324|NCT00890097|12217098|FG000|COMPLETED|Overall Study||184
11037325|NCT00890097|12217099|FG001|COMPLETED|Overall Study||173
11037326|NCT00890097|12217100|FG002|COMPLETED|Overall Study||184
11037327|NCT00890097|12217098|FG000|NOT COMPLETED|Overall Study||68
11037328|NCT00890097|12217099|FG001|NOT COMPLETED|Overall Study||86
11037329|NCT00890097|12217100|FG002|NOT COMPLETED|Overall Study||77
11037330|NCT00890162|12217110|FG000|STARTED|Overall Study||8
11037331|NCT00890162|12217111|FG001|STARTED|Overall Study||8
11037332|NCT00890162|12217110|FG000|COMPLETED|Overall Study||6
11037333|NCT00890162|12217111|FG001|COMPLETED|Overall Study||7
11037334|NCT00890162|12217110|FG000|NOT COMPLETED|Overall Study||2
11037335|NCT00890162|12217111|FG001|NOT COMPLETED|Overall Study||1
11037336|NCT00890201|12217119|FG000|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
11037337|NCT00890201|12217120|FG001|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
11037338|NCT00890201|12217119|FG000|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
11037339|NCT00890201|12217120|FG001|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
11037340|NCT00890201|12217119|FG000|NOT COMPLETED|Overall Study||5
11037341|NCT00890201|12217120|FG001|NOT COMPLETED|Overall Study||56
11037342|NCT00890396|12217128|FG000|STARTED|Overall Study||127
11037343|NCT00890396|12217129|FG001|STARTED|Overall Study||36
11037344|NCT00890396|12217128|FG000|COMPLETED|Overall Study||122
11037345|NCT00890396|12217129|FG001|COMPLETED|Overall Study||34
11037346|NCT00890396|12217128|FG000|NOT COMPLETED|Overall Study||5
11037347|NCT00890396|12217129|FG001|NOT COMPLETED|Overall Study||2
11037348|NCT00890552|12217138|FG000|STARTED|Enrollment and Pre-treatment||25
11037349|NCT00890552|12217138|FG000|COMPLETED|Enrollment and Pre-treatment||24
11037350|NCT00890552|12217138|FG000|NOT COMPLETED|Enrollment and Pre-treatment||1
11037351|NCT00890552|12217138|FG000|STARTED|On-treatment||24
11037352|NCT00890552|12217138|FG000|COMPLETED|On-treatment||14
11037353|NCT00890552|12217138|FG000|NOT COMPLETED|On-treatment||10
11037354|NCT00890617|12217142|FG000|STARTED|Overall Study||9
11037355|NCT00890617|12217142|FG000|COMPLETED|Overall Study||9
11037356|NCT00890617|12217142|FG000|NOT COMPLETED|Overall Study||0
11037357|NCT00890656|12217146|FG000|STARTED|Overall Study||90
11037358|NCT00890656|12217146|FG000|COMPLETED|Overall Study||90
11037359|NCT00890656|12217146|FG000|NOT COMPLETED|Overall Study||0
11037360|NCT00890682|12217152|FG000|STARTED|Overall Study||97
11037361|NCT00890682|12217153|FG001|STARTED|Overall Study||96
11037362|NCT00890682|12217152|FG000|COMPLETED|Overall Study||93
11037363|NCT00890682|12217153|FG001|COMPLETED|Overall Study||94
11037364|NCT00890682|12217152|FG000|NOT COMPLETED|Overall Study||4
11037365|NCT00890682|12217153|FG001|NOT COMPLETED|Overall Study||2
11037366|NCT00890695|12217161|FG000|STARTED|Overall Study||32
11037367|NCT00890695|12217162|FG001|STARTED|Overall Study||33
11037368|NCT00890695|12217161|FG000|COMPLETED|Overall Study||31
11037369|NCT00890695|12217162|FG001|COMPLETED|Overall Study||33
11037370|NCT00890695|12217161|FG000|NOT COMPLETED|Overall Study||1
11037371|NCT00890695|12217162|FG001|NOT COMPLETED|Overall Study||0
11037372|NCT00890721|12217170|FG000|STARTED|Overall Study||95
11037373|NCT00890721|12217171|FG001|STARTED|Overall Study||94
11200960|NCT01830543|12391205|FG002|COMPLETED|Overall Study||492
11200961|NCT01830543|12391203|FG000|NOT COMPLETED|Overall Study||159
11200962|NCT01830543|12391204|FG001|NOT COMPLETED|Overall Study||152
11200963|NCT01830543|12391205|FG002|NOT COMPLETED|Overall Study||214
11200964|NCT01830595|12391213|FG000|STARTED|First Period||26
11200965|NCT01830595|12391214|FG001|STARTED|First Period||28
11200966|NCT01830595|12391213|FG000|Received at Least One Dose|First Period||26
11200967|NCT01830595|12391214|FG001|Received at Least One Dose|First Period||28
11200968|NCT01830595|12391213|FG000|COMPLETED|First Period||25
11200969|NCT01830595|12391214|FG001|COMPLETED|First Period||25
11200970|NCT01830595|12391213|FG000|NOT COMPLETED|First Period||1
11200971|NCT01830595|12391214|FG001|NOT COMPLETED|First Period||3
11200972|NCT01830595|12391213|FG000|STARTED|Washout||25
11200973|NCT01830595|12391214|FG001|STARTED|Washout||25
11200974|NCT01830595|12391213|FG000|COMPLETED|Washout||23
11200975|NCT01830595|12391214|FG001|COMPLETED|Washout||23
11200976|NCT01830595|12391213|FG000|NOT COMPLETED|Washout||2
11200977|NCT01830595|12391214|FG001|NOT COMPLETED|Washout||2
11200978|NCT01830595|12391213|FG000|STARTED|Second Period||23
11200979|NCT01830595|12391214|FG001|STARTED|Second Period||23
11200980|NCT01830595|12391213|FG000|COMPLETED|Second Period||23
11200981|NCT01830595|12391214|FG001|COMPLETED|Second Period||23
11200982|NCT01830595|12391213|FG000|NOT COMPLETED|Second Period||0
11200983|NCT01830595|12391214|FG001|NOT COMPLETED|Second Period||0
11200984|NCT01830621|12391222|FG000|STARTED|Overall Study||138
11200985|NCT01830621|12391223|FG001|STARTED|Overall Study||144
11200986|NCT01830621|12391222|FG000|COMPLETED|Overall Study||138
11200987|NCT01830621|12391223|FG001|COMPLETED|Overall Study||144
11200988|NCT01830621|12391222|FG000|NOT COMPLETED|Overall Study||0
11200989|NCT01830621|12391223|FG001|NOT COMPLETED|Overall Study||0
11200990|NCT01830699|12391231|FG000|STARTED|Overall Study||13
11200991|NCT01830699|12391232|FG001|STARTED|Overall Study||20
11037374|NCT00890721|12217170|FG000|COMPLETED|Overall Study||94
11037375|NCT00890721|12217171|FG001|COMPLETED|Overall Study||93
11037376|NCT00890721|12217170|FG000|NOT COMPLETED|Overall Study||1
11037377|NCT00890721|12217171|FG001|NOT COMPLETED|Overall Study||1
11037378|NCT00890825|12217179|FG000|STARTED|Overall Study||44
11037379|NCT00890825|12217180|FG001|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
11037380|NCT00890825|12217179|FG000|COMPLETED|Overall Study||30
11037381|NCT00890825|12217180|FG001|COMPLETED|Overall Study||29
11037382|NCT00890825|12217179|FG000|NOT COMPLETED|Overall Study||14
11037383|NCT00890825|12217180|FG001|NOT COMPLETED|Overall Study||14
11037384|NCT00890916|12217186|FG000|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
11037385|NCT00890916|12217186|FG000|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
11037386|NCT00890916|12217186|FG000|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
11037387|NCT00890916|12217186|FG000|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
11037388|NCT00890916|12217186|FG000|STARTED|"Rehab - NP Off"||10
11037389|NCT00890916|12217186|FG000|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
11037390|NCT00890916|12217186|FG000|COMPLETED|"Rehab - NP Off"||10
11037391|NCT00890916|12217186|FG000|NOT COMPLETED|"Rehab - NP Off"||0
11037392|NCT00890929|12217190|FG000|STARTED|Overall Study||45
11037393|NCT00890929|12217190|FG000|Consented & Enrolled|Overall Study||45
11037394|NCT00890929|12217190|FG000|Initiated Treatment|Overall Study||43
11037395|NCT00890929|12217190|FG000|COMPLETED|Overall Study||39
11037396|NCT00890929|12217190|FG000|NOT COMPLETED|Overall Study||6
11037397|NCT00890981|12217196|FG000|STARTED|Overall Study||39
11037398|NCT00890981|12217197|FG001|STARTED|Overall Study||40
11037399|NCT00890981|12217196|FG000|COMPLETED|Overall Study||39
11037400|NCT00890981|12217197|FG001|COMPLETED|Overall Study||40
11037401|NCT00890981|12217196|FG000|NOT COMPLETED|Overall Study||0
11037402|NCT00890981|12217197|FG001|NOT COMPLETED|Overall Study||0
11200992|NCT01830699|12391231|FG000|COMPLETED|Overall Study||13
11200993|NCT01830699|12391232|FG001|COMPLETED|Overall Study||20
11335341|NCT02862535|12532957|FG001|NOT COMPLETED|Overall Study||6
11335342|NCT02862535|12532958|FG002|NOT COMPLETED|Overall Study||10
11335343|NCT02862535|12532959|FG003|NOT COMPLETED|Overall Study||11
11335344|NCT02862574|12532972|FG000|STARTED|Double-Blind Treatment Period||5
11335345|NCT02862574|12532973|FG001|STARTED|Double-Blind Treatment Period||5
11335346|NCT02862574|12532974|FG002|STARTED|Double-Blind Treatment Period||5
11335347|NCT02862574|12532972|FG000|COMPLETED|Double-Blind Treatment Period||2
11335348|NCT02862574|12532973|FG001|COMPLETED|Double-Blind Treatment Period||3
11335349|NCT02862574|12532974|FG002|COMPLETED|Double-Blind Treatment Period||1
11335350|NCT02862574|12532972|FG000|NOT COMPLETED|Double-Blind Treatment Period||3
11335351|NCT02862574|12532973|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
11335352|NCT02862574|12532974|FG002|NOT COMPLETED|Double-Blind Treatment Period||4
11335353|NCT02862574|12532972|FG000|STARTED|Open-Label Treatment Period||2
11335354|NCT02862574|12532973|FG001|STARTED|Open-Label Treatment Period||3
11335355|NCT02862574|12532974|FG002|STARTED|Open-Label Treatment Period||1
11335356|NCT02862574|12532972|FG000|COMPLETED|Open-Label Treatment Period||0
11335357|NCT02862574|12532973|FG001|COMPLETED|Open-Label Treatment Period||0
11335358|NCT02862574|12532974|FG002|COMPLETED|Open-Label Treatment Period||0
11335359|NCT02862574|12532972|FG000|NOT COMPLETED|Open-Label Treatment Period||2
11335360|NCT02862574|12532973|FG001|NOT COMPLETED|Open-Label Treatment Period||3
11335361|NCT02862574|12532974|FG002|NOT COMPLETED|Open-Label Treatment Period||1
11335362|NCT02862600|12532983|FG000|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
11335363|NCT02862600|12532983|FG000|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
11335364|NCT02862600|12532983|FG000|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
11335365|NCT02862600|12532983|FG000|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
11335366|NCT02862600|12532983|FG000|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
11335367|NCT02862600|12532983|FG000|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
11335368|NCT02862730|12532989|FG000|STARTED|Tslim Training Visit (2 Weeks)||4
11335369|NCT02862730|12532990|FG001|STARTED|Tslim Training Visit (2 Weeks)||1
11335370|NCT02862730|12532991|FG002|STARTED|Tslim Training Visit (2 Weeks)||8
11335371|NCT02862730|12532992|FG003|STARTED|Tslim Training Visit (2 Weeks)||5
11335372|NCT02862730|12532993|FG004|STARTED|Tslim Training Visit (2 Weeks)||5
11335373|NCT02862730|12532994|FG005|STARTED|Tslim Training Visit (2 Weeks)||1
11335374|NCT02862730|12532995|FG006|STARTED|Tslim Training Visit (2 Weeks)||1
11335375|NCT02862730|12532989|FG000|COMPLETED|Tslim Training Visit (2 Weeks)||4
11335376|NCT02862730|12532990|FG001|COMPLETED|Tslim Training Visit (2 Weeks)||1
11335377|NCT02862730|12532991|FG002|COMPLETED|Tslim Training Visit (2 Weeks)||7
11335378|NCT02862730|12532992|FG003|COMPLETED|Tslim Training Visit (2 Weeks)||5
11037403|NCT00891020|12217206|FG000|STARTED|24 Week Treatment Period||163
11037404|NCT00891020|12217207|FG001|STARTED|24 Week Treatment Period||363
11037405|NCT00891020|12217208|FG002|STARTED|24 Week Treatment Period||360
11037406|NCT00891020|12217206|FG000|Intent-to-Treat (ITT)|24 Week Treatment Period||163
11037407|NCT00891020|12217207|FG001|Intent-to-Treat (ITT)|24 Week Treatment Period||362
11037408|NCT00891020|12217208|FG002|Intent-to-Treat (ITT)|24 Week Treatment Period||358
11037409|NCT00891020|12217206|FG000|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
11037410|NCT00891020|12217207|FG001|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
11037411|NCT00891020|12217208|FG002|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
11037412|NCT00891020|12217206|FG000|COMPLETED|24 Week Treatment Period||126
11037413|NCT00891020|12217207|FG001|COMPLETED|24 Week Treatment Period||303
11037414|NCT00891020|12217208|FG002|COMPLETED|24 Week Treatment Period||302
11037415|NCT00891020|12217206|FG000|NOT COMPLETED|24 Week Treatment Period||37
11037416|NCT00891020|12217207|FG001|NOT COMPLETED|24 Week Treatment Period||60
11037417|NCT00891020|12217208|FG002|NOT COMPLETED|24 Week Treatment Period||58
11037418|NCT00891020|12217206|FG000|STARTED|Long-term Extension Period||55
11037419|NCT00891020|12217207|FG001|STARTED|Long-term Extension Period||196
11037420|NCT00891020|12217208|FG002|STARTED|Long-term Extension Period||193
11037421|NCT00891020|12217206|FG000|COMPLETED|Long-term Extension Period||49
11037422|NCT00891020|12217207|FG001|COMPLETED|Long-term Extension Period||172
11037423|NCT00891020|12217208|FG002|COMPLETED|Long-term Extension Period||170
11335379|NCT02862730|12532993|FG004|COMPLETED|Tslim Training Visit (2 Weeks)||5
11335380|NCT02862730|12532994|FG005|COMPLETED|Tslim Training Visit (2 Weeks)||1
11335381|NCT02862730|12532995|FG006|COMPLETED|Tslim Training Visit (2 Weeks)||1
11335382|NCT02862730|12532989|FG000|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
11335383|NCT02862730|12532990|FG001|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
11335384|NCT02862730|12532991|FG002|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
11335385|NCT02862730|12532992|FG003|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
11335386|NCT02862730|12532993|FG004|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
11335387|NCT02862730|12532994|FG005|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
11335388|NCT02862730|12532995|FG006|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
11335389|NCT02862730|12532989|FG000|STARTED|First Rest Period (1-12 Weeks)||4
11335390|NCT02862730|12532990|FG001|STARTED|First Rest Period (1-12 Weeks)||1
11335391|NCT02862730|12532991|FG002|STARTED|First Rest Period (1-12 Weeks)||7
11335392|NCT02862730|12532992|FG003|STARTED|First Rest Period (1-12 Weeks)||5
11335393|NCT02862730|12532993|FG004|STARTED|First Rest Period (1-12 Weeks)||5
11335394|NCT02862730|12532994|FG005|STARTED|First Rest Period (1-12 Weeks)||1
11335395|NCT02862730|12532995|FG006|STARTED|First Rest Period (1-12 Weeks)||1
11335396|NCT02862730|12532989|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4
11335397|NCT02862730|12532990|FG001|COMPLETED|First Rest Period (1-12 Weeks)||1
11335398|NCT02862730|12532991|FG002|COMPLETED|First Rest Period (1-12 Weeks)||7
11335399|NCT02862730|12532992|FG003|COMPLETED|First Rest Period (1-12 Weeks)||5
11335400|NCT02862730|12532993|FG004|COMPLETED|First Rest Period (1-12 Weeks)||5
11037424|NCT00891020|12217206|FG000|NOT COMPLETED|Long-term Extension Period||6
11037425|NCT00891020|12217207|FG001|NOT COMPLETED|Long-term Extension Period||24
11037426|NCT00891020|12217208|FG002|NOT COMPLETED|Long-term Extension Period||23
11335401|NCT02862730|12532994|FG005|COMPLETED|First Rest Period (1-12 Weeks)||1
11335402|NCT02862730|12532995|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1
11335403|NCT02862730|12532989|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11335404|NCT02862730|12532990|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11335405|NCT02862730|12532991|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11335406|NCT02862730|12532992|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11335407|NCT02862730|12532993|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11335408|NCT02862730|12532994|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11335409|NCT02862730|12532995|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
11335410|NCT02862730|12532989|FG000|STARTED|First Intervention (84 Hours)||4
11335411|NCT02862730|12532990|FG001|STARTED|First Intervention (84 Hours)||1
11335412|NCT02862730|12532991|FG002|STARTED|First Intervention (84 Hours)||7
11335413|NCT02862730|12532992|FG003|STARTED|First Intervention (84 Hours)||5
11335414|NCT02862730|12532993|FG004|STARTED|First Intervention (84 Hours)||5
11335415|NCT02862730|12532994|FG005|STARTED|First Intervention (84 Hours)||1
11335416|NCT02862730|12532995|FG006|STARTED|First Intervention (84 Hours)||1
11037427|NCT00891046|12217223|FG000|STARTED|Overall Study||33
11037428|NCT00891046|12217224|FG001|STARTED|Overall Study||63
11037429|NCT00891046|12217225|FG002|STARTED|Overall Study||40
11037430|NCT00891046|12217226|FG003|STARTED|Overall Study||11
11037431|NCT00891046|12217227|FG004|STARTED|Overall Study||123
11037432|NCT00891046|12217223|FG000|COMPLETED|Overall Study||21
11037433|NCT00891046|12217224|FG001|COMPLETED|Overall Study||54
11037434|NCT00891046|12217225|FG002|COMPLETED|Overall Study||17
11037435|NCT00891046|12217226|FG003|COMPLETED|Overall Study||8
11037436|NCT00891046|12217227|FG004|COMPLETED|Overall Study||84
11037437|NCT00891046|12217223|FG000|NOT COMPLETED|Overall Study||12
11037438|NCT00891046|12217224|FG001|NOT COMPLETED|Overall Study||9
11037439|NCT00891046|12217225|FG002|NOT COMPLETED|Overall Study||23
11037440|NCT00891046|12217226|FG003|NOT COMPLETED|Overall Study||3
11037441|NCT00891046|12217227|FG004|NOT COMPLETED|Overall Study||39
11037442|NCT00891176|12217258|FG000|STARTED|At 3 Years of Age||144
11037443|NCT00891176|12217259|FG001|STARTED|At 3 Years of Age||147
11335417|NCT02862730|12532989|FG000|COMPLETED|First Intervention (84 Hours)||4
11335418|NCT02862730|12532990|FG001|COMPLETED|First Intervention (84 Hours)||1
11335419|NCT02862730|12532991|FG002|COMPLETED|First Intervention (84 Hours)||7
11335420|NCT02862730|12532992|FG003|COMPLETED|First Intervention (84 Hours)||5
11037444|NCT00891176|12217260|FG002|STARTED|At 3 Years of Age||149
11037445|NCT00891176|12217261|FG003|STARTED|At 3 Years of Age||141
11037446|NCT00891176|12217258|FG000|COMPLETED|At 3 Years of Age||144
11037447|NCT00891176|12217259|FG001|COMPLETED|At 3 Years of Age||147
11037448|NCT00891176|12217260|FG002|COMPLETED|At 3 Years of Age||149
11037449|NCT00891176|12217261|FG003|COMPLETED|At 3 Years of Age||141
11037450|NCT00891176|12217258|FG000|NOT COMPLETED|At 3 Years of Age||0
11037451|NCT00891176|12217259|FG001|NOT COMPLETED|At 3 Years of Age||0
11037452|NCT00891176|12217260|FG002|NOT COMPLETED|At 3 Years of Age||0
11037453|NCT00891176|12217261|FG003|NOT COMPLETED|At 3 Years of Age||0
11037454|NCT00891176|12217258|FG000|STARTED|At 4 Years of Age||140
11037455|NCT00891176|12217259|FG001|STARTED|At 4 Years of Age||142
11037456|NCT00891176|12217260|FG002|STARTED|At 4 Years of Age||142
11037457|NCT00891176|12217261|FG003|STARTED|At 4 Years of Age||137
11037458|NCT00891176|12217258|FG000|COMPLETED|At 4 Years of Age||140
11037459|NCT00891176|12217259|FG001|COMPLETED|At 4 Years of Age||142
11037460|NCT00891176|12217260|FG002|COMPLETED|At 4 Years of Age||142
11037461|NCT00891176|12217261|FG003|COMPLETED|At 4 Years of Age||137
11037462|NCT00891176|12217258|FG000|NOT COMPLETED|At 4 Years of Age||0
11037463|NCT00891176|12217259|FG001|NOT COMPLETED|At 4 Years of Age||0
11037464|NCT00891176|12217260|FG002|NOT COMPLETED|At 4 Years of Age||0
11037465|NCT00891176|12217261|FG003|NOT COMPLETED|At 4 Years of Age||0
11037466|NCT00891176|12217258|FG000|STARTED|At 6 Years of Age||131
11037467|NCT00891176|12217259|FG001|STARTED|At 6 Years of Age||138
11037468|NCT00891176|12217260|FG002|STARTED|At 6 Years of Age||135
11037469|NCT00891176|12217261|FG003|STARTED|At 6 Years of Age||135
11037470|NCT00891176|12217258|FG000|COMPLETED|At 6 Years of Age||131
11037471|NCT00891176|12217259|FG001|COMPLETED|At 6 Years of Age||138
11037472|NCT00891176|12217260|FG002|COMPLETED|At 6 Years of Age||135
11037473|NCT00891176|12217261|FG003|COMPLETED|At 6 Years of Age||135
11037474|NCT00891176|12217258|FG000|NOT COMPLETED|At 6 Years of Age||0
11037475|NCT00891176|12217259|FG001|NOT COMPLETED|At 6 Years of Age||0
11037476|NCT00891176|12217260|FG002|NOT COMPLETED|At 6 Years of Age||0
11037477|NCT00891176|12217261|FG003|NOT COMPLETED|At 6 Years of Age||0
11037478|NCT00891202|12217279|FG000|STARTED|PAP (Up To Week 39)||20
11037479|NCT00891202|12217280|FG001|STARTED|PAP (Up To Week 39)||20
11037480|NCT00891202|12217281|FG002|STARTED|PAP (Up To Week 39)||0
11037481|NCT00891202|12217282|FG003|STARTED|PAP (Up To Week 39)||0
11037482|NCT00891202|12217279|FG000|COMPLETED|PAP (Up To Week 39)||19
11037483|NCT00891202|12217280|FG001|COMPLETED|PAP (Up To Week 39)||20
11037484|NCT00891202|12217281|FG002|COMPLETED|PAP (Up To Week 39)||0
11037485|NCT00891202|12217282|FG003|COMPLETED|PAP (Up To Week 39)||0
11037486|NCT00891202|12217279|FG000|NOT COMPLETED|PAP (Up To Week 39)||1
11037487|NCT00891202|12217280|FG001|NOT COMPLETED|PAP (Up To Week 39)||0
11037488|NCT00891202|12217281|FG002|NOT COMPLETED|PAP (Up To Week 39)||0
11037489|NCT00891202|12217282|FG003|NOT COMPLETED|PAP (Up To Week 39)||0
11037490|NCT00891202|12217279|FG000|STARTED|LTTP (Post-Week 39 up to Week 312)||0
11037491|NCT00891202|12217280|FG001|STARTED|LTTP (Post-Week 39 up to Week 312)||0
11037492|NCT00891202|12217281|FG002|STARTED|LTTP (Post-Week 39 up to Week 312)||19
11037493|NCT00891202|12217282|FG003|STARTED|LTTP (Post-Week 39 up to Week 312)||20
11037494|NCT00891202|12217279|FG000|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
11037495|NCT00891202|12217280|FG001|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
11037496|NCT00891202|12217281|FG002|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
11037497|NCT00891202|12217282|FG003|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
11037498|NCT00891202|12217279|FG000|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
11037499|NCT00891202|12217280|FG001|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
11037500|NCT00891202|12217281|FG002|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
11037501|NCT00891202|12217282|FG003|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
11037502|NCT00891228|12217293|FG000|STARTED|Overall Study||32
11037503|NCT00891228|12217294|FG001|STARTED|Overall Study||33
11037504|NCT00891228|12217295|FG002|STARTED|Overall Study||34
11037505|NCT00891228|12217293|FG000|COMPLETED|Overall Study||21
11037506|NCT00891228|12217294|FG001|COMPLETED|Overall Study||20
11037507|NCT00891228|12217295|FG002|COMPLETED|Overall Study||19
11037508|NCT00891228|12217293|FG000|NOT COMPLETED|Overall Study||11
11037509|NCT00891228|12217294|FG001|NOT COMPLETED|Overall Study||13
11037510|NCT00891228|12217295|FG002|NOT COMPLETED|Overall Study||15
11037511|NCT00891293|12217303|FG000|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
11037512|NCT00891293|12217303|FG000|COMPLETED|Overall Study||9
11037513|NCT00891293|12217303|FG000|NOT COMPLETED|Overall Study||84
11037514|NCT00891319|12217309|FG000|STARTED|Overall Study||40
11037515|NCT00891319|12217310|FG001|STARTED|Overall Study||40
11037516|NCT00891319|12217309|FG000|COMPLETED|Overall Study||32
11037517|NCT00891319|12217310|FG001|COMPLETED|Overall Study||40
11037518|NCT00891319|12217309|FG000|NOT COMPLETED|Overall Study||8
11037519|NCT00891319|12217310|FG001|NOT COMPLETED|Overall Study||0
11037520|NCT00891371|12217316|FG000|STARTED|Pre-assignment||42
11037521|NCT00891371|12217316|FG000|COMPLETED|Pre-assignment||36
11037522|NCT00891371|12217316|FG000|NOT COMPLETED|Pre-assignment||6
11037523|NCT00891371|12217316|FG000|STARTED|Treatment||36
11037524|NCT00891371|12217316|FG000|COMPLETED|Treatment||27
11037525|NCT00891371|12217316|FG000|NOT COMPLETED|Treatment||9
11037526|NCT00891436|12217322|FG000|STARTED|Overall Study||10
11037527|NCT00891436|12217323|FG001|STARTED|Overall Study||10
11037528|NCT00891436|12217322|FG000|COMPLETED|Overall Study||10
11037529|NCT00891436|12217323|FG001|COMPLETED|Overall Study||10
11037530|NCT00891436|12217322|FG000|NOT COMPLETED|Overall Study||0
11037531|NCT00891436|12217323|FG001|NOT COMPLETED|Overall Study||0
11037532|NCT00891462|12217332|FG000|STARTED|Overall Study||186
11037533|NCT00891462|12217333|FG001|STARTED|Overall Study||185
11037534|NCT00891462|12217334|FG002|STARTED|Overall Study||190
11037535|NCT00891462|12217332|FG000|COMPLETED|Overall Study||149
11037536|NCT00891462|12217333|FG001|COMPLETED|Overall Study||152
11037537|NCT00891462|12217334|FG002|COMPLETED|Overall Study||166
11037538|NCT00891462|12217332|FG000|NOT COMPLETED|Overall Study||37
11037539|NCT00891462|12217333|FG001|NOT COMPLETED|Overall Study||33
11037540|NCT00891462|12217334|FG002|NOT COMPLETED|Overall Study||24
11037541|NCT00891527|12217344|FG000|STARTED|Overall Study||50
11037542|NCT00891527|12217344|FG000|COMPLETED|Overall Study||48
11037543|NCT00891527|12217344|FG000|NOT COMPLETED|Overall Study||2
11037544|NCT00891618|12217349|FG000|STARTED|Overall Study||21
11037545|NCT00891618|12217349|FG000|COMPLETED|Overall Study||20
11037546|NCT00891618|12217349|FG000|NOT COMPLETED|Overall Study||1
11037547|NCT00891657|12217355|FG000|STARTED|Overall Study||9
11037548|NCT00891657|12217356|FG001|STARTED|Overall Study||6
11037549|NCT00891657|12217355|FG000|COMPLETED|Overall Study||8
11037550|NCT00891657|12217356|FG001|COMPLETED|Overall Study||5
11037551|NCT00891657|12217355|FG000|NOT COMPLETED|Overall Study||1
11037552|NCT00891657|12217356|FG001|NOT COMPLETED|Overall Study||1
11037553|NCT00891735|12217366|FG000|STARTED|Overall Study||275
11037554|NCT00891735|12217367|FG001|STARTED|Overall Study||274
11037555|NCT00891735|12217368|FG002|STARTED|Overall Study||275
11037556|NCT00891735|12217369|FG003|STARTED|Overall Study||273
11037557|NCT00891735|12217366|FG000|COMPLETED|Overall Study||258
11037558|NCT00891735|12217367|FG001|COMPLETED|Overall Study||258
11037559|NCT00891735|12217368|FG002|COMPLETED|Overall Study||263
11037560|NCT00891735|12217369|FG003|COMPLETED|Overall Study||258
11037561|NCT00891735|12217366|FG000|NOT COMPLETED|Overall Study||17
11037562|NCT00891735|12217367|FG001|NOT COMPLETED|Overall Study||16
11037563|NCT00891735|12217368|FG002|NOT COMPLETED|Overall Study||12
11037564|NCT00891735|12217369|FG003|NOT COMPLETED|Overall Study||15
11057645|NCT00999102|12239297|FG001|STARTED|4 Weeks at Lower Dose of Second Drug||16
11057646|NCT00999102|12239296|FG000|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
11057647|NCT00999102|12239297|FG001|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
11057648|NCT00999102|12239296|FG000|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
11057649|NCT00999102|12239297|FG001|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
11057650|NCT00999102|12239296|FG000|STARTED|4 Weeks at Higher Dose of Second Drug||15
11057651|NCT00999102|12239297|FG001|STARTED|4 Weeks at Higher Dose of Second Drug||16
11057652|NCT00999102|12239296|FG000|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
11057653|NCT00999102|12239297|FG001|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
11057654|NCT00999102|12239296|FG000|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
11057655|NCT00999102|12239297|FG001|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
11057656|NCT00999141|12239307|FG000|STARTED|Overall Study|Randomized and treated|75
11057657|NCT00999141|12239307|FG000|COMPLETED|Overall Study||75
11057658|NCT00999141|12239307|FG000|NOT COMPLETED|Overall Study||0
11057659|NCT00999167|12239365|FG000|STARTED|Part A: Open Label Safety run-in||15
11057660|NCT00999167|12239366|FG001|STARTED|Part A: Open Label Safety run-in||0
11057661|NCT00999167|12239367|FG002|STARTED|Part A: Open Label Safety run-in||0
11057662|NCT00999167|12239365|FG000|Received 9 mL BID|Part A: Open Label Safety run-in||15
11057663|NCT00999167|12239366|FG001|Received 9 mL BID|Part A: Open Label Safety run-in||0
11057664|NCT00999167|12239367|FG002|Received 9 mL BID|Part A: Open Label Safety run-in||0
11057665|NCT00999167|12239365|FG000|COMPLETED|Part A: Open Label Safety run-in||8
11057666|NCT00999167|12239366|FG001|COMPLETED|Part A: Open Label Safety run-in||0
11057667|NCT00999167|12239367|FG002|COMPLETED|Part A: Open Label Safety run-in||0
11057668|NCT00999167|12239365|FG000|NOT COMPLETED|Part A: Open Label Safety run-in||7
11057669|NCT00999167|12239366|FG001|NOT COMPLETED|Part A: Open Label Safety run-in||0
11057670|NCT00999167|12239367|FG002|NOT COMPLETED|Part A: Open Label Safety run-in||0
11057671|NCT00999167|12239365|FG000|STARTED|Part B: Randomized, Placebo Controlled||0
11057672|NCT00999167|12239366|FG001|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
11057673|NCT00999167|12239367|FG002|STARTED|Part B: Randomized, Placebo Controlled||88
11057674|NCT00999167|12239365|FG000|COMPLETED|Part B: Randomized, Placebo Controlled||0
11057675|NCT00999167|12239366|FG001|COMPLETED|Part B: Randomized, Placebo Controlled||55
11057676|NCT00999167|12239367|FG002|COMPLETED|Part B: Randomized, Placebo Controlled||67
11057677|NCT00999167|12239365|FG000|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
11057678|NCT00999167|12239366|FG001|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
11037565|NCT00891774|12217379|FG000|STARTED|Overall Study||172
11037566|NCT00891774|12217379|FG000|COMPLETED|Overall Study||158
11037567|NCT00891774|12217379|FG000|NOT COMPLETED|Overall Study||14
11037568|NCT00891813|12217383|FG000|STARTED|Overall Study||100
11037569|NCT00891813|12217383|FG000|COMPLETED|Overall Study||88
11037570|NCT00891813|12217383|FG000|NOT COMPLETED|Overall Study||12
11037571|NCT00891839|12217387|FG000|STARTED|Overall Study||45
11335421|NCT02862730|12532993|FG004|COMPLETED|First Intervention (84 Hours)||5
11037572|NCT00891839|12217387|FG000|COMPLETED|Overall Study|completed treatment|38
11037573|NCT00891839|12217387|FG000|NOT COMPLETED|Overall Study||7
11037574|NCT00891878|12217393|FG000|STARTED|Overall Study||6
11335422|NCT02862730|12532994|FG005|COMPLETED|First Intervention (84 Hours)||1
11037575|NCT00891878|12217394|FG001|STARTED|Overall Study||6
11037576|NCT00891878|12217393|FG000|COMPLETED|Overall Study||6
11037577|NCT00891878|12217394|FG001|COMPLETED|Overall Study||6
11037578|NCT00891878|12217393|FG000|NOT COMPLETED|Overall Study||0
11037579|NCT00891878|12217394|FG001|NOT COMPLETED|Overall Study||0
11037580|NCT00891930|12217400|FG000|STARTED|Part 1: Panitumumab +Irinotecan||76
11037581|NCT00891930|12217400|FG000|Received Treatment|Part 1: Panitumumab +Irinotecan||74
11037582|NCT00891930|12217400|FG000|COMPLETED|Part 1: Panitumumab +Irinotecan||36
11037583|NCT00891930|12217400|FG000|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
11037584|NCT00891930|12217400|FG000|STARTED|Part 2: Panitumumab + Ganitumab||36
11037585|NCT00891930|12217400|FG000|COMPLETED|Part 2: Panitumumab + Ganitumab||5
11037586|NCT00891930|12217400|FG000|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
11037587|NCT00891982|12217410|FG000|STARTED|Overall Study||30
11037588|NCT00891982|12217411|FG001|STARTED|Overall Study||31
11037589|NCT00891982|12217410|FG000|COMPLETED|Overall Study||28
11037590|NCT00891982|12217411|FG001|COMPLETED|Overall Study||30
11037591|NCT00891982|12217410|FG000|NOT COMPLETED|Overall Study||2
11037592|NCT00891982|12217411|FG001|NOT COMPLETED|Overall Study||1
11037593|NCT00891995|12217419|FG000|STARTED|Overall Study||50
11037594|NCT00891995|12217420|FG001|STARTED|Overall Study||21
11037595|NCT00891995|12217419|FG000|COMPLETED|Overall Study||50
11037596|NCT00891995|12217420|FG001|COMPLETED|Overall Study||21
11037597|NCT00891995|12217419|FG000|NOT COMPLETED|Overall Study||0
11037598|NCT00891995|12217420|FG001|NOT COMPLETED|Overall Study||0
11037599|NCT00892008|12217426|FG000|STARTED|Overall Study||2278
11037600|NCT00892008|12217426|FG000|COMPLETED|Overall Study||1713
11037601|NCT00892008|12217426|FG000|NOT COMPLETED|Overall Study||565
11037602|NCT00892047|12217432|FG000|STARTED|Overall Study||91
11037603|NCT00892047|12217433|FG001|STARTED|Overall Study||90
11037604|NCT00892047|12217432|FG000|COMPLETED|Overall Study||87
11037605|NCT00892047|12217433|FG001|COMPLETED|Overall Study||83
11037606|NCT00892047|12217432|FG000|NOT COMPLETED|Overall Study||4
11037607|NCT00892047|12217433|FG001|NOT COMPLETED|Overall Study||7
11037608|NCT00892099|12217444|FG000|STARTED|Overall Study||36
11037609|NCT00892099|12217445|FG001|STARTED|Overall Study||33
11037610|NCT00892099|12217446|FG002|STARTED|Overall Study||36
11037611|NCT00892099|12217444|FG000|COMPLETED|Overall Study||31
11037612|NCT00892099|12217445|FG001|COMPLETED|Overall Study||32
11037613|NCT00892099|12217446|FG002|COMPLETED|Overall Study||29
11037614|NCT00892099|12217444|FG000|NOT COMPLETED|Overall Study||5
11037615|NCT00892099|12217445|FG001|NOT COMPLETED|Overall Study||1
11037616|NCT00892099|12217446|FG002|NOT COMPLETED|Overall Study||7
11037617|NCT00892151|12217454|FG000|STARTED|Overall Study||51
11037618|NCT00892151|12217454|FG000|COMPLETED|Overall Study||50
11037619|NCT00892151|12217454|FG000|NOT COMPLETED|Overall Study||1
11037620|NCT00892177|12217461|FG000|STARTED|Phase I: Dose Level 0||3
11037621|NCT00892177|12217462|FG001|STARTED|Phase I: Dose Level 0||0
11037622|NCT00892177|12217463|FG002|STARTED|Phase I: Dose Level 0||0
11037623|NCT00892177|12217464|FG003|STARTED|Phase I: Dose Level 0||0
11037624|NCT00892177|12217465|FG004|STARTED|Phase I: Dose Level 0||0
11037625|NCT00892177|12217466|FG005|STARTED|Phase I: Dose Level 0||0
11037626|NCT00892177|12217461|FG000|COMPLETED|Phase I: Dose Level 0||3
11037627|NCT00892177|12217462|FG001|COMPLETED|Phase I: Dose Level 0||0
11037628|NCT00892177|12217463|FG002|COMPLETED|Phase I: Dose Level 0||0
11037629|NCT00892177|12217464|FG003|COMPLETED|Phase I: Dose Level 0||0
11037630|NCT00892177|12217465|FG004|COMPLETED|Phase I: Dose Level 0||0
11037631|NCT00892177|12217466|FG005|COMPLETED|Phase I: Dose Level 0||0
11037632|NCT00892177|12217461|FG000|NOT COMPLETED|Phase I: Dose Level 0||0
11037633|NCT00892177|12217462|FG001|NOT COMPLETED|Phase I: Dose Level 0||0
11037634|NCT00892177|12217463|FG002|NOT COMPLETED|Phase I: Dose Level 0||0
11037635|NCT00892177|12217464|FG003|NOT COMPLETED|Phase I: Dose Level 0||0
11037636|NCT00892177|12217465|FG004|NOT COMPLETED|Phase I: Dose Level 0||0
11037637|NCT00892177|12217466|FG005|NOT COMPLETED|Phase I: Dose Level 0||0
11037638|NCT00892177|12217461|FG000|STARTED|Phase I: Dose Level 1||0
11037639|NCT00892177|12217462|FG001|STARTED|Phase I: Dose Level 1||4
11037640|NCT00892177|12217463|FG002|STARTED|Phase I: Dose Level 1||0
11037641|NCT00892177|12217464|FG003|STARTED|Phase I: Dose Level 1||0
11037642|NCT00892177|12217465|FG004|STARTED|Phase I: Dose Level 1||0
11037643|NCT00892177|12217466|FG005|STARTED|Phase I: Dose Level 1||0
11037644|NCT00892177|12217461|FG000|COMPLETED|Phase I: Dose Level 1||0
11037645|NCT00892177|12217462|FG001|COMPLETED|Phase I: Dose Level 1||4
11037646|NCT00892177|12217463|FG002|COMPLETED|Phase I: Dose Level 1||0
11037647|NCT00892177|12217464|FG003|COMPLETED|Phase I: Dose Level 1||0
11037648|NCT00892177|12217465|FG004|COMPLETED|Phase I: Dose Level 1||0
11037649|NCT00892177|12217466|FG005|COMPLETED|Phase I: Dose Level 1||0
11037650|NCT00892177|12217461|FG000|NOT COMPLETED|Phase I: Dose Level 1||0
11037651|NCT00892177|12217462|FG001|NOT COMPLETED|Phase I: Dose Level 1||0
11037652|NCT00892177|12217463|FG002|NOT COMPLETED|Phase I: Dose Level 1||0
11037653|NCT00892177|12217464|FG003|NOT COMPLETED|Phase I: Dose Level 1||0
11037654|NCT00892177|12217465|FG004|NOT COMPLETED|Phase I: Dose Level 1||0
11037655|NCT00892177|12217466|FG005|NOT COMPLETED|Phase I: Dose Level 1||0
11037656|NCT00892177|12217461|FG000|STARTED|Phase I: Dose Level 2||0
11037657|NCT00892177|12217462|FG001|STARTED|Phase I: Dose Level 2||0
11037658|NCT00892177|12217463|FG002|STARTED|Phase I: Dose Level 2||3
11037659|NCT00892177|12217464|FG003|STARTED|Phase I: Dose Level 2||0
11037660|NCT00892177|12217465|FG004|STARTED|Phase I: Dose Level 2||0
11037661|NCT00892177|12217466|FG005|STARTED|Phase I: Dose Level 2||0
11335423|NCT02862730|12532995|FG006|COMPLETED|First Intervention (84 Hours)||1
11037662|NCT00892177|12217461|FG000|COMPLETED|Phase I: Dose Level 2||0
11037663|NCT00892177|12217462|FG001|COMPLETED|Phase I: Dose Level 2||0
11335424|NCT02862730|12532989|FG000|NOT COMPLETED|First Intervention (84 Hours)||0
11335425|NCT02862730|12532990|FG001|NOT COMPLETED|First Intervention (84 Hours)||0
11037664|NCT00892177|12217463|FG002|COMPLETED|Phase I: Dose Level 2||3
11037665|NCT00892177|12217464|FG003|COMPLETED|Phase I: Dose Level 2||0
11037666|NCT00892177|12217465|FG004|COMPLETED|Phase I: Dose Level 2||0
11037667|NCT00892177|12217466|FG005|COMPLETED|Phase I: Dose Level 2||0
11037668|NCT00892177|12217461|FG000|NOT COMPLETED|Phase I: Dose Level 2||0
11037669|NCT00892177|12217462|FG001|NOT COMPLETED|Phase I: Dose Level 2||0
11037670|NCT00892177|12217463|FG002|NOT COMPLETED|Phase I: Dose Level 2||0
11037671|NCT00892177|12217464|FG003|NOT COMPLETED|Phase I: Dose Level 2||0
11037672|NCT00892177|12217465|FG004|NOT COMPLETED|Phase I: Dose Level 2||0
11037673|NCT00892177|12217466|FG005|NOT COMPLETED|Phase I: Dose Level 2||0
11037674|NCT00892177|12217461|FG000|STARTED|Phase I: Dose Level 3||0
11037675|NCT00892177|12217462|FG001|STARTED|Phase I: Dose Level 3||0
11037676|NCT00892177|12217463|FG002|STARTED|Phase I: Dose Level 3||0
11037677|NCT00892177|12217464|FG003|STARTED|Phase I: Dose Level 3||6
11037678|NCT00892177|12217465|FG004|STARTED|Phase I: Dose Level 3||0
11037679|NCT00892177|12217466|FG005|STARTED|Phase I: Dose Level 3||0
11037680|NCT00892177|12217461|FG000|COMPLETED|Phase I: Dose Level 3||0
11037681|NCT00892177|12217462|FG001|COMPLETED|Phase I: Dose Level 3||0
11037682|NCT00892177|12217463|FG002|COMPLETED|Phase I: Dose Level 3||0
11037683|NCT00892177|12217464|FG003|COMPLETED|Phase I: Dose Level 3||6
11037684|NCT00892177|12217465|FG004|COMPLETED|Phase I: Dose Level 3||0
11037685|NCT00892177|12217466|FG005|COMPLETED|Phase I: Dose Level 3||0
11037686|NCT00892177|12217461|FG000|NOT COMPLETED|Phase I: Dose Level 3||0
11037687|NCT00892177|12217462|FG001|NOT COMPLETED|Phase I: Dose Level 3||0
11037688|NCT00892177|12217463|FG002|NOT COMPLETED|Phase I: Dose Level 3||0
11037689|NCT00892177|12217464|FG003|NOT COMPLETED|Phase I: Dose Level 3||0
11037690|NCT00892177|12217465|FG004|NOT COMPLETED|Phase I: Dose Level 3||0
11037691|NCT00892177|12217466|FG005|NOT COMPLETED|Phase I: Dose Level 3||0
11037692|NCT00892177|12217461|FG000|STARTED|Phase II||0
11037693|NCT00892177|12217462|FG001|STARTED|Phase II||0
11037694|NCT00892177|12217463|FG002|STARTED|Phase II||0
11037695|NCT00892177|12217464|FG003|STARTED|Phase II||0
11037696|NCT00892177|12217465|FG004|STARTED|Phase II||88
11037697|NCT00892177|12217466|FG005|STARTED|Phase II||40
11037698|NCT00892177|12217461|FG000|COMPLETED|Phase II||0
11037699|NCT00892177|12217462|FG001|COMPLETED|Phase II||0
11037700|NCT00892177|12217463|FG002|COMPLETED|Phase II||0
11037701|NCT00892177|12217464|FG003|COMPLETED|Phase II||0
11037702|NCT00892177|12217465|FG004|COMPLETED|Phase II||83
11037703|NCT00892177|12217466|FG005|COMPLETED|Phase II||38
11037704|NCT00892177|12217461|FG000|NOT COMPLETED|Phase II||0
11037705|NCT00892177|12217462|FG001|NOT COMPLETED|Phase II||0
11037706|NCT00892177|12217463|FG002|NOT COMPLETED|Phase II||0
11037707|NCT00892177|12217464|FG003|NOT COMPLETED|Phase II||0
11037708|NCT00892177|12217465|FG004|NOT COMPLETED|Phase II||5
11037709|NCT00892177|12217466|FG005|NOT COMPLETED|Phase II||2
11037710|NCT00892437|12217483|FG000|STARTED|Randomized Phase||56
11037711|NCT00892437|12217484|FG001|STARTED|Randomized Phase||29
11037712|NCT00892437|12217483|FG000|Randomized and Treated|Randomized Phase||50
11037713|NCT00892437|12217484|FG001|Randomized and Treated|Randomized Phase||29
11037714|NCT00892437|12217483|FG000|COMPLETED|Randomized Phase||45
11037715|NCT00892437|12217484|FG001|COMPLETED|Randomized Phase||24
11037716|NCT00892437|12217483|FG000|NOT COMPLETED|Randomized Phase||11
11037717|NCT00892437|12217484|FG001|NOT COMPLETED|Randomized Phase||5
11037718|NCT00892437|12217483|FG000|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
11037719|NCT00892437|12217484|FG001|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
11037720|NCT00892437|12217483|FG000|COMPLETED|Open-Label Extension Phase||32
11037721|NCT00892437|12217484|FG001|COMPLETED|Open-Label Extension Phase||15
11037722|NCT00892437|12217483|FG000|NOT COMPLETED|Open-Label Extension Phase||12
11037723|NCT00892437|12217484|FG001|NOT COMPLETED|Open-Label Extension Phase||4
11037724|NCT00892606|12217493|FG000|STARTED|Overall Study||38
11037725|NCT00892606|12217494|FG001|STARTED|Overall Study||37
11037726|NCT00892606|12217493|FG000|COMPLETED|Overall Study||33
11037727|NCT00892606|12217494|FG001|COMPLETED|Overall Study||33
11037728|NCT00892606|12217493|FG000|NOT COMPLETED|Overall Study||5
11037729|NCT00892606|12217494|FG001|NOT COMPLETED|Overall Study||4
11037730|NCT00892697|12217500|FG000|STARTED|Overall Study||15
11037731|NCT00892697|12217500|FG000|COMPLETED|Overall Study||15
11037732|NCT00892697|12217500|FG000|NOT COMPLETED|Overall Study||0
11037733|NCT00892710|12217508|FG000|STARTED|Overall Study||48
11037734|NCT00892710|12217509|FG001|STARTED|Overall Study||59
11037735|NCT00892710|12217510|FG002|STARTED|Overall Study||55
11037736|NCT00892710|12217508|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
11037737|NCT00892710|12217509|FG001|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
11037738|NCT00892710|12217510|FG002|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
11037739|NCT00892710|12217508|FG000|NOT COMPLETED|Overall Study||48
11037740|NCT00892710|12217509|FG001|NOT COMPLETED|Overall Study||59
11037741|NCT00892710|12217510|FG002|NOT COMPLETED|Overall Study||55
11037742|NCT00892723|12217521|FG000|STARTED|Overall Study||21
11037743|NCT00892723|12217522|FG001|STARTED|Overall Study||19
11037744|NCT00892723|12217523|FG002|STARTED|Overall Study||19
11037745|NCT00892723|12217521|FG000|COMPLETED|Overall Study||19
11037746|NCT00892723|12217522|FG001|COMPLETED|Overall Study||15
11037747|NCT00892723|12217523|FG002|COMPLETED|Overall Study||17
11037748|NCT00892723|12217521|FG000|NOT COMPLETED|Overall Study||2
11335426|NCT02862730|12532991|FG002|NOT COMPLETED|First Intervention (84 Hours)||0
11037749|NCT00892723|12217522|FG001|NOT COMPLETED|Overall Study||4
11037750|NCT00892723|12217523|FG002|NOT COMPLETED|Overall Study||2
11037751|NCT00892775|12217566|FG000|STARTED|Overall Study||332
11037752|NCT00892775|12217567|FG001|STARTED|Overall Study||166
11037753|NCT00892775|12217566|FG000|COMPLETED|Overall Study||327
11037754|NCT00892775|12217567|FG001|COMPLETED|Overall Study||165
11037755|NCT00892775|12217566|FG000|NOT COMPLETED|Overall Study||5
11037756|NCT00892775|12217567|FG001|NOT COMPLETED|Overall Study||1
11037757|NCT00892957|12217575|FG000|STARTED|Intraoperative Day 0||70
11037758|NCT00892957|12217576|FG001|STARTED|Intraoperative Day 0||70
11037759|NCT00892957|12217575|FG000|COMPLETED|Intraoperative Day 0||70
11037760|NCT00892957|12217576|FG001|COMPLETED|Intraoperative Day 0||70
11037761|NCT00892957|12217575|FG000|NOT COMPLETED|Intraoperative Day 0||0
11037762|NCT00892957|12217576|FG001|NOT COMPLETED|Intraoperative Day 0||0
11037763|NCT00892957|12217575|FG000|STARTED|Postoperative Day 1 Assessment||70
11037764|NCT00892957|12217576|FG001|STARTED|Postoperative Day 1 Assessment||70
11037765|NCT00892957|12217575|FG000|COMPLETED|Postoperative Day 1 Assessment||70
11037766|NCT00892957|12217576|FG001|COMPLETED|Postoperative Day 1 Assessment||70
11037767|NCT00892957|12217575|FG000|NOT COMPLETED|Postoperative Day 1 Assessment||0
11037768|NCT00892957|12217576|FG001|NOT COMPLETED|Postoperative Day 1 Assessment||0
11037769|NCT00892957|12217575|FG000|STARTED|Between Postoperative Day 1 and Day 14||70
11037770|NCT00892957|12217576|FG001|STARTED|Between Postoperative Day 1 and Day 14||70
11037771|NCT00892957|12217575|FG000|COMPLETED|Between Postoperative Day 1 and Day 14||70
11037772|NCT00892957|12217576|FG001|COMPLETED|Between Postoperative Day 1 and Day 14||66
11037773|NCT00892957|12217575|FG000|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
11037774|NCT00892957|12217576|FG001|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
11037775|NCT00892957|12217575|FG000|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
11037776|NCT00892957|12217576|FG001|STARTED|Postoperative Day 14 Assessment||66
11037777|NCT00892957|12217575|FG000|COMPLETED|Postoperative Day 14 Assessment||68
11037778|NCT00892957|12217576|FG001|COMPLETED|Postoperative Day 14 Assessment||66
11037779|NCT00892957|12217575|FG000|NOT COMPLETED|Postoperative Day 14 Assessment||0
11037780|NCT00892957|12217576|FG001|NOT COMPLETED|Postoperative Day 14 Assessment||0
11037781|NCT00892957|12217575|FG000|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
11037782|NCT00892957|12217576|FG001|STARTED|Postoperative Day 30 Assessment||66
11037783|NCT00892957|12217575|FG000|COMPLETED|Postoperative Day 30 Assessment||70
11037784|NCT00892957|12217576|FG001|COMPLETED|Postoperative Day 30 Assessment||66
11037785|NCT00892957|12217575|FG000|NOT COMPLETED|Postoperative Day 30 Assessment||0
11037786|NCT00892957|12217576|FG001|NOT COMPLETED|Postoperative Day 30 Assessment||0
11037787|NCT00893074|12217596|FG000|STARTED|Overall Study||24
11037788|NCT00893074|12217596|FG000|COMPLETED|Overall Study||13
11037789|NCT00893074|12217596|FG000|NOT COMPLETED|Overall Study||11
11037790|NCT00893113|12217613|FG000|STARTED|Overall Study||36
11037791|NCT00893113|12217614|FG001|STARTED|Overall Study||38
11037792|NCT00893113|12217613|FG000|COMPLETED|Overall Study||23
11037793|NCT00893113|12217614|FG001|COMPLETED|Overall Study||22
11037794|NCT00893113|12217613|FG000|NOT COMPLETED|Overall Study||13
11037795|NCT00893113|12217614|FG001|NOT COMPLETED|Overall Study||16
11037796|NCT00893152|12217622|FG000|STARTED|Overall Study||47
11037797|NCT00893152|12217623|FG001|STARTED|Overall Study||36
11037798|NCT00893152|12217622|FG000|COMPLETED|Overall Study||47
11037799|NCT00893152|12217623|FG001|COMPLETED|Overall Study||36
11037800|NCT00893152|12217622|FG000|NOT COMPLETED|Overall Study||0
11037801|NCT00893152|12217623|FG001|NOT COMPLETED|Overall Study||0
11037802|NCT00893464|12217637|FG000|STARTED|Overall Study||1
11037803|NCT00893464|12217638|FG001|STARTED|Overall Study||1
11037804|NCT00893464|12217639|FG002|STARTED|Overall Study||1
11037805|NCT00893464|12217640|FG003|STARTED|Overall Study||1
11037806|NCT00893464|12217641|FG004|STARTED|Overall Study||4
11037807|NCT00893464|12217642|FG005|STARTED|Overall Study||7
11037808|NCT00893464|12217643|FG006|STARTED|Overall Study||10
11037809|NCT00893464|12217644|FG007|STARTED|Overall Study||5
11037810|NCT00893464|12217637|FG000|COMPLETED|Overall Study||1
11037811|NCT00893464|12217638|FG001|COMPLETED|Overall Study||1
11037812|NCT00893464|12217639|FG002|COMPLETED|Overall Study||1
11037813|NCT00893464|12217640|FG003|COMPLETED|Overall Study||1
11037814|NCT00893464|12217641|FG004|COMPLETED|Overall Study||4
11037815|NCT00893464|12217642|FG005|COMPLETED|Overall Study||7
11037816|NCT00893464|12217643|FG006|COMPLETED|Overall Study||8
11037817|NCT00893464|12217644|FG007|COMPLETED|Overall Study||3
11037818|NCT00893464|12217637|FG000|NOT COMPLETED|Overall Study||0
11037819|NCT00893464|12217638|FG001|NOT COMPLETED|Overall Study||0
11037820|NCT00893464|12217639|FG002|NOT COMPLETED|Overall Study||0
11037821|NCT00893464|12217640|FG003|NOT COMPLETED|Overall Study||0
11037822|NCT00893464|12217641|FG004|NOT COMPLETED|Overall Study||0
11037823|NCT00893464|12217642|FG005|NOT COMPLETED|Overall Study||0
11037824|NCT00893464|12217643|FG006|NOT COMPLETED|Overall Study||2
11037825|NCT00893464|12217644|FG007|NOT COMPLETED|Overall Study||2
11037826|NCT00893737|12217667|FG000|STARTED|Overall Study||147
11037827|NCT00893737|12217667|FG000|COMPLETED|Overall Study||135
11037828|NCT00893737|12217667|FG000|NOT COMPLETED|Overall Study||12
11037829|NCT00893763|12217673|FG000|STARTED|Overall Study||157
11037830|NCT00893763|12217674|FG001|STARTED|Overall Study||157
11037831|NCT00893763|12217673|FG000|COMPLETED|Overall Study||47
11037832|NCT00893763|12217674|FG001|COMPLETED|Overall Study||47
11037833|NCT00893763|12217673|FG000|NOT COMPLETED|Overall Study||110
11037834|NCT00893763|12217674|FG001|NOT COMPLETED|Overall Study||110
11037835|NCT00893971|12217682|FG000|STARTED|Overall Study||16
11037836|NCT00893971|12217682|FG000|Placebo + GP MDI (PT001)|Overall Study||15
11037837|NCT00893971|12217682|FG000|Placebo + GFF MDI (PT003)|Overall Study||15
11037838|NCT00893971|12217682|FG000|Placebo + FF MDI (PT005)|Overall Study||13
11037839|NCT00893971|12217682|FG000|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
11037840|NCT00893971|12217682|FG000|COMPLETED|Overall Study||13
11037841|NCT00893971|12217682|FG000|NOT COMPLETED|Overall Study||3
11037842|NCT00893984|12217695|FG000|STARTED|Overall Study||6
11037843|NCT00893984|12217695|FG000|COMPLETED|Overall Study||0
11037844|NCT00893984|12217695|FG000|NOT COMPLETED|Overall Study||6
11037845|NCT00893997|12217699|FG000|STARTED|Overall Study||10
11037846|NCT00893997|12217699|FG000|COMPLETED|Overall Study||10
11037847|NCT00893997|12217699|FG000|NOT COMPLETED|Overall Study||0
11037848|NCT00894127|12217703|FG000|STARTED|Overall Study||128
11037849|NCT00894127|12217703|FG000|COMPLETED|Overall Study||128
11037850|NCT00894127|12217703|FG000|NOT COMPLETED|Overall Study||0
11037851|NCT00894166|12217715|FG000|STARTED|Overall Study||132
11037852|NCT00894166|12217716|FG001|STARTED|Overall Study||109
11037853|NCT00894166|12217717|FG002|STARTED|Overall Study||112
11037854|NCT00894166|12217718|FG003|STARTED|Overall Study||114
11037855|NCT00894166|12217719|FG004|STARTED|Overall Study||34
11037856|NCT00894166|12217720|FG005|STARTED|Overall Study||36
11037857|NCT00894166|12217721|FG006|STARTED|Overall Study||35
11037858|NCT00894166|12217722|FG007|STARTED|Overall Study||34
11037859|NCT00894166|12217715|FG000|COMPLETED|Overall Study||71
11037860|NCT00894166|12217716|FG001|COMPLETED|Overall Study||46
11037861|NCT00894166|12217717|FG002|COMPLETED|Overall Study||50
11037862|NCT00894166|12217718|FG003|COMPLETED|Overall Study||45
11037863|NCT00894166|12217719|FG004|COMPLETED|Overall Study||10
11037864|NCT00894166|12217720|FG005|COMPLETED|Overall Study||20
11037865|NCT00894166|12217721|FG006|COMPLETED|Overall Study||19
11037866|NCT00894166|12217722|FG007|COMPLETED|Overall Study||0
11037867|NCT00894166|12217715|FG000|NOT COMPLETED|Overall Study||61
11037868|NCT00894166|12217716|FG001|NOT COMPLETED|Overall Study||63
11037869|NCT00894166|12217717|FG002|NOT COMPLETED|Overall Study||62
11037870|NCT00894166|12217718|FG003|NOT COMPLETED|Overall Study||69
11037871|NCT00894166|12217719|FG004|NOT COMPLETED|Overall Study||24
11037872|NCT00894166|12217720|FG005|NOT COMPLETED|Overall Study||16
11037873|NCT00894166|12217721|FG006|NOT COMPLETED|Overall Study||16
11037874|NCT00894166|12217722|FG007|NOT COMPLETED|Overall Study||34
11037875|NCT00894322|12217748|FG000|STARTED|Overall Study||30
11037876|NCT00894322|12217749|FG001|STARTED|Overall Study||23
11037877|NCT00894322|12217750|FG002|STARTED|Overall Study||12
11037878|NCT00894322|12217748|FG000|COMPLETED|Overall Study||29
11037879|NCT00894322|12217749|FG001|COMPLETED|Overall Study||23
11037880|NCT00894322|12217750|FG002|COMPLETED|Overall Study||12
11037881|NCT00894322|12217748|FG000|NOT COMPLETED|Overall Study||1
11037882|NCT00894322|12217749|FG001|NOT COMPLETED|Overall Study||0
11037883|NCT00894322|12217750|FG002|NOT COMPLETED|Overall Study||0
11037884|NCT00894361|12217762|FG000|STARTED|Overall Study||200
11037885|NCT00894361|12217763|FG001|STARTED|Overall Study||200
11037886|NCT00894361|12217762|FG000|COMPLETED|Overall Study||176
11037887|NCT00894361|12217763|FG001|COMPLETED|Overall Study||136
11037888|NCT00894361|12217762|FG000|NOT COMPLETED|Overall Study||24
11037889|NCT00894361|12217763|FG001|NOT COMPLETED|Overall Study||64
11037890|NCT00894387|12217773|FG000|STARTED|Overall Study|"Started indicates all randomized patients"|821
11037891|NCT00894387|12217774|FG001|STARTED|Overall Study||818
11037892|NCT00894387|12217773|FG000|Safety Set|Overall Study||808
11037893|NCT00894387|12217774|FG001|Safety Set|Overall Study||810
11037894|NCT00894387|12217773|FG000|Full Analysis Set|Overall Study||808
11037895|NCT00894387|12217774|FG001|Full Analysis Set|Overall Study||807
11037896|NCT00894387|12217773|FG000|Completed Primary Efficacy Phase (6 m)|Overall Study||717
11037897|NCT00894387|12217774|FG001|Completed Primary Efficacy Phase (6 m)|Overall Study||707
11037898|NCT00894387|12217773|FG000|Completed Secondary Efficacy Phase (12m)|Overall Study||654
11037899|NCT00894387|12217774|FG001|Completed Secondary Efficacy Phase (12m)|Overall Study||640
11037900|NCT00894387|12217773|FG000|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
11037901|NCT00894387|12217774|FG001|COMPLETED|Overall Study||643
11037902|NCT00894387|12217773|FG000|NOT COMPLETED|Overall Study||175
11037903|NCT00894387|12217774|FG001|NOT COMPLETED|Overall Study||175
11037904|NCT00894413|12217782|FG000|STARTED|Overall Study||15
11037905|NCT00894413|12217783|FG001|STARTED|Overall Study||25
11037906|NCT00894413|12217782|FG000|COMPLETED|Overall Study||15
11037907|NCT00894413|12217783|FG001|COMPLETED|Overall Study||17
11037908|NCT00894413|12217782|FG000|NOT COMPLETED|Overall Study||0
11037909|NCT00894413|12217783|FG001|NOT COMPLETED|Overall Study||8
11037910|NCT00894465|12217791|FG000|STARTED|Overall Study||22
11037911|NCT00894465|12217792|FG001|STARTED|Overall Study||22
11037912|NCT00894465|12217791|FG000|COMPLETED|Overall Study||22
11037913|NCT00894465|12217792|FG001|COMPLETED|Overall Study||22
11037914|NCT00894465|12217791|FG000|NOT COMPLETED|Overall Study||0
11037915|NCT00894465|12217792|FG001|NOT COMPLETED|Overall Study||0
11037916|NCT00894504|12217800|FG000|STARTED|Overall Study||71
11037917|NCT00894504|12217800|FG000|COMPLETED|Overall Study||0
11037918|NCT00894504|12217800|FG000|NOT COMPLETED|Overall Study||71
11037919|NCT00894517|12217816|FG000|STARTED|Overall Study||30
11037920|NCT00894517|12217817|FG001|STARTED|Overall Study||31
11037921|NCT00894517|12217816|FG000|COMPLETED|Overall Study||28
11037922|NCT00894517|12217817|FG001|COMPLETED|Overall Study||26
11037923|NCT00894517|12217816|FG000|NOT COMPLETED|Overall Study||2
11037924|NCT00894517|12217817|FG001|NOT COMPLETED|Overall Study||5
11037925|NCT00894543|12217825|FG000|STARTED|Baseline||104
11037926|NCT00894543|12217826|FG001|STARTED|Baseline||101
11037927|NCT00894543|12217825|FG000|COMPLETED|Baseline||104
11037928|NCT00894543|12217826|FG001|COMPLETED|Baseline||101
11037929|NCT00894543|12217825|FG000|NOT COMPLETED|Baseline||0
11037930|NCT00894543|12217826|FG001|NOT COMPLETED|Baseline||0
11037931|NCT00894543|12217825|FG000|STARTED|Baseline to Week 4||104
11037932|NCT00894543|12217826|FG001|STARTED|Baseline to Week 4||101
11037933|NCT00894543|12217825|FG000|COMPLETED|Baseline to Week 4||101
11037934|NCT00894543|12217826|FG001|COMPLETED|Baseline to Week 4||99
11037935|NCT00894543|12217825|FG000|NOT COMPLETED|Baseline to Week 4||3
11037936|NCT00894543|12217826|FG001|NOT COMPLETED|Baseline to Week 4||2
11037937|NCT00894543|12217825|FG000|STARTED|Week 4 to Week 8||101
11037938|NCT00894543|12217826|FG001|STARTED|Week 4 to Week 8||99
11037939|NCT00894543|12217825|FG000|COMPLETED|Week 4 to Week 8||97
11037940|NCT00894543|12217826|FG001|COMPLETED|Week 4 to Week 8||97
11037941|NCT00894543|12217825|FG000|NOT COMPLETED|Week 4 to Week 8||4
11037942|NCT00894543|12217826|FG001|NOT COMPLETED|Week 4 to Week 8||2
11037943|NCT00894647|12217834|FG000|STARTED|Overall Study||121
11037944|NCT00894647|12217835|FG001|STARTED|Overall Study||126
11037945|NCT00894647|12217834|FG000|COMPLETED|Overall Study||111
11037946|NCT00894647|12217835|FG001|COMPLETED|Overall Study||112
11037947|NCT00894647|12217834|FG000|NOT COMPLETED|Overall Study||10
11037948|NCT00894647|12217835|FG001|NOT COMPLETED|Overall Study||14
11037949|NCT00894686|12217841|FG000|STARTED|Overall Study||179
11037950|NCT00894686|12217841|FG000|COMPLETED|Overall Study||123
11037951|NCT00894686|12217841|FG000|NOT COMPLETED|Overall Study||56
11037952|NCT00894699|12217847|FG000|STARTED|Overall Study||21
11037953|NCT00894699|12217848|FG001|STARTED|Overall Study||19
11037954|NCT00894699|12217847|FG000|COMPLETED|Overall Study||21
11037955|NCT00894699|12217848|FG001|COMPLETED|Overall Study||19
11037956|NCT00894699|12217847|FG000|NOT COMPLETED|Overall Study||0
11037957|NCT00894699|12217848|FG001|NOT COMPLETED|Overall Study||0
11037958|NCT00894738|12217856|FG000|STARTED|Overall Study||25
11037959|NCT00894738|12217857|FG001|STARTED|Overall Study||19
11037960|NCT00894738|12217856|FG000|COMPLETED|Overall Study||25
11037961|NCT00894738|12217857|FG001|COMPLETED|Overall Study||19
11037962|NCT00894738|12217856|FG000|NOT COMPLETED|Overall Study||0
11037963|NCT00894738|12217857|FG001|NOT COMPLETED|Overall Study||0
11037964|NCT00894803|12217865|FG000|STARTED|Overall Study||101
11037965|NCT00894803|12217866|FG001|STARTED|Overall Study||25
11037966|NCT00894803|12217865|FG000|COMPLETED|Overall Study||81
11037967|NCT00894803|12217866|FG001|COMPLETED|Overall Study||20
11037968|NCT00894803|12217865|FG000|NOT COMPLETED|Overall Study||20
11037969|NCT00894803|12217866|FG001|NOT COMPLETED|Overall Study||5
11037970|NCT00894933|12217872|FG000|STARTED|Overall Study||33
11037971|NCT00894933|12217872|FG000|COMPLETED|Overall Study||29
11037972|NCT00894933|12217872|FG000|NOT COMPLETED|Overall Study||4
11037973|NCT00895011|12217879|FG000|STARTED|Overall Study||100
11037974|NCT00895011|12217880|FG001|STARTED|Overall Study||99
11037975|NCT00895011|12217881|FG002|STARTED|Overall Study||99
11037976|NCT00895011|12217879|FG000|COMPLETED|Overall Study||76
11037977|NCT00895011|12217880|FG001|COMPLETED|Overall Study||85
11037978|NCT00895011|12217881|FG002|COMPLETED|Overall Study||91
11037979|NCT00895011|12217879|FG000|NOT COMPLETED|Overall Study||24
11037980|NCT00895011|12217880|FG001|NOT COMPLETED|Overall Study||14
11037981|NCT00895011|12217881|FG002|NOT COMPLETED|Overall Study||8
11037982|NCT00895037|12217893|FG000|STARTED|Overall Study||22
11037983|NCT00895037|12217894|FG001|STARTED|Overall Study||77
11037984|NCT00895037|12217895|FG002|STARTED|Overall Study||2
11037985|NCT00895037|12217893|FG000|COMPLETED|Overall Study||22
11037986|NCT00895037|12217894|FG001|COMPLETED|Overall Study||75
11037987|NCT00895037|12217895|FG002|COMPLETED|Overall Study||1
11037988|NCT00895037|12217893|FG000|NOT COMPLETED|Overall Study||0
11037989|NCT00895037|12217894|FG001|NOT COMPLETED|Overall Study||2
11037990|NCT00895037|12217895|FG002|NOT COMPLETED|Overall Study||1
11037991|NCT00895154|12217905|FG000|STARTED|Overall Study||8
11037992|NCT00895154|12217906|FG001|STARTED|Overall Study||10
11037993|NCT00895154|12217905|FG000|Follow Up|Overall Study||7
11037994|NCT00895154|12217906|FG001|Follow Up|Overall Study||8
11037995|NCT00895154|12217905|FG000|COMPLETED|Overall Study||7
11037996|NCT00895154|12217906|FG001|COMPLETED|Overall Study||8
11037997|NCT00895154|12217905|FG000|NOT COMPLETED|Overall Study||1
11037998|NCT00895154|12217906|FG001|NOT COMPLETED|Overall Study||2
11037999|NCT00895180|12217914|FG000|STARTED|Overall Study||40
11038000|NCT00895180|12217915|FG001|STARTED|Overall Study||40
11038001|NCT00895180|12217914|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
11038002|NCT00895180|12217915|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40
11038003|NCT00895180|12217914|FG000|COMPLETED|Overall Study||40
11038004|NCT00895180|12217915|FG001|COMPLETED|Overall Study||40
11038005|NCT00895180|12217914|FG000|NOT COMPLETED|Overall Study||0
11038006|NCT00895180|12217915|FG001|NOT COMPLETED|Overall Study||0
11038007|NCT00895193|12217927|FG000|STARTED|Overall Study||25
11038008|NCT00895193|12217928|FG001|STARTED|Overall Study||25
11038009|NCT00895193|12217929|FG002|STARTED|Overall Study||25
11200994|NCT01830699|12391231|FG000|NOT COMPLETED|Overall Study||0
11038010|NCT00895193|12217930|FG003|STARTED|Overall Study||25
11038011|NCT00895193|12217927|FG000|COMPLETED|Overall Study||25
11038012|NCT00895193|12217928|FG001|COMPLETED|Overall Study||25
11038013|NCT00895193|12217929|FG002|COMPLETED|Overall Study||25
11038014|NCT00895193|12217930|FG003|COMPLETED|Overall Study||25
11038015|NCT00895193|12217927|FG000|NOT COMPLETED|Overall Study||0
11038016|NCT00895193|12217928|FG001|NOT COMPLETED|Overall Study||0
11038017|NCT00895193|12217929|FG002|NOT COMPLETED|Overall Study||0
11038018|NCT00895193|12217930|FG003|NOT COMPLETED|Overall Study||0
11038019|NCT00895232|12217943|FG000|STARTED|Overall Study||7
11038020|NCT00895232|12217944|FG001|STARTED|Overall Study||6
11038021|NCT00895232|12217945|FG002|STARTED|Overall Study||8
11038022|NCT00895232|12217943|FG000|COMPLETED|Overall Study||4
11038023|NCT00895232|12217944|FG001|COMPLETED|Overall Study||2
11038024|NCT00895232|12217945|FG002|COMPLETED|Overall Study||3
11038025|NCT00895232|12217943|FG000|NOT COMPLETED|Overall Study||3
11038026|NCT00895232|12217944|FG001|NOT COMPLETED|Overall Study||4
11038027|NCT00895232|12217945|FG002|NOT COMPLETED|Overall Study||5
11038028|NCT00895245|12217953|FG000|STARTED|Overall Study||6
11038029|NCT00895245|12217953|FG000|COMPLETED|Overall Study||0
11038030|NCT00895245|12217953|FG000|NOT COMPLETED|Overall Study||6
11038031|NCT00895310|12217957|FG000|STARTED|Overall Study||30
11038032|NCT00895310|12217957|FG000|COMPLETED|Overall Study||29
11038033|NCT00895310|12217957|FG000|NOT COMPLETED|Overall Study||1
11038034|NCT00895414|12217961|FG000|STARTED|First Intervention (14 Days)||9
11038035|NCT00895414|12217962|FG001|STARTED|First Intervention (14 Days)||10
11038036|NCT00895414|12217961|FG000|COMPLETED|First Intervention (14 Days)||8
11038037|NCT00895414|12217962|FG001|COMPLETED|First Intervention (14 Days)||9
11038038|NCT00895414|12217961|FG000|NOT COMPLETED|First Intervention (14 Days)||1
11038039|NCT00895414|12217962|FG001|NOT COMPLETED|First Intervention (14 Days)||1
11038040|NCT00895414|12217961|FG000|STARTED|Second Intervention (14 Days)||8
11038041|NCT00895414|12217962|FG001|STARTED|Second Intervention (14 Days)||9
11038042|NCT00895414|12217961|FG000|COMPLETED|Second Intervention (14 Days)||8
11038043|NCT00895414|12217962|FG001|COMPLETED|Second Intervention (14 Days)||9
11038044|NCT00895414|12217961|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
11038045|NCT00895414|12217962|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
11038046|NCT00895453|12217971|FG000|STARTED|Overall Study||48
11038047|NCT00895453|12217972|FG001|STARTED|Overall Study||50
11038048|NCT00895453|12217973|FG002|STARTED|Overall Study||46
11038049|NCT00895453|12217971|FG000|COMPLETED|Overall Study||23
11038050|NCT00895453|12217972|FG001|COMPLETED|Overall Study||25
11038051|NCT00895453|12217973|FG002|COMPLETED|Overall Study||23
11038052|NCT00895453|12217971|FG000|NOT COMPLETED|Overall Study||25
11038053|NCT00895453|12217972|FG001|NOT COMPLETED|Overall Study||25
11038054|NCT00895453|12217973|FG002|NOT COMPLETED|Overall Study||23
11038055|NCT00895531|12217983|FG000|STARTED|Overall Study||38
11038056|NCT00895531|12217984|FG001|STARTED|Overall Study||37
11038057|NCT00895531|12217983|FG000|COMPLETED|Overall Study||38
11038058|NCT00895531|12217984|FG001|COMPLETED|Overall Study||37
11038059|NCT00895531|12217983|FG000|NOT COMPLETED|Overall Study||0
11038060|NCT00895531|12217984|FG001|NOT COMPLETED|Overall Study||0
11038061|NCT00895583|12217992|FG000|STARTED|Overall Study||131
11038062|NCT00895583|12217993|FG001|STARTED|Overall Study||123
11038063|NCT00895583|12217992|FG000|COMPLETED|Overall Study||87
11038064|NCT00895583|12217993|FG001|COMPLETED|Overall Study||111
11038065|NCT00895583|12217992|FG000|NOT COMPLETED|Overall Study||44
11038066|NCT00895583|12217993|FG001|NOT COMPLETED|Overall Study||12
11038067|NCT00895622|12218002|FG000|STARTED|Overall Study||65
11038068|NCT00895622|12218003|FG001|STARTED|Overall Study||56
11038069|NCT00895622|12218004|FG002|STARTED|Overall Study||57
11038070|NCT00895622|12218002|FG000|COMPLETED|Overall Study||60
11038071|NCT00895622|12218003|FG001|COMPLETED|Overall Study||52
11038072|NCT00895622|12218004|FG002|COMPLETED|Overall Study||53
11038073|NCT00895622|12218002|FG000|NOT COMPLETED|Overall Study||5
11038074|NCT00895622|12218003|FG001|NOT COMPLETED|Overall Study||4
11038075|NCT00895622|12218004|FG002|NOT COMPLETED|Overall Study||4
11038076|NCT00895661|12218020|FG000|STARTED|Overall Study||40
11038077|NCT00895661|12218020|FG000|COMPLETED|Overall Study||37
11038078|NCT00895661|12218020|FG000|NOT COMPLETED|Overall Study||3
11038079|NCT00895752|12218024|FG000|STARTED|Overall Study||6
11038080|NCT00895752|12218024|FG000|COMPLETED|Overall Study||6
11038081|NCT00895752|12218024|FG000|NOT COMPLETED|Overall Study||0
11038082|NCT00895817|12218032|FG000|STARTED|Overall Study||21
11038083|NCT00895817|12218033|FG001|STARTED|Overall Study||21
11038084|NCT00895817|12218032|FG000|COMPLETED|Overall Study||21
11343850|NCT02956486|12541123|FG001|NOT COMPLETED|Core Phase||1072
11038085|NCT00895817|12218033|FG001|COMPLETED|Overall Study||21
11038086|NCT00895817|12218032|FG000|NOT COMPLETED|Overall Study||0
11038087|NCT00895817|12218033|FG001|NOT COMPLETED|Overall Study||0
11038088|NCT00895830|12218044|FG000|STARTED|Overall Study||51
11038089|NCT00895830|12218045|FG001|STARTED|Overall Study||50
11038090|NCT00895830|12218046|FG002|STARTED|Overall Study||49
11038091|NCT00895830|12218047|FG003|STARTED|Overall Study||52
11038092|NCT00895830|12218048|FG004|STARTED|Overall Study||55
11038093|NCT00895830|12218044|FG000|COMPLETED|Overall Study||51
11038094|NCT00895830|12218045|FG001|COMPLETED|Overall Study||50
11038095|NCT00895830|12218046|FG002|COMPLETED|Overall Study||49
11038096|NCT00895830|12218047|FG003|COMPLETED|Overall Study||52
11038097|NCT00895830|12218048|FG004|COMPLETED|Overall Study||55
11038098|NCT00895830|12218044|FG000|NOT COMPLETED|Overall Study||0
11038099|NCT00895830|12218045|FG001|NOT COMPLETED|Overall Study||0
11038100|NCT00895830|12218046|FG002|NOT COMPLETED|Overall Study||0
11335427|NCT02862730|12532992|FG003|NOT COMPLETED|First Intervention (84 Hours)||0
11335428|NCT02862730|12532993|FG004|NOT COMPLETED|First Intervention (84 Hours)||0
11335429|NCT02862730|12532994|FG005|NOT COMPLETED|First Intervention (84 Hours)||0
11335430|NCT02862730|12532995|FG006|NOT COMPLETED|First Intervention (84 Hours)||0
11335431|NCT02862730|12532989|FG000|STARTED|Second Rest Period (7-45 Days)||4
11335432|NCT02862730|12532990|FG001|STARTED|Second Rest Period (7-45 Days)||1
11335433|NCT02862730|12532991|FG002|STARTED|Second Rest Period (7-45 Days)||7
11335434|NCT02862730|12532992|FG003|STARTED|Second Rest Period (7-45 Days)||5
11335435|NCT02862730|12532993|FG004|STARTED|Second Rest Period (7-45 Days)||5
11335436|NCT02862730|12532994|FG005|STARTED|Second Rest Period (7-45 Days)||1
11335437|NCT02862730|12532995|FG006|STARTED|Second Rest Period (7-45 Days)||1
11335438|NCT02862730|12532989|FG000|COMPLETED|Second Rest Period (7-45 Days)||4
11335439|NCT02862730|12532990|FG001|COMPLETED|Second Rest Period (7-45 Days)||1
11335440|NCT02862730|12532991|FG002|COMPLETED|Second Rest Period (7-45 Days)||7
11335441|NCT02862730|12532992|FG003|COMPLETED|Second Rest Period (7-45 Days)||5
11335442|NCT02862730|12532993|FG004|COMPLETED|Second Rest Period (7-45 Days)||5
11335443|NCT02862730|12532994|FG005|COMPLETED|Second Rest Period (7-45 Days)||1
11335444|NCT02862730|12532995|FG006|COMPLETED|Second Rest Period (7-45 Days)||1
11335445|NCT02862730|12532989|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11335446|NCT02862730|12532990|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11335447|NCT02862730|12532991|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11335448|NCT02862730|12532992|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11335449|NCT02862730|12532993|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11335450|NCT02862730|12532994|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11335451|NCT02862730|12532995|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0
11335452|NCT02862730|12532989|FG000|STARTED|Second Intervention (84 Hours)||4
11335453|NCT02862730|12532990|FG001|STARTED|Second Intervention (84 Hours)||1
11335454|NCT02862730|12532991|FG002|STARTED|Second Intervention (84 Hours)||7
11335455|NCT02862730|12532992|FG003|STARTED|Second Intervention (84 Hours)||5
11335456|NCT02862730|12532993|FG004|STARTED|Second Intervention (84 Hours)||5
11335457|NCT02862730|12532994|FG005|STARTED|Second Intervention (84 Hours)||1
11335458|NCT02862730|12532995|FG006|STARTED|Second Intervention (84 Hours)||1
11335459|NCT02862730|12532989|FG000|COMPLETED|Second Intervention (84 Hours)||3
11335460|NCT02862730|12532990|FG001|COMPLETED|Second Intervention (84 Hours)||1
11335461|NCT02862730|12532991|FG002|COMPLETED|Second Intervention (84 Hours)||7
11335462|NCT02862730|12532992|FG003|COMPLETED|Second Intervention (84 Hours)||5
11335463|NCT02862730|12532993|FG004|COMPLETED|Second Intervention (84 Hours)||5
11335464|NCT02862730|12532994|FG005|COMPLETED|Second Intervention (84 Hours)||1
11335465|NCT02862730|12532995|FG006|COMPLETED|Second Intervention (84 Hours)||1
11335466|NCT02862730|12532989|FG000|NOT COMPLETED|Second Intervention (84 Hours)||1
11335467|NCT02862730|12532990|FG001|NOT COMPLETED|Second Intervention (84 Hours)||0
11335468|NCT02862730|12532991|FG002|NOT COMPLETED|Second Intervention (84 Hours)||0
11335469|NCT02862730|12532992|FG003|NOT COMPLETED|Second Intervention (84 Hours)||0
11335470|NCT02862730|12532993|FG004|NOT COMPLETED|Second Intervention (84 Hours)||0
11335471|NCT02862730|12532994|FG005|NOT COMPLETED|Second Intervention (84 Hours)||0
11335472|NCT02862730|12532995|FG006|NOT COMPLETED|Second Intervention (84 Hours)||0
11335473|NCT02862730|12532989|FG000|STARTED|Third Rest Period (7-45 Days)||3
11335474|NCT02862730|12532990|FG001|STARTED|Third Rest Period (7-45 Days)||1
11335475|NCT02862730|12532991|FG002|STARTED|Third Rest Period (7-45 Days)||7
11335476|NCT02862730|12532992|FG003|STARTED|Third Rest Period (7-45 Days)||5
11335477|NCT02862730|12532993|FG004|STARTED|Third Rest Period (7-45 Days)||5
11335478|NCT02862730|12532994|FG005|STARTED|Third Rest Period (7-45 Days)||1
11335479|NCT02862730|12532995|FG006|STARTED|Third Rest Period (7-45 Days)||1
11335480|NCT02862730|12532989|FG000|COMPLETED|Third Rest Period (7-45 Days)||3
11335481|NCT02862730|12532990|FG001|COMPLETED|Third Rest Period (7-45 Days)||1
11335482|NCT02862730|12532991|FG002|COMPLETED|Third Rest Period (7-45 Days)||6
11335483|NCT02862730|12532992|FG003|COMPLETED|Third Rest Period (7-45 Days)||5
11335484|NCT02862730|12532993|FG004|COMPLETED|Third Rest Period (7-45 Days)||4
11335485|NCT02862730|12532994|FG005|COMPLETED|Third Rest Period (7-45 Days)||1
11335486|NCT02862730|12532995|FG006|COMPLETED|Third Rest Period (7-45 Days)||1
11335487|NCT02862730|12532989|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0
11335488|NCT02862730|12532990|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0
11335489|NCT02862730|12532991|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||1
11335490|NCT02862730|12532992|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0
11335491|NCT02862730|12532993|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||1
11335492|NCT02862730|12532994|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0
11335493|NCT02862730|12532995|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0
11335494|NCT02862730|12532989|FG000|STARTED|Third Intervention (84 Hours)||3
11038101|NCT00895830|12218047|FG003|NOT COMPLETED|Overall Study||0
11335495|NCT02862730|12532990|FG001|STARTED|Third Intervention (84 Hours)||1
11335496|NCT02862730|12532991|FG002|STARTED|Third Intervention (84 Hours)||6
11335497|NCT02862730|12532992|FG003|STARTED|Third Intervention (84 Hours)||5
11335498|NCT02862730|12532993|FG004|STARTED|Third Intervention (84 Hours)||4
11038102|NCT00895830|12218048|FG004|NOT COMPLETED|Overall Study||0
11335499|NCT02862730|12532994|FG005|STARTED|Third Intervention (84 Hours)||1
11335500|NCT02862730|12532995|FG006|STARTED|Third Intervention (84 Hours)||1
11335501|NCT02862730|12532989|FG000|COMPLETED|Third Intervention (84 Hours)||3
11038103|NCT00895843|12218062|FG000|STARTED|Overall Study||60
11038104|NCT00895843|12218063|FG001|STARTED|Overall Study||62
11038105|NCT00895843|12218062|FG000|COMPLETED|Overall Study||48
11038106|NCT00895843|12218063|FG001|COMPLETED|Overall Study||50
11038107|NCT00895843|12218062|FG000|NOT COMPLETED|Overall Study||12
11038108|NCT00895843|12218063|FG001|NOT COMPLETED|Overall Study||12
11038109|NCT00895895|12218074|FG000|STARTED|Period 1||107
11038110|NCT00895895|12218075|FG001|STARTED|Period 1||105
11038111|NCT00895895|12218076|FG002|STARTED|Period 1||104
11038112|NCT00895895|12218077|FG003|STARTED|Period 1||104
11038113|NCT00895895|12218078|FG004|STARTED|Period 1||106
11038114|NCT00895895|12218074|FG000|Randomized But Not Treated|Period 1||1
11038115|NCT00895895|12218075|FG001|Randomized But Not Treated|Period 1||3
11038116|NCT00895895|12218076|FG002|Randomized But Not Treated|Period 1||1
11038117|NCT00895895|12218077|FG003|Randomized But Not Treated|Period 1||1
11038118|NCT00895895|12218078|FG004|Randomized But Not Treated|Period 1||2
11038119|NCT00895895|12218074|FG000|COMPLETED|Period 1||86
11038120|NCT00895895|12218075|FG001|COMPLETED|Period 1||84
11038121|NCT00895895|12218076|FG002|COMPLETED|Period 1||84
11038122|NCT00895895|12218077|FG003|COMPLETED|Period 1||91
11038123|NCT00895895|12218078|FG004|COMPLETED|Period 1||86
11038124|NCT00895895|12218074|FG000|NOT COMPLETED|Period 1||21
11038125|NCT00895895|12218075|FG001|NOT COMPLETED|Period 1||21
11038126|NCT00895895|12218076|FG002|NOT COMPLETED|Period 1||20
11038127|NCT00895895|12218077|FG003|NOT COMPLETED|Period 1||13
11038128|NCT00895895|12218078|FG004|NOT COMPLETED|Period 1||20
11038129|NCT00895895|12218074|FG000|STARTED|After Period 1, Prior to Period 2||86
11038130|NCT00895895|12218075|FG001|STARTED|After Period 1, Prior to Period 2||84
11038131|NCT00895895|12218076|FG002|STARTED|After Period 1, Prior to Period 2||84
11038132|NCT00895895|12218077|FG003|STARTED|After Period 1, Prior to Period 2||91
11038133|NCT00895895|12218078|FG004|STARTED|After Period 1, Prior to Period 2||86
11038134|NCT00895895|12218074|FG000|COMPLETED|After Period 1, Prior to Period 2||86
11038135|NCT00895895|12218075|FG001|COMPLETED|After Period 1, Prior to Period 2||84
11038136|NCT00895895|12218076|FG002|COMPLETED|After Period 1, Prior to Period 2||82
11038137|NCT00895895|12218077|FG003|COMPLETED|After Period 1, Prior to Period 2||91
11038138|NCT00895895|12218078|FG004|COMPLETED|After Period 1, Prior to Period 2||84
11038139|NCT00895895|12218074|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||0
11038140|NCT00895895|12218075|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0
11038141|NCT00895895|12218076|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||2
11038142|NCT00895895|12218077|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0
11038143|NCT00895895|12218078|FG004|NOT COMPLETED|After Period 1, Prior to Period 2||2
11038144|NCT00895895|12218074|FG000|STARTED|Period 2||86
11038145|NCT00895895|12218075|FG001|STARTED|Period 2||84
11038146|NCT00895895|12218076|FG002|STARTED|Period 2||82
11038147|NCT00895895|12218077|FG003|STARTED|Period 2||91
11038148|NCT00895895|12218078|FG004|STARTED|Period 2||84
11038149|NCT00895895|12218074|FG000|COMPLETED|Period 2||30
11038150|NCT00895895|12218075|FG001|COMPLETED|Period 2||31
11038151|NCT00895895|12218076|FG002|COMPLETED|Period 2||33
11038152|NCT00895895|12218077|FG003|COMPLETED|Period 2||37
11038153|NCT00895895|12218078|FG004|COMPLETED|Period 2||35
11038154|NCT00895895|12218074|FG000|NOT COMPLETED|Period 2||56
11038155|NCT00895895|12218075|FG001|NOT COMPLETED|Period 2||53
11038156|NCT00895895|12218076|FG002|NOT COMPLETED|Period 2||49
11038157|NCT00895895|12218077|FG003|NOT COMPLETED|Period 2||54
11038158|NCT00895895|12218078|FG004|NOT COMPLETED|Period 2||49
11038159|NCT00895921|12218098|FG000|STARTED|Overall Study||15
11038160|NCT00895921|12218099|FG001|STARTED|Overall Study||15
11038161|NCT00895921|12218098|FG000|COMPLETED|Overall Study||15
11038162|NCT00895921|12218099|FG001|COMPLETED|Overall Study||15
11038163|NCT00895921|12218098|FG000|NOT COMPLETED|Overall Study||0
11038164|NCT00895921|12218099|FG001|NOT COMPLETED|Overall Study||0
11038165|NCT00895934|12218107|FG000|STARTED|Dose Escalation||3
11038166|NCT00895934|12218108|FG001|STARTED|Dose Escalation||3
11038167|NCT00895934|12218109|FG002|STARTED|Dose Escalation||3
11038168|NCT00895934|12218110|FG003|STARTED|Dose Escalation||6
11038169|NCT00895934|12218107|FG000|COMPLETED|Dose Escalation||3
11038170|NCT00895934|12218108|FG001|COMPLETED|Dose Escalation||3
11038171|NCT00895934|12218109|FG002|COMPLETED|Dose Escalation||3
11038172|NCT00895934|12218110|FG003|COMPLETED|Dose Escalation||6
11038173|NCT00895934|12218107|FG000|NOT COMPLETED|Dose Escalation||0
11038174|NCT00895934|12218108|FG001|NOT COMPLETED|Dose Escalation||0
11038175|NCT00895934|12218109|FG002|NOT COMPLETED|Dose Escalation||0
11038176|NCT00895934|12218110|FG003|NOT COMPLETED|Dose Escalation||0
11038177|NCT00895934|12218107|FG000|STARTED|Efficacy of Most Tolerated Dose||0
11038178|NCT00895934|12218108|FG001|STARTED|Efficacy of Most Tolerated Dose||0
11038179|NCT00895934|12218109|FG002|STARTED|Efficacy of Most Tolerated Dose||0
11038180|NCT00895934|12218110|FG003|STARTED|Efficacy of Most Tolerated Dose||37
11038181|NCT00895934|12218107|FG000|COMPLETED|Efficacy of Most Tolerated Dose||0
11038182|NCT00895934|12218108|FG001|COMPLETED|Efficacy of Most Tolerated Dose||0
11038183|NCT00895934|12218109|FG002|COMPLETED|Efficacy of Most Tolerated Dose||0
11038184|NCT00895934|12218110|FG003|COMPLETED|Efficacy of Most Tolerated Dose||37
11038185|NCT00895934|12218107|FG000|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
11038186|NCT00895934|12218108|FG001|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
11038187|NCT00895934|12218109|FG002|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
11038188|NCT00895934|12218110|FG003|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
11038189|NCT00895947|12218123|FG000|STARTED|Overall Study||100
11038190|NCT00895947|12218124|FG001|STARTED|Overall Study||100
11038191|NCT00895947|12218123|FG000|COMPLETED|Overall Study||88
11038192|NCT00895947|12218124|FG001|COMPLETED|Overall Study||90
11038193|NCT00895947|12218123|FG000|NOT COMPLETED|Overall Study||12
11038194|NCT00895947|12218124|FG001|NOT COMPLETED|Overall Study||10
11335502|NCT02862730|12532990|FG001|COMPLETED|Third Intervention (84 Hours)||1
11335503|NCT02862730|12532991|FG002|COMPLETED|Third Intervention (84 Hours)||6
11335504|NCT02862730|12532992|FG003|COMPLETED|Third Intervention (84 Hours)||4
11335505|NCT02862730|12532993|FG004|COMPLETED|Third Intervention (84 Hours)||4
11335506|NCT02862730|12532994|FG005|COMPLETED|Third Intervention (84 Hours)||1
11335507|NCT02862730|12532995|FG006|COMPLETED|Third Intervention (84 Hours)||1
11335508|NCT02862730|12532989|FG000|NOT COMPLETED|Third Intervention (84 Hours)||0
11335509|NCT02862730|12532990|FG001|NOT COMPLETED|Third Intervention (84 Hours)||0
11335510|NCT02862730|12532991|FG002|NOT COMPLETED|Third Intervention (84 Hours)||0
11335511|NCT02862730|12532992|FG003|NOT COMPLETED|Third Intervention (84 Hours)||1
11335512|NCT02862730|12532993|FG004|NOT COMPLETED|Third Intervention (84 Hours)||0
11335513|NCT02862730|12532994|FG005|NOT COMPLETED|Third Intervention (84 Hours)||0
11335514|NCT02862730|12532995|FG006|NOT COMPLETED|Third Intervention (84 Hours)||0
11335515|NCT02862730|12532989|FG000|STARTED|Fourth Rest Period (7-45 Days)||3
11335516|NCT02862730|12532990|FG001|STARTED|Fourth Rest Period (7-45 Days)||1
11335517|NCT02862730|12532991|FG002|STARTED|Fourth Rest Period (7-45 Days)||6
11335518|NCT02862730|12532992|FG003|STARTED|Fourth Rest Period (7-45 Days)||4
11335519|NCT02862730|12532993|FG004|STARTED|Fourth Rest Period (7-45 Days)||4
11335520|NCT02862730|12532994|FG005|STARTED|Fourth Rest Period (7-45 Days)||1
11335521|NCT02862730|12532995|FG006|STARTED|Fourth Rest Period (7-45 Days)||1
11335522|NCT02862730|12532989|FG000|COMPLETED|Fourth Rest Period (7-45 Days)||3
11335523|NCT02862730|12532990|FG001|COMPLETED|Fourth Rest Period (7-45 Days)||1
11335524|NCT02862730|12532991|FG002|COMPLETED|Fourth Rest Period (7-45 Days)||6
11335525|NCT02862730|12532992|FG003|COMPLETED|Fourth Rest Period (7-45 Days)||4
11335526|NCT02862730|12532993|FG004|COMPLETED|Fourth Rest Period (7-45 Days)||4
11335527|NCT02862730|12532994|FG005|COMPLETED|Fourth Rest Period (7-45 Days)||1
11335528|NCT02862730|12532995|FG006|COMPLETED|Fourth Rest Period (7-45 Days)||1
11335529|NCT02862730|12532989|FG000|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
11335530|NCT02862730|12532990|FG001|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
11335531|NCT02862730|12532991|FG002|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
11335532|NCT02862730|12532992|FG003|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
11335533|NCT02862730|12532993|FG004|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
11335534|NCT02862730|12532994|FG005|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
11335535|NCT02862730|12532995|FG006|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
11335536|NCT02862730|12532989|FG000|STARTED|Fourth Intervention (84 Hours)||3
11335537|NCT02862730|12532990|FG001|STARTED|Fourth Intervention (84 Hours)||1
11335538|NCT02862730|12532991|FG002|STARTED|Fourth Intervention (84 Hours)||6
11335539|NCT02862730|12532992|FG003|STARTED|Fourth Intervention (84 Hours)||4
11335540|NCT02862730|12532993|FG004|STARTED|Fourth Intervention (84 Hours)||4
11335541|NCT02862730|12532994|FG005|STARTED|Fourth Intervention (84 Hours)||1
11335542|NCT02862730|12532995|FG006|STARTED|Fourth Intervention (84 Hours)||1
11335543|NCT02862730|12532989|FG000|COMPLETED|Fourth Intervention (84 Hours)||3
11335544|NCT02862730|12532990|FG001|COMPLETED|Fourth Intervention (84 Hours)||1
11335545|NCT02862730|12532991|FG002|COMPLETED|Fourth Intervention (84 Hours)||6
11335546|NCT02862730|12532992|FG003|COMPLETED|Fourth Intervention (84 Hours)||4
11335547|NCT02862730|12532993|FG004|COMPLETED|Fourth Intervention (84 Hours)||4
11335548|NCT02862730|12532994|FG005|COMPLETED|Fourth Intervention (84 Hours)||1
11335549|NCT02862730|12532995|FG006|COMPLETED|Fourth Intervention (84 Hours)||1
11335550|NCT02862730|12532989|FG000|NOT COMPLETED|Fourth Intervention (84 Hours)||0
11335551|NCT02862730|12532990|FG001|NOT COMPLETED|Fourth Intervention (84 Hours)||0
11335552|NCT02862730|12532991|FG002|NOT COMPLETED|Fourth Intervention (84 Hours)||0
11335553|NCT02862730|12532992|FG003|NOT COMPLETED|Fourth Intervention (84 Hours)||0
11335554|NCT02862730|12532993|FG004|NOT COMPLETED|Fourth Intervention (84 Hours)||0
11335555|NCT02862730|12532994|FG005|NOT COMPLETED|Fourth Intervention (84 Hours)||0
11335556|NCT02862730|12532995|FG006|NOT COMPLETED|Fourth Intervention (84 Hours)||0
11335557|NCT02862912|12533012|FG000|STARTED|Overall Study||23
11335558|NCT02862912|12533013|FG001|STARTED|Overall Study||20
11335559|NCT02862912|12533012|FG000|COMPLETED|Overall Study||22
11335560|NCT02862912|12533013|FG001|COMPLETED|Overall Study||20
11335561|NCT02862912|12533012|FG000|NOT COMPLETED|Overall Study||1
11335562|NCT02862912|12533013|FG001|NOT COMPLETED|Overall Study||0
11335563|NCT02863198|12533023|FG000|STARTED|Overall Study||60
11335564|NCT02863198|12533024|FG001|STARTED|Overall Study||60
11038195|NCT00896012|12218132|FG000|STARTED|Overall Study||29
11038196|NCT00896012|12218133|FG001|STARTED|Overall Study||23
11038197|NCT00896012|12218132|FG000|COMPLETED|Overall Study||18
11038198|NCT00896012|12218133|FG001|COMPLETED|Overall Study||12
11038199|NCT00896012|12218132|FG000|NOT COMPLETED|Overall Study||11
11038200|NCT00896012|12218133|FG001|NOT COMPLETED|Overall Study||11
11038201|NCT00896038|12218141|FG000|STARTED|Overall Study||30
11038202|NCT00896038|12218142|FG001|STARTED|Overall Study||28
11038203|NCT00896038|12218141|FG000|COMPLETED|Overall Study||26
11038204|NCT00896038|12218142|FG001|COMPLETED|Overall Study||27
11038205|NCT00896038|12218141|FG000|NOT COMPLETED|Overall Study||4
11038206|NCT00896038|12218142|FG001|NOT COMPLETED|Overall Study||1
11038207|NCT00896051|12218150|FG000|STARTED|Overall Study||25
11038208|NCT00896051|12218151|FG001|STARTED|Overall Study||25
11038209|NCT00896051|12218150|FG000|COMPLETED|Overall Study||15
11038210|NCT00896051|12218151|FG001|COMPLETED|Overall Study||16
11038211|NCT00896051|12218150|FG000|NOT COMPLETED|Overall Study||10
11038212|NCT00896051|12218151|FG001|NOT COMPLETED|Overall Study||9
11038213|NCT00896064|12218168|FG000|STARTED|Overall Study||22
11038214|NCT00896064|12218169|FG001|STARTED|Overall Study||21
11038215|NCT00896064|12218168|FG000|COMPLETED|Overall Study||22
11038216|NCT00896064|12218169|FG001|COMPLETED|Overall Study||21
11038217|NCT00896064|12218168|FG000|NOT COMPLETED|Overall Study||0
11038218|NCT00896064|12218169|FG001|NOT COMPLETED|Overall Study||0
11038219|NCT00896168|12218177|FG000|STARTED|Overall Study||104
11038220|NCT00896168|12218178|FG001|STARTED|Overall Study||130
11038221|NCT00896168|12218177|FG000|COMPLETED|Overall Study||90
11038222|NCT00896168|12218178|FG001|COMPLETED|Overall Study||111
11038223|NCT00896168|12218177|FG000|NOT COMPLETED|Overall Study||14
11038224|NCT00896168|12218178|FG001|NOT COMPLETED|Overall Study||19
11038225|NCT00896181|12218184|FG000|STARTED|Overall Study||26
11038226|NCT00896181|12218184|FG000|COMPLETED|Overall Study||26
11038227|NCT00896181|12218184|FG000|NOT COMPLETED|Overall Study||0
11038228|NCT00896233|12218188|FG000|STARTED|Overall Study||10
11200995|NCT01830699|12391232|FG001|NOT COMPLETED|Overall Study||0
11200996|NCT01830816|12391241|FG000|STARTED|Overall Study||20
11200997|NCT01830816|12391242|FG001|STARTED|Overall Study||14
11200998|NCT01830816|12391243|FG002|STARTED|Overall Study||7
11200999|NCT01830816|12391241|FG000|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18
11201000|NCT01830816|12391242|FG001|Pharmacokinetic-Evaluable Population|Overall Study||14
11201001|NCT01830816|12391243|FG002|Pharmacokinetic-Evaluable Population|Overall Study||6
11201002|NCT01830816|12391241|FG000|COMPLETED|Overall Study||0
11201003|NCT01830816|12391242|FG001|COMPLETED|Overall Study||0
11201004|NCT01830816|12391243|FG002|COMPLETED|Overall Study||0
11201005|NCT01830816|12391241|FG000|NOT COMPLETED|Overall Study||20
11201006|NCT01830816|12391242|FG001|NOT COMPLETED|Overall Study||14
11201007|NCT01830816|12391243|FG002|NOT COMPLETED|Overall Study||7
11201008|NCT01830842|12391256|FG000|STARTED|Overall Study||30
11201009|NCT01830842|12391257|FG001|STARTED|Overall Study||24
11201010|NCT01830842|12391256|FG000|COMPLETED|Overall Study||25
11201011|NCT01830842|12391257|FG001|COMPLETED|Overall Study||22
11201012|NCT01830842|12391256|FG000|NOT COMPLETED|Overall Study||5
11201013|NCT01830842|12391257|FG001|NOT COMPLETED|Overall Study||2
11201014|NCT01830855|12391267|FG000|STARTED|Overall Study||1508
11201015|NCT01830855|12391268|FG001|STARTED|Overall Study||598
11201016|NCT01830855|12391269|FG002|STARTED|Overall Study||587
11201017|NCT01830855|12391270|FG003|STARTED|Overall Study||897
11201018|NCT01830855|12391267|FG000|COMPLETED|Overall Study||1353
11201019|NCT01830855|12391268|FG001|COMPLETED|Overall Study||537
11201020|NCT01830855|12391269|FG002|COMPLETED|Overall Study||521
11201021|NCT01830855|12391270|FG003|COMPLETED|Overall Study||815
11201022|NCT01830855|12391267|FG000|NOT COMPLETED|Overall Study||155
11201023|NCT01830855|12391268|FG001|NOT COMPLETED|Overall Study||61
11201024|NCT01830855|12391269|FG002|NOT COMPLETED|Overall Study||66
11201025|NCT01830855|12391270|FG003|NOT COMPLETED|Overall Study||82
11201026|NCT01830881|12391287|FG000|STARTED|Overall Study||62
11201027|NCT01830881|12391288|FG001|STARTED|Overall Study||62
11201028|NCT01830881|12391287|FG000|COMPLETED|Overall Study||62
11201029|NCT01830881|12391288|FG001|COMPLETED|Overall Study||61
11201030|NCT01830881|12391287|FG000|NOT COMPLETED|Overall Study||0
11201031|NCT01830881|12391288|FG001|NOT COMPLETED|Overall Study||1
11201032|NCT01830920|12391301|FG000|STARTED|Overall Study||126
11201033|NCT01830920|12391302|FG001|STARTED|Overall Study||46
11201034|NCT01830920|12391303|FG002|STARTED|Overall Study||48
11201035|NCT01830920|12391304|FG003|STARTED|Overall Study||125
11201036|NCT01830920|12391305|FG004|STARTED|Overall Study||107
11201037|NCT01830920|12391301|FG000|Received Allocated Drug|Overall Study||115
11201038|NCT01830920|12391302|FG001|Received Allocated Drug|Overall Study||45
11201039|NCT01830920|12391303|FG002|Received Allocated Drug|Overall Study||47
11201040|NCT01830920|12391304|FG003|Received Allocated Drug|Overall Study||119
11201041|NCT01830920|12391305|FG004|Received Allocated Drug|Overall Study||105
11201042|NCT01830920|12391301|FG000|COMPLETED|Overall Study||105
11201043|NCT01830920|12391302|FG001|COMPLETED|Overall Study||40
11201044|NCT01830920|12391303|FG002|COMPLETED|Overall Study||40
11201045|NCT01830920|12391304|FG003|COMPLETED|Overall Study||109
11201046|NCT01830920|12391305|FG004|COMPLETED|Overall Study||99
11201047|NCT01830920|12391301|FG000|NOT COMPLETED|Overall Study||21
11201048|NCT01830920|12391302|FG001|NOT COMPLETED|Overall Study||6
11201049|NCT01830920|12391303|FG002|NOT COMPLETED|Overall Study||8
11201050|NCT01830920|12391304|FG003|NOT COMPLETED|Overall Study||16
11201051|NCT01830920|12391305|FG004|NOT COMPLETED|Overall Study||8
11201052|NCT01830933|12391319|FG000|STARTED|Overall Study||823
11038229|NCT00896233|12218188|FG000|COMPLETED|Overall Study||9
11201053|NCT01830933|12391320|FG001|STARTED|Overall Study||812
11201054|NCT01830933|12391319|FG000|Completed Meet-up|Overall Study||675
11201055|NCT01830933|12391320|FG001|Completed Meet-up|Overall Study||603
11201056|NCT01830933|12391319|FG000|COMPLETED|Overall Study||655
11201057|NCT01830933|12391320|FG001|COMPLETED|Overall Study||580
11201058|NCT01830933|12391319|FG000|NOT COMPLETED|Overall Study||168
11201059|NCT01830933|12391320|FG001|NOT COMPLETED|Overall Study||232
11201060|NCT01830972|12391328|FG000|STARTED|Part I||46
11201061|NCT01830972|12391329|FG001|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
11201062|NCT01830972|12391328|FG000|COMPLETED|Part I||46
11201063|NCT01830972|12391329|FG001|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
11038230|NCT00896233|12218188|FG000|NOT COMPLETED|Overall Study||1
11038231|NCT00896298|12218195|FG000|STARTED|Overall Study||13
11038232|NCT00896298|12218196|FG001|STARTED|Overall Study||12
11038233|NCT00896298|12218195|FG000|COMPLETED|Overall Study||10
11038234|NCT00896298|12218196|FG001|COMPLETED|Overall Study||9
11038235|NCT00896298|12218195|FG000|NOT COMPLETED|Overall Study||3
11038236|NCT00896298|12218196|FG001|NOT COMPLETED|Overall Study||3
11038237|NCT00896337|12218202|FG000|STARTED|Overall Study||125
11038238|NCT00896337|12218202|FG000|COMPLETED|Overall Study||100
11038239|NCT00896337|12218202|FG000|NOT COMPLETED|Overall Study||25
11038240|NCT00896363|12218214|FG000|STARTED|Overall Study||31
11038241|NCT00896363|12218215|FG001|STARTED|Overall Study||36
11038242|NCT00896363|12218216|FG002|STARTED|Overall Study||32
11038243|NCT00896363|12218214|FG000|COMPLETED|Overall Study||25
11038244|NCT00896363|12218215|FG001|COMPLETED|Overall Study||25
11038245|NCT00896363|12218216|FG002|COMPLETED|Overall Study||24
11038246|NCT00896363|12218214|FG000|NOT COMPLETED|Overall Study||6
11038247|NCT00896363|12218215|FG001|NOT COMPLETED|Overall Study||11
11038248|NCT00896363|12218216|FG002|NOT COMPLETED|Overall Study||8
11038249|NCT00896441|12218229|FG000|STARTED|Overall Study||17
11038250|NCT00896441|12218230|FG001|STARTED|Overall Study||9
11038251|NCT00896441|12218229|FG000|COMPLETED|Overall Study||15
11038252|NCT00896441|12218230|FG001|COMPLETED|Overall Study||9
11038253|NCT00896441|12218229|FG000|NOT COMPLETED|Overall Study||2
11038254|NCT00896441|12218230|FG001|NOT COMPLETED|Overall Study||0
11038255|NCT00896454|12218235|FG000|STARTED|Overall Study||33
11038256|NCT00896454|12218235|FG000|COMPLETED|Overall Study||0
11038257|NCT00896454|12218235|FG000|NOT COMPLETED|Overall Study||33
11038258|NCT00896480|12218239|FG000|STARTED|Overall Study||24
11038259|NCT00896480|12218239|FG000|COMPLETED|Overall Study||3
11038260|NCT00896480|12218239|FG000|NOT COMPLETED|Overall Study||21
11038261|NCT00896649|12218246|FG000|STARTED|Overall Study||193
11038262|NCT00896649|12218246|FG000|COMPLETED|Overall Study||188
11038263|NCT00896649|12218246|FG000|NOT COMPLETED|Overall Study||5
11038264|NCT00896779|12218253|FG000|STARTED|Overall Study||8
11038265|NCT00896779|12218254|FG001|STARTED|Overall Study||12
11038266|NCT00896779|12218253|FG000|COMPLETED|Overall Study||8
11038267|NCT00896779|12218254|FG001|COMPLETED|Overall Study||11
11038268|NCT00896779|12218253|FG000|NOT COMPLETED|Overall Study||0
11038269|NCT00896779|12218254|FG001|NOT COMPLETED|Overall Study||1
11038270|NCT00897390|12218260|FG000|STARTED|Overall Study||24
11038271|NCT00897390|12218260|FG000|COMPLETED|Overall Study||18
11038272|NCT00897390|12218260|FG000|NOT COMPLETED|Overall Study||6
11038273|NCT00897676|12218271|FG000|STARTED|Intervention 1(6 Hours)||9
11038274|NCT00897676|12218272|FG001|STARTED|Intervention 1(6 Hours)||7
11038275|NCT00897676|12218271|FG000|COMPLETED|Intervention 1(6 Hours)||9
11038276|NCT00897676|12218272|FG001|COMPLETED|Intervention 1(6 Hours)||7
11038277|NCT00897676|12218271|FG000|NOT COMPLETED|Intervention 1(6 Hours)||0
11038278|NCT00897676|12218272|FG001|NOT COMPLETED|Intervention 1(6 Hours)||0
11038279|NCT00897676|12218271|FG000|STARTED|Intervention 2(6 Hours)||9
11038280|NCT00897676|12218272|FG001|STARTED|Intervention 2(6 Hours)||7
11038281|NCT00897676|12218271|FG000|COMPLETED|Intervention 2(6 Hours)||9
11038282|NCT00897676|12218272|FG001|COMPLETED|Intervention 2(6 Hours)||7
11038283|NCT00897676|12218271|FG000|NOT COMPLETED|Intervention 2(6 Hours)||0
11038284|NCT00897676|12218272|FG001|NOT COMPLETED|Intervention 2(6 Hours)||0
11038285|NCT00897715|12218287|FG000|STARTED|Overall Study||8
11038286|NCT00897715|12218288|FG001|STARTED|Overall Study||7
11038287|NCT00897715|12218287|FG000|COMPLETED|Overall Study||6
11038288|NCT00897715|12218288|FG001|COMPLETED|Overall Study||6
11038289|NCT00897715|12218287|FG000|NOT COMPLETED|Overall Study||2
11038290|NCT00897715|12218288|FG001|NOT COMPLETED|Overall Study||1
11038291|NCT00897897|12218294|FG000|STARTED|Overall Study||33
11038292|NCT00897897|12218294|FG000|COMPLETED|Overall Study||33
11038293|NCT00897897|12218294|FG000|NOT COMPLETED|Overall Study||0
11038294|NCT00898222|12218298|FG000|STARTED|Overall Study||4
11038295|NCT00898222|12218298|FG000|COMPLETED|Overall Study||4
11038296|NCT00898222|12218298|FG000|NOT COMPLETED|Overall Study||0
11038297|NCT00898443|12218304|FG000|STARTED|Overall Study||10
11038298|NCT00898443|12218305|FG001|STARTED|Overall Study||8
11038299|NCT00898443|12218304|FG000|COMPLETED|Overall Study||9
11038300|NCT00898443|12218305|FG001|COMPLETED|Overall Study||8
11038301|NCT00898443|12218304|FG000|NOT COMPLETED|Overall Study||1
11038302|NCT00898443|12218305|FG001|NOT COMPLETED|Overall Study||0
11038303|NCT00898560|12218311|FG000|STARTED|Overall Study||20
11201064|NCT01830972|12391328|FG000|NOT COMPLETED|Part I||0
11038304|NCT00898560|12218311|FG000|COMPLETED|Overall Study||19
11038305|NCT00898560|12218311|FG000|NOT COMPLETED|Overall Study||1
11038306|NCT00898807|12218319|FG000|STARTED|Overall Study||94
11038307|NCT00898807|12218320|FG001|STARTED|Overall Study||92
11201065|NCT01830972|12391329|FG001|NOT COMPLETED|Part I||0
11038308|NCT00898807|12218319|FG000|COMPLETED|Overall Study||86
11038309|NCT00898807|12218320|FG001|COMPLETED|Overall Study||83
11038310|NCT00898807|12218319|FG000|NOT COMPLETED|Overall Study||8
11038311|NCT00898807|12218320|FG001|NOT COMPLETED|Overall Study||9
11038312|NCT00898937|12218329|FG000|STARTED|Overall Study||25
11038313|NCT00898937|12218330|FG001|STARTED|Overall Study||21
11038314|NCT00898937|12218331|FG002|STARTED|Overall Study||9
11038315|NCT00898937|12218329|FG000|COMPLETED|Overall Study||25
11038316|NCT00898937|12218330|FG001|COMPLETED|Overall Study||21
11038317|NCT00898937|12218331|FG002|COMPLETED|Overall Study||9
11038318|NCT00898937|12218329|FG000|NOT COMPLETED|Overall Study||0
11038319|NCT00898937|12218330|FG001|NOT COMPLETED|Overall Study||0
11038320|NCT00898937|12218331|FG002|NOT COMPLETED|Overall Study||0
11038321|NCT00899353|12218339|FG000|STARTED|Overall Study||16
11038322|NCT00899353|12218339|FG000|COMPLETED|Overall Study||11
11038323|NCT00899353|12218339|FG000|NOT COMPLETED|Overall Study||5
11038324|NCT00899392|12218362|FG000|STARTED|Overall Study||68
11038325|NCT00899392|12218363|FG001|STARTED|Overall Study||74
11038326|NCT00899392|12218362|FG000|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
11038327|NCT00899392|12218363|FG001|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
11038328|NCT00899392|12218362|FG000|NOT COMPLETED|Overall Study||21
11038329|NCT00899392|12218363|FG001|NOT COMPLETED|Overall Study||24
11038330|NCT00899431|12218372|FG000|STARTED|Overall Study||22
11038331|NCT00899431|12218373|FG001|STARTED|Overall Study||8
11038332|NCT00899431|12218374|FG002|STARTED|Overall Study||9
11038333|NCT00899431|12218372|FG000|COMPLETED|Overall Study||21
11038334|NCT00899431|12218373|FG001|COMPLETED|Overall Study||8
11038335|NCT00899431|12218374|FG002|COMPLETED|Overall Study||9
11038336|NCT00899431|12218372|FG000|NOT COMPLETED|Overall Study||1
11038337|NCT00899431|12218373|FG001|NOT COMPLETED|Overall Study||0
11038338|NCT00899431|12218374|FG002|NOT COMPLETED|Overall Study||0
11038339|NCT00899470|12218385|FG000|STARTED|First Therapy||6
11038340|NCT00899470|12218386|FG001|STARTED|First Therapy||6
11038341|NCT00899470|12218387|FG002|STARTED|First Therapy||6
11038342|NCT00899470|12218388|FG003|STARTED|First Therapy||6
11038343|NCT00899470|12218385|FG000|COMPLETED|First Therapy||6
11038344|NCT00899470|12218386|FG001|COMPLETED|First Therapy||6
11038345|NCT00899470|12218387|FG002|COMPLETED|First Therapy||6
11038346|NCT00899470|12218388|FG003|COMPLETED|First Therapy||6
11038347|NCT00899470|12218385|FG000|NOT COMPLETED|First Therapy||0
11038348|NCT00899470|12218386|FG001|NOT COMPLETED|First Therapy||0
11038349|NCT00899470|12218387|FG002|NOT COMPLETED|First Therapy||0
11038350|NCT00899470|12218388|FG003|NOT COMPLETED|First Therapy||0
11038351|NCT00899470|12218385|FG000|STARTED|First Washout Period||6
11038352|NCT00899470|12218386|FG001|STARTED|First Washout Period||6
11038353|NCT00899470|12218387|FG002|STARTED|First Washout Period||6
11038354|NCT00899470|12218388|FG003|STARTED|First Washout Period||6
11038355|NCT00899470|12218385|FG000|COMPLETED|First Washout Period||6
11038356|NCT00899470|12218386|FG001|COMPLETED|First Washout Period||6
11038357|NCT00899470|12218387|FG002|COMPLETED|First Washout Period||6
11038358|NCT00899470|12218388|FG003|COMPLETED|First Washout Period||6
11038359|NCT00899470|12218385|FG000|NOT COMPLETED|First Washout Period||0
11038360|NCT00899470|12218386|FG001|NOT COMPLETED|First Washout Period||0
11038361|NCT00899470|12218387|FG002|NOT COMPLETED|First Washout Period||0
11038362|NCT00899470|12218388|FG003|NOT COMPLETED|First Washout Period||0
11038363|NCT00899470|12218385|FG000|STARTED|Second Therapy||6
11038364|NCT00899470|12218386|FG001|STARTED|Second Therapy||6
11038365|NCT00899470|12218387|FG002|STARTED|Second Therapy||6
11038366|NCT00899470|12218388|FG003|STARTED|Second Therapy||6
11038367|NCT00899470|12218385|FG000|COMPLETED|Second Therapy||6
11038368|NCT00899470|12218386|FG001|COMPLETED|Second Therapy||6
11038369|NCT00899470|12218387|FG002|COMPLETED|Second Therapy||6
11038370|NCT00899470|12218388|FG003|COMPLETED|Second Therapy||6
11038371|NCT00899470|12218385|FG000|NOT COMPLETED|Second Therapy||0
11038372|NCT00899470|12218386|FG001|NOT COMPLETED|Second Therapy||0
11038373|NCT00899470|12218387|FG002|NOT COMPLETED|Second Therapy||0
11038374|NCT00899470|12218388|FG003|NOT COMPLETED|Second Therapy||0
11038375|NCT00899470|12218385|FG000|STARTED|Second Washout||6
11038376|NCT00899470|12218386|FG001|STARTED|Second Washout||6
11038377|NCT00899470|12218387|FG002|STARTED|Second Washout||6
11038378|NCT00899470|12218388|FG003|STARTED|Second Washout||6
11038379|NCT00899470|12218385|FG000|COMPLETED|Second Washout||6
11038380|NCT00899470|12218386|FG001|COMPLETED|Second Washout||6
11038381|NCT00899470|12218387|FG002|COMPLETED|Second Washout||6
11038382|NCT00899470|12218388|FG003|COMPLETED|Second Washout||6
11038383|NCT00899470|12218385|FG000|NOT COMPLETED|Second Washout||0
11038384|NCT00899470|12218386|FG001|NOT COMPLETED|Second Washout||0
11038385|NCT00899470|12218387|FG002|NOT COMPLETED|Second Washout||0
11038386|NCT00899470|12218388|FG003|NOT COMPLETED|Second Washout||0
11038387|NCT00899470|12218385|FG000|STARTED|Third Therapy||6
11038388|NCT00899470|12218386|FG001|STARTED|Third Therapy||6
11038389|NCT00899470|12218387|FG002|STARTED|Third Therapy||6
11038390|NCT00899470|12218388|FG003|STARTED|Third Therapy||6
11038391|NCT00899470|12218385|FG000|COMPLETED|Third Therapy||6
11038392|NCT00899470|12218386|FG001|COMPLETED|Third Therapy||6
11038393|NCT00899470|12218387|FG002|COMPLETED|Third Therapy||6
11038394|NCT00899470|12218388|FG003|COMPLETED|Third Therapy||6
11038395|NCT00899470|12218385|FG000|NOT COMPLETED|Third Therapy||0
11038396|NCT00899470|12218386|FG001|NOT COMPLETED|Third Therapy||0
11038397|NCT00899470|12218387|FG002|NOT COMPLETED|Third Therapy||0
11038398|NCT00899470|12218388|FG003|NOT COMPLETED|Third Therapy||0
11038399|NCT00899470|12218385|FG000|STARTED|Third Washout||6
11038400|NCT00899470|12218386|FG001|STARTED|Third Washout||6
11038401|NCT00899470|12218387|FG002|STARTED|Third Washout||6
11038402|NCT00899470|12218388|FG003|STARTED|Third Washout||6
11038403|NCT00899470|12218385|FG000|COMPLETED|Third Washout||6
11038404|NCT00899470|12218386|FG001|COMPLETED|Third Washout||6
11038405|NCT00899470|12218387|FG002|COMPLETED|Third Washout||6
11038406|NCT00899470|12218388|FG003|COMPLETED|Third Washout||6
11038407|NCT00899470|12218385|FG000|NOT COMPLETED|Third Washout||0
11038408|NCT00899470|12218386|FG001|NOT COMPLETED|Third Washout||0
11038409|NCT00899470|12218387|FG002|NOT COMPLETED|Third Washout||0
11038410|NCT00899470|12218388|FG003|NOT COMPLETED|Third Washout||0
11038411|NCT00899470|12218385|FG000|STARTED|Fourth Therapy||6
11038412|NCT00899470|12218386|FG001|STARTED|Fourth Therapy||6
11335565|NCT02863198|12533023|FG000|COMPLETED|Overall Study||60
11335566|NCT02863198|12533024|FG001|COMPLETED|Overall Study||60
11335567|NCT02863198|12533023|FG000|NOT COMPLETED|Overall Study||0
11335568|NCT02863198|12533024|FG001|NOT COMPLETED|Overall Study||0
11335569|NCT02863263|12533032|FG000|STARTED|Overall Study||3
11335570|NCT02863263|12533033|FG001|STARTED|Overall Study||2
11335571|NCT02863263|12533032|FG000|COMPLETED|Overall Study||2
11335572|NCT02863263|12533033|FG001|COMPLETED|Overall Study||1
11335573|NCT02863263|12533032|FG000|NOT COMPLETED|Overall Study||1
11335574|NCT02863263|12533033|FG001|NOT COMPLETED|Overall Study||1
11335575|NCT02863289|12533039|FG000|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118
11335576|NCT02863289|12533039|FG000|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35
11335577|NCT02863289|12533039|FG000|NOT COMPLETED|Overall Study||83
11335578|NCT02863354|12533046|FG000|STARTED|Year 1||23
11335579|NCT02863354|12533047|FG001|STARTED|Year 1||20
11335580|NCT02863354|12533046|FG000|COMPLETED|Year 1||19
11335581|NCT02863354|12533047|FG001|COMPLETED|Year 1||18
11335582|NCT02863354|12533046|FG000|NOT COMPLETED|Year 1||4
11038413|NCT00899470|12218387|FG002|STARTED|Fourth Therapy||6
11038414|NCT00899470|12218388|FG003|STARTED|Fourth Therapy||6
11038415|NCT00899470|12218385|FG000|COMPLETED|Fourth Therapy||6
11038416|NCT00899470|12218386|FG001|COMPLETED|Fourth Therapy||6
11038417|NCT00899470|12218387|FG002|COMPLETED|Fourth Therapy||6
11038418|NCT00899470|12218388|FG003|COMPLETED|Fourth Therapy||6
11038419|NCT00899470|12218385|FG000|NOT COMPLETED|Fourth Therapy||0
11038420|NCT00899470|12218386|FG001|NOT COMPLETED|Fourth Therapy||0
11038421|NCT00899470|12218387|FG002|NOT COMPLETED|Fourth Therapy||0
11038422|NCT00899470|12218388|FG003|NOT COMPLETED|Fourth Therapy||0
11038423|NCT00899548|12218403|FG000|STARTED|Overall Study||182
11038424|NCT00899548|12218403|FG000|COMPLETED|Overall Study||179
11038425|NCT00899548|12218403|FG000|NOT COMPLETED|Overall Study||3
11038426|NCT00899574|12218411|FG000|STARTED|Overall Study||10
11038427|NCT00899574|12218411|FG000|COMPLETED|Overall Study||10
11038428|NCT00899574|12218411|FG000|NOT COMPLETED|Overall Study||0
11038429|NCT00899600|12218417|FG000|STARTED|Overall Study||50
11038430|NCT00899600|12218418|FG001|STARTED|Overall Study||52
11038431|NCT00899600|12218417|FG000|COMPLETED|Overall Study||50
11038432|NCT00899600|12218418|FG001|COMPLETED|Overall Study||52
11038433|NCT00899600|12218417|FG000|NOT COMPLETED|Overall Study||0
11038434|NCT00899600|12218418|FG001|NOT COMPLETED|Overall Study||0
11038435|NCT00899678|12218427|FG000|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
11038436|NCT00899678|12218428|FG001|STARTED|Induction Period (Weeks 0 to 6)||37
11038437|NCT00899678|12218429|FG002|STARTED|Induction Period (Weeks 0 to 6)||35
11038438|NCT00899678|12218427|FG000|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
11038439|NCT00899678|12218428|FG001|COMPLETED|Induction Period (Weeks 0 to 6)||37
11038440|NCT00899678|12218429|FG002|COMPLETED|Induction Period (Weeks 0 to 6)||35
11038441|NCT00899678|12218427|FG000|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
11038442|NCT00899678|12218428|FG001|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
11038443|NCT00899678|12218429|FG002|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
11038444|NCT00899678|12218427|FG000|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
11038445|NCT00899678|12218428|FG001|STARTED|Maintenance Period (Weeks 8 to 62)||37
11038446|NCT00899678|12218429|FG002|STARTED|Maintenance Period (Weeks 8 to 62)||35
11335583|NCT02863354|12533047|FG001|NOT COMPLETED|Year 1||2
11335584|NCT02863354|12533046|FG000|STARTED|Year 2||19
11335585|NCT02863354|12533047|FG001|STARTED|Year 2||18
11335586|NCT02863354|12533046|FG000|COMPLETED|Year 2||17
11038447|NCT00899678|12218427|FG000|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
11038448|NCT00899678|12218428|FG001|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
11038449|NCT00899678|12218429|FG002|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
11038450|NCT00899678|12218427|FG000|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
11038451|NCT00899678|12218428|FG001|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
11038452|NCT00899678|12218429|FG002|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
11038453|NCT00899717|12218439|FG000|STARTED|Overall Study||10
11038454|NCT00899717|12218440|FG001|STARTED|Overall Study||11
11038455|NCT00899717|12218439|FG000|COMPLETED|Overall Study||10
11038456|NCT00899717|12218440|FG001|COMPLETED|Overall Study||11
11038457|NCT00899717|12218439|FG000|NOT COMPLETED|Overall Study||0
11038458|NCT00899717|12218440|FG001|NOT COMPLETED|Overall Study||0
11038459|NCT00899847|12218452|FG000|STARTED|Overall Study||9
11038460|NCT00899847|12218452|FG000|COMPLETED|Overall Study||7
11038461|NCT00899847|12218452|FG000|NOT COMPLETED|Overall Study||2
11057679|NCT00999167|12239367|FG002|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
11057680|NCT00999466|12239380|FG000|STARTED|Pilot Part||6
11057681|NCT00999466|12239381|FG001|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
11057682|NCT00999466|12239382|FG002|STARTED|Pilot Part||3
11057683|NCT00999466|12239380|FG000|COMPLETED|Pilot Part||6
11057684|NCT00999466|12239381|FG001|COMPLETED|Pilot Part||0
11057685|NCT00999466|12239382|FG002|COMPLETED|Pilot Part||3
11057686|NCT00999466|12239380|FG000|NOT COMPLETED|Pilot Part||0
11057687|NCT00999466|12239381|FG001|NOT COMPLETED|Pilot Part||0
11057688|NCT00999466|12239382|FG002|NOT COMPLETED|Pilot Part||0
11057689|NCT00999466|12239380|FG000|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
11057690|NCT00999466|12239381|FG001|STARTED|Main Part||26
11057691|NCT00999466|12239382|FG002|STARTED|Main Part||25
11057692|NCT00999466|12239380|FG000|COMPLETED|Main Part||0
11057693|NCT00999466|12239381|FG001|COMPLETED|Main Part||22
11057694|NCT00999466|12239382|FG002|COMPLETED|Main Part||21
11057695|NCT00999466|12239380|FG000|NOT COMPLETED|Main Part||0
11057696|NCT00999466|12239381|FG001|NOT COMPLETED|Main Part||4
11057697|NCT00999466|12239382|FG002|NOT COMPLETED|Main Part||4
11057698|NCT00999518|12239395|FG000|STARTED|Overall Study||43
11057699|NCT00999518|12239396|FG001|STARTED|Overall Study||42
11057700|NCT00999518|12239397|FG002|STARTED|Overall Study||39
11057701|NCT00999518|12239398|FG003|STARTED|Overall Study||40
11057702|NCT00999518|12239399|FG004|STARTED|Overall Study||41
11057703|NCT00999518|12239395|FG000|Treated|Overall Study||42
11057704|NCT00999518|12239396|FG001|Treated|Overall Study||41
11057705|NCT00999518|12239397|FG002|Treated|Overall Study||37
11057706|NCT00999518|12239398|FG003|Treated|Overall Study||40
11057707|NCT00999518|12239399|FG004|Treated|Overall Study||40
11057708|NCT00999518|12239395|FG000|COMPLETED|Overall Study||19
11057709|NCT00999518|12239396|FG001|COMPLETED|Overall Study||17
11057710|NCT00999518|12239397|FG002|COMPLETED|Overall Study||17
11057711|NCT00999518|12239398|FG003|COMPLETED|Overall Study||18
11057712|NCT00999518|12239399|FG004|COMPLETED|Overall Study||17
11057713|NCT00999518|12239395|FG000|NOT COMPLETED|Overall Study||24
11057714|NCT00999518|12239396|FG001|NOT COMPLETED|Overall Study||25
11057715|NCT00999518|12239397|FG002|NOT COMPLETED|Overall Study||22
11057716|NCT00999518|12239398|FG003|NOT COMPLETED|Overall Study||22
11057717|NCT00999518|12239399|FG004|NOT COMPLETED|Overall Study||24
11057718|NCT00999544|12239415|FG000|STARTED|Overall Study||9
11057719|NCT00999544|12239415|FG000|COMPLETED|Overall Study||8
11057720|NCT00999544|12239415|FG000|NOT COMPLETED|Overall Study||1
11057721|NCT00999596|12239448|FG000|STARTED|Overall Study||107
11057722|NCT00999596|12239448|FG000|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
11057723|NCT00999596|12239448|FG000|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
11057724|NCT00999596|12239448|FG000|NOT COMPLETED|Overall Study||101
11057725|NCT00999661|12239453|FG000|STARTED|Overall Study||231
11057726|NCT00999661|12239453|FG000|COMPLETED|Overall Study||161
11057727|NCT00999661|12239453|FG000|NOT COMPLETED|Overall Study||70
11057728|NCT00999687|12239457|FG000|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
11057729|NCT00999687|12239457|FG000|COMPLETED|First Intervention||30
11057730|NCT00999687|12239457|FG000|NOT COMPLETED|First Intervention||1
11057731|NCT00999687|12239457|FG000|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
11057732|NCT00999687|12239457|FG000|COMPLETED|Second Intervention||27
11057733|NCT00999687|12239457|FG000|NOT COMPLETED|Second Intervention||3
11057734|NCT00999713|12239465|FG000|STARTED|Overall Study||26
11057735|NCT00999713|12239466|FG001|STARTED|Overall Study||17
11057736|NCT00999713|12239465|FG000|COMPLETED|Overall Study||24
11057737|NCT00999713|12239466|FG001|COMPLETED|Overall Study||17
11057738|NCT00999713|12239465|FG000|NOT COMPLETED|Overall Study||2
11057739|NCT00999713|12239466|FG001|NOT COMPLETED|Overall Study||0
11057740|NCT00999830|12239474|FG000|STARTED|Overall Study||14
11057741|NCT00999830|12239475|FG001|STARTED|Overall Study||13
11057742|NCT00999830|12239474|FG000|COMPLETED|Overall Study||14
11057743|NCT00999830|12239475|FG001|COMPLETED|Overall Study||13
11057744|NCT00999830|12239474|FG000|NOT COMPLETED|Overall Study||0
11057745|NCT00999830|12239475|FG001|NOT COMPLETED|Overall Study||0
11057746|NCT00999908|12239481|FG000|STARTED|Treatment Period 1||19
11057747|NCT00999908|12239482|FG001|STARTED|Treatment Period 1||16
11057748|NCT00999908|12239483|FG002|STARTED|Treatment Period 1||19
11057749|NCT00999908|12239481|FG000|COMPLETED|Treatment Period 1||17
11038462|NCT00900029|12218463|FG000|STARTED|Overall Study||38
11038463|NCT00900029|12218464|FG001|STARTED|Overall Study||41
11038464|NCT00900029|12218465|FG002|STARTED|Overall Study||41
11038465|NCT00900029|12218466|FG003|STARTED|Overall Study||42
11038466|NCT00900029|12218467|FG004|STARTED|Overall Study||44
11038467|NCT00900029|12218463|FG000|COMPLETED|Overall Study||35
11038468|NCT00900029|12218464|FG001|COMPLETED|Overall Study||37
11038469|NCT00900029|12218465|FG002|COMPLETED|Overall Study||38
11038470|NCT00900029|12218466|FG003|COMPLETED|Overall Study||35
11038471|NCT00900029|12218467|FG004|COMPLETED|Overall Study||38
11038472|NCT00900029|12218463|FG000|NOT COMPLETED|Overall Study||3
11038473|NCT00900029|12218464|FG001|NOT COMPLETED|Overall Study||4
11038474|NCT00900029|12218465|FG002|NOT COMPLETED|Overall Study||3
11038475|NCT00900029|12218466|FG003|NOT COMPLETED|Overall Study||7
11038476|NCT00900029|12218467|FG004|NOT COMPLETED|Overall Study||6
11038477|NCT00900146|12218484|FG000|STARTED|Dose Finding: Period II (4 Months)||93
11038478|NCT00900146|12218485|FG001|STARTED|Dose Finding: Period II (4 Months)||95
11038479|NCT00900146|12218486|FG002|STARTED|Dose Finding: Period II (4 Months)||92
11038480|NCT00900146|12218487|FG003|STARTED|Dose Finding: Period II (4 Months)||92
11038481|NCT00900146|12218488|FG004|STARTED|Dose Finding: Period II (4 Months)||179
11038482|NCT00900146|12218484|FG000|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
11038483|NCT00900146|12218485|FG001|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
11038484|NCT00900146|12218486|FG002|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
11038485|NCT00900146|12218487|FG003|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
11038486|NCT00900146|12218488|FG004|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
11038487|NCT00900146|12218484|FG000|COMPLETED|Dose Finding: Period II (4 Months)||88
11038488|NCT00900146|12218485|FG001|COMPLETED|Dose Finding: Period II (4 Months)||93
11038489|NCT00900146|12218486|FG002|COMPLETED|Dose Finding: Period II (4 Months)||87
11038490|NCT00900146|12218487|FG003|COMPLETED|Dose Finding: Period II (4 Months)||90
11038491|NCT00900146|12218488|FG004|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
11038492|NCT00900146|12218484|FG000|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
11038493|NCT00900146|12218485|FG001|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
11038494|NCT00900146|12218486|FG002|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
11038495|NCT00900146|12218487|FG003|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
11038496|NCT00900146|12218488|FG004|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
11038497|NCT00900146|12218484|FG000|STARTED|Intermediate: Period III||87
11038498|NCT00900146|12218485|FG001|STARTED|Intermediate: Period III||93
11038499|NCT00900146|12218486|FG002|STARTED|Intermediate: Period III||84
11038500|NCT00900146|12218487|FG003|STARTED|Intermediate: Period III||90
11038501|NCT00900146|12218488|FG004|STARTED|Intermediate: Period III||167
11038502|NCT00900146|12218484|FG000|Safety Set|Intermediate: Period III||86
11038503|NCT00900146|12218485|FG001|Safety Set|Intermediate: Period III||92
11038504|NCT00900146|12218486|FG002|Safety Set|Intermediate: Period III||84
11038505|NCT00900146|12218487|FG003|Safety Set|Intermediate: Period III||90
11038506|NCT00900146|12218488|FG004|Safety Set|Intermediate: Period III||166
11038507|NCT00900146|12218484|FG000|COMPLETED|Intermediate: Period III||0
11038508|NCT00900146|12218485|FG001|COMPLETED|Intermediate: Period III||0
11038509|NCT00900146|12218486|FG002|COMPLETED|Intermediate: Period III||0
11038510|NCT00900146|12218487|FG003|COMPLETED|Intermediate: Period III||0
11038511|NCT00900146|12218488|FG004|COMPLETED|Intermediate: Period III||0
11038512|NCT00900146|12218484|FG000|NOT COMPLETED|Intermediate: Period III||87
11038513|NCT00900146|12218485|FG001|NOT COMPLETED|Intermediate: Period III||93
11038514|NCT00900146|12218486|FG002|NOT COMPLETED|Intermediate: Period III||84
11038515|NCT00900146|12218487|FG003|NOT COMPLETED|Intermediate: Period III||90
11038516|NCT00900146|12218488|FG004|NOT COMPLETED|Intermediate: Period III||167
11038517|NCT00900159|12218502|FG000|STARTED|First Intervention||11
11038518|NCT00900159|12218503|FG001|STARTED|First Intervention||13
11038519|NCT00900159|12218502|FG000|COMPLETED|First Intervention||11
11038520|NCT00900159|12218503|FG001|COMPLETED|First Intervention||13
11038521|NCT00900159|12218502|FG000|NOT COMPLETED|First Intervention||0
11038522|NCT00900159|12218503|FG001|NOT COMPLETED|First Intervention||0
11038523|NCT00900159|12218502|FG000|STARTED|Washout||11
11038524|NCT00900159|12218503|FG001|STARTED|Washout||13
11038525|NCT00900159|12218502|FG000|COMPLETED|Washout||11
11038526|NCT00900159|12218503|FG001|COMPLETED|Washout||13
11038527|NCT00900159|12218502|FG000|NOT COMPLETED|Washout||0
11335587|NCT02863354|12533047|FG001|COMPLETED|Year 2||16
11335588|NCT02863354|12533046|FG000|NOT COMPLETED|Year 2||2
11335589|NCT02863354|12533047|FG001|NOT COMPLETED|Year 2||2
11343851|NCT02956486|12541124|FG002|NOT COMPLETED|Core Phase||0
11343852|NCT02956486|12541122|FG000|STARTED|Extension Phase||0
11343853|NCT02956486|12541123|FG001|STARTED|Extension Phase||0
11343997|NCT02958527|12541302|FG000|NOT COMPLETED|Overall Study||12
11038528|NCT00900159|12218503|FG001|NOT COMPLETED|Washout||0
11038529|NCT00900159|12218502|FG000|STARTED|Second Intervention||11
11038530|NCT00900159|12218503|FG001|STARTED|Second Intervention||13
11038531|NCT00900159|12218502|FG000|COMPLETED|Second Intervention||10
11038532|NCT00900159|12218503|FG001|COMPLETED|Second Intervention||13
11335590|NCT02863575|12533056|FG000|STARTED|Overall Study||161
11335591|NCT02863575|12533057|FG001|STARTED|Overall Study||161
11038533|NCT00900159|12218502|FG000|NOT COMPLETED|Second Intervention||1
11038534|NCT00900159|12218503|FG001|NOT COMPLETED|Second Intervention||0
11038535|NCT00900237|12218511|FG000|STARTED|Overall Study||7
11038536|NCT00900237|12218512|FG001|STARTED|Overall Study||7
11038537|NCT00900237|12218511|FG000|COMPLETED|Overall Study||7
11038538|NCT00900237|12218512|FG001|COMPLETED|Overall Study||7
11038539|NCT00900237|12218511|FG000|NOT COMPLETED|Overall Study||0
11038540|NCT00900237|12218512|FG001|NOT COMPLETED|Overall Study||0
11038541|NCT00900562|12218520|FG000|STARTED|Overall Study||12
11038542|NCT00900562|12218521|FG001|STARTED|Overall Study||7
11038543|NCT00900562|12218520|FG000|COMPLETED|Overall Study||0
11038544|NCT00900562|12218521|FG001|COMPLETED|Overall Study||0
11038545|NCT00900562|12218520|FG000|NOT COMPLETED|Overall Study||12
11038546|NCT00900562|12218521|FG001|NOT COMPLETED|Overall Study||7
11038547|NCT00900601|12218528|FG000|STARTED|Overall Study||9
11038548|NCT00900601|12218528|FG000|COMPLETED|Overall Study||8
11038549|NCT00900601|12218528|FG000|NOT COMPLETED|Overall Study||1
11038550|NCT00900627|12218538|FG000|STARTED|Overall Study||6
11038551|NCT00900627|12218539|FG001|STARTED|Overall Study||2
11038552|NCT00900627|12218540|FG002|STARTED|Overall Study||6
11038553|NCT00900627|12218541|FG003|STARTED|Overall Study||6
11038554|NCT00900627|12218542|FG004|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
11038555|NCT00900627|12218543|FG005|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
11038556|NCT00900627|12218538|FG000|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
11038557|NCT00900627|12218539|FG001|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
11038558|NCT00900627|12218540|FG002|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
11038559|NCT00900627|12218541|FG003|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
11038560|NCT00900627|12218542|FG004|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
11038561|NCT00900627|12218543|FG005|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
11038562|NCT00900627|12218538|FG000|NOT COMPLETED|Overall Study||6
11038563|NCT00900627|12218539|FG001|NOT COMPLETED|Overall Study||2
11038564|NCT00900627|12218540|FG002|NOT COMPLETED|Overall Study||6
11038565|NCT00900627|12218541|FG003|NOT COMPLETED|Overall Study||6
11038566|NCT00900627|12218542|FG004|NOT COMPLETED|Overall Study||29
11038567|NCT00900627|12218543|FG005|NOT COMPLETED|Overall Study||26
11038568|NCT00900666|12218559|FG000|STARTED|Overall Study||10
11038569|NCT00900666|12218560|FG001|STARTED|Overall Study||9
11038570|NCT00900666|12218559|FG000|COMPLETED|Overall Study||10
11038571|NCT00900666|12218560|FG001|COMPLETED|Overall Study||9
11038572|NCT00900666|12218559|FG000|NOT COMPLETED|Overall Study||0
11038573|NCT00900666|12218560|FG001|NOT COMPLETED|Overall Study||0
11038574|NCT00900731|12218568|FG000|STARTED|Overall Study|Randomized participants|797
11038575|NCT00900731|12218569|FG001|STARTED|Overall Study||801
11038576|NCT00900731|12218568|FG000|Safety Set: Received Study Drug|Overall Study||794
11038577|NCT00900731|12218569|FG001|Safety Set: Received Study Drug|Overall Study||799
11038578|NCT00900731|12218568|FG000|COMPLETED|Overall Study||737
11038579|NCT00900731|12218569|FG001|COMPLETED|Overall Study||740
11038580|NCT00900731|12218568|FG000|NOT COMPLETED|Overall Study||60
11038581|NCT00900731|12218569|FG001|NOT COMPLETED|Overall Study||61
11335592|NCT02863575|12533058|FG002|STARTED|Overall Study||52
11335593|NCT02863575|12533056|FG000|COMPLETED|Overall Study||160
11335594|NCT02863575|12533057|FG001|COMPLETED|Overall Study||159
11335595|NCT02863575|12533058|FG002|COMPLETED|Overall Study||51
11335596|NCT02863575|12533056|FG000|NOT COMPLETED|Overall Study||1
11335597|NCT02863575|12533057|FG001|NOT COMPLETED|Overall Study||2
11335598|NCT02863575|12533058|FG002|NOT COMPLETED|Overall Study||1
11335599|NCT02864069|12533069|FG000|STARTED|Overall Study||18
11335600|NCT02864069|12533070|FG001|STARTED|Overall Study||13
11335601|NCT02864069|12533071|FG002|STARTED|Overall Study||21
11335602|NCT02864069|12533069|FG000|COMPLETED|Overall Study||12
11335603|NCT02864069|12533070|FG001|COMPLETED|Overall Study||5
11335604|NCT02864069|12533071|FG002|COMPLETED|Overall Study||13
11335605|NCT02864069|12533069|FG000|NOT COMPLETED|Overall Study||6
11335606|NCT02864069|12533070|FG001|NOT COMPLETED|Overall Study||8
11335607|NCT02864069|12533071|FG002|NOT COMPLETED|Overall Study||8
11335608|NCT02864082|12533081|FG000|STARTED|Overall Study||10
11335609|NCT02864082|12533082|FG001|STARTED|Overall Study||9
11335610|NCT02864082|12533081|FG000|COMPLETED|Overall Study||7
11335611|NCT02864082|12533082|FG001|COMPLETED|Overall Study||5
11335612|NCT02864082|12533081|FG000|NOT COMPLETED|Overall Study||3
11335613|NCT02864082|12533082|FG001|NOT COMPLETED|Overall Study||4
11335614|NCT02864316|12533104|FG000|STARTED|Overall Study||2
11335615|NCT02864316|12533105|FG001|STARTED|Overall Study||2
11335616|NCT02864316|12533104|FG000|COMPLETED|Overall Study||0
11335617|NCT02864316|12533105|FG001|COMPLETED|Overall Study||0
11335618|NCT02864316|12533104|FG000|NOT COMPLETED|Overall Study||2
11335619|NCT02864316|12533105|FG001|NOT COMPLETED|Overall Study||2
11038582|NCT00900757|12218575|FG000|STARTED|Overall Study||57
11335620|NCT02864342|12533113|FG000|STARTED|Overall Study||70
11038583|NCT00900757|12218575|FG000|COMPLETED|Overall Study||38
11038584|NCT00900757|12218575|FG000|NOT COMPLETED|Overall Study||19
11038585|NCT00900796|12218579|FG000|STARTED|Phase 1||132
11038586|NCT00900796|12218579|FG000|COMPLETED|Phase 1||121
11038587|NCT00900796|12218579|FG000|NOT COMPLETED|Phase 1||11
11038588|NCT00900796|12218579|FG000|STARTED|Between Phase 1 and Phase 2||121
11038589|NCT00900796|12218579|FG000|COMPLETED|Between Phase 1 and Phase 2||11
11038590|NCT00900796|12218579|FG000|NOT COMPLETED|Between Phase 1 and Phase 2||110
11038591|NCT00900796|12218579|FG000|STARTED|Phase 2||11
11038592|NCT00900796|12218579|FG000|COMPLETED|Phase 2||6
11038593|NCT00900796|12218579|FG000|NOT COMPLETED|Phase 2||5
11038594|NCT00900822|12218584|FG000|STARTED|9 Months Histological Evaluation||11
11038595|NCT00900822|12218584|FG000|COMPLETED|9 Months Histological Evaluation||11
11038596|NCT00900822|12218584|FG000|NOT COMPLETED|9 Months Histological Evaluation||0
11038597|NCT00900822|12218584|FG000|STARTED|12 Months Clinical Evaluation||11
11038598|NCT00900822|12218584|FG000|COMPLETED|12 Months Clinical Evaluation||11
11038599|NCT00900822|12218584|FG000|NOT COMPLETED|12 Months Clinical Evaluation||0
11038600|NCT00901017|12218591|FG000|STARTED|Overall Study||14
11038601|NCT00901017|12218591|FG000|COMPLETED|Overall Study||14
11038602|NCT00901017|12218591|FG000|NOT COMPLETED|Overall Study||0
11038603|NCT00901186|12218600|FG000|STARTED|Overall Study||40
11038604|NCT00901186|12218601|FG001|STARTED|Overall Study||43
11038605|NCT00901186|12218600|FG000|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
11038606|NCT00901186|12218601|FG001|Safety Set|Overall Study||43
11038607|NCT00901186|12218600|FG000|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
11038608|NCT00901186|12218601|FG001|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
11038609|NCT00901186|12218600|FG000|COMPLETED|Overall Study||31
11038610|NCT00901186|12218601|FG001|COMPLETED|Overall Study||32
11038611|NCT00901186|12218600|FG000|NOT COMPLETED|Overall Study||9
11038612|NCT00901186|12218601|FG001|NOT COMPLETED|Overall Study||11
11038613|NCT00901199|12218607|FG000|STARTED|Overall Study||22
11038614|NCT00901199|12218607|FG000|COMPLETED|Overall Study||18
11038615|NCT00901199|12218607|FG000|NOT COMPLETED|Overall Study||4
11038616|NCT00901225|12218611|FG000|STARTED|Overall Study||21
11038617|NCT00901225|12218611|FG000|COMPLETED|Overall Study||20
11038618|NCT00901225|12218611|FG000|NOT COMPLETED|Overall Study||1
11038619|NCT00901316|12218617|FG000|STARTED|Overall Study||492
11038620|NCT00901316|12218618|FG001|STARTED|Overall Study||495
11038621|NCT00901316|12218617|FG000|COMPLETED|Overall Study||492
11038622|NCT00901316|12218618|FG001|COMPLETED|Overall Study||495
11038623|NCT00901316|12218617|FG000|NOT COMPLETED|Overall Study||0
11038624|NCT00901316|12218618|FG001|NOT COMPLETED|Overall Study||0
11038625|NCT00901342|12218624|FG000|STARTED|Overall Study||104
11038626|NCT00901342|12218624|FG000|Received at Least 1 Infusion|Overall Study||98
11038627|NCT00901342|12218624|FG000|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
11038628|NCT00901342|12218624|FG000|NOT COMPLETED|Overall Study||15
11038629|NCT00901394|12218631|FG000|STARTED|Overall Study||21
11038630|NCT00901394|12218632|FG001|STARTED|Overall Study||20
11038631|NCT00901394|12218633|FG002|STARTED|Overall Study||22
11038632|NCT00901394|12218631|FG000|COMPLETED|Overall Study||20
11038633|NCT00901394|12218632|FG001|COMPLETED|Overall Study||19
11038634|NCT00901394|12218633|FG002|COMPLETED|Overall Study||20
11038635|NCT00901394|12218631|FG000|NOT COMPLETED|Overall Study||1
11038636|NCT00901394|12218632|FG001|NOT COMPLETED|Overall Study||1
11038637|NCT00901394|12218633|FG002|NOT COMPLETED|Overall Study||2
11038638|NCT00901459|12218641|FG000|STARTED|Overall Study||21
11038639|NCT00901459|12218641|FG000|COMPLETED|Overall Study||15
11038640|NCT00901459|12218641|FG000|NOT COMPLETED|Overall Study||6
11038641|NCT00901485|12218652|FG000|STARTED|Overall Study||10
11038642|NCT00901485|12218653|FG001|STARTED|Overall Study||13
11038643|NCT00901485|12218652|FG000|COMPLETED|Overall Study||9
11038644|NCT00901485|12218653|FG001|COMPLETED|Overall Study||9
11038645|NCT00901485|12218652|FG000|NOT COMPLETED|Overall Study||1
11038646|NCT00901485|12218653|FG001|NOT COMPLETED|Overall Study||4
11038647|NCT00901576|12218665|FG000|STARTED|First Intervention||6
11038648|NCT00901576|12218666|FG001|STARTED|First Intervention||7
11038649|NCT00901576|12218667|FG002|STARTED|First Intervention||7
11038650|NCT00901576|12218668|FG003|STARTED|First Intervention||6
11038651|NCT00901576|12218669|FG004|STARTED|First Intervention||6
11038652|NCT00901576|12218670|FG005|STARTED|First Intervention||6
11038653|NCT00901576|12218665|FG000|COMPLETED|First Intervention||6
11038654|NCT00901576|12218666|FG001|COMPLETED|First Intervention||7
11038655|NCT00901576|12218667|FG002|COMPLETED|First Intervention||7
11038656|NCT00901576|12218668|FG003|COMPLETED|First Intervention||6
11038657|NCT00901576|12218669|FG004|COMPLETED|First Intervention||6
11038658|NCT00901576|12218670|FG005|COMPLETED|First Intervention||6
11038659|NCT00901576|12218665|FG000|NOT COMPLETED|First Intervention||0
11038660|NCT00901576|12218666|FG001|NOT COMPLETED|First Intervention||0
11038661|NCT00901576|12218667|FG002|NOT COMPLETED|First Intervention||0
11038662|NCT00901576|12218668|FG003|NOT COMPLETED|First Intervention||0
11038663|NCT00901576|12218669|FG004|NOT COMPLETED|First Intervention||0
11038664|NCT00901576|12218670|FG005|NOT COMPLETED|First Intervention||0
11038665|NCT00901576|12218665|FG000|STARTED|Washout||6
11038666|NCT00901576|12218666|FG001|STARTED|Washout||7
11038667|NCT00901576|12218667|FG002|STARTED|Washout||7
11038668|NCT00901576|12218668|FG003|STARTED|Washout||6
11038669|NCT00901576|12218669|FG004|STARTED|Washout||6
11038670|NCT00901576|12218670|FG005|STARTED|Washout||6
11038671|NCT00901576|12218665|FG000|COMPLETED|Washout||6
11038672|NCT00901576|12218666|FG001|COMPLETED|Washout||7
11038673|NCT00901576|12218667|FG002|COMPLETED|Washout||7
11038674|NCT00901576|12218668|FG003|COMPLETED|Washout||6
11038675|NCT00901576|12218669|FG004|COMPLETED|Washout||6
11038676|NCT00901576|12218670|FG005|COMPLETED|Washout||6
11038677|NCT00901576|12218665|FG000|NOT COMPLETED|Washout||0
11038678|NCT00901576|12218666|FG001|NOT COMPLETED|Washout||0
11038679|NCT00901576|12218667|FG002|NOT COMPLETED|Washout||0
11038680|NCT00901576|12218668|FG003|NOT COMPLETED|Washout||0
11038681|NCT00901576|12218669|FG004|NOT COMPLETED|Washout||0
11038682|NCT00901576|12218670|FG005|NOT COMPLETED|Washout||0
11038683|NCT00901576|12218665|FG000|STARTED|Second Intervention||6
11038684|NCT00901576|12218666|FG001|STARTED|Second Intervention||7
11038685|NCT00901576|12218667|FG002|STARTED|Second Intervention||7
11038686|NCT00901576|12218668|FG003|STARTED|Second Intervention||6
11038687|NCT00901576|12218669|FG004|STARTED|Second Intervention||6
11038688|NCT00901576|12218670|FG005|STARTED|Second Intervention||6
11038689|NCT00901576|12218665|FG000|COMPLETED|Second Intervention||5
11038690|NCT00901576|12218666|FG001|COMPLETED|Second Intervention||7
11038691|NCT00901576|12218667|FG002|COMPLETED|Second Intervention||7
11038692|NCT00901576|12218668|FG003|COMPLETED|Second Intervention||5
11038693|NCT00901576|12218669|FG004|COMPLETED|Second Intervention||6
11038694|NCT00901576|12218670|FG005|COMPLETED|Second Intervention||5
11038695|NCT00901576|12218665|FG000|NOT COMPLETED|Second Intervention||1
11038696|NCT00901576|12218666|FG001|NOT COMPLETED|Second Intervention||0
11038697|NCT00901576|12218667|FG002|NOT COMPLETED|Second Intervention||0
11038698|NCT00901576|12218668|FG003|NOT COMPLETED|Second Intervention||1
11038699|NCT00901576|12218669|FG004|NOT COMPLETED|Second Intervention||0
11038700|NCT00901576|12218670|FG005|NOT COMPLETED|Second Intervention||1
11038701|NCT00901576|12218665|FG000|STARTED|Washout||5
11038702|NCT00901576|12218666|FG001|STARTED|Washout||7
11038703|NCT00901576|12218667|FG002|STARTED|Washout||7
11038704|NCT00901576|12218668|FG003|STARTED|Washout||5
11038705|NCT00901576|12218669|FG004|STARTED|Washout||6
11038706|NCT00901576|12218670|FG005|STARTED|Washout||5
11038707|NCT00901576|12218665|FG000|COMPLETED|Washout||5
11038708|NCT00901576|12218666|FG001|COMPLETED|Washout||7
11038709|NCT00901576|12218667|FG002|COMPLETED|Washout||7
11038710|NCT00901576|12218668|FG003|COMPLETED|Washout||5
11038711|NCT00901576|12218669|FG004|COMPLETED|Washout||6
11038712|NCT00901576|12218670|FG005|COMPLETED|Washout||5
11038713|NCT00901576|12218665|FG000|NOT COMPLETED|Washout||0
11038714|NCT00901576|12218666|FG001|NOT COMPLETED|Washout||0
11038715|NCT00901576|12218667|FG002|NOT COMPLETED|Washout||0
11038716|NCT00901576|12218668|FG003|NOT COMPLETED|Washout||0
11038717|NCT00901576|12218669|FG004|NOT COMPLETED|Washout||0
11038718|NCT00901576|12218670|FG005|NOT COMPLETED|Washout||0
11038719|NCT00901576|12218665|FG000|STARTED|Third Intervention||5
11038720|NCT00901576|12218666|FG001|STARTED|Third Intervention||7
11038721|NCT00901576|12218667|FG002|STARTED|Third Intervention||7
11038722|NCT00901576|12218668|FG003|STARTED|Third Intervention||5
11038723|NCT00901576|12218669|FG004|STARTED|Third Intervention||6
11038724|NCT00901576|12218670|FG005|STARTED|Third Intervention||5
11038725|NCT00901576|12218665|FG000|COMPLETED|Third Intervention||5
11038726|NCT00901576|12218666|FG001|COMPLETED|Third Intervention||7
11038727|NCT00901576|12218667|FG002|COMPLETED|Third Intervention||7
11038728|NCT00901576|12218668|FG003|COMPLETED|Third Intervention||5
11038729|NCT00901576|12218669|FG004|COMPLETED|Third Intervention||6
11038730|NCT00901576|12218670|FG005|COMPLETED|Third Intervention||5
11038731|NCT00901576|12218665|FG000|NOT COMPLETED|Third Intervention||0
11038732|NCT00901576|12218666|FG001|NOT COMPLETED|Third Intervention||0
11038733|NCT00901576|12218667|FG002|NOT COMPLETED|Third Intervention||0
11038734|NCT00901576|12218668|FG003|NOT COMPLETED|Third Intervention||0
11038735|NCT00901576|12218669|FG004|NOT COMPLETED|Third Intervention||0
11038736|NCT00901576|12218670|FG005|NOT COMPLETED|Third Intervention||0
11038737|NCT00901628|12218680|FG000|STARTED|Overall Study||49
11038738|NCT00901628|12218681|FG001|STARTED|Overall Study||52
11038739|NCT00901628|12218680|FG000|COMPLETED|Overall Study||45
11038740|NCT00901628|12218681|FG001|COMPLETED|Overall Study||42
11038741|NCT00901628|12218680|FG000|NOT COMPLETED|Overall Study||4
11038742|NCT00901628|12218681|FG001|NOT COMPLETED|Overall Study||10
11038743|NCT00901901|12218689|FG000|STARTED|Treatment Period||362
11038744|NCT00901901|12218690|FG001|STARTED|Treatment Period||358
11038745|NCT00901901|12218689|FG000|Participants Received Treatment|Treatment Period||362
11038746|NCT00901901|12218690|FG001|Participants Received Treatment|Treatment Period||355
11038747|NCT00901901|12218689|FG000|COMPLETED|Treatment Period||193
11038748|NCT00901901|12218690|FG001|COMPLETED|Treatment Period||181
11038749|NCT00901901|12218689|FG000|NOT COMPLETED|Treatment Period||169
11038750|NCT00901901|12218690|FG001|NOT COMPLETED|Treatment Period||177
11038751|NCT00901901|12218689|FG000|STARTED|Follow-up Period||340
11038752|NCT00901901|12218690|FG001|STARTED|Follow-up Period||341
11038753|NCT00901901|12218689|FG000|COMPLETED|Follow-up Period||0
11038754|NCT00901901|12218690|FG001|COMPLETED|Follow-up Period||0
11038755|NCT00901901|12218689|FG000|NOT COMPLETED|Follow-up Period||340
11038756|NCT00901901|12218690|FG001|NOT COMPLETED|Follow-up Period||341
11038757|NCT00901927|12218698|FG000|STARTED|Overall Study||14
11038758|NCT00901927|12218698|FG000|COMPLETED|Overall Study||8
11038759|NCT00901927|12218698|FG000|NOT COMPLETED|Overall Study||6
11038760|NCT00902018|12218705|FG000|STARTED|Overall Study||7
11038761|NCT00902018|12218706|FG001|STARTED|Overall Study||3
11038762|NCT00902018|12218707|FG002|STARTED|Overall Study||10
11038763|NCT00902018|12218705|FG000|COMPLETED|Overall Study||7
11038764|NCT00902018|12218706|FG001|COMPLETED|Overall Study||3
11038765|NCT00902018|12218707|FG002|COMPLETED|Overall Study||10
11038766|NCT00902018|12218705|FG000|NOT COMPLETED|Overall Study||0
11038767|NCT00902018|12218706|FG001|NOT COMPLETED|Overall Study||0
11038768|NCT00902018|12218707|FG002|NOT COMPLETED|Overall Study||0
11038769|NCT00902161|12218723|FG000|STARTED|Pre-study Washout/Propanolol Run-in||0
11038770|NCT00902161|12218724|FG001|STARTED|Pre-study Washout/Propanolol Run-in||0
11038771|NCT00902161|12218725|FG002|STARTED|Pre-study Washout/Propanolol Run-in||22
11038772|NCT00902161|12218723|FG000|COMPLETED|Pre-study Washout/Propanolol Run-in||0
11038773|NCT00902161|12218724|FG001|COMPLETED|Pre-study Washout/Propanolol Run-in||0
11038774|NCT00902161|12218725|FG002|COMPLETED|Pre-study Washout/Propanolol Run-in||22
11038775|NCT00902161|12218723|FG000|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
11038776|NCT00902161|12218724|FG001|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
11038777|NCT00902161|12218725|FG002|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
11038778|NCT00902161|12218723|FG000|STARTED|Period 1||12
11038779|NCT00902161|12218724|FG001|STARTED|Period 1||10
11038780|NCT00902161|12218725|FG002|STARTED|Period 1||0
11038781|NCT00902161|12218723|FG000|COMPLETED|Period 1||12
11038782|NCT00902161|12218724|FG001|COMPLETED|Period 1||10
11038783|NCT00902161|12218725|FG002|COMPLETED|Period 1||0
11038784|NCT00902161|12218723|FG000|NOT COMPLETED|Period 1||0
11038785|NCT00902161|12218724|FG001|NOT COMPLETED|Period 1||0
11038786|NCT00902161|12218725|FG002|NOT COMPLETED|Period 1||0
11038787|NCT00902161|12218723|FG000|STARTED|Post-clamp Washout||0
11038788|NCT00902161|12218724|FG001|STARTED|Post-clamp Washout||0
11038789|NCT00902161|12218725|FG002|STARTED|Post-clamp Washout||22
11038790|NCT00902161|12218723|FG000|COMPLETED|Post-clamp Washout||0
11038791|NCT00902161|12218724|FG001|COMPLETED|Post-clamp Washout||0
11335621|NCT02864342|12533114|FG001|STARTED|Overall Study||68
11335622|NCT02864342|12533113|FG000|Full Analysis Set (FAS)|Overall Study||70
11335623|NCT02864342|12533114|FG001|Full Analysis Set (FAS)|Overall Study||67
11335624|NCT02864342|12533113|FG000|COMPLETED|Overall Study||55
11335625|NCT02864342|12533114|FG001|COMPLETED|Overall Study||49
11335626|NCT02864342|12533113|FG000|NOT COMPLETED|Overall Study||15
11335627|NCT02864342|12533114|FG001|NOT COMPLETED|Overall Study||19
11335628|NCT02864355|12533123|FG000|STARTED|Overall Study||25
11335629|NCT02864355|12533124|FG001|STARTED|Overall Study||28
11335630|NCT02864355|12533123|FG000|COMPLETED|Overall Study||23
11038792|NCT00902161|12218725|FG002|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
11038793|NCT00902161|12218723|FG000|NOT COMPLETED|Post-clamp Washout||0
11335631|NCT02864355|12533124|FG001|COMPLETED|Overall Study||25
11335632|NCT02864355|12533123|FG000|NOT COMPLETED|Overall Study||2
11335633|NCT02864355|12533124|FG001|NOT COMPLETED|Overall Study||3
11335634|NCT02864381|12533132|FG000|STARTED|Overall Study||72
11335635|NCT02864381|12533133|FG001|STARTED|Overall Study||72
11335636|NCT02864381|12533132|FG000|COMPLETED|Overall Study||0
11335637|NCT02864381|12533133|FG001|COMPLETED|Overall Study||0
11038794|NCT00902161|12218724|FG001|NOT COMPLETED|Post-clamp Washout||0
11335638|NCT02864381|12533132|FG000|NOT COMPLETED|Overall Study||72
11038795|NCT00902161|12218725|FG002|NOT COMPLETED|Post-clamp Washout||0
11038796|NCT00902161|12218723|FG000|STARTED|Period 2||8
11038797|NCT00902161|12218724|FG001|STARTED|Period 2||9
11038798|NCT00902161|12218725|FG002|STARTED|Period 2||0
11038799|NCT00902161|12218723|FG000|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
11038800|NCT00902161|12218724|FG001|COMPLETED|Period 2||9
11038801|NCT00902161|12218725|FG002|COMPLETED|Period 2||0
11038802|NCT00902161|12218723|FG000|NOT COMPLETED|Period 2||0
11038803|NCT00902161|12218724|FG001|NOT COMPLETED|Period 2||0
11038804|NCT00902161|12218725|FG002|NOT COMPLETED|Period 2||0
11038805|NCT00902174|12218737|FG000|STARTED|Overall Study||103
11038806|NCT00902174|12218738|FG001|STARTED|Overall Study||99
11038807|NCT00902174|12218737|FG000|COMPLETED|Overall Study||69
11038808|NCT00902174|12218738|FG001|COMPLETED|Overall Study||81
11038809|NCT00902174|12218737|FG000|NOT COMPLETED|Overall Study||34
11038810|NCT00902174|12218738|FG001|NOT COMPLETED|Overall Study||18
11038811|NCT00902226|12218747|FG000|STARTED|Overall Study||30
11335639|NCT02864381|12533133|FG001|NOT COMPLETED|Overall Study||72
11038812|NCT00902226|12218747|FG000|COMPLETED|Overall Study||30
11038813|NCT00902226|12218747|FG000|NOT COMPLETED|Overall Study||0
11038814|NCT00902265|12218751|FG000|STARTED|Overall Study||138
11038815|NCT00902265|12218751|FG000|Participants Who Received Treatment|Overall Study||137
11038816|NCT00902265|12218751|FG000|COMPLETED|Overall Study||132
11038817|NCT00902265|12218751|FG000|NOT COMPLETED|Overall Study||6
11038818|NCT00902278|12218760|FG000|STARTED|Overall Study||54
11038819|NCT00902278|12218761|FG001|STARTED|Overall Study||36
11038820|NCT00902278|12218762|FG002|STARTED|Overall Study||54
11038821|NCT00902278|12218763|FG003|STARTED|Overall Study||12
11038822|NCT00902278|12218764|FG004|STARTED|Overall Study||37
11038823|NCT00902278|12218760|FG000|COMPLETED|Overall Study||50
11038824|NCT00902278|12218761|FG001|COMPLETED|Overall Study||34
11038825|NCT00902278|12218762|FG002|COMPLETED|Overall Study||49
11038826|NCT00902278|12218763|FG003|COMPLETED|Overall Study||12
11038827|NCT00902278|12218764|FG004|COMPLETED|Overall Study||35
11038828|NCT00902278|12218760|FG000|NOT COMPLETED|Overall Study||4
11038829|NCT00902278|12218761|FG001|NOT COMPLETED|Overall Study||2
11038830|NCT00902278|12218762|FG002|NOT COMPLETED|Overall Study||5
11038831|NCT00902278|12218763|FG003|NOT COMPLETED|Overall Study||0
11038832|NCT00902278|12218764|FG004|NOT COMPLETED|Overall Study||2
11038833|NCT00902304|12218779|FG000|STARTED|Overall Study||524
11038834|NCT00902304|12218780|FG001|STARTED|Overall Study||360
11038835|NCT00902304|12218781|FG002|STARTED|Overall Study||678
11038836|NCT00902304|12218779|FG000|COMPLETED|Overall Study||466
11038837|NCT00902304|12218780|FG001|COMPLETED|Overall Study||289
11038838|NCT00902304|12218781|FG002|COMPLETED|Overall Study||568
11038839|NCT00902304|12218779|FG000|NOT COMPLETED|Overall Study||58
11038840|NCT00902304|12218780|FG001|NOT COMPLETED|Overall Study||71
11038841|NCT00902304|12218781|FG002|NOT COMPLETED|Overall Study||110
11038842|NCT00902330|12218792|FG000|STARTED|Overall Study||81
11038843|NCT00902330|12218793|FG001|STARTED|Overall Study||80
11038844|NCT00902330|12218792|FG000|COMPLETED|Overall Study||77
11038845|NCT00902330|12218793|FG001|COMPLETED|Overall Study||75
11038846|NCT00902330|12218792|FG000|NOT COMPLETED|Overall Study||4
11038847|NCT00902330|12218793|FG001|NOT COMPLETED|Overall Study||5
11038848|NCT00902486|12218806|FG000|STARTED|Treatment Period (Weeks 0 Through 12)||31
11038849|NCT00902486|12218807|FG001|STARTED|Treatment Period (Weeks 0 Through 12)||0
11038850|NCT00902486|12218808|FG002|STARTED|Treatment Period (Weeks 0 Through 12)||0
11038851|NCT00902486|12218809|FG003|STARTED|Treatment Period (Weeks 0 Through 12)||32
11038852|NCT00902486|12218810|FG004|STARTED|Treatment Period (Weeks 0 Through 12)||32
11038853|NCT00902486|12218811|FG005|STARTED|Treatment Period (Weeks 0 Through 12)||32
11038854|NCT00902486|12218806|FG000|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
11038855|NCT00902486|12218807|FG001|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
11038856|NCT00902486|12218808|FG002|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
11038857|NCT00902486|12218809|FG003|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
11038858|NCT00902486|12218810|FG004|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
11038859|NCT00902486|12218811|FG005|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
11038860|NCT00902486|12218806|FG000|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
11038861|NCT00902486|12218807|FG001|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
11038862|NCT00902486|12218808|FG002|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
11038863|NCT00902486|12218809|FG003|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
11038864|NCT00902486|12218810|FG004|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
11038865|NCT00902486|12218811|FG005|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
11038866|NCT00902486|12218806|FG000|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
11038867|NCT00902486|12218807|FG001|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
11038868|NCT00902486|12218808|FG002|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
11038869|NCT00902486|12218809|FG003|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
11038870|NCT00902486|12218810|FG004|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
11038871|NCT00902486|12218811|FG005|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
11038872|NCT00902486|12218806|FG000|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
11038873|NCT00902486|12218807|FG001|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
11038874|NCT00902486|12218808|FG002|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
11038875|NCT00902486|12218809|FG003|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
11038876|NCT00902486|12218810|FG004|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
11038877|NCT00902486|12218811|FG005|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
11038878|NCT00902486|12218806|FG000|STARTED|Extension Period (Weeks 12 Through 24)||0
11038879|NCT00902486|12218807|FG001|STARTED|Extension Period (Weeks 12 Through 24)||14
11038880|NCT00902486|12218808|FG002|STARTED|Extension Period (Weeks 12 Through 24)||15
11038881|NCT00902486|12218809|FG003|STARTED|Extension Period (Weeks 12 Through 24)||29
11038882|NCT00902486|12218810|FG004|STARTED|Extension Period (Weeks 12 Through 24)||30
11038883|NCT00902486|12218811|FG005|STARTED|Extension Period (Weeks 12 Through 24)||27
11038884|NCT00902486|12218806|FG000|COMPLETED|Extension Period (Weeks 12 Through 24)||0
11038885|NCT00902486|12218807|FG001|COMPLETED|Extension Period (Weeks 12 Through 24)||14
11038886|NCT00902486|12218808|FG002|COMPLETED|Extension Period (Weeks 12 Through 24)||13
11038887|NCT00902486|12218809|FG003|COMPLETED|Extension Period (Weeks 12 Through 24)||27
11038888|NCT00902486|12218810|FG004|COMPLETED|Extension Period (Weeks 12 Through 24)||29
11038889|NCT00902486|12218811|FG005|COMPLETED|Extension Period (Weeks 12 Through 24)||24
11038890|NCT00902486|12218806|FG000|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
11038891|NCT00902486|12218807|FG001|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
11038892|NCT00902486|12218808|FG002|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
11038893|NCT00902486|12218809|FG003|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
11038894|NCT00902486|12218810|FG004|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
11038895|NCT00902486|12218811|FG005|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
11038896|NCT00902486|12218806|FG000|STARTED|Follow-up (After Week 24)||0
11038897|NCT00902486|12218807|FG001|STARTED|Follow-up (After Week 24)||14
11038898|NCT00902486|12218808|FG002|STARTED|Follow-up (After Week 24)||13
11038899|NCT00902486|12218809|FG003|STARTED|Follow-up (After Week 24)||27
11038900|NCT00902486|12218810|FG004|STARTED|Follow-up (After Week 24)||29
11038901|NCT00902486|12218811|FG005|STARTED|Follow-up (After Week 24)||24
11038902|NCT00902486|12218806|FG000|Safety Evaluable Participants|Follow-up (After Week 24)||0
11038903|NCT00902486|12218807|FG001|Safety Evaluable Participants|Follow-up (After Week 24)||14
11038904|NCT00902486|12218808|FG002|Safety Evaluable Participants|Follow-up (After Week 24)||15
11038905|NCT00902486|12218809|FG003|Safety Evaluable Participants|Follow-up (After Week 24)||29
11038906|NCT00902486|12218810|FG004|Safety Evaluable Participants|Follow-up (After Week 24)||30
11038907|NCT00902486|12218811|FG005|Safety Evaluable Participants|Follow-up (After Week 24)||27
11038908|NCT00902486|12218806|FG000|COMPLETED|Follow-up (After Week 24)||0
11038909|NCT00902486|12218807|FG001|COMPLETED|Follow-up (After Week 24)||14
11038910|NCT00902486|12218808|FG002|COMPLETED|Follow-up (After Week 24)||13
11038911|NCT00902486|12218809|FG003|COMPLETED|Follow-up (After Week 24)||26
11038912|NCT00902486|12218810|FG004|COMPLETED|Follow-up (After Week 24)||29
11038913|NCT00902486|12218811|FG005|COMPLETED|Follow-up (After Week 24)||24
11038914|NCT00902486|12218806|FG000|NOT COMPLETED|Follow-up (After Week 24)||0
11038915|NCT00902486|12218807|FG001|NOT COMPLETED|Follow-up (After Week 24)||0
11038916|NCT00902486|12218808|FG002|NOT COMPLETED|Follow-up (After Week 24)||0
11038917|NCT00902486|12218809|FG003|NOT COMPLETED|Follow-up (After Week 24)||1
11038918|NCT00902486|12218810|FG004|NOT COMPLETED|Follow-up (After Week 24)||0
11038919|NCT00902486|12218811|FG005|NOT COMPLETED|Follow-up (After Week 24)||0
11038920|NCT00902538|12218844|FG000|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
11038921|NCT00902538|12218845|FG001|STARTED|1-Single-blind, Run-in, Single-Treatment||0
11038922|NCT00902538|12218846|FG002|STARTED|1-Single-blind, Run-in, Single-Treatment||0
11038923|NCT00902538|12218847|FG003|STARTED|1-Single-blind, Run-in, Single-Treatment||0
11038924|NCT00902538|12218848|FG004|STARTED|1-Single-blind, Run-in, Single-Treatment||0
11038925|NCT00902538|12218849|FG005|STARTED|1-Single-blind, Run-in, Single-Treatment||0
11038926|NCT00902538|12218844|FG000|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
11038927|NCT00902538|12218845|FG001|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
11038928|NCT00902538|12218846|FG002|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
11038929|NCT00902538|12218847|FG003|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
11038930|NCT00902538|12218848|FG004|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
11038931|NCT00902538|12218849|FG005|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
11038932|NCT00902538|12218844|FG000|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
11038933|NCT00902538|12218845|FG001|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
11335640|NCT02864706|12533141|FG000|STARTED|Overall Study||48
11335641|NCT02864706|12533142|FG001|STARTED|Overall Study||47
11335642|NCT02864706|12533141|FG000|Safety Set|Overall Study||48
11335643|NCT02864706|12533142|FG001|Safety Set|Overall Study||47
11335644|NCT02864706|12533141|FG000|Intent to Treat|Overall Study||46
11335645|NCT02864706|12533142|FG001|Intent to Treat|Overall Study||47
11335646|NCT02864706|12533141|FG000|COMPLETED|Overall Study||48
11335647|NCT02864706|12533142|FG001|COMPLETED|Overall Study||47
11335648|NCT02864706|12533141|FG000|NOT COMPLETED|Overall Study||0
11335649|NCT02864706|12533142|FG001|NOT COMPLETED|Overall Study||0
11335650|NCT02864732|12533150|FG000|STARTED|Overall Study||15
11335651|NCT02864732|12533151|FG001|STARTED|Overall Study||15
11335652|NCT02864732|12533150|FG000|COMPLETED|Overall Study||13
11335653|NCT02864732|12533151|FG001|COMPLETED|Overall Study||13
11335654|NCT02864732|12533150|FG000|NOT COMPLETED|Overall Study||2
11335655|NCT02864732|12533151|FG001|NOT COMPLETED|Overall Study||2
11335656|NCT02865343|12533160|FG000|STARTED|Overall Study||6
11335657|NCT02865343|12533161|FG001|STARTED|Overall Study||5
11038934|NCT00902538|12218846|FG002|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
11335658|NCT02865343|12533160|FG000|COMPLETED|Overall Study||6
11335659|NCT02865343|12533161|FG001|COMPLETED|Overall Study||3
11335660|NCT02865343|12533160|FG000|NOT COMPLETED|Overall Study||0
11038935|NCT00902538|12218847|FG003|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
11038936|NCT00902538|12218848|FG004|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
11038937|NCT00902538|12218849|FG005|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
11038938|NCT00902538|12218844|FG000|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
11335661|NCT02865343|12533161|FG001|NOT COMPLETED|Overall Study||2
11038939|NCT00902538|12218845|FG001|STARTED|2-Randomized Double-blind 3 Treatments||269
11038940|NCT00902538|12218846|FG002|STARTED|2-Randomized Double-blind 3 Treatments||270
11038941|NCT00902538|12218847|FG003|STARTED|2-Randomized Double-blind 3 Treatments||0
11038942|NCT00902538|12218848|FG004|STARTED|2-Randomized Double-blind 3 Treatments||0
11038943|NCT00902538|12218849|FG005|STARTED|2-Randomized Double-blind 3 Treatments||0
11038944|NCT00902538|12218844|FG000|COMPLETED|2-Randomized Double-blind 3 Treatments||260
11038945|NCT00902538|12218845|FG001|COMPLETED|2-Randomized Double-blind 3 Treatments||263
11038946|NCT00902538|12218846|FG002|COMPLETED|2-Randomized Double-blind 3 Treatments||262
11038947|NCT00902538|12218847|FG003|COMPLETED|2-Randomized Double-blind 3 Treatments||0
11038948|NCT00902538|12218848|FG004|COMPLETED|2-Randomized Double-blind 3 Treatments||0
11038949|NCT00902538|12218849|FG005|COMPLETED|2-Randomized Double-blind 3 Treatments||0
11038950|NCT00902538|12218844|FG000|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
11038951|NCT00902538|12218845|FG001|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
11038952|NCT00902538|12218846|FG002|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
11038953|NCT00902538|12218847|FG003|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
11038954|NCT00902538|12218848|FG004|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
11038955|NCT00902538|12218849|FG005|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
11038956|NCT00902538|12218844|FG000|STARTED|3-Single-blind, Single Treatment||0
11038957|NCT00902538|12218845|FG001|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
11038958|NCT00902538|12218846|FG002|STARTED|3-Single-blind, Single Treatment||0
11038959|NCT00902538|12218847|FG003|STARTED|3-Single-blind, Single Treatment||0
11038960|NCT00902538|12218848|FG004|STARTED|3-Single-blind, Single Treatment||0
11038961|NCT00902538|12218849|FG005|STARTED|3-Single-blind, Single Treatment||0
11038962|NCT00902538|12218844|FG000|COMPLETED|3-Single-blind, Single Treatment||0
11038963|NCT00902538|12218845|FG001|COMPLETED|3-Single-blind, Single Treatment||767
11038964|NCT00902538|12218846|FG002|COMPLETED|3-Single-blind, Single Treatment||0
11038965|NCT00902538|12218847|FG003|COMPLETED|3-Single-blind, Single Treatment||0
11038966|NCT00902538|12218848|FG004|COMPLETED|3-Single-blind, Single Treatment||0
11038967|NCT00902538|12218849|FG005|COMPLETED|3-Single-blind, Single Treatment||0
11038968|NCT00902538|12218844|FG000|NOT COMPLETED|3-Single-blind, Single Treatment||0
11038969|NCT00902538|12218845|FG001|NOT COMPLETED|3-Single-blind, Single Treatment||15
11038970|NCT00902538|12218846|FG002|NOT COMPLETED|3-Single-blind, Single Treatment||0
11038971|NCT00902538|12218847|FG003|NOT COMPLETED|3-Single-blind, Single Treatment||0
11038972|NCT00902538|12218848|FG004|NOT COMPLETED|3-Single-blind, Single Treatment||0
11038973|NCT00902538|12218849|FG005|NOT COMPLETED|3-Single-blind, Single Treatment||0
11038974|NCT00902538|12218844|FG000|STARTED|4-Randomized Double-blind 2 Treatments||0
11038975|NCT00902538|12218845|FG001|STARTED|4-Randomized Double-blind 2 Treatments||0
11038976|NCT00902538|12218846|FG002|STARTED|4-Randomized Double-blind 2 Treatments||0
11038977|NCT00902538|12218847|FG003|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
11038978|NCT00902538|12218848|FG004|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
11038979|NCT00902538|12218849|FG005|STARTED|4-Randomized Double-blind 2 Treatments||197
11038980|NCT00902538|12218844|FG000|COMPLETED|4-Randomized Double-blind 2 Treatments||0
11038981|NCT00902538|12218845|FG001|COMPLETED|4-Randomized Double-blind 2 Treatments||0
11038982|NCT00902538|12218846|FG002|COMPLETED|4-Randomized Double-blind 2 Treatments||0
11038983|NCT00902538|12218847|FG003|COMPLETED|4-Randomized Double-blind 2 Treatments||458
11038984|NCT00902538|12218848|FG004|COMPLETED|4-Randomized Double-blind 2 Treatments||95
11038985|NCT00902538|12218849|FG005|COMPLETED|4-Randomized Double-blind 2 Treatments||196
11038986|NCT00902538|12218844|FG000|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
11038987|NCT00902538|12218845|FG001|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
11038988|NCT00902538|12218846|FG002|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
11038989|NCT00902538|12218847|FG003|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
11038990|NCT00902538|12218848|FG004|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
11335662|NCT02865434|12533180|FG000|STARTED|Overall Study||3
11335663|NCT02865434|12533181|FG001|STARTED|Overall Study||3
11335664|NCT02865434|12533182|FG002|STARTED|Overall Study||3
11335665|NCT02865434|12533183|FG003|STARTED|Overall Study||3
11335666|NCT02865434|12533184|FG004|STARTED|Overall Study||3
11335667|NCT02865434|12533185|FG005|STARTED|Overall Study||3
11335668|NCT02865434|12533186|FG006|STARTED|Overall Study||3
11335669|NCT02865434|12533187|FG007|STARTED|Overall Study||3
11038991|NCT00902538|12218849|FG005|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
11038992|NCT00902564|12218861|FG000|STARTED|Overall Study||30
11038993|NCT00902564|12218861|FG000|COMPLETED|Overall Study||28
11038994|NCT00902564|12218861|FG000|NOT COMPLETED|Overall Study||2
11335670|NCT02865434|12533188|FG008|STARTED|Overall Study||3
11335671|NCT02865434|12533189|FG009|STARTED|Overall Study||6
11038995|NCT00902577|12218865|FG000|STARTED|Overall Study||50
11038996|NCT00902577|12218865|FG000|FMISO/PET|Overall Study||38
11038997|NCT00902577|12218865|FG000|DCE MRI|Overall Study||31
11038998|NCT00902577|12218865|FG000|DSE MRI|Overall Study||37
11038999|NCT00902577|12218865|FG000|DWI MRI|Overall Study||39
11039000|NCT00902577|12218865|FG000|COMPLETED|Overall Study||42
11039001|NCT00902577|12218865|FG000|NOT COMPLETED|Overall Study||8
11039002|NCT00902746|12218888|FG000|STARTED|Overall Study||149
11039003|NCT00902746|12218888|FG000|Initiation of Study Drug Administration|Overall Study||148
11039004|NCT00902746|12218888|FG000|Transfer to Step 2|Overall Study||133
11039005|NCT00902746|12218888|FG000|COMPLETED|Overall Study||113
11039006|NCT00902746|12218888|FG000|NOT COMPLETED|Overall Study||36
11039007|NCT00902850|12218894|FG000|STARTED|Overall Study||14
11039008|NCT00902850|12218895|FG001|STARTED|Overall Study||14
11039009|NCT00902850|12218894|FG000|COMPLETED|Overall Study||12
11039010|NCT00902850|12218895|FG001|COMPLETED|Overall Study||12
11039011|NCT00902850|12218894|FG000|NOT COMPLETED|Overall Study||2
11039012|NCT00902850|12218895|FG001|NOT COMPLETED|Overall Study||2
11039013|NCT00903032|12218903|FG000|STARTED|Overall Study||129
11039014|NCT00903032|12218904|FG001|STARTED|Overall Study||124
11039015|NCT00903032|12218903|FG000|COMPLETED|Overall Study||122
11039016|NCT00903032|12218904|FG001|COMPLETED|Overall Study||119
11039017|NCT00903032|12218903|FG000|NOT COMPLETED|Overall Study||7
11039018|NCT00903032|12218904|FG001|NOT COMPLETED|Overall Study||5
11039019|NCT00903162|12218910|FG000|STARTED|Overall Study||16
11039020|NCT00903162|12218910|FG000|COMPLETED|Overall Study||12
11039021|NCT00903162|12218910|FG000|NOT COMPLETED|Overall Study||4
11039022|NCT00903175|12218916|FG000|STARTED|Period 1 - First Line||238
11039023|NCT00903175|12218917|FG001|STARTED|Period 1 - First Line||231
11039024|NCT00903175|12218916|FG000|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
11039025|NCT00903175|12218917|FG001|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
11039026|NCT00903175|12218916|FG000|NOT COMPLETED|Period 1 - First Line||77
11201066|NCT01830972|12391328|FG000|STARTED|Part II||46
11201067|NCT01830972|12391329|FG001|STARTED|Part II|Entered study at Part 2|13
11201068|NCT01830972|12391328|FG000|COMPLETED|Part II||44
11201069|NCT01830972|12391329|FG001|COMPLETED|Part II||11
11201070|NCT01830972|12391328|FG000|NOT COMPLETED|Part II||2
11201071|NCT01830972|12391329|FG001|NOT COMPLETED|Part II||2
11201072|NCT01830972|12391328|FG000|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
11201073|NCT01830972|12391329|FG001|STARTED|Part III||11
11201074|NCT01830972|12391328|FG000|COMPLETED|Part III||42
11201075|NCT01830972|12391329|FG001|COMPLETED|Part III||11
11201076|NCT01830972|12391328|FG000|NOT COMPLETED|Part III||2
11201077|NCT01830972|12391329|FG001|NOT COMPLETED|Part III||0
11201078|NCT01830972|12391328|FG000|STARTED|Part IV||42
11201079|NCT01830972|12391329|FG001|STARTED|Part IV||11
11201080|NCT01830972|12391328|FG000|COMPLETED|Part IV||39
11201081|NCT01830972|12391329|FG001|COMPLETED|Part IV||10
11201082|NCT01830972|12391328|FG000|NOT COMPLETED|Part IV||3
11201083|NCT01830972|12391329|FG001|NOT COMPLETED|Part IV||1
11201084|NCT01831089|12391351|FG000|STARTED|Cohort I: Dose Level 1||3
11201085|NCT01831089|12391352|FG001|STARTED|Cohort I: Dose Level 1||0
11201086|NCT01831089|12391353|FG002|STARTED|Cohort I: Dose Level 1||0
11201087|NCT01831089|12391354|FG003|STARTED|Cohort I: Dose Level 1||0
11201088|NCT01831089|12391355|FG004|STARTED|Cohort I: Dose Level 1||0
11201089|NCT01831089|12391356|FG005|STARTED|Cohort I: Dose Level 1||0
11201090|NCT01831089|12391351|FG000|COMPLETED|Cohort I: Dose Level 1||0
11201091|NCT01831089|12391352|FG001|COMPLETED|Cohort I: Dose Level 1||0
11201092|NCT01831089|12391353|FG002|COMPLETED|Cohort I: Dose Level 1||0
11201093|NCT01831089|12391354|FG003|COMPLETED|Cohort I: Dose Level 1||0
11201094|NCT01831089|12391355|FG004|COMPLETED|Cohort I: Dose Level 1||0
11201095|NCT01831089|12391356|FG005|COMPLETED|Cohort I: Dose Level 1||0
11201096|NCT01831089|12391351|FG000|NOT COMPLETED|Cohort I: Dose Level 1||3
11201097|NCT01831089|12391352|FG001|NOT COMPLETED|Cohort I: Dose Level 1||0
11201098|NCT01831089|12391353|FG002|NOT COMPLETED|Cohort I: Dose Level 1||0
11201099|NCT01831089|12391354|FG003|NOT COMPLETED|Cohort I: Dose Level 1||0
11201100|NCT01831089|12391355|FG004|NOT COMPLETED|Cohort I: Dose Level 1||0
11201101|NCT01831089|12391356|FG005|NOT COMPLETED|Cohort I: Dose Level 1||0
11201102|NCT01831089|12391351|FG000|STARTED|Cohort II: Dose Level 2||0
11201103|NCT01831089|12391352|FG001|STARTED|Cohort II: Dose Level 2||3
11039027|NCT00903175|12218917|FG001|NOT COMPLETED|Period 1 - First Line||89
11039028|NCT00903175|12218916|FG000|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
11039029|NCT00903175|12218917|FG001|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
11039030|NCT00903175|12218916|FG000|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
11039031|NCT00903175|12218917|FG001|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
11039032|NCT00903175|12218916|FG000|NOT COMPLETED|Period 2 - Second Line||49
11039033|NCT00903175|12218917|FG001|NOT COMPLETED|Period 2 - Second Line||36
11039034|NCT00903201|12218926|FG000|STARTED|Overall Study||61
11039035|NCT00903201|12218927|FG001|STARTED|Overall Study||44
11039036|NCT00903201|12218928|FG002|STARTED|Overall Study||41
11039037|NCT00903201|12218926|FG000|COMPLETED|Overall Study||56
11039038|NCT00903201|12218927|FG001|COMPLETED|Overall Study||38
11039039|NCT00903201|12218928|FG002|COMPLETED|Overall Study||39
11039040|NCT00903201|12218926|FG000|NOT COMPLETED|Overall Study||5
11039041|NCT00903201|12218927|FG001|NOT COMPLETED|Overall Study||6
11039042|NCT00903201|12218928|FG002|NOT COMPLETED|Overall Study||2
11039043|NCT00903331|12218940|FG000|STARTED|Overall Study||59
11039044|NCT00903331|12218941|FG001|STARTED|Overall Study||119
11039045|NCT00903331|12218940|FG000|COMPLETED|Overall Study||54
11039046|NCT00903331|12218941|FG001|COMPLETED|Overall Study||101
11039047|NCT00903331|12218940|FG000|NOT COMPLETED|Overall Study||5
11201104|NCT01831089|12391353|FG002|STARTED|Cohort II: Dose Level 2||0
11201105|NCT01831089|12391354|FG003|STARTED|Cohort II: Dose Level 2||0
11201106|NCT01831089|12391355|FG004|STARTED|Cohort II: Dose Level 2||0
11039048|NCT00903331|12218941|FG001|NOT COMPLETED|Overall Study||18
11039049|NCT00903344|12218949|FG000|STARTED|Overall Study||12
11039050|NCT00903344|12218950|FG001|STARTED|Overall Study||10
11039051|NCT00903344|12218949|FG000|3 Month Visit|Overall Study||10
11039052|NCT00903344|12218950|FG001|3 Month Visit|Overall Study||10
11039053|NCT00903344|12218949|FG000|6 Month Visit|Overall Study||9
11039054|NCT00903344|12218950|FG001|6 Month Visit|Overall Study||10
11039055|NCT00903344|12218949|FG000|COMPLETED|Overall Study||7
11039056|NCT00903344|12218950|FG001|COMPLETED|Overall Study||7
11039057|NCT00903344|12218949|FG000|NOT COMPLETED|Overall Study||5
11039058|NCT00903344|12218950|FG001|NOT COMPLETED|Overall Study||3
11039059|NCT00903357|12218956|FG000|STARTED|First Intervention||27
11039060|NCT00903357|12218957|FG001|STARTED|First Intervention||27
11039061|NCT00903357|12218956|FG000|COMPLETED|First Intervention||22
11039062|NCT00903357|12218957|FG001|COMPLETED|First Intervention||23
11039063|NCT00903357|12218956|FG000|NOT COMPLETED|First Intervention||5
11039064|NCT00903357|12218957|FG001|NOT COMPLETED|First Intervention||4
11039065|NCT00903357|12218956|FG000|STARTED|Wash Out Period of 2 Weeks||22
11039066|NCT00903357|12218957|FG001|STARTED|Wash Out Period of 2 Weeks||23
11039067|NCT00903357|12218956|FG000|COMPLETED|Wash Out Period of 2 Weeks||22
11039068|NCT00903357|12218957|FG001|COMPLETED|Wash Out Period of 2 Weeks||22
11039069|NCT00903357|12218956|FG000|NOT COMPLETED|Wash Out Period of 2 Weeks||0
11039070|NCT00903357|12218957|FG001|NOT COMPLETED|Wash Out Period of 2 Weeks||1
11039071|NCT00903357|12218956|FG000|STARTED|Second Intervention||22
11039072|NCT00903357|12218957|FG001|STARTED|Second Intervention||22
11039073|NCT00903357|12218956|FG000|COMPLETED|Second Intervention||21
11039074|NCT00903357|12218957|FG001|COMPLETED|Second Intervention||22
11039075|NCT00903357|12218956|FG000|NOT COMPLETED|Second Intervention||1
11039076|NCT00903357|12218957|FG001|NOT COMPLETED|Second Intervention||0
11039077|NCT00903370|12218969|FG000|STARTED|Overall Study||127
11039078|NCT00903370|12218970|FG001|STARTED|Overall Study||133
11039079|NCT00903370|12218969|FG000|COMPLETED|Overall Study||99
11039080|NCT00903370|12218970|FG001|COMPLETED|Overall Study||109
11039081|NCT00903370|12218969|FG000|NOT COMPLETED|Overall Study||28
11039082|NCT00903370|12218970|FG001|NOT COMPLETED|Overall Study||24
11039083|NCT00903383|12218980|FG000|STARTED|Overall Study||55
11039084|NCT00903383|12218981|FG001|STARTED|Overall Study||54
11039085|NCT00903383|12218982|FG002|STARTED|Overall Study||50
11039086|NCT00903383|12218983|FG003|STARTED|Overall Study||49
11039087|NCT00903383|12218980|FG000|COMPLETED|Overall Study||48
11039088|NCT00903383|12218981|FG001|COMPLETED|Overall Study||48
11039089|NCT00903383|12218982|FG002|COMPLETED|Overall Study||47
11039090|NCT00903383|12218983|FG003|COMPLETED|Overall Study||44
11039091|NCT00903383|12218980|FG000|NOT COMPLETED|Overall Study||7
11039092|NCT00903383|12218981|FG001|NOT COMPLETED|Overall Study||6
11039093|NCT00903383|12218982|FG002|NOT COMPLETED|Overall Study||3
11039094|NCT00903383|12218983|FG003|NOT COMPLETED|Overall Study||5
11039095|NCT00903409|12218995|FG000|STARTED|Overall Study||88
11039096|NCT00903409|12218996|FG001|STARTED|Overall Study||100
11335672|NCT02865434|12533190|FG010|STARTED|Overall Study||6
11335673|NCT02865434|12533180|FG000|COMPLETED|Overall Study||3
11335674|NCT02865434|12533181|FG001|COMPLETED|Overall Study||3
11335675|NCT02865434|12533182|FG002|COMPLETED|Overall Study||3
11039097|NCT00903409|12218995|FG000|COMPLETED|Overall Study||62
11039098|NCT00903409|12218996|FG001|COMPLETED|Overall Study||73
11039099|NCT00903409|12218995|FG000|NOT COMPLETED|Overall Study||26
11039100|NCT00903409|12218996|FG001|NOT COMPLETED|Overall Study||27
11039101|NCT00903448|12219004|FG000|STARTED|Period 1: 5 Days Then 10 Day Washout||20
11039102|NCT00903448|12219005|FG001|STARTED|Period 1: 5 Days Then 10 Day Washout||20
11039103|NCT00903448|12219004|FG000|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
11039104|NCT00903448|12219005|FG001|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
11335676|NCT02865434|12533183|FG003|COMPLETED|Overall Study||3
11335677|NCT02865434|12533184|FG004|COMPLETED|Overall Study||3
11335678|NCT02865434|12533185|FG005|COMPLETED|Overall Study||3
11039105|NCT00903448|12219004|FG000|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
11039106|NCT00903448|12219005|FG001|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
11039107|NCT00903448|12219004|FG000|STARTED|Period 2: 5 Days Then 10 Day Washout||20
11039108|NCT00903448|12219005|FG001|STARTED|Period 2: 5 Days Then 10 Day Washout||20
11039109|NCT00903448|12219004|FG000|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
11039110|NCT00903448|12219005|FG001|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
11039111|NCT00903448|12219004|FG000|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
11039112|NCT00903448|12219005|FG001|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
11039113|NCT00903448|12219004|FG000|STARTED|Period 3: 5 Days||20
11039114|NCT00903448|12219005|FG001|STARTED|Period 3: 5 Days||20
11039115|NCT00903448|12219004|FG000|COMPLETED|Period 3: 5 Days||20
11039116|NCT00903448|12219005|FG001|COMPLETED|Period 3: 5 Days||20
11039117|NCT00903448|12219004|FG000|NOT COMPLETED|Period 3: 5 Days||0
11039118|NCT00903448|12219005|FG001|NOT COMPLETED|Period 3: 5 Days||0
11039119|NCT00903617|12219015|FG000|STARTED|Overall Study||19
11039120|NCT00903617|12219016|FG001|STARTED|Overall Study||20
11039121|NCT00903617|12219017|FG002|STARTED|Overall Study||20
11039122|NCT00903617|12219018|FG003|STARTED|Overall Study||21
11039123|NCT00903617|12219015|FG000|COMPLETED|Overall Study||16
11039124|NCT00903617|12219016|FG001|COMPLETED|Overall Study||15
11039125|NCT00903617|12219017|FG002|COMPLETED|Overall Study||15
11039126|NCT00903617|12219018|FG003|COMPLETED|Overall Study||20
11039127|NCT00903617|12219015|FG000|NOT COMPLETED|Overall Study||3
11039128|NCT00903617|12219016|FG001|NOT COMPLETED|Overall Study||5
11335679|NCT02865434|12533186|FG006|COMPLETED|Overall Study||3
11039129|NCT00903617|12219017|FG002|NOT COMPLETED|Overall Study||5
11039130|NCT00903617|12219018|FG003|NOT COMPLETED|Overall Study||1
11039131|NCT00903630|12219032|FG000|STARTED|Phase l||6
11039132|NCT00903630|12219033|FG001|STARTED|Phase l||5
11039133|NCT00903630|12219034|FG002|STARTED|Phase l||0
11039134|NCT00903630|12219032|FG000|COMPLETED|Phase l||6
11039135|NCT00903630|12219033|FG001|COMPLETED|Phase l||5
11039136|NCT00903630|12219034|FG002|COMPLETED|Phase l||0
11039137|NCT00903630|12219032|FG000|NOT COMPLETED|Phase l||0
11039138|NCT00903630|12219033|FG001|NOT COMPLETED|Phase l||0
11039139|NCT00903630|12219034|FG002|NOT COMPLETED|Phase l||0
11039140|NCT00903630|12219032|FG000|STARTED|Phase 2||6
11039141|NCT00903630|12219033|FG001|STARTED|Phase 2||0
11039142|NCT00903630|12219034|FG002|STARTED|Phase 2||4
11039143|NCT00903630|12219032|FG000|COMPLETED|Phase 2||6
11039144|NCT00903630|12219033|FG001|COMPLETED|Phase 2||0
11039145|NCT00903630|12219034|FG002|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
11039146|NCT00903630|12219032|FG000|NOT COMPLETED|Phase 2||0
11039147|NCT00903630|12219033|FG001|NOT COMPLETED|Phase 2||0
11039148|NCT00903630|12219034|FG002|NOT COMPLETED|Phase 2||1
11039149|NCT00903682|12219046|FG000|STARTED|Overall Study||79
11039150|NCT00903682|12219047|FG001|STARTED|Overall Study||78
11039151|NCT00903682|12219046|FG000|COMPLETED|Overall Study||63
11039152|NCT00903682|12219047|FG001|COMPLETED|Overall Study||63
11039153|NCT00903682|12219046|FG000|NOT COMPLETED|Overall Study||16
11039154|NCT00903682|12219047|FG001|NOT COMPLETED|Overall Study||15
11039155|NCT00903695|12219055|FG000|STARTED|Overall Study||8
11039156|NCT00903695|12219056|FG001|STARTED|Overall Study||2
11039157|NCT00903695|12219055|FG000|COMPLETED|Overall Study||6
11039158|NCT00903695|12219056|FG001|COMPLETED|Overall Study||2
11039159|NCT00903695|12219055|FG000|NOT COMPLETED|Overall Study||2
11039160|NCT00903695|12219056|FG001|NOT COMPLETED|Overall Study||0
11039161|NCT00903760|12219066|FG000|STARTED|Overall Study||19
11039162|NCT00903760|12219067|FG001|STARTED|Overall Study||18
11039163|NCT00903760|12219066|FG000|COMPLETED|Overall Study|Completed all 24 courses|0
11039164|NCT00903760|12219067|FG001|COMPLETED|Overall Study|Completed all 24 courses|2
11039165|NCT00903760|12219066|FG000|NOT COMPLETED|Overall Study||19
11039166|NCT00903760|12219067|FG001|NOT COMPLETED|Overall Study||16
11039167|NCT00903786|12219073|FG000|STARTED|Overall Study||21
11039168|NCT00903786|12219073|FG000|COMPLETED|Overall Study||6
11039169|NCT00903786|12219073|FG000|NOT COMPLETED|Overall Study||15
11039170|NCT00903877|12219078|FG000|STARTED|Overall Study||51
11039171|NCT00903877|12219078|FG000|COMPLETED|Overall Study||8
11039172|NCT00903877|12219078|FG000|NOT COMPLETED|Overall Study||43
11039173|NCT00903929|12219082|FG000|STARTED|Overall Study||3
11039174|NCT00903929|12219083|FG001|STARTED|Overall Study||3
11039175|NCT00903929|12219084|FG002|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
11039176|NCT00903929|12219085|FG003|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
11039177|NCT00903929|12219082|FG000|COMPLETED|Overall Study||3
11039178|NCT00903929|12219083|FG001|COMPLETED|Overall Study||3
11039179|NCT00903929|12219084|FG002|COMPLETED|Overall Study||3
11039180|NCT00903929|12219085|FG003|COMPLETED|Overall Study||6
11039181|NCT00903929|12219082|FG000|NOT COMPLETED|Overall Study||0
11039182|NCT00903929|12219083|FG001|NOT COMPLETED|Overall Study||0
11039183|NCT00903929|12219084|FG002|NOT COMPLETED|Overall Study||1
11039184|NCT00903929|12219085|FG003|NOT COMPLETED|Overall Study||3
11039185|NCT00903968|12219092|FG000|STARTED|Overall Study||3
11039186|NCT00903968|12219093|FG001|STARTED|Overall Study||3
11039187|NCT00903968|12219094|FG002|STARTED|Overall Study||3
11039188|NCT00903968|12219095|FG003|STARTED|Overall Study||3
11039189|NCT00903968|12219096|FG004|STARTED|Overall Study||4
11039190|NCT00903968|12219097|FG005|STARTED|Overall Study||6
11039191|NCT00903968|12219098|FG006|STARTED|Overall Study||3
11039192|NCT00903968|12219099|FG007|STARTED|Overall Study||33
11039193|NCT00903968|12219092|FG000|COMPLETED|Overall Study||0
11039194|NCT00903968|12219093|FG001|COMPLETED|Overall Study||0
11039195|NCT00903968|12219094|FG002|COMPLETED|Overall Study||0
11039196|NCT00903968|12219095|FG003|COMPLETED|Overall Study||0
11039197|NCT00903968|12219096|FG004|COMPLETED|Overall Study||0
11039198|NCT00903968|12219097|FG005|COMPLETED|Overall Study||0
11039199|NCT00903968|12219098|FG006|COMPLETED|Overall Study||0
11039200|NCT00903968|12219099|FG007|COMPLETED|Overall Study||0
11039201|NCT00903968|12219092|FG000|NOT COMPLETED|Overall Study||3
11039202|NCT00903968|12219093|FG001|NOT COMPLETED|Overall Study||3
11039203|NCT00903968|12219094|FG002|NOT COMPLETED|Overall Study||3
11039204|NCT00903968|12219095|FG003|NOT COMPLETED|Overall Study||3
11039205|NCT00903968|12219096|FG004|NOT COMPLETED|Overall Study||4
11039206|NCT00903968|12219097|FG005|NOT COMPLETED|Overall Study||6
11039207|NCT00903968|12219098|FG006|NOT COMPLETED|Overall Study||3
11039208|NCT00903968|12219099|FG007|NOT COMPLETED|Overall Study||33
11039209|NCT00904007|12219122|FG000|STARTED|Overall Study||55
11039210|NCT00904007|12219123|FG001|STARTED|Overall Study||56
11039211|NCT00904007|12219122|FG000|COMPLETED|Overall Study||55
11039212|NCT00904007|12219123|FG001|COMPLETED|Overall Study||56
11039213|NCT00904007|12219122|FG000|NOT COMPLETED|Overall Study||0
11039214|NCT00904007|12219123|FG001|NOT COMPLETED|Overall Study||0
11039215|NCT00904033|12219135|FG000|STARTED|Overall Study||10
11039216|NCT00904033|12219136|FG001|STARTED|Overall Study||10
11039217|NCT00904033|12219137|FG002|STARTED|Overall Study||10
11039218|NCT00904033|12219138|FG003|STARTED|Overall Study||11
11039219|NCT00904033|12219135|FG000|COMPLETED|Overall Study||9
11039220|NCT00904033|12219136|FG001|COMPLETED|Overall Study||9
11039221|NCT00904033|12219137|FG002|COMPLETED|Overall Study||9
11039222|NCT00904033|12219138|FG003|COMPLETED|Overall Study||9
11039223|NCT00904033|12219135|FG000|NOT COMPLETED|Overall Study||1
11039224|NCT00904033|12219136|FG001|NOT COMPLETED|Overall Study||1
11039225|NCT00904033|12219137|FG002|NOT COMPLETED|Overall Study||1
11039226|NCT00904033|12219138|FG003|NOT COMPLETED|Overall Study||2
11039227|NCT00904150|12219151|FG000|STARTED|Saliva Samples (DNA)||285
11039228|NCT00904150|12219152|FG001|STARTED|Saliva Samples (DNA)||300
11039229|NCT00904150|12219151|FG000|COMPLETED|Saliva Samples (DNA)||282
11039230|NCT00904150|12219152|FG001|COMPLETED|Saliva Samples (DNA)||155
11039231|NCT00904150|12219151|FG000|NOT COMPLETED|Saliva Samples (DNA)||3
11039232|NCT00904150|12219152|FG001|NOT COMPLETED|Saliva Samples (DNA)||145
11039233|NCT00904150|12219151|FG000|STARTED|Blood Samples (RNA): Follicular Phase||37
11039234|NCT00904150|12219152|FG001|STARTED|Blood Samples (RNA): Follicular Phase||32
11039235|NCT00904150|12219151|FG000|COMPLETED|Blood Samples (RNA): Follicular Phase||37
11039236|NCT00904150|12219152|FG001|COMPLETED|Blood Samples (RNA): Follicular Phase||32
11039237|NCT00904150|12219151|FG000|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
11039238|NCT00904150|12219152|FG001|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
11039239|NCT00904150|12219151|FG000|STARTED|Blood Samples (RNA): Luteal Phase||34
11039240|NCT00904150|12219152|FG001|STARTED|Blood Samples (RNA): Luteal Phase||30
11039241|NCT00904150|12219151|FG000|COMPLETED|Blood Samples (RNA): Luteal Phase||34
11039242|NCT00904150|12219152|FG001|COMPLETED|Blood Samples (RNA): Luteal Phase||30
11039243|NCT00904150|12219151|FG000|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
11039244|NCT00904150|12219152|FG001|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
11335680|NCT02865434|12533187|FG007|COMPLETED|Overall Study||3
11335681|NCT02865434|12533188|FG008|COMPLETED|Overall Study||3
11335682|NCT02865434|12533189|FG009|COMPLETED|Overall Study||6
11335683|NCT02865434|12533190|FG010|COMPLETED|Overall Study||6
11335684|NCT02865434|12533180|FG000|NOT COMPLETED|Overall Study||0
11335685|NCT02865434|12533181|FG001|NOT COMPLETED|Overall Study||0
11335686|NCT02865434|12533182|FG002|NOT COMPLETED|Overall Study||0
11335687|NCT02865434|12533183|FG003|NOT COMPLETED|Overall Study||0
11335688|NCT02865434|12533184|FG004|NOT COMPLETED|Overall Study||0
11335689|NCT02865434|12533185|FG005|NOT COMPLETED|Overall Study||0
11335690|NCT02865434|12533186|FG006|NOT COMPLETED|Overall Study||0
11335691|NCT02865434|12533187|FG007|NOT COMPLETED|Overall Study||0
11039245|NCT00904215|12219158|FG000|STARTED|Overall Study||1095
11039246|NCT00904215|12219158|FG000|COMPLETED|Overall Study||960
11039247|NCT00904215|12219158|FG000|NOT COMPLETED|Overall Study||135
11039248|NCT00904345|12219162|FG000|STARTED|Overall Study||21
11039249|NCT00904345|12219162|FG000|Stopped or Modified Treatment Due to Toxicity|Overall Study||3
11039250|NCT00904345|12219162|FG000|COMPLETED|Overall Study||18
11039251|NCT00904345|12219162|FG000|NOT COMPLETED|Overall Study||3
11039252|NCT00904371|12219166|FG000|STARTED|Overall Study||211
11039253|NCT00904371|12219166|FG000|COMPLETED|Overall Study||202
11039254|NCT00904371|12219166|FG000|NOT COMPLETED|Overall Study||9
11039255|NCT00904488|12219172|FG000|STARTED|Overall Study||5
11335692|NCT02865434|12533188|FG008|NOT COMPLETED|Overall Study||0
11335693|NCT02865434|12533189|FG009|NOT COMPLETED|Overall Study||0
11335694|NCT02865434|12533190|FG010|NOT COMPLETED|Overall Study||0
11335695|NCT02865499|12533220|FG000|STARTED|Baseline||8
11335696|NCT02865499|12533220|FG000|COMPLETED|Baseline||6
11335697|NCT02865499|12533220|FG000|NOT COMPLETED|Baseline||2
11335698|NCT02865499|12533220|FG000|STARTED|8 Weeks||6
11039256|NCT00904488|12219173|FG001|STARTED|Overall Study||6
11039257|NCT00904488|12219172|FG000|COMPLETED|Overall Study||5
11039258|NCT00904488|12219173|FG001|COMPLETED|Overall Study||6
11039259|NCT00904488|12219172|FG000|NOT COMPLETED|Overall Study||0
11039260|NCT00904488|12219173|FG001|NOT COMPLETED|Overall Study||0
11039261|NCT00904618|12219179|FG000|STARTED|Overall Study||48
11039262|NCT00904618|12219179|FG000|COMPLETED|Overall Study||48
11039263|NCT00904618|12219179|FG000|NOT COMPLETED|Overall Study||0
11039264|NCT00904670|12219186|FG000|STARTED|Open Label Phase||23
11039265|NCT00904670|12219187|FG001|STARTED|Open Label Phase||22
11039266|NCT00904670|12219186|FG000|COMPLETED|Open Label Phase||17
11039267|NCT00904670|12219187|FG001|COMPLETED|Open Label Phase||22
11039268|NCT00904670|12219186|FG000|NOT COMPLETED|Open Label Phase||6
11039269|NCT00904670|12219187|FG001|NOT COMPLETED|Open Label Phase||0
11039270|NCT00904670|12219186|FG000|STARTED|First Intervention Period||17
11039271|NCT00904670|12219187|FG001|STARTED|First Intervention Period||22
11039272|NCT00904670|12219186|FG000|COMPLETED|First Intervention Period||17
11039273|NCT00904670|12219187|FG001|COMPLETED|First Intervention Period||22
11335699|NCT02865499|12533220|FG000|COMPLETED|8 Weeks||6
11335700|NCT02865499|12533220|FG000|NOT COMPLETED|8 Weeks||0
11039274|NCT00904670|12219186|FG000|NOT COMPLETED|First Intervention Period||0
11039275|NCT00904670|12219187|FG001|NOT COMPLETED|First Intervention Period||0
11039276|NCT00904670|12219186|FG000|STARTED|Second Intervention Period||17
11039277|NCT00904670|12219187|FG001|STARTED|Second Intervention Period||22
11039278|NCT00904670|12219186|FG000|COMPLETED|Second Intervention Period||17
11039279|NCT00904670|12219187|FG001|COMPLETED|Second Intervention Period||22
11039280|NCT00904670|12219186|FG000|NOT COMPLETED|Second Intervention Period||0
11039281|NCT00904670|12219187|FG001|NOT COMPLETED|Second Intervention Period||0
11039282|NCT00904722|12219195|FG000|STARTED|Overall Study||30
11039283|NCT00904722|12219195|FG000|COMPLETED|Overall Study||29
11039284|NCT00904722|12219195|FG000|NOT COMPLETED|Overall Study||1
11335701|NCT02865499|12533220|FG000|STARTED|12 Weeks||6
11335702|NCT02865499|12533220|FG000|COMPLETED|12 Weeks||6
11335703|NCT02865499|12533220|FG000|NOT COMPLETED|12 Weeks||0
11335704|NCT02865538|12533229|FG000|STARTED|Overall Study||18
11335705|NCT02865538|12533230|FG001|STARTED|Overall Study||15
11335706|NCT02865538|12533231|FG002|STARTED|Overall Study||15
11335707|NCT02865538|12533232|FG003|STARTED|Overall Study||15
11335708|NCT02865538|12533233|FG004|STARTED|Overall Study||13
11335709|NCT02865538|12533229|FG000|COMPLETED|Overall Study||17
11335710|NCT02865538|12533230|FG001|COMPLETED|Overall Study||15
11335711|NCT02865538|12533231|FG002|COMPLETED|Overall Study||14
11335712|NCT02865538|12533232|FG003|COMPLETED|Overall Study||15
11335713|NCT02865538|12533233|FG004|COMPLETED|Overall Study||13
11335714|NCT02865538|12533229|FG000|NOT COMPLETED|Overall Study||1
11335715|NCT02865538|12533230|FG001|NOT COMPLETED|Overall Study||0
11335716|NCT02865538|12533231|FG002|NOT COMPLETED|Overall Study||1
11335717|NCT02865538|12533232|FG003|NOT COMPLETED|Overall Study||0
11335718|NCT02865538|12533233|FG004|NOT COMPLETED|Overall Study||0
11335719|NCT02865590|12533247|FG000|STARTED|Overall Study||8
11335720|NCT02865590|12533248|FG001|STARTED|Overall Study||8
11335721|NCT02865590|12533247|FG000|COMPLETED|Overall Study||8
11335722|NCT02865590|12533248|FG001|COMPLETED|Overall Study||8
11335723|NCT02865590|12533247|FG000|NOT COMPLETED|Overall Study||0
11335724|NCT02865590|12533248|FG001|NOT COMPLETED|Overall Study||0
11335725|NCT02865720|12533256|FG000|STARTED|Overall Study||0
11335726|NCT02865720|12533257|FG001|STARTED|Overall Study||8
11335727|NCT02865720|12533256|FG000|COMPLETED|Overall Study||0
11335728|NCT02865720|12533257|FG001|COMPLETED|Overall Study||8
11335729|NCT02865720|12533256|FG000|NOT COMPLETED|Overall Study||0
11335730|NCT02865720|12533257|FG001|NOT COMPLETED|Overall Study||0
11335731|NCT02866175|12533264|FG000|STARTED|Overall Study||751
11335732|NCT02866175|12533265|FG001|STARTED|Overall Study||755
11335733|NCT02866175|12533264|FG000|COMPLETED|Overall Study||616
11335734|NCT02866175|12533265|FG001|COMPLETED|Overall Study||580
11335735|NCT02866175|12533264|FG000|NOT COMPLETED|Overall Study||135
11335736|NCT02866175|12533265|FG001|NOT COMPLETED|Overall Study||175
11335737|NCT02866942|12533272|FG000|STARTED|Overall Study||479
11335738|NCT02866942|12533272|FG000|COMPLETED|Overall Study||478
11335739|NCT02866942|12533272|FG000|NOT COMPLETED|Overall Study||1
11335740|NCT02867059|12533278|FG000|STARTED|Overall Study||7
11335741|NCT02867059|12533279|FG001|STARTED|Overall Study||10
11039285|NCT00904748|12219199|FG000|STARTED|Overall Study||8
11335742|NCT02867059|12533278|FG000|COMPLETED|Overall Study||7
11335743|NCT02867059|12533279|FG001|COMPLETED|Overall Study||8
11335744|NCT02867059|12533278|FG000|NOT COMPLETED|Overall Study||0
11335745|NCT02867059|12533279|FG001|NOT COMPLETED|Overall Study||2
11335746|NCT02867150|12533285|FG000|STARTED|Overall Study||58
11335747|NCT02867150|12533285|FG000|COMPLETED|Overall Study||58
11335748|NCT02867150|12533285|FG000|NOT COMPLETED|Overall Study||0
11335749|NCT02867163|12533289|FG000|STARTED|Overall Study||25
11335750|NCT02867163|12533289|FG000|COMPLETED|Overall Study||25
11335751|NCT02867163|12533289|FG000|NOT COMPLETED|Overall Study||0
11335752|NCT02867202|12533295|FG000|STARTED|Overall Study||83
11335753|NCT02867202|12533296|FG001|STARTED|Overall Study||88
11039286|NCT00904748|12219200|FG001|STARTED|Overall Study||8
11039287|NCT00904748|12219201|FG002|STARTED|Overall Study||8
11039288|NCT00904748|12219202|FG003|STARTED|Overall Study||8
11039289|NCT00904748|12219203|FG004|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
11039290|NCT00904748|12219204|FG005|STARTED|Overall Study||8
11039291|NCT00904748|12219199|FG000|Received Treatment|Overall Study||8
11039292|NCT00904748|12219200|FG001|Received Treatment|Overall Study||8
11039293|NCT00904748|12219201|FG002|Received Treatment|Overall Study||8
11039294|NCT00904748|12219202|FG003|Received Treatment|Overall Study||8
11039295|NCT00904748|12219203|FG004|Received Treatment|Overall Study||7
11039296|NCT00904748|12219204|FG005|Received Treatment|Overall Study||8
11039297|NCT00904748|12219199|FG000|COMPLETED|Overall Study||7
11039298|NCT00904748|12219200|FG001|COMPLETED|Overall Study||7
11039299|NCT00904748|12219201|FG002|COMPLETED|Overall Study||7
11039300|NCT00904748|12219202|FG003|COMPLETED|Overall Study||6
11039301|NCT00904748|12219203|FG004|COMPLETED|Overall Study||7
11039302|NCT00904748|12219204|FG005|COMPLETED|Overall Study||8
11039303|NCT00904748|12219199|FG000|NOT COMPLETED|Overall Study||1
11039304|NCT00904748|12219200|FG001|NOT COMPLETED|Overall Study||1
11039305|NCT00904748|12219201|FG002|NOT COMPLETED|Overall Study||1
11039306|NCT00904748|12219202|FG003|NOT COMPLETED|Overall Study||2
11039307|NCT00904748|12219203|FG004|NOT COMPLETED|Overall Study||1
11335754|NCT02867202|12533295|FG000|COMPLETED|Overall Study||62
11335755|NCT02867202|12533296|FG001|COMPLETED|Overall Study||56
11039308|NCT00904748|12219204|FG005|NOT COMPLETED|Overall Study||0
11039309|NCT00904813|12219218|FG000|STARTED|Overall Study||129
11039310|NCT00904813|12219219|FG001|STARTED|Overall Study||128
11039311|NCT00904813|12219220|FG002|STARTED|Overall Study||128
11039312|NCT00904813|12219221|FG003|STARTED|Overall Study||228
11039313|NCT00904813|12219222|FG004|STARTED|Overall Study||227
11039314|NCT00904813|12219218|FG000|COMPLETED|Overall Study||129
11039315|NCT00904813|12219219|FG001|COMPLETED|Overall Study||128
11039316|NCT00904813|12219220|FG002|COMPLETED|Overall Study||128
11039317|NCT00904813|12219221|FG003|COMPLETED|Overall Study||228
11039318|NCT00904813|12219222|FG004|COMPLETED|Overall Study||227
11039319|NCT00904813|12219218|FG000|NOT COMPLETED|Overall Study||0
11039320|NCT00904813|12219219|FG001|NOT COMPLETED|Overall Study||0
11039321|NCT00904813|12219220|FG002|NOT COMPLETED|Overall Study||0
11039322|NCT00904813|12219221|FG003|NOT COMPLETED|Overall Study||0
11039323|NCT00904813|12219222|FG004|NOT COMPLETED|Overall Study||0
11039324|NCT00904826|12219245|FG000|STARTED|Overall Study||14
11039325|NCT00904826|12219245|FG000|COMPLETED|Overall Study||14
11039326|NCT00904826|12219245|FG000|NOT COMPLETED|Overall Study||0
11039327|NCT00904839|12219251|FG000|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
11039328|NCT00904839|12219252|FG001|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
11039329|NCT00904839|12219253|FG002|STARTED|Overall Study|Randomised|42
11039330|NCT00904839|12219251|FG000|COMPLETED|Overall Study||3
11039331|NCT00904839|12219252|FG001|COMPLETED|Overall Study||64
11039332|NCT00904839|12219253|FG002|COMPLETED|Overall Study||27
11039333|NCT00904839|12219251|FG000|NOT COMPLETED|Overall Study||1
11039334|NCT00904839|12219252|FG001|NOT COMPLETED|Overall Study||18
11039335|NCT00904839|12219253|FG002|NOT COMPLETED|Overall Study||15
11039336|NCT00904917|12219268|FG000|STARTED|Overall Study||7
11039337|NCT00904917|12219269|FG001|STARTED|Overall Study||11
11039338|NCT00904917|12219270|FG002|STARTED|Overall Study||8
11039339|NCT00904917|12219271|FG003|STARTED|Overall Study||8
11039340|NCT00904917|12219268|FG000|COMPLETED|Overall Study||5
11039341|NCT00904917|12219269|FG001|COMPLETED|Overall Study||9
11039342|NCT00904917|12219270|FG002|COMPLETED|Overall Study||6
11039343|NCT00904917|12219271|FG003|COMPLETED|Overall Study||6
11039344|NCT00904917|12219268|FG000|NOT COMPLETED|Overall Study||2
11039345|NCT00904917|12219269|FG001|NOT COMPLETED|Overall Study||2
11039346|NCT00904917|12219270|FG002|NOT COMPLETED|Overall Study||2
11039347|NCT00904917|12219271|FG003|NOT COMPLETED|Overall Study||2
11039348|NCT00904969|12219284|FG000|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
11039349|NCT00904969|12219284|FG000|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
11039350|NCT00904969|12219284|FG000|NOT COMPLETED|Overall Study||19
11039351|NCT00904982|12219307|FG000|STARTED|Overall Study||68
11039352|NCT00904982|12219308|FG001|STARTED|Overall Study||67
11039353|NCT00904982|12219309|FG002|STARTED|Overall Study||67
11039354|NCT00904982|12219310|FG003|STARTED|Overall Study||68
11039355|NCT00904982|12219307|FG000|COMPLETED|Overall Study||66
11039356|NCT00904982|12219308|FG001|COMPLETED|Overall Study||67
11039357|NCT00904982|12219309|FG002|COMPLETED|Overall Study||67
11039358|NCT00904982|12219310|FG003|COMPLETED|Overall Study||68
11039359|NCT00904982|12219307|FG000|NOT COMPLETED|Overall Study||2
11039360|NCT00904982|12219308|FG001|NOT COMPLETED|Overall Study||0
11039361|NCT00904982|12219309|FG002|NOT COMPLETED|Overall Study||0
11039362|NCT00904982|12219310|FG003|NOT COMPLETED|Overall Study||0
11039363|NCT00904995|12219322|FG000|STARTED|Overall Study||10
11039364|NCT00904995|12219323|FG001|STARTED|Overall Study||11
11039365|NCT00904995|12219322|FG000|COMPLETED|Overall Study||10
11039366|NCT00904995|12219323|FG001|COMPLETED|Overall Study||11
11039367|NCT00904995|12219322|FG000|NOT COMPLETED|Overall Study||0
11039368|NCT00904995|12219323|FG001|NOT COMPLETED|Overall Study||0
11039369|NCT00905021|12219329|FG000|STARTED|Overall Study||4
11039370|NCT00905021|12219329|FG000|COMPLETED|Overall Study|2 patients were off study due to AE.|2
11039371|NCT00905021|12219329|FG000|NOT COMPLETED|Overall Study||2
11039372|NCT00905034|12219334|FG000|STARTED|Overall Study||37
11039373|NCT00905034|12219334|FG000|COMPLETED|Overall Study||36
11039374|NCT00905034|12219334|FG000|NOT COMPLETED|Overall Study||1
11039375|NCT00905060|12219338|FG000|STARTED|Surgical Resection||70
11039376|NCT00905060|12219338|FG000|COMPLETED|Surgical Resection||46
11039377|NCT00905060|12219338|FG000|NOT COMPLETED|Surgical Resection||24
11039378|NCT00905060|12219338|FG000|STARTED|Vaccination Treatment Period||46
11039379|NCT00905060|12219338|FG000|COMPLETED|Vaccination Treatment Period||46
11039380|NCT00905060|12219338|FG000|NOT COMPLETED|Vaccination Treatment Period||0
11039381|NCT00905125|12219344|FG000|STARTED|Overall Study||46
11039382|NCT00905125|12219345|FG001|STARTED|Overall Study||56
11039383|NCT00905125|12219344|FG000|COMPLETED|Overall Study||42
11039384|NCT00905125|12219345|FG001|COMPLETED|Overall Study||53
11039385|NCT00905125|12219344|FG000|NOT COMPLETED|Overall Study||4
11039386|NCT00905125|12219345|FG001|NOT COMPLETED|Overall Study||3
11039387|NCT00905151|12219351|FG000|STARTED|Overall Study||206
11039388|NCT00905151|12219351|FG000|COMPLETED|Overall Study||200
11039389|NCT00905151|12219351|FG000|NOT COMPLETED|Overall Study||6
11039390|NCT00905255|12219357|FG000|STARTED|Overall Study|Randomized.|33
11039391|NCT00905255|12219358|FG001|STARTED|Overall Study||36
11039392|NCT00905255|12219357|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
11039393|NCT00905255|12219358|FG001|Safety Population|Overall Study||36
11039394|NCT00905255|12219357|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
11039395|NCT00905255|12219358|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||36
11039396|NCT00905255|12219357|FG000|COMPLETED|Overall Study||20
11039397|NCT00905255|12219358|FG001|COMPLETED|Overall Study||27
11039398|NCT00905255|12219357|FG000|NOT COMPLETED|Overall Study||13
11039399|NCT00905255|12219358|FG001|NOT COMPLETED|Overall Study||9
11039400|NCT00905268|12219369|FG000|STARTED|Overall Study||57
11039401|NCT00905268|12219370|FG001|STARTED|Overall Study||57
11039402|NCT00905268|12219371|FG002|STARTED|Overall Study||59
11039403|NCT00905268|12219372|FG003|STARTED|Overall Study||59
11039404|NCT00905268|12219369|FG000|COMPLETED|Overall Study||53
11039405|NCT00905268|12219370|FG001|COMPLETED|Overall Study||56
11039406|NCT00905268|12219371|FG002|COMPLETED|Overall Study||59
11039407|NCT00905268|12219372|FG003|COMPLETED|Overall Study||57
11039408|NCT00905268|12219369|FG000|NOT COMPLETED|Overall Study||4
11039409|NCT00905268|12219370|FG001|NOT COMPLETED|Overall Study||1
11039410|NCT00905268|12219371|FG002|NOT COMPLETED|Overall Study||0
11039411|NCT00905268|12219372|FG003|NOT COMPLETED|Overall Study||2
11335756|NCT02867202|12533295|FG000|NOT COMPLETED|Overall Study||21
11335757|NCT02867202|12533296|FG001|NOT COMPLETED|Overall Study||32
11335758|NCT02867605|12533302|FG000|STARTED|Overall Study||20
11335759|NCT02867605|12533302|FG000|COMPLETED|Overall Study||20
11335760|NCT02867605|12533302|FG000|NOT COMPLETED|Overall Study||0
11335761|NCT02867618|12533319|FG000|STARTED|Overall Study||11
11335762|NCT02867618|12533319|FG000|COMPLETED|Overall Study||11
11335763|NCT02867618|12533319|FG000|NOT COMPLETED|Overall Study||0
11335764|NCT02867709|12533326|FG000|STARTED|Treatment Period||563
11335765|NCT02867709|12533327|FG001|STARTED|Treatment Period||561
11335766|NCT02867709|12533328|FG002|STARTED|Treatment Period||562
11335767|NCT02867709|12533326|FG000|Safety Population: Received Study Drug|Treatment Period||499
11335768|NCT02867709|12533327|FG001|Safety Population: Received Study Drug|Treatment Period||478
11335769|NCT02867709|12533328|FG002|Safety Population: Received Study Drug|Treatment Period||488
11335770|NCT02867709|12533326|FG000|COMPLETED|Treatment Period||493
11335771|NCT02867709|12533327|FG001|COMPLETED|Treatment Period||474
11335772|NCT02867709|12533328|FG002|COMPLETED|Treatment Period||487
11335773|NCT02867709|12533326|FG000|NOT COMPLETED|Treatment Period||70
11335774|NCT02867709|12533327|FG001|NOT COMPLETED|Treatment Period||87
11335775|NCT02867709|12533328|FG002|NOT COMPLETED|Treatment Period||75
11335776|NCT02867709|12533326|FG000|STARTED|Safety Follow-up Period||493
11335777|NCT02867709|12533327|FG001|STARTED|Safety Follow-up Period||474
11335778|NCT02867709|12533328|FG002|STARTED|Safety Follow-up Period||487
11335779|NCT02867709|12533326|FG000|COMPLETED|Safety Follow-up Period||482
11335780|NCT02867709|12533327|FG001|COMPLETED|Safety Follow-up Period||459
11335781|NCT02867709|12533328|FG002|COMPLETED|Safety Follow-up Period||473
11335782|NCT02867709|12533326|FG000|NOT COMPLETED|Safety Follow-up Period||11
11039412|NCT00905307|12219388|FG000|STARTED|Overall Study||42
11039413|NCT00905307|12219389|FG001|STARTED|Overall Study||89
11039414|NCT00905307|12219390|FG002|STARTED|Overall Study||90
11039415|NCT00905307|12219391|FG003|STARTED|Overall Study||93
11039416|NCT00905307|12219392|FG004|STARTED|Overall Study||50
11335783|NCT02867709|12533327|FG001|NOT COMPLETED|Safety Follow-up Period||15
11335784|NCT02867709|12533328|FG002|NOT COMPLETED|Safety Follow-up Period||14
11039417|NCT00905307|12219393|FG005|STARTED|Overall Study||95
11039418|NCT00905307|12219388|FG000|COMPLETED|Overall Study||20
11039419|NCT00905307|12219389|FG001|COMPLETED|Overall Study||52
11039420|NCT00905307|12219390|FG002|COMPLETED|Overall Study||53
11039421|NCT00905307|12219391|FG003|COMPLETED|Overall Study||56
11039422|NCT00905307|12219392|FG004|COMPLETED|Overall Study||34
11039423|NCT00905307|12219393|FG005|COMPLETED|Overall Study||53
11039424|NCT00905307|12219388|FG000|NOT COMPLETED|Overall Study||22
11039425|NCT00905307|12219389|FG001|NOT COMPLETED|Overall Study||37
11039426|NCT00905307|12219390|FG002|NOT COMPLETED|Overall Study||37
11039427|NCT00905307|12219391|FG003|NOT COMPLETED|Overall Study||37
11039428|NCT00905307|12219392|FG004|NOT COMPLETED|Overall Study||16
11039429|NCT00905307|12219393|FG005|NOT COMPLETED|Overall Study||42
11039430|NCT00905359|12219422|FG000|STARTED|Overall Study||82
11039431|NCT00905359|12219423|FG001|STARTED|Overall Study||81
11039432|NCT00905359|12219422|FG000|12 Months Follow up|Overall Study||68
11039433|NCT00905359|12219423|FG001|12 Months Follow up|Overall Study||72
11039434|NCT00905359|12219422|FG000|24 Months Follow up|Overall Study||58
11039435|NCT00905359|12219423|FG001|24 Months Follow up|Overall Study||65
11039436|NCT00905359|12219422|FG000|COMPLETED|Overall Study||58
11039437|NCT00905359|12219423|FG001|COMPLETED|Overall Study||65
11039438|NCT00905359|12219422|FG000|NOT COMPLETED|Overall Study||24
11039439|NCT00905359|12219423|FG001|NOT COMPLETED|Overall Study||16
11039440|NCT00905424|12219431|FG000|STARTED|Overall Study||89
11039441|NCT00905424|12219432|FG001|STARTED|Overall Study||88
11039442|NCT00905424|12219431|FG000|COMPLETED|Overall Study||78
11039443|NCT00905424|12219432|FG001|COMPLETED|Overall Study||79
11039444|NCT00905424|12219431|FG000|NOT COMPLETED|Overall Study||11
11039445|NCT00905424|12219432|FG001|NOT COMPLETED|Overall Study||9
11039446|NCT00905437|12219442|FG000|STARTED|Overall Study||35
11039447|NCT00905437|12219443|FG001|STARTED|Overall Study||37
11039448|NCT00905437|12219442|FG000|COMPLETED|Overall Study||27
11039449|NCT00905437|12219443|FG001|COMPLETED|Overall Study||27
11039450|NCT00905437|12219442|FG000|NOT COMPLETED|Overall Study||8
11039451|NCT00905437|12219443|FG001|NOT COMPLETED|Overall Study||10
11039452|NCT00905450|12219457|FG000|STARTED|Overall Study||60
11039453|NCT00905450|12219458|FG001|STARTED|Overall Study||28
11039454|NCT00905450|12219459|FG002|STARTED|Overall Study||28
11039455|NCT00905450|12219460|FG003|STARTED|Overall Study||60
11039456|NCT00905450|12219461|FG004|STARTED|Overall Study||59
11039457|NCT00905450|12219462|FG005|STARTED|Overall Study||60
11039458|NCT00905450|12219463|FG006|STARTED|Overall Study||60
11039459|NCT00905450|12219464|FG007|STARTED|Overall Study||60
11039460|NCT00905450|12219457|FG000|COMPLETED|Overall Study||59
11039461|NCT00905450|12219458|FG001|COMPLETED|Overall Study||27
11039462|NCT00905450|12219459|FG002|COMPLETED|Overall Study||28
11039463|NCT00905450|12219460|FG003|COMPLETED|Overall Study||60
11039464|NCT00905450|12219461|FG004|COMPLETED|Overall Study||59
11039465|NCT00905450|12219462|FG005|COMPLETED|Overall Study||58
11039466|NCT00905450|12219463|FG006|COMPLETED|Overall Study||58
11039467|NCT00905450|12219464|FG007|COMPLETED|Overall Study||59
11039468|NCT00905450|12219457|FG000|NOT COMPLETED|Overall Study||1
11039469|NCT00905450|12219458|FG001|NOT COMPLETED|Overall Study||1
11039470|NCT00905450|12219459|FG002|NOT COMPLETED|Overall Study||0
11039471|NCT00905450|12219460|FG003|NOT COMPLETED|Overall Study||0
11039472|NCT00905450|12219461|FG004|NOT COMPLETED|Overall Study||0
11039473|NCT00905450|12219462|FG005|NOT COMPLETED|Overall Study||2
11039474|NCT00905450|12219463|FG006|NOT COMPLETED|Overall Study||2
11039475|NCT00905450|12219464|FG007|NOT COMPLETED|Overall Study||1
11039476|NCT00905489|12219482|FG000|STARTED|Pharmaco-kinetic (PK) Phase||85
11039477|NCT00905489|12219482|FG000|COMPLETED|Pharmaco-kinetic (PK) Phase||80
11039478|NCT00905489|12219482|FG000|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
11039479|NCT00905489|12219482|FG000|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
11039480|NCT00905489|12219482|FG000|COMPLETED|Optional Extension Phase (OEP)||39
11039481|NCT00905489|12219482|FG000|NOT COMPLETED|Optional Extension Phase (OEP)||1
11039482|NCT00905515|12219494|FG000|STARTED|Overall Study||21
11039483|NCT00905515|12219495|FG001|STARTED|Overall Study||20
11039484|NCT00905515|12219496|FG002|STARTED|Overall Study||22
11039485|NCT00905515|12219494|FG000|COMPLETED|Overall Study||19
11039486|NCT00905515|12219495|FG001|COMPLETED|Overall Study||20
11039487|NCT00905515|12219496|FG002|COMPLETED|Overall Study||20
11039488|NCT00905515|12219494|FG000|NOT COMPLETED|Overall Study||2
11039489|NCT00905515|12219495|FG001|NOT COMPLETED|Overall Study||0
11039490|NCT00905515|12219496|FG002|NOT COMPLETED|Overall Study||2
11039491|NCT00905554|12219506|FG000|STARTED|Overall Study||116
11039492|NCT00905554|12219507|FG001|STARTED|Overall Study||114
11039493|NCT00905554|12219506|FG000|COMPLETED|Overall Study||116
11039494|NCT00905554|12219507|FG001|COMPLETED|Overall Study||114
11039495|NCT00905554|12219506|FG000|NOT COMPLETED|Overall Study||0
11039496|NCT00905554|12219507|FG001|NOT COMPLETED|Overall Study||0
11039497|NCT00905580|12219515|FG000|STARTED|Overall Study||49
11039498|NCT00905580|12219516|FG001|STARTED|Overall Study||50
11039499|NCT00905580|12219515|FG000|COMPLETED|Overall Study||47
11039500|NCT00905580|12219516|FG001|COMPLETED|Overall Study||47
11039501|NCT00905580|12219515|FG000|NOT COMPLETED|Overall Study||2
11039502|NCT00905580|12219516|FG001|NOT COMPLETED|Overall Study||3
11039503|NCT00905632|12219529|FG000|STARTED|Overall Study||8
11039504|NCT00905632|12219530|FG001|STARTED|Overall Study||6
11039505|NCT00905632|12219531|FG002|STARTED|Overall Study||7
11039506|NCT00905632|12219532|FG003|STARTED|Overall Study||6
11039507|NCT00905632|12219533|FG004|STARTED|Overall Study||10
11039508|NCT00905632|12219534|FG005|STARTED|Overall Study||9
11039509|NCT00905632|12219535|FG006|STARTED|Overall Study||11
11039510|NCT00905632|12219529|FG000|COMPLETED|Overall Study||8
11039511|NCT00905632|12219530|FG001|COMPLETED|Overall Study||6
11039512|NCT00905632|12219531|FG002|COMPLETED|Overall Study||7
11039513|NCT00905632|12219532|FG003|COMPLETED|Overall Study||6
11039514|NCT00905632|12219533|FG004|COMPLETED|Overall Study||10
11039515|NCT00905632|12219534|FG005|COMPLETED|Overall Study||8
11039516|NCT00905632|12219535|FG006|COMPLETED|Overall Study||7
11039517|NCT00905632|12219529|FG000|NOT COMPLETED|Overall Study||0
11039518|NCT00905632|12219530|FG001|NOT COMPLETED|Overall Study||0
11039519|NCT00905632|12219531|FG002|NOT COMPLETED|Overall Study||0
11039520|NCT00905632|12219532|FG003|NOT COMPLETED|Overall Study||0
11039521|NCT00905632|12219533|FG004|NOT COMPLETED|Overall Study||0
11039522|NCT00905632|12219534|FG005|NOT COMPLETED|Overall Study||1
11039523|NCT00905632|12219535|FG006|NOT COMPLETED|Overall Study||4
11039524|NCT00905827|12219561|FG000|STARTED|Overall Study||70
11039525|NCT00905827|12219562|FG001|STARTED|Overall Study||69
11039526|NCT00905827|12219563|FG002|STARTED|Overall Study||73
11039527|NCT00905827|12219561|FG000|COMPLETED|Overall Study||70
11039528|NCT00905827|12219562|FG001|COMPLETED|Overall Study||69
11039529|NCT00905827|12219563|FG002|COMPLETED|Overall Study||73
11039530|NCT00905827|12219561|FG000|NOT COMPLETED|Overall Study||0
11039531|NCT00905827|12219562|FG001|NOT COMPLETED|Overall Study||0
11039532|NCT00905827|12219563|FG002|NOT COMPLETED|Overall Study||0
11039533|NCT00905840|12219571|FG000|STARTED|Overall Study||91
11039534|NCT00905840|12219571|FG000|COMPLETED|Overall Study||75
11039535|NCT00905840|12219571|FG000|NOT COMPLETED|Overall Study||16
11039536|NCT00906074|12219580|FG000|STARTED|Overall Study||90
11039537|NCT00906074|12219581|FG001|STARTED|Overall Study||90
11039538|NCT00906074|12219580|FG000|COMPLETED|Overall Study||90
11039539|NCT00906074|12219581|FG001|COMPLETED|Overall Study||90
11039540|NCT00906074|12219580|FG000|NOT COMPLETED|Overall Study||0
11039541|NCT00906074|12219581|FG001|NOT COMPLETED|Overall Study||0
11039542|NCT00906087|12219587|FG000|STARTED|Initial Washout||14
11039543|NCT00906087|12219587|FG000|Completed Screening|Initial Washout||14
11039544|NCT00906087|12219587|FG000|Begin Washout|Initial Washout||13
11039545|NCT00906087|12219587|FG000|Completed Washout and Continue Protocol|Initial Washout||12
11039546|NCT00906087|12219587|FG000|COMPLETED|Initial Washout||12
11039547|NCT00906087|12219587|FG000|NOT COMPLETED|Initial Washout||2
11039548|NCT00906087|12219587|FG000|STARTED|Cosopt Treatment 6 Weeks||12
11039549|NCT00906087|12219587|FG000|COMPLETED|Cosopt Treatment 6 Weeks||12
11039550|NCT00906087|12219587|FG000|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
11039551|NCT00906087|12219587|FG000|STARTED|Final Washout Period 4 Weeks||12
11039552|NCT00906087|12219587|FG000|COMPLETED|Final Washout Period 4 Weeks||12
11039553|NCT00906087|12219587|FG000|NOT COMPLETED|Final Washout Period 4 Weeks||0
11039554|NCT00906165|12219596|FG000|STARTED|Overall Study||14
11039555|NCT00906165|12219597|FG001|STARTED|Overall Study||14
11039556|NCT00906165|12219596|FG000|COMPLETED|Overall Study||10
11039557|NCT00906165|12219597|FG001|COMPLETED|Overall Study||14
11039558|NCT00906165|12219596|FG000|NOT COMPLETED|Overall Study||4
11039559|NCT00906165|12219597|FG001|NOT COMPLETED|Overall Study||0
11039560|NCT00906178|12219605|FG000|STARTED|Overall Study||183
11039561|NCT00906178|12219606|FG001|STARTED|Overall Study||183
11039562|NCT00906178|12219605|FG000|COMPLETED|Overall Study||168
11039563|NCT00906178|12219606|FG001|COMPLETED|Overall Study||167
11039564|NCT00906178|12219605|FG000|NOT COMPLETED|Overall Study||15
11039565|NCT00906178|12219606|FG001|NOT COMPLETED|Overall Study||16
11057750|NCT00999908|12239482|FG001|COMPLETED|Treatment Period 1||16
11057751|NCT00999908|12239483|FG002|COMPLETED|Treatment Period 1||19
11057752|NCT00999908|12239481|FG000|NOT COMPLETED|Treatment Period 1||2
11057753|NCT00999908|12239482|FG001|NOT COMPLETED|Treatment Period 1||0
11057754|NCT00999908|12239483|FG002|NOT COMPLETED|Treatment Period 1||0
11057755|NCT00999908|12239481|FG000|STARTED|Treatment Period 2||17
11057756|NCT00999908|12239482|FG001|STARTED|Treatment Period 2||16
11057757|NCT00999908|12239483|FG002|STARTED|Treatment Period 2||19
11057758|NCT00999908|12239481|FG000|COMPLETED|Treatment Period 2||16
11057759|NCT00999908|12239482|FG001|COMPLETED|Treatment Period 2||16
11057760|NCT00999908|12239483|FG002|COMPLETED|Treatment Period 2||19
11057761|NCT00999908|12239481|FG000|NOT COMPLETED|Treatment Period 2||1
11057762|NCT00999908|12239482|FG001|NOT COMPLETED|Treatment Period 2||0
11057763|NCT00999908|12239483|FG002|NOT COMPLETED|Treatment Period 2||0
11057764|NCT00999908|12239481|FG000|STARTED|Treatment Period 3||16
11057765|NCT00999908|12239482|FG001|STARTED|Treatment Period 3||16
11057766|NCT00999908|12239483|FG002|STARTED|Treatment Period 3||19
11057767|NCT00999908|12239481|FG000|COMPLETED|Treatment Period 3||16
11057768|NCT00999908|12239482|FG001|COMPLETED|Treatment Period 3||16
11057769|NCT00999908|12239483|FG002|COMPLETED|Treatment Period 3||19
11057770|NCT00999908|12239481|FG000|NOT COMPLETED|Treatment Period 3||0
11057771|NCT00999908|12239482|FG001|NOT COMPLETED|Treatment Period 3||0
11057772|NCT00999908|12239483|FG002|NOT COMPLETED|Treatment Period 3||0
11057773|NCT00999921|12239493|FG000|STARTED|Overall Study||127
11057774|NCT00999921|12239494|FG001|STARTED|Overall Study||129
11057775|NCT00999921|12239493|FG000|COMPLETED|Overall Study||117
11057776|NCT00999921|12239494|FG001|COMPLETED|Overall Study||110
11057777|NCT00999921|12239493|FG000|NOT COMPLETED|Overall Study||10
11057778|NCT00999921|12239494|FG001|NOT COMPLETED|Overall Study||19
11057779|NCT01000025|12239505|FG000|STARTED|Overall Study||480
11057780|NCT01000025|12239506|FG001|STARTED|Overall Study||240
11057781|NCT01000025|12239505|FG000|COMPLETED|Overall Study||12
11057782|NCT01000025|12239506|FG001|COMPLETED|Overall Study||2
11057783|NCT01000025|12239505|FG000|NOT COMPLETED|Overall Study||468
11335785|NCT02867995|12533338|FG000|STARTED|Overall Study|Total patients consented|9
11057784|NCT01000025|12239506|FG001|NOT COMPLETED|Overall Study||238
11057785|NCT01000051|12239514|FG000|STARTED|Overall Study||42
11057786|NCT01000051|12239515|FG001|STARTED|Overall Study||18
11057787|NCT01000051|12239514|FG000|COMPLETED|Overall Study||39
11057788|NCT01000051|12239515|FG001|COMPLETED|Overall Study||17
11057789|NCT01000051|12239514|FG000|NOT COMPLETED|Overall Study||3
11057790|NCT01000051|12239515|FG001|NOT COMPLETED|Overall Study||1
11057791|NCT01000064|12239521|FG000|STARTED|Overall Study||7
11057792|NCT01000064|12239522|FG001|STARTED|Overall Study||6
11057793|NCT01000064|12239521|FG000|COMPLETED|Overall Study||6
11057794|NCT01000064|12239522|FG001|COMPLETED|Overall Study||5
11057795|NCT01000064|12239521|FG000|NOT COMPLETED|Overall Study||1
11335786|NCT02867995|12533339|FG001|STARTED|Overall Study|Total patients consented|30
11335787|NCT02867995|12533338|FG000|COMPLETED|Overall Study|Total patients completed|9
11335788|NCT02867995|12533339|FG001|COMPLETED|Overall Study|Total patients completed|27
11335789|NCT02867995|12533338|FG000|NOT COMPLETED|Overall Study||0
11335790|NCT02867995|12533339|FG001|NOT COMPLETED|Overall Study||3
11335791|NCT02868216|12533351|FG000|STARTED|Overall Study||43
11335792|NCT02868216|12533352|FG001|STARTED|Overall Study||47
11335793|NCT02868216|12533351|FG000|COMPLETED|Overall Study||35
11335794|NCT02868216|12533352|FG001|COMPLETED|Overall Study||41
11335795|NCT02868216|12533351|FG000|NOT COMPLETED|Overall Study||8
11335796|NCT02868216|12533352|FG001|NOT COMPLETED|Overall Study||6
11335797|NCT02868229|12533362|FG000|STARTED|Overall Study||12
11335798|NCT02868229|12533363|FG001|STARTED|Overall Study||16
11335799|NCT02868229|12533364|FG002|STARTED|Overall Study||16
11335800|NCT02868229|12533365|FG003|STARTED|Overall Study||17
11335801|NCT02868229|12533362|FG000|Intent to Treat (ITT) Population|Overall Study||12
11335802|NCT02868229|12533363|FG001|Intent to Treat (ITT) Population|Overall Study||16
11335803|NCT02868229|12533364|FG002|Intent to Treat (ITT) Population|Overall Study||16
11057796|NCT01000064|12239522|FG001|NOT COMPLETED|Overall Study||1
11057797|NCT01000155|12239531|FG000|STARTED|Overall Study||5
11057798|NCT01000155|12239531|FG000|COMPLETED|Overall Study||3
11335804|NCT02868229|12533365|FG003|Intent to Treat (ITT) Population|Overall Study||17
11335805|NCT02868229|12533362|FG000|Pharmacodynamic (PD) Population|Overall Study||12
11335806|NCT02868229|12533363|FG001|Pharmacodynamic (PD) Population|Overall Study||16
11335807|NCT02868229|12533364|FG002|Pharmacodynamic (PD) Population|Overall Study||13
11335808|NCT02868229|12533365|FG003|Pharmacodynamic (PD) Population|Overall Study||12
11335809|NCT02868229|12533362|FG000|Pharmacokinetic (PK) Population|Overall Study||12
11039566|NCT00906204|12219614|FG000|STARTED|Primary Endpoint (Early Safety)||45
11039567|NCT00906204|12219615|FG001|STARTED|Primary Endpoint (Early Safety)||52
11039568|NCT00906204|12219614|FG000|COMPLETED|Primary Endpoint (Early Safety)||43
11335810|NCT02868229|12533363|FG001|Pharmacokinetic (PK) Population|Overall Study||16
11335811|NCT02868229|12533364|FG002|Pharmacokinetic (PK) Population|Overall Study||16
11335812|NCT02868229|12533365|FG003|Pharmacokinetic (PK) Population|Overall Study||17
11335813|NCT02868229|12533362|FG000|Safety Analysis Population|Overall Study||12
11335814|NCT02868229|12533363|FG001|Safety Analysis Population|Overall Study||16
11335815|NCT02868229|12533364|FG002|Safety Analysis Population|Overall Study||16
11335816|NCT02868229|12533365|FG003|Safety Analysis Population|Overall Study||17
11335817|NCT02868229|12533362|FG000|Maximum Tolerated Dose (MTD) Population|Overall Study||12
11335818|NCT02868229|12533363|FG001|Maximum Tolerated Dose (MTD) Population|Overall Study||16
11335819|NCT02868229|12533364|FG002|Maximum Tolerated Dose (MTD) Population|Overall Study||16
11039569|NCT00906204|12219615|FG001|COMPLETED|Primary Endpoint (Early Safety)||51
11335820|NCT02868229|12533365|FG003|Maximum Tolerated Dose (MTD) Population|Overall Study||16
11335821|NCT02868229|12533362|FG000|COMPLETED|Overall Study||11
11335822|NCT02868229|12533363|FG001|COMPLETED|Overall Study||16
11335823|NCT02868229|12533364|FG002|COMPLETED|Overall Study||15
11335824|NCT02868229|12533365|FG003|COMPLETED|Overall Study||12
11039570|NCT00906204|12219614|FG000|NOT COMPLETED|Primary Endpoint (Early Safety)||2
11039571|NCT00906204|12219615|FG001|NOT COMPLETED|Primary Endpoint (Early Safety)||1
11039572|NCT00906204|12219614|FG000|STARTED|Secondary Endpoints (Long-term Safety)||43
11039573|NCT00906204|12219615|FG001|STARTED|Secondary Endpoints (Long-term Safety)||51
11039574|NCT00906204|12219614|FG000|COMPLETED|Secondary Endpoints (Long-term Safety)||41
11039575|NCT00906204|12219615|FG001|COMPLETED|Secondary Endpoints (Long-term Safety)||48
11039576|NCT00906204|12219614|FG000|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
11039577|NCT00906204|12219615|FG001|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
11039578|NCT00906243|12219621|FG000|STARTED|Overall Study||6
11039579|NCT00906243|12219621|FG000|COMPLETED|Overall Study||6
11039580|NCT00906243|12219621|FG000|NOT COMPLETED|Overall Study||0
11039581|NCT00906282|12219625|FG000|STARTED|Preoperative Chemotherapy||46
11039582|NCT00906282|12219625|FG000|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
11039583|NCT00906282|12219625|FG000|NOT COMPLETED|Preoperative Chemotherapy||19
11039584|NCT00906282|12219625|FG000|STARTED|Surgical Resection||27
11039585|NCT00906282|12219625|FG000|COMPLETED|Surgical Resection||27
11039586|NCT00906282|12219625|FG000|NOT COMPLETED|Surgical Resection||0
11039587|NCT00906347|12219632|FG000|STARTED|Randomized||176
11039588|NCT00906347|12219633|FG001|STARTED|Randomized||174
11039589|NCT00906347|12219632|FG000|COMPLETED|Randomized||176
11039590|NCT00906347|12219633|FG001|COMPLETED|Randomized||174
11039591|NCT00906347|12219632|FG000|NOT COMPLETED|Randomized||0
11039592|NCT00906347|12219633|FG001|NOT COMPLETED|Randomized||0
11039593|NCT00906347|12219632|FG000|STARTED|Received Study Drug||176
11039594|NCT00906347|12219633|FG001|STARTED|Received Study Drug||174
11039595|NCT00906347|12219632|FG000|COMPLETED|Received Study Drug||136
11039596|NCT00906347|12219633|FG001|COMPLETED|Received Study Drug||143
11335825|NCT02868229|12533362|FG000|NOT COMPLETED|Overall Study||1
11039597|NCT00906347|12219632|FG000|NOT COMPLETED|Received Study Drug||40
11039598|NCT00906347|12219633|FG001|NOT COMPLETED|Received Study Drug||31
11039599|NCT00906373|12219641|FG000|STARTED|Overall Study||6
11039600|NCT00906373|12219642|FG001|STARTED|Overall Study||41
11039601|NCT00906373|12219641|FG000|Received Any Amount of Study Drug|Overall Study||6
11039602|NCT00906373|12219642|FG001|Received Any Amount of Study Drug|Overall Study||41
11039603|NCT00906373|12219641|FG000|COMPLETED|Overall Study||6
11039604|NCT00906373|12219642|FG001|COMPLETED|Overall Study||33
11039605|NCT00906373|12219641|FG000|NOT COMPLETED|Overall Study||0
11039606|NCT00906373|12219642|FG001|NOT COMPLETED|Overall Study||8
11039607|NCT00906399|12219652|FG000|STARTED|Year 1||500
11039608|NCT00906399|12219653|FG001|STARTED|Year 1||501
11039609|NCT00906399|12219654|FG002|STARTED|Year 1||515
11039610|NCT00906399|12219655|FG003|STARTED|Year 1||0
11039611|NCT00906399|12219656|FG004|STARTED|Year 1||0
11039612|NCT00906399|12219657|FG005|STARTED|Year 1||0
11039613|NCT00906399|12219658|FG006|STARTED|Year 1||0
11039614|NCT00906399|12219652|FG000|Completed Year 1 Study Treatment|Year 1||456
11039615|NCT00906399|12219653|FG001|Completed Year 1 Study Treatment|Year 1||438
11039616|NCT00906399|12219654|FG002|Completed Year 1 Study Treatment|Year 1||438
11039617|NCT00906399|12219655|FG003|Completed Year 1 Study Treatment|Year 1||0
11039618|NCT00906399|12219656|FG004|Completed Year 1 Study Treatment|Year 1||0
11039619|NCT00906399|12219657|FG005|Completed Year 1 Study Treatment|Year 1||0
11039620|NCT00906399|12219658|FG006|Completed Year 1 Study Treatment|Year 1||0
11039621|NCT00906399|12219652|FG000|COMPLETED|Year 1||456
11039622|NCT00906399|12219653|FG001|COMPLETED|Year 1||438
11039623|NCT00906399|12219654|FG002|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
11039624|NCT00906399|12219655|FG003|COMPLETED|Year 1||0
11039625|NCT00906399|12219656|FG004|COMPLETED|Year 1||0
11039626|NCT00906399|12219657|FG005|COMPLETED|Year 1||0
11039627|NCT00906399|12219658|FG006|COMPLETED|Year 1||0
11039628|NCT00906399|12219652|FG000|NOT COMPLETED|Year 1||44
11039629|NCT00906399|12219653|FG001|NOT COMPLETED|Year 1||63
11039630|NCT00906399|12219654|FG002|NOT COMPLETED|Year 1||76
11039631|NCT00906399|12219655|FG003|NOT COMPLETED|Year 1||0
11039632|NCT00906399|12219656|FG004|NOT COMPLETED|Year 1||0
11039633|NCT00906399|12219657|FG005|NOT COMPLETED|Year 1||0
11039634|NCT00906399|12219658|FG006|NOT COMPLETED|Year 1||0
11039635|NCT00906399|12219652|FG000|STARTED|Year 2||0
11039636|NCT00906399|12219653|FG001|STARTED|Year 2||0
11039637|NCT00906399|12219654|FG002|STARTED|Year 2||0
11039638|NCT00906399|12219655|FG003|STARTED|Year 2||228
11039639|NCT00906399|12219656|FG004|STARTED|Year 2||228
11039640|NCT00906399|12219657|FG005|STARTED|Year 2||438
11039641|NCT00906399|12219658|FG006|STARTED|Year 2||438
11039642|NCT00906399|12219652|FG000|Completed Year 2 Study Treatment|Year 2||0
11039643|NCT00906399|12219653|FG001|Completed Year 2 Study Treatment|Year 2||0
11039644|NCT00906399|12219654|FG002|Completed Year 2 Study Treatment|Year 2||0
11039645|NCT00906399|12219655|FG003|Completed Year 2 Study Treatment|Year 2||200
11039646|NCT00906399|12219656|FG004|Completed Year 2 Study Treatment|Year 2||196
11039647|NCT00906399|12219657|FG005|Completed Year 2 Study Treatment|Year 2||391
11039648|NCT00906399|12219658|FG006|Completed Year 2 Study Treatment|Year 2||411
11039649|NCT00906399|12219652|FG000|COMPLETED|Year 2||0
11039650|NCT00906399|12219653|FG001|COMPLETED|Year 2||0
11039651|NCT00906399|12219654|FG002|COMPLETED|Year 2||0
11039652|NCT00906399|12219655|FG003|COMPLETED|Year 2||198
11039653|NCT00906399|12219656|FG004|COMPLETED|Year 2||193
11039654|NCT00906399|12219657|FG005|COMPLETED|Year 2||391
11039655|NCT00906399|12219658|FG006|COMPLETED|Year 2||409
11039656|NCT00906399|12219652|FG000|NOT COMPLETED|Year 2||0
11039657|NCT00906399|12219653|FG001|NOT COMPLETED|Year 2||0
11039658|NCT00906399|12219654|FG002|NOT COMPLETED|Year 2||0
11335826|NCT02868229|12533363|FG001|NOT COMPLETED|Overall Study||0
11039659|NCT00906399|12219655|FG003|NOT COMPLETED|Year 2||30
11039660|NCT00906399|12219656|FG004|NOT COMPLETED|Year 2||35
11039661|NCT00906399|12219657|FG005|NOT COMPLETED|Year 2||47
11039662|NCT00906399|12219658|FG006|NOT COMPLETED|Year 2||29
11039663|NCT00906425|12219672|FG000|STARTED|Overall Study||73
11039664|NCT00906425|12219673|FG001|STARTED|Overall Study||72
11039665|NCT00906425|12219672|FG000|6 Months|Overall Study|ITT population|69
11039666|NCT00906425|12219673|FG001|6 Months|Overall Study|ITT population|64
11039667|NCT00906425|12219672|FG000|1 Year|Overall Study|ITT population|67
11335827|NCT02868229|12533364|FG002|NOT COMPLETED|Overall Study||1
11039668|NCT00906425|12219673|FG001|1 Year|Overall Study|ITT population|60
11039669|NCT00906425|12219672|FG000|2 Year|Overall Study|ITT population|62
11039670|NCT00906425|12219673|FG001|2 Year|Overall Study|ITT population|58
11335828|NCT02868229|12533365|FG003|NOT COMPLETED|Overall Study||5
11335829|NCT02868242|12533380|FG000|STARTED|Overall Study||19
11335830|NCT02868242|12533380|FG000|COMPLETED|Overall Study||19
11335831|NCT02868242|12533380|FG000|NOT COMPLETED|Overall Study||0
11335832|NCT02868281|12533388|FG000|STARTED|Overall Study||252
11335833|NCT02868281|12533389|FG001|STARTED|Overall Study||278
11335834|NCT02868281|12533388|FG000|COMPLETED|Overall Study||209
11039671|NCT00906425|12219672|FG000|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
11039672|NCT00906425|12219673|FG001|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
11039673|NCT00906425|12219672|FG000|NOT COMPLETED|Overall Study||73
11039674|NCT00906425|12219673|FG001|NOT COMPLETED|Overall Study||72
11039675|NCT00906503|12219679|FG000|STARTED|Overall Study||9
11039676|NCT00906503|12219679|FG000|COMPLETED|Overall Study||9
11039677|NCT00906503|12219679|FG000|NOT COMPLETED|Overall Study||0
11039678|NCT00906698|12219689|FG000|STARTED|Overall Study||3
11039679|NCT00906698|12219690|FG001|STARTED|Overall Study||19
11039680|NCT00906698|12219691|FG002|STARTED|Overall Study||6
11039681|NCT00906698|12219692|FG003|STARTED|Overall Study||4
11039682|NCT00906698|12219693|FG004|STARTED|Overall Study||18
11039683|NCT00906698|12219694|FG005|STARTED|Overall Study||5
11039684|NCT00906698|12219689|FG000|COMPLETED|Overall Study||0
11039685|NCT00906698|12219690|FG001|COMPLETED|Overall Study||0
11039686|NCT00906698|12219691|FG002|COMPLETED|Overall Study||0
11039687|NCT00906698|12219692|FG003|COMPLETED|Overall Study||0
11039688|NCT00906698|12219693|FG004|COMPLETED|Overall Study||0
11039689|NCT00906698|12219694|FG005|COMPLETED|Overall Study||0
11039690|NCT00906698|12219689|FG000|NOT COMPLETED|Overall Study||3
11039691|NCT00906698|12219690|FG001|NOT COMPLETED|Overall Study||19
11039692|NCT00906698|12219691|FG002|NOT COMPLETED|Overall Study||6
11039693|NCT00906698|12219692|FG003|NOT COMPLETED|Overall Study||4
11039694|NCT00906698|12219693|FG004|NOT COMPLETED|Overall Study||18
11039695|NCT00906698|12219694|FG005|NOT COMPLETED|Overall Study||5
11039696|NCT00906776|12219728|FG000|STARTED|Overall Study||11
11039697|NCT00906776|12219729|FG001|STARTED|Overall Study||8
11039698|NCT00906776|12219728|FG000|COMPLETED|Overall Study||11
11039699|NCT00906776|12219729|FG001|COMPLETED|Overall Study||8
11039700|NCT00906776|12219728|FG000|NOT COMPLETED|Overall Study||0
11039701|NCT00906776|12219729|FG001|NOT COMPLETED|Overall Study||0
11039702|NCT00906789|12219735|FG000|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
11039703|NCT00906789|12219735|FG000|COMPLETED|Overall Study||15
11039704|NCT00906789|12219735|FG000|NOT COMPLETED|Overall Study||0
11039705|NCT00906945|12219746|FG000|STARTED|Overall Study||3
11039706|NCT00906945|12219747|FG001|STARTED|Overall Study||3
11039707|NCT00906945|12219748|FG002|STARTED|Overall Study||3
11039708|NCT00906945|12219749|FG003|STARTED|Overall Study||7
11039709|NCT00906945|12219750|FG004|STARTED|Overall Study||7
11039710|NCT00906945|12219751|FG005|STARTED|Overall Study||16
11039711|NCT00906945|12219746|FG000|COMPLETED|Overall Study||3
11039712|NCT00906945|12219747|FG001|COMPLETED|Overall Study||3
11039713|NCT00906945|12219748|FG002|COMPLETED|Overall Study||3
11039714|NCT00906945|12219749|FG003|COMPLETED|Overall Study||6
11039715|NCT00906945|12219750|FG004|COMPLETED|Overall Study||6
11039716|NCT00906945|12219751|FG005|COMPLETED|Overall Study||14
11039717|NCT00906945|12219746|FG000|NOT COMPLETED|Overall Study||0
11039718|NCT00906945|12219747|FG001|NOT COMPLETED|Overall Study||0
11039719|NCT00906945|12219748|FG002|NOT COMPLETED|Overall Study||0
11039720|NCT00906945|12219749|FG003|NOT COMPLETED|Overall Study||1
11335835|NCT02868281|12533389|FG001|COMPLETED|Overall Study||234
11335836|NCT02868281|12533388|FG000|NOT COMPLETED|Overall Study||43
11335837|NCT02868281|12533389|FG001|NOT COMPLETED|Overall Study||44
11039721|NCT00906945|12219750|FG004|NOT COMPLETED|Overall Study||1
11039722|NCT00906945|12219751|FG005|NOT COMPLETED|Overall Study||2
11039723|NCT00906958|12219767|FG000|STARTED|Overall Study||10
11039724|NCT00906958|12219768|FG001|STARTED|Overall Study||10
11039725|NCT00906958|12219767|FG000|COMPLETED|Overall Study||10
11039726|NCT00906958|12219768|FG001|COMPLETED|Overall Study||10
11039727|NCT00906958|12219767|FG000|NOT COMPLETED|Overall Study||0
11039728|NCT00906958|12219768|FG001|NOT COMPLETED|Overall Study||0
11039729|NCT00906971|12219778|FG000|STARTED|Overall Study||36
11039730|NCT00906971|12219779|FG001|STARTED|Overall Study||36
11039731|NCT00906971|12219778|FG000|COMPLETED|Overall Study||28
11039732|NCT00906971|12219779|FG001|COMPLETED|Overall Study||33
11039733|NCT00906971|12219778|FG000|NOT COMPLETED|Overall Study||8
11039734|NCT00906971|12219779|FG001|NOT COMPLETED|Overall Study||3
11039735|NCT00907088|12219787|FG000|STARTED|Overall Study||122
11039736|NCT00907088|12219788|FG001|STARTED|Overall Study||129
11039737|NCT00907088|12219787|FG000|COMPLETED|Overall Study||102
11039738|NCT00907088|12219788|FG001|COMPLETED|Overall Study||99
11039739|NCT00907088|12219787|FG000|NOT COMPLETED|Overall Study||20
11039740|NCT00907088|12219788|FG001|NOT COMPLETED|Overall Study||30
11039741|NCT00907153|12219796|FG000|STARTED|Overall Study||13
11039742|NCT00907153|12219797|FG001|STARTED|Overall Study||15
11039743|NCT00907153|12219796|FG000|COMPLETED|Overall Study||11
11039744|NCT00907153|12219797|FG001|COMPLETED|Overall Study||11
11039745|NCT00907153|12219796|FG000|NOT COMPLETED|Overall Study||2
11039746|NCT00907153|12219797|FG001|NOT COMPLETED|Overall Study||4
11039747|NCT00907257|12219805|FG000|STARTED|Overall Study||123
11039748|NCT00907257|12219806|FG001|STARTED|Overall Study||124
11039749|NCT00907257|12219805|FG000|COMPLETED|Overall Study||110
11039750|NCT00907257|12219806|FG001|COMPLETED|Overall Study||112
11039751|NCT00907257|12219805|FG000|NOT COMPLETED|Overall Study||13
11039752|NCT00907257|12219806|FG001|NOT COMPLETED|Overall Study||12
11039753|NCT00907335|12219814|FG000|STARTED|Overall Study||55
11039754|NCT00907335|12219815|FG001|STARTED|Overall Study||55
11039755|NCT00907335|12219814|FG000|COMPLETED|Overall Study||47
11039756|NCT00907335|12219815|FG001|COMPLETED|Overall Study||54
11039757|NCT00907335|12219814|FG000|NOT COMPLETED|Overall Study||8
11039758|NCT00907335|12219815|FG001|NOT COMPLETED|Overall Study||1
11039759|NCT00907374|12219823|FG000|STARTED|Overall Study||14
11039760|NCT00907374|12219824|FG001|STARTED|Overall Study||13
11039761|NCT00907374|12219823|FG000|COMPLETED|Overall Study||12
11039762|NCT00907374|12219824|FG001|COMPLETED|Overall Study||11
11039763|NCT00907374|12219823|FG000|NOT COMPLETED|Overall Study||2
11039764|NCT00907374|12219824|FG001|NOT COMPLETED|Overall Study||2
11039765|NCT00907426|12219833|FG000|STARTED|Treatment Period 1 (0 to 6 Months)||215
11039766|NCT00907426|12219834|FG001|STARTED|Treatment Period 1 (0 to 6 Months)||60
11039767|NCT00907426|12219835|FG002|STARTED|Treatment Period 1 (0 to 6 Months)||93
11039768|NCT00907426|12219833|FG000|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
11039769|NCT00907426|12219834|FG001|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
11039770|NCT00907426|12219835|FG002|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
11039771|NCT00907426|12219833|FG000|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
11039772|NCT00907426|12219834|FG001|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
11039773|NCT00907426|12219835|FG002|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
11039774|NCT00907426|12219833|FG000|STARTED|Treatment Period 2 (6 to 12 Months)||195
11039775|NCT00907426|12219834|FG001|STARTED|Treatment Period 2 (6 to 12 Months)||55
11039776|NCT00907426|12219835|FG002|STARTED|Treatment Period 2 (6 to 12 Months)||84
11039777|NCT00907426|12219833|FG000|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
11039778|NCT00907426|12219834|FG001|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
11039779|NCT00907426|12219835|FG002|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
11039780|NCT00907426|12219833|FG000|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
11039781|NCT00907426|12219834|FG001|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
11039782|NCT00907426|12219835|FG002|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
11039783|NCT00907517|12219847|FG000|STARTED|Overall Study||3
11039784|NCT00907517|12219848|FG001|STARTED|Overall Study||3
11039785|NCT00907517|12219849|FG002|STARTED|Overall Study||6
11039786|NCT00907517|12219850|FG003|STARTED|Overall Study||6
11039787|NCT00907517|12219851|FG004|STARTED|Overall Study||6
11039788|NCT00907517|12219847|FG000|COMPLETED|Overall Study||0
11039789|NCT00907517|12219848|FG001|COMPLETED|Overall Study||0
11039790|NCT00907517|12219849|FG002|COMPLETED|Overall Study||2
11039791|NCT00907517|12219850|FG003|COMPLETED|Overall Study||2
11039792|NCT00907517|12219851|FG004|COMPLETED|Overall Study||1
11039793|NCT00907517|12219847|FG000|NOT COMPLETED|Overall Study||3
11039794|NCT00907517|12219848|FG001|NOT COMPLETED|Overall Study||3
11039795|NCT00907517|12219849|FG002|NOT COMPLETED|Overall Study||4
11039796|NCT00907517|12219850|FG003|NOT COMPLETED|Overall Study||4
11039797|NCT00907517|12219851|FG004|NOT COMPLETED|Overall Study||5
11039798|NCT00907621|12219865|FG000|STARTED|Overall Study||45
11039799|NCT00907621|12219866|FG001|STARTED|Overall Study||45
11039800|NCT00907621|12219865|FG000|COMPLETED|Overall Study||38
11039801|NCT00907621|12219866|FG001|COMPLETED|Overall Study||41
11039802|NCT00907621|12219865|FG000|NOT COMPLETED|Overall Study||7
11039803|NCT00907621|12219866|FG001|NOT COMPLETED|Overall Study||4
11039804|NCT00907738|12219877|FG000|STARTED|Overall Study||13
11039805|NCT00907738|12219878|FG001|STARTED|Overall Study||1
11039806|NCT00907738|12219879|FG002|STARTED|Overall Study||7
11039807|NCT00907738|12219880|FG003|STARTED|Overall Study||4
11039808|NCT00907738|12219881|FG004|STARTED|Overall Study||2
11039809|NCT00907738|12219877|FG000|COMPLETED|Overall Study||0
11039810|NCT00907738|12219878|FG001|COMPLETED|Overall Study||0
11039811|NCT00907738|12219879|FG002|COMPLETED|Overall Study||0
11039812|NCT00907738|12219880|FG003|COMPLETED|Overall Study||0
11039813|NCT00907738|12219881|FG004|COMPLETED|Overall Study||0
11039814|NCT00907738|12219877|FG000|NOT COMPLETED|Overall Study||13
11039815|NCT00907738|12219878|FG001|NOT COMPLETED|Overall Study||1
11039816|NCT00907738|12219879|FG002|NOT COMPLETED|Overall Study||7
11039817|NCT00907738|12219880|FG003|NOT COMPLETED|Overall Study||4
11039818|NCT00907738|12219881|FG004|NOT COMPLETED|Overall Study||2
11039819|NCT00907777|12219899|FG000|STARTED|Overall Study||25
11039820|NCT00907777|12219900|FG001|STARTED|Overall Study||27
11039821|NCT00907777|12219899|FG000|COMPLETED|Overall Study||25
11039822|NCT00907777|12219900|FG001|COMPLETED|Overall Study||26
11039823|NCT00907777|12219899|FG000|NOT COMPLETED|Overall Study||0
11039824|NCT00907777|12219900|FG001|NOT COMPLETED|Overall Study||1
11039825|NCT00907803|12219909|FG000|STARTED|Overall Study||45
11039826|NCT00907803|12219910|FG001|STARTED|Overall Study||46
11039827|NCT00907803|12219911|FG002|STARTED|Overall Study||16
11039828|NCT00907803|12219909|FG000|COMPLETED|Overall Study||42
11039829|NCT00907803|12219910|FG001|COMPLETED|Overall Study||43
11039830|NCT00907803|12219911|FG002|COMPLETED|Overall Study||16
11039831|NCT00907803|12219909|FG000|NOT COMPLETED|Overall Study||3
11039832|NCT00907803|12219910|FG001|NOT COMPLETED|Overall Study||3
11039833|NCT00907803|12219911|FG002|NOT COMPLETED|Overall Study||0
11039834|NCT00907881|12219919|FG000|STARTED|Overall Study||1069
11039835|NCT00907881|12219919|FG000|COMPLETED|Overall Study||984
11039836|NCT00907881|12219919|FG000|NOT COMPLETED|Overall Study||85
11039837|NCT00908011|12219925|FG000|STARTED|Overall Study||23
11039838|NCT00908011|12219926|FG001|STARTED|Overall Study||20
11039839|NCT00908011|12219925|FG000|COMPLETED|Overall Study||21
11039840|NCT00908011|12219926|FG001|COMPLETED|Overall Study||18
11039841|NCT00908011|12219925|FG000|NOT COMPLETED|Overall Study||2
11039842|NCT00908011|12219926|FG001|NOT COMPLETED|Overall Study||2
11039843|NCT00908037|12219939|FG000|STARTED|Part1 (24 Week Dose-Finding Period)||5
11039844|NCT00908037|12219940|FG001|STARTED|Part1 (24 Week Dose-Finding Period)||5
11039845|NCT00908037|12219941|FG002|STARTED|Part1 (24 Week Dose-Finding Period)||5
11039846|NCT00908037|12219942|FG003|STARTED|Part1 (24 Week Dose-Finding Period)||0
11039847|NCT00908037|12219943|FG004|STARTED|Part1 (24 Week Dose-Finding Period)||0
11039848|NCT00908037|12219944|FG005|STARTED|Part1 (24 Week Dose-Finding Period)||0
11039849|NCT00908037|12219945|FG006|STARTED|Part1 (24 Week Dose-Finding Period)||0
11039850|NCT00908037|12219946|FG007|STARTED|Part1 (24 Week Dose-Finding Period)||0
11039851|NCT00908037|12219947|FG008|STARTED|Part1 (24 Week Dose-Finding Period)||0
11039852|NCT00908037|12219948|FG009|STARTED|Part1 (24 Week Dose-Finding Period)||0
11039853|NCT00908037|12219949|FG010|STARTED|Part1 (24 Week Dose-Finding Period)||0
11039854|NCT00908037|12219950|FG011|STARTED|Part1 (24 Week Dose-Finding Period)||0
11039855|NCT00908037|12219939|FG000|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
11039856|NCT00908037|12219940|FG001|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
11039857|NCT00908037|12219941|FG002|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
11039858|NCT00908037|12219942|FG003|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039859|NCT00908037|12219943|FG004|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039860|NCT00908037|12219944|FG005|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039861|NCT00908037|12219945|FG006|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039862|NCT00908037|12219946|FG007|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039863|NCT00908037|12219947|FG008|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039864|NCT00908037|12219948|FG009|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039865|NCT00908037|12219949|FG010|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039866|NCT00908037|12219950|FG011|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039867|NCT00908037|12219939|FG000|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039868|NCT00908037|12219940|FG001|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039869|NCT00908037|12219941|FG002|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039870|NCT00908037|12219942|FG003|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039871|NCT00908037|12219943|FG004|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039872|NCT00908037|12219944|FG005|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039873|NCT00908037|12219945|FG006|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039874|NCT00908037|12219946|FG007|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039875|NCT00908037|12219947|FG008|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039876|NCT00908037|12219948|FG009|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039877|NCT00908037|12219949|FG010|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039878|NCT00908037|12219950|FG011|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
11039879|NCT00908037|12219939|FG000|STARTED|Part 2 (7 Week Randomized Period)||0
11039880|NCT00908037|12219940|FG001|STARTED|Part 2 (7 Week Randomized Period)||0
11039881|NCT00908037|12219941|FG002|STARTED|Part 2 (7 Week Randomized Period)||0
11039882|NCT00908037|12219942|FG003|STARTED|Part 2 (7 Week Randomized Period)||8
11039883|NCT00908037|12219943|FG004|STARTED|Part 2 (7 Week Randomized Period)||16
11039884|NCT00908037|12219944|FG005|STARTED|Part 2 (7 Week Randomized Period)||9
11039885|NCT00908037|12219945|FG006|STARTED|Part 2 (7 Week Randomized Period)||19
11039886|NCT00908037|12219946|FG007|STARTED|Part 2 (7 Week Randomized Period)||5
11039887|NCT00908037|12219947|FG008|STARTED|Part 2 (7 Week Randomized Period)||10
11039888|NCT00908037|12219948|FG009|STARTED|Part 2 (7 Week Randomized Period)||0
11039889|NCT00908037|12219949|FG010|STARTED|Part 2 (7 Week Randomized Period)||0
11039890|NCT00908037|12219950|FG011|STARTED|Part 2 (7 Week Randomized Period)||0
11039891|NCT00908037|12219939|FG000|COMPLETED|Part 2 (7 Week Randomized Period)||0
11039892|NCT00908037|12219940|FG001|COMPLETED|Part 2 (7 Week Randomized Period)||0
11039893|NCT00908037|12219941|FG002|COMPLETED|Part 2 (7 Week Randomized Period)||0
11039894|NCT00908037|12219942|FG003|COMPLETED|Part 2 (7 Week Randomized Period)||7
11039895|NCT00908037|12219943|FG004|COMPLETED|Part 2 (7 Week Randomized Period)||13
11039896|NCT00908037|12219944|FG005|COMPLETED|Part 2 (7 Week Randomized Period)||9
11039897|NCT00908037|12219945|FG006|COMPLETED|Part 2 (7 Week Randomized Period)||15
11039898|NCT00908037|12219946|FG007|COMPLETED|Part 2 (7 Week Randomized Period)||5
11039899|NCT00908037|12219947|FG008|COMPLETED|Part 2 (7 Week Randomized Period)||5
11039900|NCT00908037|12219948|FG009|COMPLETED|Part 2 (7 Week Randomized Period)||0
11039901|NCT00908037|12219949|FG010|COMPLETED|Part 2 (7 Week Randomized Period)||0
11039902|NCT00908037|12219950|FG011|COMPLETED|Part 2 (7 Week Randomized Period)||0
11039903|NCT00908037|12219939|FG000|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
11039904|NCT00908037|12219940|FG001|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
11039905|NCT00908037|12219941|FG002|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
11039906|NCT00908037|12219942|FG003|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
11039907|NCT00908037|12219943|FG004|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
11039908|NCT00908037|12219944|FG005|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
11039909|NCT00908037|12219945|FG006|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
11039910|NCT00908037|12219946|FG007|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
11039911|NCT00908037|12219947|FG008|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
11039912|NCT00908037|12219948|FG009|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
11039913|NCT00908037|12219949|FG010|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
11039914|NCT00908037|12219950|FG011|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
11039915|NCT00908037|12219939|FG000|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
11039916|NCT00908037|12219940|FG001|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
11039917|NCT00908037|12219941|FG002|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
11039918|NCT00908037|12219942|FG003|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
11039919|NCT00908037|12219943|FG004|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
11039920|NCT00908037|12219944|FG005|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
11039921|NCT00908037|12219945|FG006|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
11039922|NCT00908037|12219946|FG007|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
11039923|NCT00908037|12219947|FG008|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
11039924|NCT00908037|12219948|FG009|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
11039925|NCT00908037|12219949|FG010|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
11039926|NCT00908037|12219950|FG011|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
11039927|NCT00908037|12219939|FG000|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039928|NCT00908037|12219940|FG001|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039929|NCT00908037|12219941|FG002|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039930|NCT00908037|12219942|FG003|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039931|NCT00908037|12219943|FG004|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039932|NCT00908037|12219944|FG005|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039933|NCT00908037|12219945|FG006|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039934|NCT00908037|12219946|FG007|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039935|NCT00908037|12219947|FG008|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039936|NCT00908037|12219948|FG009|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
11039937|NCT00908037|12219949|FG010|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
11039938|NCT00908037|12219950|FG011|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
11039939|NCT00908037|12219939|FG000|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039940|NCT00908037|12219940|FG001|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039941|NCT00908037|12219941|FG002|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039942|NCT00908037|12219942|FG003|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039943|NCT00908037|12219943|FG004|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039944|NCT00908037|12219944|FG005|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039945|NCT00908037|12219945|FG006|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039946|NCT00908037|12219946|FG007|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039947|NCT00908037|12219947|FG008|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
11039948|NCT00908037|12219948|FG009|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
11039949|NCT00908037|12219949|FG010|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
11039950|NCT00908037|12219950|FG011|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
11039951|NCT00908076|12220004|FG000|STARTED|Overall Study||27
11039952|NCT00908076|12220005|FG001|STARTED|Overall Study||27
11039953|NCT00908076|12220004|FG000|COMPLETED|Overall Study||26
11039954|NCT00908076|12220005|FG001|COMPLETED|Overall Study||26
11039955|NCT00908076|12220004|FG000|NOT COMPLETED|Overall Study||1
11039956|NCT00908076|12220005|FG001|NOT COMPLETED|Overall Study||1
11039957|NCT00908115|12220011|FG000|STARTED|Overall Study||1258
11039958|NCT00908115|12220011|FG000|COMPLETED|Overall Study||1244
11039959|NCT00908115|12220011|FG000|NOT COMPLETED|Overall Study||14
11039960|NCT00908141|12220017|FG000|STARTED|Overall Study||8
11039961|NCT00908141|12220018|FG001|STARTED|Overall Study||9
11039962|NCT00908141|12220017|FG000|COMPLETED|Overall Study||8
11039963|NCT00908141|12220018|FG001|COMPLETED|Overall Study||8
11039964|NCT00908141|12220017|FG000|NOT COMPLETED|Overall Study||0
11039965|NCT00908141|12220018|FG001|NOT COMPLETED|Overall Study||1
11039966|NCT00908232|12220024|FG000|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
11039967|NCT00908232|12220025|FG001|STARTED|Cycle 1 to 4||0
11039968|NCT00908232|12220026|FG002|STARTED|Cycle 1 to 4||0
11039969|NCT00908232|12220027|FG003|STARTED|Cycle 1 to 4||0
11039970|NCT00908232|12220024|FG000|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
11039971|NCT00908232|12220025|FG001|COMPLETED|Cycle 1 to 4||0
11039972|NCT00908232|12220026|FG002|COMPLETED|Cycle 1 to 4||0
11039973|NCT00908232|12220027|FG003|COMPLETED|Cycle 1 to 4||0
11039974|NCT00908232|12220024|FG000|NOT COMPLETED|Cycle 1 to 4||28
11039975|NCT00908232|12220025|FG001|NOT COMPLETED|Cycle 1 to 4||0
11039976|NCT00908232|12220026|FG002|NOT COMPLETED|Cycle 1 to 4||0
11039977|NCT00908232|12220027|FG003|NOT COMPLETED|Cycle 1 to 4||0
11039978|NCT00908232|12220024|FG000|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
11039979|NCT00908232|12220025|FG001|STARTED|Randomization (Cycle 5) to Cycle 8||7
11039980|NCT00908232|12220026|FG002|STARTED|Randomization (Cycle 5) to Cycle 8||8
11039981|NCT00908232|12220027|FG003|STARTED|Randomization (Cycle 5) to Cycle 8||4
11039982|NCT00908232|12220024|FG000|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
11039983|NCT00908232|12220025|FG001|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
11039984|NCT00908232|12220026|FG002|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
11039985|NCT00908232|12220027|FG003|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
11039986|NCT00908232|12220024|FG000|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
11039987|NCT00908232|12220025|FG001|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
11039988|NCT00908232|12220026|FG002|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
11039989|NCT00908232|12220027|FG003|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
11039990|NCT00908310|12220033|FG000|STARTED|Overall Study||213
11039991|NCT00908310|12220033|FG000|COMPLETED|Overall Study||153
11039992|NCT00908310|12220033|FG000|NOT COMPLETED|Overall Study||60
11039993|NCT00908349|12220037|FG000|STARTED|Overall Study||214
11039994|NCT00908349|12220037|FG000|COMPLETED|Overall Study||179
11039995|NCT00908349|12220037|FG000|NOT COMPLETED|Overall Study||35
11039996|NCT00908375|12220043|FG000|STARTED|Overall Study||20
11039997|NCT00908375|12220044|FG001|STARTED|Overall Study||19
11039998|NCT00908375|12220043|FG000|COMPLETED|Overall Study||10
11039999|NCT00908375|12220044|FG001|COMPLETED|Overall Study||9
11040000|NCT00908375|12220043|FG000|NOT COMPLETED|Overall Study||10
11040001|NCT00908375|12220044|FG001|NOT COMPLETED|Overall Study||10
11040002|NCT00908388|12220050|FG000|STARTED|Overall Study||50
11040003|NCT00908388|12220050|FG000|COMPLETED|Overall Study||40
11040004|NCT00908388|12220050|FG000|NOT COMPLETED|Overall Study||10
11040005|NCT00908466|12220056|FG000|STARTED|Overall Study||15
11040006|NCT00908466|12220057|FG001|STARTED|Overall Study||15
11040007|NCT00908466|12220056|FG000|COMPLETED|Overall Study||14
11040008|NCT00908466|12220057|FG001|COMPLETED|Overall Study||14
11040009|NCT00908466|12220056|FG000|NOT COMPLETED|Overall Study||1
11040010|NCT00908466|12220057|FG001|NOT COMPLETED|Overall Study||1
11040011|NCT00908544|12220065|FG000|STARTED|Overall Study||20
11040012|NCT00908544|12220066|FG001|STARTED|Overall Study||22
11040013|NCT00908544|12220065|FG000|COMPLETED|Overall Study||15
11040014|NCT00908544|12220066|FG001|COMPLETED|Overall Study||16
11040015|NCT00908544|12220065|FG000|NOT COMPLETED|Overall Study||5
11040016|NCT00908544|12220066|FG001|NOT COMPLETED|Overall Study||6
11040017|NCT00908583|12220072|FG000|STARTED|Phase 1||20
11040018|NCT00908583|12220072|FG000|COMPLETED|Phase 1||15
11040019|NCT00908583|12220072|FG000|NOT COMPLETED|Phase 1||5
11040020|NCT00908583|12220072|FG000|STARTED|Phase 2||12
11040021|NCT00908583|12220072|FG000|COMPLETED|Phase 2||10
11040022|NCT00908583|12220072|FG000|NOT COMPLETED|Phase 2||2
11040023|NCT00908583|12220072|FG000|STARTED|Phase 3||10
11040024|NCT00908583|12220072|FG000|COMPLETED|Phase 3||8
11040025|NCT00908583|12220072|FG000|NOT COMPLETED|Phase 3||2
11040026|NCT00908583|12220072|FG000|STARTED|Phase 4||5
11040027|NCT00908583|12220072|FG000|COMPLETED|Phase 4||3
11040028|NCT00908583|12220072|FG000|NOT COMPLETED|Phase 4||2
11040029|NCT00908583|12220072|FG000|STARTED|Phase 5||5
11040030|NCT00908583|12220072|FG000|COMPLETED|Phase 5||2
11040031|NCT00908583|12220072|FG000|NOT COMPLETED|Phase 5||3
11040032|NCT00908596|12220094|FG000|STARTED|Overall Study||47
11040033|NCT00908596|12220095|FG001|STARTED|Overall Study||32
11040034|NCT00908596|12220096|FG002|STARTED|Overall Study||193
11040035|NCT00908596|12220097|FG003|STARTED|Overall Study||85
11040036|NCT00908596|12220094|FG000|COMPLETED|Overall Study||0
11040037|NCT00908596|12220095|FG001|COMPLETED|Overall Study||19
11040038|NCT00908596|12220096|FG002|COMPLETED|Overall Study||119
11040039|NCT00908596|12220097|FG003|COMPLETED|Overall Study||48
11040040|NCT00908596|12220094|FG000|NOT COMPLETED|Overall Study||47
11040041|NCT00908596|12220095|FG001|NOT COMPLETED|Overall Study||13
11040042|NCT00908596|12220096|FG002|NOT COMPLETED|Overall Study||74
11040043|NCT00908596|12220097|FG003|NOT COMPLETED|Overall Study||37
11040044|NCT00908791|12220107|FG000|STARTED|Overall Study||24
11040045|NCT00908791|12220107|FG000|COMPLETED|Overall Study||24
11040046|NCT00908791|12220107|FG000|NOT COMPLETED|Overall Study||0
11040047|NCT00908830|12220122|FG000|STARTED|Overall Study||5
11040048|NCT00908830|12220123|FG001|STARTED|Overall Study||5
11040049|NCT00908830|12220122|FG000|COMPLETED|Overall Study||5
11040050|NCT00908830|12220123|FG001|COMPLETED|Overall Study||5
11040051|NCT00908830|12220122|FG000|NOT COMPLETED|Overall Study||0
11040052|NCT00908830|12220123|FG001|NOT COMPLETED|Overall Study||0
11040053|NCT00908882|12220131|FG000|STARTED|Overall Study||89
11040054|NCT00908882|12220132|FG001|STARTED|Overall Study||89
11040055|NCT00908882|12220131|FG000|COMPLETED|Overall Study||61
11040056|NCT00908882|12220132|FG001|COMPLETED|Overall Study||59
11040057|NCT00908882|12220131|FG000|NOT COMPLETED|Overall Study||28
11040058|NCT00908882|12220132|FG001|NOT COMPLETED|Overall Study||30
11040059|NCT00908895|12220140|FG000|STARTED|Overall Study||57
11040060|NCT00908895|12220141|FG001|STARTED|Overall Study||63
11040061|NCT00908895|12220140|FG000|COMPLETED|Overall Study||53
11040062|NCT00908895|12220141|FG001|COMPLETED|Overall Study||57
11040063|NCT00908895|12220140|FG000|NOT COMPLETED|Overall Study||4
11040064|NCT00908895|12220141|FG001|NOT COMPLETED|Overall Study||6
11040065|NCT00908908|12220147|FG000|STARTED|Overall Study||6
11040066|NCT00908908|12220147|FG000|Adverse Event|Overall Study||0
11040067|NCT00908908|12220147|FG000|Withdrawl by Subject|Overall Study||0
11040068|NCT00908908|12220147|FG000|Administrative/Other|Overall Study||0
11040069|NCT00908908|12220147|FG000|Physician Decision|Overall Study||0
11040070|NCT00908908|12220147|FG000|COMPLETED|Overall Study||6
11040071|NCT00908908|12220147|FG000|NOT COMPLETED|Overall Study||0
11040072|NCT00908947|12220151|FG000|STARTED|Overall Study||173
11040073|NCT00908947|12220151|FG000|COMPLETED|Overall Study||83
11040074|NCT00908947|12220151|FG000|NOT COMPLETED|Overall Study||90
11040075|NCT00908960|12220159|FG000|STARTED|Overall Study||24
11040076|NCT00908960|12220160|FG001|STARTED|Overall Study||12
11040077|NCT00908960|12220161|FG002|STARTED|Overall Study||34
11040078|NCT00908960|12220159|FG000|Evaluable|Overall Study||23
11040079|NCT00908960|12220160|FG001|Evaluable|Overall Study||11
11040080|NCT00908960|12220161|FG002|Evaluable|Overall Study||32
11040081|NCT00908960|12220159|FG000|COMPLETED|Overall Study||23
11040082|NCT00908960|12220160|FG001|COMPLETED|Overall Study||11
11040083|NCT00908960|12220161|FG002|COMPLETED|Overall Study||32
11040084|NCT00908960|12220159|FG000|NOT COMPLETED|Overall Study||1
11040085|NCT00908960|12220160|FG001|NOT COMPLETED|Overall Study||1
11040086|NCT00908960|12220161|FG002|NOT COMPLETED|Overall Study||2
11040087|NCT00909038|12220169|FG000|STARTED|Overall Study||2411
11040088|NCT00909038|12220169|FG000|COMPLETED|Overall Study||1994
11040089|NCT00909038|12220169|FG000|NOT COMPLETED|Overall Study||417
11040090|NCT00909064|12220173|FG000|STARTED|Overall Study||114
11040091|NCT00909064|12220173|FG000|COMPLETED|Overall Study||114
11040092|NCT00909064|12220173|FG000|NOT COMPLETED|Overall Study||0
11040093|NCT00909090|12220179|FG000|STARTED|Overall Study||53
11040094|NCT00909090|12220180|FG001|STARTED|Overall Study||56
11040095|NCT00909090|12220179|FG000|COMPLETED|Overall Study||36
11040096|NCT00909090|12220180|FG001|COMPLETED|Overall Study||39
11040097|NCT00909090|12220179|FG000|NOT COMPLETED|Overall Study||17
11040098|NCT00909090|12220180|FG001|NOT COMPLETED|Overall Study||17
11040099|NCT00909155|12220192|FG000|STARTED|Overall Study||15
11040100|NCT00909155|12220193|FG001|STARTED|Overall Study||14
11040101|NCT00909155|12220194|FG002|STARTED|Overall Study||21
11040102|NCT00909155|12220192|FG000|COMPLETED|Overall Study||12
11040103|NCT00909155|12220193|FG001|COMPLETED|Overall Study||9
11040104|NCT00909155|12220194|FG002|COMPLETED|Overall Study||14
11040105|NCT00909155|12220192|FG000|NOT COMPLETED|Overall Study||3
11040106|NCT00909155|12220193|FG001|NOT COMPLETED|Overall Study||5
11040107|NCT00909155|12220194|FG002|NOT COMPLETED|Overall Study||7
11040108|NCT00909181|12220208|FG000|STARTED|Overall Study||210
11040109|NCT00909181|12220209|FG001|STARTED|Overall Study||214
11040110|NCT00909181|12220210|FG002|STARTED|Overall Study||202
11040111|NCT00909181|12220208|FG000|COMPLETED|Overall Study||171
11040112|NCT00909181|12220209|FG001|COMPLETED|Overall Study||196
11335838|NCT02868554|12533398|FG000|STARTED|Overall Study||10
11335839|NCT02868554|12533399|FG001|STARTED|Overall Study||12
11335840|NCT02868554|12533400|FG002|STARTED|Overall Study||12
11335841|NCT02868554|12533398|FG000|COMPLETED|Overall Study||7
11335842|NCT02868554|12533399|FG001|COMPLETED|Overall Study||12
11335843|NCT02868554|12533400|FG002|COMPLETED|Overall Study||11
11335844|NCT02868554|12533398|FG000|NOT COMPLETED|Overall Study||3
11335845|NCT02868554|12533399|FG001|NOT COMPLETED|Overall Study||0
11335846|NCT02868554|12533400|FG002|NOT COMPLETED|Overall Study||1
11335847|NCT02869295|12533413|FG000|STARTED|Overall Study||4
11335848|NCT02869295|12533414|FG001|STARTED|Overall Study||11
11335849|NCT02869295|12533415|FG002|STARTED|Overall Study||6
11040113|NCT00909181|12220210|FG002|COMPLETED|Overall Study||169
11040114|NCT00909181|12220208|FG000|NOT COMPLETED|Overall Study||39
11040115|NCT00909181|12220209|FG001|NOT COMPLETED|Overall Study||18
11335850|NCT02869295|12533416|FG003|STARTED|Overall Study||6
11335851|NCT02869295|12533417|FG004|STARTED|Overall Study||1
11335852|NCT02869295|12533413|FG000|COMPLETED|Overall Study||0
11335853|NCT02869295|12533414|FG001|COMPLETED|Overall Study||0
11335854|NCT02869295|12533415|FG002|COMPLETED|Overall Study||0
11040116|NCT00909181|12220210|FG002|NOT COMPLETED|Overall Study||33
11040117|NCT00909220|12220220|FG000|STARTED|Overall Study|Started enrolling participants May 2009|41
11040118|NCT00909220|12220221|FG001|STARTED|Overall Study|Started enrolling participants May 2009|36
11040119|NCT00909220|12220220|FG000|Data Entry|Overall Study||41
11040120|NCT00909220|12220221|FG001|Data Entry|Overall Study||36
11040121|NCT00909220|12220220|FG000|Data Analyses|Overall Study||41
11040122|NCT00909220|12220221|FG001|Data Analyses|Overall Study||36
11040123|NCT00909220|12220220|FG000|Submission for Publication|Overall Study||41
11040124|NCT00909220|12220221|FG001|Submission for Publication|Overall Study||36
11040125|NCT00909220|12220220|FG000|COMPLETED|Overall Study||41
11040126|NCT00909220|12220221|FG001|COMPLETED|Overall Study||36
11040127|NCT00909220|12220220|FG000|NOT COMPLETED|Overall Study||0
11040128|NCT00909220|12220221|FG001|NOT COMPLETED|Overall Study||0
11040129|NCT00909324|12220231|FG000|STARTED|Overall Study||72
11040130|NCT00909324|12220232|FG001|STARTED|Overall Study||90
11040131|NCT00909324|12220231|FG000|COMPLETED|Overall Study||72
11040132|NCT00909324|12220232|FG001|COMPLETED|Overall Study||90
11040133|NCT00909324|12220231|FG000|NOT COMPLETED|Overall Study||0
11040134|NCT00909324|12220232|FG001|NOT COMPLETED|Overall Study||0
11040135|NCT00909363|12220241|FG000|STARTED|Overall Study||11
11040136|NCT00909363|12220242|FG001|STARTED|Overall Study||8
11201107|NCT01831089|12391356|FG005|STARTED|Cohort II: Dose Level 2||0
11201108|NCT01831089|12391351|FG000|COMPLETED|Cohort II: Dose Level 2||0
11201109|NCT01831089|12391352|FG001|COMPLETED|Cohort II: Dose Level 2||0
11201110|NCT01831089|12391353|FG002|COMPLETED|Cohort II: Dose Level 2||0
11201111|NCT01831089|12391354|FG003|COMPLETED|Cohort II: Dose Level 2||0
11201112|NCT01831089|12391355|FG004|COMPLETED|Cohort II: Dose Level 2||0
11201113|NCT01831089|12391356|FG005|COMPLETED|Cohort II: Dose Level 2||0
11201114|NCT01831089|12391351|FG000|NOT COMPLETED|Cohort II: Dose Level 2||0
11201115|NCT01831089|12391352|FG001|NOT COMPLETED|Cohort II: Dose Level 2||3
11201116|NCT01831089|12391353|FG002|NOT COMPLETED|Cohort II: Dose Level 2||0
11201117|NCT01831089|12391354|FG003|NOT COMPLETED|Cohort II: Dose Level 2||0
11201118|NCT01831089|12391355|FG004|NOT COMPLETED|Cohort II: Dose Level 2||0
11201119|NCT01831089|12391356|FG005|NOT COMPLETED|Cohort II: Dose Level 2||0
11201120|NCT01831089|12391351|FG000|STARTED|Cohort III: Dose Level 3||0
11201121|NCT01831089|12391352|FG001|STARTED|Cohort III: Dose Level 3||0
11201122|NCT01831089|12391353|FG002|STARTED|Cohort III: Dose Level 3||6
11201123|NCT01831089|12391354|FG003|STARTED|Cohort III: Dose Level 3||0
11201124|NCT01831089|12391355|FG004|STARTED|Cohort III: Dose Level 3||0
11201125|NCT01831089|12391356|FG005|STARTED|Cohort III: Dose Level 3||0
11201126|NCT01831089|12391351|FG000|COMPLETED|Cohort III: Dose Level 3||0
11201127|NCT01831089|12391352|FG001|COMPLETED|Cohort III: Dose Level 3||0
11201128|NCT01831089|12391353|FG002|COMPLETED|Cohort III: Dose Level 3||0
11201129|NCT01831089|12391354|FG003|COMPLETED|Cohort III: Dose Level 3||0
11335855|NCT02869295|12533416|FG003|COMPLETED|Overall Study||0
11335856|NCT02869295|12533417|FG004|COMPLETED|Overall Study||0
11335857|NCT02869295|12533413|FG000|NOT COMPLETED|Overall Study||4
11335858|NCT02869295|12533414|FG001|NOT COMPLETED|Overall Study||11
11335859|NCT02869295|12533415|FG002|NOT COMPLETED|Overall Study||6
11335860|NCT02869295|12533416|FG003|NOT COMPLETED|Overall Study||6
11040137|NCT00909363|12220243|FG002|STARTED|Overall Study||5
11335861|NCT02869295|12533417|FG004|NOT COMPLETED|Overall Study||1
11335862|NCT02869334|12533431|FG000|STARTED|Overall Study||10
11335863|NCT02869334|12533432|FG001|STARTED|Overall Study||10
11335864|NCT02869334|12533431|FG000|COMPLETED|Overall Study||2
11335865|NCT02869334|12533432|FG001|COMPLETED|Overall Study||3
11335866|NCT02869334|12533431|FG000|NOT COMPLETED|Overall Study||8
11335867|NCT02869334|12533432|FG001|NOT COMPLETED|Overall Study||7
11335868|NCT02869438|12533440|FG000|STARTED|Overall Study||118
11201130|NCT01831089|12391355|FG004|COMPLETED|Cohort III: Dose Level 3||0
11201131|NCT01831089|12391356|FG005|COMPLETED|Cohort III: Dose Level 3||0
11201132|NCT01831089|12391351|FG000|NOT COMPLETED|Cohort III: Dose Level 3||0
11201133|NCT01831089|12391352|FG001|NOT COMPLETED|Cohort III: Dose Level 3||0
11201134|NCT01831089|12391353|FG002|NOT COMPLETED|Cohort III: Dose Level 3||6
11201135|NCT01831089|12391354|FG003|NOT COMPLETED|Cohort III: Dose Level 3||0
11201136|NCT01831089|12391355|FG004|NOT COMPLETED|Cohort III: Dose Level 3||0
11201137|NCT01831089|12391356|FG005|NOT COMPLETED|Cohort III: Dose Level 3||0
11201138|NCT01831089|12391351|FG000|STARTED|Cohort IV: Dose Level 4||0
11335869|NCT02869438|12533441|FG001|STARTED|Overall Study||115
11335870|NCT02869438|12533440|FG000|COMPLETED|Overall Study||115
11335871|NCT02869438|12533441|FG001|COMPLETED|Overall Study||113
11335872|NCT02869438|12533440|FG000|NOT COMPLETED|Overall Study||3
11335873|NCT02869438|12533441|FG001|NOT COMPLETED|Overall Study||2
11335874|NCT02869451|12533447|FG000|STARTED|Overall Study||5
11335875|NCT02869451|12533447|FG000|COMPLETED|Overall Study||5
11335876|NCT02869451|12533447|FG000|NOT COMPLETED|Overall Study||0
11335877|NCT02869893|12533451|FG000|STARTED|Overall Study||57
11335878|NCT02869893|12533451|FG000|COMPLETED|Overall Study||50
11335879|NCT02869893|12533451|FG000|NOT COMPLETED|Overall Study||7
11335880|NCT02870101|12533456|FG000|STARTED|Overall Study||2767
11335881|NCT02870101|12533456|FG000|COMPLETED|Overall Study||2598
11335882|NCT02870101|12533456|FG000|NOT COMPLETED|Overall Study||169
11335883|NCT02870205|12533475|FG000|STARTED|Overall Study||294
11335884|NCT02870205|12533476|FG001|STARTED|Overall Study||294
11040138|NCT00909363|12220241|FG000|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9
11040139|NCT00909363|12220242|FG001|COMPLETED|Overall Study||8
11040140|NCT00909363|12220243|FG002|COMPLETED|Overall Study||5
11040141|NCT00909363|12220241|FG000|NOT COMPLETED|Overall Study||2
11040142|NCT00909363|12220242|FG001|NOT COMPLETED|Overall Study||0
11040143|NCT00909363|12220243|FG002|NOT COMPLETED|Overall Study||0
11040144|NCT00909428|12220257|FG000|STARTED|Overall Study||18
11040145|NCT00909428|12220258|FG001|STARTED|Overall Study||15
11040146|NCT00909428|12220259|FG002|STARTED|Overall Study||9
11040147|NCT00909428|12220257|FG000|COMPLETED|Overall Study||5
11040148|NCT00909428|12220258|FG001|COMPLETED|Overall Study||5
11040149|NCT00909428|12220259|FG002|COMPLETED|Overall Study||0
11040150|NCT00909428|12220257|FG000|NOT COMPLETED|Overall Study||13
11040151|NCT00909428|12220258|FG001|NOT COMPLETED|Overall Study||10
11040152|NCT00909428|12220259|FG002|NOT COMPLETED|Overall Study||9
11040153|NCT00909480|12220268|FG000|STARTED|Overall Study||228
11040154|NCT00909480|12220269|FG001|STARTED|Overall Study||229
11040155|NCT00909480|12220268|FG000|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
11040156|NCT00909480|12220269|FG001|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
11040157|NCT00909480|12220268|FG000|COMPLETED|Overall Study||190
11040158|NCT00909480|12220269|FG001|COMPLETED|Overall Study||188
11040159|NCT00909480|12220268|FG000|NOT COMPLETED|Overall Study||38
11040160|NCT00909480|12220269|FG001|NOT COMPLETED|Overall Study||41
11040161|NCT00909532|12220277|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
11040162|NCT00909532|12220278|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
11040163|NCT00909532|12220277|FG000|Completed Treatment Period, Week 24|Overall Study||71
11040164|NCT00909532|12220278|FG001|Completed Treatment Period, Week 24|Overall Study||80
11040165|NCT00909532|12220277|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
11040166|NCT00909532|12220278|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
11040167|NCT00909532|12220277|FG000|NOT COMPLETED|Overall Study||10
11040168|NCT00909532|12220278|FG001|NOT COMPLETED|Overall Study||6
11040169|NCT00909545|12220289|FG000|STARTED|Overall Study||26
11040170|NCT00909545|12220290|FG001|STARTED|Overall Study||23
11040171|NCT00909545|12220291|FG002|STARTED|Overall Study||26
11040172|NCT00909545|12220292|FG003|STARTED|Overall Study||24
11040173|NCT00909545|12220289|FG000|COMPLETED|Overall Study||25
11040174|NCT00909545|12220290|FG001|COMPLETED|Overall Study||22
11040175|NCT00909545|12220291|FG002|COMPLETED|Overall Study||25
11040176|NCT00909545|12220292|FG003|COMPLETED|Overall Study||19
11040177|NCT00909545|12220289|FG000|NOT COMPLETED|Overall Study||1
11040178|NCT00909545|12220290|FG001|NOT COMPLETED|Overall Study||1
11040179|NCT00909545|12220291|FG002|NOT COMPLETED|Overall Study||1
11040180|NCT00909545|12220292|FG003|NOT COMPLETED|Overall Study||5
11040181|NCT00909727|12220305|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
11040182|NCT00909727|12220306|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
11040183|NCT00909727|12220305|FG000|Completed Treatment Period, Week 24|Overall Study||23
11040184|NCT00909727|12220306|FG001|Completed Treatment Period, Week 24|Overall Study||26
11057799|NCT01000155|12239531|FG000|NOT COMPLETED|Overall Study||2
11040185|NCT00909727|12220305|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
11040186|NCT00909727|12220306|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
11040187|NCT00909727|12220305|FG000|NOT COMPLETED|Overall Study||4
11040188|NCT00909727|12220306|FG001|NOT COMPLETED|Overall Study||0
11040189|NCT00909779|12220314|FG000|STARTED|Overall Study||421
11040190|NCT00909779|12220315|FG001|STARTED|Overall Study||420
11040191|NCT00909779|12220314|FG000|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
11040192|NCT00909779|12220315|FG001|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
11040193|NCT00909779|12220314|FG000|NOT COMPLETED|Overall Study||210
11040194|NCT00909779|12220315|FG001|NOT COMPLETED|Overall Study||165
11040195|NCT00909792|12220323|FG000|STARTED|Period 1||130
11040196|NCT00909792|12220324|FG001|STARTED|Period 1||128
11040197|NCT00909792|12220323|FG000|COMPLETED|Period 1||130
11040198|NCT00909792|12220324|FG001|COMPLETED|Period 1||127
11040199|NCT00909792|12220323|FG000|NOT COMPLETED|Period 1||0
11040200|NCT00909792|12220324|FG001|NOT COMPLETED|Period 1||1
11040201|NCT00909792|12220323|FG000|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
11040202|NCT00909792|12220324|FG001|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
11040203|NCT00909792|12220323|FG000|COMPLETED|Period 2||128
11040204|NCT00909792|12220324|FG001|COMPLETED|Period 2||124
11040205|NCT00909792|12220323|FG000|NOT COMPLETED|Period 2||1
11040206|NCT00909792|12220324|FG001|NOT COMPLETED|Period 2||1
11040207|NCT00909844|12220330|FG000|STARTED|Overall Study||35
11040208|NCT00909844|12220330|FG000|COMPLETED|Overall Study||31
11040209|NCT00909844|12220330|FG000|NOT COMPLETED|Overall Study||4
11040210|NCT00909857|12220337|FG000|STARTED|Overall Study||253
11040211|NCT00909857|12220338|FG001|STARTED|Overall Study||254
11040212|NCT00909857|12220337|FG000|Treated|Overall Study||234
11040213|NCT00909857|12220338|FG001|Treated|Overall Study||230
11040214|NCT00909857|12220337|FG000|COMPLETED|Overall Study||217
11040215|NCT00909857|12220338|FG001|COMPLETED|Overall Study||209
11040216|NCT00909857|12220337|FG000|NOT COMPLETED|Overall Study||36
11040217|NCT00909857|12220338|FG001|NOT COMPLETED|Overall Study||45
11040218|NCT00909870|12220346|FG000|STARTED|Overall Study||274
11040219|NCT00909870|12220347|FG001|STARTED|Overall Study||263
11040220|NCT00909870|12220346|FG000|COMPLETED|Overall Study||251
11040221|NCT00909870|12220347|FG001|COMPLETED|Overall Study||236
11040222|NCT00909870|12220346|FG000|NOT COMPLETED|Overall Study||23
11040223|NCT00909870|12220347|FG001|NOT COMPLETED|Overall Study||27
11335885|NCT02870205|12533477|FG002|STARTED|Overall Study||294
11335886|NCT02870205|12533478|FG003|STARTED|Overall Study||294
11335887|NCT02870205|12533475|FG000|COMPLETED|Overall Study||284
11040224|NCT00910000|12220360|FG000|STARTED|Overall Study||3
11335888|NCT02870205|12533476|FG001|COMPLETED|Overall Study||289
11335889|NCT02870205|12533477|FG002|COMPLETED|Overall Study||287
11335890|NCT02870205|12533478|FG003|COMPLETED|Overall Study||287
11335891|NCT02870205|12533475|FG000|NOT COMPLETED|Overall Study||10
11335892|NCT02870205|12533476|FG001|NOT COMPLETED|Overall Study||5
11335893|NCT02870205|12533477|FG002|NOT COMPLETED|Overall Study||7
11335894|NCT02870205|12533478|FG003|NOT COMPLETED|Overall Study||7
11335895|NCT02870283|12533491|FG000|STARTED|Overall Study||38
11335896|NCT02870283|12533492|FG001|STARTED|Overall Study||35
11335897|NCT02870283|12533493|FG002|STARTED|Overall Study||34
11335898|NCT02870283|12533491|FG000|COMPLETED|Overall Study||35
11335899|NCT02870283|12533492|FG001|COMPLETED|Overall Study||26
11335900|NCT02870283|12533493|FG002|COMPLETED|Overall Study||15
11335901|NCT02870283|12533491|FG000|NOT COMPLETED|Overall Study||3
11335902|NCT02870283|12533492|FG001|NOT COMPLETED|Overall Study||9
11335903|NCT02870283|12533493|FG002|NOT COMPLETED|Overall Study||19
11335904|NCT02870309|12533501|FG000|STARTED|Overall Study||4
11335905|NCT02870309|12533501|FG000|COMPLETED|Overall Study||4
11335906|NCT02870309|12533501|FG000|NOT COMPLETED|Overall Study||0
11335907|NCT02870933|12533507|FG000|STARTED|Overall Study||15
11335908|NCT02870933|12533508|FG001|STARTED|Overall Study||15
11335909|NCT02870933|12533507|FG000|COMPLETED|Overall Study||13
11335910|NCT02870933|12533508|FG001|COMPLETED|Overall Study||13
11335911|NCT02870933|12533507|FG000|NOT COMPLETED|Overall Study||2
11335912|NCT02870933|12533508|FG001|NOT COMPLETED|Overall Study||2
11335913|NCT02870972|12533520|FG000|STARTED|Overall Study||18
11335914|NCT02870972|12533521|FG001|STARTED|Overall Study||14
11335915|NCT02870972|12533522|FG002|STARTED|Overall Study||14
11335916|NCT02870972|12533523|FG003|STARTED|Overall Study||7
11335917|NCT02870972|12533524|FG004|STARTED|Overall Study||22
11335918|NCT02870972|12533520|FG000|COMPLETED|Overall Study||17
11335919|NCT02870972|12533521|FG001|COMPLETED|Overall Study||14
11335920|NCT02870972|12533522|FG002|COMPLETED|Overall Study||14
11335921|NCT02870972|12533523|FG003|COMPLETED|Overall Study||7
11335922|NCT02870972|12533524|FG004|COMPLETED|Overall Study||22
11335923|NCT02870972|12533520|FG000|NOT COMPLETED|Overall Study||1
11335924|NCT02870972|12533521|FG001|NOT COMPLETED|Overall Study||0
11335925|NCT02870972|12533522|FG002|NOT COMPLETED|Overall Study||0
11335926|NCT02870972|12533523|FG003|NOT COMPLETED|Overall Study||0
11335927|NCT02870972|12533524|FG004|NOT COMPLETED|Overall Study||0
11335928|NCT02871011|12533540|FG000|STARTED|Overall Study||7
11335929|NCT02871011|12533541|FG001|STARTED|Overall Study||13
11335930|NCT02871011|12533540|FG000|COMPLETED|Overall Study||7
11335931|NCT02871011|12533541|FG001|COMPLETED|Overall Study||13
11335932|NCT02871011|12533540|FG000|NOT COMPLETED|Overall Study||0
11335933|NCT02871011|12533541|FG001|NOT COMPLETED|Overall Study||0
11335934|NCT02871128|12533550|FG000|STARTED|Overall Study||20
11335935|NCT02871128|12533551|FG001|STARTED|Overall Study||20
11335936|NCT02871128|12533552|FG002|STARTED|Overall Study||16
11335937|NCT02871128|12533550|FG000|COMPLETED|Overall Study||20
11335938|NCT02871128|12533551|FG001|COMPLETED|Overall Study||19
11335939|NCT02871128|12533552|FG002|COMPLETED|Overall Study||15
11335940|NCT02871128|12533550|FG000|NOT COMPLETED|Overall Study||0
11335941|NCT02871128|12533551|FG001|NOT COMPLETED|Overall Study||1
11335942|NCT02871128|12533552|FG002|NOT COMPLETED|Overall Study||1
11335943|NCT02871375|12533560|FG000|STARTED|Period 1, First 14 Days of Wear||89
11335944|NCT02871375|12533561|FG001|STARTED|Period 1, First 14 Days of Wear||77
11335945|NCT02871375|12533560|FG000|COMPLETED|Period 1, First 14 Days of Wear||89
11335946|NCT02871375|12533561|FG001|COMPLETED|Period 1, First 14 Days of Wear||76
11335947|NCT02871375|12533560|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0
11335948|NCT02871375|12533561|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1
11335949|NCT02871375|12533560|FG000|STARTED|Period 2, Second 14 Days of Wear||89
11335950|NCT02871375|12533561|FG001|STARTED|Period 2, Second 14 Days of Wear||76
11335951|NCT02871375|12533560|FG000|COMPLETED|Period 2, Second 14 Days of Wear||89
11335952|NCT02871375|12533561|FG001|COMPLETED|Period 2, Second 14 Days of Wear||76
11335953|NCT02871375|12533560|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
11040225|NCT00910000|12220361|FG001|STARTED|Overall Study||3
11040226|NCT00910000|12220362|FG002|STARTED|Overall Study||3
11040227|NCT00910000|12220363|FG003|STARTED|Overall Study||2
11040228|NCT00910000|12220364|FG004|STARTED|Overall Study||3
11040229|NCT00910000|12220365|FG005|STARTED|Overall Study||1
11040230|NCT00910000|12220360|FG000|COMPLETED|Overall Study||3
11040231|NCT00910000|12220361|FG001|COMPLETED|Overall Study||0
11040232|NCT00910000|12220362|FG002|COMPLETED|Overall Study||0
11040233|NCT00910000|12220363|FG003|COMPLETED|Overall Study||0
11040234|NCT00910000|12220364|FG004|COMPLETED|Overall Study||2
11040235|NCT00910000|12220365|FG005|COMPLETED|Overall Study||0
11040236|NCT00910000|12220360|FG000|NOT COMPLETED|Overall Study||0
11040237|NCT00910000|12220361|FG001|NOT COMPLETED|Overall Study||3
11040238|NCT00910000|12220362|FG002|NOT COMPLETED|Overall Study||3
11040239|NCT00910000|12220363|FG003|NOT COMPLETED|Overall Study||2
11040240|NCT00910000|12220364|FG004|NOT COMPLETED|Overall Study||1
11040241|NCT00910000|12220365|FG005|NOT COMPLETED|Overall Study||1
11040242|NCT00910039|12220375|FG000|STARTED|Overall Study||14
11040243|NCT00910039|12220375|FG000|COMPLETED|Overall Study||13
11040244|NCT00910039|12220375|FG000|NOT COMPLETED|Overall Study||1
11040245|NCT00910091|12220382|FG000|STARTED|Pre-assignment||36
11040246|NCT00910091|12220383|FG001|STARTED|Pre-assignment||37
11040247|NCT00910091|12220382|FG000|COMPLETED|Pre-assignment||36
11040248|NCT00910091|12220383|FG001|COMPLETED|Pre-assignment||35
11040249|NCT00910091|12220382|FG000|NOT COMPLETED|Pre-assignment||0
11040250|NCT00910091|12220383|FG001|NOT COMPLETED|Pre-assignment||2
11040251|NCT00910091|12220382|FG000|STARTED|Treatment and Survival||36
11040252|NCT00910091|12220383|FG001|STARTED|Treatment and Survival||35
11040253|NCT00910091|12220382|FG000|COMPLETED|Treatment and Survival||32
11040254|NCT00910091|12220383|FG001|COMPLETED|Treatment and Survival||31
11040255|NCT00910091|12220382|FG000|NOT COMPLETED|Treatment and Survival||4
11040256|NCT00910091|12220383|FG001|NOT COMPLETED|Treatment and Survival||4
11040257|NCT00910208|12220393|FG000|STARTED|Overall Study||69
11040258|NCT00910208|12220394|FG001|STARTED|Overall Study||72
11040259|NCT00910208|12220395|FG002|STARTED|Overall Study||70
11040260|NCT00910208|12220393|FG000|COMPLETED|Overall Study||67
11040261|NCT00910208|12220394|FG001|COMPLETED|Overall Study||70
11040262|NCT00910208|12220395|FG002|COMPLETED|Overall Study||69
11040263|NCT00910208|12220393|FG000|NOT COMPLETED|Overall Study||2
11040264|NCT00910208|12220394|FG001|NOT COMPLETED|Overall Study||2
11040265|NCT00910208|12220395|FG002|NOT COMPLETED|Overall Study||1
11040266|NCT00910247|12220403|FG000|STARTED|Overall Study||274
11040267|NCT00910247|12220403|FG000|COMPLETED|Overall Study||205
11040268|NCT00910247|12220403|FG000|NOT COMPLETED|Overall Study||69
11040269|NCT00910273|12220409|FG000|STARTED|Overall Study||18
11040270|NCT00910273|12220410|FG001|STARTED|Overall Study||16
11040271|NCT00910273|12220409|FG000|COMPLETED|Overall Study||0
11040272|NCT00910273|12220410|FG001|COMPLETED|Overall Study||3
11040273|NCT00910273|12220409|FG000|NOT COMPLETED|Overall Study||18
11040274|NCT00910273|12220410|FG001|NOT COMPLETED|Overall Study||13
11040275|NCT00910299|12220418|FG000|STARTED|Overall Study||212
11040276|NCT00910299|12220419|FG001|STARTED|Overall Study||211
11040277|NCT00910299|12220418|FG000|Received at Least 1 Dose of Study Drug|Overall Study||210
11040278|NCT00910299|12220419|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210
11040279|NCT00910299|12220418|FG000|COMPLETED|Overall Study||136
11040280|NCT00910299|12220419|FG001|COMPLETED|Overall Study|"1 participant died of sepsis while on study drug and was considered a protocol completer."|137
11040281|NCT00910299|12220418|FG000|NOT COMPLETED|Overall Study||76
11040282|NCT00910299|12220419|FG001|NOT COMPLETED|Overall Study||74
11040283|NCT00910429|12220427|FG000|STARTED|Overall Study||155
11040284|NCT00910429|12220428|FG001|STARTED|Overall Study||82
11040285|NCT00910429|12220427|FG000|COMPLETED|Overall Study|Completed treatment|116
11040286|NCT00910429|12220428|FG001|COMPLETED|Overall Study|Completed treatment|61
11040287|NCT00910429|12220427|FG000|NOT COMPLETED|Overall Study||39
11040288|NCT00910429|12220428|FG001|NOT COMPLETED|Overall Study||21
11040289|NCT00910481|12220436|FG000|STARTED|Overall Study||151
11040290|NCT00910481|12220437|FG001|STARTED|Overall Study||150
11040291|NCT00910481|12220436|FG000|COMPLETED|Overall Study||151
11040292|NCT00910481|12220437|FG001|COMPLETED|Overall Study||150
11040293|NCT00910481|12220436|FG000|NOT COMPLETED|Overall Study||0
11040294|NCT00910481|12220437|FG001|NOT COMPLETED|Overall Study||0
11040295|NCT00910520|12220445|FG000|STARTED|Treatment Cycle 1||277
11040296|NCT00910520|12220446|FG001|STARTED|Treatment Cycle 1||271
11040297|NCT00910520|12220445|FG000|COMPLETED|Treatment Cycle 1||257
11040298|NCT00910520|12220446|FG001|COMPLETED|Treatment Cycle 1||247
11040299|NCT00910520|12220445|FG000|NOT COMPLETED|Treatment Cycle 1||20
11040300|NCT00910520|12220446|FG001|NOT COMPLETED|Treatment Cycle 1||24
11040301|NCT00910520|12220445|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
11040302|NCT00910520|12220446|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
11040303|NCT00910520|12220445|FG000|COMPLETED|Treatment Cycle 2||156
11040304|NCT00910520|12220446|FG001|COMPLETED|Treatment Cycle 2||215
11040305|NCT00910520|12220445|FG000|NOT COMPLETED|Treatment Cycle 2||7
11040306|NCT00910520|12220446|FG001|NOT COMPLETED|Treatment Cycle 2||8
11040307|NCT00910624|12220456|FG000|STARTED|Treatment Phase||52
11040308|NCT00910624|12220457|FG001|STARTED|Treatment Phase||85
11040309|NCT00910624|12220458|FG002|STARTED|Treatment Phase||29
11040310|NCT00910624|12220459|FG003|STARTED|Treatment Phase||2
11040311|NCT00910624|12220456|FG000|COMPLETED|Treatment Phase||22
11040312|NCT00910624|12220457|FG001|COMPLETED|Treatment Phase||64
11040313|NCT00910624|12220458|FG002|COMPLETED|Treatment Phase||20
11040314|NCT00910624|12220459|FG003|COMPLETED|Treatment Phase||2
11040315|NCT00910624|12220456|FG000|NOT COMPLETED|Treatment Phase||30
11040316|NCT00910624|12220457|FG001|NOT COMPLETED|Treatment Phase||21
11040317|NCT00910624|12220458|FG002|NOT COMPLETED|Treatment Phase||9
11040318|NCT00910624|12220459|FG003|NOT COMPLETED|Treatment Phase||0
11040319|NCT00910624|12220456|FG000|STARTED|Follow-Up Phase||48
11040320|NCT00910624|12220457|FG001|STARTED|Follow-Up Phase||80
11040321|NCT00910624|12220458|FG002|STARTED|Follow-Up Phase||29
11040322|NCT00910624|12220459|FG003|STARTED|Follow-Up Phase||2
11040323|NCT00910624|12220456|FG000|COMPLETED|Follow-Up Phase||42
11040324|NCT00910624|12220457|FG001|COMPLETED|Follow-Up Phase||76
11040325|NCT00910624|12220458|FG002|COMPLETED|Follow-Up Phase||25
11040326|NCT00910624|12220459|FG003|COMPLETED|Follow-Up Phase||2
11040327|NCT00910624|12220456|FG000|NOT COMPLETED|Follow-Up Phase||6
11040328|NCT00910624|12220457|FG001|NOT COMPLETED|Follow-Up Phase||4
11040329|NCT00910624|12220458|FG002|NOT COMPLETED|Follow-Up Phase||4
11040330|NCT00910624|12220459|FG003|NOT COMPLETED|Follow-Up Phase||0
11040331|NCT00910663|12220469|FG000|STARTED|Period 1||30
11040332|NCT00910663|12220470|FG001|STARTED|Period 1||30
11040333|NCT00910663|12220469|FG000|COMPLETED|Period 1||30
11040334|NCT00910663|12220470|FG001|COMPLETED|Period 1||29
11040335|NCT00910663|12220469|FG000|NOT COMPLETED|Period 1||0
11040336|NCT00910663|12220470|FG001|NOT COMPLETED|Period 1||1
11040337|NCT00910663|12220469|FG000|STARTED|Period 2||30
11040338|NCT00910663|12220470|FG001|STARTED|Period 2||29
11040339|NCT00910663|12220469|FG000|COMPLETED|Period 2||30
11040340|NCT00910663|12220470|FG001|COMPLETED|Period 2||29
11040341|NCT00910663|12220469|FG000|NOT COMPLETED|Period 2||0
11040342|NCT00910663|12220470|FG001|NOT COMPLETED|Period 2||0
11040343|NCT00910689|12220480|FG000|STARTED|Month 1: Optimal Acute Therapy Run in||55
11040344|NCT00910689|12220481|FG001|STARTED|Month 1: Optimal Acute Therapy Run in||53
11040345|NCT00910689|12220482|FG002|STARTED|Month 1: Optimal Acute Therapy Run in||55
11040346|NCT00910689|12220483|FG003|STARTED|Month 1: Optimal Acute Therapy Run in||69
11040347|NCT00910689|12220480|FG000|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
11040348|NCT00910689|12220481|FG001|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
11040349|NCT00910689|12220482|FG002|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
11040350|NCT00910689|12220483|FG003|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
11040351|NCT00910689|12220480|FG000|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
11040352|NCT00910689|12220481|FG001|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
11040353|NCT00910689|12220482|FG002|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
11040354|NCT00910689|12220483|FG003|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
11040355|NCT00910689|12220480|FG000|STARTED|Month 2- 4: Treatment Period||53
11040356|NCT00910689|12220481|FG001|STARTED|Month 2- 4: Treatment Period||52
11040357|NCT00910689|12220482|FG002|STARTED|Month 2- 4: Treatment Period||50
11040358|NCT00910689|12220483|FG003|STARTED|Month 2- 4: Treatment Period||59
11040359|NCT00910689|12220480|FG000|COMPLETED|Month 2- 4: Treatment Period||44
11040360|NCT00910689|12220481|FG001|COMPLETED|Month 2- 4: Treatment Period||42
11040361|NCT00910689|12220482|FG002|COMPLETED|Month 2- 4: Treatment Period||42
11040362|NCT00910689|12220483|FG003|COMPLETED|Month 2- 4: Treatment Period||48
11040363|NCT00910689|12220480|FG000|NOT COMPLETED|Month 2- 4: Treatment Period||9
11040364|NCT00910689|12220481|FG001|NOT COMPLETED|Month 2- 4: Treatment Period||10
11040365|NCT00910689|12220482|FG002|NOT COMPLETED|Month 2- 4: Treatment Period||8
11040366|NCT00910689|12220483|FG003|NOT COMPLETED|Month 2- 4: Treatment Period||11
11040367|NCT00910689|12220480|FG000|STARTED|Months 5 - 10: Evaluation Period I||44
11040368|NCT00910689|12220481|FG001|STARTED|Months 5 - 10: Evaluation Period I||42
11040369|NCT00910689|12220482|FG002|STARTED|Months 5 - 10: Evaluation Period I||42
11040370|NCT00910689|12220483|FG003|STARTED|Months 5 - 10: Evaluation Period I||48
11040371|NCT00910689|12220480|FG000|COMPLETED|Months 5 - 10: Evaluation Period I||40
11040372|NCT00910689|12220481|FG001|COMPLETED|Months 5 - 10: Evaluation Period I||35
11040373|NCT00910689|12220482|FG002|COMPLETED|Months 5 - 10: Evaluation Period I||35
11040374|NCT00910689|12220483|FG003|COMPLETED|Months 5 - 10: Evaluation Period I||41
11040375|NCT00910689|12220480|FG000|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
11040376|NCT00910689|12220481|FG001|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
11040377|NCT00910689|12220482|FG002|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
11040378|NCT00910689|12220483|FG003|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
11040379|NCT00910689|12220480|FG000|STARTED|Months 11- 16: Evaluation Period II||40
11040380|NCT00910689|12220481|FG001|STARTED|Months 11- 16: Evaluation Period II||35
11040381|NCT00910689|12220482|FG002|STARTED|Months 11- 16: Evaluation Period II||35
11040382|NCT00910689|12220483|FG003|STARTED|Months 11- 16: Evaluation Period II||41
11040383|NCT00910689|12220480|FG000|COMPLETED|Months 11- 16: Evaluation Period II||30
11040384|NCT00910689|12220481|FG001|COMPLETED|Months 11- 16: Evaluation Period II||25
11040385|NCT00910689|12220482|FG002|COMPLETED|Months 11- 16: Evaluation Period II||28
11040386|NCT00910689|12220483|FG003|COMPLETED|Months 11- 16: Evaluation Period II||35
11040387|NCT00910689|12220480|FG000|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
11040388|NCT00910689|12220481|FG001|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
11040389|NCT00910689|12220482|FG002|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
11040390|NCT00910689|12220483|FG003|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
11040391|NCT00910715|12220496|FG000|STARTED|Overall Study||108
11040392|NCT00910715|12220497|FG001|STARTED|Overall Study||117
11040393|NCT00910715|12220498|FG002|STARTED|Overall Study||81
11040394|NCT00910715|12220496|FG000|COMPLETED|Overall Study||86
11040395|NCT00910715|12220497|FG001|COMPLETED|Overall Study||91
11040396|NCT00910715|12220498|FG002|COMPLETED|Overall Study||81
11040397|NCT00910715|12220496|FG000|NOT COMPLETED|Overall Study||22
11040398|NCT00910715|12220497|FG001|NOT COMPLETED|Overall Study||26
11040399|NCT00910715|12220498|FG002|NOT COMPLETED|Overall Study||0
11040400|NCT00910728|12220517|FG000|STARTED|Overall Study||6
11040401|NCT00910728|12220518|FG001|STARTED|Overall Study||3
11040402|NCT00910728|12220519|FG002|STARTED|Overall Study||3
11040403|NCT00910728|12220520|FG003|STARTED|Overall Study||3
11040404|NCT00910728|12220521|FG004|STARTED|Overall Study||6
11040405|NCT00910728|12220522|FG005|STARTED|Overall Study||1
11040406|NCT00910728|12220523|FG006|STARTED|Overall Study||6
11040407|NCT00910728|12220524|FG007|STARTED|Overall Study||4
11040408|NCT00910728|12220525|FG008|STARTED|Overall Study||3
11040409|NCT00910728|12220517|FG000|COMPLETED|Overall Study||0
11040410|NCT00910728|12220518|FG001|COMPLETED|Overall Study||0
11040411|NCT00910728|12220519|FG002|COMPLETED|Overall Study||0
11040412|NCT00910728|12220520|FG003|COMPLETED|Overall Study||0
11040413|NCT00910728|12220521|FG004|COMPLETED|Overall Study||1
11040414|NCT00910728|12220522|FG005|COMPLETED|Overall Study||0
11040415|NCT00910728|12220523|FG006|COMPLETED|Overall Study||0
11040416|NCT00910728|12220524|FG007|COMPLETED|Overall Study||1
11040417|NCT00910728|12220525|FG008|COMPLETED|Overall Study||0
11040418|NCT00910728|12220517|FG000|NOT COMPLETED|Overall Study||6
11040419|NCT00910728|12220518|FG001|NOT COMPLETED|Overall Study||3
11040420|NCT00910728|12220519|FG002|NOT COMPLETED|Overall Study||3
11040421|NCT00910728|12220520|FG003|NOT COMPLETED|Overall Study||3
11040422|NCT00910728|12220521|FG004|NOT COMPLETED|Overall Study||5
11040423|NCT00910728|12220522|FG005|NOT COMPLETED|Overall Study||1
11040424|NCT00910728|12220523|FG006|NOT COMPLETED|Overall Study||6
11040425|NCT00910728|12220524|FG007|NOT COMPLETED|Overall Study||3
11040426|NCT00910728|12220525|FG008|NOT COMPLETED|Overall Study||3
11040427|NCT00910845|12220547|FG000|STARTED|Treatment Cycle 1||280
11040428|NCT00910845|12220548|FG001|STARTED|Treatment Cycle 1||277
11040429|NCT00910845|12220547|FG000|COMPLETED|Treatment Cycle 1||249
11040430|NCT00910845|12220548|FG001|COMPLETED|Treatment Cycle 1||243
11335954|NCT02871375|12533561|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
11335955|NCT02871440|12533572|FG000|STARTED|Overall Study||12
11335956|NCT02871440|12533573|FG001|STARTED|Overall Study||13
11335957|NCT02871440|12533574|FG002|STARTED|Overall Study||15
11335958|NCT02871440|12533572|FG000|COMPLETED|Overall Study||12
11335959|NCT02871440|12533573|FG001|COMPLETED|Overall Study||13
11335960|NCT02871440|12533574|FG002|COMPLETED|Overall Study||15
11335961|NCT02871440|12533572|FG000|NOT COMPLETED|Overall Study||0
11335962|NCT02871440|12533573|FG001|NOT COMPLETED|Overall Study||0
11335963|NCT02871440|12533574|FG002|NOT COMPLETED|Overall Study||0
11335964|NCT02871479|12533588|FG000|STARTED|Overall Study||36
11335965|NCT02871479|12533589|FG001|STARTED|Overall Study||24
11335966|NCT02871479|12533590|FG002|STARTED|Overall Study||11
11335967|NCT02871479|12533588|FG000|COMPLETED|Overall Study||33
11335968|NCT02871479|12533589|FG001|COMPLETED|Overall Study||21
11335969|NCT02871479|12533590|FG002|COMPLETED|Overall Study||11
11335970|NCT02871479|12533588|FG000|NOT COMPLETED|Overall Study||3
11335971|NCT02871479|12533589|FG001|NOT COMPLETED|Overall Study||3
11335972|NCT02871479|12533590|FG002|NOT COMPLETED|Overall Study||0
11335973|NCT02871492|12533601|FG000|STARTED|Overall Study||73
11335974|NCT02871492|12533602|FG001|STARTED|Overall Study||73
11335975|NCT02871492|12533603|FG002|STARTED|Overall Study||77
11335976|NCT02871492|12533601|FG000|COMPLETED|Overall Study||67
11335977|NCT02871492|12533602|FG001|COMPLETED|Overall Study||70
11335978|NCT02871492|12533603|FG002|COMPLETED|Overall Study||71
11335979|NCT02871492|12533601|FG000|NOT COMPLETED|Overall Study||6
11335980|NCT02871492|12533602|FG001|NOT COMPLETED|Overall Study||3
11335981|NCT02871492|12533603|FG002|NOT COMPLETED|Overall Study||6
11335982|NCT02871570|12533613|FG000|STARTED|Overall Study||8
11335983|NCT02871570|12533614|FG001|STARTED|Overall Study||8
11335984|NCT02871570|12533613|FG000|COMPLETED|Overall Study||8
11335985|NCT02871570|12533614|FG001|COMPLETED|Overall Study||8
11335986|NCT02871570|12533613|FG000|NOT COMPLETED|Overall Study||0
11335987|NCT02871570|12533614|FG001|NOT COMPLETED|Overall Study||0
11335988|NCT02871635|12533622|FG000|STARTED|Overall Study||72
11335989|NCT02871635|12533623|FG001|STARTED|Overall Study||75
11335990|NCT02871635|12533622|FG000|COMPLETED|Overall Study||54
11335991|NCT02871635|12533623|FG001|COMPLETED|Overall Study||56
11335992|NCT02871635|12533622|FG000|NOT COMPLETED|Overall Study||18
11335993|NCT02871635|12533623|FG001|NOT COMPLETED|Overall Study||19
11335994|NCT02871739|12533635|FG000|STARTED|Overall Study||6
11335995|NCT02871739|12533636|FG001|STARTED|Overall Study||6
11335996|NCT02871739|12533637|FG002|STARTED|Overall Study||4
11335997|NCT02871739|12533638|FG003|STARTED|Overall Study||7
11335998|NCT02871739|12533635|FG000|Completed First SPI|Overall Study||3
11335999|NCT02871739|12533636|FG001|Completed First SPI|Overall Study||5
11040431|NCT00910845|12220547|FG000|NOT COMPLETED|Treatment Cycle 1||31
11040432|NCT00910845|12220548|FG001|NOT COMPLETED|Treatment Cycle 1||34
11040433|NCT00910845|12220547|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
11040434|NCT00910845|12220548|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
11040435|NCT00910845|12220547|FG000|COMPLETED|Treatment Cycle 2||136
11040436|NCT00910845|12220548|FG001|COMPLETED|Treatment Cycle 2||203
11040437|NCT00910845|12220547|FG000|NOT COMPLETED|Treatment Cycle 2||5
11040438|NCT00910845|12220548|FG001|NOT COMPLETED|Treatment Cycle 2||9
11040439|NCT00910858|12220557|FG000|STARTED|Pharmacokinetic Phase||9
11040440|NCT00910858|12220558|FG001|STARTED|Pharmacokinetic Phase||0
11040441|NCT00910858|12220559|FG002|STARTED|Pharmacokinetic Phase||3
11040442|NCT00910858|12220557|FG000|COMPLETED|Pharmacokinetic Phase||8
11040443|NCT00910858|12220558|FG001|COMPLETED|Pharmacokinetic Phase||0
11040444|NCT00910858|12220559|FG002|COMPLETED|Pharmacokinetic Phase||3
11040445|NCT00910858|12220557|FG000|NOT COMPLETED|Pharmacokinetic Phase||1
11040446|NCT00910858|12220558|FG001|NOT COMPLETED|Pharmacokinetic Phase||0
11040447|NCT00910858|12220559|FG002|NOT COMPLETED|Pharmacokinetic Phase||0
11040448|NCT00910858|12220557|FG000|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
11040449|NCT00910858|12220558|FG001|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
11040450|NCT00910858|12220559|FG002|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
11040451|NCT00910858|12220557|FG000|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
11040452|NCT00910858|12220558|FG001|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
11040453|NCT00910858|12220559|FG002|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
11040454|NCT00910858|12220557|FG000|Pharmacokinetic Population|Monotherapy Phase||17
11040455|NCT00910858|12220558|FG001|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
11040456|NCT00910858|12220559|FG002|Pharmacokinetic Population|Monotherapy Phase||7
11040457|NCT00910858|12220557|FG000|COMPLETED|Monotherapy Phase||0
11040458|NCT00910858|12220558|FG001|COMPLETED|Monotherapy Phase||0
11040459|NCT00910858|12220559|FG002|COMPLETED|Monotherapy Phase||0
11040460|NCT00910858|12220557|FG000|NOT COMPLETED|Monotherapy Phase||17
11040461|NCT00910858|12220558|FG001|NOT COMPLETED|Monotherapy Phase||15
11040462|NCT00910858|12220559|FG002|NOT COMPLETED|Monotherapy Phase||7
11040463|NCT00910858|12220557|FG000|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
11040464|NCT00910858|12220558|FG001|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
11040465|NCT00910858|12220559|FG002|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
11040466|NCT00910858|12220557|FG000|COMPLETED|Combined Treatment Phase||0
11040467|NCT00910858|12220558|FG001|COMPLETED|Combined Treatment Phase||0
11040468|NCT00910858|12220559|FG002|COMPLETED|Combined Treatment Phase||0
11040469|NCT00910858|12220557|FG000|NOT COMPLETED|Combined Treatment Phase||9
11040470|NCT00910858|12220558|FG001|NOT COMPLETED|Combined Treatment Phase||10
11040471|NCT00910858|12220559|FG002|NOT COMPLETED|Combined Treatment Phase||4
11040472|NCT00910871|12220575|FG000|STARTED|Overall Study||233
11040473|NCT00910871|12220575|FG000|COMPLETED|Overall Study||179
11040474|NCT00910871|12220575|FG000|NOT COMPLETED|Overall Study||54
11040475|NCT00910910|12220581|FG000|STARTED|Overall Study||225
11040476|NCT00910910|12220582|FG001|STARTED|Overall Study||225
11040477|NCT00910910|12220581|FG000|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
11040478|NCT00910910|12220582|FG001|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
11040479|NCT00910910|12220581|FG000|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0
11040480|NCT00910910|12220582|FG001|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1
11040481|NCT00910910|12220581|FG000|NOT COMPLETED|Overall Study||225
11040482|NCT00910910|12220582|FG001|NOT COMPLETED|Overall Study||224
11040483|NCT00910962|12220591|FG000|STARTED|Overall Study||135
11040484|NCT00910962|12220592|FG001|STARTED|Overall Study||199
11040485|NCT00910962|12220593|FG002|STARTED|Overall Study||192
11040486|NCT00910962|12220591|FG000|COMPLETED|Overall Study||92
11040487|NCT00910962|12220592|FG001|COMPLETED|Overall Study||121
11040488|NCT00910962|12220593|FG002|COMPLETED|Overall Study||116
11040489|NCT00910962|12220591|FG000|NOT COMPLETED|Overall Study||43
11040490|NCT00910962|12220592|FG001|NOT COMPLETED|Overall Study||78
11040491|NCT00910962|12220593|FG002|NOT COMPLETED|Overall Study||76
11040492|NCT00910988|12220607|FG000|STARTED|Overall Study||16
11040493|NCT00910988|12220608|FG001|STARTED|Overall Study||16
11040494|NCT00910988|12220609|FG002|STARTED|Overall Study||8
11040495|NCT00910988|12220610|FG003|STARTED|Overall Study||6
11040496|NCT00910988|12220607|FG000|COMPLETED|Overall Study||14
11040497|NCT00910988|12220608|FG001|COMPLETED|Overall Study||12
11040498|NCT00910988|12220609|FG002|COMPLETED|Overall Study||5
11040499|NCT00910988|12220610|FG003|COMPLETED|Overall Study||6
11040500|NCT00910988|12220607|FG000|NOT COMPLETED|Overall Study||2
11040501|NCT00910988|12220608|FG001|NOT COMPLETED|Overall Study||4
11040502|NCT00910988|12220609|FG002|NOT COMPLETED|Overall Study||3
11040503|NCT00910988|12220610|FG003|NOT COMPLETED|Overall Study||0
11040504|NCT00911144|12220638|FG000|STARTED|Overall Study||335
11040505|NCT00911144|12220639|FG001|STARTED|Overall Study||113
11040506|NCT00911144|12220638|FG000|COMPLETED|Overall Study||319
11040507|NCT00911144|12220639|FG001|COMPLETED|Overall Study||108
11040508|NCT00911144|12220638|FG000|NOT COMPLETED|Overall Study||16
11040509|NCT00911144|12220639|FG001|NOT COMPLETED|Overall Study||5
11040510|NCT00911157|12220647|FG000|STARTED|Overall Study||29
11040511|NCT00911157|12220648|FG001|STARTED|Overall Study||10
11040512|NCT00911157|12220647|FG000|COMPLETED|Overall Study||22
11040513|NCT00911157|12220648|FG001|COMPLETED|Overall Study||8
11040514|NCT00911157|12220647|FG000|NOT COMPLETED|Overall Study||7
11040515|NCT00911157|12220648|FG001|NOT COMPLETED|Overall Study||2
11040516|NCT00911170|12220656|FG000|STARTED|Treatment Period||424
11040517|NCT00911170|12220657|FG001|STARTED|Treatment Period||423
11040518|NCT00911170|12220656|FG000|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
11040519|NCT00911170|12220657|FG001|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
11040520|NCT00911170|12220656|FG000|Received Bevacizumab|Treatment Period||423
11040521|NCT00911170|12220657|FG001|Received Bevacizumab|Treatment Period||420
11040522|NCT00911170|12220656|FG000|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
11040523|NCT00911170|12220657|FG001|Received Investigational Product|Treatment Period||419
11040524|NCT00911170|12220656|FG000|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
11040525|NCT00911170|12220657|FG001|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
11040526|NCT00911170|12220656|FG000|NOT COMPLETED|Treatment Period||27
11040527|NCT00911170|12220657|FG001|NOT COMPLETED|Treatment Period||37
11040528|NCT00911170|12220656|FG000|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
11040529|NCT00911170|12220657|FG001|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
11040530|NCT00911170|12220656|FG000|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
11040531|NCT00911170|12220657|FG001|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
11040532|NCT00911170|12220656|FG000|NOT COMPLETED|Long Term Follow-Up||423
11040533|NCT00911170|12220657|FG001|NOT COMPLETED|Long Term Follow-Up||422
11040534|NCT00911300|12220665|FG000|STARTED|Overall Study||175
11040535|NCT00911300|12220666|FG001|STARTED|Overall Study||174
11040536|NCT00911300|12220665|FG000|COMPLETED|Overall Study||140
11040537|NCT00911300|12220666|FG001|COMPLETED|Overall Study||131
11040538|NCT00911300|12220665|FG000|NOT COMPLETED|Overall Study||35
11040539|NCT00911300|12220666|FG001|NOT COMPLETED|Overall Study||43
11040540|NCT00911326|12220673|FG000|STARTED|Overall Study||101
11040541|NCT00911326|12220673|FG000|COMPLETED|Overall Study||85
11040542|NCT00911326|12220673|FG000|NOT COMPLETED|Overall Study||16
11040543|NCT00911495|12220677|FG000|STARTED|Overall Study||15
11040544|NCT00911495|12220677|FG000|COMPLETED|Overall Study||14
11040545|NCT00911495|12220677|FG000|NOT COMPLETED|Overall Study||1
11040546|NCT00911508|12220683|FG000|STARTED|Overall Study||1108
11040547|NCT00911508|12220684|FG001|STARTED|Overall Study||1096
11040548|NCT00911508|12220683|FG000|COMPLETED|Overall Study||1002
11040549|NCT00911508|12220684|FG001|COMPLETED|Overall Study||966
11040550|NCT00911508|12220683|FG000|NOT COMPLETED|Overall Study||106
11040551|NCT00911508|12220684|FG001|NOT COMPLETED|Overall Study||130
11040552|NCT00911534|12220692|FG000|STARTED|Overall Study|Randomized (treated)|147
11040553|NCT00911534|12220693|FG001|STARTED|Overall Study|Randomized (treated)|153
11040554|NCT00911534|12220692|FG000|COMPLETED|Overall Study||132
11040555|NCT00911534|12220693|FG001|COMPLETED|Overall Study||137
11040556|NCT00911534|12220692|FG000|NOT COMPLETED|Overall Study||15
11040557|NCT00911534|12220693|FG001|NOT COMPLETED|Overall Study||16
11040558|NCT00911586|12220699|FG000|STARTED|Overall Study||15
11040559|NCT00911586|12220699|FG000|COMPLETED|Overall Study||15
11040560|NCT00911586|12220699|FG000|NOT COMPLETED|Overall Study||0
11040561|NCT00911612|12220706|FG000|STARTED|Overall Study||12
11040562|NCT00911612|12220707|FG001|STARTED|Overall Study||12
11040563|NCT00911612|12220706|FG000|COMPLETED|Overall Study||12
11040564|NCT00911612|12220707|FG001|COMPLETED|Overall Study||12
11040565|NCT00911612|12220706|FG000|NOT COMPLETED|Overall Study||0
11040566|NCT00911612|12220707|FG001|NOT COMPLETED|Overall Study||0
11040567|NCT00911625|12220715|FG000|STARTED|Overall Study||57
11040568|NCT00911625|12220716|FG001|STARTED|Overall Study||57
11040569|NCT00911625|12220715|FG000|COMPLETED|Overall Study||50
11040570|NCT00911625|12220716|FG001|COMPLETED|Overall Study||57
11040571|NCT00911625|12220715|FG000|NOT COMPLETED|Overall Study||7
11040572|NCT00911625|12220716|FG001|NOT COMPLETED|Overall Study||0
11040573|NCT00911742|12220724|FG000|STARTED|Treatment Phase I||13
11040574|NCT00911742|12220725|FG001|STARTED|Treatment Phase I||13
11040575|NCT00911742|12220724|FG000|COMPLETED|Treatment Phase I||13
11040576|NCT00911742|12220725|FG001|COMPLETED|Treatment Phase I||13
11040577|NCT00911742|12220724|FG000|NOT COMPLETED|Treatment Phase I||0
11040578|NCT00911742|12220725|FG001|NOT COMPLETED|Treatment Phase I||0
11040579|NCT00911742|12220724|FG000|STARTED|Treatment Phase II||13
11040580|NCT00911742|12220725|FG001|STARTED|Treatment Phase II||13
11040581|NCT00911742|12220724|FG000|COMPLETED|Treatment Phase II||13
11040582|NCT00911742|12220725|FG001|COMPLETED|Treatment Phase II||13
11040583|NCT00911742|12220724|FG000|NOT COMPLETED|Treatment Phase II||0
11040584|NCT00911742|12220725|FG001|NOT COMPLETED|Treatment Phase II||0
11040585|NCT00911768|12220733|FG000|STARTED|Overall Study||50
11040586|NCT00911768|12220734|FG001|STARTED|Overall Study||50
11040587|NCT00911768|12220733|FG000|COMPLETED|Overall Study||44
11040588|NCT00911768|12220734|FG001|COMPLETED|Overall Study||46
11040589|NCT00911768|12220733|FG000|NOT COMPLETED|Overall Study||6
11040590|NCT00911768|12220734|FG001|NOT COMPLETED|Overall Study||4
11040591|NCT00911807|12220743|FG000|STARTED|Overall Study||72
11040592|NCT00911807|12220744|FG001|STARTED|Overall Study||70
11040593|NCT00911807|12220745|FG002|STARTED|Overall Study||75
11040594|NCT00911807|12220743|FG000|COMPLETED|Overall Study||55
11040595|NCT00911807|12220744|FG001|COMPLETED|Overall Study||52
11040596|NCT00911807|12220745|FG002|COMPLETED|Overall Study||52
11040597|NCT00911807|12220743|FG000|NOT COMPLETED|Overall Study||17
11040598|NCT00911807|12220744|FG001|NOT COMPLETED|Overall Study||18
11040599|NCT00911807|12220745|FG002|NOT COMPLETED|Overall Study||23
11057800|NCT01000285|12239537|FG000|STARTED|Overall Study||18
11057801|NCT01000285|12239537|FG000|COMPLETED|Overall Study||18
11057802|NCT01000285|12239537|FG000|NOT COMPLETED|Overall Study||0
11057803|NCT01000311|12239553|FG000|STARTED|Overall Study||258
11057804|NCT01000311|12239554|FG001|STARTED|Overall Study||271
11057805|NCT01000311|12239553|FG000|COMPLETED|Overall Study||213
11057806|NCT01000311|12239554|FG001|COMPLETED|Overall Study||201
11057807|NCT01000311|12239553|FG000|NOT COMPLETED|Overall Study||45
11057808|NCT01000311|12239554|FG001|NOT COMPLETED|Overall Study||70
11057809|NCT01000324|12239560|FG000|STARTED|Year 16||40
11057810|NCT01000324|12239560|FG000|COMPLETED|Year 16||40
11057811|NCT01000324|12239560|FG000|NOT COMPLETED|Year 16||0
11057812|NCT01000324|12239560|FG000|STARTED|Year 17||32
11057813|NCT01000324|12239560|FG000|COMPLETED|Year 17||32
11057814|NCT01000324|12239560|FG000|NOT COMPLETED|Year 17||0
11057815|NCT01000324|12239560|FG000|STARTED|Year 18||29
11057816|NCT01000324|12239560|FG000|COMPLETED|Year 18||29
11057817|NCT01000324|12239560|FG000|NOT COMPLETED|Year 18||0
11057818|NCT01000324|12239560|FG000|STARTED|Year 19||28
11057819|NCT01000324|12239560|FG000|COMPLETED|Year 19||28
11057820|NCT01000324|12239560|FG000|NOT COMPLETED|Year 19||0
11057821|NCT01000324|12239560|FG000|STARTED|Year 20||28
11057822|NCT01000324|12239560|FG000|COMPLETED|Year 20||28
11057823|NCT01000324|12239560|FG000|NOT COMPLETED|Year 20||0
11057824|NCT01000337|12239567|FG000|STARTED|Overall Study||34
11057825|NCT01000337|12239568|FG001|STARTED|Overall Study||33
11057826|NCT01000337|12239567|FG000|COMPLETED|Overall Study||30
11057827|NCT01000337|12239568|FG001|COMPLETED|Overall Study||30
11057828|NCT01000337|12239567|FG000|NOT COMPLETED|Overall Study||4
11057829|NCT01000337|12239568|FG001|NOT COMPLETED|Overall Study||3
11057830|NCT01000376|12239576|FG000|STARTED|Cycle 1 Day 1||6
11057831|NCT01000376|12239577|FG001|STARTED|Cycle 1 Day 1||6
11057832|NCT01000376|12239576|FG000|COMPLETED|Cycle 1 Day 1||4
11057833|NCT01000376|12239577|FG001|COMPLETED|Cycle 1 Day 1||6
11057834|NCT01000376|12239576|FG000|NOT COMPLETED|Cycle 1 Day 1||2
11057835|NCT01000376|12239577|FG001|NOT COMPLETED|Cycle 1 Day 1||0
11057836|NCT01000376|12239576|FG000|STARTED|Cycle 1 Day 15||4
11057837|NCT01000376|12239577|FG001|STARTED|Cycle 1 Day 15||6
11057838|NCT01000376|12239576|FG000|COMPLETED|Cycle 1 Day 15||4
11057839|NCT01000376|12239577|FG001|COMPLETED|Cycle 1 Day 15||6
11057840|NCT01000376|12239576|FG000|NOT COMPLETED|Cycle 1 Day 15||0
11057841|NCT01000376|12239577|FG001|NOT COMPLETED|Cycle 1 Day 15||0
11057842|NCT01000480|12239583|FG000|STARTED|Induction Phase||90
11057843|NCT01000480|12239583|FG000|Received at Least 1 Dose of Either Drug|Induction Phase||90
11057844|NCT01000480|12239583|FG000|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
11057845|NCT01000480|12239583|FG000|COMPLETED|Induction Phase||83
11057846|NCT01000480|12239583|FG000|NOT COMPLETED|Induction Phase||7
11057847|NCT01000480|12239583|FG000|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
11057848|NCT01000480|12239583|FG000|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
11057849|NCT01000480|12239583|FG000|COMPLETED|Concurrent Therapy Phase||65
11057850|NCT01000480|12239583|FG000|NOT COMPLETED|Concurrent Therapy Phase||10
11057851|NCT01000480|12239583|FG000|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
11057852|NCT01000480|12239583|FG000|COMPLETED|Follow-Up Period||88
11057853|NCT01000480|12239583|FG000|NOT COMPLETED|Follow-Up Period||0
11057854|NCT01000493|12239589|FG000|STARTED|Overall Study||60
11057855|NCT01000493|12239590|FG001|STARTED|Overall Study||69
11057856|NCT01000493|12239589|FG000|COMPLETED|Overall Study||21
11057857|NCT01000493|12239590|FG001|COMPLETED|Overall Study||14
11057858|NCT01000493|12239589|FG000|NOT COMPLETED|Overall Study||39
11057859|NCT01000493|12239590|FG001|NOT COMPLETED|Overall Study||55
11057860|NCT01000506|12239600|FG000|STARTED|Overall Study||155
11040600|NCT00911820|12220755|FG000|STARTED|Overall Study||45
11040601|NCT00911820|12220756|FG001|STARTED|Overall Study||43
11040602|NCT00911820|12220755|FG000|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
11040603|NCT00911820|12220756|FG001|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
11040604|NCT00911820|12220755|FG000|COMPLETED|Overall Study||0
11040605|NCT00911820|12220756|FG001|COMPLETED|Overall Study||0
11040606|NCT00911820|12220755|FG000|NOT COMPLETED|Overall Study||45
11040607|NCT00911820|12220756|FG001|NOT COMPLETED|Overall Study||43
11040608|NCT00911859|12220765|FG000|STARTED|Treatment Period||12
11040609|NCT00911859|12220766|FG001|STARTED|Treatment Period||54
11040610|NCT00911859|12220767|FG002|STARTED|Treatment Period||52
11040611|NCT00911859|12220765|FG000|Received Treatment|Treatment Period||12
11040612|NCT00911859|12220766|FG001|Received Treatment|Treatment Period||53
11040613|NCT00911859|12220767|FG002|Received Treatment|Treatment Period||52
11040614|NCT00911859|12220765|FG000|COMPLETED|Treatment Period||4
11040615|NCT00911859|12220766|FG001|COMPLETED|Treatment Period||33
11040616|NCT00911859|12220767|FG002|COMPLETED|Treatment Period||27
11040617|NCT00911859|12220765|FG000|NOT COMPLETED|Treatment Period||8
11040618|NCT00911859|12220766|FG001|NOT COMPLETED|Treatment Period||21
11040619|NCT00911859|12220767|FG002|NOT COMPLETED|Treatment Period||25
11040620|NCT00911859|12220765|FG000|STARTED|Maintainance Period||0
11040621|NCT00911859|12220766|FG001|STARTED|Maintainance Period||0
11040622|NCT00911859|12220767|FG002|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
11040623|NCT00911859|12220765|FG000|COMPLETED|Maintainance Period||0
11040624|NCT00911859|12220766|FG001|COMPLETED|Maintainance Period||0
11040625|NCT00911859|12220767|FG002|COMPLETED|Maintainance Period||0
11040626|NCT00911859|12220765|FG000|NOT COMPLETED|Maintainance Period||0
11040627|NCT00911859|12220766|FG001|NOT COMPLETED|Maintainance Period||0
11040628|NCT00911859|12220767|FG002|NOT COMPLETED|Maintainance Period||21
11201139|NCT01831089|12391352|FG001|STARTED|Cohort IV: Dose Level 4||0
11040629|NCT00911859|12220765|FG000|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
11040630|NCT00911859|12220766|FG001|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
11040631|NCT00911859|12220767|FG002|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
11040632|NCT00911859|12220765|FG000|COMPLETED|Follow-up Period||1
11040633|NCT00911859|12220766|FG001|COMPLETED|Follow-up Period||7
11040634|NCT00911859|12220767|FG002|COMPLETED|Follow-up Period||11
11040635|NCT00911859|12220765|FG000|NOT COMPLETED|Follow-up Period||11
11040636|NCT00911859|12220766|FG001|NOT COMPLETED|Follow-up Period||46
11040637|NCT00911859|12220767|FG002|NOT COMPLETED|Follow-up Period||41
11040638|NCT00911898|12220775|FG000|STARTED|Overall Study||20
11040639|NCT00911898|12220775|FG000|COMPLETED|Overall Study||20
11040640|NCT00911898|12220775|FG000|NOT COMPLETED|Overall Study||0
11040641|NCT00911937|12220781|FG000|STARTED|Overall Study||487
11040642|NCT00911937|12220782|FG001|STARTED|Overall Study||476
11040643|NCT00911937|12220781|FG000|Treated|Overall Study||474
11040644|NCT00911937|12220782|FG001|Treated|Overall Study||463
11040645|NCT00911937|12220781|FG000|COMPLETED|Overall Study||400
11040646|NCT00911937|12220782|FG001|COMPLETED|Overall Study||381
11040647|NCT00911937|12220781|FG000|NOT COMPLETED|Overall Study||87
11040648|NCT00911937|12220782|FG001|NOT COMPLETED|Overall Study||95
11040649|NCT00911989|12220788|FG000|STARTED|Overall Study||4
11040650|NCT00911989|12220788|FG000|COMPLETED|Overall Study||3
11040651|NCT00911989|12220788|FG000|NOT COMPLETED|Overall Study||1
11040652|NCT00912002|12220792|FG000|STARTED|Overall Study||6
11040653|NCT00912002|12220792|FG000|COMPLETED|Overall Study||6
11040654|NCT00912002|12220792|FG000|NOT COMPLETED|Overall Study||0
11040655|NCT00912015|12220801|FG000|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
11040656|NCT00912015|12220802|FG001|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
11040657|NCT00912015|12220803|FG002|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
11040658|NCT00912015|12220804|FG003|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
11040659|NCT00912015|12220801|FG000|COMPLETED|Overall Study||125
11040660|NCT00912015|12220802|FG001|COMPLETED|Overall Study||62
11040661|NCT00912015|12220803|FG002|COMPLETED|Overall Study||22
11040662|NCT00912015|12220804|FG003|COMPLETED|Overall Study||0
11040663|NCT00912015|12220801|FG000|NOT COMPLETED|Overall Study||16
11040664|NCT00912015|12220802|FG001|NOT COMPLETED|Overall Study||8
11040665|NCT00912015|12220803|FG002|NOT COMPLETED|Overall Study||3
11040666|NCT00912015|12220804|FG003|NOT COMPLETED|Overall Study||2
11040667|NCT00912028|12220817|FG000|STARTED|Overall Study||35
11040668|NCT00912028|12220818|FG001|STARTED|Overall Study||3
11040669|NCT00912028|12220819|FG002|STARTED|Overall Study||13
11040670|NCT00912028|12220820|FG003|STARTED|Overall Study||17
11040671|NCT00912028|12220821|FG004|STARTED|Overall Study||3
11040672|NCT00912028|12220817|FG000|COMPLETED|Overall Study||30
11040673|NCT00912028|12220818|FG001|COMPLETED|Overall Study||0
11040674|NCT00912028|12220819|FG002|COMPLETED|Overall Study||13
11040675|NCT00912028|12220820|FG003|COMPLETED|Overall Study||16
11040676|NCT00912028|12220821|FG004|COMPLETED|Overall Study||0
11040677|NCT00912028|12220817|FG000|NOT COMPLETED|Overall Study||5
11040678|NCT00912028|12220818|FG001|NOT COMPLETED|Overall Study||3
11040679|NCT00912028|12220819|FG002|NOT COMPLETED|Overall Study||0
11040680|NCT00912028|12220820|FG003|NOT COMPLETED|Overall Study||1
11040681|NCT00912028|12220821|FG004|NOT COMPLETED|Overall Study||3
11040682|NCT00912093|12220836|FG000|STARTED|The Controlled Phase||43
11040683|NCT00912093|12220837|FG001|STARTED|The Controlled Phase||45
11040684|NCT00912093|12220838|FG002|STARTED|The Controlled Phase||3
11040685|NCT00912093|12220839|FG003|STARTED|The Controlled Phase||2
11040686|NCT00912093|12220840|FG004|STARTED|The Controlled Phase||5
11040687|NCT00912093|12220836|FG000|COMPLETED|The Controlled Phase||43
11040688|NCT00912093|12220837|FG001|COMPLETED|The Controlled Phase||43
11040689|NCT00912093|12220838|FG002|COMPLETED|The Controlled Phase||3
11040690|NCT00912093|12220839|FG003|COMPLETED|The Controlled Phase||2
11040691|NCT00912093|12220840|FG004|COMPLETED|The Controlled Phase||4
11040692|NCT00912093|12220836|FG000|NOT COMPLETED|The Controlled Phase||0
11040693|NCT00912093|12220837|FG001|NOT COMPLETED|The Controlled Phase||2
11040694|NCT00912093|12220838|FG002|NOT COMPLETED|The Controlled Phase||0
11040695|NCT00912093|12220839|FG003|NOT COMPLETED|The Controlled Phase||0
11040696|NCT00912093|12220840|FG004|NOT COMPLETED|The Controlled Phase||1
11040697|NCT00912093|12220836|FG000|STARTED|The Open Label Extension (OLE) Phase||38
11040698|NCT00912093|12220837|FG001|STARTED|The Open Label Extension (OLE) Phase||35
11040699|NCT00912093|12220838|FG002|STARTED|The Open Label Extension (OLE) Phase||3
11040700|NCT00912093|12220839|FG003|STARTED|The Open Label Extension (OLE) Phase||2
11040701|NCT00912093|12220840|FG004|STARTED|The Open Label Extension (OLE) Phase||4
11040702|NCT00912093|12220836|FG000|COMPLETED|The Open Label Extension (OLE) Phase||38
11040703|NCT00912093|12220837|FG001|COMPLETED|The Open Label Extension (OLE) Phase||35
11040704|NCT00912093|12220838|FG002|COMPLETED|The Open Label Extension (OLE) Phase||3
11040705|NCT00912093|12220839|FG003|COMPLETED|The Open Label Extension (OLE) Phase||2
11040706|NCT00912093|12220840|FG004|COMPLETED|The Open Label Extension (OLE) Phase||4
11040707|NCT00912093|12220836|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
11040708|NCT00912093|12220837|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
11040709|NCT00912093|12220838|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
11040710|NCT00912093|12220839|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
11040711|NCT00912093|12220840|FG004|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
11040712|NCT00912197|12220850|FG000|STARTED|Overall Study||15
11040713|NCT00912197|12220851|FG001|STARTED|Overall Study||13
11040714|NCT00912197|12220850|FG000|COMPLETED|Overall Study||12
11040715|NCT00912197|12220851|FG001|COMPLETED|Overall Study||10
11040716|NCT00912197|12220850|FG000|NOT COMPLETED|Overall Study||3
11040717|NCT00912197|12220851|FG001|NOT COMPLETED|Overall Study||3
11040718|NCT00912288|12220861|FG000|STARTED|Overall Study||44
11040719|NCT00912288|12220862|FG001|STARTED|Overall Study||42
11040720|NCT00912288|12220861|FG000|COMPLETED|Overall Study||3
11040721|NCT00912288|12220862|FG001|COMPLETED|Overall Study||2
11040722|NCT00912288|12220861|FG000|NOT COMPLETED|Overall Study||41
11040723|NCT00912288|12220862|FG001|NOT COMPLETED|Overall Study||40
11040724|NCT00912301|12220871|FG000|STARTED|Overall Study||11
11040725|NCT00912301|12220872|FG001|STARTED|Overall Study||12
11040726|NCT00912301|12220873|FG002|STARTED|Overall Study||13
11040727|NCT00912301|12220871|FG000|COMPLETED|Overall Study||11
11040728|NCT00912301|12220872|FG001|COMPLETED|Overall Study||12
11040729|NCT00912301|12220873|FG002|COMPLETED|Overall Study||13
11040730|NCT00912301|12220871|FG000|NOT COMPLETED|Overall Study||0
11040731|NCT00912301|12220872|FG001|NOT COMPLETED|Overall Study||0
11040732|NCT00912301|12220873|FG002|NOT COMPLETED|Overall Study||0
11040733|NCT00912340|12220884|FG000|STARTED|Overall Study||24
11040734|NCT00912340|12220885|FG001|STARTED|Overall Study||30
11040735|NCT00912340|12220886|FG002|STARTED|Overall Study||4
11040736|NCT00912340|12220884|FG000|COMPLETED|Overall Study||22
11040737|NCT00912340|12220885|FG001|COMPLETED|Overall Study||26
11040738|NCT00912340|12220886|FG002|COMPLETED|Overall Study||0
11040739|NCT00912340|12220884|FG000|NOT COMPLETED|Overall Study||2
11040740|NCT00912340|12220885|FG001|NOT COMPLETED|Overall Study||4
11040741|NCT00912340|12220886|FG002|NOT COMPLETED|Overall Study||4
11040742|NCT00912405|12220894|FG000|STARTED|Overall Study||50
11040743|NCT00912405|12220894|FG000|COMPLETED|Overall Study||45
11040744|NCT00912405|12220894|FG000|NOT COMPLETED|Overall Study||5
11040745|NCT00912509|12220900|FG000|STARTED|Overall Study||20
11040746|NCT00912509|12220901|FG001|STARTED|Overall Study||10
11040747|NCT00912509|12220900|FG000|COMPLETED|Overall Study||15
11040748|NCT00912509|12220901|FG001|COMPLETED|Overall Study||7
11040749|NCT00912509|12220900|FG000|NOT COMPLETED|Overall Study||5
11040750|NCT00912509|12220901|FG001|NOT COMPLETED|Overall Study||3
11040751|NCT00912743|12220910|FG000|STARTED|Overall Study||13
11040752|NCT00912743|12220911|FG001|STARTED|Overall Study||20
11040753|NCT00912743|12220910|FG000|COMPLETED|Overall Study||0
11040754|NCT00912743|12220911|FG001|COMPLETED|Overall Study||0
11040755|NCT00912743|12220910|FG000|NOT COMPLETED|Overall Study||13
11040756|NCT00912743|12220911|FG001|NOT COMPLETED|Overall Study||20
11040757|NCT00912782|12220919|FG000|STARTED|Overall Study||27
11040758|NCT00912782|12220920|FG001|STARTED|Overall Study||25
11040759|NCT00912782|12220919|FG000|COMPLETED|Overall Study||24
11040760|NCT00912782|12220920|FG001|COMPLETED|Overall Study||20
11040761|NCT00912782|12220919|FG000|NOT COMPLETED|Overall Study||3
11040762|NCT00912782|12220920|FG001|NOT COMPLETED|Overall Study||5
11040763|NCT00912795|12220928|FG000|STARTED|Overall Study||76
11040764|NCT00912795|12220929|FG001|STARTED|Overall Study||75
11040765|NCT00912795|12220928|FG000|COMPLETED|Overall Study||29
11040766|NCT00912795|12220929|FG001|COMPLETED|Overall Study||17
11040767|NCT00912795|12220928|FG000|NOT COMPLETED|Overall Study||47
11040768|NCT00912795|12220929|FG001|NOT COMPLETED|Overall Study||58
11040769|NCT00912808|12220937|FG000|STARTED|First Intervention (6 Weeks)||11
11040770|NCT00912808|12220938|FG001|STARTED|First Intervention (6 Weeks)||12
11040771|NCT00912808|12220937|FG000|Received Intervention|First Intervention (6 Weeks)||11
11040772|NCT00912808|12220938|FG001|Received Intervention|First Intervention (6 Weeks)||12
11040773|NCT00912808|12220937|FG000|COMPLETED|First Intervention (6 Weeks)||9
11040774|NCT00912808|12220938|FG001|COMPLETED|First Intervention (6 Weeks)||11
11040775|NCT00912808|12220937|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2
11040776|NCT00912808|12220938|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1
11040777|NCT00912808|12220937|FG000|STARTED|Washout||9
11040778|NCT00912808|12220938|FG001|STARTED|Washout||11
11040779|NCT00912808|12220937|FG000|COMPLETED|Washout||9
11040780|NCT00912808|12220938|FG001|COMPLETED|Washout||10
11040781|NCT00912808|12220937|FG000|NOT COMPLETED|Washout||0
11040782|NCT00912808|12220938|FG001|NOT COMPLETED|Washout||1
11040783|NCT00912808|12220937|FG000|STARTED|Second Intervention (6 Weeks)||9
11040784|NCT00912808|12220938|FG001|STARTED|Second Intervention (6 Weeks)||10
11040785|NCT00912808|12220937|FG000|Received Intervention|Second Intervention (6 Weeks)||9
11040786|NCT00912808|12220938|FG001|Received Intervention|Second Intervention (6 Weeks)||10
11040787|NCT00912808|12220937|FG000|COMPLETED|Second Intervention (6 Weeks)||8
11040788|NCT00912808|12220938|FG001|COMPLETED|Second Intervention (6 Weeks)||9
11040789|NCT00912808|12220937|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||1
11040790|NCT00912808|12220938|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||1
11040791|NCT00912873|12220947|FG000|STARTED|Overall Study||26
11040792|NCT00912873|12220948|FG001|STARTED|Overall Study||24
11040793|NCT00912873|12220947|FG000|COMPLETED|Overall Study||26
11040794|NCT00912873|12220948|FG001|COMPLETED|Overall Study||24
11040795|NCT00912873|12220947|FG000|NOT COMPLETED|Overall Study||0
11040796|NCT00912873|12220948|FG001|NOT COMPLETED|Overall Study||0
11040797|NCT00912912|12220958|FG000|STARTED|Overall Study||5
11040798|NCT00912912|12220958|FG000|COMPLETED|Overall Study||1
11040799|NCT00912912|12220958|FG000|NOT COMPLETED|Overall Study||4
11040800|NCT00912925|12220964|FG000|STARTED|Overall Study||23
11040801|NCT00912925|12220965|FG001|STARTED|Overall Study||22
11040802|NCT00912925|12220964|FG000|COMPLETED|Overall Study||23
11040803|NCT00912925|12220965|FG001|COMPLETED|Overall Study||22
11040804|NCT00912925|12220964|FG000|NOT COMPLETED|Overall Study||0
11040805|NCT00912925|12220965|FG001|NOT COMPLETED|Overall Study||0
11040806|NCT00912964|12220974|FG000|STARTED|Overall Study||433
11040807|NCT00912964|12220975|FG001|STARTED|Overall Study||433
11040808|NCT00912964|12220976|FG002|STARTED|Overall Study||440
11040809|NCT00912964|12220974|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
11040810|NCT00912964|12220975|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
11040811|NCT00912964|12220976|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
11040812|NCT00912964|12220974|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
11040813|NCT00912964|12220975|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
11040814|NCT00912964|12220976|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
11040815|NCT00912964|12220974|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
11040816|NCT00912964|12220975|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
11040817|NCT00912964|12220976|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
11040818|NCT00912964|12220974|FG000|COMPLETED|Overall Study||367
11040819|NCT00912964|12220975|FG001|COMPLETED|Overall Study||387
11040820|NCT00912964|12220976|FG002|COMPLETED|Overall Study||386
11040821|NCT00912964|12220974|FG000|NOT COMPLETED|Overall Study||66
11040822|NCT00912964|12220975|FG001|NOT COMPLETED|Overall Study||46
11040823|NCT00912964|12220976|FG002|NOT COMPLETED|Overall Study||54
11040824|NCT00912990|12220986|FG000|STARTED|Overall Study||16
11040825|NCT00912990|12220987|FG001|STARTED|Overall Study||18
11040826|NCT00912990|12220986|FG000|COMPLETED|Overall Study||16
11040827|NCT00912990|12220987|FG001|COMPLETED|Overall Study||18
11040828|NCT00912990|12220986|FG000|NOT COMPLETED|Overall Study||0
11040829|NCT00912990|12220987|FG001|NOT COMPLETED|Overall Study||0
11040830|NCT00913003|12220995|FG000|STARTED|Overall Study||11
11040831|NCT00913003|12220996|FG001|STARTED|Overall Study||11
11040832|NCT00913003|12220995|FG000|COMPLETED|Overall Study||11
11040833|NCT00913003|12220996|FG001|COMPLETED|Overall Study||11
11040834|NCT00913003|12220995|FG000|NOT COMPLETED|Overall Study||0
11040835|NCT00913003|12220996|FG001|NOT COMPLETED|Overall Study||0
11040836|NCT00913068|12221004|FG000|STARTED|Overall Study||56
11040837|NCT00913068|12221005|FG001|STARTED|Overall Study||54
11040838|NCT00913068|12221004|FG000|COMPLETED|Overall Study||48
11040839|NCT00913068|12221005|FG001|COMPLETED|Overall Study||46
11040840|NCT00913068|12221004|FG000|NOT COMPLETED|Overall Study||8
11040841|NCT00913068|12221005|FG001|NOT COMPLETED|Overall Study||8
11040842|NCT00913081|12221011|FG000|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
11040843|NCT00913081|12221011|FG000|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
11040844|NCT00913081|12221011|FG000|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
11040845|NCT00913081|12221011|FG000|STARTED|Washout #1 (7 Days)||17
11040846|NCT00913081|12221011|FG000|COMPLETED|Washout #1 (7 Days)||17
11040847|NCT00913081|12221011|FG000|NOT COMPLETED|Washout #1 (7 Days)||0
11040848|NCT00913081|12221011|FG000|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
11040849|NCT00913081|12221011|FG000|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
11040850|NCT00913081|12221011|FG000|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
11040851|NCT00913081|12221011|FG000|STARTED|Washout #2 (7 Days)||17
11040852|NCT00913081|12221011|FG000|COMPLETED|Washout #2 (7 Days)||17
11040853|NCT00913081|12221011|FG000|NOT COMPLETED|Washout #2 (7 Days)||0
11040854|NCT00913081|12221011|FG000|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
11040855|NCT00913081|12221011|FG000|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
11040856|NCT00913081|12221011|FG000|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
11040857|NCT00913081|12221011|FG000|STARTED|Washout #3 (7days)||17
11040858|NCT00913081|12221011|FG000|COMPLETED|Washout #3 (7days)||17
11040859|NCT00913081|12221011|FG000|NOT COMPLETED|Washout #3 (7days)||0
11040860|NCT00913081|12221011|FG000|STARTED|Placebo + Niacin 500 mg (1day)||17
11040861|NCT00913081|12221011|FG000|COMPLETED|Placebo + Niacin 500 mg (1day)||17
11040862|NCT00913081|12221011|FG000|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
11040863|NCT00913133|12221021|FG000|STARTED|Overall Study||516
11040864|NCT00913133|12221021|FG000|COMPLETED|Overall Study||516
11040865|NCT00913133|12221021|FG000|NOT COMPLETED|Overall Study||0
11040866|NCT00913263|12221025|FG000|STARTED|Overall Study||24
11040867|NCT00913263|12221025|FG000|COMPLETED|Overall Study||24
11040868|NCT00913263|12221025|FG000|NOT COMPLETED|Overall Study||0
11040869|NCT00913380|12221035|FG000|STARTED|CT Examination||444
11040870|NCT00913380|12221036|FG001|STARTED|CT Examination||447
11040871|NCT00913380|12221035|FG000|COMPLETED|CT Examination||444
11040872|NCT00913380|12221036|FG001|COMPLETED|CT Examination||447
11040873|NCT00913380|12221035|FG000|NOT COMPLETED|CT Examination||0
11040874|NCT00913380|12221036|FG001|NOT COMPLETED|CT Examination||0
11040875|NCT00913380|12221035|FG000|STARTED|Clinical Outcomes||444
11040876|NCT00913380|12221036|FG001|STARTED|Clinical Outcomes||447
11040877|NCT00913380|12221035|FG000|COMPLETED|Clinical Outcomes||438
11040878|NCT00913380|12221036|FG001|COMPLETED|Clinical Outcomes||441
11040879|NCT00913380|12221035|FG000|NOT COMPLETED|Clinical Outcomes||6
11040880|NCT00913380|12221036|FG001|NOT COMPLETED|Clinical Outcomes||6
11040881|NCT00913458|12221042|FG000|STARTED|Phase 1||306
11040882|NCT00913458|12221043|FG001|STARTED|Phase 1|This arm is part of Phase 2 study|0
11040883|NCT00913458|12221044|FG002|STARTED|Phase 1|This arm is part of Phase 2 study|0
11040884|NCT00913458|12221045|FG003|STARTED|Phase 1|This arm is part of Phase 2 study|0
11040885|NCT00913458|12221046|FG004|STARTED|Phase 1|This arm is part of Phase 3 study|0
11040886|NCT00913458|12221047|FG005|STARTED|Phase 1|This arm is part of Phase 3 study|0
11040887|NCT00913458|12221048|FG006|STARTED|Phase 1|This arm is part of Phase 3 study|0
11040888|NCT00913458|12221042|FG000|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
11040889|NCT00913458|12221043|FG001|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
11040890|NCT00913458|12221044|FG002|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
11040891|NCT00913458|12221045|FG003|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
11040892|NCT00913458|12221046|FG004|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
11040893|NCT00913458|12221047|FG005|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
11040894|NCT00913458|12221048|FG006|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
11040895|NCT00913458|12221042|FG000|NOT COMPLETED|Phase 1||112
11040896|NCT00913458|12221043|FG001|NOT COMPLETED|Phase 1||0
11040897|NCT00913458|12221044|FG002|NOT COMPLETED|Phase 1||0
11040898|NCT00913458|12221045|FG003|NOT COMPLETED|Phase 1||0
11040899|NCT00913458|12221046|FG004|NOT COMPLETED|Phase 1||0
11040900|NCT00913458|12221047|FG005|NOT COMPLETED|Phase 1||0
11040901|NCT00913458|12221048|FG006|NOT COMPLETED|Phase 1||0
11040902|NCT00913458|12221042|FG000|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
11040903|NCT00913458|12221043|FG001|STARTED|Phase 2||63
11040904|NCT00913458|12221044|FG002|STARTED|Phase 2||65
11040905|NCT00913458|12221045|FG003|STARTED|Phase 2||65
11040906|NCT00913458|12221046|FG004|STARTED|Phase 2||0
11040907|NCT00913458|12221047|FG005|STARTED|Phase 2||0
11040908|NCT00913458|12221048|FG006|STARTED|Phase 2||0
11040909|NCT00913458|12221042|FG000|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
11040910|NCT00913458|12221043|FG001|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
11040911|NCT00913458|12221044|FG002|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
11040912|NCT00913458|12221045|FG003|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
11040913|NCT00913458|12221046|FG004|COMPLETED|Phase 2||0
11040914|NCT00913458|12221047|FG005|COMPLETED|Phase 2||0
11040915|NCT00913458|12221048|FG006|COMPLETED|Phase 2||0
11040916|NCT00913458|12221042|FG000|NOT COMPLETED|Phase 2||0
11040917|NCT00913458|12221043|FG001|NOT COMPLETED|Phase 2||10
11040918|NCT00913458|12221044|FG002|NOT COMPLETED|Phase 2||19
11040919|NCT00913458|12221045|FG003|NOT COMPLETED|Phase 2||33
11040920|NCT00913458|12221046|FG004|NOT COMPLETED|Phase 2||0
11040921|NCT00913458|12221047|FG005|NOT COMPLETED|Phase 2||0
11040922|NCT00913458|12221048|FG006|NOT COMPLETED|Phase 2||0
11040923|NCT00913458|12221042|FG000|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
11040924|NCT00913458|12221043|FG001|STARTED|Phase 3||0
11040925|NCT00913458|12221044|FG002|STARTED|Phase 3||0
11040926|NCT00913458|12221045|FG003|STARTED|Phase 3||0
11040927|NCT00913458|12221046|FG004|STARTED|Phase 3|Participants who completed Phase 2 study|53
11040928|NCT00913458|12221047|FG005|STARTED|Phase 3|Participants who completed Phase 2 study|46
11040929|NCT00913458|12221048|FG006|STARTED|Phase 3|Participants who completed Phase 2 study|32
11057861|NCT01000506|12239601|FG001|STARTED|Overall Study||153
11040930|NCT00913458|12221042|FG000|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
11040931|NCT00913458|12221043|FG001|COMPLETED|Phase 3||0
11040932|NCT00913458|12221044|FG002|COMPLETED|Phase 3||0
11040933|NCT00913458|12221045|FG003|COMPLETED|Phase 3||0
11040934|NCT00913458|12221046|FG004|COMPLETED|Phase 3||31
11040935|NCT00913458|12221047|FG005|COMPLETED|Phase 3||28
11040936|NCT00913458|12221048|FG006|COMPLETED|Phase 3||24
11040937|NCT00913458|12221042|FG000|NOT COMPLETED|Phase 3||0
11040938|NCT00913458|12221043|FG001|NOT COMPLETED|Phase 3||0
11040939|NCT00913458|12221044|FG002|NOT COMPLETED|Phase 3||0
11040940|NCT00913458|12221045|FG003|NOT COMPLETED|Phase 3||0
11040941|NCT00913458|12221046|FG004|NOT COMPLETED|Phase 3||22
11040942|NCT00913458|12221047|FG005|NOT COMPLETED|Phase 3||18
11040943|NCT00913458|12221048|FG006|NOT COMPLETED|Phase 3||8
11040944|NCT00913510|12221067|FG000|STARTED|Overall Study||13
11040945|NCT00913510|12221068|FG001|STARTED|Overall Study||7
11040946|NCT00913510|12221067|FG000|COMPLETED|Overall Study||5
11040947|NCT00913510|12221068|FG001|COMPLETED|Overall Study||3
11040948|NCT00913510|12221067|FG000|NOT COMPLETED|Overall Study||8
11040949|NCT00913510|12221068|FG001|NOT COMPLETED|Overall Study||4
11040950|NCT00913523|12221077|FG000|STARTED|Overall Study||162
11040951|NCT00913523|12221078|FG001|STARTED|Overall Study||159
11040952|NCT00913523|12221079|FG002|STARTED|Overall Study||161
11040953|NCT00913523|12221077|FG000|COMPLETED|Overall Study||144
11040954|NCT00913523|12221078|FG001|COMPLETED|Overall Study||143
11040955|NCT00913523|12221079|FG002|COMPLETED|Overall Study||147
11040956|NCT00913523|12221077|FG000|NOT COMPLETED|Overall Study||18
11040957|NCT00913523|12221078|FG001|NOT COMPLETED|Overall Study||16
11040958|NCT00913523|12221079|FG002|NOT COMPLETED|Overall Study||14
11040959|NCT00913627|12221091|FG000|STARTED|Overall Study||29
11040960|NCT00913627|12221092|FG001|STARTED|Overall Study||53
11040961|NCT00913627|12221093|FG002|STARTED|Overall Study||56
11040962|NCT00913627|12221094|FG003|STARTED|Overall Study||58
11040963|NCT00913627|12221091|FG000|COMPLETED|Overall Study||29
11040964|NCT00913627|12221092|FG001|COMPLETED|Overall Study||53
11040965|NCT00913627|12221093|FG002|COMPLETED|Overall Study||56
11040966|NCT00913627|12221094|FG003|COMPLETED|Overall Study||58
11040967|NCT00913627|12221091|FG000|NOT COMPLETED|Overall Study||0
11040968|NCT00913627|12221092|FG001|NOT COMPLETED|Overall Study||0
11336000|NCT02871739|12533637|FG002|Completed First SPI|Overall Study||4
11336001|NCT02871739|12533638|FG003|Completed First SPI|Overall Study||6
11336002|NCT02871739|12533635|FG000|Completed Second SPI|Overall Study||3
11336003|NCT02871739|12533636|FG001|Completed Second SPI|Overall Study||4
11336004|NCT02871739|12533637|FG002|Completed Second SPI|Overall Study||4
11336005|NCT02871739|12533638|FG003|Completed Second SPI|Overall Study||5
11336006|NCT02871739|12533635|FG000|Complete Final Survey|Overall Study||3
11336007|NCT02871739|12533636|FG001|Complete Final Survey|Overall Study||4
11040969|NCT00913627|12221093|FG002|NOT COMPLETED|Overall Study||0
11040970|NCT00913627|12221094|FG003|NOT COMPLETED|Overall Study||0
11040971|NCT00913744|12221106|FG000|STARTED|Overall Study||75
11040972|NCT00913744|12221107|FG001|STARTED|Overall Study||25
11040973|NCT00913744|12221106|FG000|COMPLETED|Overall Study||70
11040974|NCT00913744|12221107|FG001|COMPLETED|Overall Study||24
11336008|NCT02871739|12533637|FG002|Complete Final Survey|Overall Study||4
11040975|NCT00913744|12221106|FG000|NOT COMPLETED|Overall Study||5
11336009|NCT02871739|12533638|FG003|Complete Final Survey|Overall Study||5
11336010|NCT02871739|12533635|FG000|COMPLETED|Overall Study||3
11336011|NCT02871739|12533636|FG001|COMPLETED|Overall Study||4
11040976|NCT00913744|12221107|FG001|NOT COMPLETED|Overall Study||1
11040977|NCT00913770|12221116|FG000|STARTED|Overall Study||104
11040978|NCT00913770|12221117|FG001|STARTED|Overall Study||111
11040979|NCT00913770|12221118|FG002|STARTED|Overall Study||114
11040980|NCT00913770|12221116|FG000|COMPLETED|Overall Study||69
11040981|NCT00913770|12221117|FG001|COMPLETED|Overall Study||82
11040982|NCT00913770|12221118|FG002|COMPLETED|Overall Study||93
11040983|NCT00913770|12221116|FG000|NOT COMPLETED|Overall Study||35
11040984|NCT00913770|12221117|FG001|NOT COMPLETED|Overall Study||29
11040985|NCT00913770|12221118|FG002|NOT COMPLETED|Overall Study||21
11040986|NCT00913835|12221128|FG000|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
11040987|NCT00913835|12221129|FG001|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
11040988|NCT00913835|12221128|FG000|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
11040989|NCT00913835|12221129|FG001|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
11040990|NCT00913835|12221128|FG000|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
11040991|NCT00913835|12221129|FG001|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
11040992|NCT00913835|12221128|FG000|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
11040993|NCT00913835|12221129|FG001|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
11040994|NCT00913835|12221128|FG000|STARTED|Lip Dox: Olaratumab Monotherapy||0
11040995|NCT00913835|12221129|FG001|STARTED|Lip Dox: Olaratumab Monotherapy||28
11040996|NCT00913835|12221128|FG000|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
11040997|NCT00913835|12221129|FG001|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
11040998|NCT00913835|12221128|FG000|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
11040999|NCT00913835|12221129|FG001|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
11041000|NCT00913835|12221128|FG000|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
11041001|NCT00913835|12221129|FG001|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
11041002|NCT00913913|12221142|FG000|STARTED|Overall Study||8
11041003|NCT00913913|12221142|FG000|COMPLETED|Overall Study||0
11041004|NCT00913913|12221142|FG000|NOT COMPLETED|Overall Study||8
11041005|NCT00913978|12221148|FG000|STARTED|Overall Study||26
11041006|NCT00913978|12221149|FG001|STARTED|Overall Study||24
11041007|NCT00913978|12221148|FG000|COMPLETED|Overall Study||25
11336012|NCT02871739|12533637|FG002|COMPLETED|Overall Study||4
11336013|NCT02871739|12533638|FG003|COMPLETED|Overall Study||5
11336014|NCT02871739|12533635|FG000|NOT COMPLETED|Overall Study||3
11336015|NCT02871739|12533636|FG001|NOT COMPLETED|Overall Study||2
11336016|NCT02871739|12533637|FG002|NOT COMPLETED|Overall Study||0
11336017|NCT02871739|12533638|FG003|NOT COMPLETED|Overall Study||2
11336018|NCT02872012|12533653|FG000|STARTED|Overall Study||4
11336019|NCT02872012|12533654|FG001|STARTED|Overall Study||7
11336020|NCT02872012|12533655|FG002|STARTED|Overall Study||4
11336021|NCT02872012|12533656|FG003|STARTED|Overall Study||3
11336022|NCT02872012|12533657|FG004|STARTED|Overall Study||5
11336023|NCT02872012|12533653|FG000|COMPLETED|Overall Study||3
11336024|NCT02872012|12533654|FG001|COMPLETED|Overall Study||7
11336025|NCT02872012|12533655|FG002|COMPLETED|Overall Study||4
11336026|NCT02872012|12533656|FG003|COMPLETED|Overall Study||3
11336027|NCT02872012|12533657|FG004|COMPLETED|Overall Study||5
11336028|NCT02872012|12533653|FG000|NOT COMPLETED|Overall Study||1
11336029|NCT02872012|12533654|FG001|NOT COMPLETED|Overall Study||0
11336030|NCT02872012|12533655|FG002|NOT COMPLETED|Overall Study||0
11336031|NCT02872012|12533656|FG003|NOT COMPLETED|Overall Study||0
11336032|NCT02872012|12533657|FG004|NOT COMPLETED|Overall Study||0
11336033|NCT02872103|12533673|FG000|STARTED|Cycle 1||83
11336034|NCT02872103|12533674|FG001|STARTED|Cycle 1||39
11336035|NCT02872103|12533673|FG000|COMPLETED|Cycle 1||83
11336036|NCT02872103|12533674|FG001|COMPLETED|Cycle 1||38
11336037|NCT02872103|12533673|FG000|NOT COMPLETED|Cycle 1||0
11336038|NCT02872103|12533674|FG001|NOT COMPLETED|Cycle 1||1
11041008|NCT00913978|12221149|FG001|COMPLETED|Overall Study||21
11041009|NCT00913978|12221148|FG000|NOT COMPLETED|Overall Study||1
11041010|NCT00913978|12221149|FG001|NOT COMPLETED|Overall Study||3
11041011|NCT00914069|12221157|FG000|STARTED|Overall Study||84
11041012|NCT00914069|12221158|FG001|STARTED|Overall Study||88
11041013|NCT00914069|12221157|FG000|COMPLETED|Overall Study||84
11041014|NCT00914069|12221158|FG001|COMPLETED|Overall Study||88
11041015|NCT00914069|12221157|FG000|NOT COMPLETED|Overall Study||0
11041016|NCT00914069|12221158|FG001|NOT COMPLETED|Overall Study||0
11041017|NCT00914186|12221168|FG000|STARTED|Overall Study||31
11041018|NCT00914186|12221169|FG001|STARTED|Overall Study||30
11041019|NCT00914186|12221170|FG002|STARTED|Overall Study||31
11041020|NCT00914186|12221171|FG003|STARTED|Overall Study||30
11041021|NCT00914186|12221168|FG000|COMPLETED|Overall Study||28
11041022|NCT00914186|12221169|FG001|COMPLETED|Overall Study||28
11041023|NCT00914186|12221170|FG002|COMPLETED|Overall Study||29
11041024|NCT00914186|12221171|FG003|COMPLETED|Overall Study||20
11041025|NCT00914186|12221168|FG000|NOT COMPLETED|Overall Study||3
11041026|NCT00914186|12221169|FG001|NOT COMPLETED|Overall Study||2
11041027|NCT00914186|12221170|FG002|NOT COMPLETED|Overall Study||2
11041028|NCT00914186|12221171|FG003|NOT COMPLETED|Overall Study||10
11041029|NCT00914316|12221186|FG000|STARTED|Phase 1||7
11041030|NCT00914316|12221187|FG001|STARTED|Phase 1||6
11041031|NCT00914316|12221188|FG002|STARTED|Phase 1||8
11041032|NCT00914316|12221189|FG003|STARTED|Phase 1||8
11041033|NCT00914316|12221186|FG000|COMPLETED|Phase 1||2
11041034|NCT00914316|12221187|FG001|COMPLETED|Phase 1||4
11041035|NCT00914316|12221188|FG002|COMPLETED|Phase 1||3
11041036|NCT00914316|12221189|FG003|COMPLETED|Phase 1||6
11041037|NCT00914316|12221186|FG000|NOT COMPLETED|Phase 1||5
11041038|NCT00914316|12221187|FG001|NOT COMPLETED|Phase 1||2
11041039|NCT00914316|12221188|FG002|NOT COMPLETED|Phase 1||5
11041040|NCT00914316|12221189|FG003|NOT COMPLETED|Phase 1||2
11041041|NCT00914316|12221186|FG000|STARTED|Phase 2||2
11041042|NCT00914316|12221187|FG001|STARTED|Phase 2||4
11041043|NCT00914316|12221188|FG002|STARTED|Phase 2||3
11041044|NCT00914316|12221189|FG003|STARTED|Phase 2||6
11041045|NCT00914316|12221186|FG000|COMPLETED|Phase 2||1
11041046|NCT00914316|12221187|FG001|COMPLETED|Phase 2||4
11041047|NCT00914316|12221188|FG002|COMPLETED|Phase 2||2
11041048|NCT00914316|12221189|FG003|COMPLETED|Phase 2||6
11041049|NCT00914316|12221186|FG000|NOT COMPLETED|Phase 2||1
11041050|NCT00914316|12221187|FG001|NOT COMPLETED|Phase 2||0
11041051|NCT00914316|12221188|FG002|NOT COMPLETED|Phase 2||1
11041052|NCT00914316|12221189|FG003|NOT COMPLETED|Phase 2||0
11041053|NCT00914459|12221201|FG000|STARTED|Overall Study||18
11041054|NCT00914459|12221202|FG001|STARTED|Overall Study||19
11336039|NCT02872103|12533673|FG000|STARTED|Cycle 2-4||83
11336040|NCT02872103|12533674|FG001|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38
11336041|NCT02872103|12533673|FG000|COMPLETED|Cycle 2-4||81
11041055|NCT00914459|12221201|FG000|COMPLETED|Overall Study||17
11041056|NCT00914459|12221202|FG001|COMPLETED|Overall Study||18
11041057|NCT00914459|12221201|FG000|NOT COMPLETED|Overall Study||1
11041058|NCT00914459|12221202|FG001|NOT COMPLETED|Overall Study||1
11041059|NCT00914485|12221210|FG000|STARTED|Overall Study||369
11201140|NCT01831089|12391353|FG002|STARTED|Cohort IV: Dose Level 4||0
11201141|NCT01831089|12391354|FG003|STARTED|Cohort IV: Dose Level 4||6
11201142|NCT01831089|12391355|FG004|STARTED|Cohort IV: Dose Level 4||0
11201143|NCT01831089|12391356|FG005|STARTED|Cohort IV: Dose Level 4||0
11201144|NCT01831089|12391351|FG000|COMPLETED|Cohort IV: Dose Level 4||0
11201145|NCT01831089|12391352|FG001|COMPLETED|Cohort IV: Dose Level 4||0
11201146|NCT01831089|12391353|FG002|COMPLETED|Cohort IV: Dose Level 4||0
11201147|NCT01831089|12391354|FG003|COMPLETED|Cohort IV: Dose Level 4||0
11201148|NCT01831089|12391355|FG004|COMPLETED|Cohort IV: Dose Level 4||0
11201149|NCT01831089|12391356|FG005|COMPLETED|Cohort IV: Dose Level 4||0
11201150|NCT01831089|12391351|FG000|NOT COMPLETED|Cohort IV: Dose Level 4||0
11201151|NCT01831089|12391352|FG001|NOT COMPLETED|Cohort IV: Dose Level 4||0
11201152|NCT01831089|12391353|FG002|NOT COMPLETED|Cohort IV: Dose Level 4||0
11201153|NCT01831089|12391354|FG003|NOT COMPLETED|Cohort IV: Dose Level 4||6
11201154|NCT01831089|12391355|FG004|NOT COMPLETED|Cohort IV: Dose Level 4||0
11201155|NCT01831089|12391356|FG005|NOT COMPLETED|Cohort IV: Dose Level 4||0
11201156|NCT01831089|12391351|FG000|STARTED|Cohort V: Dose Level 5||0
11201157|NCT01831089|12391352|FG001|STARTED|Cohort V: Dose Level 5||0
11201158|NCT01831089|12391353|FG002|STARTED|Cohort V: Dose Level 5||0
11201159|NCT01831089|12391354|FG003|STARTED|Cohort V: Dose Level 5||0
11201160|NCT01831089|12391355|FG004|STARTED|Cohort V: Dose Level 5||37
11201161|NCT01831089|12391356|FG005|STARTED|Cohort V: Dose Level 5||0
11201162|NCT01831089|12391351|FG000|COMPLETED|Cohort V: Dose Level 5||0
11201163|NCT01831089|12391352|FG001|COMPLETED|Cohort V: Dose Level 5||0
11201164|NCT01831089|12391353|FG002|COMPLETED|Cohort V: Dose Level 5||0
11201165|NCT01831089|12391354|FG003|COMPLETED|Cohort V: Dose Level 5||0
11201166|NCT01831089|12391355|FG004|COMPLETED|Cohort V: Dose Level 5||0
11201167|NCT01831089|12391356|FG005|COMPLETED|Cohort V: Dose Level 5||0
11201168|NCT01831089|12391351|FG000|NOT COMPLETED|Cohort V: Dose Level 5||0
11201169|NCT01831089|12391352|FG001|NOT COMPLETED|Cohort V: Dose Level 5||0
11041060|NCT00914485|12221210|FG000|COMPLETED|Overall Study||369
11041061|NCT00914485|12221210|FG000|NOT COMPLETED|Overall Study||0
11041062|NCT00914589|12221217|FG000|STARTED|Overall Study||128
11041063|NCT00914589|12221218|FG001|STARTED|Overall Study||143
11041064|NCT00914589|12221219|FG002|STARTED|Overall Study||138
11041065|NCT00914589|12221217|FG000|COMPLETED|Overall Study||103
11041066|NCT00914589|12221218|FG001|COMPLETED|Overall Study||127
11041067|NCT00914589|12221219|FG002|COMPLETED|Overall Study||126
11041068|NCT00914589|12221217|FG000|NOT COMPLETED|Overall Study||25
11041069|NCT00914589|12221218|FG001|NOT COMPLETED|Overall Study||16
11041070|NCT00914589|12221219|FG002|NOT COMPLETED|Overall Study||12
11041071|NCT00914628|12221229|FG000|STARTED|Overall Study|Referred to all randomized patient|64
11041072|NCT00914628|12221230|FG001|STARTED|Overall Study|Referred to all randomized patient|28
11041073|NCT00914628|12221229|FG000|COMPLETED|Overall Study|Early termination of the Study|0
11041074|NCT00914628|12221230|FG001|COMPLETED|Overall Study|Early termination of the Study|0
11041075|NCT00914628|12221229|FG000|NOT COMPLETED|Overall Study||64
11041076|NCT00914628|12221230|FG001|NOT COMPLETED|Overall Study||28
11041077|NCT00914732|12221243|FG000|STARTED|Overall Study||165
11041078|NCT00914732|12221244|FG001|STARTED|Overall Study||167
11041079|NCT00914732|12221245|FG002|STARTED|Overall Study||191
11041080|NCT00914732|12221243|FG000|Received Second Vaccination|Overall Study||150
11041081|NCT00914732|12221244|FG001|Received Second Vaccination|Overall Study||157
11041082|NCT00914732|12221245|FG002|Received Second Vaccination|Overall Study||153
11041083|NCT00914732|12221243|FG000|COMPLETED|Overall Study||155
11041084|NCT00914732|12221244|FG001|COMPLETED|Overall Study||160
11041085|NCT00914732|12221245|FG002|COMPLETED|Overall Study||180
11041086|NCT00914732|12221243|FG000|NOT COMPLETED|Overall Study||10
11041087|NCT00914732|12221244|FG001|NOT COMPLETED|Overall Study||7
11041088|NCT00914732|12221245|FG002|NOT COMPLETED|Overall Study||11
11041089|NCT00914810|12221256|FG000|STARTED|Overall Study||20
11041090|NCT00914810|12221257|FG001|STARTED|Overall Study||19
11041091|NCT00914810|12221256|FG000|COMPLETED|Overall Study||18
11041092|NCT00914810|12221257|FG001|COMPLETED|Overall Study||18
11041093|NCT00914810|12221256|FG000|NOT COMPLETED|Overall Study||2
11041094|NCT00914810|12221257|FG001|NOT COMPLETED|Overall Study||1
11041095|NCT00914849|12221265|FG000|STARTED|Overall Study||34
11041096|NCT00914849|12221266|FG001|STARTED|Overall Study||34
11041097|NCT00914849|12221265|FG000|COMPLETED|Overall Study||33
11041098|NCT00914849|12221266|FG001|COMPLETED|Overall Study||33
11041099|NCT00914849|12221265|FG000|NOT COMPLETED|Overall Study||1
11041100|NCT00914849|12221266|FG001|NOT COMPLETED|Overall Study||1
11041101|NCT00914862|12221277|FG000|STARTED|Overall Study||6
11041102|NCT00914862|12221278|FG001|STARTED|Overall Study||6
11041103|NCT00914862|12221279|FG002|STARTED|Overall Study||8
11041104|NCT00914862|12221280|FG003|STARTED|Overall Study||8
11041105|NCT00914862|12221281|FG004|STARTED|Overall Study||28
11041106|NCT00914862|12221277|FG000|COMPLETED|Overall Study||6
11041107|NCT00914862|12221278|FG001|COMPLETED|Overall Study||6
11041108|NCT00914862|12221279|FG002|COMPLETED|Overall Study||8
11041109|NCT00914862|12221280|FG003|COMPLETED|Overall Study||8
11041110|NCT00914862|12221281|FG004|COMPLETED|Overall Study||28
11041111|NCT00914862|12221277|FG000|NOT COMPLETED|Overall Study||0
11041112|NCT00914862|12221278|FG001|NOT COMPLETED|Overall Study||0
11041113|NCT00914862|12221279|FG002|NOT COMPLETED|Overall Study||0
11041114|NCT00914862|12221280|FG003|NOT COMPLETED|Overall Study||0
11041115|NCT00914862|12221281|FG004|NOT COMPLETED|Overall Study||0
11041116|NCT00914927|12221300|FG000|STARTED|Overall Study||18
11041117|NCT00914927|12221301|FG001|STARTED|Overall Study||16
11041118|NCT00914927|12221302|FG002|STARTED|Overall Study||17
11041119|NCT00914927|12221303|FG003|STARTED|Overall Study||16
11041120|NCT00914927|12221304|FG004|STARTED|Overall Study||21
11041121|NCT00914927|12221305|FG005|STARTED|Overall Study||21
11041122|NCT00914927|12221306|FG006|STARTED|Overall Study||21
11041123|NCT00914927|12221300|FG000|COMPLETED|Overall Study||16
11041124|NCT00914927|12221301|FG001|COMPLETED|Overall Study||14
11041125|NCT00914927|12221302|FG002|COMPLETED|Overall Study||17
11041126|NCT00914927|12221303|FG003|COMPLETED|Overall Study||14
11041127|NCT00914927|12221304|FG004|COMPLETED|Overall Study||19
11041128|NCT00914927|12221305|FG005|COMPLETED|Overall Study||21
11041129|NCT00914927|12221306|FG006|COMPLETED|Overall Study||21
11041130|NCT00914927|12221300|FG000|NOT COMPLETED|Overall Study||2
11041131|NCT00914927|12221301|FG001|NOT COMPLETED|Overall Study||2
11041132|NCT00914927|12221302|FG002|NOT COMPLETED|Overall Study||0
11041133|NCT00914927|12221303|FG003|NOT COMPLETED|Overall Study||2
11041134|NCT00914927|12221304|FG004|NOT COMPLETED|Overall Study||2
11041135|NCT00914927|12221305|FG005|NOT COMPLETED|Overall Study||0
11041136|NCT00914927|12221306|FG006|NOT COMPLETED|Overall Study||0
11041137|NCT00914940|12221331|FG000|STARTED|D0 to D100 Post-transplant||41
11041138|NCT00914940|12221331|FG000|COMPLETED|D0 to D100 Post-transplant||39
11041139|NCT00914940|12221331|FG000|NOT COMPLETED|D0 to D100 Post-transplant||2
11041140|NCT00914940|12221331|FG000|STARTED|D101 to 2 Years Post-transplant||39
11041141|NCT00914940|12221331|FG000|COMPLETED|D101 to 2 Years Post-transplant||31
11041142|NCT00914940|12221331|FG000|NOT COMPLETED|D101 to 2 Years Post-transplant||8
11041143|NCT00914940|12221331|FG000|STARTED|2 Years to 5 Years Post-transplant||31
11041144|NCT00914940|12221331|FG000|COMPLETED|2 Years to 5 Years Post-transplant||28
11041145|NCT00914940|12221331|FG000|NOT COMPLETED|2 Years to 5 Years Post-transplant||3
11041146|NCT00914966|12221335|FG000|STARTED|Step 1: 1500 Units||20
11041147|NCT00914966|12221335|FG000|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
11041148|NCT00914966|12221335|FG000|NOT COMPLETED|Step 1: 1500 Units||2
11041149|NCT00914966|12221335|FG000|STARTED|Step 2: 2000 Units||13
11041150|NCT00914966|12221335|FG000|COMPLETED|Step 2: 2000 Units||12
11041151|NCT00914966|12221335|FG000|NOT COMPLETED|Step 2: 2000 Units||1
11041152|NCT00914966|12221335|FG000|STARTED|Step 3: 2500 Units||12
11041153|NCT00914966|12221335|FG000|COMPLETED|Step 3: 2500 Units||12
11041154|NCT00914966|12221335|FG000|NOT COMPLETED|Step 3: 2500 Units||0
11041155|NCT00915005|12221346|FG000|STARTED|Overall Study||105
11041156|NCT00915005|12221347|FG001|STARTED|Overall Study||76
11041157|NCT00915005|12221346|FG000|COMPLETED|Overall Study||92
11041158|NCT00915005|12221347|FG001|COMPLETED|Overall Study||57
11041159|NCT00915005|12221346|FG000|NOT COMPLETED|Overall Study||13
11041160|NCT00915005|12221347|FG001|NOT COMPLETED|Overall Study||19
11041161|NCT00915018|12221355|FG000|STARTED|Overall Study||242
11041162|NCT00915018|12221356|FG001|STARTED|Overall Study||237
11041163|NCT00915018|12221355|FG000|Received Treatment|Overall Study||240
11041164|NCT00915018|12221356|FG001|Received Treatment|Overall Study||234
11041165|NCT00915018|12221355|FG000|COMPLETED|Overall Study||27
11041166|NCT00915018|12221356|FG001|COMPLETED|Overall Study||30
11041167|NCT00915018|12221355|FG000|NOT COMPLETED|Overall Study||215
11041168|NCT00915018|12221356|FG001|NOT COMPLETED|Overall Study||207
11041169|NCT00915031|12221364|FG000|STARTED|Overall Study||714
11041170|NCT00915031|12221365|FG001|STARTED|Overall Study||24
11041171|NCT00915031|12221364|FG000|COMPLETED|Overall Study||714
11041172|NCT00915031|12221365|FG001|COMPLETED|Overall Study||24
11041173|NCT00915031|12221364|FG000|NOT COMPLETED|Overall Study||0
11041174|NCT00915031|12221365|FG001|NOT COMPLETED|Overall Study||0
11336042|NCT02872103|12533674|FG001|COMPLETED|Cycle 2-4||37
11336043|NCT02872103|12533673|FG000|NOT COMPLETED|Cycle 2-4||2
11336044|NCT02872103|12533674|FG001|NOT COMPLETED|Cycle 2-4||1
11336045|NCT02872142|12533682|FG000|STARTED|Overall Study||12
11336046|NCT02872142|12533682|FG000|COMPLETED|Overall Study||6
11336047|NCT02872142|12533682|FG000|NOT COMPLETED|Overall Study||6
11336048|NCT02872285|12533688|FG000|STARTED|Overall Study||22
11336049|NCT02872285|12533689|FG001|STARTED|Overall Study||11
11336050|NCT02872285|12533688|FG000|COMPLETED|Overall Study||17
11336051|NCT02872285|12533689|FG001|COMPLETED|Overall Study||9
11336052|NCT02872285|12533688|FG000|NOT COMPLETED|Overall Study||5
11336053|NCT02872285|12533689|FG001|NOT COMPLETED|Overall Study||2
11336054|NCT02872311|12533700|FG000|STARTED|Overall Study||59
11336055|NCT02872311|12533701|FG001|STARTED|Overall Study||60
11336056|NCT02872311|12533702|FG002|STARTED|Overall Study||20
11336057|NCT02872311|12533703|FG003|STARTED|Overall Study||20
11336058|NCT02872311|12533704|FG004|STARTED|Overall Study||20
11336059|NCT02872311|12533700|FG000|COMPLETED|Overall Study||55
11336060|NCT02872311|12533701|FG001|COMPLETED|Overall Study||58
11336061|NCT02872311|12533702|FG002|COMPLETED|Overall Study||19
11336062|NCT02872311|12533703|FG003|COMPLETED|Overall Study||20
11336063|NCT02872311|12533704|FG004|COMPLETED|Overall Study||20
11336064|NCT02872311|12533700|FG000|NOT COMPLETED|Overall Study||4
11336065|NCT02872311|12533701|FG001|NOT COMPLETED|Overall Study||2
11336066|NCT02872311|12533702|FG002|NOT COMPLETED|Overall Study||1
11336067|NCT02872311|12533703|FG003|NOT COMPLETED|Overall Study||0
11336068|NCT02872311|12533704|FG004|NOT COMPLETED|Overall Study||0
11336069|NCT02872857|12533734|FG000|STARTED|Phase 1||15
11336070|NCT02872857|12533735|FG001|STARTED|Phase 1||15
11336071|NCT02872857|12533736|FG002|STARTED|Phase 1||0
11336072|NCT02872857|12533737|FG003|STARTED|Phase 1||0
11336073|NCT02872857|12533734|FG000|COMPLETED|Phase 1||15
11041175|NCT00915148|12221370|FG000|STARTED|Overall Study|October 2009|110
11041176|NCT00915148|12221370|FG000|COMPLETED|Overall Study|August 2010|110
11041177|NCT00915148|12221370|FG000|NOT COMPLETED|Overall Study||0
11041178|NCT00915278|12221381|FG000|STARTED|Overall Study||8
11336074|NCT02872857|12533735|FG001|COMPLETED|Phase 1||15
11336075|NCT02872857|12533736|FG002|COMPLETED|Phase 1||0
11336076|NCT02872857|12533737|FG003|COMPLETED|Phase 1||0
11336077|NCT02872857|12533734|FG000|NOT COMPLETED|Phase 1||0
11336078|NCT02872857|12533735|FG001|NOT COMPLETED|Phase 1||0
11336079|NCT02872857|12533736|FG002|NOT COMPLETED|Phase 1||0
11336080|NCT02872857|12533737|FG003|NOT COMPLETED|Phase 1||0
11336081|NCT02872857|12533734|FG000|STARTED|Phase 2||0
11336082|NCT02872857|12533735|FG001|STARTED|Phase 2||0
11336083|NCT02872857|12533736|FG002|STARTED|Phase 2||15
11336084|NCT02872857|12533737|FG003|STARTED|Phase 2||15
11336085|NCT02872857|12533734|FG000|COMPLETED|Phase 2||0
11336086|NCT02872857|12533735|FG001|COMPLETED|Phase 2||0
11336087|NCT02872857|12533736|FG002|COMPLETED|Phase 2||15
11336088|NCT02872857|12533737|FG003|COMPLETED|Phase 2||15
11041179|NCT00915278|12221382|FG001|STARTED|Overall Study||5
11041180|NCT00915278|12221383|FG002|STARTED|Overall Study||3
11041181|NCT00915278|12221384|FG003|STARTED|Overall Study||5
11041182|NCT00915278|12221385|FG004|STARTED|Overall Study||3
11041183|NCT00915278|12221386|FG005|STARTED|Overall Study||9
11336089|NCT02872857|12533734|FG000|NOT COMPLETED|Phase 2||0
11336090|NCT02872857|12533735|FG001|NOT COMPLETED|Phase 2||0
11336091|NCT02872857|12533736|FG002|NOT COMPLETED|Phase 2||0
11336092|NCT02872857|12533737|FG003|NOT COMPLETED|Phase 2||0
11336093|NCT02872909|12533745|FG000|STARTED|Overall Study||32
11336094|NCT02872909|12533746|FG001|STARTED|Overall Study||18
11336095|NCT02872909|12533745|FG000|COMPLETED|Overall Study||32
11336096|NCT02872909|12533746|FG001|COMPLETED|Overall Study||18
11041184|NCT00915278|12221381|FG000|COMPLETED|Overall Study||3
11041185|NCT00915278|12221382|FG001|COMPLETED|Overall Study||2
11041186|NCT00915278|12221383|FG002|COMPLETED|Overall Study||2
11041187|NCT00915278|12221384|FG003|COMPLETED|Overall Study||2
11041188|NCT00915278|12221385|FG004|COMPLETED|Overall Study||1
11041189|NCT00915278|12221386|FG005|COMPLETED|Overall Study||1
11041190|NCT00915278|12221381|FG000|NOT COMPLETED|Overall Study||5
11041191|NCT00915278|12221382|FG001|NOT COMPLETED|Overall Study||3
11041192|NCT00915278|12221383|FG002|NOT COMPLETED|Overall Study||1
11041193|NCT00915278|12221384|FG003|NOT COMPLETED|Overall Study||3
11041194|NCT00915278|12221385|FG004|NOT COMPLETED|Overall Study||2
11041195|NCT00915278|12221386|FG005|NOT COMPLETED|Overall Study||8
11041196|NCT00915343|12221400|FG000|STARTED|Part A - First Intervention Period||32
11041197|NCT00915343|12221401|FG001|STARTED|Part A - First Intervention Period||32
11041198|NCT00915343|12221402|FG002|STARTED|Part A - First Intervention Period||0
11041199|NCT00915343|12221400|FG000|COMPLETED|Part A - First Intervention Period||32
11041200|NCT00915343|12221401|FG001|COMPLETED|Part A - First Intervention Period||32
11041201|NCT00915343|12221402|FG002|COMPLETED|Part A - First Intervention Period||0
11041202|NCT00915343|12221400|FG000|NOT COMPLETED|Part A - First Intervention Period||0
11041203|NCT00915343|12221401|FG001|NOT COMPLETED|Part A - First Intervention Period||0
11041204|NCT00915343|12221402|FG002|NOT COMPLETED|Part A - First Intervention Period||0
11041205|NCT00915343|12221400|FG000|STARTED|Part A - Second Intervention Period||32
11041206|NCT00915343|12221401|FG001|STARTED|Part A - Second Intervention Period||32
11041207|NCT00915343|12221402|FG002|STARTED|Part A - Second Intervention Period||0
11041208|NCT00915343|12221400|FG000|COMPLETED|Part A - Second Intervention Period||32
11041209|NCT00915343|12221401|FG001|COMPLETED|Part A - Second Intervention Period||32
11336097|NCT02872909|12533745|FG000|NOT COMPLETED|Overall Study||0
11336098|NCT02872909|12533746|FG001|NOT COMPLETED|Overall Study||0
11336099|NCT02872935|12533754|FG000|STARTED|Overall Study||11
11336100|NCT02872935|12533755|FG001|STARTED|Overall Study||11
11336101|NCT02872935|12533754|FG000|COMPLETED|Overall Study||11
11336102|NCT02872935|12533755|FG001|COMPLETED|Overall Study|One subject consented but did no proceed with the study.|10
11336103|NCT02872935|12533754|FG000|NOT COMPLETED|Overall Study||0
11336104|NCT02872935|12533755|FG001|NOT COMPLETED|Overall Study||1
11336105|NCT02873104|12533763|FG000|STARTED|Overall Study||47
11336106|NCT02873104|12533764|FG001|STARTED|Overall Study||23
11336107|NCT02873104|12533763|FG000|COMPLETED|Overall Study||46
11336108|NCT02873104|12533764|FG001|COMPLETED|Overall Study||23
11336109|NCT02873104|12533763|FG000|NOT COMPLETED|Overall Study||1
11336110|NCT02873104|12533764|FG001|NOT COMPLETED|Overall Study||0
11336111|NCT02873208|12533770|FG000|STARTED|Overall Study||265
11336112|NCT02873208|12533770|FG000|COMPLETED|Overall Study||167
11336113|NCT02873208|12533770|FG000|NOT COMPLETED|Overall Study||98
11336114|NCT02873221|12533777|FG000|STARTED|Treatment Period||417
11336115|NCT02873221|12533778|FG001|STARTED|Treatment Period||417
11336116|NCT02873221|12533779|FG002|STARTED|Treatment Period||420
11336117|NCT02873221|12533777|FG000|Safety Population: Received Study Drug|Treatment Period||417
11336118|NCT02873221|12533778|FG001|Safety Population: Received Study Drug|Treatment Period||404
11336119|NCT02873221|12533779|FG002|Safety Population: Received Study Drug|Treatment Period||409
11336120|NCT02873221|12533777|FG000|COMPLETED|Treatment Period||329
11336121|NCT02873221|12533778|FG001|COMPLETED|Treatment Period||291
11336122|NCT02873221|12533779|FG002|COMPLETED|Treatment Period||315
11336123|NCT02873221|12533777|FG000|NOT COMPLETED|Treatment Period||88
11041210|NCT00915343|12221402|FG002|COMPLETED|Part A - Second Intervention Period||0
11041211|NCT00915343|12221400|FG000|NOT COMPLETED|Part A - Second Intervention Period||0
11336124|NCT02873221|12533778|FG001|NOT COMPLETED|Treatment Period||126
11336125|NCT02873221|12533779|FG002|NOT COMPLETED|Treatment Period||105
11336126|NCT02873221|12533777|FG000|STARTED|Safety Follow-up Period||350
11336127|NCT02873221|12533778|FG001|STARTED|Safety Follow-up Period||356
11336128|NCT02873221|12533779|FG002|STARTED|Safety Follow-up Period||364
11336129|NCT02873221|12533777|FG000|COMPLETED|Safety Follow-up Period||343
11336130|NCT02873221|12533778|FG001|COMPLETED|Safety Follow-up Period||339
11336131|NCT02873221|12533779|FG002|COMPLETED|Safety Follow-up Period||350
11336132|NCT02873221|12533777|FG000|NOT COMPLETED|Safety Follow-up Period||7
11336133|NCT02873221|12533778|FG001|NOT COMPLETED|Safety Follow-up Period||17
11336134|NCT02873221|12533779|FG002|NOT COMPLETED|Safety Follow-up Period||14
11336135|NCT02873286|12533792|FG000|STARTED|Main Study||78
11336136|NCT02873286|12533793|FG001|STARTED|Main Study||89
11336137|NCT02873286|12533794|FG002|STARTED|Main Study||80
11336138|NCT02873286|12533795|FG003|STARTED|Main Study||90
11041212|NCT00915343|12221401|FG001|NOT COMPLETED|Part A - Second Intervention Period||0
11041213|NCT00915343|12221402|FG002|NOT COMPLETED|Part A - Second Intervention Period||0
11336139|NCT02873286|12533796|FG004|STARTED|Main Study||83
11336140|NCT02873286|12533792|FG000|COMPLETED|Main Study||76
11336141|NCT02873286|12533793|FG001|COMPLETED|Main Study||84
11336142|NCT02873286|12533794|FG002|COMPLETED|Main Study||78
11336143|NCT02873286|12533795|FG003|COMPLETED|Main Study||89
11336144|NCT02873286|12533796|FG004|COMPLETED|Main Study||81
11336145|NCT02873286|12533792|FG000|NOT COMPLETED|Main Study||2
11336146|NCT02873286|12533793|FG001|NOT COMPLETED|Main Study||5
11336147|NCT02873286|12533794|FG002|NOT COMPLETED|Main Study||2
11336148|NCT02873286|12533795|FG003|NOT COMPLETED|Main Study||1
11336149|NCT02873286|12533796|FG004|NOT COMPLETED|Main Study||2
11336150|NCT02873286|12533792|FG000|STARTED|Booster Substudy||43
11336151|NCT02873286|12533793|FG001|STARTED|Booster Substudy||0
11336152|NCT02873286|12533794|FG002|STARTED|Booster Substudy||45
11336153|NCT02873286|12533795|FG003|STARTED|Booster Substudy||0
11041214|NCT00915343|12221400|FG000|STARTED|Part B - Open Label Period||0
11041215|NCT00915343|12221401|FG001|STARTED|Part B - Open Label Period||0
11041216|NCT00915343|12221402|FG002|STARTED|Part B - Open Label Period||59
11041217|NCT00915343|12221400|FG000|COMPLETED|Part B - Open Label Period||0
11041218|NCT00915343|12221401|FG001|COMPLETED|Part B - Open Label Period||0
11041219|NCT00915343|12221402|FG002|COMPLETED|Part B - Open Label Period||57
11041220|NCT00915343|12221400|FG000|NOT COMPLETED|Part B - Open Label Period||0
11041221|NCT00915343|12221401|FG001|NOT COMPLETED|Part B - Open Label Period||0
11041222|NCT00915343|12221402|FG002|NOT COMPLETED|Part B - Open Label Period||2
11041223|NCT00915356|12221419|FG000|STARTED|Overall Study||26
11041224|NCT00915356|12221420|FG001|STARTED|Overall Study||45
11041225|NCT00915356|12221421|FG002|STARTED|Overall Study||45
11041226|NCT00915356|12221422|FG003|STARTED|Overall Study||12
11041227|NCT00915356|12221423|FG004|STARTED|Overall Study||43
11041228|NCT00915356|12221419|FG000|COMPLETED|Overall Study||25
11041229|NCT00915356|12221420|FG001|COMPLETED|Overall Study||45
11041230|NCT00915356|12221421|FG002|COMPLETED|Overall Study||45
11041231|NCT00915356|12221422|FG003|COMPLETED|Overall Study||12
11041232|NCT00915356|12221423|FG004|COMPLETED|Overall Study||43
11041233|NCT00915356|12221419|FG000|NOT COMPLETED|Overall Study||1
11041234|NCT00915356|12221420|FG001|NOT COMPLETED|Overall Study||0
11041235|NCT00915356|12221421|FG002|NOT COMPLETED|Overall Study||0
11041236|NCT00915356|12221422|FG003|NOT COMPLETED|Overall Study||0
11041237|NCT00915356|12221423|FG004|NOT COMPLETED|Overall Study||0
11041238|NCT00915473|12221437|FG000|STARTED|Screening||35
11041239|NCT00915473|12221438|FG001|STARTED|Screening||35
11041240|NCT00915473|12221437|FG000|COMPLETED|Screening||34
11041241|NCT00915473|12221438|FG001|COMPLETED|Screening||35
11041242|NCT00915473|12221437|FG000|NOT COMPLETED|Screening||1
11041243|NCT00915473|12221438|FG001|NOT COMPLETED|Screening||0
11041244|NCT00915473|12221437|FG000|STARTED|Injection||34
11041245|NCT00915473|12221438|FG001|STARTED|Injection||35
11041246|NCT00915473|12221437|FG000|COMPLETED|Injection||34
11041247|NCT00915473|12221438|FG001|COMPLETED|Injection||35
11041248|NCT00915473|12221437|FG000|NOT COMPLETED|Injection||0
11041249|NCT00915473|12221438|FG001|NOT COMPLETED|Injection||0
11041250|NCT00915473|12221437|FG000|STARTED|4-week Follow Up||34
11041251|NCT00915473|12221438|FG001|STARTED|4-week Follow Up||35
11041252|NCT00915473|12221437|FG000|COMPLETED|4-week Follow Up||33
11041253|NCT00915473|12221438|FG001|COMPLETED|4-week Follow Up||30
11041254|NCT00915473|12221437|FG000|NOT COMPLETED|4-week Follow Up||1
11336154|NCT02873286|12533796|FG004|STARTED|Booster Substudy||0
11336155|NCT02873286|12533792|FG000|COMPLETED|Booster Substudy||43
11336156|NCT02873286|12533793|FG001|COMPLETED|Booster Substudy||0
11336157|NCT02873286|12533794|FG002|COMPLETED|Booster Substudy||45
11336158|NCT02873286|12533795|FG003|COMPLETED|Booster Substudy||0
11336159|NCT02873286|12533796|FG004|COMPLETED|Booster Substudy||0
11336160|NCT02873286|12533792|FG000|NOT COMPLETED|Booster Substudy||0
11336161|NCT02873286|12533793|FG001|NOT COMPLETED|Booster Substudy||0
11336162|NCT02873286|12533794|FG002|NOT COMPLETED|Booster Substudy||0
11336163|NCT02873286|12533795|FG003|NOT COMPLETED|Booster Substudy||0
11336164|NCT02873286|12533796|FG004|NOT COMPLETED|Booster Substudy||0
11336165|NCT02873338|12533811|FG000|STARTED|Overall Study||26
11336166|NCT02873338|12533812|FG001|STARTED|Overall Study||25
11336167|NCT02873338|12533813|FG002|STARTED|Overall Study||24
11041255|NCT00915473|12221438|FG001|NOT COMPLETED|4-week Follow Up||5
11041256|NCT00915499|12221446|FG000|STARTED|Overall Study||33
11336168|NCT02873338|12533811|FG000|COMPLETED|Overall Study||8
11336169|NCT02873338|12533812|FG001|COMPLETED|Overall Study||4
11336170|NCT02873338|12533813|FG002|COMPLETED|Overall Study||6
11336171|NCT02873338|12533811|FG000|NOT COMPLETED|Overall Study||18
11336172|NCT02873338|12533812|FG001|NOT COMPLETED|Overall Study||21
11336173|NCT02873338|12533813|FG002|NOT COMPLETED|Overall Study||18
11336174|NCT02873377|12533823|FG000|STARTED|Period 1: Enrollment||65
11336175|NCT02873377|12533824|FG001|STARTED|Period 1: Enrollment||69
11336176|NCT02873377|12533823|FG000|COMPLETED|Period 1: Enrollment||65
11336177|NCT02873377|12533824|FG001|COMPLETED|Period 1: Enrollment||69
11336178|NCT02873377|12533823|FG000|NOT COMPLETED|Period 1: Enrollment||0
11336179|NCT02873377|12533824|FG001|NOT COMPLETED|Period 1: Enrollment||0
11336180|NCT02873377|12533823|FG000|STARTED|Period Title 2: 3 Months Follow up||65
11336181|NCT02873377|12533824|FG001|STARTED|Period Title 2: 3 Months Follow up||69
11336182|NCT02873377|12533823|FG000|COMPLETED|Period Title 2: 3 Months Follow up||43
11336183|NCT02873377|12533824|FG001|COMPLETED|Period Title 2: 3 Months Follow up||47
11336184|NCT02873377|12533823|FG000|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
11336185|NCT02873377|12533824|FG001|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
11336186|NCT02873377|12533823|FG000|STARTED|Period Title 3: 6 Months Follow up||65
11041257|NCT00915499|12221447|FG001|STARTED|Overall Study||33
11041258|NCT00915499|12221446|FG000|COMPLETED|Overall Study||29
11041259|NCT00915499|12221447|FG001|COMPLETED|Overall Study||31
11041260|NCT00915499|12221446|FG000|NOT COMPLETED|Overall Study||4
11201170|NCT01831089|12391353|FG002|NOT COMPLETED|Cohort V: Dose Level 5||0
11041261|NCT00915499|12221447|FG001|NOT COMPLETED|Overall Study||2
11041262|NCT00915525|12221455|FG000|STARTED|Overall Study||543
11041263|NCT00915525|12221456|FG001|STARTED|Overall Study||286
11041264|NCT00915525|12221455|FG000|COMPLETED|Overall Study||278
11041265|NCT00915525|12221456|FG001|COMPLETED|Overall Study||151
11041266|NCT00915525|12221455|FG000|NOT COMPLETED|Overall Study||265
11041267|NCT00915525|12221456|FG001|NOT COMPLETED|Overall Study||135
11041268|NCT00915538|12221484|FG000|STARTED|Overall Study||8
11041269|NCT00915538|12221485|FG001|STARTED|Overall Study||8
11041270|NCT00915538|12221484|FG000|COMPLETED|Overall Study||8
11041271|NCT00915538|12221485|FG001|COMPLETED|Overall Study||8
11041272|NCT00915538|12221484|FG000|NOT COMPLETED|Overall Study||0
11041273|NCT00915538|12221485|FG001|NOT COMPLETED|Overall Study||0
11041274|NCT00915551|12221495|FG000|STARTED|Overall Study||142
11041275|NCT00915551|12221496|FG001|STARTED|Overall Study||136
11041276|NCT00915551|12221495|FG000|COMPLETED|Overall Study||142
11041277|NCT00915551|12221496|FG001|COMPLETED|Overall Study||135
11041278|NCT00915551|12221495|FG000|NOT COMPLETED|Overall Study||0
11041279|NCT00915551|12221496|FG001|NOT COMPLETED|Overall Study||1
11041280|NCT00915590|12221504|FG000|STARTED|Overall Study||5
11041281|NCT00915590|12221505|FG001|STARTED|Overall Study||5
11041282|NCT00915590|12221504|FG000|COMPLETED|Overall Study||3
11041283|NCT00915590|12221505|FG001|COMPLETED|Overall Study||4
11041284|NCT00915590|12221504|FG000|NOT COMPLETED|Overall Study||2
11041285|NCT00915590|12221505|FG001|NOT COMPLETED|Overall Study||1
11041286|NCT00915603|12221518|FG000|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
11041287|NCT00915603|12221519|FG001|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
11041288|NCT00915603|12221518|FG000|COMPLETED|Overall Study||0
11041289|NCT00915603|12221519|FG001|COMPLETED|Overall Study||0
11041290|NCT00915603|12221518|FG000|NOT COMPLETED|Overall Study||56
11041291|NCT00915603|12221519|FG001|NOT COMPLETED|Overall Study||55
11041292|NCT00915655|12221525|FG000|STARTED|Overall Study||12
11041293|NCT00915655|12221525|FG000|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
11041294|NCT00915655|12221525|FG000|NOT COMPLETED|Overall Study||0
11041295|NCT00915759|12221529|FG000|STARTED|Overall Study|number of participants|40
11041296|NCT00915759|12221529|FG000|COMPLETED|Overall Study|number of participants|40
11041297|NCT00915759|12221529|FG000|NOT COMPLETED|Overall Study||0
11041298|NCT00915772|12221542|FG000|STARTED|Overall Study||170
11041299|NCT00915772|12221543|FG001|STARTED|Overall Study||225
11041300|NCT00915772|12221544|FG002|STARTED|Overall Study||171
11041301|NCT00915772|12221542|FG000|COMPLETED|Overall Study||134
11041302|NCT00915772|12221543|FG001|COMPLETED|Overall Study||179
11041303|NCT00915772|12221544|FG002|COMPLETED|Overall Study||142
11041304|NCT00915772|12221542|FG000|NOT COMPLETED|Overall Study||36
11041305|NCT00915772|12221543|FG001|NOT COMPLETED|Overall Study||46
11041306|NCT00915772|12221544|FG002|NOT COMPLETED|Overall Study||29
11041307|NCT00915798|12221557|FG000|STARTED|Overall Study||19
11041308|NCT00915798|12221558|FG001|STARTED|Overall Study||21
11041309|NCT00915798|12221559|FG002|STARTED|Overall Study||23
11041310|NCT00915798|12221560|FG003|STARTED|Overall Study||26
11041311|NCT00915798|12221557|FG000|COMPLETED|Overall Study||19
11041312|NCT00915798|12221558|FG001|COMPLETED|Overall Study||21
11041313|NCT00915798|12221559|FG002|COMPLETED|Overall Study||23
11041314|NCT00915798|12221560|FG003|COMPLETED|Overall Study||26
11041315|NCT00915798|12221557|FG000|NOT COMPLETED|Overall Study||0
11041316|NCT00915798|12221558|FG001|NOT COMPLETED|Overall Study||0
11041317|NCT00915798|12221559|FG002|NOT COMPLETED|Overall Study||0
11201171|NCT01831089|12391354|FG003|NOT COMPLETED|Cohort V: Dose Level 5||0
11201172|NCT01831089|12391355|FG004|NOT COMPLETED|Cohort V: Dose Level 5||37
11201173|NCT01831089|12391356|FG005|NOT COMPLETED|Cohort V: Dose Level 5||0
11201174|NCT01831089|12391351|FG000|STARTED|Cohort B: Arm B||0
11201175|NCT01831089|12391352|FG001|STARTED|Cohort B: Arm B||0
11201176|NCT01831089|12391353|FG002|STARTED|Cohort B: Arm B||0
11201177|NCT01831089|12391354|FG003|STARTED|Cohort B: Arm B||0
11201178|NCT01831089|12391355|FG004|STARTED|Cohort B: Arm B||0
11201179|NCT01831089|12391356|FG005|STARTED|Cohort B: Arm B||14
11041318|NCT00915798|12221560|FG003|NOT COMPLETED|Overall Study||0
11041319|NCT00915876|12221582|FG000|STARTED|Overall Study||20
11041320|NCT00915876|12221583|FG001|STARTED|Overall Study||21
11041321|NCT00915876|12221582|FG000|Moving Beyond First Dose|Overall Study||20
11041322|NCT00915876|12221583|FG001|Moving Beyond First Dose|Overall Study||20
11041323|NCT00915876|12221582|FG000|COMPLETED|Overall Study||20
11041324|NCT00915876|12221583|FG001|COMPLETED|Overall Study||20
11041325|NCT00915876|12221582|FG000|NOT COMPLETED|Overall Study||0
11041326|NCT00915876|12221583|FG001|NOT COMPLETED|Overall Study||1
11041327|NCT00915902|12221591|FG000|STARTED|1st Treatment Period||20
11041328|NCT00915902|12221592|FG001|STARTED|1st Treatment Period||22
11041329|NCT00915902|12221591|FG000|COMPLETED|1st Treatment Period||19
11041330|NCT00915902|12221592|FG001|COMPLETED|1st Treatment Period||22
11041331|NCT00915902|12221591|FG000|NOT COMPLETED|1st Treatment Period||1
11041332|NCT00915902|12221592|FG001|NOT COMPLETED|1st Treatment Period||0
11041333|NCT00915902|12221591|FG000|STARTED|Washout (4 Weeks)||19
11041334|NCT00915902|12221592|FG001|STARTED|Washout (4 Weeks)||22
11041335|NCT00915902|12221591|FG000|COMPLETED|Washout (4 Weeks)||19
11041336|NCT00915902|12221592|FG001|COMPLETED|Washout (4 Weeks)||21
11041337|NCT00915902|12221591|FG000|NOT COMPLETED|Washout (4 Weeks)||0
11041338|NCT00915902|12221592|FG001|NOT COMPLETED|Washout (4 Weeks)||1
11041339|NCT00915902|12221591|FG000|STARTED|2nd Treatment Period||19
11041340|NCT00915902|12221592|FG001|STARTED|2nd Treatment Period||21
11041341|NCT00915902|12221591|FG000|COMPLETED|2nd Treatment Period||19
11041342|NCT00915902|12221592|FG001|COMPLETED|2nd Treatment Period||20
11041343|NCT00915902|12221591|FG000|NOT COMPLETED|2nd Treatment Period||0
11041344|NCT00915902|12221592|FG001|NOT COMPLETED|2nd Treatment Period||1
11041345|NCT00915928|12221602|FG000|STARTED|Overall Study||25
11041346|NCT00915928|12221603|FG001|STARTED|Overall Study||22
11041347|NCT00915928|12221602|FG000|COMPLETED|Overall Study||25
11041348|NCT00915928|12221603|FG001|COMPLETED|Overall Study||22
11041349|NCT00915928|12221602|FG000|NOT COMPLETED|Overall Study||0
11041350|NCT00915928|12221603|FG001|NOT COMPLETED|Overall Study||0
11041351|NCT00915954|12221613|FG000|STARTED|Overall Study||10
11041352|NCT00915954|12221614|FG001|STARTED|Overall Study||8
11041353|NCT00915954|12221615|FG002|STARTED|Overall Study||10
11041354|NCT00915954|12221613|FG000|COMPLETED|Overall Study||10
11041355|NCT00915954|12221614|FG001|COMPLETED|Overall Study||8
11041356|NCT00915954|12221615|FG002|COMPLETED|Overall Study||10
11041357|NCT00915954|12221613|FG000|NOT COMPLETED|Overall Study||0
11041358|NCT00915954|12221614|FG001|NOT COMPLETED|Overall Study||0
11041359|NCT00915954|12221615|FG002|NOT COMPLETED|Overall Study||0
11041360|NCT00915967|12221625|FG000|STARTED|Overall Study||98
11041361|NCT00915967|12221626|FG001|STARTED|Overall Study||100
11041362|NCT00915967|12221625|FG000|COMPLETED|Overall Study||97
11041363|NCT00915967|12221626|FG001|COMPLETED|Overall Study||98
11041364|NCT00915967|12221625|FG000|NOT COMPLETED|Overall Study||1
11041365|NCT00915967|12221626|FG001|NOT COMPLETED|Overall Study||2
11041366|NCT00916006|12221634|FG000|STARTED|Overall Study||135
11041367|NCT00916006|12221635|FG001|STARTED|Overall Study||134
11041368|NCT00916006|12221634|FG000|COMPLETED|Overall Study||132
11041369|NCT00916006|12221635|FG001|COMPLETED|Overall Study||127
11041370|NCT00916006|12221634|FG000|NOT COMPLETED|Overall Study||3
11041371|NCT00916006|12221635|FG001|NOT COMPLETED|Overall Study||7
11041372|NCT00916032|12221641|FG000|STARTED|Overall Study||12
11041373|NCT00916032|12221642|FG001|STARTED|Overall Study||11
11041374|NCT00916032|12221641|FG000|COMPLETED|Overall Study||12
11041375|NCT00916032|12221642|FG001|COMPLETED|Overall Study||11
11041376|NCT00916032|12221641|FG000|NOT COMPLETED|Overall Study||0
11041377|NCT00916032|12221642|FG001|NOT COMPLETED|Overall Study||0
11041378|NCT00916058|12221655|FG000|STARTED|Phase 1||3
11041379|NCT00916058|12221656|FG001|STARTED|Phase 1||6
11041380|NCT00916058|12221657|FG002|STARTED|Phase 1||3
11041381|NCT00916058|12221658|FG003|STARTED|Phase 1||3
11041382|NCT00916058|12221659|FG004|STARTED|Phase 1||3
11041383|NCT00916058|12221660|FG005|STARTED|Phase 1||8
11041384|NCT00916058|12221661|FG006|STARTED|Phase 1||0
11041385|NCT00916058|12221655|FG000|COMPLETED|Phase 1||3
11041386|NCT00916058|12221656|FG001|COMPLETED|Phase 1||6
11041387|NCT00916058|12221657|FG002|COMPLETED|Phase 1||3
11041388|NCT00916058|12221658|FG003|COMPLETED|Phase 1||3
11041389|NCT00916058|12221659|FG004|COMPLETED|Phase 1||3
11041390|NCT00916058|12221660|FG005|COMPLETED|Phase 1||7
11041391|NCT00916058|12221661|FG006|COMPLETED|Phase 1||0
11041392|NCT00916058|12221655|FG000|NOT COMPLETED|Phase 1||0
11041393|NCT00916058|12221656|FG001|NOT COMPLETED|Phase 1||0
11041394|NCT00916058|12221657|FG002|NOT COMPLETED|Phase 1||0
11041395|NCT00916058|12221658|FG003|NOT COMPLETED|Phase 1||0
11041396|NCT00916058|12221659|FG004|NOT COMPLETED|Phase 1||0
11041397|NCT00916058|12221660|FG005|NOT COMPLETED|Phase 1||1
11041398|NCT00916058|12221661|FG006|NOT COMPLETED|Phase 1||0
11041399|NCT00916058|12221655|FG000|STARTED|Phase 2||0
11041400|NCT00916058|12221656|FG001|STARTED|Phase 2||0
11041401|NCT00916058|12221657|FG002|STARTED|Phase 2||0
11041402|NCT00916058|12221658|FG003|STARTED|Phase 2||0
11041403|NCT00916058|12221659|FG004|STARTED|Phase 2||0
11041404|NCT00916058|12221660|FG005|STARTED|Phase 2||0
11041405|NCT00916058|12221661|FG006|STARTED|Phase 2||31
11041406|NCT00916058|12221655|FG000|COMPLETED|Phase 2||0
11041407|NCT00916058|12221656|FG001|COMPLETED|Phase 2||0
11041408|NCT00916058|12221657|FG002|COMPLETED|Phase 2||0
11041409|NCT00916058|12221658|FG003|COMPLETED|Phase 2||0
11041410|NCT00916058|12221659|FG004|COMPLETED|Phase 2||0
11041411|NCT00916058|12221660|FG005|COMPLETED|Phase 2||0
11041412|NCT00916058|12221661|FG006|COMPLETED|Phase 2||28
11041413|NCT00916058|12221655|FG000|NOT COMPLETED|Phase 2||0
11041414|NCT00916058|12221656|FG001|NOT COMPLETED|Phase 2||0
11041415|NCT00916058|12221657|FG002|NOT COMPLETED|Phase 2||0
11041416|NCT00916058|12221658|FG003|NOT COMPLETED|Phase 2||0
11041417|NCT00916058|12221659|FG004|NOT COMPLETED|Phase 2||0
11041418|NCT00916058|12221660|FG005|NOT COMPLETED|Phase 2||0
11041419|NCT00916058|12221661|FG006|NOT COMPLETED|Phase 2||3
11041420|NCT00916136|12221681|FG000|STARTED|Overall Study||37
11041421|NCT00916136|12221682|FG001|STARTED|Overall Study||29
11041422|NCT00916136|12221681|FG000|COMPLETED|Overall Study||37
11041423|NCT00916136|12221682|FG001|COMPLETED|Overall Study||29
11041424|NCT00916136|12221681|FG000|NOT COMPLETED|Overall Study||0
11041425|NCT00916136|12221682|FG001|NOT COMPLETED|Overall Study||0
11041426|NCT00916149|12221691|FG000|STARTED|Overall Study||16
11041427|NCT00916149|12221692|FG001|STARTED|Overall Study||10
11041428|NCT00916149|12221693|FG002|STARTED|Overall Study||5
11041429|NCT00916149|12221691|FG000|COMPLETED|Overall Study||12
11041430|NCT00916149|12221692|FG001|COMPLETED|Overall Study||8
11041431|NCT00916149|12221693|FG002|COMPLETED|Overall Study||5
11041432|NCT00916149|12221691|FG000|NOT COMPLETED|Overall Study||4
11041433|NCT00916149|12221692|FG001|NOT COMPLETED|Overall Study||2
11041434|NCT00916149|12221693|FG002|NOT COMPLETED|Overall Study||0
11041435|NCT00916279|12221700|FG000|STARTED|Overall Study||41
11041436|NCT00916279|12221700|FG000|30 Days|Overall Study||41
11041437|NCT00916279|12221700|FG000|6 Months|Overall Study||41
11041438|NCT00916279|12221700|FG000|24 Months|Overall Study||37
11041439|NCT00916279|12221700|FG000|COMPLETED|Overall Study||37
11041440|NCT00916279|12221700|FG000|NOT COMPLETED|Overall Study||4
11041441|NCT00916305|12221709|FG000|STARTED|Overall Study||28
11041442|NCT00916305|12221710|FG001|STARTED|Overall Study||37
11041443|NCT00916305|12221709|FG000|COMPLETED|Overall Study||7
11041444|NCT00916305|12221710|FG001|COMPLETED|Overall Study||9
11041445|NCT00916305|12221709|FG000|NOT COMPLETED|Overall Study||21
11041446|NCT00916305|12221710|FG001|NOT COMPLETED|Overall Study||28
11041447|NCT00916344|12221716|FG000|STARTED|Overall Study||175
11041448|NCT00916344|12221716|FG000|COMPLETED|Overall Study||167
11041449|NCT00916344|12221716|FG000|NOT COMPLETED|Overall Study||8
11041450|NCT00916357|12221720|FG000|STARTED|Period 1||4
11041451|NCT00916357|12221721|FG001|STARTED|Period 1||4
11041452|NCT00916357|12221722|FG002|STARTED|Period 1||4
11041453|NCT00916357|12221723|FG003|STARTED|Period 1||4
11041454|NCT00916357|12221724|FG004|STARTED|Period 1||3
11041455|NCT00916357|12221725|FG005|STARTED|Period 1||4
11041456|NCT00916357|12221720|FG000|Received at Least 1 Dose of Study Drug|Period 1||4
11041457|NCT00916357|12221721|FG001|Received at Least 1 Dose of Study Drug|Period 1||4
11041458|NCT00916357|12221722|FG002|Received at Least 1 Dose of Study Drug|Period 1||4
11041459|NCT00916357|12221723|FG003|Received at Least 1 Dose of Study Drug|Period 1||4
11041460|NCT00916357|12221724|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
11041461|NCT00916357|12221725|FG005|Received at Least 1 Dose of Study Drug|Period 1||4
11041462|NCT00916357|12221720|FG000|COMPLETED|Period 1||3
11041463|NCT00916357|12221721|FG001|COMPLETED|Period 1||4
11041464|NCT00916357|12221722|FG002|COMPLETED|Period 1||4
11041465|NCT00916357|12221723|FG003|COMPLETED|Period 1||4
11041466|NCT00916357|12221724|FG004|COMPLETED|Period 1||3
11041467|NCT00916357|12221725|FG005|COMPLETED|Period 1||4
11041468|NCT00916357|12221720|FG000|NOT COMPLETED|Period 1||1
11041469|NCT00916357|12221721|FG001|NOT COMPLETED|Period 1||0
11041470|NCT00916357|12221722|FG002|NOT COMPLETED|Period 1||0
11041471|NCT00916357|12221723|FG003|NOT COMPLETED|Period 1||0
11041472|NCT00916357|12221724|FG004|NOT COMPLETED|Period 1||0
11041473|NCT00916357|12221725|FG005|NOT COMPLETED|Period 1||0
11041474|NCT00916357|12221720|FG000|STARTED|Washout (3 to 14 Days)||3
11041475|NCT00916357|12221721|FG001|STARTED|Washout (3 to 14 Days)||4
11041476|NCT00916357|12221722|FG002|STARTED|Washout (3 to 14 Days)||4
11041477|NCT00916357|12221723|FG003|STARTED|Washout (3 to 14 Days)||4
11041478|NCT00916357|12221724|FG004|STARTED|Washout (3 to 14 Days)||3
11041479|NCT00916357|12221725|FG005|STARTED|Washout (3 to 14 Days)||4
11041480|NCT00916357|12221720|FG000|COMPLETED|Washout (3 to 14 Days)||3
11041481|NCT00916357|12221721|FG001|COMPLETED|Washout (3 to 14 Days)||4
11041482|NCT00916357|12221722|FG002|COMPLETED|Washout (3 to 14 Days)||4
11041483|NCT00916357|12221723|FG003|COMPLETED|Washout (3 to 14 Days)||4
11041484|NCT00916357|12221724|FG004|COMPLETED|Washout (3 to 14 Days)||3
11041485|NCT00916357|12221725|FG005|COMPLETED|Washout (3 to 14 Days)||4
11041486|NCT00916357|12221720|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0
11041487|NCT00916357|12221721|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0
11041488|NCT00916357|12221722|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0
11041489|NCT00916357|12221723|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0
11041490|NCT00916357|12221724|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0
11041491|NCT00916357|12221725|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0
11041492|NCT00916357|12221720|FG000|STARTED|Period 2||3
11041493|NCT00916357|12221721|FG001|STARTED|Period 2||4
11041494|NCT00916357|12221722|FG002|STARTED|Period 2||4
11041495|NCT00916357|12221723|FG003|STARTED|Period 2||4
11041496|NCT00916357|12221724|FG004|STARTED|Period 2||3
11041497|NCT00916357|12221725|FG005|STARTED|Period 2||4
11041498|NCT00916357|12221720|FG000|COMPLETED|Period 2||3
11041499|NCT00916357|12221721|FG001|COMPLETED|Period 2||4
11041500|NCT00916357|12221722|FG002|COMPLETED|Period 2||4
11041501|NCT00916357|12221723|FG003|COMPLETED|Period 2||3
11041502|NCT00916357|12221724|FG004|COMPLETED|Period 2||3
11041503|NCT00916357|12221725|FG005|COMPLETED|Period 2||4
11041504|NCT00916357|12221720|FG000|NOT COMPLETED|Period 2||0
11041505|NCT00916357|12221721|FG001|NOT COMPLETED|Period 2||0
11041506|NCT00916357|12221722|FG002|NOT COMPLETED|Period 2||0
11041507|NCT00916357|12221723|FG003|NOT COMPLETED|Period 2||1
11041508|NCT00916357|12221724|FG004|NOT COMPLETED|Period 2||0
11041509|NCT00916357|12221725|FG005|NOT COMPLETED|Period 2||0
11041510|NCT00916357|12221720|FG000|STARTED|Washout (3 to 14 Days)||3
11041511|NCT00916357|12221721|FG001|STARTED|Washout (3 to 14 Days)||4
11041512|NCT00916357|12221722|FG002|STARTED|Washout (3 to 14 Days)||4
11041513|NCT00916357|12221723|FG003|STARTED|Washout (3 to 14 Days)||3
11041514|NCT00916357|12221724|FG004|STARTED|Washout (3 to 14 Days)||3
11041515|NCT00916357|12221725|FG005|STARTED|Washout (3 to 14 Days)||4
11041516|NCT00916357|12221720|FG000|COMPLETED|Washout (3 to 14 Days)||3
11041517|NCT00916357|12221721|FG001|COMPLETED|Washout (3 to 14 Days)||4
11041518|NCT00916357|12221722|FG002|COMPLETED|Washout (3 to 14 Days)||4
11041519|NCT00916357|12221723|FG003|COMPLETED|Washout (3 to 14 Days)||3
11041520|NCT00916357|12221724|FG004|COMPLETED|Washout (3 to 14 Days)||3
11041521|NCT00916357|12221725|FG005|COMPLETED|Washout (3 to 14 Days)||4
11041522|NCT00916357|12221720|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0
11041523|NCT00916357|12221721|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0
11041524|NCT00916357|12221722|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0
11041525|NCT00916357|12221723|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0
11041526|NCT00916357|12221724|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0
11041527|NCT00916357|12221725|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0
11041528|NCT00916357|12221720|FG000|STARTED|Period 3||3
11041529|NCT00916357|12221721|FG001|STARTED|Period 3||4
11041530|NCT00916357|12221722|FG002|STARTED|Period 3||4
11041531|NCT00916357|12221723|FG003|STARTED|Period 3||3
11041532|NCT00916357|12221724|FG004|STARTED|Period 3||3
11041533|NCT00916357|12221725|FG005|STARTED|Period 3||4
11041534|NCT00916357|12221720|FG000|COMPLETED|Period 3||3
11041535|NCT00916357|12221721|FG001|COMPLETED|Period 3||4
11041536|NCT00916357|12221722|FG002|COMPLETED|Period 3||4
11041537|NCT00916357|12221723|FG003|COMPLETED|Period 3||3
11041538|NCT00916357|12221724|FG004|COMPLETED|Period 3||3
11041539|NCT00916357|12221725|FG005|COMPLETED|Period 3||4
11041540|NCT00916357|12221720|FG000|NOT COMPLETED|Period 3||0
11041541|NCT00916357|12221721|FG001|NOT COMPLETED|Period 3||0
11041542|NCT00916357|12221722|FG002|NOT COMPLETED|Period 3||0
11041543|NCT00916357|12221723|FG003|NOT COMPLETED|Period 3||0
11041544|NCT00916357|12221724|FG004|NOT COMPLETED|Period 3||0
11041545|NCT00916357|12221725|FG005|NOT COMPLETED|Period 3||0
11041546|NCT00916370|12221736|FG000|STARTED|Overall Study||401
11041547|NCT00916370|12221737|FG001|STARTED|Overall Study||104
11041548|NCT00916370|12221736|FG000|COMPLETED|Overall Study||396
11041549|NCT00916370|12221737|FG001|COMPLETED|Overall Study||102
11041550|NCT00916370|12221736|FG000|NOT COMPLETED|Overall Study||5
11041551|NCT00916370|12221737|FG001|NOT COMPLETED|Overall Study||2
11041552|NCT00916383|12221744|FG000|STARTED|Overall Study||49
11041553|NCT00916383|12221744|FG000|COMPLETED|Overall Study||46
11041554|NCT00916383|12221744|FG000|NOT COMPLETED|Overall Study||3
11041555|NCT00916539|12221754|FG000|STARTED|Overall Study||31
11041556|NCT00916539|12221755|FG001|STARTED|Overall Study||31
11041557|NCT00916539|12221754|FG000|COMPLETED|Overall Study||31
11041558|NCT00916539|12221755|FG001|COMPLETED|Overall Study||31
11041559|NCT00916539|12221754|FG000|NOT COMPLETED|Overall Study||0
11041560|NCT00916539|12221755|FG001|NOT COMPLETED|Overall Study||0
11041561|NCT00916578|12221761|FG000|STARTED|Overall Study||33
11041562|NCT00916578|12221761|FG000|COMPLETED|Overall Study||26
11041563|NCT00916578|12221761|FG000|NOT COMPLETED|Overall Study||7
11041564|NCT00916617|12221769|FG000|STARTED|Overall Study||24
11041565|NCT00916617|12221770|FG001|STARTED|Overall Study||21
11041566|NCT00916617|12221771|FG002|STARTED|Overall Study||10
11041567|NCT00916617|12221772|FG003|STARTED|Overall Study||7
11041568|NCT00916617|12221769|FG000|COMPLETED|Overall Study||1
11041569|NCT00916617|12221770|FG001|COMPLETED|Overall Study||0
11041570|NCT00916617|12221771|FG002|COMPLETED|Overall Study||0
11041571|NCT00916617|12221772|FG003|COMPLETED|Overall Study||0
11041572|NCT00916617|12221769|FG000|NOT COMPLETED|Overall Study||23
11041573|NCT00916617|12221770|FG001|NOT COMPLETED|Overall Study||21
11041574|NCT00916617|12221771|FG002|NOT COMPLETED|Overall Study||10
11041575|NCT00916617|12221772|FG003|NOT COMPLETED|Overall Study||7
11041576|NCT00916643|12221782|FG000|STARTED|Overall Study||113
11041577|NCT00916643|12221782|FG000|COMPLETED|Overall Study||113
11041578|NCT00916643|12221782|FG000|NOT COMPLETED|Overall Study||0
11041579|NCT00916721|12221788|FG000|STARTED|Overall Study||35
11041580|NCT00916721|12221789|FG001|STARTED|Overall Study||39
11041581|NCT00916721|12221788|FG000|COMPLETED|Overall Study||25
11041582|NCT00916721|12221789|FG001|COMPLETED|Overall Study||29
11041583|NCT00916721|12221788|FG000|NOT COMPLETED|Overall Study||10
11041584|NCT00916721|12221789|FG001|NOT COMPLETED|Overall Study||10
11041585|NCT00916929|12221797|FG000|STARTED|Overall Study||80
11041586|NCT00916929|12221798|FG001|STARTED|Overall Study||82
11041587|NCT00916929|12221797|FG000|COMPLETED|Overall Study||70
11041588|NCT00916929|12221798|FG001|COMPLETED|Overall Study||53
11041589|NCT00916929|12221797|FG000|NOT COMPLETED|Overall Study||10
11041590|NCT00916929|12221798|FG001|NOT COMPLETED|Overall Study||29
11041591|NCT00917124|12221808|FG000|STARTED|Overall Study||100
11041592|NCT00917124|12221809|FG001|STARTED|Overall Study||100
11041593|NCT00917124|12221808|FG000|COMPLETED|Overall Study||96
11041594|NCT00917124|12221809|FG001|COMPLETED|Overall Study||94
11041595|NCT00917124|12221808|FG000|NOT COMPLETED|Overall Study||4
11041596|NCT00917124|12221809|FG001|NOT COMPLETED|Overall Study||6
11041597|NCT00917150|12221819|FG000|STARTED|Overall Study||192
11041598|NCT00917150|12221820|FG001|STARTED|Overall Study||198
11041599|NCT00917150|12221821|FG002|STARTED|Overall Study||191
11041600|NCT00917150|12221822|FG003|STARTED|Overall Study||190
11041601|NCT00917150|12221819|FG000|COMPLETED|Overall Study||155
11041602|NCT00917150|12221820|FG001|COMPLETED|Overall Study||161
11041603|NCT00917150|12221821|FG002|COMPLETED|Overall Study||149
11041604|NCT00917150|12221822|FG003|COMPLETED|Overall Study||156
11041605|NCT00917150|12221819|FG000|NOT COMPLETED|Overall Study||37
11041606|NCT00917150|12221820|FG001|NOT COMPLETED|Overall Study||37
11041607|NCT00917150|12221821|FG002|NOT COMPLETED|Overall Study||42
11041608|NCT00917150|12221822|FG003|NOT COMPLETED|Overall Study||34
11041609|NCT00917267|12221834|FG000|STARTED|Overall Study||346
11041610|NCT00917267|12221835|FG001|STARTED|Overall Study||345
11041611|NCT00917267|12221834|FG000|Intent to Treat (ITT)|Overall Study||340
11041612|NCT00917267|12221835|FG001|Intent to Treat (ITT)|Overall Study||338
11041613|NCT00917267|12221834|FG000|COMPLETED|Overall Study||307
11041614|NCT00917267|12221835|FG001|COMPLETED|Overall Study||266
11041615|NCT00917267|12221834|FG000|NOT COMPLETED|Overall Study||39
11041616|NCT00917267|12221835|FG001|NOT COMPLETED|Overall Study||79
11041617|NCT00917384|12221847|FG000|STARTED|Overall Study||238
11041618|NCT00917384|12221848|FG001|STARTED|Overall Study||117
11041619|NCT00917384|12221847|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236
11041620|NCT00917384|12221848|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115
11041621|NCT00917384|12221847|FG000|COMPLETED|Overall Study||224
11041622|NCT00917384|12221848|FG001|COMPLETED|Overall Study||113
11041623|NCT00917384|12221847|FG000|NOT COMPLETED|Overall Study||14
11041624|NCT00917384|12221848|FG001|NOT COMPLETED|Overall Study||4
11041625|NCT00917462|12221854|FG000|STARTED|Overall Study||35
11041626|NCT00917462|12221854|FG000|COMPLETED|Overall Study||34
11041627|NCT00917462|12221854|FG000|NOT COMPLETED|Overall Study||1
11041628|NCT00917501|12221860|FG000|STARTED|Overall Study||29
11041629|NCT00917501|12221861|FG001|STARTED|Overall Study||26
11041630|NCT00917501|12221860|FG000|COMPLETED|Overall Study||21
11041631|NCT00917501|12221861|FG001|COMPLETED|Overall Study||21
11041632|NCT00917501|12221860|FG000|NOT COMPLETED|Overall Study||8
11041633|NCT00917501|12221861|FG001|NOT COMPLETED|Overall Study||5
11041634|NCT00917553|12221869|FG000|STARTED|Overall Study||17
11041635|NCT00917553|12221870|FG001|STARTED|Overall Study||16
11041636|NCT00917553|12221869|FG000|COMPLETED|Overall Study||15
11041637|NCT00917553|12221870|FG001|COMPLETED|Overall Study||15
11041638|NCT00917553|12221869|FG000|NOT COMPLETED|Overall Study||2
11041639|NCT00917553|12221870|FG001|NOT COMPLETED|Overall Study||1
11057862|NCT01000506|12239602|FG002|STARTED|Overall Study||152
11057863|NCT01000506|12239603|FG003|STARTED|Overall Study||156
11057864|NCT01000506|12239600|FG000|COMPLETED|Overall Study||127
11057865|NCT01000506|12239601|FG001|COMPLETED|Overall Study||129
11057866|NCT01000506|12239602|FG002|COMPLETED|Overall Study||131
11057867|NCT01000506|12239603|FG003|COMPLETED|Overall Study||133
11057868|NCT01000506|12239600|FG000|NOT COMPLETED|Overall Study||28
11057869|NCT01000506|12239601|FG001|NOT COMPLETED|Overall Study||24
11057870|NCT01000506|12239602|FG002|NOT COMPLETED|Overall Study||21
11057871|NCT01000506|12239603|FG003|NOT COMPLETED|Overall Study||23
11057872|NCT01000610|12239613|FG000|STARTED|Overall Study||18
11057873|NCT01000610|12239613|FG000|COMPLETED|Overall Study||12
11057874|NCT01000610|12239613|FG000|NOT COMPLETED|Overall Study||6
11057875|NCT01000636|12239617|FG000|STARTED|Overall Study||9
11057876|NCT01000636|12239617|FG000|COMPLETED|Overall Study||7
11057877|NCT01000636|12239617|FG000|NOT COMPLETED|Overall Study||2
11057878|NCT01000649|12239625|FG000|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
11057879|NCT01000649|12239626|FG001|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
11057880|NCT01000649|12239627|FG002|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
11057881|NCT01000649|12239628|FG003|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
11057882|NCT01000649|12239625|FG000|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
11057883|NCT01000649|12239626|FG001|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
11057884|NCT01000649|12239627|FG002|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
11057885|NCT01000649|12239628|FG003|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
11057886|NCT01000649|12239625|FG000|COMPLETED|Overall Study||5
11057887|NCT01000649|12239626|FG001|COMPLETED|Overall Study||16
11057888|NCT01000649|12239627|FG002|COMPLETED|Overall Study||0
11057889|NCT01000649|12239628|FG003|COMPLETED|Overall Study||15
11057890|NCT01000649|12239625|FG000|NOT COMPLETED|Overall Study||5
11057891|NCT01000649|12239626|FG001|NOT COMPLETED|Overall Study||3
11057892|NCT01000649|12239627|FG002|NOT COMPLETED|Overall Study||2
11057893|NCT01000649|12239628|FG003|NOT COMPLETED|Overall Study||6
11057894|NCT01000662|12239639|FG000|STARTED|Overall Study||206
11057895|NCT01000662|12239640|FG001|STARTED|Overall Study||206
11057896|NCT01000662|12239639|FG000|COMPLETED|Overall Study||202
11057897|NCT01000662|12239640|FG001|COMPLETED|Overall Study||198
11057898|NCT01000662|12239639|FG000|NOT COMPLETED|Overall Study||4
11057899|NCT01000662|12239640|FG001|NOT COMPLETED|Overall Study||8
11057900|NCT01000727|12239650|FG000|STARTED|Overall Study||6522
11057901|NCT01000727|12239651|FG001|STARTED|Overall Study||6504
11057902|NCT01000727|12239650|FG000|COMPLETED|Overall Study||6347
11057903|NCT01000727|12239651|FG001|COMPLETED|Overall Study||6328
11057904|NCT01000727|12239650|FG000|NOT COMPLETED|Overall Study||175
11057905|NCT01000727|12239651|FG001|NOT COMPLETED|Overall Study||176
11057906|NCT01000805|12239661|FG000|STARTED|Overall Study||262
11041640|NCT00917579|12221876|FG000|STARTED|Period 1: 1st Intervention||39
11041641|NCT00917579|12221877|FG001|STARTED|Period 1: 1st Intervention||37
11041642|NCT00917579|12221876|FG000|COMPLETED|Period 1: 1st Intervention||39
11041643|NCT00917579|12221877|FG001|COMPLETED|Period 1: 1st Intervention||37
11041644|NCT00917579|12221876|FG000|NOT COMPLETED|Period 1: 1st Intervention||0
11041645|NCT00917579|12221877|FG001|NOT COMPLETED|Period 1: 1st Intervention||0
11041646|NCT00917579|12221876|FG000|STARTED|Washout >= 2 Weeks||39
11041647|NCT00917579|12221877|FG001|STARTED|Washout >= 2 Weeks||37
11041648|NCT00917579|12221876|FG000|COMPLETED|Washout >= 2 Weeks||37
11041649|NCT00917579|12221877|FG001|COMPLETED|Washout >= 2 Weeks||37
11041650|NCT00917579|12221876|FG000|NOT COMPLETED|Washout >= 2 Weeks||2
11041651|NCT00917579|12221877|FG001|NOT COMPLETED|Washout >= 2 Weeks||0
11041652|NCT00917579|12221876|FG000|STARTED|Period 2: 2nd Intervention||37
11041653|NCT00917579|12221877|FG001|STARTED|Period 2: 2nd Intervention||37
11041654|NCT00917579|12221876|FG000|COMPLETED|Period 2: 2nd Intervention||37
11041655|NCT00917579|12221877|FG001|COMPLETED|Period 2: 2nd Intervention||37
11041656|NCT00917579|12221876|FG000|NOT COMPLETED|Period 2: 2nd Intervention||0
11041657|NCT00917579|12221877|FG001|NOT COMPLETED|Period 2: 2nd Intervention||0
11041658|NCT00917644|12221883|FG000|STARTED|Period 1: First Intervention||39
11041659|NCT00917644|12221884|FG001|STARTED|Period 1: First Intervention||37
11041660|NCT00917644|12221883|FG000|COMPLETED|Period 1: First Intervention||39
11041661|NCT00917644|12221884|FG001|COMPLETED|Period 1: First Intervention||37
11041662|NCT00917644|12221883|FG000|NOT COMPLETED|Period 1: First Intervention||0
11041663|NCT00917644|12221884|FG001|NOT COMPLETED|Period 1: First Intervention||0
11041664|NCT00917644|12221883|FG000|STARTED|Period: Washout Period of > = 2 Weeks||39
11041665|NCT00917644|12221884|FG001|STARTED|Period: Washout Period of > = 2 Weeks||37
11041666|NCT00917644|12221883|FG000|COMPLETED|Period: Washout Period of > = 2 Weeks||37
11041667|NCT00917644|12221884|FG001|COMPLETED|Period: Washout Period of > = 2 Weeks||37
11041668|NCT00917644|12221883|FG000|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
11041669|NCT00917644|12221884|FG001|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
11041670|NCT00917644|12221883|FG000|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
11041671|NCT00917644|12221884|FG001|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
11041672|NCT00917644|12221883|FG000|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
11041673|NCT00917644|12221884|FG001|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
11041674|NCT00917644|12221883|FG000|NOT COMPLETED|Period 2: Second Intervention||1
11041675|NCT00917644|12221884|FG001|NOT COMPLETED|Period 2: Second Intervention||0
11041676|NCT00917735|12221892|FG000|STARTED|Overall Study||538
11041677|NCT00917735|12221893|FG001|STARTED|Overall Study||537
11041678|NCT00917735|12221892|FG000|COMPLETED|Overall Study||463
11041679|NCT00917735|12221893|FG001|COMPLETED|Overall Study||474
11041680|NCT00917735|12221892|FG000|NOT COMPLETED|Overall Study||75
11041681|NCT00917735|12221893|FG001|NOT COMPLETED|Overall Study||63
11041682|NCT00917852|12221899|FG000|STARTED|Overall Study||51
11041683|NCT00917852|12221899|FG000|COMPLETED|Overall Study||45
11041684|NCT00917852|12221899|FG000|NOT COMPLETED|Overall Study||6
11041685|NCT00917865|12221904|FG000|STARTED|Overall Study||11
11041686|NCT00917865|12221904|FG000|COMPLETED|Overall Study||11
11041687|NCT00917865|12221904|FG000|NOT COMPLETED|Overall Study||0
11041688|NCT00918125|12221917|FG000|STARTED|Overall Study||20
11041689|NCT00918125|12221918|FG001|STARTED|Overall Study||39
11041690|NCT00918125|12221917|FG000|COMPLETED|Overall Study||20
11041691|NCT00918125|12221918|FG001|COMPLETED|Overall Study||39
11041692|NCT00918125|12221917|FG000|NOT COMPLETED|Overall Study||0
11041693|NCT00918125|12221918|FG001|NOT COMPLETED|Overall Study||0
11041694|NCT00918138|12221929|FG000|STARTED|Overall Study||46
11041695|NCT00918138|12221930|FG001|STARTED|Overall Study||47
11041696|NCT00918138|12221929|FG000|COMPLETED|Overall Study||44
11041697|NCT00918138|12221930|FG001|COMPLETED|Overall Study||46
11041698|NCT00918138|12221929|FG000|NOT COMPLETED|Overall Study||2
11041699|NCT00918138|12221930|FG001|NOT COMPLETED|Overall Study||1
11041700|NCT00918203|12221938|FG000|STARTED|Treatment With or Without Olaratumab||70
11041701|NCT00918203|12221939|FG001|STARTED|Treatment With or Without Olaratumab||67
11041702|NCT00918203|12221940|FG002|STARTED|Treatment With or Without Olaratumab||0
11041703|NCT00918203|12221938|FG000|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
11041704|NCT00918203|12221939|FG001|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
11041705|NCT00918203|12221940|FG002|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
11041706|NCT00918203|12221938|FG000|Death Due to Any Cause|Treatment With or Without Olaratumab||53
11041707|NCT00918203|12221939|FG001|Death Due to Any Cause|Treatment With or Without Olaratumab||47
11041708|NCT00918203|12221940|FG002|Death Due to Any Cause|Treatment With or Without Olaratumab||0
11041709|NCT00918203|12221938|FG000|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
11041710|NCT00918203|12221939|FG001|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
11041711|NCT00918203|12221940|FG002|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
11041712|NCT00918203|12221938|FG000|COMPLETED|Treatment With or Without Olaratumab||64
11041713|NCT00918203|12221939|FG001|COMPLETED|Treatment With or Without Olaratumab||57
11041714|NCT00918203|12221940|FG002|COMPLETED|Treatment With or Without Olaratumab||0
11041715|NCT00918203|12221938|FG000|NOT COMPLETED|Treatment With or Without Olaratumab||6
11041716|NCT00918203|12221939|FG001|NOT COMPLETED|Treatment With or Without Olaratumab||10
11041717|NCT00918203|12221940|FG002|NOT COMPLETED|Treatment With or Without Olaratumab||0
11041718|NCT00918203|12221938|FG000|STARTED|Crossover to Olaratumab Monotherapy||0
11041719|NCT00918203|12221939|FG001|STARTED|Crossover to Olaratumab Monotherapy||0
11041720|NCT00918203|12221940|FG002|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
11041721|NCT00918203|12221938|FG000|COMPLETED|Crossover to Olaratumab Monotherapy||0
11041722|NCT00918203|12221939|FG001|COMPLETED|Crossover to Olaratumab Monotherapy||0
11041723|NCT00918203|12221940|FG002|COMPLETED|Crossover to Olaratumab Monotherapy||18
11041724|NCT00918203|12221938|FG000|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
11041725|NCT00918203|12221939|FG001|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
11041726|NCT00918203|12221940|FG002|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
11041727|NCT00918229|12221952|FG000|STARTED|Overall Study||24
11041728|NCT00918229|12221952|FG000|COMPLETED|Overall Study||24
11041729|NCT00918229|12221952|FG000|NOT COMPLETED|Overall Study||0
11041730|NCT00918255|12221959|FG000|STARTED|Overall Study||51
11041731|NCT00918255|12221960|FG001|STARTED|Overall Study||52
11041732|NCT00918255|12221961|FG002|STARTED|Overall Study||51
11041733|NCT00918255|12221959|FG000|COMPLETED|Overall Study||45
11041734|NCT00918255|12221960|FG001|COMPLETED|Overall Study||52
11041735|NCT00918255|12221961|FG002|COMPLETED|Overall Study||46
11041736|NCT00918255|12221959|FG000|NOT COMPLETED|Overall Study||6
11041737|NCT00918255|12221960|FG001|NOT COMPLETED|Overall Study||0
11041738|NCT00918255|12221961|FG002|NOT COMPLETED|Overall Study||5
11041739|NCT00918281|12221969|FG000|STARTED|Overall Study||70
11041740|NCT00918281|12221969|FG000|COMPLETED|Overall Study||41
11041741|NCT00918281|12221969|FG000|NOT COMPLETED|Overall Study||29
11041742|NCT00918333|12221978|FG000|STARTED|Overall Study||26
11041743|NCT00918333|12221979|FG001|STARTED|Overall Study||98
11041744|NCT00918333|12221978|FG000|COMPLETED|Overall Study||23
11041745|NCT00918333|12221979|FG001|COMPLETED|Overall Study||93
11041746|NCT00918333|12221978|FG000|NOT COMPLETED|Overall Study||3
11041747|NCT00918333|12221979|FG001|NOT COMPLETED|Overall Study||5
11041748|NCT00918346|12221988|FG000|STARTED|First Treatment Period (4 Weeks)||21
11041749|NCT00918346|12221989|FG001|STARTED|First Treatment Period (4 Weeks)||22
11041750|NCT00918346|12221988|FG000|COMPLETED|First Treatment Period (4 Weeks)||21
11041751|NCT00918346|12221989|FG001|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
11041752|NCT00918346|12221988|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||0
11041753|NCT00918346|12221989|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||1
11041754|NCT00918346|12221988|FG000|STARTED|Washout (at Least 4 Weeks)||21
11041755|NCT00918346|12221989|FG001|STARTED|Washout (at Least 4 Weeks)||21
11041756|NCT00918346|12221988|FG000|COMPLETED|Washout (at Least 4 Weeks)||21
11041757|NCT00918346|12221989|FG001|COMPLETED|Washout (at Least 4 Weeks)||21
11041758|NCT00918346|12221988|FG000|NOT COMPLETED|Washout (at Least 4 Weeks)||0
11336187|NCT02873377|12533824|FG001|STARTED|Period Title 3: 6 Months Follow up||69
11336188|NCT02873377|12533823|FG000|COMPLETED|Period Title 3: 6 Months Follow up||50
11336189|NCT02873377|12533824|FG001|COMPLETED|Period Title 3: 6 Months Follow up||46
11336190|NCT02873377|12533823|FG000|NOT COMPLETED|Period Title 3: 6 Months Follow up||15
11336191|NCT02873377|12533824|FG001|NOT COMPLETED|Period Title 3: 6 Months Follow up||23
11336192|NCT02873429|12533833|FG000|STARTED|Baseline||109
11336193|NCT02873429|12533834|FG001|STARTED|Baseline||100
11336194|NCT02873429|12533833|FG000|COMPLETED|Baseline||109
11336195|NCT02873429|12533834|FG001|COMPLETED|Baseline||100
11336196|NCT02873429|12533833|FG000|NOT COMPLETED|Baseline||0
11336197|NCT02873429|12533834|FG001|NOT COMPLETED|Baseline||0
11336198|NCT02873429|12533833|FG000|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
11336199|NCT02873429|12533834|FG001|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
11041759|NCT00918346|12221989|FG001|NOT COMPLETED|Washout (at Least 4 Weeks)||0
11041760|NCT00918346|12221988|FG000|STARTED|Second Treatment Period (4 Weeks)||21
11336200|NCT02873429|12533833|FG000|COMPLETED|6-8 Weeks||95
11041761|NCT00918346|12221989|FG001|STARTED|Second Treatment Period (4 Weeks)||21
11041762|NCT00918346|12221988|FG000|COMPLETED|Second Treatment Period (4 Weeks)||21
11041763|NCT00918346|12221989|FG001|COMPLETED|Second Treatment Period (4 Weeks)||21
11041764|NCT00918346|12221988|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
11041765|NCT00918346|12221989|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
11041766|NCT00918346|12221988|FG000|STARTED|Post Study Period||21
11041767|NCT00918346|12221989|FG001|STARTED|Post Study Period||21
11041768|NCT00918346|12221988|FG000|COMPLETED|Post Study Period||21
11041769|NCT00918346|12221989|FG001|COMPLETED|Post Study Period||21
11041770|NCT00918346|12221988|FG000|NOT COMPLETED|Post Study Period||0
11041771|NCT00918346|12221989|FG001|NOT COMPLETED|Post Study Period||0
11041772|NCT00918385|12222000|FG000|STARTED|Monotherapy||14
11041773|NCT00918385|12222001|FG001|STARTED|Monotherapy||17
11041774|NCT00918385|12222000|FG000|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
11041775|NCT00918385|12222001|FG001|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
11041776|NCT00918385|12222000|FG000|NOT COMPLETED|Monotherapy||2
11041777|NCT00918385|12222001|FG001|NOT COMPLETED|Monotherapy||6
11041778|NCT00918385|12222000|FG000|STARTED|Combination Nilutamide and Dasatinib||12
11041779|NCT00918385|12222001|FG001|STARTED|Combination Nilutamide and Dasatinib||11
11041780|NCT00918385|12222000|FG000|COMPLETED|Combination Nilutamide and Dasatinib||6
11041781|NCT00918385|12222001|FG001|COMPLETED|Combination Nilutamide and Dasatinib||3
11041782|NCT00918385|12222000|FG000|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
11041783|NCT00918385|12222001|FG001|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
11041784|NCT00918567|12222011|FG000|STARTED|Overall Study||29
11041785|NCT00918567|12222012|FG001|STARTED|Overall Study||27
11041786|NCT00918567|12222011|FG000|COMPLETED|Overall Study||24
11041787|NCT00918567|12222012|FG001|COMPLETED|Overall Study||25
11041788|NCT00918567|12222011|FG000|NOT COMPLETED|Overall Study||5
11041789|NCT00918567|12222012|FG001|NOT COMPLETED|Overall Study||2
11041790|NCT00918580|12222018|FG000|STARTED|Up to 6-month Follow-up(FU)||158
11041791|NCT00918580|12222018|FG000|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
11041792|NCT00918580|12222018|FG000|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
11041793|NCT00918580|12222018|FG000|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
11041794|NCT00918580|12222018|FG000|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
11041795|NCT00918580|12222018|FG000|STARTED|After 6-month FU to 1-year FU||147
11041796|NCT00918580|12222018|FG000|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
11041797|NCT00918580|12222018|FG000|COMPLETED|After 6-month FU to 1-year FU||87
11041798|NCT00918580|12222018|FG000|NOT COMPLETED|After 6-month FU to 1-year FU||60
11041799|NCT00918671|12222025|FG000|STARTED|Overall Study||60
11041800|NCT00918671|12222025|FG000|COMPLETED|Overall Study||60
11041801|NCT00918671|12222025|FG000|NOT COMPLETED|Overall Study||0
11041802|NCT00918684|12222029|FG000|STARTED|Two Week Drug Washout and Placebo Phase||106
11041803|NCT00918684|12222029|FG000|COMPLETED|Two Week Drug Washout and Placebo Phase||90
11041804|NCT00918684|12222029|FG000|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
11041805|NCT00918684|12222029|FG000|STARTED|Treatment Phase||90
11041806|NCT00918684|12222029|FG000|COMPLETED|Treatment Phase||65
11041807|NCT00918684|12222029|FG000|NOT COMPLETED|Treatment Phase||25
11041808|NCT00918723|12222033|FG000|STARTED|Overall Study||40
11041809|NCT00918723|12222033|FG000|COMPLETED|Overall Study||40
11041810|NCT00918723|12222033|FG000|NOT COMPLETED|Overall Study||0
11041811|NCT00918736|12222039|FG000|STARTED|Overall Study|October, 2007|50
11041812|NCT00918736|12222039|FG000|COMPLETED|Overall Study|October, 2008|46
11041813|NCT00918736|12222039|FG000|NOT COMPLETED|Overall Study||4
11041814|NCT00918749|12222046|FG000|STARTED|Overall Study||70
11041815|NCT00918749|12222047|FG001|STARTED|Overall Study||66
11041816|NCT00918749|12222048|FG002|STARTED|Overall Study||69
11041817|NCT00918749|12222046|FG000|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
11041818|NCT00918749|12222047|FG001|ITT (Intent to Treat) Population|Overall Study||66
11041819|NCT00918749|12222048|FG002|ITT (Intent to Treat) Population|Overall Study||69
11041820|NCT00918749|12222046|FG000|COMPLETED|Overall Study||63
11041821|NCT00918749|12222047|FG001|COMPLETED|Overall Study||63
11041822|NCT00918749|12222048|FG002|COMPLETED|Overall Study||62
11041823|NCT00918749|12222046|FG000|NOT COMPLETED|Overall Study||7
11041824|NCT00918749|12222047|FG001|NOT COMPLETED|Overall Study||3
11041825|NCT00918749|12222048|FG002|NOT COMPLETED|Overall Study||7
11041826|NCT00918866|12222058|FG000|STARTED|Overall Study||16
11041827|NCT00918866|12222059|FG001|STARTED|Overall Study||16
11041828|NCT00918866|12222058|FG000|COMPLETED|Overall Study||16
11041829|NCT00918866|12222059|FG001|COMPLETED|Overall Study||16
11041830|NCT00918866|12222058|FG000|NOT COMPLETED|Overall Study||0
11041831|NCT00918866|12222059|FG001|NOT COMPLETED|Overall Study||0
11041832|NCT00918879|12222067|FG000|STARTED|Overall Study|Randomized and treated|107
11041833|NCT00918879|12222068|FG001|STARTED|Overall Study|Randomized and treated|106
11041834|NCT00918879|12222067|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
11041835|NCT00918879|12222068|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
11041836|NCT00918879|12222067|FG000|NOT COMPLETED|Overall Study||6
11041837|NCT00918879|12222068|FG001|NOT COMPLETED|Overall Study||6
11041838|NCT00918931|12222074|FG000|STARTED|Overall Study||3
11041839|NCT00918931|12222074|FG000|COMPLETED|Overall Study||3
11041840|NCT00918931|12222074|FG000|NOT COMPLETED|Overall Study||0
11041841|NCT00918957|12222080|FG000|STARTED|Overall Study||32
11041842|NCT00918957|12222081|FG001|STARTED|Overall Study||30
11041843|NCT00918957|12222080|FG000|COMPLETED|Overall Study||29
11041844|NCT00918957|12222081|FG001|COMPLETED|Overall Study||30
11041845|NCT00918957|12222080|FG000|NOT COMPLETED|Overall Study||3
11041846|NCT00918957|12222081|FG001|NOT COMPLETED|Overall Study||0
11041847|NCT00919035|12222087|FG000|STARTED|Overall Study||21
11041848|NCT00919035|12222087|FG000|COMPLETED|Overall Study||21
11041849|NCT00919035|12222087|FG000|NOT COMPLETED|Overall Study||0
11041850|NCT00919061|12222091|FG000|STARTED|Overall Study||39
11041851|NCT00919061|12222091|FG000|COMPLETED|Overall Study||37
11041852|NCT00919061|12222091|FG000|NOT COMPLETED|Overall Study||2
11041853|NCT00919100|12222097|FG000|STARTED|Overall Study||40
11041854|NCT00919100|12222098|FG001|STARTED|Overall Study||41
11041855|NCT00919100|12222097|FG000|COMPLETED|Overall Study||40
11041856|NCT00919100|12222098|FG001|COMPLETED|Overall Study||41
11041857|NCT00919100|12222097|FG000|NOT COMPLETED|Overall Study||0
11041858|NCT00919100|12222098|FG001|NOT COMPLETED|Overall Study||0
11041859|NCT00919113|12222106|FG000|STARTED|Overall Study||50
11041860|NCT00919113|12222107|FG001|STARTED|Overall Study||48
11041861|NCT00919113|12222106|FG000|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
11041862|NCT00919113|12222107|FG001|Received Uracyst|Overall Study||0
11041863|NCT00919113|12222106|FG000|Received Placebo|Overall Study||0
11041864|NCT00919113|12222107|FG001|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
11041865|NCT00919113|12222106|FG000|COMPLETED|Overall Study||41
11041866|NCT00919113|12222107|FG001|COMPLETED|Overall Study||40
11041867|NCT00919113|12222106|FG000|NOT COMPLETED|Overall Study||9
11041868|NCT00919113|12222107|FG001|NOT COMPLETED|Overall Study||8
11041869|NCT00919126|12222116|FG000|STARTED|Overall Study||32
11041870|NCT00919126|12222117|FG001|STARTED|Overall Study||37
11041871|NCT00919126|12222118|FG002|STARTED|Overall Study||33
11041872|NCT00919126|12222116|FG000|COMPLETED|Overall Study||31
11041873|NCT00919126|12222117|FG001|COMPLETED|Overall Study||32
11041874|NCT00919126|12222118|FG002|COMPLETED|Overall Study||32
11041875|NCT00919126|12222116|FG000|NOT COMPLETED|Overall Study||1
11041876|NCT00919126|12222117|FG001|NOT COMPLETED|Overall Study||5
11041877|NCT00919126|12222118|FG002|NOT COMPLETED|Overall Study||1
11041878|NCT00919191|12222127|FG000|STARTED|Overall Study||26
11041879|NCT00919191|12222127|FG000|COMPLETED|Overall Study||26
11041880|NCT00919191|12222127|FG000|NOT COMPLETED|Overall Study||0
11041881|NCT00919503|12222135|FG000|STARTED|Overall Study||84
11041882|NCT00919503|12222136|FG001|STARTED|Overall Study||14
11041883|NCT00919503|12222135|FG000|COMPLETED|Overall Study||84
11041884|NCT00919503|12222136|FG001|COMPLETED|Overall Study||14
11041885|NCT00919503|12222135|FG000|NOT COMPLETED|Overall Study||0
11041886|NCT00919503|12222136|FG001|NOT COMPLETED|Overall Study||0
11041887|NCT00919633|12222146|FG000|STARTED|Overall Study||28
11041888|NCT00919633|12222147|FG001|STARTED|Overall Study||25
11041889|NCT00919633|12222148|FG002|STARTED|Overall Study||27
11041890|NCT00919633|12222149|FG003|STARTED|Overall Study||26
11041891|NCT00919633|12222146|FG000|COMPLETED|Overall Study||6
11041892|NCT00919633|12222147|FG001|COMPLETED|Overall Study||10
11041893|NCT00919633|12222148|FG002|COMPLETED|Overall Study||4
11041894|NCT00919633|12222149|FG003|COMPLETED|Overall Study||5
11041895|NCT00919633|12222146|FG000|NOT COMPLETED|Overall Study||22
11041896|NCT00919633|12222147|FG001|NOT COMPLETED|Overall Study||15
11041897|NCT00919633|12222148|FG002|NOT COMPLETED|Overall Study||23
11041898|NCT00919633|12222149|FG003|NOT COMPLETED|Overall Study||21
11041899|NCT00919711|12222161|FG000|STARTED|Overall Study||435
11041900|NCT00919711|12222162|FG001|STARTED|Overall Study||435
11041901|NCT00919711|12222161|FG000|COMPLETED|Overall Study||402
11041902|NCT00919711|12222162|FG001|COMPLETED|Overall Study||422
11041903|NCT00919711|12222161|FG000|NOT COMPLETED|Overall Study||33
11041904|NCT00919711|12222162|FG001|NOT COMPLETED|Overall Study||13
11041905|NCT00919724|12222170|FG000|STARTED|Overall Study||45
11041906|NCT00919724|12222171|FG001|STARTED|Overall Study||44
11041907|NCT00919724|12222170|FG000|COMPLETED|Overall Study||45
11041908|NCT00919724|12222171|FG001|COMPLETED|Overall Study||44
11041909|NCT00919724|12222170|FG000|NOT COMPLETED|Overall Study||0
11041910|NCT00919724|12222171|FG001|NOT COMPLETED|Overall Study||0
11041911|NCT00919802|12222177|FG000|STARTED|First Intervention - (24 Hours)||12
11041912|NCT00919802|12222178|FG001|STARTED|First Intervention - (24 Hours)||13
11041913|NCT00919802|12222177|FG000|COMPLETED|First Intervention - (24 Hours)||12
11041914|NCT00919802|12222178|FG001|COMPLETED|First Intervention - (24 Hours)||13
11041915|NCT00919802|12222177|FG000|NOT COMPLETED|First Intervention - (24 Hours)||0
11041916|NCT00919802|12222178|FG001|NOT COMPLETED|First Intervention - (24 Hours)||0
11041917|NCT00919802|12222177|FG000|STARTED|Second Intervention - (24 Hours)||12
11041918|NCT00919802|12222178|FG001|STARTED|Second Intervention - (24 Hours)||13
11041919|NCT00919802|12222177|FG000|COMPLETED|Second Intervention - (24 Hours)||12
11041920|NCT00919802|12222178|FG001|COMPLETED|Second Intervention - (24 Hours)||13
11041921|NCT00919802|12222177|FG000|NOT COMPLETED|Second Intervention - (24 Hours)||0
11041922|NCT00919802|12222178|FG001|NOT COMPLETED|Second Intervention - (24 Hours)||0
11041923|NCT00919854|12222184|FG000|STARTED|Overall Study||21
11041924|NCT00919854|12222184|FG000|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
11041925|NCT00919854|12222184|FG000|NOT COMPLETED|Overall Study||1
11041926|NCT00919867|12222194|FG000|STARTED|First Intervention||7
11041927|NCT00919867|12222195|FG001|STARTED|First Intervention||7
11041928|NCT00919867|12222196|FG002|STARTED|First Intervention||7
11041929|NCT00919867|12222197|FG003|STARTED|First Intervention||7
11041930|NCT00919867|12222198|FG004|STARTED|First Intervention||7
11041931|NCT00919867|12222199|FG005|STARTED|First Intervention||7
11041932|NCT00919867|12222194|FG000|COMPLETED|First Intervention||7
11041933|NCT00919867|12222195|FG001|COMPLETED|First Intervention||7
11041934|NCT00919867|12222196|FG002|COMPLETED|First Intervention||6
11041935|NCT00919867|12222197|FG003|COMPLETED|First Intervention||7
11041936|NCT00919867|12222198|FG004|COMPLETED|First Intervention||7
11041937|NCT00919867|12222199|FG005|COMPLETED|First Intervention||6
11041938|NCT00919867|12222194|FG000|NOT COMPLETED|First Intervention||0
11041939|NCT00919867|12222195|FG001|NOT COMPLETED|First Intervention||0
11041940|NCT00919867|12222196|FG002|NOT COMPLETED|First Intervention||1
11041941|NCT00919867|12222197|FG003|NOT COMPLETED|First Intervention||0
11041942|NCT00919867|12222198|FG004|NOT COMPLETED|First Intervention||0
11041943|NCT00919867|12222199|FG005|NOT COMPLETED|First Intervention||1
11041944|NCT00919867|12222194|FG000|STARTED|Washout||7
11041945|NCT00919867|12222195|FG001|STARTED|Washout||7
11041946|NCT00919867|12222196|FG002|STARTED|Washout||6
11041947|NCT00919867|12222197|FG003|STARTED|Washout||7
11041948|NCT00919867|12222198|FG004|STARTED|Washout||7
11041949|NCT00919867|12222199|FG005|STARTED|Washout||6
11041950|NCT00919867|12222194|FG000|COMPLETED|Washout||7
11041951|NCT00919867|12222195|FG001|COMPLETED|Washout||7
11041952|NCT00919867|12222196|FG002|COMPLETED|Washout||6
11041953|NCT00919867|12222197|FG003|COMPLETED|Washout||7
11041954|NCT00919867|12222198|FG004|COMPLETED|Washout||7
11041955|NCT00919867|12222199|FG005|COMPLETED|Washout||6
11041956|NCT00919867|12222194|FG000|NOT COMPLETED|Washout||0
11041957|NCT00919867|12222195|FG001|NOT COMPLETED|Washout||0
11041958|NCT00919867|12222196|FG002|NOT COMPLETED|Washout||0
11041959|NCT00919867|12222197|FG003|NOT COMPLETED|Washout||0
11041960|NCT00919867|12222198|FG004|NOT COMPLETED|Washout||0
11041961|NCT00919867|12222199|FG005|NOT COMPLETED|Washout||0
11041962|NCT00919867|12222194|FG000|STARTED|Second Intervention||7
11041963|NCT00919867|12222195|FG001|STARTED|Second Intervention||7
11041964|NCT00919867|12222196|FG002|STARTED|Second Intervention||6
11041965|NCT00919867|12222197|FG003|STARTED|Second Intervention||7
11041966|NCT00919867|12222198|FG004|STARTED|Second Intervention||7
11041967|NCT00919867|12222199|FG005|STARTED|Second Intervention||6
11041968|NCT00919867|12222194|FG000|COMPLETED|Second Intervention||7
11041969|NCT00919867|12222195|FG001|COMPLETED|Second Intervention||7
11041970|NCT00919867|12222196|FG002|COMPLETED|Second Intervention||6
11041971|NCT00919867|12222197|FG003|COMPLETED|Second Intervention||7
11041972|NCT00919867|12222198|FG004|COMPLETED|Second Intervention||7
11041973|NCT00919867|12222199|FG005|COMPLETED|Second Intervention||6
11041974|NCT00919867|12222194|FG000|NOT COMPLETED|Second Intervention||0
11041975|NCT00919867|12222195|FG001|NOT COMPLETED|Second Intervention||0
11041976|NCT00919867|12222196|FG002|NOT COMPLETED|Second Intervention||0
11041977|NCT00919867|12222197|FG003|NOT COMPLETED|Second Intervention||0
11041978|NCT00919867|12222198|FG004|NOT COMPLETED|Second Intervention||0
11041979|NCT00919867|12222199|FG005|NOT COMPLETED|Second Intervention||0
11041980|NCT00919867|12222194|FG000|STARTED|Washout||7
11041981|NCT00919867|12222195|FG001|STARTED|Washout||7
11041982|NCT00919867|12222196|FG002|STARTED|Washout||6
11041983|NCT00919867|12222197|FG003|STARTED|Washout||7
11041984|NCT00919867|12222198|FG004|STARTED|Washout||7
11041985|NCT00919867|12222199|FG005|STARTED|Washout||6
11041986|NCT00919867|12222194|FG000|COMPLETED|Washout||7
11041987|NCT00919867|12222195|FG001|COMPLETED|Washout||7
11041988|NCT00919867|12222196|FG002|COMPLETED|Washout||6
11041989|NCT00919867|12222197|FG003|COMPLETED|Washout||7
11041990|NCT00919867|12222198|FG004|COMPLETED|Washout||7
11041991|NCT00919867|12222199|FG005|COMPLETED|Washout||6
11041992|NCT00919867|12222194|FG000|NOT COMPLETED|Washout||0
11041993|NCT00919867|12222195|FG001|NOT COMPLETED|Washout||0
11041994|NCT00919867|12222196|FG002|NOT COMPLETED|Washout||0
11041995|NCT00919867|12222197|FG003|NOT COMPLETED|Washout||0
11041996|NCT00919867|12222198|FG004|NOT COMPLETED|Washout||0
11041997|NCT00919867|12222199|FG005|NOT COMPLETED|Washout||0
11041998|NCT00919867|12222194|FG000|STARTED|Third Intervention||7
11041999|NCT00919867|12222195|FG001|STARTED|Third Intervention||7
11042000|NCT00919867|12222196|FG002|STARTED|Third Intervention||6
11042001|NCT00919867|12222197|FG003|STARTED|Third Intervention||7
11042002|NCT00919867|12222198|FG004|STARTED|Third Intervention||7
11042003|NCT00919867|12222199|FG005|STARTED|Third Intervention||6
11042004|NCT00919867|12222194|FG000|COMPLETED|Third Intervention||7
11042005|NCT00919867|12222195|FG001|COMPLETED|Third Intervention||7
11042006|NCT00919867|12222196|FG002|COMPLETED|Third Intervention||6
11042007|NCT00919867|12222197|FG003|COMPLETED|Third Intervention||7
11042008|NCT00919867|12222198|FG004|COMPLETED|Third Intervention||7
11042009|NCT00919867|12222199|FG005|COMPLETED|Third Intervention||6
11042010|NCT00919867|12222194|FG000|NOT COMPLETED|Third Intervention||0
11042011|NCT00919867|12222195|FG001|NOT COMPLETED|Third Intervention||0
11336201|NCT02873429|12533834|FG001|COMPLETED|6-8 Weeks||97
11336202|NCT02873429|12533833|FG000|NOT COMPLETED|6-8 Weeks||10
11336203|NCT02873429|12533834|FG001|NOT COMPLETED|6-8 Weeks||1
11336204|NCT02873429|12533833|FG000|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
11336205|NCT02873429|12533834|FG001|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
11336206|NCT02873429|12533833|FG000|COMPLETED|16 Weeks||100
11336207|NCT02873429|12533834|FG001|COMPLETED|16 Weeks||96
11336208|NCT02873429|12533833|FG000|NOT COMPLETED|16 Weeks||5
11336209|NCT02873429|12533834|FG001|NOT COMPLETED|16 Weeks||2
11336210|NCT02873481|12533842|FG000|STARTED|Overall Study||15
11336211|NCT02873481|12533843|FG001|STARTED|Overall Study||17
11336212|NCT02873481|12533842|FG000|COMPLETED|Overall Study||15
11336213|NCT02873481|12533843|FG001|COMPLETED|Overall Study||17
11336214|NCT02873481|12533842|FG000|NOT COMPLETED|Overall Study||0
11336215|NCT02873481|12533843|FG001|NOT COMPLETED|Overall Study||0
11336216|NCT02873585|12533849|FG000|STARTED|Overall Study||32
11336217|NCT02873585|12533849|FG000|COMPLETED|Overall Study||32
11336218|NCT02873585|12533849|FG000|NOT COMPLETED|Overall Study||0
11336219|NCT02873689|12533859|FG000|STARTED|Overall Study||109
11042012|NCT00919867|12222196|FG002|NOT COMPLETED|Third Intervention||0
11042013|NCT00919867|12222197|FG003|NOT COMPLETED|Third Intervention||0
11042014|NCT00919867|12222198|FG004|NOT COMPLETED|Third Intervention||0
11336220|NCT02873689|12533860|FG001|STARTED|Overall Study||108
11336221|NCT02873689|12533859|FG000|Treated|Overall Study||108
11336222|NCT02873689|12533860|FG001|Treated|Overall Study||107
11336223|NCT02873689|12533859|FG000|COMPLETED|Overall Study||102
11336224|NCT02873689|12533860|FG001|COMPLETED|Overall Study||103
11042015|NCT00919867|12222199|FG005|NOT COMPLETED|Third Intervention||0
11042016|NCT00919932|12222209|FG000|STARTED|Overall Study||4
11042017|NCT00919932|12222210|FG001|STARTED|Overall Study||5
11042018|NCT00919932|12222209|FG000|COMPLETED|Overall Study||4
11042019|NCT00919932|12222210|FG001|COMPLETED|Overall Study||5
11042020|NCT00919932|12222209|FG000|NOT COMPLETED|Overall Study||0
11042021|NCT00919932|12222210|FG001|NOT COMPLETED|Overall Study||0
11042022|NCT00920023|12222216|FG000|STARTED|Overall Study||15
11042023|NCT00920023|12222216|FG000|COMPLETED|Overall Study||15
11042024|NCT00920023|12222216|FG000|NOT COMPLETED|Overall Study||0
11042025|NCT00920075|12222220|FG000|STARTED|Last Study, 25 Pts Invited,11 Responded||11
11042026|NCT00920075|12222220|FG000|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
11042027|NCT00920075|12222220|FG000|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
11042028|NCT00920075|12222220|FG000|STARTED|Post Study, 11 Pts Responded||11
11042029|NCT00920075|12222220|FG000|COMPLETED|Post Study, 11 Pts Responded||11
11042030|NCT00920075|12222220|FG000|NOT COMPLETED|Post Study, 11 Pts Responded||0
11336225|NCT02873689|12533859|FG000|NOT COMPLETED|Overall Study||7
11336226|NCT02873689|12533860|FG001|NOT COMPLETED|Overall Study||5
11336227|NCT02873702|12533868|FG000|STARTED|Healing Period (up to Week 8)||20
11336228|NCT02873702|12533869|FG001|STARTED|Healing Period (up to Week 8)||17
11336229|NCT02873702|12533870|FG002|STARTED|Healing Period (up to Week 8)||0
11336230|NCT02873702|12533871|FG003|STARTED|Healing Period (up to Week 8)||0
11336231|NCT02873702|12533868|FG000|COMPLETED|Healing Period (up to Week 8)||19
11336232|NCT02873702|12533869|FG001|COMPLETED|Healing Period (up to Week 8)||16
11336233|NCT02873702|12533870|FG002|COMPLETED|Healing Period (up to Week 8)||0
11336234|NCT02873702|12533871|FG003|COMPLETED|Healing Period (up to Week 8)||0
11336235|NCT02873702|12533868|FG000|NOT COMPLETED|Healing Period (up to Week 8)||1
11336236|NCT02873702|12533869|FG001|NOT COMPLETED|Healing Period (up to Week 8)||1
11336237|NCT02873702|12533870|FG002|NOT COMPLETED|Healing Period (up to Week 8)||0
11336238|NCT02873702|12533871|FG003|NOT COMPLETED|Healing Period (up to Week 8)||0
11336239|NCT02873702|12533868|FG000|STARTED|Maintenance Period (up to Month 6)||0
11336240|NCT02873702|12533869|FG001|STARTED|Maintenance Period (up to Month 6)||0
11042031|NCT00920140|12222229|FG000|STARTED|Phase 1 (Dose Escalation)||5
11336241|NCT02873702|12533870|FG002|STARTED|Maintenance Period (up to Month 6)||8
11336242|NCT02873702|12533871|FG003|STARTED|Maintenance Period (up to Month 6)||8
11042032|NCT00920140|12222230|FG001|STARTED|Phase 1 (Dose Escalation)||9
11336243|NCT02873702|12533868|FG000|COMPLETED|Maintenance Period (up to Month 6)||0
11336244|NCT02873702|12533869|FG001|COMPLETED|Maintenance Period (up to Month 6)||0
11336245|NCT02873702|12533870|FG002|COMPLETED|Maintenance Period (up to Month 6)||1
11336246|NCT02873702|12533871|FG003|COMPLETED|Maintenance Period (up to Month 6)||6
11336247|NCT02873702|12533868|FG000|NOT COMPLETED|Maintenance Period (up to Month 6)||0
11336248|NCT02873702|12533869|FG001|NOT COMPLETED|Maintenance Period (up to Month 6)||0
11336249|NCT02873702|12533870|FG002|NOT COMPLETED|Maintenance Period (up to Month 6)||7
11336250|NCT02873702|12533871|FG003|NOT COMPLETED|Maintenance Period (up to Month 6)||2
11336251|NCT02873754|12533881|FG000|STARTED|Overall Study||11
11336252|NCT02873754|12533881|FG000|COMPLETED|Overall Study||5
11336253|NCT02873754|12533881|FG000|NOT COMPLETED|Overall Study||6
11336254|NCT02873923|12533885|FG000|STARTED|Overall Study||2846
11336255|NCT02873923|12533885|FG000|COMPLETED|Overall Study||2846
11336256|NCT02873923|12533885|FG000|NOT COMPLETED|Overall Study||0
11336257|NCT02873936|12533892|FG000|STARTED|Overall Study||148
11336258|NCT02873936|12533893|FG001|STARTED|Overall Study||153
11336259|NCT02873936|12533894|FG002|STARTED|Overall Study||148
11336260|NCT02873936|12533892|FG000|COMPLETED|Overall Study||135
11336261|NCT02873936|12533893|FG001|COMPLETED|Overall Study||130
11336262|NCT02873936|12533894|FG002|COMPLETED|Overall Study||116
11336263|NCT02873936|12533892|FG000|NOT COMPLETED|Overall Study||13
11336264|NCT02873936|12533893|FG001|NOT COMPLETED|Overall Study||23
11336265|NCT02873936|12533894|FG002|NOT COMPLETED|Overall Study||32
11336266|NCT02874066|12533902|FG000|STARTED|Overall Study||46
11336267|NCT02874066|12533902|FG000|COMPLETED|Overall Study||46
11336268|NCT02874066|12533902|FG000|NOT COMPLETED|Overall Study||0
11336269|NCT02874092|12533908|FG000|STARTED|Overall Study||7
11336270|NCT02874092|12533909|FG001|STARTED|Overall Study||2
11336271|NCT02874092|12533908|FG000|COMPLETED|Overall Study||7
11336272|NCT02874092|12533909|FG001|COMPLETED|Overall Study||2
11336273|NCT02874092|12533908|FG000|NOT COMPLETED|Overall Study||0
11336274|NCT02874092|12533909|FG001|NOT COMPLETED|Overall Study||0
11336275|NCT02874404|12533914|FG000|STARTED|Overall Study||13
11336276|NCT02874404|12533914|FG000|COMPLETED|Overall Study||13
11336277|NCT02874404|12533914|FG000|NOT COMPLETED|Overall Study||0
11042033|NCT00920140|12222231|FG002|STARTED|Phase 1 (Dose Escalation)||0
11042034|NCT00920140|12222232|FG003|STARTED|Phase 1 (Dose Escalation)||0
11042035|NCT00920140|12222233|FG004|STARTED|Phase 1 (Dose Escalation)||0
11042036|NCT00920140|12222229|FG000|COMPLETED|Phase 1 (Dose Escalation)||0
11042037|NCT00920140|12222230|FG001|COMPLETED|Phase 1 (Dose Escalation)||0
11042038|NCT00920140|12222231|FG002|COMPLETED|Phase 1 (Dose Escalation)||0
11042039|NCT00920140|12222232|FG003|COMPLETED|Phase 1 (Dose Escalation)||0
11042040|NCT00920140|12222233|FG004|COMPLETED|Phase 1 (Dose Escalation)||0
11042041|NCT00920140|12222229|FG000|NOT COMPLETED|Phase 1 (Dose Escalation)||5
11042042|NCT00920140|12222230|FG001|NOT COMPLETED|Phase 1 (Dose Escalation)||9
11042043|NCT00920140|12222231|FG002|NOT COMPLETED|Phase 1 (Dose Escalation)||0
11042044|NCT00920140|12222232|FG003|NOT COMPLETED|Phase 1 (Dose Escalation)||0
11042045|NCT00920140|12222233|FG004|NOT COMPLETED|Phase 1 (Dose Escalation)||0
11042046|NCT00920140|12222229|FG000|STARTED|Phase 2||0
11042047|NCT00920140|12222230|FG001|STARTED|Phase 2||0
11042048|NCT00920140|12222231|FG002|STARTED|Phase 2||50
11042049|NCT00920140|12222232|FG003|STARTED|Phase 2||22
11042050|NCT00920140|12222233|FG004|STARTED|Phase 2||11
11042051|NCT00920140|12222229|FG000|COMPLETED|Phase 2||0
11042052|NCT00920140|12222230|FG001|COMPLETED|Phase 2||0
11042053|NCT00920140|12222231|FG002|COMPLETED|Phase 2||0
11042054|NCT00920140|12222232|FG003|COMPLETED|Phase 2||0
11042055|NCT00920140|12222233|FG004|COMPLETED|Phase 2||0
11042056|NCT00920140|12222229|FG000|NOT COMPLETED|Phase 2||0
11042057|NCT00920140|12222230|FG001|NOT COMPLETED|Phase 2||0
11042058|NCT00920140|12222231|FG002|NOT COMPLETED|Phase 2||50
11042059|NCT00920140|12222232|FG003|NOT COMPLETED|Phase 2||22
11042060|NCT00920140|12222233|FG004|NOT COMPLETED|Phase 2||11
11042061|NCT00920218|12222250|FG000|STARTED|Overall Study||30
11042062|NCT00920218|12222251|FG001|STARTED|Overall Study||29
11042063|NCT00920218|12222252|FG002|STARTED|Overall Study||31
11042064|NCT00920218|12222253|FG003|STARTED|Overall Study||30
11042065|NCT00920218|12222250|FG000|COMPLETED|Overall Study||28
11042066|NCT00920218|12222251|FG001|COMPLETED|Overall Study||24
11042067|NCT00920218|12222252|FG002|COMPLETED|Overall Study||23
11042068|NCT00920218|12222253|FG003|COMPLETED|Overall Study||23
11042069|NCT00920218|12222250|FG000|NOT COMPLETED|Overall Study||2
11042070|NCT00920218|12222251|FG001|NOT COMPLETED|Overall Study||5
11042071|NCT00920218|12222252|FG002|NOT COMPLETED|Overall Study||8
11042072|NCT00920218|12222253|FG003|NOT COMPLETED|Overall Study||7
11042073|NCT00920231|12222269|FG000|STARTED|Overall Study||8
11042074|NCT00920231|12222270|FG001|STARTED|Overall Study||8
11201180|NCT01831089|12391351|FG000|COMPLETED|Cohort B: Arm B||0
11201181|NCT01831089|12391352|FG001|COMPLETED|Cohort B: Arm B||0
11201182|NCT01831089|12391353|FG002|COMPLETED|Cohort B: Arm B||0
11201183|NCT01831089|12391354|FG003|COMPLETED|Cohort B: Arm B||0
11201184|NCT01831089|12391355|FG004|COMPLETED|Cohort B: Arm B||0
11201185|NCT01831089|12391356|FG005|COMPLETED|Cohort B: Arm B||0
11201186|NCT01831089|12391351|FG000|NOT COMPLETED|Cohort B: Arm B||0
11201187|NCT01831089|12391352|FG001|NOT COMPLETED|Cohort B: Arm B||0
11201188|NCT01831089|12391353|FG002|NOT COMPLETED|Cohort B: Arm B||0
11201189|NCT01831089|12391354|FG003|NOT COMPLETED|Cohort B: Arm B||0
11042075|NCT00920231|12222269|FG000|COMPLETED|Overall Study||8
11042076|NCT00920231|12222270|FG001|COMPLETED|Overall Study||8
11201190|NCT01831089|12391355|FG004|NOT COMPLETED|Cohort B: Arm B||0
11201191|NCT01831089|12391356|FG005|NOT COMPLETED|Cohort B: Arm B||14
11201192|NCT01831154|12391374|FG000|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
11201193|NCT01831154|12391375|FG001|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
11201194|NCT01831154|12391376|FG002|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
11201195|NCT01831154|12391374|FG000|COMPLETED|Overall Study||15
11201196|NCT01831154|12391375|FG001|COMPLETED|Overall Study||11
11201197|NCT01831154|12391376|FG002|COMPLETED|Overall Study||11
11201198|NCT01831154|12391374|FG000|NOT COMPLETED|Overall Study||0
11201199|NCT01831154|12391375|FG001|NOT COMPLETED|Overall Study||0
11201200|NCT01831154|12391376|FG002|NOT COMPLETED|Overall Study||0
11201201|NCT01831219|12391386|FG000|STARTED|Overall Study||73
11201202|NCT01831219|12391387|FG001|STARTED|Overall Study||45
11201203|NCT01831219|12391386|FG000|COMPLETED|Overall Study||40
11201204|NCT01831219|12391387|FG001|COMPLETED|Overall Study||21
11201205|NCT01831219|12391386|FG000|NOT COMPLETED|Overall Study||33
11201206|NCT01831219|12391387|FG001|NOT COMPLETED|Overall Study||24
11201207|NCT01831232|12391393|FG000|STARTED|Overall Study||24
11201208|NCT01831232|12391393|FG000|COMPLETED|Overall Study||24
11201209|NCT01831232|12391393|FG000|NOT COMPLETED|Overall Study||0
11201210|NCT01831258|12391397|FG000|STARTED|Overall Study||35
11201211|NCT01831258|12391398|FG001|STARTED|Overall Study||35
11201212|NCT01831258|12391397|FG000|COMPLETED|Overall Study||30
11201213|NCT01831258|12391398|FG001|COMPLETED|Overall Study||32
11201214|NCT01831258|12391397|FG000|NOT COMPLETED|Overall Study||5
11201215|NCT01831258|12391398|FG001|NOT COMPLETED|Overall Study||3
11201216|NCT01831427|12391417|FG000|STARTED|Overall Study||5
11201217|NCT01831427|12391418|FG001|STARTED|Overall Study||5
11201218|NCT01831427|12391419|FG002|STARTED|Overall Study||5
11042077|NCT00920231|12222269|FG000|NOT COMPLETED|Overall Study||0
11042078|NCT00920231|12222270|FG001|NOT COMPLETED|Overall Study||0
11042079|NCT00920374|12222280|FG000|STARTED|Overall Study||61
11042080|NCT00920374|12222281|FG001|STARTED|Overall Study||57
11042081|NCT00920374|12222280|FG000|COMPLETED|Overall Study||61
11042082|NCT00920374|12222281|FG001|COMPLETED|Overall Study||57
11042083|NCT00920374|12222280|FG000|NOT COMPLETED|Overall Study||0
11042084|NCT00920374|12222281|FG001|NOT COMPLETED|Overall Study||0
11042085|NCT00920426|12222290|FG000|STARTED|ITZ111451||8
11042086|NCT00920426|12222291|FG001|STARTED|ITZ111451||0
11042087|NCT00920426|12222292|FG002|STARTED|ITZ111451||0
11042088|NCT00920426|12222293|FG003|STARTED|ITZ111451||0
11042089|NCT00920426|12222290|FG000|COMPLETED|ITZ111451||7
11042090|NCT00920426|12222291|FG001|COMPLETED|ITZ111451||0
11336278|NCT02874534|12533921|FG000|STARTED|Overall Study||31
11336279|NCT02874534|12533922|FG001|STARTED|Overall Study||26
11336280|NCT02874534|12533921|FG000|COMPLETED|Overall Study||23
11336281|NCT02874534|12533922|FG001|COMPLETED|Overall Study||15
11336282|NCT02874534|12533921|FG000|NOT COMPLETED|Overall Study||8
11336283|NCT02874534|12533922|FG001|NOT COMPLETED|Overall Study||11
11336284|NCT02874794|12533930|FG000|STARTED|Overall Study||233
11336285|NCT02874794|12533931|FG001|STARTED|Overall Study||232
11336286|NCT02874794|12533930|FG000|COMPLETED|Overall Study||226
11336287|NCT02874794|12533931|FG001|COMPLETED|Overall Study||221
11336288|NCT02874794|12533930|FG000|NOT COMPLETED|Overall Study||7
11336289|NCT02874794|12533931|FG001|NOT COMPLETED|Overall Study||11
11336290|NCT02874846|12533942|FG000|STARTED|Overall Study||8
11336291|NCT02874846|12533943|FG001|STARTED|Overall Study||4
11336292|NCT02874846|12533942|FG000|COMPLETED|Overall Study||8
11336293|NCT02874846|12533943|FG001|COMPLETED|Overall Study||4
11336294|NCT02874846|12533942|FG000|NOT COMPLETED|Overall Study||0
11336295|NCT02874846|12533943|FG001|NOT COMPLETED|Overall Study||0
11042091|NCT00920426|12222292|FG002|COMPLETED|ITZ111451||0
11042092|NCT00920426|12222293|FG003|COMPLETED|ITZ111451||0
11042093|NCT00920426|12222290|FG000|NOT COMPLETED|ITZ111451||1
11042094|NCT00920426|12222291|FG001|NOT COMPLETED|ITZ111451||0
11201219|NCT01831427|12391420|FG003|STARTED|Overall Study||5
11201220|NCT01831427|12391421|FG004|STARTED|Overall Study||4
11201221|NCT01831427|12391422|FG005|STARTED|Overall Study||8
11201222|NCT01831427|12391423|FG006|STARTED|Overall Study||8
11201223|NCT01831427|12391424|FG007|STARTED|Overall Study||8
11201224|NCT01831427|12391425|FG008|STARTED|Overall Study||8
11336296|NCT02874924|12533953|FG000|STARTED|Overall Study||14
11336297|NCT02874924|12533954|FG001|STARTED|Overall Study||14
11042095|NCT00920426|12222292|FG002|NOT COMPLETED|ITZ111451||0
11042096|NCT00920426|12222293|FG003|NOT COMPLETED|ITZ111451||0
11042097|NCT00920426|12222290|FG000|STARTED|ITZ112929: Randomized Regimen||0
11042098|NCT00920426|12222291|FG001|STARTED|ITZ112929: Randomized Regimen||7
11042099|NCT00920426|12222292|FG002|STARTED|ITZ112929: Randomized Regimen||2
11042100|NCT00920426|12222293|FG003|STARTED|ITZ112929: Randomized Regimen||0
11042101|NCT00920426|12222290|FG000|COMPLETED|ITZ112929: Randomized Regimen||0
11042102|NCT00920426|12222291|FG001|COMPLETED|ITZ112929: Randomized Regimen||7
11042103|NCT00920426|12222292|FG002|COMPLETED|ITZ112929: Randomized Regimen||2
11042104|NCT00920426|12222293|FG003|COMPLETED|ITZ112929: Randomized Regimen||0
11042105|NCT00920426|12222290|FG000|NOT COMPLETED|ITZ112929: Randomized Regimen||0
11042106|NCT00920426|12222291|FG001|NOT COMPLETED|ITZ112929: Randomized Regimen||0
11042107|NCT00920426|12222292|FG002|NOT COMPLETED|ITZ112929: Randomized Regimen||0
11042108|NCT00920426|12222293|FG003|NOT COMPLETED|ITZ112929: Randomized Regimen||0
11042109|NCT00920426|12222290|FG000|STARTED|ITZ112929: Optimized Therapy (OT)||0
11042110|NCT00920426|12222291|FG001|STARTED|ITZ112929: Optimized Therapy (OT)||0
11042111|NCT00920426|12222292|FG002|STARTED|ITZ112929: Optimized Therapy (OT)||0
11042112|NCT00920426|12222293|FG003|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
11042113|NCT00920426|12222290|FG000|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
11042114|NCT00920426|12222291|FG001|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
11042115|NCT00920426|12222292|FG002|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
11042116|NCT00920426|12222293|FG003|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
11042117|NCT00920426|12222290|FG000|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
11057907|NCT01000805|12239662|FG001|STARTED|Overall Study||266
11336298|NCT02874924|12533955|FG002|STARTED|Overall Study||6
11336299|NCT02874924|12533953|FG000|COMPLETED|Overall Study||11
11336300|NCT02874924|12533954|FG001|COMPLETED|Overall Study||14
11336301|NCT02874924|12533955|FG002|COMPLETED|Overall Study||6
11336302|NCT02874924|12533953|FG000|NOT COMPLETED|Overall Study||3
11336303|NCT02874924|12533954|FG001|NOT COMPLETED|Overall Study||0
11336304|NCT02874924|12533955|FG002|NOT COMPLETED|Overall Study||0
11336305|NCT02875028|12533965|FG000|STARTED|First Intervention (24 Hours)||8
11336306|NCT02875028|12533966|FG001|STARTED|First Intervention (24 Hours)||8
11336307|NCT02875028|12533965|FG000|COMPLETED|First Intervention (24 Hours)||8
11336308|NCT02875028|12533966|FG001|COMPLETED|First Intervention (24 Hours)||8
11336309|NCT02875028|12533965|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
11336310|NCT02875028|12533966|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
11336311|NCT02875028|12533965|FG000|STARTED|Washout Period||8
11336312|NCT02875028|12533966|FG001|STARTED|Washout Period||8
11336313|NCT02875028|12533965|FG000|COMPLETED|Washout Period||8
11336314|NCT02875028|12533966|FG001|COMPLETED|Washout Period||7
11336315|NCT02875028|12533965|FG000|NOT COMPLETED|Washout Period||0
11336316|NCT02875028|12533966|FG001|NOT COMPLETED|Washout Period||1
11336317|NCT02875028|12533965|FG000|STARTED|Second Intervention (24 Hours)||8
11336318|NCT02875028|12533966|FG001|STARTED|Second Intervention (24 Hours)||7
11336319|NCT02875028|12533965|FG000|COMPLETED|Second Intervention (24 Hours)||8
11336320|NCT02875028|12533966|FG001|COMPLETED|Second Intervention (24 Hours)||7
11336321|NCT02875028|12533965|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
11336322|NCT02875028|12533966|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0
11336323|NCT02875080|12533977|FG000|STARTED|Overall Study||6
11336324|NCT02875080|12533978|FG001|STARTED|Overall Study||6
11336325|NCT02875080|12533979|FG002|STARTED|Overall Study||6
11336326|NCT02875080|12533977|FG000|COMPLETED|Overall Study||4
11336327|NCT02875080|12533978|FG001|COMPLETED|Overall Study||6
11336328|NCT02875080|12533979|FG002|COMPLETED|Overall Study||6
11336329|NCT02875080|12533977|FG000|NOT COMPLETED|Overall Study||2
11336330|NCT02875080|12533978|FG001|NOT COMPLETED|Overall Study||0
11336331|NCT02875080|12533979|FG002|NOT COMPLETED|Overall Study||0
11336332|NCT02875340|12533987|FG000|STARTED|Overall Study||8
11336333|NCT02875340|12533987|FG000|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
11336334|NCT02875340|12533987|FG000|NOT COMPLETED|Overall Study||8
11336335|NCT02875366|12533999|FG000|STARTED|Overall Study||36
11336336|NCT02875366|12534000|FG001|STARTED|Overall Study||34
11336337|NCT02875366|12533999|FG000|COMPLETED|Overall Study||36
11336338|NCT02875366|12534000|FG001|COMPLETED|Overall Study||31
11336339|NCT02875366|12533999|FG000|NOT COMPLETED|Overall Study||0
11336340|NCT02875366|12534000|FG001|NOT COMPLETED|Overall Study||3
11336341|NCT02875392|12534008|FG000|STARTED|Overall Study||28
11336342|NCT02875392|12534009|FG001|STARTED|Overall Study||29
11042118|NCT00920426|12222291|FG001|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
11042119|NCT00920426|12222292|FG002|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
11042120|NCT00920426|12222293|FG003|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
11042121|NCT00920439|12222305|FG000|STARTED|Overall Study||25
11042122|NCT00920439|12222305|FG000|COMPLETED|Overall Study||25
11042123|NCT00920439|12222305|FG000|NOT COMPLETED|Overall Study||0
11336343|NCT02875392|12534008|FG000|COMPLETED|Overall Study||21
11336344|NCT02875392|12534009|FG001|COMPLETED|Overall Study||21
11336345|NCT02875392|12534008|FG000|NOT COMPLETED|Overall Study||7
11336346|NCT02875392|12534009|FG001|NOT COMPLETED|Overall Study||8
11336347|NCT02875613|12534015|FG000|STARTED|Overall Study||5
11336348|NCT02875613|12534015|FG000|COMPLETED|Overall Study||4
11042124|NCT00920556|12222309|FG000|STARTED|Overall Study||24
11042125|NCT00920556|12222309|FG000|COMPLETED|Overall Study||0
11042126|NCT00920556|12222309|FG000|NOT COMPLETED|Overall Study||24
11042127|NCT00920647|12222321|FG000|STARTED|Overall Study||4
11042128|NCT00920647|12222322|FG001|STARTED|Overall Study||4
11042129|NCT00920647|12222323|FG002|STARTED|Overall Study||4
11042130|NCT00920647|12222324|FG003|STARTED|Overall Study||4
11042131|NCT00920647|12222321|FG000|COMPLETED|Overall Study||4
11042132|NCT00920647|12222322|FG001|COMPLETED|Overall Study||4
11042133|NCT00920647|12222323|FG002|COMPLETED|Overall Study||4
11042134|NCT00920647|12222324|FG003|COMPLETED|Overall Study||4
11042135|NCT00920647|12222321|FG000|NOT COMPLETED|Overall Study||0
11042136|NCT00920647|12222322|FG001|NOT COMPLETED|Overall Study||0
11042137|NCT00920647|12222323|FG002|NOT COMPLETED|Overall Study||0
11042138|NCT00920647|12222324|FG003|NOT COMPLETED|Overall Study||0
11042139|NCT00920686|12222347|FG000|STARTED|Overall Study||82
11042140|NCT00920686|12222348|FG001|STARTED|Overall Study||82
11042141|NCT00920686|12222349|FG002|STARTED|Overall Study||75
11042142|NCT00920686|12222347|FG000|COMPLETED|Overall Study||63
11042143|NCT00920686|12222348|FG001|COMPLETED|Overall Study||60
11042144|NCT00920686|12222349|FG002|COMPLETED|Overall Study||62
11042145|NCT00920686|12222347|FG000|NOT COMPLETED|Overall Study||19
11042146|NCT00920686|12222348|FG001|NOT COMPLETED|Overall Study||22
11042147|NCT00920686|12222349|FG002|NOT COMPLETED|Overall Study||13
11042148|NCT00920699|12222364|FG000|STARTED|Overall Study||29
11042149|NCT00920699|12222365|FG001|STARTED|Overall Study||30
11042150|NCT00920699|12222366|FG002|STARTED|Overall Study||32
11042151|NCT00920699|12222364|FG000|COMPLETED|Overall Study||27
11042152|NCT00920699|12222365|FG001|COMPLETED|Overall Study||29
11042153|NCT00920699|12222366|FG002|COMPLETED|Overall Study||28
11042154|NCT00920699|12222364|FG000|NOT COMPLETED|Overall Study||2
11042155|NCT00920699|12222365|FG001|NOT COMPLETED|Overall Study||1
11042156|NCT00920699|12222366|FG002|NOT COMPLETED|Overall Study||4
11042157|NCT00920790|12222374|FG000|STARTED|Overall Study||27
11042158|NCT00920790|12222374|FG000|COMPLETED|Overall Study||13
11042159|NCT00920790|12222374|FG000|NOT COMPLETED|Overall Study||14
11042160|NCT00920829|12222382|FG000|STARTED|Allocation||38
11042161|NCT00920829|12222383|FG001|STARTED|Allocation||39
11042162|NCT00920829|12222384|FG002|STARTED|Allocation||38
11042163|NCT00920829|12222385|FG003|STARTED|Allocation||37
11042164|NCT00920829|12222382|FG000|COMPLETED|Allocation||35
11042165|NCT00920829|12222383|FG001|COMPLETED|Allocation||38
11042166|NCT00920829|12222384|FG002|COMPLETED|Allocation||38
11042167|NCT00920829|12222385|FG003|COMPLETED|Allocation||35
11042168|NCT00920829|12222382|FG000|NOT COMPLETED|Allocation||3
11042169|NCT00920829|12222383|FG001|NOT COMPLETED|Allocation||1
11042170|NCT00920829|12222384|FG002|NOT COMPLETED|Allocation||0
11042171|NCT00920829|12222385|FG003|NOT COMPLETED|Allocation||2
11042172|NCT00920829|12222382|FG000|STARTED|Available for Analysis||35
11042173|NCT00920829|12222383|FG001|STARTED|Available for Analysis||38
11042174|NCT00920829|12222384|FG002|STARTED|Available for Analysis||38
11042175|NCT00920829|12222385|FG003|STARTED|Available for Analysis||35
11042176|NCT00920829|12222382|FG000|COMPLETED|Available for Analysis||27
11042177|NCT00920829|12222383|FG001|COMPLETED|Available for Analysis||27
11042178|NCT00920829|12222384|FG002|COMPLETED|Available for Analysis||28
11042179|NCT00920829|12222385|FG003|COMPLETED|Available for Analysis||24
11042180|NCT00920829|12222382|FG000|NOT COMPLETED|Available for Analysis||8
11042181|NCT00920829|12222383|FG001|NOT COMPLETED|Available for Analysis||11
11042182|NCT00920829|12222384|FG002|NOT COMPLETED|Available for Analysis||10
11042183|NCT00920829|12222385|FG003|NOT COMPLETED|Available for Analysis||11
11042184|NCT00920855|12222398|FG000|STARTED|Overall Study||5
11042185|NCT00920855|12222399|FG001|STARTED|Overall Study||4
11042186|NCT00920855|12222400|FG002|STARTED|Overall Study||31
11042187|NCT00920855|12222398|FG000|Safety and Efficacy Populations|Overall Study||5
11042188|NCT00920855|12222399|FG001|Safety and Efficacy Populations|Overall Study||4
11042189|NCT00920855|12222400|FG002|Safety and Efficacy Populations|Overall Study||31
11042190|NCT00920855|12222398|FG000|COMPLETED|Overall Study|completed eight cycles of treatment|0
11042191|NCT00920855|12222399|FG001|COMPLETED|Overall Study|completed eight cycles of treatment|1
11042192|NCT00920855|12222400|FG002|COMPLETED|Overall Study|completed eight cycles of treatment|9
11042193|NCT00920855|12222398|FG000|NOT COMPLETED|Overall Study||5
11042194|NCT00920855|12222399|FG001|NOT COMPLETED|Overall Study||3
11042195|NCT00920855|12222400|FG002|NOT COMPLETED|Overall Study||22
11042196|NCT00920907|12222411|FG000|STARTED|Induction Period||37
11042197|NCT00920907|12222412|FG001|STARTED|Induction Period||38
11042198|NCT00920907|12222411|FG000|COMPLETED|Induction Period||15
11042199|NCT00920907|12222412|FG001|COMPLETED|Induction Period||16
11042200|NCT00920907|12222411|FG000|NOT COMPLETED|Induction Period||22
11042201|NCT00920907|12222412|FG001|NOT COMPLETED|Induction Period||22
11042202|NCT00920907|12222411|FG000|STARTED|Maintenance Period||15
11042203|NCT00920907|12222412|FG001|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
11042204|NCT00920907|12222411|FG000|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
11042205|NCT00920907|12222412|FG001|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
11042206|NCT00920907|12222411|FG000|NOT COMPLETED|Maintenance Period||12
11042207|NCT00920907|12222412|FG001|NOT COMPLETED|Maintenance Period||13
11042208|NCT00921024|12222422|FG000|STARTED|Overall Study||85
11042209|NCT00921024|12222423|FG001|STARTED|Overall Study||42
11042210|NCT00921024|12222422|FG000|COMPLETED|Overall Study||81
11042211|NCT00921024|12222423|FG001|COMPLETED|Overall Study||39
11042212|NCT00921024|12222422|FG000|NOT COMPLETED|Overall Study||4
11042213|NCT00921024|12222423|FG001|NOT COMPLETED|Overall Study||3
11042214|NCT00921310|12222431|FG000|STARTED|Overall Study||2
11042215|NCT00921310|12222432|FG001|STARTED|Overall Study||6
11042216|NCT00921310|12222433|FG002|STARTED|Overall Study||4
11042217|NCT00921310|12222431|FG000|COMPLETED|Overall Study||2
11042218|NCT00921310|12222432|FG001|COMPLETED|Overall Study||6
11042219|NCT00921310|12222433|FG002|COMPLETED|Overall Study||4
11042220|NCT00921310|12222431|FG000|NOT COMPLETED|Overall Study||0
11042221|NCT00921310|12222432|FG001|NOT COMPLETED|Overall Study||0
11042222|NCT00921310|12222433|FG002|NOT COMPLETED|Overall Study||0
11042223|NCT00921518|12222447|FG000|STARTED|Overall Study||48
11042224|NCT00921518|12222448|FG001|STARTED|Overall Study||44
11042225|NCT00921518|12222447|FG000|COMPLETED|Overall Study||48
11042226|NCT00921518|12222448|FG001|COMPLETED|Overall Study||44
11042227|NCT00921518|12222447|FG000|NOT COMPLETED|Overall Study||0
11042228|NCT00921518|12222448|FG001|NOT COMPLETED|Overall Study||0
11042229|NCT00921557|12222457|FG000|STARTED|Weeks 0-48 (on Study Treatment)||17
11042230|NCT00921557|12222458|FG001|STARTED|Weeks 0-48 (on Study Treatment)||17
11042231|NCT00921557|12222459|FG002|STARTED|Weeks 0-48 (on Study Treatment)||18
11042232|NCT00921557|12222457|FG000|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
11042233|NCT00921557|12222458|FG001|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
11042234|NCT00921557|12222459|FG002|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
11042235|NCT00921557|12222457|FG000|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
11042236|NCT00921557|12222458|FG001|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
11042237|NCT00921557|12222459|FG002|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
11042238|NCT00921557|12222457|FG000|STARTED|Weeks 48-96 (on Study Treatment)||15
11042239|NCT00921557|12222458|FG001|STARTED|Weeks 48-96 (on Study Treatment)||17
11042240|NCT00921557|12222459|FG002|STARTED|Weeks 48-96 (on Study Treatment)||18
11042241|NCT00921557|12222457|FG000|COMPLETED|Weeks 48-96 (on Study Treatment)||15
11042242|NCT00921557|12222458|FG001|COMPLETED|Weeks 48-96 (on Study Treatment)||16
11042243|NCT00921557|12222459|FG002|COMPLETED|Weeks 48-96 (on Study Treatment)||17
11042244|NCT00921557|12222457|FG000|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
11042245|NCT00921557|12222458|FG001|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
11042246|NCT00921557|12222459|FG002|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
11042247|NCT00921557|12222457|FG000|STARTED|Weeks 96-144 (Off Study Treatment)||15
11042248|NCT00921557|12222458|FG001|STARTED|Weeks 96-144 (Off Study Treatment)||16
11042249|NCT00921557|12222459|FG002|STARTED|Weeks 96-144 (Off Study Treatment)||17
11042250|NCT00921557|12222457|FG000|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
11042251|NCT00921557|12222458|FG001|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
11042252|NCT00921557|12222459|FG002|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
11042253|NCT00921557|12222457|FG000|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
11042254|NCT00921557|12222458|FG001|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
11042255|NCT00921557|12222459|FG002|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
11042256|NCT00921687|12222474|FG000|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
11042257|NCT00921687|12222475|FG001|STARTED|Overall Study||363
11042258|NCT00921687|12222474|FG000|COMPLETED|Overall Study||418
11042259|NCT00921687|12222475|FG001|COMPLETED|Overall Study||363
11042260|NCT00921687|12222474|FG000|NOT COMPLETED|Overall Study||0
11042261|NCT00921687|12222475|FG001|NOT COMPLETED|Overall Study||0
11042262|NCT00921843|12222485|FG000|STARTED|Overall Study||10
11042263|NCT00921843|12222486|FG001|STARTED|Overall Study||10
11042264|NCT00921843|12222487|FG002|STARTED|Overall Study||11
11042265|NCT00921843|12222488|FG003|STARTED|Overall Study||30
11042266|NCT00921843|12222485|FG000|COMPLETED|Overall Study||10
11042267|NCT00921843|12222486|FG001|COMPLETED|Overall Study||10
11042268|NCT00921843|12222487|FG002|COMPLETED|Overall Study||11
11042269|NCT00921843|12222488|FG003|COMPLETED|Overall Study||30
11042270|NCT00921843|12222485|FG000|NOT COMPLETED|Overall Study||0
11042271|NCT00921843|12222486|FG001|NOT COMPLETED|Overall Study||0
11042272|NCT00921843|12222487|FG002|NOT COMPLETED|Overall Study||0
11042273|NCT00921843|12222488|FG003|NOT COMPLETED|Overall Study||0
11042274|NCT00921895|12222498|FG000|STARTED|Overall Study||128
11042275|NCT00921895|12222498|FG000|COMPLETED|Overall Study||128
11042276|NCT00921895|12222498|FG000|NOT COMPLETED|Overall Study||0
11042277|NCT00921934|12222503|FG000|STARTED|Overall Study||68
11042278|NCT00921934|12222503|FG000|COMPLETED|Overall Study||68
11042279|NCT00921934|12222503|FG000|NOT COMPLETED|Overall Study||0
11042280|NCT00921947|12222509|FG000|STARTED|Day 0||30
11042281|NCT00921947|12222510|FG001|STARTED|Day 0||30
11042282|NCT00921947|12222509|FG000|COMPLETED|Day 0||30
11042283|NCT00921947|12222510|FG001|COMPLETED|Day 0||30
11042284|NCT00921947|12222509|FG000|NOT COMPLETED|Day 0||0
11042285|NCT00921947|12222510|FG001|NOT COMPLETED|Day 0||0
11042286|NCT00921947|12222509|FG000|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
11042287|NCT00921947|12222510|FG001|STARTED|Day 28||30
11042288|NCT00921947|12222509|FG000|COMPLETED|Day 28||28
11042289|NCT00921947|12222510|FG001|COMPLETED|Day 28||30
11042290|NCT00921947|12222509|FG000|NOT COMPLETED|Day 28||0
11042291|NCT00921947|12222510|FG001|NOT COMPLETED|Day 28||0
11042292|NCT00922116|12222516|FG000|STARTED|Overall Study||191
11042293|NCT00922116|12222516|FG000|COMPLETED|Overall Study||176
11042294|NCT00922116|12222516|FG000|NOT COMPLETED|Overall Study||15
11042295|NCT00922194|12222520|FG000|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
11042296|NCT00922194|12222520|FG000|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
11042297|NCT00922194|12222520|FG000|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
11042298|NCT00922194|12222520|FG000|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
11042299|NCT00922194|12222520|FG000|COMPLETED|Metformin for 12 Months or More||102
11042300|NCT00922194|12222520|FG000|NOT COMPLETED|Metformin for 12 Months or More||0
11042301|NCT00922207|12222527|FG000|STARTED|Overall Study||91
11042302|NCT00922207|12222528|FG001|STARTED|Overall Study||95
11042303|NCT00922207|12222529|FG002|STARTED|Overall Study||94
11042304|NCT00922207|12222527|FG000|COMPLETED|Overall Study||85
11042305|NCT00922207|12222528|FG001|COMPLETED|Overall Study||88
11042306|NCT00922207|12222529|FG002|COMPLETED|Overall Study||90
11042307|NCT00922207|12222527|FG000|NOT COMPLETED|Overall Study||6
11042308|NCT00922207|12222528|FG001|NOT COMPLETED|Overall Study||7
11042309|NCT00922207|12222529|FG002|NOT COMPLETED|Overall Study||4
11042310|NCT00922233|12222537|FG000|STARTED|Overall Study||72
11042311|NCT00922233|12222537|FG000|COMPLETED|Overall Study||68
11042312|NCT00922233|12222537|FG000|NOT COMPLETED|Overall Study||4
11042313|NCT00922272|12222542|FG000|STARTED|Open-label Phase||92
11042314|NCT00922272|12222543|FG001|STARTED|Open-label Phase||0
11042315|NCT00922272|12222542|FG000|COMPLETED|Open-label Phase||69
11042316|NCT00922272|12222543|FG001|COMPLETED|Open-label Phase||0
11042317|NCT00922272|12222542|FG000|NOT COMPLETED|Open-label Phase||23
11042318|NCT00922272|12222543|FG001|NOT COMPLETED|Open-label Phase||0
11042319|NCT00922272|12222542|FG000|STARTED|Double-blind Phase||34
11042320|NCT00922272|12222543|FG001|STARTED|Double-blind Phase||35
11042321|NCT00922272|12222542|FG000|COMPLETED|Double-blind Phase||27
11042322|NCT00922272|12222543|FG001|COMPLETED|Double-blind Phase||29
11042323|NCT00922272|12222542|FG000|NOT COMPLETED|Double-blind Phase||7
11042324|NCT00922272|12222543|FG001|NOT COMPLETED|Double-blind Phase||6
11042325|NCT00922428|12222551|FG000|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
11042326|NCT00922428|12222551|FG000|COMPLETED|Overall Study|for 11 participants no gender was given|1374
11042327|NCT00922428|12222551|FG000|NOT COMPLETED|Overall Study||15
11042328|NCT00922441|12222564|FG000|STARTED|Overall Study||30
11042329|NCT00922441|12222565|FG001|STARTED|Overall Study||30
11042330|NCT00922441|12222566|FG002|STARTED|Overall Study||32
11042331|NCT00922441|12222564|FG000|COMPLETED|Overall Study||30
11042332|NCT00922441|12222565|FG001|COMPLETED|Overall Study||30
11042333|NCT00922441|12222566|FG002|COMPLETED|Overall Study||29
11042334|NCT00922441|12222564|FG000|NOT COMPLETED|Overall Study||0
11042335|NCT00922441|12222565|FG001|NOT COMPLETED|Overall Study||0
11042336|NCT00922441|12222566|FG002|NOT COMPLETED|Overall Study||3
11042337|NCT00922480|12222576|FG000|STARTED|Main Study||250
11042338|NCT00922480|12222577|FG001|STARTED|Main Study||255
11042339|NCT00922480|12222576|FG000|COMPLETED|Main Study||213
11042340|NCT00922480|12222577|FG001|COMPLETED|Main Study||226
11042341|NCT00922480|12222576|FG000|NOT COMPLETED|Main Study||37
11042342|NCT00922480|12222577|FG001|NOT COMPLETED|Main Study||29
11042343|NCT00922480|12222576|FG000|STARTED|Extension Study||73
11042344|NCT00922480|12222577|FG001|STARTED|Extension Study||85
11042345|NCT00922480|12222576|FG000|COMPLETED|Extension Study||68
11042346|NCT00922480|12222577|FG001|COMPLETED|Extension Study||82
11042347|NCT00922480|12222576|FG000|NOT COMPLETED|Extension Study||5
11042348|NCT00922480|12222577|FG001|NOT COMPLETED|Extension Study||3
11042349|NCT00922623|12222585|FG000|STARTED|Overall Study||93
11042350|NCT00922623|12222585|FG000|COMPLETED|Overall Study||88
11042351|NCT00922623|12222585|FG000|NOT COMPLETED|Overall Study||5
11042352|NCT00922636|12222596|FG000|STARTED|Overall Study||36
11042353|NCT00922636|12222597|FG001|STARTED|Overall Study||78
11042354|NCT00922636|12222598|FG002|STARTED|Overall Study||76
11042355|NCT00922636|12222599|FG003|STARTED|Overall Study||75
11042356|NCT00922636|12222600|FG004|STARTED|Overall Study||75
11042357|NCT00922636|12222596|FG000|Entered Optional Taper Phase|Overall Study||4
11042358|NCT00922636|12222597|FG001|Entered Optional Taper Phase|Overall Study||10
11042359|NCT00922636|12222598|FG002|Entered Optional Taper Phase|Overall Study||15
11042360|NCT00922636|12222599|FG003|Entered Optional Taper Phase|Overall Study||7
11042361|NCT00922636|12222600|FG004|Entered Optional Taper Phase|Overall Study||12
11042362|NCT00922636|12222596|FG000|COMPLETED|Overall Study||29
11042363|NCT00922636|12222597|FG001|COMPLETED|Overall Study||62
11042364|NCT00922636|12222598|FG002|COMPLETED|Overall Study||56
11042365|NCT00922636|12222599|FG003|COMPLETED|Overall Study||58
11042366|NCT00922636|12222600|FG004|COMPLETED|Overall Study||59
11042367|NCT00922636|12222596|FG000|NOT COMPLETED|Overall Study||7
11042368|NCT00922636|12222597|FG001|NOT COMPLETED|Overall Study||16
11042369|NCT00922636|12222598|FG002|NOT COMPLETED|Overall Study||20
11042370|NCT00922636|12222599|FG003|NOT COMPLETED|Overall Study||17
11042371|NCT00922636|12222600|FG004|NOT COMPLETED|Overall Study||16
11042372|NCT00922701|12222617|FG000|STARTED|Overall Study||4
11042373|NCT00922701|12222617|FG000|COMPLETED|Overall Study||4
11042374|NCT00922701|12222617|FG000|NOT COMPLETED|Overall Study||0
11042375|NCT00922766|12222621|FG000|STARTED|Overall Study||617
11042376|NCT00922766|12222621|FG000|COMPLETED|Overall Study||610
11042377|NCT00922766|12222621|FG000|NOT COMPLETED|Overall Study||7
11042378|NCT00922779|12222625|FG000|STARTED|Overall Study||6661
11042379|NCT00922779|12222625|FG000|COMPLETED|Overall Study||4334
11042380|NCT00922779|12222625|FG000|NOT COMPLETED|Overall Study||2327
11042381|NCT00922883|12222629|FG000|STARTED|Overall Study||43
11042382|NCT00922883|12222629|FG000|COMPLETED|Overall Study||43
11042383|NCT00922883|12222629|FG000|NOT COMPLETED|Overall Study||0
11042384|NCT00922935|12222636|FG000|STARTED|Overall Study||10
11042385|NCT00922935|12222637|FG001|STARTED|Overall Study||16
11042386|NCT00922935|12222638|FG002|STARTED|Overall Study||10
11042387|NCT00922935|12222636|FG000|COMPLETED|Overall Study||9
11042388|NCT00922935|12222637|FG001|COMPLETED|Overall Study||11
11042389|NCT00922935|12222638|FG002|COMPLETED|Overall Study||10
11042390|NCT00922935|12222636|FG000|NOT COMPLETED|Overall Study||1
11042391|NCT00922935|12222637|FG001|NOT COMPLETED|Overall Study||5
11042392|NCT00922935|12222638|FG002|NOT COMPLETED|Overall Study||0
11042393|NCT00922974|12222649|FG000|STARTED|Phase II Component||46
11042394|NCT00922974|12222650|FG001|STARTED|Phase II Component||0
11042395|NCT00922974|12222649|FG000|Eligible|Phase II Component||44
11042396|NCT00922974|12222650|FG001|Eligible|Phase II Component||0
11042397|NCT00922974|12222649|FG000|Eligible and Started Treatment|Phase II Component||39
11042398|NCT00922974|12222650|FG001|Eligible and Started Treatment|Phase II Component||0
11042399|NCT00922974|12222649|FG000|Eligible, Treated, Adverse Event Data|Phase II Component||34
11042400|NCT00922974|12222650|FG001|Eligible, Treated, Adverse Event Data|Phase II Component||0
11042401|NCT00922974|12222649|FG000|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39
11042402|NCT00922974|12222650|FG001|COMPLETED|Phase II Component||0
11042403|NCT00922974|12222649|FG000|NOT COMPLETED|Phase II Component||7
11042404|NCT00922974|12222650|FG001|NOT COMPLETED|Phase II Component||0
11042405|NCT00922974|12222649|FG000|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217
11042406|NCT00922974|12222650|FG001|STARTED|Phase III Component||136
11042407|NCT00922974|12222649|FG000|Eligible|Phase III Component||209
11042408|NCT00922974|12222650|FG001|Eligible|Phase III Component||130
11042409|NCT00922974|12222649|FG000|Eligible With 3 mo. NRPS Data|Phase III Component||139
11042410|NCT00922974|12222650|FG001|Eligible With 3 mo. NRPS Data|Phase III Component||76
11042411|NCT00922974|12222649|FG000|Eligible With 3 mo. FACT-G Data|Phase III Component||87
11042412|NCT00922974|12222650|FG001|Eligible With 3 mo. FACT-G Data|Phase III Component||58
11042413|NCT00922974|12222649|FG000|Eligible With Adverse Event Data|Phase III Component||202
11042414|NCT00922974|12222650|FG001|Eligible With Adverse Event Data|Phase III Component||117
11042415|NCT00922974|12222649|FG000|Eligible, Treated, Adverse Event Data|Phase III Component||148
11042416|NCT00922974|12222650|FG001|Eligible, Treated, Adverse Event Data|Phase III Component||83
11042417|NCT00922974|12222649|FG000|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||152
11042418|NCT00922974|12222650|FG001|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||100
11042419|NCT00922974|12222649|FG000|COMPLETED|Phase III Component||209
11042420|NCT00922974|12222650|FG001|COMPLETED|Phase III Component||130
11042421|NCT00922974|12222649|FG000|NOT COMPLETED|Phase III Component||8
11042422|NCT00922974|12222650|FG001|NOT COMPLETED|Phase III Component||6
11042423|NCT00922987|12222658|FG000|STARTED|Overall Study||281
11042424|NCT00922987|12222658|FG000|COMPLETED|Overall Study||277
11042425|NCT00922987|12222658|FG000|NOT COMPLETED|Overall Study||4
11042426|NCT00923078|12222665|FG000|STARTED|First Intervention (Weeks 1-4)||20
11042427|NCT00923078|12222666|FG001|STARTED|First Intervention (Weeks 1-4)||20
11042428|NCT00923078|12222667|FG002|STARTED|First Intervention (Weeks 1-4)||20
11042429|NCT00923078|12222665|FG000|COMPLETED|First Intervention (Weeks 1-4)||19
11042430|NCT00923078|12222666|FG001|COMPLETED|First Intervention (Weeks 1-4)||19
11042431|NCT00923078|12222667|FG002|COMPLETED|First Intervention (Weeks 1-4)||0
11042432|NCT00923078|12222665|FG000|NOT COMPLETED|First Intervention (Weeks 1-4)||1
11042433|NCT00923078|12222666|FG001|NOT COMPLETED|First Intervention (Weeks 1-4)||1
11042434|NCT00923078|12222667|FG002|NOT COMPLETED|First Intervention (Weeks 1-4)||20
11042435|NCT00923078|12222665|FG000|STARTED|Second Intervention (Weeks 5-8)||19
11042436|NCT00923078|12222666|FG001|STARTED|Second Intervention (Weeks 5-8)||19
11042437|NCT00923078|12222667|FG002|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
11042438|NCT00923078|12222665|FG000|COMPLETED|Second Intervention (Weeks 5-8)||19
11042439|NCT00923078|12222666|FG001|COMPLETED|Second Intervention (Weeks 5-8)||19
11042440|NCT00923078|12222667|FG002|COMPLETED|Second Intervention (Weeks 5-8)||0
11042441|NCT00923078|12222665|FG000|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
11042442|NCT00923078|12222666|FG001|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
11042443|NCT00923078|12222667|FG002|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
11042444|NCT00923091|12222682|FG000|STARTED|PeriodI-II (Randomized, Double-Blind)||335
11042445|NCT00923091|12222683|FG001|STARTED|PeriodI-II (Randomized, Double-Blind)||336
11042446|NCT00923091|12222684|FG002|STARTED|PeriodI-II (Randomized, Double-Blind)||336
11042447|NCT00923091|12222685|FG003|STARTED|PeriodI-II (Randomized, Double-Blind)||336
11042448|NCT00923091|12222686|FG004|STARTED|PeriodI-II (Randomized, Double-Blind)||336
11042449|NCT00923091|12222687|FG005|STARTED|PeriodI-II (Randomized, Double-Blind)||337
11042450|NCT00923091|12222688|FG006|STARTED|PeriodI-II (Randomized, Double-Blind)||337
11042451|NCT00923091|12222689|FG007|STARTED|PeriodI-II (Randomized, Double-Blind)||336
11042452|NCT00923091|12222690|FG008|STARTED|PeriodI-II (Randomized, Double-Blind)||0
11042453|NCT00923091|12222691|FG009|STARTED|PeriodI-II (Randomized, Double-Blind)||0
11042454|NCT00923091|12222692|FG010|STARTED|PeriodI-II (Randomized, Double-Blind)||0
11042455|NCT00923091|12222693|FG011|STARTED|PeriodI-II (Randomized, Double-Blind)||0
11042456|NCT00923091|12222694|FG012|STARTED|PeriodI-II (Randomized, Double-Blind)||0
11042457|NCT00923091|12222682|FG000|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
11042458|NCT00923091|12222683|FG001|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
11042459|NCT00923091|12222684|FG002|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
11042460|NCT00923091|12222685|FG003|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
11042461|NCT00923091|12222686|FG004|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
11042462|NCT00923091|12222687|FG005|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
11042463|NCT00923091|12222688|FG006|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
11042464|NCT00923091|12222689|FG007|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
11042465|NCT00923091|12222690|FG008|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
11042466|NCT00923091|12222691|FG009|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
11042467|NCT00923091|12222692|FG010|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
11042468|NCT00923091|12222693|FG011|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
11042469|NCT00923091|12222694|FG012|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
11042470|NCT00923091|12222682|FG000|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
11042471|NCT00923091|12222683|FG001|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
11042472|NCT00923091|12222684|FG002|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
11042473|NCT00923091|12222685|FG003|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
11042474|NCT00923091|12222686|FG004|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
11042475|NCT00923091|12222687|FG005|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
11042476|NCT00923091|12222688|FG006|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
11042477|NCT00923091|12222689|FG007|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
11042478|NCT00923091|12222690|FG008|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
11042479|NCT00923091|12222691|FG009|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
11042480|NCT00923091|12222692|FG010|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
11042481|NCT00923091|12222693|FG011|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
11042482|NCT00923091|12222694|FG012|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
11042483|NCT00923091|12222682|FG000|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
11042484|NCT00923091|12222683|FG001|STARTED|Period III (Single-Blind)||0
11042485|NCT00923091|12222684|FG002|STARTED|Period III (Single-Blind)||0
11042486|NCT00923091|12222685|FG003|STARTED|Period III (Single-Blind)||0
11042487|NCT00923091|12222686|FG004|STARTED|Period III (Single-Blind)||0
11042488|NCT00923091|12222687|FG005|STARTED|Period III (Single-Blind)||0
11042489|NCT00923091|12222688|FG006|STARTED|Period III (Single-Blind)||0
11042490|NCT00923091|12222689|FG007|STARTED|Period III (Single-Blind)||0
11042491|NCT00923091|12222690|FG008|STARTED|Period III (Single-Blind)||0
11042492|NCT00923091|12222691|FG009|STARTED|Period III (Single-Blind)||0
11042493|NCT00923091|12222692|FG010|STARTED|Period III (Single-Blind)||0
11042494|NCT00923091|12222693|FG011|STARTED|Period III (Single-Blind)||0
11042495|NCT00923091|12222694|FG012|STARTED|Period III (Single-Blind)||0
11042496|NCT00923091|12222682|FG000|COMPLETED|Period III (Single-Blind)||2520
11042497|NCT00923091|12222683|FG001|COMPLETED|Period III (Single-Blind)||0
11042498|NCT00923091|12222684|FG002|COMPLETED|Period III (Single-Blind)||0
11042499|NCT00923091|12222685|FG003|COMPLETED|Period III (Single-Blind)||0
11042500|NCT00923091|12222686|FG004|COMPLETED|Period III (Single-Blind)||0
11042501|NCT00923091|12222687|FG005|COMPLETED|Period III (Single-Blind)||0
11042502|NCT00923091|12222688|FG006|COMPLETED|Period III (Single-Blind)||0
11042503|NCT00923091|12222689|FG007|COMPLETED|Period III (Single-Blind)||0
11042504|NCT00923091|12222690|FG008|COMPLETED|Period III (Single-Blind)||0
11042505|NCT00923091|12222691|FG009|COMPLETED|Period III (Single-Blind)||0
11042506|NCT00923091|12222692|FG010|COMPLETED|Period III (Single-Blind)||0
11042507|NCT00923091|12222693|FG011|COMPLETED|Period III (Single-Blind)||0
11042508|NCT00923091|12222694|FG012|COMPLETED|Period III (Single-Blind)||0
11042509|NCT00923091|12222682|FG000|NOT COMPLETED|Period III (Single-Blind)||20
11042510|NCT00923091|12222683|FG001|NOT COMPLETED|Period III (Single-Blind)||0
11042511|NCT00923091|12222684|FG002|NOT COMPLETED|Period III (Single-Blind)||0
11042512|NCT00923091|12222685|FG003|NOT COMPLETED|Period III (Single-Blind)||0
11042513|NCT00923091|12222686|FG004|NOT COMPLETED|Period III (Single-Blind)||0
11042514|NCT00923091|12222687|FG005|NOT COMPLETED|Period III (Single-Blind)||0
11042515|NCT00923091|12222688|FG006|NOT COMPLETED|Period III (Single-Blind)||0
11042516|NCT00923091|12222689|FG007|NOT COMPLETED|Period III (Single-Blind)||0
11042517|NCT00923091|12222690|FG008|NOT COMPLETED|Period III (Single-Blind)||0
11042518|NCT00923091|12222691|FG009|NOT COMPLETED|Period III (Single-Blind)||0
11042519|NCT00923091|12222692|FG010|NOT COMPLETED|Period III (Single-Blind)||0
11042520|NCT00923091|12222693|FG011|NOT COMPLETED|Period III (Single-Blind)||0
11042521|NCT00923091|12222694|FG012|NOT COMPLETED|Period III (Single-Blind)||0
11042522|NCT00923091|12222682|FG000|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
11042523|NCT00923091|12222683|FG001|STARTED|Period IV (Double-Blind)||453
11042524|NCT00923091|12222684|FG002|STARTED|Period IV (Double-Blind)||0
11042525|NCT00923091|12222685|FG003|STARTED|Period IV (Double-Blind)||0
11042526|NCT00923091|12222686|FG004|STARTED|Period IV (Double-Blind)||0
11042527|NCT00923091|12222687|FG005|STARTED|Period IV (Double-Blind)||0
11042528|NCT00923091|12222688|FG006|STARTED|Period IV (Double-Blind)||0
11042529|NCT00923091|12222689|FG007|STARTED|Period IV (Double-Blind)||0
11042530|NCT00923091|12222690|FG008|STARTED|Period IV (Double-Blind)||0
11042531|NCT00923091|12222691|FG009|STARTED|Period IV (Double-Blind)||0
11042532|NCT00923091|12222692|FG010|STARTED|Period IV (Double-Blind)||0
11042533|NCT00923091|12222693|FG011|STARTED|Period IV (Double-Blind)||0
11042534|NCT00923091|12222694|FG012|STARTED|Period IV (Double-Blind)||0
11042535|NCT00923091|12222682|FG000|COMPLETED|Period IV (Double-Blind)||226
11042536|NCT00923091|12222683|FG001|COMPLETED|Period IV (Double-Blind)||451
11042537|NCT00923091|12222684|FG002|COMPLETED|Period IV (Double-Blind)||0
11042538|NCT00923091|12222685|FG003|COMPLETED|Period IV (Double-Blind)||0
11042539|NCT00923091|12222686|FG004|COMPLETED|Period IV (Double-Blind)||0
11042540|NCT00923091|12222687|FG005|COMPLETED|Period IV (Double-Blind)||0
11042541|NCT00923091|12222688|FG006|COMPLETED|Period IV (Double-Blind)||0
11042542|NCT00923091|12222689|FG007|COMPLETED|Period IV (Double-Blind)||0
11042543|NCT00923091|12222690|FG008|COMPLETED|Period IV (Double-Blind)||0
11042544|NCT00923091|12222691|FG009|COMPLETED|Period IV (Double-Blind)||0
11042545|NCT00923091|12222692|FG010|COMPLETED|Period IV (Double-Blind)||0
11042546|NCT00923091|12222693|FG011|COMPLETED|Period IV (Double-Blind)||0
11042547|NCT00923091|12222694|FG012|COMPLETED|Period IV (Double-Blind)||0
11042548|NCT00923091|12222682|FG000|NOT COMPLETED|Period IV (Double-Blind)||2
11042549|NCT00923091|12222683|FG001|NOT COMPLETED|Period IV (Double-Blind)||2
11042550|NCT00923091|12222684|FG002|NOT COMPLETED|Period IV (Double-Blind)||0
11042551|NCT00923091|12222685|FG003|NOT COMPLETED|Period IV (Double-Blind)||0
11042552|NCT00923091|12222686|FG004|NOT COMPLETED|Period IV (Double-Blind)||0
11042553|NCT00923091|12222687|FG005|NOT COMPLETED|Period IV (Double-Blind)||0
11042554|NCT00923091|12222688|FG006|NOT COMPLETED|Period IV (Double-Blind)||0
11042555|NCT00923091|12222689|FG007|NOT COMPLETED|Period IV (Double-Blind)||0
11042556|NCT00923091|12222690|FG008|NOT COMPLETED|Period IV (Double-Blind)||0
11042557|NCT00923091|12222691|FG009|NOT COMPLETED|Period IV (Double-Blind)||0
11042558|NCT00923091|12222692|FG010|NOT COMPLETED|Period IV (Double-Blind)||0
11042559|NCT00923091|12222693|FG011|NOT COMPLETED|Period IV (Double-Blind)||0
11042560|NCT00923091|12222694|FG012|NOT COMPLETED|Period IV (Double-Blind)||0
11042561|NCT00923091|12222682|FG000|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
11042562|NCT00923091|12222683|FG001|STARTED|Period V (Double -Blind)||0
11042563|NCT00923091|12222684|FG002|STARTED|Period V (Double -Blind)||0
11042564|NCT00923091|12222685|FG003|STARTED|Period V (Double -Blind)||0
11042565|NCT00923091|12222686|FG004|STARTED|Period V (Double -Blind)||0
11042566|NCT00923091|12222687|FG005|STARTED|Period V (Double -Blind)||0
11336349|NCT02875613|12534015|FG000|NOT COMPLETED|Overall Study||1
11336350|NCT02875834|12534023|FG000|STARTED|Open-label Phase||267
11042567|NCT00923091|12222688|FG006|STARTED|Period V (Double -Blind)||0
11042568|NCT00923091|12222689|FG007|STARTED|Period V (Double -Blind)||0
11042569|NCT00923091|12222690|FG008|STARTED|Period V (Double -Blind)||135
11042570|NCT00923091|12222691|FG009|STARTED|Period V (Double -Blind)||119
11042571|NCT00923091|12222692|FG010|STARTED|Period V (Double -Blind)||194
11042572|NCT00923091|12222693|FG011|STARTED|Period V (Double -Blind)||151
11042573|NCT00923091|12222694|FG012|STARTED|Period V (Double -Blind)||75
11042574|NCT00923091|12222682|FG000|COMPLETED|Period V (Double -Blind)||0
11042575|NCT00923091|12222683|FG001|COMPLETED|Period V (Double -Blind)||0
11042576|NCT00923091|12222684|FG002|COMPLETED|Period V (Double -Blind)||0
11042577|NCT00923091|12222685|FG003|COMPLETED|Period V (Double -Blind)||0
11042578|NCT00923091|12222686|FG004|COMPLETED|Period V (Double -Blind)||0
11042579|NCT00923091|12222687|FG005|COMPLETED|Period V (Double -Blind)||0
11042580|NCT00923091|12222688|FG006|COMPLETED|Period V (Double -Blind)||0
11042581|NCT00923091|12222689|FG007|COMPLETED|Period V (Double -Blind)||0
11042582|NCT00923091|12222690|FG008|COMPLETED|Period V (Double -Blind)||134
11042583|NCT00923091|12222691|FG009|COMPLETED|Period V (Double -Blind)||119
11042584|NCT00923091|12222692|FG010|COMPLETED|Period V (Double -Blind)||193
11042585|NCT00923091|12222693|FG011|COMPLETED|Period V (Double -Blind)||151
11042586|NCT00923091|12222694|FG012|COMPLETED|Period V (Double -Blind)||73
11042587|NCT00923091|12222682|FG000|NOT COMPLETED|Period V (Double -Blind)||0
11042588|NCT00923091|12222683|FG001|NOT COMPLETED|Period V (Double -Blind)||0
11042589|NCT00923091|12222684|FG002|NOT COMPLETED|Period V (Double -Blind)||0
11042590|NCT00923091|12222685|FG003|NOT COMPLETED|Period V (Double -Blind)||0
11042591|NCT00923091|12222686|FG004|NOT COMPLETED|Period V (Double -Blind)||0
11042592|NCT00923091|12222687|FG005|NOT COMPLETED|Period V (Double -Blind)||0
11042593|NCT00923091|12222688|FG006|NOT COMPLETED|Period V (Double -Blind)||0
11042594|NCT00923091|12222689|FG007|NOT COMPLETED|Period V (Double -Blind)||0
11042595|NCT00923091|12222690|FG008|NOT COMPLETED|Period V (Double -Blind)||1
11042596|NCT00923091|12222691|FG009|NOT COMPLETED|Period V (Double -Blind)||0
11042597|NCT00923091|12222692|FG010|NOT COMPLETED|Period V (Double -Blind)||1
11042598|NCT00923091|12222693|FG011|NOT COMPLETED|Period V (Double -Blind)||0
11042599|NCT00923091|12222694|FG012|NOT COMPLETED|Period V (Double -Blind)||2
11042600|NCT00923091|12222682|FG000|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
11042601|NCT00923091|12222683|FG001|STARTED|Period VI (Open-Label)||272
11042602|NCT00923091|12222684|FG002|STARTED|Period VI (Open-Label)||480
11042603|NCT00923091|12222685|FG003|STARTED|Period VI (Open-Label)||146
11042604|NCT00923091|12222686|FG004|STARTED|Period VI (Open-Label)||164
11042605|NCT00923091|12222687|FG005|STARTED|Period VI (Open-Label)||0
11042606|NCT00923091|12222688|FG006|STARTED|Period VI (Open-Label)||0
11042607|NCT00923091|12222689|FG007|STARTED|Period VI (Open-Label)||0
11042608|NCT00923091|12222690|FG008|STARTED|Period VI (Open-Label)||0
11042609|NCT00923091|12222691|FG009|STARTED|Period VI (Open-Label)||0
11042610|NCT00923091|12222692|FG010|STARTED|Period VI (Open-Label)||0
11042611|NCT00923091|12222693|FG011|STARTED|Period VI (Open-Label)||0
11042612|NCT00923091|12222694|FG012|STARTED|Period VI (Open-Label)||0
11042613|NCT00923091|12222682|FG000|COMPLETED|Period VI (Open-Label)||1408
11042614|NCT00923091|12222683|FG001|COMPLETED|Period VI (Open-Label)||264
11042615|NCT00923091|12222684|FG002|COMPLETED|Period VI (Open-Label)||467
11042616|NCT00923091|12222685|FG003|COMPLETED|Period VI (Open-Label)||143
11042617|NCT00923091|12222686|FG004|COMPLETED|Period VI (Open-Label)||157
11042618|NCT00923091|12222687|FG005|COMPLETED|Period VI (Open-Label)||0
11042619|NCT00923091|12222688|FG006|COMPLETED|Period VI (Open-Label)||0
11042620|NCT00923091|12222689|FG007|COMPLETED|Period VI (Open-Label)||0
11042621|NCT00923091|12222690|FG008|COMPLETED|Period VI (Open-Label)||0
11042622|NCT00923091|12222691|FG009|COMPLETED|Period VI (Open-Label)||0
11042623|NCT00923091|12222692|FG010|COMPLETED|Period VI (Open-Label)||0
11042624|NCT00923091|12222693|FG011|COMPLETED|Period VI (Open-Label)||0
11042625|NCT00923091|12222694|FG012|COMPLETED|Period VI (Open-Label)||0
11042626|NCT00923091|12222682|FG000|NOT COMPLETED|Period VI (Open-Label)||39
11042627|NCT00923091|12222683|FG001|NOT COMPLETED|Period VI (Open-Label)||8
11042628|NCT00923091|12222684|FG002|NOT COMPLETED|Period VI (Open-Label)||13
11042629|NCT00923091|12222685|FG003|NOT COMPLETED|Period VI (Open-Label)||3
11042630|NCT00923091|12222686|FG004|NOT COMPLETED|Period VI (Open-Label)||7
11042631|NCT00923091|12222687|FG005|NOT COMPLETED|Period VI (Open-Label)||0
11042632|NCT00923091|12222688|FG006|NOT COMPLETED|Period VI (Open-Label)||0
11042633|NCT00923091|12222689|FG007|NOT COMPLETED|Period VI (Open-Label)||0
11042634|NCT00923091|12222690|FG008|NOT COMPLETED|Period VI (Open-Label)||0
11042635|NCT00923091|12222691|FG009|NOT COMPLETED|Period VI (Open-Label)||0
11042636|NCT00923091|12222692|FG010|NOT COMPLETED|Period VI (Open-Label)||0
11042637|NCT00923091|12222693|FG011|NOT COMPLETED|Period VI (Open-Label)||0
11042638|NCT00923091|12222694|FG012|NOT COMPLETED|Period VI (Open-Label)||0
11042639|NCT00923117|12222721|FG000|STARTED|Overall Study||44
11042640|NCT00923117|12222722|FG001|STARTED|Overall Study||43
11042641|NCT00923117|12222721|FG000|COMPLETED|Overall Study||44
11042642|NCT00923117|12222722|FG001|COMPLETED|Overall Study||43
11042643|NCT00923117|12222721|FG000|NOT COMPLETED|Overall Study||0
11042644|NCT00923117|12222722|FG001|NOT COMPLETED|Overall Study||0
11042645|NCT00923130|12222728|FG000|STARTED|Overall Study||30
11042646|NCT00923130|12222728|FG000|COMPLETED|Overall Study||5
11042647|NCT00923130|12222728|FG000|NOT COMPLETED|Overall Study||25
11042648|NCT00923156|12222735|FG000|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
11042649|NCT00923156|12222736|FG001|STARTED|Overall Study||42
11042650|NCT00923156|12222737|FG002|STARTED|Overall Study||41
11042651|NCT00923156|12222735|FG000|COMPLETED|Overall Study||40
11042652|NCT00923156|12222736|FG001|COMPLETED|Overall Study||38
11042653|NCT00923156|12222737|FG002|COMPLETED|Overall Study||38
11042654|NCT00923156|12222735|FG000|NOT COMPLETED|Overall Study||0
11042655|NCT00923156|12222736|FG001|NOT COMPLETED|Overall Study||4
11042656|NCT00923156|12222737|FG002|NOT COMPLETED|Overall Study||3
11042657|NCT00923195|12222747|FG000|STARTED|Overall Study||2
11042658|NCT00923195|12222748|FG001|STARTED|Overall Study||2
11042659|NCT00923195|12222747|FG000|COMPLETED|Overall Study||2
11042660|NCT00923195|12222748|FG001|COMPLETED|Overall Study||1
11042661|NCT00923195|12222747|FG000|NOT COMPLETED|Overall Study||0
11042662|NCT00923195|12222748|FG001|NOT COMPLETED|Overall Study||1
11042663|NCT00923260|12222756|FG000|STARTED|Overall Study||12
11042664|NCT00923260|12222757|FG001|STARTED|Overall Study||12
11042665|NCT00923260|12222756|FG000|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
11042666|NCT00923260|12222757|FG001|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
11042667|NCT00923260|12222756|FG000|NOT COMPLETED|Overall Study||1
11042668|NCT00923260|12222757|FG001|NOT COMPLETED|Overall Study||1
11042669|NCT00923273|12222768|FG000|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
11042670|NCT00923273|12222769|FG001|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
11042671|NCT00923273|12222770|FG002|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
11042672|NCT00923273|12222771|FG003|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
11042673|NCT00923273|12222772|FG004|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
11042674|NCT00923273|12222768|FG000|COMPLETED|Phase I Treatment Period||4
11042675|NCT00923273|12222769|FG001|COMPLETED|Phase I Treatment Period||3
11042676|NCT00923273|12222770|FG002|COMPLETED|Phase I Treatment Period||3
11042677|NCT00923273|12222771|FG003|COMPLETED|Phase I Treatment Period||7
11042678|NCT00923273|12222772|FG004|COMPLETED|Phase I Treatment Period||5
11042679|NCT00923273|12222768|FG000|NOT COMPLETED|Phase I Treatment Period||0
11042680|NCT00923273|12222769|FG001|NOT COMPLETED|Phase I Treatment Period||0
11042681|NCT00923273|12222770|FG002|NOT COMPLETED|Phase I Treatment Period||0
11042682|NCT00923273|12222771|FG003|NOT COMPLETED|Phase I Treatment Period||0
11042683|NCT00923273|12222772|FG004|NOT COMPLETED|Phase I Treatment Period||0
11042684|NCT00923273|12222768|FG000|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
11042685|NCT00923273|12222769|FG001|STARTED|Phase II Treatment Period||0
11042686|NCT00923273|12222770|FG002|STARTED|Phase II Treatment Period||0
11042687|NCT00923273|12222771|FG003|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
11042688|NCT00923273|12222772|FG004|STARTED|Phase II Treatment Period||0
11042689|NCT00923273|12222768|FG000|COMPLETED|Phase II Treatment Period||0
11042690|NCT00923273|12222769|FG001|COMPLETED|Phase II Treatment Period||0
11042691|NCT00923273|12222770|FG002|COMPLETED|Phase II Treatment Period||0
11042692|NCT00923273|12222771|FG003|COMPLETED|Phase II Treatment Period||20
11042693|NCT00923273|12222772|FG004|COMPLETED|Phase II Treatment Period||0
11042694|NCT00923273|12222768|FG000|NOT COMPLETED|Phase II Treatment Period||0
11042695|NCT00923273|12222769|FG001|NOT COMPLETED|Phase II Treatment Period||0
11042696|NCT00923273|12222770|FG002|NOT COMPLETED|Phase II Treatment Period||0
11042697|NCT00923273|12222771|FG003|NOT COMPLETED|Phase II Treatment Period||7
11042698|NCT00923273|12222772|FG004|NOT COMPLETED|Phase II Treatment Period||0
11042699|NCT00923351|12222792|FG000|STARTED|Overall Study||6
11042700|NCT00923351|12222793|FG001|STARTED|Overall Study||26
11042701|NCT00923351|12222794|FG002|STARTED|Overall Study||12
11042702|NCT00923351|12222792|FG000|COMPLETED|Overall Study||6
11042703|NCT00923351|12222793|FG001|COMPLETED|Overall Study||26
11042704|NCT00923351|12222794|FG002|COMPLETED|Overall Study||0
11042705|NCT00923351|12222792|FG000|NOT COMPLETED|Overall Study||0
11042706|NCT00923351|12222793|FG001|NOT COMPLETED|Overall Study||0
11042707|NCT00923351|12222794|FG002|NOT COMPLETED|Overall Study||12
11042708|NCT00923364|12222800|FG000|STARTED|Overall Study||14
11042709|NCT00923364|12222801|FG001|STARTED|Overall Study||5
11042710|NCT00923364|12222800|FG000|COMPLETED|Overall Study||10
11042711|NCT00923364|12222801|FG001|COMPLETED|Overall Study||5
11042712|NCT00923364|12222800|FG000|NOT COMPLETED|Overall Study||4
11042713|NCT00923364|12222801|FG001|NOT COMPLETED|Overall Study||0
11042714|NCT00923481|12222806|FG000|STARTED|Overall Study||37
11042715|NCT00923481|12222806|FG000|COMPLETED|Overall Study||37
11042716|NCT00923481|12222806|FG000|NOT COMPLETED|Overall Study||0
11042717|NCT00923559|12222812|FG000|STARTED|Overall Study||40
11042718|NCT00923559|12222813|FG001|STARTED|Overall Study||40
11042719|NCT00923559|12222812|FG000|COMPLETED|Overall Study||38
11042720|NCT00923559|12222813|FG001|COMPLETED|Overall Study||37
11042721|NCT00923559|12222812|FG000|NOT COMPLETED|Overall Study||2
11042722|NCT00923559|12222813|FG001|NOT COMPLETED|Overall Study||3
11042723|NCT00923598|12222823|FG000|STARTED|Overall Study||23
11042724|NCT00923598|12222824|FG001|STARTED|Overall Study||22
11042725|NCT00923598|12222823|FG000|COMPLETED|Overall Study||19
11042726|NCT00923598|12222824|FG001|COMPLETED|Overall Study||17
11042727|NCT00923598|12222823|FG000|NOT COMPLETED|Overall Study||4
11042728|NCT00923598|12222824|FG001|NOT COMPLETED|Overall Study||5
11042729|NCT00923845|12222832|FG000|STARTED|Donor Lymphocyte Harvest||13
11042730|NCT00923845|12222833|FG001|STARTED|Donor Lymphocyte Harvest||0
11042731|NCT00923845|12222832|FG000|COMPLETED|Donor Lymphocyte Harvest||13
11042732|NCT00923845|12222833|FG001|COMPLETED|Donor Lymphocyte Harvest||0
11042733|NCT00923845|12222832|FG000|NOT COMPLETED|Donor Lymphocyte Harvest||0
11042734|NCT00923845|12222833|FG001|NOT COMPLETED|Donor Lymphocyte Harvest||0
11042735|NCT00923845|12222832|FG000|STARTED|Donor Hematopoietic Stem Cell Harvest||13
11042736|NCT00923845|12222833|FG001|STARTED|Donor Hematopoietic Stem Cell Harvest||0
11042737|NCT00923845|12222832|FG000|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
11042738|NCT00923845|12222833|FG001|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
11042739|NCT00923845|12222832|FG000|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
11042740|NCT00923845|12222833|FG001|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
11042741|NCT00923845|12222832|FG000|STARTED|Induction Therapy||0
11042742|NCT00923845|12222833|FG001|STARTED|Induction Therapy||12
11042743|NCT00923845|12222832|FG000|COMPLETED|Induction Therapy||0
11042744|NCT00923845|12222833|FG001|COMPLETED|Induction Therapy||10
11042745|NCT00923845|12222832|FG000|NOT COMPLETED|Induction Therapy||0
11042746|NCT00923845|12222833|FG001|NOT COMPLETED|Induction Therapy||2
11042747|NCT00923845|12222832|FG000|STARTED|Allogeneic Stem Cell Therapy||0
11042748|NCT00923845|12222833|FG001|STARTED|Allogeneic Stem Cell Therapy||10
11042749|NCT00923845|12222832|FG000|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
11042750|NCT00923845|12222833|FG001|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
11042751|NCT00923845|12222832|FG000|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
11042752|NCT00923845|12222833|FG001|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
11042753|NCT00923845|12222832|FG000|COMPLETED|Allogeneic Stem Cell Therapy||0
11042754|NCT00923845|12222833|FG001|COMPLETED|Allogeneic Stem Cell Therapy||10
11042755|NCT00923845|12222832|FG000|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
11042756|NCT00923845|12222833|FG001|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
11042757|NCT00923910|12222842|FG000|STARTED|Period 1||5
11042758|NCT00923910|12222843|FG001|STARTED|Period 1||5
11042759|NCT00923910|12222842|FG000|COMPLETED|Period 1||5
11042760|NCT00923910|12222843|FG001|COMPLETED|Period 1||5
11042761|NCT00923910|12222842|FG000|NOT COMPLETED|Period 1||0
11042762|NCT00923910|12222843|FG001|NOT COMPLETED|Period 1||0
11042763|NCT00923910|12222842|FG000|STARTED|Period 2||5
11042764|NCT00923910|12222843|FG001|STARTED|Period 2||5
11042765|NCT00923910|12222842|FG000|COMPLETED|Period 2||5
11042766|NCT00923910|12222843|FG001|COMPLETED|Period 2||5
11042767|NCT00923910|12222842|FG000|NOT COMPLETED|Period 2||0
11042768|NCT00923910|12222843|FG001|NOT COMPLETED|Period 2||0
11042769|NCT00923936|12222850|FG000|STARTED|Overall Study||10
11042770|NCT00923936|12222851|FG001|STARTED|Overall Study||6
11042771|NCT00923936|12222850|FG000|COMPLETED|Overall Study||2
11042772|NCT00923936|12222851|FG001|COMPLETED|Overall Study||3
11042773|NCT00923936|12222850|FG000|NOT COMPLETED|Overall Study||8
11042774|NCT00923936|12222851|FG001|NOT COMPLETED|Overall Study||3
11042775|NCT00923949|12222859|FG000|STARTED|Overall Study||1
11042776|NCT00923949|12222859|FG000|COMPLETED|Overall Study||1
11042777|NCT00923949|12222859|FG000|NOT COMPLETED|Overall Study||0
11042778|NCT00923975|12222863|FG000|STARTED|Overall Study||51
11042779|NCT00923975|12222863|FG000|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
11042780|NCT00923975|12222863|FG000|NOT COMPLETED|Overall Study||1
11042781|NCT00924001|12222867|FG000|STARTED|Overall Study||1
11042782|NCT00924001|12222867|FG000|COMPLETED|Overall Study||1
11042783|NCT00924001|12222867|FG000|NOT COMPLETED|Overall Study||0
11057908|NCT01000805|12239661|FG000|COMPLETED|Overall Study||192
11057909|NCT01000805|12239662|FG001|COMPLETED|Overall Study||204
11057910|NCT01000805|12239661|FG000|NOT COMPLETED|Overall Study||70
11057911|NCT01000805|12239662|FG001|NOT COMPLETED|Overall Study||62
11057912|NCT01000818|12239669|FG000|STARTED|Raltegravir||18
11057913|NCT01000818|12239669|FG000|COMPLETED|Raltegravir||18
11057914|NCT01000818|12239669|FG000|NOT COMPLETED|Raltegravir||0
11057915|NCT01000818|12239669|FG000|STARTED|Famotidine + Raltegravir||18
11057916|NCT01000818|12239669|FG000|COMPLETED|Famotidine + Raltegravir||18
11057917|NCT01000818|12239669|FG000|NOT COMPLETED|Famotidine + Raltegravir||0
11057918|NCT01000818|12239669|FG000|STARTED|Omeprazole + Raltegravir||18
11336351|NCT02875834|12534024|FG001|STARTED|Open-label Phase||0
11336352|NCT02875834|12534025|FG002|STARTED|Open-label Phase||0
11336353|NCT02875834|12534026|FG003|STARTED|Open-label Phase||0
11336354|NCT02875834|12534023|FG000|COMPLETED|Open-label Phase||260
11336355|NCT02875834|12534024|FG001|COMPLETED|Open-label Phase||0
11336356|NCT02875834|12534025|FG002|COMPLETED|Open-label Phase||0
11336357|NCT02875834|12534026|FG003|COMPLETED|Open-label Phase||0
11336358|NCT02875834|12534023|FG000|NOT COMPLETED|Open-label Phase||7
11336359|NCT02875834|12534024|FG001|NOT COMPLETED|Open-label Phase||0
11336360|NCT02875834|12534025|FG002|NOT COMPLETED|Open-label Phase||0
11336361|NCT02875834|12534026|FG003|NOT COMPLETED|Open-label Phase||0
11336362|NCT02875834|12534023|FG000|STARTED|Randomized Treatment Phase|No subjects were randomized in 10g TID group in RTP.|0
11336363|NCT02875834|12534024|FG001|STARTED|Randomized Treatment Phase|99 subjects were randomized in 5g QD group in RTP.|99
11336364|NCT02875834|12534025|FG002|STARTED|Randomized Treatment Phase|99 subjects were randomized in 10g QD group in RTP.|99
11336365|NCT02875834|12534026|FG003|STARTED|Randomized Treatment Phase|50 subjects were randomized in placebo group in RTP.|50
11336366|NCT02875834|12534023|FG000|COMPLETED|Randomized Treatment Phase||0
11336367|NCT02875834|12534024|FG001|COMPLETED|Randomized Treatment Phase||85
11042784|NCT00924040|12222871|FG000|STARTED|Overall Study||1
11042785|NCT00924040|12222871|FG000|COMPLETED|Overall Study||1
11042786|NCT00924040|12222871|FG000|NOT COMPLETED|Overall Study||0
11042787|NCT00924053|12222879|FG000|STARTED|Overall Study||6
11042788|NCT00924053|12222880|FG001|STARTED|Overall Study||6
11336368|NCT02875834|12534025|FG002|COMPLETED|Randomized Treatment Phase||88
11336369|NCT02875834|12534026|FG003|COMPLETED|Randomized Treatment Phase||41
11042789|NCT00924053|12222881|FG002|STARTED|Overall Study||6
11042790|NCT00924053|12222882|FG003|STARTED|Overall Study||6
11042791|NCT00924053|12222879|FG000|COMPLETED|Overall Study||6
11042792|NCT00924053|12222880|FG001|COMPLETED|Overall Study||6
11042793|NCT00924053|12222881|FG002|COMPLETED|Overall Study||6
11042794|NCT00924053|12222882|FG003|COMPLETED|Overall Study||6
11042795|NCT00924053|12222879|FG000|NOT COMPLETED|Overall Study||0
11042796|NCT00924053|12222880|FG001|NOT COMPLETED|Overall Study||0
11042797|NCT00924053|12222881|FG002|NOT COMPLETED|Overall Study||0
11042798|NCT00924053|12222882|FG003|NOT COMPLETED|Overall Study||0
11042799|NCT00924066|12222892|FG000|STARTED|Overall Study||41
11042800|NCT00924066|12222892|FG000|COMPLETED|Overall Study||41
11042801|NCT00924066|12222892|FG000|NOT COMPLETED|Overall Study||0
11042802|NCT00924118|12222899|FG000|STARTED|Overall Study||15
11042803|NCT00924118|12222900|FG001|STARTED|Overall Study||15
11042804|NCT00924118|12222899|FG000|COMPLETED|Overall Study||15
11042805|NCT00924118|12222900|FG001|COMPLETED|Overall Study||15
11042806|NCT00924118|12222899|FG000|NOT COMPLETED|Overall Study||0
11042807|NCT00924118|12222900|FG001|NOT COMPLETED|Overall Study||0
11042808|NCT00924209|12222906|FG000|STARTED|Overall Study||7
11042809|NCT00924209|12222906|FG000|COMPLETED|Overall Study||7
11042810|NCT00924209|12222906|FG000|NOT COMPLETED|Overall Study||0
11042811|NCT00924287|12222910|FG000|STARTED|Overall Study||1
11042812|NCT00924287|12222910|FG000|COMPLETED|Overall Study||0
11042813|NCT00924287|12222910|FG000|NOT COMPLETED|Overall Study||1
11042814|NCT00924313|12222914|FG000|STARTED|Overall Study||40
11042815|NCT00924313|12222914|FG000|COMPLETED|Overall Study||39
11042816|NCT00924313|12222914|FG000|NOT COMPLETED|Overall Study||1
11042817|NCT00924352|12222918|FG000|STARTED|Overall Study||12
11042818|NCT00924352|12222919|FG001|STARTED|Overall Study||44
11042819|NCT00924352|12222918|FG000|COMPLETED|Overall Study||12
11042820|NCT00924352|12222919|FG001|COMPLETED|Overall Study||44
11042821|NCT00924352|12222918|FG000|NOT COMPLETED|Overall Study||0
11042822|NCT00924352|12222919|FG001|NOT COMPLETED|Overall Study||0
11042823|NCT00924404|12222928|FG000|STARTED|Overall Study||27
11042824|NCT00924404|12222929|FG001|STARTED|Overall Study||26
11042825|NCT00924404|12222928|FG000|COMPLETED|Overall Study||21
11042826|NCT00924404|12222929|FG001|COMPLETED|Overall Study||22
11042827|NCT00924404|12222928|FG000|NOT COMPLETED|Overall Study||6
11042828|NCT00924404|12222929|FG001|NOT COMPLETED|Overall Study||4
11042829|NCT00924443|12222935|FG000|STARTED|Overall Study||69
11042830|NCT00924443|12222935|FG000|Full Analysis Set (Received Study Drug)|Overall Study||66
11042831|NCT00924443|12222935|FG000|COMPLETED|Overall Study||66
11042832|NCT00924443|12222935|FG000|NOT COMPLETED|Overall Study||3
11042833|NCT00924469|12222941|FG000|STARTED|Overall Study||30
11042834|NCT00924469|12222942|FG001|STARTED|Overall Study||28
11042835|NCT00924469|12222941|FG000|COMPLETED|Overall Study||28
11042836|NCT00924469|12222942|FG001|COMPLETED|Overall Study||26
11042837|NCT00924469|12222941|FG000|NOT COMPLETED|Overall Study||2
11042838|NCT00924469|12222942|FG001|NOT COMPLETED|Overall Study||2
11042839|NCT00924482|12222948|FG000|STARTED|Overall Study||261
11042840|NCT00924482|12222948|FG000|COMPLETED|Overall Study||261
11042841|NCT00924482|12222948|FG000|NOT COMPLETED|Overall Study||0
11042842|NCT00924508|12222953|FG000|STARTED|Overall Study||23
11042843|NCT00924508|12222953|FG000|COMPLETED|Overall Study||20
11042844|NCT00924508|12222953|FG000|NOT COMPLETED|Overall Study||3
11042845|NCT00924560|12222963|FG000|STARTED|Overall Study||458
11042846|NCT00924560|12222964|FG001|STARTED|Overall Study||448
11042847|NCT00924560|12222965|FG002|STARTED|Overall Study||455
11042848|NCT00924560|12222963|FG000|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
11336370|NCT02875834|12534023|FG000|NOT COMPLETED|Randomized Treatment Phase||0
11336371|NCT02875834|12534024|FG001|NOT COMPLETED|Randomized Treatment Phase||14
11336372|NCT02875834|12534025|FG002|NOT COMPLETED|Randomized Treatment Phase||11
11336373|NCT02875834|12534026|FG003|NOT COMPLETED|Randomized Treatment Phase||9
11042849|NCT00924560|12222964|FG001|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
11042850|NCT00924560|12222965|FG002|Received Treatment|Overall Study||0
11042851|NCT00924560|12222963|FG000|COMPLETED|Overall Study||247
11042852|NCT00924560|12222964|FG001|COMPLETED|Overall Study||240
11336374|NCT02875977|12534038|FG000|STARTED|Overall Study||100
11336375|NCT02875977|12534039|FG001|STARTED|Overall Study||100
11336376|NCT02875977|12534038|FG000|COMPLETED|Overall Study||58
11336377|NCT02875977|12534039|FG001|COMPLETED|Overall Study||71
11336378|NCT02875977|12534038|FG000|NOT COMPLETED|Overall Study||42
11336379|NCT02875977|12534039|FG001|NOT COMPLETED|Overall Study||29
11336380|NCT02876055|12534048|FG000|STARTED|Overall Study||42
11336381|NCT02876055|12534049|FG001|STARTED|Overall Study||41
11336382|NCT02876055|12534050|FG002|STARTED|Overall Study||42
11336383|NCT02876055|12534048|FG000|COMPLETED|Overall Study||42
11336384|NCT02876055|12534049|FG001|COMPLETED|Overall Study||41
11336385|NCT02876055|12534050|FG002|COMPLETED|Overall Study||42
11336386|NCT02876055|12534048|FG000|NOT COMPLETED|Overall Study||0
11336387|NCT02876055|12534049|FG001|NOT COMPLETED|Overall Study||0
11336388|NCT02876055|12534050|FG002|NOT COMPLETED|Overall Study||0
11336389|NCT02876159|12534060|FG000|STARTED|Overall Study||10
11042853|NCT00924560|12222965|FG002|COMPLETED|Overall Study||372
11042854|NCT00924560|12222963|FG000|NOT COMPLETED|Overall Study||211
11042855|NCT00924560|12222964|FG001|NOT COMPLETED|Overall Study||208
11336390|NCT02876159|12534061|FG001|STARTED|Overall Study||10
11336391|NCT02876159|12534060|FG000|COMPLETED|Overall Study||10
11042856|NCT00924560|12222965|FG002|NOT COMPLETED|Overall Study||83
11042857|NCT00924612|12222975|FG000|STARTED|Overall Study||4
11042858|NCT00924612|12222976|FG001|STARTED|Overall Study||4
11042859|NCT00924612|12222977|FG002|STARTED|Overall Study||4
11042860|NCT00924612|12222978|FG003|STARTED|Overall Study||4
11042861|NCT00924612|12222975|FG000|COMPLETED|Overall Study||4
11042862|NCT00924612|12222976|FG001|COMPLETED|Overall Study||4
11042863|NCT00924612|12222977|FG002|COMPLETED|Overall Study||4
11042864|NCT00924612|12222978|FG003|COMPLETED|Overall Study||4
11042865|NCT00924612|12222975|FG000|NOT COMPLETED|Overall Study||0
11042866|NCT00924612|12222976|FG001|NOT COMPLETED|Overall Study||0
11042867|NCT00924612|12222977|FG002|NOT COMPLETED|Overall Study||0
11042868|NCT00924612|12222978|FG003|NOT COMPLETED|Overall Study||0
11042869|NCT00924638|12222992|FG000|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
11042870|NCT00924638|12222993|FG001|STARTED|Overall Study|Randomized to Control Arm|220
11042871|NCT00924638|12222992|FG000|COMPLETED|Overall Study|Completed 6 months of follow-up|209
11042872|NCT00924638|12222993|FG001|COMPLETED|Overall Study|Completed 6 months of follow-up|207
11042873|NCT00924638|12222992|FG000|NOT COMPLETED|Overall Study||12
11042874|NCT00924638|12222993|FG001|NOT COMPLETED|Overall Study||13
11042875|NCT00924651|12223001|FG000|STARTED|Overall Study||356
11042876|NCT00924651|12223002|FG001|STARTED|Overall Study||337
11042877|NCT00924651|12223001|FG000|COMPLETED|Overall Study||331
11042878|NCT00924651|12223002|FG001|COMPLETED|Overall Study||312
11042879|NCT00924651|12223001|FG000|NOT COMPLETED|Overall Study||25
11042880|NCT00924651|12223002|FG001|NOT COMPLETED|Overall Study||25
11042881|NCT00924664|12223010|FG000|STARTED|Overall Study||322
11042882|NCT00924664|12223011|FG001|STARTED|Overall Study||527
11042883|NCT00924664|12223010|FG000|Treated|Overall Study||321
11042884|NCT00924664|12223011|FG001|Treated|Overall Study||527
11042885|NCT00924664|12223010|FG000|COMPLETED|Overall Study||0
11042886|NCT00924664|12223011|FG001|COMPLETED|Overall Study||0
11042887|NCT00924664|12223010|FG000|NOT COMPLETED|Overall Study||322
11042888|NCT00924664|12223011|FG001|NOT COMPLETED|Overall Study||527
11042889|NCT00924703|12223017|FG000|STARTED|Overall Study||68
11042890|NCT00924703|12223017|FG000|COMPLETED|Overall Study||46
11042891|NCT00924703|12223017|FG000|NOT COMPLETED|Overall Study||22
11042892|NCT00924729|12223023|FG000|STARTED|Overall Study||25
11042893|NCT00924729|12223024|FG001|STARTED|Overall Study||25
11042894|NCT00924729|12223023|FG000|COMPLETED|Overall Study||23
11042895|NCT00924729|12223024|FG001|COMPLETED|Overall Study||25
11042896|NCT00924729|12223023|FG000|NOT COMPLETED|Overall Study||2
11042897|NCT00924729|12223024|FG001|NOT COMPLETED|Overall Study||0
11042898|NCT00924781|12223036|FG000|STARTED|Overall Study||20
11042899|NCT00924781|12223037|FG001|STARTED|Overall Study||19
11042900|NCT00924781|12223036|FG000|COMPLETED|Overall Study||8
11042901|NCT00924781|12223037|FG001|COMPLETED|Overall Study||9
11042902|NCT00924781|12223036|FG000|NOT COMPLETED|Overall Study||12
11042903|NCT00924781|12223037|FG001|NOT COMPLETED|Overall Study||10
11042904|NCT00924820|12223053|FG000|STARTED|Overall Study||20
11042905|NCT00924820|12223053|FG000|COMPLETED|Overall Study||13
11042906|NCT00924820|12223053|FG000|NOT COMPLETED|Overall Study||7
11042907|NCT00924885|12223059|FG000|STARTED|Overall Study||129
11042908|NCT00924885|12223060|FG001|STARTED|Overall Study||128
11042909|NCT00924885|12223059|FG000|COMPLETED|Overall Study||126
11042910|NCT00924885|12223060|FG001|COMPLETED|Overall Study||124
11042911|NCT00924885|12223059|FG000|NOT COMPLETED|Overall Study||3
11042912|NCT00924885|12223060|FG001|NOT COMPLETED|Overall Study||4
11042913|NCT00924898|12223068|FG000|STARTED|Overall Study||92
11042914|NCT00924898|12223068|FG000|COMPLETED|Overall Study||90
11042915|NCT00924898|12223068|FG000|NOT COMPLETED|Overall Study||2
11042916|NCT00924950|12223077|FG000|STARTED|Overall Study||30
11042917|NCT00924950|12223077|FG000|COMPLETED|Overall Study||28
11042918|NCT00924950|12223077|FG000|NOT COMPLETED|Overall Study||2
11042919|NCT00925002|12223087|FG000|STARTED|Overall Study||38
11042920|NCT00925002|12223088|FG001|STARTED|Overall Study||37
11042921|NCT00925002|12223089|FG002|STARTED|Overall Study||18
11042922|NCT00925002|12223087|FG000|Treated|Overall Study||38
11042923|NCT00925002|12223088|FG001|Treated|Overall Study||37
11336392|NCT02876159|12534061|FG001|COMPLETED|Overall Study||10
11336393|NCT02876159|12534060|FG000|NOT COMPLETED|Overall Study||0
11336394|NCT02876159|12534061|FG001|NOT COMPLETED|Overall Study||0
11042924|NCT00925002|12223089|FG002|Treated|Overall Study||18
11042925|NCT00925002|12223087|FG000|COMPLETED|Overall Study||32
11042926|NCT00925002|12223088|FG001|COMPLETED|Overall Study||28
11042927|NCT00925002|12223089|FG002|COMPLETED|Overall Study||8
11042928|NCT00925002|12223087|FG000|NOT COMPLETED|Overall Study||6
11042929|NCT00925002|12223088|FG001|NOT COMPLETED|Overall Study||9
11042930|NCT00925002|12223089|FG002|NOT COMPLETED|Overall Study||10
11042931|NCT00925015|12223101|FG000|STARTED|Overall Study||8
11042932|NCT00925015|12223102|FG001|STARTED|Overall Study||6
11042933|NCT00925015|12223103|FG002|STARTED|Overall Study||6
11042934|NCT00925015|12223101|FG000|COMPLETED|Overall Study||0
11042935|NCT00925015|12223102|FG001|COMPLETED|Overall Study||0
11042936|NCT00925015|12223103|FG002|COMPLETED|Overall Study||0
11042937|NCT00925015|12223101|FG000|NOT COMPLETED|Overall Study||8
11042938|NCT00925015|12223102|FG001|NOT COMPLETED|Overall Study||6
11042939|NCT00925015|12223103|FG002|NOT COMPLETED|Overall Study||6
11042940|NCT00925054|12223120|FG000|STARTED|Overall Study||7
11042941|NCT00925054|12223121|FG001|STARTED|Overall Study||9
11042942|NCT00925054|12223122|FG002|STARTED|Overall Study||13
11042943|NCT00925054|12223123|FG003|STARTED|Overall Study||1
11042944|NCT00925054|12223124|FG004|STARTED|Overall Study||10
11042945|NCT00925054|12223120|FG000|COMPLETED|Overall Study||7
11042946|NCT00925054|12223121|FG001|COMPLETED|Overall Study||8
11042947|NCT00925054|12223122|FG002|COMPLETED|Overall Study||12
11042948|NCT00925054|12223123|FG003|COMPLETED|Overall Study||0
11042949|NCT00925054|12223124|FG004|COMPLETED|Overall Study||10
11042950|NCT00925054|12223120|FG000|NOT COMPLETED|Overall Study||0
11042951|NCT00925054|12223121|FG001|NOT COMPLETED|Overall Study||1
11042952|NCT00925054|12223122|FG002|NOT COMPLETED|Overall Study||1
11042953|NCT00925054|12223123|FG003|NOT COMPLETED|Overall Study||1
11042954|NCT00925054|12223124|FG004|NOT COMPLETED|Overall Study||0
11042955|NCT00925119|12223137|FG000|STARTED|Overall Study||31
11042956|NCT00925119|12223137|FG000|COMPLETED|Overall Study||19
11042957|NCT00925119|12223137|FG000|NOT COMPLETED|Overall Study||12
11042958|NCT00925132|12223141|FG000|STARTED|Overall Study||5
11042959|NCT00925132|12223142|FG001|STARTED|Overall Study||4
11042960|NCT00925132|12223143|FG002|STARTED|Overall Study||4
11042961|NCT00925132|12223144|FG003|STARTED|Overall Study||4
11042962|NCT00925132|12223145|FG004|STARTED|Overall Study||22
11042963|NCT00925132|12223141|FG000|COMPLETED|Overall Study||3
11042964|NCT00925132|12223142|FG001|COMPLETED|Overall Study||4
11042965|NCT00925132|12223143|FG002|COMPLETED|Overall Study||4
11042966|NCT00925132|12223144|FG003|COMPLETED|Overall Study||4
11042967|NCT00925132|12223145|FG004|COMPLETED|Overall Study||17
11042968|NCT00925132|12223141|FG000|NOT COMPLETED|Overall Study||2
11042969|NCT00925132|12223142|FG001|NOT COMPLETED|Overall Study||0
11042970|NCT00925132|12223143|FG002|NOT COMPLETED|Overall Study||0
11042971|NCT00925132|12223144|FG003|NOT COMPLETED|Overall Study||0
11042972|NCT00925132|12223145|FG004|NOT COMPLETED|Overall Study||5
11042973|NCT00925288|12223153|FG000|STARTED|Overall Study||100
11042974|NCT00925288|12223154|FG001|STARTED|Overall Study||100
11042975|NCT00925288|12223153|FG000|COMPLETED|Overall Study||91
11042976|NCT00925288|12223154|FG001|COMPLETED|Overall Study||93
11042977|NCT00925288|12223153|FG000|NOT COMPLETED|Overall Study||9
11042978|NCT00925288|12223154|FG001|NOT COMPLETED|Overall Study||7
11042979|NCT00925301|12223164|FG000|STARTED|6-Month Double-blind (Stage 1)||34
11042980|NCT00925301|12223165|FG001|STARTED|6-Month Double-blind (Stage 1)||33
11042981|NCT00925301|12223166|FG002|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
11042982|NCT00925301|12223167|FG003|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
11042983|NCT00925301|12223164|FG000|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
11042984|NCT00925301|12223165|FG001|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
11042985|NCT00925301|12223166|FG002|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
11042986|NCT00925301|12223167|FG003|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
11042987|NCT00925301|12223164|FG000|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
11042988|NCT00925301|12223165|FG001|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
11042989|NCT00925301|12223166|FG002|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
11042990|NCT00925301|12223167|FG003|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
11042991|NCT00925301|12223164|FG000|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
11042992|NCT00925301|12223165|FG001|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
11042993|NCT00925301|12223166|FG002|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
11042994|NCT00925301|12223167|FG003|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
11042995|NCT00925301|12223164|FG000|COMPLETED|6-Month Double-blind (Stage 1)||34
11042996|NCT00925301|12223165|FG001|COMPLETED|6-Month Double-blind (Stage 1)||30
11042997|NCT00925301|12223166|FG002|COMPLETED|6-Month Double-blind (Stage 1)||0
11042998|NCT00925301|12223167|FG003|COMPLETED|6-Month Double-blind (Stage 1)||0
11042999|NCT00925301|12223164|FG000|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
11043000|NCT00925301|12223165|FG001|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
11043001|NCT00925301|12223166|FG002|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
11043002|NCT00925301|12223167|FG003|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
11043003|NCT00925301|12223164|FG000|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
11043004|NCT00925301|12223165|FG001|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
11043005|NCT00925301|12223166|FG002|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
11043006|NCT00925301|12223167|FG003|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
11043007|NCT00925301|12223164|FG000|ITT-amenable|6-Month Open-label (Stage 2)||0
11336395|NCT02876575|12534070|FG000|STARTED|Overall Study||48
11336396|NCT02876575|12534070|FG000|COMPLETED|Overall Study||48
11336397|NCT02876575|12534070|FG000|NOT COMPLETED|Overall Study||0
11336398|NCT02876601|12534079|FG000|STARTED|First Intervention (24 Hours)||8
11336399|NCT02876601|12534080|FG001|STARTED|First Intervention (24 Hours)||8
11336400|NCT02876601|12534081|FG002|STARTED|First Intervention (24 Hours)||2
11336401|NCT02876601|12534082|FG003|STARTED|First Intervention (24 Hours)||2
11336402|NCT02876601|12534079|FG000|COMPLETED|First Intervention (24 Hours)||8
11336403|NCT02876601|12534080|FG001|COMPLETED|First Intervention (24 Hours)||8
11336404|NCT02876601|12534081|FG002|COMPLETED|First Intervention (24 Hours)||2
11043008|NCT00925301|12223165|FG001|ITT-amenable|6-Month Open-label (Stage 2)||0
11043009|NCT00925301|12223166|FG002|ITT-amenable|6-Month Open-label (Stage 2)||47
11043010|NCT00925301|12223167|FG003|ITT-amenable|6-Month Open-label (Stage 2)||0
11043011|NCT00925301|12223164|FG000|COMPLETED|6-Month Open-label (Stage 2)||0
11043012|NCT00925301|12223165|FG001|COMPLETED|6-Month Open-label (Stage 2)||0
11043013|NCT00925301|12223166|FG002|COMPLETED|6-Month Open-label (Stage 2)||60
11043014|NCT00925301|12223167|FG003|COMPLETED|6-Month Open-label (Stage 2)||0
11336405|NCT02876601|12534082|FG003|COMPLETED|First Intervention (24 Hours)||2
11043015|NCT00925301|12223164|FG000|NOT COMPLETED|6-Month Open-label (Stage 2)||0
11043016|NCT00925301|12223165|FG001|NOT COMPLETED|6-Month Open-label (Stage 2)||0
11043017|NCT00925301|12223166|FG002|NOT COMPLETED|6-Month Open-label (Stage 2)||3
11043018|NCT00925301|12223167|FG003|NOT COMPLETED|6-Month Open-label (Stage 2)||0
11043019|NCT00925301|12223164|FG000|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
11043020|NCT00925301|12223165|FG001|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
11043021|NCT00925301|12223166|FG002|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
11043022|NCT00925301|12223167|FG003|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
11043023|NCT00925301|12223164|FG000|ITT-amenable|12-Month Open-label Extension (Optional)||0
11043024|NCT00925301|12223165|FG001|ITT-amenable|12-Month Open-label Extension (Optional)||0
11043025|NCT00925301|12223166|FG002|ITT-amenable|12-Month Open-label Extension (Optional)||0
11043026|NCT00925301|12223167|FG003|ITT-amenable|12-Month Open-label Extension (Optional)||42
11043027|NCT00925301|12223164|FG000|COMPLETED|12-Month Open-label Extension (Optional)||0
11043028|NCT00925301|12223165|FG001|COMPLETED|12-Month Open-label Extension (Optional)||0
11043029|NCT00925301|12223166|FG002|COMPLETED|12-Month Open-label Extension (Optional)||0
11043030|NCT00925301|12223167|FG003|COMPLETED|12-Month Open-label Extension (Optional)||54
11043031|NCT00925301|12223164|FG000|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
11043032|NCT00925301|12223165|FG001|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
11043033|NCT00925301|12223166|FG002|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
11043034|NCT00925301|12223167|FG003|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
11043035|NCT00925353|12223178|FG000|STARTED|Overall Study||13
11043036|NCT00925353|12223178|FG000|COMPLETED|Overall Study||10
11043037|NCT00925353|12223178|FG000|NOT COMPLETED|Overall Study||3
11043038|NCT00925522|12223182|FG000|STARTED|Overall Study||20
11043039|NCT00925522|12223182|FG000|COMPLETED|Overall Study||0
11043040|NCT00925522|12223182|FG000|NOT COMPLETED|Overall Study||20
11043041|NCT00925587|12223188|FG000|STARTED|Overall Study||178
11043042|NCT00925587|12223189|FG001|STARTED|Overall Study||180
11043043|NCT00925587|12223188|FG000|COMPLETED|Overall Study||142
11043044|NCT00925587|12223189|FG001|COMPLETED|Overall Study||155
11043045|NCT00925587|12223188|FG000|NOT COMPLETED|Overall Study||36
11043046|NCT00925587|12223189|FG001|NOT COMPLETED|Overall Study||25
11043047|NCT00925600|12223197|FG000|STARTED|Overall Study||386
11043048|NCT00925600|12223198|FG001|STARTED|Overall Study||383
11043049|NCT00925600|12223197|FG000|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
11043050|NCT00925600|12223198|FG001|Received Treatment|Overall Study||382
11043051|NCT00925600|12223197|FG000|COMPLETED|Overall Study||354
11043052|NCT00925600|12223198|FG001|COMPLETED|Overall Study||355
11043053|NCT00925600|12223197|FG000|NOT COMPLETED|Overall Study||32
11043054|NCT00925600|12223198|FG001|NOT COMPLETED|Overall Study||28
11201225|NCT01831427|12391426|FG009|STARTED|Overall Study||10
11201226|NCT01831427|12391427|FG010|STARTED|Overall Study||8
11201227|NCT01831427|12391417|FG000|COMPLETED|Overall Study||5
11201228|NCT01831427|12391418|FG001|COMPLETED|Overall Study||4
11201229|NCT01831427|12391419|FG002|COMPLETED|Overall Study||5
11201230|NCT01831427|12391420|FG003|COMPLETED|Overall Study||4
11201231|NCT01831427|12391421|FG004|COMPLETED|Overall Study||4
11201232|NCT01831427|12391422|FG005|COMPLETED|Overall Study||7
11201233|NCT01831427|12391423|FG006|COMPLETED|Overall Study||6
11201234|NCT01831427|12391424|FG007|COMPLETED|Overall Study||7
11201235|NCT01831427|12391425|FG008|COMPLETED|Overall Study||8
11201236|NCT01831427|12391426|FG009|COMPLETED|Overall Study||9
11336406|NCT02876601|12534079|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
11201237|NCT01831427|12391427|FG010|COMPLETED|Overall Study||5
11201238|NCT01831427|12391417|FG000|NOT COMPLETED|Overall Study||0
11201239|NCT01831427|12391418|FG001|NOT COMPLETED|Overall Study||1
11201240|NCT01831427|12391419|FG002|NOT COMPLETED|Overall Study||0
11201241|NCT01831427|12391420|FG003|NOT COMPLETED|Overall Study||1
11201242|NCT01831427|12391421|FG004|NOT COMPLETED|Overall Study||0
11201243|NCT01831427|12391422|FG005|NOT COMPLETED|Overall Study||1
11201244|NCT01831427|12391423|FG006|NOT COMPLETED|Overall Study||2
11201245|NCT01831427|12391424|FG007|NOT COMPLETED|Overall Study||1
11201246|NCT01831427|12391425|FG008|NOT COMPLETED|Overall Study||0
11201247|NCT01831427|12391426|FG009|NOT COMPLETED|Overall Study||1
11201248|NCT01831427|12391427|FG010|NOT COMPLETED|Overall Study||3
11201249|NCT01831466|12391474|FG000|STARTED|Overall Study|Treated|71
11201250|NCT01831466|12391475|FG001|STARTED|Overall Study|Treated|70
11201251|NCT01831466|12391476|FG002|STARTED|Overall Study|Treated|71
11201252|NCT01831466|12391477|FG003|STARTED|Overall Study|Treated|70
11201253|NCT01831466|12391478|FG004|STARTED|Overall Study|Treated|74
11201254|NCT01831466|12391479|FG005|STARTED|Overall Study|Treated|74
11336407|NCT02876601|12534080|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
11336408|NCT02876601|12534081|FG002|NOT COMPLETED|First Intervention (24 Hours)||0
11336409|NCT02876601|12534082|FG003|NOT COMPLETED|First Intervention (24 Hours)||0
11336410|NCT02876601|12534079|FG000|STARTED|Washout (Minimum of 6 Weeks)||8
11336411|NCT02876601|12534080|FG001|STARTED|Washout (Minimum of 6 Weeks)||8
11336412|NCT02876601|12534081|FG002|STARTED|Washout (Minimum of 6 Weeks)||2
11336413|NCT02876601|12534082|FG003|STARTED|Washout (Minimum of 6 Weeks)||2
11336414|NCT02876601|12534079|FG000|COMPLETED|Washout (Minimum of 6 Weeks)||8
11336415|NCT02876601|12534080|FG001|COMPLETED|Washout (Minimum of 6 Weeks)||8
11336416|NCT02876601|12534081|FG002|COMPLETED|Washout (Minimum of 6 Weeks)||1
11336417|NCT02876601|12534082|FG003|COMPLETED|Washout (Minimum of 6 Weeks)||2
11336418|NCT02876601|12534079|FG000|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
11336419|NCT02876601|12534080|FG001|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
11336420|NCT02876601|12534081|FG002|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1
11336421|NCT02876601|12534082|FG003|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
11336422|NCT02876601|12534079|FG000|STARTED|Second Intervention (24 Hours)||8
11336423|NCT02876601|12534080|FG001|STARTED|Second Intervention (24 Hours)||8
11336424|NCT02876601|12534081|FG002|STARTED|Second Intervention (24 Hours)||1
11336425|NCT02876601|12534082|FG003|STARTED|Second Intervention (24 Hours)||2
11336426|NCT02876601|12534079|FG000|COMPLETED|Second Intervention (24 Hours)||8
11336427|NCT02876601|12534080|FG001|COMPLETED|Second Intervention (24 Hours)||8
11336428|NCT02876601|12534081|FG002|COMPLETED|Second Intervention (24 Hours)||1
11336429|NCT02876601|12534082|FG003|COMPLETED|Second Intervention (24 Hours)||2
11336430|NCT02876601|12534079|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
11336431|NCT02876601|12534080|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0
11336432|NCT02876601|12534081|FG002|NOT COMPLETED|Second Intervention (24 Hours)||0
11336433|NCT02876601|12534082|FG003|NOT COMPLETED|Second Intervention (24 Hours)||0
11336434|NCT02876757|12534129|FG000|STARTED|Overall Study||93197
11336435|NCT02876757|12534130|FG001|STARTED|Overall Study||93197
11336436|NCT02876757|12534129|FG000|COMPLETED|Overall Study||93197
11336437|NCT02876757|12534130|FG001|COMPLETED|Overall Study||93197
11043055|NCT00925704|12223214|FG000|STARTED|First Intervention||6
11043056|NCT00925704|12223215|FG001|STARTED|First Intervention||7
11043057|NCT00925704|12223216|FG002|STARTED|First Intervention||7
11043058|NCT00925704|12223217|FG003|STARTED|First Intervention||7
11043059|NCT00925704|12223218|FG004|STARTED|First Intervention||7
11043060|NCT00925704|12223219|FG005|STARTED|First Intervention||7
11043061|NCT00925704|12223214|FG000|COMPLETED|First Intervention||6
11043062|NCT00925704|12223215|FG001|COMPLETED|First Intervention||7
11043063|NCT00925704|12223216|FG002|COMPLETED|First Intervention||7
11043064|NCT00925704|12223217|FG003|COMPLETED|First Intervention||6
11043065|NCT00925704|12223218|FG004|COMPLETED|First Intervention||6
11043066|NCT00925704|12223219|FG005|COMPLETED|First Intervention||7
11043067|NCT00925704|12223214|FG000|NOT COMPLETED|First Intervention||0
11043068|NCT00925704|12223215|FG001|NOT COMPLETED|First Intervention||0
11043069|NCT00925704|12223216|FG002|NOT COMPLETED|First Intervention||0
11043070|NCT00925704|12223217|FG003|NOT COMPLETED|First Intervention||1
11043071|NCT00925704|12223218|FG004|NOT COMPLETED|First Intervention||1
11043072|NCT00925704|12223219|FG005|NOT COMPLETED|First Intervention||0
11043073|NCT00925704|12223214|FG000|STARTED|Washout||6
11043074|NCT00925704|12223215|FG001|STARTED|Washout||7
11043075|NCT00925704|12223216|FG002|STARTED|Washout||7
11043076|NCT00925704|12223217|FG003|STARTED|Washout||6
11043077|NCT00925704|12223218|FG004|STARTED|Washout||6
11043078|NCT00925704|12223219|FG005|STARTED|Washout||7
11043079|NCT00925704|12223214|FG000|COMPLETED|Washout||6
11043080|NCT00925704|12223215|FG001|COMPLETED|Washout||7
11043081|NCT00925704|12223216|FG002|COMPLETED|Washout||7
11043082|NCT00925704|12223217|FG003|COMPLETED|Washout||6
11201255|NCT01831466|12391480|FG006|STARTED|Overall Study|Treated|7
11201256|NCT01831466|12391481|FG007|STARTED|Overall Study|Treated|7
11201257|NCT01831466|12391482|FG008|STARTED|Overall Study|Treated|7
11043083|NCT00925704|12223218|FG004|COMPLETED|Washout||6
11043084|NCT00925704|12223219|FG005|COMPLETED|Washout||7
11043085|NCT00925704|12223214|FG000|NOT COMPLETED|Washout||0
11043086|NCT00925704|12223215|FG001|NOT COMPLETED|Washout||0
11043087|NCT00925704|12223216|FG002|NOT COMPLETED|Washout||0
11043088|NCT00925704|12223217|FG003|NOT COMPLETED|Washout||0
11043089|NCT00925704|12223218|FG004|NOT COMPLETED|Washout||0
11043090|NCT00925704|12223219|FG005|NOT COMPLETED|Washout||0
11043091|NCT00925704|12223214|FG000|STARTED|Second Intervention||6
11043092|NCT00925704|12223215|FG001|STARTED|Second Intervention||7
11043093|NCT00925704|12223216|FG002|STARTED|Second Intervention||7
11043094|NCT00925704|12223217|FG003|STARTED|Second Intervention||6
11043095|NCT00925704|12223218|FG004|STARTED|Second Intervention||6
11043096|NCT00925704|12223219|FG005|STARTED|Second Intervention||7
11043097|NCT00925704|12223214|FG000|COMPLETED|Second Intervention||5
11043098|NCT00925704|12223215|FG001|COMPLETED|Second Intervention||7
11043099|NCT00925704|12223216|FG002|COMPLETED|Second Intervention||7
11043100|NCT00925704|12223217|FG003|COMPLETED|Second Intervention||6
11043101|NCT00925704|12223218|FG004|COMPLETED|Second Intervention||5
11043102|NCT00925704|12223219|FG005|COMPLETED|Second Intervention||7
11043103|NCT00925704|12223214|FG000|NOT COMPLETED|Second Intervention||1
11043104|NCT00925704|12223215|FG001|NOT COMPLETED|Second Intervention||0
11043105|NCT00925704|12223216|FG002|NOT COMPLETED|Second Intervention||0
11043106|NCT00925704|12223217|FG003|NOT COMPLETED|Second Intervention||0
11043107|NCT00925704|12223218|FG004|NOT COMPLETED|Second Intervention||1
11043108|NCT00925704|12223219|FG005|NOT COMPLETED|Second Intervention||0
11043109|NCT00925704|12223214|FG000|STARTED|Washout||5
11043110|NCT00925704|12223215|FG001|STARTED|Washout||7
11043111|NCT00925704|12223216|FG002|STARTED|Washout||7
11043112|NCT00925704|12223217|FG003|STARTED|Washout||6
11043113|NCT00925704|12223218|FG004|STARTED|Washout||5
11043114|NCT00925704|12223219|FG005|STARTED|Washout||7
11043115|NCT00925704|12223214|FG000|COMPLETED|Washout||5
11043116|NCT00925704|12223215|FG001|COMPLETED|Washout||7
11043117|NCT00925704|12223216|FG002|COMPLETED|Washout||7
11043118|NCT00925704|12223217|FG003|COMPLETED|Washout||6
11043119|NCT00925704|12223218|FG004|COMPLETED|Washout||5
11043120|NCT00925704|12223219|FG005|COMPLETED|Washout||7
11043121|NCT00925704|12223214|FG000|NOT COMPLETED|Washout||0
11043122|NCT00925704|12223215|FG001|NOT COMPLETED|Washout||0
11043123|NCT00925704|12223216|FG002|NOT COMPLETED|Washout||0
11043124|NCT00925704|12223217|FG003|NOT COMPLETED|Washout||0
11043125|NCT00925704|12223218|FG004|NOT COMPLETED|Washout||0
11043126|NCT00925704|12223219|FG005|NOT COMPLETED|Washout||0
11043127|NCT00925704|12223214|FG000|STARTED|Third Intervention||5
11043128|NCT00925704|12223215|FG001|STARTED|Third Intervention||7
11043129|NCT00925704|12223216|FG002|STARTED|Third Intervention||7
11043130|NCT00925704|12223217|FG003|STARTED|Third Intervention||6
11043131|NCT00925704|12223218|FG004|STARTED|Third Intervention||5
11043132|NCT00925704|12223219|FG005|STARTED|Third Intervention||7
11043133|NCT00925704|12223214|FG000|COMPLETED|Third Intervention||5
11043134|NCT00925704|12223215|FG001|COMPLETED|Third Intervention||7
11043135|NCT00925704|12223216|FG002|COMPLETED|Third Intervention||7
11043136|NCT00925704|12223217|FG003|COMPLETED|Third Intervention||6
11043137|NCT00925704|12223218|FG004|COMPLETED|Third Intervention||5
11043138|NCT00925704|12223219|FG005|COMPLETED|Third Intervention||6
11043139|NCT00925704|12223214|FG000|NOT COMPLETED|Third Intervention||0
11043140|NCT00925704|12223215|FG001|NOT COMPLETED|Third Intervention||0
11043141|NCT00925704|12223216|FG002|NOT COMPLETED|Third Intervention||0
11043142|NCT00925704|12223217|FG003|NOT COMPLETED|Third Intervention||0
11043143|NCT00925704|12223218|FG004|NOT COMPLETED|Third Intervention||0
11043144|NCT00925704|12223219|FG005|NOT COMPLETED|Third Intervention||1
11043145|NCT00925756|12223230|FG000|STARTED|Overall Study||32
11043146|NCT00925756|12223230|FG000|COMPLETED|Overall Study||32
11043147|NCT00925756|12223230|FG000|NOT COMPLETED|Overall Study||0
11043148|NCT00925769|12223234|FG000|STARTED|Overall Study||6
11043149|NCT00925769|12223235|FG001|STARTED|Overall Study||6
11043150|NCT00925769|12223236|FG002|STARTED|Overall Study||6
11043151|NCT00925769|12223237|FG003|STARTED|Overall Study||6
11043152|NCT00925769|12223238|FG004|STARTED|Overall Study||3
11043153|NCT00925769|12223239|FG005|STARTED|Overall Study||3
11043154|NCT00925769|12223234|FG000|COMPLETED|Overall Study||0
11043155|NCT00925769|12223235|FG001|COMPLETED|Overall Study||0
11043156|NCT00925769|12223236|FG002|COMPLETED|Overall Study||0
11043157|NCT00925769|12223237|FG003|COMPLETED|Overall Study||0
11043158|NCT00925769|12223238|FG004|COMPLETED|Overall Study||0
11043159|NCT00925769|12223239|FG005|COMPLETED|Overall Study||0
11043160|NCT00925769|12223234|FG000|NOT COMPLETED|Overall Study||6
11043161|NCT00925769|12223235|FG001|NOT COMPLETED|Overall Study||6
11043162|NCT00925769|12223236|FG002|NOT COMPLETED|Overall Study||6
11043163|NCT00925769|12223237|FG003|NOT COMPLETED|Overall Study||6
11043164|NCT00925769|12223238|FG004|NOT COMPLETED|Overall Study||3
11043165|NCT00925769|12223239|FG005|NOT COMPLETED|Overall Study||3
11043166|NCT00925782|12223255|FG000|STARTED|Pretreatment (Day -30 to Day -3)||12
11043167|NCT00925782|12223256|FG001|STARTED|Pretreatment (Day -30 to Day -3)||12
11043168|NCT00925782|12223255|FG000|COMPLETED|Pretreatment (Day -30 to Day -3)||12
11043169|NCT00925782|12223256|FG001|COMPLETED|Pretreatment (Day -30 to Day -3)||12
11043170|NCT00925782|12223255|FG000|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
11043171|NCT00925782|12223256|FG001|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
11043172|NCT00925782|12223255|FG000|STARTED|Study Period (Day -3 to Day 0)||12
11043173|NCT00925782|12223256|FG001|STARTED|Study Period (Day -3 to Day 0)||12
11043174|NCT00925782|12223255|FG000|COMPLETED|Study Period (Day -3 to Day 0)||12
11043175|NCT00925782|12223256|FG001|COMPLETED|Study Period (Day -3 to Day 0)||12
11043176|NCT00925782|12223255|FG000|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
11043177|NCT00925782|12223256|FG001|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
11043178|NCT00925782|12223255|FG000|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
11043179|NCT00925782|12223256|FG001|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
11043180|NCT00925782|12223255|FG000|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
11043181|NCT00925782|12223256|FG001|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
11043182|NCT00925782|12223255|FG000|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
11043183|NCT00925782|12223256|FG001|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
11043184|NCT00925899|12223265|FG000|STARTED|Part 1||34
11043185|NCT00925899|12223266|FG001|STARTED|Part 1||38
11043186|NCT00925899|12223265|FG000|COMPLETED|Part 1||23
11043187|NCT00925899|12223266|FG001|COMPLETED|Part 1||27
11043188|NCT00925899|12223265|FG000|NOT COMPLETED|Part 1||11
11043189|NCT00925899|12223266|FG001|NOT COMPLETED|Part 1||11
11043190|NCT00925899|12223265|FG000|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
11043191|NCT00925899|12223266|FG001|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
11043192|NCT00925899|12223265|FG000|COMPLETED|Part 2||9
11043193|NCT00925899|12223266|FG001|COMPLETED|Part 2||9
11043194|NCT00925899|12223265|FG000|NOT COMPLETED|Part 2||6
11043195|NCT00925899|12223266|FG001|NOT COMPLETED|Part 2||12
11043196|NCT00925938|12223276|FG000|STARTED|Overall Study||9
11043197|NCT00925938|12223277|FG001|STARTED|Overall Study||25
11043198|NCT00925938|12223278|FG002|STARTED|Overall Study||17
11043199|NCT00925938|12223276|FG000|COMPLETED|Overall Study||9
11043200|NCT00925938|12223277|FG001|COMPLETED|Overall Study||25
11043201|NCT00925938|12223278|FG002|COMPLETED|Overall Study||17
11043202|NCT00925938|12223276|FG000|NOT COMPLETED|Overall Study||0
11043203|NCT00925938|12223277|FG001|NOT COMPLETED|Overall Study||0
11043204|NCT00925938|12223278|FG002|NOT COMPLETED|Overall Study||0
11043205|NCT00925990|12223288|FG000|STARTED|Overall Study||35
11043206|NCT00925990|12223289|FG001|STARTED|Overall Study||35
11043207|NCT00925990|12223288|FG000|COMPLETED|Overall Study||30
11043208|NCT00925990|12223289|FG001|COMPLETED|Overall Study||24
11043209|NCT00925990|12223288|FG000|NOT COMPLETED|Overall Study||5
11043210|NCT00925990|12223289|FG001|NOT COMPLETED|Overall Study||11
11043211|NCT00926003|12223298|FG000|STARTED|Baseline||53
11043212|NCT00926003|12223299|FG001|STARTED|Baseline||54
11043213|NCT00926003|12223300|FG002|STARTED|Baseline||52
11043214|NCT00926003|12223298|FG000|COMPLETED|Baseline||53
11043215|NCT00926003|12223299|FG001|COMPLETED|Baseline||54
11043216|NCT00926003|12223300|FG002|COMPLETED|Baseline||52
11043217|NCT00926003|12223298|FG000|NOT COMPLETED|Baseline||0
11043218|NCT00926003|12223299|FG001|NOT COMPLETED|Baseline||0
11043219|NCT00926003|12223300|FG002|NOT COMPLETED|Baseline||0
11043220|NCT00926003|12223298|FG000|STARTED|Post-Training Evaluation||53
11043221|NCT00926003|12223299|FG001|STARTED|Post-Training Evaluation||54
11043222|NCT00926003|12223300|FG002|STARTED|Post-Training Evaluation||52
11043223|NCT00926003|12223298|FG000|COMPLETED|Post-Training Evaluation||52
11043224|NCT00926003|12223299|FG001|COMPLETED|Post-Training Evaluation||54
11043225|NCT00926003|12223300|FG002|COMPLETED|Post-Training Evaluation||52
11043226|NCT00926003|12223298|FG000|NOT COMPLETED|Post-Training Evaluation||1
11043227|NCT00926003|12223299|FG001|NOT COMPLETED|Post-Training Evaluation||0
11043228|NCT00926003|12223300|FG002|NOT COMPLETED|Post-Training Evaluation||0
11043229|NCT00926003|12223298|FG000|STARTED|Post-Training 3-month Follow-up||52
11043230|NCT00926003|12223299|FG001|STARTED|Post-Training 3-month Follow-up||54
11043231|NCT00926003|12223300|FG002|STARTED|Post-Training 3-month Follow-up||52
11043232|NCT00926003|12223298|FG000|COMPLETED|Post-Training 3-month Follow-up||51
11043233|NCT00926003|12223299|FG001|COMPLETED|Post-Training 3-month Follow-up||54
11043234|NCT00926003|12223300|FG002|COMPLETED|Post-Training 3-month Follow-up||52
11043235|NCT00926003|12223298|FG000|NOT COMPLETED|Post-Training 3-month Follow-up||1
11043236|NCT00926003|12223299|FG001|NOT COMPLETED|Post-Training 3-month Follow-up||0
11043237|NCT00926003|12223300|FG002|NOT COMPLETED|Post-Training 3-month Follow-up||0
11043238|NCT00926029|12223311|FG000|STARTED|Overall Study||34
11043239|NCT00926029|12223312|FG001|STARTED|Overall Study||34
11043240|NCT00926029|12223313|FG002|STARTED|Overall Study||34
11043241|NCT00926029|12223311|FG000|COMPLETED|Overall Study||32
11043242|NCT00926029|12223312|FG001|COMPLETED|Overall Study||33
11043243|NCT00926029|12223313|FG002|COMPLETED|Overall Study||33
11043244|NCT00926029|12223311|FG000|NOT COMPLETED|Overall Study||2
11043245|NCT00926029|12223312|FG001|NOT COMPLETED|Overall Study||1
11043246|NCT00926029|12223313|FG002|NOT COMPLETED|Overall Study||1
11043247|NCT00926185|12223327|FG000|STARTED|Overall Study||57
11043248|NCT00926185|12223328|FG001|STARTED|Overall Study||57
11043249|NCT00926185|12223329|FG002|STARTED|Overall Study||58
11043250|NCT00926185|12223330|FG003|STARTED|Overall Study||58
11043251|NCT00926185|12223327|FG000|COMPLETED|Overall Study||54
11043252|NCT00926185|12223328|FG001|COMPLETED|Overall Study||51
11043253|NCT00926185|12223329|FG002|COMPLETED|Overall Study||48
11043254|NCT00926185|12223330|FG003|COMPLETED|Overall Study||48
11043255|NCT00926185|12223327|FG000|NOT COMPLETED|Overall Study||3
11043256|NCT00926185|12223328|FG001|NOT COMPLETED|Overall Study||6
11043257|NCT00926185|12223329|FG002|NOT COMPLETED|Overall Study||10
11043258|NCT00926185|12223330|FG003|NOT COMPLETED|Overall Study||10
11043259|NCT00926211|12223340|FG000|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
11043260|NCT00926211|12223340|FG000|COMPLETED|Overall Study||35
11043261|NCT00926211|12223340|FG000|NOT COMPLETED|Overall Study||1
11043262|NCT00926237|12223345|FG000|STARTED|Overall Study|Two subjects withdrew after receiving sham rTMS but before receiving active rTMS.|19
11043263|NCT00926237|12223346|FG001|STARTED|Overall Study|One subjects withdrew after receiving sham rTMS but before receiving active rTMS.|20
11043264|NCT00926237|12223345|FG000|COMPLETED|Overall Study||17
11043265|NCT00926237|12223346|FG001|COMPLETED|Overall Study||19
11043266|NCT00926237|12223345|FG000|NOT COMPLETED|Overall Study||2
11043267|NCT00926237|12223346|FG001|NOT COMPLETED|Overall Study||1
11043268|NCT00926263|12223358|FG000|STARTED|Overall Study||16
11043269|NCT00926263|12223359|FG001|STARTED|Overall Study||12
11043270|NCT00926263|12223358|FG000|COMPLETED|Overall Study||16
11043271|NCT00926263|12223359|FG001|COMPLETED|Overall Study||12
11043272|NCT00926263|12223358|FG000|NOT COMPLETED|Overall Study||0
11043273|NCT00926263|12223359|FG001|NOT COMPLETED|Overall Study||0
11043274|NCT00926289|12223368|FG000|STARTED|Overall Study|Number of treated patients|294
11043275|NCT00926289|12223369|FG001|STARTED|Overall Study|Number of treated patients|594
11043276|NCT00926289|12223368|FG000|COMPLETED|Overall Study||269
11043277|NCT00926289|12223369|FG001|COMPLETED|Overall Study||558
11043278|NCT00926289|12223368|FG000|NOT COMPLETED|Overall Study||25
11043279|NCT00926289|12223369|FG001|NOT COMPLETED|Overall Study||36
11043280|NCT00926328|12223377|FG000|STARTED|Overall Study||60
11043281|NCT00926328|12223378|FG001|STARTED|Overall Study||60
11043282|NCT00926328|12223377|FG000|COMPLETED|Overall Study||48
11043283|NCT00926328|12223378|FG001|COMPLETED|Overall Study||46
11043284|NCT00926328|12223377|FG000|NOT COMPLETED|Overall Study||12
11043285|NCT00926328|12223378|FG001|NOT COMPLETED|Overall Study||14
11043286|NCT00926367|12223386|FG000|STARTED|Overall Study||25
11043287|NCT00926367|12223387|FG001|STARTED|Overall Study||27
11043288|NCT00926367|12223386|FG000|COMPLETED|Overall Study||23
11043289|NCT00926367|12223387|FG001|COMPLETED|Overall Study||24
11043290|NCT00926367|12223386|FG000|NOT COMPLETED|Overall Study||2
11043291|NCT00926367|12223387|FG001|NOT COMPLETED|Overall Study||3
11043292|NCT00926380|12223398|FG000|STARTED|Year 1||33
11043293|NCT00926380|12223399|FG001|STARTED|Year 1||31
11043294|NCT00926380|12223400|FG002|STARTED|Year 1||30
11043295|NCT00926380|12223398|FG000|COMPLETED|Year 1||33
11043296|NCT00926380|12223399|FG001|COMPLETED|Year 1||30
11043297|NCT00926380|12223400|FG002|COMPLETED|Year 1||29
11043298|NCT00926380|12223398|FG000|NOT COMPLETED|Year 1||0
11043299|NCT00926380|12223399|FG001|NOT COMPLETED|Year 1||1
11043300|NCT00926380|12223400|FG002|NOT COMPLETED|Year 1||1
11043301|NCT00926380|12223398|FG000|STARTED|Year 2||33
11043302|NCT00926380|12223399|FG001|STARTED|Year 2||30
11043303|NCT00926380|12223400|FG002|STARTED|Year 2||29
11043304|NCT00926380|12223398|FG000|COMPLETED|Year 2||31
11043305|NCT00926380|12223399|FG001|COMPLETED|Year 2||28
11043306|NCT00926380|12223400|FG002|COMPLETED|Year 2||24
11043307|NCT00926380|12223398|FG000|NOT COMPLETED|Year 2||2
11043308|NCT00926380|12223399|FG001|NOT COMPLETED|Year 2||2
11043309|NCT00926380|12223400|FG002|NOT COMPLETED|Year 2||5
11043310|NCT00926393|12223410|FG000|STARTED|Overall Study||69
11043311|NCT00926393|12223411|FG001|STARTED|Overall Study||70
11043312|NCT00926393|12223410|FG000|COMPLETED|Overall Study||67
11043313|NCT00926393|12223411|FG001|COMPLETED|Overall Study||67
11043314|NCT00926393|12223410|FG000|NOT COMPLETED|Overall Study||2
11043315|NCT00926393|12223411|FG001|NOT COMPLETED|Overall Study||3
11043316|NCT00926497|12223419|FG000|STARTED|Overall Study||60
11043317|NCT00926497|12223420|FG001|STARTED|Overall Study||61
11043318|NCT00926497|12223419|FG000|COMPLETED|Overall Study||60
11043319|NCT00926497|12223420|FG001|COMPLETED|Overall Study||61
11043320|NCT00926497|12223419|FG000|NOT COMPLETED|Overall Study||0
11043321|NCT00926497|12223420|FG001|NOT COMPLETED|Overall Study||0
11043322|NCT00926536|12223428|FG000|STARTED|Overall Study||44
11043323|NCT00926536|12223429|FG001|STARTED|Overall Study||43
11043324|NCT00926536|12223428|FG000|COMPLETED|Overall Study||43
11043325|NCT00926536|12223429|FG001|COMPLETED|Overall Study||41
11043326|NCT00926536|12223428|FG000|NOT COMPLETED|Overall Study||1
11043327|NCT00926536|12223429|FG001|NOT COMPLETED|Overall Study||2
11043328|NCT00926588|12223437|FG000|STARTED|Overall Study||124
11043329|NCT00926588|12223438|FG001|STARTED|Overall Study||126
11043330|NCT00926588|12223437|FG000|COMPLETED|Overall Study||116
11043331|NCT00926588|12223438|FG001|COMPLETED|Overall Study||122
11201258|NCT01831466|12391483|FG009|STARTED|Overall Study|Treated|7
11043332|NCT00926588|12223437|FG000|NOT COMPLETED|Overall Study||8
11043333|NCT00926588|12223438|FG001|NOT COMPLETED|Overall Study||4
11043334|NCT00926783|12223446|FG000|STARTED|Overall Study||42
11043335|NCT00926783|12223447|FG001|STARTED|Overall Study||41
11043336|NCT00926783|12223446|FG000|COMPLETED|Overall Study||39
11043337|NCT00926783|12223447|FG001|COMPLETED|Overall Study||38
11043338|NCT00926783|12223446|FG000|NOT COMPLETED|Overall Study||3
11043339|NCT00926783|12223447|FG001|NOT COMPLETED|Overall Study||3
11043340|NCT00926796|12223455|FG000|STARTED|Overall Study|Number randomized|309
11043341|NCT00926796|12223456|FG001|STARTED|Overall Study|Number randomized|305
11043342|NCT00926796|12223455|FG000|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
11043343|NCT00926796|12223456|FG001|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
11043344|NCT00926796|12223455|FG000|NOT COMPLETED|Overall Study||107
11043345|NCT00926796|12223456|FG001|NOT COMPLETED|Overall Study||106
11043346|NCT00926848|12223466|FG000|STARTED|Overall Study||34
11043347|NCT00926848|12223467|FG001|STARTED|Overall Study||34
11043348|NCT00926848|12223466|FG000|COMPLETED|Overall Study||34
11043349|NCT00926848|12223467|FG001|COMPLETED|Overall Study||34
11043350|NCT00926848|12223466|FG000|NOT COMPLETED|Overall Study||0
11043351|NCT00926848|12223467|FG001|NOT COMPLETED|Overall Study||0
11043352|NCT00926887|12223485|FG000|STARTED|Overall Study||54
11043353|NCT00926887|12223486|FG001|STARTED|Overall Study||50
11043354|NCT00926887|12223485|FG000|COMPLETED|Overall Study||54
11043355|NCT00926887|12223486|FG001|COMPLETED|Overall Study||50
11043356|NCT00926887|12223485|FG000|NOT COMPLETED|Overall Study||0
11043357|NCT00926887|12223486|FG001|NOT COMPLETED|Overall Study||0
11043358|NCT00926952|12223492|FG000|STARTED|Overall Study||20
11043359|NCT00926952|12223492|FG000|COMPLETED|Overall Study||20
11043360|NCT00926952|12223492|FG000|NOT COMPLETED|Overall Study||0
11043361|NCT00927069|12223498|FG000|STARTED|Week 0 to Week 12||50
11043362|NCT00927069|12223499|FG001|STARTED|Week 0 to Week 12||35
11043363|NCT00927069|12223500|FG002|STARTED|Week 0 to Week 12||0
11043364|NCT00927069|12223501|FG003|STARTED|Week 0 to Week 12||0
11043365|NCT00927069|12223498|FG000|COMPLETED|Week 0 to Week 12||49
11043366|NCT00927069|12223499|FG001|COMPLETED|Week 0 to Week 12||34
11043367|NCT00927069|12223500|FG002|COMPLETED|Week 0 to Week 12||0
11043368|NCT00927069|12223501|FG003|COMPLETED|Week 0 to Week 12||0
11043369|NCT00927069|12223498|FG000|NOT COMPLETED|Week 0 to Week 12||1
11043370|NCT00927069|12223499|FG001|NOT COMPLETED|Week 0 to Week 12||1
11043371|NCT00927069|12223500|FG002|NOT COMPLETED|Week 0 to Week 12||0
11043372|NCT00927069|12223501|FG003|NOT COMPLETED|Week 0 to Week 12||0
11043373|NCT00927069|12223498|FG000|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
11043374|NCT00927069|12223499|FG001|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
11043375|NCT00927069|12223500|FG002|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
11043376|NCT00927069|12223501|FG003|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
11043377|NCT00927069|12223498|FG000|COMPLETED|Week 12 to Week 24||16
11043378|NCT00927069|12223499|FG001|COMPLETED|Week 12 to Week 24||11
11043379|NCT00927069|12223500|FG002|COMPLETED|Week 12 to Week 24||28
11043380|NCT00927069|12223501|FG003|COMPLETED|Week 12 to Week 24||20
11043381|NCT00927069|12223498|FG000|NOT COMPLETED|Week 12 to Week 24||2
11043382|NCT00927069|12223499|FG001|NOT COMPLETED|Week 12 to Week 24||0
11043383|NCT00927069|12223500|FG002|NOT COMPLETED|Week 12 to Week 24||3
11043384|NCT00927069|12223501|FG003|NOT COMPLETED|Week 12 to Week 24||3
11043385|NCT00927082|12223515|FG000|STARTED|Overall Study||91
11043386|NCT00927082|12223516|FG001|STARTED|Overall Study||87
11043387|NCT00927082|12223517|FG002|STARTED|Overall Study||108
11043388|NCT00927082|12223518|FG003|STARTED|Overall Study||97
11043389|NCT00927082|12223515|FG000|COMPLETED|Overall Study||79
11043390|NCT00927082|12223516|FG001|COMPLETED|Overall Study||77
11043391|NCT00927082|12223517|FG002|COMPLETED|Overall Study||86
11043392|NCT00927082|12223518|FG003|COMPLETED|Overall Study||78
11043393|NCT00927082|12223515|FG000|NOT COMPLETED|Overall Study||12
11043394|NCT00927082|12223516|FG001|NOT COMPLETED|Overall Study||10
11043395|NCT00927082|12223517|FG002|NOT COMPLETED|Overall Study||22
11043396|NCT00927082|12223518|FG003|NOT COMPLETED|Overall Study||19
11043397|NCT00927095|12223535|FG000|STARTED|Overall Study||22
11043398|NCT00927095|12223536|FG001|STARTED|Overall Study||21
11043399|NCT00927095|12223537|FG002|STARTED|Overall Study||24
11043400|NCT00927095|12223535|FG000|COMPLETED|Overall Study||16
11043401|NCT00927095|12223536|FG001|COMPLETED|Overall Study||17
11043402|NCT00927095|12223537|FG002|COMPLETED|Overall Study||22
11043403|NCT00927095|12223535|FG000|NOT COMPLETED|Overall Study||6
11043404|NCT00927095|12223536|FG001|NOT COMPLETED|Overall Study||4
11043405|NCT00927095|12223537|FG002|NOT COMPLETED|Overall Study||2
11043406|NCT00927160|12223547|FG000|STARTED|Overall Study||173
11043407|NCT00927160|12223548|FG001|STARTED|Overall Study||173
11043408|NCT00927160|12223547|FG000|COMPLETED|Overall Study||173
11043409|NCT00927160|12223548|FG001|COMPLETED|Overall Study||173
11043410|NCT00927160|12223547|FG000|NOT COMPLETED|Overall Study||0
11043411|NCT00927160|12223548|FG001|NOT COMPLETED|Overall Study||0
11043412|NCT00927186|12223556|FG000|STARTED|12 Months Primary Study||34
11043413|NCT00927186|12223557|FG001|STARTED|12 Months Primary Study||35
11043414|NCT00927186|12223556|FG000|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
11043415|NCT00927186|12223557|FG001|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
11043416|NCT00927186|12223556|FG000|COMPLETED|12 Months Primary Study||27
11043417|NCT00927186|12223557|FG001|COMPLETED|12 Months Primary Study||31
11043418|NCT00927186|12223556|FG000|NOT COMPLETED|12 Months Primary Study||7
11043419|NCT00927186|12223557|FG001|NOT COMPLETED|12 Months Primary Study||4
11043420|NCT00927186|12223556|FG000|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
11043421|NCT00927186|12223557|FG001|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
11043422|NCT00927186|12223556|FG000|COMPLETED|12 - 24 Months Extension Treatment||10
11043423|NCT00927186|12223557|FG001|COMPLETED|12 - 24 Months Extension Treatment||11
11043424|NCT00927186|12223556|FG000|NOT COMPLETED|12 - 24 Months Extension Treatment||0
11043425|NCT00927186|12223557|FG001|NOT COMPLETED|12 - 24 Months Extension Treatment||0
11043426|NCT00927251|12223566|FG000|STARTED|Overall Study||90
11043427|NCT00927251|12223566|FG000|COMPLETED|Overall Study||82
11043428|NCT00927251|12223566|FG000|NOT COMPLETED|Overall Study||8
11043429|NCT00927264|12223572|FG000|STARTED|Overall Study||165
11043430|NCT00927264|12223573|FG001|STARTED|Overall Study||165
11043431|NCT00927264|12223572|FG000|COMPLETED|Overall Study||109
11043432|NCT00927264|12223573|FG001|COMPLETED|Overall Study||140
11043433|NCT00927264|12223572|FG000|NOT COMPLETED|Overall Study||56
11043434|NCT00927264|12223573|FG001|NOT COMPLETED|Overall Study||25
11043435|NCT00927355|12223583|FG000|STARTED|Overall Study||5
11043436|NCT00927355|12223584|FG001|STARTED|Overall Study||5
11043437|NCT00927355|12223583|FG000|COMPLETED|Overall Study||4
11043438|NCT00927355|12223584|FG001|COMPLETED|Overall Study||4
11043439|NCT00927355|12223583|FG000|NOT COMPLETED|Overall Study||1
11043440|NCT00927355|12223584|FG001|NOT COMPLETED|Overall Study||1
11043441|NCT00927368|12223605|FG000|STARTED|Overall Study||153
11043442|NCT00927368|12223606|FG001|STARTED|Overall Study||157
11043443|NCT00927368|12223607|FG002|STARTED|Overall Study||143
11043444|NCT00927368|12223605|FG000|COMPLETED|Overall Study||147
11043445|NCT00927368|12223606|FG001|COMPLETED|Overall Study||152
11043446|NCT00927368|12223607|FG002|COMPLETED|Overall Study||138
11043447|NCT00927368|12223605|FG000|NOT COMPLETED|Overall Study||6
11043448|NCT00927368|12223606|FG001|NOT COMPLETED|Overall Study||5
11043449|NCT00927368|12223607|FG002|NOT COMPLETED|Overall Study||5
11043450|NCT00927394|12223617|FG000|STARTED|Overall Study||575
11043451|NCT00927394|12223618|FG001|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
11043452|NCT00927394|12223617|FG000|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
11043453|NCT00927394|12223618|FG001|Cohort 1 (Randomized)|Overall Study||165
11043454|NCT00927394|12223617|FG000|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
11043455|NCT00927394|12223618|FG001|Cohort 2 (Randomized)|Overall Study||403
11043456|NCT00927394|12223617|FG000|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
11043457|NCT00927394|12223618|FG001|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
11043458|NCT00927394|12223617|FG000|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
11043459|NCT00927394|12223618|FG001|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
11043460|NCT00927394|12223617|FG000|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
11043461|NCT00927394|12223618|FG001|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
11043462|NCT00927394|12223617|FG000|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
11043463|NCT00927394|12223618|FG001|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
11043464|NCT00927394|12223617|FG000|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
11043465|NCT00927394|12223618|FG001|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
11043466|NCT00927394|12223617|FG000|COMPLETED|Overall Study||498
11043467|NCT00927394|12223618|FG001|COMPLETED|Overall Study||483
11043468|NCT00927394|12223617|FG000|NOT COMPLETED|Overall Study||77
11043469|NCT00927394|12223618|FG001|NOT COMPLETED|Overall Study||85
11043470|NCT00927472|12223627|FG000|STARTED|Overall Study||126
11043471|NCT00927472|12223628|FG001|STARTED|Overall Study||128
11043472|NCT00927472|12223627|FG000|COMPLETED|Overall Study||115
11043473|NCT00927472|12223628|FG001|COMPLETED|Overall Study||106
11043474|NCT00927472|12223627|FG000|NOT COMPLETED|Overall Study||11
11043475|NCT00927472|12223628|FG001|NOT COMPLETED|Overall Study||22
11043476|NCT00927485|12223636|FG000|STARTED|Overall Study||21
11043477|NCT00927485|12223637|FG001|STARTED|Overall Study||23
11043478|NCT00927485|12223636|FG000|COMPLETED|Overall Study||15
11043479|NCT00927485|12223637|FG001|COMPLETED|Overall Study||19
11043480|NCT00927485|12223636|FG000|NOT COMPLETED|Overall Study||6
11043481|NCT00927485|12223637|FG001|NOT COMPLETED|Overall Study||4
11043482|NCT00927563|12223643|FG000|STARTED|Overall Study||24
11043483|NCT00927563|12223643|FG000|COMPLETED|Overall Study||22
11043484|NCT00927563|12223643|FG000|NOT COMPLETED|Overall Study||2
11043485|NCT00927576|12223649|FG000|STARTED|Overall Study||237
11043486|NCT00927576|12223650|FG001|STARTED|Overall Study||28
11043487|NCT00927576|12223649|FG000|Cognitive Testing|Overall Study||237
11043488|NCT00927576|12223650|FG001|Cognitive Testing|Overall Study||28
11043489|NCT00927576|12223649|FG000|COMPLETED|Overall Study||237
11043490|NCT00927576|12223650|FG001|COMPLETED|Overall Study||28
11043491|NCT00927576|12223649|FG000|NOT COMPLETED|Overall Study||0
11043492|NCT00927576|12223650|FG001|NOT COMPLETED|Overall Study||0
11043493|NCT00927589|12223655|FG000|STARTED|Overall Study||59
11043494|NCT00927589|12223655|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
11043495|NCT00927589|12223655|FG000|NOT COMPLETED|Overall Study||16
11043496|NCT00927758|12223659|FG000|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
11043497|NCT00927758|12223660|FG001|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
11043498|NCT00927758|12223661|FG002|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
11043499|NCT00927758|12223662|FG003|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
11043500|NCT00927758|12223663|FG004|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
11043501|NCT00927758|12223664|FG005|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
11043502|NCT00927758|12223659|FG000|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
11043503|NCT00927758|12223660|FG001|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
11043504|NCT00927758|12223661|FG002|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
11043505|NCT00927758|12223662|FG003|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
11043506|NCT00927758|12223663|FG004|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
11057919|NCT01000818|12239669|FG000|COMPLETED|Omeprazole + Raltegravir||18
11043507|NCT00927758|12223664|FG005|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
11043508|NCT00927758|12223659|FG000|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
11043509|NCT00927758|12223660|FG001|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
11043510|NCT00927758|12223661|FG002|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
11043511|NCT00927758|12223662|FG003|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
11043512|NCT00927758|12223663|FG004|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
11043513|NCT00927758|12223664|FG005|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
11043514|NCT00927758|12223659|FG000|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
11043515|NCT00927758|12223660|FG001|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
11043516|NCT00927758|12223661|FG002|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
11043517|NCT00927758|12223662|FG003|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
11043518|NCT00927758|12223663|FG004|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
11043519|NCT00927758|12223664|FG005|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
11043520|NCT00927758|12223659|FG000|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
11043521|NCT00927758|12223660|FG001|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
11043522|NCT00927758|12223661|FG002|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
11043523|NCT00927758|12223662|FG003|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
11043524|NCT00927758|12223663|FG004|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
11043525|NCT00927758|12223664|FG005|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
11043526|NCT00927758|12223659|FG000|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
11043527|NCT00927758|12223660|FG001|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
11043528|NCT00927758|12223661|FG002|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
11043529|NCT00927758|12223662|FG003|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
11043530|NCT00927758|12223663|FG004|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
11043531|NCT00927758|12223664|FG005|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
11043532|NCT00927758|12223659|FG000|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
11043533|NCT00927758|12223660|FG001|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
11043534|NCT00927758|12223661|FG002|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
11043535|NCT00927758|12223662|FG003|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
11043536|NCT00927758|12223663|FG004|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
11043537|NCT00927758|12223664|FG005|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
11043538|NCT00927758|12223659|FG000|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
11043539|NCT00927758|12223660|FG001|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
11043540|NCT00927758|12223661|FG002|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
11043541|NCT00927758|12223662|FG003|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
11043542|NCT00927758|12223663|FG004|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
11201259|NCT01831466|12391484|FG010|STARTED|Overall Study|Treated|6
11336438|NCT02876757|12534129|FG000|NOT COMPLETED|Overall Study||0
11336439|NCT02876757|12534130|FG001|NOT COMPLETED|Overall Study||0
11336440|NCT02876887|12534138|FG000|STARTED|Overall Study||23
11336441|NCT02876887|12534139|FG001|STARTED|Overall Study||21
11336442|NCT02876887|12534138|FG000|COMPLETED|Overall Study||19
11336443|NCT02876887|12534139|FG001|COMPLETED|Overall Study||21
11336444|NCT02876887|12534138|FG000|NOT COMPLETED|Overall Study||4
11336445|NCT02876887|12534139|FG001|NOT COMPLETED|Overall Study||0
11336446|NCT02876900|12534148|FG000|STARTED|Overall Study||205
11336447|NCT02876900|12534149|FG001|STARTED|Overall Study||206
11336448|NCT02876900|12534150|FG002|STARTED|Overall Study||206
11336449|NCT02876900|12534148|FG000|COMPLETED|Overall Study||166
11336450|NCT02876900|12534149|FG001|COMPLETED|Overall Study||158
11336451|NCT02876900|12534150|FG002|COMPLETED|Overall Study||162
11336452|NCT02876900|12534148|FG000|NOT COMPLETED|Overall Study||39
11043543|NCT00927758|12223664|FG005|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
11043544|NCT00927758|12223659|FG000|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
11043545|NCT00927758|12223660|FG001|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
11043546|NCT00927758|12223661|FG002|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
11043547|NCT00927758|12223662|FG003|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
11336453|NCT02876900|12534149|FG001|NOT COMPLETED|Overall Study||48
11336454|NCT02876900|12534150|FG002|NOT COMPLETED|Overall Study||44
11336455|NCT02876926|12534161|FG000|STARTED|Overall Study||21
11336456|NCT02876926|12534162|FG001|STARTED|Overall Study||22
11336457|NCT02876926|12534163|FG002|STARTED|Overall Study||22
11336458|NCT02876926|12534161|FG000|COMPLETED|Overall Study||3
11336459|NCT02876926|12534162|FG001|COMPLETED|Overall Study||3
11336460|NCT02876926|12534163|FG002|COMPLETED|Overall Study||2
11336461|NCT02876926|12534161|FG000|NOT COMPLETED|Overall Study||18
11043548|NCT00927758|12223663|FG004|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
11201260|NCT01831466|12391485|FG011|STARTED|Overall Study|Treated|7
11201261|NCT01831466|12391474|FG000|COMPLETED|Overall Study||55
11201262|NCT01831466|12391475|FG001|COMPLETED|Overall Study||52
11201263|NCT01831466|12391476|FG002|COMPLETED|Overall Study||48
11201264|NCT01831466|12391477|FG003|COMPLETED|Overall Study||51
11201265|NCT01831466|12391478|FG004|COMPLETED|Overall Study||57
11201266|NCT01831466|12391479|FG005|COMPLETED|Overall Study||48
11201267|NCT01831466|12391480|FG006|COMPLETED|Overall Study||6
11201268|NCT01831466|12391481|FG007|COMPLETED|Overall Study||5
11201269|NCT01831466|12391482|FG008|COMPLETED|Overall Study||4
11201270|NCT01831466|12391483|FG009|COMPLETED|Overall Study||2
11201271|NCT01831466|12391484|FG010|COMPLETED|Overall Study||4
11201272|NCT01831466|12391485|FG011|COMPLETED|Overall Study||3
11201273|NCT01831466|12391474|FG000|NOT COMPLETED|Overall Study||16
11201274|NCT01831466|12391475|FG001|NOT COMPLETED|Overall Study||18
11336462|NCT02876926|12534162|FG001|NOT COMPLETED|Overall Study||19
11336463|NCT02876926|12534163|FG002|NOT COMPLETED|Overall Study||20
11336464|NCT02877004|12534174|FG000|STARTED|Overall Study||20
11336465|NCT02877004|12534175|FG001|STARTED|Overall Study||20
11336466|NCT02877004|12534176|FG002|STARTED|Overall Study||20
11336467|NCT02877004|12534174|FG000|COMPLETED|Overall Study||20
11336468|NCT02877004|12534175|FG001|COMPLETED|Overall Study||20
11336469|NCT02877004|12534176|FG002|COMPLETED|Overall Study||19
11336470|NCT02877004|12534174|FG000|NOT COMPLETED|Overall Study||0
11336471|NCT02877004|12534175|FG001|NOT COMPLETED|Overall Study||0
11336472|NCT02877004|12534176|FG002|NOT COMPLETED|Overall Study||1
11336473|NCT02877082|12534184|FG000|STARTED|Overall Study||5
11336474|NCT02877082|12534184|FG000|COMPLETED|Overall Study||0
11336475|NCT02877082|12534184|FG000|NOT COMPLETED|Overall Study||5
11336476|NCT02877095|12534190|FG000|STARTED|Overall Study|First patient enrolled 1/9/17.|20
11336477|NCT02877095|12534191|FG001|STARTED|Overall Study||20
11336478|NCT02877095|12534190|FG000|COMPLETED|Overall Study||20
11336479|NCT02877095|12534191|FG001|COMPLETED|Overall Study||20
11336480|NCT02877095|12534190|FG000|NOT COMPLETED|Overall Study||0
11336481|NCT02877095|12534191|FG001|NOT COMPLETED|Overall Study||0
11336482|NCT02877485|12534199|FG000|STARTED|Overall Study||22
11336483|NCT02877485|12534200|FG001|STARTED|Overall Study||20
11336484|NCT02877485|12534199|FG000|COMPLETED|Overall Study||22
11336485|NCT02877485|12534200|FG001|COMPLETED|Overall Study||20
11336486|NCT02877485|12534199|FG000|NOT COMPLETED|Overall Study||0
11336487|NCT02877485|12534200|FG001|NOT COMPLETED|Overall Study||0
11336488|NCT02877680|12534209|FG000|STARTED|Overall Study||55
11336489|NCT02877680|12534210|FG001|STARTED|Overall Study||25
11336490|NCT02877680|12534209|FG000|COMPLETED|Overall Study||54
11336491|NCT02877680|12534210|FG001|COMPLETED|Overall Study||24
11336492|NCT02877680|12534209|FG000|NOT COMPLETED|Overall Study||1
11336493|NCT02877680|12534210|FG001|NOT COMPLETED|Overall Study||1
11343854|NCT02956486|12541124|FG002|STARTED|Extension Phase|Eligible participants who completed core and consented for extension phase, entered extension phase.|19
11343855|NCT02956486|12541122|FG000|Treated|Extension Phase||0
11343856|NCT02956486|12541123|FG001|Treated|Extension Phase||0
11343857|NCT02956486|12541124|FG002|Treated|Extension Phase||18
11343858|NCT02956486|12541122|FG000|Safety Analysis Set (SAS)|Extension Phase||0
11343859|NCT02956486|12541123|FG001|Safety Analysis Set (SAS)|Extension Phase||0
11343860|NCT02956486|12541124|FG002|Safety Analysis Set (SAS)|Extension Phase||18
11343861|NCT02956486|12541122|FG000|COMPLETED|Extension Phase||0
11343862|NCT02956486|12541123|FG001|COMPLETED|Extension Phase||0
11343863|NCT02956486|12541124|FG002|COMPLETED|Extension Phase||0
11343864|NCT02956486|12541122|FG000|NOT COMPLETED|Extension Phase||0
11343865|NCT02956486|12541123|FG001|NOT COMPLETED|Extension Phase||0
11343866|NCT02956486|12541124|FG002|NOT COMPLETED|Extension Phase||19
11343867|NCT02956616|12541135|FG000|STARTED|Overall Study||58
11343868|NCT02956616|12541136|FG001|STARTED|Overall Study||60
11043549|NCT00927758|12223664|FG005|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
11043550|NCT00927758|12223659|FG000|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
11043551|NCT00927758|12223660|FG001|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
11043552|NCT00927758|12223661|FG002|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
11043553|NCT00927758|12223662|FG003|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
11043554|NCT00927758|12223663|FG004|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
11043555|NCT00927758|12223664|FG005|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
11043556|NCT00927758|12223659|FG000|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
11043557|NCT00927758|12223660|FG001|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
11043558|NCT00927758|12223661|FG002|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
11043559|NCT00927758|12223662|FG003|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
11043560|NCT00927758|12223663|FG004|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
11043561|NCT00927758|12223664|FG005|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
11043562|NCT00927784|12223674|FG000|STARTED|Overall Study||8
11043563|NCT00927784|12223675|FG001|STARTED|Overall Study||2
11043564|NCT00927784|12223674|FG000|COMPLETED|Overall Study||6
11043565|NCT00927784|12223675|FG001|COMPLETED|Overall Study||2
11043566|NCT00927784|12223674|FG000|NOT COMPLETED|Overall Study||2
11043567|NCT00927784|12223675|FG001|NOT COMPLETED|Overall Study||0
11043568|NCT00927810|12223685|FG000|STARTED|Overall Study||75
11043569|NCT00927810|12223686|FG001|STARTED|Overall Study||181
11043570|NCT00927810|12223687|FG002|STARTED|Overall Study||25
11043571|NCT00927810|12223688|FG003|STARTED|Overall Study||60
11043572|NCT00927810|12223685|FG000|COMPLETED|Overall Study||75
11043573|NCT00927810|12223686|FG001|COMPLETED|Overall Study||173
11043574|NCT00927810|12223687|FG002|COMPLETED|Overall Study||24
11043575|NCT00927810|12223688|FG003|COMPLETED|Overall Study||58
11343869|NCT02956616|12541135|FG000|COMPLETED|Overall Study||58
11343870|NCT02956616|12541136|FG001|COMPLETED|Overall Study||60
11343871|NCT02956616|12541135|FG000|NOT COMPLETED|Overall Study||0
11343872|NCT02956616|12541136|FG001|NOT COMPLETED|Overall Study||0
11343873|NCT02956629|12541148|FG000|STARTED|Overall Study||78
11343874|NCT02956629|12541149|FG001|STARTED|Overall Study||47
11343875|NCT02956629|12541150|FG002|STARTED|Overall Study||61
11343876|NCT02956629|12541151|FG003|STARTED|Overall Study||56
11343877|NCT02956629|12541152|FG004|STARTED|Overall Study||18
11343878|NCT02956629|12541153|FG005|STARTED|Overall Study||22
11343879|NCT02956629|12541148|FG000|COMPLETED|Overall Study||73
11343880|NCT02956629|12541149|FG001|COMPLETED|Overall Study||41
11343881|NCT02956629|12541150|FG002|COMPLETED|Overall Study||57
11043576|NCT00927810|12223685|FG000|NOT COMPLETED|Overall Study||0
11043577|NCT00927810|12223686|FG001|NOT COMPLETED|Overall Study||8
11043578|NCT00927810|12223687|FG002|NOT COMPLETED|Overall Study||1
11043579|NCT00927810|12223688|FG003|NOT COMPLETED|Overall Study||2
11043580|NCT00927823|12223706|FG000|STARTED|Lead-In Period||3
11043581|NCT00927823|12223707|FG001|STARTED|Lead-In Period||3
11043582|NCT00927823|12223708|FG002|STARTED|Lead-In Period||26
11043583|NCT00927823|12223709|FG003|STARTED|Lead-In Period||5
11043584|NCT00927823|12223706|FG000|COMPLETED|Lead-In Period||3
11043585|NCT00927823|12223707|FG001|COMPLETED|Lead-In Period||3
11043586|NCT00927823|12223708|FG002|COMPLETED|Lead-In Period||26
11043587|NCT00927823|12223709|FG003|COMPLETED|Lead-In Period||5
11043588|NCT00927823|12223706|FG000|NOT COMPLETED|Lead-In Period||0
11043589|NCT00927823|12223707|FG001|NOT COMPLETED|Lead-In Period||0
11043590|NCT00927823|12223708|FG002|NOT COMPLETED|Lead-In Period||0
11043591|NCT00927823|12223709|FG003|NOT COMPLETED|Lead-In Period||0
11043592|NCT00927823|12223706|FG000|STARTED|Continuous Dosing Period||3
11043593|NCT00927823|12223707|FG001|STARTED|Continuous Dosing Period||3
11043594|NCT00927823|12223708|FG002|STARTED|Continuous Dosing Period||26
11043595|NCT00927823|12223709|FG003|STARTED|Continuous Dosing Period||5
11043596|NCT00927823|12223706|FG000|Treated|Continuous Dosing Period||3
11043597|NCT00927823|12223707|FG001|Treated|Continuous Dosing Period||3
11043598|NCT00927823|12223708|FG002|Treated|Continuous Dosing Period||23
11043599|NCT00927823|12223709|FG003|Treated|Continuous Dosing Period||5
11043600|NCT00927823|12223706|FG000|COMPLETED|Continuous Dosing Period||0
11043601|NCT00927823|12223707|FG001|COMPLETED|Continuous Dosing Period||0
11043602|NCT00927823|12223708|FG002|COMPLETED|Continuous Dosing Period||0
11043603|NCT00927823|12223709|FG003|COMPLETED|Continuous Dosing Period||0
11043604|NCT00927823|12223706|FG000|NOT COMPLETED|Continuous Dosing Period||3
11043605|NCT00927823|12223707|FG001|NOT COMPLETED|Continuous Dosing Period||3
11043606|NCT00927823|12223708|FG002|NOT COMPLETED|Continuous Dosing Period||26
11043607|NCT00927823|12223709|FG003|NOT COMPLETED|Continuous Dosing Period||5
11043608|NCT00927849|12223729|FG000|STARTED|Overall Study||21
11043609|NCT00927849|12223730|FG001|STARTED|Overall Study||21
11043610|NCT00927849|12223731|FG002|STARTED|Overall Study||21
11043611|NCT00927849|12223729|FG000|COMPLETED|Overall Study||21
11043612|NCT00927849|12223730|FG001|COMPLETED|Overall Study||21
11043613|NCT00927849|12223731|FG002|COMPLETED|Overall Study||21
11043614|NCT00927849|12223729|FG000|NOT COMPLETED|Overall Study||0
11043615|NCT00927849|12223730|FG001|NOT COMPLETED|Overall Study||0
11043616|NCT00927849|12223731|FG002|NOT COMPLETED|Overall Study||0
11043617|NCT00927862|12223741|FG000|STARTED|Overall Study||504
11043618|NCT00927862|12223742|FG001|STARTED|Overall Study||1911
11043619|NCT00927862|12223741|FG000|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
11043620|NCT00927862|12223742|FG001|COMPLETED|Overall Study||1866
11043621|NCT00927862|12223741|FG000|NOT COMPLETED|Overall Study||27
11043622|NCT00927862|12223742|FG001|NOT COMPLETED|Overall Study||45
11043623|NCT00927888|12223752|FG000|STARTED|Overall Study||29
11043624|NCT00927888|12223753|FG001|STARTED|Overall Study||27
11336494|NCT02877927|12534222|FG000|STARTED|Overall Study||368
11336495|NCT02877927|12534223|FG001|STARTED|Overall Study||367
11336496|NCT02877927|12534222|FG000|COMPLETED|Overall Study||314
11336497|NCT02877927|12534223|FG001|COMPLETED|Overall Study||310
11043625|NCT00927888|12223752|FG000|COMPLETED|Overall Study||29
11043626|NCT00927888|12223753|FG001|COMPLETED|Overall Study||27
11043627|NCT00927888|12223752|FG000|NOT COMPLETED|Overall Study||0
11043628|NCT00927888|12223753|FG001|NOT COMPLETED|Overall Study||0
11043629|NCT00927901|12223761|FG000|STARTED|Treatment Period 1||7
11043630|NCT00927901|12223762|FG001|STARTED|Treatment Period 1||7
11043631|NCT00927901|12223763|FG002|STARTED|Treatment Period 1||7
11043632|NCT00927901|12223764|FG003|STARTED|Treatment Period 1||9
11043633|NCT00927901|12223761|FG000|COMPLETED|Treatment Period 1||7
11043634|NCT00927901|12223762|FG001|COMPLETED|Treatment Period 1||7
11043635|NCT00927901|12223763|FG002|COMPLETED|Treatment Period 1||6
11043636|NCT00927901|12223764|FG003|COMPLETED|Treatment Period 1||9
11043637|NCT00927901|12223761|FG000|NOT COMPLETED|Treatment Period 1||0
11043638|NCT00927901|12223762|FG001|NOT COMPLETED|Treatment Period 1||0
11043639|NCT00927901|12223763|FG002|NOT COMPLETED|Treatment Period 1||1
11043640|NCT00927901|12223764|FG003|NOT COMPLETED|Treatment Period 1||0
11043641|NCT00927901|12223761|FG000|STARTED|Treatment Period 2||7
11043642|NCT00927901|12223762|FG001|STARTED|Treatment Period 2||7
11043643|NCT00927901|12223763|FG002|STARTED|Treatment Period 2||6
11043644|NCT00927901|12223764|FG003|STARTED|Treatment Period 2||9
11043645|NCT00927901|12223761|FG000|COMPLETED|Treatment Period 2||7
11043646|NCT00927901|12223762|FG001|COMPLETED|Treatment Period 2||7
11043647|NCT00927901|12223763|FG002|COMPLETED|Treatment Period 2||6
11043648|NCT00927901|12223764|FG003|COMPLETED|Treatment Period 2||9
11043649|NCT00927901|12223761|FG000|NOT COMPLETED|Treatment Period 2||0
11043650|NCT00927901|12223762|FG001|NOT COMPLETED|Treatment Period 2||0
11043651|NCT00927901|12223763|FG002|NOT COMPLETED|Treatment Period 2||0
11043652|NCT00927901|12223764|FG003|NOT COMPLETED|Treatment Period 2||0
11043653|NCT00927901|12223761|FG000|STARTED|Treatment Period 3||7
11043654|NCT00927901|12223762|FG001|STARTED|Treatment Period 3||7
11043655|NCT00927901|12223763|FG002|STARTED|Treatment Period 3||6
11043656|NCT00927901|12223764|FG003|STARTED|Treatment Period 3||9
11043657|NCT00927901|12223761|FG000|COMPLETED|Treatment Period 3||7
11043658|NCT00927901|12223762|FG001|COMPLETED|Treatment Period 3||7
11336498|NCT02877927|12534222|FG000|NOT COMPLETED|Overall Study||54
11043659|NCT00927901|12223763|FG002|COMPLETED|Treatment Period 3||6
11043660|NCT00927901|12223764|FG003|COMPLETED|Treatment Period 3||9
11043661|NCT00927901|12223761|FG000|NOT COMPLETED|Treatment Period 3||0
11043662|NCT00927901|12223762|FG001|NOT COMPLETED|Treatment Period 3||0
11043663|NCT00927901|12223763|FG002|NOT COMPLETED|Treatment Period 3||0
11043664|NCT00927901|12223764|FG003|NOT COMPLETED|Treatment Period 3||0
11043665|NCT00927901|12223761|FG000|STARTED|Treatment Period 4||7
11043666|NCT00927901|12223762|FG001|STARTED|Treatment Period 4||7
11043667|NCT00927901|12223763|FG002|STARTED|Treatment Period 4||6
11043668|NCT00927901|12223764|FG003|STARTED|Treatment Period 4||9
11043669|NCT00927901|12223761|FG000|COMPLETED|Treatment Period 4||7
11043670|NCT00927901|12223762|FG001|COMPLETED|Treatment Period 4||7
11043671|NCT00927901|12223763|FG002|COMPLETED|Treatment Period 4||5
11043672|NCT00927901|12223764|FG003|COMPLETED|Treatment Period 4||8
11043673|NCT00927901|12223761|FG000|NOT COMPLETED|Treatment Period 4||0
11043674|NCT00927901|12223762|FG001|NOT COMPLETED|Treatment Period 4||0
11043675|NCT00927901|12223763|FG002|NOT COMPLETED|Treatment Period 4||1
11043676|NCT00927901|12223764|FG003|NOT COMPLETED|Treatment Period 4||1
11043677|NCT00927927|12223792|FG000|STARTED|Overall Study||3
11043678|NCT00927927|12223793|FG001|STARTED|Overall Study||3
11043679|NCT00927927|12223794|FG002|STARTED|Overall Study||3
11043680|NCT00927927|12223795|FG003|STARTED|Overall Study||3
11043681|NCT00927927|12223796|FG004|STARTED|Overall Study||3
11043682|NCT00927927|12223797|FG005|STARTED|Overall Study||3
11043683|NCT00927927|12223798|FG006|STARTED|Overall Study||3
11043684|NCT00927927|12223799|FG007|STARTED|Overall Study||3
11043685|NCT00927927|12223800|FG008|STARTED|Overall Study||8
11043686|NCT00927927|12223801|FG009|STARTED|Overall Study||3
11043687|NCT00927927|12223802|FG010|STARTED|Overall Study||5
11043688|NCT00927927|12223803|FG011|STARTED|Overall Study||6
11043689|NCT00927927|12223804|FG012|STARTED|Overall Study||5
11043690|NCT00927927|12223805|FG013|STARTED|Overall Study||5
11043691|NCT00927927|12223806|FG014|STARTED|Overall Study||9
11043692|NCT00927927|12223792|FG000|Exposed|Overall Study||3
11043693|NCT00927927|12223793|FG001|Exposed|Overall Study||3
11043694|NCT00927927|12223794|FG002|Exposed|Overall Study||3
11043695|NCT00927927|12223795|FG003|Exposed|Overall Study||3
11043696|NCT00927927|12223796|FG004|Exposed|Overall Study||3
11336499|NCT02877927|12534223|FG001|NOT COMPLETED|Overall Study||57
11336500|NCT02878057|12534229|FG000|STARTED|Overall Study||30
11043697|NCT00927927|12223797|FG005|Exposed|Overall Study||3
11043698|NCT00927927|12223798|FG006|Exposed|Overall Study||3
11043699|NCT00927927|12223799|FG007|Exposed|Overall Study||3
11043700|NCT00927927|12223800|FG008|Exposed|Overall Study||8
11043701|NCT00927927|12223801|FG009|Exposed|Overall Study||3
11043702|NCT00927927|12223802|FG010|Exposed|Overall Study||5
11043703|NCT00927927|12223803|FG011|Exposed|Overall Study||5
11043704|NCT00927927|12223804|FG012|Exposed|Overall Study||5
11043705|NCT00927927|12223805|FG013|Exposed|Overall Study||5
11043706|NCT00927927|12223806|FG014|Exposed|Overall Study||9
11043707|NCT00927927|12223792|FG000|COMPLETED|Overall Study||3
11043708|NCT00927927|12223793|FG001|COMPLETED|Overall Study||3
11043709|NCT00927927|12223794|FG002|COMPLETED|Overall Study||3
11043710|NCT00927927|12223795|FG003|COMPLETED|Overall Study||3
11043711|NCT00927927|12223796|FG004|COMPLETED|Overall Study||3
11043712|NCT00927927|12223797|FG005|COMPLETED|Overall Study||3
11336501|NCT02878057|12534229|FG000|COMPLETED|Overall Study||26
11043713|NCT00927927|12223798|FG006|COMPLETED|Overall Study||3
11043714|NCT00927927|12223799|FG007|COMPLETED|Overall Study||1
11043715|NCT00927927|12223800|FG008|COMPLETED|Overall Study||8
11043716|NCT00927927|12223801|FG009|COMPLETED|Overall Study||3
11043717|NCT00927927|12223802|FG010|COMPLETED|Overall Study||5
11043718|NCT00927927|12223803|FG011|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
11043719|NCT00927927|12223804|FG012|COMPLETED|Overall Study||5
11043720|NCT00927927|12223805|FG013|COMPLETED|Overall Study||5
11043721|NCT00927927|12223806|FG014|COMPLETED|Overall Study||9
11043722|NCT00927927|12223792|FG000|NOT COMPLETED|Overall Study||0
11043723|NCT00927927|12223793|FG001|NOT COMPLETED|Overall Study||0
11043724|NCT00927927|12223794|FG002|NOT COMPLETED|Overall Study||0
11043725|NCT00927927|12223795|FG003|NOT COMPLETED|Overall Study||0
11043726|NCT00927927|12223796|FG004|NOT COMPLETED|Overall Study||0
11043727|NCT00927927|12223797|FG005|NOT COMPLETED|Overall Study||0
11043728|NCT00927927|12223798|FG006|NOT COMPLETED|Overall Study||0
11043729|NCT00927927|12223799|FG007|NOT COMPLETED|Overall Study||2
11043730|NCT00927927|12223800|FG008|NOT COMPLETED|Overall Study||0
11043731|NCT00927927|12223801|FG009|NOT COMPLETED|Overall Study||0
11043732|NCT00927927|12223802|FG010|NOT COMPLETED|Overall Study||0
11043733|NCT00927927|12223803|FG011|NOT COMPLETED|Overall Study||2
11043734|NCT00927927|12223804|FG012|NOT COMPLETED|Overall Study||0
11043735|NCT00927927|12223805|FG013|NOT COMPLETED|Overall Study||0
11043736|NCT00927927|12223806|FG014|NOT COMPLETED|Overall Study||0
11043737|NCT00927940|12223838|FG000|STARTED|Overall Study||100
11043738|NCT00927940|12223838|FG000|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
11043739|NCT00927940|12223838|FG000|NOT COMPLETED|Overall Study||1
11043740|NCT00927992|12223843|FG000|STARTED|Overall Study||11
11043741|NCT00927992|12223843|FG000|COMPLETED|Overall Study||11
11043742|NCT00927992|12223843|FG000|NOT COMPLETED|Overall Study||0
11043743|NCT00928018|12223849|FG000|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
11043744|NCT00928018|12223850|FG001|STARTED|Overall Study||73
11043745|NCT00928018|12223849|FG000|COMPLETED|Overall Study||65
11043746|NCT00928018|12223850|FG001|COMPLETED|Overall Study||73
11043747|NCT00928018|12223849|FG000|NOT COMPLETED|Overall Study||1
11043748|NCT00928018|12223850|FG001|NOT COMPLETED|Overall Study||0
11043749|NCT00928057|12223862|FG000|STARTED|Overall Study||84
11043750|NCT00928057|12223863|FG001|STARTED|Overall Study||89
11043751|NCT00928057|12223862|FG000|COMPLETED|Overall Study||82
11043752|NCT00928057|12223863|FG001|COMPLETED|Overall Study||85
11043753|NCT00928057|12223862|FG000|NOT COMPLETED|Overall Study||2
11043754|NCT00928057|12223863|FG001|NOT COMPLETED|Overall Study||4
11043755|NCT00928070|12223881|FG000|STARTED|Overall Study||283
11043756|NCT00928070|12223882|FG001|STARTED|Overall Study||283
11043757|NCT00928070|12223881|FG000|Treated|Overall Study||281
11043758|NCT00928070|12223882|FG001|Treated|Overall Study||281
11043759|NCT00928070|12223881|FG000|COMPLETED|Overall Study||220
11043760|NCT00928070|12223882|FG001|COMPLETED|Overall Study||226
11043761|NCT00928070|12223881|FG000|NOT COMPLETED|Overall Study||63
11043762|NCT00928070|12223882|FG001|NOT COMPLETED|Overall Study||57
11043763|NCT00928083|12223891|FG000|STARTED|Overall Study||10
11043764|NCT00928083|12223892|FG001|STARTED|Overall Study||8
11043765|NCT00928083|12223893|FG002|STARTED|Overall Study||8
11043766|NCT00928083|12223894|FG003|STARTED|Overall Study||6
11043767|NCT00928083|12223895|FG004|STARTED|Overall Study||7
11043768|NCT00928083|12223896|FG005|STARTED|Overall Study||6
11043769|NCT00928083|12223897|FG006|STARTED|Overall Study||6
11043770|NCT00928083|12223898|FG007|STARTED|Overall Study||6
11043771|NCT00928083|12223899|FG008|STARTED|Overall Study||6
11043772|NCT00928083|12223891|FG000|COMPLETED|Overall Study||6
11043773|NCT00928083|12223892|FG001|COMPLETED|Overall Study||8
11043774|NCT00928083|12223893|FG002|COMPLETED|Overall Study||8
11043775|NCT00928083|12223894|FG003|COMPLETED|Overall Study||5
11043776|NCT00928083|12223895|FG004|COMPLETED|Overall Study||6
11043777|NCT00928083|12223896|FG005|COMPLETED|Overall Study||6
11043778|NCT00928083|12223897|FG006|COMPLETED|Overall Study||6
11043779|NCT00928083|12223898|FG007|COMPLETED|Overall Study||6
11043780|NCT00928083|12223899|FG008|COMPLETED|Overall Study||6
11043781|NCT00928083|12223891|FG000|NOT COMPLETED|Overall Study||4
11043782|NCT00928083|12223892|FG001|NOT COMPLETED|Overall Study||0
11043783|NCT00928083|12223893|FG002|NOT COMPLETED|Overall Study||0
11043784|NCT00928083|12223894|FG003|NOT COMPLETED|Overall Study||1
11043785|NCT00928083|12223895|FG004|NOT COMPLETED|Overall Study||1
11043786|NCT00928083|12223896|FG005|NOT COMPLETED|Overall Study||0
11043787|NCT00928083|12223897|FG006|NOT COMPLETED|Overall Study||0
11043788|NCT00928083|12223898|FG007|NOT COMPLETED|Overall Study||0
11043789|NCT00928083|12223899|FG008|NOT COMPLETED|Overall Study||0
11043790|NCT00928135|12223950|FG000|STARTED|Overall Study||30
11043791|NCT00928135|12223951|FG001|STARTED|Overall Study||30
11043792|NCT00928135|12223950|FG000|COMPLETED|Overall Study||29
11043793|NCT00928135|12223951|FG001|COMPLETED|Overall Study||30
11043794|NCT00928135|12223950|FG000|NOT COMPLETED|Overall Study||1
11043795|NCT00928135|12223951|FG001|NOT COMPLETED|Overall Study||0
11043796|NCT00928174|12223957|FG000|STARTED|Overall Study||27
11043797|NCT00928174|12223957|FG000|COMPLETED|Overall Study|3 withdrawn before start of participation|22
11043798|NCT00928174|12223957|FG000|NOT COMPLETED|Overall Study||5
11043799|NCT00928187|12223964|FG000|STARTED|Overall Study||152
11043800|NCT00928187|12223965|FG001|STARTED|Overall Study||147
11043801|NCT00928187|12223966|FG002|STARTED|Overall Study||155
11043802|NCT00928187|12223964|FG000|Analysed|Overall Study||152
11043803|NCT00928187|12223965|FG001|Analysed|Overall Study||145
11043804|NCT00928187|12223966|FG002|Analysed|Overall Study||154
11043805|NCT00928187|12223964|FG000|COMPLETED|Overall Study||150
11043806|NCT00928187|12223965|FG001|COMPLETED|Overall Study||141
11043807|NCT00928187|12223966|FG002|COMPLETED|Overall Study||150
11043808|NCT00928187|12223964|FG000|NOT COMPLETED|Overall Study||2
11043809|NCT00928187|12223965|FG001|NOT COMPLETED|Overall Study||6
11043810|NCT00928187|12223966|FG002|NOT COMPLETED|Overall Study||5
11043811|NCT00928200|12223974|FG000|STARTED|Overall Study||1
11043812|NCT00928200|12223974|FG000|COMPLETED|Overall Study||1
11043813|NCT00928200|12223974|FG000|NOT COMPLETED|Overall Study||0
11043814|NCT00928252|12223978|FG000|STARTED|Overall Study||45
11043815|NCT00928252|12223978|FG000|COMPLETED|Overall Study||42
11043816|NCT00928252|12223978|FG000|NOT COMPLETED|Overall Study||3
11043817|NCT00928304|12223984|FG000|STARTED|Overall Study||39
11043818|NCT00928304|12223985|FG001|STARTED|Overall Study||70
11043819|NCT00928304|12223984|FG000|COMPLETED|Overall Study||39
11043820|NCT00928304|12223985|FG001|COMPLETED|Overall Study||70
11043821|NCT00928304|12223984|FG000|NOT COMPLETED|Overall Study||0
11043822|NCT00928304|12223985|FG001|NOT COMPLETED|Overall Study||0
11043823|NCT00928395|12223997|FG000|STARTED|Overall Study||50
11043824|NCT00928395|12223997|FG000|COMPLETED|Overall Study||29
11043825|NCT00928395|12223997|FG000|NOT COMPLETED|Overall Study||21
11043826|NCT00928408|12224001|FG000|STARTED|Overall Study|Number Enrolled|305
11043827|NCT00928408|12224001|FG000|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
11043828|NCT00928408|12224001|FG000|COMPLETED|Overall Study||282
11043829|NCT00928408|12224001|FG000|NOT COMPLETED|Overall Study||23
11057920|NCT01000818|12239669|FG000|NOT COMPLETED|Omeprazole + Raltegravir||0
11057921|NCT01000961|12239678|FG000|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
11057922|NCT01000961|12239679|FG001|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
11057923|NCT01000961|12239678|FG000|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
11043830|NCT00928421|12224005|FG000|STARTED|Overall Study||16
11043831|NCT00928421|12224005|FG000|Treated With Study Drug|Overall Study||16
11043832|NCT00928421|12224005|FG000|COMPLETED|Overall Study||16
11043833|NCT00928421|12224005|FG000|NOT COMPLETED|Overall Study||0
11043834|NCT00928434|12224012|FG000|STARTED|Overall Study|Full Analysis Set Patients|175
11043835|NCT00928434|12224013|FG001|STARTED|Overall Study|Full Analysis Set Patients|50
11043836|NCT00928434|12224014|FG002|STARTED|Overall Study|Full Analysis Set Patients|178
11043837|NCT00928434|12224012|FG000|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
11043838|NCT00928434|12224013|FG001|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
11043839|NCT00928434|12224014|FG002|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
11043840|NCT00928434|12224012|FG000|COMPLETED|Overall Study||131
11043841|NCT00928434|12224013|FG001|COMPLETED|Overall Study||36
11043842|NCT00928434|12224014|FG002|COMPLETED|Overall Study||134
11043843|NCT00928434|12224012|FG000|NOT COMPLETED|Overall Study||44
11043844|NCT00928434|12224013|FG001|NOT COMPLETED|Overall Study||14
11043845|NCT00928434|12224014|FG002|NOT COMPLETED|Overall Study||44
11043846|NCT00928486|12224030|FG000|STARTED|Overall Study||25
11043847|NCT00928486|12224030|FG000|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
11043848|NCT00928486|12224030|FG000|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
11043849|NCT00928486|12224030|FG000|NOT COMPLETED|Overall Study||10
11043850|NCT00928512|12224039|FG000|STARTED|Overall Study||41
11043851|NCT00928512|12224040|FG001|STARTED|Overall Study||43
11043852|NCT00928512|12224041|FG002|STARTED|Overall Study||49
11043853|NCT00928512|12224042|FG003|STARTED|Overall Study||54
11201275|NCT01831466|12391476|FG002|NOT COMPLETED|Overall Study||23
11043854|NCT00928512|12224043|FG004|STARTED|Overall Study||50
11043855|NCT00928512|12224039|FG000|Discontinued Prior to Week 16|Overall Study||3
11043856|NCT00928512|12224040|FG001|Discontinued Prior to Week 16|Overall Study||0
11043857|NCT00928512|12224041|FG002|Discontinued Prior to Week 16|Overall Study||2
11043858|NCT00928512|12224042|FG003|Discontinued Prior to Week 16|Overall Study||6
11043859|NCT00928512|12224043|FG004|Discontinued Prior to Week 16|Overall Study||5
11043860|NCT00928512|12224039|FG000|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
11043861|NCT00928512|12224040|FG001|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
11043862|NCT00928512|12224041|FG002|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
11043863|NCT00928512|12224042|FG003|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
11043864|NCT00928512|12224043|FG004|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
11043865|NCT00928512|12224039|FG000|Not Reassigned at Week 20 (Responders)|Overall Study||37
11043866|NCT00928512|12224040|FG001|Not Reassigned at Week 20 (Responders)|Overall Study||20
11043867|NCT00928512|12224041|FG002|Not Reassigned at Week 20 (Responders)|Overall Study||23
11043868|NCT00928512|12224042|FG003|Not Reassigned at Week 20 (Responders)|Overall Study||18
11043869|NCT00928512|12224043|FG004|Not Reassigned at Week 20 (Responders)|Overall Study||0
11043870|NCT00928512|12224039|FG000|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
11043871|NCT00928512|12224040|FG001|New Groups After Reassignment|Overall Study||115
11043872|NCT00928512|12224041|FG002|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
11043873|NCT00928512|12224042|FG003|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
11043874|NCT00928512|12224043|FG004|New Groups After Reassignment|Overall Study||0
11043875|NCT00928512|12224039|FG000|Completed Week 16|Overall Study||38
11043876|NCT00928512|12224040|FG001|Completed Week 16|Overall Study||43
11043877|NCT00928512|12224041|FG002|Completed Week 16|Overall Study||47
11043878|NCT00928512|12224042|FG003|Completed Week 16|Overall Study||48
11043879|NCT00928512|12224043|FG004|Completed Week 16|Overall Study||45
11043880|NCT00928512|12224039|FG000|Entered/Continued to Week 20 (All)|Overall Study||37
11043881|NCT00928512|12224040|FG001|Entered/Continued to Week 20 (All)|Overall Study||43
11043882|NCT00928512|12224041|FG002|Entered/Continued to Week 20 (All)|Overall Study||46
11043883|NCT00928512|12224042|FG003|Entered/Continued to Week 20 (All)|Overall Study||45
11043884|NCT00928512|12224043|FG004|Entered/Continued to Week 20 (All)|Overall Study||45
11043885|NCT00928512|12224039|FG000|COMPLETED|Overall Study||31
11043886|NCT00928512|12224040|FG001|COMPLETED|Overall Study||37
11043887|NCT00928512|12224041|FG002|COMPLETED|Overall Study||38
11043888|NCT00928512|12224042|FG003|COMPLETED|Overall Study||33
11043889|NCT00928512|12224043|FG004|COMPLETED|Overall Study||35
11043890|NCT00928512|12224039|FG000|NOT COMPLETED|Overall Study||10
11043891|NCT00928512|12224040|FG001|NOT COMPLETED|Overall Study||6
11043892|NCT00928512|12224041|FG002|NOT COMPLETED|Overall Study||11
11043893|NCT00928512|12224042|FG003|NOT COMPLETED|Overall Study||21
11043894|NCT00928512|12224043|FG004|NOT COMPLETED|Overall Study||15
11043895|NCT00928564|12224061|FG000|STARTED|Overall Study||28
11043896|NCT00928564|12224062|FG001|STARTED|Overall Study||12
11043897|NCT00928564|12224061|FG000|COMPLETED|Overall Study||22
11043898|NCT00928564|12224062|FG001|COMPLETED|Overall Study||12
11043899|NCT00928564|12224061|FG000|NOT COMPLETED|Overall Study||6
11043900|NCT00928564|12224062|FG001|NOT COMPLETED|Overall Study||0
11043901|NCT00928642|12224068|FG000|STARTED|Overall Study||8
11043902|NCT00928642|12224068|FG000|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
11043903|NCT00928642|12224068|FG000|NOT COMPLETED|Overall Study||0
11043904|NCT00928668|12224075|FG000|STARTED|Overall Study||7
11336502|NCT02878057|12534229|FG000|NOT COMPLETED|Overall Study||4
11336503|NCT02878213|12534233|FG000|STARTED|Overall Study||39
11336504|NCT02878213|12534233|FG000|COMPLETED|Overall Study||36
11336505|NCT02878213|12534233|FG000|NOT COMPLETED|Overall Study||3
11336506|NCT02878330|12534240|FG000|STARTED|Overall Study||484
11336507|NCT02878330|12534241|FG001|STARTED|Overall Study||969
11336508|NCT02878330|12534240|FG000|COMPLETED|Overall Study||455
11336509|NCT02878330|12534241|FG001|COMPLETED|Overall Study||913
11336510|NCT02878330|12534240|FG000|NOT COMPLETED|Overall Study||29
11336511|NCT02878330|12534241|FG001|NOT COMPLETED|Overall Study||56
11336512|NCT02878382|12534248|FG000|STARTED|Overall Study|total 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
11336513|NCT02878382|12534249|FG001|STARTED|Overall Study|otal 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
11336514|NCT02878382|12534248|FG000|COMPLETED|Overall Study||20
11336515|NCT02878382|12534249|FG001|COMPLETED|Overall Study||20
11336516|NCT02878382|12534248|FG000|NOT COMPLETED|Overall Study||0
11336517|NCT02878382|12534249|FG001|NOT COMPLETED|Overall Study||0
11336518|NCT02878486|12534259|FG000|STARTED|Overall Study||3
11336519|NCT02878486|12534260|FG001|STARTED|Overall Study||3
11336520|NCT02878486|12534259|FG000|COMPLETED|Overall Study||3
11336521|NCT02878486|12534260|FG001|COMPLETED|Overall Study||3
11336522|NCT02878486|12534259|FG000|NOT COMPLETED|Overall Study||0
11336523|NCT02878486|12534260|FG001|NOT COMPLETED|Overall Study||0
11336524|NCT02878590|12534266|FG000|STARTED|Overall Study||12
11336525|NCT02878590|12534266|FG000|COMPLETED|Overall Study||10
11336526|NCT02878590|12534266|FG000|NOT COMPLETED|Overall Study||2
11336527|NCT02879032|12534270|FG000|STARTED|Overall Study||130
11336528|NCT02879032|12534270|FG000|COMPLETED|Overall Study||130
11336529|NCT02879032|12534270|FG000|NOT COMPLETED|Overall Study||0
11336530|NCT02879383|12534280|FG000|STARTED|First 24 Weeks||39
11336531|NCT02879383|12534281|FG001|STARTED|First 24 Weeks||37
11336532|NCT02879383|12534282|FG002|STARTED|First 24 Weeks||17
11336533|NCT02879383|12534283|FG003|STARTED|First 24 Weeks||16
11336534|NCT02879383|12534280|FG000|COMPLETED|First 24 Weeks||39
11336535|NCT02879383|12534281|FG001|COMPLETED|First 24 Weeks||36
11336536|NCT02879383|12534282|FG002|COMPLETED|First 24 Weeks||17
11336537|NCT02879383|12534283|FG003|COMPLETED|First 24 Weeks||16
11336538|NCT02879383|12534280|FG000|NOT COMPLETED|First 24 Weeks||0
11336539|NCT02879383|12534281|FG001|NOT COMPLETED|First 24 Weeks||1
11336540|NCT02879383|12534282|FG002|NOT COMPLETED|First 24 Weeks||0
11336541|NCT02879383|12534283|FG003|NOT COMPLETED|First 24 Weeks||0
11336542|NCT02879383|12534280|FG000|STARTED|Second 24 Weeks (Crossover for Sham)||33
11336543|NCT02879383|12534281|FG001|STARTED|Second 24 Weeks (Crossover for Sham)||0
11336544|NCT02879383|12534282|FG002|STARTED|Second 24 Weeks (Crossover for Sham)||4
11336545|NCT02879383|12534283|FG003|STARTED|Second 24 Weeks (Crossover for Sham)||0
11336546|NCT02879383|12534280|FG000|COMPLETED|Second 24 Weeks (Crossover for Sham)||33
11336547|NCT02879383|12534281|FG001|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
11336548|NCT02879383|12534282|FG002|COMPLETED|Second 24 Weeks (Crossover for Sham)||4
11336549|NCT02879383|12534283|FG003|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
11043905|NCT00928668|12224076|FG001|STARTED|Overall Study||7
11043906|NCT00928668|12224077|FG002|STARTED|Overall Study||7
11043907|NCT00928668|12224078|FG003|STARTED|Overall Study||4
11043908|NCT00928668|12224079|FG004|STARTED|Overall Study||6
11043909|NCT00928668|12224075|FG000|COMPLETED|Overall Study||6
11043910|NCT00928668|12224076|FG001|COMPLETED|Overall Study||6
11043911|NCT00928668|12224077|FG002|COMPLETED|Overall Study||6
11043912|NCT00928668|12224078|FG003|COMPLETED|Overall Study||3
11043913|NCT00928668|12224079|FG004|COMPLETED|Overall Study||5
11336550|NCT02879383|12534280|FG000|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
11336551|NCT02879383|12534281|FG001|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
11336552|NCT02879383|12534282|FG002|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
11336553|NCT02879383|12534283|FG003|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
11336554|NCT02879578|12534298|FG000|STARTED|Overall Study||33
11336555|NCT02879578|12534299|FG001|STARTED|Overall Study||41
11336556|NCT02879578|12534300|FG002|STARTED|Overall Study||81
11336557|NCT02879578|12534298|FG000|Safety Analysis Set|Overall Study||33
11336558|NCT02879578|12534299|FG001|Safety Analysis Set|Overall Study||40
11336559|NCT02879578|12534300|FG002|Safety Analysis Set|Overall Study||79
11336560|NCT02879578|12534298|FG000|COMPLETED|Overall Study||23
11336561|NCT02879578|12534299|FG001|COMPLETED|Overall Study||32
11336562|NCT02879578|12534300|FG002|COMPLETED|Overall Study||49
11336563|NCT02879578|12534298|FG000|NOT COMPLETED|Overall Study||10
11336564|NCT02879578|12534299|FG001|NOT COMPLETED|Overall Study||9
11336565|NCT02879578|12534300|FG002|NOT COMPLETED|Overall Study||32
11336566|NCT02879747|12534311|FG000|STARTED|Overall Study||27
11336567|NCT02879747|12534312|FG001|STARTED|Overall Study||38
11336568|NCT02879747|12534313|FG002|STARTED|Overall Study||33
11336569|NCT02879747|12534311|FG000|COMPLETED|Overall Study||23
11336570|NCT02879747|12534312|FG001|COMPLETED|Overall Study||32
11336571|NCT02879747|12534313|FG002|COMPLETED|Overall Study||31
11336572|NCT02879747|12534311|FG000|NOT COMPLETED|Overall Study||4
11336573|NCT02879747|12534312|FG001|NOT COMPLETED|Overall Study||6
11336574|NCT02879747|12534313|FG002|NOT COMPLETED|Overall Study||2
11336575|NCT02879812|12534332|FG000|STARTED|Overall Study||23370
11336576|NCT02879812|12534333|FG001|STARTED|Overall Study||22480
11336577|NCT02879812|12534332|FG000|COMPLETED|Overall Study||22153
11336578|NCT02879812|12534333|FG001|COMPLETED|Overall Study||21029
11336579|NCT02879812|12534332|FG000|NOT COMPLETED|Overall Study||1217
11336580|NCT02879812|12534333|FG001|NOT COMPLETED|Overall Study||1451
11336581|NCT02879994|12534339|FG000|STARTED|Overall Study||11
11336582|NCT02879994|12534339|FG000|COMPLETED|Overall Study||0
11336583|NCT02879994|12534339|FG000|NOT COMPLETED|Overall Study||11
11336584|NCT02880137|12534343|FG000|STARTED|Overall Study||36
11336585|NCT02880137|12534343|FG000|COMPLETED|Overall Study||36
11336586|NCT02880137|12534343|FG000|NOT COMPLETED|Overall Study||0
11336587|NCT02880176|12534349|FG000|STARTED|Overall Study||23
11043914|NCT00928668|12224075|FG000|NOT COMPLETED|Overall Study||1
11043915|NCT00928668|12224076|FG001|NOT COMPLETED|Overall Study||1
11043916|NCT00928668|12224077|FG002|NOT COMPLETED|Overall Study||1
11043917|NCT00928668|12224078|FG003|NOT COMPLETED|Overall Study||1
11043918|NCT00928668|12224079|FG004|NOT COMPLETED|Overall Study||1
11043919|NCT00928694|12224096|FG000|STARTED|First Intervention||7
11043920|NCT00928694|12224097|FG001|STARTED|First Intervention||7
11043921|NCT00928694|12224096|FG000|COMPLETED|First Intervention||7
11043922|NCT00928694|12224097|FG001|COMPLETED|First Intervention||7
11043923|NCT00928694|12224096|FG000|NOT COMPLETED|First Intervention||0
11043924|NCT00928694|12224097|FG001|NOT COMPLETED|First Intervention||0
11043925|NCT00928694|12224096|FG000|STARTED|Second Intervention||7
11043926|NCT00928694|12224097|FG001|STARTED|Second Intervention||7
11043927|NCT00928694|12224096|FG000|COMPLETED|Second Intervention||7
11043928|NCT00928694|12224097|FG001|COMPLETED|Second Intervention||7
11043929|NCT00928694|12224096|FG000|NOT COMPLETED|Second Intervention||0
11043930|NCT00928694|12224097|FG001|NOT COMPLETED|Second Intervention||0
11043931|NCT00928707|12224105|FG000|STARTED|Overall Study||23
11043932|NCT00928707|12224106|FG001|STARTED|Overall Study||22
11043933|NCT00928707|12224105|FG000|COMPLETED|Overall Study||22
11043934|NCT00928707|12224106|FG001|COMPLETED|Overall Study||22
11043935|NCT00928707|12224105|FG000|NOT COMPLETED|Overall Study||1
11043936|NCT00928707|12224106|FG001|NOT COMPLETED|Overall Study||0
11043937|NCT00928720|12224115|FG000|STARTED|Overall Study||19
11336588|NCT02880176|12534350|FG001|STARTED|Overall Study||11
11336589|NCT02880176|12534349|FG000|Underwent Cystectomy|Overall Study||22
11336590|NCT02880176|12534350|FG001|Underwent Cystectomy|Overall Study||11
11336591|NCT02880176|12534349|FG000|Collected Postop Step Data|Overall Study||22
11336592|NCT02880176|12534350|FG001|Collected Postop Step Data|Overall Study||11
11336593|NCT02880176|12534349|FG000|Responded to 30 Day Survey|Overall Study||20
11336594|NCT02880176|12534350|FG001|Responded to 30 Day Survey|Overall Study||9
11336595|NCT02880176|12534349|FG000|COMPLETED|Overall Study||20
11043938|NCT00928720|12224116|FG001|STARTED|Overall Study||20
11043939|NCT00928720|12224117|FG002|STARTED|Overall Study||18
11043940|NCT00928720|12224115|FG000|COMPLETED|Overall Study||17
11043941|NCT00928720|12224116|FG001|COMPLETED|Overall Study||14
11043942|NCT00928720|12224117|FG002|COMPLETED|Overall Study||15
11043943|NCT00928720|12224115|FG000|NOT COMPLETED|Overall Study||2
11043944|NCT00928720|12224116|FG001|NOT COMPLETED|Overall Study||6
11043945|NCT00928720|12224117|FG002|NOT COMPLETED|Overall Study||3
11043946|NCT00928746|12224128|FG000|STARTED|Overall Study||142
11043947|NCT00928746|12224128|FG000|COMPLETED|Overall Study||136
11043948|NCT00928746|12224128|FG000|NOT COMPLETED|Overall Study||6
11043949|NCT00928772|12224137|FG000|STARTED|Overall Study||39
11043950|NCT00928772|12224138|FG001|STARTED|Overall Study||38
11043951|NCT00928772|12224139|FG002|STARTED|Overall Study||38
11043952|NCT00928772|12224137|FG000|COMPLETED|Overall Study||39
11043953|NCT00928772|12224138|FG001|COMPLETED|Overall Study||38
11043954|NCT00928772|12224139|FG002|COMPLETED|Overall Study||38
11043955|NCT00928772|12224137|FG000|NOT COMPLETED|Overall Study||0
11043956|NCT00928772|12224138|FG001|NOT COMPLETED|Overall Study||0
11043957|NCT00928772|12224139|FG002|NOT COMPLETED|Overall Study||0
11043958|NCT00928889|12224149|FG000|STARTED|Overall Study||80
11043959|NCT00928889|12224150|FG001|STARTED|Overall Study||80
11043960|NCT00928889|12224149|FG000|COMPLETED|Overall Study||75
11043961|NCT00928889|12224150|FG001|COMPLETED|Overall Study||78
11043962|NCT00928889|12224149|FG000|NOT COMPLETED|Overall Study||5
11043963|NCT00928889|12224150|FG001|NOT COMPLETED|Overall Study||2
11043964|NCT00928954|12224156|FG000|STARTED|Overall Study||4
11043965|NCT00928954|12224157|FG001|STARTED|Overall Study||6
11043966|NCT00928954|12224156|FG000|COMPLETED|Overall Study||4
11043967|NCT00928954|12224157|FG001|COMPLETED|Overall Study||6
11043968|NCT00928954|12224156|FG000|NOT COMPLETED|Overall Study||0
11043969|NCT00928954|12224157|FG001|NOT COMPLETED|Overall Study||0
11043970|NCT00929071|12224163|FG000|STARTED|Overall Study||10
11043971|NCT00929071|12224163|FG000|COMPLETED|Overall Study||10
11043972|NCT00929071|12224163|FG000|NOT COMPLETED|Overall Study||0
11043973|NCT00929110|12224173|FG000|STARTED|Overall Study||529
11043974|NCT00929110|12224174|FG001|STARTED|Overall Study||269
11043975|NCT00929110|12224175|FG002|STARTED|Overall Study||268
11043976|NCT00929110|12224173|FG000|COMPLETED|Overall Study||411
11043977|NCT00929110|12224174|FG001|COMPLETED|Overall Study||193
11043978|NCT00929110|12224175|FG002|COMPLETED|Overall Study||206
11043979|NCT00929110|12224173|FG000|NOT COMPLETED|Overall Study||118
11043980|NCT00929110|12224174|FG001|NOT COMPLETED|Overall Study||76
11043981|NCT00929110|12224175|FG002|NOT COMPLETED|Overall Study||62
11043982|NCT00929162|12224185|FG000|STARTED|Overall Study||59
11043983|NCT00929162|12224186|FG001|STARTED|Overall Study||61
11043984|NCT00929162|12224185|FG000|Patients Who Received Treatment|Overall Study||58
11043985|NCT00929162|12224186|FG001|Patients Who Received Treatment|Overall Study||58
11043986|NCT00929162|12224185|FG000|COMPLETED|Overall Study||11
11043987|NCT00929162|12224186|FG001|COMPLETED|Overall Study||19
11043988|NCT00929162|12224185|FG000|NOT COMPLETED|Overall Study||48
11043989|NCT00929162|12224186|FG001|NOT COMPLETED|Overall Study||42
11043990|NCT00929201|12224192|FG000|STARTED|Period 1||30
11043991|NCT00929201|12224193|FG001|STARTED|Period 1||31
11043992|NCT00929201|12224192|FG000|COMPLETED|Period 1||30
11043993|NCT00929201|12224193|FG001|COMPLETED|Period 1||30
11043994|NCT00929201|12224192|FG000|NOT COMPLETED|Period 1||0
11043995|NCT00929201|12224193|FG001|NOT COMPLETED|Period 1||1
11043996|NCT00929201|12224192|FG000|STARTED|7-day Washout||30
11043997|NCT00929201|12224193|FG001|STARTED|7-day Washout||30
11043998|NCT00929201|12224192|FG000|COMPLETED|7-day Washout||30
11043999|NCT00929201|12224193|FG001|COMPLETED|7-day Washout||30
11044000|NCT00929201|12224192|FG000|NOT COMPLETED|7-day Washout||0
11044001|NCT00929201|12224193|FG001|NOT COMPLETED|7-day Washout||0
11044002|NCT00929201|12224192|FG000|STARTED|Period 2||30
11044003|NCT00929201|12224193|FG001|STARTED|Period 2||30
11044004|NCT00929201|12224192|FG000|COMPLETED|Period 2||30
11044005|NCT00929201|12224193|FG001|COMPLETED|Period 2||30
11044006|NCT00929201|12224192|FG000|NOT COMPLETED|Period 2||0
11044007|NCT00929201|12224193|FG001|NOT COMPLETED|Period 2||0
11044008|NCT00929240|12224200|FG000|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
11044009|NCT00929240|12224201|FG001|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
11044010|NCT00929240|12224202|FG002|STARTED|Initial Treatment Phase||0
11044011|NCT00929240|12224200|FG000|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
11044012|NCT00929240|12224201|FG001|COMPLETED|Initial Treatment Phase||0
11044013|NCT00929240|12224202|FG002|COMPLETED|Initial Treatment Phase||0
11044014|NCT00929240|12224200|FG000|NOT COMPLETED|Initial Treatment Phase||99
11044015|NCT00929240|12224201|FG001|NOT COMPLETED|Initial Treatment Phase||0
11044016|NCT00929240|12224202|FG002|NOT COMPLETED|Initial Treatment Phase||0
11044017|NCT00929240|12224200|FG000|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
11044018|NCT00929240|12224201|FG001|STARTED|Maintenance Phase||94
11044019|NCT00929240|12224202|FG002|STARTED|Maintenance Phase||91
11044020|NCT00929240|12224200|FG000|COMPLETED|Maintenance Phase||0
11044021|NCT00929240|12224201|FG001|COMPLETED|Maintenance Phase||0
11044022|NCT00929240|12224202|FG002|COMPLETED|Maintenance Phase||0
11044023|NCT00929240|12224200|FG000|NOT COMPLETED|Maintenance Phase||0
11044024|NCT00929240|12224201|FG001|NOT COMPLETED|Maintenance Phase||94
11044025|NCT00929240|12224202|FG002|NOT COMPLETED|Maintenance Phase||91
11044026|NCT00929305|12224213|FG000|STARTED|Overall Study||43
11044027|NCT00929305|12224214|FG001|STARTED|Overall Study||43
11044028|NCT00929305|12224213|FG000|COMPLETED|Overall Study||43
11044029|NCT00929305|12224214|FG001|COMPLETED|Overall Study||43
11044030|NCT00929305|12224213|FG000|NOT COMPLETED|Overall Study||0
11044031|NCT00929305|12224214|FG001|NOT COMPLETED|Overall Study||0
11044032|NCT00929331|12224223|FG000|STARTED|Overall Study||55
11044033|NCT00929331|12224224|FG001|STARTED|Overall Study||55
11044034|NCT00929331|12224223|FG000|COMPLETED|Overall Study||55
11044035|NCT00929331|12224224|FG001|COMPLETED|Overall Study||55
11044036|NCT00929331|12224223|FG000|NOT COMPLETED|Overall Study||0
11044037|NCT00929331|12224224|FG001|NOT COMPLETED|Overall Study||0
11044038|NCT00929344|12224233|FG000|STARTED|Overall Study||50
11044039|NCT00929344|12224234|FG001|STARTED|Overall Study||50
11044040|NCT00929344|12224235|FG002|STARTED|Overall Study||50
11044041|NCT00929344|12224233|FG000|COMPLETED|Overall Study||28
11044042|NCT00929344|12224234|FG001|COMPLETED|Overall Study||37
11044043|NCT00929344|12224235|FG002|COMPLETED|Overall Study||29
11044044|NCT00929344|12224233|FG000|NOT COMPLETED|Overall Study||22
11044045|NCT00929344|12224234|FG001|NOT COMPLETED|Overall Study||13
11044046|NCT00929344|12224235|FG002|NOT COMPLETED|Overall Study||21
11044047|NCT00929357|12224245|FG000|STARTED|Overall Study||92
11044048|NCT00929357|12224246|FG001|STARTED|Overall Study||64
11044049|NCT00929357|12224245|FG000|COMPLETED|Overall Study||92
11044050|NCT00929357|12224246|FG001|COMPLETED|Overall Study||64
11044051|NCT00929357|12224245|FG000|NOT COMPLETED|Overall Study||0
11044052|NCT00929357|12224246|FG001|NOT COMPLETED|Overall Study||0
11044053|NCT00929383|12224252|FG000|STARTED|Overall Study||82
11044054|NCT00929383|12224252|FG000|COMPLETED|Overall Study||67
11044055|NCT00929383|12224252|FG000|NOT COMPLETED|Overall Study||15
11044056|NCT00929500|12224258|FG000|STARTED|Overall Study||8
11044057|NCT00929500|12224259|FG001|STARTED|Overall Study||4
11044058|NCT00929500|12224258|FG000|COMPLETED|Overall Study||4
11044059|NCT00929500|12224259|FG001|COMPLETED|Overall Study||4
11044060|NCT00929500|12224258|FG000|NOT COMPLETED|Overall Study||4
11044061|NCT00929500|12224259|FG001|NOT COMPLETED|Overall Study||0
11044062|NCT00929526|12224267|FG000|STARTED|Overall Study||375
11044063|NCT00929526|12224268|FG001|STARTED|Overall Study||377
11044064|NCT00929526|12224267|FG000|COMPLETED|Overall Study||358
11044065|NCT00929526|12224268|FG001|COMPLETED|Overall Study||348
11044066|NCT00929526|12224267|FG000|NOT COMPLETED|Overall Study||17
11044067|NCT00929526|12224268|FG001|NOT COMPLETED|Overall Study||29
11044068|NCT00929578|12224274|FG000|STARTED|Overall Study||15
11044069|NCT00929578|12224274|FG000|COMPLETED|Overall Study||15
11044070|NCT00929578|12224274|FG000|NOT COMPLETED|Overall Study||0
11044071|NCT00929643|12224283|FG000|STARTED|Overall Study||203
11044072|NCT00929643|12224283|FG000|COMPLETED|Overall Study||201
11044073|NCT00929643|12224283|FG000|NOT COMPLETED|Overall Study||2
11044074|NCT00929656|12224289|FG000|STARTED|Overall Study||13
11044075|NCT00929656|12224290|FG001|STARTED|Overall Study||9
11044076|NCT00929656|12224289|FG000|COMPLETED|Overall Study||13
11044077|NCT00929656|12224290|FG001|COMPLETED|Overall Study||8
11044078|NCT00929656|12224289|FG000|NOT COMPLETED|Overall Study||0
11044079|NCT00929656|12224290|FG001|NOT COMPLETED|Overall Study||1
11044080|NCT00929669|12224296|FG000|STARTED|Overall Study||2
11044081|NCT00929669|12224296|FG000|COMPLETED|Overall Study||1
11044082|NCT00929669|12224296|FG000|NOT COMPLETED|Overall Study||1
11044083|NCT00929695|12224302|FG000|STARTED|Overall Study||81
11044084|NCT00929695|12224303|FG001|STARTED|Overall Study||83
11044085|NCT00929695|12224302|FG000|COMPLETED|Overall Study||73
11044086|NCT00929695|12224303|FG001|COMPLETED|Overall Study||77
11044087|NCT00929695|12224302|FG000|NOT COMPLETED|Overall Study||8
11044088|NCT00929695|12224303|FG001|NOT COMPLETED|Overall Study||6
11044089|NCT00929708|12224319|FG000|STARTED|Overall Study||65
11044090|NCT00929708|12224320|FG001|STARTED|Overall Study||69
11044091|NCT00929708|12224321|FG002|STARTED|Overall Study||65
11044092|NCT00929708|12224322|FG003|STARTED|Overall Study||67
11044093|NCT00929708|12224323|FG004|STARTED|Overall Study||63
11044094|NCT00929708|12224319|FG000|COMPLETED|Overall Study||61
11044095|NCT00929708|12224320|FG001|COMPLETED|Overall Study||66
11044096|NCT00929708|12224321|FG002|COMPLETED|Overall Study||62
11044097|NCT00929708|12224322|FG003|COMPLETED|Overall Study||61
11044098|NCT00929708|12224323|FG004|COMPLETED|Overall Study||57
11044099|NCT00929708|12224319|FG000|NOT COMPLETED|Overall Study||4
11044100|NCT00929708|12224320|FG001|NOT COMPLETED|Overall Study||3
11044101|NCT00929708|12224321|FG002|NOT COMPLETED|Overall Study||3
11044102|NCT00929708|12224322|FG003|NOT COMPLETED|Overall Study||6
11044103|NCT00929708|12224323|FG004|NOT COMPLETED|Overall Study||6
11044104|NCT00929734|12224337|FG000|STARTED|Overall Study||49
11044105|NCT00929734|12224338|FG001|STARTED|Overall Study||50
11044106|NCT00929734|12224337|FG000|COMPLETED|Overall Study||47
11044107|NCT00929734|12224338|FG001|COMPLETED|Overall Study||47
11044108|NCT00929734|12224337|FG000|NOT COMPLETED|Overall Study||2
11044109|NCT00929734|12224338|FG001|NOT COMPLETED|Overall Study||3
11044110|NCT00929773|12224346|FG000|STARTED|Overall Study||50
11044111|NCT00929773|12224347|FG001|STARTED|Overall Study||50
11044112|NCT00929773|12224346|FG000|COMPLETED|Overall Study||50
11044113|NCT00929773|12224347|FG001|COMPLETED|Overall Study||50
11044114|NCT00929773|12224346|FG000|NOT COMPLETED|Overall Study||0
11201276|NCT01831466|12391477|FG003|NOT COMPLETED|Overall Study||19
11201277|NCT01831466|12391478|FG004|NOT COMPLETED|Overall Study||17
11201278|NCT01831466|12391479|FG005|NOT COMPLETED|Overall Study||26
11201279|NCT01831466|12391480|FG006|NOT COMPLETED|Overall Study||1
11201280|NCT01831466|12391481|FG007|NOT COMPLETED|Overall Study||2
11201281|NCT01831466|12391482|FG008|NOT COMPLETED|Overall Study||3
11201282|NCT01831466|12391483|FG009|NOT COMPLETED|Overall Study||5
11201283|NCT01831466|12391484|FG010|NOT COMPLETED|Overall Study||2
11201284|NCT01831466|12391485|FG011|NOT COMPLETED|Overall Study||4
11201285|NCT01831544|12391505|FG000|STARTED|Overall Study||11
11201286|NCT01831544|12391505|FG000|COMPLETED|Overall Study||8
11201287|NCT01831544|12391505|FG000|NOT COMPLETED|Overall Study||3
11201288|NCT01831726|12391509|FG000|STARTED|Overall Study||80
11201289|NCT01831726|12391509|FG000|COMPLETED|Overall Study||0
11201290|NCT01831726|12391509|FG000|NOT COMPLETED|Overall Study||80
11201291|NCT01831765|12391516|FG000|STARTED|Overall Study||381
11201292|NCT01831765|12391517|FG001|STARTED|Overall Study||382
11201293|NCT01831765|12391518|FG002|STARTED|Overall Study||380
11201294|NCT01831765|12391516|FG000|Completed 26 Weeks|Overall Study||351
11201295|NCT01831765|12391517|FG001|Completed 26 Weeks|Overall Study||355
11201296|NCT01831765|12391518|FG002|Completed 26 Weeks|Overall Study||356
11201297|NCT01831765|12391516|FG000|Completed 52 Weeks|Overall Study||337
11201298|NCT01831765|12391517|FG001|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
11201299|NCT01831765|12391518|FG002|Completed 52 Weeks|Overall Study||338
11201300|NCT01831765|12391516|FG000|COMPLETED|Overall Study||337
11201301|NCT01831765|12391517|FG001|COMPLETED|Overall Study||355
11201302|NCT01831765|12391518|FG002|COMPLETED|Overall Study||338
11201303|NCT01831765|12391516|FG000|NOT COMPLETED|Overall Study||44
11201304|NCT01831765|12391517|FG001|NOT COMPLETED|Overall Study||27
11201305|NCT01831765|12391518|FG002|NOT COMPLETED|Overall Study||42
11201306|NCT01831791|12391528|FG000|STARTED|Overall Study||120
11336596|NCT02880176|12534350|FG001|COMPLETED|Overall Study||9
11336597|NCT02880176|12534349|FG000|NOT COMPLETED|Overall Study||3
11336598|NCT02880176|12534350|FG001|NOT COMPLETED|Overall Study||2
11336599|NCT02880228|12534356|FG000|STARTED|Overall Study||11
11336600|NCT02880228|12534356|FG000|COMPLETED|Overall Study||11
11336601|NCT02880228|12534356|FG000|NOT COMPLETED|Overall Study||0
11336602|NCT02880254|12534362|FG000|STARTED|Overall Study||13
11336603|NCT02880254|12534363|FG001|STARTED|Overall Study||14
11336604|NCT02880254|12534362|FG000|COMPLETED|Overall Study||4
11336605|NCT02880254|12534363|FG001|COMPLETED|Overall Study||4
11336606|NCT02880254|12534362|FG000|NOT COMPLETED|Overall Study||9
11336607|NCT02880254|12534363|FG001|NOT COMPLETED|Overall Study||10
11336608|NCT02880475|12534371|FG000|STARTED|Overall Study||13
11336609|NCT02880475|12534372|FG001|STARTED|Overall Study||17
11336610|NCT02880475|12534371|FG000|COMPLETED|Overall Study||13
11336611|NCT02880475|12534372|FG001|COMPLETED|Overall Study||17
11336612|NCT02880475|12534371|FG000|NOT COMPLETED|Overall Study||0
11336613|NCT02880475|12534372|FG001|NOT COMPLETED|Overall Study||0
11336614|NCT02880514|12534380|FG000|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
11336615|NCT02880514|12534381|FG001|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
11336616|NCT02880514|12534380|FG000|COMPLETED|Overall Study||50
11336617|NCT02880514|12534381|FG001|COMPLETED|Overall Study||50
11336618|NCT02880514|12534380|FG000|NOT COMPLETED|Overall Study||0
11336619|NCT02880514|12534381|FG001|NOT COMPLETED|Overall Study||0
11336620|NCT02880761|12534390|FG000|STARTED|Overall Study||103
11336621|NCT02880761|12534391|FG001|STARTED|Overall Study||106
11336622|NCT02880761|12534390|FG000|COMPLETED|Overall Study||87
11336623|NCT02880761|12534391|FG001|COMPLETED|Overall Study||85
11336624|NCT02880761|12534390|FG000|NOT COMPLETED|Overall Study||16
11044115|NCT00929773|12224347|FG001|NOT COMPLETED|Overall Study||0
11044116|NCT00929838|12224358|FG000|STARTED|Overall Study||63
11044117|NCT00929838|12224359|FG001|STARTED|Overall Study||65
11044118|NCT00929838|12224360|FG002|STARTED|Overall Study||63
11201307|NCT01831791|12391528|FG000|COMPLETED|Overall Study||110
11201308|NCT01831791|12391528|FG000|NOT COMPLETED|Overall Study||10
11205175|NCT01857869|12395948|FG008|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
11205227|NCT01857882|12395974|FG000|STARTED|Overall Study||21
11336625|NCT02880761|12534391|FG001|NOT COMPLETED|Overall Study||21
11336626|NCT02880852|12534397|FG000|STARTED|Overall Study||20
11336627|NCT02880852|12534397|FG000|COMPLETED|Overall Study||20
11336628|NCT02880852|12534397|FG000|NOT COMPLETED|Overall Study||0
11336629|NCT02880865|12534403|FG000|STARTED|Overall Study||314
11044119|NCT00929838|12224361|FG003|STARTED|Overall Study||64
11044120|NCT00929838|12224358|FG000|COMPLETED|Overall Study||53
11044121|NCT00929838|12224359|FG001|COMPLETED|Overall Study||56
11044122|NCT00929838|12224360|FG002|COMPLETED|Overall Study||53
11044123|NCT00929838|12224361|FG003|COMPLETED|Overall Study||55
11044124|NCT00929838|12224358|FG000|NOT COMPLETED|Overall Study||10
11044125|NCT00929838|12224359|FG001|NOT COMPLETED|Overall Study||9
11044126|NCT00929838|12224360|FG002|NOT COMPLETED|Overall Study||10
11044127|NCT00929838|12224361|FG003|NOT COMPLETED|Overall Study||9
11044128|NCT00929864|12224373|FG000|STARTED|Overall Study||318
11044129|NCT00929864|12224374|FG001|STARTED|Overall Study||328
11044130|NCT00929864|12224373|FG000|COMPLETED|Overall Study||252
11044131|NCT00929864|12224374|FG001|COMPLETED|Overall Study||245
11044132|NCT00929864|12224373|FG000|NOT COMPLETED|Overall Study||66
11044133|NCT00929864|12224374|FG001|NOT COMPLETED|Overall Study||83
11044134|NCT00929981|12224380|FG000|STARTED|Overall Study||80
11044135|NCT00929981|12224380|FG000|COMPLETED|Overall Study||80
11044136|NCT00929981|12224380|FG000|NOT COMPLETED|Overall Study||0
11044137|NCT00929994|12224384|FG000|STARTED|Overall Study||20
11044138|NCT00929994|12224384|FG000|COMPLETED|Overall Study||14
11044139|NCT00929994|12224384|FG000|NOT COMPLETED|Overall Study||6
11044140|NCT00930046|12224393|FG000|STARTED|Overall Study||8
11044141|NCT00930046|12224394|FG001|STARTED|Overall Study||7
11044142|NCT00930046|12224393|FG000|COMPLETED|Overall Study||7
11044143|NCT00930046|12224394|FG001|COMPLETED|Overall Study||5
11044144|NCT00930046|12224393|FG000|NOT COMPLETED|Overall Study||1
11044145|NCT00930046|12224394|FG001|NOT COMPLETED|Overall Study||2
11044146|NCT00930059|12224402|FG000|STARTED|Overall Study||100
11044147|NCT00930059|12224403|FG001|STARTED|Overall Study||91
11044148|NCT00930059|12224402|FG000|COMPLETED|Overall Study||92
11044149|NCT00930059|12224403|FG001|COMPLETED|Overall Study||79
11044150|NCT00930059|12224402|FG000|NOT COMPLETED|Overall Study||8
11044151|NCT00930059|12224403|FG001|NOT COMPLETED|Overall Study||12
11044152|NCT00930176|12224409|FG000|STARTED|Overall Study||16
11044153|NCT00930176|12224409|FG000|COMPLETED|Overall Study||15
11044154|NCT00930176|12224409|FG000|NOT COMPLETED|Overall Study||1
11044155|NCT00930293|12224415|FG000|STARTED|Overall Study||24
11044156|NCT00930293|12224416|FG001|STARTED|Overall Study||26
11044157|NCT00930293|12224415|FG000|COMPLETED|Overall Study||17
11044158|NCT00930293|12224416|FG001|COMPLETED|Overall Study||19
11044159|NCT00930293|12224415|FG000|NOT COMPLETED|Overall Study||7
11044160|NCT00930293|12224416|FG001|NOT COMPLETED|Overall Study||7
11044161|NCT00930553|12224422|FG000|STARTED|Overall Study||1314
11044162|NCT00930553|12224422|FG000|Participants Entered From CAMMS223|Overall Study||141
11044163|NCT00930553|12224422|FG000|Participants Entered From CAMMS323|Overall Study||488
11044164|NCT00930553|12224422|FG000|Participants Entered From CAMMS324|Overall Study||685
11336630|NCT02880865|12534404|FG001|STARTED|Overall Study||314
11044165|NCT00930553|12224422|FG000|COMPLETED|Overall Study||1091
11044166|NCT00930553|12224422|FG000|NOT COMPLETED|Overall Study||223
11044167|NCT00930644|12224444|FG000|STARTED|Overall Study||88
11044168|NCT00930644|12224444|FG000|COMPLETED|Overall Study||65
11044169|NCT00930644|12224444|FG000|NOT COMPLETED|Overall Study||23
11044170|NCT00930761|12224453|FG000|STARTED|Overall Study||50
11044171|NCT00930761|12224454|FG001|STARTED|Overall Study||51
11044172|NCT00930761|12224453|FG000|COMPLETED|Overall Study||46
11044173|NCT00930761|12224454|FG001|COMPLETED|Overall Study||48
11044174|NCT00930761|12224453|FG000|NOT COMPLETED|Overall Study||4
11044175|NCT00930761|12224454|FG001|NOT COMPLETED|Overall Study||3
11044176|NCT00930774|12224464|FG000|STARTED|Overall Study||25
11044177|NCT00930774|12224465|FG001|STARTED|Overall Study||25
11044178|NCT00930774|12224466|FG002|STARTED|Overall Study||24
11044179|NCT00930774|12224467|FG003|STARTED|Overall Study||25
11044180|NCT00930774|12224464|FG000|COMPLETED|Overall Study||24
11044181|NCT00930774|12224465|FG001|COMPLETED|Overall Study||16
11044182|NCT00930774|12224466|FG002|COMPLETED|Overall Study||22
11044183|NCT00930774|12224467|FG003|COMPLETED|Overall Study||25
11044184|NCT00930774|12224464|FG000|NOT COMPLETED|Overall Study||1
11044185|NCT00930774|12224465|FG001|NOT COMPLETED|Overall Study||9
11044186|NCT00930774|12224466|FG002|NOT COMPLETED|Overall Study||2
11044187|NCT00930774|12224467|FG003|NOT COMPLETED|Overall Study||0
11044188|NCT00930813|12224480|FG000|STARTED|Overall Study||49
11044189|NCT00930813|12224481|FG001|STARTED|Overall Study||52
11044190|NCT00930813|12224480|FG000|COMPLETED|Overall Study||41
11044191|NCT00930813|12224481|FG001|COMPLETED|Overall Study||38
11044192|NCT00930813|12224480|FG000|NOT COMPLETED|Overall Study||8
11044193|NCT00930813|12224481|FG001|NOT COMPLETED|Overall Study||14
11044194|NCT00930930|12224491|FG000|STARTED|Overall Study||96
11044195|NCT00930930|12224492|FG001|STARTED|Overall Study||49
11044196|NCT00930930|12224491|FG000|COMPLETED|Overall Study||75
11044197|NCT00930930|12224492|FG001|COMPLETED|Overall Study||40
11336631|NCT02880865|12534403|FG000|Received MMR Dose 1|Overall Study||314
11044198|NCT00930930|12224491|FG000|NOT COMPLETED|Overall Study||21
11044199|NCT00930930|12224492|FG001|NOT COMPLETED|Overall Study||9
11044200|NCT00930969|12224498|FG000|STARTED|Overall Study||175
11044201|NCT00930969|12224498|FG000|COMPLETED|Overall Study||137
11044202|NCT00930969|12224498|FG000|NOT COMPLETED|Overall Study||38
11044203|NCT00930982|12224504|FG000|STARTED|Overall Study||60
11044204|NCT00930982|12224505|FG001|STARTED|Overall Study||64
11044205|NCT00930982|12224504|FG000|COMPLETED|Overall Study||39
11044206|NCT00930982|12224505|FG001|COMPLETED|Overall Study||35
11044207|NCT00930982|12224504|FG000|NOT COMPLETED|Overall Study||21
11044208|NCT00930982|12224505|FG001|NOT COMPLETED|Overall Study||29
11044209|NCT00931164|12224511|FG000|STARTED|Overall Study||6
11044210|NCT00931164|12224511|FG000|COMPLETED|Overall Study||6
11044211|NCT00931164|12224511|FG000|NOT COMPLETED|Overall Study||0
11044212|NCT00931242|12224517|FG000|STARTED|Overall Study||10
11044213|NCT00931242|12224518|FG001|STARTED|Overall Study||2
11044214|NCT00931242|12224517|FG000|COMPLETED|Overall Study||5
11044215|NCT00931242|12224518|FG001|COMPLETED|Overall Study||0
11044216|NCT00931242|12224517|FG000|NOT COMPLETED|Overall Study||5
11044217|NCT00931242|12224518|FG001|NOT COMPLETED|Overall Study||2
11044218|NCT00931307|12224522|FG000|STARTED|Overall Study||22
11044219|NCT00931307|12224522|FG000|COMPLETED|Overall Study||9
11044220|NCT00931307|12224522|FG000|NOT COMPLETED|Overall Study||13
11044221|NCT00931359|12224528|FG000|STARTED|Overall Study||39
11044222|NCT00931359|12224529|FG001|STARTED|Overall Study||81
11044223|NCT00931359|12224528|FG000|COMPLETED|Overall Study||33
11044224|NCT00931359|12224529|FG001|COMPLETED|Overall Study||68
11044225|NCT00931359|12224528|FG000|NOT COMPLETED|Overall Study||6
11044226|NCT00931359|12224529|FG001|NOT COMPLETED|Overall Study||13
11044227|NCT00931385|12224535|FG000|STARTED|Overall Study||25
11044228|NCT00931385|12224536|FG001|STARTED|Overall Study||23
11044229|NCT00931385|12224537|FG002|STARTED|Overall Study||25
11044230|NCT00931385|12224538|FG003|STARTED|Overall Study||26
11044231|NCT00931385|12224535|FG000|COMPLETED|Overall Study||23
11044232|NCT00931385|12224536|FG001|COMPLETED|Overall Study||21
11044233|NCT00931385|12224537|FG002|COMPLETED|Overall Study||24
11044234|NCT00931385|12224538|FG003|COMPLETED|Overall Study||21
11044235|NCT00931385|12224535|FG000|NOT COMPLETED|Overall Study||2
11044236|NCT00931385|12224536|FG001|NOT COMPLETED|Overall Study||2
11044237|NCT00931385|12224537|FG002|NOT COMPLETED|Overall Study||1
11044238|NCT00931385|12224538|FG003|NOT COMPLETED|Overall Study||5
11044239|NCT00931411|12224554|FG000|STARTED|First Intervention - 42 Days||35
11044240|NCT00931411|12224555|FG001|STARTED|First Intervention - 42 Days||38
11044241|NCT00931411|12224554|FG000|COMPLETED|First Intervention - 42 Days||31
11044242|NCT00931411|12224555|FG001|COMPLETED|First Intervention - 42 Days||35
11044243|NCT00931411|12224554|FG000|NOT COMPLETED|First Intervention - 42 Days||4
11044244|NCT00931411|12224555|FG001|NOT COMPLETED|First Intervention - 42 Days||3
11044245|NCT00931411|12224554|FG000|STARTED|After Crossover - 14 Days (up to Day 56)||31
11044246|NCT00931411|12224555|FG001|STARTED|After Crossover - 14 Days (up to Day 56)||35
11044247|NCT00931411|12224554|FG000|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
11044248|NCT00931411|12224555|FG001|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
11044249|NCT00931411|12224554|FG000|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
11044250|NCT00931411|12224555|FG001|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
11044251|NCT00931463|12224567|FG000|STARTED|Overall Study||271
11044252|NCT00931463|12224568|FG001|STARTED|Overall Study||270
11044253|NCT00931463|12224567|FG000|COMPLETED|Overall Study||254
11044254|NCT00931463|12224568|FG001|COMPLETED|Overall Study||265
11044255|NCT00931463|12224567|FG000|NOT COMPLETED|Overall Study||17
11044256|NCT00931463|12224568|FG001|NOT COMPLETED|Overall Study||5
11044257|NCT00931489|12224579|FG000|STARTED|Overall Study||40
11044258|NCT00931489|12224580|FG001|STARTED|Overall Study||40
11044259|NCT00931489|12224581|FG002|STARTED|Overall Study||5
11044260|NCT00931489|12224582|FG003|STARTED|Overall Study||39
11044261|NCT00931489|12224583|FG004|STARTED|Overall Study||7
11044262|NCT00931489|12224579|FG000|COMPLETED|Overall Study||40
11044263|NCT00931489|12224580|FG001|COMPLETED|Overall Study||40
11044264|NCT00931489|12224581|FG002|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
11044265|NCT00931489|12224582|FG003|COMPLETED|Overall Study||39
11044266|NCT00931489|12224583|FG004|COMPLETED|Overall Study||7
11044267|NCT00931489|12224579|FG000|NOT COMPLETED|Overall Study||0
11044268|NCT00931489|12224580|FG001|NOT COMPLETED|Overall Study||0
11044269|NCT00931489|12224581|FG002|NOT COMPLETED|Overall Study||0
11044270|NCT00931489|12224582|FG003|NOT COMPLETED|Overall Study||0
11044271|NCT00931489|12224583|FG004|NOT COMPLETED|Overall Study||0
11044272|NCT00931515|12224596|FG000|STARTED|Overall Study||15
11044273|NCT00931515|12224597|FG001|STARTED|Overall Study||15
11044274|NCT00931515|12224596|FG000|COMPLETED|Overall Study||13
11044275|NCT00931515|12224597|FG001|COMPLETED|Overall Study||10
11044276|NCT00931515|12224596|FG000|NOT COMPLETED|Overall Study||2
11044277|NCT00931515|12224597|FG001|NOT COMPLETED|Overall Study||5
11044278|NCT00931528|12224605|FG000|STARTED|Overall Study||121
11044279|NCT00931528|12224606|FG001|STARTED|Overall Study||121
11044280|NCT00931528|12224605|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
11044281|NCT00931528|12224606|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
11044282|NCT00931528|12224605|FG000|NOT COMPLETED|Overall Study||41
11044283|NCT00931528|12224606|FG001|NOT COMPLETED|Overall Study||60
11044284|NCT00931632|12224615|FG000|STARTED|Overall Study|Randomized|229
11044285|NCT00931632|12224616|FG001|STARTED|Overall Study|Randomized|222
11044286|NCT00931632|12224615|FG000|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
11044287|NCT00931632|12224616|FG001|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
11044288|NCT00931632|12224615|FG000|NOT COMPLETED|Overall Study||21
11044289|NCT00931632|12224616|FG001|NOT COMPLETED|Overall Study||18
11044290|NCT00931710|12224624|FG000|STARTED|Overall Study||241
11044291|NCT00931710|12224625|FG001|STARTED|Overall Study||247
11044292|NCT00931710|12224624|FG000|COMPLETED|Overall Study||207
11044293|NCT00931710|12224625|FG001|COMPLETED|Overall Study||209
11044294|NCT00931710|12224624|FG000|NOT COMPLETED|Overall Study||34
11044295|NCT00931710|12224625|FG001|NOT COMPLETED|Overall Study||38
11044296|NCT00931723|12224633|FG000|STARTED|Overall Study||173
11044297|NCT00931723|12224634|FG001|STARTED|Overall Study||183
11044298|NCT00931723|12224633|FG000|COMPLETED|Overall Study||147
11044299|NCT00931723|12224634|FG001|COMPLETED|Overall Study||144
11044300|NCT00931723|12224633|FG000|NOT COMPLETED|Overall Study||26
11044301|NCT00931723|12224634|FG001|NOT COMPLETED|Overall Study||39
11044302|NCT00931762|12224640|FG000|STARTED|Overall Study||35
11044303|NCT00931762|12224640|FG000|COMPLETED|Overall Study||0
11044304|NCT00931762|12224640|FG000|NOT COMPLETED|Overall Study||35
11044305|NCT00931801|12224647|FG000|STARTED|Overall Study||14
11044306|NCT00931801|12224648|FG001|STARTED|Overall Study||15
11044307|NCT00931801|12224649|FG002|STARTED|Overall Study||14
11044308|NCT00931801|12224647|FG000|COMPLETED|Overall Study||13
11044309|NCT00931801|12224648|FG001|COMPLETED|Overall Study||14
11044310|NCT00931801|12224649|FG002|COMPLETED|Overall Study||10
11044311|NCT00931801|12224647|FG000|NOT COMPLETED|Overall Study||1
11044312|NCT00931801|12224648|FG001|NOT COMPLETED|Overall Study||1
11044313|NCT00931801|12224649|FG002|NOT COMPLETED|Overall Study||4
11044314|NCT00931879|12224663|FG000|STARTED|Overall Study||22
11044315|NCT00931879|12224664|FG001|STARTED|Overall Study||22
11044316|NCT00931879|12224663|FG000|COMPLETED|Overall Study||19
11044317|NCT00931879|12224664|FG001|COMPLETED|Overall Study||19
11044318|NCT00931879|12224663|FG000|NOT COMPLETED|Overall Study||3
11044319|NCT00931879|12224664|FG001|NOT COMPLETED|Overall Study||3
11044320|NCT00931892|12224673|FG000|STARTED|Completed Gluten Challenge||10
11044321|NCT00931892|12224674|FG001|STARTED|Completed Gluten Challenge||10
11044322|NCT00931892|12224673|FG000|COMPLETED|Completed Gluten Challenge||10
11044323|NCT00931892|12224674|FG001|COMPLETED|Completed Gluten Challenge||10
11044324|NCT00931892|12224673|FG000|NOT COMPLETED|Completed Gluten Challenge||0
11044325|NCT00931892|12224674|FG001|NOT COMPLETED|Completed Gluten Challenge||0
11044326|NCT00931892|12224673|FG000|STARTED|Completed Endoscopies||10
11044327|NCT00931892|12224674|FG001|STARTED|Completed Endoscopies||10
11044328|NCT00931892|12224673|FG000|First Endoscopy|Completed Endoscopies||10
11044329|NCT00931892|12224674|FG001|First Endoscopy|Completed Endoscopies||10
11044330|NCT00931892|12224673|FG000|Second Endoscopy|Completed Endoscopies||10
11044331|NCT00931892|12224674|FG001|Second Endoscopy|Completed Endoscopies||10
11044332|NCT00931892|12224673|FG000|Third Endoscopy|Completed Endoscopies||10
11044333|NCT00931892|12224674|FG001|Third Endoscopy|Completed Endoscopies||9
11044334|NCT00931892|12224673|FG000|COMPLETED|Completed Endoscopies||10
11044335|NCT00931892|12224674|FG001|COMPLETED|Completed Endoscopies||9
11044336|NCT00931892|12224673|FG000|NOT COMPLETED|Completed Endoscopies||0
11044337|NCT00931892|12224674|FG001|NOT COMPLETED|Completed Endoscopies||1
11044338|NCT00931918|12224722|FG000|STARTED|Overall Study||103
11044339|NCT00931918|12224723|FG001|STARTED|Overall Study||103
11044340|NCT00931918|12224722|FG000|Safety Population: Received Study Drug|Overall Study||100
11044341|NCT00931918|12224723|FG001|Safety Population: Received Study Drug|Overall Study||101
11044342|NCT00931918|12224722|FG000|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
11044343|NCT00931918|12224723|FG001|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
11044344|NCT00931918|12224722|FG000|NOT COMPLETED|Overall Study||17
11044345|NCT00931918|12224723|FG001|NOT COMPLETED|Overall Study||17
11044346|NCT00931944|12224729|FG000|STARTED|Overall Study||74
11044347|NCT00931944|12224729|FG000|COMPLETED|Overall Study||19
11044348|NCT00931944|12224729|FG000|NOT COMPLETED|Overall Study||55
11044349|NCT00931996|12224733|FG000|STARTED|Overall Study||12
11044350|NCT00931996|12224733|FG000|COMPLETED|Overall Study||5
11044351|NCT00931996|12224733|FG000|NOT COMPLETED|Overall Study||7
11044352|NCT00932022|12224739|FG000|STARTED|Overall Study||64
11044353|NCT00932022|12224740|FG001|STARTED|Overall Study||63
11044354|NCT00932022|12224739|FG000|COMPLETED|Overall Study||59
11044355|NCT00932022|12224740|FG001|COMPLETED|Overall Study||59
11044356|NCT00932022|12224739|FG000|NOT COMPLETED|Overall Study||5
11044357|NCT00932022|12224740|FG001|NOT COMPLETED|Overall Study||4
11044358|NCT00932035|12224748|FG000|STARTED|Overall Study||18
11044359|NCT00932035|12224749|FG001|STARTED|Overall Study||21
11044360|NCT00932035|12224748|FG000|COMPLETED|Overall Study||18
11044361|NCT00932035|12224749|FG001|COMPLETED|Overall Study||21
11044362|NCT00932035|12224748|FG000|NOT COMPLETED|Overall Study||0
11044363|NCT00932035|12224749|FG001|NOT COMPLETED|Overall Study||0
11044364|NCT00932113|12224757|FG000|STARTED|Overall Study||15
11044365|NCT00932113|12224758|FG001|STARTED|Overall Study||15
11044366|NCT00932113|12224757|FG000|COMPLETED|Overall Study||14
11044367|NCT00932113|12224758|FG001|COMPLETED|Overall Study||15
11044368|NCT00932113|12224757|FG000|NOT COMPLETED|Overall Study||1
11044369|NCT00932113|12224758|FG001|NOT COMPLETED|Overall Study||0
11044370|NCT00932126|12224764|FG000|STARTED|Overall Study||3
11044371|NCT00932126|12224765|FG001|STARTED|Overall Study||3
11044372|NCT00932126|12224766|FG002|STARTED|Overall Study||3
11044373|NCT00932126|12224767|FG003|STARTED|Overall Study||3
11044374|NCT00932126|12224768|FG004|STARTED|Overall Study||5
11044375|NCT00932126|12224769|FG005|STARTED|Overall Study||3
11336632|NCT02880865|12534404|FG001|Received MMR Dose 1|Overall Study||314
11336633|NCT02880865|12534403|FG000|Received CD-JEV|Overall Study||314
11044376|NCT00932126|12224770|FG006|STARTED|Overall Study||5
11044377|NCT00932126|12224771|FG007|STARTED|Overall Study||10
11044378|NCT00932126|12224764|FG000|COMPLETED|Overall Study||0
11336634|NCT02880865|12534404|FG001|Received CD-JEV|Overall Study||309
11336635|NCT02880865|12534403|FG000|Received MMR Dose 2|Overall Study||313
11336636|NCT02880865|12534404|FG001|Received MMR Dose 2|Overall Study||311
11336637|NCT02880865|12534403|FG000|COMPLETED|Overall Study||313
11336638|NCT02880865|12534404|FG001|COMPLETED|Overall Study||311
11336639|NCT02880865|12534403|FG000|NOT COMPLETED|Overall Study||1
11336640|NCT02880865|12534404|FG001|NOT COMPLETED|Overall Study||3
11044379|NCT00932126|12224765|FG001|COMPLETED|Overall Study||0
11044380|NCT00932126|12224766|FG002|COMPLETED|Overall Study||0
11336641|NCT02881008|12534437|FG000|STARTED|Overall Study||8
11336642|NCT02881008|12534438|FG001|STARTED|Overall Study||8
11044381|NCT00932126|12224767|FG003|COMPLETED|Overall Study||0
11044382|NCT00932126|12224768|FG004|COMPLETED|Overall Study||0
11044383|NCT00932126|12224769|FG005|COMPLETED|Overall Study||0
11044384|NCT00932126|12224770|FG006|COMPLETED|Overall Study||0
11044385|NCT00932126|12224771|FG007|COMPLETED|Overall Study||0
11044386|NCT00932126|12224764|FG000|NOT COMPLETED|Overall Study||3
11044387|NCT00932126|12224765|FG001|NOT COMPLETED|Overall Study||3
11044388|NCT00932126|12224766|FG002|NOT COMPLETED|Overall Study||3
11044389|NCT00932126|12224767|FG003|NOT COMPLETED|Overall Study||3
11044390|NCT00932126|12224768|FG004|NOT COMPLETED|Overall Study||5
11044391|NCT00932126|12224769|FG005|NOT COMPLETED|Overall Study||3
11044392|NCT00932126|12224770|FG006|NOT COMPLETED|Overall Study||5
11044393|NCT00932126|12224771|FG007|NOT COMPLETED|Overall Study||10
11044394|NCT00932165|12224791|FG000|STARTED|Overall Study||451
11044395|NCT00932165|12224791|FG000|COMPLETED|Overall Study||450
11044396|NCT00932165|12224791|FG000|NOT COMPLETED|Overall Study||1
11044397|NCT00932282|12224798|FG000|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
11044398|NCT00932282|12224799|FG001|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
11044399|NCT00932282|12224798|FG000|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
11044400|NCT00932282|12224799|FG001|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
11044401|NCT00932282|12224798|FG000|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
11044402|NCT00932282|12224799|FG001|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
11044403|NCT00932282|12224798|FG000|STARTED|Modified OIT Rush Desensitization Phase||6
11044404|NCT00932282|12224799|FG001|STARTED|Modified OIT Rush Desensitization Phase||5
11044405|NCT00932282|12224798|FG000|COMPLETED|Modified OIT Rush Desensitization Phase||6
11044406|NCT00932282|12224799|FG001|COMPLETED|Modified OIT Rush Desensitization Phase||5
11044407|NCT00932282|12224798|FG000|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
11044408|NCT00932282|12224799|FG001|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
11044409|NCT00932282|12224798|FG000|STARTED|Biweekly OIT Buildup Phase||6
11044410|NCT00932282|12224799|FG001|STARTED|Biweekly OIT Buildup Phase||5
11044411|NCT00932282|12224798|FG000|COMPLETED|Biweekly OIT Buildup Phase||5
11044412|NCT00932282|12224799|FG001|COMPLETED|Biweekly OIT Buildup Phase||4
11044413|NCT00932282|12224798|FG000|NOT COMPLETED|Biweekly OIT Buildup Phase||1
11044414|NCT00932282|12224799|FG001|NOT COMPLETED|Biweekly OIT Buildup Phase||1
11044415|NCT00932282|12224798|FG000|STARTED|OIT Maintenance Phase||5
11044416|NCT00932282|12224799|FG001|STARTED|OIT Maintenance Phase||4
11044417|NCT00932282|12224798|FG000|COMPLETED|OIT Maintenance Phase||4
11044418|NCT00932282|12224799|FG001|COMPLETED|OIT Maintenance Phase||2
11044419|NCT00932282|12224798|FG000|NOT COMPLETED|OIT Maintenance Phase||1
11044420|NCT00932282|12224799|FG001|NOT COMPLETED|OIT Maintenance Phase||2
11044421|NCT00932321|12224807|FG000|STARTED|Overall Study||751
11044422|NCT00932321|12224808|FG001|STARTED|Overall Study||187
11044423|NCT00932321|12224807|FG000|MITT Population|Overall Study||705
11044424|NCT00932321|12224808|FG001|MITT Population|Overall Study||181
11044425|NCT00932321|12224807|FG000|COMPLETED|Overall Study||580
11044426|NCT00932321|12224808|FG001|COMPLETED|Overall Study||141
11044427|NCT00932321|12224807|FG000|NOT COMPLETED|Overall Study||171
11044428|NCT00932321|12224808|FG001|NOT COMPLETED|Overall Study||46
11044429|NCT00932360|12224814|FG000|STARTED|1: Visit 1/Week1||10
11044430|NCT00932360|12224815|FG001|STARTED|1: Visit 1/Week1||6
11044431|NCT00932360|12224816|FG002|STARTED|1: Visit 1/Week1||3
11044432|NCT00932360|12224817|FG003|STARTED|1: Visit 1/Week1||13
11044433|NCT00932360|12224818|FG004|STARTED|1: Visit 1/Week1||4
11044434|NCT00932360|12224819|FG005|STARTED|1: Visit 1/Week1||7
11044435|NCT00932360|12224814|FG000|COMPLETED|1: Visit 1/Week1||10
11044436|NCT00932360|12224815|FG001|COMPLETED|1: Visit 1/Week1||6
11044437|NCT00932360|12224816|FG002|COMPLETED|1: Visit 1/Week1||3
11044438|NCT00932360|12224817|FG003|COMPLETED|1: Visit 1/Week1||13
11044439|NCT00932360|12224818|FG004|COMPLETED|1: Visit 1/Week1||4
11044440|NCT00932360|12224819|FG005|COMPLETED|1: Visit 1/Week1||7
11044441|NCT00932360|12224814|FG000|NOT COMPLETED|1: Visit 1/Week1||0
11044442|NCT00932360|12224815|FG001|NOT COMPLETED|1: Visit 1/Week1||0
11044443|NCT00932360|12224816|FG002|NOT COMPLETED|1: Visit 1/Week1||0
11044444|NCT00932360|12224817|FG003|NOT COMPLETED|1: Visit 1/Week1||0
11044445|NCT00932360|12224818|FG004|NOT COMPLETED|1: Visit 1/Week1||0
11044446|NCT00932360|12224819|FG005|NOT COMPLETED|1: Visit 1/Week1||0
11044447|NCT00932360|12224814|FG000|STARTED|Washout (One Week)||10
11044448|NCT00932360|12224815|FG001|STARTED|Washout (One Week)||6
11044449|NCT00932360|12224816|FG002|STARTED|Washout (One Week)||3
11044450|NCT00932360|12224817|FG003|STARTED|Washout (One Week)||13
11044451|NCT00932360|12224818|FG004|STARTED|Washout (One Week)||4
11044452|NCT00932360|12224819|FG005|STARTED|Washout (One Week)||7
11044453|NCT00932360|12224814|FG000|COMPLETED|Washout (One Week)||10
11044454|NCT00932360|12224815|FG001|COMPLETED|Washout (One Week)||6
11044455|NCT00932360|12224816|FG002|COMPLETED|Washout (One Week)||3
11044456|NCT00932360|12224817|FG003|COMPLETED|Washout (One Week)||13
11044457|NCT00932360|12224818|FG004|COMPLETED|Washout (One Week)||2
11044458|NCT00932360|12224819|FG005|COMPLETED|Washout (One Week)||7
11044459|NCT00932360|12224814|FG000|NOT COMPLETED|Washout (One Week)||0
11044460|NCT00932360|12224815|FG001|NOT COMPLETED|Washout (One Week)||0
11044461|NCT00932360|12224816|FG002|NOT COMPLETED|Washout (One Week)||0
11044462|NCT00932360|12224817|FG003|NOT COMPLETED|Washout (One Week)||0
11044463|NCT00932360|12224818|FG004|NOT COMPLETED|Washout (One Week)||2
11044464|NCT00932360|12224819|FG005|NOT COMPLETED|Washout (One Week)||0
11044465|NCT00932360|12224814|FG000|STARTED|Visit 2/Week 2||10
11044466|NCT00932360|12224815|FG001|STARTED|Visit 2/Week 2||6
11044467|NCT00932360|12224816|FG002|STARTED|Visit 2/Week 2||3
11044468|NCT00932360|12224817|FG003|STARTED|Visit 2/Week 2||13
11044469|NCT00932360|12224818|FG004|STARTED|Visit 2/Week 2||2
11044470|NCT00932360|12224819|FG005|STARTED|Visit 2/Week 2||7
11044471|NCT00932360|12224814|FG000|COMPLETED|Visit 2/Week 2||10
11044472|NCT00932360|12224815|FG001|COMPLETED|Visit 2/Week 2||6
11044473|NCT00932360|12224816|FG002|COMPLETED|Visit 2/Week 2||3
11044474|NCT00932360|12224817|FG003|COMPLETED|Visit 2/Week 2||13
11044475|NCT00932360|12224818|FG004|COMPLETED|Visit 2/Week 2||2
11044476|NCT00932360|12224819|FG005|COMPLETED|Visit 2/Week 2||7
11044477|NCT00932360|12224814|FG000|NOT COMPLETED|Visit 2/Week 2||0
11044478|NCT00932360|12224815|FG001|NOT COMPLETED|Visit 2/Week 2||0
11044479|NCT00932360|12224816|FG002|NOT COMPLETED|Visit 2/Week 2||0
11044480|NCT00932360|12224817|FG003|NOT COMPLETED|Visit 2/Week 2||0
11044481|NCT00932360|12224818|FG004|NOT COMPLETED|Visit 2/Week 2||0
11044482|NCT00932360|12224819|FG005|NOT COMPLETED|Visit 2/Week 2||0
11044483|NCT00932360|12224814|FG000|STARTED|Washout (One Week)||10
11044484|NCT00932360|12224815|FG001|STARTED|Washout (One Week)||6
11044485|NCT00932360|12224816|FG002|STARTED|Washout (One Week)||3
11044486|NCT00932360|12224817|FG003|STARTED|Washout (One Week)||13
11044487|NCT00932360|12224818|FG004|STARTED|Washout (One Week)||2
11044488|NCT00932360|12224819|FG005|STARTED|Washout (One Week)||7
11044489|NCT00932360|12224814|FG000|COMPLETED|Washout (One Week)||10
11044490|NCT00932360|12224815|FG001|COMPLETED|Washout (One Week)||6
11044491|NCT00932360|12224816|FG002|COMPLETED|Washout (One Week)||3
11044492|NCT00932360|12224817|FG003|COMPLETED|Washout (One Week)||13
11044493|NCT00932360|12224818|FG004|COMPLETED|Washout (One Week)||2
11044494|NCT00932360|12224819|FG005|COMPLETED|Washout (One Week)||7
11044495|NCT00932360|12224814|FG000|NOT COMPLETED|Washout (One Week)||0
11044496|NCT00932360|12224815|FG001|NOT COMPLETED|Washout (One Week)||0
11044497|NCT00932360|12224816|FG002|NOT COMPLETED|Washout (One Week)||0
11044498|NCT00932360|12224817|FG003|NOT COMPLETED|Washout (One Week)||0
11044499|NCT00932360|12224818|FG004|NOT COMPLETED|Washout (One Week)||0
11044500|NCT00932360|12224819|FG005|NOT COMPLETED|Washout (One Week)||0
11044501|NCT00932360|12224814|FG000|STARTED|Visit 3/Week 3||10
11044502|NCT00932360|12224815|FG001|STARTED|Visit 3/Week 3||6
11044503|NCT00932360|12224816|FG002|STARTED|Visit 3/Week 3||3
11044504|NCT00932360|12224817|FG003|STARTED|Visit 3/Week 3||13
11044505|NCT00932360|12224818|FG004|STARTED|Visit 3/Week 3||2
11044506|NCT00932360|12224819|FG005|STARTED|Visit 3/Week 3||7
11044507|NCT00932360|12224814|FG000|COMPLETED|Visit 3/Week 3||10
11044508|NCT00932360|12224815|FG001|COMPLETED|Visit 3/Week 3||6
11044509|NCT00932360|12224816|FG002|COMPLETED|Visit 3/Week 3||3
11044510|NCT00932360|12224817|FG003|COMPLETED|Visit 3/Week 3||13
11044511|NCT00932360|12224818|FG004|COMPLETED|Visit 3/Week 3||2
11336643|NCT02881008|12534439|FG002|STARTED|Overall Study||8
11044512|NCT00932360|12224819|FG005|COMPLETED|Visit 3/Week 3||7
11044513|NCT00932360|12224814|FG000|NOT COMPLETED|Visit 3/Week 3||0
11044514|NCT00932360|12224815|FG001|NOT COMPLETED|Visit 3/Week 3||0
11044515|NCT00932360|12224816|FG002|NOT COMPLETED|Visit 3/Week 3||0
11044516|NCT00932360|12224817|FG003|NOT COMPLETED|Visit 3/Week 3||0
11044517|NCT00932360|12224818|FG004|NOT COMPLETED|Visit 3/Week 3||0
11044518|NCT00932360|12224819|FG005|NOT COMPLETED|Visit 3/Week 3||0
11044519|NCT00932373|12224844|FG000|STARTED|Overall Study||3
11044520|NCT00932373|12224845|FG001|STARTED|Overall Study||1
11044521|NCT00932373|12224846|FG002|STARTED|Overall Study||1
11044522|NCT00932373|12224847|FG003|STARTED|Overall Study||1
11044523|NCT00932373|12224848|FG004|STARTED|Overall Study||15
11044524|NCT00932373|12224849|FG005|STARTED|Overall Study||3
11044525|NCT00932373|12224850|FG006|STARTED|Overall Study||3
11044526|NCT00932373|12224851|FG007|STARTED|Overall Study||3
11044527|NCT00932373|12224852|FG008|STARTED|Overall Study||3
11044528|NCT00932373|12224853|FG009|STARTED|Overall Study||16
11044529|NCT00932373|12224854|FG010|STARTED|Overall Study||3
11044530|NCT00932373|12224844|FG000|COMPLETED|Overall Study||0
11044531|NCT00932373|12224845|FG001|COMPLETED|Overall Study||0
11044532|NCT00932373|12224846|FG002|COMPLETED|Overall Study||0
11044533|NCT00932373|12224847|FG003|COMPLETED|Overall Study||1
11044534|NCT00932373|12224848|FG004|COMPLETED|Overall Study||1
11044535|NCT00932373|12224849|FG005|COMPLETED|Overall Study||0
11044536|NCT00932373|12224850|FG006|COMPLETED|Overall Study||2
11044537|NCT00932373|12224851|FG007|COMPLETED|Overall Study||0
11044538|NCT00932373|12224852|FG008|COMPLETED|Overall Study||1
11044539|NCT00932373|12224853|FG009|COMPLETED|Overall Study||3
11044540|NCT00932373|12224854|FG010|COMPLETED|Overall Study||0
11044541|NCT00932373|12224844|FG000|NOT COMPLETED|Overall Study||3
11044542|NCT00932373|12224845|FG001|NOT COMPLETED|Overall Study||1
11044543|NCT00932373|12224846|FG002|NOT COMPLETED|Overall Study||1
11044544|NCT00932373|12224847|FG003|NOT COMPLETED|Overall Study||0
11044545|NCT00932373|12224848|FG004|NOT COMPLETED|Overall Study||14
11044546|NCT00932373|12224849|FG005|NOT COMPLETED|Overall Study||3
11044547|NCT00932373|12224850|FG006|NOT COMPLETED|Overall Study||1
11044548|NCT00932373|12224851|FG007|NOT COMPLETED|Overall Study||3
11044549|NCT00932373|12224852|FG008|NOT COMPLETED|Overall Study||2
11044550|NCT00932373|12224853|FG009|NOT COMPLETED|Overall Study||13
11044551|NCT00932373|12224854|FG010|NOT COMPLETED|Overall Study||3
11044552|NCT00932399|12224888|FG000|STARTED|Overall Study||759
11044553|NCT00932399|12224889|FG001|STARTED|Overall Study||3790
11044554|NCT00932399|12224888|FG000|COMPLETED|Overall Study||759
11044555|NCT00932399|12224889|FG001|COMPLETED|Overall Study||3790
11044556|NCT00932399|12224888|FG000|NOT COMPLETED|Overall Study||0
11336644|NCT02881008|12534440|FG003|STARTED|Overall Study||8
11044557|NCT00932399|12224889|FG001|NOT COMPLETED|Overall Study||0
11044558|NCT00932425|12224897|FG000|STARTED|Overall Study||20
11044559|NCT00932425|12224898|FG001|STARTED|Overall Study||20
11044560|NCT00932425|12224897|FG000|COMPLETED|Overall Study||20
11044561|NCT00932425|12224898|FG001|COMPLETED|Overall Study||18
11044562|NCT00932425|12224897|FG000|NOT COMPLETED|Overall Study||0
11044563|NCT00932425|12224898|FG001|NOT COMPLETED|Overall Study||2
11044564|NCT00932438|12224906|FG000|STARTED|Overall Study||40
11044565|NCT00932438|12224907|FG001|STARTED|Overall Study||30
11044566|NCT00932438|12224906|FG000|COMPLETED|Overall Study||39
11044567|NCT00932438|12224907|FG001|COMPLETED|Overall Study||30
11044568|NCT00932438|12224906|FG000|NOT COMPLETED|Overall Study||1
11044569|NCT00932438|12224907|FG001|NOT COMPLETED|Overall Study||0
11044570|NCT00932451|12224915|FG000|STARTED|Overall Study||1066
11044571|NCT00932451|12224915|FG000|COMPLETED|Overall Study||244
11044572|NCT00932451|12224915|FG000|NOT COMPLETED|Overall Study||822
11044573|NCT00932477|12224923|FG000|STARTED|Treatment 1||7
11044574|NCT00932477|12224924|FG001|STARTED|Treatment 1||8
11044575|NCT00932477|12224925|FG002|STARTED|Treatment 1||9
11044576|NCT00932477|12224926|FG003|STARTED|Treatment 1||7
11044577|NCT00932477|12224927|FG004|STARTED|Treatment 1||8
11044578|NCT00932477|12224928|FG005|STARTED|Treatment 1||8
11044579|NCT00932477|12224923|FG000|COMPLETED|Treatment 1||7
11044580|NCT00932477|12224924|FG001|COMPLETED|Treatment 1||8
11044581|NCT00932477|12224925|FG002|COMPLETED|Treatment 1||9
11044582|NCT00932477|12224926|FG003|COMPLETED|Treatment 1||7
11044583|NCT00932477|12224927|FG004|COMPLETED|Treatment 1||8
11044584|NCT00932477|12224928|FG005|COMPLETED|Treatment 1||8
11044585|NCT00932477|12224923|FG000|NOT COMPLETED|Treatment 1||0
11044586|NCT00932477|12224924|FG001|NOT COMPLETED|Treatment 1||0
11044587|NCT00932477|12224925|FG002|NOT COMPLETED|Treatment 1||0
11044588|NCT00932477|12224926|FG003|NOT COMPLETED|Treatment 1||0
11044589|NCT00932477|12224927|FG004|NOT COMPLETED|Treatment 1||0
11044590|NCT00932477|12224928|FG005|NOT COMPLETED|Treatment 1||0
11044591|NCT00932477|12224923|FG000|STARTED|Treatment 2||7
11044592|NCT00932477|12224924|FG001|STARTED|Treatment 2||8
11044593|NCT00932477|12224925|FG002|STARTED|Treatment 2||9
11044594|NCT00932477|12224926|FG003|STARTED|Treatment 2||7
11044595|NCT00932477|12224927|FG004|STARTED|Treatment 2||8
11044596|NCT00932477|12224928|FG005|STARTED|Treatment 2||8
11044597|NCT00932477|12224923|FG000|COMPLETED|Treatment 2||7
11044598|NCT00932477|12224924|FG001|COMPLETED|Treatment 2||8
11044599|NCT00932477|12224925|FG002|COMPLETED|Treatment 2||9
11044600|NCT00932477|12224926|FG003|COMPLETED|Treatment 2||7
11044601|NCT00932477|12224927|FG004|COMPLETED|Treatment 2||8
11044602|NCT00932477|12224928|FG005|COMPLETED|Treatment 2||8
11044603|NCT00932477|12224923|FG000|NOT COMPLETED|Treatment 2||0
11044604|NCT00932477|12224924|FG001|NOT COMPLETED|Treatment 2||0
11044605|NCT00932477|12224925|FG002|NOT COMPLETED|Treatment 2||0
11044606|NCT00932477|12224926|FG003|NOT COMPLETED|Treatment 2||0
11044607|NCT00932477|12224927|FG004|NOT COMPLETED|Treatment 2||0
11044608|NCT00932477|12224928|FG005|NOT COMPLETED|Treatment 2||0
11044609|NCT00932477|12224923|FG000|STARTED|Treatment 3||7
11044610|NCT00932477|12224924|FG001|STARTED|Treatment 3||8
11044611|NCT00932477|12224925|FG002|STARTED|Treatment 3||9
11044612|NCT00932477|12224926|FG003|STARTED|Treatment 3||7
11044613|NCT00932477|12224927|FG004|STARTED|Treatment 3||8
11044614|NCT00932477|12224928|FG005|STARTED|Treatment 3||8
11044615|NCT00932477|12224923|FG000|COMPLETED|Treatment 3||7
11044616|NCT00932477|12224924|FG001|COMPLETED|Treatment 3||8
11044617|NCT00932477|12224925|FG002|COMPLETED|Treatment 3||9
11044618|NCT00932477|12224926|FG003|COMPLETED|Treatment 3||7
11044619|NCT00932477|12224927|FG004|COMPLETED|Treatment 3||8
11044620|NCT00932477|12224928|FG005|COMPLETED|Treatment 3||8
11044621|NCT00932477|12224923|FG000|NOT COMPLETED|Treatment 3||0
11044622|NCT00932477|12224924|FG001|NOT COMPLETED|Treatment 3||0
11044623|NCT00932477|12224925|FG002|NOT COMPLETED|Treatment 3||0
11044624|NCT00932477|12224926|FG003|NOT COMPLETED|Treatment 3||0
11044625|NCT00932477|12224927|FG004|NOT COMPLETED|Treatment 3||0
11044626|NCT00932477|12224928|FG005|NOT COMPLETED|Treatment 3||0
11044627|NCT00932620|12224938|FG000|STARTED|Overall Study||50
11044628|NCT00932620|12224939|FG001|STARTED|Overall Study||50
11044629|NCT00932620|12224938|FG000|COMPLETED|Overall Study||50
11044630|NCT00932620|12224939|FG001|COMPLETED|Overall Study||50
11044631|NCT00932620|12224938|FG000|NOT COMPLETED|Overall Study||0
11044632|NCT00932620|12224939|FG001|NOT COMPLETED|Overall Study||0
11044633|NCT00932646|12224947|FG000|STARTED|Overall Study||25
11044634|NCT00932646|12224948|FG001|STARTED|Overall Study||25
11044635|NCT00932646|12224949|FG002|STARTED|Overall Study||25
11044636|NCT00932646|12224950|FG003|STARTED|Overall Study||25
11044637|NCT00932646|12224947|FG000|COMPLETED|Overall Study||20
11044638|NCT00932646|12224948|FG001|COMPLETED|Overall Study||22
11044639|NCT00932646|12224949|FG002|COMPLETED|Overall Study||21
11044640|NCT00932646|12224950|FG003|COMPLETED|Overall Study||24
11044641|NCT00932646|12224947|FG000|NOT COMPLETED|Overall Study||5
11044642|NCT00932646|12224948|FG001|NOT COMPLETED|Overall Study||3
11044643|NCT00932646|12224949|FG002|NOT COMPLETED|Overall Study||4
11044644|NCT00932646|12224950|FG003|NOT COMPLETED|Overall Study||1
11044645|NCT00932659|12224964|FG000|STARTED|Overall Study||8
11044646|NCT00932659|12224964|FG000|COMPLETED|Overall Study||8
11044647|NCT00932659|12224964|FG000|NOT COMPLETED|Overall Study||0
11044648|NCT00932698|12224979|FG000|STARTED|Part 1 (Dose Escalation)||3
11044649|NCT00932698|12224980|FG001|STARTED|Part 1 (Dose Escalation)||3
11044650|NCT00932698|12224981|FG002|STARTED|Part 1 (Dose Escalation)||3
11044651|NCT00932698|12224982|FG003|STARTED|Part 1 (Dose Escalation)||3
11044652|NCT00932698|12224983|FG004|STARTED|Part 1 (Dose Escalation)||3
11044653|NCT00932698|12224984|FG005|STARTED|Part 1 (Dose Escalation)||7
11044654|NCT00932698|12224985|FG006|STARTED|Part 1 (Dose Escalation)||4
11044655|NCT00932698|12224986|FG007|STARTED|Part 1 (Dose Escalation)||0
11044656|NCT00932698|12224987|FG008|STARTED|Part 1 (Dose Escalation)||0
11044657|NCT00932698|12224988|FG009|STARTED|Part 1 (Dose Escalation)||0
11044658|NCT00932698|12224989|FG010|STARTED|Part 1 (Dose Escalation)||0
11044659|NCT00932698|12224979|FG000|COMPLETED|Part 1 (Dose Escalation)||0
11044660|NCT00932698|12224980|FG001|COMPLETED|Part 1 (Dose Escalation)||0
11044661|NCT00932698|12224981|FG002|COMPLETED|Part 1 (Dose Escalation)||0
11044662|NCT00932698|12224982|FG003|COMPLETED|Part 1 (Dose Escalation)||0
11044663|NCT00932698|12224983|FG004|COMPLETED|Part 1 (Dose Escalation)||0
11044664|NCT00932698|12224984|FG005|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0
11044665|NCT00932698|12224985|FG006|COMPLETED|Part 1 (Dose Escalation)||0
11044666|NCT00932698|12224986|FG007|COMPLETED|Part 1 (Dose Escalation)||0
11044667|NCT00932698|12224987|FG008|COMPLETED|Part 1 (Dose Escalation)||0
11044668|NCT00932698|12224988|FG009|COMPLETED|Part 1 (Dose Escalation)||0
11044669|NCT00932698|12224989|FG010|COMPLETED|Part 1 (Dose Escalation)||0
11044670|NCT00932698|12224979|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||3
11044671|NCT00932698|12224980|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||3
11044672|NCT00932698|12224981|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||3
11044673|NCT00932698|12224982|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||3
11044674|NCT00932698|12224983|FG004|NOT COMPLETED|Part 1 (Dose Escalation)||3
11044675|NCT00932698|12224984|FG005|NOT COMPLETED|Part 1 (Dose Escalation)||7
11044676|NCT00932698|12224985|FG006|NOT COMPLETED|Part 1 (Dose Escalation)||4
11044677|NCT00932698|12224986|FG007|NOT COMPLETED|Part 1 (Dose Escalation)||0
11044678|NCT00932698|12224987|FG008|NOT COMPLETED|Part 1 (Dose Escalation)||0
11336645|NCT02881008|12534441|FG004|STARTED|Overall Study||8
11336646|NCT02881008|12534442|FG005|STARTED|Overall Study||8
11336647|NCT02881008|12534437|FG000|COMPLETED|Overall Study||8
11336648|NCT02881008|12534438|FG001|COMPLETED|Overall Study||8
11336649|NCT02881008|12534439|FG002|COMPLETED|Overall Study||8
11336650|NCT02881008|12534440|FG003|COMPLETED|Overall Study||8
11044679|NCT00932698|12224988|FG009|NOT COMPLETED|Part 1 (Dose Escalation)||0
11044680|NCT00932698|12224989|FG010|NOT COMPLETED|Part 1 (Dose Escalation)||0
11044681|NCT00932698|12224979|FG000|STARTED|Part 2 (Dose Expansion)||0
11044682|NCT00932698|12224980|FG001|STARTED|Part 2 (Dose Expansion)||0
11044683|NCT00932698|12224981|FG002|STARTED|Part 2 (Dose Expansion)||0
11044684|NCT00932698|12224982|FG003|STARTED|Part 2 (Dose Expansion)||0
11044685|NCT00932698|12224983|FG004|STARTED|Part 2 (Dose Expansion)||0
11044686|NCT00932698|12224984|FG005|STARTED|Part 2 (Dose Expansion)||0
11044687|NCT00932698|12224985|FG006|STARTED|Part 2 (Dose Expansion)||0
11044688|NCT00932698|12224986|FG007|STARTED|Part 2 (Dose Expansion)||20
11044689|NCT00932698|12224987|FG008|STARTED|Part 2 (Dose Expansion)||12
11044690|NCT00932698|12224988|FG009|STARTED|Part 2 (Dose Expansion)||6
11044691|NCT00932698|12224989|FG010|STARTED|Part 2 (Dose Expansion)||2
11044692|NCT00932698|12224979|FG000|COMPLETED|Part 2 (Dose Expansion)||0
11044693|NCT00932698|12224980|FG001|COMPLETED|Part 2 (Dose Expansion)||0
11044694|NCT00932698|12224981|FG002|COMPLETED|Part 2 (Dose Expansion)||0
11044695|NCT00932698|12224982|FG003|COMPLETED|Part 2 (Dose Expansion)||0
11044696|NCT00932698|12224983|FG004|COMPLETED|Part 2 (Dose Expansion)||0
11044697|NCT00932698|12224984|FG005|COMPLETED|Part 2 (Dose Expansion)||0
11044698|NCT00932698|12224985|FG006|COMPLETED|Part 2 (Dose Expansion)||0
11044699|NCT00932698|12224986|FG007|COMPLETED|Part 2 (Dose Expansion)||0
11044700|NCT00932698|12224987|FG008|COMPLETED|Part 2 (Dose Expansion)||0
11044701|NCT00932698|12224988|FG009|COMPLETED|Part 2 (Dose Expansion)||0
11044702|NCT00932698|12224989|FG010|COMPLETED|Part 2 (Dose Expansion)||0
11044703|NCT00932698|12224979|FG000|NOT COMPLETED|Part 2 (Dose Expansion)||0
11044704|NCT00932698|12224980|FG001|NOT COMPLETED|Part 2 (Dose Expansion)||0
11044705|NCT00932698|12224981|FG002|NOT COMPLETED|Part 2 (Dose Expansion)||0
11044706|NCT00932698|12224982|FG003|NOT COMPLETED|Part 2 (Dose Expansion)||0
11044707|NCT00932698|12224983|FG004|NOT COMPLETED|Part 2 (Dose Expansion)||0
11044708|NCT00932698|12224984|FG005|NOT COMPLETED|Part 2 (Dose Expansion)||0
11044709|NCT00932698|12224985|FG006|NOT COMPLETED|Part 2 (Dose Expansion)||0
11044710|NCT00932698|12224986|FG007|NOT COMPLETED|Part 2 (Dose Expansion)||20
11044711|NCT00932698|12224987|FG008|NOT COMPLETED|Part 2 (Dose Expansion)||12
11044712|NCT00932698|12224988|FG009|NOT COMPLETED|Part 2 (Dose Expansion)||6
11044713|NCT00932698|12224989|FG010|NOT COMPLETED|Part 2 (Dose Expansion)||2
11044714|NCT00932828|12225015|FG000|STARTED|Overall Study||37
11044715|NCT00932828|12225015|FG000|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
11044716|NCT00932828|12225015|FG000|NOT COMPLETED|Overall Study||5
11044717|NCT00932893|12225021|FG000|STARTED|Overall Study||173
11044718|NCT00932893|12225022|FG001|STARTED|Overall Study||174
11044719|NCT00932893|12225021|FG000|Treated|Overall Study||172
11044720|NCT00932893|12225022|FG001|Treated|Overall Study||171
11044721|NCT00932893|12225021|FG000|COMPLETED|Overall Study||40
11044722|NCT00932893|12225022|FG001|COMPLETED|Overall Study||4
11336651|NCT02881008|12534441|FG004|COMPLETED|Overall Study||8
11044723|NCT00932893|12225021|FG000|NOT COMPLETED|Overall Study||133
11044724|NCT00932893|12225022|FG001|NOT COMPLETED|Overall Study||170
11044725|NCT00933166|12225029|FG000|STARTED|Overall Study||169
11044726|NCT00933166|12225029|FG000|COMPLETED|Overall Study||151
11044727|NCT00933166|12225029|FG000|NOT COMPLETED|Overall Study||18
11044728|NCT00933244|12225036|FG000|STARTED|Overall Study||79
11044729|NCT00933244|12225037|FG001|STARTED|Overall Study||75
11044730|NCT00933244|12225038|FG002|STARTED|Overall Study||76
11044731|NCT00933244|12225036|FG000|COMPLETED|Overall Study||74
11044732|NCT00933244|12225037|FG001|COMPLETED|Overall Study||74
11044733|NCT00933244|12225038|FG002|COMPLETED|Overall Study||73
11044734|NCT00933244|12225036|FG000|NOT COMPLETED|Overall Study||5
11044735|NCT00933244|12225037|FG001|NOT COMPLETED|Overall Study||1
11044736|NCT00933244|12225038|FG002|NOT COMPLETED|Overall Study||3
11044737|NCT00933270|12225046|FG000|STARTED|Overall Study|ITT population|264
11044738|NCT00933270|12225046|FG000|COMPLETED|Overall Study||177
11044739|NCT00933270|12225046|FG000|NOT COMPLETED|Overall Study||87
11044740|NCT00933335|12225053|FG000|STARTED|Overall Study||2
11044741|NCT00933335|12225054|FG001|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
11044742|NCT00933335|12225053|FG000|COMPLETED|Overall Study||0
11044743|NCT00933335|12225054|FG001|COMPLETED|Overall Study||20
11044744|NCT00933335|12225053|FG000|NOT COMPLETED|Overall Study||2
11044745|NCT00933335|12225054|FG001|NOT COMPLETED|Overall Study||16
11044746|NCT00933491|12225068|FG000|STARTED|Overall Study||14
11044747|NCT00933491|12225069|FG001|STARTED|Overall Study||18
11044748|NCT00933491|12225068|FG000|COMPLETED|Overall Study||14
11044749|NCT00933491|12225069|FG001|COMPLETED|Overall Study||18
11044750|NCT00933491|12225068|FG000|NOT COMPLETED|Overall Study||0
11044751|NCT00933491|12225069|FG001|NOT COMPLETED|Overall Study||0
11044752|NCT00933543|12225077|FG000|STARTED|Overall Study||54
11044753|NCT00933543|12225078|FG001|STARTED|Overall Study||53
11044754|NCT00933543|12225077|FG000|COMPLETED|Overall Study||51
11044755|NCT00933543|12225078|FG001|COMPLETED|Overall Study||46
11044756|NCT00933543|12225077|FG000|NOT COMPLETED|Overall Study||3
11044757|NCT00933543|12225078|FG001|NOT COMPLETED|Overall Study||7
11044758|NCT00933608|12225086|FG000|STARTED|Overall Study||7
11044759|NCT00933608|12225087|FG001|STARTED|Overall Study||10
11044760|NCT00933608|12225086|FG000|COMPLETED|Overall Study||2
11044761|NCT00933608|12225087|FG001|COMPLETED|Overall Study||8
11044762|NCT00933608|12225086|FG000|NOT COMPLETED|Overall Study||5
11044763|NCT00933608|12225087|FG001|NOT COMPLETED|Overall Study||2
11044764|NCT00933686|12225095|FG000|STARTED|Overall Study||55
11044765|NCT00933686|12225096|FG001|STARTED|Overall Study||58
11044766|NCT00933686|12225095|FG000|COMPLETED|Overall Study||45
11044767|NCT00933686|12225096|FG001|COMPLETED|Overall Study||47
11044768|NCT00933686|12225095|FG000|NOT COMPLETED|Overall Study||10
11044769|NCT00933686|12225096|FG001|NOT COMPLETED|Overall Study||11
11044770|NCT00933933|12225107|FG000|STARTED|General Population From 16 to 89 Years||6164
11044771|NCT00933933|12225108|FG001|STARTED|General Population From 16 to 89 Years||1287
11044772|NCT00933933|12225109|FG002|STARTED|General Population From 16 to 89 Years||1206
11044773|NCT00933933|12225107|FG000|COMPLETED|General Population From 16 to 89 Years||6164
11044774|NCT00933933|12225108|FG001|COMPLETED|General Population From 16 to 89 Years||1267
11044775|NCT00933933|12225109|FG002|COMPLETED|General Population From 16 to 89 Years||1206
11044776|NCT00933933|12225107|FG000|NOT COMPLETED|General Population From 16 to 89 Years||0
11044777|NCT00933933|12225108|FG001|NOT COMPLETED|General Population From 16 to 89 Years||20
11044778|NCT00933933|12225109|FG002|NOT COMPLETED|General Population From 16 to 89 Years||0
11044779|NCT00933933|12225107|FG000|STARTED|Pregnant Females Between 16-44 Years||448
11044780|NCT00933933|12225108|FG001|STARTED|Pregnant Females Between 16-44 Years||67
11044781|NCT00933933|12225109|FG002|STARTED|Pregnant Females Between 16-44 Years||203
11044782|NCT00933933|12225107|FG000|COMPLETED|Pregnant Females Between 16-44 Years||448
11044783|NCT00933933|12225108|FG001|COMPLETED|Pregnant Females Between 16-44 Years||65
11044784|NCT00933933|12225109|FG002|COMPLETED|Pregnant Females Between 16-44 Years||203
11044785|NCT00933933|12225107|FG000|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
11044786|NCT00933933|12225108|FG001|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
11044787|NCT00933933|12225109|FG002|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
11044788|NCT00933933|12225107|FG000|STARTED|Pediatric From 2 to 21 Years||588
11044789|NCT00933933|12225108|FG001|STARTED|Pediatric From 2 to 21 Years||64
11044790|NCT00933933|12225109|FG002|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
11044791|NCT00933933|12225107|FG000|COMPLETED|Pediatric From 2 to 21 Years||588
11044792|NCT00933933|12225108|FG001|COMPLETED|Pediatric From 2 to 21 Years||64
11044793|NCT00933933|12225109|FG002|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
11044794|NCT00933933|12225107|FG000|NOT COMPLETED|Pediatric From 2 to 21 Years||0
11044795|NCT00933933|12225108|FG001|NOT COMPLETED|Pediatric From 2 to 21 Years||0
11044796|NCT00933933|12225109|FG002|NOT COMPLETED|Pediatric From 2 to 21 Years||0
11044797|NCT00934024|12225127|FG000|STARTED|Overall Study||10
11044798|NCT00934024|12225128|FG001|STARTED|Overall Study||11
11044799|NCT00934024|12225127|FG000|COMPLETED|Overall Study||10
11044800|NCT00934024|12225128|FG001|COMPLETED|Overall Study||6
11044801|NCT00934024|12225127|FG000|NOT COMPLETED|Overall Study||0
11044802|NCT00934024|12225128|FG001|NOT COMPLETED|Overall Study||5
11057924|NCT01000961|12239679|FG001|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
11057925|NCT01000961|12239678|FG000|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
11057926|NCT01000961|12239679|FG001|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
11057927|NCT01000961|12239678|FG000|STARTED|First Intervention (3 Weeks)||21
11057928|NCT01000961|12239679|FG001|STARTED|First Intervention (3 Weeks)||22
11057929|NCT01000961|12239678|FG000|COMPLETED|First Intervention (3 Weeks)||21
11057930|NCT01000961|12239679|FG001|COMPLETED|First Intervention (3 Weeks)||20
11057931|NCT01000961|12239678|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
11057932|NCT01000961|12239679|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2
11057933|NCT01000961|12239678|FG000|STARTED|Second Intervention (3 Weeks)||21
11057934|NCT01000961|12239679|FG001|STARTED|Second Intervention (3 Weeks)||20
11057935|NCT01000961|12239678|FG000|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
11057936|NCT01000961|12239679|FG001|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
11057937|NCT01000961|12239678|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
11201309|NCT01831804|12391541|FG000|STARTED|Overall Study||4
11057938|NCT01000961|12239679|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
11057939|NCT01000974|12239690|FG000|STARTED|Primary Vaccination Phase||2963
11057940|NCT01000974|12239691|FG001|STARTED|Primary Vaccination Phase||520
11057941|NCT01000974|12239692|FG002|STARTED|Primary Vaccination Phase||520
11057942|NCT01000974|12239690|FG000|COMPLETED|Primary Vaccination Phase||2625
11057943|NCT01000974|12239691|FG001|COMPLETED|Primary Vaccination Phase||470
11057944|NCT01000974|12239692|FG002|COMPLETED|Primary Vaccination Phase||457
11057945|NCT01000974|12239690|FG000|NOT COMPLETED|Primary Vaccination Phase||338
11057946|NCT01000974|12239691|FG001|NOT COMPLETED|Primary Vaccination Phase||50
11057947|NCT01000974|12239692|FG002|NOT COMPLETED|Primary Vaccination Phase||63
11057948|NCT01000974|12239690|FG000|STARTED|Booster Vaccination Phase||2337
11057949|NCT01000974|12239691|FG001|STARTED|Booster Vaccination Phase||435
11057950|NCT01000974|12239692|FG002|STARTED|Booster Vaccination Phase||400
11057951|NCT01000974|12239690|FG000|COMPLETED|Booster Vaccination Phase||2270
11057952|NCT01000974|12239691|FG001|COMPLETED|Booster Vaccination Phase||423
11336652|NCT02881008|12534442|FG005|COMPLETED|Overall Study||8
11336653|NCT02881008|12534437|FG000|NOT COMPLETED|Overall Study||0
11336654|NCT02881008|12534438|FG001|NOT COMPLETED|Overall Study||0
11336655|NCT02881008|12534439|FG002|NOT COMPLETED|Overall Study||0
11336656|NCT02881008|12534440|FG003|NOT COMPLETED|Overall Study||0
11057953|NCT01000974|12239692|FG002|COMPLETED|Booster Vaccination Phase||386
11057954|NCT01000974|12239690|FG000|NOT COMPLETED|Booster Vaccination Phase||67
11336657|NCT02881008|12534441|FG004|NOT COMPLETED|Overall Study||0
11336658|NCT02881008|12534442|FG005|NOT COMPLETED|Overall Study||0
11336659|NCT02881047|12534459|FG000|STARTED|Overall Study||8
11336660|NCT02881047|12534459|FG000|COMPLETED|Overall Study||6
11336661|NCT02881047|12534459|FG000|NOT COMPLETED|Overall Study||2
11057955|NCT01000974|12239691|FG001|NOT COMPLETED|Booster Vaccination Phase||12
11057956|NCT01000974|12239692|FG002|NOT COMPLETED|Booster Vaccination Phase||14
11057957|NCT01000987|12239706|FG000|STARTED|Overall Study||12
11057958|NCT01000987|12239707|FG001|STARTED|Overall Study||15
11057959|NCT01000987|12239708|FG002|STARTED|Overall Study||17
11057960|NCT01000987|12239706|FG000|COMPLETED|Overall Study||12
11057961|NCT01000987|12239707|FG001|COMPLETED|Overall Study||15
11057962|NCT01000987|12239708|FG002|COMPLETED|Overall Study||17
11057963|NCT01000987|12239706|FG000|NOT COMPLETED|Overall Study||0
11057964|NCT01000987|12239707|FG001|NOT COMPLETED|Overall Study||0
11057965|NCT01000987|12239708|FG002|NOT COMPLETED|Overall Study||0
11057966|NCT01001052|12239716|FG000|STARTED|Overall Study||20
11057967|NCT01001052|12239717|FG001|STARTED|Overall Study||18
11057968|NCT01001052|12239716|FG000|COMPLETED|Overall Study||20
11057969|NCT01001052|12239717|FG001|COMPLETED|Overall Study||18
11057970|NCT01001052|12239716|FG000|NOT COMPLETED|Overall Study||0
11057971|NCT01001052|12239717|FG001|NOT COMPLETED|Overall Study||0
11057972|NCT01001078|12239725|FG000|STARTED|Overall Study||50
11057973|NCT01001078|12239726|FG001|STARTED|Overall Study||50
11057974|NCT01001078|12239725|FG000|Received Allocated Intervention|Overall Study||46
11057975|NCT01001078|12239726|FG001|Received Allocated Intervention|Overall Study||46
11057976|NCT01001078|12239725|FG000|Received Crossover|Overall Study||2
11057977|NCT01001078|12239726|FG001|Received Crossover|Overall Study||3
11057978|NCT01001078|12239725|FG000|Intubated|Overall Study||2
11057979|NCT01001078|12239726|FG001|Intubated|Overall Study||1
11057980|NCT01001078|12239725|FG000|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
11057981|NCT01001078|12239726|FG001|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
11057982|NCT01001078|12239725|FG000|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
11336662|NCT02881112|12534463|FG000|STARTED|Overall Study||180
11336663|NCT02881112|12534463|FG000|COMPLETED|Overall Study||152
11044803|NCT00934050|12225139|FG000|STARTED|Enrolled Prior to 15 Dec 2009||12
11044804|NCT00934050|12225140|FG001|STARTED|Enrolled Prior to 15 Dec 2009||12
11044805|NCT00934050|12225141|FG002|STARTED|Enrolled Prior to 15 Dec 2009||12
11044806|NCT00934050|12225142|FG003|STARTED|Enrolled Prior to 15 Dec 2009||14
11044807|NCT00934050|12225143|FG004|STARTED|Enrolled Prior to 15 Dec 2009||0
11044808|NCT00934050|12225144|FG005|STARTED|Enrolled Prior to 15 Dec 2009||0
11044809|NCT00934050|12225139|FG000|COMPLETED|Enrolled Prior to 15 Dec 2009||0
11044810|NCT00934050|12225140|FG001|COMPLETED|Enrolled Prior to 15 Dec 2009||0
11044811|NCT00934050|12225141|FG002|COMPLETED|Enrolled Prior to 15 Dec 2009||0
11044812|NCT00934050|12225142|FG003|COMPLETED|Enrolled Prior to 15 Dec 2009||0
11044813|NCT00934050|12225143|FG004|COMPLETED|Enrolled Prior to 15 Dec 2009||0
11044814|NCT00934050|12225144|FG005|COMPLETED|Enrolled Prior to 15 Dec 2009||0
11044815|NCT00934050|12225139|FG000|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
11044816|NCT00934050|12225140|FG001|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
11044817|NCT00934050|12225141|FG002|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
11044818|NCT00934050|12225142|FG003|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
11044819|NCT00934050|12225143|FG004|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
11044820|NCT00934050|12225144|FG005|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
11044821|NCT00934050|12225139|FG000|STARTED|Enrolled After 15 Dec 2009||0
11044822|NCT00934050|12225140|FG001|STARTED|Enrolled After 15 Dec 2009||0
11044823|NCT00934050|12225141|FG002|STARTED|Enrolled After 15 Dec 2009||0
11044824|NCT00934050|12225142|FG003|STARTED|Enrolled After 15 Dec 2009||0
11044825|NCT00934050|12225143|FG004|STARTED|Enrolled After 15 Dec 2009||26
11044826|NCT00934050|12225144|FG005|STARTED|Enrolled After 15 Dec 2009||27
11044827|NCT00934050|12225139|FG000|COMPLETED|Enrolled After 15 Dec 2009||0
11044828|NCT00934050|12225140|FG001|COMPLETED|Enrolled After 15 Dec 2009||0
11044829|NCT00934050|12225141|FG002|COMPLETED|Enrolled After 15 Dec 2009||0
11044830|NCT00934050|12225142|FG003|COMPLETED|Enrolled After 15 Dec 2009||0
11044831|NCT00934050|12225143|FG004|COMPLETED|Enrolled After 15 Dec 2009||19
11044832|NCT00934050|12225144|FG005|COMPLETED|Enrolled After 15 Dec 2009||23
11044833|NCT00934050|12225139|FG000|NOT COMPLETED|Enrolled After 15 Dec 2009||0
11044834|NCT00934050|12225140|FG001|NOT COMPLETED|Enrolled After 15 Dec 2009||0
11044835|NCT00934050|12225141|FG002|NOT COMPLETED|Enrolled After 15 Dec 2009||0
11044836|NCT00934050|12225142|FG003|NOT COMPLETED|Enrolled After 15 Dec 2009||0
11044837|NCT00934050|12225143|FG004|NOT COMPLETED|Enrolled After 15 Dec 2009||7
11044838|NCT00934050|12225144|FG005|NOT COMPLETED|Enrolled After 15 Dec 2009||4
11044839|NCT00934089|12225156|FG000|STARTED|First Intervention Period (14 Days)||15
11044840|NCT00934089|12225157|FG001|STARTED|First Intervention Period (14 Days)||16
11044841|NCT00934089|12225156|FG000|Treated|First Intervention Period (14 Days)||14
11044842|NCT00934089|12225157|FG001|Treated|First Intervention Period (14 Days)||16
11044843|NCT00934089|12225156|FG000|COMPLETED|First Intervention Period (14 Days)||13
11044844|NCT00934089|12225157|FG001|COMPLETED|First Intervention Period (14 Days)||16
11044845|NCT00934089|12225156|FG000|NOT COMPLETED|First Intervention Period (14 Days)||2
11044846|NCT00934089|12225157|FG001|NOT COMPLETED|First Intervention Period (14 Days)||0
11044847|NCT00934089|12225156|FG000|STARTED|Washout Period (28 Days)||13
11044848|NCT00934089|12225157|FG001|STARTED|Washout Period (28 Days)||16
11044849|NCT00934089|12225156|FG000|COMPLETED|Washout Period (28 Days)||13
11044850|NCT00934089|12225157|FG001|COMPLETED|Washout Period (28 Days)||16
11044851|NCT00934089|12225156|FG000|NOT COMPLETED|Washout Period (28 Days)||0
11044852|NCT00934089|12225157|FG001|NOT COMPLETED|Washout Period (28 Days)||0
11044853|NCT00934089|12225156|FG000|STARTED|Second Intervention Period (14 Days)||13
11044854|NCT00934089|12225157|FG001|STARTED|Second Intervention Period (14 Days)||16
11044855|NCT00934089|12225156|FG000|COMPLETED|Second Intervention Period (14 Days)||13
11044856|NCT00934089|12225157|FG001|COMPLETED|Second Intervention Period (14 Days)||16
11044857|NCT00934089|12225156|FG000|NOT COMPLETED|Second Intervention Period (14 Days)||0
11044858|NCT00934089|12225157|FG001|NOT COMPLETED|Second Intervention Period (14 Days)||0
11044859|NCT00934102|12225163|FG000|STARTED|Period 1, One Night of Wear||16
11044860|NCT00934102|12225164|FG001|STARTED|Period 1, One Night of Wear||15
11044861|NCT00934102|12225165|FG002|STARTED|Period 1, One Night of Wear||15
11044862|NCT00934102|12225163|FG000|COMPLETED|Period 1, One Night of Wear||15
11044863|NCT00934102|12225164|FG001|COMPLETED|Period 1, One Night of Wear||15
11044864|NCT00934102|12225165|FG002|COMPLETED|Period 1, One Night of Wear||15
11044865|NCT00934102|12225163|FG000|NOT COMPLETED|Period 1, One Night of Wear||1
11044866|NCT00934102|12225164|FG001|NOT COMPLETED|Period 1, One Night of Wear||0
11044867|NCT00934102|12225165|FG002|NOT COMPLETED|Period 1, One Night of Wear||0
11044868|NCT00934102|12225163|FG000|STARTED|Period 2, 7 Days/6 Nights of Wear||15
11044869|NCT00934102|12225164|FG001|STARTED|Period 2, 7 Days/6 Nights of Wear||15
11044870|NCT00934102|12225165|FG002|STARTED|Period 2, 7 Days/6 Nights of Wear||15
11044871|NCT00934102|12225163|FG000|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
11044872|NCT00934102|12225164|FG001|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
11044873|NCT00934102|12225165|FG002|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
11044874|NCT00934102|12225163|FG000|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
11044875|NCT00934102|12225164|FG001|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
11058459|NCT01004172|12240348|FG000|STARTED|Overall Study||38
11044876|NCT00934102|12225165|FG002|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
11044877|NCT00934128|12225175|FG000|STARTED|First Intervention (2 Hours)||15
11044878|NCT00934128|12225176|FG001|STARTED|First Intervention (2 Hours)||15
11044879|NCT00934128|12225175|FG000|COMPLETED|First Intervention (2 Hours)||10
11044880|NCT00934128|12225176|FG001|COMPLETED|First Intervention (2 Hours)||13
11044881|NCT00934128|12225175|FG000|NOT COMPLETED|First Intervention (2 Hours)||5
11044882|NCT00934128|12225176|FG001|NOT COMPLETED|First Intervention (2 Hours)||2
11044883|NCT00934128|12225175|FG000|STARTED|Washout Period (1 Hour)||10
11044884|NCT00934128|12225176|FG001|STARTED|Washout Period (1 Hour)||13
11044885|NCT00934128|12225175|FG000|COMPLETED|Washout Period (1 Hour)||3
11044886|NCT00934128|12225176|FG001|COMPLETED|Washout Period (1 Hour)||8
11044887|NCT00934128|12225175|FG000|NOT COMPLETED|Washout Period (1 Hour)||7
11044888|NCT00934128|12225176|FG001|NOT COMPLETED|Washout Period (1 Hour)||5
11044889|NCT00934128|12225175|FG000|STARTED|Second Intervention (2 Hours)||3
11044890|NCT00934128|12225176|FG001|STARTED|Second Intervention (2 Hours)||8
11044891|NCT00934128|12225175|FG000|COMPLETED|Second Intervention (2 Hours)||3
11044892|NCT00934128|12225176|FG001|COMPLETED|Second Intervention (2 Hours)||5
11044893|NCT00934128|12225175|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0
11044894|NCT00934128|12225176|FG001|NOT COMPLETED|Second Intervention (2 Hours)||3
11044895|NCT00934141|12225186|FG000|STARTED|Overall Study||49
11044896|NCT00934141|12225187|FG001|STARTED|Overall Study||50
11044897|NCT00934141|12225188|FG002|STARTED|Overall Study||48
11044898|NCT00934141|12225189|FG003|STARTED|Overall Study||54
11044899|NCT00934141|12225186|FG000|COMPLETED|Overall Study||45
11044900|NCT00934141|12225187|FG001|COMPLETED|Overall Study||47
11044901|NCT00934141|12225188|FG002|COMPLETED|Overall Study||48
11044902|NCT00934141|12225189|FG003|COMPLETED|Overall Study||51
11044903|NCT00934141|12225186|FG000|NOT COMPLETED|Overall Study||4
11044904|NCT00934141|12225187|FG001|NOT COMPLETED|Overall Study||3
11044905|NCT00934141|12225188|FG002|NOT COMPLETED|Overall Study||0
11044906|NCT00934141|12225189|FG003|NOT COMPLETED|Overall Study||3
11044907|NCT00934362|12225203|FG000|STARTED|Overall Study||8
11044908|NCT00934362|12225204|FG001|STARTED|Overall Study||8
11044909|NCT00934362|12225203|FG000|COMPLETED|Overall Study||7
11044910|NCT00934362|12225204|FG001|COMPLETED|Overall Study||8
11044911|NCT00934362|12225203|FG000|NOT COMPLETED|Overall Study||1
11044912|NCT00934362|12225204|FG001|NOT COMPLETED|Overall Study||0
11044913|NCT00934375|12225212|FG000|STARTED|Overall Study||68
11044914|NCT00934375|12225213|FG001|STARTED|Overall Study||77
11044915|NCT00934375|12225212|FG000|COMPLETED|Overall Study||55
11044916|NCT00934375|12225213|FG001|COMPLETED|Overall Study||55
11044917|NCT00934375|12225212|FG000|NOT COMPLETED|Overall Study||13
11044918|NCT00934375|12225213|FG001|NOT COMPLETED|Overall Study||22
11044919|NCT00934440|12225219|FG000|STARTED|Overall Study||11
11044920|NCT00934440|12225219|FG000|COMPLETED|Overall Study||10
11044921|NCT00934440|12225219|FG000|NOT COMPLETED|Overall Study||1
11044922|NCT00934544|12225226|FG000|STARTED|Primary Endpoint Analysis (Interim)||146
11044923|NCT00934544|12225227|FG001|STARTED|Primary Endpoint Analysis (Interim)||73
11044924|NCT00934544|12225228|FG002|STARTED|Primary Endpoint Analysis (Interim)||0
11044925|NCT00934544|12225226|FG000|COMPLETED|Primary Endpoint Analysis (Interim)||91
11044926|NCT00934544|12225227|FG001|COMPLETED|Primary Endpoint Analysis (Interim)||31
11044927|NCT00934544|12225228|FG002|COMPLETED|Primary Endpoint Analysis (Interim)||0
11044928|NCT00934544|12225226|FG000|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55
11044929|NCT00934544|12225227|FG001|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42
11044930|NCT00934544|12225228|FG002|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0
11044931|NCT00934544|12225226|FG000|STARTED|Overall Disposition at 5 Year Follow-up||146
11044932|NCT00934544|12225227|FG001|STARTED|Overall Disposition at 5 Year Follow-up||28
11044933|NCT00934544|12225228|FG002|STARTED|Overall Disposition at 5 Year Follow-up||45
11044934|NCT00934544|12225226|FG000|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
11044935|NCT00934544|12225227|FG001|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
11044936|NCT00934544|12225228|FG002|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27
11044937|NCT00934544|12225226|FG000|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
11044938|NCT00934544|12225227|FG001|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
11044939|NCT00934544|12225228|FG002|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12
11044940|NCT00934544|12225226|FG000|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
11044941|NCT00934544|12225227|FG001|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
11044942|NCT00934544|12225228|FG002|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6
11044943|NCT00934544|12225226|FG000|COMPLETED|Overall Disposition at 5 Year Follow-up||39
11044944|NCT00934544|12225227|FG001|COMPLETED|Overall Disposition at 5 Year Follow-up||0
11044945|NCT00934544|12225228|FG002|COMPLETED|Overall Disposition at 5 Year Follow-up||11
11044946|NCT00934544|12225226|FG000|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107
11044947|NCT00934544|12225227|FG001|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28
11044948|NCT00934544|12225228|FG002|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34
11044949|NCT00934596|12225247|FG000|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
11044950|NCT00934596|12225248|FG001|STARTED|Overall Study||10
11044951|NCT00934596|12225247|FG000|COMPLETED|Overall Study||10
11201310|NCT01831804|12391542|FG001|STARTED|Overall Study||3
11201311|NCT01831804|12391543|FG002|STARTED|Overall Study||9
11201312|NCT01831804|12391544|FG003|STARTED|Overall Study||5
11201313|NCT01831804|12391545|FG004|STARTED|Overall Study||5
11201314|NCT01831804|12391546|FG005|STARTED|Overall Study||3
11201315|NCT01831804|12391547|FG006|STARTED|Overall Study||4
11201316|NCT01831804|12391548|FG007|STARTED|Overall Study||26
11201317|NCT01831804|12391549|FG008|STARTED|Overall Study||4
11201318|NCT01831804|12391541|FG000|COMPLETED|Overall Study||3
11201319|NCT01831804|12391542|FG001|COMPLETED|Overall Study||1
11201320|NCT01831804|12391543|FG002|COMPLETED|Overall Study||3
11201321|NCT01831804|12391544|FG003|COMPLETED|Overall Study||5
11201322|NCT01831804|12391545|FG004|COMPLETED|Overall Study||3
11201323|NCT01831804|12391546|FG005|COMPLETED|Overall Study||3
11201324|NCT01831804|12391547|FG006|COMPLETED|Overall Study||3
11201325|NCT01831804|12391548|FG007|COMPLETED|Overall Study||23
11201326|NCT01831804|12391549|FG008|COMPLETED|Overall Study||2
11201327|NCT01831804|12391541|FG000|NOT COMPLETED|Overall Study||1
11201328|NCT01831804|12391542|FG001|NOT COMPLETED|Overall Study||2
11201329|NCT01831804|12391543|FG002|NOT COMPLETED|Overall Study||6
11201330|NCT01831804|12391544|FG003|NOT COMPLETED|Overall Study||0
11201331|NCT01831804|12391545|FG004|NOT COMPLETED|Overall Study||2
11201332|NCT01831804|12391546|FG005|NOT COMPLETED|Overall Study||0
11201333|NCT01831804|12391547|FG006|NOT COMPLETED|Overall Study||1
11201334|NCT01831804|12391548|FG007|NOT COMPLETED|Overall Study||3
11201335|NCT01831804|12391549|FG008|NOT COMPLETED|Overall Study||2
11201336|NCT01831817|12391582|FG000|STARTED|Overall Study||35
11201337|NCT01831817|12391583|FG001|STARTED|Overall Study||34
11201338|NCT01831817|12391584|FG002|STARTED|Overall Study||35
11201339|NCT01831817|12391585|FG003|STARTED|Overall Study||36
11201340|NCT01831817|12391582|FG000|COMPLETED|Overall Study||31
11201341|NCT01831817|12391583|FG001|COMPLETED|Overall Study||34
11201342|NCT01831817|12391584|FG002|COMPLETED|Overall Study||35
11201343|NCT01831817|12391585|FG003|COMPLETED|Overall Study||36
11201344|NCT01831817|12391582|FG000|NOT COMPLETED|Overall Study||4
11201345|NCT01831817|12391583|FG001|NOT COMPLETED|Overall Study||0
11201346|NCT01831817|12391584|FG002|NOT COMPLETED|Overall Study||0
11201347|NCT01831817|12391585|FG003|NOT COMPLETED|Overall Study||0
11201348|NCT01831856|12391597|FG000|STARTED|Overall Study||67
11201349|NCT01831856|12391598|FG001|STARTED|Overall Study||67
11201350|NCT01831856|12391597|FG000|COMPLETED|Overall Study||33
11201351|NCT01831856|12391598|FG001|COMPLETED|Overall Study||30
11201352|NCT01831856|12391597|FG000|NOT COMPLETED|Overall Study||34
11201353|NCT01831856|12391598|FG001|NOT COMPLETED|Overall Study||37
11336664|NCT02881112|12534463|FG000|NOT COMPLETED|Overall Study||28
11336665|NCT02881567|12534467|FG000|STARTED|Overall Study||41
11336666|NCT02881567|12534467|FG000|COMPLETED|Overall Study||23
11336667|NCT02881567|12534467|FG000|NOT COMPLETED|Overall Study||18
11336668|NCT02881658|12534473|FG000|STARTED|Overall Study||100
11336669|NCT02881658|12534474|FG001|STARTED|Overall Study||101
11336670|NCT02881658|12534473|FG000|COMPLETED|Overall Study||98
11201354|NCT01831921|12391606|FG000|STARTED|Overall Study||150
11336671|NCT02881658|12534474|FG001|COMPLETED|Overall Study||96
11336672|NCT02881658|12534473|FG000|NOT COMPLETED|Overall Study||2
11044952|NCT00934596|12225248|FG001|COMPLETED|Overall Study||10
11336673|NCT02881658|12534474|FG001|NOT COMPLETED|Overall Study||5
11336674|NCT02881775|12534482|FG000|STARTED|Baseline||11
11336675|NCT02881775|12534483|FG001|STARTED|Baseline||9
11336676|NCT02881775|12534482|FG000|COMPLETED|Baseline||11
11336677|NCT02881775|12534483|FG001|COMPLETED|Baseline||9
11336678|NCT02881775|12534482|FG000|NOT COMPLETED|Baseline||0
11336679|NCT02881775|12534483|FG001|NOT COMPLETED|Baseline||0
11336680|NCT02881775|12534482|FG000|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9
11336681|NCT02881775|12534483|FG001|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7
11336682|NCT02881775|12534482|FG000|COMPLETED|First Intervention (1-hr Session)||9
11336683|NCT02881775|12534483|FG001|COMPLETED|First Intervention (1-hr Session)||7
11336684|NCT02881775|12534482|FG000|NOT COMPLETED|First Intervention (1-hr Session)||0
11336685|NCT02881775|12534483|FG001|NOT COMPLETED|First Intervention (1-hr Session)||0
11336686|NCT02881775|12534482|FG000|STARTED|Washout (1 Week)||9
11336687|NCT02881775|12534483|FG001|STARTED|Washout (1 Week)||7
11336688|NCT02881775|12534482|FG000|COMPLETED|Washout (1 Week)||9
11336689|NCT02881775|12534483|FG001|COMPLETED|Washout (1 Week)||7
11336690|NCT02881775|12534482|FG000|NOT COMPLETED|Washout (1 Week)||0
11044953|NCT00934596|12225247|FG000|NOT COMPLETED|Overall Study||0
11044954|NCT00934596|12225248|FG001|NOT COMPLETED|Overall Study||0
11044955|NCT00934622|12225258|FG000|STARTED|Overall Study||76
11044956|NCT00934622|12225258|FG000|COMPLETED|Overall Study||68
11044957|NCT00934622|12225258|FG000|NOT COMPLETED|Overall Study||8
11044958|NCT00934635|12225271|FG000|STARTED|Overall Study||0
11044959|NCT00934635|12225272|FG001|STARTED|Overall Study||1
11044960|NCT00934635|12225273|FG002|STARTED|Overall Study||0
11044961|NCT00934635|12225274|FG003|STARTED|Overall Study||0
11044962|NCT00934635|12225275|FG004|STARTED|Overall Study||0
11044963|NCT00934635|12225276|FG005|STARTED|Overall Study||0
11044964|NCT00934635|12225277|FG006|STARTED|Overall Study||0
11044965|NCT00934635|12225278|FG007|STARTED|Overall Study||0
11044966|NCT00934635|12225279|FG008|STARTED|Overall Study||1
11336691|NCT02881775|12534483|FG001|NOT COMPLETED|Washout (1 Week)||0
11044967|NCT00934635|12225271|FG000|COMPLETED|Overall Study||0
11044968|NCT00934635|12225272|FG001|COMPLETED|Overall Study||1
11044969|NCT00934635|12225273|FG002|COMPLETED|Overall Study||0
11044970|NCT00934635|12225274|FG003|COMPLETED|Overall Study||0
11044971|NCT00934635|12225275|FG004|COMPLETED|Overall Study||0
11044972|NCT00934635|12225276|FG005|COMPLETED|Overall Study||0
11201355|NCT01831921|12391607|FG001|STARTED|Overall Study||75
11201356|NCT01831921|12391606|FG000|6 Months|Overall Study||122
11044973|NCT00934635|12225277|FG006|COMPLETED|Overall Study||0
11044974|NCT00934635|12225278|FG007|COMPLETED|Overall Study||0
11044975|NCT00934635|12225279|FG008|COMPLETED|Overall Study||1
11044976|NCT00934635|12225271|FG000|NOT COMPLETED|Overall Study||0
11044977|NCT00934635|12225272|FG001|NOT COMPLETED|Overall Study||0
11044978|NCT00934635|12225273|FG002|NOT COMPLETED|Overall Study||0
11044979|NCT00934635|12225274|FG003|NOT COMPLETED|Overall Study||0
11044980|NCT00934635|12225275|FG004|NOT COMPLETED|Overall Study||0
11044981|NCT00934635|12225276|FG005|NOT COMPLETED|Overall Study||0
11044982|NCT00934635|12225277|FG006|NOT COMPLETED|Overall Study||0
11044983|NCT00934635|12225278|FG007|NOT COMPLETED|Overall Study||0
11044984|NCT00934635|12225279|FG008|NOT COMPLETED|Overall Study||0
11044985|NCT00934648|12225299|FG000|STARTED|Overall Study||15
11044986|NCT00934648|12225299|FG000|COMPLETED|Overall Study||6
11044987|NCT00934648|12225299|FG000|NOT COMPLETED|Overall Study||9
11044988|NCT00934661|12225305|FG000|STARTED|Overall Study||20
11044989|NCT00934661|12225306|FG001|STARTED|Overall Study||20
11044990|NCT00934661|12225305|FG000|COMPLETED|Overall Study||19
11044991|NCT00934661|12225306|FG001|COMPLETED|Overall Study||20
11044992|NCT00934661|12225305|FG000|NOT COMPLETED|Overall Study||1
11044993|NCT00934661|12225306|FG001|NOT COMPLETED|Overall Study||0
11044994|NCT00934843|12225314|FG000|STARTED|Overall Study||37
11044995|NCT00934843|12225315|FG001|STARTED|Overall Study||40
11044996|NCT00934843|12225314|FG000|COMPLETED|Overall Study||37
11044997|NCT00934843|12225315|FG001|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
11044998|NCT00934843|12225314|FG000|NOT COMPLETED|Overall Study||0
11044999|NCT00934843|12225315|FG001|NOT COMPLETED|Overall Study||1
11045000|NCT00934856|12225327|FG000|STARTED|Feasibility Part||6
11045001|NCT00934856|12225328|FG001|STARTED|Feasibility Part||6
11045002|NCT00934856|12225329|FG002|STARTED|Feasibility Part||3
11045003|NCT00934856|12225330|FG003|STARTED|Feasibility Part||6
11336692|NCT02881775|12534482|FG000|STARTED|Second Intervention (1-Hour Session)||9
11336693|NCT02881775|12534483|FG001|STARTED|Second Intervention (1-Hour Session)||7
11045004|NCT00934856|12225331|FG004|STARTED|Feasibility Part||12
11045005|NCT00934856|12225332|FG005|STARTED|Feasibility Part||9
11045006|NCT00934856|12225327|FG000|COMPLETED|Feasibility Part||1
11045007|NCT00934856|12225328|FG001|COMPLETED|Feasibility Part||1
11045008|NCT00934856|12225329|FG002|COMPLETED|Feasibility Part||0
11045009|NCT00934856|12225330|FG003|COMPLETED|Feasibility Part||1
11045010|NCT00934856|12225331|FG004|COMPLETED|Feasibility Part||12
11045011|NCT00934856|12225332|FG005|COMPLETED|Feasibility Part||6
11045012|NCT00934856|12225327|FG000|NOT COMPLETED|Feasibility Part||5
11045013|NCT00934856|12225328|FG001|NOT COMPLETED|Feasibility Part||5
11045014|NCT00934856|12225329|FG002|NOT COMPLETED|Feasibility Part||3
11045015|NCT00934856|12225330|FG003|NOT COMPLETED|Feasibility Part||5
11045016|NCT00934856|12225331|FG004|NOT COMPLETED|Feasibility Part||0
11045017|NCT00934856|12225332|FG005|NOT COMPLETED|Feasibility Part||3
11045018|NCT00934856|12225327|FG000|STARTED|Extension Part||0
11045019|NCT00934856|12225328|FG001|STARTED|Extension Part||0
11045020|NCT00934856|12225329|FG002|STARTED|Extension Part||0
11045021|NCT00934856|12225330|FG003|STARTED|Extension Part|New participants were enrolled in the extension part.|4
11045022|NCT00934856|12225331|FG004|STARTED|Extension Part|New participants were enrolled in the extension part.|28
11045023|NCT00934856|12225332|FG005|STARTED|Extension Part|New participants were enrolled in the extension part.|24
11045024|NCT00934856|12225327|FG000|COMPLETED|Extension Part||0
11045025|NCT00934856|12225328|FG001|COMPLETED|Extension Part||0
11045026|NCT00934856|12225329|FG002|COMPLETED|Extension Part||0
11045027|NCT00934856|12225330|FG003|COMPLETED|Extension Part||2
11045028|NCT00934856|12225331|FG004|COMPLETED|Extension Part||24
11045029|NCT00934856|12225332|FG005|COMPLETED|Extension Part||19
11045030|NCT00934856|12225327|FG000|NOT COMPLETED|Extension Part||0
11045031|NCT00934856|12225328|FG001|NOT COMPLETED|Extension Part||0
11045032|NCT00934856|12225329|FG002|NOT COMPLETED|Extension Part||0
11045033|NCT00934856|12225330|FG003|NOT COMPLETED|Extension Part||2
11045034|NCT00934856|12225331|FG004|NOT COMPLETED|Extension Part||4
11045035|NCT00934856|12225332|FG005|NOT COMPLETED|Extension Part||5
11045036|NCT00934934|12225366|FG000|STARTED|Overall Study||30
11045037|NCT00934934|12225367|FG001|STARTED|Overall Study||31
11045038|NCT00934934|12225366|FG000|COMPLETED|Overall Study||29
11045039|NCT00934934|12225367|FG001|COMPLETED|Overall Study||31
11045040|NCT00934934|12225366|FG000|NOT COMPLETED|Overall Study||1
11045041|NCT00934934|12225367|FG001|NOT COMPLETED|Overall Study||0
11045042|NCT00934947|12225378|FG000|STARTED|Overall Study||23
11045043|NCT00934947|12225379|FG001|STARTED|Overall Study||22
11045044|NCT00934947|12225378|FG000|COMPLETED|Overall Study||23
11045045|NCT00934947|12225379|FG001|COMPLETED|Overall Study||20
11045046|NCT00934947|12225378|FG000|NOT COMPLETED|Overall Study||0
11045047|NCT00934947|12225379|FG001|NOT COMPLETED|Overall Study||2
11045048|NCT00935012|12225387|FG000|STARTED|Overall Study||31
11045049|NCT00935012|12225387|FG000|COMPLETED|Overall Study||2
11045050|NCT00935012|12225387|FG000|NOT COMPLETED|Overall Study||29
11045051|NCT00935064|12225393|FG000|STARTED|Overall Study||30
11045052|NCT00935064|12225394|FG001|STARTED|Overall Study||30
11045053|NCT00935064|12225393|FG000|COMPLETED|Overall Study||30
11045054|NCT00935064|12225394|FG001|COMPLETED|Overall Study||30
11045055|NCT00935064|12225393|FG000|NOT COMPLETED|Overall Study||0
11045056|NCT00935064|12225394|FG001|NOT COMPLETED|Overall Study||0
11045057|NCT00935220|12225400|FG000|STARTED|Overall Study||41
11045058|NCT00935220|12225400|FG000|COMPLETED|Overall Study||39
11045059|NCT00935220|12225400|FG000|NOT COMPLETED|Overall Study||2
11045060|NCT00935259|12225404|FG000|STARTED|Period 1||16
11045061|NCT00935259|12225405|FG001|STARTED|Period 1||15
11045062|NCT00935259|12225404|FG000|COMPLETED|Period 1||15
11045063|NCT00935259|12225405|FG001|COMPLETED|Period 1||14
11045064|NCT00935259|12225404|FG000|NOT COMPLETED|Period 1||1
11045065|NCT00935259|12225405|FG001|NOT COMPLETED|Period 1||1
11045066|NCT00935259|12225404|FG000|STARTED|Period 2||15
11045067|NCT00935259|12225405|FG001|STARTED|Period 2||14
11045068|NCT00935259|12225404|FG000|COMPLETED|Period 2||15
11045069|NCT00935259|12225405|FG001|COMPLETED|Period 2||14
11045070|NCT00935259|12225404|FG000|NOT COMPLETED|Period 2||0
11045071|NCT00935259|12225405|FG001|NOT COMPLETED|Period 2||0
11045072|NCT00935272|12225415|FG000|STARTED|Overall Study||135
11045073|NCT00935272|12225416|FG001|STARTED|Overall Study||45
11045074|NCT00935272|12225415|FG000|COMPLETED|Overall Study||116
11045075|NCT00935272|12225416|FG001|COMPLETED|Overall Study||39
11045076|NCT00935272|12225415|FG000|NOT COMPLETED|Overall Study||19
11045077|NCT00935272|12225416|FG001|NOT COMPLETED|Overall Study||6
11045078|NCT00935311|12225426|FG000|STARTED|Overall Study||43
11045079|NCT00935311|12225427|FG001|STARTED|Overall Study||39
11045080|NCT00935311|12225428|FG002|STARTED|Overall Study||40
11045081|NCT00935311|12225426|FG000|COMPLETED|Overall Study||43
11045082|NCT00935311|12225427|FG001|COMPLETED|Overall Study||39
11045083|NCT00935311|12225428|FG002|COMPLETED|Overall Study||40
11045084|NCT00935311|12225426|FG000|NOT COMPLETED|Overall Study||0
11045085|NCT00935311|12225427|FG001|NOT COMPLETED|Overall Study||0
11045086|NCT00935311|12225428|FG002|NOT COMPLETED|Overall Study||0
11045087|NCT00935428|12225436|FG000|STARTED|Overall Study||231
11045088|NCT00935428|12225436|FG000|COMPLETED|Overall Study||231
11045089|NCT00935428|12225436|FG000|NOT COMPLETED|Overall Study||0
11045090|NCT00935493|12225449|FG000|STARTED|Overall Study||41
11045091|NCT00935493|12225450|FG001|STARTED|Overall Study||41
11045092|NCT00935493|12225451|FG002|STARTED|Overall Study||41
11045093|NCT00935493|12225449|FG000|COMPLETED|Overall Study||40
11045094|NCT00935493|12225450|FG001|COMPLETED|Overall Study||39
11045095|NCT00935493|12225451|FG002|COMPLETED|Overall Study||40
11045096|NCT00935493|12225449|FG000|NOT COMPLETED|Overall Study||1
11045097|NCT00935493|12225450|FG001|NOT COMPLETED|Overall Study||2
11045098|NCT00935493|12225451|FG002|NOT COMPLETED|Overall Study||1
11045099|NCT00935532|12225461|FG000|STARTED|Overall Study||215
11045100|NCT00935532|12225462|FG001|STARTED|Overall Study||212
11045101|NCT00935532|12225461|FG000|COMPLETED|Overall Study||193
11045102|NCT00935532|12225462|FG001|COMPLETED|Overall Study||201
11045103|NCT00935532|12225461|FG000|NOT COMPLETED|Overall Study||22
11045104|NCT00935532|12225462|FG001|NOT COMPLETED|Overall Study||11
11045105|NCT00935584|12225470|FG000|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
11045106|NCT00935584|12225471|FG001|STARTED|Overall Study||23
11045107|NCT00935584|12225470|FG000|COMPLETED|Overall Study||77
11045108|NCT00935584|12225471|FG001|COMPLETED|Overall Study||19
11045109|NCT00935584|12225470|FG000|NOT COMPLETED|Overall Study||49
11045110|NCT00935584|12225471|FG001|NOT COMPLETED|Overall Study||4
11045111|NCT00935701|12225475|FG000|STARTED|Overall Study||10
11045112|NCT00935701|12225475|FG000|Transition Acupressure to Acupuncture|Overall Study||9
11045113|NCT00935701|12225475|FG000|COMPLETED|Overall Study||9
11045114|NCT00935701|12225475|FG000|NOT COMPLETED|Overall Study||1
11045115|NCT00935766|12225482|FG000|STARTED|Overall Study||42
11045116|NCT00935766|12225483|FG001|STARTED|Overall Study||34
11045117|NCT00935766|12225482|FG000|COMPLETED|Overall Study||35
11045118|NCT00935766|12225483|FG001|COMPLETED|Overall Study||27
11045119|NCT00935766|12225482|FG000|NOT COMPLETED|Overall Study||7
11045120|NCT00935766|12225483|FG001|NOT COMPLETED|Overall Study||7
11045121|NCT00935792|12225492|FG000|STARTED|Overall Study||7
11045122|NCT00935792|12225493|FG001|STARTED|Overall Study||9
11045123|NCT00935792|12225494|FG002|STARTED|Overall Study||12
11045124|NCT00935792|12225492|FG000|COMPLETED|Overall Study||6
11045125|NCT00935792|12225493|FG001|COMPLETED|Overall Study||6
11045126|NCT00935792|12225494|FG002|COMPLETED|Overall Study||12
11045127|NCT00935792|12225492|FG000|NOT COMPLETED|Overall Study||1
11045128|NCT00935792|12225493|FG001|NOT COMPLETED|Overall Study||3
11045129|NCT00935792|12225494|FG002|NOT COMPLETED|Overall Study||0
11045130|NCT00935818|12225506|FG000|STARTED|Overall Study||249
11045131|NCT00935818|12225507|FG001|STARTED|Overall Study||257
11045132|NCT00935818|12225506|FG000|End of Medication Phase|Overall Study||182
11045133|NCT00935818|12225507|FG001|End of Medication Phase|Overall Study||184
11045134|NCT00935818|12225506|FG000|COMPLETED|Overall Study||158
11045135|NCT00935818|12225507|FG001|COMPLETED|Overall Study||157
11045136|NCT00935818|12225506|FG000|NOT COMPLETED|Overall Study||91
11045137|NCT00935818|12225507|FG001|NOT COMPLETED|Overall Study||100
11045138|NCT00935857|12225515|FG000|STARTED|Overall Study||14
11045139|NCT00935857|12225516|FG001|STARTED|Overall Study||16
11045140|NCT00935857|12225515|FG000|COMPLETED|Overall Study||14
11045141|NCT00935857|12225516|FG001|COMPLETED|Overall Study||16
11045142|NCT00935857|12225515|FG000|NOT COMPLETED|Overall Study||0
11045143|NCT00935857|12225516|FG001|NOT COMPLETED|Overall Study||0
11045144|NCT00935883|12225524|FG000|STARTED|Treatment Period||20
11045145|NCT00935883|12225525|FG001|STARTED|Treatment Period||40
11045146|NCT00935883|12225524|FG000|COMPLETED|Treatment Period||19
11045147|NCT00935883|12225525|FG001|COMPLETED|Treatment Period||38
11336694|NCT02881775|12534482|FG000|COMPLETED|Second Intervention (1-Hour Session)||9
11336695|NCT02881775|12534483|FG001|COMPLETED|Second Intervention (1-Hour Session)||7
11336696|NCT02881775|12534482|FG000|NOT COMPLETED|Second Intervention (1-Hour Session)||0
11336697|NCT02881775|12534483|FG001|NOT COMPLETED|Second Intervention (1-Hour Session)||0
11336698|NCT02881840|12534489|FG000|STARTED|Overall Study||6
11336699|NCT02881840|12534489|FG000|COMPLETED|Overall Study||6
11336700|NCT02881840|12534489|FG000|NOT COMPLETED|Overall Study||0
11336701|NCT02881996|12534495|FG000|STARTED|Overall Study||45
11045148|NCT00935883|12225524|FG000|NOT COMPLETED|Treatment Period||1
11045149|NCT00935883|12225525|FG001|NOT COMPLETED|Treatment Period||2
11045150|NCT00935883|12225524|FG000|STARTED|Follow-Up Period||19
11045151|NCT00935883|12225525|FG001|STARTED|Follow-Up Period||38
11045152|NCT00935883|12225524|FG000|COMPLETED|Follow-Up Period||19
11045153|NCT00935883|12225525|FG001|COMPLETED|Follow-Up Period||38
11045154|NCT00935883|12225524|FG000|NOT COMPLETED|Follow-Up Period||0
11045155|NCT00935883|12225525|FG001|NOT COMPLETED|Follow-Up Period||0
11045156|NCT00936065|12225534|FG000|STARTED|Overall Study||21
11045157|NCT00936065|12225535|FG001|STARTED|Overall Study||20
11045158|NCT00936065|12225536|FG002|STARTED|Overall Study||19
11045159|NCT00936065|12225534|FG000|Received Treatment|Overall Study||21
11045160|NCT00936065|12225535|FG001|Received Treatment|Overall Study||20
11336702|NCT02881996|12534496|FG001|STARTED|Overall Study||45
11045161|NCT00936065|12225536|FG002|Received Treatment|Overall Study||18
11045162|NCT00936065|12225534|FG000|Study Assessments Performed|Overall Study||21
11045163|NCT00936065|12225535|FG001|Study Assessments Performed|Overall Study||19
11045164|NCT00936065|12225536|FG002|Study Assessments Performed|Overall Study||18
11045165|NCT00936065|12225534|FG000|COMPLETED|Overall Study||17
11045166|NCT00936065|12225535|FG001|COMPLETED|Overall Study||16
11045167|NCT00936065|12225536|FG002|COMPLETED|Overall Study||12
11045168|NCT00936065|12225534|FG000|NOT COMPLETED|Overall Study||4
11045169|NCT00936065|12225535|FG001|NOT COMPLETED|Overall Study||4
11045170|NCT00936065|12225536|FG002|NOT COMPLETED|Overall Study||7
11045171|NCT00936117|12225544|FG000|STARTED|Overall Study||20
11045172|NCT00936117|12225544|FG000|COMPLETED|Overall Study|Completed 42 days on study drug|10
11045173|NCT00936117|12225544|FG000|NOT COMPLETED|Overall Study||10
11045174|NCT00936208|12225551|FG000|STARTED|Overall Study||1499
11045175|NCT00936208|12225552|FG001|STARTED|Overall Study||1596
11045176|NCT00936208|12225551|FG000|COMPLETED|Overall Study||1462
11045177|NCT00936208|12225552|FG001|COMPLETED|Overall Study||1574
11045178|NCT00936208|12225551|FG000|NOT COMPLETED|Overall Study||37
11045179|NCT00936208|12225552|FG001|NOT COMPLETED|Overall Study||22
11045180|NCT00936221|12225560|FG000|STARTED|Overall Study||45
11045181|NCT00936221|12225561|FG001|STARTED|Overall Study||46
11045182|NCT00936221|12225560|FG000|Received Treatment|Overall Study||44
11045183|NCT00936221|12225561|FG001|Received Treatment|Overall Study||45
11045184|NCT00936221|12225560|FG000|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
11045185|NCT00936221|12225561|FG001|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
11045186|NCT00936221|12225560|FG000|NOT COMPLETED|Overall Study||1
11045187|NCT00936221|12225561|FG001|NOT COMPLETED|Overall Study||1
11045188|NCT00936299|12225569|FG000|STARTED|Overall Study||53
11045189|NCT00936299|12225570|FG001|STARTED|Overall Study||52
11045190|NCT00936299|12225569|FG000|COMPLETED|Overall Study||40
11045191|NCT00936299|12225570|FG001|COMPLETED|Overall Study||40
11045192|NCT00936299|12225569|FG000|NOT COMPLETED|Overall Study||13
11045193|NCT00936299|12225570|FG001|NOT COMPLETED|Overall Study||12
11045194|NCT00936351|12225580|FG000|STARTED|Overall Study||18
11045195|NCT00936351|12225581|FG001|STARTED|Overall Study||16
11045196|NCT00936351|12225580|FG000|COMPLETED|Overall Study||15
11045197|NCT00936351|12225581|FG001|COMPLETED|Overall Study||14
11045198|NCT00936351|12225580|FG000|NOT COMPLETED|Overall Study||3
11045199|NCT00936351|12225581|FG001|NOT COMPLETED|Overall Study||2
11045200|NCT00936377|12225590|FG000|STARTED|Overall Study||8
11045201|NCT00936377|12225591|FG001|STARTED|Overall Study||8
11045202|NCT00936377|12225592|FG002|STARTED|Overall Study||8
11045203|NCT00936377|12225590|FG000|COMPLETED|Overall Study||8
11045204|NCT00936377|12225591|FG001|COMPLETED|Overall Study||8
11045205|NCT00936377|12225592|FG002|COMPLETED|Overall Study||8
11045206|NCT00936377|12225590|FG000|NOT COMPLETED|Overall Study||0
11045207|NCT00936377|12225591|FG001|NOT COMPLETED|Overall Study||0
11045208|NCT00936377|12225592|FG002|NOT COMPLETED|Overall Study||0
11045209|NCT00936455|12225602|FG000|STARTED|Overall Study||37
11045210|NCT00936455|12225603|FG001|STARTED|Overall Study||38
11045211|NCT00936455|12225602|FG000|COMPLETED|Overall Study||37
11045212|NCT00936455|12225603|FG001|COMPLETED|Overall Study||38
11045213|NCT00936455|12225602|FG000|NOT COMPLETED|Overall Study||0
11045214|NCT00936455|12225603|FG001|NOT COMPLETED|Overall Study||0
11045215|NCT00936481|12225617|FG000|STARTED|Overall Study||17
11045216|NCT00936481|12225618|FG001|STARTED|Overall Study||17
11045217|NCT00936481|12225617|FG000|COMPLETED|Overall Study||17
11045218|NCT00936481|12225618|FG001|COMPLETED|Overall Study||17
11045219|NCT00936481|12225617|FG000|NOT COMPLETED|Overall Study||0
11045220|NCT00936481|12225618|FG001|NOT COMPLETED|Overall Study||0
11045221|NCT00936611|12225624|FG000|STARTED|Overall Study||39
11045222|NCT00936611|12225624|FG000|Treated|Overall Study||36
11045223|NCT00936611|12225624|FG000|Starting Dose Reduction: 30 mg to 25 mg|Overall Study||12
11045224|NCT00936611|12225624|FG000|COMPLETED|Overall Study||0
11045225|NCT00936611|12225624|FG000|NOT COMPLETED|Overall Study||39
11045226|NCT00936663|12225630|FG000|STARTED|Overall Study||1
11045227|NCT00936663|12225631|FG001|STARTED|Overall Study||2
11045228|NCT00936663|12225630|FG000|COMPLETED|Overall Study||1
11045229|NCT00936663|12225631|FG001|COMPLETED|Overall Study||2
11045230|NCT00936663|12225630|FG000|NOT COMPLETED|Overall Study||0
11045231|NCT00936663|12225631|FG001|NOT COMPLETED|Overall Study||0
11045232|NCT00936702|12225637|FG000|STARTED|Overall Study||46
11045233|NCT00936702|12225637|FG000|COMPLETED|Overall Study||0
11045234|NCT00936702|12225637|FG000|NOT COMPLETED|Overall Study||46
11045235|NCT00936715|12225641|FG000|STARTED|Overall Study||24
11045236|NCT00936715|12225641|FG000|COMPLETED|Overall Study||18
11045237|NCT00936715|12225641|FG000|NOT COMPLETED|Overall Study||6
11045238|NCT00936741|12225645|FG000|STARTED|Overall Study||30
11045239|NCT00936741|12225645|FG000|COMPLETED|Overall Study||21
11045240|NCT00936741|12225645|FG000|NOT COMPLETED|Overall Study||9
11045241|NCT00936858|12225649|FG000|STARTED|Overall Study||50
11045242|NCT00936858|12225649|FG000|Participants With Medullary Thyroid Cancer|Overall Study||10
11045243|NCT00936858|12225649|FG000|COMPLETED|Overall Study||0
11045244|NCT00936858|12225649|FG000|NOT COMPLETED|Overall Study||50
11045245|NCT00936884|12225656|FG000|STARTED|Double-blind|Twenty-five subjects received MNTX, and 24 had ≥ 1 post baseline diary assessment.|25
11045246|NCT00936884|12225657|FG001|STARTED|Double-blind|Twenty-four subjects received placebo, and 23 had ≥ 1 post baseline diary assessment.|25
11045247|NCT00936884|12225658|FG002|STARTED|Double-blind|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|0
11045248|NCT00936884|12225656|FG000|COMPLETED|Double-blind||13
11045249|NCT00936884|12225657|FG001|COMPLETED|Double-blind||18
11045250|NCT00936884|12225658|FG002|COMPLETED|Double-blind||0
11045251|NCT00936884|12225656|FG000|NOT COMPLETED|Double-blind||12
11045252|NCT00936884|12225657|FG001|NOT COMPLETED|Double-blind||7
11045253|NCT00936884|12225658|FG002|NOT COMPLETED|Double-blind||0
11045254|NCT00936884|12225656|FG000|STARTED|Open-label||0
11045255|NCT00936884|12225657|FG001|STARTED|Open-label||0
11045256|NCT00936884|12225658|FG002|STARTED|Open-label||31
11045257|NCT00936884|12225656|FG000|COMPLETED|Open-label||0
11045258|NCT00936884|12225657|FG001|COMPLETED|Open-label||0
11045259|NCT00936884|12225658|FG002|COMPLETED|Open-label||12
11045260|NCT00936884|12225656|FG000|NOT COMPLETED|Open-label||0
11045261|NCT00936884|12225657|FG001|NOT COMPLETED|Open-label||0
11045262|NCT00936884|12225658|FG002|NOT COMPLETED|Open-label||19
11045263|NCT00936897|12225667|FG000|STARTED|Overall Study|Randomized|417
11045264|NCT00936897|12225668|FG001|STARTED|Overall Study|Randomized|416
11045265|NCT00936897|12225667|FG000|COMPLETED|Overall Study||398
11045266|NCT00936897|12225668|FG001|COMPLETED|Overall Study||356
11045267|NCT00936897|12225667|FG000|NOT COMPLETED|Overall Study||19
11045268|NCT00936897|12225668|FG001|NOT COMPLETED|Overall Study||60
11045269|NCT00936910|12225674|FG000|STARTED|Overall Study||13
11045270|NCT00936910|12225674|FG000|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
11045271|NCT00936910|12225674|FG000|NOT COMPLETED|Overall Study||3
11045272|NCT00936975|12225679|FG000|STARTED|Overall Study||18
11045273|NCT00936975|12225679|FG000|COMPLETED|Overall Study||12
11045274|NCT00936975|12225679|FG000|NOT COMPLETED|Overall Study||6
11045275|NCT00937040|12225686|FG000|STARTED|Overall Study||179
11045276|NCT00937040|12225687|FG001|STARTED|Overall Study||178
11045277|NCT00937040|12225686|FG000|COMPLETED|Overall Study||138
11045278|NCT00937040|12225687|FG001|COMPLETED|Overall Study||141
11045279|NCT00937040|12225686|FG000|NOT COMPLETED|Overall Study||41
11045280|NCT00937040|12225687|FG001|NOT COMPLETED|Overall Study||37
11045281|NCT00937105|12225695|FG000|STARTED|Overall Study||109
11045282|NCT00937105|12225696|FG001|STARTED|Overall Study||109
11045283|NCT00937105|12225695|FG000|COMPLETED|Overall Study||69
11045284|NCT00937105|12225696|FG001|COMPLETED|Overall Study||70
11045285|NCT00937105|12225695|FG000|NOT COMPLETED|Overall Study||40
11336703|NCT02881996|12534495|FG000|COMPLETED|Overall Study||39
11336704|NCT02881996|12534496|FG001|COMPLETED|Overall Study||43
11336705|NCT02881996|12534495|FG000|NOT COMPLETED|Overall Study||6
11336706|NCT02881996|12534496|FG001|NOT COMPLETED|Overall Study||2
11336707|NCT02882152|12534504|FG000|STARTED|Overall Study||20
11336708|NCT02882152|12534505|FG001|STARTED|Overall Study||20
11336709|NCT02882152|12534504|FG000|COMPLETED|Overall Study||19
11336710|NCT02882152|12534505|FG001|COMPLETED|Overall Study||20
11336711|NCT02882152|12534504|FG000|NOT COMPLETED|Overall Study||1
11045286|NCT00937105|12225696|FG001|NOT COMPLETED|Overall Study||39
11336712|NCT02882152|12534505|FG001|NOT COMPLETED|Overall Study||0
11336713|NCT02882178|12534511|FG000|STARTED|Overall Study||18
11336714|NCT02882178|12534511|FG000|COMPLETED|Overall Study||18
11045287|NCT00937118|12225711|FG000|STARTED|Overall Study||41
11045288|NCT00937118|12225711|FG000|COMPLETED|Overall Study||41
11336715|NCT02882178|12534511|FG000|NOT COMPLETED|Overall Study||0
11336716|NCT02882633|12534517|FG000|STARTED|Overall Study||25
11336717|NCT02882633|12534518|FG001|STARTED|Overall Study||25
11336718|NCT02882633|12534517|FG000|COMPLETED|Overall Study||23
11045289|NCT00937118|12225711|FG000|NOT COMPLETED|Overall Study||0
11045290|NCT00937157|12225718|FG000|STARTED|Overall Study||12
11045291|NCT00937157|12225718|FG000|COMPLETED|Overall Study||8
11045292|NCT00937157|12225718|FG000|NOT COMPLETED|Overall Study||4
11336719|NCT02882633|12534518|FG001|COMPLETED|Overall Study||25
11336720|NCT02882633|12534517|FG000|NOT COMPLETED|Overall Study||2
11045293|NCT00937235|12225724|FG000|STARTED|Overall Study||72
11045294|NCT00937235|12225725|FG001|STARTED|Overall Study||70
11045295|NCT00937235|12225724|FG000|COMPLETED|Overall Study||72
11045296|NCT00937235|12225725|FG001|COMPLETED|Overall Study||70
11045297|NCT00937235|12225724|FG000|NOT COMPLETED|Overall Study||0
11045298|NCT00937235|12225725|FG001|NOT COMPLETED|Overall Study||0
11045299|NCT00937326|12225736|FG000|STARTED|Overall Study||46
11045300|NCT00937326|12225737|FG001|STARTED|Overall Study||45
11045301|NCT00937326|12225738|FG002|STARTED|Overall Study||46
11045302|NCT00937326|12225739|FG003|STARTED|Overall Study||45
11045303|NCT00937326|12225740|FG004|STARTED|Overall Study||45
11045304|NCT00937326|12225736|FG000|COMPLETED|Overall Study||43
11045305|NCT00937326|12225737|FG001|COMPLETED|Overall Study||38
11045306|NCT00937326|12225738|FG002|COMPLETED|Overall Study||42
11045307|NCT00937326|12225739|FG003|COMPLETED|Overall Study||40
11045308|NCT00937326|12225740|FG004|COMPLETED|Overall Study||40
11045309|NCT00937326|12225736|FG000|NOT COMPLETED|Overall Study||3
11045310|NCT00937326|12225737|FG001|NOT COMPLETED|Overall Study||7
11045311|NCT00937326|12225738|FG002|NOT COMPLETED|Overall Study||4
11045312|NCT00937326|12225739|FG003|NOT COMPLETED|Overall Study||5
11045313|NCT00937326|12225740|FG004|NOT COMPLETED|Overall Study||5
11045314|NCT00937378|12225759|FG000|STARTED|Overall Study||167
11045315|NCT00937378|12225760|FG001|STARTED|Overall Study||159
11045316|NCT00937378|12225759|FG000|COMPLETED|Overall Study||149
11045317|NCT00937378|12225760|FG001|COMPLETED|Overall Study||141
11045318|NCT00937378|12225759|FG000|NOT COMPLETED|Overall Study||18
11045319|NCT00937378|12225760|FG001|NOT COMPLETED|Overall Study||18
11045320|NCT00937391|12225768|FG000|STARTED|Stage 1||20
11045321|NCT00937391|12225768|FG000|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
11045322|NCT00937391|12225768|FG000|COMPLETED|Stage 1||20
11045323|NCT00937391|12225768|FG000|NOT COMPLETED|Stage 1||0
11045324|NCT00937391|12225768|FG000|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
11045325|NCT00937391|12225768|FG000|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
11045326|NCT00937391|12225768|FG000|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
11045327|NCT00937391|12225768|FG000|NOT COMPLETED|Stage 2||1
11045328|NCT00937404|12225785|FG000|STARTED|Overall Study||25
11045329|NCT00937404|12225785|FG000|COMPLETED|Overall Study||23
11045330|NCT00937404|12225785|FG000|NOT COMPLETED|Overall Study||2
11045331|NCT00937495|12225789|FG000|STARTED|Overall Study||16
11045332|NCT00937495|12225789|FG000|COMPLETED|Overall Study||14
11045333|NCT00937495|12225789|FG000|NOT COMPLETED|Overall Study||2
11045334|NCT00937521|12225801|FG000|STARTED|Overall Study - Prior to Booster Dose||188
11045335|NCT00937521|12225802|FG001|STARTED|Overall Study - Prior to Booster Dose||190
11045336|NCT00937521|12225803|FG002|STARTED|Overall Study - Prior to Booster Dose||192
11045337|NCT00937521|12225804|FG003|STARTED|Overall Study - Prior to Booster Dose||188
11045338|NCT00937521|12225805|FG004|STARTED|Overall Study - Prior to Booster Dose||191
11045339|NCT00937521|12225806|FG005|STARTED|Overall Study - Prior to Booster Dose||188
11045340|NCT00937521|12225807|FG006|STARTED|Overall Study - Prior to Booster Dose||186
11045341|NCT00937521|12225808|FG007|STARTED|Overall Study - Prior to Booster Dose||184
11045342|NCT00937521|12225801|FG000|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
11045343|NCT00937521|12225802|FG001|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
11045344|NCT00937521|12225803|FG002|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
11045345|NCT00937521|12225804|FG003|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
11045346|NCT00937521|12225805|FG004|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
11045347|NCT00937521|12225806|FG005|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
11045348|NCT00937521|12225807|FG006|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
11045349|NCT00937521|12225808|FG007|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
11045350|NCT00937521|12225801|FG000|COMPLETED|Overall Study - Prior to Booster Dose||185
11045351|NCT00937521|12225802|FG001|COMPLETED|Overall Study - Prior to Booster Dose||185
11045352|NCT00937521|12225803|FG002|COMPLETED|Overall Study - Prior to Booster Dose||186
11045353|NCT00937521|12225804|FG003|COMPLETED|Overall Study - Prior to Booster Dose||187
11045354|NCT00937521|12225805|FG004|COMPLETED|Overall Study - Prior to Booster Dose||188
11045355|NCT00937521|12225806|FG005|COMPLETED|Overall Study - Prior to Booster Dose||187
11045356|NCT00937521|12225807|FG006|COMPLETED|Overall Study - Prior to Booster Dose||181
11045357|NCT00937521|12225808|FG007|COMPLETED|Overall Study - Prior to Booster Dose||183
11045358|NCT00937521|12225801|FG000|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
11045359|NCT00937521|12225802|FG001|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
11045360|NCT00937521|12225803|FG002|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
11045361|NCT00937521|12225804|FG003|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
11045362|NCT00937521|12225805|FG004|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
11045363|NCT00937521|12225806|FG005|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
11045364|NCT00937521|12225807|FG006|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
11045365|NCT00937521|12225808|FG007|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
11045366|NCT00937521|12225801|FG000|STARTED|Booster Phase||155
11045367|NCT00937521|12225802|FG001|STARTED|Booster Phase||163
11045368|NCT00937521|12225803|FG002|STARTED|Booster Phase||169
11045369|NCT00937521|12225804|FG003|STARTED|Booster Phase||170
11045370|NCT00937521|12225805|FG004|STARTED|Booster Phase||168
11045371|NCT00937521|12225806|FG005|STARTED|Booster Phase||165
11045372|NCT00937521|12225807|FG006|STARTED|Booster Phase||165
11045373|NCT00937521|12225808|FG007|STARTED|Booster Phase||161
11045374|NCT00937521|12225801|FG000|Premature Withdrawal|Booster Phase||3
11045375|NCT00937521|12225802|FG001|Premature Withdrawal|Booster Phase||2
11045376|NCT00937521|12225803|FG002|Premature Withdrawal|Booster Phase||5
11045377|NCT00937521|12225804|FG003|Premature Withdrawal|Booster Phase||3
11045378|NCT00937521|12225805|FG004|Premature Withdrawal|Booster Phase||5
11045379|NCT00937521|12225806|FG005|Premature Withdrawal|Booster Phase||5
11045380|NCT00937521|12225807|FG006|Premature Withdrawal|Booster Phase||5
11045381|NCT00937521|12225808|FG007|Premature Withdrawal|Booster Phase||2
11045382|NCT00937521|12225801|FG000|COMPLETED|Booster Phase||152
11045383|NCT00937521|12225802|FG001|COMPLETED|Booster Phase||161
11045384|NCT00937521|12225803|FG002|COMPLETED|Booster Phase||164
11045385|NCT00937521|12225804|FG003|COMPLETED|Booster Phase||167
11045386|NCT00937521|12225805|FG004|COMPLETED|Booster Phase||163
11045387|NCT00937521|12225806|FG005|COMPLETED|Booster Phase||160
11045388|NCT00937521|12225807|FG006|COMPLETED|Booster Phase||160
11045389|NCT00937521|12225808|FG007|COMPLETED|Booster Phase||159
11045390|NCT00937521|12225801|FG000|NOT COMPLETED|Booster Phase||3
11045391|NCT00937521|12225802|FG001|NOT COMPLETED|Booster Phase||2
11045392|NCT00937521|12225803|FG002|NOT COMPLETED|Booster Phase||5
11045393|NCT00937521|12225804|FG003|NOT COMPLETED|Booster Phase||3
11045394|NCT00937521|12225805|FG004|NOT COMPLETED|Booster Phase||5
11045395|NCT00937521|12225806|FG005|NOT COMPLETED|Booster Phase||5
11045396|NCT00937521|12225807|FG006|NOT COMPLETED|Booster Phase||5
11045397|NCT00937521|12225808|FG007|NOT COMPLETED|Booster Phase||2
11045398|NCT00937547|12225844|FG000|STARTED|Overall Study||96
11045399|NCT00937547|12225845|FG001|STARTED|Overall Study||84
11045400|NCT00937547|12225846|FG002|STARTED|Overall Study||149
11045401|NCT00937547|12225844|FG000|Histological Samples|Overall Study||95
11045402|NCT00937547|12225845|FG001|Histological Samples|Overall Study||78
11045403|NCT00937547|12225846|FG002|Histological Samples|Overall Study||142
11045404|NCT00937547|12225844|FG000|COMPLETED|Overall Study||95
11045405|NCT00937547|12225845|FG001|COMPLETED|Overall Study||78
11045406|NCT00937547|12225846|FG002|COMPLETED|Overall Study||142
11045407|NCT00937547|12225844|FG000|NOT COMPLETED|Overall Study||1
11045408|NCT00937547|12225845|FG001|NOT COMPLETED|Overall Study||6
11045409|NCT00937547|12225846|FG002|NOT COMPLETED|Overall Study||7
11045410|NCT00937560|12225854|FG000|STARTED|Initial Treatment||189
11045411|NCT00937560|12225854|FG000|Received Treatment|Initial Treatment||189
11045412|NCT00937560|12225854|FG000|COMPLETED|Initial Treatment||168
11045413|NCT00937560|12225854|FG000|NOT COMPLETED|Initial Treatment||21
11045414|NCT00937560|12225854|FG000|STARTED|Maintenance Treatment||168
11045415|NCT00937560|12225854|FG000|COMPLETED|Maintenance Treatment||150
11045416|NCT00937560|12225854|FG000|NOT COMPLETED|Maintenance Treatment||18
11045417|NCT00937768|12225860|FG000|STARTED|Overall Study||8
11045418|NCT00937768|12225861|FG001|STARTED|Overall Study||8
11045419|NCT00937768|12225860|FG000|COMPLETED|Overall Study||0
11045420|NCT00937768|12225861|FG001|COMPLETED|Overall Study||0
11045421|NCT00937768|12225860|FG000|NOT COMPLETED|Overall Study||8
11045422|NCT00937768|12225861|FG001|NOT COMPLETED|Overall Study||8
11045423|NCT00937794|12225867|FG000|STARTED|Overall Study||33
11045424|NCT00937794|12225867|FG000|COMPLETED|Overall Study||33
11045425|NCT00937794|12225867|FG000|NOT COMPLETED|Overall Study||0
11045426|NCT00937833|12225873|FG000|STARTED|Overall Study||73
11045427|NCT00937833|12225874|FG001|STARTED|Overall Study||77
11045428|NCT00937833|12225873|FG000|COMPLETED|Overall Study||58
11045429|NCT00937833|12225874|FG001|COMPLETED|Overall Study||60
11045430|NCT00937833|12225873|FG000|NOT COMPLETED|Overall Study||15
11045431|NCT00937833|12225874|FG001|NOT COMPLETED|Overall Study||17
11045432|NCT00937859|12225882|FG000|STARTED|Overall Study||148
11045433|NCT00937859|12225883|FG001|STARTED|Overall Study||153
11045434|NCT00937859|12225882|FG000|COMPLETED|Overall Study||129
11045435|NCT00937859|12225883|FG001|COMPLETED|Overall Study||134
11045436|NCT00937859|12225882|FG000|NOT COMPLETED|Overall Study||19
11045437|NCT00937859|12225883|FG001|NOT COMPLETED|Overall Study||19
11045438|NCT00937950|12225889|FG000|STARTED|Overall Study||2003
11045439|NCT00937950|12225889|FG000|COMPLETED|Overall Study||1787
11045440|NCT00937950|12225889|FG000|NOT COMPLETED|Overall Study||216
11045441|NCT00938015|12225893|FG000|STARTED|Overall Study||303
11045442|NCT00938015|12225893|FG000|COMPLETED|Overall Study||156
11045443|NCT00938015|12225893|FG000|NOT COMPLETED|Overall Study||147
11045444|NCT00938041|12225897|FG000|STARTED|Overall Study||32
11045445|NCT00938041|12225897|FG000|COMPLETED|Overall Study||5
11045446|NCT00938041|12225897|FG000|NOT COMPLETED|Overall Study||27
11045447|NCT00938314|12225905|FG000|STARTED|Cohort 1||24
11045448|NCT00938314|12225906|FG001|STARTED|Cohort 1||0
11045449|NCT00938314|12225907|FG002|STARTED|Cohort 1||0
11045450|NCT00938314|12225908|FG003|STARTED|Cohort 1||8
11045451|NCT00938314|12225905|FG000|COMPLETED|Cohort 1||22
11045452|NCT00938314|12225906|FG001|COMPLETED|Cohort 1||0
11045453|NCT00938314|12225907|FG002|COMPLETED|Cohort 1||0
11045454|NCT00938314|12225908|FG003|COMPLETED|Cohort 1||6
11045455|NCT00938314|12225905|FG000|NOT COMPLETED|Cohort 1||2
11045456|NCT00938314|12225906|FG001|NOT COMPLETED|Cohort 1||0
11045457|NCT00938314|12225907|FG002|NOT COMPLETED|Cohort 1||0
11045458|NCT00938314|12225908|FG003|NOT COMPLETED|Cohort 1||2
11045459|NCT00938314|12225905|FG000|STARTED|Cohort 2||0
11045460|NCT00938314|12225906|FG001|STARTED|Cohort 2||24
11045461|NCT00938314|12225907|FG002|STARTED|Cohort 2||0
11045462|NCT00938314|12225908|FG003|STARTED|Cohort 2||8
11045463|NCT00938314|12225905|FG000|COMPLETED|Cohort 2||0
11045464|NCT00938314|12225906|FG001|COMPLETED|Cohort 2||18
11045465|NCT00938314|12225907|FG002|COMPLETED|Cohort 2||0
11045466|NCT00938314|12225908|FG003|COMPLETED|Cohort 2||6
11045467|NCT00938314|12225905|FG000|NOT COMPLETED|Cohort 2||0
11045468|NCT00938314|12225906|FG001|NOT COMPLETED|Cohort 2||6
11045469|NCT00938314|12225907|FG002|NOT COMPLETED|Cohort 2||0
11045470|NCT00938314|12225908|FG003|NOT COMPLETED|Cohort 2||2
11045471|NCT00938314|12225905|FG000|STARTED|Cohort 3||0
11045472|NCT00938314|12225906|FG001|STARTED|Cohort 3||0
11045473|NCT00938314|12225907|FG002|STARTED|Cohort 3||24
11045474|NCT00938314|12225908|FG003|STARTED|Cohort 3||8
11045475|NCT00938314|12225905|FG000|COMPLETED|Cohort 3||0
11045476|NCT00938314|12225906|FG001|COMPLETED|Cohort 3||0
11045477|NCT00938314|12225907|FG002|COMPLETED|Cohort 3||20
11045478|NCT00938314|12225908|FG003|COMPLETED|Cohort 3||7
11045479|NCT00938314|12225905|FG000|NOT COMPLETED|Cohort 3||0
11045480|NCT00938314|12225906|FG001|NOT COMPLETED|Cohort 3||0
11045481|NCT00938314|12225907|FG002|NOT COMPLETED|Cohort 3||4
11045482|NCT00938314|12225908|FG003|NOT COMPLETED|Cohort 3||1
11045483|NCT00938327|12225918|FG000|STARTED|Overall Study||332
11045484|NCT00938327|12225918|FG000|COMPLETED|Overall Study||272
11045485|NCT00938327|12225918|FG000|NOT COMPLETED|Overall Study||60
11045486|NCT00938340|12225922|FG000|STARTED|Overall Study||20
11045487|NCT00938340|12225922|FG000|Received Whole Walnut Intervention|Overall Study||16
11045488|NCT00938340|12225922|FG000|Received Walnut Nutmeat Intervention|Overall Study||19
11045489|NCT00938340|12225922|FG000|Received Walnut Skins Intervention|Overall Study||15
11045490|NCT00938340|12225922|FG000|Received Walnut Oil Intervention|Overall Study||15
11045491|NCT00938340|12225922|FG000|COMPLETED|Overall Study||15
11045492|NCT00938340|12225922|FG000|NOT COMPLETED|Overall Study||5
11045493|NCT00938366|12225970|FG000|STARTED|Overall Study||9
11045494|NCT00938366|12225971|FG001|STARTED|Overall Study||9
11045495|NCT00938366|12225970|FG000|COMPLETED|Overall Study||8
11045496|NCT00938366|12225971|FG001|COMPLETED|Overall Study||9
11045497|NCT00938366|12225970|FG000|NOT COMPLETED|Overall Study||1
11045498|NCT00938366|12225971|FG001|NOT COMPLETED|Overall Study||0
11045499|NCT00938392|12225979|FG000|STARTED|Overall Study||362
11045500|NCT00938392|12225980|FG001|STARTED|Overall Study||362
11045501|NCT00938392|12225979|FG000|COMPLETED|Overall Study||360
11045502|NCT00938392|12225980|FG001|COMPLETED|Overall Study||358
11045503|NCT00938392|12225979|FG000|NOT COMPLETED|Overall Study||2
11045504|NCT00938392|12225980|FG001|NOT COMPLETED|Overall Study||4
11045505|NCT00938431|12225989|FG000|STARTED|Overall Study||15
11045506|NCT00938431|12225990|FG001|STARTED|Overall Study||23
11045507|NCT00938431|12225991|FG002|STARTED|Overall Study||9
11045508|NCT00938431|12225989|FG000|COMPLETED|Overall Study||9
11045509|NCT00938431|12225990|FG001|COMPLETED|Overall Study||14
11045510|NCT00938431|12225991|FG002|COMPLETED|Overall Study||1
11045511|NCT00938431|12225989|FG000|NOT COMPLETED|Overall Study||6
11045512|NCT00938431|12225990|FG001|NOT COMPLETED|Overall Study||9
11045513|NCT00938431|12225991|FG002|NOT COMPLETED|Overall Study||8
11045514|NCT00938457|12226003|FG000|STARTED|Overall Study||3
11045515|NCT00938457|12226003|FG000|COMPLETED|Overall Study||3
11045516|NCT00938457|12226003|FG000|NOT COMPLETED|Overall Study||0
11045517|NCT00938470|12226009|FG000|STARTED|Overall Study||34
11045518|NCT00938470|12226010|FG001|STARTED|Overall Study||28
11045519|NCT00938470|12226009|FG000|COMPLETED|Overall Study||27
11045520|NCT00938470|12226010|FG001|COMPLETED|Overall Study||25
11045521|NCT00938470|12226009|FG000|NOT COMPLETED|Overall Study||7
11045522|NCT00938470|12226010|FG001|NOT COMPLETED|Overall Study||3
11045523|NCT00938548|12226018|FG000|STARTED|Overall Study||35
11045524|NCT00938548|12226019|FG001|STARTED|Overall Study||35
11045525|NCT00938548|12226018|FG000|COMPLETED|Overall Study||35
11045526|NCT00938548|12226019|FG001|COMPLETED|Overall Study||35
11045527|NCT00938548|12226018|FG000|NOT COMPLETED|Overall Study||0
11045528|NCT00938548|12226019|FG001|NOT COMPLETED|Overall Study||0
11045529|NCT00938639|12226027|FG000|STARTED|Overall Study||120
11045530|NCT00938639|12226028|FG001|STARTED|Overall Study||120
11045531|NCT00938639|12226027|FG000|COMPLETED|Overall Study||117
11045532|NCT00938639|12226028|FG001|COMPLETED|Overall Study||116
11045533|NCT00938639|12226027|FG000|NOT COMPLETED|Overall Study||3
11045534|NCT00938639|12226028|FG001|NOT COMPLETED|Overall Study||4
11045535|NCT00938704|12226040|FG000|STARTED|Overall Study||33
11045536|NCT00938704|12226041|FG001|STARTED|Overall Study||37
11045537|NCT00938704|12226040|FG000|COMPLETED|Overall Study||33
11045538|NCT00938704|12226041|FG001|COMPLETED|Overall Study||37
11045539|NCT00938704|12226040|FG000|NOT COMPLETED|Overall Study||0
11045540|NCT00938704|12226041|FG001|NOT COMPLETED|Overall Study||0
11045541|NCT00938717|12226049|FG000|STARTED|Overall Study||403
11045542|NCT00938717|12226050|FG001|STARTED|Overall Study||402
11045543|NCT00938717|12226049|FG000|COMPLETED|Overall Study||305
11045544|NCT00938717|12226050|FG001|COMPLETED|Overall Study||294
11045545|NCT00938717|12226049|FG000|NOT COMPLETED|Overall Study||98
11045546|NCT00938717|12226050|FG001|NOT COMPLETED|Overall Study||108
11045547|NCT00938782|12226058|FG000|STARTED|Overall Study|Pre-induction of anesthesia|32
11045548|NCT00938782|12226059|FG001|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
11045549|NCT00938782|12226058|FG000|COMPLETED|Overall Study|Upon discharge from PACU|32
11045550|NCT00938782|12226059|FG001|COMPLETED|Overall Study|Upon discharge from PACU|35
11045551|NCT00938782|12226058|FG000|NOT COMPLETED|Overall Study||0
11045552|NCT00938782|12226059|FG001|NOT COMPLETED|Overall Study||0
11045553|NCT00938860|12226067|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
11045554|NCT00938860|12226068|FG001|STARTED|Overall Study||42
11045555|NCT00938860|12226067|FG000|Efficacy Population|Overall Study||40
11045556|NCT00938860|12226068|FG001|Efficacy Population|Overall Study||41
11045557|NCT00938860|12226067|FG000|COMPLETED|Overall Study||25
11045558|NCT00938860|12226068|FG001|COMPLETED|Overall Study||25
11045559|NCT00938860|12226067|FG000|NOT COMPLETED|Overall Study||25
11045560|NCT00938860|12226068|FG001|NOT COMPLETED|Overall Study||17
11045561|NCT00938886|12226076|FG000|STARTED|Overall Study||75
11045562|NCT00938886|12226077|FG001|STARTED|Overall Study||75
11045563|NCT00938886|12226076|FG000|Attended 1 Counseling Session|Overall Study||70
11045564|NCT00938886|12226077|FG001|Attended 1 Counseling Session|Overall Study||70
11045565|NCT00938886|12226076|FG000|COMPLETED|Overall Study||68
11045566|NCT00938886|12226077|FG001|COMPLETED|Overall Study||65
11045567|NCT00938886|12226076|FG000|NOT COMPLETED|Overall Study||7
11045568|NCT00938886|12226077|FG001|NOT COMPLETED|Overall Study||10
11045569|NCT00938964|12226085|FG000|STARTED|Overall Study||241
11045570|NCT00938964|12226086|FG001|STARTED|Overall Study||237
11045571|NCT00938964|12226085|FG000|COMPLETED|Overall Study||211
11045572|NCT00938964|12226086|FG001|COMPLETED|Overall Study||209
11045573|NCT00938964|12226085|FG000|NOT COMPLETED|Overall Study||30
11045574|NCT00938964|12226086|FG001|NOT COMPLETED|Overall Study||28
11045575|NCT00939003|12226094|FG000|STARTED|Double-blind Treatment Period||97
11045576|NCT00939003|12226095|FG001|STARTED|Double-blind Treatment Period||95
11045577|NCT00939003|12226094|FG000|COMPLETED|Double-blind Treatment Period||95
11045578|NCT00939003|12226095|FG001|COMPLETED|Double-blind Treatment Period||91
11045579|NCT00939003|12226094|FG000|NOT COMPLETED|Double-blind Treatment Period||2
11045580|NCT00939003|12226095|FG001|NOT COMPLETED|Double-blind Treatment Period||4
11045581|NCT00939003|12226094|FG000|STARTED|Open-label Treatment Period||95
11045582|NCT00939003|12226095|FG001|STARTED|Open-label Treatment Period||91
11045583|NCT00939003|12226094|FG000|COMPLETED|Open-label Treatment Period||66
11045584|NCT00939003|12226095|FG001|COMPLETED|Open-label Treatment Period||62
11045585|NCT00939003|12226094|FG000|NOT COMPLETED|Open-label Treatment Period||29
11045586|NCT00939003|12226095|FG001|NOT COMPLETED|Open-label Treatment Period||29
11045587|NCT00939029|12226106|FG000|STARTED|Overall Study||25
11045588|NCT00939029|12226107|FG001|STARTED|Overall Study||27
11045589|NCT00939029|12226106|FG000|COMPLETED|Overall Study||19
11045590|NCT00939029|12226107|FG001|COMPLETED|Overall Study||15
11045591|NCT00939029|12226106|FG000|NOT COMPLETED|Overall Study||6
11045592|NCT00939029|12226107|FG001|NOT COMPLETED|Overall Study||12
11045593|NCT00939055|12226115|FG000|STARTED|Overall Study||73
11045594|NCT00939055|12226116|FG001|STARTED|Overall Study||39
11045595|NCT00939055|12226115|FG000|COMPLETED|Overall Study||69
11045596|NCT00939055|12226116|FG001|COMPLETED|Overall Study||39
11045597|NCT00939055|12226115|FG000|NOT COMPLETED|Overall Study||4
11045598|NCT00939055|12226116|FG001|NOT COMPLETED|Overall Study||0
11045599|NCT00939094|12226125|FG000|STARTED|Overall Study||42
11045600|NCT00939094|12226126|FG001|STARTED|Overall Study||45
11045601|NCT00939094|12226125|FG000|COMPLETED|Overall Study||28
11045602|NCT00939094|12226126|FG001|COMPLETED|Overall Study||35
11045603|NCT00939094|12226125|FG000|NOT COMPLETED|Overall Study||14
11045604|NCT00939094|12226126|FG001|NOT COMPLETED|Overall Study||10
11045605|NCT00939107|12226134|FG000|STARTED|Overall Study||175
11045606|NCT00939107|12226135|FG001|STARTED|Overall Study||175
11045607|NCT00939107|12226134|FG000|12 Months Follow-up|Overall Study||161
11045608|NCT00939107|12226135|FG001|12 Months Follow-up|Overall Study||163
11045609|NCT00939107|12226134|FG000|COMPLETED|Overall Study||161
11045610|NCT00939107|12226135|FG001|COMPLETED|Overall Study||163
11045611|NCT00939107|12226134|FG000|NOT COMPLETED|Overall Study||14
11045612|NCT00939107|12226135|FG001|NOT COMPLETED|Overall Study||12
11045613|NCT00939120|12226143|FG000|STARTED|Overall Study||23
11045614|NCT00939120|12226144|FG001|STARTED|Overall Study||23
11045615|NCT00939120|12226143|FG000|COMPLETED|Overall Study||15
11045616|NCT00939120|12226144|FG001|COMPLETED|Overall Study||18
11045617|NCT00939120|12226143|FG000|NOT COMPLETED|Overall Study||8
11045618|NCT00939120|12226144|FG001|NOT COMPLETED|Overall Study||5
11045619|NCT00939159|12226150|FG000|STARTED|Overall Study||13
11045620|NCT00939159|12226150|FG000|COMPLETED|Overall Study||13
11045621|NCT00939159|12226150|FG000|NOT COMPLETED|Overall Study||0
11045622|NCT00939185|12226154|FG000|STARTED|Overall Study||400
11045623|NCT00939185|12226154|FG000|Received Treatment|Overall Study||390
11045624|NCT00939185|12226154|FG000|COMPLETED|Overall Study||375
11045625|NCT00939185|12226154|FG000|NOT COMPLETED|Overall Study||25
11045626|NCT00939198|12226158|FG000|STARTED|Overall Study||87
11045627|NCT00939198|12226158|FG000|COMPLETED|Overall Study||87
11045628|NCT00939198|12226158|FG000|NOT COMPLETED|Overall Study||0
11045629|NCT00939211|12226163|FG000|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
11045630|NCT00939211|12226163|FG000|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
11045631|NCT00939211|12226163|FG000|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
11045632|NCT00939211|12226163|FG000|STARTED|AZD9164 400 Mcg First, Then Placebo||28
11045633|NCT00939211|12226163|FG000|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
11045634|NCT00939211|12226163|FG000|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
11045635|NCT00939211|12226163|FG000|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
11045636|NCT00939211|12226163|FG000|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
11045637|NCT00939211|12226163|FG000|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
11045638|NCT00939211|12226163|FG000|STARTED|Spiriva 18 Mcg First, Then Placebo||28
11045639|NCT00939211|12226163|FG000|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
11045640|NCT00939211|12226163|FG000|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
11045641|NCT00939211|12226163|FG000|STARTED|Placebo||28
11045642|NCT00939211|12226163|FG000|COMPLETED|Placebo||28
11045643|NCT00939211|12226163|FG000|NOT COMPLETED|Placebo||0
11045644|NCT00939341|12226175|FG000|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
11045645|NCT00939341|12226175|FG000|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
11045646|NCT00939341|12226175|FG000|NOT COMPLETED|Overall Study||66
11057983|NCT01001078|12239726|FG001|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
11057984|NCT01001078|12239725|FG000|NOT COMPLETED|Overall Study||0
11057985|NCT01001078|12239726|FG001|NOT COMPLETED|Overall Study||0
11057986|NCT01001104|12239738|FG000|STARTED|Overall Study||35
11057987|NCT01001104|12239739|FG001|STARTED|Overall Study||37
11057988|NCT01001104|12239740|FG002|STARTED|Overall Study||36
11057989|NCT01001104|12239741|FG003|STARTED|Overall Study||37
11057990|NCT01001104|12239738|FG000|COMPLETED|Overall Study||33
11057991|NCT01001104|12239739|FG001|COMPLETED|Overall Study||36
11057992|NCT01001104|12239740|FG002|COMPLETED|Overall Study||35
11057993|NCT01001104|12239741|FG003|COMPLETED|Overall Study||34
11057994|NCT01001104|12239738|FG000|NOT COMPLETED|Overall Study||2
11057995|NCT01001104|12239739|FG001|NOT COMPLETED|Overall Study||1
11045647|NCT00939367|12226179|FG000|STARTED|First Intervention||15
11045648|NCT00939367|12226180|FG001|STARTED|First Intervention||15
11045649|NCT00939367|12226179|FG000|COMPLETED|First Intervention||15
11045650|NCT00939367|12226180|FG001|COMPLETED|First Intervention||15
11045651|NCT00939367|12226179|FG000|NOT COMPLETED|First Intervention||0
11045652|NCT00939367|12226180|FG001|NOT COMPLETED|First Intervention||0
11045653|NCT00939367|12226179|FG000|STARTED|Second Intervention||15
11045654|NCT00939367|12226180|FG001|STARTED|Second Intervention||15
11045655|NCT00939367|12226179|FG000|COMPLETED|Second Intervention||15
11045656|NCT00939367|12226180|FG001|COMPLETED|Second Intervention||15
11045657|NCT00939367|12226179|FG000|NOT COMPLETED|Second Intervention||0
11045658|NCT00939367|12226180|FG001|NOT COMPLETED|Second Intervention||0
11045659|NCT00939393|12226188|FG000|STARTED|Overall Study||37
11045660|NCT00939393|12226189|FG001|STARTED|Overall Study||35
11045661|NCT00939393|12226188|FG000|COMPLETED|Overall Study||33
11045662|NCT00939393|12226189|FG001|COMPLETED|Overall Study||35
11045663|NCT00939393|12226188|FG000|NOT COMPLETED|Overall Study||4
11045664|NCT00939393|12226189|FG001|NOT COMPLETED|Overall Study||0
11045665|NCT00939471|12226197|FG000|STARTED|Overall Study||44
11045666|NCT00939471|12226197|FG000|COMPLETED|Overall Study||33
11045667|NCT00939471|12226197|FG000|NOT COMPLETED|Overall Study||11
11045668|NCT00939484|12226204|FG000|STARTED|Overall Study||8
11045669|NCT00939484|12226205|FG001|STARTED|Overall Study||20
11045670|NCT00939484|12226206|FG002|STARTED|Overall Study||3
11045671|NCT00939484|12226204|FG000|COMPLETED|Overall Study||0
11045672|NCT00939484|12226205|FG001|COMPLETED|Overall Study||0
11045673|NCT00939484|12226206|FG002|COMPLETED|Overall Study||0
11045674|NCT00939484|12226204|FG000|NOT COMPLETED|Overall Study||8
11045675|NCT00939484|12226205|FG001|NOT COMPLETED|Overall Study||20
11045676|NCT00939484|12226206|FG002|NOT COMPLETED|Overall Study||3
11045677|NCT00939510|12226216|FG000|STARTED|Overall Study||32
11045678|NCT00939510|12226216|FG000|COMPLETED|Overall Study||31
11045679|NCT00939510|12226216|FG000|NOT COMPLETED|Overall Study||1
11045680|NCT00939523|12226220|FG000|STARTED|Overall Study||9
11045681|NCT00939523|12226220|FG000|COMPLETED|Overall Study||6
11045682|NCT00939523|12226220|FG000|NOT COMPLETED|Overall Study||3
11045683|NCT00939536|12226226|FG000|STARTED|First Intervention||12
11045684|NCT00939536|12226227|FG001|STARTED|First Intervention||12
11045685|NCT00939536|12226226|FG000|COMPLETED|First Intervention||12
11045686|NCT00939536|12226227|FG001|COMPLETED|First Intervention||12
11045687|NCT00939536|12226226|FG000|NOT COMPLETED|First Intervention||0
11045688|NCT00939536|12226227|FG001|NOT COMPLETED|First Intervention||0
11045689|NCT00939536|12226226|FG000|STARTED|Second Intervention||12
11045690|NCT00939536|12226227|FG001|STARTED|Second Intervention||12
11045691|NCT00939536|12226226|FG000|COMPLETED|Second Intervention||12
11045692|NCT00939536|12226227|FG001|COMPLETED|Second Intervention||12
11045693|NCT00939536|12226226|FG000|NOT COMPLETED|Second Intervention||0
11045694|NCT00939536|12226227|FG001|NOT COMPLETED|Second Intervention||0
11045695|NCT00939562|12226233|FG000|STARTED|Period 1||12
11045696|NCT00939562|12226234|FG001|STARTED|Period 1||12
11045697|NCT00939562|12226233|FG000|COMPLETED|Period 1||12
11045698|NCT00939562|12226234|FG001|COMPLETED|Period 1||12
11045699|NCT00939562|12226233|FG000|NOT COMPLETED|Period 1||0
11045700|NCT00939562|12226234|FG001|NOT COMPLETED|Period 1||0
11045701|NCT00939562|12226233|FG000|STARTED|Period 2||12
11045702|NCT00939562|12226234|FG001|STARTED|Period 2||12
11045703|NCT00939562|12226233|FG000|COMPLETED|Period 2||12
11045704|NCT00939562|12226234|FG001|COMPLETED|Period 2||12
11045705|NCT00939562|12226233|FG000|NOT COMPLETED|Period 2||0
11045706|NCT00939562|12226234|FG001|NOT COMPLETED|Period 2||0
11045707|NCT00939627|12226242|FG000|STARTED|Overall Study||27
11045708|NCT00939627|12226243|FG001|STARTED|Overall Study||28
11045709|NCT00939627|12226244|FG002|STARTED|Overall Study||0
11045710|NCT00939627|12226242|FG000|COMPLETED|Overall Study||0
11045711|NCT00939627|12226243|FG001|COMPLETED|Overall Study||0
11045712|NCT00939627|12226244|FG002|COMPLETED|Overall Study||0
11045713|NCT00939627|12226242|FG000|NOT COMPLETED|Overall Study||27
11045714|NCT00939627|12226243|FG001|NOT COMPLETED|Overall Study||28
11045715|NCT00939627|12226244|FG002|NOT COMPLETED|Overall Study||0
11045716|NCT00939640|12226250|FG000|STARTED|Overall Study||14
11045717|NCT00939640|12226250|FG000|COMPLETED|Overall Study||13
11045718|NCT00939640|12226250|FG000|NOT COMPLETED|Overall Study||1
11045719|NCT00939653|12226259|FG000|STARTED|Treatment Course 1||6
11045720|NCT00939653|12226259|FG000|COMPLETED|Treatment Course 1||6
11045721|NCT00939653|12226259|FG000|NOT COMPLETED|Treatment Course 1||0
11045722|NCT00939653|12226259|FG000|STARTED|Treatment Course 2||2
11045723|NCT00939653|12226259|FG000|COMPLETED|Treatment Course 2||2
11045724|NCT00939653|12226259|FG000|NOT COMPLETED|Treatment Course 2||0
11045725|NCT00939653|12226259|FG000|STARTED|Treatment Course 3||0
11045726|NCT00939653|12226259|FG000|COMPLETED|Treatment Course 3||0
11045727|NCT00939653|12226259|FG000|NOT COMPLETED|Treatment Course 3||0
11045728|NCT00939653|12226259|FG000|STARTED|Treatment Course 4||0
11045729|NCT00939653|12226259|FG000|COMPLETED|Treatment Course 4||0
11045730|NCT00939653|12226259|FG000|NOT COMPLETED|Treatment Course 4||0
11045731|NCT00939692|12226266|FG000|STARTED|Period 1 - First Intervention - 5 Days||13
11045732|NCT00939692|12226267|FG001|STARTED|Period 1 - First Intervention - 5 Days||13
11045733|NCT00939692|12226266|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||12
11045734|NCT00939692|12226267|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||13
11045735|NCT00939692|12226266|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
11045736|NCT00939692|12226267|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
11045737|NCT00939692|12226266|FG000|STARTED|Period 2 - Second Intervent - 5 Days||12
11045738|NCT00939692|12226267|FG001|STARTED|Period 2 - Second Intervent - 5 Days||13
11045739|NCT00939692|12226266|FG000|COMPLETED|Period 2 - Second Intervent - 5 Days||12
11045740|NCT00939692|12226267|FG001|COMPLETED|Period 2 - Second Intervent - 5 Days||12
11045741|NCT00939692|12226266|FG000|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
11045742|NCT00939692|12226267|FG001|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
11045743|NCT00939705|12226275|FG000|STARTED|Period 1 - First Intervention - 5 Days||9
11045744|NCT00939705|12226276|FG001|STARTED|Period 1 - First Intervention - 5 Days||9
11045745|NCT00939705|12226275|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||9
11045746|NCT00939705|12226276|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||9
11045747|NCT00939705|12226275|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
11045748|NCT00939705|12226276|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
11045749|NCT00939705|12226275|FG000|STARTED|Period 2 - Washout Period - 21 Days||9
11045750|NCT00939705|12226276|FG001|STARTED|Period 2 - Washout Period - 21 Days||9
11336721|NCT02882633|12534518|FG001|NOT COMPLETED|Overall Study||0
11336722|NCT02882711|12534524|FG000|STARTED|Overall Study||6
11336723|NCT02882711|12534524|FG000|COMPLETED|Overall Study||2
11336724|NCT02882711|12534524|FG000|NOT COMPLETED|Overall Study||4
11045751|NCT00939705|12226275|FG000|COMPLETED|Period 2 - Washout Period - 21 Days||9
11045752|NCT00939705|12226276|FG001|COMPLETED|Period 2 - Washout Period - 21 Days||9
11045753|NCT00939705|12226275|FG000|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
11336725|NCT02882854|12534530|FG000|STARTED|Overall Study||40
11201357|NCT01831921|12391607|FG001|6 Months|Overall Study||63
11045754|NCT00939705|12226276|FG001|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
11045755|NCT00939705|12226275|FG000|STARTED|Period 3 - Second Intervent - 5 Days||9
11045756|NCT00939705|12226276|FG001|STARTED|Period 3 - Second Intervent - 5 Days||9
11045757|NCT00939705|12226275|FG000|COMPLETED|Period 3 - Second Intervent - 5 Days||9
11045758|NCT00939705|12226276|FG001|COMPLETED|Period 3 - Second Intervent - 5 Days||9
11045759|NCT00939705|12226275|FG000|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
11045760|NCT00939705|12226276|FG001|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
11045761|NCT00939731|12226282|FG000|STARTED|First Intervention Period||12
11045762|NCT00939731|12226283|FG001|STARTED|First Intervention Period||12
11045763|NCT00939731|12226282|FG000|COMPLETED|First Intervention Period||12
11045764|NCT00939731|12226283|FG001|COMPLETED|First Intervention Period||12
11045765|NCT00939731|12226282|FG000|NOT COMPLETED|First Intervention Period||0
11045766|NCT00939731|12226283|FG001|NOT COMPLETED|First Intervention Period||0
11045767|NCT00939731|12226282|FG000|STARTED|Washout Period (at Least 14 Days)||12
11045768|NCT00939731|12226283|FG001|STARTED|Washout Period (at Least 14 Days)||12
11045769|NCT00939731|12226282|FG000|COMPLETED|Washout Period (at Least 14 Days)||12
11045770|NCT00939731|12226283|FG001|COMPLETED|Washout Period (at Least 14 Days)||12
11045771|NCT00939731|12226282|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11045772|NCT00939731|12226283|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11045773|NCT00939731|12226282|FG000|STARTED|Second Intervention Period||12
11045774|NCT00939731|12226283|FG001|STARTED|Second Intervention Period||12
11045775|NCT00939731|12226282|FG000|COMPLETED|Second Intervention Period||12
11045776|NCT00939731|12226283|FG001|COMPLETED|Second Intervention Period||12
11045777|NCT00939731|12226282|FG000|NOT COMPLETED|Second Intervention Period||0
11045778|NCT00939731|12226283|FG001|NOT COMPLETED|Second Intervention Period||0
11045779|NCT00939770|12226297|FG000|STARTED|Overall Study||6
11045780|NCT00939770|12226298|FG001|STARTED|Overall Study||8
11045781|NCT00939770|12226299|FG002|STARTED|Overall Study||23
11045782|NCT00939770|12226300|FG003|STARTED|Overall Study||12
11045783|NCT00939770|12226301|FG004|STARTED|Overall Study||38
11045784|NCT00939770|12226302|FG005|STARTED|Overall Study||11
11045785|NCT00939770|12226303|FG006|STARTED|Overall Study||14
11045786|NCT00939770|12226304|FG007|STARTED|Overall Study||10
11045787|NCT00939770|12226297|FG000|COMPLETED|Overall Study||1
11045788|NCT00939770|12226298|FG001|COMPLETED|Overall Study||0
11045789|NCT00939770|12226299|FG002|COMPLETED|Overall Study||3
11045790|NCT00939770|12226300|FG003|COMPLETED|Overall Study||1
11045791|NCT00939770|12226301|FG004|COMPLETED|Overall Study||1
11045792|NCT00939770|12226302|FG005|COMPLETED|Overall Study||0
11045793|NCT00939770|12226303|FG006|COMPLETED|Overall Study||0
11045794|NCT00939770|12226304|FG007|COMPLETED|Overall Study||0
11336726|NCT02882854|12534531|FG001|STARTED|Overall Study||44
11336727|NCT02882854|12534530|FG000|COMPLETED|Overall Study||39
11336728|NCT02882854|12534531|FG001|COMPLETED|Overall Study||41
11336729|NCT02882854|12534530|FG000|NOT COMPLETED|Overall Study||1
11336730|NCT02882854|12534531|FG001|NOT COMPLETED|Overall Study||3
11336731|NCT02883244|12534539|FG000|STARTED|Overall Study||24
11336732|NCT02883244|12534540|FG001|STARTED|Overall Study||26
11336733|NCT02883244|12534539|FG000|COMPLETED|Overall Study||24
11336734|NCT02883244|12534540|FG001|COMPLETED|Overall Study||25
11336735|NCT02883244|12534539|FG000|NOT COMPLETED|Overall Study||0
11336736|NCT02883244|12534540|FG001|NOT COMPLETED|Overall Study||1
11336737|NCT02883452|12534552|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13
11336738|NCT02883452|12534553|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11
11045795|NCT00939770|12226297|FG000|NOT COMPLETED|Overall Study||5
11045796|NCT00939770|12226298|FG001|NOT COMPLETED|Overall Study||8
11045797|NCT00939770|12226299|FG002|NOT COMPLETED|Overall Study||20
11045798|NCT00939770|12226300|FG003|NOT COMPLETED|Overall Study||11
11045799|NCT00939770|12226301|FG004|NOT COMPLETED|Overall Study||37
11045800|NCT00939770|12226302|FG005|NOT COMPLETED|Overall Study||11
11045801|NCT00939770|12226303|FG006|NOT COMPLETED|Overall Study||14
11336739|NCT02883452|12534554|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12
11336740|NCT02883452|12534555|FG003|STARTED|Overall Study|This cohort is only for Part 1.|8
11336741|NCT02883452|12534556|FG004|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|66
11336742|NCT02883452|12534557|FG005|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|65
11336743|NCT02883452|12534552|FG000|COMPLETED|Overall Study||8
11336744|NCT02883452|12534553|FG001|COMPLETED|Overall Study||9
11336745|NCT02883452|12534554|FG002|COMPLETED|Overall Study||7
11336746|NCT02883452|12534555|FG003|COMPLETED|Overall Study||6
11045802|NCT00939770|12226304|FG007|NOT COMPLETED|Overall Study||10
11045803|NCT00939783|12226335|FG000|STARTED|Overall Study||649
11045804|NCT00939783|12226335|FG000|Treated|Overall Study||648
11045805|NCT00939783|12226335|FG000|COMPLETED|Overall Study||0
11045806|NCT00939783|12226335|FG000|NOT COMPLETED|Overall Study||649
11045807|NCT00939796|12226339|FG000|STARTED|Overall Study||16
11045808|NCT00939796|12226339|FG000|COMPLETED|Overall Study||16
11045809|NCT00939796|12226339|FG000|NOT COMPLETED|Overall Study||0
11045810|NCT00939809|12226343|FG000|STARTED|Overall Study||31
11045811|NCT00939809|12226343|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
11045812|NCT00939809|12226343|FG000|NOT COMPLETED|Overall Study||3
11045813|NCT00939822|12226349|FG000|STARTED|Overall Study||44
11045814|NCT00939822|12226350|FG001|STARTED|Overall Study||44
11045815|NCT00939822|12226349|FG000|COMPLETED|Overall Study||42
11045816|NCT00939822|12226350|FG001|COMPLETED|Overall Study||41
11045817|NCT00939822|12226349|FG000|NOT COMPLETED|Overall Study||2
11045818|NCT00939822|12226350|FG001|NOT COMPLETED|Overall Study||3
11045819|NCT00939874|12226356|FG000|STARTED|Overall Study||52
11045820|NCT00939874|12226356|FG000|Completed Week 48|Overall Study||37
11045821|NCT00939874|12226356|FG000|COMPLETED|Overall Study||32
11045822|NCT00939874|12226356|FG000|NOT COMPLETED|Overall Study||20
11045823|NCT00939900|12226362|FG000|STARTED|Overall Study||55
11045824|NCT00939900|12226363|FG001|STARTED|Overall Study||55
11045825|NCT00939900|12226362|FG000|COMPLETED|Overall Study||53
11045826|NCT00939900|12226363|FG001|COMPLETED|Overall Study||48
11045827|NCT00939900|12226362|FG000|NOT COMPLETED|Overall Study||2
11045828|NCT00939900|12226363|FG001|NOT COMPLETED|Overall Study||7
11045829|NCT00939952|12226369|FG000|STARTED|Overall Study||7
11045830|NCT00939952|12226369|FG000|COMPLETED|Overall Study||7
11045831|NCT00939952|12226369|FG000|NOT COMPLETED|Overall Study||0
11045832|NCT00939991|12226375|FG000|STARTED|Overall Study||9
11045833|NCT00939991|12226376|FG001|STARTED|Overall Study||39
11045834|NCT00939991|12226375|FG000|COMPLETED|Overall Study||9
11045835|NCT00939991|12226376|FG001|COMPLETED|Overall Study||39
11045836|NCT00939991|12226375|FG000|NOT COMPLETED|Overall Study||0
11045837|NCT00939991|12226376|FG001|NOT COMPLETED|Overall Study||0
11045838|NCT00940017|12226382|FG000|STARTED|Overall Study||24
11045839|NCT00940017|12226382|FG000|Subjects Treated|Overall Study||21
11045840|NCT00940017|12226382|FG000|COMPLETED|Overall Study||20
11045841|NCT00940017|12226382|FG000|NOT COMPLETED|Overall Study||4
11045842|NCT00940108|12226390|FG000|STARTED|Overall Study||82
11045843|NCT00940108|12226391|FG001|STARTED|Overall Study||80
11045844|NCT00940108|12226392|FG002|STARTED|Overall Study||103
11045845|NCT00940108|12226393|FG003|STARTED|Overall Study||104
11045846|NCT00940108|12226390|FG000|COMPLETED|Overall Study||77
11045847|NCT00940108|12226391|FG001|COMPLETED|Overall Study||71
11045848|NCT00940108|12226392|FG002|COMPLETED|Overall Study||100
11045849|NCT00940108|12226393|FG003|COMPLETED|Overall Study||99
11045850|NCT00940108|12226390|FG000|NOT COMPLETED|Overall Study||5
11045851|NCT00940108|12226391|FG001|NOT COMPLETED|Overall Study||9
11045852|NCT00940108|12226392|FG002|NOT COMPLETED|Overall Study||3
11045853|NCT00940108|12226393|FG003|NOT COMPLETED|Overall Study||5
11045854|NCT00940290|12226407|FG000|STARTED|Overall Study||54
11045855|NCT00940290|12226408|FG001|STARTED|Overall Study||53
11045856|NCT00940290|12226409|FG002|STARTED|Overall Study||55
11045857|NCT00940290|12226410|FG003|STARTED|Overall Study||54
11045858|NCT00940290|12226407|FG000|COMPLETED|Overall Study||54
11045859|NCT00940290|12226408|FG001|COMPLETED|Overall Study||53
11045860|NCT00940290|12226409|FG002|COMPLETED|Overall Study||55
11045861|NCT00940290|12226410|FG003|COMPLETED|Overall Study||54
11045862|NCT00940290|12226407|FG000|NOT COMPLETED|Overall Study||0
11045863|NCT00940290|12226408|FG001|NOT COMPLETED|Overall Study||0
11045864|NCT00940290|12226409|FG002|NOT COMPLETED|Overall Study||0
11045865|NCT00940290|12226410|FG003|NOT COMPLETED|Overall Study||0
11045866|NCT00940316|12226423|FG000|STARTED|Reached First Response at 8 Weeks||13
11045867|NCT00940316|12226424|FG001|STARTED|Reached First Response at 8 Weeks||13
11336747|NCT02883452|12534556|FG004|COMPLETED|Overall Study||55
11045868|NCT00940316|12226425|FG002|STARTED|Reached First Response at 8 Weeks||2
11045869|NCT00940316|12226423|FG000|COMPLETED|Reached First Response at 8 Weeks||10
11045870|NCT00940316|12226424|FG001|COMPLETED|Reached First Response at 8 Weeks||9
11045871|NCT00940316|12226425|FG002|COMPLETED|Reached First Response at 8 Weeks||2
11045872|NCT00940316|12226423|FG000|NOT COMPLETED|Reached First Response at 8 Weeks||3
11045873|NCT00940316|12226424|FG001|NOT COMPLETED|Reached First Response at 8 Weeks||4
11045874|NCT00940316|12226425|FG002|NOT COMPLETED|Reached First Response at 8 Weeks||0
11045875|NCT00940316|12226423|FG000|STARTED|Moved on to be Treated Cycle 5||10
11045876|NCT00940316|12226424|FG001|STARTED|Moved on to be Treated Cycle 5||9
11045877|NCT00940316|12226425|FG002|STARTED|Moved on to be Treated Cycle 5||2
11045878|NCT00940316|12226423|FG000|COMPLETED|Moved on to be Treated Cycle 5||8
11045879|NCT00940316|12226424|FG001|COMPLETED|Moved on to be Treated Cycle 5||9
11045880|NCT00940316|12226425|FG002|COMPLETED|Moved on to be Treated Cycle 5||2
11045881|NCT00940316|12226423|FG000|NOT COMPLETED|Moved on to be Treated Cycle 5||2
11045882|NCT00940316|12226424|FG001|NOT COMPLETED|Moved on to be Treated Cycle 5||0
11045883|NCT00940316|12226425|FG002|NOT COMPLETED|Moved on to be Treated Cycle 5||0
11045884|NCT00940316|12226423|FG000|STARTED|Treated After Cycle 5||8
11045885|NCT00940316|12226424|FG001|STARTED|Treated After Cycle 5||9
11045886|NCT00940316|12226425|FG002|STARTED|Treated After Cycle 5||2
11045887|NCT00940316|12226423|FG000|COMPLETED|Treated After Cycle 5||8
11045888|NCT00940316|12226424|FG001|COMPLETED|Treated After Cycle 5||8
11045889|NCT00940316|12226425|FG002|COMPLETED|Treated After Cycle 5||1
11045890|NCT00940316|12226423|FG000|NOT COMPLETED|Treated After Cycle 5||0
11045891|NCT00940316|12226424|FG001|NOT COMPLETED|Treated After Cycle 5||1
11045892|NCT00940316|12226425|FG002|NOT COMPLETED|Treated After Cycle 5||1
11045893|NCT00940316|12226423|FG000|STARTED|Crossed Over to Arm A After Progression||0
11045894|NCT00940316|12226424|FG001|STARTED|Crossed Over to Arm A After Progression||3
11045895|NCT00940316|12226425|FG002|STARTED|Crossed Over to Arm A After Progression||0
11045896|NCT00940316|12226423|FG000|Treated for Cycle One|Crossed Over to Arm A After Progression||0
11045897|NCT00940316|12226424|FG001|Treated for Cycle One|Crossed Over to Arm A After Progression||3
11045898|NCT00940316|12226425|FG002|Treated for Cycle One|Crossed Over to Arm A After Progression||0
11045899|NCT00940316|12226423|FG000|COMPLETED|Crossed Over to Arm A After Progression||0
11045900|NCT00940316|12226424|FG001|COMPLETED|Crossed Over to Arm A After Progression||3
11045901|NCT00940316|12226425|FG002|COMPLETED|Crossed Over to Arm A After Progression||0
11045902|NCT00940316|12226423|FG000|NOT COMPLETED|Crossed Over to Arm A After Progression||0
11045903|NCT00940316|12226424|FG001|NOT COMPLETED|Crossed Over to Arm A After Progression||0
11045904|NCT00940316|12226425|FG002|NOT COMPLETED|Crossed Over to Arm A After Progression||0
11045905|NCT00940316|12226423|FG000|STARTED|Follow up Every 3 Months||13
11045906|NCT00940316|12226424|FG001|STARTED|Follow up Every 3 Months||13
11045907|NCT00940316|12226425|FG002|STARTED|Follow up Every 3 Months||2
11045908|NCT00940316|12226423|FG000|COMPLETED|Follow up Every 3 Months||13
11045909|NCT00940316|12226424|FG001|COMPLETED|Follow up Every 3 Months||13
11045910|NCT00940316|12226425|FG002|COMPLETED|Follow up Every 3 Months||2
11045911|NCT00940316|12226423|FG000|NOT COMPLETED|Follow up Every 3 Months||0
11045912|NCT00940316|12226424|FG001|NOT COMPLETED|Follow up Every 3 Months||0
11045913|NCT00940316|12226425|FG002|NOT COMPLETED|Follow up Every 3 Months||0
11045914|NCT00940342|12226444|FG000|STARTED|Overall Study||50
11045915|NCT00940342|12226445|FG001|STARTED|Overall Study||40
11045916|NCT00940342|12226446|FG002|STARTED|Overall Study||40
11045917|NCT00940342|12226444|FG000|COMPLETED|Overall Study||50
11045918|NCT00940342|12226445|FG001|COMPLETED|Overall Study||38
11045919|NCT00940342|12226446|FG002|COMPLETED|Overall Study||39
11045920|NCT00940342|12226444|FG000|NOT COMPLETED|Overall Study||0
11045921|NCT00940342|12226445|FG001|NOT COMPLETED|Overall Study||2
11045922|NCT00940342|12226446|FG002|NOT COMPLETED|Overall Study||1
11045923|NCT00940446|12226456|FG000|STARTED|Overall Study||30
11045924|NCT00940446|12226457|FG001|STARTED|Overall Study||30
11045925|NCT00940446|12226456|FG000|COMPLETED|Overall Study||30
11045926|NCT00940446|12226457|FG001|COMPLETED|Overall Study||30
11045927|NCT00940446|12226456|FG000|NOT COMPLETED|Overall Study||0
11045928|NCT00940446|12226457|FG001|NOT COMPLETED|Overall Study||0
11045929|NCT00940485|12226467|FG000|STARTED|Overall Study||97
11045930|NCT00940485|12226468|FG001|STARTED|Overall Study||100
11045931|NCT00940485|12226467|FG000|COMPLETED|Overall Study||82
11045932|NCT00940485|12226468|FG001|COMPLETED|Overall Study||93
11045933|NCT00940485|12226467|FG000|NOT COMPLETED|Overall Study||15
11045934|NCT00940485|12226468|FG001|NOT COMPLETED|Overall Study||7
11045935|NCT00940537|12226476|FG000|STARTED|Overall Study||5
11045936|NCT00940537|12226477|FG001|STARTED|Overall Study||9
11045937|NCT00940537|12226476|FG000|COMPLETED|Overall Study||5
11045938|NCT00940537|12226477|FG001|COMPLETED|Overall Study||9
11045939|NCT00940537|12226476|FG000|NOT COMPLETED|Overall Study||0
11045940|NCT00940537|12226477|FG001|NOT COMPLETED|Overall Study||0
11045941|NCT00940576|12226484|FG000|STARTED|Overall Study||8
11045942|NCT00940576|12226485|FG001|STARTED|Overall Study||9
11045943|NCT00940576|12226484|FG000|COMPLETED|Overall Study||8
11045944|NCT00940576|12226485|FG001|COMPLETED|Overall Study||9
11045945|NCT00940576|12226484|FG000|NOT COMPLETED|Overall Study||0
11045946|NCT00940576|12226485|FG001|NOT COMPLETED|Overall Study||0
11045947|NCT00940589|12226494|FG000|STARTED|Overall Study||39
11045948|NCT00940589|12226495|FG001|STARTED|Overall Study||34
11045949|NCT00940589|12226494|FG000|COMPLETED|Overall Study||31
11045950|NCT00940589|12226495|FG001|COMPLETED|Overall Study||29
11045951|NCT00940589|12226494|FG000|NOT COMPLETED|Overall Study||8
11045952|NCT00940589|12226495|FG001|NOT COMPLETED|Overall Study||5
11045953|NCT00940602|12226503|FG000|STARTED|Overall Study||149
11045954|NCT00940602|12226504|FG001|STARTED|Overall Study||76
11045955|NCT00940602|12226503|FG000|Safety Analysis Set|Overall Study||148
11045956|NCT00940602|12226504|FG001|Safety Analysis Set|Overall Study||76
11045957|NCT00940602|12226503|FG000|Full Analysis Set|Overall Study||149
11045958|NCT00940602|12226504|FG001|Full Analysis Set|Overall Study||76
11045959|NCT00940602|12226503|FG000|Treated|Overall Study||148
11045960|NCT00940602|12226504|FG001|Treated|Overall Study||76
11045961|NCT00940602|12226503|FG000|Untreated|Overall Study||1
11045962|NCT00940602|12226504|FG001|Untreated|Overall Study||0
11045963|NCT00940602|12226503|FG000|COMPLETED|Overall Study||0
11045964|NCT00940602|12226504|FG001|COMPLETED|Overall Study||0
11045965|NCT00940602|12226503|FG000|NOT COMPLETED|Overall Study||149
11045966|NCT00940602|12226504|FG001|NOT COMPLETED|Overall Study||76
11045967|NCT00940771|12226511|FG000|STARTED|Pre-Entry||10
11045968|NCT00940771|12226511|FG000|COMPLETED|Pre-Entry||10
11045969|NCT00940771|12226511|FG000|NOT COMPLETED|Pre-Entry||0
11045970|NCT00940771|12226511|FG000|STARTED|4 Weeks||10
11045971|NCT00940771|12226511|FG000|COMPLETED|4 Weeks||10
11045972|NCT00940771|12226511|FG000|NOT COMPLETED|4 Weeks||0
11045973|NCT00940771|12226511|FG000|STARTED|12 Weeks||10
11045974|NCT00940771|12226511|FG000|COMPLETED|12 Weeks||10
11045975|NCT00940771|12226511|FG000|NOT COMPLETED|12 Weeks||0
11045976|NCT00940771|12226511|FG000|STARTED|24 Weeks||10
11045977|NCT00940771|12226511|FG000|COMPLETED|24 Weeks||10
11045978|NCT00940771|12226511|FG000|NOT COMPLETED|24 Weeks||0
11045979|NCT00940823|12226517|FG000|STARTED|Overall Study||124
11045980|NCT00940823|12226518|FG001|STARTED|Overall Study||114
11045981|NCT00940823|12226517|FG000|COMPLETED|Overall Study||89
11045982|NCT00940823|12226518|FG001|COMPLETED|Overall Study||82
11045983|NCT00940823|12226517|FG000|NOT COMPLETED|Overall Study||35
11045984|NCT00940823|12226518|FG001|NOT COMPLETED|Overall Study||32
11045985|NCT00940875|12226528|FG000|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
11045986|NCT00940875|12226529|FG001|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
11045987|NCT00940875|12226528|FG000|COMPLETED|Treatment Phase||5
11045988|NCT00940875|12226529|FG001|COMPLETED|Treatment Phase||4
11045989|NCT00940875|12226528|FG000|NOT COMPLETED|Treatment Phase||26
11045990|NCT00940875|12226529|FG001|NOT COMPLETED|Treatment Phase||19
11045991|NCT00940875|12226528|FG000|STARTED|Post-Study Treatment||0
11045992|NCT00940875|12226529|FG001|STARTED|Post-Study Treatment||4
11045993|NCT00940875|12226528|FG000|COMPLETED|Post-Study Treatment||0
11045994|NCT00940875|12226529|FG001|COMPLETED|Post-Study Treatment||1
11045995|NCT00940875|12226528|FG000|NOT COMPLETED|Post-Study Treatment||0
11045996|NCT00940875|12226529|FG001|NOT COMPLETED|Post-Study Treatment||3
11045997|NCT00940888|12226536|FG000|STARTED|Overall Study|Total number of subjects consented|1701
11045998|NCT00940888|12226536|FG000|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
11045999|NCT00940888|12226536|FG000|NOT COMPLETED|Overall Study||835
11046000|NCT00940901|12226542|FG000|STARTED|Weeks 1-8 (Phase 1)||6
11046001|NCT00940901|12226543|FG001|STARTED|Weeks 1-8 (Phase 1)||7
11046002|NCT00940901|12226542|FG000|COMPLETED|Weeks 1-8 (Phase 1)||6
11046003|NCT00940901|12226543|FG001|COMPLETED|Weeks 1-8 (Phase 1)||7
11046004|NCT00940901|12226542|FG000|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
11046005|NCT00940901|12226543|FG001|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
11046006|NCT00940901|12226542|FG000|STARTED|Week 9-16 (Phase 2)||6
11046007|NCT00940901|12226543|FG001|STARTED|Week 9-16 (Phase 2)||7
11046008|NCT00940901|12226542|FG000|COMPLETED|Week 9-16 (Phase 2)||4
11046009|NCT00940901|12226543|FG001|COMPLETED|Week 9-16 (Phase 2)||4
11046010|NCT00940901|12226542|FG000|NOT COMPLETED|Week 9-16 (Phase 2)||2
11046011|NCT00940901|12226543|FG001|NOT COMPLETED|Week 9-16 (Phase 2)||3
11046012|NCT00940927|12226551|FG000|STARTED|Overall Study||81
11046013|NCT00940927|12226551|FG000|COMPLETED|Overall Study||81
11046014|NCT00940927|12226551|FG000|NOT COMPLETED|Overall Study||0
11046015|NCT00940992|12226558|FG000|STARTED|Overall Study||32
11046016|NCT00940992|12226559|FG001|STARTED|Overall Study||30
11046017|NCT00940992|12226560|FG002|STARTED|Overall Study||30
11046018|NCT00940992|12226558|FG000|COMPLETED|Overall Study||28
11046019|NCT00940992|12226559|FG001|COMPLETED|Overall Study||28
11046020|NCT00940992|12226560|FG002|COMPLETED|Overall Study||28
11046021|NCT00940992|12226558|FG000|NOT COMPLETED|Overall Study||4
11046022|NCT00940992|12226559|FG001|NOT COMPLETED|Overall Study||2
11046023|NCT00940992|12226560|FG002|NOT COMPLETED|Overall Study||2
11046024|NCT00941005|12226570|FG000|STARTED|Overall Study||61
11046025|NCT00941005|12226571|FG001|STARTED|Overall Study||61
11046026|NCT00941005|12226570|FG000|COMPLETED|Overall Study||61
11046027|NCT00941005|12226571|FG001|COMPLETED|Overall Study||61
11046028|NCT00941005|12226570|FG000|NOT COMPLETED|Overall Study||0
11336748|NCT02883452|12534557|FG005|COMPLETED|Overall Study||50
11336749|NCT02883452|12534552|FG000|NOT COMPLETED|Overall Study||5
11336750|NCT02883452|12534553|FG001|NOT COMPLETED|Overall Study||2
11336751|NCT02883452|12534554|FG002|NOT COMPLETED|Overall Study||5
11336752|NCT02883452|12534555|FG003|NOT COMPLETED|Overall Study||2
11336753|NCT02883452|12534556|FG004|NOT COMPLETED|Overall Study||11
11336754|NCT02883452|12534557|FG005|NOT COMPLETED|Overall Study||15
11336755|NCT02884089|12534572|FG000|STARTED|Period 1||11
11336756|NCT02884089|12534573|FG001|STARTED|Period 1||11
11336757|NCT02884089|12534574|FG002|STARTED|Period 1||9
11336758|NCT02884089|12534575|FG003|STARTED|Period 1||9
11336759|NCT02884089|12534572|FG000|Received at Least One Dose of Study Drug|Period 1||11
11336760|NCT02884089|12534573|FG001|Received at Least One Dose of Study Drug|Period 1||11
11336761|NCT02884089|12534574|FG002|Received at Least One Dose of Study Drug|Period 1||9
11336762|NCT02884089|12534575|FG003|Received at Least One Dose of Study Drug|Period 1||9
11336763|NCT02884089|12534572|FG000|COMPLETED|Period 1||9
11336764|NCT02884089|12534573|FG001|COMPLETED|Period 1||9
11336765|NCT02884089|12534574|FG002|COMPLETED|Period 1||9
11336766|NCT02884089|12534575|FG003|COMPLETED|Period 1||9
11336767|NCT02884089|12534572|FG000|NOT COMPLETED|Period 1||2
11336768|NCT02884089|12534573|FG001|NOT COMPLETED|Period 1||2
11336769|NCT02884089|12534574|FG002|NOT COMPLETED|Period 1||0
11336770|NCT02884089|12534575|FG003|NOT COMPLETED|Period 1||0
11336771|NCT02884089|12534572|FG000|STARTED|Washout Period 1||9
11336772|NCT02884089|12534573|FG001|STARTED|Washout Period 1||9
11046029|NCT00941005|12226571|FG001|NOT COMPLETED|Overall Study||0
11046030|NCT00941031|12226583|FG000|STARTED|Induction Period||66
11046031|NCT00941031|12226584|FG001|STARTED|Induction Period||138
11336773|NCT02884089|12534574|FG002|STARTED|Washout Period 1||9
11336774|NCT02884089|12534575|FG003|STARTED|Washout Period 1||9
11046032|NCT00941031|12226585|FG002|STARTED|Induction Period||133
11046033|NCT00941031|12226586|FG003|STARTED|Induction Period||67
11046034|NCT00941031|12226587|FG004|STARTED|Induction Period||0
11336775|NCT02884089|12534572|FG000|COMPLETED|Washout Period 1||9
11336776|NCT02884089|12534573|FG001|COMPLETED|Washout Period 1||7
11046035|NCT00941031|12226588|FG005|STARTED|Induction Period||0
11046036|NCT00941031|12226589|FG006|STARTED|Induction Period||0
11046037|NCT00941031|12226583|FG000|COMPLETED|Induction Period||61
11046038|NCT00941031|12226584|FG001|COMPLETED|Induction Period||134
11046039|NCT00941031|12226585|FG002|COMPLETED|Induction Period||127
11046040|NCT00941031|12226586|FG003|COMPLETED|Induction Period||58
11046041|NCT00941031|12226587|FG004|COMPLETED|Induction Period||0
11046042|NCT00941031|12226588|FG005|COMPLETED|Induction Period||0
11046043|NCT00941031|12226589|FG006|COMPLETED|Induction Period||0
11046044|NCT00941031|12226583|FG000|NOT COMPLETED|Induction Period||5
11046045|NCT00941031|12226584|FG001|NOT COMPLETED|Induction Period||4
11046046|NCT00941031|12226585|FG002|NOT COMPLETED|Induction Period||6
11046047|NCT00941031|12226586|FG003|NOT COMPLETED|Induction Period||9
11046048|NCT00941031|12226587|FG004|NOT COMPLETED|Induction Period||0
11046049|NCT00941031|12226588|FG005|NOT COMPLETED|Induction Period||0
11046050|NCT00941031|12226589|FG006|NOT COMPLETED|Induction Period||0
11046051|NCT00941031|12226583|FG000|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
11046052|NCT00941031|12226584|FG001|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
11046053|NCT00941031|12226585|FG002|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
11046054|NCT00941031|12226586|FG003|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
11046055|NCT00941031|12226587|FG004|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
11046056|NCT00941031|12226588|FG005|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
11046057|NCT00941031|12226589|FG006|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
11046058|NCT00941031|12226583|FG000|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
11046059|NCT00941031|12226584|FG001|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
11046060|NCT00941031|12226585|FG002|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
11046061|NCT00941031|12226586|FG003|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
11046062|NCT00941031|12226587|FG004|COMPLETED|Maintenance Period||56
11046063|NCT00941031|12226588|FG005|COMPLETED|Maintenance Period||61
11046064|NCT00941031|12226589|FG006|COMPLETED|Maintenance Period||204
11046065|NCT00941031|12226583|FG000|NOT COMPLETED|Maintenance Period||0
11046066|NCT00941031|12226584|FG001|NOT COMPLETED|Maintenance Period||0
11046067|NCT00941031|12226585|FG002|NOT COMPLETED|Maintenance Period||0
11046068|NCT00941031|12226586|FG003|NOT COMPLETED|Maintenance Period||0
11046069|NCT00941031|12226587|FG004|NOT COMPLETED|Maintenance Period||9
11046070|NCT00941031|12226588|FG005|NOT COMPLETED|Maintenance Period||6
11046071|NCT00941031|12226589|FG006|NOT COMPLETED|Maintenance Period||43
11046072|NCT00941070|12226608|FG000|STARTED|Overall Study||26
11046073|NCT00941070|12226608|FG000|COMPLETED|Overall Study||25
11046074|NCT00941070|12226608|FG000|NOT COMPLETED|Overall Study||1
11046075|NCT00941304|12226619|FG000|STARTED|Overall Study||31
11046076|NCT00941304|12226620|FG001|STARTED|Overall Study||30
11046077|NCT00941304|12226621|FG002|STARTED|Overall Study||31
11046078|NCT00941304|12226622|FG003|STARTED|Overall Study||30
11046079|NCT00941304|12226623|FG004|STARTED|Overall Study||31
11046080|NCT00941304|12226619|FG000|COMPLETED|Overall Study||30
11336777|NCT02884089|12534574|FG002|COMPLETED|Washout Period 1||9
11336778|NCT02884089|12534575|FG003|COMPLETED|Washout Period 1||8
11336779|NCT02884089|12534572|FG000|NOT COMPLETED|Washout Period 1||0
11336780|NCT02884089|12534573|FG001|NOT COMPLETED|Washout Period 1||2
11336781|NCT02884089|12534574|FG002|NOT COMPLETED|Washout Period 1||0
11336782|NCT02884089|12534575|FG003|NOT COMPLETED|Washout Period 1||1
11336783|NCT02884089|12534572|FG000|STARTED|Period 2||9
11046081|NCT00941304|12226620|FG001|COMPLETED|Overall Study||30
11046082|NCT00941304|12226621|FG002|COMPLETED|Overall Study||31
11046083|NCT00941304|12226622|FG003|COMPLETED|Overall Study||30
11046084|NCT00941304|12226623|FG004|COMPLETED|Overall Study||31
11046085|NCT00941304|12226619|FG000|NOT COMPLETED|Overall Study||1
11046086|NCT00941304|12226620|FG001|NOT COMPLETED|Overall Study||0
11046087|NCT00941304|12226621|FG002|NOT COMPLETED|Overall Study||0
11046088|NCT00941304|12226622|FG003|NOT COMPLETED|Overall Study||0
11046089|NCT00941304|12226623|FG004|NOT COMPLETED|Overall Study||0
11046090|NCT00941330|12226637|FG000|STARTED|Overall Study||15
11046091|NCT00941330|12226638|FG001|STARTED|Overall Study||11
11046092|NCT00941330|12226637|FG000|COMPLETED|Overall Study||14
11046093|NCT00941330|12226638|FG001|COMPLETED|Overall Study||9
11046094|NCT00941330|12226637|FG000|NOT COMPLETED|Overall Study||1
11046095|NCT00941330|12226638|FG001|NOT COMPLETED|Overall Study||2
11046096|NCT00941603|12226650|FG000|STARTED|Overall Study||104
11046097|NCT00941603|12226651|FG001|STARTED|Overall Study||105
11046098|NCT00941603|12226652|FG002|STARTED|Overall Study||104
11046099|NCT00941603|12226653|FG003|STARTED|Overall Study||104
11046100|NCT00941603|12226654|FG004|STARTED|Overall Study||105
11046101|NCT00941603|12226655|FG005|STARTED|Overall Study||97
11046102|NCT00941603|12226650|FG000|COMPLETED|Overall Study||93
11046103|NCT00941603|12226651|FG001|COMPLETED|Overall Study||89
11046104|NCT00941603|12226652|FG002|COMPLETED|Overall Study||99
11046105|NCT00941603|12226653|FG003|COMPLETED|Overall Study||100
11046106|NCT00941603|12226654|FG004|COMPLETED|Overall Study||101
11046107|NCT00941603|12226655|FG005|COMPLETED|Overall Study||94
11046108|NCT00941603|12226650|FG000|NOT COMPLETED|Overall Study||11
11046109|NCT00941603|12226651|FG001|NOT COMPLETED|Overall Study||16
11046110|NCT00941603|12226652|FG002|NOT COMPLETED|Overall Study||5
11046111|NCT00941603|12226653|FG003|NOT COMPLETED|Overall Study||4
11046112|NCT00941603|12226654|FG004|NOT COMPLETED|Overall Study||4
11046113|NCT00941603|12226655|FG005|NOT COMPLETED|Overall Study||3
11046114|NCT00941655|12226671|FG000|STARTED|Overall Study||8
11046115|NCT00941655|12226672|FG001|STARTED|Overall Study||7
11046116|NCT00941655|12226671|FG000|COMPLETED|Overall Study||3
11336784|NCT02884089|12534573|FG001|STARTED|Period 2||7
11336785|NCT02884089|12534574|FG002|STARTED|Period 2||9
11336786|NCT02884089|12534575|FG003|STARTED|Period 2||8
11336787|NCT02884089|12534572|FG000|COMPLETED|Period 2||8
11336788|NCT02884089|12534573|FG001|COMPLETED|Period 2||7
11336789|NCT02884089|12534574|FG002|COMPLETED|Period 2||9
11336790|NCT02884089|12534575|FG003|COMPLETED|Period 2||8
11336791|NCT02884089|12534572|FG000|NOT COMPLETED|Period 2||1
11336792|NCT02884089|12534573|FG001|NOT COMPLETED|Period 2||0
11336793|NCT02884089|12534574|FG002|NOT COMPLETED|Period 2||0
11336794|NCT02884089|12534575|FG003|NOT COMPLETED|Period 2||0
11336795|NCT02884089|12534572|FG000|STARTED|Washout Period 2||8
11336796|NCT02884089|12534573|FG001|STARTED|Washout Period 2||7
11336797|NCT02884089|12534574|FG002|STARTED|Washout Period 2||9
11336798|NCT02884089|12534575|FG003|STARTED|Washout Period 2||8
11336799|NCT02884089|12534572|FG000|COMPLETED|Washout Period 2||8
11336800|NCT02884089|12534573|FG001|COMPLETED|Washout Period 2||7
11336801|NCT02884089|12534574|FG002|COMPLETED|Washout Period 2||9
11336802|NCT02884089|12534575|FG003|COMPLETED|Washout Period 2||8
11336803|NCT02884089|12534572|FG000|NOT COMPLETED|Washout Period 2||0
11336804|NCT02884089|12534573|FG001|NOT COMPLETED|Washout Period 2||0
11336805|NCT02884089|12534574|FG002|NOT COMPLETED|Washout Period 2||0
11336806|NCT02884089|12534575|FG003|NOT COMPLETED|Washout Period 2||0
11336807|NCT02884089|12534572|FG000|STARTED|Period 3||8
11336808|NCT02884089|12534573|FG001|STARTED|Period 3||7
11336809|NCT02884089|12534574|FG002|STARTED|Period 3||9
11336810|NCT02884089|12534575|FG003|STARTED|Period 3||8
11336811|NCT02884089|12534572|FG000|COMPLETED|Period 3||8
11336812|NCT02884089|12534573|FG001|COMPLETED|Period 3||7
11336813|NCT02884089|12534574|FG002|COMPLETED|Period 3||8
11046117|NCT00941655|12226672|FG001|COMPLETED|Overall Study||2
11046118|NCT00941655|12226671|FG000|NOT COMPLETED|Overall Study||5
11046119|NCT00941655|12226672|FG001|NOT COMPLETED|Overall Study||5
11046120|NCT00941668|12226681|FG000|STARTED|Overall Study||24
11046121|NCT00941668|12226682|FG001|STARTED|Overall Study||25
11336814|NCT02884089|12534575|FG003|COMPLETED|Period 3||8
11336815|NCT02884089|12534572|FG000|NOT COMPLETED|Period 3||0
11336816|NCT02884089|12534573|FG001|NOT COMPLETED|Period 3||0
11336817|NCT02884089|12534574|FG002|NOT COMPLETED|Period 3||1
11336818|NCT02884089|12534575|FG003|NOT COMPLETED|Period 3||0
11336819|NCT02884089|12534572|FG000|STARTED|Washout Period 3||8
11046122|NCT00941668|12226681|FG000|COMPLETED|Overall Study||0
11046123|NCT00941668|12226682|FG001|COMPLETED|Overall Study||0
11336820|NCT02884089|12534573|FG001|STARTED|Washout Period 3||7
11336821|NCT02884089|12534574|FG002|STARTED|Washout Period 3||8
11336822|NCT02884089|12534575|FG003|STARTED|Washout Period 3||8
11336823|NCT02884089|12534572|FG000|COMPLETED|Washout Period 3||8
11336824|NCT02884089|12534573|FG001|COMPLETED|Washout Period 3||7
11336825|NCT02884089|12534574|FG002|COMPLETED|Washout Period 3||7
11336826|NCT02884089|12534575|FG003|COMPLETED|Washout Period 3||7
11336827|NCT02884089|12534572|FG000|NOT COMPLETED|Washout Period 3||0
11336828|NCT02884089|12534573|FG001|NOT COMPLETED|Washout Period 3||0
11336829|NCT02884089|12534574|FG002|NOT COMPLETED|Washout Period 3||1
11336830|NCT02884089|12534575|FG003|NOT COMPLETED|Washout Period 3||1
11336831|NCT02884089|12534572|FG000|STARTED|Period 4||8
11336832|NCT02884089|12534573|FG001|STARTED|Period 4||7
11336833|NCT02884089|12534574|FG002|STARTED|Period 4||7
11046124|NCT00941668|12226681|FG000|NOT COMPLETED|Overall Study||24
11046125|NCT00941668|12226682|FG001|NOT COMPLETED|Overall Study||25
11046126|NCT00941681|12226691|FG000|STARTED|Overall Study||12
11046127|NCT00941681|12226692|FG001|STARTED|Overall Study||11
11046128|NCT00941681|12226693|FG002|STARTED|Overall Study||12
11046129|NCT00941681|12226691|FG000|COMPLETED|Overall Study||12
11046130|NCT00941681|12226692|FG001|COMPLETED|Overall Study||10
11046131|NCT00941681|12226693|FG002|COMPLETED|Overall Study||12
11046132|NCT00941681|12226691|FG000|NOT COMPLETED|Overall Study||0
11046133|NCT00941681|12226692|FG001|NOT COMPLETED|Overall Study||1
11046134|NCT00941681|12226693|FG002|NOT COMPLETED|Overall Study||0
11046135|NCT00941720|12226701|FG000|STARTED|Overall Study||71
11046136|NCT00941720|12226701|FG000|COMPLETED|Overall Study||57
11046137|NCT00941720|12226701|FG000|NOT COMPLETED|Overall Study||14
11046138|NCT00941733|12226707|FG000|STARTED|Overall Study||239
11046139|NCT00941733|12226708|FG001|STARTED|Overall Study||119
11046140|NCT00941733|12226707|FG000|COMPLETED|Overall Study|1 year follow-up|165
11046141|NCT00941733|12226708|FG001|COMPLETED|Overall Study|1 year follow-up|91
11046142|NCT00941733|12226707|FG000|NOT COMPLETED|Overall Study||74
11046143|NCT00941733|12226708|FG001|NOT COMPLETED|Overall Study||28
11046144|NCT00941798|12226716|FG000|STARTED|Overall Study||755
11046145|NCT00941798|12226717|FG001|STARTED|Overall Study||763
11046146|NCT00941798|12226716|FG000|Full Analysis Set|Overall Study||749
11046147|NCT00941798|12226717|FG001|Full Analysis Set|Overall Study||759
11046148|NCT00941798|12226716|FG000|COMPLETED|Overall Study||561
11046149|NCT00941798|12226717|FG001|COMPLETED|Overall Study||578
11046150|NCT00941798|12226716|FG000|NOT COMPLETED|Overall Study||194
11046151|NCT00941798|12226717|FG001|NOT COMPLETED|Overall Study||185
11046152|NCT00941863|12226728|FG000|STARTED|Until Primary Completion Date (PCD)||7
11046153|NCT00941863|12226729|FG001|STARTED|Until Primary Completion Date (PCD)||3
11046154|NCT00941863|12226730|FG002|STARTED|Until Primary Completion Date (PCD)||12
11046155|NCT00941863|12226731|FG003|STARTED|Until Primary Completion Date (PCD)||17
11046156|NCT00941863|12226732|FG004|STARTED|Until Primary Completion Date (PCD)||119
11046157|NCT00941863|12226728|FG000|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
11046158|NCT00941863|12226729|FG001|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
11046159|NCT00941863|12226730|FG002|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
11046160|NCT00941863|12226731|FG003|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
11046161|NCT00941863|12226732|FG004|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
11046162|NCT00941863|12226728|FG000|COMPLETED|Until Primary Completion Date (PCD)||0
11046163|NCT00941863|12226729|FG001|COMPLETED|Until Primary Completion Date (PCD)||0
11046164|NCT00941863|12226730|FG002|COMPLETED|Until Primary Completion Date (PCD)||0
11046165|NCT00941863|12226731|FG003|COMPLETED|Until Primary Completion Date (PCD)||0
11046166|NCT00941863|12226732|FG004|COMPLETED|Until Primary Completion Date (PCD)||25
11046167|NCT00941863|12226728|FG000|NOT COMPLETED|Until Primary Completion Date (PCD)||7
11046168|NCT00941863|12226729|FG001|NOT COMPLETED|Until Primary Completion Date (PCD)||3
11046169|NCT00941863|12226730|FG002|NOT COMPLETED|Until Primary Completion Date (PCD)||12
11046170|NCT00941863|12226731|FG003|NOT COMPLETED|Until Primary Completion Date (PCD)||17
11046171|NCT00941863|12226732|FG004|NOT COMPLETED|Until Primary Completion Date (PCD)||94
11046172|NCT00941863|12226728|FG000|STARTED|Continued After PCD||0
11046173|NCT00941863|12226729|FG001|STARTED|Continued After PCD||0
11046174|NCT00941863|12226730|FG002|STARTED|Continued After PCD||0
11046175|NCT00941863|12226731|FG003|STARTED|Continued After PCD||0
11046176|NCT00941863|12226732|FG004|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
11046177|NCT00941863|12226728|FG000|COMPLETED|Continued After PCD||0
11046178|NCT00941863|12226729|FG001|COMPLETED|Continued After PCD||0
11046179|NCT00941863|12226730|FG002|COMPLETED|Continued After PCD||0
11046180|NCT00941863|12226731|FG003|COMPLETED|Continued After PCD||0
11046181|NCT00941863|12226732|FG004|COMPLETED|Continued After PCD||6
11046182|NCT00941863|12226728|FG000|NOT COMPLETED|Continued After PCD||0
11046183|NCT00941863|12226729|FG001|NOT COMPLETED|Continued After PCD||0
11046184|NCT00941863|12226730|FG002|NOT COMPLETED|Continued After PCD||0
11046185|NCT00941863|12226731|FG003|NOT COMPLETED|Continued After PCD||0
11046186|NCT00941863|12226732|FG004|NOT COMPLETED|Continued After PCD||19
11046187|NCT00941889|12226750|FG000|STARTED|Overall Study||17
11046188|NCT00941889|12226751|FG001|STARTED|Overall Study||15
11046189|NCT00941889|12226750|FG000|COMPLETED|Overall Study||5
11046190|NCT00941889|12226751|FG001|COMPLETED|Overall Study||3
11046191|NCT00941889|12226750|FG000|NOT COMPLETED|Overall Study||12
11046192|NCT00941889|12226751|FG001|NOT COMPLETED|Overall Study||12
11046193|NCT00941993|12226757|FG000|STARTED|Overall Study||109
11046194|NCT00941993|12226757|FG000|COMPLETED|Overall Study||109
11046195|NCT00941993|12226757|FG000|NOT COMPLETED|Overall Study||0
11046196|NCT00942084|12226762|FG000|STARTED|Overall Study||32
11046197|NCT00942084|12226762|FG000|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
11046198|NCT00942084|12226762|FG000|NOT COMPLETED|Overall Study||2
11046199|NCT00942149|12226766|FG000|STARTED|Overall Study||20
11046200|NCT00942149|12226766|FG000|COMPLETED|Overall Study||20
11046201|NCT00942149|12226766|FG000|NOT COMPLETED|Overall Study||0
11046202|NCT00942162|12226773|FG000|STARTED|Overall Study||71
11046203|NCT00942162|12226774|FG001|STARTED|Overall Study||50
11046204|NCT00942162|12226775|FG002|STARTED|Overall Study||2
11205228|NCT01857882|12395975|FG001|STARTED|Overall Study||20
11046205|NCT00942162|12226773|FG000|COMPLETED|Overall Study||1
11046206|NCT00942162|12226774|FG001|COMPLETED|Overall Study||0
11046207|NCT00942162|12226775|FG002|COMPLETED|Overall Study||0
11046208|NCT00942162|12226773|FG000|NOT COMPLETED|Overall Study||70
11046209|NCT00942162|12226774|FG001|NOT COMPLETED|Overall Study||50
11046210|NCT00942162|12226775|FG002|NOT COMPLETED|Overall Study||2
11046211|NCT00942175|12226789|FG000|STARTED|Overall Study||40
11046212|NCT00942175|12226790|FG001|STARTED|Overall Study||40
11046213|NCT00942175|12226791|FG002|STARTED|Overall Study||40
11046214|NCT00942175|12226792|FG003|STARTED|Overall Study||40
11046215|NCT00942175|12226789|FG000|COMPLETED|Overall Study||38
11046216|NCT00942175|12226790|FG001|COMPLETED|Overall Study||36
11046217|NCT00942175|12226791|FG002|COMPLETED|Overall Study||38
11046218|NCT00942175|12226792|FG003|COMPLETED|Overall Study||38
11046219|NCT00942175|12226789|FG000|NOT COMPLETED|Overall Study||2
11046220|NCT00942175|12226790|FG001|NOT COMPLETED|Overall Study||4
11046221|NCT00942175|12226791|FG002|NOT COMPLETED|Overall Study||2
11046222|NCT00942175|12226792|FG003|NOT COMPLETED|Overall Study||2
11046223|NCT00942188|12226814|FG000|STARTED|Overall Study||26
11046224|NCT00942188|12226815|FG001|STARTED|Overall Study||26
11046225|NCT00942188|12226816|FG002|STARTED|Overall Study||27
11046226|NCT00942188|12226817|FG003|STARTED|Overall Study||27
11046227|NCT00942188|12226814|FG000|COMPLETED|Overall Study||22
11046228|NCT00942188|12226815|FG001|COMPLETED|Overall Study||16
11046229|NCT00942188|12226816|FG002|COMPLETED|Overall Study||18
11046230|NCT00942188|12226817|FG003|COMPLETED|Overall Study||23
11046231|NCT00942188|12226814|FG000|NOT COMPLETED|Overall Study||4
11046232|NCT00942188|12226815|FG001|NOT COMPLETED|Overall Study||10
11046233|NCT00942188|12226816|FG002|NOT COMPLETED|Overall Study||9
11046234|NCT00942188|12226817|FG003|NOT COMPLETED|Overall Study||4
11046235|NCT00942266|12226829|FG000|STARTED|Overall Study||43
11046236|NCT00942266|12226830|FG001|STARTED|Overall Study||15
11046237|NCT00942266|12226829|FG000|COMPLETED|Overall Study||0
11046238|NCT00942266|12226830|FG001|COMPLETED|Overall Study||0
11046239|NCT00942266|12226829|FG000|NOT COMPLETED|Overall Study||43
11046240|NCT00942266|12226830|FG001|NOT COMPLETED|Overall Study||15
11046241|NCT00942305|12226846|FG000|STARTED|Overall Study||30
11046242|NCT00942305|12226847|FG001|STARTED|Overall Study||10
11046243|NCT00942305|12226848|FG002|STARTED|Overall Study||29
11046244|NCT00942305|12226849|FG003|STARTED|Overall Study||10
11046245|NCT00942305|12226850|FG004|STARTED|Overall Study||39
11046246|NCT00942305|12226851|FG005|STARTED|Overall Study||14
11046247|NCT00942305|12226852|FG006|STARTED|Overall Study||30
11046248|NCT00942305|12226853|FG007|STARTED|Overall Study||10
11046249|NCT00942305|12226854|FG008|STARTED|Overall Study||50
11046250|NCT00942305|12226855|FG009|STARTED|Overall Study||17
11046251|NCT00942305|12226846|FG000|COMPLETED|Overall Study||7
11046252|NCT00942305|12226847|FG001|COMPLETED|Overall Study||5
11046253|NCT00942305|12226848|FG002|COMPLETED|Overall Study||14
11046254|NCT00942305|12226849|FG003|COMPLETED|Overall Study||4
11046255|NCT00942305|12226850|FG004|COMPLETED|Overall Study||14
11046256|NCT00942305|12226851|FG005|COMPLETED|Overall Study||9
11046257|NCT00942305|12226852|FG006|COMPLETED|Overall Study||6
11046258|NCT00942305|12226853|FG007|COMPLETED|Overall Study||5
11046259|NCT00942305|12226854|FG008|COMPLETED|Overall Study||25
11046260|NCT00942305|12226855|FG009|COMPLETED|Overall Study||7
11046261|NCT00942305|12226846|FG000|NOT COMPLETED|Overall Study||23
11046262|NCT00942305|12226847|FG001|NOT COMPLETED|Overall Study||5
11046263|NCT00942305|12226848|FG002|NOT COMPLETED|Overall Study||15
11046264|NCT00942305|12226849|FG003|NOT COMPLETED|Overall Study||6
11046265|NCT00942305|12226850|FG004|NOT COMPLETED|Overall Study||25
11046266|NCT00942305|12226851|FG005|NOT COMPLETED|Overall Study||5
11046267|NCT00942305|12226852|FG006|NOT COMPLETED|Overall Study||24
11046268|NCT00942305|12226853|FG007|NOT COMPLETED|Overall Study||5
11046269|NCT00942305|12226854|FG008|NOT COMPLETED|Overall Study||25
11205229|NCT01857882|12395974|FG000|COMPLETED|Overall Study||21
11046270|NCT00942305|12226855|FG009|NOT COMPLETED|Overall Study||10
11046271|NCT00942357|12226879|FG000|STARTED|Overall Study||407
11046272|NCT00942357|12226880|FG001|STARTED|Overall Study||406
11046273|NCT00942357|12226879|FG000|COMPLETED|Overall Study||370
11046274|NCT00942357|12226880|FG001|COMPLETED|Overall Study||366
11046275|NCT00942357|12226879|FG000|NOT COMPLETED|Overall Study||37
11046276|NCT00942357|12226880|FG001|NOT COMPLETED|Overall Study||40
11046277|NCT00942422|12226886|FG000|STARTED|Overall Study||8
11046278|NCT00942422|12226886|FG000|COMPLETED|Overall Study||5
11046279|NCT00942422|12226886|FG000|NOT COMPLETED|Overall Study||3
11046280|NCT00942448|12226894|FG000|STARTED|Overall Study||77
11046281|NCT00942448|12226895|FG001|STARTED|Overall Study||76
11046282|NCT00942448|12226896|FG002|STARTED|Overall Study||78
11046283|NCT00942448|12226897|FG003|STARTED|Overall Study||75
11046284|NCT00942448|12226894|FG000|COMPLETED|Overall Study||77
11046285|NCT00942448|12226895|FG001|COMPLETED|Overall Study||76
11046286|NCT00942448|12226896|FG002|COMPLETED|Overall Study||78
11046287|NCT00942448|12226897|FG003|COMPLETED|Overall Study||75
11046288|NCT00942448|12226894|FG000|NOT COMPLETED|Overall Study||0
11046289|NCT00942448|12226895|FG001|NOT COMPLETED|Overall Study||0
11046290|NCT00942448|12226896|FG002|NOT COMPLETED|Overall Study||0
11046291|NCT00942448|12226897|FG003|NOT COMPLETED|Overall Study||0
11046292|NCT00942578|12226914|FG000|STARTED|Dose Escalation Phase||3
11046293|NCT00942578|12226915|FG001|STARTED|Dose Escalation Phase||3
11046294|NCT00942578|12226916|FG002|STARTED|Dose Escalation Phase||3
11046295|NCT00942578|12226914|FG000|COMPLETED|Dose Escalation Phase||3
11046296|NCT00942578|12226915|FG001|COMPLETED|Dose Escalation Phase||3
11046297|NCT00942578|12226916|FG002|COMPLETED|Dose Escalation Phase||3
11046298|NCT00942578|12226914|FG000|NOT COMPLETED|Dose Escalation Phase||0
11046299|NCT00942578|12226915|FG001|NOT COMPLETED|Dose Escalation Phase||0
11046300|NCT00942578|12226916|FG002|NOT COMPLETED|Dose Escalation Phase||0
11046301|NCT00942578|12226914|FG000|STARTED|Expansion Phase||11
11046302|NCT00942578|12226915|FG001|STARTED|Expansion Phase||0
11046303|NCT00942578|12226916|FG002|STARTED|Expansion Phase||43
11046304|NCT00942578|12226914|FG000|COMPLETED|Expansion Phase||11
11046305|NCT00942578|12226915|FG001|COMPLETED|Expansion Phase||0
11046306|NCT00942578|12226916|FG002|COMPLETED|Expansion Phase||43
11046307|NCT00942578|12226914|FG000|NOT COMPLETED|Expansion Phase||0
11046308|NCT00942578|12226915|FG001|NOT COMPLETED|Expansion Phase||0
11046309|NCT00942578|12226916|FG002|NOT COMPLETED|Expansion Phase||0
11046310|NCT00942604|12226931|FG000|STARTED|Overall Study||100
11046311|NCT00942604|12226932|FG001|STARTED|Overall Study||103
11046312|NCT00942604|12226931|FG000|COMPLETED|Overall Study||98
11046313|NCT00942604|12226932|FG001|COMPLETED|Overall Study||99
11046314|NCT00942604|12226931|FG000|NOT COMPLETED|Overall Study||2
11046315|NCT00942604|12226932|FG001|NOT COMPLETED|Overall Study||4
11046316|NCT00942708|12226938|FG000|STARTED|Overall Study||6
11046317|NCT00942708|12226938|FG000|COMPLETED|Overall Study||5
11046318|NCT00942708|12226938|FG000|NOT COMPLETED|Overall Study||1
11046319|NCT00942734|12226943|FG000|STARTED|Overall Study||43
11046320|NCT00942734|12226943|FG000|COMPLETED|Overall Study||35
11046321|NCT00942734|12226943|FG000|NOT COMPLETED|Overall Study||8
11046322|NCT00942786|12226947|FG000|STARTED|Overall Study||297
11046323|NCT00942786|12226947|FG000|COMPLETED|Overall Study|date of last follow-up|297
11046324|NCT00942786|12226947|FG000|NOT COMPLETED|Overall Study||0
11336834|NCT02884089|12534575|FG003|STARTED|Period 4||7
11336835|NCT02884089|12534572|FG000|COMPLETED|Period 4||7
11336836|NCT02884089|12534573|FG001|COMPLETED|Period 4||6
11336837|NCT02884089|12534574|FG002|COMPLETED|Period 4||7
11336838|NCT02884089|12534575|FG003|COMPLETED|Period 4||7
11336839|NCT02884089|12534572|FG000|NOT COMPLETED|Period 4||1
11336840|NCT02884089|12534573|FG001|NOT COMPLETED|Period 4||1
11336841|NCT02884089|12534574|FG002|NOT COMPLETED|Period 4||0
11336842|NCT02884089|12534575|FG003|NOT COMPLETED|Period 4||0
11336843|NCT02884089|12534572|FG000|STARTED|Follow-up Visit||7
11046325|NCT00942825|12226956|FG000|STARTED|Overall Study||97
11046326|NCT00942825|12226957|FG001|STARTED|Overall Study||98
11046327|NCT00942825|12226956|FG000|COMPLETED|Overall Study||97
11046328|NCT00942825|12226957|FG001|COMPLETED|Overall Study||98
11046329|NCT00942825|12226956|FG000|NOT COMPLETED|Overall Study||0
11336844|NCT02884089|12534573|FG001|STARTED|Follow-up Visit||6
11336845|NCT02884089|12534574|FG002|STARTED|Follow-up Visit||7
11336846|NCT02884089|12534575|FG003|STARTED|Follow-up Visit||7
11336847|NCT02884089|12534572|FG000|COMPLETED|Follow-up Visit||6
11336848|NCT02884089|12534573|FG001|COMPLETED|Follow-up Visit||6
11336849|NCT02884089|12534574|FG002|COMPLETED|Follow-up Visit||7
11046330|NCT00942825|12226957|FG001|NOT COMPLETED|Overall Study||0
11046331|NCT00942851|12226965|FG000|STARTED|Overall Study||12
11046332|NCT00942851|12226966|FG001|STARTED|Overall Study||12
11046333|NCT00942851|12226965|FG000|COMPLETED|Overall Study||12
11046334|NCT00942851|12226966|FG001|COMPLETED|Overall Study||11
11046335|NCT00942851|12226965|FG000|NOT COMPLETED|Overall Study||0
11046336|NCT00942851|12226966|FG001|NOT COMPLETED|Overall Study||1
11046337|NCT00942890|12226978|FG000|STARTED|Overall Study||21
11046338|NCT00942890|12226979|FG001|STARTED|Overall Study||23
11046339|NCT00942890|12226978|FG000|COMPLETED|Overall Study||21
11046340|NCT00942890|12226979|FG001|COMPLETED|Overall Study||23
11046341|NCT00942890|12226978|FG000|NOT COMPLETED|Overall Study||0
11046342|NCT00942890|12226979|FG001|NOT COMPLETED|Overall Study||0
11046343|NCT00942903|12226986|FG000|STARTED|Overall Study||20
11046344|NCT00942903|12226986|FG000|COMPLETED|Overall Study||20
11046345|NCT00942903|12226986|FG000|NOT COMPLETED|Overall Study||0
11046346|NCT00942968|12226990|FG000|STARTED|Overall Study||338
11046347|NCT00942968|12226990|FG000|Treated|Overall Study||334
11046348|NCT00942968|12226990|FG000|COMPLETED|Overall Study||109
11046349|NCT00942968|12226990|FG000|NOT COMPLETED|Overall Study||229
11046350|NCT00942994|12226996|FG000|STARTED|Overall Study||203
11046351|NCT00942994|12226997|FG001|STARTED|Overall Study||209
11046352|NCT00942994|12226996|FG000|COMPLETED|Overall Study||187
11046353|NCT00942994|12226997|FG001|COMPLETED|Overall Study||190
11046354|NCT00942994|12226996|FG000|NOT COMPLETED|Overall Study||16
11046355|NCT00942994|12226997|FG001|NOT COMPLETED|Overall Study||19
11046356|NCT00943072|12227005|FG000|STARTED|Overall Study||115
11046357|NCT00943072|12227006|FG001|STARTED|Overall Study||74
11046358|NCT00943072|12227005|FG000|Participants Received Treatment|Overall Study|Safety population (SAF)|114
11046359|NCT00943072|12227006|FG001|Participants Received Treatment|Overall Study||74
11046360|NCT00943072|12227005|FG000|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
11046361|NCT00943072|12227006|FG001|Full Analysis Set (FAS) Population|Overall Study||73
11046362|NCT00943072|12227005|FG000|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
11046363|NCT00943072|12227006|FG001|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
11046364|NCT00943072|12227005|FG000|NOT COMPLETED|Overall Study||5
11046365|NCT00943072|12227006|FG001|NOT COMPLETED|Overall Study||14
11046366|NCT00943098|12227016|FG000|STARTED|Overall Study||70
11046367|NCT00943098|12227017|FG001|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
11046368|NCT00943098|12227016|FG000|COMPLETED|Overall Study||70
11046369|NCT00943098|12227017|FG001|COMPLETED|Overall Study||72
11046370|NCT00943098|12227016|FG000|NOT COMPLETED|Overall Study||0
11046371|NCT00943098|12227017|FG001|NOT COMPLETED|Overall Study||0
11046372|NCT00943111|12227025|FG000|STARTED|52-Weeks Primary Analysis Period||106
11046373|NCT00943111|12227026|FG001|STARTED|52-Weeks Primary Analysis Period||54
11046374|NCT00943111|12227027|FG002|STARTED|52-Weeks Primary Analysis Period||0
11046375|NCT00943111|12227025|FG000|Treated|52-Weeks Primary Analysis Period||106
11046376|NCT00943111|12227026|FG001|Treated|52-Weeks Primary Analysis Period||53
11046377|NCT00943111|12227027|FG002|Treated|52-Weeks Primary Analysis Period||0
11046378|NCT00943111|12227025|FG000|COMPLETED|52-Weeks Primary Analysis Period||104
11046379|NCT00943111|12227026|FG001|COMPLETED|52-Weeks Primary Analysis Period||52
11046380|NCT00943111|12227027|FG002|COMPLETED|52-Weeks Primary Analysis Period||0
11046381|NCT00943111|12227025|FG000|NOT COMPLETED|52-Weeks Primary Analysis Period||2
11046382|NCT00943111|12227026|FG001|NOT COMPLETED|52-Weeks Primary Analysis Period||2
11046383|NCT00943111|12227027|FG002|NOT COMPLETED|52-Weeks Primary Analysis Period||0
11046384|NCT00943111|12227025|FG000|STARTED|5 Years Long-term Treatment Period||0
11046385|NCT00943111|12227026|FG001|STARTED|5 Years Long-term Treatment Period||0
11046386|NCT00943111|12227027|FG002|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
11046387|NCT00943111|12227025|FG000|COMPLETED|5 Years Long-term Treatment Period||0
11046388|NCT00943111|12227026|FG001|COMPLETED|5 Years Long-term Treatment Period||0
11046389|NCT00943111|12227027|FG002|COMPLETED|5 Years Long-term Treatment Period||77
11046390|NCT00943111|12227025|FG000|NOT COMPLETED|5 Years Long-term Treatment Period||0
11046391|NCT00943111|12227026|FG001|NOT COMPLETED|5 Years Long-term Treatment Period||0
11046392|NCT00943111|12227027|FG002|NOT COMPLETED|5 Years Long-term Treatment Period||75
11046393|NCT00943124|12227034|FG000|STARTED|Period 1||110
11046394|NCT00943124|12227035|FG001|STARTED|Period 1||110
11046395|NCT00943124|12227034|FG000|COMPLETED|Period 1||108
11046396|NCT00943124|12227035|FG001|COMPLETED|Period 1||108
11046397|NCT00943124|12227034|FG000|NOT COMPLETED|Period 1||2
11046398|NCT00943124|12227035|FG001|NOT COMPLETED|Period 1||2
11046399|NCT00943124|12227034|FG000|STARTED|Period 2||108
11046400|NCT00943124|12227035|FG001|STARTED|Period 2||108
11046401|NCT00943124|12227034|FG000|COMPLETED|Period 2||108
11046402|NCT00943124|12227035|FG001|COMPLETED|Period 2||108
11046403|NCT00943124|12227034|FG000|NOT COMPLETED|Period 2||0
11046404|NCT00943124|12227035|FG001|NOT COMPLETED|Period 2||0
11046405|NCT00943150|12227043|FG000|STARTED|Overall Study||10
11046406|NCT00943150|12227044|FG001|STARTED|Overall Study||10
11046407|NCT00943150|12227043|FG000|COMPLETED|Overall Study||10
11046408|NCT00943150|12227044|FG001|COMPLETED|Overall Study||10
11046409|NCT00943150|12227043|FG000|NOT COMPLETED|Overall Study||0
11046410|NCT00943150|12227044|FG001|NOT COMPLETED|Overall Study||0
11046411|NCT00943202|12227058|FG000|STARTED|Overall Study||133
11046412|NCT00943202|12227059|FG001|STARTED|Overall Study||133
11046413|NCT00943202|12227060|FG002|STARTED|Overall Study||133
11046414|NCT00943202|12227061|FG003|STARTED|Overall Study||132
11046415|NCT00943202|12227058|FG000|COMPLETED|Overall Study||132
11046416|NCT00943202|12227059|FG001|COMPLETED|Overall Study||131
11046417|NCT00943202|12227060|FG002|COMPLETED|Overall Study||133
11046418|NCT00943202|12227061|FG003|COMPLETED|Overall Study||131
11046419|NCT00943202|12227058|FG000|NOT COMPLETED|Overall Study||1
11046420|NCT00943202|12227059|FG001|NOT COMPLETED|Overall Study||2
11046421|NCT00943202|12227060|FG002|NOT COMPLETED|Overall Study||0
11046422|NCT00943202|12227061|FG003|NOT COMPLETED|Overall Study||1
11046423|NCT00943306|12227072|FG000|STARTED|Overall Study||19
11046424|NCT00943306|12227072|FG000|COMPLETED|Overall Study||16
11046425|NCT00943306|12227072|FG000|NOT COMPLETED|Overall Study||3
11046426|NCT00943319|12227076|FG000|STARTED|Overall Study||50
11046427|NCT00943319|12227076|FG000|COMPLETED|Overall Study||49
11046428|NCT00943319|12227076|FG000|NOT COMPLETED|Overall Study||1
11046429|NCT00943384|12227080|FG000|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
11046430|NCT00943384|12227080|FG000|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
11046431|NCT00943384|12227080|FG000|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
11046432|NCT00943384|12227080|FG000|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
11046433|NCT00943384|12227080|FG000|NOT COMPLETED|Overall Study||49
11046434|NCT00943436|12227086|FG000|STARTED|Exercise Session: 45 Minutes of Activity||10
11046435|NCT00943436|12227087|FG001|STARTED|Exercise Session: 45 Minutes of Activity||10
11046436|NCT00943436|12227086|FG000|COMPLETED|Exercise Session: 45 Minutes of Activity||10
11046437|NCT00943436|12227087|FG001|COMPLETED|Exercise Session: 45 Minutes of Activity||10
11046438|NCT00943436|12227086|FG000|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
11046439|NCT00943436|12227087|FG001|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
11046440|NCT00943436|12227086|FG000|STARTED|Rest Session: 45 Minutes of Reading||10
11046441|NCT00943436|12227087|FG001|STARTED|Rest Session: 45 Minutes of Reading||10
11046442|NCT00943436|12227086|FG000|COMPLETED|Rest Session: 45 Minutes of Reading||10
11046443|NCT00943436|12227087|FG001|COMPLETED|Rest Session: 45 Minutes of Reading||10
11046444|NCT00943436|12227086|FG000|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
11046445|NCT00943436|12227087|FG001|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
11046446|NCT00943488|12227095|FG000|STARTED|Overall Study||204
11046447|NCT00943488|12227096|FG001|STARTED|Overall Study||204
11046448|NCT00943488|12227095|FG000|COMPLETED|Overall Study||203
11046449|NCT00943488|12227096|FG001|COMPLETED|Overall Study||202
11046450|NCT00943488|12227095|FG000|NOT COMPLETED|Overall Study||1
11046451|NCT00943488|12227096|FG001|NOT COMPLETED|Overall Study||2
11046452|NCT00943579|12227104|FG000|STARTED|Overall Study||21
11046453|NCT00943579|12227105|FG001|STARTED|Overall Study||20
11046454|NCT00943579|12227104|FG000|COMPLETED|Overall Study||15
11046455|NCT00943579|12227105|FG001|COMPLETED|Overall Study||15
11046456|NCT00943579|12227104|FG000|NOT COMPLETED|Overall Study||6
11046457|NCT00943579|12227105|FG001|NOT COMPLETED|Overall Study||5
11046458|NCT00943592|12227114|FG000|STARTED|Overall Study||82
11046459|NCT00943592|12227114|FG000|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
11046460|NCT00943592|12227114|FG000|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
11046461|NCT00943592|12227114|FG000|NOT COMPLETED|Overall Study||3
11046462|NCT00943631|12227120|FG000|STARTED|Overall Study||202
11046463|NCT00943631|12227121|FG001|STARTED|Overall Study||204
11046464|NCT00943631|12227120|FG000|COMPLETED|Overall Study||198
11046465|NCT00943631|12227121|FG001|COMPLETED|Overall Study||202
11046466|NCT00943631|12227120|FG000|NOT COMPLETED|Overall Study||4
11046467|NCT00943631|12227121|FG001|NOT COMPLETED|Overall Study||2
11046468|NCT00943670|12227127|FG000|STARTED|Single-agent Trastuzumab Emtansine||51
11046469|NCT00943670|12227127|FG000|Treated|Single-agent Trastuzumab Emtansine||51
11046470|NCT00943670|12227127|FG000|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
11046471|NCT00943670|12227127|FG000|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
11046472|NCT00943670|12227127|FG000|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
11057996|NCT01001104|12239740|FG002|NOT COMPLETED|Overall Study||1
11046473|NCT00943670|12227127|FG000|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
11046474|NCT00943670|12227127|FG000|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
11046475|NCT00943735|12227142|FG000|STARTED|Overall Study||774
11046476|NCT00943735|12227142|FG000|Per Protocol Population|Overall Study||500
11046477|NCT00943735|12227142|FG000|COMPLETED|Overall Study||742
11046478|NCT00943735|12227142|FG000|NOT COMPLETED|Overall Study||32
11046479|NCT00943761|12227148|FG000|STARTED|Overall Study||21
11046480|NCT00943761|12227149|FG001|STARTED|Overall Study||24
11046481|NCT00943761|12227148|FG000|COMPLETED|Overall Study||17
11046482|NCT00943761|12227149|FG001|COMPLETED|Overall Study||23
11046483|NCT00943761|12227148|FG000|NOT COMPLETED|Overall Study||4
11046484|NCT00943761|12227149|FG001|NOT COMPLETED|Overall Study||1
11046485|NCT00943787|12227155|FG000|STARTED|Overall Study||41
11046486|NCT00943787|12227155|FG000|COMPLETED|Overall Study||34
11046487|NCT00943787|12227155|FG000|NOT COMPLETED|Overall Study||7
11046488|NCT00943800|12227159|FG000|STARTED|Overall Study||87
11046489|NCT00943800|12227159|FG000|COMPLETED|Overall Study||87
11046490|NCT00943800|12227159|FG000|NOT COMPLETED|Overall Study||0
11046491|NCT00943826|12227165|FG000|STARTED|Concurrent Phase||458
11046492|NCT00943826|12227166|FG001|STARTED|Concurrent Phase||463
11046493|NCT00943826|12227165|FG000|Treated|Concurrent Phase||452
11046494|NCT00943826|12227166|FG001|Treated|Concurrent Phase||459
11046495|NCT00943826|12227165|FG000|COMPLETED|Concurrent Phase||397
11046496|NCT00943826|12227166|FG001|COMPLETED|Concurrent Phase||421
11046497|NCT00943826|12227165|FG000|NOT COMPLETED|Concurrent Phase||61
11046498|NCT00943826|12227166|FG001|NOT COMPLETED|Concurrent Phase||42
11046499|NCT00943826|12227165|FG000|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
11046500|NCT00943826|12227166|FG001|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
11046501|NCT00943826|12227165|FG000|COMPLETED|Maintenance Phase||353
11046502|NCT00943826|12227166|FG001|COMPLETED|Maintenance Phase||331
11046503|NCT00943826|12227165|FG000|NOT COMPLETED|Maintenance Phase||43
11046504|NCT00943826|12227166|FG001|NOT COMPLETED|Maintenance Phase||39
11046505|NCT00943826|12227165|FG000|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
11046506|NCT00943826|12227166|FG001|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
11046507|NCT00943826|12227165|FG000|COMPLETED|Monotherapy Phase||204
11046508|NCT00943826|12227166|FG001|COMPLETED|Monotherapy Phase||143
11046509|NCT00943826|12227165|FG000|NOT COMPLETED|Monotherapy Phase||65
11046510|NCT00943826|12227166|FG001|NOT COMPLETED|Monotherapy Phase||16
11046511|NCT00943826|12227165|FG000|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
11046512|NCT00943826|12227166|FG001|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
11046513|NCT00943826|12227165|FG000|COMPLETED|After Primary Overall Survival Analysis||0
11046514|NCT00943826|12227166|FG001|COMPLETED|After Primary Overall Survival Analysis||0
11046515|NCT00943826|12227165|FG000|NOT COMPLETED|After Primary Overall Survival Analysis||27
11046516|NCT00943826|12227166|FG001|NOT COMPLETED|After Primary Overall Survival Analysis||20
11046517|NCT00943878|12227177|FG000|STARTED|Overall Study||202
11046518|NCT00943878|12227178|FG001|STARTED|Overall Study||200
11046519|NCT00943878|12227179|FG002|STARTED|Overall Study||203
11046520|NCT00943878|12227180|FG003|STARTED|Overall Study||200
11046521|NCT00943878|12227177|FG000|COMPLETED|Overall Study||200
11046522|NCT00943878|12227178|FG001|COMPLETED|Overall Study||198
11046523|NCT00943878|12227179|FG002|COMPLETED|Overall Study||197
11046524|NCT00943878|12227180|FG003|COMPLETED|Overall Study||198
11046525|NCT00943878|12227177|FG000|NOT COMPLETED|Overall Study||2
11046526|NCT00943878|12227178|FG001|NOT COMPLETED|Overall Study||2
11046527|NCT00943878|12227179|FG002|NOT COMPLETED|Overall Study||6
11046528|NCT00943878|12227180|FG003|NOT COMPLETED|Overall Study||2
11046529|NCT00943904|12227190|FG000|STARTED|Overall Study||31
11046530|NCT00943904|12227190|FG000|COMPLETED|Overall Study||31
11046531|NCT00943904|12227190|FG000|NOT COMPLETED|Overall Study||0
11046532|NCT00943917|12227209|FG000|STARTED|Stage I||51
11046533|NCT00943917|12227210|FG001|STARTED|Stage I||51
11046534|NCT00943917|12227211|FG002|STARTED|Stage I||53
11046535|NCT00943917|12227212|FG003|STARTED|Stage I||0
11046536|NCT00943917|12227213|FG004|STARTED|Stage I||0
11046537|NCT00943917|12227214|FG005|STARTED|Stage I||0
11046538|NCT00943917|12227215|FG006|STARTED|Stage I||0
11046539|NCT00943917|12227216|FG007|STARTED|Stage I||0
11046540|NCT00943917|12227217|FG008|STARTED|Stage I||0
11046541|NCT00943917|12227218|FG009|STARTED|Stage I||0
11046542|NCT00943917|12227219|FG010|STARTED|Stage I||0
11046543|NCT00943917|12227220|FG011|STARTED|Stage I||0
11046544|NCT00943917|12227221|FG012|STARTED|Stage I||0
11046545|NCT00943917|12227222|FG013|STARTED|Stage I||0
11046546|NCT00943917|12227223|FG014|STARTED|Stage I||0
11046547|NCT00943917|12227209|FG000|COMPLETED|Stage I||47
11046548|NCT00943917|12227210|FG001|COMPLETED|Stage I||48
11046549|NCT00943917|12227211|FG002|COMPLETED|Stage I||47
11046550|NCT00943917|12227212|FG003|COMPLETED|Stage I||0
11046551|NCT00943917|12227213|FG004|COMPLETED|Stage I||0
11046552|NCT00943917|12227214|FG005|COMPLETED|Stage I||0
11046553|NCT00943917|12227215|FG006|COMPLETED|Stage I||0
11046554|NCT00943917|12227216|FG007|COMPLETED|Stage I||0
11046555|NCT00943917|12227217|FG008|COMPLETED|Stage I||0
11046556|NCT00943917|12227218|FG009|COMPLETED|Stage I||0
11046557|NCT00943917|12227219|FG010|COMPLETED|Stage I||0
11046558|NCT00943917|12227220|FG011|COMPLETED|Stage I||0
11046559|NCT00943917|12227221|FG012|COMPLETED|Stage I||0
11046560|NCT00943917|12227222|FG013|COMPLETED|Stage I||0
11046561|NCT00943917|12227223|FG014|COMPLETED|Stage I||0
11046562|NCT00943917|12227209|FG000|NOT COMPLETED|Stage I||4
11046563|NCT00943917|12227210|FG001|NOT COMPLETED|Stage I||3
11046564|NCT00943917|12227211|FG002|NOT COMPLETED|Stage I||6
11046565|NCT00943917|12227212|FG003|NOT COMPLETED|Stage I||0
11046566|NCT00943917|12227213|FG004|NOT COMPLETED|Stage I||0
11046567|NCT00943917|12227214|FG005|NOT COMPLETED|Stage I||0
11046568|NCT00943917|12227215|FG006|NOT COMPLETED|Stage I||0
11046569|NCT00943917|12227216|FG007|NOT COMPLETED|Stage I||0
11046570|NCT00943917|12227217|FG008|NOT COMPLETED|Stage I||0
11046571|NCT00943917|12227218|FG009|NOT COMPLETED|Stage I||0
11046572|NCT00943917|12227219|FG010|NOT COMPLETED|Stage I||0
11046573|NCT00943917|12227220|FG011|NOT COMPLETED|Stage I||0
11046574|NCT00943917|12227221|FG012|NOT COMPLETED|Stage I||0
11046575|NCT00943917|12227222|FG013|NOT COMPLETED|Stage I||0
11046576|NCT00943917|12227223|FG014|NOT COMPLETED|Stage I||0
11046577|NCT00943917|12227209|FG000|STARTED|Stage II||0
11046578|NCT00943917|12227210|FG001|STARTED|Stage II||0
11046579|NCT00943917|12227211|FG002|STARTED|Stage II||0
11046580|NCT00943917|12227212|FG003|STARTED|Stage II||20
11046581|NCT00943917|12227213|FG004|STARTED|Stage II||21
11046582|NCT00943917|12227214|FG005|STARTED|Stage II||23
11046583|NCT00943917|12227215|FG006|STARTED|Stage II||23
11046584|NCT00943917|12227216|FG007|STARTED|Stage II||23
11046585|NCT00943917|12227217|FG008|STARTED|Stage II||21
11046586|NCT00943917|12227218|FG009|STARTED|Stage II||0
11046587|NCT00943917|12227219|FG010|STARTED|Stage II||0
11046588|NCT00943917|12227220|FG011|STARTED|Stage II||0
11046589|NCT00943917|12227221|FG012|STARTED|Stage II||0
11046590|NCT00943917|12227222|FG013|STARTED|Stage II||0
11046591|NCT00943917|12227223|FG014|STARTED|Stage II||0
11046592|NCT00943917|12227209|FG000|COMPLETED|Stage II||0
11046593|NCT00943917|12227210|FG001|COMPLETED|Stage II||0
11046594|NCT00943917|12227211|FG002|COMPLETED|Stage II||0
11046595|NCT00943917|12227212|FG003|COMPLETED|Stage II||20
11046596|NCT00943917|12227213|FG004|COMPLETED|Stage II||21
11046597|NCT00943917|12227214|FG005|COMPLETED|Stage II||20
11046598|NCT00943917|12227215|FG006|COMPLETED|Stage II||20
11046599|NCT00943917|12227216|FG007|COMPLETED|Stage II||23
11046600|NCT00943917|12227217|FG008|COMPLETED|Stage II||20
11046601|NCT00943917|12227218|FG009|COMPLETED|Stage II||0
11046602|NCT00943917|12227219|FG010|COMPLETED|Stage II||0
11046603|NCT00943917|12227220|FG011|COMPLETED|Stage II||0
11046604|NCT00943917|12227221|FG012|COMPLETED|Stage II||0
11046605|NCT00943917|12227222|FG013|COMPLETED|Stage II||0
11046606|NCT00943917|12227223|FG014|COMPLETED|Stage II||0
11046607|NCT00943917|12227209|FG000|NOT COMPLETED|Stage II||0
11046608|NCT00943917|12227210|FG001|NOT COMPLETED|Stage II||0
11046609|NCT00943917|12227211|FG002|NOT COMPLETED|Stage II||0
11046610|NCT00943917|12227212|FG003|NOT COMPLETED|Stage II||0
11046611|NCT00943917|12227213|FG004|NOT COMPLETED|Stage II||0
11046612|NCT00943917|12227214|FG005|NOT COMPLETED|Stage II||3
11046613|NCT00943917|12227215|FG006|NOT COMPLETED|Stage II||3
11046614|NCT00943917|12227216|FG007|NOT COMPLETED|Stage II||0
11046615|NCT00943917|12227217|FG008|NOT COMPLETED|Stage II||1
11046616|NCT00943917|12227218|FG009|NOT COMPLETED|Stage II||0
11046617|NCT00943917|12227219|FG010|NOT COMPLETED|Stage II||0
11046618|NCT00943917|12227220|FG011|NOT COMPLETED|Stage II||0
11046619|NCT00943917|12227221|FG012|NOT COMPLETED|Stage II||0
11046620|NCT00943917|12227222|FG013|NOT COMPLETED|Stage II||0
11046621|NCT00943917|12227223|FG014|NOT COMPLETED|Stage II||0
11046622|NCT00943917|12227209|FG000|STARTED|Stage II Continuation||0
11046623|NCT00943917|12227210|FG001|STARTED|Stage II Continuation||0
11046624|NCT00943917|12227211|FG002|STARTED|Stage II Continuation||0
11046625|NCT00943917|12227212|FG003|STARTED|Stage II Continuation||0
11046626|NCT00943917|12227213|FG004|STARTED|Stage II Continuation||0
11046627|NCT00943917|12227214|FG005|STARTED|Stage II Continuation||0
11046628|NCT00943917|12227215|FG006|STARTED|Stage II Continuation||0
11046629|NCT00943917|12227216|FG007|STARTED|Stage II Continuation||0
11046630|NCT00943917|12227217|FG008|STARTED|Stage II Continuation||0
11046631|NCT00943917|12227218|FG009|STARTED|Stage II Continuation||15
11046632|NCT00943917|12227219|FG010|STARTED|Stage II Continuation||15
11046633|NCT00943917|12227220|FG011|STARTED|Stage II Continuation||13
11046634|NCT00943917|12227221|FG012|STARTED|Stage II Continuation||16
11046635|NCT00943917|12227222|FG013|STARTED|Stage II Continuation||15
11046636|NCT00943917|12227223|FG014|STARTED|Stage II Continuation||12
11046637|NCT00943917|12227209|FG000|COMPLETED|Stage II Continuation||0
11046638|NCT00943917|12227210|FG001|COMPLETED|Stage II Continuation||0
11046639|NCT00943917|12227211|FG002|COMPLETED|Stage II Continuation||0
11046640|NCT00943917|12227212|FG003|COMPLETED|Stage II Continuation||0
11046641|NCT00943917|12227213|FG004|COMPLETED|Stage II Continuation||0
11046642|NCT00943917|12227214|FG005|COMPLETED|Stage II Continuation||0
11046643|NCT00943917|12227215|FG006|COMPLETED|Stage II Continuation||0
11046644|NCT00943917|12227216|FG007|COMPLETED|Stage II Continuation||0
11046645|NCT00943917|12227217|FG008|COMPLETED|Stage II Continuation||0
11046646|NCT00943917|12227218|FG009|COMPLETED|Stage II Continuation||14
11046647|NCT00943917|12227219|FG010|COMPLETED|Stage II Continuation||15
11046648|NCT00943917|12227220|FG011|COMPLETED|Stage II Continuation||11
11046649|NCT00943917|12227221|FG012|COMPLETED|Stage II Continuation||13
11046650|NCT00943917|12227222|FG013|COMPLETED|Stage II Continuation||12
11046651|NCT00943917|12227223|FG014|COMPLETED|Stage II Continuation||8
11046652|NCT00943917|12227209|FG000|NOT COMPLETED|Stage II Continuation||0
11046653|NCT00943917|12227210|FG001|NOT COMPLETED|Stage II Continuation||0
11046654|NCT00943917|12227211|FG002|NOT COMPLETED|Stage II Continuation||0
11046655|NCT00943917|12227212|FG003|NOT COMPLETED|Stage II Continuation||0
11046656|NCT00943917|12227213|FG004|NOT COMPLETED|Stage II Continuation||0
11046657|NCT00943917|12227214|FG005|NOT COMPLETED|Stage II Continuation||0
11046658|NCT00943917|12227215|FG006|NOT COMPLETED|Stage II Continuation||0
11046659|NCT00943917|12227216|FG007|NOT COMPLETED|Stage II Continuation||0
11046660|NCT00943917|12227217|FG008|NOT COMPLETED|Stage II Continuation||0
11046661|NCT00943917|12227218|FG009|NOT COMPLETED|Stage II Continuation||1
11046662|NCT00943917|12227219|FG010|NOT COMPLETED|Stage II Continuation||0
11046663|NCT00943917|12227220|FG011|NOT COMPLETED|Stage II Continuation||2
11046664|NCT00943917|12227221|FG012|NOT COMPLETED|Stage II Continuation||3
11046665|NCT00943917|12227222|FG013|NOT COMPLETED|Stage II Continuation||3
11046666|NCT00943917|12227223|FG014|NOT COMPLETED|Stage II Continuation||4
11057997|NCT01001104|12239741|FG003|NOT COMPLETED|Overall Study||3
11057998|NCT01001169|12239756|FG000|STARTED|Overall Study||30
11057999|NCT01001169|12239757|FG001|STARTED|Overall Study||30
11058000|NCT01001169|12239756|FG000|COMPLETED|Overall Study||28
11058001|NCT01001169|12239757|FG001|COMPLETED|Overall Study||29
11058002|NCT01001169|12239756|FG000|NOT COMPLETED|Overall Study||2
11058003|NCT01001169|12239757|FG001|NOT COMPLETED|Overall Study||1
11058004|NCT01001195|12239775|FG000|STARTED|Overall Study||39
11058005|NCT01001195|12239776|FG001|STARTED|Overall Study||41
11058006|NCT01001195|12239777|FG002|STARTED|Overall Study||44
11058007|NCT01001195|12239778|FG003|STARTED|Overall Study||41
11058008|NCT01001195|12239775|FG000|COMPLETED|Overall Study||37
11058009|NCT01001195|12239776|FG001|COMPLETED|Overall Study||39
11058010|NCT01001195|12239777|FG002|COMPLETED|Overall Study||44
11058011|NCT01001195|12239778|FG003|COMPLETED|Overall Study||41
11058012|NCT01001195|12239775|FG000|NOT COMPLETED|Overall Study||2
11058013|NCT01001195|12239776|FG001|NOT COMPLETED|Overall Study||2
11058014|NCT01001195|12239777|FG002|NOT COMPLETED|Overall Study||0
11058015|NCT01001195|12239778|FG003|NOT COMPLETED|Overall Study||0
11058016|NCT01001208|12239790|FG000|STARTED|Overall Study||239
11058017|NCT01001208|12239791|FG001|STARTED|Overall Study||239
11058018|NCT01001208|12239790|FG000|COMPLETED|Overall Study||211
11058019|NCT01001208|12239791|FG001|COMPLETED|Overall Study||206
11058020|NCT01001208|12239790|FG000|NOT COMPLETED|Overall Study||28
11058021|NCT01001208|12239791|FG001|NOT COMPLETED|Overall Study||33
11058022|NCT01001221|12239801|FG000|STARTED|Overall Study||5
11058023|NCT01001221|12239802|FG001|STARTED|Overall Study||5
11058024|NCT01001221|12239803|FG002|STARTED|Overall Study||3
11058025|NCT01001221|12239804|FG003|STARTED|Overall Study||6
11058026|NCT01001221|12239805|FG004|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
11058027|NCT01001221|12239801|FG000|Treated|Overall Study||5
11058028|NCT01001221|12239802|FG001|Treated|Overall Study||5
11058029|NCT01001221|12239803|FG002|Treated|Overall Study||2
11058030|NCT01001221|12239804|FG003|Treated|Overall Study||6
11058031|NCT01001221|12239805|FG004|Treated|Overall Study||0
11058032|NCT01001221|12239801|FG000|Completed 1st Treatment Cycle|Overall Study||5
11058033|NCT01001221|12239802|FG001|Completed 1st Treatment Cycle|Overall Study||5
11058034|NCT01001221|12239803|FG002|Completed 1st Treatment Cycle|Overall Study||2
11058035|NCT01001221|12239804|FG003|Completed 1st Treatment Cycle|Overall Study||6
11058036|NCT01001221|12239805|FG004|Completed 1st Treatment Cycle|Overall Study||0
11058037|NCT01001221|12239801|FG000|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
11058038|NCT01001221|12239802|FG001|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
11058039|NCT01001221|12239803|FG002|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
11058040|NCT01001221|12239804|FG003|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
11058041|NCT01001221|12239805|FG004|COMPLETED|Overall Study||0
11058042|NCT01001221|12239801|FG000|NOT COMPLETED|Overall Study||5
11058043|NCT01001221|12239802|FG001|NOT COMPLETED|Overall Study||5
11058044|NCT01001221|12239803|FG002|NOT COMPLETED|Overall Study||3
11058045|NCT01001221|12239804|FG003|NOT COMPLETED|Overall Study||6
11058046|NCT01001221|12239805|FG004|NOT COMPLETED|Overall Study||0
11058047|NCT01001299|12239816|FG000|STARTED|Overall Study||25
11058048|NCT01001299|12239816|FG000|COMPLETED|Overall Study||0
11058049|NCT01001299|12239816|FG000|NOT COMPLETED|Overall Study||25
11058050|NCT01001325|12239822|FG000|STARTED|Overall Study||234
11058051|NCT01001325|12239823|FG001|STARTED|Overall Study||234
11058052|NCT01001325|12239822|FG000|COMPLETED|Overall Study||216
11058053|NCT01001325|12239823|FG001|COMPLETED|Overall Study||224
11058054|NCT01001325|12239822|FG000|NOT COMPLETED|Overall Study||18
11058055|NCT01001325|12239823|FG001|NOT COMPLETED|Overall Study||10
11058056|NCT01001403|12239831|FG000|STARTED|Overall Study||31
11046667|NCT00944021|12227261|FG000|STARTED|Overall Study||15
11046668|NCT00944021|12227262|FG001|STARTED|Overall Study||15
11046669|NCT00944021|12227263|FG002|STARTED|Overall Study||15
11046670|NCT00944021|12227264|FG003|STARTED|Overall Study||16
11046671|NCT00944021|12227265|FG004|STARTED|Overall Study||8
11046672|NCT00944021|12227261|FG000|COMPLETED|Overall Study||14
11046673|NCT00944021|12227262|FG001|COMPLETED|Overall Study||15
11046674|NCT00944021|12227263|FG002|COMPLETED|Overall Study||15
11046675|NCT00944021|12227264|FG003|COMPLETED|Overall Study||16
11046676|NCT00944021|12227265|FG004|COMPLETED|Overall Study||8
11046677|NCT00944021|12227261|FG000|NOT COMPLETED|Overall Study||1
11046678|NCT00944021|12227262|FG001|NOT COMPLETED|Overall Study||0
11046679|NCT00944021|12227263|FG002|NOT COMPLETED|Overall Study||0
11046680|NCT00944021|12227264|FG003|NOT COMPLETED|Overall Study||0
11046681|NCT00944021|12227265|FG004|NOT COMPLETED|Overall Study||0
11046682|NCT00944034|12227289|FG000|STARTED|Overall Study||188
11046683|NCT00944034|12227290|FG001|STARTED|Overall Study||157
11046684|NCT00944034|12227291|FG002|STARTED|Overall Study||152
11046685|NCT00944034|12227292|FG003|STARTED|Overall Study||174
11046686|NCT00944034|12227293|FG004|STARTED|Overall Study||164
11046687|NCT00944034|12227294|FG005|STARTED|Overall Study||143
11046688|NCT00944034|12227295|FG006|STARTED|Overall Study||106
11046689|NCT00944034|12227296|FG007|STARTED|Overall Study||78
11046690|NCT00944034|12227297|FG008|STARTED|Overall Study||73
11046691|NCT00944034|12227298|FG009|STARTED|Overall Study||246
11046692|NCT00944034|12227299|FG010|STARTED|Overall Study||51
11046693|NCT00944034|12227300|FG011|STARTED|Overall Study||56
11046694|NCT00944034|12227289|FG000|COMPLETED|Overall Study||183
11046695|NCT00944034|12227290|FG001|COMPLETED|Overall Study||150
11046696|NCT00944034|12227291|FG002|COMPLETED|Overall Study||143
11046697|NCT00944034|12227292|FG003|COMPLETED|Overall Study||170
11046698|NCT00944034|12227293|FG004|COMPLETED|Overall Study||150
11046699|NCT00944034|12227294|FG005|COMPLETED|Overall Study||123
11046700|NCT00944034|12227295|FG006|COMPLETED|Overall Study||102
11046701|NCT00944034|12227296|FG007|COMPLETED|Overall Study||73
11046702|NCT00944034|12227297|FG008|COMPLETED|Overall Study||63
11046703|NCT00944034|12227298|FG009|COMPLETED|Overall Study||236
11046704|NCT00944034|12227299|FG010|COMPLETED|Overall Study||50
11046705|NCT00944034|12227300|FG011|COMPLETED|Overall Study||52
11046706|NCT00944034|12227289|FG000|NOT COMPLETED|Overall Study||5
11046707|NCT00944034|12227290|FG001|NOT COMPLETED|Overall Study||7
11046708|NCT00944034|12227291|FG002|NOT COMPLETED|Overall Study||9
11046709|NCT00944034|12227292|FG003|NOT COMPLETED|Overall Study||4
11046710|NCT00944034|12227293|FG004|NOT COMPLETED|Overall Study||14
11046711|NCT00944034|12227294|FG005|NOT COMPLETED|Overall Study||20
11046712|NCT00944034|12227295|FG006|NOT COMPLETED|Overall Study||4
11046713|NCT00944034|12227296|FG007|NOT COMPLETED|Overall Study||5
11046714|NCT00944034|12227297|FG008|NOT COMPLETED|Overall Study||10
11046715|NCT00944034|12227298|FG009|NOT COMPLETED|Overall Study||10
11046716|NCT00944034|12227299|FG010|NOT COMPLETED|Overall Study||1
11046717|NCT00944034|12227300|FG011|NOT COMPLETED|Overall Study||4
11046718|NCT00944047|12227343|FG000|STARTED|Overall Study||32
11046719|NCT00944047|12227343|FG000|COMPLETED|Overall Study||27
11046720|NCT00944047|12227343|FG000|NOT COMPLETED|Overall Study||5
11046721|NCT00944073|12227349|FG000|STARTED|Overall Study||292
11046722|NCT00944073|12227350|FG001|STARTED|Overall Study||291
11046723|NCT00944073|12227349|FG000|COMPLETED|Overall Study||287
11046724|NCT00944073|12227350|FG001|COMPLETED|Overall Study||287
11046725|NCT00944073|12227349|FG000|NOT COMPLETED|Overall Study||5
11046726|NCT00944073|12227350|FG001|NOT COMPLETED|Overall Study||4
11046727|NCT00944125|12227356|FG000|STARTED|Baseline to 3 Months||19
11046728|NCT00944125|12227357|FG001|STARTED|Baseline to 3 Months||22
11046729|NCT00944125|12227356|FG000|COMPLETED|Baseline to 3 Months||19
11046730|NCT00944125|12227357|FG001|COMPLETED|Baseline to 3 Months||22
11046731|NCT00944125|12227356|FG000|NOT COMPLETED|Baseline to 3 Months||0
11046732|NCT00944125|12227357|FG001|NOT COMPLETED|Baseline to 3 Months||0
11046733|NCT00944125|12227356|FG000|STARTED|3 to 6 Months||19
11046734|NCT00944125|12227357|FG001|STARTED|3 to 6 Months||22
11046735|NCT00944125|12227356|FG000|COMPLETED|3 to 6 Months||19
11046736|NCT00944125|12227357|FG001|COMPLETED|3 to 6 Months||20
11046737|NCT00944125|12227356|FG000|NOT COMPLETED|3 to 6 Months||0
11046738|NCT00944125|12227357|FG001|NOT COMPLETED|3 to 6 Months||2
11046739|NCT00944125|12227356|FG000|STARTED|6 Months to Study Completion||19
11046740|NCT00944125|12227357|FG001|STARTED|6 Months to Study Completion||20
11046741|NCT00944125|12227356|FG000|COMPLETED|6 Months to Study Completion||19
11046742|NCT00944125|12227357|FG001|COMPLETED|6 Months to Study Completion||18
11046743|NCT00944125|12227356|FG000|NOT COMPLETED|6 Months to Study Completion||0
11336850|NCT02884089|12534575|FG003|COMPLETED|Follow-up Visit||6
11336851|NCT02884089|12534572|FG000|NOT COMPLETED|Follow-up Visit||1
11336852|NCT02884089|12534573|FG001|NOT COMPLETED|Follow-up Visit||0
11336853|NCT02884089|12534574|FG002|NOT COMPLETED|Follow-up Visit||0
11336854|NCT02884089|12534575|FG003|NOT COMPLETED|Follow-up Visit||1
11336855|NCT02884414|12534585|FG000|STARTED|Overall Study||56
11336856|NCT02884414|12534585|FG000|COMPLETED|Overall Study||56
11336857|NCT02884414|12534585|FG000|NOT COMPLETED|Overall Study||0
11336858|NCT02884427|12534592|FG000|STARTED|Overall Study||48
11336859|NCT02884427|12534593|FG001|STARTED|Overall Study||52
11336860|NCT02884427|12534594|FG002|STARTED|Overall Study||50
11336861|NCT02884427|12534592|FG000|COMPLETED|Overall Study||48
11336862|NCT02884427|12534593|FG001|COMPLETED|Overall Study||52
11046744|NCT00944125|12227357|FG001|NOT COMPLETED|6 Months to Study Completion||2
11046745|NCT00944450|12227363|FG000|STARTED|Period 1||6
11046746|NCT00944450|12227364|FG001|STARTED|Period 1||6
11046747|NCT00944450|12227363|FG000|COMPLETED|Period 1||6
11046748|NCT00944450|12227364|FG001|COMPLETED|Period 1||6
11046749|NCT00944450|12227363|FG000|NOT COMPLETED|Period 1||0
11046750|NCT00944450|12227364|FG001|NOT COMPLETED|Period 1||0
11046751|NCT00944450|12227363|FG000|STARTED|Period 2||6
11046752|NCT00944450|12227364|FG001|STARTED|Period 2||6
11046753|NCT00944450|12227363|FG000|COMPLETED|Period 2||6
11046754|NCT00944450|12227364|FG001|COMPLETED|Period 2||6
11046755|NCT00944450|12227363|FG000|NOT COMPLETED|Period 2||0
11046756|NCT00944450|12227364|FG001|NOT COMPLETED|Period 2||0
11046757|NCT00944554|12227372|FG000|STARTED|Overall Study||50
11336863|NCT02884427|12534594|FG002|COMPLETED|Overall Study||50
11336864|NCT02884427|12534592|FG000|NOT COMPLETED|Overall Study||0
11046758|NCT00944554|12227373|FG001|STARTED|Overall Study||54
11046759|NCT00944554|12227372|FG000|COMPLETED|Overall Study||22
11046760|NCT00944554|12227373|FG001|COMPLETED|Overall Study||25
11046761|NCT00944554|12227372|FG000|NOT COMPLETED|Overall Study||28
11046762|NCT00944554|12227373|FG001|NOT COMPLETED|Overall Study||29
11046763|NCT00944645|12227379|FG000|STARTED|Period 1||94
11046764|NCT00944645|12227380|FG001|STARTED|Period 1||94
11046765|NCT00944645|12227379|FG000|COMPLETED|Period 1||94
11046766|NCT00944645|12227380|FG001|COMPLETED|Period 1||94
11046767|NCT00944645|12227379|FG000|NOT COMPLETED|Period 1||0
11046768|NCT00944645|12227380|FG001|NOT COMPLETED|Period 1||0
11046769|NCT00944645|12227379|FG000|STARTED|Period 2||94
11046770|NCT00944645|12227380|FG001|STARTED|Period 2||94
11046771|NCT00944645|12227379|FG000|COMPLETED|Period 2||86
11046772|NCT00944645|12227380|FG001|COMPLETED|Period 2||85
11046773|NCT00944645|12227379|FG000|NOT COMPLETED|Period 2||8
11046774|NCT00944645|12227380|FG001|NOT COMPLETED|Period 2||9
11046775|NCT00944658|12227388|FG000|STARTED|Treatment 12 Weeks||19
11046776|NCT00944658|12227389|FG001|STARTED|Treatment 12 Weeks||19
11046777|NCT00944658|12227388|FG000|COMPLETED|Treatment 12 Weeks||19
11046778|NCT00944658|12227389|FG001|COMPLETED|Treatment 12 Weeks||17
11046779|NCT00944658|12227388|FG000|NOT COMPLETED|Treatment 12 Weeks||0
11046780|NCT00944658|12227389|FG001|NOT COMPLETED|Treatment 12 Weeks||2
11046781|NCT00944658|12227388|FG000|STARTED|Follow up 4 Weeks||19
11046782|NCT00944658|12227389|FG001|STARTED|Follow up 4 Weeks||17
11046783|NCT00944658|12227388|FG000|COMPLETED|Follow up 4 Weeks||19
11046784|NCT00944658|12227389|FG001|COMPLETED|Follow up 4 Weeks||17
11046785|NCT00944658|12227388|FG000|NOT COMPLETED|Follow up 4 Weeks||0
11046786|NCT00944658|12227389|FG001|NOT COMPLETED|Follow up 4 Weeks||0
11046787|NCT00944671|12227401|FG000|STARTED|Period I||4
11046788|NCT00944671|12227402|FG001|STARTED|Period I||4
11046789|NCT00944671|12227403|FG002|STARTED|Period I||4
11046790|NCT00944671|12227404|FG003|STARTED|Period I||4
11046791|NCT00944671|12227405|FG004|STARTED|Period I||4
11046792|NCT00944671|12227406|FG005|STARTED|Period I||4
11046793|NCT00944671|12227401|FG000|COMPLETED|Period I||4
11046794|NCT00944671|12227402|FG001|COMPLETED|Period I||4
11046795|NCT00944671|12227403|FG002|COMPLETED|Period I||4
11046796|NCT00944671|12227404|FG003|COMPLETED|Period I||4
11046797|NCT00944671|12227405|FG004|COMPLETED|Period I||4
11046798|NCT00944671|12227406|FG005|COMPLETED|Period I||4
11046799|NCT00944671|12227401|FG000|NOT COMPLETED|Period I||0
11046800|NCT00944671|12227402|FG001|NOT COMPLETED|Period I||0
11046801|NCT00944671|12227403|FG002|NOT COMPLETED|Period I||0
11046802|NCT00944671|12227404|FG003|NOT COMPLETED|Period I||0
11046803|NCT00944671|12227405|FG004|NOT COMPLETED|Period I||0
11046804|NCT00944671|12227406|FG005|NOT COMPLETED|Period I||0
11046805|NCT00944671|12227401|FG000|STARTED|Period II||4
11046806|NCT00944671|12227402|FG001|STARTED|Period II||4
11046807|NCT00944671|12227403|FG002|STARTED|Period II||4
11046808|NCT00944671|12227404|FG003|STARTED|Period II||4
11046809|NCT00944671|12227405|FG004|STARTED|Period II||4
11046810|NCT00944671|12227406|FG005|STARTED|Period II||4
11046811|NCT00944671|12227401|FG000|COMPLETED|Period II||4
11046812|NCT00944671|12227402|FG001|COMPLETED|Period II||4
11046813|NCT00944671|12227403|FG002|COMPLETED|Period II||4
11046814|NCT00944671|12227404|FG003|COMPLETED|Period II||4
11046815|NCT00944671|12227405|FG004|COMPLETED|Period II||4
11046816|NCT00944671|12227406|FG005|COMPLETED|Period II||4
11046817|NCT00944671|12227401|FG000|NOT COMPLETED|Period II||0
11046818|NCT00944671|12227402|FG001|NOT COMPLETED|Period II||0
11046819|NCT00944671|12227403|FG002|NOT COMPLETED|Period II||0
11046820|NCT00944671|12227404|FG003|NOT COMPLETED|Period II||0
11046821|NCT00944671|12227405|FG004|NOT COMPLETED|Period II||0
11046822|NCT00944671|12227406|FG005|NOT COMPLETED|Period II||0
11046823|NCT00944671|12227401|FG000|STARTED|Period III||4
11046824|NCT00944671|12227402|FG001|STARTED|Period III||4
11046825|NCT00944671|12227403|FG002|STARTED|Period III||4
11046826|NCT00944671|12227404|FG003|STARTED|Period III||4
11046827|NCT00944671|12227405|FG004|STARTED|Period III||4
11046828|NCT00944671|12227406|FG005|STARTED|Period III||4
11046829|NCT00944671|12227401|FG000|COMPLETED|Period III||4
11046830|NCT00944671|12227402|FG001|COMPLETED|Period III||4
11046831|NCT00944671|12227403|FG002|COMPLETED|Period III||4
11046832|NCT00944671|12227404|FG003|COMPLETED|Period III||4
11046833|NCT00944671|12227405|FG004|COMPLETED|Period III||4
11046834|NCT00944671|12227406|FG005|COMPLETED|Period III||4
11046835|NCT00944671|12227401|FG000|NOT COMPLETED|Period III||0
11046836|NCT00944671|12227402|FG001|NOT COMPLETED|Period III||0
11046837|NCT00944671|12227403|FG002|NOT COMPLETED|Period III||0
11046838|NCT00944671|12227404|FG003|NOT COMPLETED|Period III||0
11046839|NCT00944671|12227405|FG004|NOT COMPLETED|Period III||0
11046840|NCT00944671|12227406|FG005|NOT COMPLETED|Period III||0
11046841|NCT00944697|12227416|FG000|STARTED|Overall Study||50
11046842|NCT00944697|12227417|FG001|STARTED|Overall Study||48
11046843|NCT00944697|12227416|FG000|COMPLETED|Overall Study||48
11046844|NCT00944697|12227417|FG001|COMPLETED|Overall Study||43
11046845|NCT00944697|12227416|FG000|NOT COMPLETED|Overall Study||2
11046846|NCT00944697|12227417|FG001|NOT COMPLETED|Overall Study||5
11046847|NCT00944710|12227425|FG000|STARTED|10-week Primary Outcome||40
11046848|NCT00944710|12227426|FG001|STARTED|10-week Primary Outcome||33
11046849|NCT00944710|12227425|FG000|COMPLETED|10-week Primary Outcome||40
11046850|NCT00944710|12227426|FG001|COMPLETED|10-week Primary Outcome||33
11046851|NCT00944710|12227425|FG000|NOT COMPLETED|10-week Primary Outcome||0
11046852|NCT00944710|12227426|FG001|NOT COMPLETED|10-week Primary Outcome||0
11046853|NCT00944710|12227425|FG000|STARTED|12-week Visit (Off-treatment)||40
11046854|NCT00944710|12227426|FG001|STARTED|12-week Visit (Off-treatment)||33
11046855|NCT00944710|12227425|FG000|COMPLETED|12-week Visit (Off-treatment)||40
11046856|NCT00944710|12227426|FG001|COMPLETED|12-week Visit (Off-treatment)||33
11046857|NCT00944710|12227425|FG000|NOT COMPLETED|12-week Visit (Off-treatment)||0
11046858|NCT00944710|12227426|FG001|NOT COMPLETED|12-week Visit (Off-treatment)||0
11046859|NCT00944710|12227425|FG000|STARTED|Additional Post 10-week Primary Outcome||40
11046860|NCT00944710|12227426|FG001|STARTED|Additional Post 10-week Primary Outcome||33
11046861|NCT00944710|12227425|FG000|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
11046862|NCT00944710|12227426|FG001|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
11046863|NCT00944710|12227425|FG000|COMPLETED|Additional Post 10-week Primary Outcome||23
11046864|NCT00944710|12227426|FG001|COMPLETED|Additional Post 10-week Primary Outcome||22
11046865|NCT00944710|12227425|FG000|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
11046866|NCT00944710|12227426|FG001|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
11046867|NCT00944749|12227432|FG000|STARTED|Overall Study||23
11046868|NCT00944749|12227432|FG000|COMPLETED|Overall Study||22
11046869|NCT00944749|12227432|FG000|NOT COMPLETED|Overall Study||1
11046870|NCT00945061|12227438|FG000|STARTED|Overall Study||12
11046871|NCT00945061|12227439|FG001|STARTED|Overall Study||1
11046872|NCT00945061|12227438|FG000|COMPLETED|Overall Study||12
11046873|NCT00945061|12227439|FG001|COMPLETED|Overall Study||1
11046874|NCT00945061|12227438|FG000|NOT COMPLETED|Overall Study||0
11046875|NCT00945061|12227439|FG001|NOT COMPLETED|Overall Study||0
11046876|NCT00945100|12227456|FG000|STARTED|10-week Primary Outcome||83
11046877|NCT00945100|12227457|FG001|STARTED|10-week Primary Outcome||86
11046878|NCT00945100|12227456|FG000|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
11046879|NCT00945100|12227457|FG001|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
11046880|NCT00945100|12227456|FG000|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
11046881|NCT00945100|12227457|FG001|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
11046882|NCT00945100|12227456|FG000|COMPLETED|10-week Primary Outcome||82
11046883|NCT00945100|12227457|FG001|COMPLETED|10-week Primary Outcome||83
11046884|NCT00945100|12227456|FG000|NOT COMPLETED|10-week Primary Outcome||1
11046885|NCT00945100|12227457|FG001|NOT COMPLETED|10-week Primary Outcome||3
11046886|NCT00945100|12227456|FG000|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
11046887|NCT00945100|12227457|FG001|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
11046888|NCT00945100|12227456|FG000|COMPLETED|Post-10 Week Primary Outcome||51
11046889|NCT00945100|12227457|FG001|COMPLETED|Post-10 Week Primary Outcome||56
11046890|NCT00945100|12227456|FG000|NOT COMPLETED|Post-10 Week Primary Outcome||4
11046891|NCT00945100|12227457|FG001|NOT COMPLETED|Post-10 Week Primary Outcome||7
11046892|NCT00945139|12227463|FG000|STARTED|Overall Study||46
11046893|NCT00945139|12227463|FG000|COMPLETED|Overall Study||46
11046894|NCT00945139|12227463|FG000|NOT COMPLETED|Overall Study||0
11046895|NCT00945191|12227468|FG000|STARTED|Overall Study||24
11046896|NCT00945191|12227468|FG000|COMPLETED|Overall Study||0
11046897|NCT00945191|12227468|FG000|NOT COMPLETED|Overall Study||24
11046898|NCT00945243|12227472|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
11046899|NCT00945243|12227472|FG000|COMPLETED|Overall Study||8
11046900|NCT00945243|12227472|FG000|NOT COMPLETED|Overall Study||3
11046901|NCT00945256|12227481|FG000|STARTED|Overall Study||13
11046902|NCT00945256|12227482|FG001|STARTED|Overall Study||10
11046903|NCT00945256|12227483|FG002|STARTED|Overall Study||15
11046904|NCT00945256|12227484|FG003|STARTED|Overall Study||16
11046905|NCT00945256|12227485|FG004|STARTED|Overall Study||8
11046906|NCT00945256|12227481|FG000|COMPLETED|Overall Study||9
11046907|NCT00945256|12227482|FG001|COMPLETED|Overall Study||8
11046908|NCT00945256|12227483|FG002|COMPLETED|Overall Study||7
11046909|NCT00945256|12227484|FG003|COMPLETED|Overall Study||7
11046910|NCT00945256|12227485|FG004|COMPLETED|Overall Study||7
11046911|NCT00945256|12227481|FG000|NOT COMPLETED|Overall Study||4
11046912|NCT00945256|12227482|FG001|NOT COMPLETED|Overall Study||2
11046913|NCT00945256|12227483|FG002|NOT COMPLETED|Overall Study||8
11046914|NCT00945256|12227484|FG003|NOT COMPLETED|Overall Study||9
11046915|NCT00945256|12227485|FG004|NOT COMPLETED|Overall Study||1
11046916|NCT00945282|12227499|FG000|STARTED|Overall Study||6
11046917|NCT00945282|12227500|FG001|STARTED|Overall Study||2
11046918|NCT00945282|12227499|FG000|COMPLETED|Overall Study||6
11046919|NCT00945282|12227500|FG001|COMPLETED|Overall Study||2
11046920|NCT00945282|12227499|FG000|NOT COMPLETED|Overall Study||0
11046921|NCT00945282|12227500|FG001|NOT COMPLETED|Overall Study||0
11046922|NCT00945295|12227516|FG000|STARTED|Overall Study||15
11046923|NCT00945295|12227517|FG001|STARTED|Overall Study||16
11046924|NCT00945295|12227516|FG000|COMPLETED|Overall Study||15
11046925|NCT00945295|12227517|FG001|COMPLETED|Overall Study||14
11046926|NCT00945295|12227516|FG000|NOT COMPLETED|Overall Study||0
11046927|NCT00945295|12227517|FG001|NOT COMPLETED|Overall Study||2
11046928|NCT00945321|12227523|FG000|STARTED|Period 1||7
11046929|NCT00945321|12227524|FG001|STARTED|Period 1||7
11046930|NCT00945321|12227525|FG002|STARTED|Period 1||7
11046931|NCT00945321|12227526|FG003|STARTED|Period 1||7
11046932|NCT00945321|12227527|FG004|STARTED|Period 1||7
11046933|NCT00945321|12227528|FG005|STARTED|Period 1||7
11046934|NCT00945321|12227523|FG000|COMPLETED|Period 1||7
11046935|NCT00945321|12227524|FG001|COMPLETED|Period 1||7
11046936|NCT00945321|12227525|FG002|COMPLETED|Period 1||7
11046937|NCT00945321|12227526|FG003|COMPLETED|Period 1||7
11046938|NCT00945321|12227527|FG004|COMPLETED|Period 1||6
11046939|NCT00945321|12227528|FG005|COMPLETED|Period 1||7
11046940|NCT00945321|12227523|FG000|NOT COMPLETED|Period 1||0
11046941|NCT00945321|12227524|FG001|NOT COMPLETED|Period 1||0
11046942|NCT00945321|12227525|FG002|NOT COMPLETED|Period 1||0
11046943|NCT00945321|12227526|FG003|NOT COMPLETED|Period 1||0
11046944|NCT00945321|12227527|FG004|NOT COMPLETED|Period 1||1
11046945|NCT00945321|12227528|FG005|NOT COMPLETED|Period 1||0
11046946|NCT00945321|12227523|FG000|STARTED|Period 2||7
11046947|NCT00945321|12227524|FG001|STARTED|Period 2||7
11046948|NCT00945321|12227525|FG002|STARTED|Period 2||7
11046949|NCT00945321|12227526|FG003|STARTED|Period 2||7
11046950|NCT00945321|12227527|FG004|STARTED|Period 2||6
11046951|NCT00945321|12227528|FG005|STARTED|Period 2||7
11046952|NCT00945321|12227523|FG000|COMPLETED|Period 2||7
11046953|NCT00945321|12227524|FG001|COMPLETED|Period 2||7
11046954|NCT00945321|12227525|FG002|COMPLETED|Period 2||7
11046955|NCT00945321|12227526|FG003|COMPLETED|Period 2||7
11046956|NCT00945321|12227527|FG004|COMPLETED|Period 2||6
11046957|NCT00945321|12227528|FG005|COMPLETED|Period 2||7
11046958|NCT00945321|12227523|FG000|NOT COMPLETED|Period 2||0
11046959|NCT00945321|12227524|FG001|NOT COMPLETED|Period 2||0
11046960|NCT00945321|12227525|FG002|NOT COMPLETED|Period 2||0
11046961|NCT00945321|12227526|FG003|NOT COMPLETED|Period 2||0
11046962|NCT00945321|12227527|FG004|NOT COMPLETED|Period 2||0
11046963|NCT00945321|12227528|FG005|NOT COMPLETED|Period 2||0
11046964|NCT00945321|12227523|FG000|STARTED|Period 3||7
11046965|NCT00945321|12227524|FG001|STARTED|Period 3||7
11046966|NCT00945321|12227525|FG002|STARTED|Period 3||7
11046967|NCT00945321|12227526|FG003|STARTED|Period 3||7
11046968|NCT00945321|12227527|FG004|STARTED|Period 3||6
11046969|NCT00945321|12227528|FG005|STARTED|Period 3||7
11046970|NCT00945321|12227523|FG000|COMPLETED|Period 3||7
11046971|NCT00945321|12227524|FG001|COMPLETED|Period 3||7
11046972|NCT00945321|12227525|FG002|COMPLETED|Period 3||7
11046973|NCT00945321|12227526|FG003|COMPLETED|Period 3||7
11046974|NCT00945321|12227527|FG004|COMPLETED|Period 3||6
11046975|NCT00945321|12227528|FG005|COMPLETED|Period 3||7
11046976|NCT00945321|12227523|FG000|NOT COMPLETED|Period 3||0
11046977|NCT00945321|12227524|FG001|NOT COMPLETED|Period 3||0
11046978|NCT00945321|12227525|FG002|NOT COMPLETED|Period 3||0
11046979|NCT00945321|12227526|FG003|NOT COMPLETED|Period 3||0
11046980|NCT00945321|12227527|FG004|NOT COMPLETED|Period 3||0
11046981|NCT00945321|12227528|FG005|NOT COMPLETED|Period 3||0
11046982|NCT00945321|12227523|FG000|STARTED|Period 4||7
11046983|NCT00945321|12227524|FG001|STARTED|Period 4||7
11046984|NCT00945321|12227525|FG002|STARTED|Period 4||7
11046985|NCT00945321|12227526|FG003|STARTED|Period 4||7
11046986|NCT00945321|12227527|FG004|STARTED|Period 4||6
11046987|NCT00945321|12227528|FG005|STARTED|Period 4||7
11046988|NCT00945321|12227523|FG000|COMPLETED|Period 4||7
11046989|NCT00945321|12227524|FG001|COMPLETED|Period 4||7
11046990|NCT00945321|12227525|FG002|COMPLETED|Period 4||7
11046991|NCT00945321|12227526|FG003|COMPLETED|Period 4||7
11046992|NCT00945321|12227527|FG004|COMPLETED|Period 4||6
11046993|NCT00945321|12227528|FG005|COMPLETED|Period 4||6
11046994|NCT00945321|12227523|FG000|NOT COMPLETED|Period 4||0
11046995|NCT00945321|12227524|FG001|NOT COMPLETED|Period 4||0
11046996|NCT00945321|12227525|FG002|NOT COMPLETED|Period 4||0
11046997|NCT00945321|12227526|FG003|NOT COMPLETED|Period 4||0
11046998|NCT00945321|12227527|FG004|NOT COMPLETED|Period 4||0
11046999|NCT00945321|12227528|FG005|NOT COMPLETED|Period 4||1
11047000|NCT00945334|12227548|FG000|STARTED|Overall Study||19
11047001|NCT00945334|12227549|FG001|STARTED|Overall Study||18
11047002|NCT00945334|12227548|FG000|COMPLETED|Overall Study||16
11047003|NCT00945334|12227549|FG001|COMPLETED|Overall Study||15
11047004|NCT00945334|12227548|FG000|NOT COMPLETED|Overall Study||3
11047005|NCT00945334|12227549|FG001|NOT COMPLETED|Overall Study||3
11047006|NCT00945477|12227555|FG000|STARTED|Overall Study||11
11047007|NCT00945477|12227555|FG000|COMPLETED|Overall Study||5
11047008|NCT00945477|12227555|FG000|NOT COMPLETED|Overall Study||6
11047009|NCT00945555|12227560|FG000|STARTED|Overall Study||264
11047010|NCT00945555|12227560|FG000|COMPLETED|Overall Study||236
11047011|NCT00945555|12227560|FG000|NOT COMPLETED|Overall Study||28
11047012|NCT00945594|12227566|FG000|STARTED|Overall Study||50
11047013|NCT00945594|12227567|FG001|STARTED|Overall Study||50
11047014|NCT00945594|12227566|FG000|COMPLETED|Overall Study||50
11047015|NCT00945594|12227567|FG001|COMPLETED|Overall Study||50
11047016|NCT00945594|12227566|FG000|NOT COMPLETED|Overall Study||0
11047017|NCT00945594|12227567|FG001|NOT COMPLETED|Overall Study||0
11047018|NCT00945659|12227578|FG000|STARTED|Overall Study||39
11047019|NCT00945659|12227579|FG001|STARTED|Overall Study||40
11047020|NCT00945659|12227580|FG002|STARTED|Overall Study||37
11047021|NCT00945659|12227578|FG000|Baseline|Overall Study||39
11047022|NCT00945659|12227579|FG001|Baseline|Overall Study||40
11047023|NCT00945659|12227580|FG002|Baseline|Overall Study||37
11047024|NCT00945659|12227578|FG000|3-Months|Overall Study||38
11047025|NCT00945659|12227579|FG001|3-Months|Overall Study||39
11047026|NCT00945659|12227580|FG002|3-Months|Overall Study||35
11047027|NCT00945659|12227578|FG000|6-Months|Overall Study||31
11047028|NCT00945659|12227579|FG001|6-Months|Overall Study||29
11047029|NCT00945659|12227580|FG002|6-Months|Overall Study||25
11047030|NCT00945659|12227578|FG000|9-Months|Overall Study||32
11047031|NCT00945659|12227579|FG001|9-Months|Overall Study||20
11047032|NCT00945659|12227580|FG002|9-Months|Overall Study||20
11047033|NCT00945659|12227578|FG000|12-Months|Overall Study||32
11047034|NCT00945659|12227579|FG001|12-Months|Overall Study||20
11047035|NCT00945659|12227580|FG002|12-Months|Overall Study||20
11047036|NCT00945659|12227578|FG000|COMPLETED|Overall Study||32
11047037|NCT00945659|12227579|FG001|COMPLETED|Overall Study||20
11047038|NCT00945659|12227580|FG002|COMPLETED|Overall Study||20
11047039|NCT00945659|12227578|FG000|NOT COMPLETED|Overall Study||7
11047040|NCT00945659|12227579|FG001|NOT COMPLETED|Overall Study||20
11047041|NCT00945659|12227580|FG002|NOT COMPLETED|Overall Study||17
11047042|NCT00945750|12227594|FG000|STARTED|Period I||5
11047043|NCT00945750|12227595|FG001|STARTED|Period I||5
11047044|NCT00945750|12227596|FG002|STARTED|Period I||5
11047045|NCT00945750|12227597|FG003|STARTED|Period I||5
11047046|NCT00945750|12227598|FG004|STARTED|Period I||5
11047047|NCT00945750|12227599|FG005|STARTED|Period I||5
11047048|NCT00945750|12227594|FG000|COMPLETED|Period I||5
11047049|NCT00945750|12227595|FG001|COMPLETED|Period I||5
11047050|NCT00945750|12227596|FG002|COMPLETED|Period I||5
11047051|NCT00945750|12227597|FG003|COMPLETED|Period I||5
11047052|NCT00945750|12227598|FG004|COMPLETED|Period I||5
11047053|NCT00945750|12227599|FG005|COMPLETED|Period I||5
11047054|NCT00945750|12227594|FG000|NOT COMPLETED|Period I||0
11047055|NCT00945750|12227595|FG001|NOT COMPLETED|Period I||0
11047056|NCT00945750|12227596|FG002|NOT COMPLETED|Period I||0
11047057|NCT00945750|12227597|FG003|NOT COMPLETED|Period I||0
11047058|NCT00945750|12227598|FG004|NOT COMPLETED|Period I||0
11047059|NCT00945750|12227599|FG005|NOT COMPLETED|Period I||0
11047060|NCT00945750|12227594|FG000|STARTED|Period II||5
11047061|NCT00945750|12227595|FG001|STARTED|Period II||5
11047062|NCT00945750|12227596|FG002|STARTED|Period II||5
11047063|NCT00945750|12227597|FG003|STARTED|Period II||5
11047064|NCT00945750|12227598|FG004|STARTED|Period II||5
11047065|NCT00945750|12227599|FG005|STARTED|Period II||5
11047066|NCT00945750|12227594|FG000|COMPLETED|Period II||5
11047067|NCT00945750|12227595|FG001|COMPLETED|Period II||5
11047068|NCT00945750|12227596|FG002|COMPLETED|Period II||5
11047069|NCT00945750|12227597|FG003|COMPLETED|Period II||5
11047070|NCT00945750|12227598|FG004|COMPLETED|Period II||5
11047071|NCT00945750|12227599|FG005|COMPLETED|Period II||5
11047072|NCT00945750|12227594|FG000|NOT COMPLETED|Period II||0
11047073|NCT00945750|12227595|FG001|NOT COMPLETED|Period II||0
11047074|NCT00945750|12227596|FG002|NOT COMPLETED|Period II||0
11047075|NCT00945750|12227597|FG003|NOT COMPLETED|Period II||0
11047076|NCT00945750|12227598|FG004|NOT COMPLETED|Period II||0
11047077|NCT00945750|12227599|FG005|NOT COMPLETED|Period II||0
11047078|NCT00945750|12227594|FG000|STARTED|Period III||5
11047079|NCT00945750|12227595|FG001|STARTED|Period III||5
11047080|NCT00945750|12227596|FG002|STARTED|Period III||5
11047081|NCT00945750|12227597|FG003|STARTED|Period III||5
11047082|NCT00945750|12227598|FG004|STARTED|Period III||5
11047083|NCT00945750|12227599|FG005|STARTED|Period III||5
11047084|NCT00945750|12227594|FG000|COMPLETED|Period III||5
11047085|NCT00945750|12227595|FG001|COMPLETED|Period III||5
11047086|NCT00945750|12227596|FG002|COMPLETED|Period III||5
11047087|NCT00945750|12227597|FG003|COMPLETED|Period III||5
11047088|NCT00945750|12227598|FG004|COMPLETED|Period III||5
11047089|NCT00945750|12227599|FG005|COMPLETED|Period III||5
11047090|NCT00945750|12227594|FG000|NOT COMPLETED|Period III||0
11047091|NCT00945750|12227595|FG001|NOT COMPLETED|Period III||0
11201358|NCT01831921|12391606|FG000|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
11201359|NCT01831921|12391607|FG001|12 Months|Overall Study||62
11201360|NCT01831921|12391606|FG000|18 Months|Overall Study|Of 118 eligible for this visit.|90
11201361|NCT01831921|12391607|FG001|18 Months|Overall Study|Of 59 eligible for this visit.|49
11201362|NCT01831921|12391606|FG000|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
11201363|NCT01831921|12391607|FG001|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
11201364|NCT01831921|12391606|FG000|NOT COMPLETED|Overall Study||84
11047092|NCT00945750|12227596|FG002|NOT COMPLETED|Period III||0
11047093|NCT00945750|12227597|FG003|NOT COMPLETED|Period III||0
11047094|NCT00945750|12227598|FG004|NOT COMPLETED|Period III||0
11047095|NCT00945750|12227599|FG005|NOT COMPLETED|Period III||0
11201365|NCT01831921|12391607|FG001|NOT COMPLETED|Overall Study||39
11201366|NCT01831934|12391618|FG000|STARTED|Overall Study||12
11201367|NCT01831934|12391619|FG001|STARTED|Overall Study||10
11201368|NCT01831934|12391618|FG000|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
11201369|NCT01831934|12391619|FG001|COMPLETED|Overall Study||10
11201370|NCT01831934|12391618|FG000|NOT COMPLETED|Overall Study||1
11201371|NCT01831934|12391619|FG001|NOT COMPLETED|Overall Study||0
11201372|NCT01831960|12391627|FG000|STARTED|Overall Study||20
11201373|NCT01831960|12391628|FG001|STARTED|Overall Study||22
11201374|NCT01831960|12391627|FG000|COMPLETED|Overall Study||20
11201375|NCT01831960|12391628|FG001|COMPLETED|Overall Study||22
11201376|NCT01831960|12391627|FG000|NOT COMPLETED|Overall Study||0
11201377|NCT01831960|12391628|FG001|NOT COMPLETED|Overall Study||0
11201378|NCT01832038|12391635|FG000|STARTED|Overall Study||473
11201379|NCT01832038|12391635|FG000|COMPLETED|Overall Study||238
11047096|NCT00945815|12227607|FG000|STARTED|Overall Study||35
11047097|NCT00945815|12227607|FG000|Eligible|Overall Study||32
11047098|NCT00945815|12227607|FG000|Eligible and Began Protocol Therapy|Overall Study||31
11047099|NCT00945815|12227607|FG000|COMPLETED|Overall Study||27
11047100|NCT00945815|12227607|FG000|NOT COMPLETED|Overall Study||8
11047101|NCT00945854|12227613|FG000|STARTED|Overall Study||30
11047102|NCT00945854|12227614|FG001|STARTED|Overall Study||30
11047103|NCT00945854|12227613|FG000|COMPLETED|Overall Study||28
11047104|NCT00945854|12227614|FG001|COMPLETED|Overall Study||26
11047105|NCT00945854|12227613|FG000|NOT COMPLETED|Overall Study||2
11047106|NCT00945854|12227614|FG001|NOT COMPLETED|Overall Study||4
11047107|NCT00945893|12227622|FG000|STARTED|Overall Study||60
11047108|NCT00945893|12227623|FG001|STARTED|Overall Study||240
11047109|NCT00945893|12227622|FG000|Day 15 Post Dose 1|Overall Study||60
11047110|NCT00945893|12227623|FG001|Day 15 Post Dose 1|Overall Study||238
11047111|NCT00945893|12227622|FG000|Day 15 Post Dose 2|Overall Study||54
11047112|NCT00945893|12227623|FG001|Day 15 Post Dose 2|Overall Study||226
11047113|NCT00945893|12227622|FG000|COMPLETED|Overall Study||57
11047114|NCT00945893|12227623|FG001|COMPLETED|Overall Study||230
11047115|NCT00945893|12227622|FG000|NOT COMPLETED|Overall Study||3
11047116|NCT00945893|12227623|FG001|NOT COMPLETED|Overall Study||10
11047117|NCT00945906|12227633|FG000|STARTED|Overall Study||61
11047118|NCT00945906|12227633|FG000|COMPLETED|Overall Study||54
11047119|NCT00945906|12227633|FG000|NOT COMPLETED|Overall Study||7
11047120|NCT00945945|12227639|FG000|STARTED|Overall Study||207
11047121|NCT00945945|12227640|FG001|STARTED|Overall Study||217
11047122|NCT00945945|12227639|FG000|COMPLETED|Overall Study||171
11047123|NCT00945945|12227640|FG001|COMPLETED|Overall Study||162
11047124|NCT00945945|12227639|FG000|NOT COMPLETED|Overall Study||36
11047125|NCT00945945|12227640|FG001|NOT COMPLETED|Overall Study||55
11047126|NCT00945958|12227646|FG000|STARTED|Overall Study||161
11047127|NCT00945958|12227646|FG000|COMPLETED|Overall Study||149
11047128|NCT00945958|12227646|FG000|NOT COMPLETED|Overall Study||12
11047129|NCT00946023|12227651|FG000|STARTED|Overall Study||83
11047130|NCT00946023|12227651|FG000|COMPLETED|Overall Study||83
11047131|NCT00946023|12227651|FG000|NOT COMPLETED|Overall Study||0
11047132|NCT00946088|12227657|FG000|STARTED|Overall Study||4
11047133|NCT00946088|12227658|FG001|STARTED|Overall Study||3
11047134|NCT00946088|12227657|FG000|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
11047135|NCT00946088|12227658|FG001|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
11047136|NCT00946088|12227657|FG000|NOT COMPLETED|Overall Study||0
11047137|NCT00946088|12227658|FG001|NOT COMPLETED|Overall Study||1
11047138|NCT00946101|12227668|FG000|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
11047139|NCT00946101|12227669|FG001|STARTED|Overall Study||65
11047140|NCT00946101|12227668|FG000|Day 15 Post Dose 1|Overall Study||260
11047141|NCT00946101|12227669|FG001|Day 15 Post Dose 1|Overall Study||64
11047142|NCT00946101|12227668|FG000|Day 15 Post Dose 2|Overall Study||254
11047143|NCT00946101|12227669|FG001|Day 15 Post Dose 2|Overall Study||63
11047144|NCT00946101|12227668|FG000|COMPLETED|Overall Study||257
11047145|NCT00946101|12227669|FG001|COMPLETED|Overall Study||63
11047146|NCT00946101|12227668|FG000|NOT COMPLETED|Overall Study||4
11047147|NCT00946101|12227669|FG001|NOT COMPLETED|Overall Study||2
11047148|NCT00946114|12227681|FG000|STARTED|Overall Study||20
11047149|NCT00946114|12227682|FG001|STARTED|Overall Study||12
11047150|NCT00946114|12227681|FG000|COMPLETED|Overall Study||12
11047151|NCT00946114|12227682|FG001|COMPLETED|Overall Study||10
11047152|NCT00946114|12227681|FG000|NOT COMPLETED|Overall Study||8
11047153|NCT00946114|12227682|FG001|NOT COMPLETED|Overall Study||2
11047154|NCT00946153|12227693|FG000|STARTED|Phase 1||6
11047155|NCT00946153|12227694|FG001|STARTED|Phase 1||3
11047156|NCT00946153|12227695|FG002|STARTED|Phase 1||6
11047157|NCT00946153|12227696|FG003|STARTED|Phase 1||5
11047158|NCT00946153|12227697|FG004|STARTED|Phase 1||0
11047159|NCT00946153|12227693|FG000|COMPLETED|Phase 1||6
11047160|NCT00946153|12227694|FG001|COMPLETED|Phase 1||3
11047161|NCT00946153|12227695|FG002|COMPLETED|Phase 1||6
11047162|NCT00946153|12227696|FG003|COMPLETED|Phase 1||5
11047163|NCT00946153|12227697|FG004|COMPLETED|Phase 1||0
11047164|NCT00946153|12227693|FG000|NOT COMPLETED|Phase 1||0
11047165|NCT00946153|12227694|FG001|NOT COMPLETED|Phase 1||0
11047166|NCT00946153|12227695|FG002|NOT COMPLETED|Phase 1||0
11047167|NCT00946153|12227696|FG003|NOT COMPLETED|Phase 1||0
11047168|NCT00946153|12227697|FG004|NOT COMPLETED|Phase 1||0
11047169|NCT00946153|12227693|FG000|STARTED|Phase 2||0
11047170|NCT00946153|12227694|FG001|STARTED|Phase 2||0
11047171|NCT00946153|12227695|FG002|STARTED|Phase 2||0
11047172|NCT00946153|12227696|FG003|STARTED|Phase 2||0
11047173|NCT00946153|12227697|FG004|STARTED|Phase 2||46
11047174|NCT00946153|12227693|FG000|COMPLETED|Phase 2||0
11047175|NCT00946153|12227694|FG001|COMPLETED|Phase 2||0
11047176|NCT00946153|12227695|FG002|COMPLETED|Phase 2||0
11047177|NCT00946153|12227696|FG003|COMPLETED|Phase 2||0
11047178|NCT00946153|12227697|FG004|COMPLETED|Phase 2||33
11047179|NCT00946153|12227693|FG000|NOT COMPLETED|Phase 2||0
11047180|NCT00946153|12227694|FG001|NOT COMPLETED|Phase 2||0
11047181|NCT00946153|12227695|FG002|NOT COMPLETED|Phase 2||0
11047182|NCT00946153|12227696|FG003|NOT COMPLETED|Phase 2||0
11047183|NCT00946153|12227697|FG004|NOT COMPLETED|Phase 2||13
11047184|NCT00946192|12227717|FG000|STARTED|Overall Study||43
11047185|NCT00946192|12227718|FG001|STARTED|Overall Study||40
11047186|NCT00946192|12227719|FG002|STARTED|Overall Study||38
11047187|NCT00946192|12227717|FG000|COMPLETED|Overall Study||25
11047188|NCT00946192|12227718|FG001|COMPLETED|Overall Study||22
11047189|NCT00946192|12227719|FG002|COMPLETED|Overall Study||26
11047190|NCT00946192|12227717|FG000|NOT COMPLETED|Overall Study||18
11047191|NCT00946192|12227718|FG001|NOT COMPLETED|Overall Study||18
11047192|NCT00946192|12227719|FG002|NOT COMPLETED|Overall Study||12
11047193|NCT00946270|12227730|FG000|STARTED|Overall Study||21
11047194|NCT00946270|12227731|FG001|STARTED|Overall Study||20
11047195|NCT00946270|12227732|FG002|STARTED|Overall Study||29
11047196|NCT00946270|12227730|FG000|COMPLETED|Overall Study||21
11047197|NCT00946270|12227731|FG001|COMPLETED|Overall Study||20
11047198|NCT00946270|12227732|FG002|COMPLETED|Overall Study||29
11047199|NCT00946270|12227730|FG000|NOT COMPLETED|Overall Study||0
11047200|NCT00946270|12227731|FG001|NOT COMPLETED|Overall Study||0
11047201|NCT00946270|12227732|FG002|NOT COMPLETED|Overall Study||0
11047202|NCT00946296|12227742|FG000|STARTED|Overall Study||21
11047203|NCT00946296|12227743|FG001|STARTED|Overall Study||15
11047204|NCT00946296|12227742|FG000|COMPLETED|Overall Study||18
11047205|NCT00946296|12227743|FG001|COMPLETED|Overall Study||15
11047206|NCT00946296|12227742|FG000|NOT COMPLETED|Overall Study||3
11047207|NCT00946296|12227743|FG001|NOT COMPLETED|Overall Study||0
11047208|NCT00946309|12227751|FG000|STARTED|Overall Study||22
11047209|NCT00946309|12227752|FG001|STARTED|Overall Study||23
11047210|NCT00946309|12227751|FG000|COMPLETED|Overall Study||21
11047211|NCT00946309|12227752|FG001|COMPLETED|Overall Study||19
11047212|NCT00946309|12227751|FG000|NOT COMPLETED|Overall Study||1
11047213|NCT00946309|12227752|FG001|NOT COMPLETED|Overall Study||4
11047214|NCT00946322|12227759|FG000|STARTED|Pre-treatment||12
11047215|NCT00946322|12227759|FG000|COMPLETED|Pre-treatment||11
11047216|NCT00946322|12227759|FG000|NOT COMPLETED|Pre-treatment||1
11047217|NCT00946322|12227759|FG000|STARTED|Post-treatment||11
11047218|NCT00946322|12227759|FG000|COMPLETED|Post-treatment||9
11047219|NCT00946322|12227759|FG000|NOT COMPLETED|Post-treatment||2
11047220|NCT00946348|12227765|FG000|STARTED|Overall Study||6
11047221|NCT00946348|12227766|FG001|STARTED|Overall Study||6
11047222|NCT00946348|12227765|FG000|COMPLETED|Overall Study||6
11047223|NCT00946348|12227766|FG001|COMPLETED|Overall Study||6
11047224|NCT00946348|12227765|FG000|NOT COMPLETED|Overall Study||0
11047225|NCT00946348|12227766|FG001|NOT COMPLETED|Overall Study||0
11047226|NCT00946478|12227774|FG000|STARTED|Overall Study||20
11047227|NCT00946478|12227775|FG001|STARTED|Overall Study||20
11047228|NCT00946478|12227774|FG000|COMPLETED|Overall Study||20
11047229|NCT00946478|12227775|FG001|COMPLETED|Overall Study||20
11047230|NCT00946478|12227774|FG000|NOT COMPLETED|Overall Study||0
11047231|NCT00946478|12227775|FG001|NOT COMPLETED|Overall Study||0
11047232|NCT00946530|12227785|FG000|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
11047233|NCT00946530|12227786|FG001|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
11047234|NCT00946530|12227787|FG002|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
11047235|NCT00946530|12227788|FG003|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
11047236|NCT00946530|12227785|FG000|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
11047237|NCT00946530|12227786|FG001|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
11047238|NCT00946530|12227787|FG002|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
11047239|NCT00946530|12227788|FG003|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
11047240|NCT00946530|12227785|FG000|NOT COMPLETED|Overall Study||1
11047241|NCT00946530|12227786|FG001|NOT COMPLETED|Overall Study||4
11047242|NCT00946530|12227787|FG002|NOT COMPLETED|Overall Study||1
11047243|NCT00946530|12227788|FG003|NOT COMPLETED|Overall Study||4
11047244|NCT00946647|12227807|FG000|STARTED|Phase 1 Part||6
11047245|NCT00946647|12227808|FG001|STARTED|Phase 1 Part||18
11047246|NCT00946647|12227809|FG002|STARTED|Phase 1 Part||7
11047247|NCT00946647|12227810|FG003|STARTED|Phase 1 Part||0
11047248|NCT00946647|12227811|FG004|STARTED|Phase 1 Part||0
11047249|NCT00946647|12227807|FG000|COMPLETED|Phase 1 Part||0
11047250|NCT00946647|12227808|FG001|COMPLETED|Phase 1 Part||0
11047251|NCT00946647|12227809|FG002|COMPLETED|Phase 1 Part||0
11047252|NCT00946647|12227810|FG003|COMPLETED|Phase 1 Part||0
11047253|NCT00946647|12227811|FG004|COMPLETED|Phase 1 Part||0
11047254|NCT00946647|12227807|FG000|NOT COMPLETED|Phase 1 Part||6
11047255|NCT00946647|12227808|FG001|NOT COMPLETED|Phase 1 Part||18
11047256|NCT00946647|12227809|FG002|NOT COMPLETED|Phase 1 Part||7
11047257|NCT00946647|12227810|FG003|NOT COMPLETED|Phase 1 Part||0
11047258|NCT00946647|12227811|FG004|NOT COMPLETED|Phase 1 Part||0
11047259|NCT00946647|12227807|FG000|STARTED|Phase ll Part||0
11047260|NCT00946647|12227808|FG001|STARTED|Phase ll Part||0
11047261|NCT00946647|12227809|FG002|STARTED|Phase ll Part||0
11047262|NCT00946647|12227810|FG003|STARTED|Phase ll Part||40
11047263|NCT00946647|12227811|FG004|STARTED|Phase ll Part||42
11047264|NCT00946647|12227807|FG000|Safety Set|Phase ll Part||0
11047265|NCT00946647|12227808|FG001|Safety Set|Phase ll Part||0
11047266|NCT00946647|12227809|FG002|Safety Set|Phase ll Part||0
11047267|NCT00946647|12227810|FG003|Safety Set|Phase ll Part|2 pts rand. to this grp did not receive PAN|38
11047268|NCT00946647|12227811|FG004|Safety Set|Phase ll Part|2 pts rand. to PAN+5AZA, did not receive PAN but received 5AZA|42
11047269|NCT00946647|12227807|FG000|COMPLETED|Phase ll Part||0
11047270|NCT00946647|12227808|FG001|COMPLETED|Phase ll Part||0
11047271|NCT00946647|12227809|FG002|COMPLETED|Phase ll Part||0
11047272|NCT00946647|12227810|FG003|COMPLETED|Phase ll Part||0
11047273|NCT00946647|12227811|FG004|COMPLETED|Phase ll Part||0
11047274|NCT00946647|12227807|FG000|NOT COMPLETED|Phase ll Part||0
11047275|NCT00946647|12227808|FG001|NOT COMPLETED|Phase ll Part||0
11047276|NCT00946647|12227809|FG002|NOT COMPLETED|Phase ll Part||0
11047277|NCT00946647|12227810|FG003|NOT COMPLETED|Phase ll Part||40
11047278|NCT00946647|12227811|FG004|NOT COMPLETED|Phase ll Part||42
11047279|NCT00946712|12227826|FG000|STARTED|Overall Study||671
11047280|NCT00946712|12227827|FG001|STARTED|Overall Study||662
11047281|NCT00946712|12227826|FG000|COMPLETED|Overall Study||124
11047282|NCT00946712|12227827|FG001|COMPLETED|Overall Study||0
11047283|NCT00946712|12227826|FG000|NOT COMPLETED|Overall Study||547
11047284|NCT00946712|12227827|FG001|NOT COMPLETED|Overall Study||662
11047285|NCT00946881|12227834|FG000|STARTED|First Treatment||30
11047286|NCT00946881|12227834|FG000|COMPLETED|First Treatment||28
11047287|NCT00946881|12227834|FG000|NOT COMPLETED|First Treatment||2
11047288|NCT00946881|12227834|FG000|STARTED|Retreatment||8
11047289|NCT00946881|12227834|FG000|COMPLETED|Retreatment||7
11047290|NCT00946881|12227834|FG000|NOT COMPLETED|Retreatment||1
11047291|NCT00946920|12227861|FG000|STARTED|Overall Study|Received at least one dose of degarelix.|565
11047292|NCT00946920|12227862|FG001|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
11047293|NCT00946920|12227861|FG000|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
11047294|NCT00946920|12227862|FG001|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
11047295|NCT00946920|12227861|FG000|COMPLETED|Overall Study||455
11047296|NCT00946920|12227862|FG001|COMPLETED|Overall Study||239
11047297|NCT00946920|12227861|FG000|NOT COMPLETED|Overall Study||110
11047298|NCT00946920|12227862|FG001|NOT COMPLETED|Overall Study||44
11047299|NCT00946998|12227870|FG000|STARTED|Overall Study||102
11047300|NCT00946998|12227871|FG001|STARTED|Overall Study||99
11047301|NCT00946998|12227870|FG000|Received Treatment as Randomized|Overall Study||102
11047302|NCT00946998|12227871|FG001|Received Treatment as Randomized|Overall Study||99
11047303|NCT00946998|12227870|FG000|COMPLETED|Overall Study||97
11047304|NCT00946998|12227871|FG001|COMPLETED|Overall Study||96
11047305|NCT00946998|12227870|FG000|NOT COMPLETED|Overall Study||5
11047306|NCT00946998|12227871|FG001|NOT COMPLETED|Overall Study||3
11047307|NCT00947115|12227880|FG000|STARTED|Overall Study||159
11047308|NCT00947115|12227881|FG001|STARTED|Overall Study||194
11047309|NCT00947115|12227882|FG002|STARTED|Overall Study||171
11047310|NCT00947115|12227880|FG000|COMPLETED|Overall Study||142
11047311|NCT00947115|12227881|FG001|COMPLETED|Overall Study||172
11047312|NCT00947115|12227882|FG002|COMPLETED|Overall Study||156
11047313|NCT00947115|12227880|FG000|NOT COMPLETED|Overall Study||17
11047314|NCT00947115|12227881|FG001|NOT COMPLETED|Overall Study||22
11047315|NCT00947115|12227882|FG002|NOT COMPLETED|Overall Study||15
11336865|NCT02884427|12534593|FG001|NOT COMPLETED|Overall Study||0
11336866|NCT02884427|12534594|FG002|NOT COMPLETED|Overall Study||0
11336867|NCT02884492|12534604|FG000|STARTED|Overall Study||7
11336868|NCT02884492|12534605|FG001|STARTED|Overall Study||10
11336869|NCT02884492|12534604|FG000|COMPLETED|Overall Study||7
11336870|NCT02884492|12534605|FG001|COMPLETED|Overall Study||10
11336871|NCT02884492|12534604|FG000|NOT COMPLETED|Overall Study||0
11336872|NCT02884492|12534605|FG001|NOT COMPLETED|Overall Study||0
11336873|NCT02885012|12534613|FG000|STARTED|Overall Study||1
11336874|NCT02885012|12534614|FG001|STARTED|Overall Study||2
11336875|NCT02885012|12534613|FG000|COMPLETED|Overall Study||1
11336876|NCT02885012|12534614|FG001|COMPLETED|Overall Study||2
11336877|NCT02885012|12534613|FG000|NOT COMPLETED|Overall Study||0
11336878|NCT02885012|12534614|FG001|NOT COMPLETED|Overall Study||0
11336879|NCT02885025|12534624|FG000|STARTED|Overall Study||16
11336880|NCT02885025|12534625|FG001|STARTED|Overall Study||14
11336881|NCT02885025|12534626|FG002|STARTED|Overall Study||9
11336882|NCT02885025|12534627|FG003|STARTED|Overall Study||8
11336883|NCT02885025|12534624|FG000|COMPLETED|Overall Study||16
11336884|NCT02885025|12534625|FG001|COMPLETED|Overall Study||12
11336885|NCT02885025|12534626|FG002|COMPLETED|Overall Study||9
11336886|NCT02885025|12534627|FG003|COMPLETED|Overall Study||8
11336887|NCT02885025|12534624|FG000|NOT COMPLETED|Overall Study||0
11336888|NCT02885025|12534625|FG001|NOT COMPLETED|Overall Study||2
11336889|NCT02885025|12534626|FG002|NOT COMPLETED|Overall Study||0
11336890|NCT02885025|12534627|FG003|NOT COMPLETED|Overall Study||0
11336891|NCT02885181|12534645|FG000|STARTED|Overall Study||20
11047316|NCT00947154|12227890|FG000|STARTED|Overall Study||12
11047317|NCT00947154|12227890|FG000|COMPLETED|Overall Study||11
11047318|NCT00947154|12227890|FG000|NOT COMPLETED|Overall Study||1
11336892|NCT02885181|12534646|FG001|STARTED|Overall Study||20
11336893|NCT02885181|12534647|FG002|STARTED|Overall Study||21
11336894|NCT02885181|12534648|FG003|STARTED|Overall Study||22
11336895|NCT02885181|12534645|FG000|COMPLETED|Overall Study||20
11047319|NCT00947167|12227895|FG000|STARTED|Pertuzumab Alone||4
11047320|NCT00947167|12227895|FG000|COMPLETED|Pertuzumab Alone||4
11047321|NCT00947167|12227895|FG000|NOT COMPLETED|Pertuzumab Alone||0
11201380|NCT01832038|12391635|FG000|NOT COMPLETED|Overall Study||235
11336896|NCT02885181|12534646|FG001|COMPLETED|Overall Study||19
11336897|NCT02885181|12534647|FG002|COMPLETED|Overall Study||21
11336898|NCT02885181|12534648|FG003|COMPLETED|Overall Study||19
11336899|NCT02885181|12534645|FG000|NOT COMPLETED|Overall Study||0
11047322|NCT00947167|12227895|FG000|STARTED|Erlotinib Added to Pertuzumab||3
11047323|NCT00947167|12227895|FG000|COMPLETED|Erlotinib Added to Pertuzumab||3
11047324|NCT00947167|12227895|FG000|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
11047325|NCT00947193|12227899|FG000|STARTED|Overall Study||3
11047326|NCT00947193|12227900|FG001|STARTED|Overall Study||10
11047327|NCT00947193|12227899|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11047328|NCT00947193|12227900|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
11047329|NCT00947193|12227899|FG000|COMPLETED|Overall Study||0
11047330|NCT00947193|12227900|FG001|COMPLETED|Overall Study||10
11047331|NCT00947193|12227899|FG000|NOT COMPLETED|Overall Study||3
11047332|NCT00947193|12227900|FG001|NOT COMPLETED|Overall Study||0
11047333|NCT00947219|12227908|FG000|STARTED|Overall Study||28
11047334|NCT00947219|12227909|FG001|STARTED|Overall Study||25
11047335|NCT00947219|12227910|FG002|STARTED|Overall Study||26
11047336|NCT00947219|12227908|FG000|COMPLETED|Overall Study||22
11047337|NCT00947219|12227909|FG001|COMPLETED|Overall Study||21
11047338|NCT00947219|12227910|FG002|COMPLETED|Overall Study||22
11047339|NCT00947219|12227908|FG000|NOT COMPLETED|Overall Study||6
11047340|NCT00947219|12227909|FG001|NOT COMPLETED|Overall Study||4
11047341|NCT00947219|12227910|FG002|NOT COMPLETED|Overall Study||4
11047342|NCT00947271|12227922|FG000|STARTED|3 Months Post Intervention||254
11047343|NCT00947271|12227923|FG001|STARTED|3 Months Post Intervention||252
11047344|NCT00947271|12227924|FG002|STARTED|3 Months Post Intervention||254
11047345|NCT00947271|12227925|FG003|STARTED|3 Months Post Intervention||250
11047346|NCT00947271|12227922|FG000|COMPLETED|3 Months Post Intervention||202
11047347|NCT00947271|12227923|FG001|COMPLETED|3 Months Post Intervention||204
11047348|NCT00947271|12227924|FG002|COMPLETED|3 Months Post Intervention||218
11047349|NCT00947271|12227925|FG003|COMPLETED|3 Months Post Intervention||206
11047350|NCT00947271|12227922|FG000|NOT COMPLETED|3 Months Post Intervention||52
11047351|NCT00947271|12227923|FG001|NOT COMPLETED|3 Months Post Intervention||48
11047352|NCT00947271|12227924|FG002|NOT COMPLETED|3 Months Post Intervention||36
11047353|NCT00947271|12227925|FG003|NOT COMPLETED|3 Months Post Intervention||44
11047354|NCT00947271|12227922|FG000|STARTED|6 Months Post Intervention||254
11047355|NCT00947271|12227923|FG001|STARTED|6 Months Post Intervention||252
11047356|NCT00947271|12227924|FG002|STARTED|6 Months Post Intervention||254
11047357|NCT00947271|12227925|FG003|STARTED|6 Months Post Intervention||250
11047358|NCT00947271|12227922|FG000|COMPLETED|6 Months Post Intervention||199
11047359|NCT00947271|12227923|FG001|COMPLETED|6 Months Post Intervention||199
11047360|NCT00947271|12227924|FG002|COMPLETED|6 Months Post Intervention||196
11047361|NCT00947271|12227925|FG003|COMPLETED|6 Months Post Intervention||196
11047362|NCT00947271|12227922|FG000|NOT COMPLETED|6 Months Post Intervention||55
11047363|NCT00947271|12227923|FG001|NOT COMPLETED|6 Months Post Intervention||53
11047364|NCT00947271|12227924|FG002|NOT COMPLETED|6 Months Post Intervention||58
11047365|NCT00947271|12227925|FG003|NOT COMPLETED|6 Months Post Intervention||54
11047366|NCT00947271|12227922|FG000|STARTED|9 Months Post Intervention||254
11047367|NCT00947271|12227923|FG001|STARTED|9 Months Post Intervention||252
11047368|NCT00947271|12227924|FG002|STARTED|9 Months Post Intervention||254
11047369|NCT00947271|12227925|FG003|STARTED|9 Months Post Intervention||250
11047370|NCT00947271|12227922|FG000|COMPLETED|9 Months Post Intervention||184
11047371|NCT00947271|12227923|FG001|COMPLETED|9 Months Post Intervention||192
11047372|NCT00947271|12227924|FG002|COMPLETED|9 Months Post Intervention||193
11047373|NCT00947271|12227925|FG003|COMPLETED|9 Months Post Intervention||191
11047374|NCT00947271|12227922|FG000|NOT COMPLETED|9 Months Post Intervention||70
11047375|NCT00947271|12227923|FG001|NOT COMPLETED|9 Months Post Intervention||60
11047376|NCT00947271|12227924|FG002|NOT COMPLETED|9 Months Post Intervention||61
11047377|NCT00947271|12227925|FG003|NOT COMPLETED|9 Months Post Intervention||59
11047378|NCT00947271|12227922|FG000|STARTED|12 Months Post Intervention||254
11336900|NCT02885181|12534646|FG001|NOT COMPLETED|Overall Study||1
11336901|NCT02885181|12534647|FG002|NOT COMPLETED|Overall Study||0
11336902|NCT02885181|12534648|FG003|NOT COMPLETED|Overall Study||3
11336903|NCT02885246|12534662|FG000|STARTED|Overall Study||1839
11336904|NCT02885246|12534662|FG000|COMPLETED|Overall Study||1839
11336905|NCT02885246|12534662|FG000|NOT COMPLETED|Overall Study||0
11047379|NCT00947271|12227923|FG001|STARTED|12 Months Post Intervention||252
11047380|NCT00947271|12227924|FG002|STARTED|12 Months Post Intervention||254
11047381|NCT00947271|12227925|FG003|STARTED|12 Months Post Intervention||250
11047382|NCT00947271|12227922|FG000|COMPLETED|12 Months Post Intervention||183
11047383|NCT00947271|12227923|FG001|COMPLETED|12 Months Post Intervention||192
11047384|NCT00947271|12227924|FG002|COMPLETED|12 Months Post Intervention||195
11201381|NCT01832090|12391642|FG000|STARTED|Overall Study||89
11201382|NCT01832090|12391643|FG001|STARTED|Overall Study||29
11201383|NCT01832090|12391642|FG000|COMPLETED|Overall Study||83
11201384|NCT01832090|12391643|FG001|COMPLETED|Overall Study||28
11201385|NCT01832090|12391642|FG000|NOT COMPLETED|Overall Study||6
11336906|NCT02885350|12534670|FG000|STARTED|Overall Study||20
11336907|NCT02885350|12534671|FG001|STARTED|Overall Study||20
11336908|NCT02885350|12534672|FG002|STARTED|Overall Study||20
11336909|NCT02885350|12534673|FG003|STARTED|Overall Study||20
11336910|NCT02885350|12534670|FG000|COMPLETED|Overall Study||20
11336911|NCT02885350|12534671|FG001|COMPLETED|Overall Study||20
11336912|NCT02885350|12534672|FG002|COMPLETED|Overall Study||20
11336913|NCT02885350|12534673|FG003|COMPLETED|Overall Study||20
11336914|NCT02885350|12534670|FG000|NOT COMPLETED|Overall Study||0
11336915|NCT02885350|12534671|FG001|NOT COMPLETED|Overall Study||0
11336916|NCT02885350|12534672|FG002|NOT COMPLETED|Overall Study||0
11336917|NCT02885350|12534673|FG003|NOT COMPLETED|Overall Study||0
11336918|NCT02885506|12534693|FG000|STARTED|Part A||6
11336919|NCT02885506|12534694|FG001|STARTED|Part A||6
11336920|NCT02885506|12534695|FG002|STARTED|Part A||6
11336921|NCT02885506|12534696|FG003|STARTED|Part A||6
11336922|NCT02885506|12534697|FG004|STARTED|Part A||6
11336923|NCT02885506|12534698|FG005|STARTED|Part A||6
11336924|NCT02885506|12534699|FG006|STARTED|Part A||6
11336925|NCT02885506|12534700|FG007|STARTED|Part A||14
11336926|NCT02885506|12534701|FG008|STARTED|Part A||0
11336927|NCT02885506|12534702|FG009|STARTED|Part A||0
11336928|NCT02885506|12534693|FG000|COMPLETED|Part A||6
11336929|NCT02885506|12534694|FG001|COMPLETED|Part A||6
11336930|NCT02885506|12534695|FG002|COMPLETED|Part A||6
11336931|NCT02885506|12534696|FG003|COMPLETED|Part A||6
11336932|NCT02885506|12534697|FG004|COMPLETED|Part A||6
11336933|NCT02885506|12534698|FG005|COMPLETED|Part A||6
11336934|NCT02885506|12534699|FG006|COMPLETED|Part A||6
11336935|NCT02885506|12534700|FG007|COMPLETED|Part A||14
11336936|NCT02885506|12534701|FG008|COMPLETED|Part A||0
11336937|NCT02885506|12534702|FG009|COMPLETED|Part A||0
11336938|NCT02885506|12534693|FG000|NOT COMPLETED|Part A||0
11336939|NCT02885506|12534694|FG001|NOT COMPLETED|Part A||0
11336940|NCT02885506|12534695|FG002|NOT COMPLETED|Part A||0
11336941|NCT02885506|12534696|FG003|NOT COMPLETED|Part A||0
11336942|NCT02885506|12534697|FG004|NOT COMPLETED|Part A||0
11336943|NCT02885506|12534698|FG005|NOT COMPLETED|Part A||0
11336944|NCT02885506|12534699|FG006|NOT COMPLETED|Part A||0
11336945|NCT02885506|12534700|FG007|NOT COMPLETED|Part A||0
11336946|NCT02885506|12534701|FG008|NOT COMPLETED|Part A||0
11336947|NCT02885506|12534702|FG009|NOT COMPLETED|Part A||0
11336948|NCT02885506|12534693|FG000|STARTED|Part B||0
11336949|NCT02885506|12534694|FG001|STARTED|Part B||0
11336950|NCT02885506|12534695|FG002|STARTED|Part B||0
11336951|NCT02885506|12534696|FG003|STARTED|Part B||0
11336952|NCT02885506|12534697|FG004|STARTED|Part B||0
11336953|NCT02885506|12534698|FG005|STARTED|Part B||0
11336954|NCT02885506|12534699|FG006|STARTED|Part B||0
11336955|NCT02885506|12534700|FG007|STARTED|Part B||0
11336956|NCT02885506|12534701|FG008|STARTED|Part B||4
11336957|NCT02885506|12534702|FG009|STARTED|Part B||4
11336958|NCT02885506|12534693|FG000|COMPLETED|Part B||0
11047385|NCT00947271|12227925|FG003|COMPLETED|12 Months Post Intervention||188
11047386|NCT00947271|12227922|FG000|NOT COMPLETED|12 Months Post Intervention||71
11047387|NCT00947271|12227923|FG001|NOT COMPLETED|12 Months Post Intervention||60
11047388|NCT00947271|12227924|FG002|NOT COMPLETED|12 Months Post Intervention||59
11047389|NCT00947271|12227925|FG003|NOT COMPLETED|12 Months Post Intervention||62
11047390|NCT00947297|12227935|FG000|STARTED|Overall Study||60
11047391|NCT00947297|12227935|FG000|COMPLETED|Overall Study||53
11047392|NCT00947297|12227935|FG000|NOT COMPLETED|Overall Study||7
11047393|NCT00947310|12227943|FG000|STARTED|Overall Study||514
11047394|NCT00947310|12227944|FG001|STARTED|Overall Study||500
11047395|NCT00947310|12227945|FG002|STARTED|Overall Study||486
11047396|NCT00947310|12227943|FG000|COMPLETED|Overall Study||514
11047397|NCT00947310|12227944|FG001|COMPLETED|Overall Study||500
11047398|NCT00947310|12227945|FG002|COMPLETED|Overall Study||486
11047399|NCT00947310|12227943|FG000|NOT COMPLETED|Overall Study||0
11047400|NCT00947310|12227944|FG001|NOT COMPLETED|Overall Study||0
11047401|NCT00947310|12227945|FG002|NOT COMPLETED|Overall Study||0
11047402|NCT00947349|12227957|FG000|STARTED|Triple Treatment Combination Period||4
11047403|NCT00947349|12227958|FG001|STARTED|Triple Treatment Combination Period||6
11047404|NCT00947349|12227959|FG002|STARTED|Triple Treatment Combination Period||6
11047405|NCT00947349|12227960|FG003|STARTED|Triple Treatment Combination Period||6
11047406|NCT00947349|12227957|FG000|COMPLETED|Triple Treatment Combination Period||4
11047407|NCT00947349|12227958|FG001|COMPLETED|Triple Treatment Combination Period||5
11047408|NCT00947349|12227959|FG002|COMPLETED|Triple Treatment Combination Period||6
11047409|NCT00947349|12227960|FG003|COMPLETED|Triple Treatment Combination Period||6
11336959|NCT02885506|12534694|FG001|COMPLETED|Part B||0
11336960|NCT02885506|12534695|FG002|COMPLETED|Part B||0
11336961|NCT02885506|12534696|FG003|COMPLETED|Part B||0
11336962|NCT02885506|12534697|FG004|COMPLETED|Part B||0
11336963|NCT02885506|12534698|FG005|COMPLETED|Part B||0
11336964|NCT02885506|12534699|FG006|COMPLETED|Part B||0
11336965|NCT02885506|12534700|FG007|COMPLETED|Part B||0
11336966|NCT02885506|12534701|FG008|COMPLETED|Part B||4
11336967|NCT02885506|12534702|FG009|COMPLETED|Part B||4
11336968|NCT02885506|12534693|FG000|NOT COMPLETED|Part B||0
11336969|NCT02885506|12534694|FG001|NOT COMPLETED|Part B||0
11336970|NCT02885506|12534695|FG002|NOT COMPLETED|Part B||0
11336971|NCT02885506|12534696|FG003|NOT COMPLETED|Part B||0
11336972|NCT02885506|12534697|FG004|NOT COMPLETED|Part B||0
11336973|NCT02885506|12534698|FG005|NOT COMPLETED|Part B||0
11047410|NCT00947349|12227957|FG000|NOT COMPLETED|Triple Treatment Combination Period||0
11047411|NCT00947349|12227958|FG001|NOT COMPLETED|Triple Treatment Combination Period||1
11047412|NCT00947349|12227959|FG002|NOT COMPLETED|Triple Treatment Combination Period||0
11047413|NCT00947349|12227960|FG003|NOT COMPLETED|Triple Treatment Combination Period||0
11336974|NCT02885506|12534699|FG006|NOT COMPLETED|Part B||0
11336975|NCT02885506|12534700|FG007|NOT COMPLETED|Part B||0
11336976|NCT02885506|12534701|FG008|NOT COMPLETED|Part B||0
11336977|NCT02885506|12534702|FG009|NOT COMPLETED|Part B||0
11336978|NCT02885636|12534728|FG000|STARTED|Overall Study||15
11336979|NCT02885636|12534729|FG001|STARTED|Overall Study||15
11336980|NCT02885636|12534728|FG000|COMPLETED|Overall Study||15
11336981|NCT02885636|12534729|FG001|COMPLETED|Overall Study||15
11336982|NCT02885636|12534728|FG000|NOT COMPLETED|Overall Study||0
11336983|NCT02885636|12534729|FG001|NOT COMPLETED|Overall Study||0
11336984|NCT02886234|12534737|FG000|STARTED|Overall Study||20
11336985|NCT02886234|12534738|FG001|STARTED|Overall Study||24
11336986|NCT02886234|12534737|FG000|COMPLETED|Overall Study||20
11336987|NCT02886234|12534738|FG001|COMPLETED|Overall Study||22
11336988|NCT02886234|12534737|FG000|NOT COMPLETED|Overall Study||0
11336989|NCT02886234|12534738|FG001|NOT COMPLETED|Overall Study||2
11336990|NCT02886338|12534744|FG000|STARTED|Overall Study||10
11336991|NCT02886338|12534744|FG000|COMPLETED|Overall Study||9
11336992|NCT02886338|12534744|FG000|NOT COMPLETED|Overall Study||1
11336993|NCT02886494|12534750|FG000|STARTED|Overall Study||60
11336994|NCT02886494|12534751|FG001|STARTED|Overall Study||20
11336995|NCT02886494|12534750|FG000|COMPLETED|Overall Study||43
11336996|NCT02886494|12534751|FG001|COMPLETED|Overall Study||16
11336997|NCT02886494|12534750|FG000|NOT COMPLETED|Overall Study||17
11336998|NCT02886494|12534751|FG001|NOT COMPLETED|Overall Study||4
11336999|NCT02886624|12534760|FG000|STARTED|8-week Treatment||30
11337000|NCT02886624|12534760|FG000|COMPLETED|8-week Treatment||30
11337001|NCT02886624|12534760|FG000|NOT COMPLETED|8-week Treatment||0
11337002|NCT02886624|12534760|FG000|STARTED|12-week Post Treatment Follow-up||30
11337003|NCT02886624|12534760|FG000|COMPLETED|12-week Post Treatment Follow-up||29
11047414|NCT00947349|12227957|FG000|STARTED|Overall Study Standard of Care||4
11047415|NCT00947349|12227958|FG001|STARTED|Overall Study Standard of Care||5
11047416|NCT00947349|12227959|FG002|STARTED|Overall Study Standard of Care||6
11047417|NCT00947349|12227960|FG003|STARTED|Overall Study Standard of Care||6
11047418|NCT00947349|12227957|FG000|COMPLETED|Overall Study Standard of Care||4
11047419|NCT00947349|12227958|FG001|COMPLETED|Overall Study Standard of Care||5
11047420|NCT00947349|12227959|FG002|COMPLETED|Overall Study Standard of Care||4
11047421|NCT00947349|12227960|FG003|COMPLETED|Overall Study Standard of Care||4
11047422|NCT00947349|12227957|FG000|NOT COMPLETED|Overall Study Standard of Care||0
11047423|NCT00947349|12227958|FG001|NOT COMPLETED|Overall Study Standard of Care||0
11047424|NCT00947349|12227959|FG002|NOT COMPLETED|Overall Study Standard of Care||2
11047425|NCT00947349|12227960|FG003|NOT COMPLETED|Overall Study Standard of Care||2
11047426|NCT00947427|12227990|FG000|STARTED|Overall Study||22
11047427|NCT00947427|12227991|FG001|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
11047428|NCT00947427|12227990|FG000|COMPLETED|Overall Study||21
11047429|NCT00947427|12227991|FG001|COMPLETED|Overall Study||45
11047430|NCT00947427|12227990|FG000|NOT COMPLETED|Overall Study||1
11047431|NCT00947427|12227991|FG001|NOT COMPLETED|Overall Study||4
11047432|NCT00947505|12227999|FG000|STARTED|Overall Study||33
11047433|NCT00947505|12228000|FG001|STARTED|Overall Study||16
11047434|NCT00947505|12227999|FG000|COMPLETED|Overall Study||24
11047435|NCT00947505|12228000|FG001|COMPLETED|Overall Study||14
11047436|NCT00947505|12227999|FG000|NOT COMPLETED|Overall Study||9
11047437|NCT00947505|12228000|FG001|NOT COMPLETED|Overall Study||2
11047438|NCT00947531|12228008|FG000|STARTED|Overall Study||121
11047439|NCT00947531|12228009|FG001|STARTED|Overall Study||121
11047440|NCT00947531|12228008|FG000|COMPLETED|Overall Study||107
11047441|NCT00947531|12228009|FG001|COMPLETED|Overall Study||110
11047442|NCT00947531|12228008|FG000|NOT COMPLETED|Overall Study||14
11047443|NCT00947531|12228009|FG001|NOT COMPLETED|Overall Study||11
11047444|NCT00947544|12228015|FG000|STARTED|Switch-Over Period (2 Weeks)||11
11047445|NCT00947544|12228016|FG001|STARTED|Switch-Over Period (2 Weeks)||0
11047446|NCT00947544|12228015|FG000|COMPLETED|Switch-Over Period (2 Weeks)||11
11047447|NCT00947544|12228016|FG001|COMPLETED|Switch-Over Period (2 Weeks)||0
11047448|NCT00947544|12228015|FG000|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
11047449|NCT00947544|12228016|FG001|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
11047450|NCT00947544|12228015|FG000|STARTED|Safety-Extension Period (12 Months)||11
11047451|NCT00947544|12228016|FG001|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
11047452|NCT00947544|12228015|FG000|COMPLETED|Safety-Extension Period (12 Months)||10
11047453|NCT00947544|12228016|FG001|COMPLETED|Safety-Extension Period (12 Months)||6
11047454|NCT00947544|12228015|FG000|NOT COMPLETED|Safety-Extension Period (12 Months)||1
11047455|NCT00947544|12228016|FG001|NOT COMPLETED|Safety-Extension Period (12 Months)||0
11047456|NCT00947661|12228028|FG000|STARTED|Overall Study||289
11047457|NCT00947661|12228029|FG001|STARTED|Overall Study||289
11047458|NCT00947661|12228028|FG000|COMPLETED|Overall Study||276
11047459|NCT00947661|12228029|FG001|COMPLETED|Overall Study||274
11047460|NCT00947661|12228028|FG000|NOT COMPLETED|Overall Study||13
11047461|NCT00947661|12228029|FG001|NOT COMPLETED|Overall Study||15
11047462|NCT00947752|12228037|FG000|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
11047463|NCT00947752|12228038|FG001|STARTED|7-Day Run-in Treatment Period||0
11047464|NCT00947752|12228037|FG000|COMPLETED|7-Day Run-in Treatment Period||147
11047465|NCT00947752|12228038|FG001|COMPLETED|7-Day Run-in Treatment Period||0
11047466|NCT00947752|12228037|FG000|NOT COMPLETED|7-Day Run-in Treatment Period||0
11047467|NCT00947752|12228038|FG001|NOT COMPLETED|7-Day Run-in Treatment Period||0
11047468|NCT00947752|12228037|FG000|STARTED|1st 14-day Treatment Period||76
11047469|NCT00947752|12228038|FG001|STARTED|1st 14-day Treatment Period||71
11047470|NCT00947752|12228037|FG000|COMPLETED|1st 14-day Treatment Period||76
11047471|NCT00947752|12228038|FG001|COMPLETED|1st 14-day Treatment Period||71
11047472|NCT00947752|12228037|FG000|NOT COMPLETED|1st 14-day Treatment Period||0
11047473|NCT00947752|12228038|FG001|NOT COMPLETED|1st 14-day Treatment Period||0
11047474|NCT00947752|12228037|FG000|STARTED|Crossover to 2nd 14-day Treatment Period||71
11047475|NCT00947752|12228038|FG001|STARTED|Crossover to 2nd 14-day Treatment Period||76
11047476|NCT00947752|12228037|FG000|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
11047477|NCT00947752|12228038|FG001|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
11047478|NCT00947752|12228037|FG000|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
11047479|NCT00947752|12228038|FG001|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
11047480|NCT00947765|12228046|FG000|STARTED|Overall Study||30
11047481|NCT00947765|12228047|FG001|STARTED|Overall Study||30
11047482|NCT00947765|12228046|FG000|COMPLETED|Overall Study||30
11047483|NCT00947765|12228047|FG001|COMPLETED|Overall Study||30
11047484|NCT00947765|12228046|FG000|NOT COMPLETED|Overall Study||0
11047485|NCT00947765|12228047|FG001|NOT COMPLETED|Overall Study||0
11047486|NCT00947856|12228055|FG000|STARTED|Treatment Period||78
11047487|NCT00947856|12228056|FG001|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
11047488|NCT00947856|12228055|FG000|COMPLETED|Treatment Period||0
11337004|NCT02886624|12534760|FG000|NOT COMPLETED|12-week Post Treatment Follow-up||1
11047489|NCT00947856|12228056|FG001|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
11047490|NCT00947856|12228055|FG000|NOT COMPLETED|Treatment Period||78
11047491|NCT00947856|12228056|FG001|NOT COMPLETED|Treatment Period||32
11047492|NCT00947856|12228055|FG000|STARTED|Follow-up Period||78
11047493|NCT00947856|12228056|FG001|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
11047494|NCT00947856|12228055|FG000|COMPLETED|Follow-up Period||27
11047495|NCT00947856|12228056|FG001|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
11047496|NCT00947856|12228055|FG000|NOT COMPLETED|Follow-up Period||51
11047497|NCT00947856|12228056|FG001|NOT COMPLETED|Follow-up Period||23
11047498|NCT00947882|12228075|FG000|STARTED|Overall Study|Started: Randomised.|100
11047499|NCT00947882|12228076|FG001|STARTED|Overall Study||101
11047500|NCT00947882|12228077|FG002|STARTED|Overall Study||101
11047501|NCT00947882|12228078|FG003|STARTED|Overall Study||102
11047502|NCT00947882|12228075|FG000|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
11047503|NCT00947882|12228076|FG001|Full Analysis Set (FAS)|Overall Study||101
11047504|NCT00947882|12228077|FG002|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
11047505|NCT00947882|12228078|FG003|Full Analysis Set (FAS)|Overall Study||102
11047506|NCT00947882|12228075|FG000|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
11047507|NCT00947882|12228076|FG001|Actual Treatment|Overall Study||101
11047508|NCT00947882|12228077|FG002|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
11047509|NCT00947882|12228078|FG003|Actual Treatment|Overall Study||105
11058057|NCT01001403|12239832|FG001|STARTED|Overall Study||31
11058058|NCT01001403|12239831|FG000|COMPLETED|Overall Study||31
11047510|NCT00947882|12228075|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
11047511|NCT00947882|12228076|FG001|Safety Analysis Set|Overall Study||101
11047512|NCT00947882|12228077|FG002|Safety Analysis Set|Overall Study||100
11047513|NCT00947882|12228078|FG003|Safety Analysis Set|Overall Study||105
11047514|NCT00947882|12228075|FG000|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
11047515|NCT00947882|12228076|FG001|Visit 12, Month 6|Overall Study||91
11047516|NCT00947882|12228077|FG002|Visit 12, Month 6|Overall Study||90
11047517|NCT00947882|12228078|FG003|Visit 12, Month 6|Overall Study||95
11047518|NCT00947882|12228075|FG000|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
11047519|NCT00947882|12228076|FG001|COMPLETED|Overall Study||24
11047520|NCT00947882|12228077|FG002|COMPLETED|Overall Study||22
11047521|NCT00947882|12228078|FG003|COMPLETED|Overall Study||20
11047522|NCT00947882|12228075|FG000|NOT COMPLETED|Overall Study||74
11047523|NCT00947882|12228076|FG001|NOT COMPLETED|Overall Study||77
11047524|NCT00947882|12228077|FG002|NOT COMPLETED|Overall Study||79
11047525|NCT00947882|12228078|FG003|NOT COMPLETED|Overall Study||82
11047526|NCT00948025|12228091|FG000|STARTED|Phase 1 (Pilot Phase)||14
11047527|NCT00948025|12228092|FG001|STARTED|Phase 1 (Pilot Phase)||9
11047528|NCT00948025|12228091|FG000|COMPLETED|Phase 1 (Pilot Phase)||5
11047529|NCT00948025|12228092|FG001|COMPLETED|Phase 1 (Pilot Phase)||6
11047530|NCT00948025|12228091|FG000|NOT COMPLETED|Phase 1 (Pilot Phase)||9
11047531|NCT00948025|12228092|FG001|NOT COMPLETED|Phase 1 (Pilot Phase)||3
11047532|NCT00948025|12228091|FG000|STARTED|Phase 2 (Comparative Phase)||0
11047533|NCT00948025|12228092|FG001|STARTED|Phase 2 (Comparative Phase)||0
11047534|NCT00948025|12228091|FG000|COMPLETED|Phase 2 (Comparative Phase)||0
11047535|NCT00948025|12228092|FG001|COMPLETED|Phase 2 (Comparative Phase)||0
11047536|NCT00948025|12228091|FG000|NOT COMPLETED|Phase 2 (Comparative Phase)||0
11047537|NCT00948025|12228092|FG001|NOT COMPLETED|Phase 2 (Comparative Phase)||0
11047538|NCT00948064|12228102|FG000|STARTED|Phase I||31
11047539|NCT00948064|12228103|FG001|STARTED|Phase I||0
11047540|NCT00948064|12228104|FG002|STARTED|Phase I||0
11047541|NCT00948064|12228102|FG000|COMPLETED|Phase I||30
11047542|NCT00948064|12228103|FG001|COMPLETED|Phase I||0
11047543|NCT00948064|12228104|FG002|COMPLETED|Phase I||0
11047544|NCT00948064|12228102|FG000|NOT COMPLETED|Phase I||1
11047545|NCT00948064|12228103|FG001|NOT COMPLETED|Phase I||0
11047546|NCT00948064|12228104|FG002|NOT COMPLETED|Phase I||0
11047547|NCT00948064|12228102|FG000|STARTED|Phase II||0
11047548|NCT00948064|12228103|FG001|STARTED|Phase II||52
11047549|NCT00948064|12228104|FG002|STARTED|Phase II||27
11047550|NCT00948064|12228102|FG000|COMPLETED|Phase II||0
11047551|NCT00948064|12228103|FG001|COMPLETED|Phase II||51
11047552|NCT00948064|12228104|FG002|COMPLETED|Phase II||26
11047553|NCT00948064|12228102|FG000|NOT COMPLETED|Phase II||0
11047554|NCT00948064|12228103|FG001|NOT COMPLETED|Phase II||1
11047555|NCT00948064|12228104|FG002|NOT COMPLETED|Phase II||1
11047556|NCT00948090|12228116|FG000|STARTED|Overall Study||65
11047557|NCT00948090|12228117|FG001|STARTED|Overall Study||1
11047558|NCT00948090|12228118|FG002|STARTED|Overall Study||123
11047559|NCT00948090|12228119|FG003|STARTED|Overall Study||18
11047560|NCT00948090|12228116|FG000|COMPLETED|Overall Study||22
11047561|NCT00948090|12228117|FG001|COMPLETED|Overall Study||0
11047562|NCT00948090|12228118|FG002|COMPLETED|Overall Study||67
11047563|NCT00948090|12228119|FG003|COMPLETED|Overall Study||7
11047564|NCT00948090|12228116|FG000|NOT COMPLETED|Overall Study||43
11047565|NCT00948090|12228117|FG001|NOT COMPLETED|Overall Study||1
11047566|NCT00948090|12228118|FG002|NOT COMPLETED|Overall Study||56
11047567|NCT00948090|12228119|FG003|NOT COMPLETED|Overall Study||11
11047568|NCT00948155|12228128|FG000|STARTED|First Intervention 21 Days||14
11047569|NCT00948155|12228129|FG001|STARTED|First Intervention 21 Days||15
11047570|NCT00948155|12228128|FG000|COMPLETED|First Intervention 21 Days||12
11047571|NCT00948155|12228129|FG001|COMPLETED|First Intervention 21 Days||13
11047572|NCT00948155|12228128|FG000|NOT COMPLETED|First Intervention 21 Days||2
11047573|NCT00948155|12228129|FG001|NOT COMPLETED|First Intervention 21 Days||2
11337005|NCT02886624|12534760|FG000|STARTED|48-week Post Treatment Follow-up||29
11337006|NCT02886624|12534760|FG000|COMPLETED|48-week Post Treatment Follow-up||28
11337007|NCT02886624|12534760|FG000|NOT COMPLETED|48-week Post Treatment Follow-up||1
11337008|NCT02886702|12534767|FG000|STARTED|Overall Study||284
11337009|NCT02886702|12534768|FG001|STARTED|Overall Study||286
11337010|NCT02886702|12534769|FG002|STARTED|Overall Study||285
11337011|NCT02886702|12534767|FG000|Modified Intent-to Treat (mITT)|Overall Study||263
11337012|NCT02886702|12534768|FG001|Modified Intent-to Treat (mITT)|Overall Study||266
11337013|NCT02886702|12534769|FG002|Modified Intent-to Treat (mITT)|Overall Study||275
11337014|NCT02886702|12534767|FG000|Per-Protocol Population (PP)|Overall Study||208
11337015|NCT02886702|12534768|FG001|Per-Protocol Population (PP)|Overall Study||209
11337016|NCT02886702|12534769|FG002|Per-Protocol Population (PP)|Overall Study||201
11337017|NCT02886702|12534767|FG000|COMPLETED|Overall Study||236
11337018|NCT02886702|12534768|FG001|COMPLETED|Overall Study||235
11047574|NCT00948155|12228128|FG000|STARTED|Washout 14 Days||12
11047575|NCT00948155|12228129|FG001|STARTED|Washout 14 Days||13
11047576|NCT00948155|12228128|FG000|COMPLETED|Washout 14 Days||11
11337019|NCT02886702|12534769|FG002|COMPLETED|Overall Study||232
11337020|NCT02886702|12534767|FG000|NOT COMPLETED|Overall Study||48
11337021|NCT02886702|12534768|FG001|NOT COMPLETED|Overall Study||51
11337022|NCT02886702|12534769|FG002|NOT COMPLETED|Overall Study||53
11337023|NCT02886715|12534780|FG000|STARTED|Overall Study||442
11337024|NCT02886715|12534781|FG001|STARTED|Overall Study||445
11337025|NCT02886715|12534782|FG002|STARTED|Overall Study||223
11337026|NCT02886715|12534780|FG000|Modified ITT (mITT)|Overall Study||421
11337027|NCT02886715|12534781|FG001|Modified ITT (mITT)|Overall Study||418
11337028|NCT02886715|12534782|FG002|Modified ITT (mITT)|Overall Study||217
11337029|NCT02886715|12534780|FG000|Per Protocol (PP) Population|Overall Study||346
11337030|NCT02886715|12534781|FG001|Per Protocol (PP) Population|Overall Study||351
11337031|NCT02886715|12534782|FG002|Per Protocol (PP) Population|Overall Study||176
11337032|NCT02886715|12534780|FG000|COMPLETED|Overall Study||378
11337033|NCT02886715|12534781|FG001|COMPLETED|Overall Study||390
11337034|NCT02886715|12534782|FG002|COMPLETED|Overall Study||203
11337035|NCT02886715|12534780|FG000|NOT COMPLETED|Overall Study||64
11337036|NCT02886715|12534781|FG001|NOT COMPLETED|Overall Study||55
11047577|NCT00948155|12228129|FG001|COMPLETED|Washout 14 Days||11
11047578|NCT00948155|12228128|FG000|NOT COMPLETED|Washout 14 Days||1
11047579|NCT00948155|12228129|FG001|NOT COMPLETED|Washout 14 Days||2
11047580|NCT00948155|12228128|FG000|STARTED|Second Intervention 21 Days||11
11047581|NCT00948155|12228129|FG001|STARTED|Second Intervention 21 Days||11
11047582|NCT00948155|12228128|FG000|COMPLETED|Second Intervention 21 Days||9
11047583|NCT00948155|12228129|FG001|COMPLETED|Second Intervention 21 Days||8
11047584|NCT00948155|12228128|FG000|NOT COMPLETED|Second Intervention 21 Days||2
11047585|NCT00948155|12228129|FG001|NOT COMPLETED|Second Intervention 21 Days||3
11047586|NCT00948246|12228137|FG000|STARTED|Overall Study||110
11047587|NCT00948246|12228137|FG000|COMPLETED|Overall Study||86
11047588|NCT00948246|12228137|FG000|NOT COMPLETED|Overall Study||24
11047589|NCT00948298|12228143|FG000|STARTED|Overall Study||65
11047590|NCT00948298|12228144|FG001|STARTED|Overall Study||65
11047591|NCT00948298|12228143|FG000|COMPLETED|Overall Study||55
11047592|NCT00948298|12228144|FG001|COMPLETED|Overall Study||60
11047593|NCT00948298|12228143|FG000|NOT COMPLETED|Overall Study||10
11047594|NCT00948298|12228144|FG001|NOT COMPLETED|Overall Study||5
11047595|NCT00948389|12228155|FG000|STARTED|Overall Study||6
11047596|NCT00948389|12228156|FG001|STARTED|Overall Study||3
11047597|NCT00948389|12228157|FG002|STARTED|Overall Study||7
11047598|NCT00948389|12228158|FG003|STARTED|Overall Study||9
11047599|NCT00948389|12228159|FG004|STARTED|Overall Study||1
11047600|NCT00948389|12228155|FG000|COMPLETED|Overall Study||0
11047601|NCT00948389|12228156|FG001|COMPLETED|Overall Study||0
11047602|NCT00948389|12228157|FG002|COMPLETED|Overall Study||0
11047603|NCT00948389|12228158|FG003|COMPLETED|Overall Study||0
11047604|NCT00948389|12228159|FG004|COMPLETED|Overall Study||0
11047605|NCT00948389|12228155|FG000|NOT COMPLETED|Overall Study||6
11337037|NCT02886715|12534782|FG002|NOT COMPLETED|Overall Study||20
11337038|NCT02886728|12534794|FG000|STARTED|Overall Study||417
11047606|NCT00948389|12228156|FG001|NOT COMPLETED|Overall Study||3
11047607|NCT00948389|12228157|FG002|NOT COMPLETED|Overall Study||7
11047608|NCT00948389|12228158|FG003|NOT COMPLETED|Overall Study||9
11047609|NCT00948389|12228159|FG004|NOT COMPLETED|Overall Study||1
11047610|NCT00948428|12228176|FG000|STARTED|Overall Study||185
11047611|NCT00948428|12228177|FG001|STARTED|Overall Study||185
11047612|NCT00948428|12228178|FG002|STARTED|Overall Study||92
11047613|NCT00948428|12228176|FG000|COMPLETED|Overall Study||167
11047614|NCT00948428|12228177|FG001|COMPLETED|Overall Study||167
11047615|NCT00948428|12228178|FG002|COMPLETED|Overall Study||84
11047616|NCT00948428|12228176|FG000|NOT COMPLETED|Overall Study||18
11047617|NCT00948428|12228177|FG001|NOT COMPLETED|Overall Study||18
11047618|NCT00948428|12228178|FG002|NOT COMPLETED|Overall Study||8
11047619|NCT00948441|12228188|FG000|STARTED|Overall Study||8
11047620|NCT00948441|12228189|FG001|STARTED|Overall Study||8
11047621|NCT00948441|12228188|FG000|COMPLETED|Overall Study||7
11047622|NCT00948441|12228189|FG001|COMPLETED|Overall Study||4
11047623|NCT00948441|12228188|FG000|NOT COMPLETED|Overall Study||1
11047624|NCT00948441|12228189|FG001|NOT COMPLETED|Overall Study||4
11047625|NCT00948506|12228199|FG000|STARTED|Overall Study||11
11047626|NCT00948506|12228200|FG001|STARTED|Overall Study||9
11047627|NCT00948506|12228199|FG000|COMPLETED|Overall Study||8
11047628|NCT00948506|12228200|FG001|COMPLETED|Overall Study||8
11047629|NCT00948506|12228199|FG000|NOT COMPLETED|Overall Study||3
11047630|NCT00948506|12228200|FG001|NOT COMPLETED|Overall Study||1
11047631|NCT00948610|12228211|FG000|STARTED|Overall Study||10
11047632|NCT00948610|12228212|FG001|STARTED|Overall Study||10
11047633|NCT00948610|12228211|FG000|COMPLETED|Overall Study||9
11047634|NCT00948610|12228212|FG001|COMPLETED|Overall Study||9
11047635|NCT00948610|12228211|FG000|NOT COMPLETED|Overall Study||1
11047636|NCT00948610|12228212|FG001|NOT COMPLETED|Overall Study||1
11047637|NCT00948675|12228220|FG000|STARTED|Overall Study||182
11047638|NCT00948675|12228221|FG001|STARTED|Overall Study||179
11047639|NCT00948675|12228220|FG000|Received Any Amount of Study Drug|Overall Study||171
11047640|NCT00948675|12228221|FG001|Received Any Amount of Study Drug|Overall Study||166
11047641|NCT00948675|12228220|FG000|COMPLETED|Overall Study||181
11047642|NCT00948675|12228221|FG001|COMPLETED|Overall Study||179
11047643|NCT00948675|12228220|FG000|NOT COMPLETED|Overall Study||1
11047644|NCT00948675|12228221|FG001|NOT COMPLETED|Overall Study||0
11047645|NCT00948688|12228227|FG000|STARTED|Period 1: 200 mg Vorinostat||4
11047646|NCT00948688|12228228|FG001|STARTED|Period 1: 200 mg Vorinostat||0
11047647|NCT00948688|12228227|FG000|COMPLETED|Period 1: 200 mg Vorinostat||2
11047648|NCT00948688|12228228|FG001|COMPLETED|Period 1: 200 mg Vorinostat||0
11047649|NCT00948688|12228227|FG000|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
11047650|NCT00948688|12228228|FG001|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
11047651|NCT00948688|12228227|FG000|STARTED|Period 2: 100 mg Vorinostat||0
11047652|NCT00948688|12228228|FG001|STARTED|Period 2: 100 mg Vorinostat||6
11047653|NCT00948688|12228227|FG000|COMPLETED|Period 2: 100 mg Vorinostat||0
11047654|NCT00948688|12228228|FG001|COMPLETED|Period 2: 100 mg Vorinostat||5
11047655|NCT00948688|12228227|FG000|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
11047656|NCT00948688|12228228|FG001|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
11047657|NCT00948766|12228237|FG000|STARTED|Core Study||356
11047658|NCT00948766|12228238|FG001|STARTED|Core Study||360
11047659|NCT00948766|12228237|FG000|Exposed to Study Medication|Core Study||355
11047660|NCT00948766|12228238|FG001|Exposed to Study Medication|Core Study||359
11047661|NCT00948766|12228237|FG000|COMPLETED|Core Study||229
11047662|NCT00948766|12228238|FG001|COMPLETED|Core Study||234
11047663|NCT00948766|12228237|FG000|NOT COMPLETED|Core Study||127
11047664|NCT00948766|12228238|FG001|NOT COMPLETED|Core Study||126
11047665|NCT00948766|12228237|FG000|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
11047666|NCT00948766|12228238|FG001|STARTED|Extension Study|No patients received this treatment in the extension study.|0
11047667|NCT00948766|12228237|FG000|Exposed to Study Medication|Extension Study||396
11047668|NCT00948766|12228238|FG001|Exposed to Study Medication|Extension Study||0
11047669|NCT00948766|12228237|FG000|COMPLETED|Extension Study||306
11047670|NCT00948766|12228238|FG001|COMPLETED|Extension Study||0
11047671|NCT00948766|12228237|FG000|NOT COMPLETED|Extension Study||91
11047672|NCT00948766|12228238|FG001|NOT COMPLETED|Extension Study||0
11047673|NCT00948792|12228245|FG000|STARTED|Overall Study||21
11047674|NCT00948792|12228245|FG000|COMPLETED|Overall Study||21
11047675|NCT00948792|12228245|FG000|NOT COMPLETED|Overall Study||0
11047676|NCT00948818|12228253|FG000|STARTED|Overall Study||397
11047677|NCT00948818|12228254|FG001|STARTED|Overall Study||406
11047678|NCT00948818|12228253|FG000|COMPLETED|Overall Study||335
11047679|NCT00948818|12228254|FG001|COMPLETED|Overall Study||312
11337039|NCT02886728|12534795|FG001|STARTED|Overall Study||207
11337040|NCT02886728|12534796|FG002|STARTED|Overall Study||210
11337041|NCT02886728|12534797|FG003|STARTED|Overall Study||418
11047680|NCT00948818|12228253|FG000|NOT COMPLETED|Overall Study||62
11047681|NCT00948818|12228254|FG001|NOT COMPLETED|Overall Study||94
11047682|NCT00948857|12228265|FG000|STARTED|Overall Study||3
11047683|NCT00948857|12228266|FG001|STARTED|Overall Study||2
11047684|NCT00948857|12228265|FG000|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
11047685|NCT00948857|12228266|FG001|COMPLETED|Overall Study||2
11047686|NCT00948857|12228265|FG000|NOT COMPLETED|Overall Study||1
11047687|NCT00948857|12228266|FG001|NOT COMPLETED|Overall Study||0
11047688|NCT00948896|12228280|FG000|STARTED|Randomization to 24 Months of Age||98
11047689|NCT00948896|12228281|FG001|STARTED|Randomization to 24 Months of Age||98
11047690|NCT00948896|12228282|FG002|STARTED|Randomization to 24 Months of Age||99
11047691|NCT00948896|12228283|FG003|STARTED|Randomization to 24 Months of Age||98
11047692|NCT00948896|12228284|FG004|STARTED|Randomization to 24 Months of Age||46
11047693|NCT00948896|12228285|FG005|STARTED|Randomization to 24 Months of Age||46
11047694|NCT00948896|12228286|FG006|STARTED|Randomization to 24 Months of Age||47
11047695|NCT00948896|12228287|FG007|STARTED|Randomization to 24 Months of Age||47
11337042|NCT02886728|12534794|FG000|COMPLETED|Overall Study||345
11337043|NCT02886728|12534795|FG001|COMPLETED|Overall Study||175
11047696|NCT00948896|12228280|FG000|COMPLETED|Randomization to 24 Months of Age||90
11047697|NCT00948896|12228281|FG001|COMPLETED|Randomization to 24 Months of Age||85
11047698|NCT00948896|12228282|FG002|COMPLETED|Randomization to 24 Months of Age||90
11047699|NCT00948896|12228283|FG003|COMPLETED|Randomization to 24 Months of Age||87
11047700|NCT00948896|12228284|FG004|COMPLETED|Randomization to 24 Months of Age||44
11047701|NCT00948896|12228285|FG005|COMPLETED|Randomization to 24 Months of Age||42
11047702|NCT00948896|12228286|FG006|COMPLETED|Randomization to 24 Months of Age||43
11047703|NCT00948896|12228287|FG007|COMPLETED|Randomization to 24 Months of Age||45
11047704|NCT00948896|12228280|FG000|NOT COMPLETED|Randomization to 24 Months of Age||8
11047705|NCT00948896|12228281|FG001|NOT COMPLETED|Randomization to 24 Months of Age||13
11047706|NCT00948896|12228282|FG002|NOT COMPLETED|Randomization to 24 Months of Age||9
11047707|NCT00948896|12228283|FG003|NOT COMPLETED|Randomization to 24 Months of Age||11
11047708|NCT00948896|12228284|FG004|NOT COMPLETED|Randomization to 24 Months of Age||2
11047709|NCT00948896|12228285|FG005|NOT COMPLETED|Randomization to 24 Months of Age||4
11047710|NCT00948896|12228286|FG006|NOT COMPLETED|Randomization to 24 Months of Age||4
11047711|NCT00948896|12228287|FG007|NOT COMPLETED|Randomization to 24 Months of Age||2
11047712|NCT00948896|12228280|FG000|STARTED|24 Months of Age to 36 Months of Age||90
11047713|NCT00948896|12228281|FG001|STARTED|24 Months of Age to 36 Months of Age||85
11047714|NCT00948896|12228282|FG002|STARTED|24 Months of Age to 36 Months of Age||90
11047715|NCT00948896|12228283|FG003|STARTED|24 Months of Age to 36 Months of Age||87
11047716|NCT00948896|12228284|FG004|STARTED|24 Months of Age to 36 Months of Age||44
11047717|NCT00948896|12228285|FG005|STARTED|24 Months of Age to 36 Months of Age||42
11047718|NCT00948896|12228286|FG006|STARTED|24 Months of Age to 36 Months of Age||43
11337044|NCT02886728|12534796|FG002|COMPLETED|Overall Study||174
11337045|NCT02886728|12534797|FG003|COMPLETED|Overall Study||331
11337046|NCT02886728|12534794|FG000|NOT COMPLETED|Overall Study||72
11337047|NCT02886728|12534795|FG001|NOT COMPLETED|Overall Study||32
11337048|NCT02886728|12534796|FG002|NOT COMPLETED|Overall Study||36
11337049|NCT02886728|12534797|FG003|NOT COMPLETED|Overall Study||87
11337050|NCT02886923|12534807|FG000|STARTED|Period 1||12
11337051|NCT02886923|12534808|FG001|STARTED|Period 1||11
11337052|NCT02886923|12534807|FG000|COMPLETED|Period 1||12
11337053|NCT02886923|12534808|FG001|COMPLETED|Period 1||11
11337054|NCT02886923|12534807|FG000|NOT COMPLETED|Period 1||0
11337055|NCT02886923|12534808|FG001|NOT COMPLETED|Period 1||0
11337056|NCT02886923|12534807|FG000|STARTED|Period 2||12
11337057|NCT02886923|12534808|FG001|STARTED|Period 2||11
11337058|NCT02886923|12534807|FG000|COMPLETED|Period 2||12
11337059|NCT02886923|12534808|FG001|COMPLETED|Period 2||11
11337060|NCT02886923|12534807|FG000|NOT COMPLETED|Period 2||0
11047719|NCT00948896|12228287|FG007|STARTED|24 Months of Age to 36 Months of Age||45
11047720|NCT00948896|12228280|FG000|COMPLETED|24 Months of Age to 36 Months of Age||87
11047721|NCT00948896|12228281|FG001|COMPLETED|24 Months of Age to 36 Months of Age||83
11047722|NCT00948896|12228282|FG002|COMPLETED|24 Months of Age to 36 Months of Age||85
11047723|NCT00948896|12228283|FG003|COMPLETED|24 Months of Age to 36 Months of Age||85
11047724|NCT00948896|12228284|FG004|COMPLETED|24 Months of Age to 36 Months of Age||43
11047725|NCT00948896|12228285|FG005|COMPLETED|24 Months of Age to 36 Months of Age||40
11047726|NCT00948896|12228286|FG006|COMPLETED|24 Months of Age to 36 Months of Age||43
11047727|NCT00948896|12228287|FG007|COMPLETED|24 Months of Age to 36 Months of Age||45
11047728|NCT00948896|12228280|FG000|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
11047729|NCT00948896|12228281|FG001|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
11047730|NCT00948896|12228282|FG002|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
11047731|NCT00948896|12228283|FG003|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
11047732|NCT00948896|12228284|FG004|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
11047733|NCT00948896|12228285|FG005|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
11047734|NCT00948896|12228286|FG006|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
11047735|NCT00948896|12228287|FG007|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
11047736|NCT00948922|12228312|FG000|STARTED|Overall Study||34
11047737|NCT00948922|12228313|FG001|STARTED|Overall Study||51
11047738|NCT00948922|12228314|FG002|STARTED|Overall Study||39
11047739|NCT00948922|12228312|FG000|COMPLETED|Overall Study||26
11047740|NCT00948922|12228313|FG001|COMPLETED|Overall Study||37
11047741|NCT00948922|12228314|FG002|COMPLETED|Overall Study||38
11047742|NCT00948922|12228312|FG000|NOT COMPLETED|Overall Study||8
11047743|NCT00948922|12228313|FG001|NOT COMPLETED|Overall Study||14
11047744|NCT00948922|12228314|FG002|NOT COMPLETED|Overall Study||1
11047745|NCT00948935|12228326|FG000|STARTED|Overall Study||35
11047746|NCT00948935|12228326|FG000|COMPLETED|Overall Study||35
11047747|NCT00948935|12228326|FG000|NOT COMPLETED|Overall Study||0
11047748|NCT00948974|12228332|FG000|STARTED|Overall Study||40
11047749|NCT00948974|12228333|FG001|STARTED|Overall Study||48
11047750|NCT00948974|12228332|FG000|COMPLETED|Overall Study||17
11047751|NCT00948974|12228333|FG001|COMPLETED|Overall Study||28
11047752|NCT00948974|12228332|FG000|NOT COMPLETED|Overall Study||23
11047753|NCT00948974|12228333|FG001|NOT COMPLETED|Overall Study||20
11047754|NCT00949078|12228341|FG000|STARTED|Overall Study||5
11337061|NCT02886923|12534808|FG001|NOT COMPLETED|Period 2||0
11337062|NCT02887183|12534814|FG000|STARTED|Overall Study||795
11337063|NCT02887183|12534814|FG000|Full Analysis Set|Overall Study||794
11047755|NCT00949078|12228342|FG001|STARTED|Overall Study||9
11047756|NCT00949078|12228341|FG000|COMPLETED|Overall Study||5
11047757|NCT00949078|12228342|FG001|COMPLETED|Overall Study||9
11047758|NCT00949078|12228341|FG000|NOT COMPLETED|Overall Study||0
11047759|NCT00949078|12228342|FG001|NOT COMPLETED|Overall Study||0
11047760|NCT00949117|12228350|FG000|STARTED|Overall Study||4
11047761|NCT00949117|12228351|FG001|STARTED|Overall Study||5
11047762|NCT00949117|12228350|FG000|COMPLETED|Overall Study||1
11047763|NCT00949117|12228351|FG001|COMPLETED|Overall Study||0
11047764|NCT00949117|12228350|FG000|NOT COMPLETED|Overall Study||3
11047765|NCT00949117|12228351|FG001|NOT COMPLETED|Overall Study||5
11047766|NCT00949234|12228359|FG000|STARTED|Overall Study||267
11047767|NCT00949234|12228359|FG000|COMPLETED|Overall Study||225
11047768|NCT00949234|12228359|FG000|NOT COMPLETED|Overall Study||42
11047769|NCT00949325|12228363|FG000|STARTED|Overall Study||3
11047770|NCT00949325|12228364|FG001|STARTED|Overall Study||18
11047771|NCT00949325|12228365|FG002|STARTED|Overall Study||3
11047772|NCT00949325|12228363|FG000|COMPLETED|Overall Study||3
11047773|NCT00949325|12228364|FG001|COMPLETED|Overall Study||16
11047774|NCT00949325|12228365|FG002|COMPLETED|Overall Study||3
11047775|NCT00949325|12228363|FG000|NOT COMPLETED|Overall Study||0
11047776|NCT00949325|12228364|FG001|NOT COMPLETED|Overall Study||2
11047777|NCT00949325|12228365|FG002|NOT COMPLETED|Overall Study||0
11047778|NCT00949533|12228383|FG000|STARTED|Overall Study||19
11047779|NCT00949533|12228384|FG001|STARTED|Overall Study||18
11047780|NCT00949533|12228383|FG000|COMPLETED|Overall Study||19
11047781|NCT00949533|12228384|FG001|COMPLETED|Overall Study||17
11047782|NCT00949533|12228383|FG000|NOT COMPLETED|Overall Study||0
11047783|NCT00949533|12228384|FG001|NOT COMPLETED|Overall Study||1
11047784|NCT00949650|12228392|FG000|STARTED|Overall Study|Treated patients.|230
11047785|NCT00949650|12228393|FG001|STARTED|Overall Study|Treated patients.|115
11047786|NCT00949650|12228392|FG000|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
11047787|NCT00949650|12228393|FG001|COMPLETED|Overall Study||0
11047788|NCT00949650|12228392|FG000|NOT COMPLETED|Overall Study||230
11047789|NCT00949650|12228393|FG001|NOT COMPLETED|Overall Study||115
11047790|NCT00949702|12228403|FG000|STARTED|Overall Study||132
11047791|NCT00949702|12228403|FG000|COMPLETED|Overall Study||84
11047792|NCT00949702|12228403|FG000|NOT COMPLETED|Overall Study||48
11047793|NCT00949715|12228409|FG000|STARTED|Overall Study||32
11047794|NCT00949715|12228410|FG001|STARTED|Overall Study||33
11047795|NCT00949715|12228409|FG000|COMPLETED|Overall Study||28
11047796|NCT00949715|12228410|FG001|COMPLETED|Overall Study||33
11047797|NCT00949715|12228409|FG000|NOT COMPLETED|Overall Study||4
11047798|NCT00949715|12228410|FG001|NOT COMPLETED|Overall Study||0
11047799|NCT00949884|12228418|FG000|STARTED|Overall Study||420
11047800|NCT00949884|12228419|FG001|STARTED|Overall Study||52
11047801|NCT00949884|12228420|FG002|STARTED|Overall Study||469
11047802|NCT00949884|12228418|FG000|COMPLETED|Overall Study||370
11047803|NCT00949884|12228419|FG001|COMPLETED|Overall Study||37
11047804|NCT00949884|12228420|FG002|COMPLETED|Overall Study||411
11047805|NCT00949884|12228418|FG000|NOT COMPLETED|Overall Study||50
11047806|NCT00949884|12228419|FG001|NOT COMPLETED|Overall Study||15
11047807|NCT00949884|12228420|FG002|NOT COMPLETED|Overall Study||58
11058059|NCT01001403|12239832|FG001|COMPLETED|Overall Study||31
11058060|NCT01001403|12239831|FG000|NOT COMPLETED|Overall Study||0
11058061|NCT01001403|12239832|FG001|NOT COMPLETED|Overall Study||0
11058062|NCT01001429|12239840|FG000|STARTED|Overall Study||39
11058063|NCT01001429|12239841|FG001|STARTED|Overall Study||38
11058064|NCT01001429|12239840|FG000|COMPLETED|Overall Study||39
11058065|NCT01001429|12239841|FG001|COMPLETED|Overall Study||37
11058066|NCT01001429|12239840|FG000|NOT COMPLETED|Overall Study||0
11058067|NCT01001429|12239841|FG001|NOT COMPLETED|Overall Study||1
11058068|NCT01001442|12239879|FG000|STARTED|Overall Study||4
11058069|NCT01001442|12239880|FG001|STARTED|Overall Study||3
11058070|NCT01001442|12239881|FG002|STARTED|Overall Study||4
11058071|NCT01001442|12239882|FG003|STARTED|Overall Study||3
11058072|NCT01001442|12239883|FG004|STARTED|Overall Study||4
11058073|NCT01001442|12239884|FG005|STARTED|Overall Study||3
11058074|NCT01001442|12239885|FG006|STARTED|Overall Study||10
11058075|NCT01001442|12239886|FG007|STARTED|Overall Study||4
11058076|NCT01001442|12239879|FG000|COMPLETED|Overall Study||4
11058077|NCT01001442|12239880|FG001|COMPLETED|Overall Study||3
11058078|NCT01001442|12239881|FG002|COMPLETED|Overall Study||4
11058079|NCT01001442|12239882|FG003|COMPLETED|Overall Study||3
11058080|NCT01001442|12239883|FG004|COMPLETED|Overall Study||2
11058081|NCT01001442|12239884|FG005|COMPLETED|Overall Study||3
11058082|NCT01001442|12239885|FG006|COMPLETED|Overall Study||6
11058083|NCT01001442|12239886|FG007|COMPLETED|Overall Study||2
11058084|NCT01001442|12239879|FG000|NOT COMPLETED|Overall Study||0
11058085|NCT01001442|12239880|FG001|NOT COMPLETED|Overall Study||0
11058086|NCT01001442|12239881|FG002|NOT COMPLETED|Overall Study||0
11058087|NCT01001442|12239882|FG003|NOT COMPLETED|Overall Study||0
11058088|NCT01001442|12239883|FG004|NOT COMPLETED|Overall Study||2
11058089|NCT01001442|12239884|FG005|NOT COMPLETED|Overall Study||0
11058090|NCT01001442|12239885|FG006|NOT COMPLETED|Overall Study||4
11058091|NCT01001442|12239886|FG007|NOT COMPLETED|Overall Study||2
11058092|NCT01001494|12239911|FG000|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
11058093|NCT01001494|12239912|FG001|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
11058094|NCT01001494|12239913|FG002|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
11058095|NCT01001494|12239911|FG000|COMPLETED|Overall Study||253
11058096|NCT01001494|12239912|FG001|COMPLETED|Overall Study||252
11058097|NCT01001494|12239913|FG002|COMPLETED|Overall Study||232
11058098|NCT01001494|12239911|FG000|NOT COMPLETED|Overall Study||24
11058099|NCT01001494|12239912|FG001|NOT COMPLETED|Overall Study||17
11058100|NCT01001494|12239913|FG002|NOT COMPLETED|Overall Study||41
11058101|NCT01001520|12239921|FG000|STARTED|Medication Period 1||22
11058102|NCT01001520|12239922|FG001|STARTED|Medication Period 1||24
11058103|NCT01001520|12239921|FG000|COMPLETED|Medication Period 1||18
11058104|NCT01001520|12239922|FG001|COMPLETED|Medication Period 1||17
11058105|NCT01001520|12239921|FG000|NOT COMPLETED|Medication Period 1||4
11058106|NCT01001520|12239922|FG001|NOT COMPLETED|Medication Period 1||7
11058107|NCT01001520|12239921|FG000|STARTED|Washout Period||18
11058108|NCT01001520|12239922|FG001|STARTED|Washout Period||17
11058109|NCT01001520|12239921|FG000|COMPLETED|Washout Period||16
11058110|NCT01001520|12239922|FG001|COMPLETED|Washout Period||16
11058111|NCT01001520|12239921|FG000|NOT COMPLETED|Washout Period||2
11058112|NCT01001520|12239922|FG001|NOT COMPLETED|Washout Period||1
11058113|NCT01001520|12239921|FG000|STARTED|Medication Period 2||16
11058114|NCT01001520|12239922|FG001|STARTED|Medication Period 2||16
11058115|NCT01001520|12239921|FG000|COMPLETED|Medication Period 2||16
11058116|NCT01001520|12239922|FG001|COMPLETED|Medication Period 2||13
11058117|NCT01001520|12239921|FG000|NOT COMPLETED|Medication Period 2||0
11058118|NCT01001520|12239922|FG001|NOT COMPLETED|Medication Period 2||3
11058119|NCT01001546|12239933|FG000|STARTED|Overall Study||206
11058120|NCT01001546|12239934|FG001|STARTED|Overall Study||207
11058121|NCT01001546|12239933|FG000|COMPLETED|Overall Study||206
11058122|NCT01001546|12239934|FG001|COMPLETED|Overall Study||207
11058123|NCT01001546|12239933|FG000|NOT COMPLETED|Overall Study||0
11058124|NCT01001546|12239934|FG001|NOT COMPLETED|Overall Study||0
11058125|NCT01001559|12239942|FG000|STARTED|Overall Study||95
11058126|NCT01001559|12239943|FG001|STARTED|Overall Study||147
11058127|NCT01001559|12239942|FG000|COMPLETED|Overall Study||95
11047808|NCT00949910|12228429|FG000|STARTED|Overall Study||6586
11047809|NCT00949910|12228429|FG000|COMPLETED|Overall Study||10
11047810|NCT00949910|12228429|FG000|NOT COMPLETED|Overall Study||6576
11047811|NCT00949975|12228437|FG000|STARTED|Overall Study||212
11047812|NCT00949975|12228438|FG001|STARTED|Overall Study||206
11047813|NCT00949975|12228439|FG002|STARTED|Overall Study||202
11047814|NCT00949975|12228440|FG003|STARTED|Overall Study||218
11047815|NCT00949975|12228437|FG000|COMPLETED|Overall Study||185
11047816|NCT00949975|12228438|FG001|COMPLETED|Overall Study||177
11047817|NCT00949975|12228439|FG002|COMPLETED|Overall Study||183
11047818|NCT00949975|12228440|FG003|COMPLETED|Overall Study||190
11047819|NCT00949975|12228437|FG000|NOT COMPLETED|Overall Study||27
11047820|NCT00949975|12228438|FG001|NOT COMPLETED|Overall Study||29
11047821|NCT00949975|12228439|FG002|NOT COMPLETED|Overall Study||19
11047822|NCT00949975|12228440|FG003|NOT COMPLETED|Overall Study||28
11047823|NCT00950170|12228450|FG000|STARTED|Overall Study||23
11047824|NCT00950170|12228450|FG000|COMPLETED|Overall Study||19
11047825|NCT00950170|12228450|FG000|NOT COMPLETED|Overall Study||4
11047826|NCT00950235|12228474|FG000|STARTED|Overall Study||60
11047827|NCT00950235|12228475|FG001|STARTED|Overall Study||58
11047828|NCT00950235|12228474|FG000|COMPLETED|Overall Study||58
11047829|NCT00950235|12228475|FG001|COMPLETED|Overall Study||54
11047830|NCT00950235|12228474|FG000|NOT COMPLETED|Overall Study||2
11047831|NCT00950235|12228475|FG001|NOT COMPLETED|Overall Study||4
11047832|NCT00950248|12228483|FG000|STARTED|Year 1: Baseline||85
11047833|NCT00950248|12228484|FG001|STARTED|Year 1: Baseline||0
11047834|NCT00950248|12228485|FG002|STARTED|Year 1: Baseline||0
11337064|NCT02887183|12534814|FG000|COMPLETED|Overall Study||654
11337065|NCT02887183|12534814|FG000|NOT COMPLETED|Overall Study||141
11047835|NCT00950248|12228483|FG000|COMPLETED|Year 1: Baseline||77
11047836|NCT00950248|12228484|FG001|COMPLETED|Year 1: Baseline||0
11047837|NCT00950248|12228485|FG002|COMPLETED|Year 1: Baseline||0
11047838|NCT00950248|12228483|FG000|NOT COMPLETED|Year 1: Baseline||8
11047839|NCT00950248|12228484|FG001|NOT COMPLETED|Year 1: Baseline||0
11047840|NCT00950248|12228485|FG002|NOT COMPLETED|Year 1: Baseline||0
11047841|NCT00950248|12228483|FG000|STARTED|Year 2&3 Treatment Randomization||0
11047842|NCT00950248|12228484|FG001|STARTED|Year 2&3 Treatment Randomization||39
11047843|NCT00950248|12228485|FG002|STARTED|Year 2&3 Treatment Randomization||38
11047844|NCT00950248|12228483|FG000|COMPLETED|Year 2&3 Treatment Randomization||0
11047845|NCT00950248|12228484|FG001|COMPLETED|Year 2&3 Treatment Randomization||33
11047846|NCT00950248|12228485|FG002|COMPLETED|Year 2&3 Treatment Randomization||33
11047847|NCT00950248|12228483|FG000|NOT COMPLETED|Year 2&3 Treatment Randomization||0
11047848|NCT00950248|12228484|FG001|NOT COMPLETED|Year 2&3 Treatment Randomization||6
11047849|NCT00950248|12228485|FG002|NOT COMPLETED|Year 2&3 Treatment Randomization||5
11047850|NCT00950300|12228494|FG000|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
11047851|NCT00950300|12228495|FG001|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
11047852|NCT00950300|12228494|FG000|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
11047853|NCT00950300|12228495|FG001|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
11047854|NCT00950300|12228494|FG000|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
11047855|NCT00950300|12228495|FG001|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
11047856|NCT00950300|12228494|FG000|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
11047857|NCT00950300|12228495|FG001|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
11047858|NCT00950300|12228494|FG000|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
11047859|NCT00950300|12228495|FG001|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
11047860|NCT00950300|12228494|FG000|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
11047861|NCT00950300|12228495|FG001|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
11047862|NCT00950300|12228494|FG000|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
11047863|NCT00950300|12228495|FG001|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
11047864|NCT00950300|12228494|FG000|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
11047865|NCT00950300|12228495|FG001|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
11047866|NCT00950300|12228494|FG000|NOT COMPLETED|TFFU Period||100
11047867|NCT00950300|12228495|FG001|NOT COMPLETED|TFFU Period||107
11047868|NCT00950300|12228494|FG000|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
11047869|NCT00950300|12228495|FG001|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
11047870|NCT00950300|12228494|FG000|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
11047871|NCT00950300|12228495|FG001|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
11047872|NCT00950300|12228494|FG000|NOT COMPLETED|SFU Period||78
11047873|NCT00950300|12228495|FG001|NOT COMPLETED|SFU Period||78
11047874|NCT00950352|12228504|FG000|STARTED|Overall Study||72
11047875|NCT00950352|12228505|FG001|STARTED|Overall Study||32
11047876|NCT00950352|12228504|FG000|COMPLETED|Overall Study||30
11047877|NCT00950352|12228505|FG001|COMPLETED|Overall Study||21
11047878|NCT00950352|12228504|FG000|NOT COMPLETED|Overall Study||42
11047879|NCT00950352|12228505|FG001|NOT COMPLETED|Overall Study||11
11047880|NCT00950365|12228513|FG000|STARTED|Overall Study||27
11047881|NCT00950365|12228514|FG001|STARTED|Overall Study||52
11047882|NCT00950365|12228513|FG000|COMPLETED|Overall Study||25
11047883|NCT00950365|12228514|FG001|COMPLETED|Overall Study||50
11047884|NCT00950365|12228513|FG000|NOT COMPLETED|Overall Study||2
11047885|NCT00950365|12228514|FG001|NOT COMPLETED|Overall Study||2
11047886|NCT00950599|12228528|FG000|STARTED|Double-Blind Treatment Period||55
11047887|NCT00950599|12228529|FG001|STARTED|Double-Blind Treatment Period||47
11047888|NCT00950599|12228530|FG002|STARTED|Double-Blind Treatment Period||63
11047889|NCT00950599|12228531|FG003|STARTED|Double-Blind Treatment Period||54
11047890|NCT00950599|12228532|FG004|STARTED|Double-Blind Treatment Period||52
11047891|NCT00950599|12228533|FG005|STARTED|Double-Blind Treatment Period||67
11047892|NCT00950599|12228534|FG006|STARTED|Double-Blind Treatment Period||44
11047893|NCT00950599|12228535|FG007|STARTED|Double-Blind Treatment Period||41
11047894|NCT00950599|12228536|FG008|STARTED|Double-Blind Treatment Period||0
11047895|NCT00950599|12228537|FG009|STARTED|Double-Blind Treatment Period||0
11047896|NCT00950599|12228528|FG000|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
11047897|NCT00950599|12228529|FG001|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
11047898|NCT00950599|12228530|FG002|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
11047899|NCT00950599|12228531|FG003|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
11047900|NCT00950599|12228532|FG004|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
11047901|NCT00950599|12228533|FG005|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
11047902|NCT00950599|12228534|FG006|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
11047903|NCT00950599|12228535|FG007|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
11047904|NCT00950599|12228536|FG008|COMPLETED|Double-Blind Treatment Period||0
11047905|NCT00950599|12228537|FG009|COMPLETED|Double-Blind Treatment Period||0
11047906|NCT00950599|12228528|FG000|NOT COMPLETED|Double-Blind Treatment Period||7
11047907|NCT00950599|12228529|FG001|NOT COMPLETED|Double-Blind Treatment Period||10
11047908|NCT00950599|12228530|FG002|NOT COMPLETED|Double-Blind Treatment Period||9
11047909|NCT00950599|12228531|FG003|NOT COMPLETED|Double-Blind Treatment Period||11
11047910|NCT00950599|12228532|FG004|NOT COMPLETED|Double-Blind Treatment Period||7
11047911|NCT00950599|12228533|FG005|NOT COMPLETED|Double-Blind Treatment Period||12
11047912|NCT00950599|12228534|FG006|NOT COMPLETED|Double-Blind Treatment Period||0
11047913|NCT00950599|12228535|FG007|NOT COMPLETED|Double-Blind Treatment Period||6
11047914|NCT00950599|12228536|FG008|NOT COMPLETED|Double-Blind Treatment Period||0
11047915|NCT00950599|12228537|FG009|NOT COMPLETED|Double-Blind Treatment Period||0
11047916|NCT00950599|12228528|FG000|STARTED|Follow-Up Period||0
11047917|NCT00950599|12228529|FG001|STARTED|Follow-Up Period||0
11047918|NCT00950599|12228530|FG002|STARTED|Follow-Up Period||0
11047919|NCT00950599|12228531|FG003|STARTED|Follow-Up Period||0
11047920|NCT00950599|12228532|FG004|STARTED|Follow-Up Period||0
11047921|NCT00950599|12228533|FG005|STARTED|Follow-Up Period||0
11047922|NCT00950599|12228534|FG006|STARTED|Follow-Up Period||0
11047923|NCT00950599|12228535|FG007|STARTED|Follow-Up Period||0
11047924|NCT00950599|12228536|FG008|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
11047925|NCT00950599|12228537|FG009|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
11047926|NCT00950599|12228528|FG000|COMPLETED|Follow-Up Period||0
11047927|NCT00950599|12228529|FG001|COMPLETED|Follow-Up Period||0
11047928|NCT00950599|12228530|FG002|COMPLETED|Follow-Up Period||0
11047929|NCT00950599|12228531|FG003|COMPLETED|Follow-Up Period||0
11047930|NCT00950599|12228532|FG004|COMPLETED|Follow-Up Period||0
11047931|NCT00950599|12228533|FG005|COMPLETED|Follow-Up Period||0
11047932|NCT00950599|12228534|FG006|COMPLETED|Follow-Up Period||0
11047933|NCT00950599|12228535|FG007|COMPLETED|Follow-Up Period||0
11047934|NCT00950599|12228536|FG008|COMPLETED|Follow-Up Period||296
11047935|NCT00950599|12228537|FG009|COMPLETED|Follow-Up Period||78
11047936|NCT00950599|12228528|FG000|NOT COMPLETED|Follow-Up Period||0
11047937|NCT00950599|12228529|FG001|NOT COMPLETED|Follow-Up Period||0
11047938|NCT00950599|12228530|FG002|NOT COMPLETED|Follow-Up Period||0
11047939|NCT00950599|12228531|FG003|NOT COMPLETED|Follow-Up Period||0
11047940|NCT00950599|12228532|FG004|NOT COMPLETED|Follow-Up Period||0
11047941|NCT00950599|12228533|FG005|NOT COMPLETED|Follow-Up Period||0
11047942|NCT00950599|12228534|FG006|NOT COMPLETED|Follow-Up Period||0
11047943|NCT00950599|12228535|FG007|NOT COMPLETED|Follow-Up Period||0
11047944|NCT00950599|12228536|FG008|NOT COMPLETED|Follow-Up Period||13
11047945|NCT00950599|12228537|FG009|NOT COMPLETED|Follow-Up Period||2
11047946|NCT00950612|12228562|FG000|STARTED|Overall Study||40
11047947|NCT00950612|12228563|FG001|STARTED|Overall Study||20
11047948|NCT00950612|12228562|FG000|COMPLETED|Overall Study||40
11047949|NCT00950612|12228563|FG001|COMPLETED|Overall Study||20
11047950|NCT00950612|12228562|FG000|NOT COMPLETED|Overall Study||0
11047951|NCT00950612|12228563|FG001|NOT COMPLETED|Overall Study||0
11047952|NCT00950651|12228571|FG000|STARTED|Overall Study||215
11047953|NCT00950651|12228572|FG001|STARTED|Overall Study|216 patients randomized but one never took study medication|216
11047954|NCT00950651|12228571|FG000|COMPLETED|Overall Study||184
11047955|NCT00950651|12228572|FG001|COMPLETED|Overall Study||181
11047956|NCT00950651|12228571|FG000|NOT COMPLETED|Overall Study||31
11047957|NCT00950651|12228572|FG001|NOT COMPLETED|Overall Study||35
11047958|NCT00950664|12228580|FG000|STARTED|First Intervention||49
11047959|NCT00950664|12228581|FG001|STARTED|First Intervention||53
11047960|NCT00950664|12228580|FG000|COMPLETED|First Intervention||46
11047961|NCT00950664|12228581|FG001|COMPLETED|First Intervention||48
11047962|NCT00950664|12228580|FG000|NOT COMPLETED|First Intervention||3
11047963|NCT00950664|12228581|FG001|NOT COMPLETED|First Intervention||5
11047964|NCT00950664|12228580|FG000|STARTED|Washout Period of 4 Weeks||46
11047965|NCT00950664|12228581|FG001|STARTED|Washout Period of 4 Weeks||48
11047966|NCT00950664|12228580|FG000|COMPLETED|Washout Period of 4 Weeks||46
11047967|NCT00950664|12228581|FG001|COMPLETED|Washout Period of 4 Weeks||48
11047968|NCT00950664|12228580|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0
11047969|NCT00950664|12228581|FG001|NOT COMPLETED|Washout Period of 4 Weeks||0
11047970|NCT00950664|12228580|FG000|STARTED|Second Intervention||46
11047971|NCT00950664|12228581|FG001|STARTED|Second Intervention||48
11047972|NCT00950664|12228580|FG000|COMPLETED|Second Intervention||0
11047973|NCT00950664|12228581|FG001|COMPLETED|Second Intervention||0
11047974|NCT00950664|12228580|FG000|NOT COMPLETED|Second Intervention||46
11047975|NCT00950664|12228581|FG001|NOT COMPLETED|Second Intervention||48
11047976|NCT00950729|12228587|FG000|STARTED|Driving With Running Shoes|March 2007|48
11047977|NCT00950729|12228587|FG000|COMPLETED|Driving With Running Shoes|June 2007|48
11047978|NCT00950729|12228587|FG000|NOT COMPLETED|Driving With Running Shoes||0
11047979|NCT00950729|12228587|FG000|STARTED|Driving With Plaster Cast||48
11047980|NCT00950729|12228587|FG000|COMPLETED|Driving With Plaster Cast||48
11047981|NCT00950729|12228587|FG000|NOT COMPLETED|Driving With Plaster Cast||0
11047982|NCT00950729|12228587|FG000|STARTED|Driving With Aircast||48
11047983|NCT00950729|12228587|FG000|COMPLETED|Driving With Aircast||48
11047984|NCT00950729|12228587|FG000|NOT COMPLETED|Driving With Aircast||0
11047985|NCT00950742|12228593|FG000|STARTED|Overall Study|entered and treated|16
11047986|NCT00950742|12228594|FG001|STARTED|Overall Study|entered and treated|2
11047987|NCT00950742|12228593|FG000|COMPLETED|Overall Study||0
11047988|NCT00950742|12228594|FG001|COMPLETED|Overall Study||0
11047989|NCT00950742|12228593|FG000|NOT COMPLETED|Overall Study||16
11337066|NCT02887404|12534820|FG000|STARTED|Overall Study||150
11337067|NCT02887404|12534821|FG001|STARTED|Overall Study||149
11337068|NCT02887404|12534820|FG000|COMPLETED|Overall Study||150
11337069|NCT02887404|12534821|FG001|COMPLETED|Overall Study||149
11337070|NCT02887404|12534820|FG000|NOT COMPLETED|Overall Study||0
11337071|NCT02887404|12534821|FG001|NOT COMPLETED|Overall Study||0
11337072|NCT02887521|12534830|FG000|STARTED|Overall Study||4
11337073|NCT02887521|12534831|FG001|STARTED|Overall Study||5
11337074|NCT02887521|12534830|FG000|COMPLETED|Overall Study||4
11337075|NCT02887521|12534831|FG001|COMPLETED|Overall Study||2
11337076|NCT02887521|12534830|FG000|NOT COMPLETED|Overall Study||0
11337077|NCT02887521|12534831|FG001|NOT COMPLETED|Overall Study||3
11337078|NCT02887989|12534839|FG000|STARTED|Overall Study||70
11337079|NCT02887989|12534840|FG001|STARTED|Overall Study||70
11337080|NCT02887989|12534839|FG000|COMPLETED|Overall Study||61
11337081|NCT02887989|12534840|FG001|COMPLETED|Overall Study||59
11337082|NCT02887989|12534839|FG000|NOT COMPLETED|Overall Study||9
11337083|NCT02887989|12534840|FG001|NOT COMPLETED|Overall Study||11
11337084|NCT02888080|12534848|FG000|STARTED|Overall Study||20
11337085|NCT02888080|12534849|FG001|STARTED|Overall Study||20
11337086|NCT02888080|12534848|FG000|COMPLETED|Overall Study||18
11337087|NCT02888080|12534849|FG001|COMPLETED|Overall Study||15
11337088|NCT02888080|12534848|FG000|NOT COMPLETED|Overall Study||2
11337089|NCT02888080|12534849|FG001|NOT COMPLETED|Overall Study||5
11337090|NCT02888093|12534857|FG000|STARTED|Overall Study||22
11337091|NCT02888093|12534858|FG001|STARTED|Overall Study||22
11337092|NCT02888093|12534857|FG000|COMPLETED|Overall Study||20
11337093|NCT02888093|12534858|FG001|COMPLETED|Overall Study||20
11337094|NCT02888093|12534857|FG000|NOT COMPLETED|Overall Study||2
11337095|NCT02888093|12534858|FG001|NOT COMPLETED|Overall Study||2
11337096|NCT02888106|12534872|FG000|STARTED|Overall Study||15
11337097|NCT02888106|12534873|FG001|STARTED|Overall Study||15
11337098|NCT02888106|12534874|FG002|STARTED|Overall Study||15
11337099|NCT02888106|12534875|FG003|STARTED|Overall Study||15
11337100|NCT02888106|12534876|FG004|STARTED|Overall Study||15
11337101|NCT02888106|12534877|FG005|STARTED|Overall Study||15
11337102|NCT02888106|12534872|FG000|COMPLETED|Overall Study||10
11337103|NCT02888106|12534873|FG001|COMPLETED|Overall Study||13
11337104|NCT02888106|12534874|FG002|COMPLETED|Overall Study||15
11337105|NCT02888106|12534875|FG003|COMPLETED|Overall Study||13
11337106|NCT02888106|12534876|FG004|COMPLETED|Overall Study||14
11337107|NCT02888106|12534877|FG005|COMPLETED|Overall Study||14
11337108|NCT02888106|12534872|FG000|NOT COMPLETED|Overall Study||5
11337109|NCT02888106|12534873|FG001|NOT COMPLETED|Overall Study||2
11337110|NCT02888106|12534874|FG002|NOT COMPLETED|Overall Study||0
11337111|NCT02888106|12534875|FG003|NOT COMPLETED|Overall Study||2
11337112|NCT02888106|12534876|FG004|NOT COMPLETED|Overall Study||1
11337113|NCT02888106|12534877|FG005|NOT COMPLETED|Overall Study||1
11337114|NCT02888171|12534899|FG000|STARTED|Overall Study||30
11337115|NCT02888171|12534900|FG001|STARTED|Overall Study||30
11337116|NCT02888171|12534899|FG000|COMPLETED|Overall Study||25
11337117|NCT02888171|12534900|FG001|COMPLETED|Overall Study||26
11337118|NCT02888171|12534899|FG000|NOT COMPLETED|Overall Study||5
11337119|NCT02888171|12534900|FG001|NOT COMPLETED|Overall Study||4
11337120|NCT02888665|12534909|FG000|STARTED|Overall Study||3
11047990|NCT00950742|12228594|FG001|NOT COMPLETED|Overall Study||2
11047991|NCT00950755|12228604|FG000|STARTED|Dosimetric and Therapeutic Treatment||41
11047992|NCT00950755|12228604|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
11047993|NCT00950755|12228604|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
11047994|NCT00950755|12228604|FG000|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
11047995|NCT00950755|12228604|FG000|COMPLETED|Long-Term Follow-Up||9
11047996|NCT00950755|12228604|FG000|NOT COMPLETED|Long-Term Follow-Up||9
11047997|NCT00950807|12228608|FG000|STARTED|Treatment Period 1||59
11047998|NCT00950807|12228609|FG001|STARTED|Treatment Period 1||13
11047999|NCT00950807|12228610|FG002|STARTED|Treatment Period 1||14
11048000|NCT00950807|12228611|FG003|STARTED|Treatment Period 1||12
11048001|NCT00950807|12228612|FG004|STARTED|Treatment Period 1||13
11048002|NCT00950807|12228613|FG005|STARTED|Treatment Period 1||13
11048003|NCT00950807|12228614|FG006|STARTED|Treatment Period 1||12
11048004|NCT00950807|12228615|FG007|STARTED|Treatment Period 1||14
11048005|NCT00950807|12228616|FG008|STARTED|Treatment Period 1||13
11048006|NCT00950807|12228617|FG009|STARTED|Treatment Period 1||13
11048007|NCT00950807|12228608|FG000|COMPLETED|Treatment Period 1||56
11048008|NCT00950807|12228609|FG001|COMPLETED|Treatment Period 1||13
11048009|NCT00950807|12228610|FG002|COMPLETED|Treatment Period 1||13
11048010|NCT00950807|12228611|FG003|COMPLETED|Treatment Period 1||12
11048011|NCT00950807|12228612|FG004|COMPLETED|Treatment Period 1||12
11048012|NCT00950807|12228613|FG005|COMPLETED|Treatment Period 1||11
11048013|NCT00950807|12228614|FG006|COMPLETED|Treatment Period 1||12
11048014|NCT00950807|12228615|FG007|COMPLETED|Treatment Period 1||14
11048015|NCT00950807|12228616|FG008|COMPLETED|Treatment Period 1||12
11048016|NCT00950807|12228617|FG009|COMPLETED|Treatment Period 1||13
11048017|NCT00950807|12228608|FG000|NOT COMPLETED|Treatment Period 1||3
11048018|NCT00950807|12228609|FG001|NOT COMPLETED|Treatment Period 1||0
11048019|NCT00950807|12228610|FG002|NOT COMPLETED|Treatment Period 1||1
11048020|NCT00950807|12228611|FG003|NOT COMPLETED|Treatment Period 1||0
11048021|NCT00950807|12228612|FG004|NOT COMPLETED|Treatment Period 1||1
11048022|NCT00950807|12228613|FG005|NOT COMPLETED|Treatment Period 1||2
11048023|NCT00950807|12228614|FG006|NOT COMPLETED|Treatment Period 1||0
11048024|NCT00950807|12228615|FG007|NOT COMPLETED|Treatment Period 1||0
11048025|NCT00950807|12228616|FG008|NOT COMPLETED|Treatment Period 1||1
11048026|NCT00950807|12228617|FG009|NOT COMPLETED|Treatment Period 1||0
11048027|NCT00950807|12228608|FG000|STARTED|Washout Period 1||56
11048028|NCT00950807|12228609|FG001|STARTED|Washout Period 1||13
11048029|NCT00950807|12228610|FG002|STARTED|Washout Period 1||13
11048030|NCT00950807|12228611|FG003|STARTED|Washout Period 1||12
11048031|NCT00950807|12228612|FG004|STARTED|Washout Period 1||12
11048032|NCT00950807|12228613|FG005|STARTED|Washout Period 1||11
11048033|NCT00950807|12228614|FG006|STARTED|Washout Period 1||12
11048034|NCT00950807|12228615|FG007|STARTED|Washout Period 1||14
11048035|NCT00950807|12228616|FG008|STARTED|Washout Period 1||12
11048036|NCT00950807|12228617|FG009|STARTED|Washout Period 1||13
11048037|NCT00950807|12228608|FG000|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
11048038|NCT00950807|12228609|FG001|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
11048039|NCT00950807|12228610|FG002|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
11048040|NCT00950807|12228611|FG003|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
11048041|NCT00950807|12228612|FG004|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
11048042|NCT00950807|12228613|FG005|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
11048043|NCT00950807|12228614|FG006|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
11048044|NCT00950807|12228615|FG007|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
11048045|NCT00950807|12228616|FG008|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
11048046|NCT00950807|12228617|FG009|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
11048047|NCT00950807|12228608|FG000|NOT COMPLETED|Washout Period 1||5
11048048|NCT00950807|12228609|FG001|NOT COMPLETED|Washout Period 1||0
11048049|NCT00950807|12228610|FG002|NOT COMPLETED|Washout Period 1||0
11048050|NCT00950807|12228611|FG003|NOT COMPLETED|Washout Period 1||1
11048051|NCT00950807|12228612|FG004|NOT COMPLETED|Washout Period 1||1
11048052|NCT00950807|12228613|FG005|NOT COMPLETED|Washout Period 1||0
11048053|NCT00950807|12228614|FG006|NOT COMPLETED|Washout Period 1||2
11048054|NCT00950807|12228615|FG007|NOT COMPLETED|Washout Period 1||1
11048055|NCT00950807|12228616|FG008|NOT COMPLETED|Washout Period 1||1
11048056|NCT00950807|12228617|FG009|NOT COMPLETED|Washout Period 1||0
11048057|NCT00950807|12228608|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
11048058|NCT00950807|12228609|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
11048059|NCT00950807|12228610|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
11337121|NCT02888665|12534910|FG001|STARTED|Overall Study||3
11337122|NCT02888665|12534911|FG002|STARTED|Overall Study||31
11337123|NCT02888665|12534909|FG000|COMPLETED|Overall Study||3
11337124|NCT02888665|12534910|FG001|COMPLETED|Overall Study||3
11048060|NCT00950807|12228611|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
11048061|NCT00950807|12228612|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
11048062|NCT00950807|12228613|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
11048063|NCT00950807|12228614|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
11048064|NCT00950807|12228615|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
11048065|NCT00950807|12228616|FG008|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
11048066|NCT00950807|12228617|FG009|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
11048067|NCT00950807|12228608|FG000|COMPLETED|Treatment Period 2||51
11048068|NCT00950807|12228609|FG001|COMPLETED|Treatment Period 2||12
11048069|NCT00950807|12228610|FG002|COMPLETED|Treatment Period 2||10
11048070|NCT00950807|12228611|FG003|COMPLETED|Treatment Period 2||12
11048071|NCT00950807|12228612|FG004|COMPLETED|Treatment Period 2||13
11048072|NCT00950807|12228613|FG005|COMPLETED|Treatment Period 2||9
11048073|NCT00950807|12228614|FG006|COMPLETED|Treatment Period 2||9
11048074|NCT00950807|12228615|FG007|COMPLETED|Treatment Period 2||10
11048075|NCT00950807|12228616|FG008|COMPLETED|Treatment Period 2||11
11048076|NCT00950807|12228617|FG009|COMPLETED|Treatment Period 2||11
11048077|NCT00950807|12228608|FG000|NOT COMPLETED|Treatment Period 2||2
11048078|NCT00950807|12228609|FG001|NOT COMPLETED|Treatment Period 2||1
11048079|NCT00950807|12228610|FG002|NOT COMPLETED|Treatment Period 2||0
11048080|NCT00950807|12228611|FG003|NOT COMPLETED|Treatment Period 2||1
11048081|NCT00950807|12228612|FG004|NOT COMPLETED|Treatment Period 2||0
11048082|NCT00950807|12228613|FG005|NOT COMPLETED|Treatment Period 2||1
11048083|NCT00950807|12228614|FG006|NOT COMPLETED|Treatment Period 2||1
11048084|NCT00950807|12228615|FG007|NOT COMPLETED|Treatment Period 2||3
11048085|NCT00950807|12228616|FG008|NOT COMPLETED|Treatment Period 2||0
11048086|NCT00950807|12228617|FG009|NOT COMPLETED|Treatment Period 2||0
11048087|NCT00950807|12228608|FG000|STARTED|Washout Period 2||51
11048088|NCT00950807|12228609|FG001|STARTED|Washout Period 2||12
11048089|NCT00950807|12228610|FG002|STARTED|Washout Period 2||10
11048090|NCT00950807|12228611|FG003|STARTED|Washout Period 2||12
11048091|NCT00950807|12228612|FG004|STARTED|Washout Period 2||13
11048092|NCT00950807|12228613|FG005|STARTED|Washout Period 2||9
11048093|NCT00950807|12228614|FG006|STARTED|Washout Period 2||9
11048094|NCT00950807|12228615|FG007|STARTED|Washout Period 2||10
11048095|NCT00950807|12228616|FG008|STARTED|Washout Period 2||11
11048096|NCT00950807|12228617|FG009|STARTED|Washout Period 2||11
11048097|NCT00950807|12228608|FG000|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
11048098|NCT00950807|12228609|FG001|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
11048099|NCT00950807|12228610|FG002|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
11048100|NCT00950807|12228611|FG003|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
11048101|NCT00950807|12228612|FG004|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
11048102|NCT00950807|12228613|FG005|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
11048103|NCT00950807|12228614|FG006|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
11048104|NCT00950807|12228615|FG007|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
11048105|NCT00950807|12228616|FG008|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
11048106|NCT00950807|12228617|FG009|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
11048107|NCT00950807|12228608|FG000|NOT COMPLETED|Washout Period 2||4
11048108|NCT00950807|12228609|FG001|NOT COMPLETED|Washout Period 2||1
11048109|NCT00950807|12228610|FG002|NOT COMPLETED|Washout Period 2||0
11048110|NCT00950807|12228611|FG003|NOT COMPLETED|Washout Period 2||1
11048111|NCT00950807|12228612|FG004|NOT COMPLETED|Washout Period 2||1
11048112|NCT00950807|12228613|FG005|NOT COMPLETED|Washout Period 2||0
11048113|NCT00950807|12228614|FG006|NOT COMPLETED|Washout Period 2||1
11048114|NCT00950807|12228615|FG007|NOT COMPLETED|Washout Period 2||1
11048115|NCT00950807|12228616|FG008|NOT COMPLETED|Washout Period 2||0
11048116|NCT00950807|12228617|FG009|NOT COMPLETED|Washout Period 2||0
11048117|NCT00950807|12228608|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
11048118|NCT00950807|12228609|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
11048119|NCT00950807|12228610|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
11048120|NCT00950807|12228611|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
11048121|NCT00950807|12228612|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
11048122|NCT00950807|12228613|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
11048123|NCT00950807|12228614|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
11048124|NCT00950807|12228615|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
11048125|NCT00950807|12228616|FG008|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
11048126|NCT00950807|12228617|FG009|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
11048127|NCT00950807|12228608|FG000|COMPLETED|Treatment Period 3||45
11048128|NCT00950807|12228609|FG001|COMPLETED|Treatment Period 3||9
11048129|NCT00950807|12228610|FG002|COMPLETED|Treatment Period 3||10
11048130|NCT00950807|12228611|FG003|COMPLETED|Treatment Period 3||11
11048131|NCT00950807|12228612|FG004|COMPLETED|Treatment Period 3||12
11048132|NCT00950807|12228613|FG005|COMPLETED|Treatment Period 3||9
11048133|NCT00950807|12228614|FG006|COMPLETED|Treatment Period 3||11
11048134|NCT00950807|12228615|FG007|COMPLETED|Treatment Period 3||9
11048135|NCT00950807|12228616|FG008|COMPLETED|Treatment Period 3||9
11048136|NCT00950807|12228617|FG009|COMPLETED|Treatment Period 3||10
11048137|NCT00950807|12228608|FG000|NOT COMPLETED|Treatment Period 3||1
11048138|NCT00950807|12228609|FG001|NOT COMPLETED|Treatment Period 3||0
11048139|NCT00950807|12228610|FG002|NOT COMPLETED|Treatment Period 3||0
11048140|NCT00950807|12228611|FG003|NOT COMPLETED|Treatment Period 3||0
11048141|NCT00950807|12228612|FG004|NOT COMPLETED|Treatment Period 3||0
11048142|NCT00950807|12228613|FG005|NOT COMPLETED|Treatment Period 3||0
11048143|NCT00950807|12228614|FG006|NOT COMPLETED|Treatment Period 3||1
11048144|NCT00950807|12228615|FG007|NOT COMPLETED|Treatment Period 3||1
11048145|NCT00950807|12228616|FG008|NOT COMPLETED|Treatment Period 3||0
11048146|NCT00950807|12228617|FG009|NOT COMPLETED|Treatment Period 3||1
11048147|NCT00950833|12228642|FG000|STARTED|Overall Study||112
11048148|NCT00950833|12228643|FG001|STARTED|Overall Study||108
11048149|NCT00950833|12228644|FG002|STARTED|Overall Study||223
11048150|NCT00950833|12228642|FG000|COMPLETED|Overall Study||112
11048151|NCT00950833|12228643|FG001|COMPLETED|Overall Study||108
11048152|NCT00950833|12228644|FG002|COMPLETED|Overall Study||223
11048153|NCT00950833|12228642|FG000|NOT COMPLETED|Overall Study||0
11048154|NCT00950833|12228643|FG001|NOT COMPLETED|Overall Study||0
11048155|NCT00950833|12228644|FG002|NOT COMPLETED|Overall Study||0
11048156|NCT00950859|12228656|FG000|STARTED|Overall Study||27
11201386|NCT01832090|12391643|FG001|NOT COMPLETED|Overall Study||1
11201387|NCT01832155|12391671|FG000|STARTED|Beginning of Study: Baseline at 0 Week||18
11201388|NCT01832155|12391672|FG001|STARTED|Beginning of Study: Baseline at 0 Week||18
11201389|NCT01832155|12391671|FG000|COMPLETED|Beginning of Study: Baseline at 0 Week||17
11201390|NCT01832155|12391672|FG001|COMPLETED|Beginning of Study: Baseline at 0 Week||18
11201391|NCT01832155|12391671|FG000|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
11201392|NCT01832155|12391672|FG001|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
11201393|NCT01832155|12391671|FG000|STARTED|Mid-point of Study: 0 - 4 Weeks||17
11201394|NCT01832155|12391672|FG001|STARTED|Mid-point of Study: 0 - 4 Weeks||18
11201395|NCT01832155|12391671|FG000|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
11201396|NCT01832155|12391672|FG001|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
11201397|NCT01832155|12391671|FG000|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
11201398|NCT01832155|12391672|FG001|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
11201399|NCT01832155|12391671|FG000|STARTED|End of Study: 4 - 8 Weeks||16
11201400|NCT01832155|12391672|FG001|STARTED|End of Study: 4 - 8 Weeks||18
11201401|NCT01832155|12391671|FG000|COMPLETED|End of Study: 4 - 8 Weeks||16
11201402|NCT01832155|12391672|FG001|COMPLETED|End of Study: 4 - 8 Weeks||18
11201403|NCT01832155|12391671|FG000|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
11201404|NCT01832155|12391672|FG001|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
11201405|NCT01832259|12391686|FG000|STARTED|Overall Study||15
11201406|NCT01832259|12391687|FG001|STARTED|Overall Study||15
11201407|NCT01832259|12391686|FG000|COMPLETED|Overall Study||15
11201408|NCT01832259|12391687|FG001|COMPLETED|Overall Study||15
11201409|NCT01832259|12391686|FG000|NOT COMPLETED|Overall Study||0
11201410|NCT01832259|12391687|FG001|NOT COMPLETED|Overall Study||0
11201411|NCT01832480|12391695|FG000|STARTED|Overall Study||311
11201412|NCT01832480|12391696|FG001|STARTED|Overall Study||312
11201413|NCT01832480|12391695|FG000|COMPLETED|Overall Study||270
11201414|NCT01832480|12391696|FG001|COMPLETED|Overall Study||270
11201415|NCT01832480|12391695|FG000|NOT COMPLETED|Overall Study||41
11201416|NCT01832480|12391696|FG001|NOT COMPLETED|Overall Study||42
11201417|NCT01832493|12391702|FG000|STARTED|Overall Study||50
11201418|NCT01832493|12391702|FG000|COMPLETED|Overall Study||42
11201419|NCT01832493|12391702|FG000|NOT COMPLETED|Overall Study||8
11201420|NCT01832506|12391709|FG000|STARTED|Overall Study||3
11201421|NCT01832506|12391710|FG001|STARTED|Overall Study||3
11201422|NCT01832506|12391711|FG002|STARTED|Overall Study||6
11201423|NCT01832506|12391709|FG000|COMPLETED|Overall Study||3
11201424|NCT01832506|12391710|FG001|COMPLETED|Overall Study||3
11201425|NCT01832506|12391711|FG002|COMPLETED|Overall Study||6
11201426|NCT01832506|12391709|FG000|NOT COMPLETED|Overall Study||0
11201427|NCT01832506|12391710|FG001|NOT COMPLETED|Overall Study||0
11201428|NCT01832506|12391711|FG002|NOT COMPLETED|Overall Study||0
11201429|NCT01832532|12391726|FG000|STARTED|Overall Study||23
11201430|NCT01832532|12391727|FG001|STARTED|Overall Study||11
11201431|NCT01832532|12391726|FG000|COMPLETED|Overall Study||18
11201432|NCT01832532|12391727|FG001|COMPLETED|Overall Study||9
11201433|NCT01832532|12391726|FG000|NOT COMPLETED|Overall Study||5
11201434|NCT01832532|12391727|FG001|NOT COMPLETED|Overall Study||2
11201435|NCT01832610|12391733|FG000|STARTED|Overall Study||101
11201436|NCT01832610|12391733|FG000|COMPLETED|Overall Study||97
11201437|NCT01832610|12391733|FG000|NOT COMPLETED|Overall Study||4
11201438|NCT01832727|12391746|FG000|STARTED|Overall Study||9
11201439|NCT01832727|12391747|FG001|STARTED|Overall Study||7
11201440|NCT01832727|12391748|FG002|STARTED|Overall Study||3
11048157|NCT00950859|12228657|FG001|STARTED|Overall Study||24
11048158|NCT00950859|12228656|FG000|COMPLETED|Overall Study||11
11048159|NCT00950859|12228657|FG001|COMPLETED|Overall Study||14
11048160|NCT00950859|12228656|FG000|NOT COMPLETED|Overall Study||16
11048161|NCT00950859|12228657|FG001|NOT COMPLETED|Overall Study||10
11048162|NCT00950872|12228663|FG000|STARTED|Overall Study||29
11048163|NCT00950872|12228663|FG000|COMPLETED|Overall Study||26
11048164|NCT00950872|12228663|FG000|NOT COMPLETED|Overall Study||3
11048165|NCT00950911|12228669|FG000|STARTED|Overall Study||17
11048166|NCT00950911|12228670|FG001|STARTED|Overall Study||18
11048167|NCT00950911|12228669|FG000|COMPLETED|Overall Study||5
11048168|NCT00950911|12228670|FG001|COMPLETED|Overall Study||3
11048169|NCT00950911|12228669|FG000|NOT COMPLETED|Overall Study||12
11048170|NCT00950911|12228670|FG001|NOT COMPLETED|Overall Study||15
11048171|NCT00950950|12228678|FG000|STARTED|Overall Study||12
11048172|NCT00950950|12228679|FG001|STARTED|Overall Study||12
11048173|NCT00950950|12228678|FG000|COMPLETED|Overall Study||11
11048174|NCT00950950|12228679|FG001|COMPLETED|Overall Study||11
11048175|NCT00950950|12228678|FG000|NOT COMPLETED|Overall Study||1
11048176|NCT00950950|12228679|FG001|NOT COMPLETED|Overall Study||1
11048177|NCT00950963|12228688|FG000|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
11337125|NCT02888665|12534911|FG002|COMPLETED|Overall Study||31
11337126|NCT02888665|12534909|FG000|NOT COMPLETED|Overall Study||0
11337127|NCT02888665|12534910|FG001|NOT COMPLETED|Overall Study||0
11337128|NCT02888665|12534911|FG002|NOT COMPLETED|Overall Study||0
11337129|NCT02888691|12534920|FG000|STARTED|First Intervention Period||7
11337130|NCT02888691|12534921|FG001|STARTED|First Intervention Period||7
11337131|NCT02888691|12534920|FG000|COMPLETED|First Intervention Period||6
11337132|NCT02888691|12534921|FG001|COMPLETED|First Intervention Period||7
11337133|NCT02888691|12534920|FG000|NOT COMPLETED|First Intervention Period||1
11337134|NCT02888691|12534921|FG001|NOT COMPLETED|First Intervention Period||0
11337135|NCT02888691|12534920|FG000|STARTED|Second Intervention Period|This is a cross-over study. Therefore starters does not necessarily equal completers of period 1.|7
11337136|NCT02888691|12534921|FG001|STARTED|Second Intervention Period||5
11337137|NCT02888691|12534920|FG000|COMPLETED|Second Intervention Period||7
11337138|NCT02888691|12534921|FG001|COMPLETED|Second Intervention Period||3
11337139|NCT02888691|12534920|FG000|NOT COMPLETED|Second Intervention Period||0
11337140|NCT02888691|12534921|FG001|NOT COMPLETED|Second Intervention Period||2
11337141|NCT02888756|12534930|FG000|STARTED|Vaccination Period||16
11337142|NCT02888756|12534931|FG001|STARTED|Vaccination Period||9
11337143|NCT02888756|12534932|FG002|STARTED|Vaccination Period||8
11337144|NCT02888756|12534930|FG000|COMPLETED|Vaccination Period||16
11337145|NCT02888756|12534931|FG001|COMPLETED|Vaccination Period||9
11337146|NCT02888756|12534932|FG002|COMPLETED|Vaccination Period||8
11337147|NCT02888756|12534930|FG000|NOT COMPLETED|Vaccination Period||0
11337148|NCT02888756|12534931|FG001|NOT COMPLETED|Vaccination Period||0
11337149|NCT02888756|12534932|FG002|NOT COMPLETED|Vaccination Period||0
11337150|NCT02888756|12534930|FG000|STARTED|Analytical Treatment Interruption||15
11337151|NCT02888756|12534931|FG001|STARTED|Analytical Treatment Interruption||9
11337152|NCT02888756|12534932|FG002|STARTED|Analytical Treatment Interruption||8
11337153|NCT02888756|12534930|FG000|COMPLETED|Analytical Treatment Interruption||5
11337154|NCT02888756|12534931|FG001|COMPLETED|Analytical Treatment Interruption||3
11337155|NCT02888756|12534932|FG002|COMPLETED|Analytical Treatment Interruption||3
11337156|NCT02888756|12534930|FG000|NOT COMPLETED|Analytical Treatment Interruption||10
11337157|NCT02888756|12534931|FG001|NOT COMPLETED|Analytical Treatment Interruption||6
11337158|NCT02888756|12534932|FG002|NOT COMPLETED|Analytical Treatment Interruption||5
11337159|NCT02889289|12534940|FG000|STARTED|Overall Study||1
11337160|NCT02889289|12534940|FG000|COMPLETED|Overall Study||1
11337161|NCT02889289|12534940|FG000|NOT COMPLETED|Overall Study||0
11337162|NCT02889393|12534946|FG000|STARTED|Overall Study||3
11048178|NCT00950963|12228689|FG001|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
11048179|NCT00950963|12228688|FG000|COMPLETED|Overall Study||352
11048180|NCT00950963|12228689|FG001|COMPLETED|Overall Study||357
11048181|NCT00950963|12228688|FG000|NOT COMPLETED|Overall Study||29
11201441|NCT01832727|12391749|FG003|STARTED|Overall Study||4
11201442|NCT01832727|12391750|FG004|STARTED|Overall Study||4
11201443|NCT01832727|12391751|FG005|STARTED|Overall Study||6
11337163|NCT02889393|12534947|FG001|STARTED|Overall Study||3
11337164|NCT02889393|12534946|FG000|COMPLETED|Overall Study||3
11337165|NCT02889393|12534947|FG001|COMPLETED|Overall Study||3
11337166|NCT02889393|12534946|FG000|NOT COMPLETED|Overall Study||0
11337167|NCT02889393|12534947|FG001|NOT COMPLETED|Overall Study||0
11337168|NCT02889510|12534954|FG000|STARTED|Overall Study||35
11337169|NCT02889510|12534955|FG001|STARTED|Overall Study||37
11337170|NCT02889510|12534954|FG000|COMPLETED|Overall Study||27
11337171|NCT02889510|12534955|FG001|COMPLETED|Overall Study||32
11337172|NCT02889510|12534954|FG000|NOT COMPLETED|Overall Study||8
11337173|NCT02889510|12534955|FG001|NOT COMPLETED|Overall Study||5
11337174|NCT02889562|12534963|FG000|STARTED|Overall Study||28
11337175|NCT02889562|12534964|FG001|STARTED|Overall Study||28
11337176|NCT02889562|12534963|FG000|COMPLETED|Overall Study||28
11337177|NCT02889562|12534964|FG001|COMPLETED|Overall Study||26
11337178|NCT02889562|12534963|FG000|NOT COMPLETED|Overall Study||0
11337179|NCT02889562|12534964|FG001|NOT COMPLETED|Overall Study||2
11048182|NCT00950963|12228689|FG001|NOT COMPLETED|Overall Study||24
11048183|NCT00951015|12228699|FG000|STARTED|Randomization Phase 96 Week||53
11048184|NCT00951015|12228700|FG001|STARTED|Randomization Phase 96 Week||51
11048185|NCT00951015|12228701|FG002|STARTED|Randomization Phase 96 Week||51
11048186|NCT00951015|12228702|FG003|STARTED|Randomization Phase 96 Week||50
11048187|NCT00951015|12228703|FG004|STARTED|Randomization Phase 96 Week||0
11048188|NCT00951015|12228699|FG000|COMPLETED|Randomization Phase 96 Week||48
11048189|NCT00951015|12228700|FG001|COMPLETED|Randomization Phase 96 Week||44
11048190|NCT00951015|12228701|FG002|COMPLETED|Randomization Phase 96 Week||46
11048191|NCT00951015|12228702|FG003|COMPLETED|Randomization Phase 96 Week||40
11048192|NCT00951015|12228703|FG004|COMPLETED|Randomization Phase 96 Week||0
11048193|NCT00951015|12228699|FG000|NOT COMPLETED|Randomization Phase 96 Week||5
11048194|NCT00951015|12228700|FG001|NOT COMPLETED|Randomization Phase 96 Week||7
11048195|NCT00951015|12228701|FG002|NOT COMPLETED|Randomization Phase 96 Week||5
11048196|NCT00951015|12228702|FG003|NOT COMPLETED|Randomization Phase 96 Week||10
11048197|NCT00951015|12228703|FG004|NOT COMPLETED|Randomization Phase 96 Week||0
11048198|NCT00951015|12228699|FG000|STARTED|Open-label Phase||0
11048199|NCT00951015|12228700|FG001|STARTED|Open-label Phase||0
11048200|NCT00951015|12228701|FG002|STARTED|Open-label Phase||0
11048201|NCT00951015|12228702|FG003|STARTED|Open-label Phase||0
11048202|NCT00951015|12228703|FG004|STARTED|Open-label Phase||138
11048203|NCT00951015|12228699|FG000|COMPLETED|Open-label Phase||0
11048204|NCT00951015|12228700|FG001|COMPLETED|Open-label Phase||0
11048205|NCT00951015|12228701|FG002|COMPLETED|Open-label Phase||0
11048206|NCT00951015|12228702|FG003|COMPLETED|Open-label Phase||0
11048207|NCT00951015|12228703|FG004|COMPLETED|Open-label Phase||88
11048208|NCT00951015|12228699|FG000|NOT COMPLETED|Open-label Phase||0
11048209|NCT00951015|12228700|FG001|NOT COMPLETED|Open-label Phase||0
11048210|NCT00951015|12228701|FG002|NOT COMPLETED|Open-label Phase||0
11048211|NCT00951015|12228702|FG003|NOT COMPLETED|Open-label Phase||0
11048212|NCT00951015|12228703|FG004|NOT COMPLETED|Open-label Phase||50
11048213|NCT00951041|12228728|FG000|STARTED|Overall Study||64
11048214|NCT00951041|12228729|FG001|STARTED|Overall Study||66
11048215|NCT00951041|12228728|FG000|COMPLETED|Overall Study||59
11048216|NCT00951041|12228729|FG001|COMPLETED|Overall Study||65
11048217|NCT00951041|12228728|FG000|NOT COMPLETED|Overall Study||5
11048218|NCT00951041|12228729|FG001|NOT COMPLETED|Overall Study||1
11048219|NCT00951093|12228736|FG000|STARTED|Before GBP||53
11048220|NCT00951093|12228736|FG000|COMPLETED|Before GBP||53
11048221|NCT00951093|12228736|FG000|NOT COMPLETED|Before GBP||0
11048222|NCT00951093|12228736|FG000|STARTED|6 Months After GBP||53
11048223|NCT00951093|12228736|FG000|COMPLETED|6 Months After GBP||53
11048224|NCT00951093|12228736|FG000|NOT COMPLETED|6 Months After GBP||0
11048225|NCT00951171|12228744|FG000|STARTED|Overall Study||40
11048226|NCT00951171|12228745|FG001|STARTED|Overall Study||55
11048227|NCT00951171|12228744|FG000|Pregnancy|Overall Study||1
11048228|NCT00951171|12228745|FG001|Pregnancy|Overall Study||7
11048229|NCT00951171|12228744|FG000|COMPLETED|Overall Study||38
11048230|NCT00951171|12228745|FG001|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
11048231|NCT00951171|12228744|FG000|NOT COMPLETED|Overall Study||2
11048232|NCT00951171|12228745|FG001|NOT COMPLETED|Overall Study||0
11048233|NCT00951275|12228751|FG000|STARTED|Overall Study||105
11048234|NCT00951275|12228751|FG000|COMPLETED|Overall Study||92
11048235|NCT00951275|12228751|FG000|NOT COMPLETED|Overall Study||13
11048236|NCT00951379|12228757|FG000|STARTED|Overall Study||27
11048237|NCT00951379|12228758|FG001|STARTED|Overall Study||25
11048238|NCT00951379|12228757|FG000|COMPLETED|Overall Study||21
11048239|NCT00951379|12228758|FG001|COMPLETED|Overall Study||23
11048240|NCT00951379|12228757|FG000|NOT COMPLETED|Overall Study||6
11048241|NCT00951379|12228758|FG001|NOT COMPLETED|Overall Study||2
11048242|NCT00951483|12228774|FG000|STARTED|Overall Study||47
11048243|NCT00951483|12228775|FG001|STARTED|Overall Study||44
11048244|NCT00951483|12228774|FG000|COMPLETED|Overall Study||28
11048245|NCT00951483|12228775|FG001|COMPLETED|Overall Study||44
11048246|NCT00951483|12228774|FG000|NOT COMPLETED|Overall Study||19
11048247|NCT00951483|12228775|FG001|NOT COMPLETED|Overall Study||0
11048248|NCT00951496|12228786|FG000|STARTED|Overall Study||521
11048249|NCT00951496|12228787|FG001|STARTED|Overall Study||518
11048250|NCT00951496|12228788|FG002|STARTED|Overall Study||521
11048251|NCT00951496|12228786|FG000|COMPLETED|Overall Study||511
11048252|NCT00951496|12228787|FG001|COMPLETED|Overall Study||510
11048253|NCT00951496|12228788|FG002|COMPLETED|Overall Study||508
11201444|NCT01832727|12391752|FG006|STARTED|Overall Study||8
11048254|NCT00951496|12228786|FG000|NOT COMPLETED|Overall Study||10
11048255|NCT00951496|12228787|FG001|NOT COMPLETED|Overall Study||8
11048256|NCT00951496|12228788|FG002|NOT COMPLETED|Overall Study||13
11048257|NCT00951509|12228799|FG000|STARTED|Overall Study||31
11048258|NCT00951509|12228799|FG000|Driving Condition 1|Overall Study||29
11048259|NCT00951509|12228799|FG000|Driving Condition 2|Overall Study||29
11048260|NCT00951509|12228799|FG000|Driving Condition 3|Overall Study||25
11048261|NCT00951509|12228799|FG000|Driving Condition 4|Overall Study||28
11048262|NCT00951509|12228799|FG000|Driving Condition 5|Overall Study||30
11048263|NCT00951509|12228799|FG000|COMPLETED|Overall Study||29
11048264|NCT00951509|12228799|FG000|NOT COMPLETED|Overall Study||2
11048265|NCT00951561|12228807|FG000|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
11048266|NCT00951561|12228808|FG001|STARTED|Overall Study||29
11048267|NCT00951561|12228809|FG002|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
11048268|NCT00951561|12228810|FG003|STARTED|Overall Study||27
11048269|NCT00951561|12228807|FG000|COMPLETED|Overall Study||25
11048270|NCT00951561|12228808|FG001|COMPLETED|Overall Study||29
11048271|NCT00951561|12228809|FG002|COMPLETED|Overall Study|3 subjects dropped after period 2|18
11048272|NCT00951561|12228810|FG003|COMPLETED|Overall Study|1 subject dropped after period 2|26
11048273|NCT00951561|12228807|FG000|NOT COMPLETED|Overall Study||0
11048274|NCT00951561|12228808|FG001|NOT COMPLETED|Overall Study||0
11048275|NCT00951561|12228809|FG002|NOT COMPLETED|Overall Study||3
11048276|NCT00951561|12228810|FG003|NOT COMPLETED|Overall Study||1
11048277|NCT00951665|12228821|FG000|STARTED|Phase 1b||29
11048278|NCT00951665|12228822|FG001|STARTED|Phase 1b||10
11048279|NCT00951665|12228823|FG002|STARTED|Phase 1b||21
11048280|NCT00951665|12228824|FG003|STARTED|Phase 1b||3
11048281|NCT00951665|12228825|FG004|STARTED|Phase 1b||0
11048282|NCT00951665|12228826|FG005|STARTED|Phase 1b||0
11048283|NCT00951665|12228821|FG000|Started Treatment|Phase 1b||26
11048284|NCT00951665|12228822|FG001|Started Treatment|Phase 1b||10
11048285|NCT00951665|12228823|FG002|Started Treatment|Phase 1b||21
11048286|NCT00951665|12228824|FG003|Started Treatment|Phase 1b||3
11048287|NCT00951665|12228825|FG004|Started Treatment|Phase 1b||0
11048288|NCT00951665|12228826|FG005|Started Treatment|Phase 1b||0
11048289|NCT00951665|12228821|FG000|COMPLETED|Phase 1b||7
11048290|NCT00951665|12228822|FG001|COMPLETED|Phase 1b||6
11048291|NCT00951665|12228823|FG002|COMPLETED|Phase 1b||4
11048292|NCT00951665|12228824|FG003|COMPLETED|Phase 1b||2
11048293|NCT00951665|12228825|FG004|COMPLETED|Phase 1b||0
11048294|NCT00951665|12228826|FG005|COMPLETED|Phase 1b||0
11048295|NCT00951665|12228821|FG000|NOT COMPLETED|Phase 1b||22
11048296|NCT00951665|12228822|FG001|NOT COMPLETED|Phase 1b||4
11048297|NCT00951665|12228823|FG002|NOT COMPLETED|Phase 1b||17
11048298|NCT00951665|12228824|FG003|NOT COMPLETED|Phase 1b||1
11048299|NCT00951665|12228825|FG004|NOT COMPLETED|Phase 1b||0
11048300|NCT00951665|12228826|FG005|NOT COMPLETED|Phase 1b||0
11048301|NCT00951665|12228821|FG000|STARTED|Phase 2a||0
11048302|NCT00951665|12228822|FG001|STARTED|Phase 2a||0
11048303|NCT00951665|12228823|FG002|STARTED|Phase 2a||0
11048304|NCT00951665|12228824|FG003|STARTED|Phase 2a||0
11048305|NCT00951665|12228825|FG004|STARTED|Phase 2a||22
11048306|NCT00951665|12228826|FG005|STARTED|Phase 2a||22
11048307|NCT00951665|12228821|FG000|COMPLETED|Phase 2a||0
11048308|NCT00951665|12228822|FG001|COMPLETED|Phase 2a||0
11048309|NCT00951665|12228823|FG002|COMPLETED|Phase 2a||0
11048310|NCT00951665|12228824|FG003|COMPLETED|Phase 2a||0
11048311|NCT00951665|12228825|FG004|COMPLETED|Phase 2a||10
11048312|NCT00951665|12228826|FG005|COMPLETED|Phase 2a||15
11048313|NCT00951665|12228821|FG000|NOT COMPLETED|Phase 2a||0
11048314|NCT00951665|12228822|FG001|NOT COMPLETED|Phase 2a||0
11048315|NCT00951665|12228823|FG002|NOT COMPLETED|Phase 2a||0
11048316|NCT00951665|12228824|FG003|NOT COMPLETED|Phase 2a||0
11048317|NCT00951665|12228825|FG004|NOT COMPLETED|Phase 2a||12
11048318|NCT00951665|12228826|FG005|NOT COMPLETED|Phase 2a||7
11048319|NCT00951808|12228860|FG000|STARTED|Overall Study||4
11048320|NCT00951808|12228861|FG001|STARTED|Overall Study||6
11048321|NCT00951808|12228862|FG002|STARTED|Overall Study||227
11048322|NCT00951808|12228860|FG000|COMPLETED|Overall Study||4
11048323|NCT00951808|12228861|FG001|COMPLETED|Overall Study||6
11048324|NCT00951808|12228862|FG002|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
11048325|NCT00951808|12228860|FG000|NOT COMPLETED|Overall Study||0
11048326|NCT00951808|12228861|FG001|NOT COMPLETED|Overall Study||0
11048327|NCT00951808|12228862|FG002|NOT COMPLETED|Overall Study||4
11048328|NCT00951821|12228870|FG000|STARTED|Overall Study||16
11048329|NCT00951821|12228871|FG001|STARTED|Overall Study||8
11048330|NCT00951821|12228870|FG000|COMPLETED|Overall Study||16
11048331|NCT00951821|12228871|FG001|COMPLETED|Overall Study||8
11048332|NCT00951821|12228870|FG000|NOT COMPLETED|Overall Study||0
11048333|NCT00951821|12228871|FG001|NOT COMPLETED|Overall Study||0
11048334|NCT00951899|12228879|FG000|STARTED|Overall Study||19
11048335|NCT00951899|12228880|FG001|STARTED|Overall Study||19
11048336|NCT00951899|12228879|FG000|COMPLETED|Overall Study||19
11048337|NCT00951899|12228880|FG001|COMPLETED|Overall Study||19
11048338|NCT00951899|12228879|FG000|NOT COMPLETED|Overall Study||0
11048339|NCT00951899|12228880|FG001|NOT COMPLETED|Overall Study||0
11048340|NCT00951912|12228889|FG000|STARTED|Overall Study||54
11048341|NCT00951912|12228890|FG001|STARTED|Overall Study||55
11048342|NCT00951912|12228891|FG002|STARTED|Overall Study||56
11048343|NCT00951912|12228889|FG000|COMPLETED|Overall Study||47
11048344|NCT00951912|12228890|FG001|COMPLETED|Overall Study||50
11048345|NCT00951912|12228891|FG002|COMPLETED|Overall Study||54
11048346|NCT00951912|12228889|FG000|NOT COMPLETED|Overall Study||7
11048347|NCT00951912|12228890|FG001|NOT COMPLETED|Overall Study||5
11048348|NCT00951912|12228891|FG002|NOT COMPLETED|Overall Study||2
11048349|NCT00952068|12228899|FG000|STARTED|Overall Study||47
11048350|NCT00952068|12228899|FG000|COMPLETED|Overall Study||40
11048351|NCT00952068|12228899|FG000|NOT COMPLETED|Overall Study||7
11048352|NCT00952081|12228903|FG000|STARTED|Overall Study||22
11048353|NCT00952081|12228903|FG000|COMPLETED|Overall Study||22
11048354|NCT00952081|12228903|FG000|NOT COMPLETED|Overall Study||0
11048355|NCT00952120|12228910|FG000|STARTED|Overall Study||52
11048356|NCT00952120|12228911|FG001|STARTED|Overall Study||47
11048357|NCT00952120|12228912|FG002|STARTED|Overall Study||5
11048358|NCT00952120|12228910|FG000|COMPLETED|Overall Study||52
11048359|NCT00952120|12228911|FG001|COMPLETED|Overall Study||47
11048360|NCT00952120|12228912|FG002|COMPLETED|Overall Study||5
11048361|NCT00952120|12228910|FG000|NOT COMPLETED|Overall Study||0
11048362|NCT00952120|12228911|FG001|NOT COMPLETED|Overall Study||0
11048363|NCT00952120|12228912|FG002|NOT COMPLETED|Overall Study||0
11048364|NCT00952133|12228920|FG000|STARTED|Overall Study||59
11048365|NCT00952133|12228921|FG001|STARTED|Overall Study||59
11048366|NCT00952133|12228920|FG000|COMPLETED|Overall Study||59
11048367|NCT00952133|12228921|FG001|COMPLETED|Overall Study||59
11048368|NCT00952133|12228920|FG000|NOT COMPLETED|Overall Study||0
11048369|NCT00952133|12228921|FG001|NOT COMPLETED|Overall Study||0
11048370|NCT00952211|12228931|FG000|STARTED|Overall Study||3
11048371|NCT00952211|12228932|FG001|STARTED|Overall Study||0
11048372|NCT00952211|12228931|FG000|COMPLETED|Overall Study||3
11048373|NCT00952211|12228932|FG001|COMPLETED|Overall Study||0
11048374|NCT00952211|12228931|FG000|NOT COMPLETED|Overall Study||0
11048375|NCT00952211|12228932|FG001|NOT COMPLETED|Overall Study||0
11048376|NCT00952276|12228943|FG000|STARTED|Overall Study||127
11048377|NCT00952276|12228944|FG001|STARTED|Overall Study||115
11048378|NCT00952276|12228945|FG002|STARTED|Overall Study||122
11048379|NCT00952276|12228946|FG003|STARTED|Overall Study||121
11048380|NCT00952276|12228947|FG004|STARTED|Overall Study||63
11048381|NCT00952276|12228943|FG000|COMPLETED|Overall Study||126
11048382|NCT00952276|12228944|FG001|COMPLETED|Overall Study||115
11048383|NCT00952276|12228945|FG002|COMPLETED|Overall Study||122
11048384|NCT00952276|12228946|FG003|COMPLETED|Overall Study||120
11048385|NCT00952276|12228947|FG004|COMPLETED|Overall Study||63
11048386|NCT00952276|12228943|FG000|NOT COMPLETED|Overall Study||1
11048387|NCT00952276|12228944|FG001|NOT COMPLETED|Overall Study||0
11048388|NCT00952276|12228945|FG002|NOT COMPLETED|Overall Study||0
11048389|NCT00952276|12228946|FG003|NOT COMPLETED|Overall Study||1
11048390|NCT00952276|12228947|FG004|NOT COMPLETED|Overall Study||0
11048391|NCT00952289|12228961|FG000|STARTED|All Participants||155
11048392|NCT00952289|12228962|FG001|STARTED|All Participants||154
11048393|NCT00952289|12228961|FG000|Safety Population|All Participants||155
11048394|NCT00952289|12228962|FG001|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
11048395|NCT00952289|12228961|FG000|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
11048396|NCT00952289|12228962|FG001|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
11048397|NCT00952289|12228961|FG000|NOT COMPLETED|All Participants||21
11048398|NCT00952289|12228962|FG001|NOT COMPLETED|All Participants||40
11048399|NCT00952289|12228961|FG000|STARTED|Patients Who Crossed Over to Ruxolitinib||0
11048400|NCT00952289|12228962|FG001|STARTED|Patients Who Crossed Over to Ruxolitinib||111
11048401|NCT00952289|12228961|FG000|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
11048402|NCT00952289|12228962|FG001|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
11048403|NCT00952289|12228961|FG000|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
11048404|NCT00952289|12228962|FG001|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
11048405|NCT00952315|12228971|FG000|STARTED|Overall Study||90
11048406|NCT00952315|12228972|FG001|STARTED|Overall Study||90
11048407|NCT00952315|12228973|FG002|STARTED|Overall Study||90
11048408|NCT00952315|12228971|FG000|COMPLETED|Overall Study||64
11048409|NCT00952315|12228972|FG001|COMPLETED|Overall Study||66
11048410|NCT00952315|12228973|FG002|COMPLETED|Overall Study||71
11048411|NCT00952315|12228971|FG000|NOT COMPLETED|Overall Study||26
11048412|NCT00952315|12228972|FG001|NOT COMPLETED|Overall Study||24
11048413|NCT00952315|12228973|FG002|NOT COMPLETED|Overall Study||19
11048414|NCT00952341|12228986|FG000|STARTED|Cycle 1||209
11048415|NCT00952341|12228987|FG001|STARTED|Cycle 1||212
11048416|NCT00952341|12228986|FG000|COMPLETED|Cycle 1||189
11048417|NCT00952341|12228987|FG001|COMPLETED|Cycle 1||199
11048418|NCT00952341|12228986|FG000|NOT COMPLETED|Cycle 1||20
11048419|NCT00952341|12228987|FG001|NOT COMPLETED|Cycle 1||13
11048420|NCT00952341|12228986|FG000|STARTED|Cycle 2||110
11048421|NCT00952341|12228987|FG001|STARTED|Cycle 2||130
11048422|NCT00952341|12228986|FG000|COMPLETED|Cycle 2||101
11048423|NCT00952341|12228987|FG001|COMPLETED|Cycle 2||118
11048424|NCT00952341|12228986|FG000|NOT COMPLETED|Cycle 2||9
11048425|NCT00952341|12228987|FG001|NOT COMPLETED|Cycle 2||12
11048426|NCT00952367|12228993|FG000|STARTED|Overall Study||3641
11048427|NCT00952367|12228993|FG000|COMPLETED|Overall Study||3635
11048428|NCT00952367|12228993|FG000|NOT COMPLETED|Overall Study||6
11048429|NCT00952380|12229002|FG000|STARTED|Overall Study||1
11048430|NCT00952380|12229003|FG001|STARTED|Overall Study||2
11048431|NCT00952380|12229004|FG002|STARTED|Overall Study||8
11048432|NCT00952380|12229005|FG003|STARTED|Overall Study||7
11048433|NCT00952380|12229006|FG004|STARTED|Overall Study||20
11337180|NCT02889796|12534974|FG000|STARTED|Overall Study||477
11337181|NCT02889796|12534975|FG001|STARTED|Overall Study||480
11337182|NCT02889796|12534976|FG002|STARTED|Overall Study||325
11337183|NCT02889796|12534977|FG003|STARTED|Overall Study||190
11337184|NCT02889796|12534978|FG004|STARTED|Overall Study||191
11337185|NCT02889796|12534979|FG005|STARTED|Overall Study||96
11337186|NCT02889796|12534974|FG000|COMPLETED|Overall Study||424
11337187|NCT02889796|12534975|FG001|COMPLETED|Overall Study||422
11337188|NCT02889796|12534976|FG002|COMPLETED|Overall Study||281
11337189|NCT02889796|12534977|FG003|COMPLETED|Overall Study||181
11337190|NCT02889796|12534978|FG004|COMPLETED|Overall Study||185
11337191|NCT02889796|12534979|FG005|COMPLETED|Overall Study|Completed 24 weeks of placebo treatment and not rerandomized to Filgotinib 200 mg or 100 mg groups|24
11337192|NCT02889796|12534974|FG000|NOT COMPLETED|Overall Study||53
11337193|NCT02889796|12534975|FG001|NOT COMPLETED|Overall Study||58
11337194|NCT02889796|12534976|FG002|NOT COMPLETED|Overall Study||44
11337195|NCT02889796|12534977|FG003|NOT COMPLETED|Overall Study||9
11337196|NCT02889796|12534978|FG004|NOT COMPLETED|Overall Study||6
11337197|NCT02889796|12534979|FG005|NOT COMPLETED|Overall Study||72
11337198|NCT02889861|12535002|FG000|STARTED|Overall Study||3
11337199|NCT02889861|12535002|FG000|COMPLETED|Overall Study||1
11337200|NCT02889861|12535002|FG000|NOT COMPLETED|Overall Study||2
11337201|NCT02890303|12535011|FG000|STARTED|Overall Study||100
11337202|NCT02890303|12535011|FG000|COMPLETED|Overall Study||100
11337203|NCT02890303|12535011|FG000|NOT COMPLETED|Overall Study||0
11337204|NCT02890381|12535017|FG000|STARTED|Overall Study||11
11337205|NCT02890381|12535018|FG001|STARTED|Overall Study||6
11337206|NCT02890381|12535017|FG000|COMPLETED|Overall Study||11
11337207|NCT02890381|12535018|FG001|COMPLETED|Overall Study||6
11337208|NCT02890381|12535017|FG000|NOT COMPLETED|Overall Study||0
11048434|NCT00952380|12229002|FG000|COMPLETED|Overall Study||1
11048435|NCT00952380|12229003|FG001|COMPLETED|Overall Study||1
11048436|NCT00952380|12229004|FG002|COMPLETED|Overall Study||6
11048437|NCT00952380|12229005|FG003|COMPLETED|Overall Study||4
11048438|NCT00952380|12229006|FG004|COMPLETED|Overall Study||14
11048439|NCT00952380|12229002|FG000|NOT COMPLETED|Overall Study||0
11337209|NCT02890381|12535018|FG001|NOT COMPLETED|Overall Study||0
11048440|NCT00952380|12229003|FG001|NOT COMPLETED|Overall Study||1
11048441|NCT00952380|12229004|FG002|NOT COMPLETED|Overall Study||2
11048442|NCT00952380|12229005|FG003|NOT COMPLETED|Overall Study||3
11048443|NCT00952380|12229006|FG004|NOT COMPLETED|Overall Study||6
11048444|NCT00952393|12229023|FG000|STARTED|Overall Study|10|10
11337210|NCT02890992|12535032|FG000|STARTED|12 Weeks Open-Label Dose Finding Period||4
11337211|NCT02890992|12535033|FG001|STARTED|12 Weeks Open-Label Dose Finding Period||6
11337212|NCT02890992|12535034|FG002|STARTED|12 Weeks Open-Label Dose Finding Period||4
11048445|NCT00952393|12229023|FG000|COMPLETED|Overall Study||10
11048446|NCT00952393|12229023|FG000|NOT COMPLETED|Overall Study||0
11048447|NCT00952419|12229030|FG000|STARTED|Overall Study||215
11048448|NCT00952419|12229031|FG001|STARTED|Overall Study||208
11048449|NCT00952419|12229032|FG002|STARTED|Overall Study||51
11048450|NCT00952419|12229030|FG000|COMPLETED|Overall Study||209
11048451|NCT00952419|12229031|FG001|COMPLETED|Overall Study||198
11048452|NCT00952419|12229032|FG002|COMPLETED|Overall Study||51
11048453|NCT00952419|12229030|FG000|NOT COMPLETED|Overall Study||6
11048454|NCT00952419|12229031|FG001|NOT COMPLETED|Overall Study||10
11048455|NCT00952419|12229032|FG002|NOT COMPLETED|Overall Study||0
11048456|NCT00952484|12229043|FG000|STARTED|Overall Study||6
11048457|NCT00952484|12229044|FG001|STARTED|Overall Study||7
11048458|NCT00952484|12229045|FG002|STARTED|Overall Study||16
11048459|NCT00952484|12229043|FG000|COMPLETED|Overall Study||6
11048460|NCT00952484|12229044|FG001|COMPLETED|Overall Study||6
11048461|NCT00952484|12229045|FG002|COMPLETED|Overall Study||16
11048462|NCT00952484|12229043|FG000|NOT COMPLETED|Overall Study||0
11048463|NCT00952484|12229044|FG001|NOT COMPLETED|Overall Study||1
11048464|NCT00952484|12229045|FG002|NOT COMPLETED|Overall Study||0
11048465|NCT00952523|12229054|FG000|STARTED|Overall Study||162
11048466|NCT00952523|12229054|FG000|COMPLETED|Overall Study||155
11048467|NCT00952523|12229054|FG000|NOT COMPLETED|Overall Study||7
11048468|NCT00952588|12229062|FG000|STARTED|Overall Study||48
11048469|NCT00952588|12229063|FG001|STARTED|Overall Study||26
11048470|NCT00952588|12229062|FG000|COMPLETED|Overall Study||12
11048471|NCT00952588|12229063|FG001|COMPLETED|Overall Study||2
11048472|NCT00952588|12229062|FG000|NOT COMPLETED|Overall Study||36
11048473|NCT00952588|12229063|FG001|NOT COMPLETED|Overall Study||24
11048474|NCT00952614|12229069|FG000|STARTED|Overall Study||30
11048475|NCT00952614|12229069|FG000|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
11048476|NCT00952614|12229069|FG000|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
11048477|NCT00952614|12229069|FG000|NOT COMPLETED|Overall Study||7
11048478|NCT00952653|12229074|FG000|STARTED|Period 1: MDZ Alone||28
11048479|NCT00952653|12229074|FG000|COMPLETED|Period 1: MDZ Alone||28
11048480|NCT00952653|12229074|FG000|NOT COMPLETED|Period 1: MDZ Alone||0
11048481|NCT00952653|12229074|FG000|STARTED|Period 2: Coadministration DVS SR, MDZ||28
11048482|NCT00952653|12229074|FG000|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
11048483|NCT00952653|12229074|FG000|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
11048484|NCT00952705|12229084|FG000|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
11048485|NCT00952705|12229085|FG001|STARTED|Overall Study||300
11048486|NCT00952705|12229086|FG002|STARTED|Overall Study||298
11048487|NCT00952705|12229084|FG000|COMPLETED|Overall Study||1169
11048488|NCT00952705|12229085|FG001|COMPLETED|Overall Study||290
11048489|NCT00952705|12229086|FG002|COMPLETED|Overall Study||288
11048490|NCT00952705|12229084|FG000|NOT COMPLETED|Overall Study||33
11048491|NCT00952705|12229085|FG001|NOT COMPLETED|Overall Study||10
11048492|NCT00952705|12229086|FG002|NOT COMPLETED|Overall Study||10
11048493|NCT00952718|12229100|FG000|STARTED|Overall Study||19
11048494|NCT00952718|12229101|FG001|STARTED|Overall Study||19
11048495|NCT00952718|12229100|FG000|COMPLETED|Overall Study||13
11048496|NCT00952718|12229101|FG001|COMPLETED|Overall Study||13
11048497|NCT00952718|12229100|FG000|NOT COMPLETED|Overall Study||6
11048498|NCT00952718|12229101|FG001|NOT COMPLETED|Overall Study||6
11048499|NCT00952731|12229111|FG000|STARTED|Overall Study||13
11048500|NCT00952731|12229112|FG001|STARTED|Overall Study||14
11048501|NCT00952731|12229111|FG000|Randomization|Overall Study||13
11048502|NCT00952731|12229112|FG001|Randomization|Overall Study||14
11048503|NCT00952731|12229111|FG000|Treatment & Pre-Surgery|Overall Study||12
11048504|NCT00952731|12229112|FG001|Treatment & Pre-Surgery|Overall Study||14
11048505|NCT00952731|12229111|FG000|Surgery|Overall Study||12
11048506|NCT00952731|12229112|FG001|Surgery|Overall Study||14
11048507|NCT00952731|12229111|FG000|Follow-up|Overall Study||12
11048508|NCT00952731|12229112|FG001|Follow-up|Overall Study||14
11048509|NCT00952731|12229111|FG000|COMPLETED|Overall Study||12
11048510|NCT00952731|12229112|FG001|COMPLETED|Overall Study||14
11048511|NCT00952731|12229111|FG000|NOT COMPLETED|Overall Study||1
11048512|NCT00952731|12229112|FG001|NOT COMPLETED|Overall Study||0
11048513|NCT00952822|12229118|FG000|STARTED|1st Pharmacokinetic Evaluation||9
11048514|NCT00952822|12229119|FG001|STARTED|1st Pharmacokinetic Evaluation||18
11048515|NCT00952822|12229120|FG002|STARTED|1st Pharmacokinetic Evaluation||11
11048516|NCT00952822|12229121|FG003|STARTED|1st Pharmacokinetic Evaluation||4
11048517|NCT00952822|12229118|FG000|COMPLETED|1st Pharmacokinetic Evaluation||9
11048518|NCT00952822|12229119|FG001|COMPLETED|1st Pharmacokinetic Evaluation||17
11048519|NCT00952822|12229120|FG002|COMPLETED|1st Pharmacokinetic Evaluation||11
11048520|NCT00952822|12229121|FG003|COMPLETED|1st Pharmacokinetic Evaluation||4
11048521|NCT00952822|12229118|FG000|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
11048522|NCT00952822|12229119|FG001|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
11048523|NCT00952822|12229120|FG002|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
11048524|NCT00952822|12229121|FG003|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
11048525|NCT00952822|12229118|FG000|STARTED|2nd Pharmacokinetic Evaluation||9
11337213|NCT02890992|12535035|FG003|STARTED|12 Weeks Open-Label Dose Finding Period||6
11337214|NCT02890992|12535036|FG004|STARTED|12 Weeks Open-Label Dose Finding Period||6
11048526|NCT00952822|12229119|FG001|STARTED|2nd Pharmacokinetic Evaluation||17
11048527|NCT00952822|12229120|FG002|STARTED|2nd Pharmacokinetic Evaluation||11
11048528|NCT00952822|12229121|FG003|STARTED|2nd Pharmacokinetic Evaluation||4
11048529|NCT00952822|12229118|FG000|COMPLETED|2nd Pharmacokinetic Evaluation||9
11048530|NCT00952822|12229119|FG001|COMPLETED|2nd Pharmacokinetic Evaluation||17
11048531|NCT00952822|12229120|FG002|COMPLETED|2nd Pharmacokinetic Evaluation||10
11048532|NCT00952822|12229121|FG003|COMPLETED|2nd Pharmacokinetic Evaluation||4
11048533|NCT00952822|12229118|FG000|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
11048534|NCT00952822|12229119|FG001|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
11048535|NCT00952822|12229120|FG002|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
11048536|NCT00952822|12229121|FG003|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
11048537|NCT00952848|12229132|FG000|STARTED|Overall Study||18
11048538|NCT00952848|12229132|FG000|COMPLETED|Overall Study||14
11048539|NCT00952848|12229132|FG000|NOT COMPLETED|Overall Study||4
11048540|NCT00953017|12229140|FG000|STARTED|Overall Study||106
11048541|NCT00953017|12229141|FG001|STARTED|Overall Study||107
11048542|NCT00953017|12229142|FG002|STARTED|Overall Study||106
11048543|NCT00953017|12229143|FG003|STARTED|Overall Study||106
11048544|NCT00953017|12229140|FG000|COMPLETED|Overall Study||101
11048545|NCT00953017|12229141|FG001|COMPLETED|Overall Study||101
11048546|NCT00953017|12229142|FG002|COMPLETED|Overall Study||100
11048547|NCT00953017|12229143|FG003|COMPLETED|Overall Study||101
11048548|NCT00953017|12229140|FG000|NOT COMPLETED|Overall Study||5
11048549|NCT00953017|12229141|FG001|NOT COMPLETED|Overall Study||6
11048550|NCT00953017|12229142|FG002|NOT COMPLETED|Overall Study||6
11048551|NCT00953017|12229143|FG003|NOT COMPLETED|Overall Study||5
11048552|NCT00953043|12229155|FG000|STARTED|Overall Study||30
11048553|NCT00953043|12229156|FG001|STARTED|Overall Study||30
11048554|NCT00953043|12229155|FG000|COMPLETED|Overall Study||26
11048555|NCT00953043|12229156|FG001|COMPLETED|Overall Study||28
11048556|NCT00953043|12229155|FG000|NOT COMPLETED|Overall Study||4
11048557|NCT00953043|12229156|FG001|NOT COMPLETED|Overall Study||2
11048558|NCT00953056|12229168|FG000|STARTED|Overall Study||24
11048559|NCT00953056|12229169|FG001|STARTED|Overall Study||24
11048560|NCT00953056|12229170|FG002|STARTED|Overall Study||24
11048561|NCT00953056|12229171|FG003|STARTED|Overall Study||24
11048562|NCT00953056|12229172|FG004|STARTED|Overall Study||24
11048563|NCT00953056|12229173|FG005|STARTED|Overall Study||24
11048564|NCT00953056|12229168|FG000|COMPLETED|Overall Study||24
11048565|NCT00953056|12229169|FG001|COMPLETED|Overall Study||24
11048566|NCT00953056|12229170|FG002|COMPLETED|Overall Study||24
11048567|NCT00953056|12229171|FG003|COMPLETED|Overall Study||24
11048568|NCT00953056|12229172|FG004|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
11048569|NCT00953056|12229173|FG005|COMPLETED|Overall Study||20
11048570|NCT00953056|12229168|FG000|NOT COMPLETED|Overall Study||0
11048571|NCT00953056|12229169|FG001|NOT COMPLETED|Overall Study||0
11048572|NCT00953056|12229170|FG002|NOT COMPLETED|Overall Study||0
11048573|NCT00953056|12229171|FG003|NOT COMPLETED|Overall Study||0
11048574|NCT00953056|12229172|FG004|NOT COMPLETED|Overall Study||2
11048575|NCT00953056|12229173|FG005|NOT COMPLETED|Overall Study||4
11048576|NCT00953121|12229192|FG000|STARTED|Overall Study||40
11048577|NCT00953121|12229193|FG001|STARTED|Overall Study||39
11048578|NCT00953121|12229194|FG002|STARTED|Overall Study||25
11048579|NCT00953121|12229192|FG000|COMPLETED|Overall Study||40
11048580|NCT00953121|12229193|FG001|COMPLETED|Overall Study||39
11048581|NCT00953121|12229194|FG002|COMPLETED|Overall Study||25
11048582|NCT00953121|12229192|FG000|NOT COMPLETED|Overall Study||0
11048583|NCT00953121|12229193|FG001|NOT COMPLETED|Overall Study||0
11048584|NCT00953121|12229194|FG002|NOT COMPLETED|Overall Study||0
11048585|NCT00953147|12229205|FG000|STARTED|Overall Study||298
11048586|NCT00953147|12229206|FG001|STARTED|Overall Study||505
11048587|NCT00953147|12229207|FG002|STARTED|Overall Study||307
11048588|NCT00953147|12229205|FG000|COMPLETED|Overall Study||261
11048589|NCT00953147|12229206|FG001|COMPLETED|Overall Study||439
11048590|NCT00953147|12229207|FG002|COMPLETED|Overall Study||265
11048591|NCT00953147|12229205|FG000|NOT COMPLETED|Overall Study||37
11048592|NCT00953147|12229206|FG001|NOT COMPLETED|Overall Study||66
11048593|NCT00953147|12229207|FG002|NOT COMPLETED|Overall Study||42
11048594|NCT00953160|12229215|FG000|STARTED|Overall Study||76
11048595|NCT00953160|12229215|FG000|COMPLETED|Overall Study||49
11048596|NCT00953160|12229215|FG000|NOT COMPLETED|Overall Study||27
11048597|NCT00953173|12229219|FG000|STARTED|Overall Study||671
11337215|NCT02890992|12535037|FG005|STARTED|12 Weeks Open-Label Dose Finding Period||5
11337216|NCT02890992|12535038|FG006|STARTED|12 Weeks Open-Label Dose Finding Period||6
11337217|NCT02890992|12535039|FG007|STARTED|12 Weeks Open-Label Dose Finding Period||5
11337218|NCT02890992|12535032|FG000|Treated|12 Weeks Open-Label Dose Finding Period||4
11337219|NCT02890992|12535033|FG001|Treated|12 Weeks Open-Label Dose Finding Period||6
11337220|NCT02890992|12535034|FG002|Treated|12 Weeks Open-Label Dose Finding Period||4
11337221|NCT02890992|12535035|FG003|Treated|12 Weeks Open-Label Dose Finding Period||6
11343882|NCT02956629|12541151|FG003|COMPLETED|Overall Study||55
11048598|NCT00953173|12229219|FG000|COMPLETED|Overall Study||389
11048599|NCT00953173|12229219|FG000|NOT COMPLETED|Overall Study||282
11048600|NCT00953199|12229225|FG000|STARTED|Overall Study||254
11048601|NCT00953199|12229226|FG001|STARTED|Overall Study||252
11048602|NCT00953199|12229225|FG000|COMPLETED|Overall Study||254
11048603|NCT00953199|12229226|FG001|COMPLETED|Overall Study||252
11048604|NCT00953199|12229225|FG000|NOT COMPLETED|Overall Study||0
11048605|NCT00953199|12229226|FG001|NOT COMPLETED|Overall Study||0
11337222|NCT02890992|12535036|FG004|Treated|12 Weeks Open-Label Dose Finding Period||6
11337223|NCT02890992|12535037|FG005|Treated|12 Weeks Open-Label Dose Finding Period||5
11337224|NCT02890992|12535038|FG006|Treated|12 Weeks Open-Label Dose Finding Period||6
11048606|NCT00953212|12229238|FG000|STARTED|Overall Study||76
11048607|NCT00953212|12229239|FG001|STARTED|Overall Study||74
11048608|NCT00953212|12229240|FG002|STARTED|Overall Study||78
11048609|NCT00953212|12229241|FG003|STARTED|Overall Study||76
11048610|NCT00953212|12229238|FG000|COMPLETED|Overall Study||76
11048611|NCT00953212|12229239|FG001|COMPLETED|Overall Study||74
11048612|NCT00953212|12229240|FG002|COMPLETED|Overall Study||78
11048613|NCT00953212|12229241|FG003|COMPLETED|Overall Study||76
11048614|NCT00953212|12229238|FG000|NOT COMPLETED|Overall Study||0
11048615|NCT00953212|12229239|FG001|NOT COMPLETED|Overall Study||0
11048616|NCT00953212|12229240|FG002|NOT COMPLETED|Overall Study||0
11048617|NCT00953212|12229241|FG003|NOT COMPLETED|Overall Study||0
11048618|NCT00953225|12229257|FG000|STARTED|Overall Study||46
11048619|NCT00953225|12229258|FG001|STARTED|Overall Study||37
11048620|NCT00953225|12229257|FG000|COMPLETED|Overall Study||44
11048621|NCT00953225|12229258|FG001|COMPLETED|Overall Study||37
11048622|NCT00953225|12229257|FG000|NOT COMPLETED|Overall Study||2
11048623|NCT00953225|12229258|FG001|NOT COMPLETED|Overall Study||0
11048624|NCT00953290|12229264|FG000|STARTED|Overall Study||4
11048625|NCT00953290|12229264|FG000|COMPLETED|Overall Study||4
11048626|NCT00953290|12229264|FG000|NOT COMPLETED|Overall Study||0
11048627|NCT00953407|12229276|FG000|STARTED|Overall Study||26
11048628|NCT00953407|12229277|FG001|STARTED|Overall Study||25
11048629|NCT00953407|12229278|FG002|STARTED|Overall Study||26
11048630|NCT00953407|12229279|FG003|STARTED|Overall Study||25
11048631|NCT00953407|12229280|FG004|STARTED|Overall Study||24
11048632|NCT00953407|12229276|FG000|COMPLETED|Overall Study||25
11048633|NCT00953407|12229277|FG001|COMPLETED|Overall Study||24
11048634|NCT00953407|12229278|FG002|COMPLETED|Overall Study||25
11048635|NCT00953407|12229279|FG003|COMPLETED|Overall Study||23
11048636|NCT00953407|12229280|FG004|COMPLETED|Overall Study||23
11048637|NCT00953407|12229276|FG000|NOT COMPLETED|Overall Study||1
11048638|NCT00953407|12229277|FG001|NOT COMPLETED|Overall Study||1
11048639|NCT00953407|12229278|FG002|NOT COMPLETED|Overall Study||1
11048640|NCT00953407|12229279|FG003|NOT COMPLETED|Overall Study||2
11048641|NCT00953407|12229280|FG004|NOT COMPLETED|Overall Study||1
11048642|NCT00953524|12229296|FG000|STARTED|Overall Study||249
11048643|NCT00953524|12229297|FG001|STARTED|Overall Study||254
11048644|NCT00953524|12229298|FG002|STARTED|Overall Study||247
11048645|NCT00953524|12229299|FG003|STARTED|Overall Study||99
11048646|NCT00953524|12229296|FG000|COMPLETED|Overall Study||227
11048647|NCT00953524|12229297|FG001|COMPLETED|Overall Study||239
11048648|NCT00953524|12229298|FG002|COMPLETED|Overall Study||233
11048649|NCT00953524|12229299|FG003|COMPLETED|Overall Study||91
11048650|NCT00953524|12229296|FG000|NOT COMPLETED|Overall Study||22
11048651|NCT00953524|12229297|FG001|NOT COMPLETED|Overall Study||15
11048652|NCT00953524|12229298|FG002|NOT COMPLETED|Overall Study||14
11048653|NCT00953524|12229299|FG003|NOT COMPLETED|Overall Study||8
11048654|NCT00953576|12229311|FG000|STARTED|Overall Study||6
11048655|NCT00953576|12229312|FG001|STARTED|Overall Study||5
11048656|NCT00953576|12229311|FG000|DLT Evaluable|Overall Study||3
11048657|NCT00953576|12229312|FG001|DLT Evaluable|Overall Study||5
11048658|NCT00953576|12229311|FG000|Treated|Overall Study||4
11048659|NCT00953576|12229312|FG001|Treated|Overall Study||5
11048660|NCT00953576|12229311|FG000|Pharmacokinetic (PK) Evaluable|Overall Study||4
11337225|NCT02890992|12535039|FG007|Treated|12 Weeks Open-Label Dose Finding Period||5
11337226|NCT02890992|12535032|FG000|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4
11337227|NCT02890992|12535033|FG001|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
11337228|NCT02890992|12535034|FG002|COMPLETED|12 Weeks Open-Label Dose Finding Period||4
11337229|NCT02890992|12535035|FG003|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
11337230|NCT02890992|12535036|FG004|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
11337231|NCT02890992|12535037|FG005|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
11337232|NCT02890992|12535038|FG006|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
11337233|NCT02890992|12535039|FG007|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
11337234|NCT02890992|12535032|FG000|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
11337235|NCT02890992|12535033|FG001|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
11337236|NCT02890992|12535034|FG002|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
11337237|NCT02890992|12535035|FG003|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
11337238|NCT02890992|12535036|FG004|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
11048661|NCT00953576|12229312|FG001|Pharmacokinetic (PK) Evaluable|Overall Study||3
11048662|NCT00953576|12229311|FG000|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
11048663|NCT00953576|12229312|FG001|COMPLETED|Overall Study||4
11048664|NCT00953576|12229311|FG000|NOT COMPLETED|Overall Study||2
11048665|NCT00953576|12229312|FG001|NOT COMPLETED|Overall Study||1
11048666|NCT00953654|12229324|FG000|STARTED|Overall Study||10
11048667|NCT00953654|12229325|FG001|STARTED|Overall Study||10
11048668|NCT00953654|12229326|FG002|STARTED|Overall Study||10
11048669|NCT00953654|12229324|FG000|COMPLETED|Overall Study||10
11337239|NCT02890992|12535037|FG005|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
11337240|NCT02890992|12535038|FG006|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
11337241|NCT02890992|12535039|FG007|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
11337242|NCT02890992|12535032|FG000|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3
11048670|NCT00953654|12229325|FG001|COMPLETED|Overall Study||10
11048671|NCT00953654|12229326|FG002|COMPLETED|Overall Study||10
11048672|NCT00953654|12229324|FG000|NOT COMPLETED|Overall Study||0
11048673|NCT00953654|12229325|FG001|NOT COMPLETED|Overall Study||0
11048674|NCT00953654|12229326|FG002|NOT COMPLETED|Overall Study||0
11048675|NCT00953667|12229334|FG000|STARTED|Overall Study||400
11048676|NCT00953667|12229334|FG000|COMPLETED|Overall Study||277
11048677|NCT00953667|12229334|FG000|NOT COMPLETED|Overall Study||123
11048678|NCT00953706|12229340|FG000|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
11048679|NCT00953706|12229341|FG001|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
11048680|NCT00953706|12229342|FG002|STARTED|Part A (16-Week Double-Blind Treatment)||0
11048681|NCT00953706|12229343|FG003|STARTED|Part A (16-Week Double-Blind Treatment)||0
11048682|NCT00953706|12229340|FG000|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
11048683|NCT00953706|12229341|FG001|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
11048684|NCT00953706|12229342|FG002|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
11048685|NCT00953706|12229343|FG003|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
11048686|NCT00953706|12229340|FG000|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
11048687|NCT00953706|12229341|FG001|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
11048688|NCT00953706|12229342|FG002|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
11048689|NCT00953706|12229343|FG003|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
11048690|NCT00953706|12229340|FG000|STARTED|Part B (96-Week Open-Label Extension)||0
11048691|NCT00953706|12229341|FG001|STARTED|Part B (96-Week Open-Label Extension)||0
11048692|NCT00953706|12229342|FG002|STARTED|Part B (96-Week Open-Label Extension)||5
11048693|NCT00953706|12229343|FG003|STARTED|Part B (96-Week Open-Label Extension)||33
11048694|NCT00953706|12229340|FG000|COMPLETED|Part B (96-Week Open-Label Extension)||0
11048695|NCT00953706|12229341|FG001|COMPLETED|Part B (96-Week Open-Label Extension)||0
11048696|NCT00953706|12229342|FG002|COMPLETED|Part B (96-Week Open-Label Extension)||0
11048697|NCT00953706|12229343|FG003|COMPLETED|Part B (96-Week Open-Label Extension)||0
11048698|NCT00953706|12229340|FG000|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
11048699|NCT00953706|12229341|FG001|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
11048700|NCT00953706|12229342|FG002|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
11048701|NCT00953706|12229343|FG003|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
11048702|NCT00953719|12229355|FG000|STARTED|Overall Study||169
11048703|NCT00953719|12229356|FG001|STARTED|Overall Study||74
11048704|NCT00953719|12229355|FG000|COMPLETED|Overall Study||150
11048705|NCT00953719|12229356|FG001|COMPLETED|Overall Study||69
11048706|NCT00953719|12229355|FG000|NOT COMPLETED|Overall Study||19
11048707|NCT00953719|12229356|FG001|NOT COMPLETED|Overall Study||5
11048708|NCT00953745|12229364|FG000|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
11048709|NCT00953745|12229365|FG001|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
11048710|NCT00953745|12229364|FG000|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
11048711|NCT00953745|12229365|FG001|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
11048712|NCT00953745|12229364|FG000|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
11048713|NCT00953745|12229365|FG001|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
11048714|NCT00953745|12229364|FG000|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
11048715|NCT00953745|12229365|FG001|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
11048716|NCT00953745|12229364|FG000|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
11048717|NCT00953745|12229365|FG001|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
11048718|NCT00953745|12229364|FG000|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
11048719|NCT00953745|12229365|FG001|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
11048720|NCT00953745|12229364|FG000|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
11048721|NCT00953745|12229365|FG001|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
11048722|NCT00953745|12229364|FG000|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
11048723|NCT00953745|12229365|FG001|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
11048724|NCT00953745|12229364|FG000|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
11048725|NCT00953745|12229365|FG001|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
11048726|NCT00953849|12229377|FG000|STARTED|Overall Study||6
11048727|NCT00953849|12229378|FG001|STARTED|Overall Study||6
11048728|NCT00953849|12229379|FG002|STARTED|Overall Study||4
11048729|NCT00953849|12229380|FG003|STARTED|Overall Study||5
11048730|NCT00953849|12229377|FG000|COMPLETED|Overall Study||6
11048731|NCT00953849|12229378|FG001|COMPLETED|Overall Study||6
11048732|NCT00953849|12229379|FG002|COMPLETED|Overall Study||4
11048733|NCT00953849|12229380|FG003|COMPLETED|Overall Study||5
11048734|NCT00953849|12229377|FG000|NOT COMPLETED|Overall Study||0
11048735|NCT00953849|12229378|FG001|NOT COMPLETED|Overall Study||0
11048736|NCT00953849|12229379|FG002|NOT COMPLETED|Overall Study||0
11048737|NCT00953849|12229380|FG003|NOT COMPLETED|Overall Study||0
11048738|NCT00953862|12229394|FG000|STARTED|Overall Study||18
11048739|NCT00953862|12229394|FG000|COMPLETED|Overall Study||12
11048740|NCT00953862|12229394|FG000|NOT COMPLETED|Overall Study||6
11048741|NCT00953927|12229402|FG000|STARTED|Overall Study||1399
11048742|NCT00953927|12229403|FG001|STARTED|Overall Study||1398
11048743|NCT00953927|12229402|FG000|COMPLETED|Overall Study||1294
11048744|NCT00953927|12229403|FG001|COMPLETED|Overall Study||1303
11048745|NCT00953927|12229402|FG000|NOT COMPLETED|Overall Study||105
11048746|NCT00953927|12229403|FG001|NOT COMPLETED|Overall Study||95
11048747|NCT00954109|12229409|FG000|STARTED|Overall Study||11
11048748|NCT00954109|12229409|FG000|COMPLETED|Overall Study||11
11048749|NCT00954109|12229409|FG000|NOT COMPLETED|Overall Study||0
11048750|NCT00954122|12229413|FG000|STARTED|Overall Study||35
11048751|NCT00954122|12229413|FG000|COMPLETED|Overall Study||28
11048752|NCT00954122|12229413|FG000|NOT COMPLETED|Overall Study||7
11048753|NCT00954174|12229422|FG000|STARTED|Overall Study||268
11048754|NCT00954174|12229423|FG001|STARTED|Overall Study||268
11048755|NCT00954174|12229424|FG002|STARTED|Overall Study||51
11048756|NCT00954174|12229425|FG003|STARTED|Overall Study||50
11048757|NCT00954174|12229422|FG000|COMPLETED|Overall Study||142
11048758|NCT00954174|12229423|FG001|COMPLETED|Overall Study||145
11048759|NCT00954174|12229424|FG002|COMPLETED|Overall Study||27
11048760|NCT00954174|12229425|FG003|COMPLETED|Overall Study||25
11048761|NCT00954174|12229422|FG000|NOT COMPLETED|Overall Study||126
11048762|NCT00954174|12229423|FG001|NOT COMPLETED|Overall Study||123
11048763|NCT00954174|12229424|FG002|NOT COMPLETED|Overall Study||24
11048764|NCT00954174|12229425|FG003|NOT COMPLETED|Overall Study||25
11048765|NCT00954356|12229440|FG000|STARTED|Overall Study||41
11048766|NCT00954356|12229441|FG001|STARTED|Overall Study||20
11048767|NCT00954356|12229440|FG000|COMPLETED|Overall Study||41
11048768|NCT00954356|12229441|FG001|COMPLETED|Overall Study||20
11048769|NCT00954356|12229440|FG000|NOT COMPLETED|Overall Study||0
11048770|NCT00954356|12229441|FG001|NOT COMPLETED|Overall Study||0
11048771|NCT00954421|12229447|FG000|STARTED|Screening||16
11048772|NCT00954421|12229447|FG000|COMPLETED|Screening||13
11048773|NCT00954421|12229447|FG000|NOT COMPLETED|Screening||3
11048774|NCT00954421|12229447|FG000|STARTED|Baseline||13
11048775|NCT00954421|12229447|FG000|COMPLETED|Baseline||13
11048776|NCT00954421|12229447|FG000|NOT COMPLETED|Baseline||0
11048777|NCT00954421|12229447|FG000|STARTED|6 Months of DBS||13
11048778|NCT00954421|12229447|FG000|COMPLETED|6 Months of DBS||12
11337243|NCT02890992|12535033|FG001|STARTED|130 Weeks Open-Label Extension Period||6
11337244|NCT02890992|12535034|FG002|STARTED|130 Weeks Open-Label Extension Period||4
11337245|NCT02890992|12535035|FG003|STARTED|130 Weeks Open-Label Extension Period||6
11337246|NCT02890992|12535036|FG004|STARTED|130 Weeks Open-Label Extension Period||6
11337247|NCT02890992|12535037|FG005|STARTED|130 Weeks Open-Label Extension Period||5
11337248|NCT02890992|12535038|FG006|STARTED|130 Weeks Open-Label Extension Period||6
11337249|NCT02890992|12535039|FG007|STARTED|130 Weeks Open-Label Extension Period||5
11337250|NCT02890992|12535032|FG000|Treated|130 Weeks Open-Label Extension Period||3
11337251|NCT02890992|12535033|FG001|Treated|130 Weeks Open-Label Extension Period||6
11337252|NCT02890992|12535034|FG002|Treated|130 Weeks Open-Label Extension Period||4
11337253|NCT02890992|12535035|FG003|Treated|130 Weeks Open-Label Extension Period||6
11337254|NCT02890992|12535036|FG004|Treated|130 Weeks Open-Label Extension Period||6
11337255|NCT02890992|12535037|FG005|Treated|130 Weeks Open-Label Extension Period||5
11337256|NCT02890992|12535038|FG006|Treated|130 Weeks Open-Label Extension Period||5
11337257|NCT02890992|12535039|FG007|Treated|130 Weeks Open-Label Extension Period||4
11337258|NCT02890992|12535032|FG000|COMPLETED|130 Weeks Open-Label Extension Period||3
11337259|NCT02890992|12535033|FG001|COMPLETED|130 Weeks Open-Label Extension Period||3
11337260|NCT02890992|12535034|FG002|COMPLETED|130 Weeks Open-Label Extension Period||4
11337261|NCT02890992|12535035|FG003|COMPLETED|130 Weeks Open-Label Extension Period||6
11337262|NCT02890992|12535036|FG004|COMPLETED|130 Weeks Open-Label Extension Period||6
11337263|NCT02890992|12535037|FG005|COMPLETED|130 Weeks Open-Label Extension Period||5
11337264|NCT02890992|12535038|FG006|COMPLETED|130 Weeks Open-Label Extension Period||5
11337265|NCT02890992|12535039|FG007|COMPLETED|130 Weeks Open-Label Extension Period||4
11337266|NCT02890992|12535032|FG000|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
11337267|NCT02890992|12535033|FG001|NOT COMPLETED|130 Weeks Open-Label Extension Period||3
11337268|NCT02890992|12535034|FG002|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
11337269|NCT02890992|12535035|FG003|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
11337270|NCT02890992|12535036|FG004|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
11337271|NCT02890992|12535037|FG005|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
11337272|NCT02890992|12535038|FG006|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
11343883|NCT02956629|12541152|FG004|COMPLETED|Overall Study||18
11048779|NCT00954421|12229447|FG000|NOT COMPLETED|6 Months of DBS||1
11048780|NCT00954421|12229447|FG000|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
11048781|NCT00954421|12229447|FG000|COMPLETED|VIM=ON VO=ON at 6 Months||12
11048782|NCT00954421|12229447|FG000|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
11048783|NCT00954421|12229447|FG000|STARTED|VIM=OFF VO=OFF at 6 Months||12
11048784|NCT00954421|12229447|FG000|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
11048785|NCT00954421|12229447|FG000|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
11048786|NCT00954421|12229447|FG000|STARTED|VIM=OFF VO=ON at 6 Months||12
11048787|NCT00954421|12229447|FG000|COMPLETED|VIM=OFF VO=ON at 6 Months||12
11048788|NCT00954421|12229447|FG000|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
11048789|NCT00954421|12229447|FG000|STARTED|VIM=ON VO=OFF at 6 Months||12
11048790|NCT00954421|12229447|FG000|COMPLETED|VIM=ON VO=OFF at 6 Months||11
11048791|NCT00954421|12229447|FG000|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
11048792|NCT00954447|12229455|FG000|STARTED|Overall Study||630
11048793|NCT00954447|12229456|FG001|STARTED|Overall Study||631
11048794|NCT00954447|12229455|FG000|COMPLETED|Overall Study||520
11048795|NCT00954447|12229456|FG001|COMPLETED|Overall Study||543
11048796|NCT00954447|12229455|FG000|NOT COMPLETED|Overall Study||110
11048797|NCT00954447|12229456|FG001|NOT COMPLETED|Overall Study||88
11048798|NCT00954512|12229468|FG000|STARTED|Overall Study||2
11048799|NCT00954512|12229469|FG001|STARTED|Overall Study||3
11048800|NCT00954512|12229470|FG002|STARTED|Overall Study||0
11048801|NCT00954512|12229471|FG003|STARTED|Overall Study||2
11048802|NCT00954512|12229472|FG004|STARTED|Overall Study||4
11048803|NCT00954512|12229473|FG005|STARTED|Overall Study||4
11048804|NCT00954512|12229468|FG000|COMPLETED|Overall Study||0
11048805|NCT00954512|12229469|FG001|COMPLETED|Overall Study||0
11048806|NCT00954512|12229470|FG002|COMPLETED|Overall Study||0
11048807|NCT00954512|12229471|FG003|COMPLETED|Overall Study||0
11048808|NCT00954512|12229472|FG004|COMPLETED|Overall Study||0
11048809|NCT00954512|12229473|FG005|COMPLETED|Overall Study||0
11048810|NCT00954512|12229468|FG000|NOT COMPLETED|Overall Study||2
11048811|NCT00954512|12229469|FG001|NOT COMPLETED|Overall Study||3
11048812|NCT00954512|12229470|FG002|NOT COMPLETED|Overall Study||0
11048813|NCT00954512|12229471|FG003|NOT COMPLETED|Overall Study||2
11048814|NCT00954512|12229472|FG004|NOT COMPLETED|Overall Study||4
11048815|NCT00954512|12229473|FG005|NOT COMPLETED|Overall Study||4
11048816|NCT00954538|12229488|FG000|STARTED|Part I|These subjects did not participate in Part II or III|3
11048817|NCT00954538|12229489|FG001|STARTED|Part I||0
11048818|NCT00954538|12229490|FG002|STARTED|Part I||0
11048819|NCT00954538|12229491|FG003|STARTED|Part I||0
11048820|NCT00954538|12229492|FG004|STARTED|Part I||0
11048821|NCT00954538|12229493|FG005|STARTED|Part I||0
11048822|NCT00954538|12229488|FG000|COMPLETED|Part I||3
11048823|NCT00954538|12229489|FG001|COMPLETED|Part I||0
11048824|NCT00954538|12229490|FG002|COMPLETED|Part I||0
11048825|NCT00954538|12229491|FG003|COMPLETED|Part I||0
11048826|NCT00954538|12229492|FG004|COMPLETED|Part I||0
11048827|NCT00954538|12229493|FG005|COMPLETED|Part I||0
11048828|NCT00954538|12229488|FG000|NOT COMPLETED|Part I||0
11048829|NCT00954538|12229489|FG001|NOT COMPLETED|Part I||0
11048830|NCT00954538|12229490|FG002|NOT COMPLETED|Part I||0
11048831|NCT00954538|12229491|FG003|NOT COMPLETED|Part I||0
11048832|NCT00954538|12229492|FG004|NOT COMPLETED|Part I||0
11048833|NCT00954538|12229493|FG005|NOT COMPLETED|Part I||0
11048834|NCT00954538|12229488|FG000|STARTED|Part II||0
11048835|NCT00954538|12229489|FG001|STARTED|Part II|This subject did not participate in Part I or III|1
11048836|NCT00954538|12229490|FG002|STARTED|Part II|These subjects did not participate in Part I or III|3
11048837|NCT00954538|12229491|FG003|STARTED|Part II||0
11048838|NCT00954538|12229492|FG004|STARTED|Part II||0
11048839|NCT00954538|12229493|FG005|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
11048840|NCT00954538|12229488|FG000|COMPLETED|Part II||0
11048841|NCT00954538|12229489|FG001|COMPLETED|Part II||1
11048842|NCT00954538|12229490|FG002|COMPLETED|Part II||3
11048843|NCT00954538|12229491|FG003|COMPLETED|Part II||0
11048844|NCT00954538|12229492|FG004|COMPLETED|Part II||0
11048845|NCT00954538|12229493|FG005|COMPLETED|Part II||2
11048846|NCT00954538|12229488|FG000|NOT COMPLETED|Part II||0
11048847|NCT00954538|12229489|FG001|NOT COMPLETED|Part II||0
11048848|NCT00954538|12229490|FG002|NOT COMPLETED|Part II||0
11048849|NCT00954538|12229491|FG003|NOT COMPLETED|Part II||0
11048850|NCT00954538|12229492|FG004|NOT COMPLETED|Part II||0
11048851|NCT00954538|12229493|FG005|NOT COMPLETED|Part II||0
11048852|NCT00954538|12229488|FG000|STARTED|Part III||0
11048853|NCT00954538|12229489|FG001|STARTED|Part III||0
11048854|NCT00954538|12229490|FG002|STARTED|Part III||0
11048855|NCT00954538|12229491|FG003|STARTED|Part III|These subjects did not participate in Part I or II|4
11048856|NCT00954538|12229492|FG004|STARTED|Part III|These subjects did not participate in Part I or II|6
11048857|NCT00954538|12229493|FG005|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
11048858|NCT00954538|12229488|FG000|COMPLETED|Part III||0
11048859|NCT00954538|12229489|FG001|COMPLETED|Part III||0
11048860|NCT00954538|12229490|FG002|COMPLETED|Part III||0
11048861|NCT00954538|12229491|FG003|COMPLETED|Part III||4
11048862|NCT00954538|12229492|FG004|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
11048863|NCT00954538|12229493|FG005|COMPLETED|Part III||2
11048864|NCT00954538|12229488|FG000|NOT COMPLETED|Part III||0
11048865|NCT00954538|12229489|FG001|NOT COMPLETED|Part III||0
11048866|NCT00954538|12229490|FG002|NOT COMPLETED|Part III||0
11048867|NCT00954538|12229491|FG003|NOT COMPLETED|Part III||0
11048868|NCT00954538|12229492|FG004|NOT COMPLETED|Part III||1
11048869|NCT00954538|12229493|FG005|NOT COMPLETED|Part III||0
11048870|NCT00954681|12229502|FG000|STARTED|Overall Study||15
11048871|NCT00954681|12229502|FG000|COMPLETED|Overall Study||10
11048872|NCT00954681|12229502|FG000|NOT COMPLETED|Overall Study||5
11048873|NCT00954707|12229506|FG000|STARTED|Overall Study||2509
11048874|NCT00954707|12229506|FG000|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
11048875|NCT00954707|12229506|FG000|NOT COMPLETED|Overall Study||167
11048876|NCT00954733|12229510|FG000|STARTED|Overall Study||40
11048877|NCT00954733|12229510|FG000|COMPLETED|Overall Study||39
11048878|NCT00954733|12229510|FG000|NOT COMPLETED|Overall Study||1
11048879|NCT00954824|12229514|FG000|STARTED|Overall Study||100
11048880|NCT00954824|12229514|FG000|COMPLETED|Overall Study||50
11048881|NCT00954824|12229514|FG000|NOT COMPLETED|Overall Study||50
11048882|NCT00954941|12229520|FG000|STARTED|Overall Study||50
11048883|NCT00954941|12229521|FG001|STARTED|Overall Study||48
11048884|NCT00954941|12229520|FG000|COMPLETED|Overall Study||42
11048885|NCT00954941|12229521|FG001|COMPLETED|Overall Study||41
11048886|NCT00954941|12229520|FG000|NOT COMPLETED|Overall Study||8
11048887|NCT00954941|12229521|FG001|NOT COMPLETED|Overall Study||7
11048888|NCT00954993|12229527|FG000|STARTED|Period 1||3
11048889|NCT00954993|12229527|FG000|COMPLETED|Period 1||3
11048890|NCT00954993|12229527|FG000|NOT COMPLETED|Period 1||0
11048891|NCT00954993|12229527|FG000|STARTED|Washout||3
11048892|NCT00954993|12229527|FG000|COMPLETED|Washout||3
11048893|NCT00954993|12229527|FG000|NOT COMPLETED|Washout||0
11048894|NCT00954993|12229527|FG000|STARTED|Period 2||3
11048895|NCT00954993|12229527|FG000|COMPLETED|Period 2||3
11048896|NCT00954993|12229527|FG000|NOT COMPLETED|Period 2||0
11048897|NCT00955032|12229535|FG000|STARTED|Overall Study||16
11048898|NCT00955032|12229536|FG001|STARTED|Overall Study||8
11048899|NCT00955032|12229535|FG000|COMPLETED|Overall Study||16
11048900|NCT00955032|12229536|FG001|COMPLETED|Overall Study||8
11048901|NCT00955032|12229535|FG000|NOT COMPLETED|Overall Study||0
11048902|NCT00955032|12229536|FG001|NOT COMPLETED|Overall Study||0
11048903|NCT00955110|12229551|FG000|STARTED|Qualification Phase||78
11048904|NCT00955110|12229551|FG000|COMPLETED|Qualification Phase||54
11048905|NCT00955110|12229551|FG000|NOT COMPLETED|Qualification Phase||24
11048906|NCT00955110|12229551|FG000|STARTED|Treatment Phase||41
11048907|NCT00955110|12229551|FG000|Placebo|Treatment Phase||38
11048908|NCT00955110|12229551|FG000|Oxymorphone ER 15 mg|Treatment Phase||37
11048909|NCT00955110|12229551|FG000|Oxymorphone ER 30 mg|Treatment Phase||38
11048910|NCT00955110|12229551|FG000|Oxycodone CR 30 mg|Treatment Phase||40
11048911|NCT00955110|12229551|FG000|Oxycodone CR 60 mg|Treatment Phase||40
11048912|NCT00955110|12229551|FG000|COMPLETED|Treatment Phase||35
11048913|NCT00955110|12229551|FG000|NOT COMPLETED|Treatment Phase||6
11048914|NCT00955201|12229567|FG000|STARTED|Overall Study||12
11048915|NCT00955201|12229568|FG001|STARTED|Overall Study||11
11048916|NCT00955201|12229569|FG002|STARTED|Overall Study||11
11048917|NCT00955201|12229570|FG003|STARTED|Overall Study||11
11048918|NCT00955201|12229567|FG000|COMPLETED|Overall Study||8
11048919|NCT00955201|12229568|FG001|COMPLETED|Overall Study||11
11048920|NCT00955201|12229569|FG002|COMPLETED|Overall Study||10
11048921|NCT00955201|12229570|FG003|COMPLETED|Overall Study||7
11048922|NCT00955201|12229567|FG000|NOT COMPLETED|Overall Study||4
11048923|NCT00955201|12229568|FG001|NOT COMPLETED|Overall Study||0
11048924|NCT00955201|12229569|FG002|NOT COMPLETED|Overall Study||1
11048925|NCT00955201|12229570|FG003|NOT COMPLETED|Overall Study||4
11048926|NCT00955253|12229589|FG000|STARTED|First Intervention (Day 2)||7
11048927|NCT00955253|12229590|FG001|STARTED|First Intervention (Day 2)||6
11048928|NCT00955253|12229589|FG000|COMPLETED|First Intervention (Day 2)||7
11048929|NCT00955253|12229590|FG001|COMPLETED|First Intervention (Day 2)||6
11048930|NCT00955253|12229589|FG000|NOT COMPLETED|First Intervention (Day 2)||0
11048931|NCT00955253|12229590|FG001|NOT COMPLETED|First Intervention (Day 2)||0
11048932|NCT00955253|12229589|FG000|STARTED|Second Intervention (Day 4)||7
11048933|NCT00955253|12229590|FG001|STARTED|Second Intervention (Day 4)||6
11048934|NCT00955253|12229589|FG000|COMPLETED|Second Intervention (Day 4)||7
11048935|NCT00955253|12229590|FG001|COMPLETED|Second Intervention (Day 4)||6
11048936|NCT00955253|12229589|FG000|NOT COMPLETED|Second Intervention (Day 4)||0
11048937|NCT00955253|12229590|FG001|NOT COMPLETED|Second Intervention (Day 4)||0
11058128|NCT01001559|12239943|FG001|COMPLETED|Overall Study||147
11058129|NCT01001559|12239942|FG000|NOT COMPLETED|Overall Study||0
11058130|NCT01001559|12239943|FG001|NOT COMPLETED|Overall Study||0
11058131|NCT01001572|12239951|FG000|STARTED|Single-Blind Valsartan 160 mg||932
11058132|NCT01001572|12239952|FG001|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
11058133|NCT01001572|12239953|FG002|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
11058134|NCT01001572|12239951|FG000|COMPLETED|Single-Blind Valsartan 160 mg||654
11058135|NCT01001572|12239952|FG001|COMPLETED|Single-Blind Valsartan 160 mg||0
11058136|NCT01001572|12239953|FG002|COMPLETED|Single-Blind Valsartan 160 mg||0
11058137|NCT01001572|12239951|FG000|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
11058138|NCT01001572|12239952|FG001|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
11058139|NCT01001572|12239953|FG002|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
11058140|NCT01001572|12239951|FG000|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
11058141|NCT01001572|12239952|FG001|STARTED|Double-Blind Treatment Phase||329
11048938|NCT00955266|12229597|FG000|STARTED|Overall Study||4
11048939|NCT00955266|12229598|FG001|STARTED|Overall Study||4
11048940|NCT00955266|12229597|FG000|COMPLETED|Overall Study||4
11048941|NCT00955266|12229598|FG001|COMPLETED|Overall Study||4
11048942|NCT00955266|12229597|FG000|NOT COMPLETED|Overall Study||0
11048943|NCT00955266|12229598|FG001|NOT COMPLETED|Overall Study||0
11048944|NCT00955279|12229607|FG000|STARTED|Overall Study||58
11048945|NCT00955279|12229608|FG001|STARTED|Overall Study||55
11048946|NCT00955279|12229609|FG002|STARTED|Overall Study||60
11048947|NCT00955279|12229607|FG000|COMPLETED|Overall Study||55
11048948|NCT00955279|12229608|FG001|COMPLETED|Overall Study||51
11048949|NCT00955279|12229609|FG002|COMPLETED|Overall Study||52
11048950|NCT00955279|12229607|FG000|NOT COMPLETED|Overall Study||3
11048951|NCT00955279|12229608|FG001|NOT COMPLETED|Overall Study||4
11048952|NCT00955279|12229609|FG002|NOT COMPLETED|Overall Study||8
11048953|NCT00955305|12229619|FG000|STARTED|Overall Study||88
11048954|NCT00955305|12229620|FG001|STARTED|Overall Study||87
11048955|NCT00955305|12229619|FG000|Treated|Overall Study||83
11048956|NCT00955305|12229620|FG001|Treated|Overall Study||82
11048957|NCT00955305|12229619|FG000|Eligible and Treated|Overall Study||78
11048958|NCT00955305|12229620|FG001|Eligible and Treated|Overall Study||75
11048959|NCT00955305|12229619|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
11048960|NCT00955305|12229620|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
11048961|NCT00955305|12229619|FG000|NOT COMPLETED|Overall Study||88
11048962|NCT00955305|12229620|FG001|NOT COMPLETED|Overall Study||87
11048963|NCT00955357|12229628|FG000|STARTED|Titration Phase||96
11048964|NCT00955357|12229629|FG001|STARTED|Titration Phase||360
11048965|NCT00955357|12229628|FG000|COMPLETED|Titration Phase||80
11048966|NCT00955357|12229629|FG001|COMPLETED|Titration Phase||294
11048967|NCT00955357|12229628|FG000|NOT COMPLETED|Titration Phase||16
11048968|NCT00955357|12229629|FG001|NOT COMPLETED|Titration Phase||66
11048969|NCT00955357|12229628|FG000|STARTED|Maintenance Phase||80
11048970|NCT00955357|12229629|FG001|STARTED|Maintenance Phase||294
11048971|NCT00955357|12229628|FG000|COMPLETED|Maintenance Phase||68
11048972|NCT00955357|12229629|FG001|COMPLETED|Maintenance Phase||249
11048973|NCT00955357|12229628|FG000|NOT COMPLETED|Maintenance Phase||12
11048974|NCT00955357|12229629|FG001|NOT COMPLETED|Maintenance Phase||45
11048975|NCT00955409|12229645|FG000|STARTED|Overall Study|Started=Randomized|21
11048976|NCT00955409|12229646|FG001|STARTED|Overall Study|Started=Randomized|6
11048977|NCT00955409|12229647|FG002|STARTED|Overall Study|Started=Randomized|41
11048978|NCT00955409|12229648|FG003|STARTED|Overall Study|Started=Randomized.|25
11048979|NCT00955409|12229649|FG004|STARTED|Overall Study|Started=Randomized|5
11048980|NCT00955409|12229650|FG005|STARTED|Overall Study|Started=Randomized|9
11048981|NCT00955409|12229651|FG006|STARTED|Overall Study|Started=Randomized|27
11048982|NCT00955409|12229652|FG007|STARTED|Overall Study|Started=Randomized|6
11048983|NCT00955409|12229653|FG008|STARTED|Overall Study|Started=Randomized|16
11048984|NCT00955409|12229654|FG009|STARTED|Overall Study|Started=Randomized|4
11048985|NCT00955409|12229645|FG000|Treated|Overall Study||21
11048986|NCT00955409|12229646|FG001|Treated|Overall Study||6
11048987|NCT00955409|12229647|FG002|Treated|Overall Study||41
11048988|NCT00955409|12229648|FG003|Treated|Overall Study||24
11048989|NCT00955409|12229649|FG004|Treated|Overall Study||5
11048990|NCT00955409|12229650|FG005|Treated|Overall Study||9
11048991|NCT00955409|12229651|FG006|Treated|Overall Study||27
11048992|NCT00955409|12229652|FG007|Treated|Overall Study||6
11048993|NCT00955409|12229653|FG008|Treated|Overall Study||16
11048994|NCT00955409|12229654|FG009|Treated|Overall Study||4
11048995|NCT00955409|12229645|FG000|Completed Treatment|Overall Study||12
11048996|NCT00955409|12229646|FG001|Completed Treatment|Overall Study||5
11048997|NCT00955409|12229647|FG002|Completed Treatment|Overall Study||15
11048998|NCT00955409|12229648|FG003|Completed Treatment|Overall Study||17
11048999|NCT00955409|12229649|FG004|Completed Treatment|Overall Study||3
11049000|NCT00955409|12229650|FG005|Completed Treatment|Overall Study||7
11049001|NCT00955409|12229651|FG006|Completed Treatment|Overall Study||4
11049002|NCT00955409|12229652|FG007|Completed Treatment|Overall Study||3
11049003|NCT00955409|12229653|FG008|Completed Treatment|Overall Study||2
11049004|NCT00955409|12229654|FG009|Completed Treatment|Overall Study||4
11049005|NCT00955409|12229645|FG000|COMPLETED|Overall Study|Completed study|11
11049006|NCT00955409|12229646|FG001|COMPLETED|Overall Study|Completed study|5
11049007|NCT00955409|12229647|FG002|COMPLETED|Overall Study|Completed study|15
11049008|NCT00955409|12229648|FG003|COMPLETED|Overall Study|Completed study|17
11049009|NCT00955409|12229649|FG004|COMPLETED|Overall Study|Completed study|3
11049010|NCT00955409|12229650|FG005|COMPLETED|Overall Study|Completed study|6
11049011|NCT00955409|12229651|FG006|COMPLETED|Overall Study|Completed study|3
11049012|NCT00955409|12229652|FG007|COMPLETED|Overall Study|Completed study|2
11049013|NCT00955409|12229653|FG008|COMPLETED|Overall Study|Completed study|2
11049014|NCT00955409|12229654|FG009|COMPLETED|Overall Study|Completed study|3
11049015|NCT00955409|12229645|FG000|NOT COMPLETED|Overall Study||10
11049016|NCT00955409|12229646|FG001|NOT COMPLETED|Overall Study||1
11049017|NCT00955409|12229647|FG002|NOT COMPLETED|Overall Study||26
11049018|NCT00955409|12229648|FG003|NOT COMPLETED|Overall Study||8
11049019|NCT00955409|12229649|FG004|NOT COMPLETED|Overall Study||2
11049020|NCT00955409|12229650|FG005|NOT COMPLETED|Overall Study||3
11049021|NCT00955409|12229651|FG006|NOT COMPLETED|Overall Study||24
11049022|NCT00955409|12229652|FG007|NOT COMPLETED|Overall Study||4
11049023|NCT00955409|12229653|FG008|NOT COMPLETED|Overall Study||14
11049024|NCT00955409|12229654|FG009|NOT COMPLETED|Overall Study||1
11049025|NCT00955474|12229682|FG000|STARTED|Overall Study||12
11049026|NCT00955474|12229683|FG001|STARTED|Overall Study||13
11049027|NCT00955474|12229682|FG000|COMPLETED|Overall Study||5
11049028|NCT00955474|12229683|FG001|COMPLETED|Overall Study||8
11049029|NCT00955474|12229682|FG000|NOT COMPLETED|Overall Study||7
11049030|NCT00955474|12229683|FG001|NOT COMPLETED|Overall Study||5
11049031|NCT00955487|12229693|FG000|STARTED|Overall Study||10
11049032|NCT00955487|12229694|FG001|STARTED|Overall Study||9
11049033|NCT00955487|12229695|FG002|STARTED|Overall Study||17
11049034|NCT00955487|12229696|FG003|STARTED|Overall Study||21
11049035|NCT00955487|12229697|FG004|STARTED|Overall Study||32
11049036|NCT00955487|12229698|FG005|STARTED|Overall Study||35
11049037|NCT00955487|12229693|FG000|COMPLETED|Overall Study||10
11049038|NCT00955487|12229694|FG001|COMPLETED|Overall Study||9
11049039|NCT00955487|12229695|FG002|COMPLETED|Overall Study||17
11049040|NCT00955487|12229696|FG003|COMPLETED|Overall Study||21
11049041|NCT00955487|12229697|FG004|COMPLETED|Overall Study||32
11049042|NCT00955487|12229698|FG005|COMPLETED|Overall Study||35
11049043|NCT00955487|12229693|FG000|NOT COMPLETED|Overall Study||0
11049044|NCT00955487|12229694|FG001|NOT COMPLETED|Overall Study||0
11049045|NCT00955487|12229695|FG002|NOT COMPLETED|Overall Study||0
11049046|NCT00955487|12229696|FG003|NOT COMPLETED|Overall Study||0
11049047|NCT00955487|12229697|FG004|NOT COMPLETED|Overall Study||0
11049048|NCT00955487|12229698|FG005|NOT COMPLETED|Overall Study||0
11049049|NCT00955513|12229713|FG000|STARTED|Overall Study||80
11049050|NCT00955513|12229714|FG001|STARTED|Overall Study||80
11049051|NCT00955513|12229715|FG002|STARTED|Overall Study||82
11049052|NCT00955513|12229713|FG000|COMPLETED|Overall Study||79
11049053|NCT00955513|12229714|FG001|COMPLETED|Overall Study||78
11049054|NCT00955513|12229715|FG002|COMPLETED|Overall Study||79
11049055|NCT00955513|12229713|FG000|NOT COMPLETED|Overall Study||1
11049056|NCT00955513|12229714|FG001|NOT COMPLETED|Overall Study||2
11049057|NCT00955513|12229715|FG002|NOT COMPLETED|Overall Study||3
11049058|NCT00955617|12229723|FG000|STARTED|First MRA (Between Day0 and Day21)||10
11049059|NCT00955617|12229724|FG001|STARTED|First MRA (Between Day0 and Day21)||10
11049060|NCT00955617|12229723|FG000|COMPLETED|First MRA (Between Day0 and Day21)||10
11049061|NCT00955617|12229724|FG001|COMPLETED|First MRA (Between Day0 and Day21)||10
11049062|NCT00955617|12229723|FG000|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
11049063|NCT00955617|12229724|FG001|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
11049064|NCT00955617|12229723|FG000|STARTED|Second MRA (Between Day 1 and Day 51)||10
11049065|NCT00955617|12229724|FG001|STARTED|Second MRA (Between Day 1 and Day 51)||10
11049066|NCT00955617|12229723|FG000|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
11049067|NCT00955617|12229724|FG001|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
11049068|NCT00955617|12229723|FG000|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
11049069|NCT00955617|12229724|FG001|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
11049070|NCT00955682|12229732|FG000|STARTED|Year 2 Period||253
11049071|NCT00955682|12229733|FG001|STARTED|Year 2 Period||42
11049072|NCT00955682|12229732|FG000|COMPLETED|Year 2 Period||253
11049073|NCT00955682|12229733|FG001|COMPLETED|Year 2 Period||42
11049074|NCT00955682|12229732|FG000|NOT COMPLETED|Year 2 Period||0
11049075|NCT00955682|12229733|FG001|NOT COMPLETED|Year 2 Period||0
11049076|NCT00955682|12229732|FG000|STARTED|Year 3 Period||273
11049077|NCT00955682|12229733|FG001|STARTED|Year 3 Period||47
11049078|NCT00955682|12229732|FG000|COMPLETED|Year 3 Period||273
11049079|NCT00955682|12229733|FG001|COMPLETED|Year 3 Period||47
11049080|NCT00955682|12229732|FG000|NOT COMPLETED|Year 3 Period||0
11049081|NCT00955682|12229733|FG001|NOT COMPLETED|Year 3 Period||0
11049082|NCT00955682|12229732|FG000|STARTED|Year 4 Period||246
11049083|NCT00955682|12229733|FG001|STARTED|Year 4 Period||48
11049084|NCT00955682|12229732|FG000|COMPLETED|Year 4 Period||246
11049085|NCT00955682|12229733|FG001|COMPLETED|Year 4 Period||48
11049086|NCT00955682|12229732|FG000|NOT COMPLETED|Year 4 Period||0
11049087|NCT00955682|12229733|FG001|NOT COMPLETED|Year 4 Period||0
11049088|NCT00955682|12229732|FG000|STARTED|Booster Period (Month 48- 49)||245
11049089|NCT00955682|12229733|FG001|STARTED|Booster Period (Month 48- 49)||48
11049090|NCT00955682|12229732|FG000|COMPLETED|Booster Period (Month 48- 49)||244
11049091|NCT00955682|12229733|FG001|COMPLETED|Booster Period (Month 48- 49)||47
11049092|NCT00955682|12229732|FG000|NOT COMPLETED|Booster Period (Month 48- 49)||1
11049093|NCT00955682|12229733|FG001|NOT COMPLETED|Booster Period (Month 48- 49)||1
11049094|NCT00955682|12229732|FG000|STARTED|Year 5 Period||239
11049095|NCT00955682|12229733|FG001|STARTED|Year 5 Period||47
11049096|NCT00955682|12229732|FG000|COMPLETED|Year 5 Period||239
11049097|NCT00955682|12229733|FG001|COMPLETED|Year 5 Period||47
11049098|NCT00955682|12229732|FG000|NOT COMPLETED|Year 5 Period||0
11049099|NCT00955682|12229733|FG001|NOT COMPLETED|Year 5 Period||0
11049100|NCT00955708|12229747|FG000|STARTED|Overall Study||1308
11049101|NCT00955708|12229747|FG000|COMPLETED|Overall Study||250
11049102|NCT00955708|12229747|FG000|NOT COMPLETED|Overall Study||1058
11049103|NCT00955721|12229753|FG000|STARTED|Overall Study||9
11049104|NCT00955721|12229754|FG001|STARTED|Overall Study||0
11049105|NCT00955721|12229753|FG000|COMPLETED|Overall Study||6
11049106|NCT00955721|12229754|FG001|COMPLETED|Overall Study||0
11049107|NCT00955721|12229753|FG000|NOT COMPLETED|Overall Study||3
11049108|NCT00955721|12229754|FG001|NOT COMPLETED|Overall Study||0
11049109|NCT00955747|12229763|FG000|STARTED|Overall Study||253
11049110|NCT00955747|12229764|FG001|STARTED|Overall Study||241
11049111|NCT00955747|12229763|FG000|COMPLETED|Overall Study||184
11049112|NCT00955747|12229764|FG001|COMPLETED|Overall Study||172
11049113|NCT00955747|12229763|FG000|NOT COMPLETED|Overall Study||69
11049114|NCT00955747|12229764|FG001|NOT COMPLETED|Overall Study||69
11049115|NCT00955825|12229772|FG000|STARTED|Overall Study||233
11049116|NCT00955825|12229773|FG001|STARTED|Overall Study||240
11049117|NCT00955825|12229772|FG000|COMPLETED|Overall Study||207
11049118|NCT00955825|12229773|FG001|COMPLETED|Overall Study||223
11049119|NCT00955825|12229772|FG000|NOT COMPLETED|Overall Study||26
11049120|NCT00955825|12229773|FG001|NOT COMPLETED|Overall Study||17
11049121|NCT00955877|12229782|FG000|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
11049122|NCT00955877|12229783|FG001|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
11049123|NCT00955877|12229784|FG002|STARTED|Overall Study||7
11049124|NCT00955877|12229782|FG000|COMPLETED|Overall Study||6
11049125|NCT00955877|12229783|FG001|COMPLETED|Overall Study||0
11049126|NCT00955877|12229784|FG002|COMPLETED|Overall Study||7
11049127|NCT00955877|12229782|FG000|NOT COMPLETED|Overall Study||0
11049128|NCT00955877|12229783|FG001|NOT COMPLETED|Overall Study||0
11049129|NCT00955877|12229784|FG002|NOT COMPLETED|Overall Study||0
11049130|NCT00955903|12229795|FG000|STARTED|Overall Study||55
11049131|NCT00955903|12229796|FG001|STARTED|Overall Study||54
11201445|NCT01832727|12391753|FG007|STARTED|Overall Study||6
11201446|NCT01832727|12391754|FG008|STARTED|Overall Study||18
11201447|NCT01832727|12391746|FG000|COMPLETED|Overall Study||0
11201448|NCT01832727|12391747|FG001|COMPLETED|Overall Study||0
11201449|NCT01832727|12391748|FG002|COMPLETED|Overall Study||0
11201450|NCT01832727|12391749|FG003|COMPLETED|Overall Study||0
11201451|NCT01832727|12391750|FG004|COMPLETED|Overall Study||0
11201452|NCT01832727|12391751|FG005|COMPLETED|Overall Study||0
11201453|NCT01832727|12391752|FG006|COMPLETED|Overall Study||0
11201454|NCT01832727|12391753|FG007|COMPLETED|Overall Study||0
11201455|NCT01832727|12391754|FG008|COMPLETED|Overall Study||0
11201456|NCT01832727|12391746|FG000|NOT COMPLETED|Overall Study||9
11201457|NCT01832727|12391747|FG001|NOT COMPLETED|Overall Study||7
11201458|NCT01832727|12391748|FG002|NOT COMPLETED|Overall Study||3
11201459|NCT01832727|12391749|FG003|NOT COMPLETED|Overall Study||4
11201460|NCT01832727|12391750|FG004|NOT COMPLETED|Overall Study||4
11201461|NCT01832727|12391751|FG005|NOT COMPLETED|Overall Study||6
11201462|NCT01832727|12391752|FG006|NOT COMPLETED|Overall Study||8
11201463|NCT01832727|12391753|FG007|NOT COMPLETED|Overall Study||6
11201464|NCT01832727|12391754|FG008|NOT COMPLETED|Overall Study||18
11201465|NCT01832753|12391786|FG000|STARTED|Observation Phase (Months 0-6)||5
11201466|NCT01832753|12391787|FG001|STARTED|Observation Phase (Months 0-6)||4
11201467|NCT01832753|12391788|FG002|STARTED|Observation Phase (Months 0-6)||3
11201468|NCT01832753|12391786|FG000|COMPLETED|Observation Phase (Months 0-6)||5
11201469|NCT01832753|12391787|FG001|COMPLETED|Observation Phase (Months 0-6)||4
11337273|NCT02890992|12535039|FG007|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
11337274|NCT02891070|12535066|FG000|STARTED|Overall Study||110
11337275|NCT02891070|12535067|FG001|STARTED|Overall Study||114
11337276|NCT02891070|12535066|FG000|COMPLETED|Overall Study||100
11337277|NCT02891070|12535067|FG001|COMPLETED|Overall Study||106
11337278|NCT02891070|12535066|FG000|NOT COMPLETED|Overall Study||10
11337279|NCT02891070|12535067|FG001|NOT COMPLETED|Overall Study||8
11337280|NCT02891174|12535075|FG000|STARTED|First Intervention (24 Hours)||20
11337281|NCT02891174|12535076|FG001|STARTED|First Intervention (24 Hours)||23
11337282|NCT02891174|12535075|FG000|Received First Intervention|First Intervention (24 Hours)||19
11201470|NCT01832753|12391788|FG002|COMPLETED|Observation Phase (Months 0-6)||1
11201471|NCT01832753|12391786|FG000|NOT COMPLETED|Observation Phase (Months 0-6)||0
11337283|NCT02891174|12535076|FG001|Received First Intervention|First Intervention (24 Hours)||18
11049132|NCT00955903|12229797|FG002|STARTED|Overall Study||55
11049133|NCT00955903|12229795|FG000|COMPLETED|Overall Study||49
11049134|NCT00955903|12229796|FG001|COMPLETED|Overall Study||51
11049135|NCT00955903|12229797|FG002|COMPLETED|Overall Study||48
11049136|NCT00955903|12229795|FG000|NOT COMPLETED|Overall Study||6
11049137|NCT00955903|12229796|FG001|NOT COMPLETED|Overall Study||3
11049138|NCT00955903|12229797|FG002|NOT COMPLETED|Overall Study||7
11337284|NCT02891174|12535075|FG000|COMPLETED|First Intervention (24 Hours)||17
11337285|NCT02891174|12535076|FG001|COMPLETED|First Intervention (24 Hours)||10
11049139|NCT00955916|12229805|FG000|STARTED|Overall Study||38
11049140|NCT00955916|12229805|FG000|COMPLETED|Overall Study||38
11049141|NCT00955916|12229805|FG000|NOT COMPLETED|Overall Study||0
11049142|NCT00955955|12229812|FG000|STARTED|Overall Study||19
11049143|NCT00955955|12229813|FG001|STARTED|Overall Study||28
11049144|NCT00955955|12229814|FG002|STARTED|Overall Study||28
11049145|NCT00955955|12229812|FG000|COMPLETED|Overall Study||17
11049146|NCT00955955|12229813|FG001|COMPLETED|Overall Study||28
11049147|NCT00955955|12229814|FG002|COMPLETED|Overall Study||28
11049148|NCT00955955|12229812|FG000|NOT COMPLETED|Overall Study||2
11049149|NCT00955955|12229813|FG001|NOT COMPLETED|Overall Study||0
11049150|NCT00955955|12229814|FG002|NOT COMPLETED|Overall Study||0
11049151|NCT00955968|12229830|FG000|STARTED|Overall Study||828
11049152|NCT00955968|12229831|FG001|STARTED|Overall Study||825
11049153|NCT00955968|12229830|FG000|COMPLETED|Overall Study||691
11049154|NCT00955968|12229831|FG001|COMPLETED|Overall Study||699
11049155|NCT00955968|12229830|FG000|NOT COMPLETED|Overall Study||137
11049156|NCT00955968|12229831|FG001|NOT COMPLETED|Overall Study||126
11049157|NCT00956020|12229840|FG000|STARTED|Overall Study||4
11049158|NCT00956020|12229840|FG000|COMPLETED|Overall Study||4
11049159|NCT00956020|12229840|FG000|NOT COMPLETED|Overall Study||0
11049160|NCT00956085|12229853|FG000|STARTED|Overall Study||12
11049161|NCT00956085|12229853|FG000|COMPLETED|Overall Study||12
11049162|NCT00956085|12229853|FG000|NOT COMPLETED|Overall Study||0
11049163|NCT00956254|12229857|FG000|STARTED|Overall Study||18
11049164|NCT00956254|12229857|FG000|COMPLETED|Overall Study||18
11049165|NCT00956254|12229857|FG000|NOT COMPLETED|Overall Study||0
11049166|NCT00956293|12229865|FG000|STARTED|Main Period (Pre-randomization)||0
11049167|NCT00956293|12229866|FG001|STARTED|Main Period (Pre-randomization)||0
11049168|NCT00956293|12229867|FG002|STARTED|Main Period (Pre-randomization)||207
11049169|NCT00956293|12229865|FG000|Enrolled Safety Set|Main Period (Pre-randomization)||0
11049170|NCT00956293|12229866|FG001|Enrolled Safety Set|Main Period (Pre-randomization)||0
11049171|NCT00956293|12229867|FG002|Enrolled Safety Set|Main Period (Pre-randomization)||203
11049172|NCT00956293|12229865|FG000|COMPLETED|Main Period (Pre-randomization)||0
11049173|NCT00956293|12229866|FG001|COMPLETED|Main Period (Pre-randomization)||0
11049174|NCT00956293|12229867|FG002|COMPLETED|Main Period (Pre-randomization)||77
11049175|NCT00956293|12229865|FG000|NOT COMPLETED|Main Period (Pre-randomization)||0
11049176|NCT00956293|12229866|FG001|NOT COMPLETED|Main Period (Pre-randomization)||0
11049177|NCT00956293|12229867|FG002|NOT COMPLETED|Main Period (Pre-randomization)||130
11049178|NCT00956293|12229865|FG000|STARTED|Main Period (Randomization)||24
11049179|NCT00956293|12229866|FG001|STARTED|Main Period (Randomization)||53
11049180|NCT00956293|12229867|FG002|STARTED|Main Period (Randomization)||0
11049181|NCT00956293|12229865|FG000|Full Analysis Set|Main Period (Randomization)||24
11049182|NCT00956293|12229866|FG001|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
11049183|NCT00956293|12229867|FG002|Full Analysis Set|Main Period (Randomization)||0
11049184|NCT00956293|12229865|FG000|Randomized Safety Set|Main Period (Randomization)||24
11049185|NCT00956293|12229866|FG001|Randomized Safety Set|Main Period (Randomization)||51
11049186|NCT00956293|12229867|FG002|Randomized Safety Set|Main Period (Randomization)||0
11049187|NCT00956293|12229865|FG000|COMPLETED|Main Period (Randomization)||23
11049188|NCT00956293|12229866|FG001|COMPLETED|Main Period (Randomization)||26
11049189|NCT00956293|12229867|FG002|COMPLETED|Main Period (Randomization)||0
11049190|NCT00956293|12229865|FG000|NOT COMPLETED|Main Period (Randomization)||1
11049191|NCT00956293|12229866|FG001|NOT COMPLETED|Main Period (Randomization)||27
11049192|NCT00956293|12229867|FG002|NOT COMPLETED|Main Period (Randomization)||0
11049193|NCT00956293|12229865|FG000|STARTED|Follow-up Period||20
11049194|NCT00956293|12229866|FG001|STARTED|Follow-up Period||32
11049195|NCT00956293|12229867|FG002|STARTED|Follow-up Period||0
11049196|NCT00956293|12229865|FG000|COMPLETED|Follow-up Period||0
11049197|NCT00956293|12229866|FG001|COMPLETED|Follow-up Period||0
11049198|NCT00956293|12229867|FG002|COMPLETED|Follow-up Period||0
11049199|NCT00956293|12229865|FG000|NOT COMPLETED|Follow-up Period||20
11049200|NCT00956293|12229866|FG001|NOT COMPLETED|Follow-up Period||32
11049201|NCT00956293|12229867|FG002|NOT COMPLETED|Follow-up Period||0
11049202|NCT00956540|12229877|FG000|STARTED|Overall Study||54
11049203|NCT00956540|12229878|FG001|STARTED|Overall Study||50
11049204|NCT00956540|12229879|FG002|STARTED|Overall Study||46
11049205|NCT00956540|12229880|FG003|STARTED|Overall Study||45
11049206|NCT00956540|12229877|FG000|COMPLETED|Overall Study||51
11049207|NCT00956540|12229878|FG001|COMPLETED|Overall Study||46
11049208|NCT00956540|12229879|FG002|COMPLETED|Overall Study||43
11049209|NCT00956540|12229880|FG003|COMPLETED|Overall Study||41
11049210|NCT00956540|12229877|FG000|NOT COMPLETED|Overall Study||3
11049211|NCT00956540|12229878|FG001|NOT COMPLETED|Overall Study||4
11049212|NCT00956540|12229879|FG002|NOT COMPLETED|Overall Study||3
11049213|NCT00956540|12229880|FG003|NOT COMPLETED|Overall Study||4
11049214|NCT00956592|12229892|FG000|STARTED|Overall Study||150
11049215|NCT00956592|12229893|FG001|STARTED|Overall Study||150
11049216|NCT00956592|12229892|FG000|COMPLETED|Overall Study||149
11049217|NCT00956592|12229893|FG001|COMPLETED|Overall Study||147
11049218|NCT00956592|12229892|FG000|NOT COMPLETED|Overall Study||1
11049219|NCT00956592|12229893|FG001|NOT COMPLETED|Overall Study||3
11049220|NCT00956631|12229901|FG000|STARTED|Overall Study||78
11049221|NCT00956631|12229901|FG000|COMPLETED|Overall Study||62
11049222|NCT00956631|12229901|FG000|NOT COMPLETED|Overall Study||16
11049223|NCT00956657|12229909|FG000|STARTED|Overall Study||18
11049224|NCT00956657|12229910|FG001|STARTED|Overall Study||13
11049225|NCT00956657|12229909|FG000|COMPLETED|Overall Study||18
11049226|NCT00956657|12229910|FG001|COMPLETED|Overall Study||13
11049227|NCT00956657|12229909|FG000|NOT COMPLETED|Overall Study||0
11049228|NCT00956657|12229910|FG001|NOT COMPLETED|Overall Study||0
11049229|NCT00956709|12229918|FG000|STARTED|Overall Study||16
11049230|NCT00956709|12229919|FG001|STARTED|Overall Study||19
11049231|NCT00956709|12229918|FG000|COMPLETED|Overall Study||16
11049232|NCT00956709|12229919|FG001|COMPLETED|Overall Study||19
11049233|NCT00956709|12229918|FG000|NOT COMPLETED|Overall Study||0
11049234|NCT00956709|12229919|FG001|NOT COMPLETED|Overall Study||0
11049235|NCT00956761|12229925|FG000|STARTED|Overall Study||63
11049236|NCT00956761|12229925|FG000|COMPLETED|Overall Study||63
11049237|NCT00956761|12229925|FG000|NOT COMPLETED|Overall Study||0
11049238|NCT00956813|12229932|FG000|STARTED|Flaxseed and Placebo||105
11049239|NCT00956813|12229933|FG001|STARTED|Flaxseed and Placebo||105
11049240|NCT00956813|12229932|FG000|COMPLETED|Flaxseed and Placebo||97
11049241|NCT00956813|12229933|FG001|COMPLETED|Flaxseed and Placebo||100
11049242|NCT00956813|12229932|FG000|NOT COMPLETED|Flaxseed and Placebo||8
11049243|NCT00956813|12229933|FG001|NOT COMPLETED|Flaxseed and Placebo||5
11049244|NCT00956813|12229932|FG000|STARTED|Continuation Phase||80
11049245|NCT00956813|12229933|FG001|STARTED|Continuation Phase||0
11049246|NCT00956813|12229932|FG000|COMPLETED|Continuation Phase||80
11049247|NCT00956813|12229933|FG001|COMPLETED|Continuation Phase||0
11049248|NCT00956813|12229932|FG000|NOT COMPLETED|Continuation Phase||0
11049249|NCT00956813|12229933|FG001|NOT COMPLETED|Continuation Phase||0
11049250|NCT00956839|12229943|FG000|STARTED|Overall Study||14
11049251|NCT00956839|12229944|FG001|STARTED|Overall Study||13
11049252|NCT00956839|12229945|FG002|STARTED|Overall Study||13
11337286|NCT02891174|12535075|FG000|NOT COMPLETED|First Intervention (24 Hours)||3
11337287|NCT02891174|12535076|FG001|NOT COMPLETED|First Intervention (24 Hours)||13
11337288|NCT02891174|12535075|FG000|STARTED|Second Intervention (24 Hours)||17
11337289|NCT02891174|12535076|FG001|STARTED|Second Intervention (24 Hours)||10
11337290|NCT02891174|12535075|FG000|COMPLETED|Second Intervention (24 Hours)||11
11337291|NCT02891174|12535076|FG001|COMPLETED|Second Intervention (24 Hours)||3
11337292|NCT02891174|12535075|FG000|NOT COMPLETED|Second Intervention (24 Hours)||6
11337293|NCT02891174|12535076|FG001|NOT COMPLETED|Second Intervention (24 Hours)||7
11337294|NCT02891200|12535088|FG000|STARTED|Overall Study||145
11337295|NCT02891200|12535089|FG001|STARTED|Overall Study||147
11337296|NCT02891200|12535088|FG000|COMPLETED|Overall Study||103
11337297|NCT02891200|12535089|FG001|COMPLETED|Overall Study||98
11337298|NCT02891200|12535088|FG000|NOT COMPLETED|Overall Study||42
11337299|NCT02891200|12535089|FG001|NOT COMPLETED|Overall Study||49
11337300|NCT02891408|12535102|FG000|STARTED|Overall Study||10
11337301|NCT02891408|12535103|FG001|STARTED|Overall Study||10
11337302|NCT02891408|12535104|FG002|STARTED|Overall Study||14
11337303|NCT02891408|12535105|FG003|STARTED|Overall Study||10
11337304|NCT02891408|12535106|FG004|STARTED|Overall Study||10
11337305|NCT02891408|12535107|FG005|STARTED|Overall Study||10
11337306|NCT02891408|12535108|FG006|STARTED|Overall Study||10
11337307|NCT02891408|12535102|FG000|COMPLETED|Overall Study||10
11337308|NCT02891408|12535103|FG001|COMPLETED|Overall Study||10
11337309|NCT02891408|12535104|FG002|COMPLETED|Overall Study||13
11337310|NCT02891408|12535105|FG003|COMPLETED|Overall Study||10
11337311|NCT02891408|12535106|FG004|COMPLETED|Overall Study||10
11337312|NCT02891408|12535107|FG005|COMPLETED|Overall Study||10
11337313|NCT02891408|12535108|FG006|COMPLETED|Overall Study||10
11337314|NCT02891408|12535102|FG000|NOT COMPLETED|Overall Study||0
11337315|NCT02891408|12535103|FG001|NOT COMPLETED|Overall Study||0
11049253|NCT00956839|12229943|FG000|COMPLETED|Overall Study||11
11049254|NCT00956839|12229944|FG001|COMPLETED|Overall Study||13
11049255|NCT00956839|12229945|FG002|COMPLETED|Overall Study||10
11049256|NCT00956839|12229943|FG000|NOT COMPLETED|Overall Study||3
11049257|NCT00956839|12229944|FG001|NOT COMPLETED|Overall Study||0
11049258|NCT00956839|12229945|FG002|NOT COMPLETED|Overall Study||3
11049259|NCT00956930|12229955|FG000|STARTED|Overall Study||24
11049260|NCT00956930|12229956|FG001|STARTED|Overall Study||21
11049261|NCT00956930|12229955|FG000|COMPLETED|Overall Study||24
11049262|NCT00956930|12229956|FG001|COMPLETED|Overall Study||21
11049263|NCT00956930|12229955|FG000|NOT COMPLETED|Overall Study||0
11049264|NCT00956930|12229956|FG001|NOT COMPLETED|Overall Study||0
11049265|NCT00956943|12229966|FG000|STARTED|Overall Study||43
11049266|NCT00956943|12229967|FG001|STARTED|Overall Study||44
11049267|NCT00956943|12229966|FG000|Baseline|Overall Study||43
11049268|NCT00956943|12229967|FG001|Baseline|Overall Study||44
11049269|NCT00956943|12229966|FG000|COMPLETED|Overall Study||34
11049270|NCT00956943|12229967|FG001|COMPLETED|Overall Study||34
11049271|NCT00956943|12229966|FG000|NOT COMPLETED|Overall Study||9
11049272|NCT00956943|12229967|FG001|NOT COMPLETED|Overall Study||10
11049273|NCT00957008|12229977|FG000|STARTED|Overall Study||49
11049274|NCT00957008|12229978|FG001|STARTED|Overall Study||49
11049275|NCT00957008|12229979|FG002|STARTED|Overall Study||49
11049276|NCT00957008|12229980|FG003|STARTED|Overall Study||50
11337316|NCT02891408|12535104|FG002|NOT COMPLETED|Overall Study||1
11337317|NCT02891408|12535105|FG003|NOT COMPLETED|Overall Study||0
11337318|NCT02891408|12535106|FG004|NOT COMPLETED|Overall Study||0
11337319|NCT02891408|12535107|FG005|NOT COMPLETED|Overall Study||0
11337320|NCT02891408|12535108|FG006|NOT COMPLETED|Overall Study||0
11337321|NCT02891629|12535136|FG000|STARTED|Overall Study||10
11337322|NCT02891629|12535137|FG001|STARTED|Overall Study||5
11337323|NCT02891629|12535136|FG000|COMPLETED|Overall Study||10
11337324|NCT02891629|12535137|FG001|COMPLETED|Overall Study||4
11337325|NCT02891629|12535136|FG000|NOT COMPLETED|Overall Study||0
11337326|NCT02891629|12535137|FG001|NOT COMPLETED|Overall Study||1
11337327|NCT02891681|12535146|FG000|STARTED|Overall Study||39
11337328|NCT02891681|12535147|FG001|STARTED|Overall Study||1
11337329|NCT02891681|12535148|FG002|STARTED|Overall Study||1
11337330|NCT02891681|12535146|FG000|COMPLETED|Overall Study||36
11337331|NCT02891681|12535147|FG001|COMPLETED|Overall Study||1
11337332|NCT02891681|12535148|FG002|COMPLETED|Overall Study||0
11337333|NCT02891681|12535146|FG000|NOT COMPLETED|Overall Study||3
11337334|NCT02891681|12535147|FG001|NOT COMPLETED|Overall Study||0
11337335|NCT02891681|12535148|FG002|NOT COMPLETED|Overall Study||1
11337336|NCT02891850|12535158|FG000|STARTED|Overall Study||111
11337337|NCT02891850|12535159|FG001|STARTED|Overall Study||114
11337338|NCT02891850|12535158|FG000|COMPLETED|Overall Study||104
11337339|NCT02891850|12535159|FG001|COMPLETED|Overall Study||107
11337340|NCT02891850|12535158|FG000|NOT COMPLETED|Overall Study||7
11337341|NCT02891850|12535159|FG001|NOT COMPLETED|Overall Study||7
11337342|NCT02891863|12535165|FG000|STARTED|Overall Study||9
11337343|NCT02891863|12535165|FG000|COMPLETED|Overall Study||9
11337344|NCT02891863|12535165|FG000|NOT COMPLETED|Overall Study||0
11337345|NCT02891915|12535171|FG000|STARTED|Overall Study||192
11337346|NCT02891915|12535172|FG001|STARTED|Overall Study||193
11337347|NCT02891915|12535171|FG000|COMPLETED|Overall Study||179
11337348|NCT02891915|12535172|FG001|COMPLETED|Overall Study||181
11337349|NCT02891915|12535171|FG000|NOT COMPLETED|Overall Study||13
11337350|NCT02891915|12535172|FG001|NOT COMPLETED|Overall Study||12
11337351|NCT02892019|12535180|FG000|STARTED|Overall Study||41
11337352|NCT02892019|12535181|FG001|STARTED|Overall Study||39
11337353|NCT02892019|12535180|FG000|COMPLETED|Overall Study||40
11337354|NCT02892019|12535181|FG001|COMPLETED|Overall Study||36
11337355|NCT02892019|12535180|FG000|NOT COMPLETED|Overall Study||1
11337356|NCT02892019|12535181|FG001|NOT COMPLETED|Overall Study||3
11337357|NCT02892110|12535189|FG000|STARTED|Overall Study||35
11337358|NCT02892110|12535190|FG001|STARTED|Overall Study||37
11337359|NCT02892110|12535189|FG000|COMPLETED|Overall Study||22
11337360|NCT02892110|12535190|FG001|COMPLETED|Overall Study||25
11337361|NCT02892110|12535189|FG000|NOT COMPLETED|Overall Study||13
11337362|NCT02892110|12535190|FG001|NOT COMPLETED|Overall Study||12
11337363|NCT02892344|12535198|FG000|STARTED|Overall Study||398
11337364|NCT02892344|12535199|FG001|STARTED|Overall Study||404
11337365|NCT02892344|12535198|FG000|Full Analysis Set|Overall Study||395
11337366|NCT02892344|12535199|FG001|Full Analysis Set|Overall Study||399
11337367|NCT02892344|12535198|FG000|COMPLETED|Overall Study||394
11337368|NCT02892344|12535199|FG001|COMPLETED|Overall Study||383
11337369|NCT02892344|12535198|FG000|NOT COMPLETED|Overall Study||4
11337370|NCT02892344|12535199|FG001|NOT COMPLETED|Overall Study||21
11337371|NCT02892409|12535207|FG000|STARTED|Overall Study||15
11337372|NCT02892409|12535208|FG001|STARTED|Overall Study||15
11337373|NCT02892409|12535207|FG000|COMPLETED|Overall Study||12
11337374|NCT02892409|12535208|FG001|COMPLETED|Overall Study||14
11337375|NCT02892409|12535207|FG000|NOT COMPLETED|Overall Study||3
11337376|NCT02892409|12535208|FG001|NOT COMPLETED|Overall Study||1
11337377|NCT02892422|12535214|FG000|STARTED|Overall Study|528 participants were enrolled, 524 from study 16159A and 4 from study 16323A|528
11337378|NCT02892422|12535214|FG000|COMPLETED|Overall Study||318
11337379|NCT02892422|12535214|FG000|NOT COMPLETED|Overall Study||210
11337380|NCT02892448|12535221|FG000|STARTED|Overall Study||12
11337381|NCT02892448|12535222|FG001|STARTED|Overall Study||12
11337382|NCT02892448|12535223|FG002|STARTED|Overall Study||11
11049277|NCT00957008|12229977|FG000|COMPLETED|Overall Study||28
11049278|NCT00957008|12229978|FG001|COMPLETED|Overall Study||37
11049279|NCT00957008|12229979|FG002|COMPLETED|Overall Study||32
11049280|NCT00957008|12229980|FG003|COMPLETED|Overall Study||26
11049281|NCT00957008|12229977|FG000|NOT COMPLETED|Overall Study||21
11049282|NCT00957008|12229978|FG001|NOT COMPLETED|Overall Study||12
11049283|NCT00957008|12229979|FG002|NOT COMPLETED|Overall Study||17
11049284|NCT00957008|12229980|FG003|NOT COMPLETED|Overall Study||24
11049285|NCT00957021|12229994|FG000|STARTED|Overall Study||354
11049286|NCT00957021|12229994|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
11049287|NCT00957021|12229994|FG000|NOT COMPLETED|Overall Study||117
11049288|NCT00957047|12230003|FG000|STARTED|PART I||100
11049289|NCT00957047|12230004|FG001|STARTED|PART I||96
11049290|NCT00957047|12230005|FG002|STARTED|PART I||101
11049291|NCT00957047|12230006|FG003|STARTED|PART I||98
11049292|NCT00957047|12230007|FG004|STARTED|PART I||0
11049293|NCT00957047|12230003|FG000|Randomized/Safety Population|PART I||100
11049294|NCT00957047|12230004|FG001|Randomized/Safety Population|PART I||96
11049295|NCT00957047|12230005|FG002|Randomized/Safety Population|PART I||101
11049296|NCT00957047|12230006|FG003|Randomized/Safety Population|PART I||98
11049297|NCT00957047|12230007|FG004|Randomized/Safety Population|PART I||0
11049298|NCT00957047|12230003|FG000|Intention-to-treat (ITT) Population|PART I||100
11049299|NCT00957047|12230004|FG001|Intention-to-treat (ITT) Population|PART I||96
11337383|NCT02892448|12535221|FG000|COMPLETED|Overall Study||10
11337384|NCT02892448|12535222|FG001|COMPLETED|Overall Study||10
11337385|NCT02892448|12535223|FG002|COMPLETED|Overall Study||10
11337386|NCT02892448|12535221|FG000|NOT COMPLETED|Overall Study||2
11337387|NCT02892448|12535222|FG001|NOT COMPLETED|Overall Study||2
11337388|NCT02892448|12535223|FG002|NOT COMPLETED|Overall Study||1
11337389|NCT02892513|12535233|FG000|STARTED|Overall Study||28
11337390|NCT02892513|12535234|FG001|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25
11049300|NCT00957047|12230005|FG002|Intention-to-treat (ITT) Population|PART I||100
11049301|NCT00957047|12230006|FG003|Intention-to-treat (ITT) Population|PART I||97
11049302|NCT00957047|12230007|FG004|Intention-to-treat (ITT) Population|PART I||0
11049303|NCT00957047|12230003|FG000|Per-Protocol Population|PART I||81
11049304|NCT00957047|12230004|FG001|Per-Protocol Population|PART I||70
11049305|NCT00957047|12230005|FG002|Per-Protocol Population|PART I||75
11049306|NCT00957047|12230006|FG003|Per-Protocol Population|PART I||54
11049307|NCT00957047|12230007|FG004|Per-Protocol Population|PART I||0
11049308|NCT00957047|12230003|FG000|COMPLETED|PART I||94
11049309|NCT00957047|12230004|FG001|COMPLETED|PART I||83
11049310|NCT00957047|12230005|FG002|COMPLETED|PART I||80
11049311|NCT00957047|12230006|FG003|COMPLETED|PART I||68
11049312|NCT00957047|12230007|FG004|COMPLETED|PART I||0
11049313|NCT00957047|12230003|FG000|NOT COMPLETED|PART I||6
11049314|NCT00957047|12230004|FG001|NOT COMPLETED|PART I||13
11049315|NCT00957047|12230005|FG002|NOT COMPLETED|PART I||21
11049316|NCT00957047|12230006|FG003|NOT COMPLETED|PART I||30
11049317|NCT00957047|12230007|FG004|NOT COMPLETED|PART I||0
11049318|NCT00957047|12230003|FG000|STARTED|PART II||0
11049319|NCT00957047|12230004|FG001|STARTED|PART II||0
11049320|NCT00957047|12230005|FG002|STARTED|PART II||0
11049321|NCT00957047|12230006|FG003|STARTED|PART II||0
11049322|NCT00957047|12230007|FG004|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
11049323|NCT00957047|12230003|FG000|Terminated Prematurely|PART II||0
11337391|NCT02892513|12535233|FG000|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28
11337392|NCT02892513|12535234|FG001|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24
11337393|NCT02892513|12535233|FG000|NOT COMPLETED|Overall Study||0
11337394|NCT02892513|12535234|FG001|NOT COMPLETED|Overall Study||1
11337395|NCT02892734|12535240|FG000|STARTED|Treatment on Study||3
11337396|NCT02892734|12535240|FG000|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1
11337397|NCT02892734|12535240|FG000|Went on to Start Cycle 2|Treatment on Study||1
11337398|NCT02892734|12535240|FG000|COMPLETED|Treatment on Study||1
11337399|NCT02892734|12535240|FG000|NOT COMPLETED|Treatment on Study||2
11049324|NCT00957047|12230004|FG001|Terminated Prematurely|PART II||0
11049325|NCT00957047|12230005|FG002|Terminated Prematurely|PART II||0
11049326|NCT00957047|12230006|FG003|Terminated Prematurely|PART II||0
11049327|NCT00957047|12230007|FG004|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
11049328|NCT00957047|12230003|FG000|COMPLETED|PART II||0
11049329|NCT00957047|12230004|FG001|COMPLETED|PART II||0
11337400|NCT02892734|12535240|FG000|STARTED|Follow up for 2 Years||3
11337401|NCT02892734|12535240|FG000|COMPLETED|Follow up for 2 Years||0
11337402|NCT02892734|12535240|FG000|NOT COMPLETED|Follow up for 2 Years||3
11337403|NCT02892760|12535244|FG000|STARTED|Overall Study||17
11337404|NCT02892760|12535244|FG000|Received Intervention|Overall Study||15
11337405|NCT02892760|12535244|FG000|COMPLETED|Overall Study||14
11337406|NCT02892760|12535244|FG000|NOT COMPLETED|Overall Study||3
11337407|NCT02893878|12535251|FG000|STARTED|Overall Study||13861
11337408|NCT02893878|12535252|FG001|STARTED|Overall Study||2295
11337409|NCT02893878|12535253|FG002|STARTED|Overall Study||3178
11337410|NCT02893878|12535251|FG000|COMPLETED|Overall Study||13861
11337411|NCT02893878|12535252|FG001|COMPLETED|Overall Study||2295
11337412|NCT02893878|12535253|FG002|COMPLETED|Overall Study||3178
11049330|NCT00957047|12230005|FG002|COMPLETED|PART II||0
11049331|NCT00957047|12230006|FG003|COMPLETED|PART II||0
11049332|NCT00957047|12230007|FG004|COMPLETED|PART II||223
11049333|NCT00957047|12230003|FG000|NOT COMPLETED|PART II||0
11049334|NCT00957047|12230004|FG001|NOT COMPLETED|PART II||0
11049335|NCT00957047|12230005|FG002|NOT COMPLETED|PART II||0
11049336|NCT00957047|12230006|FG003|NOT COMPLETED|PART II||0
11049337|NCT00957047|12230007|FG004|NOT COMPLETED|PART II||102
11049338|NCT00957229|12230027|FG000|STARTED|Study Start||15
11337413|NCT02893878|12535251|FG000|NOT COMPLETED|Overall Study||0
11337414|NCT02893878|12535252|FG001|NOT COMPLETED|Overall Study||0
11337415|NCT02893878|12535253|FG002|NOT COMPLETED|Overall Study||0
11337416|NCT02894502|12535267|FG000|STARTED|Baseline||155
11337417|NCT02894502|12535268|FG001|STARTED|Baseline||177
11049339|NCT00957229|12230028|FG001|STARTED|Study Start||26
11049340|NCT00957229|12230027|FG000|COMPLETED|Study Start||14
11049341|NCT00957229|12230028|FG001|COMPLETED|Study Start||23
11049342|NCT00957229|12230027|FG000|NOT COMPLETED|Study Start||1
11049343|NCT00957229|12230028|FG001|NOT COMPLETED|Study Start||3
11049344|NCT00957229|12230027|FG000|STARTED|Reallocated to or Continued Vismodegib||14
11049345|NCT00957229|12230028|FG001|STARTED|Reallocated to or Continued Vismodegib||23
11049346|NCT00957229|12230027|FG000|COMPLETED|Reallocated to or Continued Vismodegib||11
11049347|NCT00957229|12230028|FG001|COMPLETED|Reallocated to or Continued Vismodegib||21
11049348|NCT00957229|12230027|FG000|NOT COMPLETED|Reallocated to or Continued Vismodegib||3
11049349|NCT00957229|12230028|FG001|NOT COMPLETED|Reallocated to or Continued Vismodegib||2
11049350|NCT00957242|12230036|FG000|STARTED|Overall Study||73
11049351|NCT00957242|12230037|FG001|STARTED|Overall Study||72
11049352|NCT00957242|12230036|FG000|COMPLETED|Overall Study||73
11049353|NCT00957242|12230037|FG001|COMPLETED|Overall Study||72
11049354|NCT00957242|12230036|FG000|NOT COMPLETED|Overall Study||0
11049355|NCT00957242|12230037|FG001|NOT COMPLETED|Overall Study||0
11049356|NCT00957268|12230050|FG000|STARTED|Overall Study||5
11049357|NCT00957268|12230051|FG001|STARTED|Overall Study||4
11049358|NCT00957268|12230052|FG002|STARTED|Overall Study||8
11049359|NCT00957268|12230053|FG003|STARTED|Overall Study||7
11049360|NCT00957268|12230054|FG004|STARTED|Overall Study||22
11049361|NCT00957268|12230050|FG000|COMPLETED|Overall Study||5
11049362|NCT00957268|12230051|FG001|COMPLETED|Overall Study||4
11049363|NCT00957268|12230052|FG002|COMPLETED|Overall Study||7
11049364|NCT00957268|12230053|FG003|COMPLETED|Overall Study||7
11049365|NCT00957268|12230054|FG004|COMPLETED|Overall Study||22
11049366|NCT00957268|12230050|FG000|NOT COMPLETED|Overall Study||0
11049367|NCT00957268|12230051|FG001|NOT COMPLETED|Overall Study||0
11049368|NCT00957268|12230052|FG002|NOT COMPLETED|Overall Study||1
11049369|NCT00957268|12230053|FG003|NOT COMPLETED|Overall Study||0
11049370|NCT00957268|12230054|FG004|NOT COMPLETED|Overall Study||0
11049371|NCT00957333|12230066|FG000|STARTED|Overall Study||44
11049372|NCT00957333|12230066|FG000|COMPLETED|Overall Study||44
11049373|NCT00957333|12230066|FG000|NOT COMPLETED|Overall Study||0
11049374|NCT00957359|12230072|FG000|STARTED|Overall Study||14
11049375|NCT00957359|12230073|FG001|STARTED|Overall Study||15
11049376|NCT00957359|12230072|FG000|COMPLETED|Overall Study||14
11049377|NCT00957359|12230073|FG001|COMPLETED|Overall Study||15
11049378|NCT00957359|12230072|FG000|NOT COMPLETED|Overall Study||0
11049379|NCT00957359|12230073|FG001|NOT COMPLETED|Overall Study||0
11049380|NCT00957372|12230082|FG000|STARTED|PART I||80
11049381|NCT00957372|12230083|FG001|STARTED|PART I||85
11049382|NCT00957372|12230084|FG002|STARTED|PART I||88
11049383|NCT00957372|12230085|FG003|STARTED|PART I||0
11049384|NCT00957372|12230082|FG000|Safety Population|PART I||80
11049385|NCT00957372|12230083|FG001|Safety Population|PART I||85
11049386|NCT00957372|12230084|FG002|Safety Population|PART I||87
11049387|NCT00957372|12230085|FG003|Safety Population|PART I||0
11049388|NCT00957372|12230082|FG000|Intention-to-Treat Population|PART I||77
11049389|NCT00957372|12230083|FG001|Intention-to-Treat Population|PART I||84
11049390|NCT00957372|12230084|FG002|Intention-to-Treat Population|PART I||84
11049391|NCT00957372|12230085|FG003|Intention-to-Treat Population|PART I||0
11049392|NCT00957372|12230082|FG000|Per-Protocol Population|PART I||35
11049393|NCT00957372|12230083|FG001|Per-Protocol Population|PART I||47
11049394|NCT00957372|12230084|FG002|Per-Protocol Population|PART I||51
11049395|NCT00957372|12230085|FG003|Per-Protocol Population|PART I||0
11049396|NCT00957372|12230082|FG000|Randomized But Not Treated|PART I||0
11049397|NCT00957372|12230083|FG001|Randomized But Not Treated|PART I||0
11049398|NCT00957372|12230084|FG002|Randomized But Not Treated|PART I||1
11049399|NCT00957372|12230085|FG003|Randomized But Not Treated|PART I||0
11049400|NCT00957372|12230082|FG000|COMPLETED|PART I||80
11049401|NCT00957372|12230083|FG001|COMPLETED|PART I||85
11049402|NCT00957372|12230084|FG002|COMPLETED|PART I||87
11049403|NCT00957372|12230085|FG003|COMPLETED|PART I||0
11049404|NCT00957372|12230082|FG000|NOT COMPLETED|PART I||0
11049405|NCT00957372|12230083|FG001|NOT COMPLETED|PART I||0
11049406|NCT00957372|12230084|FG002|NOT COMPLETED|PART I||1
11049407|NCT00957372|12230085|FG003|NOT COMPLETED|PART I||0
11049408|NCT00957372|12230082|FG000|STARTED|PART II||0
11049409|NCT00957372|12230083|FG001|STARTED|PART II||0
11049410|NCT00957372|12230084|FG002|STARTED|PART II||0
11049411|NCT00957372|12230085|FG003|STARTED|PART II||194
11049412|NCT00957372|12230082|FG000|Safety Population|PART II||0
11049413|NCT00957372|12230083|FG001|Safety Population|PART II||0
11049414|NCT00957372|12230084|FG002|Safety Population|PART II||0
11049415|NCT00957372|12230085|FG003|Safety Population|PART II||194
11049416|NCT00957372|12230082|FG000|Intention-to-treat (ITT) Population|PART II||0
11049417|NCT00957372|12230083|FG001|Intention-to-treat (ITT) Population|PART II||0
11049418|NCT00957372|12230084|FG002|Intention-to-treat (ITT) Population|PART II||0
11049419|NCT00957372|12230085|FG003|Intention-to-treat (ITT) Population|PART II||191
11049420|NCT00957372|12230082|FG000|Per-Protocol Population|PART II||0
11049421|NCT00957372|12230083|FG001|Per-Protocol Population|PART II||0
11049422|NCT00957372|12230084|FG002|Per-Protocol Population|PART II||0
11049423|NCT00957372|12230085|FG003|Per-Protocol Population|PART II||108
11049424|NCT00957372|12230082|FG000|COMPLETED|PART II||0
11049425|NCT00957372|12230083|FG001|COMPLETED|PART II||0
11049426|NCT00957372|12230084|FG002|COMPLETED|PART II||0
11049427|NCT00957372|12230085|FG003|COMPLETED|PART II||150
11049428|NCT00957372|12230082|FG000|NOT COMPLETED|PART II||0
11049429|NCT00957372|12230083|FG001|NOT COMPLETED|PART II||0
11049430|NCT00957372|12230084|FG002|NOT COMPLETED|PART II||0
11049431|NCT00957372|12230085|FG003|NOT COMPLETED|PART II||44
11049432|NCT00957424|12230101|FG000|STARTED|Overall Study||67
11049433|NCT00957424|12230101|FG000|Follow-up #1|Overall Study||59
11049434|NCT00957424|12230101|FG000|Follow-up #2|Overall Study||50
11049435|NCT00957424|12230101|FG000|COMPLETED|Overall Study||44
11049436|NCT00957424|12230101|FG000|NOT COMPLETED|Overall Study||23
11049437|NCT00957528|12230108|FG000|STARTED|Overall Study||8
11049438|NCT00957528|12230109|FG001|STARTED|Overall Study||9
11049439|NCT00957528|12230110|FG002|STARTED|Overall Study||9
11049440|NCT00957528|12230108|FG000|COMPLETED|Overall Study||8
11049441|NCT00957528|12230109|FG001|COMPLETED|Overall Study||8
11049442|NCT00957528|12230110|FG002|COMPLETED|Overall Study||8
11049443|NCT00957528|12230108|FG000|NOT COMPLETED|Overall Study||0
11049444|NCT00957528|12230109|FG001|NOT COMPLETED|Overall Study||1
11049445|NCT00957528|12230110|FG002|NOT COMPLETED|Overall Study||1
11049446|NCT00957580|12230121|FG000|STARTED|Overall Study||33
11049447|NCT00957580|12230122|FG001|STARTED|Overall Study||33
11049448|NCT00957580|12230123|FG002|STARTED|Overall Study||15
11049449|NCT00957580|12230121|FG000|Treated|Overall Study||33
11049450|NCT00957580|12230122|FG001|Treated|Overall Study||32
11049451|NCT00957580|12230123|FG002|Treated|Overall Study||15
11049452|NCT00957580|12230121|FG000|COMPLETED|Overall Study||33
11049453|NCT00957580|12230122|FG001|COMPLETED|Overall Study||31
11049454|NCT00957580|12230123|FG002|COMPLETED|Overall Study||15
11049455|NCT00957580|12230121|FG000|NOT COMPLETED|Overall Study||0
11049456|NCT00957580|12230122|FG001|NOT COMPLETED|Overall Study||2
11049457|NCT00957580|12230123|FG002|NOT COMPLETED|Overall Study||0
11049458|NCT00957593|12230146|FG000|STARTED|Overall Study||127
11049459|NCT00957593|12230147|FG001|STARTED|Overall Study||125
11049460|NCT00957593|12230146|FG000|COMPLETED|Overall Study||127
11049461|NCT00957593|12230147|FG001|COMPLETED|Overall Study||125
11049462|NCT00957593|12230146|FG000|NOT COMPLETED|Overall Study||0
11049463|NCT00957593|12230147|FG001|NOT COMPLETED|Overall Study||0
11049464|NCT00957658|12230155|FG000|STARTED|Overall Study||234
11049465|NCT00957658|12230155|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
11049466|NCT00957658|12230155|FG000|NOT COMPLETED|Overall Study||65
11049467|NCT00957671|12230161|FG000|STARTED|Overall Study|15 subjects began the treatment phase.|15
11049468|NCT00957671|12230161|FG000|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
11049469|NCT00957671|12230161|FG000|NOT COMPLETED|Overall Study||0
11049470|NCT00957684|12230170|FG000|STARTED|PART I||102
11049471|NCT00957684|12230171|FG001|STARTED|PART I||98
11049472|NCT00957684|12230172|FG002|STARTED|PART I||100
11049473|NCT00957684|12230173|FG003|STARTED|PART I||102
11049474|NCT00957684|12230174|FG004|STARTED|PART I||0
11049475|NCT00957684|12230170|FG000|Randomised (Safety Population)|PART I||102
11049476|NCT00957684|12230171|FG001|Randomised (Safety Population)|PART I||98
11049477|NCT00957684|12230172|FG002|Randomised (Safety Population)|PART I||100
11049478|NCT00957684|12230173|FG003|Randomised (Safety Population)|PART I||102
11049479|NCT00957684|12230174|FG004|Randomised (Safety Population)|PART I||0
11049480|NCT00957684|12230170|FG000|Intention-to-treat (ITT) Population|PART I||98
11049481|NCT00957684|12230171|FG001|Intention-to-treat (ITT) Population|PART I||98
11049482|NCT00957684|12230172|FG002|Intention-to-treat (ITT) Population|PART I||99
11049483|NCT00957684|12230173|FG003|Intention-to-treat (ITT) Population|PART I||102
11049484|NCT00957684|12230174|FG004|Intention-to-treat (ITT) Population|PART I||0
11049485|NCT00957684|12230170|FG000|Per-protocol (PP)Population|PART I||72
11049486|NCT00957684|12230171|FG001|Per-protocol (PP)Population|PART I||86
11049487|NCT00957684|12230172|FG002|Per-protocol (PP)Population|PART I||94
11049488|NCT00957684|12230173|FG003|Per-protocol (PP)Population|PART I||91
11049489|NCT00957684|12230174|FG004|Per-protocol (PP)Population|PART I||0
11049490|NCT00957684|12230170|FG000|COMPLETED|PART I||71
11049491|NCT00957684|12230171|FG001|COMPLETED|PART I||85
11049492|NCT00957684|12230172|FG002|COMPLETED|PART I||90
11049493|NCT00957684|12230173|FG003|COMPLETED|PART I||84
11049494|NCT00957684|12230174|FG004|COMPLETED|PART I||0
11049495|NCT00957684|12230170|FG000|NOT COMPLETED|PART I||31
11049496|NCT00957684|12230171|FG001|NOT COMPLETED|PART I||13
11049497|NCT00957684|12230172|FG002|NOT COMPLETED|PART I||10
11049498|NCT00957684|12230173|FG003|NOT COMPLETED|PART I||18
11049499|NCT00957684|12230174|FG004|NOT COMPLETED|PART I||0
11049500|NCT00957684|12230170|FG000|STARTED|PART II||0
11049501|NCT00957684|12230171|FG001|STARTED|PART II||0
11049502|NCT00957684|12230172|FG002|STARTED|PART II||0
11049503|NCT00957684|12230173|FG003|STARTED|PART II||0
11049504|NCT00957684|12230174|FG004|STARTED|PART II||314
11049505|NCT00957684|12230170|FG000|Patients Entered Part II|PART II||0
11049506|NCT00957684|12230171|FG001|Patients Entered Part II|PART II||0
11049507|NCT00957684|12230172|FG002|Patients Entered Part II|PART II||0
11049508|NCT00957684|12230173|FG003|Patients Entered Part II|PART II||0
11049509|NCT00957684|12230174|FG004|Patients Entered Part II|PART II||314
11337418|NCT02894502|12535269|FG002|STARTED|Baseline||178
11337419|NCT02894502|12535267|FG000|COMPLETED|Baseline||128
11337420|NCT02894502|12535268|FG001|COMPLETED|Baseline||145
11337421|NCT02894502|12535269|FG002|COMPLETED|Baseline||133
11337422|NCT02894502|12535267|FG000|NOT COMPLETED|Baseline||27
11337423|NCT02894502|12535268|FG001|NOT COMPLETED|Baseline||32
11337424|NCT02894502|12535269|FG002|NOT COMPLETED|Baseline||45
11337425|NCT02894502|12535267|FG000|STARTED|First Follow up||128
11337426|NCT02894502|12535268|FG001|STARTED|First Follow up||145
11337427|NCT02894502|12535269|FG002|STARTED|First Follow up||133
11337428|NCT02894502|12535267|FG000|COMPLETED|First Follow up||94
11337429|NCT02894502|12535268|FG001|COMPLETED|First Follow up||114
11337430|NCT02894502|12535269|FG002|COMPLETED|First Follow up||93
11337431|NCT02894502|12535267|FG000|NOT COMPLETED|First Follow up||34
11337432|NCT02894502|12535268|FG001|NOT COMPLETED|First Follow up||31
11337433|NCT02894502|12535269|FG002|NOT COMPLETED|First Follow up||40
11337434|NCT02894502|12535267|FG000|STARTED|Second Follow up||94
11337435|NCT02894502|12535268|FG001|STARTED|Second Follow up||114
11337436|NCT02894502|12535269|FG002|STARTED|Second Follow up||93
11337437|NCT02894502|12535267|FG000|COMPLETED|Second Follow up||79
11337438|NCT02894502|12535268|FG001|COMPLETED|Second Follow up||96
11337439|NCT02894502|12535269|FG002|COMPLETED|Second Follow up||79
11337440|NCT02894502|12535267|FG000|NOT COMPLETED|Second Follow up||15
11049510|NCT00957684|12230170|FG000|COMPLETED|PART II||0
11049511|NCT00957684|12230171|FG001|COMPLETED|PART II||0
11049512|NCT00957684|12230172|FG002|COMPLETED|PART II||0
11049513|NCT00957684|12230173|FG003|COMPLETED|PART II||0
11337441|NCT02894502|12535268|FG001|NOT COMPLETED|Second Follow up||18
11337442|NCT02894502|12535269|FG002|NOT COMPLETED|Second Follow up||14
11337443|NCT02894502|12535267|FG000|STARTED|Third Follow up||79
11337444|NCT02894502|12535268|FG001|STARTED|Third Follow up||96
11337445|NCT02894502|12535269|FG002|STARTED|Third Follow up||79
11337446|NCT02894502|12535267|FG000|COMPLETED|Third Follow up||73
11337447|NCT02894502|12535268|FG001|COMPLETED|Third Follow up||89
11337448|NCT02894502|12535269|FG002|COMPLETED|Third Follow up||76
11337449|NCT02894502|12535267|FG000|NOT COMPLETED|Third Follow up||6
11337450|NCT02894502|12535268|FG001|NOT COMPLETED|Third Follow up||7
11337451|NCT02894502|12535269|FG002|NOT COMPLETED|Third Follow up||3
11337452|NCT02894840|12535284|FG000|STARTED|Overall Study||20
11337453|NCT02894840|12535285|FG001|STARTED|Overall Study||20
11337454|NCT02894840|12535286|FG002|STARTED|Overall Study||200
11337455|NCT02894840|12535287|FG003|STARTED|Overall Study||100
11337456|NCT02894840|12535284|FG000|COMPLETED|Overall Study||19
11337457|NCT02894840|12535285|FG001|COMPLETED|Overall Study||20
11337458|NCT02894840|12535286|FG002|COMPLETED|Overall Study||197
11337459|NCT02894840|12535287|FG003|COMPLETED|Overall Study||100
11337460|NCT02894840|12535284|FG000|NOT COMPLETED|Overall Study||1
11337461|NCT02894840|12535285|FG001|NOT COMPLETED|Overall Study||0
11337462|NCT02894840|12535286|FG002|NOT COMPLETED|Overall Study||3
11337463|NCT02894840|12535287|FG003|NOT COMPLETED|Overall Study||0
11337464|NCT02895035|12535302|FG000|STARTED|Overall Study||23
11049514|NCT00957684|12230174|FG004|COMPLETED|PART II||239
11049515|NCT00957684|12230170|FG000|NOT COMPLETED|PART II||0
11049516|NCT00957684|12230171|FG001|NOT COMPLETED|PART II||0
11337465|NCT02895035|12535303|FG001|STARTED|Overall Study||36
11337466|NCT02895035|12535302|FG000|COMPLETED|Overall Study||18
11337467|NCT02895035|12535303|FG001|COMPLETED|Overall Study||24
11337468|NCT02895035|12535302|FG000|NOT COMPLETED|Overall Study||5
11049517|NCT00957684|12230172|FG002|NOT COMPLETED|PART II||0
11049518|NCT00957684|12230173|FG003|NOT COMPLETED|PART II||0
11049519|NCT00957684|12230174|FG004|NOT COMPLETED|PART II||75
11049520|NCT00957723|12230184|FG000|STARTED|Overall Study||411
11049521|NCT00957723|12230184|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
11049522|NCT00957723|12230184|FG000|NOT COMPLETED|Overall Study||113
11049523|NCT00957801|12230194|FG000|STARTED|Overall Study||7
11049524|NCT00957801|12230195|FG001|STARTED|Overall Study||7
11049525|NCT00957801|12230196|FG002|STARTED|Overall Study||7
11049526|NCT00957801|12230197|FG003|STARTED|Overall Study||8
11049527|NCT00957801|12230194|FG000|COMPLETED|Overall Study||7
11049528|NCT00957801|12230195|FG001|COMPLETED|Overall Study||7
11049529|NCT00957801|12230196|FG002|COMPLETED|Overall Study||7
11049530|NCT00957801|12230197|FG003|COMPLETED|Overall Study||7
11049531|NCT00957801|12230194|FG000|NOT COMPLETED|Overall Study||0
11049532|NCT00957801|12230195|FG001|NOT COMPLETED|Overall Study||0
11049533|NCT00957801|12230196|FG002|NOT COMPLETED|Overall Study||0
11049534|NCT00957801|12230197|FG003|NOT COMPLETED|Overall Study||1
11049535|NCT00957853|12230210|FG000|STARTED|Overall Study||4
11049536|NCT00957853|12230211|FG001|STARTED|Overall Study||6
11049537|NCT00957853|12230212|FG002|STARTED|Overall Study||5
11049538|NCT00957853|12230210|FG000|Randomization|Overall Study||4
11049539|NCT00957853|12230211|FG001|Randomization|Overall Study||6
11049540|NCT00957853|12230212|FG002|Randomization|Overall Study||5
11049541|NCT00957853|12230210|FG000|Neoadjuvant Tx Completion|Overall Study||3
11049542|NCT00957853|12230211|FG001|Neoadjuvant Tx Completion|Overall Study||6
11049543|NCT00957853|12230212|FG002|Neoadjuvant Tx Completion|Overall Study||5
11049544|NCT00957853|12230210|FG000|COMPLETED|Overall Study||3
11049545|NCT00957853|12230211|FG001|COMPLETED|Overall Study||6
11049546|NCT00957853|12230212|FG002|COMPLETED|Overall Study||5
11049547|NCT00957853|12230210|FG000|NOT COMPLETED|Overall Study||1
11049548|NCT00957853|12230211|FG001|NOT COMPLETED|Overall Study||0
11049549|NCT00957853|12230212|FG002|NOT COMPLETED|Overall Study||0
11049550|NCT00957905|12230222|FG000|STARTED|Part A||7
11049551|NCT00957905|12230223|FG001|STARTED|Part A||0
11049552|NCT00957905|12230222|FG000|COMPLETED|Part A||7
11049553|NCT00957905|12230223|FG001|COMPLETED|Part A||0
11049554|NCT00957905|12230222|FG000|NOT COMPLETED|Part A||0
11337469|NCT02895035|12535303|FG001|NOT COMPLETED|Overall Study||12
11049555|NCT00957905|12230223|FG001|NOT COMPLETED|Part A||0
11049556|NCT00957905|12230222|FG000|STARTED|Part B||0
11049557|NCT00957905|12230223|FG001|STARTED|Part B||29
11049558|NCT00957905|12230222|FG000|COMPLETED|Part B||0
11049559|NCT00957905|12230223|FG001|COMPLETED|Part B||25
11049560|NCT00957905|12230222|FG000|NOT COMPLETED|Part B||0
11049561|NCT00957905|12230223|FG001|NOT COMPLETED|Part B||4
11049562|NCT00957931|12230229|FG000|STARTED|Overall Study||6
11049563|NCT00957931|12230229|FG000|COMPLETED|Overall Study||2
11049564|NCT00957931|12230229|FG000|NOT COMPLETED|Overall Study||4
11049565|NCT00957944|12230235|FG000|STARTED|First Intervention- 24 Hours||20
11049566|NCT00957944|12230236|FG001|STARTED|First Intervention- 24 Hours||20
11049567|NCT00957944|12230235|FG000|COMPLETED|First Intervention- 24 Hours||20
11049568|NCT00957944|12230236|FG001|COMPLETED|First Intervention- 24 Hours||19
11049569|NCT00957944|12230235|FG000|NOT COMPLETED|First Intervention- 24 Hours||0
11049570|NCT00957944|12230236|FG001|NOT COMPLETED|First Intervention- 24 Hours||1
11049571|NCT00957944|12230235|FG000|STARTED|Washout Period of at Least 5 Days||20
11049572|NCT00957944|12230236|FG001|STARTED|Washout Period of at Least 5 Days||19
11049573|NCT00957944|12230235|FG000|COMPLETED|Washout Period of at Least 5 Days||20
11049574|NCT00957944|12230236|FG001|COMPLETED|Washout Period of at Least 5 Days||19
11049575|NCT00957944|12230235|FG000|NOT COMPLETED|Washout Period of at Least 5 Days||0
11049576|NCT00957944|12230236|FG001|NOT COMPLETED|Washout Period of at Least 5 Days||0
11049577|NCT00957944|12230235|FG000|STARTED|Second Intervention- 24 Hours||20
11049578|NCT00957944|12230236|FG001|STARTED|Second Intervention- 24 Hours||19
11049579|NCT00957944|12230235|FG000|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
11049580|NCT00957944|12230236|FG001|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
11049581|NCT00957944|12230235|FG000|COMPLETED|Second Intervention- 24 Hours||20
11049582|NCT00957944|12230236|FG001|COMPLETED|Second Intervention- 24 Hours||19
11049583|NCT00957944|12230235|FG000|NOT COMPLETED|Second Intervention- 24 Hours||0
11049584|NCT00957944|12230236|FG001|NOT COMPLETED|Second Intervention- 24 Hours||0
11049585|NCT00957996|12230244|FG000|STARTED|Overall Study||117
11049586|NCT00957996|12230245|FG001|STARTED|Overall Study||117
11049587|NCT00957996|12230244|FG000|COMPLETED|Overall Study||91
11049588|NCT00957996|12230245|FG001|COMPLETED|Overall Study||89
11049589|NCT00957996|12230244|FG000|NOT COMPLETED|Overall Study||26
11049590|NCT00957996|12230245|FG001|NOT COMPLETED|Overall Study||28
11049591|NCT00958009|12230253|FG000|STARTED|Overall Study||109
11049592|NCT00958009|12230253|FG000|COMPLETED|Overall Study||107
11049593|NCT00958009|12230253|FG000|NOT COMPLETED|Overall Study||2
11049594|NCT00958035|12230259|FG000|STARTED|Overall Study||46
11049595|NCT00958035|12230260|FG001|STARTED|Overall Study||43
11049596|NCT00958035|12230259|FG000|COMPLETED|Overall Study||43
11049597|NCT00958035|12230260|FG001|COMPLETED|Overall Study||39
11049598|NCT00958035|12230259|FG000|NOT COMPLETED|Overall Study||3
11049599|NCT00958035|12230260|FG001|NOT COMPLETED|Overall Study||4
11049600|NCT00958074|12230268|FG000|STARTED|Overall Study||4
11049601|NCT00958074|12230269|FG001|STARTED|Overall Study||7
11049602|NCT00958074|12230268|FG000|COMPLETED|Overall Study||4
11049603|NCT00958074|12230269|FG001|COMPLETED|Overall Study||6
11049604|NCT00958074|12230268|FG000|NOT COMPLETED|Overall Study||0
11049605|NCT00958074|12230269|FG001|NOT COMPLETED|Overall Study||1
11049606|NCT00958126|12230283|FG000|STARTED|Overall Study||49
11049607|NCT00958126|12230284|FG001|STARTED|Overall Study||205
11049608|NCT00958126|12230285|FG002|STARTED|Overall Study||201
11049609|NCT00958126|12230286|FG003|STARTED|Overall Study||203
11049610|NCT00958126|12230287|FG004|STARTED|Overall Study||50
11049611|NCT00958126|12230288|FG005|STARTED|Overall Study||203
11049612|NCT00958126|12230289|FG006|STARTED|Overall Study||200
11049613|NCT00958126|12230290|FG007|STARTED|Overall Study||202
11049614|NCT00958126|12230283|FG000|COMPLETED|Overall Study||48
11049615|NCT00958126|12230284|FG001|COMPLETED|Overall Study||196
11049616|NCT00958126|12230285|FG002|COMPLETED|Overall Study||191
11049617|NCT00958126|12230286|FG003|COMPLETED|Overall Study||192
11049618|NCT00958126|12230287|FG004|COMPLETED|Overall Study||50
11049619|NCT00958126|12230288|FG005|COMPLETED|Overall Study||202
11049620|NCT00958126|12230289|FG006|COMPLETED|Overall Study||199
11049621|NCT00958126|12230290|FG007|COMPLETED|Overall Study||202
11049622|NCT00958126|12230283|FG000|NOT COMPLETED|Overall Study||1
11049623|NCT00958126|12230284|FG001|NOT COMPLETED|Overall Study||9
11049624|NCT00958126|12230285|FG002|NOT COMPLETED|Overall Study||10
11049625|NCT00958126|12230286|FG003|NOT COMPLETED|Overall Study||11
11049626|NCT00958126|12230287|FG004|NOT COMPLETED|Overall Study||0
11049627|NCT00958126|12230288|FG005|NOT COMPLETED|Overall Study||1
11049628|NCT00958126|12230289|FG006|NOT COMPLETED|Overall Study||1
11049629|NCT00958126|12230290|FG007|NOT COMPLETED|Overall Study||0
11049630|NCT00958165|12230312|FG000|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
11049631|NCT00958165|12230312|FG000|Treated|Overall Study||72
11049632|NCT00958165|12230312|FG000|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
11049633|NCT00958165|12230312|FG000|NOT COMPLETED|Overall Study||14
11049634|NCT00958191|12230316|FG000|STARTED|Overall Study||221
11049635|NCT00958191|12230316|FG000|COMPLETED|Overall Study||110
11049636|NCT00958191|12230316|FG000|NOT COMPLETED|Overall Study||111
11049637|NCT00958217|12230324|FG000|STARTED|Overall Study||61
11049638|NCT00958217|12230325|FG001|STARTED|Overall Study||62
11049639|NCT00958217|12230324|FG000|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
11058142|NCT01001572|12239953|FG002|STARTED|Double-Blind Treatment Phase||325
11049640|NCT00958217|12230325|FG001|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
11049641|NCT00958217|12230324|FG000|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
11049642|NCT00958217|12230325|FG001|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
11049643|NCT00958217|12230324|FG000|NOT COMPLETED|Overall Study||24
11049644|NCT00958217|12230325|FG001|NOT COMPLETED|Overall Study||25
11049645|NCT00958243|12230338|FG000|STARTED|Overall Study||26
11049646|NCT00958243|12230339|FG001|STARTED|Overall Study||105
11049647|NCT00958243|12230340|FG002|STARTED|Overall Study||96
11049648|NCT00958243|12230341|FG003|STARTED|Overall Study||28
11049649|NCT00958243|12230342|FG004|STARTED|Overall Study||109
11049650|NCT00958243|12230343|FG005|STARTED|Overall Study||109
11049651|NCT00958243|12230338|FG000|COMPLETED|Overall Study||24
11049652|NCT00958243|12230339|FG001|COMPLETED|Overall Study||99
11049653|NCT00958243|12230340|FG002|COMPLETED|Overall Study||82
11049654|NCT00958243|12230341|FG003|COMPLETED|Overall Study||25
11049655|NCT00958243|12230342|FG004|COMPLETED|Overall Study||100
11049656|NCT00958243|12230343|FG005|COMPLETED|Overall Study||99
11049657|NCT00958243|12230338|FG000|NOT COMPLETED|Overall Study||2
11049658|NCT00958243|12230339|FG001|NOT COMPLETED|Overall Study||6
11049659|NCT00958243|12230340|FG002|NOT COMPLETED|Overall Study||14
11049660|NCT00958243|12230341|FG003|NOT COMPLETED|Overall Study||3
11049661|NCT00958243|12230342|FG004|NOT COMPLETED|Overall Study||9
11049662|NCT00958243|12230343|FG005|NOT COMPLETED|Overall Study||10
11049663|NCT00958256|12230363|FG000|STARTED|Overall Study||21
11049664|NCT00958256|12230363|FG000|COMPLETED|Overall Study||18
11049665|NCT00958256|12230363|FG000|NOT COMPLETED|Overall Study||3
11049666|NCT00958282|12230369|FG000|STARTED|Overall Study||22
11049667|NCT00958282|12230370|FG001|STARTED|Overall Study||21
11049668|NCT00958282|12230369|FG000|COMPLETED|Overall Study||12
11049669|NCT00958282|12230370|FG001|COMPLETED|Overall Study||15
11049670|NCT00958282|12230369|FG000|NOT COMPLETED|Overall Study||10
11049671|NCT00958282|12230370|FG001|NOT COMPLETED|Overall Study||6
11049672|NCT00958308|12230379|FG000|STARTED|Overall Study||84
11049673|NCT00958308|12230380|FG001|STARTED|Overall Study||85
11049674|NCT00958308|12230381|FG002|STARTED|Overall Study||86
11049675|NCT00958308|12230379|FG000|COMPLETED|Overall Study||84
11049676|NCT00958308|12230380|FG001|COMPLETED|Overall Study||85
11049677|NCT00958308|12230381|FG002|COMPLETED|Overall Study||86
11049678|NCT00958308|12230379|FG000|NOT COMPLETED|Overall Study||0
11049679|NCT00958308|12230380|FG001|NOT COMPLETED|Overall Study||0
11049680|NCT00958308|12230381|FG002|NOT COMPLETED|Overall Study||0
11049681|NCT00958334|12230392|FG000|STARTED|Overall Study||22
11049682|NCT00958334|12230393|FG001|STARTED|Overall Study||22
11049683|NCT00958334|12230394|FG002|STARTED|Overall Study||21
11049684|NCT00958334|12230392|FG000|COMPLETED|Overall Study||8
11049685|NCT00958334|12230393|FG001|COMPLETED|Overall Study||5
11049686|NCT00958334|12230394|FG002|COMPLETED|Overall Study||8
11049687|NCT00958334|12230392|FG000|NOT COMPLETED|Overall Study||14
11049688|NCT00958334|12230393|FG001|NOT COMPLETED|Overall Study||17
11049689|NCT00958334|12230394|FG002|NOT COMPLETED|Overall Study||13
11049690|NCT00958360|12230404|FG000|STARTED|Overall Study||163
11049691|NCT00958360|12230405|FG001|STARTED|Overall Study||160
11049692|NCT00958360|12230404|FG000|COMPLETED|Overall Study||152
11049693|NCT00958360|12230405|FG001|COMPLETED|Overall Study||150
11049694|NCT00958360|12230404|FG000|NOT COMPLETED|Overall Study||11
11049695|NCT00958360|12230405|FG001|NOT COMPLETED|Overall Study||10
11049696|NCT00958412|12230411|FG000|STARTED|Overall Study||18
11049697|NCT00958412|12230411|FG000|COMPLETED|Overall Study||0
11049698|NCT00958412|12230411|FG000|NOT COMPLETED|Overall Study||18
11049699|NCT00958438|12230418|FG000|STARTED|Overall Study||82
11049700|NCT00958438|12230419|FG001|STARTED|Overall Study||82
11049701|NCT00958438|12230420|FG002|STARTED|Overall Study||84
11049702|NCT00958438|12230418|FG000|COMPLETED|Overall Study||72
11049703|NCT00958438|12230419|FG001|COMPLETED|Overall Study||72
11049704|NCT00958438|12230420|FG002|COMPLETED|Overall Study||78
11049705|NCT00958438|12230418|FG000|NOT COMPLETED|Overall Study||10
11049706|NCT00958438|12230419|FG001|NOT COMPLETED|Overall Study||10
11049707|NCT00958438|12230420|FG002|NOT COMPLETED|Overall Study||6
11049708|NCT00958477|12230432|FG000|STARTED|Overall Study||8
11049709|NCT00958477|12230433|FG001|STARTED|Overall Study||6
11049710|NCT00958477|12230434|FG002|STARTED|Overall Study||6
11049711|NCT00958477|12230435|FG003|STARTED|Overall Study||6
11049712|NCT00958477|12230432|FG000|COMPLETED|Overall Study||8
11049713|NCT00958477|12230433|FG001|COMPLETED|Overall Study||6
11049714|NCT00958477|12230434|FG002|COMPLETED|Overall Study||6
11049715|NCT00958477|12230435|FG003|COMPLETED|Overall Study||6
11049716|NCT00958477|12230432|FG000|NOT COMPLETED|Overall Study||0
11049717|NCT00958477|12230433|FG001|NOT COMPLETED|Overall Study||0
11049718|NCT00958477|12230434|FG002|NOT COMPLETED|Overall Study||0
11049719|NCT00958477|12230435|FG003|NOT COMPLETED|Overall Study||0
11049720|NCT00958568|12230451|FG000|STARTED|SPII (Wk 0-8, Acute Open-label)||892
11049721|NCT00958568|12230452|FG001|STARTED|SPII (Wk 0-8, Acute Open-label)||0
11049722|NCT00958568|12230453|FG002|STARTED|SPII (Wk 0-8, Acute Open-label)||0
11049723|NCT00958568|12230454|FG003|STARTED|SPII (Wk 0-8, Acute Open-label)||0
11049724|NCT00958568|12230451|FG000|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
11049725|NCT00958568|12230452|FG001|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
11049726|NCT00958568|12230453|FG002|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
11049727|NCT00958568|12230454|FG003|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
11049728|NCT00958568|12230451|FG000|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
11049729|NCT00958568|12230452|FG001|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
11049730|NCT00958568|12230453|FG002|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
11049731|NCT00958568|12230454|FG003|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
11049732|NCT00958568|12230451|FG000|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
11049733|NCT00958568|12230452|FG001|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
11049734|NCT00958568|12230453|FG002|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
11049735|NCT00958568|12230454|FG003|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
11049736|NCT00958568|12230451|FG000|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
11049737|NCT00958568|12230452|FG001|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
11049738|NCT00958568|12230453|FG002|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
11049739|NCT00958568|12230454|FG003|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
11049740|NCT00958568|12230451|FG000|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
11049741|NCT00958568|12230452|FG001|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
11049742|NCT00958568|12230453|FG002|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
11049743|NCT00958568|12230454|FG003|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
11049744|NCT00958568|12230451|FG000|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
11049745|NCT00958568|12230452|FG001|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
11049746|NCT00958568|12230453|FG002|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
11049747|NCT00958568|12230454|FG003|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
11049748|NCT00958568|12230451|FG000|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
11049749|NCT00958568|12230452|FG001|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
11049750|NCT00958568|12230453|FG002|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
11049751|NCT00958568|12230454|FG003|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
11049752|NCT00958568|12230451|FG000|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
11049753|NCT00958568|12230452|FG001|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
11049754|NCT00958568|12230453|FG002|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
11049755|NCT00958568|12230454|FG003|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
11049756|NCT00958581|12230468|FG000|STARTED|Overall Study||61
11049757|NCT00958581|12230469|FG001|STARTED|Overall Study||61
11049758|NCT00958581|12230470|FG002|STARTED|Overall Study||55
11049759|NCT00958581|12230468|FG000|COMPLETED|Overall Study||61
11049760|NCT00958581|12230469|FG001|COMPLETED|Overall Study||61
11049761|NCT00958581|12230470|FG002|COMPLETED|Overall Study||55
11049762|NCT00958581|12230468|FG000|NOT COMPLETED|Overall Study||0
11049763|NCT00958581|12230469|FG001|NOT COMPLETED|Overall Study||0
11049764|NCT00958581|12230470|FG002|NOT COMPLETED|Overall Study||0
11049765|NCT00958711|12230483|FG000|STARTED|Overall Study||42
11049766|NCT00958711|12230484|FG001|STARTED|Overall Study||48
11049767|NCT00958711|12230483|FG000|COMPLETED|Overall Study||29
11049768|NCT00958711|12230484|FG001|COMPLETED|Overall Study||27
11049769|NCT00958711|12230483|FG000|NOT COMPLETED|Overall Study||13
11049770|NCT00958711|12230484|FG001|NOT COMPLETED|Overall Study||21
11049771|NCT00958724|12230490|FG000|STARTED|Overall Study||6
11049772|NCT00958724|12230490|FG000|COMPLETED|Overall Study||0
11049773|NCT00958724|12230490|FG000|NOT COMPLETED|Overall Study||6
11049774|NCT00958776|12230496|FG000|STARTED|Overall Study||137
11049775|NCT00958776|12230497|FG001|STARTED|Overall Study||268
11049776|NCT00958776|12230496|FG000|COMPLETED|Overall Study||121
11049777|NCT00958776|12230497|FG001|COMPLETED|Overall Study||239
11049778|NCT00958776|12230496|FG000|NOT COMPLETED|Overall Study||16
11049779|NCT00958776|12230497|FG001|NOT COMPLETED|Overall Study||29
11049780|NCT00958789|12230504|FG000|STARTED|Overall Study||180
11049781|NCT00958789|12230504|FG000|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
11049782|NCT00958789|12230504|FG000|NOT COMPLETED|Overall Study||50
11049783|NCT00958828|12230513|FG000|STARTED|Period 1, 1 Week of Wear||89
11049784|NCT00958828|12230514|FG001|STARTED|Period 1, 1 Week of Wear||89
11049785|NCT00958828|12230513|FG000|COMPLETED|Period 1, 1 Week of Wear||89
11049786|NCT00958828|12230514|FG001|COMPLETED|Period 1, 1 Week of Wear||88
11049787|NCT00958828|12230513|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0
11049788|NCT00958828|12230514|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||1
11049789|NCT00958828|12230513|FG000|STARTED|Period 2, 1 Week of Wear||89
11049790|NCT00958828|12230514|FG001|STARTED|Period 2, 1 Week of Wear||88
11049791|NCT00958828|12230513|FG000|COMPLETED|Period 2, 1 Week of Wear||89
11049792|NCT00958828|12230514|FG001|COMPLETED|Period 2, 1 Week of Wear||87
11049793|NCT00958828|12230513|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||0
11049794|NCT00958828|12230514|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1
11049795|NCT00958841|12230520|FG000|STARTED|Overall Study||118
11049796|NCT00958841|12230520|FG000|Completed Month 6 (M6)|Overall Study||90
11049797|NCT00958841|12230520|FG000|Entered in Extension|Overall Study||63
11049798|NCT00958841|12230520|FG000|COMPLETED|Overall Study|Completed = Completed extension|22
11049799|NCT00958841|12230520|FG000|NOT COMPLETED|Overall Study||96
11049800|NCT00958880|12230536|FG000|STARTED|Overall Study||20
11049801|NCT00958880|12230537|FG001|STARTED|Overall Study||20
11049802|NCT00958880|12230536|FG000|COMPLETED|Overall Study||18
11049803|NCT00958880|12230537|FG001|COMPLETED|Overall Study||18
11049804|NCT00958880|12230536|FG000|NOT COMPLETED|Overall Study||2
11049805|NCT00958880|12230537|FG001|NOT COMPLETED|Overall Study||2
11049806|NCT00958919|12230543|FG000|STARTED|First Intervention||7
11049807|NCT00958919|12230544|FG001|STARTED|First Intervention||7
11049808|NCT00958919|12230543|FG000|COMPLETED|First Intervention||7
11049809|NCT00958919|12230544|FG001|COMPLETED|First Intervention||7
11049810|NCT00958919|12230543|FG000|NOT COMPLETED|First Intervention||0
11049811|NCT00958919|12230544|FG001|NOT COMPLETED|First Intervention||0
11049812|NCT00958919|12230543|FG000|STARTED|Second Intervention||7
11049813|NCT00958919|12230544|FG001|STARTED|Second Intervention||7
11049814|NCT00958919|12230543|FG000|COMPLETED|Second Intervention||7
11049815|NCT00958919|12230544|FG001|COMPLETED|Second Intervention||7
11049816|NCT00958919|12230543|FG000|NOT COMPLETED|Second Intervention||0
11049817|NCT00958919|12230544|FG001|NOT COMPLETED|Second Intervention||0
11049818|NCT00959049|12230563|FG000|STARTED|Overall Study||231
11049819|NCT00959049|12230564|FG001|STARTED|Overall Study||254
11049820|NCT00959049|12230565|FG002|STARTED|Overall Study||254
11049821|NCT00959049|12230566|FG003|STARTED|Overall Study||228
11049822|NCT00959049|12230567|FG004|STARTED|Overall Study||257
11049823|NCT00959049|12230568|FG005|STARTED|Overall Study||250
11049824|NCT00959049|12230563|FG000|COMPLETED|Overall Study||213
11049825|NCT00959049|12230564|FG001|COMPLETED|Overall Study||247
11049826|NCT00959049|12230565|FG002|COMPLETED|Overall Study||253
11049827|NCT00959049|12230566|FG003|COMPLETED|Overall Study||217
11049828|NCT00959049|12230567|FG004|COMPLETED|Overall Study||248
11049829|NCT00959049|12230568|FG005|COMPLETED|Overall Study||249
11049830|NCT00959049|12230563|FG000|NOT COMPLETED|Overall Study||18
11049831|NCT00959049|12230564|FG001|NOT COMPLETED|Overall Study||7
11049832|NCT00959049|12230565|FG002|NOT COMPLETED|Overall Study||1
11049833|NCT00959049|12230566|FG003|NOT COMPLETED|Overall Study||11
11049834|NCT00959049|12230567|FG004|NOT COMPLETED|Overall Study||9
11049835|NCT00959049|12230568|FG005|NOT COMPLETED|Overall Study||1
11049836|NCT00959166|12230595|FG000|STARTED|Overall Study||24
11049837|NCT00959166|12230596|FG001|STARTED|Overall Study||57
11049838|NCT00959166|12230595|FG000|COMPLETED|Overall Study||24
11049839|NCT00959166|12230596|FG001|COMPLETED|Overall Study||57
11049840|NCT00959166|12230595|FG000|NOT COMPLETED|Overall Study||0
11049841|NCT00959166|12230596|FG001|NOT COMPLETED|Overall Study||0
11049842|NCT00959192|12230606|FG000|STARTED|Overall Study||6
11049843|NCT00959192|12230607|FG001|STARTED|Overall Study||9
11049844|NCT00959192|12230608|FG002|STARTED|Overall Study||9
11049845|NCT00959192|12230609|FG003|STARTED|Overall Study||8
11049846|NCT00959192|12230606|FG000|COMPLETED|Overall Study||4
11049847|NCT00959192|12230607|FG001|COMPLETED|Overall Study||8
11049848|NCT00959192|12230608|FG002|COMPLETED|Overall Study||6
11049849|NCT00959192|12230609|FG003|COMPLETED|Overall Study||7
11049850|NCT00959192|12230606|FG000|NOT COMPLETED|Overall Study||2
11049851|NCT00959192|12230607|FG001|NOT COMPLETED|Overall Study||1
11049852|NCT00959192|12230608|FG002|NOT COMPLETED|Overall Study||3
11049853|NCT00959192|12230609|FG003|NOT COMPLETED|Overall Study||1
11049854|NCT00959374|12230620|FG000|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
11049855|NCT00959374|12230620|FG000|COMPLETED|Overall Study||218
11049856|NCT00959374|12230620|FG000|NOT COMPLETED|Overall Study||23
11049857|NCT00959647|12230628|FG000|STARTED|Overall Study||19
11049858|NCT00959647|12230628|FG000|COMPLETED|Overall Study||0
11049859|NCT00959647|12230628|FG000|NOT COMPLETED|Overall Study||19
11049860|NCT00959660|12230636|FG000|STARTED|Overall Study||26
11049861|NCT00959660|12230637|FG001|STARTED|Overall Study||24
11049862|NCT00959660|12230638|FG002|STARTED|Overall Study||25
11049863|NCT00959660|12230639|FG003|STARTED|Overall Study||25
11049864|NCT00959660|12230636|FG000|COMPLETED|Overall Study||24
11049865|NCT00959660|12230637|FG001|COMPLETED|Overall Study||24
11049866|NCT00959660|12230638|FG002|COMPLETED|Overall Study||22
11049867|NCT00959660|12230639|FG003|COMPLETED|Overall Study||22
11049868|NCT00959660|12230636|FG000|NOT COMPLETED|Overall Study||2
11049869|NCT00959660|12230637|FG001|NOT COMPLETED|Overall Study||0
11049870|NCT00959660|12230638|FG002|NOT COMPLETED|Overall Study||3
11049871|NCT00959660|12230639|FG003|NOT COMPLETED|Overall Study||3
11049872|NCT00959699|12230651|FG000|STARTED|Treatment Period||34
11337470|NCT02895100|12535313|FG000|STARTED|Overall Study||25
11337471|NCT02895100|12535314|FG001|STARTED|Overall Study||25
11337472|NCT02895100|12535315|FG002|STARTED|Overall Study||23
11337473|NCT02895100|12535316|FG003|STARTED|Overall Study||25
11337474|NCT02895100|12535313|FG000|COMPLETED|Overall Study||14
11337475|NCT02895100|12535314|FG001|COMPLETED|Overall Study||14
11337476|NCT02895100|12535315|FG002|COMPLETED|Overall Study||15
11337477|NCT02895100|12535316|FG003|COMPLETED|Overall Study||15
11337478|NCT02895100|12535313|FG000|NOT COMPLETED|Overall Study||11
11337479|NCT02895100|12535314|FG001|NOT COMPLETED|Overall Study||11
11337480|NCT02895100|12535315|FG002|NOT COMPLETED|Overall Study||8
11337481|NCT02895100|12535316|FG003|NOT COMPLETED|Overall Study||10
11337482|NCT02895295|12535329|FG000|STARTED|Overall Study||384
11337483|NCT02895295|12535330|FG001|STARTED|Overall Study||410
11337484|NCT02895295|12535331|FG002|STARTED|Overall Study||391
11337485|NCT02895295|12535329|FG000|COMPLETED|Overall Study||313
11337486|NCT02895295|12535330|FG001|COMPLETED|Overall Study||316
11337487|NCT02895295|12535331|FG002|COMPLETED|Overall Study||299
11337488|NCT02895295|12535329|FG000|NOT COMPLETED|Overall Study||71
11337489|NCT02895295|12535330|FG001|NOT COMPLETED|Overall Study||94
11337490|NCT02895295|12535331|FG002|NOT COMPLETED|Overall Study||92
11343884|NCT02956629|12541153|FG005|COMPLETED|Overall Study||21
11343885|NCT02956629|12541148|FG000|NOT COMPLETED|Overall Study||5
11343886|NCT02956629|12541149|FG001|NOT COMPLETED|Overall Study||6
11343887|NCT02956629|12541150|FG002|NOT COMPLETED|Overall Study||4
11343888|NCT02956629|12541151|FG003|NOT COMPLETED|Overall Study||1
11343889|NCT02956629|12541152|FG004|NOT COMPLETED|Overall Study||0
11343890|NCT02956629|12541153|FG005|NOT COMPLETED|Overall Study||1
11343891|NCT02956746|12541171|FG000|STARTED|Overall Study||40
11343892|NCT02956746|12541172|FG001|STARTED|Overall Study||40
11343893|NCT02956746|12541173|FG002|STARTED|Overall Study||42
11343894|NCT02956746|12541174|FG003|STARTED|Overall Study||42
11343895|NCT02956746|12541171|FG000|COMPLETED|Overall Study||38
11343896|NCT02956746|12541172|FG001|COMPLETED|Overall Study||37
11343897|NCT02956746|12541173|FG002|COMPLETED|Overall Study||36
11343898|NCT02956746|12541174|FG003|COMPLETED|Overall Study||38
11343899|NCT02956746|12541171|FG000|NOT COMPLETED|Overall Study||2
11343900|NCT02956746|12541172|FG001|NOT COMPLETED|Overall Study||3
11343901|NCT02956746|12541173|FG002|NOT COMPLETED|Overall Study||6
11343902|NCT02956746|12541174|FG003|NOT COMPLETED|Overall Study||4
11343903|NCT02956837|12541189|FG000|STARTED|Overall Study||100
11343904|NCT02956837|12541190|FG001|STARTED|Overall Study||99
11343905|NCT02956837|12541191|FG002|STARTED|Overall Study||99
11343906|NCT02956837|12541192|FG003|STARTED|Overall Study||102
11343907|NCT02956837|12541189|FG000|COMPLETED|Overall Study||100
11343908|NCT02956837|12541190|FG001|COMPLETED|Overall Study||96
11343909|NCT02956837|12541191|FG002|COMPLETED|Overall Study||97
11343910|NCT02956837|12541192|FG003|COMPLETED|Overall Study||99
11343911|NCT02956837|12541189|FG000|NOT COMPLETED|Overall Study||0
11049873|NCT00959699|12230652|FG001|STARTED|Treatment Period||65
11049874|NCT00959699|12230651|FG000|Treated|Treatment Period||34
11049875|NCT00959699|12230652|FG001|Treated|Treatment Period||64
11343912|NCT02956837|12541190|FG001|NOT COMPLETED|Overall Study||3
11049876|NCT00959699|12230651|FG000|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
11049877|NCT00959699|12230652|FG001|COMPLETED|Treatment Period||40
11049878|NCT00959699|12230651|FG000|NOT COMPLETED|Treatment Period||23
11049879|NCT00959699|12230652|FG001|NOT COMPLETED|Treatment Period||25
11049880|NCT00959699|12230651|FG000|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
11049881|NCT00959699|12230652|FG001|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
11049882|NCT00959699|12230651|FG000|COMPLETED|Follow-up Period||27
11049883|NCT00959699|12230652|FG001|COMPLETED|Follow-up Period||56
11049884|NCT00959699|12230651|FG000|NOT COMPLETED|Follow-up Period||6
11049885|NCT00959699|12230652|FG001|NOT COMPLETED|Follow-up Period||6
11049886|NCT00959751|12230661|FG000|STARTED|Overall Study||97
11049887|NCT00959751|12230662|FG001|STARTED|Overall Study||98
11049888|NCT00959751|12230661|FG000|COMPLETED|Overall Study||88
11049889|NCT00959751|12230662|FG001|COMPLETED|Overall Study||86
11049890|NCT00959751|12230661|FG000|NOT COMPLETED|Overall Study||9
11049891|NCT00959751|12230662|FG001|NOT COMPLETED|Overall Study||12
11049892|NCT00959764|12230671|FG000|STARTED|Overall Study||271
11049893|NCT00959764|12230672|FG001|STARTED|Overall Study||185
11049894|NCT00959764|12230673|FG002|STARTED|Overall Study||109
11049895|NCT00959764|12230671|FG000|COMPLETED|Overall Study||176
11049896|NCT00959764|12230672|FG001|COMPLETED|Overall Study||128
11049897|NCT00959764|12230673|FG002|COMPLETED|Overall Study||73
11049898|NCT00959764|12230671|FG000|NOT COMPLETED|Overall Study||95
11049899|NCT00959764|12230672|FG001|NOT COMPLETED|Overall Study||57
11049900|NCT00959764|12230673|FG002|NOT COMPLETED|Overall Study||36
11049901|NCT00959842|12230684|FG000|STARTED|Overall Study|17 were recruited and at baseline. 2 dropped out before starting the study drug. 15 finished|15
11049902|NCT00959842|12230684|FG000|COMPLETED|Overall Study||15
11049903|NCT00959842|12230684|FG000|NOT COMPLETED|Overall Study||0
11049904|NCT00959894|12230688|FG000|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
11049905|NCT00959894|12230688|FG000|COMPLETED|Overall Study||63
11049906|NCT00959894|12230688|FG000|NOT COMPLETED|Overall Study||16
11049907|NCT00959907|12230695|FG000|STARTED|Overall Study||30
11049908|NCT00959907|12230696|FG001|STARTED|Overall Study||29
11049909|NCT00959907|12230695|FG000|COMPLETED|Overall Study||27
11049910|NCT00959907|12230696|FG001|COMPLETED|Overall Study||28
11049911|NCT00959907|12230695|FG000|NOT COMPLETED|Overall Study||3
11049912|NCT00959907|12230696|FG001|NOT COMPLETED|Overall Study||1
11049913|NCT00959920|12230704|FG000|STARTED|Overall Study||72
11049914|NCT00959920|12230705|FG001|STARTED|Overall Study||67
11049915|NCT00959920|12230704|FG000|COMPLETED|Overall Study||72
11049916|NCT00959920|12230705|FG001|COMPLETED|Overall Study||66
11049917|NCT00959920|12230704|FG000|NOT COMPLETED|Overall Study||0
11049918|NCT00959920|12230705|FG001|NOT COMPLETED|Overall Study||1
11049919|NCT00959946|12230721|FG000|STARTED|Overall Study||2
11049920|NCT00959946|12230722|FG001|STARTED|Overall Study||4
11049921|NCT00959946|12230723|FG002|STARTED|Overall Study||4
11049922|NCT00959946|12230724|FG003|STARTED|Overall Study||5
11049923|NCT00959946|12230725|FG004|STARTED|Overall Study||4
11049924|NCT00959946|12230726|FG005|STARTED|Overall Study||9
11049925|NCT00959946|12230727|FG006|STARTED|Overall Study||2
11343913|NCT02956837|12541191|FG002|NOT COMPLETED|Overall Study||2
11343914|NCT02956837|12541192|FG003|NOT COMPLETED|Overall Study||3
11049926|NCT00959946|12230728|FG007|STARTED|Overall Study||2
11049927|NCT00959946|12230721|FG000|COMPLETED|Overall Study||0
11049928|NCT00959946|12230722|FG001|COMPLETED|Overall Study||0
11049929|NCT00959946|12230723|FG002|COMPLETED|Overall Study||0
11049930|NCT00959946|12230724|FG003|COMPLETED|Overall Study||0
11049931|NCT00959946|12230725|FG004|COMPLETED|Overall Study||0
11049932|NCT00959946|12230726|FG005|COMPLETED|Overall Study||0
11049933|NCT00959946|12230727|FG006|COMPLETED|Overall Study||0
11049934|NCT00959946|12230728|FG007|COMPLETED|Overall Study||0
11049935|NCT00959946|12230721|FG000|NOT COMPLETED|Overall Study||2
11049936|NCT00959946|12230722|FG001|NOT COMPLETED|Overall Study||4
11049937|NCT00959946|12230723|FG002|NOT COMPLETED|Overall Study||4
11049938|NCT00959946|12230724|FG003|NOT COMPLETED|Overall Study||5
11049939|NCT00959946|12230725|FG004|NOT COMPLETED|Overall Study||4
11049940|NCT00959946|12230726|FG005|NOT COMPLETED|Overall Study||9
11049941|NCT00959946|12230727|FG006|NOT COMPLETED|Overall Study||2
11049942|NCT00959946|12230728|FG007|NOT COMPLETED|Overall Study||2
11049943|NCT00959985|12230755|FG000|STARTED|Overall Study||8
11049944|NCT00959985|12230756|FG001|STARTED|Overall Study||7
11049945|NCT00959985|12230757|FG002|STARTED|Overall Study||4
11049946|NCT00959985|12230758|FG003|STARTED|Overall Study||4
11049947|NCT00959985|12230755|FG000|COMPLETED|Overall Study||8
11049948|NCT00959985|12230756|FG001|COMPLETED|Overall Study||7
11049949|NCT00959985|12230757|FG002|COMPLETED|Overall Study||4
11049950|NCT00959985|12230758|FG003|COMPLETED|Overall Study||4
11049951|NCT00959985|12230755|FG000|NOT COMPLETED|Overall Study||0
11049952|NCT00959985|12230756|FG001|NOT COMPLETED|Overall Study||0
11049953|NCT00959985|12230757|FG002|NOT COMPLETED|Overall Study||0
11049954|NCT00959985|12230758|FG003|NOT COMPLETED|Overall Study||0
11049955|NCT00960011|12230770|FG000|STARTED|Overall Study||33
11049956|NCT00960011|12230771|FG001|STARTED|Overall Study||25
11049957|NCT00960011|12230770|FG000|COMPLETED|Overall Study||22
11049958|NCT00960011|12230771|FG001|COMPLETED|Overall Study||23
11049959|NCT00960011|12230770|FG000|NOT COMPLETED|Overall Study||11
11049960|NCT00960011|12230771|FG001|NOT COMPLETED|Overall Study||2
11049961|NCT00960063|12230814|FG000|STARTED|Overall Study||1
11049962|NCT00960063|12230815|FG001|STARTED|Overall Study||0
11049963|NCT00960063|12230816|FG002|STARTED|Overall Study||3
11049964|NCT00960063|12230814|FG000|COMPLETED|Overall Study||0
11049965|NCT00960063|12230815|FG001|COMPLETED|Overall Study||0
11049966|NCT00960063|12230816|FG002|COMPLETED|Overall Study||0
11049967|NCT00960063|12230814|FG000|NOT COMPLETED|Overall Study||1
11049968|NCT00960063|12230815|FG001|NOT COMPLETED|Overall Study||0
11049969|NCT00960063|12230816|FG002|NOT COMPLETED|Overall Study||3
11049970|NCT00960076|12230826|FG000|STARTED|Overall Study|Randomized and treated|138
11049971|NCT00960076|12230827|FG001|STARTED|Overall Study|Randomized and treated|144
11049972|NCT00960076|12230826|FG000|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
11049973|NCT00960076|12230827|FG001|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
11049974|NCT00960076|12230826|FG000|NOT COMPLETED|Overall Study||8
11049975|NCT00960076|12230827|FG001|NOT COMPLETED|Overall Study||25
11058143|NCT01001572|12239951|FG000|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
11058144|NCT01001572|12239952|FG001|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
11058145|NCT01001572|12239953|FG002|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
11058146|NCT01001572|12239951|FG000|COMPLETED|Double-Blind Treatment Phase||0
11058147|NCT01001572|12239952|FG001|COMPLETED|Double-Blind Treatment Phase||319
11058148|NCT01001572|12239953|FG002|COMPLETED|Double-Blind Treatment Phase||306
11058149|NCT01001572|12239951|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
11058150|NCT01001572|12239952|FG001|NOT COMPLETED|Double-Blind Treatment Phase||10
11058151|NCT01001572|12239953|FG002|NOT COMPLETED|Double-Blind Treatment Phase||19
11058152|NCT01001598|12239959|FG000|STARTED|Overall Study||5
11058153|NCT01001598|12239959|FG000|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3
11058154|NCT01001598|12239959|FG000|NOT COMPLETED|Overall Study||2
11058155|NCT01001702|12239963|FG000|STARTED|Overall Study||85
11058156|NCT01001702|12239963|FG000|COMPLETED|Overall Study||13
11058157|NCT01001702|12239963|FG000|NOT COMPLETED|Overall Study||72
11058158|NCT01001767|12239969|FG000|STARTED|Overall Study||18
11058159|NCT01001767|12239970|FG001|STARTED|Overall Study||17
11058160|NCT01001767|12239969|FG000|COMPLETED|Overall Study||14
11058161|NCT01001767|12239970|FG001|COMPLETED|Overall Study||17
11058162|NCT01001767|12239969|FG000|NOT COMPLETED|Overall Study||4
11058163|NCT01001767|12239970|FG001|NOT COMPLETED|Overall Study||0
11058164|NCT01001806|12239979|FG000|STARTED|Overall Study||42
11058165|NCT01001806|12239980|FG001|STARTED|Overall Study||42
11058166|NCT01001806|12239981|FG002|STARTED|Overall Study||42
11058167|NCT01001806|12239979|FG000|COMPLETED|Overall Study||42
11058168|NCT01001806|12239980|FG001|COMPLETED|Overall Study||41
11337491|NCT02895347|12535341|FG000|STARTED|Overall Study||20
11337492|NCT02895347|12535342|FG001|STARTED|Overall Study||20
11337493|NCT02895347|12535341|FG000|COMPLETED|Overall Study||17
11337494|NCT02895347|12535342|FG001|COMPLETED|Overall Study||19
11337495|NCT02895347|12535341|FG000|NOT COMPLETED|Overall Study||3
11337496|NCT02895347|12535342|FG001|NOT COMPLETED|Overall Study||1
11337497|NCT02895360|12535355|FG000|STARTED|Phase 1 - 30 mg/m² Cohort||4
11337498|NCT02895360|12535356|FG001|STARTED|Phase 1 - 30 mg/m² Cohort||0
11337499|NCT02895360|12535357|FG002|STARTED|Phase 1 - 30 mg/m² Cohort||0
11337500|NCT02895360|12535358|FG003|STARTED|Phase 1 - 30 mg/m² Cohort||0
11058169|NCT01001806|12239981|FG002|COMPLETED|Overall Study||38
11337501|NCT02895360|12535359|FG004|STARTED|Phase 1 - 30 mg/m² Cohort||0
11337502|NCT02895360|12535360|FG005|STARTED|Phase 1 - 30 mg/m² Cohort||0
11337503|NCT02895360|12535355|FG000|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
11337504|NCT02895360|12535356|FG001|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
11337505|NCT02895360|12535357|FG002|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
11337506|NCT02895360|12535358|FG003|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
11337507|NCT02895360|12535359|FG004|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
11337508|NCT02895360|12535360|FG005|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
11337509|NCT02895360|12535355|FG000|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||4
11337510|NCT02895360|12535356|FG001|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
11337511|NCT02895360|12535357|FG002|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
11337512|NCT02895360|12535358|FG003|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
11337513|NCT02895360|12535359|FG004|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
11337514|NCT02895360|12535360|FG005|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
11337515|NCT02895360|12535355|FG000|STARTED|Phase 1 - 45 mg/m² Cohort||0
11337516|NCT02895360|12535356|FG001|STARTED|Phase 1 - 45 mg/m² Cohort||3
11337517|NCT02895360|12535357|FG002|STARTED|Phase 1 - 45 mg/m² Cohort||0
11337518|NCT02895360|12535358|FG003|STARTED|Phase 1 - 45 mg/m² Cohort||0
11337519|NCT02895360|12535359|FG004|STARTED|Phase 1 - 45 mg/m² Cohort||0
11337520|NCT02895360|12535360|FG005|STARTED|Phase 1 - 45 mg/m² Cohort||0
11337521|NCT02895360|12535355|FG000|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
11049976|NCT00960115|12230835|FG000|STARTED|Overall Study||114
11049977|NCT00960115|12230836|FG001|STARTED|Overall Study||58
11049978|NCT00960115|12230835|FG000|COMPLETED|Overall Study||95
11049979|NCT00960115|12230836|FG001|COMPLETED|Overall Study||43
11049980|NCT00960115|12230835|FG000|NOT COMPLETED|Overall Study||19
11049981|NCT00960115|12230836|FG001|NOT COMPLETED|Overall Study||15
11049982|NCT00960193|12230842|FG000|STARTED|Colchicine Alone||24
11049983|NCT00960193|12230842|FG000|COMPLETED|Colchicine Alone||24
11049984|NCT00960193|12230842|FG000|NOT COMPLETED|Colchicine Alone||0
11049985|NCT00960193|12230842|FG000|STARTED|14 Day Washout Period||24
11049986|NCT00960193|12230842|FG000|COMPLETED|14 Day Washout Period||23
11049987|NCT00960193|12230842|FG000|NOT COMPLETED|14 Day Washout Period||1
11049988|NCT00960193|12230842|FG000|STARTED|Seville Orange Juice Alone||23
11049989|NCT00960193|12230842|FG000|COMPLETED|Seville Orange Juice Alone||23
11049990|NCT00960193|12230842|FG000|NOT COMPLETED|Seville Orange Juice Alone||0
11049991|NCT00960193|12230842|FG000|STARTED|Colchicine With Seville Orange Juice||23
11049992|NCT00960193|12230842|FG000|COMPLETED|Colchicine With Seville Orange Juice||23
11049993|NCT00960193|12230842|FG000|NOT COMPLETED|Colchicine With Seville Orange Juice||0
11049994|NCT00960206|12230852|FG000|STARTED|Overall Study||190
11049995|NCT00960206|12230853|FG001|STARTED|Overall Study||185
11049996|NCT00960206|12230854|FG002|STARTED|Overall Study||89
11049997|NCT00960206|12230852|FG000|COMPLETED|Overall Study||150
11049998|NCT00960206|12230853|FG001|COMPLETED|Overall Study||158
11049999|NCT00960206|12230854|FG002|COMPLETED|Overall Study||77
11050000|NCT00960206|12230852|FG000|NOT COMPLETED|Overall Study||40
11050001|NCT00960206|12230853|FG001|NOT COMPLETED|Overall Study||27
11050002|NCT00960206|12230854|FG002|NOT COMPLETED|Overall Study||12
11050003|NCT00960323|12230863|FG000|STARTED|Colchicine Alone||24
11050004|NCT00960323|12230863|FG000|COMPLETED|Colchicine Alone||24
11050005|NCT00960323|12230863|FG000|NOT COMPLETED|Colchicine Alone||0
11050006|NCT00960323|12230863|FG000|STARTED|14 Day Washout Period||24
11050007|NCT00960323|12230863|FG000|COMPLETED|14 Day Washout Period||24
11050008|NCT00960323|12230863|FG000|NOT COMPLETED|14 Day Washout Period||0
11050009|NCT00960323|12230863|FG000|STARTED|Atorvastatin Alone||24
11050010|NCT00960323|12230863|FG000|COMPLETED|Atorvastatin Alone||23
11050011|NCT00960323|12230863|FG000|NOT COMPLETED|Atorvastatin Alone||1
11050012|NCT00960323|12230863|FG000|STARTED|Colchicine and Atorvastatin||23
11050013|NCT00960323|12230863|FG000|COMPLETED|Colchicine and Atorvastatin||23
11050014|NCT00960323|12230863|FG000|NOT COMPLETED|Colchicine and Atorvastatin||0
11050015|NCT00960375|12230873|FG000|STARTED|Overall Study||92
11050016|NCT00960375|12230874|FG001|STARTED|Overall Study||87
11050017|NCT00960375|12230873|FG000|COMPLETED|Overall Study||72
11050018|NCT00960375|12230874|FG001|COMPLETED|Overall Study||65
11050019|NCT00960375|12230873|FG000|NOT COMPLETED|Overall Study||20
11050020|NCT00960375|12230874|FG001|NOT COMPLETED|Overall Study||22
11050021|NCT00960440|12230884|FG000|STARTED|Overall Study||133
11050022|NCT00960440|12230885|FG001|STARTED|Overall Study||134
11050023|NCT00960440|12230886|FG002|STARTED|Overall Study||66
11050024|NCT00960440|12230887|FG003|STARTED|Overall Study||66
11050025|NCT00960440|12230884|FG000|COMPLETED|Overall Study||107
11050026|NCT00960440|12230885|FG001|COMPLETED|Overall Study||103
11050027|NCT00960440|12230886|FG002|COMPLETED|Overall Study||53
11050028|NCT00960440|12230887|FG003|COMPLETED|Overall Study||48
11050029|NCT00960440|12230884|FG000|NOT COMPLETED|Overall Study||26
11050030|NCT00960440|12230885|FG001|NOT COMPLETED|Overall Study||31
11050031|NCT00960440|12230886|FG002|NOT COMPLETED|Overall Study||13
11201472|NCT01832753|12391787|FG001|NOT COMPLETED|Observation Phase (Months 0-6)||0
11201473|NCT01832753|12391788|FG002|NOT COMPLETED|Observation Phase (Months 0-6)||2
11201474|NCT01832753|12391786|FG000|STARTED|Randomization Phase (Months 6-12)||5
11201475|NCT01832753|12391787|FG001|STARTED|Randomization Phase (Months 6-12)||4
11201476|NCT01832753|12391788|FG002|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0
11201477|NCT01832753|12391786|FG000|COMPLETED|Randomization Phase (Months 6-12)||4
11201478|NCT01832753|12391787|FG001|COMPLETED|Randomization Phase (Months 6-12)||3
11201479|NCT01832753|12391788|FG002|COMPLETED|Randomization Phase (Months 6-12)||0
11201480|NCT01832753|12391786|FG000|NOT COMPLETED|Randomization Phase (Months 6-12)||1
11201481|NCT01832753|12391787|FG001|NOT COMPLETED|Randomization Phase (Months 6-12)||1
11201482|NCT01832753|12391788|FG002|NOT COMPLETED|Randomization Phase (Months 6-12)||0
11201483|NCT01832753|12391786|FG000|STARTED|Open Label Dose Phase (Months 12-18)||3
11201484|NCT01832753|12391787|FG001|STARTED|Open Label Dose Phase (Months 12-18)||3
11201485|NCT01832753|12391788|FG002|STARTED|Open Label Dose Phase (Months 12-18)||0
11201486|NCT01832753|12391786|FG000|COMPLETED|Open Label Dose Phase (Months 12-18)||3
11201487|NCT01832753|12391787|FG001|COMPLETED|Open Label Dose Phase (Months 12-18)||3
11201488|NCT01832753|12391788|FG002|COMPLETED|Open Label Dose Phase (Months 12-18)||0
11201489|NCT01832753|12391786|FG000|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
11201490|NCT01832753|12391787|FG001|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
11201491|NCT01832753|12391788|FG002|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
11201492|NCT01832766|12391797|FG000|STARTED|First Intervention||7
11201493|NCT01832766|12391798|FG001|STARTED|First Intervention||6
11201494|NCT01832766|12391797|FG000|COMPLETED|First Intervention||7
11201495|NCT01832766|12391798|FG001|COMPLETED|First Intervention|one participant did not return for cross over visit|6
11201496|NCT01832766|12391797|FG000|NOT COMPLETED|First Intervention||0
11201497|NCT01832766|12391798|FG001|NOT COMPLETED|First Intervention||0
11201498|NCT01832766|12391797|FG000|STARTED|Washout||7
11201499|NCT01832766|12391798|FG001|STARTED|Washout||6
11201500|NCT01832766|12391797|FG000|COMPLETED|Washout||7
11201501|NCT01832766|12391798|FG001|COMPLETED|Washout||5
11201502|NCT01832766|12391797|FG000|NOT COMPLETED|Washout||0
11201503|NCT01832766|12391798|FG001|NOT COMPLETED|Washout||1
11201504|NCT01832766|12391797|FG000|STARTED|Second Intervention||7
11201505|NCT01832766|12391798|FG001|STARTED|Second Intervention||5
11201506|NCT01832766|12391797|FG000|COMPLETED|Second Intervention||7
11201507|NCT01832766|12391798|FG001|COMPLETED|Second Intervention||5
11201508|NCT01832766|12391797|FG000|NOT COMPLETED|Second Intervention||0
11201509|NCT01832766|12391798|FG001|NOT COMPLETED|Second Intervention||0
11201510|NCT01832818|12391804|FG000|STARTED|Overall Study||14
11201511|NCT01832818|12391804|FG000|COMPLETED|Overall Study||8
11050032|NCT00960440|12230887|FG003|NOT COMPLETED|Overall Study||18
11050033|NCT00960505|12230902|FG000|STARTED|Overall Study||34
11050034|NCT00960505|12230903|FG001|STARTED|Overall Study||35
11050035|NCT00960505|12230904|FG002|STARTED|Overall Study||31
11050036|NCT00960505|12230902|FG000|COMPLETED|Overall Study||21
11050037|NCT00960505|12230903|FG001|COMPLETED|Overall Study||25
11050038|NCT00960505|12230904|FG002|COMPLETED|Overall Study||23
11050039|NCT00960505|12230902|FG000|NOT COMPLETED|Overall Study||13
11050040|NCT00960505|12230903|FG001|NOT COMPLETED|Overall Study||10
11050041|NCT00960505|12230904|FG002|NOT COMPLETED|Overall Study||8
11050042|NCT00960531|12230922|FG000|STARTED|Overall Study|Started=Randomized|21
11050043|NCT00960531|12230923|FG001|STARTED|Overall Study|Started=Randomized|6
11050044|NCT00960531|12230924|FG002|STARTED|Overall Study|Started=Randomized|41
11050045|NCT00960531|12230925|FG003|STARTED|Overall Study|Started=Randomized.|25
11050046|NCT00960531|12230926|FG004|STARTED|Overall Study|Started=Randomized|5
11050047|NCT00960531|12230927|FG005|STARTED|Overall Study|Started=Randomized|9
11050048|NCT00960531|12230928|FG006|STARTED|Overall Study|Started=Randomized|27
11050049|NCT00960531|12230929|FG007|STARTED|Overall Study|Started=Randomized|6
11050050|NCT00960531|12230930|FG008|STARTED|Overall Study|Started=Randomized|16
11050051|NCT00960531|12230931|FG009|STARTED|Overall Study|Started=Randomized|4
11050052|NCT00960531|12230922|FG000|Treated|Overall Study||21
11050053|NCT00960531|12230923|FG001|Treated|Overall Study||6
11050054|NCT00960531|12230924|FG002|Treated|Overall Study||41
11050055|NCT00960531|12230925|FG003|Treated|Overall Study||24
11050056|NCT00960531|12230926|FG004|Treated|Overall Study||5
11050057|NCT00960531|12230927|FG005|Treated|Overall Study||9
11050058|NCT00960531|12230928|FG006|Treated|Overall Study||27
11050059|NCT00960531|12230929|FG007|Treated|Overall Study||6
11050060|NCT00960531|12230930|FG008|Treated|Overall Study||16
11050061|NCT00960531|12230931|FG009|Treated|Overall Study||4
11050062|NCT00960531|12230922|FG000|Completed Treatment|Overall Study||12
11050063|NCT00960531|12230923|FG001|Completed Treatment|Overall Study||5
11050064|NCT00960531|12230924|FG002|Completed Treatment|Overall Study||15
11050065|NCT00960531|12230925|FG003|Completed Treatment|Overall Study||17
11050066|NCT00960531|12230926|FG004|Completed Treatment|Overall Study||3
11050067|NCT00960531|12230927|FG005|Completed Treatment|Overall Study||7
11050068|NCT00960531|12230928|FG006|Completed Treatment|Overall Study||4
11050069|NCT00960531|12230929|FG007|Completed Treatment|Overall Study||3
11050070|NCT00960531|12230930|FG008|Completed Treatment|Overall Study||2
11050071|NCT00960531|12230931|FG009|Completed Treatment|Overall Study||4
11050072|NCT00960531|12230922|FG000|COMPLETED|Overall Study|Completed study|11
11050073|NCT00960531|12230923|FG001|COMPLETED|Overall Study|Completed study|5
11050074|NCT00960531|12230924|FG002|COMPLETED|Overall Study|Completed study|15
11050075|NCT00960531|12230925|FG003|COMPLETED|Overall Study|Completed study|17
11050076|NCT00960531|12230926|FG004|COMPLETED|Overall Study|Completed study|3
11050077|NCT00960531|12230927|FG005|COMPLETED|Overall Study|Completed study|6
11050078|NCT00960531|12230928|FG006|COMPLETED|Overall Study|Completed study|3
11050079|NCT00960531|12230929|FG007|COMPLETED|Overall Study|Completed study|2
11050080|NCT00960531|12230930|FG008|COMPLETED|Overall Study|Completed study|2
11050081|NCT00960531|12230931|FG009|COMPLETED|Overall Study|Completed study|3
11050082|NCT00960531|12230922|FG000|NOT COMPLETED|Overall Study||10
11050083|NCT00960531|12230923|FG001|NOT COMPLETED|Overall Study||1
11050084|NCT00960531|12230924|FG002|NOT COMPLETED|Overall Study||26
11050085|NCT00960531|12230925|FG003|NOT COMPLETED|Overall Study||8
11050086|NCT00960531|12230926|FG004|NOT COMPLETED|Overall Study||2
11050087|NCT00960531|12230927|FG005|NOT COMPLETED|Overall Study||3
11050088|NCT00960531|12230928|FG006|NOT COMPLETED|Overall Study||24
11050089|NCT00960531|12230929|FG007|NOT COMPLETED|Overall Study||4
11050090|NCT00960531|12230930|FG008|NOT COMPLETED|Overall Study||14
11050091|NCT00960531|12230931|FG009|NOT COMPLETED|Overall Study||1
11050092|NCT00960570|12230957|FG000|STARTED|Efavirenz Alone||30
11050093|NCT00960570|12230957|FG000|COMPLETED|Efavirenz Alone||30
11050094|NCT00960570|12230957|FG000|NOT COMPLETED|Efavirenz Alone||0
11050095|NCT00960570|12230957|FG000|STARTED|21 Day Washout Period||30
11050096|NCT00960570|12230957|FG000|COMPLETED|21 Day Washout Period||28
11050097|NCT00960570|12230957|FG000|NOT COMPLETED|21 Day Washout Period||2
11050098|NCT00960570|12230957|FG000|STARTED|Fenofibric Acid Alone||28
11050099|NCT00960570|12230957|FG000|COMPLETED|Fenofibric Acid Alone||28
11050100|NCT00960570|12230957|FG000|NOT COMPLETED|Fenofibric Acid Alone||0
11050101|NCT00960570|12230957|FG000|STARTED|1 Day Period Between Dosing||28
11050102|NCT00960570|12230957|FG000|COMPLETED|1 Day Period Between Dosing||25
11050103|NCT00960570|12230957|FG000|NOT COMPLETED|1 Day Period Between Dosing||3
11050104|NCT00960570|12230957|FG000|STARTED|Efavirenz and Fenofibric Acid||25
11050105|NCT00960570|12230957|FG000|COMPLETED|Efavirenz and Fenofibric Acid||25
11050106|NCT00960570|12230957|FG000|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
11050107|NCT00960622|12230966|FG000|STARTED|Overall Study||10
11050108|NCT00960622|12230967|FG001|STARTED|Overall Study||10
11050109|NCT00960622|12230966|FG000|COMPLETED|Overall Study||10
11050110|NCT00960622|12230967|FG001|COMPLETED|Overall Study||7
11050111|NCT00960622|12230966|FG000|NOT COMPLETED|Overall Study||0
11050112|NCT00960622|12230967|FG001|NOT COMPLETED|Overall Study||3
11050113|NCT00960661|12230975|FG000|STARTED|Basal Insulin Optimization Phase (BIO)||1036
11050114|NCT00960661|12230976|FG001|STARTED|Basal Insulin Optimization Phase (BIO)||0
11050115|NCT00960661|12230977|FG002|STARTED|Basal Insulin Optimization Phase (BIO)||0
11050116|NCT00960661|12230975|FG000|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
11050117|NCT00960661|12230976|FG001|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
11050118|NCT00960661|12230977|FG002|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
11050119|NCT00960661|12230975|FG000|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
11050120|NCT00960661|12230976|FG001|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
11050121|NCT00960661|12230977|FG002|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
11050122|NCT00960661|12230975|FG000|STARTED|Interventional Phase||0
11050123|NCT00960661|12230976|FG001|STARTED|Interventional Phase||316
11050124|NCT00960661|12230977|FG002|STARTED|Interventional Phase||321
11050125|NCT00960661|12230975|FG000|Intent to Treat Population|Interventional Phase||0
11050126|NCT00960661|12230976|FG001|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
11050127|NCT00960661|12230977|FG002|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
11050128|NCT00960661|12230975|FG000|Per Protocol Population|Interventional Phase||0
11050129|NCT00960661|12230976|FG001|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
11050130|NCT00960661|12230977|FG002|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
11050131|NCT00960661|12230975|FG000|COMPLETED|Interventional Phase||0
11050132|NCT00960661|12230976|FG001|COMPLETED|Interventional Phase||264
11050133|NCT00960661|12230977|FG002|COMPLETED|Interventional Phase||275
11050134|NCT00960661|12230975|FG000|NOT COMPLETED|Interventional Phase||0
11050135|NCT00960661|12230976|FG001|NOT COMPLETED|Interventional Phase||52
11050136|NCT00960661|12230977|FG002|NOT COMPLETED|Interventional Phase||46
11050137|NCT00960687|12230983|FG000|STARTED|First Intervention||27
11050138|NCT00960687|12230984|FG001|STARTED|First Intervention||27
11050139|NCT00960687|12230983|FG000|COMPLETED|First Intervention||27
11050140|NCT00960687|12230984|FG001|COMPLETED|First Intervention||27
11050141|NCT00960687|12230983|FG000|NOT COMPLETED|First Intervention||0
11050142|NCT00960687|12230984|FG001|NOT COMPLETED|First Intervention||0
11050143|NCT00960687|12230983|FG000|STARTED|Washout Period of 7 Days||27
11050144|NCT00960687|12230984|FG001|STARTED|Washout Period of 7 Days||27
11050145|NCT00960687|12230983|FG000|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
11050146|NCT00960687|12230984|FG001|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
11050147|NCT00960687|12230983|FG000|NOT COMPLETED|Washout Period of 7 Days||4
11050148|NCT00960687|12230984|FG001|NOT COMPLETED|Washout Period of 7 Days||3
11050149|NCT00960687|12230983|FG000|STARTED|Second Intervention||23
11050150|NCT00960687|12230984|FG001|STARTED|Second Intervention||24
11050151|NCT00960687|12230983|FG000|COMPLETED|Second Intervention||23
11050152|NCT00960687|12230984|FG001|COMPLETED|Second Intervention||24
11050153|NCT00960687|12230983|FG000|NOT COMPLETED|Second Intervention||0
11050154|NCT00960687|12230984|FG001|NOT COMPLETED|Second Intervention||0
11050155|NCT00960778|12230992|FG000|STARTED|Overall Study||17
11050156|NCT00960778|12230993|FG001|STARTED|Overall Study||16
11050157|NCT00960778|12230992|FG000|COMPLETED|Overall Study||8
11050158|NCT00960778|12230993|FG001|COMPLETED|Overall Study||13
11050159|NCT00960778|12230992|FG000|NOT COMPLETED|Overall Study||9
11050160|NCT00960778|12230993|FG001|NOT COMPLETED|Overall Study||3
11050161|NCT00960804|12231002|FG000|STARTED|Overall Study||7
11050162|NCT00960804|12231003|FG001|STARTED|Overall Study||4
11050163|NCT00960804|12231004|FG002|STARTED|Overall Study||10
11050164|NCT00960804|12231002|FG000|COMPLETED|Overall Study||0
11050165|NCT00960804|12231003|FG001|COMPLETED|Overall Study||0
11050166|NCT00960804|12231004|FG002|COMPLETED|Overall Study||0
11050167|NCT00960804|12231002|FG000|NOT COMPLETED|Overall Study||7
11050168|NCT00960804|12231003|FG001|NOT COMPLETED|Overall Study||4
11050169|NCT00960804|12231004|FG002|NOT COMPLETED|Overall Study||10
11050170|NCT00960843|12231014|FG000|STARTED|Overall Study||25
11050171|NCT00960843|12231015|FG001|STARTED|Overall Study||26
11050172|NCT00960843|12231014|FG000|COMPLETED|Overall Study||23
11050173|NCT00960843|12231015|FG001|COMPLETED|Overall Study||21
11050174|NCT00960843|12231014|FG000|NOT COMPLETED|Overall Study||2
11050175|NCT00960843|12231015|FG001|NOT COMPLETED|Overall Study||5
11050176|NCT00960856|12231021|FG000|STARTED|Period I||10
11050177|NCT00960856|12231022|FG001|STARTED|Period I||9
11050178|NCT00960856|12231023|FG002|STARTED|Period I||9
11050179|NCT00960856|12231024|FG003|STARTED|Period I||9
11050180|NCT00960856|12231021|FG000|COMPLETED|Period I||10
11050181|NCT00960856|12231022|FG001|COMPLETED|Period I||9
11050182|NCT00960856|12231023|FG002|COMPLETED|Period I||9
11050183|NCT00960856|12231024|FG003|COMPLETED|Period I||9
11050184|NCT00960856|12231021|FG000|NOT COMPLETED|Period I||0
11050185|NCT00960856|12231022|FG001|NOT COMPLETED|Period I||0
11050186|NCT00960856|12231023|FG002|NOT COMPLETED|Period I||0
11050187|NCT00960856|12231024|FG003|NOT COMPLETED|Period I||0
11050188|NCT00960856|12231021|FG000|STARTED|Washout Period of 7 Days||10
11050189|NCT00960856|12231022|FG001|STARTED|Washout Period of 7 Days||9
11050190|NCT00960856|12231023|FG002|STARTED|Washout Period of 7 Days||9
11050191|NCT00960856|12231024|FG003|STARTED|Washout Period of 7 Days||9
11050192|NCT00960856|12231021|FG000|COMPLETED|Washout Period of 7 Days||10
11050193|NCT00960856|12231022|FG001|COMPLETED|Washout Period of 7 Days|personal reasons|7
11050194|NCT00960856|12231023|FG002|COMPLETED|Washout Period of 7 Days||9
11050195|NCT00960856|12231024|FG003|COMPLETED|Washout Period of 7 Days||9
11050196|NCT00960856|12231021|FG000|NOT COMPLETED|Washout Period of 7 Days||0
11050197|NCT00960856|12231022|FG001|NOT COMPLETED|Washout Period of 7 Days||2
11050198|NCT00960856|12231023|FG002|NOT COMPLETED|Washout Period of 7 Days||0
11050199|NCT00960856|12231024|FG003|NOT COMPLETED|Washout Period of 7 Days||0
11050200|NCT00960856|12231021|FG000|STARTED|Period II||10
11050201|NCT00960856|12231022|FG001|STARTED|Period II||7
11050202|NCT00960856|12231023|FG002|STARTED|Period II||9
11337522|NCT02895360|12535356|FG001|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
11337523|NCT02895360|12535357|FG002|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
11337524|NCT02895360|12535358|FG003|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
11337525|NCT02895360|12535359|FG004|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
11337526|NCT02895360|12535360|FG005|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
11337527|NCT02895360|12535355|FG000|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
11337528|NCT02895360|12535356|FG001|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||3
11337529|NCT02895360|12535357|FG002|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
11337530|NCT02895360|12535358|FG003|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
11337531|NCT02895360|12535359|FG004|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
11337532|NCT02895360|12535360|FG005|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
11337533|NCT02895360|12535355|FG000|STARTED|Phase 1 - 70 mg/m² Cohort||0
11337534|NCT02895360|12535356|FG001|STARTED|Phase 1 - 70 mg/m² Cohort||0
11337535|NCT02895360|12535357|FG002|STARTED|Phase 1 - 70 mg/m² Cohort||9
11337536|NCT02895360|12535358|FG003|STARTED|Phase 1 - 70 mg/m² Cohort||0
11337537|NCT02895360|12535359|FG004|STARTED|Phase 1 - 70 mg/m² Cohort||0
11337538|NCT02895360|12535360|FG005|STARTED|Phase 1 - 70 mg/m² Cohort||0
11337539|NCT02895360|12535355|FG000|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
11337540|NCT02895360|12535356|FG001|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
11337541|NCT02895360|12535357|FG002|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
11337542|NCT02895360|12535358|FG003|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
11337543|NCT02895360|12535359|FG004|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
11337544|NCT02895360|12535360|FG005|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
11337545|NCT02895360|12535355|FG000|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
11337546|NCT02895360|12535356|FG001|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
11337547|NCT02895360|12535357|FG002|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||9
11337548|NCT02895360|12535358|FG003|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
11337549|NCT02895360|12535359|FG004|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
11337550|NCT02895360|12535360|FG005|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
11337551|NCT02895360|12535355|FG000|STARTED|Phase 1 - 90 mg/m² Cohort||0
11337552|NCT02895360|12535356|FG001|STARTED|Phase 1 - 90 mg/m² Cohort||0
11337553|NCT02895360|12535357|FG002|STARTED|Phase 1 - 90 mg/m² Cohort||0
11337554|NCT02895360|12535358|FG003|STARTED|Phase 1 - 90 mg/m² Cohort||4
11337555|NCT02895360|12535359|FG004|STARTED|Phase 1 - 90 mg/m² Cohort||0
11337556|NCT02895360|12535360|FG005|STARTED|Phase 1 - 90 mg/m² Cohort||0
11337557|NCT02895360|12535355|FG000|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
11337558|NCT02895360|12535356|FG001|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
11337559|NCT02895360|12535357|FG002|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
11050203|NCT00960856|12231024|FG003|STARTED|Period II||9
11337560|NCT02895360|12535358|FG003|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
11337561|NCT02895360|12535359|FG004|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
11337562|NCT02895360|12535360|FG005|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
11337563|NCT02895360|12535355|FG000|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
11337564|NCT02895360|12535356|FG001|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
11337565|NCT02895360|12535357|FG002|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
11337566|NCT02895360|12535358|FG003|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||4
11337567|NCT02895360|12535359|FG004|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
11337568|NCT02895360|12535360|FG005|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
11337569|NCT02895360|12535355|FG000|STARTED|Phase 2a||0
11337570|NCT02895360|12535356|FG001|STARTED|Phase 2a||0
11337571|NCT02895360|12535357|FG002|STARTED|Phase 2a||0
11337572|NCT02895360|12535358|FG003|STARTED|Phase 2a||0
11337573|NCT02895360|12535359|FG004|STARTED|Phase 2a||11
11337574|NCT02895360|12535360|FG005|STARTED|Phase 2a||12
11337575|NCT02895360|12535355|FG000|COMPLETED|Phase 2a||0
11337576|NCT02895360|12535356|FG001|COMPLETED|Phase 2a||0
11337577|NCT02895360|12535357|FG002|COMPLETED|Phase 2a||0
11337578|NCT02895360|12535358|FG003|COMPLETED|Phase 2a||0
11337579|NCT02895360|12535359|FG004|COMPLETED|Phase 2a||0
11337580|NCT02895360|12535360|FG005|COMPLETED|Phase 2a||0
11337581|NCT02895360|12535355|FG000|NOT COMPLETED|Phase 2a||0
11337582|NCT02895360|12535356|FG001|NOT COMPLETED|Phase 2a||0
11337583|NCT02895360|12535357|FG002|NOT COMPLETED|Phase 2a||0
11337584|NCT02895360|12535358|FG003|NOT COMPLETED|Phase 2a||0
11337585|NCT02895360|12535359|FG004|NOT COMPLETED|Phase 2a||11
11337586|NCT02895360|12535360|FG005|NOT COMPLETED|Phase 2a||12
11337587|NCT02895945|12535394|FG000|STARTED|Overall Study||7
11337588|NCT02895945|12535395|FG001|STARTED|Overall Study||1
11337589|NCT02895945|12535394|FG000|SAS|Overall Study||7
11337590|NCT02895945|12535395|FG001|SAS|Overall Study||1
11337591|NCT02895945|12535394|FG000|FAS|Overall Study||7
11337592|NCT02895945|12535395|FG001|FAS|Overall Study||0
11337593|NCT02895945|12535394|FG000|COMPLETED|Overall Study||5
11337594|NCT02895945|12535395|FG001|COMPLETED|Overall Study||0
11337595|NCT02895945|12535394|FG000|NOT COMPLETED|Overall Study||2
11337596|NCT02895945|12535395|FG001|NOT COMPLETED|Overall Study||1
11337597|NCT02896075|12535401|FG000|STARTED|Overall Study||40
11337598|NCT02896075|12535401|FG000|Leg Soreness|Overall Study||40
11337599|NCT02896075|12535401|FG000|COMPLETED|Overall Study||40
11337600|NCT02896075|12535401|FG000|NOT COMPLETED|Overall Study||0
11337601|NCT02896127|12535410|FG000|STARTED|COMPLETED WEEK 52||305
11050204|NCT00960856|12231021|FG000|COMPLETED|Period II||10
11050205|NCT00960856|12231022|FG001|COMPLETED|Period II||7
11050206|NCT00960856|12231023|FG002|COMPLETED|Period II||9
11050207|NCT00960856|12231024|FG003|COMPLETED|Period II||9
11050208|NCT00960856|12231021|FG000|NOT COMPLETED|Period II||0
11050209|NCT00960856|12231022|FG001|NOT COMPLETED|Period II||0
11050210|NCT00960856|12231023|FG002|NOT COMPLETED|Period II||0
11050211|NCT00960856|12231024|FG003|NOT COMPLETED|Period II||0
11050212|NCT00960856|12231021|FG000|STARTED|Washout Period of 7 Days||10
11050213|NCT00960856|12231022|FG001|STARTED|Washout Period of 7 Days||7
11050214|NCT00960856|12231023|FG002|STARTED|Washout Period of 7 Days||9
11050215|NCT00960856|12231024|FG003|STARTED|Washout Period of 7 Days||9
11050216|NCT00960856|12231021|FG000|COMPLETED|Washout Period of 7 Days||10
11050217|NCT00960856|12231022|FG001|COMPLETED|Washout Period of 7 Days||7
11050218|NCT00960856|12231023|FG002|COMPLETED|Washout Period of 7 Days||9
11050219|NCT00960856|12231024|FG003|COMPLETED|Washout Period of 7 Days||9
11050220|NCT00960856|12231021|FG000|NOT COMPLETED|Washout Period of 7 Days||0
11337602|NCT02896127|12535411|FG001|STARTED|COMPLETED WEEK 52|Includes participants originally assigned to placebo and switched to AIN457150 mg after Wk 16.|153
11337603|NCT02896127|12535410|FG000|COMPLETED|COMPLETED WEEK 52||278
11050221|NCT00960856|12231022|FG001|NOT COMPLETED|Washout Period of 7 Days||0
11050222|NCT00960856|12231023|FG002|NOT COMPLETED|Washout Period of 7 Days||0
11050223|NCT00960856|12231024|FG003|NOT COMPLETED|Washout Period of 7 Days||0
11050224|NCT00960856|12231021|FG000|STARTED|Period III||10
11050225|NCT00960856|12231022|FG001|STARTED|Period III||7
11050226|NCT00960856|12231023|FG002|STARTED|Period III||9
11050227|NCT00960856|12231024|FG003|STARTED|Period III||9
11050228|NCT00960856|12231021|FG000|COMPLETED|Period III||10
11050229|NCT00960856|12231022|FG001|COMPLETED|Period III||7
11050230|NCT00960856|12231023|FG002|COMPLETED|Period III||9
11050231|NCT00960856|12231024|FG003|COMPLETED|Period III||9
11050232|NCT00960856|12231021|FG000|NOT COMPLETED|Period III||0
11050233|NCT00960856|12231022|FG001|NOT COMPLETED|Period III||0
11050234|NCT00960856|12231023|FG002|NOT COMPLETED|Period III||0
11050235|NCT00960856|12231024|FG003|NOT COMPLETED|Period III||0
11050236|NCT00960856|12231021|FG000|STARTED|Washout Period of 7 Days||10
11050237|NCT00960856|12231022|FG001|STARTED|Washout Period of 7 Days||7
11050238|NCT00960856|12231023|FG002|STARTED|Washout Period of 7 Days||9
11050239|NCT00960856|12231024|FG003|STARTED|Washout Period of 7 Days||9
11050240|NCT00960856|12231021|FG000|COMPLETED|Washout Period of 7 Days||10
11050241|NCT00960856|12231022|FG001|COMPLETED|Washout Period of 7 Days||7
11050242|NCT00960856|12231023|FG002|COMPLETED|Washout Period of 7 Days||8
11050243|NCT00960856|12231024|FG003|COMPLETED|Washout Period of 7 Days||9
11050244|NCT00960856|12231021|FG000|NOT COMPLETED|Washout Period of 7 Days||0
11050245|NCT00960856|12231022|FG001|NOT COMPLETED|Washout Period of 7 Days||0
11050246|NCT00960856|12231023|FG002|NOT COMPLETED|Washout Period of 7 Days||1
11050247|NCT00960856|12231024|FG003|NOT COMPLETED|Washout Period of 7 Days||0
11050248|NCT00960856|12231021|FG000|STARTED|Period IV||10
11050249|NCT00960856|12231022|FG001|STARTED|Period IV||7
11050250|NCT00960856|12231023|FG002|STARTED|Period IV||8
11050251|NCT00960856|12231024|FG003|STARTED|Period IV||9
11050252|NCT00960856|12231021|FG000|COMPLETED|Period IV||10
11050253|NCT00960856|12231022|FG001|COMPLETED|Period IV||7
11050254|NCT00960856|12231023|FG002|COMPLETED|Period IV||8
11050255|NCT00960856|12231024|FG003|COMPLETED|Period IV||9
11050256|NCT00960856|12231021|FG000|NOT COMPLETED|Period IV||0
11050257|NCT00960856|12231022|FG001|NOT COMPLETED|Period IV||0
11050258|NCT00960856|12231023|FG002|NOT COMPLETED|Period IV||0
11050259|NCT00960856|12231024|FG003|NOT COMPLETED|Period IV||0
11050260|NCT00960869|12231036|FG000|STARTED|Overall Study||259
11050261|NCT00960869|12231037|FG001|STARTED|Overall Study||260
11050262|NCT00960869|12231036|FG000|Intent-to-Treat Population (ITT)|Overall Study||259
11050263|NCT00960869|12231037|FG001|Intent-to-Treat Population (ITT)|Overall Study||260
11050264|NCT00960869|12231036|FG000|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
11050265|NCT00960869|12231037|FG001|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
11050266|NCT00960869|12231036|FG000|COMPLETED|Overall Study||206
11050267|NCT00960869|12231037|FG001|COMPLETED|Overall Study||198
11050268|NCT00960869|12231036|FG000|NOT COMPLETED|Overall Study||53
11050269|NCT00960869|12231037|FG001|NOT COMPLETED|Overall Study||62
11050270|NCT00960934|12231049|FG000|STARTED|Overall Study||64
11050271|NCT00960934|12231050|FG001|STARTED|Overall Study||63
11050272|NCT00960934|12231051|FG002|STARTED|Overall Study||64
11050273|NCT00960934|12231052|FG003|STARTED|Overall Study||64
11050274|NCT00960934|12231053|FG004|STARTED|Overall Study||64
11050275|NCT00960934|12231054|FG005|STARTED|Overall Study||64
11050276|NCT00960934|12231049|FG000|Number Treated|Overall Study||64
11050277|NCT00960934|12231050|FG001|Number Treated|Overall Study|1 participant was randomized but not treated|62
11050278|NCT00960934|12231051|FG002|Number Treated|Overall Study||64
11050279|NCT00960934|12231052|FG003|Number Treated|Overall Study||64
11050280|NCT00960934|12231053|FG004|Number Treated|Overall Study|1 participant was randomized but not treated|63
11050281|NCT00960934|12231054|FG005|Number Treated|Overall Study|1 participant was randomized but not treated|63
11050282|NCT00960934|12231049|FG000|COMPLETED|Overall Study||0
11050283|NCT00960934|12231050|FG001|COMPLETED|Overall Study||0
11050284|NCT00960934|12231051|FG002|COMPLETED|Overall Study||0
11050285|NCT00960934|12231052|FG003|COMPLETED|Overall Study||0
11050286|NCT00960934|12231053|FG004|COMPLETED|Overall Study||0
11050287|NCT00960934|12231054|FG005|COMPLETED|Overall Study||0
11050288|NCT00960934|12231049|FG000|NOT COMPLETED|Overall Study||64
11050289|NCT00960934|12231050|FG001|NOT COMPLETED|Overall Study||63
11050290|NCT00960934|12231051|FG002|NOT COMPLETED|Overall Study||64
11050291|NCT00960934|12231052|FG003|NOT COMPLETED|Overall Study||64
11050292|NCT00960934|12231053|FG004|NOT COMPLETED|Overall Study||64
11050293|NCT00960934|12231054|FG005|NOT COMPLETED|Overall Study||64
11050294|NCT00960986|12231072|FG000|STARTED|Period 1 (Screening and Washout)||59
11050295|NCT00960986|12231073|FG001|STARTED|Period 1 (Screening and Washout)||63
11050296|NCT00960986|12231074|FG002|STARTED|Period 1 (Screening and Washout)||63
11050297|NCT00960986|12231075|FG003|STARTED|Period 1 (Screening and Washout)||64
11050298|NCT00960986|12231072|FG000|COMPLETED|Period 1 (Screening and Washout)||56
11050299|NCT00960986|12231073|FG001|COMPLETED|Period 1 (Screening and Washout)||59
11050300|NCT00960986|12231074|FG002|COMPLETED|Period 1 (Screening and Washout)||59
11050301|NCT00960986|12231075|FG003|COMPLETED|Period 1 (Screening and Washout)||61
11050302|NCT00960986|12231072|FG000|NOT COMPLETED|Period 1 (Screening and Washout)||3
11050303|NCT00960986|12231073|FG001|NOT COMPLETED|Period 1 (Screening and Washout)||4
11050304|NCT00960986|12231074|FG002|NOT COMPLETED|Period 1 (Screening and Washout)||4
11050305|NCT00960986|12231075|FG003|NOT COMPLETED|Period 1 (Screening and Washout)||3
11050306|NCT00960986|12231072|FG000|STARTED|Period 2 (1-week Initial Dosing Period)||56
11050307|NCT00960986|12231073|FG001|STARTED|Period 2 (1-week Initial Dosing Period)||59
11050308|NCT00960986|12231074|FG002|STARTED|Period 2 (1-week Initial Dosing Period)||59
11050309|NCT00960986|12231075|FG003|STARTED|Period 2 (1-week Initial Dosing Period)||61
11050310|NCT00960986|12231072|FG000|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
11050311|NCT00960986|12231073|FG001|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
11050312|NCT00960986|12231074|FG002|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
11050313|NCT00960986|12231075|FG003|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
11050314|NCT00960986|12231072|FG000|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
11050315|NCT00960986|12231073|FG001|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
11050316|NCT00960986|12231074|FG002|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
11050317|NCT00960986|12231075|FG003|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
11050318|NCT00960986|12231072|FG000|STARTED|Period 3 (7-week Therapy Period)||56
11050319|NCT00960986|12231073|FG001|STARTED|Period 3 (7-week Therapy Period)||59
11050320|NCT00960986|12231074|FG002|STARTED|Period 3 (7-week Therapy Period)||59
11050321|NCT00960986|12231075|FG003|STARTED|Period 3 (7-week Therapy Period)||61
11050322|NCT00960986|12231072|FG000|COMPLETED|Period 3 (7-week Therapy Period)||26
11050323|NCT00960986|12231073|FG001|COMPLETED|Period 3 (7-week Therapy Period)||36
11050324|NCT00960986|12231074|FG002|COMPLETED|Period 3 (7-week Therapy Period)||39
11050325|NCT00960986|12231075|FG003|COMPLETED|Period 3 (7-week Therapy Period)||36
11050326|NCT00960986|12231072|FG000|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
11050327|NCT00960986|12231073|FG001|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
11050328|NCT00960986|12231074|FG002|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
11050329|NCT00960986|12231075|FG003|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
11050330|NCT00960999|12231087|FG000|STARTED|Overall Study||47
11050331|NCT00960999|12231088|FG001|STARTED|Overall Study||47
11050332|NCT00960999|12231087|FG000|Eligible|Overall Study||39
11050333|NCT00960999|12231088|FG001|Eligible|Overall Study||45
11050334|NCT00960999|12231087|FG000|Started Protocol Treatment|Overall Study||39
11050335|NCT00960999|12231088|FG001|Started Protocol Treatment|Overall Study||45
11050336|NCT00960999|12231087|FG000|Primary Endpoint Population|Overall Study||38
11050337|NCT00960999|12231088|FG001|Primary Endpoint Population|Overall Study||38
11050338|NCT00960999|12231087|FG000|Peak SUV at 8 Weeks|Overall Study||3
11050339|NCT00960999|12231088|FG001|Peak SUV at 8 Weeks|Overall Study||11
11050340|NCT00960999|12231087|FG000|Peak SUV at 1 Year|Overall Study||4
11050341|NCT00960999|12231088|FG001|Peak SUV at 1 Year|Overall Study||7
11050342|NCT00960999|12231087|FG000|Normalized SUV at 8 Weeks|Overall Study||3
11050343|NCT00960999|12231088|FG001|Normalized SUV at 8 Weeks|Overall Study||9
11337604|NCT02896127|12535411|FG001|COMPLETED|COMPLETED WEEK 52||142
11337605|NCT02896127|12535410|FG000|NOT COMPLETED|COMPLETED WEEK 52||27
11337606|NCT02896127|12535411|FG001|NOT COMPLETED|COMPLETED WEEK 52||11
11337607|NCT02896127|12535410|FG000|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|280
11337608|NCT02896127|12535411|FG001|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|139
11337609|NCT02896127|12535410|FG000|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|276
11343915|NCT02956967|12541205|FG000|STARTED|Overall Study||171
11343916|NCT02956967|12541205|FG000|COMPLETED|Overall Study||123
11343917|NCT02956967|12541205|FG000|NOT COMPLETED|Overall Study||48
11050344|NCT00960999|12231087|FG000|Normalized SUV at 1 Year|Overall Study||4
11050345|NCT00960999|12231088|FG001|Normalized SUV at 1 Year|Overall Study||7
11050346|NCT00960999|12231087|FG000|FEV1 by Best Response|Overall Study||26
11050347|NCT00960999|12231088|FG001|FEV1 by Best Response|Overall Study||33
11050348|NCT00960999|12231087|FG000|DLCO by Best Response|Overall Study||23
11050349|NCT00960999|12231088|FG001|DLCO by Best Response|Overall Study||28
11050350|NCT00960999|12231087|FG000|COMPLETED|Overall Study||39
11050351|NCT00960999|12231088|FG001|COMPLETED|Overall Study||45
11050352|NCT00960999|12231087|FG000|NOT COMPLETED|Overall Study||8
11050353|NCT00960999|12231088|FG001|NOT COMPLETED|Overall Study||2
11050354|NCT00961051|12231096|FG000|STARTED|Overall Study||177
11050355|NCT00961051|12231097|FG001|STARTED|Overall Study||93
11050356|NCT00961051|12231096|FG000|COMPLETED|Overall Study||165
11050357|NCT00961051|12231097|FG001|COMPLETED|Overall Study||79
11050358|NCT00961051|12231096|FG000|NOT COMPLETED|Overall Study||12
11050359|NCT00961051|12231097|FG001|NOT COMPLETED|Overall Study||14
11050360|NCT00961116|12231103|FG000|STARTED|First Intervention||27
11050361|NCT00961116|12231104|FG001|STARTED|First Intervention||27
11050362|NCT00961116|12231103|FG000|COMPLETED|First Intervention||27
11050363|NCT00961116|12231104|FG001|COMPLETED|First Intervention||27
11050364|NCT00961116|12231103|FG000|NOT COMPLETED|First Intervention||0
11050365|NCT00961116|12231104|FG001|NOT COMPLETED|First Intervention||0
11050366|NCT00961116|12231103|FG000|STARTED|Washout Period of 7 Days||27
11050367|NCT00961116|12231104|FG001|STARTED|Washout Period of 7 Days||27
11050368|NCT00961116|12231103|FG000|COMPLETED|Washout Period of 7 Days||25
11050369|NCT00961116|12231104|FG001|COMPLETED|Washout Period of 7 Days||24
11050370|NCT00961116|12231103|FG000|NOT COMPLETED|Washout Period of 7 Days||2
11050371|NCT00961116|12231104|FG001|NOT COMPLETED|Washout Period of 7 Days||3
11050372|NCT00961116|12231103|FG000|STARTED|Second Intervention||25
11050373|NCT00961116|12231104|FG001|STARTED|Second Intervention||24
11050374|NCT00961116|12231103|FG000|COMPLETED|Second Intervention||25
11050375|NCT00961116|12231104|FG001|COMPLETED|Second Intervention||24
11050376|NCT00961116|12231103|FG000|NOT COMPLETED|Second Intervention||0
11050377|NCT00961116|12231104|FG001|NOT COMPLETED|Second Intervention||0
11050378|NCT00961181|12231111|FG000|STARTED|Overall Study||81
11050379|NCT00961181|12231111|FG000|COMPLETED|Overall Study||76
11050380|NCT00961181|12231111|FG000|NOT COMPLETED|Overall Study||5
11050381|NCT00961220|12231115|FG000|STARTED|Overall Study||17
11050382|NCT00961220|12231115|FG000|COMPLETED|Overall Study||10
11050383|NCT00961220|12231115|FG000|NOT COMPLETED|Overall Study||7
11050384|NCT00961233|12231123|FG000|STARTED|Overall Study||13
11050385|NCT00961233|12231124|FG001|STARTED|Overall Study||12
11050386|NCT00961233|12231123|FG000|COMPLETED|Overall Study||11
11050387|NCT00961233|12231124|FG001|COMPLETED|Overall Study||11
11050388|NCT00961233|12231123|FG000|NOT COMPLETED|Overall Study||2
11050389|NCT00961233|12231124|FG001|NOT COMPLETED|Overall Study||1
11050390|NCT00961259|12231132|FG000|STARTED|First Intervention||18
11050391|NCT00961259|12231133|FG001|STARTED|First Intervention||18
11050392|NCT00961259|12231134|FG002|STARTED|First Intervention||18
11050393|NCT00961259|12231132|FG000|COMPLETED|First Intervention||18
11050394|NCT00961259|12231133|FG001|COMPLETED|First Intervention||18
11050395|NCT00961259|12231134|FG002|COMPLETED|First Intervention||18
11343918|NCT02957123|12541209|FG000|STARTED|Overall Study||30
11343919|NCT02957123|12541209|FG000|COMPLETED|Overall Study||30
11343920|NCT02957123|12541209|FG000|NOT COMPLETED|Overall Study||0
11343921|NCT02957136|12541215|FG000|STARTED|Overall Study||95
11343922|NCT02957136|12541216|FG001|STARTED|Overall Study||99
11343923|NCT02957136|12541215|FG000|COMPLETED|Overall Study||93
11343924|NCT02957136|12541216|FG001|COMPLETED|Overall Study||98
11343925|NCT02957136|12541215|FG000|NOT COMPLETED|Overall Study||2
11343926|NCT02957136|12541216|FG001|NOT COMPLETED|Overall Study||1
11343927|NCT02957305|12541224|FG000|STARTED|Overall Study||106
11343928|NCT02957305|12541225|FG001|STARTED|Overall Study||105
11050396|NCT00961259|12231132|FG000|NOT COMPLETED|First Intervention||0
11050397|NCT00961259|12231133|FG001|NOT COMPLETED|First Intervention||0
11050398|NCT00961259|12231134|FG002|NOT COMPLETED|First Intervention||0
11050399|NCT00961259|12231132|FG000|STARTED|Washout Period of 7 Days||18
11050400|NCT00961259|12231133|FG001|STARTED|Washout Period of 7 Days||18
11050401|NCT00961259|12231134|FG002|STARTED|Washout Period of 7 Days||18
11050402|NCT00961259|12231132|FG000|COMPLETED|Washout Period of 7 Days||18
11050403|NCT00961259|12231133|FG001|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
11050404|NCT00961259|12231134|FG002|COMPLETED|Washout Period of 7 Days||18
11050405|NCT00961259|12231132|FG000|NOT COMPLETED|Washout Period of 7 Days||0
11050406|NCT00961259|12231133|FG001|NOT COMPLETED|Washout Period of 7 Days||1
11050407|NCT00961259|12231134|FG002|NOT COMPLETED|Washout Period of 7 Days||0
11050408|NCT00961259|12231132|FG000|STARTED|Second Intervention||18
11050409|NCT00961259|12231133|FG001|STARTED|Second Intervention||17
11050410|NCT00961259|12231134|FG002|STARTED|Second Intervention||18
11050411|NCT00961259|12231132|FG000|COMPLETED|Second Intervention||18
11050412|NCT00961259|12231133|FG001|COMPLETED|Second Intervention||17
11050413|NCT00961259|12231134|FG002|COMPLETED|Second Intervention||18
11050414|NCT00961259|12231132|FG000|NOT COMPLETED|Second Intervention||0
11050415|NCT00961259|12231133|FG001|NOT COMPLETED|Second Intervention||0
11050416|NCT00961259|12231134|FG002|NOT COMPLETED|Second Intervention||0
11050417|NCT00961259|12231132|FG000|STARTED|Washout Period of 7 Days||18
11050418|NCT00961259|12231133|FG001|STARTED|Washout Period of 7 Days||17
11050419|NCT00961259|12231134|FG002|STARTED|Washout Period of 7 Days||18
11050420|NCT00961259|12231132|FG000|COMPLETED|Washout Period of 7 Days||18
11050421|NCT00961259|12231133|FG001|COMPLETED|Washout Period of 7 Days||17
11050422|NCT00961259|12231134|FG002|COMPLETED|Washout Period of 7 Days||18
11050423|NCT00961259|12231132|FG000|NOT COMPLETED|Washout Period of 7 Days||0
11050424|NCT00961259|12231133|FG001|NOT COMPLETED|Washout Period of 7 Days||0
11050425|NCT00961259|12231134|FG002|NOT COMPLETED|Washout Period of 7 Days||0
11050426|NCT00961259|12231132|FG000|STARTED|Third Intervention||18
11050427|NCT00961259|12231133|FG001|STARTED|Third Intervention||17
11050428|NCT00961259|12231134|FG002|STARTED|Third Intervention||18
11050429|NCT00961259|12231132|FG000|COMPLETED|Third Intervention||18
11050430|NCT00961259|12231133|FG001|COMPLETED|Third Intervention||17
11050431|NCT00961259|12231134|FG002|COMPLETED|Third Intervention||18
11050432|NCT00961259|12231132|FG000|NOT COMPLETED|Third Intervention||0
11050433|NCT00961259|12231133|FG001|NOT COMPLETED|Third Intervention||0
11050434|NCT00961259|12231134|FG002|NOT COMPLETED|Third Intervention||0
11050435|NCT00961298|12231143|FG000|STARTED|Two Week Placebo Run in||15
11050436|NCT00961298|12231143|FG000|COMPLETED|Two Week Placebo Run in||14
11050437|NCT00961298|12231143|FG000|NOT COMPLETED|Two Week Placebo Run in||1
11050438|NCT00961298|12231143|FG000|STARTED|12 Weeks Duloxetine Treatment Phase||14
11050439|NCT00961298|12231143|FG000|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
11050440|NCT00961298|12231143|FG000|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
11050441|NCT00961311|12231147|FG000|STARTED|Overall Study||51
11050442|NCT00961311|12231147|FG000|COMPLETED|Overall Study||51
11050443|NCT00961311|12231147|FG000|NOT COMPLETED|Overall Study||0
11050444|NCT00961350|12231153|FG000|STARTED|Overall Study||265
11050445|NCT00961350|12231154|FG001|STARTED|Overall Study||265
11050446|NCT00961350|12231153|FG000|Intent-to-Treat Population (ITT)|Overall Study||265
11050447|NCT00961350|12231154|FG001|Intent-to-Treat Population (ITT)|Overall Study||265
11050448|NCT00961350|12231153|FG000|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
11050449|NCT00961350|12231154|FG001|Safety Population|Overall Study||265
11050450|NCT00961350|12231153|FG000|COMPLETED|Overall Study||218
11050451|NCT00961350|12231154|FG001|COMPLETED|Overall Study||198
11050452|NCT00961350|12231153|FG000|NOT COMPLETED|Overall Study||47
11050453|NCT00961350|12231154|FG001|NOT COMPLETED|Overall Study||67
11050454|NCT00961402|12231162|FG000|STARTED|Overall Study||64
11050455|NCT00961402|12231163|FG001|STARTED|Overall Study||66
11050456|NCT00961402|12231162|FG000|Randomized|Overall Study||64
11050457|NCT00961402|12231163|FG001|Randomized|Overall Study||66
11050458|NCT00961402|12231162|FG000|COMPLETED|Overall Study||63
11050459|NCT00961402|12231163|FG001|COMPLETED|Overall Study||61
11050460|NCT00961402|12231162|FG000|NOT COMPLETED|Overall Study||1
11050461|NCT00961402|12231163|FG001|NOT COMPLETED|Overall Study||5
11050462|NCT00961415|12231171|FG000|STARTED|Induction Treatment Phase||376
11050463|NCT00961415|12231172|FG001|STARTED|Induction Treatment Phase||0
11050464|NCT00961415|12231173|FG002|STARTED|Induction Treatment Phase||0
11050465|NCT00961415|12231171|FG000|COMPLETED|Induction Treatment Phase||253
11050466|NCT00961415|12231172|FG001|COMPLETED|Induction Treatment Phase||0
11050467|NCT00961415|12231173|FG002|COMPLETED|Induction Treatment Phase||0
11050468|NCT00961415|12231171|FG000|NOT COMPLETED|Induction Treatment Phase||123
11050469|NCT00961415|12231172|FG001|NOT COMPLETED|Induction Treatment Phase||0
11050470|NCT00961415|12231173|FG002|NOT COMPLETED|Induction Treatment Phase||0
11050471|NCT00961415|12231171|FG000|STARTED|Maintenance Treatment Phase||0
11050472|NCT00961415|12231172|FG001|STARTED|Maintenance Treatment Phase||125
11050473|NCT00961415|12231173|FG002|STARTED|Maintenance Treatment Phase||128
11050474|NCT00961415|12231171|FG000|COMPLETED|Maintenance Treatment Phase||0
11050475|NCT00961415|12231172|FG001|COMPLETED|Maintenance Treatment Phase||77
11050476|NCT00961415|12231173|FG002|COMPLETED|Maintenance Treatment Phase||83
11050477|NCT00961415|12231171|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
11050478|NCT00961415|12231172|FG001|NOT COMPLETED|Maintenance Treatment Phase||48
11050479|NCT00961415|12231173|FG002|NOT COMPLETED|Maintenance Treatment Phase||45
11050480|NCT00961441|12231189|FG000|STARTED|Overall Study||12
11050481|NCT00961441|12231190|FG001|STARTED|Overall Study||13
11050482|NCT00961441|12231189|FG000|Pharmacokinetic (PK-PP) Population|Overall Study||12
11050483|NCT00961441|12231190|FG001|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
11050484|NCT00961441|12231189|FG000|COMPLETED|Overall Study||12
11050485|NCT00961441|12231190|FG001|COMPLETED|Overall Study||13
11050486|NCT00961441|12231189|FG000|NOT COMPLETED|Overall Study||0
11050487|NCT00961441|12231190|FG001|NOT COMPLETED|Overall Study||0
11050488|NCT00961532|12231196|FG000|STARTED|Overall Study||14
11050489|NCT00961532|12231196|FG000|COMPLETED|Overall Study||14
11050490|NCT00961532|12231196|FG000|NOT COMPLETED|Overall Study||0
11050491|NCT00961571|12231200|FG000|STARTED|Overall Study||50
11050492|NCT00961571|12231200|FG000|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
11050493|NCT00961571|12231200|FG000|NOT COMPLETED|Overall Study||39
11050494|NCT00961636|12231207|FG000|STARTED|Overall Study||463
11050495|NCT00961636|12231208|FG001|STARTED|Overall Study||456
11050496|NCT00961636|12231209|FG002|STARTED|Overall Study||233
11050497|NCT00961636|12231207|FG000|COMPLETED|Overall Study||356
11050498|NCT00961636|12231208|FG001|COMPLETED|Overall Study||325
11050499|NCT00961636|12231209|FG002|COMPLETED|Overall Study||201
11050500|NCT00961636|12231207|FG000|NOT COMPLETED|Overall Study||107
11050501|NCT00961636|12231208|FG001|NOT COMPLETED|Overall Study||131
11050502|NCT00961636|12231209|FG002|NOT COMPLETED|Overall Study||32
11050503|NCT00961649|12231221|FG000|STARTED|Overall Study||41
11050504|NCT00961649|12231222|FG001|STARTED|Overall Study||44
11050505|NCT00961649|12231223|FG002|STARTED|Overall Study||44
11050506|NCT00961649|12231224|FG003|STARTED|Overall Study||41
11050507|NCT00961649|12231221|FG000|COMPLETED|Overall Study||32
11050508|NCT00961649|12231222|FG001|COMPLETED|Overall Study||40
11050509|NCT00961649|12231223|FG002|COMPLETED|Overall Study||39
11050510|NCT00961649|12231224|FG003|COMPLETED|Overall Study||37
11050511|NCT00961649|12231221|FG000|NOT COMPLETED|Overall Study||9
11050512|NCT00961649|12231222|FG001|NOT COMPLETED|Overall Study||4
11050513|NCT00961649|12231223|FG002|NOT COMPLETED|Overall Study||5
11050514|NCT00961649|12231224|FG003|NOT COMPLETED|Overall Study||4
11050515|NCT00961662|12231237|FG000|STARTED|Overall Study||57
11050516|NCT00961662|12231238|FG001|STARTED|Overall Study||51
11050517|NCT00961662|12231239|FG002|STARTED|Overall Study||53
11050518|NCT00961662|12231237|FG000|COMPLETED|Overall Study||35
11050519|NCT00961662|12231238|FG001|COMPLETED|Overall Study||32
11050520|NCT00961662|12231239|FG002|COMPLETED|Overall Study||34
11050521|NCT00961662|12231237|FG000|NOT COMPLETED|Overall Study||22
11050522|NCT00961662|12231238|FG001|NOT COMPLETED|Overall Study||19
11337610|NCT02896127|12535411|FG001|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|134
11337611|NCT02896127|12535410|FG000|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||4
11337612|NCT02896127|12535411|FG001|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||5
11337613|NCT02896296|12535417|FG000|STARTED|Overall Study||208
11337614|NCT02896296|12535417|FG000|COMPLETED|Overall Study||166
11337615|NCT02896296|12535417|FG000|NOT COMPLETED|Overall Study||42
11337616|NCT02896361|12535421|FG000|STARTED|First Intervention (2 Weeks)||9
11337617|NCT02896361|12535422|FG001|STARTED|First Intervention (2 Weeks)||10
11337618|NCT02896361|12535423|FG002|STARTED|First Intervention (2 Weeks)||8
11337619|NCT02896361|12535421|FG000|COMPLETED|First Intervention (2 Weeks)||9
11337620|NCT02896361|12535422|FG001|COMPLETED|First Intervention (2 Weeks)||10
11337621|NCT02896361|12535423|FG002|COMPLETED|First Intervention (2 Weeks)||8
11337622|NCT02896361|12535421|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
11337623|NCT02896361|12535422|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
11337624|NCT02896361|12535423|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0
11337625|NCT02896361|12535421|FG000|STARTED|Second Intervention (2 Weeks)||9
11337626|NCT02896361|12535422|FG001|STARTED|Second Intervention (2 Weeks)||10
11337627|NCT02896361|12535423|FG002|STARTED|Second Intervention (2 Weeks)||8
11337628|NCT02896361|12535421|FG000|COMPLETED|Second Intervention (2 Weeks)||9
11337629|NCT02896361|12535422|FG001|COMPLETED|Second Intervention (2 Weeks)||10
11337630|NCT02896361|12535423|FG002|COMPLETED|Second Intervention (2 Weeks)||8
11337631|NCT02896361|12535421|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
11337632|NCT02896361|12535422|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
11337633|NCT02896361|12535423|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
11337634|NCT02896361|12535421|FG000|STARTED|Third Intervention (2 Weeks)||9
11337635|NCT02896361|12535422|FG001|STARTED|Third Intervention (2 Weeks)||10
11337636|NCT02896361|12535423|FG002|STARTED|Third Intervention (2 Weeks)||8
11337637|NCT02896361|12535421|FG000|COMPLETED|Third Intervention (2 Weeks)||8
11337638|NCT02896361|12535422|FG001|COMPLETED|Third Intervention (2 Weeks)||9
11337639|NCT02896361|12535423|FG002|COMPLETED|Third Intervention (2 Weeks)||8
11337640|NCT02896361|12535421|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||1
11337641|NCT02896361|12535422|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||1
11337642|NCT02896361|12535423|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
11337643|NCT02896400|12535451|FG000|STARTED|Baseline||66
11050523|NCT00961662|12231239|FG002|NOT COMPLETED|Overall Study||19
11050524|NCT00961896|12231250|FG000|STARTED|Overall Study||8
11337644|NCT02896400|12535452|FG001|STARTED|Baseline||66
11337645|NCT02896400|12535453|FG002|STARTED|Baseline||66
11050525|NCT00961896|12231251|FG001|STARTED|Overall Study||3
11050526|NCT00961896|12231252|FG002|STARTED|Overall Study||7
11050527|NCT00961896|12231250|FG000|COMPLETED|Overall Study||8
11050528|NCT00961896|12231251|FG001|COMPLETED|Overall Study||3
11050529|NCT00961896|12231252|FG002|COMPLETED|Overall Study||6
11050530|NCT00961896|12231250|FG000|NOT COMPLETED|Overall Study||0
11050531|NCT00961896|12231251|FG001|NOT COMPLETED|Overall Study||0
11050532|NCT00961896|12231252|FG002|NOT COMPLETED|Overall Study||1
11050533|NCT00961961|12231267|FG000|STARTED|Phase I||177
11050534|NCT00961961|12231268|FG001|STARTED|Phase I||0
11050535|NCT00961961|12231269|FG002|STARTED|Phase I||0
11050536|NCT00961961|12231270|FG003|STARTED|Phase I||0
11050537|NCT00961961|12231267|FG000|COMPLETED|Phase I||51
11050538|NCT00961961|12231268|FG001|COMPLETED|Phase I||0
11050539|NCT00961961|12231269|FG002|COMPLETED|Phase I||0
11050540|NCT00961961|12231270|FG003|COMPLETED|Phase I||0
11050541|NCT00961961|12231267|FG000|NOT COMPLETED|Phase I||126
11050542|NCT00961961|12231268|FG001|NOT COMPLETED|Phase I||0
11050543|NCT00961961|12231269|FG002|NOT COMPLETED|Phase I||0
11050544|NCT00961961|12231270|FG003|NOT COMPLETED|Phase I||0
11050545|NCT00961961|12231267|FG000|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
11050546|NCT00961961|12231268|FG001|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
11050547|NCT00961961|12231269|FG002|STARTED|Phase II||29
11050548|NCT00961961|12231270|FG003|STARTED|Phase II||22
11050549|NCT00961961|12231267|FG000|COMPLETED|Phase II||0
11050550|NCT00961961|12231268|FG001|COMPLETED|Phase II||0
11050551|NCT00961961|12231269|FG002|COMPLETED|Phase II||17
11050552|NCT00961961|12231270|FG003|COMPLETED|Phase II||14
11050553|NCT00961961|12231267|FG000|NOT COMPLETED|Phase II||0
11050554|NCT00961961|12231268|FG001|NOT COMPLETED|Phase II||0
11050555|NCT00961961|12231269|FG002|NOT COMPLETED|Phase II||12
11050556|NCT00961961|12231270|FG003|NOT COMPLETED|Phase II||8
11050557|NCT00962000|12231290|FG000|STARTED|Period 1 - 1 Week||21
11050558|NCT00962000|12231291|FG001|STARTED|Period 1 - 1 Week||21
11050559|NCT00962000|12231290|FG000|COMPLETED|Period 1 - 1 Week||21
11050560|NCT00962000|12231291|FG001|COMPLETED|Period 1 - 1 Week||21
11050561|NCT00962000|12231290|FG000|NOT COMPLETED|Period 1 - 1 Week||0
11050562|NCT00962000|12231291|FG001|NOT COMPLETED|Period 1 - 1 Week||0
11050563|NCT00962000|12231290|FG000|STARTED|Period 2 - 1 Week||21
11050564|NCT00962000|12231291|FG001|STARTED|Period 2 - 1 Week||21
11050565|NCT00962000|12231290|FG000|COMPLETED|Period 2 - 1 Week||21
11050566|NCT00962000|12231291|FG001|COMPLETED|Period 2 - 1 Week||21
11050567|NCT00962000|12231290|FG000|NOT COMPLETED|Period 2 - 1 Week||0
11050568|NCT00962000|12231291|FG001|NOT COMPLETED|Period 2 - 1 Week||0
11050569|NCT00962000|12231290|FG000|STARTED|Period 3 - 1 Week||21
11050570|NCT00962000|12231291|FG001|STARTED|Period 3 - 1 Week||21
11050571|NCT00962000|12231290|FG000|COMPLETED|Period 3 - 1 Week||21
11050572|NCT00962000|12231291|FG001|COMPLETED|Period 3 - 1 Week||21
11050573|NCT00962000|12231290|FG000|NOT COMPLETED|Period 3 - 1 Week||0
11337646|NCT02896400|12535454|FG003|STARTED|Baseline||66
11337647|NCT02896400|12535455|FG004|STARTED|Baseline||66
11337648|NCT02896400|12535456|FG005|STARTED|Baseline||66
11337649|NCT02896400|12535457|FG006|STARTED|Baseline||66
11337650|NCT02896400|12535458|FG007|STARTED|Baseline||66
11337651|NCT02896400|12535459|FG008|STARTED|Baseline||66
11337652|NCT02896400|12535460|FG009|STARTED|Baseline||66
11337653|NCT02896400|12535461|FG010|STARTED|Baseline||66
11337654|NCT02896400|12535462|FG011|STARTED|Baseline||66
11337655|NCT02896400|12535463|FG012|STARTED|Baseline||66
11337656|NCT02896400|12535464|FG013|STARTED|Baseline||66
11337657|NCT02896400|12535465|FG014|STARTED|Baseline||66
11337658|NCT02896400|12535466|FG015|STARTED|Baseline||66
11337659|NCT02896400|12535451|FG000|COMPLETED|Baseline||66
11337660|NCT02896400|12535452|FG001|COMPLETED|Baseline||66
11337661|NCT02896400|12535453|FG002|COMPLETED|Baseline||66
11337662|NCT02896400|12535454|FG003|COMPLETED|Baseline||66
11337663|NCT02896400|12535455|FG004|COMPLETED|Baseline||66
11337664|NCT02896400|12535456|FG005|COMPLETED|Baseline||66
11337665|NCT02896400|12535457|FG006|COMPLETED|Baseline||66
11337666|NCT02896400|12535458|FG007|COMPLETED|Baseline||66
11337667|NCT02896400|12535459|FG008|COMPLETED|Baseline||66
11337668|NCT02896400|12535460|FG009|COMPLETED|Baseline||66
11337669|NCT02896400|12535461|FG010|COMPLETED|Baseline||66
11337670|NCT02896400|12535462|FG011|COMPLETED|Baseline||66
11337671|NCT02896400|12535463|FG012|COMPLETED|Baseline||66
11337672|NCT02896400|12535464|FG013|COMPLETED|Baseline||66
11337673|NCT02896400|12535465|FG014|COMPLETED|Baseline||66
11337674|NCT02896400|12535466|FG015|COMPLETED|Baseline||66
11337675|NCT02896400|12535451|FG000|NOT COMPLETED|Baseline||0
11337676|NCT02896400|12535452|FG001|NOT COMPLETED|Baseline||0
11337677|NCT02896400|12535453|FG002|NOT COMPLETED|Baseline||0
11050574|NCT00962000|12231291|FG001|NOT COMPLETED|Period 3 - 1 Week||0
11050575|NCT00962000|12231290|FG000|STARTED|Period 4 - 1 Week||21
11050576|NCT00962000|12231291|FG001|STARTED|Period 4 - 1 Week||21
11050577|NCT00962000|12231290|FG000|COMPLETED|Period 4 - 1 Week||21
11050578|NCT00962000|12231291|FG001|COMPLETED|Period 4 - 1 Week||21
11050579|NCT00962000|12231290|FG000|NOT COMPLETED|Period 4 - 1 Week||0
11050580|NCT00962000|12231291|FG001|NOT COMPLETED|Period 4 - 1 Week||0
11050581|NCT00962013|12231297|FG000|STARTED|Overall Study||120
11050582|NCT00962013|12231297|FG000|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
11050583|NCT00962013|12231297|FG000|NOT COMPLETED|Overall Study||68
11050584|NCT00962039|12231303|FG000|STARTED|Overall Study||40
11050585|NCT00962039|12231304|FG001|STARTED|Overall Study||41
11050586|NCT00962039|12231303|FG000|COMPLETED|Overall Study||35
11050587|NCT00962039|12231304|FG001|COMPLETED|Overall Study||37
11050588|NCT00962039|12231303|FG000|NOT COMPLETED|Overall Study||5
11050589|NCT00962039|12231304|FG001|NOT COMPLETED|Overall Study||4
11050590|NCT00962065|12231313|FG000|STARTED|Overall Study||12
11050591|NCT00962065|12231314|FG001|STARTED|Overall Study||12
11050592|NCT00962065|12231315|FG002|STARTED|Overall Study||12
11050593|NCT00962065|12231313|FG000|COMPLETED|Overall Study||12
11050594|NCT00962065|12231314|FG001|COMPLETED|Overall Study||12
11050595|NCT00962065|12231315|FG002|COMPLETED|Overall Study||12
11050596|NCT00962065|12231313|FG000|NOT COMPLETED|Overall Study||0
11050597|NCT00962065|12231314|FG001|NOT COMPLETED|Overall Study||0
11050598|NCT00962065|12231315|FG002|NOT COMPLETED|Overall Study||0
11050599|NCT00962078|12231325|FG000|STARTED|Overall Study||35
11050600|NCT00962078|12231326|FG001|STARTED|Overall Study||36
11050601|NCT00962078|12231325|FG000|COMPLETED|Overall Study||30
11050602|NCT00962078|12231326|FG001|COMPLETED|Overall Study||30
11050603|NCT00962078|12231325|FG000|NOT COMPLETED|Overall Study||5
11050604|NCT00962078|12231326|FG001|NOT COMPLETED|Overall Study||6
11050605|NCT00962091|12231339|FG000|STARTED|Overall Study||4
11050606|NCT00962091|12231340|FG001|STARTED|Overall Study||9
11050607|NCT00962091|12231341|FG002|STARTED|Overall Study||10
11050608|NCT00962091|12231342|FG003|STARTED|Overall Study||3
11050609|NCT00962091|12231343|FG004|STARTED|Overall Study||3
11050610|NCT00962091|12231344|FG005|STARTED|Overall Study||12
11050611|NCT00962091|12231345|FG006|STARTED|Overall Study||12
11050612|NCT00962091|12231339|FG000|COMPLETED|Overall Study||3
11050613|NCT00962091|12231340|FG001|COMPLETED|Overall Study||7
11050614|NCT00962091|12231341|FG002|COMPLETED|Overall Study||9
11050615|NCT00962091|12231342|FG003|COMPLETED|Overall Study||2
11050616|NCT00962091|12231343|FG004|COMPLETED|Overall Study||3
11050617|NCT00962091|12231344|FG005|COMPLETED|Overall Study||11
11050618|NCT00962091|12231345|FG006|COMPLETED|Overall Study||11
11050619|NCT00962091|12231339|FG000|NOT COMPLETED|Overall Study||1
11050620|NCT00962091|12231340|FG001|NOT COMPLETED|Overall Study||2
11050621|NCT00962091|12231341|FG002|NOT COMPLETED|Overall Study||1
11050622|NCT00962091|12231342|FG003|NOT COMPLETED|Overall Study||1
11050623|NCT00962091|12231343|FG004|NOT COMPLETED|Overall Study||0
11050624|NCT00962091|12231344|FG005|NOT COMPLETED|Overall Study||1
11050625|NCT00962091|12231345|FG006|NOT COMPLETED|Overall Study||1
11050626|NCT00962104|12231371|FG000|STARTED|Overall Study||195
11050627|NCT00962104|12231372|FG001|STARTED|Overall Study||196
11050628|NCT00962104|12231371|FG000|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
11050629|NCT00962104|12231372|FG001|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
11050630|NCT00962104|12231371|FG000|COMPLETED|Overall Study||155
11050631|NCT00962104|12231372|FG001|COMPLETED|Overall Study||171
11050632|NCT00962104|12231371|FG000|NOT COMPLETED|Overall Study||40
11050633|NCT00962104|12231372|FG001|NOT COMPLETED|Overall Study||25
11050634|NCT00962208|12231380|FG000|STARTED|Overall Study||51
11050635|NCT00962208|12231381|FG001|STARTED|Overall Study||51
11050636|NCT00962208|12231380|FG000|COMPLETED|Overall Study||37
11050637|NCT00962208|12231381|FG001|COMPLETED|Overall Study||41
11050638|NCT00962208|12231380|FG000|NOT COMPLETED|Overall Study||14
11050639|NCT00962208|12231381|FG001|NOT COMPLETED|Overall Study||10
11050640|NCT00962247|12231387|FG000|STARTED|Usual Sedentary||61
11050641|NCT00962247|12231387|FG000|COMPLETED|Usual Sedentary||61
11050642|NCT00962247|12231387|FG000|NOT COMPLETED|Usual Sedentary||0
11050643|NCT00962247|12231387|FG000|STARTED|25% Reduction of Sedentary Activity||61
11050644|NCT00962247|12231387|FG000|COMPLETED|25% Reduction of Sedentary Activity||56
11050645|NCT00962247|12231387|FG000|NOT COMPLETED|25% Reduction of Sedentary Activity||5
11050646|NCT00962247|12231387|FG000|STARTED|50% Reduction of Sedentary Activity||56
11050647|NCT00962247|12231387|FG000|COMPLETED|50% Reduction of Sedentary Activity||56
11050648|NCT00962247|12231387|FG000|NOT COMPLETED|50% Reduction of Sedentary Activity||0
11050649|NCT00962390|12231397|FG000|STARTED|Overall Study||29
11050650|NCT00962390|12231398|FG001|STARTED|Overall Study||29
11050651|NCT00962390|12231399|FG002|STARTED|Overall Study||29
11050652|NCT00962390|12231400|FG003|STARTED|Overall Study||29
11050653|NCT00962390|12231397|FG000|COMPLETED|Overall Study||25
11050654|NCT00962390|12231398|FG001|COMPLETED|Overall Study||26
11050655|NCT00962390|12231399|FG002|COMPLETED|Overall Study||25
11050656|NCT00962390|12231400|FG003|COMPLETED|Overall Study||28
11050657|NCT00962390|12231397|FG000|NOT COMPLETED|Overall Study||4
11050658|NCT00962390|12231398|FG001|NOT COMPLETED|Overall Study||3
11050659|NCT00962390|12231399|FG002|NOT COMPLETED|Overall Study||4
11050660|NCT00962390|12231400|FG003|NOT COMPLETED|Overall Study||1
11050661|NCT00962585|12231414|FG000|STARTED|Overall Study||43
11050662|NCT00962585|12231415|FG001|STARTED|Overall Study||42
11050663|NCT00962585|12231416|FG002|STARTED|Overall Study||42
11050664|NCT00962585|12231417|FG003|STARTED|Overall Study||42
11050665|NCT00962585|12231414|FG000|COMPLETED|Overall Study||37
11050666|NCT00962585|12231415|FG001|COMPLETED|Overall Study||40
11050667|NCT00962585|12231416|FG002|COMPLETED|Overall Study||39
11050668|NCT00962585|12231417|FG003|COMPLETED|Overall Study||42
11050669|NCT00962585|12231414|FG000|NOT COMPLETED|Overall Study||6
11050670|NCT00962585|12231415|FG001|NOT COMPLETED|Overall Study||2
11050671|NCT00962585|12231416|FG002|NOT COMPLETED|Overall Study||3
11050672|NCT00962585|12231417|FG003|NOT COMPLETED|Overall Study||0
11050673|NCT00962598|12231431|FG000|STARTED|Overall Study||7
11050674|NCT00962598|12231432|FG001|STARTED|Overall Study||9
11050675|NCT00962598|12231431|FG000|COMPLETED|Overall Study||7
11050676|NCT00962598|12231432|FG001|COMPLETED|Overall Study||9
11050677|NCT00962598|12231431|FG000|NOT COMPLETED|Overall Study||0
11050678|NCT00962598|12231432|FG001|NOT COMPLETED|Overall Study||0
11050679|NCT00962650|12231438|FG000|STARTED|Overall Study||10
11050680|NCT00962650|12231438|FG000|COMPLETED|Overall Study||8
11050681|NCT00962650|12231438|FG000|NOT COMPLETED|Overall Study||2
11050682|NCT00962741|12231442|FG000|STARTED|Overall Study||127
11050683|NCT00962741|12231442|FG000|COMPLETED|Overall Study||119
11050684|NCT00962741|12231442|FG000|NOT COMPLETED|Overall Study||8
11050685|NCT00962754|12231448|FG000|STARTED|Overall Study||86
11050686|NCT00962754|12231449|FG001|STARTED|Overall Study||84
11050687|NCT00962754|12231448|FG000|COMPLETED|Overall Study||86
11050688|NCT00962754|12231449|FG001|COMPLETED|Overall Study||84
11050689|NCT00962754|12231448|FG000|NOT COMPLETED|Overall Study||0
11050690|NCT00962754|12231449|FG001|NOT COMPLETED|Overall Study||0
11050691|NCT00962780|12231461|FG000|STARTED|Overall Study||151
11050692|NCT00962780|12231462|FG001|STARTED|Overall Study||152
11050693|NCT00962780|12231461|FG000|Vaccinated 13vPnC Dose 1|Overall Study||150
11050694|NCT00962780|12231462|FG001|Vaccinated 13vPnC Dose 1|Overall Study||151
11050695|NCT00962780|12231461|FG000|Vaccinated 13vPnC Dose 2|Overall Study||145
11050696|NCT00962780|12231462|FG001|Vaccinated 13vPnC Dose 2|Overall Study||145
11050697|NCT00962780|12231461|FG000|Vaccinated 13vPnC Dose 3|Overall Study||144
11050698|NCT00962780|12231462|FG001|Vaccinated 13vPnC Dose 3|Overall Study||142
11050699|NCT00962780|12231461|FG000|Vaccinated 23vPS Dose|Overall Study||143
11050700|NCT00962780|12231462|FG001|Vaccinated 23vPS Dose|Overall Study||139
11050701|NCT00962780|12231461|FG000|COMPLETED|Overall Study||141
11050702|NCT00962780|12231462|FG001|COMPLETED|Overall Study||138
11050703|NCT00962780|12231461|FG000|NOT COMPLETED|Overall Study||10
11050704|NCT00962780|12231462|FG001|NOT COMPLETED|Overall Study||14
11050705|NCT00962871|12231478|FG000|STARTED|Overall Study||6
11050706|NCT00962871|12231479|FG001|STARTED|Overall Study||6
11050707|NCT00962871|12231480|FG002|STARTED|Overall Study||12
11050708|NCT00962871|12231481|FG003|STARTED|Overall Study||6
11050709|NCT00962871|12231478|FG000|COMPLETED|Overall Study||6
11050710|NCT00962871|12231479|FG001|COMPLETED|Overall Study||6
11050711|NCT00962871|12231480|FG002|COMPLETED|Overall Study||12
11050712|NCT00962871|12231481|FG003|COMPLETED|Overall Study||6
11050713|NCT00962871|12231478|FG000|NOT COMPLETED|Overall Study||0
11050714|NCT00962871|12231479|FG001|NOT COMPLETED|Overall Study||0
11050715|NCT00962871|12231480|FG002|NOT COMPLETED|Overall Study||0
11050716|NCT00962871|12231481|FG003|NOT COMPLETED|Overall Study||0
11050717|NCT00962949|12231493|FG000|STARTED|Overall Study||13
11050718|NCT00962949|12231494|FG001|STARTED|Overall Study||15
11050719|NCT00962949|12231493|FG000|COMPLETED|Overall Study||13
11050720|NCT00962949|12231494|FG001|COMPLETED|Overall Study||15
11050721|NCT00962949|12231493|FG000|NOT COMPLETED|Overall Study||0
11050722|NCT00962949|12231494|FG001|NOT COMPLETED|Overall Study||0
11050723|NCT00963105|12231503|FG000|STARTED|Overall Study||34
11050724|NCT00963105|12231504|FG001|STARTED|Overall Study||35
11050725|NCT00963105|12231505|FG002|STARTED|Overall Study||35
11050726|NCT00963105|12231503|FG000|Received Treatment|Overall Study||34
11050727|NCT00963105|12231504|FG001|Received Treatment|Overall Study||34
11050728|NCT00963105|12231505|FG002|Received Treatment|Overall Study||35
11050729|NCT00963105|12231503|FG000|COMPLETED|Overall Study||34
11050730|NCT00963105|12231504|FG001|COMPLETED|Overall Study||35
11050731|NCT00963105|12231505|FG002|COMPLETED|Overall Study||35
11050732|NCT00963105|12231503|FG000|NOT COMPLETED|Overall Study||0
11050733|NCT00963105|12231504|FG001|NOT COMPLETED|Overall Study||0
11050734|NCT00963105|12231505|FG002|NOT COMPLETED|Overall Study||0
11050735|NCT00963157|12231518|FG000|STARTED|Overall Study||156
11050736|NCT00963157|12231519|FG001|STARTED|Overall Study||163
11337678|NCT02896400|12535454|FG003|NOT COMPLETED|Baseline||0
11337679|NCT02896400|12535455|FG004|NOT COMPLETED|Baseline||0
11337680|NCT02896400|12535456|FG005|NOT COMPLETED|Baseline||0
11337681|NCT02896400|12535457|FG006|NOT COMPLETED|Baseline||0
11337682|NCT02896400|12535458|FG007|NOT COMPLETED|Baseline||0
11337683|NCT02896400|12535459|FG008|NOT COMPLETED|Baseline||0
11337684|NCT02896400|12535460|FG009|NOT COMPLETED|Baseline||0
11337685|NCT02896400|12535461|FG010|NOT COMPLETED|Baseline||0
11337686|NCT02896400|12535462|FG011|NOT COMPLETED|Baseline||0
11337687|NCT02896400|12535463|FG012|NOT COMPLETED|Baseline||0
11337688|NCT02896400|12535464|FG013|NOT COMPLETED|Baseline||0
11337689|NCT02896400|12535465|FG014|NOT COMPLETED|Baseline||0
11337690|NCT02896400|12535466|FG015|NOT COMPLETED|Baseline||0
11337691|NCT02896400|12535451|FG000|STARTED|1 Month Follow-up||66
11050737|NCT00963157|12231520|FG002|STARTED|Overall Study||160
11050738|NCT00963157|12231521|FG003|STARTED|Overall Study||157
11337692|NCT02896400|12535452|FG001|STARTED|1 Month Follow-up||66
11337693|NCT02896400|12535453|FG002|STARTED|1 Month Follow-up||66
11337694|NCT02896400|12535454|FG003|STARTED|1 Month Follow-up||66
11337695|NCT02896400|12535455|FG004|STARTED|1 Month Follow-up||66
11337696|NCT02896400|12535456|FG005|STARTED|1 Month Follow-up||66
11337697|NCT02896400|12535457|FG006|STARTED|1 Month Follow-up||66
11337698|NCT02896400|12535458|FG007|STARTED|1 Month Follow-up||66
11337699|NCT02896400|12535459|FG008|STARTED|1 Month Follow-up||66
11337700|NCT02896400|12535460|FG009|STARTED|1 Month Follow-up||66
11337701|NCT02896400|12535461|FG010|STARTED|1 Month Follow-up||66
11337702|NCT02896400|12535462|FG011|STARTED|1 Month Follow-up||66
11337703|NCT02896400|12535463|FG012|STARTED|1 Month Follow-up||66
11337704|NCT02896400|12535464|FG013|STARTED|1 Month Follow-up||66
11337705|NCT02896400|12535465|FG014|STARTED|1 Month Follow-up||66
11337706|NCT02896400|12535466|FG015|STARTED|1 Month Follow-up||66
11337707|NCT02896400|12535451|FG000|COMPLETED|1 Month Follow-up||59
11337708|NCT02896400|12535452|FG001|COMPLETED|1 Month Follow-up||59
11337709|NCT02896400|12535453|FG002|COMPLETED|1 Month Follow-up||61
11337710|NCT02896400|12535454|FG003|COMPLETED|1 Month Follow-up||58
11337711|NCT02896400|12535455|FG004|COMPLETED|1 Month Follow-up||57
11337712|NCT02896400|12535456|FG005|COMPLETED|1 Month Follow-up||60
11337713|NCT02896400|12535457|FG006|COMPLETED|1 Month Follow-up||61
11337714|NCT02896400|12535458|FG007|COMPLETED|1 Month Follow-up||60
11337715|NCT02896400|12535459|FG008|COMPLETED|1 Month Follow-up||62
11337716|NCT02896400|12535460|FG009|COMPLETED|1 Month Follow-up||59
11337717|NCT02896400|12535461|FG010|COMPLETED|1 Month Follow-up||61
11337718|NCT02896400|12535462|FG011|COMPLETED|1 Month Follow-up||61
11337719|NCT02896400|12535463|FG012|COMPLETED|1 Month Follow-up||63
11337720|NCT02896400|12535464|FG013|COMPLETED|1 Month Follow-up||62
11337721|NCT02896400|12535465|FG014|COMPLETED|1 Month Follow-up||65
11337722|NCT02896400|12535466|FG015|COMPLETED|1 Month Follow-up||63
11050739|NCT00963157|12231522|FG004|STARTED|Overall Study||153
11050740|NCT00963157|12231518|FG000|COMPLETED|Overall Study||151
11050741|NCT00963157|12231519|FG001|COMPLETED|Overall Study||159
11050742|NCT00963157|12231520|FG002|COMPLETED|Overall Study||155
11050743|NCT00963157|12231521|FG003|COMPLETED|Overall Study||150
11050744|NCT00963157|12231522|FG004|COMPLETED|Overall Study||151
11050745|NCT00963157|12231518|FG000|NOT COMPLETED|Overall Study||5
11050746|NCT00963157|12231519|FG001|NOT COMPLETED|Overall Study||4
11050747|NCT00963157|12231520|FG002|NOT COMPLETED|Overall Study||5
11050748|NCT00963157|12231521|FG003|NOT COMPLETED|Overall Study||7
11050749|NCT00963157|12231522|FG004|NOT COMPLETED|Overall Study||2
11050750|NCT00963235|12231534|FG000|STARTED|Overall Study||331
11050751|NCT00963235|12231534|FG000|Vaccinated Dose 1|Overall Study||329
11050752|NCT00963235|12231534|FG000|Vaccinated Dose 2|Overall Study||300
11050753|NCT00963235|12231534|FG000|Vaccinated Dose 3|Overall Study||279
11050754|NCT00963235|12231534|FG000|Completed Dose 3 1-month Blood Draw|Overall Study||277
11050755|NCT00963235|12231534|FG000|COMPLETED|Overall Study||271
11050756|NCT00963235|12231534|FG000|NOT COMPLETED|Overall Study||60
11050757|NCT00963430|12231543|FG000|STARTED|Overall Study||60
11050758|NCT00963430|12231544|FG001|STARTED|Overall Study||60
11050759|NCT00963430|12231543|FG000|COMPLETED|Overall Study||59
11050760|NCT00963430|12231544|FG001|COMPLETED|Overall Study||57
11050761|NCT00963430|12231543|FG000|NOT COMPLETED|Overall Study||1
11050762|NCT00963430|12231544|FG001|NOT COMPLETED|Overall Study||3
11050763|NCT00963482|12231552|FG000|STARTED|Overall Study||53
11050764|NCT00963482|12231553|FG001|STARTED|Overall Study||50
11050765|NCT00963482|12231552|FG000|COMPLETED|Overall Study||25
11050766|NCT00963482|12231553|FG001|COMPLETED|Overall Study||33
11050767|NCT00963482|12231552|FG000|NOT COMPLETED|Overall Study||28
11050768|NCT00963482|12231553|FG001|NOT COMPLETED|Overall Study||17
11050769|NCT00963508|12231561|FG000|STARTED|Overall Study||206
11050770|NCT00963508|12231562|FG001|STARTED|Overall Study||197
11050771|NCT00963508|12231561|FG000|COMPLETED|Overall Study||196
11050772|NCT00963508|12231562|FG001|COMPLETED|Overall Study||169
11050773|NCT00963508|12231561|FG000|NOT COMPLETED|Overall Study||10
11050774|NCT00963508|12231562|FG001|NOT COMPLETED|Overall Study||28
11050775|NCT00963547|12231572|FG000|STARTED|Overall Study||4
11050776|NCT00963547|12231573|FG001|STARTED|Overall Study||11
11050777|NCT00963547|12231574|FG002|STARTED|Overall Study||12
11050778|NCT00963547|12231575|FG003|STARTED|Overall Study||6
11050779|NCT00963547|12231576|FG004|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
11050780|NCT00963547|12231577|FG005|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
11050781|NCT00963547|12231578|FG006|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
11050782|NCT00963547|12231572|FG000|Treated|Overall Study||3
11050783|NCT00963547|12231573|FG001|Treated|Overall Study||11
11050784|NCT00963547|12231574|FG002|Treated|Overall Study||11
11050785|NCT00963547|12231575|FG003|Treated|Overall Study||6
11050786|NCT00963547|12231576|FG004|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
11050787|NCT00963547|12231577|FG005|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
11050788|NCT00963547|12231578|FG006|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
11050789|NCT00963547|12231572|FG000|COMPLETED|Overall Study||0
11050790|NCT00963547|12231573|FG001|COMPLETED|Overall Study||0
11050791|NCT00963547|12231574|FG002|COMPLETED|Overall Study||0
11050792|NCT00963547|12231575|FG003|COMPLETED|Overall Study||0
11050793|NCT00963547|12231576|FG004|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
11050794|NCT00963547|12231577|FG005|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
11050795|NCT00963547|12231578|FG006|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
11337723|NCT02896400|12535451|FG000|NOT COMPLETED|1 Month Follow-up||7
11337724|NCT02896400|12535452|FG001|NOT COMPLETED|1 Month Follow-up||7
11337725|NCT02896400|12535453|FG002|NOT COMPLETED|1 Month Follow-up||5
11337726|NCT02896400|12535454|FG003|NOT COMPLETED|1 Month Follow-up||8
11337727|NCT02896400|12535455|FG004|NOT COMPLETED|1 Month Follow-up||9
11050796|NCT00963547|12231572|FG000|NOT COMPLETED|Overall Study||4
11050797|NCT00963547|12231573|FG001|NOT COMPLETED|Overall Study||11
11050798|NCT00963547|12231574|FG002|NOT COMPLETED|Overall Study||12
11050799|NCT00963547|12231575|FG003|NOT COMPLETED|Overall Study||6
11050800|NCT00963547|12231576|FG004|NOT COMPLETED|Overall Study||0
11337728|NCT02896400|12535456|FG005|NOT COMPLETED|1 Month Follow-up||6
11337729|NCT02896400|12535457|FG006|NOT COMPLETED|1 Month Follow-up||5
11337730|NCT02896400|12535458|FG007|NOT COMPLETED|1 Month Follow-up||6
11337731|NCT02896400|12535459|FG008|NOT COMPLETED|1 Month Follow-up||4
11050801|NCT00963547|12231577|FG005|NOT COMPLETED|Overall Study||0
11050802|NCT00963547|12231578|FG006|NOT COMPLETED|Overall Study||0
11050803|NCT00963560|12231594|FG000|STARTED|Overall Study||47
11050804|NCT00963560|12231595|FG001|STARTED|Overall Study||44
11050805|NCT00963560|12231596|FG002|STARTED|Overall Study||41
11050806|NCT00963560|12231594|FG000|COMPLETED|Overall Study||44
11050807|NCT00963560|12231595|FG001|COMPLETED|Overall Study||41
11050808|NCT00963560|12231596|FG002|COMPLETED|Overall Study||41
11050809|NCT00963560|12231594|FG000|NOT COMPLETED|Overall Study||3
11050810|NCT00963560|12231595|FG001|NOT COMPLETED|Overall Study||3
11050811|NCT00963560|12231596|FG002|NOT COMPLETED|Overall Study||0
11050812|NCT00963638|12231606|FG000|STARTED|Overall Study||20
11050813|NCT00963638|12231607|FG001|STARTED|Overall Study||20
11050814|NCT00963638|12231606|FG000|COMPLETED|Overall Study||20
11050815|NCT00963638|12231607|FG001|COMPLETED|Overall Study||20
11050816|NCT00963638|12231606|FG000|NOT COMPLETED|Overall Study||0
11050817|NCT00963638|12231607|FG001|NOT COMPLETED|Overall Study||0
11050818|NCT00963677|12231615|FG000|STARTED|Overall Study|Patients without predicted difficult intubation|35
11050819|NCT00963677|12231616|FG001|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
11050820|NCT00963677|12231615|FG000|COMPLETED|Overall Study||35
11050821|NCT00963677|12231616|FG001|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
11050822|NCT00963677|12231615|FG000|NOT COMPLETED|Overall Study||0
11050823|NCT00963677|12231616|FG001|NOT COMPLETED|Overall Study||2
11050824|NCT00963807|12231622|FG000|STARTED|Overall Study||26
11050825|NCT00963807|12231622|FG000|Completed Baseline Imaging|Overall Study||11
11050826|NCT00963807|12231622|FG000|Completed Post-Cycle 1 Imaging|Overall Study||9
11050827|NCT00963807|12231622|FG000|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
11050828|NCT00963807|12231622|FG000|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
11050829|NCT00963807|12231622|FG000|COMPLETED|Overall Study||8
11050830|NCT00963807|12231622|FG000|NOT COMPLETED|Overall Study||18
11050831|NCT00963820|12231628|FG000|STARTED|Dose Escalation Phase||3
11050832|NCT00963820|12231629|FG001|STARTED|Dose Escalation Phase||3
11050833|NCT00963820|12231630|FG002|STARTED|Dose Escalation Phase||3
11050834|NCT00963820|12231631|FG003|STARTED|Dose Escalation Phase||3
11050835|NCT00963820|12231632|FG004|STARTED|Dose Escalation Phase||4
11050836|NCT00963820|12231633|FG005|STARTED|Dose Escalation Phase||3
11050837|NCT00963820|12231634|FG006|STARTED|Dose Escalation Phase||8
11050838|NCT00963820|12231635|FG007|STARTED|Dose Escalation Phase||5
11050839|NCT00963820|12231636|FG008|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
11050840|NCT00963820|12231637|FG009|STARTED|Dose Escalation Phase||0
11050841|NCT00963820|12231638|FG010|STARTED|Dose Escalation Phase||0
11050842|NCT00963820|12231639|FG011|STARTED|Dose Escalation Phase||0
11050843|NCT00963820|12231628|FG000|COMPLETED|Dose Escalation Phase||0
11050844|NCT00963820|12231629|FG001|COMPLETED|Dose Escalation Phase||0
11050845|NCT00963820|12231630|FG002|COMPLETED|Dose Escalation Phase||0
11050846|NCT00963820|12231631|FG003|COMPLETED|Dose Escalation Phase||0
11050847|NCT00963820|12231632|FG004|COMPLETED|Dose Escalation Phase||0
11050848|NCT00963820|12231633|FG005|COMPLETED|Dose Escalation Phase||0
11050849|NCT00963820|12231634|FG006|COMPLETED|Dose Escalation Phase||0
11050850|NCT00963820|12231635|FG007|COMPLETED|Dose Escalation Phase||0
11050851|NCT00963820|12231636|FG008|COMPLETED|Dose Escalation Phase||0
11050852|NCT00963820|12231637|FG009|COMPLETED|Dose Escalation Phase||0
11050853|NCT00963820|12231638|FG010|COMPLETED|Dose Escalation Phase||0
11050854|NCT00963820|12231639|FG011|COMPLETED|Dose Escalation Phase||0
11050855|NCT00963820|12231628|FG000|NOT COMPLETED|Dose Escalation Phase||3
11050856|NCT00963820|12231629|FG001|NOT COMPLETED|Dose Escalation Phase||3
11050857|NCT00963820|12231630|FG002|NOT COMPLETED|Dose Escalation Phase||3
11050858|NCT00963820|12231631|FG003|NOT COMPLETED|Dose Escalation Phase||3
11050859|NCT00963820|12231632|FG004|NOT COMPLETED|Dose Escalation Phase||4
11050860|NCT00963820|12231633|FG005|NOT COMPLETED|Dose Escalation Phase||3
11050861|NCT00963820|12231634|FG006|NOT COMPLETED|Dose Escalation Phase||8
11050862|NCT00963820|12231635|FG007|NOT COMPLETED|Dose Escalation Phase||5
11050863|NCT00963820|12231636|FG008|NOT COMPLETED|Dose Escalation Phase||0
11050864|NCT00963820|12231637|FG009|NOT COMPLETED|Dose Escalation Phase||0
11050865|NCT00963820|12231638|FG010|NOT COMPLETED|Dose Escalation Phase||0
11050866|NCT00963820|12231639|FG011|NOT COMPLETED|Dose Escalation Phase||0
11050867|NCT00963820|12231628|FG000|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
11337732|NCT02896400|12535460|FG009|NOT COMPLETED|1 Month Follow-up||7
11050868|NCT00963820|12231629|FG001|STARTED|Expansion Phase||0
11050869|NCT00963820|12231630|FG002|STARTED|Expansion Phase||0
11050870|NCT00963820|12231631|FG003|STARTED|Expansion Phase||0
11050871|NCT00963820|12231632|FG004|STARTED|Expansion Phase||0
11050872|NCT00963820|12231633|FG005|STARTED|Expansion Phase||0
11050873|NCT00963820|12231634|FG006|STARTED|Expansion Phase||0
11050874|NCT00963820|12231635|FG007|STARTED|Expansion Phase||0
11050875|NCT00963820|12231636|FG008|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
11050876|NCT00963820|12231637|FG009|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
11050877|NCT00963820|12231638|FG010|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
11201512|NCT01832818|12391804|FG000|NOT COMPLETED|Overall Study||6
11201513|NCT01832961|12391808|FG000|STARTED|First Intervention||8
11201514|NCT01832961|12391809|FG001|STARTED|First Intervention||7
11201515|NCT01832961|12391808|FG000|COMPLETED|First Intervention||8
11050878|NCT00963820|12231639|FG011|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
11050879|NCT00963820|12231628|FG000|COMPLETED|Expansion Phase||0
11050880|NCT00963820|12231629|FG001|COMPLETED|Expansion Phase||0
11050881|NCT00963820|12231630|FG002|COMPLETED|Expansion Phase||0
11050882|NCT00963820|12231631|FG003|COMPLETED|Expansion Phase||0
11050883|NCT00963820|12231632|FG004|COMPLETED|Expansion Phase||0
11050884|NCT00963820|12231633|FG005|COMPLETED|Expansion Phase||0
11050885|NCT00963820|12231634|FG006|COMPLETED|Expansion Phase||0
11050886|NCT00963820|12231635|FG007|COMPLETED|Expansion Phase||0
11050887|NCT00963820|12231636|FG008|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
11050888|NCT00963820|12231637|FG009|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
11050889|NCT00963820|12231638|FG010|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
11050890|NCT00963820|12231639|FG011|COMPLETED|Expansion Phase||0
11050891|NCT00963820|12231628|FG000|NOT COMPLETED|Expansion Phase||0
11050892|NCT00963820|12231629|FG001|NOT COMPLETED|Expansion Phase||0
11050893|NCT00963820|12231630|FG002|NOT COMPLETED|Expansion Phase||0
11050894|NCT00963820|12231631|FG003|NOT COMPLETED|Expansion Phase||0
11050895|NCT00963820|12231632|FG004|NOT COMPLETED|Expansion Phase||0
11050896|NCT00963820|12231633|FG005|NOT COMPLETED|Expansion Phase||0
11050897|NCT00963820|12231634|FG006|NOT COMPLETED|Expansion Phase||0
11050898|NCT00963820|12231635|FG007|NOT COMPLETED|Expansion Phase||0
11050899|NCT00963820|12231636|FG008|NOT COMPLETED|Expansion Phase||10
11050900|NCT00963820|12231637|FG009|NOT COMPLETED|Expansion Phase||9
11050901|NCT00963820|12231638|FG010|NOT COMPLETED|Expansion Phase||5
11050902|NCT00963820|12231639|FG011|NOT COMPLETED|Expansion Phase||4
11050903|NCT00963859|12231656|FG000|STARTED|Overall Study||11
11050904|NCT00963859|12231656|FG000|COMPLETED|Overall Study||11
11050905|NCT00963859|12231656|FG000|NOT COMPLETED|Overall Study||0
11050906|NCT00963872|12231662|FG000|STARTED|Overall Study||25
11050907|NCT00963872|12231663|FG001|STARTED|Overall Study||6
11050908|NCT00963872|12231662|FG000|COMPLETED|Overall Study||24
11050909|NCT00963872|12231663|FG001|COMPLETED|Overall Study||5
11050910|NCT00963872|12231662|FG000|NOT COMPLETED|Overall Study||1
11050911|NCT00963872|12231663|FG001|NOT COMPLETED|Overall Study||1
11050912|NCT00963911|12231669|FG000|STARTED|Overall Study||1674
11050913|NCT00963911|12231669|FG000|COMPLETED|Overall Study||1674
11050914|NCT00963911|12231669|FG000|NOT COMPLETED|Overall Study||0
11050915|NCT00963924|12231675|FG000|STARTED|Overall Study||18
11050916|NCT00963924|12231676|FG001|STARTED|Overall Study||18
11050917|NCT00963924|12231675|FG000|COMPLETED|Overall Study||17
11050918|NCT00963924|12231676|FG001|COMPLETED|Overall Study||15
11050919|NCT00963924|12231675|FG000|NOT COMPLETED|Overall Study||1
11050920|NCT00963924|12231676|FG001|NOT COMPLETED|Overall Study||3
11050921|NCT00963937|12231687|FG000|STARTED|Overall Study||89
11050922|NCT00963937|12231688|FG001|STARTED|Overall Study||44
11050923|NCT00963937|12231689|FG002|STARTED|Overall Study||45
11050924|NCT00963937|12231687|FG000|COMPLETED|Overall Study||70
11050925|NCT00963937|12231688|FG001|COMPLETED|Overall Study||33
11050926|NCT00963937|12231689|FG002|COMPLETED|Overall Study||41
11050927|NCT00963937|12231687|FG000|NOT COMPLETED|Overall Study||19
11050928|NCT00963937|12231688|FG001|NOT COMPLETED|Overall Study||11
11050929|NCT00963937|12231689|FG002|NOT COMPLETED|Overall Study||4
11050930|NCT00963989|12231700|FG000|STARTED|Overall Study||146
11050931|NCT00963989|12231700|FG000|COMPLETED|Overall Study||127
11050932|NCT00963989|12231700|FG000|NOT COMPLETED|Overall Study||19
11050933|NCT00964028|12231706|FG000|STARTED|Overall Study||25
11050934|NCT00964028|12231707|FG001|STARTED|Overall Study||25
11050935|NCT00964028|12231706|FG000|COMPLETED|Overall Study||25
11050936|NCT00964028|12231707|FG001|COMPLETED|Overall Study||24
11050937|NCT00964028|12231706|FG000|NOT COMPLETED|Overall Study||0
11050938|NCT00964028|12231707|FG001|NOT COMPLETED|Overall Study||1
11050939|NCT00964119|12231713|FG000|STARTED|Overall Study||15
11050940|NCT00964119|12231713|FG000|COMPLETED|Overall Study||15
11050941|NCT00964119|12231713|FG000|NOT COMPLETED|Overall Study||0
11050942|NCT00964158|12231720|FG000|STARTED|Overall Study||53
11050943|NCT00964158|12231721|FG001|STARTED|Overall Study||57
11050944|NCT00964158|12231722|FG002|STARTED|Overall Study||100
11050945|NCT00964158|12231720|FG000|COMPLETED|Overall Study||53
11050946|NCT00964158|12231721|FG001|COMPLETED|Overall Study||56
11050947|NCT00964158|12231722|FG002|COMPLETED|Overall Study||92
11050948|NCT00964158|12231720|FG000|NOT COMPLETED|Overall Study||0
11050949|NCT00964158|12231721|FG001|NOT COMPLETED|Overall Study||1
11050950|NCT00964158|12231722|FG002|NOT COMPLETED|Overall Study||8
11050951|NCT00964223|12231733|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||28
11050952|NCT00964223|12231733|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
11050953|NCT00964223|12231733|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
11050954|NCT00964223|12231733|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||28
11050955|NCT00964223|12231733|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
11050956|NCT00964223|12231733|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
11050957|NCT00964353|12231740|FG000|STARTED|Overall Study||181
11050958|NCT00964353|12231741|FG001|STARTED|Overall Study||178
11050959|NCT00964353|12231740|FG000|COMPLETED|Overall Study||181
11050960|NCT00964353|12231741|FG001|COMPLETED|Overall Study||178
11050961|NCT00964353|12231740|FG000|NOT COMPLETED|Overall Study||0
11050962|NCT00964353|12231741|FG001|NOT COMPLETED|Overall Study||0
11050963|NCT00964366|12231749|FG000|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
11337733|NCT02896400|12535461|FG010|NOT COMPLETED|1 Month Follow-up||5
11337734|NCT02896400|12535462|FG011|NOT COMPLETED|1 Month Follow-up||5
11337735|NCT02896400|12535463|FG012|NOT COMPLETED|1 Month Follow-up||3
11337736|NCT02896400|12535464|FG013|NOT COMPLETED|1 Month Follow-up||4
11337737|NCT02896400|12535465|FG014|NOT COMPLETED|1 Month Follow-up||1
11337738|NCT02896400|12535466|FG015|NOT COMPLETED|1 Month Follow-up||3
11337739|NCT02896400|12535451|FG000|STARTED|3 Month Follow-up||66
11337740|NCT02896400|12535452|FG001|STARTED|3 Month Follow-up||66
11337741|NCT02896400|12535453|FG002|STARTED|3 Month Follow-up||66
11337742|NCT02896400|12535454|FG003|STARTED|3 Month Follow-up||66
11337743|NCT02896400|12535455|FG004|STARTED|3 Month Follow-up||66
11337744|NCT02896400|12535456|FG005|STARTED|3 Month Follow-up||66
11337745|NCT02896400|12535457|FG006|STARTED|3 Month Follow-up||66
11337746|NCT02896400|12535458|FG007|STARTED|3 Month Follow-up||66
11337747|NCT02896400|12535459|FG008|STARTED|3 Month Follow-up||66
11337748|NCT02896400|12535460|FG009|STARTED|3 Month Follow-up||66
11337749|NCT02896400|12535461|FG010|STARTED|3 Month Follow-up||66
11337750|NCT02896400|12535462|FG011|STARTED|3 Month Follow-up||66
11337751|NCT02896400|12535463|FG012|STARTED|3 Month Follow-up||66
11337752|NCT02896400|12535464|FG013|STARTED|3 Month Follow-up||66
11337753|NCT02896400|12535465|FG014|STARTED|3 Month Follow-up||66
11337754|NCT02896400|12535466|FG015|STARTED|3 Month Follow-up||65
11337755|NCT02896400|12535451|FG000|COMPLETED|3 Month Follow-up||60
11337756|NCT02896400|12535452|FG001|COMPLETED|3 Month Follow-up||63
11337757|NCT02896400|12535453|FG002|COMPLETED|3 Month Follow-up||60
11337758|NCT02896400|12535454|FG003|COMPLETED|3 Month Follow-up||55
11337759|NCT02896400|12535455|FG004|COMPLETED|3 Month Follow-up||54
11337760|NCT02896400|12535456|FG005|COMPLETED|3 Month Follow-up||60
11337761|NCT02896400|12535457|FG006|COMPLETED|3 Month Follow-up||62
11337762|NCT02896400|12535458|FG007|COMPLETED|3 Month Follow-up||63
11337763|NCT02896400|12535459|FG008|COMPLETED|3 Month Follow-up||60
11337764|NCT02896400|12535460|FG009|COMPLETED|3 Month Follow-up||61
11337765|NCT02896400|12535461|FG010|COMPLETED|3 Month Follow-up||60
11337766|NCT02896400|12535462|FG011|COMPLETED|3 Month Follow-up||60
11337767|NCT02896400|12535463|FG012|COMPLETED|3 Month Follow-up||63
11337768|NCT02896400|12535464|FG013|COMPLETED|3 Month Follow-up||60
11337769|NCT02896400|12535465|FG014|COMPLETED|3 Month Follow-up||62
11337770|NCT02896400|12535466|FG015|COMPLETED|3 Month Follow-up||63
11337771|NCT02896400|12535451|FG000|NOT COMPLETED|3 Month Follow-up||6
11337772|NCT02896400|12535452|FG001|NOT COMPLETED|3 Month Follow-up||3
11337773|NCT02896400|12535453|FG002|NOT COMPLETED|3 Month Follow-up||6
11337774|NCT02896400|12535454|FG003|NOT COMPLETED|3 Month Follow-up||11
11337775|NCT02896400|12535455|FG004|NOT COMPLETED|3 Month Follow-up||12
11337776|NCT02896400|12535456|FG005|NOT COMPLETED|3 Month Follow-up||6
11337777|NCT02896400|12535457|FG006|NOT COMPLETED|3 Month Follow-up||4
11337778|NCT02896400|12535458|FG007|NOT COMPLETED|3 Month Follow-up||3
11337779|NCT02896400|12535459|FG008|NOT COMPLETED|3 Month Follow-up||6
11337780|NCT02896400|12535460|FG009|NOT COMPLETED|3 Month Follow-up||5
11337781|NCT02896400|12535461|FG010|NOT COMPLETED|3 Month Follow-up||6
11337782|NCT02896400|12535462|FG011|NOT COMPLETED|3 Month Follow-up||6
11337783|NCT02896400|12535463|FG012|NOT COMPLETED|3 Month Follow-up||3
11337784|NCT02896400|12535464|FG013|NOT COMPLETED|3 Month Follow-up||6
11337785|NCT02896400|12535465|FG014|NOT COMPLETED|3 Month Follow-up||4
11337786|NCT02896400|12535466|FG015|NOT COMPLETED|3 Month Follow-up||2
11337787|NCT02896400|12535451|FG000|STARTED|Biochemical Verification at 3 Months||60
11337788|NCT02896400|12535452|FG001|STARTED|Biochemical Verification at 3 Months||63
11337789|NCT02896400|12535453|FG002|STARTED|Biochemical Verification at 3 Months||60
11337790|NCT02896400|12535454|FG003|STARTED|Biochemical Verification at 3 Months||55
11337791|NCT02896400|12535455|FG004|STARTED|Biochemical Verification at 3 Months||54
11337792|NCT02896400|12535456|FG005|STARTED|Biochemical Verification at 3 Months||60
11337793|NCT02896400|12535457|FG006|STARTED|Biochemical Verification at 3 Months||62
11337794|NCT02896400|12535458|FG007|STARTED|Biochemical Verification at 3 Months||63
11337795|NCT02896400|12535459|FG008|STARTED|Biochemical Verification at 3 Months||60
11337796|NCT02896400|12535460|FG009|STARTED|Biochemical Verification at 3 Months||61
11337797|NCT02896400|12535461|FG010|STARTED|Biochemical Verification at 3 Months||60
11337798|NCT02896400|12535462|FG011|STARTED|Biochemical Verification at 3 Months||60
11337799|NCT02896400|12535463|FG012|STARTED|Biochemical Verification at 3 Months||63
11337800|NCT02896400|12535464|FG013|STARTED|Biochemical Verification at 3 Months||60
11337801|NCT02896400|12535465|FG014|STARTED|Biochemical Verification at 3 Months||62
11337802|NCT02896400|12535466|FG015|STARTED|Biochemical Verification at 3 Months||63
11337803|NCT02896400|12535451|FG000|COMPLETED|Biochemical Verification at 3 Months||14
11337804|NCT02896400|12535452|FG001|COMPLETED|Biochemical Verification at 3 Months||15
11337805|NCT02896400|12535453|FG002|COMPLETED|Biochemical Verification at 3 Months||13
11337806|NCT02896400|12535454|FG003|COMPLETED|Biochemical Verification at 3 Months||14
11337807|NCT02896400|12535455|FG004|COMPLETED|Biochemical Verification at 3 Months||9
11337808|NCT02896400|12535456|FG005|COMPLETED|Biochemical Verification at 3 Months||11
11337809|NCT02896400|12535457|FG006|COMPLETED|Biochemical Verification at 3 Months||11
11337810|NCT02896400|12535458|FG007|COMPLETED|Biochemical Verification at 3 Months||14
11337811|NCT02896400|12535459|FG008|COMPLETED|Biochemical Verification at 3 Months||15
11050964|NCT00964366|12231750|FG001|STARTED|Overall Study||25
11050965|NCT00964366|12231749|FG000|COMPLETED|Overall Study||27
11050966|NCT00964366|12231750|FG001|COMPLETED|Overall Study||24
11050967|NCT00964366|12231749|FG000|NOT COMPLETED|Overall Study||1
11050968|NCT00964366|12231750|FG001|NOT COMPLETED|Overall Study||1
11050969|NCT00964392|12231758|FG000|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
11050970|NCT00964392|12231759|FG001|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
11050971|NCT00964392|12231758|FG000|COMPLETED|Overall Study||72
11050972|NCT00964392|12231759|FG001|COMPLETED|Overall Study||92
11050973|NCT00964392|12231758|FG000|NOT COMPLETED|Overall Study||53
11050974|NCT00964392|12231759|FG001|NOT COMPLETED|Overall Study||190
11050975|NCT00964431|12231769|FG000|STARTED|Overall Study||50
11050976|NCT00964431|12231770|FG001|STARTED|Overall Study||51
11050977|NCT00964431|12231771|FG002|STARTED|Overall Study||51
11050978|NCT00964431|12231772|FG003|STARTED|Overall Study||51
11050979|NCT00964431|12231769|FG000|COMPLETED|Overall Study||50
11050980|NCT00964431|12231770|FG001|COMPLETED|Overall Study||51
11050981|NCT00964431|12231771|FG002|COMPLETED|Overall Study||51
11050982|NCT00964431|12231772|FG003|COMPLETED|Overall Study||51
11050983|NCT00964431|12231769|FG000|NOT COMPLETED|Overall Study||0
11050984|NCT00964431|12231770|FG001|NOT COMPLETED|Overall Study||0
11050985|NCT00964431|12231771|FG002|NOT COMPLETED|Overall Study||0
11050986|NCT00964431|12231772|FG003|NOT COMPLETED|Overall Study||0
11050987|NCT00964444|12231782|FG000|STARTED|Overall Study||10
11050988|NCT00964444|12231782|FG000|COMPLETED|Overall Study||10
11050989|NCT00964444|12231782|FG000|NOT COMPLETED|Overall Study||0
11050990|NCT00964496|12231788|FG000|STARTED|Overall Study||28
11337812|NCT02896400|12535460|FG009|COMPLETED|Biochemical Verification at 3 Months||8
11337813|NCT02896400|12535461|FG010|COMPLETED|Biochemical Verification at 3 Months||5
11337814|NCT02896400|12535462|FG011|COMPLETED|Biochemical Verification at 3 Months||19
11337815|NCT02896400|12535463|FG012|COMPLETED|Biochemical Verification at 3 Months||10
11337816|NCT02896400|12535464|FG013|COMPLETED|Biochemical Verification at 3 Months||12
11337817|NCT02896400|12535465|FG014|COMPLETED|Biochemical Verification at 3 Months||7
11337818|NCT02896400|12535466|FG015|COMPLETED|Biochemical Verification at 3 Months||6
11337819|NCT02896400|12535451|FG000|NOT COMPLETED|Biochemical Verification at 3 Months||46
11337820|NCT02896400|12535452|FG001|NOT COMPLETED|Biochemical Verification at 3 Months||48
11337821|NCT02896400|12535453|FG002|NOT COMPLETED|Biochemical Verification at 3 Months||47
11337822|NCT02896400|12535454|FG003|NOT COMPLETED|Biochemical Verification at 3 Months||41
11337823|NCT02896400|12535455|FG004|NOT COMPLETED|Biochemical Verification at 3 Months||45
11337824|NCT02896400|12535456|FG005|NOT COMPLETED|Biochemical Verification at 3 Months||49
11337825|NCT02896400|12535457|FG006|NOT COMPLETED|Biochemical Verification at 3 Months||51
11337826|NCT02896400|12535458|FG007|NOT COMPLETED|Biochemical Verification at 3 Months||49
11337827|NCT02896400|12535459|FG008|NOT COMPLETED|Biochemical Verification at 3 Months||45
11337828|NCT02896400|12535460|FG009|NOT COMPLETED|Biochemical Verification at 3 Months||53
11337829|NCT02896400|12535461|FG010|NOT COMPLETED|Biochemical Verification at 3 Months||55
11337830|NCT02896400|12535462|FG011|NOT COMPLETED|Biochemical Verification at 3 Months||41
11337831|NCT02896400|12535463|FG012|NOT COMPLETED|Biochemical Verification at 3 Months||53
11337832|NCT02896400|12535464|FG013|NOT COMPLETED|Biochemical Verification at 3 Months||48
11337833|NCT02896400|12535465|FG014|NOT COMPLETED|Biochemical Verification at 3 Months||55
11337834|NCT02896400|12535466|FG015|NOT COMPLETED|Biochemical Verification at 3 Months||57
11337835|NCT02896569|12535494|FG000|STARTED|Overall Study||25
11337836|NCT02896569|12535495|FG001|STARTED|Overall Study||24
11337837|NCT02896569|12535494|FG000|COMPLETED|Overall Study||21
11337838|NCT02896569|12535495|FG001|COMPLETED|Overall Study||19
11337839|NCT02896569|12535494|FG000|NOT COMPLETED|Overall Study||4
11337840|NCT02896569|12535495|FG001|NOT COMPLETED|Overall Study||5
11050991|NCT00964496|12231789|FG001|STARTED|Overall Study||27
11050992|NCT00964496|12231788|FG000|COMPLETED|Overall Study||26
11050993|NCT00964496|12231789|FG001|COMPLETED|Overall Study||26
11050994|NCT00964496|12231788|FG000|NOT COMPLETED|Overall Study||2
11050995|NCT00964496|12231789|FG001|NOT COMPLETED|Overall Study||1
11050996|NCT00964548|12231797|FG000|STARTED|Overall Study||5
11050997|NCT00964548|12231798|FG001|STARTED|Overall Study||5
11050998|NCT00964548|12231797|FG000|COMPLETED|Overall Study||5
11050999|NCT00964548|12231798|FG001|COMPLETED|Overall Study||5
11051000|NCT00964548|12231797|FG000|NOT COMPLETED|Overall Study||0
11051001|NCT00964548|12231798|FG001|NOT COMPLETED|Overall Study||0
11051002|NCT00964678|12231804|FG000|STARTED|Overall Study||10
11051003|NCT00964678|12231804|FG000|COMPLETED|Overall Study||6
11051004|NCT00964678|12231804|FG000|NOT COMPLETED|Overall Study||4
11051005|NCT00964743|12231809|FG000|STARTED|Overall Study||2
11051006|NCT00964743|12231809|FG000|COMPLETED|Overall Study||0
11051007|NCT00964743|12231809|FG000|NOT COMPLETED|Overall Study||2
11051008|NCT00964782|12231815|FG000|STARTED|Overall Study||8
11051009|NCT00964782|12231816|FG001|STARTED|Overall Study||8
11051010|NCT00964782|12231815|FG000|COMPLETED|Overall Study||7
11051011|NCT00964782|12231816|FG001|COMPLETED|Overall Study||8
11051012|NCT00964782|12231815|FG000|NOT COMPLETED|Overall Study||1
11051013|NCT00964782|12231816|FG001|NOT COMPLETED|Overall Study||0
11051014|NCT00964795|12231824|FG000|STARTED|Overall Study|randomized|323
11051015|NCT00964795|12231824|FG000|Number of Participants Treated|Overall Study||320
11051016|NCT00964795|12231824|FG000|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
11051017|NCT00964795|12231824|FG000|NOT COMPLETED|Overall Study||307
11051018|NCT00964860|12231831|FG000|STARTED|Overall Study||30
11051019|NCT00964860|12231832|FG001|STARTED|Overall Study||30
11051020|NCT00964860|12231831|FG000|COMPLETED|Overall Study||30
11051021|NCT00964860|12231832|FG001|COMPLETED|Overall Study||29
11337841|NCT02896595|12535503|FG000|STARTED|Overall Study||50
11337842|NCT02896595|12535504|FG001|STARTED|Overall Study||50
11337843|NCT02896595|12535503|FG000|COMPLETED|Overall Study||50
11337844|NCT02896595|12535504|FG001|COMPLETED|Overall Study||50
11337845|NCT02896595|12535503|FG000|NOT COMPLETED|Overall Study||0
11337846|NCT02896595|12535504|FG001|NOT COMPLETED|Overall Study||0
11337847|NCT02896907|12535510|FG000|STARTED|Overall Study||8
11337848|NCT02896907|12535510|FG000|COMPLETED|Overall Study||8
11337849|NCT02896907|12535510|FG000|NOT COMPLETED|Overall Study||0
11337850|NCT02897115|12535516|FG000|STARTED|Overall Study||14
11337851|NCT02897115|12535517|FG001|STARTED|Overall Study||8
11337852|NCT02897115|12535516|FG000|COMPLETED|Overall Study||3
11051022|NCT00964860|12231831|FG000|NOT COMPLETED|Overall Study||0
11051023|NCT00964860|12231832|FG001|NOT COMPLETED|Overall Study||1
11051024|NCT00964886|12231842|FG000|STARTED|Overall Study||38
11051025|NCT00964886|12231843|FG001|STARTED|Overall Study||34
11051026|NCT00964886|12231844|FG002|STARTED|Overall Study||37
11051027|NCT00964886|12231845|FG003|STARTED|Overall Study||33
11337853|NCT02897115|12535517|FG001|COMPLETED|Overall Study||0
11051028|NCT00964886|12231842|FG000|COMPLETED|Overall Study||27
11051029|NCT00964886|12231843|FG001|COMPLETED|Overall Study||27
11051030|NCT00964886|12231844|FG002|COMPLETED|Overall Study||21
11051031|NCT00964886|12231845|FG003|COMPLETED|Overall Study||24
11051032|NCT00964886|12231842|FG000|NOT COMPLETED|Overall Study||11
11337854|NCT02897115|12535516|FG000|NOT COMPLETED|Overall Study||11
11337855|NCT02897115|12535517|FG001|NOT COMPLETED|Overall Study||8
11337856|NCT02897141|12535525|FG000|STARTED|Overall Study||40
11051033|NCT00964886|12231843|FG001|NOT COMPLETED|Overall Study||7
11051034|NCT00964886|12231844|FG002|NOT COMPLETED|Overall Study||16
11051035|NCT00964886|12231845|FG003|NOT COMPLETED|Overall Study||9
11051036|NCT00965081|12231861|FG000|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
11051037|NCT00965081|12231862|FG001|STARTED|Overall Study||153
11051038|NCT00965081|12231861|FG000|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
11051039|NCT00965081|12231862|FG001|COMPLETED|Overall Study||110
11051040|NCT00965081|12231861|FG000|NOT COMPLETED|Overall Study||34
11051041|NCT00965081|12231862|FG001|NOT COMPLETED|Overall Study||43
11051042|NCT00965094|12231871|FG000|STARTED|Overall Study||19
11051043|NCT00965094|12231872|FG001|STARTED|Overall Study||17
11051044|NCT00965094|12231871|FG000|COMPLETED|Overall Study||14
11051045|NCT00965094|12231872|FG001|COMPLETED|Overall Study||16
11051046|NCT00965094|12231871|FG000|NOT COMPLETED|Overall Study||5
11051047|NCT00965094|12231872|FG001|NOT COMPLETED|Overall Study||1
11051048|NCT00965185|12231881|FG000|STARTED|Overall Study||19
11051049|NCT00965185|12231882|FG001|STARTED|Overall Study||21
11051050|NCT00965185|12231881|FG000|1 Month Visit|Overall Study||18
11051051|NCT00965185|12231882|FG001|1 Month Visit|Overall Study||21
11051052|NCT00965185|12231881|FG000|3 Month Visit|Overall Study||18
11051053|NCT00965185|12231882|FG001|3 Month Visit|Overall Study||21
11051054|NCT00965185|12231881|FG000|6 Month Visit|Overall Study||18
11051055|NCT00965185|12231882|FG001|6 Month Visit|Overall Study||21
11051056|NCT00965185|12231881|FG000|9 Month Visit|Overall Study||18
11051057|NCT00965185|12231882|FG001|9 Month Visit|Overall Study||21
11051058|NCT00965185|12231881|FG000|COMPLETED|Overall Study||17
11051059|NCT00965185|12231882|FG001|COMPLETED|Overall Study||20
11051060|NCT00965185|12231881|FG000|NOT COMPLETED|Overall Study||2
11051061|NCT00965185|12231882|FG001|NOT COMPLETED|Overall Study||1
11051062|NCT00965237|12231890|FG000|STARTED|Period 1, One Week of Wear||8
11051063|NCT00965237|12231891|FG001|STARTED|Period 1, One Week of Wear||8
11051064|NCT00965237|12231890|FG000|COMPLETED|Period 1, One Week of Wear||8
11051065|NCT00965237|12231891|FG001|COMPLETED|Period 1, One Week of Wear||8
11051066|NCT00965237|12231890|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
11051067|NCT00965237|12231891|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
11051068|NCT00965237|12231890|FG000|STARTED|Period 2, One Week of Wear||8
11051069|NCT00965237|12231891|FG001|STARTED|Period 2, One Week of Wear||8
11051070|NCT00965237|12231890|FG000|COMPLETED|Period 2, One Week of Wear||8
11051071|NCT00965237|12231891|FG001|COMPLETED|Period 2, One Week of Wear||8
11051072|NCT00965237|12231890|FG000|NOT COMPLETED|Period 2, One Week of Wear||0
11051073|NCT00965237|12231891|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
11051074|NCT00965250|12231899|FG000|STARTED|Overall Study||37
11051075|NCT00965250|12231900|FG001|STARTED|Overall Study||12
11051076|NCT00965250|12231899|FG000|COMPLETED|Overall Study||37
11051077|NCT00965250|12231900|FG001|COMPLETED|Overall Study||12
11051078|NCT00965250|12231899|FG000|NOT COMPLETED|Overall Study||0
11051079|NCT00965250|12231900|FG001|NOT COMPLETED|Overall Study||0
11051080|NCT00965263|12231908|FG000|STARTED|Overall Study||6
11051081|NCT00965263|12231909|FG001|STARTED|Overall Study||9
11051082|NCT00965263|12231908|FG000|COMPLETED|Overall Study||4
11051083|NCT00965263|12231909|FG001|COMPLETED|Overall Study||6
11051084|NCT00965263|12231908|FG000|NOT COMPLETED|Overall Study||2
11051085|NCT00965263|12231909|FG001|NOT COMPLETED|Overall Study||3
11051086|NCT00965341|12231935|FG000|STARTED|Overall Study||19
11051087|NCT00965341|12231936|FG001|STARTED|Overall Study||24
11051088|NCT00965341|12231935|FG000|COMPLETED|Overall Study||13
11051089|NCT00965341|12231936|FG001|COMPLETED|Overall Study||16
11051090|NCT00965341|12231935|FG000|NOT COMPLETED|Overall Study||6
11051091|NCT00965341|12231936|FG001|NOT COMPLETED|Overall Study||8
11051092|NCT00965419|12231942|FG000|STARTED|Open Label Treatment for Responders||267
11051093|NCT00965419|12231942|FG000|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
11051094|NCT00965419|12231942|FG000|COMPLETED|Open Label Treatment for Responders||20
11051095|NCT00965419|12231942|FG000|NOT COMPLETED|Open Label Treatment for Responders||247
11051096|NCT00965419|12231942|FG000|STARTED|Follow-up Phase||80
11051097|NCT00965419|12231942|FG000|COMPLETED|Follow-up Phase||18
11051098|NCT00965419|12231942|FG000|NOT COMPLETED|Follow-up Phase||62
11058170|NCT01001806|12239979|FG000|NOT COMPLETED|Overall Study||0
11058171|NCT01001806|12239980|FG001|NOT COMPLETED|Overall Study||1
11058172|NCT01001806|12239981|FG002|NOT COMPLETED|Overall Study||4
11058173|NCT01001832|12239991|FG000|STARTED|Short-term Period||59
11058174|NCT01001832|12239992|FG001|STARTED|Short-term Period||59
11058175|NCT01001832|12239991|FG000|COMPLETED|Short-term Period||57
11058176|NCT01001832|12239992|FG001|COMPLETED|Short-term Period||56
11058177|NCT01001832|12239991|FG000|NOT COMPLETED|Short-term Period||2
11058178|NCT01001832|12239992|FG001|NOT COMPLETED|Short-term Period||3
11058179|NCT01001832|12239991|FG000|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
11058180|NCT01001832|12239992|FG001|STARTED|Long-term Period||56
11058181|NCT01001832|12239991|FG000|COMPLETED|Long-term Period||52
11058182|NCT01001832|12239992|FG001|COMPLETED|Long-term Period||51
11058183|NCT01001832|12239991|FG000|NOT COMPLETED|Long-term Period||4
11058184|NCT01001832|12239992|FG001|NOT COMPLETED|Long-term Period||5
11058185|NCT01001832|12239991|FG000|STARTED|Follow-up Period||52
11058186|NCT01001832|12239992|FG001|STARTED|Follow-up Period||51
11058187|NCT01001832|12239991|FG000|COMPLETED|Follow-up Period||34
11058188|NCT01001832|12239992|FG001|COMPLETED|Follow-up Period||30
11058189|NCT01001832|12239991|FG000|NOT COMPLETED|Follow-up Period||18
11058190|NCT01001832|12239992|FG001|NOT COMPLETED|Follow-up Period||21
11058191|NCT01001910|12240001|FG000|STARTED|Overall Study|We screened and started 28 patients in the study. However only 22 patients were evaluable for outcome, because 6 patients did not receive adequate number of cycles of treatment for analysis. While we could not evaluate these 6 patients for their outcome, their treatment-cycles were included in the safe analysis.|28
11058192|NCT01001910|12240001|FG000|COMPLETED|Overall Study|6 patients did not receive 3 cycles required for evaluation of response as per protocol s7.1.1|22
11058193|NCT01001910|12240001|FG000|NOT COMPLETED|Overall Study||6
11058194|NCT01001975|12240007|FG000|STARTED|Overall Study||5
11058195|NCT01001975|12240008|FG001|STARTED|Overall Study||5
11058196|NCT01001975|12240007|FG000|COMPLETED|Overall Study||5
11058197|NCT01001975|12240008|FG001|COMPLETED|Overall Study||5
11058198|NCT01001975|12240007|FG000|NOT COMPLETED|Overall Study||0
11058199|NCT01001975|12240008|FG001|NOT COMPLETED|Overall Study||0
11058200|NCT01001988|12240014|FG000|STARTED|Overall Study||596
11058201|NCT01001988|12240014|FG000|COMPLETED|Overall Study||479
11058202|NCT01001988|12240014|FG000|NOT COMPLETED|Overall Study||117
11058203|NCT01002105|12240020|FG000|STARTED|Overall Study||32
11058204|NCT01002105|12240021|FG001|STARTED|Overall Study||32
11058205|NCT01002105|12240020|FG000|COMPLETED|Overall Study||13
11058206|NCT01002105|12240021|FG001|COMPLETED|Overall Study||11
11058207|NCT01002105|12240020|FG000|NOT COMPLETED|Overall Study||19
11058208|NCT01002105|12240021|FG001|NOT COMPLETED|Overall Study||21
11058209|NCT01002118|12240030|FG000|STARTED|Overall Study||1
11058210|NCT01002118|12240030|FG000|Randomized Only Patient|Overall Study||1
11058211|NCT01002118|12240030|FG000|COMPLETED|Overall Study||1
11058212|NCT01002118|12240030|FG000|NOT COMPLETED|Overall Study||0
11058213|NCT01002287|12240036|FG000|STARTED|Overall Study||8
11058214|NCT01002287|12240037|FG001|STARTED|Overall Study||3
11058215|NCT01002287|12240036|FG000|COMPLETED|Overall Study||8
11058216|NCT01002287|12240037|FG001|COMPLETED|Overall Study||3
11058217|NCT01002287|12240036|FG000|NOT COMPLETED|Overall Study||0
11058218|NCT01002287|12240037|FG001|NOT COMPLETED|Overall Study||0
11051099|NCT00965458|12231949|FG000|STARTED|Overall Study||33
11051100|NCT00965458|12231950|FG001|STARTED|Overall Study||16
11051101|NCT00965458|12231949|FG000|COMPLETED|Overall Study||31
11051102|NCT00965458|12231950|FG001|COMPLETED|Overall Study||12
11051103|NCT00965458|12231949|FG000|NOT COMPLETED|Overall Study||2
11051104|NCT00965458|12231950|FG001|NOT COMPLETED|Overall Study||4
11051105|NCT00965484|12231958|FG000|STARTED|Overall Study||136
11051106|NCT00965484|12231958|FG000|COMPLETED|Overall Study||134
11051107|NCT00965484|12231958|FG000|NOT COMPLETED|Overall Study||2
11051108|NCT00965497|12231962|FG000|STARTED|Overall Study||14
11051109|NCT00965497|12231962|FG000|COMPLETED|Overall Study||13
11051110|NCT00965497|12231962|FG000|NOT COMPLETED|Overall Study||1
11051111|NCT00965523|12231966|FG000|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
11051112|NCT00965523|12231966|FG000|COMPLETED|Study 221||74
11051113|NCT00965523|12231966|FG000|NOT COMPLETED|Study 221||7
11051114|NCT00965523|12231966|FG000|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
11051115|NCT00965523|12231966|FG000|COMPLETED|Study 224||0
11051116|NCT00965523|12231966|FG000|NOT COMPLETED|Study 224||6
11051117|NCT00965562|12231973|FG000|STARTED|Overall Study||16
11051118|NCT00965562|12231974|FG001|STARTED|Overall Study||17
11051119|NCT00965562|12231975|FG002|STARTED|Overall Study||16
11051120|NCT00965562|12231973|FG000|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
11051121|NCT00965562|12231974|FG001|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
11051122|NCT00965562|12231975|FG002|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
11051123|NCT00965562|12231973|FG000|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
11051124|NCT00965562|12231974|FG001|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
11051125|NCT00965562|12231975|FG002|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
11051126|NCT00965562|12231973|FG000|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
11051127|NCT00965562|12231974|FG001|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
11051128|NCT00965562|12231975|FG002|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
11051129|NCT00965562|12231973|FG000|NOT COMPLETED|Overall Study||3
11051130|NCT00965562|12231974|FG001|NOT COMPLETED|Overall Study||4
11051131|NCT00965562|12231975|FG002|NOT COMPLETED|Overall Study||3
11051132|NCT00965575|12231986|FG000|STARTED|Overall Study|cross over, total enrolled 11|6
11051133|NCT00965575|12231987|FG001|STARTED|Overall Study|cross over, total enrolled 11|5
11051134|NCT00965575|12231986|FG000|COMPLETED|Overall Study||5
11051135|NCT00965575|12231987|FG001|COMPLETED|Overall Study||5
11051136|NCT00965575|12231986|FG000|NOT COMPLETED|Overall Study||1
11051137|NCT00965575|12231987|FG001|NOT COMPLETED|Overall Study||0
11051138|NCT00965718|12231995|FG000|STARTED|Overall Study||20
11051139|NCT00965718|12231995|FG000|COMPLETED|Overall Study||16
11051140|NCT00965718|12231995|FG000|NOT COMPLETED|Overall Study||4
11051141|NCT00965731|12232001|FG000|STARTED|Overall Study||7
11051142|NCT00965731|12232002|FG001|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
11051143|NCT00965731|12232001|FG000|COMPLETED|Overall Study||0
11051144|NCT00965731|12232002|FG001|COMPLETED|Overall Study||0
11051145|NCT00965731|12232001|FG000|NOT COMPLETED|Overall Study||7
11051146|NCT00965731|12232002|FG001|NOT COMPLETED|Overall Study||20
11051147|NCT00965848|12232013|FG000|STARTED|Overall Study||107
11051148|NCT00965848|12232014|FG001|STARTED|Overall Study||34
11051149|NCT00965848|12232015|FG002|STARTED|Overall Study||127
11051150|NCT00965848|12232013|FG000|COMPLETED|Overall Study||78
11051151|NCT00965848|12232014|FG001|COMPLETED|Overall Study||32
11051152|NCT00965848|12232015|FG002|COMPLETED|Overall Study||117
11051153|NCT00965848|12232013|FG000|NOT COMPLETED|Overall Study||29
11051154|NCT00965848|12232014|FG001|NOT COMPLETED|Overall Study||2
11051155|NCT00965848|12232015|FG002|NOT COMPLETED|Overall Study||10
11051156|NCT00966186|12232025|FG000|STARTED|Overall Study||60
11051157|NCT00966186|12232026|FG001|STARTED|Overall Study||60
11051158|NCT00966186|12232025|FG000|COMPLETED|Overall Study||60
11051159|NCT00966186|12232026|FG001|COMPLETED|Overall Study||60
11051160|NCT00966186|12232025|FG000|NOT COMPLETED|Overall Study||0
11051161|NCT00966186|12232026|FG001|NOT COMPLETED|Overall Study||0
11051162|NCT00966238|12232038|FG000|STARTED|Overall Study||20
11051163|NCT00966238|12232039|FG001|STARTED|Overall Study||20
11051164|NCT00966238|12232040|FG002|STARTED|Overall Study||20
11051165|NCT00966238|12232041|FG003|STARTED|Overall Study||20
11051166|NCT00966238|12232042|FG004|STARTED|Overall Study||20
11051167|NCT00966238|12232043|FG005|STARTED|Overall Study||20
11051168|NCT00966238|12232038|FG000|COMPLETED|Overall Study||20
11051169|NCT00966238|12232039|FG001|COMPLETED|Overall Study||20
11051170|NCT00966238|12232040|FG002|COMPLETED|Overall Study||20
11051171|NCT00966238|12232041|FG003|COMPLETED|Overall Study||20
11051172|NCT00966238|12232042|FG004|COMPLETED|Overall Study||20
11051173|NCT00966238|12232043|FG005|COMPLETED|Overall Study||20
11051174|NCT00966238|12232038|FG000|NOT COMPLETED|Overall Study||0
11051175|NCT00966238|12232039|FG001|NOT COMPLETED|Overall Study||0
11051176|NCT00966238|12232040|FG002|NOT COMPLETED|Overall Study||0
11051177|NCT00966238|12232041|FG003|NOT COMPLETED|Overall Study||0
11051178|NCT00966238|12232042|FG004|NOT COMPLETED|Overall Study||0
11051179|NCT00966238|12232043|FG005|NOT COMPLETED|Overall Study||0
11051180|NCT00966264|12232059|FG000|STARTED|Overall Study||119
11051181|NCT00966264|12232060|FG001|STARTED|Overall Study||117
11051182|NCT00966264|12232059|FG000|COMPLETED|Overall Study|5 years results|115
11051183|NCT00966264|12232060|FG001|COMPLETED|Overall Study|5 years results|114
11051184|NCT00966264|12232059|FG000|NOT COMPLETED|Overall Study||4
11051185|NCT00966264|12232060|FG001|NOT COMPLETED|Overall Study||3
11051186|NCT00966277|12232068|FG000|STARTED|Overall Study||38
11051187|NCT00966277|12232069|FG001|STARTED|Overall Study||37
11051188|NCT00966277|12232068|FG000|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
11051189|NCT00966277|12232069|FG001|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
11051190|NCT00966277|12232068|FG000|NOT COMPLETED|Overall Study||4
11051191|NCT00966277|12232069|FG001|NOT COMPLETED|Overall Study||4
11051192|NCT00966355|12232078|FG000|STARTED|Overall Study||344
11051193|NCT00966355|12232079|FG001|STARTED|Overall Study||345
11051194|NCT00966355|12232080|FG002|STARTED|Overall Study||345
11051195|NCT00966355|12232078|FG000|COMPLETED|Overall Study||260
11051196|NCT00966355|12232079|FG001|COMPLETED|Overall Study||259
11051197|NCT00966355|12232080|FG002|COMPLETED|Overall Study||261
11051198|NCT00966355|12232078|FG000|NOT COMPLETED|Overall Study||84
11051199|NCT00966355|12232079|FG001|NOT COMPLETED|Overall Study||86
11051200|NCT00966355|12232080|FG002|NOT COMPLETED|Overall Study||84
11051201|NCT00966433|12232091|FG000|STARTED|Overall Study||11
11051202|NCT00966433|12232092|FG001|STARTED|Overall Study||11
11051203|NCT00966433|12232093|FG002|STARTED|Overall Study||11
11051204|NCT00966433|12232091|FG000|COMPLETED|Overall Study||10
11051205|NCT00966433|12232092|FG001|COMPLETED|Overall Study||10
11051206|NCT00966433|12232093|FG002|COMPLETED|Overall Study||11
11051207|NCT00966433|12232091|FG000|NOT COMPLETED|Overall Study||1
11051208|NCT00966433|12232092|FG001|NOT COMPLETED|Overall Study||1
11051209|NCT00966433|12232093|FG002|NOT COMPLETED|Overall Study||0
11051210|NCT00966446|12232106|FG000|STARTED|Overall Study||76
11051211|NCT00966446|12232107|FG001|STARTED|Overall Study||74
11051212|NCT00966446|12232108|FG002|STARTED|Overall Study||73
11051213|NCT00966446|12232106|FG000|COMPLETED|Overall Study||48
11051214|NCT00966446|12232107|FG001|COMPLETED|Overall Study||49
11051215|NCT00966446|12232108|FG002|COMPLETED|Overall Study||52
11051216|NCT00966446|12232106|FG000|NOT COMPLETED|Overall Study||28
11051217|NCT00966446|12232107|FG001|NOT COMPLETED|Overall Study||25
11051218|NCT00966446|12232108|FG002|NOT COMPLETED|Overall Study||21
11051219|NCT00966550|12232118|FG000|STARTED|Overall Study||13
11051220|NCT00966550|12232119|FG001|STARTED|Overall Study||12
11051221|NCT00966550|12232118|FG000|COMPLETED|Overall Study||13
11051222|NCT00966550|12232119|FG001|COMPLETED|Overall Study||12
11051223|NCT00966550|12232118|FG000|NOT COMPLETED|Overall Study||0
11051224|NCT00966550|12232119|FG001|NOT COMPLETED|Overall Study||0
11051225|NCT00966641|12232125|FG000|STARTED|First Intervention||17
11051226|NCT00966641|12232126|FG001|STARTED|First Intervention||17
11201516|NCT01832961|12391809|FG001|COMPLETED|First Intervention||7
11051227|NCT00966641|12232125|FG000|COMPLETED|First Intervention||17
11051228|NCT00966641|12232126|FG001|COMPLETED|First Intervention||17
11051229|NCT00966641|12232125|FG000|NOT COMPLETED|First Intervention||0
11051230|NCT00966641|12232126|FG001|NOT COMPLETED|First Intervention||0
11051231|NCT00966641|12232125|FG000|STARTED|Second Intervention||17
11051232|NCT00966641|12232126|FG001|STARTED|Second Intervention||17
11051233|NCT00966641|12232125|FG000|COMPLETED|Second Intervention||17
11051234|NCT00966641|12232126|FG001|COMPLETED|Second Intervention||17
11051235|NCT00966641|12232125|FG000|NOT COMPLETED|Second Intervention||0
11051236|NCT00966641|12232126|FG001|NOT COMPLETED|Second Intervention||0
11051237|NCT00966693|12232136|FG000|STARTED|Overall Study||3
11051238|NCT00966693|12232137|FG001|STARTED|Overall Study||3
11051239|NCT00966693|12232138|FG002|STARTED|Overall Study||9
11051240|NCT00966693|12232139|FG003|STARTED|Overall Study||49
11051241|NCT00966693|12232136|FG000|Phase 1 Completed|Overall Study||2
11051242|NCT00966693|12232137|FG001|Phase 1 Completed|Overall Study||3
11051243|NCT00966693|12232138|FG002|Phase 1 Completed|Overall Study||6
11051244|NCT00966693|12232139|FG003|Phase 1 Completed|Overall Study||0
11051245|NCT00966693|12232136|FG000|Phase 2 Completed|Overall Study||0
11051246|NCT00966693|12232137|FG001|Phase 2 Completed|Overall Study||0
11051247|NCT00966693|12232138|FG002|Phase 2 Completed|Overall Study||0
11051248|NCT00966693|12232139|FG003|Phase 2 Completed|Overall Study||46
11051249|NCT00966693|12232136|FG000|COMPLETED|Overall Study||2
11051250|NCT00966693|12232137|FG001|COMPLETED|Overall Study||3
11051251|NCT00966693|12232138|FG002|COMPLETED|Overall Study||6
11051252|NCT00966693|12232139|FG003|COMPLETED|Overall Study||26
11051253|NCT00966693|12232136|FG000|NOT COMPLETED|Overall Study||1
11051254|NCT00966693|12232137|FG001|NOT COMPLETED|Overall Study||0
11051255|NCT00966693|12232138|FG002|NOT COMPLETED|Overall Study||3
11051256|NCT00966693|12232139|FG003|NOT COMPLETED|Overall Study||23
11051257|NCT00966719|12232151|FG000|STARTED|Overall Study||50
11051258|NCT00966719|12232152|FG001|STARTED|Overall Study||49
11051259|NCT00966719|12232151|FG000|COMPLETED|Overall Study||44
11051260|NCT00966719|12232152|FG001|COMPLETED|Overall Study||38
11051261|NCT00966719|12232151|FG000|NOT COMPLETED|Overall Study||6
11051262|NCT00966719|12232152|FG001|NOT COMPLETED|Overall Study||11
11051263|NCT00966823|12232158|FG000|STARTED|Overall Study||3
11051264|NCT00966823|12232158|FG000|COMPLETED|Overall Study||2
11051265|NCT00966823|12232158|FG000|NOT COMPLETED|Overall Study||1
11051266|NCT00966849|12232165|FG000|STARTED|Overall Study||3660
11051267|NCT00966849|12232166|FG001|STARTED|Overall Study||3976
11051268|NCT00966849|12232167|FG002|STARTED|Overall Study||3169
11051269|NCT00966849|12232165|FG000|COMPLETED|Overall Study||2119
11051270|NCT00966849|12232166|FG001|COMPLETED|Overall Study||2498
11051271|NCT00966849|12232167|FG002|COMPLETED|Overall Study||1876
11051272|NCT00966849|12232165|FG000|NOT COMPLETED|Overall Study||1541
11051273|NCT00966849|12232166|FG001|NOT COMPLETED|Overall Study||1478
11051274|NCT00966849|12232167|FG002|NOT COMPLETED|Overall Study||1293
11051275|NCT00966875|12232184|FG000|STARTED|Part A||54
11051276|NCT00966875|12232185|FG001|STARTED|Part A||40
11051277|NCT00966875|12232186|FG002|STARTED|Part A||35
11051278|NCT00966875|12232187|FG003|STARTED|Part A||37
11051279|NCT00966875|12232188|FG004|STARTED|Part A||57
11337857|NCT02897141|12535526|FG001|STARTED|Overall Study||40
11337858|NCT02897141|12535525|FG000|COMPLETED|Overall Study||38
11337859|NCT02897141|12535526|FG001|COMPLETED|Overall Study||39
11337860|NCT02897141|12535525|FG000|NOT COMPLETED|Overall Study||2
11337861|NCT02897141|12535526|FG001|NOT COMPLETED|Overall Study||1
11337862|NCT02897349|12535545|FG000|STARTED|Overall Study||102
11337863|NCT02897349|12535546|FG001|STARTED|Overall Study||104
11337864|NCT02897349|12535545|FG000|COMPLETED|Overall Study||97
11337865|NCT02897349|12535546|FG001|COMPLETED|Overall Study||98
11337866|NCT02897349|12535545|FG000|NOT COMPLETED|Overall Study||5
11337867|NCT02897349|12535546|FG001|NOT COMPLETED|Overall Study||6
11337868|NCT02898103|12535554|FG000|STARTED|Overall Study||4
11337869|NCT02898103|12535555|FG001|STARTED|Overall Study||3
11337870|NCT02898103|12535554|FG000|COMPLETED|Overall Study||4
11337871|NCT02898103|12535555|FG001|COMPLETED|Overall Study||3
11337872|NCT02898103|12535554|FG000|NOT COMPLETED|Overall Study||0
11337873|NCT02898103|12535555|FG001|NOT COMPLETED|Overall Study||0
11337874|NCT02898116|12535565|FG000|STARTED|Overall Study||2
11337875|NCT02898116|12535565|FG000|COMPLETED|Overall Study||0
11337876|NCT02898116|12535565|FG000|NOT COMPLETED|Overall Study||2
11337877|NCT02898454|12535572|FG000|STARTED|Overall Study||153
11337878|NCT02898454|12535573|FG001|STARTED|Overall Study||145
11337879|NCT02898454|12535574|FG002|STARTED|Overall Study||150
11337880|NCT02898454|12535572|FG000|Intent-to-Treat (ITT) Population|Overall Study||153
11337881|NCT02898454|12535573|FG001|Intent-to-Treat (ITT) Population|Overall Study||145
11337882|NCT02898454|12535574|FG002|Intent-to-Treat (ITT) Population|Overall Study||150
11337883|NCT02898454|12535572|FG000|Treated|Overall Study||152
11337884|NCT02898454|12535573|FG001|Treated|Overall Study||145
11337885|NCT02898454|12535574|FG002|Treated|Overall Study||150
11337886|NCT02898454|12535572|FG000|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150
11337887|NCT02898454|12535573|FG001|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148
11337888|NCT02898454|12535574|FG002|Safety Population|Overall Study||149
11337889|NCT02898454|12535572|FG000|COMPLETED|Overall Study||136
11337890|NCT02898454|12535573|FG001|COMPLETED|Overall Study||140
11337891|NCT02898454|12535574|FG002|COMPLETED|Overall Study||144
11051280|NCT00966875|12232189|FG005|STARTED|Part A||37
11051281|NCT00966875|12232190|FG006|STARTED|Part A||64
11051282|NCT00966875|12232191|FG007|STARTED|Part A||65
11051283|NCT00966875|12232192|FG008|STARTED|Part A||59
11051284|NCT00966875|12232184|FG000|Received ≥1 Doses of Study Drug|Part A||54
11337892|NCT02898454|12535572|FG000|NOT COMPLETED|Overall Study||17
11337893|NCT02898454|12535573|FG001|NOT COMPLETED|Overall Study||5
11337894|NCT02898454|12535574|FG002|NOT COMPLETED|Overall Study||6
11337895|NCT02898597|12535589|FG000|STARTED|Overall Study||25
11337896|NCT02898597|12535590|FG001|STARTED|Overall Study||24
11337897|NCT02898597|12535589|FG000|COMPLETED|Overall Study||21
11337898|NCT02898597|12535590|FG001|COMPLETED|Overall Study||12
11337899|NCT02898597|12535589|FG000|NOT COMPLETED|Overall Study||4
11337900|NCT02898597|12535590|FG001|NOT COMPLETED|Overall Study||12
11337901|NCT02898662|12535598|FG000|STARTED|Overall Study||40
11337902|NCT02898662|12535599|FG001|STARTED|Overall Study||41
11337903|NCT02898662|12535598|FG000|Completed Treatment|Overall Study||25
11337904|NCT02898662|12535599|FG001|Completed Treatment|Overall Study||29
11337905|NCT02898662|12535598|FG000|COMPLETED|Overall Study||11
11337906|NCT02898662|12535599|FG001|COMPLETED|Overall Study||13
11337907|NCT02898662|12535598|FG000|NOT COMPLETED|Overall Study||29
11337908|NCT02898662|12535599|FG001|NOT COMPLETED|Overall Study||28
11337909|NCT02898740|12535607|FG000|STARTED|Overall Study||21
11337910|NCT02898740|12535608|FG001|STARTED|Overall Study||19
11337911|NCT02898740|12535607|FG000|COMPLETED|Overall Study||21
11337912|NCT02898740|12535608|FG001|COMPLETED|Overall Study||19
11337913|NCT02898740|12535607|FG000|NOT COMPLETED|Overall Study||0
11337914|NCT02898740|12535608|FG001|NOT COMPLETED|Overall Study||0
11337915|NCT02898974|12535616|FG000|STARTED|Overall Study||13
11337916|NCT02898974|12535617|FG001|STARTED|Overall Study||9
11051285|NCT00966875|12232185|FG001|Received ≥1 Doses of Study Drug|Part A||40
11051286|NCT00966875|12232186|FG002|Received ≥1 Doses of Study Drug|Part A||35
11051287|NCT00966875|12232187|FG003|Received ≥1 Doses of Study Drug|Part A||37
11337917|NCT02898974|12535616|FG000|COMPLETED|Overall Study||13
11337918|NCT02898974|12535617|FG001|COMPLETED|Overall Study||9
11337919|NCT02898974|12535616|FG000|NOT COMPLETED|Overall Study||0
11051288|NCT00966875|12232188|FG004|Received ≥1 Doses of Study Drug|Part A||57
11051289|NCT00966875|12232189|FG005|Received ≥1 Doses of Study Drug|Part A||37
11051290|NCT00966875|12232190|FG006|Received ≥1 Doses of Study Drug|Part A||64
11051291|NCT00966875|12232191|FG007|Received ≥1 Doses of Study Drug|Part A||65
11337920|NCT02898974|12535617|FG001|NOT COMPLETED|Overall Study||0
11337921|NCT02899156|12535625|FG000|STARTED|Overall Study||11
11337922|NCT02899156|12535626|FG001|STARTED|Overall Study||11
11337923|NCT02899156|12535625|FG000|COMPLETED|Overall Study||10
11337924|NCT02899156|12535626|FG001|COMPLETED|Overall Study||10
11337925|NCT02899156|12535625|FG000|NOT COMPLETED|Overall Study||1
11337926|NCT02899156|12535626|FG001|NOT COMPLETED|Overall Study||1
11337927|NCT02899195|12535632|FG000|STARTED|Concurrent Durvalumab||55
11337928|NCT02899195|12535632|FG000|COMPLETED|Concurrent Durvalumab||44
11337929|NCT02899195|12535632|FG000|NOT COMPLETED|Concurrent Durvalumab||11
11337930|NCT02899195|12535632|FG000|STARTED|Maintenance Durvalumab||44
11337931|NCT02899195|12535632|FG000|COMPLETED|Maintenance Durvalumab||10
11337932|NCT02899195|12535632|FG000|NOT COMPLETED|Maintenance Durvalumab||34
11337933|NCT02899338|12535638|FG000|STARTED|Overall Study||81
11337934|NCT02899338|12535639|FG001|STARTED|Overall Study||81
11337935|NCT02899338|12535638|FG000|COMPLETED|Overall Study||78
11337936|NCT02899338|12535639|FG001|COMPLETED|Overall Study||79
11337937|NCT02899338|12535638|FG000|NOT COMPLETED|Overall Study||3
11337938|NCT02899338|12535639|FG001|NOT COMPLETED|Overall Study||2
11337939|NCT02899377|12535647|FG000|STARTED|Overall Study||13
11337940|NCT02899377|12535648|FG001|STARTED|Overall Study||12
11337941|NCT02899377|12535647|FG000|COMPLETED|Overall Study||12
11051292|NCT00966875|12232192|FG008|Received ≥1 Doses of Study Drug|Part A||59
11051293|NCT00966875|12232184|FG000|COMPLETED|Part A||48
11051294|NCT00966875|12232185|FG001|COMPLETED|Part A||36
11051295|NCT00966875|12232186|FG002|COMPLETED|Part A||33
11051296|NCT00966875|12232187|FG003|COMPLETED|Part A||34
11051297|NCT00966875|12232188|FG004|COMPLETED|Part A||52
11051298|NCT00966875|12232189|FG005|COMPLETED|Part A||33
11051299|NCT00966875|12232190|FG006|COMPLETED|Part A||52
11051300|NCT00966875|12232191|FG007|COMPLETED|Part A||58
11051301|NCT00966875|12232192|FG008|COMPLETED|Part A||51
11051302|NCT00966875|12232184|FG000|NOT COMPLETED|Part A||6
11051303|NCT00966875|12232185|FG001|NOT COMPLETED|Part A||4
11051304|NCT00966875|12232186|FG002|NOT COMPLETED|Part A||2
11051305|NCT00966875|12232187|FG003|NOT COMPLETED|Part A||3
11051306|NCT00966875|12232188|FG004|NOT COMPLETED|Part A||5
11051307|NCT00966875|12232189|FG005|NOT COMPLETED|Part A||4
11051308|NCT00966875|12232190|FG006|NOT COMPLETED|Part A||12
11051309|NCT00966875|12232191|FG007|NOT COMPLETED|Part A||7
11051310|NCT00966875|12232192|FG008|NOT COMPLETED|Part A||8
11051311|NCT00966875|12232184|FG000|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
11051312|NCT00966875|12232185|FG001|STARTED|Part B||36
11051313|NCT00966875|12232186|FG002|STARTED|Part B||33
11051314|NCT00966875|12232187|FG003|STARTED|Part B||34
11051315|NCT00966875|12232188|FG004|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
11051316|NCT00966875|12232189|FG005|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
11051317|NCT00966875|12232190|FG006|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
11051318|NCT00966875|12232191|FG007|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
11051319|NCT00966875|12232192|FG008|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
11051320|NCT00966875|12232184|FG000|COMPLETED|Part B||41
11051321|NCT00966875|12232185|FG001|COMPLETED|Part B||33
11051322|NCT00966875|12232186|FG002|COMPLETED|Part B||27
11051323|NCT00966875|12232187|FG003|COMPLETED|Part B||31
11051324|NCT00966875|12232188|FG004|COMPLETED|Part B||44
11051325|NCT00966875|12232189|FG005|COMPLETED|Part B||26
11051326|NCT00966875|12232190|FG006|COMPLETED|Part B||29
11051327|NCT00966875|12232191|FG007|COMPLETED|Part B||38
11051328|NCT00966875|12232192|FG008|COMPLETED|Part B||32
11051329|NCT00966875|12232184|FG000|NOT COMPLETED|Part B||5
11051330|NCT00966875|12232185|FG001|NOT COMPLETED|Part B||3
11051331|NCT00966875|12232186|FG002|NOT COMPLETED|Part B||6
11337942|NCT02899377|12535648|FG001|COMPLETED|Overall Study||12
11337943|NCT02899377|12535647|FG000|NOT COMPLETED|Overall Study||1
11337944|NCT02899377|12535648|FG001|NOT COMPLETED|Overall Study||0
11051332|NCT00966875|12232187|FG003|NOT COMPLETED|Part B||3
11051333|NCT00966875|12232188|FG004|NOT COMPLETED|Part B||7
11051334|NCT00966875|12232189|FG005|NOT COMPLETED|Part B||6
11051335|NCT00966875|12232190|FG006|NOT COMPLETED|Part B||22
11051336|NCT00966875|12232191|FG007|NOT COMPLETED|Part B||19
11051337|NCT00966875|12232192|FG008|NOT COMPLETED|Part B||18
11051338|NCT00966940|12232267|FG000|STARTED|Period 1, First 6 Weeks||28
11051339|NCT00966940|12232268|FG001|STARTED|Period 1, First 6 Weeks||23
11051340|NCT00966940|12232267|FG000|COMPLETED|Period 1, First 6 Weeks||25
11051341|NCT00966940|12232268|FG001|COMPLETED|Period 1, First 6 Weeks||23
11051342|NCT00966940|12232267|FG000|NOT COMPLETED|Period 1, First 6 Weeks||3
11051343|NCT00966940|12232268|FG001|NOT COMPLETED|Period 1, First 6 Weeks||0
11051344|NCT00966940|12232267|FG000|STARTED|Period 2, Second 6 Weeks||25
11051345|NCT00966940|12232268|FG001|STARTED|Period 2, Second 6 Weeks||23
11051346|NCT00966940|12232267|FG000|COMPLETED|Period 2, Second 6 Weeks||25
11051347|NCT00966940|12232268|FG001|COMPLETED|Period 2, Second 6 Weeks||23
11051348|NCT00966940|12232267|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0
11051349|NCT00966940|12232268|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0
11051350|NCT00967005|12232276|FG000|STARTED|Overall Study||13
11051351|NCT00967005|12232277|FG001|STARTED|Overall Study||15
11051352|NCT00967005|12232276|FG000|Treatment Completion|Overall Study||10
11051353|NCT00967005|12232277|FG001|Treatment Completion|Overall Study||10
11051354|NCT00967005|12232276|FG000|COMPLETED|Overall Study||6
11051355|NCT00967005|12232277|FG001|COMPLETED|Overall Study||5
11051356|NCT00967005|12232276|FG000|NOT COMPLETED|Overall Study||7
11051357|NCT00967005|12232277|FG001|NOT COMPLETED|Overall Study||10
11051358|NCT00967018|12232283|FG000|STARTED|Overall Study||77
11051359|NCT00967018|12232283|FG000|COMPLETED|Overall Study||56
11051360|NCT00967018|12232283|FG000|NOT COMPLETED|Overall Study||21
11051361|NCT00967044|12232287|FG000|STARTED|Overall Study||30
11051362|NCT00967044|12232287|FG000|COMPLETED|Overall Study||30
11051363|NCT00967044|12232287|FG000|NOT COMPLETED|Overall Study||0
11051364|NCT00967226|12232293|FG000|STARTED|Overall Study||11
11051365|NCT00967226|12232294|FG001|STARTED|Overall Study||8
11051366|NCT00967226|12232293|FG000|COMPLETED|Overall Study||9
11051367|NCT00967226|12232294|FG001|COMPLETED|Overall Study||2
11051368|NCT00967226|12232293|FG000|NOT COMPLETED|Overall Study||2
11051369|NCT00967226|12232294|FG001|NOT COMPLETED|Overall Study||6
11051370|NCT00967330|12232326|FG000|STARTED|Overall Study||122
11051371|NCT00967330|12232327|FG001|STARTED|Overall Study||60
11051372|NCT00967330|12232326|FG000|COMPLETED|Overall Study||0
11051373|NCT00967330|12232327|FG001|COMPLETED|Overall Study||0
11051374|NCT00967330|12232326|FG000|NOT COMPLETED|Overall Study||122
11051375|NCT00967330|12232327|FG001|NOT COMPLETED|Overall Study||60
11051376|NCT00967343|12232333|FG000|STARTED|Overall Study||40
11051377|NCT00967343|12232333|FG000|COMPLETED|Overall Study||2
11051378|NCT00967343|12232333|FG000|NOT COMPLETED|Overall Study||38
11051379|NCT00967369|12232339|FG000|STARTED|Overall Study||10
11051380|NCT00967369|12232340|FG001|STARTED|Overall Study||10
11051381|NCT00967369|12232339|FG000|Relapsed|Overall Study||4
11051382|NCT00967369|12232340|FG001|Relapsed|Overall Study||7
11051383|NCT00967369|12232339|FG000|Refractory|Overall Study||6
11051384|NCT00967369|12232340|FG001|Refractory|Overall Study||3
11051385|NCT00967369|12232339|FG000|COMPLETED|Overall Study||10
11051386|NCT00967369|12232340|FG001|COMPLETED|Overall Study||10
11051387|NCT00967369|12232339|FG000|NOT COMPLETED|Overall Study||0
11051388|NCT00967369|12232340|FG001|NOT COMPLETED|Overall Study||0
11051389|NCT00967473|12232346|FG000|STARTED|Overall Study||15
11051390|NCT00967473|12232346|FG000|COMPLETED|Overall Study||15
11051391|NCT00967473|12232346|FG000|NOT COMPLETED|Overall Study||0
11051392|NCT00967486|12232352|FG000|STARTED|Overall Study||98
11051393|NCT00967486|12232353|FG001|STARTED|Overall Study||102
11051394|NCT00967486|12232352|FG000|COMPLETED|Overall Study||98
11051395|NCT00967486|12232353|FG001|COMPLETED|Overall Study||102
11051396|NCT00967486|12232352|FG000|NOT COMPLETED|Overall Study||0
11051397|NCT00967486|12232353|FG001|NOT COMPLETED|Overall Study||0
11051398|NCT00967499|12232361|FG000|STARTED|Overall Study||111
11051399|NCT00967499|12232362|FG001|STARTED|Overall Study||109
11051400|NCT00967499|12232361|FG000|Treated (Full Analysis Set)|Overall Study||48
11051401|NCT00967499|12232362|FG001|Treated (Full Analysis Set)|Overall Study||50
11051402|NCT00967499|12232361|FG000|COMPLETED|Overall Study||46
11051403|NCT00967499|12232362|FG001|COMPLETED|Overall Study||49
11051404|NCT00967499|12232361|FG000|NOT COMPLETED|Overall Study||65
11051405|NCT00967499|12232362|FG001|NOT COMPLETED|Overall Study||60
11051406|NCT00967551|12232370|FG000|STARTED|Overall Study||68
11051407|NCT00967551|12232371|FG001|STARTED|Overall Study||75
11051408|NCT00967551|12232370|FG000|COMPLETED|Overall Study||68
11051409|NCT00967551|12232371|FG001|COMPLETED|Overall Study||75
11051410|NCT00967551|12232370|FG000|NOT COMPLETED|Overall Study||0
11051411|NCT00967551|12232371|FG001|NOT COMPLETED|Overall Study||0
11051412|NCT00967616|12232379|FG000|STARTED|Overall Study||50
11051413|NCT00967616|12232380|FG001|STARTED|Overall Study||50
11051414|NCT00967616|12232379|FG000|COMPLETED|Overall Study||0
11051415|NCT00967616|12232380|FG001|COMPLETED|Overall Study||0
11051416|NCT00967616|12232379|FG000|NOT COMPLETED|Overall Study||50
11051417|NCT00967616|12232380|FG001|NOT COMPLETED|Overall Study||50
11051418|NCT00967668|12232389|FG000|STARTED|Overall Study||162
11051419|NCT00967668|12232390|FG001|STARTED|Overall Study||160
11051420|NCT00967668|12232391|FG002|STARTED|Overall Study||159
11051421|NCT00967668|12232389|FG000|3-mo Assessment|Overall Study||131
11051422|NCT00967668|12232390|FG001|3-mo Assessment|Overall Study||127
11051423|NCT00967668|12232391|FG002|3-mo Assessment|Overall Study||115
11051424|NCT00967668|12232389|FG000|Completed Year 1 - 12-mo Assessment|Overall Study||120
11051425|NCT00967668|12232390|FG001|Completed Year 1 - 12-mo Assessment|Overall Study||122
11051426|NCT00967668|12232391|FG002|Completed Year 1 - 12-mo Assessment|Overall Study||119
11051427|NCT00967668|12232389|FG000|18-mo Assessment|Overall Study||95
11051428|NCT00967668|12232390|FG001|18-mo Assessment|Overall Study||102
11051429|NCT00967668|12232391|FG002|18-mo Assessment|Overall Study||92
11051430|NCT00967668|12232389|FG000|COMPLETED|Overall Study||91
11051431|NCT00967668|12232390|FG001|COMPLETED|Overall Study||104
11051432|NCT00967668|12232391|FG002|COMPLETED|Overall Study||90
11051433|NCT00967668|12232389|FG000|NOT COMPLETED|Overall Study||71
11051434|NCT00967668|12232390|FG001|NOT COMPLETED|Overall Study||56
11051435|NCT00967668|12232391|FG002|NOT COMPLETED|Overall Study||69
11051436|NCT00967694|12232402|FG000|STARTED|Overall Study||26
11051437|NCT00967694|12232402|FG000|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
11051438|NCT00967694|12232402|FG000|NOT COMPLETED|Overall Study||6
11051439|NCT00967798|12232408|FG000|STARTED|Overall Study||17
11051440|NCT00967798|12232409|FG001|STARTED|Overall Study||16
11051441|NCT00967798|12232408|FG000|COMPLETED|Overall Study||8
11051442|NCT00967798|12232409|FG001|COMPLETED|Overall Study||13
11051443|NCT00967798|12232408|FG000|NOT COMPLETED|Overall Study||9
11051444|NCT00967798|12232409|FG001|NOT COMPLETED|Overall Study||3
11051445|NCT00967941|12232418|FG000|STARTED|Overall Study||67
11051446|NCT00967941|12232419|FG001|STARTED|Overall Study||54
11051447|NCT00967941|12232420|FG002|STARTED|Overall Study||60
11051448|NCT00967941|12232418|FG000|COMPLETED|Overall Study||62
11051449|NCT00967941|12232419|FG001|COMPLETED|Overall Study||51
11051450|NCT00967941|12232420|FG002|COMPLETED|Overall Study||56
11051451|NCT00967941|12232418|FG000|NOT COMPLETED|Overall Study||5
11051452|NCT00967941|12232419|FG001|NOT COMPLETED|Overall Study||3
11051453|NCT00967941|12232420|FG002|NOT COMPLETED|Overall Study||4
11051454|NCT00967993|12232428|FG000|STARTED|Overall Study||22
11051455|NCT00967993|12232428|FG000|COMPLETED|Overall Study||18
11051456|NCT00967993|12232428|FG000|NOT COMPLETED|Overall Study||4
11051457|NCT00968019|12232432|FG000|STARTED|Overall Study||318
11051458|NCT00968019|12232432|FG000|COMPLETED|Overall Study||303
11051459|NCT00968019|12232432|FG000|NOT COMPLETED|Overall Study||15
11051460|NCT00968032|12232436|FG000|STARTED|Overall Study||63
11051461|NCT00968032|12232436|FG000|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
11051462|NCT00968032|12232436|FG000|NOT COMPLETED|Overall Study||2
11051463|NCT00968071|12232440|FG000|STARTED|Overall Study||71
11051464|NCT00968071|12232440|FG000|COMPLETED|Overall Study||71
11051465|NCT00968071|12232440|FG000|NOT COMPLETED|Overall Study||0
11051466|NCT00968227|12232444|FG000|STARTED|Overall Study||56
11051467|NCT00968227|12232444|FG000|COMPLETED|Overall Study||56
11051468|NCT00968227|12232444|FG000|NOT COMPLETED|Overall Study||0
11051469|NCT00968253|12232451|FG000|STARTED|Overall Study||3
11051470|NCT00968253|12232452|FG001|STARTED|Overall Study||9
11051471|NCT00968253|12232453|FG002|STARTED|Overall Study||12
11051472|NCT00968253|12232451|FG000|COMPLETED|Overall Study||3
11051473|NCT00968253|12232452|FG001|COMPLETED|Overall Study||6
11051474|NCT00968253|12232453|FG002|COMPLETED|Overall Study||5
11051475|NCT00968253|12232451|FG000|NOT COMPLETED|Overall Study||0
11051476|NCT00968253|12232452|FG001|NOT COMPLETED|Overall Study||3
11051477|NCT00968253|12232453|FG002|NOT COMPLETED|Overall Study||7
11051478|NCT00968344|12232464|FG000|STARTED|Overall Study|Includes screen fails|20
11051479|NCT00968344|12232465|FG001|STARTED|Overall Study|Includes screen fails|20
11051480|NCT00968344|12232464|FG000|COMPLETED|Overall Study||10
11051481|NCT00968344|12232465|FG001|COMPLETED|Overall Study||9
11051482|NCT00968344|12232464|FG000|NOT COMPLETED|Overall Study||10
11051483|NCT00968344|12232465|FG001|NOT COMPLETED|Overall Study||11
11051484|NCT00968526|12232473|FG000|STARTED|Overall Study||138
11051485|NCT00968526|12232474|FG001|STARTED|Overall Study||102
11051486|NCT00968526|12232473|FG000|COMPLETED|Overall Study||135
11051487|NCT00968526|12232474|FG001|COMPLETED|Overall Study||102
11051488|NCT00968526|12232473|FG000|NOT COMPLETED|Overall Study||3
11051489|NCT00968526|12232474|FG001|NOT COMPLETED|Overall Study||0
11051490|NCT00968539|12232491|FG000|STARTED|Overall Study||64
11337945|NCT02899650|12535659|FG000|STARTED|Overall Study||15
11337946|NCT02899650|12535660|FG001|STARTED|Overall Study||10
11337947|NCT02899650|12535661|FG002|STARTED|Overall Study||14
11337948|NCT02899650|12535662|FG003|STARTED|Overall Study|We were not able to recruit older unfit adults so this group was dropped from the study.|0
11337949|NCT02899650|12535659|FG000|COMPLETED|Overall Study||15
11337950|NCT02899650|12535660|FG001|COMPLETED|Overall Study||10
11051491|NCT00968539|12232492|FG001|STARTED|Overall Study||66
11051492|NCT00968539|12232491|FG000|COMPLETED|Overall Study||63
11051493|NCT00968539|12232492|FG001|COMPLETED|Overall Study||66
11051494|NCT00968539|12232491|FG000|NOT COMPLETED|Overall Study||1
11337951|NCT02899650|12535661|FG002|COMPLETED|Overall Study||14
11337952|NCT02899650|12535662|FG003|COMPLETED|Overall Study||0
11337953|NCT02899650|12535659|FG000|NOT COMPLETED|Overall Study||0
11337954|NCT02899650|12535660|FG001|NOT COMPLETED|Overall Study||0
11337955|NCT02899650|12535661|FG002|NOT COMPLETED|Overall Study||0
11337956|NCT02899650|12535662|FG003|NOT COMPLETED|Overall Study||0
11337957|NCT02899689|12535673|FG000|STARTED|Overall Study||209
11337958|NCT02899689|12535674|FG001|STARTED|Overall Study||210
11337959|NCT02899689|12535673|FG000|COMPLETED|Overall Study||209
11337960|NCT02899689|12535674|FG001|COMPLETED|Overall Study||208
11337961|NCT02899689|12535673|FG000|NOT COMPLETED|Overall Study||0
11337962|NCT02899689|12535674|FG001|NOT COMPLETED|Overall Study||2
11337963|NCT02899884|12535680|FG000|STARTED|Overall Study||3765
11337964|NCT02899884|12535680|FG000|COMPLETED|Overall Study||3765
11337965|NCT02899884|12535680|FG000|NOT COMPLETED|Overall Study||0
11051495|NCT00968539|12232492|FG001|NOT COMPLETED|Overall Study||0
11051496|NCT00968617|12232499|FG000|STARTED|Overall Study||7
11051497|NCT00968617|12232499|FG000|COMPLETED|Overall Study||1
11051498|NCT00968617|12232499|FG000|NOT COMPLETED|Overall Study||6
11051499|NCT00968669|12232507|FG000|STARTED|Overall Study||82
11051500|NCT00968669|12232508|FG001|STARTED|Overall Study||81
11051501|NCT00968669|12232509|FG002|STARTED|Overall Study||83
11051502|NCT00968669|12232510|FG003|STARTED|Overall Study||81
11051503|NCT00968669|12232507|FG000|COMPLETED|Overall Study||64
11051504|NCT00968669|12232508|FG001|COMPLETED|Overall Study||63
11051505|NCT00968669|12232509|FG002|COMPLETED|Overall Study||72
11051506|NCT00968669|12232510|FG003|COMPLETED|Overall Study||72
11051507|NCT00968669|12232507|FG000|NOT COMPLETED|Overall Study||18
11051508|NCT00968669|12232508|FG001|NOT COMPLETED|Overall Study||18
11051509|NCT00968669|12232509|FG002|NOT COMPLETED|Overall Study||11
11051510|NCT00968669|12232510|FG003|NOT COMPLETED|Overall Study||9
11051511|NCT00968708|12232522|FG000|STARTED|Overall Study||2679
11051512|NCT00968708|12232523|FG001|STARTED|Overall Study||2701
11051513|NCT00968708|12232522|FG000|Treated|Overall Study||2676
11051514|NCT00968708|12232523|FG001|Treated|Overall Study||2698
11051515|NCT00968708|12232522|FG000|COMPLETED|Overall Study||2361
11051516|NCT00968708|12232523|FG001|COMPLETED|Overall Study||2403
11051517|NCT00968708|12232522|FG000|NOT COMPLETED|Overall Study||318
11051518|NCT00968708|12232523|FG001|NOT COMPLETED|Overall Study||298
11051519|NCT00968799|12232529|FG000|STARTED|Overall Study||6
11051520|NCT00968799|12232529|FG000|COMPLETED|Overall Study||4
11051521|NCT00968799|12232529|FG000|NOT COMPLETED|Overall Study||2
11051522|NCT00968812|12232536|FG000|STARTED|Overall Study||483
11051523|NCT00968812|12232537|FG001|STARTED|Overall Study||485
11051524|NCT00968812|12232538|FG002|STARTED|Overall Study||482
11051525|NCT00968812|12232536|FG000|COMPLETED|Overall Study||343
11051526|NCT00968812|12232537|FG001|COMPLETED|Overall Study||323
11051527|NCT00968812|12232538|FG002|COMPLETED|Overall Study||314
11051528|NCT00968812|12232536|FG000|NOT COMPLETED|Overall Study||140
11051529|NCT00968812|12232537|FG001|NOT COMPLETED|Overall Study||162
11051530|NCT00968812|12232538|FG002|NOT COMPLETED|Overall Study||168
11051531|NCT00968838|12232551|FG000|STARTED|Overall Study||50
11051532|NCT00968838|12232552|FG001|STARTED|Overall Study||58
11051533|NCT00968838|12232551|FG000|COMPLETED|Overall Study||50
11051534|NCT00968838|12232552|FG001|COMPLETED|Overall Study||58
11051535|NCT00968838|12232551|FG000|NOT COMPLETED|Overall Study||0
11051536|NCT00968838|12232552|FG001|NOT COMPLETED|Overall Study||0
11051537|NCT00968890|12232560|FG000|STARTED|Overall Study||84
11051538|NCT00968890|12232561|FG001|STARTED|Overall Study||84
11051539|NCT00968890|12232560|FG000|COMPLETED|Overall Study||84
11051540|NCT00968890|12232561|FG001|COMPLETED|Overall Study||84
11051541|NCT00968890|12232560|FG000|NOT COMPLETED|Overall Study||0
11051542|NCT00968890|12232561|FG001|NOT COMPLETED|Overall Study||0
11051543|NCT00968968|12232569|FG000|STARTED|Overall Study||20
11051544|NCT00968968|12232570|FG001|STARTED|Overall Study||17
11051545|NCT00968968|12232569|FG000|COMPLETED|Overall Study||4
11051546|NCT00968968|12232570|FG001|COMPLETED|Overall Study||3
11051547|NCT00968968|12232569|FG000|NOT COMPLETED|Overall Study||16
11051548|NCT00968968|12232570|FG001|NOT COMPLETED|Overall Study||14
11337966|NCT02899962|12535684|FG000|STARTED|Open-label Phase||650
11337967|NCT02899962|12535685|FG001|STARTED|Open-label Phase||0
11337968|NCT02899962|12535686|FG002|STARTED|Open-label Phase||0
11051549|NCT00968981|12232580|FG000|STARTED|Overall Study||23
11051550|NCT00968981|12232581|FG001|STARTED|Overall Study||22
11051551|NCT00968981|12232582|FG002|STARTED|Overall Study||22
11051552|NCT00968981|12232580|FG000|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
11051553|NCT00968981|12232581|FG001|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
11051554|NCT00968981|12232582|FG002|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
11051555|NCT00968981|12232580|FG000|COMPLETED|Overall Study||1
11051556|NCT00968981|12232581|FG001|COMPLETED|Overall Study||0
11051557|NCT00968981|12232582|FG002|COMPLETED|Overall Study||0
11051558|NCT00968981|12232580|FG000|NOT COMPLETED|Overall Study||22
11051559|NCT00968981|12232581|FG001|NOT COMPLETED|Overall Study||22
11051560|NCT00968981|12232582|FG002|NOT COMPLETED|Overall Study||22
11051561|NCT00969124|12232591|FG000|STARTED|Overall Study||328
11051562|NCT00969124|12232591|FG000|COMPLETED|Overall Study||298
11051563|NCT00969124|12232591|FG000|NOT COMPLETED|Overall Study||30
11051564|NCT00969150|12232598|FG000|STARTED|Overall Study||182
11051565|NCT00969150|12232599|FG001|STARTED|Overall Study||175
11051566|NCT00969150|12232598|FG000|COMPLETED|Overall Study||149
11051567|NCT00969150|12232599|FG001|COMPLETED|Overall Study||135
11051568|NCT00969150|12232598|FG000|NOT COMPLETED|Overall Study||33
11051569|NCT00969150|12232599|FG001|NOT COMPLETED|Overall Study||40
11051570|NCT00969228|12232607|FG000|STARTED|Overall Study||508
11051571|NCT00969228|12232608|FG001|STARTED|Overall Study||176
11051572|NCT00969228|12232607|FG000|COMPLETED|Overall Study||465
11051573|NCT00969228|12232608|FG001|COMPLETED|Overall Study||162
11051574|NCT00969228|12232607|FG000|NOT COMPLETED|Overall Study||43
11051575|NCT00969228|12232608|FG001|NOT COMPLETED|Overall Study||14
11051576|NCT00969280|12232616|FG000|STARTED|Overall Study||21
11051577|NCT00969280|12232617|FG001|STARTED|Overall Study||21
11051578|NCT00969280|12232616|FG000|COMPLETED|Overall Study||19
11051579|NCT00969280|12232617|FG001|COMPLETED|Overall Study||18
11051580|NCT00969280|12232616|FG000|NOT COMPLETED|Overall Study||2
11051581|NCT00969280|12232617|FG001|NOT COMPLETED|Overall Study||3
11051582|NCT00969332|12232623|FG000|STARTED|Overall Study||62
11051583|NCT00969332|12232623|FG000|COMPLETED|Overall Study||51
11051584|NCT00969332|12232623|FG000|NOT COMPLETED|Overall Study||11
11051585|NCT00969436|12232631|FG000|STARTED|Overall Study||180
11051586|NCT00969436|12232632|FG001|STARTED|Overall Study||180
11051587|NCT00969436|12232633|FG002|STARTED|Overall Study||90
11051588|NCT00969436|12232631|FG000|COMPLETED|Overall Study||155
11051589|NCT00969436|12232632|FG001|COMPLETED|Overall Study||159
11051590|NCT00969436|12232633|FG002|COMPLETED|Overall Study||79
11051591|NCT00969436|12232631|FG000|NOT COMPLETED|Overall Study||25
11051592|NCT00969436|12232632|FG001|NOT COMPLETED|Overall Study||21
11051593|NCT00969436|12232633|FG002|NOT COMPLETED|Overall Study||11
11051594|NCT00969501|12232641|FG000|STARTED|Overall Study||32
11051595|NCT00969501|12232641|FG000|COMPLETED|Overall Study||27
11051596|NCT00969501|12232641|FG000|NOT COMPLETED|Overall Study||5
11051597|NCT00969540|12232647|FG000|STARTED|Overall Study||4
11051598|NCT00969540|12232648|FG001|STARTED|Overall Study||4
11051599|NCT00969540|12232647|FG000|COMPLETED|Overall Study||3
11051600|NCT00969540|12232648|FG001|COMPLETED|Overall Study||3
11051601|NCT00969540|12232647|FG000|NOT COMPLETED|Overall Study||1
11051602|NCT00969540|12232648|FG001|NOT COMPLETED|Overall Study||1
11051603|NCT00969553|12232675|FG000|STARTED|Overall Study||3
11051604|NCT00969553|12232676|FG001|STARTED|Overall Study||3
11051605|NCT00969553|12232677|FG002|STARTED|Overall Study||6
11051606|NCT00969553|12232678|FG003|STARTED|Overall Study||17
11051607|NCT00969553|12232679|FG004|STARTED|Overall Study||3
11051608|NCT00969553|12232680|FG005|STARTED|Overall Study||4
11051609|NCT00969553|12232681|FG006|STARTED|Overall Study||4
11051610|NCT00969553|12232682|FG007|STARTED|Overall Study||16
11051611|NCT00969553|12232683|FG008|STARTED|Overall Study||3
11051612|NCT00969553|12232675|FG000|COMPLETED|Overall Study||0
11051613|NCT00969553|12232676|FG001|COMPLETED|Overall Study||0
11051614|NCT00969553|12232677|FG002|COMPLETED|Overall Study||0
11051615|NCT00969553|12232678|FG003|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1
11051616|NCT00969553|12232679|FG004|COMPLETED|Overall Study||0
11051617|NCT00969553|12232680|FG005|COMPLETED|Overall Study||0
11051618|NCT00969553|12232681|FG006|COMPLETED|Overall Study||0
11051619|NCT00969553|12232682|FG007|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2
11051620|NCT00969553|12232683|FG008|COMPLETED|Overall Study||0
11051621|NCT00969553|12232675|FG000|NOT COMPLETED|Overall Study||3
11051622|NCT00969553|12232676|FG001|NOT COMPLETED|Overall Study||3
11051623|NCT00969553|12232677|FG002|NOT COMPLETED|Overall Study||6
11051624|NCT00969553|12232678|FG003|NOT COMPLETED|Overall Study||16
11051625|NCT00969553|12232679|FG004|NOT COMPLETED|Overall Study||3
11051626|NCT00969553|12232680|FG005|NOT COMPLETED|Overall Study||4
11051627|NCT00969553|12232681|FG006|NOT COMPLETED|Overall Study||4
11051628|NCT00969553|12232682|FG007|NOT COMPLETED|Overall Study||14
11051629|NCT00969553|12232683|FG008|NOT COMPLETED|Overall Study||3
11051630|NCT00969618|12232711|FG000|STARTED|Overall Study||211
11051631|NCT00969618|12232711|FG000|COMPLETED|Overall Study||133
11051632|NCT00969618|12232711|FG000|NOT COMPLETED|Overall Study||78
11051633|NCT00969709|12232719|FG000|STARTED|Overall Study||176
11051634|NCT00969709|12232720|FG001|STARTED|Overall Study||178
11051635|NCT00969709|12232721|FG002|STARTED|Overall Study||179
11051636|NCT00969709|12232722|FG003|STARTED|Overall Study||180
11051637|NCT00969709|12232719|FG000|COMPLETED|Overall Study||138
11051638|NCT00969709|12232720|FG001|COMPLETED|Overall Study||130
11051639|NCT00969709|12232721|FG002|COMPLETED|Overall Study||121
11051640|NCT00969709|12232722|FG003|COMPLETED|Overall Study||117
11051641|NCT00969709|12232719|FG000|NOT COMPLETED|Overall Study||38
11051642|NCT00969709|12232720|FG001|NOT COMPLETED|Overall Study||48
11051643|NCT00969709|12232721|FG002|NOT COMPLETED|Overall Study||58
11051644|NCT00969709|12232722|FG003|NOT COMPLETED|Overall Study||63
11051645|NCT00969761|12232748|FG000|STARTED|Discont. Before Start of Treat. Cycle 2||3
11051646|NCT00969761|12232749|FG001|STARTED|Discont. Before Start of Treat. Cycle 2||3
11051647|NCT00969761|12232750|FG002|STARTED|Discont. Before Start of Treat. Cycle 2||12
11051648|NCT00969761|12232751|FG003|STARTED|Discont. Before Start of Treat. Cycle 2||6
11051649|NCT00969761|12232752|FG004|STARTED|Discont. Before Start of Treat. Cycle 2||3
11051650|NCT00969761|12232753|FG005|STARTED|Discont. Before Start of Treat. Cycle 2||3
11051651|NCT00969761|12232754|FG006|STARTED|Discont. Before Start of Treat. Cycle 2||3
11051652|NCT00969761|12232755|FG007|STARTED|Discont. Before Start of Treat. Cycle 2||6
11051653|NCT00969761|12232756|FG008|STARTED|Discont. Before Start of Treat. Cycle 2||13
11051654|NCT00969761|12232757|FG009|STARTED|Discont. Before Start of Treat. Cycle 2||3
11051655|NCT00969761|12232758|FG010|STARTED|Discont. Before Start of Treat. Cycle 2||3
11051656|NCT00969761|12232759|FG011|STARTED|Discont. Before Start of Treat. Cycle 2||3
11051657|NCT00969761|12232748|FG000|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
11051658|NCT00969761|12232749|FG001|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
11051659|NCT00969761|12232750|FG002|COMPLETED|Discont. Before Start of Treat. Cycle 2||10
11051660|NCT00969761|12232751|FG003|COMPLETED|Discont. Before Start of Treat. Cycle 2||5
11051661|NCT00969761|12232752|FG004|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
11051662|NCT00969761|12232753|FG005|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
11051663|NCT00969761|12232754|FG006|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
11051664|NCT00969761|12232755|FG007|COMPLETED|Discont. Before Start of Treat. Cycle 2||6
11051665|NCT00969761|12232756|FG008|COMPLETED|Discont. Before Start of Treat. Cycle 2||11
11201517|NCT01832961|12391808|FG000|NOT COMPLETED|First Intervention||0
11051666|NCT00969761|12232757|FG009|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
11051667|NCT00969761|12232758|FG010|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
11051668|NCT00969761|12232759|FG011|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
11051669|NCT00969761|12232748|FG000|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
11051670|NCT00969761|12232749|FG001|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
11051671|NCT00969761|12232750|FG002|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
11051672|NCT00969761|12232751|FG003|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
11051673|NCT00969761|12232752|FG004|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
11051674|NCT00969761|12232753|FG005|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
11051675|NCT00969761|12232754|FG006|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
11051676|NCT00969761|12232755|FG007|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
11051677|NCT00969761|12232756|FG008|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
11051678|NCT00969761|12232757|FG009|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
11051679|NCT00969761|12232758|FG010|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
11051680|NCT00969761|12232759|FG011|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
11051681|NCT00969761|12232748|FG000|STARTED|Treated in and Beyond Treat. Cycle 2||2
11051682|NCT00969761|12232749|FG001|STARTED|Treated in and Beyond Treat. Cycle 2||3
11051683|NCT00969761|12232750|FG002|STARTED|Treated in and Beyond Treat. Cycle 2||10
11051684|NCT00969761|12232751|FG003|STARTED|Treated in and Beyond Treat. Cycle 2||5
11051685|NCT00969761|12232752|FG004|STARTED|Treated in and Beyond Treat. Cycle 2||3
11051686|NCT00969761|12232753|FG005|STARTED|Treated in and Beyond Treat. Cycle 2||3
11051687|NCT00969761|12232754|FG006|STARTED|Treated in and Beyond Treat. Cycle 2||3
11051688|NCT00969761|12232755|FG007|STARTED|Treated in and Beyond Treat. Cycle 2||6
11051689|NCT00969761|12232756|FG008|STARTED|Treated in and Beyond Treat. Cycle 2||11
11051690|NCT00969761|12232757|FG009|STARTED|Treated in and Beyond Treat. Cycle 2||2
11051691|NCT00969761|12232758|FG010|STARTED|Treated in and Beyond Treat. Cycle 2||3
11051692|NCT00969761|12232759|FG011|STARTED|Treated in and Beyond Treat. Cycle 2||3
11051693|NCT00969761|12232748|FG000|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
11051694|NCT00969761|12232749|FG001|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
11051695|NCT00969761|12232750|FG002|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
11051696|NCT00969761|12232751|FG003|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
11051697|NCT00969761|12232752|FG004|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
11051698|NCT00969761|12232753|FG005|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
11051699|NCT00969761|12232754|FG006|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
11051700|NCT00969761|12232755|FG007|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
11051701|NCT00969761|12232756|FG008|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
11051702|NCT00969761|12232757|FG009|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
11051703|NCT00969761|12232758|FG010|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
11051704|NCT00969761|12232759|FG011|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
11051705|NCT00969761|12232748|FG000|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
11051706|NCT00969761|12232749|FG001|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
11051707|NCT00969761|12232750|FG002|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10
11051708|NCT00969761|12232751|FG003|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5
11051709|NCT00969761|12232752|FG004|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
11051710|NCT00969761|12232753|FG005|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
11051711|NCT00969761|12232754|FG006|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
11051712|NCT00969761|12232755|FG007|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6
11051713|NCT00969761|12232756|FG008|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11
11051714|NCT00969761|12232757|FG009|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
11051715|NCT00969761|12232758|FG010|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
11051716|NCT00969761|12232759|FG011|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
11051717|NCT00969878|12232787|FG000|STARTED|Overall Study||148
11051718|NCT00969878|12232788|FG001|STARTED|Overall Study||152
11051719|NCT00969878|12232787|FG000|COMPLETED|Overall Study||118
11051720|NCT00969878|12232788|FG001|COMPLETED|Overall Study||126
11051721|NCT00969878|12232787|FG000|NOT COMPLETED|Overall Study||30
11051722|NCT00969878|12232788|FG001|NOT COMPLETED|Overall Study||26
11051723|NCT00970073|12232799|FG000|STARTED|Overall Study||10
11051724|NCT00970073|12232800|FG001|STARTED|Overall Study||10
11051725|NCT00970073|12232801|FG002|STARTED|Overall Study||10
11051726|NCT00970073|12232799|FG000|COMPLETED|Overall Study||10
11051727|NCT00970073|12232800|FG001|COMPLETED|Overall Study||10
11051728|NCT00970073|12232801|FG002|COMPLETED|Overall Study||10
11051729|NCT00970073|12232799|FG000|NOT COMPLETED|Overall Study||0
11051730|NCT00970073|12232800|FG001|NOT COMPLETED|Overall Study||0
11051731|NCT00970073|12232801|FG002|NOT COMPLETED|Overall Study||0
11051732|NCT00970203|12232811|FG000|STARTED|Overall Study||7
11051733|NCT00970203|12232812|FG001|STARTED|Overall Study||6
11051734|NCT00970203|12232811|FG000|COMPLETED|Overall Study||7
11051735|NCT00970203|12232812|FG001|COMPLETED|Overall Study||6
11051736|NCT00970203|12232811|FG000|NOT COMPLETED|Overall Study||0
11051737|NCT00970203|12232812|FG001|NOT COMPLETED|Overall Study||0
11051738|NCT00970216|12232818|FG000|STARTED|Overall Study||160
11051739|NCT00970216|12232818|FG000|COMPLETED|Overall Study||80
11051740|NCT00970216|12232818|FG000|NOT COMPLETED|Overall Study||80
11051741|NCT00970268|12232824|FG000|STARTED|Overall Study||139
11051742|NCT00970268|12232825|FG001|STARTED|Overall Study||152
11337969|NCT02899962|12535684|FG000|COMPLETED|Open-label Phase||623
11337970|NCT02899962|12535685|FG001|COMPLETED|Open-label Phase||0
11337971|NCT02899962|12535686|FG002|COMPLETED|Open-label Phase||0
11337972|NCT02899962|12535684|FG000|NOT COMPLETED|Open-label Phase||27
11337973|NCT02899962|12535685|FG001|NOT COMPLETED|Open-label Phase||0
11337974|NCT02899962|12535686|FG002|NOT COMPLETED|Open-label Phase||0
11337975|NCT02899962|12535684|FG000|STARTED|Maintenance Phase||0
11337976|NCT02899962|12535685|FG001|STARTED|Maintenance Phase||272
11337977|NCT02899962|12535686|FG002|STARTED|Maintenance Phase||273
11337978|NCT02899962|12535684|FG000|COMPLETED|Maintenance Phase||0
11337979|NCT02899962|12535685|FG001|COMPLETED|Maintenance Phase||131
11337980|NCT02899962|12535686|FG002|COMPLETED|Maintenance Phase||120
11337981|NCT02899962|12535684|FG000|NOT COMPLETED|Maintenance Phase||0
11337982|NCT02899962|12535685|FG001|NOT COMPLETED|Maintenance Phase||141
11337983|NCT02899962|12535686|FG002|NOT COMPLETED|Maintenance Phase||153
11337984|NCT02899988|12535697|FG000|STARTED|Induction Period (16 Weeks)||52
11337985|NCT02899988|12535698|FG001|STARTED|Induction Period (16 Weeks)||51
11337986|NCT02899988|12535699|FG002|STARTED|Induction Period (16 Weeks)||51
11337987|NCT02899988|12535700|FG003|STARTED|Induction Period (16 Weeks)||51
11337988|NCT02899988|12535701|FG004|STARTED|Induction Period (16 Weeks)||0
11337989|NCT02899988|12535702|FG005|STARTED|Induction Period (16 Weeks)||0
11337990|NCT02899988|12535703|FG006|STARTED|Induction Period (16 Weeks)||0
11337991|NCT02899988|12535704|FG007|STARTED|Induction Period (16 Weeks)||0
11337992|NCT02899988|12535705|FG008|STARTED|Induction Period (16 Weeks)||0
11337993|NCT02899988|12535706|FG009|STARTED|Induction Period (16 Weeks)||0
11337994|NCT02899988|12535707|FG010|STARTED|Induction Period (16 Weeks)||0
11337995|NCT02899988|12535697|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||52
11337996|NCT02899988|12535698|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
11337997|NCT02899988|12535699|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
11337998|NCT02899988|12535700|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
11337999|NCT02899988|12535701|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11338000|NCT02899988|12535702|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11338001|NCT02899988|12535703|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11338002|NCT02899988|12535704|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11338003|NCT02899988|12535705|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11338004|NCT02899988|12535706|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11338005|NCT02899988|12535707|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
11338006|NCT02899988|12535697|FG000|COMPLETED|Induction Period (16 Weeks)||50
11338007|NCT02899988|12535698|FG001|COMPLETED|Induction Period (16 Weeks)||49
11338008|NCT02899988|12535699|FG002|COMPLETED|Induction Period (16 Weeks)||51
11338009|NCT02899988|12535700|FG003|COMPLETED|Induction Period (16 Weeks)||49
11338010|NCT02899988|12535701|FG004|COMPLETED|Induction Period (16 Weeks)||0
11338011|NCT02899988|12535702|FG005|COMPLETED|Induction Period (16 Weeks)||0
11338012|NCT02899988|12535703|FG006|COMPLETED|Induction Period (16 Weeks)||0
11338013|NCT02899988|12535704|FG007|COMPLETED|Induction Period (16 Weeks)||0
11338014|NCT02899988|12535705|FG008|COMPLETED|Induction Period (16 Weeks)||0
11051743|NCT00970268|12232824|FG000|COMPLETED|Overall Study||96
11051744|NCT00970268|12232825|FG001|COMPLETED|Overall Study||103
11051745|NCT00970268|12232824|FG000|NOT COMPLETED|Overall Study||43
11051746|NCT00970268|12232825|FG001|NOT COMPLETED|Overall Study||49
11338015|NCT02899988|12535706|FG009|COMPLETED|Induction Period (16 Weeks)||0
11338016|NCT02899988|12535707|FG010|COMPLETED|Induction Period (16 Weeks)||0
11338017|NCT02899988|12535697|FG000|NOT COMPLETED|Induction Period (16 Weeks)||2
11338018|NCT02899988|12535698|FG001|NOT COMPLETED|Induction Period (16 Weeks)||2
11338019|NCT02899988|12535699|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
11338020|NCT02899988|12535700|FG003|NOT COMPLETED|Induction Period (16 Weeks)||2
11338021|NCT02899988|12535701|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
11338022|NCT02899988|12535702|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
11338023|NCT02899988|12535703|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
11338024|NCT02899988|12535704|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
11338025|NCT02899988|12535705|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0
11338026|NCT02899988|12535706|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0
11338027|NCT02899988|12535707|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0
11338028|NCT02899988|12535697|FG000|STARTED|Maintenance Period (88 Weeks)|No participants received placebo during maintenance period.|0
11338029|NCT02899988|12535698|FG001|STARTED|Maintenance Period (88 Weeks)|No participants received 30 mg mirikizumab Q8W in both induction and maintenance.|0
11338030|NCT02899988|12535699|FG002|STARTED|Maintenance Period (88 Weeks)|No participants received 100 mg mirikizumab Q8W in both induction and maintenance.|0
11338031|NCT02899988|12535700|FG003|STARTED|Maintenance Period (88 Weeks)||0
11338032|NCT02899988|12535701|FG004|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction period.|15
11338033|NCT02899988|12535702|FG005|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction period.|30
11338034|NCT02899988|12535703|FG006|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction period.|34
11051747|NCT00970281|12232839|FG000|STARTED|Overall Study||46
11051748|NCT00970281|12232840|FG001|STARTED|Overall Study||45
11051749|NCT00970281|12232839|FG000|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
11051750|NCT00970281|12232840|FG001|Full Analysis Set|Overall Study||45
11051751|NCT00970281|12232839|FG000|COMPLETED|Overall Study||44
11051752|NCT00970281|12232840|FG001|COMPLETED|Overall Study||29
11051753|NCT00970281|12232839|FG000|NOT COMPLETED|Overall Study||2
11051754|NCT00970281|12232840|FG001|NOT COMPLETED|Overall Study||16
11051755|NCT00970294|12232846|FG000|STARTED|Overall Study||11
11051756|NCT00970294|12232846|FG000|COMPLETED|Overall Study||6
11051757|NCT00970294|12232846|FG000|NOT COMPLETED|Overall Study||5
11051758|NCT00970307|12232853|FG000|STARTED|Overall Study||141
11051759|NCT00970307|12232854|FG001|STARTED|Overall Study||139
11051760|NCT00970307|12232855|FG002|STARTED|Overall Study||141
11051761|NCT00970307|12232853|FG000|COMPLETED|Overall Study||138
11051762|NCT00970307|12232854|FG001|COMPLETED|Overall Study||136
11051763|NCT00970307|12232855|FG002|COMPLETED|Overall Study||139
11051764|NCT00970307|12232853|FG000|NOT COMPLETED|Overall Study||3
11051765|NCT00970307|12232854|FG001|NOT COMPLETED|Overall Study||3
11051766|NCT00970307|12232855|FG002|NOT COMPLETED|Overall Study||2
11051767|NCT00970320|12232868|FG000|STARTED|Overall Study||25
11051768|NCT00970320|12232869|FG001|STARTED|Overall Study||24
11051769|NCT00970320|12232870|FG002|STARTED|Overall Study||48
11051770|NCT00970320|12232871|FG003|STARTED|Overall Study||50
11051771|NCT00970320|12232872|FG004|STARTED|Overall Study||1571
11338035|NCT02899988|12535704|FG007|STARTED|Maintenance Period (88 Weeks)|Participants received placebo during induction period.|50
11338036|NCT02899988|12535705|FG008|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction arm.|34
11051772|NCT00970320|12232868|FG000|COMPLETED|Overall Study||25
11051773|NCT00970320|12232869|FG001|COMPLETED|Overall Study||13
11051774|NCT00970320|12232870|FG002|COMPLETED|Overall Study||35
11051775|NCT00970320|12232871|FG003|COMPLETED|Overall Study||36
11051776|NCT00970320|12232872|FG004|COMPLETED|Overall Study||1031
11051777|NCT00970320|12232868|FG000|NOT COMPLETED|Overall Study||0
11051778|NCT00970320|12232869|FG001|NOT COMPLETED|Overall Study||11
11051779|NCT00970320|12232870|FG002|NOT COMPLETED|Overall Study||13
11051780|NCT00970320|12232871|FG003|NOT COMPLETED|Overall Study||14
11051781|NCT00970320|12232872|FG004|NOT COMPLETED|Overall Study||540
11051782|NCT00970359|12232884|FG000|STARTED|Overall Study||24
11051783|NCT00970359|12232884|FG000|COMPLETED|Overall Study||20
11051784|NCT00970359|12232884|FG000|NOT COMPLETED|Overall Study||4
11051785|NCT00970489|12232890|FG000|STARTED|Overall Study||758
11051786|NCT00970489|12232891|FG001|STARTED|Overall Study||758
11051787|NCT00970489|12232890|FG000|COMPLETED|Overall Study||704
11051788|NCT00970489|12232891|FG001|COMPLETED|Overall Study||717
11051789|NCT00970489|12232890|FG000|NOT COMPLETED|Overall Study||54
11051790|NCT00970489|12232891|FG001|NOT COMPLETED|Overall Study||41
11051791|NCT00970502|12232897|FG000|STARTED|Overall Study||15
11051792|NCT00970502|12232897|FG000|COMPLETED|Overall Study||14
11051793|NCT00970502|12232897|FG000|NOT COMPLETED|Overall Study||1
11051794|NCT00970593|12232912|FG000|STARTED|Overall Study||11
11051795|NCT00970593|12232913|FG001|STARTED|Overall Study||15
11051796|NCT00970593|12232914|FG002|STARTED|Overall Study||13
11051797|NCT00970593|12232915|FG003|STARTED|Overall Study||12
11051798|NCT00970593|12232916|FG004|STARTED|Overall Study||20
11051799|NCT00970593|12232917|FG005|STARTED|Overall Study||5
11051800|NCT00970593|12232918|FG006|STARTED|Overall Study||16
11051801|NCT00970593|12232912|FG000|COMPLETED|Overall Study||10
11051802|NCT00970593|12232913|FG001|COMPLETED|Overall Study||14
11051803|NCT00970593|12232914|FG002|COMPLETED|Overall Study||7
11051804|NCT00970593|12232915|FG003|COMPLETED|Overall Study||12
11051805|NCT00970593|12232916|FG004|COMPLETED|Overall Study||20
11051806|NCT00970593|12232917|FG005|COMPLETED|Overall Study||5
11051807|NCT00970593|12232918|FG006|COMPLETED|Overall Study||14
11051808|NCT00970593|12232912|FG000|NOT COMPLETED|Overall Study||1
11051809|NCT00970593|12232913|FG001|NOT COMPLETED|Overall Study||1
11051810|NCT00970593|12232914|FG002|NOT COMPLETED|Overall Study||6
11051811|NCT00970593|12232915|FG003|NOT COMPLETED|Overall Study||0
11051812|NCT00970593|12232916|FG004|NOT COMPLETED|Overall Study||0
11051813|NCT00970593|12232917|FG005|NOT COMPLETED|Overall Study||0
11051814|NCT00970593|12232918|FG006|NOT COMPLETED|Overall Study||2
11051815|NCT00970632|12232941|FG000|STARTED|Overall Study||172
11051816|NCT00970632|12232942|FG001|STARTED|Overall Study||171
11051817|NCT00970632|12232943|FG002|STARTED|Overall Study||168
11051818|NCT00970632|12232941|FG000|COMPLETED|Overall Study||148
11051819|NCT00970632|12232942|FG001|COMPLETED|Overall Study||156
11051820|NCT00970632|12232943|FG002|COMPLETED|Overall Study||150
11051821|NCT00970632|12232941|FG000|NOT COMPLETED|Overall Study||24
11051822|NCT00970632|12232942|FG001|NOT COMPLETED|Overall Study||15
11051823|NCT00970632|12232943|FG002|NOT COMPLETED|Overall Study||18
11051824|NCT00970814|12232953|FG000|STARTED|Overall Study||66
11051825|NCT00970814|12232954|FG001|STARTED|Overall Study||64
11051826|NCT00970814|12232953|FG000|COMPLETED|Overall Study||58
11051827|NCT00970814|12232954|FG001|COMPLETED|Overall Study||50
11051828|NCT00970814|12232953|FG000|NOT COMPLETED|Overall Study||8
11051829|NCT00970814|12232954|FG001|NOT COMPLETED|Overall Study||14
11338037|NCT02899988|12535706|FG009|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction arm.|21
11338038|NCT02899988|12535707|FG010|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction arm.|15
11338039|NCT02899988|12535697|FG000|Rescue Participants|Maintenance Period (88 Weeks)||0
11338040|NCT02899988|12535698|FG001|Rescue Participants|Maintenance Period (88 Weeks)||0
11338041|NCT02899988|12535699|FG002|Rescue Participants|Maintenance Period (88 Weeks)||0
11338042|NCT02899988|12535700|FG003|Rescue Participants|Maintenance Period (88 Weeks)|In PRN not regaining ≥ PASI 90 after 3 consecutive doses of drug or have < PASI 50 after 1 dose.|10
11338043|NCT02899988|12535701|FG004|Rescue Participants|Maintenance Period (88 Weeks)||0
11338044|NCT02899988|12535702|FG005|Rescue Participants|Maintenance Period (88 Weeks)||0
11338045|NCT02899988|12535703|FG006|Rescue Participants|Maintenance Period (88 Weeks)||0
11338046|NCT02899988|12535704|FG007|Rescue Participants|Maintenance Period (88 Weeks)||0
11338047|NCT02899988|12535705|FG008|Rescue Participants|Maintenance Period (88 Weeks)||0
11338048|NCT02899988|12535706|FG009|Rescue Participants|Maintenance Period (88 Weeks)||0
11338049|NCT02899988|12535707|FG010|Rescue Participants|Maintenance Period (88 Weeks)||0
11338050|NCT02899988|12535697|FG000|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
11338051|NCT02899988|12535698|FG001|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
11338052|NCT02899988|12535699|FG002|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
11338053|NCT02899988|12535700|FG003|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||13
11338054|NCT02899988|12535701|FG004|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||9
11051830|NCT00970853|12232962|FG000|STARTED|Overall Study||89
11051831|NCT00970853|12232963|FG001|STARTED|Overall Study||98
11051832|NCT00970853|12232962|FG000|COMPLETED|Overall Study||89
11051833|NCT00970853|12232963|FG001|COMPLETED|Overall Study||98
11051834|NCT00970853|12232962|FG000|NOT COMPLETED|Overall Study||0
11051835|NCT00970853|12232963|FG001|NOT COMPLETED|Overall Study||0
11051836|NCT00970944|12232971|FG000|STARTED|Overall Study||87
11051837|NCT00970944|12232972|FG001|STARTED|Overall Study||97
11051838|NCT00970944|12232971|FG000|COMPLETED|Overall Study||86
11051839|NCT00970944|12232972|FG001|COMPLETED|Overall Study||95
11051840|NCT00970944|12232971|FG000|NOT COMPLETED|Overall Study||1
11051841|NCT00970944|12232972|FG001|NOT COMPLETED|Overall Study||2
11051842|NCT00971048|12232983|FG000|STARTED|Overall Study||30
11051843|NCT00971048|12232984|FG001|STARTED|Overall Study||33
11051844|NCT00971048|12232985|FG002|STARTED|Overall Study||12
11051845|NCT00971048|12232986|FG003|STARTED|Overall Study||13
11051846|NCT00971048|12232983|FG000|COMPLETED|Overall Study||29
11051847|NCT00971048|12232984|FG001|COMPLETED|Overall Study||31
11051848|NCT00971048|12232985|FG002|COMPLETED|Overall Study||11
11051849|NCT00971048|12232986|FG003|COMPLETED|Overall Study||11
11051850|NCT00971048|12232983|FG000|NOT COMPLETED|Overall Study||1
11051851|NCT00971048|12232984|FG001|NOT COMPLETED|Overall Study||2
11051852|NCT00971048|12232985|FG002|NOT COMPLETED|Overall Study||1
11051853|NCT00971048|12232986|FG003|NOT COMPLETED|Overall Study||2
11051854|NCT00971178|12233001|FG000|STARTED|Overall Study||35
11051855|NCT00971178|12233002|FG001|STARTED|Overall Study||35
11051856|NCT00971178|12233003|FG002|STARTED|Overall Study||35
11051857|NCT00971178|12233001|FG000|COMPLETED|Overall Study||33
11051858|NCT00971178|12233002|FG001|COMPLETED|Overall Study||33
11051859|NCT00971178|12233003|FG002|COMPLETED|Overall Study||33
11051860|NCT00971178|12233001|FG000|NOT COMPLETED|Overall Study||2
11051861|NCT00971178|12233002|FG001|NOT COMPLETED|Overall Study||2
11051862|NCT00971178|12233003|FG002|NOT COMPLETED|Overall Study||2
11051863|NCT00971204|12233011|FG000|STARTED|Overall Study|100 enrolled participants|100
11051864|NCT00971204|12233011|FG000|Treated|Overall Study||86
11051865|NCT00971204|12233011|FG000|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
11051866|NCT00971204|12233011|FG000|NOT COMPLETED|Overall Study||24
11051867|NCT00971243|12233020|FG000|STARTED|Double Blind Period||87
11051868|NCT00971243|12233021|FG001|STARTED|Double Blind Period||93
11051869|NCT00971243|12233022|FG002|STARTED|Double Blind Period||91
11051870|NCT00971243|12233023|FG003|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
11051871|NCT00971243|12233024|FG004|STARTED|Double Blind Period||88
11051872|NCT00971243|12233020|FG000|COMPLETED|Double Blind Period||68
11051873|NCT00971243|12233021|FG001|COMPLETED|Double Blind Period||82
11051874|NCT00971243|12233022|FG002|COMPLETED|Double Blind Period||72
11051875|NCT00971243|12233023|FG003|COMPLETED|Double Blind Period||74
11051876|NCT00971243|12233024|FG004|COMPLETED|Double Blind Period||70
11051877|NCT00971243|12233020|FG000|NOT COMPLETED|Double Blind Period||19
11201518|NCT01832961|12391809|FG001|NOT COMPLETED|First Intervention||0
11201519|NCT01832961|12391808|FG000|STARTED|Washout||8
11201520|NCT01832961|12391809|FG001|STARTED|Washout||7
11201521|NCT01832961|12391808|FG000|COMPLETED|Washout||8
11201522|NCT01832961|12391809|FG001|COMPLETED|Washout||7
11201523|NCT01832961|12391808|FG000|NOT COMPLETED|Washout||0
11201524|NCT01832961|12391809|FG001|NOT COMPLETED|Washout||0
11201525|NCT01832961|12391808|FG000|STARTED|Second Intervention||8
11201526|NCT01832961|12391809|FG001|STARTED|Second Intervention||7
11201527|NCT01832961|12391808|FG000|COMPLETED|Second Intervention||8
11201528|NCT01832961|12391809|FG001|COMPLETED|Second Intervention||7
11201529|NCT01832961|12391808|FG000|NOT COMPLETED|Second Intervention||0
11338055|NCT02899988|12535702|FG005|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||18
11338056|NCT02899988|12535703|FG006|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||26
11338057|NCT02899988|12535704|FG007|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||42
11338058|NCT02899988|12535705|FG008|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||24
11338059|NCT02899988|12535706|FG009|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||17
11338060|NCT02899988|12535707|FG010|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
11338061|NCT02899988|12535697|FG000|COMPLETED|Maintenance Period (88 Weeks)||0
11338062|NCT02899988|12535698|FG001|COMPLETED|Maintenance Period (88 Weeks)||0
11338063|NCT02899988|12535699|FG002|COMPLETED|Maintenance Period (88 Weeks)||0
11338064|NCT02899988|12535700|FG003|COMPLETED|Maintenance Period (88 Weeks)||0
11338065|NCT02899988|12535701|FG004|COMPLETED|Maintenance Period (88 Weeks)||13
11338066|NCT02899988|12535702|FG005|COMPLETED|Maintenance Period (88 Weeks)||27
11338067|NCT02899988|12535703|FG006|COMPLETED|Maintenance Period (88 Weeks)||30
11338068|NCT02899988|12535704|FG007|COMPLETED|Maintenance Period (88 Weeks)||45
11338069|NCT02899988|12535705|FG008|COMPLETED|Maintenance Period (88 Weeks)||30
11338070|NCT02899988|12535706|FG009|COMPLETED|Maintenance Period (88 Weeks)||19
11338071|NCT02899988|12535707|FG010|COMPLETED|Maintenance Period (88 Weeks)||13
11338072|NCT02899988|12535697|FG000|NOT COMPLETED|Maintenance Period (88 Weeks)||0
11338073|NCT02899988|12535698|FG001|NOT COMPLETED|Maintenance Period (88 Weeks)||0
11051878|NCT00971243|12233021|FG001|NOT COMPLETED|Double Blind Period||11
11051879|NCT00971243|12233022|FG002|NOT COMPLETED|Double Blind Period||19
11051880|NCT00971243|12233023|FG003|NOT COMPLETED|Double Blind Period||14
11051881|NCT00971243|12233024|FG004|NOT COMPLETED|Double Blind Period||18
11051882|NCT00971243|12233020|FG000|STARTED|Open-label Period||68
11051883|NCT00971243|12233021|FG001|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
11338074|NCT02899988|12535699|FG002|NOT COMPLETED|Maintenance Period (88 Weeks)||0
11338075|NCT02899988|12535700|FG003|NOT COMPLETED|Maintenance Period (88 Weeks)||0
11338076|NCT02899988|12535701|FG004|NOT COMPLETED|Maintenance Period (88 Weeks)||2
11201530|NCT01832961|12391809|FG001|NOT COMPLETED|Second Intervention||0
11201531|NCT01832961|12391808|FG000|STARTED|Third Intervention||8
11201532|NCT01832961|12391809|FG001|STARTED|Third Intervention||7
11201533|NCT01832961|12391808|FG000|COMPLETED|Third Intervention||8
11201534|NCT01832961|12391809|FG001|COMPLETED|Third Intervention||7
11338077|NCT02899988|12535702|FG005|NOT COMPLETED|Maintenance Period (88 Weeks)||3
11338078|NCT02899988|12535703|FG006|NOT COMPLETED|Maintenance Period (88 Weeks)||4
11338079|NCT02899988|12535704|FG007|NOT COMPLETED|Maintenance Period (88 Weeks)||5
11338080|NCT02899988|12535705|FG008|NOT COMPLETED|Maintenance Period (88 Weeks)||4
11338081|NCT02899988|12535706|FG009|NOT COMPLETED|Maintenance Period (88 Weeks)||2
11338082|NCT02899988|12535707|FG010|NOT COMPLETED|Maintenance Period (88 Weeks)||2
11051884|NCT00971243|12233022|FG002|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
11051885|NCT00971243|12233023|FG003|STARTED|Open-label Period||74
11051886|NCT00971243|12233024|FG004|STARTED|Open-label Period||70
11051887|NCT00971243|12233020|FG000|COMPLETED|Open-label Period||60
11051888|NCT00971243|12233021|FG001|COMPLETED|Open-label Period||71
11051889|NCT00971243|12233022|FG002|COMPLETED|Open-label Period||66
11051890|NCT00971243|12233023|FG003|COMPLETED|Open-label Period||64
11051891|NCT00971243|12233024|FG004|COMPLETED|Open-label Period||64
11051892|NCT00971243|12233020|FG000|NOT COMPLETED|Open-label Period||8
11051893|NCT00971243|12233021|FG001|NOT COMPLETED|Open-label Period||10
11051894|NCT00971243|12233022|FG002|NOT COMPLETED|Open-label Period||5
11051895|NCT00971243|12233023|FG003|NOT COMPLETED|Open-label Period||10
11051896|NCT00971243|12233024|FG004|NOT COMPLETED|Open-label Period||6
11051897|NCT00971282|12233036|FG000|STARTED|Overall Study||30
11051898|NCT00971282|12233036|FG000|COMPLETED|Overall Study||30
11051899|NCT00971282|12233036|FG000|NOT COMPLETED|Overall Study||0
11051900|NCT00971295|12233042|FG000|STARTED|Overall Study||10
11051901|NCT00971295|12233043|FG001|STARTED|Overall Study||10
11051902|NCT00971295|12233042|FG000|COMPLETED|Overall Study||10
11051903|NCT00971295|12233043|FG001|COMPLETED|Overall Study||9
11051904|NCT00971295|12233042|FG000|NOT COMPLETED|Overall Study||0
11051905|NCT00971295|12233043|FG001|NOT COMPLETED|Overall Study||1
11051906|NCT00971321|12233051|FG000|STARTED|Up to Day 42||104
11051907|NCT00971321|12233052|FG001|STARTED|Up to Day 42||53
11051908|NCT00971321|12233051|FG000|COMPLETED|Up to Day 42||104
11051909|NCT00971321|12233052|FG001|COMPLETED|Up to Day 42||53
11051910|NCT00971321|12233051|FG000|NOT COMPLETED|Up to Day 42||0
11051911|NCT00971321|12233052|FG001|NOT COMPLETED|Up to Day 42||0
11051912|NCT00971321|12233051|FG000|STARTED|Up to Month 7||104
11051913|NCT00971321|12233052|FG001|STARTED|Up to Month 7||53
11051914|NCT00971321|12233051|FG000|COMPLETED|Up to Month 7||100
11051915|NCT00971321|12233052|FG001|COMPLETED|Up to Month 7||51
11051916|NCT00971321|12233051|FG000|NOT COMPLETED|Up to Month 7||4
11051917|NCT00971321|12233052|FG001|NOT COMPLETED|Up to Month 7||2
11051918|NCT00971321|12233051|FG000|STARTED|Up to Month 11-12||104
11051919|NCT00971321|12233052|FG001|STARTED|Up to Month 11-12||53
11051920|NCT00971321|12233051|FG000|COMPLETED|Up to Month 11-12||99
11051921|NCT00971321|12233052|FG001|COMPLETED|Up to Month 11-12||50
11051922|NCT00971321|12233051|FG000|NOT COMPLETED|Up to Month 11-12||5
11338083|NCT02899988|12535697|FG000|STARTED|Follow-Up (16 Weeks)||0
11338084|NCT02899988|12535698|FG001|STARTED|Follow-Up (16 Weeks)||0
11338085|NCT02899988|12535699|FG002|STARTED|Follow-Up (16 Weeks)||0
11338086|NCT02899988|12535700|FG003|STARTED|Follow-Up (16 Weeks)||0
11338087|NCT02899988|12535701|FG004|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
11338088|NCT02899988|12535702|FG005|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|4
11338089|NCT02899988|12535703|FG006|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
11338090|NCT02899988|12535704|FG007|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
11338091|NCT02899988|12535705|FG008|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|6
11051923|NCT00971321|12233052|FG001|NOT COMPLETED|Up to Month 11-12||3
11051924|NCT00971425|12233060|FG000|STARTED|Overall Study||72
11201535|NCT01832961|12391808|FG000|NOT COMPLETED|Third Intervention||0
11201536|NCT01832961|12391809|FG001|NOT COMPLETED|Third Intervention||0
11201537|NCT01833026|12391826|FG000|STARTED|Overall Study||22
11201538|NCT01833026|12391827|FG001|STARTED|Overall Study||34
11201539|NCT01833026|12391826|FG000|COMPLETED|Overall Study||22
11051925|NCT00971425|12233061|FG001|STARTED|Overall Study||73
11051926|NCT00971425|12233060|FG000|COMPLETED|Overall Study||71
11338092|NCT02899988|12535706|FG009|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
11338093|NCT02899988|12535707|FG010|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|0
11338094|NCT02899988|12535697|FG000|COMPLETED|Follow-Up (16 Weeks)||0
11338095|NCT02899988|12535698|FG001|COMPLETED|Follow-Up (16 Weeks)||0
11338096|NCT02899988|12535699|FG002|COMPLETED|Follow-Up (16 Weeks)||0
11051927|NCT00971425|12233061|FG001|COMPLETED|Overall Study||71
11051928|NCT00971425|12233060|FG000|NOT COMPLETED|Overall Study||1
11051929|NCT00971425|12233061|FG001|NOT COMPLETED|Overall Study||2
11051930|NCT00971620|12233069|FG000|STARTED|Overall Study||9
11051931|NCT00971620|12233070|FG001|STARTED|Overall Study||9
11051932|NCT00971620|12233069|FG000|COMPLETED|Overall Study||9
11051933|NCT00971620|12233070|FG001|COMPLETED|Overall Study||9
11051934|NCT00971620|12233069|FG000|NOT COMPLETED|Overall Study||0
11051935|NCT00971620|12233070|FG001|NOT COMPLETED|Overall Study||0
11051936|NCT00971633|12233076|FG000|STARTED|Period 1||2
11051937|NCT00971633|12233077|FG001|STARTED|Period 1||2
11051938|NCT00971633|12233078|FG002|STARTED|Period 1||2
11051939|NCT00971633|12233079|FG003|STARTED|Period 1||2
11051940|NCT00971633|12233080|FG004|STARTED|Period 1||2
11051941|NCT00971633|12233081|FG005|STARTED|Period 1||2
11051942|NCT00971633|12233076|FG000|COMPLETED|Period 1||2
11051943|NCT00971633|12233077|FG001|COMPLETED|Period 1||2
11051944|NCT00971633|12233078|FG002|COMPLETED|Period 1||2
11051945|NCT00971633|12233079|FG003|COMPLETED|Period 1||2
11051946|NCT00971633|12233080|FG004|COMPLETED|Period 1||2
11051947|NCT00971633|12233081|FG005|COMPLETED|Period 1||2
11051948|NCT00971633|12233076|FG000|NOT COMPLETED|Period 1||0
11051949|NCT00971633|12233077|FG001|NOT COMPLETED|Period 1||0
11051950|NCT00971633|12233078|FG002|NOT COMPLETED|Period 1||0
11051951|NCT00971633|12233079|FG003|NOT COMPLETED|Period 1||0
11051952|NCT00971633|12233080|FG004|NOT COMPLETED|Period 1||0
11051953|NCT00971633|12233081|FG005|NOT COMPLETED|Period 1||0
11051954|NCT00971633|12233076|FG000|STARTED|Period 2||2
11051955|NCT00971633|12233077|FG001|STARTED|Period 2||2
11051956|NCT00971633|12233078|FG002|STARTED|Period 2||2
11051957|NCT00971633|12233079|FG003|STARTED|Period 2||2
11051958|NCT00971633|12233080|FG004|STARTED|Period 2||2
11051959|NCT00971633|12233081|FG005|STARTED|Period 2||2
11051960|NCT00971633|12233076|FG000|COMPLETED|Period 2||2
11051961|NCT00971633|12233077|FG001|COMPLETED|Period 2||2
11051962|NCT00971633|12233078|FG002|COMPLETED|Period 2||2
11051963|NCT00971633|12233079|FG003|COMPLETED|Period 2||2
11051964|NCT00971633|12233080|FG004|COMPLETED|Period 2||2
11051965|NCT00971633|12233081|FG005|COMPLETED|Period 2||2
11051966|NCT00971633|12233076|FG000|NOT COMPLETED|Period 2||0
11051967|NCT00971633|12233077|FG001|NOT COMPLETED|Period 2||0
11051968|NCT00971633|12233078|FG002|NOT COMPLETED|Period 2||0
11051969|NCT00971633|12233079|FG003|NOT COMPLETED|Period 2||0
11051970|NCT00971633|12233080|FG004|NOT COMPLETED|Period 2||0
11051971|NCT00971633|12233081|FG005|NOT COMPLETED|Period 2||0
11051972|NCT00971633|12233076|FG000|STARTED|Period 3||2
11051973|NCT00971633|12233077|FG001|STARTED|Period 3||2
11051974|NCT00971633|12233078|FG002|STARTED|Period 3||2
11051975|NCT00971633|12233079|FG003|STARTED|Period 3||2
11051976|NCT00971633|12233080|FG004|STARTED|Period 3||2
11051977|NCT00971633|12233081|FG005|STARTED|Period 3||2
11051978|NCT00971633|12233076|FG000|COMPLETED|Period 3||2
11051979|NCT00971633|12233077|FG001|COMPLETED|Period 3||2
11051980|NCT00971633|12233078|FG002|COMPLETED|Period 3||2
11051981|NCT00971633|12233079|FG003|COMPLETED|Period 3||2
11051982|NCT00971633|12233080|FG004|COMPLETED|Period 3||2
11051983|NCT00971633|12233081|FG005|COMPLETED|Period 3||2
11051984|NCT00971633|12233076|FG000|NOT COMPLETED|Period 3||0
11051985|NCT00971633|12233077|FG001|NOT COMPLETED|Period 3||0
11051986|NCT00971633|12233078|FG002|NOT COMPLETED|Period 3||0
11338097|NCT02899988|12535700|FG003|COMPLETED|Follow-Up (16 Weeks)||0
11051987|NCT00971633|12233079|FG003|NOT COMPLETED|Period 3||0
11051988|NCT00971633|12233080|FG004|NOT COMPLETED|Period 3||0
11051989|NCT00971633|12233081|FG005|NOT COMPLETED|Period 3||0
11051990|NCT00971737|12233091|FG000|STARTED|Overall Study||30
11051991|NCT00971737|12233092|FG001|STARTED|Overall Study||30
11051992|NCT00971737|12233091|FG000|COMPLETED|Overall Study||30
11051993|NCT00971737|12233092|FG001|COMPLETED|Overall Study||30
11051994|NCT00971737|12233091|FG000|NOT COMPLETED|Overall Study||0
11051995|NCT00971737|12233092|FG001|NOT COMPLETED|Overall Study||0
11051996|NCT00971750|12233098|FG000|STARTED|Overall Study||253
11051997|NCT00971750|12233098|FG000|COMPLETED|Overall Study||253
11051998|NCT00971750|12233098|FG000|NOT COMPLETED|Overall Study||0
11051999|NCT00971789|12233104|FG000|STARTED|Overall Study||18
11052000|NCT00971789|12233104|FG000|COMPLETED|Overall Study||18
11052001|NCT00971789|12233104|FG000|NOT COMPLETED|Overall Study||0
11058219|NCT01002339|12240046|FG000|STARTED|Overall Study||44
11058220|NCT01002339|12240047|FG001|STARTED|Overall Study||43
11058221|NCT01002339|12240048|FG002|STARTED|Overall Study||47
11052002|NCT00971841|12233108|FG000|STARTED|Overall Study||1
11052003|NCT00971841|12233108|FG000|COMPLETED|Overall Study||1
11052004|NCT00971841|12233108|FG000|NOT COMPLETED|Overall Study||0
11052005|NCT00971932|12233112|FG000|STARTED|Overall Study|Number of participants treated.|33
11052006|NCT00971932|12233112|FG000|COMPLETED|Overall Study||26
11052007|NCT00971932|12233112|FG000|NOT COMPLETED|Overall Study||7
11052008|NCT00971945|12233116|FG000|STARTED|Overall Study||6
11052009|NCT00971945|12233116|FG000|COMPLETED|Overall Study||0
11052010|NCT00971945|12233116|FG000|NOT COMPLETED|Overall Study||6
11052011|NCT00971997|12233120|FG000|STARTED|Overall Study||135
11052012|NCT00971997|12233120|FG000|COMPLETED|Overall Study||116
11052013|NCT00971997|12233120|FG000|NOT COMPLETED|Overall Study||19
11052014|NCT00972088|12233127|FG000|STARTED|Overall Study||26
11052015|NCT00972088|12233127|FG000|COMPLETED|Overall Study||26
11052016|NCT00972088|12233127|FG000|NOT COMPLETED|Overall Study||0
11052017|NCT00972153|12233134|FG000|STARTED|Overall Study||12
11052018|NCT00972153|12233135|FG001|STARTED|Overall Study||12
11052019|NCT00972153|12233136|FG002|STARTED|Overall Study||12
11052020|NCT00972153|12233134|FG000|COMPLETED|Overall Study||12
11052021|NCT00972153|12233135|FG001|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
11052022|NCT00972153|12233136|FG002|COMPLETED|Overall Study||12
11052023|NCT00972153|12233134|FG000|NOT COMPLETED|Overall Study||0
11052024|NCT00972153|12233135|FG001|NOT COMPLETED|Overall Study||1
11052025|NCT00972153|12233136|FG002|NOT COMPLETED|Overall Study||0
11052026|NCT00972205|12233144|FG000|STARTED|Overall Study||12
11052027|NCT00972205|12233144|FG000|COMPLETED|Overall Study||12
11052028|NCT00972205|12233144|FG000|NOT COMPLETED|Overall Study||0
11338098|NCT02899988|12535701|FG004|COMPLETED|Follow-Up (16 Weeks)||2
11338099|NCT02899988|12535702|FG005|COMPLETED|Follow-Up (16 Weeks)||4
11338100|NCT02899988|12535703|FG006|COMPLETED|Follow-Up (16 Weeks)||3
11338101|NCT02899988|12535704|FG007|COMPLETED|Follow-Up (16 Weeks)||3
11338102|NCT02899988|12535705|FG008|COMPLETED|Follow-Up (16 Weeks)||6
11338103|NCT02899988|12535706|FG009|COMPLETED|Follow-Up (16 Weeks)||2
11338104|NCT02899988|12535707|FG010|COMPLETED|Follow-Up (16 Weeks)||0
11338105|NCT02899988|12535697|FG000|NOT COMPLETED|Follow-Up (16 Weeks)||0
11338106|NCT02899988|12535698|FG001|NOT COMPLETED|Follow-Up (16 Weeks)||0
11338107|NCT02899988|12535699|FG002|NOT COMPLETED|Follow-Up (16 Weeks)||0
11338108|NCT02899988|12535700|FG003|NOT COMPLETED|Follow-Up (16 Weeks)||0
11338109|NCT02899988|12535701|FG004|NOT COMPLETED|Follow-Up (16 Weeks)||0
11338110|NCT02899988|12535702|FG005|NOT COMPLETED|Follow-Up (16 Weeks)||0
11338111|NCT02899988|12535703|FG006|NOT COMPLETED|Follow-Up (16 Weeks)||0
11338112|NCT02899988|12535704|FG007|NOT COMPLETED|Follow-Up (16 Weeks)||0
11338113|NCT02899988|12535705|FG008|NOT COMPLETED|Follow-Up (16 Weeks)||0
11338114|NCT02899988|12535706|FG009|NOT COMPLETED|Follow-Up (16 Weeks)||0
11338115|NCT02899988|12535707|FG010|NOT COMPLETED|Follow-Up (16 Weeks)||0
11338116|NCT02900092|12535739|FG000|STARTED|Overall Study||10
11338117|NCT02900092|12535739|FG000|COMPLETED|Overall Study||9
11338118|NCT02900092|12535739|FG000|NOT COMPLETED|Overall Study||1
11338119|NCT02900170|12535743|FG000|STARTED|Overall Study||8
11338120|NCT02900170|12535743|FG000|COMPLETED|Overall Study||0
11338121|NCT02900170|12535743|FG000|NOT COMPLETED|Overall Study||8
11338122|NCT02900378|12535749|FG000|STARTED|Randomization (Visit 2)||310
11338123|NCT02900378|12535750|FG001|STARTED|Randomization (Visit 2)||311
11338124|NCT02900378|12535749|FG000|COMPLETED|Randomization (Visit 2)||287
11338125|NCT02900378|12535750|FG001|COMPLETED|Randomization (Visit 2)||283
11338126|NCT02900378|12535749|FG000|NOT COMPLETED|Randomization (Visit 2)||23
11338127|NCT02900378|12535750|FG001|NOT COMPLETED|Randomization (Visit 2)||28
11338128|NCT02900378|12535749|FG000|STARTED|Treatment Phase||309
11338129|NCT02900378|12535750|FG001|STARTED|Treatment Phase||310
11338130|NCT02900378|12535749|FG000|Full Analysis Set|Treatment Phase||302
11338131|NCT02900378|12535750|FG001|Full Analysis Set|Treatment Phase||302
11338132|NCT02900378|12535749|FG000|COMPLETED|Treatment Phase||309
11338133|NCT02900378|12535750|FG001|COMPLETED|Treatment Phase||310
11338134|NCT02900378|12535749|FG000|NOT COMPLETED|Treatment Phase||0
11338135|NCT02900378|12535750|FG001|NOT COMPLETED|Treatment Phase||0
11338136|NCT02901054|12535756|FG000|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
11338137|NCT02901054|12535756|FG000|COMPLETED|Overall Study||15
11338138|NCT02901054|12535756|FG000|NOT COMPLETED|Overall Study||4
11338139|NCT02901080|12535760|FG000|STARTED|Overall Study||161
11338140|NCT02901080|12535760|FG000|COMPLETED|Overall Study||112
11338141|NCT02901080|12535760|FG000|NOT COMPLETED|Overall Study||49
11338142|NCT02901249|12535766|FG000|STARTED|Overall Study||68
11338143|NCT02901249|12535766|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|43
11338144|NCT02901249|12535766|FG000|NOT COMPLETED|Overall Study||25
11338145|NCT02901275|12535770|FG000|STARTED|Overall Study||29
11338146|NCT02901275|12535770|FG000|Placebo + Placebo|Overall Study||29
11338147|NCT02901275|12535770|FG000|Hydromorphone (Oral) 4mg + Placebo|Overall Study||29
11338148|NCT02901275|12535770|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 2.5mg|Overall Study||29
11052029|NCT00972244|12233153|FG000|STARTED|Overall Study||59
11052030|NCT00972244|12233154|FG001|STARTED|Overall Study||56
11052031|NCT00972244|12233155|FG002|STARTED|Overall Study||58
11052032|NCT00972244|12233156|FG003|STARTED|Overall Study||52
11338149|NCT02901275|12535770|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 5mg|Overall Study||29
11338150|NCT02901275|12535770|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 10mg|Overall Study||29
11338151|NCT02901275|12535770|FG000|COMPLETED|Overall Study||29
11338152|NCT02901275|12535770|FG000|NOT COMPLETED|Overall Study||0
11338153|NCT02901431|12535790|FG000|STARTED|PK Part||12
11338154|NCT02901431|12535791|FG001|STARTED|PK Part||11
11338155|NCT02901431|12535792|FG002|STARTED|PK Part||15
11052033|NCT00972244|12233157|FG004|STARTED|Overall Study||54
11052034|NCT00972244|12233153|FG000|COMPLETED|Overall Study||54
11052035|NCT00972244|12233154|FG001|COMPLETED|Overall Study||51
11052036|NCT00972244|12233155|FG002|COMPLETED|Overall Study||56
11052037|NCT00972244|12233156|FG003|COMPLETED|Overall Study||52
11052038|NCT00972244|12233157|FG004|COMPLETED|Overall Study||45
11052039|NCT00972244|12233153|FG000|NOT COMPLETED|Overall Study||5
11052040|NCT00972244|12233154|FG001|NOT COMPLETED|Overall Study||5
11052041|NCT00972244|12233155|FG002|NOT COMPLETED|Overall Study||2
11052042|NCT00972244|12233156|FG003|NOT COMPLETED|Overall Study||0
11052043|NCT00972244|12233157|FG004|NOT COMPLETED|Overall Study||9
11052044|NCT00972283|12233171|FG000|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
11052045|NCT00972283|12233172|FG001|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
11052046|NCT00972283|12233171|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
11052047|NCT00972283|12233172|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
11052048|NCT00972283|12233171|FG000|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
11052049|NCT00972283|12233172|FG001|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
11052050|NCT00972283|12233171|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
11052051|NCT00972283|12233172|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
11052052|NCT00972283|12233171|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
11052053|NCT00972283|12233172|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
11052054|NCT00972283|12233171|FG000|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
11052055|NCT00972283|12233172|FG001|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
11052056|NCT00972283|12233171|FG000|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
11052057|NCT00972283|12233172|FG001|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
11052058|NCT00972283|12233171|FG000|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
11052059|NCT00972283|12233172|FG001|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
11052060|NCT00972322|12233180|FG000|STARTED|Overall Study||28
11052061|NCT00972322|12233181|FG001|STARTED|Overall Study||28
11052062|NCT00972322|12233180|FG000|COMPLETED|Overall Study||25
11052063|NCT00972322|12233181|FG001|COMPLETED|Overall Study||25
11052064|NCT00972322|12233180|FG000|NOT COMPLETED|Overall Study||3
11052065|NCT00972322|12233181|FG001|NOT COMPLETED|Overall Study||3
11052066|NCT00972335|12233187|FG000|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
11052067|NCT00972335|12233187|FG000|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
11052068|NCT00972335|12233187|FG000|NOT COMPLETED|Overall Study||17
11052069|NCT00972374|12233194|FG000|STARTED|Overall Study||15
11052070|NCT00972374|12233195|FG001|STARTED|Overall Study||15
11052071|NCT00972374|12233196|FG002|STARTED|Overall Study||14
11052072|NCT00972374|12233194|FG000|COMPLETED|Overall Study||13
11052073|NCT00972374|12233195|FG001|COMPLETED|Overall Study||15
11052074|NCT00972374|12233196|FG002|COMPLETED|Overall Study||13
11052075|NCT00972374|12233194|FG000|NOT COMPLETED|Overall Study||2
11052076|NCT00972374|12233195|FG001|NOT COMPLETED|Overall Study||0
11052077|NCT00972374|12233196|FG002|NOT COMPLETED|Overall Study||1
11052078|NCT00972439|12233206|FG000|STARTED|Overall Study||17
11052079|NCT00972439|12233207|FG001|STARTED|Overall Study||16
11052080|NCT00972439|12233206|FG000|COMPLETED|Overall Study||17
11052081|NCT00972439|12233207|FG001|COMPLETED|Overall Study||16
11052082|NCT00972439|12233206|FG000|NOT COMPLETED|Overall Study||0
11052083|NCT00972439|12233207|FG001|NOT COMPLETED|Overall Study||0
11052084|NCT00972504|12233213|FG000|STARTED|Overall Study||54
11052085|NCT00972504|12233213|FG000|COMPLETED|Overall Study||51
11052086|NCT00972504|12233213|FG000|NOT COMPLETED|Overall Study||3
11052087|NCT00972517|12233223|FG000|STARTED|Overall Study||31
11052088|NCT00972517|12233224|FG001|STARTED|Overall Study||31
11052089|NCT00972517|12233225|FG002|STARTED|Overall Study||60
11052090|NCT00972517|12233226|FG003|STARTED|Overall Study||30
11052091|NCT00972517|12233227|FG004|STARTED|Overall Study||34
11052092|NCT00972517|12233228|FG005|STARTED|Overall Study||58
11052093|NCT00972517|12233223|FG000|COMPLETED|Overall Study||31
11052094|NCT00972517|12233224|FG001|COMPLETED|Overall Study||30
11052095|NCT00972517|12233225|FG002|COMPLETED|Overall Study||60
11052096|NCT00972517|12233226|FG003|COMPLETED|Overall Study||27
11052097|NCT00972517|12233227|FG004|COMPLETED|Overall Study||33
11052098|NCT00972517|12233228|FG005|COMPLETED|Overall Study||58
11052099|NCT00972517|12233223|FG000|NOT COMPLETED|Overall Study||0
11052100|NCT00972517|12233224|FG001|NOT COMPLETED|Overall Study||1
11052101|NCT00972517|12233225|FG002|NOT COMPLETED|Overall Study||0
11052102|NCT00972517|12233226|FG003|NOT COMPLETED|Overall Study||3
11052103|NCT00972517|12233227|FG004|NOT COMPLETED|Overall Study||1
11052104|NCT00972517|12233228|FG005|NOT COMPLETED|Overall Study||0
11052105|NCT00972530|12233250|FG000|STARTED|Overall Study||44
11052106|NCT00972530|12233251|FG001|STARTED|Overall Study||46
11052107|NCT00972530|12233250|FG000|COMPLETED|Overall Study||44
11052108|NCT00972530|12233251|FG001|COMPLETED|Overall Study||46
11052109|NCT00972530|12233250|FG000|NOT COMPLETED|Overall Study||0
11052110|NCT00972530|12233251|FG001|NOT COMPLETED|Overall Study||0
11052111|NCT00972543|12233259|FG000|STARTED|Overall Study||5
11052112|NCT00972543|12233260|FG001|STARTED|Overall Study||1
11052113|NCT00972543|12233259|FG000|COMPLETED|Overall Study||0
11052114|NCT00972543|12233260|FG001|COMPLETED|Overall Study||0
11052115|NCT00972543|12233259|FG000|NOT COMPLETED|Overall Study||5
11052116|NCT00972543|12233260|FG001|NOT COMPLETED|Overall Study||1
11052117|NCT00972595|12233266|FG000|STARTED|Period 1||23
11052118|NCT00972595|12233267|FG001|STARTED|Period 1||22
11052119|NCT00972595|12233266|FG000|COMPLETED|Period 1||22
11052120|NCT00972595|12233267|FG001|COMPLETED|Period 1||22
11052121|NCT00972595|12233266|FG000|NOT COMPLETED|Period 1||1
11052122|NCT00972595|12233267|FG001|NOT COMPLETED|Period 1||0
11052123|NCT00972595|12233266|FG000|STARTED|Period 2||22
11052124|NCT00972595|12233267|FG001|STARTED|Period 2||22
11052125|NCT00972595|12233266|FG000|COMPLETED|Period 2||22
11052126|NCT00972595|12233267|FG001|COMPLETED|Period 2||22
11052127|NCT00972595|12233266|FG000|NOT COMPLETED|Period 2||0
11052128|NCT00972595|12233267|FG001|NOT COMPLETED|Period 2||0
11052129|NCT00972621|12233275|FG000|STARTED|Overall Study||200
11052130|NCT00972621|12233276|FG001|STARTED|Overall Study||200
11052131|NCT00972621|12233275|FG000|COMPLETED|Overall Study||200
11052132|NCT00972621|12233276|FG001|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
11052133|NCT00972621|12233275|FG000|NOT COMPLETED|Overall Study||0
11052134|NCT00972621|12233276|FG001|NOT COMPLETED|Overall Study||1
11052135|NCT00972725|12233284|FG000|STARTED|Overall Study||13
11052136|NCT00972725|12233285|FG001|STARTED|Overall Study||15
11052137|NCT00972725|12233284|FG000|COMPLETED|Overall Study||13
11052138|NCT00972725|12233285|FG001|COMPLETED|Overall Study||15
11052139|NCT00972725|12233284|FG000|NOT COMPLETED|Overall Study||0
11052140|NCT00972725|12233285|FG001|NOT COMPLETED|Overall Study||0
11052141|NCT00972777|12233293|FG000|STARTED|Overall Study||231
11052142|NCT00972777|12233294|FG001|STARTED|Overall Study||243
11052143|NCT00972777|12233293|FG000|COMPLETED|Overall Study||217
11052144|NCT00972777|12233294|FG001|COMPLETED|Overall Study||229
11052145|NCT00972777|12233293|FG000|NOT COMPLETED|Overall Study||14
11052146|NCT00972777|12233294|FG001|NOT COMPLETED|Overall Study||14
11052147|NCT00972816|12233308|FG000|STARTED|Overall Study||173
11052148|NCT00972816|12233309|FG001|STARTED|Overall Study||169
11052149|NCT00972816|12233310|FG002|STARTED|Overall Study||169
11052150|NCT00972816|12233311|FG003|STARTED|Overall Study||169
11052151|NCT00972816|12233312|FG004|STARTED|Overall Study||169
11052152|NCT00972816|12233313|FG005|STARTED|Overall Study||169
11052153|NCT00972816|12233314|FG006|STARTED|Overall Study||169
11052154|NCT00972816|12233315|FG007|STARTED|Overall Study||170
11052155|NCT00972816|12233308|FG000|COMPLETED|Overall Study||156
11052156|NCT00972816|12233309|FG001|COMPLETED|Overall Study||158
11052157|NCT00972816|12233310|FG002|COMPLETED|Overall Study||160
11052158|NCT00972816|12233311|FG003|COMPLETED|Overall Study||161
11052159|NCT00972816|12233312|FG004|COMPLETED|Overall Study||157
11052160|NCT00972816|12233313|FG005|COMPLETED|Overall Study||158
11052161|NCT00972816|12233314|FG006|COMPLETED|Overall Study||159
11052162|NCT00972816|12233315|FG007|COMPLETED|Overall Study||161
11052163|NCT00972816|12233308|FG000|NOT COMPLETED|Overall Study||17
11052164|NCT00972816|12233309|FG001|NOT COMPLETED|Overall Study||11
11052165|NCT00972816|12233310|FG002|NOT COMPLETED|Overall Study||9
11052166|NCT00972816|12233311|FG003|NOT COMPLETED|Overall Study||8
11052167|NCT00972816|12233312|FG004|NOT COMPLETED|Overall Study||12
11052168|NCT00972816|12233313|FG005|NOT COMPLETED|Overall Study||11
11052169|NCT00972816|12233314|FG006|NOT COMPLETED|Overall Study||10
11052170|NCT00972816|12233315|FG007|NOT COMPLETED|Overall Study||9
11052171|NCT00972959|12233333|FG000|STARTED|Overall Study||17
11052172|NCT00972959|12233333|FG000|COMPLETED|Overall Study||17
11052173|NCT00972959|12233333|FG000|NOT COMPLETED|Overall Study||0
11052174|NCT00973102|12233339|FG000|STARTED|Overall Study||24
11052175|NCT00973102|12233340|FG001|STARTED|Overall Study||26
11052176|NCT00973102|12233339|FG000|COMPLETED|Overall Study||23
11052177|NCT00973102|12233340|FG001|COMPLETED|Overall Study||25
11052178|NCT00973102|12233339|FG000|NOT COMPLETED|Overall Study||1
11052179|NCT00973102|12233340|FG001|NOT COMPLETED|Overall Study||1
11052180|NCT00973349|12233362|FG000|STARTED|Overall Study||170
11052181|NCT00973349|12233363|FG001|STARTED|Overall Study||168
11052182|NCT00973349|12233364|FG002|STARTED|Overall Study||171
11052183|NCT00973349|12233365|FG003|STARTED|Overall Study||168
11052184|NCT00973349|12233366|FG004|STARTED|Overall Study||170
11052185|NCT00973349|12233367|FG005|STARTED|Overall Study||169
11052186|NCT00973349|12233368|FG006|STARTED|Overall Study||174
11052187|NCT00973349|12233369|FG007|STARTED|Overall Study||169
11052188|NCT00973349|12233370|FG008|STARTED|Overall Study||171
11052189|NCT00973349|12233371|FG009|STARTED|Overall Study||169
11052190|NCT00973349|12233372|FG010|STARTED|Overall Study||174
11052191|NCT00973349|12233373|FG011|STARTED|Overall Study||169
11052192|NCT00973349|12233374|FG012|STARTED|Overall Study||169
11052193|NCT00973349|12233375|FG013|STARTED|Overall Study||171
11052194|NCT00973349|12233376|FG014|STARTED|Overall Study||170
11052195|NCT00973349|12233377|FG015|STARTED|Overall Study||167
11052196|NCT00973349|12233362|FG000|COMPLETED|Overall Study||166
11052197|NCT00973349|12233363|FG001|COMPLETED|Overall Study||165
11052198|NCT00973349|12233364|FG002|COMPLETED|Overall Study||166
11052199|NCT00973349|12233365|FG003|COMPLETED|Overall Study||163
11052200|NCT00973349|12233366|FG004|COMPLETED|Overall Study||165
11052201|NCT00973349|12233367|FG005|COMPLETED|Overall Study||165
11052202|NCT00973349|12233368|FG006|COMPLETED|Overall Study||172
11052203|NCT00973349|12233369|FG007|COMPLETED|Overall Study||166
11052204|NCT00973349|12233370|FG008|COMPLETED|Overall Study||167
11052205|NCT00973349|12233371|FG009|COMPLETED|Overall Study||163
11052206|NCT00973349|12233372|FG010|COMPLETED|Overall Study||174
11052207|NCT00973349|12233373|FG011|COMPLETED|Overall Study||167
11052208|NCT00973349|12233374|FG012|COMPLETED|Overall Study||168
11052209|NCT00973349|12233375|FG013|COMPLETED|Overall Study||171
11052210|NCT00973349|12233376|FG014|COMPLETED|Overall Study||168
11052211|NCT00973349|12233377|FG015|COMPLETED|Overall Study||165
11052212|NCT00973349|12233362|FG000|NOT COMPLETED|Overall Study||4
11052213|NCT00973349|12233363|FG001|NOT COMPLETED|Overall Study||3
11052214|NCT00973349|12233364|FG002|NOT COMPLETED|Overall Study||5
11052215|NCT00973349|12233365|FG003|NOT COMPLETED|Overall Study||5
11052216|NCT00973349|12233366|FG004|NOT COMPLETED|Overall Study||5
11052217|NCT00973349|12233367|FG005|NOT COMPLETED|Overall Study||4
11052218|NCT00973349|12233368|FG006|NOT COMPLETED|Overall Study||2
11052219|NCT00973349|12233369|FG007|NOT COMPLETED|Overall Study||3
11052220|NCT00973349|12233370|FG008|NOT COMPLETED|Overall Study||4
11052221|NCT00973349|12233371|FG009|NOT COMPLETED|Overall Study||6
11052222|NCT00973349|12233372|FG010|NOT COMPLETED|Overall Study||0
11052223|NCT00973349|12233373|FG011|NOT COMPLETED|Overall Study||2
11052224|NCT00973349|12233374|FG012|NOT COMPLETED|Overall Study||1
11052225|NCT00973349|12233375|FG013|NOT COMPLETED|Overall Study||0
11052226|NCT00973349|12233376|FG014|NOT COMPLETED|Overall Study||2
11052227|NCT00973349|12233377|FG015|NOT COMPLETED|Overall Study||2
11052228|NCT00973362|12233405|FG000|STARTED|Baseline Evaluation||11644
11052229|NCT00973362|12233406|FG001|STARTED|Baseline Evaluation||1252
11052230|NCT00973362|12233405|FG000|Evaluable for Analysis|Baseline Evaluation||10871
11052231|NCT00973362|12233406|FG001|Evaluable for Analysis|Baseline Evaluation||958
11052232|NCT00973362|12233405|FG000|Conclusive Disease Status|Baseline Evaluation||819
11052233|NCT00973362|12233406|FG001|Conclusive Disease Status|Baseline Evaluation||939
11052234|NCT00973362|12233405|FG000|COMPLETED|Baseline Evaluation||10871
11052235|NCT00973362|12233406|FG001|COMPLETED|Baseline Evaluation||1029
11052236|NCT00973362|12233405|FG000|NOT COMPLETED|Baseline Evaluation||773
11052237|NCT00973362|12233406|FG001|NOT COMPLETED|Baseline Evaluation||223
11052238|NCT00973362|12233405|FG000|STARTED|3-Year Follow-up||10871
11052239|NCT00973362|12233406|FG001|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
11052240|NCT00973362|12233405|FG000|COMPLETED|3-Year Follow-up||10854
11052241|NCT00973362|12233406|FG001|COMPLETED|3-Year Follow-up||0
11052242|NCT00973362|12233405|FG000|NOT COMPLETED|3-Year Follow-up||17
11052243|NCT00973362|12233406|FG001|NOT COMPLETED|3-Year Follow-up||0
11052244|NCT00973479|12233417|FG000|STARTED|Overall Study||197
11052245|NCT00973479|12233418|FG001|STARTED|Overall Study||395
11052246|NCT00973479|12233417|FG000|COMPLETED|Overall Study||160
11052247|NCT00973479|12233418|FG001|COMPLETED|Overall Study||326
11052248|NCT00973479|12233417|FG000|NOT COMPLETED|Overall Study||37
11052249|NCT00973479|12233418|FG001|NOT COMPLETED|Overall Study||69
11052250|NCT00973622|12233428|FG000|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
11052251|NCT00973622|12233429|FG001|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
11052252|NCT00973622|12233428|FG000|COMPLETED|Overall Study|Completed three sessions of rTMS|16
11052253|NCT00973622|12233429|FG001|COMPLETED|Overall Study|Completed three sessions of rTMS|14
11052254|NCT00973622|12233428|FG000|NOT COMPLETED|Overall Study||31
11052255|NCT00973622|12233429|FG001|NOT COMPLETED|Overall Study||5
11052256|NCT00973674|12233437|FG000|STARTED|Overall Study||24
11052257|NCT00973674|12233438|FG001|STARTED|Overall Study||26
11052258|NCT00973674|12233437|FG000|COMPLETED|Overall Study||22
11052259|NCT00973674|12233438|FG001|COMPLETED|Overall Study||26
11052260|NCT00973674|12233437|FG000|NOT COMPLETED|Overall Study||2
11052261|NCT00973674|12233438|FG001|NOT COMPLETED|Overall Study||0
11052262|NCT00973700|12233450|FG000|STARTED|Overall Study||56
11052263|NCT00973700|12233451|FG001|STARTED|Overall Study||56
11052264|NCT00973700|12233452|FG002|STARTED|Overall Study||168
11052265|NCT00973700|12233453|FG003|STARTED|Overall Study||336
11052266|NCT00973700|12233454|FG004|STARTED|Overall Study||168
11052267|NCT00973700|12233450|FG000|COMPLETED|Overall Study||49
11052268|NCT00973700|12233451|FG001|COMPLETED|Overall Study||54
11052269|NCT00973700|12233452|FG002|COMPLETED|Overall Study||158
11052270|NCT00973700|12233453|FG003|COMPLETED|Overall Study||318
11052271|NCT00973700|12233454|FG004|COMPLETED|Overall Study||158
11052272|NCT00973700|12233450|FG000|NOT COMPLETED|Overall Study||7
11052273|NCT00973700|12233451|FG001|NOT COMPLETED|Overall Study||2
11052274|NCT00973700|12233452|FG002|NOT COMPLETED|Overall Study||10
11052275|NCT00973700|12233453|FG003|NOT COMPLETED|Overall Study||18
11052276|NCT00973700|12233454|FG004|NOT COMPLETED|Overall Study||10
11052277|NCT00973739|12233481|FG000|STARTED|Overall Study||21
11052278|NCT00973739|12233481|FG000|COMPLETED|Overall Study||17
11052279|NCT00973739|12233481|FG000|NOT COMPLETED|Overall Study||4
11052280|NCT00973752|12233485|FG000|STARTED|Overall Study||30
11052281|NCT00973752|12233485|FG000|COMPLETED|Overall Study||30
11052282|NCT00973752|12233485|FG000|NOT COMPLETED|Overall Study||0
11052283|NCT00973765|12233491|FG000|STARTED|Overall Study|96|96
11052284|NCT00973765|12233492|FG001|STARTED|Overall Study|116|116
11052285|NCT00973765|12233491|FG000|COMPLETED|Overall Study|88|88
11052286|NCT00973765|12233492|FG001|COMPLETED|Overall Study|102|102
11052287|NCT00973765|12233491|FG000|NOT COMPLETED|Overall Study||8
11052288|NCT00973765|12233492|FG001|NOT COMPLETED|Overall Study||14
11052289|NCT00973921|12233498|FG000|STARTED|Overall Study||40
11052290|NCT00973921|12233498|FG000|COMPLETED|Overall Study||31
11052291|NCT00973921|12233498|FG000|NOT COMPLETED|Overall Study||9
11052292|NCT00973973|12233504|FG000|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
11052293|NCT00973973|12233505|FG001|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
11052294|NCT00973973|12233504|FG000|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
11052295|NCT00973973|12233505|FG001|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
11052296|NCT00973973|12233504|FG000|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
11052297|NCT00973973|12233505|FG001|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
11052298|NCT00973973|12233504|FG000|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
11052299|NCT00973973|12233505|FG001|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
11052300|NCT00973973|12233504|FG000|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
11052301|NCT00973973|12233505|FG001|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
11052302|NCT00973973|12233504|FG000|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
11052303|NCT00973973|12233505|FG001|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
11052304|NCT00973973|12233504|FG000|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
11052305|NCT00973973|12233505|FG001|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
11052306|NCT00974051|12233511|FG000|STARTED|Overall Study||6
11052307|NCT00974051|12233512|FG001|STARTED|Overall Study||4
11052308|NCT00974051|12233513|FG002|STARTED|Overall Study||6
11052309|NCT00974051|12233511|FG000|COMPLETED|Overall Study||6
11052310|NCT00974051|12233512|FG001|COMPLETED|Overall Study||4
11052311|NCT00974051|12233513|FG002|COMPLETED|Overall Study||6
11052312|NCT00974051|12233511|FG000|NOT COMPLETED|Overall Study||0
11052313|NCT00974051|12233512|FG001|NOT COMPLETED|Overall Study||0
11052314|NCT00974051|12233513|FG002|NOT COMPLETED|Overall Study||0
11052315|NCT00974090|12233524|FG000|STARTED|Period 1: Double Blind Period||98
11338156|NCT02901431|12535793|FG003|STARTED|PK Part||0
11338157|NCT02901431|12535794|FG004|STARTED|PK Part||0
11338158|NCT02901431|12535795|FG005|STARTED|PK Part||0
11338159|NCT02901431|12535796|FG006|STARTED|PK Part||0
11338160|NCT02901431|12535797|FG007|STARTED|PK Part||0
11338161|NCT02901431|12535798|FG008|STARTED|PK Part||0
11338162|NCT02901431|12535799|FG009|STARTED|PK Part||0
11338163|NCT02901431|12535800|FG010|STARTED|PK Part||0
11338164|NCT02901431|12535801|FG011|STARTED|PK Part||0
11338165|NCT02901431|12535802|FG012|STARTED|PK Part||0
11338166|NCT02901431|12535790|FG000|COMPLETED|PK Part||5
11338167|NCT02901431|12535791|FG001|COMPLETED|PK Part||5
11338168|NCT02901431|12535792|FG002|COMPLETED|PK Part||6
11338169|NCT02901431|12535793|FG003|COMPLETED|PK Part||0
11338170|NCT02901431|12535794|FG004|COMPLETED|PK Part||0
11338171|NCT02901431|12535795|FG005|COMPLETED|PK Part||0
11338172|NCT02901431|12535796|FG006|COMPLETED|PK Part||0
11338173|NCT02901431|12535797|FG007|COMPLETED|PK Part||0
11338174|NCT02901431|12535798|FG008|COMPLETED|PK Part||0
11338175|NCT02901431|12535799|FG009|COMPLETED|PK Part||0
11338176|NCT02901431|12535800|FG010|COMPLETED|PK Part||0
11338177|NCT02901431|12535801|FG011|COMPLETED|PK Part||0
11338178|NCT02901431|12535802|FG012|COMPLETED|PK Part||0
11338179|NCT02901431|12535790|FG000|NOT COMPLETED|PK Part||7
11338180|NCT02901431|12535791|FG001|NOT COMPLETED|PK Part||6
11338181|NCT02901431|12535792|FG002|NOT COMPLETED|PK Part||9
11338182|NCT02901431|12535793|FG003|NOT COMPLETED|PK Part||0
11338183|NCT02901431|12535794|FG004|NOT COMPLETED|PK Part||0
11338184|NCT02901431|12535795|FG005|NOT COMPLETED|PK Part||0
11338185|NCT02901431|12535796|FG006|NOT COMPLETED|PK Part||0
11338186|NCT02901431|12535797|FG007|NOT COMPLETED|PK Part||0
11338187|NCT02901431|12535798|FG008|NOT COMPLETED|PK Part||0
11338188|NCT02901431|12535799|FG009|NOT COMPLETED|PK Part||0
11338189|NCT02901431|12535800|FG010|NOT COMPLETED|PK Part||0
11338190|NCT02901431|12535801|FG011|NOT COMPLETED|PK Part||0
11338191|NCT02901431|12535802|FG012|NOT COMPLETED|PK Part||0
11338192|NCT02901431|12535790|FG000|STARTED|Main Treatment Part||0
11338193|NCT02901431|12535791|FG001|STARTED|Main Treatment Part||0
11338194|NCT02901431|12535792|FG002|STARTED|Main Treatment Part||0
11338195|NCT02901431|12535793|FG003|STARTED|Main Treatment Part||112
11338196|NCT02901431|12535794|FG004|STARTED|Main Treatment Part||57
11338197|NCT02901431|12535795|FG005|STARTED|Main Treatment Part||66
11338198|NCT02901431|12535796|FG006|STARTED|Main Treatment Part||66
11338199|NCT02901431|12535797|FG007|STARTED|Main Treatment Part||7
11052316|NCT00974090|12233525|FG001|STARTED|Period 1: Double Blind Period||96
11052317|NCT00974090|12233524|FG000|COMPLETED|Period 1: Double Blind Period||95
11052318|NCT00974090|12233525|FG001|COMPLETED|Period 1: Double Blind Period||95
11052319|NCT00974090|12233524|FG000|NOT COMPLETED|Period 1: Double Blind Period||3
11052320|NCT00974090|12233525|FG001|NOT COMPLETED|Period 1: Double Blind Period||1
11201540|NCT01833026|12391827|FG001|COMPLETED|Overall Study||34
11052321|NCT00974090|12233524|FG000|STARTED|Period 2: Open-label Period||95
11052322|NCT00974090|12233525|FG001|STARTED|Period 2: Open-label Period||95
11052323|NCT00974090|12233524|FG000|COMPLETED|Period 2: Open-label Period||87
11052324|NCT00974090|12233525|FG001|COMPLETED|Period 2: Open-label Period||85
11052325|NCT00974090|12233524|FG000|NOT COMPLETED|Period 2: Open-label Period||8
11052326|NCT00974090|12233525|FG001|NOT COMPLETED|Period 2: Open-label Period||10
11052327|NCT00974142|12233535|FG000|STARTED|Overall Study||8
11052328|NCT00974142|12233536|FG001|STARTED|Overall Study||9
11052329|NCT00974142|12233535|FG000|COMPLETED|Overall Study||8
11052330|NCT00974142|12233536|FG001|COMPLETED|Overall Study||9
11052331|NCT00974142|12233535|FG000|NOT COMPLETED|Overall Study||0
11052332|NCT00974142|12233536|FG001|NOT COMPLETED|Overall Study||0
11052333|NCT00974220|12233544|FG000|STARTED|Treatment Period 1||9
11052334|NCT00974220|12233545|FG001|STARTED|Treatment Period 1||7
11052335|NCT00974220|12233544|FG000|COMPLETED|Treatment Period 1||7
11052336|NCT00974220|12233545|FG001|COMPLETED|Treatment Period 1||5
11052337|NCT00974220|12233544|FG000|NOT COMPLETED|Treatment Period 1||2
11052338|NCT00974220|12233545|FG001|NOT COMPLETED|Treatment Period 1||2
11052339|NCT00974220|12233544|FG000|STARTED|Treatment Period 2||7
11052340|NCT00974220|12233545|FG001|STARTED|Treatment Period 2||5
11052341|NCT00974220|12233544|FG000|COMPLETED|Treatment Period 2||7
11052342|NCT00974220|12233545|FG001|COMPLETED|Treatment Period 2||5
11052343|NCT00974220|12233544|FG000|NOT COMPLETED|Treatment Period 2||0
11052344|NCT00974220|12233545|FG001|NOT COMPLETED|Treatment Period 2||0
11052345|NCT00974233|12233551|FG000|STARTED|Induction Chemoimmunotherapy||34
11052346|NCT00974233|12233551|FG000|COMPLETED|Induction Chemoimmunotherapy||19
11052347|NCT00974233|12233551|FG000|NOT COMPLETED|Induction Chemoimmunotherapy||15
11052348|NCT00974233|12233551|FG000|STARTED|Maintenance Lenalidomide||19
11052349|NCT00974233|12233551|FG000|COMPLETED|Maintenance Lenalidomide||6
11052350|NCT00974233|12233551|FG000|NOT COMPLETED|Maintenance Lenalidomide||13
11052351|NCT00974246|12233563|FG000|STARTED|Overall Study||27
11052352|NCT00974246|12233563|FG000|COMPLETED|Overall Study||27
11052353|NCT00974246|12233563|FG000|NOT COMPLETED|Overall Study||0
11052354|NCT00974259|12233570|FG000|STARTED|Overall Study||59
11052355|NCT00974259|12233571|FG001|STARTED|Overall Study||63
11052356|NCT00974259|12233570|FG000|COMPLETED|Overall Study||57
11052357|NCT00974259|12233571|FG001|COMPLETED|Overall Study||62
11052358|NCT00974259|12233570|FG000|NOT COMPLETED|Overall Study||2
11052359|NCT00974259|12233571|FG001|NOT COMPLETED|Overall Study||1
11052360|NCT00974311|12233579|FG000|STARTED|DB Phase (up to 24 Months)||800
11052361|NCT00974311|12233580|FG001|STARTED|DB Phase (up to 24 Months)||399
11052362|NCT00974311|12233579|FG000|COMPLETED|DB Phase (up to 24 Months)||109
11052363|NCT00974311|12233580|FG001|COMPLETED|DB Phase (up to 24 Months)||50
11052364|NCT00974311|12233579|FG000|NOT COMPLETED|DB Phase (up to 24 Months)||691
11052365|NCT00974311|12233580|FG001|NOT COMPLETED|DB Phase (up to 24 Months)||349
11052366|NCT00974311|12233579|FG000|STARTED|OLE Phase (up to 77 Months)||109
11052367|NCT00974311|12233580|FG001|STARTED|OLE Phase (up to 77 Months)||50
11052368|NCT00974311|12233579|FG000|COMPLETED|OLE Phase (up to 77 Months)||0
11052369|NCT00974311|12233580|FG001|COMPLETED|OLE Phase (up to 77 Months)||0
11052370|NCT00974311|12233579|FG000|NOT COMPLETED|OLE Phase (up to 77 Months)||109
11052371|NCT00974311|12233580|FG001|NOT COMPLETED|OLE Phase (up to 77 Months)||50
11052372|NCT00974350|12233592|FG000|STARTED|Overall Study||45
11052373|NCT00974350|12233593|FG001|STARTED|Overall Study||47
11052374|NCT00974350|12233594|FG002|STARTED|Overall Study||32
11052375|NCT00974350|12233592|FG000|COMPLETED|Overall Study||42
11052376|NCT00974350|12233593|FG001|COMPLETED|Overall Study||47
11052377|NCT00974350|12233594|FG002|COMPLETED|Overall Study||31
11052378|NCT00974350|12233592|FG000|NOT COMPLETED|Overall Study||3
11052379|NCT00974350|12233593|FG001|NOT COMPLETED|Overall Study||0
11052380|NCT00974350|12233594|FG002|NOT COMPLETED|Overall Study||1
11052381|NCT00974363|12233605|FG000|STARTED|Overall Study||521
11052382|NCT00974363|12233606|FG001|STARTED|Overall Study||168
11052383|NCT00974363|12233605|FG000|COMPLETED|Overall Study||521
11052384|NCT00974363|12233606|FG001|COMPLETED|Overall Study||168
11052385|NCT00974363|12233605|FG000|NOT COMPLETED|Overall Study||0
11052386|NCT00974363|12233606|FG001|NOT COMPLETED|Overall Study||0
11052387|NCT00974376|12233614|FG000|STARTED|Overall Study||75
11052388|NCT00974376|12233615|FG001|STARTED|Overall Study||75
11052389|NCT00974376|12233614|FG000|COMPLETED|Overall Study||41
11052390|NCT00974376|12233615|FG001|COMPLETED|Overall Study||42
11052391|NCT00974376|12233614|FG000|NOT COMPLETED|Overall Study||34
11052392|NCT00974376|12233615|FG001|NOT COMPLETED|Overall Study||33
11052393|NCT00974480|12233624|FG000|STARTED|Overall Study||40
11052394|NCT00974480|12233625|FG001|STARTED|Overall Study||40
11052395|NCT00974480|12233626|FG002|STARTED|Overall Study||40
11052396|NCT00974480|12233624|FG000|COMPLETED|Overall Study||29
11052397|NCT00974480|12233625|FG001|COMPLETED|Overall Study||33
11052398|NCT00974480|12233626|FG002|COMPLETED|Overall Study||30
11052399|NCT00974480|12233624|FG000|NOT COMPLETED|Overall Study||11
11052400|NCT00974480|12233625|FG001|NOT COMPLETED|Overall Study||7
11052401|NCT00974480|12233626|FG002|NOT COMPLETED|Overall Study||10
11052402|NCT00974493|12233642|FG000|STARTED|Overall Study||527
11052403|NCT00974493|12233643|FG001|STARTED|Overall Study||527
11052404|NCT00974493|12233642|FG000|COMPLETED|Overall Study||509
11052405|NCT00974493|12233643|FG001|COMPLETED|Overall Study||506
11052406|NCT00974493|12233642|FG000|NOT COMPLETED|Overall Study||18
11052407|NCT00974493|12233643|FG001|NOT COMPLETED|Overall Study||21
11052408|NCT00974675|12233653|FG000|STARTED|Overall Study||8
11052409|NCT00974675|12233654|FG001|STARTED|Overall Study||8
11052410|NCT00974675|12233655|FG002|STARTED|Overall Study||3
11052411|NCT00974675|12233656|FG003|STARTED|Overall Study||4
11052412|NCT00974675|12233653|FG000|COMPLETED|Overall Study||6
11052413|NCT00974675|12233654|FG001|COMPLETED|Overall Study||7
11052414|NCT00974675|12233655|FG002|COMPLETED|Overall Study||1
11052415|NCT00974675|12233656|FG003|COMPLETED|Overall Study||2
11052416|NCT00974675|12233653|FG000|NOT COMPLETED|Overall Study||2
11052417|NCT00974675|12233654|FG001|NOT COMPLETED|Overall Study||1
11052418|NCT00974675|12233655|FG002|NOT COMPLETED|Overall Study||2
11052419|NCT00974675|12233656|FG003|NOT COMPLETED|Overall Study||2
11052420|NCT00974818|12233668|FG000|STARTED|Overall Study||25
11052421|NCT00974818|12233669|FG001|STARTED|Overall Study||25
11052422|NCT00974818|12233668|FG000|COMPLETED|Overall Study||25
11052423|NCT00974818|12233669|FG001|COMPLETED|Overall Study||25
11052424|NCT00974818|12233668|FG000|NOT COMPLETED|Overall Study||0
11052425|NCT00974818|12233669|FG001|NOT COMPLETED|Overall Study||0
11052426|NCT00974974|12233677|FG000|STARTED|IR CD-LD Dose Adjustment||0
11052427|NCT00974974|12233678|FG001|STARTED|IR CD-LD Dose Adjustment||471
11052428|NCT00974974|12233677|FG000|COMPLETED|IR CD-LD Dose Adjustment||0
11052429|NCT00974974|12233678|FG001|COMPLETED|IR CD-LD Dose Adjustment||450
11052430|NCT00974974|12233677|FG000|NOT COMPLETED|IR CD-LD Dose Adjustment||0
11052431|NCT00974974|12233678|FG001|NOT COMPLETED|IR CD-LD Dose Adjustment||21
11052432|NCT00974974|12233677|FG000|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
11052433|NCT00974974|12233678|FG001|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
11052434|NCT00974974|12233677|FG000|COMPLETED|IPX066 Dose Conversion||393
11052435|NCT00974974|12233678|FG001|COMPLETED|IPX066 Dose Conversion||0
11052436|NCT00974974|12233677|FG000|NOT COMPLETED|IPX066 Dose Conversion||57
11052437|NCT00974974|12233678|FG001|NOT COMPLETED|IPX066 Dose Conversion||0
11052438|NCT00974974|12233677|FG000|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
11052439|NCT00974974|12233678|FG001|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
11052440|NCT00974974|12233677|FG000|COMPLETED|Maintenance - Double Blind Treatment||186
11052441|NCT00974974|12233678|FG001|COMPLETED|Maintenance - Double Blind Treatment||182
11052442|NCT00974974|12233677|FG000|NOT COMPLETED|Maintenance - Double Blind Treatment||15
11052443|NCT00974974|12233678|FG001|NOT COMPLETED|Maintenance - Double Blind Treatment||10
11052444|NCT00975000|12233686|FG000|STARTED|Overall Study||57
11052445|NCT00975000|12233687|FG001|STARTED|Overall Study||57
11052446|NCT00975000|12233686|FG000|Completed Titration Phase|Overall Study||54
11052447|NCT00975000|12233687|FG001|Completed Titration Phase|Overall Study||55
11338200|NCT02901431|12535798|FG008|STARTED|Main Treatment Part||0
11338201|NCT02901431|12535799|FG009|STARTED|Main Treatment Part||0
11338202|NCT02901431|12535800|FG010|STARTED|Main Treatment Part||0
11338203|NCT02901431|12535801|FG011|STARTED|Main Treatment Part||0
11338204|NCT02901431|12535802|FG012|STARTED|Main Treatment Part||0
11338205|NCT02901431|12535790|FG000|COMPLETED|Main Treatment Part||0
11338206|NCT02901431|12535791|FG001|COMPLETED|Main Treatment Part||0
11338207|NCT02901431|12535792|FG002|COMPLETED|Main Treatment Part||0
11338208|NCT02901431|12535793|FG003|COMPLETED|Main Treatment Part||86
11338209|NCT02901431|12535794|FG004|COMPLETED|Main Treatment Part||50
11338210|NCT02901431|12535795|FG005|COMPLETED|Main Treatment Part||54
11338211|NCT02901431|12535796|FG006|COMPLETED|Main Treatment Part||55
11338212|NCT02901431|12535797|FG007|COMPLETED|Main Treatment Part||7
11338213|NCT02901431|12535798|FG008|COMPLETED|Main Treatment Part||0
11338214|NCT02901431|12535799|FG009|COMPLETED|Main Treatment Part||0
11338215|NCT02901431|12535800|FG010|COMPLETED|Main Treatment Part||0
11338216|NCT02901431|12535801|FG011|COMPLETED|Main Treatment Part||0
11338217|NCT02901431|12535802|FG012|COMPLETED|Main Treatment Part||0
11338218|NCT02901431|12535790|FG000|NOT COMPLETED|Main Treatment Part||0
11338219|NCT02901431|12535791|FG001|NOT COMPLETED|Main Treatment Part||0
11338220|NCT02901431|12535792|FG002|NOT COMPLETED|Main Treatment Part||0
11338221|NCT02901431|12535793|FG003|NOT COMPLETED|Main Treatment Part||26
11338222|NCT02901431|12535794|FG004|NOT COMPLETED|Main Treatment Part||7
11338223|NCT02901431|12535795|FG005|NOT COMPLETED|Main Treatment Part||12
11338224|NCT02901431|12535796|FG006|NOT COMPLETED|Main Treatment Part||11
11338225|NCT02901431|12535797|FG007|NOT COMPLETED|Main Treatment Part||0
11338226|NCT02901431|12535798|FG008|NOT COMPLETED|Main Treatment Part||0
11338227|NCT02901431|12535799|FG009|NOT COMPLETED|Main Treatment Part||0
11338228|NCT02901431|12535800|FG010|NOT COMPLETED|Main Treatment Part||0
11338229|NCT02901431|12535801|FG011|NOT COMPLETED|Main Treatment Part||0
11338230|NCT02901431|12535802|FG012|NOT COMPLETED|Main Treatment Part||0
11338231|NCT02901431|12535790|FG000|STARTED|Open Label Part||0
11338232|NCT02901431|12535791|FG001|STARTED|Open Label Part||0
11338233|NCT02901431|12535792|FG002|STARTED|Open Label Part||0
11338234|NCT02901431|12535793|FG003|STARTED|Open Label Part||0
11338235|NCT02901431|12535794|FG004|STARTED|Open Label Part||0
11338236|NCT02901431|12535795|FG005|STARTED|Open Label Part||0
11338237|NCT02901431|12535796|FG006|STARTED|Open Label Part||0
11338238|NCT02901431|12535797|FG007|STARTED|Open Label Part||0
11338239|NCT02901431|12535798|FG008|STARTED|Open Label Part||68
11338240|NCT02901431|12535799|FG009|STARTED|Open Label Part||35
11338241|NCT02901431|12535800|FG010|STARTED|Open Label Part||40
11338242|NCT02901431|12535801|FG011|STARTED|Open Label Part||46
11338243|NCT02901431|12535802|FG012|STARTED|Open Label Part||5
11338244|NCT02901431|12535790|FG000|COMPLETED|Open Label Part||0
11052448|NCT00975000|12233686|FG000|Completed Efficacy Assessment Phase|Overall Study||54
11052449|NCT00975000|12233687|FG001|Completed Efficacy Assessment Phase|Overall Study||54
11052450|NCT00975000|12233686|FG000|Completed Maintenance Phase|Overall Study||52
11052451|NCT00975000|12233687|FG001|Completed Maintenance Phase|Overall Study||52
11052452|NCT00975000|12233686|FG000|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
11052453|NCT00975000|12233687|FG001|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
11052454|NCT00975000|12233686|FG000|NOT COMPLETED|Overall Study||5
11052455|NCT00975000|12233687|FG001|NOT COMPLETED|Overall Study||5
11052456|NCT00975130|12233693|FG000|STARTED|Study Part 1||3366
11052457|NCT00975130|12233694|FG001|STARTED|Study Part 1||0
11052458|NCT00975130|12233695|FG002|STARTED|Study Part 1||0
11052459|NCT00975130|12233693|FG000|COMPLETED|Study Part 1||3086
11052460|NCT00975130|12233694|FG001|COMPLETED|Study Part 1||0
11052461|NCT00975130|12233695|FG002|COMPLETED|Study Part 1||0
11052462|NCT00975130|12233693|FG000|NOT COMPLETED|Study Part 1||280
11052463|NCT00975130|12233694|FG001|NOT COMPLETED|Study Part 1||0
11052464|NCT00975130|12233695|FG002|NOT COMPLETED|Study Part 1||0
11052465|NCT00975130|12233693|FG000|STARTED|Study Part 2||0
11052466|NCT00975130|12233694|FG001|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
11052467|NCT00975130|12233695|FG002|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
11052468|NCT00975130|12233693|FG000|COMPLETED|Study Part 2||0
11052469|NCT00975130|12233694|FG001|COMPLETED|Study Part 2||212
11052470|NCT00975130|12233695|FG002|COMPLETED|Study Part 2||238
11052471|NCT00975130|12233693|FG000|NOT COMPLETED|Study Part 2||0
11052472|NCT00975130|12233694|FG001|NOT COMPLETED|Study Part 2||38
11052473|NCT00975130|12233695|FG002|NOT COMPLETED|Study Part 2||17
11052474|NCT00975143|12233710|FG000|STARTED|Overall Study||464
11052475|NCT00975143|12233711|FG001|STARTED|Overall Study||461
11052476|NCT00975143|12233710|FG000|Completed Treatment (Week 20)|Overall Study||403
11052477|NCT00975143|12233711|FG001|Completed Treatment (Week 20)|Overall Study||410
11052478|NCT00975143|12233710|FG000|COMPLETED|Overall Study||394
11052479|NCT00975143|12233711|FG001|COMPLETED|Overall Study||401
11052480|NCT00975143|12233710|FG000|NOT COMPLETED|Overall Study||70
11052481|NCT00975143|12233711|FG001|NOT COMPLETED|Overall Study||60
11052482|NCT00975156|12233719|FG000|STARTED|Overall Study||11
11052483|NCT00975156|12233720|FG001|STARTED|Overall Study||10
11052484|NCT00975156|12233719|FG000|COMPLETED|Overall Study||11
11052485|NCT00975156|12233720|FG001|COMPLETED|Overall Study||9
11052486|NCT00975156|12233719|FG000|NOT COMPLETED|Overall Study||0
11052487|NCT00975156|12233720|FG001|NOT COMPLETED|Overall Study||1
11052488|NCT00975195|12233732|FG000|STARTED|Overall Study||1244
11052489|NCT00975195|12233733|FG001|STARTED|Overall Study||1244
11052490|NCT00975195|12233732|FG000|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
11052491|NCT00975195|12233733|FG001|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
11052492|NCT00975195|12233732|FG000|NOT COMPLETED|Overall Study||228
11052493|NCT00975195|12233733|FG001|NOT COMPLETED|Overall Study||233
11052494|NCT00975221|12233741|FG000|STARTED|Titration Phase (Weeks 1-12)||34
11052495|NCT00975221|12233742|FG001|STARTED|Titration Phase (Weeks 1-12)||33
11052496|NCT00975221|12233741|FG000|Received Study Drug|Titration Phase (Weeks 1-12)||34
11052497|NCT00975221|12233742|FG001|Received Study Drug|Titration Phase (Weeks 1-12)||33
11052498|NCT00975221|12233741|FG000|COMPLETED|Titration Phase (Weeks 1-12)||31
11052499|NCT00975221|12233742|FG001|COMPLETED|Titration Phase (Weeks 1-12)||29
11052500|NCT00975221|12233741|FG000|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
11052501|NCT00975221|12233742|FG001|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
11052502|NCT00975221|12233741|FG000|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
11052503|NCT00975221|12233742|FG001|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
11052504|NCT00975221|12233741|FG000|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
11052505|NCT00975221|12233742|FG001|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
11052506|NCT00975221|12233741|FG000|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
11052507|NCT00975221|12233742|FG001|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
11052508|NCT00975221|12233741|FG000|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
11052509|NCT00975221|12233742|FG001|STARTED|Open-label Extension Phase (Weeks 29-52)||28
11052510|NCT00975221|12233741|FG000|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
11052511|NCT00975221|12233742|FG001|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
11052512|NCT00975221|12233741|FG000|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
11052513|NCT00975221|12233742|FG001|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
11052514|NCT00975286|12233752|FG000|STARTED|Overall Study|Randomized.|223
11052515|NCT00975286|12233753|FG001|STARTED|Overall Study||223
11052516|NCT00975286|12233752|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
11052517|NCT00975286|12233753|FG001|Safety Population|Overall Study||223
11052518|NCT00975286|12233752|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
11052519|NCT00975286|12233753|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||223
11052520|NCT00975286|12233752|FG000|COMPLETED|Overall Study||211
11052521|NCT00975286|12233753|FG001|COMPLETED|Overall Study||194
11052522|NCT00975286|12233752|FG000|NOT COMPLETED|Overall Study||12
11052523|NCT00975286|12233753|FG001|NOT COMPLETED|Overall Study||29
11052524|NCT00975416|12233761|FG000|STARTED|Overall Study||14
11052525|NCT00975416|12233762|FG001|STARTED|Overall Study||16
11052526|NCT00975416|12233761|FG000|COMPLETED|Overall Study||11
11052527|NCT00975416|12233762|FG001|COMPLETED|Overall Study||11
11052528|NCT00975416|12233761|FG000|NOT COMPLETED|Overall Study||3
11052529|NCT00975416|12233762|FG001|NOT COMPLETED|Overall Study||5
11052530|NCT00975481|12233769|FG000|STARTED|First Intervention Period||6
11052531|NCT00975481|12233770|FG001|STARTED|First Intervention Period||6
11052532|NCT00975481|12233771|FG002|STARTED|First Intervention Period||6
11052533|NCT00975481|12233772|FG003|STARTED|First Intervention Period||6
11052534|NCT00975481|12233773|FG004|STARTED|First Intervention Period||6
11052535|NCT00975481|12233774|FG005|STARTED|First Intervention Period||6
11052536|NCT00975481|12233769|FG000|COMPLETED|First Intervention Period||6
11052537|NCT00975481|12233770|FG001|COMPLETED|First Intervention Period||6
11052538|NCT00975481|12233771|FG002|COMPLETED|First Intervention Period||6
11052539|NCT00975481|12233772|FG003|COMPLETED|First Intervention Period||6
11052540|NCT00975481|12233773|FG004|COMPLETED|First Intervention Period||6
11052541|NCT00975481|12233774|FG005|COMPLETED|First Intervention Period||6
11052542|NCT00975481|12233769|FG000|NOT COMPLETED|First Intervention Period||0
11052543|NCT00975481|12233770|FG001|NOT COMPLETED|First Intervention Period||0
11052544|NCT00975481|12233771|FG002|NOT COMPLETED|First Intervention Period||0
11052545|NCT00975481|12233772|FG003|NOT COMPLETED|First Intervention Period||0
11052546|NCT00975481|12233773|FG004|NOT COMPLETED|First Intervention Period||0
11052547|NCT00975481|12233774|FG005|NOT COMPLETED|First Intervention Period||0
11052548|NCT00975481|12233769|FG000|STARTED|Washout Period (at Least 7 Days)||6
11052549|NCT00975481|12233770|FG001|STARTED|Washout Period (at Least 7 Days)||6
11052550|NCT00975481|12233771|FG002|STARTED|Washout Period (at Least 7 Days)||6
11052551|NCT00975481|12233772|FG003|STARTED|Washout Period (at Least 7 Days)||6
11052552|NCT00975481|12233773|FG004|STARTED|Washout Period (at Least 7 Days)||6
11052553|NCT00975481|12233774|FG005|STARTED|Washout Period (at Least 7 Days)||6
11052554|NCT00975481|12233769|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
11052555|NCT00975481|12233770|FG001|COMPLETED|Washout Period (at Least 7 Days)||6
11052556|NCT00975481|12233771|FG002|COMPLETED|Washout Period (at Least 7 Days)||6
11052557|NCT00975481|12233772|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
11052558|NCT00975481|12233773|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
11052559|NCT00975481|12233774|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
11052560|NCT00975481|12233769|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052561|NCT00975481|12233770|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052562|NCT00975481|12233771|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052563|NCT00975481|12233772|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052564|NCT00975481|12233773|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052565|NCT00975481|12233774|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052566|NCT00975481|12233769|FG000|STARTED|Second Intervention Period||6
11052567|NCT00975481|12233770|FG001|STARTED|Second Intervention Period||6
11052568|NCT00975481|12233771|FG002|STARTED|Second Intervention Period||6
11052569|NCT00975481|12233772|FG003|STARTED|Second Intervention Period||6
11052570|NCT00975481|12233773|FG004|STARTED|Second Intervention Period||6
11052571|NCT00975481|12233774|FG005|STARTED|Second Intervention Period||6
11052572|NCT00975481|12233769|FG000|COMPLETED|Second Intervention Period||4
11052573|NCT00975481|12233770|FG001|COMPLETED|Second Intervention Period||5
11052574|NCT00975481|12233771|FG002|COMPLETED|Second Intervention Period||5
11052575|NCT00975481|12233772|FG003|COMPLETED|Second Intervention Period||6
11052576|NCT00975481|12233773|FG004|COMPLETED|Second Intervention Period||6
11052577|NCT00975481|12233774|FG005|COMPLETED|Second Intervention Period||6
11052578|NCT00975481|12233769|FG000|NOT COMPLETED|Second Intervention Period||2
11052579|NCT00975481|12233770|FG001|NOT COMPLETED|Second Intervention Period||1
11052580|NCT00975481|12233771|FG002|NOT COMPLETED|Second Intervention Period||1
11052581|NCT00975481|12233772|FG003|NOT COMPLETED|Second Intervention Period||0
11052582|NCT00975481|12233773|FG004|NOT COMPLETED|Second Intervention Period||0
11052583|NCT00975481|12233774|FG005|NOT COMPLETED|Second Intervention Period||0
11052584|NCT00975481|12233769|FG000|STARTED|Washout Period (at Least 7 Days)||4
11052585|NCT00975481|12233770|FG001|STARTED|Washout Period (at Least 7 Days)||5
11052586|NCT00975481|12233771|FG002|STARTED|Washout Period (at Least 7 Days)||5
11052587|NCT00975481|12233772|FG003|STARTED|Washout Period (at Least 7 Days)||6
11052588|NCT00975481|12233773|FG004|STARTED|Washout Period (at Least 7 Days)||6
11052589|NCT00975481|12233774|FG005|STARTED|Washout Period (at Least 7 Days)||6
11052590|NCT00975481|12233769|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
11052591|NCT00975481|12233770|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
11052592|NCT00975481|12233771|FG002|COMPLETED|Washout Period (at Least 7 Days)||5
11052593|NCT00975481|12233772|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
11052594|NCT00975481|12233773|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
11052595|NCT00975481|12233774|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
11052596|NCT00975481|12233769|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052597|NCT00975481|12233770|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052598|NCT00975481|12233771|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052599|NCT00975481|12233772|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052600|NCT00975481|12233773|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052601|NCT00975481|12233774|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052602|NCT00975481|12233769|FG000|STARTED|Third Intervention Period||4
11052603|NCT00975481|12233770|FG001|STARTED|Third Intervention Period||5
11052604|NCT00975481|12233771|FG002|STARTED|Third Intervention Period||5
11052605|NCT00975481|12233772|FG003|STARTED|Third Intervention Period||6
11052606|NCT00975481|12233773|FG004|STARTED|Third Intervention Period||6
11052607|NCT00975481|12233774|FG005|STARTED|Third Intervention Period||6
11052608|NCT00975481|12233769|FG000|COMPLETED|Third Intervention Period||4
11052609|NCT00975481|12233770|FG001|COMPLETED|Third Intervention Period||5
11052610|NCT00975481|12233771|FG002|COMPLETED|Third Intervention Period||5
11052611|NCT00975481|12233772|FG003|COMPLETED|Third Intervention Period||6
11052612|NCT00975481|12233773|FG004|COMPLETED|Third Intervention Period||6
11052613|NCT00975481|12233774|FG005|COMPLETED|Third Intervention Period||6
11052614|NCT00975481|12233769|FG000|NOT COMPLETED|Third Intervention Period||0
11052615|NCT00975481|12233770|FG001|NOT COMPLETED|Third Intervention Period||0
11052616|NCT00975481|12233771|FG002|NOT COMPLETED|Third Intervention Period||0
11052617|NCT00975481|12233772|FG003|NOT COMPLETED|Third Intervention Period||0
11052618|NCT00975481|12233773|FG004|NOT COMPLETED|Third Intervention Period||0
11052619|NCT00975481|12233774|FG005|NOT COMPLETED|Third Intervention Period||0
11052620|NCT00975481|12233769|FG000|STARTED|Washout Period (at Least 7 Days)||4
11052621|NCT00975481|12233770|FG001|STARTED|Washout Period (at Least 7 Days)||5
11052622|NCT00975481|12233771|FG002|STARTED|Washout Period (at Least 7 Days)||5
11052623|NCT00975481|12233772|FG003|STARTED|Washout Period (at Least 7 Days)||6
11052624|NCT00975481|12233773|FG004|STARTED|Washout Period (at Least 7 Days)||6
11052625|NCT00975481|12233774|FG005|STARTED|Washout Period (at Least 7 Days)||6
11052626|NCT00975481|12233769|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
11052627|NCT00975481|12233770|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
11052628|NCT00975481|12233771|FG002|COMPLETED|Washout Period (at Least 7 Days)||5
11052629|NCT00975481|12233772|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
11052630|NCT00975481|12233773|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
11052631|NCT00975481|12233774|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
11052632|NCT00975481|12233769|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052633|NCT00975481|12233770|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052634|NCT00975481|12233771|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052635|NCT00975481|12233772|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052636|NCT00975481|12233773|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052637|NCT00975481|12233774|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052638|NCT00975481|12233769|FG000|STARTED|Fourth Intervention Period||4
11052639|NCT00975481|12233770|FG001|STARTED|Fourth Intervention Period||5
11052640|NCT00975481|12233771|FG002|STARTED|Fourth Intervention Period||5
11052641|NCT00975481|12233772|FG003|STARTED|Fourth Intervention Period||6
11052642|NCT00975481|12233773|FG004|STARTED|Fourth Intervention Period||6
11052643|NCT00975481|12233774|FG005|STARTED|Fourth Intervention Period||6
11052644|NCT00975481|12233769|FG000|COMPLETED|Fourth Intervention Period||4
11052645|NCT00975481|12233770|FG001|COMPLETED|Fourth Intervention Period||5
11052646|NCT00975481|12233771|FG002|COMPLETED|Fourth Intervention Period||4
11052647|NCT00975481|12233772|FG003|COMPLETED|Fourth Intervention Period||5
11052648|NCT00975481|12233773|FG004|COMPLETED|Fourth Intervention Period||6
11052649|NCT00975481|12233774|FG005|COMPLETED|Fourth Intervention Period||6
11052650|NCT00975481|12233769|FG000|NOT COMPLETED|Fourth Intervention Period||0
11052651|NCT00975481|12233770|FG001|NOT COMPLETED|Fourth Intervention Period||0
11052652|NCT00975481|12233771|FG002|NOT COMPLETED|Fourth Intervention Period||1
11052653|NCT00975481|12233772|FG003|NOT COMPLETED|Fourth Intervention Period||1
11052654|NCT00975481|12233773|FG004|NOT COMPLETED|Fourth Intervention Period||0
11052655|NCT00975481|12233774|FG005|NOT COMPLETED|Fourth Intervention Period||0
11052656|NCT00975481|12233769|FG000|STARTED|Washout Period (at Least 7 Days)||4
11338245|NCT02901431|12535791|FG001|COMPLETED|Open Label Part||0
11052657|NCT00975481|12233770|FG001|STARTED|Washout Period (at Least 7 Days)||5
11052658|NCT00975481|12233771|FG002|STARTED|Washout Period (at Least 7 Days)||4
11052659|NCT00975481|12233772|FG003|STARTED|Washout Period (at Least 7 Days)||5
11052660|NCT00975481|12233773|FG004|STARTED|Washout Period (at Least 7 Days)||6
11052661|NCT00975481|12233774|FG005|STARTED|Washout Period (at Least 7 Days)||6
11052662|NCT00975481|12233769|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
11052663|NCT00975481|12233770|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
11052664|NCT00975481|12233771|FG002|COMPLETED|Washout Period (at Least 7 Days)||4
11052665|NCT00975481|12233772|FG003|COMPLETED|Washout Period (at Least 7 Days)||5
11052666|NCT00975481|12233773|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
11052667|NCT00975481|12233774|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
11052668|NCT00975481|12233769|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052669|NCT00975481|12233770|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052670|NCT00975481|12233771|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052671|NCT00975481|12233772|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052672|NCT00975481|12233773|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052673|NCT00975481|12233774|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052674|NCT00975481|12233769|FG000|STARTED|Fifth Intervention Period||4
11338246|NCT02901431|12535792|FG002|COMPLETED|Open Label Part||0
11338247|NCT02901431|12535793|FG003|COMPLETED|Open Label Part||0
11052675|NCT00975481|12233770|FG001|STARTED|Fifth Intervention Period||5
11052676|NCT00975481|12233771|FG002|STARTED|Fifth Intervention Period||4
11052677|NCT00975481|12233772|FG003|STARTED|Fifth Intervention Period||5
11052678|NCT00975481|12233773|FG004|STARTED|Fifth Intervention Period||6
11052679|NCT00975481|12233774|FG005|STARTED|Fifth Intervention Period||6
11052680|NCT00975481|12233769|FG000|COMPLETED|Fifth Intervention Period||4
11052681|NCT00975481|12233770|FG001|COMPLETED|Fifth Intervention Period||5
11052682|NCT00975481|12233771|FG002|COMPLETED|Fifth Intervention Period||4
11052683|NCT00975481|12233772|FG003|COMPLETED|Fifth Intervention Period||5
11052684|NCT00975481|12233773|FG004|COMPLETED|Fifth Intervention Period||5
11052685|NCT00975481|12233774|FG005|COMPLETED|Fifth Intervention Period||6
11052686|NCT00975481|12233769|FG000|NOT COMPLETED|Fifth Intervention Period||0
11052687|NCT00975481|12233770|FG001|NOT COMPLETED|Fifth Intervention Period||0
11052688|NCT00975481|12233771|FG002|NOT COMPLETED|Fifth Intervention Period||0
11052689|NCT00975481|12233772|FG003|NOT COMPLETED|Fifth Intervention Period||0
11052690|NCT00975481|12233773|FG004|NOT COMPLETED|Fifth Intervention Period||1
11052691|NCT00975481|12233774|FG005|NOT COMPLETED|Fifth Intervention Period||0
11052692|NCT00975481|12233769|FG000|STARTED|Washout Period (at Least 7 Days)||4
11052693|NCT00975481|12233770|FG001|STARTED|Washout Period (at Least 7 Days)||5
11052694|NCT00975481|12233771|FG002|STARTED|Washout Period (at Least 7 Days)||4
11052695|NCT00975481|12233772|FG003|STARTED|Washout Period (at Least 7 Days)||5
11052696|NCT00975481|12233773|FG004|STARTED|Washout Period (at Least 7 Days)||5
11052697|NCT00975481|12233774|FG005|STARTED|Washout Period (at Least 7 Days)||6
11052698|NCT00975481|12233769|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
11052699|NCT00975481|12233770|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
11052700|NCT00975481|12233771|FG002|COMPLETED|Washout Period (at Least 7 Days)||4
11052701|NCT00975481|12233772|FG003|COMPLETED|Washout Period (at Least 7 Days)||5
11052702|NCT00975481|12233773|FG004|COMPLETED|Washout Period (at Least 7 Days)||5
11052703|NCT00975481|12233774|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
11052704|NCT00975481|12233769|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052705|NCT00975481|12233770|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052706|NCT00975481|12233771|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052707|NCT00975481|12233772|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052708|NCT00975481|12233773|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052709|NCT00975481|12233774|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11052710|NCT00975481|12233769|FG000|STARTED|Sixth Intervention Period||4
11052711|NCT00975481|12233770|FG001|STARTED|Sixth Intervention Period||5
11052712|NCT00975481|12233771|FG002|STARTED|Sixth Intervention Period||4
11052713|NCT00975481|12233772|FG003|STARTED|Sixth Intervention Period||5
11052714|NCT00975481|12233773|FG004|STARTED|Sixth Intervention Period||5
11052715|NCT00975481|12233774|FG005|STARTED|Sixth Intervention Period||6
11052716|NCT00975481|12233769|FG000|COMPLETED|Sixth Intervention Period||4
11052717|NCT00975481|12233770|FG001|COMPLETED|Sixth Intervention Period||5
11338248|NCT02901431|12535794|FG004|COMPLETED|Open Label Part||0
11338249|NCT02901431|12535795|FG005|COMPLETED|Open Label Part||0
11338250|NCT02901431|12535796|FG006|COMPLETED|Open Label Part||0
11338251|NCT02901431|12535797|FG007|COMPLETED|Open Label Part||0
11338252|NCT02901431|12535798|FG008|COMPLETED|Open Label Part||20
11338253|NCT02901431|12535799|FG009|COMPLETED|Open Label Part||11
11338254|NCT02901431|12535800|FG010|COMPLETED|Open Label Part||11
11338255|NCT02901431|12535801|FG011|COMPLETED|Open Label Part||7
11338256|NCT02901431|12535802|FG012|COMPLETED|Open Label Part||2
11338257|NCT02901431|12535790|FG000|NOT COMPLETED|Open Label Part||0
11338258|NCT02901431|12535791|FG001|NOT COMPLETED|Open Label Part||0
11338259|NCT02901431|12535792|FG002|NOT COMPLETED|Open Label Part||0
11338260|NCT02901431|12535793|FG003|NOT COMPLETED|Open Label Part||0
11338261|NCT02901431|12535794|FG004|NOT COMPLETED|Open Label Part||0
11338262|NCT02901431|12535795|FG005|NOT COMPLETED|Open Label Part||0
11338263|NCT02901431|12535796|FG006|NOT COMPLETED|Open Label Part||0
11338264|NCT02901431|12535797|FG007|NOT COMPLETED|Open Label Part||0
11338265|NCT02901431|12535798|FG008|NOT COMPLETED|Open Label Part||48
11338266|NCT02901431|12535799|FG009|NOT COMPLETED|Open Label Part||24
11338267|NCT02901431|12535800|FG010|NOT COMPLETED|Open Label Part||29
11338268|NCT02901431|12535801|FG011|NOT COMPLETED|Open Label Part||39
11338269|NCT02901431|12535802|FG012|NOT COMPLETED|Open Label Part||3
11338270|NCT02901899|12535827|FG000|STARTED|Reached 1st Response Assessment||45
11052718|NCT00975481|12233771|FG002|COMPLETED|Sixth Intervention Period||4
11052719|NCT00975481|12233772|FG003|COMPLETED|Sixth Intervention Period||5
11052720|NCT00975481|12233773|FG004|COMPLETED|Sixth Intervention Period||5
11052721|NCT00975481|12233774|FG005|COMPLETED|Sixth Intervention Period||6
11052722|NCT00975481|12233769|FG000|NOT COMPLETED|Sixth Intervention Period||0
11052723|NCT00975481|12233770|FG001|NOT COMPLETED|Sixth Intervention Period||0
11052724|NCT00975481|12233771|FG002|NOT COMPLETED|Sixth Intervention Period||0
11052725|NCT00975481|12233772|FG003|NOT COMPLETED|Sixth Intervention Period||0
11052726|NCT00975481|12233773|FG004|NOT COMPLETED|Sixth Intervention Period||0
11052727|NCT00975481|12233774|FG005|NOT COMPLETED|Sixth Intervention Period||0
11052728|NCT00975507|12233794|FG000|STARTED|Overall Study||323
11052729|NCT00975507|12233795|FG001|STARTED|Overall Study||157
11338271|NCT02901899|12535827|FG000|Registered|Reached 1st Response Assessment||45
11052730|NCT00975507|12233794|FG000|Vaccinated at Visit 1|Overall Study||323
11052731|NCT00975507|12233795|FG001|Vaccinated at Visit 1|Overall Study||157
11052732|NCT00975507|12233794|FG000|Vaccinated at Visit 2|Overall Study||310
11052733|NCT00975507|12233795|FG001|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
11052734|NCT00975507|12233794|FG000|COMPLETED|Overall Study||303
11052735|NCT00975507|12233795|FG001|COMPLETED|Overall Study||153
11052736|NCT00975507|12233794|FG000|NOT COMPLETED|Overall Study||20
11052737|NCT00975507|12233795|FG001|NOT COMPLETED|Overall Study||4
11052738|NCT00975585|12233805|FG000|STARTED|Overall Study||184
11052739|NCT00975585|12233806|FG001|STARTED|Overall Study||195
11052740|NCT00975585|12233805|FG000|COMPLETED|Overall Study||177
11052741|NCT00975585|12233806|FG001|COMPLETED|Overall Study||183
11052742|NCT00975585|12233805|FG000|NOT COMPLETED|Overall Study||7
11052743|NCT00975585|12233806|FG001|NOT COMPLETED|Overall Study||12
11052744|NCT00975637|12233819|FG000|STARTED|Overall Study||40
11052745|NCT00975637|12233820|FG001|STARTED|Overall Study||39
11052746|NCT00975637|12233821|FG002|STARTED|Overall Study||42
11052747|NCT00975637|12233822|FG003|STARTED|Overall Study||38
11052748|NCT00975637|12233823|FG004|STARTED|Overall Study||39
11052749|NCT00975637|12233819|FG000|COMPLETED|Overall Study||37
11052750|NCT00975637|12233820|FG001|COMPLETED|Overall Study||38
11052751|NCT00975637|12233821|FG002|COMPLETED|Overall Study||40
11052752|NCT00975637|12233822|FG003|COMPLETED|Overall Study||32
11052753|NCT00975637|12233823|FG004|COMPLETED|Overall Study||37
11052754|NCT00975637|12233819|FG000|NOT COMPLETED|Overall Study||3
11052755|NCT00975637|12233820|FG001|NOT COMPLETED|Overall Study||1
11052756|NCT00975637|12233821|FG002|NOT COMPLETED|Overall Study||2
11052757|NCT00975637|12233822|FG003|NOT COMPLETED|Overall Study||6
11052758|NCT00975637|12233823|FG004|NOT COMPLETED|Overall Study||2
11052759|NCT00975650|12233835|FG000|STARTED|Period 1||13
11052760|NCT00975650|12233836|FG001|STARTED|Period 1||16
11052761|NCT00975650|12233837|FG002|STARTED|Period 1||14
11052762|NCT00975650|12233838|FG003|STARTED|Period 1||14
11052763|NCT00975650|12233835|FG000|COMPLETED|Period 1||13
11052764|NCT00975650|12233836|FG001|COMPLETED|Period 1||16
11052765|NCT00975650|12233837|FG002|COMPLETED|Period 1||14
11052766|NCT00975650|12233838|FG003|COMPLETED|Period 1||14
11052767|NCT00975650|12233835|FG000|NOT COMPLETED|Period 1||0
11052768|NCT00975650|12233836|FG001|NOT COMPLETED|Period 1||0
11052769|NCT00975650|12233837|FG002|NOT COMPLETED|Period 1||0
11052770|NCT00975650|12233838|FG003|NOT COMPLETED|Period 1||0
11052771|NCT00975650|12233835|FG000|STARTED|Period 2||13
11052772|NCT00975650|12233836|FG001|STARTED|Period 2||16
11052773|NCT00975650|12233837|FG002|STARTED|Period 2||14
11052774|NCT00975650|12233838|FG003|STARTED|Period 2||14
11052775|NCT00975650|12233835|FG000|COMPLETED|Period 2||12
11052776|NCT00975650|12233836|FG001|COMPLETED|Period 2||14
11052777|NCT00975650|12233837|FG002|COMPLETED|Period 2||14
11052778|NCT00975650|12233838|FG003|COMPLETED|Period 2||14
11052779|NCT00975650|12233835|FG000|NOT COMPLETED|Period 2||1
11052780|NCT00975650|12233836|FG001|NOT COMPLETED|Period 2||2
11052781|NCT00975650|12233837|FG002|NOT COMPLETED|Period 2||0
11052782|NCT00975650|12233838|FG003|NOT COMPLETED|Period 2||0
11052783|NCT00975650|12233835|FG000|STARTED|Period 3||12
11052784|NCT00975650|12233836|FG001|STARTED|Period 3||14
11052785|NCT00975650|12233837|FG002|STARTED|Period 3||14
11052786|NCT00975650|12233838|FG003|STARTED|Period 3||14
11052787|NCT00975650|12233835|FG000|COMPLETED|Period 3||12
11052788|NCT00975650|12233836|FG001|COMPLETED|Period 3||14
11052789|NCT00975650|12233837|FG002|COMPLETED|Period 3||14
11052790|NCT00975650|12233838|FG003|COMPLETED|Period 3||14
11052791|NCT00975650|12233835|FG000|NOT COMPLETED|Period 3||0
11052792|NCT00975650|12233836|FG001|NOT COMPLETED|Period 3||0
11052793|NCT00975650|12233837|FG002|NOT COMPLETED|Period 3||0
11052794|NCT00975650|12233838|FG003|NOT COMPLETED|Period 3||0
11052795|NCT00975650|12233835|FG000|STARTED|Period 4||12
11052796|NCT00975650|12233836|FG001|STARTED|Period 4||14
11052797|NCT00975650|12233837|FG002|STARTED|Period 4||14
11052798|NCT00975650|12233838|FG003|STARTED|Period 4||14
11052799|NCT00975650|12233835|FG000|COMPLETED|Period 4||12
11052800|NCT00975650|12233836|FG001|COMPLETED|Period 4||14
11052801|NCT00975650|12233837|FG002|COMPLETED|Period 4||14
11052802|NCT00975650|12233838|FG003|COMPLETED|Period 4||14
11052803|NCT00975650|12233835|FG000|NOT COMPLETED|Period 4||0
11052804|NCT00975650|12233836|FG001|NOT COMPLETED|Period 4||0
11052805|NCT00975650|12233837|FG002|NOT COMPLETED|Period 4||0
11052806|NCT00975650|12233838|FG003|NOT COMPLETED|Period 4||0
11052807|NCT00975676|12233850|FG000|STARTED|Overall Study||32
11052808|NCT00975676|12233851|FG001|STARTED|Overall Study||91
11052809|NCT00975676|12233850|FG000|COMPLETED|Overall Study||26
11052810|NCT00975676|12233851|FG001|COMPLETED|Overall Study||83
11052811|NCT00975676|12233850|FG000|NOT COMPLETED|Overall Study||6
11052812|NCT00975676|12233851|FG001|NOT COMPLETED|Overall Study||8
11052813|NCT00975689|12233864|FG000|STARTED|Overall Study||17
11052814|NCT00975689|12233865|FG001|STARTED|Overall Study||18
11052815|NCT00975689|12233864|FG000|COMPLETED|Overall Study||15
11052816|NCT00975689|12233865|FG001|COMPLETED|Overall Study||15
11052817|NCT00975689|12233864|FG000|NOT COMPLETED|Overall Study||2
11052818|NCT00975689|12233865|FG001|NOT COMPLETED|Overall Study||3
11052819|NCT00975715|12233873|FG000|STARTED|Titration Period||48
11052820|NCT00975715|12233874|FG001|STARTED|Titration Period||51
11052821|NCT00975715|12233873|FG000|COMPLETED|Titration Period||41
11052822|NCT00975715|12233874|FG001|COMPLETED|Titration Period||51
11052823|NCT00975715|12233873|FG000|NOT COMPLETED|Titration Period||7
11052824|NCT00975715|12233874|FG001|NOT COMPLETED|Titration Period||0
11052825|NCT00975715|12233873|FG000|STARTED|Maintenance Period||41
11052826|NCT00975715|12233874|FG001|STARTED|Maintenance Period||51
11052827|NCT00975715|12233873|FG000|COMPLETED|Maintenance Period||39
11052828|NCT00975715|12233874|FG001|COMPLETED|Maintenance Period||50
11052829|NCT00975715|12233873|FG000|NOT COMPLETED|Maintenance Period||2
11052830|NCT00975715|12233874|FG001|NOT COMPLETED|Maintenance Period||1
11052831|NCT00975780|12233882|FG000|STARTED|Allocation||400
11052832|NCT00975780|12233883|FG001|STARTED|Allocation||434
11052833|NCT00975780|12233882|FG000|COMPLETED|Allocation||400
11052834|NCT00975780|12233883|FG001|COMPLETED|Allocation||434
11052835|NCT00975780|12233882|FG000|NOT COMPLETED|Allocation||0
11052836|NCT00975780|12233883|FG001|NOT COMPLETED|Allocation||0
11052837|NCT00975780|12233882|FG000|STARTED|Follow Up||400
11052838|NCT00975780|12233883|FG001|STARTED|Follow Up||434
11052839|NCT00975780|12233882|FG000|COMPLETED|Follow Up||298
11052840|NCT00975780|12233883|FG001|COMPLETED|Follow Up||277
11052841|NCT00975780|12233882|FG000|NOT COMPLETED|Follow Up||102
11052842|NCT00975780|12233883|FG001|NOT COMPLETED|Follow Up||157
11052843|NCT00975806|12233892|FG000|STARTED|Overall Study||5
11052844|NCT00975806|12233893|FG001|STARTED|Overall Study||7
11052845|NCT00975806|12233894|FG002|STARTED|Overall Study||4
11052846|NCT00975806|12233892|FG000|COMPLETED|Overall Study|Participants were prematurely discontinued|0
11052847|NCT00975806|12233893|FG001|COMPLETED|Overall Study|Participants were prematurely discontinued|0
11052848|NCT00975806|12233894|FG002|COMPLETED|Overall Study|Participants were prematurely discontinued|0
11052849|NCT00975806|12233892|FG000|NOT COMPLETED|Overall Study||5
11052850|NCT00975806|12233893|FG001|NOT COMPLETED|Overall Study||7
11052851|NCT00975806|12233894|FG002|NOT COMPLETED|Overall Study||4
11052852|NCT00975884|12233906|FG000|STARTED|Overall Study||184
11052853|NCT00975884|12233907|FG001|STARTED|Overall Study||122
11052854|NCT00975884|12233906|FG000|COMPLETED|Overall Study||168
11052855|NCT00975884|12233907|FG001|COMPLETED|Overall Study||107
11052856|NCT00975884|12233906|FG000|NOT COMPLETED|Overall Study||16
11052857|NCT00975884|12233907|FG001|NOT COMPLETED|Overall Study||15
11052858|NCT00975923|12233925|FG000|STARTED|Overall Study||30
11052859|NCT00975923|12233926|FG001|STARTED|Overall Study||30
11338272|NCT02901899|12535827|FG000|Started Treatment|Reached 1st Response Assessment||43
11338273|NCT02901899|12535827|FG000|Attempted 2 Cycles of Treatment/Reached First Response|Reached 1st Response Assessment||37
11338274|NCT02901899|12535827|FG000|COMPLETED|Reached 1st Response Assessment||37
11338275|NCT02901899|12535827|FG000|NOT COMPLETED|Reached 1st Response Assessment||8
11338276|NCT02901899|12535827|FG000|STARTED|Continued Treatment After 1st Response||37
11338277|NCT02901899|12535827|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||21
11338278|NCT02901899|12535827|FG000|COMPLETED|Continued Treatment After 1st Response||21
11338279|NCT02901899|12535827|FG000|NOT COMPLETED|Continued Treatment After 1st Response||16
11338280|NCT02901899|12535827|FG000|STARTED|Follow up|All patients who receive at least one dose of study drug go into the follow up period.|43
11338281|NCT02901899|12535827|FG000|COMPLETED|Follow up||27
11338282|NCT02901899|12535827|FG000|NOT COMPLETED|Follow up||16
11338283|NCT02901951|12535831|FG000|STARTED|Overall Study||103
11338284|NCT02901951|12535831|FG000|COMPLETED|Overall Study||103
11338285|NCT02901951|12535831|FG000|NOT COMPLETED|Overall Study||0
11338286|NCT02902081|12535835|FG000|STARTED|Overall Study||38
11338287|NCT02902081|12535835|FG000|COMPLETED|Overall Study||38
11338288|NCT02902081|12535835|FG000|NOT COMPLETED|Overall Study||0
11338289|NCT02902146|12535845|FG000|STARTED|Overall Study||381
11338290|NCT02902146|12535846|FG001|STARTED|Overall Study||376
11338291|NCT02902146|12535845|FG000|COMPLETED|Overall Study||381
11338292|NCT02902146|12535846|FG001|COMPLETED|Overall Study||376
11338293|NCT02902146|12535845|FG000|NOT COMPLETED|Overall Study||0
11338294|NCT02902146|12535846|FG001|NOT COMPLETED|Overall Study||0
11338295|NCT02902172|12535854|FG000|STARTED|Overall Study||16
11052860|NCT00975923|12233925|FG000|COMPLETED|Overall Study||30
11052861|NCT00975923|12233926|FG001|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
11052862|NCT00975923|12233925|FG000|NOT COMPLETED|Overall Study||0
11052863|NCT00975923|12233926|FG001|NOT COMPLETED|Overall Study||1
11052864|NCT00975975|12233933|FG000|STARTED|Overall Study||17
11052865|NCT00975975|12233933|FG000|COMPLETED|Overall Study||11
11052866|NCT00975975|12233933|FG000|NOT COMPLETED|Overall Study||6
11338296|NCT02902172|12535855|FG001|STARTED|Overall Study||20
11338297|NCT02902172|12535854|FG000|COMPLETED|Overall Study||16
11338298|NCT02902172|12535855|FG001|COMPLETED|Overall Study||20
11338299|NCT02902172|12535854|FG000|NOT COMPLETED|Overall Study||0
11338300|NCT02902172|12535855|FG001|NOT COMPLETED|Overall Study||0
11338301|NCT02902237|12535862|FG000|STARTED|Overall Study||17
11343929|NCT02957305|12541224|FG000|COMPLETED|Overall Study||106
11338302|NCT02902237|12535862|FG000|COMPLETED|Overall Study|STUDY INITIATION: 2017 03 29, 1st Patient In, STUDY COMPLETION: 2019 11 05, Date of Study End|17
11338303|NCT02902237|12535862|FG000|NOT COMPLETED|Overall Study||0
11338304|NCT02902770|12535876|FG000|STARTED|Overall Study||50
11338305|NCT02902770|12535877|FG001|STARTED|Overall Study||50
11338306|NCT02902770|12535878|FG002|STARTED|Overall Study||50
11338307|NCT02902770|12535876|FG000|COMPLETED|Overall Study||50
11338308|NCT02902770|12535877|FG001|COMPLETED|Overall Study||50
11338309|NCT02902770|12535878|FG002|COMPLETED|Overall Study||50
11338310|NCT02902770|12535876|FG000|NOT COMPLETED|Overall Study||0
11052867|NCT00976027|12233939|FG000|STARTED|Overall Study||6108
11052868|NCT00976027|12233940|FG001|STARTED|Overall Study||3050
11201541|NCT01833026|12391826|FG000|NOT COMPLETED|Overall Study||0
11201542|NCT01833026|12391827|FG001|NOT COMPLETED|Overall Study||0
11201543|NCT01833065|12391836|FG000|STARTED|Overall Study|Randomized patients - As treated|65
11201544|NCT01833065|12391837|FG001|STARTED|Overall Study|Randomized patients - As treated|53
11201545|NCT01833065|12391838|FG002|STARTED|Overall Study|Randomized patients - As treated|35
11201546|NCT01833065|12391839|FG003|STARTED|Overall Study|Randomized patients - As treated|50
11201547|NCT01833065|12391840|FG004|STARTED|Overall Study|Randomized patients - As treated|110
11201548|NCT01833065|12391836|FG000|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
11201549|NCT01833065|12391837|FG001|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
11201550|NCT01833065|12391838|FG002|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
11201551|NCT01833065|12391839|FG003|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
11201552|NCT01833065|12391840|FG004|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
11201553|NCT01833065|12391836|FG000|COMPLETED|Overall Study||41
11201554|NCT01833065|12391837|FG001|COMPLETED|Overall Study||40
11201555|NCT01833065|12391838|FG002|COMPLETED|Overall Study||23
11201556|NCT01833065|12391839|FG003|COMPLETED|Overall Study||41
11338311|NCT02902770|12535877|FG001|NOT COMPLETED|Overall Study||0
11052869|NCT00976027|12233939|FG000|COMPLETED|Overall Study||5697
11052870|NCT00976027|12233940|FG001|COMPLETED|Overall Study||2835
11052871|NCT00976027|12233939|FG000|NOT COMPLETED|Overall Study||411
11052872|NCT00976027|12233940|FG001|NOT COMPLETED|Overall Study||215
11052873|NCT00976183|12233946|FG000|STARTED|Overall Study||18
11052874|NCT00976183|12233946|FG000|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
11052875|NCT00976183|12233946|FG000|NOT COMPLETED|Overall Study||0
11052876|NCT00976209|12233952|FG000|STARTED|Treatment Period 1||165
11052877|NCT00976209|12233953|FG001|STARTED|Treatment Period 1||166
11052878|NCT00976209|12233952|FG000|COMPLETED|Treatment Period 1||162
11052879|NCT00976209|12233953|FG001|COMPLETED|Treatment Period 1||165
11052880|NCT00976209|12233952|FG000|NOT COMPLETED|Treatment Period 1||3
11052881|NCT00976209|12233953|FG001|NOT COMPLETED|Treatment Period 1||1
11052882|NCT00976209|12233952|FG000|STARTED|Wash-out Period||162
11201557|NCT01833065|12391840|FG004|COMPLETED|Overall Study||74
11052883|NCT00976209|12233953|FG001|STARTED|Wash-out Period||165
11052884|NCT00976209|12233952|FG000|COMPLETED|Wash-out Period||158
11052885|NCT00976209|12233953|FG001|COMPLETED|Wash-out Period||163
11052886|NCT00976209|12233952|FG000|NOT COMPLETED|Wash-out Period||4
11052887|NCT00976209|12233953|FG001|NOT COMPLETED|Wash-out Period||2
11052888|NCT00976209|12233952|FG000|STARTED|Treatment Period 2||158
11052889|NCT00976209|12233953|FG001|STARTED|Treatment Period 2||163
11052890|NCT00976209|12233952|FG000|COMPLETED|Treatment Period 2||158
11052891|NCT00976209|12233953|FG001|COMPLETED|Treatment Period 2||161
11052892|NCT00976209|12233952|FG000|NOT COMPLETED|Treatment Period 2||0
11052893|NCT00976209|12233953|FG001|NOT COMPLETED|Treatment Period 2||2
11052894|NCT00976248|12233958|FG000|STARTED|Overall Study||33
11052895|NCT00976248|12233958|FG000|COMPLETED|Overall Study||33
11201558|NCT01833065|12391836|FG000|NOT COMPLETED|Overall Study||24
11201559|NCT01833065|12391837|FG001|NOT COMPLETED|Overall Study||13
11201560|NCT01833065|12391838|FG002|NOT COMPLETED|Overall Study||12
11201561|NCT01833065|12391839|FG003|NOT COMPLETED|Overall Study||9
11201562|NCT01833065|12391840|FG004|NOT COMPLETED|Overall Study||36
11201563|NCT01833078|12391850|FG000|STARTED|Overall Study||5
11201564|NCT01833078|12391850|FG000|COMPLETED|Overall Study||5
11201565|NCT01833078|12391850|FG000|NOT COMPLETED|Overall Study||0
11201566|NCT01833117|12391856|FG000|STARTED|Overall Study||43
11201567|NCT01833117|12391857|FG001|STARTED|Overall Study||19
11201568|NCT01833117|12391856|FG000|COMPLETED|Overall Study||43
11201569|NCT01833117|12391857|FG001|COMPLETED|Overall Study||19
11201570|NCT01833117|12391856|FG000|NOT COMPLETED|Overall Study||0
11201571|NCT01833117|12391857|FG001|NOT COMPLETED|Overall Study||0
11201572|NCT01833130|12391865|FG000|STARTED|Overall Study||25
11201573|NCT01833130|12391866|FG001|STARTED|Overall Study||27
11201574|NCT01833130|12391865|FG000|COMPLETED|Overall Study||15
11201575|NCT01833130|12391866|FG001|COMPLETED|Overall Study||8
11201576|NCT01833130|12391865|FG000|NOT COMPLETED|Overall Study||10
11201577|NCT01833130|12391866|FG001|NOT COMPLETED|Overall Study||19
11201578|NCT01833143|12391872|FG000|STARTED|Overall Study||17
11201579|NCT01833143|12391872|FG000|COMPLETED|Overall Study||16
11201580|NCT01833143|12391872|FG000|NOT COMPLETED|Overall Study||1
11201581|NCT01833169|12391876|FG000|STARTED|Overall Study||146
11201582|NCT01833169|12391876|FG000|Consented to be Followed for Survival|Overall Study||128
11201583|NCT01833169|12391876|FG000|COMPLETED|Overall Study||0
11201584|NCT01833169|12391876|FG000|NOT COMPLETED|Overall Study||146
11201585|NCT01833247|12391880|FG000|STARTED|Overall Study||12
11201586|NCT01833247|12391880|FG000|COMPLETED|Overall Study||12
11201587|NCT01833247|12391880|FG000|NOT COMPLETED|Overall Study||0
11201588|NCT01833403|12391884|FG000|STARTED|Overall Study||4
11201589|NCT01833403|12391884|FG000|COMPLETED|Overall Study||4
11201590|NCT01833403|12391884|FG000|NOT COMPLETED|Overall Study||0
11201591|NCT01833455|12391891|FG000|STARTED|Overall Study||4
11201592|NCT01833455|12391892|FG001|STARTED|Overall Study||4
11201593|NCT01833455|12391891|FG000|Completed 1st Baseline|Overall Study||4
11201594|NCT01833455|12391892|FG001|Completed 1st Baseline|Overall Study||4
11201595|NCT01833455|12391891|FG000|Completed 1st Intervention|Overall Study||3
11201596|NCT01833455|12391892|FG001|Completed 1st Intervention|Overall Study||4
11201597|NCT01833455|12391891|FG000|Completed 2nd Baseline (Washout)|Overall Study||3
11201598|NCT01833455|12391892|FG001|Completed 2nd Baseline (Washout)|Overall Study||4
11201599|NCT01833455|12391891|FG000|COMPLETED|Overall Study||3
11201600|NCT01833455|12391892|FG001|COMPLETED|Overall Study||4
11201601|NCT01833455|12391891|FG000|NOT COMPLETED|Overall Study||1
11201602|NCT01833455|12391892|FG001|NOT COMPLETED|Overall Study||0
11201603|NCT01833481|12391913|FG000|STARTED|Overall Study||10
11201604|NCT01833481|12391914|FG001|STARTED|Overall Study||10
11201605|NCT01833481|12391915|FG002|STARTED|Overall Study||10
11338312|NCT02902770|12535878|FG002|NOT COMPLETED|Overall Study||0
11338313|NCT02902809|12535886|FG000|STARTED|Overall Study||28
11338314|NCT02902809|12535886|FG000|Treatment Received|Overall Study||28
11338315|NCT02902809|12535886|FG000|Treatment Completed|Overall Study||2
11338316|NCT02902809|12535886|FG000|COMPLETED|Overall Study||0
11338317|NCT02902809|12535886|FG000|NOT COMPLETED|Overall Study||28
11201606|NCT01833481|12391913|FG000|COMPLETED|Overall Study||10
11201607|NCT01833481|12391914|FG001|COMPLETED|Overall Study||10
11201608|NCT01833481|12391915|FG002|COMPLETED|Overall Study||10
11201609|NCT01833481|12391913|FG000|NOT COMPLETED|Overall Study||0
11052896|NCT00976248|12233958|FG000|NOT COMPLETED|Overall Study||0
11052897|NCT00976274|12233965|FG000|STARTED|Overall Study||31
11052898|NCT00976274|12233966|FG001|STARTED|Overall Study||29
11052899|NCT00976274|12233965|FG000|COMPLETED|Overall Study||24
11052900|NCT00976274|12233966|FG001|COMPLETED|Overall Study||21
11052901|NCT00976274|12233965|FG000|NOT COMPLETED|Overall Study||7
11052902|NCT00976274|12233966|FG001|NOT COMPLETED|Overall Study||8
11052903|NCT00976352|12233974|FG000|STARTED|Overall Study||3
11052904|NCT00976352|12233975|FG001|STARTED|Overall Study||10
11052905|NCT00976352|12233974|FG000|COMPLETED|Overall Study||3
11052906|NCT00976352|12233975|FG001|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
11052907|NCT00976352|12233974|FG000|NOT COMPLETED|Overall Study||0
11052908|NCT00976352|12233975|FG001|NOT COMPLETED|Overall Study||4
11052909|NCT00976391|12233987|FG000|STARTED|Treatment Period (52 Weeks)||285
11052910|NCT00976391|12233988|FG001|STARTED|Treatment Period (52 Weeks)||281
11052911|NCT00976391|12233987|FG000|COMPLETED|Treatment Period (52 Weeks)||243
11052912|NCT00976391|12233988|FG001|COMPLETED|Treatment Period (52 Weeks)||242
11052913|NCT00976391|12233987|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||42
11052914|NCT00976391|12233988|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||39
11052915|NCT00976391|12233987|FG000|STARTED|Follow-up Period (8 Weeks)||285
11052916|NCT00976391|12233988|FG001|STARTED|Follow-up Period (8 Weeks)||281
11052917|NCT00976391|12233987|FG000|COMPLETED|Follow-up Period (8 Weeks)||256
11052918|NCT00976391|12233988|FG001|COMPLETED|Follow-up Period (8 Weeks)||247
11052919|NCT00976391|12233987|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||29
11052920|NCT00976391|12233988|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||34
11052921|NCT00976404|12233996|FG000|STARTED|Overall Study||14
11052922|NCT00976404|12233997|FG001|STARTED|Overall Study||14
11052923|NCT00976404|12233996|FG000|COMPLETED|Overall Study||14
11052924|NCT00976404|12233997|FG001|COMPLETED|Overall Study||14
11052925|NCT00976404|12233996|FG000|NOT COMPLETED|Overall Study||0
11052926|NCT00976404|12233997|FG001|NOT COMPLETED|Overall Study||0
11052927|NCT00976456|12234007|FG000|STARTED|Overall Study||135
11052928|NCT00976456|12234008|FG001|STARTED|Overall Study||136
11052929|NCT00976456|12234007|FG000|COMPLETED|Overall Study||92
11052930|NCT00976456|12234008|FG001|COMPLETED|Overall Study||98
11052931|NCT00976456|12234007|FG000|NOT COMPLETED|Overall Study||43
11052932|NCT00976456|12234008|FG001|NOT COMPLETED|Overall Study||38
11052933|NCT00976482|12234014|FG000|STARTED|Overall Study||1745
11052934|NCT00976482|12234014|FG000|Eligible for Last Follow up|Overall Study||1487
11052935|NCT00976482|12234014|FG000|COMPLETED|Overall Study||1486
11052936|NCT00976482|12234014|FG000|NOT COMPLETED|Overall Study||259
11052937|NCT00976495|12234021|FG000|STARTED|Overall Study||25
11052938|NCT00976495|12234022|FG001|STARTED|Overall Study||24
11052939|NCT00976495|12234023|FG002|STARTED|Overall Study||26
11052940|NCT00976495|12234021|FG000|COMPLETED|Overall Study||25
11052941|NCT00976495|12234022|FG001|COMPLETED|Overall Study||23
11052942|NCT00976495|12234023|FG002|COMPLETED|Overall Study||26
11052943|NCT00976495|12234021|FG000|NOT COMPLETED|Overall Study||0
11052944|NCT00976495|12234022|FG001|NOT COMPLETED|Overall Study||1
11052945|NCT00976495|12234023|FG002|NOT COMPLETED|Overall Study||0
11052946|NCT00976508|12234033|FG000|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
11052947|NCT00976508|12234034|FG001|STARTED|Overall Study||6
11052948|NCT00976508|12234033|FG000|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
11052949|NCT00976508|12234034|FG001|COMPLETED|Overall Study||0
11052950|NCT00976508|12234033|FG000|NOT COMPLETED|Overall Study||14
11052951|NCT00976508|12234034|FG001|NOT COMPLETED|Overall Study||6
11201610|NCT01833481|12391914|FG001|NOT COMPLETED|Overall Study||0
11338318|NCT02902913|12535890|FG000|STARTED|Overall Study||9
11338319|NCT02902913|12535890|FG000|First Intervention (1 Day)|Overall Study||9
11338320|NCT02902913|12535890|FG000|Washout (7 Days)|Overall Study||9
11338321|NCT02902913|12535890|FG000|Second Intervention (1 Day)|Overall Study||9
11338322|NCT02902913|12535890|FG000|Washout (7 Days)|Overall Study||9
11052952|NCT00976521|12234047|FG000|STARTED|Overall Study||118
11052953|NCT00976521|12234048|FG001|STARTED|Overall Study||111
11052954|NCT00976521|12234049|FG002|STARTED|Overall Study||111
11052955|NCT00976521|12234050|FG003|STARTED|Overall Study||112
11052956|NCT00976521|12234047|FG000|COMPLETED|Overall Study||109
11052957|NCT00976521|12234048|FG001|COMPLETED|Overall Study||99
11052958|NCT00976521|12234049|FG002|COMPLETED|Overall Study||102
11052959|NCT00976521|12234050|FG003|COMPLETED|Overall Study||93
11052960|NCT00976521|12234047|FG000|NOT COMPLETED|Overall Study||9
11052961|NCT00976521|12234048|FG001|NOT COMPLETED|Overall Study||12
11052962|NCT00976521|12234049|FG002|NOT COMPLETED|Overall Study||9
11052963|NCT00976521|12234050|FG003|NOT COMPLETED|Overall Study||19
11052964|NCT00976560|12234063|FG000|STARTED|Overall Study||64
11052965|NCT00976560|12234064|FG001|STARTED|Overall Study||64
11052966|NCT00976560|12234063|FG000|COMPLETED|Overall Study||50
11052967|NCT00976560|12234064|FG001|COMPLETED|Overall Study||51
11052968|NCT00976560|12234063|FG000|NOT COMPLETED|Overall Study||14
11052969|NCT00976560|12234064|FG001|NOT COMPLETED|Overall Study||13
11052970|NCT00976573|12234072|FG000|STARTED|Overall Study||75
11052971|NCT00976573|12234073|FG001|STARTED|Overall Study||74
11052972|NCT00976573|12234072|FG000|COMPLETED|Overall Study||71
11052973|NCT00976573|12234073|FG001|COMPLETED|Overall Study||71
11052974|NCT00976573|12234072|FG000|NOT COMPLETED|Overall Study||4
11052975|NCT00976573|12234073|FG001|NOT COMPLETED|Overall Study||3
11052976|NCT00976599|12234081|FG000|STARTED|Overall Study||15
11052977|NCT00976599|12234082|FG001|STARTED|Overall Study||14
11052978|NCT00976599|12234081|FG000|COMPLETED|Overall Study||15
11052979|NCT00976599|12234082|FG001|COMPLETED|Overall Study||14
11052980|NCT00976599|12234081|FG000|NOT COMPLETED|Overall Study||0
11052981|NCT00976599|12234082|FG001|NOT COMPLETED|Overall Study||0
11052982|NCT00976664|12234090|FG000|STARTED|Overall Study||25
11052983|NCT00976664|12234091|FG001|STARTED|Overall Study||25
11052984|NCT00976664|12234090|FG000|COMPLETED|Overall Study||22
11052985|NCT00976664|12234091|FG001|COMPLETED|Overall Study||24
11052986|NCT00976664|12234090|FG000|NOT COMPLETED|Overall Study||3
11052987|NCT00976664|12234091|FG001|NOT COMPLETED|Overall Study||1
11052988|NCT00976677|12234099|FG000|STARTED|Overall Study||5
11052989|NCT00976677|12234100|FG001|STARTED|Overall Study||5
11052990|NCT00976677|12234099|FG000|COMPLETED|Overall Study||0
11052991|NCT00976677|12234100|FG001|COMPLETED|Overall Study||0
11052992|NCT00976677|12234099|FG000|NOT COMPLETED|Overall Study||5
11052993|NCT00976677|12234100|FG001|NOT COMPLETED|Overall Study||5
11052994|NCT00976703|12234108|FG000|STARTED|Overall Study||99
11052995|NCT00976703|12234109|FG001|STARTED|Overall Study||98
11052996|NCT00976703|12234108|FG000|COMPLETED|Overall Study||96
11052997|NCT00976703|12234109|FG001|COMPLETED|Overall Study||95
11052998|NCT00976703|12234108|FG000|NOT COMPLETED|Overall Study||3
11052999|NCT00976703|12234109|FG001|NOT COMPLETED|Overall Study||3
11053000|NCT00976716|12234115|FG000|STARTED|Overall Study||80
11053001|NCT00976716|12234115|FG000|COMPLETED|Overall Study||79
11053002|NCT00976716|12234115|FG000|NOT COMPLETED|Overall Study||1
11053003|NCT00976820|12234124|FG000|STARTED|Overall Study||67
11053004|NCT00976820|12234125|FG001|STARTED|Overall Study||128
11053005|NCT00976820|12234126|FG002|STARTED|Overall Study||64
11053006|NCT00976820|12234127|FG003|STARTED|Overall Study||63
11053007|NCT00976820|12234124|FG000|COMPLETED|Overall Study||59
11053008|NCT00976820|12234125|FG001|COMPLETED|Overall Study||108
11053009|NCT00976820|12234126|FG002|COMPLETED|Overall Study||60
11053010|NCT00976820|12234127|FG003|COMPLETED|Overall Study||56
11053011|NCT00976820|12234124|FG000|NOT COMPLETED|Overall Study||8
11053012|NCT00976820|12234125|FG001|NOT COMPLETED|Overall Study||20
11053013|NCT00976820|12234126|FG002|NOT COMPLETED|Overall Study||4
11053014|NCT00976820|12234127|FG003|NOT COMPLETED|Overall Study||7
11053015|NCT00976898|12234178|FG000|STARTED|Overall Study||83
11053016|NCT00976898|12234178|FG000|COMPLETED|Overall Study||78
11053017|NCT00976898|12234178|FG000|NOT COMPLETED|Overall Study||5
11053018|NCT00976937|12234184|FG000|STARTED|Overall Study|Randomized|158
11053019|NCT00976937|12234185|FG001|STARTED|Overall Study||161
11053020|NCT00976937|12234184|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
11053021|NCT00976937|12234185|FG001|Treated/Safety Population|Overall Study||161
11053022|NCT00976937|12234184|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
11053023|NCT00976937|12234185|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||161
11053024|NCT00976937|12234184|FG000|COMPLETED|Overall Study||142
11053025|NCT00976937|12234185|FG001|COMPLETED|Overall Study||150
11053026|NCT00976937|12234184|FG000|NOT COMPLETED|Overall Study||16
11053027|NCT00976937|12234185|FG001|NOT COMPLETED|Overall Study||11
11053028|NCT00976950|12234191|FG000|STARTED|Overall Study||42
11053029|NCT00976950|12234191|FG000|COMPLETED|Overall Study||36
11053030|NCT00976950|12234191|FG000|NOT COMPLETED|Overall Study||6
11053031|NCT00976989|12234198|FG000|STARTED|Overall Study||73
11053032|NCT00976989|12234199|FG001|STARTED|Overall Study||75
11053033|NCT00976989|12234200|FG002|STARTED|Overall Study||77
11053034|NCT00976989|12234198|FG000|COMPLETED|Overall Study||60
11053035|NCT00976989|12234199|FG001|COMPLETED|Overall Study||63
11053036|NCT00976989|12234200|FG002|COMPLETED|Overall Study||60
11053037|NCT00976989|12234198|FG000|NOT COMPLETED|Overall Study||13
11053038|NCT00976989|12234199|FG001|NOT COMPLETED|Overall Study||12
11053039|NCT00976989|12234200|FG002|NOT COMPLETED|Overall Study||17
11053040|NCT00977080|12234212|FG000|STARTED|Overall Study||62
11053041|NCT00977080|12234213|FG001|STARTED|Overall Study||64
11053042|NCT00977080|12234214|FG002|STARTED|Overall Study||72
11053043|NCT00977080|12234215|FG003|STARTED|Overall Study||70
11053044|NCT00977080|12234212|FG000|COMPLETED|Overall Study||50
11053045|NCT00977080|12234213|FG001|COMPLETED|Overall Study||44
11053046|NCT00977080|12234214|FG002|COMPLETED|Overall Study||56
11053047|NCT00977080|12234215|FG003|COMPLETED|Overall Study||53
11053048|NCT00977080|12234212|FG000|NOT COMPLETED|Overall Study||12
11053049|NCT00977080|12234213|FG001|NOT COMPLETED|Overall Study||20
11053050|NCT00977080|12234214|FG002|NOT COMPLETED|Overall Study||16
11053051|NCT00977080|12234215|FG003|NOT COMPLETED|Overall Study||17
11053052|NCT00977106|12234227|FG000|STARTED|Overall Study||47
11053053|NCT00977106|12234228|FG001|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
11053054|NCT00977106|12234227|FG000|COMPLETED|Overall Study||37
11053055|NCT00977106|12234228|FG001|COMPLETED|Overall Study||45
11053056|NCT00977106|12234227|FG000|NOT COMPLETED|Overall Study||10
11053057|NCT00977106|12234228|FG001|NOT COMPLETED|Overall Study||11
11053058|NCT00977171|12234236|FG000|STARTED|Overall Study||3
11053059|NCT00977171|12234236|FG000|COMPLETED|Overall Study||3
11053060|NCT00977171|12234236|FG000|NOT COMPLETED|Overall Study||0
11058222|NCT01002339|12240046|FG000|COMPLETED|Overall Study||44
11058223|NCT01002339|12240047|FG001|COMPLETED|Overall Study||42
11058224|NCT01002339|12240048|FG002|COMPLETED|Overall Study||42
11058225|NCT01002339|12240046|FG000|NOT COMPLETED|Overall Study||0
11058226|NCT01002339|12240047|FG001|NOT COMPLETED|Overall Study||1
11058227|NCT01002339|12240048|FG002|NOT COMPLETED|Overall Study||5
11058228|NCT01002456|12240058|FG000|STARTED|Overall Study||98
11058229|NCT01002456|12240059|FG001|STARTED|Overall Study||122
11058230|NCT01002456|12240058|FG000|COMPLETED|Overall Study||98
11058231|NCT01002456|12240059|FG001|COMPLETED|Overall Study||122
11058232|NCT01002456|12240058|FG000|NOT COMPLETED|Overall Study||0
11058233|NCT01002456|12240059|FG001|NOT COMPLETED|Overall Study||0
11058234|NCT01002482|12240069|FG000|STARTED|Overall Study||1351
11058235|NCT01002482|12240070|FG001|STARTED|Overall Study||1333
11058236|NCT01002482|12240069|FG000|COMPLETED|Overall Study||1336
11058237|NCT01002482|12240070|FG001|COMPLETED|Overall Study||1312
11058238|NCT01002482|12240069|FG000|NOT COMPLETED|Overall Study||15
11058239|NCT01002482|12240070|FG001|NOT COMPLETED|Overall Study||21
11058240|NCT01002547|12240079|FG000|STARTED|Overall Study||32
11058241|NCT01002547|12240080|FG001|STARTED|Overall Study||36
11058242|NCT01002547|12240081|FG002|STARTED|Overall Study||37
11058243|NCT01002547|12240079|FG000|COMPLETED|Overall Study||24
11058244|NCT01002547|12240080|FG001|COMPLETED|Overall Study||33
11058245|NCT01002547|12240081|FG002|COMPLETED|Overall Study||29
11058246|NCT01002547|12240079|FG000|NOT COMPLETED|Overall Study||8
11058247|NCT01002547|12240080|FG001|NOT COMPLETED|Overall Study||3
11058248|NCT01002547|12240081|FG002|NOT COMPLETED|Overall Study||8
11058460|NCT01004172|12240348|FG000|COMPLETED|Overall Study||0
11058461|NCT01004172|12240348|FG000|NOT COMPLETED|Overall Study||38
11058462|NCT01004185|12240355|FG000|STARTED|Overall Study||19
11058463|NCT01004185|12240356|FG001|STARTED|Overall Study||20
11058464|NCT01004185|12240355|FG000|COMPLETED|Overall Study||10
11058465|NCT01004185|12240356|FG001|COMPLETED|Overall Study||11
11058466|NCT01004185|12240355|FG000|NOT COMPLETED|Overall Study||9
11058467|NCT01004185|12240356|FG001|NOT COMPLETED|Overall Study||9
11058468|NCT01004250|12240362|FG000|STARTED|Induction Therapy Period||109
11058469|NCT01004250|12240362|FG000|Received at Least One Dose of Study Drug|Induction Therapy Period||109
11058470|NCT01004250|12240362|FG000|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
11058471|NCT01004250|12240362|FG000|COMPLETED|Induction Therapy Period||94
11058472|NCT01004250|12240362|FG000|NOT COMPLETED|Induction Therapy Period||15
11058473|NCT01004250|12240362|FG000|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
11058474|NCT01004250|12240362|FG000|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
11058475|NCT01004250|12240362|FG000|COMPLETED|Maintenance Therapy Period||46
11058476|NCT01004250|12240362|FG000|NOT COMPLETED|Maintenance Therapy Period||26
11058477|NCT01004250|12240362|FG000|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
11058478|NCT01004250|12240362|FG000|COMPLETED|Follow-Up (FU) Period||100
11058479|NCT01004250|12240362|FG000|NOT COMPLETED|Follow-Up (FU) Period||1
11058480|NCT01004354|12240370|FG000|STARTED|Overall Study||12
11058481|NCT01004354|12240370|FG000|COMPLETED|Overall Study||12
11058482|NCT01004354|12240370|FG000|NOT COMPLETED|Overall Study||0
11058483|NCT01004393|12240374|FG000|STARTED|Overall Study||12
11053061|NCT00977184|12234242|FG000|STARTED|Overall Study||13
11053062|NCT00977184|12234243|FG001|STARTED|Overall Study||13
11053063|NCT00977184|12234242|FG000|COMPLETED|Overall Study||13
11053064|NCT00977184|12234243|FG001|COMPLETED|Overall Study||13
11053065|NCT00977184|12234242|FG000|NOT COMPLETED|Overall Study||0
11053066|NCT00977184|12234243|FG001|NOT COMPLETED|Overall Study||0
11053067|NCT00977197|12234258|FG000|STARTED|Overall Study||41
11053068|NCT00977197|12234259|FG001|STARTED|Overall Study||44
11053069|NCT00977197|12234258|FG000|COMPLETED|Overall Study||32
11053070|NCT00977197|12234259|FG001|COMPLETED|Overall Study||35
11053071|NCT00977197|12234258|FG000|NOT COMPLETED|Overall Study||9
11053072|NCT00977197|12234259|FG001|NOT COMPLETED|Overall Study||9
11053073|NCT00977314|12234267|FG000|STARTED|Overall Study||30
11053074|NCT00977314|12234268|FG001|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
11053075|NCT00977314|12234267|FG000|COMPLETED|Overall Study||28
11053076|NCT00977314|12234268|FG001|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
11053077|NCT00977314|12234267|FG000|NOT COMPLETED|Overall Study||2
11053078|NCT00977314|12234268|FG001|NOT COMPLETED|Overall Study||0
11053079|NCT00977379|12234276|FG000|STARTED|Overall Study|Randomized|12
11053080|NCT00977379|12234277|FG001|STARTED|Overall Study|Randomized|12
11053081|NCT00977379|12234276|FG000|Treated|Overall Study||12
11053082|NCT00977379|12234277|FG001|Treated|Overall Study||11
11053083|NCT00977379|12234276|FG000|COMPLETED|Overall Study||0
11053084|NCT00977379|12234277|FG001|COMPLETED|Overall Study||0
11053085|NCT00977379|12234276|FG000|NOT COMPLETED|Overall Study||12
11053086|NCT00977379|12234277|FG001|NOT COMPLETED|Overall Study||12
11053087|NCT00977431|12234288|FG000|STARTED|Overall Study||7
11053088|NCT00977431|12234289|FG001|STARTED|Overall Study||6
11053089|NCT00977431|12234290|FG002|STARTED|Overall Study||7
11053090|NCT00977431|12234291|FG003|STARTED|Overall Study||3
11053091|NCT00977431|12234292|FG004|STARTED|Overall Study||13
11053092|NCT00977431|12234288|FG000|Discontinued Afatinib Before/on Day 42|Overall Study||1
11053093|NCT00977431|12234289|FG001|Discontinued Afatinib Before/on Day 42|Overall Study||0
11053094|NCT00977431|12234290|FG002|Discontinued Afatinib Before/on Day 42|Overall Study||4
11053095|NCT00977431|12234291|FG003|Discontinued Afatinib Before/on Day 42|Overall Study||0
11053096|NCT00977431|12234292|FG004|Discontinued Afatinib Before/on Day 42|Overall Study||3
11053097|NCT00977431|12234288|FG000|COMPLETED|Overall Study||0
11053098|NCT00977431|12234289|FG001|COMPLETED|Overall Study||0
11053099|NCT00977431|12234290|FG002|COMPLETED|Overall Study||0
11053100|NCT00977431|12234291|FG003|COMPLETED|Overall Study||0
11053101|NCT00977431|12234292|FG004|COMPLETED|Overall Study||0
11053102|NCT00977431|12234288|FG000|NOT COMPLETED|Overall Study||7
11053103|NCT00977431|12234289|FG001|NOT COMPLETED|Overall Study||6
11053104|NCT00977431|12234290|FG002|NOT COMPLETED|Overall Study||7
11053105|NCT00977431|12234291|FG003|NOT COMPLETED|Overall Study||3
11053106|NCT00977431|12234292|FG004|NOT COMPLETED|Overall Study||13
11053107|NCT00977470|12234310|FG000|STARTED|Overall Study||38
11053108|NCT00977470|12234311|FG001|STARTED|Overall Study||38
11053109|NCT00977470|12234310|FG000|COMPLETED|Overall Study||0
11053110|NCT00977470|12234311|FG001|COMPLETED|Overall Study||0
11053111|NCT00977470|12234310|FG000|NOT COMPLETED|Overall Study||38
11053112|NCT00977470|12234311|FG001|NOT COMPLETED|Overall Study||38
11053113|NCT00977548|12234317|FG000|STARTED|Overall Study||39
11053114|NCT00977548|12234317|FG000|COMPLETED|Overall Study||26
11053115|NCT00977548|12234317|FG000|NOT COMPLETED|Overall Study||13
11053116|NCT00977561|12234323|FG000|STARTED|Overall Study||5
11053117|NCT00977561|12234324|FG001|STARTED|Overall Study||4
11053118|NCT00977561|12234323|FG000|COMPLETED|Overall Study||0
11053119|NCT00977561|12234324|FG001|COMPLETED|Overall Study||0
11053120|NCT00977561|12234323|FG000|NOT COMPLETED|Overall Study||5
11053121|NCT00977561|12234324|FG001|NOT COMPLETED|Overall Study||4
11053122|NCT00977613|12234332|FG000|STARTED|Overall Study||50
11053123|NCT00977613|12234332|FG000|COMPLETED|Overall Study||34
11053124|NCT00977613|12234332|FG000|NOT COMPLETED|Overall Study||16
11053125|NCT00977665|12234338|FG000|STARTED|Overall Study||84
11053126|NCT00977665|12234339|FG001|STARTED|Overall Study||90
11053127|NCT00977665|12234338|FG000|COMPLETED|Overall Study||63
11053128|NCT00977665|12234339|FG001|COMPLETED|Overall Study||75
11053129|NCT00977665|12234338|FG000|NOT COMPLETED|Overall Study||21
11053130|NCT00977665|12234339|FG001|NOT COMPLETED|Overall Study||15
11053131|NCT00977704|12234345|FG000|STARTED|Overall Study||20
11053132|NCT00977704|12234345|FG000|COMPLETED|Overall Study||20
11053133|NCT00977704|12234345|FG000|NOT COMPLETED|Overall Study||0
11053134|NCT00977769|12234352|FG000|STARTED|Overall Study||25
11053135|NCT00977769|12234353|FG001|STARTED|Overall Study||26
11053136|NCT00977769|12234354|FG002|STARTED|Overall Study||25
11053137|NCT00977769|12234352|FG000|COMPLETED|Overall Study||25
11053138|NCT00977769|12234353|FG001|COMPLETED|Overall Study||26
11053139|NCT00977769|12234354|FG002|COMPLETED|Overall Study||25
11053140|NCT00977769|12234352|FG000|NOT COMPLETED|Overall Study||0
11053141|NCT00977769|12234353|FG001|NOT COMPLETED|Overall Study||0
11053142|NCT00977769|12234354|FG002|NOT COMPLETED|Overall Study||0
11053143|NCT00977808|12234362|FG000|STARTED|Overall Study||12
11053144|NCT00977808|12234362|FG000|Completion of Open-Loop Admission|Overall Study||12
11053145|NCT00977808|12234362|FG000|Completion of Closed-Loop Admission|Overall Study||11
11053146|NCT00977808|12234362|FG000|COMPLETED|Overall Study||11
11053147|NCT00977808|12234362|FG000|NOT COMPLETED|Overall Study||1
11053148|NCT00977938|12234371|FG000|STARTED|Treatment (12-30 mo. Post Procedure)||5020
11053149|NCT00977938|12234372|FG001|STARTED|Treatment (12-30 mo. Post Procedure)||4941
11053150|NCT00977938|12234373|FG002|STARTED|Treatment (12-30 mo. Post Procedure)||842
11053151|NCT00977938|12234374|FG003|STARTED|Treatment (12-30 mo. Post Procedure)||845
11053152|NCT00977938|12234371|FG000|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
11053153|NCT00977938|12234372|FG001|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
11053154|NCT00977938|12234373|FG002|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
11053155|NCT00977938|12234374|FG003|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
11053156|NCT00977938|12234371|FG000|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
11053157|NCT00977938|12234372|FG001|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
11053158|NCT00977938|12234373|FG002|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
11053159|NCT00977938|12234374|FG003|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
11053160|NCT00977938|12234371|FG000|STARTED|Observation (30-33 mo. Post Procedure)||4783
11053161|NCT00977938|12234372|FG001|STARTED|Observation (30-33 mo. Post Procedure)||4716
11053162|NCT00977938|12234373|FG002|STARTED|Observation (30-33 mo. Post Procedure)||796
11053163|NCT00977938|12234374|FG003|STARTED|Observation (30-33 mo. Post Procedure)||784
11053164|NCT00977938|12234371|FG000|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
11053165|NCT00977938|12234372|FG001|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
11053166|NCT00977938|12234373|FG002|COMPLETED|Observation (30-33 mo. Post Procedure)||784
11053167|NCT00977938|12234374|FG003|COMPLETED|Observation (30-33 mo. Post Procedure)||781
11053168|NCT00977938|12234371|FG000|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
11053169|NCT00977938|12234372|FG001|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
11053170|NCT00977938|12234373|FG002|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
11053171|NCT00977938|12234374|FG003|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
11053172|NCT00978029|12234389|FG000|STARTED|Overall Study||65
11053173|NCT00978029|12234390|FG001|STARTED|Overall Study||66
11053174|NCT00978029|12234391|FG002|STARTED|Overall Study||65
11053175|NCT00978029|12234389|FG000|COMPLETED|Overall Study||64
11053176|NCT00978029|12234390|FG001|COMPLETED|Overall Study||63
11053177|NCT00978029|12234391|FG002|COMPLETED|Overall Study||59
11053178|NCT00978029|12234389|FG000|NOT COMPLETED|Overall Study||1
11053179|NCT00978029|12234390|FG001|NOT COMPLETED|Overall Study||3
11053180|NCT00978029|12234391|FG002|NOT COMPLETED|Overall Study||6
11053181|NCT00978042|12234401|FG000|STARTED|Initial Treatment Period||235
11053182|NCT00978042|12234402|FG001|STARTED|Initial Treatment Period||47
11053183|NCT00978042|12234401|FG000|MITT_treated With VOLUMA XC|Initial Treatment Period||235
11053184|NCT00978042|12234402|FG001|MITT_treated With VOLUMA XC|Initial Treatment Period||35
11053185|NCT00978042|12234401|FG000|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
11053186|NCT00978042|12234402|FG001|COMPLETED|Initial Treatment Period||32
11053187|NCT00978042|12234401|FG000|NOT COMPLETED|Initial Treatment Period||61
11053188|NCT00978042|12234402|FG001|NOT COMPLETED|Initial Treatment Period||15
11053189|NCT00978042|12234401|FG000|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
11053190|NCT00978042|12234402|FG001|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
11053191|NCT00978042|12234401|FG000|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
11053192|NCT00978042|12234402|FG001|COMPLETED|Received Repeat Treatment||23
11053193|NCT00978042|12234401|FG000|NOT COMPLETED|Received Repeat Treatment||43
11053194|NCT00978042|12234402|FG001|NOT COMPLETED|Received Repeat Treatment||3
11053195|NCT00978068|12234410|FG000|STARTED|Overall Study||87
11053196|NCT00978068|12234411|FG001|STARTED|Overall Study||89
11053197|NCT00978068|12234410|FG000|Initiated Study Drugs|Overall Study||84
11053198|NCT00978068|12234411|FG001|Initiated Study Drugs|Overall Study||86
11053199|NCT00978068|12234410|FG000|COMPLETED|Overall Study||83
11053200|NCT00978068|12234411|FG001|COMPLETED|Overall Study||80
11053201|NCT00978068|12234410|FG000|NOT COMPLETED|Overall Study||4
11053202|NCT00978068|12234411|FG001|NOT COMPLETED|Overall Study||9
11053203|NCT00978120|12234425|FG000|STARTED|Overall Study||110
11053204|NCT00978120|12234426|FG001|STARTED|Overall Study||107
11053205|NCT00978120|12234427|FG002|STARTED|Overall Study||87
11053206|NCT00978120|12234428|FG003|STARTED|Overall Study||86
11053207|NCT00978120|12234425|FG000|COMPLETED|Overall Study||108
11053208|NCT00978120|12234426|FG001|COMPLETED|Overall Study||107
11053209|NCT00978120|12234427|FG002|COMPLETED|Overall Study||84
11053210|NCT00978120|12234428|FG003|COMPLETED|Overall Study||84
11053211|NCT00978120|12234425|FG000|NOT COMPLETED|Overall Study||2
11053212|NCT00978120|12234426|FG001|NOT COMPLETED|Overall Study||0
11053213|NCT00978120|12234427|FG002|NOT COMPLETED|Overall Study||3
11053214|NCT00978120|12234428|FG003|NOT COMPLETED|Overall Study||2
11053215|NCT00978250|12234446|FG000|STARTED|Overall Study||25
11053216|NCT00978250|12234447|FG001|STARTED|Overall Study||30
11053217|NCT00978250|12234448|FG002|STARTED|Overall Study||18
11053218|NCT00978250|12234449|FG003|STARTED|Overall Study||22
11053219|NCT00978250|12234446|FG000|COMPLETED|Overall Study||25
11053220|NCT00978250|12234447|FG001|COMPLETED|Overall Study||29
11053221|NCT00978250|12234448|FG002|COMPLETED|Overall Study||18
11053222|NCT00978250|12234449|FG003|COMPLETED|Overall Study||21
11053223|NCT00978250|12234446|FG000|NOT COMPLETED|Overall Study||0
11053224|NCT00978250|12234447|FG001|NOT COMPLETED|Overall Study||1
11053225|NCT00978250|12234448|FG002|NOT COMPLETED|Overall Study||0
11053226|NCT00978250|12234449|FG003|NOT COMPLETED|Overall Study||1
11053227|NCT00978341|12234461|FG000|STARTED|First Intervention||8
11053228|NCT00978341|12234462|FG001|STARTED|First Intervention||7
11053229|NCT00978341|12234461|FG000|COMPLETED|First Intervention||8
11053230|NCT00978341|12234462|FG001|COMPLETED|First Intervention||7
11053231|NCT00978341|12234461|FG000|NOT COMPLETED|First Intervention||0
11053232|NCT00978341|12234462|FG001|NOT COMPLETED|First Intervention||0
11053233|NCT00978341|12234461|FG000|STARTED|Washout Period of 2 Weeks||8
11053234|NCT00978341|12234462|FG001|STARTED|Washout Period of 2 Weeks||7
11053235|NCT00978341|12234461|FG000|COMPLETED|Washout Period of 2 Weeks||7
11053236|NCT00978341|12234462|FG001|COMPLETED|Washout Period of 2 Weeks||7
11053237|NCT00978341|12234461|FG000|NOT COMPLETED|Washout Period of 2 Weeks||1
11053238|NCT00978341|12234462|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
11053239|NCT00978341|12234461|FG000|STARTED|Second Intervention||7
11053240|NCT00978341|12234462|FG001|STARTED|Second Intervention||7
11053241|NCT00978341|12234461|FG000|COMPLETED|Second Intervention||7
11053242|NCT00978341|12234462|FG001|COMPLETED|Second Intervention||7
11053243|NCT00978341|12234461|FG000|NOT COMPLETED|Second Intervention||0
11053244|NCT00978341|12234462|FG001|NOT COMPLETED|Second Intervention||0
11053245|NCT00978380|12234469|FG000|STARTED|Overall Study||63
11053246|NCT00978380|12234469|FG000|COMPLETED|Overall Study||44
11053247|NCT00978380|12234469|FG000|NOT COMPLETED|Overall Study||19
11053248|NCT00978432|12234477|FG000|STARTED|Overall Study||10
11053249|NCT00978432|12234478|FG001|STARTED|Overall Study||5
11053250|NCT00978432|12234479|FG002|STARTED|Overall Study||18
11053251|NCT00978432|12234477|FG000|COMPLETED|Overall Study||7
11053252|NCT00978432|12234478|FG001|COMPLETED|Overall Study||4
11053253|NCT00978432|12234479|FG002|COMPLETED|Overall Study||13
11053254|NCT00978432|12234477|FG000|NOT COMPLETED|Overall Study||3
11053255|NCT00978432|12234478|FG001|NOT COMPLETED|Overall Study||1
11053256|NCT00978432|12234479|FG002|NOT COMPLETED|Overall Study||5
11053257|NCT00978445|12234487|FG000|STARTED|Overall Study||12
11053258|NCT00978445|12234488|FG001|STARTED|Overall Study||13
11053259|NCT00978445|12234487|FG000|COMPLETED|Overall Study||10
11053260|NCT00978445|12234488|FG001|COMPLETED|Overall Study||12
11053261|NCT00978445|12234487|FG000|NOT COMPLETED|Overall Study||2
11053262|NCT00978445|12234488|FG001|NOT COMPLETED|Overall Study||1
11053263|NCT00978627|12234497|FG000|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
11053264|NCT00978627|12234498|FG001|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
11053265|NCT00978627|12234497|FG000|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
11053266|NCT00978627|12234498|FG001|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
11053267|NCT00978627|12234497|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
11053268|NCT00978627|12234498|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
11053269|NCT00978627|12234497|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
11053270|NCT00978627|12234498|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
11053271|NCT00978627|12234497|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
11053272|NCT00978627|12234498|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
11053273|NCT00978627|12234497|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
11053274|NCT00978627|12234498|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
11053275|NCT00978627|12234497|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
11053276|NCT00978627|12234498|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
11053277|NCT00978731|12234508|FG000|STARTED|Overall Study||22
11053278|NCT00978731|12234509|FG001|STARTED|Overall Study||15
11053279|NCT00978731|12234510|FG002|STARTED|Overall Study||5
11053280|NCT00978731|12234511|FG003|STARTED|Overall Study||4
11053281|NCT00978731|12234508|FG000|COMPLETED|Overall Study||0
11053282|NCT00978731|12234509|FG001|COMPLETED|Overall Study||0
11053283|NCT00978731|12234510|FG002|COMPLETED|Overall Study||0
11053284|NCT00978731|12234511|FG003|COMPLETED|Overall Study||0
11053285|NCT00978731|12234508|FG000|NOT COMPLETED|Overall Study||22
11053286|NCT00978731|12234509|FG001|NOT COMPLETED|Overall Study||15
11053287|NCT00978731|12234510|FG002|NOT COMPLETED|Overall Study||5
11053288|NCT00978731|12234511|FG003|NOT COMPLETED|Overall Study||4
11053289|NCT00978757|12234527|FG000|STARTED|Overall Study|June 2001|22
11053290|NCT00978757|12234528|FG001|STARTED|Overall Study|June 2001|20
11053291|NCT00978757|12234527|FG000|COMPLETED|Overall Study|June 2008|21
11053292|NCT00978757|12234528|FG001|COMPLETED|Overall Study|June 2008|17
11053293|NCT00978757|12234527|FG000|NOT COMPLETED|Overall Study||1
11053294|NCT00978757|12234528|FG001|NOT COMPLETED|Overall Study||3
11053295|NCT00979017|12234534|FG000|STARTED|Overall Study||41
11053296|NCT00979017|12234534|FG000|COMPLETED|Overall Study||41
11053297|NCT00979017|12234534|FG000|NOT COMPLETED|Overall Study||0
11053298|NCT00979069|12234540|FG000|STARTED|Overall Study||10
11053299|NCT00979069|12234541|FG001|STARTED|Overall Study||10
11053300|NCT00979069|12234540|FG000|COMPLETED|Overall Study||10
11053301|NCT00979069|12234541|FG001|COMPLETED|Overall Study||8
11053302|NCT00979069|12234540|FG000|NOT COMPLETED|Overall Study||0
11053303|NCT00979069|12234541|FG001|NOT COMPLETED|Overall Study||2
11053304|NCT00979121|12234549|FG000|STARTED|Overall Study||379
11053305|NCT00979121|12234550|FG001|STARTED|Overall Study||366
11053306|NCT00979121|12234549|FG000|COMPLETED|Overall Study||379
11053307|NCT00979121|12234550|FG001|COMPLETED|Overall Study||366
11053308|NCT00979121|12234549|FG000|NOT COMPLETED|Overall Study||0
11053309|NCT00979121|12234550|FG001|NOT COMPLETED|Overall Study||0
11053310|NCT00979134|12234565|FG000|STARTED|Overall Study||43
11053311|NCT00979134|12234566|FG001|STARTED|Overall Study||6
11053312|NCT00979134|12234567|FG002|STARTED|Overall Study||45
11053313|NCT00979134|12234565|FG000|COMPLETED|Overall Study|At DCO|10
11053314|NCT00979134|12234566|FG001|COMPLETED|Overall Study|At DCO|0
11053315|NCT00979134|12234567|FG002|COMPLETED|Overall Study|At DCO|5
11053316|NCT00979134|12234565|FG000|NOT COMPLETED|Overall Study||33
11053317|NCT00979134|12234566|FG001|NOT COMPLETED|Overall Study||6
11053318|NCT00979134|12234567|FG002|NOT COMPLETED|Overall Study||40
11053319|NCT00979199|12234580|FG000|STARTED|Overall Study||697
11053320|NCT00979199|12234580|FG000|COMPLETED|Overall Study||475
11053321|NCT00979199|12234580|FG000|NOT COMPLETED|Overall Study||222
11053322|NCT00979303|12234586|FG000|STARTED|Overall Study||37
11053323|NCT00979303|12234587|FG001|STARTED|Overall Study||37
11053324|NCT00979303|12234586|FG000|COMPLETED|Overall Study||37
11053325|NCT00979303|12234587|FG001|COMPLETED|Overall Study||37
11053326|NCT00979303|12234586|FG000|NOT COMPLETED|Overall Study||0
11053327|NCT00979303|12234587|FG001|NOT COMPLETED|Overall Study||0
11053328|NCT00979407|12234595|FG000|STARTED|Overall Study||167
11053329|NCT00979407|12234596|FG001|STARTED|Overall Study||167
11053330|NCT00979407|12234595|FG000|COMPLETED|Overall Study||161
11053331|NCT00979407|12234596|FG001|COMPLETED|Overall Study||160
11053332|NCT00979407|12234595|FG000|NOT COMPLETED|Overall Study||6
11053333|NCT00979407|12234596|FG001|NOT COMPLETED|Overall Study||7
11053334|NCT00979420|12234608|FG000|STARTED|Overall Study||178
11053335|NCT00979420|12234609|FG001|STARTED|Overall Study||57
11053336|NCT00979420|12234610|FG002|STARTED|Overall Study||60
11053337|NCT00979420|12234611|FG003|STARTED|Overall Study||61
11053338|NCT00979420|12234608|FG000|COMPLETED|Overall Study||171
11053339|NCT00979420|12234609|FG001|COMPLETED|Overall Study||57
11053340|NCT00979420|12234610|FG002|COMPLETED|Overall Study||59
11053341|NCT00979420|12234611|FG003|COMPLETED|Overall Study||59
11053342|NCT00979420|12234608|FG000|NOT COMPLETED|Overall Study||7
11053343|NCT00979420|12234609|FG001|NOT COMPLETED|Overall Study||0
11053344|NCT00979420|12234610|FG002|NOT COMPLETED|Overall Study||1
11053345|NCT00979420|12234611|FG003|NOT COMPLETED|Overall Study||2
11053346|NCT00979459|12234619|FG000|STARTED|First Intervention||6
11053347|NCT00979459|12234620|FG001|STARTED|First Intervention||6
11053348|NCT00979459|12234619|FG000|COMPLETED|First Intervention||6
11053349|NCT00979459|12234620|FG001|COMPLETED|First Intervention||6
11053350|NCT00979459|12234619|FG000|NOT COMPLETED|First Intervention||0
11053351|NCT00979459|12234620|FG001|NOT COMPLETED|First Intervention||0
11053352|NCT00979459|12234619|FG000|STARTED|7-day Washout Period||6
11053353|NCT00979459|12234620|FG001|STARTED|7-day Washout Period||6
11053354|NCT00979459|12234619|FG000|COMPLETED|7-day Washout Period||6
11053355|NCT00979459|12234620|FG001|COMPLETED|7-day Washout Period||6
11053356|NCT00979459|12234619|FG000|NOT COMPLETED|7-day Washout Period||0
11053357|NCT00979459|12234620|FG001|NOT COMPLETED|7-day Washout Period||0
11053358|NCT00979459|12234619|FG000|STARTED|Second Intervention||6
11053359|NCT00979459|12234620|FG001|STARTED|Second Intervention||6
11053360|NCT00979459|12234619|FG000|COMPLETED|Second Intervention||6
11053361|NCT00979459|12234620|FG001|COMPLETED|Second Intervention||6
11053362|NCT00979459|12234619|FG000|NOT COMPLETED|Second Intervention||0
11053363|NCT00979459|12234620|FG001|NOT COMPLETED|Second Intervention||0
11053364|NCT00979576|12234631|FG000|STARTED|Combination Treatment Phase||3
11053365|NCT00979576|12234632|FG001|STARTED|Combination Treatment Phase||6
11053366|NCT00979576|12234633|FG002|STARTED|Combination Treatment Phase||9
11053367|NCT00979576|12234631|FG000|COMPLETED|Combination Treatment Phase||0
11053368|NCT00979576|12234632|FG001|COMPLETED|Combination Treatment Phase||0
11053369|NCT00979576|12234633|FG002|COMPLETED|Combination Treatment Phase||0
11053370|NCT00979576|12234631|FG000|NOT COMPLETED|Combination Treatment Phase||3
11053371|NCT00979576|12234632|FG001|NOT COMPLETED|Combination Treatment Phase||6
11053372|NCT00979576|12234633|FG002|NOT COMPLETED|Combination Treatment Phase||9
11053373|NCT00979576|12234631|FG000|STARTED|Combination Followed by Monotherapy||0
11053374|NCT00979576|12234632|FG001|STARTED|Combination Followed by Monotherapy||2
11053375|NCT00979576|12234633|FG002|STARTED|Combination Followed by Monotherapy||1
11053376|NCT00979576|12234631|FG000|COMPLETED|Combination Followed by Monotherapy||0
11053377|NCT00979576|12234632|FG001|COMPLETED|Combination Followed by Monotherapy||0
11053378|NCT00979576|12234633|FG002|COMPLETED|Combination Followed by Monotherapy||0
11053379|NCT00979576|12234631|FG000|NOT COMPLETED|Combination Followed by Monotherapy||0
11053380|NCT00979576|12234632|FG001|NOT COMPLETED|Combination Followed by Monotherapy||2
11053381|NCT00979576|12234633|FG002|NOT COMPLETED|Combination Followed by Monotherapy||1
11053382|NCT00979602|12234644|FG000|STARTED|Overall Study||2025
11053383|NCT00979602|12234645|FG001|STARTED|Overall Study||2023
11053384|NCT00979602|12234644|FG000|COMPLETED|Overall Study||1880
11053385|NCT00979602|12234645|FG001|COMPLETED|Overall Study||1890
11053386|NCT00979602|12234644|FG000|NOT COMPLETED|Overall Study||145
11053387|NCT00979602|12234645|FG001|NOT COMPLETED|Overall Study||133
11053388|NCT00979615|12234665|FG000|STARTED|Overall Study||63
11053389|NCT00979615|12234666|FG001|STARTED|Overall Study||66
11053390|NCT00979615|12234665|FG000|COMPLETED|Overall Study||57
11053391|NCT00979615|12234666|FG001|COMPLETED|Overall Study||58
11053392|NCT00979615|12234665|FG000|NOT COMPLETED|Overall Study||6
11053393|NCT00979615|12234666|FG001|NOT COMPLETED|Overall Study||8
11053394|NCT00979628|12234675|FG000|STARTED|Overall Study||153
11053395|NCT00979628|12234676|FG001|STARTED|Overall Study||142
11053396|NCT00979628|12234677|FG002|STARTED|Overall Study||80
11053397|NCT00979628|12234675|FG000|COMPLETED|Overall Study||144
11053398|NCT00979628|12234676|FG001|COMPLETED|Overall Study||133
11053399|NCT00979628|12234677|FG002|COMPLETED|Overall Study||74
11053400|NCT00979628|12234675|FG000|NOT COMPLETED|Overall Study||9
11053401|NCT00979628|12234676|FG001|NOT COMPLETED|Overall Study||9
11053402|NCT00979628|12234677|FG002|NOT COMPLETED|Overall Study||6
11053403|NCT00979654|12234688|FG000|STARTED|Overall Study||103
11053404|NCT00979654|12234688|FG000|COMPLETED|Overall Study||67
11053405|NCT00979654|12234688|FG000|NOT COMPLETED|Overall Study||36
11053406|NCT00979732|12234694|FG000|STARTED|Overall Study||15
11053407|NCT00979732|12234695|FG001|STARTED|Overall Study||18
11053408|NCT00979732|12234694|FG000|COMPLETED|Overall Study||12
11053409|NCT00979732|12234695|FG001|COMPLETED|Overall Study||17
11338323|NCT02902913|12535890|FG000|Third Intervention (1 Day)|Overall Study||9
11338324|NCT02902913|12535890|FG000|Washout (7 Days)|Overall Study||9
11338325|NCT02902913|12535890|FG000|Ibuprofen (400mg)|Overall Study||9
11338326|NCT02902913|12535890|FG000|COMPLETED|Overall Study||9
11338327|NCT02902913|12535890|FG000|NOT COMPLETED|Overall Study||0
11338328|NCT02902965|12535898|FG000|STARTED|Overall Study||74
11338329|NCT02902965|12535898|FG000|COMPLETED|Overall Study||64
11338330|NCT02902965|12535898|FG000|NOT COMPLETED|Overall Study||10
11338331|NCT02903030|12535905|FG000|STARTED|First Intervention (8 Weeks)||8
11338332|NCT02903030|12535906|FG001|STARTED|First Intervention (8 Weeks)||5
11338333|NCT02903030|12535905|FG000|Received Intervention|First Intervention (8 Weeks)||6
11338334|NCT02903030|12535906|FG001|Received Intervention|First Intervention (8 Weeks)||4
11338335|NCT02903030|12535905|FG000|COMPLETED|First Intervention (8 Weeks)||6
11338336|NCT02903030|12535906|FG001|COMPLETED|First Intervention (8 Weeks)||4
11338337|NCT02903030|12535905|FG000|NOT COMPLETED|First Intervention (8 Weeks)||2
11338338|NCT02903030|12535906|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1
11338339|NCT02903030|12535905|FG000|STARTED|Washout (3 Weeks)||6
11338340|NCT02903030|12535906|FG001|STARTED|Washout (3 Weeks)||4
11053410|NCT00979732|12234694|FG000|NOT COMPLETED|Overall Study||3
11053411|NCT00979732|12234695|FG001|NOT COMPLETED|Overall Study||1
11053412|NCT00979745|12234703|FG000|STARTED|Overall Study||38
11053413|NCT00979745|12234704|FG001|STARTED|Overall Study||36
11338341|NCT02903030|12535905|FG000|COMPLETED|Washout (3 Weeks)||6
11053414|NCT00979745|12234703|FG000|COMPLETED|Overall Study||34
11053415|NCT00979745|12234704|FG001|COMPLETED|Overall Study||34
11053416|NCT00979745|12234703|FG000|NOT COMPLETED|Overall Study||4
11053417|NCT00979745|12234704|FG001|NOT COMPLETED|Overall Study||2
11053418|NCT00979875|12234710|FG000|STARTED|Intervention 1||2
11053419|NCT00979875|12234711|FG001|STARTED|Intervention 1||2
11053420|NCT00979875|12234712|FG002|STARTED|Intervention 1||3
11053421|NCT00979875|12234713|FG003|STARTED|Intervention 1||2
11053422|NCT00979875|12234714|FG004|STARTED|Intervention 1||3
11053423|NCT00979875|12234715|FG005|STARTED|Intervention 1||2
11053424|NCT00979875|12234710|FG000|Received at Least 1 Dose of Study Drug|Intervention 1||2
11053425|NCT00979875|12234711|FG001|Received at Least 1 Dose of Study Drug|Intervention 1||2
11053426|NCT00979875|12234712|FG002|Received at Least 1 Dose of Study Drug|Intervention 1||3
11053427|NCT00979875|12234713|FG003|Received at Least 1 Dose of Study Drug|Intervention 1||2
11053428|NCT00979875|12234714|FG004|Received at Least 1 Dose of Study Drug|Intervention 1||3
11053429|NCT00979875|12234715|FG005|Received at Least 1 Dose of Study Drug|Intervention 1||2
11053430|NCT00979875|12234710|FG000|COMPLETED|Intervention 1||2
11053431|NCT00979875|12234711|FG001|COMPLETED|Intervention 1||2
11053432|NCT00979875|12234712|FG002|COMPLETED|Intervention 1||3
11053433|NCT00979875|12234713|FG003|COMPLETED|Intervention 1||2
11053434|NCT00979875|12234714|FG004|COMPLETED|Intervention 1||3
11053435|NCT00979875|12234715|FG005|COMPLETED|Intervention 1||2
11053436|NCT00979875|12234710|FG000|NOT COMPLETED|Intervention 1||0
11053437|NCT00979875|12234711|FG001|NOT COMPLETED|Intervention 1||0
11053438|NCT00979875|12234712|FG002|NOT COMPLETED|Intervention 1||0
11053439|NCT00979875|12234713|FG003|NOT COMPLETED|Intervention 1||0
11053440|NCT00979875|12234714|FG004|NOT COMPLETED|Intervention 1||0
11053441|NCT00979875|12234715|FG005|NOT COMPLETED|Intervention 1||0
11053442|NCT00979875|12234710|FG000|STARTED|Washout 1 (3 to 14 Days)||2
11053443|NCT00979875|12234711|FG001|STARTED|Washout 1 (3 to 14 Days)||2
11053444|NCT00979875|12234712|FG002|STARTED|Washout 1 (3 to 14 Days)||3
11053445|NCT00979875|12234713|FG003|STARTED|Washout 1 (3 to 14 Days)||2
11053446|NCT00979875|12234714|FG004|STARTED|Washout 1 (3 to 14 Days)||3
11053447|NCT00979875|12234715|FG005|STARTED|Washout 1 (3 to 14 Days)||2
11053448|NCT00979875|12234710|FG000|COMPLETED|Washout 1 (3 to 14 Days)||2
11053449|NCT00979875|12234711|FG001|COMPLETED|Washout 1 (3 to 14 Days)||2
11053450|NCT00979875|12234712|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3
11053451|NCT00979875|12234713|FG003|COMPLETED|Washout 1 (3 to 14 Days)||2
11053452|NCT00979875|12234714|FG004|COMPLETED|Washout 1 (3 to 14 Days)||3
11053453|NCT00979875|12234715|FG005|COMPLETED|Washout 1 (3 to 14 Days)||2
11053454|NCT00979875|12234710|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
11053455|NCT00979875|12234711|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
11053456|NCT00979875|12234712|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
11053457|NCT00979875|12234713|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
11053458|NCT00979875|12234714|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
11053459|NCT00979875|12234715|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
11053460|NCT00979875|12234710|FG000|STARTED|Intervention 2||2
11053461|NCT00979875|12234711|FG001|STARTED|Intervention 2||2
11053462|NCT00979875|12234712|FG002|STARTED|Intervention 2||3
11053463|NCT00979875|12234713|FG003|STARTED|Intervention 2||2
11053464|NCT00979875|12234714|FG004|STARTED|Intervention 2||3
11053465|NCT00979875|12234715|FG005|STARTED|Intervention 2||2
11053466|NCT00979875|12234710|FG000|COMPLETED|Intervention 2||2
11053467|NCT00979875|12234711|FG001|COMPLETED|Intervention 2||2
11053468|NCT00979875|12234712|FG002|COMPLETED|Intervention 2||3
11053469|NCT00979875|12234713|FG003|COMPLETED|Intervention 2||2
11053470|NCT00979875|12234714|FG004|COMPLETED|Intervention 2||3
11053471|NCT00979875|12234715|FG005|COMPLETED|Intervention 2||2
11053472|NCT00979875|12234710|FG000|NOT COMPLETED|Intervention 2||0
11053473|NCT00979875|12234711|FG001|NOT COMPLETED|Intervention 2||0
11053474|NCT00979875|12234712|FG002|NOT COMPLETED|Intervention 2||0
11338342|NCT02903030|12535906|FG001|COMPLETED|Washout (3 Weeks)||4
11338343|NCT02903030|12535905|FG000|NOT COMPLETED|Washout (3 Weeks)||0
11338344|NCT02903030|12535906|FG001|NOT COMPLETED|Washout (3 Weeks)||0
11338345|NCT02903030|12535905|FG000|STARTED|Second Intervention (8 Weeks)||6
11338346|NCT02903030|12535906|FG001|STARTED|Second Intervention (8 Weeks)||4
11338347|NCT02903030|12535905|FG000|COMPLETED|Second Intervention (8 Weeks)||6
11338348|NCT02903030|12535906|FG001|COMPLETED|Second Intervention (8 Weeks)||4
11338349|NCT02903030|12535905|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
11053475|NCT00979875|12234713|FG003|NOT COMPLETED|Intervention 2||0
11053476|NCT00979875|12234714|FG004|NOT COMPLETED|Intervention 2||0
11053477|NCT00979875|12234715|FG005|NOT COMPLETED|Intervention 2||0
11053478|NCT00979875|12234710|FG000|STARTED|Washout 2 (3 to 14 Days)||2
11053479|NCT00979875|12234711|FG001|STARTED|Washout 2 (3 to 14 Days)||2
11053480|NCT00979875|12234712|FG002|STARTED|Washout 2 (3 to 14 Days)||3
11053481|NCT00979875|12234713|FG003|STARTED|Washout 2 (3 to 14 Days)||2
11053482|NCT00979875|12234714|FG004|STARTED|Washout 2 (3 to 14 Days)||3
11053483|NCT00979875|12234715|FG005|STARTED|Washout 2 (3 to 14 Days)||2
11053484|NCT00979875|12234710|FG000|COMPLETED|Washout 2 (3 to 14 Days)||2
11053485|NCT00979875|12234711|FG001|COMPLETED|Washout 2 (3 to 14 Days)||2
11053486|NCT00979875|12234712|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3
11053487|NCT00979875|12234713|FG003|COMPLETED|Washout 2 (3 to 14 Days)||2
11053488|NCT00979875|12234714|FG004|COMPLETED|Washout 2 (3 to 14 Days)||3
11053489|NCT00979875|12234715|FG005|COMPLETED|Washout 2 (3 to 14 Days)||2
11053490|NCT00979875|12234710|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
11053491|NCT00979875|12234711|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
11053492|NCT00979875|12234712|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
11053493|NCT00979875|12234713|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
11053494|NCT00979875|12234714|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
11053495|NCT00979875|12234715|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
11053496|NCT00979875|12234710|FG000|STARTED|Intervention 3||2
11053497|NCT00979875|12234711|FG001|STARTED|Intervention 3||2
11053498|NCT00979875|12234712|FG002|STARTED|Intervention 3||3
11053499|NCT00979875|12234713|FG003|STARTED|Intervention 3||2
11053500|NCT00979875|12234714|FG004|STARTED|Intervention 3||3
11053501|NCT00979875|12234715|FG005|STARTED|Intervention 3||2
11053502|NCT00979875|12234710|FG000|COMPLETED|Intervention 3||2
11053503|NCT00979875|12234711|FG001|COMPLETED|Intervention 3||2
11053504|NCT00979875|12234712|FG002|COMPLETED|Intervention 3||3
11053505|NCT00979875|12234713|FG003|COMPLETED|Intervention 3||2
11053506|NCT00979875|12234714|FG004|COMPLETED|Intervention 3||3
11053507|NCT00979875|12234715|FG005|COMPLETED|Intervention 3||2
11053508|NCT00979875|12234710|FG000|NOT COMPLETED|Intervention 3||0
11053509|NCT00979875|12234711|FG001|NOT COMPLETED|Intervention 3||0
11053510|NCT00979875|12234712|FG002|NOT COMPLETED|Intervention 3||0
11053511|NCT00979875|12234713|FG003|NOT COMPLETED|Intervention 3||0
11053512|NCT00979875|12234714|FG004|NOT COMPLETED|Intervention 3||0
11053513|NCT00979875|12234715|FG005|NOT COMPLETED|Intervention 3||0
11053514|NCT00979940|12234731|FG000|STARTED|Overall Study||32
11053515|NCT00979940|12234732|FG001|STARTED|Overall Study||28
11053516|NCT00979940|12234731|FG000|COMPLETED|Overall Study||32
11053517|NCT00979940|12234732|FG001|COMPLETED|Overall Study||28
11053518|NCT00979940|12234731|FG000|NOT COMPLETED|Overall Study||0
11053519|NCT00979940|12234732|FG001|NOT COMPLETED|Overall Study||0
11338350|NCT02903030|12535906|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
11338351|NCT02903121|12535917|FG000|STARTED|Overall Study||57
11338352|NCT02903121|12535918|FG001|STARTED|Overall Study||52
11338353|NCT02903121|12535917|FG000|COMPLETED|Overall Study||34
11338354|NCT02903121|12535918|FG001|COMPLETED|Overall Study||38
11338355|NCT02903121|12535917|FG000|NOT COMPLETED|Overall Study||23
11338356|NCT02903121|12535918|FG001|NOT COMPLETED|Overall Study||14
11338357|NCT02903238|12535924|FG000|STARTED|Overall Study||21
11338358|NCT02903238|12535924|FG000|COMPLETED|Overall Study||17
11338359|NCT02903238|12535924|FG000|NOT COMPLETED|Overall Study||4
11338360|NCT02903368|12535931|FG000|STARTED|Overall Study||59
11338361|NCT02903368|12535932|FG001|STARTED|Overall Study||59
11338362|NCT02903368|12535931|FG000|COMPLETED|Overall Study||55
11053520|NCT00979953|12234742|FG000|STARTED|Overall Study||101
11053521|NCT00979953|12234743|FG001|STARTED|Overall Study||99
11338363|NCT02903368|12535932|FG001|COMPLETED|Overall Study||59
11338364|NCT02903368|12535931|FG000|NOT COMPLETED|Overall Study||4
11053522|NCT00979953|12234744|FG002|STARTED|Overall Study||104
11053523|NCT00979953|12234745|FG003|STARTED|Overall Study||104
11053524|NCT00979953|12234742|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101
11053525|NCT00979953|12234743|FG001|Received at Least 1 Dose of Study Drug|Overall Study||99
11053526|NCT00979953|12234744|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104
11338365|NCT02903368|12535932|FG001|NOT COMPLETED|Overall Study||0
11338366|NCT02903394|12535943|FG000|STARTED|Overall Study||5
11053527|NCT00979953|12234745|FG003|Received at Least 1 Dose of Study Drug|Overall Study||104
11053528|NCT00979953|12234742|FG000|COMPLETED|Overall Study||93
11053529|NCT00979953|12234743|FG001|COMPLETED|Overall Study||94
11053530|NCT00979953|12234744|FG002|COMPLETED|Overall Study||82
11053531|NCT00979953|12234745|FG003|COMPLETED|Overall Study||97
11053532|NCT00979953|12234742|FG000|NOT COMPLETED|Overall Study||8
11053533|NCT00979953|12234743|FG001|NOT COMPLETED|Overall Study||5
11053534|NCT00979953|12234744|FG002|NOT COMPLETED|Overall Study||22
11053535|NCT00979953|12234745|FG003|NOT COMPLETED|Overall Study||7
11053536|NCT00979992|12234755|FG000|STARTED|Overall Study||35
11053537|NCT00979992|12234755|FG000|COMPLETED|Overall Study||30
11053538|NCT00979992|12234755|FG000|NOT COMPLETED|Overall Study||5
11053539|NCT00980005|12234761|FG000|STARTED|Overall Study||1055
11053540|NCT00980005|12234762|FG001|STARTED|Overall Study||1061
11053541|NCT00980005|12234761|FG000|COMPLETED|Overall Study||1008
11053542|NCT00980005|12234762|FG001|COMPLETED|Overall Study||998
11053543|NCT00980005|12234761|FG000|NOT COMPLETED|Overall Study||47
11053544|NCT00980005|12234762|FG001|NOT COMPLETED|Overall Study||63
11053545|NCT00980018|12234772|FG000|STARTED|Overall Study||52
11053546|NCT00980018|12234772|FG000|COMPLETED|Overall Study||40
11053547|NCT00980018|12234772|FG000|NOT COMPLETED|Overall Study||12
11053548|NCT00980044|12234779|FG000|STARTED|Overall Study||17
11053549|NCT00980044|12234780|FG001|STARTED|Overall Study||19
11053550|NCT00980044|12234781|FG002|STARTED|Overall Study||17
11053551|NCT00980044|12234779|FG000|COMPLETED|Overall Study||12
11053552|NCT00980044|12234780|FG001|COMPLETED|Overall Study||12
11053553|NCT00980044|12234781|FG002|COMPLETED|Overall Study||12
11053554|NCT00980044|12234779|FG000|NOT COMPLETED|Overall Study||5
11053555|NCT00980044|12234780|FG001|NOT COMPLETED|Overall Study||7
11053556|NCT00980044|12234781|FG002|NOT COMPLETED|Overall Study||5
11053557|NCT00980057|12234794|FG000|STARTED|Overall Study||318
11053558|NCT00980057|12234795|FG001|STARTED|Overall Study||160
11053559|NCT00980057|12234794|FG000|COMPLETED|Overall Study||299
11053560|NCT00980057|12234795|FG001|COMPLETED|Overall Study||155
11053561|NCT00980057|12234794|FG000|NOT COMPLETED|Overall Study||19
11338367|NCT02903394|12535944|FG001|STARTED|Overall Study||50
11338368|NCT02903394|12535943|FG000|COMPLETED|Overall Study||5
11338369|NCT02903394|12535944|FG001|COMPLETED|Overall Study||50
11338370|NCT02903394|12535943|FG000|NOT COMPLETED|Overall Study||0
11338371|NCT02903394|12535944|FG001|NOT COMPLETED|Overall Study||0
11338372|NCT02903407|12535953|FG000|STARTED|Overall Study||4
11338373|NCT02903407|12535954|FG001|STARTED|Overall Study||3
11338374|NCT02903407|12535953|FG000|COMPLETED|Overall Study||4
11338375|NCT02903407|12535954|FG001|COMPLETED|Overall Study||3
11338376|NCT02903407|12535953|FG000|NOT COMPLETED|Overall Study||0
11338377|NCT02903407|12535954|FG001|NOT COMPLETED|Overall Study||0
11338378|NCT02903420|12535960|FG000|STARTED|Overall Study||28
11338379|NCT02903420|12535960|FG000|COMPLETED|Overall Study||25
11338380|NCT02903420|12535960|FG000|NOT COMPLETED|Overall Study||3
11338381|NCT02903446|12535966|FG000|STARTED|Overall Study||10
11338382|NCT02903446|12535967|FG001|STARTED|Overall Study||10
11338383|NCT02903446|12535966|FG000|COMPLETED|Overall Study||10
11053562|NCT00980057|12234795|FG001|NOT COMPLETED|Overall Study||5
11338384|NCT02903446|12535967|FG001|COMPLETED|Overall Study||10
11338385|NCT02903446|12535966|FG000|NOT COMPLETED|Overall Study||0
11338386|NCT02903446|12535967|FG001|NOT COMPLETED|Overall Study||0
11338387|NCT02903511|12535975|FG000|STARTED|Overall Study||26
11338388|NCT02903511|12535976|FG001|STARTED|Overall Study||25
11338389|NCT02903511|12535975|FG000|Received Intervention|Overall Study||25
11338390|NCT02903511|12535976|FG001|Received Intervention|Overall Study||25
11338391|NCT02903511|12535975|FG000|COMPLETED|Overall Study||22
11338392|NCT02903511|12535976|FG001|COMPLETED|Overall Study||23
11338393|NCT02903511|12535975|FG000|NOT COMPLETED|Overall Study||4
11338394|NCT02903511|12535976|FG001|NOT COMPLETED|Overall Study||2
11338395|NCT02903836|12535985|FG000|STARTED|Overall Study||74
11338396|NCT02903836|12535986|FG001|STARTED|Overall Study||73
11338397|NCT02903836|12535987|FG002|STARTED|Overall Study||77
11338398|NCT02903836|12535985|FG000|COMPLETED|Overall Study||71
11338399|NCT02903836|12535986|FG001|COMPLETED|Overall Study||69
11053563|NCT00980148|12234804|FG000|STARTED|Overall Study||284
11053564|NCT00980148|12234805|FG001|STARTED|Overall Study||283
11053565|NCT00980148|12234804|FG000|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
11053566|NCT00980148|12234805|FG001|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
11053567|NCT00980148|12234804|FG000|NOT COMPLETED|Overall Study||129
11053568|NCT00980148|12234805|FG001|NOT COMPLETED|Overall Study||128
11053569|NCT00980174|12234813|FG000|STARTED|Overall Study||121
11053570|NCT00980174|12234814|FG001|STARTED|Overall Study||121
11053571|NCT00980174|12234813|FG000|COMPLETED|Overall Study||117
11053572|NCT00980174|12234814|FG001|COMPLETED|Overall Study||111
11053573|NCT00980174|12234813|FG000|NOT COMPLETED|Overall Study||4
11053574|NCT00980174|12234814|FG001|NOT COMPLETED|Overall Study||10
11053575|NCT00980200|12234820|FG000|STARTED|7-day Treatment Period 1||15
11053576|NCT00980200|12234821|FG001|STARTED|7-day Treatment Period 1||14
11053577|NCT00980200|12234822|FG002|STARTED|7-day Treatment Period 1||15
11053578|NCT00980200|12234823|FG003|STARTED|7-day Treatment Period 1||16
11053579|NCT00980200|12234824|FG004|STARTED|7-day Treatment Period 1||15
11053580|NCT00980200|12234820|FG000|COMPLETED|7-day Treatment Period 1||15
11053581|NCT00980200|12234821|FG001|COMPLETED|7-day Treatment Period 1||13
11053582|NCT00980200|12234822|FG002|COMPLETED|7-day Treatment Period 1||15
11053583|NCT00980200|12234823|FG003|COMPLETED|7-day Treatment Period 1||16
11053584|NCT00980200|12234824|FG004|COMPLETED|7-day Treatment Period 1||15
11053585|NCT00980200|12234820|FG000|NOT COMPLETED|7-day Treatment Period 1||0
11053586|NCT00980200|12234821|FG001|NOT COMPLETED|7-day Treatment Period 1||1
11053587|NCT00980200|12234822|FG002|NOT COMPLETED|7-day Treatment Period 1||0
11053588|NCT00980200|12234823|FG003|NOT COMPLETED|7-day Treatment Period 1||0
11053589|NCT00980200|12234824|FG004|NOT COMPLETED|7-day Treatment Period 1||0
11053590|NCT00980200|12234820|FG000|STARTED|7-day Washout Period 1||15
11053591|NCT00980200|12234821|FG001|STARTED|7-day Washout Period 1||13
11053592|NCT00980200|12234822|FG002|STARTED|7-day Washout Period 1||15
11053593|NCT00980200|12234823|FG003|STARTED|7-day Washout Period 1||16
11338400|NCT02903836|12535987|FG002|COMPLETED|Overall Study||73
11338401|NCT02903836|12535985|FG000|NOT COMPLETED|Overall Study||3
11053594|NCT00980200|12234824|FG004|STARTED|7-day Washout Period 1||15
11053595|NCT00980200|12234820|FG000|COMPLETED|7-day Washout Period 1||15
11053596|NCT00980200|12234821|FG001|COMPLETED|7-day Washout Period 1||13
11053597|NCT00980200|12234822|FG002|COMPLETED|7-day Washout Period 1||15
11053598|NCT00980200|12234823|FG003|COMPLETED|7-day Washout Period 1||16
11053599|NCT00980200|12234824|FG004|COMPLETED|7-day Washout Period 1||15
11053600|NCT00980200|12234820|FG000|NOT COMPLETED|7-day Washout Period 1||0
11053601|NCT00980200|12234821|FG001|NOT COMPLETED|7-day Washout Period 1||0
11053602|NCT00980200|12234822|FG002|NOT COMPLETED|7-day Washout Period 1||0
11053603|NCT00980200|12234823|FG003|NOT COMPLETED|7-day Washout Period 1||0
11053604|NCT00980200|12234824|FG004|NOT COMPLETED|7-day Washout Period 1||0
11053605|NCT00980200|12234820|FG000|STARTED|7-day Treatment Period 2||15
11053606|NCT00980200|12234821|FG001|STARTED|7-day Treatment Period 2||13
11053607|NCT00980200|12234822|FG002|STARTED|7-day Treatment Period 2||15
11053608|NCT00980200|12234823|FG003|STARTED|7-day Treatment Period 2||16
11053609|NCT00980200|12234824|FG004|STARTED|7-day Treatment Period 2||15
11053610|NCT00980200|12234820|FG000|COMPLETED|7-day Treatment Period 2||15
11053611|NCT00980200|12234821|FG001|COMPLETED|7-day Treatment Period 2||13
11053612|NCT00980200|12234822|FG002|COMPLETED|7-day Treatment Period 2||15
11053613|NCT00980200|12234823|FG003|COMPLETED|7-day Treatment Period 2||16
11053614|NCT00980200|12234824|FG004|COMPLETED|7-day Treatment Period 2||15
11053615|NCT00980200|12234820|FG000|NOT COMPLETED|7-day Treatment Period 2||0
11053616|NCT00980200|12234821|FG001|NOT COMPLETED|7-day Treatment Period 2||0
11053617|NCT00980200|12234822|FG002|NOT COMPLETED|7-day Treatment Period 2||0
11053618|NCT00980200|12234823|FG003|NOT COMPLETED|7-day Treatment Period 2||0
11053619|NCT00980200|12234824|FG004|NOT COMPLETED|7-day Treatment Period 2||0
11053620|NCT00980200|12234820|FG000|STARTED|7-day Washout Period 2||15
11053621|NCT00980200|12234821|FG001|STARTED|7-day Washout Period 2||13
11053622|NCT00980200|12234822|FG002|STARTED|7-day Washout Period 2||15
11053623|NCT00980200|12234823|FG003|STARTED|7-day Washout Period 2||16
11053624|NCT00980200|12234824|FG004|STARTED|7-day Washout Period 2||15
11053625|NCT00980200|12234820|FG000|COMPLETED|7-day Washout Period 2||15
11053626|NCT00980200|12234821|FG001|COMPLETED|7-day Washout Period 2||13
11053627|NCT00980200|12234822|FG002|COMPLETED|7-day Washout Period 2||15
11053628|NCT00980200|12234823|FG003|COMPLETED|7-day Washout Period 2||16
11053629|NCT00980200|12234824|FG004|COMPLETED|7-day Washout Period 2||15
11053630|NCT00980200|12234820|FG000|NOT COMPLETED|7-day Washout Period 2||0
11201611|NCT01833481|12391915|FG002|NOT COMPLETED|Overall Study||0
11201612|NCT01833494|12391923|FG000|STARTED|Overall Study||161
11201613|NCT01833494|12391923|FG000|COMPLETED|Overall Study||116
11201614|NCT01833494|12391923|FG000|NOT COMPLETED|Overall Study||45
11053631|NCT00980200|12234821|FG001|NOT COMPLETED|7-day Washout Period 2||0
11201615|NCT01833520|12391929|FG000|STARTED|Overall Study||3
11201616|NCT01833520|12391930|FG001|STARTED|Overall Study||3
11201617|NCT01833520|12391931|FG002|STARTED|Overall Study||9
11201618|NCT01833520|12391932|FG003|STARTED|Overall Study||3
11201619|NCT01833520|12391929|FG000|COMPLETED|Overall Study||0
11201620|NCT01833520|12391930|FG001|COMPLETED|Overall Study||0
11201621|NCT01833520|12391931|FG002|COMPLETED|Overall Study||1
11201622|NCT01833520|12391932|FG003|COMPLETED|Overall Study||0
11201623|NCT01833520|12391929|FG000|NOT COMPLETED|Overall Study||3
11201624|NCT01833520|12391930|FG001|NOT COMPLETED|Overall Study||3
11201625|NCT01833520|12391931|FG002|NOT COMPLETED|Overall Study||8
11201626|NCT01833520|12391932|FG003|NOT COMPLETED|Overall Study||3
11201627|NCT01833533|12391946|FG000|STARTED|Overall Study||100
11201628|NCT01833533|12391947|FG001|STARTED|Overall Study||205
11201629|NCT01833533|12391946|FG000|COMPLETED|Overall Study||94
11201630|NCT01833533|12391947|FG001|COMPLETED|Overall Study||184
11201631|NCT01833533|12391946|FG000|NOT COMPLETED|Overall Study||6
11201632|NCT01833533|12391947|FG001|NOT COMPLETED|Overall Study||21
11201633|NCT01833546|12391957|FG000|STARTED|Overall Study||3
11201634|NCT01833546|12391958|FG001|STARTED|Overall Study||3
11201635|NCT01833546|12391959|FG002|STARTED|Overall Study||8
11201636|NCT01833546|12391960|FG003|STARTED|Overall Study||6
11201637|NCT01833546|12391957|FG000|COMPLETED|Overall Study||3
11201638|NCT01833546|12391958|FG001|COMPLETED|Overall Study||3
11201639|NCT01833546|12391959|FG002|COMPLETED|Overall Study||8
11201640|NCT01833546|12391960|FG003|COMPLETED|Overall Study||6
11201641|NCT01833546|12391957|FG000|NOT COMPLETED|Overall Study||0
11201642|NCT01833546|12391958|FG001|NOT COMPLETED|Overall Study||0
11201643|NCT01833546|12391959|FG002|NOT COMPLETED|Overall Study||0
11201644|NCT01833546|12391960|FG003|NOT COMPLETED|Overall Study||0
11201645|NCT01833741|12391971|FG000|STARTED|Overall Study||1137
11201646|NCT01833741|12391971|FG000|COMPLETED|Overall Study||997
11201647|NCT01833741|12391971|FG000|NOT COMPLETED|Overall Study||140
11201648|NCT01833832|12391975|FG000|STARTED|Overall Study||11
11201649|NCT01833832|12391975|FG000|COMPLETED|Overall Study||10
11201650|NCT01833832|12391975|FG000|NOT COMPLETED|Overall Study||1
11201651|NCT01833845|12391979|FG000|STARTED|Overall Study||4
11201652|NCT01833845|12391979|FG000|COMPLETED|Overall Study||4
11201653|NCT01833845|12391979|FG000|NOT COMPLETED|Overall Study||0
11201654|NCT01833897|12391983|FG000|STARTED|Overall Study||8
11201655|NCT01833897|12391983|FG000|COMPLETED|Overall Study||7
11201656|NCT01833897|12391983|FG000|NOT COMPLETED|Overall Study||1
11201657|NCT01833936|12391989|FG000|STARTED|Overall Study||20
11201658|NCT01833936|12391990|FG001|STARTED|Overall Study||20
11201659|NCT01833936|12391989|FG000|COMPLETED|Overall Study||16
11201660|NCT01833936|12391990|FG001|COMPLETED|Overall Study||18
11201661|NCT01833936|12391989|FG000|NOT COMPLETED|Overall Study||4
11201662|NCT01833936|12391990|FG001|NOT COMPLETED|Overall Study||2
11201663|NCT01833988|12391996|FG000|STARTED|Overall Study||16
11201664|NCT01833988|12391997|FG001|STARTED|Overall Study||16
11201665|NCT01833988|12391996|FG000|COMPLETED|Overall Study||16
11201666|NCT01833988|12391997|FG001|COMPLETED|Overall Study||16
11201667|NCT01833988|12391996|FG000|NOT COMPLETED|Overall Study||0
11201668|NCT01833988|12391997|FG001|NOT COMPLETED|Overall Study||0
11201669|NCT01834027|12392010|FG000|STARTED|Overall Study||28
11201670|NCT01834027|12392011|FG001|STARTED|Overall Study||28
11201671|NCT01834027|12392010|FG000|COMPLETED|Overall Study||28
11201672|NCT01834027|12392011|FG001|COMPLETED|Overall Study||28
11201673|NCT01834027|12392010|FG000|NOT COMPLETED|Overall Study||0
11201674|NCT01834027|12392011|FG001|NOT COMPLETED|Overall Study||0
11201675|NCT01834222|12392017|FG000|STARTED|Overall Study||659
11053632|NCT00980200|12234822|FG002|NOT COMPLETED|7-day Washout Period 2||0
11053633|NCT00980200|12234823|FG003|NOT COMPLETED|7-day Washout Period 2||0
11053634|NCT00980200|12234824|FG004|NOT COMPLETED|7-day Washout Period 2||0
11053635|NCT00980200|12234820|FG000|STARTED|7-day Treatment Period 3||15
11053636|NCT00980200|12234821|FG001|STARTED|7-day Treatment Period 3||13
11053637|NCT00980200|12234822|FG002|STARTED|7-day Treatment Period 3||15
11053638|NCT00980200|12234823|FG003|STARTED|7-day Treatment Period 3||16
11053639|NCT00980200|12234824|FG004|STARTED|7-day Treatment Period 3||15
11053640|NCT00980200|12234820|FG000|COMPLETED|7-day Treatment Period 3||15
11053641|NCT00980200|12234821|FG001|COMPLETED|7-day Treatment Period 3||12
11053642|NCT00980200|12234822|FG002|COMPLETED|7-day Treatment Period 3||15
11053643|NCT00980200|12234823|FG003|COMPLETED|7-day Treatment Period 3||16
11053644|NCT00980200|12234824|FG004|COMPLETED|7-day Treatment Period 3||14
11053645|NCT00980200|12234820|FG000|NOT COMPLETED|7-day Treatment Period 3||0
11053646|NCT00980200|12234821|FG001|NOT COMPLETED|7-day Treatment Period 3||1
11053647|NCT00980200|12234822|FG002|NOT COMPLETED|7-day Treatment Period 3||0
11053648|NCT00980200|12234823|FG003|NOT COMPLETED|7-day Treatment Period 3||0
11053649|NCT00980200|12234824|FG004|NOT COMPLETED|7-day Treatment Period 3||1
11053650|NCT00980200|12234820|FG000|STARTED|7-day Washout Period 3||15
11053651|NCT00980200|12234821|FG001|STARTED|7-day Washout Period 3||12
11053652|NCT00980200|12234822|FG002|STARTED|7-day Washout Period 3||15
11053653|NCT00980200|12234823|FG003|STARTED|7-day Washout Period 3||16
11053654|NCT00980200|12234824|FG004|STARTED|7-day Washout Period 3||14
11053655|NCT00980200|12234820|FG000|COMPLETED|7-day Washout Period 3||15
11053656|NCT00980200|12234821|FG001|COMPLETED|7-day Washout Period 3||12
11053657|NCT00980200|12234822|FG002|COMPLETED|7-day Washout Period 3||15
11053658|NCT00980200|12234823|FG003|COMPLETED|7-day Washout Period 3||16
11053659|NCT00980200|12234824|FG004|COMPLETED|7-day Washout Period 3||14
11053660|NCT00980200|12234820|FG000|NOT COMPLETED|7-day Washout Period 3||0
11053661|NCT00980200|12234821|FG001|NOT COMPLETED|7-day Washout Period 3||0
11053662|NCT00980200|12234822|FG002|NOT COMPLETED|7-day Washout Period 3||0
11053663|NCT00980200|12234823|FG003|NOT COMPLETED|7-day Washout Period 3||0
11053664|NCT00980200|12234824|FG004|NOT COMPLETED|7-day Washout Period 3||0
11053665|NCT00980200|12234820|FG000|STARTED|7-day Treatment Period 4||15
11053666|NCT00980200|12234821|FG001|STARTED|7-day Treatment Period 4||12
11053667|NCT00980200|12234822|FG002|STARTED|7-day Treatment Period 4||15
11053668|NCT00980200|12234823|FG003|STARTED|7-day Treatment Period 4||16
11053669|NCT00980200|12234824|FG004|STARTED|7-day Treatment Period 4||14
11053670|NCT00980200|12234820|FG000|COMPLETED|7-day Treatment Period 4||15
11053671|NCT00980200|12234821|FG001|COMPLETED|7-day Treatment Period 4||12
11201676|NCT01834222|12392017|FG000|Treated|Overall Study||658
11201677|NCT01834222|12392017|FG000|COMPLETED|Overall Study||658
11201678|NCT01834222|12392017|FG000|NOT COMPLETED|Overall Study||1
11201679|NCT01834261|12392023|FG000|STARTED|MIT fMRI and MEG Resting State Study||11
11053672|NCT00980200|12234822|FG002|COMPLETED|7-day Treatment Period 4||15
11053673|NCT00980200|12234823|FG003|COMPLETED|7-day Treatment Period 4||16
11053674|NCT00980200|12234824|FG004|COMPLETED|7-day Treatment Period 4||14
11053675|NCT00980200|12234820|FG000|NOT COMPLETED|7-day Treatment Period 4||0
11053676|NCT00980200|12234821|FG001|NOT COMPLETED|7-day Treatment Period 4||0
11053677|NCT00980200|12234822|FG002|NOT COMPLETED|7-day Treatment Period 4||0
11053678|NCT00980200|12234823|FG003|NOT COMPLETED|7-day Treatment Period 4||0
11053679|NCT00980200|12234824|FG004|NOT COMPLETED|7-day Treatment Period 4||0
11053680|NCT00980200|12234820|FG000|STARTED|7-day Washout Period 4||15
11053681|NCT00980200|12234821|FG001|STARTED|7-day Washout Period 4||12
11053682|NCT00980200|12234822|FG002|STARTED|7-day Washout Period 4||15
11053683|NCT00980200|12234823|FG003|STARTED|7-day Washout Period 4||16
11053684|NCT00980200|12234824|FG004|STARTED|7-day Washout Period 4||14
11053685|NCT00980200|12234820|FG000|COMPLETED|7-day Washout Period 4||15
11053686|NCT00980200|12234821|FG001|COMPLETED|7-day Washout Period 4||12
11053687|NCT00980200|12234822|FG002|COMPLETED|7-day Washout Period 4||15
11053688|NCT00980200|12234823|FG003|COMPLETED|7-day Washout Period 4||16
11053689|NCT00980200|12234824|FG004|COMPLETED|7-day Washout Period 4||14
11053690|NCT00980200|12234820|FG000|NOT COMPLETED|7-day Washout Period 4||0
11053691|NCT00980200|12234821|FG001|NOT COMPLETED|7-day Washout Period 4||0
11053692|NCT00980200|12234822|FG002|NOT COMPLETED|7-day Washout Period 4||0
11053693|NCT00980200|12234823|FG003|NOT COMPLETED|7-day Washout Period 4||0
11053694|NCT00980200|12234824|FG004|NOT COMPLETED|7-day Washout Period 4||0
11053695|NCT00980200|12234820|FG000|STARTED|7-day Treatment Period 5||15
11053696|NCT00980200|12234821|FG001|STARTED|7-day Treatment Period 5||12
11053697|NCT00980200|12234822|FG002|STARTED|7-day Treatment Period 5||15
11053698|NCT00980200|12234823|FG003|STARTED|7-day Treatment Period 5||16
11053699|NCT00980200|12234824|FG004|STARTED|7-day Treatment Period 5||14
11338402|NCT02903836|12535986|FG001|NOT COMPLETED|Overall Study||4
11338403|NCT02903836|12535987|FG002|NOT COMPLETED|Overall Study||4
11338404|NCT02903966|12535997|FG000|STARTED|Part A (Day 1 to 43)||12
11338405|NCT02903966|12535998|FG001|STARTED|Part A (Day 1 to 43)||24
11338406|NCT02903966|12535997|FG000|COMPLETED|Part A (Day 1 to 43)||11
11338407|NCT02903966|12535998|FG001|COMPLETED|Part A (Day 1 to 43)||24
11338408|NCT02903966|12535997|FG000|NOT COMPLETED|Part A (Day 1 to 43)||1
11338409|NCT02903966|12535998|FG001|NOT COMPLETED|Part A (Day 1 to 43)||0
11338410|NCT02903966|12535997|FG000|STARTED|Part B (Day 44 to 112)||11
11338411|NCT02903966|12535998|FG001|STARTED|Part B (Day 44 to 112)||24
11338412|NCT02903966|12535997|FG000|COMPLETED|Part B (Day 44 to 112)||11
11338413|NCT02903966|12535998|FG001|COMPLETED|Part B (Day 44 to 112)||22
11338414|NCT02903966|12535997|FG000|NOT COMPLETED|Part B (Day 44 to 112)||0
11338415|NCT02903966|12535998|FG001|NOT COMPLETED|Part B (Day 44 to 112)||2
11338416|NCT02904057|12536012|FG000|STARTED|Overall Study||19
11338417|NCT02904057|12536013|FG001|STARTED|Overall Study||10
11053700|NCT00980200|12234820|FG000|COMPLETED|7-day Treatment Period 5||15
11053701|NCT00980200|12234821|FG001|COMPLETED|7-day Treatment Period 5||12
11053702|NCT00980200|12234822|FG002|COMPLETED|7-day Treatment Period 5||15
11053703|NCT00980200|12234823|FG003|COMPLETED|7-day Treatment Period 5||16
11053704|NCT00980200|12234824|FG004|COMPLETED|7-day Treatment Period 5||14
11053705|NCT00980200|12234820|FG000|NOT COMPLETED|7-day Treatment Period 5||0
11053706|NCT00980200|12234821|FG001|NOT COMPLETED|7-day Treatment Period 5||0
11053707|NCT00980200|12234822|FG002|NOT COMPLETED|7-day Treatment Period 5||0
11053708|NCT00980200|12234823|FG003|NOT COMPLETED|7-day Treatment Period 5||0
11053709|NCT00980200|12234824|FG004|NOT COMPLETED|7-day Treatment Period 5||0
11053710|NCT00980278|12234838|FG000|STARTED|Overall Study||13
11053711|NCT00980278|12234839|FG001|STARTED|Overall Study||13
11053712|NCT00980278|12234838|FG000|COMPLETED|Overall Study||11
11053713|NCT00980278|12234839|FG001|COMPLETED|Overall Study||13
11053714|NCT00980278|12234838|FG000|NOT COMPLETED|Overall Study||2
11053715|NCT00980278|12234839|FG001|NOT COMPLETED|Overall Study||0
11053716|NCT00980330|12234852|FG000|STARTED|Overall Study||66
11053717|NCT00980330|12234853|FG001|STARTED|Overall Study||65
11053718|NCT00980330|12234854|FG002|STARTED|Overall Study||66
11053719|NCT00980330|12234855|FG003|STARTED|Overall Study||66
11053720|NCT00980330|12234856|FG004|STARTED|Overall Study||68
11053721|NCT00980330|12234857|FG005|STARTED|Overall Study||65
11053722|NCT00980330|12234858|FG006|STARTED|Overall Study||66
11053723|NCT00980330|12234852|FG000|COMPLETED|Overall Study||61
11053724|NCT00980330|12234853|FG001|COMPLETED|Overall Study||60
11053725|NCT00980330|12234854|FG002|COMPLETED|Overall Study||58
11338418|NCT02904057|12536012|FG000|COMPLETED|Overall Study||19
11338419|NCT02904057|12536013|FG001|COMPLETED|Overall Study||10
11338420|NCT02904057|12536012|FG000|NOT COMPLETED|Overall Study||0
11338421|NCT02904057|12536013|FG001|NOT COMPLETED|Overall Study||0
11338422|NCT02904096|12536021|FG000|STARTED|Overall Study||130
11338423|NCT02904096|12536022|FG001|STARTED|Overall Study||126
11338424|NCT02904096|12536021|FG000|COMPLETED|Overall Study||111
11338425|NCT02904096|12536022|FG001|COMPLETED|Overall Study||105
11338426|NCT02904096|12536021|FG000|NOT COMPLETED|Overall Study||19
11338427|NCT02904096|12536022|FG001|NOT COMPLETED|Overall Study||21
11338428|NCT02904200|12536028|FG000|STARTED|Overall Study|One pat. early terminated on own decision, due to travelling distance between home and hospital.|2
11338429|NCT02904200|12536029|FG001|STARTED|Overall Study|No statistical evaluation was performed because only 2 subjects were included in one arm.|0
11338430|NCT02904200|12536028|FG000|COMPLETED|Overall Study||1
11338431|NCT02904200|12536029|FG001|COMPLETED|Overall Study||0
11338432|NCT02904200|12536028|FG000|NOT COMPLETED|Overall Study||1
11338433|NCT02904200|12536029|FG001|NOT COMPLETED|Overall Study||0
11338434|NCT02904226|12536041|FG000|STARTED|Overall Study||40
11338435|NCT02904226|12536042|FG001|STARTED|Overall Study||31
11338436|NCT02904226|12536043|FG002|STARTED|Overall Study||30
11338437|NCT02904226|12536044|FG003|STARTED|Overall Study||100
11338438|NCT02904226|12536045|FG004|STARTED|Overall Study||11
11338439|NCT02904226|12536046|FG005|STARTED|Overall Study||0
11338440|NCT02904226|12536047|FG006|STARTED|Overall Study||6
11338441|NCT02904226|12536048|FG007|STARTED|Overall Study||0
11338442|NCT02904226|12536041|FG000|COMPLETED|Overall Study||0
11338443|NCT02904226|12536042|FG001|COMPLETED|Overall Study||2
11338444|NCT02904226|12536043|FG002|COMPLETED|Overall Study||0
11338445|NCT02904226|12536044|FG003|COMPLETED|Overall Study||4
11338446|NCT02904226|12536045|FG004|COMPLETED|Overall Study||0
11338447|NCT02904226|12536046|FG005|COMPLETED|Overall Study||0
11338448|NCT02904226|12536047|FG006|COMPLETED|Overall Study||0
11338449|NCT02904226|12536048|FG007|COMPLETED|Overall Study||0
11338450|NCT02904226|12536041|FG000|NOT COMPLETED|Overall Study||40
11338451|NCT02904226|12536042|FG001|NOT COMPLETED|Overall Study||29
11338452|NCT02904226|12536043|FG002|NOT COMPLETED|Overall Study||30
11338453|NCT02904226|12536044|FG003|NOT COMPLETED|Overall Study||96
11338454|NCT02904226|12536045|FG004|NOT COMPLETED|Overall Study||11
11338455|NCT02904226|12536046|FG005|NOT COMPLETED|Overall Study||0
11338456|NCT02904226|12536047|FG006|NOT COMPLETED|Overall Study||6
11338457|NCT02904226|12536048|FG007|NOT COMPLETED|Overall Study||0
11338458|NCT02904265|12536066|FG000|STARTED|Overall Study|Study closed due to only 3 participants recruited|1
11338459|NCT02904265|12536067|FG001|STARTED|Overall Study|Study closed due to only 3 participants recruited|2
11338460|NCT02904265|12536066|FG000|COMPLETED|Overall Study||0
11338461|NCT02904265|12536067|FG001|COMPLETED|Overall Study||0
11338462|NCT02904265|12536066|FG000|NOT COMPLETED|Overall Study||1
11338463|NCT02904265|12536067|FG001|NOT COMPLETED|Overall Study||2
11338464|NCT02904512|12536075|FG000|STARTED|Overall Study||9
11053726|NCT00980330|12234855|FG003|COMPLETED|Overall Study||61
11053727|NCT00980330|12234856|FG004|COMPLETED|Overall Study||63
11053728|NCT00980330|12234857|FG005|COMPLETED|Overall Study||61
11053729|NCT00980330|12234858|FG006|COMPLETED|Overall Study||59
11053730|NCT00980330|12234852|FG000|NOT COMPLETED|Overall Study||5
11338465|NCT02904512|12536076|FG001|STARTED|Overall Study||7
11338466|NCT02904512|12536075|FG000|COMPLETED|Overall Study||6
11338467|NCT02904512|12536076|FG001|COMPLETED|Overall Study||7
11338468|NCT02904512|12536075|FG000|NOT COMPLETED|Overall Study||3
11338469|NCT02904512|12536076|FG001|NOT COMPLETED|Overall Study||0
11338470|NCT02904902|12536082|FG000|STARTED|Overall Study||15
11338471|NCT02904902|12536082|FG000|COMPLETED|Overall Study||14
11338472|NCT02904902|12536082|FG000|NOT COMPLETED|Overall Study||1
11338473|NCT02904915|12536088|FG000|STARTED|Overall Study||25
11338474|NCT02904915|12536089|FG001|STARTED|Overall Study||25
11053731|NCT00980330|12234853|FG001|NOT COMPLETED|Overall Study||5
11053732|NCT00980330|12234854|FG002|NOT COMPLETED|Overall Study||8
11053733|NCT00980330|12234855|FG003|NOT COMPLETED|Overall Study||5
11053734|NCT00980330|12234856|FG004|NOT COMPLETED|Overall Study||5
11053735|NCT00980330|12234857|FG005|NOT COMPLETED|Overall Study||4
11053736|NCT00980330|12234858|FG006|NOT COMPLETED|Overall Study||7
11053737|NCT00980343|12234877|FG000|STARTED|Overall Study||21
11053738|NCT00980343|12234878|FG001|STARTED|Overall Study||23
11053739|NCT00980343|12234877|FG000|COMPLETED|Overall Study||20
11053740|NCT00980343|12234878|FG001|COMPLETED|Overall Study||20
11053741|NCT00980343|12234877|FG000|NOT COMPLETED|Overall Study||1
11053742|NCT00980343|12234878|FG001|NOT COMPLETED|Overall Study||3
11053743|NCT00980395|12234885|FG000|STARTED|Overall Study||24
11053744|NCT00980395|12234885|FG000|COMPLETED|Overall Study||24
11053745|NCT00980395|12234885|FG000|NOT COMPLETED|Overall Study||0
11053746|NCT00980590|12234891|FG000|STARTED|Overall Study||50
11053747|NCT00980590|12234892|FG001|STARTED|Overall Study||50
11053748|NCT00980590|12234891|FG000|COMPLETED|Overall Study||50
11053749|NCT00980590|12234892|FG001|COMPLETED|Overall Study||50
11053750|NCT00980590|12234891|FG000|NOT COMPLETED|Overall Study||0
11053751|NCT00980590|12234892|FG001|NOT COMPLETED|Overall Study||0
11053752|NCT00980642|12234900|FG000|STARTED|Overall Study||36
11053753|NCT00980642|12234901|FG001|STARTED|Overall Study||20
11053754|NCT00980642|12234900|FG000|COMPLETED|Overall Study||36
11053755|NCT00980642|12234901|FG001|COMPLETED|Overall Study||20
11053756|NCT00980642|12234900|FG000|NOT COMPLETED|Overall Study||0
11053757|NCT00980642|12234901|FG001|NOT COMPLETED|Overall Study||0
11053758|NCT00980655|12234910|FG000|STARTED|Overall Study||61
11053759|NCT00980655|12234911|FG001|STARTED|Overall Study||190
11053760|NCT00980655|12234910|FG000|Vaccinated 13vPnC Dose 1|Overall Study||59
11053761|NCT00980655|12234911|FG001|Vaccinated 13vPnC Dose 1|Overall Study||188
11053762|NCT00980655|12234910|FG000|Vaccinated 13vPnC Dose 2|Overall Study||55
11053763|NCT00980655|12234911|FG001|Vaccinated 13vPnC Dose 2|Overall Study||176
11053764|NCT00980655|12234910|FG000|Vaccinated 13vPnC Dose 3|Overall Study||54
11053765|NCT00980655|12234911|FG001|Vaccinated 13vPnC Dose 3|Overall Study||167
11053766|NCT00980655|12234910|FG000|Vaccinated 13vPnC Dose 4|Overall Study||46
11053767|NCT00980655|12234911|FG001|Vaccinated 13vPnC Dose 4|Overall Study||146
11053768|NCT00980655|12234910|FG000|Vaccinated 23vPS Dose|Overall Study||45
11053769|NCT00980655|12234911|FG001|Vaccinated 23vPS Dose|Overall Study||140
11053770|NCT00980655|12234910|FG000|COMPLETED|Overall Study||45
11053771|NCT00980655|12234911|FG001|COMPLETED|Overall Study||139
11053772|NCT00980655|12234910|FG000|NOT COMPLETED|Overall Study||16
11053773|NCT00980655|12234911|FG001|NOT COMPLETED|Overall Study||51
11053774|NCT00980681|12234922|FG000|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
11053775|NCT00980681|12234922|FG000|COMPLETED|TOF MRA||10
11053776|NCT00980681|12234922|FG000|NOT COMPLETED|TOF MRA||0
11053777|NCT00980681|12234922|FG000|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
11053778|NCT00980681|12234922|FG000|COMPLETED|Dotarem MRA||10
11053779|NCT00980681|12234922|FG000|NOT COMPLETED|Dotarem MRA||0
11053780|NCT00980746|12234934|FG000|STARTED|Overall Study||85
11053781|NCT00980746|12234935|FG001|STARTED|Overall Study||89
11053782|NCT00980746|12234936|FG002|STARTED|Overall Study||95
11053783|NCT00980746|12234937|FG003|STARTED|Overall Study||100
11053784|NCT00980746|12234938|FG004|STARTED|Overall Study||92
11053785|NCT00980746|12234939|FG005|STARTED|Overall Study||96
11053786|NCT00980746|12234934|FG000|Randomized|Overall Study||85
11053787|NCT00980746|12234935|FG001|Randomized|Overall Study||89
11053788|NCT00980746|12234936|FG002|Randomized|Overall Study||95
11053789|NCT00980746|12234937|FG003|Randomized|Overall Study||100
11053790|NCT00980746|12234938|FG004|Randomized|Overall Study||92
11053791|NCT00980746|12234939|FG005|Randomized|Overall Study||96
11053792|NCT00980746|12234934|FG000|Safety Population|Overall Study||85
11053793|NCT00980746|12234935|FG001|Safety Population|Overall Study||89
11053794|NCT00980746|12234936|FG002|Safety Population|Overall Study||95
11053795|NCT00980746|12234937|FG003|Safety Population|Overall Study||100
11053796|NCT00980746|12234938|FG004|Safety Population|Overall Study||92
11053797|NCT00980746|12234939|FG005|Safety Population|Overall Study||96
11053798|NCT00980746|12234934|FG000|Per-protocol|Overall Study||55
11053799|NCT00980746|12234935|FG001|Per-protocol|Overall Study||66
11053800|NCT00980746|12234936|FG002|Per-protocol|Overall Study||73
11053801|NCT00980746|12234937|FG003|Per-protocol|Overall Study||62
11053802|NCT00980746|12234938|FG004|Per-protocol|Overall Study||73
11053803|NCT00980746|12234939|FG005|Per-protocol|Overall Study||74
11053804|NCT00980746|12234934|FG000|COMPLETED|Overall Study||58
11053805|NCT00980746|12234935|FG001|COMPLETED|Overall Study||67
11053806|NCT00980746|12234936|FG002|COMPLETED|Overall Study||75
11053807|NCT00980746|12234937|FG003|COMPLETED|Overall Study||64
11053808|NCT00980746|12234938|FG004|COMPLETED|Overall Study||75
11053809|NCT00980746|12234939|FG005|COMPLETED|Overall Study||78
11053810|NCT00980746|12234934|FG000|NOT COMPLETED|Overall Study||27
11053811|NCT00980746|12234935|FG001|NOT COMPLETED|Overall Study||22
11053812|NCT00980746|12234936|FG002|NOT COMPLETED|Overall Study||20
11053813|NCT00980746|12234937|FG003|NOT COMPLETED|Overall Study||36
11053814|NCT00980746|12234938|FG004|NOT COMPLETED|Overall Study||17
11053815|NCT00980746|12234939|FG005|NOT COMPLETED|Overall Study||18
11053816|NCT00980785|12234955|FG000|STARTED|Overall Study||6
11053817|NCT00980785|12234956|FG001|STARTED|Overall Study||8
11053818|NCT00980785|12234955|FG000|COMPLETED|Overall Study||6
11053819|NCT00980785|12234956|FG001|COMPLETED|Overall Study||8
11053820|NCT00980785|12234955|FG000|NOT COMPLETED|Overall Study||0
11053821|NCT00980785|12234956|FG001|NOT COMPLETED|Overall Study||0
11053822|NCT00980798|12234964|FG000|STARTED|Overall Study||149
11053823|NCT00980798|12234965|FG001|STARTED|Overall Study||139
11053824|NCT00980798|12234964|FG000|COMPLETED|Overall Study||116
11053825|NCT00980798|12234965|FG001|COMPLETED|Overall Study||84
11053826|NCT00980798|12234964|FG000|NOT COMPLETED|Overall Study||33
11053827|NCT00980798|12234965|FG001|NOT COMPLETED|Overall Study||55
11053828|NCT00980980|12234974|FG000|STARTED|Overall Study||16
11053829|NCT00980980|12234975|FG001|STARTED|Overall Study||14
11053830|NCT00980980|12234976|FG002|STARTED|Overall Study||13
11053831|NCT00980980|12234974|FG000|COMPLETED|Overall Study||16
11053832|NCT00980980|12234975|FG001|COMPLETED|Overall Study||13
11053833|NCT00980980|12234976|FG002|COMPLETED|Overall Study||13
11053834|NCT00980980|12234974|FG000|NOT COMPLETED|Overall Study||0
11053835|NCT00980980|12234975|FG001|NOT COMPLETED|Overall Study||1
11053836|NCT00980980|12234976|FG002|NOT COMPLETED|Overall Study||0
11053837|NCT00981019|12234987|FG000|STARTED|Overall Study||778
11053838|NCT00981019|12234987|FG000|COMPLETED|Overall Study||301
11053839|NCT00981019|12234987|FG000|NOT COMPLETED|Overall Study||477
11053840|NCT00981045|12234993|FG000|STARTED|Overall Study||1290
11053841|NCT00981045|12234994|FG001|STARTED|Overall Study||1294
11053842|NCT00981045|12234993|FG000|COMPLETED|Overall Study||1276
11053843|NCT00981045|12234994|FG001|COMPLETED|Overall Study||1285
11053844|NCT00981045|12234993|FG000|NOT COMPLETED|Overall Study||14
11053845|NCT00981045|12234994|FG001|NOT COMPLETED|Overall Study||9
11053846|NCT00981084|12235002|FG000|STARTED|First Intervention (One Day)||16
11053847|NCT00981084|12235003|FG001|STARTED|First Intervention (One Day)||17
11053848|NCT00981084|12235002|FG000|COMPLETED|First Intervention (One Day)||16
11053849|NCT00981084|12235003|FG001|COMPLETED|First Intervention (One Day)||17
11053850|NCT00981084|12235002|FG000|NOT COMPLETED|First Intervention (One Day)||0
11053851|NCT00981084|12235003|FG001|NOT COMPLETED|First Intervention (One Day)||0
11053852|NCT00981084|12235002|FG000|STARTED|Washout Period (7 Days)||16
11053853|NCT00981084|12235003|FG001|STARTED|Washout Period (7 Days)||17
11053854|NCT00981084|12235002|FG000|COMPLETED|Washout Period (7 Days)||16
11053855|NCT00981084|12235003|FG001|COMPLETED|Washout Period (7 Days)||17
11053856|NCT00981084|12235002|FG000|NOT COMPLETED|Washout Period (7 Days)||0
11053857|NCT00981084|12235003|FG001|NOT COMPLETED|Washout Period (7 Days)||0
11053858|NCT00981084|12235002|FG000|STARTED|Second Intervention (One Day)||16
11053859|NCT00981084|12235003|FG001|STARTED|Second Intervention (One Day)||17
11053860|NCT00981084|12235002|FG000|COMPLETED|Second Intervention (One Day)||16
11053861|NCT00981084|12235003|FG001|COMPLETED|Second Intervention (One Day)||17
11053862|NCT00981084|12235002|FG000|NOT COMPLETED|Second Intervention (One Day)||0
11053863|NCT00981084|12235003|FG001|NOT COMPLETED|Second Intervention (One Day)||0
11053864|NCT00981084|12235002|FG000|STARTED|Post Intervention (Data Analysis)||16
11053865|NCT00981084|12235003|FG001|STARTED|Post Intervention (Data Analysis)||17
11053866|NCT00981084|12235002|FG000|COMPLETED|Post Intervention (Data Analysis)||14
11053867|NCT00981084|12235003|FG001|COMPLETED|Post Intervention (Data Analysis)||16
11053868|NCT00981084|12235002|FG000|NOT COMPLETED|Post Intervention (Data Analysis)||2
11053869|NCT00981084|12235003|FG001|NOT COMPLETED|Post Intervention (Data Analysis)||1
11053870|NCT00981149|12235013|FG000|STARTED|Overall Study||12
11053871|NCT00981149|12235014|FG001|STARTED|Overall Study||12
11053872|NCT00981149|12235013|FG000|COMPLETED|Overall Study||10
11053873|NCT00981149|12235014|FG001|COMPLETED|Overall Study||9
11053874|NCT00981149|12235013|FG000|NOT COMPLETED|Overall Study||2
11053875|NCT00981149|12235014|FG001|NOT COMPLETED|Overall Study||3
11053876|NCT00981175|12235023|FG000|STARTED|Primary Dose Vaccination||101
11053877|NCT00981175|12235024|FG001|STARTED|Primary Dose Vaccination||101
11053878|NCT00981175|12235023|FG000|COMPLETED|Primary Dose Vaccination||98
11053879|NCT00981175|12235024|FG001|COMPLETED|Primary Dose Vaccination||99
11053880|NCT00981175|12235023|FG000|NOT COMPLETED|Primary Dose Vaccination||3
11053881|NCT00981175|12235024|FG001|NOT COMPLETED|Primary Dose Vaccination||2
11053882|NCT00981175|12235023|FG000|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
11053883|NCT00981175|12235024|FG001|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
11053884|NCT00981175|12235023|FG000|COMPLETED|Booster Dose Vaccination||53
11053885|NCT00981175|12235024|FG001|COMPLETED|Booster Dose Vaccination||40
11053886|NCT00981175|12235023|FG000|NOT COMPLETED|Booster Dose Vaccination||2
11053887|NCT00981175|12235024|FG001|NOT COMPLETED|Booster Dose Vaccination||3
11053888|NCT00981214|12235037|FG000|STARTED|Overall Study||19
11053889|NCT00981214|12235037|FG000|COMPLETED|Overall Study||19
11053890|NCT00981214|12235037|FG000|NOT COMPLETED|Overall Study||0
11053891|NCT00981227|12235047|FG000|STARTED|Overall Study||102
11053892|NCT00981227|12235048|FG001|STARTED|Overall Study||94
11053893|NCT00981227|12235049|FG002|STARTED|Overall Study||94
11053894|NCT00981227|12235050|FG003|STARTED|Overall Study||94
11053895|NCT00981227|12235051|FG004|STARTED|Overall Study||90
11053896|NCT00981227|12235052|FG005|STARTED|Overall Study||93
11053897|NCT00981227|12235047|FG000|Randomized|Overall Study||102
11053898|NCT00981227|12235048|FG001|Randomized|Overall Study||94
11053899|NCT00981227|12235049|FG002|Randomized|Overall Study||94
11053900|NCT00981227|12235050|FG003|Randomized|Overall Study||94
11053901|NCT00981227|12235051|FG004|Randomized|Overall Study||90
11053902|NCT00981227|12235052|FG005|Randomized|Overall Study||93
11053903|NCT00981227|12235047|FG000|Safety Population|Overall Study||102
11053904|NCT00981227|12235048|FG001|Safety Population|Overall Study||94
11053905|NCT00981227|12235049|FG002|Safety Population|Overall Study||94
11053906|NCT00981227|12235050|FG003|Safety Population|Overall Study||94
11053907|NCT00981227|12235051|FG004|Safety Population|Overall Study||90
11053908|NCT00981227|12235052|FG005|Safety Population|Overall Study||93
11053909|NCT00981227|12235047|FG000|Per-Protocol|Overall Study||69
11053910|NCT00981227|12235048|FG001|Per-Protocol|Overall Study||72
11053911|NCT00981227|12235049|FG002|Per-Protocol|Overall Study||67
11053912|NCT00981227|12235050|FG003|Per-Protocol|Overall Study||68
11053913|NCT00981227|12235051|FG004|Per-Protocol|Overall Study||50
11053914|NCT00981227|12235052|FG005|Per-Protocol|Overall Study||70
11053915|NCT00981227|12235047|FG000|COMPLETED|Overall Study||80
11053916|NCT00981227|12235048|FG001|COMPLETED|Overall Study||75
11053917|NCT00981227|12235049|FG002|COMPLETED|Overall Study||73
11053918|NCT00981227|12235050|FG003|COMPLETED|Overall Study||73
11053919|NCT00981227|12235051|FG004|COMPLETED|Overall Study||60
11053920|NCT00981227|12235052|FG005|COMPLETED|Overall Study||75
11053921|NCT00981227|12235047|FG000|NOT COMPLETED|Overall Study||22
11053922|NCT00981227|12235048|FG001|NOT COMPLETED|Overall Study||19
11053923|NCT00981227|12235049|FG002|NOT COMPLETED|Overall Study||21
11053924|NCT00981227|12235050|FG003|NOT COMPLETED|Overall Study||21
11053925|NCT00981227|12235051|FG004|NOT COMPLETED|Overall Study||30
11053926|NCT00981227|12235052|FG005|NOT COMPLETED|Overall Study||18
11053927|NCT00981253|12235072|FG000|STARTED|Overall Study||76
11053928|NCT00981253|12235073|FG001|STARTED|Overall Study||75
11053929|NCT00981253|12235072|FG000|COMPLETED|Overall Study||73
11053930|NCT00981253|12235073|FG001|COMPLETED|Overall Study||72
11053931|NCT00981253|12235072|FG000|NOT COMPLETED|Overall Study||3
11053932|NCT00981253|12235073|FG001|NOT COMPLETED|Overall Study||3
11053933|NCT00981292|12235086|FG000|STARTED|Day 1||7
11053934|NCT00981292|12235087|FG001|STARTED|Day 1||4
11053935|NCT00981292|12235088|FG002|STARTED|Day 1||6
11053936|NCT00981292|12235089|FG003|STARTED|Day 1||4
11053937|NCT00981292|12235090|FG004|STARTED|Day 1||4
11053938|NCT00981292|12235091|FG005|STARTED|Day 1||7
11053939|NCT00981292|12235086|FG000|COMPLETED|Day 1||6
11053940|NCT00981292|12235087|FG001|COMPLETED|Day 1||4
11053941|NCT00981292|12235088|FG002|COMPLETED|Day 1||6
11053942|NCT00981292|12235089|FG003|COMPLETED|Day 1||4
11053943|NCT00981292|12235090|FG004|COMPLETED|Day 1||4
11053944|NCT00981292|12235091|FG005|COMPLETED|Day 1||5
11053945|NCT00981292|12235086|FG000|NOT COMPLETED|Day 1||1
11053946|NCT00981292|12235087|FG001|NOT COMPLETED|Day 1||0
11053947|NCT00981292|12235088|FG002|NOT COMPLETED|Day 1||0
11053948|NCT00981292|12235089|FG003|NOT COMPLETED|Day 1||0
11053949|NCT00981292|12235090|FG004|NOT COMPLETED|Day 1||0
11053950|NCT00981292|12235091|FG005|NOT COMPLETED|Day 1||2
11053951|NCT00981292|12235086|FG000|STARTED|Day 2||6
11053952|NCT00981292|12235087|FG001|STARTED|Day 2||4
11053953|NCT00981292|12235088|FG002|STARTED|Day 2||6
11053954|NCT00981292|12235089|FG003|STARTED|Day 2||4
11053955|NCT00981292|12235090|FG004|STARTED|Day 2||4
11053956|NCT00981292|12235091|FG005|STARTED|Day 2||5
11053957|NCT00981292|12235086|FG000|COMPLETED|Day 2||4
11053958|NCT00981292|12235087|FG001|COMPLETED|Day 2||4
11053959|NCT00981292|12235088|FG002|COMPLETED|Day 2||6
11053960|NCT00981292|12235089|FG003|COMPLETED|Day 2||4
11053961|NCT00981292|12235090|FG004|COMPLETED|Day 2||4
11053962|NCT00981292|12235091|FG005|COMPLETED|Day 2||5
11053963|NCT00981292|12235086|FG000|NOT COMPLETED|Day 2||2
11053964|NCT00981292|12235087|FG001|NOT COMPLETED|Day 2||0
11053965|NCT00981292|12235088|FG002|NOT COMPLETED|Day 2||0
11053966|NCT00981292|12235089|FG003|NOT COMPLETED|Day 2||0
11053967|NCT00981292|12235090|FG004|NOT COMPLETED|Day 2||0
11053968|NCT00981292|12235091|FG005|NOT COMPLETED|Day 2||0
11053969|NCT00981292|12235086|FG000|STARTED|Day 3||4
11053970|NCT00981292|12235087|FG001|STARTED|Day 3||4
11053971|NCT00981292|12235088|FG002|STARTED|Day 3||6
11053972|NCT00981292|12235089|FG003|STARTED|Day 3||4
11053973|NCT00981292|12235090|FG004|STARTED|Day 3||4
11053974|NCT00981292|12235091|FG005|STARTED|Day 3||5
11053975|NCT00981292|12235086|FG000|COMPLETED|Day 3||4
11053976|NCT00981292|12235087|FG001|COMPLETED|Day 3||4
11053977|NCT00981292|12235088|FG002|COMPLETED|Day 3||6
11053978|NCT00981292|12235089|FG003|COMPLETED|Day 3||4
11053979|NCT00981292|12235090|FG004|COMPLETED|Day 3||4
11053980|NCT00981292|12235091|FG005|COMPLETED|Day 3||4
11053981|NCT00981292|12235086|FG000|NOT COMPLETED|Day 3||0
11053982|NCT00981292|12235087|FG001|NOT COMPLETED|Day 3||0
11053983|NCT00981292|12235088|FG002|NOT COMPLETED|Day 3||0
11053984|NCT00981292|12235089|FG003|NOT COMPLETED|Day 3||0
11053985|NCT00981292|12235090|FG004|NOT COMPLETED|Day 3||0
11053986|NCT00981292|12235091|FG005|NOT COMPLETED|Day 3||1
11053987|NCT00981305|12235105|FG000|STARTED|Overall Study||69
11053988|NCT00981305|12235106|FG001|STARTED|Overall Study||67
11053989|NCT00981305|12235105|FG000|COMPLETED|Overall Study||50
11053990|NCT00981305|12235106|FG001|COMPLETED|Overall Study||57
11053991|NCT00981305|12235105|FG000|NOT COMPLETED|Overall Study||19
11053992|NCT00981305|12235106|FG001|NOT COMPLETED|Overall Study||10
11053993|NCT00981409|12235114|FG000|STARTED|Overall Study||30
11053994|NCT00981409|12235115|FG001|STARTED|Overall Study||11
11053995|NCT00981409|12235114|FG000|COMPLETED|Overall Study||24
11053996|NCT00981409|12235115|FG001|COMPLETED|Overall Study||10
11053997|NCT00981409|12235114|FG000|NOT COMPLETED|Overall Study||6
11053998|NCT00981409|12235115|FG001|NOT COMPLETED|Overall Study||1
11053999|NCT00981435|12235124|FG000|STARTED|Overall Study||31
11054000|NCT00981435|12235125|FG001|STARTED|Overall Study||29
11054001|NCT00981435|12235126|FG002|STARTED|Overall Study||37
11054002|NCT00981435|12235124|FG000|COMPLETED|Overall Study||31
11054003|NCT00981435|12235125|FG001|COMPLETED|Overall Study||29
11054004|NCT00981435|12235126|FG002|COMPLETED|Overall Study||37
11054005|NCT00981435|12235124|FG000|NOT COMPLETED|Overall Study||0
11054006|NCT00981435|12235125|FG001|NOT COMPLETED|Overall Study||0
11054007|NCT00981435|12235126|FG002|NOT COMPLETED|Overall Study||0
11054008|NCT00981461|12235136|FG000|STARTED|Overall Study||48
11054009|NCT00981461|12235137|FG001|STARTED|Overall Study||24
11054010|NCT00981461|12235136|FG000|COMPLETED|Overall Study||43
11054011|NCT00981461|12235137|FG001|COMPLETED|Overall Study||22
11054012|NCT00981461|12235136|FG000|NOT COMPLETED|Overall Study||5
11054013|NCT00981461|12235137|FG001|NOT COMPLETED|Overall Study||2
11054014|NCT00981474|12235145|FG000|STARTED|Overall Study||228
11054015|NCT00981474|12235146|FG001|STARTED|Overall Study||232
11054016|NCT00981474|12235145|FG000|COMPLETED|Overall Study||228
11054017|NCT00981474|12235146|FG001|COMPLETED|Overall Study||232
11054018|NCT00981474|12235145|FG000|NOT COMPLETED|Overall Study||0
11054019|NCT00981474|12235146|FG001|NOT COMPLETED|Overall Study||0
11054020|NCT00981526|12235156|FG000|STARTED|Overall Study||26
11054021|NCT00981526|12235157|FG001|STARTED|Overall Study||28
11054022|NCT00981526|12235156|FG000|COMPLETED|Overall Study||22
11054023|NCT00981526|12235157|FG001|COMPLETED|Overall Study||22
11054024|NCT00981526|12235156|FG000|NOT COMPLETED|Overall Study||4
11054025|NCT00981526|12235157|FG001|NOT COMPLETED|Overall Study||6
11054026|NCT00981578|12235165|FG000|STARTED|Overall Study||17
11054027|NCT00981578|12235165|FG000|COMPLETED|Overall Study||14
11054028|NCT00981578|12235165|FG000|NOT COMPLETED|Overall Study||3
11054029|NCT00981630|12235173|FG000|STARTED|Overall Study||32
11054030|NCT00981630|12235174|FG001|STARTED|Overall Study||32
11054031|NCT00981630|12235175|FG002|STARTED|Overall Study||32
11054032|NCT00981630|12235176|FG003|STARTED|Overall Study||32
11054033|NCT00981630|12235173|FG000|COMPLETED|Overall Study||32
11054034|NCT00981630|12235174|FG001|COMPLETED|Overall Study||32
11054035|NCT00981630|12235175|FG002|COMPLETED|Overall Study||32
11054036|NCT00981630|12235176|FG003|COMPLETED|Overall Study||32
11054037|NCT00981630|12235173|FG000|NOT COMPLETED|Overall Study||0
11054038|NCT00981630|12235174|FG001|NOT COMPLETED|Overall Study||0
11054039|NCT00981630|12235175|FG002|NOT COMPLETED|Overall Study||0
11054040|NCT00981630|12235176|FG003|NOT COMPLETED|Overall Study||0
11054041|NCT00981669|12235188|FG000|STARTED|Overall Study||40
11054042|NCT00981669|12235189|FG001|STARTED|Overall Study||40
11054043|NCT00981669|12235188|FG000|COMPLETED|Overall Study||39
11054044|NCT00981669|12235189|FG001|COMPLETED|Overall Study||40
11054045|NCT00981669|12235188|FG000|NOT COMPLETED|Overall Study||1
11054046|NCT00981669|12235189|FG001|NOT COMPLETED|Overall Study||0
11054047|NCT00981682|12235195|FG000|STARTED|Overall Study||376
11054048|NCT00981682|12235195|FG000|COMPLETED|Overall Study||234
11054049|NCT00981682|12235195|FG000|NOT COMPLETED|Overall Study||142
11054050|NCT00981747|12235199|FG000|STARTED|Losartan||12
11054051|NCT00981747|12235199|FG000|Started Losartan|Losartan||12
11054052|NCT00981747|12235199|FG000|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
11054053|NCT00981747|12235199|FG000|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
11054054|NCT00981747|12235199|FG000|NOT COMPLETED|Losartan||2
11054055|NCT00981747|12235199|FG000|STARTED|Placebo Oral Tablet||10
11054056|NCT00981747|12235199|FG000|Started Placebo Oral Tablet|Placebo Oral Tablet||10
11054057|NCT00981747|12235199|FG000|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
11054058|NCT00981747|12235199|FG000|COMPLETED|Placebo Oral Tablet||9
11054059|NCT00981747|12235199|FG000|NOT COMPLETED|Placebo Oral Tablet||1
11054060|NCT00981747|12235199|FG000|STARTED|Sildenafil||9
11054061|NCT00981747|12235199|FG000|Started Sildenafil|Sildenafil||9
11054062|NCT00981747|12235199|FG000|Completed Sildenafil|Sildenafil||9
11054063|NCT00981747|12235199|FG000|COMPLETED|Sildenafil||9
11054064|NCT00981747|12235199|FG000|NOT COMPLETED|Sildenafil||0
11054065|NCT00981747|12235199|FG000|STARTED|Sildenafil and Losartan||9
11054066|NCT00981747|12235199|FG000|Started Sildenafil and Losartan|Sildenafil and Losartan||9
11054067|NCT00981747|12235199|FG000|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
11054068|NCT00981747|12235199|FG000|COMPLETED|Sildenafil and Losartan||9
11054069|NCT00981747|12235199|FG000|NOT COMPLETED|Sildenafil and Losartan||0
11054070|NCT00981799|12235213|FG000|STARTED|Overall Study||6
11054071|NCT00981799|12235214|FG001|STARTED|Overall Study||7
11054072|NCT00981799|12235215|FG002|STARTED|Overall Study||10
11054073|NCT00981799|12235216|FG003|STARTED|Overall Study||0
11054074|NCT00981799|12235213|FG000|COMPLETED|Overall Study||5
11054075|NCT00981799|12235214|FG001|COMPLETED|Overall Study||6
11054076|NCT00981799|12235215|FG002|COMPLETED|Overall Study||10
11054077|NCT00981799|12235216|FG003|COMPLETED|Overall Study||0
11054078|NCT00981799|12235213|FG000|NOT COMPLETED|Overall Study||1
11054079|NCT00981799|12235214|FG001|NOT COMPLETED|Overall Study||1
11054080|NCT00981799|12235215|FG002|NOT COMPLETED|Overall Study||0
11054081|NCT00981799|12235216|FG003|NOT COMPLETED|Overall Study||0
11054082|NCT00981812|12235227|FG000|STARTED|Overall Study||20
11054083|NCT00981812|12235227|FG000|COMPLETED|Overall Study||20
11054084|NCT00981812|12235227|FG000|NOT COMPLETED|Overall Study||0
11054085|NCT00981825|12235233|FG000|STARTED|First Intervention||11
11054086|NCT00981825|12235234|FG001|STARTED|First Intervention||11
11054087|NCT00981825|12235233|FG000|COMPLETED|First Intervention||11
11054088|NCT00981825|12235234|FG001|COMPLETED|First Intervention||11
11054089|NCT00981825|12235233|FG000|NOT COMPLETED|First Intervention||0
11054090|NCT00981825|12235234|FG001|NOT COMPLETED|First Intervention||0
11054091|NCT00981825|12235233|FG000|STARTED|Washout After 1st Intervention||11
11054092|NCT00981825|12235234|FG001|STARTED|Washout After 1st Intervention||11
11054093|NCT00981825|12235233|FG000|COMPLETED|Washout After 1st Intervention||11
11054094|NCT00981825|12235234|FG001|COMPLETED|Washout After 1st Intervention||11
11054095|NCT00981825|12235233|FG000|NOT COMPLETED|Washout After 1st Intervention||0
11054096|NCT00981825|12235234|FG001|NOT COMPLETED|Washout After 1st Intervention||0
11054097|NCT00981825|12235233|FG000|STARTED|Second Intervention||11
11054098|NCT00981825|12235234|FG001|STARTED|Second Intervention||11
11054099|NCT00981825|12235233|FG000|COMPLETED|Second Intervention||11
11054100|NCT00981825|12235234|FG001|COMPLETED|Second Intervention||11
11054101|NCT00981825|12235233|FG000|NOT COMPLETED|Second Intervention||0
11054102|NCT00981825|12235234|FG001|NOT COMPLETED|Second Intervention||0
11054103|NCT00982007|12235244|FG000|STARTED|Overall Study||250
11054104|NCT00982007|12235245|FG001|STARTED|Overall Study||257
11054105|NCT00982007|12235246|FG002|STARTED|Overall Study||253
11054106|NCT00982007|12235247|FG003|STARTED|Overall Study||251
11054107|NCT00982007|12235244|FG000|COMPLETED|Overall Study||246
11054108|NCT00982007|12235245|FG001|COMPLETED|Overall Study||253
11054109|NCT00982007|12235246|FG002|COMPLETED|Overall Study||253
11054110|NCT00982007|12235247|FG003|COMPLETED|Overall Study||245
11054111|NCT00982007|12235244|FG000|NOT COMPLETED|Overall Study||4
11054112|NCT00982007|12235245|FG001|NOT COMPLETED|Overall Study||4
11054113|NCT00982007|12235246|FG002|NOT COMPLETED|Overall Study||0
11054114|NCT00982007|12235247|FG003|NOT COMPLETED|Overall Study||6
11054115|NCT00982020|12235259|FG000|STARTED|Overall Study||102
11054116|NCT00982020|12235260|FG001|STARTED|Overall Study||101
11054117|NCT00982020|12235259|FG000|Received at Least 1 Dose of Study Drug|Overall Study||102
11054118|NCT00982020|12235260|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101
11054119|NCT00982020|12235259|FG000|COMPLETED|Overall Study||45
11054120|NCT00982020|12235260|FG001|COMPLETED|Overall Study||37
11054121|NCT00982020|12235259|FG000|NOT COMPLETED|Overall Study||57
11054122|NCT00982020|12235260|FG001|NOT COMPLETED|Overall Study||64
11054123|NCT00982033|12235273|FG000|STARTED|Overall Study||25
11054124|NCT00982033|12235274|FG001|STARTED|Overall Study||27
11054125|NCT00982033|12235273|FG000|COMPLETED|Overall Study||25
11054126|NCT00982033|12235274|FG001|COMPLETED|Overall Study||27
11054127|NCT00982033|12235273|FG000|NOT COMPLETED|Overall Study||0
11054128|NCT00982033|12235274|FG001|NOT COMPLETED|Overall Study||0
11054129|NCT00982072|12235282|FG000|STARTED|Overall Study||25
11338475|NCT02904915|12536088|FG000|COMPLETED|Overall Study||25
11338476|NCT02904915|12536089|FG001|COMPLETED|Overall Study||25
11338477|NCT02904915|12536088|FG000|NOT COMPLETED|Overall Study||0
11338478|NCT02904915|12536089|FG001|NOT COMPLETED|Overall Study||0
11054130|NCT00982072|12235283|FG001|STARTED|Overall Study||27
11054131|NCT00982072|12235282|FG000|COMPLETED|Overall Study||25
11054132|NCT00982072|12235283|FG001|COMPLETED|Overall Study||25
11338479|NCT02905149|12536097|FG000|STARTED|Overall Study||30
11054133|NCT00982072|12235282|FG000|NOT COMPLETED|Overall Study||0
11054134|NCT00982072|12235283|FG001|NOT COMPLETED|Overall Study||2
11054135|NCT00982137|12235293|FG000|STARTED|Overall Study||36
11054136|NCT00982137|12235294|FG001|STARTED|Overall Study||36
11054137|NCT00982137|12235295|FG002|STARTED|Overall Study||18
11054138|NCT00982137|12235296|FG003|STARTED|Overall Study||18
11054139|NCT00982137|12235293|FG000|COMPLETED|Overall Study||36
11054140|NCT00982137|12235294|FG001|COMPLETED|Overall Study||35
11054141|NCT00982137|12235295|FG002|COMPLETED|Overall Study||18
11054142|NCT00982137|12235296|FG003|COMPLETED|Overall Study||17
11054143|NCT00982137|12235293|FG000|NOT COMPLETED|Overall Study||0
11054144|NCT00982137|12235294|FG001|NOT COMPLETED|Overall Study||1
11054145|NCT00982137|12235295|FG002|NOT COMPLETED|Overall Study||0
11054146|NCT00982137|12235296|FG003|NOT COMPLETED|Overall Study||1
11054147|NCT00982189|12235317|FG000|STARTED|Overall Study||10
11054148|NCT00982189|12235318|FG001|STARTED|Overall Study||9
11054149|NCT00982189|12235319|FG002|STARTED|Overall Study||9
11054150|NCT00982189|12235320|FG003|STARTED|Overall Study||9
11054151|NCT00982189|12235317|FG000|COMPLETED|Overall Study||10
11054152|NCT00982189|12235318|FG001|COMPLETED|Overall Study||9
11054153|NCT00982189|12235319|FG002|COMPLETED|Overall Study||9
11054154|NCT00982189|12235320|FG003|COMPLETED|Overall Study||9
11054155|NCT00982189|12235317|FG000|NOT COMPLETED|Overall Study||0
11054156|NCT00982189|12235318|FG001|NOT COMPLETED|Overall Study||0
11054157|NCT00982189|12235319|FG002|NOT COMPLETED|Overall Study||0
11054158|NCT00982189|12235320|FG003|NOT COMPLETED|Overall Study||0
11054159|NCT00982228|12235334|FG000|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
11054160|NCT00982228|12235335|FG001|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
11054161|NCT00982228|12235334|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
11054162|NCT00982228|12235335|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
11054163|NCT00982228|12235334|FG000|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
11054164|NCT00982228|12235335|FG001|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
11054165|NCT00982228|12235334|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
11054166|NCT00982228|12235335|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
11054167|NCT00982228|12235334|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
11054168|NCT00982228|12235335|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
11054169|NCT00982228|12235334|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
11054170|NCT00982228|12235335|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
11054171|NCT00982228|12235334|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
11054172|NCT00982228|12235335|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
11054173|NCT00982228|12235334|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
11054174|NCT00982228|12235335|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
11054175|NCT00982280|12235341|FG000|STARTED|Observation Period||82
11054176|NCT00982280|12235341|FG000|COMPLETED|Observation Period||63
11054177|NCT00982280|12235341|FG000|NOT COMPLETED|Observation Period||19
11054178|NCT00982280|12235341|FG000|STARTED|Titration and Optimal Dose Period||63
11054179|NCT00982280|12235341|FG000|COMPLETED|Titration and Optimal Dose Period||55
11054180|NCT00982280|12235341|FG000|NOT COMPLETED|Titration and Optimal Dose Period||8
11054181|NCT00982280|12235341|FG000|STARTED|Maintenance Period||55
11054182|NCT00982280|12235341|FG000|COMPLETED|Maintenance Period||54
11054183|NCT00982280|12235341|FG000|NOT COMPLETED|Maintenance Period||1
11054184|NCT00982319|12235348|FG000|STARTED|Overall Study||17
11054185|NCT00982319|12235349|FG001|STARTED|Overall Study||17
11054186|NCT00982319|12235348|FG000|COMPLETED|Overall Study||15
11054187|NCT00982319|12235349|FG001|COMPLETED|Overall Study||15
11338480|NCT02905149|12536098|FG001|STARTED|Overall Study||30
11338481|NCT02905149|12536097|FG000|COMPLETED|Overall Study||28
11338482|NCT02905149|12536098|FG001|COMPLETED|Overall Study||30
11054188|NCT00982319|12235348|FG000|NOT COMPLETED|Overall Study||2
11054189|NCT00982319|12235349|FG001|NOT COMPLETED|Overall Study||2
11054190|NCT00982345|12235355|FG000|STARTED|Overall Study||20
11054191|NCT00982345|12235355|FG000|COMPLETED|Overall Study||18
11054192|NCT00982345|12235355|FG000|NOT COMPLETED|Overall Study||2
11054193|NCT00982397|12235361|FG000|STARTED|Phase I||236
11054194|NCT00982397|12235362|FG001|STARTED|Phase I||0
11054195|NCT00982397|12235361|FG000|COMPLETED|Phase I||236
11054196|NCT00982397|12235362|FG001|COMPLETED|Phase I||0
11054197|NCT00982397|12235361|FG000|NOT COMPLETED|Phase I||0
11054198|NCT00982397|12235362|FG001|NOT COMPLETED|Phase I||0
11054199|NCT00982397|12235361|FG000|STARTED|Phase II/Overall Study||2019
11054200|NCT00982397|12235362|FG001|STARTED|Phase II/Overall Study||751
11054201|NCT00982397|12235361|FG000|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
11054202|NCT00982397|12235362|FG001|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
11054203|NCT00982397|12235361|FG000|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
11054204|NCT00982397|12235362|FG001|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
11054205|NCT00982397|12235361|FG000|COMPLETED|Phase II/Overall Study||2019
11054206|NCT00982397|12235362|FG001|COMPLETED|Phase II/Overall Study||751
11054207|NCT00982397|12235361|FG000|NOT COMPLETED|Phase II/Overall Study||0
11054208|NCT00982397|12235362|FG001|NOT COMPLETED|Phase II/Overall Study||0
11054209|NCT00982410|12235373|FG000|STARTED|3-month Follow-up Assessment||65
11054210|NCT00982410|12235374|FG001|STARTED|3-month Follow-up Assessment||66
11054211|NCT00982410|12235373|FG000|COMPLETED|3-month Follow-up Assessment||56
11054212|NCT00982410|12235374|FG001|COMPLETED|3-month Follow-up Assessment||53
11054213|NCT00982410|12235373|FG000|NOT COMPLETED|3-month Follow-up Assessment||9
11054214|NCT00982410|12235374|FG001|NOT COMPLETED|3-month Follow-up Assessment||13
11054215|NCT00982410|12235373|FG000|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
11054216|NCT00982410|12235374|FG001|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
11054217|NCT00982410|12235373|FG000|COMPLETED|6-month Follow-up Assessment||59
11054218|NCT00982410|12235374|FG001|COMPLETED|6-month Follow-up Assessment||53
11054219|NCT00982410|12235373|FG000|NOT COMPLETED|6-month Follow-up Assessment||6
11054220|NCT00982410|12235374|FG001|NOT COMPLETED|6-month Follow-up Assessment||11
11054221|NCT00982410|12235373|FG000|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
11054222|NCT00982410|12235374|FG001|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
11054223|NCT00982410|12235373|FG000|COMPLETED|12-month Follow-up Assessment||56
11054224|NCT00982410|12235374|FG001|COMPLETED|12-month Follow-up Assessment||55
11054225|NCT00982410|12235373|FG000|NOT COMPLETED|12-month Follow-up Assessment||9
11054226|NCT00982410|12235374|FG001|NOT COMPLETED|12-month Follow-up Assessment||9
11058249|NCT01002573|12240091|FG000|STARTED|Overall Study||58
11058250|NCT01002573|12240092|FG001|STARTED|Overall Study||60
11058251|NCT01002573|12240091|FG000|COMPLETED|Overall Study||47
11058252|NCT01002573|12240092|FG001|COMPLETED|Overall Study||53
11058253|NCT01002573|12240091|FG000|NOT COMPLETED|Overall Study||11
11058254|NCT01002573|12240092|FG001|NOT COMPLETED|Overall Study||7
11058255|NCT01002742|12240100|FG000|STARTED|Overall Study||119
11058256|NCT01002742|12240101|FG001|STARTED|Overall Study||117
11058257|NCT01002742|12240100|FG000|COMPLETED|Overall Study||119
11058258|NCT01002742|12240101|FG001|COMPLETED|Overall Study||116
11058259|NCT01002742|12240100|FG000|NOT COMPLETED|Overall Study||0
11058260|NCT01002742|12240101|FG001|NOT COMPLETED|Overall Study||1
11058261|NCT01002755|12240107|FG000|STARTED|Overall Study||36
11338483|NCT02905149|12536097|FG000|NOT COMPLETED|Overall Study||2
11338484|NCT02905149|12536098|FG001|NOT COMPLETED|Overall Study||0
11338485|NCT02905266|12536106|FG000|STARTED|Treatment Phase Part 1||53
11058262|NCT01002755|12240107|FG000|COMPLETED|Overall Study||36
11058263|NCT01002755|12240107|FG000|NOT COMPLETED|Overall Study||0
11058264|NCT01002989|12240111|FG000|STARTED|Overall Study||98
11058265|NCT01002989|12240111|FG000|COMPLETED|Overall Study||93
11058266|NCT01002989|12240111|FG000|NOT COMPLETED|Overall Study||5
11058267|NCT01003067|12240117|FG000|STARTED|Overall Study||136
11058268|NCT01003067|12240118|FG001|STARTED|Overall Study||131
11058269|NCT01003067|12240117|FG000|COMPLETED|Overall Study||103
11058270|NCT01003067|12240118|FG001|COMPLETED|Overall Study||107
11058271|NCT01003067|12240117|FG000|NOT COMPLETED|Overall Study||33
11058272|NCT01003067|12240118|FG001|NOT COMPLETED|Overall Study||24
11058273|NCT01003080|12240126|FG000|STARTED|Overall Study||50
11058274|NCT01003080|12240127|FG001|STARTED|Overall Study||61
11058275|NCT01003080|12240126|FG000|COMPLETED|Overall Study||50
11058276|NCT01003080|12240127|FG001|COMPLETED|Overall Study||61
11058277|NCT01003080|12240126|FG000|NOT COMPLETED|Overall Study||0
11058278|NCT01003080|12240127|FG001|NOT COMPLETED|Overall Study||0
11058279|NCT01003106|12240137|FG000|STARTED|Baseline to Month 6||22
11058280|NCT01003106|12240138|FG001|STARTED|Baseline to Month 6||20
11338486|NCT02905266|12536107|FG001|STARTED|Treatment Phase Part 1||53
11058281|NCT01003106|12240139|FG002|STARTED|Baseline to Month 6||0
11058282|NCT01003106|12240140|FG003|STARTED|Baseline to Month 6||0
11058283|NCT01003106|12240141|FG004|STARTED|Baseline to Month 6||19
11058284|NCT01003106|12240142|FG005|STARTED|Baseline to Month 6||20
11058285|NCT01003106|12240143|FG006|STARTED|Baseline to Month 6||0
11058286|NCT01003106|12240144|FG007|STARTED|Baseline to Month 6||0
11058287|NCT01003106|12240137|FG000|COMPLETED|Baseline to Month 6||22
11058288|NCT01003106|12240138|FG001|COMPLETED|Baseline to Month 6||20
11054227|NCT00982423|12235383|FG000|STARTED|Overall Study||13
11054228|NCT00982423|12235384|FG001|STARTED|Overall Study||19
11054229|NCT00982423|12235383|FG000|COMPLETED|Overall Study||13
11054230|NCT00982423|12235384|FG001|COMPLETED|Overall Study||19
11054231|NCT00982423|12235383|FG000|NOT COMPLETED|Overall Study||0
11054232|NCT00982423|12235384|FG001|NOT COMPLETED|Overall Study||0
11054233|NCT00982488|12235396|FG000|STARTED|Overall Study|Received treatment|185
11054234|NCT00982488|12235397|FG001|STARTED|Overall Study|Received treatment|14
11054235|NCT00982488|12235398|FG002|STARTED|Overall Study|Received treatment|34
11054236|NCT00982488|12235399|FG003|STARTED|Overall Study|Received treatment|3
11054237|NCT00982488|12235400|FG004|STARTED|Overall Study|Received treatment|1
11054238|NCT00982488|12235396|FG000|COMPLETED|Overall Study|Still receiving treatment|0
11054239|NCT00982488|12235397|FG001|COMPLETED|Overall Study|Still receiving treatment|0
11054240|NCT00982488|12235398|FG002|COMPLETED|Overall Study|Still receiving treatment|0
11054241|NCT00982488|12235399|FG003|COMPLETED|Overall Study|Still receiving treatment|0
11054242|NCT00982488|12235400|FG004|COMPLETED|Overall Study|Still receiving treatment|0
11054243|NCT00982488|12235396|FG000|NOT COMPLETED|Overall Study||185
11054244|NCT00982488|12235397|FG001|NOT COMPLETED|Overall Study||14
11054245|NCT00982488|12235398|FG002|NOT COMPLETED|Overall Study||34
11054246|NCT00982488|12235399|FG003|NOT COMPLETED|Overall Study||3
11054247|NCT00982488|12235400|FG004|NOT COMPLETED|Overall Study||1
11054248|NCT00982553|12235412|FG000|STARTED|Phase1||14
11054249|NCT00982553|12235412|FG000|COMPLETED|Phase1||14
11054250|NCT00982553|12235412|FG000|NOT COMPLETED|Phase1||0
11054251|NCT00982553|12235412|FG000|STARTED|Phase2||14
11054252|NCT00982553|12235412|FG000|COMPLETED|Phase2||14
11054253|NCT00982553|12235412|FG000|NOT COMPLETED|Phase2||0
11054254|NCT00982553|12235412|FG000|STARTED|Phase3||14
11054255|NCT00982553|12235412|FG000|COMPLETED|Phase3||14
11054256|NCT00982553|12235412|FG000|NOT COMPLETED|Phase3||0
11054257|NCT00982592|12235423|FG000|STARTED|Overall Study||64
11054258|NCT00982592|12235424|FG001|STARTED|Overall Study||60
11054259|NCT00982592|12235423|FG000|Treatment Received|Overall Study||63
11054260|NCT00982592|12235424|FG001|Treatment Received|Overall Study||52
11054261|NCT00982592|12235423|FG000|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
11054262|NCT00982592|12235424|FG001|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
11054263|NCT00982592|12235423|FG000|NOT COMPLETED|Overall Study||31
11054264|NCT00982592|12235424|FG001|NOT COMPLETED|Overall Study||33
11054265|NCT00982644|12235432|FG000|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
11054266|NCT00982644|12235433|FG001|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
11054267|NCT00982644|12235432|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
11338487|NCT02905266|12536106|FG000|COMPLETED|Treatment Phase Part 1||24
11338488|NCT02905266|12536107|FG001|COMPLETED|Treatment Phase Part 1||30
11338489|NCT02905266|12536106|FG000|NOT COMPLETED|Treatment Phase Part 1||29
11338490|NCT02905266|12536107|FG001|NOT COMPLETED|Treatment Phase Part 1||23
11338491|NCT02905266|12536106|FG000|STARTED|Transition From Part 1 to Part 2||24
11338492|NCT02905266|12536107|FG001|STARTED|Transition From Part 1 to Part 2||30
11338493|NCT02905266|12536106|FG000|COMPLETED|Transition From Part 1 to Part 2||20
11338494|NCT02905266|12536107|FG001|COMPLETED|Transition From Part 1 to Part 2||22
11338495|NCT02905266|12536106|FG000|NOT COMPLETED|Transition From Part 1 to Part 2||4
11054268|NCT00982644|12235433|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
11054269|NCT00982644|12235432|FG000|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
11054270|NCT00982644|12235433|FG001|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
11054271|NCT00982644|12235432|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
11054272|NCT00982644|12235433|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
11054273|NCT00982644|12235432|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
11054274|NCT00982644|12235433|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
11054275|NCT00982644|12235432|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
11054276|NCT00982644|12235433|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
11054277|NCT00982644|12235432|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
11054278|NCT00982644|12235433|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
11054279|NCT00982644|12235432|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
11054280|NCT00982644|12235433|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
11054281|NCT00982657|12235443|FG000|STARTED|Overall Study||12
11054282|NCT00982657|12235444|FG001|STARTED|Overall Study||3
11054283|NCT00982657|12235445|FG002|STARTED|Overall Study||3
11054284|NCT00982657|12235446|FG003|STARTED|Overall Study||16
11054285|NCT00982657|12235443|FG000|COMPLETED|Overall Study||11
11054286|NCT00982657|12235444|FG001|COMPLETED|Overall Study||3
11054287|NCT00982657|12235445|FG002|COMPLETED|Overall Study||1
11054288|NCT00982657|12235446|FG003|COMPLETED|Overall Study||7
11054289|NCT00982657|12235443|FG000|NOT COMPLETED|Overall Study||1
11054290|NCT00982657|12235444|FG001|NOT COMPLETED|Overall Study||0
11054291|NCT00982657|12235445|FG002|NOT COMPLETED|Overall Study||2
11054292|NCT00982657|12235446|FG003|NOT COMPLETED|Overall Study||9
11054293|NCT00982735|12235466|FG000|STARTED|Overall Study||987
11054294|NCT00982735|12235466|FG000|COMPLETED|Overall Study||757
11054295|NCT00982735|12235466|FG000|NOT COMPLETED|Overall Study||230
11054296|NCT00982865|12235474|FG000|STARTED|Overall Study||49
11054297|NCT00982865|12235475|FG001|STARTED|Overall Study||82
11054298|NCT00982865|12235476|FG002|STARTED|Overall Study||15
11054299|NCT00982865|12235477|FG003|STARTED|Overall Study||34
11054300|NCT00982865|12235474|FG000|COMPLETED|Overall Study||49
11338496|NCT02905266|12536107|FG001|NOT COMPLETED|Transition From Part 1 to Part 2||8
11338497|NCT02905266|12536106|FG000|STARTED|Maintenance Phase Part 2||20
11338498|NCT02905266|12536107|FG001|STARTED|Maintenance Phase Part 2||22
11338499|NCT02905266|12536106|FG000|COMPLETED|Maintenance Phase Part 2||8
11338500|NCT02905266|12536107|FG001|COMPLETED|Maintenance Phase Part 2||14
11338501|NCT02905266|12536106|FG000|NOT COMPLETED|Maintenance Phase Part 2||12
11338502|NCT02905266|12536107|FG001|NOT COMPLETED|Maintenance Phase Part 2||8
11338503|NCT02905331|12536115|FG000|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
11338504|NCT02905331|12536116|FG001|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
11338505|NCT02905331|12536117|FG002|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
11338506|NCT02905331|12536115|FG000|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
11338507|NCT02905331|12536116|FG001|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
11338508|NCT02905331|12536117|FG002|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
11338509|NCT02905331|12536115|FG000|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
11338510|NCT02905331|12536116|FG001|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
11338511|NCT02905331|12536117|FG002|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
11338512|NCT02905331|12536115|FG000|STARTED|Active Treatment and Follow up (wk16-40)||0
11338513|NCT02905331|12536116|FG001|STARTED|Active Treatment and Follow up (wk16-40)||61
11338514|NCT02905331|12536117|FG002|STARTED|Active Treatment and Follow up (wk16-40)||13
11338515|NCT02905331|12536115|FG000|COMPLETED|Active Treatment and Follow up (wk16-40)||0
11338516|NCT02905331|12536116|FG001|COMPLETED|Active Treatment and Follow up (wk16-40)||53
11338517|NCT02905331|12536117|FG002|COMPLETED|Active Treatment and Follow up (wk16-40)||13
11338518|NCT02905331|12536115|FG000|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
11338519|NCT02905331|12536116|FG001|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
11338520|NCT02905331|12536117|FG002|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
11054301|NCT00982865|12235475|FG001|COMPLETED|Overall Study||82
11054302|NCT00982865|12235476|FG002|COMPLETED|Overall Study||15
11054303|NCT00982865|12235477|FG003|COMPLETED|Overall Study||34
11054304|NCT00982865|12235474|FG000|NOT COMPLETED|Overall Study||0
11338521|NCT02905435|12536125|FG000|STARTED|Overall Study||14
11338522|NCT02905435|12536125|FG000|COMPLETED|Overall Study||7
11054305|NCT00982865|12235475|FG001|NOT COMPLETED|Overall Study||0
11054306|NCT00982865|12235476|FG002|NOT COMPLETED|Overall Study||0
11054307|NCT00982865|12235477|FG003|NOT COMPLETED|Overall Study||0
11054308|NCT00982878|12235524|FG000|STARTED|Overall Study||13
11054309|NCT00982878|12235524|FG000|COMPLETED|Overall Study||12
11054310|NCT00982878|12235524|FG000|NOT COMPLETED|Overall Study||1
11054311|NCT00982930|12235528|FG000|STARTED|Overall Study||55
11054312|NCT00982930|12235528|FG000|COMPLETED|Overall Study||51
11054313|NCT00982930|12235528|FG000|NOT COMPLETED|Overall Study||4
11054314|NCT00983073|12235532|FG000|STARTED|Observation Period||224
11054315|NCT00983073|12235532|FG000|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
11054316|NCT00983073|12235532|FG000|NOT COMPLETED|Observation Period||24
11054317|NCT00983073|12235532|FG000|STARTED|Titration and Optimal Dose Period||200
11054318|NCT00983073|12235532|FG000|COMPLETED|Titration and Optimal Dose Period||160
11054319|NCT00983073|12235532|FG000|NOT COMPLETED|Titration and Optimal Dose Period||40
11054320|NCT00983073|12235532|FG000|STARTED|Maintenance Period||160
11054321|NCT00983073|12235532|FG000|COMPLETED|Maintenance Period||144
11054322|NCT00983073|12235532|FG000|NOT COMPLETED|Maintenance Period||16
11054323|NCT00983216|12235537|FG000|STARTED|Colchicine Alone||24
11054324|NCT00983216|12235537|FG000|COMPLETED|Colchicine Alone||24
11054325|NCT00983216|12235537|FG000|NOT COMPLETED|Colchicine Alone||0
11054326|NCT00983216|12235537|FG000|STARTED|14 Day Washout Period||24
11054327|NCT00983216|12235537|FG000|COMPLETED|14 Day Washout Period||24
11054328|NCT00983216|12235537|FG000|NOT COMPLETED|14 Day Washout Period||0
11054329|NCT00983216|12235537|FG000|STARTED|Ketoconazole Alone||24
11054330|NCT00983216|12235537|FG000|COMPLETED|Ketoconazole Alone||24
11054331|NCT00983216|12235537|FG000|NOT COMPLETED|Ketoconazole Alone||0
11054332|NCT00983216|12235537|FG000|STARTED|Colchicine With Ketoconazole||24
11054333|NCT00983216|12235537|FG000|COMPLETED|Colchicine With Ketoconazole||24
11054334|NCT00983216|12235537|FG000|NOT COMPLETED|Colchicine With Ketoconazole||0
11054335|NCT00983242|12235544|FG000|STARTED|Colchicine Alone||24
11054336|NCT00983242|12235544|FG000|COMPLETED|Colchicine Alone||24
11054337|NCT00983242|12235544|FG000|NOT COMPLETED|Colchicine Alone||0
11054338|NCT00983242|12235544|FG000|STARTED|14 Day Washout Period||24
11054339|NCT00983242|12235544|FG000|COMPLETED|14 Day Washout Period||24
11054340|NCT00983242|12235544|FG000|NOT COMPLETED|14 Day Washout Period||0
11054341|NCT00983242|12235544|FG000|STARTED|Verapamil HCl ER Alone||24
11054342|NCT00983242|12235544|FG000|COMPLETED|Verapamil HCl ER Alone||24
11054343|NCT00983242|12235544|FG000|NOT COMPLETED|Verapamil HCl ER Alone||0
11054344|NCT00983242|12235544|FG000|STARTED|Colchicine With Verapamil HCl ER||24
11054345|NCT00983242|12235544|FG000|COMPLETED|Colchicine With Verapamil HCl ER||24
11054346|NCT00983242|12235544|FG000|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
11054347|NCT00983281|12235553|FG000|STARTED|Overall Study||805
11054348|NCT00983281|12235554|FG001|STARTED|Overall Study||909
11054349|NCT00983281|12235553|FG000|COMPLETED|Overall Study||805
11054350|NCT00983281|12235554|FG001|COMPLETED|Overall Study||909
11054351|NCT00983281|12235553|FG000|NOT COMPLETED|Overall Study||0
11054352|NCT00983281|12235554|FG001|NOT COMPLETED|Overall Study||0
11054353|NCT00983294|12235560|FG000|STARTED|Colchicine Alone||24
11054354|NCT00983294|12235560|FG000|COMPLETED|Colchicine Alone||24
11054355|NCT00983294|12235560|FG000|NOT COMPLETED|Colchicine Alone||0
11054356|NCT00983294|12235560|FG000|STARTED|14 Day Washout Period||24
11054357|NCT00983294|12235560|FG000|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
11054358|NCT00983294|12235560|FG000|NOT COMPLETED|14 Day Washout Period||2
11054359|NCT00983294|12235560|FG000|STARTED|Azithromycin Alone||22
11054360|NCT00983294|12235560|FG000|COMPLETED|Azithromycin Alone||22
11054361|NCT00983294|12235560|FG000|NOT COMPLETED|Azithromycin Alone||0
11054362|NCT00983294|12235560|FG000|STARTED|Colchicine With Azithromycin||22
11054363|NCT00983294|12235560|FG000|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
11054364|NCT00983294|12235560|FG000|NOT COMPLETED|Colchicine With Azithromycin||1
11054365|NCT00983307|12235567|FG000|STARTED|Overall Study||17
11054366|NCT00983307|12235567|FG000|COMPLETED|Overall Study||17
11054367|NCT00983307|12235567|FG000|NOT COMPLETED|Overall Study||0
11054368|NCT00983346|12235571|FG000|STARTED|Overall Study||17
11054369|NCT00983346|12235571|FG000|COMPLETED|Overall Study||17
11054370|NCT00983346|12235571|FG000|NOT COMPLETED|Overall Study||0
11054371|NCT00983359|12235575|FG000|STARTED|Overall Study||40
11054372|NCT00983359|12235575|FG000|Not Eligible for Analysis|Overall Study||1
11054373|NCT00983359|12235575|FG000|COMPLETED|Overall Study||39
11054374|NCT00983359|12235575|FG000|NOT COMPLETED|Overall Study||1
11054375|NCT00983372|12235579|FG000|STARTED|Colchicine Alone||24
11054376|NCT00983372|12235579|FG000|COMPLETED|Colchicine Alone||24
11054377|NCT00983372|12235579|FG000|NOT COMPLETED|Colchicine Alone||0
11054378|NCT00983372|12235579|FG000|STARTED|14 Day Washout Period||24
11054379|NCT00983372|12235579|FG000|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
11054380|NCT00983372|12235579|FG000|NOT COMPLETED|14 Day Washout Period||1
11054381|NCT00983372|12235579|FG000|STARTED|Diltiazem ER Alone||23
11054382|NCT00983372|12235579|FG000|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
11054383|NCT00983372|12235579|FG000|NOT COMPLETED|Diltiazem ER Alone||3
11054384|NCT00983372|12235579|FG000|STARTED|Colchicine With Diltiazem ER||20
11054385|NCT00983372|12235579|FG000|COMPLETED|Colchicine With Diltiazem ER||20
11054386|NCT00983372|12235579|FG000|NOT COMPLETED|Colchicine With Diltiazem ER||0
11054387|NCT00983385|12235586|FG000|STARTED|Observation Period||208
11054388|NCT00983385|12235586|FG000|COMPLETED|Observation Period||176
11054389|NCT00983385|12235586|FG000|NOT COMPLETED|Observation Period||32
11054390|NCT00983385|12235586|FG000|STARTED|Titration and Optimal Dose Period||176
11054391|NCT00983385|12235586|FG000|COMPLETED|Titration and Optimal Dose Period||140
11054392|NCT00983385|12235586|FG000|NOT COMPLETED|Titration and Optimal Dose Period||36
11054393|NCT00983385|12235586|FG000|STARTED|Maintenance Period||140
11054394|NCT00983385|12235586|FG000|COMPLETED|Maintenance Period||117
11054395|NCT00983385|12235586|FG000|NOT COMPLETED|Maintenance Period||23
11054396|NCT00983476|12235608|FG000|STARTED|Overall Study||95
11054397|NCT00983476|12235609|FG001|STARTED|Overall Study||93
11054398|NCT00983476|12235610|FG002|STARTED|Overall Study||88
11054399|NCT00983476|12235608|FG000|6 Month Follow up Assessment|Overall Study||71
11054400|NCT00983476|12235609|FG001|6 Month Follow up Assessment|Overall Study||62
11054401|NCT00983476|12235610|FG002|6 Month Follow up Assessment|Overall Study||74
11054402|NCT00983476|12235608|FG000|COMPLETED|Overall Study||78
11054403|NCT00983476|12235609|FG001|COMPLETED|Overall Study||71
11054404|NCT00983476|12235610|FG002|COMPLETED|Overall Study||88
11054405|NCT00983476|12235608|FG000|NOT COMPLETED|Overall Study||17
11054406|NCT00983476|12235609|FG001|NOT COMPLETED|Overall Study||22
11054407|NCT00983476|12235610|FG002|NOT COMPLETED|Overall Study||0
11054408|NCT00983489|12235627|FG000|STARTED|Overall Study||511
11054409|NCT00983489|12235628|FG001|STARTED|Overall Study||453
11054410|NCT00983489|12235629|FG002|STARTED|Overall Study||447
11054411|NCT00983489|12235627|FG000|COMPLETED|Overall Study||326
11054412|NCT00983489|12235628|FG001|COMPLETED|Overall Study||168
11054413|NCT00983489|12235629|FG002|COMPLETED|Overall Study||135
11054414|NCT00983489|12235627|FG000|NOT COMPLETED|Overall Study||185
11054415|NCT00983489|12235628|FG001|NOT COMPLETED|Overall Study||285
11054416|NCT00983489|12235629|FG002|NOT COMPLETED|Overall Study||312
11054417|NCT00983515|12235637|FG000|STARTED|Colchicine Alone||24
11054418|NCT00983515|12235637|FG000|COMPLETED|Colchicine Alone||24
11338523|NCT02905435|12536125|FG000|NOT COMPLETED|Overall Study||7
11338524|NCT02905825|12536130|FG000|STARTED|Overall Study||53
11338525|NCT02905825|12536130|FG000|COMPLETED|Overall Study||41
11338526|NCT02905825|12536130|FG000|NOT COMPLETED|Overall Study||12
11338527|NCT02905981|12536134|FG000|STARTED|Overall Study||1
11338528|NCT02905981|12536134|FG000|COMPLETED|Overall Study||0
11338529|NCT02905981|12536134|FG000|NOT COMPLETED|Overall Study||1
11338530|NCT02906358|12536140|FG000|STARTED|Overall Study||58
11338531|NCT02906358|12536141|FG001|STARTED|Overall Study||53
11338532|NCT02906358|12536140|FG000|Completed 3 Month Measures|Overall Study||36
11338533|NCT02906358|12536141|FG001|Completed 3 Month Measures|Overall Study||33
11338534|NCT02906358|12536140|FG000|COMPLETED|Overall Study||36
11338535|NCT02906358|12536141|FG001|COMPLETED|Overall Study||31
11338536|NCT02906358|12536140|FG000|NOT COMPLETED|Overall Study||22
11338537|NCT02906358|12536141|FG001|NOT COMPLETED|Overall Study||22
11338538|NCT02906566|12536149|FG000|STARTED|Overall Study||24
11338539|NCT02906566|12536150|FG001|STARTED|Overall Study||10
11338540|NCT02906566|12536149|FG000|COMPLETED|Overall Study||21
11338541|NCT02906566|12536150|FG001|COMPLETED|Overall Study||10
11338542|NCT02906566|12536149|FG000|NOT COMPLETED|Overall Study||3
11338543|NCT02906566|12536150|FG001|NOT COMPLETED|Overall Study||0
11338544|NCT02906579|12536158|FG000|STARTED|Overall Study||11
11338545|NCT02906579|12536158|FG000|Completed Cycle 1 (Placebo)|Overall Study||11
11338546|NCT02906579|12536158|FG000|Completed Cycle 2 (10 mg IW-1973)|Overall Study||11
11338547|NCT02906579|12536158|FG000|Completed Cycle 3 (20 mg IW-1973)|Overall Study||11
11338548|NCT02906579|12536158|FG000|Completed Cycle 4 (30 mg IW-1973)|Overall Study||10
11338549|NCT02906579|12536158|FG000|Completed Cycle 5 (40 mg IW-1973)|Overall Study||9
11338550|NCT02906579|12536158|FG000|Completed Cycle 6 (50 mg IW-1973)|Overall Study||9
11338551|NCT02906579|12536158|FG000|COMPLETED|Overall Study||9
11338552|NCT02906579|12536158|FG000|NOT COMPLETED|Overall Study||2
11338553|NCT02906644|12536180|FG000|STARTED|First 2 Weeks||31
11338554|NCT02906644|12536181|FG001|STARTED|First 2 Weeks||30
11338555|NCT02906644|12536180|FG000|COMPLETED|First 2 Weeks||30
11338556|NCT02906644|12536181|FG001|COMPLETED|First 2 Weeks||27
11338557|NCT02906644|12536180|FG000|NOT COMPLETED|First 2 Weeks||1
11338558|NCT02906644|12536181|FG001|NOT COMPLETED|First 2 Weeks||3
11338559|NCT02906644|12536180|FG000|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30
11054419|NCT00983515|12235637|FG000|NOT COMPLETED|Colchicine Alone||0
11338560|NCT02906644|12536181|FG001|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27
11054420|NCT00983515|12235637|FG000|STARTED|14 Day Washout Period||24
11054421|NCT00983515|12235637|FG000|COMPLETED|14 Day Washout Period||24
11054422|NCT00983515|12235637|FG000|NOT COMPLETED|14 Day Washout Period||0
11054423|NCT00983515|12235637|FG000|STARTED|Ritonavir Alone||24
11054424|NCT00983515|12235637|FG000|COMPLETED|Ritonavir Alone||18
11054425|NCT00983515|12235637|FG000|NOT COMPLETED|Ritonavir Alone||6
11054426|NCT00983515|12235637|FG000|STARTED|Colchicine With Ritonavir||18
11054427|NCT00983515|12235637|FG000|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
11205230|NCT01857882|12395975|FG001|COMPLETED|Overall Study||20
11338561|NCT02906644|12536180|FG000|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17
11338562|NCT02906644|12536181|FG001|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20
11338563|NCT02906644|12536180|FG000|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14
11338564|NCT02906644|12536181|FG001|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16
11338565|NCT02906644|12536180|FG000|COMPLETED|Weeks 3 to 14||14
11338566|NCT02906644|12536181|FG001|COMPLETED|Weeks 3 to 14||16
11338567|NCT02906644|12536180|FG000|NOT COMPLETED|Weeks 3 to 14||16
11338568|NCT02906644|12536181|FG001|NOT COMPLETED|Weeks 3 to 14||11
11338569|NCT02906670|12536198|FG000|STARTED|Cohort 1, QW||1
11338570|NCT02906670|12536199|FG001|STARTED|Cohort 1, QW||0
11338571|NCT02906670|12536200|FG002|STARTED|Cohort 1, QW||0
11054428|NCT00983515|12235637|FG000|NOT COMPLETED|Colchicine With Ritonavir||1
11054429|NCT00983528|12235644|FG000|STARTED|Overall Study||6
11205231|NCT01857882|12395974|FG000|NOT COMPLETED|Overall Study||0
11205232|NCT01857882|12395975|FG001|NOT COMPLETED|Overall Study||0
11205233|NCT01857973|12395981|FG000|STARTED|Overall Study||78
11205234|NCT01857973|12395981|FG000|Exploratory A Phase|Overall Study||9
11205235|NCT01857973|12395981|FG000|Xploratory B Phase|Overall Study||9
11205236|NCT01857973|12395981|FG000|Phase 1|Overall Study||17
11205237|NCT01857973|12395981|FG000|Phase 2|Overall Study||14
11205238|NCT01857973|12395981|FG000|Phase 3|Overall Study||10
11205239|NCT01857973|12395981|FG000|Phase 4|Overall Study||10
11205240|NCT01857973|12395981|FG000|Phase 6|Overall Study||4
11205241|NCT01857973|12395981|FG000|Phase 7|Overall Study||4
11205242|NCT01857973|12395981|FG000|COMPLETED|Overall Study||73
11205243|NCT01857973|12395981|FG000|NOT COMPLETED|Overall Study||5
11205244|NCT01857986|12395987|FG000|STARTED|Overall Study||39
11205245|NCT01857986|12395988|FG001|STARTED|Overall Study||37
11205246|NCT01857986|12395987|FG000|COMPLETED|Overall Study||34
11205247|NCT01857986|12395988|FG001|COMPLETED|Overall Study||30
11205248|NCT01857986|12395987|FG000|NOT COMPLETED|Overall Study||5
11205249|NCT01857986|12395988|FG001|NOT COMPLETED|Overall Study||7
11205250|NCT01858194|12395996|FG000|STARTED|Overall Study||8
11205251|NCT01858194|12395997|FG001|STARTED|Overall Study||9
11338572|NCT02906670|12536201|FG003|STARTED|Cohort 1, QW||0
11338573|NCT02906670|12536202|FG004|STARTED|Cohort 1, QW||0
11338574|NCT02906670|12536203|FG005|STARTED|Cohort 1, QW||0
11338575|NCT02906670|12536204|FG006|STARTED|Cohort 1, QW||0
11338576|NCT02906670|12536205|FG007|STARTED|Cohort 1, QW||0
11338577|NCT02906670|12536206|FG008|STARTED|Cohort 1, QW||0
11338578|NCT02906670|12536207|FG009|STARTED|Cohort 1, QW||0
11338579|NCT02906670|12536198|FG000|COMPLETED|Cohort 1, QW||0
11338580|NCT02906670|12536199|FG001|COMPLETED|Cohort 1, QW||0
11338581|NCT02906670|12536200|FG002|COMPLETED|Cohort 1, QW||0
11338582|NCT02906670|12536201|FG003|COMPLETED|Cohort 1, QW||0
11338583|NCT02906670|12536202|FG004|COMPLETED|Cohort 1, QW||0
11338584|NCT02906670|12536203|FG005|COMPLETED|Cohort 1, QW||0
11338585|NCT02906670|12536204|FG006|COMPLETED|Cohort 1, QW||0
11338586|NCT02906670|12536205|FG007|COMPLETED|Cohort 1, QW||0
11338587|NCT02906670|12536206|FG008|COMPLETED|Cohort 1, QW||0
11054430|NCT00983528|12235644|FG000|COMPLETED|Overall Study||0
11054431|NCT00983528|12235644|FG000|NOT COMPLETED|Overall Study||6
11054432|NCT00983541|12235648|FG000|STARTED|Overall Study||1
11054433|NCT00983541|12235648|FG000|COMPLETED|Overall Study||1
11054434|NCT00983541|12235648|FG000|NOT COMPLETED|Overall Study||0
11054435|NCT00983580|12235654|FG000|STARTED|Overall Study||54
11054436|NCT00983580|12235655|FG001|STARTED|Overall Study||53
11054437|NCT00983580|12235654|FG000|COMPLETED|Overall Study||49
11054438|NCT00983580|12235655|FG001|COMPLETED|Overall Study||49
11054439|NCT00983580|12235654|FG000|NOT COMPLETED|Overall Study||5
11054440|NCT00983580|12235655|FG001|NOT COMPLETED|Overall Study||4
11054441|NCT00983619|12235674|FG000|STARTED|Overall Study||3
11054442|NCT00983619|12235675|FG001|STARTED|Overall Study||4
11054443|NCT00983619|12235676|FG002|STARTED|Overall Study||3
11054444|NCT00983619|12235677|FG003|STARTED|Overall Study||6
11054445|NCT00983619|12235678|FG004|STARTED|Overall Study||3
11054446|NCT00983619|12235679|FG005|STARTED|Overall Study||76
11054447|NCT00983619|12235680|FG006|STARTED|Overall Study||3
11054448|NCT00983619|12235681|FG007|STARTED|Overall Study||3
11054449|NCT00983619|12235682|FG008|STARTED|Overall Study||1
11054450|NCT00983619|12235683|FG009|STARTED|Overall Study||3
11054451|NCT00983619|12235684|FG010|STARTED|Overall Study||17
11054452|NCT00983619|12235685|FG011|STARTED|Overall Study||14
11054453|NCT00983619|12235674|FG000|COMPLETED|Overall Study||0
11054454|NCT00983619|12235675|FG001|COMPLETED|Overall Study||0
11054455|NCT00983619|12235676|FG002|COMPLETED|Overall Study||0
11054456|NCT00983619|12235677|FG003|COMPLETED|Overall Study||1
11054457|NCT00983619|12235678|FG004|COMPLETED|Overall Study||0
11054458|NCT00983619|12235679|FG005|COMPLETED|Overall Study||9
11054459|NCT00983619|12235680|FG006|COMPLETED|Overall Study||0
11054460|NCT00983619|12235681|FG007|COMPLETED|Overall Study||1
11054461|NCT00983619|12235682|FG008|COMPLETED|Overall Study||0
11054462|NCT00983619|12235683|FG009|COMPLETED|Overall Study||0
11054463|NCT00983619|12235684|FG010|COMPLETED|Overall Study||6
11054464|NCT00983619|12235685|FG011|COMPLETED|Overall Study||3
11054465|NCT00983619|12235674|FG000|NOT COMPLETED|Overall Study||3
11054466|NCT00983619|12235675|FG001|NOT COMPLETED|Overall Study||4
11054467|NCT00983619|12235676|FG002|NOT COMPLETED|Overall Study||3
11054468|NCT00983619|12235677|FG003|NOT COMPLETED|Overall Study||5
11054469|NCT00983619|12235678|FG004|NOT COMPLETED|Overall Study||3
11054470|NCT00983619|12235679|FG005|NOT COMPLETED|Overall Study||67
11054471|NCT00983619|12235680|FG006|NOT COMPLETED|Overall Study||3
11054472|NCT00983619|12235681|FG007|NOT COMPLETED|Overall Study||2
11054473|NCT00983619|12235682|FG008|NOT COMPLETED|Overall Study||1
11054474|NCT00983619|12235683|FG009|NOT COMPLETED|Overall Study||3
11054475|NCT00983619|12235684|FG010|NOT COMPLETED|Overall Study||11
11054476|NCT00983619|12235685|FG011|NOT COMPLETED|Overall Study||11
11054477|NCT00983749|12235733|FG000|STARTED|Acute Phase (Enrollment to Hospital DC)||13
11054478|NCT00983749|12235734|FG001|STARTED|Acute Phase (Enrollment to Hospital DC)||10
11338588|NCT02906670|12536207|FG009|COMPLETED|Cohort 1, QW||0
11338589|NCT02906670|12536198|FG000|NOT COMPLETED|Cohort 1, QW||1
11338590|NCT02906670|12536199|FG001|NOT COMPLETED|Cohort 1, QW||0
11338591|NCT02906670|12536200|FG002|NOT COMPLETED|Cohort 1, QW||0
11054479|NCT00983749|12235733|FG000|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
11054480|NCT00983749|12235734|FG001|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
11054481|NCT00983749|12235733|FG000|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
11054482|NCT00983749|12235734|FG001|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
11054483|NCT00983749|12235733|FG000|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
11054484|NCT00983749|12235734|FG001|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
11054485|NCT00983749|12235733|FG000|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
11054486|NCT00983749|12235734|FG001|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
11054487|NCT00983749|12235733|FG000|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
11054488|NCT00983749|12235734|FG001|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
11054489|NCT00983801|12235740|FG000|STARTED|Overall Study|Participants who received treatment.|52
11054490|NCT00983801|12235740|FG000|COMPLETED|Overall Study|Participants who were taken off treatment.|52
11054491|NCT00983801|12235740|FG000|NOT COMPLETED|Overall Study||0
11054492|NCT00983827|12235744|FG000|STARTED|Overall Study||8
11054493|NCT00983827|12235744|FG000|COMPLETED|Overall Study||7
11054494|NCT00983827|12235744|FG000|NOT COMPLETED|Overall Study||1
11054495|NCT00983853|12235754|FG000|STARTED|Overall Study||7
11054496|NCT00983853|12235755|FG001|STARTED|Overall Study|1 subject was randomized but not dosed|7
11054497|NCT00983853|12235756|FG002|STARTED|Overall Study|1 subject was randomized but not dosed|17
11054498|NCT00983853|12235757|FG003|STARTED|Overall Study||8
11054499|NCT00983853|12235758|FG004|STARTED|Overall Study||15
11054500|NCT00983853|12235759|FG005|STARTED|Overall Study||8
11054501|NCT00983853|12235754|FG000|COMPLETED|Overall Study||6
11054502|NCT00983853|12235755|FG001|COMPLETED|Overall Study||5
11054503|NCT00983853|12235756|FG002|COMPLETED|Overall Study||14
11054504|NCT00983853|12235757|FG003|COMPLETED|Overall Study||6
11054505|NCT00983853|12235758|FG004|COMPLETED|Overall Study||12
11054506|NCT00983853|12235759|FG005|COMPLETED|Overall Study||7
11054507|NCT00983853|12235754|FG000|NOT COMPLETED|Overall Study||1
11054508|NCT00983853|12235755|FG001|NOT COMPLETED|Overall Study||2
11054509|NCT00983853|12235756|FG002|NOT COMPLETED|Overall Study||3
11054510|NCT00983853|12235757|FG003|NOT COMPLETED|Overall Study||2
11054511|NCT00983853|12235758|FG004|NOT COMPLETED|Overall Study||3
11054512|NCT00983853|12235759|FG005|NOT COMPLETED|Overall Study||1
11054513|NCT00983892|12235777|FG000|STARTED|Overall Study||66
11054514|NCT00983892|12235778|FG001|STARTED|Overall Study||68
11054515|NCT00983892|12235777|FG000|COMPLETED|Overall Study||56
11054516|NCT00983892|12235778|FG001|COMPLETED|Overall Study||56
11201680|NCT01834261|12392024|FG001|STARTED|MIT fMRI and MEG Resting State Study||10
11205258|NCT01858363|12396007|FG000|Pre-discharge Visit|Overall Study||219
11054517|NCT00983892|12235777|FG000|NOT COMPLETED|Overall Study||10
11054518|NCT00983892|12235778|FG001|NOT COMPLETED|Overall Study||12
11054519|NCT00983905|12235784|FG000|STARTED|Theophylline Alone||30
11054520|NCT00983905|12235784|FG000|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
11054521|NCT00983905|12235784|FG000|NOT COMPLETED|Theophylline Alone||1
11054522|NCT00983905|12235784|FG000|STARTED|4 Day Washout Period||29
11054523|NCT00983905|12235784|FG000|COMPLETED|4 Day Washout Period||29
11054524|NCT00983905|12235784|FG000|NOT COMPLETED|4 Day Washout Period||0
11054525|NCT00983905|12235784|FG000|STARTED|Colchicine Alone||29
11054526|NCT00983905|12235784|FG000|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
11054527|NCT00983905|12235784|FG000|NOT COMPLETED|Colchicine Alone||2
11054528|NCT00983905|12235784|FG000|STARTED|Theophylline With Colchicine||27
11054529|NCT00983905|12235784|FG000|COMPLETED|Theophylline With Colchicine||27
11054530|NCT00983905|12235784|FG000|NOT COMPLETED|Theophylline With Colchicine||0
11054531|NCT00983918|12235795|FG000|STARTED|Overall Study||20
11054532|NCT00983918|12235796|FG001|STARTED|Overall Study||20
11054533|NCT00983918|12235797|FG002|STARTED|Overall Study||20
11054534|NCT00983918|12235798|FG003|STARTED|Overall Study||20
11054535|NCT00983918|12235795|FG000|COMPLETED|Overall Study||20
11054536|NCT00983918|12235796|FG001|COMPLETED|Overall Study||18
11054537|NCT00983918|12235797|FG002|COMPLETED|Overall Study||18
11054538|NCT00983918|12235798|FG003|COMPLETED|Overall Study||18
11054539|NCT00983918|12235795|FG000|NOT COMPLETED|Overall Study||0
11054540|NCT00983918|12235796|FG001|NOT COMPLETED|Overall Study||2
11054541|NCT00983918|12235797|FG002|NOT COMPLETED|Overall Study||2
11054542|NCT00983918|12235798|FG003|NOT COMPLETED|Overall Study||2
11054543|NCT00983931|12235808|FG000|STARTED|Colchicine Alone||24
11054544|NCT00983931|12235808|FG000|COMPLETED|Colchicine Alone||24
11054545|NCT00983931|12235808|FG000|NOT COMPLETED|Colchicine Alone||0
11054546|NCT00983931|12235808|FG000|STARTED|14 Day Washout Period||24
11054547|NCT00983931|12235808|FG000|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
11054548|NCT00983931|12235808|FG000|NOT COMPLETED|14 Day Washout Period||1
11054549|NCT00983931|12235808|FG000|STARTED|Colchicine With Cyclosporine||23
11054550|NCT00983931|12235808|FG000|COMPLETED|Colchicine With Cyclosporine||23
11054551|NCT00983931|12235808|FG000|NOT COMPLETED|Colchicine With Cyclosporine||0
11054552|NCT00983957|12235814|FG000|STARTED|Overall Study||20
11054553|NCT00983957|12235814|FG000|Treatment A|Overall Study||20
11054554|NCT00983957|12235814|FG000|Treatment B|Overall Study||20
11054555|NCT00983957|12235814|FG000|Treatment C|Overall Study||18
11054556|NCT00983957|12235814|FG000|COMPLETED|Overall Study||18
11054557|NCT00983957|12235814|FG000|NOT COMPLETED|Overall Study||2
11054558|NCT00983983|12235827|FG000|STARTED|Overall Study||8
11054559|NCT00983983|12235828|FG001|STARTED|Overall Study||9
11054560|NCT00983983|12235829|FG002|STARTED|Overall Study||7
11054561|NCT00983983|12235827|FG000|COMPLETED|Overall Study||6
11054562|NCT00983983|12235828|FG001|COMPLETED|Overall Study||8
11054563|NCT00983983|12235829|FG002|COMPLETED|Overall Study||6
11054564|NCT00983983|12235827|FG000|NOT COMPLETED|Overall Study||2
11054565|NCT00983983|12235828|FG001|NOT COMPLETED|Overall Study||1
11054566|NCT00983983|12235829|FG002|NOT COMPLETED|Overall Study||1
11054567|NCT00984009|12235838|FG000|STARTED|Colchicine Alone||22
11054568|NCT00984009|12235838|FG000|COMPLETED|Colchicine Alone||22
11054569|NCT00984009|12235838|FG000|NOT COMPLETED|Colchicine Alone||0
11054570|NCT00984009|12235838|FG000|STARTED|14 Day Washout Period||22
11054571|NCT00984009|12235838|FG000|COMPLETED|14 Day Washout Period||22
11054572|NCT00984009|12235838|FG000|NOT COMPLETED|14 Day Washout Period||0
11054573|NCT00984009|12235838|FG000|STARTED|Grapefruit Juice Alone||22
11054574|NCT00984009|12235838|FG000|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
11054575|NCT00984009|12235838|FG000|NOT COMPLETED|Grapefruit Juice Alone||1
11054576|NCT00984009|12235838|FG000|STARTED|Colchicine With Grapefruit Juice||21
11054577|NCT00984009|12235838|FG000|COMPLETED|Colchicine With Grapefruit Juice||21
11338592|NCT02906670|12536201|FG003|NOT COMPLETED|Cohort 1, QW||0
11338593|NCT02906670|12536202|FG004|NOT COMPLETED|Cohort 1, QW||0
11338594|NCT02906670|12536203|FG005|NOT COMPLETED|Cohort 1, QW||0
11338595|NCT02906670|12536204|FG006|NOT COMPLETED|Cohort 1, QW||0
11338596|NCT02906670|12536205|FG007|NOT COMPLETED|Cohort 1, QW||0
11338597|NCT02906670|12536206|FG008|NOT COMPLETED|Cohort 1, QW||0
11338598|NCT02906670|12536207|FG009|NOT COMPLETED|Cohort 1, QW||0
11338599|NCT02906670|12536198|FG000|STARTED|Cohort 2, QW||0
11338600|NCT02906670|12536199|FG001|STARTED|Cohort 2, QW||1
11338601|NCT02906670|12536200|FG002|STARTED|Cohort 2, QW||0
11338602|NCT02906670|12536201|FG003|STARTED|Cohort 2, QW||0
11338603|NCT02906670|12536202|FG004|STARTED|Cohort 2, QW||0
11338604|NCT02906670|12536203|FG005|STARTED|Cohort 2, QW||0
11338605|NCT02906670|12536204|FG006|STARTED|Cohort 2, QW||0
11338606|NCT02906670|12536205|FG007|STARTED|Cohort 2, QW||0
11338607|NCT02906670|12536206|FG008|STARTED|Cohort 2, QW||0
11338608|NCT02906670|12536207|FG009|STARTED|Cohort 2, QW||0
11054578|NCT00984009|12235838|FG000|NOT COMPLETED|Colchicine With Grapefruit Juice||0
11054579|NCT00984022|12235847|FG000|STARTED|Overall Study||43
11054580|NCT00984022|12235848|FG001|STARTED|Overall Study||49
11338609|NCT02906670|12536198|FG000|COMPLETED|Cohort 2, QW||0
11338610|NCT02906670|12536199|FG001|COMPLETED|Cohort 2, QW||0
11338611|NCT02906670|12536200|FG002|COMPLETED|Cohort 2, QW||0
11338612|NCT02906670|12536201|FG003|COMPLETED|Cohort 2, QW||0
11338613|NCT02906670|12536202|FG004|COMPLETED|Cohort 2, QW||0
11338614|NCT02906670|12536203|FG005|COMPLETED|Cohort 2, QW||0
11338615|NCT02906670|12536204|FG006|COMPLETED|Cohort 2, QW||0
11338616|NCT02906670|12536205|FG007|COMPLETED|Cohort 2, QW||0
11338617|NCT02906670|12536206|FG008|COMPLETED|Cohort 2, QW||0
11338618|NCT02906670|12536207|FG009|COMPLETED|Cohort 2, QW||0
11338619|NCT02906670|12536198|FG000|NOT COMPLETED|Cohort 2, QW||0
11054581|NCT00984022|12235847|FG000|COMPLETED|Overall Study||33
11054582|NCT00984022|12235848|FG001|COMPLETED|Overall Study||35
11054583|NCT00984022|12235847|FG000|NOT COMPLETED|Overall Study||10
11054584|NCT00984022|12235848|FG001|NOT COMPLETED|Overall Study||14
11054585|NCT00984061|12235854|FG000|STARTED|Colchicine Alone||24
11054586|NCT00984061|12235854|FG000|COMPLETED|Colchicine Alone||24
11054587|NCT00984061|12235854|FG000|NOT COMPLETED|Colchicine Alone||0
11054588|NCT00984061|12235854|FG000|STARTED|21 Day Washout Period||24
11054589|NCT00984061|12235854|FG000|COMPLETED|21 Day Washout Period||24
11054590|NCT00984061|12235854|FG000|NOT COMPLETED|21 Day Washout Period||0
11054591|NCT00984061|12235854|FG000|STARTED|Clarithromycin Alone||24
11058289|NCT01003106|12240139|FG002|COMPLETED|Baseline to Month 6||0
11338620|NCT02906670|12536199|FG001|NOT COMPLETED|Cohort 2, QW||1
11338621|NCT02906670|12536200|FG002|NOT COMPLETED|Cohort 2, QW||0
11338622|NCT02906670|12536201|FG003|NOT COMPLETED|Cohort 2, QW||0
11338623|NCT02906670|12536202|FG004|NOT COMPLETED|Cohort 2, QW||0
11338624|NCT02906670|12536203|FG005|NOT COMPLETED|Cohort 2, QW||0
11338625|NCT02906670|12536204|FG006|NOT COMPLETED|Cohort 2, QW||0
11338626|NCT02906670|12536205|FG007|NOT COMPLETED|Cohort 2, QW||0
11338627|NCT02906670|12536206|FG008|NOT COMPLETED|Cohort 2, QW||0
11338628|NCT02906670|12536207|FG009|NOT COMPLETED|Cohort 2, QW||0
11338629|NCT02906670|12536198|FG000|STARTED|Cohort 3, QW||0
11338630|NCT02906670|12536199|FG001|STARTED|Cohort 3, QW||0
11054592|NCT00984061|12235854|FG000|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
11054593|NCT00984061|12235854|FG000|NOT COMPLETED|Clarithromycin Alone||1
11054594|NCT00984061|12235854|FG000|STARTED|Colchicine With Clarithromycin||23
11054595|NCT00984061|12235854|FG000|COMPLETED|Colchicine With Clarithromycin||23
11054596|NCT00984061|12235854|FG000|NOT COMPLETED|Colchicine With Clarithromycin||0
11054597|NCT00984126|12235865|FG000|STARTED|Overall Study||27
11054598|NCT00984126|12235866|FG001|STARTED|Overall Study||28
11054599|NCT00984126|12235867|FG002|STARTED|Overall Study||23
11054600|NCT00984126|12235868|FG003|STARTED|Overall Study||135
11054601|NCT00984126|12235865|FG000|COMPLETED|Overall Study||20
11054602|NCT00984126|12235866|FG001|COMPLETED|Overall Study||20
11054603|NCT00984126|12235867|FG002|COMPLETED|Overall Study||16
11054604|NCT00984126|12235868|FG003|COMPLETED|Overall Study||76
11054605|NCT00984126|12235865|FG000|NOT COMPLETED|Overall Study||7
11054606|NCT00984126|12235866|FG001|NOT COMPLETED|Overall Study||8
11054607|NCT00984126|12235867|FG002|NOT COMPLETED|Overall Study||7
11054608|NCT00984126|12235868|FG003|NOT COMPLETED|Overall Study||59
11054609|NCT00984139|12235887|FG000|STARTED|Overall Study||306
11054610|NCT00984139|12235887|FG000|COMPLETED|Overall Study||306
11054611|NCT00984139|12235887|FG000|NOT COMPLETED|Overall Study||0
11054612|NCT00984165|12235895|FG000|STARTED|Overall Study||9
11054613|NCT00984165|12235896|FG001|STARTED|Overall Study||1
11054614|NCT00984165|12235897|FG002|STARTED|Overall Study||4
11054615|NCT00984165|12235898|FG003|STARTED|Overall Study||4
11054616|NCT00984165|12235895|FG000|COMPLETED|Overall Study||2
11054617|NCT00984165|12235896|FG001|COMPLETED|Overall Study||0
11054618|NCT00984165|12235897|FG002|COMPLETED|Overall Study||4
11054619|NCT00984165|12235898|FG003|COMPLETED|Overall Study||0
11054620|NCT00984165|12235895|FG000|NOT COMPLETED|Overall Study||7
11054621|NCT00984165|12235896|FG001|NOT COMPLETED|Overall Study||1
11054622|NCT00984165|12235897|FG002|NOT COMPLETED|Overall Study||0
11054623|NCT00984165|12235898|FG003|NOT COMPLETED|Overall Study||4
11054624|NCT00984204|12235909|FG000|STARTED|Overall Study||188
11054625|NCT00984204|12235909|FG000|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
11054626|NCT00984204|12235909|FG000|NOT COMPLETED|Overall Study||15
11054627|NCT00984256|12235915|FG000|STARTED|Overall Study||6
11054628|NCT00984256|12235916|FG001|STARTED|Overall Study||30
11054629|NCT00984256|12235915|FG000|COMPLETED|Overall Study||6
11054630|NCT00984256|12235916|FG001|COMPLETED|Overall Study||29
11054631|NCT00984256|12235915|FG000|NOT COMPLETED|Overall Study||0
11054632|NCT00984256|12235916|FG001|NOT COMPLETED|Overall Study||1
11054633|NCT00984282|12235933|FG000|STARTED|Double Blind Treatment||207
11054634|NCT00984282|12235934|FG001|STARTED|Double Blind Treatment||210
11054635|NCT00984282|12235933|FG000|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
11054636|NCT00984282|12235934|FG001|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
11054637|NCT00984282|12235933|FG000|COMPLETED|Double Blind Treatment||103
11054638|NCT00984282|12235934|FG001|COMPLETED|Double Blind Treatment||172
11054639|NCT00984282|12235933|FG000|NOT COMPLETED|Double Blind Treatment||104
11054640|NCT00984282|12235934|FG001|NOT COMPLETED|Double Blind Treatment||38
11054641|NCT00984282|12235933|FG000|STARTED|Open-label Treatment||86
11054642|NCT00984282|12235934|FG001|STARTED|Open-label Treatment||161
11054643|NCT00984282|12235933|FG000|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
11054644|NCT00984282|12235934|FG001|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
11054645|NCT00984282|12235933|FG000|COMPLETED|Open-label Treatment||0
11054646|NCT00984282|12235934|FG001|COMPLETED|Open-label Treatment||0
11054647|NCT00984282|12235933|FG000|NOT COMPLETED|Open-label Treatment||86
11054648|NCT00984282|12235934|FG001|NOT COMPLETED|Open-label Treatment||161
11054649|NCT00984282|12235933|FG000|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
11054650|NCT00984282|12235934|FG001|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
11054651|NCT00984282|12235933|FG000|COMPLETED|Long Term Follow-up||3
11054652|NCT00984282|12235934|FG001|COMPLETED|Long Term Follow-up||4
11054653|NCT00984282|12235933|FG000|NOT COMPLETED|Long Term Follow-up||69
11054654|NCT00984282|12235934|FG001|NOT COMPLETED|Long Term Follow-up||120
11054655|NCT00984295|12235945|FG000|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
11054656|NCT00984295|12235946|FG001|STARTED|Overall Study||485
11054657|NCT00984295|12235947|FG002|STARTED|Overall Study||479
11054658|NCT00984295|12235945|FG000|Visit 1|Overall Study||949
11054659|NCT00984295|12235946|FG001|Visit 1|Overall Study||485
11054660|NCT00984295|12235947|FG002|Visit 1|Overall Study||479
11054661|NCT00984295|12235945|FG000|Visit 2|Overall Study||909
11054662|NCT00984295|12235946|FG001|Visit 2|Overall Study||468
11054663|NCT00984295|12235947|FG002|Visit 2|Overall Study||453
11054664|NCT00984295|12235945|FG000|COMPLETED|Overall Study||884
11054665|NCT00984295|12235946|FG001|COMPLETED|Overall Study||453
11054666|NCT00984295|12235947|FG002|COMPLETED|Overall Study||442
11054667|NCT00984295|12235945|FG000|NOT COMPLETED|Overall Study||65
11054668|NCT00984295|12235946|FG001|NOT COMPLETED|Overall Study||32
11054669|NCT00984295|12235947|FG002|NOT COMPLETED|Overall Study||37
11054670|NCT00984308|12235957|FG000|STARTED|Overall Study||110
11054671|NCT00984308|12235958|FG001|STARTED|Overall Study||115
11054672|NCT00984308|12235957|FG000|COMPLETED|Overall Study||92
11054673|NCT00984308|12235958|FG001|COMPLETED|Overall Study||109
11054674|NCT00984308|12235957|FG000|NOT COMPLETED|Overall Study||18
11054675|NCT00984308|12235958|FG001|NOT COMPLETED|Overall Study||6
11054676|NCT00984334|12235969|FG000|STARTED|Overall Study||8
11054677|NCT00984334|12235970|FG001|STARTED|Overall Study||8
11054678|NCT00984334|12235971|FG002|STARTED|Overall Study||8
11054679|NCT00984334|12235972|FG003|STARTED|Overall Study||8
11054680|NCT00984334|12235973|FG004|STARTED|Overall Study||8
11054681|NCT00984334|12235969|FG000|COMPLETED|Overall Study||7
11054682|NCT00984334|12235970|FG001|COMPLETED|Overall Study||7
11054683|NCT00984334|12235971|FG002|COMPLETED|Overall Study||8
11054684|NCT00984334|12235972|FG003|COMPLETED|Overall Study||7
11054685|NCT00984334|12235973|FG004|COMPLETED|Overall Study||7
11054686|NCT00984334|12235969|FG000|NOT COMPLETED|Overall Study||1
11054687|NCT00984334|12235970|FG001|NOT COMPLETED|Overall Study||1
11054688|NCT00984334|12235971|FG002|NOT COMPLETED|Overall Study||0
11054689|NCT00984334|12235972|FG003|NOT COMPLETED|Overall Study||1
11054690|NCT00984334|12235973|FG004|NOT COMPLETED|Overall Study||1
11054691|NCT00984542|12235985|FG000|STARTED|Overall Study||50
11054692|NCT00984542|12235985|FG000|COMPLETED|Overall Study||9
11054693|NCT00984542|12235985|FG000|NOT COMPLETED|Overall Study||41
11054694|NCT00984568|12235992|FG000|STARTED|Overall Study||15
11054695|NCT00984568|12235993|FG001|STARTED|Overall Study||13
11054696|NCT00984568|12235992|FG000|COMPLETED|Overall Study||7
11054697|NCT00984568|12235993|FG001|COMPLETED|Overall Study||7
11054698|NCT00984568|12235992|FG000|NOT COMPLETED|Overall Study||8
11054699|NCT00984568|12235993|FG001|NOT COMPLETED|Overall Study||6
11054700|NCT00984594|12236001|FG000|STARTED|Overall Study||2
11054701|NCT00984594|12236002|FG001|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
11054702|NCT00984594|12236001|FG000|COMPLETED|Overall Study||1
11054703|NCT00984594|12236002|FG001|COMPLETED|Overall Study||1
11054704|NCT00984594|12236001|FG000|NOT COMPLETED|Overall Study||1
11054705|NCT00984594|12236002|FG001|NOT COMPLETED|Overall Study||1
11054706|NCT00984620|12236012|FG000|STARTED|Overall Study||81
11054707|NCT00984620|12236013|FG001|STARTED|Overall Study||79
11054708|NCT00984620|12236012|FG000|COMPLETED|Overall Study||75
11054709|NCT00984620|12236013|FG001|COMPLETED|Overall Study||67
11054710|NCT00984620|12236012|FG000|NOT COMPLETED|Overall Study||6
11054711|NCT00984620|12236013|FG001|NOT COMPLETED|Overall Study||12
11054712|NCT00984659|12236025|FG000|STARTED|2-week Run-in Period||418
11054713|NCT00984659|12236026|FG001|STARTED|2-week Run-in Period||0
11054714|NCT00984659|12236027|FG002|STARTED|2-week Run-in Period||0
11054715|NCT00984659|12236028|FG003|STARTED|2-week Run-in Period||0
11054716|NCT00984659|12236025|FG000|COMPLETED|2-week Run-in Period||366
11054717|NCT00984659|12236026|FG001|COMPLETED|2-week Run-in Period||0
11054718|NCT00984659|12236027|FG002|COMPLETED|2-week Run-in Period||0
11054719|NCT00984659|12236028|FG003|COMPLETED|2-week Run-in Period||0
11054720|NCT00984659|12236025|FG000|NOT COMPLETED|2-week Run-in Period||52
11054721|NCT00984659|12236026|FG001|NOT COMPLETED|2-week Run-in Period||0
11054722|NCT00984659|12236027|FG002|NOT COMPLETED|2-week Run-in Period||0
11054723|NCT00984659|12236028|FG003|NOT COMPLETED|2-week Run-in Period||0
11054724|NCT00984659|12236025|FG000|STARTED|6-week Double-blind Treatment Period||0
11054725|NCT00984659|12236026|FG001|STARTED|6-week Double-blind Treatment Period||75
11054726|NCT00984659|12236027|FG002|STARTED|6-week Double-blind Treatment Period||152
11054727|NCT00984659|12236028|FG003|STARTED|6-week Double-blind Treatment Period||139
11054728|NCT00984659|12236025|FG000|COMPLETED|6-week Double-blind Treatment Period||0
11054729|NCT00984659|12236026|FG001|COMPLETED|6-week Double-blind Treatment Period||69
11054730|NCT00984659|12236027|FG002|COMPLETED|6-week Double-blind Treatment Period||141
11054731|NCT00984659|12236028|FG003|COMPLETED|6-week Double-blind Treatment Period||126
11054732|NCT00984659|12236025|FG000|NOT COMPLETED|6-week Double-blind Treatment Period||0
11054733|NCT00984659|12236026|FG001|NOT COMPLETED|6-week Double-blind Treatment Period||6
11054734|NCT00984659|12236027|FG002|NOT COMPLETED|6-week Double-blind Treatment Period||11
11054735|NCT00984659|12236028|FG003|NOT COMPLETED|6-week Double-blind Treatment Period||13
11054736|NCT00984698|12236037|FG000|STARTED|Overall Study||21
11054737|NCT00984698|12236038|FG001|STARTED|Overall Study||22
11054738|NCT00984698|12236037|FG000|COMPLETED|Overall Study||18
11054739|NCT00984698|12236038|FG001|COMPLETED|Overall Study||14
11054740|NCT00984698|12236037|FG000|NOT COMPLETED|Overall Study||3
11054741|NCT00984698|12236038|FG001|NOT COMPLETED|Overall Study||8
11054742|NCT00984815|12236044|FG000|STARTED|Overall Study||86
11054743|NCT00984815|12236044|FG000|COMPLETED|Overall Study||56
11054744|NCT00984815|12236044|FG000|NOT COMPLETED|Overall Study||30
11054745|NCT00984867|12236050|FG000|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
11054746|NCT00984867|12236051|FG001|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
11338631|NCT02906670|12536200|FG002|STARTED|Cohort 3, QW||4
11338632|NCT02906670|12536201|FG003|STARTED|Cohort 3, QW||0
11338633|NCT02906670|12536202|FG004|STARTED|Cohort 3, QW||0
11338634|NCT02906670|12536203|FG005|STARTED|Cohort 3, QW||0
11338635|NCT02906670|12536204|FG006|STARTED|Cohort 3, QW||0
11338636|NCT02906670|12536205|FG007|STARTED|Cohort 3, QW||0
11338637|NCT02906670|12536206|FG008|STARTED|Cohort 3, QW||0
11338638|NCT02906670|12536207|FG009|STARTED|Cohort 3, QW||0
11338639|NCT02906670|12536198|FG000|COMPLETED|Cohort 3, QW||0
11338640|NCT02906670|12536199|FG001|COMPLETED|Cohort 3, QW||0
11338641|NCT02906670|12536200|FG002|COMPLETED|Cohort 3, QW||0
11338642|NCT02906670|12536201|FG003|COMPLETED|Cohort 3, QW||0
11338643|NCT02906670|12536202|FG004|COMPLETED|Cohort 3, QW||0
11338644|NCT02906670|12536203|FG005|COMPLETED|Cohort 3, QW||0
11054747|NCT00984867|12236050|FG000|COMPLETED|Overall Study||203
11054748|NCT00984867|12236051|FG001|COMPLETED|Overall Study||208
11054749|NCT00984867|12236050|FG000|NOT COMPLETED|Overall Study||23
11054750|NCT00984867|12236051|FG001|NOT COMPLETED|Overall Study||17
11054751|NCT00985010|12236061|FG000|STARTED|Overall Study||4
11054752|NCT00985010|12236062|FG001|STARTED|Overall Study||5
11054753|NCT00985010|12236061|FG000|COMPLETED|Overall Study||4
11054754|NCT00985010|12236062|FG001|COMPLETED|Overall Study||5
11054755|NCT00985010|12236061|FG000|NOT COMPLETED|Overall Study||0
11338645|NCT02906670|12536204|FG006|COMPLETED|Cohort 3, QW||0
11054756|NCT00985010|12236062|FG001|NOT COMPLETED|Overall Study||0
11054757|NCT00985088|12236076|FG000|STARTED|Overall Study||222
11054758|NCT00985088|12236077|FG001|STARTED|Overall Study||114
11054759|NCT00985088|12236078|FG002|STARTED|Overall Study||112
11054760|NCT00985088|12236079|FG003|STARTED|Overall Study||221
11054761|NCT00985088|12236080|FG004|STARTED|Overall Study||223
11054762|NCT00985088|12236081|FG005|STARTED|Overall Study||115
11054763|NCT00985088|12236082|FG006|STARTED|Overall Study||111
11054764|NCT00985088|12236083|FG007|STARTED|Overall Study||222
11054765|NCT00985088|12236076|FG000|COMPLETED|Overall Study||211
11054766|NCT00985088|12236077|FG001|COMPLETED|Overall Study||112
11054767|NCT00985088|12236078|FG002|COMPLETED|Overall Study||108
11054768|NCT00985088|12236079|FG003|COMPLETED|Overall Study||214
11054769|NCT00985088|12236080|FG004|COMPLETED|Overall Study||214
11054770|NCT00985088|12236081|FG005|COMPLETED|Overall Study||108
11054771|NCT00985088|12236082|FG006|COMPLETED|Overall Study||107
11054772|NCT00985088|12236083|FG007|COMPLETED|Overall Study||216
11054773|NCT00985088|12236076|FG000|NOT COMPLETED|Overall Study||11
11054774|NCT00985088|12236077|FG001|NOT COMPLETED|Overall Study||2
11054775|NCT00985088|12236078|FG002|NOT COMPLETED|Overall Study||4
11054776|NCT00985088|12236079|FG003|NOT COMPLETED|Overall Study||7
11054777|NCT00985088|12236080|FG004|NOT COMPLETED|Overall Study||9
11054778|NCT00985088|12236081|FG005|NOT COMPLETED|Overall Study||7
11054779|NCT00985088|12236082|FG006|NOT COMPLETED|Overall Study||4
11054780|NCT00985088|12236083|FG007|NOT COMPLETED|Overall Study||6
11054781|NCT00985114|12236113|FG000|STARTED|Overall Study|38 randomized, 34 received the device|34
11054782|NCT00985114|12236114|FG001|STARTED|Overall Study||39
11054783|NCT00985114|12236113|FG000|Diet + Lifestyle Counseling Cross-over|Overall Study||0
11054784|NCT00985114|12236114|FG001|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
11054785|NCT00985114|12236113|FG000|COMPLETED|Overall Study||33
11054786|NCT00985114|12236114|FG001|COMPLETED|Overall Study||37
11054787|NCT00985114|12236113|FG000|NOT COMPLETED|Overall Study||1
11054788|NCT00985114|12236114|FG001|NOT COMPLETED|Overall Study||2
11054789|NCT00985140|12236120|FG000|STARTED|Overall Study||15
11054790|NCT00985140|12236120|FG000|COMPLETED|Overall Study||15
11054791|NCT00985140|12236120|FG000|NOT COMPLETED|Overall Study||0
11054792|NCT00985153|12236128|FG000|STARTED|Overall Study||985
11054793|NCT00985153|12236129|FG001|STARTED|Overall Study||968
11054794|NCT00985153|12236130|FG002|STARTED|Overall Study||962
11054795|NCT00985153|12236131|FG003|STARTED|Overall Study||1012
11054796|NCT00985153|12236128|FG000|Vaccinated at Visit 1|Overall Study||985
11054797|NCT00985153|12236129|FG001|Vaccinated at Visit 1|Overall Study||968
11054798|NCT00985153|12236130|FG002|Vaccinated at Visit 1|Overall Study||962
11054799|NCT00985153|12236131|FG003|Vaccinated at Visit 1|Overall Study||1012
11054800|NCT00985153|12236128|FG000|COMPLETED|Overall Study||950
11054801|NCT00985153|12236129|FG001|COMPLETED|Overall Study||924
11054802|NCT00985153|12236130|FG002|COMPLETED|Overall Study||918
11054803|NCT00985153|12236131|FG003|COMPLETED|Overall Study||965
11054804|NCT00985153|12236128|FG000|NOT COMPLETED|Overall Study||35
11054805|NCT00985153|12236129|FG001|NOT COMPLETED|Overall Study||44
11054806|NCT00985153|12236130|FG002|NOT COMPLETED|Overall Study||44
11054807|NCT00985153|12236131|FG003|NOT COMPLETED|Overall Study||47
11338646|NCT02906670|12536205|FG007|COMPLETED|Cohort 3, QW||0
11338647|NCT02906670|12536206|FG008|COMPLETED|Cohort 3, QW||0
11338648|NCT02906670|12536207|FG009|COMPLETED|Cohort 3, QW||0
11338649|NCT02906670|12536198|FG000|NOT COMPLETED|Cohort 3, QW||0
11338650|NCT02906670|12536199|FG001|NOT COMPLETED|Cohort 3, QW||0
11338651|NCT02906670|12536200|FG002|NOT COMPLETED|Cohort 3, QW||4
11054808|NCT00985166|12236144|FG000|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
11054809|NCT00985166|12236145|FG001|STARTED|Overall Study||205
11054810|NCT00985166|12236146|FG002|STARTED|Overall Study||195
11054811|NCT00985166|12236144|FG000|Vaccinated at Visit 1|Overall Study||399
11054812|NCT00985166|12236145|FG001|Vaccinated at Visit 1|Overall Study||205
11054813|NCT00985166|12236146|FG002|Vaccinated at Visit 1|Overall Study||195
11054814|NCT00985166|12236144|FG000|COMPLETED|Overall Study||392
11054815|NCT00985166|12236145|FG001|COMPLETED|Overall Study||201
11054816|NCT00985166|12236146|FG002|COMPLETED|Overall Study||188
11054817|NCT00985166|12236144|FG000|NOT COMPLETED|Overall Study||9
11054818|NCT00985166|12236145|FG001|NOT COMPLETED|Overall Study||4
11054819|NCT00985166|12236146|FG002|NOT COMPLETED|Overall Study||7
11054820|NCT00985192|12236156|FG000|STARTED|Overall Study||49
11054821|NCT00985192|12236156|FG000|COMPLETED|Overall Study||45
11054822|NCT00985192|12236156|FG000|NOT COMPLETED|Overall Study||4
11054823|NCT00985231|12236162|FG000|STARTED|Overall Study||133
11054824|NCT00985231|12236163|FG001|STARTED|Overall Study||132
11054825|NCT00985231|12236162|FG000|COMPLETED|Overall Study||130
11054826|NCT00985231|12236163|FG001|COMPLETED|Overall Study||129
11054827|NCT00985231|12236162|FG000|NOT COMPLETED|Overall Study||3
11054828|NCT00985231|12236163|FG001|NOT COMPLETED|Overall Study||3
11054829|NCT00985257|12236169|FG000|STARTED|Overall Study||123
11054830|NCT00985257|12236169|FG000|COMPLETED|Overall Study||123
11054831|NCT00985257|12236169|FG000|NOT COMPLETED|Overall Study||0
11054832|NCT00985426|12236175|FG000|STARTED|Overall Study||258
11054833|NCT00985426|12236176|FG001|STARTED|Overall Study||263
11054834|NCT00985426|12236175|FG000|COMPLETED|Overall Study||215
11054835|NCT00985426|12236176|FG001|COMPLETED|Overall Study||219
11054836|NCT00985426|12236175|FG000|NOT COMPLETED|Overall Study||43
11054837|NCT00985426|12236176|FG001|NOT COMPLETED|Overall Study||44
11054838|NCT00985439|12236186|FG000|STARTED|Overall Study||49
11054839|NCT00985439|12236187|FG001|STARTED|Overall Study||51
11054840|NCT00985439|12236188|FG002|STARTED|Overall Study||51
11054841|NCT00985439|12236189|FG003|STARTED|Overall Study||51
11054842|NCT00985439|12236186|FG000|COMPLETED|Overall Study||49
11054843|NCT00985439|12236187|FG001|COMPLETED|Overall Study||51
11054844|NCT00985439|12236188|FG002|COMPLETED|Overall Study||50
11054845|NCT00985439|12236189|FG003|COMPLETED|Overall Study||51
11054846|NCT00985439|12236186|FG000|NOT COMPLETED|Overall Study||0
11054847|NCT00985439|12236187|FG001|NOT COMPLETED|Overall Study||0
11054848|NCT00985439|12236188|FG002|NOT COMPLETED|Overall Study||1
11054849|NCT00985439|12236189|FG003|NOT COMPLETED|Overall Study||0
11054850|NCT00985465|12236201|FG000|STARTED|Overall Study||141
11054851|NCT00985465|12236202|FG001|STARTED|Overall Study||69
11054852|NCT00985465|12236201|FG000|COMPLETED|Overall Study||140
11054853|NCT00985465|12236202|FG001|COMPLETED|Overall Study||66
11054854|NCT00985465|12236201|FG000|NOT COMPLETED|Overall Study||1
11054855|NCT00985465|12236202|FG001|NOT COMPLETED|Overall Study||3
11054856|NCT00985491|12236209|FG000|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
11054857|NCT00985491|12236209|FG000|Received Device|Overall Study||43
11054858|NCT00985491|12236209|FG000|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
11054859|NCT00985491|12236209|FG000|NOT COMPLETED|Overall Study||19
11054860|NCT00985504|12236216|FG000|STARTED|Acute Treatment Period||244
11054861|NCT00985504|12236217|FG001|STARTED|Acute Treatment Period||239
11054862|NCT00985504|12236216|FG000|COMPLETED|Acute Treatment Period||229
11054863|NCT00985504|12236217|FG001|COMPLETED|Acute Treatment Period||227
11054864|NCT00985504|12236216|FG000|NOT COMPLETED|Acute Treatment Period||15
11054865|NCT00985504|12236217|FG001|NOT COMPLETED|Acute Treatment Period||12
11054866|NCT00985504|12236216|FG000|STARTED|Optimization Period||229
11054867|NCT00985504|12236217|FG001|STARTED|Optimization Period||227
11054868|NCT00985504|12236216|FG000|COMPLETED|Optimization Period||203
11054869|NCT00985504|12236217|FG001|COMPLETED|Optimization Period||204
11054870|NCT00985504|12236216|FG000|NOT COMPLETED|Optimization Period||26
11054871|NCT00985504|12236217|FG001|NOT COMPLETED|Optimization Period||23
11054872|NCT00985517|12236227|FG000|STARTED|Overall Study||3
11054873|NCT00985517|12236228|FG001|STARTED|Overall Study||3
11054874|NCT00985517|12236229|FG002|STARTED|Overall Study||24
11054875|NCT00985517|12236230|FG003|STARTED|Overall Study||27
11054876|NCT00985517|12236227|FG000|COMPLETED|Overall Study||3
11054877|NCT00985517|12236228|FG001|COMPLETED|Overall Study||3
11054878|NCT00985517|12236229|FG002|COMPLETED|Overall Study||23
11054879|NCT00985517|12236230|FG003|COMPLETED|Overall Study||24
11054880|NCT00985517|12236227|FG000|NOT COMPLETED|Overall Study||0
11054881|NCT00985517|12236228|FG001|NOT COMPLETED|Overall Study||0
11054882|NCT00985517|12236229|FG002|NOT COMPLETED|Overall Study||1
11054883|NCT00985517|12236230|FG003|NOT COMPLETED|Overall Study||3
11054884|NCT00985543|12236241|FG000|STARTED|Overall Study||22
11054885|NCT00985543|12236241|FG000|COMPLETED|Overall Study||22
11054886|NCT00985543|12236241|FG000|NOT COMPLETED|Overall Study||0
11054887|NCT00985621|12236251|FG000|STARTED|Overall Study||142
11054888|NCT00985621|12236252|FG001|STARTED|Overall Study||161
11054889|NCT00985621|12236253|FG002|STARTED|Overall Study||152
11054890|NCT00985621|12236254|FG003|STARTED|Overall Study||159
11054891|NCT00985621|12236251|FG000|Treated|Overall Study||141
11054892|NCT00985621|12236252|FG001|Treated|Overall Study||161
11054893|NCT00985621|12236253|FG002|Treated|Overall Study||150
11054894|NCT00985621|12236254|FG003|Treated|Overall Study||158
11054895|NCT00985621|12236251|FG000|COMPLETED|Overall Study||28
11054896|NCT00985621|12236252|FG001|COMPLETED|Overall Study||30
11054897|NCT00985621|12236253|FG002|COMPLETED|Overall Study||29
11054898|NCT00985621|12236254|FG003|COMPLETED|Overall Study||22
11054899|NCT00985621|12236251|FG000|NOT COMPLETED|Overall Study||114
11054900|NCT00985621|12236252|FG001|NOT COMPLETED|Overall Study||131
11054901|NCT00985621|12236253|FG002|NOT COMPLETED|Overall Study||123
11054902|NCT00985621|12236254|FG003|NOT COMPLETED|Overall Study||137
11054903|NCT00985673|12236272|FG000|STARTED|Overall Study||102
11054904|NCT00985673|12236273|FG001|STARTED|Overall Study||104
11054905|NCT00985673|12236274|FG002|STARTED|Overall Study||102
11054906|NCT00985673|12236275|FG003|STARTED|Overall Study||100
11054907|NCT00985673|12236276|FG004|STARTED|Overall Study||101
11054908|NCT00985673|12236277|FG005|STARTED|Overall Study||102
11054909|NCT00985673|12236272|FG000|COMPLETED|Overall Study||95
11054910|NCT00985673|12236273|FG001|COMPLETED|Overall Study||93
11054911|NCT00985673|12236274|FG002|COMPLETED|Overall Study||90
11054912|NCT00985673|12236275|FG003|COMPLETED|Overall Study||88
11054913|NCT00985673|12236276|FG004|COMPLETED|Overall Study||93
11054914|NCT00985673|12236277|FG005|COMPLETED|Overall Study||96
11054915|NCT00985673|12236272|FG000|NOT COMPLETED|Overall Study||7
11054916|NCT00985673|12236273|FG001|NOT COMPLETED|Overall Study||11
11054917|NCT00985673|12236274|FG002|NOT COMPLETED|Overall Study||12
11054918|NCT00985673|12236275|FG003|NOT COMPLETED|Overall Study||12
11054919|NCT00985673|12236276|FG004|NOT COMPLETED|Overall Study||8
11054920|NCT00985673|12236277|FG005|NOT COMPLETED|Overall Study||6
11054921|NCT00985686|12236296|FG000|STARTED|Overall Study||18
11054922|NCT00985686|12236297|FG001|STARTED|Overall Study||16
11054923|NCT00985686|12236298|FG002|STARTED|Overall Study||13
11054924|NCT00985686|12236299|FG003|STARTED|Overall Study||16
11054925|NCT00985686|12236296|FG000|Visit 1: Baseline Data Collection|Overall Study||18
11054926|NCT00985686|12236297|FG001|Visit 1: Baseline Data Collection|Overall Study||15
11054927|NCT00985686|12236298|FG002|Visit 1: Baseline Data Collection|Overall Study||13
11054928|NCT00985686|12236299|FG003|Visit 1: Baseline Data Collection|Overall Study||16
11054929|NCT00985686|12236296|FG000|Visit 2: Data Collection at 8 Weeks|Overall Study||18
11054930|NCT00985686|12236297|FG001|Visit 2: Data Collection at 8 Weeks|Overall Study||15
11054931|NCT00985686|12236298|FG002|Visit 2: Data Collection at 8 Weeks|Overall Study||13
11054932|NCT00985686|12236299|FG003|Visit 2: Data Collection at 8 Weeks|Overall Study||16
11054933|NCT00985686|12236296|FG000|Visit 3: Data Collection at 16 Weeks|Overall Study||17
11054934|NCT00985686|12236297|FG001|Visit 3: Data Collection at 16 Weeks|Overall Study||15
11054935|NCT00985686|12236298|FG002|Visit 3: Data Collection at 16 Weeks|Overall Study||13
11054936|NCT00985686|12236299|FG003|Visit 3: Data Collection at 16 Weeks|Overall Study||16
11054937|NCT00985686|12236296|FG000|Visit 4: Data Collection at 24 Weeks|Overall Study||17
11054938|NCT00985686|12236297|FG001|Visit 4: Data Collection at 24 Weeks|Overall Study||15
11054939|NCT00985686|12236298|FG002|Visit 4: Data Collection at 24 Weeks|Overall Study||13
11054940|NCT00985686|12236299|FG003|Visit 4: Data Collection at 24 Weeks|Overall Study||14
11054941|NCT00985686|12236296|FG000|COMPLETED|Overall Study||17
11054942|NCT00985686|12236297|FG001|COMPLETED|Overall Study||15
11054943|NCT00985686|12236298|FG002|COMPLETED|Overall Study||13
11054944|NCT00985686|12236299|FG003|COMPLETED|Overall Study||14
11054945|NCT00985686|12236296|FG000|NOT COMPLETED|Overall Study||1
11054946|NCT00985686|12236297|FG001|NOT COMPLETED|Overall Study||1
11054947|NCT00985686|12236298|FG002|NOT COMPLETED|Overall Study||0
11054948|NCT00985686|12236299|FG003|NOT COMPLETED|Overall Study||2
11054949|NCT00985712|12236309|FG000|STARTED|Overall Study||133
11054950|NCT00985712|12236310|FG001|STARTED|Overall Study||130
11054951|NCT00985712|12236309|FG000|Received at Least One Dose of Study Drug|Overall Study||131
11054952|NCT00985712|12236310|FG001|Received at Least One Dose of Study Drug|Overall Study||130
11054953|NCT00985712|12236309|FG000|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
11054954|NCT00985712|12236310|FG001|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
11054955|NCT00985712|12236309|FG000|COMPLETED|Overall Study||127
11054956|NCT00985712|12236310|FG001|COMPLETED|Overall Study||123
11054957|NCT00985712|12236309|FG000|NOT COMPLETED|Overall Study||6
11054958|NCT00985712|12236310|FG001|NOT COMPLETED|Overall Study||7
11054959|NCT00985725|12236318|FG000|STARTED|Overall Study||71
11054960|NCT00985725|12236319|FG001|STARTED|Overall Study||72
11054961|NCT00985725|12236318|FG000|COMPLETED|Overall Study||60
11054962|NCT00985725|12236319|FG001|COMPLETED|Overall Study||59
11054963|NCT00985725|12236318|FG000|NOT COMPLETED|Overall Study||11
11054964|NCT00985725|12236319|FG001|NOT COMPLETED|Overall Study||13
11054965|NCT00985751|12236330|FG000|STARTED|Overall Study||51
11054966|NCT00985751|12236331|FG001|STARTED|Overall Study||52
11054967|NCT00985751|12236332|FG002|STARTED|Overall Study||52
11054968|NCT00985751|12236333|FG003|STARTED|Overall Study||51
11054969|NCT00985751|12236334|FG004|STARTED|Overall Study||51
11054970|NCT00985751|12236330|FG000|COMPLETED|Overall Study||51
11054971|NCT00985751|12236331|FG001|COMPLETED|Overall Study||52
11054972|NCT00985751|12236332|FG002|COMPLETED|Overall Study||52
11054973|NCT00985751|12236333|FG003|COMPLETED|Overall Study||51
11054974|NCT00985751|12236334|FG004|COMPLETED|Overall Study||50
11054975|NCT00985751|12236330|FG000|NOT COMPLETED|Overall Study||0
11054976|NCT00985751|12236331|FG001|NOT COMPLETED|Overall Study||0
11054977|NCT00985751|12236332|FG002|NOT COMPLETED|Overall Study||0
11054978|NCT00985751|12236333|FG003|NOT COMPLETED|Overall Study||0
11054979|NCT00985751|12236334|FG004|NOT COMPLETED|Overall Study||1
11054980|NCT00985790|12236351|FG000|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
11054981|NCT00985790|12236352|FG001|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
11054982|NCT00985790|12236351|FG000|COMPLETED|Overall Study||291
11054983|NCT00985790|12236352|FG001|COMPLETED|Overall Study||293
11054984|NCT00985790|12236351|FG000|NOT COMPLETED|Overall Study||7
11054985|NCT00985790|12236352|FG001|NOT COMPLETED|Overall Study||8
11054986|NCT00985829|12236363|FG000|STARTED|Overall Study||28
11054987|NCT00985829|12236363|FG000|COMPLETED|Overall Study||28
11054988|NCT00985829|12236363|FG000|NOT COMPLETED|Overall Study||0
11054989|NCT00985907|12236368|FG000|STARTED|Overall Study||13
11054990|NCT00985907|12236368|FG000|COMPLETED|Overall Study||0
11054991|NCT00985907|12236368|FG000|NOT COMPLETED|Overall Study||13
11054992|NCT00985946|12236372|FG000|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
11054993|NCT00985946|12236372|FG000|COMPLETED|Overall Study||8
11054994|NCT00985946|12236372|FG000|NOT COMPLETED|Overall Study||7
11054995|NCT00985959|12236379|FG000|STARTED|Overall Study|Number of participants treated|6
11054996|NCT00985959|12236380|FG001|STARTED|Overall Study|Number of participants treated|6
11054997|NCT00985959|12236381|FG002|STARTED|Overall Study|Number of participants treated|87
11054998|NCT00985959|12236379|FG000|COMPLETED|Overall Study|Completed all 9 cycles|3
11054999|NCT00985959|12236380|FG001|COMPLETED|Overall Study|Completed all 9 cycles|3
11055000|NCT00985959|12236381|FG002|COMPLETED|Overall Study||28
11055001|NCT00985959|12236379|FG000|NOT COMPLETED|Overall Study||3
11055002|NCT00985959|12236380|FG001|NOT COMPLETED|Overall Study||3
11055003|NCT00985959|12236381|FG002|NOT COMPLETED|Overall Study||59
11055004|NCT00985985|12236399|FG000|STARTED|Overall Study||241
11055005|NCT00985985|12236400|FG001|STARTED|Overall Study||242
11055006|NCT00985985|12236401|FG002|STARTED|Overall Study||120
11055007|NCT00985985|12236402|FG003|STARTED|Overall Study||120
11055008|NCT00985985|12236399|FG000|Safety Population|Overall Study||241
11055009|NCT00985985|12236400|FG001|Safety Population|Overall Study||242
11055010|NCT00985985|12236401|FG002|Safety Population|Overall Study||119
11055011|NCT00985985|12236402|FG003|Safety Population|Overall Study||118
11055012|NCT00985985|12236399|FG000|Full Analysis Set (FAS) Population|Overall Study||241
11055013|NCT00985985|12236400|FG001|Full Analysis Set (FAS) Population|Overall Study||242
11055014|NCT00985985|12236401|FG002|Full Analysis Set (FAS) Population|Overall Study||120
11055015|NCT00985985|12236402|FG003|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
11055016|NCT00985985|12236399|FG000|COMPLETED|Overall Study||217
11055017|NCT00985985|12236400|FG001|COMPLETED|Overall Study||218
11055018|NCT00985985|12236401|FG002|COMPLETED|Overall Study||109
11055019|NCT00985985|12236402|FG003|COMPLETED|Overall Study||107
11055020|NCT00985985|12236399|FG000|NOT COMPLETED|Overall Study||24
11055021|NCT00985985|12236400|FG001|NOT COMPLETED|Overall Study||24
11055022|NCT00985985|12236401|FG002|NOT COMPLETED|Overall Study||11
11055023|NCT00985985|12236402|FG003|NOT COMPLETED|Overall Study||13
11055024|NCT00986102|12236421|FG000|STARTED|Overall Study|Number of participants who received study medication|53
11055025|NCT00986102|12236422|FG001|STARTED|Overall Study|Number of participants who received study medication|77
11055026|NCT00986102|12236423|FG002|STARTED|Overall Study|Number of participants who received study medication|19
11055027|NCT00986102|12236424|FG003|STARTED|Overall Study|Number of participants who received study medication|67
11055028|NCT00986102|12236421|FG000|COMPLETED|Overall Study||52
11055029|NCT00986102|12236422|FG001|COMPLETED|Overall Study||75
11055030|NCT00986102|12236423|FG002|COMPLETED|Overall Study||19
11055031|NCT00986102|12236424|FG003|COMPLETED|Overall Study||66
11055032|NCT00986102|12236421|FG000|NOT COMPLETED|Overall Study||1
11055033|NCT00986102|12236422|FG001|NOT COMPLETED|Overall Study||2
11055034|NCT00986102|12236423|FG002|NOT COMPLETED|Overall Study||0
11055035|NCT00986102|12236424|FG003|NOT COMPLETED|Overall Study||1
11055036|NCT00986154|12236436|FG000|STARTED|Overall Study||4143
11055037|NCT00986154|12236437|FG001|STARTED|Overall Study||4149
11055038|NCT00986154|12236436|FG000|Safety Analysis Set (Received Drug)|Overall Study||4118
11055039|NCT00986154|12236437|FG001|Safety Analysis Set (Received Drug)|Overall Study||4122
11055040|NCT00986154|12236436|FG000|COMPLETED|Overall Study||3937
11055041|NCT00986154|12236437|FG001|COMPLETED|Overall Study||3955
11055042|NCT00986154|12236436|FG000|NOT COMPLETED|Overall Study||206
11055043|NCT00986154|12236437|FG001|NOT COMPLETED|Overall Study||194
11055044|NCT00986180|12236445|FG000|STARTED|Overall Study||321
11055045|NCT00986180|12236446|FG001|STARTED|Overall Study||324
11055046|NCT00986180|12236445|FG000|COMPLETED|Overall Study||277
11055047|NCT00986180|12236446|FG001|COMPLETED|Overall Study||268
11055048|NCT00986180|12236445|FG000|NOT COMPLETED|Overall Study||44
11055049|NCT00986180|12236446|FG001|NOT COMPLETED|Overall Study||56
11055050|NCT00986232|12236456|FG000|STARTED|Overall Study||387
11055051|NCT00986232|12236457|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
11055052|NCT00986232|12236458|FG002|STARTED|Overall Study||381
11055053|NCT00986232|12236459|FG003|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
11055054|NCT00986232|12236456|FG000|Vaccination Visit 1|Overall Study||387
11055055|NCT00986232|12236457|FG001|Vaccination Visit 1|Overall Study||393
11055056|NCT00986232|12236458|FG002|Vaccination Visit 1|Overall Study||381
11055057|NCT00986232|12236459|FG003|Vaccination Visit 1|Overall Study||390
11055058|NCT00986232|12236456|FG000|Vaccination Visit 2|Overall Study||360
11055059|NCT00986232|12236457|FG001|Vaccination Visit 2|Overall Study||365
11055060|NCT00986232|12236458|FG002|Vaccination Visit 2|Overall Study||360
11055061|NCT00986232|12236459|FG003|Vaccination Visit 2|Overall Study||0
11055062|NCT00986232|12236456|FG000|COMPLETED|Overall Study||336
11055063|NCT00986232|12236457|FG001|COMPLETED|Overall Study||343
11055064|NCT00986232|12236458|FG002|COMPLETED|Overall Study||346
11055065|NCT00986232|12236459|FG003|COMPLETED|Overall Study||370
11055066|NCT00986232|12236456|FG000|NOT COMPLETED|Overall Study||51
11055067|NCT00986232|12236457|FG001|NOT COMPLETED|Overall Study||50
11055068|NCT00986232|12236458|FG002|NOT COMPLETED|Overall Study||35
11055069|NCT00986232|12236459|FG003|NOT COMPLETED|Overall Study||20
11055070|NCT00986245|12236475|FG000|STARTED|First Intervention||41
11055071|NCT00986245|12236476|FG001|STARTED|First Intervention||41
11055072|NCT00986245|12236475|FG000|COMPLETED|First Intervention||31
11055073|NCT00986245|12236476|FG001|COMPLETED|First Intervention||33
11055074|NCT00986245|12236475|FG000|NOT COMPLETED|First Intervention||10
11055075|NCT00986245|12236476|FG001|NOT COMPLETED|First Intervention||8
11055076|NCT00986245|12236475|FG000|STARTED|Second Intervention||31
11055077|NCT00986245|12236476|FG001|STARTED|Second Intervention||33
11055078|NCT00986245|12236475|FG000|COMPLETED|Second Intervention||29
11055079|NCT00986245|12236476|FG001|COMPLETED|Second Intervention||32
11055080|NCT00986245|12236475|FG000|NOT COMPLETED|Second Intervention||2
11055081|NCT00986245|12236476|FG001|NOT COMPLETED|Second Intervention||1
11055082|NCT00986258|12236487|FG000|STARTED|Observation Period||136
11055083|NCT00986258|12236487|FG000|COMPLETED|Observation Period||125
11055084|NCT00986258|12236487|FG000|NOT COMPLETED|Observation Period||11
11055085|NCT00986258|12236487|FG000|STARTED|Titration and Optimal Dose Period||125
11055086|NCT00986258|12236487|FG000|COMPLETED|Titration and Optimal Dose Period||102
11055087|NCT00986258|12236487|FG000|NOT COMPLETED|Titration and Optimal Dose Period||23
11055088|NCT00986258|12236487|FG000|STARTED|Maintenance Period||102
11055089|NCT00986258|12236487|FG000|COMPLETED|Maintenance Period||93
11055090|NCT00986258|12236487|FG000|NOT COMPLETED|Maintenance Period||9
11055091|NCT00986349|12236501|FG000|STARTED|Overall Study|attempted implant procedures|23
11055092|NCT00986349|12236501|FG000|Successful Implant Procedure|Overall Study|successful device implant procedure|20
11055093|NCT00986349|12236501|FG000|Early Explant|Overall Study||4
11055094|NCT00986349|12236501|FG000|COMPLETED|Overall Study||16
11055095|NCT00986349|12236501|FG000|NOT COMPLETED|Overall Study||7
11055096|NCT00986362|12236516|FG000|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
11055097|NCT00986362|12236517|FG001|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
11055098|NCT00986362|12236516|FG000|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
11055099|NCT00986362|12236517|FG001|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
11055100|NCT00986362|12236516|FG000|NOT COMPLETED|Overall Study||2
11055101|NCT00986362|12236517|FG001|NOT COMPLETED|Overall Study||1
11055102|NCT00986401|12236525|FG000|STARTED|Period 1||22
11055103|NCT00986401|12236526|FG001|STARTED|Period 1||22
11055104|NCT00986401|12236525|FG000|COMPLETED|Period 1||22
11055105|NCT00986401|12236526|FG001|COMPLETED|Period 1||21
11055106|NCT00986401|12236525|FG000|NOT COMPLETED|Period 1||0
11055107|NCT00986401|12236526|FG001|NOT COMPLETED|Period 1||1
11055108|NCT00986401|12236525|FG000|STARTED|Period 2||22
11055109|NCT00986401|12236526|FG001|STARTED|Period 2||21
11055110|NCT00986401|12236525|FG000|COMPLETED|Period 2||22
11055111|NCT00986401|12236526|FG001|COMPLETED|Period 2||21
11055112|NCT00986401|12236525|FG000|NOT COMPLETED|Period 2||0
11055113|NCT00986401|12236526|FG001|NOT COMPLETED|Period 2||0
11055114|NCT00986427|12236537|FG000|STARTED|Overall Study||12
11055115|NCT00986427|12236538|FG001|STARTED|Overall Study||12
11055116|NCT00986427|12236537|FG000|COMPLETED|Overall Study||8
11055117|NCT00986427|12236538|FG001|COMPLETED|Overall Study||12
11055118|NCT00986427|12236537|FG000|NOT COMPLETED|Overall Study||4
11055119|NCT00986427|12236538|FG001|NOT COMPLETED|Overall Study||0
11055120|NCT00986440|12236550|FG000|STARTED|Overall Study||41
11055121|NCT00986440|12236551|FG001|STARTED|Overall Study||43
11055122|NCT00986440|12236550|FG000|Randomized, But Not Dosed|Overall Study||0
11055123|NCT00986440|12236551|FG001|Randomized, But Not Dosed|Overall Study||1
11055124|NCT00986440|12236550|FG000|COMPLETED|Overall Study||0
11055125|NCT00986440|12236551|FG001|COMPLETED|Overall Study||0
11055126|NCT00986440|12236550|FG000|NOT COMPLETED|Overall Study||41
11055127|NCT00986440|12236551|FG001|NOT COMPLETED|Overall Study||43
11055128|NCT00986453|12236557|FG000|STARTED|Overall Study||45
11055129|NCT00986453|12236557|FG000|COMPLETED|Overall Study||43
11055130|NCT00986453|12236557|FG000|NOT COMPLETED|Overall Study||2
11055131|NCT00986479|12236565|FG000|STARTED|Period 1||12
11055132|NCT00986479|12236566|FG001|STARTED|Period 1||10
11055133|NCT00986479|12236565|FG000|COMPLETED|Period 1||10
11055134|NCT00986479|12236566|FG001|COMPLETED|Period 1||10
11055135|NCT00986479|12236565|FG000|NOT COMPLETED|Period 1||2
11055136|NCT00986479|12236566|FG001|NOT COMPLETED|Period 1||0
11055137|NCT00986479|12236565|FG000|STARTED|Period 2||10
11055138|NCT00986479|12236566|FG001|STARTED|Period 2||10
11055139|NCT00986479|12236565|FG000|COMPLETED|Period 2||10
11055140|NCT00986479|12236566|FG001|COMPLETED|Period 2||10
11055141|NCT00986479|12236565|FG000|NOT COMPLETED|Period 2||0
11055142|NCT00986479|12236566|FG001|NOT COMPLETED|Period 2||0
11055143|NCT00986544|12236574|FG000|STARTED|Overall Study||53
11055144|NCT00986544|12236575|FG001|STARTED|Overall Study||53
11055145|NCT00986544|12236574|FG000|COMPLETED|Overall Study||53
11055146|NCT00986544|12236575|FG001|COMPLETED|Overall Study||53
11055147|NCT00986544|12236574|FG000|NOT COMPLETED|Overall Study||0
11055148|NCT00986544|12236575|FG001|NOT COMPLETED|Overall Study||0
11055149|NCT00986570|12236582|FG000|STARTED|Overall Study||121
11055150|NCT00986570|12236582|FG000|COMPLETED|Overall Study||114
11055151|NCT00986570|12236582|FG000|NOT COMPLETED|Overall Study||7
11058290|NCT01003106|12240140|FG003|COMPLETED|Baseline to Month 6||0
11058291|NCT01003106|12240141|FG004|COMPLETED|Baseline to Month 6||19
11058292|NCT01003106|12240142|FG005|COMPLETED|Baseline to Month 6||20
11058293|NCT01003106|12240143|FG006|COMPLETED|Baseline to Month 6||0
11058294|NCT01003106|12240144|FG007|COMPLETED|Baseline to Month 6||0
11058295|NCT01003106|12240137|FG000|NOT COMPLETED|Baseline to Month 6||0
11058296|NCT01003106|12240138|FG001|NOT COMPLETED|Baseline to Month 6||0
11058297|NCT01003106|12240139|FG002|NOT COMPLETED|Baseline to Month 6||0
11058298|NCT01003106|12240140|FG003|NOT COMPLETED|Baseline to Month 6||0
11058299|NCT01003106|12240141|FG004|NOT COMPLETED|Baseline to Month 6||0
11058300|NCT01003106|12240142|FG005|NOT COMPLETED|Baseline to Month 6||0
11058301|NCT01003106|12240143|FG006|NOT COMPLETED|Baseline to Month 6||0
11058302|NCT01003106|12240144|FG007|NOT COMPLETED|Baseline to Month 6||0
11058303|NCT01003106|12240137|FG000|STARTED|Month 6-Month 36||0
11058304|NCT01003106|12240138|FG001|STARTED|Month 6-Month 36||0
11058305|NCT01003106|12240139|FG002|STARTED|Month 6-Month 36||19
11058306|NCT01003106|12240140|FG003|STARTED|Month 6-Month 36||20
11058307|NCT01003106|12240141|FG004|STARTED|Month 6-Month 36||0
11058308|NCT01003106|12240142|FG005|STARTED|Month 6-Month 36||0
11058309|NCT01003106|12240143|FG006|STARTED|Month 6-Month 36||20
11058310|NCT01003106|12240144|FG007|STARTED|Month 6-Month 36||18
11058311|NCT01003106|12240137|FG000|COMPLETED|Month 6-Month 36||0
11058312|NCT01003106|12240138|FG001|COMPLETED|Month 6-Month 36||0
11058313|NCT01003106|12240139|FG002|COMPLETED|Month 6-Month 36||18
11058314|NCT01003106|12240140|FG003|COMPLETED|Month 6-Month 36||20
11058315|NCT01003106|12240141|FG004|COMPLETED|Month 6-Month 36||0
11058316|NCT01003106|12240142|FG005|COMPLETED|Month 6-Month 36||0
11058317|NCT01003106|12240143|FG006|COMPLETED|Month 6-Month 36||19
11058318|NCT01003106|12240144|FG007|COMPLETED|Month 6-Month 36||18
11058319|NCT01003106|12240137|FG000|NOT COMPLETED|Month 6-Month 36||0
11058320|NCT01003106|12240138|FG001|NOT COMPLETED|Month 6-Month 36||0
11058321|NCT01003106|12240139|FG002|NOT COMPLETED|Month 6-Month 36||1
11058322|NCT01003106|12240140|FG003|NOT COMPLETED|Month 6-Month 36||0
11058323|NCT01003106|12240141|FG004|NOT COMPLETED|Month 6-Month 36||0
11058324|NCT01003106|12240142|FG005|NOT COMPLETED|Month 6-Month 36||0
11058325|NCT01003106|12240143|FG006|NOT COMPLETED|Month 6-Month 36||1
11058326|NCT01003106|12240144|FG007|NOT COMPLETED|Month 6-Month 36||0
11058327|NCT01003184|12240160|FG000|STARTED|Overall Study||111
11058328|NCT01003184|12240161|FG001|STARTED|Overall Study||111
11058329|NCT01003184|12240160|FG000|Full Analysis Set (FAS)|Overall Study||111
11058330|NCT01003184|12240161|FG001|Full Analysis Set (FAS)|Overall Study||105
11058331|NCT01003184|12240160|FG000|COMPLETED|Overall Study||92
11058332|NCT01003184|12240161|FG001|COMPLETED|Overall Study||99
11058333|NCT01003184|12240160|FG000|NOT COMPLETED|Overall Study||19
11058334|NCT01003184|12240161|FG001|NOT COMPLETED|Overall Study||12
11058335|NCT01003210|12240169|FG000|STARTED|Overall Study||105
11058336|NCT01003210|12240170|FG001|STARTED|Overall Study||105
11058337|NCT01003210|12240169|FG000|COMPLETED|Overall Study||104
11058338|NCT01003210|12240170|FG001|COMPLETED|Overall Study||102
11058339|NCT01003210|12240169|FG000|NOT COMPLETED|Overall Study||1
11058340|NCT01003210|12240170|FG001|NOT COMPLETED|Overall Study||3
11058341|NCT01003249|12240176|FG000|STARTED|First Intervention (4 Weeks)||7
11058342|NCT01003249|12240177|FG001|STARTED|First Intervention (4 Weeks)||5
11058343|NCT01003249|12240176|FG000|Received Intervention|First Intervention (4 Weeks)||7
11058344|NCT01003249|12240177|FG001|Received Intervention|First Intervention (4 Weeks)||5
11058345|NCT01003249|12240176|FG000|COMPLETED|First Intervention (4 Weeks)||5
11058346|NCT01003249|12240177|FG001|COMPLETED|First Intervention (4 Weeks)||3
11058347|NCT01003249|12240176|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
11058348|NCT01003249|12240177|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2
11058349|NCT01003249|12240176|FG000|STARTED|Washout (3 Weeks)||4
11058350|NCT01003249|12240177|FG001|STARTED|Washout (3 Weeks)||3
11338652|NCT02906670|12536201|FG003|NOT COMPLETED|Cohort 3, QW||0
11338653|NCT02906670|12536202|FG004|NOT COMPLETED|Cohort 3, QW||0
11338654|NCT02906670|12536203|FG005|NOT COMPLETED|Cohort 3, QW||0
11338655|NCT02906670|12536204|FG006|NOT COMPLETED|Cohort 3, QW||0
11338656|NCT02906670|12536205|FG007|NOT COMPLETED|Cohort 3, QW||0
11338657|NCT02906670|12536206|FG008|NOT COMPLETED|Cohort 3, QW||0
11338658|NCT02906670|12536207|FG009|NOT COMPLETED|Cohort 3, QW||0
11338659|NCT02906670|12536198|FG000|STARTED|Cohort 4, Q2W||0
11338660|NCT02906670|12536199|FG001|STARTED|Cohort 4, Q2W||0
11338661|NCT02906670|12536200|FG002|STARTED|Cohort 4, Q2W||0
11338662|NCT02906670|12536201|FG003|STARTED|Cohort 4, Q2W||0
11338663|NCT02906670|12536202|FG004|STARTED|Cohort 4, Q2W||0
11338664|NCT02906670|12536203|FG005|STARTED|Cohort 4, Q2W||3
11338665|NCT02906670|12536204|FG006|STARTED|Cohort 4, Q2W||0
11338666|NCT02906670|12536205|FG007|STARTED|Cohort 4, Q2W||0
11338667|NCT02906670|12536206|FG008|STARTED|Cohort 4, Q2W||0
11338668|NCT02906670|12536207|FG009|STARTED|Cohort 4, Q2W||0
11338669|NCT02906670|12536198|FG000|COMPLETED|Cohort 4, Q2W||0
11338670|NCT02906670|12536199|FG001|COMPLETED|Cohort 4, Q2W||0
11338671|NCT02906670|12536200|FG002|COMPLETED|Cohort 4, Q2W||0
11055152|NCT00986583|12236588|FG000|STARTED|Overall Study||38
11055153|NCT00986583|12236589|FG001|STARTED|Overall Study||32
11055154|NCT00986583|12236588|FG000|COMPLETED|Overall Study||38
11055155|NCT00986583|12236589|FG001|COMPLETED|Overall Study||32
11055156|NCT00986583|12236588|FG000|NOT COMPLETED|Overall Study||0
11055157|NCT00986583|12236589|FG001|NOT COMPLETED|Overall Study||0
11055158|NCT00986674|12236599|FG000|STARTED|Overall Study||47
11055159|NCT00986674|12236600|FG001|STARTED|Overall Study||45
11055160|NCT00986674|12236601|FG002|STARTED|Overall Study||48
11055161|NCT00986674|12236599|FG000|Treated|Overall Study||43
11055162|NCT00986674|12236600|FG001|Treated|Overall Study||42
11338672|NCT02906670|12536201|FG003|COMPLETED|Cohort 4, Q2W||0
11338673|NCT02906670|12536202|FG004|COMPLETED|Cohort 4, Q2W||0
11338674|NCT02906670|12536203|FG005|COMPLETED|Cohort 4, Q2W||0
11338675|NCT02906670|12536204|FG006|COMPLETED|Cohort 4, Q2W||0
11338676|NCT02906670|12536205|FG007|COMPLETED|Cohort 4, Q2W||0
11338677|NCT02906670|12536206|FG008|COMPLETED|Cohort 4, Q2W||0
11055163|NCT00986674|12236601|FG002|Treated|Overall Study||47
11055164|NCT00986674|12236599|FG000|Eligible and Treated|Overall Study||39
11055165|NCT00986674|12236600|FG001|Eligible and Treated|Overall Study||41
11055166|NCT00986674|12236601|FG002|Eligible and Treated|Overall Study||47
11055167|NCT00986674|12236599|FG000|COMPLETED|Overall Study||0
11055168|NCT00986674|12236600|FG001|COMPLETED|Overall Study||0
11055169|NCT00986674|12236601|FG002|COMPLETED|Overall Study||0
11055170|NCT00986674|12236599|FG000|NOT COMPLETED|Overall Study||47
11055171|NCT00986674|12236600|FG001|NOT COMPLETED|Overall Study||45
11055172|NCT00986674|12236601|FG002|NOT COMPLETED|Overall Study||48
11055173|NCT00986830|12236609|FG000|STARTED|Overall Study||74
11055174|NCT00986830|12236609|FG000|Treated|Overall Study||69
11055175|NCT00986830|12236609|FG000|COMPLETED|Overall Study||66
11055176|NCT00986830|12236609|FG000|NOT COMPLETED|Overall Study||8
11055177|NCT00986856|12236615|FG000|STARTED|Overall Study||42
11055178|NCT00986856|12236616|FG001|STARTED|Overall Study||16
11055179|NCT00986856|12236615|FG000|COMPLETED|Overall Study||42
11055180|NCT00986856|12236616|FG001|COMPLETED|Overall Study||16
11055181|NCT00986856|12236615|FG000|NOT COMPLETED|Overall Study||0
11055182|NCT00986856|12236616|FG001|NOT COMPLETED|Overall Study||0
11055183|NCT00986921|12236624|FG000|STARTED|Overall Study||25
11055184|NCT00986921|12236625|FG001|STARTED|Overall Study||25
11055185|NCT00986921|12236624|FG000|COMPLETED|Overall Study||24
11055186|NCT00986921|12236625|FG001|COMPLETED|Overall Study||25
11055187|NCT00986921|12236624|FG000|NOT COMPLETED|Overall Study||1
11055188|NCT00986921|12236625|FG001|NOT COMPLETED|Overall Study||0
11055189|NCT00986973|12236634|FG000|STARTED|Overall Study||6
11055190|NCT00986973|12236634|FG000|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
11055191|NCT00986973|12236634|FG000|NOT COMPLETED|Overall Study||1
11055192|NCT00986986|12236641|FG000|STARTED|Overall Study||10
11055193|NCT00986986|12236642|FG001|STARTED|Overall Study||10
11055194|NCT00986986|12236641|FG000|COMPLETED|Overall Study||10
11055195|NCT00986986|12236642|FG001|COMPLETED|Overall Study||9
11055196|NCT00986986|12236641|FG000|NOT COMPLETED|Overall Study||0
11055197|NCT00986986|12236642|FG001|NOT COMPLETED|Overall Study||1
11055198|NCT00987337|12236652|FG000|STARTED|Overall Study||96
11055199|NCT00987337|12236653|FG001|STARTED|Overall Study||96
11055200|NCT00987337|12236654|FG002|STARTED|Overall Study||96
11055201|NCT00987337|12236652|FG000|COMPLETED|Overall Study||39
11055202|NCT00987337|12236653|FG001|COMPLETED|Overall Study||41
11055203|NCT00987337|12236654|FG002|COMPLETED|Overall Study||45
11055204|NCT00987337|12236652|FG000|NOT COMPLETED|Overall Study||57
11055205|NCT00987337|12236653|FG001|NOT COMPLETED|Overall Study||55
11055206|NCT00987337|12236654|FG002|NOT COMPLETED|Overall Study||51
11055207|NCT00987389|12236666|FG000|STARTED|Overall Study||176
11055208|NCT00987389|12236667|FG001|STARTED|Overall Study||176
11055209|NCT00987389|12236668|FG002|STARTED|Overall Study||175
11055210|NCT00987389|12236669|FG003|STARTED|Overall Study||177
11055211|NCT00987389|12236666|FG000|COMPLETED|Overall Study||167
11055212|NCT00987389|12236667|FG001|COMPLETED|Overall Study||168
11055213|NCT00987389|12236668|FG002|COMPLETED|Overall Study||167
11055214|NCT00987389|12236669|FG003|COMPLETED|Overall Study||174
11055215|NCT00987389|12236666|FG000|NOT COMPLETED|Overall Study||9
11055216|NCT00987389|12236667|FG001|NOT COMPLETED|Overall Study||8
11055217|NCT00987389|12236668|FG002|NOT COMPLETED|Overall Study||8
11055218|NCT00987389|12236669|FG003|NOT COMPLETED|Overall Study||3
11055219|NCT00987402|12236679|FG000|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
11055220|NCT00987402|12236680|FG001|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
11055221|NCT00987402|12236679|FG000|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
11055222|NCT00987402|12236680|FG001|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
11055223|NCT00987402|12236679|FG000|NOT COMPLETED|Overall Study||86
11055224|NCT00987402|12236680|FG001|NOT COMPLETED|Overall Study||98
11055225|NCT00987415|12236688|FG000|STARTED|Overall Study||128
11055226|NCT00987415|12236689|FG001|STARTED|Overall Study||125
11055227|NCT00987415|12236688|FG000|COMPLETED|Overall Study||119
11055228|NCT00987415|12236689|FG001|COMPLETED|Overall Study||116
11338678|NCT02906670|12536207|FG009|COMPLETED|Cohort 4, Q2W||0
11055229|NCT00987415|12236688|FG000|NOT COMPLETED|Overall Study||9
11055230|NCT00987415|12236689|FG001|NOT COMPLETED|Overall Study||9
11055231|NCT00987467|12236695|FG000|STARTED|Overall Study||12
11055232|NCT00987467|12236695|FG000|COMPLETED|Overall Study||10
11055233|NCT00987467|12236695|FG000|NOT COMPLETED|Overall Study||2
11055234|NCT00987480|12236700|FG000|STARTED|Overall Study||45
11055235|NCT00987480|12236700|FG000|COMPLETED|Overall Study||45
11055236|NCT00987480|12236700|FG000|NOT COMPLETED|Overall Study||0
11055237|NCT00987558|12236704|FG000|STARTED|Overall Study||13
11055238|NCT00987558|12236705|FG001|STARTED|Overall Study||17
11055239|NCT00987558|12236704|FG000|Simvastatin|Overall Study||13
11055240|NCT00987558|12236705|FG001|Simvastatin|Overall Study||12
11055241|NCT00987558|12236704|FG000|Washout|Overall Study||13
11055242|NCT00987558|12236705|FG001|Washout|Overall Study||12
11055243|NCT00987558|12236704|FG000|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
11055244|NCT00987558|12236705|FG001|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
11055245|NCT00987558|12236704|FG000|COMPLETED|Overall Study||12
11055246|NCT00987558|12236705|FG001|COMPLETED|Overall Study||12
11055247|NCT00987558|12236704|FG000|NOT COMPLETED|Overall Study||1
11055248|NCT00987558|12236705|FG001|NOT COMPLETED|Overall Study||5
11055249|NCT00987623|12236714|FG000|STARTED|Overall Study||145
11055250|NCT00987623|12236715|FG001|STARTED|Overall Study||154
11055251|NCT00987623|12236714|FG000|COMPLETED|Overall Study||140
11055252|NCT00987623|12236715|FG001|COMPLETED|Overall Study||151
11055253|NCT00987623|12236714|FG000|NOT COMPLETED|Overall Study||5
11055254|NCT00987623|12236715|FG001|NOT COMPLETED|Overall Study||3
11055255|NCT00987727|12236723|FG000|STARTED|Overall Study||41
11055256|NCT00987727|12236724|FG001|STARTED|Overall Study||41
11055257|NCT00987727|12236723|FG000|COMPLETED|Overall Study||36
11055258|NCT00987727|12236724|FG001|COMPLETED|Overall Study||34
11055259|NCT00987727|12236723|FG000|NOT COMPLETED|Overall Study||5
11055260|NCT00987727|12236724|FG001|NOT COMPLETED|Overall Study||7
11055261|NCT00987831|12236733|FG000|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
11055262|NCT00987831|12236734|FG001|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
11055263|NCT00987831|12236735|FG002|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
11055264|NCT00987831|12236733|FG000|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
11055265|NCT00987831|12236734|FG001|COMPLETED|Overall Study|all controls returned for two visits|52
11055266|NCT00987831|12236735|FG002|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
11055267|NCT00987831|12236733|FG000|NOT COMPLETED|Overall Study||1
11055268|NCT00987831|12236734|FG001|NOT COMPLETED|Overall Study||3
11055269|NCT00987831|12236735|FG002|NOT COMPLETED|Overall Study||0
11055270|NCT00987935|12236753|FG000|STARTED|Overall Study||4
11055271|NCT00987935|12236754|FG001|STARTED|Overall Study||3
11055272|NCT00987935|12236755|FG002|STARTED|Overall Study||3
11055273|NCT00987935|12236756|FG003|STARTED|Overall Study||3
11055274|NCT00987935|12236757|FG004|STARTED|Overall Study||7
11055275|NCT00987935|12236758|FG005|STARTED|Overall Study||3
11055276|NCT00987935|12236759|FG006|STARTED|Overall Study||16
11055277|NCT00987935|12236760|FG007|STARTED|Overall Study||63
11055278|NCT00987935|12236761|FG008|STARTED|Overall Study||32
11055279|NCT00987935|12236753|FG000|COMPLETED|Overall Study||0
11055280|NCT00987935|12236754|FG001|COMPLETED|Overall Study||0
11055281|NCT00987935|12236755|FG002|COMPLETED|Overall Study||0
11055282|NCT00987935|12236756|FG003|COMPLETED|Overall Study||0
11055283|NCT00987935|12236757|FG004|COMPLETED|Overall Study||0
11055284|NCT00987935|12236758|FG005|COMPLETED|Overall Study||0
11055285|NCT00987935|12236759|FG006|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
11055286|NCT00987935|12236760|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
11055287|NCT00987935|12236761|FG008|COMPLETED|Overall Study||0
11055288|NCT00987935|12236753|FG000|NOT COMPLETED|Overall Study||4
11055289|NCT00987935|12236754|FG001|NOT COMPLETED|Overall Study||3
11055290|NCT00987935|12236755|FG002|NOT COMPLETED|Overall Study||3
11055291|NCT00987935|12236756|FG003|NOT COMPLETED|Overall Study||3
11055292|NCT00987935|12236757|FG004|NOT COMPLETED|Overall Study||7
11338679|NCT02906670|12536198|FG000|NOT COMPLETED|Cohort 4, Q2W||0
11338680|NCT02906670|12536199|FG001|NOT COMPLETED|Cohort 4, Q2W||0
11338681|NCT02906670|12536200|FG002|NOT COMPLETED|Cohort 4, Q2W||0
11338682|NCT02906670|12536201|FG003|NOT COMPLETED|Cohort 4, Q2W||0
11338683|NCT02906670|12536202|FG004|NOT COMPLETED|Cohort 4, Q2W||0
11338684|NCT02906670|12536203|FG005|NOT COMPLETED|Cohort 4, Q2W||3
11338685|NCT02906670|12536204|FG006|NOT COMPLETED|Cohort 4, Q2W||0
11338686|NCT02906670|12536205|FG007|NOT COMPLETED|Cohort 4, Q2W||0
11338687|NCT02906670|12536206|FG008|NOT COMPLETED|Cohort 4, Q2W||0
11338688|NCT02906670|12536207|FG009|NOT COMPLETED|Cohort 4, Q2W||0
11338689|NCT02906670|12536198|FG000|STARTED|Cohort 5, Q2W||0
11338690|NCT02906670|12536199|FG001|STARTED|Cohort 5, Q2W||0
11338691|NCT02906670|12536200|FG002|STARTED|Cohort 5, Q2W||0
11338692|NCT02906670|12536201|FG003|STARTED|Cohort 5, Q2W||0
11338693|NCT02906670|12536202|FG004|STARTED|Cohort 5, Q2W||0
11338694|NCT02906670|12536203|FG005|STARTED|Cohort 5, Q2W||0
11338695|NCT02906670|12536204|FG006|STARTED|Cohort 5, Q2W||7
11338696|NCT02906670|12536205|FG007|STARTED|Cohort 5, Q2W||0
11338697|NCT02906670|12536206|FG008|STARTED|Cohort 5, Q2W||0
11338698|NCT02906670|12536207|FG009|STARTED|Cohort 5, Q2W||0
11338699|NCT02906670|12536198|FG000|COMPLETED|Cohort 5, Q2W||0
11338700|NCT02906670|12536199|FG001|COMPLETED|Cohort 5, Q2W||0
11338701|NCT02906670|12536200|FG002|COMPLETED|Cohort 5, Q2W||0
11338702|NCT02906670|12536201|FG003|COMPLETED|Cohort 5, Q2W||0
11338703|NCT02906670|12536202|FG004|COMPLETED|Cohort 5, Q2W||0
11338704|NCT02906670|12536203|FG005|COMPLETED|Cohort 5, Q2W||0
11338705|NCT02906670|12536204|FG006|COMPLETED|Cohort 5, Q2W||0
11338706|NCT02906670|12536205|FG007|COMPLETED|Cohort 5, Q2W||0
11055293|NCT00987935|12236758|FG005|NOT COMPLETED|Overall Study||3
11055294|NCT00987935|12236759|FG006|NOT COMPLETED|Overall Study||15
11055295|NCT00987935|12236760|FG007|NOT COMPLETED|Overall Study||62
11055296|NCT00987935|12236761|FG008|NOT COMPLETED|Overall Study||32
11055297|NCT00987948|12236787|FG000|STARTED|Overall Study||15
11055298|NCT00987948|12236787|FG000|COMPLETED|Overall Study||12
11055299|NCT00987948|12236787|FG000|NOT COMPLETED|Overall Study||3
11055300|NCT00988000|12236794|FG000|STARTED|Overall Study||49
11055301|NCT00988000|12236795|FG001|STARTED|Overall Study||51
11055302|NCT00988000|12236796|FG002|STARTED|Overall Study||57
11055303|NCT00988000|12236794|FG000|COMPLETED|Overall Study||49
11055304|NCT00988000|12236795|FG001|COMPLETED|Overall Study||51
11055305|NCT00988000|12236796|FG002|COMPLETED|Overall Study||57
11055306|NCT00988000|12236794|FG000|NOT COMPLETED|Overall Study||0
11055307|NCT00988000|12236795|FG001|NOT COMPLETED|Overall Study||0
11055308|NCT00988000|12236796|FG002|NOT COMPLETED|Overall Study||0
11055309|NCT00988013|12236810|FG000|STARTED|Overall Study||3
11055310|NCT00988013|12236811|FG001|STARTED|Overall Study||3
11055311|NCT00988013|12236812|FG002|STARTED|Overall Study||6
11055312|NCT00988013|12236813|FG003|STARTED|Overall Study||2
11055313|NCT00988013|12236810|FG000|COMPLETED|Overall Study||3
11055314|NCT00988013|12236811|FG001|COMPLETED|Overall Study||3
11055315|NCT00988013|12236812|FG002|COMPLETED|Overall Study||6
11055316|NCT00988013|12236813|FG003|COMPLETED|Overall Study||2
11055317|NCT00988013|12236810|FG000|NOT COMPLETED|Overall Study||0
11055318|NCT00988013|12236811|FG001|NOT COMPLETED|Overall Study||0
11055319|NCT00988013|12236812|FG002|NOT COMPLETED|Overall Study||0
11055320|NCT00988013|12236813|FG003|NOT COMPLETED|Overall Study||0
11055321|NCT00988065|12236828|FG000|STARTED|Overall Study|Randomized to double-blind treatment|148
11338707|NCT02906670|12536206|FG008|COMPLETED|Cohort 5, Q2W||0
11338708|NCT02906670|12536207|FG009|COMPLETED|Cohort 5, Q2W||0
11338709|NCT02906670|12536198|FG000|NOT COMPLETED|Cohort 5, Q2W||0
11338710|NCT02906670|12536199|FG001|NOT COMPLETED|Cohort 5, Q2W||0
11338711|NCT02906670|12536200|FG002|NOT COMPLETED|Cohort 5, Q2W||0
11338712|NCT02906670|12536201|FG003|NOT COMPLETED|Cohort 5, Q2W||0
11338713|NCT02906670|12536202|FG004|NOT COMPLETED|Cohort 5, Q2W||0
11338714|NCT02906670|12536203|FG005|NOT COMPLETED|Cohort 5, Q2W||0
11338715|NCT02906670|12536204|FG006|NOT COMPLETED|Cohort 5, Q2W||7
11338716|NCT02906670|12536205|FG007|NOT COMPLETED|Cohort 5, Q2W||0
11338717|NCT02906670|12536206|FG008|NOT COMPLETED|Cohort 5, Q2W||0
11338718|NCT02906670|12536207|FG009|NOT COMPLETED|Cohort 5, Q2W||0
11338719|NCT02906670|12536198|FG000|STARTED|Cohort 5P, Q2W||0
11055322|NCT00988065|12236829|FG001|STARTED|Overall Study|Randomized to double-blind treatment|150
11055323|NCT00988065|12236830|FG002|STARTED|Overall Study|Randomized to double-blind treatment|150
11055324|NCT00988065|12236828|FG000|Received First Randomized Dose|Overall Study||148
11055325|NCT00988065|12236829|FG001|Received First Randomized Dose|Overall Study||150
11055326|NCT00988065|12236830|FG002|Received First Randomized Dose|Overall Study||150
11055327|NCT00988065|12236828|FG000|Received Second Randomized Dose|Overall Study||139
11055328|NCT00988065|12236829|FG001|Received Second Randomized Dose|Overall Study||135
11055329|NCT00988065|12236830|FG002|Received Second Randomized Dose|Overall Study||145
11055330|NCT00988065|12236828|FG000|Received Third Randomized Dose|Overall Study||135
11055331|NCT00988065|12236829|FG001|Received Third Randomized Dose|Overall Study||127
11055332|NCT00988065|12236830|FG002|Received Third Randomized Dose|Overall Study||135
11055333|NCT00988065|12236828|FG000|COMPLETED|Overall Study||135
11055334|NCT00988065|12236829|FG001|COMPLETED|Overall Study||127
11055335|NCT00988065|12236830|FG002|COMPLETED|Overall Study||135
11055336|NCT00988065|12236828|FG000|NOT COMPLETED|Overall Study||13
11055337|NCT00988065|12236829|FG001|NOT COMPLETED|Overall Study||23
11055338|NCT00988065|12236830|FG002|NOT COMPLETED|Overall Study||15
11055339|NCT00988091|12236840|FG000|STARTED|Double-blind Period||298
11055340|NCT00988091|12236841|FG001|STARTED|Double-blind Period||298
11055341|NCT00988091|12236840|FG000|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
11055342|NCT00988091|12236841|FG001|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
11055343|NCT00988091|12236840|FG000|COMPLETED|Double-blind Period||255
11055344|NCT00988091|12236841|FG001|COMPLETED|Double-blind Period||251
11055345|NCT00988091|12236840|FG000|NOT COMPLETED|Double-blind Period||43
11338720|NCT02906670|12536199|FG001|STARTED|Cohort 5P, Q2W||0
11338721|NCT02906670|12536200|FG002|STARTED|Cohort 5P, Q2W||0
11338722|NCT02906670|12536201|FG003|STARTED|Cohort 5P, Q2W||0
11338723|NCT02906670|12536202|FG004|STARTED|Cohort 5P, Q2W||0
11338724|NCT02906670|12536203|FG005|STARTED|Cohort 5P, Q2W||0
11338725|NCT02906670|12536204|FG006|STARTED|Cohort 5P, Q2W||0
11338726|NCT02906670|12536205|FG007|STARTED|Cohort 5P, Q2W||3
11338727|NCT02906670|12536206|FG008|STARTED|Cohort 5P, Q2W||0
11338728|NCT02906670|12536207|FG009|STARTED|Cohort 5P, Q2W||0
11055346|NCT00988091|12236841|FG001|NOT COMPLETED|Double-blind Period||47
11055347|NCT00988091|12236840|FG000|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
11055348|NCT00988091|12236841|FG001|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
11055349|NCT00988091|12236840|FG000|COMPLETED|Open-label Period||208
11055350|NCT00988091|12236841|FG001|COMPLETED|Open-label Period||192
11055351|NCT00988091|12236840|FG000|NOT COMPLETED|Open-label Period||21
11055352|NCT00988091|12236841|FG001|NOT COMPLETED|Open-label Period||33
11055353|NCT00988117|12236848|FG000|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
11055354|NCT00988117|12236848|FG000|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
11055355|NCT00988117|12236848|FG000|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
11055356|NCT00988117|12236848|FG000|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
11055357|NCT00988117|12236848|FG000|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
11055358|NCT00988117|12236848|FG000|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
11055359|NCT00988143|12236856|FG000|STARTED|Overall Study||220
11055360|NCT00988143|12236857|FG001|STARTED|Overall Study||190
11055361|NCT00988143|12236858|FG002|STARTED|Overall Study||190
11055362|NCT00988143|12236856|FG000|COMPLETED|Overall Study||220
11055363|NCT00988143|12236857|FG001|COMPLETED|Overall Study||190
11055364|NCT00988143|12236858|FG002|COMPLETED|Overall Study||190
11055365|NCT00988143|12236856|FG000|NOT COMPLETED|Overall Study||0
11055366|NCT00988143|12236857|FG001|NOT COMPLETED|Overall Study||0
11055367|NCT00988143|12236858|FG002|NOT COMPLETED|Overall Study||0
11055368|NCT00988156|12236868|FG000|STARTED|Overall Study||149
11055369|NCT00988156|12236869|FG001|STARTED|Overall Study||155
11055370|NCT00988156|12236868|FG000|Intention-to-Treat Set (ITT)|Overall Study||129
11055371|NCT00988156|12236869|FG001|Intention-to-Treat Set (ITT)|Overall Study||134
11055372|NCT00988156|12236868|FG000|Per Protocol Set (PP)|Overall Study||101
11055373|NCT00988156|12236869|FG001|Per Protocol Set (PP)|Overall Study||97
11055374|NCT00988156|12236868|FG000|Safety Set|Overall Study||129
11055375|NCT00988156|12236869|FG001|Safety Set|Overall Study||134
11055376|NCT00988156|12236868|FG000|COMPLETED|Overall Study||132
11055377|NCT00988156|12236869|FG001|COMPLETED|Overall Study||135
11055378|NCT00988156|12236868|FG000|NOT COMPLETED|Overall Study||17
11055379|NCT00988156|12236869|FG001|NOT COMPLETED|Overall Study||20
11055380|NCT00988169|12236875|FG000|STARTED|Overall Study||6
11055381|NCT00988169|12236875|FG000|COMPLETED|Overall Study||5
11055382|NCT00988169|12236875|FG000|NOT COMPLETED|Overall Study||1
11055383|NCT00988208|12236881|FG000|STARTED|Overall Study||526
11055384|NCT00988208|12236882|FG001|STARTED|Overall Study||533
11055385|NCT00988208|12236881|FG000|Treated|Overall Study||521
11055386|NCT00988208|12236882|FG001|Treated|Overall Study||525
11055387|NCT00988208|12236881|FG000|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
11055388|NCT00988208|12236882|FG001|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
11055389|NCT00988208|12236881|FG000|NOT COMPLETED|Overall Study||431
11055390|NCT00988208|12236882|FG001|NOT COMPLETED|Overall Study||438
11055391|NCT00988221|12236891|FG000|STARTED|Part I||35
11055392|NCT00988221|12236892|FG001|STARTED|Part I||34
11055393|NCT00988221|12236893|FG002|STARTED|Part I||119
11055394|NCT00988221|12236894|FG003|STARTED|Part I|No patients received placebo in Part I of this study.|0
11055395|NCT00988221|12236891|FG000|COMPLETED|Part I||31
11055396|NCT00988221|12236892|FG001|COMPLETED|Part I||24
11055397|NCT00988221|12236893|FG002|COMPLETED|Part I||111
11055398|NCT00988221|12236894|FG003|COMPLETED|Part I||0
11055399|NCT00988221|12236891|FG000|NOT COMPLETED|Part I||4
11055400|NCT00988221|12236892|FG001|NOT COMPLETED|Part I||10
11055401|NCT00988221|12236893|FG002|NOT COMPLETED|Part I||8
11055402|NCT00988221|12236894|FG003|NOT COMPLETED|Part I||0
11055403|NCT00988221|12236891|FG000|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
11055404|NCT00988221|12236892|FG001|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
11055405|NCT00988221|12236893|FG002|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
11055406|NCT00988221|12236894|FG003|STARTED|Part II||84
11055407|NCT00988221|12236891|FG000|COMPLETED|Part II||15
11055408|NCT00988221|12236892|FG001|COMPLETED|Part II||11
11055409|NCT00988221|12236893|FG002|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
11055410|NCT00988221|12236894|FG003|COMPLETED|Part II||81
11055411|NCT00988221|12236891|FG000|NOT COMPLETED|Part II||1
11055412|NCT00988221|12236892|FG001|NOT COMPLETED|Part II||0
11055413|NCT00988221|12236893|FG002|NOT COMPLETED|Part II||3
11055414|NCT00988221|12236894|FG003|NOT COMPLETED|Part II||3
11338729|NCT02906670|12536198|FG000|COMPLETED|Cohort 5P, Q2W||0
11338730|NCT02906670|12536199|FG001|COMPLETED|Cohort 5P, Q2W||0
11338731|NCT02906670|12536200|FG002|COMPLETED|Cohort 5P, Q2W||0
11055415|NCT00988221|12236891|FG000|STARTED|Part III||30
11055416|NCT00988221|12236892|FG001|STARTED|Part III||24
11055417|NCT00988221|12236893|FG002|STARTED|Part III||106
11338732|NCT02906670|12536201|FG003|COMPLETED|Cohort 5P, Q2W||0
11338733|NCT02906670|12536202|FG004|COMPLETED|Cohort 5P, Q2W||0
11338734|NCT02906670|12536203|FG005|COMPLETED|Cohort 5P, Q2W||0
11338735|NCT02906670|12536204|FG006|COMPLETED|Cohort 5P, Q2W||0
11055418|NCT00988221|12236894|FG003|STARTED|Part III|No patients received placebo in Part III of this study.|0
11055419|NCT00988221|12236891|FG000|COMPLETED|Part III||29
11055420|NCT00988221|12236892|FG001|COMPLETED|Part III||23
11055421|NCT00988221|12236893|FG002|COMPLETED|Part III||103
11055422|NCT00988221|12236894|FG003|COMPLETED|Part III||0
11055423|NCT00988221|12236891|FG000|NOT COMPLETED|Part III||1
11055424|NCT00988221|12236892|FG001|NOT COMPLETED|Part III||1
11055425|NCT00988221|12236893|FG002|NOT COMPLETED|Part III||3
11055426|NCT00988221|12236894|FG003|NOT COMPLETED|Part III||0
11055427|NCT00988325|12236916|FG000|STARTED|Overall Study||40
11055428|NCT00988325|12236917|FG001|STARTED|Overall Study||20
11055429|NCT00988325|12236918|FG002|STARTED|Overall Study||5
11055430|NCT00988325|12236916|FG000|COMPLETED|Overall Study||40
11055431|NCT00988325|12236917|FG001|COMPLETED|Overall Study||20
11055432|NCT00988325|12236918|FG002|COMPLETED|Overall Study||5
11055433|NCT00988325|12236916|FG000|NOT COMPLETED|Overall Study||0
11055434|NCT00988325|12236917|FG001|NOT COMPLETED|Overall Study||0
11055435|NCT00988325|12236918|FG002|NOT COMPLETED|Overall Study||0
11055436|NCT00988351|12236932|FG000|STARTED|Overall Study||78
11055437|NCT00988351|12236933|FG001|STARTED|Overall Study||78
11055438|NCT00988351|12236932|FG000|CPAP Titration|Overall Study|8 declined CPAP treatment|78
11055439|NCT00988351|12236933|FG001|CPAP Titration|Overall Study|no titration needed|78
11055440|NCT00988351|12236932|FG000|PAP Setup|Overall Study|CPAP treatment started|70
11055441|NCT00988351|12236933|FG001|PAP Setup|Overall Study|APAP treatment started|78
11055442|NCT00988351|12236932|FG000|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
11055443|NCT00988351|12236933|FG001|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
11055444|NCT00988351|12236932|FG000|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
11055445|NCT00988351|12236933|FG001|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
11055446|NCT00988351|12236932|FG000|COMPLETED|Overall Study||59
11055447|NCT00988351|12236933|FG001|COMPLETED|Overall Study||66
11055448|NCT00988351|12236932|FG000|NOT COMPLETED|Overall Study||19
11055449|NCT00988351|12236933|FG001|NOT COMPLETED|Overall Study||12
11055450|NCT00988429|12236942|FG000|STARTED|Overall Study||226
11055451|NCT00988429|12236943|FG001|STARTED|Overall Study||216
11055452|NCT00988429|12236944|FG002|STARTED|Overall Study||211
11055453|NCT00988429|12236942|FG000|Safety Population|Overall Study||224
11055454|NCT00988429|12236943|FG001|Safety Population|Overall Study||216
11055455|NCT00988429|12236944|FG002|Safety Population|Overall Study||210
11055456|NCT00988429|12236942|FG000|Intention-to-treat (ITT) Population|Overall Study||220
11055457|NCT00988429|12236943|FG001|Intention-to-treat (ITT) Population|Overall Study||215
11055458|NCT00988429|12236944|FG002|Intention-to-treat (ITT) Population|Overall Study||205
11055459|NCT00988429|12236942|FG000|COMPLETED|Overall Study||189
11055460|NCT00988429|12236943|FG001|COMPLETED|Overall Study||173
11055461|NCT00988429|12236944|FG002|COMPLETED|Overall Study||142
11055462|NCT00988429|12236942|FG000|NOT COMPLETED|Overall Study||37
11055463|NCT00988429|12236943|FG001|NOT COMPLETED|Overall Study||43
11055464|NCT00988429|12236944|FG002|NOT COMPLETED|Overall Study||69
11055465|NCT00988442|12236955|FG000|STARTED|Overall Study||30
11055466|NCT00988442|12236956|FG001|STARTED|Overall Study||29
11055467|NCT00988442|12236955|FG000|COMPLETED|Overall Study||0
11055468|NCT00988442|12236956|FG001|COMPLETED|Overall Study||1
11055469|NCT00988442|12236955|FG000|NOT COMPLETED|Overall Study||30
11055470|NCT00988442|12236956|FG001|NOT COMPLETED|Overall Study||28
11055471|NCT00988533|12236965|FG000|STARTED|Overall Study||30
11055472|NCT00988533|12236965|FG000|COMPLETED|Overall Study||27
11055473|NCT00988533|12236965|FG000|NOT COMPLETED|Overall Study||3
11055474|NCT00988559|12236973|FG000|STARTED|Overall Study||10
11055475|NCT00988559|12236974|FG001|STARTED|Overall Study||11
11055476|NCT00988559|12236975|FG002|STARTED|Overall Study||11
11055477|NCT00988559|12236976|FG003|STARTED|Overall Study||7
11055478|NCT00988559|12236973|FG000|COMPLETED|Overall Study||9
11055479|NCT00988559|12236974|FG001|COMPLETED|Overall Study||9
11055480|NCT00988559|12236975|FG002|COMPLETED|Overall Study||9
11055481|NCT00988559|12236976|FG003|COMPLETED|Overall Study||6
11055482|NCT00988559|12236973|FG000|NOT COMPLETED|Overall Study||1
11055483|NCT00988559|12236974|FG001|NOT COMPLETED|Overall Study||2
11055484|NCT00988559|12236975|FG002|NOT COMPLETED|Overall Study||2
11055485|NCT00988559|12236976|FG003|NOT COMPLETED|Overall Study||1
11055486|NCT00988598|12236988|FG000|STARTED|Overall Study||10
11055487|NCT00988598|12236989|FG001|STARTED|Overall Study||5
11055488|NCT00988598|12236988|FG000|COMPLETED|Overall Study||8
11055489|NCT00988598|12236989|FG001|COMPLETED|Overall Study||5
11055490|NCT00988598|12236988|FG000|NOT COMPLETED|Overall Study||2
11055491|NCT00988598|12236989|FG001|NOT COMPLETED|Overall Study||0
11055492|NCT00988832|12236995|FG000|STARTED|Overall Study||380
11055493|NCT00988832|12236995|FG000|COMPLETED|Overall Study||380
11055494|NCT00988832|12236995|FG000|NOT COMPLETED|Overall Study||0
11055495|NCT00988858|12237002|FG000|STARTED|Overall Study||55
11055496|NCT00988858|12237002|FG000|COMPLETED|Overall Study||45
11205259|NCT01858363|12396008|FG001|Pre-discharge Visit|Overall Study||72
11055497|NCT00988858|12237002|FG000|NOT COMPLETED|Overall Study||10
11055498|NCT00988884|12237008|FG000|STARTED|Overall Study||621
11055499|NCT00988884|12237009|FG001|STARTED|Overall Study||620
11055500|NCT00988884|12237008|FG000|COMPLETED|Overall Study||586
11055501|NCT00988884|12237009|FG001|COMPLETED|Overall Study||584
11055502|NCT00988884|12237008|FG000|NOT COMPLETED|Overall Study||35
11055503|NCT00988884|12237009|FG001|NOT COMPLETED|Overall Study||36
11055504|NCT00989014|12237019|FG000|STARTED|Overall Study||31
11055505|NCT00989014|12237020|FG001|STARTED|Overall Study||31
11055506|NCT00989014|12237021|FG002|STARTED|Overall Study||28
11055507|NCT00989014|12237022|FG003|STARTED|Overall Study||32
11055508|NCT00989014|12237019|FG000|COMPLETED|Overall Study||31
11055509|NCT00989014|12237020|FG001|COMPLETED|Overall Study||31
11055510|NCT00989014|12237021|FG002|COMPLETED|Overall Study||28
11055511|NCT00989014|12237022|FG003|COMPLETED|Overall Study||32
11055512|NCT00989014|12237019|FG000|NOT COMPLETED|Overall Study||0
11055513|NCT00989014|12237020|FG001|NOT COMPLETED|Overall Study||0
11055514|NCT00989014|12237021|FG002|NOT COMPLETED|Overall Study||0
11055515|NCT00989014|12237022|FG003|NOT COMPLETED|Overall Study||0
11055516|NCT00989092|12237034|FG000|STARTED|Overall Study||228
11055517|NCT00989092|12237035|FG001|STARTED|Overall Study||59
11055518|NCT00989092|12237034|FG000|Treated With Darbepoetin Alfa|Overall Study||226
11055519|NCT00989092|12237035|FG001|Treated With Darbepoetin Alfa|Overall Study||33
11055520|NCT00989092|12237034|FG000|COMPLETED|Overall Study||138
11055521|NCT00989092|12237035|FG001|COMPLETED|Overall Study||31
11055522|NCT00989092|12237034|FG000|NOT COMPLETED|Overall Study||90
11055523|NCT00989092|12237035|FG001|NOT COMPLETED|Overall Study||28
11055524|NCT00989157|12237044|FG000|STARTED|Overall Study||10
11055525|NCT00989157|12237045|FG001|STARTED|Overall Study||10
11055526|NCT00989157|12237044|FG000|COMPLETED|Overall Study||10
11055527|NCT00989157|12237045|FG001|COMPLETED|Overall Study||10
11055528|NCT00989157|12237044|FG000|NOT COMPLETED|Overall Study||0
11055529|NCT00989157|12237045|FG001|NOT COMPLETED|Overall Study||0
11055530|NCT00989196|12237053|FG000|STARTED|PK Crossover Period||10
11055531|NCT00989196|12237054|FG001|STARTED|PK Crossover Period||12
11055532|NCT00989196|12237053|FG000|COMPLETED|PK Crossover Period||10
11055533|NCT00989196|12237054|FG001|COMPLETED|PK Crossover Period||12
11055534|NCT00989196|12237053|FG000|NOT COMPLETED|PK Crossover Period||0
11055535|NCT00989196|12237054|FG001|NOT COMPLETED|PK Crossover Period||0
11055536|NCT00989196|12237053|FG000|STARTED|Treatment Period||10
11055537|NCT00989196|12237054|FG001|STARTED|Treatment Period||12
11055538|NCT00989196|12237053|FG000|COMPLETED|Treatment Period||9
11055539|NCT00989196|12237054|FG001|COMPLETED|Treatment Period||12
11055540|NCT00989196|12237053|FG000|NOT COMPLETED|Treatment Period||1
11055541|NCT00989196|12237054|FG001|NOT COMPLETED|Treatment Period||0
11055542|NCT00989235|12237062|FG000|STARTED|Overall Study||58
11055543|NCT00989235|12237063|FG001|STARTED|Overall Study||50
11055544|NCT00989235|12237062|FG000|Number Rescued to Open-Label Treatment|Overall Study||4
11338736|NCT02906670|12536205|FG007|COMPLETED|Cohort 5P, Q2W||0
11338737|NCT02906670|12536206|FG008|COMPLETED|Cohort 5P, Q2W||0
11338738|NCT02906670|12536207|FG009|COMPLETED|Cohort 5P, Q2W||0
11338739|NCT02906670|12536198|FG000|NOT COMPLETED|Cohort 5P, Q2W||0
11338740|NCT02906670|12536199|FG001|NOT COMPLETED|Cohort 5P, Q2W||0
11338741|NCT02906670|12536200|FG002|NOT COMPLETED|Cohort 5P, Q2W||0
11338742|NCT02906670|12536201|FG003|NOT COMPLETED|Cohort 5P, Q2W||0
11338743|NCT02906670|12536202|FG004|NOT COMPLETED|Cohort 5P, Q2W||0
11338744|NCT02906670|12536203|FG005|NOT COMPLETED|Cohort 5P, Q2W||0
11338745|NCT02906670|12536204|FG006|NOT COMPLETED|Cohort 5P, Q2W||0
11338746|NCT02906670|12536205|FG007|NOT COMPLETED|Cohort 5P, Q2W||3
11338747|NCT02906670|12536206|FG008|NOT COMPLETED|Cohort 5P, Q2W||0
11338748|NCT02906670|12536207|FG009|NOT COMPLETED|Cohort 5P, Q2W||0
11338749|NCT02906670|12536198|FG000|STARTED|Cohort 6P, Q2W||0
11338750|NCT02906670|12536199|FG001|STARTED|Cohort 6P, Q2W||0
11055545|NCT00989235|12237063|FG001|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
11055546|NCT00989235|12237062|FG000|Number Completing Double-Blind Treatment|Overall Study||51
11055547|NCT00989235|12237063|FG001|Number Completing Double-Blind Treatment|Overall Study||41
11055548|NCT00989235|12237062|FG000|COMPLETED|Overall Study||55
11055549|NCT00989235|12237063|FG001|COMPLETED|Overall Study||44
11055550|NCT00989235|12237062|FG000|NOT COMPLETED|Overall Study||3
11055551|NCT00989235|12237063|FG001|NOT COMPLETED|Overall Study||6
11055552|NCT00989261|12237074|FG000|STARTED|Overall Study||157
11205260|NCT01858363|12396007|FG000|1-month Visit|Overall Study||214
11205261|NCT01858363|12396008|FG001|1-month Visit|Overall Study||68
11205262|NCT01858363|12396007|FG000|6-month Visit|Overall Study||208
11205263|NCT01858363|12396008|FG001|6-month Visit|Overall Study||64
11205264|NCT01858363|12396007|FG000|12-month Vist|Overall Study||205
11055553|NCT00989261|12237075|FG001|STARTED|Overall Study||176
11055554|NCT00989261|12237074|FG000|COMPLETED|Overall Study||142
11055555|NCT00989261|12237075|FG001|COMPLETED|Overall Study||154
11055556|NCT00989261|12237074|FG000|NOT COMPLETED|Overall Study||15
11055557|NCT00989261|12237075|FG001|NOT COMPLETED|Overall Study||22
11055558|NCT00989287|12237083|FG000|STARTED|Overall Study||65
11055559|NCT00989287|12237084|FG001|STARTED|Overall Study||66
11055560|NCT00989287|12237083|FG000|COMPLETED|Overall Study||64
11055561|NCT00989287|12237084|FG001|COMPLETED|Overall Study||65
11055562|NCT00989287|12237083|FG000|NOT COMPLETED|Overall Study||1
11055563|NCT00989287|12237084|FG001|NOT COMPLETED|Overall Study||1
11055564|NCT00989573|12237106|FG000|STARTED|Overall Study||65
11055565|NCT00989573|12237107|FG001|STARTED|Overall Study||63
11055566|NCT00989573|12237108|FG002|STARTED|Overall Study||63
11055567|NCT00989573|12237106|FG000|COMPLETED|Overall Study||52
11055568|NCT00989573|12237107|FG001|COMPLETED|Overall Study||41
11055569|NCT00989573|12237108|FG002|COMPLETED|Overall Study||55
11055570|NCT00989573|12237106|FG000|NOT COMPLETED|Overall Study||13
11055571|NCT00989573|12237107|FG001|NOT COMPLETED|Overall Study||22
11338751|NCT02906670|12536200|FG002|STARTED|Cohort 6P, Q2W||0
11338752|NCT02906670|12536201|FG003|STARTED|Cohort 6P, Q2W||0
11338753|NCT02906670|12536202|FG004|STARTED|Cohort 6P, Q2W||0
11338754|NCT02906670|12536203|FG005|STARTED|Cohort 6P, Q2W||0
11338755|NCT02906670|12536204|FG006|STARTED|Cohort 6P, Q2W||0
11338756|NCT02906670|12536205|FG007|STARTED|Cohort 6P, Q2W||0
11338757|NCT02906670|12536206|FG008|STARTED|Cohort 6P, Q2W||4
11338758|NCT02906670|12536207|FG009|STARTED|Cohort 6P, Q2W||0
11338759|NCT02906670|12536198|FG000|COMPLETED|Cohort 6P, Q2W||0
11338760|NCT02906670|12536199|FG001|COMPLETED|Cohort 6P, Q2W||0
11338761|NCT02906670|12536200|FG002|COMPLETED|Cohort 6P, Q2W||0
11338762|NCT02906670|12536201|FG003|COMPLETED|Cohort 6P, Q2W||0
11338763|NCT02906670|12536202|FG004|COMPLETED|Cohort 6P, Q2W||0
11338764|NCT02906670|12536203|FG005|COMPLETED|Cohort 6P, Q2W||0
11338765|NCT02906670|12536204|FG006|COMPLETED|Cohort 6P, Q2W||0
11338766|NCT02906670|12536205|FG007|COMPLETED|Cohort 6P, Q2W||0
11338767|NCT02906670|12536206|FG008|COMPLETED|Cohort 6P, Q2W||0
11338768|NCT02906670|12536207|FG009|COMPLETED|Cohort 6P, Q2W||0
11338769|NCT02906670|12536198|FG000|NOT COMPLETED|Cohort 6P, Q2W||0
11338770|NCT02906670|12536199|FG001|NOT COMPLETED|Cohort 6P, Q2W||0
11338771|NCT02906670|12536200|FG002|NOT COMPLETED|Cohort 6P, Q2W||0
11338772|NCT02906670|12536201|FG003|NOT COMPLETED|Cohort 6P, Q2W||0
11338773|NCT02906670|12536202|FG004|NOT COMPLETED|Cohort 6P, Q2W||0
11338774|NCT02906670|12536203|FG005|NOT COMPLETED|Cohort 6P, Q2W||0
11338775|NCT02906670|12536204|FG006|NOT COMPLETED|Cohort 6P, Q2W||0
11338776|NCT02906670|12536205|FG007|NOT COMPLETED|Cohort 6P, Q2W||0
11338777|NCT02906670|12536206|FG008|NOT COMPLETED|Cohort 6P, Q2W||4
11338778|NCT02906670|12536207|FG009|NOT COMPLETED|Cohort 6P, Q2W||0
11338779|NCT02906670|12536198|FG000|STARTED|Cohort 4P, QW||0
11338780|NCT02906670|12536199|FG001|STARTED|Cohort 4P, QW||0
11338781|NCT02906670|12536200|FG002|STARTED|Cohort 4P, QW||0
11338782|NCT02906670|12536201|FG003|STARTED|Cohort 4P, QW||3
11338783|NCT02906670|12536202|FG004|STARTED|Cohort 4P, QW||0
11338784|NCT02906670|12536203|FG005|STARTED|Cohort 4P, QW||0
11338785|NCT02906670|12536204|FG006|STARTED|Cohort 4P, QW||0
11055572|NCT00989573|12237108|FG002|NOT COMPLETED|Overall Study||8
11055573|NCT00989586|12237118|FG000|STARTED|Overall Study||18
11338786|NCT02906670|12536205|FG007|STARTED|Cohort 4P, QW||0
11338787|NCT02906670|12536206|FG008|STARTED|Cohort 4P, QW||0
11338788|NCT02906670|12536207|FG009|STARTED|Cohort 4P, QW||0
11338789|NCT02906670|12536198|FG000|COMPLETED|Cohort 4P, QW||0
11338790|NCT02906670|12536199|FG001|COMPLETED|Cohort 4P, QW||0
11338791|NCT02906670|12536200|FG002|COMPLETED|Cohort 4P, QW||0
11338792|NCT02906670|12536201|FG003|COMPLETED|Cohort 4P, QW||0
11338793|NCT02906670|12536202|FG004|COMPLETED|Cohort 4P, QW||0
11338794|NCT02906670|12536203|FG005|COMPLETED|Cohort 4P, QW||0
11338795|NCT02906670|12536204|FG006|COMPLETED|Cohort 4P, QW||0
11338796|NCT02906670|12536205|FG007|COMPLETED|Cohort 4P, QW||0
11338797|NCT02906670|12536206|FG008|COMPLETED|Cohort 4P, QW||0
11338798|NCT02906670|12536207|FG009|COMPLETED|Cohort 4P, QW||0
11338799|NCT02906670|12536198|FG000|NOT COMPLETED|Cohort 4P, QW||0
11338800|NCT02906670|12536199|FG001|NOT COMPLETED|Cohort 4P, QW||0
11338801|NCT02906670|12536200|FG002|NOT COMPLETED|Cohort 4P, QW||0
11338802|NCT02906670|12536201|FG003|NOT COMPLETED|Cohort 4P, QW||3
11338803|NCT02906670|12536202|FG004|NOT COMPLETED|Cohort 4P, QW||0
11338804|NCT02906670|12536203|FG005|NOT COMPLETED|Cohort 4P, QW||0
11338805|NCT02906670|12536204|FG006|NOT COMPLETED|Cohort 4P, QW||0
11338806|NCT02906670|12536205|FG007|NOT COMPLETED|Cohort 4P, QW||0
11338807|NCT02906670|12536206|FG008|NOT COMPLETED|Cohort 4P, QW||0
11338808|NCT02906670|12536207|FG009|NOT COMPLETED|Cohort 4P, QW||0
11338809|NCT02906670|12536198|FG000|STARTED|Cohort 7P, Q2W||0
11338810|NCT02906670|12536199|FG001|STARTED|Cohort 7P, Q2W||0
11338811|NCT02906670|12536200|FG002|STARTED|Cohort 7P, Q2W||0
11338812|NCT02906670|12536201|FG003|STARTED|Cohort 7P, Q2W||0
11338813|NCT02906670|12536202|FG004|STARTED|Cohort 7P, Q2W||0
11338814|NCT02906670|12536203|FG005|STARTED|Cohort 7P, Q2W||0
11338815|NCT02906670|12536204|FG006|STARTED|Cohort 7P, Q2W||0
11338816|NCT02906670|12536205|FG007|STARTED|Cohort 7P, Q2W||0
11338817|NCT02906670|12536206|FG008|STARTED|Cohort 7P, Q2W||0
11055574|NCT00989586|12237119|FG001|STARTED|Overall Study||17
11055575|NCT00989586|12237118|FG000|COMPLETED|Overall Study||18
11055576|NCT00989586|12237119|FG001|COMPLETED|Overall Study||17
11055577|NCT00989586|12237118|FG000|NOT COMPLETED|Overall Study||0
11055578|NCT00989586|12237119|FG001|NOT COMPLETED|Overall Study||0
11055579|NCT00989612|12237126|FG000|STARTED|Overall Study||100
11055580|NCT00989612|12237126|FG000|COMPLETED|Overall Study||100
11055581|NCT00989612|12237126|FG000|NOT COMPLETED|Overall Study||0
11055582|NCT00989664|12237132|FG000|STARTED|Dosimetric and Therapeutic Treatment||61
11055583|NCT00989664|12237132|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
11055584|NCT00989664|12237132|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
11055585|NCT00989664|12237132|FG000|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
11055586|NCT00989664|12237132|FG000|COMPLETED|Long-Term Follow-Up||11
11055587|NCT00989664|12237132|FG000|NOT COMPLETED|Long-Term Follow-Up||3
11055588|NCT00989768|12237138|FG000|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
11201681|NCT01834261|12392023|FG000|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
11201682|NCT01834261|12392024|FG001|COMPLETED|MIT fMRI and MEG Resting State Study||9
11201683|NCT01834261|12392023|FG000|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
11201684|NCT01834261|12392024|FG001|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
11201685|NCT01834261|12392023|FG000|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
11201686|NCT01834261|12392024|FG001|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
11201687|NCT01834261|12392023|FG000|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
11201688|NCT01834261|12392024|FG001|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
11201689|NCT01834261|12392023|FG000|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
11201690|NCT01834261|12392024|FG001|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
11201691|NCT01834274|12392032|FG000|STARTED|Overall Study||50
11201692|NCT01834274|12392033|FG001|STARTED|Overall Study||46
11201693|NCT01834274|12392032|FG000|COMPLETED|Overall Study||3
11201694|NCT01834274|12392033|FG001|COMPLETED|Overall Study||5
11201695|NCT01834274|12392032|FG000|NOT COMPLETED|Overall Study||47
11201696|NCT01834274|12392033|FG001|NOT COMPLETED|Overall Study||41
11201697|NCT01834326|12392041|FG000|STARTED|Overall Study||10
11201698|NCT01834326|12392042|FG001|STARTED|Overall Study||8
11201699|NCT01834326|12392041|FG000|COMPLETED|Overall Study||8
11201700|NCT01834326|12392042|FG001|COMPLETED|Overall Study||2
11201701|NCT01834326|12392041|FG000|NOT COMPLETED|Overall Study||2
11201702|NCT01834326|12392042|FG001|NOT COMPLETED|Overall Study||6
11201703|NCT01834404|12392050|FG000|STARTED|Overall Study||12
11201704|NCT01834404|12392051|FG001|STARTED|Overall Study||12
11201705|NCT01834404|12392050|FG000|COMPLETED|Overall Study||12
11201706|NCT01834404|12392051|FG001|COMPLETED|Overall Study||12
11201707|NCT01834404|12392050|FG000|NOT COMPLETED|Overall Study||0
11201708|NCT01834404|12392051|FG001|NOT COMPLETED|Overall Study||0
11201709|NCT01834586|12392057|FG000|STARTED|Overall Study||30
11201710|NCT01834586|12392057|FG000|COMPLETED|Overall Study||29
11201711|NCT01834586|12392057|FG000|NOT COMPLETED|Overall Study||1
11201712|NCT01834651|12392061|FG000|STARTED|Overall Study||17
11201713|NCT01834651|12392061|FG000|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
11201714|NCT01834651|12392061|FG000|NOT COMPLETED|Overall Study||1
11201715|NCT01834716|12392069|FG000|STARTED|Overall Study||4
11201716|NCT01834716|12392070|FG001|STARTED|Overall Study||12
11201717|NCT01834716|12392069|FG000|COMPLETED|Overall Study||4
11201718|NCT01834716|12392070|FG001|COMPLETED|Overall Study||11
11201719|NCT01834716|12392069|FG000|NOT COMPLETED|Overall Study||0
11201720|NCT01834716|12392070|FG001|NOT COMPLETED|Overall Study||1
11201721|NCT01834729|12392080|FG000|STARTED|Overall Study||18
11338818|NCT02906670|12536207|FG009|STARTED|Cohort 7P, Q2W||3
11338819|NCT02906670|12536198|FG000|COMPLETED|Cohort 7P, Q2W||0
11338820|NCT02906670|12536199|FG001|COMPLETED|Cohort 7P, Q2W||0
11338821|NCT02906670|12536200|FG002|COMPLETED|Cohort 7P, Q2W||0
11338822|NCT02906670|12536201|FG003|COMPLETED|Cohort 7P, Q2W||0
11338823|NCT02906670|12536202|FG004|COMPLETED|Cohort 7P, Q2W||0
11338824|NCT02906670|12536203|FG005|COMPLETED|Cohort 7P, Q2W||0
11338825|NCT02906670|12536204|FG006|COMPLETED|Cohort 7P, Q2W||0
11338826|NCT02906670|12536205|FG007|COMPLETED|Cohort 7P, Q2W||0
11338827|NCT02906670|12536206|FG008|COMPLETED|Cohort 7P, Q2W||0
11338828|NCT02906670|12536207|FG009|COMPLETED|Cohort 7P, Q2W||0
11338829|NCT02906670|12536198|FG000|NOT COMPLETED|Cohort 7P, Q2W||0
11338830|NCT02906670|12536199|FG001|NOT COMPLETED|Cohort 7P, Q2W||0
11201722|NCT01834729|12392081|FG001|STARTED|Overall Study||20
11201723|NCT01834729|12392082|FG002|STARTED|Overall Study||18
11201724|NCT01834729|12392083|FG003|STARTED|Overall Study||18
11201725|NCT01834729|12392080|FG000|COMPLETED|Overall Study||17
11201726|NCT01834729|12392081|FG001|COMPLETED|Overall Study||19
11201727|NCT01834729|12392082|FG002|COMPLETED|Overall Study||15
11201728|NCT01834729|12392083|FG003|COMPLETED|Overall Study||16
11201729|NCT01834729|12392080|FG000|NOT COMPLETED|Overall Study||1
11201730|NCT01834729|12392081|FG001|NOT COMPLETED|Overall Study||1
11338831|NCT02906670|12536200|FG002|NOT COMPLETED|Cohort 7P, Q2W||0
11055589|NCT00989768|12237138|FG000|COMPLETED|Overall Study||28
11055590|NCT00989768|12237138|FG000|NOT COMPLETED|Overall Study||1
11055591|NCT00989781|12237148|FG000|STARTED|Ovarian Response to hCG||21
11055592|NCT00989781|12237149|FG001|STARTED|Ovarian Response to hCG||20
11055593|NCT00989781|12237148|FG000|COMPLETED|Ovarian Response to hCG||18
11055594|NCT00989781|12237149|FG001|COMPLETED|Ovarian Response to hCG||18
11055595|NCT00989781|12237148|FG000|NOT COMPLETED|Ovarian Response to hCG||3
11055596|NCT00989781|12237149|FG001|NOT COMPLETED|Ovarian Response to hCG||2
11055597|NCT00989781|12237148|FG000|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
11055598|NCT00989781|12237149|FG001|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
11055599|NCT00989781|12237148|FG000|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
11055600|NCT00989781|12237149|FG001|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
11055601|NCT00989781|12237148|FG000|NOT COMPLETED|Adrenal Response ot ACTH||5
11055602|NCT00989781|12237149|FG001|NOT COMPLETED|Adrenal Response ot ACTH||3
11055603|NCT00989833|12237159|FG000|STARTED|Overall Study||21
11055604|NCT00989833|12237160|FG001|STARTED|Overall Study||22
11055605|NCT00989833|12237161|FG002|STARTED|Overall Study||23
11055606|NCT00989833|12237159|FG000|COMPLETED|Overall Study||19
11055607|NCT00989833|12237160|FG001|COMPLETED|Overall Study||19
11055608|NCT00989833|12237161|FG002|COMPLETED|Overall Study||21
11055609|NCT00989833|12237159|FG000|NOT COMPLETED|Overall Study||2
11055610|NCT00989833|12237160|FG001|NOT COMPLETED|Overall Study||3
11055611|NCT00989833|12237161|FG002|NOT COMPLETED|Overall Study||2
11055612|NCT00989911|12237169|FG000|STARTED|Overall Study||10
11055613|NCT00989911|12237169|FG000|COMPLETED|Overall Study||7
11055614|NCT00989911|12237169|FG000|NOT COMPLETED|Overall Study||3
11055615|NCT00989950|12237177|FG000|STARTED|Open Label Dose Optimization||6
11055616|NCT00989950|12237178|FG001|STARTED|Open Label Dose Optimization||9
11055617|NCT00989950|12237179|FG002|STARTED|Open Label Dose Optimization||4
11055618|NCT00989950|12237180|FG003|STARTED|Open Label Dose Optimization||7
11055619|NCT00989950|12237177|FG000|COMPLETED|Open Label Dose Optimization||6
11055620|NCT00989950|12237178|FG001|COMPLETED|Open Label Dose Optimization||9
11055621|NCT00989950|12237179|FG002|COMPLETED|Open Label Dose Optimization||4
11055622|NCT00989950|12237180|FG003|COMPLETED|Open Label Dose Optimization||7
11055623|NCT00989950|12237177|FG000|NOT COMPLETED|Open Label Dose Optimization||0
11055624|NCT00989950|12237178|FG001|NOT COMPLETED|Open Label Dose Optimization||0
11055625|NCT00989950|12237179|FG002|NOT COMPLETED|Open Label Dose Optimization||0
11055626|NCT00989950|12237180|FG003|NOT COMPLETED|Open Label Dose Optimization||0
11055627|NCT00989950|12237177|FG000|STARTED|Randomized Phase||6
11055628|NCT00989950|12237178|FG001|STARTED|Randomized Phase||9
11055629|NCT00989950|12237179|FG002|STARTED|Randomized Phase||4
11055630|NCT00989950|12237180|FG003|STARTED|Randomized Phase||7
11055631|NCT00989950|12237177|FG000|COMPLETED|Randomized Phase||5
11055632|NCT00989950|12237178|FG001|COMPLETED|Randomized Phase||8
11055633|NCT00989950|12237179|FG002|COMPLETED|Randomized Phase||4
11055634|NCT00989950|12237180|FG003|COMPLETED|Randomized Phase||7
11055635|NCT00989950|12237177|FG000|NOT COMPLETED|Randomized Phase||1
11055636|NCT00989950|12237178|FG001|NOT COMPLETED|Randomized Phase||1
11055637|NCT00989950|12237179|FG002|NOT COMPLETED|Randomized Phase||0
11055638|NCT00989950|12237180|FG003|NOT COMPLETED|Randomized Phase||0
11055639|NCT00989963|12237193|FG000|STARTED|Overall Study||12
11055640|NCT00989963|12237194|FG001|STARTED|Overall Study||12
11055641|NCT00989963|12237195|FG002|STARTED|Overall Study||12
11055642|NCT00989963|12237193|FG000|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|13
11055643|NCT00989963|12237194|FG001|Safety Population|Overall Study||12
11055644|NCT00989963|12237195|FG002|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|11
11055645|NCT00989963|12237193|FG000|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|12
11055646|NCT00989963|12237194|FG001|Per-Protocol Population|Overall Study||11
11055647|NCT00989963|12237195|FG002|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|10
11055648|NCT00989963|12237193|FG000|COMPLETED|Overall Study||11
11055649|NCT00989963|12237194|FG001|COMPLETED|Overall Study||11
11055650|NCT00989963|12237195|FG002|COMPLETED|Overall Study||11
11055651|NCT00989963|12237193|FG000|NOT COMPLETED|Overall Study||1
11055652|NCT00989963|12237194|FG001|NOT COMPLETED|Overall Study||1
11055653|NCT00989963|12237195|FG002|NOT COMPLETED|Overall Study||1
11055654|NCT00989989|12237206|FG000|STARTED|Overall Study||132
11055655|NCT00989989|12237207|FG001|STARTED|Overall Study||133
11055656|NCT00989989|12237208|FG002|STARTED|Overall Study||131
11055657|NCT00989989|12237206|FG000|COMPLETED|Overall Study||114
11055658|NCT00989989|12237207|FG001|COMPLETED|Overall Study||123
11055659|NCT00989989|12237208|FG002|COMPLETED|Overall Study||108
11055660|NCT00989989|12237206|FG000|NOT COMPLETED|Overall Study||18
11055661|NCT00989989|12237207|FG001|NOT COMPLETED|Overall Study||10
11055662|NCT00989989|12237208|FG002|NOT COMPLETED|Overall Study||23
11055663|NCT00990093|12237216|FG000|STARTED|Test Period 1 (1-14 Days)||19
11055664|NCT00990093|12237217|FG001|STARTED|Test Period 1 (1-14 Days)||17
11055665|NCT00990093|12237216|FG000|COMPLETED|Test Period 1 (1-14 Days)||15
11055666|NCT00990093|12237217|FG001|COMPLETED|Test Period 1 (1-14 Days)||15
11055667|NCT00990093|12237216|FG000|NOT COMPLETED|Test Period 1 (1-14 Days)||4
11055668|NCT00990093|12237217|FG001|NOT COMPLETED|Test Period 1 (1-14 Days)||2
11055669|NCT00990093|12237216|FG000|STARTED|Test Period 2 (15-28 Days)||15
11055670|NCT00990093|12237217|FG001|STARTED|Test Period 2 (15-28 Days)||15
11055671|NCT00990093|12237216|FG000|COMPLETED|Test Period 2 (15-28 Days)||13
11055672|NCT00990093|12237217|FG001|COMPLETED|Test Period 2 (15-28 Days)||14
11055673|NCT00990093|12237216|FG000|NOT COMPLETED|Test Period 2 (15-28 Days)||2
11055674|NCT00990093|12237217|FG001|NOT COMPLETED|Test Period 2 (15-28 Days)||1
11055675|NCT00990106|12237225|FG000|STARTED|Overall Study||32
11055676|NCT00990106|12237226|FG001|STARTED|Overall Study||35
11055677|NCT00990106|12237225|FG000|COMPLETED|Overall Study||23
11055678|NCT00990106|12237226|FG001|COMPLETED|Overall Study||23
11055679|NCT00990106|12237225|FG000|NOT COMPLETED|Overall Study||9
11055680|NCT00990106|12237226|FG001|NOT COMPLETED|Overall Study||12
11055681|NCT00990184|12237232|FG000|STARTED|Overall Study||21
11055682|NCT00990184|12237232|FG000|COMPLETED|Overall Study||20
11055683|NCT00990184|12237232|FG000|NOT COMPLETED|Overall Study||1
11055684|NCT00990236|12237240|FG000|STARTED|Overall Study||89
11055685|NCT00990236|12237241|FG001|STARTED|Overall Study||96
11055686|NCT00990236|12237240|FG000|COMPLETED|Overall Study||89
11055687|NCT00990236|12237241|FG001|COMPLETED|Overall Study||96
11055688|NCT00990236|12237240|FG000|NOT COMPLETED|Overall Study||0
11055689|NCT00990236|12237241|FG001|NOT COMPLETED|Overall Study||0
11055690|NCT00990249|12237247|FG000|STARTED|Overall Study||120
11055691|NCT00990249|12237247|FG000|COMPLETED|Overall Study||107
11055692|NCT00990249|12237247|FG000|NOT COMPLETED|Overall Study||13
11055693|NCT00990288|12237253|FG000|STARTED|Overall Study||97
11055694|NCT00990288|12237254|FG001|STARTED|Overall Study||99
11055695|NCT00990288|12237253|FG000|COMPLETED|Overall Study||97
11055696|NCT00990288|12237254|FG001|COMPLETED|Overall Study||99
11055697|NCT00990288|12237253|FG000|NOT COMPLETED|Overall Study||0
11055698|NCT00990288|12237254|FG001|NOT COMPLETED|Overall Study||0
11055699|NCT00990314|12237260|FG000|STARTED|Overall Study||31
11055700|NCT00990314|12237260|FG000|COMPLETED|Overall Study||19
11055701|NCT00990314|12237260|FG000|NOT COMPLETED|Overall Study||12
11055702|NCT00990340|12237266|FG000|STARTED|First 14-day Treatment||27
11055703|NCT00990340|12237267|FG001|STARTED|First 14-day Treatment||25
11055704|NCT00990340|12237266|FG000|COMPLETED|First 14-day Treatment||21
11055705|NCT00990340|12237267|FG001|COMPLETED|First 14-day Treatment||21
11055706|NCT00990340|12237266|FG000|NOT COMPLETED|First 14-day Treatment||6
11055707|NCT00990340|12237267|FG001|NOT COMPLETED|First 14-day Treatment||4
11055708|NCT00990340|12237266|FG000|STARTED|Second 14-day Treatment||21
11055709|NCT00990340|12237267|FG001|STARTED|Second 14-day Treatment||21
11055710|NCT00990340|12237266|FG000|COMPLETED|Second 14-day Treatment||21
11055711|NCT00990340|12237267|FG001|COMPLETED|Second 14-day Treatment||21
11055712|NCT00990340|12237266|FG000|NOT COMPLETED|Second 14-day Treatment||0
11055713|NCT00990340|12237267|FG001|NOT COMPLETED|Second 14-day Treatment||0
11055714|NCT00990509|12237277|FG000|STARTED|Overall Study||5
11055715|NCT00990509|12237278|FG001|STARTED|Overall Study||9
11055716|NCT00990509|12237277|FG000|COMPLETED|Overall Study||5
11055717|NCT00990509|12237278|FG001|COMPLETED|Overall Study||8
11055718|NCT00990509|12237277|FG000|NOT COMPLETED|Overall Study||0
11055719|NCT00990509|12237278|FG001|NOT COMPLETED|Overall Study||1
11055720|NCT00990561|12237286|FG000|STARTED|Period 1||20
11055721|NCT00990561|12237287|FG001|STARTED|Period 1||20
11055722|NCT00990561|12237288|FG002|STARTED|Period 1||0
11055723|NCT00990561|12237289|FG003|STARTED|Period 1||0
11055724|NCT00990561|12237286|FG000|COMPLETED|Period 1||20
11055725|NCT00990561|12237287|FG001|COMPLETED|Period 1||19
11055726|NCT00990561|12237288|FG002|COMPLETED|Period 1||0
11055727|NCT00990561|12237289|FG003|COMPLETED|Period 1||0
11055728|NCT00990561|12237286|FG000|NOT COMPLETED|Period 1||0
11055729|NCT00990561|12237287|FG001|NOT COMPLETED|Period 1||1
11055730|NCT00990561|12237288|FG002|NOT COMPLETED|Period 1||0
11055731|NCT00990561|12237289|FG003|NOT COMPLETED|Period 1||0
11055732|NCT00990561|12237286|FG000|STARTED|Period 2||0
11055733|NCT00990561|12237287|FG001|STARTED|Period 2||0
11055734|NCT00990561|12237288|FG002|STARTED|Period 2||20
11055735|NCT00990561|12237289|FG003|STARTED|Period 2||19
11055736|NCT00990561|12237286|FG000|COMPLETED|Period 2||0
11055737|NCT00990561|12237287|FG001|COMPLETED|Period 2||0
11055738|NCT00990561|12237288|FG002|COMPLETED|Period 2||20
11055739|NCT00990561|12237289|FG003|COMPLETED|Period 2||17
11055740|NCT00990561|12237286|FG000|NOT COMPLETED|Period 2||0
11055741|NCT00990561|12237287|FG001|NOT COMPLETED|Period 2||0
11055742|NCT00990561|12237288|FG002|NOT COMPLETED|Period 2||0
11055743|NCT00990561|12237289|FG003|NOT COMPLETED|Period 2||2
11055744|NCT00990652|12237295|FG000|STARTED|Pre-surgical Bortezomib||10
11055745|NCT00990652|12237295|FG000|COMPLETED|Pre-surgical Bortezomib||9
11055746|NCT00990652|12237295|FG000|NOT COMPLETED|Pre-surgical Bortezomib||1
11055747|NCT00990652|12237295|FG000|STARTED|Surgical Resection||9
11055748|NCT00990652|12237295|FG000|COMPLETED|Surgical Resection||9
11055749|NCT00990652|12237295|FG000|NOT COMPLETED|Surgical Resection||0
11055750|NCT00990652|12237295|FG000|STARTED|Post-sugery Bortezomib + Temozolomide||9
11055751|NCT00990652|12237295|FG000|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
11055752|NCT00990652|12237295|FG000|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
11055753|NCT00990665|12237300|FG000|STARTED|Overall Study||178
11055754|NCT00990665|12237300|FG000|COMPLETED|Overall Study||130
11055755|NCT00990665|12237300|FG000|NOT COMPLETED|Overall Study||48
11055756|NCT00990704|12237308|FG000|STARTED|Overall Study||14
11055757|NCT00990704|12237309|FG001|STARTED|Overall Study||33
11055758|NCT00990704|12237308|FG000|COMPLETED|Overall Study||13
11055759|NCT00990704|12237309|FG001|COMPLETED|Overall Study||31
11055760|NCT00990704|12237308|FG000|NOT COMPLETED|Overall Study||1
11055761|NCT00990704|12237309|FG001|NOT COMPLETED|Overall Study||2
11055762|NCT00990769|12237317|FG000|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
11055763|NCT00990769|12237318|FG001|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
11055764|NCT00990769|12237317|FG000|COMPLETED|Overall Study||22
11055765|NCT00990769|12237318|FG001|COMPLETED|Overall Study||18
11055766|NCT00990769|12237317|FG000|NOT COMPLETED|Overall Study||0
11055767|NCT00990769|12237318|FG001|NOT COMPLETED|Overall Study||0
11055768|NCT00990782|12237324|FG000|STARTED|Overall Study||93
11055769|NCT00990782|12237324|FG000|COMPLETED|Overall Study||88
11055770|NCT00990782|12237324|FG000|NOT COMPLETED|Overall Study||5
11055771|NCT00990821|12237342|FG000|STARTED|Overall Study||14
11055772|NCT00990821|12237343|FG001|STARTED|Overall Study||16
11055773|NCT00990821|12237344|FG002|STARTED|Overall Study||14
11055774|NCT00990821|12237345|FG003|STARTED|Overall Study||8
11055775|NCT00990821|12237346|FG004|STARTED|Overall Study||17
11055776|NCT00990821|12237347|FG005|STARTED|Overall Study||17
11055777|NCT00990821|12237348|FG006|STARTED|Overall Study||12
11055778|NCT00990821|12237349|FG007|STARTED|Overall Study||14
11055779|NCT00990821|12237350|FG008|STARTED|Overall Study||12
11055780|NCT00990821|12237351|FG009|STARTED|Overall Study||14
11055781|NCT00990821|12237352|FG010|STARTED|Overall Study||12
11055782|NCT00990821|12237353|FG011|STARTED|Overall Study||14
11055783|NCT00990821|12237354|FG012|STARTED|Overall Study||12
11055784|NCT00990821|12237355|FG013|STARTED|Overall Study||12
11055785|NCT00990821|12237342|FG000|COMPLETED|Overall Study||14
11055786|NCT00990821|12237343|FG001|COMPLETED|Overall Study||14
11055787|NCT00990821|12237344|FG002|COMPLETED|Overall Study||14
11055788|NCT00990821|12237345|FG003|COMPLETED|Overall Study||8
11055789|NCT00990821|12237346|FG004|COMPLETED|Overall Study||14
11055790|NCT00990821|12237347|FG005|COMPLETED|Overall Study||14
11055791|NCT00990821|12237348|FG006|COMPLETED|Overall Study||11
11055792|NCT00990821|12237349|FG007|COMPLETED|Overall Study||14
11055793|NCT00990821|12237350|FG008|COMPLETED|Overall Study||12
11055794|NCT00990821|12237351|FG009|COMPLETED|Overall Study||13
11055795|NCT00990821|12237352|FG010|COMPLETED|Overall Study||9
11055796|NCT00990821|12237353|FG011|COMPLETED|Overall Study||9
11055797|NCT00990821|12237354|FG012|COMPLETED|Overall Study||10
11055798|NCT00990821|12237355|FG013|COMPLETED|Overall Study||11
11055799|NCT00990821|12237342|FG000|NOT COMPLETED|Overall Study||0
11055800|NCT00990821|12237343|FG001|NOT COMPLETED|Overall Study||2
11055801|NCT00990821|12237344|FG002|NOT COMPLETED|Overall Study||0
11055802|NCT00990821|12237345|FG003|NOT COMPLETED|Overall Study||0
11055803|NCT00990821|12237346|FG004|NOT COMPLETED|Overall Study||3
11055804|NCT00990821|12237347|FG005|NOT COMPLETED|Overall Study||3
11055805|NCT00990821|12237348|FG006|NOT COMPLETED|Overall Study||1
11055806|NCT00990821|12237349|FG007|NOT COMPLETED|Overall Study||0
11055807|NCT00990821|12237350|FG008|NOT COMPLETED|Overall Study||0
11055808|NCT00990821|12237351|FG009|NOT COMPLETED|Overall Study||1
11055809|NCT00990821|12237352|FG010|NOT COMPLETED|Overall Study||3
11055810|NCT00990821|12237353|FG011|NOT COMPLETED|Overall Study||5
11055811|NCT00990821|12237354|FG012|NOT COMPLETED|Overall Study||2
11055812|NCT00990821|12237355|FG013|NOT COMPLETED|Overall Study||1
11055813|NCT00990938|12237378|FG000|STARTED|Overall Study||3
11055814|NCT00990938|12237379|FG001|STARTED|Overall Study||12
11055815|NCT00990938|12237380|FG002|STARTED|Overall Study||12
11055816|NCT00990938|12237381|FG003|STARTED|Overall Study||12
11055817|NCT00990938|12237382|FG004|STARTED|Overall Study||12
11055818|NCT00990938|12237383|FG005|STARTED|Overall Study||12
11055819|NCT00990938|12237378|FG000|COMPLETED|Overall Study||3
11055820|NCT00990938|12237379|FG001|COMPLETED|Overall Study||12
11055821|NCT00990938|12237380|FG002|COMPLETED|Overall Study||12
11055822|NCT00990938|12237381|FG003|COMPLETED|Overall Study||12
11055823|NCT00990938|12237382|FG004|COMPLETED|Overall Study||12
11055824|NCT00990938|12237383|FG005|COMPLETED|Overall Study||12
11055825|NCT00990938|12237378|FG000|NOT COMPLETED|Overall Study||0
11055826|NCT00990938|12237379|FG001|NOT COMPLETED|Overall Study||0
11055827|NCT00990938|12237380|FG002|NOT COMPLETED|Overall Study||0
11055828|NCT00990938|12237381|FG003|NOT COMPLETED|Overall Study||0
11055829|NCT00990938|12237382|FG004|NOT COMPLETED|Overall Study||0
11055830|NCT00990938|12237383|FG005|NOT COMPLETED|Overall Study||0
11055831|NCT00990964|12237397|FG000|STARTED|Overall Study|Total number of subjects enrolled|2014
11055832|NCT00990964|12237397|FG000|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
11055833|NCT00990964|12237397|FG000|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
11055834|NCT00990964|12237397|FG000|NOT COMPLETED|Overall Study||212
11055835|NCT00991029|12237404|FG000|STARTED|Overall Study||2432
11055836|NCT00991029|12237405|FG001|STARTED|Overall Study||2449
11055837|NCT00991029|12237404|FG000|COMPLETED|Overall Study||2276
11055838|NCT00991029|12237405|FG001|COMPLETED|Overall Study||2281
11055839|NCT00991029|12237404|FG000|NOT COMPLETED|Overall Study||156
11055840|NCT00991029|12237405|FG001|NOT COMPLETED|Overall Study||168
11055841|NCT00991081|12237413|FG000|STARTED|Phase I, Formative Research||20
11055842|NCT00991081|12237414|FG001|STARTED|Phase I, Formative Research||0
11055843|NCT00991081|12237415|FG002|STARTED|Phase I, Formative Research||0
11055844|NCT00991081|12237413|FG000|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
11055845|NCT00991081|12237414|FG001|COMPLETED|Phase I, Formative Research||0
11055846|NCT00991081|12237415|FG002|COMPLETED|Phase I, Formative Research||0
11338832|NCT02906670|12536201|FG003|NOT COMPLETED|Cohort 7P, Q2W||0
11338833|NCT02906670|12536202|FG004|NOT COMPLETED|Cohort 7P, Q2W||0
11338834|NCT02906670|12536203|FG005|NOT COMPLETED|Cohort 7P, Q2W||0
11338835|NCT02906670|12536204|FG006|NOT COMPLETED|Cohort 7P, Q2W||0
11338836|NCT02906670|12536205|FG007|NOT COMPLETED|Cohort 7P, Q2W||0
11338837|NCT02906670|12536206|FG008|NOT COMPLETED|Cohort 7P, Q2W||0
11338838|NCT02906670|12536207|FG009|NOT COMPLETED|Cohort 7P, Q2W||3
11338839|NCT02906670|12536198|FG000|STARTED|Cohort 5P, QW||0
11338840|NCT02906670|12536199|FG001|STARTED|Cohort 5P, QW||0
11055847|NCT00991081|12237413|FG000|NOT COMPLETED|Phase I, Formative Research||0
11055848|NCT00991081|12237414|FG001|NOT COMPLETED|Phase I, Formative Research||0
11055849|NCT00991081|12237415|FG002|NOT COMPLETED|Phase I, Formative Research||0
11055850|NCT00991081|12237413|FG000|STARTED|Phase II, Randomized Control Trial||0
11055851|NCT00991081|12237414|FG001|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
11055852|NCT00991081|12237415|FG002|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
11055853|NCT00991081|12237413|FG000|Received First Clinical Call|Phase II, Randomized Control Trial||0
11055854|NCT00991081|12237414|FG001|Received First Clinical Call|Phase II, Randomized Control Trial||16
11055855|NCT00991081|12237415|FG002|Received First Clinical Call|Phase II, Randomized Control Trial||17
11055856|NCT00991081|12237413|FG000|COMPLETED|Phase II, Randomized Control Trial||0
11055857|NCT00991081|12237414|FG001|COMPLETED|Phase II, Randomized Control Trial||15
11055858|NCT00991081|12237415|FG002|COMPLETED|Phase II, Randomized Control Trial||15
11055859|NCT00991081|12237413|FG000|NOT COMPLETED|Phase II, Randomized Control Trial||0
11055860|NCT00991081|12237414|FG001|NOT COMPLETED|Phase II, Randomized Control Trial||2
11055861|NCT00991081|12237415|FG002|NOT COMPLETED|Phase II, Randomized Control Trial||4
11055862|NCT00991185|12237421|FG000|STARTED|Overall Study||8
11055863|NCT00991185|12237421|FG000|COMPLETED|Overall Study||8
11055864|NCT00991185|12237421|FG000|NOT COMPLETED|Overall Study||0
11338841|NCT02906670|12536200|FG002|STARTED|Cohort 5P, QW||0
11338842|NCT02906670|12536201|FG003|STARTED|Cohort 5P, QW||0
11055865|NCT00991276|12237431|FG000|STARTED|First Intervention Period||15
11055866|NCT00991276|12237432|FG001|STARTED|First Intervention Period||13
11055867|NCT00991276|12237433|FG002|STARTED|First Intervention Period||14
11055868|NCT00991276|12237434|FG003|STARTED|First Intervention Period||15
11055869|NCT00991276|12237435|FG004|STARTED|First Intervention Period||15
11055870|NCT00991276|12237436|FG005|STARTED|First Intervention Period||13
11055871|NCT00991276|12237431|FG000|COMPLETED|First Intervention Period||15
11055872|NCT00991276|12237432|FG001|COMPLETED|First Intervention Period||10
11055873|NCT00991276|12237433|FG002|COMPLETED|First Intervention Period||14
11055874|NCT00991276|12237434|FG003|COMPLETED|First Intervention Period||11
11055875|NCT00991276|12237435|FG004|COMPLETED|First Intervention Period||11
11055876|NCT00991276|12237436|FG005|COMPLETED|First Intervention Period||12
11055877|NCT00991276|12237431|FG000|NOT COMPLETED|First Intervention Period||0
11055878|NCT00991276|12237432|FG001|NOT COMPLETED|First Intervention Period||3
11055879|NCT00991276|12237433|FG002|NOT COMPLETED|First Intervention Period||0
11055880|NCT00991276|12237434|FG003|NOT COMPLETED|First Intervention Period||4
11055881|NCT00991276|12237435|FG004|NOT COMPLETED|First Intervention Period||4
11055882|NCT00991276|12237436|FG005|NOT COMPLETED|First Intervention Period||1
11055883|NCT00991276|12237431|FG000|STARTED|Placebo Wash-out Period (7 Days)||15
11055884|NCT00991276|12237432|FG001|STARTED|Placebo Wash-out Period (7 Days)||10
11055885|NCT00991276|12237433|FG002|STARTED|Placebo Wash-out Period (7 Days)||14
11055886|NCT00991276|12237434|FG003|STARTED|Placebo Wash-out Period (7 Days)||11
11055887|NCT00991276|12237435|FG004|STARTED|Placebo Wash-out Period (7 Days)||11
11055888|NCT00991276|12237436|FG005|STARTED|Placebo Wash-out Period (7 Days)||12
11055889|NCT00991276|12237431|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||15
11055890|NCT00991276|12237432|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||10
11055891|NCT00991276|12237433|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14
11055892|NCT00991276|12237434|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||11
11055893|NCT00991276|12237435|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||11
11055894|NCT00991276|12237436|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||12
11055895|NCT00991276|12237431|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
11055896|NCT00991276|12237432|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
11055897|NCT00991276|12237433|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
11055898|NCT00991276|12237434|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
11055899|NCT00991276|12237435|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
11055900|NCT00991276|12237436|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
11055901|NCT00991276|12237431|FG000|STARTED|Second Intervention Period||15
11055902|NCT00991276|12237432|FG001|STARTED|Second Intervention Period||10
11055903|NCT00991276|12237433|FG002|STARTED|Second Intervention Period||14
11055904|NCT00991276|12237434|FG003|STARTED|Second Intervention Period||11
11055905|NCT00991276|12237435|FG004|STARTED|Second Intervention Period||11
11055906|NCT00991276|12237436|FG005|STARTED|Second Intervention Period||12
11055907|NCT00991276|12237431|FG000|COMPLETED|Second Intervention Period||14
11055908|NCT00991276|12237432|FG001|COMPLETED|Second Intervention Period||8
11055909|NCT00991276|12237433|FG002|COMPLETED|Second Intervention Period||14
11055910|NCT00991276|12237434|FG003|COMPLETED|Second Intervention Period||9
11055911|NCT00991276|12237435|FG004|COMPLETED|Second Intervention Period||10
11055912|NCT00991276|12237436|FG005|COMPLETED|Second Intervention Period||11
11055913|NCT00991276|12237431|FG000|NOT COMPLETED|Second Intervention Period||1
11055914|NCT00991276|12237432|FG001|NOT COMPLETED|Second Intervention Period||2
11055915|NCT00991276|12237433|FG002|NOT COMPLETED|Second Intervention Period||0
11055916|NCT00991276|12237434|FG003|NOT COMPLETED|Second Intervention Period||2
11055917|NCT00991276|12237435|FG004|NOT COMPLETED|Second Intervention Period||1
11055918|NCT00991276|12237436|FG005|NOT COMPLETED|Second Intervention Period||1
11055919|NCT00991276|12237431|FG000|STARTED|Placebo Wash-out Period (7 Days)||14
11055920|NCT00991276|12237432|FG001|STARTED|Placebo Wash-out Period (7 Days)||8
11055921|NCT00991276|12237433|FG002|STARTED|Placebo Wash-out Period (7 Days)||14
11055922|NCT00991276|12237434|FG003|STARTED|Placebo Wash-out Period (7 Days)||9
11055923|NCT00991276|12237435|FG004|STARTED|Placebo Wash-out Period (7 Days)||10
11055924|NCT00991276|12237436|FG005|STARTED|Placebo Wash-out Period (7 Days)||11
11055925|NCT00991276|12237431|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||14
11055926|NCT00991276|12237432|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||8
11055927|NCT00991276|12237433|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14
11055928|NCT00991276|12237434|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||9
11055929|NCT00991276|12237435|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||10
11055930|NCT00991276|12237436|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||11
11055931|NCT00991276|12237431|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
11055932|NCT00991276|12237432|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
11055933|NCT00991276|12237433|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
11055934|NCT00991276|12237434|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
11055935|NCT00991276|12237435|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
11055936|NCT00991276|12237436|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
11055937|NCT00991276|12237431|FG000|STARTED|Third Intervention Period||14
11338843|NCT02906670|12536202|FG004|STARTED|Cohort 5P, QW||3
11338844|NCT02906670|12536203|FG005|STARTED|Cohort 5P, QW||0
11338845|NCT02906670|12536204|FG006|STARTED|Cohort 5P, QW||0
11338846|NCT02906670|12536205|FG007|STARTED|Cohort 5P, QW||0
11055938|NCT00991276|12237432|FG001|STARTED|Third Intervention Period||8
11055939|NCT00991276|12237433|FG002|STARTED|Third Intervention Period||14
11055940|NCT00991276|12237434|FG003|STARTED|Third Intervention Period||9
11055941|NCT00991276|12237435|FG004|STARTED|Third Intervention Period||10
11055942|NCT00991276|12237436|FG005|STARTED|Third Intervention Period||11
11055943|NCT00991276|12237431|FG000|COMPLETED|Third Intervention Period||13
11055944|NCT00991276|12237432|FG001|COMPLETED|Third Intervention Period||8
11055945|NCT00991276|12237433|FG002|COMPLETED|Third Intervention Period||13
11055946|NCT00991276|12237434|FG003|COMPLETED|Third Intervention Period||8
11055947|NCT00991276|12237435|FG004|COMPLETED|Third Intervention Period||10
11055948|NCT00991276|12237436|FG005|COMPLETED|Third Intervention Period||10
11055949|NCT00991276|12237431|FG000|NOT COMPLETED|Third Intervention Period||1
11055950|NCT00991276|12237432|FG001|NOT COMPLETED|Third Intervention Period||0
11055951|NCT00991276|12237433|FG002|NOT COMPLETED|Third Intervention Period||1
11055952|NCT00991276|12237434|FG003|NOT COMPLETED|Third Intervention Period||1
11055953|NCT00991276|12237435|FG004|NOT COMPLETED|Third Intervention Period||0
11055954|NCT00991276|12237436|FG005|NOT COMPLETED|Third Intervention Period||1
11055955|NCT00991289|12237445|FG000|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
11055956|NCT00991289|12237445|FG000|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
11201731|NCT01834729|12392082|FG002|NOT COMPLETED|Overall Study||3
11201732|NCT01834729|12392083|FG003|NOT COMPLETED|Overall Study||2
11201733|NCT01835015|12392099|FG000|STARTED|Overall Study||6
11201734|NCT01835015|12392100|FG001|STARTED|Overall Study||6
11201735|NCT01835015|12392101|FG002|STARTED|Overall Study||7
11201736|NCT01835015|12392102|FG003|STARTED|Overall Study||6
11201737|NCT01835015|12392103|FG004|STARTED|Overall Study||6
11201738|NCT01835015|12392099|FG000|COMPLETED|Overall Study||6
11201739|NCT01835015|12392100|FG001|COMPLETED|Overall Study||6
11201740|NCT01835015|12392101|FG002|COMPLETED|Overall Study||6
11201741|NCT01835015|12392102|FG003|COMPLETED|Overall Study||6
11201742|NCT01835015|12392103|FG004|COMPLETED|Overall Study||6
11201743|NCT01835015|12392099|FG000|NOT COMPLETED|Overall Study||0
11201744|NCT01835015|12392100|FG001|NOT COMPLETED|Overall Study||0
11201745|NCT01835015|12392101|FG002|NOT COMPLETED|Overall Study||1
11201746|NCT01835015|12392102|FG003|NOT COMPLETED|Overall Study||0
11201747|NCT01835015|12392103|FG004|NOT COMPLETED|Overall Study||0
11201748|NCT01835132|12392116|FG000|STARTED|Initial Phase||8
11201749|NCT01835132|12392116|FG000|COMPLETED|Initial Phase||6
11201750|NCT01835132|12392116|FG000|NOT COMPLETED|Initial Phase||2
11201751|NCT01835132|12392116|FG000|STARTED|1st Extension Phase||6
11201752|NCT01835132|12392116|FG000|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
11201753|NCT01835132|12392116|FG000|NOT COMPLETED|1st Extension Phase||0
11201754|NCT01835132|12392116|FG000|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
11201755|NCT01835132|12392116|FG000|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
11201756|NCT01835132|12392116|FG000|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
11201757|NCT01835158|12392122|FG000|STARTED|Overall Study||79
11201758|NCT01835158|12392123|FG001|STARTED|Overall Study||78
11201759|NCT01835158|12392122|FG000|COMPLETED|Overall Study||78
11201760|NCT01835158|12392123|FG001|COMPLETED|Overall Study||72
11201761|NCT01835158|12392122|FG000|NOT COMPLETED|Overall Study||1
11201762|NCT01835158|12392123|FG001|NOT COMPLETED|Overall Study||6
11201763|NCT01835223|12392131|FG000|STARTED|Overall Study||30
11201764|NCT01835223|12392132|FG001|STARTED|Overall Study||3
11201765|NCT01835223|12392131|FG000|COMPLETED|Overall Study||21
11201766|NCT01835223|12392132|FG001|COMPLETED|Overall Study||2
11201767|NCT01835223|12392131|FG000|NOT COMPLETED|Overall Study||9
11201768|NCT01835223|12392132|FG001|NOT COMPLETED|Overall Study||1
11201769|NCT01835262|12392142|FG000|STARTED|Overall Study||45
11201770|NCT01835262|12392143|FG001|STARTED|Overall Study||45
11201771|NCT01835262|12392142|FG000|COMPLETED|Overall Study||45
11201772|NCT01835262|12392143|FG001|COMPLETED|Overall Study||45
11201773|NCT01835262|12392142|FG000|NOT COMPLETED|Overall Study||0
11201774|NCT01835262|12392143|FG001|NOT COMPLETED|Overall Study||0
11201775|NCT01835379|12392151|FG000|STARTED|Overall Study||41
11201776|NCT01835379|12392152|FG001|STARTED|Overall Study||41
11201777|NCT01835379|12392151|FG000|COMPLETED|Overall Study||41
11201778|NCT01835379|12392152|FG001|COMPLETED|Overall Study||41
11201779|NCT01835379|12392151|FG000|NOT COMPLETED|Overall Study||0
11201780|NCT01835379|12392152|FG001|NOT COMPLETED|Overall Study||0
11201781|NCT01835431|12392160|FG000|STARTED|Overall Study||182
11201782|NCT01835431|12392161|FG001|STARTED|Overall Study||180
11201783|NCT01835431|12392160|FG000|Exposed|Overall Study|One subject was withdrawn before exposure.|181
11201784|NCT01835431|12392161|FG001|Exposed|Overall Study|One subject was withdrawn before exposure|179
11201785|NCT01835431|12392160|FG000|COMPLETED|Overall Study||174
11201786|NCT01835431|12392161|FG001|COMPLETED|Overall Study||168
11201787|NCT01835431|12392160|FG000|NOT COMPLETED|Overall Study||8
11201788|NCT01835431|12392161|FG001|NOT COMPLETED|Overall Study||12
11201789|NCT01835470|12392167|FG000|STARTED|Short Term Treatment Period (to Week 16)||20
11201790|NCT01835470|12392167|FG000|COMPLETED|Short Term Treatment Period (to Week 16)||20
11201791|NCT01835470|12392167|FG000|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
11201792|NCT01835470|12392167|FG000|STARTED|Long Term Treatment Period||20
11201793|NCT01835470|12392167|FG000|COMPLETED|Long Term Treatment Period|Completed LT period|16
11201794|NCT01835470|12392167|FG000|NOT COMPLETED|Long Term Treatment Period||4
11201795|NCT01835496|12392172|FG000|STARTED|Overall Study||8
11201796|NCT01835496|12392172|FG000|COMPLETED|Overall Study||8
11201797|NCT01835496|12392172|FG000|NOT COMPLETED|Overall Study||0
11201798|NCT01835548|12392178|FG000|STARTED|Screening/Washout Period||0
11201799|NCT01835548|12392179|FG001|STARTED|Screening/Washout Period||0
11201800|NCT01835548|12392180|FG002|STARTED|Screening/Washout Period||87
11201801|NCT01835548|12392178|FG000|COMPLETED|Screening/Washout Period||0
11201802|NCT01835548|12392179|FG001|COMPLETED|Screening/Washout Period||0
11201803|NCT01835548|12392180|FG002|COMPLETED|Screening/Washout Period||87
11201804|NCT01835548|12392178|FG000|NOT COMPLETED|Screening/Washout Period||0
11201805|NCT01835548|12392179|FG001|NOT COMPLETED|Screening/Washout Period||0
11201806|NCT01835548|12392180|FG002|NOT COMPLETED|Screening/Washout Period||0
11201807|NCT01835548|12392178|FG000|STARTED|Dose Optimization Period||0
11201808|NCT01835548|12392179|FG001|STARTED|Dose Optimization Period||0
11201809|NCT01835548|12392180|FG002|STARTED|Dose Optimization Period||87
11201810|NCT01835548|12392178|FG000|COMPLETED|Dose Optimization Period||0
11201811|NCT01835548|12392179|FG001|COMPLETED|Dose Optimization Period||0
11201812|NCT01835548|12392180|FG002|COMPLETED|Dose Optimization Period||85
11055957|NCT00991289|12237445|FG000|COMPLETED|Overall Study|Completed study.|55
11055958|NCT00991289|12237445|FG000|NOT COMPLETED|Overall Study||12
11055959|NCT00991302|12237451|FG000|STARTED|Overall Study||86
11055960|NCT00991302|12237452|FG001|STARTED|Overall Study||86
11055961|NCT00991302|12237451|FG000|COMPLETED|Overall Study||72
11055962|NCT00991302|12237452|FG001|COMPLETED|Overall Study||73
11055963|NCT00991302|12237451|FG000|NOT COMPLETED|Overall Study||14
11055964|NCT00991302|12237452|FG001|NOT COMPLETED|Overall Study||13
11055965|NCT00991341|12237460|FG000|STARTED|Overall Study||742
11055966|NCT00991341|12237461|FG001|STARTED|Overall Study||739
11055967|NCT00991341|12237460|FG000|COMPLETED|Overall Study||538
11055968|NCT00991341|12237461|FG001|COMPLETED|Overall Study||560
11055969|NCT00991341|12237460|FG000|NOT COMPLETED|Overall Study||204
11055970|NCT00991341|12237461|FG001|NOT COMPLETED|Overall Study||179
11055971|NCT00991406|12237467|FG000|STARTED|Overall Study||9
11055972|NCT00991406|12237467|FG000|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8
11055973|NCT00991406|12237467|FG000|NOT COMPLETED|Overall Study||1
11055974|NCT00991458|12237474|FG000|STARTED|Overall Study||207
11055975|NCT00991458|12237475|FG001|STARTED|Overall Study||209
11055976|NCT00991458|12237476|FG002|STARTED|Overall Study||205
11055977|NCT00991458|12237474|FG000|COMPLETED|Overall Study||187
11055978|NCT00991458|12237475|FG001|COMPLETED|Overall Study||181
11055979|NCT00991458|12237476|FG002|COMPLETED|Overall Study||180
11055980|NCT00991458|12237474|FG000|NOT COMPLETED|Overall Study||20
11055981|NCT00991458|12237475|FG001|NOT COMPLETED|Overall Study||28
11055982|NCT00991458|12237476|FG002|NOT COMPLETED|Overall Study||25
11055983|NCT00991510|12237486|FG000|STARTED|Period I (Days 1-14)||22
11055984|NCT00991510|12237487|FG001|STARTED|Period I (Days 1-14)||21
11055985|NCT00991510|12237486|FG000|COMPLETED|Period I (Days 1-14)||21
11055986|NCT00991510|12237487|FG001|COMPLETED|Period I (Days 1-14)||21
11055987|NCT00991510|12237486|FG000|NOT COMPLETED|Period I (Days 1-14)||1
11055988|NCT00991510|12237487|FG001|NOT COMPLETED|Period I (Days 1-14)||0
11055989|NCT00991510|12237486|FG000|STARTED|Period II (Days 15-28)||21
11055990|NCT00991510|12237487|FG001|STARTED|Period II (Days 15-28)||21
11055991|NCT00991510|12237486|FG000|COMPLETED|Period II (Days 15-28)||21
11055992|NCT00991510|12237487|FG001|COMPLETED|Period II (Days 15-28)||21
11055993|NCT00991510|12237486|FG000|NOT COMPLETED|Period II (Days 15-28)||0
11055994|NCT00991510|12237487|FG001|NOT COMPLETED|Period II (Days 15-28)||0
11055995|NCT00991510|12237486|FG000|STARTED|Period III (Days 29-112)||21
11055996|NCT00991510|12237487|FG001|STARTED|Period III (Days 29-112)||21
11055997|NCT00991510|12237486|FG000|COMPLETED|Period III (Days 29-112)||20
11055998|NCT00991510|12237487|FG001|COMPLETED|Period III (Days 29-112)||20
11055999|NCT00991510|12237486|FG000|NOT COMPLETED|Period III (Days 29-112)||1
11056000|NCT00991510|12237487|FG001|NOT COMPLETED|Period III (Days 29-112)||1
11056001|NCT00991809|12237499|FG000|STARTED|Overall Study||12
11056002|NCT00991809|12237500|FG001|STARTED|Overall Study||10
11056003|NCT00991809|12237499|FG000|COMPLETED|Overall Study||8
11056004|NCT00991809|12237500|FG001|COMPLETED|Overall Study||4
11056005|NCT00991809|12237499|FG000|NOT COMPLETED|Overall Study||4
11056006|NCT00991809|12237500|FG001|NOT COMPLETED|Overall Study||6
11056007|NCT00991939|12237510|FG000|STARTED|Overall Study||5
11056008|NCT00991939|12237511|FG001|STARTED|Overall Study||3
11056009|NCT00991939|12237510|FG000|COMPLETED|Overall Study||0
11056010|NCT00991939|12237511|FG001|COMPLETED|Overall Study||1
11056011|NCT00991939|12237510|FG000|NOT COMPLETED|Overall Study||5
11056012|NCT00991939|12237511|FG001|NOT COMPLETED|Overall Study||2
11056013|NCT00991952|12237521|FG000|STARTED|Overall Study||13
11056014|NCT00991952|12237522|FG001|STARTED|Overall Study||6
11056015|NCT00991952|12237521|FG000|COMPLETED|Overall Study||13
11056016|NCT00991952|12237522|FG001|COMPLETED|Overall Study||5
11056017|NCT00991952|12237521|FG000|NOT COMPLETED|Overall Study||0
11056018|NCT00991952|12237522|FG001|NOT COMPLETED|Overall Study||1
11056019|NCT00992017|12237528|FG000|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
11056020|NCT00992017|12237528|FG000|Received Both Study Vaccinations|Overall Study||124
11056021|NCT00992017|12237528|FG000|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
11056022|NCT00992017|12237528|FG000|COMPLETED|Overall Study||118
11056023|NCT00992017|12237528|FG000|NOT COMPLETED|Overall Study||10
11056024|NCT00992056|12237539|FG000|STARTED|Treatment Period 1 (6 Weeks)||12
11056025|NCT00992056|12237540|FG001|STARTED|Treatment Period 1 (6 Weeks)||12
11056026|NCT00992056|12237539|FG000|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
11056027|NCT00992056|12237540|FG001|COMPLETED|Treatment Period 1 (6 Weeks)||10
11056028|NCT00992056|12237539|FG000|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
11056029|NCT00992056|12237540|FG001|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
11056030|NCT00992056|12237539|FG000|STARTED|Washout Period (2 Weeks)||11
11056031|NCT00992056|12237540|FG001|STARTED|Washout Period (2 Weeks)||10
11056032|NCT00992056|12237539|FG000|COMPLETED|Washout Period (2 Weeks)||10
11056033|NCT00992056|12237540|FG001|COMPLETED|Washout Period (2 Weeks)||10
11056034|NCT00992056|12237539|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
11056035|NCT00992056|12237540|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
11056036|NCT00992056|12237539|FG000|STARTED|Treatment Period 2 (6 Weeks)||10
11056037|NCT00992056|12237540|FG001|STARTED|Treatment Period 2 (6 Weeks)||10
11056038|NCT00992056|12237539|FG000|COMPLETED|Treatment Period 2 (6 Weeks)||10
11056039|NCT00992056|12237540|FG001|COMPLETED|Treatment Period 2 (6 Weeks)||10
11056040|NCT00992056|12237539|FG000|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
11056041|NCT00992056|12237540|FG001|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
11056042|NCT00992108|12237548|FG000|STARTED|Overall Study||7
11056043|NCT00992108|12237549|FG001|STARTED|Overall Study||10
11056044|NCT00992108|12237548|FG000|COMPLETED|Overall Study||7
11056045|NCT00992108|12237549|FG001|COMPLETED|Overall Study||9
11056046|NCT00992108|12237548|FG000|NOT COMPLETED|Overall Study||0
11056047|NCT00992108|12237549|FG001|NOT COMPLETED|Overall Study||1
11056048|NCT00992186|12237555|FG000|STARTED|Overall Study||46
11056049|NCT00992186|12237555|FG000|COMPLETED|Overall Study||0
11056050|NCT00992186|12237555|FG000|NOT COMPLETED|Overall Study||46
11056051|NCT00992225|12237560|FG000|STARTED|Overall Study||43
11056052|NCT00992225|12237560|FG000|Received at Least One Dose of Study Drug|Overall Study||33
11056053|NCT00992225|12237560|FG000|COMPLETED|Overall Study||33
11056054|NCT00992225|12237560|FG000|NOT COMPLETED|Overall Study||10
11056055|NCT00992264|12237580|FG000|STARTED|Overall Study||116
11056056|NCT00992264|12237581|FG001|STARTED|Overall Study||116
11056057|NCT00992264|12237582|FG002|STARTED|Overall Study||117
11056058|NCT00992264|12237583|FG003|STARTED|Overall Study||117
11056059|NCT00992264|12237584|FG004|STARTED|Overall Study||117
11056060|NCT00992264|12237585|FG005|STARTED|Overall Study||117
11056061|NCT00992264|12237586|FG006|STARTED|Overall Study||116
11056062|NCT00992264|12237587|FG007|STARTED|Overall Study||117
11056063|NCT00992264|12237588|FG008|STARTED|Overall Study||116
11056064|NCT00992264|12237589|FG009|STARTED|Overall Study||116
11056065|NCT00992264|12237590|FG010|STARTED|Overall Study||117
11056066|NCT00992264|12237591|FG011|STARTED|Overall Study||117
11056067|NCT00992264|12237592|FG012|STARTED|Overall Study||116
11056068|NCT00992264|12237593|FG013|STARTED|Overall Study||117
11056069|NCT00992264|12237594|FG014|STARTED|Overall Study||117
11056070|NCT00992264|12237595|FG015|STARTED|Overall Study||116
11056071|NCT00992264|12237580|FG000|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
11056072|NCT00992264|12237581|FG001|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
11056073|NCT00992264|12237582|FG002|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
11056074|NCT00992264|12237583|FG003|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
11056075|NCT00992264|12237584|FG004|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
11056076|NCT00992264|12237585|FG005|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
11056077|NCT00992264|12237586|FG006|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
11056078|NCT00992264|12237587|FG007|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
11056079|NCT00992264|12237588|FG008|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
11056080|NCT00992264|12237589|FG009|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
11056081|NCT00992264|12237590|FG010|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
11056082|NCT00992264|12237591|FG011|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
11056083|NCT00992264|12237592|FG012|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
11056084|NCT00992264|12237593|FG013|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
11056085|NCT00992264|12237594|FG014|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
11056086|NCT00992264|12237595|FG015|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
11056087|NCT00992264|12237580|FG000|NOT COMPLETED|Overall Study||0
11056088|NCT00992264|12237581|FG001|NOT COMPLETED|Overall Study||0
11056089|NCT00992264|12237582|FG002|NOT COMPLETED|Overall Study||0
11056090|NCT00992264|12237583|FG003|NOT COMPLETED|Overall Study||0
11056091|NCT00992264|12237584|FG004|NOT COMPLETED|Overall Study||0
11056092|NCT00992264|12237585|FG005|NOT COMPLETED|Overall Study||0
11056093|NCT00992264|12237586|FG006|NOT COMPLETED|Overall Study||0
11056094|NCT00992264|12237587|FG007|NOT COMPLETED|Overall Study||0
11056095|NCT00992264|12237588|FG008|NOT COMPLETED|Overall Study||0
11056096|NCT00992264|12237589|FG009|NOT COMPLETED|Overall Study||0
11056097|NCT00992264|12237590|FG010|NOT COMPLETED|Overall Study||0
11056098|NCT00992264|12237591|FG011|NOT COMPLETED|Overall Study||0
11056099|NCT00992264|12237592|FG012|NOT COMPLETED|Overall Study||0
11056100|NCT00992264|12237593|FG013|NOT COMPLETED|Overall Study||0
11056101|NCT00992264|12237594|FG014|NOT COMPLETED|Overall Study||0
11056102|NCT00992264|12237595|FG015|NOT COMPLETED|Overall Study||0
11056103|NCT00992394|12237608|FG000|STARTED|Overall Study||88
11056104|NCT00992394|12237609|FG001|STARTED|Overall Study||86
11056105|NCT00992394|12237608|FG000|Safety Population|Overall Study||87
11056106|NCT00992394|12237609|FG001|Safety Population|Overall Study||84
11056107|NCT00992394|12237608|FG000|mITT Population|Overall Study||86
11056108|NCT00992394|12237609|FG001|mITT Population|Overall Study||84
11056109|NCT00992394|12237608|FG000|COMPLETED|Overall Study||64
11056110|NCT00992394|12237609|FG001|COMPLETED|Overall Study||72
11056111|NCT00992394|12237608|FG000|NOT COMPLETED|Overall Study||24
11056112|NCT00992394|12237609|FG001|NOT COMPLETED|Overall Study||14
11056113|NCT00992407|12237617|FG000|STARTED|Overall Study||37
11056114|NCT00992407|12237618|FG001|STARTED|Overall Study||38
11056115|NCT00992407|12237617|FG000|Treated|Overall Study||20
11056116|NCT00992407|12237618|FG001|Treated|Overall Study||25
11056117|NCT00992407|12237617|FG000|COMPLETED|Overall Study||6
11056118|NCT00992407|12237618|FG001|COMPLETED|Overall Study||14
11056119|NCT00992407|12237617|FG000|NOT COMPLETED|Overall Study||31
11056120|NCT00992407|12237618|FG001|NOT COMPLETED|Overall Study||24
11056121|NCT00992433|12237629|FG000|STARTED|Overall Study||95
11056122|NCT00992433|12237630|FG001|STARTED|Overall Study||97
11056123|NCT00992433|12237629|FG000|COMPLETED|Overall Study||91
11056124|NCT00992433|12237630|FG001|COMPLETED|Overall Study||90
11056125|NCT00992433|12237629|FG000|NOT COMPLETED|Overall Study||4
11056126|NCT00992433|12237630|FG001|NOT COMPLETED|Overall Study||7
11056127|NCT00992446|12237636|FG000|STARTED|Overall Study||27
11056128|NCT00992446|12237636|FG000|COMPLETED|Overall Study||19
11056129|NCT00992446|12237636|FG000|NOT COMPLETED|Overall Study||8
11056130|NCT00992459|12237642|FG000|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
11056131|NCT00992459|12237643|FG001|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
11056132|NCT00992459|12237642|FG000|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
11056133|NCT00992459|12237643|FG001|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
11056134|NCT00992459|12237642|FG000|NOT COMPLETED|Overall Study||1
11056135|NCT00992459|12237643|FG001|NOT COMPLETED|Overall Study||1
11056136|NCT00992511|12237653|FG000|STARTED|Overall Study||76
11056137|NCT00992511|12237654|FG001|STARTED|Overall Study||73
11056138|NCT00992511|12237655|FG002|STARTED|Overall Study||76
11056139|NCT00992511|12237656|FG003|STARTED|Overall Study||75
11056140|NCT00992511|12237653|FG000|COMPLETED|Overall Study||74
11056141|NCT00992511|12237654|FG001|COMPLETED|Overall Study||73
11056142|NCT00992511|12237655|FG002|COMPLETED|Overall Study||74
11338847|NCT02906670|12536206|FG008|STARTED|Cohort 5P, QW||0
11338848|NCT02906670|12536207|FG009|STARTED|Cohort 5P, QW||0
11338849|NCT02906670|12536198|FG000|COMPLETED|Cohort 5P, QW||0
11338850|NCT02906670|12536199|FG001|COMPLETED|Cohort 5P, QW||0
11338851|NCT02906670|12536200|FG002|COMPLETED|Cohort 5P, QW||0
11338852|NCT02906670|12536201|FG003|COMPLETED|Cohort 5P, QW||0
11338853|NCT02906670|12536202|FG004|COMPLETED|Cohort 5P, QW||0
11338854|NCT02906670|12536203|FG005|COMPLETED|Cohort 5P, QW||0
11338855|NCT02906670|12536204|FG006|COMPLETED|Cohort 5P, QW||0
11338856|NCT02906670|12536205|FG007|COMPLETED|Cohort 5P, QW||0
11338857|NCT02906670|12536206|FG008|COMPLETED|Cohort 5P, QW||0
11338858|NCT02906670|12536207|FG009|COMPLETED|Cohort 5P, QW||0
11338859|NCT02906670|12536198|FG000|NOT COMPLETED|Cohort 5P, QW||0
11338860|NCT02906670|12536199|FG001|NOT COMPLETED|Cohort 5P, QW||0
11338861|NCT02906670|12536200|FG002|NOT COMPLETED|Cohort 5P, QW||0
11338862|NCT02906670|12536201|FG003|NOT COMPLETED|Cohort 5P, QW||0
11338863|NCT02906670|12536202|FG004|NOT COMPLETED|Cohort 5P, QW||3
11338864|NCT02906670|12536203|FG005|NOT COMPLETED|Cohort 5P, QW||0
11338865|NCT02906670|12536204|FG006|NOT COMPLETED|Cohort 5P, QW||0
11338866|NCT02906670|12536205|FG007|NOT COMPLETED|Cohort 5P, QW||0
11338867|NCT02906670|12536206|FG008|NOT COMPLETED|Cohort 5P, QW||0
11338868|NCT02906670|12536207|FG009|NOT COMPLETED|Cohort 5P, QW||0
11338869|NCT02906696|12536257|FG000|STARTED|Overall Study||8
11338870|NCT02906696|12536257|FG000|COMPLETED|Overall Study||8
11338871|NCT02906696|12536257|FG000|NOT COMPLETED|Overall Study||0
11338872|NCT02906709|12536263|FG000|STARTED|Phase A (Week 0 to Week 16)||123
11338873|NCT02906709|12536264|FG001|STARTED|Phase A (Week 0 to Week 16)||61
11338874|NCT02906709|12536263|FG000|COMPLETED|Phase A (Week 0 to Week 16)||122
11056143|NCT00992511|12237656|FG003|COMPLETED|Overall Study||70
11056144|NCT00992511|12237653|FG000|NOT COMPLETED|Overall Study||2
11056145|NCT00992511|12237654|FG001|NOT COMPLETED|Overall Study||0
11338875|NCT02906709|12536264|FG001|COMPLETED|Phase A (Week 0 to Week 16)||58
11338876|NCT02906709|12536263|FG000|NOT COMPLETED|Phase A (Week 0 to Week 16)||1
11338877|NCT02906709|12536264|FG001|NOT COMPLETED|Phase A (Week 0 to Week 16)||3
11056146|NCT00992511|12237655|FG002|NOT COMPLETED|Overall Study||2
11056147|NCT00992511|12237656|FG003|NOT COMPLETED|Overall Study||5
11058351|NCT01003249|12240176|FG000|COMPLETED|Washout (3 Weeks)||4
11338878|NCT02906709|12536263|FG000|STARTED|Phase B (Extension, Week 17 to Week 52)||122
11338879|NCT02906709|12536264|FG001|STARTED|Phase B (Extension, Week 17 to Week 52)||58
11338880|NCT02906709|12536263|FG000|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117
11338881|NCT02906709|12536264|FG001|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58
11338882|NCT02906709|12536263|FG000|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5
11338883|NCT02906709|12536264|FG001|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0
11058352|NCT01003249|12240177|FG001|COMPLETED|Washout (3 Weeks)||3
11058353|NCT01003249|12240176|FG000|NOT COMPLETED|Washout (3 Weeks)||0
11058354|NCT01003249|12240177|FG001|NOT COMPLETED|Washout (3 Weeks)||0
11058355|NCT01003249|12240176|FG000|STARTED|Second Intervention (4 Weeks)||4
11058356|NCT01003249|12240177|FG001|STARTED|Second Intervention (4 Weeks)||3
11058357|NCT01003249|12240176|FG000|COMPLETED|Second Intervention (4 Weeks)||3
11058358|NCT01003249|12240177|FG001|COMPLETED|Second Intervention (4 Weeks)||2
11058359|NCT01003249|12240176|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
11058360|NCT01003249|12240177|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
11058361|NCT01003275|12240189|FG000|STARTED|Overall Study||11
11058362|NCT01003275|12240190|FG001|STARTED|Overall Study||11
11058363|NCT01003275|12240189|FG000|COMPLETED|Overall Study||10
11058364|NCT01003275|12240190|FG001|COMPLETED|Overall Study||11
11058365|NCT01003275|12240189|FG000|NOT COMPLETED|Overall Study||1
11058366|NCT01003275|12240190|FG001|NOT COMPLETED|Overall Study||0
11058367|NCT01003288|12240198|FG000|STARTED|Overall Study||255
11058368|NCT01003288|12240198|FG000|COMPLETED|Overall Study||255
11058369|NCT01003288|12240198|FG000|NOT COMPLETED|Overall Study||0
11058370|NCT01003301|12240205|FG000|STARTED|Overall Study||10
11058371|NCT01003301|12240206|FG001|STARTED|Overall Study||9
11058372|NCT01003301|12240205|FG000|COMPLETED|Overall Study||10
11058373|NCT01003301|12240206|FG001|COMPLETED|Overall Study||9
11058374|NCT01003301|12240205|FG000|NOT COMPLETED|Overall Study||0
11058375|NCT01003301|12240206|FG001|NOT COMPLETED|Overall Study||0
11058376|NCT01003418|12240214|FG000|STARTED|Overall Study||5
11058377|NCT01003418|12240215|FG001|STARTED|Overall Study||3
11058378|NCT01003418|12240214|FG000|COMPLETED|Overall Study||5
11058379|NCT01003418|12240215|FG001|COMPLETED|Overall Study||3
11058380|NCT01003418|12240214|FG000|NOT COMPLETED|Overall Study||0
11058381|NCT01003418|12240215|FG001|NOT COMPLETED|Overall Study||0
11058382|NCT01003639|12240223|FG000|STARTED|Overall Study||86
11058383|NCT01003639|12240224|FG001|STARTED|Overall Study||79
11058384|NCT01003639|12240223|FG000|COMPLETED|Overall Study||69
11058385|NCT01003639|12240224|FG001|COMPLETED|Overall Study||57
11058386|NCT01003639|12240223|FG000|NOT COMPLETED|Overall Study||17
11058387|NCT01003639|12240224|FG001|NOT COMPLETED|Overall Study||22
11058388|NCT01003769|12240230|FG000|STARTED|Overall Study||5
11058389|NCT01003769|12240230|FG000|COMPLETED|Overall Study||5
11058390|NCT01003769|12240230|FG000|NOT COMPLETED|Overall Study||0
11058391|NCT01003886|12240234|FG000|STARTED|Overall Study||989
11058392|NCT01003886|12240234|FG000|COMPLETED|Overall Study||759
11058393|NCT01003886|12240234|FG000|NOT COMPLETED|Overall Study||230
11058394|NCT01003899|12240238|FG000|STARTED|Overall Study|enrolled|47
11058395|NCT01003899|12240238|FG000|COMPLETED|Overall Study||0
11058396|NCT01003899|12240238|FG000|NOT COMPLETED|Overall Study||47
11058397|NCT01003938|12240242|FG000|STARTED|Overall Study||6
11338884|NCT02906813|12536279|FG000|STARTED|Intervention Period 1 (3 Days)||3
11338885|NCT02906813|12536280|FG001|STARTED|Intervention Period 1 (3 Days)||3
11338886|NCT02906813|12536281|FG002|STARTED|Intervention Period 1 (3 Days)||3
11338887|NCT02906813|12536279|FG000|COMPLETED|Intervention Period 1 (3 Days)||3
11338888|NCT02906813|12536280|FG001|COMPLETED|Intervention Period 1 (3 Days)||3
11338889|NCT02906813|12536281|FG002|COMPLETED|Intervention Period 1 (3 Days)||3
11338890|NCT02906813|12536279|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11338891|NCT02906813|12536280|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11338892|NCT02906813|12536281|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
11338893|NCT02906813|12536279|FG000|STARTED|Washout Period 1 (at Least 3 Days)||3
11338894|NCT02906813|12536280|FG001|STARTED|Washout Period 1 (at Least 3 Days)||3
11338895|NCT02906813|12536281|FG002|STARTED|Washout Period 1 (at Least 3 Days)||3
11338896|NCT02906813|12536279|FG000|COMPLETED|Washout Period 1 (at Least 3 Days)||3
11338897|NCT02906813|12536280|FG001|COMPLETED|Washout Period 1 (at Least 3 Days)||3
11338898|NCT02906813|12536281|FG002|COMPLETED|Washout Period 1 (at Least 3 Days)||3
11338899|NCT02906813|12536279|FG000|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
11338900|NCT02906813|12536280|FG001|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
11338901|NCT02906813|12536281|FG002|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
11338902|NCT02906813|12536279|FG000|STARTED|Intervention Period 2 (3 Days)||3
11058398|NCT01003938|12240242|FG000|COMPLETED|Overall Study||6
11058399|NCT01003938|12240242|FG000|NOT COMPLETED|Overall Study||0
11058400|NCT01003990|12240249|FG000|STARTED|Overall Study||459
11058401|NCT01003990|12240250|FG001|STARTED|Overall Study||154
11058402|NCT01003990|12240251|FG002|STARTED|Overall Study||96
11056148|NCT00992589|12237666|FG000|STARTED|Open-Label Phase||344
11056149|NCT00992589|12237667|FG001|STARTED|Open-Label Phase||0
11056150|NCT00992589|12237668|FG002|STARTED|Open-Label Phase||0
11056151|NCT00992589|12237669|FG003|STARTED|Open-Label Phase||0
11056152|NCT00992589|12237666|FG000|COMPLETED|Open-Label Phase||267
11056153|NCT00992589|12237667|FG001|COMPLETED|Open-Label Phase||0
11056154|NCT00992589|12237668|FG002|COMPLETED|Open-Label Phase||0
11338903|NCT02906813|12536280|FG001|STARTED|Intervention Period 2 (3 Days)||3
11056155|NCT00992589|12237669|FG003|COMPLETED|Open-Label Phase||0
11056156|NCT00992589|12237666|FG000|NOT COMPLETED|Open-Label Phase||77
11056157|NCT00992589|12237667|FG001|NOT COMPLETED|Open-Label Phase||0
11056158|NCT00992589|12237668|FG002|NOT COMPLETED|Open-Label Phase||0
11056159|NCT00992589|12237669|FG003|NOT COMPLETED|Open-Label Phase||0
11056160|NCT00992589|12237666|FG000|STARTED|Double-Blind Phase||0
11056161|NCT00992589|12237667|FG001|STARTED|Double-Blind Phase||89
11056162|NCT00992589|12237668|FG002|STARTED|Double-Blind Phase||90
11056163|NCT00992589|12237669|FG003|STARTED|Double-Blind Phase||88
11056164|NCT00992589|12237666|FG000|COMPLETED|Double-Blind Phase||0
11056165|NCT00992589|12237667|FG001|COMPLETED|Double-Blind Phase||76
11056166|NCT00992589|12237668|FG002|COMPLETED|Double-Blind Phase||77
11056167|NCT00992589|12237669|FG003|COMPLETED|Double-Blind Phase||78
11056168|NCT00992589|12237666|FG000|NOT COMPLETED|Double-Blind Phase||0
11056169|NCT00992589|12237667|FG001|NOT COMPLETED|Double-Blind Phase||13
11056170|NCT00992589|12237668|FG002|NOT COMPLETED|Double-Blind Phase||13
11056171|NCT00992589|12237669|FG003|NOT COMPLETED|Double-Blind Phase||10
11056172|NCT00992602|12237687|FG000|STARTED|Overall Study||3
11056173|NCT00992602|12237687|FG000|COMPLETED|Overall Study||0
11056174|NCT00992602|12237687|FG000|NOT COMPLETED|Overall Study||3
11056175|NCT00992719|12237694|FG000|STARTED|Overall Study||28
11056176|NCT00992719|12237695|FG001|STARTED|Overall Study||28
11056177|NCT00992719|12237696|FG002|STARTED|Overall Study||28
11056178|NCT00992719|12237694|FG000|COMPLETED|Overall Study||27
11056179|NCT00992719|12237695|FG001|COMPLETED|Overall Study||27
11056180|NCT00992719|12237696|FG002|COMPLETED|Overall Study||28
11056181|NCT00992719|12237694|FG000|NOT COMPLETED|Overall Study||1
11056182|NCT00992719|12237695|FG001|NOT COMPLETED|Overall Study||1
11056183|NCT00992719|12237696|FG002|NOT COMPLETED|Overall Study||0
11056184|NCT00992784|12237707|FG000|STARTED|Overall Study||180
11056185|NCT00992784|12237708|FG001|STARTED|Overall Study||104
11056186|NCT00992784|12237709|FG002|STARTED|Overall Study||86
11056187|NCT00992784|12237707|FG000|COMPLETED|Overall Study||177
11056188|NCT00992784|12237708|FG001|COMPLETED|Overall Study||102
11056189|NCT00992784|12237709|FG002|COMPLETED|Overall Study||85
11056190|NCT00992784|12237707|FG000|NOT COMPLETED|Overall Study||3
11056191|NCT00992784|12237708|FG001|NOT COMPLETED|Overall Study||2
11056192|NCT00992784|12237709|FG002|NOT COMPLETED|Overall Study||1
11056193|NCT00992836|12237717|FG000|STARTED|Overall Study||155
11056194|NCT00992836|12237717|FG000|Received Both Study Vaccinations|Overall Study||150
11056195|NCT00992836|12237717|FG000|COMPLETED|Overall Study||150
11056196|NCT00992836|12237717|FG000|NOT COMPLETED|Overall Study||5
11056197|NCT00992927|12237729|FG000|STARTED|Overall Study||32
11056198|NCT00992927|12237730|FG001|STARTED|Overall Study||22
11056199|NCT00992927|12237729|FG000|COMPLETED|Overall Study||32
11056200|NCT00992927|12237730|FG001|COMPLETED|Overall Study||22
11056201|NCT00992927|12237729|FG000|NOT COMPLETED|Overall Study||0
11056202|NCT00992927|12237730|FG001|NOT COMPLETED|Overall Study||0
11056203|NCT00992992|12237736|FG000|STARTED|Overall Study||25
11056204|NCT00992992|12237736|FG000|COMPLETED|Overall Study||0
11056205|NCT00992992|12237736|FG000|NOT COMPLETED|Overall Study||25
11056206|NCT00993031|12237742|FG000|STARTED|Overall Study||195
11056207|NCT00993031|12237743|FG001|STARTED|Overall Study||194
11056208|NCT00993031|12237742|FG000|Delivered|Overall Study||187
11056209|NCT00993031|12237743|FG001|Delivered|Overall Study||190
11056210|NCT00993031|12237742|FG000|COMPLETED|Overall Study||173
11056211|NCT00993031|12237743|FG001|COMPLETED|Overall Study||175
11056212|NCT00993031|12237742|FG000|NOT COMPLETED|Overall Study||22
11056213|NCT00993031|12237743|FG001|NOT COMPLETED|Overall Study||19
11056214|NCT00993044|12237753|FG000|STARTED|Irinotecan 30 mg||6
11056215|NCT00993044|12237753|FG000|COMPLETED|Irinotecan 30 mg||6
11056216|NCT00993044|12237753|FG000|NOT COMPLETED|Irinotecan 30 mg||0
11056217|NCT00993044|12237753|FG000|STARTED|Irinotecan 50 mg||7
11056218|NCT00993044|12237753|FG000|COMPLETED|Irinotecan 50 mg||6
11056219|NCT00993044|12237753|FG000|NOT COMPLETED|Irinotecan 50 mg||1
11056220|NCT00993148|12237758|FG000|STARTED|Overall Study||25
11056221|NCT00993148|12237758|FG000|COMPLETED|Overall Study||22
11056222|NCT00993148|12237758|FG000|NOT COMPLETED|Overall Study||3
11056223|NCT00993187|12237764|FG000|STARTED|Overall Study||147
11056224|NCT00993187|12237765|FG001|STARTED|Overall Study||145
11056225|NCT00993187|12237764|FG000|Received at Least 1 Dose of Study Drug|Overall Study||146
11338904|NCT02906813|12536281|FG002|STARTED|Intervention Period 2 (3 Days)||3
11338905|NCT02906813|12536279|FG000|COMPLETED|Intervention Period 2 (3 Days)||3
11338906|NCT02906813|12536280|FG001|COMPLETED|Intervention Period 2 (3 Days)||3
11338907|NCT02906813|12536281|FG002|COMPLETED|Intervention Period 2 (3 Days)||3
11338908|NCT02906813|12536279|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11338909|NCT02906813|12536280|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11338910|NCT02906813|12536281|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
11338911|NCT02906813|12536279|FG000|STARTED|Washout Period 2 (at Least 3 Days)||3
11058484|NCT01004393|12240374|FG000|COMPLETED|Overall Study||12
11058485|NCT01004393|12240374|FG000|NOT COMPLETED|Overall Study||0
11058486|NCT01004406|12240380|FG000|STARTED|Overall Study||21
11058487|NCT01004406|12240381|FG001|STARTED|Overall Study||10
11058488|NCT01004406|12240380|FG000|COMPLETED|Overall Study||18
11058489|NCT01004406|12240381|FG001|COMPLETED|Overall Study||10
11058490|NCT01004406|12240380|FG000|NOT COMPLETED|Overall Study||3
11058491|NCT01004406|12240381|FG001|NOT COMPLETED|Overall Study||0
11058492|NCT01004432|12240387|FG000|STARTED|Open-label (OL) Period (Week 0 - 16)||433
11058493|NCT01004432|12240388|FG001|STARTED|Open-label (OL) Period (Week 0 - 16)||0
11058494|NCT01004432|12240389|FG002|STARTED|Open-label (OL) Period (Week 0 - 16)||0
11058495|NCT01004432|12240390|FG003|STARTED|Open-label (OL) Period (Week 0 - 16)||0
11058496|NCT01004432|12240391|FG004|STARTED|Open-label (OL) Period (Week 0 - 16)||0
11058497|NCT01004432|12240387|FG000|COMPLETED|Open-label (OL) Period (Week 0 - 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
11058498|NCT01004432|12240388|FG001|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
11058499|NCT01004432|12240389|FG002|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
11058500|NCT01004432|12240390|FG003|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
11058501|NCT01004432|12240391|FG004|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
11058502|NCT01004432|12240387|FG000|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||83
11058503|NCT01004432|12240388|FG001|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
11058504|NCT01004432|12240389|FG002|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
11058505|NCT01004432|12240390|FG003|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
11058506|NCT01004432|12240391|FG004|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
11058507|NCT01004432|12240387|FG000|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
11058508|NCT01004432|12240388|FG001|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
11058509|NCT01004432|12240389|FG002|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
11058510|NCT01004432|12240390|FG003|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
11058511|NCT01004432|12240391|FG004|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
11058512|NCT01004432|12240387|FG000|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
11058513|NCT01004432|12240388|FG001|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
11058514|NCT01004432|12240389|FG002|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
11058515|NCT01004432|12240390|FG003|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
11058516|NCT01004432|12240391|FG004|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
11058517|NCT01004432|12240387|FG000|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
11058518|NCT01004432|12240388|FG001|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
11058519|NCT01004432|12240389|FG002|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
11058520|NCT01004432|12240390|FG003|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
11058521|NCT01004432|12240391|FG004|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
11058522|NCT01004432|12240387|FG000|STARTED|OL Study Extension (Week 52 - 76)||0
11058523|NCT01004432|12240388|FG001|STARTED|OL Study Extension (Week 52 - 76)||0
11058524|NCT01004432|12240389|FG002|STARTED|OL Study Extension (Week 52 - 76)||0
11058525|NCT01004432|12240390|FG003|STARTED|OL Study Extension (Week 52 - 76)||0
11058526|NCT01004432|12240391|FG004|STARTED|OL Study Extension (Week 52 - 76)||212
11058527|NCT01004432|12240387|FG000|COMPLETED|OL Study Extension (Week 52 - 76)||0
11058528|NCT01004432|12240388|FG001|COMPLETED|OL Study Extension (Week 52 - 76)||0
11058529|NCT01004432|12240389|FG002|COMPLETED|OL Study Extension (Week 52 - 76)||0
11058530|NCT01004432|12240390|FG003|COMPLETED|OL Study Extension (Week 52 - 76)||0
11058531|NCT01004432|12240391|FG004|COMPLETED|OL Study Extension (Week 52 - 76)||194
11058532|NCT01004432|12240387|FG000|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
11058533|NCT01004432|12240388|FG001|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
11058534|NCT01004432|12240389|FG002|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
11058535|NCT01004432|12240390|FG003|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
11058536|NCT01004432|12240391|FG004|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
11058537|NCT01004614|12240409|FG000|STARTED|First Intervention||12
11343998|NCT02958553|12541315|FG000|STARTED|Phase I, 1st Visit -Passive Prosthesis||8
11343999|NCT02958553|12541315|FG000|COMPLETED|Phase I, 1st Visit -Passive Prosthesis||8
11344000|NCT02958553|12541315|FG000|NOT COMPLETED|Phase I, 1st Visit -Passive Prosthesis||0
11344001|NCT02958553|12541315|FG000|STARTED|Phase I, 2nd Visit -Fitted With emPOWER||8
11344002|NCT02958553|12541315|FG000|COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||8
11344003|NCT02958553|12541315|FG000|NOT COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||0
11344004|NCT02958553|12541315|FG000|STARTED|Phase I, 3rd Visit -2 Week emPOWER FU||8
11344005|NCT02958553|12541315|FG000|COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||7
11344006|NCT02958553|12541315|FG000|NOT COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||1
11058538|NCT01004614|12240410|FG001|STARTED|First Intervention||12
11058539|NCT01004614|12240411|FG002|STARTED|First Intervention||12
11058540|NCT01004614|12240412|FG003|STARTED|First Intervention||12
11058541|NCT01004614|12240409|FG000|COMPLETED|First Intervention||12
11058542|NCT01004614|12240410|FG001|COMPLETED|First Intervention||12
11058543|NCT01004614|12240411|FG002|COMPLETED|First Intervention||12
11058544|NCT01004614|12240412|FG003|COMPLETED|First Intervention||12
11058545|NCT01004614|12240409|FG000|NOT COMPLETED|First Intervention||0
11058546|NCT01004614|12240410|FG001|NOT COMPLETED|First Intervention||0
11058547|NCT01004614|12240411|FG002|NOT COMPLETED|First Intervention||0
11058548|NCT01004614|12240412|FG003|NOT COMPLETED|First Intervention||0
11058549|NCT01004614|12240409|FG000|STARTED|Washout||12
11058550|NCT01004614|12240410|FG001|STARTED|Washout||12
11058551|NCT01004614|12240411|FG002|STARTED|Washout||12
11058552|NCT01004614|12240412|FG003|STARTED|Washout||12
11058553|NCT01004614|12240409|FG000|COMPLETED|Washout||12
11058554|NCT01004614|12240410|FG001|COMPLETED|Washout||11
11058555|NCT01004614|12240411|FG002|COMPLETED|Washout||12
11058556|NCT01004614|12240412|FG003|COMPLETED|Washout||12
11344007|NCT02958553|12541315|FG000|STARTED|Phase II, 4th Visit -3 Month emPOWER FU|Only 4 subjects started Phase II of the study. Phase II was optional per protocol.|7
11344008|NCT02958553|12541315|FG000|COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||4
11344009|NCT02958553|12541315|FG000|NOT COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||3
11344010|NCT02958553|12541315|FG000|STARTED|Phase II, 5th Visit -Crossover Visit||4
11344011|NCT02958553|12541315|FG000|COMPLETED|Phase II, 5th Visit -Crossover Visit||4
11344012|NCT02958553|12541315|FG000|NOT COMPLETED|Phase II, 5th Visit -Crossover Visit||0
11344013|NCT02958553|12541315|FG000|STARTED|Phase II, 6th Visit -6 Month emPOWER FU||4
11344014|NCT02958553|12541315|FG000|COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
11344015|NCT02958553|12541315|FG000|NOT COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
11344016|NCT02958553|12541315|FG000|STARTED|Phase II, 7th Visit -12 Month emPOWER FU||2
11344017|NCT02958553|12541315|FG000|COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||2
11344018|NCT02958553|12541315|FG000|NOT COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||0
11344019|NCT02958787|12541320|FG000|STARTED|Overall Study||135
11344020|NCT02958787|12541320|FG000|COMPLETED|Overall Study||135
11344021|NCT02958787|12541320|FG000|NOT COMPLETED|Overall Study||0
11344022|NCT02958826|12541326|FG000|STARTED|Overall Study||80
11344023|NCT02958826|12541327|FG001|STARTED|Overall Study||80
11344024|NCT02958826|12541326|FG000|COMPLETED|Overall Study||80
11344025|NCT02958826|12541327|FG001|COMPLETED|Overall Study||80
11344026|NCT02958826|12541326|FG000|NOT COMPLETED|Overall Study||0
11344027|NCT02958826|12541327|FG001|NOT COMPLETED|Overall Study||0
11344028|NCT02958956|12541337|FG000|STARTED|Overall Study||38190
11344029|NCT02958956|12541338|FG001|STARTED|Overall Study||198317
11344030|NCT02958956|12541337|FG000|COMPLETED|Overall Study||38190
11344031|NCT02958956|12541338|FG001|COMPLETED|Overall Study||198317
11344032|NCT02958956|12541337|FG000|NOT COMPLETED|Overall Study||0
11344033|NCT02958956|12541338|FG001|NOT COMPLETED|Overall Study||0
11344034|NCT02958969|12541345|FG000|STARTED|Overall Study||50
11344035|NCT02958969|12541345|FG000|COMPLETED|Overall Study||50
11344036|NCT02958969|12541345|FG000|NOT COMPLETED|Overall Study||0
11344037|NCT02958982|12541360|FG000|STARTED|Cohort 1: 25 mg in SAD Study||1
11344038|NCT02958982|12541361|FG001|STARTED|Cohort 1: 25 mg in SAD Study||3
11344039|NCT02958982|12541362|FG002|STARTED|Cohort 1: 25 mg in SAD Study||0
11344040|NCT02958982|12541363|FG003|STARTED|Cohort 1: 25 mg in SAD Study||0
11344041|NCT02958982|12541364|FG004|STARTED|Cohort 1: 25 mg in SAD Study||0
11344042|NCT02958982|12541365|FG005|STARTED|Cohort 1: 25 mg in SAD Study||0
11344043|NCT02958982|12541366|FG006|STARTED|Cohort 1: 25 mg in SAD Study||0
11344044|NCT02958982|12541367|FG007|STARTED|Cohort 1: 25 mg in SAD Study||0
11344045|NCT02958982|12541368|FG008|STARTED|Cohort 1: 25 mg in SAD Study||0
11344046|NCT02958982|12541369|FG009|STARTED|Cohort 1: 25 mg in SAD Study||0
11344047|NCT02958982|12541370|FG010|STARTED|Cohort 1: 25 mg in SAD Study||0
11344048|NCT02958982|12541360|FG000|COMPLETED|Cohort 1: 25 mg in SAD Study||1
11344049|NCT02958982|12541361|FG001|COMPLETED|Cohort 1: 25 mg in SAD Study||3
11344050|NCT02958982|12541362|FG002|COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344051|NCT02958982|12541363|FG003|COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344052|NCT02958982|12541364|FG004|COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344053|NCT02958982|12541365|FG005|COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344054|NCT02958982|12541366|FG006|COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344055|NCT02958982|12541367|FG007|COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344056|NCT02958982|12541368|FG008|COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344057|NCT02958982|12541369|FG009|COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344058|NCT02958982|12541370|FG010|COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344059|NCT02958982|12541360|FG000|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344060|NCT02958982|12541361|FG001|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
11058557|NCT01004614|12240409|FG000|NOT COMPLETED|Washout||0
11058558|NCT01004614|12240410|FG001|NOT COMPLETED|Washout||1
11058559|NCT01004614|12240411|FG002|NOT COMPLETED|Washout||0
11344061|NCT02958982|12541362|FG002|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344062|NCT02958982|12541363|FG003|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344063|NCT02958982|12541364|FG004|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
11058560|NCT01004614|12240412|FG003|NOT COMPLETED|Washout||0
11058561|NCT01004614|12240409|FG000|STARTED|Second Intervention||12
11058562|NCT01004614|12240410|FG001|STARTED|Second Intervention||11
11058563|NCT01004614|12240411|FG002|STARTED|Second Intervention||12
11344064|NCT02958982|12541365|FG005|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344065|NCT02958982|12541366|FG006|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344066|NCT02958982|12541367|FG007|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344067|NCT02958982|12541368|FG008|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344068|NCT02958982|12541369|FG009|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344069|NCT02958982|12541370|FG010|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
11344070|NCT02958982|12541360|FG000|STARTED|Cohort 2: 50 mg in SAD Study||2
11344071|NCT02958982|12541361|FG001|STARTED|Cohort 2: 50 mg in SAD Study||0
11344072|NCT02958982|12541362|FG002|STARTED|Cohort 2: 50 mg in SAD Study||4
11344073|NCT02958982|12541363|FG003|STARTED|Cohort 2: 50 mg in SAD Study||0
11344074|NCT02958982|12541364|FG004|STARTED|Cohort 2: 50 mg in SAD Study||0
11344075|NCT02958982|12541365|FG005|STARTED|Cohort 2: 50 mg in SAD Study||0
11344076|NCT02958982|12541366|FG006|STARTED|Cohort 2: 50 mg in SAD Study||0
11344077|NCT02958982|12541367|FG007|STARTED|Cohort 2: 50 mg in SAD Study||0
11344078|NCT02958982|12541368|FG008|STARTED|Cohort 2: 50 mg in SAD Study||0
11344079|NCT02958982|12541369|FG009|STARTED|Cohort 2: 50 mg in SAD Study||0
11344080|NCT02958982|12541370|FG010|STARTED|Cohort 2: 50 mg in SAD Study||0
11344081|NCT02958982|12541360|FG000|COMPLETED|Cohort 2: 50 mg in SAD Study||2
11344082|NCT02958982|12541361|FG001|COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344083|NCT02958982|12541362|FG002|COMPLETED|Cohort 2: 50 mg in SAD Study||4
11344084|NCT02958982|12541363|FG003|COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344085|NCT02958982|12541364|FG004|COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344086|NCT02958982|12541365|FG005|COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344087|NCT02958982|12541366|FG006|COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344088|NCT02958982|12541367|FG007|COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344089|NCT02958982|12541368|FG008|COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344090|NCT02958982|12541369|FG009|COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344091|NCT02958982|12541370|FG010|COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344092|NCT02958982|12541360|FG000|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344093|NCT02958982|12541361|FG001|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344094|NCT02958982|12541362|FG002|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344095|NCT02958982|12541363|FG003|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344096|NCT02958982|12541364|FG004|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344097|NCT02958982|12541365|FG005|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344098|NCT02958982|12541366|FG006|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344099|NCT02958982|12541367|FG007|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344100|NCT02958982|12541368|FG008|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344101|NCT02958982|12541369|FG009|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344102|NCT02958982|12541370|FG010|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
11344103|NCT02958982|12541360|FG000|STARTED|Cohort 3: 100 mg in SAD Study||2
11344104|NCT02958982|12541361|FG001|STARTED|Cohort 3: 100 mg in SAD Study||0
11344105|NCT02958982|12541362|FG002|STARTED|Cohort 3: 100 mg in SAD Study||0
11344106|NCT02958982|12541363|FG003|STARTED|Cohort 3: 100 mg in SAD Study||4
11344107|NCT02958982|12541364|FG004|STARTED|Cohort 3: 100 mg in SAD Study||0
11344108|NCT02958982|12541365|FG005|STARTED|Cohort 3: 100 mg in SAD Study||0
11344109|NCT02958982|12541366|FG006|STARTED|Cohort 3: 100 mg in SAD Study||0
11344110|NCT02958982|12541367|FG007|STARTED|Cohort 3: 100 mg in SAD Study||0
11344111|NCT02958982|12541368|FG008|STARTED|Cohort 3: 100 mg in SAD Study||0
11344112|NCT02958982|12541369|FG009|STARTED|Cohort 3: 100 mg in SAD Study||0
11344113|NCT02958982|12541370|FG010|STARTED|Cohort 3: 100 mg in SAD Study||0
11344114|NCT02958982|12541360|FG000|COMPLETED|Cohort 3: 100 mg in SAD Study||2
11344115|NCT02958982|12541361|FG001|COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344116|NCT02958982|12541362|FG002|COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344117|NCT02958982|12541363|FG003|COMPLETED|Cohort 3: 100 mg in SAD Study||4
11344118|NCT02958982|12541364|FG004|COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344119|NCT02958982|12541365|FG005|COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344120|NCT02958982|12541366|FG006|COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344121|NCT02958982|12541367|FG007|COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344122|NCT02958982|12541368|FG008|COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344123|NCT02958982|12541369|FG009|COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344124|NCT02958982|12541370|FG010|COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344125|NCT02958982|12541360|FG000|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344126|NCT02958982|12541361|FG001|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344127|NCT02958982|12541362|FG002|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344128|NCT02958982|12541363|FG003|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
11058564|NCT01004614|12240412|FG003|STARTED|Second Intervention||12
11058565|NCT01004614|12240409|FG000|COMPLETED|Second Intervention||12
11058566|NCT01004614|12240410|FG001|COMPLETED|Second Intervention||11
11058567|NCT01004614|12240411|FG002|COMPLETED|Second Intervention||12
11058568|NCT01004614|12240412|FG003|COMPLETED|Second Intervention||12
11058569|NCT01004614|12240409|FG000|NOT COMPLETED|Second Intervention||0
11058570|NCT01004614|12240410|FG001|NOT COMPLETED|Second Intervention||0
11058571|NCT01004614|12240411|FG002|NOT COMPLETED|Second Intervention||0
11058572|NCT01004614|12240412|FG003|NOT COMPLETED|Second Intervention||0
11058573|NCT01004705|12240422|FG000|STARTED|Run-In||44
11058574|NCT01004705|12240423|FG001|STARTED|Run-In||0
11058575|NCT01004705|12240424|FG002|STARTED|Run-In||0
11058576|NCT01004705|12240422|FG000|COMPLETED|Run-In||36
11058577|NCT01004705|12240423|FG001|COMPLETED|Run-In||0
11058578|NCT01004705|12240424|FG002|COMPLETED|Run-In||0
11058579|NCT01004705|12240422|FG000|NOT COMPLETED|Run-In||8
11058580|NCT01004705|12240423|FG001|NOT COMPLETED|Run-In||0
11058581|NCT01004705|12240424|FG002|NOT COMPLETED|Run-In||0
11058582|NCT01004705|12240422|FG000|STARTED|Period 1 (12 Weeks)||0
11058583|NCT01004705|12240423|FG001|STARTED|Period 1 (12 Weeks)||18
11058584|NCT01004705|12240424|FG002|STARTED|Period 1 (12 Weeks)||18
11058585|NCT01004705|12240422|FG000|COMPLETED|Period 1 (12 Weeks)||0
11058586|NCT01004705|12240423|FG001|COMPLETED|Period 1 (12 Weeks)||13
11058587|NCT01004705|12240424|FG002|COMPLETED|Period 1 (12 Weeks)||13
11058588|NCT01004705|12240422|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
11058589|NCT01004705|12240423|FG001|NOT COMPLETED|Period 1 (12 Weeks)||5
11058590|NCT01004705|12240424|FG002|NOT COMPLETED|Period 1 (12 Weeks)||5
11058591|NCT01004705|12240422|FG000|STARTED|Washout Period (6 Weeks)||0
11058592|NCT01004705|12240423|FG001|STARTED|Washout Period (6 Weeks)||13
11058593|NCT01004705|12240424|FG002|STARTED|Washout Period (6 Weeks)||13
11058594|NCT01004705|12240422|FG000|COMPLETED|Washout Period (6 Weeks)||0
11058595|NCT01004705|12240423|FG001|COMPLETED|Washout Period (6 Weeks)||13
11058596|NCT01004705|12240424|FG002|COMPLETED|Washout Period (6 Weeks)||13
11058597|NCT01004705|12240422|FG000|NOT COMPLETED|Washout Period (6 Weeks)||0
11058598|NCT01004705|12240423|FG001|NOT COMPLETED|Washout Period (6 Weeks)||0
11058599|NCT01004705|12240424|FG002|NOT COMPLETED|Washout Period (6 Weeks)||0
11058600|NCT01004705|12240422|FG000|STARTED|Period 2 (12 Weeks)||0
11058601|NCT01004705|12240423|FG001|STARTED|Period 2 (12 Weeks)||13
11058602|NCT01004705|12240424|FG002|STARTED|Period 2 (12 Weeks)||13
11058603|NCT01004705|12240422|FG000|COMPLETED|Period 2 (12 Weeks)||0
11058604|NCT01004705|12240423|FG001|COMPLETED|Period 2 (12 Weeks)||13
11058605|NCT01004705|12240424|FG002|COMPLETED|Period 2 (12 Weeks)||9
11058606|NCT01004705|12240422|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
11058607|NCT01004705|12240423|FG001|NOT COMPLETED|Period 2 (12 Weeks)||0
11058608|NCT01004705|12240424|FG002|NOT COMPLETED|Period 2 (12 Weeks)||4
11058609|NCT01004718|12240431|FG000|STARTED|Overall Study||10
11058610|NCT01004718|12240431|FG000|COMPLETED|Overall Study||10
11058611|NCT01004718|12240431|FG000|NOT COMPLETED|Overall Study||0
11058612|NCT01004744|12240436|FG000|STARTED|Overall Study||10
11058613|NCT01004744|12240436|FG000|COMPLETED|Overall Study||10
11058614|NCT01004744|12240436|FG000|NOT COMPLETED|Overall Study||0
11058615|NCT01004770|12240445|FG000|STARTED|Overall Study||10
11058616|NCT01004770|12240446|FG001|STARTED|Overall Study||10
11058617|NCT01004770|12240447|FG002|STARTED|Overall Study||10
11058618|NCT01004770|12240448|FG003|STARTED|Overall Study||10
11058619|NCT01004770|12240449|FG004|STARTED|Overall Study||10
11058620|NCT01004770|12240445|FG000|COMPLETED|Overall Study||10
11058621|NCT01004770|12240446|FG001|COMPLETED|Overall Study||10
11058622|NCT01004770|12240447|FG002|COMPLETED|Overall Study||10
11058623|NCT01004770|12240448|FG003|COMPLETED|Overall Study||10
11058624|NCT01004770|12240449|FG004|COMPLETED|Overall Study||10
11058625|NCT01004770|12240445|FG000|NOT COMPLETED|Overall Study||0
11058626|NCT01004770|12240446|FG001|NOT COMPLETED|Overall Study||0
11058627|NCT01004770|12240447|FG002|NOT COMPLETED|Overall Study||0
11058628|NCT01004770|12240448|FG003|NOT COMPLETED|Overall Study||0
11058629|NCT01004770|12240449|FG004|NOT COMPLETED|Overall Study||0
11058630|NCT01004822|12240469|FG000|STARTED|Overall Study||3
11058631|NCT01004822|12240470|FG001|STARTED|Overall Study||3
11058632|NCT01004822|12240471|FG002|STARTED|Overall Study||4
11058633|NCT01004822|12240472|FG003|STARTED|Overall Study||4
11058634|NCT01004822|12240473|FG004|STARTED|Overall Study||4
11058635|NCT01004822|12240474|FG005|STARTED|Overall Study||4
11058636|NCT01004822|12240475|FG006|STARTED|Overall Study||4
11058637|NCT01004822|12240476|FG007|STARTED|Overall Study||5
11058638|NCT01004822|12240469|FG000|Treated|Overall Study||3
11058639|NCT01004822|12240470|FG001|Treated|Overall Study||3
11058640|NCT01004822|12240471|FG002|Treated|Overall Study||3
11058641|NCT01004822|12240472|FG003|Treated|Overall Study||4
11058642|NCT01004822|12240473|FG004|Treated|Overall Study||4
11058643|NCT01004822|12240474|FG005|Treated|Overall Study||4
11058644|NCT01004822|12240475|FG006|Treated|Overall Study||4
11058645|NCT01004822|12240476|FG007|Treated|Overall Study||5
11058646|NCT01004822|12240469|FG000|COMPLETED|Overall Study||0
11058647|NCT01004822|12240470|FG001|COMPLETED|Overall Study||0
11058648|NCT01004822|12240471|FG002|COMPLETED|Overall Study||0
11058649|NCT01004822|12240472|FG003|COMPLETED|Overall Study||0
11058650|NCT01004822|12240473|FG004|COMPLETED|Overall Study||0
11058651|NCT01004822|12240474|FG005|COMPLETED|Overall Study||0
11058652|NCT01004822|12240475|FG006|COMPLETED|Overall Study||0
11058653|NCT01004822|12240476|FG007|COMPLETED|Overall Study||0
11058654|NCT01004822|12240469|FG000|NOT COMPLETED|Overall Study||3
11058655|NCT01004822|12240470|FG001|NOT COMPLETED|Overall Study||3
11058656|NCT01004822|12240471|FG002|NOT COMPLETED|Overall Study||4
11058657|NCT01004822|12240472|FG003|NOT COMPLETED|Overall Study||4
11058658|NCT01004822|12240473|FG004|NOT COMPLETED|Overall Study||4
11058659|NCT01004822|12240474|FG005|NOT COMPLETED|Overall Study||4
11058660|NCT01004822|12240475|FG006|NOT COMPLETED|Overall Study||4
11058661|NCT01004822|12240476|FG007|NOT COMPLETED|Overall Study||5
11058662|NCT01004848|12240498|FG000|STARTED|Overall Study||210
11058663|NCT01004848|12240499|FG001|STARTED|Overall Study||192
11058664|NCT01004848|12240498|FG000|COMPLETED|Overall Study||155
11058665|NCT01004848|12240499|FG001|COMPLETED|Overall Study||147
11058666|NCT01004848|12240498|FG000|NOT COMPLETED|Overall Study||55
11058667|NCT01004848|12240499|FG001|NOT COMPLETED|Overall Study||45
11058668|NCT01004939|12240507|FG000|STARTED|Overall Study||120
11058669|NCT01004939|12240507|FG000|COMPLETED|Overall Study||120
11058670|NCT01004939|12240507|FG000|NOT COMPLETED|Overall Study||0
11058671|NCT01004991|12240513|FG000|STARTED|Overall Study||12
11058672|NCT01004991|12240513|FG000|COMPLETED|Overall Study||12
11058673|NCT01004991|12240513|FG000|NOT COMPLETED|Overall Study||0
11058674|NCT01005251|12240522|FG000|STARTED|Overall Study||134
11058675|NCT01005251|12240523|FG001|STARTED|Overall Study||125
11058676|NCT01005251|12240524|FG002|STARTED|Overall Study||136
11058677|NCT01005251|12240525|FG003|STARTED|Overall Study||126
11058678|NCT01005251|12240526|FG004|STARTED|Overall Study||140
11058679|NCT01005251|12240522|FG000|COMPLETED|Overall Study||121
11058680|NCT01005251|12240523|FG001|COMPLETED|Overall Study||109
11058681|NCT01005251|12240524|FG002|COMPLETED|Overall Study||114
11058682|NCT01005251|12240525|FG003|COMPLETED|Overall Study||114
11058683|NCT01005251|12240526|FG004|COMPLETED|Overall Study||122
11058684|NCT01005251|12240522|FG000|NOT COMPLETED|Overall Study||13
11058685|NCT01005251|12240523|FG001|NOT COMPLETED|Overall Study||16
11058686|NCT01005251|12240524|FG002|NOT COMPLETED|Overall Study||22
11058687|NCT01005251|12240525|FG003|NOT COMPLETED|Overall Study||12
11058688|NCT01005251|12240526|FG004|NOT COMPLETED|Overall Study||18
11058689|NCT01005290|12240538|FG000|STARTED|Run-In||52
11058690|NCT01005290|12240539|FG001|STARTED|Run-In||0
11058691|NCT01005290|12240540|FG002|STARTED|Run-In||0
11058692|NCT01005290|12240538|FG000|COMPLETED|Run-In||38
11058693|NCT01005290|12240539|FG001|COMPLETED|Run-In||0
11058694|NCT01005290|12240540|FG002|COMPLETED|Run-In||0
11058695|NCT01005290|12240538|FG000|NOT COMPLETED|Run-In||14
11058696|NCT01005290|12240539|FG001|NOT COMPLETED|Run-In||0
11058697|NCT01005290|12240540|FG002|NOT COMPLETED|Run-In||0
11058698|NCT01005290|12240538|FG000|STARTED|Period 1 (5 Weeks)||0
11058699|NCT01005290|12240539|FG001|STARTED|Period 1 (5 Weeks)||20
11058700|NCT01005290|12240540|FG002|STARTED|Period 1 (5 Weeks)||18
11058701|NCT01005290|12240538|FG000|COMPLETED|Period 1 (5 Weeks)||0
11058702|NCT01005290|12240539|FG001|COMPLETED|Period 1 (5 Weeks)||13
11058703|NCT01005290|12240540|FG002|COMPLETED|Period 1 (5 Weeks)||9
11058704|NCT01005290|12240538|FG000|NOT COMPLETED|Period 1 (5 Weeks)||0
11058705|NCT01005290|12240539|FG001|NOT COMPLETED|Period 1 (5 Weeks)||7
11058706|NCT01005290|12240540|FG002|NOT COMPLETED|Period 1 (5 Weeks)||9
11058707|NCT01005290|12240538|FG000|STARTED|Washout Period (2 Weeks)||0
11058708|NCT01005290|12240539|FG001|STARTED|Washout Period (2 Weeks)||13
11058709|NCT01005290|12240540|FG002|STARTED|Washout Period (2 Weeks)||9
11058710|NCT01005290|12240538|FG000|COMPLETED|Washout Period (2 Weeks)||0
11058711|NCT01005290|12240539|FG001|COMPLETED|Washout Period (2 Weeks)||13
11058712|NCT01005290|12240540|FG002|COMPLETED|Washout Period (2 Weeks)||9
11058713|NCT01005290|12240538|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
11058714|NCT01005290|12240539|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
11058715|NCT01005290|12240540|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
11058716|NCT01005290|12240538|FG000|STARTED|Period 2 (5 Weeks)||0
11058717|NCT01005290|12240539|FG001|STARTED|Period 2 (5 Weeks)||13
11058718|NCT01005290|12240540|FG002|STARTED|Period 2 (5 Weeks)||9
11058719|NCT01005290|12240538|FG000|COMPLETED|Period 2 (5 Weeks)||0
11058720|NCT01005290|12240539|FG001|COMPLETED|Period 2 (5 Weeks)||13
11058721|NCT01005290|12240540|FG002|COMPLETED|Period 2 (5 Weeks)||7
11058722|NCT01005290|12240538|FG000|NOT COMPLETED|Period 2 (5 Weeks)||0
11058723|NCT01005290|12240539|FG001|NOT COMPLETED|Period 2 (5 Weeks)||0
11058724|NCT01005290|12240540|FG002|NOT COMPLETED|Period 2 (5 Weeks)||2
11058725|NCT01005316|12240550|FG000|STARTED|Overall Study||50
11058726|NCT01005316|12240551|FG001|STARTED|Overall Study||97
11058727|NCT01005316|12240552|FG002|STARTED|Overall Study||16
11058728|NCT01005316|12240553|FG003|STARTED|Overall Study||127
11058729|NCT01005316|12240550|FG000|COMPLETED|Overall Study||0
11058730|NCT01005316|12240551|FG001|COMPLETED|Overall Study||21
11058731|NCT01005316|12240552|FG002|COMPLETED|Overall Study||5
11058732|NCT01005316|12240553|FG003|COMPLETED|Overall Study||19
11058733|NCT01005316|12240550|FG000|NOT COMPLETED|Overall Study||50
11058734|NCT01005316|12240551|FG001|NOT COMPLETED|Overall Study||76
11058735|NCT01005316|12240552|FG002|NOT COMPLETED|Overall Study||11
11058736|NCT01005316|12240553|FG003|NOT COMPLETED|Overall Study||108
11058737|NCT01005329|12240564|FG000|STARTED|Overall Study||34
11058738|NCT01005329|12240564|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
11058739|NCT01005329|12240564|FG000|NOT COMPLETED|Overall Study||4
11058740|NCT01005355|12240572|FG000|STARTED|Overall Study||3
11058741|NCT01005355|12240573|FG001|STARTED|Overall Study||6
11058742|NCT01005355|12240574|FG002|STARTED|Overall Study||6
11058743|NCT01005355|12240572|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11058744|NCT01005355|12240573|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
11058745|NCT01005355|12240574|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11058746|NCT01005355|12240572|FG000|COMPLETED|Overall Study||3
11058747|NCT01005355|12240573|FG001|COMPLETED|Overall Study||6
11058748|NCT01005355|12240574|FG002|COMPLETED|Overall Study||6
11058749|NCT01005355|12240572|FG000|NOT COMPLETED|Overall Study||0
11058750|NCT01005355|12240573|FG001|NOT COMPLETED|Overall Study||0
11058751|NCT01005355|12240574|FG002|NOT COMPLETED|Overall Study||0
11058752|NCT01005407|12240587|FG000|STARTED|Overall Study||1969
11058753|NCT01005407|12240588|FG001|STARTED|Overall Study||483
11058754|NCT01005407|12240587|FG000|COMPLETED|Overall Study||1818
11058755|NCT01005407|12240588|FG001|COMPLETED|Overall Study||451
11058756|NCT01005407|12240587|FG000|NOT COMPLETED|Overall Study||151
11058757|NCT01005407|12240588|FG001|NOT COMPLETED|Overall Study||32
11344129|NCT02958982|12541364|FG004|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344130|NCT02958982|12541365|FG005|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344131|NCT02958982|12541366|FG006|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344132|NCT02958982|12541367|FG007|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344133|NCT02958982|12541368|FG008|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344134|NCT02958982|12541369|FG009|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344135|NCT02958982|12541370|FG010|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
11344136|NCT02958982|12541360|FG000|STARTED|Cohort 4: 200 mg in SAD Study||2
11344137|NCT02958982|12541361|FG001|STARTED|Cohort 4: 200 mg in SAD Study||0
11344138|NCT02958982|12541362|FG002|STARTED|Cohort 4: 200 mg in SAD Study||0
11344139|NCT02958982|12541363|FG003|STARTED|Cohort 4: 200 mg in SAD Study||0
11344140|NCT02958982|12541364|FG004|STARTED|Cohort 4: 200 mg in SAD Study||6
11344141|NCT02958982|12541365|FG005|STARTED|Cohort 4: 200 mg in SAD Study||0
11344142|NCT02958982|12541366|FG006|STARTED|Cohort 4: 200 mg in SAD Study||0
11344143|NCT02958982|12541367|FG007|STARTED|Cohort 4: 200 mg in SAD Study||0
11344144|NCT02958982|12541368|FG008|STARTED|Cohort 4: 200 mg in SAD Study||0
11344145|NCT02958982|12541369|FG009|STARTED|Cohort 4: 200 mg in SAD Study||0
11344146|NCT02958982|12541370|FG010|STARTED|Cohort 4: 200 mg in SAD Study||0
11344147|NCT02958982|12541360|FG000|COMPLETED|Cohort 4: 200 mg in SAD Study||2
11344148|NCT02958982|12541361|FG001|COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344149|NCT02958982|12541362|FG002|COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344150|NCT02958982|12541363|FG003|COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344151|NCT02958982|12541364|FG004|COMPLETED|Cohort 4: 200 mg in SAD Study||6
11344152|NCT02958982|12541365|FG005|COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344153|NCT02958982|12541366|FG006|COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344154|NCT02958982|12541367|FG007|COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344155|NCT02958982|12541368|FG008|COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344156|NCT02958982|12541369|FG009|COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344157|NCT02958982|12541370|FG010|COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344158|NCT02958982|12541360|FG000|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344159|NCT02958982|12541361|FG001|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344160|NCT02958982|12541362|FG002|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344161|NCT02958982|12541363|FG003|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344162|NCT02958982|12541364|FG004|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344163|NCT02958982|12541365|FG005|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344164|NCT02958982|12541366|FG006|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344165|NCT02958982|12541367|FG007|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344166|NCT02958982|12541368|FG008|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344167|NCT02958982|12541369|FG009|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344168|NCT02958982|12541370|FG010|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
11344169|NCT02958982|12541360|FG000|STARTED|Cohort 5: 400 mg in SAD Study||2
11344170|NCT02958982|12541361|FG001|STARTED|Cohort 5: 400 mg in SAD Study||0
11344171|NCT02958982|12541362|FG002|STARTED|Cohort 5: 400 mg in SAD Study||0
11344172|NCT02958982|12541363|FG003|STARTED|Cohort 5: 400 mg in SAD Study||0
11344173|NCT02958982|12541364|FG004|STARTED|Cohort 5: 400 mg in SAD Study||0
11344174|NCT02958982|12541365|FG005|STARTED|Cohort 5: 400 mg in SAD Study||6
11344175|NCT02958982|12541366|FG006|STARTED|Cohort 5: 400 mg in SAD Study||0
11344176|NCT02958982|12541367|FG007|STARTED|Cohort 5: 400 mg in SAD Study||0
11344177|NCT02958982|12541368|FG008|STARTED|Cohort 5: 400 mg in SAD Study||0
11344178|NCT02958982|12541369|FG009|STARTED|Cohort 5: 400 mg in SAD Study||0
11344179|NCT02958982|12541370|FG010|STARTED|Cohort 5: 400 mg in SAD Study||0
11344180|NCT02958982|12541360|FG000|COMPLETED|Cohort 5: 400 mg in SAD Study||2
11344181|NCT02958982|12541361|FG001|COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344182|NCT02958982|12541362|FG002|COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344183|NCT02958982|12541363|FG003|COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344184|NCT02958982|12541364|FG004|COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344185|NCT02958982|12541365|FG005|COMPLETED|Cohort 5: 400 mg in SAD Study||6
11344186|NCT02958982|12541366|FG006|COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344187|NCT02958982|12541367|FG007|COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344188|NCT02958982|12541368|FG008|COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344189|NCT02958982|12541369|FG009|COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344190|NCT02958982|12541370|FG010|COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344191|NCT02958982|12541360|FG000|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344192|NCT02958982|12541361|FG001|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344193|NCT02958982|12541362|FG002|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344194|NCT02958982|12541363|FG003|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344195|NCT02958982|12541364|FG004|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344196|NCT02958982|12541365|FG005|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
11058758|NCT01005459|12240596|FG000|STARTED|Overall Study||23
11058759|NCT01005459|12240597|FG001|STARTED|Overall Study||23
11058760|NCT01005459|12240596|FG000|COMPLETED|Overall Study||23
11058761|NCT01005459|12240597|FG001|COMPLETED|Overall Study||23
11058762|NCT01005459|12240596|FG000|NOT COMPLETED|Overall Study||0
11058763|NCT01005459|12240597|FG001|NOT COMPLETED|Overall Study||0
11058764|NCT01005576|12240603|FG000|STARTED|Overall Study||21
11058765|NCT01005576|12240603|FG000|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
11058766|NCT01005576|12240603|FG000|NOT COMPLETED|Overall Study||0
11058767|NCT01005602|12240609|FG000|STARTED|Overall Study||66
11058768|NCT01005602|12240610|FG001|STARTED|Overall Study||66
11058769|NCT01005602|12240609|FG000|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
11058770|NCT01005602|12240610|FG001|COMPLETED|Overall Study||66
11058771|NCT01005602|12240609|FG000|NOT COMPLETED|Overall Study||1
11058772|NCT01005602|12240610|FG001|NOT COMPLETED|Overall Study||0
11058773|NCT01005680|12240625|FG000|STARTED|Overall Study||126
11058774|NCT01005680|12240626|FG001|STARTED|Overall Study||130
11058775|NCT01005680|12240625|FG000|Received at Least 1 Dose of Study Drug|Overall Study||125
11058776|NCT01005680|12240626|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127
11058777|NCT01005680|12240625|FG000|COMPLETED|Overall Study||120
11058778|NCT01005680|12240626|FG001|COMPLETED|Overall Study||119
11058779|NCT01005680|12240625|FG000|NOT COMPLETED|Overall Study||6
11058780|NCT01005680|12240626|FG001|NOT COMPLETED|Overall Study||11
11058781|NCT01005706|12240635|FG000|STARTED|Overall Study||23
11058782|NCT01005706|12240636|FG001|STARTED|Overall Study||17
11058783|NCT01005706|12240635|FG000|COMPLETED|Overall Study||23
11058784|NCT01005706|12240636|FG001|COMPLETED|Overall Study||17
11058785|NCT01005706|12240635|FG000|NOT COMPLETED|Overall Study||0
11058786|NCT01005706|12240636|FG001|NOT COMPLETED|Overall Study||0
11058787|NCT01005719|12240642|FG000|STARTED|Period 1||10
11058788|NCT01005719|12240643|FG001|STARTED|Period 1||10
11058789|NCT01005719|12240644|FG002|STARTED|Period 1||10
11058790|NCT01005719|12240645|FG003|STARTED|Period 1||11
11058791|NCT01005719|12240646|FG004|STARTED|Period 1||11
11058792|NCT01005719|12240647|FG005|STARTED|Period 1||11
11058793|NCT01005719|12240642|FG000|COMPLETED|Period 1||10
11058794|NCT01005719|12240643|FG001|COMPLETED|Period 1||10
11058795|NCT01005719|12240644|FG002|COMPLETED|Period 1||10
11058796|NCT01005719|12240645|FG003|COMPLETED|Period 1||10
11058797|NCT01005719|12240646|FG004|COMPLETED|Period 1||11
11058798|NCT01005719|12240647|FG005|COMPLETED|Period 1||10
11058799|NCT01005719|12240642|FG000|NOT COMPLETED|Period 1||0
11058800|NCT01005719|12240643|FG001|NOT COMPLETED|Period 1||0
11058801|NCT01005719|12240644|FG002|NOT COMPLETED|Period 1||0
11058802|NCT01005719|12240645|FG003|NOT COMPLETED|Period 1||1
11058803|NCT01005719|12240646|FG004|NOT COMPLETED|Period 1||0
11058804|NCT01005719|12240647|FG005|NOT COMPLETED|Period 1||1
11058805|NCT01005719|12240642|FG000|STARTED|Period 2||10
11058806|NCT01005719|12240643|FG001|STARTED|Period 2||10
11058807|NCT01005719|12240644|FG002|STARTED|Period 2||10
11058808|NCT01005719|12240645|FG003|STARTED|Period 2||10
11058809|NCT01005719|12240646|FG004|STARTED|Period 2||11
11058810|NCT01005719|12240647|FG005|STARTED|Period 2||10
11058811|NCT01005719|12240642|FG000|COMPLETED|Period 2||10
11058812|NCT01005719|12240643|FG001|COMPLETED|Period 2||10
11058813|NCT01005719|12240644|FG002|COMPLETED|Period 2||10
11058814|NCT01005719|12240645|FG003|COMPLETED|Period 2||10
11058815|NCT01005719|12240646|FG004|COMPLETED|Period 2||10
11058816|NCT01005719|12240647|FG005|COMPLETED|Period 2||9
11058817|NCT01005719|12240642|FG000|NOT COMPLETED|Period 2||0
11058818|NCT01005719|12240643|FG001|NOT COMPLETED|Period 2||0
11058819|NCT01005719|12240644|FG002|NOT COMPLETED|Period 2||0
11058820|NCT01005719|12240645|FG003|NOT COMPLETED|Period 2||0
11058821|NCT01005719|12240646|FG004|NOT COMPLETED|Period 2||1
11058822|NCT01005719|12240647|FG005|NOT COMPLETED|Period 2||1
11058823|NCT01005719|12240642|FG000|STARTED|Period 3||10
11058824|NCT01005719|12240643|FG001|STARTED|Period 3||10
11058825|NCT01005719|12240644|FG002|STARTED|Period 3||10
11058826|NCT01005719|12240645|FG003|STARTED|Period 3||10
11058827|NCT01005719|12240646|FG004|STARTED|Period 3||10
11058828|NCT01005719|12240647|FG005|STARTED|Period 3||9
11058829|NCT01005719|12240642|FG000|COMPLETED|Period 3||10
11058830|NCT01005719|12240643|FG001|COMPLETED|Period 3||10
11058831|NCT01005719|12240644|FG002|COMPLETED|Period 3||10
11058832|NCT01005719|12240645|FG003|COMPLETED|Period 3||10
11058833|NCT01005719|12240646|FG004|COMPLETED|Period 3||10
11058834|NCT01005719|12240647|FG005|COMPLETED|Period 3||9
11058835|NCT01005719|12240642|FG000|NOT COMPLETED|Period 3||0
11058836|NCT01005719|12240643|FG001|NOT COMPLETED|Period 3||0
11058837|NCT01005719|12240644|FG002|NOT COMPLETED|Period 3||0
11058838|NCT01005719|12240645|FG003|NOT COMPLETED|Period 3||0
11058839|NCT01005719|12240646|FG004|NOT COMPLETED|Period 3||0
11058840|NCT01005719|12240647|FG005|NOT COMPLETED|Period 3||0
11058841|NCT01005732|12240656|FG000|STARTED|Overall Study||54
11058842|NCT01005732|12240656|FG000|COMPLETED|Overall Study||43
11058843|NCT01005732|12240656|FG000|NOT COMPLETED|Overall Study||11
11058844|NCT01005810|12240666|FG000|STARTED|Overall Study||58
11058845|NCT01005810|12240667|FG001|STARTED|Overall Study||58
11058846|NCT01005810|12240666|FG000|COMPLETED|Overall Study||37
11058847|NCT01005810|12240667|FG001|COMPLETED|Overall Study||33
11058848|NCT01005810|12240666|FG000|NOT COMPLETED|Overall Study||21
11058849|NCT01005810|12240667|FG001|NOT COMPLETED|Overall Study||25
11058850|NCT01005875|12240673|FG000|STARTED|Overall Study||5
11058851|NCT01005875|12240673|FG000|COMPLETED|Overall Study||2
11058852|NCT01005875|12240673|FG000|NOT COMPLETED|Overall Study||3
11058853|NCT01005888|12240681|FG000|STARTED|First Intervention||12
11058854|NCT01005888|12240682|FG001|STARTED|First Intervention||12
11344197|NCT02958982|12541366|FG006|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344198|NCT02958982|12541367|FG007|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344199|NCT02958982|12541368|FG008|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344200|NCT02958982|12541369|FG009|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344201|NCT02958982|12541370|FG010|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
11344202|NCT02958982|12541360|FG000|STARTED|Cohort 1 : 25 mg in MAD Study||0
11344203|NCT02958982|12541361|FG001|STARTED|Cohort 1 : 25 mg in MAD Study||0
11344204|NCT02958982|12541362|FG002|STARTED|Cohort 1 : 25 mg in MAD Study||0
11344205|NCT02958982|12541363|FG003|STARTED|Cohort 1 : 25 mg in MAD Study||0
11344206|NCT02958982|12541364|FG004|STARTED|Cohort 1 : 25 mg in MAD Study||0
11344207|NCT02958982|12541365|FG005|STARTED|Cohort 1 : 25 mg in MAD Study||0
11344208|NCT02958982|12541366|FG006|STARTED|Cohort 1 : 25 mg in MAD Study||2
11344209|NCT02958982|12541367|FG007|STARTED|Cohort 1 : 25 mg in MAD Study||6
11344210|NCT02958982|12541368|FG008|STARTED|Cohort 1 : 25 mg in MAD Study||0
11344211|NCT02958982|12541369|FG009|STARTED|Cohort 1 : 25 mg in MAD Study||0
11344212|NCT02958982|12541370|FG010|STARTED|Cohort 1 : 25 mg in MAD Study||0
11344213|NCT02958982|12541360|FG000|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344214|NCT02958982|12541361|FG001|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344215|NCT02958982|12541362|FG002|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344216|NCT02958982|12541363|FG003|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344217|NCT02958982|12541364|FG004|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344218|NCT02958982|12541365|FG005|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344219|NCT02958982|12541366|FG006|COMPLETED|Cohort 1 : 25 mg in MAD Study||2
11344220|NCT02958982|12541367|FG007|COMPLETED|Cohort 1 : 25 mg in MAD Study||6
11344221|NCT02958982|12541368|FG008|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344222|NCT02958982|12541369|FG009|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344223|NCT02958982|12541370|FG010|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344224|NCT02958982|12541360|FG000|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344225|NCT02958982|12541361|FG001|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344226|NCT02958982|12541362|FG002|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344227|NCT02958982|12541363|FG003|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344228|NCT02958982|12541364|FG004|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344229|NCT02958982|12541365|FG005|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344230|NCT02958982|12541366|FG006|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344231|NCT02958982|12541367|FG007|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344232|NCT02958982|12541368|FG008|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344233|NCT02958982|12541369|FG009|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344234|NCT02958982|12541370|FG010|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
11344235|NCT02958982|12541360|FG000|STARTED|Cohort 2: 100 mg in MAD Study||0
11344236|NCT02958982|12541361|FG001|STARTED|Cohort 2: 100 mg in MAD Study||0
11344237|NCT02958982|12541362|FG002|STARTED|Cohort 2: 100 mg in MAD Study||0
11344238|NCT02958982|12541363|FG003|STARTED|Cohort 2: 100 mg in MAD Study||0
11344239|NCT02958982|12541364|FG004|STARTED|Cohort 2: 100 mg in MAD Study||0
11344240|NCT02958982|12541365|FG005|STARTED|Cohort 2: 100 mg in MAD Study||0
11344241|NCT02958982|12541366|FG006|STARTED|Cohort 2: 100 mg in MAD Study||2
11344242|NCT02958982|12541367|FG007|STARTED|Cohort 2: 100 mg in MAD Study||0
11344243|NCT02958982|12541368|FG008|STARTED|Cohort 2: 100 mg in MAD Study||6
11344244|NCT02958982|12541369|FG009|STARTED|Cohort 2: 100 mg in MAD Study||0
11344245|NCT02958982|12541370|FG010|STARTED|Cohort 2: 100 mg in MAD Study||0
11344246|NCT02958982|12541360|FG000|COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344247|NCT02958982|12541361|FG001|COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344248|NCT02958982|12541362|FG002|COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344249|NCT02958982|12541363|FG003|COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344250|NCT02958982|12541364|FG004|COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344251|NCT02958982|12541365|FG005|COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344252|NCT02958982|12541366|FG006|COMPLETED|Cohort 2: 100 mg in MAD Study||2
11344253|NCT02958982|12541367|FG007|COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344254|NCT02958982|12541368|FG008|COMPLETED|Cohort 2: 100 mg in MAD Study||6
11344255|NCT02958982|12541369|FG009|COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344256|NCT02958982|12541370|FG010|COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344257|NCT02958982|12541360|FG000|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344258|NCT02958982|12541361|FG001|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344259|NCT02958982|12541362|FG002|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344260|NCT02958982|12541363|FG003|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344261|NCT02958982|12541364|FG004|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
11058855|NCT01005888|12240681|FG000|COMPLETED|First Intervention||11
11058856|NCT01005888|12240682|FG001|COMPLETED|First Intervention||11
11058857|NCT01005888|12240681|FG000|NOT COMPLETED|First Intervention||1
11058858|NCT01005888|12240682|FG001|NOT COMPLETED|First Intervention||1
11058859|NCT01005888|12240681|FG000|STARTED|Second Intervention||11
11058860|NCT01005888|12240682|FG001|STARTED|Second Intervention||11
11058861|NCT01005888|12240681|FG000|COMPLETED|Second Intervention||10
11058862|NCT01005888|12240682|FG001|COMPLETED|Second Intervention||10
11058863|NCT01005888|12240681|FG000|NOT COMPLETED|Second Intervention||1
11058864|NCT01005888|12240682|FG001|NOT COMPLETED|Second Intervention||1
11058865|NCT01005901|12240690|FG000|STARTED|Overall Study||552
11058866|NCT01005901|12240691|FG001|STARTED|Overall Study||270
11058867|NCT01005901|12240690|FG000|Safety Population|Overall Study||550
11058868|NCT01005901|12240691|FG001|Safety Population|Overall Study||267
11058869|NCT01005901|12240690|FG000|Full Analysis Set|Overall Study||534
11058870|NCT01005901|12240691|FG001|Full Analysis Set|Overall Study||260
11058871|NCT01005901|12240690|FG000|COMPLETED|Overall Study||450
11058872|NCT01005901|12240691|FG001|COMPLETED|Overall Study||212
11058873|NCT01005901|12240690|FG000|NOT COMPLETED|Overall Study||102
11058874|NCT01005901|12240691|FG001|NOT COMPLETED|Overall Study||58
11058875|NCT01005966|12240697|FG000|STARTED|Treatment Period 1 (14 Days)||13
11058876|NCT01005966|12240698|FG001|STARTED|Treatment Period 1 (14 Days)||13
11058877|NCT01005966|12240699|FG002|STARTED|Treatment Period 1 (14 Days)||13
11058878|NCT01005966|12240700|FG003|STARTED|Treatment Period 1 (14 Days)||13
11058879|NCT01005966|12240701|FG004|STARTED|Treatment Period 1 (14 Days)||13
11058880|NCT01005966|12240697|FG000|COMPLETED|Treatment Period 1 (14 Days)||11
11058881|NCT01005966|12240698|FG001|COMPLETED|Treatment Period 1 (14 Days)||13
11058882|NCT01005966|12240699|FG002|COMPLETED|Treatment Period 1 (14 Days)||12
11058883|NCT01005966|12240700|FG003|COMPLETED|Treatment Period 1 (14 Days)||13
11058884|NCT01005966|12240701|FG004|COMPLETED|Treatment Period 1 (14 Days)||13
11058885|NCT01005966|12240697|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
11058886|NCT01005966|12240698|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
11058887|NCT01005966|12240699|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1
11058888|NCT01005966|12240700|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||0
11058889|NCT01005966|12240701|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0
11058890|NCT01005966|12240697|FG000|STARTED|Washout Period 1 (4 Days)||11
11058891|NCT01005966|12240698|FG001|STARTED|Washout Period 1 (4 Days)||13
11058892|NCT01005966|12240699|FG002|STARTED|Washout Period 1 (4 Days)||12
11058893|NCT01005966|12240700|FG003|STARTED|Washout Period 1 (4 Days)||13
11058894|NCT01005966|12240701|FG004|STARTED|Washout Period 1 (4 Days)||13
11058895|NCT01005966|12240697|FG000|COMPLETED|Washout Period 1 (4 Days)||11
11058896|NCT01005966|12240698|FG001|COMPLETED|Washout Period 1 (4 Days)||13
11058897|NCT01005966|12240699|FG002|COMPLETED|Washout Period 1 (4 Days)||12
11058898|NCT01005966|12240700|FG003|COMPLETED|Washout Period 1 (4 Days)||12
11058899|NCT01005966|12240701|FG004|COMPLETED|Washout Period 1 (4 Days)||13
11058900|NCT01005966|12240697|FG000|NOT COMPLETED|Washout Period 1 (4 Days)||0
11058901|NCT01005966|12240698|FG001|NOT COMPLETED|Washout Period 1 (4 Days)||0
11058902|NCT01005966|12240699|FG002|NOT COMPLETED|Washout Period 1 (4 Days)||0
11058903|NCT01005966|12240700|FG003|NOT COMPLETED|Washout Period 1 (4 Days)||1
11058904|NCT01005966|12240701|FG004|NOT COMPLETED|Washout Period 1 (4 Days)||0
11058905|NCT01005966|12240697|FG000|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
11058906|NCT01005966|12240698|FG001|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
11058907|NCT01005966|12240699|FG002|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
11058908|NCT01005966|12240700|FG003|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
11058909|NCT01005966|12240701|FG004|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
11058910|NCT01005966|12240697|FG000|COMPLETED|Treatment Period 2 (14 Days)||13
11058911|NCT01005966|12240698|FG001|COMPLETED|Treatment Period 2 (14 Days)||12
11058912|NCT01005966|12240699|FG002|COMPLETED|Treatment Period 2 (14 Days)||10
11058913|NCT01005966|12240700|FG003|COMPLETED|Treatment Period 2 (14 Days)||11
11058914|NCT01005966|12240701|FG004|COMPLETED|Treatment Period 2 (14 Days)||11
11058915|NCT01005966|12240697|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11058916|NCT01005966|12240698|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
11058917|NCT01005966|12240699|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2
11058918|NCT01005966|12240700|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
11058919|NCT01005966|12240701|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11058920|NCT01005966|12240697|FG000|STARTED|Washout Period 2 (4 Days)||13
11058921|NCT01005966|12240698|FG001|STARTED|Washout Period 2 (4 Days)||12
11058922|NCT01005966|12240699|FG002|STARTED|Washout Period 2 (4 Days)||10
11058923|NCT01005966|12240700|FG003|STARTED|Washout Period 2 (4 Days)||11
11058924|NCT01005966|12240701|FG004|STARTED|Washout Period 2 (4 Days)||11
11058925|NCT01005966|12240697|FG000|COMPLETED|Washout Period 2 (4 Days)||13
11058926|NCT01005966|12240698|FG001|COMPLETED|Washout Period 2 (4 Days)||12
11058927|NCT01005966|12240699|FG002|COMPLETED|Washout Period 2 (4 Days)||10
11058928|NCT01005966|12240700|FG003|COMPLETED|Washout Period 2 (4 Days)||11
11058929|NCT01005966|12240701|FG004|COMPLETED|Washout Period 2 (4 Days)||11
11058930|NCT01005966|12240697|FG000|NOT COMPLETED|Washout Period 2 (4 Days)||0
11058931|NCT01005966|12240698|FG001|NOT COMPLETED|Washout Period 2 (4 Days)||0
11058932|NCT01005966|12240699|FG002|NOT COMPLETED|Washout Period 2 (4 Days)||0
11058933|NCT01005966|12240700|FG003|NOT COMPLETED|Washout Period 2 (4 Days)||0
11058934|NCT01005966|12240701|FG004|NOT COMPLETED|Washout Period 2 (4 Days)||0
11058935|NCT01005966|12240697|FG000|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
11058936|NCT01005966|12240698|FG001|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
11058937|NCT01005966|12240699|FG002|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
11058938|NCT01005966|12240700|FG003|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
11058939|NCT01005966|12240701|FG004|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
11058940|NCT01005966|12240697|FG000|COMPLETED|Treatment Period 3 (14 Days)||12
11058941|NCT01005966|12240698|FG001|COMPLETED|Treatment Period 3 (14 Days)||7
11058942|NCT01005966|12240699|FG002|COMPLETED|Treatment Period 3 (14 Days)||12
11058943|NCT01005966|12240700|FG003|COMPLETED|Treatment Period 3 (14 Days)||13
11058944|NCT01005966|12240701|FG004|COMPLETED|Treatment Period 3 (14 Days)||11
11058945|NCT01005966|12240697|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11058946|NCT01005966|12240698|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1
11058947|NCT01005966|12240699|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11058948|NCT01005966|12240700|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11058949|NCT01005966|12240701|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||1
11058950|NCT01005966|12240697|FG000|STARTED|Washout Period 3 ( 4 Days)||12
11058951|NCT01005966|12240698|FG001|STARTED|Washout Period 3 ( 4 Days)||7
11058952|NCT01005966|12240699|FG002|STARTED|Washout Period 3 ( 4 Days)||12
11058953|NCT01005966|12240700|FG003|STARTED|Washout Period 3 ( 4 Days)||13
11058954|NCT01005966|12240701|FG004|STARTED|Washout Period 3 ( 4 Days)||11
11058955|NCT01005966|12240697|FG000|COMPLETED|Washout Period 3 ( 4 Days)||12
11058956|NCT01005966|12240698|FG001|COMPLETED|Washout Period 3 ( 4 Days)||7
11058957|NCT01005966|12240699|FG002|COMPLETED|Washout Period 3 ( 4 Days)||12
11058958|NCT01005966|12240700|FG003|COMPLETED|Washout Period 3 ( 4 Days)||13
11058959|NCT01005966|12240701|FG004|COMPLETED|Washout Period 3 ( 4 Days)||11
11058960|NCT01005966|12240697|FG000|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
11058961|NCT01005966|12240698|FG001|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
11058962|NCT01005966|12240699|FG002|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
11058963|NCT01005966|12240700|FG003|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
11058964|NCT01005966|12240701|FG004|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
11058965|NCT01005966|12240697|FG000|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
11058966|NCT01005966|12240698|FG001|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
11058967|NCT01005966|12240699|FG002|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
11058968|NCT01005966|12240700|FG003|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
11058969|NCT01005966|12240701|FG004|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
11058970|NCT01005966|12240697|FG000|COMPLETED|Treatment Period 4 (14 Days)||10
11058971|NCT01005966|12240698|FG001|COMPLETED|Treatment Period 4 (14 Days)||10
11058972|NCT01005966|12240699|FG002|COMPLETED|Treatment Period 4 (14 Days)||11
11058973|NCT01005966|12240700|FG003|COMPLETED|Treatment Period 4 (14 Days)||10
11058974|NCT01005966|12240701|FG004|COMPLETED|Treatment Period 4 (14 Days)||12
11058975|NCT01005966|12240697|FG000|NOT COMPLETED|Treatment Period 4 (14 Days)||0
11058976|NCT01005966|12240698|FG001|NOT COMPLETED|Treatment Period 4 (14 Days)||1
11058977|NCT01005966|12240699|FG002|NOT COMPLETED|Treatment Period 4 (14 Days)||0
11058978|NCT01005966|12240700|FG003|NOT COMPLETED|Treatment Period 4 (14 Days)||0
11058979|NCT01005966|12240701|FG004|NOT COMPLETED|Treatment Period 4 (14 Days)||1
11058980|NCT01005966|12240697|FG000|STARTED|Washout Period 4 (4 Days)||10
11058981|NCT01005966|12240698|FG001|STARTED|Washout Period 4 (4 Days)||10
11058982|NCT01005966|12240699|FG002|STARTED|Washout Period 4 (4 Days)||11
11058983|NCT01005966|12240700|FG003|STARTED|Washout Period 4 (4 Days)||10
11058984|NCT01005966|12240701|FG004|STARTED|Washout Period 4 (4 Days)||12
11058985|NCT01005966|12240697|FG000|COMPLETED|Washout Period 4 (4 Days)||10
11058986|NCT01005966|12240698|FG001|COMPLETED|Washout Period 4 (4 Days)||10
11058987|NCT01005966|12240699|FG002|COMPLETED|Washout Period 4 (4 Days)||11
11058988|NCT01005966|12240700|FG003|COMPLETED|Washout Period 4 (4 Days)||10
11058989|NCT01005966|12240701|FG004|COMPLETED|Washout Period 4 (4 Days)||12
11058990|NCT01005966|12240697|FG000|NOT COMPLETED|Washout Period 4 (4 Days)||0
11058991|NCT01005966|12240698|FG001|NOT COMPLETED|Washout Period 4 (4 Days)||0
11058992|NCT01005966|12240699|FG002|NOT COMPLETED|Washout Period 4 (4 Days)||0
11344262|NCT02958982|12541365|FG005|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344263|NCT02958982|12541366|FG006|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
11058993|NCT01005966|12240700|FG003|NOT COMPLETED|Washout Period 4 (4 Days)||0
11058994|NCT01005966|12240701|FG004|NOT COMPLETED|Washout Period 4 (4 Days)||0
11058995|NCT01005966|12240697|FG000|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
11058996|NCT01005966|12240698|FG001|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
11058997|NCT01005966|12240699|FG002|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
11058998|NCT01005966|12240700|FG003|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
11205267|NCT01858363|12396008|FG001|24-month Visit|Overall Study||58
11344264|NCT02958982|12541367|FG007|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344265|NCT02958982|12541368|FG008|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344266|NCT02958982|12541369|FG009|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344267|NCT02958982|12541370|FG010|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
11344268|NCT02958982|12541360|FG000|STARTED|Cohort 3: 400 mg in MAD Study||0
11344269|NCT02958982|12541361|FG001|STARTED|Cohort 3: 400 mg in MAD Study||0
11344270|NCT02958982|12541362|FG002|STARTED|Cohort 3: 400 mg in MAD Study||0
11344271|NCT02958982|12541363|FG003|STARTED|Cohort 3: 400 mg in MAD Study||0
11058999|NCT01005966|12240701|FG004|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
11059000|NCT01005966|12240697|FG000|COMPLETED|Treatment Period 5 (14 Days)||9
11059001|NCT01005966|12240698|FG001|COMPLETED|Treatment Period 5 (14 Days)||12
11059002|NCT01005966|12240699|FG002|COMPLETED|Treatment Period 5 (14 Days)||11
11059003|NCT01005966|12240700|FG003|COMPLETED|Treatment Period 5 (14 Days)||11
11059004|NCT01005966|12240701|FG004|COMPLETED|Treatment Period 5 (14 Days)||10
11059005|NCT01005966|12240697|FG000|NOT COMPLETED|Treatment Period 5 (14 Days)||0
11059006|NCT01005966|12240698|FG001|NOT COMPLETED|Treatment Period 5 (14 Days)||0
11059007|NCT01005966|12240699|FG002|NOT COMPLETED|Treatment Period 5 (14 Days)||0
11059008|NCT01005966|12240700|FG003|NOT COMPLETED|Treatment Period 5 (14 Days)||0
11059009|NCT01005966|12240701|FG004|NOT COMPLETED|Treatment Period 5 (14 Days)||0
11059010|NCT01006122|12240718|FG000|STARTED|First Double-blind Intervention Period||47
11059011|NCT01006122|12240719|FG001|STARTED|First Double-blind Intervention Period||48
11059012|NCT01006122|12240718|FG000|COMPLETED|First Double-blind Intervention Period||31
11059013|NCT01006122|12240719|FG001|COMPLETED|First Double-blind Intervention Period||31
11059014|NCT01006122|12240718|FG000|NOT COMPLETED|First Double-blind Intervention Period||16
11059015|NCT01006122|12240719|FG001|NOT COMPLETED|First Double-blind Intervention Period||17
11059016|NCT01006122|12240718|FG000|STARTED|Wash-out Period (at Least 7 Days)||31
11059017|NCT01006122|12240719|FG001|STARTED|Wash-out Period (at Least 7 Days)||31
11059018|NCT01006122|12240718|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||31
11059019|NCT01006122|12240719|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||31
11059020|NCT01006122|12240718|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
11059021|NCT01006122|12240719|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
11059022|NCT01006122|12240718|FG000|STARTED|Second Double-blind Intervention Period||31
11059023|NCT01006122|12240719|FG001|STARTED|Second Double-blind Intervention Period||31
11059024|NCT01006122|12240718|FG000|COMPLETED|Second Double-blind Intervention Period||29
11059025|NCT01006122|12240719|FG001|COMPLETED|Second Double-blind Intervention Period||24
11059026|NCT01006122|12240718|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2
11059027|NCT01006122|12240719|FG001|NOT COMPLETED|Second Double-blind Intervention Period||7
11059028|NCT01006135|12240725|FG000|STARTED|Overall Study||4852
11059029|NCT01006135|12240725|FG000|COMPLETED|Overall Study||4712
11059030|NCT01006135|12240725|FG000|NOT COMPLETED|Overall Study||140
11059031|NCT01006252|12240731|FG000|STARTED|Overall Study||168
11059032|NCT01006252|12240732|FG001|STARTED|Overall Study||168
11059033|NCT01006252|12240731|FG000|Received Treatment|Overall Study||164
11059034|NCT01006252|12240732|FG001|Received Treatment|Overall Study||161
11059035|NCT01006252|12240731|FG000|COMPLETED|Overall Study||168
11059036|NCT01006252|12240732|FG001|COMPLETED|Overall Study||168
11059037|NCT01006252|12240731|FG000|NOT COMPLETED|Overall Study||0
11059038|NCT01006252|12240732|FG001|NOT COMPLETED|Overall Study||0
11059039|NCT01006291|12240745|FG000|STARTED|Overall Study||229
11059040|NCT01006291|12240746|FG001|STARTED|Overall Study||228
11059041|NCT01006291|12240747|FG002|STARTED|Overall Study||230
11059042|NCT01006291|12240745|FG000|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
11059043|NCT01006291|12240746|FG001|Exposed|Overall Study|2 subjects received IDeg OD FF|226
11059044|NCT01006291|12240747|FG002|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
11059045|NCT01006291|12240745|FG000|COMPLETED|Overall Study||203
11059046|NCT01006291|12240746|FG001|COMPLETED|Overall Study||204
11059047|NCT01006291|12240747|FG002|COMPLETED|Overall Study||203
11059048|NCT01006291|12240745|FG000|NOT COMPLETED|Overall Study||26
11059049|NCT01006291|12240746|FG001|NOT COMPLETED|Overall Study||24
11059050|NCT01006291|12240747|FG002|NOT COMPLETED|Overall Study||27
11059051|NCT01006356|12240755|FG000|STARTED|Overall Study||141
11059052|NCT01006356|12240755|FG000|COMPLETED|Overall Study||99
11059053|NCT01006356|12240755|FG000|NOT COMPLETED|Overall Study||42
11059054|NCT01006369|12240761|FG000|STARTED|Overall Study||13
11059055|NCT01006369|12240762|FG001|STARTED|Overall Study||25
11059056|NCT01006369|12240761|FG000|COMPLETED|Overall Study||1
11059057|NCT01006369|12240762|FG001|COMPLETED|Overall Study||0
11059058|NCT01006369|12240761|FG000|NOT COMPLETED|Overall Study||12
11059059|NCT01006369|12240762|FG001|NOT COMPLETED|Overall Study||25
11059060|NCT01006538|12240769|FG000|STARTED|Overall Study||244
11059061|NCT01006538|12240770|FG001|STARTED|Overall Study||119
11059062|NCT01006538|12240769|FG000|COMPLETED|Overall Study||233
11059063|NCT01006538|12240770|FG001|COMPLETED|Overall Study||115
11059064|NCT01006538|12240769|FG000|NOT COMPLETED|Overall Study||11
11059065|NCT01006538|12240770|FG001|NOT COMPLETED|Overall Study||4
11059066|NCT01006590|12240778|FG000|STARTED|Overall Study|Randomised and treated|147
11059067|NCT01006590|12240779|FG001|STARTED|Overall Study|Randomised and treated|139
11059068|NCT01006590|12240778|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
11059069|NCT01006590|12240779|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
11059070|NCT01006590|12240778|FG000|NOT COMPLETED|Overall Study||28
11059071|NCT01006590|12240779|FG001|NOT COMPLETED|Overall Study||32
11059072|NCT01006603|12240787|FG000|STARTED|Overall Study|Completed lead-in period and were randomised|360
11059073|NCT01006603|12240788|FG001|STARTED|Overall Study|Completed lead-in period and were randomised|360
11059074|NCT01006603|12240787|FG000|COMPLETED|Overall Study||289
11059075|NCT01006603|12240788|FG001|COMPLETED|Overall Study||285
11059076|NCT01006603|12240787|FG000|NOT COMPLETED|Overall Study||71
11059077|NCT01006603|12240788|FG001|NOT COMPLETED|Overall Study||75
11059078|NCT01006616|12240798|FG000|STARTED|Period 1 (6 Months)||152
11344272|NCT02958982|12541364|FG004|STARTED|Cohort 3: 400 mg in MAD Study||0
11059079|NCT01006616|12240799|FG001|STARTED|Period 1 (6 Months)||156
11059080|NCT01006616|12240800|FG002|STARTED|Period 1 (6 Months)||153
11059081|NCT01006616|12240801|FG003|STARTED|Period 1 (6 Months)||155
11059082|NCT01006616|12240798|FG000|Treated|Period 1 (6 Months)||152
11344273|NCT02958982|12541365|FG005|STARTED|Cohort 3: 400 mg in MAD Study||0
11344274|NCT02958982|12541366|FG006|STARTED|Cohort 3: 400 mg in MAD Study||2
11344275|NCT02958982|12541367|FG007|STARTED|Cohort 3: 400 mg in MAD Study||0
11344276|NCT02958982|12541368|FG008|STARTED|Cohort 3: 400 mg in MAD Study||0
11344277|NCT02958982|12541369|FG009|STARTED|Cohort 3: 400 mg in MAD Study||6
11344278|NCT02958982|12541370|FG010|STARTED|Cohort 3: 400 mg in MAD Study||0
11344279|NCT02958982|12541360|FG000|COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344280|NCT02958982|12541361|FG001|COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344281|NCT02958982|12541362|FG002|COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344282|NCT02958982|12541363|FG003|COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344283|NCT02958982|12541364|FG004|COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344284|NCT02958982|12541365|FG005|COMPLETED|Cohort 3: 400 mg in MAD Study||0
11059083|NCT01006616|12240799|FG001|Treated|Period 1 (6 Months)||156
11059084|NCT01006616|12240800|FG002|Treated|Period 1 (6 Months)||152
11059085|NCT01006616|12240801|FG003|Treated|Period 1 (6 Months)||154
11059086|NCT01006616|12240798|FG000|COMPLETED|Period 1 (6 Months)||126
11059087|NCT01006616|12240799|FG001|COMPLETED|Period 1 (6 Months)||102
11059088|NCT01006616|12240800|FG002|COMPLETED|Period 1 (6 Months)||102
11059089|NCT01006616|12240801|FG003|COMPLETED|Period 1 (6 Months)||128
11059090|NCT01006616|12240798|FG000|NOT COMPLETED|Period 1 (6 Months)||26
11059091|NCT01006616|12240799|FG001|NOT COMPLETED|Period 1 (6 Months)||54
11059092|NCT01006616|12240800|FG002|NOT COMPLETED|Period 1 (6 Months)||51
11059093|NCT01006616|12240801|FG003|NOT COMPLETED|Period 1 (6 Months)||27
11059094|NCT01006616|12240798|FG000|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
11059095|NCT01006616|12240799|FG001|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
11059096|NCT01006616|12240800|FG002|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
11059097|NCT01006616|12240801|FG003|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
11059098|NCT01006616|12240798|FG000|Treated|Period 2 (18 Months)||75
11344285|NCT02958982|12541366|FG006|COMPLETED|Cohort 3: 400 mg in MAD Study||2
11344286|NCT02958982|12541367|FG007|COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344287|NCT02958982|12541368|FG008|COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344288|NCT02958982|12541369|FG009|COMPLETED|Cohort 3: 400 mg in MAD Study||6
11344289|NCT02958982|12541370|FG010|COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344290|NCT02958982|12541360|FG000|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344291|NCT02958982|12541361|FG001|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344292|NCT02958982|12541362|FG002|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344293|NCT02958982|12541363|FG003|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344294|NCT02958982|12541364|FG004|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344295|NCT02958982|12541365|FG005|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344296|NCT02958982|12541366|FG006|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344297|NCT02958982|12541367|FG007|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344298|NCT02958982|12541368|FG008|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
11059099|NCT01006616|12240799|FG001|Treated|Period 2 (18 Months)||63
11344299|NCT02958982|12541369|FG009|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344300|NCT02958982|12541370|FG010|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
11344301|NCT02958982|12541360|FG000|STARTED|Proof of Concept Study||0
11344302|NCT02958982|12541361|FG001|STARTED|Proof of Concept Study||0
11344303|NCT02958982|12541362|FG002|STARTED|Proof of Concept Study||0
11344304|NCT02958982|12541363|FG003|STARTED|Proof of Concept Study||0
11344305|NCT02958982|12541364|FG004|STARTED|Proof of Concept Study||0
11344306|NCT02958982|12541365|FG005|STARTED|Proof of Concept Study||0
11344307|NCT02958982|12541366|FG006|STARTED|Proof of Concept Study||0
11344308|NCT02958982|12541367|FG007|STARTED|Proof of Concept Study||0
11344309|NCT02958982|12541368|FG008|STARTED|Proof of Concept Study||0
11344310|NCT02958982|12541369|FG009|STARTED|Proof of Concept Study||0
11344311|NCT02958982|12541370|FG010|STARTED|Proof of Concept Study||1
11344312|NCT02958982|12541360|FG000|COMPLETED|Proof of Concept Study||0
11344313|NCT02958982|12541361|FG001|COMPLETED|Proof of Concept Study||0
11344314|NCT02958982|12541362|FG002|COMPLETED|Proof of Concept Study||0
11344315|NCT02958982|12541363|FG003|COMPLETED|Proof of Concept Study||0
11344316|NCT02958982|12541364|FG004|COMPLETED|Proof of Concept Study||0
11344317|NCT02958982|12541365|FG005|COMPLETED|Proof of Concept Study||0
11344318|NCT02958982|12541366|FG006|COMPLETED|Proof of Concept Study||0
11344319|NCT02958982|12541367|FG007|COMPLETED|Proof of Concept Study||0
11344320|NCT02958982|12541368|FG008|COMPLETED|Proof of Concept Study||0
11344321|NCT02958982|12541369|FG009|COMPLETED|Proof of Concept Study||0
11344322|NCT02958982|12541370|FG010|COMPLETED|Proof of Concept Study||1
11344323|NCT02958982|12541360|FG000|NOT COMPLETED|Proof of Concept Study||0
11344324|NCT02958982|12541361|FG001|NOT COMPLETED|Proof of Concept Study||0
11344325|NCT02958982|12541362|FG002|NOT COMPLETED|Proof of Concept Study||0
11344326|NCT02958982|12541363|FG003|NOT COMPLETED|Proof of Concept Study||0
11344327|NCT02958982|12541364|FG004|NOT COMPLETED|Proof of Concept Study||0
11344328|NCT02958982|12541365|FG005|NOT COMPLETED|Proof of Concept Study||0
11344329|NCT02958982|12541366|FG006|NOT COMPLETED|Proof of Concept Study||0
11344330|NCT02958982|12541367|FG007|NOT COMPLETED|Proof of Concept Study||0
11344331|NCT02958982|12541368|FG008|NOT COMPLETED|Proof of Concept Study||0
11344332|NCT02958982|12541369|FG009|NOT COMPLETED|Proof of Concept Study||0
11344333|NCT02958982|12541370|FG010|NOT COMPLETED|Proof of Concept Study||0
11344334|NCT02958995|12541405|FG000|STARTED|Overall Study||2630666
11059100|NCT01006616|12240800|FG002|Treated|Period 2 (18 Months)||55
11059101|NCT01006616|12240801|FG003|Treated|Period 2 (18 Months)||82
11059102|NCT01006616|12240798|FG000|COMPLETED|Period 2 (18 Months)||0
11059103|NCT01006616|12240799|FG001|COMPLETED|Period 2 (18 Months)||0
11059104|NCT01006616|12240800|FG002|COMPLETED|Period 2 (18 Months)||0
11059105|NCT01006616|12240801|FG003|COMPLETED|Period 2 (18 Months)||0
11059106|NCT01006616|12240798|FG000|NOT COMPLETED|Period 2 (18 Months)||75
11059107|NCT01006616|12240799|FG001|NOT COMPLETED|Period 2 (18 Months)||63
11059108|NCT01006616|12240800|FG002|NOT COMPLETED|Period 2 (18 Months)||55
11059109|NCT01006616|12240801|FG003|NOT COMPLETED|Period 2 (18 Months)||82
11059110|NCT01006629|12240811|FG000|STARTED|Overall Study||100
11059111|NCT01006629|12240811|FG000|COMPLETED|Overall Study||94
11059112|NCT01006629|12240811|FG000|NOT COMPLETED|Overall Study||6
11059113|NCT01006655|12240817|FG000|STARTED|First Intervention||11
11059114|NCT01006655|12240818|FG001|STARTED|First Intervention||10
11059115|NCT01006655|12240817|FG000|COMPLETED|First Intervention||11
11059116|NCT01006655|12240818|FG001|COMPLETED|First Intervention||10
11059117|NCT01006655|12240817|FG000|NOT COMPLETED|First Intervention||0
11059118|NCT01006655|12240818|FG001|NOT COMPLETED|First Intervention||0
11059119|NCT01006655|12240817|FG000|STARTED|Washout Period of 2 Weeks||11
11059120|NCT01006655|12240818|FG001|STARTED|Washout Period of 2 Weeks||10
11059121|NCT01006655|12240817|FG000|COMPLETED|Washout Period of 2 Weeks||11
11059122|NCT01006655|12240818|FG001|COMPLETED|Washout Period of 2 Weeks||10
11059123|NCT01006655|12240817|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
11059124|NCT01006655|12240818|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
11059125|NCT01006655|12240817|FG000|STARTED|Second Intervention||11
11205268|NCT01858363|12396007|FG000|36-month Visit|Overall Study||169
11205269|NCT01858363|12396008|FG001|36-month Visit|Overall Study||53
11205270|NCT01858363|12396007|FG000|48-month Visit|Overall Study||157
11205271|NCT01858363|12396008|FG001|48-month Visit|Overall Study||53
11205272|NCT01858363|12396007|FG000|COMPLETED|Overall Study||146
11205273|NCT01858363|12396008|FG001|COMPLETED|Overall Study||46
11205274|NCT01858363|12396007|FG000|NOT COMPLETED|Overall Study||76
11205275|NCT01858363|12396008|FG001|NOT COMPLETED|Overall Study||26
11205276|NCT01858376|12396014|FG000|STARTED|Overall Study||24
11205277|NCT01858376|12396014|FG000|COMPLETED|Overall Study||20
11205278|NCT01858376|12396014|FG000|NOT COMPLETED|Overall Study||4
11344335|NCT02958995|12541406|FG001|STARTED|Overall Study||107495
11344336|NCT02958995|12541405|FG000|COMPLETED|Overall Study||2630666
11344337|NCT02958995|12541406|FG001|COMPLETED|Overall Study||107495
11344338|NCT02958995|12541405|FG000|NOT COMPLETED|Overall Study||0
11344339|NCT02958995|12541406|FG001|NOT COMPLETED|Overall Study||0
11344340|NCT02959138|12541415|FG000|STARTED|Overall Study||10
11344341|NCT02959138|12541416|FG001|STARTED|Overall Study||10
11344342|NCT02959138|12541417|FG002|STARTED|Overall Study||16
11344343|NCT02959138|12541415|FG000|COMPLETED|Overall Study||10
11344344|NCT02959138|12541416|FG001|COMPLETED|Overall Study||9
11344345|NCT02959138|12541417|FG002|COMPLETED|Overall Study||16
11344346|NCT02959138|12541415|FG000|NOT COMPLETED|Overall Study||0
11344347|NCT02959138|12541416|FG001|NOT COMPLETED|Overall Study||1
11344348|NCT02959138|12541417|FG002|NOT COMPLETED|Overall Study||0
11344349|NCT02959177|12541432|FG000|STARTED|Double-Blind Treatment Phase||115
11344350|NCT02959177|12541433|FG001|STARTED|Double-Blind Treatment Phase||114
11344351|NCT02959177|12541434|FG002|STARTED|Double-Blind Treatment Phase||230
11344352|NCT02959177|12541432|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115
11344353|NCT02959177|12541433|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114
11344354|NCT02959177|12541434|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230
11344355|NCT02959177|12541432|FG000|COMPLETED|Double-Blind Treatment Phase||104
11344356|NCT02959177|12541433|FG001|COMPLETED|Double-Blind Treatment Phase||111
11344357|NCT02959177|12541434|FG002|COMPLETED|Double-Blind Treatment Phase||225
11344358|NCT02959177|12541432|FG000|NOT COMPLETED|Double-Blind Treatment Phase||11
11344359|NCT02959177|12541433|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3
11344360|NCT02959177|12541434|FG002|NOT COMPLETED|Double-Blind Treatment Phase||5
11344361|NCT02959177|12541432|FG000|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
11344362|NCT02959177|12541433|FG001|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
11344363|NCT02959177|12541434|FG002|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|100
11344364|NCT02959177|12541432|FG000|COMPLETED|Follow-up Post Treatment Phase||51
11205279|NCT01858389|12396020|FG000|STARTED|Overall Study|Enrolled|16
11205280|NCT01858389|12396021|FG001|STARTED|Overall Study|Enrolled|25
11205281|NCT01858389|12396020|FG000|Received Treatment|Overall Study||16
11205282|NCT01858389|12396021|FG001|Received Treatment|Overall Study||22
11344365|NCT02959177|12541433|FG001|COMPLETED|Follow-up Post Treatment Phase||51
11205283|NCT01858389|12396020|FG000|COMPLETED|Overall Study||0
11205284|NCT01858389|12396021|FG001|COMPLETED|Overall Study||0
11205285|NCT01858389|12396020|FG000|NOT COMPLETED|Overall Study||16
11205286|NCT01858389|12396021|FG001|NOT COMPLETED|Overall Study||25
11205287|NCT01858428|12396031|FG000|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
11205288|NCT01858428|12396032|FG001|STARTED|Overall Study||200
11205289|NCT01858428|12396031|FG000|COMPLETED|Overall Study||99
11205290|NCT01858428|12396032|FG001|COMPLETED|Overall Study||190
11205291|NCT01858428|12396031|FG000|NOT COMPLETED|Overall Study||1
11205292|NCT01858428|12396032|FG001|NOT COMPLETED|Overall Study||10
11059126|NCT01006655|12240818|FG001|STARTED|Second Intervention||10
11059127|NCT01006655|12240817|FG000|COMPLETED|Second Intervention||11
11059128|NCT01006655|12240818|FG001|COMPLETED|Second Intervention||10
11059129|NCT01006655|12240817|FG000|NOT COMPLETED|Second Intervention||0
11059130|NCT01006655|12240818|FG001|NOT COMPLETED|Second Intervention||0
11059131|NCT01006707|12240824|FG000|STARTED|Study Session 1||15
11059132|NCT01006707|12240825|FG001|STARTED|Study Session 1||0
11059133|NCT01006707|12240826|FG002|STARTED|Study Session 1||0
11059134|NCT01006707|12240824|FG000|COMPLETED|Study Session 1||10
11059135|NCT01006707|12240825|FG001|COMPLETED|Study Session 1||0
11059136|NCT01006707|12240826|FG002|COMPLETED|Study Session 1||0
11059137|NCT01006707|12240824|FG000|NOT COMPLETED|Study Session 1||5
11059138|NCT01006707|12240825|FG001|NOT COMPLETED|Study Session 1||0
11059139|NCT01006707|12240826|FG002|NOT COMPLETED|Study Session 1||0
11059140|NCT01006707|12240824|FG000|STARTED|Study Session 2||0
11059141|NCT01006707|12240825|FG001|STARTED|Study Session 2||4
11059142|NCT01006707|12240826|FG002|STARTED|Study Session 2||6
11059143|NCT01006707|12240824|FG000|COMPLETED|Study Session 2||0
11059144|NCT01006707|12240825|FG001|COMPLETED|Study Session 2||4
11059145|NCT01006707|12240826|FG002|COMPLETED|Study Session 2||6
11059146|NCT01006707|12240824|FG000|NOT COMPLETED|Study Session 2||0
11059147|NCT01006707|12240825|FG001|NOT COMPLETED|Study Session 2||0
11059148|NCT01006707|12240826|FG002|NOT COMPLETED|Study Session 2||0
11059149|NCT01006707|12240824|FG000|STARTED|Study Session 3||0
11059150|NCT01006707|12240825|FG001|STARTED|Study Session 3||4
11059151|NCT01006707|12240826|FG002|STARTED|Study Session 3||6
11059152|NCT01006707|12240824|FG000|COMPLETED|Study Session 3||0
11059153|NCT01006707|12240825|FG001|COMPLETED|Study Session 3||4
11059154|NCT01006707|12240826|FG002|COMPLETED|Study Session 3||6
11059155|NCT01006707|12240824|FG000|NOT COMPLETED|Study Session 3||0
11059156|NCT01006707|12240825|FG001|NOT COMPLETED|Study Session 3||0
11059157|NCT01006707|12240826|FG002|NOT COMPLETED|Study Session 3||0
11059158|NCT01006889|12240834|FG000|STARTED|Overall Study||20
11059159|NCT01006889|12240834|FG000|COMPLETED|Overall Study||17
11059160|NCT01006889|12240834|FG000|NOT COMPLETED|Overall Study||3
11059161|NCT01006967|12240841|FG000|STARTED|Overall Study||253
11059162|NCT01006967|12240842|FG001|STARTED|Overall Study||253
11059163|NCT01006967|12240841|FG000|Received Treatment|Overall Study||245
11059164|NCT01006967|12240842|FG001|Received Treatment|Overall Study||245
11059165|NCT01006967|12240841|FG000|3 Month Follow-up|Overall Study||212
11059166|NCT01006967|12240842|FG001|3 Month Follow-up|Overall Study||210
11059167|NCT01006967|12240841|FG000|COMPLETED|Overall Study||187
11059168|NCT01006967|12240842|FG001|COMPLETED|Overall Study||190
11059169|NCT01006967|12240841|FG000|NOT COMPLETED|Overall Study||66
11059170|NCT01006967|12240842|FG001|NOT COMPLETED|Overall Study||63
11059171|NCT01006980|12240852|FG000|STARTED|Vemurafenib and Dacarbazine||337
11059172|NCT01006980|12240853|FG001|STARTED|Vemurafenib and Dacarbazine||338
11059173|NCT01006980|12240852|FG000|Treated|Vemurafenib and Dacarbazine||336
11059174|NCT01006980|12240853|FG001|Treated|Vemurafenib and Dacarbazine||293
11059175|NCT01006980|12240852|FG000|COMPLETED|Vemurafenib and Dacarbazine||0
11059176|NCT01006980|12240853|FG001|COMPLETED|Vemurafenib and Dacarbazine||0
11059177|NCT01006980|12240852|FG000|NOT COMPLETED|Vemurafenib and Dacarbazine||337
11059178|NCT01006980|12240853|FG001|NOT COMPLETED|Vemurafenib and Dacarbazine||338
11059179|NCT01006980|12240852|FG000|STARTED|Crossover: Dacarbazine to Vemurafenib||0
11059180|NCT01006980|12240853|FG001|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
11059181|NCT01006980|12240852|FG000|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
11059182|NCT01006980|12240853|FG001|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
11059183|NCT01006980|12240852|FG000|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
11059184|NCT01006980|12240853|FG001|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
11059185|NCT01007032|12240864|FG000|STARTED|Overall Study||4
11059186|NCT01007032|12240865|FG001|STARTED|Overall Study||7
11059187|NCT01007032|12240866|FG002|STARTED|Overall Study||3
11059188|NCT01007032|12240867|FG003|STARTED|Overall Study||7
11059189|NCT01007032|12240864|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
11059190|NCT01007032|12240865|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
11059191|NCT01007032|12240866|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
11059192|NCT01007032|12240867|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
11059193|NCT01007032|12240864|FG000|COMPLETED|Overall Study||4
11059194|NCT01007032|12240865|FG001|COMPLETED|Overall Study||6
11059195|NCT01007032|12240866|FG002|COMPLETED|Overall Study||2
11059196|NCT01007032|12240867|FG003|COMPLETED|Overall Study||6
11059197|NCT01007032|12240864|FG000|NOT COMPLETED|Overall Study||0
11059198|NCT01007032|12240865|FG001|NOT COMPLETED|Overall Study||1
11059199|NCT01007032|12240866|FG002|NOT COMPLETED|Overall Study||1
11059200|NCT01007032|12240867|FG003|NOT COMPLETED|Overall Study||1
11059201|NCT01007071|12240884|FG000|STARTED|Overall Study||6
11059202|NCT01007071|12240885|FG001|STARTED|Overall Study||5
11059203|NCT01007071|12240884|FG000|COMPLETED|Overall Study||6
11059204|NCT01007071|12240885|FG001|COMPLETED|Overall Study||5
11059205|NCT01007071|12240884|FG000|NOT COMPLETED|Overall Study||0
11059206|NCT01007071|12240885|FG001|NOT COMPLETED|Overall Study||0
11059207|NCT01007110|12240894|FG000|STARTED|Allocation||32
11059208|NCT01007110|12240895|FG001|STARTED|Allocation||35
11059209|NCT01007110|12240894|FG000|COMPLETED|Allocation||25
11059210|NCT01007110|12240895|FG001|COMPLETED|Allocation||27
11059211|NCT01007110|12240894|FG000|NOT COMPLETED|Allocation||7
11059212|NCT01007110|12240895|FG001|NOT COMPLETED|Allocation||8
11059213|NCT01007110|12240894|FG000|STARTED|Follow-Up at 24 Weeks||25
11059214|NCT01007110|12240895|FG001|STARTED|Follow-Up at 24 Weeks||27
11059215|NCT01007110|12240894|FG000|COMPLETED|Follow-Up at 24 Weeks||25
11059216|NCT01007110|12240895|FG001|COMPLETED|Follow-Up at 24 Weeks||23
11059217|NCT01007110|12240894|FG000|NOT COMPLETED|Follow-Up at 24 Weeks||0
11059218|NCT01007110|12240895|FG001|NOT COMPLETED|Follow-Up at 24 Weeks||4
11059219|NCT01007110|12240894|FG000|STARTED|Follow-Up at 32 Weeks||25
11059220|NCT01007110|12240895|FG001|STARTED|Follow-Up at 32 Weeks||23
11059221|NCT01007110|12240894|FG000|COMPLETED|Follow-Up at 32 Weeks||24
11059222|NCT01007110|12240895|FG001|COMPLETED|Follow-Up at 32 Weeks||22
11059223|NCT01007110|12240894|FG000|NOT COMPLETED|Follow-Up at 32 Weeks||1
11059224|NCT01007110|12240895|FG001|NOT COMPLETED|Follow-Up at 32 Weeks||1
11059225|NCT01007110|12240894|FG000|STARTED|Follow-Up at 36 Weeks||24
11059226|NCT01007110|12240895|FG001|STARTED|Follow-Up at 36 Weeks||22
11059227|NCT01007110|12240894|FG000|COMPLETED|Follow-Up at 36 Weeks||24
11059228|NCT01007110|12240895|FG001|COMPLETED|Follow-Up at 36 Weeks||20
11059229|NCT01007110|12240894|FG000|NOT COMPLETED|Follow-Up at 36 Weeks||0
11059230|NCT01007110|12240895|FG001|NOT COMPLETED|Follow-Up at 36 Weeks||2
11059231|NCT01007110|12240894|FG000|STARTED|Neonatal Behavioral Assessment Scale (NB||24
11059232|NCT01007110|12240895|FG001|STARTED|Neonatal Behavioral Assessment Scale (NB||20
11059233|NCT01007110|12240894|FG000|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
11059234|NCT01007110|12240895|FG001|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
11059235|NCT01007110|12240894|FG000|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
11059236|NCT01007110|12240895|FG001|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
11059237|NCT01007123|12240906|FG000|STARTED|Overall Study||48
11059238|NCT01007123|12240907|FG001|STARTED|Overall Study||47
11059239|NCT01007123|12240908|FG002|STARTED|Overall Study||48
11059240|NCT01007123|12240909|FG003|STARTED|Overall Study||47
11059241|NCT01007123|12240906|FG000|COMPLETED|Overall Study||42
11059242|NCT01007123|12240907|FG001|COMPLETED|Overall Study||41
11059243|NCT01007123|12240908|FG002|COMPLETED|Overall Study||37
11059244|NCT01007123|12240909|FG003|COMPLETED|Overall Study||41
11059245|NCT01007123|12240906|FG000|NOT COMPLETED|Overall Study||6
11059246|NCT01007123|12240907|FG001|NOT COMPLETED|Overall Study||6
11059247|NCT01007123|12240908|FG002|NOT COMPLETED|Overall Study||11
11059248|NCT01007123|12240909|FG003|NOT COMPLETED|Overall Study||6
11059249|NCT01007136|12240925|FG000|STARTED|Overall Study||19
11059250|NCT01007136|12240926|FG001|STARTED|Overall Study|One additional subject was excluded prior to randomization due to illicit drug use.|17
11059251|NCT01007136|12240927|FG002|STARTED|Overall Study||15
11059252|NCT01007136|12240928|FG003|STARTED|Overall Study||6
11059253|NCT01007136|12240929|FG004|STARTED|Overall Study||4
11059254|NCT01007136|12240925|FG000|COMPLETED|Overall Study||15
11059255|NCT01007136|12240926|FG001|COMPLETED|Overall Study||13
11059256|NCT01007136|12240927|FG002|COMPLETED|Overall Study||15
11059257|NCT01007136|12240928|FG003|COMPLETED|Overall Study||6
11059258|NCT01007136|12240929|FG004|COMPLETED|Overall Study||4
11059259|NCT01007136|12240925|FG000|NOT COMPLETED|Overall Study||4
11059260|NCT01007136|12240926|FG001|NOT COMPLETED|Overall Study||4
11059261|NCT01007136|12240927|FG002|NOT COMPLETED|Overall Study||0
11059262|NCT01007136|12240928|FG003|NOT COMPLETED|Overall Study||0
11059263|NCT01007136|12240929|FG004|NOT COMPLETED|Overall Study||0
11059264|NCT01007149|12240942|FG000|STARTED|Overall Study||20
11059265|NCT01007149|12240943|FG001|STARTED|Overall Study||21
11059266|NCT01007149|12240942|FG000|COMPLETED|Overall Study||20
11059267|NCT01007149|12240943|FG001|COMPLETED|Overall Study||20
11059268|NCT01007149|12240942|FG000|NOT COMPLETED|Overall Study||0
11059269|NCT01007149|12240943|FG001|NOT COMPLETED|Overall Study||1
11059270|NCT01007253|12240949|FG000|STARTED|First Intervention||6
11059271|NCT01007253|12240950|FG001|STARTED|First Intervention||5
11059272|NCT01007253|12240951|FG002|STARTED|First Intervention||5
11059273|NCT01007253|12240952|FG003|STARTED|First Intervention||5
11059274|NCT01007253|12240949|FG000|COMPLETED|First Intervention||6
11059275|NCT01007253|12240950|FG001|COMPLETED|First Intervention||5
11059276|NCT01007253|12240951|FG002|COMPLETED|First Intervention||5
11059277|NCT01007253|12240952|FG003|COMPLETED|First Intervention||5
11059278|NCT01007253|12240949|FG000|NOT COMPLETED|First Intervention||0
11059279|NCT01007253|12240950|FG001|NOT COMPLETED|First Intervention||0
11059280|NCT01007253|12240951|FG002|NOT COMPLETED|First Intervention||0
11059281|NCT01007253|12240952|FG003|NOT COMPLETED|First Intervention||0
11059282|NCT01007253|12240949|FG000|STARTED|Washout Period (2 Weeks) # 1||6
11059283|NCT01007253|12240950|FG001|STARTED|Washout Period (2 Weeks) # 1||5
11059284|NCT01007253|12240951|FG002|STARTED|Washout Period (2 Weeks) # 1||5
11059285|NCT01007253|12240952|FG003|STARTED|Washout Period (2 Weeks) # 1||5
11059286|NCT01007253|12240949|FG000|COMPLETED|Washout Period (2 Weeks) # 1||6
11059287|NCT01007253|12240950|FG001|COMPLETED|Washout Period (2 Weeks) # 1||5
11059288|NCT01007253|12240951|FG002|COMPLETED|Washout Period (2 Weeks) # 1||5
11059289|NCT01007253|12240952|FG003|COMPLETED|Washout Period (2 Weeks) # 1||5
11059290|NCT01007253|12240949|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
11059291|NCT01007253|12240950|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
11059292|NCT01007253|12240951|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
11059293|NCT01007253|12240952|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
11059294|NCT01007253|12240949|FG000|STARTED|Second Intervention||6
11059295|NCT01007253|12240950|FG001|STARTED|Second Intervention||5
11059296|NCT01007253|12240951|FG002|STARTED|Second Intervention||5
11059297|NCT01007253|12240952|FG003|STARTED|Second Intervention||5
11059298|NCT01007253|12240949|FG000|COMPLETED|Second Intervention||6
11059299|NCT01007253|12240950|FG001|COMPLETED|Second Intervention||5
11059300|NCT01007253|12240951|FG002|COMPLETED|Second Intervention||5
11059301|NCT01007253|12240952|FG003|COMPLETED|Second Intervention||5
11059302|NCT01007253|12240949|FG000|NOT COMPLETED|Second Intervention||0
11059303|NCT01007253|12240950|FG001|NOT COMPLETED|Second Intervention||0
11059304|NCT01007253|12240951|FG002|NOT COMPLETED|Second Intervention||0
11059305|NCT01007253|12240952|FG003|NOT COMPLETED|Second Intervention||0
11059306|NCT01007253|12240949|FG000|STARTED|Washout Period (2 Weeks) # 2||6
11059307|NCT01007253|12240950|FG001|STARTED|Washout Period (2 Weeks) # 2||5
11059308|NCT01007253|12240951|FG002|STARTED|Washout Period (2 Weeks) # 2||5
11059309|NCT01007253|12240952|FG003|STARTED|Washout Period (2 Weeks) # 2||5
11059310|NCT01007253|12240949|FG000|COMPLETED|Washout Period (2 Weeks) # 2||6
11059311|NCT01007253|12240950|FG001|COMPLETED|Washout Period (2 Weeks) # 2||5
11059312|NCT01007253|12240951|FG002|COMPLETED|Washout Period (2 Weeks) # 2||5
11059313|NCT01007253|12240952|FG003|COMPLETED|Washout Period (2 Weeks) # 2||5
11059314|NCT01007253|12240949|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
11059315|NCT01007253|12240950|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
11059316|NCT01007253|12240951|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
11059317|NCT01007253|12240952|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
11059318|NCT01007253|12240949|FG000|STARTED|Third Intervention||6
11059319|NCT01007253|12240950|FG001|STARTED|Third Intervention||5
11059320|NCT01007253|12240951|FG002|STARTED|Third Intervention||5
11059321|NCT01007253|12240952|FG003|STARTED|Third Intervention||5
11059322|NCT01007253|12240949|FG000|COMPLETED|Third Intervention||6
11059323|NCT01007253|12240950|FG001|COMPLETED|Third Intervention||5
11059324|NCT01007253|12240951|FG002|COMPLETED|Third Intervention||5
11344366|NCT02959177|12541434|FG002|COMPLETED|Follow-up Post Treatment Phase||98
11344367|NCT02959177|12541432|FG000|NOT COMPLETED|Follow-up Post Treatment Phase||1
11344368|NCT02959177|12541433|FG001|NOT COMPLETED|Follow-up Post Treatment Phase||1
11344369|NCT02959177|12541434|FG002|NOT COMPLETED|Follow-up Post Treatment Phase||2
11344370|NCT02959190|12541452|FG000|STARTED|Open Label||120
11344371|NCT02959190|12541453|FG001|STARTED|Open Label||126
11344372|NCT02959190|12541454|FG002|STARTED|Open Label||32
11344373|NCT02959190|12541455|FG003|STARTED|Open Label||33
11344374|NCT02959190|12541452|FG000|Received at Least 1 Dose of Study Drug|Open Label||120
11344375|NCT02959190|12541453|FG001|Received at Least 1 Dose of Study Drug|Open Label||126
11344376|NCT02959190|12541454|FG002|Received at Least 1 Dose of Study Drug|Open Label||32
11344377|NCT02959190|12541455|FG003|Received at Least 1 Dose of Study Drug|Open Label||33
11344378|NCT02959190|12541452|FG000|120mg/120mg Galcanezumab - EM|Open Label||58
11344379|NCT02959190|12541453|FG001|120mg/120mg Galcanezumab - EM|Open Label||0
11344380|NCT02959190|12541454|FG002|120mg/120mg Galcanezumab - EM|Open Label||0
11344381|NCT02959190|12541455|FG003|120mg/120mg Galcanezumab - EM|Open Label||0
11344382|NCT02959190|12541452|FG000|240mg/240mg Galcanezumab - EM|Open Label||0
11344383|NCT02959190|12541453|FG001|240mg/240mg Galcanezumab - EM|Open Label||62
11344384|NCT02959190|12541454|FG002|240mg/240mg Galcanezumab - EM|Open Label||0
11344385|NCT02959190|12541455|FG003|240mg/240mg Galcanezumab - EM|Open Label||0
11344386|NCT02959190|12541452|FG000|Placebo/ 120mg Galcanezumab - EM|Open Label||62
11344387|NCT02959190|12541453|FG001|Placebo/ 120mg Galcanezumab - EM|Open Label||0
11344388|NCT02959190|12541454|FG002|Placebo/ 120mg Galcanezumab - EM|Open Label||0
11344389|NCT02959190|12541455|FG003|Placebo/ 120mg Galcanezumab - EM|Open Label||0
11344390|NCT02959190|12541452|FG000|Placebo/ 240mg Galcanezumab - EM|Open Label||0
11344391|NCT02959190|12541453|FG001|Placebo/ 240mg Galcanezumab - EM|Open Label||64
11059325|NCT01007253|12240952|FG003|COMPLETED|Third Intervention||5
11059326|NCT01007253|12240949|FG000|NOT COMPLETED|Third Intervention||0
11059327|NCT01007253|12240950|FG001|NOT COMPLETED|Third Intervention||0
11059328|NCT01007253|12240951|FG002|NOT COMPLETED|Third Intervention||0
11059329|NCT01007253|12240952|FG003|NOT COMPLETED|Third Intervention||0
11059330|NCT01007253|12240949|FG000|STARTED|Washout Period (2 Weeks) # 3||6
11059331|NCT01007253|12240950|FG001|STARTED|Washout Period (2 Weeks) # 3||5
11059332|NCT01007253|12240951|FG002|STARTED|Washout Period (2 Weeks) # 3||5
11059333|NCT01007253|12240952|FG003|STARTED|Washout Period (2 Weeks) # 3||5
11059334|NCT01007253|12240949|FG000|COMPLETED|Washout Period (2 Weeks) # 3||5
11059335|NCT01007253|12240950|FG001|COMPLETED|Washout Period (2 Weeks) # 3||5
11059336|NCT01007253|12240951|FG002|COMPLETED|Washout Period (2 Weeks) # 3||5
11059337|NCT01007253|12240952|FG003|COMPLETED|Washout Period (2 Weeks) # 3||5
11059338|NCT01007253|12240949|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
11059339|NCT01007253|12240950|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
11059340|NCT01007253|12240951|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
11059341|NCT01007253|12240952|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
11059342|NCT01007253|12240949|FG000|STARTED|Fourth Intervention||5
11059343|NCT01007253|12240950|FG001|STARTED|Fourth Intervention||5
11059344|NCT01007253|12240951|FG002|STARTED|Fourth Intervention||5
11059345|NCT01007253|12240952|FG003|STARTED|Fourth Intervention||5
11059346|NCT01007253|12240949|FG000|COMPLETED|Fourth Intervention||5
11059347|NCT01007253|12240950|FG001|COMPLETED|Fourth Intervention||5
11059348|NCT01007253|12240951|FG002|COMPLETED|Fourth Intervention||5
11059349|NCT01007253|12240952|FG003|COMPLETED|Fourth Intervention||5
11059350|NCT01007253|12240949|FG000|NOT COMPLETED|Fourth Intervention||0
11059351|NCT01007253|12240950|FG001|NOT COMPLETED|Fourth Intervention||0
11059352|NCT01007253|12240951|FG002|NOT COMPLETED|Fourth Intervention||0
11059353|NCT01007253|12240952|FG003|NOT COMPLETED|Fourth Intervention||0
11059354|NCT01007396|12240962|FG000|STARTED|Overall Study||322
11059355|NCT01007396|12240962|FG000|COMPLETED|Overall Study||275
11059356|NCT01007396|12240962|FG000|NOT COMPLETED|Overall Study||47
11059357|NCT01007435|12240970|FG000|STARTED|Overall Study||289
11059358|NCT01007435|12240971|FG001|STARTED|Overall Study||290
11344392|NCT02959190|12541454|FG002|Placebo/ 240mg Galcanezumab - EM|Open Label||0
11344393|NCT02959190|12541455|FG003|Placebo/ 240mg Galcanezumab - EM|Open Label||0
11344394|NCT02959190|12541452|FG000|COMPLETED|Open Label||113
11344395|NCT02959190|12541453|FG001|COMPLETED|Open Label||110
11344396|NCT02959190|12541454|FG002|COMPLETED|Open Label||28
11344397|NCT02959190|12541455|FG003|COMPLETED|Open Label||27
11344398|NCT02959190|12541452|FG000|NOT COMPLETED|Open Label||7
11344399|NCT02959190|12541453|FG001|NOT COMPLETED|Open Label||16
11344400|NCT02959190|12541454|FG002|NOT COMPLETED|Open Label||4
11344401|NCT02959190|12541455|FG003|NOT COMPLETED|Open Label||6
11344402|NCT02959190|12541452|FG000|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|117
11344403|NCT02959190|12541453|FG001|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|120
11344404|NCT02959190|12541454|FG002|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
11344405|NCT02959190|12541455|FG003|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
11344406|NCT02959190|12541452|FG000|COMPLETED|Post Treatment Follow Up||114
11344407|NCT02959190|12541453|FG001|COMPLETED|Post Treatment Follow Up||119
11344408|NCT02959190|12541454|FG002|COMPLETED|Post Treatment Follow Up||31
11344409|NCT02959190|12541455|FG003|COMPLETED|Post Treatment Follow Up||32
11344410|NCT02959190|12541452|FG000|NOT COMPLETED|Post Treatment Follow Up||3
11344411|NCT02959190|12541453|FG001|NOT COMPLETED|Post Treatment Follow Up||1
11344412|NCT02959190|12541454|FG002|NOT COMPLETED|Post Treatment Follow Up||1
11344413|NCT02959190|12541455|FG003|NOT COMPLETED|Post Treatment Follow Up||0
11344414|NCT02959307|12541476|FG000|STARTED|Phase 1||18
11344415|NCT02959307|12541477|FG001|STARTED|Phase 1||31
11344416|NCT02959307|12541476|FG000|COMPLETED|Phase 1||15
11344417|NCT02959307|12541477|FG001|COMPLETED|Phase 1||23
11344418|NCT02959307|12541476|FG000|NOT COMPLETED|Phase 1||3
11344419|NCT02959307|12541477|FG001|NOT COMPLETED|Phase 1||8
11344420|NCT02959307|12541476|FG000|STARTED|Phase 2|This group is increased as those in sham were re-randomized to sham or NIR.|28
11344421|NCT02959307|12541477|FG001|STARTED|Phase 2|This group is decreased as those in sham were re-randomized to sham or NIR.|10
11344422|NCT02959307|12541476|FG000|COMPLETED|Phase 2||26
11344423|NCT02959307|12541477|FG001|COMPLETED|Phase 2||10
11344424|NCT02959307|12541476|FG000|NOT COMPLETED|Phase 2||2
11344425|NCT02959307|12541477|FG001|NOT COMPLETED|Phase 2||0
11344426|NCT02959437|12541487|FG000|STARTED|Overall Study||62
11059359|NCT01007435|12240972|FG002|STARTED|Overall Study||291
11059360|NCT01007435|12240973|FG003|STARTED|Overall Study||292
11059361|NCT01007435|12240970|FG000|COMPLETED|Overall Study||226
11059362|NCT01007435|12240971|FG001|COMPLETED|Overall Study||231
11059363|NCT01007435|12240972|FG002|COMPLETED|Overall Study||227
11344427|NCT02959437|12541488|FG001|STARTED|Overall Study||8
11344428|NCT02959437|12541489|FG002|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
11344429|NCT02959437|12541490|FG003|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
11344430|NCT02959437|12541487|FG000|COMPLETED|Overall Study||0
11344431|NCT02959437|12541488|FG001|COMPLETED|Overall Study||0
11059364|NCT01007435|12240973|FG003|COMPLETED|Overall Study||236
11059365|NCT01007435|12240970|FG000|NOT COMPLETED|Overall Study||63
11059366|NCT01007435|12240971|FG001|NOT COMPLETED|Overall Study||59
11059367|NCT01007435|12240972|FG002|NOT COMPLETED|Overall Study||64
11059368|NCT01007435|12240973|FG003|NOT COMPLETED|Overall Study||56
11059369|NCT01007448|12240985|FG000|STARTED|Overall Study||30
11059370|NCT01007448|12240986|FG001|STARTED|Overall Study||29
11059371|NCT01007448|12240985|FG000|Full Analysis Population|Overall Study||30
11059372|NCT01007448|12240986|FG001|Full Analysis Population|Overall Study||29
11059373|NCT01007448|12240985|FG000|Safety Population|Overall Study||30
11059374|NCT01007448|12240986|FG001|Safety Population|Overall Study||29
11059375|NCT01007448|12240985|FG000|COMPLETED|Overall Study||20
11059376|NCT01007448|12240986|FG001|COMPLETED|Overall Study||20
11059377|NCT01007448|12240985|FG000|NOT COMPLETED|Overall Study||10
11059378|NCT01007448|12240986|FG001|NOT COMPLETED|Overall Study||9
11059379|NCT01007526|12240992|FG000|STARTED|Overall Study||31
11059380|NCT01007526|12240992|FG000|COMPLETED|Overall Study||31
11059381|NCT01007526|12240992|FG000|NOT COMPLETED|Overall Study||0
11059382|NCT01007552|12240996|FG000|STARTED|Overall Study||50
11059383|NCT01007552|12240996|FG000|COMPLETED|Overall Study||49
11059384|NCT01007552|12240996|FG000|NOT COMPLETED|Overall Study||1
11059385|NCT01007591|12241002|FG000|STARTED|Overall Study||27
11059386|NCT01007591|12241003|FG001|STARTED|Overall Study||13
11059387|NCT01007591|12241002|FG000|COMPLETED|Overall Study||26
11059388|NCT01007591|12241003|FG001|COMPLETED|Overall Study||12
11059389|NCT01007591|12241002|FG000|NOT COMPLETED|Overall Study||1
11059390|NCT01007591|12241003|FG001|NOT COMPLETED|Overall Study||1
11059391|NCT01007643|12241011|FG000|STARTED|Overall Study||8
11059392|NCT01007643|12241012|FG001|STARTED|Overall Study||14
11059393|NCT01007643|12241011|FG000|COMPLETED|Overall Study||8
11059394|NCT01007643|12241012|FG001|COMPLETED|Overall Study||14
11059395|NCT01007643|12241011|FG000|NOT COMPLETED|Overall Study||0
11059396|NCT01007643|12241012|FG001|NOT COMPLETED|Overall Study||0
11059397|NCT01007656|12241018|FG000|STARTED|Overall Study||31
11059398|NCT01007656|12241018|FG000|COMPLETED|Overall Study||31
11059399|NCT01007656|12241018|FG000|NOT COMPLETED|Overall Study||0
11059400|NCT01007812|12241022|FG000|STARTED|Period 1, One Week||25
11059401|NCT01007812|12241023|FG001|STARTED|Period 1, One Week||25
11059402|NCT01007812|12241022|FG000|COMPLETED|Period 1, One Week||24
11059403|NCT01007812|12241023|FG001|COMPLETED|Period 1, One Week||24
11059404|NCT01007812|12241022|FG000|NOT COMPLETED|Period 1, One Week||1
11059405|NCT01007812|12241023|FG001|NOT COMPLETED|Period 1, One Week||1
11059406|NCT01007812|12241022|FG000|STARTED|Period 2, One Week||24
11059407|NCT01007812|12241023|FG001|STARTED|Period 2, One Week||24
11059408|NCT01007812|12241022|FG000|COMPLETED|Period 2, One Week||24
11059409|NCT01007812|12241023|FG001|COMPLETED|Period 2, One Week||24
11059410|NCT01007812|12241022|FG000|NOT COMPLETED|Period 2, One Week||0
11059411|NCT01007812|12241023|FG001|NOT COMPLETED|Period 2, One Week||0
11344432|NCT02959437|12541489|FG002|COMPLETED|Overall Study||0
11344433|NCT02959437|12541490|FG003|COMPLETED|Overall Study||0
11344434|NCT02959437|12541487|FG000|NOT COMPLETED|Overall Study||62
11344435|NCT02959437|12541488|FG001|NOT COMPLETED|Overall Study||8
11344436|NCT02959437|12541489|FG002|NOT COMPLETED|Overall Study||0
11344437|NCT02959437|12541490|FG003|NOT COMPLETED|Overall Study||0
11344438|NCT02959671|12541501|FG000|STARTED|Overall Study||34
11344439|NCT02959671|12541501|FG000|COMPLETED|Overall Study||29
11344440|NCT02959671|12541501|FG000|NOT COMPLETED|Overall Study||5
11344441|NCT02959814|12541505|FG000|STARTED|Overall Study|22-02-2017|329
11344442|NCT02959814|12541505|FG000|COMPLETED|Overall Study|17-10-2017|272
11344443|NCT02959814|12541505|FG000|NOT COMPLETED|Overall Study||57
11344444|NCT02959827|12541510|FG000|STARTED|Overall Study||2320
11344445|NCT02959827|12541510|FG000|COMPLETED|Overall Study||2320
11344446|NCT02959827|12541510|FG000|NOT COMPLETED|Overall Study||0
11344447|NCT02959840|12541521|FG000|STARTED|Overall Study||60
11059412|NCT01007838|12241033|FG000|STARTED|Overall Study||12
11059413|NCT01007838|12241034|FG001|STARTED|Overall Study||11
11059414|NCT01007838|12241035|FG002|STARTED|Overall Study||5
11059415|NCT01007838|12241036|FG003|STARTED|Overall Study||4
11059416|NCT01007838|12241033|FG000|COMPLETED|Overall Study||9
11344448|NCT02959840|12541522|FG001|STARTED|Overall Study||60
11344449|NCT02959840|12541523|FG002|STARTED|Overall Study||60
11344450|NCT02959840|12541521|FG000|COMPLETED|Overall Study||60
11344451|NCT02959840|12541522|FG001|COMPLETED|Overall Study||60
11344452|NCT02959840|12541523|FG002|COMPLETED|Overall Study||60
11344453|NCT02959840|12541521|FG000|NOT COMPLETED|Overall Study||0
11344454|NCT02959840|12541522|FG001|NOT COMPLETED|Overall Study||0
11059417|NCT01007838|12241034|FG001|COMPLETED|Overall Study||11
11059418|NCT01007838|12241035|FG002|COMPLETED|Overall Study||5
11059419|NCT01007838|12241036|FG003|COMPLETED|Overall Study||4
11059420|NCT01007838|12241033|FG000|NOT COMPLETED|Overall Study||3
11059421|NCT01007838|12241034|FG001|NOT COMPLETED|Overall Study||0
11059422|NCT01007838|12241035|FG002|NOT COMPLETED|Overall Study||0
11059423|NCT01007838|12241036|FG003|NOT COMPLETED|Overall Study||0
11059424|NCT01007916|12241046|FG000|STARTED|Period 1, 4 Weeks of Wear||23
11059425|NCT01007916|12241047|FG001|STARTED|Period 1, 4 Weeks of Wear||26
11059426|NCT01007916|12241046|FG000|COMPLETED|Period 1, 4 Weeks of Wear||22
11059427|NCT01007916|12241047|FG001|COMPLETED|Period 1, 4 Weeks of Wear||26
11059428|NCT01007916|12241046|FG000|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
11059429|NCT01007916|12241047|FG001|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
11059430|NCT01007916|12241046|FG000|STARTED|Period 2, 4 Weeks of Wear||22
11059431|NCT01007916|12241047|FG001|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
11059432|NCT01007916|12241046|FG000|COMPLETED|Period 2, 4 Weeks of Wear||21
11059433|NCT01007916|12241047|FG001|COMPLETED|Period 2, 4 Weeks of Wear||25
11059434|NCT01007916|12241046|FG000|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
11059435|NCT01007916|12241047|FG001|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
11059436|NCT01007942|12241055|FG000|STARTED|Overall Study||284
11059437|NCT01007942|12241056|FG001|STARTED|Overall Study||285
11059438|NCT01007942|12241055|FG000|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
11059439|NCT01007942|12241056|FG001|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
11059440|NCT01007942|12241055|FG000|NOT COMPLETED|Overall Study||281
11059441|NCT01007942|12241056|FG001|NOT COMPLETED|Overall Study||278
11059442|NCT01007994|12241068|FG000|STARTED|Overall Study||17
11059443|NCT01007994|12241069|FG001|STARTED|Overall Study||16
11059444|NCT01007994|12241068|FG000|COMPLETED|Overall Study||15
11059445|NCT01007994|12241069|FG001|COMPLETED|Overall Study||14
11059446|NCT01007994|12241068|FG000|NOT COMPLETED|Overall Study||2
11059447|NCT01007994|12241069|FG001|NOT COMPLETED|Overall Study||2
11059448|NCT01008059|12241075|FG000|STARTED|Control Sequential Alfentanil||6
11059449|NCT01008059|12241076|FG001|STARTED|Control Sequential Alfentanil||0
11059450|NCT01008059|12241077|FG002|STARTED|Control Sequential Alfentanil||0
11059451|NCT01008059|12241078|FG003|STARTED|Control Sequential Alfentanil||0
11059452|NCT01008059|12241079|FG004|STARTED|Control Sequential Alfentanil||0
11059453|NCT01008059|12241080|FG005|STARTED|Control Sequential Alfentanil||0
11059454|NCT01008059|12241081|FG006|STARTED|Control Sequential Alfentanil||0
11059455|NCT01008059|12241082|FG007|STARTED|Control Sequential Alfentanil||0
11059456|NCT01008059|12241075|FG000|COMPLETED|Control Sequential Alfentanil||6
11059457|NCT01008059|12241076|FG001|COMPLETED|Control Sequential Alfentanil||0
11059458|NCT01008059|12241077|FG002|COMPLETED|Control Sequential Alfentanil||0
11059459|NCT01008059|12241078|FG003|COMPLETED|Control Sequential Alfentanil||0
11059460|NCT01008059|12241079|FG004|COMPLETED|Control Sequential Alfentanil||0
11059461|NCT01008059|12241080|FG005|COMPLETED|Control Sequential Alfentanil||0
11059462|NCT01008059|12241081|FG006|COMPLETED|Control Sequential Alfentanil||0
11059463|NCT01008059|12241082|FG007|COMPLETED|Control Sequential Alfentanil||0
11059464|NCT01008059|12241075|FG000|NOT COMPLETED|Control Sequential Alfentanil||0
11059465|NCT01008059|12241076|FG001|NOT COMPLETED|Control Sequential Alfentanil||0
11059466|NCT01008059|12241077|FG002|NOT COMPLETED|Control Sequential Alfentanil||0
11059467|NCT01008059|12241078|FG003|NOT COMPLETED|Control Sequential Alfentanil||0
11059468|NCT01008059|12241079|FG004|NOT COMPLETED|Control Sequential Alfentanil||0
11059469|NCT01008059|12241080|FG005|NOT COMPLETED|Control Sequential Alfentanil||0
11059470|NCT01008059|12241081|FG006|NOT COMPLETED|Control Sequential Alfentanil||0
11059471|NCT01008059|12241082|FG007|NOT COMPLETED|Control Sequential Alfentanil||0
11059472|NCT01008059|12241075|FG000|STARTED|Rifampin Sequential Alfentanil||0
11059473|NCT01008059|12241076|FG001|STARTED|Rifampin Sequential Alfentanil||6
11059474|NCT01008059|12241077|FG002|STARTED|Rifampin Sequential Alfentanil||0
11059475|NCT01008059|12241078|FG003|STARTED|Rifampin Sequential Alfentanil||0
11059476|NCT01008059|12241079|FG004|STARTED|Rifampin Sequential Alfentanil||0
11059477|NCT01008059|12241080|FG005|STARTED|Rifampin Sequential Alfentanil||0
11059478|NCT01008059|12241081|FG006|STARTED|Rifampin Sequential Alfentanil||0
11059479|NCT01008059|12241082|FG007|STARTED|Rifampin Sequential Alfentanil||0
11059480|NCT01008059|12241075|FG000|COMPLETED|Rifampin Sequential Alfentanil||0
11059481|NCT01008059|12241076|FG001|COMPLETED|Rifampin Sequential Alfentanil||6
11059482|NCT01008059|12241077|FG002|COMPLETED|Rifampin Sequential Alfentanil||0
11059483|NCT01008059|12241078|FG003|COMPLETED|Rifampin Sequential Alfentanil||0
11059484|NCT01008059|12241079|FG004|COMPLETED|Rifampin Sequential Alfentanil||0
11059485|NCT01008059|12241080|FG005|COMPLETED|Rifampin Sequential Alfentanil||0
11059486|NCT01008059|12241081|FG006|COMPLETED|Rifampin Sequential Alfentanil||0
11059487|NCT01008059|12241082|FG007|COMPLETED|Rifampin Sequential Alfentanil||0
11059488|NCT01008059|12241075|FG000|NOT COMPLETED|Rifampin Sequential Alfentanil||0
11059489|NCT01008059|12241076|FG001|NOT COMPLETED|Rifampin Sequential Alfentanil||0
11059490|NCT01008059|12241077|FG002|NOT COMPLETED|Rifampin Sequential Alfentanil||0
11059491|NCT01008059|12241078|FG003|NOT COMPLETED|Rifampin Sequential Alfentanil||0
11059492|NCT01008059|12241079|FG004|NOT COMPLETED|Rifampin Sequential Alfentanil||0
11059493|NCT01008059|12241080|FG005|NOT COMPLETED|Rifampin Sequential Alfentanil||0
11059494|NCT01008059|12241081|FG006|NOT COMPLETED|Rifampin Sequential Alfentanil||0
11059495|NCT01008059|12241082|FG007|NOT COMPLETED|Rifampin Sequential Alfentanil||0
11059496|NCT01008059|12241075|FG000|STARTED|Grapefruit Juice Sequential Alfentanil||0
11059497|NCT01008059|12241076|FG001|STARTED|Grapefruit Juice Sequential Alfentanil||0
11059498|NCT01008059|12241077|FG002|STARTED|Grapefruit Juice Sequential Alfentanil||6
11059499|NCT01008059|12241078|FG003|STARTED|Grapefruit Juice Sequential Alfentanil||0
11059500|NCT01008059|12241079|FG004|STARTED|Grapefruit Juice Sequential Alfentanil||0
11059501|NCT01008059|12241080|FG005|STARTED|Grapefruit Juice Sequential Alfentanil||0
11059502|NCT01008059|12241081|FG006|STARTED|Grapefruit Juice Sequential Alfentanil||0
11059503|NCT01008059|12241082|FG007|STARTED|Grapefruit Juice Sequential Alfentanil||0
11059504|NCT01008059|12241075|FG000|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059505|NCT01008059|12241076|FG001|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059506|NCT01008059|12241077|FG002|COMPLETED|Grapefruit Juice Sequential Alfentanil||6
11059507|NCT01008059|12241078|FG003|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059508|NCT01008059|12241079|FG004|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059509|NCT01008059|12241080|FG005|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059510|NCT01008059|12241081|FG006|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059511|NCT01008059|12241082|FG007|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059512|NCT01008059|12241075|FG000|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059513|NCT01008059|12241076|FG001|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059514|NCT01008059|12241077|FG002|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059515|NCT01008059|12241078|FG003|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059516|NCT01008059|12241079|FG004|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059517|NCT01008059|12241080|FG005|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059518|NCT01008059|12241081|FG006|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059519|NCT01008059|12241082|FG007|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
11059520|NCT01008059|12241075|FG000|STARTED|Ketoconazole Sequential Alfentanil||0
11059521|NCT01008059|12241076|FG001|STARTED|Ketoconazole Sequential Alfentanil||0
11059522|NCT01008059|12241077|FG002|STARTED|Ketoconazole Sequential Alfentanil||0
11059523|NCT01008059|12241078|FG003|STARTED|Ketoconazole Sequential Alfentanil||6
11059524|NCT01008059|12241079|FG004|STARTED|Ketoconazole Sequential Alfentanil||0
11059525|NCT01008059|12241080|FG005|STARTED|Ketoconazole Sequential Alfentanil||0
11059526|NCT01008059|12241081|FG006|STARTED|Ketoconazole Sequential Alfentanil||0
11059527|NCT01008059|12241082|FG007|STARTED|Ketoconazole Sequential Alfentanil||0
11059528|NCT01008059|12241075|FG000|COMPLETED|Ketoconazole Sequential Alfentanil||0
11059529|NCT01008059|12241076|FG001|COMPLETED|Ketoconazole Sequential Alfentanil||0
11059530|NCT01008059|12241077|FG002|COMPLETED|Ketoconazole Sequential Alfentanil||0
11059531|NCT01008059|12241078|FG003|COMPLETED|Ketoconazole Sequential Alfentanil||6
11059532|NCT01008059|12241079|FG004|COMPLETED|Ketoconazole Sequential Alfentanil||0
11059533|NCT01008059|12241080|FG005|COMPLETED|Ketoconazole Sequential Alfentanil||0
11059534|NCT01008059|12241081|FG006|COMPLETED|Ketoconazole Sequential Alfentanil||0
11059535|NCT01008059|12241082|FG007|COMPLETED|Ketoconazole Sequential Alfentanil||0
11059536|NCT01008059|12241075|FG000|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
11059537|NCT01008059|12241076|FG001|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
11059538|NCT01008059|12241077|FG002|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
11059539|NCT01008059|12241078|FG003|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
11059540|NCT01008059|12241079|FG004|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
11059541|NCT01008059|12241080|FG005|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
11059542|NCT01008059|12241081|FG006|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
11059543|NCT01008059|12241082|FG007|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
11059544|NCT01008059|12241075|FG000|STARTED|Control Simultaneous Alfentanil||0
11059545|NCT01008059|12241076|FG001|STARTED|Control Simultaneous Alfentanil||0
11059546|NCT01008059|12241077|FG002|STARTED|Control Simultaneous Alfentanil||0
11059547|NCT01008059|12241078|FG003|STARTED|Control Simultaneous Alfentanil||0
11059548|NCT01008059|12241079|FG004|STARTED|Control Simultaneous Alfentanil||6
11059549|NCT01008059|12241080|FG005|STARTED|Control Simultaneous Alfentanil||0
11059550|NCT01008059|12241081|FG006|STARTED|Control Simultaneous Alfentanil||0
11059551|NCT01008059|12241082|FG007|STARTED|Control Simultaneous Alfentanil||0
11059552|NCT01008059|12241075|FG000|COMPLETED|Control Simultaneous Alfentanil||0
11059553|NCT01008059|12241076|FG001|COMPLETED|Control Simultaneous Alfentanil||0
11059554|NCT01008059|12241077|FG002|COMPLETED|Control Simultaneous Alfentanil||0
11059555|NCT01008059|12241078|FG003|COMPLETED|Control Simultaneous Alfentanil||0
11059556|NCT01008059|12241079|FG004|COMPLETED|Control Simultaneous Alfentanil||6
11059557|NCT01008059|12241080|FG005|COMPLETED|Control Simultaneous Alfentanil||0
11059558|NCT01008059|12241081|FG006|COMPLETED|Control Simultaneous Alfentanil||0
11059559|NCT01008059|12241082|FG007|COMPLETED|Control Simultaneous Alfentanil||0
11059560|NCT01008059|12241075|FG000|NOT COMPLETED|Control Simultaneous Alfentanil||0
11059561|NCT01008059|12241076|FG001|NOT COMPLETED|Control Simultaneous Alfentanil||0
11059562|NCT01008059|12241077|FG002|NOT COMPLETED|Control Simultaneous Alfentanil||0
11059563|NCT01008059|12241078|FG003|NOT COMPLETED|Control Simultaneous Alfentanil||0
11059564|NCT01008059|12241079|FG004|NOT COMPLETED|Control Simultaneous Alfentanil||0
11059565|NCT01008059|12241080|FG005|NOT COMPLETED|Control Simultaneous Alfentanil||0
11059566|NCT01008059|12241081|FG006|NOT COMPLETED|Control Simultaneous Alfentanil||0
11059567|NCT01008059|12241082|FG007|NOT COMPLETED|Control Simultaneous Alfentanil||0
11059568|NCT01008059|12241075|FG000|STARTED|Rifampin Simultaneous Alfentanil||0
11059569|NCT01008059|12241076|FG001|STARTED|Rifampin Simultaneous Alfentanil||0
11059570|NCT01008059|12241077|FG002|STARTED|Rifampin Simultaneous Alfentanil||0
11059571|NCT01008059|12241078|FG003|STARTED|Rifampin Simultaneous Alfentanil||0
11059572|NCT01008059|12241079|FG004|STARTED|Rifampin Simultaneous Alfentanil||0
11059573|NCT01008059|12241080|FG005|STARTED|Rifampin Simultaneous Alfentanil||6
11059574|NCT01008059|12241081|FG006|STARTED|Rifampin Simultaneous Alfentanil||0
11059575|NCT01008059|12241082|FG007|STARTED|Rifampin Simultaneous Alfentanil||0
11344455|NCT02959840|12541523|FG002|NOT COMPLETED|Overall Study||0
11344456|NCT02959853|12541533|FG000|STARTED|Overall Study||11
11344457|NCT02959853|12541534|FG001|STARTED|Overall Study||12
11344458|NCT02959853|12541533|FG000|COMPLETED|Overall Study||7
11344459|NCT02959853|12541534|FG001|COMPLETED|Overall Study||10
11344460|NCT02959853|12541533|FG000|NOT COMPLETED|Overall Study||4
11344461|NCT02959853|12541534|FG001|NOT COMPLETED|Overall Study||2
11344462|NCT02959866|12541541|FG000|STARTED|Overall Study||59
11344463|NCT02959866|12541541|FG000|Telephone Interview at 1 Month Follow-up|Overall Study||59
11344464|NCT02959866|12541541|FG000|COMPLETED|Overall Study||58
11344465|NCT02959866|12541541|FG000|NOT COMPLETED|Overall Study||1
11344466|NCT02959892|12541548|FG000|STARTED|Overall Study||6
11344467|NCT02959892|12541549|FG001|STARTED|Overall Study||6
11344468|NCT02959892|12541548|FG000|COMPLETED|Overall Study||5
11344469|NCT02959892|12541549|FG001|COMPLETED|Overall Study||5
11344470|NCT02959892|12541548|FG000|NOT COMPLETED|Overall Study||1
11059576|NCT01008059|12241075|FG000|COMPLETED|Rifampin Simultaneous Alfentanil||0
11059577|NCT01008059|12241076|FG001|COMPLETED|Rifampin Simultaneous Alfentanil||0
11059578|NCT01008059|12241077|FG002|COMPLETED|Rifampin Simultaneous Alfentanil||0
11059579|NCT01008059|12241078|FG003|COMPLETED|Rifampin Simultaneous Alfentanil||0
11059580|NCT01008059|12241079|FG004|COMPLETED|Rifampin Simultaneous Alfentanil||0
11059581|NCT01008059|12241080|FG005|COMPLETED|Rifampin Simultaneous Alfentanil||6
11059582|NCT01008059|12241081|FG006|COMPLETED|Rifampin Simultaneous Alfentanil||0
11059583|NCT01008059|12241082|FG007|COMPLETED|Rifampin Simultaneous Alfentanil||0
11059584|NCT01008059|12241075|FG000|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
11059585|NCT01008059|12241076|FG001|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
11059586|NCT01008059|12241077|FG002|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
11059587|NCT01008059|12241078|FG003|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
11059588|NCT01008059|12241079|FG004|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
11059589|NCT01008059|12241080|FG005|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
11059590|NCT01008059|12241081|FG006|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
11059591|NCT01008059|12241082|FG007|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
11059592|NCT01008059|12241075|FG000|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
11059593|NCT01008059|12241076|FG001|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
11059594|NCT01008059|12241077|FG002|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
11059595|NCT01008059|12241078|FG003|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
11059596|NCT01008059|12241079|FG004|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
11059597|NCT01008059|12241080|FG005|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
11059598|NCT01008059|12241081|FG006|STARTED|Grapefruit Juice Simultaneous Alfentanil||6
11059599|NCT01008059|12241082|FG007|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
11059600|NCT01008059|12241075|FG000|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059601|NCT01008059|12241076|FG001|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059602|NCT01008059|12241077|FG002|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059603|NCT01008059|12241078|FG003|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059604|NCT01008059|12241079|FG004|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059605|NCT01008059|12241080|FG005|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059606|NCT01008059|12241081|FG006|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6
11059607|NCT01008059|12241082|FG007|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059608|NCT01008059|12241075|FG000|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059609|NCT01008059|12241076|FG001|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059610|NCT01008059|12241077|FG002|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059611|NCT01008059|12241078|FG003|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059612|NCT01008059|12241079|FG004|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059613|NCT01008059|12241080|FG005|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059614|NCT01008059|12241081|FG006|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059615|NCT01008059|12241082|FG007|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
11059616|NCT01008059|12241075|FG000|STARTED|Ketoconazole Simultaneous Alfentanil||0
11059617|NCT01008059|12241076|FG001|STARTED|Ketoconazole Simultaneous Alfentanil||0
11059618|NCT01008059|12241077|FG002|STARTED|Ketoconazole Simultaneous Alfentanil||0
11059619|NCT01008059|12241078|FG003|STARTED|Ketoconazole Simultaneous Alfentanil||0
11059620|NCT01008059|12241079|FG004|STARTED|Ketoconazole Simultaneous Alfentanil||0
11059621|NCT01008059|12241080|FG005|STARTED|Ketoconazole Simultaneous Alfentanil||0
11059622|NCT01008059|12241081|FG006|STARTED|Ketoconazole Simultaneous Alfentanil||0
11059623|NCT01008059|12241082|FG007|STARTED|Ketoconazole Simultaneous Alfentanil||6
11059624|NCT01008059|12241075|FG000|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059625|NCT01008059|12241076|FG001|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059626|NCT01008059|12241077|FG002|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059627|NCT01008059|12241078|FG003|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059628|NCT01008059|12241079|FG004|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059629|NCT01008059|12241080|FG005|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059630|NCT01008059|12241081|FG006|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059631|NCT01008059|12241082|FG007|COMPLETED|Ketoconazole Simultaneous Alfentanil||6
11059632|NCT01008059|12241075|FG000|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059633|NCT01008059|12241076|FG001|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059634|NCT01008059|12241077|FG002|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059635|NCT01008059|12241078|FG003|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059636|NCT01008059|12241079|FG004|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059637|NCT01008059|12241080|FG005|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059638|NCT01008059|12241081|FG006|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059639|NCT01008059|12241082|FG007|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
11059640|NCT01008150|12241097|FG000|STARTED|Overall Study||43
11059641|NCT01008150|12241098|FG001|STARTED|Overall Study||43
11059642|NCT01008150|12241099|FG002|STARTED|Overall Study||43
11059643|NCT01008150|12241100|FG003|STARTED|Overall Study||12
11059644|NCT01008150|12241097|FG000|COMPLETED|Overall Study||42
11059645|NCT01008150|12241098|FG001|COMPLETED|Overall Study||42
11059646|NCT01008150|12241099|FG002|COMPLETED|Overall Study||42
11059647|NCT01008150|12241100|FG003|COMPLETED|Overall Study||12
11059648|NCT01008150|12241097|FG000|NOT COMPLETED|Overall Study||1
11059649|NCT01008150|12241098|FG001|NOT COMPLETED|Overall Study||1
11059650|NCT01008150|12241099|FG002|NOT COMPLETED|Overall Study||1
11059651|NCT01008150|12241100|FG003|NOT COMPLETED|Overall Study||0
11059652|NCT01008280|12241113|FG000|STARTED|Overall Study||88
11059653|NCT01008280|12241114|FG001|STARTED|Overall Study||92
11059654|NCT01008280|12241113|FG000|COMPLETED|Overall Study||67
11059655|NCT01008280|12241114|FG001|COMPLETED|Overall Study||73
11059656|NCT01008280|12241113|FG000|NOT COMPLETED|Overall Study||21
11059657|NCT01008280|12241114|FG001|NOT COMPLETED|Overall Study||19
11059658|NCT01008319|12241122|FG000|STARTED|Overall Study||60
11059659|NCT01008319|12241123|FG001|STARTED|Overall Study||60
11059660|NCT01008319|12241122|FG000|COMPLETED|Overall Study||60
11059661|NCT01008319|12241123|FG001|COMPLETED|Overall Study||60
11059662|NCT01008319|12241122|FG000|NOT COMPLETED|Overall Study||0
11059663|NCT01008319|12241123|FG001|NOT COMPLETED|Overall Study||0
11059664|NCT01008410|12241135|FG000|STARTED|Overall Study||133
11059665|NCT01008410|12241136|FG001|STARTED|Overall Study||132
11059666|NCT01008410|12241135|FG000|Received at Least 1 Dose of Study Drug|Overall Study||133
11059667|NCT01008410|12241136|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132
11059668|NCT01008410|12241135|FG000|COMPLETED|Overall Study||108
11059669|NCT01008410|12241136|FG001|COMPLETED|Overall Study||116
11059670|NCT01008410|12241135|FG000|NOT COMPLETED|Overall Study||25
11059671|NCT01008410|12241136|FG001|NOT COMPLETED|Overall Study||16
11205293|NCT01858532|12396042|FG000|STARTED|Overall Study||1325
11205294|NCT01858532|12396043|FG001|STARTED|Overall Study||1323
11205295|NCT01858532|12396044|FG002|STARTED|Overall Study||509
11205296|NCT01858532|12396045|FG003|STARTED|Overall Study||511
11205297|NCT01858532|12396042|FG000|COMPLETED|Overall Study||1144
11205298|NCT01858532|12396043|FG001|COMPLETED|Overall Study||1131
11205299|NCT01858532|12396044|FG002|COMPLETED|Overall Study||411
11205300|NCT01858532|12396045|FG003|COMPLETED|Overall Study||418
11205301|NCT01858532|12396042|FG000|NOT COMPLETED|Overall Study||181
11205302|NCT01858532|12396043|FG001|NOT COMPLETED|Overall Study||192
11205303|NCT01858532|12396044|FG002|NOT COMPLETED|Overall Study||98
11205304|NCT01858532|12396045|FG003|NOT COMPLETED|Overall Study||93
11205305|NCT01858545|12396057|FG000|STARTED|Overall Study||27
11205306|NCT01858545|12396058|FG001|STARTED|Overall Study||29
11205307|NCT01858545|12396057|FG000|COMPLETED|Overall Study||23
11205308|NCT01858545|12396058|FG001|COMPLETED|Overall Study||23
11205309|NCT01858545|12396057|FG000|NOT COMPLETED|Overall Study||4
11059672|NCT01008423|12241144|FG000|STARTED|Overall Study||134
11059673|NCT01008423|12241145|FG001|STARTED|Overall Study||147
11059674|NCT01008423|12241144|FG000|Received at Least 1 Dose of Study Drug|Overall Study||134
11059675|NCT01008423|12241145|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147
11059676|NCT01008423|12241144|FG000|COMPLETED|Overall Study||115
11059677|NCT01008423|12241145|FG001|COMPLETED|Overall Study||125
11059678|NCT01008423|12241144|FG000|NOT COMPLETED|Overall Study||19
11059679|NCT01008423|12241145|FG001|NOT COMPLETED|Overall Study||22
11059680|NCT01008449|12241153|FG000|STARTED|Overall Study||200
11059681|NCT01008449|12241154|FG001|STARTED|Overall Study||198
11059682|NCT01008449|12241153|FG000|COMPLETED|Overall Study||171
11059683|NCT01008449|12241154|FG001|COMPLETED|Overall Study||179
11059684|NCT01008449|12241153|FG000|NOT COMPLETED|Overall Study||29
11059685|NCT01008449|12241154|FG001|NOT COMPLETED|Overall Study||19
11059686|NCT01008462|12241160|FG000|STARTED|Overall Study||16
11059687|NCT01008462|12241160|FG000|COMPLETED|Overall Study||16
11059688|NCT01008462|12241160|FG000|NOT COMPLETED|Overall Study||0
11059689|NCT01008475|12241171|FG000|STARTED|Overall Study||3
11059690|NCT01008475|12241172|FG001|STARTED|Overall Study||3
11059691|NCT01008475|12241173|FG002|STARTED|Overall Study||7
11059692|NCT01008475|12241174|FG003|STARTED|Overall Study||3
11059693|NCT01008475|12241175|FG004|STARTED|Overall Study||72
11059694|NCT01008475|12241176|FG005|STARTED|Overall Study||73
11059695|NCT01008475|12241177|FG006|STARTED|Overall Study||71
11059696|NCT01008475|12241171|FG000|Safety Analysis Set|Overall Study||3
11059697|NCT01008475|12241172|FG001|Safety Analysis Set|Overall Study||3
11059698|NCT01008475|12241173|FG002|Safety Analysis Set|Overall Study||7
11059699|NCT01008475|12241174|FG003|Safety Analysis Set|Overall Study||3
11059700|NCT01008475|12241175|FG004|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
11059701|NCT01008475|12241176|FG005|Safety Analysis Set|Overall Study||72
11059702|NCT01008475|12241177|FG006|Safety Analysis Set|Overall Study||69
11059703|NCT01008475|12241171|FG000|COMPLETED|Overall Study||3
11059704|NCT01008475|12241172|FG001|COMPLETED|Overall Study||3
11059705|NCT01008475|12241173|FG002|COMPLETED|Overall Study||7
11059706|NCT01008475|12241174|FG003|COMPLETED|Overall Study||3
11059707|NCT01008475|12241175|FG004|COMPLETED|Overall Study||67
11059708|NCT01008475|12241176|FG005|COMPLETED|Overall Study||67
11059709|NCT01008475|12241177|FG006|COMPLETED|Overall Study||67
11059710|NCT01008475|12241171|FG000|NOT COMPLETED|Overall Study||0
11059711|NCT01008475|12241172|FG001|NOT COMPLETED|Overall Study||0
11059712|NCT01008475|12241173|FG002|NOT COMPLETED|Overall Study||0
11059713|NCT01008475|12241174|FG003|NOT COMPLETED|Overall Study||0
11059714|NCT01008475|12241175|FG004|NOT COMPLETED|Overall Study||5
11059715|NCT01008475|12241176|FG005|NOT COMPLETED|Overall Study||6
11059716|NCT01008475|12241177|FG006|NOT COMPLETED|Overall Study||4
11059717|NCT01008553|12241193|FG000|STARTED|Period 1 (Titration Period)||258
11059718|NCT01008553|12241194|FG001|STARTED|Period 1 (Titration Period)||0
11059719|NCT01008553|12241195|FG002|STARTED|Period 1 (Titration Period)||0
11059720|NCT01008553|12241193|FG000|COMPLETED|Period 1 (Titration Period)||163
11059721|NCT01008553|12241194|FG001|COMPLETED|Period 1 (Titration Period)||0
11059722|NCT01008553|12241195|FG002|COMPLETED|Period 1 (Titration Period)||0
11059723|NCT01008553|12241193|FG000|NOT COMPLETED|Period 1 (Titration Period)||95
11059724|NCT01008553|12241194|FG001|NOT COMPLETED|Period 1 (Titration Period)||0
11059725|NCT01008553|12241195|FG002|NOT COMPLETED|Period 1 (Titration Period)||0
11059726|NCT01008553|12241193|FG000|STARTED|Period 2 (Double-Blind Period)||0
11059727|NCT01008553|12241194|FG001|STARTED|Period 2 (Double-Blind Period)||84
11059728|NCT01008553|12241195|FG002|STARTED|Period 2 (Double-Blind Period)||79
11059729|NCT01008553|12241193|FG000|COMPLETED|Period 2 (Double-Blind Period)||0
11059730|NCT01008553|12241194|FG001|COMPLETED|Period 2 (Double-Blind Period)||47
11059731|NCT01008553|12241195|FG002|COMPLETED|Period 2 (Double-Blind Period)||28
11059732|NCT01008553|12241193|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0
11059733|NCT01008553|12241194|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||37
11059734|NCT01008553|12241195|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||51
11059735|NCT01008605|12241204|FG000|STARTED|Overall Study||48
11059736|NCT01008605|12241204|FG000|COMPLETED|Overall Study||48
11059737|NCT01008605|12241204|FG000|NOT COMPLETED|Overall Study||0
11059738|NCT01008618|12241216|FG000|STARTED|Period 1 (Titration Period)||218
11059739|NCT01008618|12241217|FG001|STARTED|Period 1 (Titration Period)||0
11059740|NCT01008618|12241218|FG002|STARTED|Period 1 (Titration Period)||0
11059741|NCT01008618|12241216|FG000|COMPLETED|Period 1 (Titration Period)||150
11059742|NCT01008618|12241217|FG001|COMPLETED|Period 1 (Titration Period)||0
11059743|NCT01008618|12241218|FG002|COMPLETED|Period 1 (Titration Period)||0
11059744|NCT01008618|12241216|FG000|NOT COMPLETED|Period 1 (Titration Period)||68
11059745|NCT01008618|12241217|FG001|NOT COMPLETED|Period 1 (Titration Period)||0
11059746|NCT01008618|12241218|FG002|NOT COMPLETED|Period 1 (Titration Period)||0
11059747|NCT01008618|12241216|FG000|STARTED|Period 2 (Double-Blind Period)||0
11059748|NCT01008618|12241217|FG001|STARTED|Period 2 (Double-Blind Period)||73
11059749|NCT01008618|12241218|FG002|STARTED|Period 2 (Double-Blind Period)||77
11059750|NCT01008618|12241216|FG000|COMPLETED|Period 2 (Double-Blind Period)||0
11059751|NCT01008618|12241217|FG001|COMPLETED|Period 2 (Double-Blind Period)||37
11059752|NCT01008618|12241218|FG002|COMPLETED|Period 2 (Double-Blind Period)||39
11059753|NCT01008618|12241216|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0
11059754|NCT01008618|12241217|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||36
11059755|NCT01008618|12241218|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||38
11059756|NCT01008696|12241229|FG000|STARTED|Overall Study||108
11059757|NCT01008696|12241230|FG001|STARTED|Overall Study||109
11059758|NCT01008696|12241229|FG000|COMPLETED|Overall Study||91
11059759|NCT01008696|12241230|FG001|COMPLETED|Overall Study||92
11059760|NCT01008696|12241229|FG000|NOT COMPLETED|Overall Study||17
11344471|NCT02959892|12541549|FG001|NOT COMPLETED|Overall Study||1
11344472|NCT02959970|12541557|FG000|STARTED|Overall Study||17
11344473|NCT02959970|12541558|FG001|STARTED|Overall Study||83
11344474|NCT02959970|12541557|FG000|COMPLETED|Overall Study||15
11344475|NCT02959970|12541558|FG001|COMPLETED|Overall Study||76
11344476|NCT02959970|12541557|FG000|NOT COMPLETED|Overall Study||2
11344477|NCT02959970|12541558|FG001|NOT COMPLETED|Overall Study||7
11344478|NCT02959983|12541568|FG000|STARTED|Overall Study||172
11344479|NCT02959983|12541569|FG001|STARTED|Overall Study||174
11344480|NCT02959983|12541568|FG000|COMPLETED|Overall Study||146
11344481|NCT02959983|12541569|FG001|COMPLETED|Overall Study||149
11344482|NCT02959983|12541568|FG000|NOT COMPLETED|Overall Study||26
11344483|NCT02959983|12541569|FG001|NOT COMPLETED|Overall Study||25
11205310|NCT01858545|12396058|FG001|NOT COMPLETED|Overall Study||6
11344484|NCT02959996|12541577|FG000|STARTED|Overall Study||40
11344485|NCT02959996|12541578|FG001|STARTED|Overall Study||39
11344486|NCT02959996|12541577|FG000|COMPLETED|Overall Study||40
11344487|NCT02959996|12541578|FG001|COMPLETED|Overall Study||39
11344488|NCT02959996|12541577|FG000|NOT COMPLETED|Overall Study||0
11059761|NCT01008696|12241230|FG001|NOT COMPLETED|Overall Study||17
11059762|NCT01008722|12241239|FG000|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
11059763|NCT01008722|12241240|FG001|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
11059764|NCT01008722|12241239|FG000|COMPLETED|Overall Study||36
11059765|NCT01008722|12241240|FG001|COMPLETED|Overall Study||71
11059766|NCT01008722|12241239|FG000|NOT COMPLETED|Overall Study||0
11059767|NCT01008722|12241240|FG001|NOT COMPLETED|Overall Study||0
11059768|NCT01008748|12241246|FG000|STARTED|Overall Study||200
11059769|NCT01008748|12241246|FG000|Baseline|Overall Study||188
11059770|NCT01008748|12241246|FG000|Week 0|Overall Study||182
11059771|NCT01008748|12241246|FG000|Week 3|Overall Study||168
11059772|NCT01008748|12241246|FG000|Week 26|Overall Study||119
11059773|NCT01008748|12241246|FG000|COMPLETED|Overall Study||119
11059774|NCT01008748|12241246|FG000|NOT COMPLETED|Overall Study||81
11059775|NCT01008904|12241250|FG000|STARTED|Overall Study||29
11059776|NCT01008904|12241250|FG000|COMPLETED|Overall Study||25
11059777|NCT01008904|12241250|FG000|NOT COMPLETED|Overall Study||4
11059778|NCT01008943|12241254|FG000|STARTED|Overall Study||16
11059779|NCT01008943|12241254|FG000|COMPLETED|Overall Study||15
11059780|NCT01008943|12241254|FG000|NOT COMPLETED|Overall Study||1
11059781|NCT01008969|12241258|FG000|STARTED|Overall Study||10
11059782|NCT01008969|12241258|FG000|COMPLETED|Overall Study||10
11059783|NCT01008969|12241258|FG000|NOT COMPLETED|Overall Study||0
11059784|NCT01008995|12241264|FG000|STARTED|Controlled Period||162
11059785|NCT01008995|12241265|FG001|STARTED|Controlled Period||160
11059786|NCT01008995|12241266|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
11059787|NCT01008995|12241267|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
11059788|NCT01008995|12241264|FG000|COMPLETED|Controlled Period||159
11059789|NCT01008995|12241265|FG001|COMPLETED|Controlled Period||157
11059790|NCT01008995|12241266|FG002|COMPLETED|Controlled Period||0
11059791|NCT01008995|12241267|FG003|COMPLETED|Controlled Period||0
11205311|NCT01858558|12396066|FG000|STARTED|Overall Study||70
11205312|NCT01858558|12396067|FG001|STARTED|Overall Study||31
11205313|NCT01858558|12396066|FG000|COMPLETED|Overall Study||61
11205314|NCT01858558|12396067|FG001|COMPLETED|Overall Study||29
11205315|NCT01858558|12396066|FG000|NOT COMPLETED|Overall Study||9
11205316|NCT01858558|12396067|FG001|NOT COMPLETED|Overall Study||2
11205317|NCT01858636|12396073|FG000|STARTED|Overall Study|Subjects consented|235
11205318|NCT01858636|12396073|FG000|Device Deployment|Overall Study||211
11205319|NCT01858636|12396073|FG000|COMPLETED|Overall Study||207
11205320|NCT01858636|12396073|FG000|NOT COMPLETED|Overall Study||28
11205321|NCT01858701|12396078|FG000|STARTED|Period 1, First 30 Days of Wear||20
11205322|NCT01858701|12396079|FG001|STARTED|Period 1, First 30 Days of Wear||20
11205323|NCT01858701|12396078|FG000|COMPLETED|Period 1, First 30 Days of Wear||20
11205324|NCT01858701|12396079|FG001|COMPLETED|Period 1, First 30 Days of Wear||19
11205325|NCT01858701|12396078|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
11205326|NCT01858701|12396079|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1
11205327|NCT01858701|12396078|FG000|STARTED|Washout Period, 1-13 Days||20
11205328|NCT01858701|12396079|FG001|STARTED|Washout Period, 1-13 Days||19
11344489|NCT02959996|12541578|FG001|NOT COMPLETED|Overall Study||0
11059792|NCT01008995|12241264|FG000|NOT COMPLETED|Controlled Period||3
11059793|NCT01008995|12241265|FG001|NOT COMPLETED|Controlled Period||3
11059794|NCT01008995|12241266|FG002|NOT COMPLETED|Controlled Period||0
11059795|NCT01008995|12241267|FG003|NOT COMPLETED|Controlled Period||0
11059796|NCT01008995|12241264|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
11205329|NCT01858701|12396078|FG000|COMPLETED|Washout Period, 1-13 Days||18
11205330|NCT01858701|12396079|FG001|COMPLETED|Washout Period, 1-13 Days||17
11205331|NCT01858701|12396078|FG000|NOT COMPLETED|Washout Period, 1-13 Days||2
11205332|NCT01858701|12396079|FG001|NOT COMPLETED|Washout Period, 1-13 Days||2
11205333|NCT01858701|12396078|FG000|STARTED|Period 2, Second 30 Days of Wear||18
11205334|NCT01858701|12396079|FG001|STARTED|Period 2, Second 30 Days of Wear||17
11205335|NCT01858701|12396078|FG000|COMPLETED|Period 2, Second 30 Days of Wear||18
11205336|NCT01858701|12396079|FG001|COMPLETED|Period 2, Second 30 Days of Wear||16
11205337|NCT01858701|12396078|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
11205338|NCT01858701|12396079|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
11205339|NCT01858753|12396087|FG000|STARTED|Overall Study||5
11205340|NCT01858753|12396088|FG001|STARTED|Overall Study||0
11205341|NCT01858753|12396087|FG000|COMPLETED|Overall Study||0
11205342|NCT01858753|12396088|FG001|COMPLETED|Overall Study||0
11205343|NCT01858753|12396087|FG000|NOT COMPLETED|Overall Study||5
11205344|NCT01858753|12396088|FG001|NOT COMPLETED|Overall Study||0
11205345|NCT01858766|12396113|FG000|STARTED|Overall Study||27
11059797|NCT01008995|12241265|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
11059798|NCT01008995|12241266|FG002|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
11059799|NCT01008995|12241267|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
11059800|NCT01008995|12241264|FG000|COMPLETED|After Controlled Period||0
11059801|NCT01008995|12241265|FG001|COMPLETED|After Controlled Period||0
11059802|NCT01008995|12241266|FG002|COMPLETED|After Controlled Period||156
11059803|NCT01008995|12241267|FG003|COMPLETED|After Controlled Period||156
11059804|NCT01008995|12241264|FG000|NOT COMPLETED|After Controlled Period||0
11059805|NCT01008995|12241265|FG001|NOT COMPLETED|After Controlled Period||0
11059806|NCT01008995|12241266|FG002|NOT COMPLETED|After Controlled Period||2
11059807|NCT01008995|12241267|FG003|NOT COMPLETED|After Controlled Period||1
11059808|NCT01009034|12241275|FG000|STARTED|Overall Study||14
11059809|NCT01009034|12241275|FG000|COMPLETED|Overall Study||10
11059810|NCT01009034|12241275|FG000|NOT COMPLETED|Overall Study||4
11059811|NCT01009047|12241281|FG000|STARTED|Overall Study||113
11059812|NCT01009047|12241282|FG001|STARTED|Overall Study||115
11059813|NCT01009047|12241281|FG000|COMPLETED|Overall Study||85
11059814|NCT01009047|12241282|FG001|COMPLETED|Overall Study||89
11059815|NCT01009047|12241281|FG000|NOT COMPLETED|Overall Study||28
11059816|NCT01009047|12241282|FG001|NOT COMPLETED|Overall Study||26
11059817|NCT01009060|12241290|FG000|STARTED|Overall Study||25
11059818|NCT01009060|12241291|FG001|STARTED|Overall Study||25
11059819|NCT01009060|12241290|FG000|COMPLETED|Overall Study||21
11059820|NCT01009060|12241291|FG001|COMPLETED|Overall Study||20
11059821|NCT01009060|12241290|FG000|NOT COMPLETED|Overall Study||4
11059822|NCT01009060|12241291|FG001|NOT COMPLETED|Overall Study||5
11059823|NCT01009086|12241304|FG000|STARTED|Overall Study||206
11059824|NCT01009086|12241305|FG001|STARTED|Overall Study||205
11059825|NCT01009086|12241306|FG002|STARTED|Overall Study||204
11059826|NCT01009086|12241304|FG000|COMPLETED|Overall Study||162
11059827|NCT01009086|12241305|FG001|COMPLETED|Overall Study||158
11059828|NCT01009086|12241306|FG002|COMPLETED|Overall Study||170
11059829|NCT01009086|12241304|FG000|NOT COMPLETED|Overall Study||44
11059830|NCT01009086|12241305|FG001|NOT COMPLETED|Overall Study||47
11059831|NCT01009086|12241306|FG002|NOT COMPLETED|Overall Study||34
11059832|NCT01009099|12241321|FG000|STARTED|Overall Study||58
11059833|NCT01009099|12241322|FG001|STARTED|Overall Study||61
11059834|NCT01009099|12241321|FG000|COMPLETED|Overall Study||53
11059835|NCT01009099|12241322|FG001|COMPLETED|Overall Study||57
11059836|NCT01009099|12241321|FG000|NOT COMPLETED|Overall Study||5
11059837|NCT01009099|12241322|FG001|NOT COMPLETED|Overall Study||4
11059838|NCT01009138|12241330|FG000|STARTED|Overall Study||106
11059839|NCT01009138|12241331|FG001|STARTED|Overall Study||108
11059840|NCT01009138|12241330|FG000|COMPLETED|Overall Study||93
11059841|NCT01009138|12241331|FG001|COMPLETED|Overall Study||88
11059842|NCT01009138|12241330|FG000|NOT COMPLETED|Overall Study||13
11059843|NCT01009138|12241331|FG001|NOT COMPLETED|Overall Study||20
11059844|NCT01009203|12241337|FG000|STARTED|Overall Study||13
11059845|NCT01009203|12241337|FG000|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
11059846|NCT01009203|12241337|FG000|COMPLETED|Overall Study||6
11059847|NCT01009203|12241337|FG000|NOT COMPLETED|Overall Study||7
11059848|NCT01009281|12241341|FG000|STARTED|Overall Study||7
11059849|NCT01009281|12241341|FG000|COMPLETED|Overall Study||0
11059850|NCT01009281|12241341|FG000|NOT COMPLETED|Overall Study||7
11059851|NCT01009333|12241345|FG000|STARTED|Week 1||2
11059852|NCT01009333|12241346|FG001|STARTED|Week 1||3
11059853|NCT01009333|12241347|FG002|STARTED|Week 1||2
11059854|NCT01009333|12241348|FG003|STARTED|Week 1||2
11205346|NCT01858766|12396114|FG001|STARTED|Overall Study||28
11205347|NCT01858766|12396115|FG002|STARTED|Overall Study||11
11205348|NCT01858766|12396116|FG003|STARTED|Overall Study||10
11205349|NCT01858766|12396117|FG004|STARTED|Overall Study||27
11344490|NCT02960217|12541586|FG000|STARTED|Maintenance Phase: Treatment Period 1||22
11344491|NCT02960217|12541587|FG001|STARTED|Maintenance Phase: Treatment Period 1||21
11344492|NCT02960217|12541586|FG000|COMPLETED|Maintenance Phase: Treatment Period 1||21
11344493|NCT02960217|12541587|FG001|COMPLETED|Maintenance Phase: Treatment Period 1||21
11344494|NCT02960217|12541586|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 1||1
11344495|NCT02960217|12541587|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 1||0
11344496|NCT02960217|12541586|FG000|STARTED|Maintenance Phase: Crossover Washout||21
11344497|NCT02960217|12541587|FG001|STARTED|Maintenance Phase: Crossover Washout||21
11344498|NCT02960217|12541586|FG000|COMPLETED|Maintenance Phase: Crossover Washout||21
11344499|NCT02960217|12541587|FG001|COMPLETED|Maintenance Phase: Crossover Washout||21
11344500|NCT02960217|12541586|FG000|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
11344501|NCT02960217|12541587|FG001|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
11344502|NCT02960217|12541586|FG000|STARTED|Maintenance Phase: Treatment Period 2||21
11059855|NCT01009333|12241349|FG004|STARTED|Week 1||2
11059856|NCT01009333|12241350|FG005|STARTED|Week 1||2
11059857|NCT01009333|12241345|FG000|COMPLETED|Week 1||2
11059858|NCT01009333|12241346|FG001|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
11059859|NCT01009333|12241347|FG002|COMPLETED|Week 1||2
11059860|NCT01009333|12241348|FG003|COMPLETED|Week 1||2
11059861|NCT01009333|12241349|FG004|COMPLETED|Week 1||2
11059862|NCT01009333|12241350|FG005|COMPLETED|Week 1||2
11059863|NCT01009333|12241345|FG000|NOT COMPLETED|Week 1||0
11059864|NCT01009333|12241346|FG001|NOT COMPLETED|Week 1||0
11059865|NCT01009333|12241347|FG002|NOT COMPLETED|Week 1||0
11059866|NCT01009333|12241348|FG003|NOT COMPLETED|Week 1||0
11059867|NCT01009333|12241349|FG004|NOT COMPLETED|Week 1||0
11059868|NCT01009333|12241350|FG005|NOT COMPLETED|Week 1||0
11059869|NCT01009333|12241345|FG000|STARTED|Week 2||2
11059870|NCT01009333|12241346|FG001|STARTED|Week 2||2
11059871|NCT01009333|12241347|FG002|STARTED|Week 2||2
11059872|NCT01009333|12241348|FG003|STARTED|Week 2||2
11059873|NCT01009333|12241349|FG004|STARTED|Week 2||2
11059874|NCT01009333|12241350|FG005|STARTED|Week 2||2
11059875|NCT01009333|12241345|FG000|COMPLETED|Week 2||2
11059876|NCT01009333|12241346|FG001|COMPLETED|Week 2||2
11059877|NCT01009333|12241347|FG002|COMPLETED|Week 2||2
11059878|NCT01009333|12241348|FG003|COMPLETED|Week 2||2
11059879|NCT01009333|12241349|FG004|COMPLETED|Week 2||2
11059880|NCT01009333|12241350|FG005|COMPLETED|Week 2||2
11059881|NCT01009333|12241345|FG000|NOT COMPLETED|Week 2||0
11059882|NCT01009333|12241346|FG001|NOT COMPLETED|Week 2||0
11059883|NCT01009333|12241347|FG002|NOT COMPLETED|Week 2||0
11059884|NCT01009333|12241348|FG003|NOT COMPLETED|Week 2||0
11059885|NCT01009333|12241349|FG004|NOT COMPLETED|Week 2||0
11059886|NCT01009333|12241350|FG005|NOT COMPLETED|Week 2||0
11059887|NCT01009333|12241345|FG000|STARTED|Week 3||2
11059888|NCT01009333|12241346|FG001|STARTED|Week 3||2
11059889|NCT01009333|12241347|FG002|STARTED|Week 3||2
11059890|NCT01009333|12241348|FG003|STARTED|Week 3||2
11059891|NCT01009333|12241349|FG004|STARTED|Week 3||2
11059892|NCT01009333|12241350|FG005|STARTED|Week 3||2
11059893|NCT01009333|12241345|FG000|COMPLETED|Week 3||2
11059894|NCT01009333|12241346|FG001|COMPLETED|Week 3||2
11059895|NCT01009333|12241347|FG002|COMPLETED|Week 3||2
11059896|NCT01009333|12241348|FG003|COMPLETED|Week 3||2
11059897|NCT01009333|12241349|FG004|COMPLETED|Week 3||2
11059898|NCT01009333|12241350|FG005|COMPLETED|Week 3||2
11059899|NCT01009333|12241345|FG000|NOT COMPLETED|Week 3||0
11059900|NCT01009333|12241346|FG001|NOT COMPLETED|Week 3||0
11059901|NCT01009333|12241347|FG002|NOT COMPLETED|Week 3||0
11059902|NCT01009333|12241348|FG003|NOT COMPLETED|Week 3||0
11059903|NCT01009333|12241349|FG004|NOT COMPLETED|Week 3||0
11059904|NCT01009333|12241350|FG005|NOT COMPLETED|Week 3||0
11059905|NCT01009346|12241358|FG000|STARTED|Overall Study||9
11059906|NCT01009346|12241358|FG000|COMPLETED|Overall Study||5
11059907|NCT01009346|12241358|FG000|NOT COMPLETED|Overall Study||4
11059908|NCT01009463|12241367|FG000|STARTED|4-week, Open-label Run-In Period||2071
11059909|NCT01009463|12241368|FG001|STARTED|4-week, Open-label Run-In Period||0
11059910|NCT01009463|12241369|FG002|STARTED|4-week, Open-label Run-In Period||0
11059911|NCT01009463|12241370|FG003|STARTED|4-week, Open-label Run-In Period||0
11059912|NCT01009463|12241371|FG004|STARTED|4-week, Open-label Run-In Period||0
11059913|NCT01009463|12241367|FG000|COMPLETED|4-week, Open-label Run-In Period||1622
11059914|NCT01009463|12241368|FG001|COMPLETED|4-week, Open-label Run-In Period||0
11059915|NCT01009463|12241369|FG002|COMPLETED|4-week, Open-label Run-In Period||0
11059916|NCT01009463|12241370|FG003|COMPLETED|4-week, Open-label Run-In Period||0
11059917|NCT01009463|12241371|FG004|COMPLETED|4-week, Open-label Run-In Period||0
11059918|NCT01009463|12241367|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||449
11059919|NCT01009463|12241368|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0
11059920|NCT01009463|12241369|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0
11059921|NCT01009463|12241370|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0
11059922|NCT01009463|12241371|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0
11059923|NCT01009463|12241367|FG000|STARTED|52-week, Double-blind Treatment Period||0
11059924|NCT01009463|12241368|FG001|STARTED|52-week, Double-blind Treatment Period||409
11059925|NCT01009463|12241369|FG002|STARTED|52-week, Double-blind Treatment Period||408
11059926|NCT01009463|12241370|FG003|STARTED|52-week, Double-blind Treatment Period||403
11059927|NCT01009463|12241371|FG004|STARTED|52-week, Double-blind Treatment Period||402
11059928|NCT01009463|12241367|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
11059929|NCT01009463|12241368|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
11059930|NCT01009463|12241369|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
11059931|NCT01009463|12241370|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
11059932|NCT01009463|12241371|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
11059933|NCT01009463|12241367|FG000|COMPLETED|52-week, Double-blind Treatment Period||0
11059934|NCT01009463|12241368|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
11059935|NCT01009463|12241369|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
11059936|NCT01009463|12241370|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
11059937|NCT01009463|12241371|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
11059938|NCT01009463|12241367|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0
11059939|NCT01009463|12241368|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||115
11059940|NCT01009463|12241369|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||93
11059941|NCT01009463|12241370|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||91
11205350|NCT01858766|12396118|FG005|STARTED|Overall Study||28
11059942|NCT01009463|12241371|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||101
11059943|NCT01009515|12241382|FG000|STARTED|Overall Study||19
11059944|NCT01009515|12241382|FG000|COMPLETED|Overall Study||16
11059945|NCT01009515|12241382|FG000|NOT COMPLETED|Overall Study||3
11059946|NCT01009554|12241388|FG000|STARTED|Overall Study||48
11059947|NCT01009554|12241389|FG001|STARTED|Overall Study||48
11059948|NCT01009554|12241388|FG000|COMPLETED|Overall Study||46
11059949|NCT01009554|12241389|FG001|COMPLETED|Overall Study||41
11059950|NCT01009554|12241388|FG000|NOT COMPLETED|Overall Study||2
11059951|NCT01009554|12241389|FG001|NOT COMPLETED|Overall Study||7
11059952|NCT01009580|12241397|FG000|STARTED|Overall Study||224
11059953|NCT01009580|12241398|FG001|STARTED|Overall Study||223
11059954|NCT01009580|12241397|FG000|Exposed|Overall Study||224
11059955|NCT01009580|12241398|FG001|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
11059956|NCT01009580|12241397|FG000|COMPLETED|Overall Study||197
11059957|NCT01009580|12241398|FG001|COMPLETED|Overall Study||188
11059958|NCT01009580|12241397|FG000|NOT COMPLETED|Overall Study||27
11059959|NCT01009580|12241398|FG001|NOT COMPLETED|Overall Study||35
11059960|NCT01009619|12241406|FG000|STARTED|Overall Study||40
11059961|NCT01009619|12241407|FG001|STARTED|Overall Study||43
11059962|NCT01009619|12241406|FG000|COMPLETED|Overall Study||40
11059963|NCT01009619|12241407|FG001|COMPLETED|Overall Study||43
11205351|NCT01858766|12396119|FG006|STARTED|Overall Study||7
11205352|NCT01858766|12396120|FG007|STARTED|Overall Study||7
11205353|NCT01858766|12396121|FG008|STARTED|Overall Study||1
11205354|NCT01858766|12396122|FG009|STARTED|Overall Study||4
11205355|NCT01858766|12396123|FG010|STARTED|Overall Study||5
11205356|NCT01858766|12396124|FG011|STARTED|Overall Study||30
11344503|NCT02960217|12541587|FG001|STARTED|Maintenance Phase: Treatment Period 2||21
11344504|NCT02960217|12541586|FG000|COMPLETED|Maintenance Phase: Treatment Period 2||20
11344505|NCT02960217|12541587|FG001|COMPLETED|Maintenance Phase: Treatment Period 2||18
11344506|NCT02960217|12541586|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 2||1
11344507|NCT02960217|12541587|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 2||3
11344508|NCT02960217|12541586|FG000|STARTED|Open-Label Extension Phase||20
11344509|NCT02960217|12541587|FG001|STARTED|Open-Label Extension Phase|5 participants completed the double blind period but did not continue in the open label period.|13
11344510|NCT02960217|12541586|FG000|COMPLETED|Open-Label Extension Phase||0
11344511|NCT02960217|12541587|FG001|COMPLETED|Open-Label Extension Phase||0
11344512|NCT02960217|12541586|FG000|NOT COMPLETED|Open-Label Extension Phase||20
11205357|NCT01858766|12396125|FG012|STARTED|Overall Study||30
11205358|NCT01858766|12396126|FG013|STARTED|Overall Study||29
11205359|NCT01858766|12396127|FG014|STARTED|Overall Study||31
11205360|NCT01858766|12396128|FG015|STARTED|Overall Study||26
11205361|NCT01858766|12396129|FG016|STARTED|Overall Study||25
11344513|NCT02960217|12541587|FG001|NOT COMPLETED|Open-Label Extension Phase||13
11344514|NCT02960295|12541597|FG000|STARTED|Overall Study||10
11344515|NCT02960295|12541597|FG000|COMPLETED|Overall Study||10
11344516|NCT02960295|12541597|FG000|NOT COMPLETED|Overall Study||0
11344517|NCT02960438|12541606|FG000|STARTED|Treatment Phase (Double-blind): 24 Weeks||56
11344518|NCT02960438|12541607|FG001|STARTED|Treatment Phase (Double-blind): 24 Weeks||29
11344519|NCT02960438|12541608|FG002|STARTED|Treatment Phase (Double-blind): 24 Weeks||54
11344520|NCT02960438|12541609|FG003|STARTED|Treatment Phase (Double-blind): 24 Weeks||55
11344521|NCT02960438|12541606|FG000|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
11344522|NCT02960438|12541607|FG001|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||28
11344523|NCT02960438|12541608|FG002|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
11344524|NCT02960438|12541609|FG003|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
11344525|NCT02960438|12541606|FG000|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||47
11344526|NCT02960438|12541607|FG001|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||26
11344527|NCT02960438|12541608|FG002|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||50
11344528|NCT02960438|12541609|FG003|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||46
11059964|NCT01009619|12241406|FG000|NOT COMPLETED|Overall Study||0
11059965|NCT01009619|12241407|FG001|NOT COMPLETED|Overall Study||0
11059966|NCT01009645|12241417|FG000|STARTED|Overall Study||31
11059967|NCT01009645|12241418|FG001|STARTED|Overall Study||31
11059968|NCT01009645|12241419|FG002|STARTED|Overall Study||32
11059969|NCT01009645|12241420|FG003|STARTED|Overall Study||31
11059970|NCT01009645|12241417|FG000|COMPLETED|Overall Study||29
11059971|NCT01009645|12241418|FG001|COMPLETED|Overall Study||23
11059972|NCT01009645|12241419|FG002|COMPLETED|Overall Study||28
11059973|NCT01009645|12241420|FG003|COMPLETED|Overall Study||26
11059974|NCT01009645|12241417|FG000|NOT COMPLETED|Overall Study||2
11059975|NCT01009645|12241418|FG001|NOT COMPLETED|Overall Study||8
11059976|NCT01009645|12241419|FG002|NOT COMPLETED|Overall Study||4
11059977|NCT01009645|12241420|FG003|NOT COMPLETED|Overall Study||5
11059978|NCT01009762|12241432|FG000|STARTED|Overall Study||1
11059979|NCT01009762|12241433|FG001|STARTED|Overall Study||10
11059980|NCT01009762|12241432|FG000|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
11059981|NCT01009762|12241433|FG001|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
11059982|NCT01009762|12241432|FG000|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
11059983|NCT01009762|12241433|FG001|COMPLETED|Overall Study|10 participants received vaccine|10
11059984|NCT01009762|12241432|FG000|NOT COMPLETED|Overall Study||0
11059985|NCT01009762|12241433|FG001|NOT COMPLETED|Overall Study||0
11059986|NCT01009814|12241446|FG000|STARTED|Overall Study||10
11059987|NCT01009814|12241447|FG001|STARTED|Overall Study||10
11059988|NCT01009814|12241448|FG002|STARTED|Overall Study||10
11059989|NCT01009814|12241449|FG003|STARTED|Overall Study||10
11059990|NCT01009814|12241450|FG004|STARTED|Overall Study||10
11059991|NCT01009814|12241446|FG000|COMPLETED|Overall Study||9
11059992|NCT01009814|12241447|FG001|COMPLETED|Overall Study||9
11059993|NCT01009814|12241448|FG002|COMPLETED|Overall Study||10
11059994|NCT01009814|12241449|FG003|COMPLETED|Overall Study||10
11059995|NCT01009814|12241450|FG004|COMPLETED|Overall Study||10
11059996|NCT01009814|12241446|FG000|NOT COMPLETED|Overall Study||1
11059997|NCT01009814|12241447|FG001|NOT COMPLETED|Overall Study||1
11059998|NCT01009814|12241448|FG002|NOT COMPLETED|Overall Study||0
11059999|NCT01009814|12241449|FG003|NOT COMPLETED|Overall Study||0
11060000|NCT01009814|12241450|FG004|NOT COMPLETED|Overall Study||0
11060001|NCT01009840|12241466|FG000|STARTED|Overall Study||30
11060002|NCT01009840|12241466|FG000|COMPLETED|Overall Study||16
11060003|NCT01009840|12241466|FG000|NOT COMPLETED|Overall Study||14
11060004|NCT01009918|12241473|FG000|STARTED|Overall Study||158
11060005|NCT01009918|12241474|FG001|STARTED|Overall Study||156
11060006|NCT01009918|12241475|FG002|STARTED|Overall Study||154
11060007|NCT01009918|12241473|FG000|COMPLETED|Overall Study||134
11060008|NCT01009918|12241474|FG001|COMPLETED|Overall Study||132
11060009|NCT01009918|12241475|FG002|COMPLETED|Overall Study||124
11060010|NCT01009918|12241473|FG000|NOT COMPLETED|Overall Study||24
11060011|NCT01009918|12241474|FG001|NOT COMPLETED|Overall Study||24
11060012|NCT01009918|12241475|FG002|NOT COMPLETED|Overall Study||30
11060013|NCT01009983|12241483|FG000|STARTED|Overall Study||14
11060014|NCT01009983|12241483|FG000|COMPLETED|Overall Study||13
11060015|NCT01009983|12241483|FG000|NOT COMPLETED|Overall Study||1
11060016|NCT01010009|12241490|FG000|STARTED|Overall Study||8
11060017|NCT01010009|12241491|FG001|STARTED|Overall Study||8
11060018|NCT01010009|12241492|FG002|STARTED|Overall Study||8
11060019|NCT01010009|12241490|FG000|COMPLETED|Overall Study||8
11060020|NCT01010009|12241491|FG001|COMPLETED|Overall Study||8
11060021|NCT01010009|12241492|FG002|COMPLETED|Overall Study||8
11060022|NCT01010009|12241490|FG000|NOT COMPLETED|Overall Study||0
11060023|NCT01010009|12241491|FG001|NOT COMPLETED|Overall Study||0
11060024|NCT01010009|12241492|FG002|NOT COMPLETED|Overall Study||0
11060025|NCT01010061|12241502|FG000|STARTED|Overall Study||238
11060026|NCT01010061|12241503|FG001|STARTED|Overall Study||118
11060027|NCT01010061|12241502|FG000|Received Study Drug|Overall Study||236
11060028|NCT01010061|12241503|FG001|Received Study Drug|Overall Study||116
11060029|NCT01010061|12241502|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|190
11060030|NCT01010061|12241503|FG001|COMPLETED|Overall Study||78
11060031|NCT01010061|12241502|FG000|NOT COMPLETED|Overall Study||48
11060032|NCT01010061|12241503|FG001|NOT COMPLETED|Overall Study||40
11060033|NCT01010126|12241517|FG000|STARTED|Overall Study||27
11060034|NCT01010126|12241518|FG001|STARTED|Overall Study||58
11060035|NCT01010126|12241519|FG002|STARTED|Overall Study||28
11060036|NCT01010126|12241520|FG003|STARTED|Overall Study||57
11060037|NCT01010126|12241521|FG004|STARTED|Overall Study||58
11060038|NCT01010126|12241522|FG005|STARTED|Overall Study||24
11060039|NCT01010126|12241517|FG000|COMPLETED|Overall Study||26
11060040|NCT01010126|12241518|FG001|COMPLETED|Overall Study||58
11060041|NCT01010126|12241519|FG002|COMPLETED|Overall Study||27
11060042|NCT01010126|12241520|FG003|COMPLETED|Overall Study||57
11060043|NCT01010126|12241521|FG004|COMPLETED|Overall Study||55
11060044|NCT01010126|12241522|FG005|COMPLETED|Overall Study||24
11060045|NCT01010126|12241517|FG000|NOT COMPLETED|Overall Study||1
11060046|NCT01010126|12241518|FG001|NOT COMPLETED|Overall Study||0
11060047|NCT01010126|12241519|FG002|NOT COMPLETED|Overall Study||1
11060048|NCT01010126|12241520|FG003|NOT COMPLETED|Overall Study||0
11060049|NCT01010126|12241521|FG004|NOT COMPLETED|Overall Study||3
11060050|NCT01010126|12241522|FG005|NOT COMPLETED|Overall Study||0
11060051|NCT01010204|12241538|FG000|STARTED|Overall Study||31
11060052|NCT01010204|12241539|FG001|STARTED|Overall Study||29
11060053|NCT01010204|12241538|FG000|COMPLETED|Overall Study||24
11060054|NCT01010204|12241539|FG001|COMPLETED|Overall Study||20
11060055|NCT01010204|12241538|FG000|NOT COMPLETED|Overall Study||7
11060056|NCT01010204|12241539|FG001|NOT COMPLETED|Overall Study||9
11060057|NCT01010217|12241550|FG000|STARTED|Overall Study||89
11060058|NCT01010217|12241551|FG001|STARTED|Overall Study||56
11060059|NCT01010217|12241552|FG002|STARTED|Overall Study||22
11060060|NCT01010217|12241553|FG003|STARTED|Overall Study||6
11060061|NCT01010217|12241554|FG004|STARTED|Overall Study||3
11060062|NCT01010217|12241550|FG000|COMPLETED|Overall Study||84
11060063|NCT01010217|12241551|FG001|COMPLETED|Overall Study||51
11060064|NCT01010217|12241552|FG002|COMPLETED|Overall Study||21
11060065|NCT01010217|12241553|FG003|COMPLETED|Overall Study||0
11060066|NCT01010217|12241554|FG004|COMPLETED|Overall Study||0
11060067|NCT01010217|12241550|FG000|NOT COMPLETED|Overall Study||5
11060068|NCT01010217|12241551|FG001|NOT COMPLETED|Overall Study||5
11060069|NCT01010217|12241552|FG002|NOT COMPLETED|Overall Study||1
11060070|NCT01010217|12241553|FG003|NOT COMPLETED|Overall Study||6
11060071|NCT01010217|12241554|FG004|NOT COMPLETED|Overall Study||3
11060072|NCT01010230|12241568|FG000|STARTED|Overall Study||32
11060073|NCT01010230|12241569|FG001|STARTED|Overall Study||33
11060074|NCT01010230|12241568|FG000|COMPLETED|Overall Study||22
11060075|NCT01010230|12241569|FG001|COMPLETED|Overall Study||26
11060076|NCT01010230|12241568|FG000|NOT COMPLETED|Overall Study||10
11060077|NCT01010230|12241569|FG001|NOT COMPLETED|Overall Study||7
11060078|NCT01010282|12241578|FG000|STARTED|Overall Study||97
11060079|NCT01010282|12241579|FG001|STARTED|Overall Study||95
11060080|NCT01010282|12241580|FG002|STARTED|Overall Study||96
11060081|NCT01010282|12241578|FG000|COMPLETED|Overall Study||91
11060082|NCT01010282|12241579|FG001|COMPLETED|Overall Study||88
11060083|NCT01010282|12241580|FG002|COMPLETED|Overall Study||77
11060084|NCT01010282|12241578|FG000|NOT COMPLETED|Overall Study||6
11060085|NCT01010282|12241579|FG001|NOT COMPLETED|Overall Study||7
11060086|NCT01010282|12241580|FG002|NOT COMPLETED|Overall Study||19
11060087|NCT01010399|12241588|FG000|STARTED|Overall Study||36
11060088|NCT01010399|12241588|FG000|COMPLETED|Overall Study||31
11060089|NCT01010399|12241588|FG000|NOT COMPLETED|Overall Study||5
11060090|NCT01010477|12241594|FG000|STARTED|Overall Study||27
11060091|NCT01010477|12241595|FG001|STARTED|Overall Study||25
11060092|NCT01010477|12241594|FG000|COMPLETED|Overall Study||21
11060093|NCT01010477|12241595|FG001|COMPLETED|Overall Study||22
11060094|NCT01010477|12241594|FG000|NOT COMPLETED|Overall Study||6
11060095|NCT01010477|12241595|FG001|NOT COMPLETED|Overall Study||3
11060096|NCT01010503|12241601|FG000|STARTED|Overall Study||32
11060097|NCT01010503|12241601|FG000|COMPLETED|Overall Study||30
11060098|NCT01010503|12241601|FG000|NOT COMPLETED|Overall Study||2
11060099|NCT01010555|12241605|FG000|STARTED|First Four Weeks of Wear||11
11060100|NCT01010555|12241606|FG001|STARTED|First Four Weeks of Wear||10
11060101|NCT01010555|12241605|FG000|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
11060102|NCT01010555|12241606|FG001|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
11060103|NCT01010555|12241605|FG000|NOT COMPLETED|First Four Weeks of Wear||0
11060104|NCT01010555|12241606|FG001|NOT COMPLETED|First Four Weeks of Wear||0
11060105|NCT01010555|12241605|FG000|STARTED|Second Four Weeks of Wear||10
11060106|NCT01010555|12241606|FG001|STARTED|Second Four Weeks of Wear||9
11060107|NCT01010555|12241605|FG000|COMPLETED|Second Four Weeks of Wear||10
11060108|NCT01010555|12241606|FG001|COMPLETED|Second Four Weeks of Wear||9
11060109|NCT01010555|12241605|FG000|NOT COMPLETED|Second Four Weeks of Wear||0
11060110|NCT01010555|12241606|FG001|NOT COMPLETED|Second Four Weeks of Wear||0
11060111|NCT01010568|12241616|FG000|STARTED|Overall Study||10
11060112|NCT01010568|12241616|FG000|COMPLETED|Overall Study||5
11060113|NCT01010568|12241616|FG000|NOT COMPLETED|Overall Study||5
11060114|NCT01010633|12241623|FG000|STARTED|Overall Study||203
11060115|NCT01010633|12241624|FG001|STARTED|Overall Study||203
11060116|NCT01010633|12241623|FG000|COMPLETED|Overall Study||199
11060117|NCT01010633|12241624|FG001|COMPLETED|Overall Study||198
11060118|NCT01010633|12241623|FG000|NOT COMPLETED|Overall Study||4
11060119|NCT01010633|12241624|FG001|NOT COMPLETED|Overall Study||5
11060120|NCT01010750|12241636|FG000|STARTED|First Intervention||3
11060121|NCT01010750|12241637|FG001|STARTED|First Intervention||4
11060122|NCT01010750|12241638|FG002|STARTED|First Intervention||3
11060123|NCT01010750|12241639|FG003|STARTED|First Intervention||3
11060124|NCT01010750|12241640|FG004|STARTED|First Intervention||2
11060125|NCT01010750|12241641|FG005|STARTED|First Intervention||3
11060126|NCT01010750|12241636|FG000|COMPLETED|First Intervention||3
11060127|NCT01010750|12241637|FG001|COMPLETED|First Intervention||4
11060128|NCT01010750|12241638|FG002|COMPLETED|First Intervention||3
11060129|NCT01010750|12241639|FG003|COMPLETED|First Intervention||3
11060130|NCT01010750|12241640|FG004|COMPLETED|First Intervention||2
11060131|NCT01010750|12241641|FG005|COMPLETED|First Intervention||3
11060132|NCT01010750|12241636|FG000|NOT COMPLETED|First Intervention||0
11060133|NCT01010750|12241637|FG001|NOT COMPLETED|First Intervention||0
11060134|NCT01010750|12241638|FG002|NOT COMPLETED|First Intervention||0
11060135|NCT01010750|12241639|FG003|NOT COMPLETED|First Intervention||0
11060136|NCT01010750|12241640|FG004|NOT COMPLETED|First Intervention||0
11060137|NCT01010750|12241641|FG005|NOT COMPLETED|First Intervention||0
11060138|NCT01010750|12241636|FG000|STARTED|Second Intervention||3
11060139|NCT01010750|12241637|FG001|STARTED|Second Intervention||4
11060140|NCT01010750|12241638|FG002|STARTED|Second Intervention||3
11060141|NCT01010750|12241639|FG003|STARTED|Second Intervention||3
11060142|NCT01010750|12241640|FG004|STARTED|Second Intervention||2
11060143|NCT01010750|12241641|FG005|STARTED|Second Intervention||3
11060144|NCT01010750|12241636|FG000|COMPLETED|Second Intervention||3
11060145|NCT01010750|12241637|FG001|COMPLETED|Second Intervention||3
11060146|NCT01010750|12241638|FG002|COMPLETED|Second Intervention||3
11060147|NCT01010750|12241639|FG003|COMPLETED|Second Intervention||3
11060148|NCT01010750|12241640|FG004|COMPLETED|Second Intervention||2
11060149|NCT01010750|12241641|FG005|COMPLETED|Second Intervention||3
11060150|NCT01010750|12241636|FG000|NOT COMPLETED|Second Intervention||0
11060151|NCT01010750|12241637|FG001|NOT COMPLETED|Second Intervention||1
11060152|NCT01010750|12241638|FG002|NOT COMPLETED|Second Intervention||0
11060153|NCT01010750|12241639|FG003|NOT COMPLETED|Second Intervention||0
11060154|NCT01010750|12241640|FG004|NOT COMPLETED|Second Intervention||0
11060155|NCT01010750|12241641|FG005|NOT COMPLETED|Second Intervention||0
11060156|NCT01010750|12241636|FG000|STARTED|Third Intervention||3
11060157|NCT01010750|12241637|FG001|STARTED|Third Intervention||3
11060158|NCT01010750|12241638|FG002|STARTED|Third Intervention||3
11060159|NCT01010750|12241639|FG003|STARTED|Third Intervention||3
11060160|NCT01010750|12241640|FG004|STARTED|Third Intervention||2
11060161|NCT01010750|12241641|FG005|STARTED|Third Intervention||3
11060162|NCT01010750|12241636|FG000|COMPLETED|Third Intervention||3
11060163|NCT01010750|12241637|FG001|COMPLETED|Third Intervention||3
11060164|NCT01010750|12241638|FG002|COMPLETED|Third Intervention||3
11060165|NCT01010750|12241639|FG003|COMPLETED|Third Intervention||3
11060166|NCT01010750|12241640|FG004|COMPLETED|Third Intervention||2
11060167|NCT01010750|12241641|FG005|COMPLETED|Third Intervention||3
11060168|NCT01010750|12241636|FG000|NOT COMPLETED|Third Intervention||0
11060169|NCT01010750|12241637|FG001|NOT COMPLETED|Third Intervention||0
11060170|NCT01010750|12241638|FG002|NOT COMPLETED|Third Intervention||0
11060171|NCT01010750|12241639|FG003|NOT COMPLETED|Third Intervention||0
11060172|NCT01010750|12241640|FG004|NOT COMPLETED|Third Intervention||0
11060173|NCT01010750|12241641|FG005|NOT COMPLETED|Third Intervention||0
11060174|NCT01010763|12241651|FG000|STARTED|Overall Study||96
11060175|NCT01010763|12241652|FG001|STARTED|Overall Study||84
11060176|NCT01010763|12241651|FG000|COMPLETED|Overall Study||61
11060177|NCT01010763|12241652|FG001|COMPLETED|Overall Study||54
11060178|NCT01010763|12241651|FG000|NOT COMPLETED|Overall Study||35
11060179|NCT01010763|12241652|FG001|NOT COMPLETED|Overall Study||30
11060180|NCT01010776|12241658|FG000|STARTED|Main Phase||223
11060181|NCT01010776|12241658|FG000|Treated|Main Phase||218
11060182|NCT01010776|12241658|FG000|COMPLETED|Main Phase||174
11060183|NCT01010776|12241658|FG000|NOT COMPLETED|Main Phase||49
11060184|NCT01010776|12241658|FG000|STARTED|In-Between Main Phase & Extension Phase||174
11060185|NCT01010776|12241658|FG000|COMPLETED|In-Between Main Phase & Extension Phase||159
11060186|NCT01010776|12241658|FG000|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
11060187|NCT01010776|12241658|FG000|STARTED|Extension Phase||159
11060188|NCT01010776|12241658|FG000|COMPLETED|Extension Phase||156
11060189|NCT01010776|12241658|FG000|NOT COMPLETED|Extension Phase||3
11060190|NCT01010854|12241673|FG000|STARTED|Overall Study||6
11060191|NCT01010854|12241673|FG000|COMPLETED|Overall Study||6
11060192|NCT01010854|12241673|FG000|NOT COMPLETED|Overall Study||0
11060193|NCT01010867|12241677|FG000|STARTED|Overall Study||31
11060194|NCT01010867|12241677|FG000|COMPLETED|Overall Study||30
11060195|NCT01010867|12241677|FG000|NOT COMPLETED|Overall Study||1
11060196|NCT01010906|12241687|FG000|STARTED|Overall Study||10
11344529|NCT02960438|12541606|FG000|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
11344530|NCT02960438|12541607|FG001|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||3
11344531|NCT02960438|12541608|FG002|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||4
11344532|NCT02960438|12541609|FG003|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
11344533|NCT02960438|12541606|FG000|STARTED|Extension Phase (Open-label): 80 Weeks||47
11060197|NCT01010906|12241688|FG001|STARTED|Overall Study||10
11060198|NCT01010906|12241689|FG002|STARTED|Overall Study||10
11060199|NCT01010906|12241690|FG003|STARTED|Overall Study||10
11060200|NCT01010906|12241691|FG004|STARTED|Overall Study||10
11060201|NCT01010906|12241692|FG005|STARTED|Overall Study||10
11060202|NCT01010906|12241687|FG000|COMPLETED|Overall Study||10
11060203|NCT01010906|12241688|FG001|COMPLETED|Overall Study||10
11060204|NCT01010906|12241689|FG002|COMPLETED|Overall Study||10
11344534|NCT02960438|12541607|FG001|STARTED|Extension Phase (Open-label): 80 Weeks||26
11344535|NCT02960438|12541608|FG002|STARTED|Extension Phase (Open-label): 80 Weeks||50
11344536|NCT02960438|12541609|FG003|STARTED|Extension Phase (Open-label): 80 Weeks||46
11344537|NCT02960438|12541606|FG000|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
11060205|NCT01010906|12241690|FG003|COMPLETED|Overall Study||10
11060206|NCT01010906|12241691|FG004|COMPLETED|Overall Study||10
11060207|NCT01010906|12241692|FG005|COMPLETED|Overall Study||10
11060208|NCT01010906|12241687|FG000|NOT COMPLETED|Overall Study||0
11060209|NCT01010906|12241688|FG001|NOT COMPLETED|Overall Study||0
11060210|NCT01010906|12241689|FG002|NOT COMPLETED|Overall Study||0
11060211|NCT01010906|12241690|FG003|NOT COMPLETED|Overall Study||0
11060212|NCT01010906|12241691|FG004|NOT COMPLETED|Overall Study||0
11060213|NCT01010906|12241692|FG005|NOT COMPLETED|Overall Study||0
11060214|NCT01010932|12241706|FG000|STARTED|Overall Study||222
11060215|NCT01010932|12241706|FG000|COMPLETED|Overall Study||200
11060216|NCT01010932|12241706|FG000|NOT COMPLETED|Overall Study||22
11060217|NCT01010971|12241717|FG000|STARTED|Overall Study||225
11060218|NCT01010971|12241718|FG001|STARTED|Overall Study||226
11060219|NCT01010971|12241719|FG002|STARTED|Overall Study||220
11060220|NCT01010971|12241717|FG000|COMPLETED|Overall Study||222
11060221|NCT01010971|12241718|FG001|COMPLETED|Overall Study||218
11060222|NCT01010971|12241719|FG002|COMPLETED|Overall Study||207
11060223|NCT01010971|12241717|FG000|NOT COMPLETED|Overall Study||3
11060224|NCT01010971|12241718|FG001|NOT COMPLETED|Overall Study||8
11060225|NCT01010971|12241719|FG002|NOT COMPLETED|Overall Study||13
11060226|NCT01010984|12241727|FG000|STARTED|Overall Study||20
11060227|NCT01010984|12241727|FG000|COMPLETED|Overall Study||20
11060228|NCT01010984|12241727|FG000|NOT COMPLETED|Overall Study||0
11060229|NCT01011049|12241736|FG000|STARTED|Overall Study||507
11060230|NCT01011049|12241737|FG001|STARTED|Overall Study||252
11060231|NCT01011049|12241738|FG002|STARTED|Overall Study||243
11060232|NCT01011049|12241739|FG003|STARTED|Overall Study||246
11060233|NCT01011049|12241736|FG000|COMPLETED|Overall Study||506
11060234|NCT01011049|12241737|FG001|COMPLETED|Overall Study||250
11060235|NCT01011049|12241738|FG002|COMPLETED|Overall Study||239
11060236|NCT01011049|12241739|FG003|COMPLETED|Overall Study||246
11060237|NCT01011049|12241736|FG000|NOT COMPLETED|Overall Study||1
11060238|NCT01011049|12241737|FG001|NOT COMPLETED|Overall Study||2
11060239|NCT01011049|12241738|FG002|NOT COMPLETED|Overall Study||4
11060240|NCT01011049|12241739|FG003|NOT COMPLETED|Overall Study||0
11060241|NCT01011075|12241749|FG000|STARTED|Overall Study||34
11060242|NCT01011075|12241749|FG000|COMPLETED|Overall Study||34
11060243|NCT01011075|12241749|FG000|NOT COMPLETED|Overall Study||0
11060244|NCT01011153|12241756|FG000|STARTED|Overall Study||54
11060245|NCT01011153|12241757|FG001|STARTED|Overall Study||75
11060246|NCT01011153|12241758|FG002|STARTED|Overall Study||54
11060247|NCT01011153|12241756|FG000|COMPLETED|Overall Study||46
11060248|NCT01011153|12241757|FG001|COMPLETED|Overall Study||64
11060249|NCT01011153|12241758|FG002|COMPLETED|Overall Study||45
11060250|NCT01011153|12241756|FG000|NOT COMPLETED|Overall Study||8
11060251|NCT01011153|12241757|FG001|NOT COMPLETED|Overall Study||11
11060252|NCT01011153|12241758|FG002|NOT COMPLETED|Overall Study||9
11060253|NCT01011179|12241776|FG000|STARTED|Overall Study||24
11060254|NCT01011179|12241777|FG001|STARTED|Overall Study||22
11060255|NCT01011179|12241776|FG000|COMPLETED|Overall Study||20
11060256|NCT01011179|12241777|FG001|COMPLETED|Overall Study||20
11060257|NCT01011179|12241776|FG000|NOT COMPLETED|Overall Study||4
11060258|NCT01011179|12241777|FG001|NOT COMPLETED|Overall Study||2
11060259|NCT01011218|12241789|FG000|STARTED|Overall Study||9
11060260|NCT01011218|12241790|FG001|STARTED|Overall Study||9
11060261|NCT01011218|12241791|FG002|STARTED|Overall Study||26
11060262|NCT01011218|12241792|FG003|STARTED|Overall Study||26
11060263|NCT01011218|12241789|FG000|COMPLETED|Overall Study||9
11060264|NCT01011218|12241790|FG001|COMPLETED|Overall Study||9
11060265|NCT01011218|12241791|FG002|COMPLETED|Overall Study||26
11060266|NCT01011218|12241792|FG003|COMPLETED|Overall Study||26
11060267|NCT01011218|12241789|FG000|NOT COMPLETED|Overall Study||0
11060268|NCT01011218|12241790|FG001|NOT COMPLETED|Overall Study||0
11060269|NCT01011218|12241791|FG002|NOT COMPLETED|Overall Study||0
11060270|NCT01011218|12241792|FG003|NOT COMPLETED|Overall Study||0
11060271|NCT01011283|12241804|FG000|STARTED|Overall Study||13
11060272|NCT01011283|12241805|FG001|STARTED|Overall Study||13
11060273|NCT01011283|12241804|FG000|COMPLETED|Overall Study||2
11060274|NCT01011283|12241805|FG001|COMPLETED|Overall Study||2
11060275|NCT01011283|12241804|FG000|NOT COMPLETED|Overall Study||11
11060276|NCT01011283|12241805|FG001|NOT COMPLETED|Overall Study||11
11060277|NCT01011309|12241814|FG000|STARTED|Overall Study||14
11060278|NCT01011309|12241815|FG001|STARTED|Overall Study||10
11344538|NCT02960438|12541607|FG001|COMPLETED|Extension Phase (Open-label): 80 Weeks||17
11344539|NCT02960438|12541608|FG002|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
11344540|NCT02960438|12541609|FG003|COMPLETED|Extension Phase (Open-label): 80 Weeks||35
11344541|NCT02960438|12541606|FG000|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
11344542|NCT02960438|12541607|FG001|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||9
11344543|NCT02960438|12541608|FG002|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||14
11344544|NCT02960438|12541609|FG003|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
11060279|NCT01011309|12241816|FG002|STARTED|Overall Study||21
11060280|NCT01011309|12241814|FG000|COMPLETED|Overall Study||12
11060281|NCT01011309|12241815|FG001|COMPLETED|Overall Study||7
11060282|NCT01011309|12241816|FG002|COMPLETED|Overall Study||16
11060283|NCT01011309|12241814|FG000|NOT COMPLETED|Overall Study||2
11060284|NCT01011309|12241815|FG001|NOT COMPLETED|Overall Study||3
11060285|NCT01011309|12241816|FG002|NOT COMPLETED|Overall Study||5
11060286|NCT01011335|12241828|FG000|STARTED|Overall Study||11
11060287|NCT01011335|12241829|FG001|STARTED|Overall Study||12
11060288|NCT01011335|12241830|FG002|STARTED|Overall Study||12
11060289|NCT01011335|12241831|FG003|STARTED|Overall Study||12
11060290|NCT01011335|12241832|FG004|STARTED|Overall Study||13
11060291|NCT01011335|12241833|FG005|STARTED|Overall Study||12
11060292|NCT01011335|12241834|FG006|STARTED|Overall Study||12
11060293|NCT01011335|12241835|FG007|STARTED|Overall Study||12
11060294|NCT01011335|12241836|FG008|STARTED|Overall Study||12
11060295|NCT01011335|12241837|FG009|STARTED|Overall Study||12
11060296|NCT01011335|12241838|FG010|STARTED|Overall Study||12
11060297|NCT01011335|12241839|FG011|STARTED|Overall Study||22
11060298|NCT01011335|12241840|FG012|STARTED|Overall Study||22
11060299|NCT01011335|12241828|FG000|COMPLETED|Overall Study||10
11060300|NCT01011335|12241829|FG001|COMPLETED|Overall Study||11
11060301|NCT01011335|12241830|FG002|COMPLETED|Overall Study||11
11060302|NCT01011335|12241831|FG003|COMPLETED|Overall Study||10
11060303|NCT01011335|12241832|FG004|COMPLETED|Overall Study||12
11060304|NCT01011335|12241833|FG005|COMPLETED|Overall Study||11
11060305|NCT01011335|12241834|FG006|COMPLETED|Overall Study||9
11060306|NCT01011335|12241835|FG007|COMPLETED|Overall Study||10
11060307|NCT01011335|12241836|FG008|COMPLETED|Overall Study||10
11060308|NCT01011335|12241837|FG009|COMPLETED|Overall Study||12
11060309|NCT01011335|12241838|FG010|COMPLETED|Overall Study||6
11060310|NCT01011335|12241839|FG011|COMPLETED|Overall Study||21
11060311|NCT01011335|12241840|FG012|COMPLETED|Overall Study||19
11060312|NCT01011335|12241828|FG000|NOT COMPLETED|Overall Study||1
11060313|NCT01011335|12241829|FG001|NOT COMPLETED|Overall Study||1
11344545|NCT02960490|12541629|FG000|STARTED|Treatment Phase(Double-blind): 12 Weeks||34
11344546|NCT02960490|12541630|FG001|STARTED|Treatment Phase(Double-blind): 12 Weeks||32
11344547|NCT02960490|12541631|FG002|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
11344548|NCT02960490|12541632|FG003|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
11344549|NCT02960490|12541633|FG004|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
11344550|NCT02960490|12541634|FG005|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
11344551|NCT02960490|12541635|FG006|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
11344552|NCT02960490|12541636|FG007|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
11344553|NCT02960490|12541637|FG008|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
11344554|NCT02960490|12541638|FG009|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
11344555|NCT02960490|12541629|FG000|Treated|Treatment Phase(Double-blind): 12 Weeks||33
11344556|NCT02960490|12541630|FG001|Treated|Treatment Phase(Double-blind): 12 Weeks||31
11344557|NCT02960490|12541631|FG002|Treated|Treatment Phase(Double-blind): 12 Weeks||0
11344558|NCT02960490|12541632|FG003|Treated|Treatment Phase(Double-blind): 12 Weeks||0
11344559|NCT02960490|12541633|FG004|Treated|Treatment Phase(Double-blind): 12 Weeks||0
11344560|NCT02960490|12541634|FG005|Treated|Treatment Phase(Double-blind): 12 Weeks||0
11344561|NCT02960490|12541635|FG006|Treated|Treatment Phase(Double-blind): 12 Weeks||0
11344562|NCT02960490|12541636|FG007|Treated|Treatment Phase(Double-blind): 12 Weeks||0
11344563|NCT02960490|12541637|FG008|Treated|Treatment Phase(Double-blind): 12 Weeks||0
11344564|NCT02960490|12541638|FG009|Treated|Treatment Phase(Double-blind): 12 Weeks||0
11344565|NCT02960490|12541629|FG000|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||33
11344566|NCT02960490|12541630|FG001|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||31
11344567|NCT02960490|12541631|FG002|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
11344568|NCT02960490|12541632|FG003|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
11344569|NCT02960490|12541633|FG004|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
11344570|NCT02960490|12541634|FG005|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
11060314|NCT01011335|12241830|FG002|NOT COMPLETED|Overall Study||1
11060315|NCT01011335|12241831|FG003|NOT COMPLETED|Overall Study||2
11060316|NCT01011335|12241832|FG004|NOT COMPLETED|Overall Study||1
11060317|NCT01011335|12241833|FG005|NOT COMPLETED|Overall Study||1
11060318|NCT01011335|12241834|FG006|NOT COMPLETED|Overall Study||3
11060319|NCT01011335|12241835|FG007|NOT COMPLETED|Overall Study||2
11060320|NCT01011335|12241836|FG008|NOT COMPLETED|Overall Study||2
11060321|NCT01011335|12241837|FG009|NOT COMPLETED|Overall Study||0
11060322|NCT01011335|12241838|FG010|NOT COMPLETED|Overall Study||6
11060323|NCT01011335|12241839|FG011|NOT COMPLETED|Overall Study||1
11060324|NCT01011335|12241840|FG012|NOT COMPLETED|Overall Study||3
11060325|NCT01011387|12241877|FG000|STARTED|Overall Study||16
11060326|NCT01011387|12241877|FG000|COMPLETED|Overall Study||10
11060327|NCT01011387|12241877|FG000|NOT COMPLETED|Overall Study||6
11060328|NCT01011413|12241883|FG000|STARTED|Overall Study|312 randomised|312
11060329|NCT01011413|12241884|FG001|STARTED|Overall Study|324 randomised|324
11060330|NCT01011413|12241883|FG000|Did Not Start Study Drug|Overall Study||3
11060331|NCT01011413|12241884|FG001|Did Not Start Study Drug|Overall Study||3
11060332|NCT01011413|12241883|FG000|In Modified ITT|Overall Study||309
11060333|NCT01011413|12241884|FG001|In Modified ITT|Overall Study||321
11060334|NCT01011413|12241883|FG000|Died Before Week 48|Overall Study||3
11060335|NCT01011413|12241884|FG001|Died Before Week 48|Overall Study||2
11060336|NCT01011413|12241883|FG000|Lost to Follow up Before w48|Overall Study||3
11060337|NCT01011413|12241884|FG001|Lost to Follow up Before w48|Overall Study||4
11060338|NCT01011413|12241883|FG000|Withdrew Consent Before w48|Overall Study||3
11060339|NCT01011413|12241884|FG001|Withdrew Consent Before w48|Overall Study||3
11060340|NCT01011413|12241883|FG000|Attended w48 Visit|Overall Study||295
11060341|NCT01011413|12241884|FG001|Attended w48 Visit|Overall Study||311
11060342|NCT01011413|12241883|FG000|Died Between Week 48 and 96|Overall Study||2
11060343|NCT01011413|12241884|FG001|Died Between Week 48 and 96|Overall Study||3
11060344|NCT01011413|12241883|FG000|Withdrew Consent Between Week 48 and 96|Overall Study||2
11344571|NCT02960490|12541635|FG006|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
11060345|NCT01011413|12241884|FG001|Withdrew Consent Between Week 48 and 96|Overall Study||6
11060346|NCT01011413|12241883|FG000|Lost to Follow-up Between Week 48 and 96|Overall Study||10
11060347|NCT01011413|12241884|FG001|Lost to Follow-up Between Week 48 and 96|Overall Study||4
11060348|NCT01011413|12241883|FG000|COMPLETED|Overall Study||286
11060349|NCT01011413|12241884|FG001|COMPLETED|Overall Study||299
11060350|NCT01011413|12241883|FG000|NOT COMPLETED|Overall Study||26
11060351|NCT01011413|12241884|FG001|NOT COMPLETED|Overall Study||25
11060352|NCT01011439|12241897|FG000|STARTED|Overall Study||72
11060353|NCT01011439|12241897|FG000|COMPLETED|Overall Study||15
11060354|NCT01011439|12241897|FG000|NOT COMPLETED|Overall Study||57
11060355|NCT01011465|12241910|FG000|STARTED|Overall Study||36
11060356|NCT01011465|12241911|FG001|STARTED|Overall Study||20
11060357|NCT01011465|12241912|FG002|STARTED|Overall Study||36
11060358|NCT01011465|12241913|FG003|STARTED|Overall Study||18
11060359|NCT01011465|12241914|FG004|STARTED|Overall Study||47
11060360|NCT01011465|12241915|FG005|STARTED|Overall Study||29
11060361|NCT01011465|12241916|FG006|STARTED|Overall Study||52
11060362|NCT01011465|12241917|FG007|STARTED|Overall Study||32
11060363|NCT01011465|12241910|FG000|COMPLETED|Overall Study||34
11060364|NCT01011465|12241911|FG001|COMPLETED|Overall Study||19
11060365|NCT01011465|12241912|FG002|COMPLETED|Overall Study||36
11060366|NCT01011465|12241913|FG003|COMPLETED|Overall Study||18
11060367|NCT01011465|12241914|FG004|COMPLETED|Overall Study||46
11060368|NCT01011465|12241915|FG005|COMPLETED|Overall Study||29
11060369|NCT01011465|12241916|FG006|COMPLETED|Overall Study||51
11060370|NCT01011465|12241917|FG007|COMPLETED|Overall Study||32
11060371|NCT01011465|12241910|FG000|NOT COMPLETED|Overall Study||2
11060372|NCT01011465|12241911|FG001|NOT COMPLETED|Overall Study||1
11060373|NCT01011465|12241912|FG002|NOT COMPLETED|Overall Study||0
11060374|NCT01011465|12241913|FG003|NOT COMPLETED|Overall Study||0
11060375|NCT01011465|12241914|FG004|NOT COMPLETED|Overall Study||1
11060376|NCT01011465|12241915|FG005|NOT COMPLETED|Overall Study||0
11060377|NCT01011465|12241916|FG006|NOT COMPLETED|Overall Study||1
11060378|NCT01011465|12241917|FG007|NOT COMPLETED|Overall Study||0
11060379|NCT01011556|12241937|FG000|STARTED|Overall Study||58
11060380|NCT01011556|12241938|FG001|STARTED|Overall Study||56
11060381|NCT01011556|12241939|FG002|STARTED|Overall Study||55
11060382|NCT01011556|12241940|FG003|STARTED|Overall Study||64
11060383|NCT01011556|12241937|FG000|Received at Least 1 Dose of Study Drug|Overall Study||57
11060384|NCT01011556|12241938|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56
11060385|NCT01011556|12241939|FG002|Received at Least 1 Dose of Study Drug|Overall Study||54
11060386|NCT01011556|12241940|FG003|Received at Least 1 Dose of Study Drug|Overall Study||64
11060387|NCT01011556|12241937|FG000|COMPLETED|Overall Study||52
11060388|NCT01011556|12241938|FG001|COMPLETED|Overall Study||48
11060389|NCT01011556|12241939|FG002|COMPLETED|Overall Study||45
11060390|NCT01011556|12241940|FG003|COMPLETED|Overall Study||51
11060391|NCT01011556|12241937|FG000|NOT COMPLETED|Overall Study||6
11060392|NCT01011556|12241938|FG001|NOT COMPLETED|Overall Study||8
11060393|NCT01011556|12241939|FG002|NOT COMPLETED|Overall Study||10
11060394|NCT01011556|12241940|FG003|NOT COMPLETED|Overall Study||13
11060395|NCT01011673|12241955|FG000|STARTED|Randomized||62
11060396|NCT01011673|12241956|FG001|STARTED|Randomized||61
11060397|NCT01011673|12241955|FG000|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
11060398|NCT01011673|12241956|FG001|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
11060399|NCT01011673|12241955|FG000|NOT COMPLETED|Randomized||2
11060400|NCT01011673|12241956|FG001|NOT COMPLETED|Randomized||1
11060401|NCT01011673|12241955|FG000|STARTED|Emergency Department Portion||60
11060402|NCT01011673|12241956|FG001|STARTED|Emergency Department Portion||60
11060403|NCT01011673|12241955|FG000|COMPLETED|Emergency Department Portion||60
11060404|NCT01011673|12241956|FG001|COMPLETED|Emergency Department Portion||60
11060405|NCT01011673|12241955|FG000|NOT COMPLETED|Emergency Department Portion||0
11060406|NCT01011673|12241956|FG001|NOT COMPLETED|Emergency Department Portion||0
11060407|NCT01011673|12241955|FG000|STARTED|24 Hour Follow-up||60
11060408|NCT01011673|12241956|FG001|STARTED|24 Hour Follow-up||60
11060409|NCT01011673|12241955|FG000|COMPLETED|24 Hour Follow-up||57
11060410|NCT01011673|12241956|FG001|COMPLETED|24 Hour Follow-up||57
11060411|NCT01011673|12241955|FG000|NOT COMPLETED|24 Hour Follow-up||3
11060412|NCT01011673|12241956|FG001|NOT COMPLETED|24 Hour Follow-up||3
11060413|NCT01011738|12241965|FG000|STARTED|Overall Study||877
11060414|NCT01011738|12241966|FG001|STARTED|Overall Study||912
11060415|NCT01011738|12241967|FG002|STARTED|Overall Study||53
11060416|NCT01011738|12241965|FG000|COMPLETED|Overall Study||553
11060417|NCT01011738|12241966|FG001|COMPLETED|Overall Study||618
11060418|NCT01011738|12241967|FG002|COMPLETED|Overall Study||36
11060419|NCT01011738|12241965|FG000|NOT COMPLETED|Overall Study||324
11060420|NCT01011738|12241966|FG001|NOT COMPLETED|Overall Study||294
11060421|NCT01011738|12241967|FG002|NOT COMPLETED|Overall Study||17
11060422|NCT01011816|12241978|FG000|STARTED|26-Week Primary Endpoint||164
11060423|NCT01011816|12241979|FG001|STARTED|26-Week Primary Endpoint||56
11060424|NCT01011816|12241978|FG000|COMPLETED|26-Week Primary Endpoint||157
11060425|NCT01011816|12241979|FG001|COMPLETED|26-Week Primary Endpoint||54
11060426|NCT01011816|12241978|FG000|NOT COMPLETED|26-Week Primary Endpoint||7
11060427|NCT01011816|12241979|FG001|NOT COMPLETED|26-Week Primary Endpoint||2
11060428|NCT01011816|12241978|FG000|STARTED|78-Week Extended Follow-up||157
11060429|NCT01011816|12241979|FG001|STARTED|78-Week Extended Follow-up||54
11060430|NCT01011816|12241978|FG000|COMPLETED|78-Week Extended Follow-up||85
11060431|NCT01011816|12241979|FG001|COMPLETED|78-Week Extended Follow-up||26
11060432|NCT01011816|12241978|FG000|NOT COMPLETED|78-Week Extended Follow-up||72
11060433|NCT01011816|12241979|FG001|NOT COMPLETED|78-Week Extended Follow-up||28
11060434|NCT01011829|12241989|FG000|STARTED|Overall Study||10
11060435|NCT01011829|12241990|FG001|STARTED|Overall Study||10
11060436|NCT01011829|12241989|FG000|COMPLETED|Overall Study||6
11060437|NCT01011829|12241990|FG001|COMPLETED|Overall Study||1
11060438|NCT01011829|12241989|FG000|NOT COMPLETED|Overall Study||4
11060439|NCT01011829|12241990|FG001|NOT COMPLETED|Overall Study||9
11060440|NCT01011868|12241999|FG000|STARTED|After Week 18 Follow-up||170
11060441|NCT01011868|12242000|FG001|STARTED|After Week 18 Follow-up||169
11060442|NCT01011868|12242001|FG002|STARTED|After Week 18 Follow-up||155
11060443|NCT01011868|12241999|FG000|COMPLETED|After Week 18 Follow-up||147
11060444|NCT01011868|12242000|FG001|COMPLETED|After Week 18 Follow-up||153
11060445|NCT01011868|12242001|FG002|COMPLETED|After Week 18 Follow-up||129
11344572|NCT02960490|12541636|FG007|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
11344573|NCT02960490|12541637|FG008|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
11344574|NCT02960490|12541638|FG009|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
11344575|NCT02960490|12541629|FG000|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||33
11344576|NCT02960490|12541630|FG001|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||31
11344577|NCT02960490|12541631|FG002|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
11344578|NCT02960490|12541632|FG003|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
11344579|NCT02960490|12541633|FG004|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
11344580|NCT02960490|12541634|FG005|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
11344581|NCT02960490|12541635|FG006|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
11344582|NCT02960490|12541636|FG007|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
11344583|NCT02960490|12541637|FG008|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
11344584|NCT02960490|12541638|FG009|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
11344585|NCT02960490|12541629|FG000|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||29
11344586|NCT02960490|12541630|FG001|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||26
11344587|NCT02960490|12541631|FG002|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11344588|NCT02960490|12541632|FG003|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11344589|NCT02960490|12541633|FG004|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11344590|NCT02960490|12541634|FG005|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11344591|NCT02960490|12541635|FG006|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11344592|NCT02960490|12541636|FG007|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11344593|NCT02960490|12541637|FG008|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11344594|NCT02960490|12541638|FG009|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11344595|NCT02960490|12541629|FG000|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||5
11344596|NCT02960490|12541630|FG001|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||6
11344597|NCT02960490|12541631|FG002|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11344598|NCT02960490|12541632|FG003|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11344599|NCT02960490|12541633|FG004|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11060446|NCT01011868|12241999|FG000|NOT COMPLETED|After Week 18 Follow-up||23
11060447|NCT01011868|12242000|FG001|NOT COMPLETED|After Week 18 Follow-up||16
11060448|NCT01011868|12242001|FG002|NOT COMPLETED|After Week 18 Follow-up||26
11060449|NCT01011868|12241999|FG000|STARTED|After Week 78 Follow-up||170
11060450|NCT01011868|12242000|FG001|STARTED|After Week 78 Follow-up||169
11060451|NCT01011868|12242001|FG002|STARTED|After Week 78 Follow-up||155
11060452|NCT01011868|12241999|FG000|COMPLETED|After Week 78 Follow-up||118
11060453|NCT01011868|12242000|FG001|COMPLETED|After Week 78 Follow-up||131
11060454|NCT01011868|12242001|FG002|COMPLETED|After Week 78 Follow-up||111
11060455|NCT01011868|12241999|FG000|NOT COMPLETED|After Week 78 Follow-up||52
11344600|NCT02960490|12541634|FG005|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11060456|NCT01011868|12242000|FG001|NOT COMPLETED|After Week 78 Follow-up||38
11205362|NCT01858766|12396130|FG017|STARTED|Overall Study||27
11060457|NCT01011868|12242001|FG002|NOT COMPLETED|After Week 78 Follow-up||44
11060458|NCT01011894|12242009|FG000|STARTED|Overall Study||26
11060459|NCT01011894|12242009|FG000|COMPLETED|Overall Study||26
11060460|NCT01011894|12242009|FG000|NOT COMPLETED|Overall Study||0
11060461|NCT01011907|12242015|FG000|STARTED|Overall Study||31
11060462|NCT01011907|12242016|FG001|STARTED|Overall Study||33
11060463|NCT01011907|12242015|FG000|COMPLETED|Overall Study||17
11060464|NCT01011907|12242016|FG001|COMPLETED|Overall Study||18
11060465|NCT01011907|12242015|FG000|NOT COMPLETED|Overall Study||14
11060466|NCT01011907|12242016|FG001|NOT COMPLETED|Overall Study||15
11060467|NCT01011933|12242022|FG000|STARTED|Overall Study|total enrolled|54
11060468|NCT01011933|12242022|FG000|COMPLETED|Overall Study|total eligible and evaluable|50
11060469|NCT01011933|12242022|FG000|NOT COMPLETED|Overall Study||4
11060470|NCT01011946|12242032|FG000|STARTED|Overall Study||36
11060471|NCT01011946|12242032|FG000|COMPLETED|Overall Study||33
11060472|NCT01011946|12242032|FG000|NOT COMPLETED|Overall Study||3
11060473|NCT01012037|12242039|FG000|STARTED|Overall Study||44
11060474|NCT01012037|12242040|FG001|STARTED|Overall Study||223
11060475|NCT01012037|12242041|FG002|STARTED|Overall Study||224
11060476|NCT01012037|12242039|FG000|COMPLETED|Overall Study||43
11060477|NCT01012037|12242040|FG001|COMPLETED|Overall Study||207
11060478|NCT01012037|12242041|FG002|COMPLETED|Overall Study||214
11060479|NCT01012037|12242039|FG000|NOT COMPLETED|Overall Study||1
11060480|NCT01012037|12242040|FG001|NOT COMPLETED|Overall Study||16
11060481|NCT01012037|12242041|FG002|NOT COMPLETED|Overall Study||10
11060482|NCT01012089|12242051|FG000|STARTED|Overall Study||6
11060483|NCT01012089|12242051|FG000|COMPLETED|Overall Study||6
11060484|NCT01012089|12242051|FG000|NOT COMPLETED|Overall Study||0
11060485|NCT01012219|12242057|FG000|STARTED|Period 1|Number randomized|36
11060486|NCT01012219|12242057|FG000|COMPLETED|Period 1||35
11060487|NCT01012219|12242057|FG000|NOT COMPLETED|Period 1||1
11060488|NCT01012219|12242057|FG000|STARTED|Period 2|Number who completed Period 1|35
11060489|NCT01012219|12242057|FG000|COMPLETED|Period 2||34
11060490|NCT01012219|12242057|FG000|NOT COMPLETED|Period 2||1
11060491|NCT01012219|12242057|FG000|STARTED|Period 3|of the 36 who started Period 1|20
11060492|NCT01012219|12242057|FG000|COMPLETED|Period 3||20
11060493|NCT01012219|12242057|FG000|NOT COMPLETED|Period 3||0
11060494|NCT01012245|12242068|FG000|STARTED|Overall Study||28812
11060495|NCT01012245|12242068|FG000|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
11060496|NCT01012245|12242068|FG000|NOT COMPLETED|Overall Study||2427
11060497|NCT01012258|12242079|FG000|STARTED|Overall Study||66
11060498|NCT01012258|12242079|FG000|COMPLETED|Overall Study||0
11060499|NCT01012258|12242079|FG000|NOT COMPLETED|Overall Study||66
11060500|NCT01012297|12242086|FG000|STARTED|Overall Study||54
11060501|NCT01012297|12242087|FG001|STARTED|Overall Study||53
11060502|NCT01012297|12242086|FG000|COMPLETED|Overall Study||54
11060503|NCT01012297|12242087|FG001|COMPLETED|Overall Study||53
11060504|NCT01012297|12242086|FG000|NOT COMPLETED|Overall Study||0
11060505|NCT01012297|12242087|FG001|NOT COMPLETED|Overall Study||0
11060506|NCT01012323|12242093|FG000|STARTED|Overall Study||51
11060507|NCT01012323|12242093|FG000|COMPLETED|Overall Study||50
11060508|NCT01012323|12242093|FG000|NOT COMPLETED|Overall Study||1
11060509|NCT01012336|12242097|FG000|STARTED|Overall Study||85
11060510|NCT01012336|12242097|FG000|COMPLETED|Overall Study||85
11060511|NCT01012336|12242097|FG000|NOT COMPLETED|Overall Study||0
11060512|NCT01012362|12242106|FG000|STARTED|Overall Study||9
11060513|NCT01012362|12242107|FG001|STARTED|Overall Study||6
11060514|NCT01012362|12242108|FG002|STARTED|Overall Study||3
11060515|NCT01012362|12242109|FG003|STARTED|Overall Study||4
11060516|NCT01012362|12242110|FG004|STARTED|Overall Study||9
11060517|NCT01012362|12242106|FG000|COMPLETED|Overall Study||9
11060518|NCT01012362|12242107|FG001|COMPLETED|Overall Study||6
11060519|NCT01012362|12242108|FG002|COMPLETED|Overall Study||3
11060520|NCT01012362|12242109|FG003|COMPLETED|Overall Study||4
11060521|NCT01012362|12242110|FG004|COMPLETED|Overall Study||9
11060522|NCT01012362|12242106|FG000|NOT COMPLETED|Overall Study||0
11060523|NCT01012362|12242107|FG001|NOT COMPLETED|Overall Study||0
11060524|NCT01012362|12242108|FG002|NOT COMPLETED|Overall Study||0
11060525|NCT01012362|12242109|FG003|NOT COMPLETED|Overall Study||0
11060526|NCT01012362|12242110|FG004|NOT COMPLETED|Overall Study||0
11060527|NCT01012388|12242126|FG000|STARTED|Overall Study||100
11060528|NCT01012388|12242126|FG000|COMPLETED|Overall Study||100
11060529|NCT01012388|12242126|FG000|NOT COMPLETED|Overall Study||0
11060530|NCT01012440|12242130|FG000|STARTED|Overall Study||5
11060531|NCT01012440|12242130|FG000|COMPLETED|Overall Study||3
11205363|NCT01858766|12396131|FG018|STARTED|Overall Study||26
11205364|NCT01858766|12396113|FG000|COMPLETED|Overall Study||26
11205365|NCT01858766|12396114|FG001|COMPLETED|Overall Study||28
11205366|NCT01858766|12396115|FG002|COMPLETED|Overall Study||10
11205367|NCT01858766|12396116|FG003|COMPLETED|Overall Study||10
11060532|NCT01012440|12242130|FG000|NOT COMPLETED|Overall Study||2
11060533|NCT01012492|12242134|FG000|STARTED|Overall Study||10
11060534|NCT01012492|12242134|FG000|COMPLETED|Overall Study||10
11060535|NCT01012492|12242134|FG000|NOT COMPLETED|Overall Study||0
11060536|NCT01012622|12242138|FG000|STARTED|Overall Study||142
11060537|NCT01012622|12242138|FG000|COMPLETED|Overall Study||111
11060538|NCT01012622|12242138|FG000|NOT COMPLETED|Overall Study||31
11060539|NCT01012661|12242142|FG000|STARTED|Overall Study||50
11060540|NCT01012661|12242142|FG000|COMPLETED|Overall Study||50
11060541|NCT01012661|12242142|FG000|NOT COMPLETED|Overall Study||0
11060542|NCT01012674|12242148|FG000|STARTED|Overall Study||211
11060543|NCT01012674|12242148|FG000|COMPLETED|Overall Study||187
11060544|NCT01012674|12242148|FG000|NOT COMPLETED|Overall Study||24
11060545|NCT01012713|12242156|FG000|STARTED|Overall Study||30
11060546|NCT01012713|12242156|FG000|COMPLETED|Overall Study||27
11060547|NCT01012713|12242156|FG000|NOT COMPLETED|Overall Study||3
11060548|NCT01012739|12242161|FG000|STARTED|Treatment Period 1||9
11060549|NCT01012739|12242162|FG001|STARTED|Treatment Period 1||8
11060550|NCT01012739|12242163|FG002|STARTED|Treatment Period 1||9
11060551|NCT01012739|12242164|FG003|STARTED|Treatment Period 1||9
11060552|NCT01012739|12242161|FG000|COMPLETED|Treatment Period 1||9
11060553|NCT01012739|12242162|FG001|COMPLETED|Treatment Period 1||8
11060554|NCT01012739|12242163|FG002|COMPLETED|Treatment Period 1||9
11060555|NCT01012739|12242164|FG003|COMPLETED|Treatment Period 1||8
11060556|NCT01012739|12242161|FG000|NOT COMPLETED|Treatment Period 1||0
11060557|NCT01012739|12242162|FG001|NOT COMPLETED|Treatment Period 1||0
11060558|NCT01012739|12242163|FG002|NOT COMPLETED|Treatment Period 1||0
11060559|NCT01012739|12242164|FG003|NOT COMPLETED|Treatment Period 1||1
11060560|NCT01012739|12242161|FG000|STARTED|Treatment Period 2||9
11060561|NCT01012739|12242162|FG001|STARTED|Treatment Period 2||8
11060562|NCT01012739|12242163|FG002|STARTED|Treatment Period 2||9
11060563|NCT01012739|12242164|FG003|STARTED|Treatment Period 2||8
11060564|NCT01012739|12242161|FG000|COMPLETED|Treatment Period 2||9
11060565|NCT01012739|12242162|FG001|COMPLETED|Treatment Period 2||8
11060566|NCT01012739|12242163|FG002|COMPLETED|Treatment Period 2||9
11060567|NCT01012739|12242164|FG003|COMPLETED|Treatment Period 2||7
11060568|NCT01012739|12242161|FG000|NOT COMPLETED|Treatment Period 2||0
11060569|NCT01012739|12242162|FG001|NOT COMPLETED|Treatment Period 2||0
11060570|NCT01012739|12242163|FG002|NOT COMPLETED|Treatment Period 2||0
11060571|NCT01012739|12242164|FG003|NOT COMPLETED|Treatment Period 2||1
11060572|NCT01012739|12242161|FG000|STARTED|Treatment Period 3||9
11060573|NCT01012739|12242162|FG001|STARTED|Treatment Period 3||8
11060574|NCT01012739|12242163|FG002|STARTED|Treatment Period 3||9
11060575|NCT01012739|12242164|FG003|STARTED|Treatment Period 3||7
11060576|NCT01012739|12242161|FG000|COMPLETED|Treatment Period 3||9
11060577|NCT01012739|12242162|FG001|COMPLETED|Treatment Period 3||8
11060578|NCT01012739|12242163|FG002|COMPLETED|Treatment Period 3||9
11060579|NCT01012739|12242164|FG003|COMPLETED|Treatment Period 3||7
11060580|NCT01012739|12242161|FG000|NOT COMPLETED|Treatment Period 3||0
11060581|NCT01012739|12242162|FG001|NOT COMPLETED|Treatment Period 3||0
11060582|NCT01012739|12242163|FG002|NOT COMPLETED|Treatment Period 3||0
11060583|NCT01012739|12242164|FG003|NOT COMPLETED|Treatment Period 3||0
11060584|NCT01012739|12242161|FG000|STARTED|Treatment Period 4||9
11060585|NCT01012739|12242162|FG001|STARTED|Treatment Period 4||8
11060586|NCT01012739|12242163|FG002|STARTED|Treatment Period 4||9
11060587|NCT01012739|12242164|FG003|STARTED|Treatment Period 4||7
11060588|NCT01012739|12242161|FG000|COMPLETED|Treatment Period 4||9
11060589|NCT01012739|12242162|FG001|COMPLETED|Treatment Period 4||8
11060590|NCT01012739|12242163|FG002|COMPLETED|Treatment Period 4||9
11060591|NCT01012739|12242164|FG003|COMPLETED|Treatment Period 4||7
11060592|NCT01012739|12242161|FG000|NOT COMPLETED|Treatment Period 4||0
11060593|NCT01012739|12242162|FG001|NOT COMPLETED|Treatment Period 4||0
11060594|NCT01012739|12242163|FG002|NOT COMPLETED|Treatment Period 4||0
11060595|NCT01012739|12242164|FG003|NOT COMPLETED|Treatment Period 4||0
11060596|NCT01012765|12242175|FG000|STARTED|Treatment Period 1||20
11060597|NCT01012765|12242176|FG001|STARTED|Treatment Period 1||21
11060598|NCT01012765|12242177|FG002|STARTED|Treatment Period 1||23
11060599|NCT01012765|12242178|FG003|STARTED|Treatment Period 1||18
11060600|NCT01012765|12242179|FG004|STARTED|Treatment Period 1||22
11060601|NCT01012765|12242180|FG005|STARTED|Treatment Period 1||25
11060602|NCT01012765|12242175|FG000|COMPLETED|Treatment Period 1||17
11060603|NCT01012765|12242176|FG001|COMPLETED|Treatment Period 1||21
11060604|NCT01012765|12242177|FG002|COMPLETED|Treatment Period 1||21
11060605|NCT01012765|12242178|FG003|COMPLETED|Treatment Period 1||15
11060606|NCT01012765|12242179|FG004|COMPLETED|Treatment Period 1||19
11060607|NCT01012765|12242180|FG005|COMPLETED|Treatment Period 1||25
11060608|NCT01012765|12242175|FG000|NOT COMPLETED|Treatment Period 1||3
11060609|NCT01012765|12242176|FG001|NOT COMPLETED|Treatment Period 1||0
11060610|NCT01012765|12242177|FG002|NOT COMPLETED|Treatment Period 1||2
11060611|NCT01012765|12242178|FG003|NOT COMPLETED|Treatment Period 1||3
11060612|NCT01012765|12242179|FG004|NOT COMPLETED|Treatment Period 1||3
11060613|NCT01012765|12242180|FG005|NOT COMPLETED|Treatment Period 1||0
11060614|NCT01012765|12242175|FG000|STARTED|Treatment Period 2||17
11060615|NCT01012765|12242176|FG001|STARTED|Treatment Period 2||21
11060616|NCT01012765|12242177|FG002|STARTED|Treatment Period 2||21
11060617|NCT01012765|12242178|FG003|STARTED|Treatment Period 2||15
11060618|NCT01012765|12242179|FG004|STARTED|Treatment Period 2||19
11060619|NCT01012765|12242180|FG005|STARTED|Treatment Period 2||25
11060620|NCT01012765|12242175|FG000|COMPLETED|Treatment Period 2||16
11060621|NCT01012765|12242176|FG001|COMPLETED|Treatment Period 2||19
11060622|NCT01012765|12242177|FG002|COMPLETED|Treatment Period 2||18
11060623|NCT01012765|12242178|FG003|COMPLETED|Treatment Period 2||15
11060624|NCT01012765|12242179|FG004|COMPLETED|Treatment Period 2||18
11060625|NCT01012765|12242180|FG005|COMPLETED|Treatment Period 2||24
11060626|NCT01012765|12242175|FG000|NOT COMPLETED|Treatment Period 2||1
11060627|NCT01012765|12242176|FG001|NOT COMPLETED|Treatment Period 2||2
11060628|NCT01012765|12242177|FG002|NOT COMPLETED|Treatment Period 2||3
11060629|NCT01012765|12242178|FG003|NOT COMPLETED|Treatment Period 2||0
11060630|NCT01012765|12242179|FG004|NOT COMPLETED|Treatment Period 2||1
11060631|NCT01012765|12242180|FG005|NOT COMPLETED|Treatment Period 2||1
11060632|NCT01012765|12242175|FG000|STARTED|Treatment Period 3||16
11060633|NCT01012765|12242176|FG001|STARTED|Treatment Period 3||19
11060634|NCT01012765|12242177|FG002|STARTED|Treatment Period 3||18
11060635|NCT01012765|12242178|FG003|STARTED|Treatment Period 3||15
11060636|NCT01012765|12242179|FG004|STARTED|Treatment Period 3||18
11060637|NCT01012765|12242180|FG005|STARTED|Treatment Period 3||24
11060638|NCT01012765|12242175|FG000|COMPLETED|Treatment Period 3||16
11344601|NCT02960490|12541635|FG006|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11344602|NCT02960490|12541636|FG007|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11344603|NCT02960490|12541637|FG008|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11344604|NCT02960490|12541638|FG009|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
11344605|NCT02960490|12541629|FG000|STARTED|Re-randomized Participants: 12 Weeks||0
11344606|NCT02960490|12541630|FG001|STARTED|Re-randomized Participants: 12 Weeks||0
11344607|NCT02960490|12541631|FG002|STARTED|Re-randomized Participants: 12 Weeks||15
11344608|NCT02960490|12541632|FG003|STARTED|Re-randomized Participants: 12 Weeks||14
11344609|NCT02960490|12541633|FG004|STARTED|Re-randomized Participants: 12 Weeks||14
11344610|NCT02960490|12541634|FG005|STARTED|Re-randomized Participants: 12 Weeks||12
11344611|NCT02960490|12541635|FG006|STARTED|Re-randomized Participants: 12 Weeks||0
11344612|NCT02960490|12541636|FG007|STARTED|Re-randomized Participants: 12 Weeks||0
11344613|NCT02960490|12541637|FG008|STARTED|Re-randomized Participants: 12 Weeks||0
11344614|NCT02960490|12541638|FG009|STARTED|Re-randomized Participants: 12 Weeks||0
11344615|NCT02960490|12541629|FG000|Treated|Re-randomized Participants: 12 Weeks||0
11344616|NCT02960490|12541630|FG001|Treated|Re-randomized Participants: 12 Weeks||0
11344617|NCT02960490|12541631|FG002|Treated|Re-randomized Participants: 12 Weeks||15
11344618|NCT02960490|12541632|FG003|Treated|Re-randomized Participants: 12 Weeks||14
11344619|NCT02960490|12541633|FG004|Treated|Re-randomized Participants: 12 Weeks||14
11344620|NCT02960490|12541634|FG005|Treated|Re-randomized Participants: 12 Weeks||12
11344621|NCT02960490|12541635|FG006|Treated|Re-randomized Participants: 12 Weeks||0
11344622|NCT02960490|12541636|FG007|Treated|Re-randomized Participants: 12 Weeks||0
11344623|NCT02960490|12541637|FG008|Treated|Re-randomized Participants: 12 Weeks||0
11344624|NCT02960490|12541638|FG009|Treated|Re-randomized Participants: 12 Weeks||0
11344625|NCT02960490|12541629|FG000|FAS|Re-randomized Participants: 12 Weeks||0
11344626|NCT02960490|12541630|FG001|FAS|Re-randomized Participants: 12 Weeks||0
11344627|NCT02960490|12541631|FG002|FAS|Re-randomized Participants: 12 Weeks||15
11344628|NCT02960490|12541632|FG003|FAS|Re-randomized Participants: 12 Weeks||14
11060639|NCT01012765|12242176|FG001|COMPLETED|Treatment Period 3||19
11060640|NCT01012765|12242177|FG002|COMPLETED|Treatment Period 3||18
11060641|NCT01012765|12242178|FG003|COMPLETED|Treatment Period 3||15
11060642|NCT01012765|12242179|FG004|COMPLETED|Treatment Period 3||18
11060643|NCT01012765|12242180|FG005|COMPLETED|Treatment Period 3||24
11060644|NCT01012765|12242175|FG000|NOT COMPLETED|Treatment Period 3||0
11060645|NCT01012765|12242176|FG001|NOT COMPLETED|Treatment Period 3||0
11060646|NCT01012765|12242177|FG002|NOT COMPLETED|Treatment Period 3||0
11060647|NCT01012765|12242178|FG003|NOT COMPLETED|Treatment Period 3||0
11060648|NCT01012765|12242179|FG004|NOT COMPLETED|Treatment Period 3||0
11060649|NCT01012765|12242180|FG005|NOT COMPLETED|Treatment Period 3||0
11060650|NCT01012921|12242190|FG000|STARTED|Overall Study||57
11060651|NCT01012921|12242191|FG001|STARTED|Overall Study||60
11060652|NCT01012921|12242190|FG000|COMPLETED|Overall Study||47
11060653|NCT01012921|12242191|FG001|COMPLETED|Overall Study||47
11344629|NCT02960490|12541633|FG004|FAS|Re-randomized Participants: 12 Weeks||14
11344630|NCT02960490|12541634|FG005|FAS|Re-randomized Participants: 12 Weeks||12
11344631|NCT02960490|12541635|FG006|FAS|Re-randomized Participants: 12 Weeks||0
11344632|NCT02960490|12541636|FG007|FAS|Re-randomized Participants: 12 Weeks||0
11344633|NCT02960490|12541637|FG008|FAS|Re-randomized Participants: 12 Weeks||0
11344634|NCT02960490|12541638|FG009|FAS|Re-randomized Participants: 12 Weeks||0
11344635|NCT02960490|12541629|FG000|SAS|Re-randomized Participants: 12 Weeks||0
11344636|NCT02960490|12541630|FG001|SAS|Re-randomized Participants: 12 Weeks||0
11344637|NCT02960490|12541631|FG002|SAS|Re-randomized Participants: 12 Weeks||15
11060654|NCT01012921|12242190|FG000|NOT COMPLETED|Overall Study||10
11060655|NCT01012921|12242191|FG001|NOT COMPLETED|Overall Study||13
11060656|NCT01012947|12242202|FG000|STARTED|Overall Study||212
11060657|NCT01012947|12242203|FG001|STARTED|Overall Study||215
11060658|NCT01012947|12242204|FG002|STARTED|Overall Study||241
11060659|NCT01012947|12242205|FG003|STARTED|Overall Study||211
11060660|NCT01012947|12242206|FG004|STARTED|Overall Study||236
11060661|NCT01012947|12242202|FG000|COMPLETED|Overall Study||81
11060662|NCT01012947|12242203|FG001|COMPLETED|Overall Study||80
11060663|NCT01012947|12242204|FG002|COMPLETED|Overall Study||111
11060664|NCT01012947|12242205|FG003|COMPLETED|Overall Study||93
11060665|NCT01012947|12242206|FG004|COMPLETED|Overall Study||94
11060666|NCT01012947|12242202|FG000|NOT COMPLETED|Overall Study||131
11060667|NCT01012947|12242203|FG001|NOT COMPLETED|Overall Study||135
11060668|NCT01012947|12242204|FG002|NOT COMPLETED|Overall Study||130
11060669|NCT01012947|12242205|FG003|NOT COMPLETED|Overall Study||118
11060670|NCT01012947|12242206|FG004|NOT COMPLETED|Overall Study||142
11060671|NCT01012973|12242220|FG000|STARTED|Overall Study||106
11060672|NCT01012973|12242221|FG001|STARTED|Overall Study||71
11060673|NCT01012973|12242220|FG000|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
11060674|NCT01012973|12242221|FG001|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
11060675|NCT01012973|12242220|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
11060676|NCT01012973|12242221|FG001|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
11060677|NCT01012973|12242220|FG000|Completed Week 24, From FAS|Overall Study||97
11060678|NCT01012973|12242221|FG001|Completed Week 24, From FAS|Overall Study||57
11060679|NCT01012973|12242220|FG000|Completed Week 52, From FAS|Overall Study||91
11060680|NCT01012973|12242221|FG001|Completed Week 52, From FAS|Overall Study||52
11060681|NCT01012973|12242220|FG000|COMPLETED|Overall Study||90
11060682|NCT01012973|12242221|FG001|COMPLETED|Overall Study||52
11060683|NCT01012973|12242220|FG000|NOT COMPLETED|Overall Study||16
11060684|NCT01012973|12242221|FG001|NOT COMPLETED|Overall Study||19
11205368|NCT01858766|12396117|FG004|COMPLETED|Overall Study||26
11205369|NCT01858766|12396118|FG005|COMPLETED|Overall Study||24
11205370|NCT01858766|12396119|FG006|COMPLETED|Overall Study||7
11205371|NCT01858766|12396120|FG007|COMPLETED|Overall Study||5
11205372|NCT01858766|12396121|FG008|COMPLETED|Overall Study||1
11205373|NCT01858766|12396122|FG009|COMPLETED|Overall Study||4
11205374|NCT01858766|12396123|FG010|COMPLETED|Overall Study||5
11205375|NCT01858766|12396124|FG011|COMPLETED|Overall Study||25
11205376|NCT01858766|12396125|FG012|COMPLETED|Overall Study||25
11205377|NCT01858766|12396126|FG013|COMPLETED|Overall Study||26
11205378|NCT01858766|12396127|FG014|COMPLETED|Overall Study||23
11205379|NCT01858766|12396128|FG015|COMPLETED|Overall Study||20
11205380|NCT01858766|12396129|FG016|COMPLETED|Overall Study||22
11205381|NCT01858766|12396130|FG017|COMPLETED|Overall Study||23
11205382|NCT01858766|12396131|FG018|COMPLETED|Overall Study||22
11205383|NCT01858766|12396113|FG000|NOT COMPLETED|Overall Study||1
11205384|NCT01858766|12396114|FG001|NOT COMPLETED|Overall Study||0
11205385|NCT01858766|12396115|FG002|NOT COMPLETED|Overall Study||1
11205386|NCT01858766|12396116|FG003|NOT COMPLETED|Overall Study||0
11205387|NCT01858766|12396117|FG004|NOT COMPLETED|Overall Study||1
11205388|NCT01858766|12396118|FG005|NOT COMPLETED|Overall Study||4
11205389|NCT01858766|12396119|FG006|NOT COMPLETED|Overall Study||0
11205390|NCT01858766|12396120|FG007|NOT COMPLETED|Overall Study||2
11205391|NCT01858766|12396121|FG008|NOT COMPLETED|Overall Study||0
11205392|NCT01858766|12396122|FG009|NOT COMPLETED|Overall Study||0
11205393|NCT01858766|12396123|FG010|NOT COMPLETED|Overall Study||0
11205394|NCT01858766|12396124|FG011|NOT COMPLETED|Overall Study||5
11205395|NCT01858766|12396125|FG012|NOT COMPLETED|Overall Study||5
11205396|NCT01858766|12396126|FG013|NOT COMPLETED|Overall Study||3
11205397|NCT01858766|12396127|FG014|NOT COMPLETED|Overall Study||8
11205398|NCT01858766|12396128|FG015|NOT COMPLETED|Overall Study||6
11205399|NCT01858766|12396129|FG016|NOT COMPLETED|Overall Study||3
11205400|NCT01858766|12396130|FG017|NOT COMPLETED|Overall Study||4
11205401|NCT01858766|12396131|FG018|NOT COMPLETED|Overall Study||4
11205402|NCT01859013|12396166|FG000|STARTED|Overall Study||16
11205403|NCT01859013|12396167|FG001|STARTED|Overall Study||14
11205404|NCT01859013|12396166|FG000|COMPLETED|Overall Study||12
11205405|NCT01859013|12396167|FG001|COMPLETED|Overall Study||9
11205406|NCT01859013|12396166|FG000|NOT COMPLETED|Overall Study||4
11205407|NCT01859013|12396167|FG001|NOT COMPLETED|Overall Study||5
11205408|NCT01859078|12396173|FG000|STARTED|Overall Study||28
11205409|NCT01859078|12396173|FG000|COMPLETED|Overall Study||28
11205410|NCT01859078|12396173|FG000|NOT COMPLETED|Overall Study||0
11205411|NCT01859143|12396181|FG000|STARTED|Overall Study||240
11060685|NCT01012999|12242231|FG000|STARTED|Overall Study||16
11060686|NCT01012999|12242231|FG000|COMPLETED|Overall Study||15
11060687|NCT01012999|12242231|FG000|NOT COMPLETED|Overall Study||1
11060688|NCT01013194|12242237|FG000|STARTED|Overall Study||9
11060689|NCT01013194|12242238|FG001|STARTED|Overall Study||16
11060690|NCT01013194|12242237|FG000|COMPLETED|Overall Study|Consecutive patients|9
11060691|NCT01013194|12242238|FG001|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
11060692|NCT01013194|12242237|FG000|NOT COMPLETED|Overall Study||0
11060693|NCT01013194|12242238|FG001|NOT COMPLETED|Overall Study||0
11060694|NCT01013207|12242248|FG000|STARTED|CPAP Pre Nexus (S9)||50
11060695|NCT01013207|12242248|FG000|COMPLETED|CPAP Pre Nexus (S9)||50
11060696|NCT01013207|12242248|FG000|NOT COMPLETED|CPAP Pre Nexus (S9)||0
11060697|NCT01013207|12242248|FG000|STARTED|Nexus (S9)||50
11060698|NCT01013207|12242248|FG000|COMPLETED|Nexus (S9)||50
11060699|NCT01013207|12242248|FG000|NOT COMPLETED|Nexus (S9)||0
11060700|NCT01013207|12242248|FG000|STARTED|CPAP Post Nexus (S9)||50
11060701|NCT01013207|12242248|FG000|COMPLETED|CPAP Post Nexus (S9)||44
11060702|NCT01013207|12242248|FG000|NOT COMPLETED|CPAP Post Nexus (S9)||6
11060703|NCT01013285|12242254|FG000|STARTED|Overall Study||70
11060704|NCT01013285|12242255|FG001|STARTED|Overall Study||110
11060705|NCT01013285|12242254|FG000|COMPLETED|Overall Study||22
11060706|NCT01013285|12242255|FG001|COMPLETED|Overall Study||21
11060707|NCT01013285|12242254|FG000|NOT COMPLETED|Overall Study||48
11060708|NCT01013285|12242255|FG001|NOT COMPLETED|Overall Study||89
11060709|NCT01013350|12242262|FG000|STARTED|Overall Study||198
11060710|NCT01013350|12242263|FG001|STARTED|Overall Study||963
11060711|NCT01013350|12242262|FG000|Safety Analysis Set|Overall Study||198
11060712|NCT01013350|12242263|FG001|Safety Analysis Set|Overall Study||950
11060713|NCT01013350|12242262|FG000|COMPLETED|Overall Study||160
11060714|NCT01013350|12242263|FG001|COMPLETED|Overall Study||771
11060715|NCT01013350|12242262|FG000|NOT COMPLETED|Overall Study||38
11060716|NCT01013350|12242263|FG001|NOT COMPLETED|Overall Study||192
11060717|NCT01013597|12242270|FG000|STARTED|Overall Study||13
11060718|NCT01013597|12242270|FG000|COMPLETED|Overall Study||12
11060719|NCT01013597|12242270|FG000|NOT COMPLETED|Overall Study||1
11060720|NCT01013740|12242276|FG000|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
11060721|NCT01013740|12242277|FG001|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
11060722|NCT01013740|12242276|FG000|Ongoing|Overall Study||0
11060723|NCT01013740|12242277|FG001|Ongoing|Overall Study||0
11060724|NCT01013740|12242276|FG000|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
11060725|NCT01013740|12242277|FG001|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
11060726|NCT01013740|12242276|FG000|NOT COMPLETED|Overall Study||11
11060727|NCT01013740|12242277|FG001|NOT COMPLETED|Overall Study||19
11060728|NCT01013753|12242285|FG000|STARTED|Overall Study|Entered and treated|198
11060729|NCT01013753|12242285|FG000|Received Placebo|Overall Study||125
11060730|NCT01013753|12242285|FG000|Received Olo 2 mcg qd|Overall Study||121
11060731|NCT01013753|12242285|FG000|Received Olo 5 mcg qd|Overall Study||130
11060732|NCT01013753|12242285|FG000|Received Olo 10 mcg qd|Overall Study||127
11060733|NCT01013753|12242285|FG000|Received Olo 20 mcg qd|Overall Study||124
11060734|NCT01013753|12242285|FG000|Received Form 12 mcg Bid|Overall Study||125
11060735|NCT01013753|12242285|FG000|COMPLETED|Overall Study||182
11060736|NCT01013753|12242285|FG000|NOT COMPLETED|Overall Study||16
11060737|NCT01013792|12242301|FG000|STARTED|Overall Study||14
11060738|NCT01013792|12242302|FG001|STARTED|Overall Study||16
11060739|NCT01013792|12242301|FG000|COMPLETED|Overall Study||12
11060740|NCT01013792|12242302|FG001|COMPLETED|Overall Study||11
11060741|NCT01013792|12242301|FG000|NOT COMPLETED|Overall Study||2
11060742|NCT01013792|12242302|FG001|NOT COMPLETED|Overall Study||5
11060743|NCT01013844|12242310|FG000|STARTED|Overall Study||65
11060744|NCT01013844|12242311|FG001|STARTED|Overall Study||65
11060745|NCT01013844|12242310|FG000|COMPLETED|Overall Study||65
11060746|NCT01013844|12242311|FG001|COMPLETED|Overall Study||65
11060747|NCT01013844|12242310|FG000|NOT COMPLETED|Overall Study||0
11060748|NCT01013844|12242311|FG001|NOT COMPLETED|Overall Study||0
11060749|NCT01013870|12242323|FG000|STARTED|Overall Study||28
11060750|NCT01013870|12242324|FG001|STARTED|Overall Study||24
11060751|NCT01013870|12242323|FG000|COMPLETED|Overall Study||27
11060752|NCT01013870|12242324|FG001|COMPLETED|Overall Study||21
11060753|NCT01013870|12242323|FG000|NOT COMPLETED|Overall Study||1
11060754|NCT01013870|12242324|FG001|NOT COMPLETED|Overall Study||3
11060755|NCT01013883|12242332|FG000|STARTED|Overall Study||270
11060756|NCT01013883|12242333|FG001|STARTED|Overall Study||243
11060757|NCT01013883|12242332|FG000|COMPLETED|Overall Study||268
11060758|NCT01013883|12242333|FG001|COMPLETED|Overall Study||241
11060759|NCT01013883|12242332|FG000|NOT COMPLETED|Overall Study||2
11060760|NCT01013883|12242333|FG001|NOT COMPLETED|Overall Study||2
11060761|NCT01013961|12242341|FG000|STARTED|Overall Study||16
11205412|NCT01859143|12396182|FG001|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
11205413|NCT01859143|12396181|FG000|COMPLETED|Overall Study||238
11205414|NCT01859143|12396182|FG001|COMPLETED|Overall Study||60
11205415|NCT01859143|12396181|FG000|NOT COMPLETED|Overall Study||2
11205416|NCT01859143|12396182|FG001|NOT COMPLETED|Overall Study||0
11205417|NCT01859195|12396191|FG000|STARTED|Overall Study||24
11205418|NCT01859195|12396192|FG001|STARTED|Overall Study||12
11205419|NCT01859195|12396191|FG000|COMPLETED|Overall Study||24
11205420|NCT01859195|12396192|FG001|COMPLETED|Overall Study||12
11060762|NCT01013961|12242342|FG001|STARTED|Overall Study||15
11205421|NCT01859195|12396191|FG000|NOT COMPLETED|Overall Study||0
11205422|NCT01859195|12396192|FG001|NOT COMPLETED|Overall Study||0
11205423|NCT01859247|12396208|FG000|STARTED|Overall Study||1
11205424|NCT01859247|12396209|FG001|STARTED|Overall Study||1
11205425|NCT01859247|12396210|FG002|STARTED|Overall Study||1
11205426|NCT01859247|12396211|FG003|STARTED|Overall Study||1
11205427|NCT01859247|12396212|FG004|STARTED|Overall Study||1
11205428|NCT01859247|12396213|FG005|STARTED|Overall Study||1
11205429|NCT01859247|12396214|FG006|STARTED|Overall Study||1
11205430|NCT01859247|12396215|FG007|STARTED|Overall Study||1
11205431|NCT01859247|12396208|FG000|COMPLETED|Overall Study||1
11060763|NCT01013961|12242341|FG000|COMPLETED|Overall Study||13
11060764|NCT01013961|12242342|FG001|COMPLETED|Overall Study||12
11060765|NCT01013961|12242341|FG000|NOT COMPLETED|Overall Study||3
11060766|NCT01013961|12242342|FG001|NOT COMPLETED|Overall Study||3
11060767|NCT01014013|12242350|FG000|STARTED|Overall Study||135
11060768|NCT01014013|12242351|FG001|STARTED|Overall Study||136
11060769|NCT01014013|12242350|FG000|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
11060770|NCT01014013|12242351|FG001|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
11060771|NCT01014013|12242350|FG000|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
11060772|NCT01014013|12242351|FG001|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
11060773|NCT01014013|12242350|FG000|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
11060774|NCT01014013|12242351|FG001|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
11060775|NCT01014013|12242350|FG000|NOT COMPLETED|Overall Study||51
11060776|NCT01014013|12242351|FG001|NOT COMPLETED|Overall Study||56
11060777|NCT01014091|12242365|FG000|STARTED|Overall Study||7
11060778|NCT01014091|12242366|FG001|STARTED|Overall Study||13
11060779|NCT01014091|12242367|FG002|STARTED|Overall Study||5
11060780|NCT01014091|12242368|FG003|STARTED|Overall Study||15
11205432|NCT01859247|12396209|FG001|COMPLETED|Overall Study||1
11205433|NCT01859247|12396210|FG002|COMPLETED|Overall Study||1
11205434|NCT01859247|12396211|FG003|COMPLETED|Overall Study||1
11344638|NCT02960490|12541632|FG003|SAS|Re-randomized Participants: 12 Weeks||14
11344639|NCT02960490|12541633|FG004|SAS|Re-randomized Participants: 12 Weeks||14
11344640|NCT02960490|12541634|FG005|SAS|Re-randomized Participants: 12 Weeks||12
11344641|NCT02960490|12541635|FG006|SAS|Re-randomized Participants: 12 Weeks||0
11344642|NCT02960490|12541636|FG007|SAS|Re-randomized Participants: 12 Weeks||0
11344643|NCT02960490|12541637|FG008|SAS|Re-randomized Participants: 12 Weeks||0
11344644|NCT02960490|12541638|FG009|SAS|Re-randomized Participants: 12 Weeks||0
11344645|NCT02960490|12541629|FG000|COMPLETED|Re-randomized Participants: 12 Weeks||0
11344646|NCT02960490|12541630|FG001|COMPLETED|Re-randomized Participants: 12 Weeks||0
11344647|NCT02960490|12541631|FG002|COMPLETED|Re-randomized Participants: 12 Weeks||13
11344648|NCT02960490|12541632|FG003|COMPLETED|Re-randomized Participants: 12 Weeks||12
11344649|NCT02960490|12541633|FG004|COMPLETED|Re-randomized Participants: 12 Weeks||13
11344650|NCT02960490|12541634|FG005|COMPLETED|Re-randomized Participants: 12 Weeks||10
11344651|NCT02960490|12541635|FG006|COMPLETED|Re-randomized Participants: 12 Weeks||0
11344652|NCT02960490|12541636|FG007|COMPLETED|Re-randomized Participants: 12 Weeks||0
11344653|NCT02960490|12541637|FG008|COMPLETED|Re-randomized Participants: 12 Weeks||0
11344654|NCT02960490|12541638|FG009|COMPLETED|Re-randomized Participants: 12 Weeks||0
11344655|NCT02960490|12541629|FG000|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
11344656|NCT02960490|12541630|FG001|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
11344657|NCT02960490|12541631|FG002|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
11344658|NCT02960490|12541632|FG003|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
11344659|NCT02960490|12541633|FG004|NOT COMPLETED|Re-randomized Participants: 12 Weeks||1
11344660|NCT02960490|12541634|FG005|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
11344661|NCT02960490|12541635|FG006|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
11344662|NCT02960490|12541636|FG007|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
11344663|NCT02960490|12541637|FG008|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
11344664|NCT02960490|12541638|FG009|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
11344665|NCT02960490|12541629|FG000|STARTED|Extension Phase(Open-label): 80 Weeks||0
11344666|NCT02960490|12541630|FG001|STARTED|Extension Phase(Open-label): 80 Weeks||0
11344667|NCT02960490|12541631|FG002|STARTED|Extension Phase(Open-label): 80 Weeks||0
11344668|NCT02960490|12541632|FG003|STARTED|Extension Phase(Open-label): 80 Weeks||0
11344669|NCT02960490|12541633|FG004|STARTED|Extension Phase(Open-label): 80 Weeks||0
11344670|NCT02960490|12541634|FG005|STARTED|Extension Phase(Open-label): 80 Weeks||0
11344671|NCT02960490|12541635|FG006|STARTED|Extension Phase(Open-label): 80 Weeks||13
11344672|NCT02960490|12541636|FG007|STARTED|Extension Phase(Open-label): 80 Weeks|One Participant who completed Core Treatment Phase (Placebo Then E6011 400 mg arm) had inadequate therapeutic effect at Week 24, hence did not started Extension phase.|11
11344673|NCT02960490|12541637|FG008|STARTED|Extension Phase(Open-label): 80 Weeks||13
11344674|NCT02960490|12541638|FG009|STARTED|Extension Phase(Open-label): 80 Weeks||10
11344675|NCT02960490|12541629|FG000|Treated|Extension Phase(Open-label): 80 Weeks||0
11344676|NCT02960490|12541630|FG001|Treated|Extension Phase(Open-label): 80 Weeks||0
11344677|NCT02960490|12541631|FG002|Treated|Extension Phase(Open-label): 80 Weeks||0
11344678|NCT02960490|12541632|FG003|Treated|Extension Phase(Open-label): 80 Weeks||0
11344679|NCT02960490|12541633|FG004|Treated|Extension Phase(Open-label): 80 Weeks||0
11060781|NCT01014091|12242369|FG004|STARTED|Overall Study||6
11060782|NCT01014091|12242370|FG005|STARTED|Overall Study||12
11060783|NCT01014091|12242365|FG000|COMPLETED|Overall Study||7
11060784|NCT01014091|12242366|FG001|COMPLETED|Overall Study||13
11060785|NCT01014091|12242367|FG002|COMPLETED|Overall Study||5
11060786|NCT01014091|12242368|FG003|COMPLETED|Overall Study||15
11060787|NCT01014091|12242369|FG004|COMPLETED|Overall Study||6
11060788|NCT01014091|12242370|FG005|COMPLETED|Overall Study||12
11060789|NCT01014091|12242365|FG000|NOT COMPLETED|Overall Study||0
11060790|NCT01014091|12242366|FG001|NOT COMPLETED|Overall Study||0
11060791|NCT01014091|12242367|FG002|NOT COMPLETED|Overall Study||0
11060792|NCT01014091|12242368|FG003|NOT COMPLETED|Overall Study||0
11060793|NCT01014091|12242369|FG004|NOT COMPLETED|Overall Study||0
11060794|NCT01014091|12242370|FG005|NOT COMPLETED|Overall Study||0
11060795|NCT01014143|12242396|FG000|STARTED|First Intervention||10
11060796|NCT01014143|12242397|FG001|STARTED|First Intervention||9
11060797|NCT01014143|12242398|FG002|STARTED|First Intervention||9
11060798|NCT01014143|12242396|FG000|COMPLETED|First Intervention||10
11060799|NCT01014143|12242397|FG001|COMPLETED|First Intervention||9
11060800|NCT01014143|12242398|FG002|COMPLETED|First Intervention||9
11060801|NCT01014143|12242396|FG000|NOT COMPLETED|First Intervention||0
11060802|NCT01014143|12242397|FG001|NOT COMPLETED|First Intervention||0
11060803|NCT01014143|12242398|FG002|NOT COMPLETED|First Intervention||0
11060804|NCT01014143|12242396|FG000|STARTED|Washout Period After 1st Intervention||10
11060805|NCT01014143|12242397|FG001|STARTED|Washout Period After 1st Intervention||9
11060806|NCT01014143|12242398|FG002|STARTED|Washout Period After 1st Intervention||9
11060807|NCT01014143|12242396|FG000|COMPLETED|Washout Period After 1st Intervention||10
11060808|NCT01014143|12242397|FG001|COMPLETED|Washout Period After 1st Intervention||9
11060809|NCT01014143|12242398|FG002|COMPLETED|Washout Period After 1st Intervention||9
11060810|NCT01014143|12242396|FG000|NOT COMPLETED|Washout Period After 1st Intervention||0
11060811|NCT01014143|12242397|FG001|NOT COMPLETED|Washout Period After 1st Intervention||0
11060812|NCT01014143|12242398|FG002|NOT COMPLETED|Washout Period After 1st Intervention||0
11060813|NCT01014143|12242396|FG000|STARTED|Second Intervention||10
11060814|NCT01014143|12242397|FG001|STARTED|Second Intervention||9
11060815|NCT01014143|12242398|FG002|STARTED|Second Intervention||9
11060816|NCT01014143|12242396|FG000|COMPLETED|Second Intervention||8
11060817|NCT01014143|12242397|FG001|COMPLETED|Second Intervention||9
11060818|NCT01014143|12242398|FG002|COMPLETED|Second Intervention||9
11060819|NCT01014143|12242396|FG000|NOT COMPLETED|Second Intervention||2
11060820|NCT01014143|12242397|FG001|NOT COMPLETED|Second Intervention||0
11060821|NCT01014143|12242398|FG002|NOT COMPLETED|Second Intervention||0
11060822|NCT01014143|12242396|FG000|STARTED|Washout After 2nd Intervention||8
11060823|NCT01014143|12242397|FG001|STARTED|Washout After 2nd Intervention||9
11060824|NCT01014143|12242398|FG002|STARTED|Washout After 2nd Intervention||9
11060825|NCT01014143|12242396|FG000|COMPLETED|Washout After 2nd Intervention||8
11060826|NCT01014143|12242397|FG001|COMPLETED|Washout After 2nd Intervention||9
11060827|NCT01014143|12242398|FG002|COMPLETED|Washout After 2nd Intervention||9
11060828|NCT01014143|12242396|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
11060829|NCT01014143|12242397|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
11060830|NCT01014143|12242398|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
11060831|NCT01014143|12242396|FG000|STARTED|Third Intervention||8
11060832|NCT01014143|12242397|FG001|STARTED|Third Intervention||9
11060833|NCT01014143|12242398|FG002|STARTED|Third Intervention||9
11060834|NCT01014143|12242396|FG000|COMPLETED|Third Intervention||8
11060835|NCT01014143|12242397|FG001|COMPLETED|Third Intervention||9
11060836|NCT01014143|12242398|FG002|COMPLETED|Third Intervention||9
11060837|NCT01014143|12242396|FG000|NOT COMPLETED|Third Intervention||0
11060838|NCT01014143|12242397|FG001|NOT COMPLETED|Third Intervention||0
11060839|NCT01014143|12242398|FG002|NOT COMPLETED|Third Intervention||0
11060840|NCT01014169|12242408|FG000|STARTED|Overall Study||65
11060841|NCT01014169|12242409|FG001|STARTED|Overall Study||61
11060842|NCT01014169|12242408|FG000|COMPLETED|Overall Study||58
11205435|NCT01859247|12396212|FG004|COMPLETED|Overall Study||1
11060843|NCT01014169|12242409|FG001|COMPLETED|Overall Study||48
11060844|NCT01014169|12242408|FG000|NOT COMPLETED|Overall Study||7
11060845|NCT01014169|12242409|FG001|NOT COMPLETED|Overall Study||13
11060846|NCT01014208|12242417|FG000|STARTED|Overall Study||225
11060847|NCT01014208|12242418|FG001|STARTED|Overall Study||222
11060848|NCT01014208|12242417|FG000|Intent-to-Treat Population|Overall Study||223
11060849|NCT01014208|12242418|FG001|Intent-to-Treat Population|Overall Study||222
11060850|NCT01014208|12242417|FG000|COMPLETED|Overall Study||131
11060851|NCT01014208|12242418|FG001|COMPLETED|Overall Study||122
11060852|NCT01014208|12242417|FG000|NOT COMPLETED|Overall Study||94
11060853|NCT01014208|12242418|FG001|NOT COMPLETED|Overall Study||100
11060854|NCT01014351|12242424|FG000|STARTED|Overall Study||70
11060855|NCT01014351|12242424|FG000|COMPLETED|Overall Study||33
11344680|NCT02960490|12541634|FG005|Treated|Extension Phase(Open-label): 80 Weeks||0
11344681|NCT02960490|12541635|FG006|Treated|Extension Phase(Open-label): 80 Weeks||13
11344682|NCT02960490|12541636|FG007|Treated|Extension Phase(Open-label): 80 Weeks||11
11344683|NCT02960490|12541637|FG008|Treated|Extension Phase(Open-label): 80 Weeks||13
11344684|NCT02960490|12541638|FG009|Treated|Extension Phase(Open-label): 80 Weeks||10
11344685|NCT02960490|12541629|FG000|FAS|Extension Phase(Open-label): 80 Weeks||0
11060856|NCT01014351|12242424|FG000|NOT COMPLETED|Overall Study||37
11060857|NCT01014390|12242428|FG000|STARTED|Overall Study||187
11060858|NCT01014390|12242428|FG000|COMPLETED|Overall Study||177
11060859|NCT01014390|12242428|FG000|NOT COMPLETED|Overall Study||10
11060860|NCT01014403|12242434|FG000|STARTED|Overall Study||34
11060861|NCT01014403|12242435|FG001|STARTED|Overall Study||28
11060862|NCT01014403|12242434|FG000|COMPLETED|Overall Study||34
11060863|NCT01014403|12242435|FG001|COMPLETED|Overall Study||28
11060864|NCT01014403|12242434|FG000|NOT COMPLETED|Overall Study||0
11060865|NCT01014403|12242435|FG001|NOT COMPLETED|Overall Study||0
11060866|NCT01014442|12242443|FG000|STARTED|Overall Study||33
11060867|NCT01014442|12242444|FG001|STARTED|Overall Study||35
11060868|NCT01014442|12242443|FG000|COMPLETED|Overall Study||26
11060869|NCT01014442|12242444|FG001|COMPLETED|Overall Study||16
11060870|NCT01014442|12242443|FG000|NOT COMPLETED|Overall Study||7
11060871|NCT01014442|12242444|FG001|NOT COMPLETED|Overall Study||19
11060872|NCT01014455|12242456|FG000|STARTED|Overall Study||82
11060873|NCT01014455|12242457|FG001|STARTED|Overall Study||87
11060874|NCT01014455|12242456|FG000|COMPLETED|Overall Study||82
11060875|NCT01014455|12242457|FG001|COMPLETED|Overall Study||87
11060876|NCT01014455|12242456|FG000|NOT COMPLETED|Overall Study||0
11060877|NCT01014455|12242457|FG001|NOT COMPLETED|Overall Study||0
11060878|NCT01014533|12242465|FG000|STARTED|Overall Study||29
11060879|NCT01014533|12242466|FG001|STARTED|Overall Study||30
11060880|NCT01014533|12242465|FG000|COMPLETED|Overall Study||24
11060881|NCT01014533|12242466|FG001|COMPLETED|Overall Study||25
11060882|NCT01014533|12242465|FG000|NOT COMPLETED|Overall Study||5
11060883|NCT01014533|12242466|FG001|NOT COMPLETED|Overall Study||5
11060884|NCT01014585|12242477|FG000|STARTED|Overall Study||51
11060885|NCT01014585|12242478|FG001|STARTED|Overall Study||100
11060886|NCT01014585|12242479|FG002|STARTED|Overall Study||60
11060887|NCT01014585|12242480|FG003|STARTED|Overall Study||129
11060888|NCT01014585|12242477|FG000|COMPLETED|Overall Study||31
11060889|NCT01014585|12242478|FG001|COMPLETED|Overall Study||75
11060890|NCT01014585|12242479|FG002|COMPLETED|Overall Study||37
11060891|NCT01014585|12242480|FG003|COMPLETED|Overall Study||99
11060892|NCT01014585|12242477|FG000|NOT COMPLETED|Overall Study||20
11060893|NCT01014585|12242478|FG001|NOT COMPLETED|Overall Study||25
11060894|NCT01014585|12242479|FG002|NOT COMPLETED|Overall Study||23
11060895|NCT01014585|12242480|FG003|NOT COMPLETED|Overall Study||30
11060896|NCT01014624|12242492|FG000|STARTED|Overall Study||29
11060897|NCT01014624|12242493|FG001|STARTED|Overall Study||27
11060898|NCT01014624|12242492|FG000|COMPLETED|Overall Study||27
11060899|NCT01014624|12242493|FG001|COMPLETED|Overall Study||26
11060900|NCT01014624|12242492|FG000|NOT COMPLETED|Overall Study||2
11060901|NCT01014624|12242493|FG001|NOT COMPLETED|Overall Study||1
11060902|NCT01014689|12242503|FG000|STARTED|Overall Study||191
11060903|NCT01014689|12242504|FG001|STARTED|Overall Study||187
11060904|NCT01014689|12242503|FG000|COMPLETED|Overall Study||178
11060905|NCT01014689|12242504|FG001|COMPLETED|Overall Study||174
11060906|NCT01014689|12242503|FG000|NOT COMPLETED|Overall Study||13
11060907|NCT01014689|12242504|FG001|NOT COMPLETED|Overall Study||13
11060908|NCT01014728|12242512|FG000|STARTED|Overall Study||18
11060909|NCT01014728|12242513|FG001|STARTED|Overall Study||15
11060910|NCT01014728|12242512|FG000|COMPLETED|Overall Study||18
11060911|NCT01014728|12242513|FG001|COMPLETED|Overall Study||15
11060912|NCT01014728|12242512|FG000|NOT COMPLETED|Overall Study||0
11060913|NCT01014728|12242513|FG001|NOT COMPLETED|Overall Study||0
11060914|NCT01014741|12242521|FG000|STARTED|Overall Study||105
11060915|NCT01014741|12242522|FG001|STARTED|Overall Study||95
11060916|NCT01014741|12242521|FG000|COMPLETED|Overall Study||94
11060917|NCT01014741|12242522|FG001|COMPLETED|Overall Study||90
11060918|NCT01014741|12242521|FG000|NOT COMPLETED|Overall Study||11
11060919|NCT01014741|12242522|FG001|NOT COMPLETED|Overall Study||5
11060920|NCT01014871|12242528|FG000|STARTED|Overall Study||30
11060921|NCT01014871|12242528|FG000|COMPLETED|Overall Study||30
11060922|NCT01014871|12242528|FG000|NOT COMPLETED|Overall Study||0
11060923|NCT01014910|12242536|FG000|STARTED|Overall Study||80
11060924|NCT01014910|12242537|FG001|STARTED|Overall Study||81
11060925|NCT01014910|12242536|FG000|COMPLETED|Overall Study||80
11060926|NCT01014910|12242537|FG001|COMPLETED|Overall Study||79
11060927|NCT01014910|12242536|FG000|NOT COMPLETED|Overall Study||0
11060928|NCT01014910|12242537|FG001|NOT COMPLETED|Overall Study||2
11060929|NCT01014975|12242543|FG000|STARTED|Overall Study||8
11060930|NCT01014975|12242544|FG001|STARTED|Overall Study||16
11060931|NCT01014975|12242545|FG002|STARTED|Overall Study||16
11060932|NCT01014975|12242543|FG000|COMPLETED|Overall Study||4
11060933|NCT01014975|12242544|FG001|COMPLETED|Overall Study||13
11060934|NCT01014975|12242545|FG002|COMPLETED|Overall Study||10
11060935|NCT01014975|12242543|FG000|NOT COMPLETED|Overall Study||4
11060936|NCT01014975|12242544|FG001|NOT COMPLETED|Overall Study||3
11060937|NCT01014975|12242545|FG002|NOT COMPLETED|Overall Study||6
11060938|NCT01014988|12242559|FG000|STARTED|Overall Study||130
11060939|NCT01014988|12242560|FG001|STARTED|Overall Study||7
11060940|NCT01014988|12242561|FG002|STARTED|Overall Study||11
11060941|NCT01014988|12242562|FG003|STARTED|Overall Study||12
11060942|NCT01014988|12242563|FG004|STARTED|Overall Study||27
11060943|NCT01014988|12242564|FG005|STARTED|Overall Study||14
11060944|NCT01014988|12242559|FG000|COMPLETED|Overall Study||107
11060945|NCT01014988|12242560|FG001|COMPLETED|Overall Study||7
11060946|NCT01014988|12242561|FG002|COMPLETED|Overall Study||9
11060947|NCT01014988|12242562|FG003|COMPLETED|Overall Study||12
11060948|NCT01014988|12242563|FG004|COMPLETED|Overall Study||26
11060949|NCT01014988|12242564|FG005|COMPLETED|Overall Study||11
11060950|NCT01014988|12242559|FG000|NOT COMPLETED|Overall Study||23
11060951|NCT01014988|12242560|FG001|NOT COMPLETED|Overall Study||0
11060952|NCT01014988|12242561|FG002|NOT COMPLETED|Overall Study||2
11060953|NCT01014988|12242562|FG003|NOT COMPLETED|Overall Study||0
11060954|NCT01014988|12242563|FG004|NOT COMPLETED|Overall Study||1
11060955|NCT01014988|12242564|FG005|NOT COMPLETED|Overall Study||3
11060956|NCT01015118|12242588|FG000|STARTED|Overall Study||911
11060957|NCT01015118|12242589|FG001|STARTED|Overall Study||455
11060958|NCT01015118|12242588|FG000|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
11060959|NCT01015118|12242589|FG001|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
11060960|NCT01015118|12242588|FG000|NOT COMPLETED|Overall Study||669
11060961|NCT01015118|12242589|FG001|NOT COMPLETED|Overall Study||327
11060962|NCT01015131|12242595|FG000|STARTED|Overall Study||44
11060963|NCT01015131|12242595|FG000|COMPLETED|Overall Study||36
11060964|NCT01015131|12242595|FG000|NOT COMPLETED|Overall Study||8
11060965|NCT01015170|12242599|FG000|STARTED|Overall Study||454
11060966|NCT01015170|12242599|FG000|COMPLETED|Overall Study||215
11060967|NCT01015170|12242599|FG000|NOT COMPLETED|Overall Study||239
11060968|NCT01015287|12242607|FG000|STARTED|Overall Study||1996
11060969|NCT01015287|12242608|FG001|STARTED|Overall Study||2037
11060970|NCT01015287|12242607|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1996
11060971|NCT01015287|12242608|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2037
11060972|NCT01015287|12242607|FG000|COMPLETED|Overall Study||1924
11060973|NCT01015287|12242608|FG001|COMPLETED|Overall Study||1958
11060974|NCT01015287|12242607|FG000|NOT COMPLETED|Overall Study||72
11060975|NCT01015287|12242608|FG001|NOT COMPLETED|Overall Study||79
11060976|NCT01015326|12242618|FG000|STARTED|Overall Study||12
11060977|NCT01015326|12242619|FG001|STARTED|Overall Study||20
11060978|NCT01015326|12242618|FG000|COMPLETED|Overall Study||11
11060979|NCT01015326|12242619|FG001|COMPLETED|Overall Study||18
11060980|NCT01015326|12242618|FG000|NOT COMPLETED|Overall Study||1
11060981|NCT01015326|12242619|FG001|NOT COMPLETED|Overall Study||2
11060982|NCT01015443|12242627|FG000|STARTED|Overall Study||191
11060983|NCT01015443|12242628|FG001|STARTED|Overall Study||94
11060984|NCT01015443|12242627|FG000|Treated|Overall Study||191
11060985|NCT01015443|12242628|FG001|Treated|Overall Study||93
11060986|NCT01015443|12242627|FG000|COMPLETED|Overall Study||191
11060987|NCT01015443|12242628|FG001|COMPLETED|Overall Study||94
11060988|NCT01015443|12242627|FG000|NOT COMPLETED|Overall Study||0
11060989|NCT01015443|12242628|FG001|NOT COMPLETED|Overall Study||0
11060990|NCT01015534|12242636|FG000|STARTED|Overall Study||28
11060991|NCT01015534|12242637|FG001|STARTED|Overall Study||27
11060992|NCT01015534|12242636|FG000|COMPLETED|Overall Study||27
11060993|NCT01015534|12242637|FG001|COMPLETED|Overall Study||27
11060994|NCT01015534|12242636|FG000|NOT COMPLETED|Overall Study||1
11060995|NCT01015534|12242637|FG001|NOT COMPLETED|Overall Study||0
11060996|NCT01015560|12242646|FG000|STARTED|Overall Study||44
11060997|NCT01015560|12242646|FG000|Eligible and Analyzable|Overall Study||43
11060998|NCT01015560|12242646|FG000|COMPLETED|Overall Study||41
11060999|NCT01015560|12242646|FG000|NOT COMPLETED|Overall Study||3
11061000|NCT01015586|12242652|FG000|STARTED|Overall Study||21
11061001|NCT01015586|12242653|FG001|STARTED|Overall Study||22
11061002|NCT01015586|12242652|FG000|COMPLETED|Overall Study||14
11061003|NCT01015586|12242653|FG001|COMPLETED|Overall Study||11
11061004|NCT01015586|12242652|FG000|NOT COMPLETED|Overall Study||7
11061005|NCT01015586|12242653|FG001|NOT COMPLETED|Overall Study||11
11061006|NCT01015612|12242659|FG000|STARTED|Overall Study||634
11061007|NCT01015612|12242659|FG000|COMPLETED|Overall Study||481
11061008|NCT01015612|12242659|FG000|NOT COMPLETED|Overall Study||153
11061009|NCT01015638|12242665|FG000|STARTED|Overall Study||17
11061010|NCT01015638|12242666|FG001|STARTED|Overall Study||19
11061011|NCT01015638|12242665|FG000|COMPLETED|Overall Study||16
11061012|NCT01015638|12242666|FG001|COMPLETED|Overall Study||19
11061013|NCT01015638|12242665|FG000|NOT COMPLETED|Overall Study||1
11061014|NCT01015638|12242666|FG001|NOT COMPLETED|Overall Study||0
11061015|NCT01015677|12242675|FG000|STARTED|Overall Study||34
11061016|NCT01015677|12242676|FG001|STARTED|Overall Study||32
11061017|NCT01015677|12242677|FG002|STARTED|Overall Study||33
11061018|NCT01015677|12242675|FG000|COMPLETED|Overall Study||33
11061019|NCT01015677|12242676|FG001|COMPLETED|Overall Study||28
11061020|NCT01015677|12242677|FG002|COMPLETED|Overall Study||33
11061021|NCT01015677|12242675|FG000|NOT COMPLETED|Overall Study||1
11061022|NCT01015677|12242676|FG001|NOT COMPLETED|Overall Study||4
11061023|NCT01015677|12242677|FG002|NOT COMPLETED|Overall Study||0
11061024|NCT01015703|12242690|FG000|STARTED|Overall Study||10
11061025|NCT01015703|12242691|FG001|STARTED|Overall Study||10
11061026|NCT01015703|12242692|FG002|STARTED|Overall Study||10
11061027|NCT01015703|12242693|FG003|STARTED|Overall Study||10
11061028|NCT01015703|12242694|FG004|STARTED|Overall Study||10
11061029|NCT01015703|12242690|FG000|COMPLETED|Overall Study||8
11061030|NCT01015703|12242691|FG001|COMPLETED|Overall Study||9
11061031|NCT01015703|12242692|FG002|COMPLETED|Overall Study||10
11061032|NCT01015703|12242693|FG003|COMPLETED|Overall Study||10
11061033|NCT01015703|12242694|FG004|COMPLETED|Overall Study||10
11061034|NCT01015703|12242690|FG000|NOT COMPLETED|Overall Study||2
11061035|NCT01015703|12242691|FG001|NOT COMPLETED|Overall Study||1
11061036|NCT01015703|12242692|FG002|NOT COMPLETED|Overall Study||0
11061037|NCT01015703|12242693|FG003|NOT COMPLETED|Overall Study||0
11061038|NCT01015703|12242694|FG004|NOT COMPLETED|Overall Study||0
11061039|NCT01015768|12242706|FG000|STARTED|Overall Study||30
11061040|NCT01015768|12242707|FG001|STARTED|Overall Study||30
11061041|NCT01015768|12242706|FG000|COMPLETED|Overall Study||26
11061042|NCT01015768|12242707|FG001|COMPLETED|Overall Study||26
11061043|NCT01015768|12242706|FG000|NOT COMPLETED|Overall Study||4
11061044|NCT01015768|12242707|FG001|NOT COMPLETED|Overall Study||4
11061045|NCT01015781|12242717|FG000|STARTED|Overall Study||150
11061046|NCT01015781|12242718|FG001|STARTED|Overall Study||150
11061047|NCT01015781|12242717|FG000|COMPLETED|Overall Study||113
11061048|NCT01015781|12242718|FG001|COMPLETED|Overall Study||121
11061049|NCT01015781|12242717|FG000|NOT COMPLETED|Overall Study||37
11061050|NCT01015781|12242718|FG001|NOT COMPLETED|Overall Study||29
11061051|NCT01015807|12242727|FG000|STARTED|Overall Study||30
11061052|NCT01015807|12242728|FG001|STARTED|Overall Study||30
11061053|NCT01015807|12242729|FG002|STARTED|Overall Study||30
11061054|NCT01015807|12242727|FG000|COMPLETED|Overall Study||30
11061055|NCT01015807|12242728|FG001|COMPLETED|Overall Study||30
11061056|NCT01015807|12242729|FG002|COMPLETED|Overall Study||30
11061057|NCT01015807|12242727|FG000|NOT COMPLETED|Overall Study||0
11061058|NCT01015807|12242728|FG001|NOT COMPLETED|Overall Study||0
11061059|NCT01015807|12242729|FG002|NOT COMPLETED|Overall Study||0
11061060|NCT01015820|12242739|FG000|STARTED|Overall Study||15
11061061|NCT01015820|12242740|FG001|STARTED|Overall Study||15
11061062|NCT01015820|12242739|FG000|COMPLETED|Overall Study||14
11061063|NCT01015820|12242740|FG001|COMPLETED|Overall Study||15
11061064|NCT01015820|12242739|FG000|NOT COMPLETED|Overall Study||1
11061065|NCT01015820|12242740|FG001|NOT COMPLETED|Overall Study||0
11061066|NCT01015976|12242746|FG000|STARTED|Overall Study||5
11061067|NCT01015976|12242747|FG001|STARTED|Overall Study||5
11061068|NCT01015976|12242746|FG000|COMPLETED|Overall Study||5
11061069|NCT01015976|12242747|FG001|COMPLETED|Overall Study||5
11061070|NCT01015976|12242746|FG000|NOT COMPLETED|Overall Study||0
11061071|NCT01015976|12242747|FG001|NOT COMPLETED|Overall Study||0
11061072|NCT01016015|12242751|FG000|STARTED|Overall Study||178
11061073|NCT01016015|12242751|FG000|COMPLETED|Overall Study||159
11061074|NCT01016015|12242751|FG000|NOT COMPLETED|Overall Study||19
11061075|NCT01016067|12242757|FG000|STARTED|Overall Study||11
11061076|NCT01016067|12242758|FG001|STARTED|Overall Study||12
11061077|NCT01016067|12242757|FG000|COMPLETED|Overall Study||9
11061078|NCT01016067|12242758|FG001|COMPLETED|Overall Study||8
11061079|NCT01016067|12242757|FG000|NOT COMPLETED|Overall Study||2
11061080|NCT01016067|12242758|FG001|NOT COMPLETED|Overall Study||4
11061081|NCT01016106|12242766|FG000|STARTED|Overall Study||17
11061082|NCT01016106|12242767|FG001|STARTED|Overall Study||18
11061083|NCT01016106|12242766|FG000|COMPLETED|Overall Study||17
11061084|NCT01016106|12242767|FG001|COMPLETED|Overall Study||18
11061085|NCT01016106|12242766|FG000|NOT COMPLETED|Overall Study||0
11061086|NCT01016106|12242767|FG001|NOT COMPLETED|Overall Study||0
11061087|NCT01016132|12242773|FG000|STARTED|Overall Study||152
11061088|NCT01016132|12242773|FG000|COMPLETED|Overall Study||151
11061089|NCT01016132|12242773|FG000|NOT COMPLETED|Overall Study||1
11061090|NCT01016262|12242780|FG000|STARTED|Double-blind Phase||41
11061091|NCT01016262|12242781|FG001|STARTED|Double-blind Phase||39
11061092|NCT01016262|12242782|FG002|STARTED|Double-blind Phase||39
11061093|NCT01016262|12242783|FG003|STARTED|Double-blind Phase||0
11061094|NCT01016262|12242784|FG004|STARTED|Double-blind Phase||0
11061095|NCT01016262|12242785|FG005|STARTED|Double-blind Phase||0
11061096|NCT01016262|12242780|FG000|COMPLETED|Double-blind Phase||40
11061097|NCT01016262|12242781|FG001|COMPLETED|Double-blind Phase||38
11061098|NCT01016262|12242782|FG002|COMPLETED|Double-blind Phase||30
11061099|NCT01016262|12242783|FG003|COMPLETED|Double-blind Phase||0
11061100|NCT01016262|12242784|FG004|COMPLETED|Double-blind Phase||0
11061101|NCT01016262|12242785|FG005|COMPLETED|Double-blind Phase||0
11061102|NCT01016262|12242780|FG000|NOT COMPLETED|Double-blind Phase||1
11061103|NCT01016262|12242781|FG001|NOT COMPLETED|Double-blind Phase||1
11061104|NCT01016262|12242782|FG002|NOT COMPLETED|Double-blind Phase||9
11061105|NCT01016262|12242783|FG003|NOT COMPLETED|Double-blind Phase||0
11061106|NCT01016262|12242784|FG004|NOT COMPLETED|Double-blind Phase||0
11061107|NCT01016262|12242785|FG005|NOT COMPLETED|Double-blind Phase||0
11061108|NCT01016262|12242780|FG000|STARTED|Open-Label Phase||0
11061109|NCT01016262|12242781|FG001|STARTED|Open-Label Phase||0
11061110|NCT01016262|12242782|FG002|STARTED|Open-Label Phase||0
11061111|NCT01016262|12242783|FG003|STARTED|Open-Label Phase||44
11061112|NCT01016262|12242784|FG004|STARTED|Open-Label Phase||52
11061113|NCT01016262|12242785|FG005|STARTED|Open-Label Phase||20
11061114|NCT01016262|12242780|FG000|COMPLETED|Open-Label Phase||0
11061115|NCT01016262|12242781|FG001|COMPLETED|Open-Label Phase||0
11061116|NCT01016262|12242782|FG002|COMPLETED|Open-Label Phase||0
11061117|NCT01016262|12242783|FG003|COMPLETED|Open-Label Phase||42
11061118|NCT01016262|12242784|FG004|COMPLETED|Open-Label Phase||50
11061119|NCT01016262|12242785|FG005|COMPLETED|Open-Label Phase||20
11061120|NCT01016262|12242780|FG000|NOT COMPLETED|Open-Label Phase||0
11061121|NCT01016262|12242781|FG001|NOT COMPLETED|Open-Label Phase||0
11061122|NCT01016262|12242782|FG002|NOT COMPLETED|Open-Label Phase||0
11061123|NCT01016262|12242783|FG003|NOT COMPLETED|Open-Label Phase||2
11061124|NCT01016262|12242784|FG004|NOT COMPLETED|Open-Label Phase||2
11061125|NCT01016262|12242785|FG005|NOT COMPLETED|Open-Label Phase||0
11061126|NCT01016483|12242800|FG000|STARTED|Safety Run-in Part||27
11061127|NCT01016483|12242801|FG001|STARTED|Safety Run-in Part||26
11061128|NCT01016483|12242802|FG002|STARTED|Safety Run-in Part||0
11061129|NCT01016483|12242803|FG003|STARTED|Safety Run-in Part||0
11061130|NCT01016483|12242800|FG000|COMPLETED|Safety Run-in Part||27
11061131|NCT01016483|12242801|FG001|COMPLETED|Safety Run-in Part||26
11061132|NCT01016483|12242802|FG002|COMPLETED|Safety Run-in Part||0
11061133|NCT01016483|12242803|FG003|COMPLETED|Safety Run-in Part||0
11061134|NCT01016483|12242800|FG000|NOT COMPLETED|Safety Run-in Part||0
11061135|NCT01016483|12242801|FG001|NOT COMPLETED|Safety Run-in Part||0
11061136|NCT01016483|12242802|FG002|NOT COMPLETED|Safety Run-in Part||0
11061137|NCT01016483|12242803|FG003|NOT COMPLETED|Safety Run-in Part||0
11061138|NCT01016483|12242800|FG000|STARTED|Phase II||0
11061139|NCT01016483|12242801|FG001|STARTED|Phase II||0
11061140|NCT01016483|12242802|FG002|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
11061141|NCT01016483|12242803|FG003|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
11061142|NCT01016483|12242800|FG000|Treated (Safety Analysis Set [SAF])|Phase II||0
11061143|NCT01016483|12242801|FG001|Treated (Safety Analysis Set [SAF])|Phase II||0
11061144|NCT01016483|12242802|FG002|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
11061145|NCT01016483|12242803|FG003|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
11061146|NCT01016483|12242800|FG000|COMPLETED|Phase II||0
11061147|NCT01016483|12242801|FG001|COMPLETED|Phase II||0
11061148|NCT01016483|12242802|FG002|COMPLETED|Phase II||44
11061149|NCT01016483|12242803|FG003|COMPLETED|Phase II||44
11061150|NCT01016483|12242800|FG000|NOT COMPLETED|Phase II||0
11061151|NCT01016483|12242801|FG001|NOT COMPLETED|Phase II||0
11061152|NCT01016483|12242802|FG002|NOT COMPLETED|Phase II||0
11061153|NCT01016483|12242803|FG003|NOT COMPLETED|Phase II||0
11061154|NCT01016600|12242845|FG000|STARTED|Overall Study||9
11061155|NCT01016600|12242846|FG001|STARTED|Overall Study||4
11061156|NCT01016600|12242847|FG002|STARTED|Overall Study||6
11061157|NCT01016600|12242848|FG003|STARTED|Overall Study||12
11061158|NCT01016600|12242845|FG000|COMPLETED|Overall Study||8
11061159|NCT01016600|12242846|FG001|COMPLETED|Overall Study||4
11061160|NCT01016600|12242847|FG002|COMPLETED|Overall Study||6
11061161|NCT01016600|12242848|FG003|COMPLETED|Overall Study||12
11061162|NCT01016600|12242845|FG000|NOT COMPLETED|Overall Study||1
11061163|NCT01016600|12242846|FG001|NOT COMPLETED|Overall Study||0
11061164|NCT01016600|12242847|FG002|NOT COMPLETED|Overall Study||0
11061165|NCT01016600|12242848|FG003|NOT COMPLETED|Overall Study||0
11061166|NCT01016652|12242861|FG000|STARTED|Period 1||25
11061167|NCT01016652|12242862|FG001|STARTED|Period 1||24
11061168|NCT01016652|12242861|FG000|COMPLETED|Period 1||25
11061169|NCT01016652|12242862|FG001|COMPLETED|Period 1||24
11061170|NCT01016652|12242861|FG000|NOT COMPLETED|Period 1||0
11061171|NCT01016652|12242862|FG001|NOT COMPLETED|Period 1||0
11061172|NCT01016652|12242861|FG000|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
11061173|NCT01016652|12242862|FG001|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
11061174|NCT01016652|12242861|FG000|COMPLETED|Period 2||25
11061175|NCT01016652|12242862|FG001|COMPLETED|Period 2||24
11061176|NCT01016652|12242861|FG000|NOT COMPLETED|Period 2||0
11061177|NCT01016652|12242862|FG001|NOT COMPLETED|Period 2||0
11061178|NCT01016678|12242870|FG000|STARTED|Overall Study||20
11061179|NCT01016678|12242871|FG001|STARTED|Overall Study||17
11061180|NCT01016678|12242872|FG002|STARTED|Overall Study||19
11061181|NCT01016678|12242873|FG003|STARTED|Overall Study||19
11061182|NCT01016678|12242874|FG004|STARTED|Overall Study||19
11061183|NCT01016678|12242870|FG000|COMPLETED|Overall Study||18
11061184|NCT01016678|12242871|FG001|COMPLETED|Overall Study||14
11061185|NCT01016678|12242872|FG002|COMPLETED|Overall Study||15
11061186|NCT01016678|12242873|FG003|COMPLETED|Overall Study||19
11061187|NCT01016678|12242874|FG004|COMPLETED|Overall Study||13
11061188|NCT01016678|12242870|FG000|NOT COMPLETED|Overall Study||2
11061189|NCT01016678|12242871|FG001|NOT COMPLETED|Overall Study||3
11061190|NCT01016678|12242872|FG002|NOT COMPLETED|Overall Study||4
11061191|NCT01016678|12242873|FG003|NOT COMPLETED|Overall Study||0
11061192|NCT01016678|12242874|FG004|NOT COMPLETED|Overall Study||6
11061193|NCT01016691|12242895|FG000|STARTED|Overall Study||17
11061194|NCT01016691|12242896|FG001|STARTED|Overall Study||12
11061195|NCT01016691|12242897|FG002|STARTED|Overall Study||18
11061196|NCT01016691|12242895|FG000|COMPLETED|Overall Study||17
11061197|NCT01016691|12242896|FG001|COMPLETED|Overall Study||12
11061198|NCT01016691|12242897|FG002|COMPLETED|Overall Study||18
11061199|NCT01016691|12242895|FG000|NOT COMPLETED|Overall Study||0
11061200|NCT01016691|12242896|FG001|NOT COMPLETED|Overall Study||0
11061201|NCT01016691|12242897|FG002|NOT COMPLETED|Overall Study||0
11061202|NCT01016769|12242909|FG000|STARTED|Overall Study||4
11061203|NCT01016769|12242910|FG001|STARTED|Overall Study||7
11344686|NCT02960490|12541630|FG001|FAS|Extension Phase(Open-label): 80 Weeks||0
11344687|NCT02960490|12541631|FG002|FAS|Extension Phase(Open-label): 80 Weeks||0
11344688|NCT02960490|12541632|FG003|FAS|Extension Phase(Open-label): 80 Weeks||0
11344689|NCT02960490|12541633|FG004|FAS|Extension Phase(Open-label): 80 Weeks||0
11061204|NCT01016769|12242911|FG002|STARTED|Overall Study||7
11061205|NCT01016769|12242912|FG003|STARTED|Overall Study||30
11344690|NCT02960490|12541634|FG005|FAS|Extension Phase(Open-label): 80 Weeks||0
11344691|NCT02960490|12541635|FG006|FAS|Extension Phase(Open-label): 80 Weeks||13
11061206|NCT01016769|12242909|FG000|COMPLETED|Overall Study||3
11061207|NCT01016769|12242910|FG001|COMPLETED|Overall Study||6
11061208|NCT01016769|12242911|FG002|COMPLETED|Overall Study||6
11061209|NCT01016769|12242912|FG003|COMPLETED|Overall Study||30
11061210|NCT01016769|12242909|FG000|NOT COMPLETED|Overall Study||1
11061211|NCT01016769|12242910|FG001|NOT COMPLETED|Overall Study||1
11061212|NCT01016769|12242911|FG002|NOT COMPLETED|Overall Study||1
11061213|NCT01016769|12242912|FG003|NOT COMPLETED|Overall Study||0
11061214|NCT01016834|12242921|FG000|STARTED|Overall Study||242
11061215|NCT01016834|12242921|FG000|COMPLETED|Overall Study||220
11061216|NCT01016834|12242921|FG000|NOT COMPLETED|Overall Study||22
11061217|NCT01016873|12242928|FG000|STARTED|12 Months||75
11061218|NCT01016873|12242929|FG001|STARTED|12 Months||75
11061219|NCT01016873|12242930|FG002|STARTED|12 Months||80
11061220|NCT01016873|12242928|FG000|COMPLETED|12 Months||74
11061221|NCT01016873|12242929|FG001|COMPLETED|12 Months||72
11061222|NCT01016873|12242930|FG002|COMPLETED|12 Months||79
11061223|NCT01016873|12242928|FG000|NOT COMPLETED|12 Months||1
11061224|NCT01016873|12242929|FG001|NOT COMPLETED|12 Months||3
11061225|NCT01016873|12242930|FG002|NOT COMPLETED|12 Months||1
11061226|NCT01016873|12242928|FG000|STARTED|24 Months||74
11061227|NCT01016873|12242929|FG001|STARTED|24 Months||72
11061228|NCT01016873|12242930|FG002|STARTED|24 Months||79
11061229|NCT01016873|12242928|FG000|COMPLETED|24 Months||69
11061230|NCT01016873|12242929|FG001|COMPLETED|24 Months||68
11061231|NCT01016873|12242930|FG002|COMPLETED|24 Months||73
11061232|NCT01016873|12242928|FG000|NOT COMPLETED|24 Months||5
11061233|NCT01016873|12242929|FG001|NOT COMPLETED|24 Months||4
11061234|NCT01016873|12242930|FG002|NOT COMPLETED|24 Months||6
11061235|NCT01016873|12242928|FG000|STARTED|36 Months||69
11061236|NCT01016873|12242929|FG001|STARTED|36 Months||68
11061237|NCT01016873|12242930|FG002|STARTED|36 Months||73
11344692|NCT02960490|12541636|FG007|FAS|Extension Phase(Open-label): 80 Weeks||11
11344693|NCT02960490|12541637|FG008|FAS|Extension Phase(Open-label): 80 Weeks||13
11344694|NCT02960490|12541638|FG009|FAS|Extension Phase(Open-label): 80 Weeks||10
11344695|NCT02960490|12541629|FG000|SAS|Extension Phase(Open-label): 80 Weeks||0
11344696|NCT02960490|12541630|FG001|SAS|Extension Phase(Open-label): 80 Weeks||0
11344697|NCT02960490|12541631|FG002|SAS|Extension Phase(Open-label): 80 Weeks||0
11344698|NCT02960490|12541632|FG003|SAS|Extension Phase(Open-label): 80 Weeks||0
11344699|NCT02960490|12541633|FG004|SAS|Extension Phase(Open-label): 80 Weeks||0
11344700|NCT02960490|12541634|FG005|SAS|Extension Phase(Open-label): 80 Weeks||0
11344701|NCT02960490|12541635|FG006|SAS|Extension Phase(Open-label): 80 Weeks||13
11344702|NCT02960490|12541636|FG007|SAS|Extension Phase(Open-label): 80 Weeks||11
11344703|NCT02960490|12541637|FG008|SAS|Extension Phase(Open-label): 80 Weeks||13
11344704|NCT02960490|12541638|FG009|SAS|Extension Phase(Open-label): 80 Weeks||10
11344705|NCT02960490|12541629|FG000|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
11344706|NCT02960490|12541630|FG001|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
11344707|NCT02960490|12541631|FG002|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
11344708|NCT02960490|12541632|FG003|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
11344709|NCT02960490|12541633|FG004|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
11344710|NCT02960490|12541634|FG005|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
11344711|NCT02960490|12541635|FG006|COMPLETED|Extension Phase(Open-label): 80 Weeks||4
11344712|NCT02960490|12541636|FG007|COMPLETED|Extension Phase(Open-label): 80 Weeks||5
11344713|NCT02960490|12541637|FG008|COMPLETED|Extension Phase(Open-label): 80 Weeks||9
11344714|NCT02960490|12541638|FG009|COMPLETED|Extension Phase(Open-label): 80 Weeks||3
11344715|NCT02960490|12541629|FG000|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
11344716|NCT02960490|12541630|FG001|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
11344717|NCT02960490|12541631|FG002|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
11344718|NCT02960490|12541632|FG003|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
11344719|NCT02960490|12541633|FG004|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
11344720|NCT02960490|12541634|FG005|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
11344721|NCT02960490|12541635|FG006|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||9
11344722|NCT02960490|12541636|FG007|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||6
11344723|NCT02960490|12541637|FG008|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||4
11061238|NCT01016873|12242928|FG000|COMPLETED|36 Months||58
11061239|NCT01016873|12242929|FG001|COMPLETED|36 Months||64
11061240|NCT01016873|12242930|FG002|COMPLETED|36 Months||67
11061241|NCT01016873|12242928|FG000|NOT COMPLETED|36 Months||11
11061242|NCT01016873|12242929|FG001|NOT COMPLETED|36 Months||4
11061243|NCT01016873|12242930|FG002|NOT COMPLETED|36 Months||6
11061244|NCT01016912|12242943|FG000|STARTED|End of Treatment Period||8
11061245|NCT01016912|12242944|FG001|STARTED|End of Treatment Period||9
11061246|NCT01016912|12242945|FG002|STARTED|End of Treatment Period||10
11061247|NCT01016912|12242946|FG003|STARTED|End of Treatment Period||9
11061248|NCT01016912|12242947|FG004|STARTED|End of Treatment Period||9
11061249|NCT01016912|12242943|FG000|Received Treatment|End of Treatment Period||8
11061250|NCT01016912|12242944|FG001|Received Treatment|End of Treatment Period||9
11061251|NCT01016912|12242945|FG002|Received Treatment|End of Treatment Period||10
11061252|NCT01016912|12242946|FG003|Received Treatment|End of Treatment Period||9
11061253|NCT01016912|12242947|FG004|Received Treatment|End of Treatment Period||9
11061254|NCT01016912|12242943|FG000|COMPLETED|End of Treatment Period||8
11061255|NCT01016912|12242944|FG001|COMPLETED|End of Treatment Period||6
11061256|NCT01016912|12242945|FG002|COMPLETED|End of Treatment Period||9
11061257|NCT01016912|12242946|FG003|COMPLETED|End of Treatment Period||5
11061258|NCT01016912|12242947|FG004|COMPLETED|End of Treatment Period||5
11061259|NCT01016912|12242943|FG000|NOT COMPLETED|End of Treatment Period||0
11061260|NCT01016912|12242944|FG001|NOT COMPLETED|End of Treatment Period||3
11061261|NCT01016912|12242945|FG002|NOT COMPLETED|End of Treatment Period||1
11061262|NCT01016912|12242946|FG003|NOT COMPLETED|End of Treatment Period||4
11061263|NCT01016912|12242947|FG004|NOT COMPLETED|End of Treatment Period||4
11061264|NCT01016912|12242943|FG000|STARTED|Follow-up Period||8
11061265|NCT01016912|12242944|FG001|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
11061266|NCT01016912|12242945|FG002|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
11061267|NCT01016912|12242946|FG003|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
11061268|NCT01016912|12242947|FG004|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
11344724|NCT02960490|12541638|FG009|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||7
11344725|NCT02960854|12541662|FG000|STARTED|Overall Study||15
11344726|NCT02960854|12541663|FG001|STARTED|Overall Study||16
11344727|NCT02960854|12541662|FG000|COMPLETED|Overall Study||8
11344728|NCT02960854|12541663|FG001|COMPLETED|Overall Study||7
11344729|NCT02960854|12541662|FG000|NOT COMPLETED|Overall Study||7
11344730|NCT02960854|12541663|FG001|NOT COMPLETED|Overall Study||9
11344731|NCT02961062|12541671|FG000|STARTED|Overall Study||20
11344732|NCT02961062|12541672|FG001|STARTED|Overall Study||20
11344733|NCT02961062|12541671|FG000|COMPLETED|Overall Study||20
11344734|NCT02961062|12541672|FG001|COMPLETED|Overall Study||20
11344735|NCT02961062|12541671|FG000|NOT COMPLETED|Overall Study||0
11344736|NCT02961062|12541672|FG001|NOT COMPLETED|Overall Study||0
11344737|NCT02961218|12541680|FG000|STARTED|Overall Study||25
11344738|NCT02961218|12541681|FG001|STARTED|Overall Study||24
11344739|NCT02961218|12541680|FG000|Safety Analysis Set|Overall Study||25
11344740|NCT02961218|12541681|FG001|Safety Analysis Set|Overall Study||24
11344741|NCT02961218|12541680|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||25
11344742|NCT02961218|12541681|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
11344743|NCT02961218|12541680|FG000|Primary PD Analysis Set|Overall Study||25
11344744|NCT02961218|12541681|FG001|Primary PD Analysis Set|Overall Study||24
11344745|NCT02961218|12541680|FG000|COMPLETED|Overall Study||22
11344746|NCT02961218|12541681|FG001|COMPLETED|Overall Study||19
11344747|NCT02961218|12541680|FG000|NOT COMPLETED|Overall Study||3
11344748|NCT02961218|12541681|FG001|NOT COMPLETED|Overall Study||5
11344749|NCT02961244|12541691|FG000|STARTED|Overall Study||64
11344750|NCT02961244|12541692|FG001|STARTED|Overall Study||64
11344751|NCT02961244|12541691|FG000|Patients Excluded During Randomization|Overall Study||0
11344752|NCT02961244|12541692|FG001|Patients Excluded During Randomization|Overall Study||1
11344753|NCT02961244|12541691|FG000|COMPLETED|Overall Study||63
11344754|NCT02961244|12541692|FG001|COMPLETED|Overall Study||55
11344755|NCT02961244|12541691|FG000|NOT COMPLETED|Overall Study||1
11344756|NCT02961244|12541692|FG001|NOT COMPLETED|Overall Study||9
11344757|NCT02961751|12541698|FG000|STARTED|Overall Study||211
11344758|NCT02961751|12541698|FG000|COMPLETED|Overall Study||196
11344759|NCT02961751|12541698|FG000|NOT COMPLETED|Overall Study||15
11344760|NCT02961764|12541704|FG000|STARTED|Overall Study||160
11344761|NCT02961764|12541705|FG001|STARTED|Overall Study||153
11344762|NCT02961764|12541704|FG000|COMPLETED|Overall Study||121
11344763|NCT02961764|12541705|FG001|COMPLETED|Overall Study||128
11344764|NCT02961764|12541704|FG000|NOT COMPLETED|Overall Study||39
11344765|NCT02961764|12541705|FG001|NOT COMPLETED|Overall Study||25
11344766|NCT02961790|12541715|FG000|STARTED|Overall Study||50
11344767|NCT02961790|12541716|FG001|STARTED|Overall Study||51
11344768|NCT02961790|12541717|FG002|STARTED|Overall Study||24
11344769|NCT02961790|12541718|FG003|STARTED|Overall Study||25
11344770|NCT02961790|12541715|FG000|COMPLETED|Overall Study||35
11344771|NCT02961790|12541716|FG001|COMPLETED|Overall Study||40
11344772|NCT02961790|12541717|FG002|COMPLETED|Overall Study||18
11344773|NCT02961790|12541718|FG003|COMPLETED|Overall Study||20
11344774|NCT02961790|12541715|FG000|NOT COMPLETED|Overall Study||15
11344775|NCT02961790|12541716|FG001|NOT COMPLETED|Overall Study||11
11344776|NCT02961790|12541717|FG002|NOT COMPLETED|Overall Study||6
11344777|NCT02961790|12541718|FG003|NOT COMPLETED|Overall Study||5
11344778|NCT02961894|12541729|FG000|STARTED|Overall Study||121
11344779|NCT02961894|12541729|FG000|COMPLETED|Overall Study||121
11344780|NCT02961894|12541729|FG000|NOT COMPLETED|Overall Study||0
11344781|NCT02961920|12541735|FG000|STARTED|Overall Study||25
11344782|NCT02961920|12541736|FG001|STARTED|Overall Study||25
11061269|NCT01016912|12242943|FG000|COMPLETED|Follow-up Period||8
11061270|NCT01016912|12242944|FG001|COMPLETED|Follow-up Period||9
11061271|NCT01016912|12242945|FG002|COMPLETED|Follow-up Period||9
11344783|NCT02961920|12541735|FG000|COMPLETED|Overall Study||24
11344784|NCT02961920|12541736|FG001|COMPLETED|Overall Study||24
11344785|NCT02961920|12541735|FG000|NOT COMPLETED|Overall Study||1
11344786|NCT02961920|12541736|FG001|NOT COMPLETED|Overall Study||1
11344787|NCT02961946|12541745|FG000|STARTED|Overall Study||66
11344788|NCT02961946|12541746|FG001|STARTED|Overall Study||66
11061272|NCT01016912|12242946|FG003|COMPLETED|Follow-up Period||8
11061273|NCT01016912|12242947|FG004|COMPLETED|Follow-up Period||9
11061274|NCT01016912|12242943|FG000|NOT COMPLETED|Follow-up Period||0
11061275|NCT01016912|12242944|FG001|NOT COMPLETED|Follow-up Period||0
11061276|NCT01016912|12242945|FG002|NOT COMPLETED|Follow-up Period||1
11061277|NCT01016912|12242946|FG003|NOT COMPLETED|Follow-up Period||1
11061278|NCT01016912|12242947|FG004|NOT COMPLETED|Follow-up Period||0
11061279|NCT01016938|12242979|FG000|STARTED|Overall Study||16
11061280|NCT01016938|12242979|FG000|COMPLETED|Overall Study||7
11061281|NCT01016938|12242979|FG000|NOT COMPLETED|Overall Study||9
11061282|NCT01016964|12242986|FG000|STARTED|Overall Study||21
11061283|NCT01016964|12242987|FG001|STARTED|Overall Study||42
11061284|NCT01016964|12242986|FG000|COMPLETED|Overall Study||18
11061285|NCT01016964|12242987|FG001|COMPLETED|Overall Study||39
11061286|NCT01016964|12242986|FG000|NOT COMPLETED|Overall Study||3
11061287|NCT01016964|12242987|FG001|NOT COMPLETED|Overall Study||3
11061288|NCT01016977|12242995|FG000|STARTED|Overall Study||20
11061289|NCT01016977|12242996|FG001|STARTED|Overall Study||20
11061290|NCT01016977|12242995|FG000|COMPLETED|Overall Study||17
11061291|NCT01016977|12242996|FG001|COMPLETED|Overall Study||18
11061292|NCT01016977|12242995|FG000|NOT COMPLETED|Overall Study||3
11061293|NCT01016977|12242996|FG001|NOT COMPLETED|Overall Study||2
11061294|NCT01017003|12243005|FG000|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
11061295|NCT01017003|12243005|FG000|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
11061296|NCT01017003|12243005|FG000|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
11061297|NCT01017003|12243005|FG000|STARTED|14 Day Washout Period||13
11061298|NCT01017003|12243005|FG000|COMPLETED|14 Day Washout Period||13
11061299|NCT01017003|12243005|FG000|NOT COMPLETED|14 Day Washout Period||0
11061300|NCT01017003|12243005|FG000|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
11061301|NCT01017003|12243005|FG000|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
11061302|NCT01017003|12243005|FG000|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
11061303|NCT01017003|12243005|FG000|STARTED|Colchicine 0.6 mg Final Dose||13
11061304|NCT01017003|12243005|FG000|COMPLETED|Colchicine 0.6 mg Final Dose||13
11061305|NCT01017003|12243005|FG000|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
11061306|NCT01017029|12243013|FG000|STARTED|Overall Study||89
11061307|NCT01017029|12243014|FG001|STARTED|Overall Study||92
11061308|NCT01017029|12243013|FG000|COMPLETED|Overall Study||85
11061309|NCT01017029|12243014|FG001|COMPLETED|Overall Study||90
11061310|NCT01017029|12243013|FG000|NOT COMPLETED|Overall Study||4
11061311|NCT01017029|12243014|FG001|NOT COMPLETED|Overall Study||2
11061312|NCT01017042|12243020|FG000|STARTED|Overall Study||13
11061313|NCT01017042|12243020|FG000|COMPLETED|Overall Study||13
11061314|NCT01017042|12243020|FG000|NOT COMPLETED|Overall Study||0
11061315|NCT01017120|12243031|FG000|STARTED|Overall Study||373
11061316|NCT01017120|12243032|FG001|STARTED|Overall Study||369
11061317|NCT01017120|12243031|FG000|COMPLETED|Overall Study||307
11061318|NCT01017120|12243032|FG001|COMPLETED|Overall Study||334
11061319|NCT01017120|12243031|FG000|NOT COMPLETED|Overall Study||66
11061320|NCT01017120|12243032|FG001|NOT COMPLETED|Overall Study||35
11061321|NCT01017146|12243040|FG000|STARTED|Overall Study||372
11061322|NCT01017146|12243041|FG001|STARTED|Overall Study||372
11061323|NCT01017146|12243040|FG000|COMPLETED|Overall Study||306
11061324|NCT01017146|12243041|FG001|COMPLETED|Overall Study||333
11061325|NCT01017146|12243040|FG000|NOT COMPLETED|Overall Study||66
11061326|NCT01017146|12243041|FG001|NOT COMPLETED|Overall Study||39
11061327|NCT01017237|12243049|FG000|STARTED|Overall Study||10
11061328|NCT01017237|12243050|FG001|STARTED|Overall Study||8
11061329|NCT01017237|12243049|FG000|COMPLETED|Overall Study||5
11061330|NCT01017237|12243050|FG001|COMPLETED|Overall Study||6
11061331|NCT01017237|12243049|FG000|NOT COMPLETED|Overall Study||5
11061332|NCT01017237|12243050|FG001|NOT COMPLETED|Overall Study||2
11061333|NCT01017250|12243059|FG000|STARTED|Overall Study||15
11061334|NCT01017250|12243059|FG000|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
11061335|NCT01017250|12243059|FG000|COMPLETED|Overall Study||15
11061336|NCT01017250|12243059|FG000|NOT COMPLETED|Overall Study||0
11061337|NCT01017497|12243064|FG000|STARTED|Overall Study||49
11061338|NCT01017497|12243064|FG000|COMPLETED|Overall Study||49
11061339|NCT01017497|12243064|FG000|NOT COMPLETED|Overall Study||0
11061340|NCT01017536|12243072|FG000|STARTED|Overall Study||13
11061341|NCT01017536|12243073|FG001|STARTED|Overall Study||13
11061342|NCT01017536|12243072|FG000|COMPLETED|Overall Study||13
11061343|NCT01017536|12243073|FG001|COMPLETED|Overall Study||13
11061344|NCT01017536|12243072|FG000|NOT COMPLETED|Overall Study||0
11061345|NCT01017536|12243073|FG001|NOT COMPLETED|Overall Study||0
11061346|NCT01017549|12243079|FG000|STARTED|Eligibility Through 6 Month Follow-up||44
11061347|NCT01017549|12243079|FG000|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
11061348|NCT01017549|12243079|FG000|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
11061349|NCT01017549|12243079|FG000|STARTED|One-year Follow-up||43
11061350|NCT01017549|12243079|FG000|COMPLETED|One-year Follow-up||36
11061351|NCT01017549|12243079|FG000|NOT COMPLETED|One-year Follow-up||7
11061352|NCT01017549|12243079|FG000|STARTED|5 Year Follow-up||36
11061353|NCT01017549|12243079|FG000|COMPLETED|5 Year Follow-up||24
11061354|NCT01017549|12243079|FG000|NOT COMPLETED|5 Year Follow-up||12
11061355|NCT01017575|12243088|FG000|STARTED|Overall Study||8
11061356|NCT01017575|12243089|FG001|STARTED|Overall Study||9
11061357|NCT01017575|12243090|FG002|STARTED|Overall Study||8
11061358|NCT01017575|12243091|FG003|STARTED|Overall Study||8
11061359|NCT01017575|12243092|FG004|STARTED|Overall Study||9
11061360|NCT01017575|12243088|FG000|COMPLETED|Overall Study||7
11061361|NCT01017575|12243089|FG001|COMPLETED|Overall Study||7
11061362|NCT01017575|12243090|FG002|COMPLETED|Overall Study||8
11061363|NCT01017575|12243091|FG003|COMPLETED|Overall Study||7
11061364|NCT01017575|12243092|FG004|COMPLETED|Overall Study||6
11061365|NCT01017575|12243088|FG000|NOT COMPLETED|Overall Study||1
11061366|NCT01017575|12243089|FG001|NOT COMPLETED|Overall Study||2
11061367|NCT01017575|12243090|FG002|NOT COMPLETED|Overall Study||0
11061368|NCT01017575|12243091|FG003|NOT COMPLETED|Overall Study||1
11061369|NCT01017575|12243092|FG004|NOT COMPLETED|Overall Study||3
11061370|NCT01017601|12243106|FG000|STARTED|Overall Study||26
11061371|NCT01017601|12243107|FG001|STARTED|Overall Study||24
11061372|NCT01017601|12243106|FG000|COMPLETED|Overall Study||14
11061373|NCT01017601|12243107|FG001|COMPLETED|Overall Study||11
11061374|NCT01017601|12243106|FG000|NOT COMPLETED|Overall Study||12
11061375|NCT01017601|12243107|FG001|NOT COMPLETED|Overall Study||13
11061376|NCT01017653|12243113|FG000|STARTED|Overall Study||16
11061377|NCT01017653|12243113|FG000|COMPLETED|Overall Study||16
11061378|NCT01017653|12243113|FG000|NOT COMPLETED|Overall Study||0
11061379|NCT01017731|12243117|FG000|STARTED|Overall Study||68
11061380|NCT01017731|12243117|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66
11061381|NCT01017731|12243117|FG000|COMPLETED|Overall Study||60
11061382|NCT01017731|12243117|FG000|NOT COMPLETED|Overall Study||8
11061383|NCT01017874|12243124|FG000|STARTED|Overall Study||118
11061384|NCT01017874|12243125|FG001|STARTED|Overall Study||118
11061385|NCT01017874|12243124|FG000|Received at Least 1 Dose of Study Drug|Overall Study||114
11061386|NCT01017874|12243125|FG001|Received at Least 1 Dose of Study Drug|Overall Study||118
11061387|NCT01017874|12243124|FG000|COMPLETED|Overall Study||88
11061388|NCT01017874|12243125|FG001|COMPLETED|Overall Study||92
11061389|NCT01017874|12243124|FG000|NOT COMPLETED|Overall Study||30
11061390|NCT01017874|12243125|FG001|NOT COMPLETED|Overall Study||26
11061391|NCT01017952|12243135|FG000|STARTED|4-week, Open-label Run-In Period||2092
11061392|NCT01017952|12243136|FG001|STARTED|4-week, Open-label Run-In Period||0
11061393|NCT01017952|12243137|FG002|STARTED|4-week, Open-label Run-In Period||0
11061394|NCT01017952|12243138|FG003|STARTED|4-week, Open-label Run-In Period||0
11061395|NCT01017952|12243139|FG004|STARTED|4-week, Open-label Run-In Period||0
11061396|NCT01017952|12243135|FG000|COMPLETED|4-week, Open-label Run-In Period||1633
11061397|NCT01017952|12243136|FG001|COMPLETED|4-week, Open-label Run-In Period||0
11061398|NCT01017952|12243137|FG002|COMPLETED|4-week, Open-label Run-In Period||0
11061399|NCT01017952|12243138|FG003|COMPLETED|4-week, Open-label Run-In Period||0
11061400|NCT01017952|12243139|FG004|COMPLETED|4-week, Open-label Run-In Period||0
11061401|NCT01017952|12243135|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||459
11061402|NCT01017952|12243136|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0
11061403|NCT01017952|12243137|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0
11061404|NCT01017952|12243138|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0
11061405|NCT01017952|12243139|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0
11061406|NCT01017952|12243135|FG000|STARTED|52-week, Double-blind Treatment Period||0
11061407|NCT01017952|12243136|FG001|STARTED|52-week, Double-blind Treatment Period||409
11061408|NCT01017952|12243137|FG002|STARTED|52-week, Double-blind Treatment Period||412
11061409|NCT01017952|12243138|FG003|STARTED|52-week, Double-blind Treatment Period||403
11061410|NCT01017952|12243139|FG004|STARTED|52-week, Double-blind Treatment Period||409
11061411|NCT01017952|12243135|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
11061412|NCT01017952|12243136|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
11061413|NCT01017952|12243137|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
11061414|NCT01017952|12243138|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
11061415|NCT01017952|12243139|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
11061416|NCT01017952|12243135|FG000|COMPLETED|52-week, Double-blind Treatment Period||0
11061417|NCT01017952|12243136|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
11061418|NCT01017952|12243137|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
11061419|NCT01017952|12243138|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
11061420|NCT01017952|12243139|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
11061421|NCT01017952|12243135|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0
11061422|NCT01017952|12243136|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||125
11061423|NCT01017952|12243137|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||109
11061424|NCT01017952|12243138|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||112
11061425|NCT01017952|12243139|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||103
11061426|NCT01018030|12243152|FG000|STARTED|Overall Study||246
11061427|NCT01018030|12243153|FG001|STARTED|Overall Study||243
11061428|NCT01018030|12243154|FG002|STARTED|Overall Study||252
11061429|NCT01018030|12243152|FG000|COMPLETED|Overall Study||227
11061430|NCT01018030|12243153|FG001|COMPLETED|Overall Study||232
11061431|NCT01018030|12243154|FG002|COMPLETED|Overall Study||239
11061432|NCT01018030|12243152|FG000|NOT COMPLETED|Overall Study||19
11061433|NCT01018030|12243153|FG001|NOT COMPLETED|Overall Study||11
11061434|NCT01018030|12243154|FG002|NOT COMPLETED|Overall Study||13
11061435|NCT01018056|12243167|FG000|STARTED|Overall Study||12
11061436|NCT01018056|12243168|FG001|STARTED|Overall Study||12
11061437|NCT01018056|12243169|FG002|STARTED|Overall Study||6
11061438|NCT01018056|12243167|FG000|COMPLETED|Overall Study||9
11061439|NCT01018056|12243168|FG001|COMPLETED|Overall Study||10
11061440|NCT01018056|12243169|FG002|COMPLETED|Overall Study||5
11061441|NCT01018056|12243167|FG000|NOT COMPLETED|Overall Study||3
11061442|NCT01018056|12243168|FG001|NOT COMPLETED|Overall Study||2
11061443|NCT01018056|12243169|FG002|NOT COMPLETED|Overall Study||1
11061444|NCT01018095|12243182|FG000|STARTED|Overall Study||135
11061445|NCT01018095|12243183|FG001|STARTED|Overall Study||135
11061446|NCT01018095|12243182|FG000|COMPLETED|Overall Study||79
11061447|NCT01018095|12243183|FG001|COMPLETED|Overall Study||73
11061448|NCT01018095|12243182|FG000|NOT COMPLETED|Overall Study||56
11061449|NCT01018095|12243183|FG001|NOT COMPLETED|Overall Study||62
11061450|NCT01018134|12243195|FG000|STARTED|Overall Study||30
11061451|NCT01018134|12243196|FG001|STARTED|Overall Study||31
11061452|NCT01018134|12243197|FG002|STARTED|Overall Study||30
11061453|NCT01018134|12243198|FG003|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
11061454|NCT01018134|12243199|FG004|STARTED|Overall Study||15
11061455|NCT01018134|12243200|FG005|STARTED|Overall Study||15
11061456|NCT01018134|12243195|FG000|COMPLETED|Overall Study||30
11061457|NCT01018134|12243196|FG001|COMPLETED|Overall Study||30
11061458|NCT01018134|12243197|FG002|COMPLETED|Overall Study||29
11061459|NCT01018134|12243198|FG003|COMPLETED|Overall Study||29
11061460|NCT01018134|12243199|FG004|COMPLETED|Overall Study||15
11061461|NCT01018134|12243200|FG005|COMPLETED|Overall Study||15
11061462|NCT01018134|12243195|FG000|NOT COMPLETED|Overall Study||0
11061463|NCT01018134|12243196|FG001|NOT COMPLETED|Overall Study||1
11061464|NCT01018134|12243197|FG002|NOT COMPLETED|Overall Study||1
11061465|NCT01018134|12243198|FG003|NOT COMPLETED|Overall Study||0
11061466|NCT01018134|12243199|FG004|NOT COMPLETED|Overall Study||0
11061467|NCT01018134|12243200|FG005|NOT COMPLETED|Overall Study||0
11061468|NCT01018186|12243217|FG000|STARTED|2-week Run-in Period||617
11061469|NCT01018186|12243218|FG001|STARTED|2-week Run-in Period||0
11061470|NCT01018186|12243219|FG002|STARTED|2-week Run-in Period||0
11061471|NCT01018186|12243220|FG003|STARTED|2-week Run-in Period||0
11061472|NCT01018186|12243217|FG000|COMPLETED|2-week Run-in Period||503
11344789|NCT02961946|12541747|FG002|STARTED|Overall Study||66
11344790|NCT02961946|12541745|FG000|COMPLETED|Overall Study||66
11344791|NCT02961946|12541746|FG001|COMPLETED|Overall Study||66
11344792|NCT02961946|12541747|FG002|COMPLETED|Overall Study||66
11344793|NCT02961946|12541745|FG000|NOT COMPLETED|Overall Study||0
11344794|NCT02961946|12541746|FG001|NOT COMPLETED|Overall Study||0
11344795|NCT02961946|12541747|FG002|NOT COMPLETED|Overall Study||0
11344796|NCT02962284|12541757|FG000|STARTED|Overall Study||9
11344797|NCT02962284|12541758|FG001|STARTED|Overall Study||11
11061473|NCT01018186|12243218|FG001|COMPLETED|2-week Run-in Period||0
11061474|NCT01018186|12243219|FG002|COMPLETED|2-week Run-in Period||0
11061475|NCT01018186|12243220|FG003|COMPLETED|2-week Run-in Period||0
11061476|NCT01018186|12243217|FG000|NOT COMPLETED|2-week Run-in Period||114
11061477|NCT01018186|12243218|FG001|NOT COMPLETED|2-week Run-in Period||0
11061478|NCT01018186|12243219|FG002|NOT COMPLETED|2-week Run-in Period||0
11061479|NCT01018186|12243220|FG003|NOT COMPLETED|2-week Run-in Period||0
11061480|NCT01018186|12243217|FG000|STARTED|52-week Double-blind Treatment Period||0
11061481|NCT01018186|12243218|FG001|STARTED|52-week Double-blind Treatment Period||201
11061482|NCT01018186|12243219|FG002|STARTED|52-week Double-blind Treatment Period||202
11344798|NCT02962284|12541757|FG000|COMPLETED|Overall Study||4
11344799|NCT02962284|12541758|FG001|COMPLETED|Overall Study||8
11344800|NCT02962284|12541757|FG000|NOT COMPLETED|Overall Study||5
11344801|NCT02962284|12541758|FG001|NOT COMPLETED|Overall Study||3
11344802|NCT02962427|12541768|FG000|STARTED|Overall Study||3
11344803|NCT02962427|12541769|FG001|STARTED|Overall Study||1
11061483|NCT01018186|12243220|FG003|STARTED|52-week Double-blind Treatment Period||100
11061484|NCT01018186|12243217|FG000|COMPLETED|52-week Double-blind Treatment Period||0
11061485|NCT01018186|12243218|FG001|COMPLETED|52-week Double-blind Treatment Period||161
11061486|NCT01018186|12243219|FG002|COMPLETED|52-week Double-blind Treatment Period||161
11061487|NCT01018186|12243220|FG003|COMPLETED|52-week Double-blind Treatment Period||71
11344804|NCT02962427|12541768|FG000|COMPLETED|Overall Study||3
11061488|NCT01018186|12243217|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0
11061489|NCT01018186|12243218|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||40
11061490|NCT01018186|12243219|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||41
11061491|NCT01018186|12243220|FG003|NOT COMPLETED|52-week Double-blind Treatment Period||29
11061492|NCT01018264|12243234|FG000|STARTED|Overall Study||10
11344805|NCT02962427|12541769|FG001|COMPLETED|Overall Study||1
11344806|NCT02962427|12541768|FG000|NOT COMPLETED|Overall Study||0
11344807|NCT02962427|12541769|FG001|NOT COMPLETED|Overall Study||0
11344808|NCT02962609|12541779|FG000|STARTED|Overall Study||38
11344809|NCT02962609|12541780|FG001|STARTED|Overall Study||42
11344810|NCT02962609|12541779|FG000|COMPLETED|Overall Study||38
11344811|NCT02962609|12541780|FG001|COMPLETED|Overall Study||42
11344812|NCT02962609|12541779|FG000|NOT COMPLETED|Overall Study||0
11344813|NCT02962609|12541780|FG001|NOT COMPLETED|Overall Study||0
11344814|NCT02962648|12541786|FG000|STARTED|Overall Study||103
11344815|NCT02962648|12541786|FG000|COMPLETED|Overall Study||94
11344816|NCT02962648|12541786|FG000|NOT COMPLETED|Overall Study||9
11344817|NCT02962674|12541790|FG000|STARTED|Overall Study|"Although a total of 49 subjects were consented to participate in the study, three (3) of those subjects are not included in the study analysis as they did not actually receive treatment. These 3 subjects could not be treated because of their anatomy and therefore are considered treatment attempts. The final enrollment number (treated subjects only)is 46 subjects."|49
11344818|NCT02962674|12541790|FG000|3 Month Endpoint|Overall Study|All treated subjects that completed the 3-month endpoint visit per protocol.|46
11344819|NCT02962674|12541790|FG000|12 Month Durability|Overall Study|All subjects that completed the 12-month follow-up visit per protocol.|46
11061493|NCT01018264|12243235|FG001|STARTED|Overall Study||13
11061494|NCT01018264|12243234|FG000|COMPLETED|Overall Study||9
11061495|NCT01018264|12243235|FG001|COMPLETED|Overall Study||12
11061496|NCT01018264|12243234|FG000|NOT COMPLETED|Overall Study||1
11061497|NCT01018264|12243235|FG001|NOT COMPLETED|Overall Study||1
11061498|NCT01018394|12243243|FG000|STARTED|Overall Study||40
11061499|NCT01018394|12243244|FG001|STARTED|Overall Study||41
11061500|NCT01018394|12243243|FG000|COMPLETED|Overall Study||31
11061501|NCT01018394|12243244|FG001|COMPLETED|Overall Study||33
11061502|NCT01018394|12243243|FG000|NOT COMPLETED|Overall Study||9
11061503|NCT01018394|12243244|FG001|NOT COMPLETED|Overall Study||8
11061504|NCT01018420|12243252|FG000|STARTED|Overall Study||15
11061505|NCT01018420|12243253|FG001|STARTED|Overall Study||3
11061506|NCT01018420|12243252|FG000|COMPLETED|Overall Study||15
11061507|NCT01018420|12243253|FG001|COMPLETED|Overall Study||3
11061508|NCT01018420|12243252|FG000|NOT COMPLETED|Overall Study||0
11061509|NCT01018420|12243253|FG001|NOT COMPLETED|Overall Study||0
11061510|NCT01018511|12243280|FG000|STARTED|Overall Study||341
11061511|NCT01018511|12243281|FG001|STARTED|Overall Study||327
11061512|NCT01018511|12243282|FG002|STARTED|Overall Study||339
11061513|NCT01018511|12243283|FG003|STARTED|Overall Study||327
11061514|NCT01018511|12243280|FG000|Randomized and Treated|Overall Study||341
11061515|NCT01018511|12243281|FG001|Randomized and Treated|Overall Study||326
11061516|NCT01018511|12243282|FG002|Randomized and Treated|Overall Study||338
11061517|NCT01018511|12243283|FG003|Randomized and Treated|Overall Study||324
11061518|NCT01018511|12243280|FG000|COMPLETED|Overall Study||315
11061519|NCT01018511|12243281|FG001|COMPLETED|Overall Study||295
11061520|NCT01018511|12243282|FG002|COMPLETED|Overall Study||299
11061521|NCT01018511|12243283|FG003|COMPLETED|Overall Study||294
11061522|NCT01018511|12243280|FG000|NOT COMPLETED|Overall Study||26
11061523|NCT01018511|12243281|FG001|NOT COMPLETED|Overall Study||32
11061524|NCT01018511|12243282|FG002|NOT COMPLETED|Overall Study||40
11061525|NCT01018511|12243283|FG003|NOT COMPLETED|Overall Study||33
11061526|NCT01018680|12243301|FG000|STARTED|Overall Study||260
11061527|NCT01018680|12243302|FG001|STARTED|Overall Study||264
11061528|NCT01018680|12243301|FG000|COMPLETED|Overall Study||199
11061529|NCT01018680|12243302|FG001|COMPLETED|Overall Study||189
11061530|NCT01018680|12243301|FG000|NOT COMPLETED|Overall Study||61
11061531|NCT01018680|12243302|FG001|NOT COMPLETED|Overall Study||75
11061532|NCT01018732|12243311|FG000|STARTED|Overall Study||50
11061533|NCT01018732|12243312|FG001|STARTED|Overall Study||51
11061534|NCT01018732|12243313|FG002|STARTED|Overall Study||54
11061535|NCT01018732|12243311|FG000|COMPLETED|Overall Study||49
11061536|NCT01018732|12243312|FG001|COMPLETED|Overall Study||49
11061537|NCT01018732|12243313|FG002|COMPLETED|Overall Study||50
11061538|NCT01018732|12243311|FG000|NOT COMPLETED|Overall Study||1
11061539|NCT01018732|12243312|FG001|NOT COMPLETED|Overall Study||2
11061540|NCT01018732|12243313|FG002|NOT COMPLETED|Overall Study||4
11061541|NCT01018862|12243324|FG000|STARTED|Overall Study||161
11061542|NCT01018862|12243325|FG001|STARTED|Overall Study||166
11061543|NCT01018862|12243326|FG002|STARTED|Overall Study||162
11061544|NCT01018862|12243324|FG000|COMPLETED|Overall Study||148
11061545|NCT01018862|12243325|FG001|COMPLETED|Overall Study||156
11061546|NCT01018862|12243326|FG002|COMPLETED|Overall Study||146
11061547|NCT01018862|12243324|FG000|NOT COMPLETED|Overall Study||13
11061548|NCT01018862|12243325|FG001|NOT COMPLETED|Overall Study||10
11061549|NCT01018862|12243326|FG002|NOT COMPLETED|Overall Study||16
11061550|NCT01018953|12243334|FG000|STARTED|Overall Study||8
11061551|NCT01018953|12243334|FG000|BIM 23A760 1 mg|Overall Study||3
11061552|NCT01018953|12243334|FG000|BIM 23A760 2 mg|Overall Study||2
11061553|NCT01018953|12243334|FG000|BIM 23A760 4 mg|Overall Study||3
11061554|NCT01018953|12243334|FG000|COMPLETED|Overall Study||0
11061555|NCT01018953|12243334|FG000|NOT COMPLETED|Overall Study||8
11061556|NCT01018979|12243341|FG000|STARTED|Overall Study||7
11061557|NCT01018979|12243342|FG001|STARTED|Overall Study|A total of 20 subjects were randomized.|13
11061558|NCT01018979|12243341|FG000|Received at Least One Dose|Overall Study||7
11061559|NCT01018979|12243342|FG001|Received at Least One Dose|Overall Study||12
11061560|NCT01018979|12243341|FG000|COMPLETED|Overall Study||4
11061561|NCT01018979|12243342|FG001|COMPLETED|Overall Study||3
11061562|NCT01018979|12243341|FG000|NOT COMPLETED|Overall Study||3
11061563|NCT01018979|12243342|FG001|NOT COMPLETED|Overall Study||10
11205436|NCT01859247|12396213|FG005|COMPLETED|Overall Study||1
11205437|NCT01859247|12396214|FG006|COMPLETED|Overall Study||1
11205438|NCT01859247|12396215|FG007|COMPLETED|Overall Study||1
11205439|NCT01859247|12396208|FG000|NOT COMPLETED|Overall Study||0
11205440|NCT01859247|12396209|FG001|NOT COMPLETED|Overall Study||0
11205441|NCT01859247|12396210|FG002|NOT COMPLETED|Overall Study||0
11205442|NCT01859247|12396211|FG003|NOT COMPLETED|Overall Study||0
11205443|NCT01859247|12396212|FG004|NOT COMPLETED|Overall Study||0
11205444|NCT01859247|12396213|FG005|NOT COMPLETED|Overall Study||0
11205445|NCT01859247|12396214|FG006|NOT COMPLETED|Overall Study||0
11205446|NCT01859247|12396215|FG007|NOT COMPLETED|Overall Study||0
11205447|NCT01859312|12396234|FG000|STARTED|Overall Study||8
11205448|NCT01859312|12396234|FG000|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
11205449|NCT01859312|12396234|FG000|NOT COMPLETED|Overall Study||0
11205450|NCT01859325|12396241|FG000|STARTED|Overall Study||15
11205451|NCT01859325|12396242|FG001|STARTED|Overall Study||16
11205452|NCT01859325|12396243|FG002|STARTED|Overall Study||2
11205453|NCT01859325|12396241|FG000|COMPLETED|Overall Study||12
11205454|NCT01859325|12396242|FG001|COMPLETED|Overall Study||12
11205455|NCT01859325|12396243|FG002|COMPLETED|Overall Study||2
11205456|NCT01859325|12396241|FG000|NOT COMPLETED|Overall Study||3
11205457|NCT01859325|12396242|FG001|NOT COMPLETED|Overall Study||4
11205458|NCT01859325|12396243|FG002|NOT COMPLETED|Overall Study||0
11205459|NCT01859390|12396251|FG000|STARTED|Overall Study||36
11205460|NCT01859390|12396252|FG001|STARTED|Overall Study||37
11205461|NCT01859390|12396251|FG000|Withdrawals|Overall Study||2
11205462|NCT01859390|12396252|FG001|Withdrawals|Overall Study||2
11205463|NCT01859390|12396251|FG000|COMPLETED|Overall Study||35
11205464|NCT01859390|12396252|FG001|COMPLETED|Overall Study||30
11205465|NCT01859390|12396251|FG000|NOT COMPLETED|Overall Study||1
11205466|NCT01859390|12396252|FG001|NOT COMPLETED|Overall Study||7
11205467|NCT01859403|12396260|FG000|STARTED|Primary Endpoint Measure||21
11205468|NCT01859403|12396261|FG001|STARTED|Primary Endpoint Measure||30
11205469|NCT01859403|12396260|FG000|COMPLETED|Primary Endpoint Measure||20
11205470|NCT01859403|12396261|FG001|COMPLETED|Primary Endpoint Measure||26
11205471|NCT01859403|12396260|FG000|NOT COMPLETED|Primary Endpoint Measure||1
11205472|NCT01859403|12396261|FG001|NOT COMPLETED|Primary Endpoint Measure||4
11205473|NCT01859403|12396260|FG000|STARTED|Secondary Endpoint Measure||20
11205474|NCT01859403|12396261|FG001|STARTED|Secondary Endpoint Measure||26
11205475|NCT01859403|12396260|FG000|COMPLETED|Secondary Endpoint Measure||14
11205476|NCT01859403|12396261|FG001|COMPLETED|Secondary Endpoint Measure||18
11061564|NCT01018992|12243353|FG000|STARTED|Overall Study||63
11061565|NCT01018992|12243354|FG001|STARTED|Overall Study||65
11061566|NCT01018992|12243353|FG000|COMPLETED|Overall Study||47
11061567|NCT01018992|12243354|FG001|COMPLETED|Overall Study||49
11061568|NCT01018992|12243353|FG000|NOT COMPLETED|Overall Study||16
11061569|NCT01018992|12243354|FG001|NOT COMPLETED|Overall Study||16
11061570|NCT01019135|12243363|FG000|STARTED|Overall Study||55
11061571|NCT01019135|12243364|FG001|STARTED|Overall Study||59
11061572|NCT01019135|12243365|FG002|STARTED|Overall Study||55
11061573|NCT01019135|12243363|FG000|COMPLETED|Overall Study||35
11061574|NCT01019135|12243364|FG001|COMPLETED|Overall Study||40
11061575|NCT01019135|12243365|FG002|COMPLETED|Overall Study||24
11061576|NCT01019135|12243363|FG000|NOT COMPLETED|Overall Study||20
11061577|NCT01019135|12243364|FG001|NOT COMPLETED|Overall Study||19
11061578|NCT01019135|12243365|FG002|NOT COMPLETED|Overall Study||31
11205477|NCT01859403|12396260|FG000|NOT COMPLETED|Secondary Endpoint Measure||6
11205478|NCT01859403|12396261|FG001|NOT COMPLETED|Secondary Endpoint Measure||8
11205479|NCT01859494|12396267|FG000|STARTED|Overall Study||219
11205480|NCT01859494|12396267|FG000|COMPLETED|Overall Study||218
11205481|NCT01859494|12396267|FG000|NOT COMPLETED|Overall Study||1
11205482|NCT01859507|12396271|FG000|STARTED|Overall Study||32
11205483|NCT01859507|12396271|FG000|COMPLETED|Overall Study||28
11205484|NCT01859507|12396271|FG000|NOT COMPLETED|Overall Study||4
11205485|NCT01859598|12396276|FG000|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
11205486|NCT01859598|12396276|FG000|COMPLETED|Visit 2 at 3 Months||17253
11205487|NCT01859598|12396276|FG000|NOT COMPLETED|Visit 2 at 3 Months||1742
11205488|NCT01859598|12396276|FG000|STARTED|Visit 3 at 6 Months||17253
11205489|NCT01859598|12396276|FG000|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
11205490|NCT01859598|12396276|FG000|NOT COMPLETED|Visit 3 at 6 Months||912
11205491|NCT01859611|12396282|FG000|STARTED|Overall Study||51
11205492|NCT01859611|12396282|FG000|COMPLETED|Overall Study||43
11205493|NCT01859611|12396282|FG000|NOT COMPLETED|Overall Study||8
11205494|NCT01859637|12396286|FG000|STARTED|Overall Study||6
11205495|NCT01859637|12396286|FG000|COMPLETED|Overall Study||6
11205496|NCT01859637|12396286|FG000|NOT COMPLETED|Overall Study||0
11205497|NCT01859702|12396290|FG000|STARTED|Overall Study||36
11205498|NCT01859702|12396290|FG000|COMPLETED|Overall Study||31
11205499|NCT01859702|12396290|FG000|NOT COMPLETED|Overall Study||5
11205500|NCT01859715|12396297|FG000|STARTED|Overall Study||141
11205501|NCT01859715|12396298|FG001|STARTED|Overall Study||91
11205502|NCT01859715|12396299|FG002|STARTED|Overall Study||116
11205503|NCT01859715|12396297|FG000|COMPLETED|Overall Study||125
11205504|NCT01859715|12396298|FG001|COMPLETED|Overall Study||83
11205505|NCT01859715|12396299|FG002|COMPLETED|Overall Study||93
11205506|NCT01859715|12396297|FG000|NOT COMPLETED|Overall Study||16
11205507|NCT01859715|12396298|FG001|NOT COMPLETED|Overall Study||8
11205508|NCT01859715|12396299|FG002|NOT COMPLETED|Overall Study||23
11205509|NCT01859741|12396317|FG000|STARTED|Overall Study||3
11205510|NCT01859741|12396318|FG001|STARTED|Overall Study||3
11205511|NCT01859741|12396319|FG002|STARTED|Overall Study||6
11205512|NCT01859741|12396320|FG003|STARTED|Overall Study||3
11205513|NCT01859741|12396321|FG004|STARTED|Overall Study||6
11205514|NCT01859741|12396322|FG005|STARTED|Overall Study||6
11205515|NCT01859741|12396323|FG006|STARTED|Overall Study||72
11205516|NCT01859741|12396324|FG007|STARTED|Overall Study||73
11205517|NCT01859741|12396317|FG000|COMPLETED|Overall Study||0
11205518|NCT01859741|12396318|FG001|COMPLETED|Overall Study||0
11205519|NCT01859741|12396319|FG002|COMPLETED|Overall Study||0
11205520|NCT01859741|12396320|FG003|COMPLETED|Overall Study||0
11205521|NCT01859741|12396321|FG004|COMPLETED|Overall Study||0
11205522|NCT01859741|12396322|FG005|COMPLETED|Overall Study||0
11205523|NCT01859741|12396323|FG006|COMPLETED|Overall Study||2
11205524|NCT01859741|12396324|FG007|COMPLETED|Overall Study||3
11205525|NCT01859741|12396317|FG000|NOT COMPLETED|Overall Study||3
11205526|NCT01859741|12396318|FG001|NOT COMPLETED|Overall Study||3
11205527|NCT01859741|12396319|FG002|NOT COMPLETED|Overall Study||6
11205528|NCT01859741|12396320|FG003|NOT COMPLETED|Overall Study||3
11205529|NCT01859741|12396321|FG004|NOT COMPLETED|Overall Study||6
11205530|NCT01859741|12396322|FG005|NOT COMPLETED|Overall Study||6
11205531|NCT01859741|12396323|FG006|NOT COMPLETED|Overall Study||70
11205532|NCT01859741|12396324|FG007|NOT COMPLETED|Overall Study||70
11205533|NCT01859793|12396344|FG000|STARTED|First Intervention (8 Weeks)||20
11205534|NCT01859793|12396345|FG001|STARTED|First Intervention (8 Weeks)||18
11205535|NCT01859793|12396344|FG000|COMPLETED|First Intervention (8 Weeks)||15
11205536|NCT01859793|12396345|FG001|COMPLETED|First Intervention (8 Weeks)||17
11205537|NCT01859793|12396344|FG000|NOT COMPLETED|First Intervention (8 Weeks)||5
11205538|NCT01859793|12396345|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1
11205539|NCT01859793|12396344|FG000|STARTED|Washout Period (4 Weeks)||15
11205540|NCT01859793|12396345|FG001|STARTED|Washout Period (4 Weeks)||17
11205541|NCT01859793|12396344|FG000|COMPLETED|Washout Period (4 Weeks)||14
11205542|NCT01859793|12396345|FG001|COMPLETED|Washout Period (4 Weeks)||16
11205543|NCT01859793|12396344|FG000|NOT COMPLETED|Washout Period (4 Weeks)||1
11205544|NCT01859793|12396345|FG001|NOT COMPLETED|Washout Period (4 Weeks)||1
11205545|NCT01859793|12396344|FG000|STARTED|2nd Intervention Period||14
11344820|NCT02962674|12541790|FG000|24 Month Durability|Overall Study|All subjects that completed the 24-month follow-up visit. Note that at the time of study termination, all subjects would have reached this milestone.|32
11344821|NCT02962674|12541790|FG000|36 Month Durability|Overall Study|All subjects that completed the 36-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|18
11344822|NCT02962674|12541790|FG000|48 Month Durability|Overall Study|All subjects that completed the 48-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|4
11344823|NCT02962674|12541790|FG000|COMPLETED|Overall Study|Study was terminated by sponsor prior to reaching 60 Month study completion mainly due to COVID-19 effects on subject follow-up.|0
11344824|NCT02962674|12541790|FG000|NOT COMPLETED|Overall Study||49
11344825|NCT02962687|12541798|FG000|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
11344826|NCT02962687|12541799|FG001|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
11344827|NCT02962687|12541798|FG000|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30
11344828|NCT02962687|12541799|FG001|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32
11344829|NCT02962687|12541798|FG000|NOT COMPLETED|Overall Study||10
11344830|NCT02962687|12541799|FG001|NOT COMPLETED|Overall Study||8
11344831|NCT02962739|12541807|FG000|STARTED|Overall Study||6
11344832|NCT02962739|12541808|FG001|STARTED|Overall Study||7
11344833|NCT02962739|12541809|FG002|STARTED|Overall Study||7
11344834|NCT02962739|12541810|FG003|STARTED|Overall Study||6
11344835|NCT02962739|12541811|FG004|STARTED|Overall Study||6
11344836|NCT02962739|12541812|FG005|STARTED|Overall Study||6
11344837|NCT02962739|12541807|FG000|COMPLETED|Overall Study||6
11344838|NCT02962739|12541808|FG001|COMPLETED|Overall Study||6
11344839|NCT02962739|12541809|FG002|COMPLETED|Overall Study||6
11344840|NCT02962739|12541810|FG003|COMPLETED|Overall Study||6
11344841|NCT02962739|12541811|FG004|COMPLETED|Overall Study||5
11344842|NCT02962739|12541812|FG005|COMPLETED|Overall Study||6
11344843|NCT02962739|12541807|FG000|NOT COMPLETED|Overall Study||0
11344844|NCT02962739|12541808|FG001|NOT COMPLETED|Overall Study||1
11344845|NCT02962739|12541809|FG002|NOT COMPLETED|Overall Study||1
11344846|NCT02962739|12541810|FG003|NOT COMPLETED|Overall Study||0
11344847|NCT02962739|12541811|FG004|NOT COMPLETED|Overall Study||1
11344848|NCT02962739|12541812|FG005|NOT COMPLETED|Overall Study||0
11344849|NCT02962765|12541818|FG000|STARTED|Overall Study||78
11344850|NCT02962765|12541818|FG000|FAS Population|Overall Study||78
11344851|NCT02962765|12541818|FG000|SAF Population|Overall Study||78
11344852|NCT02962765|12541818|FG000|Prophylactic Treatment Group|Overall Study||77
11344853|NCT02962765|12541818|FG000|On Demand Treatment Group|Overall Study||2
11344854|NCT02962765|12541818|FG000|SURG Population|Overall Study||4
11344855|NCT02962765|12541818|FG000|COMPLETED|Overall Study||61
11344856|NCT02962765|12541818|FG000|NOT COMPLETED|Overall Study||17
11344857|NCT02962882|12541829|FG000|STARTED|Overall Study||50
11344858|NCT02962882|12541829|FG000|COMPLETED|Overall Study||14
11344859|NCT02962882|12541829|FG000|NOT COMPLETED|Overall Study||36
11344860|NCT02962908|12541838|FG000|STARTED|Overall Study||58
11061579|NCT01019252|12243375|FG000|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
11061580|NCT01019252|12243376|FG001|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
11061581|NCT01019252|12243375|FG000|COMPLETED|Initial CBT for ADHD vs. Wait List||21
11061582|NCT01019252|12243376|FG001|COMPLETED|Initial CBT for ADHD vs. Wait List||22
11061583|NCT01019252|12243375|FG000|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
11061584|NCT01019252|12243376|FG001|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
11061585|NCT01019252|12243375|FG000|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
11061586|NCT01019252|12243376|FG001|STARTED|Wait List Cross-over to CBT for ADHD||22
11061587|NCT01019252|12243375|FG000|COMPLETED|Wait List Cross-over to CBT for ADHD||21
11061588|NCT01019252|12243376|FG001|COMPLETED|Wait List Cross-over to CBT for ADHD||15
11061589|NCT01019252|12243375|FG000|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
11061590|NCT01019252|12243376|FG001|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
11061591|NCT01019317|12243382|FG000|STARTED|Overall Study||151
11061592|NCT01019317|12243382|FG000|COMPLETED|Overall Study||147
11061593|NCT01019317|12243382|FG000|NOT COMPLETED|Overall Study||4
11061594|NCT01019369|12243388|FG000|STARTED|Overall Study||86
11061595|NCT01019369|12243389|FG001|STARTED|Overall Study||46
11061596|NCT01019369|12243388|FG000|COMPLETED|Overall Study||76
11061597|NCT01019369|12243389|FG001|COMPLETED|Overall Study||39
11061598|NCT01019369|12243388|FG000|NOT COMPLETED|Overall Study||10
11061599|NCT01019369|12243389|FG001|NOT COMPLETED|Overall Study||7
11061600|NCT01019486|12243399|FG000|STARTED|Overall Study||5
11061601|NCT01019486|12243400|FG001|STARTED|Overall Study||5
11061602|NCT01019486|12243401|FG002|STARTED|Overall Study||16
11061603|NCT01019486|12243399|FG000|COMPLETED|Overall Study||4
11061604|NCT01019486|12243400|FG001|COMPLETED|Overall Study||4
11061605|NCT01019486|12243401|FG002|COMPLETED|Overall Study||15
11061606|NCT01019486|12243399|FG000|NOT COMPLETED|Overall Study||1
11061607|NCT01019486|12243400|FG001|NOT COMPLETED|Overall Study||1
11061608|NCT01019486|12243401|FG002|NOT COMPLETED|Overall Study||1
11061609|NCT01019694|12243413|FG000|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
11061610|NCT01019694|12243414|FG001|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
11061611|NCT01019694|12243415|FG002|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
11061612|NCT01019694|12243413|FG000|COMPLETED|Overall Study||133
11061613|NCT01019694|12243414|FG001|COMPLETED|Overall Study||118
11061614|NCT01019694|12243415|FG002|COMPLETED|Overall Study||110
11061615|NCT01019694|12243413|FG000|NOT COMPLETED|Overall Study||24
11061616|NCT01019694|12243414|FG001|NOT COMPLETED|Overall Study||38
11061617|NCT01019694|12243415|FG002|NOT COMPLETED|Overall Study||47
11061618|NCT01019707|12243423|FG000|STARTED|First Phase||3
11061619|NCT01019707|12243424|FG001|STARTED|First Phase||3
11061620|NCT01019707|12243423|FG000|COMPLETED|First Phase||3
11061621|NCT01019707|12243424|FG001|COMPLETED|First Phase||3
11061622|NCT01019707|12243423|FG000|NOT COMPLETED|First Phase||0
11061623|NCT01019707|12243424|FG001|NOT COMPLETED|First Phase||0
11061624|NCT01019707|12243423|FG000|STARTED|Washout||3
11061625|NCT01019707|12243424|FG001|STARTED|Washout||3
11061626|NCT01019707|12243423|FG000|COMPLETED|Washout||3
11061627|NCT01019707|12243424|FG001|COMPLETED|Washout||1
11061628|NCT01019707|12243423|FG000|NOT COMPLETED|Washout||0
11061629|NCT01019707|12243424|FG001|NOT COMPLETED|Washout||2
11061630|NCT01019707|12243423|FG000|STARTED|Second Phase||3
11061631|NCT01019707|12243424|FG001|STARTED|Second Phase||1
11061632|NCT01019707|12243423|FG000|COMPLETED|Second Phase||3
11061633|NCT01019707|12243424|FG001|COMPLETED|Second Phase||1
11061634|NCT01019707|12243423|FG000|NOT COMPLETED|Second Phase||0
11061635|NCT01019707|12243424|FG001|NOT COMPLETED|Second Phase||0
11061636|NCT01019928|12243432|FG000|STARTED|Period 1||7
11061637|NCT01019928|12243433|FG001|STARTED|Period 1||7
11061638|NCT01019928|12243432|FG000|COMPLETED|Period 1||7
11061639|NCT01019928|12243433|FG001|COMPLETED|Period 1||7
11061640|NCT01019928|12243432|FG000|NOT COMPLETED|Period 1||0
11061641|NCT01019928|12243433|FG001|NOT COMPLETED|Period 1||0
11061642|NCT01019928|12243432|FG000|STARTED|Period 2||7
11061643|NCT01019928|12243433|FG001|STARTED|Period 2||7
11061644|NCT01019928|12243432|FG000|COMPLETED|Period 2||7
11061645|NCT01019928|12243433|FG001|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
11061646|NCT01019928|12243432|FG000|NOT COMPLETED|Period 2||0
11061647|NCT01019928|12243433|FG001|NOT COMPLETED|Period 2||1
11061648|NCT01019928|12243432|FG000|STARTED|Period 3||7
11061649|NCT01019928|12243433|FG001|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
11061650|NCT01019928|12243432|FG000|COMPLETED|Period 3||7
11061651|NCT01019928|12243433|FG001|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
11061652|NCT01019928|12243432|FG000|NOT COMPLETED|Period 3||0
11061653|NCT01019928|12243433|FG001|NOT COMPLETED|Period 3||0
11061654|NCT01020006|12243442|FG000|STARTED|Overall Study||8
11061655|NCT01020006|12243443|FG001|STARTED|Overall Study||18
11061656|NCT01020006|12243444|FG002|STARTED|Overall Study||16
11061657|NCT01020006|12243442|FG000|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
11061658|NCT01020006|12243443|FG001|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
11061659|NCT01020006|12243444|FG002|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
11061660|NCT01020006|12243442|FG000|NOT COMPLETED|Overall Study||8
11061661|NCT01020006|12243443|FG001|NOT COMPLETED|Overall Study||18
11061662|NCT01020006|12243444|FG002|NOT COMPLETED|Overall Study||16
11061663|NCT01020019|12243454|FG000|STARTED|Overall Study||61
11061664|NCT01020019|12243455|FG001|STARTED|Overall Study||61
11061665|NCT01020019|12243454|FG000|COMPLETED|Overall Study||35
11061666|NCT01020019|12243455|FG001|COMPLETED|Overall Study||32
11061667|NCT01020019|12243454|FG000|NOT COMPLETED|Overall Study||26
11061668|NCT01020019|12243455|FG001|NOT COMPLETED|Overall Study||29
11061669|NCT01020123|12243468|FG000|STARTED|Main Period||93
11061670|NCT01020123|12243469|FG001|STARTED|Main Period||91
11061671|NCT01020123|12243470|FG002|STARTED|Main Period||52
11061672|NCT01020123|12243471|FG003|STARTED|Main Period||40
11061673|NCT01020123|12243472|FG004|STARTED|Main Period||88
11061674|NCT01020123|12243473|FG005|STARTED|Main Period||94
11061675|NCT01020123|12243474|FG006|STARTED|Main Period||72
11061676|NCT01020123|12243468|FG000|COMPLETED|Main Period||76
11061677|NCT01020123|12243469|FG001|COMPLETED|Main Period||77
11061678|NCT01020123|12243470|FG002|COMPLETED|Main Period||44
11061679|NCT01020123|12243471|FG003|COMPLETED|Main Period||33
11061680|NCT01020123|12243472|FG004|COMPLETED|Main Period||77
11061681|NCT01020123|12243473|FG005|COMPLETED|Main Period||83
11061682|NCT01020123|12243474|FG006|COMPLETED|Main Period||61
11061683|NCT01020123|12243468|FG000|NOT COMPLETED|Main Period||17
11061684|NCT01020123|12243469|FG001|NOT COMPLETED|Main Period||14
11061685|NCT01020123|12243470|FG002|NOT COMPLETED|Main Period||8
11061686|NCT01020123|12243471|FG003|NOT COMPLETED|Main Period||7
11061687|NCT01020123|12243472|FG004|NOT COMPLETED|Main Period||11
11061688|NCT01020123|12243473|FG005|NOT COMPLETED|Main Period||11
11061689|NCT01020123|12243474|FG006|NOT COMPLETED|Main Period||11
11061690|NCT01020123|12243468|FG000|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
11061691|NCT01020123|12243469|FG001|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
11061692|NCT01020123|12243470|FG002|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
11061693|NCT01020123|12243471|FG003|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
11061694|NCT01020123|12243472|FG004|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
11061695|NCT01020123|12243473|FG005|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
11061696|NCT01020123|12243474|FG006|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
11061697|NCT01020123|12243468|FG000|COMPLETED|Extention Period||37
11061698|NCT01020123|12243469|FG001|COMPLETED|Extention Period||33
11061699|NCT01020123|12243470|FG002|COMPLETED|Extention Period||17
11061700|NCT01020123|12243471|FG003|COMPLETED|Extention Period||12
11061701|NCT01020123|12243472|FG004|COMPLETED|Extention Period||31
11061702|NCT01020123|12243473|FG005|COMPLETED|Extention Period||36
11061703|NCT01020123|12243474|FG006|COMPLETED|Extention Period||18
11061704|NCT01020123|12243468|FG000|NOT COMPLETED|Extention Period||3
11061705|NCT01020123|12243469|FG001|NOT COMPLETED|Extention Period||2
11344861|NCT02962908|12541839|FG001|STARTED|Overall Study||58
11344862|NCT02962908|12541840|FG002|STARTED|Overall Study||32
11344863|NCT02962908|12541841|FG003|STARTED|Overall Study||27
11344864|NCT02962908|12541838|FG000|COMPLETED|Overall Study||58
11344865|NCT02962908|12541839|FG001|COMPLETED|Overall Study||50
11344866|NCT02962908|12541840|FG002|COMPLETED|Overall Study||32
11344867|NCT02962908|12541841|FG003|COMPLETED|Overall Study||24
11344868|NCT02962908|12541838|FG000|NOT COMPLETED|Overall Study||0
11344869|NCT02962908|12541839|FG001|NOT COMPLETED|Overall Study||8
11344870|NCT02962908|12541840|FG002|NOT COMPLETED|Overall Study||0
11344871|NCT02962908|12541841|FG003|NOT COMPLETED|Overall Study||3
11344872|NCT02962934|12541859|FG000|STARTED|Overall Study||12
11061706|NCT01020123|12243470|FG002|NOT COMPLETED|Extention Period||2
11061707|NCT01020123|12243471|FG003|NOT COMPLETED|Extention Period||1
11061708|NCT01020123|12243472|FG004|NOT COMPLETED|Extention Period||0
11061709|NCT01020123|12243473|FG005|NOT COMPLETED|Extention Period||2
11061710|NCT01020123|12243474|FG006|NOT COMPLETED|Extention Period||1
11061711|NCT01020305|12243491|FG000|STARTED|Overall Study||5
11061712|NCT01020305|12243491|FG000|COMPLETED|Overall Study||3
11061713|NCT01020305|12243491|FG000|NOT COMPLETED|Overall Study||2
11061714|NCT01020435|12243497|FG000|STARTED|Overall Study||24
11344873|NCT02962934|12541860|FG001|STARTED|Overall Study||6
11344874|NCT02962934|12541859|FG000|COMPLETED|Overall Study||12
11344875|NCT02962934|12541860|FG001|COMPLETED|Overall Study||6
11344876|NCT02962934|12541859|FG000|NOT COMPLETED|Overall Study||0
11344877|NCT02962934|12541860|FG001|NOT COMPLETED|Overall Study||0
11344878|NCT02962960|12541869|FG000|STARTED|Overall Study||14
11344879|NCT02962960|12541870|FG001|STARTED|Overall Study||13
11344880|NCT02962960|12541871|FG002|STARTED|Overall Study||9
11344881|NCT02962960|12541869|FG000|COMPLETED|Overall Study||11
11344882|NCT02962960|12541870|FG001|COMPLETED|Overall Study||11
11344883|NCT02962960|12541871|FG002|COMPLETED|Overall Study||9
11344884|NCT02962960|12541869|FG000|NOT COMPLETED|Overall Study||3
11344885|NCT02962960|12541870|FG001|NOT COMPLETED|Overall Study||2
11344886|NCT02962960|12541871|FG002|NOT COMPLETED|Overall Study||0
11344887|NCT02963311|12541881|FG000|STARTED|Overall Study||9
11344888|NCT02963311|12541881|FG000|COMPLETED|Overall Study||4
11344889|NCT02963311|12541881|FG000|NOT COMPLETED|Overall Study||5
11344890|NCT02963376|12541889|FG000|STARTED|Overall Study||6
11344891|NCT02963376|12541890|FG001|STARTED|Overall Study||2
11344892|NCT02963376|12541891|FG002|STARTED|Overall Study||6
11344893|NCT02963376|12541892|FG003|STARTED|Overall Study||2
11344894|NCT02963376|12541893|FG004|STARTED|Overall Study||6
11344895|NCT02963376|12541894|FG005|STARTED|Overall Study||2
11344896|NCT02963376|12541889|FG000|COMPLETED|Overall Study||6
11344897|NCT02963376|12541890|FG001|COMPLETED|Overall Study||2
11344898|NCT02963376|12541891|FG002|COMPLETED|Overall Study||6
11344899|NCT02963376|12541892|FG003|COMPLETED|Overall Study||2
11344900|NCT02963376|12541893|FG004|COMPLETED|Overall Study||6
11344901|NCT02963376|12541894|FG005|COMPLETED|Overall Study||2
11344902|NCT02963376|12541889|FG000|NOT COMPLETED|Overall Study||0
11344903|NCT02963376|12541890|FG001|NOT COMPLETED|Overall Study||0
11344904|NCT02963376|12541891|FG002|NOT COMPLETED|Overall Study||0
11344905|NCT02963376|12541892|FG003|NOT COMPLETED|Overall Study||0
11344906|NCT02963376|12541893|FG004|NOT COMPLETED|Overall Study||0
11344907|NCT02963376|12541894|FG005|NOT COMPLETED|Overall Study||0
11344908|NCT02963441|12541916|FG000|STARTED|Overall Study||900
11344909|NCT02963441|12541916|FG000|COMPLETED|Overall Study||819
11344910|NCT02963441|12541916|FG000|NOT COMPLETED|Overall Study||81
11344911|NCT02963597|12541923|FG000|STARTED|Overall Study||10
11344912|NCT02963597|12541924|FG001|STARTED|Overall Study||11
11344913|NCT02963597|12541923|FG000|COMPLETED|Overall Study||10
11344914|NCT02963597|12541924|FG001|COMPLETED|Overall Study||11
11344915|NCT02963597|12541923|FG000|NOT COMPLETED|Overall Study||0
11344916|NCT02963597|12541924|FG001|NOT COMPLETED|Overall Study||0
11344917|NCT02963701|12541932|FG000|STARTED|Period 1 (Including Washout) (2 Days)||28
11344918|NCT02963701|12541933|FG001|STARTED|Period 1 (Including Washout) (2 Days)||28
11344919|NCT02963701|12541932|FG000|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
11344920|NCT02963701|12541933|FG001|COMPLETED|Period 1 (Including Washout) (2 Days)||28
11344921|NCT02963701|12541932|FG000|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
11344922|NCT02963701|12541933|FG001|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
11344923|NCT02963701|12541932|FG000|STARTED|Period 2 (2 Days)||27
11344924|NCT02963701|12541933|FG001|STARTED|Period 2 (2 Days)||28
11344925|NCT02963701|12541932|FG000|COMPLETED|Period 2 (2 Days)||27
11344926|NCT02963701|12541933|FG001|COMPLETED|Period 2 (2 Days)||28
11344927|NCT02963701|12541932|FG000|NOT COMPLETED|Period 2 (2 Days)||0
11344928|NCT02963701|12541933|FG001|NOT COMPLETED|Period 2 (2 Days)||0
11344929|NCT02963922|12541941|FG000|STARTED|Overall Study||198
11344930|NCT02963922|12541942|FG001|STARTED|Overall Study||198
11344931|NCT02963922|12541941|FG000|COMPLETED|Overall Study||166
11344932|NCT02963922|12541942|FG001|COMPLETED|Overall Study||168
11344933|NCT02963922|12541941|FG000|NOT COMPLETED|Overall Study||32
11344934|NCT02963922|12541942|FG001|NOT COMPLETED|Overall Study||30
11344935|NCT02963935|12541950|FG000|STARTED|Overall Study||142
11344936|NCT02963935|12541951|FG001|STARTED|Overall Study||140
11344937|NCT02963935|12541950|FG000|COMPLETED|Overall Study||114
11344938|NCT02963935|12541951|FG001|COMPLETED|Overall Study||103
11344939|NCT02963935|12541950|FG000|NOT COMPLETED|Overall Study||28
11344940|NCT02963935|12541951|FG001|NOT COMPLETED|Overall Study||37
11344941|NCT02963974|12541957|FG000|STARTED|Overall Study||20
11344942|NCT02963974|12541957|FG000|COMPLETED|Overall Study||19
11344943|NCT02963974|12541957|FG000|NOT COMPLETED|Overall Study||1
11344944|NCT02963987|12541961|FG000|STARTED|First Intervention Period||31
11344945|NCT02963987|12541962|FG001|STARTED|First Intervention Period||19
11344946|NCT02963987|12541961|FG000|COMPLETED|First Intervention Period||31
11344947|NCT02963987|12541962|FG001|COMPLETED|First Intervention Period||19
11061715|NCT01020435|12243498|FG001|STARTED|Overall Study||27
11061716|NCT01020435|12243497|FG000|COMPLETED|Overall Study||24
11061717|NCT01020435|12243498|FG001|COMPLETED|Overall Study||26
11061718|NCT01020435|12243497|FG000|NOT COMPLETED|Overall Study||0
11061719|NCT01020435|12243498|FG001|NOT COMPLETED|Overall Study||1
11061720|NCT01020448|12243505|FG000|STARTED|Pre-assignment||339
11061721|NCT01020448|12243505|FG000|COMPLETED|Pre-assignment||326
11061722|NCT01020448|12243505|FG000|NOT COMPLETED|Pre-assignment||13
11061723|NCT01020448|12243505|FG000|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
11061724|NCT01020448|12243505|FG000|COMPLETED|Treatment||299
11061725|NCT01020448|12243505|FG000|NOT COMPLETED|Treatment||26
11061726|NCT01020474|12243512|FG000|STARTED|Overall Study||54
11061727|NCT01020474|12243513|FG001|STARTED|Overall Study||53
11061728|NCT01020474|12243512|FG000|COMPLETED|Overall Study||44
11061729|NCT01020474|12243513|FG001|COMPLETED|Overall Study||36
11061730|NCT01020474|12243512|FG000|NOT COMPLETED|Overall Study||10
11061731|NCT01020474|12243513|FG001|NOT COMPLETED|Overall Study||17
11061732|NCT01020487|12243522|FG000|STARTED|Part 1||12
11061733|NCT01020487|12243523|FG001|STARTED|Part 1||0
11061734|NCT01020487|12243524|FG002|STARTED|Part 1||0
11061735|NCT01020487|12243522|FG000|COMPLETED|Part 1||12
11061736|NCT01020487|12243523|FG001|COMPLETED|Part 1||0
11061737|NCT01020487|12243524|FG002|COMPLETED|Part 1||0
11061738|NCT01020487|12243522|FG000|NOT COMPLETED|Part 1||0
11061739|NCT01020487|12243523|FG001|NOT COMPLETED|Part 1||0
11061740|NCT01020487|12243524|FG002|NOT COMPLETED|Part 1||0
11061741|NCT01020487|12243522|FG000|STARTED|Part 2 Double-blind Treatment Period||0
11061742|NCT01020487|12243523|FG001|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
11061743|NCT01020487|12243524|FG002|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
11061744|NCT01020487|12243522|FG000|Received Treatment|Part 2 Double-blind Treatment Period||0
11061745|NCT01020487|12243523|FG001|Received Treatment|Part 2 Double-blind Treatment Period||18
11061746|NCT01020487|12243524|FG002|Received Treatment|Part 2 Double-blind Treatment Period||18
11061747|NCT01020487|12243522|FG000|COMPLETED|Part 2 Double-blind Treatment Period||0
11061748|NCT01020487|12243523|FG001|COMPLETED|Part 2 Double-blind Treatment Period||16
11061749|NCT01020487|12243524|FG002|COMPLETED|Part 2 Double-blind Treatment Period||13
11061750|NCT01020487|12243522|FG000|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
11061751|NCT01020487|12243523|FG001|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
11061752|NCT01020487|12243524|FG002|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
11061753|NCT01020487|12243522|FG000|STARTED|Part 2 Open-label Period||0
11061754|NCT01020487|12243523|FG001|STARTED|Part 2 Open-label Period||16
11061755|NCT01020487|12243524|FG002|STARTED|Part 2 Open-label Period||13
11061756|NCT01020487|12243522|FG000|COMPLETED|Part 2 Open-label Period||0
11061757|NCT01020487|12243523|FG001|COMPLETED|Part 2 Open-label Period||12
11061758|NCT01020487|12243524|FG002|COMPLETED|Part 2 Open-label Period||12
11344948|NCT02963987|12541961|FG000|NOT COMPLETED|First Intervention Period||0
11344949|NCT02963987|12541962|FG001|NOT COMPLETED|First Intervention Period||0
11061759|NCT01020487|12243522|FG000|NOT COMPLETED|Part 2 Open-label Period||0
11061760|NCT01020487|12243523|FG001|NOT COMPLETED|Part 2 Open-label Period||4
11061761|NCT01020487|12243524|FG002|NOT COMPLETED|Part 2 Open-label Period||1
11061762|NCT01020526|12243534|FG000|STARTED|Overall Study||63
11061763|NCT01020526|12243534|FG000|COMPLETED|Overall Study||49
11061764|NCT01020526|12243534|FG000|NOT COMPLETED|Overall Study||14
11061765|NCT01020591|12243540|FG000|STARTED|Overall Study||15
11061766|NCT01020591|12243541|FG001|STARTED|Overall Study||15
11061767|NCT01020591|12243540|FG000|COMPLETED|Overall Study||15
11061768|NCT01020591|12243541|FG001|COMPLETED|Overall Study||15
11061769|NCT01020591|12243540|FG000|NOT COMPLETED|Overall Study||0
11061770|NCT01020591|12243541|FG001|NOT COMPLETED|Overall Study||0
11061771|NCT01020747|12243549|FG000|STARTED|Overall Study||20
11061772|NCT01020747|12243549|FG000|COMPLETED|Overall Study||19
11061773|NCT01020747|12243549|FG000|NOT COMPLETED|Overall Study||1
11061774|NCT01020773|12243556|FG000|STARTED|Overall Study||35
11061775|NCT01020773|12243557|FG001|STARTED|Overall Study||32
11061776|NCT01020773|12243556|FG000|COMPLETED|Overall Study||31
11061777|NCT01020773|12243557|FG001|COMPLETED|Overall Study||29
11061778|NCT01020773|12243556|FG000|NOT COMPLETED|Overall Study||4
11061779|NCT01020773|12243557|FG001|NOT COMPLETED|Overall Study||3
11061780|NCT01020786|12243563|FG000|STARTED|Induction Period||109
11061781|NCT01020786|12243563|FG000|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
11061782|NCT01020786|12243563|FG000|NOT COMPLETED|Induction Period||49
11061783|NCT01020786|12243563|FG000|STARTED|Maintenance Period||60
11061784|NCT01020786|12243563|FG000|COMPLETED|Maintenance Period||0
11061785|NCT01020786|12243563|FG000|NOT COMPLETED|Maintenance Period||60
11061786|NCT01020799|12243571|FG000|STARTED|Overall Study||98
11061787|NCT01020799|12243572|FG001|STARTED|Overall Study||99
11061788|NCT01020799|12243573|FG002|STARTED|Overall Study||50
11061789|NCT01020799|12243571|FG000|Patients Received Treatment|Overall Study||96
11205546|NCT01859793|12396345|FG001|STARTED|2nd Intervention Period||16
11205547|NCT01859793|12396344|FG000|COMPLETED|2nd Intervention Period||14
11205548|NCT01859793|12396345|FG001|COMPLETED|2nd Intervention Period||16
11205549|NCT01859793|12396344|FG000|NOT COMPLETED|2nd Intervention Period||0
11205550|NCT01859793|12396345|FG001|NOT COMPLETED|2nd Intervention Period||0
11205551|NCT01859923|12396355|FG000|STARTED|Overall Study||7
11205552|NCT01859923|12396356|FG001|STARTED|Overall Study||6
11205553|NCT01859923|12396357|FG002|STARTED|Overall Study||12
11205554|NCT01859923|12396358|FG003|STARTED|Overall Study||12
11205555|NCT01859923|12396355|FG000|COMPLETED|Overall Study||7
11205556|NCT01859923|12396356|FG001|COMPLETED|Overall Study||6
11205557|NCT01859923|12396357|FG002|COMPLETED|Overall Study||11
11205558|NCT01859923|12396358|FG003|COMPLETED|Overall Study||11
11205559|NCT01859923|12396355|FG000|NOT COMPLETED|Overall Study||0
11205560|NCT01859923|12396356|FG001|NOT COMPLETED|Overall Study||0
11205561|NCT01859923|12396357|FG002|NOT COMPLETED|Overall Study||1
11205562|NCT01859923|12396358|FG003|NOT COMPLETED|Overall Study||1
11205563|NCT01859949|12396373|FG000|STARTED|Overall Study|Treated participants|29
11205564|NCT01859949|12396374|FG001|STARTED|Overall Study|Treated participants|32
11205565|NCT01859949|12396373|FG000|COMPLETED|Overall Study||15
11205566|NCT01859949|12396374|FG001|COMPLETED|Overall Study||15
11205567|NCT01859949|12396373|FG000|NOT COMPLETED|Overall Study||14
11205568|NCT01859949|12396374|FG001|NOT COMPLETED|Overall Study||17
11205569|NCT01859988|12396386|FG000|STARTED|Overall Study||63
11205570|NCT01859988|12396387|FG001|STARTED|Overall Study||64
11205571|NCT01859988|12396388|FG002|STARTED|Overall Study||62
11205572|NCT01859988|12396389|FG003|STARTED|Overall Study||65
11344950|NCT02963987|12541961|FG000|STARTED|Second Intervention Period||31
11344951|NCT02963987|12541962|FG001|STARTED|Second Intervention Period||19
11344952|NCT02963987|12541961|FG000|COMPLETED|Second Intervention Period||31
11344953|NCT02963987|12541962|FG001|COMPLETED|Second Intervention Period||19
11344954|NCT02963987|12541961|FG000|NOT COMPLETED|Second Intervention Period||0
11344955|NCT02963987|12541962|FG001|NOT COMPLETED|Second Intervention Period||0
11344956|NCT02964234|12541972|FG000|STARTED|Overall Study||76
11344957|NCT02964234|12541973|FG001|STARTED|Overall Study||69
11344958|NCT02964234|12541972|FG000|COMPLETED|Overall Study||54
11344959|NCT02964234|12541973|FG001|COMPLETED|Overall Study||56
11344960|NCT02964234|12541972|FG000|NOT COMPLETED|Overall Study||22
11344961|NCT02964234|12541973|FG001|NOT COMPLETED|Overall Study||13
11344962|NCT02964247|12541981|FG000|STARTED|Overall Study||203
11344963|NCT02964247|12541982|FG001|STARTED|Overall Study||100
11061790|NCT01020799|12243572|FG001|Patients Received Treatment|Overall Study||99
11205573|NCT01859988|12396390|FG004|STARTED|Overall Study||65
11205574|NCT01859988|12396391|FG005|STARTED|Overall Study||61
11205575|NCT01859988|12396386|FG000|Treated|Overall Study||63
11205576|NCT01859988|12396387|FG001|Treated|Overall Study||64
11344964|NCT02964247|12541981|FG000|Exposed to Trial Product|Overall Study||202
11344965|NCT02964247|12541982|FG001|Exposed to Trial Product|Overall Study||100
11344966|NCT02964247|12541981|FG000|COMPLETED|Overall Study||200
11344967|NCT02964247|12541982|FG001|COMPLETED|Overall Study||98
11344968|NCT02964247|12541981|FG000|NOT COMPLETED|Overall Study||3
11344969|NCT02964247|12541982|FG001|NOT COMPLETED|Overall Study||2
11344970|NCT02964312|12541988|FG000|STARTED|Overall Study||166
11344971|NCT02964312|12541988|FG000|1-Month Follow-up|Overall Study||164
11344972|NCT02964312|12541988|FG000|3-Month Follow-up|Overall Study||159
11344973|NCT02964312|12541988|FG000|6-Month Follow-up|Overall Study||152
11344974|NCT02964312|12541988|FG000|12-Month Follow-up|Overall Study||139
11205577|NCT01859988|12396388|FG002|Treated|Overall Study||61
11205578|NCT01859988|12396389|FG003|Treated|Overall Study||65
11205579|NCT01859988|12396390|FG004|Treated|Overall Study||65
11205580|NCT01859988|12396391|FG005|Treated|Overall Study||61
11344975|NCT02964312|12541988|FG000|18-Month Follow-up|Overall Study||112
11344976|NCT02964312|12541988|FG000|24-Month Follow-up|Overall Study||102
11344977|NCT02964312|12541988|FG000|COMPLETED|Overall Study||102
11061791|NCT01020799|12243573|FG002|Patients Received Treatment|Overall Study||50
11061792|NCT01020799|12243571|FG000|Full Analysis Set|Overall Study||91
11061793|NCT01020799|12243572|FG001|Full Analysis Set|Overall Study||94
11061794|NCT01020799|12243573|FG002|Full Analysis Set|Overall Study||49
11061795|NCT01020799|12243571|FG000|COMPLETED|Overall Study||79
11061796|NCT01020799|12243572|FG001|COMPLETED|Overall Study||85
11061797|NCT01020799|12243573|FG002|COMPLETED|Overall Study||43
11061798|NCT01020799|12243571|FG000|NOT COMPLETED|Overall Study||19
11061799|NCT01020799|12243572|FG001|NOT COMPLETED|Overall Study||14
11061800|NCT01020799|12243573|FG002|NOT COMPLETED|Overall Study||7
11061801|NCT01020812|12243581|FG000|STARTED|Overall Study||11
11061802|NCT01020812|12243581|FG000|COMPLETED|Overall Study||8
11061803|NCT01020812|12243581|FG000|NOT COMPLETED|Overall Study||3
11061804|NCT01020838|12243585|FG000|STARTED|Overall Study||218
11061805|NCT01020838|12243585|FG000|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
11061806|NCT01020838|12243585|FG000|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
11061807|NCT01020838|12243585|FG000|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
11061808|NCT01020838|12243585|FG000|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
11061809|NCT01020838|12243585|FG000|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
11344978|NCT02964312|12541988|FG000|NOT COMPLETED|Overall Study||64
11344979|NCT02964325|12541997|FG000|STARTED|Overall Study||164
11344980|NCT02964325|12541998|FG001|STARTED|Overall Study||166
11344981|NCT02964325|12541997|FG000|Full Analysis Set|Overall Study||164
11344982|NCT02964325|12541998|FG001|Full Analysis Set|Overall Study||166
11344983|NCT02964325|12541997|FG000|Modified Intent-to-Treat|Overall Study||145
11344984|NCT02964325|12541998|FG001|Modified Intent-to-Treat|Overall Study||152
11344985|NCT02964325|12541997|FG000|Safety Set|Overall Study||141
11344986|NCT02964325|12541998|FG001|Safety Set|Overall Study||161
11344987|NCT02964325|12541997|FG000|COMPLETED|Overall Study||143
11344988|NCT02964325|12541998|FG001|COMPLETED|Overall Study||143
11344989|NCT02964325|12541997|FG000|NOT COMPLETED|Overall Study||21
11344990|NCT02964325|12541998|FG001|NOT COMPLETED|Overall Study||23
11344991|NCT02964338|12542007|FG000|STARTED|Overall Study||84
11344992|NCT02964338|12542008|FG001|STARTED|Overall Study||88
11344993|NCT02964338|12542009|FG002|STARTED|Overall Study||87
11344994|NCT02964338|12542007|FG000|Safety Analysis Set|Overall Study||83
11344995|NCT02964338|12542008|FG001|Safety Analysis Set|Overall Study||88
11344996|NCT02964338|12542009|FG002|Safety Analysis Set|Overall Study||87
11344997|NCT02964338|12542007|FG000|Full Analysis Set|Overall Study||81
11344998|NCT02964338|12542008|FG001|Full Analysis Set|Overall Study||86
11344999|NCT02964338|12542009|FG002|Full Analysis Set|Overall Study||87
11345000|NCT02964338|12542007|FG000|COMPLETED|Overall Study||67
11345001|NCT02964338|12542008|FG001|COMPLETED|Overall Study||64
11345002|NCT02964338|12542009|FG002|COMPLETED|Overall Study||68
11345003|NCT02964338|12542007|FG000|NOT COMPLETED|Overall Study||17
11345004|NCT02964338|12542008|FG001|NOT COMPLETED|Overall Study||24
11345005|NCT02964338|12542009|FG002|NOT COMPLETED|Overall Study||19
11345006|NCT02964416|12542019|FG000|STARTED|Overall Study||39
11345007|NCT02964416|12542020|FG001|STARTED|Overall Study||41
11345008|NCT02964416|12542019|FG000|COMPLETED|Overall Study||38
11345009|NCT02964416|12542020|FG001|COMPLETED|Overall Study||41
11345010|NCT02964416|12542019|FG000|NOT COMPLETED|Overall Study||1
11345011|NCT02964416|12542020|FG001|NOT COMPLETED|Overall Study||0
11345012|NCT02964767|12542029|FG000|STARTED|Overall Study||171
11345013|NCT02964767|12542030|FG001|STARTED|Overall Study||48
11345014|NCT02964767|12542029|FG000|COMPLETED|Overall Study||171
11345015|NCT02964767|12542030|FG001|COMPLETED|Overall Study||48
11345016|NCT02964767|12542029|FG000|NOT COMPLETED|Overall Study||0
11345017|NCT02964767|12542030|FG001|NOT COMPLETED|Overall Study||0
11345018|NCT02964910|12542039|FG000|STARTED|Overall Study||235
11345019|NCT02964910|12542040|FG001|STARTED|Overall Study||240
11205581|NCT01859988|12396386|FG000|COMPLETED|Overall Study||52
11205582|NCT01859988|12396387|FG001|COMPLETED|Overall Study||52
11205583|NCT01859988|12396388|FG002|COMPLETED|Overall Study||34
11205584|NCT01859988|12396389|FG003|COMPLETED|Overall Study||55
11205585|NCT01859988|12396390|FG004|COMPLETED|Overall Study||42
11205586|NCT01859988|12396391|FG005|COMPLETED|Overall Study||42
11205587|NCT01859988|12396386|FG000|NOT COMPLETED|Overall Study||11
11345020|NCT02964910|12542039|FG000|COMPLETED|Overall Study||192
11345021|NCT02964910|12542040|FG001|COMPLETED|Overall Study||196
11345022|NCT02964910|12542039|FG000|NOT COMPLETED|Overall Study||43
11345023|NCT02964910|12542040|FG001|NOT COMPLETED|Overall Study||44
11345024|NCT02965144|12542048|FG000|STARTED|Overall Study||13
11345025|NCT02965144|12542048|FG000|COMPLETED|Overall Study||13
11345026|NCT02965144|12542048|FG000|NOT COMPLETED|Overall Study||0
11345027|NCT02965378|12542057|FG000|STARTED|Overall Study||25
11345028|NCT02965378|12542058|FG001|STARTED|Overall Study||9
11345029|NCT02965378|12542057|FG000|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||0
11345030|NCT02965378|12542058|FG001|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||2
11345031|NCT02965378|12542057|FG000|COMPLETED|Overall Study||0
11345032|NCT02965378|12542058|FG001|COMPLETED|Overall Study||0
11061810|NCT01020838|12243585|FG000|COMPLETED|Overall Study||35
11061811|NCT01020838|12243585|FG000|NOT COMPLETED|Overall Study||183
11061812|NCT01020877|12243600|FG000|STARTED|First Intervention||19
11061813|NCT01020877|12243601|FG001|STARTED|First Intervention||19
11061814|NCT01020877|12243600|FG000|COMPLETED|First Intervention||19
11061815|NCT01020877|12243601|FG001|COMPLETED|First Intervention||19
11061816|NCT01020877|12243600|FG000|NOT COMPLETED|First Intervention||0
11061817|NCT01020877|12243601|FG001|NOT COMPLETED|First Intervention||0
11061818|NCT01020877|12243600|FG000|STARTED|Washout of 7 Days||19
11061819|NCT01020877|12243601|FG001|STARTED|Washout of 7 Days||19
11061820|NCT01020877|12243600|FG000|COMPLETED|Washout of 7 Days||19
11061821|NCT01020877|12243601|FG001|COMPLETED|Washout of 7 Days||19
11061822|NCT01020877|12243600|FG000|NOT COMPLETED|Washout of 7 Days||0
11061823|NCT01020877|12243601|FG001|NOT COMPLETED|Washout of 7 Days||0
11061824|NCT01020877|12243600|FG000|STARTED|Second Intervention||19
11061825|NCT01020877|12243601|FG001|STARTED|Second Intervention||19
11061826|NCT01020877|12243600|FG000|COMPLETED|Second Intervention||18
11061827|NCT01020877|12243601|FG001|COMPLETED|Second Intervention||19
11061828|NCT01020877|12243600|FG000|NOT COMPLETED|Second Intervention||1
11061829|NCT01020877|12243601|FG001|NOT COMPLETED|Second Intervention||0
11061830|NCT01020981|12243609|FG000|STARTED|Overall Study||150
11345033|NCT02965378|12542057|FG000|NOT COMPLETED|Overall Study||25
11345034|NCT02965378|12542058|FG001|NOT COMPLETED|Overall Study||9
11345035|NCT02965456|12542066|FG000|STARTED|Overall Study||413
11345036|NCT02965456|12542067|FG001|STARTED|Overall Study||407
11345037|NCT02965456|12542066|FG000|Intent-to-treat (ITT) Population|Overall Study||413
11345038|NCT02965456|12542067|FG001|Intent-to-treat (ITT) Population|Overall Study||407
11345039|NCT02965456|12542066|FG000|Safety Population|Overall Study||389
11345040|NCT02965456|12542067|FG001|Safety Population|Overall Study||398
11345041|NCT02965456|12542066|FG000|COMPLETED|Overall Study||342
11345042|NCT02965456|12542067|FG001|COMPLETED|Overall Study||364
11345043|NCT02965456|12542066|FG000|NOT COMPLETED|Overall Study||71
11345044|NCT02965456|12542067|FG001|NOT COMPLETED|Overall Study||43
11345045|NCT02965534|12542073|FG000|STARTED|Overall Study|test period: 14 days with each test glasses|45
11345046|NCT02965534|12542074|FG001|STARTED|Overall Study|test period: 14 days with each test glasses|55
11345047|NCT02965534|12542073|FG000|COMPLETED|Overall Study||45
11345048|NCT02965534|12542074|FG001|COMPLETED|Overall Study||55
11345049|NCT02965534|12542073|FG000|NOT COMPLETED|Overall Study||0
11345050|NCT02965534|12542074|FG001|NOT COMPLETED|Overall Study||0
11345051|NCT02965573|12542083|FG000|STARTED|Overall Study||12
11345052|NCT02965573|12542084|FG001|STARTED|Overall Study||12
11345053|NCT02965573|12542083|FG000|COMPLETED|Overall Study||11
11345054|NCT02965573|12542084|FG001|COMPLETED|Overall Study||12
11345055|NCT02965573|12542083|FG000|NOT COMPLETED|Overall Study||1
11345056|NCT02965573|12542084|FG001|NOT COMPLETED|Overall Study||0
11345057|NCT02965599|12542092|FG000|STARTED|Overall Study||2
11345058|NCT02965599|12542093|FG001|STARTED|Overall Study||1
11345059|NCT02965599|12542092|FG000|COMPLETED|Overall Study||1
11345060|NCT02965599|12542093|FG001|COMPLETED|Overall Study||1
11345061|NCT02965599|12542092|FG000|NOT COMPLETED|Overall Study||1
11345062|NCT02965599|12542093|FG001|NOT COMPLETED|Overall Study||0
11345063|NCT02965781|12542103|FG000|STARTED|Overall Study||46
11345064|NCT02965781|12542104|FG001|STARTED|Overall Study||46
11345065|NCT02965781|12542105|FG002|STARTED|Overall Study||47
11345066|NCT02965781|12542103|FG000|COMPLETED|Overall Study||46
11345067|NCT02965781|12542104|FG001|COMPLETED|Overall Study||46
11345068|NCT02965781|12542105|FG002|COMPLETED|Overall Study||47
11345069|NCT02965781|12542103|FG000|NOT COMPLETED|Overall Study||0
11345070|NCT02965781|12542104|FG001|NOT COMPLETED|Overall Study||0
11345071|NCT02965781|12542105|FG002|NOT COMPLETED|Overall Study||0
11345072|NCT02965820|12542113|FG000|STARTED|Period 1, First 30 Days||59
11345073|NCT02965820|12542114|FG001|STARTED|Period 1, First 30 Days||62
11345074|NCT02965820|12542113|FG000|COMPLETED|Period 1, First 30 Days||59
11345075|NCT02965820|12542114|FG001|COMPLETED|Period 1, First 30 Days||62
11345076|NCT02965820|12542113|FG000|NOT COMPLETED|Period 1, First 30 Days||0
11345077|NCT02965820|12542114|FG001|NOT COMPLETED|Period 1, First 30 Days||0
11061831|NCT01020981|12243610|FG001|STARTED|Overall Study||150
11061832|NCT01020981|12243609|FG000|COMPLETED|Overall Study||66
11061833|NCT01020981|12243610|FG001|COMPLETED|Overall Study||60
11061834|NCT01020981|12243609|FG000|NOT COMPLETED|Overall Study||84
11061835|NCT01020981|12243610|FG001|NOT COMPLETED|Overall Study||90
11345078|NCT02965820|12542113|FG000|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
11345079|NCT02965820|12542114|FG001|STARTED|Period 2, Second 30 Days||62
11345080|NCT02965820|12542113|FG000|COMPLETED|Period 2, Second 30 Days||57
11345081|NCT02965820|12542114|FG001|COMPLETED|Period 2, Second 30 Days||61
11345082|NCT02965820|12542113|FG000|NOT COMPLETED|Period 2, Second 30 Days||1
11345083|NCT02965820|12542114|FG001|NOT COMPLETED|Period 2, Second 30 Days||1
11345084|NCT02965833|12542120|FG000|STARTED|Period 1, First 30 Days of Wear||67
11345085|NCT02965833|12542121|FG001|STARTED|Period 1, First 30 Days of Wear||54
11345086|NCT02965833|12542120|FG000|COMPLETED|Period 1, First 30 Days of Wear||64
11061836|NCT01021007|12243620|FG000|STARTED|Overall Study||36
11061837|NCT01021007|12243621|FG001|STARTED|Overall Study||37
11061838|NCT01021007|12243620|FG000|COMPLETED|Overall Study||34
11061839|NCT01021007|12243621|FG001|COMPLETED|Overall Study||33
11061840|NCT01021007|12243620|FG000|NOT COMPLETED|Overall Study||2
11061841|NCT01021007|12243621|FG001|NOT COMPLETED|Overall Study||4
11061842|NCT01021020|12243627|FG000|STARTED|Period I||28
11061843|NCT01021020|12243627|FG000|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
11061844|NCT01021020|12243627|FG000|NOT COMPLETED|Period I||2
11061845|NCT01021020|12243627|FG000|STARTED|14 Day Washout Period A||26
11061846|NCT01021020|12243627|FG000|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
11061847|NCT01021020|12243627|FG000|NOT COMPLETED|14 Day Washout Period A||1
11061848|NCT01021020|12243627|FG000|STARTED|Period II||25
11061849|NCT01021020|12243627|FG000|COMPLETED|Period II||25
11061850|NCT01021020|12243627|FG000|NOT COMPLETED|Period II||0
11061851|NCT01021020|12243627|FG000|STARTED|14 Day Washout Period B||25
11061852|NCT01021020|12243627|FG000|COMPLETED|14 Day Washout Period B||25
11061853|NCT01021020|12243627|FG000|NOT COMPLETED|14 Day Washout Period B||0
11061854|NCT01021020|12243627|FG000|STARTED|Period III||25
11061855|NCT01021020|12243627|FG000|COMPLETED|Period III||25
11061856|NCT01021020|12243627|FG000|NOT COMPLETED|Period III||0
11061857|NCT01021111|12243639|FG000|STARTED|Overall Study||17
11061858|NCT01021111|12243639|FG000|COMPLETED|Overall Study||17
11061859|NCT01021111|12243639|FG000|NOT COMPLETED|Overall Study||0
11061860|NCT01021137|12243647|FG000|STARTED|Overall Study||62
11061861|NCT01021137|12243648|FG001|STARTED|Overall Study||20
11061862|NCT01021137|12243649|FG002|STARTED|Overall Study||11
11061863|NCT01021137|12243650|FG003|STARTED|Overall Study||41
11061864|NCT01021137|12243647|FG000|COMPLETED|Overall Study||52
11061865|NCT01021137|12243648|FG001|COMPLETED|Overall Study||16
11061866|NCT01021137|12243649|FG002|COMPLETED|Overall Study||9
11061867|NCT01021137|12243650|FG003|COMPLETED|Overall Study||32
11061868|NCT01021137|12243647|FG000|NOT COMPLETED|Overall Study||10
11061869|NCT01021137|12243648|FG001|NOT COMPLETED|Overall Study||4
11061870|NCT01021137|12243649|FG002|NOT COMPLETED|Overall Study||2
11061871|NCT01021137|12243650|FG003|NOT COMPLETED|Overall Study||9
11061872|NCT01021215|12243663|FG000|STARTED|Overall Study||60
11061873|NCT01021215|12243664|FG001|STARTED|Overall Study||20
11061874|NCT01021215|12243663|FG000|Received Allocated Intervention|Overall Study||60
11061875|NCT01021215|12243664|FG001|Received Allocated Intervention|Overall Study||20
11061876|NCT01021215|12243663|FG000|COMPLETED|Overall Study||57
11061877|NCT01021215|12243664|FG001|COMPLETED|Overall Study||20
11061878|NCT01021215|12243663|FG000|NOT COMPLETED|Overall Study||3
11061879|NCT01021215|12243664|FG001|NOT COMPLETED|Overall Study||0
11205588|NCT01859988|12396387|FG001|NOT COMPLETED|Overall Study||12
11205589|NCT01859988|12396388|FG002|NOT COMPLETED|Overall Study||28
11205590|NCT01859988|12396389|FG003|NOT COMPLETED|Overall Study||10
11205591|NCT01859988|12396390|FG004|NOT COMPLETED|Overall Study||23
11205592|NCT01859988|12396391|FG005|NOT COMPLETED|Overall Study||19
11205593|NCT01860079|12396407|FG000|STARTED|Overall Study||384
11205594|NCT01860079|12396408|FG001|STARTED|Overall Study||385
11205595|NCT01860079|12396407|FG000|COMPLETED|Overall Study||370
11205596|NCT01860079|12396408|FG001|COMPLETED|Overall Study||363
11205597|NCT01860079|12396407|FG000|NOT COMPLETED|Overall Study||14
11205598|NCT01860079|12396408|FG001|NOT COMPLETED|Overall Study||22
11205599|NCT01860170|12396417|FG000|STARTED|Overall Study||3
11205600|NCT01860170|12396418|FG001|STARTED|Overall Study||3
11205601|NCT01860170|12396419|FG002|STARTED|Overall Study||22
11205602|NCT01860170|12396417|FG000|COMPLETED|Overall Study||3
11205603|NCT01860170|12396418|FG001|COMPLETED|Overall Study||3
11205604|NCT01860170|12396419|FG002|COMPLETED|Overall Study||22
11205605|NCT01860170|12396417|FG000|NOT COMPLETED|Overall Study||0
11205606|NCT01860170|12396418|FG001|NOT COMPLETED|Overall Study||0
11205607|NCT01860170|12396419|FG002|NOT COMPLETED|Overall Study||0
11205608|NCT01860287|12396430|FG000|STARTED|Overall Study||18
11205609|NCT01860287|12396431|FG001|STARTED|Overall Study||15
11205610|NCT01860287|12396432|FG002|STARTED|Overall Study||15
11205611|NCT01860287|12396430|FG000|COMPLETED|Overall Study||18
11205612|NCT01860287|12396431|FG001|COMPLETED|Overall Study||15
11205613|NCT01860287|12396432|FG002|COMPLETED|Overall Study||15
11205614|NCT01860287|12396430|FG000|NOT COMPLETED|Overall Study||0
11205615|NCT01860287|12396431|FG001|NOT COMPLETED|Overall Study||0
11205616|NCT01860287|12396432|FG002|NOT COMPLETED|Overall Study||0
11205617|NCT01860521|12396442|FG000|STARTED|Overall Study|September 2011|52
11205618|NCT01860521|12396443|FG001|STARTED|Overall Study|September 2011|52
11205619|NCT01860521|12396442|FG000|COMPLETED|Overall Study|June 2013|52
11205620|NCT01860521|12396443|FG001|COMPLETED|Overall Study|June 2013|52
11061880|NCT04525456|12243670|FG000|STARTED|Overall Study||20
11061881|NCT04525456|12243670|FG000|COMPLETED|Overall Study||20
11061882|NCT04525456|12243670|FG000|NOT COMPLETED|Overall Study||0
11061883|NCT04102501|12243677|FG000|STARTED|Overall Study||33
11061884|NCT04102501|12243678|FG001|STARTED|Overall Study||32
11061885|NCT04102501|12243677|FG000|11 Month Visit|Overall Study||25
11061886|NCT04102501|12243678|FG001|11 Month Visit|Overall Study||20
11061887|NCT04102501|12243677|FG000|COMPLETED|Overall Study||25
11061888|NCT04102501|12243678|FG001|COMPLETED|Overall Study||20
11061889|NCT04102501|12243677|FG000|NOT COMPLETED|Overall Study||8
11061890|NCT04102501|12243678|FG001|NOT COMPLETED|Overall Study||12
11061891|NCT04087343|12243688|FG000|STARTED|Overall Study||4
11061892|NCT04087343|12243689|FG001|STARTED|Overall Study||5
11061893|NCT04087343|12243688|FG000|COMPLETED|Overall Study||4
11061894|NCT04087343|12243689|FG001|COMPLETED|Overall Study||5
11061895|NCT04087343|12243688|FG000|NOT COMPLETED|Overall Study||0
11061896|NCT04087343|12243689|FG001|NOT COMPLETED|Overall Study||0
11205621|NCT01860521|12396442|FG000|NOT COMPLETED|Overall Study||0
11205622|NCT01860521|12396443|FG001|NOT COMPLETED|Overall Study||0
11205623|NCT01860534|12396451|FG000|STARTED|ROP #1||14
11205624|NCT01860534|12396452|FG001|STARTED|ROP #1||14
11205625|NCT01860534|12396451|FG000|COMPLETED|ROP #1||14
11205626|NCT01860534|12396452|FG001|COMPLETED|ROP #1||13
11205627|NCT01860534|12396451|FG000|NOT COMPLETED|ROP #1||0
11205628|NCT01860534|12396452|FG001|NOT COMPLETED|ROP #1||1
11205629|NCT01860534|12396451|FG000|STARTED|ROP #2||14
11205630|NCT01860534|12396452|FG001|STARTED|ROP #2||13
11205631|NCT01860534|12396451|FG000|COMPLETED|ROP #2||13
11205632|NCT01860534|12396452|FG001|COMPLETED|ROP #2||13
11205633|NCT01860534|12396451|FG000|NOT COMPLETED|ROP #2||1
11205634|NCT01860534|12396452|FG001|NOT COMPLETED|ROP #2||0
11205635|NCT01860573|12396462|FG000|STARTED|Overall Study||83
11205636|NCT01860573|12396463|FG001|STARTED|Overall Study||85
11205637|NCT01860573|12396462|FG000|COMPLETED|Overall Study||83
11205638|NCT01860573|12396463|FG001|COMPLETED|Overall Study||85
11205639|NCT01860573|12396462|FG000|NOT COMPLETED|Overall Study||0
11205640|NCT01860573|12396463|FG001|NOT COMPLETED|Overall Study||0
11205641|NCT01860586|12396469|FG000|STARTED|Overall Study||20
11205642|NCT01860586|12396469|FG000|COMPLETED|Overall Study||20
11205643|NCT01860586|12396469|FG000|NOT COMPLETED|Overall Study||0
11205644|NCT01860651|12396476|FG000|STARTED|Overall Study||56
11205645|NCT01860651|12396477|FG001|STARTED|Overall Study||47
11205646|NCT01860651|12396476|FG000|COMPLETED|Overall Study||31
11205647|NCT01860651|12396477|FG001|COMPLETED|Overall Study||39
11205648|NCT01860651|12396476|FG000|NOT COMPLETED|Overall Study||25
11205649|NCT01860651|12396477|FG001|NOT COMPLETED|Overall Study||8
11205650|NCT01860677|12396489|FG000|STARTED|First Intervention (1 Day)||8
11205651|NCT01860677|12396490|FG001|STARTED|First Intervention (1 Day)||0
11205652|NCT01860677|12396489|FG000|COMPLETED|First Intervention (1 Day)||8
11205653|NCT01860677|12396490|FG001|COMPLETED|First Intervention (1 Day)||0
11205654|NCT01860677|12396489|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11205655|NCT01860677|12396490|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11205656|NCT01860677|12396489|FG000|STARTED|Second Intervention (1 Day)||8
11345087|NCT02965833|12542121|FG001|COMPLETED|Period 1, First 30 Days of Wear||52
11345088|NCT02965833|12542120|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3
11345089|NCT02965833|12542121|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||2
11345090|NCT02965833|12542120|FG000|STARTED|Period 2, Second 30 Days of Wear||64
11345091|NCT02965833|12542121|FG001|STARTED|Period 2, Second 30 Days of Wear||52
11345092|NCT02965833|12542120|FG000|COMPLETED|Period 2, Second 30 Days of Wear||62
11345093|NCT02965833|12542121|FG001|COMPLETED|Period 2, Second 30 Days of Wear||52
11345094|NCT02965833|12542120|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
11345095|NCT02965833|12542121|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
11345096|NCT02965924|12542127|FG000|STARTED|Overall Study||20
11345097|NCT02965924|12542127|FG000|COMPLETED|Overall Study||20
11345098|NCT02965924|12542127|FG000|NOT COMPLETED|Overall Study||0
11345099|NCT02965989|12542133|FG000|STARTED|Overall Study||26
11345100|NCT02965989|12542134|FG001|STARTED|Overall Study||22
11205657|NCT01860677|12396490|FG001|STARTED|Second Intervention (1 Day)||0
11205658|NCT01860677|12396489|FG000|COMPLETED|Second Intervention (1 Day)||1
11205659|NCT01860677|12396490|FG001|COMPLETED|Second Intervention (1 Day)||0
11205660|NCT01860677|12396489|FG000|NOT COMPLETED|Second Intervention (1 Day)||7
11205661|NCT01860677|12396490|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11345101|NCT02965989|12542133|FG000|COMPLETED|Overall Study||26
11345102|NCT02965989|12542134|FG001|COMPLETED|Overall Study||22
11345103|NCT02965989|12542133|FG000|NOT COMPLETED|Overall Study||0
11345104|NCT02965989|12542134|FG001|NOT COMPLETED|Overall Study||0
11345105|NCT02966002|12542146|FG000|STARTED|Overall Study||9
11345106|NCT02966002|12542146|FG000|COMPLETED|Overall Study||5
11345107|NCT02966002|12542146|FG000|NOT COMPLETED|Overall Study||4
11345108|NCT02966015|12542152|FG000|STARTED|Inclusion Visit||95
11061897|NCT03656107|12243697|FG000|STARTED|Overall Study||28
11061898|NCT03656107|12243698|FG001|STARTED|Overall Study||28
11061899|NCT03656107|12243697|FG000|COMPLETED|Overall Study||25
11061900|NCT03656107|12243698|FG001|COMPLETED|Overall Study||27
11061901|NCT03656107|12243697|FG000|NOT COMPLETED|Overall Study||3
11061902|NCT03656107|12243698|FG001|NOT COMPLETED|Overall Study||1
11061903|NCT03554850|12243704|FG000|STARTED|Overall Study||201
11061904|NCT03554850|12243704|FG000|COMPLETED|Overall Study||190
11061905|NCT03554850|12243704|FG000|NOT COMPLETED|Overall Study||11
11061906|NCT03426566|12243712|FG000|STARTED|Overall Study||974
11061907|NCT03426566|12243712|FG000|COMPLETED|Overall Study||974
11061908|NCT03426566|12243712|FG000|NOT COMPLETED|Overall Study||0
11061909|NCT03398356|12243721|FG000|STARTED|Before Treatment||15
11061910|NCT03398356|12243722|FG001|STARTED|Before Treatment||21
11061911|NCT03398356|12243723|FG002|STARTED|Before Treatment||11
11061912|NCT03398356|12243721|FG000|COMPLETED|Before Treatment||12
11061913|NCT03398356|12243722|FG001|COMPLETED|Before Treatment||13
11061914|NCT03398356|12243723|FG002|COMPLETED|Before Treatment|only baseline parameters were taken, this group did not participate in the further part of the study|0
11061915|NCT03398356|12243721|FG000|NOT COMPLETED|Before Treatment||3
11061916|NCT03398356|12243722|FG001|NOT COMPLETED|Before Treatment||8
11061917|NCT03398356|12243723|FG002|NOT COMPLETED|Before Treatment||11
11061918|NCT03398356|12243721|FG000|STARTED|After 6 Weeks of Treatment||12
11345109|NCT02966015|12542153|FG001|STARTED|Inclusion Visit||58
11345110|NCT02966015|12542152|FG000|COMPLETED|Inclusion Visit||87
11061919|NCT03398356|12243722|FG001|STARTED|After 6 Weeks of Treatment||13
11061920|NCT03398356|12243723|FG002|STARTED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
11061921|NCT03398356|12243721|FG000|COMPLETED|After 6 Weeks of Treatment||12
11061922|NCT03398356|12243722|FG001|COMPLETED|After 6 Weeks of Treatment||11
11061923|NCT03398356|12243723|FG002|COMPLETED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
11061924|NCT03398356|12243721|FG000|NOT COMPLETED|After 6 Weeks of Treatment||0
11061925|NCT03398356|12243722|FG001|NOT COMPLETED|After 6 Weeks of Treatment||2
11061926|NCT03398356|12243723|FG002|NOT COMPLETED|After 6 Weeks of Treatment||0
11061927|NCT03398356|12243721|FG000|STARTED|Post 6 Week Period Initial Evaluation|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|14
11061928|NCT03398356|12243722|FG001|STARTED|Post 6 Week Period Initial Evaluation||11
11061929|NCT03398356|12243723|FG002|STARTED|Post 6 Week Period Initial Evaluation||0
11061930|NCT03398356|12243721|FG000|COMPLETED|Post 6 Week Period Initial Evaluation||14
11061931|NCT03398356|12243722|FG001|COMPLETED|Post 6 Week Period Initial Evaluation||11
11061932|NCT03398356|12243723|FG002|COMPLETED|Post 6 Week Period Initial Evaluation||0
11061933|NCT03398356|12243721|FG000|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
11061934|NCT03398356|12243722|FG001|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
11061935|NCT03398356|12243723|FG002|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
11061936|NCT03398356|12243721|FG000|STARTED|After 12 Weeks of Treatment||14
11061937|NCT03398356|12243722|FG001|STARTED|After 12 Weeks of Treatment||11
11061938|NCT03398356|12243723|FG002|STARTED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
11061939|NCT03398356|12243721|FG000|COMPLETED|After 12 Weeks of Treatment||14
11061940|NCT03398356|12243722|FG001|COMPLETED|After 12 Weeks of Treatment||11
11061941|NCT03398356|12243723|FG002|COMPLETED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
11061942|NCT03398356|12243721|FG000|NOT COMPLETED|After 12 Weeks of Treatment||0
11061943|NCT03398356|12243722|FG001|NOT COMPLETED|After 12 Weeks of Treatment||0
11061944|NCT03398356|12243723|FG002|NOT COMPLETED|After 12 Weeks of Treatment||0
11061945|NCT03398356|12243721|FG000|STARTED|After 15 Weeks of Treatment||14
11061946|NCT03398356|12243722|FG001|STARTED|After 15 Weeks of Treatment||11
11061947|NCT03398356|12243723|FG002|STARTED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
11061948|NCT03398356|12243721|FG000|COMPLETED|After 15 Weeks of Treatment||14
11061949|NCT03398356|12243722|FG001|COMPLETED|After 15 Weeks of Treatment||11
11061950|NCT03398356|12243723|FG002|COMPLETED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
11061951|NCT03398356|12243721|FG000|NOT COMPLETED|After 15 Weeks of Treatment||0
11061952|NCT03398356|12243722|FG001|NOT COMPLETED|After 15 Weeks of Treatment||0
11061953|NCT03398356|12243723|FG002|NOT COMPLETED|After 15 Weeks of Treatment||0
11061954|NCT03365791|12243731|FG000|STARTED|Overall Study||76
11061955|NCT03365791|12243731|FG000|Full Analysis Set (FAS)|Overall Study||75
11061956|NCT03365791|12243731|FG000|COMPLETED|Overall Study||4
11061957|NCT03365791|12243731|FG000|NOT COMPLETED|Overall Study||72
11061958|NCT03125148|12243738|FG000|STARTED|Overall Study||9
11061959|NCT03125148|12243739|FG001|STARTED|Overall Study||8
11061960|NCT03125148|12243738|FG000|COMPLETED|Overall Study||9
11061961|NCT03125148|12243739|FG001|COMPLETED|Overall Study||8
11061962|NCT03125148|12243738|FG000|NOT COMPLETED|Overall Study||0
11061963|NCT03125148|12243739|FG001|NOT COMPLETED|Overall Study||0
11205662|NCT01860703|12396497|FG000|STARTED|Overall Study||13
11205663|NCT01860703|12396498|FG001|STARTED|Overall Study||13
11205664|NCT01860703|12396499|FG002|STARTED|Overall Study||12
11205665|NCT01860703|12396500|FG003|STARTED|Overall Study||12
11205666|NCT01860703|12396497|FG000|COMPLETED|Overall Study||11
11205667|NCT01860703|12396498|FG001|COMPLETED|Overall Study||8
11205668|NCT01860703|12396499|FG002|COMPLETED|Overall Study||11
11205669|NCT01860703|12396500|FG003|COMPLETED|Overall Study||10
11205670|NCT01860703|12396497|FG000|NOT COMPLETED|Overall Study||2
11205671|NCT01860703|12396498|FG001|NOT COMPLETED|Overall Study||5
11205672|NCT01860703|12396499|FG002|NOT COMPLETED|Overall Study||1
11205673|NCT01860703|12396500|FG003|NOT COMPLETED|Overall Study||2
11061964|NCT02819440|12243747|FG000|STARTED|Overall Study||61
11061965|NCT02819440|12243748|FG001|STARTED|Overall Study||64
11061966|NCT02819440|12243747|FG000|COMPLETED|Overall Study||48
11061967|NCT02819440|12243748|FG001|COMPLETED|Overall Study||52
11061968|NCT02819440|12243747|FG000|NOT COMPLETED|Overall Study||13
11061969|NCT02819440|12243748|FG001|NOT COMPLETED|Overall Study||12
11061970|NCT02782741|12243756|FG000|STARTED|Blinded Treatment Period: up to Week 49||51
11061971|NCT02782741|12243757|FG001|STARTED|Blinded Treatment Period: up to Week 49||49
11061972|NCT02782741|12243756|FG000|Safety Population|Blinded Treatment Period: up to Week 49||51
11061973|NCT02782741|12243757|FG001|Safety Population|Blinded Treatment Period: up to Week 49||49
11061974|NCT02782741|12243756|FG000|COMPLETED|Blinded Treatment Period: up to Week 49||51
11061975|NCT02782741|12243757|FG001|COMPLETED|Blinded Treatment Period: up to Week 49||44
11061976|NCT02782741|12243756|FG000|NOT COMPLETED|Blinded Treatment Period: up to Week 49||0
11061977|NCT02782741|12243757|FG001|NOT COMPLETED|Blinded Treatment Period: up to Week 49||5
11061978|NCT02782741|12243756|FG000|STARTED|Open-label Long-term: Week 50 to 145||51
11061979|NCT02782741|12243757|FG001|STARTED|Open-label Long-term: Week 50 to 145||44
11061980|NCT02782741|12243756|FG000|Safety Population|Open-label Long-term: Week 50 to 145||51
11061981|NCT02782741|12243757|FG001|Safety Population|Open-label Long-term: Week 50 to 145||44
11061982|NCT02782741|12243756|FG000|COMPLETED|Open-label Long-term: Week 50 to 145||0
11061983|NCT02782741|12243757|FG001|COMPLETED|Open-label Long-term: Week 50 to 145||0
11061984|NCT02782741|12243756|FG000|NOT COMPLETED|Open-label Long-term: Week 50 to 145||51
11061985|NCT02782741|12243757|FG001|NOT COMPLETED|Open-label Long-term: Week 50 to 145||44
11061986|NCT02647359|12243769|FG000|STARTED|Stage 1: Double-Masked Period (48 Weeks)||26
11061987|NCT02647359|12243770|FG001|STARTED|Stage 1: Double-Masked Period (48 Weeks)||13
11061988|NCT02647359|12243769|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Double-Masked Period (48 Weeks)||26
11061989|NCT02647359|12243770|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Double-Masked Period (48 Weeks)||13
11061990|NCT02647359|12243769|FG000|COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||22
11061991|NCT02647359|12243770|FG001|COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||12
11061992|NCT02647359|12243769|FG000|NOT COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||4
11061993|NCT02647359|12243770|FG001|NOT COMPLETED|Stage 1: Double-Masked Period (48 Weeks)||1
11061994|NCT02647359|12243769|FG000|STARTED|Stage 2: Open-Label Extension (96 Weeks)||22
11061995|NCT02647359|12243770|FG001|STARTED|Stage 2: Open-Label Extension (96 Weeks)|1 participant completed Stage 1 but did not enter open-label part|11
11061996|NCT02647359|12243769|FG000|COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||12
11061997|NCT02647359|12243770|FG001|COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||7
11061998|NCT02647359|12243769|FG000|NOT COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||10
11061999|NCT02647359|12243770|FG001|NOT COMPLETED|Stage 2: Open-Label Extension (96 Weeks)||4
11062000|NCT02647359|12243769|FG000|STARTED|Open-Label Sub-Study (96 Weeks)|2 participants completed open-label 144-weeks but did not enter open-label sub-study|10
11062001|NCT02647359|12243770|FG001|STARTED|Open-Label Sub-Study (96 Weeks)||7
11062002|NCT02647359|12243769|FG000|COMPLETED|Open-Label Sub-Study (96 Weeks)||2
11062003|NCT02647359|12243770|FG001|COMPLETED|Open-Label Sub-Study (96 Weeks)||3
11062004|NCT02647359|12243769|FG000|NOT COMPLETED|Open-Label Sub-Study (96 Weeks)||8
11062005|NCT02647359|12243770|FG001|NOT COMPLETED|Open-Label Sub-Study (96 Weeks)||4
11062006|NCT02485691|12243782|FG000|STARTED|Overall Study||129
11062007|NCT02485691|12243783|FG001|STARTED|Overall Study||126
11062008|NCT02485691|12243782|FG000|Treated|Overall Study||126
11062009|NCT02485691|12243783|FG001|Treated|Overall Study||124
11062010|NCT02485691|12243782|FG000|COMPLETED|Overall Study||0
11062011|NCT02485691|12243783|FG001|COMPLETED|Overall Study||0
11062012|NCT02485691|12243782|FG000|NOT COMPLETED|Overall Study||129
11062013|NCT02485691|12243783|FG001|NOT COMPLETED|Overall Study||126
11062014|NCT02201251|12243792|FG000|STARTED|Overall Study||28
11062015|NCT02201251|12243793|FG001|STARTED|Overall Study||35
11062016|NCT02201251|12243792|FG000|COMPLETED|Overall Study||24
11062017|NCT02201251|12243793|FG001|COMPLETED|Overall Study||32
11062018|NCT02201251|12243792|FG000|NOT COMPLETED|Overall Study||4
11062019|NCT02201251|12243793|FG001|NOT COMPLETED|Overall Study||3
11062020|NCT02000596|12243802|FG000|STARTED|Cohort 1||2
11062021|NCT02000596|12243803|FG001|STARTED|Cohort 1||0
11062022|NCT02000596|12243804|FG002|STARTED|Cohort 1||0
11062023|NCT02000596|12243802|FG000|COMPLETED|Cohort 1||2
11062024|NCT02000596|12243803|FG001|COMPLETED|Cohort 1||0
11062025|NCT02000596|12243804|FG002|COMPLETED|Cohort 1||0
11062026|NCT02000596|12243802|FG000|NOT COMPLETED|Cohort 1||0
11062027|NCT02000596|12243803|FG001|NOT COMPLETED|Cohort 1||0
11062028|NCT02000596|12243804|FG002|NOT COMPLETED|Cohort 1||0
11062029|NCT02000596|12243802|FG000|STARTED|Cohort 2||0
11062030|NCT02000596|12243803|FG001|STARTED|Cohort 2||0
11062031|NCT02000596|12243804|FG002|STARTED|Cohort 2||2
11062032|NCT02000596|12243802|FG000|COMPLETED|Cohort 2||0
11062033|NCT02000596|12243803|FG001|COMPLETED|Cohort 2||0
11062034|NCT02000596|12243804|FG002|COMPLETED|Cohort 2||2
11062035|NCT02000596|12243802|FG000|NOT COMPLETED|Cohort 2||0
11062036|NCT02000596|12243803|FG001|NOT COMPLETED|Cohort 2||0
11062037|NCT02000596|12243804|FG002|NOT COMPLETED|Cohort 2||0
11062038|NCT00929253|12243814|FG000|STARTED|Overall Study||91
11062039|NCT00929253|12243815|FG001|STARTED|Overall Study||79
11062040|NCT00929253|12243814|FG000|COMPLETED|Overall Study||91
11062041|NCT00929253|12243815|FG001|COMPLETED|Overall Study||79
11062042|NCT00929253|12243814|FG000|NOT COMPLETED|Overall Study||0
11062043|NCT00929253|12243815|FG001|NOT COMPLETED|Overall Study||0
11062044|NCT00657241|12243823|FG000|STARTED|Overall Study||15
11062045|NCT00657241|12243824|FG001|STARTED|Overall Study||15
11062046|NCT00657241|12243823|FG000|COMPLETED|Overall Study||15
11062047|NCT00657241|12243824|FG001|COMPLETED|Overall Study||15
11062048|NCT00657241|12243823|FG000|NOT COMPLETED|Overall Study||0
11062049|NCT00657241|12243824|FG001|NOT COMPLETED|Overall Study||0
11062050|NCT01021293|12243836|FG000|STARTED|Overall Study||550
11062051|NCT01021293|12243837|FG001|STARTED|Overall Study||550
11062052|NCT01021293|12243836|FG000|COMPLETED|Overall Study||538
11062053|NCT01021293|12243837|FG001|COMPLETED|Overall Study||526
11062054|NCT01021293|12243836|FG000|NOT COMPLETED|Overall Study||12
11062055|NCT01021293|12243837|FG001|NOT COMPLETED|Overall Study||24
11062056|NCT01021306|12243848|FG000|STARTED|2 Month (Primary Outcome)||20
11062057|NCT01021306|12243849|FG001|STARTED|2 Month (Primary Outcome)||20
11062058|NCT01021306|12243850|FG002|STARTED|2 Month (Primary Outcome)||19
11062059|NCT01021306|12243851|FG003|STARTED|2 Month (Primary Outcome)||21
11062060|NCT01021306|12243848|FG000|COMPLETED|2 Month (Primary Outcome)||14
11062061|NCT01021306|12243849|FG001|COMPLETED|2 Month (Primary Outcome)||14
11062062|NCT01021306|12243850|FG002|COMPLETED|2 Month (Primary Outcome)||14
11062063|NCT01021306|12243851|FG003|COMPLETED|2 Month (Primary Outcome)||17
11062064|NCT01021306|12243848|FG000|NOT COMPLETED|2 Month (Primary Outcome)||6
11062065|NCT01021306|12243849|FG001|NOT COMPLETED|2 Month (Primary Outcome)||6
11062066|NCT01021306|12243850|FG002|NOT COMPLETED|2 Month (Primary Outcome)||5
11062067|NCT01021306|12243851|FG003|NOT COMPLETED|2 Month (Primary Outcome)||4
11062068|NCT01021306|12243848|FG000|STARTED|6 Month (Follow-up)||14
11062069|NCT01021306|12243849|FG001|STARTED|6 Month (Follow-up)||14
11062070|NCT01021306|12243850|FG002|STARTED|6 Month (Follow-up)||14
11062071|NCT01021306|12243851|FG003|STARTED|6 Month (Follow-up)||17
11062072|NCT01021306|12243848|FG000|COMPLETED|6 Month (Follow-up)||11
11062073|NCT01021306|12243849|FG001|COMPLETED|6 Month (Follow-up)||13
11062074|NCT01021306|12243850|FG002|COMPLETED|6 Month (Follow-up)||14
11062075|NCT01021306|12243851|FG003|COMPLETED|6 Month (Follow-up)||14
11062076|NCT01021306|12243848|FG000|NOT COMPLETED|6 Month (Follow-up)||3
11062077|NCT01021306|12243849|FG001|NOT COMPLETED|6 Month (Follow-up)||1
11062078|NCT01021306|12243850|FG002|NOT COMPLETED|6 Month (Follow-up)||0
11062079|NCT01021306|12243851|FG003|NOT COMPLETED|6 Month (Follow-up)||3
11062080|NCT01021332|12243861|FG000|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
11062081|NCT01021332|12243861|FG000|Safety Analysis Set (SAF)|Overall Study||1066
11062082|NCT01021332|12243861|FG000|Full Analysis Set (FAS)|Overall Study||1009
11062083|NCT01021332|12243861|FG000|COMPLETED|Overall Study||960
11062084|NCT01021332|12243861|FG000|NOT COMPLETED|Overall Study||106
11062085|NCT01021423|12243869|FG000|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
11062086|NCT01021423|12243870|FG001|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
11062087|NCT01021423|12243869|FG000|COMPLETED|Overall Study||0
11062088|NCT01021423|12243870|FG001|COMPLETED|Overall Study||0
11062089|NCT01021423|12243869|FG000|NOT COMPLETED|Overall Study||4
11062090|NCT01021423|12243870|FG001|NOT COMPLETED|Overall Study||5
11062091|NCT01021553|12243879|FG000|STARTED|Overall Study||27
11062092|NCT01021553|12243880|FG001|STARTED|Overall Study||22
11062093|NCT01021553|12243881|FG002|STARTED|Overall Study||28
11062094|NCT01021553|12243879|FG000|COMPLETED|Overall Study||23
11062095|NCT01021553|12243880|FG001|COMPLETED|Overall Study||17
11062096|NCT01021553|12243881|FG002|COMPLETED|Overall Study||25
11062097|NCT01021553|12243879|FG000|NOT COMPLETED|Overall Study||4
11062098|NCT01021553|12243880|FG001|NOT COMPLETED|Overall Study||5
11062099|NCT01021553|12243881|FG002|NOT COMPLETED|Overall Study||3
11062100|NCT01021618|12243896|FG000|STARTED|Overall Study||44
11062101|NCT01021618|12243897|FG001|STARTED|Overall Study||96
11062102|NCT01021618|12243896|FG000|COMPLETED|Overall Study||44
11062103|NCT01021618|12243897|FG001|COMPLETED|Overall Study||96
11062104|NCT01021618|12243896|FG000|NOT COMPLETED|Overall Study||0
11062105|NCT01021618|12243897|FG001|NOT COMPLETED|Overall Study||0
11062106|NCT01021683|12243903|FG000|STARTED|Overall Study||203
11062107|NCT01021683|12243903|FG000|COMPLETED|Overall Study||132
11062108|NCT01021683|12243903|FG000|NOT COMPLETED|Overall Study||71
11062109|NCT01021748|12243916|FG000|STARTED|Overall Study||6
11062110|NCT01021748|12243917|FG001|STARTED|Overall Study||5
11062111|NCT01021748|12243918|FG002|STARTED|Overall Study||7
11062112|NCT01021748|12243919|FG003|STARTED|Overall Study||7
11062113|NCT01021748|12243920|FG004|STARTED|Overall Study||9
11062114|NCT01021748|12243921|FG005|STARTED|Overall Study||3
11062115|NCT01021748|12243922|FG006|STARTED|Overall Study||3
11062116|NCT01021748|12243923|FG007|STARTED|Overall Study||6
11062117|NCT01021748|12243924|FG008|STARTED|Overall Study||17
11062118|NCT01021748|12243916|FG000|Treated|Overall Study||6
11062119|NCT01021748|12243917|FG001|Treated|Overall Study|One participant was allocated, but not treated.|4
11062120|NCT01021748|12243918|FG002|Treated|Overall Study||7
11062121|NCT01021748|12243919|FG003|Treated|Overall Study||7
11062122|NCT01021748|12243920|FG004|Treated|Overall Study||9
11062123|NCT01021748|12243921|FG005|Treated|Overall Study||3
11062124|NCT01021748|12243922|FG006|Treated|Overall Study||3
11062125|NCT01021748|12243923|FG007|Treated|Overall Study||6
11062126|NCT01021748|12243924|FG008|Treated|Overall Study||17
11062127|NCT01021748|12243916|FG000|COMPLETED|Overall Study||0
11062128|NCT01021748|12243917|FG001|COMPLETED|Overall Study||0
11062129|NCT01021748|12243918|FG002|COMPLETED|Overall Study||0
11062130|NCT01021748|12243919|FG003|COMPLETED|Overall Study||0
11062131|NCT01021748|12243920|FG004|COMPLETED|Overall Study||0
11062132|NCT01021748|12243921|FG005|COMPLETED|Overall Study||0
11062133|NCT01021748|12243922|FG006|COMPLETED|Overall Study||0
11062134|NCT01021748|12243923|FG007|COMPLETED|Overall Study||0
11062135|NCT01021748|12243924|FG008|COMPLETED|Overall Study||1
11062136|NCT01021748|12243916|FG000|NOT COMPLETED|Overall Study||6
11062137|NCT01021748|12243917|FG001|NOT COMPLETED|Overall Study||5
11062138|NCT01021748|12243918|FG002|NOT COMPLETED|Overall Study||7
11062139|NCT01021748|12243919|FG003|NOT COMPLETED|Overall Study||7
11062140|NCT01021748|12243920|FG004|NOT COMPLETED|Overall Study||9
11062141|NCT01021748|12243921|FG005|NOT COMPLETED|Overall Study||3
11062142|NCT01021748|12243922|FG006|NOT COMPLETED|Overall Study||3
11062143|NCT01021748|12243923|FG007|NOT COMPLETED|Overall Study||6
11062144|NCT01021748|12243924|FG008|NOT COMPLETED|Overall Study||16
11062145|NCT01021761|12243947|FG000|STARTED|Overall Study||42
11062146|NCT01021761|12243948|FG001|STARTED|Overall Study||42
11062147|NCT01021761|12243949|FG002|STARTED|Overall Study||42
11062148|NCT01021761|12243947|FG000|COMPLETED|Overall Study||41
11062149|NCT01021761|12243948|FG001|COMPLETED|Overall Study||38
11062150|NCT01021761|12243949|FG002|COMPLETED|Overall Study||42
11062151|NCT01021761|12243947|FG000|NOT COMPLETED|Overall Study||1
11062152|NCT01021761|12243948|FG001|NOT COMPLETED|Overall Study||4
11062153|NCT01021761|12243949|FG002|NOT COMPLETED|Overall Study||0
11062154|NCT01021813|12243959|FG000|STARTED|DB Treatment Phase||522
11062155|NCT01021813|12243960|FG001|STARTED|DB Treatment Phase||259
11062156|NCT01021813|12243961|FG002|STARTED|DB Treatment Phase||0
11062157|NCT01021813|12243962|FG003|STARTED|DB Treatment Phase||0
11062158|NCT01021813|12243963|FG004|STARTED|DB Treatment Phase||0
11062159|NCT01021813|12243959|FG000|Treated|DB Treatment Phase||521
11062160|NCT01021813|12243960|FG001|Treated|DB Treatment Phase||258
11062161|NCT01021813|12243961|FG002|Treated|DB Treatment Phase||0
11062162|NCT01021813|12243962|FG003|Treated|DB Treatment Phase||0
11062163|NCT01021813|12243963|FG004|Treated|DB Treatment Phase||0
11062164|NCT01021813|12243959|FG000|COMPLETED|DB Treatment Phase||322
11062165|NCT01021813|12243960|FG001|COMPLETED|DB Treatment Phase||162
11062166|NCT01021813|12243961|FG002|COMPLETED|DB Treatment Phase||0
11062167|NCT01021813|12243962|FG003|COMPLETED|DB Treatment Phase||0
11062168|NCT01021813|12243963|FG004|COMPLETED|DB Treatment Phase||0
11062169|NCT01021813|12243959|FG000|NOT COMPLETED|DB Treatment Phase||200
11062170|NCT01021813|12243960|FG001|NOT COMPLETED|DB Treatment Phase||97
11062171|NCT01021813|12243961|FG002|NOT COMPLETED|DB Treatment Phase||0
11062172|NCT01021813|12243962|FG003|NOT COMPLETED|DB Treatment Phase||0
11062173|NCT01021813|12243963|FG004|NOT COMPLETED|DB Treatment Phase||0
11062174|NCT01021813|12243959|FG000|STARTED|DB Randomized Discontinuation Phase||0
11062175|NCT01021813|12243960|FG001|STARTED|DB Randomized Discontinuation Phase||0
11062176|NCT01021813|12243961|FG002|STARTED|DB Randomized Discontinuation Phase||156
11062177|NCT01021813|12243962|FG003|STARTED|DB Randomized Discontinuation Phase||166
11062178|NCT01021813|12243963|FG004|STARTED|DB Randomized Discontinuation Phase||162
11062179|NCT01021813|12243959|FG000|COMPLETED|DB Randomized Discontinuation Phase||0
11062180|NCT01021813|12243960|FG001|COMPLETED|DB Randomized Discontinuation Phase||0
11062181|NCT01021813|12243961|FG002|COMPLETED|DB Randomized Discontinuation Phase||152
11062182|NCT01021813|12243962|FG003|COMPLETED|DB Randomized Discontinuation Phase||161
11062183|NCT01021813|12243963|FG004|COMPLETED|DB Randomized Discontinuation Phase||157
11062184|NCT01021813|12243959|FG000|NOT COMPLETED|DB Randomized Discontinuation Phase||0
11062185|NCT01021813|12243960|FG001|NOT COMPLETED|DB Randomized Discontinuation Phase||0
11062186|NCT01021813|12243961|FG002|NOT COMPLETED|DB Randomized Discontinuation Phase||4
11062187|NCT01021813|12243962|FG003|NOT COMPLETED|DB Randomized Discontinuation Phase||5
11062188|NCT01021813|12243963|FG004|NOT COMPLETED|DB Randomized Discontinuation Phase||5
11062189|NCT01021852|12243988|FG000|STARTED|Treatment Period 1||40
11062190|NCT01021852|12243989|FG001|STARTED|Treatment Period 1||40
11062191|NCT01021852|12243990|FG002|STARTED|Treatment Period 1||41
11062192|NCT01021852|12243991|FG003|STARTED|Treatment Period 1||40
11062193|NCT01021852|12243992|FG004|STARTED|Treatment Period 1||42
11062194|NCT01021852|12243993|FG005|STARTED|Treatment Period 1||41
11062195|NCT01021852|12243994|FG006|STARTED|Treatment Period 1||41
11062196|NCT01021852|12243995|FG007|STARTED|Treatment Period 1||41
11062197|NCT01021852|12243988|FG000|Treated|Treatment Period 1||40
11062198|NCT01021852|12243989|FG001|Treated|Treatment Period 1||40
11062199|NCT01021852|12243990|FG002|Treated|Treatment Period 1||41
11062200|NCT01021852|12243991|FG003|Treated|Treatment Period 1||38
11062201|NCT01021852|12243992|FG004|Treated|Treatment Period 1||42
11062202|NCT01021852|12243993|FG005|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
11062203|NCT01021852|12243994|FG006|Treated|Treatment Period 1||41
11345111|NCT02966015|12542153|FG001|COMPLETED|Inclusion Visit||55
11345112|NCT02966015|12542152|FG000|NOT COMPLETED|Inclusion Visit||8
11345113|NCT02966015|12542153|FG001|NOT COMPLETED|Inclusion Visit||3
11062204|NCT01021852|12243995|FG007|Treated|Treatment Period 1||41
11062205|NCT01021852|12243988|FG000|COMPLETED|Treatment Period 1||37
11062206|NCT01021852|12243989|FG001|COMPLETED|Treatment Period 1||39
11062207|NCT01021852|12243990|FG002|COMPLETED|Treatment Period 1||39
11062208|NCT01021852|12243991|FG003|COMPLETED|Treatment Period 1||38
11062209|NCT01021852|12243992|FG004|COMPLETED|Treatment Period 1||39
11062210|NCT01021852|12243993|FG005|COMPLETED|Treatment Period 1||39
11062211|NCT01021852|12243994|FG006|COMPLETED|Treatment Period 1||41
11345114|NCT02966015|12542152|FG000|STARTED|Test Period||87
11062212|NCT01021852|12243995|FG007|COMPLETED|Treatment Period 1||40
11062213|NCT01021852|12243988|FG000|NOT COMPLETED|Treatment Period 1||3
11062214|NCT01021852|12243989|FG001|NOT COMPLETED|Treatment Period 1||1
11062215|NCT01021852|12243990|FG002|NOT COMPLETED|Treatment Period 1||2
11062216|NCT01021852|12243991|FG003|NOT COMPLETED|Treatment Period 1||2
11062217|NCT01021852|12243992|FG004|NOT COMPLETED|Treatment Period 1||3
11062218|NCT01021852|12243993|FG005|NOT COMPLETED|Treatment Period 1||2
11062219|NCT01021852|12243994|FG006|NOT COMPLETED|Treatment Period 1||0
11062220|NCT01021852|12243995|FG007|NOT COMPLETED|Treatment Period 1||1
11062221|NCT01021852|12243988|FG000|STARTED|Washout Period-Placebo||37
11062222|NCT01021852|12243989|FG001|STARTED|Washout Period-Placebo||39
11062223|NCT01021852|12243990|FG002|STARTED|Washout Period-Placebo||39
11062224|NCT01021852|12243991|FG003|STARTED|Washout Period-Placebo||38
11062225|NCT01021852|12243992|FG004|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
11062226|NCT01021852|12243993|FG005|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
11062227|NCT01021852|12243994|FG006|STARTED|Washout Period-Placebo||41
11062228|NCT01021852|12243995|FG007|STARTED|Washout Period-Placebo||40
11062229|NCT01021852|12243988|FG000|COMPLETED|Washout Period-Placebo||37
11062230|NCT01021852|12243989|FG001|COMPLETED|Washout Period-Placebo||39
11062231|NCT01021852|12243990|FG002|COMPLETED|Washout Period-Placebo||39
11062232|NCT01021852|12243991|FG003|COMPLETED|Washout Period-Placebo||37
11062233|NCT01021852|12243992|FG004|COMPLETED|Washout Period-Placebo||39
11062234|NCT01021852|12243993|FG005|COMPLETED|Washout Period-Placebo||38
11062235|NCT01021852|12243994|FG006|COMPLETED|Washout Period-Placebo||40
11062236|NCT01021852|12243995|FG007|COMPLETED|Washout Period-Placebo||40
11345115|NCT02966015|12542153|FG001|STARTED|Test Period||55
11345116|NCT02966015|12542152|FG000|COMPLETED|Test Period||87
11345117|NCT02966015|12542153|FG001|COMPLETED|Test Period||55
11345118|NCT02966015|12542152|FG000|NOT COMPLETED|Test Period||0
11345119|NCT02966015|12542153|FG001|NOT COMPLETED|Test Period||0
11345120|NCT02966028|12542162|FG000|STARTED|Overall Study||92
11345121|NCT02966028|12542163|FG001|STARTED|Overall Study||91
11345122|NCT02966028|12542164|FG002|STARTED|Overall Study||91
11345123|NCT02966028|12542162|FG000|COMPLETED|Overall Study||68
11345124|NCT02966028|12542163|FG001|COMPLETED|Overall Study||57
11345125|NCT02966028|12542164|FG002|COMPLETED|Overall Study||60
11345126|NCT02966028|12542162|FG000|NOT COMPLETED|Overall Study||24
11345127|NCT02966028|12542163|FG001|NOT COMPLETED|Overall Study||34
11345128|NCT02966028|12542164|FG002|NOT COMPLETED|Overall Study||31
11345129|NCT02966275|12542176|FG000|STARTED|Overall Study||10
11062237|NCT01021852|12243988|FG000|NOT COMPLETED|Washout Period-Placebo||0
11062238|NCT01021852|12243989|FG001|NOT COMPLETED|Washout Period-Placebo||0
11062239|NCT01021852|12243990|FG002|NOT COMPLETED|Washout Period-Placebo||0
11062240|NCT01021852|12243991|FG003|NOT COMPLETED|Washout Period-Placebo||1
11062241|NCT01021852|12243992|FG004|NOT COMPLETED|Washout Period-Placebo||1
11062242|NCT01021852|12243993|FG005|NOT COMPLETED|Washout Period-Placebo||1
11062243|NCT01021852|12243994|FG006|NOT COMPLETED|Washout Period-Placebo||1
11062244|NCT01021852|12243995|FG007|NOT COMPLETED|Washout Period-Placebo||0
11062245|NCT01021852|12243988|FG000|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
11062246|NCT01021852|12243989|FG001|STARTED|Washout Period-No Drug||39
11062247|NCT01021852|12243990|FG002|STARTED|Washout Period-No Drug||39
11062248|NCT01021852|12243991|FG003|STARTED|Washout Period-No Drug||37
11062249|NCT01021852|12243992|FG004|STARTED|Washout Period-No Drug||39
11062250|NCT01021852|12243993|FG005|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
11062251|NCT01021852|12243994|FG006|STARTED|Washout Period-No Drug||40
11062252|NCT01021852|12243995|FG007|STARTED|Washout Period-No Drug||40
11062253|NCT01021852|12243988|FG000|COMPLETED|Washout Period-No Drug||37
11062254|NCT01021852|12243989|FG001|COMPLETED|Washout Period-No Drug||39
11062255|NCT01021852|12243990|FG002|COMPLETED|Washout Period-No Drug||39
11062256|NCT01021852|12243991|FG003|COMPLETED|Washout Period-No Drug||37
11062257|NCT01021852|12243992|FG004|COMPLETED|Washout Period-No Drug||39
11062258|NCT01021852|12243993|FG005|COMPLETED|Washout Period-No Drug||38
11062259|NCT01021852|12243994|FG006|COMPLETED|Washout Period-No Drug||40
11062260|NCT01021852|12243995|FG007|COMPLETED|Washout Period-No Drug||40
11062261|NCT01021852|12243988|FG000|NOT COMPLETED|Washout Period-No Drug||1
11062262|NCT01021852|12243989|FG001|NOT COMPLETED|Washout Period-No Drug||0
11062263|NCT01021852|12243990|FG002|NOT COMPLETED|Washout Period-No Drug||0
11062264|NCT01021852|12243991|FG003|NOT COMPLETED|Washout Period-No Drug||0
11062265|NCT01021852|12243992|FG004|NOT COMPLETED|Washout Period-No Drug||0
11062266|NCT01021852|12243993|FG005|NOT COMPLETED|Washout Period-No Drug||1
11345130|NCT02966275|12542176|FG000|COMPLETED|Overall Study||10
11345131|NCT02966275|12542176|FG000|NOT COMPLETED|Overall Study||0
11345132|NCT02966314|12542185|FG000|STARTED|Overall Study||5
11345133|NCT02966314|12542186|FG001|STARTED|Overall Study||5
11062267|NCT01021852|12243994|FG006|NOT COMPLETED|Washout Period-No Drug||0
11062268|NCT01021852|12243995|FG007|NOT COMPLETED|Washout Period-No Drug||0
11062269|NCT01021852|12243988|FG000|STARTED|Treatment Period 2||37
11062270|NCT01021852|12243989|FG001|STARTED|Treatment Period 2||39
11062271|NCT01021852|12243990|FG002|STARTED|Treatment Period 2||39
11062272|NCT01021852|12243991|FG003|STARTED|Treatment Period 2||37
11062273|NCT01021852|12243992|FG004|STARTED|Treatment Period 2||39
11062274|NCT01021852|12243993|FG005|STARTED|Treatment Period 2||38
11062275|NCT01021852|12243994|FG006|STARTED|Treatment Period 2||40
11062276|NCT01021852|12243995|FG007|STARTED|Treatment Period 2||40
11062277|NCT01021852|12243988|FG000|COMPLETED|Treatment Period 2||37
11062278|NCT01021852|12243989|FG001|COMPLETED|Treatment Period 2||38
11062279|NCT01021852|12243990|FG002|COMPLETED|Treatment Period 2||38
11062280|NCT01021852|12243991|FG003|COMPLETED|Treatment Period 2||37
11062281|NCT01021852|12243992|FG004|COMPLETED|Treatment Period 2||37
11062282|NCT01021852|12243993|FG005|COMPLETED|Treatment Period 2||37
11062283|NCT01021852|12243994|FG006|COMPLETED|Treatment Period 2||37
11062284|NCT01021852|12243995|FG007|COMPLETED|Treatment Period 2||38
11062285|NCT01021852|12243988|FG000|NOT COMPLETED|Treatment Period 2||0
11062286|NCT01021852|12243989|FG001|NOT COMPLETED|Treatment Period 2||1
11062287|NCT01021852|12243990|FG002|NOT COMPLETED|Treatment Period 2||1
11062288|NCT01021852|12243991|FG003|NOT COMPLETED|Treatment Period 2||0
11062289|NCT01021852|12243992|FG004|NOT COMPLETED|Treatment Period 2||2
11062290|NCT01021852|12243993|FG005|NOT COMPLETED|Treatment Period 2||1
11062291|NCT01021852|12243994|FG006|NOT COMPLETED|Treatment Period 2||3
11062292|NCT01021852|12243995|FG007|NOT COMPLETED|Treatment Period 2||2
11062293|NCT01021878|12244011|FG000|STARTED|Overall Study||33
11062294|NCT01021878|12244012|FG001|STARTED|Overall Study||27
11062295|NCT01021878|12244011|FG000|Completed Follow-up|Overall Study||17
11062296|NCT01021878|12244012|FG001|Completed Follow-up|Overall Study||17
11062297|NCT01021878|12244011|FG000|COMPLETED|Overall Study||17
11062298|NCT01021878|12244012|FG001|COMPLETED|Overall Study||17
11062299|NCT01021878|12244011|FG000|NOT COMPLETED|Overall Study||16
11062300|NCT01021878|12244012|FG001|NOT COMPLETED|Overall Study||10
11062301|NCT01021956|12244025|FG000|STARTED|Overall Study||3
11062302|NCT01021956|12244026|FG001|STARTED|Overall Study||3
11062303|NCT01021956|12244027|FG002|STARTED|Overall Study||3
11062304|NCT01021956|12244028|FG003|STARTED|Overall Study||1
11062305|NCT01021956|12244025|FG000|COMPLETED|Overall Study||3
11062306|NCT01021956|12244026|FG001|COMPLETED|Overall Study||3
11062307|NCT01021956|12244027|FG002|COMPLETED|Overall Study||3
11062308|NCT01021956|12244028|FG003|COMPLETED|Overall Study||1
11062309|NCT01021956|12244025|FG000|NOT COMPLETED|Overall Study||0
11062310|NCT01021956|12244026|FG001|NOT COMPLETED|Overall Study||0
11062311|NCT01021956|12244027|FG002|NOT COMPLETED|Overall Study||0
11062312|NCT01021956|12244028|FG003|NOT COMPLETED|Overall Study||0
11062313|NCT01022073|12244041|FG000|STARTED|Overall Study||86
11062314|NCT01022073|12244042|FG001|STARTED|Overall Study||70
11062315|NCT01022073|12244041|FG000|COMPLETED|Overall Study||67
11062316|NCT01022073|12244042|FG001|COMPLETED|Overall Study||52
11062317|NCT01022073|12244041|FG000|NOT COMPLETED|Overall Study||19
11062318|NCT01022073|12244042|FG001|NOT COMPLETED|Overall Study||18
11062319|NCT01022112|12244053|FG000|STARTED|Overall Study||82
11062320|NCT01022112|12244054|FG001|STARTED|Overall Study||74
11062321|NCT01022112|12244055|FG002|STARTED|Overall Study||77
11062322|NCT01022112|12244056|FG003|STARTED|Overall Study||75
11062323|NCT01022112|12244057|FG004|STARTED|Overall Study||75
11062324|NCT01022112|12244053|FG000|COMPLETED|Overall Study||79
11062325|NCT01022112|12244054|FG001|COMPLETED|Overall Study||71
11062326|NCT01022112|12244055|FG002|COMPLETED|Overall Study||74
11062327|NCT01022112|12244056|FG003|COMPLETED|Overall Study||72
11062328|NCT01022112|12244057|FG004|COMPLETED|Overall Study||65
11062329|NCT01022112|12244053|FG000|NOT COMPLETED|Overall Study||3
11062330|NCT01022112|12244054|FG001|NOT COMPLETED|Overall Study||3
11062331|NCT01022112|12244055|FG002|NOT COMPLETED|Overall Study||3
11062332|NCT01022112|12244056|FG003|NOT COMPLETED|Overall Study||3
11062333|NCT01022112|12244057|FG004|NOT COMPLETED|Overall Study||10
11062334|NCT01022190|12244069|FG000|STARTED|Overall Study||42
11062335|NCT01022190|12244069|FG000|COMPLETED|Overall Study||42
11062336|NCT01022190|12244069|FG000|NOT COMPLETED|Overall Study||0
11062337|NCT01022203|12244075|FG000|STARTED|PreTreatment Assessment||58
11062338|NCT01022203|12244076|FG001|STARTED|PreTreatment Assessment||56
11062339|NCT01022203|12244075|FG000|COMPLETED|PreTreatment Assessment||58
11062340|NCT01022203|12244076|FG001|COMPLETED|PreTreatment Assessment||56
11062341|NCT01022203|12244075|FG000|NOT COMPLETED|PreTreatment Assessment||0
11062342|NCT01022203|12244076|FG001|NOT COMPLETED|PreTreatment Assessment||0
11062343|NCT01022203|12244075|FG000|STARTED|Post Treatment Assessment||58
11062344|NCT01022203|12244076|FG001|STARTED|Post Treatment Assessment||56
11062345|NCT01022203|12244075|FG000|COMPLETED|Post Treatment Assessment||44
11062346|NCT01022203|12244076|FG001|COMPLETED|Post Treatment Assessment||42
11062347|NCT01022203|12244075|FG000|NOT COMPLETED|Post Treatment Assessment||14
11062348|NCT01022203|12244076|FG001|NOT COMPLETED|Post Treatment Assessment||14
11062349|NCT01022203|12244075|FG000|STARTED|Follow-Up Assessment||44
11062350|NCT01022203|12244076|FG001|STARTED|Follow-Up Assessment||42
11062351|NCT01022203|12244075|FG000|COMPLETED|Follow-Up Assessment||42
11062352|NCT01022203|12244076|FG001|COMPLETED|Follow-Up Assessment||40
11062353|NCT01022203|12244075|FG000|NOT COMPLETED|Follow-Up Assessment||2
11062354|NCT01022203|12244076|FG001|NOT COMPLETED|Follow-Up Assessment||2
11205674|NCT01860807|12396518|FG000|STARTED|Overall Study||64
11205675|NCT01860807|12396519|FG001|STARTED|Overall Study||61
11062355|NCT01022242|12244087|FG000|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
11062356|NCT01022242|12244088|FG001|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
11062357|NCT01022242|12244087|FG000|COMPLETED|Overall Study||49
11062358|NCT01022242|12244088|FG001|COMPLETED|Overall Study||46
11062359|NCT01022242|12244087|FG000|NOT COMPLETED|Overall Study||21
11062360|NCT01022242|12244088|FG001|NOT COMPLETED|Overall Study||19
11062361|NCT01022307|12244096|FG000|STARTED|Overall Study||184
11062362|NCT01022307|12244097|FG001|STARTED|Overall Study||28
11062363|NCT01022307|12244096|FG000|COMPLETED|Overall Study||184
11062364|NCT01022307|12244097|FG001|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
11062365|NCT01022307|12244096|FG000|NOT COMPLETED|Overall Study||0
11062366|NCT01022307|12244097|FG001|NOT COMPLETED|Overall Study||4
11062367|NCT01022359|12244105|FG000|STARTED|Overall Study||39
11062368|NCT01022359|12244106|FG001|STARTED|Overall Study||41
11062369|NCT01022359|12244105|FG000|COMPLETED|Overall Study||39
11062370|NCT01022359|12244106|FG001|COMPLETED|Overall Study||41
11062371|NCT01022359|12244105|FG000|NOT COMPLETED|Overall Study||0
11062372|NCT01022359|12244106|FG001|NOT COMPLETED|Overall Study||0
11062373|NCT01022424|12244112|FG000|STARTED|Overall Study||13
11062374|NCT01022424|12244112|FG000|COMPLETED|Overall Study||9
11062375|NCT01022424|12244112|FG000|NOT COMPLETED|Overall Study||4
11062376|NCT01022502|12244120|FG000|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
11062377|NCT01022502|12244120|FG000|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
11062378|NCT01022502|12244120|FG000|NOT COMPLETED|Overall Study||3
11062379|NCT01022567|12244128|FG000|STARTED|Overall Study||273
11062380|NCT01022567|12244129|FG001|STARTED|Overall Study||257
11062381|NCT01022567|12244128|FG000|COMPLETED|Overall Study||272
11345134|NCT02966314|12542185|FG000|COMPLETED|Overall Study||4
11345135|NCT02966314|12542186|FG001|COMPLETED|Overall Study||5
11345136|NCT02966314|12542185|FG000|NOT COMPLETED|Overall Study||1
11062382|NCT01022567|12244129|FG001|COMPLETED|Overall Study||242
11062383|NCT01022567|12244128|FG000|NOT COMPLETED|Overall Study||1
11062384|NCT01022567|12244129|FG001|NOT COMPLETED|Overall Study||15
11062385|NCT01022580|12244137|FG000|STARTED|Overall Study||252
11062386|NCT01022580|12244138|FG001|STARTED|Overall Study||259
11062387|NCT01022580|12244137|FG000|COMPLETED|Overall Study|Survived to discharge|234
11062388|NCT01022580|12244138|FG001|COMPLETED|Overall Study|Survived to discharge.|237
11062389|NCT01022580|12244137|FG000|NOT COMPLETED|Overall Study||18
11062390|NCT01022580|12244138|FG001|NOT COMPLETED|Overall Study||22
11062391|NCT01022762|12244152|FG000|STARTED|Overall Study||218
11062392|NCT01022762|12244153|FG001|STARTED|Overall Study||222
11062393|NCT01022762|12244152|FG000|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
11062394|NCT01022762|12244153|FG001|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
11062395|NCT01022762|12244152|FG000|COMPLETED|Overall Study||196
11062396|NCT01022762|12244153|FG001|COMPLETED|Overall Study||194
11062397|NCT01022762|12244152|FG000|NOT COMPLETED|Overall Study||22
11062398|NCT01022762|12244153|FG001|NOT COMPLETED|Overall Study||28
11062399|NCT01022853|12244164|FG000|STARTED|Overall Study|entered and treated|3
11062400|NCT01022853|12244165|FG001|STARTED|Overall Study|entered and treated|4
11062401|NCT01022853|12244166|FG002|STARTED|Overall Study|entered and treated|13
11062402|NCT01022853|12244167|FG003|STARTED|Overall Study|entered and treated|8
11062403|NCT01022853|12244168|FG004|STARTED|Overall Study|entered and treated|2
11062404|NCT01022853|12244164|FG000|COMPLETED|Overall Study||0
11062405|NCT01022853|12244165|FG001|COMPLETED|Overall Study||0
11062406|NCT01022853|12244166|FG002|COMPLETED|Overall Study||0
11062407|NCT01022853|12244167|FG003|COMPLETED|Overall Study||0
11062408|NCT01022853|12244168|FG004|COMPLETED|Overall Study||0
11062409|NCT01022853|12244164|FG000|NOT COMPLETED|Overall Study||3
11062410|NCT01022853|12244165|FG001|NOT COMPLETED|Overall Study||4
11062411|NCT01022853|12244166|FG002|NOT COMPLETED|Overall Study||13
11062412|NCT01022853|12244167|FG003|NOT COMPLETED|Overall Study||8
11062413|NCT01022853|12244168|FG004|NOT COMPLETED|Overall Study||2
11062414|NCT01022996|12244183|FG000|STARTED|Overall Study||57
11062415|NCT01022996|12244183|FG000|COMPLETED|Overall Study||0
11062416|NCT01022996|12244183|FG000|NOT COMPLETED|Overall Study||57
11062417|NCT01023022|12244187|FG000|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
11062418|NCT01023022|12244187|FG000|COMPLETED|Overall Study||162
11062419|NCT01023022|12244187|FG000|NOT COMPLETED|Overall Study||14
11062420|NCT01023035|12244194|FG000|STARTED|Treatment Period||249
11062421|NCT01023035|12244195|FG001|STARTED|Treatment Period||251
11062422|NCT01023035|12244196|FG002|STARTED|Treatment Period||187
11062423|NCT01023035|12244194|FG000|COMPLETED|Treatment Period||177
11062424|NCT01023035|12244195|FG001|COMPLETED|Treatment Period||166
11062425|NCT01023035|12244196|FG002|COMPLETED|Treatment Period||69
11062426|NCT01023035|12244194|FG000|NOT COMPLETED|Treatment Period||72
11062427|NCT01023035|12244195|FG001|NOT COMPLETED|Treatment Period||85
11062428|NCT01023035|12244196|FG002|NOT COMPLETED|Treatment Period||118
11062429|NCT01023035|12244194|FG000|STARTED|Follow-up Period (up to Week 72)||238
11062430|NCT01023035|12244195|FG001|STARTED|Follow-up Period (up to Week 72)||235
11062431|NCT01023035|12244196|FG002|STARTED|Follow-up Period (up to Week 72)||147
11062432|NCT01023035|12244194|FG000|COMPLETED|Follow-up Period (up to Week 72)||210
11062433|NCT01023035|12244195|FG001|COMPLETED|Follow-up Period (up to Week 72)||207
11205676|NCT01860807|12396518|FG000|COMPLETED|Overall Study||34
11062434|NCT01023035|12244196|FG002|COMPLETED|Follow-up Period (up to Week 72)||108
11062435|NCT01023035|12244194|FG000|NOT COMPLETED|Follow-up Period (up to Week 72)||28
11062436|NCT01023035|12244195|FG001|NOT COMPLETED|Follow-up Period (up to Week 72)||28
11062437|NCT01023035|12244196|FG002|NOT COMPLETED|Follow-up Period (up to Week 72)||39
11062438|NCT01023061|12244206|FG000|STARTED|Overall Study||24
11062439|NCT01023061|12244206|FG000|COMPLETED|Overall Study||22
11062440|NCT01023061|12244206|FG000|NOT COMPLETED|Overall Study||2
11062441|NCT01023074|12244213|FG000|STARTED|Overall Study||26
11062442|NCT01023074|12244214|FG001|STARTED|Overall Study||13
11062443|NCT01023074|12244215|FG002|STARTED|Overall Study||13
11062444|NCT01023074|12244213|FG000|COMPLETED|Overall Study||26
11062445|NCT01023074|12244214|FG001|COMPLETED|Overall Study||13
11062446|NCT01023074|12244215|FG002|COMPLETED|Overall Study||13
11062447|NCT01023074|12244213|FG000|NOT COMPLETED|Overall Study||0
11062448|NCT01023074|12244214|FG001|NOT COMPLETED|Overall Study||0
11062449|NCT01023074|12244215|FG002|NOT COMPLETED|Overall Study||0
11062450|NCT01023178|12244230|FG000|STARTED|Overall Study||5
11062451|NCT01023178|12244231|FG001|STARTED|Overall Study||8
11062452|NCT01023178|12244232|FG002|STARTED|Overall Study||7
11062453|NCT01023178|12244230|FG000|COMPLETED|Overall Study||3
11062454|NCT01023178|12244231|FG001|COMPLETED|Overall Study||6
11345137|NCT02966314|12542186|FG001|NOT COMPLETED|Overall Study||0
11345138|NCT02966340|12542192|FG000|STARTED|Overall Study||37
11345139|NCT02966340|12542193|FG001|STARTED|Overall Study||33
11062455|NCT01023178|12244232|FG002|COMPLETED|Overall Study||4
11062456|NCT01023178|12244230|FG000|NOT COMPLETED|Overall Study||2
11062457|NCT01023178|12244231|FG001|NOT COMPLETED|Overall Study||2
11062458|NCT01023178|12244232|FG002|NOT COMPLETED|Overall Study||3
11062459|NCT01023217|12244242|FG000|STARTED|Overall Study||45
11062460|NCT01023217|12244243|FG001|STARTED|Overall Study||45
11062461|NCT01023217|12244242|FG000|COMPLETED|Overall Study||44
11062462|NCT01023217|12244243|FG001|COMPLETED|Overall Study||45
11062463|NCT01023217|12244242|FG000|NOT COMPLETED|Overall Study||1
11062464|NCT01023217|12244243|FG001|NOT COMPLETED|Overall Study||0
11062465|NCT01023256|12244253|FG000|STARTED|Overall Study||25
11345140|NCT02966340|12542192|FG000|COMPLETED|Overall Study||34
11345141|NCT02966340|12542193|FG001|COMPLETED|Overall Study||30
11345142|NCT02966340|12542192|FG000|NOT COMPLETED|Overall Study||3
11345143|NCT02966340|12542193|FG001|NOT COMPLETED|Overall Study||3
11345144|NCT02966353|12542199|FG000|STARTED|Overall Study||51
11345145|NCT02966353|12542199|FG000|Completed After Data Cutoff|Overall Study||1
11345146|NCT02966353|12542199|FG000|COMPLETED|Overall Study||29
11345147|NCT02966353|12542199|FG000|NOT COMPLETED|Overall Study||22
11062466|NCT01023256|12244254|FG001|STARTED|Overall Study||22
11345148|NCT02966509|12542205|FG000|STARTED|Baseline Satisfaction Survey||105
11345149|NCT02966509|12542206|FG001|STARTED|Baseline Satisfaction Survey||108
11345150|NCT02966509|12542205|FG000|COMPLETED|Baseline Satisfaction Survey||101
11345151|NCT02966509|12542206|FG001|COMPLETED|Baseline Satisfaction Survey||101
11345152|NCT02966509|12542205|FG000|NOT COMPLETED|Baseline Satisfaction Survey||4
11345153|NCT02966509|12542206|FG001|NOT COMPLETED|Baseline Satisfaction Survey||7
11345154|NCT02966509|12542205|FG000|STARTED|6 Month Satisfaction Decision Survey||105
11345155|NCT02966509|12542206|FG001|STARTED|6 Month Satisfaction Decision Survey||108
11345156|NCT02966509|12542205|FG000|COMPLETED|6 Month Satisfaction Decision Survey||80
11345157|NCT02966509|12542206|FG001|COMPLETED|6 Month Satisfaction Decision Survey||77
11345158|NCT02966509|12542205|FG000|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
11345159|NCT02966509|12542206|FG001|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
11345160|NCT02966509|12542205|FG000|STARTED|6 Month Satisfaction Survey||105
11345161|NCT02966509|12542206|FG001|STARTED|6 Month Satisfaction Survey||108
11345162|NCT02966509|12542205|FG000|COMPLETED|6 Month Satisfaction Survey||58
11345163|NCT02966509|12542206|FG001|COMPLETED|6 Month Satisfaction Survey||60
11345164|NCT02966509|12542205|FG000|NOT COMPLETED|6 Month Satisfaction Survey||47
11345165|NCT02966509|12542206|FG001|NOT COMPLETED|6 Month Satisfaction Survey||48
11345166|NCT02966509|12542205|FG000|STARTED|6-Month Utilization and Cost||105
11345167|NCT02966509|12542206|FG001|STARTED|6-Month Utilization and Cost||108
11345168|NCT02966509|12542205|FG000|COMPLETED|6-Month Utilization and Cost||105
11345169|NCT02966509|12542206|FG001|COMPLETED|6-Month Utilization and Cost||108
11345170|NCT02966509|12542205|FG000|NOT COMPLETED|6-Month Utilization and Cost||0
11345171|NCT02966509|12542206|FG001|NOT COMPLETED|6-Month Utilization and Cost||0
11345172|NCT02966509|12542205|FG000|STARTED|15-Month Utilization and Cost||105
11345173|NCT02966509|12542206|FG001|STARTED|15-Month Utilization and Cost||108
11345174|NCT02966509|12542205|FG000|COMPLETED|15-Month Utilization and Cost||105
11345175|NCT02966509|12542206|FG001|COMPLETED|15-Month Utilization and Cost||108
11345176|NCT02966509|12542205|FG000|NOT COMPLETED|15-Month Utilization and Cost||0
11345177|NCT02966509|12542206|FG001|NOT COMPLETED|15-Month Utilization and Cost||0
11345178|NCT02966509|12542205|FG000|STARTED|End of Life Utilization and Cost 6 Month||105
11345179|NCT02966509|12542206|FG001|STARTED|End of Life Utilization and Cost 6 Month||108
11345180|NCT02966509|12542205|FG000|COMPLETED|End of Life Utilization and Cost 6 Month||36
11345181|NCT02966509|12542206|FG001|COMPLETED|End of Life Utilization and Cost 6 Month||33
11345182|NCT02966509|12542205|FG000|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
11345183|NCT02966509|12542206|FG001|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
11345184|NCT02966509|12542205|FG000|STARTED|End of Life Utilization and Cost 15month||105
11345185|NCT02966509|12542206|FG001|STARTED|End of Life Utilization and Cost 15month||108
11345186|NCT02966509|12542205|FG000|COMPLETED|End of Life Utilization and Cost 15month||60
11345187|NCT02966509|12542206|FG001|COMPLETED|End of Life Utilization and Cost 15month||60
11345188|NCT02966509|12542205|FG000|NOT COMPLETED|End of Life Utilization and Cost 15month||45
11345189|NCT02966509|12542206|FG001|NOT COMPLETED|End of Life Utilization and Cost 15month||48
11345190|NCT02966795|12542214|FG000|STARTED|Overall Study||23
11345191|NCT02966795|12542215|FG001|STARTED|Overall Study||61
11345192|NCT02966795|12542214|FG000|COMPLETED|Overall Study||23
11345193|NCT02966795|12542215|FG001|COMPLETED|Overall Study||60
11345194|NCT02966795|12542214|FG000|NOT COMPLETED|Overall Study||0
11345195|NCT02966795|12542215|FG001|NOT COMPLETED|Overall Study||1
11345196|NCT02966834|12542226|FG000|STARTED|Main Study Period (Up to 12 Weeks)||36
11345197|NCT02966834|12542227|FG001|STARTED|Main Study Period (Up to 12 Weeks)||16
11062467|NCT01023256|12244255|FG002|STARTED|Overall Study||24
11062468|NCT01023256|12244256|FG003|STARTED|Overall Study||27
11062469|NCT01023256|12244253|FG000|COMPLETED|Overall Study||21
11062470|NCT01023256|12244254|FG001|COMPLETED|Overall Study||19
11062471|NCT01023256|12244255|FG002|COMPLETED|Overall Study||23
11062472|NCT01023256|12244256|FG003|COMPLETED|Overall Study||22
11062473|NCT01023256|12244253|FG000|NOT COMPLETED|Overall Study||4
11062474|NCT01023256|12244254|FG001|NOT COMPLETED|Overall Study||3
11062475|NCT01023256|12244255|FG002|NOT COMPLETED|Overall Study||1
11062476|NCT01023256|12244256|FG003|NOT COMPLETED|Overall Study||5
11062477|NCT01023269|12244269|FG000|STARTED|Overall Study||3
11062478|NCT01023269|12244270|FG001|STARTED|Overall Study||2
11062479|NCT01023269|12244269|FG000|COMPLETED|Overall Study||1
11062480|NCT01023269|12244270|FG001|COMPLETED|Overall Study||2
11062481|NCT01023269|12244269|FG000|NOT COMPLETED|Overall Study||2
11062482|NCT01023269|12244270|FG001|NOT COMPLETED|Overall Study||0
11062483|NCT01023308|12244276|FG000|STARTED|Overall Study||387
11062484|NCT01023308|12244277|FG001|STARTED|Overall Study||381
11062485|NCT01023308|12244276|FG000|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
11062486|NCT01023308|12244277|FG001|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
11062487|NCT01023308|12244276|FG000|NOT COMPLETED|Overall Study||285
11062488|NCT01023308|12244277|FG001|NOT COMPLETED|Overall Study||279
11205677|NCT01860807|12396519|FG001|COMPLETED|Overall Study||32
11205678|NCT01860807|12396518|FG000|NOT COMPLETED|Overall Study||30
11205679|NCT01860807|12396519|FG001|NOT COMPLETED|Overall Study||29
11205680|NCT01860846|12396525|FG000|STARTED|Overall Study||106
11205681|NCT01860846|12396525|FG000|Month 1|Overall Study||97
11205682|NCT01860846|12396525|FG000|Month 2|Overall Study||83
11205683|NCT01860846|12396525|FG000|Month 4|Overall Study||82
11205684|NCT01860846|12396525|FG000|Month 6|Overall Study||85
11205685|NCT01860846|12396525|FG000|Month 12|Overall Study||73
11205686|NCT01860846|12396525|FG000|COMPLETED|Overall Study||73
11205687|NCT01860846|12396525|FG000|NOT COMPLETED|Overall Study||33
11205688|NCT01860950|12396535|FG000|STARTED|Overall Study||14
11205689|NCT01860950|12396536|FG001|STARTED|Overall Study||15
11205690|NCT01860950|12396537|FG002|STARTED|Overall Study||10
11205691|NCT01860950|12396538|FG003|STARTED|Overall Study||13
11205692|NCT01860950|12396539|FG004|STARTED|Overall Study||14
11205693|NCT01860950|12396540|FG005|STARTED|Overall Study||13
11205694|NCT01860950|12396535|FG000|COMPLETED|Overall Study||14
11205695|NCT01860950|12396536|FG001|COMPLETED|Overall Study||15
11205696|NCT01860950|12396537|FG002|COMPLETED|Overall Study||10
11205697|NCT01860950|12396538|FG003|COMPLETED|Overall Study||13
11205698|NCT01860950|12396539|FG004|COMPLETED|Overall Study||14
11205699|NCT01860950|12396540|FG005|COMPLETED|Overall Study||13
11205700|NCT01860950|12396535|FG000|NOT COMPLETED|Overall Study||0
11205701|NCT01860950|12396536|FG001|NOT COMPLETED|Overall Study||0
11205702|NCT01860950|12396537|FG002|NOT COMPLETED|Overall Study||0
11205703|NCT01860950|12396538|FG003|NOT COMPLETED|Overall Study||0
11205704|NCT01860950|12396539|FG004|NOT COMPLETED|Overall Study||0
11205705|NCT01860950|12396540|FG005|NOT COMPLETED|Overall Study||0
11205706|NCT01860989|12396555|FG000|STARTED|Overall Study||11
11205707|NCT01860989|12396555|FG000|COMPLETED|Overall Study||6
11205708|NCT01860989|12396555|FG000|NOT COMPLETED|Overall Study||5
11205709|NCT01861002|12396559|FG000|STARTED|Overall Study||15
11205710|NCT01861002|12396559|FG000|COMPLETED|Overall Study||14
11205711|NCT01861002|12396559|FG000|NOT COMPLETED|Overall Study||1
11205712|NCT01861028|12396567|FG000|STARTED|Overall Study||44
11205713|NCT01861028|12396567|FG000|COMPLETED|Overall Study||44
11205714|NCT01861028|12396567|FG000|NOT COMPLETED|Overall Study||0
11205715|NCT01861054|12396574|FG000|STARTED|Overall Study||18
11205716|NCT01861054|12396575|FG001|STARTED|Overall Study||2
11205717|NCT01861054|12396574|FG000|Safety Population|Overall Study||18
11205718|NCT01861054|12396575|FG001|Safety Population|Overall Study||2
11205719|NCT01861054|12396574|FG000|PK Population|Overall Study||4
11205720|NCT01861054|12396575|FG001|PK Population|Overall Study||2
11205721|NCT01861054|12396574|FG000|COMPLETED|Overall Study||18
11205722|NCT01861054|12396575|FG001|COMPLETED|Overall Study||2
11205723|NCT01861054|12396574|FG000|NOT COMPLETED|Overall Study||0
11205724|NCT01861054|12396575|FG001|NOT COMPLETED|Overall Study||0
11205725|NCT01861301|12396584|FG000|STARTED|Overall Study||18
11205726|NCT01861301|12396584|FG000|COMPLETED|Overall Study||18
11205727|NCT01861301|12396584|FG000|NOT COMPLETED|Overall Study||0
11205728|NCT01861457|12396591|FG000|STARTED|Overall Study||20
11205729|NCT01861457|12396592|FG001|STARTED|Overall Study||19
11205730|NCT01861457|12396591|FG000|COMPLETED|Overall Study||20
11205731|NCT01861457|12396592|FG001|COMPLETED|Overall Study||19
11345198|NCT02966834|12542228|FG002|STARTED|Main Study Period (Up to 12 Weeks)||23
11345199|NCT02966834|12542229|FG003|STARTED|Main Study Period (Up to 12 Weeks)||27
11345200|NCT02966834|12542230|FG004|STARTED|Main Study Period (Up to 12 Weeks)||23
11345201|NCT02966834|12542231|FG005|STARTED|Main Study Period (Up to 12 Weeks)||22
11345202|NCT02966834|12542226|FG000|COMPLETED|Main Study Period (Up to 12 Weeks)||35
11345203|NCT02966834|12542227|FG001|COMPLETED|Main Study Period (Up to 12 Weeks)||16
11345204|NCT02966834|12542228|FG002|COMPLETED|Main Study Period (Up to 12 Weeks)||19
11345205|NCT02966834|12542229|FG003|COMPLETED|Main Study Period (Up to 12 Weeks)||19
11345206|NCT02966834|12542230|FG004|COMPLETED|Main Study Period (Up to 12 Weeks)||22
11345207|NCT02966834|12542231|FG005|COMPLETED|Main Study Period (Up to 12 Weeks)||17
11062489|NCT01023477|12244285|FG000|STARTED|Overall Study||7
11062490|NCT01023477|12244286|FG001|STARTED|Overall Study||5
11062491|NCT01023477|12244285|FG000|COMPLETED|Overall Study||7
11062492|NCT01023477|12244286|FG001|COMPLETED|Overall Study||5
11062493|NCT01023477|12244285|FG000|NOT COMPLETED|Overall Study||0
11062494|NCT01023477|12244286|FG001|NOT COMPLETED|Overall Study||0
11062495|NCT01023516|12244294|FG000|STARTED|Overall Study||313
11062496|NCT01023516|12244295|FG001|STARTED|Overall Study||302
11062497|NCT01023516|12244294|FG000|COMPLETED|Overall Study||289
11062498|NCT01023516|12244295|FG001|COMPLETED|Overall Study||284
11062499|NCT01023516|12244294|FG000|NOT COMPLETED|Overall Study||24
11062500|NCT01023516|12244295|FG001|NOT COMPLETED|Overall Study||18
11062501|NCT01023568|12244304|FG000|STARTED|Overall Study||45
11062502|NCT01023568|12244305|FG001|STARTED|Overall Study||44
11062503|NCT01023568|12244306|FG002|STARTED|Overall Study||45
11345208|NCT02966834|12542226|FG000|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
11345209|NCT02966834|12542227|FG001|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||0
11345210|NCT02966834|12542228|FG002|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||4
11345211|NCT02966834|12542229|FG003|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||8
11345212|NCT02966834|12542230|FG004|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
11345213|NCT02966834|12542231|FG005|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||5
11345214|NCT02966834|12542226|FG000|STARTED|Final Study Period (Up to 4 Weeks)||35
11345215|NCT02966834|12542227|FG001|STARTED|Final Study Period (Up to 4 Weeks)||16
11345216|NCT02966834|12542228|FG002|STARTED|Final Study Period (Up to 4 Weeks)||19
11345217|NCT02966834|12542229|FG003|STARTED|Final Study Period (Up to 4 Weeks)||19
11345218|NCT02966834|12542230|FG004|STARTED|Final Study Period (Up to 4 Weeks)|One participant did not enter Final Study Period.|21
11345219|NCT02966834|12542231|FG005|STARTED|Final Study Period (Up to 4 Weeks)||17
11345220|NCT02966834|12542226|FG000|COMPLETED|Final Study Period (Up to 4 Weeks)||35
11345221|NCT02966834|12542227|FG001|COMPLETED|Final Study Period (Up to 4 Weeks)||16
11345222|NCT02966834|12542228|FG002|COMPLETED|Final Study Period (Up to 4 Weeks)||19
11345223|NCT02966834|12542229|FG003|COMPLETED|Final Study Period (Up to 4 Weeks)||19
11345224|NCT02966834|12542230|FG004|COMPLETED|Final Study Period (Up to 4 Weeks)||21
11345225|NCT02966834|12542231|FG005|COMPLETED|Final Study Period (Up to 4 Weeks)||17
11345226|NCT02966834|12542226|FG000|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
11345227|NCT02966834|12542227|FG001|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
11345228|NCT02966834|12542228|FG002|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
11345229|NCT02966834|12542229|FG003|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
11345230|NCT02966834|12542230|FG004|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
11345231|NCT02966834|12542231|FG005|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
11345232|NCT02966834|12542226|FG000|STARTED|Follow-up (Up to 4 Weeks)||35
11345233|NCT02966834|12542227|FG001|STARTED|Follow-up (Up to 4 Weeks)||16
11345234|NCT02966834|12542228|FG002|STARTED|Follow-up (Up to 4 Weeks)|4 participants discontinued study treatment in Main study period and directly entered follow-up.|23
11345235|NCT02966834|12542229|FG003|STARTED|Follow-up (Up to 4 Weeks)|8 participants discontinued study treatment in Main Study period and directly entered follow-up.|27
11345236|NCT02966834|12542230|FG004|STARTED|Follow-up (Up to 4 Weeks)|1 participant who completed main study period directly entered follow-up in this arm|22
11345237|NCT02966834|12542231|FG005|STARTED|Follow-up (Up to 4 Weeks)|5 participants discontinued study treatment in Main study period and directly entered follow-up|22
11345238|NCT02966834|12542226|FG000|COMPLETED|Follow-up (Up to 4 Weeks)||35
11345239|NCT02966834|12542227|FG001|COMPLETED|Follow-up (Up to 4 Weeks)||16
11345240|NCT02966834|12542228|FG002|COMPLETED|Follow-up (Up to 4 Weeks)||22
11345241|NCT02966834|12542229|FG003|COMPLETED|Follow-up (Up to 4 Weeks)||22
11345242|NCT02966834|12542230|FG004|COMPLETED|Follow-up (Up to 4 Weeks)||22
11345243|NCT02966834|12542231|FG005|COMPLETED|Follow-up (Up to 4 Weeks)||21
11345244|NCT02966834|12542226|FG000|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
11345245|NCT02966834|12542227|FG001|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
11345246|NCT02966834|12542228|FG002|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
11345247|NCT02966834|12542229|FG003|NOT COMPLETED|Follow-up (Up to 4 Weeks)||5
11345248|NCT02966834|12542230|FG004|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
11345249|NCT02966834|12542231|FG005|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
11345250|NCT02967016|12542282|FG000|STARTED|Overall Study||25
11345251|NCT02967016|12542283|FG001|STARTED|Overall Study||25
11345252|NCT02967016|12542282|FG000|COMPLETED|Overall Study||25
11345253|NCT02967016|12542283|FG001|COMPLETED|Overall Study||25
11345254|NCT02967016|12542282|FG000|NOT COMPLETED|Overall Study||0
11345255|NCT02967016|12542283|FG001|NOT COMPLETED|Overall Study||0
11345256|NCT02967055|12542289|FG000|STARTED|Overall Study|Assessed for eligibility|54
11345257|NCT02967055|12542289|FG000|In-person Screening|Overall Study||14
11345258|NCT02967055|12542289|FG000|Enrolled|Overall Study|Enrolled|9
11345259|NCT02967055|12542289|FG000|Completed 4 Week Follow-up Visit|Overall Study||8
11345260|NCT02967055|12542289|FG000|COMPLETED|Overall Study||5
11345261|NCT02967055|12542289|FG000|NOT COMPLETED|Overall Study||49
11345262|NCT02967354|12542298|FG000|STARTED|Overall Study||8
11345263|NCT02967354|12542299|FG001|STARTED|Overall Study||7
11345264|NCT02967354|12542300|FG002|STARTED|Overall Study||9
11345265|NCT02967354|12542301|FG003|STARTED|Overall Study||7
11345266|NCT02967354|12542302|FG004|STARTED|Overall Study||8
11345267|NCT02967354|12542298|FG000|COMPLETED|Overall Study||8
11062504|NCT01023568|12244304|FG000|COMPLETED|Overall Study||45
11062505|NCT01023568|12244305|FG001|COMPLETED|Overall Study||44
11062506|NCT01023568|12244306|FG002|COMPLETED|Overall Study||45
11062507|NCT01023568|12244304|FG000|NOT COMPLETED|Overall Study||0
11345268|NCT02967354|12542299|FG001|COMPLETED|Overall Study||7
11345269|NCT02967354|12542300|FG002|COMPLETED|Overall Study||9
11345270|NCT02967354|12542301|FG003|COMPLETED|Overall Study||7
11345271|NCT02967354|12542302|FG004|COMPLETED|Overall Study||8
11345272|NCT02967354|12542298|FG000|NOT COMPLETED|Overall Study||0
11345273|NCT02967354|12542299|FG001|NOT COMPLETED|Overall Study||0
11345274|NCT02967354|12542300|FG002|NOT COMPLETED|Overall Study||0
11345275|NCT02967354|12542301|FG003|NOT COMPLETED|Overall Study||0
11062508|NCT01023568|12244305|FG001|NOT COMPLETED|Overall Study||0
11062509|NCT01023568|12244306|FG002|NOT COMPLETED|Overall Study||0
11062510|NCT01023581|12244321|FG000|STARTED|Overall Study||109
11062511|NCT01023581|12244322|FG001|STARTED|Overall Study||112
11062512|NCT01023581|12244323|FG002|STARTED|Overall Study||113
11062513|NCT01023581|12244324|FG003|STARTED|Overall Study||114
11062514|NCT01023581|12244325|FG004|STARTED|Overall Study||111
11062515|NCT01023581|12244326|FG005|STARTED|Overall Study||111
11062516|NCT01023581|12244327|FG006|STARTED|Overall Study||114
11062517|NCT01023581|12244321|FG000|Received Study Treatment|Overall Study||106
11062518|NCT01023581|12244322|FG001|Received Study Treatment|Overall Study||112
11062519|NCT01023581|12244323|FG002|Received Study Treatment|Overall Study||110
11062520|NCT01023581|12244324|FG003|Received Study Treatment|Overall Study||109
11062521|NCT01023581|12244325|FG004|Received Study Treatment|Overall Study||111
11062522|NCT01023581|12244326|FG005|Received Study Treatment|Overall Study||106
11062523|NCT01023581|12244327|FG006|Received Study Treatment|Overall Study||114
11062524|NCT01023581|12244321|FG000|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
11062525|NCT01023581|12244322|FG001|COMPLETED|Overall Study||89
11062526|NCT01023581|12244323|FG002|COMPLETED|Overall Study||71
11062527|NCT01023581|12244324|FG003|COMPLETED|Overall Study||94
11062528|NCT01023581|12244325|FG004|COMPLETED|Overall Study||95
11062529|NCT01023581|12244326|FG005|COMPLETED|Overall Study||92
11062530|NCT01023581|12244327|FG006|COMPLETED|Overall Study||94
11062531|NCT01023581|12244321|FG000|NOT COMPLETED|Overall Study||35
11062532|NCT01023581|12244322|FG001|NOT COMPLETED|Overall Study||23
11062533|NCT01023581|12244323|FG002|NOT COMPLETED|Overall Study||42
11062534|NCT01023581|12244324|FG003|NOT COMPLETED|Overall Study||20
11062535|NCT01023581|12244325|FG004|NOT COMPLETED|Overall Study||16
11062536|NCT01023581|12244326|FG005|NOT COMPLETED|Overall Study||19
11062537|NCT01023581|12244327|FG006|NOT COMPLETED|Overall Study||20
11062538|NCT01023659|12244346|FG000|STARTED|Overall Study||258
11062539|NCT01023659|12244347|FG001|STARTED|Overall Study||365
11062540|NCT01023659|12244348|FG002|STARTED|Overall Study||264
11062541|NCT01023659|12244346|FG000|COMPLETED|Overall Study||185
11062542|NCT01023659|12244347|FG001|COMPLETED|Overall Study||137
11062543|NCT01023659|12244348|FG002|COMPLETED|Overall Study||165
11062544|NCT01023659|12244346|FG000|NOT COMPLETED|Overall Study||73
11062545|NCT01023659|12244347|FG001|NOT COMPLETED|Overall Study||228
11062546|NCT01023659|12244348|FG002|NOT COMPLETED|Overall Study||99
11062547|NCT01023672|12244357|FG000|STARTED|Overall Study||20
11062548|NCT01023672|12244357|FG000|COMPLETED|Overall Study||17
11062549|NCT01023672|12244357|FG000|NOT COMPLETED|Overall Study||3
11062550|NCT01023711|12244361|FG000|STARTED|Overall Study||107
11062551|NCT01023711|12244361|FG000|COMPLETED|Overall Study||107
11062552|NCT01023711|12244361|FG000|NOT COMPLETED|Overall Study||0
11062553|NCT01023724|12244368|FG000|STARTED|Overall Study||25
11062554|NCT01023724|12244369|FG001|STARTED|Overall Study||25
11062555|NCT01023724|12244368|FG000|COMPLETED|Overall Study||21
11062556|NCT01023724|12244369|FG001|COMPLETED|Overall Study||22
11062557|NCT01023724|12244368|FG000|NOT COMPLETED|Overall Study||4
11062558|NCT01023724|12244369|FG001|NOT COMPLETED|Overall Study||3
11062559|NCT01023776|12244375|FG000|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
11062560|NCT01023776|12244375|FG000|COMPLETED|Overall Study||20
11062561|NCT01023776|12244375|FG000|NOT COMPLETED|Overall Study||0
11062562|NCT01023789|12244379|FG000|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
11062563|NCT01023789|12244379|FG000|COMPLETED|30-day Follow-up Visit||812
11062564|NCT01023789|12244379|FG000|NOT COMPLETED|30-day Follow-up Visit||0
11062565|NCT01023789|12244379|FG000|STARTED|180-day Clinical Follow-up||812
11345276|NCT02967354|12542302|FG004|NOT COMPLETED|Overall Study||0
11345277|NCT02967367|12542319|FG000|STARTED|Overall Study||36
11062566|NCT01023789|12244379|FG000|COMPLETED|180-day Clinical Follow-up||812
11062567|NCT01023789|12244379|FG000|NOT COMPLETED|180-day Clinical Follow-up||0
11062568|NCT01023789|12244379|FG000|STARTED|1 - Year Visit||812
11062569|NCT01023789|12244379|FG000|COMPLETED|1 - Year Visit||812
11062570|NCT01023789|12244379|FG000|NOT COMPLETED|1 - Year Visit||0
11062571|NCT01023789|12244379|FG000|STARTED|2 - Year Visit||812
11062572|NCT01023789|12244379|FG000|COMPLETED|2 - Year Visit||812
11062573|NCT01023789|12244379|FG000|NOT COMPLETED|2 - Year Visit||0
11062574|NCT01023789|12244379|FG000|STARTED|3 - Year Visit||812
11062575|NCT01023789|12244379|FG000|COMPLETED|3 - Year Visit||769
11062576|NCT01023789|12244379|FG000|NOT COMPLETED|3 - Year Visit||43
11062577|NCT01023815|12244387|FG000|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
11062578|NCT01023815|12244388|FG001|STARTED|Pre-randomization Period (Day 1 to 90)||0
11062579|NCT01023815|12244389|FG002|STARTED|Pre-randomization Period (Day 1 to 90)||0
11062580|NCT01023815|12244390|FG003|STARTED|Pre-randomization Period (Day 1 to 90)||0
11062581|NCT01023815|12244387|FG000|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
11062582|NCT01023815|12244388|FG001|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
11062583|NCT01023815|12244389|FG002|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
11062584|NCT01023815|12244390|FG003|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
11062585|NCT01023815|12244387|FG000|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
11062586|NCT01023815|12244388|FG001|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
11062587|NCT01023815|12244389|FG002|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
11062588|NCT01023815|12244390|FG003|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
11062589|NCT01023815|12244387|FG000|STARTED|Randomized Period (Day 90 to Month 12)||0
11062590|NCT01023815|12244388|FG001|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
11345278|NCT02967367|12542319|FG000|COMPLETED|Overall Study||22
11345279|NCT02967367|12542319|FG000|NOT COMPLETED|Overall Study||14
11345280|NCT02967393|12542325|FG000|STARTED|Overall Study||20
11345281|NCT02967393|12542326|FG001|STARTED|Overall Study||20
11345282|NCT02967393|12542325|FG000|COMPLETED|Overall Study||20
11345283|NCT02967393|12542326|FG001|COMPLETED|Overall Study||20
11345284|NCT02967393|12542325|FG000|NOT COMPLETED|Overall Study||0
11345285|NCT02967393|12542326|FG001|NOT COMPLETED|Overall Study||0
11345286|NCT02967458|12542334|FG000|STARTED|Overall Study||55
11345287|NCT02967458|12542334|FG000|COMPLETED|Overall Study||55
11345288|NCT02967458|12542334|FG000|NOT COMPLETED|Overall Study||0
11345289|NCT02967510|12542343|FG000|STARTED|Overall Study||70
11345290|NCT02967510|12542344|FG001|STARTED|Overall Study||70
11345291|NCT02967510|12542345|FG002|STARTED|Overall Study||72
11345292|NCT02967510|12542346|FG003|STARTED|Overall Study||71
11345293|NCT02967510|12542343|FG000|COMPLETED|Overall Study||66
11345294|NCT02967510|12542344|FG001|COMPLETED|Overall Study||67
11345295|NCT02967510|12542345|FG002|COMPLETED|Overall Study||65
11345296|NCT02967510|12542346|FG003|COMPLETED|Overall Study||63
11345297|NCT02967510|12542343|FG000|NOT COMPLETED|Overall Study||4
11345298|NCT02967510|12542344|FG001|NOT COMPLETED|Overall Study||3
11345299|NCT02967510|12542345|FG002|NOT COMPLETED|Overall Study||7
11345300|NCT02967510|12542346|FG003|NOT COMPLETED|Overall Study||8
11345301|NCT02967562|12542358|FG000|STARTED|Overall Study||32
11345302|NCT02967562|12542359|FG001|STARTED|Overall Study||31
11345303|NCT02967562|12542358|FG000|COMPLETED|Overall Study||30
11345304|NCT02967562|12542359|FG001|COMPLETED|Overall Study||30
11345305|NCT02967562|12542358|FG000|NOT COMPLETED|Overall Study||2
11345306|NCT02967562|12542359|FG001|NOT COMPLETED|Overall Study||1
11345307|NCT02967679|12542365|FG000|STARTED|Overall Study||15
11345308|NCT02967679|12542365|FG000|COMPLETED|Overall Study||14
11345309|NCT02967679|12542365|FG000|NOT COMPLETED|Overall Study||1
11345310|NCT02967991|12542369|FG000|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
11345311|NCT02967991|12542370|FG001|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
11345312|NCT02967991|12542369|FG000|COMPLETED|Overall Study||10
11345313|NCT02967991|12542370|FG001|COMPLETED|Overall Study||10
11345314|NCT02967991|12542369|FG000|NOT COMPLETED|Overall Study||0
11345315|NCT02967991|12542370|FG001|NOT COMPLETED|Overall Study||0
11345316|NCT02968134|12542380|FG000|STARTED|Overall Study||8
11345317|NCT02968134|12542380|FG000|COMPLETED|Overall Study||8
11345318|NCT02968134|12542380|FG000|NOT COMPLETED|Overall Study||0
11345319|NCT02968173|12542384|FG000|STARTED|Overall Study||50
11062591|NCT01023815|12244389|FG002|STARTED|Randomized Period (Day 90 to Month 12)||68
11345320|NCT02968173|12542384|FG000|COMPLETED|Overall Study||49
11062592|NCT01023815|12244390|FG003|STARTED|Randomized Period (Day 90 to Month 12)||71
11062593|NCT01023815|12244387|FG000|COMPLETED|Randomized Period (Day 90 to Month 12)||0
11062594|NCT01023815|12244388|FG001|COMPLETED|Randomized Period (Day 90 to Month 12)||42
11062595|NCT01023815|12244389|FG002|COMPLETED|Randomized Period (Day 90 to Month 12)||60
11062596|NCT01023815|12244390|FG003|COMPLETED|Randomized Period (Day 90 to Month 12)||68
11062597|NCT01023815|12244387|FG000|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
11062598|NCT01023815|12244388|FG001|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
11062599|NCT01023815|12244389|FG002|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
11062600|NCT01023815|12244390|FG003|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
11062601|NCT01023841|12244403|FG000|STARTED|Overall Study||48
11062602|NCT01023841|12244404|FG001|STARTED|Overall Study||23
11062603|NCT01023841|12244403|FG000|COMPLETED|Overall Study||47
11062604|NCT01023841|12244404|FG001|COMPLETED|Overall Study||23
11062605|NCT01023841|12244403|FG000|NOT COMPLETED|Overall Study||1
11062606|NCT01023841|12244404|FG001|NOT COMPLETED|Overall Study||0
11062607|NCT01023958|12244410|FG000|STARTED|Overall Study||50
11062608|NCT01023958|12244410|FG000|COMPLETED|Overall Study||0
11062609|NCT01023958|12244410|FG000|NOT COMPLETED|Overall Study||50
11062610|NCT01024010|12244416|FG000|STARTED|Overall Study||48
11062611|NCT01024010|12244417|FG001|STARTED|Overall Study||34
11062612|NCT01024010|12244416|FG000|COMPLETED|Overall Study||48
11062613|NCT01024010|12244417|FG001|COMPLETED|Overall Study||34
11062614|NCT01024010|12244416|FG000|NOT COMPLETED|Overall Study||0
11062615|NCT01024010|12244417|FG001|NOT COMPLETED|Overall Study||0
11062616|NCT01024036|12244425|FG000|STARTED|Blinded Treatment||53
11062617|NCT01024036|12244426|FG001|STARTED|Blinded Treatment||26
11062618|NCT01024036|12244425|FG000|COMPLETED|Blinded Treatment||31
11062619|NCT01024036|12244426|FG001|COMPLETED|Blinded Treatment||6
11062620|NCT01024036|12244425|FG000|NOT COMPLETED|Blinded Treatment||22
11062621|NCT01024036|12244426|FG001|NOT COMPLETED|Blinded Treatment||20
11062622|NCT01024036|12244425|FG000|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
11062623|NCT01024036|12244426|FG001|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
11062624|NCT01024036|12244425|FG000|COMPLETED|Unblinded Treatment||0
11062625|NCT01024036|12244426|FG001|COMPLETED|Unblinded Treatment||10
11062626|NCT01024036|12244425|FG000|NOT COMPLETED|Unblinded Treatment||0
11062627|NCT01024036|12244426|FG001|NOT COMPLETED|Unblinded Treatment||3
11062628|NCT01024036|12244425|FG000|STARTED|Follow-Up Period||14
11062629|NCT01024036|12244426|FG001|STARTED|Follow-Up Period||6
11062630|NCT01024036|12244425|FG000|COMPLETED|Follow-Up Period||9
11062631|NCT01024036|12244426|FG001|COMPLETED|Follow-Up Period||3
11062632|NCT01024036|12244425|FG000|NOT COMPLETED|Follow-Up Period||5
11062633|NCT01024036|12244426|FG001|NOT COMPLETED|Follow-Up Period||3
11062634|NCT01024231|12244442|FG000|STARTED|Overall Study||14
11062635|NCT01024231|12244443|FG001|STARTED|Overall Study||17
11062636|NCT01024231|12244444|FG002|STARTED|Overall Study||16
11062637|NCT01024231|12244445|FG003|STARTED|Overall Study||6
11062638|NCT01024231|12244446|FG004|STARTED|Overall Study||17
11062639|NCT01024231|12244447|FG005|STARTED|Overall Study||16
11062640|NCT01024231|12244448|FG006|STARTED|Overall Study||41
11062641|NCT01024231|12244442|FG000|COMPLETED|Overall Study||2
11062642|NCT01024231|12244443|FG001|COMPLETED|Overall Study||2
11062643|NCT01024231|12244444|FG002|COMPLETED|Overall Study||6
11062644|NCT01024231|12244445|FG003|COMPLETED|Overall Study||1
11062645|NCT01024231|12244446|FG004|COMPLETED|Overall Study||0
11062646|NCT01024231|12244447|FG005|COMPLETED|Overall Study||0
11062647|NCT01024231|12244448|FG006|COMPLETED|Overall Study||20
11062648|NCT01024231|12244442|FG000|NOT COMPLETED|Overall Study||12
11062649|NCT01024231|12244443|FG001|NOT COMPLETED|Overall Study||15
11062650|NCT01024231|12244444|FG002|NOT COMPLETED|Overall Study||10
11062651|NCT01024231|12244445|FG003|NOT COMPLETED|Overall Study||5
11062652|NCT01024231|12244446|FG004|NOT COMPLETED|Overall Study||17
11062653|NCT01024231|12244447|FG005|NOT COMPLETED|Overall Study||16
11062654|NCT01024231|12244448|FG006|NOT COMPLETED|Overall Study||21
11062655|NCT01024244|12244474|FG000|STARTED|Overall Study||22
11062656|NCT01024244|12244475|FG001|STARTED|Overall Study||12
11062657|NCT01024244|12244476|FG002|STARTED|Overall Study||15
11062658|NCT01024244|12244477|FG003|STARTED|Overall Study||14
11062659|NCT01024244|12244478|FG004|STARTED|Overall Study||15
11062660|NCT01024244|12244474|FG000|COMPLETED|Overall Study||5
11062661|NCT01024244|12244475|FG001|COMPLETED|Overall Study||1
11062662|NCT01024244|12244476|FG002|COMPLETED|Overall Study||1
11062663|NCT01024244|12244477|FG003|COMPLETED|Overall Study||1
11062664|NCT01024244|12244478|FG004|COMPLETED|Overall Study||1
11062665|NCT01024244|12244474|FG000|NOT COMPLETED|Overall Study||17
11062666|NCT01024244|12244475|FG001|NOT COMPLETED|Overall Study||11
11062667|NCT01024244|12244476|FG002|NOT COMPLETED|Overall Study||14
11062668|NCT01024244|12244477|FG003|NOT COMPLETED|Overall Study||13
11062669|NCT01024244|12244478|FG004|NOT COMPLETED|Overall Study||14
11062670|NCT01024296|12244490|FG000|STARTED|Overall Study||4
11062671|NCT01024296|12244490|FG000|COMPLETED|Overall Study||4
11062672|NCT01024296|12244490|FG000|NOT COMPLETED|Overall Study||0
11062673|NCT01024309|12244496|FG000|STARTED|Overall Study||35
11062674|NCT01024309|12244497|FG001|STARTED|Overall Study||31
11062675|NCT01024309|12244496|FG000|COMPLETED|Overall Study||27
11062676|NCT01024309|12244497|FG001|COMPLETED|Overall Study||27
11062677|NCT01024309|12244496|FG000|NOT COMPLETED|Overall Study||8
11062678|NCT01024309|12244497|FG001|NOT COMPLETED|Overall Study||4
11062679|NCT01024335|12244505|FG000|STARTED|Overall Study||20
11062680|NCT01024335|12244506|FG001|STARTED|Overall Study||40
11062681|NCT01024335|12244505|FG000|COMPLETED|Overall Study||7
11062682|NCT01024335|12244506|FG001|COMPLETED|Overall Study||14
11062683|NCT01024335|12244505|FG000|NOT COMPLETED|Overall Study||13
11062684|NCT01024335|12244506|FG001|NOT COMPLETED|Overall Study||26
11062685|NCT01024387|12244512|FG000|STARTED|Overall Study||60
11062686|NCT01024387|12244512|FG000|Evaluable for PFS|Overall Study||54
11062687|NCT01024387|12244512|FG000|Evaluable for Response|Overall Study||53
11062688|NCT01024387|12244512|FG000|COMPLETED|Overall Study||0
11062689|NCT01024387|12244512|FG000|NOT COMPLETED|Overall Study||60
11062690|NCT01024465|12244516|FG000|STARTED|Overall Study||26
11062691|NCT01024465|12244516|FG000|COMPLETED|Overall Study||23
11062692|NCT01024465|12244516|FG000|NOT COMPLETED|Overall Study||3
11062693|NCT01024569|12244522|FG000|STARTED|Overall Study||276
11062694|NCT01024569|12244523|FG001|STARTED|Overall Study||279
11062695|NCT01024569|12244522|FG000|COMPLETED|Overall Study||251
11062696|NCT01024569|12244523|FG001|COMPLETED|Overall Study||268
11062697|NCT01024569|12244522|FG000|NOT COMPLETED|Overall Study||25
11062698|NCT01024569|12244523|FG001|NOT COMPLETED|Overall Study||11
11062699|NCT01024686|12244534|FG000|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6
11062700|NCT01024686|12244535|FG001|STARTED|Overall Study||0
11062701|NCT01024686|12244536|FG002|STARTED|Overall Study||0
11062702|NCT01024686|12244534|FG000|COMPLETED|Overall Study||6
11062703|NCT01024686|12244535|FG001|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
11062704|NCT01024686|12244536|FG002|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
11062705|NCT01024686|12244534|FG000|NOT COMPLETED|Overall Study||0
11062706|NCT01024686|12244535|FG001|NOT COMPLETED|Overall Study||0
11062707|NCT01024686|12244536|FG002|NOT COMPLETED|Overall Study||0
11062708|NCT01024738|12244547|FG000|STARTED|First Intervention:||7
11062709|NCT01024738|12244548|FG001|STARTED|First Intervention:||7
11062710|NCT01024738|12244549|FG002|STARTED|First Intervention:||8
11062711|NCT01024738|12244547|FG000|COMPLETED|First Intervention:||7
11062712|NCT01024738|12244548|FG001|COMPLETED|First Intervention:||7
11062713|NCT01024738|12244549|FG002|COMPLETED|First Intervention:||8
11062714|NCT01024738|12244547|FG000|NOT COMPLETED|First Intervention:||0
11062715|NCT01024738|12244548|FG001|NOT COMPLETED|First Intervention:||0
11062716|NCT01024738|12244549|FG002|NOT COMPLETED|First Intervention:||0
11062717|NCT01024738|12244547|FG000|STARTED|Washout After 1st Intervention||7
11062718|NCT01024738|12244548|FG001|STARTED|Washout After 1st Intervention||7
11062719|NCT01024738|12244549|FG002|STARTED|Washout After 1st Intervention||8
11062720|NCT01024738|12244547|FG000|COMPLETED|Washout After 1st Intervention||7
11062721|NCT01024738|12244548|FG001|COMPLETED|Washout After 1st Intervention||7
11062722|NCT01024738|12244549|FG002|COMPLETED|Washout After 1st Intervention||8
11062723|NCT01024738|12244547|FG000|NOT COMPLETED|Washout After 1st Intervention||0
11062724|NCT01024738|12244548|FG001|NOT COMPLETED|Washout After 1st Intervention||0
11062725|NCT01024738|12244549|FG002|NOT COMPLETED|Washout After 1st Intervention||0
11062726|NCT01024738|12244547|FG000|STARTED|Second Intervention:||7
11062727|NCT01024738|12244548|FG001|STARTED|Second Intervention:||7
11062728|NCT01024738|12244549|FG002|STARTED|Second Intervention:||8
11062729|NCT01024738|12244547|FG000|COMPLETED|Second Intervention:||7
11062730|NCT01024738|12244548|FG001|COMPLETED|Second Intervention:||7
11062731|NCT01024738|12244549|FG002|COMPLETED|Second Intervention:||8
11062732|NCT01024738|12244547|FG000|NOT COMPLETED|Second Intervention:||0
11062733|NCT01024738|12244548|FG001|NOT COMPLETED|Second Intervention:||0
11062734|NCT01024738|12244549|FG002|NOT COMPLETED|Second Intervention:||0
11062735|NCT01024738|12244547|FG000|STARTED|Washout After 2nd Intervention||7
11062736|NCT01024738|12244548|FG001|STARTED|Washout After 2nd Intervention||7
11062737|NCT01024738|12244549|FG002|STARTED|Washout After 2nd Intervention||8
11062738|NCT01024738|12244547|FG000|COMPLETED|Washout After 2nd Intervention||7
11062739|NCT01024738|12244548|FG001|COMPLETED|Washout After 2nd Intervention||7
11062740|NCT01024738|12244549|FG002|COMPLETED|Washout After 2nd Intervention||8
11062741|NCT01024738|12244547|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
11062742|NCT01024738|12244548|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
11062743|NCT01024738|12244549|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
11062744|NCT01024738|12244547|FG000|STARTED|Third Intervention:||7
11062745|NCT01024738|12244548|FG001|STARTED|Third Intervention:||7
11062746|NCT01024738|12244549|FG002|STARTED|Third Intervention:||8
11062747|NCT01024738|12244547|FG000|COMPLETED|Third Intervention:||7
11062748|NCT01024738|12244548|FG001|COMPLETED|Third Intervention:||7
11062749|NCT01024738|12244549|FG002|COMPLETED|Third Intervention:||8
11062750|NCT01024738|12244547|FG000|NOT COMPLETED|Third Intervention:||0
11062751|NCT01024738|12244548|FG001|NOT COMPLETED|Third Intervention:||0
11062752|NCT01024738|12244549|FG002|NOT COMPLETED|Third Intervention:||0
11062753|NCT01024751|12244559|FG000|STARTED|Enrolled Participants||156
11062754|NCT01024751|12244560|FG001|STARTED|Enrolled Participants||156
11062755|NCT01024751|12244559|FG000|COMPLETED|Enrolled Participants||153
11062756|NCT01024751|12244560|FG001|COMPLETED|Enrolled Participants||152
11062757|NCT01024751|12244559|FG000|NOT COMPLETED|Enrolled Participants||3
11062758|NCT01024751|12244560|FG001|NOT COMPLETED|Enrolled Participants||4
11062759|NCT01024751|12244559|FG000|STARTED|Eligible Participants||153
11062760|NCT01024751|12244560|FG001|STARTED|Eligible Participants||152
11062761|NCT01024751|12244559|FG000|COMPLETED|Eligible Participants||153
11062762|NCT01024751|12244560|FG001|COMPLETED|Eligible Participants||149
11062763|NCT01024751|12244559|FG000|NOT COMPLETED|Eligible Participants||0
11062764|NCT01024751|12244560|FG001|NOT COMPLETED|Eligible Participants||3
11062765|NCT01024855|12244566|FG000|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
11062766|NCT01024855|12244566|FG000|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
11062767|NCT01024855|12244566|FG000|NOT COMPLETED|Overall Study||1
11062768|NCT01024920|12244573|FG000|STARTED|Overall Study||67
11062769|NCT01024920|12244574|FG001|STARTED|Overall Study||32
11062770|NCT01024920|12244573|FG000|Treated|Overall Study||64
11062771|NCT01024920|12244574|FG001|Treated|Overall Study||32
11062772|NCT01024920|12244573|FG000|COMPLETED|Overall Study||0
11062773|NCT01024920|12244574|FG001|COMPLETED|Overall Study||0
11062774|NCT01024920|12244573|FG000|NOT COMPLETED|Overall Study||67
11062775|NCT01024920|12244574|FG001|NOT COMPLETED|Overall Study||32
11062776|NCT01024946|12244580|FG000|STARTED|Overall Study||11
11062777|NCT01024946|12244580|FG000|COMPLETED|Overall Study||6
11062778|NCT01024946|12244580|FG000|NOT COMPLETED|Overall Study||5
11062779|NCT01024959|12244584|FG000|STARTED|Overall Study||507
11062780|NCT01024959|12244584|FG000|COMPLETED|Overall Study||466
11062781|NCT01024959|12244584|FG000|NOT COMPLETED|Overall Study||41
11062782|NCT01024972|12244595|FG000|STARTED|Overall Study||16
11062783|NCT01024972|12244596|FG001|STARTED|Overall Study||15
11062784|NCT01024972|12244595|FG000|COMPLETED|Overall Study||16
11062785|NCT01024972|12244596|FG001|COMPLETED|Overall Study||15
11062786|NCT01024972|12244595|FG000|NOT COMPLETED|Overall Study||0
11062787|NCT01024972|12244596|FG001|NOT COMPLETED|Overall Study||0
11062788|NCT01025037|12244603|FG000|STARTED|Overall Study||61
11062789|NCT01025037|12244603|FG000|COMPLETED|Overall Study||50
11345321|NCT02968173|12542384|FG000|NOT COMPLETED|Overall Study||1
11345322|NCT02968277|12542392|FG000|STARTED|Overall Study||10
11345323|NCT02968277|12542393|FG001|STARTED|Overall Study||7
11345324|NCT02968277|12542394|FG002|STARTED|Overall Study||13
11345325|NCT02968277|12542392|FG000|COMPLETED|Overall Study||10
11345326|NCT02968277|12542393|FG001|COMPLETED|Overall Study||7
11345327|NCT02968277|12542394|FG002|COMPLETED|Overall Study||13
11062790|NCT01025037|12244603|FG000|NOT COMPLETED|Overall Study||11
11062791|NCT01025076|12244607|FG000|STARTED|Overall Study||14
11062792|NCT01025076|12244607|FG000|COMPLETED|Overall Study||14
11062793|NCT01025076|12244607|FG000|NOT COMPLETED|Overall Study||0
11062794|NCT01025154|12244611|FG000|STARTED|Overall Study||59
11062795|NCT01025154|12244611|FG000|COMPLETED|Overall Study||57
11062796|NCT01025154|12244611|FG000|NOT COMPLETED|Overall Study||2
11062797|NCT01025193|12244615|FG000|STARTED|Overall Study||8
11062798|NCT01025193|12244615|FG000|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
11062799|NCT01025193|12244615|FG000|NOT COMPLETED|Overall Study||4
11062800|NCT01025232|12244625|FG000|STARTED|Overall Study||46
11062801|NCT01025232|12244626|FG001|STARTED|Overall Study||42
11345328|NCT02968277|12542392|FG000|NOT COMPLETED|Overall Study||0
11345329|NCT02968277|12542393|FG001|NOT COMPLETED|Overall Study||0
11345330|NCT02968277|12542394|FG002|NOT COMPLETED|Overall Study||0
11062802|NCT01025232|12244625|FG000|COMPLETED|Overall Study||43
11345331|NCT02968368|12542408|FG000|STARTED|Double Blind Phase||111
11345332|NCT02968368|12542409|FG001|STARTED|Double Blind Phase||56
11345333|NCT02968368|12542408|FG000|COMPLETED|Double Blind Phase||90
11345334|NCT02968368|12542409|FG001|COMPLETED|Double Blind Phase||39
11062803|NCT01025232|12244626|FG001|COMPLETED|Overall Study||36
11345335|NCT02968368|12542408|FG000|NOT COMPLETED|Double Blind Phase||21
11062804|NCT01025232|12244625|FG000|NOT COMPLETED|Overall Study||3
11345336|NCT02968368|12542409|FG001|NOT COMPLETED|Double Blind Phase||17
11345337|NCT02968368|12542408|FG000|STARTED|Open Label Phase||86
11345338|NCT02968368|12542409|FG001|STARTED|Open Label Phase||39
11062805|NCT01025232|12244626|FG001|NOT COMPLETED|Overall Study||6
11062806|NCT01025284|12244635|FG000|STARTED|Overall Study||38
11062807|NCT01025284|12244636|FG001|STARTED|Overall Study||18
11062808|NCT01025284|12244637|FG002|STARTED|Overall Study||8
11062809|NCT01025284|12244635|FG000|Received at Least 1 Dose of Study Drug|Overall Study||38
11062810|NCT01025284|12244636|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18
11345339|NCT02968368|12542408|FG000|COMPLETED|Open Label Phase||67
11345340|NCT02968368|12542409|FG001|COMPLETED|Open Label Phase||25
11062811|NCT01025284|12244637|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
11062812|NCT01025284|12244635|FG000|COMPLETED|Overall Study||38
11205732|NCT01861457|12396591|FG000|NOT COMPLETED|Overall Study||0
11205733|NCT01861457|12396592|FG001|NOT COMPLETED|Overall Study||0
11205734|NCT01861522|12396600|FG000|STARTED|Overall Study||240
11205735|NCT01861522|12396601|FG001|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
11205736|NCT01861522|12396600|FG000|COMPLETED|Overall Study||237
11205737|NCT01861522|12396601|FG001|COMPLETED|Overall Study||232
11205738|NCT01861522|12396600|FG000|NOT COMPLETED|Overall Study||3
11205739|NCT01861522|12396601|FG001|NOT COMPLETED|Overall Study||0
11205740|NCT01861574|12396611|FG000|STARTED|Overall Study||28
11205741|NCT01861574|12396612|FG001|STARTED|Overall Study||25
11205742|NCT01861574|12396613|FG002|STARTED|Overall Study||27
11205743|NCT01861574|12396614|FG003|STARTED|Overall Study||28
11205744|NCT01861574|12396611|FG000|COMPLETED|Overall Study||28
11205745|NCT01861574|12396612|FG001|COMPLETED|Overall Study||25
11205746|NCT01861574|12396613|FG002|COMPLETED|Overall Study||27
11205747|NCT01861574|12396614|FG003|COMPLETED|Overall Study||28
11205748|NCT01861574|12396611|FG000|NOT COMPLETED|Overall Study||0
11205749|NCT01861574|12396612|FG001|NOT COMPLETED|Overall Study||0
11205750|NCT01861574|12396613|FG002|NOT COMPLETED|Overall Study||0
11205751|NCT01861574|12396614|FG003|NOT COMPLETED|Overall Study||0
11205752|NCT01861587|12396629|FG000|STARTED|Overall Study||14
11205753|NCT01861587|12396630|FG001|STARTED|Overall Study||13
11205754|NCT01861587|12396629|FG000|COMPLETED|Overall Study||14
11205755|NCT01861587|12396630|FG001|COMPLETED|Overall Study||13
11205756|NCT01861587|12396629|FG000|NOT COMPLETED|Overall Study||0
11205757|NCT01861587|12396630|FG001|NOT COMPLETED|Overall Study||0
11205758|NCT01861665|12396642|FG000|STARTED|Overall Study||10
11205759|NCT01861665|12396643|FG001|STARTED|Overall Study||17
11205760|NCT01861665|12396642|FG000|COMPLETED|Overall Study||10
11205761|NCT01861665|12396643|FG001|COMPLETED|Overall Study||17
11205762|NCT01861665|12396642|FG000|NOT COMPLETED|Overall Study||0
11205763|NCT01861665|12396643|FG001|NOT COMPLETED|Overall Study||0
11205764|NCT01861704|12396651|FG000|STARTED|Overall Study||70
11205765|NCT01861704|12396652|FG001|STARTED|Overall Study||107
11205766|NCT01861704|12396651|FG000|COMPLETED|Overall Study||67
11205767|NCT01861704|12396652|FG001|COMPLETED|Overall Study||104
11205768|NCT01861704|12396651|FG000|NOT COMPLETED|Overall Study||3
11205769|NCT01861704|12396652|FG001|NOT COMPLETED|Overall Study||3
11205770|NCT01861756|12396660|FG000|STARTED|Overall Study||101
11205771|NCT01861756|12396661|FG001|STARTED|Overall Study||103
11205772|NCT01861756|12396660|FG000|COMPLETED|Overall Study||88
11205773|NCT01861756|12396661|FG001|COMPLETED|Overall Study||85
11205774|NCT01861756|12396660|FG000|NOT COMPLETED|Overall Study||13
11205775|NCT01861756|12396661|FG001|NOT COMPLETED|Overall Study||18
11205776|NCT01861925|12396670|FG000|STARTED|Overall Study||34
11205777|NCT01861925|12396671|FG001|STARTED|Overall Study||8
11205778|NCT01861925|12396672|FG002|STARTED|Overall Study||8
11205779|NCT01861925|12396670|FG000|COMPLETED|Overall Study||34
11205780|NCT01861925|12396671|FG001|COMPLETED|Overall Study||8
11205781|NCT01861925|12396672|FG002|COMPLETED|Overall Study||8
11205782|NCT01861925|12396670|FG000|NOT COMPLETED|Overall Study||0
11205783|NCT01861925|12396671|FG001|NOT COMPLETED|Overall Study||0
11205784|NCT01861925|12396672|FG002|NOT COMPLETED|Overall Study||0
11205785|NCT01862029|12396681|FG000|STARTED|Overall Study||9
11205786|NCT01862029|12396681|FG000|COMPLETED|Overall Study||8
11205787|NCT01862029|12396681|FG000|NOT COMPLETED|Overall Study||1
11205788|NCT01862133|12396686|FG000|STARTED|Overall Study||105
11205789|NCT01862133|12396687|FG001|STARTED|Overall Study||31
11205790|NCT01862133|12396686|FG000|Returned During 6 mo Study|Overall Study||92
11205791|NCT01862133|12396687|FG001|Returned During 6 mo Study|Overall Study||31
11205792|NCT01862133|12396686|FG000|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
11205793|NCT01862133|12396687|FG001|COMPLETED|Overall Study||31
11205794|NCT01862133|12396686|FG000|NOT COMPLETED|Overall Study||0
11205795|NCT01862133|12396687|FG001|NOT COMPLETED|Overall Study||0
11205796|NCT01862159|12396693|FG000|STARTED|Overall Study||25038
11205797|NCT01862159|12396693|FG000|COMPLETED|Overall Study||25038
11205798|NCT01862159|12396693|FG000|NOT COMPLETED|Overall Study||0
11205799|NCT01862250|12396697|FG000|STARTED|Overall Study||12
11062813|NCT01025284|12244636|FG001|COMPLETED|Overall Study||16
11062814|NCT01025284|12244637|FG002|COMPLETED|Overall Study||8
11062815|NCT01025284|12244635|FG000|NOT COMPLETED|Overall Study||0
11062816|NCT01025284|12244636|FG001|NOT COMPLETED|Overall Study||2
11062817|NCT01025284|12244637|FG002|NOT COMPLETED|Overall Study||0
11062818|NCT01025336|12244652|FG000|STARTED|Overall Study||130
11062819|NCT01025336|12244653|FG001|STARTED|Overall Study||210
11062820|NCT01025336|12244654|FG002|STARTED|Overall Study||179
11062821|NCT01025336|12244655|FG003|STARTED|Overall Study||221
11062822|NCT01025336|12244656|FG004|STARTED|Overall Study||222
11062823|NCT01025336|12244652|FG000|COMPLETED|Overall Study||130
11062824|NCT01025336|12244653|FG001|COMPLETED|Overall Study||210
11062825|NCT01025336|12244654|FG002|COMPLETED|Overall Study||179
11062826|NCT01025336|12244655|FG003|COMPLETED|Overall Study||219
11062827|NCT01025336|12244656|FG004|COMPLETED|Overall Study||222
11062828|NCT01025336|12244652|FG000|NOT COMPLETED|Overall Study||0
11062829|NCT01025336|12244653|FG001|NOT COMPLETED|Overall Study||0
11062830|NCT01025336|12244654|FG002|NOT COMPLETED|Overall Study||0
11062831|NCT01025336|12244655|FG003|NOT COMPLETED|Overall Study||2
11062832|NCT01025336|12244656|FG004|NOT COMPLETED|Overall Study||0
11062833|NCT01025427|12244680|FG000|STARTED|Overall Study||16
11062834|NCT01025427|12244680|FG000|COMPLETED|Overall Study||16
11062835|NCT01025427|12244680|FG000|NOT COMPLETED|Overall Study||0
11062836|NCT01025453|12244684|FG000|STARTED|Overall Study||37
11062837|NCT01025453|12244684|FG000|COMPLETED|Overall Study||37
11062838|NCT01025453|12244684|FG000|NOT COMPLETED|Overall Study||0
11062839|NCT01025635|12244690|FG000|STARTED|Overall Study||198
11062840|NCT01025635|12244691|FG001|STARTED|Overall Study||203
11062841|NCT01025635|12244690|FG000|COMPLETED|Overall Study||175
11062842|NCT01025635|12244691|FG001|COMPLETED|Overall Study||178
11062843|NCT01025635|12244690|FG000|NOT COMPLETED|Overall Study||23
11062844|NCT01025635|12244691|FG001|NOT COMPLETED|Overall Study||25
11062845|NCT01025752|12244699|FG000|STARTED|Overall Study||62
11062846|NCT01025752|12244700|FG001|STARTED|Overall Study||63
11062847|NCT01025752|12244699|FG000|COMPLETED|Overall Study||54
11062848|NCT01025752|12244700|FG001|COMPLETED|Overall Study||50
11062849|NCT01025752|12244699|FG000|NOT COMPLETED|Overall Study||8
11062850|NCT01025752|12244700|FG001|NOT COMPLETED|Overall Study||13
11062851|NCT01025791|12244709|FG000|STARTED|Period 1||2
11062852|NCT01025791|12244710|FG001|STARTED|Period 1||2
11062853|NCT01025791|12244711|FG002|STARTED|Period 1||2
11062854|NCT01025791|12244712|FG003|STARTED|Period 1||2
11062855|NCT01025791|12244713|FG004|STARTED|Period 1||2
11062856|NCT01025791|12244714|FG005|STARTED|Period 1||2
11062857|NCT01025791|12244715|FG006|STARTED|Period 1||2
11062858|NCT01025791|12244716|FG007|STARTED|Period 1||2
11062859|NCT01025791|12244717|FG008|STARTED|Period 1||2
11062860|NCT01025791|12244718|FG009|STARTED|Period 1||1
11062861|NCT01025791|12244719|FG010|STARTED|Period 1||2
11062862|NCT01025791|12244720|FG011|STARTED|Period 1||1
11062863|NCT01025791|12244721|FG012|STARTED|Period 1||2
11062864|NCT01025791|12244722|FG013|STARTED|Period 1||1
11062865|NCT01025791|12244709|FG000|COMPLETED|Period 1||2
11062866|NCT01025791|12244710|FG001|COMPLETED|Period 1||2
11062867|NCT01025791|12244711|FG002|COMPLETED|Period 1||2
11062868|NCT01025791|12244712|FG003|COMPLETED|Period 1||2
11062869|NCT01025791|12244713|FG004|COMPLETED|Period 1||2
11062870|NCT01025791|12244714|FG005|COMPLETED|Period 1||2
11062871|NCT01025791|12244715|FG006|COMPLETED|Period 1||2
11062872|NCT01025791|12244716|FG007|COMPLETED|Period 1||2
11062873|NCT01025791|12244717|FG008|COMPLETED|Period 1||2
11062874|NCT01025791|12244718|FG009|COMPLETED|Period 1||1
11062875|NCT01025791|12244719|FG010|COMPLETED|Period 1||2
11062876|NCT01025791|12244720|FG011|COMPLETED|Period 1||1
11062877|NCT01025791|12244721|FG012|COMPLETED|Period 1||2
11062878|NCT01025791|12244722|FG013|COMPLETED|Period 1||1
11062879|NCT01025791|12244709|FG000|NOT COMPLETED|Period 1||0
11062880|NCT01025791|12244710|FG001|NOT COMPLETED|Period 1||0
11062881|NCT01025791|12244711|FG002|NOT COMPLETED|Period 1||0
11062882|NCT01025791|12244712|FG003|NOT COMPLETED|Period 1||0
11062883|NCT01025791|12244713|FG004|NOT COMPLETED|Period 1||0
11062884|NCT01025791|12244714|FG005|NOT COMPLETED|Period 1||0
11062885|NCT01025791|12244715|FG006|NOT COMPLETED|Period 1||0
11062886|NCT01025791|12244716|FG007|NOT COMPLETED|Period 1||0
11062887|NCT01025791|12244717|FG008|NOT COMPLETED|Period 1||0
11062888|NCT01025791|12244718|FG009|NOT COMPLETED|Period 1||0
11062889|NCT01025791|12244719|FG010|NOT COMPLETED|Period 1||0
11062890|NCT01025791|12244720|FG011|NOT COMPLETED|Period 1||0
11062891|NCT01025791|12244721|FG012|NOT COMPLETED|Period 1||0
11062892|NCT01025791|12244722|FG013|NOT COMPLETED|Period 1||0
11062893|NCT01025791|12244709|FG000|STARTED|Period 2||2
11062894|NCT01025791|12244710|FG001|STARTED|Period 2||2
11062895|NCT01025791|12244711|FG002|STARTED|Period 2||2
11062896|NCT01025791|12244712|FG003|STARTED|Period 2||2
11062897|NCT01025791|12244713|FG004|STARTED|Period 2||2
11062898|NCT01025791|12244714|FG005|STARTED|Period 2||2
11062899|NCT01025791|12244715|FG006|STARTED|Period 2||2
11062900|NCT01025791|12244716|FG007|STARTED|Period 2||2
11062901|NCT01025791|12244717|FG008|STARTED|Period 2||2
11062902|NCT01025791|12244718|FG009|STARTED|Period 2||1
11062903|NCT01025791|12244719|FG010|STARTED|Period 2||2
11062904|NCT01025791|12244720|FG011|STARTED|Period 2||1
11062905|NCT01025791|12244721|FG012|STARTED|Period 2||2
11062906|NCT01025791|12244722|FG013|STARTED|Period 2||1
11062907|NCT01025791|12244709|FG000|COMPLETED|Period 2||2
11062908|NCT01025791|12244710|FG001|COMPLETED|Period 2||2
11062909|NCT01025791|12244711|FG002|COMPLETED|Period 2||2
11062910|NCT01025791|12244712|FG003|COMPLETED|Period 2||2
11062911|NCT01025791|12244713|FG004|COMPLETED|Period 2||2
11062912|NCT01025791|12244714|FG005|COMPLETED|Period 2||2
11062913|NCT01025791|12244715|FG006|COMPLETED|Period 2||2
11062914|NCT01025791|12244716|FG007|COMPLETED|Period 2||2
11062915|NCT01025791|12244717|FG008|COMPLETED|Period 2||2
11062916|NCT01025791|12244718|FG009|COMPLETED|Period 2||1
11062917|NCT01025791|12244719|FG010|COMPLETED|Period 2||2
11062918|NCT01025791|12244720|FG011|COMPLETED|Period 2||1
11062919|NCT01025791|12244721|FG012|COMPLETED|Period 2||2
11062920|NCT01025791|12244722|FG013|COMPLETED|Period 2||1
11062921|NCT01025791|12244709|FG000|NOT COMPLETED|Period 2||0
11062922|NCT01025791|12244710|FG001|NOT COMPLETED|Period 2||0
11062923|NCT01025791|12244711|FG002|NOT COMPLETED|Period 2||0
11062924|NCT01025791|12244712|FG003|NOT COMPLETED|Period 2||0
11062925|NCT01025791|12244713|FG004|NOT COMPLETED|Period 2||0
11062926|NCT01025791|12244714|FG005|NOT COMPLETED|Period 2||0
11062927|NCT01025791|12244715|FG006|NOT COMPLETED|Period 2||0
11062928|NCT01025791|12244716|FG007|NOT COMPLETED|Period 2||0
11062929|NCT01025791|12244717|FG008|NOT COMPLETED|Period 2||0
11062930|NCT01025791|12244718|FG009|NOT COMPLETED|Period 2||0
11062931|NCT01025791|12244719|FG010|NOT COMPLETED|Period 2||0
11062932|NCT01025791|12244720|FG011|NOT COMPLETED|Period 2||0
11062933|NCT01025791|12244721|FG012|NOT COMPLETED|Period 2||0
11062934|NCT01025791|12244722|FG013|NOT COMPLETED|Period 2||0
11062935|NCT01025791|12244709|FG000|STARTED|Period 3||2
11062936|NCT01025791|12244710|FG001|STARTED|Period 3||2
11062937|NCT01025791|12244711|FG002|STARTED|Period 3||2
11062938|NCT01025791|12244712|FG003|STARTED|Period 3||2
11062939|NCT01025791|12244713|FG004|STARTED|Period 3||2
11062940|NCT01025791|12244714|FG005|STARTED|Period 3||2
11062941|NCT01025791|12244715|FG006|STARTED|Period 3||2
11062942|NCT01025791|12244716|FG007|STARTED|Period 3||2
11062943|NCT01025791|12244717|FG008|STARTED|Period 3||2
11062944|NCT01025791|12244718|FG009|STARTED|Period 3||1
11062945|NCT01025791|12244719|FG010|STARTED|Period 3||2
11062946|NCT01025791|12244720|FG011|STARTED|Period 3||1
11062947|NCT01025791|12244721|FG012|STARTED|Period 3||2
11062948|NCT01025791|12244722|FG013|STARTED|Period 3||1
11062949|NCT01025791|12244709|FG000|COMPLETED|Period 3||2
11062950|NCT01025791|12244710|FG001|COMPLETED|Period 3||2
11062951|NCT01025791|12244711|FG002|COMPLETED|Period 3||2
11062952|NCT01025791|12244712|FG003|COMPLETED|Period 3||2
11062953|NCT01025791|12244713|FG004|COMPLETED|Period 3||2
11062954|NCT01025791|12244714|FG005|COMPLETED|Period 3||2
11062955|NCT01025791|12244715|FG006|COMPLETED|Period 3||2
11062956|NCT01025791|12244716|FG007|COMPLETED|Period 3||2
11062957|NCT01025791|12244717|FG008|COMPLETED|Period 3||2
11062958|NCT01025791|12244718|FG009|COMPLETED|Period 3||1
11345341|NCT02968368|12542408|FG000|NOT COMPLETED|Open Label Phase||19
11345342|NCT02968368|12542409|FG001|NOT COMPLETED|Open Label Phase||14
11345343|NCT02968420|12542420|FG000|STARTED|Overall Study||6
11345344|NCT02968420|12542421|FG001|STARTED|Overall Study||6
11345345|NCT02968420|12542422|FG002|STARTED|Overall Study||6
11345346|NCT02968420|12542420|FG000|COMPLETED|Overall Study||6
11345347|NCT02968420|12542421|FG001|COMPLETED|Overall Study||6
11345348|NCT02968420|12542422|FG002|COMPLETED|Overall Study||6
11345349|NCT02968420|12542420|FG000|NOT COMPLETED|Overall Study||0
11345350|NCT02968420|12542421|FG001|NOT COMPLETED|Overall Study||0
11345351|NCT02968420|12542422|FG002|NOT COMPLETED|Overall Study||0
11345352|NCT02968433|12542430|FG000|STARTED|Overall Study||16
11345353|NCT02968433|12542430|FG000|COMPLETED|Overall Study||15
11345354|NCT02968433|12542430|FG000|NOT COMPLETED|Overall Study||1
11062959|NCT01025791|12244719|FG010|COMPLETED|Period 3||2
11062960|NCT01025791|12244720|FG011|COMPLETED|Period 3||1
11062961|NCT01025791|12244721|FG012|COMPLETED|Period 3||2
11062962|NCT01025791|12244722|FG013|COMPLETED|Period 3||1
11062963|NCT01025791|12244709|FG000|NOT COMPLETED|Period 3||0
11062964|NCT01025791|12244710|FG001|NOT COMPLETED|Period 3||0
11062965|NCT01025791|12244711|FG002|NOT COMPLETED|Period 3||0
11062966|NCT01025791|12244712|FG003|NOT COMPLETED|Period 3||0
11062967|NCT01025791|12244713|FG004|NOT COMPLETED|Period 3||0
11062968|NCT01025791|12244714|FG005|NOT COMPLETED|Period 3||0
11062969|NCT01025791|12244715|FG006|NOT COMPLETED|Period 3||0
11062970|NCT01025791|12244716|FG007|NOT COMPLETED|Period 3||0
11062971|NCT01025791|12244717|FG008|NOT COMPLETED|Period 3||0
11062972|NCT01025791|12244718|FG009|NOT COMPLETED|Period 3||0
11062973|NCT01025791|12244719|FG010|NOT COMPLETED|Period 3||0
11062974|NCT01025791|12244720|FG011|NOT COMPLETED|Period 3||0
11062975|NCT01025791|12244721|FG012|NOT COMPLETED|Period 3||0
11062976|NCT01025791|12244722|FG013|NOT COMPLETED|Period 3||0
11062977|NCT01025791|12244709|FG000|STARTED|Period 4||2
11062978|NCT01025791|12244710|FG001|STARTED|Period 4||2
11062979|NCT01025791|12244711|FG002|STARTED|Period 4||2
11062980|NCT01025791|12244712|FG003|STARTED|Period 4||2
11062981|NCT01025791|12244713|FG004|STARTED|Period 4||2
11062982|NCT01025791|12244714|FG005|STARTED|Period 4||2
11062983|NCT01025791|12244715|FG006|STARTED|Period 4||2
11062984|NCT01025791|12244716|FG007|STARTED|Period 4||2
11062985|NCT01025791|12244717|FG008|STARTED|Period 4||2
11062986|NCT01025791|12244718|FG009|STARTED|Period 4||1
11062987|NCT01025791|12244719|FG010|STARTED|Period 4||2
11062988|NCT01025791|12244720|FG011|STARTED|Period 4||1
11062989|NCT01025791|12244721|FG012|STARTED|Period 4||2
11062990|NCT01025791|12244722|FG013|STARTED|Period 4||1
11062991|NCT01025791|12244709|FG000|COMPLETED|Period 4||2
11062992|NCT01025791|12244710|FG001|COMPLETED|Period 4||2
11062993|NCT01025791|12244711|FG002|COMPLETED|Period 4||2
11062994|NCT01025791|12244712|FG003|COMPLETED|Period 4||2
11062995|NCT01025791|12244713|FG004|COMPLETED|Period 4||2
11062996|NCT01025791|12244714|FG005|COMPLETED|Period 4||2
11345355|NCT02968576|12542440|FG000|STARTED|Overall Study||11
11062997|NCT01025791|12244715|FG006|COMPLETED|Period 4||2
11062998|NCT01025791|12244716|FG007|COMPLETED|Period 4||2
11062999|NCT01025791|12244717|FG008|COMPLETED|Period 4||2
11063000|NCT01025791|12244718|FG009|COMPLETED|Period 4||1
11063001|NCT01025791|12244719|FG010|COMPLETED|Period 4||2
11063002|NCT01025791|12244720|FG011|COMPLETED|Period 4||1
11063003|NCT01025791|12244721|FG012|COMPLETED|Period 4||2
11063004|NCT01025791|12244722|FG013|COMPLETED|Period 4||1
11063005|NCT01025791|12244709|FG000|NOT COMPLETED|Period 4||0
11063006|NCT01025791|12244710|FG001|NOT COMPLETED|Period 4||0
11063007|NCT01025791|12244711|FG002|NOT COMPLETED|Period 4||0
11063008|NCT01025791|12244712|FG003|NOT COMPLETED|Period 4||0
11063009|NCT01025791|12244713|FG004|NOT COMPLETED|Period 4||0
11063010|NCT01025791|12244714|FG005|NOT COMPLETED|Period 4||0
11063011|NCT01025791|12244715|FG006|NOT COMPLETED|Period 4||0
11063012|NCT01025791|12244716|FG007|NOT COMPLETED|Period 4||0
11063013|NCT01025791|12244717|FG008|NOT COMPLETED|Period 4||0
11063014|NCT01025791|12244718|FG009|NOT COMPLETED|Period 4||0
11063015|NCT01025791|12244719|FG010|NOT COMPLETED|Period 4||0
11063016|NCT01025791|12244720|FG011|NOT COMPLETED|Period 4||0
11063017|NCT01025791|12244721|FG012|NOT COMPLETED|Period 4||0
11063018|NCT01025791|12244722|FG013|NOT COMPLETED|Period 4||0
11063019|NCT01025791|12244709|FG000|STARTED|Period 5||2
11063020|NCT01025791|12244710|FG001|STARTED|Period 5||2
11063021|NCT01025791|12244711|FG002|STARTED|Period 5||2
11063022|NCT01025791|12244712|FG003|STARTED|Period 5||2
11063023|NCT01025791|12244713|FG004|STARTED|Period 5||0
11063024|NCT01025791|12244714|FG005|STARTED|Period 5||0
11063025|NCT01025791|12244715|FG006|STARTED|Period 5||0
11063026|NCT01025791|12244716|FG007|STARTED|Period 5||0
11063027|NCT01025791|12244717|FG008|STARTED|Period 5||0
11063028|NCT01025791|12244718|FG009|STARTED|Period 5||0
11063029|NCT01025791|12244719|FG010|STARTED|Period 5||0
11063030|NCT01025791|12244720|FG011|STARTED|Period 5||0
11063031|NCT01025791|12244721|FG012|STARTED|Period 5||0
11063032|NCT01025791|12244722|FG013|STARTED|Period 5||0
11063033|NCT01025791|12244709|FG000|COMPLETED|Period 5||2
11063034|NCT01025791|12244710|FG001|COMPLETED|Period 5||2
11063035|NCT01025791|12244711|FG002|COMPLETED|Period 5||2
11063036|NCT01025791|12244712|FG003|COMPLETED|Period 5||2
11063037|NCT01025791|12244713|FG004|COMPLETED|Period 5||0
11063038|NCT01025791|12244714|FG005|COMPLETED|Period 5||0
11063039|NCT01025791|12244715|FG006|COMPLETED|Period 5||0
11063040|NCT01025791|12244716|FG007|COMPLETED|Period 5||0
11063041|NCT01025791|12244717|FG008|COMPLETED|Period 5||0
11063042|NCT01025791|12244718|FG009|COMPLETED|Period 5||0
11063043|NCT01025791|12244719|FG010|COMPLETED|Period 5||0
11063044|NCT01025791|12244720|FG011|COMPLETED|Period 5||0
11063045|NCT01025791|12244721|FG012|COMPLETED|Period 5||0
11063046|NCT01025791|12244722|FG013|COMPLETED|Period 5||0
11063047|NCT01025791|12244709|FG000|NOT COMPLETED|Period 5||0
11063048|NCT01025791|12244710|FG001|NOT COMPLETED|Period 5||0
11063049|NCT01025791|12244711|FG002|NOT COMPLETED|Period 5||0
11063050|NCT01025791|12244712|FG003|NOT COMPLETED|Period 5||0
11063051|NCT01025791|12244713|FG004|NOT COMPLETED|Period 5||0
11063052|NCT01025791|12244714|FG005|NOT COMPLETED|Period 5||0
11063053|NCT01025791|12244715|FG006|NOT COMPLETED|Period 5||0
11063054|NCT01025791|12244716|FG007|NOT COMPLETED|Period 5||0
11063055|NCT01025791|12244717|FG008|NOT COMPLETED|Period 5||0
11063056|NCT01025791|12244718|FG009|NOT COMPLETED|Period 5||0
11063057|NCT01025791|12244719|FG010|NOT COMPLETED|Period 5||0
11063058|NCT01025791|12244720|FG011|NOT COMPLETED|Period 5||0
11063059|NCT01025791|12244721|FG012|NOT COMPLETED|Period 5||0
11063060|NCT01025791|12244722|FG013|NOT COMPLETED|Period 5||0
11063061|NCT01025817|12244775|FG000|STARTED|Completed Study Medication||309
11063062|NCT01025817|12244776|FG001|STARTED|Completed Study Medication||304
11063063|NCT01025817|12244775|FG000|COMPLETED|Completed Study Medication||204
11063064|NCT01025817|12244776|FG001|COMPLETED|Completed Study Medication||232
11063065|NCT01025817|12244775|FG000|NOT COMPLETED|Completed Study Medication||105
11063066|NCT01025817|12244776|FG001|NOT COMPLETED|Completed Study Medication||72
11063067|NCT01025817|12244775|FG000|STARTED|Completed Study||309
11063068|NCT01025817|12244776|FG001|STARTED|Completed Study||304
11063069|NCT01025817|12244775|FG000|COMPLETED|Completed Study|Completed study phase|293
11063070|NCT01025817|12244776|FG001|COMPLETED|Completed Study|Completed study phase|282
11063071|NCT01025817|12244775|FG000|NOT COMPLETED|Completed Study||16
11063072|NCT01025817|12244776|FG001|NOT COMPLETED|Completed Study||22
11063073|NCT01025830|12244782|FG000|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
11063074|NCT01025830|12244783|FG001|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
11063075|NCT01025830|12244782|FG000|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
11063076|NCT01025830|12244783|FG001|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
11063077|NCT01025830|12244782|FG000|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
11063078|NCT01025830|12244783|FG001|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
11063079|NCT01025830|12244782|FG000|STARTED|Washout Period of 30 Days||8
11063080|NCT01025830|12244783|FG001|STARTED|Washout Period of 30 Days||12
11063081|NCT01025830|12244782|FG000|COMPLETED|Washout Period of 30 Days||8
11063082|NCT01025830|12244783|FG001|COMPLETED|Washout Period of 30 Days||12
11063083|NCT01025830|12244782|FG000|NOT COMPLETED|Washout Period of 30 Days||0
11063084|NCT01025830|12244783|FG001|NOT COMPLETED|Washout Period of 30 Days||0
11063085|NCT01025830|12244782|FG000|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
11063086|NCT01025830|12244783|FG001|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
11063087|NCT01025830|12244782|FG000|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
11063088|NCT01025830|12244783|FG001|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
11063089|NCT01025830|12244782|FG000|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
11063090|NCT01025830|12244783|FG001|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
11063091|NCT01025843|12244804|FG000|STARTED|Period 1||2
11063092|NCT01025843|12244805|FG001|STARTED|Period 1||2
11063093|NCT01025843|12244806|FG002|STARTED|Period 1||2
11063094|NCT01025843|12244807|FG003|STARTED|Period 1||2
11063095|NCT01025843|12244808|FG004|STARTED|Period 1||2
11063096|NCT01025843|12244809|FG005|STARTED|Period 1||2
11063097|NCT01025843|12244810|FG006|STARTED|Period 1||2
11063098|NCT01025843|12244811|FG007|STARTED|Period 1||2
11063099|NCT01025843|12244812|FG008|STARTED|Period 1||2
11063100|NCT01025843|12244813|FG009|STARTED|Period 1||2
11063101|NCT01025843|12244804|FG000|COMPLETED|Period 1||2
11063102|NCT01025843|12244805|FG001|COMPLETED|Period 1||2
11063103|NCT01025843|12244806|FG002|COMPLETED|Period 1||2
11063104|NCT01025843|12244807|FG003|COMPLETED|Period 1||2
11063105|NCT01025843|12244808|FG004|COMPLETED|Period 1||2
11063106|NCT01025843|12244809|FG005|COMPLETED|Period 1||2
11063107|NCT01025843|12244810|FG006|COMPLETED|Period 1||2
11063108|NCT01025843|12244811|FG007|COMPLETED|Period 1||2
11063109|NCT01025843|12244812|FG008|COMPLETED|Period 1||2
11063110|NCT01025843|12244813|FG009|COMPLETED|Period 1||2
11063111|NCT01025843|12244804|FG000|NOT COMPLETED|Period 1||0
11063112|NCT01025843|12244805|FG001|NOT COMPLETED|Period 1||0
11063113|NCT01025843|12244806|FG002|NOT COMPLETED|Period 1||0
11063114|NCT01025843|12244807|FG003|NOT COMPLETED|Period 1||0
11063115|NCT01025843|12244808|FG004|NOT COMPLETED|Period 1||0
11063116|NCT01025843|12244809|FG005|NOT COMPLETED|Period 1||0
11063117|NCT01025843|12244810|FG006|NOT COMPLETED|Period 1||0
11063118|NCT01025843|12244811|FG007|NOT COMPLETED|Period 1||0
11063119|NCT01025843|12244812|FG008|NOT COMPLETED|Period 1||0
11063120|NCT01025843|12244813|FG009|NOT COMPLETED|Period 1||0
11063121|NCT01025843|12244804|FG000|STARTED|Washout 1||2
11063122|NCT01025843|12244805|FG001|STARTED|Washout 1||2
11063123|NCT01025843|12244806|FG002|STARTED|Washout 1||2
11063124|NCT01025843|12244807|FG003|STARTED|Washout 1||2
11063125|NCT01025843|12244808|FG004|STARTED|Washout 1||2
11063126|NCT01025843|12244809|FG005|STARTED|Washout 1||2
11063127|NCT01025843|12244810|FG006|STARTED|Washout 1||2
11205800|NCT01862250|12396697|FG000|COMPLETED|Overall Study||8
11063128|NCT01025843|12244811|FG007|STARTED|Washout 1||2
11063129|NCT01025843|12244812|FG008|STARTED|Washout 1||2
11063130|NCT01025843|12244813|FG009|STARTED|Washout 1||2
11063131|NCT01025843|12244804|FG000|COMPLETED|Washout 1||2
11063132|NCT01025843|12244805|FG001|COMPLETED|Washout 1||2
11063133|NCT01025843|12244806|FG002|COMPLETED|Washout 1||2
11063134|NCT01025843|12244807|FG003|COMPLETED|Washout 1||2
11063135|NCT01025843|12244808|FG004|COMPLETED|Washout 1||2
11063136|NCT01025843|12244809|FG005|COMPLETED|Washout 1||2
11063137|NCT01025843|12244810|FG006|COMPLETED|Washout 1||2
11063138|NCT01025843|12244811|FG007|COMPLETED|Washout 1||2
11063139|NCT01025843|12244812|FG008|COMPLETED|Washout 1||2
11063140|NCT01025843|12244813|FG009|COMPLETED|Washout 1||2
11063141|NCT01025843|12244804|FG000|NOT COMPLETED|Washout 1||0
11063142|NCT01025843|12244805|FG001|NOT COMPLETED|Washout 1||0
11063143|NCT01025843|12244806|FG002|NOT COMPLETED|Washout 1||0
11063144|NCT01025843|12244807|FG003|NOT COMPLETED|Washout 1||0
11063145|NCT01025843|12244808|FG004|NOT COMPLETED|Washout 1||0
11063146|NCT01025843|12244809|FG005|NOT COMPLETED|Washout 1||0
11063147|NCT01025843|12244810|FG006|NOT COMPLETED|Washout 1||0
11063148|NCT01025843|12244811|FG007|NOT COMPLETED|Washout 1||0
11063149|NCT01025843|12244812|FG008|NOT COMPLETED|Washout 1||0
11063150|NCT01025843|12244813|FG009|NOT COMPLETED|Washout 1||0
11063151|NCT01025843|12244804|FG000|STARTED|Period 2||2
11063152|NCT01025843|12244805|FG001|STARTED|Period 2||2
11063153|NCT01025843|12244806|FG002|STARTED|Period 2||2
11063154|NCT01025843|12244807|FG003|STARTED|Period 2||2
11063155|NCT01025843|12244808|FG004|STARTED|Period 2||2
11063156|NCT01025843|12244809|FG005|STARTED|Period 2||2
11063157|NCT01025843|12244810|FG006|STARTED|Period 2||2
11063158|NCT01025843|12244811|FG007|STARTED|Period 2||2
11063159|NCT01025843|12244812|FG008|STARTED|Period 2||2
11063160|NCT01025843|12244813|FG009|STARTED|Period 2||2
11063161|NCT01025843|12244804|FG000|COMPLETED|Period 2||2
11063162|NCT01025843|12244805|FG001|COMPLETED|Period 2||2
11063163|NCT01025843|12244806|FG002|COMPLETED|Period 2||2
11063164|NCT01025843|12244807|FG003|COMPLETED|Period 2||2
11063165|NCT01025843|12244808|FG004|COMPLETED|Period 2||2
11063166|NCT01025843|12244809|FG005|COMPLETED|Period 2||2
11063167|NCT01025843|12244810|FG006|COMPLETED|Period 2||2
11063168|NCT01025843|12244811|FG007|COMPLETED|Period 2||2
11063169|NCT01025843|12244812|FG008|COMPLETED|Period 2||2
11063170|NCT01025843|12244813|FG009|COMPLETED|Period 2||2
11063171|NCT01025843|12244804|FG000|NOT COMPLETED|Period 2||0
11063172|NCT01025843|12244805|FG001|NOT COMPLETED|Period 2||0
11063173|NCT01025843|12244806|FG002|NOT COMPLETED|Period 2||0
11063174|NCT01025843|12244807|FG003|NOT COMPLETED|Period 2||0
11063175|NCT01025843|12244808|FG004|NOT COMPLETED|Period 2||0
11063176|NCT01025843|12244809|FG005|NOT COMPLETED|Period 2||0
11063177|NCT01025843|12244810|FG006|NOT COMPLETED|Period 2||0
11063178|NCT01025843|12244811|FG007|NOT COMPLETED|Period 2||0
11063179|NCT01025843|12244812|FG008|NOT COMPLETED|Period 2||0
11063180|NCT01025843|12244813|FG009|NOT COMPLETED|Period 2||0
11063181|NCT01025843|12244804|FG000|STARTED|Washout 2||2
11063182|NCT01025843|12244805|FG001|STARTED|Washout 2||2
11063183|NCT01025843|12244806|FG002|STARTED|Washout 2||2
11063184|NCT01025843|12244807|FG003|STARTED|Washout 2||2
11063185|NCT01025843|12244808|FG004|STARTED|Washout 2||2
11063186|NCT01025843|12244809|FG005|STARTED|Washout 2||2
11063187|NCT01025843|12244810|FG006|STARTED|Washout 2||2
11063188|NCT01025843|12244811|FG007|STARTED|Washout 2||2
11063189|NCT01025843|12244812|FG008|STARTED|Washout 2||2
11063190|NCT01025843|12244813|FG009|STARTED|Washout 2||2
11063191|NCT01025843|12244804|FG000|COMPLETED|Washout 2||2
11063192|NCT01025843|12244805|FG001|COMPLETED|Washout 2||2
11063193|NCT01025843|12244806|FG002|COMPLETED|Washout 2||2
11063194|NCT01025843|12244807|FG003|COMPLETED|Washout 2||2
11063195|NCT01025843|12244808|FG004|COMPLETED|Washout 2||2
11063196|NCT01025843|12244809|FG005|COMPLETED|Washout 2||2
11063197|NCT01025843|12244810|FG006|COMPLETED|Washout 2||2
11063198|NCT01025843|12244811|FG007|COMPLETED|Washout 2||2
11063199|NCT01025843|12244812|FG008|COMPLETED|Washout 2||2
11063200|NCT01025843|12244813|FG009|COMPLETED|Washout 2||2
11063201|NCT01025843|12244804|FG000|NOT COMPLETED|Washout 2||0
11063202|NCT01025843|12244805|FG001|NOT COMPLETED|Washout 2||0
11063203|NCT01025843|12244806|FG002|NOT COMPLETED|Washout 2||0
11063204|NCT01025843|12244807|FG003|NOT COMPLETED|Washout 2||0
11063205|NCT01025843|12244808|FG004|NOT COMPLETED|Washout 2||0
11063206|NCT01025843|12244809|FG005|NOT COMPLETED|Washout 2||0
11063207|NCT01025843|12244810|FG006|NOT COMPLETED|Washout 2||0
11063208|NCT01025843|12244811|FG007|NOT COMPLETED|Washout 2||0
11063209|NCT01025843|12244812|FG008|NOT COMPLETED|Washout 2||0
11063210|NCT01025843|12244813|FG009|NOT COMPLETED|Washout 2||0
11063211|NCT01025843|12244804|FG000|STARTED|Period 3||2
11063212|NCT01025843|12244805|FG001|STARTED|Period 3||2
11063213|NCT01025843|12244806|FG002|STARTED|Period 3||2
11063214|NCT01025843|12244807|FG003|STARTED|Period 3||2
11063215|NCT01025843|12244808|FG004|STARTED|Period 3||2
11063216|NCT01025843|12244809|FG005|STARTED|Period 3||2
11063217|NCT01025843|12244810|FG006|STARTED|Period 3||2
11063218|NCT01025843|12244811|FG007|STARTED|Period 3||2
11063219|NCT01025843|12244812|FG008|STARTED|Period 3||2
11063220|NCT01025843|12244813|FG009|STARTED|Period 3||2
11063221|NCT01025843|12244804|FG000|COMPLETED|Period 3||2
11063222|NCT01025843|12244805|FG001|COMPLETED|Period 3||2
11063223|NCT01025843|12244806|FG002|COMPLETED|Period 3||2
11063224|NCT01025843|12244807|FG003|COMPLETED|Period 3||2
11063225|NCT01025843|12244808|FG004|COMPLETED|Period 3||2
11063226|NCT01025843|12244809|FG005|COMPLETED|Period 3||2
11063227|NCT01025843|12244810|FG006|COMPLETED|Period 3||2
11063228|NCT01025843|12244811|FG007|COMPLETED|Period 3||2
11063229|NCT01025843|12244812|FG008|COMPLETED|Period 3||2
11063230|NCT01025843|12244813|FG009|COMPLETED|Period 3||2
11063231|NCT01025843|12244804|FG000|NOT COMPLETED|Period 3||0
11063232|NCT01025843|12244805|FG001|NOT COMPLETED|Period 3||0
11063233|NCT01025843|12244806|FG002|NOT COMPLETED|Period 3||0
11063234|NCT01025843|12244807|FG003|NOT COMPLETED|Period 3||0
11063235|NCT01025843|12244808|FG004|NOT COMPLETED|Period 3||0
11063236|NCT01025843|12244809|FG005|NOT COMPLETED|Period 3||0
11063237|NCT01025843|12244810|FG006|NOT COMPLETED|Period 3||0
11063238|NCT01025843|12244811|FG007|NOT COMPLETED|Period 3||0
11063239|NCT01025843|12244812|FG008|NOT COMPLETED|Period 3||0
11063240|NCT01025843|12244813|FG009|NOT COMPLETED|Period 3||0
11063241|NCT01025843|12244804|FG000|STARTED|Washout 3||2
11063242|NCT01025843|12244805|FG001|STARTED|Washout 3||2
11063243|NCT01025843|12244806|FG002|STARTED|Washout 3||2
11063244|NCT01025843|12244807|FG003|STARTED|Washout 3||2
11063245|NCT01025843|12244808|FG004|STARTED|Washout 3||2
11063246|NCT01025843|12244809|FG005|STARTED|Washout 3||2
11063247|NCT01025843|12244810|FG006|STARTED|Washout 3||2
11063248|NCT01025843|12244811|FG007|STARTED|Washout 3||2
11063249|NCT01025843|12244812|FG008|STARTED|Washout 3||2
11063250|NCT01025843|12244813|FG009|STARTED|Washout 3||2
11063251|NCT01025843|12244804|FG000|COMPLETED|Washout 3||2
11063252|NCT01025843|12244805|FG001|COMPLETED|Washout 3||2
11063253|NCT01025843|12244806|FG002|COMPLETED|Washout 3||2
11063254|NCT01025843|12244807|FG003|COMPLETED|Washout 3||2
11063255|NCT01025843|12244808|FG004|COMPLETED|Washout 3||2
11063256|NCT01025843|12244809|FG005|COMPLETED|Washout 3||2
11063257|NCT01025843|12244810|FG006|COMPLETED|Washout 3||2
11063258|NCT01025843|12244811|FG007|COMPLETED|Washout 3||2
11063259|NCT01025843|12244812|FG008|COMPLETED|Washout 3||2
11063260|NCT01025843|12244813|FG009|COMPLETED|Washout 3||2
11063261|NCT01025843|12244804|FG000|NOT COMPLETED|Washout 3||0
11063262|NCT01025843|12244805|FG001|NOT COMPLETED|Washout 3||0
11063263|NCT01025843|12244806|FG002|NOT COMPLETED|Washout 3||0
11063264|NCT01025843|12244807|FG003|NOT COMPLETED|Washout 3||0
11063265|NCT01025843|12244808|FG004|NOT COMPLETED|Washout 3||0
11063266|NCT01025843|12244809|FG005|NOT COMPLETED|Washout 3||0
11063267|NCT01025843|12244810|FG006|NOT COMPLETED|Washout 3||0
11063268|NCT01025843|12244811|FG007|NOT COMPLETED|Washout 3||0
11063269|NCT01025843|12244812|FG008|NOT COMPLETED|Washout 3||0
11063270|NCT01025843|12244813|FG009|NOT COMPLETED|Washout 3||0
11063271|NCT01025843|12244804|FG000|STARTED|Period 4||2
11063272|NCT01025843|12244805|FG001|STARTED|Period 4||2
11063273|NCT01025843|12244806|FG002|STARTED|Period 4||2
11063274|NCT01025843|12244807|FG003|STARTED|Period 4||2
11063275|NCT01025843|12244808|FG004|STARTED|Period 4||2
11063276|NCT01025843|12244809|FG005|STARTED|Period 4||2
11063277|NCT01025843|12244810|FG006|STARTED|Period 4||2
11063278|NCT01025843|12244811|FG007|STARTED|Period 4||2
11063279|NCT01025843|12244812|FG008|STARTED|Period 4||2
11063280|NCT01025843|12244813|FG009|STARTED|Period 4||2
11063281|NCT01025843|12244804|FG000|COMPLETED|Period 4||2
11063282|NCT01025843|12244805|FG001|COMPLETED|Period 4||2
11063283|NCT01025843|12244806|FG002|COMPLETED|Period 4||2
11063284|NCT01025843|12244807|FG003|COMPLETED|Period 4||2
11063285|NCT01025843|12244808|FG004|COMPLETED|Period 4||2
11063286|NCT01025843|12244809|FG005|COMPLETED|Period 4||2
11063287|NCT01025843|12244810|FG006|COMPLETED|Period 4||2
11063288|NCT01025843|12244811|FG007|COMPLETED|Period 4||2
11063289|NCT01025843|12244812|FG008|COMPLETED|Period 4||2
11063290|NCT01025843|12244813|FG009|COMPLETED|Period 4||2
11063291|NCT01025843|12244804|FG000|NOT COMPLETED|Period 4||0
11063292|NCT01025843|12244805|FG001|NOT COMPLETED|Period 4||0
11063293|NCT01025843|12244806|FG002|NOT COMPLETED|Period 4||0
11063294|NCT01025843|12244807|FG003|NOT COMPLETED|Period 4||0
11063295|NCT01025843|12244808|FG004|NOT COMPLETED|Period 4||0
11063296|NCT01025843|12244809|FG005|NOT COMPLETED|Period 4||0
11063297|NCT01025843|12244810|FG006|NOT COMPLETED|Period 4||0
11063298|NCT01025843|12244811|FG007|NOT COMPLETED|Period 4||0
11063299|NCT01025843|12244812|FG008|NOT COMPLETED|Period 4||0
11063300|NCT01025843|12244813|FG009|NOT COMPLETED|Period 4||0
11063301|NCT01025843|12244804|FG000|STARTED|Washout 4||2
11063302|NCT01025843|12244805|FG001|STARTED|Washout 4||2
11063303|NCT01025843|12244806|FG002|STARTED|Washout 4||2
11063304|NCT01025843|12244807|FG003|STARTED|Washout 4||2
11063305|NCT01025843|12244808|FG004|STARTED|Washout 4||2
11063306|NCT01025843|12244809|FG005|STARTED|Washout 4||2
11063307|NCT01025843|12244810|FG006|STARTED|Washout 4||2
11063308|NCT01025843|12244811|FG007|STARTED|Washout 4||2
11063309|NCT01025843|12244812|FG008|STARTED|Washout 4||2
11063310|NCT01025843|12244813|FG009|STARTED|Washout 4||2
11063311|NCT01025843|12244804|FG000|COMPLETED|Washout 4||2
11063312|NCT01025843|12244805|FG001|COMPLETED|Washout 4||2
11063313|NCT01025843|12244806|FG002|COMPLETED|Washout 4||1
11063314|NCT01025843|12244807|FG003|COMPLETED|Washout 4||1
11063315|NCT01025843|12244808|FG004|COMPLETED|Washout 4||2
11063316|NCT01025843|12244809|FG005|COMPLETED|Washout 4||2
11063317|NCT01025843|12244810|FG006|COMPLETED|Washout 4||2
11063318|NCT01025843|12244811|FG007|COMPLETED|Washout 4||2
11063319|NCT01025843|12244812|FG008|COMPLETED|Washout 4||2
11063320|NCT01025843|12244813|FG009|COMPLETED|Washout 4||2
11063321|NCT01025843|12244804|FG000|NOT COMPLETED|Washout 4||0
11063322|NCT01025843|12244805|FG001|NOT COMPLETED|Washout 4||0
11063323|NCT01025843|12244806|FG002|NOT COMPLETED|Washout 4||1
11063324|NCT01025843|12244807|FG003|NOT COMPLETED|Washout 4||1
11063325|NCT01025843|12244808|FG004|NOT COMPLETED|Washout 4||0
11063326|NCT01025843|12244809|FG005|NOT COMPLETED|Washout 4||0
11063327|NCT01025843|12244810|FG006|NOT COMPLETED|Washout 4||0
11063328|NCT01025843|12244811|FG007|NOT COMPLETED|Washout 4||0
11063329|NCT01025843|12244812|FG008|NOT COMPLETED|Washout 4||0
11063330|NCT01025843|12244813|FG009|NOT COMPLETED|Washout 4||0
11063331|NCT01025843|12244804|FG000|STARTED|Period 5||2
11063332|NCT01025843|12244805|FG001|STARTED|Period 5||2
11063333|NCT01025843|12244806|FG002|STARTED|Period 5||1
11063334|NCT01025843|12244807|FG003|STARTED|Period 5||1
11063335|NCT01025843|12244808|FG004|STARTED|Period 5||2
11063336|NCT01025843|12244809|FG005|STARTED|Period 5||2
11063337|NCT01025843|12244810|FG006|STARTED|Period 5||2
11063338|NCT01025843|12244811|FG007|STARTED|Period 5||2
11063339|NCT01025843|12244812|FG008|STARTED|Period 5||2
11063340|NCT01025843|12244813|FG009|STARTED|Period 5||2
11063341|NCT01025843|12244804|FG000|COMPLETED|Period 5||2
11063342|NCT01025843|12244805|FG001|COMPLETED|Period 5||2
11063343|NCT01025843|12244806|FG002|COMPLETED|Period 5||1
11063344|NCT01025843|12244807|FG003|COMPLETED|Period 5||1
11063345|NCT01025843|12244808|FG004|COMPLETED|Period 5||2
11063346|NCT01025843|12244809|FG005|COMPLETED|Period 5||2
11063347|NCT01025843|12244810|FG006|COMPLETED|Period 5||2
11063348|NCT01025843|12244811|FG007|COMPLETED|Period 5||2
11063349|NCT01025843|12244812|FG008|COMPLETED|Period 5||2
11063350|NCT01025843|12244813|FG009|COMPLETED|Period 5||2
11063351|NCT01025843|12244804|FG000|NOT COMPLETED|Period 5||0
11063352|NCT01025843|12244805|FG001|NOT COMPLETED|Period 5||0
11063353|NCT01025843|12244806|FG002|NOT COMPLETED|Period 5||0
11063354|NCT01025843|12244807|FG003|NOT COMPLETED|Period 5||0
11063355|NCT01025843|12244808|FG004|NOT COMPLETED|Period 5||0
11063356|NCT01025843|12244809|FG005|NOT COMPLETED|Period 5||0
11063357|NCT01025843|12244810|FG006|NOT COMPLETED|Period 5||0
11063358|NCT01025843|12244811|FG007|NOT COMPLETED|Period 5||0
11063359|NCT01025843|12244812|FG008|NOT COMPLETED|Period 5||0
11063360|NCT01025843|12244813|FG009|NOT COMPLETED|Period 5||0
11063361|NCT01026038|12244844|FG000|STARTED|Overall Study||130
11063362|NCT01026038|12244845|FG001|STARTED|Overall Study||65
11063363|NCT01026038|12244846|FG002|STARTED|Overall Study||67
11063364|NCT01026038|12244844|FG000|COMPLETED|Overall Study||129
11063365|NCT01026038|12244845|FG001|COMPLETED|Overall Study||64
11063366|NCT01026038|12244846|FG002|COMPLETED|Overall Study||67
11063367|NCT01026038|12244844|FG000|NOT COMPLETED|Overall Study||1
11063368|NCT01026038|12244845|FG001|NOT COMPLETED|Overall Study||1
11063369|NCT01026038|12244846|FG002|NOT COMPLETED|Overall Study||0
11063370|NCT01026103|12244854|FG000|STARTED|Overall Study||30
11063371|NCT01026103|12244854|FG000|Consented|Overall Study||30
11063372|NCT01026103|12244854|FG000|COMPLETED|Overall Study||28
11063373|NCT01026103|12244854|FG000|NOT COMPLETED|Overall Study||2
11063374|NCT01026142|12244860|FG000|STARTED|Overall Study||224
11063375|NCT01026142|12244861|FG001|STARTED|Overall Study||228
11063376|NCT01026142|12244860|FG000|COMPLETED|Overall Study||52
11063377|NCT01026142|12244861|FG001|COMPLETED|Overall Study||65
11063378|NCT01026142|12244860|FG000|NOT COMPLETED|Overall Study||172
11345356|NCT02968576|12542441|FG001|STARTED|Overall Study||14
11345357|NCT02968576|12542440|FG000|COMPLETED|Overall Study||11
11345358|NCT02968576|12542441|FG001|COMPLETED|Overall Study||13
11345359|NCT02968576|12542440|FG000|NOT COMPLETED|Overall Study||0
11345360|NCT02968576|12542441|FG001|NOT COMPLETED|Overall Study||1
11345361|NCT02968758|12542447|FG000|STARTED|Overall Study||797
11345362|NCT02968758|12542448|FG001|STARTED|Overall Study||1664
11345363|NCT02968758|12542447|FG000|COMPLETED|Overall Study||797
11345364|NCT02968758|12542448|FG001|COMPLETED|Overall Study||1664
11345365|NCT02968758|12542447|FG000|NOT COMPLETED|Overall Study||0
11345366|NCT02968758|12542448|FG001|NOT COMPLETED|Overall Study||0
11345367|NCT02968914|12542455|FG000|STARTED|Overall Study||90
11345368|NCT02968914|12542456|FG001|STARTED|Overall Study||90
11345369|NCT02968914|12542455|FG000|COMPLETED|Overall Study||90
11345370|NCT02968914|12542456|FG001|COMPLETED|Overall Study||90
11345371|NCT02968914|12542455|FG000|NOT COMPLETED|Overall Study||0
11345372|NCT02968914|12542456|FG001|NOT COMPLETED|Overall Study||0
11345373|NCT02968979|12542462|FG000|STARTED|Overall Study||539
11063379|NCT01026142|12244861|FG001|NOT COMPLETED|Overall Study||163
11063380|NCT01026181|12244870|FG000|STARTED|Overall Study||51
11063381|NCT01026181|12244871|FG001|STARTED|Overall Study||51
11063382|NCT01026181|12244872|FG002|STARTED|Overall Study||48
11063383|NCT01026181|12244870|FG000|COMPLETED|Overall Study||51
11063384|NCT01026181|12244871|FG001|COMPLETED|Overall Study||51
11063385|NCT01026181|12244872|FG002|COMPLETED|Overall Study||48
11063386|NCT01026181|12244870|FG000|NOT COMPLETED|Overall Study||0
11063387|NCT01026181|12244871|FG001|NOT COMPLETED|Overall Study||0
11063388|NCT01026181|12244872|FG002|NOT COMPLETED|Overall Study||0
11063389|NCT01026194|12244882|FG000|STARTED|Period 1：Double Blind Period||101
11063390|NCT01026194|12244883|FG001|STARTED|Period 1：Double Blind Period||103
11063391|NCT01026194|12244882|FG000|COMPLETED|Period 1：Double Blind Period||98
11063392|NCT01026194|12244883|FG001|COMPLETED|Period 1：Double Blind Period||98
11063393|NCT01026194|12244882|FG000|NOT COMPLETED|Period 1：Double Blind Period||3
11063394|NCT01026194|12244883|FG001|NOT COMPLETED|Period 1：Double Blind Period||5
11063395|NCT01026194|12244882|FG000|STARTED|Period 2：Open-label Period||98
11063396|NCT01026194|12244883|FG001|STARTED|Period 2：Open-label Period||98
11063397|NCT01026194|12244882|FG000|COMPLETED|Period 2：Open-label Period||91
11063398|NCT01026194|12244883|FG001|COMPLETED|Period 2：Open-label Period||88
11063399|NCT01026194|12244882|FG000|NOT COMPLETED|Period 2：Open-label Period||7
11063400|NCT01026194|12244883|FG001|NOT COMPLETED|Period 2：Open-label Period||10
11063401|NCT01026324|12244894|FG000|STARTED|Treatment Allocation||5
11063402|NCT01026324|12244895|FG001|STARTED|Treatment Allocation||3
11063403|NCT01026324|12244896|FG002|STARTED|Treatment Allocation||4
11063404|NCT01026324|12244894|FG000|Discontinued Intervention (Toxicity)|Treatment Allocation||1
11063405|NCT01026324|12244895|FG001|Discontinued Intervention (Toxicity)|Treatment Allocation||0
11063406|NCT01026324|12244896|FG002|Discontinued Intervention (Toxicity)|Treatment Allocation||0
11063407|NCT01026324|12244894|FG000|Discontinuted Intervention (Progression)|Treatment Allocation||3
11063408|NCT01026324|12244895|FG001|Discontinuted Intervention (Progression)|Treatment Allocation||3
11063409|NCT01026324|12244896|FG002|Discontinuted Intervention (Progression)|Treatment Allocation||4
11063410|NCT01026324|12244894|FG000|Discontinued Intervention (Withdrew)|Treatment Allocation||1
11063411|NCT01026324|12244895|FG001|Discontinued Intervention (Withdrew)|Treatment Allocation||0
11063412|NCT01026324|12244896|FG002|Discontinued Intervention (Withdrew)|Treatment Allocation||0
11063413|NCT01026324|12244894|FG000|COMPLETED|Treatment Allocation||5
11063414|NCT01026324|12244895|FG001|COMPLETED|Treatment Allocation||3
11063415|NCT01026324|12244896|FG002|COMPLETED|Treatment Allocation||4
11063416|NCT01026324|12244894|FG000|NOT COMPLETED|Treatment Allocation||0
11063417|NCT01026324|12244895|FG001|NOT COMPLETED|Treatment Allocation||0
11063418|NCT01026324|12244896|FG002|NOT COMPLETED|Treatment Allocation||0
11063419|NCT01026324|12244894|FG000|STARTED|Follow up/Survival||5
11345374|NCT02968979|12542462|FG000|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531
11345375|NCT02968979|12542462|FG000|NOT COMPLETED|Overall Study||8
11345376|NCT02968992|12542514|FG000|STARTED|Overall Study||18
11345377|NCT02968992|12542515|FG001|STARTED|Overall Study||18
11345378|NCT02968992|12542514|FG000|COMPLETED|Overall Study||18
11345379|NCT02968992|12542515|FG001|COMPLETED|Overall Study||17
11345380|NCT02968992|12542514|FG000|NOT COMPLETED|Overall Study||0
11345381|NCT02968992|12542515|FG001|NOT COMPLETED|Overall Study||1
11345382|NCT02969018|12542529|FG000|STARTED|Overall Study||25
11345383|NCT02969018|12542530|FG001|STARTED|Overall Study||29
11345384|NCT02969018|12542531|FG002|STARTED|Overall Study||26
11345385|NCT02969018|12542532|FG003|STARTED|Overall Study||25
11345386|NCT02969018|12542533|FG004|STARTED|Overall Study||29
11345387|NCT02969018|12542534|FG005|STARTED|Overall Study||25
11345388|NCT02969018|12542535|FG006|STARTED|Overall Study||30
11345389|NCT02969018|12542536|FG007|STARTED|Overall Study||23
11345390|NCT02969018|12542529|FG000|COMPLETED|Overall Study||21
11345391|NCT02969018|12542530|FG001|COMPLETED|Overall Study||21
11345392|NCT02969018|12542531|FG002|COMPLETED|Overall Study||20
11345393|NCT02969018|12542532|FG003|COMPLETED|Overall Study||20
11345394|NCT02969018|12542533|FG004|COMPLETED|Overall Study||27
11345395|NCT02969018|12542534|FG005|COMPLETED|Overall Study||17
11345396|NCT02969018|12542535|FG006|COMPLETED|Overall Study||22
11345397|NCT02969018|12542536|FG007|COMPLETED|Overall Study||16
11345398|NCT02969018|12542529|FG000|NOT COMPLETED|Overall Study||4
11345399|NCT02969018|12542530|FG001|NOT COMPLETED|Overall Study||8
11345400|NCT02969018|12542531|FG002|NOT COMPLETED|Overall Study||6
11345401|NCT02969018|12542532|FG003|NOT COMPLETED|Overall Study||5
11345402|NCT02969018|12542533|FG004|NOT COMPLETED|Overall Study||2
11345403|NCT02969018|12542534|FG005|NOT COMPLETED|Overall Study||8
11345404|NCT02969018|12542535|FG006|NOT COMPLETED|Overall Study||8
11345405|NCT02969018|12542536|FG007|NOT COMPLETED|Overall Study||7
11345406|NCT02969031|12542559|FG000|STARTED|Enrolled and Randomized||73
11345407|NCT02969031|12542560|FG001|STARTED|Enrolled and Randomized||75
11345408|NCT02969031|12542559|FG000|COMPLETED|Enrolled and Randomized||73
11345409|NCT02969031|12542560|FG001|COMPLETED|Enrolled and Randomized||75
11345410|NCT02969031|12542559|FG000|NOT COMPLETED|Enrolled and Randomized||0
11345411|NCT02969031|12542560|FG001|NOT COMPLETED|Enrolled and Randomized||0
11345412|NCT02969031|12542559|FG000|STARTED|Collection of Baseline Surveys||73
11345413|NCT02969031|12542560|FG001|STARTED|Collection of Baseline Surveys||75
11345414|NCT02969031|12542559|FG000|COMPLETED|Collection of Baseline Surveys||34
11345415|NCT02969031|12542560|FG001|COMPLETED|Collection of Baseline Surveys||23
11345416|NCT02969031|12542559|FG000|NOT COMPLETED|Collection of Baseline Surveys||39
11345417|NCT02969031|12542560|FG001|NOT COMPLETED|Collection of Baseline Surveys||52
11345418|NCT02969031|12542559|FG000|STARTED|Collection of Baseline Recordings||34
11345419|NCT02969031|12542560|FG001|STARTED|Collection of Baseline Recordings||23
11345420|NCT02969031|12542559|FG000|COMPLETED|Collection of Baseline Recordings||22
11345421|NCT02969031|12542560|FG001|COMPLETED|Collection of Baseline Recordings||18
11345422|NCT02969031|12542559|FG000|NOT COMPLETED|Collection of Baseline Recordings||12
11063420|NCT01026324|12244895|FG001|STARTED|Follow up/Survival||3
11063421|NCT01026324|12244896|FG002|STARTED|Follow up/Survival||4
11063422|NCT01026324|12244894|FG000|Follow up Discontinuation (Death)|Follow up/Survival||4
11063423|NCT01026324|12244895|FG001|Follow up Discontinuation (Death)|Follow up/Survival||3
11063424|NCT01026324|12244896|FG002|Follow up Discontinuation (Death)|Follow up/Survival||4
11063425|NCT01026324|12244894|FG000|COMPLETED|Follow up/Survival||4
11063426|NCT01026324|12244895|FG001|COMPLETED|Follow up/Survival||3
11063427|NCT01026324|12244896|FG002|COMPLETED|Follow up/Survival||4
11063428|NCT01026324|12244894|FG000|NOT COMPLETED|Follow up/Survival||1
11063429|NCT01026324|12244895|FG001|NOT COMPLETED|Follow up/Survival||0
11063430|NCT01026324|12244896|FG002|NOT COMPLETED|Follow up/Survival||0
11063431|NCT01026389|12244907|FG000|STARTED|Overall Study||93
11063432|NCT01026389|12244908|FG001|STARTED|Overall Study||93
11063433|NCT01026389|12244907|FG000|COMPLETED|Overall Study||88
11063434|NCT01026389|12244908|FG001|COMPLETED|Overall Study||88
11063435|NCT01026389|12244907|FG000|NOT COMPLETED|Overall Study||5
11063436|NCT01026389|12244908|FG001|NOT COMPLETED|Overall Study||5
11063437|NCT01026402|12244931|FG000|STARTED|Overall Study||6
11063438|NCT01026402|12244932|FG001|STARTED|Overall Study||8
11063439|NCT01026402|12244933|FG002|STARTED|Overall Study||33
11063440|NCT01026402|12244934|FG003|STARTED|Overall Study||18
11063441|NCT01026402|12244935|FG004|STARTED|Overall Study||3
11063442|NCT01026402|12244936|FG005|STARTED|Overall Study||5
11063443|NCT01026402|12244937|FG006|STARTED|Overall Study||8
11063444|NCT01026402|12244938|FG007|STARTED|Overall Study||3
11063445|NCT01026402|12244939|FG008|STARTED|Overall Study||7
11063446|NCT01026402|12244940|FG009|STARTED|Overall Study||3
11063447|NCT01026402|12244941|FG010|STARTED|Overall Study||7
11063448|NCT01026402|12244942|FG011|STARTED|Overall Study||8
11063449|NCT01026402|12244943|FG012|STARTED|Overall Study||8
11063450|NCT01026402|12244944|FG013|STARTED|Overall Study||6
11063451|NCT01026402|12244945|FG014|STARTED|Overall Study||3
11063452|NCT01026402|12244946|FG015|STARTED|Overall Study||5
11063453|NCT01026402|12244947|FG016|STARTED|Overall Study||4
11063454|NCT01026402|12244931|FG000|COMPLETED|Overall Study||6
11063455|NCT01026402|12244932|FG001|COMPLETED|Overall Study||8
11063456|NCT01026402|12244933|FG002|COMPLETED|Overall Study||33
11063457|NCT01026402|12244934|FG003|COMPLETED|Overall Study||18
11063458|NCT01026402|12244935|FG004|COMPLETED|Overall Study||3
11063459|NCT01026402|12244936|FG005|COMPLETED|Overall Study||5
11063460|NCT01026402|12244937|FG006|COMPLETED|Overall Study||8
11063461|NCT01026402|12244938|FG007|COMPLETED|Overall Study||3
11063462|NCT01026402|12244939|FG008|COMPLETED|Overall Study||7
11063463|NCT01026402|12244940|FG009|COMPLETED|Overall Study||3
11063464|NCT01026402|12244941|FG010|COMPLETED|Overall Study||7
11063465|NCT01026402|12244942|FG011|COMPLETED|Overall Study||8
11063466|NCT01026402|12244943|FG012|COMPLETED|Overall Study||8
11345423|NCT02969031|12542560|FG001|NOT COMPLETED|Collection of Baseline Recordings||5
11345424|NCT02969031|12542559|FG000|STARTED|Completed Intervention||22
11345425|NCT02969031|12542560|FG001|STARTED|Completed Intervention||18
11063467|NCT01026402|12244944|FG013|COMPLETED|Overall Study||6
11063468|NCT01026402|12244945|FG014|COMPLETED|Overall Study||3
11063469|NCT01026402|12244946|FG015|COMPLETED|Overall Study||5
11063470|NCT01026402|12244947|FG016|COMPLETED|Overall Study||4
11063471|NCT01026402|12244931|FG000|NOT COMPLETED|Overall Study||0
11063472|NCT01026402|12244932|FG001|NOT COMPLETED|Overall Study||0
11063473|NCT01026402|12244933|FG002|NOT COMPLETED|Overall Study||0
11063474|NCT01026402|12244934|FG003|NOT COMPLETED|Overall Study||0
11063475|NCT01026402|12244935|FG004|NOT COMPLETED|Overall Study||0
11063476|NCT01026402|12244936|FG005|NOT COMPLETED|Overall Study||0
11063477|NCT01026402|12244937|FG006|NOT COMPLETED|Overall Study||0
11063478|NCT01026402|12244938|FG007|NOT COMPLETED|Overall Study||0
11063479|NCT01026402|12244939|FG008|NOT COMPLETED|Overall Study||0
11063480|NCT01026402|12244940|FG009|NOT COMPLETED|Overall Study||0
11063481|NCT01026402|12244941|FG010|NOT COMPLETED|Overall Study||0
11063482|NCT01026402|12244942|FG011|NOT COMPLETED|Overall Study||0
11063483|NCT01026402|12244943|FG012|NOT COMPLETED|Overall Study||0
11063484|NCT01026402|12244944|FG013|NOT COMPLETED|Overall Study||0
11063485|NCT01026402|12244945|FG014|NOT COMPLETED|Overall Study||0
11063486|NCT01026402|12244946|FG015|NOT COMPLETED|Overall Study||0
11063487|NCT01026402|12244947|FG016|NOT COMPLETED|Overall Study||0
11063488|NCT01026454|12244988|FG000|STARTED|First Intervention||18
11063489|NCT01026454|12244989|FG001|STARTED|First Intervention||14
11063490|NCT01026454|12244988|FG000|COMPLETED|First Intervention||18
11063491|NCT01026454|12244989|FG001|COMPLETED|First Intervention||14
11063492|NCT01026454|12244988|FG000|NOT COMPLETED|First Intervention||0
11063493|NCT01026454|12244989|FG001|NOT COMPLETED|First Intervention||0
11063494|NCT01026454|12244988|FG000|STARTED|Washout||18
11063495|NCT01026454|12244989|FG001|STARTED|Washout||14
11063496|NCT01026454|12244988|FG000|COMPLETED|Washout||18
11063497|NCT01026454|12244989|FG001|COMPLETED|Washout||14
11063498|NCT01026454|12244988|FG000|NOT COMPLETED|Washout||0
11063499|NCT01026454|12244989|FG001|NOT COMPLETED|Washout||0
11063500|NCT01026454|12244988|FG000|STARTED|Second Intervention||17
11063501|NCT01026454|12244989|FG001|STARTED|Second Intervention||14
11063502|NCT01026454|12244988|FG000|COMPLETED|Second Intervention||16
11063503|NCT01026454|12244989|FG001|COMPLETED|Second Intervention||13
11063504|NCT01026454|12244988|FG000|NOT COMPLETED|Second Intervention||1
11063505|NCT01026454|12244989|FG001|NOT COMPLETED|Second Intervention||1
11063506|NCT01026493|12245003|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
11063507|NCT01026493|12245004|FG001|STARTED|Overall Study||7
11063508|NCT01026493|12245005|FG002|STARTED|Overall Study||9
11063509|NCT01026493|12245006|FG003|STARTED|Overall Study||8
11063510|NCT01026493|12245007|FG004|STARTED|Overall Study||75
11063511|NCT01026493|12245008|FG005|STARTED|Overall Study||76
11063512|NCT01026493|12245009|FG006|STARTED|Overall Study||36
11063513|NCT01026493|12245010|FG007|STARTED|Overall Study||38
11063514|NCT01026493|12245003|FG000|COMPLETED|Overall Study||8
11063515|NCT01026493|12245004|FG001|COMPLETED|Overall Study||6
11063516|NCT01026493|12245005|FG002|COMPLETED|Overall Study||9
11063517|NCT01026493|12245006|FG003|COMPLETED|Overall Study||8
11063518|NCT01026493|12245007|FG004|COMPLETED|Overall Study||73
11063519|NCT01026493|12245008|FG005|COMPLETED|Overall Study||73
11063520|NCT01026493|12245009|FG006|COMPLETED|Overall Study||32
11063521|NCT01026493|12245010|FG007|COMPLETED|Overall Study||37
11063522|NCT01026493|12245003|FG000|NOT COMPLETED|Overall Study||0
11063523|NCT01026493|12245004|FG001|NOT COMPLETED|Overall Study||1
11063524|NCT01026493|12245005|FG002|NOT COMPLETED|Overall Study||0
11063525|NCT01026493|12245006|FG003|NOT COMPLETED|Overall Study||0
11063526|NCT01026493|12245007|FG004|NOT COMPLETED|Overall Study||2
11063527|NCT01026493|12245008|FG005|NOT COMPLETED|Overall Study||3
11063528|NCT01026493|12245009|FG006|NOT COMPLETED|Overall Study||4
11063529|NCT01026493|12245010|FG007|NOT COMPLETED|Overall Study||1
11063530|NCT01026623|12245031|FG000|STARTED|Overall Study||6
11063531|NCT01026623|12245032|FG001|STARTED|Overall Study||5
11063532|NCT01026623|12245033|FG002|STARTED|Overall Study||5
11063533|NCT01026623|12245031|FG000|COMPLETED|Overall Study||6
11345426|NCT02969031|12542559|FG000|COMPLETED|Completed Intervention||15
11345427|NCT02969031|12542560|FG001|COMPLETED|Completed Intervention||14
11345428|NCT02969031|12542559|FG000|NOT COMPLETED|Completed Intervention||7
11345429|NCT02969031|12542560|FG001|NOT COMPLETED|Completed Intervention||4
11345430|NCT02969031|12542559|FG000|STARTED|Collection of Follow-Up Surveys||15
11345431|NCT02969031|12542560|FG001|STARTED|Collection of Follow-Up Surveys||14
11063534|NCT01026623|12245032|FG001|COMPLETED|Overall Study||5
11063535|NCT01026623|12245033|FG002|COMPLETED|Overall Study||5
11063536|NCT01026623|12245031|FG000|NOT COMPLETED|Overall Study||0
11063537|NCT01026623|12245032|FG001|NOT COMPLETED|Overall Study||0
11063538|NCT01026623|12245033|FG002|NOT COMPLETED|Overall Study||0
11063539|NCT01026792|12245042|FG000|STARTED|Overall Study||38
11063540|NCT01026792|12245042|FG000|COMPLETED|Overall Study||37
11063541|NCT01026792|12245042|FG000|NOT COMPLETED|Overall Study||1
11063542|NCT01026805|12245046|FG000|STARTED|Overall Study||11
11063543|NCT01026805|12245046|FG000|COMPLETED|Overall Study||11
11063544|NCT01026805|12245046|FG000|NOT COMPLETED|Overall Study||0
11063545|NCT01026818|12245053|FG000|STARTED|Screening Period||583
11063546|NCT01026818|12245054|FG001|STARTED|Screening Period||0
11345432|NCT02969031|12542559|FG000|COMPLETED|Collection of Follow-Up Surveys||15
11345433|NCT02969031|12542560|FG001|COMPLETED|Collection of Follow-Up Surveys||12
11345434|NCT02969031|12542559|FG000|NOT COMPLETED|Collection of Follow-Up Surveys||0
11345435|NCT02969031|12542560|FG001|NOT COMPLETED|Collection of Follow-Up Surveys||2
11345436|NCT02969031|12542559|FG000|STARTED|Collection of Follow-Up Recordings||15
11345437|NCT02969031|12542560|FG001|STARTED|Collection of Follow-Up Recordings||12
11345438|NCT02969031|12542559|FG000|COMPLETED|Collection of Follow-Up Recordings||15
11345439|NCT02969031|12542560|FG001|COMPLETED|Collection of Follow-Up Recordings||12
11345440|NCT02969031|12542559|FG000|NOT COMPLETED|Collection of Follow-Up Recordings||0
11345441|NCT02969031|12542560|FG001|NOT COMPLETED|Collection of Follow-Up Recordings||0
11345442|NCT02969031|12542559|FG000|STARTED|Completed and Analyzed||15
11345443|NCT02969031|12542560|FG001|STARTED|Completed and Analyzed||12
11345444|NCT02969031|12542559|FG000|COMPLETED|Completed and Analyzed||15
11345445|NCT02969031|12542560|FG001|COMPLETED|Completed and Analyzed||12
11345446|NCT02969031|12542559|FG000|NOT COMPLETED|Completed and Analyzed||0
11063547|NCT01026818|12245055|FG002|STARTED|Screening Period||0
11063548|NCT01026818|12245056|FG003|STARTED|Screening Period||0
11063549|NCT01026818|12245053|FG000|COMPLETED|Screening Period||423
11063550|NCT01026818|12245054|FG001|COMPLETED|Screening Period||0
11063551|NCT01026818|12245055|FG002|COMPLETED|Screening Period||0
11063552|NCT01026818|12245056|FG003|COMPLETED|Screening Period||0
11345447|NCT02969031|12542560|FG001|NOT COMPLETED|Completed and Analyzed||0
11345448|NCT02969044|12542568|FG000|STARTED|Overall Study||42
11063553|NCT01026818|12245053|FG000|NOT COMPLETED|Screening Period||160
11063554|NCT01026818|12245054|FG001|NOT COMPLETED|Screening Period||0
11063555|NCT01026818|12245055|FG002|NOT COMPLETED|Screening Period||0
11063556|NCT01026818|12245056|FG003|NOT COMPLETED|Screening Period||0
11063557|NCT01026818|12245053|FG000|STARTED|DB Treatment Period (Month 0 - 9)||0
11063558|NCT01026818|12245054|FG001|STARTED|DB Treatment Period (Month 0 - 9)||139
11063559|NCT01026818|12245055|FG002|STARTED|DB Treatment Period (Month 0 - 9)||143
11063560|NCT01026818|12245056|FG003|STARTED|DB Treatment Period (Month 0 - 9)||141
11063561|NCT01026818|12245053|FG000|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
11063562|NCT01026818|12245054|FG001|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
11063563|NCT01026818|12245055|FG002|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
11063564|NCT01026818|12245056|FG003|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
11063565|NCT01026818|12245053|FG000|COMPLETED|DB Treatment Period (Month 0 - 9)||0
11063566|NCT01026818|12245054|FG001|COMPLETED|DB Treatment Period (Month 0 - 9)||114
11063567|NCT01026818|12245055|FG002|COMPLETED|DB Treatment Period (Month 0 - 9)||122
11063568|NCT01026818|12245056|FG003|COMPLETED|DB Treatment Period (Month 0 - 9)||115
11063569|NCT01026818|12245053|FG000|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
11063570|NCT01026818|12245054|FG001|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
11063571|NCT01026818|12245055|FG002|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
11063572|NCT01026818|12245056|FG003|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
11063573|NCT01026818|12245053|FG000|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
11063574|NCT01026818|12245054|FG001|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
11063575|NCT01026818|12245055|FG002|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
11063576|NCT01026818|12245056|FG003|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
11063577|NCT01026818|12245053|FG000|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
11063578|NCT01026818|12245054|FG001|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
11063579|NCT01026818|12245055|FG002|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
11063580|NCT01026818|12245056|FG003|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
11063581|NCT01026818|12245053|FG000|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
11063582|NCT01026818|12245054|FG001|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
11063583|NCT01026818|12245055|FG002|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
11063584|NCT01026818|12245056|FG003|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
11063585|NCT01026818|12245053|FG000|STARTED|OL Period (Month 10.5 - 13.5)||0
11063586|NCT01026818|12245054|FG001|STARTED|OL Period (Month 10.5 - 13.5)||105
11063587|NCT01026818|12245055|FG002|STARTED|OL Period (Month 10.5 - 13.5)||117
11063588|NCT01026818|12245056|FG003|STARTED|OL Period (Month 10.5 - 13.5)||108
11063589|NCT01026818|12245053|FG000|COMPLETED|OL Period (Month 10.5 - 13.5)||0
11063590|NCT01026818|12245054|FG001|COMPLETED|OL Period (Month 10.5 - 13.5)||98
11063591|NCT01026818|12245055|FG002|COMPLETED|OL Period (Month 10.5 - 13.5)||112
11063592|NCT01026818|12245056|FG003|COMPLETED|OL Period (Month 10.5 - 13.5)||105
11063593|NCT01026818|12245053|FG000|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
11063594|NCT01026818|12245054|FG001|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
11063595|NCT01026818|12245055|FG002|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
11063596|NCT01026818|12245056|FG003|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
11063597|NCT01026831|12245070|FG000|STARTED|Overall Study|randomized|320
11345449|NCT02969044|12542569|FG001|STARTED|Overall Study||28
11345450|NCT02969044|12542568|FG000|COMPLETED|Overall Study||37
11345451|NCT02969044|12542569|FG001|COMPLETED|Overall Study||22
11345452|NCT02969044|12542568|FG000|NOT COMPLETED|Overall Study||5
11345453|NCT02969044|12542569|FG001|NOT COMPLETED|Overall Study||6
11345454|NCT02969187|12542577|FG000|STARTED|Overall Study||63
11345455|NCT02969187|12542578|FG001|STARTED|Overall Study||63
11345456|NCT02969187|12542577|FG000|COMPLETED|Overall Study||51
11345457|NCT02969187|12542578|FG001|COMPLETED|Overall Study||50
11345458|NCT02969187|12542577|FG000|NOT COMPLETED|Overall Study||12
11345459|NCT02969187|12542578|FG001|NOT COMPLETED|Overall Study||13
11345460|NCT02969317|12542586|FG000|STARTED|Overall Study||12
11345461|NCT02969317|12542586|FG000|COMPLETED|Overall Study||12
11345462|NCT02969317|12542586|FG000|NOT COMPLETED|Overall Study||0
11345463|NCT02969382|12542593|FG000|STARTED|Overall Study||125
11345464|NCT02969382|12542594|FG001|STARTED|Overall Study||120
11345465|NCT02969382|12542593|FG000|Subjects Continued Into Extension Study|Overall Study||79
11345466|NCT02969382|12542594|FG001|Subjects Continued Into Extension Study|Overall Study||78
11345467|NCT02969382|12542593|FG000|COMPLETED|Overall Study||99
11345468|NCT02969382|12542594|FG001|COMPLETED|Overall Study||94
11345469|NCT02969382|12542593|FG000|NOT COMPLETED|Overall Study||26
11345470|NCT02969382|12542594|FG001|NOT COMPLETED|Overall Study||26
11345471|NCT02969408|12542600|FG000|STARTED|Overall Study||397
11345472|NCT02969408|12542600|FG000|Used ABS eMDPI at Least Once|Overall Study||370
11345473|NCT02969408|12542600|FG000|COMPLETED|Overall Study||381
11345474|NCT02969408|12542600|FG000|NOT COMPLETED|Overall Study||16
11345475|NCT02969421|12542606|FG000|STARTED|Overall Study||33
11345476|NCT02969421|12542607|FG001|STARTED|Overall Study||33
11063598|NCT01026831|12245071|FG001|STARTED|Overall Study|randomized|323
11063599|NCT01026831|12245070|FG000|COMPLETED|Overall Study||306
11063600|NCT01026831|12245071|FG001|COMPLETED|Overall Study||312
11063601|NCT01026831|12245070|FG000|NOT COMPLETED|Overall Study||14
11063602|NCT01026831|12245071|FG001|NOT COMPLETED|Overall Study||11
11063603|NCT01026844|12245079|FG000|STARTED|Overall Study||19
11063604|NCT01026844|12245080|FG001|STARTED|Overall Study||8
11063605|NCT01026844|12245079|FG000|COMPLETED|Overall Study||19
11345477|NCT02969421|12542606|FG000|COMPLETED|Overall Study||33
11063606|NCT01026844|12245080|FG001|COMPLETED|Overall Study||8
11063607|NCT01026844|12245079|FG000|NOT COMPLETED|Overall Study||0
11063608|NCT01026844|12245080|FG001|NOT COMPLETED|Overall Study||0
11063609|NCT01026909|12245088|FG000|STARTED|Overall Study||1
11063610|NCT01026909|12245089|FG001|STARTED|Overall Study||2
11063611|NCT01026909|12245088|FG000|COMPLETED|Overall Study||1
11063612|NCT01026909|12245089|FG001|COMPLETED|Overall Study||2
11063613|NCT01026909|12245088|FG000|NOT COMPLETED|Overall Study||0
11063614|NCT01026909|12245089|FG001|NOT COMPLETED|Overall Study||0
11063615|NCT01026948|12245095|FG000|STARTED|Overall Study||70
11063616|NCT01026948|12245095|FG000|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
11063617|NCT01026948|12245095|FG000|NOT COMPLETED|Overall Study||8
11063618|NCT01026974|12245104|FG000|STARTED|Overall Study||16
11063619|NCT01026974|12245105|FG001|STARTED|Overall Study||14
11063620|NCT01026974|12245106|FG002|STARTED|Overall Study||41
11063621|NCT01026974|12245107|FG003|STARTED|Overall Study||49
11063622|NCT01026974|12245104|FG000|COMPLETED|Overall Study||15
11063623|NCT01026974|12245105|FG001|COMPLETED|Overall Study||12
11063624|NCT01026974|12245106|FG002|COMPLETED|Overall Study||29
11063625|NCT01026974|12245107|FG003|COMPLETED|Overall Study||46
11063626|NCT01026974|12245104|FG000|NOT COMPLETED|Overall Study||1
11063627|NCT01026974|12245105|FG001|NOT COMPLETED|Overall Study||2
11063628|NCT01026974|12245106|FG002|NOT COMPLETED|Overall Study||12
11063629|NCT01026974|12245107|FG003|NOT COMPLETED|Overall Study||3
11063630|NCT01027000|12245122|FG000|STARTED|Overall Study||68
11063631|NCT01027000|12245122|FG000|COMPLETED|Overall Study||68
11063632|NCT01027000|12245122|FG000|NOT COMPLETED|Overall Study||0
11063633|NCT01027195|12245128|FG000|STARTED|Overall Study||71
11063634|NCT01027195|12245129|FG001|STARTED|Overall Study||69
11063635|NCT01027195|12245128|FG000|COMPLETED|Overall Study||71
11063636|NCT01027195|12245129|FG001|COMPLETED|Overall Study||69
11063637|NCT01027195|12245128|FG000|NOT COMPLETED|Overall Study||0
11063638|NCT01027195|12245129|FG001|NOT COMPLETED|Overall Study||0
11063639|NCT01027273|12245137|FG000|STARTED|Overall Study||301
11063640|NCT01027273|12245138|FG001|STARTED|Overall Study||299
11063641|NCT01027273|12245137|FG000|COMPLETED|Overall Study||242
11063642|NCT01027273|12245138|FG001|COMPLETED|Overall Study||266
11063643|NCT01027273|12245137|FG000|NOT COMPLETED|Overall Study||59
11063644|NCT01027273|12245138|FG001|NOT COMPLETED|Overall Study||33
11063645|NCT01027286|12245146|FG000|STARTED|Overall Study||50
11063646|NCT01027286|12245147|FG001|STARTED|Overall Study||50
11063647|NCT01027286|12245146|FG000|Preoperative|Overall Study||50
11063648|NCT01027286|12245147|FG001|Preoperative|Overall Study||50
11063649|NCT01027286|12245146|FG000|Day of Surgery|Overall Study||50
11063650|NCT01027286|12245147|FG001|Day of Surgery|Overall Study||50
11063651|NCT01027286|12245146|FG000|4 Week Postoperative|Overall Study||49
11063652|NCT01027286|12245147|FG001|4 Week Postoperative|Overall Study||50
11063653|NCT01027286|12245146|FG000|12 Week Postoperative|Overall Study||49
11063654|NCT01027286|12245147|FG001|12 Week Postoperative|Overall Study||49
11063655|NCT01027286|12245146|FG000|COMPLETED|Overall Study||49
11063656|NCT01027286|12245147|FG001|COMPLETED|Overall Study||49
11063657|NCT01027286|12245146|FG000|NOT COMPLETED|Overall Study||1
11063658|NCT01027286|12245147|FG001|NOT COMPLETED|Overall Study||1
11063659|NCT01027351|12245159|FG000|STARTED|Overall Study||29
11063660|NCT01027351|12245160|FG001|STARTED|Overall Study||19
11063661|NCT01027351|12245161|FG002|STARTED|Overall Study||14
11063662|NCT01027351|12245162|FG003|STARTED|Overall Study||8
11063663|NCT01027351|12245163|FG004|STARTED|Overall Study||43
11063664|NCT01027351|12245164|FG005|STARTED|Overall Study||50
11063665|NCT01027351|12245159|FG000|COMPLETED|Overall Study||26
11063666|NCT01027351|12245160|FG001|COMPLETED|Overall Study||18
11063667|NCT01027351|12245161|FG002|COMPLETED|Overall Study||13
11063668|NCT01027351|12245162|FG003|COMPLETED|Overall Study||6
11063669|NCT01027351|12245163|FG004|COMPLETED|Overall Study||32
11063670|NCT01027351|12245164|FG005|COMPLETED|Overall Study||45
11063671|NCT01027351|12245159|FG000|NOT COMPLETED|Overall Study||3
11345478|NCT02969421|12542607|FG001|COMPLETED|Overall Study||33
11345479|NCT02969421|12542606|FG000|NOT COMPLETED|Overall Study||0
11345480|NCT02969421|12542607|FG001|NOT COMPLETED|Overall Study||0
11345481|NCT02969499|12542613|FG000|STARTED|Overall Study||33
11345482|NCT02969499|12542613|FG000|COMPLETED|Overall Study||33
11063672|NCT01027351|12245160|FG001|NOT COMPLETED|Overall Study||1
11063673|NCT01027351|12245161|FG002|NOT COMPLETED|Overall Study||1
11063674|NCT01027351|12245162|FG003|NOT COMPLETED|Overall Study||2
11063675|NCT01027351|12245163|FG004|NOT COMPLETED|Overall Study||11
11063676|NCT01027351|12245164|FG005|NOT COMPLETED|Overall Study||5
11063677|NCT01027364|12245189|FG000|STARTED|Overall Study||63
11345483|NCT02969499|12542613|FG000|NOT COMPLETED|Overall Study||0
11345484|NCT02969525|12542622|FG000|STARTED|Double-Blind Period||42
11345485|NCT02969525|12542623|FG001|STARTED|Double-Blind Period||41
11345486|NCT02969525|12542624|FG002|STARTED|Double-Blind Period||41
11345487|NCT02969525|12542625|FG003|STARTED|Double-Blind Period||41
11345488|NCT02969525|12542626|FG004|STARTED|Double-Blind Period||41
11345489|NCT02969525|12542627|FG005|STARTED|Double-Blind Period||0
11345490|NCT02969525|12542628|FG006|STARTED|Double-Blind Period||0
11345491|NCT02969525|12542629|FG007|STARTED|Double-Blind Period||0
11345492|NCT02969525|12542630|FG008|STARTED|Double-Blind Period||0
11345493|NCT02969525|12542631|FG009|STARTED|Double-Blind Period||0
11345494|NCT02969525|12542632|FG010|STARTED|Double-Blind Period||0
11345495|NCT02969525|12542633|FG011|STARTED|Double-Blind Period||0
11345496|NCT02969525|12542622|FG000|Completed Double-Blind Period|Double-Blind Period||42
11063678|NCT01027364|12245190|FG001|STARTED|Overall Study||29
11063679|NCT01027364|12245191|FG002|STARTED|Overall Study||27
11063680|NCT01027364|12245192|FG003|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
11063681|NCT01027364|12245189|FG000|Enrolled in Sequential PK Subgroup|Overall Study||22
11063682|NCT01027364|12245190|FG001|Enrolled in Sequential PK Subgroup|Overall Study||0
11063683|NCT01027364|12245191|FG002|Enrolled in Sequential PK Subgroup|Overall Study||0
11063684|NCT01027364|12245192|FG003|Enrolled in Sequential PK Subgroup|Overall Study||0
11063685|NCT01027364|12245189|FG000|Joined Arm 4 for Surgery Then Returned|Overall Study||5
11063686|NCT01027364|12245190|FG001|Joined Arm 4 for Surgery Then Returned|Overall Study||0
11063687|NCT01027364|12245191|FG002|Joined Arm 4 for Surgery Then Returned|Overall Study||1
11063688|NCT01027364|12245192|FG003|Joined Arm 4 for Surgery Then Returned|Overall Study||0
11063689|NCT01027364|12245189|FG000|Started Arm 4 Then Joined Another Arm|Overall Study||2
11063690|NCT01027364|12245190|FG001|Started Arm 4 Then Joined Another Arm|Overall Study||0
11063691|NCT01027364|12245191|FG002|Started Arm 4 Then Joined Another Arm|Overall Study||0
11063692|NCT01027364|12245192|FG003|Started Arm 4 Then Joined Another Arm|Overall Study||0
11063693|NCT01027364|12245189|FG000|COMPLETED|Overall Study||59
11063694|NCT01027364|12245190|FG001|COMPLETED|Overall Study||27
11063695|NCT01027364|12245191|FG002|COMPLETED|Overall Study||26
11063696|NCT01027364|12245192|FG003|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
11063697|NCT01027364|12245189|FG000|NOT COMPLETED|Overall Study||4
11063698|NCT01027364|12245190|FG001|NOT COMPLETED|Overall Study||2
11063699|NCT01027364|12245191|FG002|NOT COMPLETED|Overall Study||1
11063700|NCT01027364|12245192|FG003|NOT COMPLETED|Overall Study||1
11063701|NCT01027416|12245220|FG000|STARTED|Overall Study||31
11063702|NCT01027416|12245221|FG001|STARTED|Overall Study||28
11063703|NCT01027416|12245220|FG000|COMPLETED|Overall Study||30
11063704|NCT01027416|12245221|FG001|COMPLETED|Overall Study||23
11063705|NCT01027416|12245220|FG000|NOT COMPLETED|Overall Study||1
11063706|NCT01027416|12245221|FG001|NOT COMPLETED|Overall Study||5
11063707|NCT01027468|12245227|FG000|STARTED|Overall Study||160
11063708|NCT01027468|12245227|FG000|COMPLETED|Overall Study||160
11063709|NCT01027468|12245227|FG000|NOT COMPLETED|Overall Study||0
11063710|NCT01027559|12245234|FG000|STARTED|Overall Study||26
11063711|NCT01027559|12245235|FG001|STARTED|Overall Study||34
11063712|NCT01027559|12245236|FG002|STARTED|Overall Study||31
11063713|NCT01027559|12245234|FG000|COMPLETED|Overall Study||20
11063714|NCT01027559|12245235|FG001|COMPLETED|Overall Study||26
11063715|NCT01027559|12245236|FG002|COMPLETED|Overall Study||22
11063716|NCT01027559|12245234|FG000|NOT COMPLETED|Overall Study||6
11063717|NCT01027559|12245235|FG001|NOT COMPLETED|Overall Study||8
11063718|NCT01027559|12245236|FG002|NOT COMPLETED|Overall Study||9
11063719|NCT01027598|12245247|FG000|STARTED|Overall Study|One patient was enrolled but not treated|134
11063720|NCT01027598|12245248|FG001|STARTED|Overall Study||67
11063721|NCT01027598|12245247|FG000|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
11063722|NCT01027598|12245248|FG001|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
11063723|NCT01027598|12245247|FG000|NOT COMPLETED|Overall Study||134
11063724|NCT01027598|12245248|FG001|NOT COMPLETED|Overall Study||67
11063725|NCT01027650|12245262|FG000|STARTED|Overall Study||6
11063726|NCT01027650|12245263|FG001|STARTED|Overall Study||6
11063727|NCT01027650|12245264|FG002|STARTED|Overall Study||6
11063728|NCT01027650|12245265|FG003|STARTED|Overall Study||3
11063729|NCT01027650|12245266|FG004|STARTED|Overall Study||25
11063730|NCT01027650|12245267|FG005|STARTED|Overall Study||26
11063731|NCT01027650|12245268|FG006|STARTED|Overall Study||25
11063732|NCT01027650|12245269|FG007|STARTED|Overall Study||24
11063733|NCT01027650|12245262|FG000|COMPLETED|Overall Study||6
11063734|NCT01027650|12245263|FG001|COMPLETED|Overall Study||6
11063735|NCT01027650|12245264|FG002|COMPLETED|Overall Study||6
11063736|NCT01027650|12245265|FG003|COMPLETED|Overall Study||3
11063737|NCT01027650|12245266|FG004|COMPLETED|Overall Study||23
11345497|NCT02969525|12542623|FG001|Completed Double-Blind Period|Double-Blind Period||41
11345498|NCT02969525|12542624|FG002|Completed Double-Blind Period|Double-Blind Period||40
11345499|NCT02969525|12542625|FG003|Completed Double-Blind Period|Double-Blind Period||39
11063738|NCT01027650|12245267|FG005|COMPLETED|Overall Study||24
11063739|NCT01027650|12245268|FG006|COMPLETED|Overall Study||24
11063740|NCT01027650|12245269|FG007|COMPLETED|Overall Study||24
11063741|NCT01027650|12245262|FG000|NOT COMPLETED|Overall Study||0
11063742|NCT01027650|12245263|FG001|NOT COMPLETED|Overall Study||0
11063743|NCT01027650|12245264|FG002|NOT COMPLETED|Overall Study||0
11063744|NCT01027650|12245265|FG003|NOT COMPLETED|Overall Study||0
11063745|NCT01027650|12245266|FG004|NOT COMPLETED|Overall Study||2
11063746|NCT01027650|12245267|FG005|NOT COMPLETED|Overall Study||2
11063747|NCT01027650|12245268|FG006|NOT COMPLETED|Overall Study||1
11063748|NCT01027650|12245269|FG007|NOT COMPLETED|Overall Study||0
11063749|NCT01027754|12245289|FG000|STARTED|Overall Study||57
11063750|NCT01027754|12245290|FG001|STARTED|Overall Study||55
11063751|NCT01027754|12245289|FG000|COMPLETED|Overall Study||55
11063752|NCT01027754|12245290|FG001|COMPLETED|Overall Study||47
11063753|NCT01027754|12245289|FG000|NOT COMPLETED|Overall Study||2
11063754|NCT01027754|12245290|FG001|NOT COMPLETED|Overall Study||8
11063755|NCT01027780|12245298|FG000|STARTED|Overall Study||105
11063756|NCT01027780|12245299|FG001|STARTED|Overall Study||103
11063757|NCT01027780|12245298|FG000|COMPLETED|Overall Study||105
11063758|NCT01027780|12245299|FG001|COMPLETED|Overall Study||102
11063759|NCT01027780|12245298|FG000|NOT COMPLETED|Overall Study||0
11063760|NCT01027780|12245299|FG001|NOT COMPLETED|Overall Study||1
11063761|NCT01027793|12245308|FG000|STARTED|Overall Study||17
11063762|NCT01027793|12245309|FG001|STARTED|Overall Study||15
11063763|NCT01027793|12245308|FG000|COMPLETED|Overall Study||10
11063764|NCT01027793|12245309|FG001|COMPLETED|Overall Study||12
11063765|NCT01027793|12245308|FG000|NOT COMPLETED|Overall Study||7
11063766|NCT01027793|12245309|FG001|NOT COMPLETED|Overall Study||3
11063767|NCT01027806|12245317|FG000|STARTED|Overall Study||32
11063768|NCT01027806|12245318|FG001|STARTED|Overall Study||32
11063769|NCT01027806|12245317|FG000|COMPLETED|Overall Study||28
11063770|NCT01027806|12245318|FG001|COMPLETED|Overall Study||29
11063771|NCT01027806|12245317|FG000|NOT COMPLETED|Overall Study||4
11063772|NCT01027806|12245318|FG001|NOT COMPLETED|Overall Study||3
11063773|NCT01027819|12245326|FG000|STARTED|Overall Study||40
11063774|NCT01027819|12245327|FG001|STARTED|Overall Study||40
11063775|NCT01027819|12245326|FG000|COMPLETED|Overall Study||40
11063776|NCT01027819|12245327|FG001|COMPLETED|Overall Study||40
11063777|NCT01027819|12245326|FG000|NOT COMPLETED|Overall Study||0
11063778|NCT01027819|12245327|FG001|NOT COMPLETED|Overall Study||0
11063779|NCT01027845|12245335|FG000|STARTED|Primary Vaccination Phase||237
11063780|NCT01027845|12245336|FG001|STARTED|Primary Vaccination Phase||123
11063781|NCT01027845|12245337|FG002|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
11063782|NCT01027845|12245338|FG003|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
11063783|NCT01027845|12245335|FG000|COMPLETED|Primary Vaccination Phase||233
11063784|NCT01027845|12245336|FG001|COMPLETED|Primary Vaccination Phase||122
11063785|NCT01027845|12245337|FG002|COMPLETED|Primary Vaccination Phase||0
11063786|NCT01027845|12245338|FG003|COMPLETED|Primary Vaccination Phase||0
11063787|NCT01027845|12245335|FG000|NOT COMPLETED|Primary Vaccination Phase||4
11063788|NCT01027845|12245336|FG001|NOT COMPLETED|Primary Vaccination Phase||1
11063789|NCT01027845|12245337|FG002|NOT COMPLETED|Primary Vaccination Phase||0
11063790|NCT01027845|12245338|FG003|NOT COMPLETED|Primary Vaccination Phase||0
11063791|NCT01027845|12245335|FG000|STARTED|Booster Vaccination Phase||228
11063792|NCT01027845|12245336|FG001|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0
11063793|NCT01027845|12245337|FG002|STARTED|Booster Vaccination Phase||119
11063794|NCT01027845|12245338|FG003|STARTED|Booster Vaccination Phase||1
11063795|NCT01027845|12245335|FG000|COMPLETED|Booster Vaccination Phase||226
11063796|NCT01027845|12245336|FG001|COMPLETED|Booster Vaccination Phase||0
11063797|NCT01027845|12245337|FG002|COMPLETED|Booster Vaccination Phase||119
11063798|NCT01027845|12245338|FG003|COMPLETED|Booster Vaccination Phase||1
11063799|NCT01027845|12245335|FG000|NOT COMPLETED|Booster Vaccination Phase||2
11063800|NCT01027845|12245336|FG001|NOT COMPLETED|Booster Vaccination Phase||0
11063801|NCT01027845|12245337|FG002|NOT COMPLETED|Booster Vaccination Phase||0
11063802|NCT01027845|12245338|FG003|NOT COMPLETED|Booster Vaccination Phase||0
11063803|NCT01027871|12245350|FG000|STARTED|Overall Study||93
11063804|NCT01027871|12245351|FG001|STARTED|Overall Study||98
11063805|NCT01027871|12245352|FG002|STARTED|Overall Study||98
11063806|NCT01027871|12245350|FG000|Received at Least One Dose of Study Drug|Overall Study||93
11063807|NCT01027871|12245351|FG001|Received at Least One Dose of Study Drug|Overall Study||98
11063808|NCT01027871|12245352|FG002|Received at Least One Dose of Study Drug|Overall Study||97
11063809|NCT01027871|12245350|FG000|COMPLETED|Overall Study||91
11063810|NCT01027871|12245351|FG001|COMPLETED|Overall Study||85
11063811|NCT01027871|12245352|FG002|COMPLETED|Overall Study||91
11063812|NCT01027871|12245350|FG000|NOT COMPLETED|Overall Study||2
11063813|NCT01027871|12245351|FG001|NOT COMPLETED|Overall Study||13
11063814|NCT01027871|12245352|FG002|NOT COMPLETED|Overall Study||7
11063815|NCT01027884|12245367|FG000|STARTED|Overall Study||34
11063816|NCT01027884|12245368|FG001|STARTED|Overall Study||32
11063817|NCT01027884|12245367|FG000|COMPLETED|Overall Study||30
11063818|NCT01027884|12245368|FG001|COMPLETED|Overall Study||25
11063819|NCT01027884|12245367|FG000|NOT COMPLETED|Overall Study||4
11063820|NCT01027884|12245368|FG001|NOT COMPLETED|Overall Study||7
11063821|NCT01027897|12245376|FG000|STARTED|Overall Study||30
11063822|NCT01027897|12245376|FG000|COMPLETED|Overall Study||28
11063823|NCT01027897|12245376|FG000|NOT COMPLETED|Overall Study||2
11063824|NCT01027910|12245382|FG000|STARTED|Overall Study||6
11063825|NCT01027910|12245383|FG001|STARTED|Overall Study||14
11063826|NCT01027910|12245382|FG000|COMPLETED|Overall Study||6
11063827|NCT01027910|12245383|FG001|COMPLETED|Overall Study||14
11063828|NCT01027910|12245382|FG000|NOT COMPLETED|Overall Study||0
11063829|NCT01027910|12245383|FG001|NOT COMPLETED|Overall Study||0
11063830|NCT01027949|12245391|FG000|STARTED|Overall Study||894
11063831|NCT01027949|12245391|FG000|COMPLETED|Overall Study||208
11063832|NCT01027949|12245391|FG000|NOT COMPLETED|Overall Study||686
11063833|NCT01028014|12245401|FG000|STARTED|Overall Study||10
11063834|NCT01028014|12245402|FG001|STARTED|Overall Study||10
11063835|NCT01028014|12245403|FG002|STARTED|Overall Study||10
11063836|NCT01028014|12245404|FG003|STARTED|Overall Study||10
11063837|NCT01028014|12245405|FG004|STARTED|Overall Study||10
11063838|NCT01028014|12245406|FG005|STARTED|Overall Study||6
11063839|NCT01028014|12245401|FG000|COMPLETED|Overall Study||9
11063840|NCT01028014|12245402|FG001|COMPLETED|Overall Study||8
11063841|NCT01028014|12245403|FG002|COMPLETED|Overall Study||10
11063842|NCT01028014|12245404|FG003|COMPLETED|Overall Study||9
11063843|NCT01028014|12245405|FG004|COMPLETED|Overall Study||9
11063844|NCT01028014|12245406|FG005|COMPLETED|Overall Study||4
11063845|NCT01028014|12245401|FG000|NOT COMPLETED|Overall Study||1
11063846|NCT01028014|12245402|FG001|NOT COMPLETED|Overall Study||2
11063847|NCT01028014|12245403|FG002|NOT COMPLETED|Overall Study||0
11063848|NCT01028014|12245404|FG003|NOT COMPLETED|Overall Study||1
11063849|NCT01028014|12245405|FG004|NOT COMPLETED|Overall Study||1
11063850|NCT01028014|12245406|FG005|NOT COMPLETED|Overall Study||2
11063851|NCT01028027|12245422|FG000|STARTED|Overall Study||180
11063852|NCT01028027|12245423|FG001|STARTED|Overall Study||177
11063853|NCT01028027|12245422|FG000|COMPLETED|Overall Study||164
11063854|NCT01028027|12245423|FG001|COMPLETED|Overall Study||164
11063855|NCT01028027|12245422|FG000|NOT COMPLETED|Overall Study||16
11063856|NCT01028027|12245423|FG001|NOT COMPLETED|Overall Study||13
11063857|NCT01028053|12245429|FG000|STARTED|Overall Study||365
11063858|NCT01028053|12245429|FG000|COMPLETED|Overall Study||232
11063859|NCT01028053|12245429|FG000|NOT COMPLETED|Overall Study||133
11063860|NCT01028131|12245439|FG000|STARTED|Overall Study||26
11063861|NCT01028131|12245440|FG001|STARTED|Overall Study||26
11063862|NCT01028131|12245441|FG002|STARTED|Overall Study||28
11063863|NCT01028131|12245442|FG003|STARTED|Overall Study||30
11063864|NCT01028131|12245439|FG000|Completed Intervention/Control Session|Overall Study||26
11063865|NCT01028131|12245440|FG001|Completed Intervention/Control Session|Overall Study||26
11063866|NCT01028131|12245441|FG002|Completed Intervention/Control Session|Overall Study||28
11063867|NCT01028131|12245442|FG003|Completed Intervention/Control Session|Overall Study||30
11063868|NCT01028131|12245439|FG000|COMPLETED|Overall Study||23
11063869|NCT01028131|12245440|FG001|COMPLETED|Overall Study||23
11063870|NCT01028131|12245441|FG002|COMPLETED|Overall Study||22
11063871|NCT01028131|12245442|FG003|COMPLETED|Overall Study||26
11063872|NCT01028131|12245439|FG000|NOT COMPLETED|Overall Study||3
11063873|NCT01028131|12245440|FG001|NOT COMPLETED|Overall Study||3
11063874|NCT01028131|12245441|FG002|NOT COMPLETED|Overall Study||6
11063875|NCT01028131|12245442|FG003|NOT COMPLETED|Overall Study||4
11063876|NCT01028222|12245454|FG000|STARTED|Overall Study||42
11063877|NCT01028222|12245455|FG001|STARTED|Overall Study||13
11063878|NCT01028222|12245454|FG000|Cross Over From DTIC to Nilotinib|Overall Study||0
11063879|NCT01028222|12245455|FG001|Cross Over From DTIC to Nilotinib|Overall Study||10
11063880|NCT01028222|12245454|FG000|COMPLETED|Overall Study||4
11063881|NCT01028222|12245455|FG001|COMPLETED|Overall Study||0
11063882|NCT01028222|12245454|FG000|NOT COMPLETED|Overall Study||38
11063883|NCT01028222|12245455|FG001|NOT COMPLETED|Overall Study||13
11063884|NCT01028352|12245462|FG000|STARTED|Overall Study||35
11063885|NCT01028352|12245462|FG000|COMPLETED|Overall Study||29
11063886|NCT01028352|12245462|FG000|NOT COMPLETED|Overall Study||6
11063887|NCT01028378|12245466|FG000|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
11063888|NCT01028378|12245466|FG000|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
11063889|NCT01028378|12245466|FG000|NOT COMPLETED|Overall Study||17
11063890|NCT01028391|12245472|FG000|STARTED|Overall Study||164
11063891|NCT01028391|12245473|FG001|STARTED|Overall Study||153
11063892|NCT01028391|12245472|FG000|COMPLETED|Overall Study||150
11063893|NCT01028391|12245473|FG001|COMPLETED|Overall Study||142
11063894|NCT01028391|12245472|FG000|NOT COMPLETED|Overall Study||14
11063895|NCT01028391|12245473|FG001|NOT COMPLETED|Overall Study||11
11063896|NCT01028560|12245481|FG000|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27
11063897|NCT01028560|12245482|FG001|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31
11063898|NCT01028560|12245481|FG000|Started Study Protocol|Overall Study||23
11063899|NCT01028560|12245482|FG001|Started Study Protocol|Overall Study||27
11063900|NCT01028560|12245481|FG000|COMPLETED|Overall Study||17
11063901|NCT01028560|12245482|FG001|COMPLETED|Overall Study||13
11063902|NCT01028560|12245481|FG000|NOT COMPLETED|Overall Study||10
11063903|NCT01028560|12245482|FG001|NOT COMPLETED|Overall Study||18
11063904|NCT01028651|12245489|FG000|STARTED|Overall Study||13
11063905|NCT01028651|12245489|FG000|COMPLETED|Overall Study||10
11063906|NCT01028651|12245489|FG000|NOT COMPLETED|Overall Study||3
11063907|NCT01028677|12245497|FG000|STARTED|Overall Study||10
11063908|NCT01028677|12245498|FG001|STARTED|Overall Study||7
11063909|NCT01028677|12245497|FG000|COMPLETED|Overall Study||8
11063910|NCT01028677|12245498|FG001|COMPLETED|Overall Study||6
11063911|NCT01028677|12245497|FG000|NOT COMPLETED|Overall Study||2
11063912|NCT01028677|12245498|FG001|NOT COMPLETED|Overall Study||1
11063913|NCT01028820|12245504|FG000|STARTED|Overall Study||13
11063914|NCT01028820|12245504|FG000|COMPLETED|Overall Study||12
11063915|NCT01028820|12245504|FG000|NOT COMPLETED|Overall Study||1
11063916|NCT01028911|12245511|FG000|STARTED|Overall Study||7
11063917|NCT01028911|12245512|FG001|STARTED|Overall Study||2
11063918|NCT01028911|12245511|FG000|COMPLETED|Overall Study||7
11063919|NCT01028911|12245512|FG001|COMPLETED|Overall Study||2
11063920|NCT01028911|12245511|FG000|NOT COMPLETED|Overall Study||0
11063921|NCT01028911|12245512|FG001|NOT COMPLETED|Overall Study||0
11205801|NCT01862250|12396697|FG000|NOT COMPLETED|Overall Study||4
11205802|NCT01862328|12396708|FG000|STARTED|Overall Study||4
11205803|NCT01862328|12396709|FG001|STARTED|Overall Study||18
11205804|NCT01862328|12396710|FG002|STARTED|Overall Study||6
11205805|NCT01862328|12396711|FG003|STARTED|Overall Study||7
11205806|NCT01862328|12396712|FG004|STARTED|Overall Study||12
11205807|NCT01862328|12396713|FG005|STARTED|Overall Study||7
11205808|NCT01862328|12396714|FG006|STARTED|Overall Study||10
11345500|NCT02969525|12542626|FG004|Completed Double-Blind Period|Double-Blind Period||41
11205809|NCT01862328|12396708|FG000|COMPLETED|Overall Study||0
11205810|NCT01862328|12396709|FG001|COMPLETED|Overall Study||0
11205811|NCT01862328|12396710|FG002|COMPLETED|Overall Study||0
11205812|NCT01862328|12396711|FG003|COMPLETED|Overall Study||0
11205813|NCT01862328|12396712|FG004|COMPLETED|Overall Study||0
11205814|NCT01862328|12396713|FG005|COMPLETED|Overall Study||0
11205815|NCT01862328|12396714|FG006|COMPLETED|Overall Study||0
11205816|NCT01862328|12396708|FG000|NOT COMPLETED|Overall Study||4
11205817|NCT01862328|12396709|FG001|NOT COMPLETED|Overall Study||18
11205818|NCT01862328|12396710|FG002|NOT COMPLETED|Overall Study||6
11205819|NCT01862328|12396711|FG003|NOT COMPLETED|Overall Study||7
11205820|NCT01862328|12396712|FG004|NOT COMPLETED|Overall Study||12
11205821|NCT01862328|12396713|FG005|NOT COMPLETED|Overall Study||7
11205822|NCT01862328|12396714|FG006|NOT COMPLETED|Overall Study||10
11205823|NCT01862419|12396738|FG000|STARTED|Overall Study||1201
11205824|NCT01862419|12396739|FG001|STARTED|Overall Study||1192
11205825|NCT01862419|12396738|FG000|COMPLETED|Overall Study||1201
11205826|NCT01862419|12396739|FG001|COMPLETED|Overall Study||1192
11205827|NCT01862419|12396738|FG000|NOT COMPLETED|Overall Study||0
11205828|NCT01862419|12396739|FG001|NOT COMPLETED|Overall Study||0
11205829|NCT01862484|12396747|FG000|STARTED|Overall Study||15
11345501|NCT02969525|12542627|FG005|Completed Double-Blind Period|Double-Blind Period||0
11345502|NCT02969525|12542628|FG006|Completed Double-Blind Period|Double-Blind Period||0
11345503|NCT02969525|12542629|FG007|Completed Double-Blind Period|Double-Blind Period||0
11345504|NCT02969525|12542630|FG008|Completed Double-Blind Period|Double-Blind Period||0
11345505|NCT02969525|12542631|FG009|Completed Double-Blind Period|Double-Blind Period||0
11345506|NCT02969525|12542632|FG010|Completed Double-Blind Period|Double-Blind Period||0
11345507|NCT02969525|12542633|FG011|Completed Double-Blind Period|Double-Blind Period||0
11345508|NCT02969525|12542622|FG000|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
11345509|NCT02969525|12542623|FG001|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
11345510|NCT02969525|12542624|FG002|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
11345511|NCT02969525|12542625|FG003|Completed Wk12 and Started Dose-Blind|Double-Blind Period||37
11345512|NCT02969525|12542626|FG004|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
11345513|NCT02969525|12542627|FG005|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
11345514|NCT02969525|12542628|FG006|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
11345515|NCT02969525|12542629|FG007|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
11345516|NCT02969525|12542630|FG008|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
11345517|NCT02969525|12542631|FG009|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
11345518|NCT02969525|12542632|FG010|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
11345519|NCT02969525|12542633|FG011|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
11345520|NCT02969525|12542622|FG000|COMPLETED|Double-Blind Period||40
11345521|NCT02969525|12542623|FG001|COMPLETED|Double-Blind Period||41
11345522|NCT02969525|12542624|FG002|COMPLETED|Double-Blind Period||40
11345523|NCT02969525|12542625|FG003|COMPLETED|Double-Blind Period||37
11345524|NCT02969525|12542626|FG004|COMPLETED|Double-Blind Period||41
11345525|NCT02969525|12542627|FG005|COMPLETED|Double-Blind Period||0
11345526|NCT02969525|12542628|FG006|COMPLETED|Double-Blind Period||0
11345527|NCT02969525|12542629|FG007|COMPLETED|Double-Blind Period||0
11345528|NCT02969525|12542630|FG008|COMPLETED|Double-Blind Period||0
11345529|NCT02969525|12542631|FG009|COMPLETED|Double-Blind Period||0
11345530|NCT02969525|12542632|FG010|COMPLETED|Double-Blind Period||0
11345531|NCT02969525|12542633|FG011|COMPLETED|Double-Blind Period||0
11345532|NCT02969525|12542622|FG000|NOT COMPLETED|Double-Blind Period||2
11345533|NCT02969525|12542623|FG001|NOT COMPLETED|Double-Blind Period||0
11345534|NCT02969525|12542624|FG002|NOT COMPLETED|Double-Blind Period||1
11345535|NCT02969525|12542625|FG003|NOT COMPLETED|Double-Blind Period||4
11345536|NCT02969525|12542626|FG004|NOT COMPLETED|Double-Blind Period||0
11205830|NCT01862484|12396748|FG001|STARTED|Overall Study||14
11205831|NCT01862484|12396747|FG000|COMPLETED|Overall Study||13
11205832|NCT01862484|12396748|FG001|COMPLETED|Overall Study||6
11205833|NCT01862484|12396747|FG000|NOT COMPLETED|Overall Study||2
11205834|NCT01862484|12396748|FG001|NOT COMPLETED|Overall Study||8
11205835|NCT01862536|12396756|FG000|STARTED|Overall Study||13
11205836|NCT01862536|12396757|FG001|STARTED|Overall Study||23
11205837|NCT01862536|12396756|FG000|COMPLETED|Overall Study||10
11345537|NCT02969525|12542627|FG005|NOT COMPLETED|Double-Blind Period||0
11345538|NCT02969525|12542628|FG006|NOT COMPLETED|Double-Blind Period||0
11345539|NCT02969525|12542629|FG007|NOT COMPLETED|Double-Blind Period||0
11345540|NCT02969525|12542630|FG008|NOT COMPLETED|Double-Blind Period||0
11345541|NCT02969525|12542631|FG009|NOT COMPLETED|Double-Blind Period||0
11345542|NCT02969525|12542632|FG010|NOT COMPLETED|Double-Blind Period||0
11345543|NCT02969525|12542633|FG011|NOT COMPLETED|Double-Blind Period||0
11345544|NCT02969525|12542622|FG000|STARTED|Dose-Blind Period||0
11345545|NCT02969525|12542623|FG001|STARTED|Dose-Blind Period||0
11345546|NCT02969525|12542624|FG002|STARTED|Dose-Blind Period||0
11345547|NCT02969525|12542625|FG003|STARTED|Dose-Blind Period||0
11345548|NCT02969525|12542626|FG004|STARTED|Dose-Blind Period||0
11345549|NCT02969525|12542627|FG005|STARTED|Dose-Blind Period||20
11345550|NCT02969525|12542628|FG006|STARTED|Dose-Blind Period||20
11345551|NCT02969525|12542629|FG007|STARTED|Dose-Blind Period||22
11345552|NCT02969525|12542630|FG008|STARTED|Dose-Blind Period||19
11345553|NCT02969525|12542631|FG009|STARTED|Dose-Blind Period||37
11345554|NCT02969525|12542632|FG010|STARTED|Dose-Blind Period||40
11345555|NCT02969525|12542633|FG011|STARTED|Dose-Blind Period||41
11345556|NCT02969525|12542622|FG000|COMPLETED|Dose-Blind Period||0
11063922|NCT01028937|12245518|FG000|STARTED|Overall Study||6
11063923|NCT01028937|12245518|FG000|COMPLETED|Overall Study||6
11063924|NCT01028937|12245518|FG000|NOT COMPLETED|Overall Study||0
11063925|NCT01029054|12245522|FG000|STARTED|Phase I||4
11063926|NCT01029054|12245523|FG001|STARTED|Phase I||13
11063927|NCT01029054|12245524|FG002|STARTED|Phase I||18
11063928|NCT01029054|12245522|FG000|COMPLETED|Phase I||4
11063929|NCT01029054|12245523|FG001|COMPLETED|Phase I||13
11063930|NCT01029054|12245524|FG002|COMPLETED|Phase I||18
11063931|NCT01029054|12245522|FG000|NOT COMPLETED|Phase I||0
11063932|NCT01029054|12245523|FG001|NOT COMPLETED|Phase I||0
11063933|NCT01029054|12245524|FG002|NOT COMPLETED|Phase I||0
11063934|NCT01029054|12245522|FG000|STARTED|Phase II||0
11063935|NCT01029054|12245523|FG001|STARTED|Phase II||0
11063936|NCT01029054|12245524|FG002|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
11063937|NCT01029054|12245522|FG000|COMPLETED|Phase II||0
11063938|NCT01029054|12245523|FG001|COMPLETED|Phase II||0
11063939|NCT01029054|12245524|FG002|COMPLETED|Phase II||18
11063940|NCT01029054|12245522|FG000|NOT COMPLETED|Phase II||0
11063941|NCT01029054|12245523|FG001|NOT COMPLETED|Phase II||0
11063942|NCT01029054|12245524|FG002|NOT COMPLETED|Phase II||0
11063943|NCT01029262|12245530|FG000|STARTED|Overall Study||79
11063944|NCT01029262|12245531|FG001|STARTED|Overall Study||160
11063945|NCT01029262|12245530|FG000|COMPLETED|Overall Study||0
11063946|NCT01029262|12245531|FG001|COMPLETED|Overall Study||0
11063947|NCT01029262|12245530|FG000|NOT COMPLETED|Overall Study||79
11063948|NCT01029262|12245531|FG001|NOT COMPLETED|Overall Study||160
11063949|NCT01029340|12245547|FG000|STARTED|Part A Treatment Period||14
11063950|NCT01029340|12245548|FG001|STARTED|Part A Treatment Period||14
11063951|NCT01029340|12245549|FG002|STARTED|Part A Treatment Period||0
11063952|NCT01029340|12245550|FG003|STARTED|Part A Treatment Period||0
11063953|NCT01029340|12245551|FG004|STARTED|Part A Treatment Period||0
11063954|NCT01029340|12245552|FG005|STARTED|Part A Treatment Period||0
11063955|NCT01029340|12245547|FG000|Participants Received Treatment|Part A Treatment Period||14
11063956|NCT01029340|12245548|FG001|Participants Received Treatment|Part A Treatment Period||14
11063957|NCT01029340|12245549|FG002|Participants Received Treatment|Part A Treatment Period||0
11063958|NCT01029340|12245550|FG003|Participants Received Treatment|Part A Treatment Period||0
11345557|NCT02969525|12542623|FG001|COMPLETED|Dose-Blind Period||0
11345558|NCT02969525|12542624|FG002|COMPLETED|Dose-Blind Period||0
11345559|NCT02969525|12542625|FG003|COMPLETED|Dose-Blind Period||0
11345560|NCT02969525|12542626|FG004|COMPLETED|Dose-Blind Period||0
11345561|NCT02969525|12542627|FG005|COMPLETED|Dose-Blind Period||20
11345562|NCT02969525|12542628|FG006|COMPLETED|Dose-Blind Period||18
11345563|NCT02969525|12542629|FG007|COMPLETED|Dose-Blind Period||22
11345564|NCT02969525|12542630|FG008|COMPLETED|Dose-Blind Period||18
11063959|NCT01029340|12245551|FG004|Participants Received Treatment|Part A Treatment Period||0
11063960|NCT01029340|12245552|FG005|Participants Received Treatment|Part A Treatment Period||0
11063961|NCT01029340|12245547|FG000|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
11063962|NCT01029340|12245548|FG001|Safety Population|Part A Treatment Period||14
11063963|NCT01029340|12245549|FG002|Safety Population|Part A Treatment Period||0
11063964|NCT01029340|12245550|FG003|Safety Population|Part A Treatment Period||0
11345565|NCT02969525|12542631|FG009|COMPLETED|Dose-Blind Period||34
11345566|NCT02969525|12542632|FG010|COMPLETED|Dose-Blind Period||38
11345567|NCT02969525|12542633|FG011|COMPLETED|Dose-Blind Period||39
11345568|NCT02969525|12542622|FG000|NOT COMPLETED|Dose-Blind Period||0
11345569|NCT02969525|12542623|FG001|NOT COMPLETED|Dose-Blind Period||0
11345570|NCT02969525|12542624|FG002|NOT COMPLETED|Dose-Blind Period||0
11345571|NCT02969525|12542625|FG003|NOT COMPLETED|Dose-Blind Period||0
11345572|NCT02969525|12542626|FG004|NOT COMPLETED|Dose-Blind Period||0
11345573|NCT02969525|12542627|FG005|NOT COMPLETED|Dose-Blind Period||0
11345574|NCT02969525|12542628|FG006|NOT COMPLETED|Dose-Blind Period||2
11345575|NCT02969525|12542629|FG007|NOT COMPLETED|Dose-Blind Period||0
11063965|NCT01029340|12245551|FG004|Safety Population|Part A Treatment Period||0
11063966|NCT01029340|12245552|FG005|Safety Population|Part A Treatment Period||0
11063967|NCT01029340|12245547|FG000|COMPLETED|Part A Treatment Period||14
11063968|NCT01029340|12245548|FG001|COMPLETED|Part A Treatment Period||14
11063969|NCT01029340|12245549|FG002|COMPLETED|Part A Treatment Period||0
11063970|NCT01029340|12245550|FG003|COMPLETED|Part A Treatment Period||0
11063971|NCT01029340|12245551|FG004|COMPLETED|Part A Treatment Period||0
11063972|NCT01029340|12245552|FG005|COMPLETED|Part A Treatment Period||0
11063973|NCT01029340|12245547|FG000|NOT COMPLETED|Part A Treatment Period||0
11063974|NCT01029340|12245548|FG001|NOT COMPLETED|Part A Treatment Period||0
11063975|NCT01029340|12245549|FG002|NOT COMPLETED|Part A Treatment Period||0
11063976|NCT01029340|12245550|FG003|NOT COMPLETED|Part A Treatment Period||0
11063977|NCT01029340|12245551|FG004|NOT COMPLETED|Part A Treatment Period||0
11063978|NCT01029340|12245552|FG005|NOT COMPLETED|Part A Treatment Period||0
11063979|NCT01029340|12245547|FG000|STARTED|Part A Follow up Period||14
11063980|NCT01029340|12245548|FG001|STARTED|Part A Follow up Period||14
11063981|NCT01029340|12245549|FG002|STARTED|Part A Follow up Period||0
11063982|NCT01029340|12245550|FG003|STARTED|Part A Follow up Period||0
11063983|NCT01029340|12245551|FG004|STARTED|Part A Follow up Period||0
11063984|NCT01029340|12245552|FG005|STARTED|Part A Follow up Period||0
11063985|NCT01029340|12245547|FG000|COMPLETED|Part A Follow up Period||14
11063986|NCT01029340|12245548|FG001|COMPLETED|Part A Follow up Period||14
11063987|NCT01029340|12245549|FG002|COMPLETED|Part A Follow up Period||0
11063988|NCT01029340|12245550|FG003|COMPLETED|Part A Follow up Period||0
11063989|NCT01029340|12245551|FG004|COMPLETED|Part A Follow up Period||0
11063990|NCT01029340|12245552|FG005|COMPLETED|Part A Follow up Period||0
11063991|NCT01029340|12245547|FG000|NOT COMPLETED|Part A Follow up Period||0
11063992|NCT01029340|12245548|FG001|NOT COMPLETED|Part A Follow up Period||0
11063993|NCT01029340|12245549|FG002|NOT COMPLETED|Part A Follow up Period||0
11063994|NCT01029340|12245550|FG003|NOT COMPLETED|Part A Follow up Period||0
11063995|NCT01029340|12245551|FG004|NOT COMPLETED|Part A Follow up Period||0
11063996|NCT01029340|12245552|FG005|NOT COMPLETED|Part A Follow up Period||0
11063997|NCT01029340|12245547|FG000|STARTED|Part B Treatment Period||0
11063998|NCT01029340|12245548|FG001|STARTED|Part B Treatment Period||0
11063999|NCT01029340|12245549|FG002|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
11064000|NCT01029340|12245550|FG003|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
11064001|NCT01029340|12245551|FG004|STARTED|Part B Treatment Period||0
11064002|NCT01029340|12245552|FG005|STARTED|Part B Treatment Period||0
11064003|NCT01029340|12245547|FG000|Participants Received Treatment|Part B Treatment Period||0
11064004|NCT01029340|12245548|FG001|Participants Received Treatment|Part B Treatment Period||0
11064005|NCT01029340|12245549|FG002|Participants Received Treatment|Part B Treatment Period||30
11064006|NCT01029340|12245550|FG003|Participants Received Treatment|Part B Treatment Period||32
11064007|NCT01029340|12245551|FG004|Participants Received Treatment|Part B Treatment Period||0
11064008|NCT01029340|12245552|FG005|Participants Received Treatment|Part B Treatment Period||0
11064009|NCT01029340|12245547|FG000|COMPLETED|Part B Treatment Period||0
11064010|NCT01029340|12245548|FG001|COMPLETED|Part B Treatment Period||0
11064011|NCT01029340|12245549|FG002|COMPLETED|Part B Treatment Period||29
11064012|NCT01029340|12245550|FG003|COMPLETED|Part B Treatment Period||32
11064013|NCT01029340|12245551|FG004|COMPLETED|Part B Treatment Period||0
11064014|NCT01029340|12245552|FG005|COMPLETED|Part B Treatment Period||0
11064015|NCT01029340|12245547|FG000|NOT COMPLETED|Part B Treatment Period||0
11064016|NCT01029340|12245548|FG001|NOT COMPLETED|Part B Treatment Period||0
11064017|NCT01029340|12245549|FG002|NOT COMPLETED|Part B Treatment Period||2
11064018|NCT01029340|12245550|FG003|NOT COMPLETED|Part B Treatment Period||0
11064019|NCT01029340|12245551|FG004|NOT COMPLETED|Part B Treatment Period||0
11064020|NCT01029340|12245552|FG005|NOT COMPLETED|Part B Treatment Period||0
11064021|NCT01029340|12245547|FG000|STARTED|Part B Follow up Period||0
11064022|NCT01029340|12245548|FG001|STARTED|Part B Follow up Period||0
11064023|NCT01029340|12245549|FG002|STARTED|Part B Follow up Period||29
11064024|NCT01029340|12245550|FG003|STARTED|Part B Follow up Period||32
11064025|NCT01029340|12245551|FG004|STARTED|Part B Follow up Period||0
11064026|NCT01029340|12245552|FG005|STARTED|Part B Follow up Period||0
11064027|NCT01029340|12245547|FG000|COMPLETED|Part B Follow up Period||0
11064028|NCT01029340|12245548|FG001|COMPLETED|Part B Follow up Period||0
11064029|NCT01029340|12245549|FG002|COMPLETED|Part B Follow up Period||29
11064030|NCT01029340|12245550|FG003|COMPLETED|Part B Follow up Period||32
11064031|NCT01029340|12245551|FG004|COMPLETED|Part B Follow up Period||0
11064032|NCT01029340|12245552|FG005|COMPLETED|Part B Follow up Period||0
11064033|NCT01029340|12245547|FG000|NOT COMPLETED|Part B Follow up Period||0
11064034|NCT01029340|12245548|FG001|NOT COMPLETED|Part B Follow up Period||0
11064035|NCT01029340|12245549|FG002|NOT COMPLETED|Part B Follow up Period||0
11064036|NCT01029340|12245550|FG003|NOT COMPLETED|Part B Follow up Period||0
11064037|NCT01029340|12245551|FG004|NOT COMPLETED|Part B Follow up Period||0
11064038|NCT01029340|12245552|FG005|NOT COMPLETED|Part B Follow up Period||0
11064039|NCT01029340|12245547|FG000|STARTED|Extension Period||0
11064040|NCT01029340|12245548|FG001|STARTED|Extension Period||0
11064041|NCT01029340|12245549|FG002|STARTED|Extension Period||0
11064042|NCT01029340|12245550|FG003|STARTED|Extension Period||0
11064043|NCT01029340|12245551|FG004|STARTED|Extension Period||0
11064044|NCT01029340|12245552|FG005|STARTED|Extension Period||55
11064045|NCT01029340|12245547|FG000|COMPLETED|Extension Period||0
11064046|NCT01029340|12245548|FG001|COMPLETED|Extension Period||0
11064047|NCT01029340|12245549|FG002|COMPLETED|Extension Period||0
11064048|NCT01029340|12245550|FG003|COMPLETED|Extension Period||0
11064049|NCT01029340|12245551|FG004|COMPLETED|Extension Period||0
11064050|NCT01029340|12245552|FG005|COMPLETED|Extension Period||43
11064051|NCT01029340|12245547|FG000|NOT COMPLETED|Extension Period||0
11064052|NCT01029340|12245548|FG001|NOT COMPLETED|Extension Period||0
11064053|NCT01029340|12245549|FG002|NOT COMPLETED|Extension Period||0
11064054|NCT01029340|12245550|FG003|NOT COMPLETED|Extension Period||0
11064055|NCT01029340|12245551|FG004|NOT COMPLETED|Extension Period||0
11064056|NCT01029340|12245552|FG005|NOT COMPLETED|Extension Period||12
11064057|NCT01029340|12245547|FG000|STARTED|Part C Treatment Period||0
11064058|NCT01029340|12245548|FG001|STARTED|Part C Treatment Period||0
11064059|NCT01029340|12245549|FG002|STARTED|Part C Treatment Period||0
11064060|NCT01029340|12245550|FG003|STARTED|Part C Treatment Period||0
11064061|NCT01029340|12245551|FG004|STARTED|Part C Treatment Period||5
11064062|NCT01029340|12245552|FG005|STARTED|Part C Treatment Period||0
11064063|NCT01029340|12245547|FG000|Participants Received Treatment|Part C Treatment Period||0
11064064|NCT01029340|12245548|FG001|Participants Received Treatment|Part C Treatment Period||0
11064065|NCT01029340|12245549|FG002|Participants Received Treatment|Part C Treatment Period||0
11064066|NCT01029340|12245550|FG003|Participants Received Treatment|Part C Treatment Period||0
11064067|NCT01029340|12245551|FG004|Participants Received Treatment|Part C Treatment Period||5
11064068|NCT01029340|12245552|FG005|Participants Received Treatment|Part C Treatment Period||0
11064069|NCT01029340|12245547|FG000|COMPLETED|Part C Treatment Period||0
11064070|NCT01029340|12245548|FG001|COMPLETED|Part C Treatment Period||0
11064071|NCT01029340|12245549|FG002|COMPLETED|Part C Treatment Period||0
11064072|NCT01029340|12245550|FG003|COMPLETED|Part C Treatment Period||0
11064073|NCT01029340|12245551|FG004|COMPLETED|Part C Treatment Period||5
11064074|NCT01029340|12245552|FG005|COMPLETED|Part C Treatment Period||0
11064075|NCT01029340|12245547|FG000|NOT COMPLETED|Part C Treatment Period||0
11064076|NCT01029340|12245548|FG001|NOT COMPLETED|Part C Treatment Period||0
11064077|NCT01029340|12245549|FG002|NOT COMPLETED|Part C Treatment Period||0
11064078|NCT01029340|12245550|FG003|NOT COMPLETED|Part C Treatment Period||0
11064079|NCT01029340|12245551|FG004|NOT COMPLETED|Part C Treatment Period||0
11064080|NCT01029340|12245552|FG005|NOT COMPLETED|Part C Treatment Period||0
11064081|NCT01029340|12245547|FG000|STARTED|Part C Follow up Period||0
11064082|NCT01029340|12245548|FG001|STARTED|Part C Follow up Period||0
11064083|NCT01029340|12245549|FG002|STARTED|Part C Follow up Period||0
11064084|NCT01029340|12245550|FG003|STARTED|Part C Follow up Period||0
11064085|NCT01029340|12245551|FG004|STARTED|Part C Follow up Period||5
11064086|NCT01029340|12245552|FG005|STARTED|Part C Follow up Period||0
11064087|NCT01029340|12245547|FG000|COMPLETED|Part C Follow up Period||0
11064088|NCT01029340|12245548|FG001|COMPLETED|Part C Follow up Period||0
11064089|NCT01029340|12245549|FG002|COMPLETED|Part C Follow up Period||0
11345576|NCT02969525|12542630|FG008|NOT COMPLETED|Dose-Blind Period||1
11345577|NCT02969525|12542631|FG009|NOT COMPLETED|Dose-Blind Period||3
11345578|NCT02969525|12542632|FG010|NOT COMPLETED|Dose-Blind Period||2
11345579|NCT02969525|12542633|FG011|NOT COMPLETED|Dose-Blind Period||2
11345580|NCT02969590|12542655|FG000|STARTED|Screening Period||5
11345581|NCT02969590|12542656|FG001|STARTED|Screening Period||0
11345582|NCT02969590|12542657|FG002|STARTED|Screening Period||0
11345583|NCT02969590|12542655|FG000|COMPLETED|Screening Period||4
11345584|NCT02969590|12542656|FG001|COMPLETED|Screening Period||0
11345585|NCT02969590|12542657|FG002|COMPLETED|Screening Period||0
11345586|NCT02969590|12542655|FG000|NOT COMPLETED|Screening Period||1
11345587|NCT02969590|12542656|FG001|NOT COMPLETED|Screening Period||0
11345588|NCT02969590|12542657|FG002|NOT COMPLETED|Screening Period||0
11345589|NCT02969590|12542655|FG000|STARTED|Treatment Period 1||0
11345590|NCT02969590|12542656|FG001|STARTED|Treatment Period 1||2
11345591|NCT02969590|12542657|FG002|STARTED|Treatment Period 1||2
11345592|NCT02969590|12542655|FG000|COMPLETED|Treatment Period 1||0
11345593|NCT02969590|12542656|FG001|COMPLETED|Treatment Period 1||2
11345594|NCT02969590|12542657|FG002|COMPLETED|Treatment Period 1||2
11345595|NCT02969590|12542655|FG000|NOT COMPLETED|Treatment Period 1||0
11345596|NCT02969590|12542656|FG001|NOT COMPLETED|Treatment Period 1||0
11345597|NCT02969590|12542657|FG002|NOT COMPLETED|Treatment Period 1||0
11345598|NCT02969590|12542655|FG000|STARTED|Treatment Period 2||0
11345599|NCT02969590|12542656|FG001|STARTED|Treatment Period 2||2
11345600|NCT02969590|12542657|FG002|STARTED|Treatment Period 2||2
11345601|NCT02969590|12542655|FG000|COMPLETED|Treatment Period 2||0
11064090|NCT01029340|12245550|FG003|COMPLETED|Part C Follow up Period||0
11064091|NCT01029340|12245551|FG004|COMPLETED|Part C Follow up Period||5
11064092|NCT01029340|12245552|FG005|COMPLETED|Part C Follow up Period||0
11064093|NCT01029340|12245547|FG000|NOT COMPLETED|Part C Follow up Period||0
11064094|NCT01029340|12245548|FG001|NOT COMPLETED|Part C Follow up Period||0
11064095|NCT01029340|12245549|FG002|NOT COMPLETED|Part C Follow up Period||0
11064096|NCT01029340|12245550|FG003|NOT COMPLETED|Part C Follow up Period||0
11064097|NCT01029340|12245551|FG004|NOT COMPLETED|Part C Follow up Period||0
11064098|NCT01029340|12245552|FG005|NOT COMPLETED|Part C Follow up Period||0
11064099|NCT01029353|12245569|FG000|STARTED|Overall Study||148
11064100|NCT01029353|12245570|FG001|STARTED|Overall Study||162
11064101|NCT01029353|12245571|FG002|STARTED|Overall Study||100
11064102|NCT01029353|12245572|FG003|STARTED|Overall Study||119
11064103|NCT01029353|12245569|FG000|Included in ITT Analysis|Overall Study||146
11064104|NCT01029353|12245570|FG001|Included in ITT Analysis|Overall Study||162
11064105|NCT01029353|12245571|FG002|Included in ITT Analysis|Overall Study||100
11064106|NCT01029353|12245572|FG003|Included in ITT Analysis|Overall Study||119
11064107|NCT01029353|12245569|FG000|Reached Network Status|Overall Study||146
11064108|NCT01029353|12245570|FG001|Reached Network Status|Overall Study||162
11064109|NCT01029353|12245571|FG002|Reached Network Status|Overall Study||100
11064110|NCT01029353|12245572|FG003|Reached Network Status|Overall Study||119
11064111|NCT01029353|12245569|FG000|COMPLETED|Overall Study||141
11064112|NCT01029353|12245570|FG001|COMPLETED|Overall Study||154
11064113|NCT01029353|12245571|FG002|COMPLETED|Overall Study||93
11064114|NCT01029353|12245572|FG003|COMPLETED|Overall Study||115
11064115|NCT01029353|12245569|FG000|NOT COMPLETED|Overall Study||7
11064116|NCT01029353|12245570|FG001|NOT COMPLETED|Overall Study||8
11064117|NCT01029353|12245571|FG002|NOT COMPLETED|Overall Study||7
11064118|NCT01029353|12245572|FG003|NOT COMPLETED|Overall Study||4
11064119|NCT01029366|12245584|FG000|STARTED|Overall Study||18
11064120|NCT01029366|12245585|FG001|STARTED|Overall Study||8
11064121|NCT01029366|12245584|FG000|COMPLETED|Overall Study||14
11064122|NCT01029366|12245585|FG001|COMPLETED|Overall Study||6
11064123|NCT01029366|12245584|FG000|NOT COMPLETED|Overall Study||4
11064124|NCT01029366|12245585|FG001|NOT COMPLETED|Overall Study||2
11064125|NCT01029392|12245594|FG000|STARTED|Overall Study||37
11064126|NCT01029392|12245595|FG001|STARTED|Overall Study||38
11064127|NCT01029392|12245594|FG000|COMPLETED|Overall Study||17
11064128|NCT01029392|12245595|FG001|COMPLETED|Overall Study||27
11064129|NCT01029392|12245594|FG000|NOT COMPLETED|Overall Study||20
11064130|NCT01029392|12245595|FG001|NOT COMPLETED|Overall Study||11
11064131|NCT01029405|12245607|FG000|STARTED|Overall Study||36
11064132|NCT01029405|12245608|FG001|STARTED|Overall Study||37
11064133|NCT01029405|12245609|FG002|STARTED|Overall Study||35
11064134|NCT01029405|12245610|FG003|STARTED|Overall Study||37
11064135|NCT01029405|12245607|FG000|COMPLETED|Overall Study||34
11064136|NCT01029405|12245608|FG001|COMPLETED|Overall Study||34
11064137|NCT01029405|12245609|FG002|COMPLETED|Overall Study||31
11064138|NCT01029405|12245610|FG003|COMPLETED|Overall Study||32
11064139|NCT01029405|12245607|FG000|NOT COMPLETED|Overall Study||2
11064140|NCT01029405|12245608|FG001|NOT COMPLETED|Overall Study||3
11064141|NCT01029405|12245609|FG002|NOT COMPLETED|Overall Study||4
11064142|NCT01029405|12245610|FG003|NOT COMPLETED|Overall Study||5
11064143|NCT01029535|12245620|FG000|STARTED|Overall Study||103
11064144|NCT01029535|12245620|FG000|COMPLETED|Overall Study||72
11064145|NCT01029535|12245620|FG000|NOT COMPLETED|Overall Study||31
11064146|NCT01029587|12245625|FG000|STARTED|Overall Study||1
11064147|NCT01029587|12245625|FG000|COMPLETED|Overall Study||1
11064148|NCT01029587|12245625|FG000|NOT COMPLETED|Overall Study||0
11064149|NCT01029652|12245631|FG000|STARTED|Core Study (0-12 Weeks)||115
11064150|NCT01029652|12245632|FG001|STARTED|Core Study (0-12 Weeks)||115
11064151|NCT01029652|12245631|FG000|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
11064152|NCT01029652|12245632|FG001|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
11064153|NCT01029652|12245631|FG000|COMPLETED|Core Study (0-12 Weeks)||109
11064154|NCT01029652|12245632|FG001|COMPLETED|Core Study (0-12 Weeks)||105
11064155|NCT01029652|12245631|FG000|NOT COMPLETED|Core Study (0-12 Weeks)||6
11064156|NCT01029652|12245632|FG001|NOT COMPLETED|Core Study (0-12 Weeks)||10
11064157|NCT01029652|12245631|FG000|STARTED|Extension Study 1 (12-24 Weeks)||90
11064158|NCT01029652|12245632|FG001|STARTED|Extension Study 1 (12-24 Weeks)||85
11064159|NCT01029652|12245631|FG000|COMPLETED|Extension Study 1 (12-24 Weeks)||87
11064160|NCT01029652|12245632|FG001|COMPLETED|Extension Study 1 (12-24 Weeks)||80
11064161|NCT01029652|12245631|FG000|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
11064162|NCT01029652|12245632|FG001|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
11064163|NCT01029652|12245631|FG000|STARTED|Extension Study 2 (25-72 Weeks)||69
11064164|NCT01029652|12245632|FG001|STARTED|Extension Study 2 (25-72 Weeks)||66
11064165|NCT01029652|12245631|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
11064166|NCT01029652|12245632|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
11064167|NCT01029652|12245631|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||68
11064168|NCT01029652|12245632|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||63
11064169|NCT01029652|12245631|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
11345602|NCT02969590|12542656|FG001|COMPLETED|Treatment Period 2||2
11345603|NCT02969590|12542657|FG002|COMPLETED|Treatment Period 2||2
11064170|NCT01029652|12245632|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
11064171|NCT01029691|12245659|FG000|STARTED|APAP Initiation to Week 1 or Delivery||20
11064172|NCT01029691|12245660|FG001|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
11064173|NCT01029691|12245661|FG002|STARTED|APAP Initiation to Week 1 or Delivery||77
11064174|NCT01029691|12245659|FG000|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
11064175|NCT01029691|12245660|FG001|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
11064176|NCT01029691|12245661|FG002|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
11064177|NCT01029691|12245659|FG000|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
11064178|NCT01029691|12245660|FG001|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
11064179|NCT01029691|12245661|FG002|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
11064180|NCT01029691|12245659|FG000|COMPLETED|APAP Initiation to Week 1 or Delivery||20
11064181|NCT01029691|12245660|FG001|COMPLETED|APAP Initiation to Week 1 or Delivery||16
11345604|NCT02969590|12542655|FG000|NOT COMPLETED|Treatment Period 2||0
11345605|NCT02969590|12542656|FG001|NOT COMPLETED|Treatment Period 2||0
11345606|NCT02969590|12542657|FG002|NOT COMPLETED|Treatment Period 2||0
11064182|NCT01029691|12245661|FG002|COMPLETED|APAP Initiation to Week 1 or Delivery||77
11064183|NCT01029691|12245659|FG000|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
11064184|NCT01029691|12245660|FG001|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
11064185|NCT01029691|12245661|FG002|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
11064186|NCT01029691|12245659|FG000|STARTED|Continued APAP to Delivery||20
11064187|NCT01029691|12245660|FG001|STARTED|Continued APAP to Delivery||16
11064188|NCT01029691|12245661|FG002|STARTED|Continued APAP to Delivery||77
11064189|NCT01029691|12245659|FG000|COMPLETED|Continued APAP to Delivery||20
11064190|NCT01029691|12245660|FG001|COMPLETED|Continued APAP to Delivery||16
11064191|NCT01029691|12245661|FG002|COMPLETED|Continued APAP to Delivery||76
11064192|NCT01029691|12245659|FG000|NOT COMPLETED|Continued APAP to Delivery||0
11064193|NCT01029691|12245660|FG001|NOT COMPLETED|Continued APAP to Delivery||0
11064194|NCT01029691|12245661|FG002|NOT COMPLETED|Continued APAP to Delivery||1
11064195|NCT01029704|12245679|FG000|STARTED|Overall Study||5
11064196|NCT01029704|12245680|FG001|STARTED|Overall Study||5
11064197|NCT01029704|12245681|FG002|STARTED|Overall Study||5
11064198|NCT01029704|12245682|FG003|STARTED|Overall Study||5
11064199|NCT01029704|12245683|FG004|STARTED|Overall Study||28
11064200|NCT01029704|12245684|FG005|STARTED|Overall Study||24
11064201|NCT01029704|12245685|FG006|STARTED|Overall Study||23
11064202|NCT01029704|12245686|FG007|STARTED|Overall Study||28
11064203|NCT01029704|12245687|FG008|STARTED|Overall Study||26
11064204|NCT01029704|12245679|FG000|COMPLETED|Overall Study||5
11064205|NCT01029704|12245680|FG001|COMPLETED|Overall Study||5
11064206|NCT01029704|12245681|FG002|COMPLETED|Overall Study||5
11064207|NCT01029704|12245682|FG003|COMPLETED|Overall Study||5
11064208|NCT01029704|12245683|FG004|COMPLETED|Overall Study||23
11064209|NCT01029704|12245684|FG005|COMPLETED|Overall Study||20
11064210|NCT01029704|12245685|FG006|COMPLETED|Overall Study||19
11064211|NCT01029704|12245686|FG007|COMPLETED|Overall Study||22
11064212|NCT01029704|12245687|FG008|COMPLETED|Overall Study||25
11064213|NCT01029704|12245679|FG000|NOT COMPLETED|Overall Study||0
11064214|NCT01029704|12245680|FG001|NOT COMPLETED|Overall Study||0
11064215|NCT01029704|12245681|FG002|NOT COMPLETED|Overall Study||0
11064216|NCT01029704|12245682|FG003|NOT COMPLETED|Overall Study||0
11064217|NCT01029704|12245683|FG004|NOT COMPLETED|Overall Study||5
11064218|NCT01029704|12245684|FG005|NOT COMPLETED|Overall Study||4
11064219|NCT01029704|12245685|FG006|NOT COMPLETED|Overall Study||4
11064220|NCT01029704|12245686|FG007|NOT COMPLETED|Overall Study||6
11064221|NCT01029704|12245687|FG008|NOT COMPLETED|Overall Study||1
11064222|NCT01029730|12245707|FG000|STARTED|Combination Therapy||55
11064223|NCT01029730|12245707|FG000|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
11064224|NCT01029730|12245707|FG000|NOT COMPLETED|Combination Therapy||16
11064225|NCT01029730|12245707|FG000|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
11064226|NCT01029730|12245707|FG000|COMPLETED|Maintenance Therapy||14
11064227|NCT01029730|12245707|FG000|NOT COMPLETED|Maintenance Therapy||23
11064228|NCT01029782|12245713|FG000|STARTED|Overall Study||102
11064229|NCT01029782|12245714|FG001|STARTED|Overall Study||104
11064230|NCT01029782|12245713|FG000|COMPLETED|Overall Study||99
11064231|NCT01029782|12245714|FG001|COMPLETED|Overall Study||96
11064232|NCT01029782|12245713|FG000|NOT COMPLETED|Overall Study||3
11064233|NCT01029782|12245714|FG001|NOT COMPLETED|Overall Study||8
11064234|NCT01029795|12245722|FG000|STARTED|Overall Study||16
11064235|NCT01029795|12245723|FG001|STARTED|Overall Study||22
11064236|NCT01029795|12245722|FG000|COMPLETED|Overall Study||0
11064237|NCT01029795|12245723|FG001|COMPLETED|Overall Study||0
11064238|NCT01029795|12245722|FG000|NOT COMPLETED|Overall Study||16
11064239|NCT01029795|12245723|FG001|NOT COMPLETED|Overall Study||22
11064240|NCT01029886|12245731|FG000|STARTED|Overall Study||461
11064241|NCT01029886|12245732|FG001|STARTED|Overall Study||451
11064242|NCT01029886|12245731|FG000|Intent to Treat (ITT)|Overall Study||461
11064243|NCT01029886|12245732|FG001|Intent to Treat (ITT)|Overall Study||450
11064244|NCT01029886|12245731|FG000|COMPLETED|Overall Study||400
11064245|NCT01029886|12245732|FG001|COMPLETED|Overall Study||391
11064246|NCT01029886|12245731|FG000|NOT COMPLETED|Overall Study||61
11064247|NCT01029886|12245732|FG001|NOT COMPLETED|Overall Study||60
11064248|NCT01029912|12245744|FG000|STARTED|Overall Study||14
11064249|NCT01029912|12245745|FG001|STARTED|Overall Study||12
11064250|NCT01029912|12245744|FG000|COMPLETED|Overall Study||12
11064251|NCT01029912|12245745|FG001|COMPLETED|Overall Study||12
11064252|NCT01029912|12245744|FG000|NOT COMPLETED|Overall Study||2
11064253|NCT01029912|12245745|FG001|NOT COMPLETED|Overall Study||0
11064254|NCT01029925|12245751|FG000|STARTED|Completion of Cycle 1 (28 Days)||7
11064255|NCT01029925|12245751|FG000|COMPLETED|Completion of Cycle 1 (28 Days)||3
11064256|NCT01029925|12245751|FG000|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
11064257|NCT01029925|12245751|FG000|STARTED|Completion of Cycle 2 (56 Days)||3
11064258|NCT01029925|12245751|FG000|COMPLETED|Completion of Cycle 2 (56 Days)||2
11064259|NCT01029925|12245751|FG000|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
11064260|NCT01030133|12245757|FG000|STARTED|Overall Study||14
11064261|NCT01030133|12245758|FG001|STARTED|Overall Study||14
11064262|NCT01030133|12245757|FG000|COMPLETED|Overall Study||12
11064263|NCT01030133|12245758|FG001|COMPLETED|Overall Study||12
11064264|NCT01030133|12245757|FG000|NOT COMPLETED|Overall Study||2
11205838|NCT01862536|12396757|FG001|COMPLETED|Overall Study||16
11064265|NCT01030133|12245758|FG001|NOT COMPLETED|Overall Study||2
11064266|NCT01030289|12245768|FG000|STARTED|Overall Study||9
11064267|NCT01030289|12245769|FG001|STARTED|Overall Study||10
11064268|NCT01030289|12245768|FG000|COMPLETED|Overall Study||9
11064269|NCT01030289|12245769|FG001|COMPLETED|Overall Study||10
11064270|NCT01030289|12245768|FG000|NOT COMPLETED|Overall Study||0
11064271|NCT01030289|12245769|FG001|NOT COMPLETED|Overall Study||0
11064272|NCT01030406|12245781|FG000|STARTED|Overall Study||10
11064273|NCT01030406|12245782|FG001|STARTED|Overall Study||10
11064274|NCT01030406|12245783|FG002|STARTED|Overall Study||10
11064275|NCT01030406|12245784|FG003|STARTED|Overall Study||10
11064276|NCT01030406|12245785|FG004|STARTED|Overall Study||9
11064277|NCT01030406|12245781|FG000|COMPLETED|Overall Study||10
11064278|NCT01030406|12245782|FG001|COMPLETED|Overall Study||10
11064279|NCT01030406|12245783|FG002|COMPLETED|Overall Study||9
11064280|NCT01030406|12245784|FG003|COMPLETED|Overall Study||9
11064281|NCT01030406|12245785|FG004|COMPLETED|Overall Study||9
11064282|NCT01030406|12245781|FG000|NOT COMPLETED|Overall Study||0
11064283|NCT01030406|12245782|FG001|NOT COMPLETED|Overall Study||0
11064284|NCT01030406|12245783|FG002|NOT COMPLETED|Overall Study||1
11064285|NCT01030406|12245784|FG003|NOT COMPLETED|Overall Study||1
11064286|NCT01030406|12245785|FG004|NOT COMPLETED|Overall Study||0
11064287|NCT01030458|12245799|FG000|STARTED|Overall Study||94
11064288|NCT01030458|12245800|FG001|STARTED|Overall Study||89
11064289|NCT01030458|12245799|FG000|COMPLETED|Overall Study||67
11064290|NCT01030458|12245800|FG001|COMPLETED|Overall Study||57
11064291|NCT01030458|12245799|FG000|NOT COMPLETED|Overall Study||27
11064292|NCT01030458|12245800|FG001|NOT COMPLETED|Overall Study||32
11064293|NCT01030523|12245808|FG000|STARTED|Overall Study||50
11064294|NCT01030523|12245809|FG001|STARTED|Overall Study||51
11064295|NCT01030523|12245808|FG000|COMPLETED|Overall Study||44
11064296|NCT01030523|12245809|FG001|COMPLETED|Overall Study||46
11064297|NCT01030523|12245808|FG000|NOT COMPLETED|Overall Study||6
11064298|NCT01030523|12245809|FG001|NOT COMPLETED|Overall Study||5
11064299|NCT01030536|12245820|FG000|STARTED|Overall Study||7
11064300|NCT01030536|12245821|FG001|STARTED|Overall Study||6
11064301|NCT01030536|12245822|FG002|STARTED|Overall Study||6
11064302|NCT01030536|12245823|FG003|STARTED|Overall Study||3
11064303|NCT01030536|12245824|FG004|STARTED|Overall Study||1
11064304|NCT01030536|12245820|FG000|COMPLETED|Overall Study||0
11064305|NCT01030536|12245821|FG001|COMPLETED|Overall Study||0
11064306|NCT01030536|12245822|FG002|COMPLETED|Overall Study||0
11064307|NCT01030536|12245823|FG003|COMPLETED|Overall Study||0
11064308|NCT01030536|12245824|FG004|COMPLETED|Overall Study||0
11064309|NCT01030536|12245820|FG000|NOT COMPLETED|Overall Study||7
11064310|NCT01030536|12245821|FG001|NOT COMPLETED|Overall Study||6
11064311|NCT01030536|12245822|FG002|NOT COMPLETED|Overall Study||6
11064312|NCT01030536|12245823|FG003|NOT COMPLETED|Overall Study||3
11064313|NCT01030536|12245824|FG004|NOT COMPLETED|Overall Study||1
11064314|NCT01030653|12245842|FG000|STARTED|Loading Dose & First Maintenance Regimen||4
11064315|NCT01030653|12245843|FG001|STARTED|Loading Dose & First Maintenance Regimen||4
11064316|NCT01030653|12245842|FG000|COMPLETED|Loading Dose & First Maintenance Regimen||4
11064317|NCT01030653|12245843|FG001|COMPLETED|Loading Dose & First Maintenance Regimen||4
11064318|NCT01030653|12245842|FG000|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
11064319|NCT01030653|12245843|FG001|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
11064320|NCT01030653|12245842|FG000|STARTED|7-Day Washout Period||4
11064321|NCT01030653|12245843|FG001|STARTED|7-Day Washout Period||4
11064322|NCT01030653|12245842|FG000|COMPLETED|7-Day Washout Period||4
11064323|NCT01030653|12245843|FG001|COMPLETED|7-Day Washout Period||4
11064324|NCT01030653|12245842|FG000|NOT COMPLETED|7-Day Washout Period||0
11064325|NCT01030653|12245843|FG001|NOT COMPLETED|7-Day Washout Period||0
11064326|NCT01030653|12245842|FG000|STARTED|Loading Dose & 2nd Maintenance Regimen||4
11064327|NCT01030653|12245843|FG001|STARTED|Loading Dose & 2nd Maintenance Regimen||4
11064328|NCT01030653|12245842|FG000|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
11064329|NCT01030653|12245843|FG001|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
11064330|NCT01030653|12245842|FG000|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
11064331|NCT01030653|12245843|FG001|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
11064332|NCT01030666|12245852|FG000|STARTED|Overall Study||28
11064333|NCT01030666|12245853|FG001|STARTED|Overall Study||33
11064334|NCT01030666|12245852|FG000|COMPLETED|Overall Study||25
11064335|NCT01030666|12245853|FG001|COMPLETED|Overall Study||31
11064336|NCT01030666|12245852|FG000|NOT COMPLETED|Overall Study||3
11064337|NCT01030666|12245853|FG001|NOT COMPLETED|Overall Study||2
11064338|NCT01030718|12245863|FG000|STARTED|Studies CA180-031 and -036 Combined||30
11064339|NCT01030718|12245864|FG001|STARTED|Studies CA180-031 and -036 Combined||11
11064340|NCT01030718|12245865|FG002|STARTED|Studies CA180-031 and -036 Combined||13
11064341|NCT01030718|12245863|FG000|COMPLETED|Studies CA180-031 and -036 Combined||26
11064342|NCT01030718|12245864|FG001|COMPLETED|Studies CA180-031 and -036 Combined||2
11064343|NCT01030718|12245865|FG002|COMPLETED|Studies CA180-031 and -036 Combined||1
11064344|NCT01030718|12245863|FG000|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
11064345|NCT01030718|12245864|FG001|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
11064346|NCT01030718|12245865|FG002|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
11064347|NCT01030718|12245863|FG000|STARTED|Study CA180-036 Only||29
11064348|NCT01030718|12245864|FG001|STARTED|Study CA180-036 Only||9
11064349|NCT01030718|12245865|FG002|STARTED|Study CA180-036 Only||6
11064350|NCT01030718|12245863|FG000|COMPLETED|Study CA180-036 Only||26
11064351|NCT01030718|12245864|FG001|COMPLETED|Study CA180-036 Only||2
11064352|NCT01030718|12245865|FG002|COMPLETED|Study CA180-036 Only||1
11064353|NCT01030718|12245863|FG000|NOT COMPLETED|Study CA180-036 Only||3
11064354|NCT01030718|12245864|FG001|NOT COMPLETED|Study CA180-036 Only||7
11064355|NCT01030718|12245865|FG002|NOT COMPLETED|Study CA180-036 Only||5
11064356|NCT01030783|12245885|FG000|STARTED|Overall Study||260
11064357|NCT01030783|12245886|FG001|STARTED|Overall Study||257
11064358|NCT01030783|12245885|FG000|COMPLETED|Overall Study||211
11064359|NCT01030783|12245886|FG001|COMPLETED|Overall Study||231
11064360|NCT01030783|12245885|FG000|NOT COMPLETED|Overall Study||49
11064361|NCT01030783|12245886|FG001|NOT COMPLETED|Overall Study||26
11064362|NCT01030822|12245895|FG000|STARTED|Overall Study||100
11064363|NCT01030822|12245896|FG001|STARTED|Overall Study||95
11064364|NCT01030822|12245897|FG002|STARTED|Overall Study||87
11064365|NCT01030822|12245895|FG000|COMPLETED|Overall Study||69
11064366|NCT01030822|12245896|FG001|COMPLETED|Overall Study||71
11064367|NCT01030822|12245897|FG002|COMPLETED|Overall Study||61
11064368|NCT01030822|12245895|FG000|NOT COMPLETED|Overall Study||31
11064369|NCT01030822|12245896|FG001|NOT COMPLETED|Overall Study||24
11064370|NCT01030822|12245897|FG002|NOT COMPLETED|Overall Study||26
11064371|NCT01030861|12245908|FG000|STARTED|Overall Study||44
11064372|NCT01030861|12245909|FG001|STARTED|Overall Study||32
11064373|NCT01030861|12245908|FG000|COMPLETED|Overall Study||44
11064374|NCT01030861|12245909|FG001|COMPLETED|Overall Study||32
11064375|NCT01030861|12245908|FG000|NOT COMPLETED|Overall Study||0
11064376|NCT01030861|12245909|FG001|NOT COMPLETED|Overall Study||0
11064377|NCT01030874|12245917|FG000|STARTED|Overall Study|1 with impaired decision making capacity|178
11064378|NCT01030874|12245918|FG001|STARTED|Overall Study|1 with impaired decision making capacity|178
11064379|NCT01030874|12245917|FG000|COMPLETED|Overall Study||160
11064380|NCT01030874|12245918|FG001|COMPLETED|Overall Study||162
11064381|NCT01030874|12245917|FG000|NOT COMPLETED|Overall Study||18
11064382|NCT01030874|12245918|FG001|NOT COMPLETED|Overall Study||16
11064383|NCT01030952|12245926|FG000|STARTED|Overall Study||51
11064384|NCT01030952|12245927|FG001|STARTED|Overall Study||52
11064385|NCT01030952|12245926|FG000|COMPLETED|Overall Study||49
11064386|NCT01030952|12245927|FG001|COMPLETED|Overall Study||49
11064387|NCT01030952|12245926|FG000|NOT COMPLETED|Overall Study||2
11064388|NCT01030952|12245927|FG001|NOT COMPLETED|Overall Study||3
11064389|NCT01030965|12245939|FG000|STARTED|Overall Study||71
11345607|NCT02969655|12542669|FG000|STARTED|Overall Study||136
11345608|NCT02969655|12542670|FG001|STARTED|Overall Study||135
11345609|NCT02969655|12542669|FG000|COMPLETED|Overall Study||115
11345610|NCT02969655|12542670|FG001|COMPLETED|Overall Study||120
11345611|NCT02969655|12542669|FG000|NOT COMPLETED|Overall Study||21
11345612|NCT02969655|12542670|FG001|NOT COMPLETED|Overall Study||15
11345613|NCT02969707|12542679|FG000|STARTED|Overall Study||49
11064390|NCT01030965|12245940|FG001|STARTED|Overall Study||71
11064391|NCT01030965|12245941|FG002|STARTED|Overall Study||72
11064392|NCT01030965|12245942|FG003|STARTED|Overall Study||71
11064393|NCT01030965|12245939|FG000|COMPLETED|Overall Study||67
11345614|NCT02969707|12542680|FG001|STARTED|Overall Study||52
11345615|NCT02969707|12542679|FG000|COMPLETED|Overall Study||41
11345616|NCT02969707|12542680|FG001|COMPLETED|Overall Study||44
11345617|NCT02969707|12542679|FG000|NOT COMPLETED|Overall Study||8
11345618|NCT02969707|12542680|FG001|NOT COMPLETED|Overall Study||8
11345619|NCT02969863|12542691|FG000|STARTED|Overall Study||4
11345620|NCT02969863|12542692|FG001|STARTED|Overall Study||4
11345621|NCT02969863|12542693|FG002|STARTED|Overall Study||4
11064394|NCT01030965|12245940|FG001|COMPLETED|Overall Study||65
11064395|NCT01030965|12245941|FG002|COMPLETED|Overall Study||68
11064396|NCT01030965|12245942|FG003|COMPLETED|Overall Study||64
11345622|NCT02969863|12542694|FG003|STARTED|Overall Study||4
11345623|NCT02969863|12542695|FG004|STARTED|Overall Study||4
11345624|NCT02969863|12542696|FG005|STARTED|Overall Study||4
11064397|NCT01030965|12245939|FG000|NOT COMPLETED|Overall Study||4
11064398|NCT01030965|12245940|FG001|NOT COMPLETED|Overall Study||6
11064399|NCT01030965|12245941|FG002|NOT COMPLETED|Overall Study||4
11064400|NCT01030965|12245942|FG003|NOT COMPLETED|Overall Study||7
11064401|NCT01031004|12245954|FG000|STARTED|Overall Study||25
11064402|NCT01031004|12245955|FG001|STARTED|Overall Study||25
11064403|NCT01031004|12245954|FG000|COMPLETED|Overall Study||24
11064404|NCT01031004|12245955|FG001|COMPLETED|Overall Study||24
11064405|NCT01031004|12245954|FG000|NOT COMPLETED|Overall Study||1
11064406|NCT01031004|12245955|FG001|NOT COMPLETED|Overall Study||1
11064407|NCT01031043|12245961|FG000|STARTED|Overall Study||5
11345625|NCT02969863|12542691|FG000|COMPLETED|Overall Study||3
11345626|NCT02969863|12542692|FG001|COMPLETED|Overall Study||4
11064408|NCT01031043|12245961|FG000|COMPLETED|Overall Study||4
11064409|NCT01031043|12245961|FG000|NOT COMPLETED|Overall Study||1
11064410|NCT01031069|12245969|FG000|STARTED|Overall Study||129
11064411|NCT01031069|12245970|FG001|STARTED|Overall Study||128
11064412|NCT01031069|12245971|FG002|STARTED|Overall Study||144
11064413|NCT01031069|12245972|FG003|STARTED|Overall Study||145
11064414|NCT01031069|12245969|FG000|COMPLETED|Overall Study||117
11064415|NCT01031069|12245970|FG001|COMPLETED|Overall Study||117
11064416|NCT01031069|12245971|FG002|COMPLETED|Overall Study||103
11064417|NCT01031069|12245972|FG003|COMPLETED|Overall Study||111
11064418|NCT01031069|12245969|FG000|NOT COMPLETED|Overall Study||12
11064419|NCT01031069|12245970|FG001|NOT COMPLETED|Overall Study||11
11064420|NCT01031069|12245971|FG002|NOT COMPLETED|Overall Study||41
11064421|NCT01031069|12245972|FG003|NOT COMPLETED|Overall Study||34
11064422|NCT01031095|12245986|FG000|STARTED|Overall Study||100
11064423|NCT01031095|12245987|FG001|STARTED|Overall Study||100
11064424|NCT01031095|12245986|FG000|COMPLETED|Overall Study||100
11064425|NCT01031095|12245987|FG001|COMPLETED|Overall Study||100
11064426|NCT01031095|12245986|FG000|NOT COMPLETED|Overall Study||0
11064427|NCT01031095|12245987|FG001|NOT COMPLETED|Overall Study||0
11064428|NCT01031134|12245995|FG000|STARTED|Overall Study||114
11064429|NCT01031134|12245996|FG001|STARTED|Overall Study||88
11064430|NCT01031134|12245995|FG000|COMPLETED|Overall Study||103
11064431|NCT01031134|12245996|FG001|COMPLETED|Overall Study||78
11064432|NCT01031134|12245995|FG000|NOT COMPLETED|Overall Study||11
11064433|NCT01031134|12245996|FG001|NOT COMPLETED|Overall Study||10
11064434|NCT01031381|12246002|FG000|STARTED|Overall Study||59
11064435|NCT01031381|12246002|FG000|COMPLETED|Overall Study||50
11064436|NCT01031381|12246002|FG000|NOT COMPLETED|Overall Study||9
11064437|NCT01031420|12246007|FG000|STARTED|Overall Study||54
11064438|NCT01031420|12246007|FG000|COMPLETED|Overall Study||44
11064439|NCT01031420|12246007|FG000|NOT COMPLETED|Overall Study||10
11064440|NCT01031446|12246011|FG000|STARTED|Overall Study||55
11064441|NCT01031446|12246011|FG000|COMPLETED|Overall Study||0
11064442|NCT01031446|12246011|FG000|NOT COMPLETED|Overall Study||55
11064443|NCT01031498|12246020|FG000|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
11064444|NCT01031498|12246021|FG001|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
11064445|NCT01031498|12246022|FG002|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
11064446|NCT01031498|12246020|FG000|COMPLETED|Overall Study||47
11064447|NCT01031498|12246021|FG001|COMPLETED|Overall Study||48
11064448|NCT01031498|12246022|FG002|COMPLETED|Overall Study||48
11064449|NCT01031498|12246020|FG000|NOT COMPLETED|Overall Study||2
11064450|NCT01031498|12246021|FG001|NOT COMPLETED|Overall Study||3
11064451|NCT01031498|12246022|FG002|NOT COMPLETED|Overall Study||2
11064452|NCT01031537|12246030|FG000|STARTED|Overall Study||66
11064453|NCT01031537|12246030|FG000|COMPLETED|Overall Study||34
11064454|NCT01031537|12246030|FG000|NOT COMPLETED|Overall Study||32
11064455|NCT01031680|12246036|FG000|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
11064456|NCT01031680|12246037|FG001|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
11064457|NCT01031680|12246036|FG000|COMPLETED|Overall Study||403
11064458|NCT01031680|12246037|FG001|COMPLETED|Overall Study||404
11064459|NCT01031680|12246036|FG000|NOT COMPLETED|Overall Study||57
11064460|NCT01031680|12246037|FG001|NOT COMPLETED|Overall Study||58
11064461|NCT01031706|12246045|FG000|STARTED|Overall Study||14
11064462|NCT01031706|12246046|FG001|STARTED|Overall Study||9
11064463|NCT01031706|12246045|FG000|COMPLETED|Overall Study||12
11064464|NCT01031706|12246046|FG001|COMPLETED|Overall Study||8
11064465|NCT01031706|12246045|FG000|NOT COMPLETED|Overall Study||2
11064466|NCT01031706|12246046|FG001|NOT COMPLETED|Overall Study||1
11064467|NCT01031810|12246052|FG000|STARTED|Overall Study||13
11064468|NCT01031810|12246052|FG000|COMPLETED|Overall Study||9
11064469|NCT01031810|12246052|FG000|NOT COMPLETED|Overall Study||4
11064470|NCT01031836|12246064|FG000|STARTED|Stage I||5
11064471|NCT01031836|12246065|FG001|STARTED|Stage I||5
11064472|NCT01031836|12246066|FG002|STARTED|Stage I||5
11064473|NCT01031836|12246067|FG003|STARTED|Stage I||5
11064474|NCT01031836|12246068|FG004|STARTED|Stage I||5
11064475|NCT01031836|12246069|FG005|STARTED|Stage I||5
11064476|NCT01031836|12246064|FG000|COMPLETED|Stage I||4
11064477|NCT01031836|12246065|FG001|COMPLETED|Stage I||3
11064478|NCT01031836|12246066|FG002|COMPLETED|Stage I||5
11064479|NCT01031836|12246067|FG003|COMPLETED|Stage I||5
11064480|NCT01031836|12246068|FG004|COMPLETED|Stage I||5
11064481|NCT01031836|12246069|FG005|COMPLETED|Stage I||4
11064482|NCT01031836|12246064|FG000|NOT COMPLETED|Stage I||1
11064483|NCT01031836|12246065|FG001|NOT COMPLETED|Stage I||2
11064484|NCT01031836|12246066|FG002|NOT COMPLETED|Stage I||0
11064485|NCT01031836|12246067|FG003|NOT COMPLETED|Stage I||0
11064486|NCT01031836|12246068|FG004|NOT COMPLETED|Stage I||0
11064487|NCT01031836|12246069|FG005|NOT COMPLETED|Stage I||1
11064488|NCT01031836|12246064|FG000|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
11064489|NCT01031836|12246065|FG001|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
11064490|NCT01031836|12246066|FG002|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
11064491|NCT01031836|12246067|FG003|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
11064492|NCT01031836|12246068|FG004|STARTED|Stage II||5
11064493|NCT01031836|12246069|FG005|STARTED|Stage II||4
11064494|NCT01031836|12246064|FG000|COMPLETED|Stage II||1
11064495|NCT01031836|12246065|FG001|COMPLETED|Stage II||1
11064496|NCT01031836|12246066|FG002|COMPLETED|Stage II||2
11064497|NCT01031836|12246067|FG003|COMPLETED|Stage II||1
11064498|NCT01031836|12246068|FG004|COMPLETED|Stage II||3
11064499|NCT01031836|12246069|FG005|COMPLETED|Stage II||3
11064500|NCT01031836|12246064|FG000|NOT COMPLETED|Stage II||2
11064501|NCT01031836|12246065|FG001|NOT COMPLETED|Stage II||0
11064502|NCT01031836|12246066|FG002|NOT COMPLETED|Stage II||2
11064503|NCT01031836|12246067|FG003|NOT COMPLETED|Stage II||3
11064504|NCT01031836|12246068|FG004|NOT COMPLETED|Stage II||2
11064505|NCT01031836|12246069|FG005|NOT COMPLETED|Stage II||1
11064506|NCT01031914|12246083|FG000|STARTED|Overall Study||36
11064507|NCT01031914|12246083|FG000|COMPLETED|Overall Study||36
11064508|NCT01031914|12246083|FG000|NOT COMPLETED|Overall Study||0
11064509|NCT01031953|12246087|FG000|STARTED|Overall Study||11
11064510|NCT01031953|12246087|FG000|COMPLETED|Overall Study||11
11064511|NCT01031953|12246087|FG000|NOT COMPLETED|Overall Study||0
11064512|NCT01031979|12246099|FG000|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
11064513|NCT01031979|12246100|FG001|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
11064514|NCT01031979|12246099|FG000|Completed Primary Outcome Measure|Overall Study||12
11064515|NCT01031979|12246100|FG001|Completed Primary Outcome Measure|Overall Study||12
11064516|NCT01031979|12246099|FG000|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
11064517|NCT01031979|12246100|FG001|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
11064518|NCT01031979|12246099|FG000|NOT COMPLETED|Overall Study||5
11064519|NCT01031979|12246100|FG001|NOT COMPLETED|Overall Study||4
11064520|NCT01032018|12246108|FG000|STARTED|Overall Study||77
11064521|NCT01032018|12246109|FG001|STARTED|Overall Study||73
11064522|NCT01032018|12246108|FG000|COMPLETED|Overall Study||71
11064523|NCT01032018|12246109|FG001|COMPLETED|Overall Study||67
11064524|NCT01032018|12246108|FG000|NOT COMPLETED|Overall Study||6
11064525|NCT01032018|12246109|FG001|NOT COMPLETED|Overall Study||6
11064526|NCT01032044|12246117|FG000|STARTED|Overall Study||82
11064527|NCT01032044|12246118|FG001|STARTED|Overall Study||82
11064528|NCT01032044|12246117|FG000|Procedure|Overall Study||74
11064529|NCT01032044|12246118|FG001|Procedure|Overall Study||75
11345627|NCT02969863|12542693|FG002|COMPLETED|Overall Study||4
11345628|NCT02969863|12542694|FG003|COMPLETED|Overall Study||4
11345629|NCT02969863|12542695|FG004|COMPLETED|Overall Study||4
11345630|NCT02969863|12542696|FG005|COMPLETED|Overall Study||4
11345631|NCT02969863|12542691|FG000|NOT COMPLETED|Overall Study||1
11345632|NCT02969863|12542692|FG001|NOT COMPLETED|Overall Study||0
11345633|NCT02969863|12542693|FG002|NOT COMPLETED|Overall Study||0
11345634|NCT02969863|12542694|FG003|NOT COMPLETED|Overall Study||0
11345635|NCT02969863|12542695|FG004|NOT COMPLETED|Overall Study||0
11345636|NCT02969863|12542696|FG005|NOT COMPLETED|Overall Study||0
11345637|NCT02969876|12542710|FG000|STARTED|Overall Study||2
11345638|NCT02969876|12542710|FG000|COMPLETED|Overall Study||2
11345639|NCT02969876|12542710|FG000|NOT COMPLETED|Overall Study||0
11345640|NCT02970006|12542715|FG000|STARTED|Overall Study||15
11345641|NCT02970006|12542715|FG000|COMPLETED|Overall Study||14
11345642|NCT02970006|12542715|FG000|NOT COMPLETED|Overall Study||1
11345643|NCT02970032|12542719|FG000|STARTED|Standard Heparin Dose||20
11345644|NCT02970032|12542719|FG000|COMPLETED|Standard Heparin Dose||20
11345645|NCT02970032|12542719|FG000|NOT COMPLETED|Standard Heparin Dose||0
11345646|NCT02970032|12542719|FG000|STARTED|Real Time Heparin Dose Adjustment||20
11345647|NCT02970032|12542719|FG000|COMPLETED|Real Time Heparin Dose Adjustment||20
11345648|NCT02970032|12542719|FG000|NOT COMPLETED|Real Time Heparin Dose Adjustment||0
11345649|NCT02970162|12542726|FG000|STARTED|Overall Study||13
11345650|NCT02970162|12542727|FG001|STARTED|Overall Study||13
11345651|NCT02970162|12542726|FG000|COMPLETED|Overall Study||13
11345652|NCT02970162|12542727|FG001|COMPLETED|Overall Study||13
11345653|NCT02970162|12542726|FG000|NOT COMPLETED|Overall Study||0
11345654|NCT02970162|12542727|FG001|NOT COMPLETED|Overall Study||0
11345655|NCT02970292|12542735|FG000|STARTED|Overall Study||198
11345656|NCT02970292|12542736|FG001|STARTED|Overall Study||198
11345657|NCT02970292|12542735|FG000|COMPLETED|Overall Study||174
11345658|NCT02970292|12542736|FG001|COMPLETED|Overall Study||190
11345659|NCT02970292|12542735|FG000|NOT COMPLETED|Overall Study||24
11345660|NCT02970292|12542736|FG001|NOT COMPLETED|Overall Study||8
11345661|NCT02970305|12542744|FG000|STARTED|Overall Study||201
11345662|NCT02970305|12542745|FG001|STARTED|Overall Study||202
11345663|NCT02970305|12542744|FG000|COMPLETED|Overall Study||172
11345664|NCT02970305|12542745|FG001|COMPLETED|Overall Study||174
11345665|NCT02970305|12542744|FG000|NOT COMPLETED|Overall Study||29
11064530|NCT01032044|12246117|FG000|COMPLETED|Overall Study||57
11064531|NCT01032044|12246118|FG001|COMPLETED|Overall Study||62
11064532|NCT01032044|12246117|FG000|NOT COMPLETED|Overall Study||25
11064533|NCT01032044|12246118|FG001|NOT COMPLETED|Overall Study||20
11064534|NCT01032070|12246126|FG000|STARTED|Overall Study||13
11064535|NCT01032070|12246127|FG001|STARTED|Overall Study||12
11064536|NCT01032070|12246126|FG000|COMPLETED|Overall Study||0
11064537|NCT01032070|12246127|FG001|COMPLETED|Overall Study||0
11064538|NCT01032070|12246126|FG000|NOT COMPLETED|Overall Study||13
11345666|NCT02970305|12542745|FG001|NOT COMPLETED|Overall Study||28
11345667|NCT02970422|12542751|FG000|STARTED|Overall Study||200
11345668|NCT02970422|12542751|FG000|COMPLETED|Overall Study||200
11345669|NCT02970422|12542751|FG000|NOT COMPLETED|Overall Study||0
11345670|NCT02970552|12542776|FG000|STARTED|Overall Study||70
11345671|NCT02970552|12542777|FG001|STARTED|Overall Study||70
11064539|NCT01032070|12246127|FG001|NOT COMPLETED|Overall Study||12
11064540|NCT01032135|12246138|FG000|STARTED|2 Week Randomization||311
11064541|NCT01032135|12246139|FG001|STARTED|2 Week Randomization||93
11064542|NCT01032135|12246140|FG002|STARTED|2 Week Randomization||96
11064543|NCT01032135|12246141|FG003|STARTED|2 Week Randomization||0
11064544|NCT01032135|12246142|FG004|STARTED|2 Week Randomization||0
11064545|NCT01032135|12246143|FG005|STARTED|2 Week Randomization||0
11064546|NCT01032135|12246144|FG006|STARTED|2 Week Randomization||0
11064547|NCT01032135|12246138|FG000|COMPLETED|2 Week Randomization||311
11064548|NCT01032135|12246139|FG001|COMPLETED|2 Week Randomization||93
11064549|NCT01032135|12246140|FG002|COMPLETED|2 Week Randomization||96
11064550|NCT01032135|12246141|FG003|COMPLETED|2 Week Randomization||0
11064551|NCT01032135|12246142|FG004|COMPLETED|2 Week Randomization||0
11064552|NCT01032135|12246143|FG005|COMPLETED|2 Week Randomization||0
11064553|NCT01032135|12246144|FG006|COMPLETED|2 Week Randomization||0
11064554|NCT01032135|12246138|FG000|NOT COMPLETED|2 Week Randomization||0
11064555|NCT01032135|12246139|FG001|NOT COMPLETED|2 Week Randomization||0
11064556|NCT01032135|12246140|FG002|NOT COMPLETED|2 Week Randomization||0
11064557|NCT01032135|12246141|FG003|NOT COMPLETED|2 Week Randomization||0
11064558|NCT01032135|12246142|FG004|NOT COMPLETED|2 Week Randomization||0
11064559|NCT01032135|12246143|FG005|NOT COMPLETED|2 Week Randomization||0
11064560|NCT01032135|12246144|FG006|NOT COMPLETED|2 Week Randomization||0
11064561|NCT01032135|12246138|FG000|STARTED|8 Week Randomization||227
11064562|NCT01032135|12246139|FG001|STARTED|8 Week Randomization||0
11064563|NCT01032135|12246140|FG002|STARTED|8 Week Randomization||0
11064564|NCT01032135|12246141|FG003|STARTED|8 Week Randomization||41
11064565|NCT01032135|12246142|FG004|STARTED|8 Week Randomization||43
11064566|NCT01032135|12246143|FG005|STARTED|8 Week Randomization||48
11064567|NCT01032135|12246144|FG006|STARTED|8 Week Randomization||54
11064568|NCT01032135|12246138|FG000|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
11064569|NCT01032135|12246139|FG001|12 Week Follow up|8 Week Randomization||0
11064570|NCT01032135|12246140|FG002|12 Week Follow up|8 Week Randomization||0
11064571|NCT01032135|12246141|FG003|12 Week Follow up|8 Week Randomization||34
11064572|NCT01032135|12246142|FG004|12 Week Follow up|8 Week Randomization||38
11064573|NCT01032135|12246143|FG005|12 Week Follow up|8 Week Randomization||36
11064574|NCT01032135|12246144|FG006|12 Week Follow up|8 Week Randomization||41
11064575|NCT01032135|12246138|FG000|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
11064576|NCT01032135|12246139|FG001|COMPLETED|8 Week Randomization||0
11064577|NCT01032135|12246140|FG002|COMPLETED|8 Week Randomization||0
11064578|NCT01032135|12246141|FG003|COMPLETED|8 Week Randomization||30
11064579|NCT01032135|12246142|FG004|COMPLETED|8 Week Randomization||34
11064580|NCT01032135|12246143|FG005|COMPLETED|8 Week Randomization||31
11064581|NCT01032135|12246144|FG006|COMPLETED|8 Week Randomization||36
11064582|NCT01032135|12246138|FG000|NOT COMPLETED|8 Week Randomization||26
11064583|NCT01032135|12246139|FG001|NOT COMPLETED|8 Week Randomization||0
11064584|NCT01032135|12246140|FG002|NOT COMPLETED|8 Week Randomization||0
11064585|NCT01032135|12246141|FG003|NOT COMPLETED|8 Week Randomization||11
11064586|NCT01032135|12246142|FG004|NOT COMPLETED|8 Week Randomization||9
11064587|NCT01032135|12246143|FG005|NOT COMPLETED|8 Week Randomization||17
11064588|NCT01032135|12246144|FG006|NOT COMPLETED|8 Week Randomization||18
11064589|NCT01032174|12246160|FG000|STARTED|Overall Study||63
11064590|NCT01032174|12246161|FG001|STARTED|Overall Study||60
11064591|NCT01032174|12246160|FG000|COMPLETED|Overall Study||63
11064592|NCT01032174|12246161|FG001|COMPLETED|Overall Study||59
11064593|NCT01032174|12246160|FG000|NOT COMPLETED|Overall Study||0
11064594|NCT01032174|12246161|FG001|NOT COMPLETED|Overall Study||1
11064595|NCT01032200|12246169|FG000|STARTED|Overall Study||26
11064596|NCT01032200|12246170|FG001|STARTED|Overall Study||28
11064597|NCT01032200|12246169|FG000|COMPLETED|Overall Study||22
11064598|NCT01032200|12246170|FG001|COMPLETED|Overall Study||21
11064599|NCT01032200|12246169|FG000|NOT COMPLETED|Overall Study||4
11064600|NCT01032200|12246170|FG001|NOT COMPLETED|Overall Study||7
11064601|NCT01032239|12246178|FG000|STARTED|Overall Study|randomized to ITB arm|31
11064602|NCT01032239|12246179|FG001|STARTED|Overall Study|randomized to BMT arm|29
11064603|NCT01032239|12246178|FG000|Implant|Overall Study|implanted|25
11064604|NCT01032239|12246179|FG001|Implant|Overall Study||0
11064605|NCT01032239|12246178|FG000|COMPLETED|Overall Study||24
11064606|NCT01032239|12246179|FG001|COMPLETED|Overall Study||24
11064607|NCT01032239|12246178|FG000|NOT COMPLETED|Overall Study||7
11064608|NCT01032239|12246179|FG001|NOT COMPLETED|Overall Study||5
11064609|NCT01032291|12246188|FG000|STARTED|Safety Lead-in||8
11064610|NCT01032291|12246189|FG001|STARTED|Safety Lead-in||0
11064611|NCT01032291|12246190|FG002|STARTED|Safety Lead-in||0
11064612|NCT01032291|12246188|FG000|COMPLETED|Safety Lead-in|Participants with disease progression|6
11064613|NCT01032291|12246189|FG001|COMPLETED|Safety Lead-in||0
11064614|NCT01032291|12246190|FG002|COMPLETED|Safety Lead-in||0
11064615|NCT01032291|12246188|FG000|NOT COMPLETED|Safety Lead-in||2
11064616|NCT01032291|12246189|FG001|NOT COMPLETED|Safety Lead-in||0
11064617|NCT01032291|12246190|FG002|NOT COMPLETED|Safety Lead-in||0
11064618|NCT01032291|12246188|FG000|STARTED|Proof of Concept||0
11064619|NCT01032291|12246189|FG001|STARTED|Proof of Concept||22
11064620|NCT01032291|12246190|FG002|STARTED|Proof of Concept||21
11064621|NCT01032291|12246188|FG000|Intent to Treat and Safety Populations|Proof of Concept||0
11064622|NCT01032291|12246189|FG001|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
11064623|NCT01032291|12246190|FG002|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
11064624|NCT01032291|12246188|FG000|COMPLETED|Proof of Concept||0
11064625|NCT01032291|12246189|FG001|COMPLETED|Proof of Concept|Participants with disease progression|14
11064626|NCT01032291|12246190|FG002|COMPLETED|Proof of Concept|Participants with disease progression|18
11064627|NCT01032291|12246188|FG000|NOT COMPLETED|Proof of Concept||0
11064628|NCT01032291|12246189|FG001|NOT COMPLETED|Proof of Concept||8
11064629|NCT01032291|12246190|FG002|NOT COMPLETED|Proof of Concept||3
11064630|NCT01032330|12246205|FG000|STARTED|Overall Study||183
11064631|NCT01032330|12246206|FG001|STARTED|Overall Study||175
11064632|NCT01032330|12246207|FG002|STARTED|Overall Study||97
11064633|NCT01032330|12246208|FG003|STARTED|Overall Study||104
11064634|NCT01032330|12246205|FG000|COMPLETED|Overall Study||165
11064635|NCT01032330|12246206|FG001|COMPLETED|Overall Study||151
11064636|NCT01032330|12246207|FG002|COMPLETED|Overall Study||87
11064637|NCT01032330|12246208|FG003|COMPLETED|Overall Study||90
11064638|NCT01032330|12246205|FG000|NOT COMPLETED|Overall Study||18
11064639|NCT01032330|12246206|FG001|NOT COMPLETED|Overall Study||24
11064640|NCT01032330|12246207|FG002|NOT COMPLETED|Overall Study||10
11064641|NCT01032330|12246208|FG003|NOT COMPLETED|Overall Study||14
11064642|NCT01032382|12246228|FG000|STARTED|Overall Study||16
11064643|NCT01032382|12246229|FG001|STARTED|Overall Study||14
11064644|NCT01032382|12246228|FG000|COMPLETED|Overall Study||11
11064645|NCT01032382|12246229|FG001|COMPLETED|Overall Study||9
11064646|NCT01032382|12246228|FG000|NOT COMPLETED|Overall Study||5
11064647|NCT01032382|12246229|FG001|NOT COMPLETED|Overall Study||5
11064648|NCT01032538|12246235|FG000|STARTED|Overall Study|Knees|99
11064649|NCT01032538|12246235|FG000|COMPLETED|Overall Study|Knees|99
11064650|NCT01032538|12246235|FG000|NOT COMPLETED|Overall Study||0
11064651|NCT01032629|12246244|FG000|STARTED|Overall Study||1442
11064652|NCT01032629|12246245|FG001|STARTED|Overall Study||1445
11064653|NCT01032629|12246246|FG002|STARTED|Overall Study||1443
11064654|NCT01032629|12246244|FG000|Treated|Overall Study||1441
11064655|NCT01032629|12246245|FG001|Treated|Overall Study||1445
11064656|NCT01032629|12246246|FG002|Treated|Overall Study||1441
11064657|NCT01032629|12246244|FG000|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
11064658|NCT01032629|12246245|FG001|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
11064659|NCT01032629|12246246|FG002|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
11064660|NCT01032629|12246244|FG000|NOT COMPLETED|Overall Study||145
11064661|NCT01032629|12246245|FG001|NOT COMPLETED|Overall Study||101
11064662|NCT01032629|12246246|FG002|NOT COMPLETED|Overall Study||88
11064663|NCT01032694|12246257|FG000|STARTED|Overall Study||20
11064664|NCT01032694|12246258|FG001|STARTED|Overall Study||10
11064665|NCT01032694|12246257|FG000|COMPLETED|Overall Study||20
11064666|NCT01032694|12246258|FG001|COMPLETED|Overall Study||10
11064667|NCT01032694|12246257|FG000|NOT COMPLETED|Overall Study||0
11064668|NCT01032694|12246258|FG001|NOT COMPLETED|Overall Study||0
11064669|NCT01032733|12246266|FG000|STARTED|Overall Study||17
11064670|NCT01032733|12246267|FG001|STARTED|Overall Study||17
11064671|NCT01032733|12246266|FG000|COMPLETED|Overall Study||16
11064672|NCT01032733|12246267|FG001|COMPLETED|Overall Study||16
11064673|NCT01032733|12246266|FG000|NOT COMPLETED|Overall Study||1
11064674|NCT01032733|12246267|FG001|NOT COMPLETED|Overall Study||1
11064675|NCT01032759|12246276|FG000|STARTED|Overall Study||32
11064676|NCT01032759|12246277|FG001|STARTED|Overall Study||31
11064677|NCT01032759|12246276|FG000|Completed 24 Hour Assessment|Overall Study||32
11064678|NCT01032759|12246277|FG001|Completed 24 Hour Assessment|Overall Study||30
11064679|NCT01032759|12246276|FG000|Completed 48 Hour Assessment|Overall Study||31
11064680|NCT01032759|12246277|FG001|Completed 48 Hour Assessment|Overall Study||28
11064681|NCT01032759|12246276|FG000|COMPLETED|Overall Study||31
11064682|NCT01032759|12246277|FG001|COMPLETED|Overall Study||28
11064683|NCT01032759|12246276|FG000|NOT COMPLETED|Overall Study||1
11064684|NCT01032759|12246277|FG001|NOT COMPLETED|Overall Study||3
11064685|NCT01032837|12246287|FG000|STARTED|Overall Study||26
11064686|NCT01032837|12246288|FG001|STARTED|Overall Study||26
11064687|NCT01032837|12246289|FG002|STARTED|Overall Study||25
11064688|NCT01032837|12246290|FG003|STARTED|Overall Study||25
11064689|NCT01032837|12246287|FG000|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
11064690|NCT01032837|12246288|FG001|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
11064691|NCT01032837|12246289|FG002|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
11064692|NCT01032837|12246290|FG003|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
11205839|NCT01862536|12396756|FG000|NOT COMPLETED|Overall Study||3
11205840|NCT01862536|12396757|FG001|NOT COMPLETED|Overall Study||7
11205841|NCT01862614|12396765|FG000|STARTED|First Appointment.|Received articaine injection at first appointment.|40
11205842|NCT01862614|12396766|FG001|STARTED|First Appointment.|Received buffered articaine at first appointment.|40
11205843|NCT01862614|12396765|FG000|COMPLETED|First Appointment.||40
11205844|NCT01862614|12396766|FG001|COMPLETED|First Appointment.||40
11205845|NCT01862614|12396765|FG000|NOT COMPLETED|First Appointment.||0
11205846|NCT01862614|12396766|FG001|NOT COMPLETED|First Appointment.||0
11205847|NCT01862614|12396765|FG000|STARTED|2 Week Washout Period.||40
11205848|NCT01862614|12396766|FG001|STARTED|2 Week Washout Period.||40
11205849|NCT01862614|12396765|FG000|COMPLETED|2 Week Washout Period.||40
11205850|NCT01862614|12396766|FG001|COMPLETED|2 Week Washout Period.||40
11205851|NCT01862614|12396765|FG000|NOT COMPLETED|2 Week Washout Period.||0
11205852|NCT01862614|12396766|FG001|NOT COMPLETED|2 Week Washout Period.||0
11205853|NCT01862614|12396765|FG000|STARTED|Second Appointment.|Received buffered articaine at second appointment.|40
11205854|NCT01862614|12396766|FG001|STARTED|Second Appointment.|Received articaine at second appointment.|40
11205855|NCT01862614|12396765|FG000|COMPLETED|Second Appointment.||40
11205856|NCT01862614|12396766|FG001|COMPLETED|Second Appointment.||40
11205857|NCT01862614|12396765|FG000|NOT COMPLETED|Second Appointment.||0
11205858|NCT01862614|12396766|FG001|NOT COMPLETED|Second Appointment.||0
11205859|NCT01862640|12396776|FG000|STARTED|Overall Study||20
11205860|NCT01862640|12396777|FG001|STARTED|Overall Study||137
11205861|NCT01862640|12396778|FG002|STARTED|Overall Study||140
11205862|NCT01862640|12396779|FG003|STARTED|Overall Study||136
11205863|NCT01862640|12396776|FG000|COMPLETED|Overall Study||13
11205864|NCT01862640|12396777|FG001|COMPLETED|Overall Study||121
11205865|NCT01862640|12396778|FG002|COMPLETED|Overall Study||122
11205866|NCT01862640|12396779|FG003|COMPLETED|Overall Study||121
11205867|NCT01862640|12396776|FG000|NOT COMPLETED|Overall Study||7
11205868|NCT01862640|12396777|FG001|NOT COMPLETED|Overall Study||16
11205869|NCT01862640|12396778|FG002|NOT COMPLETED|Overall Study||18
11205870|NCT01862640|12396779|FG003|NOT COMPLETED|Overall Study||15
11205871|NCT01862796|12396791|FG000|STARTED|Overall Study||19
11205872|NCT01862796|12396792|FG001|STARTED|Overall Study||18
11205873|NCT01862796|12396793|FG002|STARTED|Overall Study||24
11205874|NCT01862796|12396791|FG000|COMPLETED|Overall Study||19
11205875|NCT01862796|12396792|FG001|COMPLETED|Overall Study||18
11205876|NCT01862796|12396793|FG002|COMPLETED|Overall Study||23
11205877|NCT01862796|12396791|FG000|NOT COMPLETED|Overall Study||0
11205878|NCT01862796|12396792|FG001|NOT COMPLETED|Overall Study||0
11205879|NCT01862796|12396793|FG002|NOT COMPLETED|Overall Study||1
11205880|NCT01862874|12396803|FG000|STARTED|Overall Study|Randomized participants|562
11205881|NCT01862874|12396804|FG001|STARTED|Overall Study|Randomized participants|562
11205882|NCT01862874|12396803|FG000|Vaccination 1|Overall Study||561
11345672|NCT02970552|12542776|FG000|COMPLETED|Overall Study||67
11345673|NCT02970552|12542777|FG001|COMPLETED|Overall Study||67
11345674|NCT02970552|12542776|FG000|NOT COMPLETED|Overall Study||3
11345675|NCT02970552|12542777|FG001|NOT COMPLETED|Overall Study||3
11345676|NCT02970669|12542789|FG000|STARTED|Double-blind Period||70
11345677|NCT02970669|12542790|FG001|STARTED|Double-blind Period||70
11345678|NCT02970669|12542789|FG000|COMPLETED|Double-blind Period||62
11345679|NCT02970669|12542790|FG001|COMPLETED|Double-blind Period||64
11345680|NCT02970669|12542789|FG000|NOT COMPLETED|Double-blind Period||8
11345681|NCT02970669|12542790|FG001|NOT COMPLETED|Double-blind Period||6
11345682|NCT02970669|12542789|FG000|STARTED|Open-label Period||62
11345683|NCT02970669|12542790|FG001|STARTED|Open-label Period||64
11345684|NCT02970669|12542789|FG000|COMPLETED|Open-label Period||58
11345685|NCT02970669|12542790|FG001|COMPLETED|Open-label Period||62
11345686|NCT02970669|12542789|FG000|NOT COMPLETED|Open-label Period||4
11345687|NCT02970669|12542790|FG001|NOT COMPLETED|Open-label Period||2
11345688|NCT02970812|12542800|FG000|STARTED|Overall Study||30
11345689|NCT02970812|12542801|FG001|STARTED|Overall Study||30
11345690|NCT02970812|12542800|FG000|COMPLETED|Overall Study||22
11205883|NCT01862874|12396804|FG001|Vaccination 1|Overall Study||562
11205884|NCT01862874|12396803|FG000|Vaccination 2|Overall Study||539
11205885|NCT01862874|12396804|FG001|Vaccination 2|Overall Study||542
11205886|NCT01862874|12396803|FG000|Vaccination 3|Overall Study||530
11205887|NCT01862874|12396804|FG001|Vaccination 3|Overall Study||532
11205888|NCT01862874|12396803|FG000|COMPLETED|Overall Study||483
11205889|NCT01862874|12396804|FG001|COMPLETED|Overall Study||485
11345691|NCT02970812|12542801|FG001|COMPLETED|Overall Study||28
11345692|NCT02970812|12542800|FG000|NOT COMPLETED|Overall Study||8
11345693|NCT02970812|12542801|FG001|NOT COMPLETED|Overall Study||2
11345694|NCT02970942|12542811|FG000|STARTED|Overall Study||80
11345695|NCT02970942|12542812|FG001|STARTED|Overall Study||78
11064693|NCT01032837|12246287|FG000|COMPLETED|Overall Study|Represents patients who completed treatment.|26
11064694|NCT01032837|12246288|FG001|COMPLETED|Overall Study|Represents patients who completed treatment.|23
11064695|NCT01032837|12246289|FG002|COMPLETED|Overall Study|Represents patients who completed treatment.|24
11064696|NCT01032837|12246290|FG003|COMPLETED|Overall Study|Represents patients who completed treatment.|22
11064697|NCT01032837|12246287|FG000|NOT COMPLETED|Overall Study||0
11064698|NCT01032837|12246288|FG001|NOT COMPLETED|Overall Study||3
11064699|NCT01032837|12246289|FG002|NOT COMPLETED|Overall Study||1
11064700|NCT01032837|12246290|FG003|NOT COMPLETED|Overall Study||3
11064701|NCT01032850|12246300|FG000|STARTED|Overall Study||15
11064702|NCT01032850|12246300|FG000|COMPLETED|Overall Study||13
11064703|NCT01032850|12246300|FG000|NOT COMPLETED|Overall Study||2
11064704|NCT01032889|12246307|FG000|STARTED|Overall Study||41
11064705|NCT01032889|12246308|FG001|STARTED|Overall Study||43
11064706|NCT01032889|12246309|FG002|STARTED|Overall Study||45
11064707|NCT01032889|12246307|FG000|Received Treatment|Overall Study||41
11064708|NCT01032889|12246308|FG001|Received Treatment|Overall Study||43
11064709|NCT01032889|12246309|FG002|Received Treatment|Overall Study||45
11345696|NCT02970942|12542813|FG002|STARTED|Overall Study||82
11345697|NCT02970942|12542814|FG003|STARTED|Overall Study||80
11345698|NCT02970942|12542811|FG000|Full Analysis Set|Overall Study||80
11345699|NCT02970942|12542812|FG001|Full Analysis Set|Overall Study||78
11345700|NCT02970942|12542813|FG002|Full Analysis Set|Overall Study||82
11345701|NCT02970942|12542814|FG003|Full Analysis Set|Overall Study||80
11345702|NCT02970942|12542811|FG000|Safety Analysis Set|Overall Study||80
11345703|NCT02970942|12542812|FG001|Safety Analysis Set|Overall Study||78
11345704|NCT02970942|12542813|FG002|Safety Analysis Set|Overall Study||81
11345705|NCT02970942|12542814|FG003|Safety Analysis Set|Overall Study||80
11345706|NCT02970942|12542811|FG000|Exposed|Overall Study||80
11345707|NCT02970942|12542812|FG001|Exposed|Overall Study||78
11064710|NCT01032889|12246307|FG000|COMPLETED|Overall Study||33
11064711|NCT01032889|12246308|FG001|COMPLETED|Overall Study||28
11205890|NCT01862874|12396803|FG000|NOT COMPLETED|Overall Study||79
11205891|NCT01862874|12396804|FG001|NOT COMPLETED|Overall Study||77
11205892|NCT01862991|12396813|FG000|STARTED|Overall Study||24
11205893|NCT01862991|12396814|FG001|STARTED|Overall Study||28
11205894|NCT01862991|12396815|FG002|STARTED|Overall Study||28
11205895|NCT01862991|12396813|FG000|COMPLETED|Overall Study||21
11205896|NCT01862991|12396814|FG001|COMPLETED|Overall Study||27
11205897|NCT01862991|12396815|FG002|COMPLETED|Overall Study||27
11205898|NCT01862991|12396813|FG000|NOT COMPLETED|Overall Study||3
11205899|NCT01862991|12396814|FG001|NOT COMPLETED|Overall Study||1
11345708|NCT02970942|12542813|FG002|Exposed|Overall Study||81
11345709|NCT02970942|12542814|FG003|Exposed|Overall Study||80
11064712|NCT01032889|12246309|FG002|COMPLETED|Overall Study||42
11064713|NCT01032889|12246307|FG000|NOT COMPLETED|Overall Study||8
11064714|NCT01032889|12246308|FG001|NOT COMPLETED|Overall Study||15
11064715|NCT01032889|12246309|FG002|NOT COMPLETED|Overall Study||3
11064716|NCT01032915|12246321|FG000|STARTED|Overall Study||29
11064717|NCT01032915|12246322|FG001|STARTED|Overall Study||31
11064718|NCT01032915|12246323|FG002|STARTED|Overall Study||31
11064719|NCT01032915|12246324|FG003|STARTED|Overall Study||34
11064720|NCT01032915|12246321|FG000|COMPLETED|Overall Study||21
11064721|NCT01032915|12246322|FG001|COMPLETED|Overall Study||20
11064722|NCT01032915|12246323|FG002|COMPLETED|Overall Study||24
11064723|NCT01032915|12246324|FG003|COMPLETED|Overall Study||27
11064724|NCT01032915|12246321|FG000|NOT COMPLETED|Overall Study||8
11064725|NCT01032915|12246322|FG001|NOT COMPLETED|Overall Study||11
11345710|NCT02970942|12542811|FG000|COMPLETED|Overall Study||76
11345711|NCT02970942|12542812|FG001|COMPLETED|Overall Study||72
11345712|NCT02970942|12542813|FG002|COMPLETED|Overall Study||77
11345713|NCT02970942|12542814|FG003|COMPLETED|Overall Study||77
11345714|NCT02970942|12542811|FG000|NOT COMPLETED|Overall Study||4
11345715|NCT02970942|12542812|FG001|NOT COMPLETED|Overall Study||6
11345716|NCT02970942|12542813|FG002|NOT COMPLETED|Overall Study||5
11345717|NCT02970942|12542814|FG003|NOT COMPLETED|Overall Study||3
11345718|NCT02971007|12542827|FG000|STARTED|Overall Study||46
11345719|NCT02971007|12542828|FG001|STARTED|Overall Study||45
11345720|NCT02971007|12542829|FG002|STARTED|Overall Study||46
11345721|NCT02971007|12542827|FG000|COMPLETED|Overall Study||44
11345722|NCT02971007|12542828|FG001|COMPLETED|Overall Study||42
11345723|NCT02971007|12542829|FG002|COMPLETED|Overall Study||45
11345724|NCT02971007|12542827|FG000|NOT COMPLETED|Overall Study||2
11345725|NCT02971007|12542828|FG001|NOT COMPLETED|Overall Study||3
11345726|NCT02971007|12542829|FG002|NOT COMPLETED|Overall Study||1
11345727|NCT02971163|12542839|FG000|STARTED|Overall Study||24
11345728|NCT02971163|12542840|FG001|STARTED|Overall Study||26
11345729|NCT02971163|12542839|FG000|COMPLETED|Overall Study||20
11345730|NCT02971163|12542840|FG001|COMPLETED|Overall Study||24
11345731|NCT02971163|12542839|FG000|NOT COMPLETED|Overall Study||4
11345732|NCT02971163|12542840|FG001|NOT COMPLETED|Overall Study||2
11345733|NCT02971202|12542849|FG000|STARTED|Overall Study||12
11345734|NCT02971202|12542850|FG001|STARTED|Overall Study||10
11345735|NCT02971202|12542851|FG002|STARTED|Overall Study||11
11345736|NCT02971202|12542849|FG000|Started Study|Overall Study||11
11345737|NCT02971202|12542850|FG001|Started Study|Overall Study||10
11345738|NCT02971202|12542851|FG002|Started Study|Overall Study||10
11345739|NCT02971202|12542849|FG000|COMPLETED|Overall Study||10
11345740|NCT02971202|12542850|FG001|COMPLETED|Overall Study||10
11345741|NCT02971202|12542851|FG002|COMPLETED|Overall Study||10
11345742|NCT02971202|12542849|FG000|NOT COMPLETED|Overall Study||2
11345743|NCT02971202|12542850|FG001|NOT COMPLETED|Overall Study||0
11345744|NCT02971202|12542851|FG002|NOT COMPLETED|Overall Study||1
11345745|NCT02971228|12542859|FG000|STARTED|Overall Study||1
11345746|NCT02971228|12542860|FG001|STARTED|Overall Study||7
11345747|NCT02971228|12542861|FG002|STARTED|Overall Study||5
11345748|NCT02971228|12542862|FG003|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
11345749|NCT02971228|12542863|FG004|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
11345750|NCT02971228|12542859|FG000|Randomized and Treated|Overall Study||0
11345751|NCT02971228|12542860|FG001|Randomized and Treated|Overall Study||7
11345752|NCT02971228|12542861|FG002|Randomized and Treated|Overall Study||5
11345753|NCT02971228|12542862|FG003|Randomized and Treated|Overall Study||0
11345754|NCT02971228|12542863|FG004|Randomized and Treated|Overall Study||0
11345755|NCT02971228|12542859|FG000|COMPLETED|Overall Study||0
11345756|NCT02971228|12542860|FG001|COMPLETED|Overall Study||5
11345757|NCT02971228|12542861|FG002|COMPLETED|Overall Study||5
11064726|NCT01032915|12246323|FG002|NOT COMPLETED|Overall Study||7
11064727|NCT01032915|12246324|FG003|NOT COMPLETED|Overall Study||7
11064728|NCT01032928|12246334|FG000|STARTED|Overall Study||30
11064729|NCT01032928|12246334|FG000|COMPLETED|Overall Study||30
11064730|NCT01032928|12246334|FG000|NOT COMPLETED|Overall Study||0
11064731|NCT01032954|12246345|FG000|STARTED|Overall Study||30
11064732|NCT01032954|12246346|FG001|STARTED|Overall Study||30
11064733|NCT01032954|12246347|FG002|STARTED|Overall Study||30
11064734|NCT01032954|12246345|FG000|COMPLETED|Overall Study||26
11064735|NCT01032954|12246346|FG001|COMPLETED|Overall Study||29
11064736|NCT01032954|12246347|FG002|COMPLETED|Overall Study||30
11064737|NCT01032954|12246345|FG000|NOT COMPLETED|Overall Study||4
11064738|NCT01032954|12246346|FG001|NOT COMPLETED|Overall Study||1
11205900|NCT01862991|12396815|FG002|NOT COMPLETED|Overall Study||1
11345758|NCT02971228|12542862|FG003|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
11345759|NCT02971228|12542863|FG004|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
11345760|NCT02971228|12542859|FG000|NOT COMPLETED|Overall Study||1
11345761|NCT02971228|12542860|FG001|NOT COMPLETED|Overall Study||2
11345762|NCT02971228|12542861|FG002|NOT COMPLETED|Overall Study||0
11345763|NCT02971228|12542862|FG003|NOT COMPLETED|Overall Study||0
11064739|NCT01032954|12246347|FG002|NOT COMPLETED|Overall Study||0
11064740|NCT01032993|12246357|FG000|STARTED|Overall Study||19
11064741|NCT01032993|12246358|FG001|STARTED|Overall Study||20
11064742|NCT01032993|12246357|FG000|COMPLETED|Overall Study||19
11064743|NCT01032993|12246358|FG001|COMPLETED|Overall Study||20
11064744|NCT01032993|12246357|FG000|NOT COMPLETED|Overall Study||0
11064745|NCT01032993|12246358|FG001|NOT COMPLETED|Overall Study||0
11064746|NCT01033019|12246366|FG000|STARTED|Overall Study||16
11064747|NCT01033019|12246367|FG001|STARTED|Overall Study||8
11064748|NCT01033019|12246366|FG000|COMPLETED|Overall Study||15
11064749|NCT01033019|12246367|FG001|COMPLETED|Overall Study||8
11064750|NCT01033019|12246366|FG000|NOT COMPLETED|Overall Study||1
11064751|NCT01033019|12246367|FG001|NOT COMPLETED|Overall Study||0
11064752|NCT01033071|12246377|FG000|STARTED|Overall Study||355
11064753|NCT01033071|12246378|FG001|STARTED|Overall Study||352
11064754|NCT01033071|12246379|FG002|STARTED|Overall Study||364
11064755|NCT01033071|12246377|FG000|COMPLETED|Overall Study||300
11064756|NCT01033071|12246378|FG001|COMPLETED|Overall Study||275
11064757|NCT01033071|12246379|FG002|COMPLETED|Overall Study||317
11064758|NCT01033071|12246377|FG000|NOT COMPLETED|Overall Study||55
11064759|NCT01033071|12246378|FG001|NOT COMPLETED|Overall Study||77
11064760|NCT01033071|12246379|FG002|NOT COMPLETED|Overall Study||47
11064761|NCT01033136|12246389|FG000|STARTED|Baseline Assessment||36
11064762|NCT01033136|12246390|FG001|STARTED|Baseline Assessment||32
11064763|NCT01033136|12246389|FG000|COMPLETED|Baseline Assessment||30
11064764|NCT01033136|12246390|FG001|COMPLETED|Baseline Assessment||26
11064765|NCT01033136|12246389|FG000|NOT COMPLETED|Baseline Assessment||6
11064766|NCT01033136|12246390|FG001|NOT COMPLETED|Baseline Assessment||6
11064767|NCT01033136|12246389|FG000|STARTED|Post-Treatment (1 Week)||30
11064768|NCT01033136|12246390|FG001|STARTED|Post-Treatment (1 Week)||26
11064769|NCT01033136|12246389|FG000|COMPLETED|Post-Treatment (1 Week)||16
11064770|NCT01033136|12246390|FG001|COMPLETED|Post-Treatment (1 Week)||15
11064771|NCT01033136|12246389|FG000|NOT COMPLETED|Post-Treatment (1 Week)||14
11064772|NCT01033136|12246390|FG001|NOT COMPLETED|Post-Treatment (1 Week)||11
11064773|NCT01033136|12246389|FG000|STARTED|Follow-Up (3 Month)||16
11064774|NCT01033136|12246390|FG001|STARTED|Follow-Up (3 Month)||15
11064775|NCT01033136|12246389|FG000|COMPLETED|Follow-Up (3 Month)||14
11064776|NCT01033136|12246390|FG001|COMPLETED|Follow-Up (3 Month)||13
11064777|NCT01033136|12246389|FG000|NOT COMPLETED|Follow-Up (3 Month)||2
11064778|NCT01033136|12246390|FG001|NOT COMPLETED|Follow-Up (3 Month)||2
11064779|NCT01033227|12246400|FG000|STARTED|Overall Study||3
11064780|NCT01033227|12246401|FG001|STARTED|Overall Study||2
11064781|NCT01033227|12246400|FG000|COMPLETED|Overall Study||3
11064782|NCT01033227|12246401|FG001|COMPLETED|Overall Study||2
11064783|NCT01033227|12246400|FG000|NOT COMPLETED|Overall Study||0
11064784|NCT01033227|12246401|FG001|NOT COMPLETED|Overall Study||0
11064785|NCT01033240|12246412|FG000|STARTED|Overall Study||55
11064786|NCT01033240|12246413|FG001|STARTED|Overall Study||53
11064787|NCT01033240|12246414|FG002|STARTED|Overall Study||55
11064788|NCT01033240|12246412|FG000|COMPLETED|Overall Study||6
11064789|NCT01033240|12246413|FG001|COMPLETED|Overall Study||3
11064790|NCT01033240|12246414|FG002|COMPLETED|Overall Study||2
11064791|NCT01033240|12246412|FG000|NOT COMPLETED|Overall Study||49
11064792|NCT01033240|12246413|FG001|NOT COMPLETED|Overall Study||50
11064793|NCT01033240|12246414|FG002|NOT COMPLETED|Overall Study||53
11064794|NCT01033383|12246426|FG000|STARTED|Overall Study||20
11064795|NCT01033383|12246427|FG001|STARTED|Overall Study||20
11064796|NCT01033383|12246428|FG002|STARTED|Overall Study||20
11064797|NCT01033383|12246429|FG003|STARTED|Overall Study||20
11064798|NCT01033383|12246426|FG000|COMPLETED|Overall Study||20
11064799|NCT01033383|12246427|FG001|COMPLETED|Overall Study||20
11064800|NCT01033383|12246428|FG002|COMPLETED|Overall Study||20
11064801|NCT01033383|12246429|FG003|COMPLETED|Overall Study||20
11064802|NCT01033383|12246426|FG000|NOT COMPLETED|Overall Study||0
11064803|NCT01033383|12246427|FG001|NOT COMPLETED|Overall Study||0
11064804|NCT01033383|12246428|FG002|NOT COMPLETED|Overall Study||0
11064805|NCT01033383|12246429|FG003|NOT COMPLETED|Overall Study||0
11064806|NCT01033422|12246442|FG000|STARTED|Overall Study||34
11064807|NCT01033422|12246443|FG001|STARTED|Overall Study||32
11064808|NCT01033422|12246444|FG002|STARTED|Overall Study||23
11064809|NCT01033422|12246442|FG000|COMPLETED|Overall Study||33
11064810|NCT01033422|12246443|FG001|COMPLETED|Overall Study||28
11064811|NCT01033422|12246444|FG002|COMPLETED|Overall Study||22
11064812|NCT01033422|12246442|FG000|NOT COMPLETED|Overall Study||1
11064813|NCT01033422|12246443|FG001|NOT COMPLETED|Overall Study||4
11064814|NCT01033422|12246444|FG002|NOT COMPLETED|Overall Study||1
11064815|NCT01033448|12246452|FG000|STARTED|Overall Study||59
11064816|NCT01033448|12246452|FG000|COMPLETED|Overall Study||47
11064817|NCT01033448|12246452|FG000|NOT COMPLETED|Overall Study||12
11064818|NCT01033487|12246458|FG000|STARTED|First Intervention Period||2
11064819|NCT01033487|12246459|FG001|STARTED|First Intervention Period||3
11064820|NCT01033487|12246460|FG002|STARTED|First Intervention Period||2
11064821|NCT01033487|12246461|FG003|STARTED|First Intervention Period||2
11064822|NCT01033487|12246462|FG004|STARTED|First Intervention Period||2
11064823|NCT01033487|12246463|FG005|STARTED|First Intervention Period||2
11064824|NCT01033487|12246464|FG006|STARTED|First Intervention Period||2
11064825|NCT01033487|12246465|FG007|STARTED|First Intervention Period||3
11064826|NCT01033487|12246466|FG008|STARTED|First Intervention Period||2
11064827|NCT01033487|12246467|FG009|STARTED|First Intervention Period||2
11064828|NCT01033487|12246458|FG000|COMPLETED|First Intervention Period||2
11064829|NCT01033487|12246459|FG001|COMPLETED|First Intervention Period||3
11064830|NCT01033487|12246460|FG002|COMPLETED|First Intervention Period||2
11064831|NCT01033487|12246461|FG003|COMPLETED|First Intervention Period||2
11064832|NCT01033487|12246462|FG004|COMPLETED|First Intervention Period||2
11064833|NCT01033487|12246463|FG005|COMPLETED|First Intervention Period||2
11064834|NCT01033487|12246464|FG006|COMPLETED|First Intervention Period||2
11064835|NCT01033487|12246465|FG007|COMPLETED|First Intervention Period||3
11064836|NCT01033487|12246466|FG008|COMPLETED|First Intervention Period||2
11064837|NCT01033487|12246467|FG009|COMPLETED|First Intervention Period||2
11064838|NCT01033487|12246458|FG000|NOT COMPLETED|First Intervention Period||0
11064839|NCT01033487|12246459|FG001|NOT COMPLETED|First Intervention Period||0
11064840|NCT01033487|12246460|FG002|NOT COMPLETED|First Intervention Period||0
11064841|NCT01033487|12246461|FG003|NOT COMPLETED|First Intervention Period||0
11064842|NCT01033487|12246462|FG004|NOT COMPLETED|First Intervention Period||0
11064843|NCT01033487|12246463|FG005|NOT COMPLETED|First Intervention Period||0
11064844|NCT01033487|12246464|FG006|NOT COMPLETED|First Intervention Period||0
11064845|NCT01033487|12246465|FG007|NOT COMPLETED|First Intervention Period||0
11064846|NCT01033487|12246466|FG008|NOT COMPLETED|First Intervention Period||0
11064847|NCT01033487|12246467|FG009|NOT COMPLETED|First Intervention Period||0
11064848|NCT01033487|12246458|FG000|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
11064849|NCT01033487|12246459|FG001|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
11064850|NCT01033487|12246460|FG002|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
11064851|NCT01033487|12246461|FG003|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
11064852|NCT01033487|12246462|FG004|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
11064853|NCT01033487|12246463|FG005|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
11064854|NCT01033487|12246464|FG006|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
11064855|NCT01033487|12246465|FG007|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
11064856|NCT01033487|12246466|FG008|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
11064857|NCT01033487|12246467|FG009|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
11064858|NCT01033487|12246458|FG000|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
11064859|NCT01033487|12246459|FG001|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
11064860|NCT01033487|12246460|FG002|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
11064861|NCT01033487|12246461|FG003|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
11064862|NCT01033487|12246462|FG004|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
11064863|NCT01033487|12246463|FG005|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
11064864|NCT01033487|12246464|FG006|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
11064865|NCT01033487|12246465|FG007|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
11064866|NCT01033487|12246466|FG008|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
11064867|NCT01033487|12246467|FG009|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
11064868|NCT01033487|12246458|FG000|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
11064869|NCT01033487|12246459|FG001|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
11064870|NCT01033487|12246460|FG002|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
11064871|NCT01033487|12246461|FG003|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
11064872|NCT01033487|12246462|FG004|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
11064873|NCT01033487|12246463|FG005|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
11064874|NCT01033487|12246464|FG006|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
11064875|NCT01033487|12246465|FG007|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
11064876|NCT01033487|12246466|FG008|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
11064877|NCT01033487|12246467|FG009|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
11064878|NCT01033487|12246458|FG000|STARTED|Second Intervention Period||2
11064879|NCT01033487|12246459|FG001|STARTED|Second Intervention Period||3
11064880|NCT01033487|12246460|FG002|STARTED|Second Intervention Period||2
11064881|NCT01033487|12246461|FG003|STARTED|Second Intervention Period||2
11064882|NCT01033487|12246462|FG004|STARTED|Second Intervention Period||2
11064883|NCT01033487|12246463|FG005|STARTED|Second Intervention Period||2
11064884|NCT01033487|12246464|FG006|STARTED|Second Intervention Period||2
11345764|NCT02971228|12542863|FG004|NOT COMPLETED|Overall Study||0
11345765|NCT02971293|12542874|FG000|STARTED|Overall Study||42
11345766|NCT02971293|12542874|FG000|COMPLETED|Overall Study||31
11345767|NCT02971293|12542874|FG000|NOT COMPLETED|Overall Study||11
11345768|NCT02971488|12542882|FG000|STARTED|Overall Study||529
11345769|NCT02971488|12542882|FG000|COMPLETED|Overall Study||529
11345770|NCT02971488|12542882|FG000|NOT COMPLETED|Overall Study||0
11345771|NCT02971605|12542889|FG000|STARTED|Overall Study||13
11345772|NCT02971605|12542889|FG000|COMPLETED|Overall Study||12
11064885|NCT01033487|12246465|FG007|STARTED|Second Intervention Period||3
11064886|NCT01033487|12246466|FG008|STARTED|Second Intervention Period||2
11064887|NCT01033487|12246467|FG009|STARTED|Second Intervention Period||2
11064888|NCT01033487|12246458|FG000|COMPLETED|Second Intervention Period||2
11064889|NCT01033487|12246459|FG001|COMPLETED|Second Intervention Period||3
11064890|NCT01033487|12246460|FG002|COMPLETED|Second Intervention Period||2
11345773|NCT02971605|12542889|FG000|NOT COMPLETED|Overall Study||1
11064891|NCT01033487|12246461|FG003|COMPLETED|Second Intervention Period||2
11064892|NCT01033487|12246462|FG004|COMPLETED|Second Intervention Period||2
11064893|NCT01033487|12246463|FG005|COMPLETED|Second Intervention Period||2
11064894|NCT01033487|12246464|FG006|COMPLETED|Second Intervention Period||2
11064895|NCT01033487|12246465|FG007|COMPLETED|Second Intervention Period||3
11064896|NCT01033487|12246466|FG008|COMPLETED|Second Intervention Period||2
11064897|NCT01033487|12246467|FG009|COMPLETED|Second Intervention Period||2
11064898|NCT01033487|12246458|FG000|NOT COMPLETED|Second Intervention Period||0
11064899|NCT01033487|12246459|FG001|NOT COMPLETED|Second Intervention Period||0
11064900|NCT01033487|12246460|FG002|NOT COMPLETED|Second Intervention Period||0
11064901|NCT01033487|12246461|FG003|NOT COMPLETED|Second Intervention Period||0
11064902|NCT01033487|12246462|FG004|NOT COMPLETED|Second Intervention Period||0
11064903|NCT01033487|12246463|FG005|NOT COMPLETED|Second Intervention Period||0
11064904|NCT01033487|12246464|FG006|NOT COMPLETED|Second Intervention Period||0
11064905|NCT01033487|12246465|FG007|NOT COMPLETED|Second Intervention Period||0
11064906|NCT01033487|12246466|FG008|NOT COMPLETED|Second Intervention Period||0
11064907|NCT01033487|12246467|FG009|NOT COMPLETED|Second Intervention Period||0
11064908|NCT01033487|12246458|FG000|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
11064909|NCT01033487|12246459|FG001|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
11064910|NCT01033487|12246460|FG002|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
11064911|NCT01033487|12246461|FG003|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
11064912|NCT01033487|12246462|FG004|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
11064913|NCT01033487|12246463|FG005|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
11064914|NCT01033487|12246464|FG006|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
11064915|NCT01033487|12246465|FG007|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
11064916|NCT01033487|12246466|FG008|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
11064917|NCT01033487|12246467|FG009|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
11064918|NCT01033487|12246458|FG000|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
11064919|NCT01033487|12246459|FG001|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
11064920|NCT01033487|12246460|FG002|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
11064921|NCT01033487|12246461|FG003|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
11064922|NCT01033487|12246462|FG004|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
11064923|NCT01033487|12246463|FG005|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
11064924|NCT01033487|12246464|FG006|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
11064925|NCT01033487|12246465|FG007|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
11064926|NCT01033487|12246466|FG008|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
11064927|NCT01033487|12246467|FG009|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
11064928|NCT01033487|12246458|FG000|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
11064929|NCT01033487|12246459|FG001|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
11064930|NCT01033487|12246460|FG002|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
11064931|NCT01033487|12246461|FG003|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
11064932|NCT01033487|12246462|FG004|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
11064933|NCT01033487|12246463|FG005|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
11064934|NCT01033487|12246464|FG006|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
11064935|NCT01033487|12246465|FG007|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
11064936|NCT01033487|12246466|FG008|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
11064937|NCT01033487|12246467|FG009|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
11064938|NCT01033487|12246458|FG000|STARTED|Third Intervention Period||2
11064939|NCT01033487|12246459|FG001|STARTED|Third Intervention Period||3
11064940|NCT01033487|12246460|FG002|STARTED|Third Intervention Period||2
11064941|NCT01033487|12246461|FG003|STARTED|Third Intervention Period||2
11064942|NCT01033487|12246462|FG004|STARTED|Third Intervention Period||2
11064943|NCT01033487|12246463|FG005|STARTED|Third Intervention Period||2
11064944|NCT01033487|12246464|FG006|STARTED|Third Intervention Period||2
11064945|NCT01033487|12246465|FG007|STARTED|Third Intervention Period||3
11064946|NCT01033487|12246466|FG008|STARTED|Third Intervention Period||2
11064947|NCT01033487|12246467|FG009|STARTED|Third Intervention Period||2
11064948|NCT01033487|12246458|FG000|COMPLETED|Third Intervention Period||2
11064949|NCT01033487|12246459|FG001|COMPLETED|Third Intervention Period||3
11064950|NCT01033487|12246460|FG002|COMPLETED|Third Intervention Period||2
11064951|NCT01033487|12246461|FG003|COMPLETED|Third Intervention Period||2
11064952|NCT01033487|12246462|FG004|COMPLETED|Third Intervention Period||2
11064953|NCT01033487|12246463|FG005|COMPLETED|Third Intervention Period||2
11064954|NCT01033487|12246464|FG006|COMPLETED|Third Intervention Period||2
11064955|NCT01033487|12246465|FG007|COMPLETED|Third Intervention Period||3
11345774|NCT02971631|12542895|FG000|STARTED|First Intervention - One Day||3
11345775|NCT02971631|12542896|FG001|STARTED|First Intervention - One Day||2
11345776|NCT02971631|12542895|FG000|COMPLETED|First Intervention - One Day||3
11064956|NCT01033487|12246466|FG008|COMPLETED|Third Intervention Period||2
11064957|NCT01033487|12246467|FG009|COMPLETED|Third Intervention Period||2
11064958|NCT01033487|12246458|FG000|NOT COMPLETED|Third Intervention Period||0
11064959|NCT01033487|12246459|FG001|NOT COMPLETED|Third Intervention Period||0
11064960|NCT01033487|12246460|FG002|NOT COMPLETED|Third Intervention Period||0
11064961|NCT01033487|12246461|FG003|NOT COMPLETED|Third Intervention Period||0
11064962|NCT01033487|12246462|FG004|NOT COMPLETED|Third Intervention Period||0
11064963|NCT01033487|12246463|FG005|NOT COMPLETED|Third Intervention Period||0
11064964|NCT01033487|12246464|FG006|NOT COMPLETED|Third Intervention Period||0
11064965|NCT01033487|12246465|FG007|NOT COMPLETED|Third Intervention Period||0
11064966|NCT01033487|12246466|FG008|NOT COMPLETED|Third Intervention Period||0
11064967|NCT01033487|12246467|FG009|NOT COMPLETED|Third Intervention Period||0
11064968|NCT01033487|12246458|FG000|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
11064969|NCT01033487|12246459|FG001|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
11064970|NCT01033487|12246460|FG002|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
11064971|NCT01033487|12246461|FG003|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
11064972|NCT01033487|12246462|FG004|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
11064973|NCT01033487|12246463|FG005|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
11064974|NCT01033487|12246464|FG006|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
11064975|NCT01033487|12246465|FG007|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
11064976|NCT01033487|12246466|FG008|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
11064977|NCT01033487|12246467|FG009|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
11064978|NCT01033487|12246458|FG000|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
11064979|NCT01033487|12246459|FG001|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
11064980|NCT01033487|12246460|FG002|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
11064981|NCT01033487|12246461|FG003|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
11064982|NCT01033487|12246462|FG004|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
11064983|NCT01033487|12246463|FG005|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
11064984|NCT01033487|12246464|FG006|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
11064985|NCT01033487|12246465|FG007|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
11064986|NCT01033487|12246466|FG008|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
11064987|NCT01033487|12246467|FG009|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
11064988|NCT01033487|12246458|FG000|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
11064989|NCT01033487|12246459|FG001|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
11064990|NCT01033487|12246460|FG002|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
11064991|NCT01033487|12246461|FG003|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
11064992|NCT01033487|12246462|FG004|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
11064993|NCT01033487|12246463|FG005|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
11064994|NCT01033487|12246464|FG006|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
11064995|NCT01033487|12246465|FG007|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
11064996|NCT01033487|12246466|FG008|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
11064997|NCT01033487|12246467|FG009|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
11064998|NCT01033487|12246458|FG000|STARTED|Fourth Intervention Period||2
11064999|NCT01033487|12246459|FG001|STARTED|Fourth Intervention Period||3
11065000|NCT01033487|12246460|FG002|STARTED|Fourth Intervention Period||2
11065001|NCT01033487|12246461|FG003|STARTED|Fourth Intervention Period||2
11065002|NCT01033487|12246462|FG004|STARTED|Fourth Intervention Period||2
11065003|NCT01033487|12246463|FG005|STARTED|Fourth Intervention Period||2
11065004|NCT01033487|12246464|FG006|STARTED|Fourth Intervention Period||2
11065005|NCT01033487|12246465|FG007|STARTED|Fourth Intervention Period||3
11065006|NCT01033487|12246466|FG008|STARTED|Fourth Intervention Period||2
11065007|NCT01033487|12246467|FG009|STARTED|Fourth Intervention Period||2
11065008|NCT01033487|12246458|FG000|COMPLETED|Fourth Intervention Period||2
11065009|NCT01033487|12246459|FG001|COMPLETED|Fourth Intervention Period||3
11065010|NCT01033487|12246460|FG002|COMPLETED|Fourth Intervention Period||2
11065011|NCT01033487|12246461|FG003|COMPLETED|Fourth Intervention Period||2
11065012|NCT01033487|12246462|FG004|COMPLETED|Fourth Intervention Period||2
11065013|NCT01033487|12246463|FG005|COMPLETED|Fourth Intervention Period||2
11065014|NCT01033487|12246464|FG006|COMPLETED|Fourth Intervention Period||2
11065015|NCT01033487|12246465|FG007|COMPLETED|Fourth Intervention Period||3
11065016|NCT01033487|12246466|FG008|COMPLETED|Fourth Intervention Period||1
11065017|NCT01033487|12246467|FG009|COMPLETED|Fourth Intervention Period||2
11065018|NCT01033487|12246458|FG000|NOT COMPLETED|Fourth Intervention Period||0
11065019|NCT01033487|12246459|FG001|NOT COMPLETED|Fourth Intervention Period||0
11065020|NCT01033487|12246460|FG002|NOT COMPLETED|Fourth Intervention Period||0
11065021|NCT01033487|12246461|FG003|NOT COMPLETED|Fourth Intervention Period||0
11065022|NCT01033487|12246462|FG004|NOT COMPLETED|Fourth Intervention Period||0
11065023|NCT01033487|12246463|FG005|NOT COMPLETED|Fourth Intervention Period||0
11065024|NCT01033487|12246464|FG006|NOT COMPLETED|Fourth Intervention Period||0
11065025|NCT01033487|12246465|FG007|NOT COMPLETED|Fourth Intervention Period||0
11065026|NCT01033487|12246466|FG008|NOT COMPLETED|Fourth Intervention Period||1
11065027|NCT01033487|12246467|FG009|NOT COMPLETED|Fourth Intervention Period||0
11065028|NCT01033487|12246458|FG000|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
11065029|NCT01033487|12246459|FG001|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
11065030|NCT01033487|12246460|FG002|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
11065031|NCT01033487|12246461|FG003|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
11065032|NCT01033487|12246462|FG004|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
11065033|NCT01033487|12246463|FG005|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
11065034|NCT01033487|12246464|FG006|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
11065035|NCT01033487|12246465|FG007|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
11065036|NCT01033487|12246466|FG008|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
11065037|NCT01033487|12246467|FG009|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
11065038|NCT01033487|12246458|FG000|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
11065039|NCT01033487|12246459|FG001|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
11065040|NCT01033487|12246460|FG002|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
11065041|NCT01033487|12246461|FG003|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
11065042|NCT01033487|12246462|FG004|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
11065043|NCT01033487|12246463|FG005|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
11065044|NCT01033487|12246464|FG006|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
11065045|NCT01033487|12246465|FG007|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
11065046|NCT01033487|12246466|FG008|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
11065047|NCT01033487|12246467|FG009|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
11065048|NCT01033487|12246458|FG000|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
11065049|NCT01033487|12246459|FG001|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
11065050|NCT01033487|12246460|FG002|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
11065051|NCT01033487|12246461|FG003|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
11065052|NCT01033487|12246462|FG004|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
11065053|NCT01033487|12246463|FG005|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
11065054|NCT01033487|12246464|FG006|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
11065055|NCT01033487|12246465|FG007|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
11065056|NCT01033487|12246466|FG008|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
11065057|NCT01033487|12246467|FG009|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
11065058|NCT01033487|12246458|FG000|STARTED|Fifth Intervention Period||2
11065059|NCT01033487|12246459|FG001|STARTED|Fifth Intervention Period||3
11065060|NCT01033487|12246460|FG002|STARTED|Fifth Intervention Period||2
11065061|NCT01033487|12246461|FG003|STARTED|Fifth Intervention Period||2
11065062|NCT01033487|12246462|FG004|STARTED|Fifth Intervention Period||2
11065063|NCT01033487|12246463|FG005|STARTED|Fifth Intervention Period||2
11065064|NCT01033487|12246464|FG006|STARTED|Fifth Intervention Period||2
11065065|NCT01033487|12246465|FG007|STARTED|Fifth Intervention Period||3
11065066|NCT01033487|12246466|FG008|STARTED|Fifth Intervention Period||1
11065067|NCT01033487|12246467|FG009|STARTED|Fifth Intervention Period||2
11065068|NCT01033487|12246458|FG000|COMPLETED|Fifth Intervention Period||2
11065069|NCT01033487|12246459|FG001|COMPLETED|Fifth Intervention Period||3
11065070|NCT01033487|12246460|FG002|COMPLETED|Fifth Intervention Period||2
11065071|NCT01033487|12246461|FG003|COMPLETED|Fifth Intervention Period||2
11065072|NCT01033487|12246462|FG004|COMPLETED|Fifth Intervention Period||2
11065073|NCT01033487|12246463|FG005|COMPLETED|Fifth Intervention Period||2
11065074|NCT01033487|12246464|FG006|COMPLETED|Fifth Intervention Period||2
11065075|NCT01033487|12246465|FG007|COMPLETED|Fifth Intervention Period||3
11065076|NCT01033487|12246466|FG008|COMPLETED|Fifth Intervention Period||1
11065077|NCT01033487|12246467|FG009|COMPLETED|Fifth Intervention Period||2
11065078|NCT01033487|12246458|FG000|NOT COMPLETED|Fifth Intervention Period||0
11065079|NCT01033487|12246459|FG001|NOT COMPLETED|Fifth Intervention Period||0
11065080|NCT01033487|12246460|FG002|NOT COMPLETED|Fifth Intervention Period||0
11065081|NCT01033487|12246461|FG003|NOT COMPLETED|Fifth Intervention Period||0
11065082|NCT01033487|12246462|FG004|NOT COMPLETED|Fifth Intervention Period||0
11065083|NCT01033487|12246463|FG005|NOT COMPLETED|Fifth Intervention Period||0
11065084|NCT01033487|12246464|FG006|NOT COMPLETED|Fifth Intervention Period||0
11065085|NCT01033487|12246465|FG007|NOT COMPLETED|Fifth Intervention Period||0
11065086|NCT01033487|12246466|FG008|NOT COMPLETED|Fifth Intervention Period||0
11065087|NCT01033487|12246467|FG009|NOT COMPLETED|Fifth Intervention Period||0
11065088|NCT01033565|12246481|FG000|STARTED|Overall Study||1
11065089|NCT01033565|12246481|FG000|COMPLETED|Overall Study||1
11065090|NCT01033565|12246481|FG000|NOT COMPLETED|Overall Study||0
11065091|NCT01033643|12246490|FG000|STARTED|Overall Study||6
11065092|NCT01033643|12246491|FG001|STARTED|Overall Study||6
11065093|NCT01033643|12246492|FG002|STARTED|Overall Study||6
11065094|NCT01033643|12246493|FG003|STARTED|Overall Study||4
11065095|NCT01033643|12246494|FG004|STARTED|Overall Study||0
11065096|NCT01033643|12246495|FG005|STARTED|Overall Study||8
11065097|NCT01033643|12246490|FG000|COMPLETED|Overall Study||6
11065098|NCT01033643|12246491|FG001|COMPLETED|Overall Study||3
11065099|NCT01033643|12246492|FG002|COMPLETED|Overall Study||6
11065100|NCT01033643|12246493|FG003|COMPLETED|Overall Study||4
11065101|NCT01033643|12246494|FG004|COMPLETED|Overall Study||0
11065102|NCT01033643|12246495|FG005|COMPLETED|Overall Study||7
11065103|NCT01033643|12246490|FG000|NOT COMPLETED|Overall Study||0
11065104|NCT01033643|12246491|FG001|NOT COMPLETED|Overall Study||3
11065105|NCT01033643|12246492|FG002|NOT COMPLETED|Overall Study||0
11065106|NCT01033643|12246493|FG003|NOT COMPLETED|Overall Study||0
11065107|NCT01033643|12246494|FG004|NOT COMPLETED|Overall Study||0
11065108|NCT01033643|12246495|FG005|NOT COMPLETED|Overall Study||1
11065109|NCT01033734|12246509|FG000|STARTED|Overall Study||8
11065110|NCT01033734|12246509|FG000|COMPLETED|Overall Study||7
11065111|NCT01033734|12246509|FG000|NOT COMPLETED|Overall Study||1
11065112|NCT01033747|12246524|FG000|STARTED|Overall Study||51
11065113|NCT01033747|12246525|FG001|STARTED|Overall Study||19
11065114|NCT01033747|12246524|FG000|COMPLETED|Overall Study||14
11065115|NCT01033747|12246525|FG001|COMPLETED|Overall Study||4
11065116|NCT01033747|12246524|FG000|NOT COMPLETED|Overall Study||37
11065117|NCT01033747|12246525|FG001|NOT COMPLETED|Overall Study||15
11065118|NCT01033773|12246531|FG000|STARTED|Overall Study||86
11065119|NCT01033773|12246531|FG000|COMPLETED|Overall Study||51
11065120|NCT01033773|12246531|FG000|NOT COMPLETED|Overall Study||35
11065121|NCT01033825|12246542|FG000|STARTED|Overall Study||51
11065122|NCT01033825|12246543|FG001|STARTED|Overall Study||60
11065123|NCT01033825|12246544|FG002|STARTED|Overall Study||57
11065124|NCT01033825|12246545|FG003|STARTED|Overall Study||48
11065125|NCT01033825|12246546|FG004|STARTED|Overall Study||58
11065126|NCT01033825|12246547|FG005|STARTED|Overall Study||18
11065127|NCT01033825|12246548|FG006|STARTED|Overall Study||18
11065128|NCT01033825|12246542|FG000|COMPLETED|Overall Study||48
11065129|NCT01033825|12246543|FG001|COMPLETED|Overall Study||57
11065130|NCT01033825|12246544|FG002|COMPLETED|Overall Study||55
11065131|NCT01033825|12246545|FG003|COMPLETED|Overall Study||46
11065132|NCT01033825|12246546|FG004|COMPLETED|Overall Study||56
11065133|NCT01033825|12246547|FG005|COMPLETED|Overall Study||18
11065134|NCT01033825|12246548|FG006|COMPLETED|Overall Study||18
11065135|NCT01033825|12246542|FG000|NOT COMPLETED|Overall Study||3
11065136|NCT01033825|12246543|FG001|NOT COMPLETED|Overall Study||3
11065137|NCT01033825|12246544|FG002|NOT COMPLETED|Overall Study||2
11065138|NCT01033825|12246545|FG003|NOT COMPLETED|Overall Study||2
11065139|NCT01033825|12246546|FG004|NOT COMPLETED|Overall Study||2
11065140|NCT01033825|12246547|FG005|NOT COMPLETED|Overall Study||0
11065141|NCT01033825|12246548|FG006|NOT COMPLETED|Overall Study||0
11065142|NCT01033851|12246568|FG000|STARTED|Overall Study||48
11065143|NCT01033851|12246569|FG001|STARTED|Overall Study||41
11065144|NCT01033851|12246568|FG000|COMPLETED|Overall Study||45
11065145|NCT01033851|12246569|FG001|COMPLETED|Overall Study||34
11065146|NCT01033851|12246568|FG000|NOT COMPLETED|Overall Study||3
11065147|NCT01033851|12246569|FG001|NOT COMPLETED|Overall Study||7
11065148|NCT01033864|12246577|FG000|STARTED|Overall Study||12
11065149|NCT01033864|12246578|FG001|STARTED|Overall Study||11
11065150|NCT01033864|12246577|FG000|COMPLETED|Overall Study||12
11065151|NCT01033864|12246578|FG001|COMPLETED|Overall Study||11
11065152|NCT01033864|12246577|FG000|NOT COMPLETED|Overall Study||0
11065153|NCT01033864|12246578|FG001|NOT COMPLETED|Overall Study||0
11065154|NCT01033942|12246587|FG000|STARTED|Overall Study||20
11065155|NCT01033942|12246588|FG001|STARTED|Overall Study||19
11065156|NCT01033942|12246589|FG002|STARTED|Overall Study||19
11065157|NCT01033942|12246587|FG000|COMPLETED|Overall Study||18
11065158|NCT01033942|12246588|FG001|COMPLETED|Overall Study||15
11065159|NCT01033942|12246589|FG002|COMPLETED|Overall Study||18
11065160|NCT01033942|12246587|FG000|NOT COMPLETED|Overall Study||2
11065161|NCT01033942|12246588|FG001|NOT COMPLETED|Overall Study||4
11065162|NCT01033942|12246589|FG002|NOT COMPLETED|Overall Study||1
11065163|NCT01034111|12246599|FG000|STARTED|Overall Study||30
11065164|NCT01034111|12246599|FG000|COMPLETED|Overall Study||30
11065165|NCT01034111|12246599|FG000|NOT COMPLETED|Overall Study||0
11065166|NCT01034137|12246606|FG000|STARTED|Overall Study||106
11065167|NCT01034137|12246607|FG001|STARTED|Overall Study||103
11065168|NCT01034137|12246608|FG002|STARTED|Overall Study||108
11065169|NCT01034137|12246606|FG000|COMPLETED|Overall Study||78
11065170|NCT01034137|12246607|FG001|COMPLETED|Overall Study||81
11065171|NCT01034137|12246608|FG002|COMPLETED|Overall Study||78
11065172|NCT01034137|12246606|FG000|NOT COMPLETED|Overall Study||28
11065173|NCT01034137|12246607|FG001|NOT COMPLETED|Overall Study||22
11065174|NCT01034137|12246608|FG002|NOT COMPLETED|Overall Study||30
11065175|NCT01034163|12246619|FG000|STARTED|Overall Study||27
11065176|NCT01034163|12246620|FG001|STARTED|Overall Study||14
11065177|NCT01034163|12246619|FG000|Untreated (Not in Safety Set)|Overall Study||1
11065178|NCT01034163|12246620|FG001|Untreated (Not in Safety Set)|Overall Study||2
11065179|NCT01034163|12246619|FG000|Safety Set|Overall Study||26
11065180|NCT01034163|12246620|FG001|Safety Set|Overall Study||12
11065181|NCT01034163|12246619|FG000|In Open Label Phase After Unblinding|Overall Study||5
11065182|NCT01034163|12246620|FG001|In Open Label Phase After Unblinding|Overall Study||0
11065183|NCT01034163|12246619|FG000|COMPLETED|Overall Study||0
11065184|NCT01034163|12246620|FG001|COMPLETED|Overall Study||0
11065185|NCT01034163|12246619|FG000|NOT COMPLETED|Overall Study||27
11345777|NCT02971631|12542896|FG001|COMPLETED|First Intervention - One Day||2
11345778|NCT02971631|12542895|FG000|NOT COMPLETED|First Intervention - One Day||0
11345779|NCT02971631|12542896|FG001|NOT COMPLETED|First Intervention - One Day||0
11345780|NCT02971631|12542895|FG000|STARTED|Second Intervention - One Day||3
11345781|NCT02971631|12542896|FG001|STARTED|Second Intervention - One Day||2
11345782|NCT02971631|12542895|FG000|COMPLETED|Second Intervention - One Day||3
11345783|NCT02971631|12542896|FG001|COMPLETED|Second Intervention - One Day||2
11345784|NCT02971631|12542895|FG000|NOT COMPLETED|Second Intervention - One Day||0
11345785|NCT02971631|12542896|FG001|NOT COMPLETED|Second Intervention - One Day||0
11345786|NCT02971670|12542907|FG000|STARTED|Overall Study||13
11345787|NCT02971670|12542908|FG001|STARTED|Overall Study||2
11345788|NCT02971670|12542909|FG002|STARTED|Overall Study||5
11345789|NCT02971670|12542910|FG003|STARTED|Overall Study||3
11345790|NCT02971670|12542907|FG000|COMPLETED|Overall Study||9
11345791|NCT02971670|12542908|FG001|COMPLETED|Overall Study||1
11345792|NCT02971670|12542909|FG002|COMPLETED|Overall Study||4
11065186|NCT01034163|12246620|FG001|NOT COMPLETED|Overall Study||14
11065187|NCT01034176|12246628|FG000|STARTED|Overall Study||22
11065188|NCT01034176|12246629|FG001|STARTED|Overall Study||21
11065189|NCT01034176|12246628|FG000|COMPLETED|Overall Study||20
11345793|NCT02971670|12542910|FG003|COMPLETED|Overall Study||1
11345794|NCT02971670|12542907|FG000|NOT COMPLETED|Overall Study||4
11345795|NCT02971670|12542908|FG001|NOT COMPLETED|Overall Study||1
11345796|NCT02971670|12542909|FG002|NOT COMPLETED|Overall Study||1
11345797|NCT02971670|12542910|FG003|NOT COMPLETED|Overall Study||2
11065190|NCT01034176|12246629|FG001|COMPLETED|Overall Study||19
11065191|NCT01034176|12246628|FG000|NOT COMPLETED|Overall Study||2
11345798|NCT02971735|12542922|FG000|STARTED|Overall Study||30
11065192|NCT01034176|12246629|FG001|NOT COMPLETED|Overall Study||2
11065193|NCT01034358|12246635|FG000|STARTED|Overall Study||15
11065194|NCT01034358|12246635|FG000|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
11065195|NCT01034358|12246635|FG000|NOT COMPLETED|Overall Study||2
11065196|NCT01034397|12246641|FG000|STARTED|Overall Study||35
11065197|NCT01034397|12246642|FG001|STARTED|Overall Study||19
11065198|NCT01034397|12246641|FG000|COMPLETED|Overall Study||28
11065199|NCT01034397|12246642|FG001|COMPLETED|Overall Study||17
11065200|NCT01034397|12246641|FG000|NOT COMPLETED|Overall Study||7
11065201|NCT01034397|12246642|FG001|NOT COMPLETED|Overall Study||2
11065202|NCT01034462|12246659|FG000|STARTED|Overall Study||217
11065203|NCT01034462|12246660|FG001|STARTED|Overall Study||217
11065204|NCT01034462|12246659|FG000|COMPLETED|Overall Study||172
11065205|NCT01034462|12246660|FG001|COMPLETED|Overall Study||163
11065206|NCT01034462|12246659|FG000|NOT COMPLETED|Overall Study||45
11065207|NCT01034462|12246660|FG001|NOT COMPLETED|Overall Study||54
11065208|NCT01034527|12246670|FG000|STARTED|Overall Study||307
11065209|NCT01034527|12246671|FG001|STARTED|Overall Study||216
11065210|NCT01034527|12246670|FG000|COMPLETED|Overall Study||307
11065211|NCT01034527|12246671|FG001|COMPLETED|Overall Study||216
11065212|NCT01034527|12246670|FG000|NOT COMPLETED|Overall Study||0
11065213|NCT01034527|12246671|FG001|NOT COMPLETED|Overall Study||0
11065214|NCT01034540|12246679|FG000|STARTED|Overall Study||11
11065215|NCT01034540|12246680|FG001|STARTED|Overall Study||12
11065216|NCT01034540|12246679|FG000|Completed 1st Treatment Intervention|Overall Study||11
11065217|NCT01034540|12246680|FG001|Completed 1st Treatment Intervention|Overall Study||11
11065218|NCT01034540|12246679|FG000|COMPLETED|Overall Study||11
11065219|NCT01034540|12246680|FG001|COMPLETED|Overall Study||11
11065220|NCT01034540|12246679|FG000|NOT COMPLETED|Overall Study||0
11065221|NCT01034540|12246680|FG001|NOT COMPLETED|Overall Study||1
11205901|NCT01863017|12396825|FG000|STARTED|Overall Study||12
11205902|NCT01863017|12396826|FG001|STARTED|Overall Study||19
11205903|NCT01863017|12396825|FG000|Normal Weight Participants|Overall Study||5
11205904|NCT01863017|12396826|FG001|Normal Weight Participants|Overall Study||5
11205905|NCT01863017|12396825|FG000|Obese Participants|Overall Study||4
11205906|NCT01863017|12396826|FG001|Obese Participants|Overall Study||7
11205907|NCT01863017|12396825|FG000|Participants With PWS|Overall Study||3
11205908|NCT01863017|12396826|FG001|Participants With PWS|Overall Study||7
11205909|NCT01863017|12396825|FG000|COMPLETED|Overall Study||12
11205910|NCT01863017|12396826|FG001|COMPLETED|Overall Study||19
11205911|NCT01863017|12396825|FG000|NOT COMPLETED|Overall Study||0
11205912|NCT01863017|12396826|FG001|NOT COMPLETED|Overall Study||0
11205913|NCT01863030|12396832|FG000|STARTED|Baseline||31
11205914|NCT01863030|12396832|FG000|COMPLETED|Baseline||31
11205915|NCT01863030|12396832|FG000|NOT COMPLETED|Baseline||0
11205916|NCT01863030|12396832|FG000|STARTED|Follow up||31
11205917|NCT01863030|12396832|FG000|2 Weeks|Follow up||31
11205918|NCT01863030|12396832|FG000|3 Months|Follow up||28
11205919|NCT01863030|12396832|FG000|6 Months|Follow up||29
11205920|NCT01863030|12396832|FG000|12 Months|Follow up||26
11205921|NCT01863030|12396832|FG000|24 Months|Follow up||13
11205922|NCT01863030|12396832|FG000|COMPLETED|Follow up||13
11205923|NCT01863030|12396832|FG000|NOT COMPLETED|Follow up||18
11345799|NCT02971735|12542923|FG001|STARTED|Overall Study||30
11345800|NCT02971735|12542922|FG000|COMPLETED|Overall Study||30
11345801|NCT02971735|12542923|FG001|COMPLETED|Overall Study||30
11345802|NCT02971735|12542922|FG000|NOT COMPLETED|Overall Study||0
11345803|NCT02971735|12542923|FG001|NOT COMPLETED|Overall Study||0
11345804|NCT02971800|12542929|FG000|STARTED|Overall Study||37
11345805|NCT02971800|12542929|FG000|COMPLETED|Overall Study||30
11205924|NCT01863134|12396839|FG000|STARTED|Overall Study||72
11205925|NCT01863134|12396840|FG001|STARTED|Overall Study||68
11205926|NCT01863134|12396839|FG000|COMPLETED|Overall Study||72
11345806|NCT02971800|12542929|FG000|NOT COMPLETED|Overall Study||7
11345807|NCT02972242|12542935|FG000|STARTED|Overall Study||82
11345808|NCT02972242|12542936|FG001|STARTED|Overall Study||93
11345809|NCT02972242|12542935|FG000|COMPLETED|Overall Study||81
11345810|NCT02972242|12542936|FG001|COMPLETED|Overall Study||93
11345811|NCT02972242|12542935|FG000|NOT COMPLETED|Overall Study||1
11205927|NCT01863134|12396840|FG001|COMPLETED|Overall Study||68
11205928|NCT01863134|12396839|FG000|NOT COMPLETED|Overall Study||0
11205929|NCT01863134|12396840|FG001|NOT COMPLETED|Overall Study||0
11205930|NCT01863368|12396848|FG000|STARTED|Phase I, Day 0 to Day 35||46
11205931|NCT01863368|12396849|FG001|STARTED|Phase I, Day 0 to Day 35||48
11205932|NCT01863368|12396848|FG000|Treated|Phase I, Day 0 to Day 35||46
11205933|NCT01863368|12396849|FG001|Treated|Phase I, Day 0 to Day 35||47
11205934|NCT01863368|12396848|FG000|COMPLETED|Phase I, Day 0 to Day 35||43
11205935|NCT01863368|12396849|FG001|COMPLETED|Phase I, Day 0 to Day 35||41
11205936|NCT01863368|12396848|FG000|NOT COMPLETED|Phase I, Day 0 to Day 35||3
11065222|NCT01034553|12246688|FG000|STARTED|Overall Study||3
11065223|NCT01034553|12246689|FG001|STARTED|Overall Study||4
11065224|NCT01034553|12246690|FG002|STARTED|Overall Study||3
11345812|NCT02972242|12542936|FG001|NOT COMPLETED|Overall Study||0
11345813|NCT02972359|12542942|FG000|STARTED|Overall Study||318
11345814|NCT02972359|12542942|FG000|COMPLETED|Overall Study||247
11345815|NCT02972359|12542942|FG000|NOT COMPLETED|Overall Study||71
11065225|NCT01034553|12246691|FG003|STARTED|Overall Study||3
11065226|NCT01034553|12246692|FG004|STARTED|Overall Study||6
11065227|NCT01034553|12246693|FG005|STARTED|Overall Study||7
11065228|NCT01034553|12246688|FG000|COMPLETED|Overall Study||3
11065229|NCT01034553|12246689|FG001|COMPLETED|Overall Study||4
11345816|NCT02972502|12542948|FG000|STARTED|Overall Study||35
11345817|NCT02972502|12542949|FG001|STARTED|Overall Study||31
11345818|NCT02972502|12542948|FG000|COMPLETED|Overall Study||31
11345819|NCT02972502|12542949|FG001|COMPLETED|Overall Study||29
11345820|NCT02972502|12542948|FG000|NOT COMPLETED|Overall Study||4
11345821|NCT02972502|12542949|FG001|NOT COMPLETED|Overall Study||2
11345822|NCT02972515|12542955|FG000|STARTED|Overall Study||166
11345823|NCT02972515|12542955|FG000|COMPLETED|Overall Study||88
11345824|NCT02972515|12542955|FG000|NOT COMPLETED|Overall Study||78
11345825|NCT02972554|12542961|FG000|STARTED|Overall Study||44
11345826|NCT02972554|12542962|FG001|STARTED|Overall Study||48
11345827|NCT02972554|12542961|FG000|COMPLETED|Overall Study||44
11345828|NCT02972554|12542962|FG001|COMPLETED|Overall Study||48
11345829|NCT02972554|12542961|FG000|NOT COMPLETED|Overall Study||0
11345830|NCT02972554|12542962|FG001|NOT COMPLETED|Overall Study||0
11345831|NCT02972632|12542968|FG000|STARTED|Overall Study||123
11345832|NCT02972632|12542968|FG000|Safety Analysis Set|Overall Study||122
11345833|NCT02972632|12542968|FG000|COMPLETED|Overall Study||106
11345834|NCT02972632|12542968|FG000|NOT COMPLETED|Overall Study||17
11345835|NCT02972658|12542976|FG000|STARTED|Overall Study||76
11345836|NCT02972658|12542977|FG001|STARTED|Overall Study||139
11345837|NCT02972658|12542978|FG002|STARTED|Overall Study||75
11345838|NCT02972658|12542979|FG003|STARTED|Overall Study||131
11345839|NCT02972658|12542976|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
11345840|NCT02972658|12542977|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139
11345841|NCT02972658|12542978|FG002|Received at Least 1 Dose of Study Drug|Overall Study||74
11345842|NCT02972658|12542979|FG003|Received at Least 1 Dose of Study Drug|Overall Study||131
11345843|NCT02972658|12542976|FG000|COMPLETED|Overall Study||0
11345844|NCT02972658|12542977|FG001|COMPLETED|Overall Study|"1 participant was incorrectly marked as Completed rather than study terminated by Sponsor."|1
11345845|NCT02972658|12542978|FG002|COMPLETED|Overall Study||0
11345846|NCT02972658|12542979|FG003|COMPLETED|Overall Study||0
11345847|NCT02972658|12542976|FG000|NOT COMPLETED|Overall Study||76
11345848|NCT02972658|12542977|FG001|NOT COMPLETED|Overall Study||138
11345849|NCT02972658|12542978|FG002|NOT COMPLETED|Overall Study||75
11345850|NCT02972658|12542979|FG003|NOT COMPLETED|Overall Study||131
11345851|NCT02973048|12542991|FG000|STARTED|Overall Study||20
11345852|NCT02973048|12542992|FG001|STARTED|Overall Study||20
11345853|NCT02973048|12542991|FG000|COMPLETED|Overall Study||19
11345854|NCT02973048|12542992|FG001|COMPLETED|Overall Study||17
11345855|NCT02973048|12542991|FG000|NOT COMPLETED|Overall Study||1
11345856|NCT02973048|12542992|FG001|NOT COMPLETED|Overall Study||3
11345857|NCT02973087|12543000|FG000|STARTED|Overall Study||13
11345858|NCT02973087|12543001|FG001|STARTED|Overall Study||10
11345859|NCT02973087|12543000|FG000|COMPLETED|Overall Study||9
11345860|NCT02973087|12543001|FG001|COMPLETED|Overall Study||8
11345861|NCT02973087|12543000|FG000|NOT COMPLETED|Overall Study||4
11345862|NCT02973087|12543001|FG001|NOT COMPLETED|Overall Study||2
11345863|NCT02973100|12543012|FG000|STARTED|Overall Study||82
11345864|NCT02973100|12543013|FG001|STARTED|Overall Study||81
11345865|NCT02973100|12543014|FG002|STARTED|Overall Study||79
11345866|NCT02973100|12543015|FG003|STARTED|Overall Study||76
11345867|NCT02973100|12543012|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81
11345868|NCT02973100|12543013|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81
11345869|NCT02973100|12543014|FG002|Received at Least 1 Dose of Study Drug|Overall Study||79
11345870|NCT02973100|12543015|FG003|Received at Least 1 Dose of Study Drug|Overall Study||76
11345871|NCT02973100|12543012|FG000|COMPLETED|Overall Study||75
11345872|NCT02973100|12543013|FG001|COMPLETED|Overall Study||73
11345873|NCT02973100|12543014|FG002|COMPLETED|Overall Study||75
11345874|NCT02973100|12543015|FG003|COMPLETED|Overall Study||69
11345875|NCT02973100|12543012|FG000|NOT COMPLETED|Overall Study||7
11345876|NCT02973100|12543013|FG001|NOT COMPLETED|Overall Study||8
11345877|NCT02973100|12543014|FG002|NOT COMPLETED|Overall Study||4
11345878|NCT02973100|12543015|FG003|NOT COMPLETED|Overall Study||7
11345879|NCT02973438|12543032|FG000|STARTED|First Treatment Session (4 Days)||2
11345880|NCT02973438|12543033|FG001|STARTED|First Treatment Session (4 Days)||1
11345881|NCT02973438|12543034|FG002|STARTED|First Treatment Session (4 Days)||2
11345882|NCT02973438|12543035|FG003|STARTED|First Treatment Session (4 Days)||1
11345883|NCT02973438|12543032|FG000|COMPLETED|First Treatment Session (4 Days)||2
11345884|NCT02973438|12543033|FG001|COMPLETED|First Treatment Session (4 Days)||1
11345885|NCT02973438|12543034|FG002|COMPLETED|First Treatment Session (4 Days)||2
11345886|NCT02973438|12543035|FG003|COMPLETED|First Treatment Session (4 Days)||1
11345887|NCT02973438|12543032|FG000|NOT COMPLETED|First Treatment Session (4 Days)||0
11345888|NCT02973438|12543033|FG001|NOT COMPLETED|First Treatment Session (4 Days)||0
11345889|NCT02973438|12543034|FG002|NOT COMPLETED|First Treatment Session (4 Days)||0
11345890|NCT02973438|12543035|FG003|NOT COMPLETED|First Treatment Session (4 Days)||0
11065230|NCT01034553|12246690|FG002|COMPLETED|Overall Study||3
11345891|NCT02973438|12543032|FG000|STARTED|Washout (Three Weeks)||2
11345892|NCT02973438|12543033|FG001|STARTED|Washout (Three Weeks)||1
11065231|NCT01034553|12246691|FG003|COMPLETED|Overall Study||3
11065232|NCT01034553|12246692|FG004|COMPLETED|Overall Study||6
11065233|NCT01034553|12246693|FG005|COMPLETED|Overall Study||7
11065234|NCT01034553|12246688|FG000|NOT COMPLETED|Overall Study||0
11065235|NCT01034553|12246689|FG001|NOT COMPLETED|Overall Study||0
11065236|NCT01034553|12246690|FG002|NOT COMPLETED|Overall Study||0
11065237|NCT01034553|12246691|FG003|NOT COMPLETED|Overall Study||0
11065238|NCT01034553|12246692|FG004|NOT COMPLETED|Overall Study||0
11065239|NCT01034553|12246693|FG005|NOT COMPLETED|Overall Study||0
11065240|NCT01034579|12246709|FG000|STARTED|Overall Study||158
11065241|NCT01034579|12246710|FG001|STARTED|Overall Study||166
11065242|NCT01034579|12246709|FG000|COMPLETED|Overall Study||158
11065243|NCT01034579|12246710|FG001|COMPLETED|Overall Study||166
11065244|NCT01034579|12246709|FG000|NOT COMPLETED|Overall Study||0
11065245|NCT01034579|12246710|FG001|NOT COMPLETED|Overall Study||0
11065246|NCT01034592|12246716|FG000|STARTED|Overall Study||2
11065247|NCT01034592|12246716|FG000|COMPLETED|Overall Study||2
11065248|NCT01034592|12246716|FG000|NOT COMPLETED|Overall Study||0
11065249|NCT01034657|12246721|FG000|STARTED|Core Phase||34
11065250|NCT01034657|12246722|FG001|STARTED|Core Phase||0
11065251|NCT01034657|12246723|FG002|STARTED|Core Phase||0
11065252|NCT01034657|12246721|FG000|COMPLETED|Core Phase||20
11065253|NCT01034657|12246722|FG001|COMPLETED|Core Phase||0
11065254|NCT01034657|12246723|FG002|COMPLETED|Core Phase||0
11065255|NCT01034657|12246721|FG000|NOT COMPLETED|Core Phase||14
11065256|NCT01034657|12246722|FG001|NOT COMPLETED|Core Phase||0
11065257|NCT01034657|12246723|FG002|NOT COMPLETED|Core Phase||0
11065258|NCT01034657|12246721|FG000|STARTED|Randomized Phase||6
11065259|NCT01034657|12246722|FG001|STARTED|Randomized Phase||6
11065260|NCT01034657|12246723|FG002|STARTED|Randomized Phase||1
11065261|NCT01034657|12246721|FG000|COMPLETED|Randomized Phase||1
11065262|NCT01034657|12246722|FG001|COMPLETED|Randomized Phase||0
11065263|NCT01034657|12246723|FG002|COMPLETED|Randomized Phase||0
11065264|NCT01034657|12246721|FG000|NOT COMPLETED|Randomized Phase||5
11065265|NCT01034657|12246722|FG001|NOT COMPLETED|Randomized Phase||6
11065266|NCT01034657|12246723|FG002|NOT COMPLETED|Randomized Phase||1
11065267|NCT01034709|12246735|FG000|STARTED|Overall Study||53
11065268|NCT01034709|12246736|FG001|STARTED|Overall Study||58
11065269|NCT01034709|12246735|FG000|COMPLETED|Overall Study||44
11065270|NCT01034709|12246736|FG001|COMPLETED|Overall Study||42
11065271|NCT01034709|12246735|FG000|NOT COMPLETED|Overall Study||9
11065272|NCT01034709|12246736|FG001|NOT COMPLETED|Overall Study||16
11065273|NCT01035047|12246744|FG000|STARTED|Overall Study||52
11065274|NCT01035047|12246745|FG001|STARTED|Overall Study||53
11065275|NCT01035047|12246744|FG000|COMPLETED|Overall Study||52
11065276|NCT01035047|12246745|FG001|COMPLETED|Overall Study||53
11065277|NCT01035047|12246744|FG000|NOT COMPLETED|Overall Study||0
11065278|NCT01035047|12246745|FG001|NOT COMPLETED|Overall Study||0
11065279|NCT01035060|12246753|FG000|STARTED|Overall Study||39
11065280|NCT01035060|12246754|FG001|STARTED|Overall Study||29
11065281|NCT01035060|12246753|FG000|COMPLETED|Overall Study||15
11065282|NCT01035060|12246754|FG001|COMPLETED|Overall Study||15
11065283|NCT01035060|12246753|FG000|NOT COMPLETED|Overall Study||24
11065284|NCT01035060|12246754|FG001|NOT COMPLETED|Overall Study||14
11065285|NCT01035099|12246762|FG000|STARTED|Overall Study||18
11065286|NCT01035099|12246763|FG001|STARTED|Overall Study||22
11065287|NCT01035099|12246762|FG000|COMPLETED|Overall Study||18
11065288|NCT01035099|12246763|FG001|COMPLETED|Overall Study||22
11065289|NCT01035099|12246762|FG000|NOT COMPLETED|Overall Study||0
11065290|NCT01035099|12246763|FG001|NOT COMPLETED|Overall Study||0
11065291|NCT01035138|12246773|FG000|STARTED|Overall Study||73
11065292|NCT01035138|12246774|FG001|STARTED|Overall Study||60
11065293|NCT01035138|12246775|FG002|STARTED|Overall Study||47
11065294|NCT01035138|12246773|FG000|COMPLETED|Overall Study||0
11065295|NCT01035138|12246774|FG001|COMPLETED|Overall Study||0
11065296|NCT01035138|12246775|FG002|COMPLETED|Overall Study||0
11065297|NCT01035138|12246773|FG000|NOT COMPLETED|Overall Study||73
11065298|NCT01035138|12246774|FG001|NOT COMPLETED|Overall Study||60
11065299|NCT01035138|12246775|FG002|NOT COMPLETED|Overall Study||47
11065300|NCT01035151|12246787|FG000|STARTED|Overall Study||209
11065301|NCT01035151|12246788|FG001|STARTED|Overall Study||200
11065302|NCT01035151|12246787|FG000|COMPLETED|Overall Study||188
11065303|NCT01035151|12246788|FG001|COMPLETED|Overall Study||185
11065304|NCT01035151|12246787|FG000|NOT COMPLETED|Overall Study||21
11065305|NCT01035151|12246788|FG001|NOT COMPLETED|Overall Study||15
11065306|NCT01035229|12246796|FG000|STARTED|Overall Study||362
11065307|NCT01035229|12246797|FG001|STARTED|Overall Study||184
11065308|NCT01035229|12246796|FG000|COMPLETED|Overall Study||0
11065309|NCT01035229|12246797|FG001|COMPLETED|Overall Study||0
11065310|NCT01035229|12246796|FG000|NOT COMPLETED|Overall Study||362
11065311|NCT01035229|12246797|FG001|NOT COMPLETED|Overall Study||184
11065312|NCT01035255|12246807|FG000|STARTED|Overall Study||4209
11065313|NCT01035255|12246808|FG001|STARTED|Overall Study||4233
11065314|NCT01035255|12246807|FG000|GCP Violations|Overall Study||18
11065315|NCT01035255|12246808|FG001|GCP Violations|Overall Study||19
11065316|NCT01035255|12246807|FG000|Mis-randomized|Overall Study||4
11065317|NCT01035255|12246808|FG001|Mis-randomized|Overall Study||2
11065318|NCT01035255|12246807|FG000|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
11065319|NCT01035255|12246808|FG001|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
11065320|NCT01035255|12246807|FG000|COMPLETED|Overall Study||3468
11065321|NCT01035255|12246808|FG001|COMPLETED|Overall Study||3371
11065322|NCT01035255|12246807|FG000|NOT COMPLETED|Overall Study||741
11065323|NCT01035255|12246808|FG001|NOT COMPLETED|Overall Study||862
11065324|NCT01035333|12246814|FG000|STARTED|Overall Study||19
11065325|NCT01035333|12246814|FG000|COMPLETED|Overall Study||9
11065326|NCT01035333|12246814|FG000|NOT COMPLETED|Overall Study||10
11065327|NCT01035346|12246820|FG000|STARTED|Overall Study||7
11065328|NCT01035346|12246821|FG001|STARTED|Overall Study||9
11065329|NCT01035346|12246820|FG000|COMPLETED|Overall Study||7
11065330|NCT01035346|12246821|FG001|COMPLETED|Overall Study||9
11065331|NCT01035346|12246820|FG000|NOT COMPLETED|Overall Study||0
11065332|NCT01035346|12246821|FG001|NOT COMPLETED|Overall Study||0
11065333|NCT01035463|12246829|FG000|STARTED|Overall Study||6
11065334|NCT01035463|12246830|FG001|STARTED|Overall Study||3
11065335|NCT01035463|12246831|FG002|STARTED|Overall Study||6
11065336|NCT01035463|12246832|FG003|STARTED|Overall Study||4
11065337|NCT01035463|12246833|FG004|STARTED|Overall Study||7
11065338|NCT01035463|12246834|FG005|STARTED|Overall Study||33
11065339|NCT01035463|12246829|FG000|COMPLETED|Overall Study||6
11065340|NCT01035463|12246830|FG001|COMPLETED|Overall Study||1
11065341|NCT01035463|12246831|FG002|COMPLETED|Overall Study||1
11065342|NCT01035463|12246832|FG003|COMPLETED|Overall Study||2
11065343|NCT01035463|12246833|FG004|COMPLETED|Overall Study||1
11065344|NCT01035463|12246834|FG005|COMPLETED|Overall Study||15
11065345|NCT01035463|12246829|FG000|NOT COMPLETED|Overall Study||0
11065346|NCT01035463|12246830|FG001|NOT COMPLETED|Overall Study||2
11065347|NCT01035463|12246831|FG002|NOT COMPLETED|Overall Study||5
11065348|NCT01035463|12246832|FG003|NOT COMPLETED|Overall Study||2
11065349|NCT01035463|12246833|FG004|NOT COMPLETED|Overall Study||6
11065350|NCT01035463|12246834|FG005|NOT COMPLETED|Overall Study||18
11065351|NCT01035606|12246844|FG000|STARTED|Overall Study||19
11065352|NCT01035606|12246845|FG001|STARTED|Overall Study||19
11065353|NCT01035606|12246846|FG002|STARTED|Overall Study||11
11065354|NCT01035606|12246844|FG000|COMPLETED|Overall Study||16
11065355|NCT01035606|12246845|FG001|COMPLETED|Overall Study||16
11065356|NCT01035606|12246846|FG002|COMPLETED|Overall Study||7
11065357|NCT01035606|12246844|FG000|NOT COMPLETED|Overall Study||3
11065358|NCT01035606|12246845|FG001|NOT COMPLETED|Overall Study||3
11065359|NCT01035606|12246846|FG002|NOT COMPLETED|Overall Study||4
11065360|NCT01035658|12246858|FG000|STARTED|Overall Study||5
11065361|NCT01035658|12246859|FG001|STARTED|Overall Study||8
11065362|NCT01035658|12246860|FG002|STARTED|Overall Study||3
11065363|NCT01035658|12246861|FG003|STARTED|Overall Study||6
11065364|NCT01035658|12246858|FG000|COMPLETED|Overall Study||5
11065365|NCT01035658|12246859|FG001|COMPLETED|Overall Study||8
11065366|NCT01035658|12246860|FG002|COMPLETED|Overall Study||3
11065367|NCT01035658|12246861|FG003|COMPLETED|Overall Study||6
11065368|NCT01035658|12246858|FG000|NOT COMPLETED|Overall Study||0
11065369|NCT01035658|12246859|FG001|NOT COMPLETED|Overall Study||0
11065370|NCT01035658|12246860|FG002|NOT COMPLETED|Overall Study||0
11065371|NCT01035658|12246861|FG003|NOT COMPLETED|Overall Study||0
11065372|NCT01035749|12246878|FG000|STARTED|Overall Study||66
11065373|NCT01035749|12246879|FG001|STARTED|Overall Study||66
11065374|NCT01035749|12246880|FG002|STARTED|Overall Study||68
11065375|NCT01035749|12246881|FG003|STARTED|Overall Study||110
11065376|NCT01035749|12246878|FG000|COMPLETED|Overall Study||66
11065377|NCT01035749|12246879|FG001|COMPLETED|Overall Study||66
11065378|NCT01035749|12246880|FG002|COMPLETED|Overall Study||68
11065379|NCT01035749|12246881|FG003|COMPLETED|Overall Study||110
11065380|NCT01035749|12246878|FG000|NOT COMPLETED|Overall Study||0
11065381|NCT01035749|12246879|FG001|NOT COMPLETED|Overall Study||0
11065382|NCT01035749|12246880|FG002|NOT COMPLETED|Overall Study||0
11065383|NCT01035749|12246881|FG003|NOT COMPLETED|Overall Study||0
11065384|NCT01035788|12246893|FG000|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
11065385|NCT01035788|12246894|FG001|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
11065386|NCT01035788|12246893|FG000|COMPLETED|Overall Study||17
11065387|NCT01035788|12246894|FG001|COMPLETED|Overall Study||9
11065388|NCT01035788|12246893|FG000|NOT COMPLETED|Overall Study||6
11065389|NCT01035788|12246894|FG001|NOT COMPLETED|Overall Study||14
11065390|NCT01035905|12246902|FG000|STARTED|Overall Study||32
11065391|NCT01035905|12246903|FG001|STARTED|Overall Study||31
11065392|NCT01035905|12246902|FG000|COMPLETED|Overall Study||31
11065393|NCT01035905|12246903|FG001|COMPLETED|Overall Study||30
11065394|NCT01035905|12246902|FG000|NOT COMPLETED|Overall Study||1
11065395|NCT01035905|12246903|FG001|NOT COMPLETED|Overall Study||1
11065396|NCT01036009|12246911|FG000|STARTED|Overall Study||17
11065397|NCT01036009|12246912|FG001|STARTED|Overall Study||26
11065398|NCT01036009|12246911|FG000|COMPLETED|Overall Study||17
11065399|NCT01036009|12246912|FG001|COMPLETED|Overall Study||26
11065400|NCT01036009|12246911|FG000|NOT COMPLETED|Overall Study||0
11065401|NCT01036009|12246912|FG001|NOT COMPLETED|Overall Study||0
11065402|NCT01036022|12246925|FG000|STARTED|Overall Study||15
11065403|NCT01036022|12246926|FG001|STARTED|Overall Study||11
11065404|NCT01036022|12246927|FG002|STARTED|Overall Study||12
11065405|NCT01036022|12246928|FG003|STARTED|Overall Study||12
11065406|NCT01036022|12246929|FG004|STARTED|Overall Study||12
11065407|NCT01036022|12246930|FG005|STARTED|Overall Study||16
11065408|NCT01036022|12246925|FG000|COMPLETED|Overall Study||13
11065409|NCT01036022|12246926|FG001|COMPLETED|Overall Study||7
11065410|NCT01036022|12246927|FG002|COMPLETED|Overall Study||8
11065411|NCT01036022|12246928|FG003|COMPLETED|Overall Study||10
11065412|NCT01036022|12246929|FG004|COMPLETED|Overall Study||9
11065413|NCT01036022|12246930|FG005|COMPLETED|Overall Study||13
11065414|NCT01036022|12246925|FG000|NOT COMPLETED|Overall Study||2
11065415|NCT01036022|12246926|FG001|NOT COMPLETED|Overall Study||4
11065416|NCT01036022|12246927|FG002|NOT COMPLETED|Overall Study||4
11065417|NCT01036022|12246928|FG003|NOT COMPLETED|Overall Study||2
11065418|NCT01036022|12246929|FG004|NOT COMPLETED|Overall Study||3
11065419|NCT01036022|12246930|FG005|NOT COMPLETED|Overall Study||3
11065420|NCT01036165|12246952|FG000|STARTED|Overall Study||103
11065421|NCT01036165|12246952|FG000|COMPLETED|Overall Study||88
11065422|NCT01036165|12246952|FG000|NOT COMPLETED|Overall Study||15
11065423|NCT01036321|12246958|FG000|STARTED|Overall Study||36
11065424|NCT01036321|12246959|FG001|STARTED|Overall Study||35
11065425|NCT01036321|12246958|FG000|COMPLETED|Overall Study||31
11345893|NCT02973438|12543034|FG002|STARTED|Washout (Three Weeks)||2
11345894|NCT02973438|12543035|FG003|STARTED|Washout (Three Weeks)||1
11345895|NCT02973438|12543032|FG000|COMPLETED|Washout (Three Weeks)||2
11345896|NCT02973438|12543033|FG001|COMPLETED|Washout (Three Weeks)||1
11345897|NCT02973438|12543034|FG002|COMPLETED|Washout (Three Weeks)||2
11345898|NCT02973438|12543035|FG003|COMPLETED|Washout (Three Weeks)||1
11345899|NCT02973438|12543032|FG000|NOT COMPLETED|Washout (Three Weeks)||0
11345900|NCT02973438|12543033|FG001|NOT COMPLETED|Washout (Three Weeks)||0
11345901|NCT02973438|12543034|FG002|NOT COMPLETED|Washout (Three Weeks)||0
11345902|NCT02973438|12543035|FG003|NOT COMPLETED|Washout (Three Weeks)||0
11345903|NCT02973438|12543032|FG000|STARTED|Second Treatment Session (4 Days)||2
11345904|NCT02973438|12543033|FG001|STARTED|Second Treatment Session (4 Days)||1
11345905|NCT02973438|12543034|FG002|STARTED|Second Treatment Session (4 Days)||2
11345906|NCT02973438|12543035|FG003|STARTED|Second Treatment Session (4 Days)||1
11345907|NCT02973438|12543032|FG000|COMPLETED|Second Treatment Session (4 Days)||2
11345908|NCT02973438|12543033|FG001|COMPLETED|Second Treatment Session (4 Days)||1
11345909|NCT02973438|12543034|FG002|COMPLETED|Second Treatment Session (4 Days)||2
11345910|NCT02973438|12543035|FG003|COMPLETED|Second Treatment Session (4 Days)||1
11345911|NCT02973438|12543032|FG000|NOT COMPLETED|Second Treatment Session (4 Days)||0
11345912|NCT02973438|12543033|FG001|NOT COMPLETED|Second Treatment Session (4 Days)||0
11345913|NCT02973438|12543034|FG002|NOT COMPLETED|Second Treatment Session (4 Days)||0
11345914|NCT02973438|12543035|FG003|NOT COMPLETED|Second Treatment Session (4 Days)||0
11345915|NCT02973477|12543048|FG000|STARTED|First Intervention||19
11345916|NCT02973477|12543049|FG001|STARTED|First Intervention||26
11345917|NCT02973477|12543048|FG000|COMPLETED|First Intervention||19
11345918|NCT02973477|12543049|FG001|COMPLETED|First Intervention||24
11345919|NCT02973477|12543048|FG000|NOT COMPLETED|First Intervention||0
11345920|NCT02973477|12543049|FG001|NOT COMPLETED|First Intervention||2
11345921|NCT02973477|12543048|FG000|STARTED|Washout||19
11345922|NCT02973477|12543049|FG001|STARTED|Washout||24
11345923|NCT02973477|12543048|FG000|COMPLETED|Washout||18
11345924|NCT02973477|12543049|FG001|COMPLETED|Washout||24
11345925|NCT02973477|12543048|FG000|NOT COMPLETED|Washout||1
11345926|NCT02973477|12543049|FG001|NOT COMPLETED|Washout||0
11345927|NCT02973477|12543048|FG000|STARTED|Second Intervention||18
11345928|NCT02973477|12543049|FG001|STARTED|Second Intervention||24
11065426|NCT01036321|12246959|FG001|COMPLETED|Overall Study||31
11345929|NCT02973477|12543048|FG000|COMPLETED|Second Intervention||17
11345930|NCT02973477|12543049|FG001|COMPLETED|Second Intervention||24
11065427|NCT01036321|12246958|FG000|NOT COMPLETED|Overall Study||5
11065428|NCT01036321|12246959|FG001|NOT COMPLETED|Overall Study||4
11065429|NCT01036438|12246967|FG000|STARTED|Overall Study||101
11065430|NCT01036438|12246968|FG001|STARTED|Overall Study||100
11065431|NCT01036438|12246967|FG000|COMPLETED|Overall Study||91
11065432|NCT01036438|12246968|FG001|COMPLETED|Overall Study||90
11065433|NCT01036438|12246967|FG000|NOT COMPLETED|Overall Study||10
11065434|NCT01036438|12246968|FG001|NOT COMPLETED|Overall Study||10
11065435|NCT01036490|12246976|FG000|STARTED|Overall Study||18
11065436|NCT01036490|12246977|FG001|STARTED|Overall Study||18
11065437|NCT01036490|12246976|FG000|COMPLETED|Overall Study||14
11065438|NCT01036490|12246977|FG001|COMPLETED|Overall Study||18
11065439|NCT01036490|12246976|FG000|NOT COMPLETED|Overall Study||4
11065440|NCT01036490|12246977|FG001|NOT COMPLETED|Overall Study||0
11065441|NCT01036529|12246985|FG000|STARTED|Overall Study||13
11065442|NCT01036529|12246986|FG001|STARTED|Overall Study||15
11065443|NCT01036529|12246985|FG000|Baseline Visit|Overall Study||10
11065444|NCT01036529|12246986|FG001|Baseline Visit|Overall Study||13
11065445|NCT01036529|12246985|FG000|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
11065446|NCT01036529|12246986|FG001|Index Procedure|Overall Study|Index Procedure: Surgery|11
11065447|NCT01036529|12246985|FG000|3 Month Follow-up|Overall Study||7
11065448|NCT01036529|12246986|FG001|3 Month Follow-up|Overall Study||9
11065449|NCT01036529|12246985|FG000|6 Month Follow-up|Overall Study||6
11065450|NCT01036529|12246986|FG001|6 Month Follow-up|Overall Study||7
11065451|NCT01036529|12246985|FG000|12 Month Follow-up|Overall Study||4
11065452|NCT01036529|12246986|FG001|12 Month Follow-up|Overall Study||3
11065453|NCT01036529|12246985|FG000|Requested Crossover|Overall Study||1
11065454|NCT01036529|12246986|FG001|Requested Crossover|Overall Study||2
11065455|NCT01036529|12246985|FG000|Crossover to Other Group|Overall Study||1
11065456|NCT01036529|12246986|FG001|Crossover to Other Group|Overall Study||1
11065457|NCT01036529|12246985|FG000|COMPLETED|Overall Study||0
11065458|NCT01036529|12246986|FG001|COMPLETED|Overall Study||0
11065459|NCT01036529|12246985|FG000|NOT COMPLETED|Overall Study||13
11065460|NCT01036529|12246986|FG001|NOT COMPLETED|Overall Study||15
11065461|NCT01036594|12246992|FG000|STARTED|Run-In: Ketoconazole Only (200 mg)||32
11065462|NCT01036594|12246993|FG001|STARTED|Run-In: Ketoconazole Only (200 mg)|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
11065463|NCT01036594|12246992|FG000|COMPLETED|Run-In: Ketoconazole Only (200 mg)||31
11065464|NCT01036594|12246993|FG001|COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
11065465|NCT01036594|12246992|FG000|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||1
11065466|NCT01036594|12246993|FG001|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
11065467|NCT01036594|12246992|FG000|STARTED|First Treatment Regimen||31
11065468|NCT01036594|12246993|FG001|STARTED|First Treatment Regimen|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
11065469|NCT01036594|12246992|FG000|COMPLETED|First Treatment Regimen||30
11065470|NCT01036594|12246993|FG001|COMPLETED|First Treatment Regimen||0
11065471|NCT01036594|12246992|FG000|NOT COMPLETED|First Treatment Regimen||1
11065472|NCT01036594|12246993|FG001|NOT COMPLETED|First Treatment Regimen||0
11345931|NCT02973477|12543048|FG000|NOT COMPLETED|Second Intervention||1
11345932|NCT02973477|12543049|FG001|NOT COMPLETED|Second Intervention||0
11345933|NCT02973503|12543061|FG000|STARTED|Overall Study||117
11345934|NCT02973503|12543061|FG000|COMPLETED|Overall Study||117
11345935|NCT02973503|12543061|FG000|NOT COMPLETED|Overall Study||0
11345936|NCT02973516|12543072|FG000|STARTED|Overall Study||30
11345937|NCT02973516|12543073|FG001|STARTED|Overall Study||10
11345938|NCT02973516|12543072|FG000|COMPLETED|Overall Study||30
11345939|NCT02973516|12543073|FG001|COMPLETED|Overall Study||10
11345940|NCT02973516|12543072|FG000|NOT COMPLETED|Overall Study||0
11345941|NCT02973516|12543073|FG001|NOT COMPLETED|Overall Study||0
11345942|NCT02973802|12543079|FG000|STARTED|Overall Study||12
11345943|NCT02973802|12543079|FG000|COMPLETED|Overall Study||10
11345944|NCT02973802|12543079|FG000|NOT COMPLETED|Overall Study||2
11345945|NCT02974010|12543088|FG000|STARTED|Overall Study||12
11345946|NCT02974010|12543089|FG001|STARTED|Overall Study||5
11345947|NCT02974010|12543090|FG002|STARTED|Overall Study||4
11345948|NCT02974010|12543091|FG003|STARTED|Overall Study||1
11345949|NCT02974010|12543088|FG000|COMPLETED|Overall Study||6
11345950|NCT02974010|12543089|FG001|COMPLETED|Overall Study||2
11345951|NCT02974010|12543090|FG002|COMPLETED|Overall Study||2
11345952|NCT02974010|12543091|FG003|COMPLETED|Overall Study||1
11345953|NCT02974010|12543088|FG000|NOT COMPLETED|Overall Study||6
11345954|NCT02974010|12543089|FG001|NOT COMPLETED|Overall Study||3
11345955|NCT02974010|12543090|FG002|NOT COMPLETED|Overall Study||2
11345956|NCT02974010|12543091|FG003|NOT COMPLETED|Overall Study||0
11345957|NCT02974088|12543103|FG000|STARTED|Overall Study||23
11345958|NCT02974088|12543104|FG001|STARTED|Overall Study||24
11345959|NCT02974088|12543103|FG000|COMPLETED|Overall Study||23
11345960|NCT02974088|12543104|FG001|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21
11345961|NCT02974088|12543103|FG000|NOT COMPLETED|Overall Study||0
11065473|NCT01036594|12246992|FG000|STARTED|Week 12 Evaluation||30
11065474|NCT01036594|12246993|FG001|STARTED|Week 12 Evaluation|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
11065475|NCT01036594|12246992|FG000|COMPLETED|Week 12 Evaluation||24
11065476|NCT01036594|12246993|FG001|COMPLETED|Week 12 Evaluation||0
11065477|NCT01036594|12246992|FG000|NOT COMPLETED|Week 12 Evaluation||6
11345962|NCT02974088|12543104|FG001|NOT COMPLETED|Overall Study||3
11345963|NCT02974114|12543113|FG000|STARTED|Overall Study||6
11065478|NCT01036594|12246993|FG001|NOT COMPLETED|Week 12 Evaluation||0
11065479|NCT01036594|12246992|FG000|STARTED|Treatment Regiments Post Week 12||15
11065480|NCT01036594|12246993|FG001|STARTED|Treatment Regiments Post Week 12||9
11345964|NCT02974114|12543114|FG001|STARTED|Overall Study||7
11345965|NCT02974114|12543115|FG002|STARTED|Overall Study||8
11345966|NCT02974114|12543113|FG000|COMPLETED|Overall Study||6
11345967|NCT02974114|12543114|FG001|COMPLETED|Overall Study||6
11345968|NCT02974114|12543115|FG002|COMPLETED|Overall Study||6
11345969|NCT02974114|12543113|FG000|NOT COMPLETED|Overall Study||0
11065481|NCT01036594|12246992|FG000|COMPLETED|Treatment Regiments Post Week 12||13
11065482|NCT01036594|12246993|FG001|COMPLETED|Treatment Regiments Post Week 12||5
11065483|NCT01036594|12246992|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||2
11065484|NCT01036594|12246993|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4
11065485|NCT01036724|12247001|FG000|STARTED|Overall Study||52
11065486|NCT01036724|12247002|FG001|STARTED|Overall Study||55
11065487|NCT01036724|12247001|FG000|COMPLETED|Overall Study||46
11065488|NCT01036724|12247002|FG001|COMPLETED|Overall Study||47
11065489|NCT01036724|12247001|FG000|NOT COMPLETED|Overall Study||6
11065490|NCT01036724|12247002|FG001|NOT COMPLETED|Overall Study||8
11065491|NCT01036763|12247008|FG000|STARTED|Overall Study||1264
11065492|NCT01036763|12247008|FG000|COMPLETED|Overall Study||1171
11065493|NCT01036763|12247008|FG000|NOT COMPLETED|Overall Study||93
11065494|NCT01036802|12247014|FG000|STARTED|Overall Study||2
11065495|NCT01036802|12247015|FG001|STARTED|Overall Study||1
11065496|NCT01036802|12247014|FG000|COMPLETED|Overall Study||2
11065497|NCT01036802|12247015|FG001|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
11065498|NCT01036802|12247014|FG000|NOT COMPLETED|Overall Study||0
11065499|NCT01036802|12247015|FG001|NOT COMPLETED|Overall Study||0
11065500|NCT01037088|12247022|FG000|STARTED|Overall Study||39
11065501|NCT01037088|12247022|FG000|Received 3.53% THC|Overall Study||36
11065502|NCT01037088|12247022|FG000|Received 1.29% THC|Overall Study||37
11065503|NCT01037088|12247022|FG000|Received Placebo|Overall Study||38
11065504|NCT01037088|12247022|FG000|COMPLETED|Overall Study||36
11065505|NCT01037088|12247022|FG000|NOT COMPLETED|Overall Study||3
11065506|NCT01037114|12247031|FG000|STARTED|Year 16||49
11065507|NCT01037114|12247031|FG000|COMPLETED|Year 16||49
11065508|NCT01037114|12247031|FG000|NOT COMPLETED|Year 16||0
11065509|NCT01037114|12247031|FG000|STARTED|Year 17||48
11065510|NCT01037114|12247031|FG000|COMPLETED|Year 17||48
11065511|NCT01037114|12247031|FG000|NOT COMPLETED|Year 17||0
11065512|NCT01037114|12247031|FG000|STARTED|Year 18||44
11065513|NCT01037114|12247031|FG000|COMPLETED|Year 18||44
11065514|NCT01037114|12247031|FG000|NOT COMPLETED|Year 18||0
11065515|NCT01037114|12247031|FG000|STARTED|Year 19||45
11065516|NCT01037114|12247031|FG000|COMPLETED|Year 19||45
11065517|NCT01037114|12247031|FG000|NOT COMPLETED|Year 19||0
11065518|NCT01037114|12247031|FG000|STARTED|Year 20||45
11065519|NCT01037114|12247031|FG000|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
11065520|NCT01037114|12247031|FG000|NOT COMPLETED|Year 20||1
11065521|NCT01037127|12247037|FG000|STARTED|Overall Study||40
11065522|NCT01037127|12247038|FG001|STARTED|Overall Study||57
11065523|NCT01037127|12247037|FG000|COMPLETED|Overall Study||35
11065524|NCT01037127|12247038|FG001|COMPLETED|Overall Study||36
11065525|NCT01037127|12247037|FG000|NOT COMPLETED|Overall Study||5
11065526|NCT01037127|12247038|FG001|NOT COMPLETED|Overall Study||21
11065527|NCT01037192|12247056|FG000|STARTED|Overall Study||3
11065528|NCT01037192|12247057|FG001|STARTED|Overall Study||1
11065529|NCT01037192|12247056|FG000|COMPLETED|Overall Study||3
11065530|NCT01037192|12247057|FG001|COMPLETED|Overall Study||1
11065531|NCT01037192|12247056|FG000|NOT COMPLETED|Overall Study||0
11065532|NCT01037192|12247057|FG001|NOT COMPLETED|Overall Study||0
11065533|NCT01037218|12247069|FG000|STARTED|Overall Study||147
11065534|NCT01037218|12247070|FG001|STARTED|Overall Study||149
11065535|NCT01037218|12247071|FG002|STARTED|Overall Study||155
11065536|NCT01037218|12247072|FG003|STARTED|Overall Study||150
11065537|NCT01037218|12247069|FG000|Safety Population|Overall Study||147
11065538|NCT01037218|12247070|FG001|Safety Population|Overall Study||148
11065539|NCT01037218|12247071|FG002|Safety Population|Overall Study||154
11065540|NCT01037218|12247072|FG003|Safety Population|Overall Study||150
11065541|NCT01037218|12247069|FG000|mITT Population|Overall Study||141
11065542|NCT01037218|12247070|FG001|mITT Population|Overall Study||140
11065543|NCT01037218|12247071|FG002|mITT Population|Overall Study||147
11065544|NCT01037218|12247072|FG003|mITT Population|Overall Study||141
11065545|NCT01037218|12247069|FG000|COMPLETED|Overall Study||131
11065546|NCT01037218|12247070|FG001|COMPLETED|Overall Study||128
11065547|NCT01037218|12247071|FG002|COMPLETED|Overall Study||134
11065548|NCT01037218|12247072|FG003|COMPLETED|Overall Study||134
11065549|NCT01037218|12247069|FG000|NOT COMPLETED|Overall Study||16
11065550|NCT01037218|12247070|FG001|NOT COMPLETED|Overall Study||21
11065551|NCT01037218|12247071|FG002|NOT COMPLETED|Overall Study||21
11065552|NCT01037218|12247072|FG003|NOT COMPLETED|Overall Study||16
11065553|NCT01037244|12247086|FG000|STARTED|Overall Study||154
11065554|NCT01037244|12247087|FG001|STARTED|Overall Study||152
11065555|NCT01037244|12247088|FG002|STARTED|Overall Study||158
11065556|NCT01037244|12247089|FG003|STARTED|Overall Study||154
11065557|NCT01037244|12247086|FG000|mITT (Modified Intent-to-Treat)|Overall Study||150
11065558|NCT01037244|12247087|FG001|mITT (Modified Intent-to-Treat)|Overall Study||148
11065559|NCT01037244|12247088|FG002|mITT (Modified Intent-to-Treat)|Overall Study||154
11065560|NCT01037244|12247089|FG003|mITT (Modified Intent-to-Treat)|Overall Study||153
11065561|NCT01037244|12247086|FG000|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
11065562|NCT01037244|12247087|FG001|Safety Population|Overall Study||150
11065563|NCT01037244|12247088|FG002|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
11065564|NCT01037244|12247089|FG003|Safety Population|Overall Study||152
11065565|NCT01037244|12247086|FG000|COMPLETED|Overall Study||141
11065566|NCT01037244|12247087|FG001|COMPLETED|Overall Study||138
11065567|NCT01037244|12247088|FG002|COMPLETED|Overall Study||144
11065568|NCT01037244|12247089|FG003|COMPLETED|Overall Study||140
11065569|NCT01037244|12247086|FG000|NOT COMPLETED|Overall Study||13
11065570|NCT01037244|12247087|FG001|NOT COMPLETED|Overall Study||14
11065571|NCT01037244|12247088|FG002|NOT COMPLETED|Overall Study||14
11065572|NCT01037244|12247089|FG003|NOT COMPLETED|Overall Study||14
11065573|NCT01037309|12247105|FG000|STARTED|Subcutaneous Cohort 1 - 6||3
11065574|NCT01037309|12247106|FG001|STARTED|Subcutaneous Cohort 1 - 6||3
11065575|NCT01037309|12247107|FG002|STARTED|Subcutaneous Cohort 1 - 6||3
11065576|NCT01037309|12247108|FG003|STARTED|Subcutaneous Cohort 1 - 6||3
11065577|NCT01037309|12247109|FG004|STARTED|Subcutaneous Cohort 1 - 6||3
11065578|NCT01037309|12247110|FG005|STARTED|Subcutaneous Cohort 1 - 6||3
11065579|NCT01037309|12247111|FG006|STARTED|Subcutaneous Cohort 1 - 6||0
11065580|NCT01037309|12247112|FG007|STARTED|Subcutaneous Cohort 1 - 6||0
11065581|NCT01037309|12247113|FG008|STARTED|Subcutaneous Cohort 1 - 6||0
11065582|NCT01037309|12247105|FG000|COMPLETED|Subcutaneous Cohort 1 - 6||3
11065583|NCT01037309|12247106|FG001|COMPLETED|Subcutaneous Cohort 1 - 6||3
11065584|NCT01037309|12247107|FG002|COMPLETED|Subcutaneous Cohort 1 - 6||3
11065585|NCT01037309|12247108|FG003|COMPLETED|Subcutaneous Cohort 1 - 6||3
11065586|NCT01037309|12247109|FG004|COMPLETED|Subcutaneous Cohort 1 - 6||3
11065587|NCT01037309|12247110|FG005|COMPLETED|Subcutaneous Cohort 1 - 6||3
11065588|NCT01037309|12247111|FG006|COMPLETED|Subcutaneous Cohort 1 - 6||0
11065589|NCT01037309|12247112|FG007|COMPLETED|Subcutaneous Cohort 1 - 6||0
11065590|NCT01037309|12247113|FG008|COMPLETED|Subcutaneous Cohort 1 - 6||0
11065591|NCT01037309|12247105|FG000|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
11065592|NCT01037309|12247106|FG001|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
11065593|NCT01037309|12247107|FG002|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
11065594|NCT01037309|12247108|FG003|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
11065595|NCT01037309|12247109|FG004|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
11065596|NCT01037309|12247110|FG005|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
11065597|NCT01037309|12247111|FG006|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
11065598|NCT01037309|12247112|FG007|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
11065599|NCT01037309|12247113|FG008|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
11065600|NCT01037309|12247105|FG000|STARTED|Intravenous Period 7 - 9||0
11065601|NCT01037309|12247106|FG001|STARTED|Intravenous Period 7 - 9||0
11065602|NCT01037309|12247107|FG002|STARTED|Intravenous Period 7 - 9||0
11065603|NCT01037309|12247108|FG003|STARTED|Intravenous Period 7 - 9||0
11065604|NCT01037309|12247109|FG004|STARTED|Intravenous Period 7 - 9||0
11065605|NCT01037309|12247110|FG005|STARTED|Intravenous Period 7 - 9||0
11065606|NCT01037309|12247111|FG006|STARTED|Intravenous Period 7 - 9||3
11065607|NCT01037309|12247112|FG007|STARTED|Intravenous Period 7 - 9||3
11065608|NCT01037309|12247113|FG008|STARTED|Intravenous Period 7 - 9||3
11065609|NCT01037309|12247105|FG000|COMPLETED|Intravenous Period 7 - 9||0
11065610|NCT01037309|12247106|FG001|COMPLETED|Intravenous Period 7 - 9||0
11065611|NCT01037309|12247107|FG002|COMPLETED|Intravenous Period 7 - 9||0
11065612|NCT01037309|12247108|FG003|COMPLETED|Intravenous Period 7 - 9||0
11065613|NCT01037309|12247109|FG004|COMPLETED|Intravenous Period 7 - 9||0
11065614|NCT01037309|12247110|FG005|COMPLETED|Intravenous Period 7 - 9||0
11065615|NCT01037309|12247111|FG006|COMPLETED|Intravenous Period 7 - 9||3
11065616|NCT01037309|12247112|FG007|COMPLETED|Intravenous Period 7 - 9||3
11065617|NCT01037309|12247113|FG008|COMPLETED|Intravenous Period 7 - 9||3
11065618|NCT01037309|12247105|FG000|NOT COMPLETED|Intravenous Period 7 - 9||0
11065619|NCT01037309|12247106|FG001|NOT COMPLETED|Intravenous Period 7 - 9||0
11065620|NCT01037309|12247107|FG002|NOT COMPLETED|Intravenous Period 7 - 9||0
11065621|NCT01037309|12247108|FG003|NOT COMPLETED|Intravenous Period 7 - 9||0
11065622|NCT01037309|12247109|FG004|NOT COMPLETED|Intravenous Period 7 - 9||0
11065623|NCT01037309|12247110|FG005|NOT COMPLETED|Intravenous Period 7 - 9||0
11065624|NCT01037309|12247111|FG006|NOT COMPLETED|Intravenous Period 7 - 9||0
11065625|NCT01037309|12247112|FG007|NOT COMPLETED|Intravenous Period 7 - 9||0
11065626|NCT01037309|12247113|FG008|NOT COMPLETED|Intravenous Period 7 - 9||0
11065627|NCT01037413|12247136|FG000|STARTED|Part A: Skin Testing||25
11065628|NCT01037413|12247137|FG001|STARTED|Part A: Skin Testing||0
11065629|NCT01037413|12247136|FG000|COMPLETED|Part A: Skin Testing||23
11065630|NCT01037413|12247137|FG001|COMPLETED|Part A: Skin Testing||0
11065631|NCT01037413|12247136|FG000|NOT COMPLETED|Part A: Skin Testing||2
11065632|NCT01037413|12247137|FG001|NOT COMPLETED|Part A: Skin Testing||0
11065633|NCT01037413|12247136|FG000|STARTED|Part B: Scar Revision|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
11065634|NCT01037413|12247137|FG001|STARTED|Part B: Scar Revision|Participants who completed Part A of the study and were negative for skin sensitization.|23
11065635|NCT01037413|12247136|FG000|Treated|Part B: Scar Revision||0
11065636|NCT01037413|12247137|FG001|Treated|Part B: Scar Revision||22
11065637|NCT01037413|12247136|FG000|COMPLETED|Part B: Scar Revision||0
11065638|NCT01037413|12247137|FG001|COMPLETED|Part B: Scar Revision||21
11065639|NCT01037413|12247136|FG000|NOT COMPLETED|Part B: Scar Revision||0
11065640|NCT01037413|12247137|FG001|NOT COMPLETED|Part B: Scar Revision||2
11065641|NCT01037452|12247154|FG000|STARTED|Overall Study||30
11065642|NCT01037452|12247155|FG001|STARTED|Overall Study||30
11065643|NCT01037452|12247156|FG002|STARTED|Overall Study||30
11065644|NCT01037452|12247157|FG003|STARTED|Overall Study||30
11065645|NCT01037452|12247154|FG000|COMPLETED|Overall Study||30
11065646|NCT01037452|12247155|FG001|COMPLETED|Overall Study||30
11065647|NCT01037452|12247156|FG002|COMPLETED|Overall Study||30
11065648|NCT01037452|12247157|FG003|COMPLETED|Overall Study||30
11065649|NCT01037452|12247154|FG000|NOT COMPLETED|Overall Study||0
11065650|NCT01037452|12247155|FG001|NOT COMPLETED|Overall Study||0
11065651|NCT01037452|12247156|FG002|NOT COMPLETED|Overall Study||0
11065652|NCT01037452|12247157|FG003|NOT COMPLETED|Overall Study||0
11065653|NCT01037790|12247172|FG000|STARTED|Overall Study||63
11065654|NCT01037790|12247173|FG001|STARTED|Overall Study||18
11065655|NCT01037790|12247174|FG002|STARTED|Overall Study||19
11065656|NCT01037790|12247175|FG003|STARTED|Overall Study||30
11065657|NCT01037790|12247176|FG004|STARTED|Overall Study||11
11065658|NCT01037790|12247172|FG000|COMPLETED|Overall Study||63
11065659|NCT01037790|12247173|FG001|COMPLETED|Overall Study||18
11065660|NCT01037790|12247174|FG002|COMPLETED|Overall Study||19
11065661|NCT01037790|12247175|FG003|COMPLETED|Overall Study||30
11065662|NCT01037790|12247176|FG004|COMPLETED|Overall Study||11
11065663|NCT01037790|12247172|FG000|NOT COMPLETED|Overall Study||0
11065664|NCT01037790|12247173|FG001|NOT COMPLETED|Overall Study||0
11065665|NCT01037790|12247174|FG002|NOT COMPLETED|Overall Study||0
11065666|NCT01037790|12247175|FG003|NOT COMPLETED|Overall Study||0
11065667|NCT01037790|12247176|FG004|NOT COMPLETED|Overall Study||0
11065668|NCT01037881|12247195|FG000|STARTED|Overall Study||25
11345970|NCT02974114|12543114|FG001|NOT COMPLETED|Overall Study||1
11345971|NCT02974114|12543115|FG002|NOT COMPLETED|Overall Study||2
11345972|NCT02974140|12543125|FG000|STARTED|Overall Study||39
11345973|NCT02974140|12543125|FG000|CRS (Left or Right Eye)|Overall Study||38
11345974|NCT02974140|12543125|FG000|Manual (Fellow Eye)|Overall Study||38
11345975|NCT02974140|12543125|FG000|COMPLETED|Overall Study||0
11345976|NCT02974140|12543125|FG000|NOT COMPLETED|Overall Study||39
11345977|NCT02974153|12543135|FG000|STARTED|Overall Study||374
11345978|NCT02974153|12543136|FG001|STARTED|Overall Study||372
11345979|NCT02974153|12543137|FG002|STARTED|Overall Study||375
11345980|NCT02974153|12543135|FG000|Participants Treated|Overall Study||350
11345981|NCT02974153|12543136|FG001|Participants Treated|Overall Study||356
11345982|NCT02974153|12543137|FG002|Participants Treated|Overall Study||366
11345983|NCT02974153|12543135|FG000|COMPLETED|Overall Study||322
11345984|NCT02974153|12543136|FG001|COMPLETED|Overall Study||324
11345985|NCT02974153|12543137|FG002|COMPLETED|Overall Study||325
11345986|NCT02974153|12543135|FG000|NOT COMPLETED|Overall Study||52
11345987|NCT02974153|12543136|FG001|NOT COMPLETED|Overall Study||48
11345988|NCT02974153|12543137|FG002|NOT COMPLETED|Overall Study||50
11065669|NCT01037881|12247196|FG001|STARTED|Overall Study||24
11065670|NCT01037881|12247197|FG002|STARTED|Overall Study||25
11065671|NCT01037881|12247198|FG003|STARTED|Overall Study||25
11065672|NCT01037881|12247199|FG004|STARTED|Overall Study||29
11065673|NCT01037881|12247200|FG005|STARTED|Overall Study||30
11065674|NCT01037881|12247201|FG006|STARTED|Overall Study||25
11065675|NCT01037881|12247195|FG000|COMPLETED|Overall Study||19
11065676|NCT01037881|12247196|FG001|COMPLETED|Overall Study||22
11345989|NCT02974296|12543147|FG000|STARTED|Overall Study||10
11345990|NCT02974296|12543148|FG001|STARTED|Overall Study||23
11345991|NCT02974296|12543147|FG000|COMPLETED|Overall Study||10
11345992|NCT02974296|12543148|FG001|COMPLETED|Overall Study||22
11345993|NCT02974296|12543147|FG000|NOT COMPLETED|Overall Study||0
11345994|NCT02974296|12543148|FG001|NOT COMPLETED|Overall Study||1
11345995|NCT02974543|12543156|FG000|STARTED|Overall Study||11
11065677|NCT01037881|12247197|FG002|COMPLETED|Overall Study||22
11065678|NCT01037881|12247198|FG003|COMPLETED|Overall Study||24
11065679|NCT01037881|12247199|FG004|COMPLETED|Overall Study||26
11065680|NCT01037881|12247200|FG005|COMPLETED|Overall Study||27
11065681|NCT01037881|12247201|FG006|COMPLETED|Overall Study||23
11065682|NCT01037881|12247195|FG000|NOT COMPLETED|Overall Study||6
11065683|NCT01037881|12247196|FG001|NOT COMPLETED|Overall Study||2
11065684|NCT01037881|12247197|FG002|NOT COMPLETED|Overall Study||3
11065685|NCT01037881|12247198|FG003|NOT COMPLETED|Overall Study||1
11065686|NCT01037881|12247199|FG004|NOT COMPLETED|Overall Study||3
11065687|NCT01037881|12247200|FG005|NOT COMPLETED|Overall Study||3
11065688|NCT01037881|12247201|FG006|NOT COMPLETED|Overall Study||2
11065689|NCT01037985|12247226|FG000|STARTED|Part A: Skin Testing (50 Days)||41
11065690|NCT01037985|12247227|FG001|STARTED|Part A: Skin Testing (50 Days)||0
11065691|NCT01037985|12247226|FG000|COMPLETED|Part A: Skin Testing (50 Days)||37
11065692|NCT01037985|12247227|FG001|COMPLETED|Part A: Skin Testing (50 Days)||0
11065693|NCT01037985|12247226|FG000|NOT COMPLETED|Part A: Skin Testing (50 Days)||4
11065694|NCT01037985|12247227|FG001|NOT COMPLETED|Part A: Skin Testing (50 Days)||0
11065695|NCT01037985|12247226|FG000|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
11065696|NCT01037985|12247227|FG001|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who completed Part A of the study and were negative for skin sensitization.|37
11065697|NCT01037985|12247226|FG000|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||0
11065698|NCT01037985|12247227|FG001|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||33
11065699|NCT01037985|12247226|FG000|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
11065700|NCT01037985|12247227|FG001|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||32
11065701|NCT01037985|12247226|FG000|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
11065702|NCT01037985|12247227|FG001|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||5
11065703|NCT01038128|12247237|FG000|STARTED|Overall Study||5
11065704|NCT01038128|12247237|FG000|Baseline Visit|Overall Study||3
11065705|NCT01038128|12247237|FG000|COMPLETED|Overall Study||1
11065706|NCT01038128|12247237|FG000|NOT COMPLETED|Overall Study||4
11065707|NCT01038297|12247246|FG000|STARTED|Part A: Skin Testing Phase (50 Days)||10
11065708|NCT01038297|12247247|FG001|STARTED|Part A: Skin Testing Phase (50 Days)||10
11065709|NCT01038297|12247248|FG002|STARTED|Part A: Skin Testing Phase (50 Days)||10
11065710|NCT01038297|12247246|FG000|COMPLETED|Part A: Skin Testing Phase (50 Days)||9
11065711|NCT01038297|12247247|FG001|COMPLETED|Part A: Skin Testing Phase (50 Days)||10
11065712|NCT01038297|12247248|FG002|COMPLETED|Part A: Skin Testing Phase (50 Days)||10
11065713|NCT01038297|12247246|FG000|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||1
11065714|NCT01038297|12247247|FG001|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0
11065715|NCT01038297|12247248|FG002|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0
11065716|NCT01038297|12247246|FG000|STARTED|Part B: Active Dosing Phase (13 Weeks)||9
11065717|NCT01038297|12247247|FG001|STARTED|Part B: Active Dosing Phase (13 Weeks)||10
11065718|NCT01038297|12247248|FG002|STARTED|Part B: Active Dosing Phase (13 Weeks)||10
11065719|NCT01038297|12247246|FG000|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||9
11065720|NCT01038297|12247247|FG001|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10
11065721|NCT01038297|12247248|FG002|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10
11065722|NCT01038297|12247246|FG000|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
11065723|NCT01038297|12247247|FG001|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
11065724|NCT01038297|12247248|FG002|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
11065725|NCT01038323|12247268|FG000|STARTED|Overall Study||20
11205937|NCT01863368|12396849|FG001|NOT COMPLETED|Phase I, Day 0 to Day 35||7
11205938|NCT01863368|12396848|FG000|STARTED|Phase II, Day 35 to Day 90||43
11205939|NCT01863368|12396849|FG001|STARTED|Phase II, Day 35 to Day 90||41
11205940|NCT01863368|12396848|FG000|COMPLETED|Phase II, Day 35 to Day 90||41
11205941|NCT01863368|12396849|FG001|COMPLETED|Phase II, Day 35 to Day 90||41
11205942|NCT01863368|12396848|FG000|NOT COMPLETED|Phase II, Day 35 to Day 90||2
11205943|NCT01863368|12396849|FG001|NOT COMPLETED|Phase II, Day 35 to Day 90||0
11205944|NCT01863433|12396856|FG000|STARTED|Overall Study||120
11205945|NCT01863433|12396856|FG000|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
11205946|NCT01863433|12396856|FG000|NOT COMPLETED|Overall Study||1
11205947|NCT01863498|12396862|FG000|STARTED|Overall Study||33
11205948|NCT01863498|12396863|FG001|STARTED|Overall Study||32
11205949|NCT01863498|12396862|FG000|COMPLETED|Overall Study||33
11205950|NCT01863498|12396863|FG001|COMPLETED|Overall Study||32
11205951|NCT01863498|12396862|FG000|NOT COMPLETED|Overall Study||0
11205952|NCT01863498|12396863|FG001|NOT COMPLETED|Overall Study||0
11205953|NCT01863563|12396869|FG000|STARTED|Overall Study||100
11205954|NCT01863563|12396869|FG000|COMPLETED|Overall Study||100
11205955|NCT01863563|12396869|FG000|NOT COMPLETED|Overall Study||0
11205956|NCT01863667|12396875|FG000|STARTED|Overall Study||33
11205957|NCT01863667|12396876|FG001|STARTED|Overall Study||32
11205958|NCT01863667|12396875|FG000|COMPLETED|Overall Study||0
11205959|NCT01863667|12396876|FG001|COMPLETED|Overall Study||0
11205960|NCT01863667|12396875|FG000|NOT COMPLETED|Overall Study||33
11205961|NCT01863667|12396876|FG001|NOT COMPLETED|Overall Study||32
11205962|NCT01863680|12396882|FG000|STARTED|Overall Study||178
11205963|NCT01863680|12396882|FG000|Subjects Started COS Treatment|Overall Study||169
11345996|NCT02974543|12543157|FG001|STARTED|Overall Study||10
11345997|NCT02974543|12543156|FG000|Began Washout Period|Overall Study||10
11345998|NCT02974543|12543157|FG001|Began Washout Period|Overall Study||10
11345999|NCT02974543|12543156|FG000|Began Crossover Assignment|Overall Study||10
11346000|NCT02974543|12543157|FG001|Began Crossover Assignment|Overall Study||10
11346001|NCT02974543|12543156|FG000|COMPLETED|Overall Study||10
11346002|NCT02974543|12543157|FG001|COMPLETED|Overall Study||10
11346003|NCT02974543|12543156|FG000|NOT COMPLETED|Overall Study||1
11065726|NCT01038323|12247269|FG001|STARTED|Overall Study||19
11065727|NCT01038323|12247270|FG002|STARTED|Overall Study||19
11065728|NCT01038323|12247268|FG000|COMPLETED|Overall Study||17
11065729|NCT01038323|12247269|FG001|COMPLETED|Overall Study||17
11065730|NCT01038323|12247270|FG002|COMPLETED|Overall Study||15
11065731|NCT01038323|12247268|FG000|NOT COMPLETED|Overall Study||3
11065732|NCT01038323|12247269|FG001|NOT COMPLETED|Overall Study||2
11065733|NCT01038323|12247270|FG002|NOT COMPLETED|Overall Study||4
11065734|NCT01038336|12247281|FG000|STARTED|Overall Study||43
11065735|NCT01038336|12247282|FG001|STARTED|Overall Study||42
11065736|NCT01038336|12247283|FG002|STARTED|Overall Study||44
11065737|NCT01038336|12247281|FG000|COMPLETED|Overall Study||43
11065738|NCT01038336|12247282|FG001|COMPLETED|Overall Study||42
11065739|NCT01038336|12247283|FG002|COMPLETED|Overall Study||44
11065740|NCT01038336|12247281|FG000|NOT COMPLETED|Overall Study||0
11065741|NCT01038336|12247282|FG001|NOT COMPLETED|Overall Study||0
11065742|NCT01038336|12247283|FG002|NOT COMPLETED|Overall Study||0
11065743|NCT01038427|12247299|FG000|STARTED|Overall Study||317
11346004|NCT02974543|12543157|FG001|NOT COMPLETED|Overall Study||0
11065744|NCT01038427|12247300|FG001|STARTED|Overall Study||320
11065745|NCT01038427|12247301|FG002|STARTED|Overall Study||158
11065746|NCT01038427|12247299|FG000|Per-Protocol (PPP) Population|Overall Study||306
11065747|NCT01038427|12247300|FG001|Per-Protocol (PPP) Population|Overall Study||307
11065748|NCT01038427|12247301|FG002|Per-Protocol (PPP) Population|Overall Study||150
11065749|NCT01038427|12247299|FG000|Intent-to-Treat (ITT) Population|Overall Study||314
11065750|NCT01038427|12247300|FG001|Intent-to-Treat (ITT) Population|Overall Study||314
11065751|NCT01038427|12247301|FG002|Intent-to-Treat (ITT) Population|Overall Study||156
11065752|NCT01038427|12247299|FG000|COMPLETED|Overall Study||314
11065753|NCT01038427|12247300|FG001|COMPLETED|Overall Study||314
11065754|NCT01038427|12247301|FG002|COMPLETED|Overall Study||154
11065755|NCT01038427|12247299|FG000|NOT COMPLETED|Overall Study||3
11065756|NCT01038427|12247300|FG001|NOT COMPLETED|Overall Study||6
11065757|NCT01038427|12247301|FG002|NOT COMPLETED|Overall Study||4
11065758|NCT01038557|12247312|FG000|STARTED|Overall Study||82
11065759|NCT01038557|12247313|FG001|STARTED|Overall Study||86
11065760|NCT01038557|12247314|FG002|STARTED|Overall Study||86
11065761|NCT01038557|12247312|FG000|COMPLETED|Overall Study||82
11065762|NCT01038557|12247313|FG001|COMPLETED|Overall Study||86
11065763|NCT01038557|12247314|FG002|COMPLETED|Overall Study||86
11065764|NCT01038557|12247312|FG000|NOT COMPLETED|Overall Study||0
11065765|NCT01038557|12247313|FG001|NOT COMPLETED|Overall Study||0
11065766|NCT01038557|12247314|FG002|NOT COMPLETED|Overall Study||0
11065767|NCT01038609|12247327|FG000|STARTED|Overall Study||50
11065768|NCT01038609|12247328|FG001|STARTED|Overall Study||52
11065769|NCT01038609|12247329|FG002|STARTED|Overall Study||49
11065770|NCT01038609|12247330|FG003|STARTED|Overall Study||48
11065771|NCT01038609|12247331|FG004|STARTED|Overall Study||51
11065772|NCT01038609|12247327|FG000|COMPLETED|Overall Study||49
11065773|NCT01038609|12247328|FG001|COMPLETED|Overall Study||51
11065774|NCT01038609|12247329|FG002|COMPLETED|Overall Study||48
11065775|NCT01038609|12247330|FG003|COMPLETED|Overall Study||47
11065776|NCT01038609|12247331|FG004|COMPLETED|Overall Study||50
11065777|NCT01038609|12247327|FG000|NOT COMPLETED|Overall Study||1
11065778|NCT01038609|12247328|FG001|NOT COMPLETED|Overall Study||1
11065779|NCT01038609|12247329|FG002|NOT COMPLETED|Overall Study||1
11065780|NCT01038609|12247330|FG003|NOT COMPLETED|Overall Study||1
11065781|NCT01038609|12247331|FG004|NOT COMPLETED|Overall Study||1
11065782|NCT01038635|12247352|FG000|STARTED|Overall Study||5
11065783|NCT01038635|12247353|FG001|STARTED|Overall Study||3
11065784|NCT01038635|12247354|FG002|STARTED|Overall Study||3
11065785|NCT01038635|12247355|FG003|STARTED|Overall Study||3
11065786|NCT01038635|12247356|FG004|STARTED|Overall Study||4
11065787|NCT01038635|12247357|FG005|STARTED|Overall Study||3
11065788|NCT01038635|12247358|FG006|STARTED|Overall Study||7
11065789|NCT01038635|12247359|FG007|STARTED|Overall Study||20
11065790|NCT01038635|12247360|FG008|STARTED|Overall Study||40
11065791|NCT01038635|12247352|FG000|COMPLETED|Overall Study||3
11205964|NCT01863680|12396882|FG000|Subjects Received hCG Injection|Overall Study||162
11065792|NCT01038635|12247353|FG001|COMPLETED|Overall Study||3
11065793|NCT01038635|12247354|FG002|COMPLETED|Overall Study||3
11065794|NCT01038635|12247355|FG003|COMPLETED|Overall Study||3
11065795|NCT01038635|12247356|FG004|COMPLETED|Overall Study||3
11065796|NCT01038635|12247357|FG005|COMPLETED|Overall Study||3
11065797|NCT01038635|12247358|FG006|COMPLETED|Overall Study||5
11065798|NCT01038635|12247359|FG007|COMPLETED|Overall Study||15
11065799|NCT01038635|12247360|FG008|COMPLETED|Overall Study||38
11065800|NCT01038635|12247352|FG000|NOT COMPLETED|Overall Study||2
11065801|NCT01038635|12247353|FG001|NOT COMPLETED|Overall Study||0
11065802|NCT01038635|12247354|FG002|NOT COMPLETED|Overall Study||0
11065803|NCT01038635|12247355|FG003|NOT COMPLETED|Overall Study||0
11065804|NCT01038635|12247356|FG004|NOT COMPLETED|Overall Study||1
11205965|NCT01863680|12396882|FG000|Subjects Received Study Drug|Overall Study||149
11205966|NCT01863680|12396882|FG000|Subjects Who Have Undergone IVF/ET|Overall Study||123
11205967|NCT01863680|12396882|FG000|COMPLETED|Overall Study||121
11205968|NCT01863680|12396882|FG000|NOT COMPLETED|Overall Study||57
11205969|NCT01863732|12396890|FG000|STARTED|Overall Study||100
11205970|NCT01863732|12396891|FG001|STARTED|Overall Study||87
11205971|NCT01863732|12396892|FG002|STARTED|Overall Study||46
11205972|NCT01863732|12396893|FG003|STARTED|Overall Study||41
11205973|NCT01863732|12396890|FG000|COMPLETED|Overall Study||87
11065805|NCT01038635|12247357|FG005|NOT COMPLETED|Overall Study||0
11065806|NCT01038635|12247358|FG006|NOT COMPLETED|Overall Study||2
11065807|NCT01038635|12247359|FG007|NOT COMPLETED|Overall Study||5
11065808|NCT01038635|12247360|FG008|NOT COMPLETED|Overall Study||2
11065809|NCT01038687|12247384|FG000|STARTED|Overall Study||12
11065810|NCT01038687|12247385|FG001|STARTED|Overall Study||11
11065811|NCT01038687|12247386|FG002|STARTED|Overall Study||13
11065812|NCT01038687|12247384|FG000|COMPLETED|Overall Study||12
11065813|NCT01038687|12247385|FG001|COMPLETED|Overall Study||9
11065814|NCT01038687|12247386|FG002|COMPLETED|Overall Study||12
11065815|NCT01038687|12247384|FG000|NOT COMPLETED|Overall Study||0
11065816|NCT01038687|12247385|FG001|NOT COMPLETED|Overall Study||2
11065817|NCT01038687|12247386|FG002|NOT COMPLETED|Overall Study||1
11065818|NCT01038713|12247397|FG000|STARTED|Overall Study||26
11065819|NCT01038713|12247398|FG001|STARTED|Overall Study||20
11065820|NCT01038713|12247399|FG002|STARTED|Overall Study||17
11065821|NCT01038713|12247397|FG000|COMPLETED|Overall Study||21
11065822|NCT01038713|12247398|FG001|COMPLETED|Overall Study||17
11065823|NCT01038713|12247399|FG002|COMPLETED|Overall Study||16
11065824|NCT01038713|12247397|FG000|NOT COMPLETED|Overall Study||5
11065825|NCT01038713|12247398|FG001|NOT COMPLETED|Overall Study||3
11065826|NCT01038713|12247399|FG002|NOT COMPLETED|Overall Study||1
11065827|NCT01038856|12247407|FG000|STARTED|Overall Study||5
11065828|NCT01038856|12247407|FG000|COMPLETED|Overall Study||3
11065829|NCT01038856|12247407|FG000|NOT COMPLETED|Overall Study||2
11065830|NCT01038869|12247413|FG000|STARTED|Overall Study||20
11065831|NCT01038869|12247413|FG000|COMPLETED|Overall Study||13
11065832|NCT01038869|12247413|FG000|NOT COMPLETED|Overall Study||7
11065833|NCT01038921|12247423|FG000|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
11065834|NCT01038921|12247424|FG001|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
11065835|NCT01038921|12247423|FG000|COMPLETED|Overall Study|2 subjects withdrew|17
11065836|NCT01038921|12247424|FG001|COMPLETED|Overall Study||20
11065837|NCT01038921|12247423|FG000|NOT COMPLETED|Overall Study||2
11065838|NCT01038921|12247424|FG001|NOT COMPLETED|Overall Study||0
11065839|NCT01039207|12247430|FG000|STARTED|Overall Study||31
11065840|NCT01039207|12247430|FG000|COMPLETED|Overall Study||31
11065841|NCT01039207|12247430|FG000|NOT COMPLETED|Overall Study||0
11065842|NCT01039376|12247436|FG000|STARTED|Overall Study||240
11065843|NCT01039376|12247437|FG001|STARTED|Overall Study||240
11065844|NCT01039376|12247436|FG000|COMPLETED|Overall Study||110
11065845|NCT01039376|12247437|FG001|COMPLETED|Overall Study||114
11065846|NCT01039376|12247436|FG000|NOT COMPLETED|Overall Study||130
11065847|NCT01039376|12247437|FG001|NOT COMPLETED|Overall Study||126
11065848|NCT01039428|12247446|FG000|STARTED|Overall Study||35
11065849|NCT01039428|12247447|FG001|STARTED|Overall Study||28
11065850|NCT01039428|12247446|FG000|COMPLETED|Overall Study||33
11065851|NCT01039428|12247447|FG001|COMPLETED|Overall Study||28
11065852|NCT01039428|12247446|FG000|NOT COMPLETED|Overall Study||2
11065853|NCT01039428|12247447|FG001|NOT COMPLETED|Overall Study||0
11065854|NCT01039467|12247455|FG000|STARTED|Overall Study||196
11065855|NCT01039467|12247456|FG001|STARTED|Overall Study||189
11065856|NCT01039467|12247455|FG000|COMPLETED|Overall Study||156
11065857|NCT01039467|12247456|FG001|COMPLETED|Overall Study||140
11065858|NCT01039467|12247455|FG000|NOT COMPLETED|Overall Study||40
11065859|NCT01039467|12247456|FG001|NOT COMPLETED|Overall Study||49
11065860|NCT01039519|12247464|FG000|STARTED|Treatment||27
11065861|NCT01039519|12247464|FG000|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
11065862|NCT01039519|12247464|FG000|NOT COMPLETED|Treatment||27
11065863|NCT01039519|12247464|FG000|STARTED|Survival Follow-up||27
11065864|NCT01039519|12247464|FG000|COMPLETED|Survival Follow-up||0
11065865|NCT01039519|12247464|FG000|NOT COMPLETED|Survival Follow-up||27
11065866|NCT01039584|12247471|FG000|STARTED|Overall Study||246
11065867|NCT01039584|12247472|FG001|STARTED|Overall Study||243
11065868|NCT01039584|12247473|FG002|STARTED|Overall Study||122
11065869|NCT01039584|12247471|FG000|COMPLETED|Overall Study||143
11065870|NCT01039584|12247472|FG001|COMPLETED|Overall Study||146
11065871|NCT01039584|12247473|FG002|COMPLETED|Overall Study||65
11065872|NCT01039584|12247471|FG000|NOT COMPLETED|Overall Study||103
11065873|NCT01039584|12247472|FG001|NOT COMPLETED|Overall Study||97
11065874|NCT01039584|12247473|FG002|NOT COMPLETED|Overall Study||57
11065875|NCT01039675|12247483|FG000|STARTED|Overall Study||9
11065876|NCT01039675|12247484|FG001|STARTED|Overall Study||42
11065877|NCT01039675|12247483|FG000|COMPLETED|Overall Study||9
11065878|NCT01039675|12247484|FG001|COMPLETED|Overall Study||35
11065879|NCT01039675|12247483|FG000|NOT COMPLETED|Overall Study||0
11065880|NCT01039675|12247484|FG001|NOT COMPLETED|Overall Study||7
11065881|NCT01039688|12247493|FG000|STARTED|Overall Study||373
11065882|NCT01039688|12247494|FG001|STARTED|Overall Study||397
11065883|NCT01039688|12247495|FG002|STARTED|Overall Study||186
11065884|NCT01039688|12247493|FG000|COMPLETED|Overall Study||266
11065885|NCT01039688|12247494|FG001|COMPLETED|Overall Study||286
11065886|NCT01039688|12247495|FG002|COMPLETED|Overall Study||106
11065887|NCT01039688|12247493|FG000|NOT COMPLETED|Overall Study||107
11065888|NCT01039688|12247494|FG001|NOT COMPLETED|Overall Study||111
11065889|NCT01039688|12247495|FG002|NOT COMPLETED|Overall Study||80
11065890|NCT01039792|12247508|FG000|STARTED|Overall Study||29
11065891|NCT01039792|12247509|FG001|STARTED|Overall Study||28
11065892|NCT01039792|12247508|FG000|COMPLETED|Overall Study||23
11065893|NCT01039792|12247509|FG001|COMPLETED|Overall Study||27
11065894|NCT01039792|12247508|FG000|NOT COMPLETED|Overall Study||6
11065895|NCT01039792|12247509|FG001|NOT COMPLETED|Overall Study||1
11065896|NCT01040052|12247515|FG000|STARTED|Overall Study||30
11065897|NCT01040052|12247515|FG000|COMPLETED|Overall Study||30
11065898|NCT01040052|12247515|FG000|NOT COMPLETED|Overall Study||0
11065899|NCT01040130|12247519|FG000|STARTED|Overall Study|Number of patients entered and treated|25
11065900|NCT01040130|12247520|FG001|STARTED|Overall Study||25
11065901|NCT01040130|12247521|FG002|STARTED|Overall Study||25
11065902|NCT01040130|12247522|FG003|STARTED|Overall Study||25
11065903|NCT01040130|12247523|FG004|STARTED|Overall Study||25
11065904|NCT01040130|12247524|FG005|STARTED|Overall Study||26
11065905|NCT01040130|12247519|FG000|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
11065906|NCT01040130|12247520|FG001|COMPLETED|Overall Study||22
11065907|NCT01040130|12247521|FG002|COMPLETED|Overall Study||23
11065908|NCT01040130|12247522|FG003|COMPLETED|Overall Study||20
11065909|NCT01040130|12247523|FG004|COMPLETED|Overall Study||25
11065910|NCT01040130|12247524|FG005|COMPLETED|Overall Study||22
11065911|NCT01040130|12247519|FG000|NOT COMPLETED|Overall Study||3
11065912|NCT01040130|12247520|FG001|NOT COMPLETED|Overall Study||3
11065913|NCT01040130|12247521|FG002|NOT COMPLETED|Overall Study||2
11065914|NCT01040130|12247522|FG003|NOT COMPLETED|Overall Study||5
11065915|NCT01040130|12247523|FG004|NOT COMPLETED|Overall Study||0
11065916|NCT01040130|12247524|FG005|NOT COMPLETED|Overall Study||4
11065917|NCT01040169|12247536|FG000|STARTED|Overall Study||35
11065918|NCT01040169|12247537|FG001|STARTED|Overall Study||44
11065919|NCT01040169|12247536|FG000|COMPLETED|Overall Study||32
11065920|NCT01040169|12247537|FG001|COMPLETED|Overall Study||36
11065921|NCT01040169|12247536|FG000|NOT COMPLETED|Overall Study||3
11065922|NCT01040169|12247537|FG001|NOT COMPLETED|Overall Study||8
11065923|NCT01040208|12247546|FG000|STARTED|Overall Study||45
11065924|NCT01040208|12247547|FG001|STARTED|Overall Study||28
11065925|NCT01040208|12247548|FG002|STARTED|Overall Study||38
11065926|NCT01040208|12247546|FG000|COMPLETED|Overall Study||39
11065927|NCT01040208|12247547|FG001|COMPLETED|Overall Study||15
11065928|NCT01040208|12247548|FG002|COMPLETED|Overall Study||35
11065929|NCT01040208|12247546|FG000|NOT COMPLETED|Overall Study||6
11065930|NCT01040208|12247547|FG001|NOT COMPLETED|Overall Study||13
11065931|NCT01040208|12247548|FG002|NOT COMPLETED|Overall Study||3
11065932|NCT01040260|12247563|FG000|STARTED|Overall Study||53
11065933|NCT01040260|12247564|FG001|STARTED|Overall Study||50
11065934|NCT01040260|12247563|FG000|COMPLETED|Overall Study||38
11065935|NCT01040260|12247564|FG001|COMPLETED|Overall Study||39
11065936|NCT01040260|12247563|FG000|NOT COMPLETED|Overall Study||15
11065937|NCT01040260|12247564|FG001|NOT COMPLETED|Overall Study||11
11065938|NCT01040351|12247572|FG000|STARTED|Overall Study|October 2006|55
11065939|NCT01040351|12247573|FG001|STARTED|Overall Study|October 2006|55
11065940|NCT01040351|12247572|FG000|COMPLETED|Overall Study|May 2010|54
11065941|NCT01040351|12247573|FG001|COMPLETED|Overall Study|May 2010|53
11065942|NCT01040351|12247572|FG000|NOT COMPLETED|Overall Study||1
11065943|NCT01040351|12247573|FG001|NOT COMPLETED|Overall Study||2
11065944|NCT01040403|12247579|FG000|STARTED|Overall Study||233
11065945|NCT01040403|12247579|FG000|Completed Olo 5|Overall Study||106
11065946|NCT01040403|12247579|FG000|Completed T+O 1.25/5|Overall Study||105
11065947|NCT01040403|12247579|FG000|Completed T+O 2.5/5|Overall Study||111
11065948|NCT01040403|12247579|FG000|Completed T+O 5/5|Overall Study||106
11065949|NCT01040403|12247579|FG000|Completed Olo 10|Overall Study||109
11065950|NCT01040403|12247579|FG000|Completed T+O 1.25/10|Overall Study||106
11065951|NCT01040403|12247579|FG000|Completed T+O 2.5/10|Overall Study||110
11065952|NCT01040403|12247579|FG000|Completed T+O 5/10|Overall Study||107
11065953|NCT01040403|12247579|FG000|COMPLETED|Overall Study|All treatment periods|213
11065954|NCT01040403|12247579|FG000|NOT COMPLETED|Overall Study||20
11065955|NCT01040689|12247598|FG000|STARTED|Overall Study||27
11065956|NCT01040689|12247599|FG001|STARTED|Overall Study||27
11065957|NCT01040689|12247600|FG002|STARTED|Overall Study||27
11065958|NCT01040689|12247601|FG003|STARTED|Overall Study||27
11065959|NCT01040689|12247598|FG000|COMPLETED|Overall Study||24
11065960|NCT01040689|12247599|FG001|COMPLETED|Overall Study||25
11065961|NCT01040689|12247600|FG002|COMPLETED|Overall Study||23
11065962|NCT01040689|12247601|FG003|COMPLETED|Overall Study||23
11065963|NCT01040689|12247598|FG000|NOT COMPLETED|Overall Study||3
11065964|NCT01040689|12247599|FG001|NOT COMPLETED|Overall Study||2
11065965|NCT01040689|12247600|FG002|NOT COMPLETED|Overall Study||4
11065966|NCT01040689|12247601|FG003|NOT COMPLETED|Overall Study||4
11065967|NCT01040728|12247616|FG000|STARTED|Overall Study||31
11065968|NCT01040728|12247617|FG001|STARTED|Overall Study||30
11065969|NCT01040728|12247618|FG002|STARTED|Overall Study||31
11065970|NCT01040728|12247619|FG003|STARTED|Overall Study||30
11065971|NCT01040728|12247616|FG000|COMPLETED|Overall Study||27
11065972|NCT01040728|12247617|FG001|COMPLETED|Overall Study||19
11065973|NCT01040728|12247618|FG002|COMPLETED|Overall Study||30
11065974|NCT01040728|12247619|FG003|COMPLETED|Overall Study||24
11065975|NCT01040728|12247616|FG000|NOT COMPLETED|Overall Study||4
11065976|NCT01040728|12247617|FG001|NOT COMPLETED|Overall Study||11
11065977|NCT01040728|12247618|FG002|NOT COMPLETED|Overall Study||1
11065978|NCT01040728|12247619|FG003|NOT COMPLETED|Overall Study||6
11065979|NCT01040780|12247637|FG000|STARTED|Overall Study||200
11065980|NCT01040780|12247638|FG001|STARTED|Overall Study||199
11065981|NCT01040780|12247637|FG000|COMPLETED|Overall Study||199
11065982|NCT01040780|12247638|FG001|COMPLETED|Overall Study||196
11065983|NCT01040780|12247637|FG000|NOT COMPLETED|Overall Study||1
11065984|NCT01040780|12247638|FG001|NOT COMPLETED|Overall Study||3
11065985|NCT01040793|12247647|FG000|STARTED|Overall Study|Entered and treated|26
11065986|NCT01040793|12247648|FG001|STARTED|Overall Study||26
11065987|NCT01040793|12247649|FG002|STARTED|Overall Study||26
11065988|NCT01040793|12247650|FG003|STARTED|Overall Study||26
11065989|NCT01040793|12247651|FG004|STARTED|Overall Study||26
11065990|NCT01040793|12247652|FG005|STARTED|Overall Study||27
11065991|NCT01040793|12247647|FG000|COMPLETED|Overall Study||20
11065992|NCT01040793|12247648|FG001|COMPLETED|Overall Study||21
11065993|NCT01040793|12247649|FG002|COMPLETED|Overall Study||23
11065994|NCT01040793|12247650|FG003|COMPLETED|Overall Study||22
11065995|NCT01040793|12247651|FG004|COMPLETED|Overall Study||22
11065996|NCT01040793|12247652|FG005|COMPLETED|Overall Study||26
11065997|NCT01040793|12247647|FG000|NOT COMPLETED|Overall Study||6
11065998|NCT01040793|12247648|FG001|NOT COMPLETED|Overall Study||5
11065999|NCT01040793|12247649|FG002|NOT COMPLETED|Overall Study||3
11066000|NCT01040793|12247650|FG003|NOT COMPLETED|Overall Study||4
11066001|NCT01040793|12247651|FG004|NOT COMPLETED|Overall Study||4
11066002|NCT01040793|12247652|FG005|NOT COMPLETED|Overall Study||1
11066003|NCT01040819|12247664|FG000|STARTED|Overall Study||13
11066004|NCT01040819|12247665|FG001|STARTED|Overall Study||12
11066005|NCT01040819|12247664|FG000|COMPLETED|Overall Study||13
11066006|NCT01040819|12247665|FG001|COMPLETED|Overall Study||12
11066007|NCT01040819|12247664|FG000|NOT COMPLETED|Overall Study||0
11066008|NCT01040819|12247665|FG001|NOT COMPLETED|Overall Study||0
11066009|NCT01040832|12247673|FG000|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
11066010|NCT01040832|12247674|FG001|STARTED|Overall Study||53
11066011|NCT01040832|12247673|FG000|COMPLETED|Overall Study||8
11066012|NCT01040832|12247674|FG001|COMPLETED|Overall Study||16
11066013|NCT01040832|12247673|FG000|NOT COMPLETED|Overall Study||46
11066014|NCT01040832|12247674|FG001|NOT COMPLETED|Overall Study||37
11066015|NCT01040845|12247682|FG000|STARTED|Overall Study||15
11066016|NCT01040845|12247683|FG001|STARTED|Overall Study||15
11066017|NCT01040845|12247682|FG000|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
11066018|NCT01040845|12247683|FG001|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
11066019|NCT01040845|12247682|FG000|NOT COMPLETED|Overall Study||2
11066020|NCT01040845|12247683|FG001|NOT COMPLETED|Overall Study||1
11066021|NCT01040858|12247693|FG000|STARTED|Overall Study||59
11066022|NCT01040858|12247694|FG001|STARTED|Overall Study||69
11066023|NCT01040858|12247693|FG000|COMPLETED|Overall Study||50
11066024|NCT01040858|12247694|FG001|COMPLETED|Overall Study||69
11066025|NCT01040858|12247693|FG000|NOT COMPLETED|Overall Study||9
11066026|NCT01040858|12247694|FG001|NOT COMPLETED|Overall Study||0
11066027|NCT01040871|12247705|FG000|STARTED|Overall Study|Intent to Treat, Randomized|84
11066028|NCT01040871|12247706|FG001|STARTED|Overall Study|Intent to Treat, Randomized|80
11066029|NCT01040871|12247705|FG000|COMPLETED|Overall Study||71
11066030|NCT01040871|12247706|FG001|COMPLETED|Overall Study||73
11066031|NCT01040871|12247705|FG000|NOT COMPLETED|Overall Study||13
11066032|NCT01040871|12247706|FG001|NOT COMPLETED|Overall Study||7
11066033|NCT01041209|12247714|FG000|STARTED|Overall Study||60
11066034|NCT01041209|12247715|FG001|STARTED|Overall Study||60
11066035|NCT01041209|12247714|FG000|COMPLETED|Overall Study||60
11066036|NCT01041209|12247715|FG001|COMPLETED|Overall Study||60
11066037|NCT01041209|12247714|FG000|NOT COMPLETED|Overall Study||0
11066038|NCT01041209|12247715|FG001|NOT COMPLETED|Overall Study||0
11066039|NCT01041248|12247722|FG000|STARTED|Overall Study|January 2010|1
11066040|NCT01041248|12247722|FG000|COMPLETED|Overall Study||1
11066041|NCT01041248|12247722|FG000|NOT COMPLETED|Overall Study||0
11066042|NCT01041274|12247729|FG000|STARTED|Overall Study||49
11066043|NCT01041274|12247730|FG001|STARTED|Overall Study||46
11066044|NCT01041274|12247729|FG000|COMPLETED|Overall Study||26
11066045|NCT01041274|12247730|FG001|COMPLETED|Overall Study||25
11066046|NCT01041274|12247729|FG000|NOT COMPLETED|Overall Study||23
11066047|NCT01041274|12247730|FG001|NOT COMPLETED|Overall Study||21
11066048|NCT01041287|12247738|FG000|STARTED|Treatment Period 1 (3 Months)||19
11066049|NCT01041287|12247739|FG001|STARTED|Treatment Period 1 (3 Months)||19
11066050|NCT01041287|12247738|FG000|COMPLETED|Treatment Period 1 (3 Months)||19
11066051|NCT01041287|12247739|FG001|COMPLETED|Treatment Period 1 (3 Months)||19
11066052|NCT01041287|12247738|FG000|NOT COMPLETED|Treatment Period 1 (3 Months)||0
11066053|NCT01041287|12247739|FG001|NOT COMPLETED|Treatment Period 1 (3 Months)||0
11066054|NCT01041287|12247738|FG000|STARTED|Treatment Period 2 (3 Months)||19
11066055|NCT01041287|12247739|FG001|STARTED|Treatment Period 2 (3 Months)||19
11066056|NCT01041287|12247738|FG000|COMPLETED|Treatment Period 2 (3 Months)||16
11066057|NCT01041287|12247739|FG001|COMPLETED|Treatment Period 2 (3 Months)||14
11066058|NCT01041287|12247738|FG000|NOT COMPLETED|Treatment Period 2 (3 Months)||3
11066059|NCT01041287|12247739|FG001|NOT COMPLETED|Treatment Period 2 (3 Months)||5
11066060|NCT01041404|12247747|FG000|STARTED|Overall Study||290
11066061|NCT01041404|12247748|FG001|STARTED|Overall Study||294
11066062|NCT01041404|12247747|FG000|Entered Follow-Up|Overall Study||251
11066063|NCT01041404|12247748|FG001|Entered Follow-Up|Overall Study||251
11066064|NCT01041404|12247747|FG000|Died in Follow-up|Overall Study||199
11066065|NCT01041404|12247748|FG001|Died in Follow-up|Overall Study||200
11066066|NCT01041404|12247747|FG000|Lost to Follow-up|Overall Study||12
11066067|NCT01041404|12247748|FG001|Lost to Follow-up|Overall Study||10
11066068|NCT01041404|12247747|FG000|Alive in Follow-up|Overall Study||40
11066069|NCT01041404|12247748|FG001|Alive in Follow-up|Overall Study||41
11066070|NCT01041404|12247747|FG000|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
11066071|NCT01041404|12247748|FG001|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
11066072|NCT01041404|12247747|FG000|NOT COMPLETED|Overall Study||290
11066073|NCT01041404|12247748|FG001|NOT COMPLETED|Overall Study||294
11066074|NCT01041417|12247759|FG000|STARTED|Overall Study||80
11066075|NCT01041417|12247760|FG001|STARTED|Overall Study||79
11066076|NCT01041417|12247759|FG000|COMPLETED|Overall Study||73
11066077|NCT01041417|12247760|FG001|COMPLETED|Overall Study||76
11066078|NCT01041417|12247759|FG000|NOT COMPLETED|Overall Study||7
11066079|NCT01041417|12247760|FG001|NOT COMPLETED|Overall Study||3
11066080|NCT01041495|12247770|FG000|STARTED|Overall Study||16
11066081|NCT01041495|12247771|FG001|STARTED|Overall Study||12
11066082|NCT01041495|12247770|FG000|COMPLETED|Overall Study||12
11066083|NCT01041495|12247771|FG001|COMPLETED|Overall Study||5
11066084|NCT01041495|12247770|FG000|NOT COMPLETED|Overall Study||4
11066085|NCT01041495|12247771|FG001|NOT COMPLETED|Overall Study||7
11066086|NCT01041521|12247779|FG000|STARTED|Overall Study||61
11066087|NCT01041521|12247780|FG001|STARTED|Overall Study||56
11066088|NCT01041521|12247779|FG000|COMPLETED|Overall Study||44
11066089|NCT01041521|12247780|FG001|COMPLETED|Overall Study||40
11066090|NCT01041521|12247779|FG000|NOT COMPLETED|Overall Study||17
11066091|NCT01041521|12247780|FG001|NOT COMPLETED|Overall Study||16
11066092|NCT01041573|12247790|FG000|STARTED|Overall Study||540
11066093|NCT01041573|12247791|FG001|STARTED|Overall Study||871
11066094|NCT01041573|12247792|FG002|STARTED|Overall Study||394
11066095|NCT01041573|12247793|FG003|STARTED|Overall Study||64
11066096|NCT01041573|12247790|FG000|COMPLETED|Overall Study||535
11066097|NCT01041573|12247791|FG001|COMPLETED|Overall Study||858
11066098|NCT01041573|12247792|FG002|COMPLETED|Overall Study||387
11066099|NCT01041573|12247793|FG003|COMPLETED|Overall Study||62
11066100|NCT01041573|12247790|FG000|NOT COMPLETED|Overall Study||5
11066101|NCT01041573|12247791|FG001|NOT COMPLETED|Overall Study||13
11066102|NCT01041573|12247792|FG002|NOT COMPLETED|Overall Study||7
11066103|NCT01041573|12247793|FG003|NOT COMPLETED|Overall Study||2
11066104|NCT01041638|12247812|FG000|STARTED|Overall Study||105
11066105|NCT01041638|12247812|FG000|COMPLETED|Overall Study||78
11066106|NCT01041638|12247812|FG000|NOT COMPLETED|Overall Study||27
11066107|NCT01041781|12247818|FG000|STARTED|Overall Study||154
11066108|NCT01041781|12247819|FG001|STARTED|Overall Study||158
11066109|NCT01041781|12247818|FG000|COMPLETED|Overall Study||154
11066110|NCT01041781|12247819|FG001|COMPLETED|Overall Study||158
11066111|NCT01041781|12247818|FG000|NOT COMPLETED|Overall Study||0
11066112|NCT01041781|12247819|FG001|NOT COMPLETED|Overall Study||0
11066113|NCT01041859|12247835|FG000|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
11066114|NCT01041859|12247836|FG001|STARTED|Open-Label Titration||0
11066115|NCT01041859|12247837|FG002|STARTED|Open-Label Titration||0
11066116|NCT01041859|12247835|FG000|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
11346005|NCT02974634|12543173|FG000|STARTED|Overall Study||106
11346006|NCT02974634|12543174|FG001|STARTED|Overall Study||110
11346007|NCT02974634|12543173|FG000|COMPLETED|Overall Study||78
11346008|NCT02974634|12543174|FG001|COMPLETED|Overall Study||89
11346009|NCT02974634|12543173|FG000|NOT COMPLETED|Overall Study||28
11346010|NCT02974634|12543174|FG001|NOT COMPLETED|Overall Study||21
11346011|NCT02974842|12543181|FG000|STARTED|Overall Study|Participants|50
11346012|NCT02974842|12543181|FG000|COMPLETED|Overall Study||42
11066117|NCT01041859|12247836|FG001|COMPLETED|Open-Label Titration||0
11066118|NCT01041859|12247837|FG002|COMPLETED|Open-Label Titration||0
11066119|NCT01041859|12247835|FG000|NOT COMPLETED|Open-Label Titration||101
11066120|NCT01041859|12247836|FG001|NOT COMPLETED|Open-Label Titration||0
11066121|NCT01041859|12247837|FG002|NOT COMPLETED|Open-Label Titration||0
11066122|NCT01041859|12247835|FG000|STARTED|Double-Blind Maintenance||0
11066123|NCT01041859|12247836|FG001|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
11066124|NCT01041859|12247837|FG002|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
11066125|NCT01041859|12247835|FG000|COMPLETED|Double-Blind Maintenance||0
11066126|NCT01041859|12247836|FG001|COMPLETED|Double-Blind Maintenance||120
11066127|NCT01041859|12247837|FG002|COMPLETED|Double-Blind Maintenance||107
11066128|NCT01041859|12247835|FG000|NOT COMPLETED|Double-Blind Maintenance||0
11066129|NCT01041859|12247836|FG001|NOT COMPLETED|Double-Blind Maintenance||46
11066130|NCT01041859|12247837|FG002|NOT COMPLETED|Double-Blind Maintenance||45
11066131|NCT01041976|12247846|FG000|STARTED|Overall Study||42
11346013|NCT02974842|12543181|FG000|NOT COMPLETED|Overall Study||8
11346014|NCT02974855|12543189|FG000|STARTED|Overall Study||7
11346015|NCT02974855|12543190|FG001|STARTED|Overall Study||6
11346016|NCT02974855|12543191|FG002|STARTED|Overall Study||6
11346017|NCT02974855|12543192|FG003|STARTED|Overall Study||7
11346018|NCT02974855|12543189|FG000|COMPLETED|Overall Study||7
11346019|NCT02974855|12543190|FG001|COMPLETED|Overall Study||5
11346020|NCT02974855|12543191|FG002|COMPLETED|Overall Study||6
11066132|NCT01041976|12247847|FG001|STARTED|Overall Study||42
11066133|NCT01041976|12247846|FG000|6 Month Follow-up|Overall Study||39
11066134|NCT01041976|12247847|FG001|6 Month Follow-up|Overall Study||41
11066135|NCT01041976|12247846|FG000|12 Month Follow-up|Overall Study||37
11066136|NCT01041976|12247847|FG001|12 Month Follow-up|Overall Study||38
11066137|NCT01041976|12247846|FG000|18 Month Follow-up|Overall Study||37
11066138|NCT01041976|12247847|FG001|18 Month Follow-up|Overall Study||38
11066139|NCT01041976|12247846|FG000|COMPLETED|Overall Study||37
11066140|NCT01041976|12247847|FG001|COMPLETED|Overall Study||38
11066141|NCT01041976|12247846|FG000|NOT COMPLETED|Overall Study||5
11066142|NCT01041976|12247847|FG001|NOT COMPLETED|Overall Study||4
11066143|NCT01042093|12247857|FG000|STARTED|Overall Study||40
11066144|NCT01042093|12247858|FG001|STARTED|Overall Study||40
11066145|NCT01042093|12247859|FG002|STARTED|Overall Study||40
11066146|NCT01042093|12247860|FG003|STARTED|Overall Study||40
11066147|NCT01042093|12247857|FG000|COMPLETED|Overall Study||38
11066148|NCT01042093|12247858|FG001|COMPLETED|Overall Study||38
11066149|NCT01042093|12247859|FG002|COMPLETED|Overall Study||38
11346021|NCT02974855|12543192|FG003|COMPLETED|Overall Study||6
11346022|NCT02974855|12543189|FG000|NOT COMPLETED|Overall Study||0
11346023|NCT02974855|12543190|FG001|NOT COMPLETED|Overall Study||1
11346024|NCT02974855|12543191|FG002|NOT COMPLETED|Overall Study||0
11346025|NCT02974855|12543192|FG003|NOT COMPLETED|Overall Study||1
11346026|NCT02974868|12543209|FG000|STARTED|Initial 24-Week Treatment Period (TP)||24
11346027|NCT02974868|12543210|FG001|STARTED|Initial 24-Week Treatment Period (TP)||23
11066150|NCT01042093|12247860|FG003|COMPLETED|Overall Study||36
11066151|NCT01042093|12247857|FG000|NOT COMPLETED|Overall Study||2
11066152|NCT01042093|12247858|FG001|NOT COMPLETED|Overall Study||2
11346028|NCT02974868|12543211|FG002|STARTED|Initial 24-Week Treatment Period (TP)||48
11346029|NCT02974868|12543212|FG003|STARTED|Initial 24-Week Treatment Period (TP)||47
11346030|NCT02974868|12543209|FG000|COMPLETED|Initial 24-Week Treatment Period (TP)||20
11346031|NCT02974868|12543210|FG001|COMPLETED|Initial 24-Week Treatment Period (TP)||14
11346032|NCT02974868|12543211|FG002|COMPLETED|Initial 24-Week Treatment Period (TP)||45
11346033|NCT02974868|12543212|FG003|COMPLETED|Initial 24-Week Treatment Period (TP)||35
11346034|NCT02974868|12543209|FG000|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||4
11346035|NCT02974868|12543210|FG001|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||9
11066153|NCT01042093|12247859|FG002|NOT COMPLETED|Overall Study||2
11066154|NCT01042093|12247860|FG003|NOT COMPLETED|Overall Study||4
11346036|NCT02974868|12543211|FG002|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||3
11346037|NCT02974868|12543212|FG003|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||12
11346038|NCT02974868|12543209|FG000|STARTED|Single-Blind Extension (SBE) Period||17
11346039|NCT02974868|12543210|FG001|STARTED|Single-Blind Extension (SBE) Period||12
11346040|NCT02974868|12543211|FG002|STARTED|Single-Blind Extension (SBE) Period||38
11346041|NCT02974868|12543212|FG003|STARTED|Single-Blind Extension (SBE) Period||29
11346042|NCT02974868|12543209|FG000|COMPLETED|Single-Blind Extension (SBE) Period||15
11346043|NCT02974868|12543210|FG001|COMPLETED|Single-Blind Extension (SBE) Period||11
11346044|NCT02974868|12543211|FG002|COMPLETED|Single-Blind Extension (SBE) Period||27
11346045|NCT02974868|12543212|FG003|COMPLETED|Single-Blind Extension (SBE) Period||23
11346046|NCT02974868|12543209|FG000|NOT COMPLETED|Single-Blind Extension (SBE) Period||2
11346047|NCT02974868|12543210|FG001|NOT COMPLETED|Single-Blind Extension (SBE) Period||1
11346048|NCT02974868|12543211|FG002|NOT COMPLETED|Single-Blind Extension (SBE) Period||11
11346049|NCT02974868|12543212|FG003|NOT COMPLETED|Single-Blind Extension (SBE) Period||6
11346050|NCT02974868|12543209|FG000|STARTED|Cross-Over Extension (COE) Period||7
11346051|NCT02974868|12543210|FG001|STARTED|Cross-Over Extension (COE) Period||2
11346052|NCT02974868|12543211|FG002|STARTED|Cross-Over Extension (COE) Period||11
11346053|NCT02974868|12543212|FG003|STARTED|Cross-Over Extension (COE) Period||3
11346054|NCT02974868|12543209|FG000|COMPLETED|Cross-Over Extension (COE) Period||5
11346055|NCT02974868|12543210|FG001|COMPLETED|Cross-Over Extension (COE) Period||1
11346056|NCT02974868|12543211|FG002|COMPLETED|Cross-Over Extension (COE) Period||8
11346057|NCT02974868|12543212|FG003|COMPLETED|Cross-Over Extension (COE) Period||3
11346058|NCT02974868|12543209|FG000|NOT COMPLETED|Cross-Over Extension (COE) Period||2
11346059|NCT02974868|12543210|FG001|NOT COMPLETED|Cross-Over Extension (COE) Period||1
11346060|NCT02974868|12543211|FG002|NOT COMPLETED|Cross-Over Extension (COE) Period||3
11346061|NCT02974868|12543212|FG003|NOT COMPLETED|Cross-Over Extension (COE) Period||0
11346062|NCT02975206|12543256|FG000|STARTED|Overall Study||161
11346063|NCT02975206|12543257|FG001|STARTED|Overall Study||161
11346064|NCT02975206|12543258|FG002|STARTED|Overall Study||162
11346065|NCT02975206|12543256|FG000|COMPLETED|Overall Study||134
11346066|NCT02975206|12543257|FG001|COMPLETED|Overall Study||144
11346067|NCT02975206|12543258|FG002|COMPLETED|Overall Study||145
11346068|NCT02975206|12543256|FG000|NOT COMPLETED|Overall Study||27
11346069|NCT02975206|12543257|FG001|NOT COMPLETED|Overall Study||17
11346070|NCT02975206|12543258|FG002|NOT COMPLETED|Overall Study||17
11346071|NCT02975297|12543268|FG000|STARTED|Overall Study||41
11346072|NCT02975297|12543269|FG001|STARTED|Overall Study||41
11346073|NCT02975297|12543268|FG000|COMPLETED|Overall Study||34
11346074|NCT02975297|12543269|FG001|COMPLETED|Overall Study||35
11346075|NCT02975297|12543268|FG000|NOT COMPLETED|Overall Study||7
11346076|NCT02975297|12543269|FG001|NOT COMPLETED|Overall Study||6
11346077|NCT02975336|12543279|FG000|STARTED|DBPC (52 Weeks)||117
11346078|NCT02975336|12543280|FG001|STARTED|DBPC (52 Weeks)||118
11346079|NCT02975336|12543281|FG002|STARTED|DBPC (52 Weeks)||117
11346080|NCT02975336|12543282|FG003|STARTED|DBPC (52 Weeks)||117
11346081|NCT02975336|12543283|FG004|STARTED|DBPC (52 Weeks)||0
11346082|NCT02975336|12543284|FG005|STARTED|DBPC (52 Weeks)||0
11346083|NCT02975336|12543285|FG006|STARTED|DBPC (52 Weeks)||0
11346084|NCT02975336|12543286|FG007|STARTED|DBPC (52 Weeks)||0
11346085|NCT02975336|12543279|FG000|COMPLETED|DBPC (52 Weeks)||85
11346086|NCT02975336|12543280|FG001|COMPLETED|DBPC (52 Weeks)||89
11346087|NCT02975336|12543281|FG002|COMPLETED|DBPC (52 Weeks)||90
11346088|NCT02975336|12543282|FG003|COMPLETED|DBPC (52 Weeks)||84
11346089|NCT02975336|12543283|FG004|COMPLETED|DBPC (52 Weeks)||0
11346090|NCT02975336|12543284|FG005|COMPLETED|DBPC (52 Weeks)||0
11346091|NCT02975336|12543285|FG006|COMPLETED|DBPC (52 Weeks)||0
11346092|NCT02975336|12543286|FG007|COMPLETED|DBPC (52 Weeks)||0
11066155|NCT01042145|12247875|FG000|STARTED|Overall Study||41
11066156|NCT01042145|12247876|FG001|STARTED|Overall Study||46
11066157|NCT01042145|12247875|FG000|COMPLETED|Overall Study||40
11066158|NCT01042145|12247876|FG001|COMPLETED|Overall Study||45
11066159|NCT01042145|12247875|FG000|NOT COMPLETED|Overall Study||1
11066160|NCT01042145|12247876|FG001|NOT COMPLETED|Overall Study||1
11066161|NCT01042158|12247882|FG000|STARTED|Overall Study||25
11066162|NCT01042158|12247882|FG000|COMPLETED|Overall Study||24
11066163|NCT01042158|12247882|FG000|NOT COMPLETED|Overall Study||1
11066164|NCT01042236|12247886|FG000|STARTED|Treatment Period 1||3
11066165|NCT01042236|12247887|FG001|STARTED|Treatment Period 1||4
11066166|NCT01042236|12247888|FG002|STARTED|Treatment Period 1||3
11066167|NCT01042236|12247889|FG003|STARTED|Treatment Period 1||5
11066168|NCT01042236|12247890|FG004|STARTED|Treatment Period 1||4
11066169|NCT01042236|12247891|FG005|STARTED|Treatment Period 1||3
11066170|NCT01042236|12247886|FG000|COMPLETED|Treatment Period 1||3
11066171|NCT01042236|12247887|FG001|COMPLETED|Treatment Period 1||3
11066172|NCT01042236|12247888|FG002|COMPLETED|Treatment Period 1||3
11066173|NCT01042236|12247889|FG003|COMPLETED|Treatment Period 1||5
11066174|NCT01042236|12247890|FG004|COMPLETED|Treatment Period 1||3
11066175|NCT01042236|12247891|FG005|COMPLETED|Treatment Period 1||3
11066176|NCT01042236|12247886|FG000|NOT COMPLETED|Treatment Period 1||0
11066177|NCT01042236|12247887|FG001|NOT COMPLETED|Treatment Period 1||1
11066178|NCT01042236|12247888|FG002|NOT COMPLETED|Treatment Period 1||0
11066179|NCT01042236|12247889|FG003|NOT COMPLETED|Treatment Period 1||0
11066180|NCT01042236|12247890|FG004|NOT COMPLETED|Treatment Period 1||1
11066181|NCT01042236|12247891|FG005|NOT COMPLETED|Treatment Period 1||0
11066182|NCT01042236|12247886|FG000|STARTED|Treatment Period 2||3
11066183|NCT01042236|12247887|FG001|STARTED|Treatment Period 2||3
11066184|NCT01042236|12247888|FG002|STARTED|Treatment Period 2||3
11066185|NCT01042236|12247889|FG003|STARTED|Treatment Period 2||5
11066186|NCT01042236|12247890|FG004|STARTED|Treatment Period 2||3
11066187|NCT01042236|12247891|FG005|STARTED|Treatment Period 2||3
11066188|NCT01042236|12247886|FG000|COMPLETED|Treatment Period 2||3
11066189|NCT01042236|12247887|FG001|COMPLETED|Treatment Period 2||3
11066190|NCT01042236|12247888|FG002|COMPLETED|Treatment Period 2||3
11066191|NCT01042236|12247889|FG003|COMPLETED|Treatment Period 2||5
11066192|NCT01042236|12247890|FG004|COMPLETED|Treatment Period 2||3
11066193|NCT01042236|12247891|FG005|COMPLETED|Treatment Period 2||3
11066194|NCT01042236|12247886|FG000|NOT COMPLETED|Treatment Period 2||0
11066195|NCT01042236|12247887|FG001|NOT COMPLETED|Treatment Period 2||0
11066196|NCT01042236|12247888|FG002|NOT COMPLETED|Treatment Period 2||0
11066197|NCT01042236|12247889|FG003|NOT COMPLETED|Treatment Period 2||0
11066198|NCT01042236|12247890|FG004|NOT COMPLETED|Treatment Period 2||0
11066199|NCT01042236|12247891|FG005|NOT COMPLETED|Treatment Period 2||0
11066200|NCT01042236|12247886|FG000|STARTED|Treatment Period 3||3
11066201|NCT01042236|12247887|FG001|STARTED|Treatment Period 3||3
11066202|NCT01042236|12247888|FG002|STARTED|Treatment Period 3||3
11066203|NCT01042236|12247889|FG003|STARTED|Treatment Period 3||5
11066204|NCT01042236|12247890|FG004|STARTED|Treatment Period 3||3
11066205|NCT01042236|12247891|FG005|STARTED|Treatment Period 3||3
11066206|NCT01042236|12247886|FG000|COMPLETED|Treatment Period 3||3
11066207|NCT01042236|12247887|FG001|COMPLETED|Treatment Period 3||3
11066208|NCT01042236|12247888|FG002|COMPLETED|Treatment Period 3||3
11346093|NCT02975336|12543279|FG000|NOT COMPLETED|DBPC (52 Weeks)||32
11346094|NCT02975336|12543280|FG001|NOT COMPLETED|DBPC (52 Weeks)||29
11346095|NCT02975336|12543281|FG002|NOT COMPLETED|DBPC (52 Weeks)||27
11346096|NCT02975336|12543282|FG003|NOT COMPLETED|DBPC (52 Weeks)||33
11346097|NCT02975336|12543283|FG004|NOT COMPLETED|DBPC (52 Weeks)||0
11346098|NCT02975336|12543284|FG005|NOT COMPLETED|DBPC (52 Weeks)||0
11346099|NCT02975336|12543285|FG006|NOT COMPLETED|DBPC (52 Weeks)||0
11346100|NCT02975336|12543286|FG007|NOT COMPLETED|DBPC (52 Weeks)||0
11346101|NCT02975336|12543279|FG000|STARTED|LTE (104 Weeks)||0
11346102|NCT02975336|12543280|FG001|STARTED|LTE (104 Weeks)||0
11346103|NCT02975336|12543281|FG002|STARTED|LTE (104 Weeks)||0
11346104|NCT02975336|12543282|FG003|STARTED|LTE (104 Weeks)||0
11346105|NCT02975336|12543283|FG004|STARTED|LTE (104 Weeks)||62
11346106|NCT02975336|12543284|FG005|STARTED|LTE (104 Weeks)||69
11346107|NCT02975336|12543285|FG006|STARTED|LTE (104 Weeks)||80
11346108|NCT02975336|12543286|FG007|STARTED|LTE (104 Weeks)||72
11346109|NCT02975336|12543279|FG000|COMPLETED|LTE (104 Weeks)||0
11346110|NCT02975336|12543280|FG001|COMPLETED|LTE (104 Weeks)||0
11346111|NCT02975336|12543281|FG002|COMPLETED|LTE (104 Weeks)||0
11346112|NCT02975336|12543282|FG003|COMPLETED|LTE (104 Weeks)||0
11346113|NCT02975336|12543283|FG004|COMPLETED|LTE (104 Weeks)||0
11346114|NCT02975336|12543284|FG005|COMPLETED|LTE (104 Weeks)||0
11346115|NCT02975336|12543285|FG006|COMPLETED|LTE (104 Weeks)||0
11346116|NCT02975336|12543286|FG007|COMPLETED|LTE (104 Weeks)||0
11346117|NCT02975336|12543279|FG000|NOT COMPLETED|LTE (104 Weeks)||0
11346118|NCT02975336|12543280|FG001|NOT COMPLETED|LTE (104 Weeks)||0
11346119|NCT02975336|12543281|FG002|NOT COMPLETED|LTE (104 Weeks)||0
11346120|NCT02975336|12543282|FG003|NOT COMPLETED|LTE (104 Weeks)||0
11066209|NCT01042236|12247889|FG003|COMPLETED|Treatment Period 3||3
11066210|NCT01042236|12247890|FG004|COMPLETED|Treatment Period 3||3
11066211|NCT01042236|12247891|FG005|COMPLETED|Treatment Period 3||3
11066212|NCT01042236|12247886|FG000|NOT COMPLETED|Treatment Period 3||0
11066213|NCT01042236|12247887|FG001|NOT COMPLETED|Treatment Period 3||0
11066214|NCT01042236|12247888|FG002|NOT COMPLETED|Treatment Period 3||0
11066215|NCT01042236|12247889|FG003|NOT COMPLETED|Treatment Period 3||2
11066216|NCT01042236|12247890|FG004|NOT COMPLETED|Treatment Period 3||0
11066217|NCT01042236|12247891|FG005|NOT COMPLETED|Treatment Period 3||0
11066218|NCT01042288|12247899|FG000|STARTED|Overall Study||69
11066219|NCT01042288|12247899|FG000|Maintenance|Overall Study||27
11066220|NCT01042288|12247899|FG000|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
11066221|NCT01042288|12247899|FG000|NOT COMPLETED|Overall Study||69
11066222|NCT01042366|12247906|FG000|STARTED|Overall Study||5
11066223|NCT01042366|12247907|FG001|STARTED|Overall Study||6
11066224|NCT01042366|12247908|FG002|STARTED|Overall Study||4
11066225|NCT01042366|12247906|FG000|COMPLETED|Overall Study||5
11066226|NCT01042366|12247907|FG001|COMPLETED|Overall Study||6
11066227|NCT01042366|12247908|FG002|COMPLETED|Overall Study||4
11066228|NCT01042366|12247906|FG000|NOT COMPLETED|Overall Study||0
11066229|NCT01042366|12247907|FG001|NOT COMPLETED|Overall Study||0
11066230|NCT01042366|12247908|FG002|NOT COMPLETED|Overall Study||0
11205974|NCT01863732|12396891|FG001|COMPLETED|Overall Study||75
11205975|NCT01863732|12396892|FG002|COMPLETED|Overall Study||35
11205976|NCT01863732|12396893|FG003|COMPLETED|Overall Study||33
11205977|NCT01863732|12396890|FG000|NOT COMPLETED|Overall Study||13
11205978|NCT01863732|12396891|FG001|NOT COMPLETED|Overall Study||12
11205979|NCT01863732|12396892|FG002|NOT COMPLETED|Overall Study||11
11205980|NCT01863732|12396893|FG003|NOT COMPLETED|Overall Study||8
11205981|NCT01863758|12396902|FG000|STARTED|Pharmacokinetic Assessment||66
11205982|NCT01863758|12396902|FG000|COMPLETED|Pharmacokinetic Assessment||66
11205983|NCT01863758|12396902|FG000|NOT COMPLETED|Pharmacokinetic Assessment||0
11066231|NCT01042392|12247916|FG000|STARTED|Period II(Randomized,Double Blinded,8wk)||257
11066232|NCT01042392|12247917|FG001|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
11066233|NCT01042392|12247918|FG002|STARTED|Period II(Randomized,Double Blinded,8wk)||249
11066234|NCT01042392|12247919|FG003|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
11066235|NCT01042392|12247916|FG000|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
11066236|NCT01042392|12247917|FG001|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
11066237|NCT01042392|12247918|FG002|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
11066238|NCT01042392|12247919|FG003|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
11066239|NCT01042392|12247916|FG000|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
11066240|NCT01042392|12247917|FG001|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
11066241|NCT01042392|12247918|FG002|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
11066242|NCT01042392|12247919|FG003|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
11066243|NCT01042392|12247916|FG000|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
11066244|NCT01042392|12247917|FG001|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
11066245|NCT01042392|12247918|FG002|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
11066246|NCT01042392|12247919|FG003|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
11066247|NCT01042392|12247916|FG000|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
11066248|NCT01042392|12247917|FG001|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
11066249|NCT01042392|12247918|FG002|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
11066250|NCT01042392|12247919|FG003|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
11066251|NCT01042392|12247916|FG000|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
11066252|NCT01042392|12247917|FG001|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
11066253|NCT01042392|12247918|FG002|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
11066254|NCT01042392|12247919|FG003|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
11066255|NCT01042392|12247916|FG000|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
11066256|NCT01042392|12247917|FG001|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
11066257|NCT01042392|12247918|FG002|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
11066258|NCT01042392|12247919|FG003|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
11066259|NCT01042392|12247916|FG000|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
11066260|NCT01042392|12247917|FG001|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
11066261|NCT01042392|12247918|FG002|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
11066262|NCT01042392|12247919|FG003|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
11066263|NCT01042496|12247933|FG000|STARTED|Overall Study||29
11066264|NCT01042496|12247934|FG001|STARTED|Overall Study||33
11066265|NCT01042496|12247933|FG000|COMPLETED|Overall Study||29
11066266|NCT01042496|12247934|FG001|COMPLETED|Overall Study||33
11066267|NCT01042496|12247933|FG000|NOT COMPLETED|Overall Study||0
11066268|NCT01042496|12247934|FG001|NOT COMPLETED|Overall Study||0
11066269|NCT01042509|12247944|FG000|STARTED|Overall Study||15
11066270|NCT01042509|12247944|FG000|COMPLETED|Overall Study||15
11066271|NCT01042509|12247944|FG000|NOT COMPLETED|Overall Study||0
11066272|NCT01042535|12247948|FG000|STARTED|Overall Study||44
11066273|NCT01042535|12247948|FG000|COMPLETED|Overall Study||36
11066274|NCT01042535|12247948|FG000|NOT COMPLETED|Overall Study||8
11066275|NCT01042600|12247954|FG000|STARTED|Overall Study||31
11066276|NCT01042600|12247955|FG001|STARTED|Overall Study||30
11066277|NCT01042600|12247954|FG000|COMPLETED|Overall Study||30
11066278|NCT01042600|12247955|FG001|COMPLETED|Overall Study||30
11066279|NCT01042600|12247954|FG000|NOT COMPLETED|Overall Study||1
11066280|NCT01042600|12247955|FG001|NOT COMPLETED|Overall Study||0
11066281|NCT01042613|12247964|FG000|STARTED|Overall Study||72
11066282|NCT01042613|12247965|FG001|STARTED|Overall Study||74
11066283|NCT01042613|12247964|FG000|COMPLETED|Overall Study||72
11066284|NCT01042613|12247965|FG001|COMPLETED|Overall Study||74
11066285|NCT01042613|12247964|FG000|NOT COMPLETED|Overall Study||0
11066286|NCT01042613|12247965|FG001|NOT COMPLETED|Overall Study||0
11066287|NCT01042678|12247974|FG000|STARTED|Overall Study||6
11066288|NCT01042678|12247975|FG001|STARTED|Overall Study||6
11066289|NCT01042678|12247976|FG002|STARTED|Overall Study||6
11066290|NCT01042678|12247977|FG003|STARTED|Overall Study||0
11066291|NCT01042678|12247978|FG004|STARTED|Overall Study||0
11066292|NCT01042678|12247979|FG005|STARTED|Overall Study||0
11066293|NCT01042678|12247974|FG000|COMPLETED|Overall Study||5
11066294|NCT01042678|12247975|FG001|COMPLETED|Overall Study||6
11066295|NCT01042678|12247976|FG002|COMPLETED|Overall Study||6
11066296|NCT01042678|12247977|FG003|COMPLETED|Overall Study||0
11066297|NCT01042678|12247978|FG004|COMPLETED|Overall Study||0
11066298|NCT01042678|12247979|FG005|COMPLETED|Overall Study||0
11066299|NCT01042678|12247974|FG000|NOT COMPLETED|Overall Study||1
11066300|NCT01042678|12247975|FG001|NOT COMPLETED|Overall Study||0
11066301|NCT01042678|12247976|FG002|NOT COMPLETED|Overall Study||0
11066302|NCT01042678|12247977|FG003|NOT COMPLETED|Overall Study||0
11066303|NCT01042678|12247978|FG004|NOT COMPLETED|Overall Study||0
11066304|NCT01042678|12247979|FG005|NOT COMPLETED|Overall Study||0
11066305|NCT01042795|12247987|FG000|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
11205984|NCT01863758|12396902|FG000|STARTED|Prophylactic Treatment-Phase I||66
11066306|NCT01042795|12247987|FG000|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
11066307|NCT01042795|12247987|FG000|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
11066308|NCT01042795|12247987|FG000|STARTED|Follow up - 22 Months After Drug Start||2
11066309|NCT01042795|12247987|FG000|COMPLETED|Follow up - 22 Months After Drug Start||0
11066310|NCT01042795|12247987|FG000|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
11066311|NCT01042938|12247993|FG000|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
11066312|NCT01042938|12247994|FG001|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
11066313|NCT01042938|12247993|FG000|COMPLETED|Overall Study||14
11066314|NCT01042938|12247994|FG001|COMPLETED|Overall Study||16
11066315|NCT01042938|12247993|FG000|NOT COMPLETED|Overall Study||3
11066316|NCT01042938|12247994|FG001|NOT COMPLETED|Overall Study||2
11066317|NCT01042977|12248004|FG000|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
11066318|NCT01042977|12248005|FG001|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
11066319|NCT01042977|12248004|FG000|COMPLETED|Overall Study||441
11066320|NCT01042977|12248005|FG001|COMPLETED|Overall Study||428
11066321|NCT01042977|12248004|FG000|NOT COMPLETED|Overall Study||41
11066322|NCT01042977|12248005|FG001|NOT COMPLETED|Overall Study||55
11066323|NCT01043094|12248013|FG000|STARTED|Overall Study||8
11346121|NCT02975336|12543283|FG004|NOT COMPLETED|LTE (104 Weeks)||62
11346122|NCT02975336|12543284|FG005|NOT COMPLETED|LTE (104 Weeks)||69
11346123|NCT02975336|12543285|FG006|NOT COMPLETED|LTE (104 Weeks)||80
11346124|NCT02975336|12543286|FG007|NOT COMPLETED|LTE (104 Weeks)||72
11346125|NCT02975349|12543305|FG000|STARTED|Active Treatment Period (24 Weeks)||54
11346126|NCT02975349|12543306|FG001|STARTED|Active Treatment Period (24 Weeks)||0
11346127|NCT02975349|12543307|FG002|STARTED|Active Treatment Period (24 Weeks)||52
11346128|NCT02975349|12543308|FG003|STARTED|Active Treatment Period (24 Weeks)||53
11346129|NCT02975349|12543309|FG004|STARTED|Active Treatment Period (24 Weeks)||54
11346130|NCT02975349|12543310|FG005|STARTED|Active Treatment Period (24 Weeks)||54
11346131|NCT02975349|12543305|FG000|COMPLETED|Active Treatment Period (24 Weeks)||49
11346132|NCT02975349|12543306|FG001|COMPLETED|Active Treatment Period (24 Weeks)||0
11346133|NCT02975349|12543307|FG002|COMPLETED|Active Treatment Period (24 Weeks)||47
11346134|NCT02975349|12543308|FG003|COMPLETED|Active Treatment Period (24 Weeks)||48
11346135|NCT02975349|12543309|FG004|COMPLETED|Active Treatment Period (24 Weeks)||48
11346136|NCT02975349|12543310|FG005|COMPLETED|Active Treatment Period (24 Weeks)||52
11346137|NCT02975349|12543305|FG000|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
11346138|NCT02975349|12543306|FG001|NOT COMPLETED|Active Treatment Period (24 Weeks)||0
11346139|NCT02975349|12543307|FG002|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
11346140|NCT02975349|12543308|FG003|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
11346141|NCT02975349|12543309|FG004|NOT COMPLETED|Active Treatment Period (24 Weeks)||6
11346142|NCT02975349|12543310|FG005|NOT COMPLETED|Active Treatment Period (24 Weeks)||2
11066324|NCT01043094|12248014|FG001|STARTED|Overall Study||8
11066325|NCT01043094|12248013|FG000|COMPLETED|Overall Study||8
11066326|NCT01043094|12248014|FG001|COMPLETED|Overall Study||8
11066327|NCT01043094|12248013|FG000|NOT COMPLETED|Overall Study||0
11066328|NCT01043094|12248014|FG001|NOT COMPLETED|Overall Study||0
11066329|NCT01043133|12248022|FG000|STARTED|Overall Study||75
11066330|NCT01043133|12248023|FG001|STARTED|Overall Study||80
11066331|NCT01043133|12248022|FG000|COMPLETED|Overall Study||74
11066332|NCT01043133|12248023|FG001|COMPLETED|Overall Study||78
11066333|NCT01043133|12248022|FG000|NOT COMPLETED|Overall Study||1
11066334|NCT01043133|12248023|FG001|NOT COMPLETED|Overall Study||2
11066335|NCT01043146|12248035|FG000|STARTED|Overall Study||10
11066336|NCT01043146|12248036|FG001|STARTED|Overall Study||8
11066337|NCT01043146|12248037|FG002|STARTED|Overall Study||8
11066338|NCT01043146|12248038|FG003|STARTED|Overall Study||8
11066339|NCT01043146|12248039|FG004|STARTED|Overall Study||8
11066340|NCT01043146|12248040|FG005|STARTED|Overall Study||8
11066341|NCT01043146|12248035|FG000|COMPLETED|Overall Study||10
11066342|NCT01043146|12248036|FG001|COMPLETED|Overall Study||8
11066343|NCT01043146|12248037|FG002|COMPLETED|Overall Study||8
11066344|NCT01043146|12248038|FG003|COMPLETED|Overall Study||8
11066345|NCT01043146|12248039|FG004|COMPLETED|Overall Study||8
11066346|NCT01043146|12248040|FG005|COMPLETED|Overall Study||8
11066347|NCT01043146|12248035|FG000|NOT COMPLETED|Overall Study||0
11066348|NCT01043146|12248036|FG001|NOT COMPLETED|Overall Study||0
11066349|NCT01043146|12248037|FG002|NOT COMPLETED|Overall Study||0
11066350|NCT01043146|12248038|FG003|NOT COMPLETED|Overall Study||0
11066351|NCT01043146|12248039|FG004|NOT COMPLETED|Overall Study||0
11066352|NCT01043146|12248040|FG005|NOT COMPLETED|Overall Study||0
11066353|NCT01043185|12248054|FG000|STARTED|Period 1 - First Intervention||3
11066354|NCT01043185|12248055|FG001|STARTED|Period 1 - First Intervention||2
11066355|NCT01043185|12248056|FG002|STARTED|Period 1 - First Intervention||3
11066356|NCT01043185|12248057|FG003|STARTED|Period 1 - First Intervention||2
11066357|NCT01043185|12248058|FG004|STARTED|Period 1 - First Intervention||2
11066358|NCT01043185|12248059|FG005|STARTED|Period 1 - First Intervention||3
11066359|NCT01043185|12248060|FG006|STARTED|Period 1 - First Intervention||3
11066360|NCT01043185|12248061|FG007|STARTED|Period 1 - First Intervention||3
11066361|NCT01043185|12248062|FG008|STARTED|Period 1 - First Intervention||3
11066362|NCT01043185|12248063|FG009|STARTED|Period 1 - First Intervention||3
11066363|NCT01043185|12248054|FG000|COMPLETED|Period 1 - First Intervention||3
11066364|NCT01043185|12248055|FG001|COMPLETED|Period 1 - First Intervention||2
11066365|NCT01043185|12248056|FG002|COMPLETED|Period 1 - First Intervention||3
11066366|NCT01043185|12248057|FG003|COMPLETED|Period 1 - First Intervention||2
11066367|NCT01043185|12248058|FG004|COMPLETED|Period 1 - First Intervention||2
11066368|NCT01043185|12248059|FG005|COMPLETED|Period 1 - First Intervention||3
11066369|NCT01043185|12248060|FG006|COMPLETED|Period 1 - First Intervention||3
11066370|NCT01043185|12248061|FG007|COMPLETED|Period 1 - First Intervention||3
11066371|NCT01043185|12248062|FG008|COMPLETED|Period 1 - First Intervention||3
11066372|NCT01043185|12248063|FG009|COMPLETED|Period 1 - First Intervention||3
11066373|NCT01043185|12248054|FG000|NOT COMPLETED|Period 1 - First Intervention||0
11066374|NCT01043185|12248055|FG001|NOT COMPLETED|Period 1 - First Intervention||0
11066375|NCT01043185|12248056|FG002|NOT COMPLETED|Period 1 - First Intervention||0
11066376|NCT01043185|12248057|FG003|NOT COMPLETED|Period 1 - First Intervention||0
11066377|NCT01043185|12248058|FG004|NOT COMPLETED|Period 1 - First Intervention||0
11066378|NCT01043185|12248059|FG005|NOT COMPLETED|Period 1 - First Intervention||0
11066379|NCT01043185|12248060|FG006|NOT COMPLETED|Period 1 - First Intervention||0
11066380|NCT01043185|12248061|FG007|NOT COMPLETED|Period 1 - First Intervention||0
11066381|NCT01043185|12248062|FG008|NOT COMPLETED|Period 1 - First Intervention||0
11066382|NCT01043185|12248063|FG009|NOT COMPLETED|Period 1 - First Intervention||0
11066383|NCT01043185|12248054|FG000|STARTED|Period 2 - First Washout Period||3
11066384|NCT01043185|12248055|FG001|STARTED|Period 2 - First Washout Period||2
11066385|NCT01043185|12248056|FG002|STARTED|Period 2 - First Washout Period||3
11066386|NCT01043185|12248057|FG003|STARTED|Period 2 - First Washout Period||2
11066387|NCT01043185|12248058|FG004|STARTED|Period 2 - First Washout Period||2
11066388|NCT01043185|12248059|FG005|STARTED|Period 2 - First Washout Period||3
11066389|NCT01043185|12248060|FG006|STARTED|Period 2 - First Washout Period||3
11066390|NCT01043185|12248061|FG007|STARTED|Period 2 - First Washout Period||3
11066391|NCT01043185|12248062|FG008|STARTED|Period 2 - First Washout Period||3
11066392|NCT01043185|12248063|FG009|STARTED|Period 2 - First Washout Period||3
11066393|NCT01043185|12248054|FG000|COMPLETED|Period 2 - First Washout Period||3
11066394|NCT01043185|12248055|FG001|COMPLETED|Period 2 - First Washout Period||2
11066395|NCT01043185|12248056|FG002|COMPLETED|Period 2 - First Washout Period||3
11346143|NCT02975349|12543305|FG000|STARTED|Blinded Extension Period (24 Weeks)||0
11346144|NCT02975349|12543306|FG001|STARTED|Blinded Extension Period (24 Weeks)||49
11346145|NCT02975349|12543307|FG002|STARTED|Blinded Extension Period (24 Weeks)||47
11346146|NCT02975349|12543308|FG003|STARTED|Blinded Extension Period (24 Weeks)||48
11346147|NCT02975349|12543309|FG004|STARTED|Blinded Extension Period (24 Weeks)||48
11346148|NCT02975349|12543310|FG005|STARTED|Blinded Extension Period (24 Weeks)||52
11346149|NCT02975349|12543305|FG000|COMPLETED|Blinded Extension Period (24 Weeks)||0
11346150|NCT02975349|12543306|FG001|COMPLETED|Blinded Extension Period (24 Weeks)||42
11346151|NCT02975349|12543307|FG002|COMPLETED|Blinded Extension Period (24 Weeks)||43
11346152|NCT02975349|12543308|FG003|COMPLETED|Blinded Extension Period (24 Weeks)||44
11346153|NCT02975349|12543309|FG004|COMPLETED|Blinded Extension Period (24 Weeks)||46
11346154|NCT02975349|12543310|FG005|COMPLETED|Blinded Extension Period (24 Weeks)||52
11066396|NCT01043185|12248057|FG003|COMPLETED|Period 2 - First Washout Period||2
11066397|NCT01043185|12248058|FG004|COMPLETED|Period 2 - First Washout Period||2
11066398|NCT01043185|12248059|FG005|COMPLETED|Period 2 - First Washout Period||3
11066399|NCT01043185|12248060|FG006|COMPLETED|Period 2 - First Washout Period||3
11066400|NCT01043185|12248061|FG007|COMPLETED|Period 2 - First Washout Period||3
11066401|NCT01043185|12248062|FG008|COMPLETED|Period 2 - First Washout Period||3
11066402|NCT01043185|12248063|FG009|COMPLETED|Period 2 - First Washout Period||3
11066403|NCT01043185|12248054|FG000|NOT COMPLETED|Period 2 - First Washout Period||0
11066404|NCT01043185|12248055|FG001|NOT COMPLETED|Period 2 - First Washout Period||0
11066405|NCT01043185|12248056|FG002|NOT COMPLETED|Period 2 - First Washout Period||0
11066406|NCT01043185|12248057|FG003|NOT COMPLETED|Period 2 - First Washout Period||0
11066407|NCT01043185|12248058|FG004|NOT COMPLETED|Period 2 - First Washout Period||0
11066408|NCT01043185|12248059|FG005|NOT COMPLETED|Period 2 - First Washout Period||0
11066409|NCT01043185|12248060|FG006|NOT COMPLETED|Period 2 - First Washout Period||0
11066410|NCT01043185|12248061|FG007|NOT COMPLETED|Period 2 - First Washout Period||0
11066411|NCT01043185|12248062|FG008|NOT COMPLETED|Period 2 - First Washout Period||0
11066412|NCT01043185|12248063|FG009|NOT COMPLETED|Period 2 - First Washout Period||0
11066413|NCT01043185|12248054|FG000|STARTED|Period 3 - Second Intervention||3
11066414|NCT01043185|12248055|FG001|STARTED|Period 3 - Second Intervention||2
11066415|NCT01043185|12248056|FG002|STARTED|Period 3 - Second Intervention||3
11066416|NCT01043185|12248057|FG003|STARTED|Period 3 - Second Intervention||2
11066417|NCT01043185|12248058|FG004|STARTED|Period 3 - Second Intervention||2
11066418|NCT01043185|12248059|FG005|STARTED|Period 3 - Second Intervention||3
11066419|NCT01043185|12248060|FG006|STARTED|Period 3 - Second Intervention||3
11066420|NCT01043185|12248061|FG007|STARTED|Period 3 - Second Intervention||3
11066421|NCT01043185|12248062|FG008|STARTED|Period 3 - Second Intervention||3
11066422|NCT01043185|12248063|FG009|STARTED|Period 3 - Second Intervention||3
11066423|NCT01043185|12248054|FG000|COMPLETED|Period 3 - Second Intervention||3
11066424|NCT01043185|12248055|FG001|COMPLETED|Period 3 - Second Intervention||2
11066425|NCT01043185|12248056|FG002|COMPLETED|Period 3 - Second Intervention||3
11066426|NCT01043185|12248057|FG003|COMPLETED|Period 3 - Second Intervention||2
11066427|NCT01043185|12248058|FG004|COMPLETED|Period 3 - Second Intervention||2
11066428|NCT01043185|12248059|FG005|COMPLETED|Period 3 - Second Intervention||3
11066429|NCT01043185|12248060|FG006|COMPLETED|Period 3 - Second Intervention||3
11066430|NCT01043185|12248061|FG007|COMPLETED|Period 3 - Second Intervention||3
11066431|NCT01043185|12248062|FG008|COMPLETED|Period 3 - Second Intervention||3
11066432|NCT01043185|12248063|FG009|COMPLETED|Period 3 - Second Intervention||3
11066433|NCT01043185|12248054|FG000|NOT COMPLETED|Period 3 - Second Intervention||0
11066434|NCT01043185|12248055|FG001|NOT COMPLETED|Period 3 - Second Intervention||0
11066435|NCT01043185|12248056|FG002|NOT COMPLETED|Period 3 - Second Intervention||0
11066436|NCT01043185|12248057|FG003|NOT COMPLETED|Period 3 - Second Intervention||0
11066437|NCT01043185|12248058|FG004|NOT COMPLETED|Period 3 - Second Intervention||0
11066438|NCT01043185|12248059|FG005|NOT COMPLETED|Period 3 - Second Intervention||0
11066439|NCT01043185|12248060|FG006|NOT COMPLETED|Period 3 - Second Intervention||0
11066440|NCT01043185|12248061|FG007|NOT COMPLETED|Period 3 - Second Intervention||0
11066441|NCT01043185|12248062|FG008|NOT COMPLETED|Period 3 - Second Intervention||0
11066442|NCT01043185|12248063|FG009|NOT COMPLETED|Period 3 - Second Intervention||0
11066443|NCT01043185|12248054|FG000|STARTED|Period 4 - Second Washout Period||3
11066444|NCT01043185|12248055|FG001|STARTED|Period 4 - Second Washout Period||2
11066445|NCT01043185|12248056|FG002|STARTED|Period 4 - Second Washout Period||3
11066446|NCT01043185|12248057|FG003|STARTED|Period 4 - Second Washout Period||2
11066447|NCT01043185|12248058|FG004|STARTED|Period 4 - Second Washout Period||2
11066448|NCT01043185|12248059|FG005|STARTED|Period 4 - Second Washout Period||3
11066449|NCT01043185|12248060|FG006|STARTED|Period 4 - Second Washout Period||3
11066450|NCT01043185|12248061|FG007|STARTED|Period 4 - Second Washout Period||3
11066451|NCT01043185|12248062|FG008|STARTED|Period 4 - Second Washout Period||3
11066452|NCT01043185|12248063|FG009|STARTED|Period 4 - Second Washout Period||3
11066453|NCT01043185|12248054|FG000|COMPLETED|Period 4 - Second Washout Period||3
11066454|NCT01043185|12248055|FG001|COMPLETED|Period 4 - Second Washout Period||2
11066455|NCT01043185|12248056|FG002|COMPLETED|Period 4 - Second Washout Period||3
11066456|NCT01043185|12248057|FG003|COMPLETED|Period 4 - Second Washout Period||2
11066457|NCT01043185|12248058|FG004|COMPLETED|Period 4 - Second Washout Period||2
11066458|NCT01043185|12248059|FG005|COMPLETED|Period 4 - Second Washout Period||3
11066459|NCT01043185|12248060|FG006|COMPLETED|Period 4 - Second Washout Period||3
11066460|NCT01043185|12248061|FG007|COMPLETED|Period 4 - Second Washout Period||3
11066461|NCT01043185|12248062|FG008|COMPLETED|Period 4 - Second Washout Period||3
11066462|NCT01043185|12248063|FG009|COMPLETED|Period 4 - Second Washout Period||3
11066463|NCT01043185|12248054|FG000|NOT COMPLETED|Period 4 - Second Washout Period||0
11066464|NCT01043185|12248055|FG001|NOT COMPLETED|Period 4 - Second Washout Period||0
11066465|NCT01043185|12248056|FG002|NOT COMPLETED|Period 4 - Second Washout Period||0
11066466|NCT01043185|12248057|FG003|NOT COMPLETED|Period 4 - Second Washout Period||0
11066467|NCT01043185|12248058|FG004|NOT COMPLETED|Period 4 - Second Washout Period||0
11066468|NCT01043185|12248059|FG005|NOT COMPLETED|Period 4 - Second Washout Period||0
11066469|NCT01043185|12248060|FG006|NOT COMPLETED|Period 4 - Second Washout Period||0
11066470|NCT01043185|12248061|FG007|NOT COMPLETED|Period 4 - Second Washout Period||0
11066471|NCT01043185|12248062|FG008|NOT COMPLETED|Period 4 - Second Washout Period||0
11066472|NCT01043185|12248063|FG009|NOT COMPLETED|Period 4 - Second Washout Period||0
11066473|NCT01043185|12248054|FG000|STARTED|Period 5 - Third Intervention||3
11066474|NCT01043185|12248055|FG001|STARTED|Period 5 - Third Intervention||2
11066475|NCT01043185|12248056|FG002|STARTED|Period 5 - Third Intervention||3
11066476|NCT01043185|12248057|FG003|STARTED|Period 5 - Third Intervention||2
11066477|NCT01043185|12248058|FG004|STARTED|Period 5 - Third Intervention||2
11066478|NCT01043185|12248059|FG005|STARTED|Period 5 - Third Intervention||3
11066479|NCT01043185|12248060|FG006|STARTED|Period 5 - Third Intervention||3
11066480|NCT01043185|12248061|FG007|STARTED|Period 5 - Third Intervention||3
11066481|NCT01043185|12248062|FG008|STARTED|Period 5 - Third Intervention||3
11066482|NCT01043185|12248063|FG009|STARTED|Period 5 - Third Intervention||3
11066483|NCT01043185|12248054|FG000|COMPLETED|Period 5 - Third Intervention||3
11066484|NCT01043185|12248055|FG001|COMPLETED|Period 5 - Third Intervention||2
11066485|NCT01043185|12248056|FG002|COMPLETED|Period 5 - Third Intervention||3
11066486|NCT01043185|12248057|FG003|COMPLETED|Period 5 - Third Intervention||2
11066487|NCT01043185|12248058|FG004|COMPLETED|Period 5 - Third Intervention||2
11066488|NCT01043185|12248059|FG005|COMPLETED|Period 5 - Third Intervention||3
11066489|NCT01043185|12248060|FG006|COMPLETED|Period 5 - Third Intervention||3
11066490|NCT01043185|12248061|FG007|COMPLETED|Period 5 - Third Intervention||3
11066491|NCT01043185|12248062|FG008|COMPLETED|Period 5 - Third Intervention||3
11066492|NCT01043185|12248063|FG009|COMPLETED|Period 5 - Third Intervention||3
11066493|NCT01043185|12248054|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
11066494|NCT01043185|12248055|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
11066495|NCT01043185|12248056|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
11066496|NCT01043185|12248057|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
11066497|NCT01043185|12248058|FG004|NOT COMPLETED|Period 5 - Third Intervention||0
11066498|NCT01043185|12248059|FG005|NOT COMPLETED|Period 5 - Third Intervention||0
11066499|NCT01043185|12248060|FG006|NOT COMPLETED|Period 5 - Third Intervention||0
11066500|NCT01043185|12248061|FG007|NOT COMPLETED|Period 5 - Third Intervention||0
11066501|NCT01043185|12248062|FG008|NOT COMPLETED|Period 5 - Third Intervention||0
11066502|NCT01043185|12248063|FG009|NOT COMPLETED|Period 5 - Third Intervention||0
11066503|NCT01043185|12248054|FG000|STARTED|Period 6 - Third Washout Period||3
11066504|NCT01043185|12248055|FG001|STARTED|Period 6 - Third Washout Period||2
11066505|NCT01043185|12248056|FG002|STARTED|Period 6 - Third Washout Period||3
11066506|NCT01043185|12248057|FG003|STARTED|Period 6 - Third Washout Period||2
11066507|NCT01043185|12248058|FG004|STARTED|Period 6 - Third Washout Period||2
11066508|NCT01043185|12248059|FG005|STARTED|Period 6 - Third Washout Period||3
11066509|NCT01043185|12248060|FG006|STARTED|Period 6 - Third Washout Period||3
11066510|NCT01043185|12248061|FG007|STARTED|Period 6 - Third Washout Period||3
11066511|NCT01043185|12248062|FG008|STARTED|Period 6 - Third Washout Period||3
11066512|NCT01043185|12248063|FG009|STARTED|Period 6 - Third Washout Period||3
11066513|NCT01043185|12248054|FG000|COMPLETED|Period 6 - Third Washout Period||3
11066514|NCT01043185|12248055|FG001|COMPLETED|Period 6 - Third Washout Period||2
11066515|NCT01043185|12248056|FG002|COMPLETED|Period 6 - Third Washout Period||3
11066516|NCT01043185|12248057|FG003|COMPLETED|Period 6 - Third Washout Period||2
11066517|NCT01043185|12248058|FG004|COMPLETED|Period 6 - Third Washout Period||2
11066518|NCT01043185|12248059|FG005|COMPLETED|Period 6 - Third Washout Period||3
11066519|NCT01043185|12248060|FG006|COMPLETED|Period 6 - Third Washout Period||3
11066520|NCT01043185|12248061|FG007|COMPLETED|Period 6 - Third Washout Period||3
11066521|NCT01043185|12248062|FG008|COMPLETED|Period 6 - Third Washout Period||2
11066522|NCT01043185|12248063|FG009|COMPLETED|Period 6 - Third Washout Period||3
11066523|NCT01043185|12248054|FG000|NOT COMPLETED|Period 6 - Third Washout Period||0
11066524|NCT01043185|12248055|FG001|NOT COMPLETED|Period 6 - Third Washout Period||0
11066525|NCT01043185|12248056|FG002|NOT COMPLETED|Period 6 - Third Washout Period||0
11066526|NCT01043185|12248057|FG003|NOT COMPLETED|Period 6 - Third Washout Period||0
11066527|NCT01043185|12248058|FG004|NOT COMPLETED|Period 6 - Third Washout Period||0
11066528|NCT01043185|12248059|FG005|NOT COMPLETED|Period 6 - Third Washout Period||0
11066529|NCT01043185|12248060|FG006|NOT COMPLETED|Period 6 - Third Washout Period||0
11066530|NCT01043185|12248061|FG007|NOT COMPLETED|Period 6 - Third Washout Period||0
11066531|NCT01043185|12248062|FG008|NOT COMPLETED|Period 6 - Third Washout Period||1
11066532|NCT01043185|12248063|FG009|NOT COMPLETED|Period 6 - Third Washout Period||0
11066533|NCT01043185|12248054|FG000|STARTED|Period 7 - Fourth Intervention||3
11066534|NCT01043185|12248055|FG001|STARTED|Period 7 - Fourth Intervention||2
11066535|NCT01043185|12248056|FG002|STARTED|Period 7 - Fourth Intervention||3
11066536|NCT01043185|12248057|FG003|STARTED|Period 7 - Fourth Intervention||2
11066537|NCT01043185|12248058|FG004|STARTED|Period 7 - Fourth Intervention||2
11066538|NCT01043185|12248059|FG005|STARTED|Period 7 - Fourth Intervention||3
11066539|NCT01043185|12248060|FG006|STARTED|Period 7 - Fourth Intervention||3
11066540|NCT01043185|12248061|FG007|STARTED|Period 7 - Fourth Intervention||3
11066541|NCT01043185|12248062|FG008|STARTED|Period 7 - Fourth Intervention||2
11066542|NCT01043185|12248063|FG009|STARTED|Period 7 - Fourth Intervention||3
11066543|NCT01043185|12248054|FG000|COMPLETED|Period 7 - Fourth Intervention||3
11066544|NCT01043185|12248055|FG001|COMPLETED|Period 7 - Fourth Intervention||2
11066545|NCT01043185|12248056|FG002|COMPLETED|Period 7 - Fourth Intervention||3
11346155|NCT02975349|12543305|FG000|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
11066546|NCT01043185|12248057|FG003|COMPLETED|Period 7 - Fourth Intervention||2
11066547|NCT01043185|12248058|FG004|COMPLETED|Period 7 - Fourth Intervention||2
11066548|NCT01043185|12248059|FG005|COMPLETED|Period 7 - Fourth Intervention||3
11066549|NCT01043185|12248060|FG006|COMPLETED|Period 7 - Fourth Intervention||3
11066550|NCT01043185|12248061|FG007|COMPLETED|Period 7 - Fourth Intervention||3
11066551|NCT01043185|12248062|FG008|COMPLETED|Period 7 - Fourth Intervention||2
11066552|NCT01043185|12248063|FG009|COMPLETED|Period 7 - Fourth Intervention||3
11066553|NCT01043185|12248054|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0
11066554|NCT01043185|12248055|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0
11066555|NCT01043185|12248056|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0
11066556|NCT01043185|12248057|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0
11066557|NCT01043185|12248058|FG004|NOT COMPLETED|Period 7 - Fourth Intervention||0
11066558|NCT01043185|12248059|FG005|NOT COMPLETED|Period 7 - Fourth Intervention||0
11066559|NCT01043185|12248060|FG006|NOT COMPLETED|Period 7 - Fourth Intervention||0
11066560|NCT01043185|12248061|FG007|NOT COMPLETED|Period 7 - Fourth Intervention||0
11066561|NCT01043185|12248062|FG008|NOT COMPLETED|Period 7 - Fourth Intervention||0
11066562|NCT01043185|12248063|FG009|NOT COMPLETED|Period 7 - Fourth Intervention||0
11066563|NCT01043393|12248077|FG000|STARTED|Overall Study||12
11066564|NCT01043393|12248078|FG001|STARTED|Overall Study||12
11066565|NCT01043393|12248077|FG000|COMPLETED|Overall Study||12
11066566|NCT01043393|12248078|FG001|COMPLETED|Overall Study||12
11066567|NCT01043393|12248077|FG000|NOT COMPLETED|Overall Study||0
11066568|NCT01043393|12248078|FG001|NOT COMPLETED|Overall Study||0
11066569|NCT01043432|12248088|FG000|STARTED|Overall Study||22
11066570|NCT01043432|12248089|FG001|STARTED|Overall Study||51
11066571|NCT01043432|12248090|FG002|STARTED|Overall Study||12
11066572|NCT01043432|12248091|FG003|STARTED|Overall Study||48
11066573|NCT01043432|12248088|FG000|COMPLETED|Overall Study||22
11066574|NCT01043432|12248089|FG001|COMPLETED|Overall Study||51
11066575|NCT01043432|12248090|FG002|COMPLETED|Overall Study||12
11066576|NCT01043432|12248091|FG003|COMPLETED|Overall Study||48
11066577|NCT01043432|12248088|FG000|NOT COMPLETED|Overall Study||0
11066578|NCT01043432|12248089|FG001|NOT COMPLETED|Overall Study||0
11066579|NCT01043432|12248090|FG002|NOT COMPLETED|Overall Study||0
11066580|NCT01043432|12248091|FG003|NOT COMPLETED|Overall Study||0
11066581|NCT01043523|12248098|FG000|STARTED|Overall Study||52
11066582|NCT01043523|12248098|FG000|Participants With Unenhanced Images|Overall Study||51
11066583|NCT01043523|12248098|FG000|COMPLETED|Overall Study||52
11066584|NCT01043523|12248098|FG000|NOT COMPLETED|Overall Study||0
11066585|NCT01043562|12248106|FG000|STARTED|Overall Study||20
11066586|NCT01043562|12248106|FG000|COMPLETED|Overall Study||20
11066587|NCT01043562|12248106|FG000|NOT COMPLETED|Overall Study||0
11066588|NCT01043640|12248113|FG000|STARTED|Overall Study||46
11066589|NCT01043640|12248113|FG000|COMPLETED|Overall Study||46
11066590|NCT01043640|12248113|FG000|NOT COMPLETED|Overall Study||0
11066591|NCT01043653|12248117|FG000|STARTED|Overall Study||250
11066592|NCT01043653|12248117|FG000|COMPLETED|Overall Study||186
11066593|NCT01043653|12248117|FG000|NOT COMPLETED|Overall Study||64
11066594|NCT01043705|12248124|FG000|STARTED|Overall Study||459
11066595|NCT01043705|12248125|FG001|STARTED|Overall Study||578
11066596|NCT01043705|12248126|FG002|STARTED|Overall Study||578
11066597|NCT01043705|12248124|FG000|COMPLETED|Overall Study||352
11066598|NCT01043705|12248125|FG001|COMPLETED|Overall Study||447
11066599|NCT01043705|12248126|FG002|COMPLETED|Overall Study||498
11066600|NCT01043705|12248124|FG000|NOT COMPLETED|Overall Study||107
11066601|NCT01043705|12248125|FG001|NOT COMPLETED|Overall Study||131
11066602|NCT01043705|12248126|FG002|NOT COMPLETED|Overall Study||80
11066603|NCT01043874|12248134|FG000|STARTED|Overall Study||45
11066604|NCT01043874|12248134|FG000|COMPLETED|Overall Study||39
11066605|NCT01043874|12248134|FG000|NOT COMPLETED|Overall Study||6
11066606|NCT01043926|12248140|FG000|STARTED|Overall Study||8
11066607|NCT01043926|12248141|FG001|STARTED|Overall Study||8
11066608|NCT01043926|12248142|FG002|STARTED|Overall Study||0
11066609|NCT01043926|12248143|FG003|STARTED|Overall Study||0
11066610|NCT01043926|12248140|FG000|COMPLETED|Overall Study||8
11066611|NCT01043926|12248141|FG001|COMPLETED|Overall Study||8
11066612|NCT01043926|12248142|FG002|COMPLETED|Overall Study||0
11066613|NCT01043926|12248143|FG003|COMPLETED|Overall Study||0
11066614|NCT01043926|12248140|FG000|NOT COMPLETED|Overall Study||0
11066615|NCT01043926|12248141|FG001|NOT COMPLETED|Overall Study||0
11066616|NCT01043926|12248142|FG002|NOT COMPLETED|Overall Study||0
11066617|NCT01043926|12248143|FG003|NOT COMPLETED|Overall Study||0
11066618|NCT01043939|12248151|FG000|STARTED|First Intervention||12
11066619|NCT01043939|12248152|FG001|STARTED|First Intervention||12
11066620|NCT01043939|12248151|FG000|COMPLETED|First Intervention||12
11066621|NCT01043939|12248152|FG001|COMPLETED|First Intervention||12
11066622|NCT01043939|12248151|FG000|NOT COMPLETED|First Intervention||0
11066623|NCT01043939|12248152|FG001|NOT COMPLETED|First Intervention||0
11066624|NCT01043939|12248151|FG000|STARTED|Washout Period||12
11066625|NCT01043939|12248152|FG001|STARTED|Washout Period||12
11066626|NCT01043939|12248151|FG000|COMPLETED|Washout Period||12
11066627|NCT01043939|12248152|FG001|COMPLETED|Washout Period||12
11066628|NCT01043939|12248151|FG000|NOT COMPLETED|Washout Period||0
11066629|NCT01043939|12248152|FG001|NOT COMPLETED|Washout Period||0
11066630|NCT01043939|12248151|FG000|STARTED|Second Intervention||12
11066631|NCT01043939|12248152|FG001|STARTED|Second Intervention||12
11066632|NCT01043939|12248151|FG000|COMPLETED|Second Intervention||12
11066633|NCT01043939|12248152|FG001|COMPLETED|Second Intervention||12
11066634|NCT01043939|12248151|FG000|NOT COMPLETED|Second Intervention||0
11066635|NCT01043939|12248152|FG001|NOT COMPLETED|Second Intervention||0
11066636|NCT01044030|12248161|FG000|STARTED|Overall Study||160
11066637|NCT01044030|12248162|FG001|STARTED|Overall Study||166
11066638|NCT01044030|12248161|FG000|COMPLETED|Overall Study||141
11066639|NCT01044030|12248162|FG001|COMPLETED|Overall Study||146
11066640|NCT01044030|12248161|FG000|NOT COMPLETED|Overall Study||19
11066641|NCT01044030|12248162|FG001|NOT COMPLETED|Overall Study||20
11066642|NCT01044212|12248170|FG000|STARTED|Overall Study||35
11066643|NCT01044212|12248171|FG001|STARTED|Overall Study||37
11066644|NCT01044212|12248170|FG000|COMPLETED|Overall Study||30
11066645|NCT01044212|12248171|FG001|COMPLETED|Overall Study||30
11066646|NCT01044212|12248170|FG000|NOT COMPLETED|Overall Study||5
11066647|NCT01044212|12248171|FG001|NOT COMPLETED|Overall Study||7
11066648|NCT01044264|12248180|FG000|STARTED|Overall Study||200
11066649|NCT01044264|12248181|FG001|STARTED|Overall Study||202
11066650|NCT01044264|12248182|FG002|STARTED|Overall Study||200
11066651|NCT01044264|12248180|FG000|COMPLETED|Overall Study||110
11066652|NCT01044264|12248181|FG001|COMPLETED|Overall Study||108
11066653|NCT01044264|12248182|FG002|COMPLETED|Overall Study||108
11066654|NCT01044264|12248180|FG000|NOT COMPLETED|Overall Study||90
11066655|NCT01044264|12248181|FG001|NOT COMPLETED|Overall Study||94
11066656|NCT01044264|12248182|FG002|NOT COMPLETED|Overall Study||92
11066657|NCT01044290|12248193|FG000|STARTED|Randomization||75
11066658|NCT01044290|12248194|FG001|STARTED|Randomization||74
11066659|NCT01044290|12248195|FG002|STARTED|Randomization||72
11066660|NCT01044290|12248193|FG000|Randomized|Randomization||75
11066661|NCT01044290|12248194|FG001|Randomized|Randomization||74
11066662|NCT01044290|12248195|FG002|Randomized|Randomization||72
11066663|NCT01044290|12248193|FG000|COMPLETED|Randomization||75
11066664|NCT01044290|12248194|FG001|COMPLETED|Randomization||74
11346156|NCT02975349|12543306|FG001|NOT COMPLETED|Blinded Extension Period (24 Weeks)||7
11346157|NCT02975349|12543307|FG002|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
11346158|NCT02975349|12543308|FG003|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
11346159|NCT02975349|12543309|FG004|NOT COMPLETED|Blinded Extension Period (24 Weeks)||2
11346160|NCT02975349|12543310|FG005|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
11066665|NCT01044290|12248195|FG002|COMPLETED|Randomization||72
11066666|NCT01044290|12248193|FG000|NOT COMPLETED|Randomization||0
11066667|NCT01044290|12248194|FG001|NOT COMPLETED|Randomization||0
11066668|NCT01044290|12248195|FG002|NOT COMPLETED|Randomization||0
11066669|NCT01044290|12248193|FG000|STARTED|Follow-up 1||75
11066670|NCT01044290|12248194|FG001|STARTED|Follow-up 1||74
11066671|NCT01044290|12248195|FG002|STARTED|Follow-up 1||72
11066672|NCT01044290|12248193|FG000|Completed F1 Interview|Follow-up 1||61
11066673|NCT01044290|12248194|FG001|Completed F1 Interview|Follow-up 1||60
11066674|NCT01044290|12248195|FG002|Completed F1 Interview|Follow-up 1||61
11066675|NCT01044290|12248193|FG000|COMPLETED|Follow-up 1||70
11066676|NCT01044290|12248194|FG001|COMPLETED|Follow-up 1||69
11066677|NCT01044290|12248195|FG002|COMPLETED|Follow-up 1||71
11066678|NCT01044290|12248193|FG000|NOT COMPLETED|Follow-up 1||5
11066679|NCT01044290|12248194|FG001|NOT COMPLETED|Follow-up 1||5
11066680|NCT01044290|12248195|FG002|NOT COMPLETED|Follow-up 1||1
11066681|NCT01044290|12248193|FG000|STARTED|Follow-Up 2||70
11066682|NCT01044290|12248194|FG001|STARTED|Follow-Up 2||69
11066683|NCT01044290|12248195|FG002|STARTED|Follow-Up 2||71
11066684|NCT01044290|12248193|FG000|Completed F2 Interview|Follow-Up 2||64
11066685|NCT01044290|12248194|FG001|Completed F2 Interview|Follow-Up 2||57
11066686|NCT01044290|12248195|FG002|Completed F2 Interview|Follow-Up 2||64
11066687|NCT01044290|12248193|FG000|COMPLETED|Follow-Up 2||70
11346161|NCT02975557|12543332|FG000|STARTED|Overall Study||4
11346162|NCT02975557|12543333|FG001|STARTED|Overall Study||5
11346163|NCT02975557|12543334|FG002|STARTED|Overall Study||6
11346164|NCT02975557|12543332|FG000|COMPLETED|Overall Study||3
11346165|NCT02975557|12543333|FG001|COMPLETED|Overall Study||2
11346166|NCT02975557|12543334|FG002|COMPLETED|Overall Study||5
11346167|NCT02975557|12543332|FG000|NOT COMPLETED|Overall Study||1
11346168|NCT02975557|12543333|FG001|NOT COMPLETED|Overall Study||3
11346169|NCT02975557|12543334|FG002|NOT COMPLETED|Overall Study||1
11066688|NCT01044290|12248194|FG001|COMPLETED|Follow-Up 2||67
11066689|NCT01044290|12248195|FG002|COMPLETED|Follow-Up 2||69
11346170|NCT02975804|12543344|FG000|STARTED|Overall Study||9
11346171|NCT02975804|12543345|FG001|STARTED|Overall Study||9
11346172|NCT02975804|12543344|FG000|COMPLETED|Overall Study||9
11346173|NCT02975804|12543345|FG001|COMPLETED|Overall Study||9
11346174|NCT02975804|12543344|FG000|NOT COMPLETED|Overall Study||0
11346175|NCT02975804|12543345|FG001|NOT COMPLETED|Overall Study||0
11346176|NCT02975973|12543355|FG000|STARTED|Overall Study||1
11346177|NCT02975973|12543356|FG001|STARTED|Overall Study||2
11346178|NCT02975973|12543357|FG002|STARTED|Overall Study||1
11346179|NCT02975973|12543358|FG003|STARTED|Overall Study||4
11346180|NCT02975973|12543355|FG000|COMPLETED|Overall Study||0
11066690|NCT01044290|12248193|FG000|NOT COMPLETED|Follow-Up 2||0
11066691|NCT01044290|12248194|FG001|NOT COMPLETED|Follow-Up 2||2
11066692|NCT01044290|12248195|FG002|NOT COMPLETED|Follow-Up 2||2
11066693|NCT01044303|12248213|FG000|STARTED|Overall Study||32
11066694|NCT01044303|12248213|FG000|COMPLETED|Overall Study||30
11066695|NCT01044303|12248213|FG000|NOT COMPLETED|Overall Study||2
11066696|NCT01044433|12248220|FG000|STARTED|Overall Study||44
11346181|NCT02975973|12543356|FG001|COMPLETED|Overall Study||1
11346182|NCT02975973|12543357|FG002|COMPLETED|Overall Study||0
11346183|NCT02975973|12543358|FG003|COMPLETED|Overall Study||4
11066697|NCT01044433|12248220|FG000|COMPLETED|Overall Study||38
11066698|NCT01044433|12248220|FG000|NOT COMPLETED|Overall Study||6
11066699|NCT01044459|12248227|FG000|STARTED|Overall Study||312
11066700|NCT01044459|12248228|FG001|STARTED|Overall Study||293
11066701|NCT01044459|12248227|FG000|COMPLETED|Overall Study||179
11066702|NCT01044459|12248228|FG001|COMPLETED|Overall Study||162
11066703|NCT01044459|12248227|FG000|NOT COMPLETED|Overall Study||133
11066704|NCT01044459|12248228|FG001|NOT COMPLETED|Overall Study||131
11066705|NCT01044498|12248236|FG000|STARTED|Overall Study||23
11066706|NCT01044498|12248237|FG001|STARTED|Overall Study||23
11066707|NCT01044498|12248236|FG000|COMPLETED|Overall Study||20
11066708|NCT01044498|12248237|FG001|COMPLETED|Overall Study||21
11066709|NCT01044498|12248236|FG000|NOT COMPLETED|Overall Study||3
11066710|NCT01044498|12248237|FG001|NOT COMPLETED|Overall Study||2
11066711|NCT01044537|12248250|FG000|STARTED|Overall Study||6
11066712|NCT01044537|12248251|FG001|STARTED|Overall Study||6
11066713|NCT01044537|12248252|FG002|STARTED|Overall Study||6
11066714|NCT01044537|12248253|FG003|STARTED|Overall Study||6
11066715|NCT01044537|12248254|FG004|STARTED|Overall Study||5
11066716|NCT01044537|12248255|FG005|STARTED|Overall Study||5
11066717|NCT01044537|12248256|FG006|STARTED|Overall Study||16
11066718|NCT01044537|12248250|FG000|COMPLETED|Overall Study||6
11066719|NCT01044537|12248251|FG001|COMPLETED|Overall Study||6
11066720|NCT01044537|12248252|FG002|COMPLETED|Overall Study||6
11066721|NCT01044537|12248253|FG003|COMPLETED|Overall Study||6
11066722|NCT01044537|12248254|FG004|COMPLETED|Overall Study||5
11066723|NCT01044537|12248255|FG005|COMPLETED|Overall Study||5
11066724|NCT01044537|12248256|FG006|COMPLETED|Overall Study||16
11066725|NCT01044537|12248250|FG000|NOT COMPLETED|Overall Study||0
11066726|NCT01044537|12248251|FG001|NOT COMPLETED|Overall Study||0
11066727|NCT01044537|12248252|FG002|NOT COMPLETED|Overall Study||0
11066728|NCT01044537|12248253|FG003|NOT COMPLETED|Overall Study||0
11066729|NCT01044537|12248254|FG004|NOT COMPLETED|Overall Study||0
11066730|NCT01044537|12248255|FG005|NOT COMPLETED|Overall Study||0
11066731|NCT01044537|12248256|FG006|NOT COMPLETED|Overall Study||0
11066732|NCT01044576|12248272|FG000|STARTED|Overall Study||200
11066733|NCT01044576|12248272|FG000|COMPLETED|Overall Study||200
11066734|NCT01044576|12248272|FG000|NOT COMPLETED|Overall Study||0
11066735|NCT01044589|12248278|FG000|STARTED|Overall Study||6
11066736|NCT01044589|12248279|FG001|STARTED|Overall Study||7
11066737|NCT01044589|12248278|FG000|COMPLETED|Overall Study||3
11066738|NCT01044589|12248279|FG001|COMPLETED|Overall Study||2
11066739|NCT01044589|12248278|FG000|NOT COMPLETED|Overall Study||3
11066740|NCT01044589|12248279|FG001|NOT COMPLETED|Overall Study||5
11066741|NCT01044693|12248285|FG000|STARTED|Overall Study||3
11066742|NCT01044693|12248286|FG001|STARTED|Overall Study||1
11066743|NCT01044693|12248287|FG002|STARTED|Overall Study||1
11066744|NCT01044693|12248288|FG003|STARTED|Overall Study||1
11066745|NCT01044693|12248289|FG004|STARTED|Overall Study||1
11066746|NCT01044693|12248290|FG005|STARTED|Overall Study||2
11066747|NCT01044693|12248291|FG006|STARTED|Overall Study||1
11066748|NCT01044693|12248292|FG007|STARTED|Overall Study||1
11066749|NCT01044693|12248293|FG008|STARTED|Overall Study||1
11066750|NCT01044693|12248294|FG009|STARTED|Overall Study||1
11066751|NCT01044693|12248295|FG010|STARTED|Overall Study||1
11066752|NCT01044693|12248296|FG011|STARTED|Overall Study||1
11066753|NCT01044693|12248297|FG012|STARTED|Overall Study||2
11066754|NCT01044693|12248298|FG013|STARTED|Overall Study||1
11066755|NCT01044693|12248299|FG014|STARTED|Overall Study||1
11066756|NCT01044693|12248300|FG015|STARTED|Overall Study||1
11066757|NCT01044693|12248285|FG000|COMPLETED|Overall Study||3
11066758|NCT01044693|12248286|FG001|COMPLETED|Overall Study||1
11066759|NCT01044693|12248287|FG002|COMPLETED|Overall Study||1
11066760|NCT01044693|12248288|FG003|COMPLETED|Overall Study||1
11066761|NCT01044693|12248289|FG004|COMPLETED|Overall Study||1
11066762|NCT01044693|12248290|FG005|COMPLETED|Overall Study||2
11066763|NCT01044693|12248291|FG006|COMPLETED|Overall Study||1
11066764|NCT01044693|12248292|FG007|COMPLETED|Overall Study||1
11066765|NCT01044693|12248293|FG008|COMPLETED|Overall Study||1
11066766|NCT01044693|12248294|FG009|COMPLETED|Overall Study||1
11066767|NCT01044693|12248295|FG010|COMPLETED|Overall Study||1
11066768|NCT01044693|12248296|FG011|COMPLETED|Overall Study||1
11066769|NCT01044693|12248297|FG012|COMPLETED|Overall Study||2
11066770|NCT01044693|12248298|FG013|COMPLETED|Overall Study||1
11066771|NCT01044693|12248299|FG014|COMPLETED|Overall Study||1
11066772|NCT01044693|12248300|FG015|COMPLETED|Overall Study||1
11066773|NCT01044693|12248285|FG000|NOT COMPLETED|Overall Study||0
11066774|NCT01044693|12248286|FG001|NOT COMPLETED|Overall Study||0
11066775|NCT01044693|12248287|FG002|NOT COMPLETED|Overall Study||0
11066776|NCT01044693|12248288|FG003|NOT COMPLETED|Overall Study||0
11066777|NCT01044693|12248289|FG004|NOT COMPLETED|Overall Study||0
11066778|NCT01044693|12248290|FG005|NOT COMPLETED|Overall Study||0
11066779|NCT01044693|12248291|FG006|NOT COMPLETED|Overall Study||0
11066780|NCT01044693|12248292|FG007|NOT COMPLETED|Overall Study||0
11066781|NCT01044693|12248293|FG008|NOT COMPLETED|Overall Study||0
11066782|NCT01044693|12248294|FG009|NOT COMPLETED|Overall Study||0
11066783|NCT01044693|12248295|FG010|NOT COMPLETED|Overall Study||0
11066784|NCT01044693|12248296|FG011|NOT COMPLETED|Overall Study||0
11066785|NCT01044693|12248297|FG012|NOT COMPLETED|Overall Study||0
11066786|NCT01044693|12248298|FG013|NOT COMPLETED|Overall Study||0
11066787|NCT01044693|12248299|FG014|NOT COMPLETED|Overall Study||0
11066788|NCT01044693|12248300|FG015|NOT COMPLETED|Overall Study||0
11066789|NCT01044706|12248312|FG000|STARTED|Overall Study||30
11066790|NCT01044706|12248313|FG001|STARTED|Overall Study||30
11066791|NCT01044706|12248312|FG000|COMPLETED|Overall Study||30
11066792|NCT01044706|12248313|FG001|COMPLETED|Overall Study||30
11066793|NCT01044706|12248312|FG000|NOT COMPLETED|Overall Study||0
11066794|NCT01044706|12248313|FG001|NOT COMPLETED|Overall Study||0
11346184|NCT02975973|12543355|FG000|NOT COMPLETED|Overall Study||1
11346185|NCT02975973|12543356|FG001|NOT COMPLETED|Overall Study||1
11346186|NCT02975973|12543357|FG002|NOT COMPLETED|Overall Study||1
11346187|NCT02975973|12543358|FG003|NOT COMPLETED|Overall Study||0
11346188|NCT02976103|12543370|FG000|STARTED|Overall Study||67
11346189|NCT02976103|12543371|FG001|STARTED|Overall Study||72
11346190|NCT02976103|12543370|FG000|COMPLETED|Overall Study|54 participants answered final (T3) questionnaire|54
11346191|NCT02976103|12543371|FG001|COMPLETED|Overall Study|64 participants answered final (T3 questionnaire)|64
11346192|NCT02976103|12543370|FG000|NOT COMPLETED|Overall Study||13
11346193|NCT02976103|12543371|FG001|NOT COMPLETED|Overall Study||8
11346194|NCT02976181|12543378|FG000|STARTED|Overall Study||113
11066795|NCT01044732|12248321|FG000|STARTED|Overall Study||222
11066796|NCT01044732|12248322|FG001|STARTED|Overall Study||226
11066797|NCT01044732|12248321|FG000|COMPLETED|Overall Study||173
11346195|NCT02976181|12543378|FG000|COMPLETED|Overall Study||112
11066798|NCT01044732|12248322|FG001|COMPLETED|Overall Study||176
11066799|NCT01044732|12248321|FG000|NOT COMPLETED|Overall Study||49
11346196|NCT02976181|12543378|FG000|NOT COMPLETED|Overall Study||1
11346197|NCT02976519|12543390|FG000|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
11346198|NCT02976519|12543391|FG001|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
11066800|NCT01044732|12248322|FG001|NOT COMPLETED|Overall Study||50
11066801|NCT01044745|12248330|FG000|STARTED|Overall Study||20
11066802|NCT01044745|12248330|FG000|COMPLETED|Overall Study||18
11066803|NCT01044745|12248330|FG000|NOT COMPLETED|Overall Study||2
11066804|NCT01044758|12248342|FG000|STARTED|Overall Study||12
11066805|NCT01044758|12248343|FG001|STARTED|Overall Study||12
11066806|NCT01044758|12248344|FG002|STARTED|Overall Study||11
11066807|NCT01044758|12248345|FG003|STARTED|Overall Study||12
11066808|NCT01044758|12248346|FG004|STARTED|Overall Study||11
11066809|NCT01044758|12248347|FG005|STARTED|Overall Study||11
11066810|NCT01044758|12248348|FG006|STARTED|Overall Study||27
11066811|NCT01044758|12248342|FG000|COMPLETED|Overall Study||8
11066812|NCT01044758|12248343|FG001|COMPLETED|Overall Study||12
11066813|NCT01044758|12248344|FG002|COMPLETED|Overall Study||7
11066814|NCT01044758|12248345|FG003|COMPLETED|Overall Study||10
11066815|NCT01044758|12248346|FG004|COMPLETED|Overall Study||9
11066816|NCT01044758|12248347|FG005|COMPLETED|Overall Study||8
11066817|NCT01044758|12248348|FG006|COMPLETED|Overall Study||17
11066818|NCT01044758|12248342|FG000|NOT COMPLETED|Overall Study||4
11066819|NCT01044758|12248343|FG001|NOT COMPLETED|Overall Study||0
11066820|NCT01044758|12248344|FG002|NOT COMPLETED|Overall Study||4
11066821|NCT01044758|12248345|FG003|NOT COMPLETED|Overall Study||2
11066822|NCT01044758|12248346|FG004|NOT COMPLETED|Overall Study||2
11066823|NCT01044758|12248347|FG005|NOT COMPLETED|Overall Study||3
11066824|NCT01044758|12248348|FG006|NOT COMPLETED|Overall Study||10
11066825|NCT01044771|12248367|FG000|STARTED|Overall Study||20
11066826|NCT01044771|12248367|FG000|COMPLETED|Overall Study||20
11066827|NCT01044771|12248367|FG000|NOT COMPLETED|Overall Study||0
11066828|NCT01044862|12248375|FG000|STARTED|Overall Study||299
11066829|NCT01044862|12248376|FG001|STARTED|Overall Study||300
11066830|NCT01044862|12248377|FG002|STARTED|Overall Study||301
11066831|NCT01044862|12248375|FG000|COMPLETED|Overall Study||246
11066832|NCT01044862|12248376|FG001|COMPLETED|Overall Study||251
11066833|NCT01044862|12248377|FG002|COMPLETED|Overall Study||249
11346199|NCT02976519|12543392|FG002|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
11346200|NCT02976519|12543393|FG003|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
11346201|NCT02976519|12543394|FG004|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
11346202|NCT02976519|12543395|FG005|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
11346203|NCT02976519|12543396|FG006|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
11346204|NCT02976519|12543390|FG000|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
11346205|NCT02976519|12543391|FG001|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
11346206|NCT02976519|12543392|FG002|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
11346207|NCT02976519|12543393|FG003|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
11346208|NCT02976519|12543394|FG004|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
11346209|NCT02976519|12543395|FG005|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
11346210|NCT02976519|12543396|FG006|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
11346211|NCT02976519|12543390|FG000|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
11066834|NCT01044862|12248375|FG000|NOT COMPLETED|Overall Study||53
11066835|NCT01044862|12248376|FG001|NOT COMPLETED|Overall Study||49
11066836|NCT01044862|12248377|FG002|NOT COMPLETED|Overall Study||52
11066837|NCT01044966|12248385|FG000|STARTED|Induction Phase||12
11066838|NCT01044966|12248385|FG000|COMPLETED|Induction Phase||12
11066839|NCT01044966|12248385|FG000|NOT COMPLETED|Induction Phase||0
11066840|NCT01044966|12248385|FG000|STARTED|Consolidation Phase||12
11066841|NCT01044966|12248385|FG000|COMPLETED|Consolidation Phase||2
11066842|NCT01044966|12248385|FG000|NOT COMPLETED|Consolidation Phase||10
11066843|NCT01045031|12248392|FG000|STARTED|Overall Study||58
11066844|NCT01045031|12248393|FG001|STARTED|Overall Study||56
11066845|NCT01045031|12248392|FG000|COMPLETED|Overall Study||49
11066846|NCT01045031|12248393|FG001|COMPLETED|Overall Study||50
11066847|NCT01045031|12248392|FG000|NOT COMPLETED|Overall Study||9
11066848|NCT01045031|12248393|FG001|NOT COMPLETED|Overall Study||6
11066849|NCT01045057|12248403|FG000|STARTED|Overall Study||27
11066850|NCT01045057|12248403|FG000|COMPLETED|Overall Study||27
11066851|NCT01045057|12248403|FG000|NOT COMPLETED|Overall Study||0
11066852|NCT01045096|12248412|FG000|STARTED|Overall Study||12
11066853|NCT01045096|12248413|FG001|STARTED|Overall Study||12
11066854|NCT01045096|12248414|FG002|STARTED|Overall Study||12
11066855|NCT01045096|12248412|FG000|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
11066856|NCT01045096|12248413|FG001|Pharmacokinetic Set|Overall Study||11
11066857|NCT01045096|12248414|FG002|Pharmacokinetic Set|Overall Study||11
11066858|NCT01045096|12248412|FG000|COMPLETED|Overall Study||9
11066859|NCT01045096|12248413|FG001|COMPLETED|Overall Study||12
11066860|NCT01045096|12248414|FG002|COMPLETED|Overall Study||12
11066861|NCT01045096|12248412|FG000|NOT COMPLETED|Overall Study||3
11066862|NCT01045096|12248413|FG001|NOT COMPLETED|Overall Study||0
11066863|NCT01045096|12248414|FG002|NOT COMPLETED|Overall Study||0
11066864|NCT01045122|12248422|FG000|STARTED|Dexmedetomidine Then Propofol||5
11066865|NCT01045122|12248423|FG001|STARTED|Dexmedetomidine Then Propofol||6
11066866|NCT01045122|12248422|FG000|COMPLETED|Dexmedetomidine Then Propofol||5
11066867|NCT01045122|12248423|FG001|COMPLETED|Dexmedetomidine Then Propofol||6
11066868|NCT01045122|12248422|FG000|NOT COMPLETED|Dexmedetomidine Then Propofol||0
11066869|NCT01045122|12248423|FG001|NOT COMPLETED|Dexmedetomidine Then Propofol||0
11066870|NCT01045122|12248422|FG000|STARTED|Propofol Then Dexmedetomidine||5
11066871|NCT01045122|12248423|FG001|STARTED|Propofol Then Dexmedetomidine||6
11066872|NCT01045122|12248422|FG000|COMPLETED|Propofol Then Dexmedetomidine||5
11066873|NCT01045122|12248423|FG001|COMPLETED|Propofol Then Dexmedetomidine||6
11066874|NCT01045122|12248422|FG000|NOT COMPLETED|Propofol Then Dexmedetomidine||0
11066875|NCT01045122|12248423|FG001|NOT COMPLETED|Propofol Then Dexmedetomidine||0
11066876|NCT01045135|12248429|FG000|STARTED|Overall Study||300
11066877|NCT01045135|12248429|FG000|COMPLETED|Overall Study||274
11066878|NCT01045135|12248429|FG000|NOT COMPLETED|Overall Study||26
11066879|NCT01045161|12248438|FG000|STARTED|Part A - 12 Weeks Double Blind Treatment||182
11066880|NCT01045161|12248439|FG001|STARTED|Part A - 12 Weeks Double Blind Treatment||184
11066881|NCT01045161|12248440|FG002|STARTED|Part A - 12 Weeks Double Blind Treatment||178
11066882|NCT01045161|12248438|FG000|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
11066883|NCT01045161|12248439|FG001|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
11066884|NCT01045161|12248440|FG002|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
11066885|NCT01045161|12248438|FG000|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
11066886|NCT01045161|12248439|FG001|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
11066887|NCT01045161|12248440|FG002|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
11066888|NCT01045161|12248438|FG000|STARTED|Part B - 40 Additional Weeks Open Label||147
11066889|NCT01045161|12248439|FG001|STARTED|Part B - 40 Additional Weeks Open Label||154
11066890|NCT01045161|12248440|FG002|STARTED|Part B - 40 Additional Weeks Open Label||147
11066891|NCT01045161|12248438|FG000|COMPLETED|Part B - 40 Additional Weeks Open Label||111
11066892|NCT01045161|12248439|FG001|COMPLETED|Part B - 40 Additional Weeks Open Label||118
11066893|NCT01045161|12248440|FG002|COMPLETED|Part B - 40 Additional Weeks Open Label||115
11066894|NCT01045161|12248438|FG000|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
11205985|NCT01863758|12396902|FG000|COMPLETED|Prophylactic Treatment-Phase I||66
11205986|NCT01863758|12396902|FG000|NOT COMPLETED|Prophylactic Treatment-Phase I||0
11205987|NCT01863758|12396902|FG000|STARTED|Prophylactic Treatment-Phase II||66
11205988|NCT01863758|12396902|FG000|COMPLETED|Prophylactic Treatment-Phase II||64
11205989|NCT01863758|12396902|FG000|NOT COMPLETED|Prophylactic Treatment-Phase II||2
11205990|NCT01863771|12396906|FG000|STARTED|Induction Phase||144
11205991|NCT01863771|12396907|FG001|STARTED|Induction Phase||0
11205992|NCT01863771|12396908|FG002|STARTED|Induction Phase||0
11205993|NCT01863771|12396909|FG003|STARTED|Induction Phase||0
11205994|NCT01863771|12396906|FG000|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
11205995|NCT01863771|12396907|FG001|COMPLETED|Induction Phase||0
11205996|NCT01863771|12396908|FG002|COMPLETED|Induction Phase||0
11205997|NCT01863771|12396909|FG003|COMPLETED|Induction Phase||0
11205998|NCT01863771|12396906|FG000|NOT COMPLETED|Induction Phase||21
11205999|NCT01863771|12396907|FG001|NOT COMPLETED|Induction Phase||0
11206000|NCT01863771|12396908|FG002|NOT COMPLETED|Induction Phase||0
11206001|NCT01863771|12396909|FG003|NOT COMPLETED|Induction Phase||0
11206002|NCT01863771|12396906|FG000|STARTED|Maintenance Phase||0
11206003|NCT01863771|12396907|FG001|STARTED|Maintenance Phase||32
11206004|NCT01863771|12396908|FG002|STARTED|Maintenance Phase||31
11206005|NCT01863771|12396909|FG003|STARTED|Maintenance Phase||60
11206006|NCT01863771|12396906|FG000|COMPLETED|Maintenance Phase||0
11206007|NCT01863771|12396907|FG001|COMPLETED|Maintenance Phase||27
11206008|NCT01863771|12396908|FG002|COMPLETED|Maintenance Phase||19
11206009|NCT01863771|12396909|FG003|COMPLETED|Maintenance Phase||17
11206010|NCT01863771|12396906|FG000|NOT COMPLETED|Maintenance Phase||0
11206011|NCT01863771|12396907|FG001|NOT COMPLETED|Maintenance Phase||5
11206012|NCT01863771|12396908|FG002|NOT COMPLETED|Maintenance Phase||12
11206013|NCT01863771|12396909|FG003|NOT COMPLETED|Maintenance Phase||43
11206014|NCT01863849|12396919|FG000|STARTED|Overall Study||60
11206015|NCT01863849|12396920|FG001|STARTED|Overall Study||60
11206016|NCT01863849|12396919|FG000|COMPLETED|Overall Study||59
11206017|NCT01863849|12396920|FG001|COMPLETED|Overall Study||60
11206018|NCT01863849|12396919|FG000|NOT COMPLETED|Overall Study||1
11206019|NCT01863849|12396920|FG001|NOT COMPLETED|Overall Study||0
11206020|NCT01863953|12396930|FG000|STARTED|Overall Study||38
11206021|NCT01863953|12396931|FG001|STARTED|Overall Study||36
11206022|NCT01863953|12396932|FG002|STARTED|Overall Study||38
11206023|NCT01863953|12396930|FG000|COMPLETED|Overall Study||38
11206024|NCT01863953|12396931|FG001|COMPLETED|Overall Study||36
11206025|NCT01863953|12396932|FG002|COMPLETED|Overall Study||37
11206026|NCT01863953|12396930|FG000|NOT COMPLETED|Overall Study||0
11206027|NCT01863953|12396931|FG001|NOT COMPLETED|Overall Study||0
11206028|NCT01863953|12396932|FG002|NOT COMPLETED|Overall Study||1
11206029|NCT01864005|12396942|FG000|STARTED|Overall Study||29
11206030|NCT01864005|12396943|FG001|STARTED|Overall Study||31
11206031|NCT01864005|12396942|FG000|COMPLETED|Overall Study||26
11206032|NCT01864005|12396943|FG001|COMPLETED|Overall Study||25
11206033|NCT01864005|12396942|FG000|NOT COMPLETED|Overall Study||3
11206034|NCT01864005|12396943|FG001|NOT COMPLETED|Overall Study||6
11206035|NCT01864148|12396954|FG000|STARTED|Overall Study||93
11206036|NCT01864148|12396955|FG001|STARTED|Overall Study||45
11206037|NCT01864148|12396956|FG002|STARTED|Overall Study||95
11206038|NCT01864148|12396957|FG003|STARTED|Overall Study||94
11206039|NCT01864148|12396958|FG004|STARTED|Overall Study||92
11206040|NCT01864148|12396954|FG000|Randomized and Dosed|Overall Study||93
11206041|NCT01864148|12396955|FG001|Randomized and Dosed|Overall Study||45
11206042|NCT01864148|12396956|FG002|Randomized and Dosed|Overall Study||95
11206043|NCT01864148|12396957|FG003|Randomized and Dosed|Overall Study||93
11206044|NCT01864148|12396958|FG004|Randomized and Dosed|Overall Study||92
11206045|NCT01864148|12396954|FG000|COMPLETED|Overall Study||73
11206046|NCT01864148|12396955|FG001|COMPLETED|Overall Study||40
11066895|NCT01045161|12248439|FG001|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
11066896|NCT01045161|12248440|FG002|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
11066897|NCT01045174|12248459|FG000|STARTED|Overall Study||90
11066898|NCT01045174|12248460|FG001|STARTED|Overall Study||90
11066899|NCT01045174|12248459|FG000|COMPLETED|Overall Study||90
11066900|NCT01045174|12248460|FG001|COMPLETED|Overall Study||90
11066901|NCT01045174|12248459|FG000|NOT COMPLETED|Overall Study||0
11066902|NCT01045174|12248460|FG001|NOT COMPLETED|Overall Study||0
11066903|NCT01045187|12248466|FG000|STARTED|Overall Study||15
11066904|NCT01045187|12248466|FG000|COMPLETED|Overall Study||15
11066905|NCT01045187|12248466|FG000|NOT COMPLETED|Overall Study||0
11066906|NCT01045265|12248470|FG000|STARTED|Overall Study||16
11066907|NCT01045265|12248470|FG000|COMPLETED|Overall Study||16
11066908|NCT01045265|12248470|FG000|NOT COMPLETED|Overall Study||0
11066909|NCT01045421|12248480|FG000|STARTED|Phase 1||1
11066910|NCT01045421|12248481|FG001|STARTED|Phase 1||3
11066911|NCT01045421|12248482|FG002|STARTED|Phase 1||4
11066912|NCT01045421|12248483|FG003|STARTED|Phase 1||12
11066913|NCT01045421|12248484|FG004|STARTED|Phase 1||3
11066914|NCT01045421|12248485|FG005|STARTED|Phase 1||1
11066915|NCT01045421|12248486|FG006|STARTED|Phase 1||0
11066916|NCT01045421|12248487|FG007|STARTED|Phase 1||0
11066917|NCT01045421|12248488|FG008|STARTED|Phase 1||0
11066918|NCT01045421|12248489|FG009|STARTED|Phase 1||0
11066919|NCT01045421|12248490|FG010|STARTED|Phase 1||0
11066920|NCT01045421|12248480|FG000|COMPLETED|Phase 1||1
11066921|NCT01045421|12248481|FG001|COMPLETED|Phase 1||3
11066922|NCT01045421|12248482|FG002|COMPLETED|Phase 1||4
11066923|NCT01045421|12248483|FG003|COMPLETED|Phase 1||11
11066924|NCT01045421|12248484|FG004|COMPLETED|Phase 1||2
11066925|NCT01045421|12248485|FG005|COMPLETED|Phase 1||1
11066926|NCT01045421|12248486|FG006|COMPLETED|Phase 1||0
11066927|NCT01045421|12248487|FG007|COMPLETED|Phase 1||0
11066928|NCT01045421|12248488|FG008|COMPLETED|Phase 1||0
11066929|NCT01045421|12248489|FG009|COMPLETED|Phase 1||0
11066930|NCT01045421|12248490|FG010|COMPLETED|Phase 1||0
11066931|NCT01045421|12248480|FG000|NOT COMPLETED|Phase 1||0
11066932|NCT01045421|12248481|FG001|NOT COMPLETED|Phase 1||0
11066933|NCT01045421|12248482|FG002|NOT COMPLETED|Phase 1||0
11066934|NCT01045421|12248483|FG003|NOT COMPLETED|Phase 1||1
11066935|NCT01045421|12248484|FG004|NOT COMPLETED|Phase 1||1
11066936|NCT01045421|12248485|FG005|NOT COMPLETED|Phase 1||0
11066937|NCT01045421|12248486|FG006|NOT COMPLETED|Phase 1||0
11066938|NCT01045421|12248487|FG007|NOT COMPLETED|Phase 1||0
11066939|NCT01045421|12248488|FG008|NOT COMPLETED|Phase 1||0
11066940|NCT01045421|12248489|FG009|NOT COMPLETED|Phase 1||0
11066941|NCT01045421|12248490|FG010|NOT COMPLETED|Phase 1||0
11066942|NCT01045421|12248480|FG000|STARTED|Phase 2||0
11066943|NCT01045421|12248481|FG001|STARTED|Phase 2||0
11066944|NCT01045421|12248482|FG002|STARTED|Phase 2||0
11066945|NCT01045421|12248483|FG003|STARTED|Phase 2||0
11066946|NCT01045421|12248484|FG004|STARTED|Phase 2||0
11206047|NCT01864148|12396956|FG002|COMPLETED|Overall Study||84
11066947|NCT01045421|12248485|FG005|STARTED|Phase 2||0
11066948|NCT01045421|12248486|FG006|STARTED|Phase 2||53
11066949|NCT01045421|12248487|FG007|STARTED|Phase 2||55
11066950|NCT01045421|12248488|FG008|STARTED|Phase 2||55
11066951|NCT01045421|12248489|FG009|STARTED|Phase 2||26
11066952|NCT01045421|12248490|FG010|STARTED|Phase 2||60
11066953|NCT01045421|12248480|FG000|COMPLETED|Phase 2||0
11066954|NCT01045421|12248481|FG001|COMPLETED|Phase 2||0
11066955|NCT01045421|12248482|FG002|COMPLETED|Phase 2||0
11066956|NCT01045421|12248483|FG003|COMPLETED|Phase 2||0
11066957|NCT01045421|12248484|FG004|COMPLETED|Phase 2||0
11066958|NCT01045421|12248485|FG005|COMPLETED|Phase 2||0
11066959|NCT01045421|12248486|FG006|COMPLETED|Phase 2||53
11066960|NCT01045421|12248487|FG007|COMPLETED|Phase 2||50
11066961|NCT01045421|12248488|FG008|COMPLETED|Phase 2||53
11066962|NCT01045421|12248489|FG009|COMPLETED|Phase 2||23
11066963|NCT01045421|12248490|FG010|COMPLETED|Phase 2||58
11066964|NCT01045421|12248480|FG000|NOT COMPLETED|Phase 2||0
11066965|NCT01045421|12248481|FG001|NOT COMPLETED|Phase 2||0
11066966|NCT01045421|12248482|FG002|NOT COMPLETED|Phase 2||0
11066967|NCT01045421|12248483|FG003|NOT COMPLETED|Phase 2||0
11066968|NCT01045421|12248484|FG004|NOT COMPLETED|Phase 2||0
11066969|NCT01045421|12248485|FG005|NOT COMPLETED|Phase 2||0
11066970|NCT01045421|12248486|FG006|NOT COMPLETED|Phase 2||0
11066971|NCT01045421|12248487|FG007|NOT COMPLETED|Phase 2||5
11066972|NCT01045421|12248488|FG008|NOT COMPLETED|Phase 2||2
11066973|NCT01045421|12248489|FG009|NOT COMPLETED|Phase 2||3
11066974|NCT01045421|12248490|FG010|NOT COMPLETED|Phase 2||2
11066975|NCT01045447|12248513|FG000|STARTED|Overall Study||232
11066976|NCT01045447|12248514|FG001|STARTED|Overall Study||233
11066977|NCT01045447|12248513|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
11066978|NCT01045447|12248514|FG001|Exposed|Overall Study||233
11066979|NCT01045447|12248513|FG000|COMPLETED|Overall Study||196
11066980|NCT01045447|12248514|FG001|COMPLETED|Overall Study||205
11066981|NCT01045447|12248513|FG000|NOT COMPLETED|Overall Study||36
11066982|NCT01045447|12248514|FG001|NOT COMPLETED|Overall Study||28
11066983|NCT01045460|12248522|FG000|STARTED|Overall Study||17
11066984|NCT01045460|12248523|FG001|STARTED|Overall Study||18
11066985|NCT01045460|12248522|FG000|COMPLETED|Overall Study||11
11066986|NCT01045460|12248523|FG001|COMPLETED|Overall Study||15
11066987|NCT01045460|12248522|FG000|NOT COMPLETED|Overall Study||6
11066988|NCT01045460|12248523|FG001|NOT COMPLETED|Overall Study||3
11066989|NCT01045499|12248531|FG000|STARTED|Overall Study||137
11066990|NCT01045499|12248531|FG000|COMPLETED|Overall Study||127
11066991|NCT01045499|12248531|FG000|NOT COMPLETED|Overall Study||10
11066992|NCT01045551|12248535|FG000|STARTED|Overall Study||10
11066993|NCT01045551|12248535|FG000|COMPLETED|Overall Study||10
11066994|NCT01045551|12248535|FG000|NOT COMPLETED|Overall Study||0
11066995|NCT01045707|12248542|FG000|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
11066996|NCT01045707|12248543|FG001|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
11066997|NCT01045707|12248542|FG000|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
11066998|NCT01045707|12248543|FG001|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
11066999|NCT01045707|12248542|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
11067000|NCT01045707|12248543|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
11067001|NCT01045707|12248542|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
11067002|NCT01045707|12248543|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
11067003|NCT01045707|12248542|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
11067004|NCT01045707|12248543|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
11067005|NCT01045707|12248542|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
11067006|NCT01045707|12248543|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
11067007|NCT01045707|12248542|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
11067008|NCT01045707|12248543|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
11067009|NCT01045798|12248551|FG000|STARTED|Overall Study||6
11067010|NCT01045798|12248552|FG001|STARTED|Overall Study||9
11067011|NCT01045798|12248551|FG000|COMPLETED|Overall Study||4
11067012|NCT01045798|12248552|FG001|COMPLETED|Overall Study||5
11067013|NCT01045798|12248551|FG000|NOT COMPLETED|Overall Study||2
11067014|NCT01045798|12248552|FG001|NOT COMPLETED|Overall Study||4
11067015|NCT01045967|12248560|FG000|STARTED|First Intervention||28
11067016|NCT01045967|12248561|FG001|STARTED|First Intervention||28
11067017|NCT01045967|12248560|FG000|COMPLETED|First Intervention||28
11067018|NCT01045967|12248561|FG001|COMPLETED|First Intervention||28
11067019|NCT01045967|12248560|FG000|NOT COMPLETED|First Intervention||0
11067020|NCT01045967|12248561|FG001|NOT COMPLETED|First Intervention||0
11067021|NCT01045967|12248560|FG000|STARTED|Washout of 7 Days||28
11067022|NCT01045967|12248561|FG001|STARTED|Washout of 7 Days||28
11067023|NCT01045967|12248560|FG000|COMPLETED|Washout of 7 Days||28
11067024|NCT01045967|12248561|FG001|COMPLETED|Washout of 7 Days||28
11067025|NCT01045967|12248560|FG000|NOT COMPLETED|Washout of 7 Days||0
11067026|NCT01045967|12248561|FG001|NOT COMPLETED|Washout of 7 Days||0
11067027|NCT01045967|12248560|FG000|STARTED|Second Intervention||28
11206048|NCT01864148|12396957|FG003|COMPLETED|Overall Study||68
11067028|NCT01045967|12248561|FG001|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
11067029|NCT01045967|12248560|FG000|COMPLETED|Second Intervention||28
11067030|NCT01045967|12248561|FG001|COMPLETED|Second Intervention||27
11067031|NCT01045967|12248560|FG000|NOT COMPLETED|Second Intervention||0
11067032|NCT01045967|12248561|FG001|NOT COMPLETED|Second Intervention||1
11067033|NCT01045993|12248571|FG000|STARTED|Overall Study||26
11067034|NCT01045993|12248572|FG001|STARTED|Overall Study||5
11067035|NCT01045993|12248573|FG002|STARTED|Overall Study||5
11067036|NCT01045993|12248574|FG003|STARTED|Overall Study||25
11067037|NCT01045993|12248571|FG000|COMPLETED|Overall Study||26
11067038|NCT01045993|12248572|FG001|COMPLETED|Overall Study||4
11067039|NCT01045993|12248573|FG002|COMPLETED|Overall Study||5
11067040|NCT01045993|12248574|FG003|COMPLETED|Overall Study||25
11067041|NCT01045993|12248571|FG000|NOT COMPLETED|Overall Study||0
11067042|NCT01045993|12248572|FG001|NOT COMPLETED|Overall Study||1
11067043|NCT01045993|12248573|FG002|NOT COMPLETED|Overall Study||0
11067044|NCT01045993|12248574|FG003|NOT COMPLETED|Overall Study||0
11067045|NCT01046084|12248586|FG000|STARTED|First Intervention||25
11067046|NCT01046084|12248587|FG001|STARTED|First Intervention||25
11067047|NCT01046084|12248586|FG000|COMPLETED|First Intervention||25
11067048|NCT01046084|12248587|FG001|COMPLETED|First Intervention||25
11067049|NCT01046084|12248586|FG000|NOT COMPLETED|First Intervention||0
11067050|NCT01046084|12248587|FG001|NOT COMPLETED|First Intervention||0
11067051|NCT01046084|12248586|FG000|STARTED|First Washout of 7 Days||25
11067052|NCT01046084|12248587|FG001|STARTED|First Washout of 7 Days||25
11067053|NCT01046084|12248586|FG000|COMPLETED|First Washout of 7 Days||25
11067054|NCT01046084|12248587|FG001|COMPLETED|First Washout of 7 Days||25
11067055|NCT01046084|12248586|FG000|NOT COMPLETED|First Washout of 7 Days||0
11067056|NCT01046084|12248587|FG001|NOT COMPLETED|First Washout of 7 Days||0
11067057|NCT01046084|12248586|FG000|STARTED|Second Intervention||25
11067058|NCT01046084|12248587|FG001|STARTED|Second Intervention||25
11067059|NCT01046084|12248586|FG000|COMPLETED|Second Intervention||25
11067060|NCT01046084|12248587|FG001|COMPLETED|Second Intervention||25
11067061|NCT01046084|12248586|FG000|NOT COMPLETED|Second Intervention||0
11067062|NCT01046084|12248587|FG001|NOT COMPLETED|Second Intervention||0
11067063|NCT01046084|12248586|FG000|STARTED|Second Washout of 7 Days||25
11067064|NCT01046084|12248587|FG001|STARTED|Second Washout of 7 Days||25
11067065|NCT01046084|12248586|FG000|COMPLETED|Second Washout of 7 Days||25
11067066|NCT01046084|12248587|FG001|COMPLETED|Second Washout of 7 Days||25
11067067|NCT01046084|12248586|FG000|NOT COMPLETED|Second Washout of 7 Days||0
11067068|NCT01046084|12248587|FG001|NOT COMPLETED|Second Washout of 7 Days||0
11067069|NCT01046084|12248586|FG000|STARTED|Third Intervention||25
11067070|NCT01046084|12248587|FG001|STARTED|Third Intervention||25
11346212|NCT02976519|12543391|FG001|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
11346213|NCT02976519|12543392|FG002|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
11346214|NCT02976519|12543393|FG003|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
11067071|NCT01046084|12248586|FG000|COMPLETED|Third Intervention||25
11067072|NCT01046084|12248587|FG001|COMPLETED|Third Intervention||25
11067073|NCT01046084|12248586|FG000|NOT COMPLETED|Third Intervention||0
11067074|NCT01046084|12248587|FG001|NOT COMPLETED|Third Intervention||0
11067075|NCT01046084|12248586|FG000|STARTED|Third Washout of 7 Days||25
11067076|NCT01046084|12248587|FG001|STARTED|Third Washout of 7 Days||25
11067077|NCT01046084|12248586|FG000|COMPLETED|Third Washout of 7 Days||23
11067078|NCT01046084|12248587|FG001|COMPLETED|Third Washout of 7 Days||25
11067079|NCT01046084|12248586|FG000|NOT COMPLETED|Third Washout of 7 Days||2
11067080|NCT01046084|12248587|FG001|NOT COMPLETED|Third Washout of 7 Days||0
11067081|NCT01046084|12248586|FG000|STARTED|Fourth Intervention||23
11067082|NCT01046084|12248587|FG001|STARTED|Fourth Intervention||25
11067083|NCT01046084|12248586|FG000|COMPLETED|Fourth Intervention||23
11067084|NCT01046084|12248587|FG001|COMPLETED|Fourth Intervention||25
11067085|NCT01046084|12248586|FG000|NOT COMPLETED|Fourth Intervention||0
11067086|NCT01046084|12248587|FG001|NOT COMPLETED|Fourth Intervention||0
11067087|NCT01046110|12248595|FG000|STARTED|Overall Study||229
11067088|NCT01046110|12248596|FG001|STARTED|Overall Study||229
11206049|NCT01864148|12396958|FG004|COMPLETED|Overall Study||69
11206050|NCT01864148|12396954|FG000|NOT COMPLETED|Overall Study||20
11206051|NCT01864148|12396955|FG001|NOT COMPLETED|Overall Study||5
11206052|NCT01864148|12396956|FG002|NOT COMPLETED|Overall Study||11
11206053|NCT01864148|12396957|FG003|NOT COMPLETED|Overall Study||26
11206054|NCT01864148|12396958|FG004|NOT COMPLETED|Overall Study||23
11206055|NCT01864174|12396977|FG000|STARTED|Double Blind Treatment - All Treated||283
11206056|NCT01864174|12396978|FG001|STARTED|Double Blind Treatment - All Treated||285
11206057|NCT01864174|12396977|FG000|COMPLETED|Double Blind Treatment - All Treated||268
11206058|NCT01864174|12396978|FG001|COMPLETED|Double Blind Treatment - All Treated||271
11206059|NCT01864174|12396977|FG000|NOT COMPLETED|Double Blind Treatment - All Treated||15
11206060|NCT01864174|12396978|FG001|NOT COMPLETED|Double Blind Treatment - All Treated||14
11206061|NCT01864174|12396977|FG000|STARTED|Double Blind - Compliant Randomized||268
11206062|NCT01864174|12396978|FG001|STARTED|Double Blind - Compliant Randomized||271
11067089|NCT01046110|12248595|FG000|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
11067090|NCT01046110|12248596|FG001|Exposed|Overall Study|1 subject was randomised in error|228
11067091|NCT01046110|12248595|FG000|COMPLETED|Overall Study||174
11067092|NCT01046110|12248596|FG001|COMPLETED|Overall Study||174
11067093|NCT01046110|12248595|FG000|NOT COMPLETED|Overall Study||55
11067094|NCT01046110|12248596|FG001|NOT COMPLETED|Overall Study||55
11067095|NCT01046136|12248604|FG000|STARTED|Overall Study||188
11067096|NCT01046136|12248605|FG001|STARTED|Overall Study||190
11067097|NCT01046136|12248604|FG000|COMPLETED|Overall Study||184
11067098|NCT01046136|12248605|FG001|COMPLETED|Overall Study||182
11067099|NCT01046136|12248604|FG000|NOT COMPLETED|Overall Study||4
11067100|NCT01046136|12248605|FG001|NOT COMPLETED|Overall Study||8
11067101|NCT01046253|12248615|FG000|STARTED|First Intervention||25
11067102|NCT01046253|12248616|FG001|STARTED|First Intervention||25
11067103|NCT01046253|12248615|FG000|COMPLETED|First Intervention||25
11067104|NCT01046253|12248616|FG001|COMPLETED|First Intervention||25
11067105|NCT01046253|12248615|FG000|NOT COMPLETED|First Intervention||0
11067106|NCT01046253|12248616|FG001|NOT COMPLETED|First Intervention||0
11067107|NCT01046253|12248615|FG000|STARTED|First Washout of 7 Days||25
11067108|NCT01046253|12248616|FG001|STARTED|First Washout of 7 Days||25
11067109|NCT01046253|12248615|FG000|COMPLETED|First Washout of 7 Days||25
11067110|NCT01046253|12248616|FG001|COMPLETED|First Washout of 7 Days||25
11067111|NCT01046253|12248615|FG000|NOT COMPLETED|First Washout of 7 Days||0
11067112|NCT01046253|12248616|FG001|NOT COMPLETED|First Washout of 7 Days||0
11067113|NCT01046253|12248615|FG000|STARTED|Second Intervention||25
11067114|NCT01046253|12248616|FG001|STARTED|Second Intervention||25
11067115|NCT01046253|12248615|FG000|COMPLETED|Second Intervention||25
11067116|NCT01046253|12248616|FG001|COMPLETED|Second Intervention||23
11067117|NCT01046253|12248615|FG000|NOT COMPLETED|Second Intervention||0
11067118|NCT01046253|12248616|FG001|NOT COMPLETED|Second Intervention||2
11067119|NCT01046253|12248615|FG000|STARTED|Second Washout of 7 Days||25
11067120|NCT01046253|12248616|FG001|STARTED|Second Washout of 7 Days||23
11067121|NCT01046253|12248615|FG000|COMPLETED|Second Washout of 7 Days||25
11067122|NCT01046253|12248616|FG001|COMPLETED|Second Washout of 7 Days||23
11067123|NCT01046253|12248615|FG000|NOT COMPLETED|Second Washout of 7 Days||0
11067124|NCT01046253|12248616|FG001|NOT COMPLETED|Second Washout of 7 Days||0
11067125|NCT01046253|12248615|FG000|STARTED|Third Intervention||25
11067126|NCT01046253|12248616|FG001|STARTED|Third Intervention||23
11067127|NCT01046253|12248615|FG000|COMPLETED|Third Intervention||25
11067128|NCT01046253|12248616|FG001|COMPLETED|Third Intervention||23
11067129|NCT01046253|12248615|FG000|NOT COMPLETED|Third Intervention||0
11067130|NCT01046253|12248616|FG001|NOT COMPLETED|Third Intervention||0
11067131|NCT01046253|12248615|FG000|STARTED|Third Washout of 7 Days||25
11067132|NCT01046253|12248616|FG001|STARTED|Third Washout of 7 Days||23
11067133|NCT01046253|12248615|FG000|COMPLETED|Third Washout of 7 Days||25
11067134|NCT01046253|12248616|FG001|COMPLETED|Third Washout of 7 Days||23
11067135|NCT01046253|12248615|FG000|NOT COMPLETED|Third Washout of 7 Days||0
11346215|NCT02976519|12543394|FG004|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
11346216|NCT02976519|12543395|FG005|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
11346217|NCT02976519|12543396|FG006|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
11346218|NCT02976519|12543390|FG000|STARTED|Wash-out Period (Part 2 Only)||0
11346219|NCT02976519|12543391|FG001|STARTED|Wash-out Period (Part 2 Only)||0
11346220|NCT02976519|12543392|FG002|STARTED|Wash-out Period (Part 2 Only)||0
11346221|NCT02976519|12543393|FG003|STARTED|Wash-out Period (Part 2 Only)||0
11346222|NCT02976519|12543394|FG004|STARTED|Wash-out Period (Part 2 Only)||0
11346223|NCT02976519|12543395|FG005|STARTED|Wash-out Period (Part 2 Only)||12
11346224|NCT02976519|12543396|FG006|STARTED|Wash-out Period (Part 2 Only)||12
11346225|NCT02976519|12543390|FG000|COMPLETED|Wash-out Period (Part 2 Only)||0
11346226|NCT02976519|12543391|FG001|COMPLETED|Wash-out Period (Part 2 Only)||0
11346227|NCT02976519|12543392|FG002|COMPLETED|Wash-out Period (Part 2 Only)||0
11346228|NCT02976519|12543393|FG003|COMPLETED|Wash-out Period (Part 2 Only)||0
11067136|NCT01046253|12248616|FG001|NOT COMPLETED|Third Washout of 7 Days||0
11067137|NCT01046253|12248615|FG000|STARTED|Fourth Intervention||25
11067138|NCT01046253|12248616|FG001|STARTED|Fourth Intervention||23
11346229|NCT02976519|12543394|FG004|COMPLETED|Wash-out Period (Part 2 Only)||0
11346230|NCT02976519|12543395|FG005|COMPLETED|Wash-out Period (Part 2 Only)||12
11346231|NCT02976519|12543396|FG006|COMPLETED|Wash-out Period (Part 2 Only)||10
11067139|NCT01046253|12248615|FG000|COMPLETED|Fourth Intervention||25
11067140|NCT01046253|12248616|FG001|COMPLETED|Fourth Intervention||23
11067141|NCT01046253|12248615|FG000|NOT COMPLETED|Fourth Intervention||0
11067142|NCT01046253|12248616|FG001|NOT COMPLETED|Fourth Intervention||0
11067143|NCT01046643|12248624|FG000|STARTED|First Period Treatment or Placebo||9
11067144|NCT01046643|12248625|FG001|STARTED|First Period Treatment or Placebo||7
11067145|NCT01046643|12248626|FG002|STARTED|First Period Treatment or Placebo||7
11067146|NCT01046643|12248627|FG003|STARTED|First Period Treatment or Placebo||7
11067147|NCT01046643|12248624|FG000|COMPLETED|First Period Treatment or Placebo||9
11067148|NCT01046643|12248625|FG001|COMPLETED|First Period Treatment or Placebo||6
11067149|NCT01046643|12248626|FG002|COMPLETED|First Period Treatment or Placebo||7
11067150|NCT01046643|12248627|FG003|COMPLETED|First Period Treatment or Placebo||7
11067151|NCT01046643|12248624|FG000|NOT COMPLETED|First Period Treatment or Placebo||0
11346232|NCT02976519|12543390|FG000|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
11346233|NCT02976519|12543391|FG001|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
11346234|NCT02976519|12543392|FG002|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
11346235|NCT02976519|12543393|FG003|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
11067152|NCT01046643|12248625|FG001|NOT COMPLETED|First Period Treatment or Placebo||1
11067153|NCT01046643|12248626|FG002|NOT COMPLETED|First Period Treatment or Placebo||0
11067154|NCT01046643|12248627|FG003|NOT COMPLETED|First Period Treatment or Placebo||0
11067155|NCT01046643|12248624|FG000|STARTED|Washout Period||9
11067156|NCT01046643|12248625|FG001|STARTED|Washout Period||6
11067157|NCT01046643|12248626|FG002|STARTED|Washout Period||7
11067158|NCT01046643|12248627|FG003|STARTED|Washout Period||7
11067159|NCT01046643|12248624|FG000|COMPLETED|Washout Period||9
11067160|NCT01046643|12248625|FG001|COMPLETED|Washout Period||6
11067161|NCT01046643|12248626|FG002|COMPLETED|Washout Period||7
11067162|NCT01046643|12248627|FG003|COMPLETED|Washout Period||7
11067163|NCT01046643|12248624|FG000|NOT COMPLETED|Washout Period||0
11067164|NCT01046643|12248625|FG001|NOT COMPLETED|Washout Period||0
11067165|NCT01046643|12248626|FG002|NOT COMPLETED|Washout Period||0
11067166|NCT01046643|12248627|FG003|NOT COMPLETED|Washout Period||0
11067167|NCT01046643|12248624|FG000|STARTED|Second Period Treatment or Placebo||9
11067168|NCT01046643|12248625|FG001|STARTED|Second Period Treatment or Placebo||6
11067169|NCT01046643|12248626|FG002|STARTED|Second Period Treatment or Placebo||7
11067170|NCT01046643|12248627|FG003|STARTED|Second Period Treatment or Placebo||7
11067171|NCT01046643|12248624|FG000|COMPLETED|Second Period Treatment or Placebo||9
11067172|NCT01046643|12248625|FG001|COMPLETED|Second Period Treatment or Placebo||6
11067173|NCT01046643|12248626|FG002|COMPLETED|Second Period Treatment or Placebo||7
11067174|NCT01046643|12248627|FG003|COMPLETED|Second Period Treatment or Placebo||7
11067175|NCT01046643|12248624|FG000|NOT COMPLETED|Second Period Treatment or Placebo||0
11067176|NCT01046643|12248625|FG001|NOT COMPLETED|Second Period Treatment or Placebo||0
11067177|NCT01046643|12248626|FG002|NOT COMPLETED|Second Period Treatment or Placebo||0
11067178|NCT01046643|12248627|FG003|NOT COMPLETED|Second Period Treatment or Placebo||0
11067179|NCT01046669|12248639|FG000|STARTED|Overall Study||226
11067180|NCT01046669|12248640|FG001|STARTED|Overall Study||224
11067181|NCT01046669|12248639|FG000|COMPLETED|Overall Study||226
11067182|NCT01046669|12248640|FG001|COMPLETED|Overall Study||223
11067183|NCT01046669|12248639|FG000|NOT COMPLETED|Overall Study||0
11067184|NCT01046669|12248640|FG001|NOT COMPLETED|Overall Study||1
11067185|NCT01046682|12248648|FG000|STARTED|Overall Study||20
11067186|NCT01046682|12248649|FG001|STARTED|Overall Study||20
11067187|NCT01046682|12248648|FG000|COMPLETED|Overall Study||18
11067188|NCT01046682|12248649|FG001|COMPLETED|Overall Study||20
11067189|NCT01046682|12248648|FG000|NOT COMPLETED|Overall Study||2
11067190|NCT01046682|12248649|FG001|NOT COMPLETED|Overall Study||0
11067191|NCT01046695|12248657|FG000|STARTED|Overall Study||20
11067192|NCT01046695|12248658|FG001|STARTED|Overall Study||22
11067193|NCT01046695|12248657|FG000|COMPLETED|Overall Study||20
11067194|NCT01046695|12248658|FG001|COMPLETED|Overall Study||20
11067195|NCT01046695|12248657|FG000|NOT COMPLETED|Overall Study||0
11067196|NCT01046695|12248658|FG001|NOT COMPLETED|Overall Study||2
11067197|NCT01046877|12248664|FG000|STARTED|Overall Study||25
11067198|NCT01046877|12248664|FG000|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
11067199|NCT01046877|12248664|FG000|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
11067200|NCT01046877|12248664|FG000|COMPLETED|Overall Study||7
11067201|NCT01046877|12248664|FG000|NOT COMPLETED|Overall Study||18
11067202|NCT01046903|12248668|FG000|STARTED|Overall Study||503
11067203|NCT01046903|12248668|FG000|COMPLETED|Overall Study||475
11067204|NCT01046903|12248668|FG000|NOT COMPLETED|Overall Study||28
11067205|NCT01047007|12248676|FG000|STARTED|Overall Study||3
11067206|NCT01047007|12248677|FG001|STARTED|Overall Study||6
11067207|NCT01047007|12248678|FG002|STARTED|Overall Study||2
11067208|NCT01047007|12248679|FG003|STARTED|Overall Study||0
11067209|NCT01047007|12248676|FG000|Treated|Overall Study||3
11067210|NCT01047007|12248677|FG001|Treated|Overall Study||6
11067211|NCT01047007|12248678|FG002|Treated|Overall Study||2
11067212|NCT01047007|12248679|FG003|Treated|Overall Study||0
11067213|NCT01047007|12248676|FG000|COMPLETED|Overall Study||1
11067214|NCT01047007|12248677|FG001|COMPLETED|Overall Study||0
11067215|NCT01047007|12248678|FG002|COMPLETED|Overall Study||0
11067216|NCT01047007|12248679|FG003|COMPLETED|Overall Study||0
11067217|NCT01047007|12248676|FG000|NOT COMPLETED|Overall Study||2
11067218|NCT01047007|12248677|FG001|NOT COMPLETED|Overall Study||6
11067219|NCT01047007|12248678|FG002|NOT COMPLETED|Overall Study||2
11067220|NCT01047007|12248679|FG003|NOT COMPLETED|Overall Study||0
11067221|NCT01047189|12248691|FG000|STARTED|Overall Study||13
11067222|NCT01047189|12248692|FG001|STARTED|Overall Study||13
11067223|NCT01047189|12248691|FG000|COMPLETED|Overall Study||9
11067224|NCT01047189|12248692|FG001|COMPLETED|Overall Study||13
11067225|NCT01047189|12248691|FG000|NOT COMPLETED|Overall Study||4
11067226|NCT01047189|12248692|FG001|NOT COMPLETED|Overall Study||0
11067227|NCT01047241|12248698|FG000|STARTED|Overall Study||50
11067228|NCT01047241|12248698|FG000|COMPLETED|Overall Study||50
11067229|NCT01047241|12248698|FG000|NOT COMPLETED|Overall Study||0
11067230|NCT01047293|12248705|FG000|STARTED|Overall Study||4
11067231|NCT01047293|12248706|FG001|STARTED|Overall Study||8
11067232|NCT01047293|12248707|FG002|STARTED|Overall Study||9
11067233|NCT01047293|12248708|FG003|STARTED|Overall Study||26
11067234|NCT01047293|12248705|FG000|COMPLETED|Overall Study||3
11067235|NCT01047293|12248706|FG001|COMPLETED|Overall Study||7
11067236|NCT01047293|12248707|FG002|COMPLETED|Overall Study||9
11067237|NCT01047293|12248708|FG003|COMPLETED|Overall Study||26
11067238|NCT01047293|12248705|FG000|NOT COMPLETED|Overall Study||1
11067239|NCT01047293|12248706|FG001|NOT COMPLETED|Overall Study||1
11067240|NCT01047293|12248707|FG002|NOT COMPLETED|Overall Study||0
11067241|NCT01047293|12248708|FG003|NOT COMPLETED|Overall Study||0
11067242|NCT01047306|12248717|FG000|STARTED|Overall Study||19
11067243|NCT01047306|12248718|FG001|STARTED|Overall Study||6
11067244|NCT01047306|12248717|FG000|Discontinued From the Study|Overall Study||3
11067245|NCT01047306|12248718|FG001|Discontinued From the Study|Overall Study||0
11067246|NCT01047306|12248717|FG000|COMPLETED|Overall Study||16
11067247|NCT01047306|12248718|FG001|COMPLETED|Overall Study||6
11067248|NCT01047306|12248717|FG000|NOT COMPLETED|Overall Study||3
11067249|NCT01047306|12248718|FG001|NOT COMPLETED|Overall Study||0
11067250|NCT01047332|12248728|FG000|STARTED|Overall Study||61
11067251|NCT01047332|12248729|FG001|STARTED|Overall Study||68
11067252|NCT01047332|12248728|FG000|COMPLETED|Overall Study|Alive at final follow-up|4
11067253|NCT01047332|12248729|FG001|COMPLETED|Overall Study|Alive at final follow-up|4
11067254|NCT01047332|12248728|FG000|NOT COMPLETED|Overall Study||57
11067255|NCT01047332|12248729|FG001|NOT COMPLETED|Overall Study||64
11067256|NCT01047345|12248737|FG000|STARTED|Base Study||618
11067257|NCT01047345|12248738|FG001|STARTED|Base Study||306
11067258|NCT01047345|12248739|FG002|STARTED|Base Study||0
11067259|NCT01047345|12248737|FG000|Vaccination 1|Base Study||615
11067260|NCT01047345|12248738|FG001|Vaccination 1|Base Study||306
11067261|NCT01047345|12248739|FG002|Vaccination 1|Base Study||0
11067262|NCT01047345|12248737|FG000|Vaccination 2|Base Study||604
11067263|NCT01047345|12248738|FG001|Vaccination 2|Base Study||304
11067264|NCT01047345|12248739|FG002|Vaccination 2|Base Study||0
11067265|NCT01047345|12248737|FG000|Vaccination 3|Base Study||597
11067266|NCT01047345|12248738|FG001|Vaccination 3|Base Study||300
11067267|NCT01047345|12248739|FG002|Vaccination 3|Base Study||0
11067268|NCT01047345|12248737|FG000|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
11067269|NCT01047345|12248738|FG001|COMPLETED|Base Study||300
11067270|NCT01047345|12248739|FG002|COMPLETED|Base Study||0
11067271|NCT01047345|12248737|FG000|NOT COMPLETED|Base Study||22
11067272|NCT01047345|12248738|FG001|NOT COMPLETED|Base Study||6
11067273|NCT01047345|12248739|FG002|NOT COMPLETED|Base Study||0
11067274|NCT01047345|12248737|FG000|STARTED|Extension||0
11067275|NCT01047345|12248738|FG001|STARTED|Extension||0
11067276|NCT01047345|12248739|FG002|STARTED|Extension|Not all eligible participants elected to participate in extension|102
11067277|NCT01047345|12248737|FG000|Vaccination 4|Extension||0
11346236|NCT02976519|12543394|FG004|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
11346237|NCT02976519|12543395|FG005|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
11346238|NCT02976519|12543396|FG006|NOT COMPLETED|Wash-out Period (Part 2 Only)||2
11346239|NCT02976519|12543390|FG000|STARTED|Treatment Period 2 (Part 2 Only)||0
11346240|NCT02976519|12543391|FG001|STARTED|Treatment Period 2 (Part 2 Only)||0
11346241|NCT02976519|12543392|FG002|STARTED|Treatment Period 2 (Part 2 Only)||0
11346242|NCT02976519|12543393|FG003|STARTED|Treatment Period 2 (Part 2 Only)||0
11346243|NCT02976519|12543394|FG004|STARTED|Treatment Period 2 (Part 2 Only)||0
11346244|NCT02976519|12543395|FG005|STARTED|Treatment Period 2 (Part 2 Only)||12
11346245|NCT02976519|12543396|FG006|STARTED|Treatment Period 2 (Part 2 Only)||10
11346246|NCT02976519|12543390|FG000|COMPLETED|Treatment Period 2 (Part 2 Only)||0
11346247|NCT02976519|12543391|FG001|COMPLETED|Treatment Period 2 (Part 2 Only)||0
11067278|NCT01047345|12248738|FG001|Vaccination 4|Extension||0
11067279|NCT01047345|12248739|FG002|Vaccination 4|Extension||102
11067280|NCT01047345|12248737|FG000|Vaccination 5|Extension||0
11067281|NCT01047345|12248738|FG001|Vaccination 5|Extension||0
11067282|NCT01047345|12248739|FG002|Vaccination 5|Extension||99
11067283|NCT01047345|12248737|FG000|Vaccination 6|Extension||0
11067284|NCT01047345|12248738|FG001|Vaccination 6|Extension||0
11067285|NCT01047345|12248739|FG002|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
11067286|NCT01047345|12248737|FG000|COMPLETED|Extension||0
11067287|NCT01047345|12248738|FG001|COMPLETED|Extension||0
11067288|NCT01047345|12248739|FG002|COMPLETED|Extension||96
11346248|NCT02976519|12543392|FG002|COMPLETED|Treatment Period 2 (Part 2 Only)||0
11346249|NCT02976519|12543393|FG003|COMPLETED|Treatment Period 2 (Part 2 Only)||0
11346250|NCT02976519|12543394|FG004|COMPLETED|Treatment Period 2 (Part 2 Only)||0
11346251|NCT02976519|12543395|FG005|COMPLETED|Treatment Period 2 (Part 2 Only)||12
11067289|NCT01047345|12248737|FG000|NOT COMPLETED|Extension||0
11067290|NCT01047345|12248738|FG001|NOT COMPLETED|Extension||0
11067291|NCT01047345|12248739|FG002|NOT COMPLETED|Extension||6
11067292|NCT01047358|12248747|FG000|STARTED|Overall Study||206
11067293|NCT01047358|12248747|FG000|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
11067294|NCT01047358|12248747|FG000|NOT COMPLETED|Overall Study||0
11067295|NCT01047436|12248754|FG000|STARTED|Overall Study||16
11067296|NCT01047436|12248755|FG001|STARTED|Overall Study||15
11067297|NCT01047436|12248754|FG000|COMPLETED|Overall Study||15
11067298|NCT01047436|12248755|FG001|COMPLETED|Overall Study||15
11067299|NCT01047436|12248754|FG000|NOT COMPLETED|Overall Study||1
11067300|NCT01047436|12248755|FG001|NOT COMPLETED|Overall Study||0
11067301|NCT01047475|12248763|FG000|STARTED|Overall Study||34
11067302|NCT01047475|12248764|FG001|STARTED|Overall Study||38
11067303|NCT01047475|12248763|FG000|COMPLETED|Overall Study||29
11067304|NCT01047475|12248764|FG001|COMPLETED|Overall Study||31
11067305|NCT01047475|12248763|FG000|NOT COMPLETED|Overall Study||5
11067306|NCT01047475|12248764|FG001|NOT COMPLETED|Overall Study||7
11067307|NCT01047527|12248773|FG000|STARTED|Overall Study||180
11067308|NCT01047527|12248774|FG001|STARTED|Overall Study||173
11067309|NCT01047527|12248775|FG002|STARTED|Overall Study||172
11067310|NCT01047527|12248773|FG000|8 Weeks|Overall Study||148
11067311|NCT01047527|12248774|FG001|8 Weeks|Overall Study||142
11067312|NCT01047527|12248775|FG002|8 Weeks|Overall Study||138
11067313|NCT01047527|12248773|FG000|24 Weeks|Overall Study||111
11067314|NCT01047527|12248774|FG001|24 Weeks|Overall Study||123
11067315|NCT01047527|12248775|FG002|24 Weeks|Overall Study||119
11067316|NCT01047527|12248773|FG000|COMPLETED|Overall Study||95
11067317|NCT01047527|12248774|FG001|COMPLETED|Overall Study||112
11067318|NCT01047527|12248775|FG002|COMPLETED|Overall Study||107
11067319|NCT01047527|12248773|FG000|NOT COMPLETED|Overall Study||85
11067320|NCT01047527|12248774|FG001|NOT COMPLETED|Overall Study||61
11067321|NCT01047527|12248775|FG002|NOT COMPLETED|Overall Study||65
11067322|NCT01047553|12248786|FG000|STARTED|Overall Study||125
11067323|NCT01047553|12248787|FG001|STARTED|Overall Study||126
11067324|NCT01047553|12248786|FG000|COMPLETED|Overall Study||108
11067325|NCT01047553|12248787|FG001|COMPLETED|Overall Study||117
11067326|NCT01047553|12248786|FG000|NOT COMPLETED|Overall Study||17
11067327|NCT01047553|12248787|FG001|NOT COMPLETED|Overall Study||9
11067328|NCT01047709|12248793|FG000|STARTED|Positional Therapy (1 Night)||9
11067329|NCT01047709|12248794|FG001|STARTED|Positional Therapy (1 Night)||9
11067330|NCT01047709|12248793|FG000|COMPLETED|Positional Therapy (1 Night)||9
11067331|NCT01047709|12248794|FG001|COMPLETED|Positional Therapy (1 Night)||9
11067332|NCT01047709|12248793|FG000|NOT COMPLETED|Positional Therapy (1 Night)||0
11067333|NCT01047709|12248794|FG001|NOT COMPLETED|Positional Therapy (1 Night)||0
11067334|NCT01047709|12248793|FG000|STARTED|Control/Positioning ad Lib (1 Night)||9
11067335|NCT01047709|12248794|FG001|STARTED|Control/Positioning ad Lib (1 Night)||9
11067336|NCT01047709|12248793|FG000|COMPLETED|Control/Positioning ad Lib (1 Night)||9
11067337|NCT01047709|12248794|FG001|COMPLETED|Control/Positioning ad Lib (1 Night)||9
11067338|NCT01047709|12248793|FG000|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
11067339|NCT01047709|12248794|FG001|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
11067340|NCT01047839|12248803|FG000|STARTED|Overall Study||12
11067341|NCT01047839|12248804|FG001|STARTED|Overall Study||29
11067342|NCT01047839|12248805|FG002|STARTED|Overall Study||59
11067343|NCT01047839|12248803|FG000|COMPLETED|Overall Study||10
11067344|NCT01047839|12248804|FG001|COMPLETED|Overall Study||29
11067345|NCT01047839|12248805|FG002|COMPLETED|Overall Study||53
11067346|NCT01047839|12248803|FG000|NOT COMPLETED|Overall Study||2
11067347|NCT01047839|12248804|FG001|NOT COMPLETED|Overall Study||0
11067348|NCT01047839|12248805|FG002|NOT COMPLETED|Overall Study||6
11067349|NCT01048099|12248820|FG000|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
11067350|NCT01048099|12248820|FG000|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
11067351|NCT01048099|12248820|FG000|NOT COMPLETED|Patients Enrolled and Blood Collected||57
11067352|NCT01048099|12248820|FG000|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
11067353|NCT01048099|12248820|FG000|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
11206063|NCT01864174|12396977|FG000|COMPLETED|Double Blind - Compliant Randomized||245
11206064|NCT01864174|12396978|FG001|COMPLETED|Double Blind - Compliant Randomized||245
11206065|NCT01864174|12396977|FG000|NOT COMPLETED|Double Blind - Compliant Randomized||23
11206066|NCT01864174|12396978|FG001|NOT COMPLETED|Double Blind - Compliant Randomized||26
11206067|NCT01864174|12396977|FG000|STARTED|Off Treatment Follow-Up||9
11206068|NCT01864174|12396978|FG001|STARTED|Off Treatment Follow-Up||1
11206069|NCT01864174|12396977|FG000|COMPLETED|Off Treatment Follow-Up||6
11206070|NCT01864174|12396978|FG001|COMPLETED|Off Treatment Follow-Up||1
11206071|NCT01864174|12396977|FG000|NOT COMPLETED|Off Treatment Follow-Up||3
11206072|NCT01864174|12396978|FG001|NOT COMPLETED|Off Treatment Follow-Up||0
11206073|NCT01864200|12396986|FG000|STARTED|Overall Study||45
11206074|NCT01864200|12396987|FG001|STARTED|Overall Study||29
11206075|NCT01864200|12396986|FG000|COMPLETED|Overall Study||43
11206076|NCT01864200|12396987|FG001|COMPLETED|Overall Study||26
11206077|NCT01864200|12396986|FG000|NOT COMPLETED|Overall Study||2
11067354|NCT01048099|12248820|FG000|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
11067355|NCT01048099|12248820|FG000|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
11067356|NCT01048099|12248820|FG000|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
11067357|NCT01048099|12248820|FG000|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
11067358|NCT01048099|12248820|FG000|STARTED|Treatment Per Protocol||14
11067359|NCT01048099|12248820|FG000|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
11067360|NCT01048099|12248820|FG000|NOT COMPLETED|Treatment Per Protocol||14
11067361|NCT01048242|12248828|FG000|STARTED|Overall Study||12
11067362|NCT01048242|12248829|FG001|STARTED|Overall Study||15
11067363|NCT01048242|12248828|FG000|COMPLETED|Overall Study||8
11067364|NCT01048242|12248829|FG001|COMPLETED|Overall Study||13
11067365|NCT01048242|12248828|FG000|NOT COMPLETED|Overall Study||4
11067366|NCT01048242|12248829|FG001|NOT COMPLETED|Overall Study||2
11067367|NCT01048333|12248835|FG000|STARTED|Treatment Period 1||21
11067368|NCT01048333|12248836|FG001|STARTED|Treatment Period 1||19
11067369|NCT01048333|12248837|FG002|STARTED|Treatment Period 1||16
11067370|NCT01048333|12248838|FG003|STARTED|Treatment Period 1||18
11067371|NCT01048333|12248839|FG004|STARTED|Treatment Period 1||17
11067372|NCT01048333|12248840|FG005|STARTED|Treatment Period 1||18
11067373|NCT01048333|12248835|FG000|COMPLETED|Treatment Period 1||21
11067374|NCT01048333|12248836|FG001|COMPLETED|Treatment Period 1||19
11067375|NCT01048333|12248837|FG002|COMPLETED|Treatment Period 1||16
11067376|NCT01048333|12248838|FG003|COMPLETED|Treatment Period 1||18
11067377|NCT01048333|12248839|FG004|COMPLETED|Treatment Period 1||17
11067378|NCT01048333|12248840|FG005|COMPLETED|Treatment Period 1||18
11067379|NCT01048333|12248835|FG000|NOT COMPLETED|Treatment Period 1||0
11067380|NCT01048333|12248836|FG001|NOT COMPLETED|Treatment Period 1||0
11067381|NCT01048333|12248837|FG002|NOT COMPLETED|Treatment Period 1||0
11067382|NCT01048333|12248838|FG003|NOT COMPLETED|Treatment Period 1||0
11067383|NCT01048333|12248839|FG004|NOT COMPLETED|Treatment Period 1||0
11067384|NCT01048333|12248840|FG005|NOT COMPLETED|Treatment Period 1||0
11067385|NCT01048333|12248835|FG000|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
11067386|NCT01048333|12248836|FG001|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
11067387|NCT01048333|12248837|FG002|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
11067388|NCT01048333|12248838|FG003|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
11067389|NCT01048333|12248839|FG004|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
11067390|NCT01048333|12248840|FG005|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
11067391|NCT01048333|12248835|FG000|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
11067392|NCT01048333|12248836|FG001|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
11067393|NCT01048333|12248837|FG002|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
11067394|NCT01048333|12248838|FG003|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
11067395|NCT01048333|12248839|FG004|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
11067396|NCT01048333|12248840|FG005|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
11067397|NCT01048333|12248835|FG000|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
11067398|NCT01048333|12248836|FG001|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
11067399|NCT01048333|12248837|FG002|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
11067400|NCT01048333|12248838|FG003|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
11067401|NCT01048333|12248839|FG004|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
11067402|NCT01048333|12248840|FG005|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
11067403|NCT01048333|12248835|FG000|STARTED|Treatment Period 2||21
11067404|NCT01048333|12248836|FG001|STARTED|Treatment Period 2||19
11067405|NCT01048333|12248837|FG002|STARTED|Treatment Period 2||16
11067406|NCT01048333|12248838|FG003|STARTED|Treatment Period 2||18
11067407|NCT01048333|12248839|FG004|STARTED|Treatment Period 2||17
11067408|NCT01048333|12248840|FG005|STARTED|Treatment Period 2||18
11067409|NCT01048333|12248835|FG000|COMPLETED|Treatment Period 2||21
11067410|NCT01048333|12248836|FG001|COMPLETED|Treatment Period 2||19
11067411|NCT01048333|12248837|FG002|COMPLETED|Treatment Period 2||16
11067412|NCT01048333|12248838|FG003|COMPLETED|Treatment Period 2||18
11067413|NCT01048333|12248839|FG004|COMPLETED|Treatment Period 2||17
11067414|NCT01048333|12248840|FG005|COMPLETED|Treatment Period 2||18
11067415|NCT01048333|12248835|FG000|NOT COMPLETED|Treatment Period 2||0
11067416|NCT01048333|12248836|FG001|NOT COMPLETED|Treatment Period 2||0
11067417|NCT01048333|12248837|FG002|NOT COMPLETED|Treatment Period 2||0
11067418|NCT01048333|12248838|FG003|NOT COMPLETED|Treatment Period 2||0
11067419|NCT01048333|12248839|FG004|NOT COMPLETED|Treatment Period 2||0
11067420|NCT01048333|12248840|FG005|NOT COMPLETED|Treatment Period 2||0
11067421|NCT01048333|12248835|FG000|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
11346252|NCT02976519|12543396|FG006|COMPLETED|Treatment Period 2 (Part 2 Only)||9
11067422|NCT01048333|12248836|FG001|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
11067423|NCT01048333|12248837|FG002|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
11067424|NCT01048333|12248838|FG003|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
11067425|NCT01048333|12248839|FG004|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
11067426|NCT01048333|12248840|FG005|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
11067427|NCT01048333|12248835|FG000|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
11067428|NCT01048333|12248836|FG001|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
11067429|NCT01048333|12248837|FG002|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
11067430|NCT01048333|12248838|FG003|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
11067431|NCT01048333|12248839|FG004|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
11067432|NCT01048333|12248840|FG005|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
11067433|NCT01048333|12248835|FG000|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
11067434|NCT01048333|12248836|FG001|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
11067435|NCT01048333|12248837|FG002|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
11067436|NCT01048333|12248838|FG003|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
11067437|NCT01048333|12248839|FG004|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
11067438|NCT01048333|12248840|FG005|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
11067439|NCT01048333|12248835|FG000|STARTED|Treatment Period 3||21
11067440|NCT01048333|12248836|FG001|STARTED|Treatment Period 3||18
11067441|NCT01048333|12248837|FG002|STARTED|Treatment Period 3||16
11067442|NCT01048333|12248838|FG003|STARTED|Treatment Period 3||18
11067443|NCT01048333|12248839|FG004|STARTED|Treatment Period 3||17
11067444|NCT01048333|12248840|FG005|STARTED|Treatment Period 3||18
11067445|NCT01048333|12248835|FG000|COMPLETED|Treatment Period 3||21
11067446|NCT01048333|12248836|FG001|COMPLETED|Treatment Period 3||18
11067447|NCT01048333|12248837|FG002|COMPLETED|Treatment Period 3||16
11067448|NCT01048333|12248838|FG003|COMPLETED|Treatment Period 3||18
11206078|NCT01864200|12396987|FG001|NOT COMPLETED|Overall Study||3
11206079|NCT01864291|12396993|FG000|STARTED|Overall Study||9
11206080|NCT01864291|12396993|FG000|COMPLETED|Overall Study|7/9 subjects had a minimum of one year followup since enrollment.|7
11206081|NCT01864291|12396993|FG000|NOT COMPLETED|Overall Study||2
11206082|NCT01864434|12396999|FG000|STARTED|Overall Study||25
11206083|NCT01864434|12397000|FG001|STARTED|Overall Study||25
11206084|NCT01864434|12396999|FG000|COMPLETED|Overall Study||25
11206085|NCT01864434|12397000|FG001|COMPLETED|Overall Study||25
11206086|NCT01864434|12396999|FG000|NOT COMPLETED|Overall Study||0
11206087|NCT01864434|12397000|FG001|NOT COMPLETED|Overall Study||0
11206088|NCT01864525|12397008|FG000|STARTED|Overall Study||10
11206089|NCT01864525|12397009|FG001|STARTED|Overall Study||7
11206090|NCT01864525|12397008|FG000|COMPLETED|Overall Study||9
11206091|NCT01864525|12397009|FG001|COMPLETED|Overall Study||7
11206092|NCT01864525|12397008|FG000|NOT COMPLETED|Overall Study||1
11206093|NCT01864525|12397009|FG001|NOT COMPLETED|Overall Study||0
11206094|NCT01864538|12397015|FG000|STARTED|Overall Study||11
11206095|NCT01864538|12397015|FG000|COMPLETED|Overall Study||0
11206096|NCT01864538|12397015|FG000|NOT COMPLETED|Overall Study||11
11206097|NCT01864564|12397021|FG000|STARTED|Overall Study||480
11206098|NCT01864564|12397022|FG001|STARTED|Overall Study||482
11206099|NCT01864564|12397021|FG000|COMPLETED|Overall Study||443
11206100|NCT01864564|12397022|FG001|COMPLETED|Overall Study||387
11346253|NCT02976519|12543390|FG000|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
11346254|NCT02976519|12543391|FG001|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
11346255|NCT02976519|12543392|FG002|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
11346256|NCT02976519|12543393|FG003|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
11346257|NCT02976519|12543394|FG004|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
11346258|NCT02976519|12543395|FG005|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
11346259|NCT02976519|12543396|FG006|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1
11346260|NCT02977507|12543416|FG000|STARTED|Overall Study||8
11346261|NCT02977507|12543417|FG001|STARTED|Overall Study||10
11346262|NCT02977507|12543416|FG000|COMPLETED|Overall Study||6
11346263|NCT02977507|12543417|FG001|COMPLETED|Overall Study||10
11346264|NCT02977507|12543416|FG000|NOT COMPLETED|Overall Study||2
11346265|NCT02977507|12543417|FG001|NOT COMPLETED|Overall Study||0
11346266|NCT02977572|12543426|FG000|STARTED|Overall Study||58
11346267|NCT02977572|12543427|FG001|STARTED|Overall Study||56
11346268|NCT02977572|12543426|FG000|COMPLETED|Overall Study||56
11346269|NCT02977572|12543427|FG001|COMPLETED|Overall Study||54
11346270|NCT02977572|12543426|FG000|NOT COMPLETED|Overall Study||2
11346271|NCT02977572|12543427|FG001|NOT COMPLETED|Overall Study||2
11346272|NCT02978157|12543439|FG000|STARTED|Overall Study||52
11346273|NCT02978157|12543440|FG001|STARTED|Overall Study||50
11346274|NCT02978157|12543439|FG000|COMPLETED|Overall Study||52
11346275|NCT02978157|12543440|FG001|COMPLETED|Overall Study||50
11346276|NCT02978157|12543439|FG000|NOT COMPLETED|Overall Study||0
11346277|NCT02978157|12543440|FG001|NOT COMPLETED|Overall Study||0
11067449|NCT01048333|12248839|FG004|COMPLETED|Treatment Period 3||17
11067450|NCT01048333|12248840|FG005|COMPLETED|Treatment Period 3||18
11067451|NCT01048333|12248835|FG000|NOT COMPLETED|Treatment Period 3||0
11067452|NCT01048333|12248836|FG001|NOT COMPLETED|Treatment Period 3||0
11067453|NCT01048333|12248837|FG002|NOT COMPLETED|Treatment Period 3||0
11206101|NCT01864564|12397021|FG000|NOT COMPLETED|Overall Study||37
11206102|NCT01864564|12397022|FG001|NOT COMPLETED|Overall Study||95
11206103|NCT01865084|12397031|FG000|STARTED|Double Blind Period (DB)||116
11206104|NCT01865084|12397032|FG001|STARTED|Double Blind Period (DB)||102
11206105|NCT01865084|12397033|FG002|STARTED|Double Blind Period (DB)||113
11206106|NCT01865084|12397031|FG000|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
11206107|NCT01865084|12397032|FG001|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
11206108|NCT01865084|12397033|FG002|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
11206109|NCT01865084|12397031|FG000|COMPLETED|Double Blind Period (DB)||111
11206110|NCT01865084|12397032|FG001|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
11206111|NCT01865084|12397033|FG002|COMPLETED|Double Blind Period (DB)||107
11067454|NCT01048333|12248838|FG003|NOT COMPLETED|Treatment Period 3||0
11067455|NCT01048333|12248839|FG004|NOT COMPLETED|Treatment Period 3||0
11206112|NCT01865084|12397031|FG000|NOT COMPLETED|Double Blind Period (DB)||5
11346278|NCT02978183|12543448|FG000|STARTED|Overall Study||34
11346279|NCT02978183|12543449|FG001|STARTED|Overall Study||36
11067456|NCT01048333|12248840|FG005|NOT COMPLETED|Treatment Period 3||0
11067457|NCT01048424|12248850|FG000|STARTED|Overall Study||10
11067458|NCT01048424|12248851|FG001|STARTED|Overall Study||10
11067459|NCT01048424|12248850|FG000|COMPLETED|Overall Study||8
11067460|NCT01048424|12248851|FG001|COMPLETED|Overall Study||10
11067461|NCT01048424|12248850|FG000|NOT COMPLETED|Overall Study||2
11067462|NCT01048424|12248851|FG001|NOT COMPLETED|Overall Study||0
11067463|NCT01048502|12248862|FG000|STARTED|Overall Study||24
11067464|NCT01048502|12248863|FG001|STARTED|Overall Study||23
11067465|NCT01048502|12248864|FG002|STARTED|Overall Study||28
11067466|NCT01048502|12248865|FG003|STARTED|Overall Study||25
11067467|NCT01048502|12248862|FG000|COMPLETED|Overall Study||20
11067468|NCT01048502|12248863|FG001|COMPLETED|Overall Study||16
11067469|NCT01048502|12248864|FG002|COMPLETED|Overall Study||23
11067470|NCT01048502|12248865|FG003|COMPLETED|Overall Study||21
11067471|NCT01048502|12248862|FG000|NOT COMPLETED|Overall Study||4
11067472|NCT01048502|12248863|FG001|NOT COMPLETED|Overall Study||7
11067473|NCT01048502|12248864|FG002|NOT COMPLETED|Overall Study||5
11067474|NCT01048502|12248865|FG003|NOT COMPLETED|Overall Study||4
11067475|NCT01048541|12248876|FG000|STARTED|Overall Study||18
11067476|NCT01048541|12248877|FG001|STARTED|Overall Study||19
11067477|NCT01048541|12248876|FG000|COMPLETED|Overall Study||17
11067478|NCT01048541|12248877|FG001|COMPLETED|Overall Study||19
11067479|NCT01048541|12248876|FG000|NOT COMPLETED|Overall Study||1
11067480|NCT01048541|12248877|FG001|NOT COMPLETED|Overall Study||0
11067481|NCT01048593|12248886|FG000|STARTED|Overall Study||3
11067482|NCT01048593|12248887|FG001|STARTED|Overall Study||2
11067483|NCT01048593|12248888|FG002|STARTED|Overall Study||1
11067484|NCT01048593|12248886|FG000|COMPLETED|Overall Study||3
11067485|NCT01048593|12248887|FG001|COMPLETED|Overall Study||2
11067486|NCT01048593|12248888|FG002|COMPLETED|Overall Study||1
11067487|NCT01048593|12248886|FG000|NOT COMPLETED|Overall Study||0
11067488|NCT01048593|12248887|FG001|NOT COMPLETED|Overall Study||0
11067489|NCT01048593|12248888|FG002|NOT COMPLETED|Overall Study||0
11067490|NCT01048606|12248900|FG000|STARTED|Overall Study||28
11067491|NCT01048606|12248901|FG001|STARTED|Overall Study||15
11067492|NCT01048606|12248902|FG002|STARTED|Overall Study||26
11067493|NCT01048606|12248903|FG003|STARTED|Overall Study||10
11067494|NCT01048606|12248900|FG000|COMPLETED|Overall Study||16
11067495|NCT01048606|12248901|FG001|COMPLETED|Overall Study||8
11067496|NCT01048606|12248902|FG002|COMPLETED|Overall Study||16
11067497|NCT01048606|12248903|FG003|COMPLETED|Overall Study||5
11067498|NCT01048606|12248900|FG000|NOT COMPLETED|Overall Study||12
11067499|NCT01048606|12248901|FG001|NOT COMPLETED|Overall Study||7
11067500|NCT01048606|12248902|FG002|NOT COMPLETED|Overall Study||10
11067501|NCT01048606|12248903|FG003|NOT COMPLETED|Overall Study||5
11067502|NCT01048658|12248915|FG000|STARTED|Overall Study||80
11067503|NCT01048658|12248916|FG001|STARTED|Overall Study||80
11067504|NCT01048658|12248915|FG000|COMPLETED|Overall Study||80
11067505|NCT01048658|12248916|FG001|COMPLETED|Overall Study||80
11067506|NCT01048658|12248915|FG000|NOT COMPLETED|Overall Study||0
11067507|NCT01048658|12248916|FG001|NOT COMPLETED|Overall Study||0
11067508|NCT01048671|12248925|FG000|STARTED|Overall Study||66
11067509|NCT01048671|12248926|FG001|STARTED|Overall Study||264
11067510|NCT01048671|12248927|FG002|STARTED|Overall Study||152
11067511|NCT01048671|12248925|FG000|COMPLETED|Overall Study||66
11067512|NCT01048671|12248926|FG001|COMPLETED|Overall Study||263
11067513|NCT01048671|12248927|FG002|COMPLETED|Overall Study||151
11067514|NCT01048671|12248925|FG000|NOT COMPLETED|Overall Study||0
11067515|NCT01048671|12248926|FG001|NOT COMPLETED|Overall Study||1
11067516|NCT01048671|12248927|FG002|NOT COMPLETED|Overall Study||1
11067517|NCT01048697|12248935|FG000|STARTED|Overall Study||18
11067518|NCT01048697|12248935|FG000|COMPLETED|Overall Study||18
11067519|NCT01048697|12248935|FG000|NOT COMPLETED|Overall Study||0
11067520|NCT01048788|12248942|FG000|STARTED|Overall Study||8
11067521|NCT01048788|12248943|FG001|STARTED|Overall Study||30
11067522|NCT01048788|12248944|FG002|STARTED|Overall Study||13
11067523|NCT01048788|12248942|FG000|COMPLETED|Overall Study||3
11067524|NCT01048788|12248943|FG001|COMPLETED|Overall Study||28
11067525|NCT01048788|12248944|FG002|COMPLETED|Overall Study||11
11067526|NCT01048788|12248942|FG000|NOT COMPLETED|Overall Study||5
11067527|NCT01048788|12248943|FG001|NOT COMPLETED|Overall Study||2
11067528|NCT01048788|12248944|FG002|NOT COMPLETED|Overall Study||2
11067529|NCT01048866|12248954|FG000|STARTED|Overall Study||101
11067530|NCT01048866|12248955|FG001|STARTED|Overall Study||97
11067531|NCT01048866|12248954|FG000|COMPLETED|Overall Study||97
11067532|NCT01048866|12248955|FG001|COMPLETED|Overall Study||92
11067533|NCT01048866|12248954|FG000|NOT COMPLETED|Overall Study||4
11067534|NCT01048866|12248955|FG001|NOT COMPLETED|Overall Study||5
11067535|NCT01048879|12248964|FG000|STARTED|Overall Study||1
11067536|NCT01048879|12248965|FG001|STARTED|Overall Study||9
11067537|NCT01048879|12248966|FG002|STARTED|Overall Study||5
11067538|NCT01048879|12248964|FG000|COMPLETED|Overall Study||1
11067539|NCT01048879|12248965|FG001|COMPLETED|Overall Study||9
11067540|NCT01048879|12248966|FG002|COMPLETED|Overall Study||5
11067541|NCT01048879|12248964|FG000|NOT COMPLETED|Overall Study||0
11067542|NCT01048879|12248965|FG001|NOT COMPLETED|Overall Study||0
11067543|NCT01048879|12248966|FG002|NOT COMPLETED|Overall Study||0
11067544|NCT01048905|12248974|FG000|STARTED|Overall Study||13
11067545|NCT01048905|12248974|FG000|COMPLETED|Overall Study||12
11067546|NCT01048905|12248974|FG000|NOT COMPLETED|Overall Study||1
11206113|NCT01865084|12397032|FG001|NOT COMPLETED|Double Blind Period (DB)||4
11206114|NCT01865084|12397033|FG002|NOT COMPLETED|Double Blind Period (DB)||6
11067547|NCT01048944|12248982|FG000|STARTED|Overall Study||32
11067548|NCT01048944|12248983|FG001|STARTED|Overall Study||38
11067549|NCT01048944|12248984|FG002|STARTED|Overall Study||35
11067550|NCT01048944|12248985|FG003|STARTED|Overall Study||21
11067551|NCT01048944|12248982|FG000|COMPLETED|Overall Study||24
11067552|NCT01048944|12248983|FG001|COMPLETED|Overall Study||28
11067553|NCT01048944|12248984|FG002|COMPLETED|Overall Study||25
11067554|NCT01048944|12248985|FG003|COMPLETED|Overall Study||19
11067555|NCT01048944|12248982|FG000|NOT COMPLETED|Overall Study||8
11067556|NCT01048944|12248983|FG001|NOT COMPLETED|Overall Study||10
11067557|NCT01048944|12248984|FG002|NOT COMPLETED|Overall Study||10
11067558|NCT01048944|12248985|FG003|NOT COMPLETED|Overall Study||2
11067559|NCT01049009|12248997|FG000|STARTED|Treatment Period 1 (12 Weeks)||23
11067560|NCT01049009|12248998|FG001|STARTED|Treatment Period 1 (12 Weeks)||21
11067561|NCT01049009|12248997|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||21
11067562|NCT01049009|12248998|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||18
11067563|NCT01049009|12248997|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
11067564|NCT01049009|12248998|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
11067565|NCT01049009|12248997|FG000|STARTED|Treatment Period 2 (12 Weeks)||21
11067566|NCT01049009|12248998|FG001|STARTED|Treatment Period 2 (12 Weeks)||18
11067567|NCT01049009|12248997|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||11
11067568|NCT01049009|12248998|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||8
11067569|NCT01049009|12248997|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
11067570|NCT01049009|12248998|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
11067571|NCT01049217|12249006|FG000|STARTED|Overall Study||183
11067572|NCT01049217|12249007|FG001|STARTED|Overall Study||194
11067573|NCT01049217|12249006|FG000|Treated|Overall Study||183
11067574|NCT01049217|12249007|FG001|Treated|Overall Study||192
11067575|NCT01049217|12249006|FG000|COMPLETED|Overall Study||127
11067576|NCT01049217|12249007|FG001|COMPLETED|Overall Study||131
11067577|NCT01049217|12249006|FG000|NOT COMPLETED|Overall Study||56
11067578|NCT01049217|12249007|FG001|NOT COMPLETED|Overall Study||63
11067579|NCT01049243|12249013|FG000|STARTED|Overall Study||20
11067580|NCT01049243|12249013|FG000|COMPLETED|Overall Study||18
11067581|NCT01049243|12249013|FG000|NOT COMPLETED|Overall Study||2
11067582|NCT01049308|12249018|FG000|STARTED|Evaluation of Cognitive Impairment||251
11067583|NCT01049308|12249018|FG000|COMPLETED|Evaluation of Cognitive Impairment||251
11067584|NCT01049308|12249018|FG000|NOT COMPLETED|Evaluation of Cognitive Impairment||0
11067585|NCT01049308|12249018|FG000|STARTED|Pill Counts||251
11067586|NCT01049308|12249018|FG000|COMPLETED|Pill Counts||168
11067587|NCT01049308|12249018|FG000|NOT COMPLETED|Pill Counts||83
11067588|NCT01049334|12249027|FG000|STARTED|Overall Study||102
11067589|NCT01049334|12249028|FG001|STARTED|Overall Study||102
11067590|NCT01049334|12249027|FG000|COMPLETED|Overall Study||93
11067591|NCT01049334|12249028|FG001|COMPLETED|Overall Study||95
11067592|NCT01049334|12249027|FG000|NOT COMPLETED|Overall Study||9
11067593|NCT01049334|12249028|FG001|NOT COMPLETED|Overall Study||7
11067594|NCT01049360|12249034|FG000|STARTED|Period 1||6
11067595|NCT01049360|12249035|FG001|STARTED|Period 1||6
11067596|NCT01049360|12249036|FG002|STARTED|Period 1||7
11067597|NCT01049360|12249037|FG003|STARTED|Period 1||7
11067598|NCT01049360|12249038|FG004|STARTED|Period 1||7
11067599|NCT01049360|12249039|FG005|STARTED|Period 1||6
11067600|NCT01049360|12249040|FG006|STARTED|Period 1||6
11067601|NCT01049360|12249041|FG007|STARTED|Period 1||6
11067602|NCT01049360|12249042|FG008|STARTED|Period 1||7
11067603|NCT01049360|12249043|FG009|STARTED|Period 1||6
11067604|NCT01049360|12249044|FG010|STARTED|Period 1||6
11067605|NCT01049360|12249045|FG011|STARTED|Period 1||6
11067606|NCT01049360|12249046|FG012|STARTED|Period 1||6
11067607|NCT01049360|12249047|FG013|STARTED|Period 1||7
11067608|NCT01049360|12249048|FG014|STARTED|Period 1||7
11067609|NCT01049360|12249049|FG015|STARTED|Period 1||7
11067610|NCT01049360|12249050|FG016|STARTED|Period 1||6
11067611|NCT01049360|12249051|FG017|STARTED|Period 1||6
11067612|NCT01049360|12249052|FG018|STARTED|Period 1||6
11067613|NCT01049360|12249053|FG019|STARTED|Period 1||7
11067614|NCT01049360|12249034|FG000|COMPLETED|Period 1||6
11067615|NCT01049360|12249035|FG001|COMPLETED|Period 1||5
11067616|NCT01049360|12249036|FG002|COMPLETED|Period 1||7
11067617|NCT01049360|12249037|FG003|COMPLETED|Period 1||6
11067618|NCT01049360|12249038|FG004|COMPLETED|Period 1||7
11067619|NCT01049360|12249039|FG005|COMPLETED|Period 1||6
11067620|NCT01049360|12249040|FG006|COMPLETED|Period 1||6
11067621|NCT01049360|12249041|FG007|COMPLETED|Period 1||4
11067622|NCT01049360|12249042|FG008|COMPLETED|Period 1||5
11067623|NCT01049360|12249043|FG009|COMPLETED|Period 1||6
11067624|NCT01049360|12249044|FG010|COMPLETED|Period 1||5
11067625|NCT01049360|12249045|FG011|COMPLETED|Period 1||6
11067626|NCT01049360|12249046|FG012|COMPLETED|Period 1||4
11067627|NCT01049360|12249047|FG013|COMPLETED|Period 1||6
11067628|NCT01049360|12249048|FG014|COMPLETED|Period 1||7
11067629|NCT01049360|12249049|FG015|COMPLETED|Period 1||7
11067630|NCT01049360|12249050|FG016|COMPLETED|Period 1||5
11067631|NCT01049360|12249051|FG017|COMPLETED|Period 1||6
11067632|NCT01049360|12249052|FG018|COMPLETED|Period 1||5
11067633|NCT01049360|12249053|FG019|COMPLETED|Period 1||7
11067634|NCT01049360|12249034|FG000|NOT COMPLETED|Period 1||0
11067635|NCT01049360|12249035|FG001|NOT COMPLETED|Period 1||1
11067636|NCT01049360|12249036|FG002|NOT COMPLETED|Period 1||0
11067637|NCT01049360|12249037|FG003|NOT COMPLETED|Period 1||1
11067638|NCT01049360|12249038|FG004|NOT COMPLETED|Period 1||0
11067639|NCT01049360|12249039|FG005|NOT COMPLETED|Period 1||0
11067640|NCT01049360|12249040|FG006|NOT COMPLETED|Period 1||0
11067641|NCT01049360|12249041|FG007|NOT COMPLETED|Period 1||2
11067642|NCT01049360|12249042|FG008|NOT COMPLETED|Period 1||2
11067643|NCT01049360|12249043|FG009|NOT COMPLETED|Period 1||0
11067644|NCT01049360|12249044|FG010|NOT COMPLETED|Period 1||1
11067645|NCT01049360|12249045|FG011|NOT COMPLETED|Period 1||0
11067646|NCT01049360|12249046|FG012|NOT COMPLETED|Period 1||2
11067647|NCT01049360|12249047|FG013|NOT COMPLETED|Period 1||1
11067648|NCT01049360|12249048|FG014|NOT COMPLETED|Period 1||0
11067649|NCT01049360|12249049|FG015|NOT COMPLETED|Period 1||0
11067650|NCT01049360|12249050|FG016|NOT COMPLETED|Period 1||1
11067651|NCT01049360|12249051|FG017|NOT COMPLETED|Period 1||0
11067652|NCT01049360|12249052|FG018|NOT COMPLETED|Period 1||1
11067653|NCT01049360|12249053|FG019|NOT COMPLETED|Period 1||0
11067654|NCT01049360|12249034|FG000|STARTED|Period 2||6
11067655|NCT01049360|12249035|FG001|STARTED|Period 2||5
11067656|NCT01049360|12249036|FG002|STARTED|Period 2||7
11067657|NCT01049360|12249037|FG003|STARTED|Period 2||6
11067658|NCT01049360|12249038|FG004|STARTED|Period 2||7
11067659|NCT01049360|12249039|FG005|STARTED|Period 2||6
11067660|NCT01049360|12249040|FG006|STARTED|Period 2||6
11067661|NCT01049360|12249041|FG007|STARTED|Period 2||4
11067662|NCT01049360|12249042|FG008|STARTED|Period 2||5
11067663|NCT01049360|12249043|FG009|STARTED|Period 2||6
11067664|NCT01049360|12249044|FG010|STARTED|Period 2||5
11067665|NCT01049360|12249045|FG011|STARTED|Period 2||6
11067666|NCT01049360|12249046|FG012|STARTED|Period 2||4
11067667|NCT01049360|12249047|FG013|STARTED|Period 2||6
11067668|NCT01049360|12249048|FG014|STARTED|Period 2||7
11067669|NCT01049360|12249049|FG015|STARTED|Period 2||7
11067670|NCT01049360|12249050|FG016|STARTED|Period 2||5
11067671|NCT01049360|12249051|FG017|STARTED|Period 2||6
11067672|NCT01049360|12249052|FG018|STARTED|Period 2||5
11067673|NCT01049360|12249053|FG019|STARTED|Period 2||7
11067674|NCT01049360|12249034|FG000|COMPLETED|Period 2||6
11067675|NCT01049360|12249035|FG001|COMPLETED|Period 2||4
11067676|NCT01049360|12249036|FG002|COMPLETED|Period 2||7
11067677|NCT01049360|12249037|FG003|COMPLETED|Period 2||4
11067678|NCT01049360|12249038|FG004|COMPLETED|Period 2||7
11067679|NCT01049360|12249039|FG005|COMPLETED|Period 2||5
11067680|NCT01049360|12249040|FG006|COMPLETED|Period 2||6
11067681|NCT01049360|12249041|FG007|COMPLETED|Period 2||4
11067682|NCT01049360|12249042|FG008|COMPLETED|Period 2||4
11067683|NCT01049360|12249043|FG009|COMPLETED|Period 2||6
11067684|NCT01049360|12249044|FG010|COMPLETED|Period 2||5
11067685|NCT01049360|12249045|FG011|COMPLETED|Period 2||6
11067686|NCT01049360|12249046|FG012|COMPLETED|Period 2||4
11067687|NCT01049360|12249047|FG013|COMPLETED|Period 2||6
11067688|NCT01049360|12249048|FG014|COMPLETED|Period 2||5
11067689|NCT01049360|12249049|FG015|COMPLETED|Period 2||6
11067690|NCT01049360|12249050|FG016|COMPLETED|Period 2||5
11067691|NCT01049360|12249051|FG017|COMPLETED|Period 2||6
11067692|NCT01049360|12249052|FG018|COMPLETED|Period 2||5
11067693|NCT01049360|12249053|FG019|COMPLETED|Period 2||5
11067694|NCT01049360|12249034|FG000|NOT COMPLETED|Period 2||0
11067695|NCT01049360|12249035|FG001|NOT COMPLETED|Period 2||1
11067696|NCT01049360|12249036|FG002|NOT COMPLETED|Period 2||0
11067697|NCT01049360|12249037|FG003|NOT COMPLETED|Period 2||2
11067698|NCT01049360|12249038|FG004|NOT COMPLETED|Period 2||0
11067699|NCT01049360|12249039|FG005|NOT COMPLETED|Period 2||1
11067700|NCT01049360|12249040|FG006|NOT COMPLETED|Period 2||0
11067701|NCT01049360|12249041|FG007|NOT COMPLETED|Period 2||0
11067702|NCT01049360|12249042|FG008|NOT COMPLETED|Period 2||1
11067703|NCT01049360|12249043|FG009|NOT COMPLETED|Period 2||0
11067704|NCT01049360|12249044|FG010|NOT COMPLETED|Period 2||0
11346280|NCT02978183|12543448|FG000|COMPLETED|Overall Study||34
11067705|NCT01049360|12249045|FG011|NOT COMPLETED|Period 2||0
11067706|NCT01049360|12249046|FG012|NOT COMPLETED|Period 2||0
11067707|NCT01049360|12249047|FG013|NOT COMPLETED|Period 2||0
11067708|NCT01049360|12249048|FG014|NOT COMPLETED|Period 2||2
11067709|NCT01049360|12249049|FG015|NOT COMPLETED|Period 2||1
11067710|NCT01049360|12249050|FG016|NOT COMPLETED|Period 2||0
11067711|NCT01049360|12249051|FG017|NOT COMPLETED|Period 2||0
11067712|NCT01049360|12249052|FG018|NOT COMPLETED|Period 2||0
11067713|NCT01049360|12249053|FG019|NOT COMPLETED|Period 2||2
11067714|NCT01049360|12249034|FG000|STARTED|Period 3||6
11067715|NCT01049360|12249035|FG001|STARTED|Period 3||4
11067716|NCT01049360|12249036|FG002|STARTED|Period 3||7
11346281|NCT02978183|12543449|FG001|COMPLETED|Overall Study||36
11346282|NCT02978183|12543448|FG000|NOT COMPLETED|Overall Study||0
11067717|NCT01049360|12249037|FG003|STARTED|Period 3||4
11067718|NCT01049360|12249038|FG004|STARTED|Period 3||7
11067719|NCT01049360|12249039|FG005|STARTED|Period 3||5
11067720|NCT01049360|12249040|FG006|STARTED|Period 3||6
11067721|NCT01049360|12249041|FG007|STARTED|Period 3||4
11067722|NCT01049360|12249042|FG008|STARTED|Period 3||4
11067723|NCT01049360|12249043|FG009|STARTED|Period 3||6
11067724|NCT01049360|12249044|FG010|STARTED|Period 3||5
11067725|NCT01049360|12249045|FG011|STARTED|Period 3||6
11067726|NCT01049360|12249046|FG012|STARTED|Period 3||4
11067727|NCT01049360|12249047|FG013|STARTED|Period 3||6
11067728|NCT01049360|12249048|FG014|STARTED|Period 3||5
11067729|NCT01049360|12249049|FG015|STARTED|Period 3||6
11067730|NCT01049360|12249050|FG016|STARTED|Period 3||5
11067731|NCT01049360|12249051|FG017|STARTED|Period 3||6
11067732|NCT01049360|12249052|FG018|STARTED|Period 3||5
11067733|NCT01049360|12249053|FG019|STARTED|Period 3||5
11067734|NCT01049360|12249034|FG000|COMPLETED|Period 3||6
11067735|NCT01049360|12249035|FG001|COMPLETED|Period 3||4
11067736|NCT01049360|12249036|FG002|COMPLETED|Period 3||7
11067737|NCT01049360|12249037|FG003|COMPLETED|Period 3||4
11067738|NCT01049360|12249038|FG004|COMPLETED|Period 3||7
11067739|NCT01049360|12249039|FG005|COMPLETED|Period 3||5
11067740|NCT01049360|12249040|FG006|COMPLETED|Period 3||6
11067741|NCT01049360|12249041|FG007|COMPLETED|Period 3||4
11067742|NCT01049360|12249042|FG008|COMPLETED|Period 3||4
11067743|NCT01049360|12249043|FG009|COMPLETED|Period 3||6
11067744|NCT01049360|12249044|FG010|COMPLETED|Period 3||5
11067745|NCT01049360|12249045|FG011|COMPLETED|Period 3||6
11067746|NCT01049360|12249046|FG012|COMPLETED|Period 3||4
11067747|NCT01049360|12249047|FG013|COMPLETED|Period 3||6
11067748|NCT01049360|12249048|FG014|COMPLETED|Period 3||5
11067749|NCT01049360|12249049|FG015|COMPLETED|Period 3||6
11067750|NCT01049360|12249050|FG016|COMPLETED|Period 3||5
11067751|NCT01049360|12249051|FG017|COMPLETED|Period 3||6
11067752|NCT01049360|12249052|FG018|COMPLETED|Period 3||5
11067753|NCT01049360|12249053|FG019|COMPLETED|Period 3||5
11067754|NCT01049360|12249034|FG000|NOT COMPLETED|Period 3||0
11067755|NCT01049360|12249035|FG001|NOT COMPLETED|Period 3||0
11067756|NCT01049360|12249036|FG002|NOT COMPLETED|Period 3||0
11067757|NCT01049360|12249037|FG003|NOT COMPLETED|Period 3||0
11067758|NCT01049360|12249038|FG004|NOT COMPLETED|Period 3||0
11067759|NCT01049360|12249039|FG005|NOT COMPLETED|Period 3||0
11067760|NCT01049360|12249040|FG006|NOT COMPLETED|Period 3||0
11067761|NCT01049360|12249041|FG007|NOT COMPLETED|Period 3||0
11067762|NCT01049360|12249042|FG008|NOT COMPLETED|Period 3||0
11067763|NCT01049360|12249043|FG009|NOT COMPLETED|Period 3||0
11067764|NCT01049360|12249044|FG010|NOT COMPLETED|Period 3||0
11067765|NCT01049360|12249045|FG011|NOT COMPLETED|Period 3||0
11067766|NCT01049360|12249046|FG012|NOT COMPLETED|Period 3||0
11067767|NCT01049360|12249047|FG013|NOT COMPLETED|Period 3||0
11067768|NCT01049360|12249048|FG014|NOT COMPLETED|Period 3||0
11067769|NCT01049360|12249049|FG015|NOT COMPLETED|Period 3||0
11067770|NCT01049360|12249050|FG016|NOT COMPLETED|Period 3||0
11067771|NCT01049360|12249051|FG017|NOT COMPLETED|Period 3||0
11206115|NCT01865084|12397031|FG000|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
11206116|NCT01865084|12397032|FG001|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
11206117|NCT01865084|12397033|FG002|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
11206118|NCT01865084|12397031|FG000|COMPLETED|Open Label Extension (OLE) Period||0
11206119|NCT01865084|12397032|FG001|COMPLETED|Open Label Extension (OLE) Period||139
11206120|NCT01865084|12397033|FG002|COMPLETED|Open Label Extension (OLE) Period||158
11206121|NCT01865084|12397031|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0
11206122|NCT01865084|12397032|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||11
11206123|NCT01865084|12397033|FG002|NOT COMPLETED|Open Label Extension (OLE) Period||7
11206124|NCT01865448|12397047|FG000|STARTED|Overall Study||17
11206125|NCT01865448|12397048|FG001|STARTED|Overall Study||17
11206126|NCT01865448|12397047|FG000|COMPLETED|Overall Study||15
11206127|NCT01865448|12397048|FG001|COMPLETED|Overall Study||14
11206128|NCT01865448|12397047|FG000|NOT COMPLETED|Overall Study||2
11206129|NCT01865448|12397048|FG001|NOT COMPLETED|Overall Study||3
11206130|NCT01865487|12397061|FG000|STARTED|Overall Study||15
11206131|NCT01865487|12397062|FG001|STARTED|Overall Study||15
11206132|NCT01865487|12397063|FG002|STARTED|Overall Study||15
11206133|NCT01865487|12397064|FG003|STARTED|Overall Study||5
11206134|NCT01865487|12397065|FG004|STARTED|Overall Study||12
11206135|NCT01865487|12397066|FG005|STARTED|Overall Study||4
11206136|NCT01865487|12397067|FG006|STARTED|Overall Study||12
11206137|NCT01865487|12397068|FG007|STARTED|Overall Study||4
11206138|NCT01865487|12397069|FG008|STARTED|Overall Study||12
11206139|NCT01865487|12397070|FG009|STARTED|Overall Study||4
11206140|NCT01865487|12397061|FG000|COMPLETED|Overall Study||15
11206141|NCT01865487|12397062|FG001|COMPLETED|Overall Study||15
11206142|NCT01865487|12397063|FG002|COMPLETED|Overall Study||15
11206143|NCT01865487|12397064|FG003|COMPLETED|Overall Study||4
11206144|NCT01865487|12397065|FG004|COMPLETED|Overall Study||11
11206145|NCT01865487|12397066|FG005|COMPLETED|Overall Study||4
11206146|NCT01865487|12397067|FG006|COMPLETED|Overall Study||11
11206147|NCT01865487|12397068|FG007|COMPLETED|Overall Study||4
11206148|NCT01865487|12397069|FG008|COMPLETED|Overall Study||12
11206149|NCT01865487|12397070|FG009|COMPLETED|Overall Study||4
11206150|NCT01865487|12397061|FG000|NOT COMPLETED|Overall Study||0
11346283|NCT02978183|12543449|FG001|NOT COMPLETED|Overall Study||0
11067772|NCT01049360|12249052|FG018|NOT COMPLETED|Period 3||0
11067773|NCT01049360|12249053|FG019|NOT COMPLETED|Period 3||0
11067774|NCT01049360|12249034|FG000|STARTED|Period 4||6
11067775|NCT01049360|12249035|FG001|STARTED|Period 4||4
11346284|NCT02978339|12543455|FG000|STARTED|Overall Study||15
11346285|NCT02978339|12543455|FG000|COMPLETED|Overall Study||15
11346286|NCT02978339|12543455|FG000|NOT COMPLETED|Overall Study||0
11346287|NCT02978417|12543461|FG000|STARTED|Overall Study||5
11346288|NCT02978417|12543462|FG001|STARTED|Overall Study||5
11067776|NCT01049360|12249036|FG002|STARTED|Period 4||7
11067777|NCT01049360|12249037|FG003|STARTED|Period 4||4
11067778|NCT01049360|12249038|FG004|STARTED|Period 4||7
11067779|NCT01049360|12249039|FG005|STARTED|Period 4||5
11206151|NCT01865487|12397062|FG001|NOT COMPLETED|Overall Study||0
11346289|NCT02978417|12543461|FG000|COMPLETED|Overall Study||3
11206152|NCT01865487|12397063|FG002|NOT COMPLETED|Overall Study||0
11206153|NCT01865487|12397064|FG003|NOT COMPLETED|Overall Study||1
11206154|NCT01865487|12397065|FG004|NOT COMPLETED|Overall Study||1
11206155|NCT01865487|12397066|FG005|NOT COMPLETED|Overall Study||0
11206156|NCT01865487|12397067|FG006|NOT COMPLETED|Overall Study||1
11206157|NCT01865487|12397068|FG007|NOT COMPLETED|Overall Study||0
11346290|NCT02978417|12543462|FG001|COMPLETED|Overall Study||3
11067780|NCT01049360|12249040|FG006|STARTED|Period 4||6
11067781|NCT01049360|12249041|FG007|STARTED|Period 4||4
11067782|NCT01049360|12249042|FG008|STARTED|Period 4||4
11067783|NCT01049360|12249043|FG009|STARTED|Period 4||6
11067784|NCT01049360|12249044|FG010|STARTED|Period 4||5
11067785|NCT01049360|12249045|FG011|STARTED|Period 4||6
11067786|NCT01049360|12249046|FG012|STARTED|Period 4||4
11067787|NCT01049360|12249047|FG013|STARTED|Period 4||6
11067788|NCT01049360|12249048|FG014|STARTED|Period 4||5
11067789|NCT01049360|12249049|FG015|STARTED|Period 4||6
11067790|NCT01049360|12249050|FG016|STARTED|Period 4||5
11067791|NCT01049360|12249051|FG017|STARTED|Period 4||6
11067792|NCT01049360|12249052|FG018|STARTED|Period 4||5
11067793|NCT01049360|12249053|FG019|STARTED|Period 4||5
11067794|NCT01049360|12249034|FG000|COMPLETED|Period 4||6
11067795|NCT01049360|12249035|FG001|COMPLETED|Period 4||4
11067796|NCT01049360|12249036|FG002|COMPLETED|Period 4||7
11067797|NCT01049360|12249037|FG003|COMPLETED|Period 4||3
11067798|NCT01049360|12249038|FG004|COMPLETED|Period 4||7
11067799|NCT01049360|12249039|FG005|COMPLETED|Period 4||5
11067800|NCT01049360|12249040|FG006|COMPLETED|Period 4||6
11067801|NCT01049360|12249041|FG007|COMPLETED|Period 4||4
11067802|NCT01049360|12249042|FG008|COMPLETED|Period 4||4
11067803|NCT01049360|12249043|FG009|COMPLETED|Period 4||6
11067804|NCT01049360|12249044|FG010|COMPLETED|Period 4||5
11067805|NCT01049360|12249045|FG011|COMPLETED|Period 4||6
11067806|NCT01049360|12249046|FG012|COMPLETED|Period 4||4
11067807|NCT01049360|12249047|FG013|COMPLETED|Period 4||6
11067808|NCT01049360|12249048|FG014|COMPLETED|Period 4||5
11067809|NCT01049360|12249049|FG015|COMPLETED|Period 4||6
11067810|NCT01049360|12249050|FG016|COMPLETED|Period 4||5
11346291|NCT02978417|12543461|FG000|NOT COMPLETED|Overall Study||2
11346292|NCT02978417|12543462|FG001|NOT COMPLETED|Overall Study||2
11346293|NCT02978508|12543470|FG000|STARTED|Overall Study||70
11346294|NCT02978508|12543471|FG001|STARTED|Overall Study||70
11346295|NCT02978508|12543470|FG000|COMPLETED|Overall Study||70
11067811|NCT01049360|12249051|FG017|COMPLETED|Period 4||5
11067812|NCT01049360|12249052|FG018|COMPLETED|Period 4||5
11067813|NCT01049360|12249053|FG019|COMPLETED|Period 4||5
11067814|NCT01049360|12249034|FG000|NOT COMPLETED|Period 4||0
11067815|NCT01049360|12249035|FG001|NOT COMPLETED|Period 4||0
11067816|NCT01049360|12249036|FG002|NOT COMPLETED|Period 4||0
11067817|NCT01049360|12249037|FG003|NOT COMPLETED|Period 4||1
11067818|NCT01049360|12249038|FG004|NOT COMPLETED|Period 4||0
11067819|NCT01049360|12249039|FG005|NOT COMPLETED|Period 4||0
11067820|NCT01049360|12249040|FG006|NOT COMPLETED|Period 4||0
11067821|NCT01049360|12249041|FG007|NOT COMPLETED|Period 4||0
11067822|NCT01049360|12249042|FG008|NOT COMPLETED|Period 4||0
11067823|NCT01049360|12249043|FG009|NOT COMPLETED|Period 4||0
11067824|NCT01049360|12249044|FG010|NOT COMPLETED|Period 4||0
11067825|NCT01049360|12249045|FG011|NOT COMPLETED|Period 4||0
11067826|NCT01049360|12249046|FG012|NOT COMPLETED|Period 4||0
11067827|NCT01049360|12249047|FG013|NOT COMPLETED|Period 4||0
11067828|NCT01049360|12249048|FG014|NOT COMPLETED|Period 4||0
11067829|NCT01049360|12249049|FG015|NOT COMPLETED|Period 4||0
11067830|NCT01049360|12249050|FG016|NOT COMPLETED|Period 4||0
11067831|NCT01049360|12249051|FG017|NOT COMPLETED|Period 4||1
11067832|NCT01049360|12249052|FG018|NOT COMPLETED|Period 4||0
11067833|NCT01049360|12249053|FG019|NOT COMPLETED|Period 4||0
11067834|NCT01049373|12249067|FG000|STARTED|Overall Study||112
11067835|NCT01049373|12249068|FG001|STARTED|Overall Study||109
11067836|NCT01049373|12249067|FG000|COMPLETED|Overall Study||73
11067837|NCT01049373|12249068|FG001|COMPLETED|Overall Study||65
11067838|NCT01049373|12249067|FG000|NOT COMPLETED|Overall Study||39
11067839|NCT01049373|12249068|FG001|NOT COMPLETED|Overall Study||44
11067840|NCT01049412|12249078|FG000|STARTED|Period I||70
11067841|NCT01049412|12249079|FG001|STARTED|Period I||68
11067842|NCT01049412|12249078|FG000|Took at Least One Dose of Study Drug|Period I||69
11067843|NCT01049412|12249079|FG001|Took at Least One Dose of Study Drug|Period I||68
11067844|NCT01049412|12249078|FG000|COMPLETED|Period I||62
11067845|NCT01049412|12249079|FG001|COMPLETED|Period I||55
11067846|NCT01049412|12249078|FG000|NOT COMPLETED|Period I||8
11067847|NCT01049412|12249079|FG001|NOT COMPLETED|Period I||13
11067848|NCT01049412|12249078|FG000|STARTED|Period II||62
11067849|NCT01049412|12249079|FG001|STARTED|Period II||55
11067850|NCT01049412|12249078|FG000|COMPLETED|Period II||58
11067851|NCT01049412|12249079|FG001|COMPLETED|Period II||52
11067852|NCT01049412|12249078|FG000|NOT COMPLETED|Period II||4
11067853|NCT01049412|12249079|FG001|NOT COMPLETED|Period II||3
11067854|NCT01049503|12249093|FG000|STARTED|Overall Study||52
11067855|NCT01049503|12249094|FG001|STARTED|Overall Study||48
11067856|NCT01049503|12249095|FG002|STARTED|Overall Study||56
11067857|NCT01049503|12249096|FG003|STARTED|Overall Study||55
11067858|NCT01049503|12249097|FG004|STARTED|Overall Study||56
11067859|NCT01049503|12249098|FG005|STARTED|Overall Study||48
11067860|NCT01049503|12249093|FG000|COMPLETED|Overall Study||41
11067861|NCT01049503|12249094|FG001|COMPLETED|Overall Study||36
11067862|NCT01049503|12249095|FG002|COMPLETED|Overall Study||32
11067863|NCT01049503|12249096|FG003|COMPLETED|Overall Study||29
11067864|NCT01049503|12249097|FG004|COMPLETED|Overall Study||29
11067865|NCT01049503|12249098|FG005|COMPLETED|Overall Study||40
11067866|NCT01049503|12249093|FG000|NOT COMPLETED|Overall Study||11
11067867|NCT01049503|12249094|FG001|NOT COMPLETED|Overall Study||12
11067868|NCT01049503|12249095|FG002|NOT COMPLETED|Overall Study||24
11067869|NCT01049503|12249096|FG003|NOT COMPLETED|Overall Study||26
11346296|NCT02978508|12543471|FG001|COMPLETED|Overall Study||70
11346297|NCT02978508|12543470|FG000|NOT COMPLETED|Overall Study||0
11346298|NCT02978508|12543471|FG001|NOT COMPLETED|Overall Study||0
11346299|NCT02979054|12543479|FG000|STARTED|Overall Study||71
11067870|NCT01049503|12249097|FG004|NOT COMPLETED|Overall Study||27
11067871|NCT01049503|12249098|FG005|NOT COMPLETED|Overall Study||8
11067872|NCT01049581|12249123|FG000|STARTED|Overall Study||13
11067873|NCT01049581|12249124|FG001|STARTED|Overall Study||14
11067874|NCT01049581|12249123|FG000|COMPLETED|Overall Study||11
11067875|NCT01049581|12249124|FG001|COMPLETED|Overall Study||13
11067876|NCT01049581|12249123|FG000|NOT COMPLETED|Overall Study||2
11067877|NCT01049581|12249124|FG001|NOT COMPLETED|Overall Study||1
11067878|NCT01049776|12249133|FG000|STARTED|Overall Study||32
11346300|NCT02979054|12543480|FG001|STARTED|Overall Study||64
11346301|NCT02979054|12543479|FG000|COMPLETED|Overall Study||71
11346302|NCT02979054|12543480|FG001|COMPLETED|Overall Study||64
11346303|NCT02979054|12543479|FG000|NOT COMPLETED|Overall Study||0
11346304|NCT02979054|12543480|FG001|NOT COMPLETED|Overall Study||0
11346305|NCT02979197|12543489|FG000|STARTED|Overall Study||48
11346306|NCT02979197|12543490|FG001|STARTED|Overall Study||49
11346307|NCT02979197|12543491|FG002|STARTED|Overall Study||8
11346308|NCT02979197|12543489|FG000|COMPLETED|Overall Study||44
11346309|NCT02979197|12543490|FG001|COMPLETED|Overall Study||45
11346310|NCT02979197|12543491|FG002|COMPLETED|Overall Study||8
11346311|NCT02979197|12543489|FG000|NOT COMPLETED|Overall Study||4
11346312|NCT02979197|12543490|FG001|NOT COMPLETED|Overall Study||4
11346313|NCT02979197|12543491|FG002|NOT COMPLETED|Overall Study||0
11346314|NCT02979249|12543499|FG000|STARTED|Overall Study||16
11346315|NCT02979249|12543499|FG000|COMPLETED|Overall Study||10
11346316|NCT02979249|12543499|FG000|NOT COMPLETED|Overall Study||6
11346317|NCT02979262|12543505|FG000|STARTED|Overall Study||33
11346318|NCT02979262|12543506|FG001|STARTED|Overall Study||29
11346319|NCT02979262|12543505|FG000|Received Allocated Intervention|Overall Study||30
11346320|NCT02979262|12543506|FG001|Received Allocated Intervention|Overall Study||27
11346321|NCT02979262|12543505|FG000|COMPLETED|Overall Study||21
11346322|NCT02979262|12543506|FG001|COMPLETED|Overall Study||20
11067879|NCT01049776|12249133|FG000|COMPLETED|Overall Study||12
11067880|NCT01049776|12249133|FG000|NOT COMPLETED|Overall Study||20
11067881|NCT01049802|12249139|FG000|STARTED|Overall Study||20
11067882|NCT01049802|12249140|FG001|STARTED|Overall Study||10
11067883|NCT01049802|12249139|FG000|COMPLETED|Overall Study||20
11067884|NCT01049802|12249140|FG001|COMPLETED|Overall Study||10
11067885|NCT01049802|12249139|FG000|NOT COMPLETED|Overall Study||0
11067886|NCT01049802|12249140|FG001|NOT COMPLETED|Overall Study||0
11067887|NCT01049919|12249148|FG000|STARTED|Overall Study||117
11067888|NCT01049919|12249149|FG001|STARTED|Overall Study|One participant is counted in both treatment groups due to one leg being randomized to each group.|36
11067889|NCT01049919|12249148|FG000|COMPLETED|Overall Study||65
11067890|NCT01049919|12249149|FG001|COMPLETED|Overall Study|Incl. 11 participants that received crossover treatment after completing 52 week primary follow up.|19
11067891|NCT01049919|12249148|FG000|NOT COMPLETED|Overall Study||52
11067892|NCT01049919|12249149|FG001|NOT COMPLETED|Overall Study||17
11067893|NCT01049945|12249157|FG000|STARTED|Overall Study||3
11067894|NCT01049945|12249158|FG001|STARTED|Overall Study||6
11067895|NCT01049945|12249159|FG002|STARTED|Overall Study||3
11067896|NCT01049945|12249160|FG003|STARTED|Overall Study||6
11067897|NCT01049945|12249161|FG004|STARTED|Overall Study||3
11067898|NCT01049945|12249162|FG005|STARTED|Overall Study||49
11067899|NCT01049945|12249157|FG000|COMPLETED|Overall Study||3
11067900|NCT01049945|12249158|FG001|COMPLETED|Overall Study||6
11067901|NCT01049945|12249159|FG002|COMPLETED|Overall Study||3
11067902|NCT01049945|12249160|FG003|COMPLETED|Overall Study||6
11067903|NCT01049945|12249161|FG004|COMPLETED|Overall Study||3
11067904|NCT01049945|12249162|FG005|COMPLETED|Overall Study||49
11067905|NCT01049945|12249157|FG000|NOT COMPLETED|Overall Study||0
11067906|NCT01049945|12249158|FG001|NOT COMPLETED|Overall Study||0
11067907|NCT01049945|12249159|FG002|NOT COMPLETED|Overall Study||0
11067908|NCT01049945|12249160|FG003|NOT COMPLETED|Overall Study||0
11067909|NCT01049945|12249161|FG004|NOT COMPLETED|Overall Study||0
11067910|NCT01049945|12249162|FG005|NOT COMPLETED|Overall Study||0
11067911|NCT01049984|12249178|FG000|STARTED|Overall Study||163
11067912|NCT01049984|12249179|FG001|STARTED|Overall Study||165
11067913|NCT01049984|12249178|FG000|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
11067914|NCT01049984|12249179|FG001|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
11067915|NCT01049984|12249178|FG000|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
11067916|NCT01049984|12249179|FG001|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
11067917|NCT01049984|12249178|FG000|COMPLETED|Overall Study||144
11067918|NCT01049984|12249179|FG001|COMPLETED|Overall Study||146
11067919|NCT01049984|12249178|FG000|NOT COMPLETED|Overall Study||19
11067920|NCT01049984|12249179|FG001|NOT COMPLETED|Overall Study||19
11067921|NCT01050062|12249187|FG000|STARTED|Overall Study||1070
11067922|NCT01050062|12249188|FG001|STARTED|Overall Study||355
11067923|NCT01050062|12249187|FG000|COMPLETED|Overall Study||799
11067924|NCT01050062|12249188|FG001|COMPLETED|Overall Study||243
11067925|NCT01050062|12249187|FG000|NOT COMPLETED|Overall Study||271
11067926|NCT01050062|12249188|FG001|NOT COMPLETED|Overall Study||112
11067927|NCT01050153|12249198|FG000|STARTED|Overall Study||25
11067928|NCT01050153|12249199|FG001|STARTED|Overall Study||25
11067929|NCT01050153|12249198|FG000|COMPLETED|Overall Study||25
11067930|NCT01050153|12249199|FG001|COMPLETED|Overall Study||25
11067931|NCT01050153|12249198|FG000|NOT COMPLETED|Overall Study||0
11067932|NCT01050153|12249199|FG001|NOT COMPLETED|Overall Study||0
11067933|NCT01050205|12249207|FG000|STARTED|Overall Study||148
11067934|NCT01050205|12249208|FG001|STARTED|Overall Study||75
11067935|NCT01050205|12249207|FG000|COMPLETED|Overall Study||137
11067936|NCT01050205|12249208|FG001|COMPLETED|Overall Study||71
11067937|NCT01050205|12249207|FG000|NOT COMPLETED|Overall Study||11
11067938|NCT01050205|12249208|FG001|NOT COMPLETED|Overall Study||4
11067939|NCT01050231|12249216|FG000|STARTED|Overall Study||10
11067940|NCT01050231|12249217|FG001|STARTED|Overall Study||10
11067941|NCT01050231|12249216|FG000|COMPLETED|Overall Study||10
11067942|NCT01050231|12249217|FG001|COMPLETED|Overall Study||10
11067943|NCT01050231|12249216|FG000|NOT COMPLETED|Overall Study||0
11067944|NCT01050231|12249217|FG001|NOT COMPLETED|Overall Study||0
11067945|NCT01050257|12249226|FG000|STARTED|Overall Study||50
11067946|NCT01050257|12249227|FG001|STARTED|Overall Study||53
11067947|NCT01050257|12249228|FG002|STARTED|Overall Study||15
11067948|NCT01050257|12249226|FG000|Received Treatment|Overall Study||49
11067949|NCT01050257|12249227|FG001|Received Treatment|Overall Study||50
11067950|NCT01050257|12249228|FG002|Received Treatment|Overall Study||14
11067951|NCT01050257|12249226|FG000|Safety Population: Actual Dose Received|Overall Study||48
11067952|NCT01050257|12249227|FG001|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
11067953|NCT01050257|12249228|FG002|Safety Population: Actual Dose Received|Overall Study||14
11067954|NCT01050257|12249226|FG000|Intent-to-treat Infected Confirmed|Overall Study||30
11067955|NCT01050257|12249227|FG001|Intent-to-treat Infected Confirmed|Overall Study||32
11067956|NCT01050257|12249228|FG002|Intent-to-treat Infected Confirmed|Overall Study||10
11067957|NCT01050257|12249226|FG000|Switched to Oral Treatment|Overall Study||28
11067958|NCT01050257|12249227|FG001|Switched to Oral Treatment|Overall Study||31
11067959|NCT01050257|12249228|FG002|Switched to Oral Treatment|Overall Study||3
11067960|NCT01050257|12249226|FG000|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
11067961|NCT01050257|12249227|FG001|COMPLETED|Overall Study||40
11067962|NCT01050257|12249228|FG002|COMPLETED|Overall Study||8
11067963|NCT01050257|12249226|FG000|NOT COMPLETED|Overall Study||11
11067964|NCT01050257|12249227|FG001|NOT COMPLETED|Overall Study||13
11067965|NCT01050257|12249228|FG002|NOT COMPLETED|Overall Study||7
11067966|NCT01050530|12249238|FG000|STARTED|Overall Study||82
11067967|NCT01050530|12249239|FG001|STARTED|Overall Study||80
11067968|NCT01050530|12249238|FG000|COMPLETED|Overall Study||74
11067969|NCT01050530|12249239|FG001|COMPLETED|Overall Study||70
11067970|NCT01050530|12249238|FG000|NOT COMPLETED|Overall Study||8
11067971|NCT01050530|12249239|FG001|NOT COMPLETED|Overall Study||10
11067972|NCT01050543|12249247|FG000|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
11067973|NCT01050543|12249248|FG001|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
11067974|NCT01050543|12249247|FG000|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
11067975|NCT01050543|12249248|FG001|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
11067976|NCT01050543|12249247|FG000|NOT COMPLETED|Overall Study||4
11067977|NCT01050543|12249248|FG001|NOT COMPLETED|Overall Study||4
11067978|NCT01050569|12249257|FG000|STARTED|Overall Study||79
11067979|NCT01050569|12249258|FG001|STARTED|Overall Study||76
11067980|NCT01050569|12249259|FG002|STARTED|Overall Study||80
11067981|NCT01050569|12249257|FG000|COMPLETED|Overall Study||41
11067982|NCT01050569|12249258|FG001|COMPLETED|Overall Study||52
11067983|NCT01050569|12249259|FG002|COMPLETED|Overall Study||47
11067984|NCT01050569|12249257|FG000|NOT COMPLETED|Overall Study||38
11067985|NCT01050569|12249258|FG001|NOT COMPLETED|Overall Study||24
11067986|NCT01050569|12249259|FG002|NOT COMPLETED|Overall Study||33
11067987|NCT01050582|12249273|FG000|STARTED|Overall Study||133
11067988|NCT01050582|12249274|FG001|STARTED|Overall Study||51
11067989|NCT01050582|12249273|FG000|COMPLETED|Overall Study||133
11067990|NCT01050582|12249274|FG001|COMPLETED|Overall Study||51
11067991|NCT01050582|12249273|FG000|NOT COMPLETED|Overall Study||0
11067992|NCT01050582|12249274|FG001|NOT COMPLETED|Overall Study||0
11067993|NCT01050634|12249280|FG000|STARTED|Overall Study||980
11067994|NCT01050634|12249280|FG000|Received Treatment|Overall Study||924
11067995|NCT01050634|12249280|FG000|COMPLETED|Overall Study||852
11067996|NCT01050634|12249280|FG000|NOT COMPLETED|Overall Study||128
11067997|NCT01050647|12249286|FG000|STARTED|Overall Study||10
11067998|NCT01050647|12249287|FG001|STARTED|Overall Study||11
11067999|NCT01050647|12249286|FG000|COMPLETED|Overall Study||10
11068000|NCT01050647|12249287|FG001|COMPLETED|Overall Study||11
11068001|NCT01050647|12249286|FG000|NOT COMPLETED|Overall Study||0
11068002|NCT01050647|12249287|FG001|NOT COMPLETED|Overall Study||0
11068003|NCT01050660|12249295|FG000|STARTED|Overall Study||67
11068004|NCT01050660|12249296|FG001|STARTED|Overall Study||69
11068005|NCT01050660|12249295|FG000|COMPLETED|Overall Study||67
11068006|NCT01050660|12249296|FG001|COMPLETED|Overall Study||69
11068007|NCT01050660|12249295|FG000|NOT COMPLETED|Overall Study||0
11068008|NCT01050660|12249296|FG001|NOT COMPLETED|Overall Study||0
11068009|NCT01050673|12249304|FG000|STARTED|Overall Study||21
11068010|NCT01050673|12249305|FG001|STARTED|Overall Study||19
11068011|NCT01050673|12249304|FG000|COMPLETED|Overall Study||17
11068012|NCT01050673|12249305|FG001|COMPLETED|Overall Study||14
11068013|NCT01050673|12249304|FG000|NOT COMPLETED|Overall Study||4
11068014|NCT01050673|12249305|FG001|NOT COMPLETED|Overall Study||5
11068015|NCT01050764|12249311|FG000|STARTED|Overall Study||10
11068016|NCT01050764|12249311|FG000|Received HSCT Graft|Overall Study||8
11068017|NCT01050764|12249311|FG000|Received Infusion of T-reg Cells|Overall Study||7
11068018|NCT01050764|12249311|FG000|Received Infusion of T-con Cells|Overall Study||7
11068019|NCT01050764|12249311|FG000|COMPLETED|Overall Study||7
11068020|NCT01050764|12249311|FG000|NOT COMPLETED|Overall Study||3
11068021|NCT01050790|12249315|FG000|STARTED|Overall Study||17
11068022|NCT01050790|12249315|FG000|COMPLETED|Overall Study||16
11068023|NCT01050790|12249315|FG000|NOT COMPLETED|Overall Study||1
11068024|NCT01050816|12249320|FG000|STARTED|Overall Study||30
11068025|NCT01050816|12249320|FG000|COMPLETED|Overall Study||26
11068026|NCT01050816|12249320|FG000|NOT COMPLETED|Overall Study||4
11068027|NCT01050907|12249324|FG000|STARTED|Overall Study||4
11068028|NCT01050907|12249324|FG000|COMPLETED|Overall Study||4
11068029|NCT01050907|12249324|FG000|NOT COMPLETED|Overall Study||0
11068030|NCT01050946|12249328|FG000|STARTED|Overall Study||1
11068031|NCT01050946|12249328|FG000|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
11068032|NCT01050946|12249328|FG000|NOT COMPLETED|Overall Study||0
11068033|NCT01050998|12249338|FG000|STARTED|Overall Study||48
11068034|NCT01050998|12249339|FG001|STARTED|Overall Study||49
11068035|NCT01050998|12249340|FG002|STARTED|Overall Study||49
11068036|NCT01050998|12249341|FG003|STARTED|Overall Study||48
11068037|NCT01050998|12249342|FG004|STARTED|Overall Study||96
11068038|NCT01050998|12249338|FG000|COMPLETED|Overall Study||44
11068039|NCT01050998|12249339|FG001|COMPLETED|Overall Study||47
11068040|NCT01050998|12249340|FG002|COMPLETED|Overall Study||46
11068041|NCT01050998|12249341|FG003|COMPLETED|Overall Study||45
11068042|NCT01050998|12249342|FG004|COMPLETED|Overall Study||82
11068043|NCT01050998|12249338|FG000|NOT COMPLETED|Overall Study||4
11068044|NCT01050998|12249339|FG001|NOT COMPLETED|Overall Study||2
11068045|NCT01050998|12249340|FG002|NOT COMPLETED|Overall Study||3
11206158|NCT01865487|12397069|FG008|NOT COMPLETED|Overall Study||0
11346323|NCT02979262|12543505|FG000|NOT COMPLETED|Overall Study||12
11346324|NCT02979262|12543506|FG001|NOT COMPLETED|Overall Study||9
11346325|NCT02979301|12543514|FG000|STARTED|Overall Study||11
11068046|NCT01050998|12249341|FG003|NOT COMPLETED|Overall Study||3
11068047|NCT01050998|12249342|FG004|NOT COMPLETED|Overall Study||14
11068048|NCT01051063|12249360|FG000|STARTED|Overall Study||12
11068049|NCT01051063|12249361|FG001|STARTED|Overall Study||5
11068050|NCT01051063|12249360|FG000|COMPLETED|Overall Study||2
11068051|NCT01051063|12249361|FG001|COMPLETED|Overall Study||1
11068052|NCT01051063|12249360|FG000|NOT COMPLETED|Overall Study||10
11068053|NCT01051063|12249361|FG001|NOT COMPLETED|Overall Study||4
11068054|NCT01051310|12249368|FG000|STARTED|Overall Study||18
11068055|NCT01051310|12249368|FG000|COMPLETED|Overall Study||13
11068056|NCT01051310|12249368|FG000|NOT COMPLETED|Overall Study||5
11068057|NCT01051323|12249374|FG000|STARTED|Overall Study||1580
11068058|NCT01051323|12249374|FG000|Received at Least One Dose|Overall Study||1547
11068059|NCT01051323|12249374|FG000|COMPLETED|Overall Study||1041
11068060|NCT01051323|12249374|FG000|NOT COMPLETED|Overall Study||539
11068061|NCT01051349|12249382|FG000|STARTED|Overall Study||410
11068062|NCT01051349|12249382|FG000|COMPLETED|Overall Study||237
11068063|NCT01051349|12249382|FG000|NOT COMPLETED|Overall Study||173
11346326|NCT02979301|12543515|FG001|STARTED|Overall Study||11
11346327|NCT02979301|12543514|FG000|COMPLETED|Overall Study||10
11346328|NCT02979301|12543515|FG001|COMPLETED|Overall Study||11
11346329|NCT02979301|12543514|FG000|NOT COMPLETED|Overall Study||1
11346330|NCT02979301|12543515|FG001|NOT COMPLETED|Overall Study||0
11346331|NCT02979431|12543525|FG000|STARTED|Overall Study||44
11346332|NCT02979431|12543526|FG001|STARTED|Overall Study||46
11346333|NCT02979431|12543527|FG002|STARTED|Overall Study||45
11068064|NCT01051440|12249391|FG000|STARTED|Overall Study||1
11068065|NCT01051440|12249392|FG001|STARTED|Overall Study||1
11068066|NCT01051440|12249391|FG000|COMPLETED|Overall Study||1
11068067|NCT01051440|12249392|FG001|COMPLETED|Overall Study||1
11068068|NCT01051440|12249391|FG000|NOT COMPLETED|Overall Study||0
11068069|NCT01051440|12249392|FG001|NOT COMPLETED|Overall Study||0
11068070|NCT01051466|12249400|FG000|STARTED|Overall Study||32
11068071|NCT01051466|12249401|FG001|STARTED|Overall Study||28
11068072|NCT01051466|12249400|FG000|COMPLETED|Overall Study||24
11068073|NCT01051466|12249401|FG001|COMPLETED|Overall Study||23
11206159|NCT01865487|12397070|FG009|NOT COMPLETED|Overall Study||0
11206160|NCT01865552|12397104|FG000|STARTED|Period 1||23
11206161|NCT01865552|12397105|FG001|STARTED|Period 1||23
11206162|NCT01865552|12397106|FG002|STARTED|Period 1||23
11206163|NCT01865552|12397107|FG003|STARTED|Period 1||23
11068074|NCT01051466|12249400|FG000|NOT COMPLETED|Overall Study||8
11068075|NCT01051466|12249401|FG001|NOT COMPLETED|Overall Study||5
11068076|NCT01051518|12249411|FG000|STARTED|Overall Study||126
11068077|NCT01051518|12249411|FG000|COMPLETED|Overall Study||53
11068078|NCT01051518|12249411|FG000|NOT COMPLETED|Overall Study||73
11068079|NCT01051557|12249427|FG000|STARTED|Overall Study||4
11068080|NCT01051557|12249428|FG001|STARTED|Overall Study||3
11068081|NCT01051557|12249429|FG002|STARTED|Overall Study||6
11068082|NCT01051557|12249430|FG003|STARTED|Overall Study||3
11068083|NCT01051557|12249431|FG004|STARTED|Overall Study||8
11068084|NCT01051557|12249432|FG005|STARTED|Overall Study||6
11068085|NCT01051557|12249433|FG006|STARTED|Overall Study||6
11068086|NCT01051557|12249427|FG000|COMPLETED|Overall Study||0
11068087|NCT01051557|12249428|FG001|COMPLETED|Overall Study||0
11068088|NCT01051557|12249429|FG002|COMPLETED|Overall Study||0
11068089|NCT01051557|12249430|FG003|COMPLETED|Overall Study||0
11068090|NCT01051557|12249431|FG004|COMPLETED|Overall Study||1
11068091|NCT01051557|12249432|FG005|COMPLETED|Overall Study||0
11068092|NCT01051557|12249433|FG006|COMPLETED|Overall Study||0
11346334|NCT02979431|12543528|FG003|STARTED|Overall Study||45
11346335|NCT02979431|12543525|FG000|Included in the mITT Population|Overall Study||42
11346336|NCT02979431|12543526|FG001|Included in the mITT Population|Overall Study||45
11068093|NCT01051557|12249427|FG000|NOT COMPLETED|Overall Study||4
11068094|NCT01051557|12249428|FG001|NOT COMPLETED|Overall Study||3
11068095|NCT01051557|12249429|FG002|NOT COMPLETED|Overall Study||6
11068096|NCT01051557|12249430|FG003|NOT COMPLETED|Overall Study||3
11206164|NCT01865552|12397108|FG004|STARTED|Period 1||23
11206165|NCT01865552|12397109|FG005|STARTED|Period 1||23
11206166|NCT01865552|12397104|FG000|Discontinued From Period 1|Period 1||1
11206167|NCT01865552|12397105|FG001|Discontinued From Period 1|Period 1||0
11206168|NCT01865552|12397106|FG002|Discontinued From Period 1|Period 1||0
11206169|NCT01865552|12397107|FG003|Discontinued From Period 1|Period 1||1
11206170|NCT01865552|12397108|FG004|Discontinued From Period 1|Period 1||3
11206171|NCT01865552|12397109|FG005|Discontinued From Period 1|Period 1||1
11206172|NCT01865552|12397104|FG000|COMPLETED|Period 1||22
11206173|NCT01865552|12397105|FG001|COMPLETED|Period 1||23
11206174|NCT01865552|12397106|FG002|COMPLETED|Period 1||23
11346337|NCT02979431|12543527|FG002|Included in the mITT Population|Overall Study||43
11346338|NCT02979431|12543528|FG003|Included in the mITT Population|Overall Study||45
11346339|NCT02979431|12543525|FG000|Included in the Safety Population|Overall Study||40
11346340|NCT02979431|12543526|FG001|Included in the Safety Population|Overall Study||45
11346341|NCT02979431|12543527|FG002|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44
11346342|NCT02979431|12543528|FG003|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46
11346343|NCT02979431|12543525|FG000|COMPLETED|Overall Study||40
11346344|NCT02979431|12543526|FG001|COMPLETED|Overall Study||44
11346345|NCT02979431|12543527|FG002|COMPLETED|Overall Study||43
11346346|NCT02979431|12543528|FG003|COMPLETED|Overall Study||44
11346347|NCT02979431|12543525|FG000|NOT COMPLETED|Overall Study||4
11346348|NCT02979431|12543526|FG001|NOT COMPLETED|Overall Study||2
11346349|NCT02979431|12543527|FG002|NOT COMPLETED|Overall Study||2
11346350|NCT02979431|12543528|FG003|NOT COMPLETED|Overall Study||1
11346351|NCT02979444|12543541|FG000|STARTED|Overall Study||405
11346352|NCT02979444|12543542|FG001|STARTED|Overall Study||310
11068097|NCT01051557|12249431|FG004|NOT COMPLETED|Overall Study||7
11068098|NCT01051557|12249432|FG005|NOT COMPLETED|Overall Study||6
11068099|NCT01051557|12249433|FG006|NOT COMPLETED|Overall Study||6
11346353|NCT02979444|12543543|FG002|STARTED|Overall Study||159
11346354|NCT02979444|12543541|FG000|COMPLETED|Overall Study||382
11346355|NCT02979444|12543542|FG001|COMPLETED|Overall Study||293
11346356|NCT02979444|12543543|FG002|COMPLETED|Overall Study||149
11346357|NCT02979444|12543541|FG000|NOT COMPLETED|Overall Study||23
11346358|NCT02979444|12543542|FG001|NOT COMPLETED|Overall Study||17
11346359|NCT02979444|12543543|FG002|NOT COMPLETED|Overall Study||10
11346360|NCT02979613|12543553|FG000|STARTED|Double-Blind Phase||245
11346361|NCT02979613|12543554|FG001|STARTED|Double-Blind Phase||245
11346362|NCT02979613|12543553|FG000|COMPLETED|Double-Blind Phase||235
11346363|NCT02979613|12543554|FG001|COMPLETED|Double-Blind Phase||237
11346364|NCT02979613|12543553|FG000|NOT COMPLETED|Double-Blind Phase||10
11346365|NCT02979613|12543554|FG001|NOT COMPLETED|Double-Blind Phase||8
11346366|NCT02979613|12543553|FG000|STARTED|Open-Label Extension (OLE) Phase||235
11346367|NCT02979613|12543554|FG001|STARTED|Open-Label Extension (OLE) Phase||237
11346368|NCT02979613|12543553|FG000|COMPLETED|Open-Label Extension (OLE) Phase||232
11346369|NCT02979613|12543554|FG001|COMPLETED|Open-Label Extension (OLE) Phase||231
11346370|NCT02979613|12543553|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||3
11346371|NCT02979613|12543554|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||6
11346372|NCT02979626|12543564|FG000|STARTED|Overall Study||313
11346373|NCT02979626|12543565|FG001|STARTED|Overall Study||98
11346374|NCT02979626|12543564|FG000|COMPLETED|Overall Study||313
11346375|NCT02979626|12543565|FG001|COMPLETED|Overall Study||98
11346376|NCT02979626|12543564|FG000|NOT COMPLETED|Overall Study||0
11346377|NCT02979626|12543565|FG001|NOT COMPLETED|Overall Study||0
11346378|NCT02979639|12543571|FG000|STARTED|Overall Study||401
11068100|NCT01051570|12249450|FG000|STARTED|Overall Study||26
11068101|NCT01051570|12249450|FG000|COMPLETED|Overall Study||26
11346379|NCT02979639|12543571|FG000|COMPLETED|Overall Study||387
11346380|NCT02979639|12543571|FG000|NOT COMPLETED|Overall Study||14
11346381|NCT02979899|12543577|FG000|STARTED|Overall Study||64
11346382|NCT02979899|12543578|FG001|STARTED|Overall Study||64
11346383|NCT02979899|12543577|FG000|COMPLETED|Overall Study||64
11068102|NCT01051570|12249450|FG000|NOT COMPLETED|Overall Study||0
11068103|NCT01051596|12249454|FG000|STARTED|Overall Study||75
11068104|NCT01051596|12249454|FG000|COMPLETED|Overall Study||75
11068105|NCT01051596|12249454|FG000|NOT COMPLETED|Overall Study||0
11068106|NCT01051661|12249464|FG000|STARTED|Overall Study||610
11068107|NCT01051661|12249465|FG001|STARTED|Overall Study||1438
11068108|NCT01051661|12249466|FG002|STARTED|Overall Study||612
11068109|NCT01051661|12249467|FG003|STARTED|Overall Study||1436
11068110|NCT01051661|12249468|FG004|STARTED|Overall Study||613
11068111|NCT01051661|12249469|FG005|STARTED|Overall Study||1436
11068112|NCT01051661|12249464|FG000|COMPLETED|Overall Study||576
11068113|NCT01051661|12249465|FG001|COMPLETED|Overall Study||1375
11068114|NCT01051661|12249466|FG002|COMPLETED|Overall Study||573
11068115|NCT01051661|12249467|FG003|COMPLETED|Overall Study||1380
11068116|NCT01051661|12249468|FG004|COMPLETED|Overall Study||578
11068117|NCT01051661|12249469|FG005|COMPLETED|Overall Study||1369
11068118|NCT01051661|12249464|FG000|NOT COMPLETED|Overall Study||34
11068119|NCT01051661|12249465|FG001|NOT COMPLETED|Overall Study||63
11068120|NCT01051661|12249466|FG002|NOT COMPLETED|Overall Study||39
11068121|NCT01051661|12249467|FG003|NOT COMPLETED|Overall Study||56
11068122|NCT01051661|12249468|FG004|NOT COMPLETED|Overall Study||35
11068123|NCT01051661|12249469|FG005|NOT COMPLETED|Overall Study||67
11068124|NCT01051739|12249506|FG000|STARTED|Overall Study||120
11068125|NCT01051739|12249507|FG001|STARTED|Overall Study||60
11068126|NCT01051739|12249506|FG000|COMPLETED|Overall Study||92
11068127|NCT01051739|12249507|FG001|COMPLETED|Overall Study||47
11068128|NCT01051739|12249506|FG000|NOT COMPLETED|Overall Study||28
11068129|NCT01051739|12249507|FG001|NOT COMPLETED|Overall Study||13
11068130|NCT01051778|12249515|FG000|STARTED|Overall Study|June 2006|30
11068131|NCT01051778|12249516|FG001|STARTED|Overall Study|June 2006|30
11068132|NCT01051778|12249515|FG000|COMPLETED|Overall Study|November 2009|30
11068133|NCT01051778|12249516|FG001|COMPLETED|Overall Study|November 2009|30
11068134|NCT01051778|12249515|FG000|NOT COMPLETED|Overall Study||0
11068135|NCT01051778|12249516|FG001|NOT COMPLETED|Overall Study||0
11068136|NCT01051791|12249522|FG000|STARTED|Overall Study||13
11068137|NCT01051791|12249522|FG000|COMPLETED|Overall Study||9
11068138|NCT01051791|12249522|FG000|NOT COMPLETED|Overall Study||4
11068139|NCT01051817|12249529|FG000|STARTED|Overall Study||38
11068140|NCT01051817|12249530|FG001|STARTED|Overall Study||35
11068141|NCT01051817|12249529|FG000|COMPLETED|Overall Study||35
11068142|NCT01051817|12249530|FG001|COMPLETED|Overall Study||26
11068143|NCT01051817|12249529|FG000|NOT COMPLETED|Overall Study||3
11068144|NCT01051817|12249530|FG001|NOT COMPLETED|Overall Study||9
11068145|NCT01051856|12249538|FG000|STARTED|Overall Study||33
11068146|NCT01051856|12249539|FG001|STARTED|Overall Study||35
11346384|NCT02979899|12543578|FG001|COMPLETED|Overall Study||64
11346385|NCT02979899|12543577|FG000|NOT COMPLETED|Overall Study||0
11346386|NCT02979899|12543578|FG001|NOT COMPLETED|Overall Study||0
11346387|NCT02979925|12543586|FG000|STARTED|Overall Study||28
11346388|NCT02979925|12543587|FG001|STARTED|Overall Study||29
11346389|NCT02979925|12543586|FG000|COMPLETED|Overall Study||28
11346390|NCT02979925|12543587|FG001|COMPLETED|Overall Study||23
11346391|NCT02979925|12543586|FG000|NOT COMPLETED|Overall Study||0
11346392|NCT02979925|12543587|FG001|NOT COMPLETED|Overall Study||6
11346393|NCT02980042|12543595|FG000|STARTED|Overall Study||100
11346394|NCT02980042|12543596|FG001|STARTED|Overall Study||100
11346395|NCT02980042|12543595|FG000|COMPLETED|Overall Study|All 100 subjects completed their Week 24 infusion. 7 subjects did not complete the 12 month visit.|93
11346396|NCT02980042|12543596|FG001|COMPLETED|Overall Study||100
11346397|NCT02980042|12543595|FG000|NOT COMPLETED|Overall Study||7
11346398|NCT02980042|12543596|FG001|NOT COMPLETED|Overall Study||0
11346399|NCT02980107|12543616|FG000|STARTED|Overall Study||105
11346400|NCT02980107|12543617|FG001|STARTED|Overall Study||107
11346401|NCT02980107|12543616|FG000|COMPLETED|Overall Study||54
11346402|NCT02980107|12543617|FG001|COMPLETED|Overall Study||45
11346403|NCT02980107|12543616|FG000|NOT COMPLETED|Overall Study||51
11346404|NCT02980107|12543617|FG001|NOT COMPLETED|Overall Study||62
11346405|NCT02980133|12543627|FG000|STARTED|Overall Study||209
11346406|NCT02980133|12543628|FG001|STARTED|Overall Study||211
11346407|NCT02980133|12543629|FG002|STARTED|Overall Study||210
11346408|NCT02980133|12543630|FG003|STARTED|Overall Study||211
11346409|NCT02980133|12543627|FG000|Received at Least 1 Dose of Study Drug|Overall Study||209
11346410|NCT02980133|12543628|FG001|Received at Least 1 Dose of Study Drug|Overall Study||211
11346411|NCT02980133|12543629|FG002|Received at Least 1 Dose of Study Drug|Overall Study||208
11346412|NCT02980133|12543630|FG003|Received at Least 1 Dose of Study Drug|Overall Study||211
11346413|NCT02980133|12543627|FG000|COMPLETED|Overall Study||202
11346414|NCT02980133|12543628|FG001|COMPLETED|Overall Study||206
11346415|NCT02980133|12543629|FG002|COMPLETED|Overall Study||203
11346416|NCT02980133|12543630|FG003|COMPLETED|Overall Study||205
11346417|NCT02980133|12543627|FG000|NOT COMPLETED|Overall Study||7
11346418|NCT02980133|12543628|FG001|NOT COMPLETED|Overall Study||5
11346419|NCT02980133|12543629|FG002|NOT COMPLETED|Overall Study||7
11068147|NCT01051856|12249538|FG000|COMPLETED|Overall Study||32
11068148|NCT01051856|12249539|FG001|COMPLETED|Overall Study||35
11068149|NCT01051856|12249538|FG000|NOT COMPLETED|Overall Study||1
11068150|NCT01051856|12249539|FG001|NOT COMPLETED|Overall Study||0
11068151|NCT01051960|12249545|FG000|STARTED|Overall Study||12
11068152|NCT01051960|12249545|FG000|COMPLETED|Overall Study||11
11068153|NCT01051960|12249545|FG000|NOT COMPLETED|Overall Study||1
11068154|NCT01051986|12249551|FG000|STARTED|Overall Study||112
11068155|NCT01051986|12249552|FG001|STARTED|Overall Study||112
11068156|NCT01051986|12249551|FG000|COMPLETED|Overall Study||107
11068157|NCT01051986|12249552|FG001|COMPLETED|Overall Study||108
11068158|NCT01051986|12249551|FG000|NOT COMPLETED|Overall Study||5
11068159|NCT01051986|12249552|FG001|NOT COMPLETED|Overall Study||4
11068160|NCT01052012|12249564|FG000|STARTED|Overall Study||32
11068161|NCT01052012|12249565|FG001|STARTED|Overall Study||23
11068162|NCT01052012|12249566|FG002|STARTED|Overall Study||30
11068163|NCT01052012|12249567|FG003|STARTED|Overall Study||20
11068164|NCT01052012|12249568|FG004|STARTED|Overall Study||140
11068165|NCT01052012|12249569|FG005|STARTED|Overall Study||86
11068166|NCT01052012|12249564|FG000|COMPLETED|Overall Study||28
11068167|NCT01052012|12249565|FG001|COMPLETED|Overall Study||17
11068168|NCT01052012|12249566|FG002|COMPLETED|Overall Study||30
11068169|NCT01052012|12249567|FG003|COMPLETED|Overall Study||19
11068170|NCT01052012|12249568|FG004|COMPLETED|Overall Study||124
11068171|NCT01052012|12249569|FG005|COMPLETED|Overall Study||76
11068172|NCT01052012|12249564|FG000|NOT COMPLETED|Overall Study||4
11068173|NCT01052012|12249565|FG001|NOT COMPLETED|Overall Study||6
11068174|NCT01052012|12249566|FG002|NOT COMPLETED|Overall Study||0
11068175|NCT01052012|12249567|FG003|NOT COMPLETED|Overall Study||1
11068176|NCT01052012|12249568|FG004|NOT COMPLETED|Overall Study||16
11068177|NCT01052012|12249569|FG005|NOT COMPLETED|Overall Study||10
11068178|NCT01052038|12249586|FG000|STARTED|Overall Study||40
11068179|NCT01052038|12249587|FG001|STARTED|Overall Study||40
11068180|NCT01052038|12249588|FG002|STARTED|Overall Study||40
11068181|NCT01052038|12249586|FG000|COMPLETED|Overall Study||36
11068182|NCT01052038|12249587|FG001|COMPLETED|Overall Study||34
11068183|NCT01052038|12249588|FG002|COMPLETED|Overall Study||36
11068184|NCT01052038|12249586|FG000|NOT COMPLETED|Overall Study||4
11068185|NCT01052038|12249587|FG001|NOT COMPLETED|Overall Study||6
11068186|NCT01052038|12249588|FG002|NOT COMPLETED|Overall Study||4
11068187|NCT01052077|12249598|FG000|STARTED|Phase A||769
11068188|NCT01052077|12249599|FG001|STARTED|Phase A||0
11068189|NCT01052077|12249600|FG002|STARTED|Phase A||0
11068190|NCT01052077|12249601|FG003|STARTED|Phase A||0
11068191|NCT01052077|12249598|FG000|COMPLETED|Phase A||623
11068192|NCT01052077|12249599|FG001|COMPLETED|Phase A||0
11068193|NCT01052077|12249600|FG002|COMPLETED|Phase A||0
11068194|NCT01052077|12249601|FG003|COMPLETED|Phase A||0
11068195|NCT01052077|12249598|FG000|NOT COMPLETED|Phase A||146
11068196|NCT01052077|12249599|FG001|NOT COMPLETED|Phase A||0
11068197|NCT01052077|12249600|FG002|NOT COMPLETED|Phase A||0
11068198|NCT01052077|12249601|FG003|NOT COMPLETED|Phase A||0
11068199|NCT01052077|12249598|FG000|STARTED|Phase B||0
11068200|NCT01052077|12249599|FG001|STARTED|Phase B||185
11068201|NCT01052077|12249600|FG002|STARTED|Phase B||187
11068202|NCT01052077|12249601|FG003|STARTED|Phase B||0
11068203|NCT01052077|12249598|FG000|COMPLETED|Phase B||0
11068204|NCT01052077|12249599|FG001|COMPLETED|Phase B||167
11068205|NCT01052077|12249600|FG002|COMPLETED|Phase B||171
11068206|NCT01052077|12249601|FG003|COMPLETED|Phase B||0
11068207|NCT01052077|12249598|FG000|NOT COMPLETED|Phase B||0
11068208|NCT01052077|12249599|FG001|NOT COMPLETED|Phase B||18
11068209|NCT01052077|12249600|FG002|NOT COMPLETED|Phase B||16
11068210|NCT01052077|12249601|FG003|NOT COMPLETED|Phase B||0
11068211|NCT01052077|12249598|FG000|STARTED|Phase A+||0
11068212|NCT01052077|12249599|FG001|STARTED|Phase A+||0
11068213|NCT01052077|12249600|FG002|STARTED|Phase A+||0
11068214|NCT01052077|12249601|FG003|STARTED|Phase A+||251
11068215|NCT01052077|12249598|FG000|COMPLETED|Phase A+||0
11068216|NCT01052077|12249599|FG001|COMPLETED|Phase A+||0
11068217|NCT01052077|12249600|FG002|COMPLETED|Phase A+||0
11068218|NCT01052077|12249601|FG003|COMPLETED|Phase A+||230
11068219|NCT01052077|12249598|FG000|NOT COMPLETED|Phase A+||0
11068220|NCT01052077|12249599|FG001|NOT COMPLETED|Phase A+||0
11068221|NCT01052077|12249600|FG002|NOT COMPLETED|Phase A+||0
11068222|NCT01052077|12249601|FG003|NOT COMPLETED|Phase A+||21
11068223|NCT01052116|12249609|FG000|STARTED|Overall Study||193
11068224|NCT01052116|12249610|FG001|STARTED|Overall Study||193
11068225|NCT01052116|12249609|FG000|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
11068226|NCT01052116|12249610|FG001|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
11068227|NCT01052116|12249609|FG000|NOT COMPLETED|Overall Study||14
11068228|NCT01052116|12249610|FG001|NOT COMPLETED|Overall Study||27
11068229|NCT01052207|12249618|FG000|STARTED|Overall Study||60
11068230|NCT01052207|12249619|FG001|STARTED|Overall Study||42
11068231|NCT01052207|12249618|FG000|COMPLETED|Overall Study||60
11068232|NCT01052207|12249619|FG001|COMPLETED|Overall Study||42
11068233|NCT01052207|12249618|FG000|NOT COMPLETED|Overall Study||0
11068234|NCT01052207|12249619|FG001|NOT COMPLETED|Overall Study||0
11068235|NCT01052272|12249629|FG000|STARTED|Overall Study||18
11068236|NCT01052272|12249630|FG001|STARTED|Overall Study||18
11068237|NCT01052272|12249631|FG002|STARTED|Overall Study||18
11068238|NCT01052272|12249632|FG003|STARTED|Overall Study||18
11068239|NCT01052272|12249629|FG000|COMPLETED|Overall Study||13
11068240|NCT01052272|12249630|FG001|COMPLETED|Overall Study||11
11068241|NCT01052272|12249631|FG002|COMPLETED|Overall Study||10
11068242|NCT01052272|12249632|FG003|COMPLETED|Overall Study||11
11068243|NCT01052272|12249629|FG000|NOT COMPLETED|Overall Study||5
11068244|NCT01052272|12249630|FG001|NOT COMPLETED|Overall Study||7
11068245|NCT01052272|12249631|FG002|NOT COMPLETED|Overall Study||8
11068246|NCT01052272|12249632|FG003|NOT COMPLETED|Overall Study||7
11068247|NCT01052428|12249644|FG000|STARTED|Overall Study||19
11068248|NCT01052428|12249645|FG001|STARTED|Overall Study||19
11068249|NCT01052428|12249644|FG000|COMPLETED|Overall Study||18
11068250|NCT01052428|12249645|FG001|COMPLETED|Overall Study||18
11068251|NCT01052428|12249644|FG000|NOT COMPLETED|Overall Study||1
11068252|NCT01052428|12249645|FG001|NOT COMPLETED|Overall Study||1
11068253|NCT01052480|12249653|FG000|STARTED|Overall Study||49
11068254|NCT01052480|12249654|FG001|STARTED|Overall Study||49
11068255|NCT01052480|12249653|FG000|COMPLETED|Overall Study||41
11068256|NCT01052480|12249654|FG001|COMPLETED|Overall Study||32
11068257|NCT01052480|12249653|FG000|NOT COMPLETED|Overall Study||8
11068258|NCT01052480|12249654|FG001|NOT COMPLETED|Overall Study||17
11068259|NCT01052493|12249660|FG000|STARTED|Intervention 1 (Up to 10 Days)||4
11068260|NCT01052493|12249661|FG001|STARTED|Intervention 1 (Up to 10 Days)||4
11068261|NCT01052493|12249662|FG002|STARTED|Intervention 1 (Up to 10 Days)||4
11068262|NCT01052493|12249660|FG000|COMPLETED|Intervention 1 (Up to 10 Days)||3
11068263|NCT01052493|12249661|FG001|COMPLETED|Intervention 1 (Up to 10 Days)||4
11068264|NCT01052493|12249662|FG002|COMPLETED|Intervention 1 (Up to 10 Days)||4
11068265|NCT01052493|12249660|FG000|NOT COMPLETED|Intervention 1 (Up to 10 Days)||1
11068266|NCT01052493|12249661|FG001|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
11068267|NCT01052493|12249662|FG002|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
11068268|NCT01052493|12249660|FG000|STARTED|Washout Period 1 (up to 5 Days)||3
11068269|NCT01052493|12249661|FG001|STARTED|Washout Period 1 (up to 5 Days)||4
11068270|NCT01052493|12249662|FG002|STARTED|Washout Period 1 (up to 5 Days)||4
11068271|NCT01052493|12249660|FG000|COMPLETED|Washout Period 1 (up to 5 Days)||3
11068272|NCT01052493|12249661|FG001|COMPLETED|Washout Period 1 (up to 5 Days)||4
11068273|NCT01052493|12249662|FG002|COMPLETED|Washout Period 1 (up to 5 Days)||4
11068274|NCT01052493|12249660|FG000|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
11068275|NCT01052493|12249661|FG001|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
11068276|NCT01052493|12249662|FG002|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
11206175|NCT01865552|12397107|FG003|COMPLETED|Period 1||22
11068277|NCT01052493|12249660|FG000|STARTED|Intervention 2 (up to 10 Days)|Replacement subject recruited|4
11068278|NCT01052493|12249661|FG001|STARTED|Intervention 2 (up to 10 Days)||4
11068279|NCT01052493|12249662|FG002|STARTED|Intervention 2 (up to 10 Days)||4
11068280|NCT01052493|12249660|FG000|COMPLETED|Intervention 2 (up to 10 Days)||4
11068281|NCT01052493|12249661|FG001|COMPLETED|Intervention 2 (up to 10 Days)||4
11068282|NCT01052493|12249662|FG002|COMPLETED|Intervention 2 (up to 10 Days)||4
11068283|NCT01052493|12249660|FG000|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
11068284|NCT01052493|12249661|FG001|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
11068285|NCT01052493|12249662|FG002|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
11068286|NCT01052493|12249660|FG000|STARTED|Washout Period 2 (up to 5 Days)||4
11068287|NCT01052493|12249661|FG001|STARTED|Washout Period 2 (up to 5 Days)||4
11068288|NCT01052493|12249662|FG002|STARTED|Washout Period 2 (up to 5 Days)||4
11068289|NCT01052493|12249660|FG000|COMPLETED|Washout Period 2 (up to 5 Days)||4
11068290|NCT01052493|12249661|FG001|COMPLETED|Washout Period 2 (up to 5 Days)||4
11068291|NCT01052493|12249662|FG002|COMPLETED|Washout Period 2 (up to 5 Days)||4
11068292|NCT01052493|12249660|FG000|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
11068293|NCT01052493|12249661|FG001|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
11068294|NCT01052493|12249662|FG002|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
11068295|NCT01052493|12249660|FG000|STARTED|Intervention 3 (up to 10 Days)||4
11068296|NCT01052493|12249661|FG001|STARTED|Intervention 3 (up to 10 Days)||4
11068297|NCT01052493|12249662|FG002|STARTED|Intervention 3 (up to 10 Days)||4
11068298|NCT01052493|12249660|FG000|COMPLETED|Intervention 3 (up to 10 Days)||4
11068299|NCT01052493|12249661|FG001|COMPLETED|Intervention 3 (up to 10 Days)||4
11068300|NCT01052493|12249662|FG002|COMPLETED|Intervention 3 (up to 10 Days)||4
11068301|NCT01052493|12249660|FG000|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
11068302|NCT01052493|12249661|FG001|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
11068303|NCT01052493|12249662|FG002|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
11068304|NCT01052545|12249677|FG000|STARTED|Overall Study||867
11068305|NCT01052545|12249678|FG001|STARTED|Overall Study||731
11068306|NCT01052545|12249677|FG000|COMPLETED|Overall Study||867
11068307|NCT01052545|12249678|FG001|COMPLETED|Overall Study||731
11068308|NCT01052545|12249677|FG000|NOT COMPLETED|Overall Study||0
11068309|NCT01052545|12249678|FG001|NOT COMPLETED|Overall Study||0
11068310|NCT01052662|12249699|FG000|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
11068311|NCT01052662|12249700|FG001|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
11068312|NCT01052662|12249701|FG002|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
11068313|NCT01052662|12249699|FG000|Stabilization Phase|Overall Study||21
11068314|NCT01052662|12249700|FG001|Stabilization Phase|Overall Study||21
11068315|NCT01052662|12249701|FG002|Stabilization Phase|Overall Study||26
11068316|NCT01052662|12249699|FG000|Discontinuation Phase|Overall Study||6
11068317|NCT01052662|12249700|FG001|Discontinuation Phase|Overall Study||5
11068318|NCT01052662|12249701|FG002|Discontinuation Phase|Overall Study||10
11068319|NCT01052662|12249699|FG000|COMPLETED|Overall Study||6
11068320|NCT01052662|12249700|FG001|COMPLETED|Overall Study||5
11068321|NCT01052662|12249701|FG002|COMPLETED|Overall Study||10
11068322|NCT01052662|12249699|FG000|NOT COMPLETED|Overall Study||22
11068323|NCT01052662|12249700|FG001|NOT COMPLETED|Overall Study||22
11068324|NCT01052662|12249701|FG002|NOT COMPLETED|Overall Study||22
11068325|NCT01052701|12249711|FG000|STARTED|Overall Study||14
11068326|NCT01052701|12249712|FG001|STARTED|Overall Study||12
11068327|NCT01052701|12249711|FG000|COMPLETED|Overall Study||14
11068328|NCT01052701|12249712|FG001|COMPLETED|Overall Study||12
11068329|NCT01052701|12249711|FG000|NOT COMPLETED|Overall Study||0
11068330|NCT01052701|12249712|FG001|NOT COMPLETED|Overall Study||0
11068331|NCT01052714|12249720|FG000|STARTED|Overall Study||42
11068332|NCT01052714|12249721|FG001|STARTED|Overall Study||62
11068333|NCT01052714|12249722|FG002|STARTED|Overall Study||17
11068334|NCT01052714|12249720|FG000|COMPLETED|Overall Study||17
11068335|NCT01052714|12249721|FG001|COMPLETED|Overall Study||33
11068336|NCT01052714|12249722|FG002|COMPLETED|Overall Study||15
11068337|NCT01052714|12249720|FG000|NOT COMPLETED|Overall Study||25
11068338|NCT01052714|12249721|FG001|NOT COMPLETED|Overall Study||29
11068339|NCT01052714|12249722|FG002|NOT COMPLETED|Overall Study||2
11068340|NCT01052779|12249730|FG000|STARTED|Overall Study||80
11068341|NCT01052779|12249731|FG001|STARTED|Overall Study||82
11068342|NCT01052779|12249730|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80
11068343|NCT01052779|12249731|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81
11068344|NCT01052779|12249730|FG000|COMPLETED|Overall Study||75
11068345|NCT01052779|12249731|FG001|COMPLETED|Overall Study||73
11068346|NCT01052779|12249730|FG000|NOT COMPLETED|Overall Study||5
11068347|NCT01052779|12249731|FG001|NOT COMPLETED|Overall Study||9
11068348|NCT01052831|12249739|FG000|STARTED|Overall Study||26
11068349|NCT01052831|12249740|FG001|STARTED|Overall Study||24
11068350|NCT01052831|12249739|FG000|COMPLETED|Overall Study||22
11068351|NCT01052831|12249740|FG001|COMPLETED|Overall Study||23
11068352|NCT01052831|12249739|FG000|NOT COMPLETED|Overall Study||4
11068353|NCT01052831|12249740|FG001|NOT COMPLETED|Overall Study||1
11068354|NCT01052844|12249748|FG000|STARTED|Overall Study||40
11068355|NCT01052844|12249749|FG001|STARTED|Overall Study||40
11068356|NCT01052844|12249748|FG000|COMPLETED|Overall Study||40
11068357|NCT01052844|12249749|FG001|COMPLETED|Overall Study||39
11068358|NCT01052844|12249748|FG000|NOT COMPLETED|Overall Study||0
11068359|NCT01052844|12249749|FG001|NOT COMPLETED|Overall Study||1
11068360|NCT01052948|12249759|FG000|STARTED|Overall Study||27812
11068361|NCT01052948|12249760|FG001|STARTED|Overall Study||14669
11068362|NCT01052948|12249761|FG002|STARTED|Overall Study||15147
11068363|NCT01052948|12249762|FG003|STARTED|Overall Study||29311
11068364|NCT01052948|12249759|FG000|COMPLETED|Overall Study||27812
11068365|NCT01052948|12249760|FG001|COMPLETED|Overall Study||14669
11068366|NCT01052948|12249761|FG002|COMPLETED|Overall Study||15147
11068367|NCT01052948|12249762|FG003|COMPLETED|Overall Study||29311
11068368|NCT01052948|12249759|FG000|NOT COMPLETED|Overall Study||0
11068369|NCT01052948|12249760|FG001|NOT COMPLETED|Overall Study||0
11068370|NCT01052948|12249761|FG002|NOT COMPLETED|Overall Study||0
11068371|NCT01052948|12249762|FG003|NOT COMPLETED|Overall Study||0
11068372|NCT01053000|12249772|FG000|STARTED|Overall Study||5
11068373|NCT01053000|12249773|FG001|STARTED|Overall Study||5
11068374|NCT01053000|12249772|FG000|COMPLETED|Overall Study||5
11068375|NCT01053000|12249773|FG001|COMPLETED|Overall Study||5
11068376|NCT01053000|12249772|FG000|NOT COMPLETED|Overall Study||0
11068377|NCT01053000|12249773|FG001|NOT COMPLETED|Overall Study||0
11068378|NCT01053013|12249781|FG000|STARTED|Overall Study||24
11068379|NCT01053013|12249782|FG001|STARTED|Overall Study||34
11068380|NCT01053013|12249781|FG000|COMPLETED|Overall Study||24
11068381|NCT01053013|12249782|FG001|COMPLETED|Overall Study||34
11068382|NCT01053013|12249781|FG000|NOT COMPLETED|Overall Study||0
11068383|NCT01053013|12249782|FG001|NOT COMPLETED|Overall Study||0
11068384|NCT01053078|12249886|FG000|STARTED|Overall Study||14
11068385|NCT01053078|12249887|FG001|STARTED|Overall Study||15
11068386|NCT01053078|12249886|FG000|COMPLETED|Overall Study||10
11068387|NCT01053078|12249887|FG001|COMPLETED|Overall Study||12
11068388|NCT01053078|12249886|FG000|NOT COMPLETED|Overall Study||4
11068389|NCT01053078|12249887|FG001|NOT COMPLETED|Overall Study||3
11068390|NCT01053156|12249897|FG000|STARTED|First Intervention (Week 1-12)||33
11068391|NCT01053156|12249898|FG001|STARTED|First Intervention (Week 1-12)||33
11068392|NCT01053156|12249897|FG000|COMPLETED|First Intervention (Week 1-12)||28
11068393|NCT01053156|12249898|FG001|COMPLETED|First Intervention (Week 1-12)||27
11068394|NCT01053156|12249897|FG000|NOT COMPLETED|First Intervention (Week 1-12)||5
11068395|NCT01053156|12249898|FG001|NOT COMPLETED|First Intervention (Week 1-12)||6
11068396|NCT01053156|12249897|FG000|STARTED|Second Intervention (Week 13-24)||28
11068397|NCT01053156|12249898|FG001|STARTED|Second Intervention (Week 13-24)||27
11068398|NCT01053156|12249897|FG000|COMPLETED|Second Intervention (Week 13-24)||26
11068399|NCT01053156|12249898|FG001|COMPLETED|Second Intervention (Week 13-24)||22
11068400|NCT01053156|12249897|FG000|NOT COMPLETED|Second Intervention (Week 13-24)||2
11068401|NCT01053156|12249898|FG001|NOT COMPLETED|Second Intervention (Week 13-24)||5
11068402|NCT01053247|12249910|FG000|STARTED|Overall Study||269
11068403|NCT01053247|12249911|FG001|STARTED|Overall Study||260
11068404|NCT01053247|12249912|FG002|STARTED|Overall Study||264
11068405|NCT01053247|12249910|FG000|COMPLETED|Overall Study||249
11068406|NCT01053247|12249911|FG001|COMPLETED|Overall Study||241
11068407|NCT01053247|12249912|FG002|COMPLETED|Overall Study||236
11068408|NCT01053247|12249910|FG000|NOT COMPLETED|Overall Study||20
11068409|NCT01053247|12249911|FG001|NOT COMPLETED|Overall Study||19
11068410|NCT01053247|12249912|FG002|NOT COMPLETED|Overall Study||28
11068411|NCT01053312|12249920|FG000|STARTED|Overall Study||7
11068412|NCT01053312|12249920|FG000|COMPLETED|Overall Study||7
11068413|NCT01053312|12249920|FG000|NOT COMPLETED|Overall Study||0
11068414|NCT01053429|12249938|FG000|STARTED|Overall Study||3391
11068415|NCT01053429|12249938|FG000|COMPLETED|Overall Study||3018
11068416|NCT01053429|12249938|FG000|NOT COMPLETED|Overall Study||373
11068417|NCT01053507|12249944|FG000|STARTED|Overall Study||11
11068418|NCT01053507|12249945|FG001|STARTED|Overall Study||12
11068419|NCT01053507|12249944|FG000|COMPLETED|Overall Study||8
11068420|NCT01053507|12249945|FG001|COMPLETED|Overall Study||11
11068421|NCT01053507|12249944|FG000|NOT COMPLETED|Overall Study||3
11068422|NCT01053507|12249945|FG001|NOT COMPLETED|Overall Study||1
11068423|NCT01053663|12249954|FG000|STARTED|Overall Study||9
11068424|NCT01053663|12249954|FG000|COMPLETED|Overall Study||3
11068425|NCT01053663|12249954|FG000|NOT COMPLETED|Overall Study||6
11068426|NCT01053741|12249966|FG000|STARTED|1st Intervention||5
11068427|NCT01053741|12249967|FG001|STARTED|1st Intervention||6
11068428|NCT01053741|12249966|FG000|COMPLETED|1st Intervention||5
11068429|NCT01053741|12249967|FG001|COMPLETED|1st Intervention||6
11068430|NCT01053741|12249966|FG000|NOT COMPLETED|1st Intervention||0
11068431|NCT01053741|12249967|FG001|NOT COMPLETED|1st Intervention||0
11068432|NCT01053741|12249966|FG000|STARTED|14 Day Washout||5
11068433|NCT01053741|12249967|FG001|STARTED|14 Day Washout||6
11068434|NCT01053741|12249966|FG000|COMPLETED|14 Day Washout||5
11068435|NCT01053741|12249967|FG001|COMPLETED|14 Day Washout||6
11068436|NCT01053741|12249966|FG000|NOT COMPLETED|14 Day Washout||0
11068437|NCT01053741|12249967|FG001|NOT COMPLETED|14 Day Washout||0
11068438|NCT01053741|12249966|FG000|STARTED|2nd Study Intervention||5
11068439|NCT01053741|12249967|FG001|STARTED|2nd Study Intervention||6
11068440|NCT01053741|12249966|FG000|COMPLETED|2nd Study Intervention||5
11068441|NCT01053741|12249967|FG001|COMPLETED|2nd Study Intervention||5
11068442|NCT01053741|12249966|FG000|NOT COMPLETED|2nd Study Intervention||0
11068443|NCT01053741|12249967|FG001|NOT COMPLETED|2nd Study Intervention||1
11068444|NCT01053819|12249973|FG000|STARTED|Overall Study||6
11068445|NCT01053819|12249973|FG000|COMPLETED|Overall Study||6
11068446|NCT01053819|12249973|FG000|NOT COMPLETED|Overall Study||0
11068447|NCT01053897|12249978|FG000|STARTED|Overall Study||5
11068448|NCT01053897|12249978|FG000|COMPLETED|Overall Study||5
11068449|NCT01053897|12249978|FG000|NOT COMPLETED|Overall Study||0
11068450|NCT01053962|12249993|FG000|STARTED|Pretreatment Period||14
11068451|NCT01053962|12249994|FG001|STARTED|Pretreatment Period||15
11068452|NCT01053962|12249995|FG002|STARTED|Pretreatment Period||16
11068453|NCT01053962|12249996|FG003|STARTED|Pretreatment Period||17
11068454|NCT01053962|12249997|FG004|STARTED|Pretreatment Period||22
11068455|NCT01053962|12249993|FG000|COMPLETED|Pretreatment Period||14
11068456|NCT01053962|12249994|FG001|COMPLETED|Pretreatment Period||14
11068457|NCT01053962|12249995|FG002|COMPLETED|Pretreatment Period||15
11068458|NCT01053962|12249996|FG003|COMPLETED|Pretreatment Period||15
11068459|NCT01053962|12249997|FG004|COMPLETED|Pretreatment Period||20
11068460|NCT01053962|12249993|FG000|NOT COMPLETED|Pretreatment Period||0
11068461|NCT01053962|12249994|FG001|NOT COMPLETED|Pretreatment Period||1
11068462|NCT01053962|12249995|FG002|NOT COMPLETED|Pretreatment Period||1
11068463|NCT01053962|12249996|FG003|NOT COMPLETED|Pretreatment Period||2
11068464|NCT01053962|12249997|FG004|NOT COMPLETED|Pretreatment Period||2
11068465|NCT01053962|12249993|FG000|STARTED|Treatment Period||14
11068466|NCT01053962|12249994|FG001|STARTED|Treatment Period||14
11068467|NCT01053962|12249995|FG002|STARTED|Treatment Period||15
11068468|NCT01053962|12249996|FG003|STARTED|Treatment Period||15
11068469|NCT01053962|12249997|FG004|STARTED|Treatment Period||20
11068470|NCT01053962|12249993|FG000|COMPLETED|Treatment Period||13
11068471|NCT01053962|12249994|FG001|COMPLETED|Treatment Period||14
11068472|NCT01053962|12249995|FG002|COMPLETED|Treatment Period||15
11068473|NCT01053962|12249996|FG003|COMPLETED|Treatment Period||15
11068474|NCT01053962|12249997|FG004|COMPLETED|Treatment Period||17
11068475|NCT01053962|12249993|FG000|NOT COMPLETED|Treatment Period||1
11068476|NCT01053962|12249994|FG001|NOT COMPLETED|Treatment Period||0
11068477|NCT01053962|12249995|FG002|NOT COMPLETED|Treatment Period||0
11068478|NCT01053962|12249996|FG003|NOT COMPLETED|Treatment Period||0
11068479|NCT01053962|12249997|FG004|NOT COMPLETED|Treatment Period||3
11068480|NCT01053962|12249993|FG000|STARTED|Follow-up Period||13
11068481|NCT01053962|12249994|FG001|STARTED|Follow-up Period||14
11068482|NCT01053962|12249995|FG002|STARTED|Follow-up Period||15
11068483|NCT01053962|12249996|FG003|STARTED|Follow-up Period||15
11068484|NCT01053962|12249997|FG004|STARTED|Follow-up Period||17
11068485|NCT01053962|12249993|FG000|COMPLETED|Follow-up Period||13
11068486|NCT01053962|12249994|FG001|COMPLETED|Follow-up Period||14
11068487|NCT01053962|12249995|FG002|COMPLETED|Follow-up Period||15
11068488|NCT01053962|12249996|FG003|COMPLETED|Follow-up Period||15
11068489|NCT01053962|12249997|FG004|COMPLETED|Follow-up Period||17
11068490|NCT01053962|12249993|FG000|NOT COMPLETED|Follow-up Period||0
11068491|NCT01053962|12249994|FG001|NOT COMPLETED|Follow-up Period||0
11068492|NCT01053962|12249995|FG002|NOT COMPLETED|Follow-up Period||0
11068493|NCT01053962|12249996|FG003|NOT COMPLETED|Follow-up Period||0
11068494|NCT01053962|12249997|FG004|NOT COMPLETED|Follow-up Period||0
11068495|NCT01053988|12250019|FG000|STARTED|2-week, Single-blind Run-In Period||1390
11068496|NCT01053988|12250020|FG001|STARTED|2-week, Single-blind Run-In Period||0
11068497|NCT01053988|12250021|FG002|STARTED|2-week, Single-blind Run-In Period||0
11068498|NCT01053988|12250022|FG003|STARTED|2-week, Single-blind Run-In Period||0
11068499|NCT01053988|12250023|FG004|STARTED|2-week, Single-blind Run-In Period||0
11068500|NCT01053988|12250024|FG005|STARTED|2-week, Single-blind Run-In Period||0
11068501|NCT01053988|12250019|FG000|COMPLETED|2-week, Single-blind Run-In Period||1030
11068502|NCT01053988|12250020|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
11068503|NCT01053988|12250021|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
11068504|NCT01053988|12250022|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
11068505|NCT01053988|12250023|FG004|COMPLETED|2-week, Single-blind Run-In Period||0
11068506|NCT01053988|12250024|FG005|COMPLETED|2-week, Single-blind Run-In Period||0
11346420|NCT02980133|12543630|FG003|NOT COMPLETED|Overall Study||6
11346421|NCT02980211|12543643|FG000|STARTED|Overall Study||17
11346422|NCT02980211|12543643|FG000|COMPLETED|Overall Study||17
11346423|NCT02980211|12543643|FG000|NOT COMPLETED|Overall Study||0
11346424|NCT02980224|12543649|FG000|STARTED|Overall Study||89
11346425|NCT02980224|12543650|FG001|STARTED|Overall Study||91
11346426|NCT02980224|12543649|FG000|COMPLETED|Overall Study||85
11346427|NCT02980224|12543650|FG001|COMPLETED|Overall Study||88
11346428|NCT02980224|12543649|FG000|NOT COMPLETED|Overall Study||4
11346429|NCT02980224|12543650|FG001|NOT COMPLETED|Overall Study||3
11068507|NCT01053988|12250019|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||360
11068508|NCT01053988|12250020|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
11068509|NCT01053988|12250021|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
11068510|NCT01053988|12250022|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
11068511|NCT01053988|12250023|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0
11068512|NCT01053988|12250024|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0
11068513|NCT01053988|12250019|FG000|STARTED|24-week, Double-blind Treatment Period||0
11068514|NCT01053988|12250020|FG001|STARTED|24-week, Double-blind Treatment Period||207
11068515|NCT01053988|12250021|FG002|STARTED|24-week, Double-blind Treatment Period||206
11068516|NCT01053988|12250022|FG003|STARTED|24-week, Double-blind Treatment Period||205
11068517|NCT01053988|12250023|FG004|STARTED|24-week, Double-blind Treatment Period||206
11068518|NCT01053988|12250024|FG005|STARTED|24-week, Double-blind Treatment Period||206
11068519|NCT01053988|12250019|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
11068520|NCT01053988|12250020|FG001|COMPLETED|24-week, Double-blind Treatment Period||138
11068521|NCT01053988|12250021|FG002|COMPLETED|24-week, Double-blind Treatment Period||145
11068522|NCT01053988|12250022|FG003|COMPLETED|24-week, Double-blind Treatment Period||142
11068523|NCT01053988|12250023|FG004|COMPLETED|24-week, Double-blind Treatment Period||147
11068524|NCT01053988|12250024|FG005|COMPLETED|24-week, Double-blind Treatment Period||151
11068525|NCT01053988|12250019|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
11068526|NCT01053988|12250020|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||69
11068527|NCT01053988|12250021|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||61
11068528|NCT01053988|12250022|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||63
11068529|NCT01053988|12250023|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||59
11068530|NCT01053988|12250024|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||55
11068531|NCT01054079|12250036|FG000|STARTED|Overall Study||20
11068532|NCT01054079|12250036|FG000|# Recieved Proper PSA Testing|Overall Study||10
11068533|NCT01054079|12250036|FG000|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
11068534|NCT01054079|12250036|FG000|NOT COMPLETED|Overall Study||0
11068535|NCT01054144|12250040|FG000|STARTED|Overall Study||27
11068536|NCT01054144|12250040|FG000|COMPLETED|Overall Study||25
11346430|NCT02980523|12543661|FG000|STARTED|Overall Study||30
11346431|NCT02980523|12543662|FG001|STARTED|Overall Study||30
11346432|NCT02980523|12543663|FG002|STARTED|Overall Study||30
11346433|NCT02980523|12543664|FG003|STARTED|Overall Study||30
11068537|NCT01054144|12250040|FG000|NOT COMPLETED|Overall Study||2
11068538|NCT01054170|12250049|FG000|STARTED|Overall Study||25
11068539|NCT01054170|12250050|FG001|STARTED|Overall Study||27
11068540|NCT01054170|12250049|FG000|COMPLETED|Overall Study||21
11068541|NCT01054170|12250050|FG001|COMPLETED|Overall Study||21
11068542|NCT01054170|12250049|FG000|NOT COMPLETED|Overall Study||4
11068543|NCT01054170|12250050|FG001|NOT COMPLETED|Overall Study||6
11068544|NCT01054183|12250058|FG000|STARTED|Overall Study||10
11068545|NCT01054183|12250059|FG001|STARTED|Overall Study||12
11068546|NCT01054183|12250058|FG000|COMPLETED|Overall Study||10
11068547|NCT01054183|12250059|FG001|COMPLETED|Overall Study||12
11068548|NCT01054183|12250058|FG000|NOT COMPLETED|Overall Study||0
11068549|NCT01054183|12250059|FG001|NOT COMPLETED|Overall Study||0
11068550|NCT01054209|12250067|FG000|STARTED|Overall Study||58
11068551|NCT01054209|12250068|FG001|STARTED|Overall Study||58
11068552|NCT01054209|12250067|FG000|COMPLETED|Overall Study||58
11068553|NCT01054209|12250068|FG001|COMPLETED|Overall Study||58
11068554|NCT01054209|12250067|FG000|NOT COMPLETED|Overall Study||0
11068555|NCT01054209|12250068|FG001|NOT COMPLETED|Overall Study||0
11068556|NCT01054222|12250074|FG000|STARTED|Overall Study||31
11068557|NCT01054222|12250074|FG000|COMPLETED|Overall Study||20
11068558|NCT01054222|12250074|FG000|NOT COMPLETED|Overall Study||11
11068559|NCT01054300|12250080|FG000|STARTED|Period 1||13
11068560|NCT01054300|12250081|FG001|STARTED|Period 1||13
11068561|NCT01054300|12250082|FG002|STARTED|Period 1||13
11068562|NCT01054300|12250083|FG003|STARTED|Period 1||13
11068563|NCT01054300|12250080|FG000|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
11068564|NCT01054300|12250081|FG001|COMPLETED|Period 1||13
11068565|NCT01054300|12250082|FG002|COMPLETED|Period 1||13
11068566|NCT01054300|12250083|FG003|COMPLETED|Period 1||13
11068567|NCT01054300|12250080|FG000|NOT COMPLETED|Period 1||1
11068568|NCT01054300|12250081|FG001|NOT COMPLETED|Period 1||0
11068569|NCT01054300|12250082|FG002|NOT COMPLETED|Period 1||0
11068570|NCT01054300|12250083|FG003|NOT COMPLETED|Period 1||0
11068571|NCT01054300|12250080|FG000|STARTED|Period 2||12
11068572|NCT01054300|12250081|FG001|STARTED|Period 2||13
11068573|NCT01054300|12250082|FG002|STARTED|Period 2||13
11068574|NCT01054300|12250083|FG003|STARTED|Period 2||13
11068575|NCT01054300|12250080|FG000|COMPLETED|Period 2||12
11068576|NCT01054300|12250081|FG001|COMPLETED|Period 2||13
11068577|NCT01054300|12250082|FG002|COMPLETED|Period 2||12
11068578|NCT01054300|12250083|FG003|COMPLETED|Period 2||13
11068579|NCT01054300|12250080|FG000|NOT COMPLETED|Period 2||0
11068580|NCT01054300|12250081|FG001|NOT COMPLETED|Period 2||0
11068581|NCT01054300|12250082|FG002|NOT COMPLETED|Period 2||1
11068582|NCT01054300|12250083|FG003|NOT COMPLETED|Period 2||0
11068583|NCT01054339|12250096|FG000|STARTED|Overall Study||3
11068584|NCT01054339|12250097|FG001|STARTED|Overall Study||3
11068585|NCT01054339|12250098|FG002|STARTED|Overall Study||3
11068586|NCT01054339|12250096|FG000|COMPLETED|Overall Study||3
11068587|NCT01054339|12250097|FG001|COMPLETED|Overall Study||3
11068588|NCT01054339|12250098|FG002|COMPLETED|Overall Study||3
11068589|NCT01054339|12250096|FG000|NOT COMPLETED|Overall Study||0
11068590|NCT01054339|12250097|FG001|NOT COMPLETED|Overall Study||0
11068591|NCT01054339|12250098|FG002|NOT COMPLETED|Overall Study||0
11068592|NCT01054404|12250110|FG000|STARTED|Overall Study||10
11068593|NCT01054404|12250111|FG001|STARTED|Overall Study||13
11068594|NCT01054404|12250110|FG000|COMPLETED|Overall Study||10
11068595|NCT01054404|12250111|FG001|COMPLETED|Overall Study||13
11068596|NCT01054404|12250110|FG000|NOT COMPLETED|Overall Study||0
11068597|NCT01054404|12250111|FG001|NOT COMPLETED|Overall Study||0
11068598|NCT01054443|12250121|FG000|STARTED|Overall Study||5
11068599|NCT01054443|12250122|FG001|STARTED|Overall Study||5
11068600|NCT01054443|12250123|FG002|STARTED|Overall Study||5
11068601|NCT01054443|12250124|FG003|STARTED|Overall Study||5
11068602|NCT01054443|12250121|FG000|COMPLETED|Overall Study||5
11068603|NCT01054443|12250122|FG001|COMPLETED|Overall Study||5
11068604|NCT01054443|12250123|FG002|COMPLETED|Overall Study||5
11068605|NCT01054443|12250124|FG003|COMPLETED|Overall Study||4
11068606|NCT01054443|12250121|FG000|NOT COMPLETED|Overall Study||0
11068607|NCT01054443|12250122|FG001|NOT COMPLETED|Overall Study||0
11068608|NCT01054443|12250123|FG002|NOT COMPLETED|Overall Study||0
11068609|NCT01054443|12250124|FG003|NOT COMPLETED|Overall Study||1
11068610|NCT01054456|12250137|FG000|STARTED|Overall Study||36
11068611|NCT01054456|12250137|FG000|COMPLETED|Overall Study||35
11068612|NCT01054456|12250137|FG000|NOT COMPLETED|Overall Study||1
11068613|NCT01054560|12250143|FG000|STARTED|Overall Study||58
11068614|NCT01054560|12250144|FG001|STARTED|Overall Study||55
11068615|NCT01054560|12250143|FG000|COMPLETED|Overall Study||45
11068616|NCT01054560|12250144|FG001|COMPLETED|Overall Study||27
11068617|NCT01054560|12250143|FG000|NOT COMPLETED|Overall Study||13
11068618|NCT01054560|12250144|FG001|NOT COMPLETED|Overall Study||28
11068619|NCT01054573|12250156|FG000|STARTED|Overall Study||9
11068620|NCT01054573|12250157|FG001|STARTED|Overall Study||32
11068621|NCT01054573|12250158|FG002|STARTED|Overall Study||22
11068622|NCT01054573|12250159|FG003|STARTED|Overall Study||27
11068623|NCT01054573|12250156|FG000|COMPLETED|Overall Study||8
11068624|NCT01054573|12250157|FG001|COMPLETED|Overall Study||28
11068625|NCT01054573|12250158|FG002|COMPLETED|Overall Study||19
11068626|NCT01054573|12250159|FG003|COMPLETED|Overall Study||25
11068627|NCT01054573|12250156|FG000|NOT COMPLETED|Overall Study||1
11068628|NCT01054573|12250157|FG001|NOT COMPLETED|Overall Study||4
11068629|NCT01054573|12250158|FG002|NOT COMPLETED|Overall Study||3
11068630|NCT01054573|12250159|FG003|NOT COMPLETED|Overall Study||2
11068631|NCT01054586|12250182|FG000|STARTED|Overall Study||43
11068632|NCT01054586|12250183|FG001|STARTED|Overall Study||15
11068633|NCT01054586|12250184|FG002|STARTED|Overall Study||8
11068634|NCT01054586|12250185|FG003|STARTED|Overall Study||101
11068635|NCT01054586|12250182|FG000|COMPLETED|Overall Study||43
11068636|NCT01054586|12250183|FG001|COMPLETED|Overall Study||15
11068637|NCT01054586|12250184|FG002|COMPLETED|Overall Study||8
11068638|NCT01054586|12250185|FG003|COMPLETED|Overall Study||101
11068639|NCT01054586|12250182|FG000|NOT COMPLETED|Overall Study||0
11068640|NCT01054586|12250183|FG001|NOT COMPLETED|Overall Study||0
11068641|NCT01054586|12250184|FG002|NOT COMPLETED|Overall Study||0
11068642|NCT01054586|12250185|FG003|NOT COMPLETED|Overall Study||0
11068643|NCT01054599|12250207|FG000|STARTED|Overall Study||13
11068644|NCT01054599|12250208|FG001|STARTED|Overall Study||16
11068645|NCT01054599|12250207|FG000|COMPLETED|Overall Study||9
11068646|NCT01054599|12250208|FG001|COMPLETED|Overall Study||9
11068647|NCT01054599|12250207|FG000|NOT COMPLETED|Overall Study||4
11068648|NCT01054599|12250208|FG001|NOT COMPLETED|Overall Study||7
11346434|NCT02980523|12543665|FG004|STARTED|Overall Study||30
11346435|NCT02980523|12543661|FG000|COMPLETED|Overall Study||27
11346436|NCT02980523|12543662|FG001|COMPLETED|Overall Study||19
11346437|NCT02980523|12543663|FG002|COMPLETED|Overall Study||24
11346438|NCT02980523|12543664|FG003|COMPLETED|Overall Study||21
11346439|NCT02980523|12543665|FG004|COMPLETED|Overall Study||20
11346440|NCT02980523|12543661|FG000|NOT COMPLETED|Overall Study||3
11346441|NCT02980523|12543662|FG001|NOT COMPLETED|Overall Study||11
11346442|NCT02980523|12543663|FG002|NOT COMPLETED|Overall Study||6
11346443|NCT02980523|12543664|FG003|NOT COMPLETED|Overall Study||9
11346444|NCT02980523|12543665|FG004|NOT COMPLETED|Overall Study||10
11346445|NCT02980601|12543682|FG000|STARTED|Overall Study||6
11068649|NCT01054625|12250217|FG000|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
11068650|NCT01054625|12250218|FG001|STARTED|Overall Study||12
11346446|NCT02980601|12543683|FG001|STARTED|Overall Study||4
11068651|NCT01054625|12250219|FG002|STARTED|Overall Study||10
11068652|NCT01054625|12250217|FG000|COMPLETED|Overall Study||6
11068653|NCT01054625|12250218|FG001|COMPLETED|Overall Study||9
11068654|NCT01054625|12250219|FG002|COMPLETED|Overall Study||9
11068655|NCT01054625|12250217|FG000|NOT COMPLETED|Overall Study||2
11068656|NCT01054625|12250218|FG001|NOT COMPLETED|Overall Study||3
11068657|NCT01054625|12250219|FG002|NOT COMPLETED|Overall Study||1
11206176|NCT01865552|12397108|FG004|COMPLETED|Period 1||20
11206177|NCT01865552|12397109|FG005|COMPLETED|Period 1||22
11206178|NCT01865552|12397104|FG000|NOT COMPLETED|Period 1||1
11206179|NCT01865552|12397105|FG001|NOT COMPLETED|Period 1||0
11206180|NCT01865552|12397106|FG002|NOT COMPLETED|Period 1||0
11206181|NCT01865552|12397107|FG003|NOT COMPLETED|Period 1||1
11206182|NCT01865552|12397108|FG004|NOT COMPLETED|Period 1||3
11206183|NCT01865552|12397109|FG005|NOT COMPLETED|Period 1||1
11206184|NCT01865552|12397104|FG000|STARTED|Period 2||22
11206185|NCT01865552|12397105|FG001|STARTED|Period 2||23
11206186|NCT01865552|12397106|FG002|STARTED|Period 2||23
11206187|NCT01865552|12397107|FG003|STARTED|Period 2||22
11206188|NCT01865552|12397108|FG004|STARTED|Period 2||20
11206189|NCT01865552|12397109|FG005|STARTED|Period 2||22
11206190|NCT01865552|12397104|FG000|COMPLETED|Period 2||22
11206191|NCT01865552|12397105|FG001|COMPLETED|Period 2||23
11206192|NCT01865552|12397106|FG002|COMPLETED|Period 2||23
11206193|NCT01865552|12397107|FG003|COMPLETED|Period 2||22
11206194|NCT01865552|12397108|FG004|COMPLETED|Period 2||20
11206195|NCT01865552|12397109|FG005|COMPLETED|Period 2||22
11206196|NCT01865552|12397104|FG000|NOT COMPLETED|Period 2||0
11206197|NCT01865552|12397105|FG001|NOT COMPLETED|Period 2||0
11206198|NCT01865552|12397106|FG002|NOT COMPLETED|Period 2||0
11206199|NCT01865552|12397107|FG003|NOT COMPLETED|Period 2||0
11206200|NCT01865552|12397108|FG004|NOT COMPLETED|Period 2||0
11206201|NCT01865552|12397109|FG005|NOT COMPLETED|Period 2||0
11206202|NCT01865708|12397123|FG000|STARTED|Overall Study||10
11206203|NCT01865708|12397123|FG000|COMPLETED|Overall Study||10
11206204|NCT01865708|12397123|FG000|NOT COMPLETED|Overall Study||0
11206205|NCT01865747|12397129|FG000|STARTED|Overall Study (ITT)||330
11206206|NCT01865747|12397130|FG001|STARTED|Overall Study (ITT)||328
11206207|NCT01865747|12397129|FG000|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
11206208|NCT01865747|12397130|FG001|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
11206209|NCT01865747|12397129|FG000|NOT COMPLETED|Overall Study (ITT)||198
11206210|NCT01865747|12397130|FG001|NOT COMPLETED|Overall Study (ITT)||255
11206211|NCT01865747|12397129|FG000|STARTED|Primary Intent to Treat (PITT)||187
11206212|NCT01865747|12397130|FG001|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
11206213|NCT01865747|12397129|FG000|COMPLETED|Primary Intent to Treat (PITT)||56
11206214|NCT01865747|12397130|FG001|COMPLETED|Primary Intent to Treat (PITT)||36
11206215|NCT01865747|12397129|FG000|NOT COMPLETED|Primary Intent to Treat (PITT)||131
11206216|NCT01865747|12397130|FG001|NOT COMPLETED|Primary Intent to Treat (PITT)||152
11206217|NCT01866098|12397139|FG000|STARTED|Overall Study||51
11206218|NCT01866098|12397140|FG001|STARTED|Overall Study||47
11206219|NCT01866098|12397141|FG002|STARTED|Overall Study||46
11206220|NCT01866098|12397139|FG000|COMPLETED|Overall Study||32
11206221|NCT01866098|12397140|FG001|COMPLETED|Overall Study||20
11206222|NCT01866098|12397141|FG002|COMPLETED|Overall Study||25
11206223|NCT01866098|12397139|FG000|NOT COMPLETED|Overall Study||19
11206224|NCT01866098|12397140|FG001|NOT COMPLETED|Overall Study||27
11206225|NCT01866098|12397141|FG002|NOT COMPLETED|Overall Study||21
11206226|NCT01866150|12397149|FG000|STARTED|Overall Study||450
11206227|NCT01866150|12397149|FG000|COMPLETED|Overall Study||450
11206228|NCT01866150|12397149|FG000|NOT COMPLETED|Overall Study||0
11346447|NCT02980601|12543682|FG000|COMPLETED|Overall Study||1
11346448|NCT02980601|12543683|FG001|COMPLETED|Overall Study||1
11346449|NCT02980601|12543682|FG000|NOT COMPLETED|Overall Study||5
11346450|NCT02980601|12543683|FG001|NOT COMPLETED|Overall Study||3
11346451|NCT02980692|12543694|FG000|STARTED|Overall Study||78
11346452|NCT02980692|12543695|FG001|STARTED|Overall Study||79
11346453|NCT02980692|12543696|FG002|STARTED|Overall Study||77
11346454|NCT02980692|12543697|FG003|STARTED|Overall Study||78
11346455|NCT02980692|12543698|FG004|STARTED|Overall Study||79
11346456|NCT02980692|12543694|FG000|COMPLETED|Overall Study||69
11346457|NCT02980692|12543695|FG001|COMPLETED|Overall Study||73
11346458|NCT02980692|12543696|FG002|COMPLETED|Overall Study||65
11346459|NCT02980692|12543697|FG003|COMPLETED|Overall Study||69
11346460|NCT02980692|12543698|FG004|COMPLETED|Overall Study||68
11346461|NCT02980692|12543694|FG000|NOT COMPLETED|Overall Study||9
11346462|NCT02980692|12543695|FG001|NOT COMPLETED|Overall Study||6
11346463|NCT02980692|12543696|FG002|NOT COMPLETED|Overall Study||12
11068658|NCT01054703|12250227|FG000|STARTED|Overall Study||14
11068659|NCT01054703|12250227|FG000|COMPLETED|Overall Study||14
11068660|NCT01054703|12250227|FG000|NOT COMPLETED|Overall Study||0
11068661|NCT01054729|12250235|FG000|STARTED|Overall Study||16
11068662|NCT01054729|12250236|FG001|STARTED|Overall Study||19
11068663|NCT01054729|12250237|FG002|STARTED|Overall Study||15
11068664|NCT01054729|12250238|FG003|STARTED|Overall Study||14
11068665|NCT01054729|12250235|FG000|Randomized and Treated|Overall Study||16
11068666|NCT01054729|12250236|FG001|Randomized and Treated|Overall Study||18
11068667|NCT01054729|12250237|FG002|Randomized and Treated|Overall Study||15
11068668|NCT01054729|12250238|FG003|Randomized and Treated|Overall Study||14
11068669|NCT01054729|12250235|FG000|COMPLETED|Overall Study||12
11068670|NCT01054729|12250236|FG001|COMPLETED|Overall Study||14
11068671|NCT01054729|12250237|FG002|COMPLETED|Overall Study||9
11068672|NCT01054729|12250238|FG003|COMPLETED|Overall Study||11
11068673|NCT01054729|12250235|FG000|NOT COMPLETED|Overall Study||4
11068674|NCT01054729|12250236|FG001|NOT COMPLETED|Overall Study||5
11068675|NCT01054729|12250237|FG002|NOT COMPLETED|Overall Study||6
11068676|NCT01054729|12250238|FG003|NOT COMPLETED|Overall Study||3
11068677|NCT01054742|12250248|FG000|STARTED|Overall Study||2
11068678|NCT01054742|12250248|FG000|COMPLETED|Overall Study||2
11068679|NCT01054742|12250248|FG000|NOT COMPLETED|Overall Study||0
11068680|NCT01054768|12250254|FG000|STARTED|Overall Study||17
11068681|NCT01054768|12250255|FG001|STARTED|Overall Study||20
11068682|NCT01054768|12250254|FG000|COMPLETED|Overall Study||9
11068683|NCT01054768|12250255|FG001|COMPLETED|Overall Study||17
11068684|NCT01054768|12250254|FG000|NOT COMPLETED|Overall Study||8
11068685|NCT01054768|12250255|FG001|NOT COMPLETED|Overall Study||3
11068686|NCT01054820|12250261|FG000|STARTED|Overall Study||123
11068687|NCT01054820|12250261|FG000|COMPLETED|Overall Study||121
11068688|NCT01054820|12250261|FG000|NOT COMPLETED|Overall Study||2
11068689|NCT01054846|12250267|FG000|STARTED|Overall Study||322
11068690|NCT01054846|12250268|FG001|STARTED|Overall Study||68
11068691|NCT01054846|12250267|FG000|COMPLETED|Overall Study||246
11068692|NCT01054846|12250268|FG001|COMPLETED|Overall Study||51
11068693|NCT01054846|12250267|FG000|NOT COMPLETED|Overall Study||76
11068694|NCT01054846|12250268|FG001|NOT COMPLETED|Overall Study||17
11068695|NCT01054885|12250279|FG000|STARTED|2-week, Single-blind Run-In Period||1577
11068696|NCT01054885|12250280|FG001|STARTED|2-week, Single-blind Run-In Period||0
11068697|NCT01054885|12250281|FG002|STARTED|2-week, Single-blind Run-In Period||0
11068698|NCT01054885|12250282|FG003|STARTED|2-week, Single-blind Run-In Period||0
11068699|NCT01054885|12250283|FG004|STARTED|2-week, Single-blind Run-In Period||0
11068700|NCT01054885|12250284|FG005|STARTED|2-week, Single-blind Run-In Period||0
11068701|NCT01054885|12250285|FG006|STARTED|2-week, Single-blind Run-In Period||0
11068702|NCT01054885|12250279|FG000|COMPLETED|2-week, Single-blind Run-In Period||1226
11068703|NCT01054885|12250280|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
11068704|NCT01054885|12250281|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
11068705|NCT01054885|12250282|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
11068706|NCT01054885|12250283|FG004|COMPLETED|2-week, Single-blind Run-In Period||0
11068707|NCT01054885|12250284|FG005|COMPLETED|2-week, Single-blind Run-In Period||0
11068708|NCT01054885|12250285|FG006|COMPLETED|2-week, Single-blind Run-In Period||0
11068709|NCT01054885|12250279|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||351
11068710|NCT01054885|12250280|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
11068711|NCT01054885|12250281|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
11068712|NCT01054885|12250282|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
11068713|NCT01054885|12250283|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0
11068714|NCT01054885|12250284|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0
11068715|NCT01054885|12250285|FG006|NOT COMPLETED|2-week, Single-blind Run-In Period||0
11068716|NCT01054885|12250279|FG000|STARTED|24-week, Double-blind Treatment Period||0
11068717|NCT01054885|12250280|FG001|STARTED|24-week, Double-blind Treatment Period||205
11068718|NCT01054885|12250281|FG002|STARTED|24-week, Double-blind Treatment Period||204
11068719|NCT01054885|12250282|FG003|STARTED|24-week, Double-blind Treatment Period||203
11068720|NCT01054885|12250283|FG004|STARTED|24-week, Double-blind Treatment Period||203
11068721|NCT01054885|12250284|FG005|STARTED|24-week, Double-blind Treatment Period||204
11068722|NCT01054885|12250285|FG006|STARTED|24-week, Double-blind Treatment Period||205
11068723|NCT01054885|12250279|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
11068724|NCT01054885|12250280|FG001|COMPLETED|24-week, Double-blind Treatment Period||146
11068725|NCT01054885|12250281|FG002|COMPLETED|24-week, Double-blind Treatment Period||155
11068726|NCT01054885|12250282|FG003|COMPLETED|24-week, Double-blind Treatment Period||160
11068727|NCT01054885|12250283|FG004|COMPLETED|24-week, Double-blind Treatment Period||161
11068728|NCT01054885|12250284|FG005|COMPLETED|24-week, Double-blind Treatment Period||144
11068729|NCT01054885|12250285|FG006|COMPLETED|24-week, Double-blind Treatment Period||158
11068730|NCT01054885|12250279|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
11068731|NCT01054885|12250280|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||59
11068732|NCT01054885|12250281|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||49
11068733|NCT01054885|12250282|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||43
11068734|NCT01054885|12250283|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||42
11068735|NCT01054885|12250284|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||60
11068736|NCT01054885|12250285|FG006|NOT COMPLETED|24-week, Double-blind Treatment Period||47
11068737|NCT01054911|12250300|FG000|STARTED|Overall Study||5
11068738|NCT01054911|12250300|FG000|COMPLETED|Overall Study||5
11068739|NCT01054911|12250300|FG000|NOT COMPLETED|Overall Study||0
11068740|NCT01054976|12250306|FG000|STARTED|Overall Study||92
11068741|NCT01054976|12250306|FG000|COMPLETED|Overall Study||57
11068742|NCT01054976|12250306|FG000|NOT COMPLETED|Overall Study||35
11068743|NCT01055028|12250312|FG000|STARTED|Screening||9
11068744|NCT01055028|12250313|FG001|STARTED|Screening||9
11068745|NCT01055028|12250312|FG000|COMPLETED|Screening||8
11068746|NCT01055028|12250313|FG001|COMPLETED|Screening||8
11068747|NCT01055028|12250312|FG000|NOT COMPLETED|Screening||1
11068748|NCT01055028|12250313|FG001|NOT COMPLETED|Screening||1
11068749|NCT01055028|12250312|FG000|STARTED|Treatment Cycles 1 to 3||8
11068750|NCT01055028|12250313|FG001|STARTED|Treatment Cycles 1 to 3||8
11068751|NCT01055028|12250312|FG000|COMPLETED|Treatment Cycles 1 to 3||6
11068752|NCT01055028|12250313|FG001|COMPLETED|Treatment Cycles 1 to 3||5
11068753|NCT01055028|12250312|FG000|NOT COMPLETED|Treatment Cycles 1 to 3||2
11068754|NCT01055028|12250313|FG001|NOT COMPLETED|Treatment Cycles 1 to 3||3
11068755|NCT01055028|12250312|FG000|STARTED|Inter-treatment Period||6
11068756|NCT01055028|12250313|FG001|STARTED|Inter-treatment Period||5
11068757|NCT01055028|12250312|FG000|COMPLETED|Inter-treatment Period||6
11068758|NCT01055028|12250313|FG001|COMPLETED|Inter-treatment Period||2
11068759|NCT01055028|12250312|FG000|NOT COMPLETED|Inter-treatment Period||0
11068760|NCT01055028|12250313|FG001|NOT COMPLETED|Inter-treatment Period||3
11068761|NCT01055028|12250312|FG000|STARTED|Treatment Cycles 4 to 6||6
11068762|NCT01055028|12250313|FG001|STARTED|Treatment Cycles 4 to 6||2
11068763|NCT01055028|12250312|FG000|COMPLETED|Treatment Cycles 4 to 6||6
11068764|NCT01055028|12250313|FG001|COMPLETED|Treatment Cycles 4 to 6||2
11068765|NCT01055028|12250312|FG000|NOT COMPLETED|Treatment Cycles 4 to 6||0
11068766|NCT01055028|12250313|FG001|NOT COMPLETED|Treatment Cycles 4 to 6||0
11068767|NCT01055067|12250323|FG000|STARTED|Overall Study||27
11068768|NCT01055067|12250323|FG000|COMPLETED|Overall Study||27
11068769|NCT01055067|12250323|FG000|NOT COMPLETED|Overall Study||0
11068770|NCT01055132|12250329|FG000|STARTED|Period 1 (5-9 Days)||36
11346464|NCT02980692|12543697|FG003|NOT COMPLETED|Overall Study||9
11346465|NCT02980692|12543698|FG004|NOT COMPLETED|Overall Study||11
11346466|NCT02980705|12543713|FG000|STARTED|Overall Study||50
11346467|NCT02980705|12543714|FG001|STARTED|Overall Study||51
11346468|NCT02980705|12543713|FG000|COMPLETED|Overall Study||42
11346469|NCT02980705|12543714|FG001|COMPLETED|Overall Study||40
11346470|NCT02980705|12543713|FG000|NOT COMPLETED|Overall Study||8
11346471|NCT02980705|12543714|FG001|NOT COMPLETED|Overall Study||11
11346472|NCT02980783|12543721|FG000|STARTED|Overall Study||53
11346473|NCT02980783|12543721|FG000|COMPLETED|Overall Study||52
11346474|NCT02980783|12543721|FG000|NOT COMPLETED|Overall Study||1
11346475|NCT02980874|12543727|FG000|STARTED|Overall Study||231
11346476|NCT02980874|12543728|FG001|STARTED|Overall Study||229
11346477|NCT02980874|12543727|FG000|COMPLETED|Overall Study||128
11346478|NCT02980874|12543728|FG001|COMPLETED|Overall Study||127
11346479|NCT02980874|12543727|FG000|NOT COMPLETED|Overall Study||103
11346480|NCT02980874|12543728|FG001|NOT COMPLETED|Overall Study||102
11346481|NCT02980978|12543736|FG000|STARTED|Overall Study||60
11346482|NCT02980978|12543737|FG001|STARTED|Overall Study||58
11346483|NCT02980978|12543736|FG000|COMPLETED|Overall Study||54
11346484|NCT02980978|12543737|FG001|COMPLETED|Overall Study||50
11346485|NCT02980978|12543736|FG000|NOT COMPLETED|Overall Study||6
11346486|NCT02980978|12543737|FG001|NOT COMPLETED|Overall Study||8
11346487|NCT02981342|12543747|FG000|STARTED|Overall Study||7
11346488|NCT02981342|12543748|FG001|STARTED|Overall Study||33
11346489|NCT02981342|12543749|FG002|STARTED|Overall Study||33
11346490|NCT02981342|12543750|FG003|STARTED|Overall Study||33
11346491|NCT02981342|12543747|FG000|Received at Least One Dose of Study Drug|Overall Study||7
11346492|NCT02981342|12543748|FG001|Received at Least One Dose of Study Drug|Overall Study||32
11346493|NCT02981342|12543749|FG002|Received at Least One Dose of Study Drug|Overall Study||33
11346494|NCT02981342|12543750|FG003|Received at Least One Dose of Study Drug|Overall Study||26
11068771|NCT01055132|12250330|FG001|STARTED|Period 1 (5-9 Days)||33
11068772|NCT01055132|12250329|FG000|COMPLETED|Period 1 (5-9 Days)||35
11068773|NCT01055132|12250330|FG001|COMPLETED|Period 1 (5-9 Days)||33
11068774|NCT01055132|12250329|FG000|NOT COMPLETED|Period 1 (5-9 Days)||1
11068775|NCT01055132|12250330|FG001|NOT COMPLETED|Period 1 (5-9 Days)||0
11068776|NCT01055132|12250329|FG000|STARTED|Period 2 (5-9 Days)||35
11068777|NCT01055132|12250330|FG001|STARTED|Period 2 (5-9 Days)||33
11068778|NCT01055132|12250329|FG000|COMPLETED|Period 2 (5-9 Days)||35
11346495|NCT02981342|12543747|FG000|COMPLETED|Overall Study||7
11346496|NCT02981342|12543748|FG001|COMPLETED|Overall Study||22
11346497|NCT02981342|12543749|FG002|COMPLETED|Overall Study||20
11346498|NCT02981342|12543750|FG003|COMPLETED|Overall Study||19
11068779|NCT01055132|12250330|FG001|COMPLETED|Period 2 (5-9 Days)||32
11068780|NCT01055132|12250329|FG000|NOT COMPLETED|Period 2 (5-9 Days)||0
11068781|NCT01055132|12250330|FG001|NOT COMPLETED|Period 2 (5-9 Days)||1
11068782|NCT01055171|12250342|FG000|STARTED|Overall Study|Randomized to receive medication.|29
11068783|NCT01055171|12250343|FG001|STARTED|Overall Study|Randomized to receive placebo.|28
11068784|NCT01055171|12250342|FG000|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
11068785|NCT01055171|12250343|FG001|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
11068786|NCT01055171|12250342|FG000|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
11068787|NCT01055171|12250343|FG001|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
11068788|NCT01055171|12250342|FG000|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
11068789|NCT01055171|12250343|FG001|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
11068790|NCT01055171|12250342|FG000|NOT COMPLETED|Overall Study||11
11068791|NCT01055171|12250343|FG001|NOT COMPLETED|Overall Study||7
11068792|NCT01055184|12250349|FG000|STARTED|Overall Study||34
11068793|NCT01055184|12250349|FG000|COMPLETED|Overall Study||34
11068794|NCT01055184|12250349|FG000|NOT COMPLETED|Overall Study||0
11068795|NCT01055197|12250355|FG000|STARTED|Overall Study||51
11068796|NCT01055197|12250356|FG001|STARTED|Overall Study||46
11068797|NCT01055197|12250355|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
11068798|NCT01055197|12250356|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
11068799|NCT01055197|12250355|FG000|NOT COMPLETED|Overall Study||9
11068800|NCT01055197|12250356|FG001|NOT COMPLETED|Overall Study||2
11068801|NCT01055223|12250362|FG000|STARTED|Overall Study||98483
11068802|NCT01055223|12250362|FG000|COMPLETED|Overall Study||98483
11068803|NCT01055223|12250362|FG000|NOT COMPLETED|Overall Study||0
11068804|NCT01055262|12250375|FG000|STARTED|Overall Study||169
11068805|NCT01055262|12250375|FG000|COMPLETED|Overall Study||160
11068806|NCT01055262|12250375|FG000|NOT COMPLETED|Overall Study||9
11068807|NCT01055314|12250381|FG000|STARTED|Overall Study||100
11068808|NCT01055314|12250382|FG001|STARTED|Overall Study||75
11068809|NCT01055314|12250381|FG000|COMPLETED|Overall Study||55
11068810|NCT01055314|12250382|FG001|COMPLETED|Overall Study||37
11068811|NCT01055314|12250381|FG000|NOT COMPLETED|Overall Study||45
11068812|NCT01055314|12250382|FG001|NOT COMPLETED|Overall Study||38
11068813|NCT01055457|12250399|FG000|STARTED|Overall Study||40
11068814|NCT01055457|12250400|FG001|STARTED|Overall Study||40
11068815|NCT01055457|12250401|FG002|STARTED|Overall Study||38
11068816|NCT01055457|12250402|FG003|STARTED|Overall Study||40
11068817|NCT01055457|12250403|FG004|STARTED|Overall Study||41
11068818|NCT01055457|12250404|FG005|STARTED|Overall Study||18
11068819|NCT01055457|12250405|FG006|STARTED|Overall Study||19
11068820|NCT01055457|12250406|FG007|STARTED|Overall Study||19
11068821|NCT01055457|12250407|FG008|STARTED|Overall Study||20
11068822|NCT01055457|12250408|FG009|STARTED|Overall Study||20
11068823|NCT01055457|12250399|FG000|COMPLETED|Overall Study||39
11068824|NCT01055457|12250400|FG001|COMPLETED|Overall Study||39
11068825|NCT01055457|12250401|FG002|COMPLETED|Overall Study||36
11068826|NCT01055457|12250402|FG003|COMPLETED|Overall Study||37
11068827|NCT01055457|12250403|FG004|COMPLETED|Overall Study||38
11068828|NCT01055457|12250404|FG005|COMPLETED|Overall Study||15
11068829|NCT01055457|12250405|FG006|COMPLETED|Overall Study||18
11068830|NCT01055457|12250406|FG007|COMPLETED|Overall Study||18
11068831|NCT01055457|12250407|FG008|COMPLETED|Overall Study||20
11068832|NCT01055457|12250408|FG009|COMPLETED|Overall Study||19
11068833|NCT01055457|12250399|FG000|NOT COMPLETED|Overall Study||1
11068834|NCT01055457|12250400|FG001|NOT COMPLETED|Overall Study||1
11068835|NCT01055457|12250401|FG002|NOT COMPLETED|Overall Study||2
11068836|NCT01055457|12250402|FG003|NOT COMPLETED|Overall Study||3
11068837|NCT01055457|12250403|FG004|NOT COMPLETED|Overall Study||3
11068838|NCT01055457|12250404|FG005|NOT COMPLETED|Overall Study||3
11068839|NCT01055457|12250405|FG006|NOT COMPLETED|Overall Study||1
11068840|NCT01055457|12250406|FG007|NOT COMPLETED|Overall Study||1
11068841|NCT01055457|12250407|FG008|NOT COMPLETED|Overall Study||0
11068842|NCT01055457|12250408|FG009|NOT COMPLETED|Overall Study||1
11068843|NCT01055496|12250432|FG000|STARTED|Overall Study||48
11068844|NCT01055496|12250433|FG001|STARTED|Overall Study||55
11068845|NCT01055496|12250432|FG000|COMPLETED|Overall Study||33
11068846|NCT01055496|12250433|FG001|COMPLETED|Overall Study||25
11068847|NCT01055496|12250432|FG000|NOT COMPLETED|Overall Study||15
11068848|NCT01055496|12250433|FG001|NOT COMPLETED|Overall Study||30
11068849|NCT01055613|12250462|FG000|STARTED|Overall Study||200
11068850|NCT01055613|12250463|FG001|STARTED|Overall Study||100
11068851|NCT01055613|12250462|FG000|COMPLETED|Overall Study||191
11068852|NCT01055613|12250463|FG001|COMPLETED|Overall Study||96
11068853|NCT01055613|12250462|FG000|NOT COMPLETED|Overall Study||9
11068854|NCT01055613|12250463|FG001|NOT COMPLETED|Overall Study||4
11068855|NCT01055639|12250471|FG000|STARTED|Overall Study||66
11068856|NCT01055639|12250472|FG001|STARTED|Overall Study||60
11068857|NCT01055639|12250471|FG000|COMPLETED|Overall Study||45
11068858|NCT01055639|12250472|FG001|COMPLETED|Overall Study||31
11068859|NCT01055639|12250471|FG000|NOT COMPLETED|Overall Study||21
11068860|NCT01055639|12250472|FG001|NOT COMPLETED|Overall Study||29
11068861|NCT01055704|12250482|FG000|STARTED|Overall Study||16
11068862|NCT01055704|12250483|FG001|STARTED|Overall Study||8
11068863|NCT01055704|12250484|FG002|STARTED|Overall Study||16
11068864|NCT01055704|12250485|FG003|STARTED|Overall Study||8
11068865|NCT01055704|12250482|FG000|COMPLETED|Overall Study||16
11068866|NCT01055704|12250483|FG001|COMPLETED|Overall Study||8
11068867|NCT01055704|12250484|FG002|COMPLETED|Overall Study||16
11068868|NCT01055704|12250485|FG003|COMPLETED|Overall Study||8
11068869|NCT01055704|12250482|FG000|NOT COMPLETED|Overall Study||0
11068870|NCT01055704|12250483|FG001|NOT COMPLETED|Overall Study||0
11068871|NCT01055704|12250484|FG002|NOT COMPLETED|Overall Study||0
11068872|NCT01055704|12250485|FG003|NOT COMPLETED|Overall Study||0
11068873|NCT01055769|12250495|FG000|STARTED|First Intervention||10
11068874|NCT01055769|12250496|FG001|STARTED|First Intervention||10
11068875|NCT01055769|12250495|FG000|COMPLETED|First Intervention||10
11068876|NCT01055769|12250496|FG001|COMPLETED|First Intervention||10
11068877|NCT01055769|12250495|FG000|NOT COMPLETED|First Intervention||0
11068878|NCT01055769|12250496|FG001|NOT COMPLETED|First Intervention||0
11068879|NCT01055769|12250495|FG000|STARTED|Washout Period of Atleast 4 Days||10
11068880|NCT01055769|12250496|FG001|STARTED|Washout Period of Atleast 4 Days||10
11068881|NCT01055769|12250495|FG000|COMPLETED|Washout Period of Atleast 4 Days||10
11068882|NCT01055769|12250496|FG001|COMPLETED|Washout Period of Atleast 4 Days||10
11068883|NCT01055769|12250495|FG000|NOT COMPLETED|Washout Period of Atleast 4 Days||0
11068884|NCT01055769|12250496|FG001|NOT COMPLETED|Washout Period of Atleast 4 Days||0
11068885|NCT01055769|12250495|FG000|STARTED|Second Intervention||10
11068886|NCT01055769|12250496|FG001|STARTED|Second Intervention||10
11068887|NCT01055769|12250495|FG000|COMPLETED|Second Intervention||10
11068888|NCT01055769|12250496|FG001|COMPLETED|Second Intervention||10
11068889|NCT01055769|12250495|FG000|NOT COMPLETED|Second Intervention||0
11068890|NCT01055769|12250496|FG001|NOT COMPLETED|Second Intervention||0
11068891|NCT01055782|12250505|FG000|STARTED|Overall Study||555
11068892|NCT01055782|12250506|FG001|STARTED|Overall Study||449
11068893|NCT01055782|12250505|FG000|COMPLETED|Overall Study||555
11068894|NCT01055782|12250506|FG001|COMPLETED|Overall Study||449
11068895|NCT01055782|12250505|FG000|NOT COMPLETED|Overall Study||0
11068896|NCT01055782|12250506|FG001|NOT COMPLETED|Overall Study||0
11068897|NCT01055834|12250516|FG000|STARTED|Treatment Period I||21
11068898|NCT01055834|12250517|FG001|STARTED|Treatment Period I||21
11068899|NCT01055834|12250516|FG000|COMPLETED|Treatment Period I||20
11068900|NCT01055834|12250517|FG001|COMPLETED|Treatment Period I||21
11068901|NCT01055834|12250516|FG000|NOT COMPLETED|Treatment Period I||1
11068902|NCT01055834|12250517|FG001|NOT COMPLETED|Treatment Period I||0
11068903|NCT01055834|12250516|FG000|STARTED|Treatment Period II||20
11068904|NCT01055834|12250517|FG001|STARTED|Treatment Period II||21
11068905|NCT01055834|12250516|FG000|COMPLETED|Treatment Period II||20
11068906|NCT01055834|12250517|FG001|COMPLETED|Treatment Period II||21
11068907|NCT01055834|12250516|FG000|NOT COMPLETED|Treatment Period II||0
11068908|NCT01055834|12250517|FG001|NOT COMPLETED|Treatment Period II||0
11068909|NCT01055834|12250516|FG000|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
11068910|NCT01055834|12250517|FG001|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
11068911|NCT01055834|12250516|FG000|COMPLETED|Treatment Period III||0
11068912|NCT01055834|12250517|FG001|COMPLETED|Treatment Period III||14
11346499|NCT02981342|12543747|FG000|NOT COMPLETED|Overall Study||0
11346500|NCT02981342|12543748|FG001|NOT COMPLETED|Overall Study||11
11346501|NCT02981342|12543749|FG002|NOT COMPLETED|Overall Study||13
11346502|NCT02981342|12543750|FG003|NOT COMPLETED|Overall Study||14
11346503|NCT02981368|12543764|FG000|STARTED|Overall Study||268
11346504|NCT02981368|12543765|FG001|STARTED|Overall Study||117
11068913|NCT01055834|12250516|FG000|NOT COMPLETED|Treatment Period III||0
11068914|NCT01055834|12250517|FG001|NOT COMPLETED|Treatment Period III||0
11068915|NCT01055886|12250528|FG000|STARTED|Overall Study||33
11068916|NCT01055886|12250529|FG001|STARTED|Overall Study||32
11068917|NCT01055886|12250528|FG000|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
11068918|NCT01055886|12250529|FG001|Reached Pre-quit Period|Overall Study|1 lost to contact|31
11346505|NCT02981368|12543764|FG000|COMPLETED|Overall Study||248
11346506|NCT02981368|12543765|FG001|COMPLETED|Overall Study||102
11346507|NCT02981368|12543764|FG000|NOT COMPLETED|Overall Study||20
11346508|NCT02981368|12543765|FG001|NOT COMPLETED|Overall Study||15
11346509|NCT02981524|12543798|FG000|STARTED|Overall Study||17
11068919|NCT01055886|12250528|FG000|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
11068920|NCT01055886|12250529|FG001|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
11068921|NCT01055886|12250528|FG000|NOT COMPLETED|Overall Study||5
11068922|NCT01055886|12250529|FG001|NOT COMPLETED|Overall Study||11
11068923|NCT01056016|12250537|FG000|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
11068924|NCT01056016|12250538|FG001|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
11068925|NCT01056016|12250537|FG000|COMPLETED|Overall Study||20
11068926|NCT01056016|12250538|FG001|COMPLETED|Overall Study||26
11068927|NCT01056016|12250537|FG000|NOT COMPLETED|Overall Study||2
11068928|NCT01056016|12250538|FG001|NOT COMPLETED|Overall Study||1
11068929|NCT01056107|12250548|FG000|STARTED|Overall Study||11
11068930|NCT01056107|12250549|FG001|STARTED|Overall Study||11
11068931|NCT01056107|12250550|FG002|STARTED|Overall Study||12
11068932|NCT01056107|12250551|FG003|STARTED|Overall Study||12
11068933|NCT01056107|12250548|FG000|COMPLETED|Overall Study||11
11068934|NCT01056107|12250549|FG001|COMPLETED|Overall Study||10
11068935|NCT01056107|12250550|FG002|COMPLETED|Overall Study||9
11068936|NCT01056107|12250551|FG003|COMPLETED|Overall Study||12
11068937|NCT01056107|12250548|FG000|NOT COMPLETED|Overall Study||0
11068938|NCT01056107|12250549|FG001|NOT COMPLETED|Overall Study||1
11068939|NCT01056107|12250550|FG002|NOT COMPLETED|Overall Study||3
11068940|NCT01056107|12250551|FG003|NOT COMPLETED|Overall Study||0
11068941|NCT01056198|12250563|FG000|STARTED|Overall Study||24
11068942|NCT01056198|12250564|FG001|STARTED|Overall Study||24
11068943|NCT01056198|12250563|FG000|COMPLETED|Overall Study||24
11068944|NCT01056198|12250564|FG001|COMPLETED|Overall Study||24
11068945|NCT01056198|12250563|FG000|NOT COMPLETED|Overall Study||0
11068946|NCT01056198|12250564|FG001|NOT COMPLETED|Overall Study||0
11068947|NCT01056263|12250572|FG000|STARTED|Overall Study||52
11068948|NCT01056263|12250572|FG000|COMPLETED|Overall Study||0
11068949|NCT01056263|12250572|FG000|NOT COMPLETED|Overall Study||52
11068950|NCT01056276|12250578|FG000|STARTED|Treatment Period-Cycles 1-8||18
11068951|NCT01056276|12250579|FG001|STARTED|Treatment Period-Cycles 1-8||41
11068952|NCT01056276|12250578|FG000|COMPLETED|Treatment Period-Cycles 1-8||5
11068953|NCT01056276|12250579|FG001|COMPLETED|Treatment Period-Cycles 1-8||33
11068954|NCT01056276|12250578|FG000|NOT COMPLETED|Treatment Period-Cycles 1-8||13
11068955|NCT01056276|12250579|FG001|NOT COMPLETED|Treatment Period-Cycles 1-8||8
11068956|NCT01056276|12250578|FG000|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
11068957|NCT01056276|12250579|FG001|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
11068958|NCT01056276|12250578|FG000|COMPLETED|Maintenance Therapy||0
11068959|NCT01056276|12250579|FG001|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
11068960|NCT01056276|12250578|FG000|NOT COMPLETED|Maintenance Therapy||0
11068961|NCT01056276|12250579|FG001|NOT COMPLETED|Maintenance Therapy||28
11068962|NCT01056289|12250590|FG000|STARTED|Open-label Phase||480
11068963|NCT01056289|12250591|FG001|STARTED|Open-label Phase||0
11068964|NCT01056289|12250592|FG002|STARTED|Open-label Phase||0
11068965|NCT01056289|12250593|FG003|STARTED|Open-label Phase||0
11068966|NCT01056289|12250590|FG000|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
11068967|NCT01056289|12250591|FG001|COMPLETED|Open-label Phase||0
11068968|NCT01056289|12250592|FG002|COMPLETED|Open-label Phase||0
11068969|NCT01056289|12250593|FG003|COMPLETED|Open-label Phase||0
11068970|NCT01056289|12250590|FG000|NOT COMPLETED|Open-label Phase||119
11068971|NCT01056289|12250591|FG001|NOT COMPLETED|Open-label Phase||0
11068972|NCT01056289|12250592|FG002|NOT COMPLETED|Open-label Phase||0
11068973|NCT01056289|12250593|FG003|NOT COMPLETED|Open-label Phase||0
11068974|NCT01056289|12250590|FG000|STARTED|Double-blind Phase||0
11068975|NCT01056289|12250591|FG001|STARTED|Double-blind Phase||73
11068976|NCT01056289|12250592|FG002|STARTED|Double-blind Phase||140
11068977|NCT01056289|12250593|FG003|STARTED|Double-blind Phase||148
11068978|NCT01056289|12250590|FG000|COMPLETED|Double-blind Phase||0
11068979|NCT01056289|12250591|FG001|COMPLETED|Double-blind Phase||69
11068980|NCT01056289|12250592|FG002|COMPLETED|Double-blind Phase||127
11068981|NCT01056289|12250593|FG003|COMPLETED|Double-blind Phase||138
11068982|NCT01056289|12250590|FG000|NOT COMPLETED|Double-blind Phase||0
11068983|NCT01056289|12250591|FG001|NOT COMPLETED|Double-blind Phase||4
11068984|NCT01056289|12250592|FG002|NOT COMPLETED|Double-blind Phase||13
11068985|NCT01056289|12250593|FG003|NOT COMPLETED|Double-blind Phase||10
11068986|NCT01056302|12250603|FG000|STARTED|Overall Study||3
11068987|NCT01056302|12250603|FG000|COMPLETED|Overall Study|The study was completed with 3 datasets from patients who had maxillofacial trauma and were treated|3
11068988|NCT01056302|12250603|FG000|NOT COMPLETED|Overall Study||0
11068989|NCT01056328|12250610|FG000|STARTED|Overall Study||164
11068990|NCT01056328|12250611|FG001|STARTED|Overall Study||160
11068991|NCT01056328|12250610|FG000|COMPLETED|Overall Study||147
11068992|NCT01056328|12250611|FG001|COMPLETED|Overall Study||144
11068993|NCT01056328|12250610|FG000|NOT COMPLETED|Overall Study||17
11068994|NCT01056328|12250611|FG001|NOT COMPLETED|Overall Study||16
11068995|NCT01056341|12250625|FG000|STARTED|Overall Study||55
11068996|NCT01056341|12250626|FG001|STARTED|Overall Study||99
11068997|NCT01056341|12250627|FG002|STARTED|Overall Study||103
11068998|NCT01056341|12250628|FG003|STARTED|Overall Study||101
11068999|NCT01056341|12250629|FG004|STARTED|Overall Study||102
11069000|NCT01056341|12250625|FG000|Interim Analysis|Overall Study||25
11069001|NCT01056341|12250626|FG001|Interim Analysis|Overall Study||41
11069002|NCT01056341|12250627|FG002|Interim Analysis|Overall Study||41
11069003|NCT01056341|12250628|FG003|Interim Analysis|Overall Study||40
11069004|NCT01056341|12250629|FG004|Interim Analysis|Overall Study||43
11069005|NCT01056341|12250625|FG000|COMPLETED|Overall Study||19
11069006|NCT01056341|12250626|FG001|COMPLETED|Overall Study||63
11069007|NCT01056341|12250627|FG002|COMPLETED|Overall Study||88
11069008|NCT01056341|12250628|FG003|COMPLETED|Overall Study||65
11069009|NCT01056341|12250629|FG004|COMPLETED|Overall Study||88
11069010|NCT01056341|12250625|FG000|NOT COMPLETED|Overall Study||36
11069011|NCT01056341|12250626|FG001|NOT COMPLETED|Overall Study||36
11069012|NCT01056341|12250627|FG002|NOT COMPLETED|Overall Study||15
11069013|NCT01056341|12250628|FG003|NOT COMPLETED|Overall Study||36
11069014|NCT01056341|12250629|FG004|NOT COMPLETED|Overall Study||14
11069015|NCT01056380|12250649|FG000|STARTED|Overall Study||37
11069016|NCT01056380|12250650|FG001|STARTED|Overall Study||42
11069017|NCT01056380|12250649|FG000|COMPLETED|Overall Study||35
11069018|NCT01056380|12250650|FG001|COMPLETED|Overall Study||39
11069019|NCT01056380|12250649|FG000|NOT COMPLETED|Overall Study||2
11069020|NCT01056380|12250650|FG001|NOT COMPLETED|Overall Study||3
11069021|NCT01056484|12250660|FG000|STARTED|Randomized Controlled Trial||64
11069022|NCT01056484|12250661|FG001|STARTED|Randomized Controlled Trial||59
11069023|NCT01056484|12250660|FG000|COMPLETED|Randomized Controlled Trial||57
11069024|NCT01056484|12250661|FG001|COMPLETED|Randomized Controlled Trial||58
11069025|NCT01056484|12250660|FG000|NOT COMPLETED|Randomized Controlled Trial||7
11069026|NCT01056484|12250661|FG001|NOT COMPLETED|Randomized Controlled Trial||1
11069027|NCT01056484|12250660|FG000|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
11069028|NCT01056484|12250661|FG001|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
11069029|NCT01056484|12250660|FG000|COMPLETED|Follow up - Non-randomized||57
11069030|NCT01056484|12250661|FG001|COMPLETED|Follow up - Non-randomized||56
11069031|NCT01056484|12250660|FG000|NOT COMPLETED|Follow up - Non-randomized||0
11069032|NCT01056484|12250661|FG001|NOT COMPLETED|Follow up - Non-randomized||2
11069033|NCT01056510|12250670|FG000|STARTED|Overall Study||178
11069034|NCT01056510|12250671|FG001|STARTED|Overall Study||179
11069035|NCT01056510|12250670|FG000|COMPLETED|Overall Study||124
11069036|NCT01056510|12250671|FG001|COMPLETED|Overall Study||115
11069037|NCT01056510|12250670|FG000|NOT COMPLETED|Overall Study||54
11069038|NCT01056510|12250671|FG001|NOT COMPLETED|Overall Study||64
11069039|NCT01056523|12250677|FG000|STARTED|Overall Study||4
11069040|NCT01056523|12250678|FG001|STARTED|Overall Study||3
11069041|NCT01056523|12250679|FG002|STARTED|Overall Study||5
11069042|NCT01056523|12250680|FG003|STARTED|Overall Study||6
11069043|NCT01056523|12250681|FG004|STARTED|Overall Study||3
11069044|NCT01056523|12250682|FG005|STARTED|Overall Study||3
11069045|NCT01056523|12250683|FG006|STARTED|Overall Study||5
11069046|NCT01056523|12250677|FG000|COMPLETED|Overall Study||3
11069047|NCT01056523|12250678|FG001|COMPLETED|Overall Study||3
11069048|NCT01056523|12250679|FG002|COMPLETED|Overall Study||3
11069049|NCT01056523|12250680|FG003|COMPLETED|Overall Study||3
11069050|NCT01056523|12250681|FG004|COMPLETED|Overall Study||3
11069051|NCT01056523|12250682|FG005|COMPLETED|Overall Study||3
11069052|NCT01056523|12250683|FG006|COMPLETED|Overall Study||4
11069053|NCT01056523|12250677|FG000|NOT COMPLETED|Overall Study||1
11069054|NCT01056523|12250678|FG001|NOT COMPLETED|Overall Study||0
11069055|NCT01056523|12250679|FG002|NOT COMPLETED|Overall Study||2
11069056|NCT01056523|12250680|FG003|NOT COMPLETED|Overall Study||3
11069057|NCT01056523|12250681|FG004|NOT COMPLETED|Overall Study||0
11069058|NCT01056523|12250682|FG005|NOT COMPLETED|Overall Study||0
11069059|NCT01056523|12250683|FG006|NOT COMPLETED|Overall Study||1
11069060|NCT01056536|12250691|FG000|STARTED|Overall Study||596
11069061|NCT01056536|12250692|FG001|STARTED|Overall Study||356
11069062|NCT01056536|12250693|FG002|STARTED|Overall Study||729
11069063|NCT01056536|12250691|FG000|COMPLETED|Overall Study||394
11069064|NCT01056536|12250692|FG001|COMPLETED|Overall Study||240
11069065|NCT01056536|12250693|FG002|COMPLETED|Overall Study||481
11069066|NCT01056536|12250691|FG000|NOT COMPLETED|Overall Study||202
11069067|NCT01056536|12250692|FG001|NOT COMPLETED|Overall Study||116
11069068|NCT01056536|12250693|FG002|NOT COMPLETED|Overall Study||248
11069069|NCT01056601|12250701|FG000|STARTED|Overall Study||7
11069070|NCT01056601|12250701|FG000|COMPLETED|Overall Study||7
11069071|NCT01056601|12250701|FG000|NOT COMPLETED|Overall Study||0
11069072|NCT01056640|12250707|FG000|STARTED|Overall Study||102
11069073|NCT01056640|12250708|FG001|STARTED|Overall Study||103
11069074|NCT01056640|12250707|FG000|COMPLETED|Overall Study||76
11069075|NCT01056640|12250708|FG001|COMPLETED|Overall Study||91
11069076|NCT01056640|12250707|FG000|NOT COMPLETED|Overall Study||26
11069077|NCT01056640|12250708|FG001|NOT COMPLETED|Overall Study||12
11346510|NCT02981524|12543798|FG000|COMPLETED|Overall Study||0
11346511|NCT02981524|12543798|FG000|NOT COMPLETED|Overall Study||17
11346512|NCT02981602|12543807|FG000|STARTED|Overall Study||6
11346513|NCT02981602|12543808|FG001|STARTED|Overall Study||12
11346514|NCT02981602|12543809|FG002|STARTED|Overall Study||6
11346515|NCT02981602|12543810|FG003|STARTED|Overall Study||5
11346516|NCT02981602|12543811|FG004|STARTED|Overall Study||2
11069078|NCT01056653|12250717|FG000|STARTED|Overall Study||46
11069079|NCT01056653|12250718|FG001|STARTED|Overall Study||23
11069080|NCT01056653|12250719|FG002|STARTED|Overall Study||44
11069081|NCT01056653|12250717|FG000|COMPLETED|Overall Study||46
11069082|NCT01056653|12250718|FG001|COMPLETED|Overall Study||23
11069083|NCT01056653|12250719|FG002|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
11069084|NCT01056653|12250717|FG000|NOT COMPLETED|Overall Study||0
11069085|NCT01056653|12250718|FG001|NOT COMPLETED|Overall Study||0
11069086|NCT01056653|12250719|FG002|NOT COMPLETED|Overall Study||2
11069087|NCT01056718|12250728|FG000|STARTED|Overall Study||53
11069088|NCT01056718|12250728|FG000|COMPLETED|Overall Study||50
11346517|NCT02981602|12543807|FG000|COMPLETED|Overall Study||6
11346518|NCT02981602|12543808|FG001|COMPLETED|Overall Study||12
11346519|NCT02981602|12543809|FG002|COMPLETED|Overall Study||6
11346520|NCT02981602|12543810|FG003|COMPLETED|Overall Study||4
11346521|NCT02981602|12543811|FG004|COMPLETED|Overall Study||2
11346522|NCT02981602|12543807|FG000|NOT COMPLETED|Overall Study||0
11346523|NCT02981602|12543808|FG001|NOT COMPLETED|Overall Study||0
11346524|NCT02981602|12543809|FG002|NOT COMPLETED|Overall Study||0
11346525|NCT02981602|12543810|FG003|NOT COMPLETED|Overall Study||1
11346526|NCT02981602|12543811|FG004|NOT COMPLETED|Overall Study||0
11346527|NCT02981953|12543824|FG000|STARTED|Overall Study||40
11346528|NCT02981953|12543824|FG000|COMPLETED|Overall Study||29
11346529|NCT02981953|12543824|FG000|NOT COMPLETED|Overall Study||11
11346530|NCT02982018|12543830|FG000|STARTED|Overall Study||67
11346531|NCT02982018|12543831|FG001|STARTED|Overall Study||64
11346532|NCT02982018|12543830|FG000|COMPLETED|Overall Study||62
11346533|NCT02982018|12543831|FG001|COMPLETED|Overall Study||61
11346534|NCT02982018|12543830|FG000|NOT COMPLETED|Overall Study||5
11346535|NCT02982018|12543831|FG001|NOT COMPLETED|Overall Study||3
11346536|NCT02982187|12543839|FG000|STARTED|Overall Study||20
11346537|NCT02982187|12543840|FG001|STARTED|Overall Study||20
11346538|NCT02982187|12543841|FG002|STARTED|Overall Study||20
11346539|NCT02982187|12543842|FG003|STARTED|Overall Study||20
11346540|NCT02982187|12543843|FG004|STARTED|Overall Study||20
11346541|NCT02982187|12543844|FG005|STARTED|Overall Study||20
11346542|NCT02982187|12543845|FG006|STARTED|Overall Study||20
11346543|NCT02982187|12543846|FG007|STARTED|Overall Study||20
11346544|NCT02982187|12543839|FG000|COMPLETED|Overall Study||20
11346545|NCT02982187|12543840|FG001|COMPLETED|Overall Study||20
11346546|NCT02982187|12543841|FG002|COMPLETED|Overall Study||20
11346547|NCT02982187|12543842|FG003|COMPLETED|Overall Study||20
11346548|NCT02982187|12543843|FG004|COMPLETED|Overall Study||20
11069089|NCT01056718|12250728|FG000|NOT COMPLETED|Overall Study||3
11069090|NCT01056822|12250735|FG000|STARTED|Overall Study||47
11069091|NCT01056822|12250736|FG001|STARTED|Overall Study||42
11069092|NCT01056822|12250735|FG000|Intention-to-treat (ITT) Population: YES|Overall Study||43
11069093|NCT01056822|12250736|FG001|Intention-to-treat (ITT) Population: YES|Overall Study||38
11069094|NCT01056822|12250735|FG000|Intention-to-treat (ITT) Population: NO|Overall Study||4
11069095|NCT01056822|12250736|FG001|Intention-to-treat (ITT) Population: NO|Overall Study||4
11069096|NCT01056822|12250735|FG000|Per-protocol (PP) Population: YES|Overall Study||29
11069097|NCT01056822|12250736|FG001|Per-protocol (PP) Population: YES|Overall Study||25
11069098|NCT01056822|12250735|FG000|Per-protocol (PP) Population: NO|Overall Study||18
11069099|NCT01056822|12250736|FG001|Per-protocol (PP) Population: NO|Overall Study||17
11069100|NCT01056822|12250735|FG000|Safety (SAF) Population: YES|Overall Study||46
11069101|NCT01056822|12250736|FG001|Safety (SAF) Population: YES|Overall Study||40
11069102|NCT01056822|12250735|FG000|Safety (SAF) Population: NO|Overall Study||1
11069103|NCT01056822|12250736|FG001|Safety (SAF) Population: NO|Overall Study||2
11069104|NCT01056822|12250735|FG000|COMPLETED|Overall Study||39
11069105|NCT01056822|12250736|FG001|COMPLETED|Overall Study||35
11069106|NCT01056822|12250735|FG000|NOT COMPLETED|Overall Study||8
11069107|NCT01056822|12250736|FG001|NOT COMPLETED|Overall Study||7
11069108|NCT01056913|12250743|FG000|STARTED|Overall Study||62
11069109|NCT01056913|12250743|FG000|COMPLETED|Overall Study||62
11069110|NCT01056913|12250743|FG000|NOT COMPLETED|Overall Study||0
11069111|NCT01057017|12250747|FG000|STARTED|Overall Study||5
11069112|NCT01057017|12250747|FG000|COMPLETED|Overall Study||5
11069113|NCT01057017|12250747|FG000|NOT COMPLETED|Overall Study||0
11069114|NCT01057225|12250751|FG000|STARTED|Overall Study||3
11069115|NCT01057225|12250752|FG001|STARTED|Overall Study||3
11069116|NCT01057225|12250753|FG002|STARTED|Overall Study||6
11069117|NCT01057225|12250754|FG003|STARTED|Overall Study||7
11069118|NCT01057225|12250755|FG004|STARTED|Overall Study||22
11069119|NCT01057225|12250756|FG005|STARTED|Overall Study||23
11069120|NCT01057225|12250751|FG000|COMPLETED|Overall Study||3
11069121|NCT01057225|12250752|FG001|COMPLETED|Overall Study||3
11069122|NCT01057225|12250753|FG002|COMPLETED|Overall Study||6
11069123|NCT01057225|12250754|FG003|COMPLETED|Overall Study||7
11069124|NCT01057225|12250755|FG004|COMPLETED|Overall Study||22
11069125|NCT01057225|12250756|FG005|COMPLETED|Overall Study||23
11069126|NCT01057225|12250751|FG000|NOT COMPLETED|Overall Study||0
11069127|NCT01057225|12250752|FG001|NOT COMPLETED|Overall Study||0
11069128|NCT01057225|12250753|FG002|NOT COMPLETED|Overall Study||0
11069129|NCT01057225|12250754|FG003|NOT COMPLETED|Overall Study||0
11069130|NCT01057225|12250755|FG004|NOT COMPLETED|Overall Study||0
11069131|NCT01057225|12250756|FG005|NOT COMPLETED|Overall Study||0
11069132|NCT01057251|12250771|FG000|STARTED|Overall Study||290
11069133|NCT01057251|12250772|FG001|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
11069134|NCT01057251|12250771|FG000|COMPLETED|Overall Study||262
11069135|NCT01057251|12250772|FG001|COMPLETED|Overall Study||114
11069136|NCT01057251|12250771|FG000|NOT COMPLETED|Overall Study||28
11069137|NCT01057251|12250772|FG001|NOT COMPLETED|Overall Study||29
11069138|NCT01057277|12250778|FG000|STARTED|Overall Study||3
11069139|NCT01057277|12250778|FG000|COMPLETED|Overall Study||3
11069140|NCT01057277|12250778|FG000|NOT COMPLETED|Overall Study||0
11069141|NCT01057381|12250786|FG000|STARTED|Overall Study||26
11069142|NCT01057381|12250787|FG001|STARTED|Overall Study||27
11069143|NCT01057381|12250788|FG002|STARTED|Overall Study||30
11069144|NCT01057381|12250789|FG003|STARTED|Overall Study||26
11069145|NCT01057381|12250786|FG000|COMPLETED|Overall Study||26
11069146|NCT01057381|12250787|FG001|COMPLETED|Overall Study||27
11069147|NCT01057381|12250788|FG002|COMPLETED|Overall Study||30
11069148|NCT01057381|12250789|FG003|COMPLETED|Overall Study||26
11069149|NCT01057381|12250786|FG000|NOT COMPLETED|Overall Study||0
11069150|NCT01057381|12250787|FG001|NOT COMPLETED|Overall Study||0
11069151|NCT01057381|12250788|FG002|NOT COMPLETED|Overall Study||0
11069152|NCT01057381|12250789|FG003|NOT COMPLETED|Overall Study||0
11069153|NCT01057394|12250799|FG000|STARTED|Overall Study||0
11069154|NCT01057394|12250800|FG001|STARTED|Overall Study|21 enrolled participants|21
11069155|NCT01057394|12250799|FG000|COMPLETED|Overall Study||0
11069156|NCT01057394|12250800|FG001|COMPLETED|Overall Study|19 treated participants|19
11069157|NCT01057394|12250799|FG000|NOT COMPLETED|Overall Study||0
11069158|NCT01057394|12250800|FG001|NOT COMPLETED|Overall Study||2
11069159|NCT01057433|12250804|FG000|STARTED|Overall Study||24
11069160|NCT01057433|12250804|FG000|COMPLETED|Overall Study||23
11069161|NCT01057433|12250804|FG000|NOT COMPLETED|Overall Study||1
11069162|NCT01057589|12250808|FG000|STARTED|Overall Study||66
11069163|NCT01057589|12250808|FG000|COMPLETED|Overall Study||0
11069164|NCT01057589|12250808|FG000|NOT COMPLETED|Overall Study||66
11069165|NCT01057693|12250812|FG000|STARTED|Single-Blind Phase (Up to Week 6)||665
11069166|NCT01057693|12250813|FG001|STARTED|Single-Blind Phase (Up to Week 6)||0
11069167|NCT01057693|12250814|FG002|STARTED|Single-Blind Phase (Up to Week 6)||0
11069168|NCT01057693|12250812|FG000|COMPLETED|Single-Blind Phase (Up to Week 6)||566
11069169|NCT01057693|12250813|FG001|COMPLETED|Single-Blind Phase (Up to Week 6)||0
11069170|NCT01057693|12250814|FG002|COMPLETED|Single-Blind Phase (Up to Week 6)||0
11069171|NCT01057693|12250812|FG000|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
11069172|NCT01057693|12250813|FG001|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
11069173|NCT01057693|12250814|FG002|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
11069174|NCT01057693|12250812|FG000|STARTED|Between Single-Blind and Double-Blind||566
11069175|NCT01057693|12250813|FG001|STARTED|Between Single-Blind and Double-Blind||0
11069176|NCT01057693|12250814|FG002|STARTED|Between Single-Blind and Double-Blind||0
11069177|NCT01057693|12250812|FG000|COMPLETED|Between Single-Blind and Double-Blind||296
11069178|NCT01057693|12250813|FG001|COMPLETED|Between Single-Blind and Double-Blind||0
11069179|NCT01057693|12250814|FG002|COMPLETED|Between Single-Blind and Double-Blind||0
11069180|NCT01057693|12250812|FG000|NOT COMPLETED|Between Single-Blind and Double-Blind||270
11069181|NCT01057693|12250813|FG001|NOT COMPLETED|Between Single-Blind and Double-Blind||0
11069182|NCT01057693|12250814|FG002|NOT COMPLETED|Between Single-Blind and Double-Blind||0
11069183|NCT01057693|12250812|FG000|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
11069184|NCT01057693|12250813|FG001|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
11069185|NCT01057693|12250814|FG002|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
11069186|NCT01057693|12250812|FG000|Treated|Double-Blind Phase (Week 7 to Week 19)||0
11069187|NCT01057693|12250813|FG001|Treated|Double-Blind Phase (Week 7 to Week 19)||147
11069188|NCT01057693|12250814|FG002|Treated|Double-Blind Phase (Week 7 to Week 19)||147
11069189|NCT01057693|12250812|FG000|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
11069190|NCT01057693|12250813|FG001|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
11069191|NCT01057693|12250814|FG002|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
11069192|NCT01057693|12250812|FG000|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
11069193|NCT01057693|12250813|FG001|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
11069194|NCT01057693|12250814|FG002|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
11069195|NCT01057810|12250824|FG000|STARTED|Overall Study||199
11069196|NCT01057810|12250825|FG001|STARTED|Overall Study||399
11069197|NCT01057810|12250824|FG000|COMPLETED|Overall Study||1
11069198|NCT01057810|12250825|FG001|COMPLETED|Overall Study||1
11069199|NCT01057810|12250824|FG000|NOT COMPLETED|Overall Study||198
11069200|NCT01057810|12250825|FG001|NOT COMPLETED|Overall Study||398
11069201|NCT01057862|12250833|FG000|STARTED|Overall Study||5
11069202|NCT01057862|12250834|FG001|STARTED|Overall Study||4
11069203|NCT01057862|12250833|FG000|COMPLETED|Overall Study||4
11069204|NCT01057862|12250834|FG001|COMPLETED|Overall Study||2
11069205|NCT01057862|12250833|FG000|NOT COMPLETED|Overall Study||1
11069206|NCT01057862|12250834|FG001|NOT COMPLETED|Overall Study||2
11069207|NCT01057888|12250843|FG000|STARTED|Overall Study||2504
11069208|NCT01057888|12250844|FG001|STARTED|Overall Study||2406
11069209|NCT01057888|12250845|FG002|STARTED|Overall Study||2494
11069210|NCT01057888|12250843|FG000|COMPLETED|Overall Study||2504
11069211|NCT01057888|12250844|FG001|COMPLETED|Overall Study||2406
11069212|NCT01057888|12250845|FG002|COMPLETED|Overall Study||2494
11069213|NCT01057888|12250843|FG000|NOT COMPLETED|Overall Study||0
11069214|NCT01057888|12250844|FG001|NOT COMPLETED|Overall Study||0
11069215|NCT01057888|12250845|FG002|NOT COMPLETED|Overall Study||0
11069216|NCT01057901|12250853|FG000|STARTED|Overall Study||376
11069217|NCT01057901|12250854|FG001|STARTED|Overall Study||372
11069218|NCT01057901|12250853|FG000|COMPLETED|Overall Study||116
11069219|NCT01057901|12250854|FG001|COMPLETED|Overall Study||126
11069220|NCT01057901|12250853|FG000|NOT COMPLETED|Overall Study||260
11069221|NCT01057901|12250854|FG001|NOT COMPLETED|Overall Study||246
11069222|NCT01058005|12250863|FG000|STARTED|Overall Study||38
11069223|NCT01058005|12250864|FG001|STARTED|Overall Study||25
11069224|NCT01058005|12250865|FG002|STARTED|Overall Study||21
11069225|NCT01058005|12250863|FG000|Dosed With Study Treatment|Overall Study||36
11069226|NCT01058005|12250864|FG001|Dosed With Study Treatment|Overall Study||22
11069227|NCT01058005|12250865|FG002|Dosed With Study Treatment|Overall Study||17
11069228|NCT01058005|12250863|FG000|COMPLETED|Overall Study||0
11069229|NCT01058005|12250864|FG001|COMPLETED|Overall Study||0
11069230|NCT01058005|12250865|FG002|COMPLETED|Overall Study||1
11069231|NCT01058005|12250863|FG000|NOT COMPLETED|Overall Study||38
11069232|NCT01058005|12250864|FG001|NOT COMPLETED|Overall Study||25
11069233|NCT01058005|12250865|FG002|NOT COMPLETED|Overall Study||20
11069234|NCT01058070|12250873|FG000|STARTED|Overall Study||44
11069235|NCT01058070|12250873|FG000|COMPLETED|Overall Study||33
11069236|NCT01058070|12250873|FG000|NOT COMPLETED|Overall Study||11
11069237|NCT01058096|12250880|FG000|STARTED|Double-blind Treatment Phase||154
11069238|NCT01058096|12250881|FG001|STARTED|Double-blind Treatment Phase||158
11069239|NCT01058096|12250880|FG000|COMPLETED|Double-blind Treatment Phase||106
11069240|NCT01058096|12250881|FG001|COMPLETED|Double-blind Treatment Phase||108
11069241|NCT01058096|12250880|FG000|NOT COMPLETED|Double-blind Treatment Phase||48
11069242|NCT01058096|12250881|FG001|NOT COMPLETED|Double-blind Treatment Phase||50
11069243|NCT01058096|12250880|FG000|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
11069244|NCT01058096|12250881|FG001|STARTED|Safety Follow-up||134
11069245|NCT01058096|12250880|FG000|COMPLETED|Safety Follow-up||129
11069246|NCT01058096|12250881|FG001|COMPLETED|Safety Follow-up||130
11069247|NCT01058096|12250880|FG000|NOT COMPLETED|Safety Follow-up||4
11069248|NCT01058096|12250881|FG001|NOT COMPLETED|Safety Follow-up||4
11069249|NCT01058239|12250887|FG000|STARTED|Overall Study||7
11069250|NCT01058239|12250887|FG000|COMPLETED|Overall Study||7
11069251|NCT01058239|12250887|FG000|NOT COMPLETED|Overall Study||0
11069252|NCT01058265|12250893|FG000|STARTED|Overall Study||22
11069253|NCT01058265|12250894|FG001|STARTED|Overall Study||25
11069254|NCT01058265|12250893|FG000|COMPLETED|Overall Study||11
11069255|NCT01058265|12250894|FG001|COMPLETED|Overall Study||13
11069256|NCT01058265|12250893|FG000|NOT COMPLETED|Overall Study||11
11069257|NCT01058265|12250894|FG001|NOT COMPLETED|Overall Study||12
11069258|NCT01058304|12250902|FG000|STARTED|Overall Study||159
11069259|NCT01058304|12250903|FG001|STARTED|Overall Study||161
11069260|NCT01058304|12250902|FG000|COMPLETED|Overall Study||132
11069261|NCT01058304|12250903|FG001|COMPLETED|Overall Study||128
11069262|NCT01058304|12250902|FG000|NOT COMPLETED|Overall Study||27
11069263|NCT01058304|12250903|FG001|NOT COMPLETED|Overall Study||33
11069264|NCT01058356|12250909|FG000|STARTED|Overall Study||214
11069265|NCT01058356|12250909|FG000|COMPLETED|Overall Study||172
11069266|NCT01058356|12250909|FG000|NOT COMPLETED|Overall Study||42
11069267|NCT01058395|12250915|FG000|STARTED|Overall Study||7
11069268|NCT01058395|12250916|FG001|STARTED|Overall Study||8
11069269|NCT01058395|12250915|FG000|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
11069270|NCT01058395|12250916|FG001|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
11069271|NCT01058395|12250915|FG000|NOT COMPLETED|Overall Study||3
11069272|NCT01058395|12250916|FG001|NOT COMPLETED|Overall Study||1
11069273|NCT01058421|12250924|FG000|STARTED|1 Month Outcomes||59
11069274|NCT01058421|12250925|FG001|STARTED|1 Month Outcomes||61
11069275|NCT01058421|12250924|FG000|COMPLETED|1 Month Outcomes||20
11069276|NCT01058421|12250925|FG001|COMPLETED|1 Month Outcomes||19
11069277|NCT01058421|12250924|FG000|NOT COMPLETED|1 Month Outcomes||39
11069278|NCT01058421|12250925|FG001|NOT COMPLETED|1 Month Outcomes||42
11069279|NCT01058421|12250924|FG000|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
11069280|NCT01058421|12250925|FG001|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
11069281|NCT01058421|12250924|FG000|COMPLETED|3 Month Outcomes||29
11069282|NCT01058421|12250925|FG001|COMPLETED|3 Month Outcomes||29
11346549|NCT02982187|12543844|FG005|COMPLETED|Overall Study||20
11346550|NCT02982187|12543845|FG006|COMPLETED|Overall Study||19
11346551|NCT02982187|12543846|FG007|COMPLETED|Overall Study||20
11346552|NCT02982187|12543839|FG000|NOT COMPLETED|Overall Study||0
11346553|NCT02982187|12543840|FG001|NOT COMPLETED|Overall Study||0
11346554|NCT02982187|12543841|FG002|NOT COMPLETED|Overall Study||0
11346555|NCT02982187|12543842|FG003|NOT COMPLETED|Overall Study||0
11346556|NCT02982187|12543843|FG004|NOT COMPLETED|Overall Study||0
11346557|NCT02982187|12543844|FG005|NOT COMPLETED|Overall Study||0
11346558|NCT02982187|12543845|FG006|NOT COMPLETED|Overall Study||1
11346559|NCT02982187|12543846|FG007|NOT COMPLETED|Overall Study||0
11346560|NCT02982213|12543858|FG000|STARTED|Overall Study||75
11346561|NCT02982213|12543859|FG001|STARTED|Overall Study||75
11346562|NCT02982213|12543858|FG000|COMPLETED|Overall Study||70
11346563|NCT02982213|12543859|FG001|COMPLETED|Overall Study||74
11346564|NCT02982213|12543858|FG000|NOT COMPLETED|Overall Study||5
11346565|NCT02982213|12543859|FG001|NOT COMPLETED|Overall Study||1
11069283|NCT01058421|12250924|FG000|NOT COMPLETED|3 Month Outcomes||20
11069284|NCT01058421|12250925|FG001|NOT COMPLETED|3 Month Outcomes||26
11069285|NCT01058421|12250924|FG000|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
11069286|NCT01058421|12250925|FG001|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
11069287|NCT01058421|12250924|FG000|COMPLETED|6 Month Outcomes||27
11069288|NCT01058421|12250925|FG001|COMPLETED|6 Month Outcomes||24
11346566|NCT02982239|12543867|FG000|STARTED|Overall Study||20
11346567|NCT02982239|12543868|FG001|STARTED|Overall Study||20
11069289|NCT01058421|12250924|FG000|NOT COMPLETED|6 Month Outcomes||19
11069290|NCT01058421|12250925|FG001|NOT COMPLETED|6 Month Outcomes||26
11069291|NCT01058655|12250935|FG000|STARTED|Overall Study||3
11069292|NCT01058655|12250936|FG001|STARTED|Overall Study||3
11069293|NCT01058655|12250937|FG002|STARTED|Overall Study||8
11069294|NCT01058655|12250938|FG003|STARTED|Overall Study||42
11069295|NCT01058655|12250935|FG000|Evaluable|Overall Study||3
11346568|NCT02982239|12543867|FG000|COMPLETED|Overall Study||17
11069296|NCT01058655|12250936|FG001|Evaluable|Overall Study||3
11069297|NCT01058655|12250937|FG002|Evaluable|Overall Study||6
11069298|NCT01058655|12250938|FG003|Evaluable|Overall Study||40
11069299|NCT01058655|12250935|FG000|COMPLETED|Overall Study||0
11069300|NCT01058655|12250936|FG001|COMPLETED|Overall Study||0
11069301|NCT01058655|12250937|FG002|COMPLETED|Overall Study||0
11069302|NCT01058655|12250938|FG003|COMPLETED|Overall Study||0
11069303|NCT01058655|12250935|FG000|NOT COMPLETED|Overall Study||3
11069304|NCT01058655|12250936|FG001|NOT COMPLETED|Overall Study||3
11069305|NCT01058655|12250937|FG002|NOT COMPLETED|Overall Study||8
11069306|NCT01058655|12250938|FG003|NOT COMPLETED|Overall Study||42
11346569|NCT02982239|12543868|FG001|COMPLETED|Overall Study||18
11346570|NCT02982239|12543867|FG000|NOT COMPLETED|Overall Study||3
11346571|NCT02982239|12543868|FG001|NOT COMPLETED|Overall Study||2
11346572|NCT02982590|12543877|FG000|STARTED|Overall Study||13
11346573|NCT02982590|12543878|FG001|STARTED|Overall Study||14
11346574|NCT02982590|12543877|FG000|COMPLETED|Overall Study||9
11346575|NCT02982590|12543878|FG001|COMPLETED|Overall Study||13
11346576|NCT02982590|12543877|FG000|NOT COMPLETED|Overall Study||4
11346577|NCT02982590|12543878|FG001|NOT COMPLETED|Overall Study||1
11346578|NCT02982772|12543886|FG000|STARTED|Enrollment||245
11346579|NCT02982772|12543887|FG001|STARTED|Enrollment||243
11346580|NCT02982772|12543886|FG000|COMPLETED|Enrollment||245
11346581|NCT02982772|12543887|FG001|COMPLETED|Enrollment||243
11346582|NCT02982772|12543886|FG000|NOT COMPLETED|Enrollment||0
11346583|NCT02982772|12543887|FG001|NOT COMPLETED|Enrollment||0
11346584|NCT02982772|12543886|FG000|STARTED|Intervention||245
11346585|NCT02982772|12543887|FG001|STARTED|Intervention||243
11346586|NCT02982772|12543886|FG000|COMPLETED|Intervention||226
11346587|NCT02982772|12543887|FG001|COMPLETED|Intervention||230
11346588|NCT02982772|12543886|FG000|NOT COMPLETED|Intervention||19
11346589|NCT02982772|12543887|FG001|NOT COMPLETED|Intervention||13
11346590|NCT02982772|12543886|FG000|STARTED|1M Follow-Up||226
11346591|NCT02982772|12543887|FG001|STARTED|1M Follow-Up||230
11346592|NCT02982772|12543886|FG000|COMPLETED|1M Follow-Up||205
11346593|NCT02982772|12543887|FG001|COMPLETED|1M Follow-Up||212
11346594|NCT02982772|12543886|FG000|NOT COMPLETED|1M Follow-Up||21
11346595|NCT02982772|12543887|FG001|NOT COMPLETED|1M Follow-Up||18
11346596|NCT02982772|12543886|FG000|STARTED|3M Follow-Up||205
11346597|NCT02982772|12543887|FG001|STARTED|3M Follow-Up||212
11346598|NCT02982772|12543886|FG000|COMPLETED|3M Follow-Up||188
11346599|NCT02982772|12543887|FG001|COMPLETED|3M Follow-Up||201
11346600|NCT02982772|12543886|FG000|NOT COMPLETED|3M Follow-Up||17
11069307|NCT01058668|12250952|FG000|STARTED|Double-blind Treatment Phase||161
11069308|NCT01058668|12250953|FG001|STARTED|Double-blind Treatment Phase||167
11069309|NCT01058668|12250954|FG002|STARTED|Double-blind Treatment Phase||169
11069310|NCT01058668|12250952|FG000|COMPLETED|Double-blind Treatment Phase||122
11346601|NCT02982772|12543887|FG001|NOT COMPLETED|3M Follow-Up||11
11346602|NCT02982772|12543886|FG000|STARTED|6M Follow-Up||188
11346603|NCT02982772|12543887|FG001|STARTED|6M Follow-Up||201
11346604|NCT02982772|12543886|FG000|COMPLETED|6M Follow-Up||177
11069311|NCT01058668|12250953|FG001|COMPLETED|Double-blind Treatment Phase||129
11069312|NCT01058668|12250954|FG002|COMPLETED|Double-blind Treatment Phase||119
11069313|NCT01058668|12250952|FG000|NOT COMPLETED|Double-blind Treatment Phase||39
11069314|NCT01058668|12250953|FG001|NOT COMPLETED|Double-blind Treatment Phase||38
11069315|NCT01058668|12250954|FG002|NOT COMPLETED|Double-blind Treatment Phase||50
11069316|NCT01058668|12250952|FG000|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
11069317|NCT01058668|12250953|FG001|STARTED|Safety Follow-up||146
11069318|NCT01058668|12250954|FG002|STARTED|Safety Follow-up||148
11069319|NCT01058668|12250952|FG000|COMPLETED|Safety Follow-up||139
11069320|NCT01058668|12250953|FG001|COMPLETED|Safety Follow-up||146
11069321|NCT01058668|12250954|FG002|COMPLETED|Safety Follow-up||141
11069322|NCT01058668|12250952|FG000|NOT COMPLETED|Safety Follow-up||5
11069323|NCT01058668|12250953|FG001|NOT COMPLETED|Safety Follow-up||0
11069324|NCT01058668|12250954|FG002|NOT COMPLETED|Safety Follow-up||7
11069325|NCT01058707|12250969|FG000|STARTED|Overall Study||31
11069326|NCT01058707|12250970|FG001|STARTED|Overall Study||30
11069327|NCT01058707|12250971|FG002|STARTED|Overall Study||33
11069328|NCT01058707|12250972|FG003|STARTED|Overall Study||22
11069329|NCT01058707|12250973|FG004|STARTED|Overall Study||39
11069330|NCT01058707|12250974|FG005|STARTED|Overall Study||17
11069331|NCT01058707|12250975|FG006|STARTED|Overall Study||26
11069332|NCT01058707|12250969|FG000|COMPLETED|Overall Study||0
11069333|NCT01058707|12250970|FG001|COMPLETED|Overall Study||0
11069334|NCT01058707|12250971|FG002|COMPLETED|Overall Study||0
11069335|NCT01058707|12250972|FG003|COMPLETED|Overall Study||0
11069336|NCT01058707|12250973|FG004|COMPLETED|Overall Study||0
11069337|NCT01058707|12250974|FG005|COMPLETED|Overall Study||0
11069338|NCT01058707|12250975|FG006|COMPLETED|Overall Study||0
11069339|NCT01058707|12250969|FG000|NOT COMPLETED|Overall Study||31
11069340|NCT01058707|12250970|FG001|NOT COMPLETED|Overall Study||30
11069341|NCT01058707|12250971|FG002|NOT COMPLETED|Overall Study||33
11069342|NCT01058707|12250972|FG003|NOT COMPLETED|Overall Study||22
11069343|NCT01058707|12250973|FG004|NOT COMPLETED|Overall Study||39
11069344|NCT01058707|12250974|FG005|NOT COMPLETED|Overall Study||17
11069345|NCT01058707|12250975|FG006|NOT COMPLETED|Overall Study||26
11069346|NCT01058863|12251013|FG000|STARTED|Overall Study||72
11069347|NCT01058863|12251013|FG000|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
11069348|NCT01058863|12251013|FG000|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
11069349|NCT01058863|12251013|FG000|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
11069350|NCT01058863|12251013|FG000|Treated With ProAir® HFA 90 mcg|Overall Study||70
11069351|NCT01058863|12251013|FG000|Treated With ProAir® HFA 180 mcg|Overall Study||68
11069352|NCT01058863|12251013|FG000|Treated With Placebo Inhaler|Overall Study||69
11069353|NCT01058863|12251013|FG000|COMPLETED|Overall Study||68
11069354|NCT01058863|12251013|FG000|NOT COMPLETED|Overall Study||4
11069355|NCT01058941|12251028|FG000|STARTED|Overall Study||34
11069356|NCT01058941|12251029|FG001|STARTED|Overall Study||33
11069357|NCT01058941|12251028|FG000|COMPLETED|Overall Study||25
11069358|NCT01058941|12251029|FG001|COMPLETED|Overall Study||22
11069359|NCT01058941|12251028|FG000|NOT COMPLETED|Overall Study||9
11069360|NCT01058941|12251029|FG001|NOT COMPLETED|Overall Study||11
11069361|NCT01058993|12251035|FG000|STARTED|Overall Study||6
11069362|NCT01058993|12251035|FG000|COMPLETED|Overall Study||6
11069363|NCT01058993|12251035|FG000|NOT COMPLETED|Overall Study||0
11069364|NCT01059175|12251041|FG000|STARTED|Overall Study||43
11069365|NCT01059175|12251042|FG001|STARTED|Overall Study||41
11206229|NCT01866163|12397158|FG000|STARTED|Overall Study||323
11346605|NCT02982772|12543887|FG001|COMPLETED|6M Follow-Up||192
11346606|NCT02982772|12543886|FG000|NOT COMPLETED|6M Follow-Up||11
11346607|NCT02982772|12543887|FG001|NOT COMPLETED|6M Follow-Up||9
11346608|NCT02982772|12543886|FG000|STARTED|12M Follow-Up||177
11346609|NCT02982772|12543887|FG001|STARTED|12M Follow-Up||192
11346610|NCT02982772|12543886|FG000|COMPLETED|12M Follow-Up||166
11346611|NCT02982772|12543887|FG001|COMPLETED|12M Follow-Up||187
11346612|NCT02982772|12543886|FG000|NOT COMPLETED|12M Follow-Up||11
11346613|NCT02982772|12543887|FG001|NOT COMPLETED|12M Follow-Up||5
11346614|NCT02982863|12543900|FG000|STARTED|Overall Study||5745
11346615|NCT02982863|12543901|FG001|STARTED|Overall Study||16745
11346616|NCT02982863|12543902|FG002|STARTED|Overall Study||13238
11346617|NCT02982863|12543903|FG003|STARTED|Overall Study||10158
11346618|NCT02982863|12543904|FG004|STARTED|Overall Study||2760
11346619|NCT02982863|12543900|FG000|COMPLETED|Overall Study||4936
11346620|NCT02982863|12543901|FG001|COMPLETED|Overall Study||12484
11346621|NCT02982863|12543902|FG002|COMPLETED|Overall Study||11386
11069366|NCT01059175|12251041|FG000|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
11069367|NCT01059175|12251042|FG001|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
11069368|NCT01059175|12251041|FG000|NOT COMPLETED|Overall Study||21
11069369|NCT01059175|12251042|FG001|NOT COMPLETED|Overall Study||20
11069370|NCT01059305|12251048|FG000|STARTED|Overall Study||10
11069371|NCT01059305|12251048|FG000|COMPLETED|Overall Study||10
11069372|NCT01059305|12251048|FG000|NOT COMPLETED|Overall Study||0
11069373|NCT01059318|12251052|FG000|STARTED|Core Study (26 Week)|This is safety set and Pharmacodynamic set|24
11069374|NCT01059318|12251052|FG000|Everolimus 2.5 mg for 4 Weeks|Core Study (26 Week)||24
11069375|NCT01059318|12251052|FG000|Everolimus 5 mg for 4 Weeks|Core Study (26 Week)||24
11069376|NCT01059318|12251052|FG000|Everolimus 10 mg for 18 Weeks|Core Study (26 Week)||24
11069377|NCT01059318|12251052|FG000|Pharmacokinetics (PK) Analysis Set|Core Study (26 Week)|For 8 patients plasma rather than whole blood sample was collected, hence excluded from PK set.|16
11069378|NCT01059318|12251052|FG000|COMPLETED|Core Study (26 Week)||20
11069379|NCT01059318|12251052|FG000|NOT COMPLETED|Core Study (26 Week)||4
11069380|NCT01059318|12251052|FG000|STARTED|Extension (36 Week)||20
11069381|NCT01059318|12251052|FG000|COMPLETED|Extension (36 Week)||17
11069382|NCT01059318|12251052|FG000|NOT COMPLETED|Extension (36 Week)||3
11069383|NCT01059344|12251061|FG000|STARTED|Overall Study||140
11069384|NCT01059344|12251062|FG001|STARTED|Overall Study||141
11069385|NCT01059344|12251061|FG000|COMPLETED|Overall Study||118
11069386|NCT01059344|12251062|FG001|COMPLETED|Overall Study||95
11069387|NCT01059344|12251061|FG000|NOT COMPLETED|Overall Study||22
11069388|NCT01059344|12251062|FG001|NOT COMPLETED|Overall Study||46
11069389|NCT01059357|12251070|FG000|STARTED|Overall Study||58
11069390|NCT01059357|12251070|FG000|COMPLETED|Overall Study||54
11069391|NCT01059357|12251070|FG000|NOT COMPLETED|Overall Study||4
11069392|NCT01059435|12251084|FG000|STARTED|Overall Study||14
11069393|NCT01059435|12251085|FG001|STARTED|Overall Study||6
11069394|NCT01059435|12251086|FG002|STARTED|Overall Study||8
11069395|NCT01059435|12251087|FG003|STARTED|Overall Study||9
11069396|NCT01059435|12251088|FG004|STARTED|Overall Study||6
11069397|NCT01059435|12251089|FG005|STARTED|Overall Study||9
11069398|NCT01059435|12251090|FG006|STARTED|Overall Study||6
11069399|NCT01059435|12251091|FG007|STARTED|Overall Study||4
11069400|NCT01059435|12251092|FG008|STARTED|Overall Study||6
11069401|NCT01059435|12251093|FG009|STARTED|Overall Study||6
11069402|NCT01059435|12251084|FG000|Received Study Drug|Overall Study||14
11069403|NCT01059435|12251085|FG001|Received Study Drug|Overall Study||6
11069404|NCT01059435|12251086|FG002|Received Study Drug|Overall Study||6
11069405|NCT01059435|12251087|FG003|Received Study Drug|Overall Study||9
11069406|NCT01059435|12251088|FG004|Received Study Drug|Overall Study||6
11069407|NCT01059435|12251089|FG005|Received Study Drug|Overall Study||9
11069408|NCT01059435|12251090|FG006|Received Study Drug|Overall Study||6
11069409|NCT01059435|12251091|FG007|Received Study Drug|Overall Study||4
11069410|NCT01059435|12251092|FG008|Received Study Drug|Overall Study||6
11069411|NCT01059435|12251093|FG009|Received Study Drug|Overall Study||6
11069412|NCT01059435|12251084|FG000|COMPLETED|Overall Study||14
11069413|NCT01059435|12251085|FG001|COMPLETED|Overall Study||6
11069414|NCT01059435|12251086|FG002|COMPLETED|Overall Study||6
11069415|NCT01059435|12251087|FG003|COMPLETED|Overall Study||9
11069416|NCT01059435|12251088|FG004|COMPLETED|Overall Study||6
11069417|NCT01059435|12251089|FG005|COMPLETED|Overall Study||9
11069418|NCT01059435|12251090|FG006|COMPLETED|Overall Study||6
11069419|NCT01059435|12251091|FG007|COMPLETED|Overall Study||4
11069420|NCT01059435|12251092|FG008|COMPLETED|Overall Study||6
11069421|NCT01059435|12251093|FG009|COMPLETED|Overall Study||6
11069422|NCT01059435|12251084|FG000|NOT COMPLETED|Overall Study||0
11069423|NCT01059435|12251085|FG001|NOT COMPLETED|Overall Study||0
11069424|NCT01059435|12251086|FG002|NOT COMPLETED|Overall Study||2
11069425|NCT01059435|12251087|FG003|NOT COMPLETED|Overall Study||0
11069426|NCT01059435|12251088|FG004|NOT COMPLETED|Overall Study||0
11069427|NCT01059435|12251089|FG005|NOT COMPLETED|Overall Study||0
11069428|NCT01059435|12251090|FG006|NOT COMPLETED|Overall Study||0
11069429|NCT01059435|12251091|FG007|NOT COMPLETED|Overall Study||0
11069430|NCT01059435|12251092|FG008|NOT COMPLETED|Overall Study||0
11069431|NCT01059435|12251093|FG009|NOT COMPLETED|Overall Study||0
11069432|NCT01059526|12251127|FG000|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
11069433|NCT01059526|12251128|FG001|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
11069434|NCT01059526|12251127|FG000|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
11069435|NCT01059526|12251128|FG001|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
11069436|NCT01059526|12251127|FG000|COMPLETED|Overall Study||11
11069437|NCT01059526|12251128|FG001|COMPLETED|Overall Study||18
11069438|NCT01059526|12251127|FG000|NOT COMPLETED|Overall Study||30
11069439|NCT01059526|12251128|FG001|NOT COMPLETED|Overall Study||22
11069440|NCT01059539|12251134|FG000|STARTED|Overall Study||403
11069441|NCT01059539|12251134|FG000|COMPLETED|Overall Study||132
11069442|NCT01059539|12251134|FG000|NOT COMPLETED|Overall Study||271
11069443|NCT01059565|12251140|FG000|STARTED|24-Week Randomized Phase||49
11069444|NCT01059565|12251141|FG001|STARTED|24-Week Randomized Phase||52
11069445|NCT01059565|12251140|FG000|Randomized and Treated|24-Week Randomized Phase||48
11069446|NCT01059565|12251141|FG001|Randomized and Treated|24-Week Randomized Phase||52
11069447|NCT01059565|12251140|FG000|COMPLETED|24-Week Randomized Phase||39
11069448|NCT01059565|12251141|FG001|COMPLETED|24-Week Randomized Phase||45
11069449|NCT01059565|12251140|FG000|NOT COMPLETED|24-Week Randomized Phase||10
11069450|NCT01059565|12251141|FG001|NOT COMPLETED|24-Week Randomized Phase||7
11069451|NCT01059565|12251140|FG000|STARTED|24-Week Open-Label Phase||39
11069452|NCT01059565|12251141|FG001|STARTED|24-Week Open-Label Phase||45
11069453|NCT01059565|12251140|FG000|COMPLETED|24-Week Open-Label Phase||34
11069454|NCT01059565|12251141|FG001|COMPLETED|24-Week Open-Label Phase||42
11069455|NCT01059565|12251140|FG000|NOT COMPLETED|24-Week Open-Label Phase||5
11069456|NCT01059565|12251141|FG001|NOT COMPLETED|24-Week Open-Label Phase||3
11069457|NCT01059617|12251153|FG000|STARTED|Overall Study||33
11069458|NCT01059617|12251154|FG001|STARTED|Overall Study||34
11346622|NCT02982863|12543903|FG003|COMPLETED|Overall Study||8758
11346623|NCT02982863|12543904|FG004|COMPLETED|Overall Study||2268
11346624|NCT02982863|12543900|FG000|NOT COMPLETED|Overall Study||809
11346625|NCT02982863|12543901|FG001|NOT COMPLETED|Overall Study||4261
11346626|NCT02982863|12543902|FG002|NOT COMPLETED|Overall Study||1852
11346627|NCT02982863|12543903|FG003|NOT COMPLETED|Overall Study||1400
11346628|NCT02982863|12543904|FG004|NOT COMPLETED|Overall Study||492
11346629|NCT02982928|12543920|FG000|STARTED|Overall Study||11
11346630|NCT02982928|12543920|FG000|COMPLETED|Overall Study||11
11346631|NCT02982928|12543920|FG000|NOT COMPLETED|Overall Study||0
11346632|NCT02983058|12543926|FG000|STARTED|Overall Study||7
11346633|NCT02983058|12543927|FG001|STARTED|Overall Study||5
11346634|NCT02983058|12543926|FG000|COMPLETED|Overall Study||2
11346635|NCT02983058|12543927|FG001|COMPLETED|Overall Study||2
11346636|NCT02983058|12543926|FG000|NOT COMPLETED|Overall Study||5
11346637|NCT02983058|12543927|FG001|NOT COMPLETED|Overall Study||3
11346638|NCT02983227|12543935|FG000|STARTED|Overall Study||410
11346639|NCT02983227|12543936|FG001|STARTED|Overall Study||86
11346640|NCT02983227|12543935|FG000|COMPLETED|Overall Study||351
11346641|NCT02983227|12543936|FG001|COMPLETED|Overall Study||72
11346642|NCT02983227|12543935|FG000|NOT COMPLETED|Overall Study||59
11346643|NCT02983227|12543936|FG001|NOT COMPLETED|Overall Study||14
11346644|NCT02983305|12543944|FG000|STARTED|Overall Study||12
11346645|NCT02983305|12543945|FG001|STARTED|Overall Study||10
11346646|NCT02983305|12543944|FG000|COMPLETED|Overall Study||10
11346647|NCT02983305|12543945|FG001|COMPLETED|Overall Study||10
11346648|NCT02983305|12543944|FG000|NOT COMPLETED|Overall Study||2
11346649|NCT02983305|12543945|FG001|NOT COMPLETED|Overall Study||0
11346650|NCT02983448|12543951|FG000|STARTED|Overall Study||12
11346651|NCT02983448|12543952|FG001|STARTED|Overall Study||12
11346652|NCT02983448|12543951|FG000|COMPLETED|Overall Study||12
11346653|NCT02983448|12543952|FG001|COMPLETED|Overall Study||12
11346654|NCT02983448|12543951|FG000|NOT COMPLETED|Overall Study||0
11346655|NCT02983448|12543952|FG001|NOT COMPLETED|Overall Study||0
11346656|NCT02983552|12543964|FG000|STARTED|Overall Study||69
11069459|NCT01059617|12251155|FG002|STARTED|Overall Study||33
11069460|NCT01059617|12251156|FG003|STARTED|Overall Study||33
11069461|NCT01059617|12251153|FG000|COMPLETED|Overall Study||26
11069462|NCT01059617|12251154|FG001|COMPLETED|Overall Study||33
11069463|NCT01059617|12251155|FG002|COMPLETED|Overall Study||25
11069464|NCT01059617|12251156|FG003|COMPLETED|Overall Study||27
11069465|NCT01059617|12251153|FG000|NOT COMPLETED|Overall Study||7
11069466|NCT01059617|12251154|FG001|NOT COMPLETED|Overall Study||1
11346657|NCT02983552|12543965|FG001|STARTED|Overall Study||69
11346658|NCT02983552|12543966|FG002|STARTED|Overall Study||92
11069467|NCT01059617|12251155|FG002|NOT COMPLETED|Overall Study||8
11346659|NCT02983552|12543967|FG003|STARTED|Overall Study||90
11346660|NCT02983552|12543964|FG000|4 Week Visit|Overall Study||69
11346661|NCT02983552|12543965|FG001|4 Week Visit|Overall Study||67
11069468|NCT01059617|12251156|FG003|NOT COMPLETED|Overall Study||6
11069469|NCT01059630|12251176|FG000|STARTED|Overall Study||209
11069470|NCT01059630|12251177|FG001|STARTED|Overall Study||204
11069471|NCT01059630|12251176|FG000|COMPLETED|Overall Study||82
11069472|NCT01059630|12251177|FG001|COMPLETED|Overall Study||101
11069473|NCT01059630|12251176|FG000|NOT COMPLETED|Overall Study||127
11069474|NCT01059630|12251177|FG001|NOT COMPLETED|Overall Study||103
11206230|NCT01866163|12397159|FG001|STARTED|Overall Study||103
11206231|NCT01866163|12397158|FG000|COMPLETED|Overall Study||313
11206232|NCT01866163|12397159|FG001|COMPLETED|Overall Study||99
11206233|NCT01866163|12397158|FG000|NOT COMPLETED|Overall Study||10
11206234|NCT01866163|12397159|FG001|NOT COMPLETED|Overall Study||4
11206235|NCT01866293|12397165|FG000|STARTED|Overall Study||11
11206236|NCT01866293|12397165|FG000|COMPLETED|Overall Study||9
11206237|NCT01866293|12397165|FG000|NOT COMPLETED|Overall Study||2
11206238|NCT01866306|12397176|FG000|STARTED|Overall Study||6
11206239|NCT01866306|12397177|FG001|STARTED|Overall Study||6
11206240|NCT01866306|12397178|FG002|STARTED|Overall Study||6
11206241|NCT01866306|12397179|FG003|STARTED|Overall Study||6
11206242|NCT01866306|12397180|FG004|STARTED|Overall Study||6
11206243|NCT01866306|12397181|FG005|STARTED|Overall Study||6
11206244|NCT01866306|12397182|FG006|STARTED|Overall Study||23
11206245|NCT01866306|12397176|FG000|COMPLETED|Overall Study||6
11206246|NCT01866306|12397177|FG001|COMPLETED|Overall Study||6
11206247|NCT01866306|12397178|FG002|COMPLETED|Overall Study||6
11206248|NCT01866306|12397179|FG003|COMPLETED|Overall Study||6
11206249|NCT01866306|12397180|FG004|COMPLETED|Overall Study||6
11206250|NCT01866306|12397181|FG005|COMPLETED|Overall Study||6
11206251|NCT01866306|12397182|FG006|COMPLETED|Overall Study||23
11206252|NCT01866306|12397176|FG000|NOT COMPLETED|Overall Study||0
11206253|NCT01866306|12397177|FG001|NOT COMPLETED|Overall Study||0
11206254|NCT01866306|12397178|FG002|NOT COMPLETED|Overall Study||0
11206255|NCT01866306|12397179|FG003|NOT COMPLETED|Overall Study||0
11206256|NCT01866306|12397180|FG004|NOT COMPLETED|Overall Study||0
11206257|NCT01866306|12397181|FG005|NOT COMPLETED|Overall Study||0
11206258|NCT01866306|12397182|FG006|NOT COMPLETED|Overall Study||0
11206259|NCT01866319|12397201|FG000|STARTED|Overall Study||278
11206260|NCT01866319|12397202|FG001|STARTED|Overall Study||279
11206261|NCT01866319|12397203|FG002|STARTED|Overall Study||277
11206262|NCT01866319|12397201|FG000|Treated|Overall Study||256
11206263|NCT01866319|12397202|FG001|Treated|Overall Study||278
11206264|NCT01866319|12397203|FG002|Treated|Overall Study||277
11206265|NCT01866319|12397201|FG000|COMPLETED|Overall Study||71
11206266|NCT01866319|12397202|FG001|COMPLETED|Overall Study||101
11206267|NCT01866319|12397203|FG002|COMPLETED|Overall Study||97
11206268|NCT01866319|12397201|FG000|NOT COMPLETED|Overall Study||207
11206269|NCT01866319|12397202|FG001|NOT COMPLETED|Overall Study||178
11206270|NCT01866319|12397203|FG002|NOT COMPLETED|Overall Study||180
11206271|NCT01866410|12397211|FG000|STARTED|Overall Study||37
11206272|NCT01866410|12397211|FG000|COMPLETED|Overall Study||37
11206273|NCT01866410|12397211|FG000|NOT COMPLETED|Overall Study||0
11206274|NCT01866423|12397218|FG000|STARTED|Overall Study||4
11206275|NCT01866423|12397218|FG000|COMPLETED|Overall Study||0
11206276|NCT01866423|12397218|FG000|NOT COMPLETED|Overall Study||4
11206277|NCT01866592|12397222|FG000|STARTED|Overall Study||81
11206278|NCT01866592|12397222|FG000|COMPLETED|Overall Study||58
11206279|NCT01866592|12397222|FG000|NOT COMPLETED|Overall Study||23
11206280|NCT01866826|12397226|FG000|STARTED|Phase I -Initial Randomization - 4 Weeks||23
11206281|NCT01866826|12397227|FG001|STARTED|Phase I -Initial Randomization - 4 Weeks||23
11346662|NCT02983552|12543966|FG002|4 Week Visit|Overall Study||85
11069475|NCT01059643|12251183|FG000|STARTED|Overall Study||103
11069476|NCT01059643|12251183|FG000|Received at Least 1 Dose of Study Drug|Overall Study||103
11069477|NCT01059643|12251183|FG000|COMPLETED|Overall Study||97
11069478|NCT01059643|12251183|FG000|NOT COMPLETED|Overall Study||6
11069479|NCT01059682|12251192|FG000|STARTED|Overall Study||474
11069480|NCT01059682|12251193|FG001|STARTED|Overall Study||462
11069481|NCT01059682|12251192|FG000|COMPLETED|Overall Study||464
11069482|NCT01059682|12251193|FG001|COMPLETED|Overall Study||444
11069483|NCT01059682|12251192|FG000|NOT COMPLETED|Overall Study||10
11069484|NCT01059682|12251193|FG001|NOT COMPLETED|Overall Study||18
11069485|NCT01059760|12251201|FG000|STARTED|Overall Study||16
11069486|NCT01059760|12251202|FG001|STARTED|Overall Study||14
11069487|NCT01059760|12251201|FG000|COMPLETED|Overall Study||16
11069488|NCT01059760|12251202|FG001|COMPLETED|Overall Study||14
11069489|NCT01059760|12251201|FG000|NOT COMPLETED|Overall Study||0
11069490|NCT01059760|12251202|FG001|NOT COMPLETED|Overall Study||0
11069491|NCT01059773|12251211|FG000|STARTED|Overall Study||244
11069492|NCT01059773|12251212|FG001|STARTED|Overall Study||245
11069493|NCT01059773|12251211|FG000|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
11069494|NCT01059773|12251212|FG001|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
11069495|NCT01059773|12251211|FG000|NOT COMPLETED|Overall Study||20
11069496|NCT01059773|12251212|FG001|NOT COMPLETED|Overall Study||24
11069497|NCT01059799|12251225|FG000|STARTED|Overall Study||289
11069498|NCT01059799|12251226|FG001|STARTED|Overall Study||146
11069499|NCT01059799|12251225|FG000|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
11069500|NCT01059799|12251226|FG001|Exposed|Overall Study||146
11069501|NCT01059799|12251225|FG000|COMPLETED|Overall Study||258
11069502|NCT01059799|12251226|FG001|COMPLETED|Overall Study||136
11069503|NCT01059799|12251225|FG000|NOT COMPLETED|Overall Study||31
11069504|NCT01059799|12251226|FG001|NOT COMPLETED|Overall Study||10
11069505|NCT01059812|12251234|FG000|STARTED|Overall Study||282
11069506|NCT01059812|12251235|FG001|STARTED|Overall Study||142
11069507|NCT01059812|12251234|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
11069508|NCT01059812|12251235|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
11069509|NCT01059812|12251234|FG000|COMPLETED|Overall Study||245
11069510|NCT01059812|12251235|FG001|COMPLETED|Overall Study||126
11069511|NCT01059812|12251234|FG000|NOT COMPLETED|Overall Study||37
11069512|NCT01059812|12251235|FG001|NOT COMPLETED|Overall Study||16
11069513|NCT01059825|12251247|FG000|STARTED|Enrolled, Run-in Period||0
11069514|NCT01059825|12251248|FG001|STARTED|Enrolled, Run-in Period||0
11069515|NCT01059825|12251249|FG002|STARTED|Enrolled, Run-in Period||0
11069516|NCT01059825|12251250|FG003|STARTED|Enrolled, Run-in Period||0
11069517|NCT01059825|12251251|FG004|STARTED|Enrolled, Run-in Period||0
11069518|NCT01059825|12251252|FG005|STARTED|Enrolled, Run-in Period||0
11069519|NCT01059825|12251253|FG006|STARTED|Enrolled, Run-in Period||375
11069520|NCT01059825|12251247|FG000|COMPLETED|Enrolled, Run-in Period||0
11069521|NCT01059825|12251248|FG001|COMPLETED|Enrolled, Run-in Period||0
11069522|NCT01059825|12251249|FG002|COMPLETED|Enrolled, Run-in Period||0
11069523|NCT01059825|12251250|FG003|COMPLETED|Enrolled, Run-in Period||0
11069524|NCT01059825|12251251|FG004|COMPLETED|Enrolled, Run-in Period||0
11069525|NCT01059825|12251252|FG005|COMPLETED|Enrolled, Run-in Period||0
11069526|NCT01059825|12251253|FG006|COMPLETED|Enrolled, Run-in Period||328
11069527|NCT01059825|12251247|FG000|NOT COMPLETED|Enrolled, Run-in Period||0
11069528|NCT01059825|12251248|FG001|NOT COMPLETED|Enrolled, Run-in Period||0
11069529|NCT01059825|12251249|FG002|NOT COMPLETED|Enrolled, Run-in Period||0
11069530|NCT01059825|12251250|FG003|NOT COMPLETED|Enrolled, Run-in Period||0
11069531|NCT01059825|12251251|FG004|NOT COMPLETED|Enrolled, Run-in Period||0
11069532|NCT01059825|12251252|FG005|NOT COMPLETED|Enrolled, Run-in Period||0
11069533|NCT01059825|12251253|FG006|NOT COMPLETED|Enrolled, Run-in Period||47
11069534|NCT01059825|12251247|FG000|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
11069535|NCT01059825|12251248|FG001|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
11069536|NCT01059825|12251249|FG002|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
11069537|NCT01059825|12251250|FG003|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
11069538|NCT01059825|12251251|FG004|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
11069539|NCT01059825|12251252|FG005|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
11069540|NCT01059825|12251253|FG006|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
11069541|NCT01059825|12251247|FG000|COMPLETED|Treatment Period||44
11069542|NCT01059825|12251248|FG001|COMPLETED|Treatment Period||50
11069543|NCT01059825|12251249|FG002|COMPLETED|Treatment Period||49
11069544|NCT01059825|12251250|FG003|COMPLETED|Treatment Period||44
11069545|NCT01059825|12251251|FG004|COMPLETED|Treatment Period||47
11069546|NCT01059825|12251252|FG005|COMPLETED|Treatment Period||52
11069547|NCT01059825|12251253|FG006|COMPLETED|Treatment Period||0
11069548|NCT01059825|12251247|FG000|NOT COMPLETED|Treatment Period||10
11069549|NCT01059825|12251248|FG001|NOT COMPLETED|Treatment Period||4
11069550|NCT01059825|12251249|FG002|NOT COMPLETED|Treatment Period||6
11069551|NCT01059825|12251250|FG003|NOT COMPLETED|Treatment Period||11
11069552|NCT01059825|12251251|FG004|NOT COMPLETED|Treatment Period||8
11069553|NCT01059825|12251252|FG005|NOT COMPLETED|Treatment Period||3
11069554|NCT01059825|12251253|FG006|NOT COMPLETED|Treatment Period||0
11069555|NCT01059851|12251271|FG000|STARTED|Overall Study||8
11069556|NCT01059851|12251272|FG001|STARTED|Overall Study||8
11069557|NCT01059851|12251273|FG002|STARTED|Overall Study||0
11069558|NCT01059851|12251274|FG003|STARTED|Overall Study||0
11069559|NCT01059851|12251275|FG004|STARTED|Overall Study||0
11069560|NCT01059851|12251276|FG005|STARTED|Overall Study||0
11069561|NCT01059851|12251271|FG000|COMPLETED|Overall Study||8
11069562|NCT01059851|12251272|FG001|COMPLETED|Overall Study||8
11069563|NCT01059851|12251273|FG002|COMPLETED|Overall Study||0
11069564|NCT01059851|12251274|FG003|COMPLETED|Overall Study||0
11069565|NCT01059851|12251275|FG004|COMPLETED|Overall Study||0
11069566|NCT01059851|12251276|FG005|COMPLETED|Overall Study||0
11069567|NCT01059851|12251271|FG000|NOT COMPLETED|Overall Study||0
11069568|NCT01059851|12251272|FG001|NOT COMPLETED|Overall Study||0
11069569|NCT01059851|12251273|FG002|NOT COMPLETED|Overall Study||0
11069570|NCT01059851|12251274|FG003|NOT COMPLETED|Overall Study||0
11069571|NCT01059851|12251275|FG004|NOT COMPLETED|Overall Study||0
11069572|NCT01059851|12251276|FG005|NOT COMPLETED|Overall Study||0
11069573|NCT01059864|12251286|FG000|STARTED|Open-Label Run-In Phase||111
11069574|NCT01059864|12251287|FG001|STARTED|Open-Label Run-In Phase||0
11069575|NCT01059864|12251288|FG002|STARTED|Open-Label Run-In Phase||0
11069576|NCT01059864|12251286|FG000|COMPLETED|Open-Label Run-In Phase||98
11069577|NCT01059864|12251287|FG001|COMPLETED|Open-Label Run-In Phase||0
11069578|NCT01059864|12251288|FG002|COMPLETED|Open-Label Run-In Phase||0
11069579|NCT01059864|12251286|FG000|NOT COMPLETED|Open-Label Run-In Phase||13
11069580|NCT01059864|12251287|FG001|NOT COMPLETED|Open-Label Run-In Phase||0
11069581|NCT01059864|12251288|FG002|NOT COMPLETED|Open-Label Run-In Phase||0
11069582|NCT01059864|12251286|FG000|STARTED|Double-Blind Treatment Phase||0
11069583|NCT01059864|12251287|FG001|STARTED|Double-Blind Treatment Phase||50
11069584|NCT01059864|12251288|FG002|STARTED|Double-Blind Treatment Phase||48
11069585|NCT01059864|12251286|FG000|Treated|Double-Blind Treatment Phase||0
11069586|NCT01059864|12251287|FG001|Treated|Double-Blind Treatment Phase||50
11069587|NCT01059864|12251288|FG002|Treated|Double-Blind Treatment Phase||47
11069588|NCT01059864|12251286|FG000|COMPLETED|Double-Blind Treatment Phase||0
11069589|NCT01059864|12251287|FG001|COMPLETED|Double-Blind Treatment Phase||47
11069590|NCT01059864|12251288|FG002|COMPLETED|Double-Blind Treatment Phase||45
11069591|NCT01059864|12251286|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
11069592|NCT01059864|12251287|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3
11069593|NCT01059864|12251288|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3
11069594|NCT01059877|12251297|FG000|STARTED|Overall Study||6
11069595|NCT01059877|12251298|FG001|STARTED|Overall Study||5
11069596|NCT01059877|12251297|FG000|COMPLETED|Overall Study||6
11069597|NCT01059877|12251298|FG001|COMPLETED|Overall Study||3
11069598|NCT01059877|12251297|FG000|NOT COMPLETED|Overall Study||0
11069599|NCT01059877|12251298|FG001|NOT COMPLETED|Overall Study||2
11069600|NCT01059903|12251306|FG000|STARTED|Period 1: First Intervention- 24 Hours||25
11069601|NCT01059903|12251307|FG001|STARTED|Period 1: First Intervention- 24 Hours||25
11069602|NCT01059903|12251306|FG000|COMPLETED|Period 1: First Intervention- 24 Hours||24
11069603|NCT01059903|12251307|FG001|COMPLETED|Period 1: First Intervention- 24 Hours||24
11069604|NCT01059903|12251306|FG000|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
11069605|NCT01059903|12251307|FG001|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
11069606|NCT01059903|12251306|FG000|STARTED|Period 2: Washout Period (>= 5 Days)||24
11069607|NCT01059903|12251307|FG001|STARTED|Period 2: Washout Period (>= 5 Days)||24
11069608|NCT01059903|12251306|FG000|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
11069609|NCT01059903|12251307|FG001|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
11069610|NCT01059903|12251306|FG000|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
11069611|NCT01059903|12251307|FG001|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
11069612|NCT01059903|12251306|FG000|STARTED|Period 3: Second Intervention- 24 Hours||24
11069613|NCT01059903|12251307|FG001|STARTED|Period 3: Second Intervention- 24 Hours||24
11069614|NCT01059903|12251306|FG000|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
11069615|NCT01059903|12251307|FG001|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
11069616|NCT01059903|12251306|FG000|COMPLETED|Period 3: Second Intervention- 24 Hours||24
11069617|NCT01059903|12251307|FG001|COMPLETED|Period 3: Second Intervention- 24 Hours||24
11069618|NCT01059903|12251306|FG000|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
11069619|NCT01059903|12251307|FG001|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
11069620|NCT01059929|12251315|FG000|STARTED|Overall Study||20
11069621|NCT01059929|12251316|FG001|STARTED|Overall Study||21
11069622|NCT01059929|12251315|FG000|COMPLETED|Overall Study||20
11069623|NCT01059929|12251316|FG001|COMPLETED|Overall Study||21
11069624|NCT01059929|12251315|FG000|NOT COMPLETED|Overall Study||0
11069625|NCT01059929|12251316|FG001|NOT COMPLETED|Overall Study||0
11069626|NCT01059994|12251326|FG000|STARTED|Overall Study||3
11069627|NCT01059994|12251327|FG001|STARTED|Overall Study||2
11069628|NCT01059994|12251328|FG002|STARTED|Overall Study||3
11069629|NCT01059994|12251329|FG003|STARTED|Overall Study||4
11069630|NCT01059994|12251326|FG000|COMPLETED|Overall Study||3
11069631|NCT01059994|12251327|FG001|COMPLETED|Overall Study||2
11069632|NCT01059994|12251328|FG002|COMPLETED|Overall Study||3
11069633|NCT01059994|12251329|FG003|COMPLETED|Overall Study||3
11069634|NCT01059994|12251326|FG000|NOT COMPLETED|Overall Study||0
11069635|NCT01059994|12251327|FG001|NOT COMPLETED|Overall Study||0
11069636|NCT01059994|12251328|FG002|NOT COMPLETED|Overall Study||0
11069637|NCT01059994|12251329|FG003|NOT COMPLETED|Overall Study||1
11069638|NCT01060007|12251339|FG000|STARTED|Overall Study||80
11069639|NCT01060007|12251339|FG000|COMPLETED|Overall Study||76
11069640|NCT01060007|12251339|FG000|NOT COMPLETED|Overall Study||4
11206282|NCT01866826|12397226|FG000|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22
11206283|NCT01866826|12397227|FG001|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23
11206284|NCT01866826|12397226|FG000|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1
11206285|NCT01866826|12397227|FG001|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0
11206286|NCT01866826|12397226|FG000|STARTED|Wash-Out Period - 4 -6 Weeks||22
11206287|NCT01866826|12397227|FG001|STARTED|Wash-Out Period - 4 -6 Weeks||23
11206288|NCT01866826|12397226|FG000|COMPLETED|Wash-Out Period - 4 -6 Weeks||22
11206289|NCT01866826|12397227|FG001|COMPLETED|Wash-Out Period - 4 -6 Weeks||20
11206290|NCT01866826|12397226|FG000|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0
11206291|NCT01866826|12397227|FG001|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3
11206292|NCT01866826|12397226|FG000|STARTED|Second Intervention - 4 Weeks||22
11206293|NCT01866826|12397227|FG001|STARTED|Second Intervention - 4 Weeks||20
11206294|NCT01866826|12397226|FG000|COMPLETED|Second Intervention - 4 Weeks||22
11206295|NCT01866826|12397227|FG001|COMPLETED|Second Intervention - 4 Weeks||20
11206296|NCT01866826|12397226|FG000|NOT COMPLETED|Second Intervention - 4 Weeks||0
11206297|NCT01866826|12397227|FG001|NOT COMPLETED|Second Intervention - 4 Weeks||0
11206298|NCT01866839|12397233|FG000|STARTED|Overall Study||40
11206299|NCT01866839|12397233|FG000|COMPLETED|Overall Study||30
11069641|NCT01060020|12251346|FG000|STARTED|Overall Study||20
11069642|NCT01060020|12251346|FG000|COMPLETED|Overall Study||20
11069643|NCT01060020|12251346|FG000|NOT COMPLETED|Overall Study||0
11069644|NCT01060059|12251353|FG000|STARTED|Overall Study||444
11069645|NCT01060059|12251354|FG001|STARTED|Overall Study||438
11069646|NCT01060059|12251353|FG000|COMPLETED|Overall Study||377
11069647|NCT01060059|12251354|FG001|COMPLETED|Overall Study||371
11069648|NCT01060059|12251353|FG000|NOT COMPLETED|Overall Study||67
11069649|NCT01060059|12251354|FG001|NOT COMPLETED|Overall Study||67
11069650|NCT01060072|12251364|FG000|STARTED|Overall Study||206
11069651|NCT01060072|12251365|FG001|STARTED|Overall Study||201
11069652|NCT01060072|12251364|FG000|COMPLETED|Overall Study||204
11069653|NCT01060072|12251365|FG001|COMPLETED|Overall Study||196
11069654|NCT01060072|12251364|FG000|NOT COMPLETED|Overall Study||2
11069655|NCT01060072|12251365|FG001|NOT COMPLETED|Overall Study||5
11069656|NCT01060098|12251374|FG000|STARTED|Overall Study||25
11069657|NCT01060098|12251375|FG001|STARTED|Overall Study||15
11069658|NCT01060098|12251376|FG002|STARTED|Overall Study||8
11069659|NCT01060098|12251374|FG000|COMPLETED|Overall Study||25
11069660|NCT01060098|12251375|FG001|COMPLETED|Overall Study||15
11069661|NCT01060098|12251376|FG002|COMPLETED|Overall Study||8
11069662|NCT01060098|12251374|FG000|NOT COMPLETED|Overall Study||0
11069663|NCT01060098|12251375|FG001|NOT COMPLETED|Overall Study||0
11069664|NCT01060098|12251376|FG002|NOT COMPLETED|Overall Study||0
11069665|NCT01060111|12251387|FG000|STARTED|Overall Study||81
11069666|NCT01060111|12251388|FG001|STARTED|Overall Study||84
11069667|NCT01060111|12251389|FG002|STARTED|Overall Study||80
11069668|NCT01060111|12251387|FG000|Treated|Overall Study||81
11069669|NCT01060111|12251388|FG001|Treated|Overall Study||83
11069670|NCT01060111|12251389|FG002|Treated|Overall Study||79
11069671|NCT01060111|12251387|FG000|COMPLETED|Overall Study||54
11069672|NCT01060111|12251388|FG001|COMPLETED|Overall Study||61
11069673|NCT01060111|12251389|FG002|COMPLETED|Overall Study||45
11069674|NCT01060111|12251387|FG000|NOT COMPLETED|Overall Study||27
11069675|NCT01060111|12251388|FG001|NOT COMPLETED|Overall Study||23
11346663|NCT02983552|12543967|FG003|4 Week Visit|Overall Study||84
11346664|NCT02983552|12543964|FG000|8 Week Visit|Overall Study||67
11346665|NCT02983552|12543965|FG001|8 Week Visit|Overall Study||68
11346666|NCT02983552|12543966|FG002|8 Week Visit|Overall Study||85
11346667|NCT02983552|12543967|FG003|8 Week Visit|Overall Study||84
11346668|NCT02983552|12543964|FG000|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
11346669|NCT02983552|12543965|FG001|16 Week Visit|Overall Study||66
11346670|NCT02983552|12543966|FG002|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
11346671|NCT02983552|12543967|FG003|16 Week Visit|Overall Study||72
11346672|NCT02983552|12543964|FG000|COMPLETED|Overall Study||69
11346673|NCT02983552|12543965|FG001|COMPLETED|Overall Study||67
11346674|NCT02983552|12543966|FG002|COMPLETED|Overall Study||92
11346675|NCT02983552|12543967|FG003|COMPLETED|Overall Study||90
11346676|NCT02983552|12543964|FG000|NOT COMPLETED|Overall Study||0
11346677|NCT02983552|12543965|FG001|NOT COMPLETED|Overall Study||2
11346678|NCT02983552|12543966|FG002|NOT COMPLETED|Overall Study||0
11069676|NCT01060111|12251389|FG002|NOT COMPLETED|Overall Study||35
11069677|NCT01060124|12251400|FG000|STARTED|Overall Study||103
11069678|NCT01060124|12251400|FG000|COMPLETED|Overall Study||66
11069679|NCT01060124|12251400|FG000|NOT COMPLETED|Overall Study||37
11069680|NCT01060150|12251404|FG000|STARTED|Overall Study||115
11069681|NCT01060150|12251404|FG000|Treated|Overall Study||113
11069682|NCT01060150|12251404|FG000|COMPLETED|Overall Study||92
11069683|NCT01060150|12251404|FG000|NOT COMPLETED|Overall Study||23
11069684|NCT01060345|12251408|FG000|STARTED|Overall Study||20
11069685|NCT01060345|12251408|FG000|COMPLETED|Overall Study||20
11069686|NCT01060345|12251408|FG000|NOT COMPLETED|Overall Study||0
11069687|NCT01060384|12251412|FG000|STARTED|Overall Study||6
11069688|NCT01060384|12251413|FG001|STARTED|Overall Study||4
11069689|NCT01060384|12251414|FG002|STARTED|Overall Study||0
11069690|NCT01060384|12251415|FG003|STARTED|Overall Study||0
11069691|NCT01060384|12251416|FG004|STARTED|Overall Study||36
11069692|NCT01060384|12251412|FG000|COMPLETED|Overall Study||6
11069693|NCT01060384|12251413|FG001|COMPLETED|Overall Study||3
11069694|NCT01060384|12251414|FG002|COMPLETED|Overall Study||0
11069695|NCT01060384|12251415|FG003|COMPLETED|Overall Study||0
11069696|NCT01060384|12251416|FG004|COMPLETED|Overall Study||34
11069697|NCT01060384|12251412|FG000|NOT COMPLETED|Overall Study||0
11069698|NCT01060384|12251413|FG001|NOT COMPLETED|Overall Study||1
11069699|NCT01060384|12251414|FG002|NOT COMPLETED|Overall Study||0
11069700|NCT01060384|12251415|FG003|NOT COMPLETED|Overall Study||0
11069701|NCT01060384|12251416|FG004|NOT COMPLETED|Overall Study||2
11069702|NCT01060540|12251427|FG000|STARTED|Overall Study||303
11069703|NCT01060540|12251428|FG001|STARTED|Overall Study||298
11069704|NCT01060540|12251427|FG000|COMPLETED|Overall Study||239
11069705|NCT01060540|12251428|FG001|COMPLETED|Overall Study||233
11069706|NCT01060540|12251427|FG000|NOT COMPLETED|Overall Study||64
11069707|NCT01060540|12251428|FG001|NOT COMPLETED|Overall Study||65
11069708|NCT01060553|12251436|FG000|STARTED|Overall Study||15
11069709|NCT01060553|12251437|FG001|STARTED|Overall Study||15
11069710|NCT01060553|12251436|FG000|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
11069711|NCT01060553|12251437|FG001|COMPLETED|Overall Study||5
11069712|NCT01060553|12251436|FG000|NOT COMPLETED|Overall Study||9
11069713|NCT01060553|12251437|FG001|NOT COMPLETED|Overall Study||10
11069714|NCT01060592|12251444|FG000|STARTED|4-6w||35
11069715|NCT01060592|12251445|FG001|STARTED|4-6w||49
11069716|NCT01060592|12251444|FG000|COMPLETED|4-6w||23
11069717|NCT01060592|12251445|FG001|COMPLETED|4-6w||39
11069718|NCT01060592|12251444|FG000|NOT COMPLETED|4-6w||12
11069719|NCT01060592|12251445|FG001|NOT COMPLETED|4-6w||10
11069720|NCT01060592|12251444|FG000|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
11069721|NCT01060592|12251445|FG001|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
11069722|NCT01060592|12251444|FG000|COMPLETED|12m||35
11069723|NCT01060592|12251445|FG001|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
11069724|NCT01060592|12251444|FG000|NOT COMPLETED|12m||0
11069725|NCT01060592|12251445|FG001|NOT COMPLETED|12m||18
11069726|NCT01060670|12251453|FG000|STARTED|Run In||0
11069727|NCT01060670|12251454|FG001|STARTED|Run In||545
11069728|NCT01060670|12251453|FG000|COMPLETED|Run In||0
11069729|NCT01060670|12251454|FG001|COMPLETED|Run In||307
11069730|NCT01060670|12251453|FG000|NOT COMPLETED|Run In||0
11069731|NCT01060670|12251454|FG001|NOT COMPLETED|Run In||238
11069732|NCT01060670|12251453|FG000|STARTED|Treatment Phase||154
11069733|NCT01060670|12251454|FG001|STARTED|Treatment Phase||153
11069734|NCT01060670|12251453|FG000|Healed at End of Treatment Phase|Treatment Phase||79
11069735|NCT01060670|12251454|FG001|Healed at End of Treatment Phase|Treatment Phase||49
11069736|NCT01060670|12251453|FG000|Did Not Heal by Treatment Visit 17|Treatment Phase||49
11069737|NCT01060670|12251454|FG001|Did Not Heal by Treatment Visit 17|Treatment Phase||68
11069738|NCT01060670|12251453|FG000|Withdrew From Treatment|Treatment Phase||26
11069739|NCT01060670|12251454|FG001|Withdrew From Treatment|Treatment Phase||36
11069740|NCT01060670|12251453|FG000|COMPLETED|Treatment Phase||128
11069741|NCT01060670|12251454|FG001|COMPLETED|Treatment Phase||117
11069742|NCT01060670|12251453|FG000|NOT COMPLETED|Treatment Phase||26
11069743|NCT01060670|12251454|FG001|NOT COMPLETED|Treatment Phase||36
11069744|NCT01060670|12251453|FG000|STARTED|Follow up Phase||128
11069745|NCT01060670|12251454|FG001|STARTED|Follow up Phase||117
11069746|NCT01060670|12251453|FG000|Recurrence|Follow up Phase||14
11069747|NCT01060670|12251454|FG001|Recurrence|Follow up Phase||9
11069748|NCT01060670|12251453|FG000|Withdrew From Follow up Phase|Follow up Phase||22
11069749|NCT01060670|12251454|FG001|Withdrew From Follow up Phase|Follow up Phase||35
11069750|NCT01060670|12251453|FG000|COMPLETED|Follow up Phase||106
11069751|NCT01060670|12251454|FG001|COMPLETED|Follow up Phase||82
11069752|NCT01060670|12251453|FG000|NOT COMPLETED|Follow up Phase||22
11069753|NCT01060670|12251454|FG001|NOT COMPLETED|Follow up Phase||35
11069754|NCT01061008|12251464|FG000|STARTED|Overall Study||16
11069755|NCT01061008|12251465|FG001|STARTED|Overall Study||15
11069756|NCT01061008|12251464|FG000|COMPLETED|Overall Study||10
11069757|NCT01061008|12251465|FG001|COMPLETED|Overall Study||9
11346679|NCT02983552|12543967|FG003|NOT COMPLETED|Overall Study||0
11346680|NCT02983604|12543985|FG000|STARTED|Overall Study||4
11069758|NCT01061008|12251464|FG000|NOT COMPLETED|Overall Study||6
11069759|NCT01061008|12251465|FG001|NOT COMPLETED|Overall Study||6
11346681|NCT02983604|12543986|FG001|STARTED|Overall Study||3
11346682|NCT02983604|12543987|FG002|STARTED|Overall Study||4
11346683|NCT02983604|12543988|FG003|STARTED|Overall Study||3
11346684|NCT02983604|12543985|FG000|COMPLETED|Overall Study||4
11346685|NCT02983604|12543986|FG001|COMPLETED|Overall Study||3
11346686|NCT02983604|12543987|FG002|COMPLETED|Overall Study||3
11346687|NCT02983604|12543988|FG003|COMPLETED|Overall Study||3
11346688|NCT02983604|12543985|FG000|NOT COMPLETED|Overall Study||0
11346689|NCT02983604|12543986|FG001|NOT COMPLETED|Overall Study||0
11346690|NCT02983604|12543987|FG002|NOT COMPLETED|Overall Study||1
11346691|NCT02983604|12543988|FG003|NOT COMPLETED|Overall Study||0
11346692|NCT02983825|12543998|FG000|STARTED|Overall Study|Of 21 enrolled subjects, 9 became ineligible for between consent and intervention|12
11346693|NCT02983825|12543998|FG000|COMPLETED|Overall Study|Of 12 subjects starting intervention, 3 met specified stopping critieria|9
11346694|NCT02983825|12543998|FG000|NOT COMPLETED|Overall Study||3
11346695|NCT02983877|12544002|FG000|STARTED|Overall Study||38
11069760|NCT01061034|12251471|FG000|STARTED|Aspirin||9
11069761|NCT01061034|12251471|FG000|COMPLETED|Aspirin||9
11069762|NCT01061034|12251471|FG000|NOT COMPLETED|Aspirin||0
11069763|NCT01061034|12251471|FG000|STARTED|Aspirin Plus Omeprazole||9
11069764|NCT01061034|12251471|FG000|COMPLETED|Aspirin Plus Omeprazole||9
11069765|NCT01061034|12251471|FG000|NOT COMPLETED|Aspirin Plus Omeprazole||0
11069766|NCT01061177|12251475|FG000|STARTED|Overall Study||1089
11069767|NCT01061177|12251475|FG000|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
11069768|NCT01061177|12251475|FG000|ITT_CyR (Ph+ Patients Only)|Overall Study||983
11069769|NCT01061177|12251475|FG000|COMPLETED|Overall Study||881
11069770|NCT01061177|12251475|FG000|NOT COMPLETED|Overall Study||208
11069771|NCT01061333|12251479|FG000|STARTED|Period 1: Placebo Run-in||8
11069772|NCT01061333|12251480|FG001|STARTED|Period 1: Placebo Run-in||8
11069773|NCT01061333|12251479|FG000|COMPLETED|Period 1: Placebo Run-in||8
11069774|NCT01061333|12251480|FG001|COMPLETED|Period 1: Placebo Run-in||8
11069775|NCT01061333|12251479|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0
11069776|NCT01061333|12251480|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0
11069777|NCT01061333|12251479|FG000|STARTED|Period 2: 20-day Washout||8
11069778|NCT01061333|12251480|FG001|STARTED|Period 2: 20-day Washout||8
11069779|NCT01061333|12251479|FG000|COMPLETED|Period 2: 20-day Washout||8
11069780|NCT01061333|12251480|FG001|COMPLETED|Period 2: 20-day Washout||8
11069781|NCT01061333|12251479|FG000|NOT COMPLETED|Period 2: 20-day Washout||0
11069782|NCT01061333|12251480|FG001|NOT COMPLETED|Period 2: 20-day Washout||0
11069783|NCT01061333|12251479|FG000|STARTED|Period 3: Nedocromil-Montelukast X-over||8
11069784|NCT01061333|12251480|FG001|STARTED|Period 3: Nedocromil-Montelukast X-over||8
11069785|NCT01061333|12251479|FG000|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
11069786|NCT01061333|12251480|FG001|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
11069787|NCT01061333|12251479|FG000|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
11069788|NCT01061333|12251480|FG001|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
11069789|NCT01061333|12251479|FG000|STARTED|Period 4: 20-day Washout||8
11069790|NCT01061333|12251480|FG001|STARTED|Period 4: 20-day Washout||8
11069791|NCT01061333|12251479|FG000|COMPLETED|Period 4: 20-day Washout||8
11069792|NCT01061333|12251480|FG001|COMPLETED|Period 4: 20-day Washout||7
11069793|NCT01061333|12251479|FG000|NOT COMPLETED|Period 4: 20-day Washout||0
11069794|NCT01061333|12251480|FG001|NOT COMPLETED|Period 4: 20-day Washout||1
11069795|NCT01061333|12251479|FG000|STARTED|Period 5: Nedocromil-Montelukast X-over||8
11069796|NCT01061333|12251480|FG001|STARTED|Period 5: Nedocromil-Montelukast X-over||7
11069797|NCT01061333|12251479|FG000|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
11069798|NCT01061333|12251480|FG001|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
11069799|NCT01061333|12251479|FG000|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
11069800|NCT01061333|12251480|FG001|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
11069801|NCT01061333|12251479|FG000|STARTED|Period 6: 20-day Washout||8
11069802|NCT01061333|12251480|FG001|STARTED|Period 6: 20-day Washout||7
11069803|NCT01061333|12251479|FG000|COMPLETED|Period 6: 20-day Washout||8
11069804|NCT01061333|12251480|FG001|COMPLETED|Period 6: 20-day Washout||7
11069805|NCT01061333|12251479|FG000|NOT COMPLETED|Period 6: 20-day Washout||0
11069806|NCT01061333|12251480|FG001|NOT COMPLETED|Period 6: 20-day Washout||0
11069807|NCT01061333|12251479|FG000|STARTED|Period 7: Mometasone||8
11069808|NCT01061333|12251480|FG001|STARTED|Period 7: Mometasone||7
11069809|NCT01061333|12251479|FG000|COMPLETED|Period 7: Mometasone||8
11069810|NCT01061333|12251480|FG001|COMPLETED|Period 7: Mometasone||7
11069811|NCT01061333|12251479|FG000|NOT COMPLETED|Period 7: Mometasone||0
11069812|NCT01061333|12251480|FG001|NOT COMPLETED|Period 7: Mometasone||0
11069813|NCT01061359|12251491|FG000|STARTED|Overall Study||1972
11069814|NCT01061359|12251491|FG000|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
11069815|NCT01061359|12251491|FG000|NOT COMPLETED|Overall Study||1302
11069816|NCT01061385|12251497|FG000|STARTED|Overall Study||21
11069817|NCT01061385|12251498|FG001|STARTED|Overall Study||9
11069818|NCT01061385|12251497|FG000|COMPLETED|Overall Study||20
11069819|NCT01061385|12251498|FG001|COMPLETED|Overall Study||8
11069820|NCT01061385|12251497|FG000|NOT COMPLETED|Overall Study||1
11069821|NCT01061385|12251498|FG001|NOT COMPLETED|Overall Study||1
11069822|NCT01061476|12251505|FG000|STARTED|Overall Study||12
11069823|NCT01061476|12251505|FG000|COMPLETED|Overall Study||12
11069824|NCT01061476|12251505|FG000|NOT COMPLETED|Overall Study||0
11069825|NCT01061528|12251511|FG000|STARTED|Overall Study||62
11069826|NCT01061528|12251512|FG001|STARTED|Overall Study||54
11069827|NCT01061528|12251511|FG000|COMPLETED|Overall Study||59
11069828|NCT01061528|12251512|FG001|COMPLETED|Overall Study||52
11069829|NCT01061528|12251511|FG000|NOT COMPLETED|Overall Study||3
11069830|NCT01061528|12251512|FG001|NOT COMPLETED|Overall Study||2
11069831|NCT01061567|12251518|FG000|STARTED|Overall Study||1814
11069832|NCT01061567|12251518|FG000|COMPLETED|Overall Study||1738
11069833|NCT01061567|12251518|FG000|NOT COMPLETED|Overall Study||76
11069834|NCT01061606|12251522|FG000|STARTED|Overall Study||8
11069835|NCT01061606|12251522|FG000|COMPLETED|Overall Study||0
11069836|NCT01061606|12251522|FG000|NOT COMPLETED|Overall Study||8
11069837|NCT01061671|12251528|FG000|STARTED|Overall Study||433
11069838|NCT01061671|12251529|FG001|STARTED|Overall Study||452
11069839|NCT01061671|12251528|FG000|COMPLETED|Overall Study||386
11069840|NCT01061671|12251529|FG001|COMPLETED|Overall Study||397
11069841|NCT01061671|12251528|FG000|NOT COMPLETED|Overall Study||47
11069842|NCT01061671|12251529|FG001|NOT COMPLETED|Overall Study||55
11069843|NCT01061710|12251535|FG000|STARTED|Overall Study||20
11069844|NCT01061710|12251535|FG000|COMPLETED|Overall Study||6
11069845|NCT01061710|12251535|FG000|NOT COMPLETED|Overall Study||14
11069846|NCT01061723|12251545|FG000|STARTED|Overall Study||50
11069847|NCT01061723|12251546|FG001|STARTED|Overall Study||49
11069848|NCT01061723|12251547|FG002|STARTED|Overall Study||50
11069849|NCT01061723|12251548|FG003|STARTED|Overall Study||52
11069850|NCT01061723|12251549|FG004|STARTED|Overall Study||50
11069851|NCT01061723|12251550|FG005|STARTED|Overall Study||50
11069852|NCT01061723|12251545|FG000|Treated|Overall Study||50
11069853|NCT01061723|12251546|FG001|Treated|Overall Study||49
11069854|NCT01061723|12251547|FG002|Treated|Overall Study||50
11069855|NCT01061723|12251548|FG003|Treated|Overall Study||52
11069856|NCT01061723|12251549|FG004|Treated|Overall Study||50
11069857|NCT01061723|12251550|FG005|Treated|Overall Study||49
11069858|NCT01061723|12251545|FG000|COMPLETED|Overall Study||46
11069859|NCT01061723|12251546|FG001|COMPLETED|Overall Study||43
11069860|NCT01061723|12251547|FG002|COMPLETED|Overall Study||40
11069861|NCT01061723|12251548|FG003|COMPLETED|Overall Study||44
11069862|NCT01061723|12251549|FG004|COMPLETED|Overall Study||47
11069863|NCT01061723|12251550|FG005|COMPLETED|Overall Study||41
11069864|NCT01061723|12251545|FG000|NOT COMPLETED|Overall Study||4
11069865|NCT01061723|12251546|FG001|NOT COMPLETED|Overall Study||6
11069866|NCT01061723|12251547|FG002|NOT COMPLETED|Overall Study||10
11069867|NCT01061723|12251548|FG003|NOT COMPLETED|Overall Study||8
11069868|NCT01061723|12251549|FG004|NOT COMPLETED|Overall Study||3
11069869|NCT01061723|12251550|FG005|NOT COMPLETED|Overall Study||9
11069870|NCT01061736|12251579|FG000|STARTED|Overall Study||50
11069871|NCT01061736|12251580|FG001|STARTED|Overall Study||50
11069872|NCT01061736|12251581|FG002|STARTED|Overall Study||51
11069873|NCT01061736|12251582|FG003|STARTED|Overall Study||51
11069874|NCT01061736|12251583|FG004|STARTED|Overall Study||52
11069875|NCT01061736|12251584|FG005|STARTED|Overall Study||52
11069876|NCT01061736|12251585|FG006|STARTED|Overall Study||84
11069877|NCT01061736|12251586|FG007|STARTED|Overall Study||430
11069878|NCT01061736|12251587|FG008|STARTED|Overall Study||427
11069879|NCT01061736|12251588|FG009|STARTED|Overall Study||428
11069880|NCT01061736|12251579|FG000|Treated|Overall Study||50
11069881|NCT01061736|12251580|FG001|Treated|Overall Study||50
11069882|NCT01061736|12251581|FG002|Treated|Overall Study||51
11069883|NCT01061736|12251582|FG003|Treated|Overall Study||51
11069884|NCT01061736|12251583|FG004|Treated|Overall Study||51
11069885|NCT01061736|12251584|FG005|Treated|Overall Study||52
11069886|NCT01061736|12251585|FG006|Treated|Overall Study||84
11346696|NCT02983877|12544002|FG000|COMPLETED|Overall Study||38
11346697|NCT02983877|12544002|FG000|NOT COMPLETED|Overall Study||0
11346698|NCT02983981|12544007|FG000|STARTED|Overall Study||20
11346699|NCT02983981|12544007|FG000|COMPLETED|Overall Study||20
11346700|NCT02983981|12544007|FG000|NOT COMPLETED|Overall Study||0
11346701|NCT02984267|12544013|FG000|STARTED|Overall Study||8
11346702|NCT02984267|12544014|FG001|STARTED|Overall Study||10
11346703|NCT02984267|12544013|FG000|COMPLETED|Overall Study||7
11346704|NCT02984267|12544014|FG001|COMPLETED|Overall Study||9
11346705|NCT02984267|12544013|FG000|NOT COMPLETED|Overall Study||1
11346706|NCT02984267|12544014|FG001|NOT COMPLETED|Overall Study||1
11346707|NCT02984644|12544022|FG000|STARTED|Overall Study||20
11346708|NCT02984644|12544023|FG001|STARTED|Overall Study||10
11346709|NCT02984644|12544022|FG000|COMPLETED|Overall Study||20
11346710|NCT02984644|12544023|FG001|COMPLETED|Overall Study||10
11346711|NCT02984644|12544022|FG000|NOT COMPLETED|Overall Study||0
11346712|NCT02984644|12544023|FG001|NOT COMPLETED|Overall Study||0
11346713|NCT02984683|12544052|FG000|STARTED|Overall Study||11
11346714|NCT02984683|12544053|FG001|STARTED|Overall Study||12
11346715|NCT02984683|12544052|FG000|COMPLETED|Overall Study||0
11346716|NCT02984683|12544053|FG001|COMPLETED|Overall Study||0
11069887|NCT01061736|12251586|FG007|Treated|Overall Study||428
11069888|NCT01061736|12251587|FG008|Treated|Overall Study||426
11069889|NCT01061736|12251588|FG009|Treated|Overall Study||428
11069890|NCT01061736|12251579|FG000|Rescued|Overall Study||0
11069891|NCT01061736|12251580|FG001|Rescued|Overall Study||0
11069892|NCT01061736|12251581|FG002|Rescued|Overall Study||0
11069893|NCT01061736|12251582|FG003|Rescued|Overall Study||0
11069894|NCT01061736|12251583|FG004|Rescued|Overall Study||0
11069895|NCT01061736|12251584|FG005|Rescued|Overall Study||0
11069896|NCT01061736|12251585|FG006|Rescued|Overall Study||0
11069897|NCT01061736|12251586|FG007|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
11069898|NCT01061736|12251587|FG008|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
11069899|NCT01061736|12251588|FG009|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
11069900|NCT01061736|12251579|FG000|COMPLETED|Overall Study||37
11069901|NCT01061736|12251580|FG001|COMPLETED|Overall Study||46
11346717|NCT02984683|12544052|FG000|NOT COMPLETED|Overall Study||11
11069902|NCT01061736|12251581|FG002|COMPLETED|Overall Study||45
11069903|NCT01061736|12251582|FG003|COMPLETED|Overall Study||48
11069904|NCT01061736|12251583|FG004|COMPLETED|Overall Study||45
11069905|NCT01061736|12251584|FG005|COMPLETED|Overall Study||49
11069906|NCT01061736|12251585|FG006|COMPLETED|Overall Study||0
11069907|NCT01061736|12251586|FG007|COMPLETED|Overall Study||336
11069908|NCT01061736|12251587|FG008|COMPLETED|Overall Study||330
11069909|NCT01061736|12251588|FG009|COMPLETED|Overall Study||354
11069910|NCT01061736|12251579|FG000|NOT COMPLETED|Overall Study||13
11069911|NCT01061736|12251580|FG001|NOT COMPLETED|Overall Study||4
11069912|NCT01061736|12251581|FG002|NOT COMPLETED|Overall Study||6
11069913|NCT01061736|12251582|FG003|NOT COMPLETED|Overall Study||3
11069914|NCT01061736|12251583|FG004|NOT COMPLETED|Overall Study||7
11069915|NCT01061736|12251584|FG005|NOT COMPLETED|Overall Study||3
11069916|NCT01061736|12251585|FG006|NOT COMPLETED|Overall Study||84
11069917|NCT01061736|12251586|FG007|NOT COMPLETED|Overall Study||94
11346718|NCT02984683|12544053|FG001|NOT COMPLETED|Overall Study||12
11346719|NCT02984709|12544061|FG000|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
11346720|NCT02984709|12544062|FG001|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
11346721|NCT02984709|12544061|FG000|COMPLETED|Overall Study||24
11346722|NCT02984709|12544062|FG001|COMPLETED|Overall Study||24
11346723|NCT02984709|12544061|FG000|NOT COMPLETED|Overall Study||0
11346724|NCT02984709|12544062|FG001|NOT COMPLETED|Overall Study||0
11346725|NCT02984878|12544072|FG000|STARTED|Overall Study||30
11346726|NCT02984878|12544073|FG001|STARTED|Overall Study||41
11346727|NCT02984878|12544072|FG000|COMPLETED|Overall Study||30
11069918|NCT01061736|12251587|FG008|NOT COMPLETED|Overall Study||97
11069919|NCT01061736|12251588|FG009|NOT COMPLETED|Overall Study||74
11069920|NCT01061775|12251613|FG000|STARTED|Overall Study||19
11069921|NCT01061775|12251613|FG000|COMPLETED|Overall Study||16
11069922|NCT01061775|12251613|FG000|NOT COMPLETED|Overall Study||3
11069923|NCT01061866|12251618|FG000|STARTED|Overall Study||7
11069924|NCT01061866|12251618|FG000|COMPLETED|Overall Study||5
11069925|NCT01061866|12251618|FG000|NOT COMPLETED|Overall Study||2
11069926|NCT01062009|12251626|FG000|STARTED|Overall Study||7
11069927|NCT01062009|12251627|FG001|STARTED|Overall Study||6
11069928|NCT01062009|12251628|FG002|STARTED|Overall Study||6
11069929|NCT01062009|12251629|FG003|STARTED|Overall Study||6
11069930|NCT01062009|12251626|FG000|COMPLETED|Overall Study||6
11069931|NCT01062009|12251627|FG001|COMPLETED|Overall Study||6
11069932|NCT01062009|12251628|FG002|COMPLETED|Overall Study||6
11069933|NCT01062009|12251629|FG003|COMPLETED|Overall Study||6
11069934|NCT01062009|12251626|FG000|NOT COMPLETED|Overall Study||1
11069935|NCT01062009|12251627|FG001|NOT COMPLETED|Overall Study||0
11069936|NCT01062009|12251628|FG002|NOT COMPLETED|Overall Study||0
11069937|NCT01062009|12251629|FG003|NOT COMPLETED|Overall Study||0
11069938|NCT01062061|12251639|FG000|STARTED|Overall Study||754
11346728|NCT02984878|12544073|FG001|COMPLETED|Overall Study||41
11346729|NCT02984878|12544072|FG000|NOT COMPLETED|Overall Study||0
11346730|NCT02984878|12544073|FG001|NOT COMPLETED|Overall Study||0
11346731|NCT02984943|12544082|FG000|STARTED|Overall Study||14
11346732|NCT02984943|12544082|FG000|COMPLETED|Overall Study||10
11346733|NCT02984943|12544082|FG000|NOT COMPLETED|Overall Study||4
11346734|NCT02984982|12544088|FG000|STARTED|Overall Study||102
11346735|NCT02984982|12544089|FG001|STARTED|Overall Study||104
11346736|NCT02984982|12544088|FG000|Treated|Overall Study||102
11346737|NCT02984982|12544089|FG001|Treated|Overall Study||103
11346738|NCT02984982|12544088|FG000|COMPLETED|Overall Study||94
11346739|NCT02984982|12544089|FG001|COMPLETED|Overall Study||94
11346740|NCT02984982|12544088|FG000|NOT COMPLETED|Overall Study||8
11346741|NCT02984982|12544089|FG001|NOT COMPLETED|Overall Study||10
11346742|NCT02984995|12544098|FG000|STARTED|Overall Study||34
11346743|NCT02984995|12544099|FG001|STARTED|Overall Study||3
11346744|NCT02984995|12544098|FG000|COMPLETED|Overall Study||9
11346745|NCT02984995|12544099|FG001|COMPLETED|Overall Study||0
11346746|NCT02984995|12544098|FG000|NOT COMPLETED|Overall Study||25
11346747|NCT02984995|12544099|FG001|NOT COMPLETED|Overall Study||3
11069939|NCT01062061|12251639|FG000|COMPLETED|Overall Study||727
11069940|NCT01062061|12251639|FG000|NOT COMPLETED|Overall Study||27
11069941|NCT01062074|12251647|FG000|STARTED|Overall Study||3605
11069942|NCT01062074|12251647|FG000|COMPLETED|Overall Study||3605
11069943|NCT01062074|12251647|FG000|NOT COMPLETED|Overall Study||0
11069944|NCT01062113|12251654|FG000|STARTED|Overall Study||133
11069945|NCT01062113|12251655|FG001|STARTED|Overall Study||64
11069946|NCT01062113|12251656|FG002|STARTED|Overall Study||58
11346748|NCT02985021|12544111|FG000|STARTED|Overall Study||2
11346749|NCT02985021|12544111|FG000|COMPLETED|Overall Study||1
11346750|NCT02985021|12544111|FG000|NOT COMPLETED|Overall Study||1
11346751|NCT02985398|12544115|FG000|STARTED|Overall Study||128
11346752|NCT02985398|12544115|FG000|Participants Treated|Overall Study||128
11346753|NCT02985398|12544115|FG000|COMPLETED|Overall Study||106
11069947|NCT01062113|12251654|FG000|COMPLETED|Overall Study||93
11069948|NCT01062113|12251655|FG001|COMPLETED|Overall Study||42
11069949|NCT01062113|12251656|FG002|COMPLETED|Overall Study||27
11069950|NCT01062113|12251654|FG000|NOT COMPLETED|Overall Study||40
11069951|NCT01062113|12251655|FG001|NOT COMPLETED|Overall Study||22
11069952|NCT01062113|12251656|FG002|NOT COMPLETED|Overall Study||31
11069953|NCT01062126|12251664|FG000|STARTED|Overall Study||3389
11069954|NCT01062126|12251664|FG000|COMPLETED|Overall Study||2856
11069955|NCT01062126|12251664|FG000|NOT COMPLETED|Overall Study||533
11069956|NCT01062165|12251668|FG000|STARTED|Overall Study||18
11069957|NCT01062165|12251668|FG000|COMPLETED|Overall Study||18
11069958|NCT01062165|12251668|FG000|NOT COMPLETED|Overall Study||0
11069959|NCT01062230|12251672|FG000|STARTED|Overall Study||6
11069960|NCT01062230|12251672|FG000|COMPLETED|Overall Study||6
11069961|NCT01062230|12251672|FG000|NOT COMPLETED|Overall Study||0
11069962|NCT01062256|12251679|FG000|STARTED|Overall Study||55
11069963|NCT01062256|12251680|FG001|STARTED|Overall Study||103
11069964|NCT01062256|12251681|FG002|STARTED|Overall Study||107
11069965|NCT01062256|12251679|FG000|COMPLETED|Overall Study||52
11069966|NCT01062256|12251680|FG001|COMPLETED|Overall Study||96
11069967|NCT01062256|12251681|FG002|COMPLETED|Overall Study||103
11069968|NCT01062256|12251679|FG000|NOT COMPLETED|Overall Study||3
11069969|NCT01062256|12251680|FG001|NOT COMPLETED|Overall Study||7
11069970|NCT01062256|12251681|FG002|NOT COMPLETED|Overall Study||4
11069971|NCT01062269|12251689|FG000|STARTED|Overall Study||42
11069972|NCT01062269|12251689|FG000|COMPLETED|Overall Study||42
11069973|NCT01062269|12251689|FG000|NOT COMPLETED|Overall Study||0
11069974|NCT01062308|12251699|FG000|STARTED|Overall Study||80
11069975|NCT01062308|12251700|FG001|STARTED|Overall Study||82
11069976|NCT01062308|12251699|FG000|COMPLETED|Overall Study||64
11069977|NCT01062308|12251700|FG001|COMPLETED|Overall Study||72
11069978|NCT01062308|12251699|FG000|NOT COMPLETED|Overall Study||16
11069979|NCT01062308|12251700|FG001|NOT COMPLETED|Overall Study||10
11069980|NCT01062555|12251708|FG000|STARTED|Phase 1||266
11069981|NCT01062555|12251709|FG001|STARTED|Phase 1||261
11069982|NCT01062555|12251710|FG002|STARTED|Phase 1||0
11069983|NCT01062555|12251711|FG003|STARTED|Phase 1||0
11069984|NCT01062555|12251708|FG000|COMPLETED|Phase 1||243
11069985|NCT01062555|12251709|FG001|COMPLETED|Phase 1||235
11069986|NCT01062555|12251710|FG002|COMPLETED|Phase 1||0
11069987|NCT01062555|12251711|FG003|COMPLETED|Phase 1||0
11069988|NCT01062555|12251708|FG000|NOT COMPLETED|Phase 1||23
11069989|NCT01062555|12251709|FG001|NOT COMPLETED|Phase 1||26
11346754|NCT02985398|12544115|FG000|NOT COMPLETED|Overall Study||22
11346755|NCT02985450|12544119|FG000|STARTED|Overall Study||82
11346756|NCT02985450|12544119|FG000|COMPLETED|Overall Study||75
11069990|NCT01062555|12251710|FG002|NOT COMPLETED|Phase 1||0
11069991|NCT01062555|12251711|FG003|NOT COMPLETED|Phase 1||0
11069992|NCT01062555|12251708|FG000|STARTED|Phase 2||0
11346757|NCT02985450|12544119|FG000|NOT COMPLETED|Overall Study||7
11346758|NCT02985710|12544128|FG000|STARTED|Overall Study||69
11346759|NCT02985710|12544129|FG001|STARTED|Overall Study||33
11346760|NCT02985710|12544128|FG000|COMPLETED|Overall Study||65
11346761|NCT02985710|12544129|FG001|COMPLETED|Overall Study||33
11346762|NCT02985710|12544128|FG000|NOT COMPLETED|Overall Study||4
11346763|NCT02985710|12544129|FG001|NOT COMPLETED|Overall Study||0
11346764|NCT02985827|12544137|FG000|STARTED|Overall Study||33
11346765|NCT02985827|12544138|FG001|STARTED|Overall Study||15
11346766|NCT02985827|12544137|FG000|COMPLETED|Overall Study||33
11346767|NCT02985827|12544138|FG001|COMPLETED|Overall Study||15
11346768|NCT02985827|12544137|FG000|NOT COMPLETED|Overall Study||0
11346769|NCT02985827|12544138|FG001|NOT COMPLETED|Overall Study||0
11346770|NCT02985879|12544147|FG000|STARTED|Overall Study||126
11346771|NCT02985879|12544148|FG001|STARTED|Overall Study||127
11069993|NCT01062555|12251709|FG001|STARTED|Phase 2||0
11069994|NCT01062555|12251710|FG002|STARTED|Phase 2||86
11069995|NCT01062555|12251711|FG003|STARTED|Phase 2||87
11069996|NCT01062555|12251708|FG000|COMPLETED|Phase 2||0
11069997|NCT01062555|12251709|FG001|COMPLETED|Phase 2||0
11069998|NCT01062555|12251710|FG002|COMPLETED|Phase 2||71
11069999|NCT01062555|12251711|FG003|COMPLETED|Phase 2||53
11070000|NCT01062555|12251708|FG000|NOT COMPLETED|Phase 2||0
11070001|NCT01062555|12251709|FG001|NOT COMPLETED|Phase 2||0
11070002|NCT01062555|12251710|FG002|NOT COMPLETED|Phase 2||15
11070003|NCT01062555|12251711|FG003|NOT COMPLETED|Phase 2||34
11070004|NCT01062568|12251723|FG000|STARTED|Overall Study||10
11070005|NCT01062568|12251724|FG001|STARTED|Overall Study||40
11070006|NCT01062568|12251723|FG000|COMPLETED|Overall Study||10
11070007|NCT01062568|12251724|FG001|COMPLETED|Overall Study||40
11070008|NCT01062568|12251723|FG000|NOT COMPLETED|Overall Study||0
11070009|NCT01062568|12251724|FG001|NOT COMPLETED|Overall Study||0
11070010|NCT01062763|12251737|FG000|STARTED|Overall Study|119 randomized.|58
11070011|NCT01062763|12251738|FG001|STARTED|Overall Study||61
11070012|NCT01062763|12251737|FG000|COMPLETED|Overall Study||55
11070013|NCT01062763|12251738|FG001|COMPLETED|Overall Study||57
11070014|NCT01062763|12251737|FG000|NOT COMPLETED|Overall Study||3
11070015|NCT01062763|12251738|FG001|NOT COMPLETED|Overall Study||4
11070016|NCT01062841|12251746|FG000|STARTED|Overall Study||203
11070017|NCT01062841|12251747|FG001|STARTED|Overall Study||215
11070018|NCT01062841|12251746|FG000|COMPLETED|Overall Study||154
11070019|NCT01062841|12251747|FG001|COMPLETED|Overall Study||162
11070020|NCT01062841|12251746|FG000|NOT COMPLETED|Overall Study||49
11070021|NCT01062841|12251747|FG001|NOT COMPLETED|Overall Study||53
11070022|NCT01062893|12251755|FG000|STARTED|Overall Study||41
11070023|NCT01062893|12251756|FG001|STARTED|Overall Study||41
11070024|NCT01062893|12251755|FG000|COMPLETED|Overall Study||27
11070025|NCT01062893|12251756|FG001|COMPLETED|Overall Study||28
11070026|NCT01062893|12251755|FG000|NOT COMPLETED|Overall Study||14
11070027|NCT01062893|12251756|FG001|NOT COMPLETED|Overall Study||13
11070028|NCT01062971|12251764|FG000|STARTED|Overall Study||60
11070029|NCT01062971|12251765|FG001|STARTED|Overall Study||63
11070030|NCT01062971|12251764|FG000|COMPLETED|Overall Study||56
11070031|NCT01062971|12251765|FG001|COMPLETED|Overall Study||56
11070032|NCT01062971|12251764|FG000|NOT COMPLETED|Overall Study||4
11070033|NCT01062971|12251765|FG001|NOT COMPLETED|Overall Study||7
11070034|NCT01063036|12251771|FG000|STARTED|Participants Treated With Study Drug||92
11070035|NCT01063036|12251771|FG000|COMPLETED|Participants Treated With Study Drug||86
11070036|NCT01063036|12251771|FG000|NOT COMPLETED|Participants Treated With Study Drug||6
11070037|NCT01063036|12251771|FG000|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
11070038|NCT01063036|12251771|FG000|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
11070039|NCT01063036|12251771|FG000|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
11070040|NCT01063049|12251778|FG000|STARTED|Overall Study||200
11070041|NCT01063049|12251779|FG001|STARTED|Overall Study||200
11070042|NCT01063049|12251780|FG002|STARTED|Overall Study||200
11070043|NCT01063049|12251778|FG000|COMPLETED|Overall Study||200
11070044|NCT01063049|12251779|FG001|COMPLETED|Overall Study||200
11070045|NCT01063049|12251780|FG002|COMPLETED|Overall Study||200
11070046|NCT01063049|12251778|FG000|NOT COMPLETED|Overall Study||0
11070047|NCT01063049|12251779|FG001|NOT COMPLETED|Overall Study||0
11070048|NCT01063049|12251780|FG002|NOT COMPLETED|Overall Study||0
11070049|NCT01063062|12251790|FG000|STARTED|Overall Study||30
11070050|NCT01063062|12251791|FG001|STARTED|Overall Study||77
11070051|NCT01063062|12251790|FG000|Received Study Drug|Overall Study||29
11346772|NCT02985879|12544149|FG002|STARTED|Overall Study||125
11070052|NCT01063062|12251791|FG001|Received Study Drug|Overall Study||76
11070053|NCT01063062|12251790|FG000|COMPLETED|Overall Study||22
11070054|NCT01063062|12251791|FG001|COMPLETED|Overall Study||65
11070055|NCT01063062|12251790|FG000|NOT COMPLETED|Overall Study||8
11070056|NCT01063062|12251791|FG001|NOT COMPLETED|Overall Study||12
11070057|NCT01063075|12251798|FG000|STARTED|Overall Study||2
11070058|NCT01063075|12251799|FG001|STARTED|Overall Study||3
11070059|NCT01063075|12251800|FG002|STARTED|Overall Study||14
11070060|NCT01063075|12251801|FG003|STARTED|Overall Study||15
11070061|NCT01063075|12251798|FG000|COMPLETED|Overall Study||1
11070062|NCT01063075|12251799|FG001|COMPLETED|Overall Study||1
11070063|NCT01063075|12251800|FG002|COMPLETED|Overall Study||9
11070064|NCT01063075|12251801|FG003|COMPLETED|Overall Study||14
11070065|NCT01063075|12251798|FG000|NOT COMPLETED|Overall Study||1
11070066|NCT01063075|12251799|FG001|NOT COMPLETED|Overall Study||2
11070067|NCT01063075|12251800|FG002|NOT COMPLETED|Overall Study||5
11070068|NCT01063075|12251801|FG003|NOT COMPLETED|Overall Study||1
11070069|NCT01063153|12251813|FG000|STARTED|Overall Study||33
11070070|NCT01063153|12251814|FG001|STARTED|Overall Study||38
11346773|NCT02985879|12544147|FG000|COMPLETED|Overall Study||50
11346774|NCT02985879|12544148|FG001|COMPLETED|Overall Study||52
11070071|NCT01063153|12251813|FG000|COMPLETED|Overall Study||31
11346775|NCT02985879|12544149|FG002|COMPLETED|Overall Study||48
11346776|NCT02985879|12544147|FG000|NOT COMPLETED|Overall Study||76
11346777|NCT02985879|12544148|FG001|NOT COMPLETED|Overall Study||75
11346778|NCT02985879|12544149|FG002|NOT COMPLETED|Overall Study||77
11346779|NCT02985996|12544168|FG000|STARTED|Overall Study||5
11346780|NCT02985996|12544169|FG001|STARTED|Overall Study||8
11346781|NCT02985996|12544170|FG002|STARTED|Overall Study||10
11346782|NCT02985996|12544171|FG003|STARTED|Overall Study||7
11346783|NCT02985996|12544172|FG004|STARTED|Overall Study||9
11346784|NCT02985996|12544168|FG000|COMPLETED|Overall Study||5
11346785|NCT02985996|12544169|FG001|COMPLETED|Overall Study||7
11346786|NCT02985996|12544170|FG002|COMPLETED|Overall Study||9
11346787|NCT02985996|12544171|FG003|COMPLETED|Overall Study||7
11346788|NCT02985996|12544172|FG004|COMPLETED|Overall Study||9
11346789|NCT02985996|12544168|FG000|NOT COMPLETED|Overall Study||0
11346790|NCT02985996|12544169|FG001|NOT COMPLETED|Overall Study||1
11346791|NCT02985996|12544170|FG002|NOT COMPLETED|Overall Study||1
11346792|NCT02985996|12544171|FG003|NOT COMPLETED|Overall Study||0
11346793|NCT02985996|12544172|FG004|NOT COMPLETED|Overall Study||0
11346794|NCT02986074|12544188|FG000|STARTED|First Trial Period||26
11346795|NCT02986074|12544189|FG001|STARTED|First Trial Period||29
11346796|NCT02986074|12544190|FG002|STARTED|First Trial Period||0
11346797|NCT02986074|12544191|FG003|STARTED|First Trial Period||0
11346798|NCT02986074|12544188|FG000|COMPLETED|First Trial Period||25
11346799|NCT02986074|12544189|FG001|COMPLETED|First Trial Period||29
11346800|NCT02986074|12544190|FG002|COMPLETED|First Trial Period||0
11346801|NCT02986074|12544191|FG003|COMPLETED|First Trial Period||0
11346802|NCT02986074|12544188|FG000|NOT COMPLETED|First Trial Period||1
11346803|NCT02986074|12544189|FG001|NOT COMPLETED|First Trial Period||0
11346804|NCT02986074|12544190|FG002|NOT COMPLETED|First Trial Period||0
11346805|NCT02986074|12544191|FG003|NOT COMPLETED|First Trial Period||0
11346806|NCT02986074|12544188|FG000|STARTED|Second Trial Period||25
11346807|NCT02986074|12544189|FG001|STARTED|Second Trial Period||29
11346808|NCT02986074|12544190|FG002|STARTED|Second Trial Period||0
11346809|NCT02986074|12544191|FG003|STARTED|Second Trial Period||0
11346810|NCT02986074|12544188|FG000|COMPLETED|Second Trial Period||25
11346811|NCT02986074|12544189|FG001|COMPLETED|Second Trial Period||29
11070072|NCT01063153|12251814|FG001|COMPLETED|Overall Study||26
11070073|NCT01063153|12251813|FG000|NOT COMPLETED|Overall Study||2
11346812|NCT02986074|12544190|FG002|COMPLETED|Second Trial Period||0
11346813|NCT02986074|12544191|FG003|COMPLETED|Second Trial Period||0
11346814|NCT02986074|12544188|FG000|NOT COMPLETED|Second Trial Period||0
11346815|NCT02986074|12544189|FG001|NOT COMPLETED|Second Trial Period||0
11346816|NCT02986074|12544190|FG002|NOT COMPLETED|Second Trial Period||0
11346817|NCT02986074|12544191|FG003|NOT COMPLETED|Second Trial Period||0
11070074|NCT01063153|12251814|FG001|NOT COMPLETED|Overall Study||12
11070075|NCT01063283|12251826|FG000|STARTED|Cycle 1||20
11346818|NCT02986074|12544188|FG000|STARTED|Follow up Period||0
11346819|NCT02986074|12544189|FG001|STARTED|Follow up Period||0
11346820|NCT02986074|12544190|FG002|STARTED|Follow up Period||21
11070076|NCT01063283|12251827|FG001|STARTED|Cycle 1||0
11070077|NCT01063283|12251828|FG002|STARTED|Cycle 1||0
11070078|NCT01063283|12251826|FG000|COMPLETED|Cycle 1||17
11070079|NCT01063283|12251827|FG001|COMPLETED|Cycle 1||0
11070080|NCT01063283|12251828|FG002|COMPLETED|Cycle 1||0
11070081|NCT01063283|12251826|FG000|NOT COMPLETED|Cycle 1||3
11070082|NCT01063283|12251827|FG001|NOT COMPLETED|Cycle 1||0
11070083|NCT01063283|12251828|FG002|NOT COMPLETED|Cycle 1||0
11070084|NCT01063283|12251826|FG000|STARTED|Randomized Phase (Cycle 2 and Beyond)||0
11070085|NCT01063283|12251827|FG001|STARTED|Randomized Phase (Cycle 2 and Beyond)||6
11070086|NCT01063283|12251828|FG002|STARTED|Randomized Phase (Cycle 2 and Beyond)||11
11070087|NCT01063283|12251826|FG000|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
11070088|NCT01063283|12251827|FG001|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6
11070089|NCT01063283|12251828|FG002|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11
11070090|NCT01063283|12251826|FG000|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
11070091|NCT01063283|12251827|FG001|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
11070092|NCT01063283|12251828|FG002|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
11070093|NCT01063348|12251836|FG000|STARTED|Overall Study||35
11070094|NCT01063348|12251837|FG001|STARTED|Overall Study||31
11070095|NCT01063348|12251836|FG000|COMPLETED|Overall Study||32
11070096|NCT01063348|12251837|FG001|COMPLETED|Overall Study||21
11070097|NCT01063348|12251836|FG000|NOT COMPLETED|Overall Study||3
11070098|NCT01063348|12251837|FG001|NOT COMPLETED|Overall Study||10
11070099|NCT01063595|12251843|FG000|STARTED|Enrolled in Study and Randomized||32
11070100|NCT01063595|12251844|FG001|STARTED|Enrolled in Study and Randomized||31
11070101|NCT01063595|12251843|FG000|Received Treatment|Enrolled in Study and Randomized||31
11070102|NCT01063595|12251844|FG001|Received Treatment|Enrolled in Study and Randomized||29
11070103|NCT01063595|12251843|FG000|COMPLETED|Enrolled in Study and Randomized||31
11070104|NCT01063595|12251844|FG001|COMPLETED|Enrolled in Study and Randomized||29
11070105|NCT01063595|12251843|FG000|NOT COMPLETED|Enrolled in Study and Randomized||1
11070106|NCT01063595|12251844|FG001|NOT COMPLETED|Enrolled in Study and Randomized||2
11070107|NCT01063595|12251843|FG000|STARTED|First Intervention||31
11070108|NCT01063595|12251844|FG001|STARTED|First Intervention||29
11070109|NCT01063595|12251843|FG000|COMPLETED|First Intervention||29
11070110|NCT01063595|12251844|FG001|COMPLETED|First Intervention||24
11070111|NCT01063595|12251843|FG000|NOT COMPLETED|First Intervention||2
11070112|NCT01063595|12251844|FG001|NOT COMPLETED|First Intervention||5
11070113|NCT01063595|12251843|FG000|STARTED|Second Intervention||29
11070114|NCT01063595|12251844|FG001|STARTED|Second Intervention||24
11070115|NCT01063595|12251843|FG000|COMPLETED|Second Intervention||29
11070116|NCT01063595|12251844|FG001|COMPLETED|Second Intervention||24
11070117|NCT01063595|12251843|FG000|NOT COMPLETED|Second Intervention||0
11070118|NCT01063595|12251844|FG001|NOT COMPLETED|Second Intervention||0
11070119|NCT01063712|12251850|FG000|STARTED|Overall Study||29
11070120|NCT01063712|12251850|FG000|COMPLETED|Overall Study||29
11070121|NCT01063712|12251850|FG000|NOT COMPLETED|Overall Study||0
11346821|NCT02986074|12544191|FG003|STARTED|Follow up Period||22
11346822|NCT02986074|12544188|FG000|3 Month Follow up|Follow up Period||0
11070122|NCT01063764|12251855|FG000|STARTED|1st Period (From Week 8 to Week 22)||73
11070123|NCT01063764|12251855|FG000|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
11070124|NCT01063764|12251855|FG000|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
11070125|NCT01063764|12251855|FG000|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
11070126|NCT01063764|12251855|FG000|COMPLETED|2nd Period (Week 22 to the End of Study)||35
11070127|NCT01063764|12251855|FG000|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
11070128|NCT01063829|12251863|FG000|STARTED|Overall Study||33
11070129|NCT01063829|12251864|FG001|STARTED|Overall Study||31
11070130|NCT01063829|12251865|FG002|STARTED|Overall Study||34
11070131|NCT01063829|12251866|FG003|STARTED|Overall Study||33
11070132|NCT01063829|12251863|FG000|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
11070133|NCT01063829|12251864|FG001|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
11070134|NCT01063829|12251865|FG002|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
11070135|NCT01063829|12251866|FG003|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
11070136|NCT01063829|12251863|FG000|NOT COMPLETED|Overall Study||16
11070137|NCT01063829|12251864|FG001|NOT COMPLETED|Overall Study||10
11070138|NCT01063829|12251865|FG002|NOT COMPLETED|Overall Study||10
11070139|NCT01063829|12251866|FG003|NOT COMPLETED|Overall Study||21
11070140|NCT01063855|12251878|FG000|STARTED|Overall Study||245
11070141|NCT01063855|12251879|FG001|STARTED|Overall Study||250
11070142|NCT01063855|12251878|FG000|COMPLETED|Overall Study||208
11346823|NCT02986074|12544189|FG001|3 Month Follow up|Follow up Period||0
11346824|NCT02986074|12544190|FG002|3 Month Follow up|Follow up Period||21
11346825|NCT02986074|12544191|FG003|3 Month Follow up|Follow up Period||21
11346826|NCT02986074|12544188|FG000|6 Month Follow up|Follow up Period||0
11070143|NCT01063855|12251879|FG001|COMPLETED|Overall Study||221
11070144|NCT01063855|12251878|FG000|NOT COMPLETED|Overall Study||37
11070145|NCT01063855|12251879|FG001|NOT COMPLETED|Overall Study||29
11070146|NCT01063868|12251891|FG000|STARTED|Overall Study||35
11070147|NCT01063868|12251892|FG001|STARTED|Overall Study||12
11070148|NCT01063868|12251891|FG000|COMPLETED|Overall Study||0
11070149|NCT01063868|12251892|FG001|COMPLETED|Overall Study||0
11070150|NCT01063868|12251891|FG000|NOT COMPLETED|Overall Study||35
11070151|NCT01063868|12251892|FG001|NOT COMPLETED|Overall Study||12
11070152|NCT01063881|12251901|FG000|STARTED|Overall Study||147
11070153|NCT01063881|12251902|FG001|STARTED|Overall Study||125
11070154|NCT01063881|12251903|FG002|STARTED|Overall Study||13
11070155|NCT01063881|12251901|FG000|COMPLETED|Overall Study||92
11070156|NCT01063881|12251902|FG001|COMPLETED|Overall Study||114
11070157|NCT01063881|12251903|FG002|COMPLETED|Overall Study||12
11070158|NCT01063881|12251901|FG000|NOT COMPLETED|Overall Study||55
11070159|NCT01063881|12251902|FG001|NOT COMPLETED|Overall Study||11
11070160|NCT01063881|12251903|FG002|NOT COMPLETED|Overall Study||1
11070161|NCT01063907|12251918|FG000|STARTED|Overall Study||15
11070162|NCT01063907|12251919|FG001|STARTED|Overall Study||80
11070163|NCT01063907|12251918|FG000|COMPLETED|Overall Study||15
11070164|NCT01063907|12251919|FG001|COMPLETED|Overall Study||80
11070165|NCT01063907|12251918|FG000|NOT COMPLETED|Overall Study||0
11070166|NCT01063907|12251919|FG001|NOT COMPLETED|Overall Study||0
11070167|NCT01063972|12251943|FG000|STARTED|Overall Study||310
11070168|NCT01063972|12251944|FG001|STARTED|Overall Study||296
11070169|NCT01063972|12251943|FG000|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296
11070170|NCT01063972|12251944|FG001|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284
11070171|NCT01063972|12251943|FG000|NOT COMPLETED|Overall Study||14
11070172|NCT01063972|12251944|FG001|NOT COMPLETED|Overall Study||12
11070173|NCT01064076|12251950|FG000|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
11070174|NCT01064076|12251950|FG000|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
11070175|NCT01064076|12251950|FG000|NOT COMPLETED|Overall Study||18
11070176|NCT01064167|12251957|FG000|STARTED|Overall Study||130
11070177|NCT01064167|12251958|FG001|STARTED|Overall Study||130
11070178|NCT01064167|12251957|FG000|COMPLETED|Overall Study||116
11070179|NCT01064167|12251958|FG001|COMPLETED|Overall Study||115
11070180|NCT01064167|12251957|FG000|NOT COMPLETED|Overall Study||14
11070181|NCT01064167|12251958|FG001|NOT COMPLETED|Overall Study||15
11070182|NCT01064284|12251966|FG000|STARTED|Overall Study|Taking into account the analyzed patients only|125
11070183|NCT01064284|12251967|FG001|STARTED|Overall Study|Taking into account the analyzed patients only|126
11070184|NCT01064284|12251966|FG000|COMPLETED|Overall Study||107
11070185|NCT01064284|12251967|FG001|COMPLETED|Overall Study||109
11070186|NCT01064284|12251966|FG000|NOT COMPLETED|Overall Study||18
11070187|NCT01064284|12251967|FG001|NOT COMPLETED|Overall Study||17
11070188|NCT01064297|12251977|FG000|STARTED|Overall Study||2567
11070189|NCT01064297|12251978|FG001|STARTED|Overall Study||219
11070190|NCT01064297|12251979|FG002|STARTED|Overall Study||630
11070191|NCT01064297|12251977|FG000|COMPLETED|Overall Study||1776
11070192|NCT01064297|12251978|FG001|COMPLETED|Overall Study||171
11070193|NCT01064297|12251979|FG002|COMPLETED|Overall Study||497
11070194|NCT01064297|12251977|FG000|NOT COMPLETED|Overall Study||791
11070195|NCT01064297|12251978|FG001|NOT COMPLETED|Overall Study||48
11070196|NCT01064297|12251979|FG002|NOT COMPLETED|Overall Study||133
11070197|NCT01064310|12251996|FG000|STARTED|Period 1||82
11070198|NCT01064310|12251997|FG001|STARTED|Period 1||86
11070199|NCT01064310|12251998|FG002|STARTED|Period 1||0
11070200|NCT01064310|12251996|FG000|COMPLETED|Period 1||68
11070201|NCT01064310|12251997|FG001|COMPLETED|Period 1||68
11070202|NCT01064310|12251998|FG002|COMPLETED|Period 1||0
11070203|NCT01064310|12251996|FG000|NOT COMPLETED|Period 1||14
11070204|NCT01064310|12251997|FG001|NOT COMPLETED|Period 1||18
11070205|NCT01064310|12251998|FG002|NOT COMPLETED|Period 1||0
11070206|NCT01064310|12251996|FG000|STARTED|Period 2||68
11070207|NCT01064310|12251997|FG001|STARTED|Period 2||68
11070208|NCT01064310|12251998|FG002|STARTED|Period 2||0
11070209|NCT01064310|12251996|FG000|COMPLETED|Period 2||64
11070210|NCT01064310|12251997|FG001|COMPLETED|Period 2||62
11070211|NCT01064310|12251998|FG002|COMPLETED|Period 2||0
11070212|NCT01064310|12251996|FG000|NOT COMPLETED|Period 2||4
11070213|NCT01064310|12251997|FG001|NOT COMPLETED|Period 2||6
11070214|NCT01064310|12251998|FG002|NOT COMPLETED|Period 2||0
11070215|NCT01064310|12251996|FG000|STARTED|Open Label Pazopinib||0
11070216|NCT01064310|12251997|FG001|STARTED|Open Label Pazopinib||0
11070217|NCT01064310|12251998|FG002|STARTED|Open Label Pazopinib||84
11070218|NCT01064310|12251996|FG000|COMPLETED|Open Label Pazopinib||0
11070219|NCT01064310|12251997|FG001|COMPLETED|Open Label Pazopinib||0
11070220|NCT01064310|12251998|FG002|COMPLETED|Open Label Pazopinib||0
11070221|NCT01064310|12251996|FG000|NOT COMPLETED|Open Label Pazopinib||0
11070222|NCT01064310|12251997|FG001|NOT COMPLETED|Open Label Pazopinib||0
11070223|NCT01064310|12251998|FG002|NOT COMPLETED|Open Label Pazopinib||84
11070224|NCT01064323|12252007|FG000|STARTED|Overall Study||10
11070225|NCT01064323|12252007|FG000|COMPLETED|Overall Study||10
11070226|NCT01064323|12252007|FG000|NOT COMPLETED|Overall Study||0
11070227|NCT01064362|12252013|FG000|STARTED|Overall Study||1559
11070228|NCT01064362|12252014|FG001|STARTED|Overall Study||11883
11070229|NCT01064362|12252013|FG000|COMPLETED|Overall Study||1559
11070230|NCT01064362|12252014|FG001|COMPLETED|Overall Study||11883
11070231|NCT01064362|12252013|FG000|NOT COMPLETED|Overall Study||0
11070232|NCT01064362|12252014|FG001|NOT COMPLETED|Overall Study||0
11070233|NCT01064401|12252022|FG000|STARTED|Overall Study||922
11070234|NCT01064401|12252023|FG001|STARTED|Overall Study||919
11070235|NCT01064401|12252022|FG000|COMPLETED|Overall Study||694
11070236|NCT01064401|12252023|FG001|COMPLETED|Overall Study||724
11070237|NCT01064401|12252022|FG000|NOT COMPLETED|Overall Study||228
11070238|NCT01064401|12252023|FG001|NOT COMPLETED|Overall Study||195
11070239|NCT01064414|12252033|FG000|STARTED|Core Period: Baseline to Week 26||90
11070240|NCT01064414|12252034|FG001|STARTED|Core Period: Baseline to Week 26||90
11070241|NCT01064414|12252035|FG002|STARTED|Core Period: Baseline to Week 26||89
11070242|NCT01064414|12252033|FG000|COMPLETED|Core Period: Baseline to Week 26||77
11070243|NCT01064414|12252034|FG001|COMPLETED|Core Period: Baseline to Week 26||75
11070244|NCT01064414|12252035|FG002|COMPLETED|Core Period: Baseline to Week 26||82
11070245|NCT01064414|12252033|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||13
11070246|NCT01064414|12252034|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||15
11070247|NCT01064414|12252035|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||7
11070248|NCT01064414|12252033|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
11070249|NCT01064414|12252034|FG001|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
11070250|NCT01064414|12252035|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
11070251|NCT01064414|12252033|FG000|COMPLETED|Extension Period: Week 26 to Week 52||64
11070252|NCT01064414|12252034|FG001|COMPLETED|Extension Period: Week 26 to Week 52||67
11070253|NCT01064414|12252035|FG002|COMPLETED|Extension Period: Week 26 to Week 52||76
11070254|NCT01064414|12252033|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
11070255|NCT01064414|12252034|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
11070256|NCT01064414|12252035|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
11070257|NCT01064531|12252048|FG000|STARTED|Overall Study||21
11070258|NCT01064531|12252049|FG001|STARTED|Overall Study||20
11070259|NCT01064531|12252048|FG000|COMPLETED|Overall Study||18
11070260|NCT01064531|12252049|FG001|COMPLETED|Overall Study||13
11070261|NCT01064531|12252048|FG000|NOT COMPLETED|Overall Study||3
11070262|NCT01064531|12252049|FG001|NOT COMPLETED|Overall Study||7
11070263|NCT01064622|12252058|FG000|STARTED|Lead-in Phase I||0
11070264|NCT01064622|12252059|FG001|STARTED|Lead-in Phase I||7
11070265|NCT01064622|12252058|FG000|COMPLETED|Lead-in Phase I||0
11070266|NCT01064622|12252059|FG001|COMPLETED|Lead-in Phase I||7
11070267|NCT01064622|12252058|FG000|NOT COMPLETED|Lead-in Phase I||0
11070268|NCT01064622|12252059|FG001|NOT COMPLETED|Lead-in Phase I||0
11070269|NCT01064622|12252058|FG000|STARTED|Randomized Phase II||55
11070270|NCT01064622|12252059|FG001|STARTED|Randomized Phase II||56
11070271|NCT01064622|12252058|FG000|COMPLETED|Randomized Phase II||53
11070272|NCT01064622|12252059|FG001|COMPLETED|Randomized Phase II||53
11070273|NCT01064622|12252058|FG000|NOT COMPLETED|Randomized Phase II||2
11070274|NCT01064622|12252059|FG001|NOT COMPLETED|Randomized Phase II||3
11070275|NCT01064622|12252058|FG000|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
11070276|NCT01064622|12252059|FG001|STARTED|Crossover of Arm I||0
11070277|NCT01064622|12252058|FG000|COMPLETED|Crossover of Arm I||22
11070278|NCT01064622|12252059|FG001|COMPLETED|Crossover of Arm I||0
11070279|NCT01064622|12252058|FG000|NOT COMPLETED|Crossover of Arm I||0
11070280|NCT01064622|12252059|FG001|NOT COMPLETED|Crossover of Arm I||0
11070281|NCT01064687|12252072|FG000|STARTED|Overall Study||279
11070282|NCT01064687|12252073|FG001|STARTED|Overall Study||280
11070283|NCT01064687|12252074|FG002|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
11070284|NCT01064687|12252075|FG003|STARTED|Overall Study||141
11070285|NCT01064687|12252072|FG000|Received at Least 1 Dose of Study Drug|Overall Study||279
11070286|NCT01064687|12252073|FG001|Received at Least 1 Dose of Study Drug|Overall Study||280
11070287|NCT01064687|12252074|FG002|Received at Least 1 Dose of Study Drug|Overall Study||276
11070288|NCT01064687|12252075|FG003|Received at Least 1 Dose of Study Drug|Overall Study||141
11070289|NCT01064687|12252072|FG000|Completed 26 Weeks|Overall Study||260
11070290|NCT01064687|12252073|FG001|Completed 26 Weeks|Overall Study||263
11070291|NCT01064687|12252074|FG002|Completed 26 Weeks|Overall Study||252
11070292|NCT01064687|12252075|FG003|Completed 26 Weeks|Overall Study||124
11070293|NCT01064687|12252072|FG000|COMPLETED|Overall Study||245
11070294|NCT01064687|12252073|FG001|COMPLETED|Overall Study||254
11070295|NCT01064687|12252074|FG002|COMPLETED|Overall Study||237
11070296|NCT01064687|12252075|FG003|COMPLETED|Overall Study||124
11070297|NCT01064687|12252072|FG000|NOT COMPLETED|Overall Study||34
11070298|NCT01064687|12252073|FG001|NOT COMPLETED|Overall Study||26
11070299|NCT01064687|12252074|FG002|NOT COMPLETED|Overall Study||41
11070300|NCT01064687|12252075|FG003|NOT COMPLETED|Overall Study||17
11070301|NCT01064713|12252098|FG000|STARTED|Overall Study||13
11070302|NCT01064713|12252099|FG001|STARTED|Overall Study||4
11070303|NCT01064713|12252098|FG000|COMPLETED|Overall Study||13
11070304|NCT01064713|12252099|FG001|COMPLETED|Overall Study||4
11070305|NCT01064713|12252098|FG000|NOT COMPLETED|Overall Study||0
11070306|NCT01064713|12252099|FG001|NOT COMPLETED|Overall Study||0
11070307|NCT01064739|12252105|FG000|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
11070308|NCT01064739|12252105|FG000|COMPLETED|Fixed Sodium Study Diet||14
11070309|NCT01064739|12252105|FG000|NOT COMPLETED|Fixed Sodium Study Diet||0
11070310|NCT01064739|12252105|FG000|STARTED|Fixed Sodium Diet + Fava Beans||14
11070311|NCT01064739|12252105|FG000|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
11070312|NCT01064739|12252105|FG000|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
11070313|NCT01064830|12252117|FG000|STARTED|Overall Study||10
11070314|NCT01064830|12252118|FG001|STARTED|Overall Study||11
11070315|NCT01064830|12252117|FG000|COMPLETED|Overall Study||8
11070316|NCT01064830|12252118|FG001|COMPLETED|Overall Study||7
11070317|NCT01064830|12252117|FG000|NOT COMPLETED|Overall Study||2
11070318|NCT01064830|12252118|FG001|NOT COMPLETED|Overall Study||4
11070319|NCT01064856|12252128|FG000|STARTED|Double-blind (DB) Period||84
11070320|NCT01064856|12252129|FG001|STARTED|Double-blind (DB) Period||81
11070321|NCT01064856|12252130|FG002|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
11070322|NCT01064856|12252131|FG003|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
11070323|NCT01064856|12252128|FG000|COMPLETED|Double-blind (DB) Period||82
11070324|NCT01064856|12252129|FG001|COMPLETED|Double-blind (DB) Period||81
11070325|NCT01064856|12252130|FG002|COMPLETED|Double-blind (DB) Period||0
11070326|NCT01064856|12252131|FG003|COMPLETED|Double-blind (DB) Period||0
11070327|NCT01064856|12252128|FG000|NOT COMPLETED|Double-blind (DB) Period||2
11070328|NCT01064856|12252129|FG001|NOT COMPLETED|Double-blind (DB) Period||0
11070329|NCT01064856|12252130|FG002|NOT COMPLETED|Double-blind (DB) Period||0
11070330|NCT01064856|12252131|FG003|NOT COMPLETED|Double-blind (DB) Period||0
11070331|NCT01064856|12252128|FG000|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
11070332|NCT01064856|12252129|FG001|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
11070333|NCT01064856|12252130|FG002|STARTED|Open-label (OL) Period||82
11070334|NCT01064856|12252131|FG003|STARTED|Open-label (OL) Period||81
11070335|NCT01064856|12252128|FG000|COMPLETED|Open-label (OL) Period||0
11070336|NCT01064856|12252129|FG001|COMPLETED|Open-label (OL) Period||0
11070337|NCT01064856|12252130|FG002|COMPLETED|Open-label (OL) Period||56
11070338|NCT01064856|12252131|FG003|COMPLETED|Open-label (OL) Period||61
11070339|NCT01064856|12252128|FG000|NOT COMPLETED|Open-label (OL) Period||0
11070340|NCT01064856|12252129|FG001|NOT COMPLETED|Open-label (OL) Period||0
11070341|NCT01064856|12252130|FG002|NOT COMPLETED|Open-label (OL) Period||26
11070342|NCT01064856|12252131|FG003|NOT COMPLETED|Open-label (OL) Period||20
11070343|NCT01064882|12252141|FG000|STARTED|Overall Study||36
11070344|NCT01064882|12252142|FG001|STARTED|Overall Study||34
11070345|NCT01064882|12252143|FG002|STARTED|Overall Study||34
11070346|NCT01064882|12252141|FG000|COMPLETED|Overall Study||34
11070347|NCT01064882|12252142|FG001|COMPLETED|Overall Study||32
11070348|NCT01064882|12252143|FG002|COMPLETED|Overall Study||32
11070349|NCT01064882|12252141|FG000|NOT COMPLETED|Overall Study||2
11070350|NCT01064882|12252142|FG001|NOT COMPLETED|Overall Study||2
11070351|NCT01064882|12252143|FG002|NOT COMPLETED|Overall Study||2
11070352|NCT01064947|12252151|FG000|STARTED|Overall Study||70
11070353|NCT01064947|12252151|FG000|COMPLETED|Overall Study||29
11070354|NCT01064947|12252151|FG000|NOT COMPLETED|Overall Study||41
11070355|NCT01065350|12252161|FG000|STARTED|Overall Study||43
11070356|NCT01065350|12252162|FG001|STARTED|Overall Study||42
11070357|NCT01065350|12252161|FG000|COMPLETED|Overall Study||43
11070358|NCT01065350|12252162|FG001|COMPLETED|Overall Study||41
11070359|NCT01065350|12252161|FG000|NOT COMPLETED|Overall Study||0
11070360|NCT01065350|12252162|FG001|NOT COMPLETED|Overall Study||1
11070361|NCT01065428|12252170|FG000|STARTED|Overall Study||17
11070362|NCT01065428|12252171|FG001|STARTED|Overall Study||35
11070363|NCT01065428|12252170|FG000|COMPLETED|Overall Study||17
11070364|NCT01065428|12252171|FG001|COMPLETED|Overall Study||35
11070365|NCT01065428|12252170|FG000|NOT COMPLETED|Overall Study||0
11070366|NCT01065428|12252171|FG001|NOT COMPLETED|Overall Study||0
11070367|NCT01065480|12252179|FG000|STARTED|Overall Study||48
11070368|NCT01065480|12252180|FG001|STARTED|Overall Study||43
11070369|NCT01065480|12252179|FG000|COMPLETED|Overall Study||48
11070370|NCT01065480|12252180|FG001|COMPLETED|Overall Study||43
11070371|NCT01065480|12252179|FG000|NOT COMPLETED|Overall Study||0
11070372|NCT01065480|12252180|FG001|NOT COMPLETED|Overall Study||0
11070373|NCT01065506|12252188|FG000|STARTED|Overall Study||64
11070374|NCT01065506|12252189|FG001|STARTED|Overall Study||72
11070375|NCT01065506|12252188|FG000|End of Treatment|Overall Study||44
11070376|NCT01065506|12252189|FG001|End of Treatment|Overall Study||37
11070377|NCT01065506|12252188|FG000|4-Month Follow-Up|Overall Study||35
11070378|NCT01065506|12252189|FG001|4-Month Follow-Up|Overall Study||34
11070379|NCT01065506|12252188|FG000|COMPLETED|Overall Study||32
11070380|NCT01065506|12252189|FG001|COMPLETED|Overall Study||34
11070381|NCT01065506|12252188|FG000|NOT COMPLETED|Overall Study||32
11070382|NCT01065506|12252189|FG001|NOT COMPLETED|Overall Study||38
11070383|NCT01065558|12252195|FG000|STARTED|Overall Study||5
11070384|NCT01065558|12252195|FG000|COMPLETED|Overall Study||5
11070385|NCT01065558|12252195|FG000|NOT COMPLETED|Overall Study||0
11070386|NCT01065571|12252201|FG000|STARTED|Overall Study||10
11070387|NCT01065571|12252202|FG001|STARTED|Overall Study||5
11070388|NCT01065571|12252201|FG000|COMPLETED|Overall Study||7
11070389|NCT01065571|12252202|FG001|COMPLETED|Overall Study||5
11070390|NCT01065571|12252201|FG000|NOT COMPLETED|Overall Study||3
11070391|NCT01065571|12252202|FG001|NOT COMPLETED|Overall Study||0
11070392|NCT01065597|12252210|FG000|STARTED|Overall Study||13
11070393|NCT01065597|12252210|FG000|COMPLETED|Overall Study||12
11070394|NCT01065597|12252210|FG000|NOT COMPLETED|Overall Study||1
11070395|NCT01065714|12252214|FG000|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
11070396|NCT01065714|12252214|FG000|COMPLETED|Overall Study||20
11070397|NCT01065714|12252214|FG000|NOT COMPLETED|Overall Study||0
11070398|NCT01065766|12252221|FG000|STARTED|Overall Study||4065
11070399|NCT01065766|12252221|FG000|COMPLETED|Overall Study||4033
11070400|NCT01065766|12252221|FG000|NOT COMPLETED|Overall Study||32
11070401|NCT01065844|12252225|FG000|STARTED|Overall Study||15
11070402|NCT01065844|12252225|FG000|COMPLETED|Overall Study||10
11070403|NCT01065844|12252225|FG000|NOT COMPLETED|Overall Study||5
11070404|NCT01066000|12252229|FG000|STARTED|Overall Study||33
11070405|NCT01066000|12252229|FG000|COMPLETED|Overall Study||24
11070406|NCT01066000|12252229|FG000|NOT COMPLETED|Overall Study||9
11070407|NCT01066026|12252233|FG000|STARTED|Overall Study|Each patient was injected with hyaluronic acid in each nasolabial fold (total: 2 injections)|25
11070408|NCT01066026|12252233|FG000|COMPLETED|Overall Study||23
11070409|NCT01066026|12252233|FG000|NOT COMPLETED|Overall Study||2
11070410|NCT01066039|12252239|FG000|STARTED|Overall Study||202
11070411|NCT01066039|12252239|FG000|Treated|Overall Study||200
11070412|NCT01066039|12252239|FG000|COMPLETED|Overall Study||158
11070413|NCT01066039|12252239|FG000|NOT COMPLETED|Overall Study||44
11070414|NCT01066052|12252245|FG000|STARTED|Overall Study||64
11070415|NCT01066052|12252246|FG001|STARTED|Overall Study||51
11070416|NCT01066052|12252245|FG000|Treated|Overall Study||61
11070417|NCT01066052|12252246|FG001|Treated|Overall Study||0
11070418|NCT01066052|12252245|FG000|COMPLETED|Overall Study||61
11070419|NCT01066052|12252246|FG001|COMPLETED|Overall Study||51
11070420|NCT01066052|12252245|FG000|NOT COMPLETED|Overall Study||3
11070421|NCT01066052|12252246|FG001|NOT COMPLETED|Overall Study||0
11070422|NCT01066104|12252253|FG000|STARTED|Overall Study||14
11070423|NCT01066104|12252254|FG001|STARTED|Overall Study||13
11070424|NCT01066104|12252253|FG000|COMPLETED|Overall Study||12
11070425|NCT01066104|12252254|FG001|COMPLETED|Overall Study||12
11070426|NCT01066104|12252253|FG000|NOT COMPLETED|Overall Study||2
11070427|NCT01066104|12252254|FG001|NOT COMPLETED|Overall Study||1
11070428|NCT01066143|12252260|FG000|STARTED|Overall Study||8
11070429|NCT01066143|12252260|FG000|COMPLETED|Overall Study||0
11070430|NCT01066143|12252260|FG000|NOT COMPLETED|Overall Study||8
11070431|NCT01066156|12252264|FG000|STARTED|Overall Study||34
11070432|NCT01066156|12252264|FG000|COMPLETED|Overall Study||24
11070433|NCT01066156|12252264|FG000|NOT COMPLETED|Overall Study||10
11070434|NCT01066364|12252270|FG000|STARTED|Overall Study||25
11070435|NCT01066364|12252271|FG001|STARTED|Overall Study||25
11070436|NCT01066364|12252270|FG000|COMPLETED|Overall Study||22
11070437|NCT01066364|12252271|FG001|COMPLETED|Overall Study||23
11070438|NCT01066364|12252270|FG000|NOT COMPLETED|Overall Study||3
11070439|NCT01066364|12252271|FG001|NOT COMPLETED|Overall Study||2
11070440|NCT01066520|12252280|FG000|STARTED|Overall Study||143
11070441|NCT01066520|12252281|FG001|STARTED|Overall Study||140
11070442|NCT01066520|12252282|FG002|STARTED|Overall Study||137
11070443|NCT01066520|12252280|FG000|COMPLETED|Overall Study||143
11070444|NCT01066520|12252281|FG001|COMPLETED|Overall Study||140
11070445|NCT01066520|12252282|FG002|COMPLETED|Overall Study||137
11070446|NCT01066520|12252280|FG000|NOT COMPLETED|Overall Study||0
11070447|NCT01066520|12252281|FG001|NOT COMPLETED|Overall Study||0
11070448|NCT01066520|12252282|FG002|NOT COMPLETED|Overall Study||0
11070449|NCT01066546|12252290|FG000|STARTED|Overall Study||5
11070450|NCT01066546|12252290|FG000|COMPLETED|Overall Study||0
11070451|NCT01066546|12252290|FG000|NOT COMPLETED|Overall Study||5
11070452|NCT01066585|12252296|FG000|STARTED|Overall Study||211
11070453|NCT01066585|12252297|FG001|STARTED|Overall Study||199
11070454|NCT01066585|12252296|FG000|COMPLETED|Overall Study||210
11070455|NCT01066585|12252297|FG001|COMPLETED|Overall Study||196
11070456|NCT01066585|12252296|FG000|NOT COMPLETED|Overall Study||1
11070457|NCT01066585|12252297|FG001|NOT COMPLETED|Overall Study||3
11206300|NCT01866839|12397233|FG000|NOT COMPLETED|Overall Study||10
11206301|NCT01866917|12397239|FG000|STARTED|Overall Study||17
11206302|NCT01866917|12397240|FG001|STARTED|Overall Study||18
11206303|NCT01866917|12397239|FG000|COMPLETED|Overall Study||13
11206304|NCT01866917|12397240|FG001|COMPLETED|Overall Study||12
11206305|NCT01866917|12397239|FG000|NOT COMPLETED|Overall Study||4
11206306|NCT01866917|12397240|FG001|NOT COMPLETED|Overall Study||6
11206307|NCT01866943|12397248|FG000|STARTED|Overall Study||19
11206308|NCT01866943|12397249|FG001|STARTED|Overall Study||22
11206309|NCT01866943|12397248|FG000|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
11206310|NCT01866943|12397249|FG001|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
11206311|NCT01866943|12397248|FG000|NOT COMPLETED|Overall Study||19
11206312|NCT01866943|12397249|FG001|NOT COMPLETED|Overall Study||22
11206313|NCT01867008|12397258|FG000|STARTED|Overall Study||55
11206314|NCT01867008|12397258|FG000|COMPLETED|Overall Study||54
11206315|NCT01867008|12397258|FG000|NOT COMPLETED|Overall Study||1
11346827|NCT02986074|12544189|FG001|6 Month Follow up|Follow up Period||0
11346828|NCT02986074|12544190|FG002|6 Month Follow up|Follow up Period||21
11206316|NCT01867021|12397264|FG000|STARTED|Overall Study||1452
11206317|NCT01867021|12397265|FG001|STARTED|Overall Study||1450
11206318|NCT01867021|12397264|FG000|COMPLETED|Overall Study||1450
11206319|NCT01867021|12397265|FG001|COMPLETED|Overall Study||1440
11206320|NCT01867021|12397264|FG000|NOT COMPLETED|Overall Study||2
11346829|NCT02986074|12544191|FG003|6 Month Follow up|Follow up Period||20
11206321|NCT01867021|12397265|FG001|NOT COMPLETED|Overall Study||10
11206322|NCT01867047|12397278|FG000|STARTED|Overall Study||31
11206323|NCT01867047|12397279|FG001|STARTED|Overall Study||28
11206324|NCT01867047|12397278|FG000|COMPLETED|Overall Study||23
11206325|NCT01867047|12397279|FG001|COMPLETED|Overall Study||23
11206326|NCT01867047|12397278|FG000|NOT COMPLETED|Overall Study||8
11206327|NCT01867047|12397279|FG001|NOT COMPLETED|Overall Study||5
11206328|NCT01867086|12397289|FG000|STARTED|Overall Study||1
11206329|NCT01867086|12397289|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
11206330|NCT01867086|12397289|FG000|NOT COMPLETED|Overall Study||1
11206331|NCT01867164|12397295|FG000|STARTED|Overall Study||81
11206332|NCT01867164|12397296|FG001|STARTED|Overall Study||79
11206333|NCT01867164|12397295|FG000|COMPLETED|Overall Study||81
11206334|NCT01867164|12397296|FG001|COMPLETED|Overall Study||79
11206335|NCT01867164|12397295|FG000|NOT COMPLETED|Overall Study||0
11206336|NCT01867164|12397296|FG001|NOT COMPLETED|Overall Study||0
11206337|NCT01867216|12397309|FG000|STARTED|Overall Study||16
11206338|NCT01867216|12397310|FG001|STARTED|Overall Study||8
11206339|NCT01867216|12397311|FG002|STARTED|Overall Study||8
11206340|NCT01867216|12397312|FG003|STARTED|Overall Study||8
11206341|NCT01867216|12397313|FG004|STARTED|Overall Study||9
11206342|NCT01867216|12397314|FG005|STARTED|Overall Study||8
11206343|NCT01867216|12397315|FG006|STARTED|Overall Study||9
11206344|NCT01867216|12397309|FG000|Received Study Drug|Overall Study||14
11346830|NCT02986074|12544188|FG000|COMPLETED|Follow up Period||0
11346831|NCT02986074|12544189|FG001|COMPLETED|Follow up Period||0
11346832|NCT02986074|12544190|FG002|COMPLETED|Follow up Period||20
11346833|NCT02986074|12544191|FG003|COMPLETED|Follow up Period||19
11346834|NCT02986074|12544188|FG000|NOT COMPLETED|Follow up Period||0
11346835|NCT02986074|12544189|FG001|NOT COMPLETED|Follow up Period||0
11346836|NCT02986074|12544190|FG002|NOT COMPLETED|Follow up Period||1
11346837|NCT02986074|12544191|FG003|NOT COMPLETED|Follow up Period||3
11346838|NCT02986139|12544198|FG000|STARTED|Overall Study||56
11346839|NCT02986139|12544199|FG001|STARTED|Overall Study||55
11346840|NCT02986139|12544198|FG000|Received Etanercept|Overall Study||56
11346841|NCT02986139|12544199|FG001|Received Etanercept|Overall Study||53
11346842|NCT02986139|12544198|FG000|COMPLETED|Overall Study||55
11346843|NCT02986139|12544199|FG001|COMPLETED|Overall Study||51
11346844|NCT02986139|12544198|FG000|NOT COMPLETED|Overall Study||1
11346845|NCT02986139|12544199|FG001|NOT COMPLETED|Overall Study||4
11346846|NCT02986282|12544209|FG000|STARTED|Overall Study||115
11346847|NCT02986282|12544209|FG000|COMPLETED|Overall Study||99
11346848|NCT02986282|12544209|FG000|NOT COMPLETED|Overall Study||16
11346849|NCT02986373|12544213|FG000|STARTED|Overall Study||145
11346850|NCT02986373|12544213|FG000|COMPLETED|Overall Study||106
11346851|NCT02986373|12544213|FG000|NOT COMPLETED|Overall Study||39
11346852|NCT02986711|12544219|FG000|STARTED|Overall Study||78
11346853|NCT02986711|12544220|FG001|STARTED|Overall Study||80
11346854|NCT02986711|12544219|FG000|COMPLETED|Overall Study||70
11346855|NCT02986711|12544220|FG001|COMPLETED|Overall Study||70
11346856|NCT02986711|12544219|FG000|NOT COMPLETED|Overall Study||8
11346857|NCT02986711|12544220|FG001|NOT COMPLETED|Overall Study||10
11346858|NCT02986802|12544230|FG000|STARTED|Overall Study||1360
11346859|NCT02986802|12544231|FG001|STARTED|Overall Study||2839
11346860|NCT02986802|12544232|FG002|STARTED|Overall Study||1873
11346861|NCT02986802|12544233|FG003|STARTED|Overall Study||83060
11346862|NCT02986802|12544230|FG000|COMPLETED|Overall Study||1360
11346863|NCT02986802|12544231|FG001|COMPLETED|Overall Study||2839
11346864|NCT02986802|12544232|FG002|COMPLETED|Overall Study||1873
11346865|NCT02986802|12544233|FG003|COMPLETED|Overall Study||83060
11346866|NCT02986802|12544230|FG000|NOT COMPLETED|Overall Study||0
11346867|NCT02986802|12544231|FG001|NOT COMPLETED|Overall Study||0
11346868|NCT02986802|12544232|FG002|NOT COMPLETED|Overall Study||0
11346869|NCT02986802|12544233|FG003|NOT COMPLETED|Overall Study||0
11346870|NCT02986854|12544246|FG000|STARTED|Overall Study||301
11070458|NCT01066624|12252306|FG000|STARTED|Overall Study||38
11346871|NCT02986854|12544247|FG001|STARTED|Overall Study||300
11346872|NCT02986854|12544248|FG002|STARTED|Overall Study||100
11070459|NCT01066624|12252307|FG001|STARTED|Overall Study||40
11070460|NCT01066624|12252308|FG002|STARTED|Overall Study||39
11070461|NCT01066624|12252306|FG000|COMPLETED|Overall Study||38
11346873|NCT02986854|12544246|FG000|COMPLETED|Overall Study||298
11346874|NCT02986854|12544247|FG001|COMPLETED|Overall Study||288
11346875|NCT02986854|12544248|FG002|COMPLETED|Overall Study||97
11070462|NCT01066624|12252307|FG001|COMPLETED|Overall Study||40
11070463|NCT01066624|12252308|FG002|COMPLETED|Overall Study||39
11070464|NCT01066624|12252306|FG000|NOT COMPLETED|Overall Study||0
11070465|NCT01066624|12252307|FG001|NOT COMPLETED|Overall Study||0
11070466|NCT01066624|12252308|FG002|NOT COMPLETED|Overall Study||0
11070467|NCT01066780|12252316|FG000|STARTED|Overall Study||24
11070468|NCT01066780|12252317|FG001|STARTED|Overall Study||24
11070469|NCT01066780|12252316|FG000|COMPLETED|Overall Study||23
11070470|NCT01066780|12252317|FG001|COMPLETED|Overall Study||23
11070471|NCT01066780|12252316|FG000|NOT COMPLETED|Overall Study||1
11070472|NCT01066780|12252317|FG001|NOT COMPLETED|Overall Study||1
11070473|NCT01066793|12252327|FG000|STARTED|Overall Study||1128
11070474|NCT01066793|12252328|FG001|STARTED|Overall Study||572
11070475|NCT01066793|12252329|FG002|STARTED|Overall Study||484
11070476|NCT01066793|12252330|FG003|STARTED|Overall Study||143
11070477|NCT01066793|12252331|FG004|STARTED|Overall Study||11
11070478|NCT01066793|12252332|FG005|STARTED|Overall Study||5
11070479|NCT01066793|12252327|FG000|COMPLETED|Overall Study||754
11070480|NCT01066793|12252328|FG001|COMPLETED|Overall Study||495
11070481|NCT01066793|12252329|FG002|COMPLETED|Overall Study||369
11070482|NCT01066793|12252330|FG003|COMPLETED|Overall Study||94
11070483|NCT01066793|12252331|FG004|COMPLETED|Overall Study||11
11070484|NCT01066793|12252332|FG005|COMPLETED|Overall Study||4
11070485|NCT01066793|12252327|FG000|NOT COMPLETED|Overall Study||374
11070486|NCT01066793|12252328|FG001|NOT COMPLETED|Overall Study||77
11070487|NCT01066793|12252329|FG002|NOT COMPLETED|Overall Study||115
11070488|NCT01066793|12252330|FG003|NOT COMPLETED|Overall Study||49
11070489|NCT01066793|12252331|FG004|NOT COMPLETED|Overall Study||0
11070490|NCT01066793|12252332|FG005|NOT COMPLETED|Overall Study||1
11070491|NCT01066819|12252353|FG000|STARTED|Overall Study||1006
11070492|NCT01066819|12252354|FG001|STARTED|Overall Study||348
11070493|NCT01066819|12252355|FG002|STARTED|Overall Study||257
11070494|NCT01066819|12252356|FG003|STARTED|Overall Study||25
11070495|NCT01066819|12252357|FG004|STARTED|Overall Study||7
11070496|NCT01066819|12252358|FG005|STARTED|Overall Study||13
11070497|NCT01066819|12252353|FG000|COMPLETED|Overall Study||317
11070498|NCT01066819|12252354|FG001|COMPLETED|Overall Study||177
11070499|NCT01066819|12252355|FG002|COMPLETED|Overall Study||111
11070500|NCT01066819|12252356|FG003|COMPLETED|Overall Study||8
11070501|NCT01066819|12252357|FG004|COMPLETED|Overall Study||3
11070502|NCT01066819|12252358|FG005|COMPLETED|Overall Study||7
11070503|NCT01066819|12252353|FG000|NOT COMPLETED|Overall Study||689
11070504|NCT01066819|12252354|FG001|NOT COMPLETED|Overall Study||171
11070505|NCT01066819|12252355|FG002|NOT COMPLETED|Overall Study||146
11070506|NCT01066819|12252356|FG003|NOT COMPLETED|Overall Study||17
11070507|NCT01066819|12252357|FG004|NOT COMPLETED|Overall Study||4
11070508|NCT01066819|12252358|FG005|NOT COMPLETED|Overall Study||6
11070509|NCT01066871|12252374|FG000|STARTED|Overall Study||20
11070510|NCT01066871|12252375|FG001|STARTED|Overall Study||18
11070511|NCT01066871|12252376|FG002|STARTED|Overall Study||18
11070512|NCT01066871|12252377|FG003|STARTED|Overall Study||18
11070513|NCT01066871|12252374|FG000|COMPLETED|Overall Study||16
11070514|NCT01066871|12252375|FG001|COMPLETED|Overall Study||13
11070515|NCT01066871|12252376|FG002|COMPLETED|Overall Study||12
11346876|NCT02986854|12544246|FG000|NOT COMPLETED|Overall Study||3
11346877|NCT02986854|12544247|FG001|NOT COMPLETED|Overall Study||12
11346878|NCT02986854|12544248|FG002|NOT COMPLETED|Overall Study||3
11346879|NCT02986958|12544260|FG000|STARTED|Overall Study||49
11070516|NCT01066871|12252377|FG003|COMPLETED|Overall Study||13
11070517|NCT01066871|12252374|FG000|NOT COMPLETED|Overall Study||4
11070518|NCT01066871|12252375|FG001|NOT COMPLETED|Overall Study||5
11070519|NCT01066871|12252376|FG002|NOT COMPLETED|Overall Study||6
11070520|NCT01066871|12252377|FG003|NOT COMPLETED|Overall Study||5
11070521|NCT01066897|12252394|FG000|STARTED|Overall Study||7
11070522|NCT01066897|12252395|FG001|STARTED|Overall Study||9
11070523|NCT01066897|12252394|FG000|COMPLETED|Overall Study||5
11070524|NCT01066897|12252395|FG001|COMPLETED|Overall Study||9
11070525|NCT01066897|12252394|FG000|NOT COMPLETED|Overall Study||2
11070526|NCT01066897|12252395|FG001|NOT COMPLETED|Overall Study||0
11070527|NCT01066923|12252406|FG000|STARTED|Overall Study||28
11070528|NCT01066923|12252407|FG001|STARTED|Overall Study||32
11070529|NCT01066923|12252408|FG002|STARTED|Overall Study||33
11070530|NCT01066923|12252409|FG003|STARTED|Overall Study||31
11070531|NCT01066923|12252406|FG000|Platelet Closure Time|Overall Study||25
11070532|NCT01066923|12252407|FG001|Platelet Closure Time|Overall Study||29
11070533|NCT01066923|12252408|FG002|Platelet Closure Time|Overall Study||25
11070534|NCT01066923|12252409|FG003|Platelet Closure Time|Overall Study||23
11070535|NCT01066923|12252406|FG000|Vascular Function|Overall Study||13
11070536|NCT01066923|12252407|FG001|Vascular Function|Overall Study||14
11070537|NCT01066923|12252408|FG002|Vascular Function|Overall Study||12
11070538|NCT01066923|12252409|FG003|Vascular Function|Overall Study||13
11070539|NCT01066923|12252406|FG000|Activation of Coagulation|Overall Study||0
11070540|NCT01066923|12252407|FG001|Activation of Coagulation|Overall Study||0
11070541|NCT01066923|12252408|FG002|Activation of Coagulation|Overall Study||0
11070542|NCT01066923|12252409|FG003|Activation of Coagulation|Overall Study||0
11070543|NCT01066923|12252406|FG000|Retinal Imaging|Overall Study||0
11070544|NCT01066923|12252407|FG001|Retinal Imaging|Overall Study||0
11070545|NCT01066923|12252408|FG002|Retinal Imaging|Overall Study||0
11070546|NCT01066923|12252409|FG003|Retinal Imaging|Overall Study||0
11070547|NCT01066923|12252406|FG000|COMPLETED|Overall Study||25
11070548|NCT01066923|12252407|FG001|COMPLETED|Overall Study||29
11070549|NCT01066923|12252408|FG002|COMPLETED|Overall Study||25
11070550|NCT01066923|12252409|FG003|COMPLETED|Overall Study||23
11070551|NCT01066923|12252406|FG000|NOT COMPLETED|Overall Study||3
11070552|NCT01066923|12252407|FG001|NOT COMPLETED|Overall Study||3
11070553|NCT01066923|12252408|FG002|NOT COMPLETED|Overall Study||8
11070554|NCT01066923|12252409|FG003|NOT COMPLETED|Overall Study||8
11070555|NCT01066936|12252419|FG000|STARTED|Overall Study||20
11070556|NCT01066936|12252419|FG000|COMPLETED|Overall Study||10
11070557|NCT01066936|12252419|FG000|NOT COMPLETED|Overall Study||10
11070558|NCT01067105|12252425|FG000|STARTED|Overall Study||824
11070559|NCT01067105|12252425|FG000|COMPLETED|Overall Study||683
11206345|NCT01867216|12397310|FG001|Received Study Drug|Overall Study||8
11206346|NCT01867216|12397311|FG002|Received Study Drug|Overall Study||8
11206347|NCT01867216|12397312|FG003|Received Study Drug|Overall Study||8
11206348|NCT01867216|12397313|FG004|Received Study Drug|Overall Study||9
11206349|NCT01867216|12397314|FG005|Received Study Drug|Overall Study||8
11206350|NCT01867216|12397315|FG006|Received Study Drug|Overall Study||9
11206351|NCT01867216|12397309|FG000|COMPLETED|Overall Study||12
11206352|NCT01867216|12397310|FG001|COMPLETED|Overall Study||8
11206353|NCT01867216|12397311|FG002|COMPLETED|Overall Study||8
11206354|NCT01867216|12397312|FG003|COMPLETED|Overall Study||8
11206355|NCT01867216|12397313|FG004|COMPLETED|Overall Study||8
11206356|NCT01867216|12397314|FG005|COMPLETED|Overall Study||8
11206357|NCT01867216|12397315|FG006|COMPLETED|Overall Study||8
11206358|NCT01867216|12397309|FG000|NOT COMPLETED|Overall Study||4
11206359|NCT01867216|12397310|FG001|NOT COMPLETED|Overall Study||0
11206360|NCT01867216|12397311|FG002|NOT COMPLETED|Overall Study||0
11206361|NCT01867216|12397312|FG003|NOT COMPLETED|Overall Study||0
11206362|NCT01867216|12397313|FG004|NOT COMPLETED|Overall Study||1
11206363|NCT01867216|12397314|FG005|NOT COMPLETED|Overall Study||0
11206364|NCT01867216|12397315|FG006|NOT COMPLETED|Overall Study||1
11206365|NCT01867294|12397341|FG000|STARTED|Overall Study||9
11206366|NCT01867294|12397342|FG001|STARTED|Overall Study||10
11206367|NCT01867294|12397343|FG002|STARTED|Overall Study||0
11206368|NCT01867294|12397344|FG003|STARTED|Overall Study||0
11206369|NCT01867294|12397341|FG000|COMPLETED|Overall Study||8
11206370|NCT01867294|12397342|FG001|COMPLETED|Overall Study||9
11206371|NCT01867294|12397343|FG002|COMPLETED|Overall Study||0
11206372|NCT01867294|12397344|FG003|COMPLETED|Overall Study||0
11206373|NCT01867294|12397341|FG000|NOT COMPLETED|Overall Study||1
11206374|NCT01867294|12397342|FG001|NOT COMPLETED|Overall Study||1
11206375|NCT01867294|12397343|FG002|NOT COMPLETED|Overall Study||0
11206376|NCT01867294|12397344|FG003|NOT COMPLETED|Overall Study||0
11206377|NCT01867307|12397354|FG000|STARTED|Overall Study|Started are the treated patients|18
11206378|NCT01867307|12397355|FG001|STARTED|Overall Study|Started are the treated patients|19
11206379|NCT01867307|12397354|FG000|COMPLETED|Overall Study||15
11206380|NCT01867307|12397355|FG001|COMPLETED|Overall Study||16
11206381|NCT01867307|12397354|FG000|NOT COMPLETED|Overall Study||3
11206382|NCT01867307|12397355|FG001|NOT COMPLETED|Overall Study||3
11206383|NCT01867424|12397363|FG000|STARTED|Overall Study||12
11206384|NCT01867424|12397364|FG001|STARTED|Overall Study||12
11206385|NCT01867424|12397363|FG000|COMPLETED|Overall Study||10
11206386|NCT01867424|12397364|FG001|COMPLETED|Overall Study||11
11206387|NCT01867424|12397363|FG000|NOT COMPLETED|Overall Study||2
11206388|NCT01867424|12397364|FG001|NOT COMPLETED|Overall Study||1
11206389|NCT01867515|12397373|FG000|STARTED|Overall Study||13
11206390|NCT01867515|12397374|FG001|STARTED|Overall Study||12
11206391|NCT01867515|12397375|FG002|STARTED|Overall Study||25
11206392|NCT01867515|12397373|FG000|COMPLETED|Overall Study||13
11206393|NCT01867515|12397374|FG001|COMPLETED|Overall Study||11
11206394|NCT01867515|12397375|FG002|COMPLETED|Overall Study||14
11206395|NCT01867515|12397373|FG000|NOT COMPLETED|Overall Study||0
11206396|NCT01867515|12397374|FG001|NOT COMPLETED|Overall Study||1
11206397|NCT01867515|12397375|FG002|NOT COMPLETED|Overall Study||11
11206398|NCT01867632|12397385|FG000|STARTED|Overall Study||65
11206399|NCT01867632|12397386|FG001|STARTED|Overall Study||66
11206400|NCT01867632|12397385|FG000|COMPLETED|Overall Study||65
11206401|NCT01867632|12397386|FG001|COMPLETED|Overall Study||66
11206402|NCT01867632|12397385|FG000|NOT COMPLETED|Overall Study||0
11206403|NCT01867632|12397386|FG001|NOT COMPLETED|Overall Study||0
11206404|NCT01867658|12397392|FG000|STARTED|Overall Study||112
11206405|NCT01867658|12397392|FG000|COMPLETED|Overall Study||103
11206406|NCT01867658|12397392|FG000|NOT COMPLETED|Overall Study||9
11206407|NCT01867671|12397398|FG000|STARTED|Overall Study||96
11206408|NCT01867671|12397399|FG001|STARTED|Overall Study||50
11206409|NCT01867671|12397398|FG000|COMPLETED|Overall Study||67
11206410|NCT01867671|12397399|FG001|COMPLETED|Overall Study||22
11206411|NCT01867671|12397398|FG000|NOT COMPLETED|Overall Study||29
11206412|NCT01867671|12397399|FG001|NOT COMPLETED|Overall Study||28
11206413|NCT01867710|12397409|FG000|STARTED|Overall Study||41
11206414|NCT01867710|12397410|FG001|STARTED|Overall Study||41
11206415|NCT01867710|12397411|FG002|STARTED|Overall Study||40
11206416|NCT01867710|12397412|FG003|STARTED|Overall Study||42
11206417|NCT01867710|12397409|FG000|Treated|Overall Study||41
11206418|NCT01867710|12397410|FG001|Treated|Overall Study||41
11206419|NCT01867710|12397411|FG002|Treated|Overall Study||39
11206420|NCT01867710|12397412|FG003|Treated|Overall Study||42
11206421|NCT01867710|12397409|FG000|COMPLETED|Overall Study||0
11070560|NCT01067105|12252425|FG000|NOT COMPLETED|Overall Study||141
11070561|NCT01067326|12252431|FG000|STARTED|Overall Study||14
11070562|NCT01067326|12252432|FG001|STARTED|Overall Study||8
11070563|NCT01067326|12252431|FG000|COMPLETED|Overall Study||12
11070564|NCT01067326|12252432|FG001|COMPLETED|Overall Study||5
11070565|NCT01067326|12252431|FG000|NOT COMPLETED|Overall Study||2
11070566|NCT01067326|12252432|FG001|NOT COMPLETED|Overall Study||3
11070567|NCT01067339|12252440|FG000|STARTED|Overall Study||31
11070568|NCT01067339|12252441|FG001|STARTED|Overall Study||34
11070569|NCT01067339|12252440|FG000|COMPLETED|Overall Study||25
11070570|NCT01067339|12252441|FG001|COMPLETED|Overall Study||29
11070571|NCT01067339|12252440|FG000|NOT COMPLETED|Overall Study||6
11070572|NCT01067339|12252441|FG001|NOT COMPLETED|Overall Study||5
11070573|NCT01067352|12252450|FG000|STARTED|Overall Study||9
11070574|NCT01067352|12252451|FG001|STARTED|Overall Study||6
11070575|NCT01067352|12252452|FG002|STARTED|Overall Study||10
11070576|NCT01067352|12252450|FG000|COMPLETED|Overall Study||8
11070577|NCT01067352|12252451|FG001|COMPLETED|Overall Study||3
11070578|NCT01067352|12252452|FG002|COMPLETED|Overall Study||9
11070579|NCT01067352|12252450|FG000|NOT COMPLETED|Overall Study||1
11070580|NCT01067352|12252451|FG001|NOT COMPLETED|Overall Study||3
11070581|NCT01067352|12252452|FG002|NOT COMPLETED|Overall Study||1
11070582|NCT01067456|12252462|FG000|STARTED|Overall Study||30
11070583|NCT01067456|12252463|FG001|STARTED|Overall Study||29
11070584|NCT01067456|12252462|FG000|COMPLETED|Overall Study||30
11070585|NCT01067456|12252463|FG001|COMPLETED|Overall Study||29
11070586|NCT01067456|12252462|FG000|NOT COMPLETED|Overall Study||0
11070587|NCT01067456|12252463|FG001|NOT COMPLETED|Overall Study||0
11070588|NCT01067469|12252473|FG000|STARTED|Overall Study||36
11070589|NCT01067469|12252474|FG001|STARTED|Overall Study||35
11070590|NCT01067469|12252473|FG000|90 mg/m^2|Overall Study||0
11070591|NCT01067469|12252474|FG001|90 mg/m^2|Overall Study||12
11070592|NCT01067469|12252473|FG000|75 mg/m^2|Overall Study||0
11070593|NCT01067469|12252474|FG001|75 mg/m^2|Overall Study||21
11070594|NCT01067469|12252473|FG000|COMPLETED|Overall Study||36
11070595|NCT01067469|12252474|FG001|COMPLETED|Overall Study||33
11070596|NCT01067469|12252473|FG000|NOT COMPLETED|Overall Study||0
11070597|NCT01067469|12252474|FG001|NOT COMPLETED|Overall Study||2
11070598|NCT01067508|12252482|FG000|STARTED|Overall Study||10
11070599|NCT01067508|12252483|FG001|STARTED|Overall Study||9
11070600|NCT01067508|12252482|FG000|COMPLETED|Overall Study||10
11070601|NCT01067508|12252483|FG001|COMPLETED|Overall Study||7
11070602|NCT01067508|12252482|FG000|NOT COMPLETED|Overall Study||0
11070603|NCT01067508|12252483|FG001|NOT COMPLETED|Overall Study||2
11070604|NCT01067716|12252492|FG000|STARTED|Overall Study|110 eyes|57
11070605|NCT01067716|12252493|FG001|STARTED|Overall Study|25 eyes|13
11070606|NCT01067716|12252494|FG002|STARTED|Overall Study|15 eyes|9
11070607|NCT01067716|12252492|FG000|COMPLETED|Overall Study|110 eyes|57
11070608|NCT01067716|12252493|FG001|COMPLETED|Overall Study|25 eyes|13
11070609|NCT01067716|12252494|FG002|COMPLETED|Overall Study|15 eyes|9
11070610|NCT01067716|12252492|FG000|NOT COMPLETED|Overall Study||0
11070611|NCT01067716|12252493|FG001|NOT COMPLETED|Overall Study||0
11070612|NCT01067716|12252494|FG002|NOT COMPLETED|Overall Study||0
11070613|NCT01067768|12252504|FG000|STARTED|Overall Study||604
11070614|NCT01067768|12252505|FG001|STARTED|Overall Study||605
11070615|NCT01067768|12252504|FG000|COMPLETED|Overall Study||604
11206422|NCT01867710|12397410|FG001|COMPLETED|Overall Study||0
11206423|NCT01867710|12397411|FG002|COMPLETED|Overall Study||0
11206424|NCT01867710|12397412|FG003|COMPLETED|Overall Study||0
11206425|NCT01867710|12397409|FG000|NOT COMPLETED|Overall Study||41
11070616|NCT01067768|12252505|FG001|COMPLETED|Overall Study||605
11070617|NCT01067768|12252504|FG000|NOT COMPLETED|Overall Study||0
11070618|NCT01067768|12252505|FG001|NOT COMPLETED|Overall Study||0
11070619|NCT01067781|12252515|FG000|STARTED|Up to Day 180||203
11070620|NCT01067781|12252516|FG001|STARTED|Up to Day 180||199
11070621|NCT01067781|12252517|FG002|STARTED|Up to Day 180||97
11070622|NCT01067781|12252518|FG003|STARTED|Up to Day 180||101
11346880|NCT02986958|12544261|FG001|STARTED|Overall Study||44
11346881|NCT02986958|12544260|FG000|COMPLETED|Overall Study||49
11346882|NCT02986958|12544261|FG001|COMPLETED|Overall Study||44
11346883|NCT02986958|12544260|FG000|NOT COMPLETED|Overall Study||0
11346884|NCT02986958|12544261|FG001|NOT COMPLETED|Overall Study||0
11346885|NCT02987205|12544267|FG000|STARTED|Overall Study||163
11346886|NCT02987205|12544267|FG000|Treated - Bilateral NLF Injection|Overall Study||163
11070623|NCT01067781|12252515|FG000|COMPLETED|Up to Day 180||173
11070624|NCT01067781|12252516|FG001|COMPLETED|Up to Day 180||168
11070625|NCT01067781|12252517|FG002|COMPLETED|Up to Day 180||89
11070626|NCT01067781|12252518|FG003|COMPLETED|Up to Day 180||89
11070627|NCT01067781|12252515|FG000|NOT COMPLETED|Up to Day 180||30
11070628|NCT01067781|12252516|FG001|NOT COMPLETED|Up to Day 180||31
11070629|NCT01067781|12252517|FG002|NOT COMPLETED|Up to Day 180||8
11070630|NCT01067781|12252518|FG003|NOT COMPLETED|Up to Day 180||12
11070631|NCT01067781|12252515|FG000|STARTED|180 to Day 720||173
11070632|NCT01067781|12252516|FG001|STARTED|180 to Day 720||168
11070633|NCT01067781|12252517|FG002|STARTED|180 to Day 720||89
11346887|NCT02987205|12544267|FG000|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
11346888|NCT02987205|12544267|FG000|NOT COMPLETED|Overall Study||4
11070634|NCT01067781|12252518|FG003|STARTED|180 to Day 720||89
11070635|NCT01067781|12252515|FG000|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
11070636|NCT01067781|12252516|FG001|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
11070637|NCT01067781|12252517|FG002|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
11070638|NCT01067781|12252518|FG003|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
11070639|NCT01067781|12252515|FG000|NOT COMPLETED|180 to Day 720||170
11070640|NCT01067781|12252516|FG001|NOT COMPLETED|180 to Day 720||164
11070641|NCT01067781|12252517|FG002|NOT COMPLETED|180 to Day 720||89
11070642|NCT01067781|12252518|FG003|NOT COMPLETED|180 to Day 720||89
11070643|NCT01067846|12252532|FG000|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
11070644|NCT01067846|12252533|FG001|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
11070645|NCT01067846|12252532|FG000|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
11070646|NCT01067846|12252533|FG001|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
11070647|NCT01067846|12252532|FG000|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
11070648|NCT01067846|12252533|FG001|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
11070649|NCT01067846|12252532|FG000|NOT COMPLETED|Overall Study||19
11070650|NCT01067846|12252533|FG001|NOT COMPLETED|Overall Study||19
11070651|NCT01067976|12252539|FG000|STARTED|Overall Study|screened and enrolled|446
11070652|NCT01067976|12252539|FG000|Received Treatment|Overall Study|treatment started|426
11070653|NCT01067976|12252539|FG000|Fulfilled Requirements of FAS Population|Overall Study||390
11346889|NCT02987231|12544275|FG000|STARTED|Overall Study||30
11346890|NCT02987231|12544276|FG001|STARTED|Overall Study||30
11346891|NCT02987231|12544275|FG000|COMPLETED|Overall Study||30
11346892|NCT02987231|12544276|FG001|COMPLETED|Overall Study||30
11346893|NCT02987231|12544275|FG000|NOT COMPLETED|Overall Study||0
11346894|NCT02987231|12544276|FG001|NOT COMPLETED|Overall Study||0
11346895|NCT02987374|12544282|FG000|STARTED|Overall Study||10
11346896|NCT02987374|12544282|FG000|COMPLETED|Overall Study||10
11346897|NCT02987374|12544282|FG000|NOT COMPLETED|Overall Study||0
11346898|NCT02987621|12544286|FG000|STARTED|Overall Study||7
11346899|NCT02987621|12544287|FG001|STARTED|Overall Study||7
11346900|NCT02987621|12544286|FG000|COMPLETED|Overall Study||7
11346901|NCT02987621|12544287|FG001|COMPLETED|Overall Study||7
11070654|NCT01067976|12252539|FG000|COMPLETED|Overall Study|study course completed|424
11070655|NCT01067976|12252539|FG000|NOT COMPLETED|Overall Study||22
11070656|NCT01068158|12252559|FG000|STARTED|Overall Study||169
11070657|NCT01068158|12252560|FG001|STARTED|Overall Study||202
11070658|NCT01068158|12252559|FG000|COMPLETED|Overall Study||161
11070659|NCT01068158|12252560|FG001|COMPLETED|Overall Study||198
11346902|NCT02987621|12544286|FG000|NOT COMPLETED|Overall Study||0
11346903|NCT02987621|12544287|FG001|NOT COMPLETED|Overall Study||0
11346904|NCT02987660|12544297|FG000|STARTED|Overall Study||10
11346905|NCT02987660|12544298|FG001|STARTED|Overall Study||10
11070660|NCT01068158|12252559|FG000|NOT COMPLETED|Overall Study||8
11070661|NCT01068158|12252560|FG001|NOT COMPLETED|Overall Study||4
11070662|NCT01068262|12252570|FG000|STARTED|Overall Study||23
11070663|NCT01068262|12252571|FG001|STARTED|Overall Study||9
11070664|NCT01068262|12252572|FG002|STARTED|Overall Study||10
11070665|NCT01068262|12252573|FG003|STARTED|Overall Study||2
11070666|NCT01068262|12252570|FG000|COMPLETED|Overall Study||20
11070667|NCT01068262|12252571|FG001|COMPLETED|Overall Study||8
11070668|NCT01068262|12252572|FG002|COMPLETED|Overall Study||9
11070669|NCT01068262|12252573|FG003|COMPLETED|Overall Study||2
11070670|NCT01068262|12252570|FG000|NOT COMPLETED|Overall Study||3
11070671|NCT01068262|12252571|FG001|NOT COMPLETED|Overall Study||1
11070672|NCT01068262|12252572|FG002|NOT COMPLETED|Overall Study||1
11070673|NCT01068262|12252573|FG003|NOT COMPLETED|Overall Study||0
11070674|NCT01068418|12252586|FG000|STARTED|Overall Study|26 participants found to be eligible|26
11070675|NCT01068418|12252586|FG000|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
11070676|NCT01068418|12252586|FG000|COMPLETED|Overall Study|14 participants completed all study procedures.|14
11070677|NCT01068418|12252586|FG000|NOT COMPLETED|Overall Study||12
11070678|NCT01068509|12252593|FG000|STARTED|Overall Study||7
11070679|NCT01068509|12252594|FG001|STARTED|Overall Study||29
11070680|NCT01068509|12252595|FG002|STARTED|Overall Study||27
11070681|NCT01068509|12252593|FG000|COMPLETED|Overall Study||1
11070682|NCT01068509|12252594|FG001|COMPLETED|Overall Study||7
11070683|NCT01068509|12252595|FG002|COMPLETED|Overall Study||6
11070684|NCT01068509|12252593|FG000|NOT COMPLETED|Overall Study||6
11070685|NCT01068509|12252594|FG001|NOT COMPLETED|Overall Study||22
11070686|NCT01068509|12252595|FG002|NOT COMPLETED|Overall Study||21
11070687|NCT01068548|12252604|FG000|STARTED|Overall Study||66
11070688|NCT01068548|12252605|FG001|STARTED|Overall Study||63
11070689|NCT01068548|12252604|FG000|COMPLETED|Overall Study||66
11070690|NCT01068548|12252605|FG001|COMPLETED|Overall Study||63
11070691|NCT01068548|12252604|FG000|NOT COMPLETED|Overall Study||0
11070692|NCT01068548|12252605|FG001|NOT COMPLETED|Overall Study||0
11070693|NCT01068600|12252614|FG000|STARTED|Overall Study||159
11070694|NCT01068600|12252615|FG001|STARTED|Overall Study||159
11070695|NCT01068600|12252614|FG000|COMPLETED|Overall Study||148
11070696|NCT01068600|12252615|FG001|COMPLETED|Overall Study||142
11070697|NCT01068600|12252614|FG000|NOT COMPLETED|Overall Study||11
11070698|NCT01068600|12252615|FG001|NOT COMPLETED|Overall Study||17
11070699|NCT01068626|12252623|FG000|STARTED|Overall Study||30
11070700|NCT01068626|12252624|FG001|STARTED|Overall Study||29
11070701|NCT01068626|12252623|FG000|COMPLETED|Overall Study||27
11070702|NCT01068626|12252624|FG001|COMPLETED|Overall Study||27
11070703|NCT01068626|12252623|FG000|NOT COMPLETED|Overall Study||3
11070704|NCT01068626|12252624|FG001|NOT COMPLETED|Overall Study||2
11070705|NCT01068652|12252632|FG000|STARTED|Overall Study||200
11070706|NCT01068652|12252633|FG001|STARTED|Overall Study||203
11070707|NCT01068652|12252632|FG000|COMPLETED|Overall Study||182
11070708|NCT01068652|12252633|FG001|COMPLETED|Overall Study||188
11070709|NCT01068652|12252632|FG000|NOT COMPLETED|Overall Study||18
11070710|NCT01068652|12252633|FG001|NOT COMPLETED|Overall Study||15
11070711|NCT01068665|12252641|FG000|STARTED|Overall Study||230
11070712|NCT01068665|12252642|FG001|STARTED|Overall Study||230
11070713|NCT01068665|12252641|FG000|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
11070714|NCT01068665|12252642|FG001|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
11070715|NCT01068665|12252641|FG000|Exposed|Overall Study||228
11070716|NCT01068665|12252642|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
11070717|NCT01068665|12252641|FG000|COMPLETED|Overall Study||200
11070718|NCT01068665|12252642|FG001|COMPLETED|Overall Study||201
11070719|NCT01068665|12252641|FG000|NOT COMPLETED|Overall Study||30
11070720|NCT01068665|12252642|FG001|NOT COMPLETED|Overall Study||29
11070721|NCT01068678|12252650|FG000|STARTED|Overall Study||230
11070722|NCT01068678|12252651|FG001|STARTED|Overall Study||230
11070723|NCT01068678|12252650|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
11070724|NCT01068678|12252651|FG001|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
11070725|NCT01068678|12252650|FG000|COMPLETED|Overall Study||192
11070726|NCT01068678|12252651|FG001|COMPLETED|Overall Study||206
11070727|NCT01068678|12252650|FG000|NOT COMPLETED|Overall Study||38
11070728|NCT01068678|12252651|FG001|NOT COMPLETED|Overall Study||24
11070729|NCT01068717|12252657|FG000|STARTED|Period 1: Treatment Schedule Phase 1||7
11070730|NCT01068717|12252658|FG001|STARTED|Period 1: Treatment Schedule Phase 1||6
11070731|NCT01068717|12252659|FG002|STARTED|Period 1: Treatment Schedule Phase 1||7
11070732|NCT01068717|12252660|FG003|STARTED|Period 1: Treatment Schedule Phase 1||7
11070733|NCT01068717|12252657|FG000|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
11070734|NCT01068717|12252658|FG001|COMPLETED|Period 1: Treatment Schedule Phase 1||6
11070735|NCT01068717|12252659|FG002|COMPLETED|Period 1: Treatment Schedule Phase 1||7
11070736|NCT01068717|12252660|FG003|COMPLETED|Period 1: Treatment Schedule Phase 1||7
11070737|NCT01068717|12252657|FG000|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
11070738|NCT01068717|12252658|FG001|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
11070739|NCT01068717|12252659|FG002|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
11070740|NCT01068717|12252660|FG003|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
11070741|NCT01068717|12252657|FG000|STARTED|Period 2: Treatment Schedule Phase 2||6
11070742|NCT01068717|12252658|FG001|STARTED|Period 2: Treatment Schedule Phase 2||6
11070743|NCT01068717|12252659|FG002|STARTED|Period 2: Treatment Schedule Phase 2||7
11070744|NCT01068717|12252660|FG003|STARTED|Period 2: Treatment Schedule Phase 2||7
11070745|NCT01068717|12252657|FG000|COMPLETED|Period 2: Treatment Schedule Phase 2||6
11070746|NCT01068717|12252658|FG001|COMPLETED|Period 2: Treatment Schedule Phase 2||6
11070747|NCT01068717|12252659|FG002|COMPLETED|Period 2: Treatment Schedule Phase 2||7
11070748|NCT01068717|12252660|FG003|COMPLETED|Period 2: Treatment Schedule Phase 2||7
11070749|NCT01068717|12252657|FG000|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
11070750|NCT01068717|12252658|FG001|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
11070751|NCT01068717|12252659|FG002|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
11070752|NCT01068717|12252660|FG003|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
11070753|NCT01068717|12252657|FG000|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
11070754|NCT01068717|12252658|FG001|STARTED|Period 3: Treatment Schedule Phase 3||6
11070755|NCT01068717|12252659|FG002|STARTED|Period 3: Treatment Schedule Phase 3||7
11070756|NCT01068717|12252660|FG003|STARTED|Period 3: Treatment Schedule Phase 3||7
11070757|NCT01068717|12252657|FG000|COMPLETED|Period 3: Treatment Schedule Phase 3||7
11070758|NCT01068717|12252658|FG001|COMPLETED|Period 3: Treatment Schedule Phase 3||6
11070759|NCT01068717|12252659|FG002|COMPLETED|Period 3: Treatment Schedule Phase 3||7
11070760|NCT01068717|12252660|FG003|COMPLETED|Period 3: Treatment Schedule Phase 3||7
11070761|NCT01068717|12252657|FG000|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
11070762|NCT01068717|12252658|FG001|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
11070763|NCT01068717|12252659|FG002|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
11070764|NCT01068717|12252660|FG003|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
11070765|NCT01068717|12252657|FG000|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
11070766|NCT01068717|12252658|FG001|STARTED|Period 4: Treatment Schedule Phase 4||6
11070767|NCT01068717|12252659|FG002|STARTED|Period 4: Treatment Schedule Phase 4||7
11070768|NCT01068717|12252660|FG003|STARTED|Period 4: Treatment Schedule Phase 4||7
11070769|NCT01068717|12252657|FG000|COMPLETED|Period 4: Treatment Schedule Phase 4||7
11070770|NCT01068717|12252658|FG001|COMPLETED|Period 4: Treatment Schedule Phase 4||6
11070771|NCT01068717|12252659|FG002|COMPLETED|Period 4: Treatment Schedule Phase 4||7
11070772|NCT01068717|12252660|FG003|COMPLETED|Period 4: Treatment Schedule Phase 4||7
11070773|NCT01068717|12252657|FG000|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
11070774|NCT01068717|12252658|FG001|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
11070775|NCT01068717|12252659|FG002|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
11070776|NCT01068717|12252660|FG003|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
11070777|NCT01068730|12252674|FG000|STARTED|Period 1||7
11070778|NCT01068730|12252675|FG001|STARTED|Period 1||7
11070779|NCT01068730|12252676|FG002|STARTED|Period 1||7
11070780|NCT01068730|12252677|FG003|STARTED|Period 1||7
11070781|NCT01068730|12252674|FG000|COMPLETED|Period 1||7
11070782|NCT01068730|12252675|FG001|COMPLETED|Period 1||7
11070783|NCT01068730|12252676|FG002|COMPLETED|Period 1||7
11070784|NCT01068730|12252677|FG003|COMPLETED|Period 1||7
11070785|NCT01068730|12252674|FG000|NOT COMPLETED|Period 1||0
11070786|NCT01068730|12252675|FG001|NOT COMPLETED|Period 1||0
11070787|NCT01068730|12252676|FG002|NOT COMPLETED|Period 1||0
11070788|NCT01068730|12252677|FG003|NOT COMPLETED|Period 1||0
11070789|NCT01068730|12252674|FG000|STARTED|Period 2||7
11070790|NCT01068730|12252675|FG001|STARTED|Period 2||7
11070791|NCT01068730|12252676|FG002|STARTED|Period 2||7
11070792|NCT01068730|12252677|FG003|STARTED|Period 2||7
11070793|NCT01068730|12252674|FG000|COMPLETED|Period 2||7
11070794|NCT01068730|12252675|FG001|COMPLETED|Period 2||7
11070795|NCT01068730|12252676|FG002|COMPLETED|Period 2||7
11070796|NCT01068730|12252677|FG003|COMPLETED|Period 2||7
11070797|NCT01068730|12252674|FG000|NOT COMPLETED|Period 2||0
11070798|NCT01068730|12252675|FG001|NOT COMPLETED|Period 2||0
11070799|NCT01068730|12252676|FG002|NOT COMPLETED|Period 2||0
11070800|NCT01068730|12252677|FG003|NOT COMPLETED|Period 2||0
11070801|NCT01068730|12252674|FG000|STARTED|Period 3||7
11070802|NCT01068730|12252675|FG001|STARTED|Period 3||7
11070803|NCT01068730|12252676|FG002|STARTED|Period 3||7
11070804|NCT01068730|12252677|FG003|STARTED|Period 3||7
11070805|NCT01068730|12252674|FG000|COMPLETED|Period 3||6
11070806|NCT01068730|12252675|FG001|COMPLETED|Period 3||7
11070807|NCT01068730|12252676|FG002|COMPLETED|Period 3||7
11070808|NCT01068730|12252677|FG003|COMPLETED|Period 3||7
11070809|NCT01068730|12252674|FG000|NOT COMPLETED|Period 3||1
11070810|NCT01068730|12252675|FG001|NOT COMPLETED|Period 3||0
11070811|NCT01068730|12252676|FG002|NOT COMPLETED|Period 3||0
11070812|NCT01068730|12252677|FG003|NOT COMPLETED|Period 3||0
11070813|NCT01068730|12252674|FG000|STARTED|Period 4||6
11070814|NCT01068730|12252675|FG001|STARTED|Period 4||7
11070815|NCT01068730|12252676|FG002|STARTED|Period 4||7
11070816|NCT01068730|12252677|FG003|STARTED|Period 4||7
11070817|NCT01068730|12252674|FG000|COMPLETED|Period 4||6
11070818|NCT01068730|12252675|FG001|COMPLETED|Period 4||6
11070819|NCT01068730|12252676|FG002|COMPLETED|Period 4||7
11070820|NCT01068730|12252677|FG003|COMPLETED|Period 4||7
11070821|NCT01068730|12252674|FG000|NOT COMPLETED|Period 4||0
11070822|NCT01068730|12252675|FG001|NOT COMPLETED|Period 4||1
11070823|NCT01068730|12252676|FG002|NOT COMPLETED|Period 4||0
11070824|NCT01068730|12252677|FG003|NOT COMPLETED|Period 4||0
11070825|NCT01068743|12252694|FG000|STARTED|Period 1||6
11070826|NCT01068743|12252695|FG001|STARTED|Period 1||6
11070827|NCT01068743|12252696|FG002|STARTED|Period 1||6
11070828|NCT01068743|12252697|FG003|STARTED|Period 1||6
11070829|NCT01068743|12252694|FG000|COMPLETED|Period 1||6
11070830|NCT01068743|12252695|FG001|COMPLETED|Period 1||6
11070831|NCT01068743|12252696|FG002|COMPLETED|Period 1||6
11070832|NCT01068743|12252697|FG003|COMPLETED|Period 1||6
11070833|NCT01068743|12252694|FG000|NOT COMPLETED|Period 1||0
11070834|NCT01068743|12252695|FG001|NOT COMPLETED|Period 1||0
11070835|NCT01068743|12252696|FG002|NOT COMPLETED|Period 1||0
11070836|NCT01068743|12252697|FG003|NOT COMPLETED|Period 1||0
11070837|NCT01068743|12252694|FG000|STARTED|Period 2||6
11070838|NCT01068743|12252695|FG001|STARTED|Period 2||6
11070839|NCT01068743|12252696|FG002|STARTED|Period 2||6
11070840|NCT01068743|12252697|FG003|STARTED|Period 2||6
11070841|NCT01068743|12252694|FG000|COMPLETED|Period 2||6
11070842|NCT01068743|12252695|FG001|COMPLETED|Period 2||6
11070843|NCT01068743|12252696|FG002|COMPLETED|Period 2||6
11070844|NCT01068743|12252697|FG003|COMPLETED|Period 2||6
11070845|NCT01068743|12252694|FG000|NOT COMPLETED|Period 2||0
11070846|NCT01068743|12252695|FG001|NOT COMPLETED|Period 2||0
11070847|NCT01068743|12252696|FG002|NOT COMPLETED|Period 2||0
11070848|NCT01068743|12252697|FG003|NOT COMPLETED|Period 2||0
11070849|NCT01068743|12252694|FG000|STARTED|Period 3||6
11070850|NCT01068743|12252695|FG001|STARTED|Period 3||6
11070851|NCT01068743|12252696|FG002|STARTED|Period 3||6
11070852|NCT01068743|12252697|FG003|STARTED|Period 3||6
11070853|NCT01068743|12252694|FG000|COMPLETED|Period 3||6
11070854|NCT01068743|12252695|FG001|COMPLETED|Period 3||5
11070855|NCT01068743|12252696|FG002|COMPLETED|Period 3||6
11070856|NCT01068743|12252697|FG003|COMPLETED|Period 3||6
11070857|NCT01068743|12252694|FG000|NOT COMPLETED|Period 3||0
11070858|NCT01068743|12252695|FG001|NOT COMPLETED|Period 3||1
11070859|NCT01068743|12252696|FG002|NOT COMPLETED|Period 3||0
11070860|NCT01068743|12252697|FG003|NOT COMPLETED|Period 3||0
11070861|NCT01068743|12252694|FG000|STARTED|Period 4||6
11070862|NCT01068743|12252695|FG001|STARTED|Period 4||5
11070863|NCT01068743|12252696|FG002|STARTED|Period 4||6
11070864|NCT01068743|12252697|FG003|STARTED|Period 4||6
11070865|NCT01068743|12252694|FG000|COMPLETED|Period 4||6
11070866|NCT01068743|12252695|FG001|COMPLETED|Period 4||5
11070867|NCT01068743|12252696|FG002|COMPLETED|Period 4||6
11070868|NCT01068743|12252697|FG003|COMPLETED|Period 4||6
11070869|NCT01068743|12252694|FG000|NOT COMPLETED|Period 4||0
11070870|NCT01068743|12252695|FG001|NOT COMPLETED|Period 4||0
11070871|NCT01068743|12252696|FG002|NOT COMPLETED|Period 4||0
11070872|NCT01068743|12252697|FG003|NOT COMPLETED|Period 4||0
11070873|NCT01068769|12252710|FG000|STARTED|Overall Study||34
11070874|NCT01068769|12252710|FG000|COMPLETED|Overall Study||33
11070875|NCT01068769|12252710|FG000|NOT COMPLETED|Overall Study||1
11070876|NCT01068821|12252716|FG000|STARTED|Overall Study||31
11070877|NCT01068821|12252717|FG001|STARTED|Overall Study||29
11070878|NCT01068821|12252716|FG000|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
11070879|NCT01068821|12252717|FG001|COMPLETED|Overall Study||29
11070880|NCT01068821|12252716|FG000|NOT COMPLETED|Overall Study||1
11070881|NCT01068821|12252717|FG001|NOT COMPLETED|Overall Study||0
11070882|NCT01068860|12252733|FG000|STARTED|Overall Study||33
11070883|NCT01068860|12252734|FG001|STARTED|Overall Study||17
11070884|NCT01068860|12252735|FG002|STARTED|Overall Study||33
11070885|NCT01068860|12252736|FG003|STARTED|Overall Study||17
11070886|NCT01068860|12252737|FG004|STARTED|Overall Study||32
11070887|NCT01068860|12252738|FG005|STARTED|Overall Study||16
11070888|NCT01068860|12252739|FG006|STARTED|Overall Study||28
11070889|NCT01068860|12252740|FG007|STARTED|Overall Study||15
11070890|NCT01068860|12252741|FG008|STARTED|Overall Study||28
11070891|NCT01068860|12252742|FG009|STARTED|Overall Study||27
11070892|NCT01068860|12252733|FG000|COMPLETED|Overall Study||33
11070893|NCT01068860|12252734|FG001|COMPLETED|Overall Study||16
11070894|NCT01068860|12252735|FG002|COMPLETED|Overall Study||33
11070895|NCT01068860|12252736|FG003|COMPLETED|Overall Study||16
11070896|NCT01068860|12252737|FG004|COMPLETED|Overall Study||32
11070897|NCT01068860|12252738|FG005|COMPLETED|Overall Study||14
11070898|NCT01068860|12252739|FG006|COMPLETED|Overall Study||28
11070899|NCT01068860|12252740|FG007|COMPLETED|Overall Study||15
11070900|NCT01068860|12252741|FG008|COMPLETED|Overall Study||28
11070901|NCT01068860|12252742|FG009|COMPLETED|Overall Study||23
11070902|NCT01068860|12252733|FG000|NOT COMPLETED|Overall Study||0
11070903|NCT01068860|12252734|FG001|NOT COMPLETED|Overall Study||1
11070904|NCT01068860|12252735|FG002|NOT COMPLETED|Overall Study||0
11070905|NCT01068860|12252736|FG003|NOT COMPLETED|Overall Study||1
11070906|NCT01068860|12252737|FG004|NOT COMPLETED|Overall Study||0
11070907|NCT01068860|12252738|FG005|NOT COMPLETED|Overall Study||2
11070908|NCT01068860|12252739|FG006|NOT COMPLETED|Overall Study||0
11070909|NCT01068860|12252740|FG007|NOT COMPLETED|Overall Study||0
11070910|NCT01068860|12252741|FG008|NOT COMPLETED|Overall Study||0
11070911|NCT01068860|12252742|FG009|NOT COMPLETED|Overall Study||4
11070912|NCT01068873|12252764|FG000|STARTED|Overall Study||1
11070913|NCT01068873|12252764|FG000|COMPLETED|Overall Study||1
11070914|NCT01068873|12252764|FG000|NOT COMPLETED|Overall Study||0
11070915|NCT01068912|12252771|FG000|STARTED|Overall Study||134
11070916|NCT01068912|12252772|FG001|STARTED|Overall Study||195
11070917|NCT01068912|12252773|FG002|STARTED|Overall Study||201
11070918|NCT01068912|12252771|FG000|COMPLETED|Overall Study||123
11070919|NCT01068912|12252772|FG001|COMPLETED|Overall Study||173
11070920|NCT01068912|12252773|FG002|COMPLETED|Overall Study||186
11070921|NCT01068912|12252771|FG000|NOT COMPLETED|Overall Study||11
11070922|NCT01068912|12252772|FG001|NOT COMPLETED|Overall Study||22
11070923|NCT01068912|12252773|FG002|NOT COMPLETED|Overall Study||15
11070924|NCT01068964|12252783|FG000|STARTED|Overall Study||121
11070925|NCT01068964|12252784|FG001|STARTED|Overall Study||114
11070926|NCT01068964|12252783|FG000|COMPLETED|Overall Study||113
11070927|NCT01068964|12252784|FG001|COMPLETED|Overall Study||104
11070928|NCT01068964|12252783|FG000|NOT COMPLETED|Overall Study||8
11070929|NCT01068964|12252784|FG001|NOT COMPLETED|Overall Study||10
11070930|NCT01069003|12252793|FG000|STARTED|Overall Study||399
11070931|NCT01069003|12252794|FG001|STARTED|Overall Study||412
11070932|NCT01069003|12252795|FG002|STARTED|Overall Study||1451
11070933|NCT01069003|12252793|FG000|COMPLETED|Overall Study||353
11070934|NCT01069003|12252794|FG001|COMPLETED|Overall Study||358
11070935|NCT01069003|12252795|FG002|COMPLETED|Overall Study||976
11070936|NCT01069003|12252793|FG000|NOT COMPLETED|Overall Study||46
11070937|NCT01069003|12252794|FG001|NOT COMPLETED|Overall Study||54
11070938|NCT01069003|12252795|FG002|NOT COMPLETED|Overall Study||475
11070939|NCT01069172|12252805|FG000|STARTED|Overall Study|30 eyes|30
11070940|NCT01069172|12252806|FG001|STARTED|Overall Study|30 eyes|30
11070941|NCT01069172|12252805|FG000|COMPLETED|Overall Study|29 eyes|29
11070942|NCT01069172|12252806|FG001|COMPLETED|Overall Study|30 eyes|30
11070943|NCT01069172|12252805|FG000|NOT COMPLETED|Overall Study||1
11070944|NCT01069172|12252806|FG001|NOT COMPLETED|Overall Study||0
11070945|NCT01069185|12252815|FG000|STARTED|Overall Study||47
11070946|NCT01069185|12252816|FG001|STARTED|Overall Study||45
11346906|NCT02987660|12544297|FG000|COMPLETED|Overall Study||0
11346907|NCT02987660|12544298|FG001|COMPLETED|Overall Study||0
11346908|NCT02987660|12544297|FG000|NOT COMPLETED|Overall Study||10
11346909|NCT02987660|12544298|FG001|NOT COMPLETED|Overall Study||10
11346910|NCT02987829|12544310|FG000|STARTED|Overall Study||1
11070947|NCT01069185|12252815|FG000|COMPLETED|Overall Study||47
11070948|NCT01069185|12252816|FG001|COMPLETED|Overall Study||45
11070949|NCT01069185|12252815|FG000|NOT COMPLETED|Overall Study||0
11070950|NCT01069185|12252816|FG001|NOT COMPLETED|Overall Study||0
11070951|NCT01069289|12252824|FG000|STARTED|Overall Study||636
11070952|NCT01069289|12252825|FG001|STARTED|Overall Study||657
11070953|NCT01069289|12252824|FG000|COMPLETED|Overall Study||594
11070954|NCT01069289|12252825|FG001|COMPLETED|Overall Study||601
11070955|NCT01069289|12252824|FG000|NOT COMPLETED|Overall Study||42
11070956|NCT01069289|12252825|FG001|NOT COMPLETED|Overall Study||56
11070957|NCT01069315|12252835|FG000|STARTED|Overall Study||27
11070958|NCT01069315|12252836|FG001|STARTED|Overall Study||30
11070959|NCT01069315|12252837|FG002|STARTED|Overall Study||28
11070960|NCT01069315|12252838|FG003|STARTED|Overall Study||26
11070961|NCT01069315|12252835|FG000|COMPLETED|Overall Study||23
11070962|NCT01069315|12252836|FG001|COMPLETED|Overall Study||24
11070963|NCT01069315|12252837|FG002|COMPLETED|Overall Study||23
11070964|NCT01069315|12252838|FG003|COMPLETED|Overall Study||19
11070965|NCT01069315|12252835|FG000|NOT COMPLETED|Overall Study||4
11070966|NCT01069315|12252836|FG001|NOT COMPLETED|Overall Study||6
11346911|NCT02987829|12544311|FG001|STARTED|Overall Study||1
11346912|NCT02987829|12544312|FG002|STARTED|Overall Study||2
11070967|NCT01069315|12252837|FG002|NOT COMPLETED|Overall Study||5
11070968|NCT01069315|12252838|FG003|NOT COMPLETED|Overall Study||7
11070969|NCT01069341|12252852|FG000|STARTED|Overall Study||4
11070970|NCT01069341|12252852|FG000|COMPLETED|Overall Study||3
11070971|NCT01069341|12252852|FG000|NOT COMPLETED|Overall Study||1
11070972|NCT01069354|12252856|FG000|STARTED|Overall Study||102
11070973|NCT01069354|12252856|FG000|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
11070974|NCT01069354|12252856|FG000|NOT COMPLETED|Overall Study||1
11070975|NCT01069419|12252864|FG000|STARTED|Overall Study||1117
11070976|NCT01069419|12252864|FG000|Safety Set|Overall Study||1111
11070977|NCT01069419|12252864|FG000|Full Analysis Set|Overall Study||851
11070978|NCT01069419|12252864|FG000|COMPLETED|Overall Study||402
11070979|NCT01069419|12252864|FG000|NOT COMPLETED|Overall Study||715
11070980|NCT01069484|12252870|FG000|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
11070981|NCT01069484|12252871|FG001|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
11070982|NCT01069484|12252870|FG000|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
11070983|NCT01069484|12252871|FG001|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
11070984|NCT01069484|12252870|FG000|NOT COMPLETED|Overall Study||12
11070985|NCT01069484|12252871|FG001|NOT COMPLETED|Overall Study||3
11070986|NCT01069510|12252880|FG000|STARTED|Overall Study||8
11070987|NCT01069510|12252881|FG001|STARTED|Overall Study||7
11070988|NCT01069510|12252880|FG000|COMPLETED|Overall Study||8
11070989|NCT01069510|12252881|FG001|COMPLETED|Overall Study||7
11070990|NCT01069510|12252880|FG000|NOT COMPLETED|Overall Study||0
11070991|NCT01069510|12252881|FG001|NOT COMPLETED|Overall Study||0
11070992|NCT01069523|12252889|FG000|STARTED|Overall Study||13
11070993|NCT01069523|12252890|FG001|STARTED|Overall Study||16
11070994|NCT01069523|12252889|FG000|COMPLETED|Overall Study||9
11070995|NCT01069523|12252890|FG001|COMPLETED|Overall Study||9
11070996|NCT01069523|12252889|FG000|NOT COMPLETED|Overall Study||4
11070997|NCT01069523|12252890|FG001|NOT COMPLETED|Overall Study||7
11070998|NCT01069562|12252900|FG000|STARTED|Overall Study||20
11070999|NCT01069562|12252901|FG001|STARTED|Overall Study||20
11071000|NCT01069562|12252900|FG000|COMPLETED|Overall Study||20
11071001|NCT01069562|12252901|FG001|COMPLETED|Overall Study||20
11071002|NCT01069562|12252900|FG000|NOT COMPLETED|Overall Study||0
11071003|NCT01069562|12252901|FG001|NOT COMPLETED|Overall Study||0
11071004|NCT01069627|12252907|FG000|STARTED|Overall Study||20
11071005|NCT01069627|12252907|FG000|COMPLETED|Overall Study||0
11071006|NCT01069627|12252907|FG000|NOT COMPLETED|Overall Study||20
11071007|NCT01069705|12252911|FG000|STARTED|Overall Study||49
11071008|NCT01069705|12252911|FG000|COMPLETED|Overall Study||46
11346913|NCT02987829|12544313|FG003|STARTED|Overall Study||7
11346914|NCT02987829|12544314|FG004|STARTED|Overall Study||51
11346915|NCT02987829|12544315|FG005|STARTED|Overall Study||10
11346916|NCT02987829|12544310|FG000|COMPLETED|Overall Study||1
11346917|NCT02987829|12544311|FG001|COMPLETED|Overall Study||1
11346918|NCT02987829|12544312|FG002|COMPLETED|Overall Study||2
11346919|NCT02987829|12544313|FG003|COMPLETED|Overall Study||7
11346920|NCT02987829|12544314|FG004|COMPLETED|Overall Study||51
11346921|NCT02987829|12544315|FG005|COMPLETED|Overall Study||10
11346922|NCT02987829|12544310|FG000|NOT COMPLETED|Overall Study||0
11346923|NCT02987829|12544311|FG001|NOT COMPLETED|Overall Study||0
11346924|NCT02987829|12544312|FG002|NOT COMPLETED|Overall Study||0
11346925|NCT02987829|12544313|FG003|NOT COMPLETED|Overall Study||0
11071009|NCT01069705|12252911|FG000|NOT COMPLETED|Overall Study||3
11071010|NCT01069900|12252917|FG000|STARTED|Overall Study||305
11071011|NCT01069900|12252918|FG001|STARTED|Overall Study||153
11071012|NCT01069900|12252917|FG000|Treated|Overall Study||301
11071013|NCT01069900|12252918|FG001|Treated|Overall Study||150
11071014|NCT01069900|12252917|FG000|COMPLETED|Overall Study||287
11071015|NCT01069900|12252918|FG001|COMPLETED|Overall Study||149
11071016|NCT01069900|12252917|FG000|NOT COMPLETED|Overall Study||18
11071017|NCT01069900|12252918|FG001|NOT COMPLETED|Overall Study||4
11071018|NCT01069939|12252926|FG000|STARTED|Randomised and Included in the Analyses||213
11071019|NCT01069939|12252927|FG001|STARTED|Randomised and Included in the Analyses||214
11071020|NCT01069939|12252926|FG000|COMPLETED|Randomised and Included in the Analyses||164
11071021|NCT01069939|12252927|FG001|COMPLETED|Randomised and Included in the Analyses||137
11071022|NCT01069939|12252926|FG000|NOT COMPLETED|Randomised and Included in the Analyses||49
11071023|NCT01069939|12252927|FG001|NOT COMPLETED|Randomised and Included in the Analyses||77
11206426|NCT01867710|12397410|FG001|NOT COMPLETED|Overall Study||41
11206427|NCT01867710|12397411|FG002|NOT COMPLETED|Overall Study||40
11206428|NCT01867710|12397412|FG003|NOT COMPLETED|Overall Study||42
11206429|NCT01868009|12397422|FG000|STARTED|Period 1 (5-9 Days)||143
11206430|NCT01868009|12397423|FG001|STARTED|Period 1 (5-9 Days)||144
11206431|NCT01868009|12397422|FG000|COMPLETED|Period 1 (5-9 Days)||143
11206432|NCT01868009|12397423|FG001|COMPLETED|Period 1 (5-9 Days)||142
11206433|NCT01868009|12397422|FG000|NOT COMPLETED|Period 1 (5-9 Days)||0
11206434|NCT01868009|12397423|FG001|NOT COMPLETED|Period 1 (5-9 Days)||2
11206435|NCT01868009|12397422|FG000|STARTED|Period 2 (5-9 Days)||143
11206436|NCT01868009|12397423|FG001|STARTED|Period 2 (5-9 Days)||142
11206437|NCT01868009|12397422|FG000|COMPLETED|Period 2 (5-9 Days)||141
11071024|NCT01069939|12252926|FG000|STARTED|At Data Cut Off Date (26 Feb 2011)||213
11071025|NCT01069939|12252927|FG001|STARTED|At Data Cut Off Date (26 Feb 2011)||214
11071026|NCT01069939|12252926|FG000|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
11071027|NCT01069939|12252927|FG001|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
11071028|NCT01069939|12252926|FG000|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
11071029|NCT01069939|12252927|FG001|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
11071030|NCT01070043|12252935|FG000|STARTED|Run-In Phase||60
11071031|NCT01070043|12252936|FG001|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
11071032|NCT01070043|12252937|FG002|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
11071033|NCT01070043|12252935|FG000|COMPLETED|Run-In Phase||42
11071034|NCT01070043|12252936|FG001|COMPLETED|Run-In Phase||0
11071035|NCT01070043|12252937|FG002|COMPLETED|Run-In Phase||0
11071036|NCT01070043|12252935|FG000|NOT COMPLETED|Run-In Phase||18
11206438|NCT01868009|12397423|FG001|COMPLETED|Period 2 (5-9 Days)||142
11206439|NCT01868009|12397422|FG000|NOT COMPLETED|Period 2 (5-9 Days)||2
11206440|NCT01868009|12397423|FG001|NOT COMPLETED|Period 2 (5-9 Days)||0
11346926|NCT02987829|12544314|FG004|NOT COMPLETED|Overall Study||0
11346927|NCT02987829|12544315|FG005|NOT COMPLETED|Overall Study||0
11346928|NCT02987868|12544332|FG000|STARTED|First Intervention||8
11346929|NCT02987868|12544333|FG001|STARTED|First Intervention||8
11346930|NCT02987868|12544332|FG000|COMPLETED|First Intervention||8
11346931|NCT02987868|12544333|FG001|COMPLETED|First Intervention||8
11346932|NCT02987868|12544332|FG000|NOT COMPLETED|First Intervention||0
11346933|NCT02987868|12544333|FG001|NOT COMPLETED|First Intervention||0
11346934|NCT02987868|12544332|FG000|STARTED|Wash Out Period 1 Week||8
11346935|NCT02987868|12544333|FG001|STARTED|Wash Out Period 1 Week||8
11346936|NCT02987868|12544332|FG000|COMPLETED|Wash Out Period 1 Week||8
11346937|NCT02987868|12544333|FG001|COMPLETED|Wash Out Period 1 Week||8
11346938|NCT02987868|12544332|FG000|NOT COMPLETED|Wash Out Period 1 Week||0
11346939|NCT02987868|12544333|FG001|NOT COMPLETED|Wash Out Period 1 Week||0
11346940|NCT02987868|12544332|FG000|STARTED|Second Intervention||8
11346941|NCT02987868|12544333|FG001|STARTED|Second Intervention||8
11346942|NCT02987868|12544332|FG000|COMPLETED|Second Intervention||8
11346943|NCT02987868|12544333|FG001|COMPLETED|Second Intervention||8
11346944|NCT02987868|12544332|FG000|NOT COMPLETED|Second Intervention||0
11346945|NCT02987868|12544333|FG001|NOT COMPLETED|Second Intervention||0
11346946|NCT02987972|12544342|FG000|STARTED|Overall Study||351
11346947|NCT02987972|12544343|FG001|STARTED|Overall Study||350
11346948|NCT02987972|12544344|FG002|STARTED|Overall Study||350
11346949|NCT02987972|12544342|FG000|Vaccination 1|Overall Study||350
11346950|NCT02987972|12544343|FG001|Vaccination 1|Overall Study||347
11346951|NCT02987972|12544344|FG002|Vaccination 1|Overall Study||347
11346952|NCT02987972|12544342|FG000|Vaccination 2|Overall Study||333
11346953|NCT02987972|12544343|FG001|Vaccination 2|Overall Study||335
11346954|NCT02987972|12544344|FG002|Vaccination 2|Overall Study||335
11346955|NCT02987972|12544342|FG000|Vaccination 3|Overall Study||330
11346956|NCT02987972|12544343|FG001|Vaccination 3|Overall Study||331
11346957|NCT02987972|12544344|FG002|Vaccination 3|Overall Study||332
11346958|NCT02987972|12544342|FG000|Vaccination 4|Overall Study||310
11346959|NCT02987972|12544343|FG001|Vaccination 4|Overall Study||306
11346960|NCT02987972|12544344|FG002|Vaccination 4|Overall Study||311
11346961|NCT02987972|12544342|FG000|COMPLETED|Overall Study||308
11346962|NCT02987972|12544343|FG001|COMPLETED|Overall Study||305
11346963|NCT02987972|12544344|FG002|COMPLETED|Overall Study||308
11346964|NCT02987972|12544342|FG000|NOT COMPLETED|Overall Study||43
11346965|NCT02987972|12544343|FG001|NOT COMPLETED|Overall Study||45
11346966|NCT02987972|12544344|FG002|NOT COMPLETED|Overall Study||42
11346967|NCT02988050|12544354|FG000|STARTED|Overall Study||30
11346968|NCT02988050|12544355|FG001|STARTED|Overall Study||30
11206441|NCT01868022|12397438|FG000|STARTED|Overall Study||3
11206442|NCT01868022|12397439|FG001|STARTED|Overall Study||3
11206443|NCT01868022|12397440|FG002|STARTED|Overall Study||14
11206444|NCT01868022|12397441|FG003|STARTED|Overall Study||3
11206445|NCT01868022|12397442|FG004|STARTED|Overall Study||3
11206446|NCT01868022|12397443|FG005|STARTED|Overall Study||3
11206447|NCT01868022|12397444|FG006|STARTED|Overall Study||3
11071037|NCT01070043|12252936|FG001|NOT COMPLETED|Run-In Phase||0
11071038|NCT01070043|12252937|FG002|NOT COMPLETED|Run-In Phase||0
11071039|NCT01070043|12252935|FG000|STARTED|Double-Blind Treatment||0
11071040|NCT01070043|12252936|FG001|STARTED|Double-Blind Treatment||21
11071041|NCT01070043|12252937|FG002|STARTED|Double-Blind Treatment||21
11071042|NCT01070043|12252935|FG000|COMPLETED|Double-Blind Treatment||0
11071043|NCT01070043|12252936|FG001|COMPLETED|Double-Blind Treatment||21
11071044|NCT01070043|12252937|FG002|COMPLETED|Double-Blind Treatment||19
11071045|NCT01070043|12252935|FG000|NOT COMPLETED|Double-Blind Treatment||0
11071046|NCT01070043|12252936|FG001|NOT COMPLETED|Double-Blind Treatment||0
11071047|NCT01070043|12252937|FG002|NOT COMPLETED|Double-Blind Treatment||2
11071048|NCT01070095|12252943|FG000|STARTED|Baseline Period||19
11071049|NCT01070095|12252944|FG001|STARTED|Baseline Period||830
11346969|NCT02988050|12544354|FG000|COMPLETED|Overall Study||30
11346970|NCT02988050|12544355|FG001|COMPLETED|Overall Study||30
11346971|NCT02988050|12544354|FG000|NOT COMPLETED|Overall Study||0
11346972|NCT02988050|12544355|FG001|NOT COMPLETED|Overall Study||0
11346973|NCT02988115|12544363|FG000|STARTED|Overall Study||234
11346974|NCT02988115|12544364|FG001|STARTED|Overall Study||111
11346975|NCT02988115|12544363|FG000|COMPLETED|Overall Study||220
11346976|NCT02988115|12544364|FG001|COMPLETED|Overall Study||107
11071050|NCT01070095|12252943|FG000|COMPLETED|Baseline Period||18
11071051|NCT01070095|12252944|FG001|COMPLETED|Baseline Period||830
11071052|NCT01070095|12252943|FG000|NOT COMPLETED|Baseline Period||1
11071053|NCT01070095|12252944|FG001|NOT COMPLETED|Baseline Period||0
11071054|NCT01070095|12252943|FG000|STARTED|Intervention Period||18
11071055|NCT01070095|12252944|FG001|STARTED|Intervention Period||890
11071056|NCT01070095|12252943|FG000|COMPLETED|Intervention Period||18
11071057|NCT01070095|12252944|FG001|COMPLETED|Intervention Period||890
11071058|NCT01070095|12252943|FG000|NOT COMPLETED|Intervention Period||0
11071059|NCT01070095|12252944|FG001|NOT COMPLETED|Intervention Period||0
11071060|NCT01070173|12252954|FG000|STARTED|Overall Study||33
11071061|NCT01070173|12252955|FG001|STARTED|Overall Study||8
11071062|NCT01070173|12252956|FG002|STARTED|Overall Study||11
11071063|NCT01070173|12252954|FG000|COMPLETED|Overall Study||33
11071064|NCT01070173|12252955|FG001|COMPLETED|Overall Study||8
11071065|NCT01070173|12252956|FG002|COMPLETED|Overall Study||11
11071066|NCT01070173|12252954|FG000|NOT COMPLETED|Overall Study||0
11071067|NCT01070173|12252955|FG001|NOT COMPLETED|Overall Study||0
11346977|NCT02988115|12544363|FG000|NOT COMPLETED|Overall Study||14
11346978|NCT02988115|12544364|FG001|NOT COMPLETED|Overall Study||4
11346979|NCT02988193|12544372|FG000|STARTED|Overall Study||12
11346980|NCT02988193|12544373|FG001|STARTED|Overall Study||16
11346981|NCT02988193|12544372|FG000|COMPLETED|Overall Study||12
11346982|NCT02988193|12544373|FG001|COMPLETED|Overall Study||16
11346983|NCT02988193|12544372|FG000|NOT COMPLETED|Overall Study||0
11346984|NCT02988193|12544373|FG001|NOT COMPLETED|Overall Study||0
11346985|NCT02988219|12544381|FG000|STARTED|Overall Study||25
11346986|NCT02988219|12544382|FG001|STARTED|Overall Study||25
11346987|NCT02988219|12544381|FG000|COMPLETED|Overall Study||24
11071068|NCT01070173|12252956|FG002|NOT COMPLETED|Overall Study||0
11071069|NCT01070303|12252966|FG000|STARTED|Overall Study||177
11071070|NCT01070303|12252966|FG000|COMPLETED|Overall Study||88
11071071|NCT01070303|12252966|FG000|NOT COMPLETED|Overall Study||89
11071072|NCT01070316|12252976|FG000|STARTED|Main Phase||20
11071073|NCT01070316|12252976|FG000|COMPLETED|Main Phase||20
11071074|NCT01070316|12252976|FG000|NOT COMPLETED|Main Phase||0
11071075|NCT01070316|12252976|FG000|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
11071076|NCT01070316|12252976|FG000|COMPLETED|Extension Phase||14
11071077|NCT01070316|12252976|FG000|NOT COMPLETED|Extension Phase||4
11071078|NCT01070329|12252982|FG000|STARTED|Overall Study||261
11071079|NCT01070329|12252983|FG001|STARTED|Overall Study||266
11071080|NCT01070329|12252982|FG000|COMPLETED|Overall Study||209
11071081|NCT01070329|12252983|FG001|COMPLETED|Overall Study||217
11071082|NCT01070329|12252982|FG000|NOT COMPLETED|Overall Study||52
11071083|NCT01070329|12252983|FG001|NOT COMPLETED|Overall Study||49
11071084|NCT01070381|12252989|FG000|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
11071085|NCT01070381|12252990|FG001|STARTED|Period 1, 1 Week of Wear||107
11071086|NCT01070381|12252989|FG000|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
11071087|NCT01070381|12252990|FG001|COMPLETED|Period 1, 1 Week of Wear||107
11071088|NCT01070381|12252989|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0
11071089|NCT01070381|12252990|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||0
11071090|NCT01070381|12252989|FG000|STARTED|Period 2, 1 Week of Wear||109
11071091|NCT01070381|12252990|FG001|STARTED|Period 2, 1 Week of Wear||107
11071092|NCT01070381|12252989|FG000|COMPLETED|Period 2, 1 Week of Wear||108
11071093|NCT01070381|12252990|FG001|COMPLETED|Period 2, 1 Week of Wear||106
11071094|NCT01070381|12252989|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||1
11071095|NCT01070381|12252990|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1
11071096|NCT01070394|12252996|FG000|STARTED|Overall Study||40
11071097|NCT01070394|12252996|FG000|COMPLETED|Overall Study||33
11071098|NCT01070394|12252996|FG000|NOT COMPLETED|Overall Study||7
11071099|NCT01070550|12253008|FG000|STARTED|Overall Study||3356
11071100|NCT01070550|12253009|FG001|STARTED|Overall Study||316
11071101|NCT01070550|12253010|FG002|STARTED|Overall Study||744
11071102|NCT01070550|12253011|FG003|STARTED|Overall Study||201
11071103|NCT01070550|12253012|FG004|STARTED|Overall Study||21
11071104|NCT01070550|12253013|FG005|STARTED|Overall Study||42
11071105|NCT01070550|12253008|FG000|COMPLETED|Overall Study||2071
11071106|NCT01070550|12253009|FG001|COMPLETED|Overall Study||254
11071107|NCT01070550|12253010|FG002|COMPLETED|Overall Study||528
11071108|NCT01070550|12253011|FG003|COMPLETED|Overall Study||124
11071109|NCT01070550|12253012|FG004|COMPLETED|Overall Study||20
11346988|NCT02988219|12544382|FG001|COMPLETED|Overall Study||22
11346989|NCT02988219|12544381|FG000|NOT COMPLETED|Overall Study||1
11346990|NCT02988219|12544382|FG001|NOT COMPLETED|Overall Study||3
11346991|NCT02988349|12544390|FG000|STARTED|Overall Study||21
11071110|NCT01070550|12253013|FG005|COMPLETED|Overall Study||35
11071111|NCT01070550|12253008|FG000|NOT COMPLETED|Overall Study||1285
11071112|NCT01070550|12253009|FG001|NOT COMPLETED|Overall Study||62
11071113|NCT01070550|12253010|FG002|NOT COMPLETED|Overall Study||216
11071114|NCT01070550|12253011|FG003|NOT COMPLETED|Overall Study||77
11071115|NCT01070550|12253012|FG004|NOT COMPLETED|Overall Study||1
11071116|NCT01070550|12253013|FG005|NOT COMPLETED|Overall Study||7
11071117|NCT01070693|12253030|FG000|STARTED|Overall Study||150
11071118|NCT01070693|12253031|FG001|STARTED|Overall Study||149
11071119|NCT01070693|12253030|FG000|COMPLETED|Overall Study||122
11071120|NCT01070693|12253031|FG001|COMPLETED|Overall Study||110
11071121|NCT01070693|12253030|FG000|NOT COMPLETED|Overall Study||28
11071122|NCT01070693|12253031|FG001|NOT COMPLETED|Overall Study||39
11071123|NCT01070771|12253037|FG000|STARTED|Overall Study|September 2008|203
11071124|NCT01070771|12253037|FG000|COMPLETED|Overall Study|August 2012|200
11071125|NCT01070771|12253037|FG000|NOT COMPLETED|Overall Study||3
11071126|NCT01070784|12253044|FG000|STARTED|Overall Study||130
11071127|NCT01070784|12253045|FG001|STARTED|Overall Study||130
11071128|NCT01070784|12253044|FG000|COMPLETED|Overall Study||110
11071129|NCT01070784|12253045|FG001|COMPLETED|Overall Study||112
11071130|NCT01070784|12253044|FG000|NOT COMPLETED|Overall Study||20
11071131|NCT01070784|12253045|FG001|NOT COMPLETED|Overall Study||18
11071132|NCT01070810|12253053|FG000|STARTED|Overall Study||45
11071133|NCT01070810|12253054|FG001|STARTED|Overall Study||43
11071134|NCT01070810|12253053|FG000|COMPLETED|Overall Study||45
11071135|NCT01070810|12253054|FG001|COMPLETED|Overall Study||43
11071136|NCT01070810|12253053|FG000|NOT COMPLETED|Overall Study||0
11071137|NCT01070810|12253054|FG001|NOT COMPLETED|Overall Study||0
11071138|NCT01070888|12253064|FG000|STARTED|First Intervention (14 Days)||2
11071139|NCT01070888|12253065|FG001|STARTED|First Intervention (14 Days)||4
11071140|NCT01070888|12253064|FG000|COMPLETED|First Intervention (14 Days)||2
11071141|NCT01070888|12253065|FG001|COMPLETED|First Intervention (14 Days)||2
11071142|NCT01070888|12253064|FG000|NOT COMPLETED|First Intervention (14 Days)||0
11071143|NCT01070888|12253065|FG001|NOT COMPLETED|First Intervention (14 Days)||2
11071144|NCT01070888|12253064|FG000|STARTED|Washout (14 Days)||2
11071145|NCT01070888|12253065|FG001|STARTED|Washout (14 Days)||2
11071146|NCT01070888|12253064|FG000|COMPLETED|Washout (14 Days)||1
11071147|NCT01070888|12253065|FG001|COMPLETED|Washout (14 Days)||2
11071148|NCT01070888|12253064|FG000|NOT COMPLETED|Washout (14 Days)||1
11071149|NCT01070888|12253065|FG001|NOT COMPLETED|Washout (14 Days)||0
11071150|NCT01070888|12253064|FG000|STARTED|Second Intervention (14 Days)||1
11071151|NCT01070888|12253065|FG001|STARTED|Second Intervention (14 Days)||2
11071152|NCT01070888|12253064|FG000|COMPLETED|Second Intervention (14 Days)||1
11071153|NCT01070888|12253065|FG001|COMPLETED|Second Intervention (14 Days)||2
11071154|NCT01070888|12253064|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
11071155|NCT01070888|12253065|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
11071156|NCT01070979|12253074|FG000|STARTED|Overall Study||79
11071157|NCT01070979|12253075|FG001|STARTED|Overall Study||85
11071158|NCT01070979|12253076|FG002|STARTED|Overall Study||85
11071159|NCT01070979|12253074|FG000|COMPLETED|Overall Study||68
11071160|NCT01070979|12253075|FG001|COMPLETED|Overall Study||73
11071161|NCT01070979|12253076|FG002|COMPLETED|Overall Study||72
11071162|NCT01070979|12253074|FG000|NOT COMPLETED|Overall Study||11
11071163|NCT01070979|12253075|FG001|NOT COMPLETED|Overall Study||12
11071164|NCT01070979|12253076|FG002|NOT COMPLETED|Overall Study||13
11071165|NCT01071044|12253086|FG000|STARTED|Overall Study||15
11071166|NCT01071044|12253087|FG001|STARTED|Overall Study||11
11071167|NCT01071044|12253086|FG000|COMPLETED|Overall Study||13
11071168|NCT01071044|12253087|FG001|COMPLETED|Overall Study||11
11071169|NCT01071044|12253086|FG000|NOT COMPLETED|Overall Study||2
11071170|NCT01071044|12253087|FG001|NOT COMPLETED|Overall Study||0
11071171|NCT01071070|12253098|FG000|STARTED|Overall Study||108
11071172|NCT01071070|12253099|FG001|STARTED|Overall Study||108
11071173|NCT01071070|12253098|FG000|COMPLETED|Overall Study||104
11071174|NCT01071070|12253099|FG001|COMPLETED|Overall Study||105
11071175|NCT01071070|12253098|FG000|NOT COMPLETED|Overall Study||4
11071176|NCT01071070|12253099|FG001|NOT COMPLETED|Overall Study||3
11071177|NCT01071083|12253110|FG000|STARTED|Overall Study||42
11071178|NCT01071083|12253111|FG001|STARTED|Overall Study||45
11071179|NCT01071083|12253112|FG002|STARTED|Overall Study||17
11071180|NCT01071083|12253113|FG003|STARTED|Overall Study||17
11071181|NCT01071083|12253114|FG004|STARTED|Overall Study||54
11071182|NCT01071083|12253110|FG000|COMPLETED|Overall Study||35
11071183|NCT01071083|12253111|FG001|COMPLETED|Overall Study||43
11071184|NCT01071083|12253112|FG002|COMPLETED|Overall Study||12
11071185|NCT01071083|12253113|FG003|COMPLETED|Overall Study||15
11071186|NCT01071083|12253114|FG004|COMPLETED|Overall Study||46
11071187|NCT01071083|12253110|FG000|NOT COMPLETED|Overall Study||7
11071188|NCT01071083|12253111|FG001|NOT COMPLETED|Overall Study||2
11071189|NCT01071083|12253112|FG002|NOT COMPLETED|Overall Study||5
11071190|NCT01071083|12253113|FG003|NOT COMPLETED|Overall Study||2
11071191|NCT01071083|12253114|FG004|NOT COMPLETED|Overall Study||8
11071192|NCT01071096|12253126|FG000|STARTED|First Intervention (90 Days)||10
11071193|NCT01071096|12253127|FG001|STARTED|First Intervention (90 Days)||10
11071194|NCT01071096|12253126|FG000|COMPLETED|First Intervention (90 Days)||9
11071195|NCT01071096|12253127|FG001|COMPLETED|First Intervention (90 Days)||10
11071196|NCT01071096|12253126|FG000|NOT COMPLETED|First Intervention (90 Days)||1
11071197|NCT01071096|12253127|FG001|NOT COMPLETED|First Intervention (90 Days)||0
11071198|NCT01071096|12253126|FG000|STARTED|Washout Period (30 Days)||9
11071199|NCT01071096|12253127|FG001|STARTED|Washout Period (30 Days)||10
11071200|NCT01071096|12253126|FG000|COMPLETED|Washout Period (30 Days)||9
11071201|NCT01071096|12253127|FG001|COMPLETED|Washout Period (30 Days)||10
11071202|NCT01071096|12253126|FG000|NOT COMPLETED|Washout Period (30 Days)||0
11071203|NCT01071096|12253127|FG001|NOT COMPLETED|Washout Period (30 Days)||0
11071204|NCT01071096|12253126|FG000|STARTED|Second Intervention (90 Days)||9
11071205|NCT01071096|12253127|FG001|STARTED|Second Intervention (90 Days)||10
11071206|NCT01071096|12253126|FG000|COMPLETED|Second Intervention (90 Days)||9
11071207|NCT01071096|12253127|FG001|COMPLETED|Second Intervention (90 Days)||10
11071208|NCT01071096|12253126|FG000|NOT COMPLETED|Second Intervention (90 Days)||0
11071209|NCT01071096|12253127|FG001|NOT COMPLETED|Second Intervention (90 Days)||0
11071210|NCT01071200|12253146|FG000|STARTED|Overall Study||67
11071211|NCT01071200|12253147|FG001|STARTED|Overall Study||66
11071212|NCT01071200|12253146|FG000|COMPLETED|Overall Study||60
11071213|NCT01071200|12253147|FG001|COMPLETED|Overall Study||63
11071214|NCT01071200|12253146|FG000|NOT COMPLETED|Overall Study||7
11071215|NCT01071200|12253147|FG001|NOT COMPLETED|Overall Study||3
11071216|NCT01071252|12253158|FG000|STARTED|Overall Study||29
11071217|NCT01071252|12253159|FG001|STARTED|Overall Study||26
11071218|NCT01071252|12253160|FG002|STARTED|Overall Study||21
11071219|NCT01071252|12253161|FG003|STARTED|Overall Study||27
11071220|NCT01071252|12253162|FG004|STARTED|Overall Study||22
11071221|NCT01071252|12253158|FG000|COMPLETED|Overall Study||14
11071222|NCT01071252|12253159|FG001|COMPLETED|Overall Study||16
11071223|NCT01071252|12253160|FG002|COMPLETED|Overall Study||17
11071224|NCT01071252|12253161|FG003|COMPLETED|Overall Study||20
11071225|NCT01071252|12253162|FG004|COMPLETED|Overall Study||11
11071226|NCT01071252|12253158|FG000|NOT COMPLETED|Overall Study||15
11071227|NCT01071252|12253159|FG001|NOT COMPLETED|Overall Study||10
11071228|NCT01071252|12253160|FG002|NOT COMPLETED|Overall Study||4
11071229|NCT01071252|12253161|FG003|NOT COMPLETED|Overall Study||7
11071230|NCT01071252|12253162|FG004|NOT COMPLETED|Overall Study||11
11071231|NCT01071278|12253174|FG000|STARTED|Overall Study||2390
11071232|NCT01071278|12253174|FG000|COMPLETED|Overall Study||1677
11071233|NCT01071278|12253174|FG000|NOT COMPLETED|Overall Study||713
11071234|NCT01071317|12253182|FG000|STARTED|Overall Study||25
11071235|NCT01071317|12253183|FG001|STARTED|Overall Study||25
11071236|NCT01071317|12253182|FG000|COMPLETED|Overall Study||23
11071237|NCT01071317|12253183|FG001|COMPLETED|Overall Study||23
11071238|NCT01071317|12253182|FG000|NOT COMPLETED|Overall Study||2
11071239|NCT01071317|12253183|FG001|NOT COMPLETED|Overall Study||2
11071240|NCT01071356|12253191|FG000|STARTED|Overall Study||111
11071241|NCT01071356|12253192|FG001|STARTED|Overall Study||106
11071242|NCT01071356|12253191|FG000|COMPLETED|Overall Study||104
11071243|NCT01071356|12253192|FG001|COMPLETED|Overall Study||97
11071244|NCT01071356|12253191|FG000|NOT COMPLETED|Overall Study||7
11071245|NCT01071356|12253192|FG001|NOT COMPLETED|Overall Study||9
11071246|NCT01071395|12253200|FG000|STARTED|Overall Study||36
11071247|NCT01071395|12253201|FG001|STARTED|Overall Study||32
11071248|NCT01071395|12253200|FG000|COMPLETED|Overall Study||31
11071249|NCT01071395|12253201|FG001|COMPLETED|Overall Study||30
11071250|NCT01071395|12253200|FG000|NOT COMPLETED|Overall Study||5
11071251|NCT01071395|12253201|FG001|NOT COMPLETED|Overall Study||2
11071252|NCT01071512|12253207|FG000|STARTED|Overall Study||20
11071253|NCT01071512|12253207|FG000|COMPLETED|Overall Study||15
11071254|NCT01071512|12253207|FG000|NOT COMPLETED|Overall Study||5
11071255|NCT01071538|12253211|FG000|STARTED|Overall Study||15
11071256|NCT01071538|12253211|FG000|COMPLETED|Overall Study||13
11071257|NCT01071538|12253211|FG000|NOT COMPLETED|Overall Study||2
11071258|NCT01071798|12253215|FG000|STARTED|Participants Who Received One Cycle||1653
11071259|NCT01071798|12253215|FG000|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
11071260|NCT01071798|12253215|FG000|COMPLETED|Participants Who Received One Cycle||1588
11071261|NCT01071798|12253215|FG000|NOT COMPLETED|Participants Who Received One Cycle||65
11071262|NCT01071798|12253215|FG000|STARTED|Subpopulation Who Received Two Cycles||820
11071263|NCT01071798|12253215|FG000|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
11071264|NCT01071798|12253215|FG000|COMPLETED|Subpopulation Who Received Two Cycles||805
11071265|NCT01071798|12253215|FG000|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
11071266|NCT01071915|12253229|FG000|STARTED|Overall Study|Intention to Treat Analysis Set|157
11071267|NCT01071915|12253229|FG000|Full Analysis Set (FAS)|Overall Study||155
11071268|NCT01071915|12253229|FG000|Safety Analysis Set|Overall Study||156
11071269|NCT01071915|12253229|FG000|COMPLETED|Overall Study||148
11071270|NCT01071915|12253229|FG000|NOT COMPLETED|Overall Study||9
11071271|NCT01071954|12253233|FG000|STARTED|Overall Study||66
11071272|NCT01071954|12253233|FG000|Received Treatment|Overall Study||65
11071273|NCT01071954|12253233|FG000|COMPLETED|Overall Study||39
11071274|NCT01071954|12253233|FG000|NOT COMPLETED|Overall Study||27
11071275|NCT01072006|12253241|FG000|STARTED|Overall Study||14
11071276|NCT01072006|12253242|FG001|STARTED|Overall Study||5
11071277|NCT01072006|12253243|FG002|STARTED|Overall Study||0
11071278|NCT01072006|12253244|FG003|STARTED|Overall Study||11
11071279|NCT01072006|12253241|FG000|COMPLETED|Overall Study||14
11071280|NCT01072006|12253242|FG001|COMPLETED|Overall Study||5
11071281|NCT01072006|12253243|FG002|COMPLETED|Overall Study||0
11071282|NCT01072006|12253244|FG003|COMPLETED|Overall Study||11
11071283|NCT01072006|12253241|FG000|NOT COMPLETED|Overall Study||0
11071284|NCT01072006|12253242|FG001|NOT COMPLETED|Overall Study||0
11071285|NCT01072006|12253243|FG002|NOT COMPLETED|Overall Study||0
11071286|NCT01072006|12253244|FG003|NOT COMPLETED|Overall Study||0
11071287|NCT01072032|12253257|FG000|STARTED|Overall Study||13
11071288|NCT01072032|12253258|FG001|STARTED|Overall Study||14
11071289|NCT01072032|12253257|FG000|COMPLETED|Overall Study||5
11071290|NCT01072032|12253258|FG001|COMPLETED|Overall Study||5
11071291|NCT01072032|12253257|FG000|NOT COMPLETED|Overall Study||8
11346992|NCT02988349|12544391|FG001|STARTED|Overall Study||21
11346993|NCT02988349|12544390|FG000|COMPLETED|Overall Study||21
11346994|NCT02988349|12544391|FG001|COMPLETED|Overall Study||21
11346995|NCT02988349|12544390|FG000|NOT COMPLETED|Overall Study||0
11346996|NCT02988349|12544391|FG001|NOT COMPLETED|Overall Study||0
11346997|NCT02988622|12544397|FG000|STARTED|Overall Study||100
11346998|NCT02988622|12544397|FG000|COMPLETED|Overall Study||83
11346999|NCT02988622|12544397|FG000|NOT COMPLETED|Overall Study||17
11347000|NCT02988843|12544403|FG000|STARTED|Overall Study||1
11347001|NCT02988843|12544403|FG000|COMPLETED|Overall Study||1
11347002|NCT02988843|12544403|FG000|NOT COMPLETED|Overall Study||0
11347003|NCT02988856|12544407|FG000|STARTED|Overall Study||11
11071292|NCT01072032|12253258|FG001|NOT COMPLETED|Overall Study||9
11071293|NCT01072136|12253267|FG000|STARTED|Overall Study||44
11071294|NCT01072136|12253268|FG001|STARTED|Overall Study||43
11071295|NCT01072136|12253267|FG000|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
11071296|NCT01072136|12253268|FG001|Met All Enrollment Criteria|Overall Study||25
11071297|NCT01072136|12253267|FG000|COMPLETED|Overall Study||21
11071298|NCT01072136|12253268|FG001|COMPLETED|Overall Study||12
11071299|NCT01072136|12253267|FG000|NOT COMPLETED|Overall Study||23
11071300|NCT01072136|12253268|FG001|NOT COMPLETED|Overall Study||31
11071301|NCT01072149|12253277|FG000|STARTED|Treatment Period 1 (28 Days)||3
11071302|NCT01072149|12253278|FG001|STARTED|Treatment Period 1 (28 Days)||3
11071303|NCT01072149|12253279|FG002|STARTED|Treatment Period 1 (28 Days)||3
11071304|NCT01072149|12253280|FG003|STARTED|Treatment Period 1 (28 Days)||3
11071305|NCT01072149|12253281|FG004|STARTED|Treatment Period 1 (28 Days)||3
11071306|NCT01072149|12253282|FG005|STARTED|Treatment Period 1 (28 Days)||3
11071307|NCT01072149|12253283|FG006|STARTED|Treatment Period 1 (28 Days)||3
11071308|NCT01072149|12253284|FG007|STARTED|Treatment Period 1 (28 Days)||3
11071309|NCT01072149|12253285|FG008|STARTED|Treatment Period 1 (28 Days)||3
11071310|NCT01072149|12253286|FG009|STARTED|Treatment Period 1 (28 Days)||3
11071311|NCT01072149|12253287|FG010|STARTED|Treatment Period 1 (28 Days)||3
11071312|NCT01072149|12253288|FG011|STARTED|Treatment Period 1 (28 Days)||3
11071313|NCT01072149|12253289|FG012|STARTED|Treatment Period 1 (28 Days)||3
11071314|NCT01072149|12253290|FG013|STARTED|Treatment Period 1 (28 Days)||3
11071315|NCT01072149|12253291|FG014|STARTED|Treatment Period 1 (28 Days)||3
11071316|NCT01072149|12253292|FG015|STARTED|Treatment Period 1 (28 Days)||3
11071317|NCT01072149|12253293|FG016|STARTED|Treatment Period 1 (28 Days)||3
11071318|NCT01072149|12253294|FG017|STARTED|Treatment Period 1 (28 Days)||3
11071319|NCT01072149|12253277|FG000|COMPLETED|Treatment Period 1 (28 Days)||3
11071320|NCT01072149|12253278|FG001|COMPLETED|Treatment Period 1 (28 Days)||3
11071321|NCT01072149|12253279|FG002|COMPLETED|Treatment Period 1 (28 Days)||2
11071322|NCT01072149|12253280|FG003|COMPLETED|Treatment Period 1 (28 Days)||3
11071323|NCT01072149|12253281|FG004|COMPLETED|Treatment Period 1 (28 Days)||3
11347004|NCT02988856|12544407|FG000|COMPLETED|Overall Study||8
11347005|NCT02988856|12544407|FG000|NOT COMPLETED|Overall Study||3
11347006|NCT02988882|12544413|FG000|STARTED|Overall Study||44
11347007|NCT02988882|12544414|FG001|STARTED|Overall Study||42
11071324|NCT01072149|12253282|FG005|COMPLETED|Treatment Period 1 (28 Days)||3
11071325|NCT01072149|12253283|FG006|COMPLETED|Treatment Period 1 (28 Days)||3
11071326|NCT01072149|12253284|FG007|COMPLETED|Treatment Period 1 (28 Days)||3
11071327|NCT01072149|12253285|FG008|COMPLETED|Treatment Period 1 (28 Days)||3
11071328|NCT01072149|12253286|FG009|COMPLETED|Treatment Period 1 (28 Days)||3
11071329|NCT01072149|12253287|FG010|COMPLETED|Treatment Period 1 (28 Days)||2
11071330|NCT01072149|12253288|FG011|COMPLETED|Treatment Period 1 (28 Days)||3
11071331|NCT01072149|12253289|FG012|COMPLETED|Treatment Period 1 (28 Days)||3
11071332|NCT01072149|12253290|FG013|COMPLETED|Treatment Period 1 (28 Days)||3
11071333|NCT01072149|12253291|FG014|COMPLETED|Treatment Period 1 (28 Days)||3
11071334|NCT01072149|12253292|FG015|COMPLETED|Treatment Period 1 (28 Days)||3
11071335|NCT01072149|12253293|FG016|COMPLETED|Treatment Period 1 (28 Days)||3
11071336|NCT01072149|12253294|FG017|COMPLETED|Treatment Period 1 (28 Days)||2
11071337|NCT01072149|12253277|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071338|NCT01072149|12253278|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071339|NCT01072149|12253279|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1
11071340|NCT01072149|12253280|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071341|NCT01072149|12253281|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071342|NCT01072149|12253282|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071343|NCT01072149|12253283|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071344|NCT01072149|12253284|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071345|NCT01072149|12253285|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071346|NCT01072149|12253286|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071347|NCT01072149|12253287|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||1
11071348|NCT01072149|12253288|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071349|NCT01072149|12253289|FG012|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071350|NCT01072149|12253290|FG013|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071351|NCT01072149|12253291|FG014|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071352|NCT01072149|12253292|FG015|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071353|NCT01072149|12253293|FG016|NOT COMPLETED|Treatment Period 1 (28 Days)||0
11071354|NCT01072149|12253294|FG017|NOT COMPLETED|Treatment Period 1 (28 Days)||1
11071355|NCT01072149|12253277|FG000|STARTED|Washout Period 1 (14 Days)||3
11071356|NCT01072149|12253278|FG001|STARTED|Washout Period 1 (14 Days)||3
11071357|NCT01072149|12253279|FG002|STARTED|Washout Period 1 (14 Days)||2
11071358|NCT01072149|12253280|FG003|STARTED|Washout Period 1 (14 Days)||3
11071359|NCT01072149|12253281|FG004|STARTED|Washout Period 1 (14 Days)||3
11071360|NCT01072149|12253282|FG005|STARTED|Washout Period 1 (14 Days)||3
11071361|NCT01072149|12253283|FG006|STARTED|Washout Period 1 (14 Days)||3
11071362|NCT01072149|12253284|FG007|STARTED|Washout Period 1 (14 Days)||3
11071363|NCT01072149|12253285|FG008|STARTED|Washout Period 1 (14 Days)||3
11071364|NCT01072149|12253286|FG009|STARTED|Washout Period 1 (14 Days)||3
11071365|NCT01072149|12253287|FG010|STARTED|Washout Period 1 (14 Days)||2
11071366|NCT01072149|12253288|FG011|STARTED|Washout Period 1 (14 Days)||3
11071367|NCT01072149|12253289|FG012|STARTED|Washout Period 1 (14 Days)||3
11071368|NCT01072149|12253290|FG013|STARTED|Washout Period 1 (14 Days)||3
11071369|NCT01072149|12253291|FG014|STARTED|Washout Period 1 (14 Days)||3
11071370|NCT01072149|12253292|FG015|STARTED|Washout Period 1 (14 Days)||3
11071371|NCT01072149|12253293|FG016|STARTED|Washout Period 1 (14 Days)||3
11071372|NCT01072149|12253294|FG017|STARTED|Washout Period 1 (14 Days)||2
11071373|NCT01072149|12253277|FG000|COMPLETED|Washout Period 1 (14 Days)||3
11071374|NCT01072149|12253278|FG001|COMPLETED|Washout Period 1 (14 Days)||3
11071375|NCT01072149|12253279|FG002|COMPLETED|Washout Period 1 (14 Days)||2
11071376|NCT01072149|12253280|FG003|COMPLETED|Washout Period 1 (14 Days)||3
11071377|NCT01072149|12253281|FG004|COMPLETED|Washout Period 1 (14 Days)||3
11071378|NCT01072149|12253282|FG005|COMPLETED|Washout Period 1 (14 Days)||3
11071379|NCT01072149|12253283|FG006|COMPLETED|Washout Period 1 (14 Days)||3
11071380|NCT01072149|12253284|FG007|COMPLETED|Washout Period 1 (14 Days)||3
11071381|NCT01072149|12253285|FG008|COMPLETED|Washout Period 1 (14 Days)||3
11071382|NCT01072149|12253286|FG009|COMPLETED|Washout Period 1 (14 Days)||3
11071383|NCT01072149|12253287|FG010|COMPLETED|Washout Period 1 (14 Days)||2
11071384|NCT01072149|12253288|FG011|COMPLETED|Washout Period 1 (14 Days)||3
11071385|NCT01072149|12253289|FG012|COMPLETED|Washout Period 1 (14 Days)||3
11071386|NCT01072149|12253290|FG013|COMPLETED|Washout Period 1 (14 Days)||3
11071387|NCT01072149|12253291|FG014|COMPLETED|Washout Period 1 (14 Days)||3
11071388|NCT01072149|12253292|FG015|COMPLETED|Washout Period 1 (14 Days)||3
11071389|NCT01072149|12253293|FG016|COMPLETED|Washout Period 1 (14 Days)||3
11071390|NCT01072149|12253294|FG017|COMPLETED|Washout Period 1 (14 Days)||2
11071391|NCT01072149|12253277|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071392|NCT01072149|12253278|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071393|NCT01072149|12253279|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071394|NCT01072149|12253280|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071395|NCT01072149|12253281|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071396|NCT01072149|12253282|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071397|NCT01072149|12253283|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0
11347008|NCT02988882|12544413|FG000|COMPLETED|Overall Study||41
11347009|NCT02988882|12544414|FG001|COMPLETED|Overall Study||40
11347010|NCT02988882|12544413|FG000|NOT COMPLETED|Overall Study||3
11347011|NCT02988882|12544414|FG001|NOT COMPLETED|Overall Study||2
11071398|NCT01072149|12253284|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071399|NCT01072149|12253285|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071400|NCT01072149|12253286|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071401|NCT01072149|12253287|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071402|NCT01072149|12253288|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071403|NCT01072149|12253289|FG012|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071404|NCT01072149|12253290|FG013|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071405|NCT01072149|12253291|FG014|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071406|NCT01072149|12253292|FG015|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071407|NCT01072149|12253293|FG016|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071408|NCT01072149|12253294|FG017|NOT COMPLETED|Washout Period 1 (14 Days)||0
11071409|NCT01072149|12253277|FG000|STARTED|Treatment Period 2 (28 Days)||3
11071410|NCT01072149|12253278|FG001|STARTED|Treatment Period 2 (28 Days)||3
11071411|NCT01072149|12253279|FG002|STARTED|Treatment Period 2 (28 Days)||2
11071412|NCT01072149|12253280|FG003|STARTED|Treatment Period 2 (28 Days)||3
11347012|NCT02988986|12544420|FG000|STARTED|Overall Study||28
11347013|NCT02988986|12544420|FG000|COMPLETED|Overall Study||25
11347014|NCT02988986|12544420|FG000|NOT COMPLETED|Overall Study||3
11347015|NCT02989168|12544427|FG000|STARTED|Overall Study||11
11347016|NCT02989168|12544428|FG001|STARTED|Overall Study||3
11347017|NCT02989168|12544427|FG000|COMPLETED|Overall Study||7
11347018|NCT02989168|12544428|FG001|COMPLETED|Overall Study||0
11347019|NCT02989168|12544427|FG000|NOT COMPLETED|Overall Study||4
11347020|NCT02989168|12544428|FG001|NOT COMPLETED|Overall Study||3
11347021|NCT02989246|12544436|FG000|STARTED|Overall Study||32
11347022|NCT02989246|12544436|FG000|COMPLETED|Overall Study||32
11347023|NCT02989246|12544436|FG000|NOT COMPLETED|Overall Study||0
11347024|NCT02989389|12544450|FG000|STARTED|Period 1||3
11347025|NCT02989389|12544451|FG001|STARTED|Period 1||4
11347026|NCT02989389|12544452|FG002|STARTED|Period 1||3
11347027|NCT02989389|12544453|FG003|STARTED|Period 1||3
11347028|NCT02989389|12544454|FG004|STARTED|Period 1||3
11347029|NCT02989389|12544455|FG005|STARTED|Period 1||3
11347030|NCT02989389|12544456|FG006|STARTED|Period 1||6
11347031|NCT02989389|12544457|FG007|STARTED|Period 1||5
11347032|NCT02989389|12544458|FG008|STARTED|Period 1||6
11347033|NCT02989389|12544459|FG009|STARTED|Period 1||6
11347034|NCT02989389|12544450|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
11347035|NCT02989389|12544451|FG001|Received at Least 1 Dose of Study Drug|Period 1||4
11347036|NCT02989389|12544452|FG002|Received at Least 1 Dose of Study Drug|Period 1||3
11347037|NCT02989389|12544453|FG003|Received at Least 1 Dose of Study Drug|Period 1||3
11347038|NCT02989389|12544454|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
11347039|NCT02989389|12544455|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
11347040|NCT02989389|12544456|FG006|Received at Least 1 Dose of Study Drug|Period 1||6
11347041|NCT02989389|12544457|FG007|Received at Least 1 Dose of Study Drug|Period 1||5
11347042|NCT02989389|12544458|FG008|Received at Least 1 Dose of Study Drug|Period 1||6
11347043|NCT02989389|12544459|FG009|Received at Least 1 Dose of Study Drug|Period 1||6
11347044|NCT02989389|12544450|FG000|COMPLETED|Period 1||3
11347045|NCT02989389|12544451|FG001|COMPLETED|Period 1||3
11347046|NCT02989389|12544452|FG002|COMPLETED|Period 1||3
11071413|NCT01072149|12253281|FG004|STARTED|Treatment Period 2 (28 Days)||3
11071414|NCT01072149|12253282|FG005|STARTED|Treatment Period 2 (28 Days)||3
11071415|NCT01072149|12253283|FG006|STARTED|Treatment Period 2 (28 Days)||3
11071416|NCT01072149|12253284|FG007|STARTED|Treatment Period 2 (28 Days)||3
11071417|NCT01072149|12253285|FG008|STARTED|Treatment Period 2 (28 Days)||3
11071418|NCT01072149|12253286|FG009|STARTED|Treatment Period 2 (28 Days)||3
11071419|NCT01072149|12253287|FG010|STARTED|Treatment Period 2 (28 Days)||2
11071420|NCT01072149|12253288|FG011|STARTED|Treatment Period 2 (28 Days)||3
11071421|NCT01072149|12253289|FG012|STARTED|Treatment Period 2 (28 Days)||3
11071422|NCT01072149|12253290|FG013|STARTED|Treatment Period 2 (28 Days)||3
11071423|NCT01072149|12253291|FG014|STARTED|Treatment Period 2 (28 Days)||3
11347047|NCT02989389|12544453|FG003|COMPLETED|Period 1||3
11347048|NCT02989389|12544454|FG004|COMPLETED|Period 1||3
11347049|NCT02989389|12544455|FG005|COMPLETED|Period 1||3
11071424|NCT01072149|12253292|FG015|STARTED|Treatment Period 2 (28 Days)||3
11071425|NCT01072149|12253293|FG016|STARTED|Treatment Period 2 (28 Days)||3
11071426|NCT01072149|12253294|FG017|STARTED|Treatment Period 2 (28 Days)||2
11071427|NCT01072149|12253277|FG000|COMPLETED|Treatment Period 2 (28 Days)||3
11071428|NCT01072149|12253278|FG001|COMPLETED|Treatment Period 2 (28 Days)||2
11071429|NCT01072149|12253279|FG002|COMPLETED|Treatment Period 2 (28 Days)||1
11071430|NCT01072149|12253280|FG003|COMPLETED|Treatment Period 2 (28 Days)||3
11071431|NCT01072149|12253281|FG004|COMPLETED|Treatment Period 2 (28 Days)||3
11071432|NCT01072149|12253282|FG005|COMPLETED|Treatment Period 2 (28 Days)||3
11071433|NCT01072149|12253283|FG006|COMPLETED|Treatment Period 2 (28 Days)||3
11071434|NCT01072149|12253284|FG007|COMPLETED|Treatment Period 2 (28 Days)||2
11071435|NCT01072149|12253285|FG008|COMPLETED|Treatment Period 2 (28 Days)||3
11071436|NCT01072149|12253286|FG009|COMPLETED|Treatment Period 2 (28 Days)||3
11071437|NCT01072149|12253287|FG010|COMPLETED|Treatment Period 2 (28 Days)||2
11071438|NCT01072149|12253288|FG011|COMPLETED|Treatment Period 2 (28 Days)||3
11071439|NCT01072149|12253289|FG012|COMPLETED|Treatment Period 2 (28 Days)||3
11071440|NCT01072149|12253290|FG013|COMPLETED|Treatment Period 2 (28 Days)||3
11071441|NCT01072149|12253291|FG014|COMPLETED|Treatment Period 2 (28 Days)||3
11071442|NCT01072149|12253292|FG015|COMPLETED|Treatment Period 2 (28 Days)||3
11071443|NCT01072149|12253293|FG016|COMPLETED|Treatment Period 2 (28 Days)||3
11071444|NCT01072149|12253294|FG017|COMPLETED|Treatment Period 2 (28 Days)||2
11071445|NCT01072149|12253277|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071446|NCT01072149|12253278|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1
11071447|NCT01072149|12253279|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1
11071448|NCT01072149|12253280|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071449|NCT01072149|12253281|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071450|NCT01072149|12253282|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071451|NCT01072149|12253283|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071452|NCT01072149|12253284|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||1
11071453|NCT01072149|12253285|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071454|NCT01072149|12253286|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071455|NCT01072149|12253287|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071456|NCT01072149|12253288|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071457|NCT01072149|12253289|FG012|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071458|NCT01072149|12253290|FG013|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071459|NCT01072149|12253291|FG014|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071460|NCT01072149|12253292|FG015|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071461|NCT01072149|12253293|FG016|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071462|NCT01072149|12253294|FG017|NOT COMPLETED|Treatment Period 2 (28 Days)||0
11071463|NCT01072149|12253277|FG000|STARTED|Washout Period 2 (14 Days)||3
11071464|NCT01072149|12253278|FG001|STARTED|Washout Period 2 (14 Days)||2
11071465|NCT01072149|12253279|FG002|STARTED|Washout Period 2 (14 Days)||1
11071466|NCT01072149|12253280|FG003|STARTED|Washout Period 2 (14 Days)||3
11071467|NCT01072149|12253281|FG004|STARTED|Washout Period 2 (14 Days)||3
11071468|NCT01072149|12253282|FG005|STARTED|Washout Period 2 (14 Days)||3
11071469|NCT01072149|12253283|FG006|STARTED|Washout Period 2 (14 Days)||3
11071470|NCT01072149|12253284|FG007|STARTED|Washout Period 2 (14 Days)||2
11071471|NCT01072149|12253285|FG008|STARTED|Washout Period 2 (14 Days)||3
11071472|NCT01072149|12253286|FG009|STARTED|Washout Period 2 (14 Days)||3
11071473|NCT01072149|12253287|FG010|STARTED|Washout Period 2 (14 Days)||2
11071474|NCT01072149|12253288|FG011|STARTED|Washout Period 2 (14 Days)||3
11071475|NCT01072149|12253289|FG012|STARTED|Washout Period 2 (14 Days)||3
11071476|NCT01072149|12253290|FG013|STARTED|Washout Period 2 (14 Days)||3
11071477|NCT01072149|12253291|FG014|STARTED|Washout Period 2 (14 Days)||3
11071478|NCT01072149|12253292|FG015|STARTED|Washout Period 2 (14 Days)||3
11071479|NCT01072149|12253293|FG016|STARTED|Washout Period 2 (14 Days)||3
11071480|NCT01072149|12253294|FG017|STARTED|Washout Period 2 (14 Days)||2
11071481|NCT01072149|12253277|FG000|COMPLETED|Washout Period 2 (14 Days)||2
11071482|NCT01072149|12253278|FG001|COMPLETED|Washout Period 2 (14 Days)||2
11071483|NCT01072149|12253279|FG002|COMPLETED|Washout Period 2 (14 Days)||1
11071484|NCT01072149|12253280|FG003|COMPLETED|Washout Period 2 (14 Days)||3
11071485|NCT01072149|12253281|FG004|COMPLETED|Washout Period 2 (14 Days)||3
11071486|NCT01072149|12253282|FG005|COMPLETED|Washout Period 2 (14 Days)||3
11071487|NCT01072149|12253283|FG006|COMPLETED|Washout Period 2 (14 Days)||3
11071488|NCT01072149|12253284|FG007|COMPLETED|Washout Period 2 (14 Days)||2
11071489|NCT01072149|12253285|FG008|COMPLETED|Washout Period 2 (14 Days)||3
11071490|NCT01072149|12253286|FG009|COMPLETED|Washout Period 2 (14 Days)||3
11071491|NCT01072149|12253287|FG010|COMPLETED|Washout Period 2 (14 Days)||2
11071492|NCT01072149|12253288|FG011|COMPLETED|Washout Period 2 (14 Days)||3
11071493|NCT01072149|12253289|FG012|COMPLETED|Washout Period 2 (14 Days)||2
11071494|NCT01072149|12253290|FG013|COMPLETED|Washout Period 2 (14 Days)||3
11071495|NCT01072149|12253291|FG014|COMPLETED|Washout Period 2 (14 Days)||3
11071496|NCT01072149|12253292|FG015|COMPLETED|Washout Period 2 (14 Days)||1
11071497|NCT01072149|12253293|FG016|COMPLETED|Washout Period 2 (14 Days)||3
11071498|NCT01072149|12253294|FG017|COMPLETED|Washout Period 2 (14 Days)||2
11071499|NCT01072149|12253277|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||1
11071500|NCT01072149|12253278|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071501|NCT01072149|12253279|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071502|NCT01072149|12253280|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071503|NCT01072149|12253281|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071504|NCT01072149|12253282|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071505|NCT01072149|12253283|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071506|NCT01072149|12253284|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071507|NCT01072149|12253285|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071508|NCT01072149|12253286|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071509|NCT01072149|12253287|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071510|NCT01072149|12253288|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071511|NCT01072149|12253289|FG012|NOT COMPLETED|Washout Period 2 (14 Days)||1
11071512|NCT01072149|12253290|FG013|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071513|NCT01072149|12253291|FG014|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071514|NCT01072149|12253292|FG015|NOT COMPLETED|Washout Period 2 (14 Days)||2
11071515|NCT01072149|12253293|FG016|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071516|NCT01072149|12253294|FG017|NOT COMPLETED|Washout Period 2 (14 Days)||0
11071517|NCT01072149|12253277|FG000|STARTED|Treatment Period 3 (28 Days)||2
11071518|NCT01072149|12253278|FG001|STARTED|Treatment Period 3 (28 Days)||2
11071519|NCT01072149|12253279|FG002|STARTED|Treatment Period 3 (28 Days)||1
11071520|NCT01072149|12253280|FG003|STARTED|Treatment Period 3 (28 Days)||3
11071521|NCT01072149|12253281|FG004|STARTED|Treatment Period 3 (28 Days)||3
11071522|NCT01072149|12253282|FG005|STARTED|Treatment Period 3 (28 Days)||3
11071523|NCT01072149|12253283|FG006|STARTED|Treatment Period 3 (28 Days)||3
11071524|NCT01072149|12253284|FG007|STARTED|Treatment Period 3 (28 Days)||2
11071525|NCT01072149|12253285|FG008|STARTED|Treatment Period 3 (28 Days)||3
11071526|NCT01072149|12253286|FG009|STARTED|Treatment Period 3 (28 Days)||3
11071527|NCT01072149|12253287|FG010|STARTED|Treatment Period 3 (28 Days)||2
11071528|NCT01072149|12253288|FG011|STARTED|Treatment Period 3 (28 Days)||3
11071529|NCT01072149|12253289|FG012|STARTED|Treatment Period 3 (28 Days)||2
11071530|NCT01072149|12253290|FG013|STARTED|Treatment Period 3 (28 Days)||3
11071531|NCT01072149|12253291|FG014|STARTED|Treatment Period 3 (28 Days)||3
11071532|NCT01072149|12253292|FG015|STARTED|Treatment Period 3 (28 Days)||1
11071533|NCT01072149|12253293|FG016|STARTED|Treatment Period 3 (28 Days)||3
11071534|NCT01072149|12253294|FG017|STARTED|Treatment Period 3 (28 Days)||2
11071535|NCT01072149|12253277|FG000|COMPLETED|Treatment Period 3 (28 Days)||2
11071536|NCT01072149|12253278|FG001|COMPLETED|Treatment Period 3 (28 Days)||2
11071537|NCT01072149|12253279|FG002|COMPLETED|Treatment Period 3 (28 Days)||0
11071538|NCT01072149|12253280|FG003|COMPLETED|Treatment Period 3 (28 Days)||3
11071539|NCT01072149|12253281|FG004|COMPLETED|Treatment Period 3 (28 Days)||3
11071540|NCT01072149|12253282|FG005|COMPLETED|Treatment Period 3 (28 Days)||3
11071541|NCT01072149|12253283|FG006|COMPLETED|Treatment Period 3 (28 Days)||3
11071542|NCT01072149|12253284|FG007|COMPLETED|Treatment Period 3 (28 Days)||2
11071543|NCT01072149|12253285|FG008|COMPLETED|Treatment Period 3 (28 Days)||3
11071544|NCT01072149|12253286|FG009|COMPLETED|Treatment Period 3 (28 Days)||3
11071545|NCT01072149|12253287|FG010|COMPLETED|Treatment Period 3 (28 Days)||2
11071546|NCT01072149|12253288|FG011|COMPLETED|Treatment Period 3 (28 Days)||3
11071547|NCT01072149|12253289|FG012|COMPLETED|Treatment Period 3 (28 Days)||2
11071548|NCT01072149|12253290|FG013|COMPLETED|Treatment Period 3 (28 Days)||2
11071549|NCT01072149|12253291|FG014|COMPLETED|Treatment Period 3 (28 Days)||3
11071550|NCT01072149|12253292|FG015|COMPLETED|Treatment Period 3 (28 Days)||1
11071551|NCT01072149|12253293|FG016|COMPLETED|Treatment Period 3 (28 Days)||3
11071552|NCT01072149|12253294|FG017|COMPLETED|Treatment Period 3 (28 Days)||2
11071553|NCT01072149|12253277|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11206448|NCT01868022|12397445|FG007|STARTED|Overall Study||25
11206449|NCT01868022|12397446|FG008|STARTED|Overall Study||8
11206450|NCT01868022|12397438|FG000|COMPLETED|Overall Study||3
11206451|NCT01868022|12397439|FG001|COMPLETED|Overall Study||3
11206452|NCT01868022|12397440|FG002|COMPLETED|Overall Study||13
11206453|NCT01868022|12397441|FG003|COMPLETED|Overall Study||2
11206454|NCT01868022|12397442|FG004|COMPLETED|Overall Study||1
11206455|NCT01868022|12397443|FG005|COMPLETED|Overall Study||2
11206456|NCT01868022|12397444|FG006|COMPLETED|Overall Study||3
11206457|NCT01868022|12397445|FG007|COMPLETED|Overall Study||16
11206458|NCT01868022|12397446|FG008|COMPLETED|Overall Study||6
11206459|NCT01868022|12397438|FG000|NOT COMPLETED|Overall Study||0
11206460|NCT01868022|12397439|FG001|NOT COMPLETED|Overall Study||0
11206461|NCT01868022|12397440|FG002|NOT COMPLETED|Overall Study||1
11206462|NCT01868022|12397441|FG003|NOT COMPLETED|Overall Study||1
11206463|NCT01868022|12397442|FG004|NOT COMPLETED|Overall Study||2
11206464|NCT01868022|12397443|FG005|NOT COMPLETED|Overall Study||1
11206465|NCT01868022|12397444|FG006|NOT COMPLETED|Overall Study||0
11206466|NCT01868022|12397445|FG007|NOT COMPLETED|Overall Study||9
11206467|NCT01868022|12397446|FG008|NOT COMPLETED|Overall Study||2
11206468|NCT01868035|12397472|FG000|STARTED|Overall Study||15
11206469|NCT01868035|12397472|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
11206470|NCT01868035|12397472|FG000|NOT COMPLETED|Overall Study||7
11206471|NCT01868074|12397478|FG000|STARTED|Overall Study||36
11206472|NCT01868074|12397479|FG001|STARTED|Overall Study||36
11206473|NCT01868074|12397478|FG000|COMPLETED|Overall Study||29
11206474|NCT01868074|12397479|FG001|COMPLETED|Overall Study||32
11206475|NCT01868074|12397478|FG000|NOT COMPLETED|Overall Study||7
11206476|NCT01868074|12397479|FG001|NOT COMPLETED|Overall Study||4
11206477|NCT01868165|12397485|FG000|STARTED|Overall Study||337
11206478|NCT01868165|12397485|FG000|COMPLETED|Overall Study||292
11071554|NCT01072149|12253278|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071555|NCT01072149|12253279|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||1
11071556|NCT01072149|12253280|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071557|NCT01072149|12253281|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071558|NCT01072149|12253282|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071559|NCT01072149|12253283|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071560|NCT01072149|12253284|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071561|NCT01072149|12253285|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071562|NCT01072149|12253286|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071563|NCT01072149|12253287|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071564|NCT01072149|12253288|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071565|NCT01072149|12253289|FG012|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071566|NCT01072149|12253290|FG013|NOT COMPLETED|Treatment Period 3 (28 Days)||1
11071567|NCT01072149|12253291|FG014|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071568|NCT01072149|12253292|FG015|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071569|NCT01072149|12253293|FG016|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071570|NCT01072149|12253294|FG017|NOT COMPLETED|Treatment Period 3 (28 Days)||0
11071571|NCT01072188|12253306|FG000|STARTED|Overall Study||22
11071572|NCT01072188|12253307|FG001|STARTED|Overall Study||23
11071573|NCT01072188|12253306|FG000|COMPLETED|Overall Study||22
11071574|NCT01072188|12253307|FG001|COMPLETED|Overall Study||23
11071575|NCT01072188|12253306|FG000|NOT COMPLETED|Overall Study||0
11071576|NCT01072188|12253307|FG001|NOT COMPLETED|Overall Study||0
11071577|NCT01072201|12253315|FG000|STARTED|Overall Study||30
11071578|NCT01072201|12253316|FG001|STARTED|Overall Study||30
11071579|NCT01072201|12253315|FG000|COMPLETED|Overall Study||30
11347050|NCT02989389|12544456|FG006|COMPLETED|Period 1||6
11347051|NCT02989389|12544457|FG007|COMPLETED|Period 1||5
11071580|NCT01072201|12253316|FG001|COMPLETED|Overall Study||29
11071581|NCT01072201|12253315|FG000|NOT COMPLETED|Overall Study||0
11071582|NCT01072201|12253316|FG001|NOT COMPLETED|Overall Study||1
11071583|NCT01072331|12253325|FG000|STARTED|Overall Study||34
11071584|NCT01072331|12253326|FG001|STARTED|Overall Study||33
11071585|NCT01072331|12253327|FG002|STARTED|Overall Study||32
11071586|NCT01072331|12253325|FG000|COMPLETED|Overall Study||34
11071587|NCT01072331|12253326|FG001|COMPLETED|Overall Study||33
11071588|NCT01072331|12253327|FG002|COMPLETED|Overall Study||32
11071589|NCT01072331|12253325|FG000|NOT COMPLETED|Overall Study||0
11071590|NCT01072331|12253326|FG001|NOT COMPLETED|Overall Study||0
11071591|NCT01072331|12253327|FG002|NOT COMPLETED|Overall Study||0
11071592|NCT01072344|12253337|FG000|STARTED|Overall Study||46
11071593|NCT01072344|12253338|FG001|STARTED|Overall Study||47
11071594|NCT01072344|12253337|FG000|COMPLETED|Overall Study||35
11071595|NCT01072344|12253338|FG001|COMPLETED|Overall Study||29
11071596|NCT01072344|12253337|FG000|NOT COMPLETED|Overall Study||11
11071597|NCT01072344|12253338|FG001|NOT COMPLETED|Overall Study||18
11071598|NCT01072357|12253346|FG000|STARTED|Overall Study||15
11071599|NCT01072357|12253347|FG001|STARTED|Overall Study||15
11071600|NCT01072357|12253346|FG000|COMPLETED|Overall Study||15
11071601|NCT01072357|12253347|FG001|COMPLETED|Overall Study||14
11071602|NCT01072357|12253346|FG000|NOT COMPLETED|Overall Study||0
11071603|NCT01072357|12253347|FG001|NOT COMPLETED|Overall Study||1
11071604|NCT01072396|12253355|FG000|STARTED|Period One||63
11071605|NCT01072396|12253356|FG001|STARTED|Period One||63
11071606|NCT01072396|12253355|FG000|COMPLETED|Period One||58
11071607|NCT01072396|12253356|FG001|COMPLETED|Period One||61
11071608|NCT01072396|12253355|FG000|NOT COMPLETED|Period One||5
11071609|NCT01072396|12253356|FG001|NOT COMPLETED|Period One||2
11071610|NCT01072396|12253355|FG000|STARTED|Washout Period||58
11071611|NCT01072396|12253356|FG001|STARTED|Washout Period||61
11071612|NCT01072396|12253355|FG000|COMPLETED|Washout Period||58
11071613|NCT01072396|12253356|FG001|COMPLETED|Washout Period||60
11071614|NCT01072396|12253355|FG000|NOT COMPLETED|Washout Period||0
11071615|NCT01072396|12253356|FG001|NOT COMPLETED|Washout Period||1
11071616|NCT01072396|12253355|FG000|STARTED|Period Two||58
11071617|NCT01072396|12253356|FG001|STARTED|Period Two||60
11071618|NCT01072396|12253355|FG000|COMPLETED|Period Two||57
11071619|NCT01072396|12253356|FG001|COMPLETED|Period Two||57
11071620|NCT01072396|12253355|FG000|NOT COMPLETED|Period Two||1
11071621|NCT01072396|12253356|FG001|NOT COMPLETED|Period Two||3
11071622|NCT01072409|12253362|FG000|STARTED|Overall Study||45
11071623|NCT01072409|12253362|FG000|COMPLETED|Overall Study||38
11071624|NCT01072409|12253362|FG000|NOT COMPLETED|Overall Study||7
11071625|NCT01072448|12253368|FG000|STARTED|Overall Study||163
11071626|NCT01072448|12253369|FG001|STARTED|Overall Study||160
11071627|NCT01072448|12253368|FG000|COMPLETED|Overall Study||144
11071628|NCT01072448|12253369|FG001|COMPLETED|Overall Study||130
11071629|NCT01072448|12253368|FG000|NOT COMPLETED|Overall Study||19
11071630|NCT01072448|12253369|FG001|NOT COMPLETED|Overall Study||30
11071631|NCT01072500|12253377|FG000|STARTED|Overall Study||818
11071632|NCT01072500|12253378|FG001|STARTED|Overall Study||817
11071633|NCT01072500|12253377|FG000|COMPLETED|Overall Study||794
11071634|NCT01072500|12253378|FG001|COMPLETED|Overall Study||803
11071635|NCT01072500|12253377|FG000|NOT COMPLETED|Overall Study||24
11071636|NCT01072500|12253378|FG001|NOT COMPLETED|Overall Study||14
11071637|NCT01072539|12253386|FG000|STARTED|Overall Study||3172
11071638|NCT01072539|12253386|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
11071639|NCT01072539|12253386|FG000|NOT COMPLETED|Overall Study||3
11071640|NCT01072617|12253390|FG000|STARTED|Overall Study||8
11071641|NCT01072617|12253390|FG000|COMPLETED|Overall Study||8
11071642|NCT01072617|12253390|FG000|NOT COMPLETED|Overall Study||0
11206479|NCT01868165|12397485|FG000|NOT COMPLETED|Overall Study||45
11206480|NCT01868243|12397491|FG000|STARTED|Overall Study||15
11206481|NCT01868243|12397492|FG001|STARTED|Overall Study||12
11206482|NCT01868243|12397491|FG000|COMPLETED|Overall Study||15
11206483|NCT01868243|12397492|FG001|COMPLETED|Overall Study||11
11206484|NCT01868243|12397491|FG000|NOT COMPLETED|Overall Study||0
11206485|NCT01868243|12397492|FG001|NOT COMPLETED|Overall Study||1
11206486|NCT01868334|12397502|FG000|STARTED|Year 1 RCCT Study||13186
11206487|NCT01868334|12397503|FG001|STARTED|Year 1 RCCT Study||17185
11206488|NCT01868334|12397504|FG002|STARTED|Year 1 RCCT Study||19274
11206489|NCT01868334|12397505|FG003|STARTED|Year 1 RCCT Study||20904
11206490|NCT01868334|12397502|FG000|COMPLETED|Year 1 RCCT Study||13186
11206491|NCT01868334|12397503|FG001|COMPLETED|Year 1 RCCT Study||17185
11206492|NCT01868334|12397504|FG002|COMPLETED|Year 1 RCCT Study||19274
11206493|NCT01868334|12397505|FG003|COMPLETED|Year 1 RCCT Study||20904
11206494|NCT01868334|12397502|FG000|NOT COMPLETED|Year 1 RCCT Study||0
11206495|NCT01868334|12397503|FG001|NOT COMPLETED|Year 1 RCCT Study||0
11206496|NCT01868334|12397504|FG002|NOT COMPLETED|Year 1 RCCT Study||0
11206497|NCT01868334|12397505|FG003|NOT COMPLETED|Year 1 RCCT Study||0
11206498|NCT01868334|12397502|FG000|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
11206499|NCT01868334|12397503|FG001|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
11206500|NCT01868334|12397504|FG002|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
11206501|NCT01868334|12397505|FG003|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
11206502|NCT01868334|12397502|FG000|COMPLETED|Year 2 Pre-post Study||22324
11206503|NCT01868334|12397503|FG001|COMPLETED|Year 2 Pre-post Study||8047
11206504|NCT01868334|12397504|FG002|COMPLETED|Year 2 Pre-post Study||20904
11347052|NCT02989389|12544458|FG008|COMPLETED|Period 1||5
11347053|NCT02989389|12544459|FG009|COMPLETED|Period 1||6
11347054|NCT02989389|12544450|FG000|NOT COMPLETED|Period 1||0
11347055|NCT02989389|12544451|FG001|NOT COMPLETED|Period 1||1
11347056|NCT02989389|12544452|FG002|NOT COMPLETED|Period 1||0
11347057|NCT02989389|12544453|FG003|NOT COMPLETED|Period 1||0
11347058|NCT02989389|12544454|FG004|NOT COMPLETED|Period 1||0
11347059|NCT02989389|12544455|FG005|NOT COMPLETED|Period 1||0
11347060|NCT02989389|12544456|FG006|NOT COMPLETED|Period 1||0
11347061|NCT02989389|12544457|FG007|NOT COMPLETED|Period 1||0
11347062|NCT02989389|12544458|FG008|NOT COMPLETED|Period 1||1
11347063|NCT02989389|12544459|FG009|NOT COMPLETED|Period 1||0
11347064|NCT02989389|12544450|FG000|STARTED|Period 2||3
11347065|NCT02989389|12544451|FG001|STARTED|Period 2||3
11347066|NCT02989389|12544452|FG002|STARTED|Period 2||3
11347067|NCT02989389|12544453|FG003|STARTED|Period 2||3
11347068|NCT02989389|12544454|FG004|STARTED|Period 2||3
11347069|NCT02989389|12544455|FG005|STARTED|Period 2||3
11347070|NCT02989389|12544456|FG006|STARTED|Period 2|Part B was planned as a single period study.|0
11347071|NCT02989389|12544457|FG007|STARTED|Period 2|Part B was planned as a single period study.|0
11347072|NCT02989389|12544458|FG008|STARTED|Period 2|Part B was planned as a single period study.|0
11347073|NCT02989389|12544459|FG009|STARTED|Period 2|Part B was planned as a single period study.|0
11347074|NCT02989389|12544450|FG000|COMPLETED|Period 2||3
11347075|NCT02989389|12544451|FG001|COMPLETED|Period 2||3
11347076|NCT02989389|12544452|FG002|COMPLETED|Period 2||3
11347077|NCT02989389|12544453|FG003|COMPLETED|Period 2||3
11347078|NCT02989389|12544454|FG004|COMPLETED|Period 2||3
11347079|NCT02989389|12544455|FG005|COMPLETED|Period 2||3
11347080|NCT02989389|12544456|FG006|COMPLETED|Period 2||0
11347081|NCT02989389|12544457|FG007|COMPLETED|Period 2||0
11206505|NCT01868334|12397505|FG003|COMPLETED|Year 2 Pre-post Study||19274
11206506|NCT01868334|12397502|FG000|NOT COMPLETED|Year 2 Pre-post Study||0
11206507|NCT01868334|12397503|FG001|NOT COMPLETED|Year 2 Pre-post Study||0
11206508|NCT01868334|12397504|FG002|NOT COMPLETED|Year 2 Pre-post Study||0
11347082|NCT02989389|12544458|FG008|COMPLETED|Period 2||0
11347083|NCT02989389|12544459|FG009|COMPLETED|Period 2||0
11347084|NCT02989389|12544450|FG000|NOT COMPLETED|Period 2||0
11347085|NCT02989389|12544451|FG001|NOT COMPLETED|Period 2||0
11347086|NCT02989389|12544452|FG002|NOT COMPLETED|Period 2||0
11206509|NCT01868334|12397505|FG003|NOT COMPLETED|Year 2 Pre-post Study||0
11206510|NCT01868425|12397545|FG000|STARTED|Overall Study||55
11206511|NCT01868425|12397546|FG001|STARTED|Overall Study||57
11206512|NCT01868425|12397545|FG000|COMPLETED|Overall Study||55
11206513|NCT01868425|12397546|FG001|COMPLETED|Overall Study||57
11206514|NCT01868425|12397545|FG000|NOT COMPLETED|Overall Study||0
11206515|NCT01868425|12397546|FG001|NOT COMPLETED|Overall Study||0
11206516|NCT01868477|12397554|FG000|STARTED|Overall Study||12
11206517|NCT01868477|12397555|FG001|STARTED|Overall Study||11
11206518|NCT01868477|12397554|FG000|Switched to EPO+DFX|Overall Study||5
11206519|NCT01868477|12397555|FG001|Switched to EPO+DFX|Overall Study||0
11206520|NCT01868477|12397554|FG000|Not Switched to EPO+DFX|Overall Study||7
11206521|NCT01868477|12397555|FG001|Not Switched to EPO+DFX|Overall Study||0
11206522|NCT01868477|12397554|FG000|COMPLETED|Overall Study||8
11206523|NCT01868477|12397555|FG001|COMPLETED|Overall Study||6
11206524|NCT01868477|12397554|FG000|NOT COMPLETED|Overall Study||4
11206525|NCT01868477|12397555|FG001|NOT COMPLETED|Overall Study||5
11071643|NCT01072630|12253398|FG000|STARTED|Overall Study||230
11071644|NCT01072630|12253399|FG001|STARTED|Overall Study||232
11071645|NCT01072630|12253400|FG002|STARTED|Overall Study||30
11071646|NCT01072630|12253398|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
11071647|NCT01072630|12253399|FG001|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
11071648|NCT01072630|12253400|FG002|Safety Population|Overall Study|Treated participants.|30
11071649|NCT01072630|12253398|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
11071650|NCT01072630|12253399|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
11071651|NCT01072630|12253400|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
11071652|NCT01072630|12253398|FG000|COMPLETED|Overall Study||175
11071653|NCT01072630|12253399|FG001|COMPLETED|Overall Study||172
11071654|NCT01072630|12253400|FG002|COMPLETED|Overall Study||17
11071655|NCT01072630|12253398|FG000|NOT COMPLETED|Overall Study||55
11071656|NCT01072630|12253399|FG001|NOT COMPLETED|Overall Study||60
11071657|NCT01072630|12253400|FG002|NOT COMPLETED|Overall Study||13
11071658|NCT01072643|12253409|FG000|STARTED|Overall Study||4
11071659|NCT01072643|12253409|FG000|COMPLETED|Overall Study||4
11071660|NCT01072643|12253409|FG000|NOT COMPLETED|Overall Study||0
11071661|NCT01072656|12253434|FG000|STARTED|First Intervention||5
11071662|NCT01072656|12253435|FG001|STARTED|First Intervention||4
11071663|NCT01072656|12253434|FG000|COMPLETED|First Intervention||5
11071664|NCT01072656|12253435|FG001|COMPLETED|First Intervention||4
11071665|NCT01072656|12253434|FG000|NOT COMPLETED|First Intervention||0
11071666|NCT01072656|12253435|FG001|NOT COMPLETED|First Intervention||0
11071667|NCT01072656|12253434|FG000|STARTED|Second Intervention||5
11071668|NCT01072656|12253435|FG001|STARTED|Second Intervention||4
11071669|NCT01072656|12253434|FG000|COMPLETED|Second Intervention||5
11071670|NCT01072656|12253435|FG001|COMPLETED|Second Intervention||4
11071671|NCT01072656|12253434|FG000|NOT COMPLETED|Second Intervention||0
11071672|NCT01072656|12253435|FG001|NOT COMPLETED|Second Intervention||0
11071673|NCT01072669|12253444|FG000|STARTED|Overall Study||15
11071674|NCT01072669|12253445|FG001|STARTED|Overall Study||5
11071675|NCT01072669|12253444|FG000|COMPLETED|Overall Study||15
11071676|NCT01072669|12253445|FG001|COMPLETED|Overall Study||5
11071677|NCT01072669|12253444|FG000|NOT COMPLETED|Overall Study||0
11071678|NCT01072669|12253445|FG001|NOT COMPLETED|Overall Study||0
11071679|NCT01072773|12253451|FG000|STARTED|Overall Study||2
11071680|NCT01072773|12253451|FG000|COMPLETED|Overall Study||2
11071681|NCT01072773|12253451|FG000|NOT COMPLETED|Overall Study||0
11071682|NCT01072877|12253460|FG000|STARTED|Overall Study||56
11071683|NCT01072877|12253461|FG001|STARTED|Overall Study||57
11347087|NCT02989389|12544453|FG003|NOT COMPLETED|Period 2||0
11071684|NCT01072877|12253462|FG002|STARTED|Overall Study||51
11347088|NCT02989389|12544454|FG004|NOT COMPLETED|Period 2||0
11071685|NCT01072877|12253463|FG003|STARTED|Overall Study||52
11071686|NCT01072877|12253464|FG004|STARTED|Overall Study||63
11071687|NCT01072877|12253460|FG000|COMPLETED|Overall Study||55
11071688|NCT01072877|12253461|FG001|COMPLETED|Overall Study||56
11071689|NCT01072877|12253462|FG002|COMPLETED|Overall Study||51
11071690|NCT01072877|12253463|FG003|COMPLETED|Overall Study||50
11071691|NCT01072877|12253464|FG004|COMPLETED|Overall Study||63
11071692|NCT01072877|12253460|FG000|NOT COMPLETED|Overall Study||1
11071693|NCT01072877|12253461|FG001|NOT COMPLETED|Overall Study||1
11071694|NCT01072877|12253462|FG002|NOT COMPLETED|Overall Study||0
11071695|NCT01072877|12253463|FG003|NOT COMPLETED|Overall Study||2
11071696|NCT01072877|12253464|FG004|NOT COMPLETED|Overall Study||0
11071697|NCT01072929|12253481|FG000|STARTED|Overall Study||199
11071698|NCT01072929|12253482|FG001|STARTED|Overall Study||201
11071699|NCT01072929|12253483|FG002|STARTED|Overall Study||33
11071700|NCT01072929|12253481|FG000|Safety Population|Overall Study|Treated participants|199
11071701|NCT01072929|12253482|FG001|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
11071702|NCT01072929|12253483|FG002|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
11071703|NCT01072929|12253481|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
11071704|NCT01072929|12253482|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
11071705|NCT01072929|12253483|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
11071706|NCT01072929|12253481|FG000|COMPLETED|Overall Study||155
11071707|NCT01072929|12253482|FG001|COMPLETED|Overall Study||150
11071708|NCT01072929|12253483|FG002|COMPLETED|Overall Study||24
11071709|NCT01072929|12253481|FG000|NOT COMPLETED|Overall Study||44
11071710|NCT01072929|12253482|FG001|NOT COMPLETED|Overall Study||51
11071711|NCT01072929|12253483|FG002|NOT COMPLETED|Overall Study||9
11071712|NCT01073020|12253496|FG000|STARTED|Overall Study||23
11071713|NCT01073020|12253497|FG001|STARTED|Overall Study||22
11071714|NCT01073020|12253498|FG002|STARTED|Overall Study||22
11071715|NCT01073020|12253499|FG003|STARTED|Overall Study||21
11071716|NCT01073020|12253496|FG000|COMPLETED|Overall Study||16
11071717|NCT01073020|12253497|FG001|COMPLETED|Overall Study||17
11071718|NCT01073020|12253498|FG002|COMPLETED|Overall Study||19
11071719|NCT01073020|12253499|FG003|COMPLETED|Overall Study||19
11071720|NCT01073020|12253496|FG000|NOT COMPLETED|Overall Study||7
11071721|NCT01073020|12253497|FG001|NOT COMPLETED|Overall Study||5
11071722|NCT01073020|12253498|FG002|NOT COMPLETED|Overall Study||3
11071723|NCT01073020|12253499|FG003|NOT COMPLETED|Overall Study||2
11071724|NCT01073163|12253509|FG000|STARTED|Overall Study||54
11071725|NCT01073163|12253509|FG000|Enrolled But Not Treated|Overall Study||1
11071726|NCT01073163|12253509|FG000|Treated With <6 Cycles|Overall Study||4
11071727|NCT01073163|12253509|FG000|Treated With >=6 Cycles|Overall Study||49
11071728|NCT01073163|12253509|FG000|COMPLETED|Overall Study|Patients completed study|51
11071729|NCT01073163|12253509|FG000|NOT COMPLETED|Overall Study||3
11071730|NCT01073267|12253517|FG000|STARTED|Overall Study||4
11071731|NCT01073267|12253517|FG000|COMPLETED|Overall Study||1
11071732|NCT01073267|12253517|FG000|NOT COMPLETED|Overall Study||3
11071733|NCT01073293|12253523|FG000|STARTED|Overall Study||526
11071734|NCT01073293|12253524|FG001|STARTED|Overall Study||528
11071735|NCT01073293|12253523|FG000|COMPLETED|Overall Study||521
11071736|NCT01073293|12253524|FG001|COMPLETED|Overall Study||517
11071737|NCT01073293|12253523|FG000|NOT COMPLETED|Overall Study||5
11071738|NCT01073293|12253524|FG001|NOT COMPLETED|Overall Study||11
11071739|NCT01073449|12253530|FG000|STARTED|Overall Study||3362
11071740|NCT01073449|12253530|FG000|COMPLETED|Overall Study||3362
11071741|NCT01073449|12253530|FG000|NOT COMPLETED|Overall Study||0
11071742|NCT01073462|12253534|FG000|STARTED|Overall Study||67
11071743|NCT01073462|12253534|FG000|COMPLETED|Overall Study||26
11071744|NCT01073462|12253534|FG000|NOT COMPLETED|Overall Study||41
11071745|NCT01073566|12253540|FG000|STARTED|Period 1 (6 Weeks)||19
11071746|NCT01073566|12253541|FG001|STARTED|Period 1 (6 Weeks)||19
11071747|NCT01073566|12253540|FG000|COMPLETED|Period 1 (6 Weeks)||19
11071748|NCT01073566|12253541|FG001|COMPLETED|Period 1 (6 Weeks)||19
11071749|NCT01073566|12253540|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
11071750|NCT01073566|12253541|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
11071751|NCT01073566|12253540|FG000|STARTED|Period 2 (6 Weeks)||19
11071752|NCT01073566|12253541|FG001|STARTED|Period 2 (6 Weeks)||19
11071753|NCT01073566|12253540|FG000|COMPLETED|Period 2 (6 Weeks)||18
11071754|NCT01073566|12253541|FG001|COMPLETED|Period 2 (6 Weeks)||19
11071755|NCT01073566|12253540|FG000|NOT COMPLETED|Period 2 (6 Weeks)||1
11071756|NCT01073566|12253541|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
11071757|NCT01073605|12253550|FG000|STARTED|Overall Study||68
11071758|NCT01073605|12253551|FG001|STARTED|Overall Study||71
11071759|NCT01073605|12253552|FG002|STARTED|Overall Study||69
11071760|NCT01073605|12253550|FG000|Received Treatment|Overall Study||68
11071761|NCT01073605|12253551|FG001|Received Treatment|Overall Study||70
11071762|NCT01073605|12253552|FG002|Received Treatment|Overall Study||68
11071763|NCT01073605|12253550|FG000|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
11071764|NCT01073605|12253551|FG001|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
11071765|NCT01073605|12253552|FG002|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
11071766|NCT01073605|12253550|FG000|NOT COMPLETED|Overall Study||62
11071767|NCT01073605|12253551|FG001|NOT COMPLETED|Overall Study||67
11071768|NCT01073605|12253552|FG002|NOT COMPLETED|Overall Study||61
11071769|NCT01073618|12253560|FG000|STARTED|Overall Study||692
11071770|NCT01073618|12253560|FG000|COMPLETED|Overall Study||385
11071771|NCT01073618|12253560|FG000|NOT COMPLETED|Overall Study||307
11071772|NCT01073631|12253564|FG000|STARTED|Overall Study||543
11071773|NCT01073631|12253564|FG000|COMPLETED|Overall Study||374
11071774|NCT01073631|12253564|FG000|NOT COMPLETED|Overall Study||169
11071775|NCT01073657|12253570|FG000|STARTED|Overall Study||17
11071776|NCT01073657|12253571|FG001|STARTED|Overall Study||16
11071777|NCT01073657|12253570|FG000|COMPLETED|Overall Study||17
11071778|NCT01073657|12253571|FG001|COMPLETED|Overall Study||16
11071779|NCT01073657|12253570|FG000|NOT COMPLETED|Overall Study||0
11071780|NCT01073657|12253571|FG001|NOT COMPLETED|Overall Study||0
11071781|NCT01073865|12253579|FG000|STARTED|Overall Study|Number of patients randomised|109
11071782|NCT01073865|12253580|FG001|STARTED|Overall Study|Number of patients randomised|113
11071783|NCT01073865|12253579|FG000|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
11071784|NCT01073865|12253580|FG001|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
11071785|NCT01073865|12253579|FG000|COMPLETED|Overall Study|Number of patients completed the study|81
11071786|NCT01073865|12253580|FG001|COMPLETED|Overall Study|Number of patients completed the study|74
11071787|NCT01073865|12253579|FG000|NOT COMPLETED|Overall Study||28
11071788|NCT01073865|12253580|FG001|NOT COMPLETED|Overall Study||39
11071789|NCT01073930|12253588|FG000|STARTED|Overall Study||307
11071790|NCT01073930|12253589|FG001|STARTED|Overall Study||301
11071791|NCT01073930|12253588|FG000|Safety Population (Treated)|Overall Study||305
11071792|NCT01073930|12253589|FG001|Safety Population (Treated)|Overall Study||298
11071793|NCT01073930|12253588|FG000|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
11071794|NCT01073930|12253589|FG001|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
11071795|NCT01073930|12253588|FG000|COMPLETED|Overall Study||304
11071796|NCT01073930|12253589|FG001|COMPLETED|Overall Study||295
11071797|NCT01073930|12253588|FG000|NOT COMPLETED|Overall Study||3
11071798|NCT01073930|12253589|FG001|NOT COMPLETED|Overall Study||6
11071799|NCT01073943|12253597|FG000|STARTED|Overall Study||300
11071800|NCT01073943|12253598|FG001|STARTED|Overall Study||303
11071801|NCT01073943|12253597|FG000|Safety Population (Treated)|Overall Study||296
11071802|NCT01073943|12253598|FG001|Safety Population (Treated)|Overall Study||302
11071803|NCT01073943|12253597|FG000|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
11071804|NCT01073943|12253598|FG001|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
11071805|NCT01073943|12253597|FG000|COMPLETED|Overall Study||287
11071806|NCT01073943|12253598|FG001|COMPLETED|Overall Study||295
11071807|NCT01073943|12253597|FG000|NOT COMPLETED|Overall Study||13
11071808|NCT01073943|12253598|FG001|NOT COMPLETED|Overall Study||8
11071809|NCT01074008|12253613|FG000|STARTED|Overall Study||8
11071810|NCT01074008|12253614|FG001|STARTED|Overall Study||8
11071811|NCT01074008|12253615|FG002|STARTED|Overall Study||8
11071812|NCT01074008|12253616|FG003|STARTED|Overall Study||8
11071813|NCT01074008|12253617|FG004|STARTED|Overall Study||8
11071814|NCT01074008|12253618|FG005|STARTED|Overall Study||7
11071815|NCT01074008|12253619|FG006|STARTED|Overall Study||8
11071816|NCT01074008|12253620|FG007|STARTED|Overall Study||8
11071817|NCT01074008|12253621|FG008|STARTED|Overall Study||11
11071818|NCT01074008|12253613|FG000|Completed Direct-acting Antiviral Agent|Overall Study||8
11071819|NCT01074008|12253614|FG001|Completed Direct-acting Antiviral Agent|Overall Study||7
11071820|NCT01074008|12253615|FG002|Completed Direct-acting Antiviral Agent|Overall Study||7
11071821|NCT01074008|12253616|FG003|Completed Direct-acting Antiviral Agent|Overall Study||8
11071822|NCT01074008|12253617|FG004|Completed Direct-acting Antiviral Agent|Overall Study||8
11071823|NCT01074008|12253618|FG005|Completed Direct-acting Antiviral Agent|Overall Study||5
11071824|NCT01074008|12253619|FG006|Completed Direct-acting Antiviral Agent|Overall Study||8
11071825|NCT01074008|12253620|FG007|Completed Direct-acting Antiviral Agent|Overall Study||7
11071826|NCT01074008|12253621|FG008|Completed Direct-acting Antiviral Agent|Overall Study||5
11071827|NCT01074008|12253613|FG000|COMPLETED|Overall Study||7
11071828|NCT01074008|12253614|FG001|COMPLETED|Overall Study||5
11071829|NCT01074008|12253615|FG002|COMPLETED|Overall Study||6
11071830|NCT01074008|12253616|FG003|COMPLETED|Overall Study||7
11071831|NCT01074008|12253617|FG004|COMPLETED|Overall Study||6
11071832|NCT01074008|12253618|FG005|COMPLETED|Overall Study||7
11071833|NCT01074008|12253619|FG006|COMPLETED|Overall Study||7
11071834|NCT01074008|12253620|FG007|COMPLETED|Overall Study||8
11071835|NCT01074008|12253621|FG008|COMPLETED|Overall Study||7
11071836|NCT01074008|12253613|FG000|NOT COMPLETED|Overall Study||1
11071837|NCT01074008|12253614|FG001|NOT COMPLETED|Overall Study||3
11071838|NCT01074008|12253615|FG002|NOT COMPLETED|Overall Study||2
11071839|NCT01074008|12253616|FG003|NOT COMPLETED|Overall Study||1
11071840|NCT01074008|12253617|FG004|NOT COMPLETED|Overall Study||2
11071841|NCT01074008|12253618|FG005|NOT COMPLETED|Overall Study||0
11071842|NCT01074008|12253619|FG006|NOT COMPLETED|Overall Study||1
11071843|NCT01074008|12253620|FG007|NOT COMPLETED|Overall Study||0
11347089|NCT02989389|12544455|FG005|NOT COMPLETED|Period 2||0
11347090|NCT02989389|12544456|FG006|NOT COMPLETED|Period 2||0
11347091|NCT02989389|12544457|FG007|NOT COMPLETED|Period 2||0
11347092|NCT02989389|12544458|FG008|NOT COMPLETED|Period 2||0
11347093|NCT02989389|12544459|FG009|NOT COMPLETED|Period 2||0
11347094|NCT02989389|12544450|FG000|STARTED|Period 3||3
11347095|NCT02989389|12544451|FG001|STARTED|Period 3||3
11347096|NCT02989389|12544452|FG002|STARTED|Period 3||3
11071844|NCT01074008|12253621|FG008|NOT COMPLETED|Overall Study||4
11071845|NCT01074034|12253650|FG000|STARTED|Overall Study||211
11071846|NCT01074034|12253650|FG000|COMPLETED|Overall Study||205
11071847|NCT01074034|12253650|FG000|NOT COMPLETED|Overall Study||6
11071848|NCT01074047|12253657|FG000|STARTED|Treatment Phase||241
11071849|NCT01074047|12253658|FG001|STARTED|Treatment Phase||247
11071850|NCT01074047|12253657|FG000|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
11071851|NCT01074047|12253658|FG001|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
11071852|NCT01074047|12253657|FG000|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
11071853|NCT01074047|12253658|FG001|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
11071854|NCT01074047|12253657|FG000|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
11071855|NCT01074047|12253658|FG001|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
11071856|NCT01074047|12253657|FG000|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
11347097|NCT02989389|12544453|FG003|STARTED|Period 3||3
11071857|NCT01074047|12253658|FG001|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
11347098|NCT02989389|12544454|FG004|STARTED|Period 3||3
11347099|NCT02989389|12544455|FG005|STARTED|Period 3||3
11347100|NCT02989389|12544456|FG006|STARTED|Period 3||0
11347101|NCT02989389|12544457|FG007|STARTED|Period 3||0
11347102|NCT02989389|12544458|FG008|STARTED|Period 3||0
11347103|NCT02989389|12544459|FG009|STARTED|Period 3||0
11347104|NCT02989389|12544450|FG000|COMPLETED|Period 3||3
11347105|NCT02989389|12544451|FG001|COMPLETED|Period 3||3
11071858|NCT01074047|12253657|FG000|NOT COMPLETED|Treatment Phase||217
11071859|NCT01074047|12253658|FG001|NOT COMPLETED|Treatment Phase||234
11347106|NCT02989389|12544452|FG002|COMPLETED|Period 3||3
11347107|NCT02989389|12544453|FG003|COMPLETED|Period 3||3
11347108|NCT02989389|12544454|FG004|COMPLETED|Period 3||3
11071860|NCT01074047|12253657|FG000|STARTED|Survival Follow-Up Phase||140
11071861|NCT01074047|12253658|FG001|STARTED|Survival Follow-Up Phase||163
11071862|NCT01074047|12253657|FG000|COMPLETED|Survival Follow-Up Phase||16
11071863|NCT01074047|12253658|FG001|COMPLETED|Survival Follow-Up Phase||27
11071864|NCT01074047|12253657|FG000|NOT COMPLETED|Survival Follow-Up Phase||124
11071865|NCT01074047|12253658|FG001|NOT COMPLETED|Survival Follow-Up Phase||136
11071866|NCT01074047|12253657|FG000|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
11071867|NCT01074047|12253658|FG001|STARTED|Extension Phase||0
11071868|NCT01074047|12253657|FG000|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
11071869|NCT01074047|12253658|FG001|Safety Population|Extension Phase||0
11071870|NCT01074047|12253657|FG000|COMPLETED|Extension Phase||0
11071871|NCT01074047|12253658|FG001|COMPLETED|Extension Phase||0
11071872|NCT01074047|12253657|FG000|NOT COMPLETED|Extension Phase||22
11071873|NCT01074047|12253658|FG001|NOT COMPLETED|Extension Phase||0
11071874|NCT01074099|12253673|FG000|STARTED|Overall Study||2
11071875|NCT01074099|12253674|FG001|STARTED|Overall Study||3
11071876|NCT01074099|12253673|FG000|COMPLETED|Overall Study||2
11071877|NCT01074099|12253674|FG001|COMPLETED|Overall Study||3
11071878|NCT01074099|12253673|FG000|NOT COMPLETED|Overall Study||0
11071879|NCT01074099|12253674|FG001|NOT COMPLETED|Overall Study||0
11071880|NCT01074125|12253683|FG000|STARTED|Overall Study||51
11071881|NCT01074125|12253684|FG001|STARTED|Overall Study||52
11071882|NCT01074125|12253685|FG002|STARTED|Overall Study||48
11071883|NCT01074125|12253683|FG000|COMPLETED|Overall Study||39
11071884|NCT01074125|12253684|FG001|COMPLETED|Overall Study||47
11071885|NCT01074125|12253685|FG002|COMPLETED|Overall Study||36
11071886|NCT01074125|12253683|FG000|NOT COMPLETED|Overall Study||12
11071887|NCT01074125|12253684|FG001|NOT COMPLETED|Overall Study||5
11347109|NCT02989389|12544455|FG005|COMPLETED|Period 3||3
11071888|NCT01074125|12253685|FG002|NOT COMPLETED|Overall Study||12
11071889|NCT01074164|12253698|FG000|STARTED|Overall Study||7
11071890|NCT01074164|12253699|FG001|STARTED|Overall Study||8
11071891|NCT01074164|12253698|FG000|COMPLETED|Overall Study||4
11071892|NCT01074164|12253699|FG001|COMPLETED|Overall Study||7
11347110|NCT02989389|12544456|FG006|COMPLETED|Period 3||0
11347111|NCT02989389|12544457|FG007|COMPLETED|Period 3||0
11071893|NCT01074164|12253698|FG000|NOT COMPLETED|Overall Study||3
11071894|NCT01074164|12253699|FG001|NOT COMPLETED|Overall Study||1
11071895|NCT01074177|12253705|FG000|STARTED|Overall Study||24
11071896|NCT01074177|12253705|FG000|COMPLETED|Overall Study||24
11071897|NCT01074177|12253705|FG000|NOT COMPLETED|Overall Study||0
11071898|NCT01074216|12253709|FG000|STARTED|Overall Study||54
11071899|NCT01074216|12253709|FG000|COMPLETED|Overall Study||41
11071900|NCT01074216|12253709|FG000|NOT COMPLETED|Overall Study||13
11071901|NCT01074229|12253716|FG000|STARTED|Overall Study||25
11071902|NCT01074229|12253717|FG001|STARTED|Overall Study||25
11071903|NCT01074229|12253718|FG002|STARTED|Overall Study||25
11071904|NCT01074229|12253716|FG000|COMPLETED|Overall Study||23
11071905|NCT01074229|12253717|FG001|COMPLETED|Overall Study||22
11071906|NCT01074229|12253718|FG002|COMPLETED|Overall Study||21
11347112|NCT02989389|12544458|FG008|COMPLETED|Period 3||0
11347113|NCT02989389|12544459|FG009|COMPLETED|Period 3||0
11347114|NCT02989389|12544450|FG000|NOT COMPLETED|Period 3||0
11347115|NCT02989389|12544451|FG001|NOT COMPLETED|Period 3||0
11347116|NCT02989389|12544452|FG002|NOT COMPLETED|Period 3||0
11071907|NCT01074229|12253716|FG000|NOT COMPLETED|Overall Study||2
11071908|NCT01074229|12253717|FG001|NOT COMPLETED|Overall Study||3
11347117|NCT02989389|12544453|FG003|NOT COMPLETED|Period 3||0
11347118|NCT02989389|12544454|FG004|NOT COMPLETED|Period 3||0
11071909|NCT01074229|12253718|FG002|NOT COMPLETED|Overall Study||4
11071910|NCT01074242|12253728|FG000|STARTED|Overall Study||3798
11071911|NCT01074242|12253728|FG000|Received at Least 1 Dose of Vaccine|Overall Study||3395
11071912|NCT01074242|12253728|FG000|COMPLETED|Overall Study||3395
11071913|NCT01074242|12253728|FG000|NOT COMPLETED|Overall Study||403
11071914|NCT01074255|12253732|FG000|STARTED|Overall Study||3141
11071915|NCT01074255|12253732|FG000|Treated|Overall Study||3139
11071916|NCT01074255|12253732|FG000|COMPLETED|Overall Study||3139
11071917|NCT01074255|12253732|FG000|NOT COMPLETED|Overall Study||2
11071918|NCT01074268|12253738|FG000|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
11071919|NCT01074268|12253739|FG001|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
11071920|NCT01074268|12253738|FG000|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
11071921|NCT01074268|12253739|FG001|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
11071922|NCT01074268|12253738|FG000|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
11071923|NCT01074268|12253739|FG001|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
11071924|NCT01074268|12253738|FG000|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
11071925|NCT01074268|12253739|FG001|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
11071926|NCT01074268|12253738|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
11071927|NCT01074268|12253739|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
11347119|NCT02989389|12544455|FG005|NOT COMPLETED|Period 3||0
11347120|NCT02989389|12544456|FG006|NOT COMPLETED|Period 3||0
11347121|NCT02989389|12544457|FG007|NOT COMPLETED|Period 3||0
11347122|NCT02989389|12544458|FG008|NOT COMPLETED|Period 3||0
11347123|NCT02989389|12544459|FG009|NOT COMPLETED|Period 3||0
11347124|NCT02989493|12544501|FG000|STARTED|Overall Study||29
11347125|NCT02989493|12544502|FG001|STARTED|Overall Study||32
11347126|NCT02989493|12544501|FG000|COMPLETED|Overall Study||29
11347127|NCT02989493|12544502|FG001|COMPLETED|Overall Study||32
11347128|NCT02989493|12544501|FG000|NOT COMPLETED|Overall Study||0
11347129|NCT02989493|12544502|FG001|NOT COMPLETED|Overall Study||0
11347130|NCT02989545|12544508|FG000|STARTED|Control Period - no Intervention||20
11347131|NCT02989545|12544508|FG000|COMPLETED|Control Period - no Intervention||20
11347132|NCT02989545|12544508|FG000|NOT COMPLETED|Control Period - no Intervention||0
11347133|NCT02989545|12544508|FG000|STARTED|Treatment Period - Anal Tape Provided||20
11347134|NCT02989545|12544508|FG000|COMPLETED|Treatment Period - Anal Tape Provided||20
11347135|NCT02989545|12544508|FG000|NOT COMPLETED|Treatment Period - Anal Tape Provided||0
11347136|NCT02989610|12544516|FG000|STARTED|Overall Study||234
11347137|NCT02989610|12544516|FG000|COMPLETED|Overall Study||195
11347138|NCT02989610|12544516|FG000|NOT COMPLETED|Overall Study||39
11347139|NCT02989649|12544520|FG000|STARTED|Overall Study||593
11071928|NCT01074268|12253738|FG000|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
11071929|NCT01074268|12253739|FG001|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
11071930|NCT01074268|12253738|FG000|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
11071931|NCT01074268|12253739|FG001|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
11071932|NCT01074268|12253738|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
11071933|NCT01074268|12253739|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
11071934|NCT01074307|12253747|FG000|STARTED|Overall Study||66
11071935|NCT01074307|12253748|FG001|STARTED|Overall Study||114
11071936|NCT01074307|12253747|FG000|COMPLETED|Overall Study||44
11071937|NCT01074307|12253748|FG001|COMPLETED|Overall Study||102
11071938|NCT01074307|12253747|FG000|NOT COMPLETED|Overall Study||22
11071939|NCT01074307|12253748|FG001|NOT COMPLETED|Overall Study||12
11071940|NCT01074450|12253756|FG000|STARTED|First Intervention||12
11071941|NCT01074450|12253757|FG001|STARTED|First Intervention||12
11071942|NCT01074450|12253756|FG000|COMPLETED|First Intervention||12
11071943|NCT01074450|12253757|FG001|COMPLETED|First Intervention||10
11071944|NCT01074450|12253756|FG000|NOT COMPLETED|First Intervention||0
11071945|NCT01074450|12253757|FG001|NOT COMPLETED|First Intervention||2
11071946|NCT01074450|12253756|FG000|STARTED|Washout of 7 Days||12
11071947|NCT01074450|12253757|FG001|STARTED|Washout of 7 Days||10
11071948|NCT01074450|12253756|FG000|COMPLETED|Washout of 7 Days||12
11071949|NCT01074450|12253757|FG001|COMPLETED|Washout of 7 Days||10
11071950|NCT01074450|12253756|FG000|NOT COMPLETED|Washout of 7 Days||0
11071951|NCT01074450|12253757|FG001|NOT COMPLETED|Washout of 7 Days||0
11071952|NCT01074450|12253756|FG000|STARTED|Second Intervention||12
11206526|NCT01868503|12397568|FG000|STARTED|Overall Study||7
11206527|NCT01868503|12397568|FG000|COMPLETED|Overall Study||5
11206528|NCT01868503|12397568|FG000|NOT COMPLETED|Overall Study||2
11206529|NCT01868542|12397576|FG000|STARTED|Overall Study||23
11206530|NCT01868542|12397577|FG001|STARTED|Overall Study||23
11206531|NCT01868542|12397576|FG000|COMPLETED|Overall Study||23
11071953|NCT01074450|12253757|FG001|STARTED|Second Intervention||10
11071954|NCT01074450|12253756|FG000|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
11071955|NCT01074450|12253757|FG001|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
11071956|NCT01074450|12253756|FG000|NOT COMPLETED|Second Intervention||1
11071957|NCT01074450|12253757|FG001|NOT COMPLETED|Second Intervention||1
11071958|NCT01074463|12253765|FG000|STARTED|First Intervention||12
11071959|NCT01074463|12253766|FG001|STARTED|First Intervention||12
11071960|NCT01074463|12253765|FG000|COMPLETED|First Intervention||12
11071961|NCT01074463|12253766|FG001|COMPLETED|First Intervention||12
11071962|NCT01074463|12253765|FG000|NOT COMPLETED|First Intervention||0
11071963|NCT01074463|12253766|FG001|NOT COMPLETED|First Intervention||0
11071964|NCT01074463|12253765|FG000|STARTED|Washout of 7 Days||12
11071965|NCT01074463|12253766|FG001|STARTED|Washout of 7 Days||12
11071966|NCT01074463|12253765|FG000|COMPLETED|Washout of 7 Days||12
11071967|NCT01074463|12253766|FG001|COMPLETED|Washout of 7 Days||12
11071968|NCT01074463|12253765|FG000|NOT COMPLETED|Washout of 7 Days||0
11071969|NCT01074463|12253766|FG001|NOT COMPLETED|Washout of 7 Days||0
11071970|NCT01074463|12253765|FG000|STARTED|Second Intervention||12
11071971|NCT01074463|12253766|FG001|STARTED|Second Intervention||12
11071972|NCT01074463|12253765|FG000|COMPLETED|Second Intervention||12
11071973|NCT01074463|12253766|FG001|COMPLETED|Second Intervention||12
11071974|NCT01074463|12253765|FG000|NOT COMPLETED|Second Intervention||0
11071975|NCT01074463|12253766|FG001|NOT COMPLETED|Second Intervention||0
11071976|NCT01074554|12253774|FG000|STARTED|Overall Study||14
11071977|NCT01074554|12253775|FG001|STARTED|Overall Study||15
11071978|NCT01074554|12253774|FG000|COMPLETED|Overall Study||11
11071979|NCT01074554|12253775|FG001|COMPLETED|Overall Study||11
11071980|NCT01074554|12253774|FG000|NOT COMPLETED|Overall Study||3
11071981|NCT01074554|12253775|FG001|NOT COMPLETED|Overall Study||4
11071982|NCT01074658|12253781|FG000|STARTED|Overall Study||1015
11071983|NCT01074658|12253781|FG000|Attempted Implant|Overall Study||996
11071984|NCT01074658|12253781|FG000|COMPLETED|Overall Study||996
11071985|NCT01074658|12253781|FG000|NOT COMPLETED|Overall Study||19
11071986|NCT01074931|12253785|FG000|STARTED|Overall Study||98
11206532|NCT01868542|12397577|FG001|COMPLETED|Overall Study||21
11206533|NCT01868542|12397576|FG000|NOT COMPLETED|Overall Study||0
11206534|NCT01868542|12397577|FG001|NOT COMPLETED|Overall Study||2
11206535|NCT01868594|12397585|FG000|STARTED|Overall Study||76
11071987|NCT01074931|12253785|FG000|COMPLETED|Overall Study||92
11071988|NCT01074931|12253785|FG000|NOT COMPLETED|Overall Study||6
11071989|NCT01074944|12253793|FG000|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
11071990|NCT01074944|12253794|FG001|STARTED|Lead-in Period (up to 78 Weeks)||0
11071991|NCT01074944|12253795|FG002|STARTED|Lead-in Period (up to 78 Weeks)||0
11071992|NCT01074944|12253796|FG003|STARTED|Lead-in Period (up to 78 Weeks)||0
11206536|NCT01868594|12397586|FG001|STARTED|Overall Study||75
11206537|NCT01868594|12397585|FG000|COMPLETED|Overall Study||72
11206538|NCT01868594|12397586|FG001|COMPLETED|Overall Study||72
11206539|NCT01868594|12397585|FG000|NOT COMPLETED|Overall Study||4
11206540|NCT01868594|12397586|FG001|NOT COMPLETED|Overall Study||3
11206541|NCT01868633|12397596|FG000|STARTED|Overall Study||26
11206542|NCT01868633|12397597|FG001|STARTED|Overall Study||26
11206543|NCT01868633|12397596|FG000|COMPLETED|Overall Study||26
11206544|NCT01868633|12397597|FG001|COMPLETED|Overall Study||26
11071993|NCT01074944|12253797|FG004|STARTED|Lead-in Period (up to 78 Weeks)||0
11071994|NCT01074944|12253793|FG000|COMPLETED|Lead-in Period (up to 78 Weeks)||157
11071995|NCT01074944|12253794|FG001|COMPLETED|Lead-in Period (up to 78 Weeks)||0
11071996|NCT01074944|12253795|FG002|COMPLETED|Lead-in Period (up to 78 Weeks)||0
11071997|NCT01074944|12253796|FG003|COMPLETED|Lead-in Period (up to 78 Weeks)||0
11071998|NCT01074944|12253797|FG004|COMPLETED|Lead-in Period (up to 78 Weeks)||0
11071999|NCT01074944|12253793|FG000|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
11072000|NCT01074944|12253794|FG001|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
11072001|NCT01074944|12253795|FG002|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
11072002|NCT01074944|12253796|FG003|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
11072003|NCT01074944|12253797|FG004|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
11072004|NCT01074944|12253793|FG000|STARTED|Primary Analysis Period (up to 52 Weeks)||0
11072005|NCT01074944|12253794|FG001|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
11072006|NCT01074944|12253795|FG002|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
11072007|NCT01074944|12253796|FG003|STARTED|Primary Analysis Period (up to 52 Weeks)||0
11072008|NCT01074944|12253797|FG004|STARTED|Primary Analysis Period (up to 52 Weeks)||0
11072009|NCT01074944|12253793|FG000|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
11072010|NCT01074944|12253794|FG001|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
11072011|NCT01074944|12253795|FG002|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
11072012|NCT01074944|12253796|FG003|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
11072013|NCT01074944|12253797|FG004|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
11072014|NCT01074944|12253793|FG000|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
11072015|NCT01074944|12253794|FG001|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
11072016|NCT01074944|12253795|FG002|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
11072017|NCT01074944|12253796|FG003|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
11072018|NCT01074944|12253797|FG004|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
11072019|NCT01074944|12253793|FG000|STARTED|Long Term Treatment||0
11206545|NCT01868633|12397596|FG000|NOT COMPLETED|Overall Study||0
11206546|NCT01868633|12397597|FG001|NOT COMPLETED|Overall Study||0
11206547|NCT01868646|12397605|FG000|STARTED|Overall Study||76
11206548|NCT01868646|12397606|FG001|STARTED|Overall Study||72
11206549|NCT01868646|12397605|FG000|COMPLETED|Overall Study||73
11206550|NCT01868646|12397606|FG001|COMPLETED|Overall Study||67
11206551|NCT01868646|12397605|FG000|NOT COMPLETED|Overall Study||3
11206552|NCT01868646|12397606|FG001|NOT COMPLETED|Overall Study||5
11206553|NCT01868776|12397614|FG000|STARTED|Overall Study||50
11206554|NCT01868776|12397615|FG001|STARTED|Overall Study||50
11206555|NCT01868776|12397614|FG000|COMPLETED|Overall Study||50
11206556|NCT01868776|12397615|FG001|COMPLETED|Overall Study||50
11347140|NCT02989649|12544520|FG000|Started But Not Treated|Overall Study||84
11347141|NCT02989649|12544520|FG000|Eligible to Enter Into Treatment Period|Overall Study||509
11347142|NCT02989649|12544520|FG000|COMPLETED|Overall Study||173
11347143|NCT02989649|12544520|FG000|NOT COMPLETED|Overall Study||420
11347144|NCT02989714|12544524|FG000|STARTED|Overall Study||13
11347145|NCT02989714|12544524|FG000|Started Nivolumab|Overall Study||12
11347146|NCT02989714|12544524|FG000|COMPLETED|Overall Study||12
11347147|NCT02989714|12544524|FG000|NOT COMPLETED|Overall Study||1
11347148|NCT02989727|12544533|FG000|STARTED|Overall Study||46
11347149|NCT02989727|12544534|FG001|STARTED|Overall Study||44
11347150|NCT02989727|12544535|FG002|STARTED|Overall Study||30
11347151|NCT02989727|12544536|FG003|STARTED|Overall Study||30
11347152|NCT02989727|12544533|FG000|COMPLETED|Overall Study||46
11347153|NCT02989727|12544534|FG001|COMPLETED|Overall Study||44
11347154|NCT02989727|12544535|FG002|COMPLETED|Overall Study||30
11347155|NCT02989727|12544536|FG003|COMPLETED|Overall Study||30
11347156|NCT02989727|12544533|FG000|NOT COMPLETED|Overall Study||0
11347157|NCT02989727|12544534|FG001|NOT COMPLETED|Overall Study||0
11347158|NCT02989727|12544535|FG002|NOT COMPLETED|Overall Study||0
11347159|NCT02989727|12544536|FG003|NOT COMPLETED|Overall Study||0
11347160|NCT02989805|12544546|FG000|STARTED|Overall Study||160
11072020|NCT01074944|12253794|FG001|STARTED|Long Term Treatment||0
11072021|NCT01074944|12253795|FG002|STARTED|Long Term Treatment||0
11072022|NCT01074944|12253796|FG003|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
11072023|NCT01074944|12253797|FG004|STARTED|Long Term Treatment||0
11072024|NCT01074944|12253793|FG000|COMPLETED|Long Term Treatment||0
11072025|NCT01074944|12253794|FG001|COMPLETED|Long Term Treatment||0
11347161|NCT02989805|12544547|FG001|STARTED|Overall Study||166
11347162|NCT02989805|12544546|FG000|COMPLETED|Overall Study||154
11347163|NCT02989805|12544547|FG001|COMPLETED|Overall Study||162
11347164|NCT02989805|12544546|FG000|NOT COMPLETED|Overall Study||6
11347165|NCT02989805|12544547|FG001|NOT COMPLETED|Overall Study||4
11072026|NCT01074944|12253795|FG002|COMPLETED|Long Term Treatment||0
11072027|NCT01074944|12253796|FG003|COMPLETED|Long Term Treatment||95
11072028|NCT01074944|12253797|FG004|COMPLETED|Long Term Treatment||0
11072029|NCT01074944|12253793|FG000|NOT COMPLETED|Long Term Treatment||0
11072030|NCT01074944|12253794|FG001|NOT COMPLETED|Long Term Treatment||0
11072031|NCT01074944|12253795|FG002|NOT COMPLETED|Long Term Treatment||0
11072032|NCT01074944|12253796|FG003|NOT COMPLETED|Long Term Treatment||26
11072033|NCT01074944|12253797|FG004|NOT COMPLETED|Long Term Treatment||0
11072034|NCT01074944|12253793|FG000|STARTED|Extended Treatment (up to 42 Months)||0
11072035|NCT01074944|12253794|FG001|STARTED|Extended Treatment (up to 42 Months)||0
11072036|NCT01074944|12253795|FG002|STARTED|Extended Treatment (up to 42 Months)||0
11072037|NCT01074944|12253796|FG003|STARTED|Extended Treatment (up to 42 Months)||0
11072038|NCT01074944|12253797|FG004|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
11072039|NCT01074944|12253793|FG000|COMPLETED|Extended Treatment (up to 42 Months)||0
11072040|NCT01074944|12253794|FG001|COMPLETED|Extended Treatment (up to 42 Months)||0
11072041|NCT01074944|12253795|FG002|COMPLETED|Extended Treatment (up to 42 Months)||0
11072042|NCT01074944|12253796|FG003|COMPLETED|Extended Treatment (up to 42 Months)||0
11072043|NCT01074944|12253797|FG004|COMPLETED|Extended Treatment (up to 42 Months)||20
11072044|NCT01074944|12253793|FG000|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
11072045|NCT01074944|12253794|FG001|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
11072046|NCT01074944|12253795|FG002|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
11072047|NCT01074944|12253796|FG003|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
11072048|NCT01074944|12253797|FG004|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
11072049|NCT01075048|12253808|FG000|STARTED|Overall Study||9
11072050|NCT01075048|12253809|FG001|STARTED|Overall Study||60
11206557|NCT01868776|12397614|FG000|NOT COMPLETED|Overall Study||0
11206558|NCT01868776|12397615|FG001|NOT COMPLETED|Overall Study||0
11206559|NCT01868789|12397623|FG000|STARTED|Overall Study||9
11206560|NCT01868789|12397624|FG001|STARTED|Overall Study||14
11206561|NCT01868789|12397623|FG000|COMPLETED|Overall Study||7
11206562|NCT01868789|12397624|FG001|COMPLETED|Overall Study||12
11206563|NCT01868789|12397623|FG000|NOT COMPLETED|Overall Study||2
11206564|NCT01868789|12397624|FG001|NOT COMPLETED|Overall Study||2
11206565|NCT01868893|12397630|FG000|STARTED|Overall Study||20
11206566|NCT01868893|12397630|FG000|COMPLETED|Overall Study||0
11206567|NCT01868893|12397630|FG000|NOT COMPLETED|Overall Study||20
11206568|NCT01868997|12397638|FG000|STARTED|Overall Study|randomized and treated|45
11072051|NCT01075048|12253810|FG002|STARTED|Overall Study||62
11072052|NCT01075048|12253808|FG000|Did Not Receive Treatment|Overall Study||0
11072053|NCT01075048|12253809|FG001|Did Not Receive Treatment|Overall Study||1
11072054|NCT01075048|12253810|FG002|Did Not Receive Treatment|Overall Study||0
11072055|NCT01075048|12253808|FG000|COMPLETED|Overall Study||0
11072056|NCT01075048|12253809|FG001|COMPLETED|Overall Study||0
11072057|NCT01075048|12253810|FG002|COMPLETED|Overall Study||0
11072058|NCT01075048|12253808|FG000|NOT COMPLETED|Overall Study||9
11072059|NCT01075048|12253809|FG001|NOT COMPLETED|Overall Study||60
11072060|NCT01075048|12253810|FG002|NOT COMPLETED|Overall Study||62
11072061|NCT01075074|12253824|FG000|STARTED|Overall Study||25
11072062|NCT01075074|12253825|FG001|STARTED|Overall Study||25
11072063|NCT01075074|12253826|FG002|STARTED|Overall Study||25
11072064|NCT01075074|12253824|FG000|COMPLETED|Overall Study||24
11072065|NCT01075074|12253825|FG001|COMPLETED|Overall Study||23
11072066|NCT01075074|12253826|FG002|COMPLETED|Overall Study||23
11072067|NCT01075074|12253824|FG000|NOT COMPLETED|Overall Study||1
11072068|NCT01075074|12253825|FG001|NOT COMPLETED|Overall Study||2
11072069|NCT01075074|12253826|FG002|NOT COMPLETED|Overall Study||2
11072070|NCT01075087|12253840|FG000|STARTED|Overall Study||9
11072071|NCT01075087|12253841|FG001|STARTED|Overall Study||10
11072072|NCT01075087|12253840|FG000|COMPLETED|Overall Study||9
11072073|NCT01075087|12253841|FG001|COMPLETED|Overall Study||10
11072074|NCT01075087|12253840|FG000|NOT COMPLETED|Overall Study||0
11072075|NCT01075087|12253841|FG001|NOT COMPLETED|Overall Study||0
11072076|NCT01075100|12253849|FG000|STARTED|Overall Study||49
11072077|NCT01075100|12253850|FG001|STARTED|Overall Study||54
11072078|NCT01075100|12253849|FG000|COMPLETED|Overall Study||0
11072079|NCT01075100|12253850|FG001|COMPLETED|Overall Study||1
11072080|NCT01075100|12253849|FG000|NOT COMPLETED|Overall Study||49
11072081|NCT01075100|12253850|FG001|NOT COMPLETED|Overall Study||53
11072082|NCT01075152|12253860|FG000|STARTED|Overall Study|randomized|88
11072083|NCT01075152|12253861|FG001|STARTED|Overall Study|randomized|89
11072084|NCT01075152|12253860|FG000|COMPLETED|Overall Study||87
11072085|NCT01075152|12253861|FG001|COMPLETED|Overall Study||89
11072086|NCT01075152|12253860|FG000|NOT COMPLETED|Overall Study||1
11072087|NCT01075152|12253861|FG001|NOT COMPLETED|Overall Study||0
11072088|NCT01075178|12253871|FG000|STARTED|Subject Matching|eligible for matching|1148
11072089|NCT01075178|12253872|FG001|STARTED|Subject Matching|eligible for matching|1421
11072090|NCT01075178|12253871|FG000|COMPLETED|Subject Matching|subjects matched|1018
11072091|NCT01075178|12253872|FG001|COMPLETED|Subject Matching|subjects matched|1018
11072092|NCT01075178|12253871|FG000|NOT COMPLETED|Subject Matching||130
11072093|NCT01075178|12253872|FG001|NOT COMPLETED|Subject Matching||403
11072094|NCT01075178|12253871|FG000|STARTED|Subject Chart Review|subjects matched|1018
11072095|NCT01075178|12253872|FG001|STARTED|Subject Chart Review|subjects matched|1018
11072096|NCT01075178|12253871|FG000|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
11072097|NCT01075178|12253872|FG001|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
11072098|NCT01075178|12253871|FG000|NOT COMPLETED|Subject Chart Review||9
11072099|NCT01075178|12253872|FG001|NOT COMPLETED|Subject Chart Review||9
11072100|NCT01075191|12253878|FG000|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
11072101|NCT01075191|12253878|FG000|Discontinued Year 1|Overall Study||7
11072102|NCT01075191|12253878|FG000|Discontinued Year 2|Overall Study||6
11072103|NCT01075191|12253878|FG000|Discontinued Year 3|Overall Study||5
11072104|NCT01075191|12253878|FG000|COMPLETED|Overall Study||42
11072105|NCT01075191|12253878|FG000|NOT COMPLETED|Overall Study||18
11072106|NCT01075204|12253882|FG000|STARTED|Overall Study||335
11072107|NCT01075204|12253882|FG000|COMPLETED|Overall Study||335
11072108|NCT01075204|12253882|FG000|NOT COMPLETED|Overall Study||0
11072109|NCT01075217|12253888|FG000|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
11072110|NCT01075217|12253889|FG001|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
11072111|NCT01075217|12253888|FG000|COMPLETED|Overall Study||82
11072112|NCT01075217|12253889|FG001|COMPLETED|Overall Study||84
11072113|NCT01075217|12253888|FG000|NOT COMPLETED|Overall Study||2
11072114|NCT01075217|12253889|FG001|NOT COMPLETED|Overall Study||1
11072115|NCT01075243|12253906|FG000|STARTED|Overall Study||163
11072116|NCT01075243|12253907|FG001|STARTED|Overall Study||158
11072117|NCT01075243|12253908|FG002|STARTED|Overall Study||80
11072118|NCT01075243|12253906|FG000|COMPLETED|Overall Study||157
11072119|NCT01075243|12253907|FG001|COMPLETED|Overall Study||155
11072120|NCT01075243|12253908|FG002|COMPLETED|Overall Study||80
11072121|NCT01075243|12253906|FG000|NOT COMPLETED|Overall Study||6
11072122|NCT01075243|12253907|FG001|NOT COMPLETED|Overall Study||3
11072123|NCT01075243|12253908|FG002|NOT COMPLETED|Overall Study||0
11072124|NCT01075256|12253921|FG000|STARTED|Overall Study||64
11072125|NCT01075256|12253922|FG001|STARTED|Overall Study||66
11072126|NCT01075256|12253923|FG002|STARTED|Overall Study||65
11072127|NCT01075256|12253921|FG000|COMPLETED|Overall Study||63
11072128|NCT01075256|12253922|FG001|COMPLETED|Overall Study||66
11072129|NCT01075256|12253923|FG002|COMPLETED|Overall Study||65
11072130|NCT01075256|12253921|FG000|NOT COMPLETED|Overall Study||1
11072131|NCT01075256|12253922|FG001|NOT COMPLETED|Overall Study||0
11072132|NCT01075256|12253923|FG002|NOT COMPLETED|Overall Study||0
11072133|NCT01075282|12253939|FG000|STARTED|Overall Study||273
11072134|NCT01075282|12253940|FG001|STARTED|Overall Study||272
11072135|NCT01075282|12253941|FG002|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
11072136|NCT01075282|12253939|FG000|Received at Least One Dose of Study Drug|Overall Study||273
11072137|NCT01075282|12253940|FG001|Received at Least One Dose of Study Drug|Overall Study||272
11072138|NCT01075282|12253941|FG002|Received at Least One Dose of Study Drug|Overall Study||262
11072139|NCT01075282|12253939|FG000|COMPLETED|Overall Study||242
11072140|NCT01075282|12253940|FG001|COMPLETED|Overall Study||243
11072141|NCT01075282|12253941|FG002|COMPLETED|Overall Study||238
11072142|NCT01075282|12253939|FG000|NOT COMPLETED|Overall Study||31
11072143|NCT01075282|12253940|FG001|NOT COMPLETED|Overall Study||29
11072144|NCT01075282|12253941|FG002|NOT COMPLETED|Overall Study||27
11072145|NCT01075321|12253950|FG000|STARTED|Overall Study||7
11072146|NCT01075321|12253951|FG001|STARTED|Overall Study||9
11072147|NCT01075321|12253952|FG002|STARTED|Overall Study||9
11072148|NCT01075321|12253953|FG003|STARTED|Overall Study||33
11072149|NCT01075321|12253950|FG000|COMPLETED|Overall Study||6
11072150|NCT01075321|12253951|FG001|COMPLETED|Overall Study||9
11072151|NCT01075321|12253952|FG002|COMPLETED|Overall Study||7
11072152|NCT01075321|12253953|FG003|COMPLETED|Overall Study||31
11072153|NCT01075321|12253950|FG000|NOT COMPLETED|Overall Study||1
11072154|NCT01075321|12253951|FG001|NOT COMPLETED|Overall Study||0
11072155|NCT01075321|12253952|FG002|NOT COMPLETED|Overall Study||2
11072156|NCT01075321|12253953|FG003|NOT COMPLETED|Overall Study||2
11072157|NCT01075347|12253967|FG000|STARTED|Overall Study||82
11072158|NCT01075347|12253968|FG001|STARTED|Overall Study||83
11072159|NCT01075347|12253967|FG000|COMPLETED|Overall Study||82
11072160|NCT01075347|12253968|FG001|COMPLETED|Overall Study||83
11072161|NCT01075347|12253967|FG000|NOT COMPLETED|Overall Study||0
11072162|NCT01075347|12253968|FG001|NOT COMPLETED|Overall Study||0
11072163|NCT01075399|12253974|FG000|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
11072164|NCT01075399|12253974|FG000|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
11072165|NCT01075399|12253974|FG000|NOT COMPLETED|Overall Study||8
11072166|NCT01075412|12253980|FG000|STARTED|Overall Study||4
11072167|NCT01075412|12253981|FG001|STARTED|Overall Study||2
11072168|NCT01075412|12253980|FG000|COMPLETED|Overall Study||4
11072169|NCT01075412|12253981|FG001|COMPLETED|Overall Study||1
11072170|NCT01075412|12253980|FG000|NOT COMPLETED|Overall Study||0
11072171|NCT01075412|12253981|FG001|NOT COMPLETED|Overall Study||1
11072172|NCT01075516|12253988|FG000|STARTED|Overall Study||107
11072173|NCT01075516|12253989|FG001|STARTED|Overall Study||102
11072174|NCT01075516|12253988|FG000|COMPLETED|Overall Study||89
11072175|NCT01075516|12253989|FG001|COMPLETED|Overall Study||86
11072176|NCT01075516|12253988|FG000|NOT COMPLETED|Overall Study||18
11072177|NCT01075516|12253989|FG001|NOT COMPLETED|Overall Study||16
11072178|NCT01075646|12253999|FG000|STARTED|Overall Study||33
11072179|NCT01075646|12254000|FG001|STARTED|Overall Study||34
11072180|NCT01075646|12254001|FG002|STARTED|Overall Study||53
11072181|NCT01075646|12254002|FG003|STARTED|Overall Study||46
11072182|NCT01075646|12253999|FG000|COMPLETED|Overall Study||29
11072183|NCT01075646|12254000|FG001|COMPLETED|Overall Study||31
11072184|NCT01075646|12254001|FG002|COMPLETED|Overall Study||52
11072185|NCT01075646|12254002|FG003|COMPLETED|Overall Study||44
11072186|NCT01075646|12253999|FG000|NOT COMPLETED|Overall Study||4
11072187|NCT01075646|12254000|FG001|NOT COMPLETED|Overall Study||3
11072188|NCT01075646|12254001|FG002|NOT COMPLETED|Overall Study||1
11072189|NCT01075646|12254002|FG003|NOT COMPLETED|Overall Study||2
11072190|NCT01075685|12254014|FG000|STARTED|Overall Study||743
11072191|NCT01075685|12254015|FG001|STARTED|Overall Study||414
11072192|NCT01075685|12254014|FG000|Met Inclusion Criteria|Overall Study||734
11072193|NCT01075685|12254015|FG001|Met Inclusion Criteria|Overall Study||413
11072194|NCT01075685|12254014|FG000|Completed Baseline Measures|Overall Study||225
11072195|NCT01075685|12254015|FG001|Completed Baseline Measures|Overall Study||263
11072196|NCT01075685|12254014|FG000|COMPLETED|Overall Study||151
11072197|NCT01075685|12254015|FG001|COMPLETED|Overall Study||188
11072198|NCT01075685|12254014|FG000|NOT COMPLETED|Overall Study||592
11072199|NCT01075685|12254015|FG001|NOT COMPLETED|Overall Study||226
11072200|NCT01075763|12254023|FG000|STARTED|Overall Study||23
11072201|NCT01075763|12254024|FG001|STARTED|Overall Study||19
11072202|NCT01075763|12254023|FG000|COMPLETED|Overall Study||19
11072203|NCT01075763|12254024|FG001|COMPLETED|Overall Study||15
11072204|NCT01075763|12254023|FG000|NOT COMPLETED|Overall Study||4
11072205|NCT01075763|12254024|FG001|NOT COMPLETED|Overall Study||4
11072206|NCT01075815|12254032|FG000|STARTED|Overall Study|Number of participants treated.|40
11072207|NCT01075815|12254033|FG001|STARTED|Overall Study|Number of participants treated.|35
11072208|NCT01075815|12254032|FG000|COMPLETED|Overall Study||30
11072209|NCT01075815|12254033|FG001|COMPLETED|Overall Study||31
11072210|NCT01075815|12254032|FG000|NOT COMPLETED|Overall Study||10
11072211|NCT01075815|12254033|FG001|NOT COMPLETED|Overall Study||4
11072212|NCT01075958|12254039|FG000|STARTED|Overall Study||283
11072213|NCT01075958|12254039|FG000|COMPLETED|Overall Study||239
11072214|NCT01075958|12254039|FG000|NOT COMPLETED|Overall Study||44
11072215|NCT01075971|12254043|FG000|STARTED|Overall Study||52
11072216|NCT01075971|12254043|FG000|COMPLETED|Overall Study||52
11072217|NCT01075971|12254043|FG000|NOT COMPLETED|Overall Study||0
11072218|NCT01075984|12254052|FG000|STARTED|Treatment Phase||10
11072219|NCT01075984|12254053|FG001|STARTED|Treatment Phase||11
11072220|NCT01075984|12254054|FG002|STARTED|Treatment Phase||21
11072221|NCT01075984|12254055|FG003|STARTED|Treatment Phase||24
11072222|NCT01075984|12254056|FG004|STARTED|Treatment Phase||213
11072223|NCT01075984|12254052|FG000|COMPLETED|Treatment Phase||10
11072224|NCT01075984|12254053|FG001|COMPLETED|Treatment Phase||10
11072225|NCT01075984|12254054|FG002|COMPLETED|Treatment Phase||14
11072226|NCT01075984|12254055|FG003|COMPLETED|Treatment Phase||17
11072227|NCT01075984|12254056|FG004|COMPLETED|Treatment Phase||153
11072228|NCT01075984|12254052|FG000|NOT COMPLETED|Treatment Phase||0
11072229|NCT01075984|12254053|FG001|NOT COMPLETED|Treatment Phase||1
11072230|NCT01075984|12254054|FG002|NOT COMPLETED|Treatment Phase||7
11072231|NCT01075984|12254055|FG003|NOT COMPLETED|Treatment Phase||7
11072232|NCT01075984|12254056|FG004|NOT COMPLETED|Treatment Phase||60
11072233|NCT01075984|12254052|FG000|STARTED|Follow-up Phase||10
11072234|NCT01075984|12254053|FG001|STARTED|Follow-up Phase||10
11072235|NCT01075984|12254054|FG002|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
11072236|NCT01075984|12254055|FG003|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
11072237|NCT01075984|12254056|FG004|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
11072238|NCT01075984|12254052|FG000|COMPLETED|Follow-up Phase||10
11072239|NCT01075984|12254053|FG001|COMPLETED|Follow-up Phase||10
11072240|NCT01075984|12254054|FG002|COMPLETED|Follow-up Phase||19
11072241|NCT01075984|12254055|FG003|COMPLETED|Follow-up Phase||19
11072242|NCT01075984|12254056|FG004|COMPLETED|Follow-up Phase||165
11072243|NCT01075984|12254052|FG000|NOT COMPLETED|Follow-up Phase||0
11072244|NCT01075984|12254053|FG001|NOT COMPLETED|Follow-up Phase||0
11072245|NCT01075984|12254054|FG002|NOT COMPLETED|Follow-up Phase||1
11072246|NCT01075984|12254055|FG003|NOT COMPLETED|Follow-up Phase||2
11072247|NCT01075984|12254056|FG004|NOT COMPLETED|Follow-up Phase||47
11072248|NCT01076010|12254071|FG000|STARTED|Overall Study||161
11072249|NCT01076010|12254072|FG001|STARTED|Overall Study||88
11072250|NCT01076010|12254073|FG002|STARTED|Overall Study||28
11072251|NCT01076010|12254071|FG000|COMPLETED|Overall Study||36
11072252|NCT01076010|12254072|FG001|COMPLETED|Overall Study||49
11072253|NCT01076010|12254073|FG002|COMPLETED|Overall Study||26
11072254|NCT01076010|12254071|FG000|NOT COMPLETED|Overall Study||125
11072255|NCT01076010|12254072|FG001|NOT COMPLETED|Overall Study||39
11072256|NCT01076010|12254073|FG002|NOT COMPLETED|Overall Study||2
11072257|NCT01076036|12254081|FG000|STARTED|Overall Study||10
11072258|NCT01076036|12254081|FG000|# of Procedures|Overall Study||8
11072259|NCT01076036|12254081|FG000|Complete CorPath Procedures|Overall Study||8
11072260|NCT01076036|12254081|FG000|COMPLETED|Overall Study||8
11072261|NCT01076036|12254081|FG000|NOT COMPLETED|Overall Study||2
11072262|NCT01076049|12254088|FG000|STARTED|Overall Study||52
11072263|NCT01076049|12254089|FG001|STARTED|Overall Study||55
11072264|NCT01076049|12254090|FG002|STARTED|Overall Study||1
11072265|NCT01076049|12254088|FG000|COMPLETED|Overall Study||45
11072266|NCT01076049|12254089|FG001|COMPLETED|Overall Study||52
11072267|NCT01076049|12254090|FG002|COMPLETED|Overall Study||1
11072268|NCT01076049|12254088|FG000|NOT COMPLETED|Overall Study||7
11072269|NCT01076049|12254089|FG001|NOT COMPLETED|Overall Study||3
11072270|NCT01076049|12254090|FG002|NOT COMPLETED|Overall Study||0
11072271|NCT01076075|12254102|FG000|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
11072272|NCT01076075|12254103|FG001|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
11072273|NCT01076075|12254102|FG000|Completed Phase A|Overall Study||199
11072274|NCT01076075|12254103|FG001|Completed Phase A|Overall Study||189
11072275|NCT01076075|12254102|FG000|COMPLETED|Overall Study||172
11072276|NCT01076075|12254103|FG001|COMPLETED|Overall Study||167
11072277|NCT01076075|12254102|FG000|NOT COMPLETED|Overall Study||41
11072278|NCT01076075|12254103|FG001|NOT COMPLETED|Overall Study||47
11072279|NCT01076088|12254118|FG000|STARTED|Overall Study||122
11072280|NCT01076088|12254119|FG001|STARTED|Overall Study||125
11072281|NCT01076088|12254120|FG002|STARTED|Overall Study||126
11072282|NCT01076088|12254121|FG003|STARTED|Overall Study||124
11072283|NCT01076088|12254122|FG004|STARTED|Overall Study||120
11072284|NCT01076088|12254123|FG005|STARTED|Overall Study||127
11072285|NCT01076088|12254118|FG000|COMPLETED|Overall Study||111
11072286|NCT01076088|12254119|FG001|COMPLETED|Overall Study||107
11072287|NCT01076088|12254120|FG002|COMPLETED|Overall Study||109
11072288|NCT01076088|12254121|FG003|COMPLETED|Overall Study||109
11072289|NCT01076088|12254122|FG004|COMPLETED|Overall Study||104
11072290|NCT01076088|12254123|FG005|COMPLETED|Overall Study||104
11072291|NCT01076088|12254118|FG000|NOT COMPLETED|Overall Study||11
11072292|NCT01076088|12254119|FG001|NOT COMPLETED|Overall Study||18
11072293|NCT01076088|12254120|FG002|NOT COMPLETED|Overall Study||17
11072294|NCT01076088|12254121|FG003|NOT COMPLETED|Overall Study||15
11072295|NCT01076088|12254122|FG004|NOT COMPLETED|Overall Study||16
11072296|NCT01076088|12254123|FG005|NOT COMPLETED|Overall Study||23
11072297|NCT01076153|12254138|FG000|STARTED|Overall Study||760
11072298|NCT01076153|12254138|FG000|COMPLETED|Overall Study||749
11072299|NCT01076153|12254138|FG000|NOT COMPLETED|Overall Study||11
11072300|NCT01076166|12254146|FG000|STARTED|Overall Study||337
11072301|NCT01076166|12254146|FG000|COMPLETED|Overall Study||328
11072302|NCT01076166|12254146|FG000|NOT COMPLETED|Overall Study||9
11072303|NCT01076179|12254153|FG000|STARTED|Overall Study||502
11072304|NCT01076179|12254153|FG000|COMPLETED|Overall Study||501
11072305|NCT01076179|12254153|FG000|NOT COMPLETED|Overall Study||1
11072306|NCT01076192|12254158|FG000|STARTED|Overall Study||547
11072307|NCT01076192|12254158|FG000|COMPLETED|Overall Study||350
11072308|NCT01076192|12254158|FG000|NOT COMPLETED|Overall Study||197
11072309|NCT01076205|12254163|FG000|STARTED|Overall Study||7229
11072310|NCT01076205|12254163|FG000|COMPLETED|Overall Study||1210
11072311|NCT01076205|12254163|FG000|NOT COMPLETED|Overall Study||6019
11072312|NCT01076231|12254183|FG000|STARTED|Overall Study||34
11072313|NCT01076231|12254183|FG000|COMPLETED|Overall Study||0
11072314|NCT01076231|12254183|FG000|NOT COMPLETED|Overall Study||34
11072315|NCT01076244|12254187|FG000|STARTED|Overall Study||46
11072316|NCT01076244|12254187|FG000|COMPLETED|Overall Study||42
11072317|NCT01076244|12254187|FG000|NOT COMPLETED|Overall Study||4
11072318|NCT01076270|12254191|FG000|STARTED|Overall Study||1
11072319|NCT01076270|12254191|FG000|COMPLETED|Overall Study||1
11072320|NCT01076270|12254191|FG000|NOT COMPLETED|Overall Study||0
11072321|NCT01076283|12254197|FG000|STARTED|Overall Study||7
11072322|NCT01076283|12254198|FG001|STARTED|Overall Study||7
11072323|NCT01076283|12254197|FG000|COMPLETED|Overall Study||6
11072324|NCT01076283|12254198|FG001|COMPLETED|Overall Study||7
11072325|NCT01076283|12254197|FG000|NOT COMPLETED|Overall Study||1
11072326|NCT01076283|12254198|FG001|NOT COMPLETED|Overall Study||0
11072327|NCT01076296|12254204|FG000|STARTED|Overall Study||54
11072328|NCT01076296|12254205|FG001|STARTED|Overall Study||196
11072329|NCT01076296|12254206|FG002|STARTED|Overall Study||51
11072330|NCT01076296|12254207|FG003|STARTED|Overall Study||199
11072331|NCT01076296|12254208|FG004|STARTED|Overall Study||59
11072332|NCT01076296|12254209|FG005|STARTED|Overall Study||191
11072333|NCT01076296|12254210|FG006|STARTED|Overall Study||51
11072334|NCT01076296|12254211|FG007|STARTED|Overall Study||199
11072335|NCT01076296|12254204|FG000|COMPLETED|Overall Study||54
11072336|NCT01076296|12254205|FG001|COMPLETED|Overall Study||196
11072337|NCT01076296|12254206|FG002|COMPLETED|Overall Study||51
11072338|NCT01076296|12254207|FG003|COMPLETED|Overall Study||199
11072339|NCT01076296|12254208|FG004|COMPLETED|Overall Study||59
11072340|NCT01076296|12254209|FG005|COMPLETED|Overall Study||191
11072341|NCT01076296|12254210|FG006|COMPLETED|Overall Study||51
11072342|NCT01076296|12254211|FG007|COMPLETED|Overall Study||199
11072343|NCT01076296|12254204|FG000|NOT COMPLETED|Overall Study||0
11072344|NCT01076296|12254205|FG001|NOT COMPLETED|Overall Study||0
11072345|NCT01076296|12254206|FG002|NOT COMPLETED|Overall Study||0
11072346|NCT01076296|12254207|FG003|NOT COMPLETED|Overall Study||0
11072347|NCT01076296|12254208|FG004|NOT COMPLETED|Overall Study||0
11072348|NCT01076296|12254209|FG005|NOT COMPLETED|Overall Study||0
11072349|NCT01076296|12254210|FG006|NOT COMPLETED|Overall Study||0
11072350|NCT01076296|12254211|FG007|NOT COMPLETED|Overall Study||0
11072351|NCT01076335|12254229|FG000|STARTED|Overall Study||40
11072352|NCT01076335|12254229|FG000|COMPLETED|Overall Study||36
11072353|NCT01076335|12254229|FG000|NOT COMPLETED|Overall Study||4
11072354|NCT01076348|12254233|FG000|STARTED|Overall Study||73
11072355|NCT01076348|12254233|FG000|COMPLETED|Overall Study||51
11072356|NCT01076348|12254233|FG000|NOT COMPLETED|Overall Study||22
11072357|NCT01076361|12254237|FG000|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
11072358|NCT01076361|12254237|FG000|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
11072359|NCT01076361|12254237|FG000|NOT COMPLETED|Overall Study||21
11072360|NCT01076400|12254241|FG000|STARTED|Overall Study||7
11072361|NCT01076400|12254242|FG001|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
11072362|NCT01076400|12254243|FG002|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
11072363|NCT01076400|12254241|FG000|COMPLETED|Overall Study||0
11072364|NCT01076400|12254242|FG001|COMPLETED|Overall Study||0
11072365|NCT01076400|12254243|FG002|COMPLETED|Overall Study||0
11072366|NCT01076400|12254241|FG000|NOT COMPLETED|Overall Study||7
11072367|NCT01076400|12254242|FG001|NOT COMPLETED|Overall Study||0
11072368|NCT01076400|12254243|FG002|NOT COMPLETED|Overall Study||0
11072369|NCT01076452|12254249|FG000|STARTED|Overall Study||147
11072370|NCT01076452|12254250|FG001|STARTED|Overall Study||152
11072371|NCT01076452|12254249|FG000|COMPLETED|Overall Study||123
11072372|NCT01076452|12254250|FG001|COMPLETED|Overall Study||138
11072373|NCT01076452|12254249|FG000|NOT COMPLETED|Overall Study||24
11072374|NCT01076452|12254250|FG001|NOT COMPLETED|Overall Study||14
11072375|NCT01076504|12254256|FG000|STARTED|Overall Study||80
11206569|NCT01868997|12397639|FG001|STARTED|Overall Study|randomized and treated|42
11206570|NCT01868997|12397638|FG000|COMPLETED|Overall Study||38
11206571|NCT01868997|12397639|FG001|COMPLETED|Overall Study||36
11206572|NCT01868997|12397638|FG000|NOT COMPLETED|Overall Study||7
11072376|NCT01076504|12254256|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
11072377|NCT01076504|12254256|FG000|NOT COMPLETED|Overall Study||80
11072378|NCT01076543|12254266|FG000|STARTED|Overall Study||8
11072379|NCT01076543|12254267|FG001|STARTED|Overall Study||3
11072380|NCT01076543|12254268|FG002|STARTED|Overall Study||6
11072381|NCT01076543|12254269|FG003|STARTED|Overall Study||39
11072382|NCT01076543|12254270|FG004|STARTED|Overall Study||15
11072383|NCT01076543|12254271|FG005|STARTED|Overall Study||39
11072384|NCT01076543|12254266|FG000|COMPLETED|Overall Study||6
11072385|NCT01076543|12254267|FG001|COMPLETED|Overall Study||3
11072386|NCT01076543|12254268|FG002|COMPLETED|Overall Study||6
11072387|NCT01076543|12254269|FG003|COMPLETED|Overall Study||39
11072388|NCT01076543|12254270|FG004|COMPLETED|Overall Study||15
11072389|NCT01076543|12254271|FG005|COMPLETED|Overall Study||39
11072390|NCT01076543|12254266|FG000|NOT COMPLETED|Overall Study||2
11072391|NCT01076543|12254267|FG001|NOT COMPLETED|Overall Study||0
11072392|NCT01076543|12254268|FG002|NOT COMPLETED|Overall Study||0
11072393|NCT01076543|12254269|FG003|NOT COMPLETED|Overall Study||0
11072394|NCT01076543|12254270|FG004|NOT COMPLETED|Overall Study||0
11072395|NCT01076543|12254271|FG005|NOT COMPLETED|Overall Study||0
11072396|NCT01076647|12254288|FG000|STARTED|Overall Study||233
11072397|NCT01076647|12254289|FG001|STARTED|Overall Study||234
11072398|NCT01076647|12254288|FG000|COMPLETED|Overall Study||208
11072399|NCT01076647|12254289|FG001|COMPLETED|Overall Study||209
11072400|NCT01076647|12254288|FG000|NOT COMPLETED|Overall Study||25
11072401|NCT01076647|12254289|FG001|NOT COMPLETED|Overall Study||25
11072402|NCT01076686|12254299|FG000|STARTED|Overall Study||17
11072403|NCT01076686|12254300|FG001|STARTED|Overall Study||14
11072404|NCT01076686|12254301|FG002|STARTED|Overall Study||32
11072405|NCT01076686|12254302|FG003|STARTED|Overall Study||31
11072406|NCT01076686|12254299|FG000|COMPLETED|Overall Study||17
11072407|NCT01076686|12254300|FG001|COMPLETED|Overall Study||14
11072408|NCT01076686|12254301|FG002|COMPLETED|Overall Study||32
11072409|NCT01076686|12254302|FG003|COMPLETED|Overall Study||31
11072410|NCT01076686|12254299|FG000|NOT COMPLETED|Overall Study||0
11347166|NCT02990000|12544555|FG000|STARTED|Overall Study|155 patients were randomly assigned to the Pragmatic Match condition|155
11347167|NCT02990000|12544556|FG001|STARTED|Overall Study|133 patients were randomly assigned to the Scientific Match condition|133
11347168|NCT02990000|12544555|FG000|Begin Treatment|Overall Study|119 Pragmatic Match patients actually began treatment (attended at least 1 session)|119
11072411|NCT01076686|12254300|FG001|NOT COMPLETED|Overall Study||0
11072412|NCT01076686|12254301|FG002|NOT COMPLETED|Overall Study||0
11072413|NCT01076686|12254302|FG003|NOT COMPLETED|Overall Study||0
11072414|NCT01076959|12254312|FG000|STARTED|Overall Study||7740
11072415|NCT01076959|12254312|FG000|COMPLETED|Overall Study||5490
11072416|NCT01076959|12254312|FG000|NOT COMPLETED|Overall Study||2250
11072417|NCT01076972|12254329|FG000|STARTED|Overall Study||1184
11072418|NCT01076972|12254329|FG000|COMPLETED|Overall Study||1184
11072419|NCT01076972|12254329|FG000|NOT COMPLETED|Overall Study||0
11072420|NCT01076985|12254343|FG000|STARTED|Overall Study||24
11072421|NCT01076985|12254343|FG000|COMPLETED|Overall Study||24
11072422|NCT01076985|12254343|FG000|NOT COMPLETED|Overall Study||0
11072423|NCT01077024|12254351|FG000|STARTED|Overall Study||267
11072424|NCT01077024|12254352|FG001|STARTED|Overall Study||271
11072425|NCT01077024|12254351|FG000|COMPLETED|Overall Study||236
11072426|NCT01077024|12254352|FG001|COMPLETED|Overall Study||243
11072427|NCT01077024|12254351|FG000|NOT COMPLETED|Overall Study||31
11072428|NCT01077024|12254352|FG001|NOT COMPLETED|Overall Study||28
11072429|NCT01077050|12254358|FG000|STARTED|Overall Study||1951
11072430|NCT01077050|12254358|FG000|COMPLETED|Overall Study||1942
11072431|NCT01077050|12254358|FG000|NOT COMPLETED|Overall Study||9
11072432|NCT01077063|12254364|FG000|STARTED|Overall Study||4
11072433|NCT01077063|12254365|FG001|STARTED|Overall Study||3
11072434|NCT01077063|12254364|FG000|COMPLETED|Overall Study||0
11072435|NCT01077063|12254365|FG001|COMPLETED|Overall Study||0
11072436|NCT01077063|12254364|FG000|NOT COMPLETED|Overall Study||4
11072437|NCT01077063|12254365|FG001|NOT COMPLETED|Overall Study||3
11072438|NCT01077076|12254371|FG000|STARTED|First Intervention||5
11072439|NCT01077076|12254372|FG001|STARTED|First Intervention||5
11072440|NCT01077076|12254373|FG002|STARTED|First Intervention||5
11072441|NCT01077076|12254374|FG003|STARTED|First Intervention||5
11072442|NCT01077076|12254375|FG004|STARTED|First Intervention||5
11072443|NCT01077076|12254376|FG005|STARTED|First Intervention||5
11072444|NCT01077076|12254371|FG000|COMPLETED|First Intervention||4
11072445|NCT01077076|12254372|FG001|COMPLETED|First Intervention||5
11072446|NCT01077076|12254373|FG002|COMPLETED|First Intervention||5
11072447|NCT01077076|12254374|FG003|COMPLETED|First Intervention||5
11072448|NCT01077076|12254375|FG004|COMPLETED|First Intervention||5
11072449|NCT01077076|12254376|FG005|COMPLETED|First Intervention||5
11072450|NCT01077076|12254371|FG000|NOT COMPLETED|First Intervention||1
11072451|NCT01077076|12254372|FG001|NOT COMPLETED|First Intervention||0
11072452|NCT01077076|12254373|FG002|NOT COMPLETED|First Intervention||0
11072453|NCT01077076|12254374|FG003|NOT COMPLETED|First Intervention||0
11072454|NCT01077076|12254375|FG004|NOT COMPLETED|First Intervention||0
11072455|NCT01077076|12254376|FG005|NOT COMPLETED|First Intervention||0
11072456|NCT01077076|12254371|FG000|STARTED|Washout Period of 2 Weeks||4
11072457|NCT01077076|12254372|FG001|STARTED|Washout Period of 2 Weeks||5
11072458|NCT01077076|12254373|FG002|STARTED|Washout Period of 2 Weeks||5
11072459|NCT01077076|12254374|FG003|STARTED|Washout Period of 2 Weeks||5
11072460|NCT01077076|12254375|FG004|STARTED|Washout Period of 2 Weeks||5
11072461|NCT01077076|12254376|FG005|STARTED|Washout Period of 2 Weeks||5
11072462|NCT01077076|12254371|FG000|COMPLETED|Washout Period of 2 Weeks||4
11072463|NCT01077076|12254372|FG001|COMPLETED|Washout Period of 2 Weeks||5
11072464|NCT01077076|12254373|FG002|COMPLETED|Washout Period of 2 Weeks||5
11072465|NCT01077076|12254374|FG003|COMPLETED|Washout Period of 2 Weeks||5
11072466|NCT01077076|12254375|FG004|COMPLETED|Washout Period of 2 Weeks||5
11072467|NCT01077076|12254376|FG005|COMPLETED|Washout Period of 2 Weeks||5
11072468|NCT01077076|12254371|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
11072469|NCT01077076|12254372|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
11072470|NCT01077076|12254373|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
11072471|NCT01077076|12254374|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
11072472|NCT01077076|12254375|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0
11072473|NCT01077076|12254376|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0
11072474|NCT01077076|12254371|FG000|STARTED|Second Intervention||4
11072475|NCT01077076|12254372|FG001|STARTED|Second Intervention||5
11072476|NCT01077076|12254373|FG002|STARTED|Second Intervention||5
11347169|NCT02990000|12544556|FG001|Begin Treatment|Overall Study|99 Scientifically Matched patients actually began treatment (attended at least one session)|99
11347170|NCT02990000|12544555|FG000|COMPLETED|Overall Study|119 patients provided naturalistic treatment data and were included in analyses|119
11347171|NCT02990000|12544556|FG001|COMPLETED|Overall Study|99 patients provided naturalistic treatment data and were included in analyses|99
11347172|NCT02990000|12544555|FG000|NOT COMPLETED|Overall Study||36
11347173|NCT02990000|12544556|FG001|NOT COMPLETED|Overall Study||34
11347174|NCT02990910|12544564|FG000|STARTED|Overall Study||140
11347175|NCT02990910|12544565|FG001|STARTED|Overall Study||140
11347176|NCT02990910|12544564|FG000|COMPLETED|Overall Study||134
11347177|NCT02990910|12544565|FG001|COMPLETED|Overall Study||130
11347178|NCT02990910|12544564|FG000|NOT COMPLETED|Overall Study||6
11347179|NCT02990910|12544565|FG001|NOT COMPLETED|Overall Study||10
11347180|NCT02991040|12544571|FG000|STARTED|Overall Study||100
11347181|NCT02991040|12544571|FG000|COMPLETED|Overall Study||96
11347182|NCT02991040|12544571|FG000|NOT COMPLETED|Overall Study||4
11347183|NCT02991118|12544579|FG000|STARTED|Overall Study||257
11347184|NCT02991118|12544580|FG001|STARTED|Overall Study||522
11347185|NCT02991118|12544579|FG000|COMPLETED|Overall Study||250
11347186|NCT02991118|12544580|FG001|COMPLETED|Overall Study||490
11347187|NCT02991118|12544579|FG000|NOT COMPLETED|Overall Study||7
11347188|NCT02991118|12544580|FG001|NOT COMPLETED|Overall Study||32
11347189|NCT02991729|12544588|FG000|STARTED|Overall Study||105
11347190|NCT02991729|12544589|FG001|STARTED|Overall Study||92
11347191|NCT02991729|12544588|FG000|COMPLETED|Overall Study||105
11347192|NCT02991729|12544589|FG001|COMPLETED|Overall Study||92
11347193|NCT02991729|12544588|FG000|NOT COMPLETED|Overall Study||0
11347194|NCT02991729|12544589|FG001|NOT COMPLETED|Overall Study||0
11347195|NCT02991820|12544599|FG000|STARTED|Overall Study||12
11347196|NCT02991820|12544600|FG001|STARTED|Overall Study||31
11347197|NCT02991820|12544599|FG000|COMPLETED|Overall Study||12
11347198|NCT02991820|12544600|FG001|COMPLETED|Overall Study||31
11347199|NCT02991820|12544599|FG000|NOT COMPLETED|Overall Study||0
11347200|NCT02991820|12544600|FG001|NOT COMPLETED|Overall Study||0
11347201|NCT02991859|12544625|FG000|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
11347202|NCT02991859|12544626|FG001|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
11347203|NCT02991859|12544627|FG002|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
11347204|NCT02991859|12544628|FG003|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
11347205|NCT02991859|12544629|FG004|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
11347206|NCT02991859|12544630|FG005|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
11347207|NCT02991859|12544631|FG006|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
11347208|NCT02991859|12544632|FG007|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
11347209|NCT02991859|12544633|FG008|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
11347210|NCT02991859|12544634|FG009|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
11347211|NCT02991859|12544635|FG010|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
11347212|NCT02991859|12544636|FG011|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
11347213|NCT02991859|12544637|FG012|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
11347214|NCT02991859|12544638|FG013|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
11347215|NCT02991859|12544639|FG014|STARTED|Period 1,Escalation Phase 1,Upto Day 7||6
11347216|NCT02991859|12544640|FG015|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
11347217|NCT02991859|12544641|FG016|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
11347218|NCT02991859|12544625|FG000|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
11347219|NCT02991859|12544626|FG001|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
11347220|NCT02991859|12544627|FG002|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
11347221|NCT02991859|12544628|FG003|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
11347222|NCT02991859|12544629|FG004|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
11347223|NCT02991859|12544630|FG005|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
11347224|NCT02991859|12544631|FG006|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
11347225|NCT02991859|12544632|FG007|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
11072477|NCT01077076|12254374|FG003|STARTED|Second Intervention||5
11072478|NCT01077076|12254375|FG004|STARTED|Second Intervention||5
11072479|NCT01077076|12254376|FG005|STARTED|Second Intervention||5
11072480|NCT01077076|12254371|FG000|COMPLETED|Second Intervention||4
11072481|NCT01077076|12254372|FG001|COMPLETED|Second Intervention||5
11072482|NCT01077076|12254373|FG002|COMPLETED|Second Intervention||5
11072483|NCT01077076|12254374|FG003|COMPLETED|Second Intervention||5
11072484|NCT01077076|12254375|FG004|COMPLETED|Second Intervention||5
11072485|NCT01077076|12254376|FG005|COMPLETED|Second Intervention||5
11072486|NCT01077076|12254371|FG000|NOT COMPLETED|Second Intervention||0
11072487|NCT01077076|12254372|FG001|NOT COMPLETED|Second Intervention||0
11072488|NCT01077076|12254373|FG002|NOT COMPLETED|Second Intervention||0
11072489|NCT01077076|12254374|FG003|NOT COMPLETED|Second Intervention||0
11072490|NCT01077076|12254375|FG004|NOT COMPLETED|Second Intervention||0
11072491|NCT01077076|12254376|FG005|NOT COMPLETED|Second Intervention||0
11072492|NCT01077076|12254371|FG000|STARTED|Washout Period of 2 Weeks||4
11072493|NCT01077076|12254372|FG001|STARTED|Washout Period of 2 Weeks||5
11072494|NCT01077076|12254373|FG002|STARTED|Washout Period of 2 Weeks||5
11072495|NCT01077076|12254374|FG003|STARTED|Washout Period of 2 Weeks||5
11072496|NCT01077076|12254375|FG004|STARTED|Washout Period of 2 Weeks||5
11072497|NCT01077076|12254376|FG005|STARTED|Washout Period of 2 Weeks||5
11072498|NCT01077076|12254371|FG000|COMPLETED|Washout Period of 2 Weeks||4
11072499|NCT01077076|12254372|FG001|COMPLETED|Washout Period of 2 Weeks||5
11072500|NCT01077076|12254373|FG002|COMPLETED|Washout Period of 2 Weeks||5
11072501|NCT01077076|12254374|FG003|COMPLETED|Washout Period of 2 Weeks||5
11072502|NCT01077076|12254375|FG004|COMPLETED|Washout Period of 2 Weeks||5
11347226|NCT02991859|12544633|FG008|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
11072503|NCT01077076|12254376|FG005|COMPLETED|Washout Period of 2 Weeks||5
11072504|NCT01077076|12254371|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
11072505|NCT01077076|12254372|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
11072506|NCT01077076|12254373|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
11072507|NCT01077076|12254374|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
11072508|NCT01077076|12254375|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0
11072509|NCT01077076|12254376|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0
11072510|NCT01077076|12254371|FG000|STARTED|Third Intervention||4
11072511|NCT01077076|12254372|FG001|STARTED|Third Intervention||5
11072512|NCT01077076|12254373|FG002|STARTED|Third Intervention||5
11072513|NCT01077076|12254374|FG003|STARTED|Third Intervention||5
11072514|NCT01077076|12254375|FG004|STARTED|Third Intervention||5
11072515|NCT01077076|12254376|FG005|STARTED|Third Intervention||5
11072516|NCT01077076|12254371|FG000|COMPLETED|Third Intervention||4
11072517|NCT01077076|12254372|FG001|COMPLETED|Third Intervention||5
11072518|NCT01077076|12254373|FG002|COMPLETED|Third Intervention||5
11072519|NCT01077076|12254374|FG003|COMPLETED|Third Intervention||5
11072520|NCT01077076|12254375|FG004|COMPLETED|Third Intervention||5
11072521|NCT01077076|12254376|FG005|COMPLETED|Third Intervention||4
11072522|NCT01077076|12254371|FG000|NOT COMPLETED|Third Intervention||0
11072523|NCT01077076|12254372|FG001|NOT COMPLETED|Third Intervention||0
11072524|NCT01077076|12254373|FG002|NOT COMPLETED|Third Intervention||0
11072525|NCT01077076|12254374|FG003|NOT COMPLETED|Third Intervention||0
11072526|NCT01077076|12254375|FG004|NOT COMPLETED|Third Intervention||0
11072527|NCT01077076|12254376|FG005|NOT COMPLETED|Third Intervention||1
11072528|NCT01077128|12254384|FG000|STARTED|Overall Study||500
11072529|NCT01077128|12254384|FG000|COMPLETED|Overall Study||433
11072530|NCT01077128|12254384|FG000|NOT COMPLETED|Overall Study||67
11072531|NCT01077154|12254440|FG000|STARTED|Overall Study||2253
11072532|NCT01077154|12254441|FG001|STARTED|Overall Study||2256
11072533|NCT01077154|12254440|FG000|Received Study Drug|Overall Study||2229
11072534|NCT01077154|12254441|FG001|Received Study Drug|Overall Study||2230
11072535|NCT01077154|12254440|FG000|COMPLETED|Overall Study||27
11072536|NCT01077154|12254441|FG001|COMPLETED|Overall Study||28
11072537|NCT01077154|12254440|FG000|NOT COMPLETED|Overall Study||2226
11072538|NCT01077154|12254441|FG001|NOT COMPLETED|Overall Study||2228
11072539|NCT01077193|12254447|FG000|STARTED|Overall Study||44
11072540|NCT01077193|12254447|FG000|COMPLETED|Overall Study||0
11072541|NCT01077193|12254447|FG000|NOT COMPLETED|Overall Study||44
11072542|NCT01077258|12254451|FG000|STARTED|Overall Study||4208
11072543|NCT01077258|12254451|FG000|COMPLETED|Overall Study||1640
11347227|NCT02991859|12544634|FG009|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
11347228|NCT02991859|12544635|FG010|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
11347229|NCT02991859|12544636|FG011|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
11347230|NCT02991859|12544637|FG012|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
11347231|NCT02991859|12544638|FG013|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
11347232|NCT02991859|12544639|FG014|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||6
11347233|NCT02991859|12544640|FG015|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
11347234|NCT02991859|12544641|FG016|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
11347235|NCT02991859|12544625|FG000|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11347236|NCT02991859|12544626|FG001|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
11347237|NCT02991859|12544627|FG002|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11347238|NCT02991859|12544628|FG003|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11347239|NCT02991859|12544629|FG004|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
11347240|NCT02991859|12544630|FG005|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11347241|NCT02991859|12544631|FG006|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11347242|NCT02991859|12544632|FG007|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11347243|NCT02991859|12544633|FG008|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11347244|NCT02991859|12544634|FG009|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11347245|NCT02991859|12544635|FG010|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11072544|NCT01077258|12254451|FG000|NOT COMPLETED|Overall Study||2568
11072545|NCT01077271|12254468|FG000|STARTED|Overall Study||124
11072546|NCT01077271|12254468|FG000|Participants Treated With Palivizumab|Overall Study||120
11072547|NCT01077271|12254468|FG000|Number of Participants Analyzed|Overall Study||120
11072548|NCT01077271|12254468|FG000|COMPLETED|Overall Study||102
11072549|NCT01077271|12254468|FG000|NOT COMPLETED|Overall Study||22
11206573|NCT01868997|12397639|FG001|NOT COMPLETED|Overall Study||6
11206574|NCT01869075|12397651|FG000|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
11206575|NCT01869075|12397652|FG001|STARTED|Phase 0 (Baseline)||418
11206576|NCT01869075|12397653|FG002|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
11206577|NCT01869075|12397654|FG003|STARTED|Phase 0 (Baseline)||416
11206578|NCT01869075|12397655|FG004|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
11206579|NCT01869075|12397656|FG005|STARTED|Phase 0 (Baseline)||341
11206580|NCT01869075|12397651|FG000|COMPLETED|Phase 0 (Baseline)||0
11206581|NCT01869075|12397652|FG001|COMPLETED|Phase 0 (Baseline)||418
11206582|NCT01869075|12397653|FG002|COMPLETED|Phase 0 (Baseline)||0
11206583|NCT01869075|12397654|FG003|COMPLETED|Phase 0 (Baseline)||416
11206584|NCT01869075|12397655|FG004|COMPLETED|Phase 0 (Baseline)||0
11206585|NCT01869075|12397656|FG005|COMPLETED|Phase 0 (Baseline)||341
11206586|NCT01869075|12397651|FG000|NOT COMPLETED|Phase 0 (Baseline)||0
11206587|NCT01869075|12397652|FG001|NOT COMPLETED|Phase 0 (Baseline)||0
11072550|NCT01077284|12254483|FG000|STARTED|Overall Study||33
11072551|NCT01077284|12254484|FG001|STARTED|Overall Study||33
11072552|NCT01077284|12254485|FG002|STARTED|Overall Study||33
11072553|NCT01077284|12254483|FG000|COMPLETED|Overall Study||28
11072554|NCT01077284|12254484|FG001|COMPLETED|Overall Study||28
11072555|NCT01077284|12254485|FG002|COMPLETED|Overall Study||30
11072556|NCT01077284|12254483|FG000|NOT COMPLETED|Overall Study||5
11072557|NCT01077284|12254484|FG001|NOT COMPLETED|Overall Study||5
11072558|NCT01077284|12254485|FG002|NOT COMPLETED|Overall Study||3
11072559|NCT01077310|12254495|FG000|STARTED|Overall Study||67
11072560|NCT01077310|12254496|FG001|STARTED|Overall Study||33
11072561|NCT01077310|12254495|FG000|COMPLETED|Overall Study||67
11072562|NCT01077310|12254496|FG001|COMPLETED|Overall Study||33
11072563|NCT01077310|12254495|FG000|NOT COMPLETED|Overall Study||0
11072564|NCT01077310|12254496|FG001|NOT COMPLETED|Overall Study||0
11072565|NCT01077323|12254510|FG000|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
11072566|NCT01077323|12254511|FG001|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
11072567|NCT01077323|12254512|FG002|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
11072568|NCT01077323|12254510|FG000|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
11072569|NCT01077323|12254511|FG001|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
11072570|NCT01077323|12254512|FG002|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
11072571|NCT01077323|12254510|FG000|NOT COMPLETED|Overall Study||11378
11072572|NCT01077323|12254511|FG001|NOT COMPLETED|Overall Study||386263
11072573|NCT01077323|12254512|FG002|NOT COMPLETED|Overall Study||11912089
11072574|NCT01077362|12254523|FG000|STARTED|Overall Study||104
11072575|NCT01077362|12254524|FG001|STARTED|Overall Study||103
11072576|NCT01077362|12254525|FG002|STARTED|Overall Study||105
11072577|NCT01077362|12254523|FG000|COMPLETED|Overall Study||73
11072578|NCT01077362|12254524|FG001|COMPLETED|Overall Study||84
11072579|NCT01077362|12254525|FG002|COMPLETED|Overall Study||81
11072580|NCT01077362|12254523|FG000|NOT COMPLETED|Overall Study||31
11072581|NCT01077362|12254524|FG001|NOT COMPLETED|Overall Study||19
11072582|NCT01077362|12254525|FG002|NOT COMPLETED|Overall Study||24
11072583|NCT01077375|12254540|FG000|STARTED|Overall Study||21
11072584|NCT01077375|12254541|FG001|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
11072585|NCT01077375|12254540|FG000|COMPLETED|Overall Study||11
11072586|NCT01077375|12254541|FG001|COMPLETED|Overall Study||51
11072587|NCT01077375|12254540|FG000|NOT COMPLETED|Overall Study||10
11072588|NCT01077375|12254541|FG001|NOT COMPLETED|Overall Study||35
11072589|NCT01077401|12254551|FG000|STARTED|Overall Study||77
11072590|NCT01077401|12254552|FG001|STARTED|Overall Study||75
11072591|NCT01077401|12254551|FG000|COMPLETED|Overall Study||59
11072592|NCT01077401|12254552|FG001|COMPLETED|Overall Study||54
11072593|NCT01077401|12254551|FG000|NOT COMPLETED|Overall Study||18
11072594|NCT01077401|12254552|FG001|NOT COMPLETED|Overall Study||21
11347246|NCT02991859|12544636|FG011|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11347247|NCT02991859|12544637|FG012|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11347248|NCT02991859|12544638|FG013|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11347249|NCT02991859|12544639|FG014|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11072595|NCT01077518|12254560|FG000|STARTED|Treatment Phase - no Optional Ofa||173
11072596|NCT01077518|12254561|FG001|STARTED|Treatment Phase - no Optional Ofa||173
11072597|NCT01077518|12254562|FG002|STARTED|Treatment Phase - no Optional Ofa||0
11072598|NCT01077518|12254560|FG000|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
11072599|NCT01077518|12254561|FG001|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
11072600|NCT01077518|12254562|FG002|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||0
11072601|NCT01077518|12254560|FG000|Safety Population|Treatment Phase - no Optional Ofa||172
11072602|NCT01077518|12254561|FG001|Safety Population|Treatment Phase - no Optional Ofa||170
11072603|NCT01077518|12254562|FG002|Safety Population|Treatment Phase - no Optional Ofa||0
11072604|NCT01077518|12254560|FG000|COMPLETED|Treatment Phase - no Optional Ofa||95
11072605|NCT01077518|12254561|FG001|COMPLETED|Treatment Phase - no Optional Ofa||108
11072606|NCT01077518|12254562|FG002|COMPLETED|Treatment Phase - no Optional Ofa||0
11072607|NCT01077518|12254560|FG000|NOT COMPLETED|Treatment Phase - no Optional Ofa||78
11072608|NCT01077518|12254561|FG001|NOT COMPLETED|Treatment Phase - no Optional Ofa||65
11072609|NCT01077518|12254562|FG002|NOT COMPLETED|Treatment Phase - no Optional Ofa||0
11072610|NCT01077518|12254560|FG000|STARTED|Optional Ofa Phase||0
11347250|NCT02991859|12544640|FG015|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11347251|NCT02991859|12544641|FG016|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
11347252|NCT02991859|12544625|FG000|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
11347253|NCT02991859|12544626|FG001|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
11347254|NCT02991859|12544627|FG002|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
11347255|NCT02991859|12544628|FG003|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
11347256|NCT02991859|12544629|FG004|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
11347257|NCT02991859|12544630|FG005|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
11072611|NCT01077518|12254561|FG001|STARTED|Optional Ofa Phase||0
11347258|NCT02991859|12544631|FG006|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
11347259|NCT02991859|12544632|FG007|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
11347260|NCT02991859|12544633|FG008|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
11347261|NCT02991859|12544634|FG009|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
11347262|NCT02991859|12544635|FG010|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
11347263|NCT02991859|12544636|FG011|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
11347264|NCT02991859|12544637|FG012|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
11347265|NCT02991859|12544638|FG013|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
11347266|NCT02991859|12544639|FG014|STARTED|Period 1,Escalation Phase2,Upto Day 14||6
11072612|NCT01077518|12254562|FG002|STARTED|Optional Ofa Phase||32
11072613|NCT01077518|12254560|FG000|Completed 5-year Follow-up|Optional Ofa Phase||0
11072614|NCT01077518|12254561|FG001|Completed 5-year Follow-up|Optional Ofa Phase||0
11072615|NCT01077518|12254562|FG002|Completed 5-year Follow-up|Optional Ofa Phase||12
11072616|NCT01077518|12254560|FG000|COMPLETED|Optional Ofa Phase||0
11072617|NCT01077518|12254561|FG001|COMPLETED|Optional Ofa Phase||0
11072618|NCT01077518|12254562|FG002|COMPLETED|Optional Ofa Phase||16
11072619|NCT01077518|12254560|FG000|NOT COMPLETED|Optional Ofa Phase||0
11072620|NCT01077518|12254561|FG001|NOT COMPLETED|Optional Ofa Phase||0
11072621|NCT01077518|12254562|FG002|NOT COMPLETED|Optional Ofa Phase||16
11072622|NCT01077544|12254573|FG000|STARTED|Overall Study||8
11072623|NCT01077544|12254574|FG001|STARTED|Overall Study||7
11072624|NCT01077544|12254573|FG000|COMPLETED|Overall Study||5
11072625|NCT01077544|12254574|FG001|COMPLETED|Overall Study||2
11072626|NCT01077544|12254573|FG000|NOT COMPLETED|Overall Study||3
11072627|NCT01077544|12254574|FG001|NOT COMPLETED|Overall Study||5
11072628|NCT01077596|12254592|FG000|STARTED|Overall Study||350
11072629|NCT01077596|12254593|FG001|STARTED|Overall Study||1050
11072630|NCT01077596|12254594|FG002|STARTED|Overall Study||457
11072631|NCT01077596|12254595|FG003|STARTED|Overall Study||1370
11072632|NCT01077596|12254596|FG004|STARTED|Overall Study||294
11072633|NCT01077596|12254597|FG005|STARTED|Overall Study||882
11072634|NCT01077596|12254598|FG006|STARTED|Overall Study||308
11072635|NCT01077596|12254599|FG007|STARTED|Overall Study||837
11072636|NCT01077596|12254600|FG008|STARTED|Overall Study||2842
11072637|NCT01077596|12254601|FG009|STARTED|Overall Study||28420
11072638|NCT01077596|12254602|FG010|STARTED|Overall Study||2215
11072639|NCT01077596|12254603|FG011|STARTED|Overall Study||22150
11072640|NCT01077596|12254592|FG000|COMPLETED|Overall Study||350
11072641|NCT01077596|12254593|FG001|COMPLETED|Overall Study||1050
11072642|NCT01077596|12254594|FG002|COMPLETED|Overall Study||457
11072643|NCT01077596|12254595|FG003|COMPLETED|Overall Study||1370
11072644|NCT01077596|12254596|FG004|COMPLETED|Overall Study||294
11072645|NCT01077596|12254597|FG005|COMPLETED|Overall Study||882
11072646|NCT01077596|12254598|FG006|COMPLETED|Overall Study||308
11072647|NCT01077596|12254599|FG007|COMPLETED|Overall Study||837
11072648|NCT01077596|12254600|FG008|COMPLETED|Overall Study||2842
11072649|NCT01077596|12254601|FG009|COMPLETED|Overall Study||28420
11072650|NCT01077596|12254602|FG010|COMPLETED|Overall Study||2215
11072651|NCT01077596|12254603|FG011|COMPLETED|Overall Study||22150
11072652|NCT01077596|12254592|FG000|NOT COMPLETED|Overall Study||0
11072653|NCT01077596|12254593|FG001|NOT COMPLETED|Overall Study||0
11072654|NCT01077596|12254594|FG002|NOT COMPLETED|Overall Study||0
11072655|NCT01077596|12254595|FG003|NOT COMPLETED|Overall Study||0
11072656|NCT01077596|12254596|FG004|NOT COMPLETED|Overall Study||0
11072657|NCT01077596|12254597|FG005|NOT COMPLETED|Overall Study||0
11072658|NCT01077596|12254598|FG006|NOT COMPLETED|Overall Study||0
11072659|NCT01077596|12254599|FG007|NOT COMPLETED|Overall Study||0
11072660|NCT01077596|12254600|FG008|NOT COMPLETED|Overall Study||0
11072661|NCT01077596|12254601|FG009|NOT COMPLETED|Overall Study||0
11072662|NCT01077596|12254602|FG010|NOT COMPLETED|Overall Study||0
11072663|NCT01077596|12254603|FG011|NOT COMPLETED|Overall Study||0
11072664|NCT01077622|12254624|FG000|STARTED|Overall Study||10
11072665|NCT01077622|12254624|FG000|COMPLETED|Overall Study||7
11072666|NCT01077622|12254624|FG000|NOT COMPLETED|Overall Study||3
11072667|NCT01077713|12254630|FG000|STARTED|Overall Study||44
11072668|NCT01077713|12254631|FG001|STARTED|Overall Study||42
11072669|NCT01077713|12254630|FG000|COMPLETED|Overall Study||8
11072670|NCT01077713|12254631|FG001|COMPLETED|Overall Study||6
11072671|NCT01077713|12254630|FG000|NOT COMPLETED|Overall Study||36
11072672|NCT01077713|12254631|FG001|NOT COMPLETED|Overall Study||36
11072673|NCT01077739|12254639|FG000|STARTED|Overall Study||25
11072674|NCT01077739|12254640|FG001|STARTED|Overall Study||50
11072675|NCT01077739|12254639|FG000|COMPLETED|Overall Study||20
11072676|NCT01077739|12254640|FG001|COMPLETED|Overall Study||40
11072677|NCT01077739|12254639|FG000|NOT COMPLETED|Overall Study||5
11072678|NCT01077739|12254640|FG001|NOT COMPLETED|Overall Study||10
11072679|NCT01077804|12254646|FG000|STARTED|Overall Study||7585
11072680|NCT01077804|12254646|FG000|COMPLETED|Overall Study||7386
11072681|NCT01077804|12254646|FG000|NOT COMPLETED|Overall Study||199
11072682|NCT01077921|12254652|FG000|STARTED|First Intervention||14
11072683|NCT01077921|12254653|FG001|STARTED|First Intervention||13
11072684|NCT01077921|12254652|FG000|COMPLETED|First Intervention||13
11072685|NCT01077921|12254653|FG001|COMPLETED|First Intervention||12
11072686|NCT01077921|12254652|FG000|NOT COMPLETED|First Intervention||1
11072687|NCT01077921|12254653|FG001|NOT COMPLETED|First Intervention||1
11072688|NCT01077921|12254652|FG000|STARTED|Washout||13
11072689|NCT01077921|12254653|FG001|STARTED|Washout||12
11072690|NCT01077921|12254652|FG000|COMPLETED|Washout||13
11072691|NCT01077921|12254653|FG001|COMPLETED|Washout||10
11072692|NCT01077921|12254652|FG000|NOT COMPLETED|Washout||0
11072693|NCT01077921|12254653|FG001|NOT COMPLETED|Washout||2
11072694|NCT01077921|12254652|FG000|STARTED|Second Intervention||13
11072695|NCT01077921|12254653|FG001|STARTED|Second Intervention||10
11072696|NCT01077921|12254652|FG000|COMPLETED|Second Intervention||13
11072697|NCT01077921|12254653|FG001|COMPLETED|Second Intervention||9
11072698|NCT01077921|12254652|FG000|NOT COMPLETED|Second Intervention||0
11072699|NCT01077921|12254653|FG001|NOT COMPLETED|Second Intervention||1
11072700|NCT01077960|12254660|FG000|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
11072701|NCT01077960|12254660|FG000|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
11072702|NCT01077960|12254660|FG000|NOT COMPLETED|Overall Study||16
11072703|NCT01077973|12254667|FG000|STARTED|Overall Study||41
11072704|NCT01077973|12254668|FG001|STARTED|Overall Study||79
11072705|NCT01077973|12254669|FG002|STARTED|Overall Study||80
11072706|NCT01077973|12254667|FG000|COMPLETED|Overall Study||41
11072707|NCT01077973|12254668|FG001|COMPLETED|Overall Study||79
11072708|NCT01077973|12254669|FG002|COMPLETED|Overall Study||80
11072709|NCT01077973|12254667|FG000|NOT COMPLETED|Overall Study||0
11072710|NCT01077973|12254668|FG001|NOT COMPLETED|Overall Study||0
11072711|NCT01077973|12254669|FG002|NOT COMPLETED|Overall Study||0
11072712|NCT01078090|12254679|FG000|STARTED|Overall Study||5745
11072713|NCT01078090|12254679|FG000|COMPLETED|Overall Study||1152
11072714|NCT01078090|12254679|FG000|NOT COMPLETED|Overall Study||4593
11072715|NCT01078116|12254697|FG000|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
11072716|NCT01078116|12254697|FG000|COMPLETED|Overall Study||76
11072717|NCT01078116|12254697|FG000|NOT COMPLETED|Overall Study||48
11072718|NCT01078155|12254701|FG000|STARTED|Overall Study||131
11072719|NCT01078155|12254701|FG000|COMPLETED|Overall Study||87
11072720|NCT01078155|12254701|FG000|NOT COMPLETED|Overall Study||44
11072721|NCT01078168|12254707|FG000|STARTED|Overall Study||11
11072722|NCT01078168|12254708|FG001|STARTED|Overall Study||11
11072723|NCT01078168|12254707|FG000|COMPLETED|Overall Study||11
11072724|NCT01078168|12254708|FG001|COMPLETED|Overall Study||10
11072725|NCT01078168|12254707|FG000|NOT COMPLETED|Overall Study||0
11072726|NCT01078168|12254708|FG001|NOT COMPLETED|Overall Study||1
11072727|NCT01078207|12254714|FG000|STARTED|Overall Study||100
11072728|NCT01078207|12254714|FG000|COMPLETED|Overall Study||100
11072729|NCT01078207|12254714|FG000|NOT COMPLETED|Overall Study||0
11072730|NCT01078220|12254718|FG000|STARTED|Overall Study||189629
11347267|NCT02991859|12544640|FG015|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
11347268|NCT02991859|12544641|FG016|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
11347269|NCT02991859|12544625|FG000|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
11347270|NCT02991859|12544626|FG001|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
11347271|NCT02991859|12544627|FG002|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
11347272|NCT02991859|12544628|FG003|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
11347273|NCT02991859|12544629|FG004|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
11347274|NCT02991859|12544630|FG005|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
11347275|NCT02991859|12544631|FG006|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
11347276|NCT02991859|12544632|FG007|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
11072731|NCT01078220|12254718|FG000|COMPLETED|Overall Study||189629
11072732|NCT01078220|12254718|FG000|NOT COMPLETED|Overall Study||0
11072733|NCT01078233|12254731|FG000|STARTED|Overall Study||656
11072734|NCT01078233|12254732|FG001|STARTED|Overall Study||296
11072735|NCT01078233|12254733|FG002|STARTED|Overall Study||1681
11072736|NCT01078233|12254734|FG003|STARTED|Overall Study||631
11072737|NCT01078233|12254735|FG004|STARTED|Overall Study||3199
11072738|NCT01078233|12254736|FG005|STARTED|Overall Study||154
11072739|NCT01078233|12254731|FG000|COMPLETED|Overall Study||656
11072740|NCT01078233|12254732|FG001|COMPLETED|Overall Study||296
11072741|NCT01078233|12254733|FG002|COMPLETED|Overall Study||1681
11072742|NCT01078233|12254734|FG003|COMPLETED|Overall Study||631
11072743|NCT01078233|12254735|FG004|COMPLETED|Overall Study||3199
11072744|NCT01078233|12254736|FG005|COMPLETED|Overall Study||154
11072745|NCT01078233|12254731|FG000|NOT COMPLETED|Overall Study||0
11072746|NCT01078233|12254732|FG001|NOT COMPLETED|Overall Study||0
11072747|NCT01078233|12254733|FG002|NOT COMPLETED|Overall Study||0
11072748|NCT01078233|12254734|FG003|NOT COMPLETED|Overall Study||0
11072749|NCT01078233|12254735|FG004|NOT COMPLETED|Overall Study||0
11072750|NCT01078233|12254736|FG005|NOT COMPLETED|Overall Study||0
11072751|NCT01078246|12254751|FG000|STARTED|Overall Study||1041
11072752|NCT01078246|12254752|FG001|STARTED|Overall Study||405
11072753|NCT01078246|12254753|FG002|STARTED|Overall Study||1963
11072754|NCT01078246|12254754|FG003|STARTED|Overall Study||152
11072755|NCT01078246|12254755|FG004|STARTED|Overall Study||3310
11072756|NCT01078246|12254756|FG005|STARTED|Overall Study||231
11072757|NCT01078246|12254757|FG006|STARTED|Overall Study||22
11072758|NCT01078246|12254751|FG000|COMPLETED|Overall Study||1041
11072759|NCT01078246|12254752|FG001|COMPLETED|Overall Study||405
11072760|NCT01078246|12254753|FG002|COMPLETED|Overall Study||1963
11072761|NCT01078246|12254754|FG003|COMPLETED|Overall Study||152
11072762|NCT01078246|12254755|FG004|COMPLETED|Overall Study||3310
11072763|NCT01078246|12254756|FG005|COMPLETED|Overall Study||231
11072764|NCT01078246|12254757|FG006|COMPLETED|Overall Study||22
11072765|NCT01078246|12254751|FG000|NOT COMPLETED|Overall Study||0
11072766|NCT01078246|12254752|FG001|NOT COMPLETED|Overall Study||0
11072767|NCT01078246|12254753|FG002|NOT COMPLETED|Overall Study||0
11072768|NCT01078246|12254754|FG003|NOT COMPLETED|Overall Study||0
11347277|NCT02991859|12544633|FG008|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
11347278|NCT02991859|12544634|FG009|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
11347279|NCT02991859|12544635|FG010|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
11347280|NCT02991859|12544636|FG011|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
11347281|NCT02991859|12544637|FG012|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
11347282|NCT02991859|12544638|FG013|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
11347283|NCT02991859|12544639|FG014|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||6
11347284|NCT02991859|12544640|FG015|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
11347285|NCT02991859|12544641|FG016|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
11347286|NCT02991859|12544625|FG000|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347287|NCT02991859|12544626|FG001|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347288|NCT02991859|12544627|FG002|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347289|NCT02991859|12544628|FG003|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347290|NCT02991859|12544629|FG004|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347291|NCT02991859|12544630|FG005|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347292|NCT02991859|12544631|FG006|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347293|NCT02991859|12544632|FG007|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347294|NCT02991859|12544633|FG008|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347295|NCT02991859|12544634|FG009|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347296|NCT02991859|12544635|FG010|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347297|NCT02991859|12544636|FG011|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347298|NCT02991859|12544637|FG012|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347299|NCT02991859|12544638|FG013|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347300|NCT02991859|12544639|FG014|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347301|NCT02991859|12544640|FG015|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347302|NCT02991859|12544641|FG016|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
11347303|NCT02991859|12544625|FG000|STARTED|Period1, Escalation Phase3, Upto Day21||2
11347304|NCT02991859|12544626|FG001|STARTED|Period1, Escalation Phase3, Upto Day21||2
11347305|NCT02991859|12544627|FG002|STARTED|Period1, Escalation Phase3, Upto Day21||2
11347306|NCT02991859|12544628|FG003|STARTED|Period1, Escalation Phase3, Upto Day21||2
11347307|NCT02991859|12544629|FG004|STARTED|Period1, Escalation Phase3, Upto Day21||2
11347308|NCT02991859|12544630|FG005|STARTED|Period1, Escalation Phase3, Upto Day21||3
11347309|NCT02991859|12544631|FG006|STARTED|Period1, Escalation Phase3, Upto Day21||2
11347310|NCT02991859|12544632|FG007|STARTED|Period1, Escalation Phase3, Upto Day21||2
11347311|NCT02991859|12544633|FG008|STARTED|Period1, Escalation Phase3, Upto Day21||2
11347312|NCT02991859|12544634|FG009|STARTED|Period1, Escalation Phase3, Upto Day21||2
11347313|NCT02991859|12544635|FG010|STARTED|Period1, Escalation Phase3, Upto Day21||2
11347314|NCT02991859|12544636|FG011|STARTED|Period1, Escalation Phase3, Upto Day21||2
11347315|NCT02991859|12544637|FG012|STARTED|Period1, Escalation Phase3, Upto Day21||7
11347316|NCT02991859|12544638|FG013|STARTED|Period1, Escalation Phase3, Upto Day21||7
11347317|NCT02991859|12544639|FG014|STARTED|Period1, Escalation Phase3, Upto Day21||6
11347318|NCT02991859|12544640|FG015|STARTED|Period1, Escalation Phase3, Upto Day21||3
11347319|NCT02991859|12544641|FG016|STARTED|Period1, Escalation Phase3, Upto Day21||3
11347320|NCT02991859|12544625|FG000|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
11072769|NCT01078246|12254755|FG004|NOT COMPLETED|Overall Study||0
11072770|NCT01078246|12254756|FG005|NOT COMPLETED|Overall Study||0
11072771|NCT01078246|12254757|FG006|NOT COMPLETED|Overall Study||0
11072772|NCT01078298|12254767|FG000|STARTED|Overall Study||256
11072773|NCT01078298|12254768|FG001|STARTED|Overall Study||269
11072774|NCT01078298|12254767|FG000|COMPLETED|Overall Study||175
11072775|NCT01078298|12254768|FG001|COMPLETED|Overall Study||179
11072776|NCT01078298|12254767|FG000|NOT COMPLETED|Overall Study||81
11072777|NCT01078298|12254768|FG001|NOT COMPLETED|Overall Study||90
11072778|NCT01078363|12254776|FG000|STARTED|Overall Study||47
11072779|NCT01078363|12254777|FG001|STARTED|Overall Study||49
11072780|NCT01078363|12254776|FG000|COMPLETED|Overall Study||47
11072781|NCT01078363|12254777|FG001|COMPLETED|Overall Study||49
11072782|NCT01078363|12254776|FG000|NOT COMPLETED|Overall Study||0
11072783|NCT01078363|12254777|FG001|NOT COMPLETED|Overall Study||0
11072784|NCT01078376|12254789|FG000|STARTED|Overall Study||9
11072785|NCT01078376|12254790|FG001|STARTED|Overall Study||9
11072786|NCT01078376|12254791|FG002|STARTED|Overall Study||8
11072787|NCT01078376|12254792|FG003|STARTED|Overall Study||3
11072788|NCT01078376|12254789|FG000|COMPLETED|Overall Study||9
11072789|NCT01078376|12254790|FG001|COMPLETED|Overall Study||9
11072790|NCT01078376|12254791|FG002|COMPLETED|Overall Study||8
11072791|NCT01078376|12254792|FG003|COMPLETED|Overall Study||3
11072792|NCT01078376|12254789|FG000|NOT COMPLETED|Overall Study||0
11072793|NCT01078376|12254790|FG001|NOT COMPLETED|Overall Study||0
11072794|NCT01078376|12254791|FG002|NOT COMPLETED|Overall Study||0
11072795|NCT01078376|12254792|FG003|NOT COMPLETED|Overall Study||0
11072796|NCT01078389|12254807|FG000|STARTED|Overall Study||157
11072797|NCT01078389|12254808|FG001|STARTED|Overall Study||157
11072798|NCT01078389|12254807|FG000|COMPLETED|Overall Study||93
11072799|NCT01078389|12254808|FG001|COMPLETED|Overall Study||90
11072800|NCT01078389|12254807|FG000|NOT COMPLETED|Overall Study||64
11072801|NCT01078389|12254808|FG001|NOT COMPLETED|Overall Study||67
11072802|NCT01078402|12254817|FG000|STARTED|Overall Study||431
11072803|NCT01078402|12254818|FG001|STARTED|Overall Study||124
11072804|NCT01078402|12254819|FG002|STARTED|Overall Study||234
11072805|NCT01078402|12254817|FG000|COMPLETED|Overall Study||324
11072806|NCT01078402|12254818|FG001|COMPLETED|Overall Study||95
11072807|NCT01078402|12254819|FG002|COMPLETED|Overall Study||166
11072808|NCT01078402|12254817|FG000|NOT COMPLETED|Overall Study||107
11072809|NCT01078402|12254818|FG001|NOT COMPLETED|Overall Study||29
11072810|NCT01078402|12254819|FG002|NOT COMPLETED|Overall Study||68
11072811|NCT01078441|12254831|FG000|STARTED|Overall Study||2
11072812|NCT01078441|12254831|FG000|COMPLETED|Overall Study||1
11072813|NCT01078441|12254831|FG000|NOT COMPLETED|Overall Study||1
11072814|NCT01078545|12254835|FG000|STARTED|Overall Study||729
11072815|NCT01078545|12254835|FG000|Intent-to-treat Population|Overall Study||729
11072816|NCT01078545|12254835|FG000|Per Protocol Population|Overall Study||661
11072817|NCT01078545|12254835|FG000|COMPLETED|Overall Study||703
11072818|NCT01078545|12254835|FG000|NOT COMPLETED|Overall Study||26
11072819|NCT01078558|12254842|FG000|STARTED|Overall Study||2836
11072820|NCT01078558|12254843|FG001|STARTED|Overall Study||1127
11072821|NCT01078558|12254844|FG002|STARTED|Overall Study||1957
11072822|NCT01078558|12254842|FG000|Oligoarticular PsA|Overall Study||0
11072823|NCT01078558|12254843|FG001|Oligoarticular PsA|Overall Study||197
11072824|NCT01078558|12254844|FG002|Oligoarticular PsA|Overall Study||0
11072825|NCT01078558|12254842|FG000|COMPLETED|Overall Study||818
11072826|NCT01078558|12254843|FG001|COMPLETED|Overall Study||372
11072827|NCT01078558|12254844|FG002|COMPLETED|Overall Study||596
11072828|NCT01078558|12254842|FG000|NOT COMPLETED|Overall Study||2018
11072829|NCT01078558|12254843|FG001|NOT COMPLETED|Overall Study||755
11072830|NCT01078558|12254844|FG002|NOT COMPLETED|Overall Study||1361
11072831|NCT01078571|12254852|FG000|STARTED|Overall Study||705
11072832|NCT01078571|12254852|FG000|Safety Population|Overall Study||675
11072833|NCT01078571|12254852|FG000|Intent-to-treat (ITT) Population|Overall Study||591
11072834|NCT01078571|12254852|FG000|COMPLETED|Overall Study||590
11072835|NCT01078571|12254852|FG000|NOT COMPLETED|Overall Study||115
11072836|NCT01078584|12254861|FG000|STARTED|Overall Study||7993
11072837|NCT01078584|12254861|FG000|Participants Conducted Visit 2 (3-month)|Overall Study||7125
11072838|NCT01078584|12254861|FG000|Participants Conducted Visit 3 (6-month)|Overall Study||5833
11072839|NCT01078584|12254861|FG000|Participants Conducted Visit 4(12-month)|Overall Study||4983
11072840|NCT01078584|12254861|FG000|COMPLETED|Overall Study||4983
11072841|NCT01078584|12254861|FG000|NOT COMPLETED|Overall Study||3010
11072842|NCT01078623|12254878|FG000|STARTED|Treatment Period 1||6
11072843|NCT01078623|12254879|FG001|STARTED|Treatment Period 1||6
11072844|NCT01078623|12254880|FG002|STARTED|Treatment Period 1||7
11072845|NCT01078623|12254881|FG003|STARTED|Treatment Period 1||6
11072846|NCT01078623|12254882|FG004|STARTED|Treatment Period 1||7
11072847|NCT01078623|12254883|FG005|STARTED|Treatment Period 1||6
11072848|NCT01078623|12254884|FG006|STARTED|Treatment Period 1||7
11072849|NCT01078623|12254885|FG007|STARTED|Treatment Period 1||7
11072850|NCT01078623|12254886|FG008|STARTED|Treatment Period 1||6
11072851|NCT01078623|12254887|FG009|STARTED|Treatment Period 1||7
11072852|NCT01078623|12254888|FG010|STARTED|Treatment Period 1||7
11072853|NCT01078623|12254889|FG011|STARTED|Treatment Period 1||7
11072854|NCT01078623|12254890|FG012|STARTED|Treatment Period 1||7
11072855|NCT01078623|12254891|FG013|STARTED|Treatment Period 1||7
11072856|NCT01078623|12254892|FG014|STARTED|Treatment Period 1||7
11072857|NCT01078623|12254893|FG015|STARTED|Treatment Period 1||7
11072858|NCT01078623|12254894|FG016|STARTED|Treatment Period 1||7
11072859|NCT01078623|12254895|FG017|STARTED|Treatment Period 1||7
11072860|NCT01078623|12254896|FG018|STARTED|Treatment Period 1||7
11072861|NCT01078623|12254897|FG019|STARTED|Treatment Period 1||7
11072862|NCT01078623|12254878|FG000|COMPLETED|Treatment Period 1||5
11072863|NCT01078623|12254879|FG001|COMPLETED|Treatment Period 1||5
11347321|NCT02991859|12544626|FG001|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
11347322|NCT02991859|12544627|FG002|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
11347323|NCT02991859|12544628|FG003|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
11347324|NCT02991859|12544629|FG004|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
11347325|NCT02991859|12544630|FG005|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
11347326|NCT02991859|12544631|FG006|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
11347327|NCT02991859|12544632|FG007|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
11347328|NCT02991859|12544633|FG008|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
11347329|NCT02991859|12544634|FG009|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
11347330|NCT02991859|12544635|FG010|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
11347331|NCT02991859|12544636|FG011|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
11347332|NCT02991859|12544637|FG012|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
11347333|NCT02991859|12544638|FG013|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
11347334|NCT02991859|12544639|FG014|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
11347335|NCT02991859|12544640|FG015|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
11347336|NCT02991859|12544641|FG016|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
11347337|NCT02991859|12544625|FG000|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347338|NCT02991859|12544626|FG001|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347339|NCT02991859|12544627|FG002|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347340|NCT02991859|12544628|FG003|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347341|NCT02991859|12544629|FG004|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347342|NCT02991859|12544630|FG005|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347343|NCT02991859|12544631|FG006|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347344|NCT02991859|12544632|FG007|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347345|NCT02991859|12544633|FG008|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347346|NCT02991859|12544634|FG009|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347347|NCT02991859|12544635|FG010|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347348|NCT02991859|12544636|FG011|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347349|NCT02991859|12544637|FG012|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
11347350|NCT02991859|12544638|FG013|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
11347351|NCT02991859|12544639|FG014|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347352|NCT02991859|12544640|FG015|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347353|NCT02991859|12544641|FG016|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
11347354|NCT02991859|12544625|FG000|STARTED|Period1, Escalation Phase4, Upto Day28||2
11347355|NCT02991859|12544626|FG001|STARTED|Period1, Escalation Phase4, Upto Day28||2
11347356|NCT02991859|12544627|FG002|STARTED|Period1, Escalation Phase4, Upto Day28||2
11347357|NCT02991859|12544628|FG003|STARTED|Period1, Escalation Phase4, Upto Day28||2
11347358|NCT02991859|12544629|FG004|STARTED|Period1, Escalation Phase4, Upto Day28||2
11347359|NCT02991859|12544630|FG005|STARTED|Period1, Escalation Phase4, Upto Day28|1 Par completed Phase 3 did not enter Phase 4|2
11347360|NCT02991859|12544631|FG006|STARTED|Period1, Escalation Phase4, Upto Day28||2
11347361|NCT02991859|12544632|FG007|STARTED|Period1, Escalation Phase4, Upto Day28||2
11347362|NCT02991859|12544633|FG008|STARTED|Period1, Escalation Phase4, Upto Day28||2
11347363|NCT02991859|12544634|FG009|STARTED|Period1, Escalation Phase4, Upto Day28||2
11072864|NCT01078623|12254880|FG002|COMPLETED|Treatment Period 1||6
11072865|NCT01078623|12254881|FG003|COMPLETED|Treatment Period 1||6
11072866|NCT01078623|12254882|FG004|COMPLETED|Treatment Period 1||7
11347364|NCT02991859|12544635|FG010|STARTED|Period1, Escalation Phase4, Upto Day28||2
11347365|NCT02991859|12544636|FG011|STARTED|Period1, Escalation Phase4, Upto Day28||2
11347366|NCT02991859|12544637|FG012|STARTED|Period1, Escalation Phase4, Upto Day28||6
11347367|NCT02991859|12544638|FG013|STARTED|Period1, Escalation Phase4, Upto Day28||6
11347368|NCT02991859|12544639|FG014|STARTED|Period1, Escalation Phase4, Upto Day28||6
11347369|NCT02991859|12544640|FG015|STARTED|Period1, Escalation Phase4, Upto Day28||3
11347370|NCT02991859|12544641|FG016|STARTED|Period1, Escalation Phase4, Upto Day28||3
11347371|NCT02991859|12544625|FG000|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
11347372|NCT02991859|12544626|FG001|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
11347373|NCT02991859|12544627|FG002|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
11347374|NCT02991859|12544628|FG003|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
11347375|NCT02991859|12544629|FG004|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
11347376|NCT02991859|12544630|FG005|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
11347377|NCT02991859|12544631|FG006|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
11347378|NCT02991859|12544632|FG007|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
11347379|NCT02991859|12544633|FG008|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
11347380|NCT02991859|12544634|FG009|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
11347381|NCT02991859|12544635|FG010|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
11347382|NCT02991859|12544636|FG011|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
11347383|NCT02991859|12544637|FG012|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
11347384|NCT02991859|12544638|FG013|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
11072867|NCT01078623|12254883|FG005|COMPLETED|Treatment Period 1||5
11072868|NCT01078623|12254884|FG006|COMPLETED|Treatment Period 1||6
11072869|NCT01078623|12254885|FG007|COMPLETED|Treatment Period 1||6
11072870|NCT01078623|12254886|FG008|COMPLETED|Treatment Period 1||5
11072871|NCT01078623|12254887|FG009|COMPLETED|Treatment Period 1||6
11072872|NCT01078623|12254888|FG010|COMPLETED|Treatment Period 1||6
11072873|NCT01078623|12254889|FG011|COMPLETED|Treatment Period 1||7
11072874|NCT01078623|12254890|FG012|COMPLETED|Treatment Period 1||7
11072875|NCT01078623|12254891|FG013|COMPLETED|Treatment Period 1||7
11072876|NCT01078623|12254892|FG014|COMPLETED|Treatment Period 1||7
11072877|NCT01078623|12254893|FG015|COMPLETED|Treatment Period 1||7
11072878|NCT01078623|12254894|FG016|COMPLETED|Treatment Period 1||7
11072879|NCT01078623|12254895|FG017|COMPLETED|Treatment Period 1||7
11072880|NCT01078623|12254896|FG018|COMPLETED|Treatment Period 1||7
11072881|NCT01078623|12254897|FG019|COMPLETED|Treatment Period 1||7
11072882|NCT01078623|12254878|FG000|NOT COMPLETED|Treatment Period 1||1
11072883|NCT01078623|12254879|FG001|NOT COMPLETED|Treatment Period 1||1
11072884|NCT01078623|12254880|FG002|NOT COMPLETED|Treatment Period 1||1
11072885|NCT01078623|12254881|FG003|NOT COMPLETED|Treatment Period 1||0
11072886|NCT01078623|12254882|FG004|NOT COMPLETED|Treatment Period 1||0
11072887|NCT01078623|12254883|FG005|NOT COMPLETED|Treatment Period 1||1
11072888|NCT01078623|12254884|FG006|NOT COMPLETED|Treatment Period 1||1
11072889|NCT01078623|12254885|FG007|NOT COMPLETED|Treatment Period 1||1
11072890|NCT01078623|12254886|FG008|NOT COMPLETED|Treatment Period 1||1
11072891|NCT01078623|12254887|FG009|NOT COMPLETED|Treatment Period 1||1
11072892|NCT01078623|12254888|FG010|NOT COMPLETED|Treatment Period 1||1
11072893|NCT01078623|12254889|FG011|NOT COMPLETED|Treatment Period 1||0
11072894|NCT01078623|12254890|FG012|NOT COMPLETED|Treatment Period 1||0
11072895|NCT01078623|12254891|FG013|NOT COMPLETED|Treatment Period 1||0
11072896|NCT01078623|12254892|FG014|NOT COMPLETED|Treatment Period 1||0
11072897|NCT01078623|12254893|FG015|NOT COMPLETED|Treatment Period 1||0
11072898|NCT01078623|12254894|FG016|NOT COMPLETED|Treatment Period 1||0
11072899|NCT01078623|12254895|FG017|NOT COMPLETED|Treatment Period 1||0
11072900|NCT01078623|12254896|FG018|NOT COMPLETED|Treatment Period 1||0
11072901|NCT01078623|12254897|FG019|NOT COMPLETED|Treatment Period 1||0
11072902|NCT01078623|12254878|FG000|STARTED|Treatment Period 2||5
11072903|NCT01078623|12254879|FG001|STARTED|Treatment Period 2||5
11072904|NCT01078623|12254880|FG002|STARTED|Treatment Period 2||6
11072905|NCT01078623|12254881|FG003|STARTED|Treatment Period 2||6
11072906|NCT01078623|12254882|FG004|STARTED|Treatment Period 2||7
11072907|NCT01078623|12254883|FG005|STARTED|Treatment Period 2||5
11072908|NCT01078623|12254884|FG006|STARTED|Treatment Period 2||6
11072909|NCT01078623|12254885|FG007|STARTED|Treatment Period 2||6
11072910|NCT01078623|12254886|FG008|STARTED|Treatment Period 2||5
11072911|NCT01078623|12254887|FG009|STARTED|Treatment Period 2||6
11072912|NCT01078623|12254888|FG010|STARTED|Treatment Period 2||6
11072913|NCT01078623|12254889|FG011|STARTED|Treatment Period 2||7
11072914|NCT01078623|12254890|FG012|STARTED|Treatment Period 2||7
11072915|NCT01078623|12254891|FG013|STARTED|Treatment Period 2||7
11072916|NCT01078623|12254892|FG014|STARTED|Treatment Period 2||7
11072917|NCT01078623|12254893|FG015|STARTED|Treatment Period 2||7
11072918|NCT01078623|12254894|FG016|STARTED|Treatment Period 2||7
11072919|NCT01078623|12254895|FG017|STARTED|Treatment Period 2||7
11072920|NCT01078623|12254896|FG018|STARTED|Treatment Period 2||7
11072921|NCT01078623|12254897|FG019|STARTED|Treatment Period 2||7
11072922|NCT01078623|12254878|FG000|COMPLETED|Treatment Period 2||5
11072923|NCT01078623|12254879|FG001|COMPLETED|Treatment Period 2||5
11072924|NCT01078623|12254880|FG002|COMPLETED|Treatment Period 2||6
11072925|NCT01078623|12254881|FG003|COMPLETED|Treatment Period 2||6
11072926|NCT01078623|12254882|FG004|COMPLETED|Treatment Period 2||7
11347385|NCT02991859|12544639|FG014|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
11347386|NCT02991859|12544640|FG015|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
11347387|NCT02991859|12544641|FG016|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
11347388|NCT02991859|12544625|FG000|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347389|NCT02991859|12544626|FG001|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347390|NCT02991859|12544627|FG002|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347391|NCT02991859|12544628|FG003|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347392|NCT02991859|12544629|FG004|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11072927|NCT01078623|12254883|FG005|COMPLETED|Treatment Period 2||4
11072928|NCT01078623|12254884|FG006|COMPLETED|Treatment Period 2||5
11072929|NCT01078623|12254885|FG007|COMPLETED|Treatment Period 2||6
11072930|NCT01078623|12254886|FG008|COMPLETED|Treatment Period 2||5
11072931|NCT01078623|12254887|FG009|COMPLETED|Treatment Period 2||6
11072932|NCT01078623|12254888|FG010|COMPLETED|Treatment Period 2||6
11072933|NCT01078623|12254889|FG011|COMPLETED|Treatment Period 2||7
11072934|NCT01078623|12254890|FG012|COMPLETED|Treatment Period 2||7
11072935|NCT01078623|12254891|FG013|COMPLETED|Treatment Period 2||7
11072936|NCT01078623|12254892|FG014|COMPLETED|Treatment Period 2||7
11072937|NCT01078623|12254893|FG015|COMPLETED|Treatment Period 2||7
11072938|NCT01078623|12254894|FG016|COMPLETED|Treatment Period 2||7
11072939|NCT01078623|12254895|FG017|COMPLETED|Treatment Period 2||7
11072940|NCT01078623|12254896|FG018|COMPLETED|Treatment Period 2||6
11072941|NCT01078623|12254897|FG019|COMPLETED|Treatment Period 2||7
11072942|NCT01078623|12254878|FG000|NOT COMPLETED|Treatment Period 2||0
11072943|NCT01078623|12254879|FG001|NOT COMPLETED|Treatment Period 2||0
11072944|NCT01078623|12254880|FG002|NOT COMPLETED|Treatment Period 2||0
11072945|NCT01078623|12254881|FG003|NOT COMPLETED|Treatment Period 2||0
11072946|NCT01078623|12254882|FG004|NOT COMPLETED|Treatment Period 2||0
11072947|NCT01078623|12254883|FG005|NOT COMPLETED|Treatment Period 2||1
11072948|NCT01078623|12254884|FG006|NOT COMPLETED|Treatment Period 2||1
11072949|NCT01078623|12254885|FG007|NOT COMPLETED|Treatment Period 2||0
11072950|NCT01078623|12254886|FG008|NOT COMPLETED|Treatment Period 2||0
11072951|NCT01078623|12254887|FG009|NOT COMPLETED|Treatment Period 2||0
11072952|NCT01078623|12254888|FG010|NOT COMPLETED|Treatment Period 2||0
11072953|NCT01078623|12254889|FG011|NOT COMPLETED|Treatment Period 2||0
11072954|NCT01078623|12254890|FG012|NOT COMPLETED|Treatment Period 2||0
11072955|NCT01078623|12254891|FG013|NOT COMPLETED|Treatment Period 2||0
11072956|NCT01078623|12254892|FG014|NOT COMPLETED|Treatment Period 2||0
11072957|NCT01078623|12254893|FG015|NOT COMPLETED|Treatment Period 2||0
11072958|NCT01078623|12254894|FG016|NOT COMPLETED|Treatment Period 2||0
11072959|NCT01078623|12254895|FG017|NOT COMPLETED|Treatment Period 2||0
11072960|NCT01078623|12254896|FG018|NOT COMPLETED|Treatment Period 2||1
11072961|NCT01078623|12254897|FG019|NOT COMPLETED|Treatment Period 2||0
11072962|NCT01078623|12254878|FG000|STARTED|Treatment Period 3||5
11072963|NCT01078623|12254879|FG001|STARTED|Treatment Period 3||5
11072964|NCT01078623|12254880|FG002|STARTED|Treatment Period 3||6
11072965|NCT01078623|12254881|FG003|STARTED|Treatment Period 3||6
11072966|NCT01078623|12254882|FG004|STARTED|Treatment Period 3||7
11072967|NCT01078623|12254883|FG005|STARTED|Treatment Period 3||4
11072968|NCT01078623|12254884|FG006|STARTED|Treatment Period 3||5
11072969|NCT01078623|12254885|FG007|STARTED|Treatment Period 3||6
11072970|NCT01078623|12254886|FG008|STARTED|Treatment Period 3||5
11072971|NCT01078623|12254887|FG009|STARTED|Treatment Period 3||6
11072972|NCT01078623|12254888|FG010|STARTED|Treatment Period 3||6
11072973|NCT01078623|12254889|FG011|STARTED|Treatment Period 3||7
11072974|NCT01078623|12254890|FG012|STARTED|Treatment Period 3||7
11072975|NCT01078623|12254891|FG013|STARTED|Treatment Period 3||7
11072976|NCT01078623|12254892|FG014|STARTED|Treatment Period 3||7
11072977|NCT01078623|12254893|FG015|STARTED|Treatment Period 3||7
11072978|NCT01078623|12254894|FG016|STARTED|Treatment Period 3||7
11072979|NCT01078623|12254895|FG017|STARTED|Treatment Period 3||7
11072980|NCT01078623|12254896|FG018|STARTED|Treatment Period 3||6
11072981|NCT01078623|12254897|FG019|STARTED|Treatment Period 3||7
11072982|NCT01078623|12254878|FG000|COMPLETED|Treatment Period 3||5
11072983|NCT01078623|12254879|FG001|COMPLETED|Treatment Period 3||5
11072984|NCT01078623|12254880|FG002|COMPLETED|Treatment Period 3||6
11072985|NCT01078623|12254881|FG003|COMPLETED|Treatment Period 3||6
11072986|NCT01078623|12254882|FG004|COMPLETED|Treatment Period 3||6
11072987|NCT01078623|12254883|FG005|COMPLETED|Treatment Period 3||4
11072988|NCT01078623|12254884|FG006|COMPLETED|Treatment Period 3||5
11072989|NCT01078623|12254885|FG007|COMPLETED|Treatment Period 3||6
11072990|NCT01078623|12254886|FG008|COMPLETED|Treatment Period 3||5
11072991|NCT01078623|12254887|FG009|COMPLETED|Treatment Period 3||6
11072992|NCT01078623|12254888|FG010|COMPLETED|Treatment Period 3||6
11072993|NCT01078623|12254889|FG011|COMPLETED|Treatment Period 3||7
11072994|NCT01078623|12254890|FG012|COMPLETED|Treatment Period 3||7
11072995|NCT01078623|12254891|FG013|COMPLETED|Treatment Period 3||6
11072996|NCT01078623|12254892|FG014|COMPLETED|Treatment Period 3||7
11072997|NCT01078623|12254893|FG015|COMPLETED|Treatment Period 3||7
11072998|NCT01078623|12254894|FG016|COMPLETED|Treatment Period 3||7
11072999|NCT01078623|12254895|FG017|COMPLETED|Treatment Period 3||7
11073000|NCT01078623|12254896|FG018|COMPLETED|Treatment Period 3||6
11073001|NCT01078623|12254897|FG019|COMPLETED|Treatment Period 3||7
11073002|NCT01078623|12254878|FG000|NOT COMPLETED|Treatment Period 3||0
11073003|NCT01078623|12254879|FG001|NOT COMPLETED|Treatment Period 3||0
11073004|NCT01078623|12254880|FG002|NOT COMPLETED|Treatment Period 3||0
11073005|NCT01078623|12254881|FG003|NOT COMPLETED|Treatment Period 3||0
11073006|NCT01078623|12254882|FG004|NOT COMPLETED|Treatment Period 3||1
11073007|NCT01078623|12254883|FG005|NOT COMPLETED|Treatment Period 3||0
11073008|NCT01078623|12254884|FG006|NOT COMPLETED|Treatment Period 3||0
11073009|NCT01078623|12254885|FG007|NOT COMPLETED|Treatment Period 3||0
11073010|NCT01078623|12254886|FG008|NOT COMPLETED|Treatment Period 3||0
11073011|NCT01078623|12254887|FG009|NOT COMPLETED|Treatment Period 3||0
11073012|NCT01078623|12254888|FG010|NOT COMPLETED|Treatment Period 3||0
11073013|NCT01078623|12254889|FG011|NOT COMPLETED|Treatment Period 3||0
11073014|NCT01078623|12254890|FG012|NOT COMPLETED|Treatment Period 3||0
11073015|NCT01078623|12254891|FG013|NOT COMPLETED|Treatment Period 3||1
11073016|NCT01078623|12254892|FG014|NOT COMPLETED|Treatment Period 3||0
11073017|NCT01078623|12254893|FG015|NOT COMPLETED|Treatment Period 3||0
11073018|NCT01078623|12254894|FG016|NOT COMPLETED|Treatment Period 3||0
11073019|NCT01078623|12254895|FG017|NOT COMPLETED|Treatment Period 3||0
11073020|NCT01078623|12254896|FG018|NOT COMPLETED|Treatment Period 3||0
11073021|NCT01078623|12254897|FG019|NOT COMPLETED|Treatment Period 3||0
11073022|NCT01078623|12254878|FG000|STARTED|Treatment Period 4||5
11073023|NCT01078623|12254879|FG001|STARTED|Treatment Period 4||5
11073024|NCT01078623|12254880|FG002|STARTED|Treatment Period 4||6
11073025|NCT01078623|12254881|FG003|STARTED|Treatment Period 4||6
11073026|NCT01078623|12254882|FG004|STARTED|Treatment Period 4||6
11073027|NCT01078623|12254883|FG005|STARTED|Treatment Period 4||4
11073028|NCT01078623|12254884|FG006|STARTED|Treatment Period 4||5
11073029|NCT01078623|12254885|FG007|STARTED|Treatment Period 4||6
11073030|NCT01078623|12254886|FG008|STARTED|Treatment Period 4||5
11073031|NCT01078623|12254887|FG009|STARTED|Treatment Period 4||6
11073032|NCT01078623|12254888|FG010|STARTED|Treatment Period 4||6
11073033|NCT01078623|12254889|FG011|STARTED|Treatment Period 4||7
11073034|NCT01078623|12254890|FG012|STARTED|Treatment Period 4||7
11073035|NCT01078623|12254891|FG013|STARTED|Treatment Period 4||6
11073036|NCT01078623|12254892|FG014|STARTED|Treatment Period 4||7
11073037|NCT01078623|12254893|FG015|STARTED|Treatment Period 4||7
11073038|NCT01078623|12254894|FG016|STARTED|Treatment Period 4||7
11073039|NCT01078623|12254895|FG017|STARTED|Treatment Period 4||7
11073040|NCT01078623|12254896|FG018|STARTED|Treatment Period 4||6
11073041|NCT01078623|12254897|FG019|STARTED|Treatment Period 4||7
11073042|NCT01078623|12254878|FG000|COMPLETED|Treatment Period 4||5
11073043|NCT01078623|12254879|FG001|COMPLETED|Treatment Period 4||5
11073044|NCT01078623|12254880|FG002|COMPLETED|Treatment Period 4||5
11073045|NCT01078623|12254881|FG003|COMPLETED|Treatment Period 4||6
11073046|NCT01078623|12254882|FG004|COMPLETED|Treatment Period 4||6
11073047|NCT01078623|12254883|FG005|COMPLETED|Treatment Period 4||4
11073048|NCT01078623|12254884|FG006|COMPLETED|Treatment Period 4||5
11073049|NCT01078623|12254885|FG007|COMPLETED|Treatment Period 4||6
11073050|NCT01078623|12254886|FG008|COMPLETED|Treatment Period 4||5
11073051|NCT01078623|12254887|FG009|COMPLETED|Treatment Period 4||6
11073052|NCT01078623|12254888|FG010|COMPLETED|Treatment Period 4||6
11073053|NCT01078623|12254889|FG011|COMPLETED|Treatment Period 4||7
11073054|NCT01078623|12254890|FG012|COMPLETED|Treatment Period 4||7
11073055|NCT01078623|12254891|FG013|COMPLETED|Treatment Period 4||6
11073056|NCT01078623|12254892|FG014|COMPLETED|Treatment Period 4||7
11073057|NCT01078623|12254893|FG015|COMPLETED|Treatment Period 4||6
11073058|NCT01078623|12254894|FG016|COMPLETED|Treatment Period 4||7
11073059|NCT01078623|12254895|FG017|COMPLETED|Treatment Period 4||7
11073060|NCT01078623|12254896|FG018|COMPLETED|Treatment Period 4||6
11073061|NCT01078623|12254897|FG019|COMPLETED|Treatment Period 4||7
11073062|NCT01078623|12254878|FG000|NOT COMPLETED|Treatment Period 4||0
11073063|NCT01078623|12254879|FG001|NOT COMPLETED|Treatment Period 4||0
11073064|NCT01078623|12254880|FG002|NOT COMPLETED|Treatment Period 4||1
11073065|NCT01078623|12254881|FG003|NOT COMPLETED|Treatment Period 4||0
11073066|NCT01078623|12254882|FG004|NOT COMPLETED|Treatment Period 4||0
11073067|NCT01078623|12254883|FG005|NOT COMPLETED|Treatment Period 4||0
11073068|NCT01078623|12254884|FG006|NOT COMPLETED|Treatment Period 4||0
11073069|NCT01078623|12254885|FG007|NOT COMPLETED|Treatment Period 4||0
11073070|NCT01078623|12254886|FG008|NOT COMPLETED|Treatment Period 4||0
11073071|NCT01078623|12254887|FG009|NOT COMPLETED|Treatment Period 4||0
11073072|NCT01078623|12254888|FG010|NOT COMPLETED|Treatment Period 4||0
11073073|NCT01078623|12254889|FG011|NOT COMPLETED|Treatment Period 4||0
11073074|NCT01078623|12254890|FG012|NOT COMPLETED|Treatment Period 4||0
11073075|NCT01078623|12254891|FG013|NOT COMPLETED|Treatment Period 4||0
11073076|NCT01078623|12254892|FG014|NOT COMPLETED|Treatment Period 4||0
11073077|NCT01078623|12254893|FG015|NOT COMPLETED|Treatment Period 4||1
11073078|NCT01078623|12254894|FG016|NOT COMPLETED|Treatment Period 4||0
11073079|NCT01078623|12254895|FG017|NOT COMPLETED|Treatment Period 4||0
11073080|NCT01078623|12254896|FG018|NOT COMPLETED|Treatment Period 4||0
11073081|NCT01078623|12254897|FG019|NOT COMPLETED|Treatment Period 4||0
11073082|NCT01078675|12254911|FG000|STARTED|Overall Study||250
11073083|NCT01078675|12254912|FG001|STARTED|Overall Study||65
11073084|NCT01078675|12254911|FG000|Patients Treated|Overall Study||198
11073085|NCT01078675|12254912|FG001|Patients Treated|Overall Study||0
11073086|NCT01078675|12254911|FG000|COMPLETED|Overall Study||182
11073087|NCT01078675|12254912|FG001|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
11073088|NCT01078675|12254911|FG000|NOT COMPLETED|Overall Study||68
11073089|NCT01078675|12254912|FG001|NOT COMPLETED|Overall Study||6
11073090|NCT01078753|12254920|FG000|STARTED|Treatment Period I||45
11073091|NCT01078753|12254921|FG001|STARTED|Treatment Period I||44
11073092|NCT01078753|12254920|FG000|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
11073093|NCT01078753|12254921|FG001|Full Analysis Set|Treatment Period I||44
11073094|NCT01078753|12254920|FG000|COMPLETED|Treatment Period I||45
11073095|NCT01078753|12254921|FG001|COMPLETED|Treatment Period I||44
11073096|NCT01078753|12254920|FG000|NOT COMPLETED|Treatment Period I||0
11073097|NCT01078753|12254921|FG001|NOT COMPLETED|Treatment Period I||0
11073098|NCT01078753|12254920|FG000|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
11073099|NCT01078753|12254921|FG001|STARTED|Treatment Period II||44
11073100|NCT01078753|12254920|FG000|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
11073101|NCT01078753|12254921|FG001|Full Analysis Set|Treatment Period II||44
11073102|NCT01078753|12254920|FG000|COMPLETED|Treatment Period II||45
11073103|NCT01078753|12254921|FG001|COMPLETED|Treatment Period II||44
11073104|NCT01078753|12254920|FG000|NOT COMPLETED|Treatment Period II||0
11073105|NCT01078753|12254921|FG001|NOT COMPLETED|Treatment Period II||0
11073106|NCT01078805|12254927|FG000|STARTED|Overall Study||4167
11073107|NCT01078805|12254927|FG000|Took at Least 1 Dose of Study Drug|Overall Study||4085
11073108|NCT01078805|12254927|FG000|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
11073109|NCT01078805|12254927|FG000|COMPLETED|Overall Study||2117
11073110|NCT01078805|12254927|FG000|NOT COMPLETED|Overall Study||2050
11073111|NCT01078909|12254936|FG000|STARTED|Overall Study||25
11073112|NCT01078909|12254937|FG001|STARTED|Overall Study||25
11073113|NCT01078909|12254938|FG002|STARTED|Overall Study||25
11073114|NCT01078909|12254939|FG003|STARTED|Overall Study||25
11073115|NCT01078909|12254940|FG004|STARTED|Overall Study||25
11073116|NCT01078909|12254936|FG000|COMPLETED|Overall Study||23
11073117|NCT01078909|12254937|FG001|COMPLETED|Overall Study||21
11073118|NCT01078909|12254938|FG002|COMPLETED|Overall Study||24
11073119|NCT01078909|12254939|FG003|COMPLETED|Overall Study||24
11073120|NCT01078909|12254940|FG004|COMPLETED|Overall Study||23
11073121|NCT01078909|12254936|FG000|NOT COMPLETED|Overall Study||2
11073122|NCT01078909|12254937|FG001|NOT COMPLETED|Overall Study||4
11073123|NCT01078909|12254938|FG002|NOT COMPLETED|Overall Study||1
11073124|NCT01078909|12254939|FG003|NOT COMPLETED|Overall Study||1
11073125|NCT01078909|12254940|FG004|NOT COMPLETED|Overall Study||2
11073126|NCT01078922|12254952|FG000|STARTED|Overall Study||11
11073127|NCT01078922|12254952|FG000|COMPLETED|Overall Study||10
11073128|NCT01078922|12254952|FG000|NOT COMPLETED|Overall Study||1
11073129|NCT01078974|12254957|FG000|STARTED|Overall Study||7
11073130|NCT01078974|12254957|FG000|COMPLETED|Overall Study||4
11073131|NCT01078974|12254957|FG000|NOT COMPLETED|Overall Study||3
11073132|NCT01079130|12254967|FG000|STARTED|Overall Study||85
11073133|NCT01079130|12254968|FG001|STARTED|Overall Study||85
11073134|NCT01079130|12254969|FG002|STARTED|Overall Study||84
11073135|NCT01079130|12254970|FG003|STARTED|Overall Study||86
11073136|NCT01079130|12254971|FG004|STARTED|Overall Study||86
11073137|NCT01079130|12254972|FG005|STARTED|Overall Study||85
11073138|NCT01079130|12254967|FG000|Safety Set: Received Study Drug|Overall Study||84
11073139|NCT01079130|12254968|FG001|Safety Set: Received Study Drug|Overall Study||81
11073140|NCT01079130|12254969|FG002|Safety Set: Received Study Drug|Overall Study||84
11073141|NCT01079130|12254970|FG003|Safety Set: Received Study Drug|Overall Study||85
11073142|NCT01079130|12254971|FG004|Safety Set: Received Study Drug|Overall Study||84
11073143|NCT01079130|12254972|FG005|Safety Set: Received Study Drug|Overall Study||84
11073144|NCT01079130|12254967|FG000|Full Analysis Set (FAS)|Overall Study||84
11073145|NCT01079130|12254968|FG001|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
11073146|NCT01079130|12254969|FG002|Full Analysis Set (FAS)|Overall Study||83
11073147|NCT01079130|12254970|FG003|Full Analysis Set (FAS)|Overall Study||85
11073148|NCT01079130|12254971|FG004|Full Analysis Set (FAS)|Overall Study||84
11073149|NCT01079130|12254972|FG005|Full Analysis Set (FAS)|Overall Study||84
11073150|NCT01079130|12254967|FG000|COMPLETED|Overall Study||83
11073151|NCT01079130|12254968|FG001|COMPLETED|Overall Study||78
11073152|NCT01079130|12254969|FG002|COMPLETED|Overall Study||83
11073153|NCT01079130|12254970|FG003|COMPLETED|Overall Study||81
11073154|NCT01079130|12254971|FG004|COMPLETED|Overall Study||78
11073155|NCT01079130|12254972|FG005|COMPLETED|Overall Study||80
11073156|NCT01079130|12254967|FG000|NOT COMPLETED|Overall Study||2
11073157|NCT01079130|12254968|FG001|NOT COMPLETED|Overall Study||7
11073158|NCT01079130|12254969|FG002|NOT COMPLETED|Overall Study||1
11073159|NCT01079130|12254970|FG003|NOT COMPLETED|Overall Study||5
11073160|NCT01079130|12254971|FG004|NOT COMPLETED|Overall Study||8
11073161|NCT01079130|12254972|FG005|NOT COMPLETED|Overall Study||5
11073162|NCT01079143|12254990|FG000|STARTED|Overall Study||36
11073163|NCT01079143|12254991|FG001|STARTED|Overall Study||60
11073164|NCT01079143|12254992|FG002|STARTED|Overall Study||39
11073165|NCT01079143|12254993|FG003|STARTED|Overall Study||59
11073166|NCT01079143|12254990|FG000|Exposed|Overall Study||36
11073167|NCT01079143|12254991|FG001|Exposed|Overall Study||60
11073168|NCT01079143|12254992|FG002|Exposed|Overall Study||39
11073169|NCT01079143|12254993|FG003|Exposed|Overall Study||59
11073170|NCT01079143|12254990|FG000|Month 3 (M3) Biopsies|Overall Study||36
11073171|NCT01079143|12254991|FG001|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
11073172|NCT01079143|12254992|FG002|Month 3 (M3) Biopsies|Overall Study||39
11073173|NCT01079143|12254993|FG003|Month 3 (M3) Biopsies|Overall Study||59
11073174|NCT01079143|12254990|FG000|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
11073175|NCT01079143|12254991|FG001|Month 12 (M12) Biopsies|Overall Study||43
11073176|NCT01079143|12254992|FG002|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
11073177|NCT01079143|12254993|FG003|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
11073178|NCT01079143|12254990|FG000|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
11073179|NCT01079143|12254991|FG001|M3 and M12 Biopsies|Overall Study||43
11073180|NCT01079143|12254992|FG002|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
11073181|NCT01079143|12254993|FG003|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
11073182|NCT01079143|12254990|FG000|COMPLETED|Overall Study||27
11073183|NCT01079143|12254991|FG001|COMPLETED|Overall Study||43
11073184|NCT01079143|12254992|FG002|COMPLETED|Overall Study||34
11073185|NCT01079143|12254993|FG003|COMPLETED|Overall Study||54
11073186|NCT01079143|12254990|FG000|NOT COMPLETED|Overall Study||9
11073187|NCT01079143|12254991|FG001|NOT COMPLETED|Overall Study||17
11073188|NCT01079143|12254992|FG002|NOT COMPLETED|Overall Study||5
11073189|NCT01079143|12254993|FG003|NOT COMPLETED|Overall Study||5
11073190|NCT01079182|12255007|FG000|STARTED|Overall Study||4681
11073191|NCT01079182|12255007|FG000|COMPLETED|Overall Study||1962
11073192|NCT01079182|12255007|FG000|NOT COMPLETED|Overall Study||2719
11073193|NCT01079195|12255011|FG000|STARTED|Overall Study||15873
11073194|NCT01079195|12255011|FG000|COMPLETED|Overall Study||14442
11073195|NCT01079195|12255011|FG000|NOT COMPLETED|Overall Study||1431
11073196|NCT01079234|12255018|FG000|STARTED|Main: Week 0 to 26||164
11073197|NCT01079234|12255019|FG001|STARTED|Main: Week 0 to 26||165
11073198|NCT01079234|12255020|FG002|STARTED|Main: Week 0 to 26||164
11073199|NCT01079234|12255021|FG003|STARTED|Main: Week 0 to 26||0
11073200|NCT01079234|12255018|FG000|Exposed|Main: Week 0 to 26||164
11073201|NCT01079234|12255019|FG001|Exposed|Main: Week 0 to 26||165
11073202|NCT01079234|12255020|FG002|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
11073203|NCT01079234|12255021|FG003|Exposed|Main: Week 0 to 26||0
11073204|NCT01079234|12255018|FG000|COMPLETED|Main: Week 0 to 26||138
11073205|NCT01079234|12255019|FG001|COMPLETED|Main: Week 0 to 26||139
11073206|NCT01079234|12255020|FG002|COMPLETED|Main: Week 0 to 26||152
11073207|NCT01079234|12255021|FG003|COMPLETED|Main: Week 0 to 26||0
11073208|NCT01079234|12255018|FG000|NOT COMPLETED|Main: Week 0 to 26||26
11073209|NCT01079234|12255019|FG001|NOT COMPLETED|Main: Week 0 to 26||26
11073210|NCT01079234|12255020|FG002|NOT COMPLETED|Main: Week 0 to 26||12
11073211|NCT01079234|12255021|FG003|NOT COMPLETED|Main: Week 0 to 26||0
11073212|NCT01079234|12255018|FG000|STARTED|Extension: Week 27 to 52||0
11073213|NCT01079234|12255019|FG001|STARTED|Extension: Week 27 to 52||0
11073214|NCT01079234|12255020|FG002|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
11073215|NCT01079234|12255021|FG003|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
11073216|NCT01079234|12255018|FG000|COMPLETED|Extension: Week 27 to 52||0
11073217|NCT01079234|12255019|FG001|COMPLETED|Extension: Week 27 to 52||0
11073218|NCT01079234|12255020|FG002|COMPLETED|Extension: Week 27 to 52||122
11073219|NCT01079234|12255021|FG003|COMPLETED|Extension: Week 27 to 52||223
11073220|NCT01079234|12255018|FG000|NOT COMPLETED|Extension: Week 27 to 52||0
11073221|NCT01079234|12255019|FG001|NOT COMPLETED|Extension: Week 27 to 52||0
11073222|NCT01079234|12255020|FG002|NOT COMPLETED|Extension: Week 27 to 52||11
11073223|NCT01079234|12255021|FG003|NOT COMPLETED|Extension: Week 27 to 52||16
11073224|NCT01079299|12255032|FG000|STARTED|Overall Study||27
11073225|NCT01079299|12255033|FG001|STARTED|Overall Study||25
11073226|NCT01079299|12255032|FG000|COMPLETED|Overall Study||27
11073227|NCT01079299|12255033|FG001|COMPLETED|Overall Study||25
11073228|NCT01079299|12255032|FG000|NOT COMPLETED|Overall Study||0
11073229|NCT01079299|12255033|FG001|NOT COMPLETED|Overall Study||0
11073230|NCT01079390|12255042|FG000|STARTED|Overall Study||15
11073231|NCT01079390|12255043|FG001|STARTED|Overall Study||15
11073232|NCT01079390|12255044|FG002|STARTED|Overall Study||14
11073233|NCT01079390|12255042|FG000|COMPLETED|Overall Study||10
11073234|NCT01079390|12255043|FG001|COMPLETED|Overall Study||10
11073235|NCT01079390|12255044|FG002|COMPLETED|Overall Study||10
11073236|NCT01079390|12255042|FG000|NOT COMPLETED|Overall Study||5
11073237|NCT01079390|12255043|FG001|NOT COMPLETED|Overall Study||5
11073238|NCT01079390|12255044|FG002|NOT COMPLETED|Overall Study||4
11073239|NCT01079663|12255056|FG000|STARTED|Overall Study||30
11073240|NCT01079663|12255057|FG001|STARTED|Overall Study||30
11073241|NCT01079663|12255056|FG000|COMPLETED|Overall Study||30
11073242|NCT01079663|12255057|FG001|COMPLETED|Overall Study||26
11073243|NCT01079663|12255056|FG000|NOT COMPLETED|Overall Study||0
11073244|NCT01079663|12255057|FG001|NOT COMPLETED|Overall Study||4
11073245|NCT01079741|12255068|FG000|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
11073246|NCT01079741|12255069|FG001|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
11073247|NCT01079741|12255070|FG002|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
11073248|NCT01079741|12255071|FG003|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
11073249|NCT01079741|12255072|FG004|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
11073250|NCT01079741|12255068|FG000|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
11073251|NCT01079741|12255069|FG001|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
11073252|NCT01079741|12255070|FG002|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
11073253|NCT01079741|12255071|FG003|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
11073254|NCT01079741|12255072|FG004|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
11073255|NCT01079741|12255068|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
11073256|NCT01079741|12255069|FG001|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
11073257|NCT01079741|12255070|FG002|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
11073258|NCT01079741|12255071|FG003|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
11073259|NCT01079741|12255072|FG004|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
11073260|NCT01079741|12255068|FG000|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
11073261|NCT01079741|12255069|FG001|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
11073262|NCT01079741|12255070|FG002|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
11073263|NCT01079741|12255071|FG003|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
11073264|NCT01079741|12255072|FG004|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
11073265|NCT01079741|12255068|FG000|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
11073266|NCT01079741|12255069|FG001|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
11073267|NCT01079741|12255070|FG002|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
11073268|NCT01079741|12255071|FG003|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
11073269|NCT01079741|12255072|FG004|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
11073270|NCT01079741|12255068|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
11073271|NCT01079741|12255069|FG001|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
11073272|NCT01079741|12255070|FG002|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
11073273|NCT01079741|12255071|FG003|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
11073274|NCT01079741|12255072|FG004|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
11073275|NCT01079741|12255068|FG000|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
11073276|NCT01079741|12255069|FG001|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
11073277|NCT01079741|12255070|FG002|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
11073278|NCT01079741|12255071|FG003|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
11073279|NCT01079741|12255072|FG004|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
11073280|NCT01079741|12255068|FG000|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
11073281|NCT01079741|12255069|FG001|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
11073282|NCT01079741|12255070|FG002|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
11073283|NCT01079741|12255071|FG003|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
11073284|NCT01079741|12255072|FG004|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
11073285|NCT01079741|12255068|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
11073286|NCT01079741|12255069|FG001|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
11073287|NCT01079741|12255070|FG002|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
11073288|NCT01079741|12255071|FG003|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
11073289|NCT01079741|12255072|FG004|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
11073290|NCT01079741|12255068|FG000|STARTED|Phase 2 (Weeks 37-48)||0
11073291|NCT01079741|12255069|FG001|STARTED|Phase 2 (Weeks 37-48)||0
11073292|NCT01079741|12255070|FG002|STARTED|Phase 2 (Weeks 37-48)||0
11073293|NCT01079741|12255071|FG003|STARTED|Phase 2 (Weeks 37-48)||12
11073294|NCT01079741|12255072|FG004|STARTED|Phase 2 (Weeks 37-48)||12
11073295|NCT01079741|12255068|FG000|COMPLETED|Phase 2 (Weeks 37-48)||0
11073296|NCT01079741|12255069|FG001|COMPLETED|Phase 2 (Weeks 37-48)||0
11073297|NCT01079741|12255070|FG002|COMPLETED|Phase 2 (Weeks 37-48)||0
11073298|NCT01079741|12255071|FG003|COMPLETED|Phase 2 (Weeks 37-48)||12
11073299|NCT01079741|12255072|FG004|COMPLETED|Phase 2 (Weeks 37-48)||9
11073300|NCT01079741|12255068|FG000|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
11073301|NCT01079741|12255069|FG001|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
11073302|NCT01079741|12255070|FG002|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
11073303|NCT01079741|12255071|FG003|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
11073304|NCT01079741|12255072|FG004|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
11073305|NCT01079806|12255086|FG000|STARTED|Day 1 to Week 96||120
11073306|NCT01079806|12255087|FG001|STARTED|Day 1 to Week 96||60
11073307|NCT01079806|12255086|FG000|Received Treatment|Day 1 to Week 96||120
11073308|NCT01079806|12255087|FG001|Received Treatment|Day 1 to Week 96||60
11073309|NCT01079806|12255086|FG000|Primary Endpoint Cohort|Day 1 to Week 96||82
11073310|NCT01079806|12255087|FG001|Primary Endpoint Cohort|Day 1 to Week 96||41
11073311|NCT01079806|12255086|FG000|COMPLETED|Day 1 to Week 96||113
11073312|NCT01079806|12255087|FG001|COMPLETED|Day 1 to Week 96||53
11073313|NCT01079806|12255086|FG000|NOT COMPLETED|Day 1 to Week 96||7
11073314|NCT01079806|12255087|FG001|NOT COMPLETED|Day 1 to Week 96||7
11073315|NCT01079806|12255086|FG000|STARTED|Long-term Follow-up: Day 1-End of Study||111
11073316|NCT01079806|12255087|FG001|STARTED|Long-term Follow-up: Day 1-End of Study||58
11073317|NCT01079806|12255086|FG000|COMPLETED|Long-term Follow-up: Day 1-End of Study||92
11073318|NCT01079806|12255087|FG001|COMPLETED|Long-term Follow-up: Day 1-End of Study||43
11073319|NCT01079806|12255086|FG000|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19
11073320|NCT01079806|12255087|FG001|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15
11073321|NCT01079832|12255095|FG000|STARTED|Overall Study||50
11073322|NCT01079832|12255095|FG000|COMPLETED|Overall Study||49
11073323|NCT01079832|12255095|FG000|NOT COMPLETED|Overall Study||1
11073324|NCT01079936|12255103|FG000|STARTED|Phase I: MTD||16
11073325|NCT01079936|12255104|FG001|STARTED|Phase I: MTD||0
11073326|NCT01079936|12255105|FG002|STARTED|Phase I: MTD||0
11073327|NCT01079936|12255106|FG003|STARTED|Phase I: MTD||0
11073328|NCT01079936|12255107|FG004|STARTED|Phase I: MTD||0
11073329|NCT01079936|12255103|FG000|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
11073330|NCT01079936|12255104|FG001|COMPLETED|Phase I: MTD||0
11073331|NCT01079936|12255105|FG002|COMPLETED|Phase I: MTD||0
11073332|NCT01079936|12255106|FG003|COMPLETED|Phase I: MTD||0
11073333|NCT01079936|12255107|FG004|COMPLETED|Phase I: MTD||0
11073334|NCT01079936|12255103|FG000|NOT COMPLETED|Phase I: MTD||4
11073335|NCT01079936|12255104|FG001|NOT COMPLETED|Phase I: MTD||0
11073336|NCT01079936|12255105|FG002|NOT COMPLETED|Phase I: MTD||0
11073337|NCT01079936|12255106|FG003|NOT COMPLETED|Phase I: MTD||0
11073338|NCT01079936|12255107|FG004|NOT COMPLETED|Phase I: MTD||0
11073339|NCT01079936|12255103|FG000|STARTED|Phase II||0
11073340|NCT01079936|12255104|FG001|STARTED|Phase II||3
11073341|NCT01079936|12255105|FG002|STARTED|Phase II||6
11073342|NCT01079936|12255106|FG003|STARTED|Phase II||24
11073343|NCT01079936|12255107|FG004|STARTED|Phase II||26
11073344|NCT01079936|12255103|FG000|COMPLETED|Phase II||0
11073345|NCT01079936|12255104|FG001|COMPLETED|Phase II||3
11073346|NCT01079936|12255105|FG002|COMPLETED|Phase II||5
11073347|NCT01079936|12255106|FG003|COMPLETED|Phase II||24
11073348|NCT01079936|12255107|FG004|COMPLETED|Phase II||25
11073349|NCT01079936|12255103|FG000|NOT COMPLETED|Phase II||0
11073350|NCT01079936|12255104|FG001|NOT COMPLETED|Phase II||0
11073351|NCT01079936|12255105|FG002|NOT COMPLETED|Phase II||1
11073352|NCT01079936|12255106|FG003|NOT COMPLETED|Phase II||0
11073353|NCT01079936|12255107|FG004|NOT COMPLETED|Phase II||1
11073354|NCT01079949|12255120|FG000|STARTED|Overall Study||46
11073355|NCT01079949|12255121|FG001|STARTED|Overall Study||47
11073356|NCT01079949|12255120|FG000|COMPLETED|Overall Study||31
11073357|NCT01079949|12255121|FG001|COMPLETED|Overall Study||34
11073358|NCT01079949|12255120|FG000|NOT COMPLETED|Overall Study||15
11073359|NCT01079949|12255121|FG001|NOT COMPLETED|Overall Study||13
11073360|NCT01079962|12255129|FG000|STARTED|Overall Study||105
11073361|NCT01079962|12255130|FG001|STARTED|Overall Study||104
11073362|NCT01079962|12255129|FG000|COMPLETED|Overall Study||90
11073363|NCT01079962|12255130|FG001|COMPLETED|Overall Study||89
11073364|NCT01079962|12255129|FG000|NOT COMPLETED|Overall Study||15
11073365|NCT01079962|12255130|FG001|NOT COMPLETED|Overall Study||15
11073366|NCT01079988|12255141|FG000|STARTED|Overall Study||10
11073367|NCT01079988|12255142|FG001|STARTED|Overall Study||1
11073368|NCT01079988|12255143|FG002|STARTED|Overall Study||8
11073369|NCT01079988|12255144|FG003|STARTED|Overall Study||20
11073370|NCT01079988|12255145|FG004|STARTED|Overall Study||2
11073371|NCT01079988|12255141|FG000|COMPLETED|Overall Study||9
11073372|NCT01079988|12255142|FG001|COMPLETED|Overall Study||1
11073373|NCT01079988|12255143|FG002|COMPLETED|Overall Study||8
11073374|NCT01079988|12255144|FG003|COMPLETED|Overall Study||17
11073375|NCT01079988|12255145|FG004|COMPLETED|Overall Study||1
11073376|NCT01079988|12255141|FG000|NOT COMPLETED|Overall Study||1
11073377|NCT01079988|12255142|FG001|NOT COMPLETED|Overall Study||0
11073378|NCT01079988|12255143|FG002|NOT COMPLETED|Overall Study||0
11073379|NCT01079988|12255144|FG003|NOT COMPLETED|Overall Study||3
11073380|NCT01079988|12255145|FG004|NOT COMPLETED|Overall Study||1
11073381|NCT01080118|12255159|FG000|STARTED|Overall Study||15
11073382|NCT01080118|12255160|FG001|STARTED|Overall Study||15
11073383|NCT01080118|12255161|FG002|STARTED|Overall Study||30
11073384|NCT01080118|12255162|FG003|STARTED|Overall Study||30
11073385|NCT01080118|12255159|FG000|COMPLETED|Overall Study||15
11073386|NCT01080118|12255160|FG001|COMPLETED|Overall Study||15
11073387|NCT01080118|12255161|FG002|COMPLETED|Overall Study||30
11073388|NCT01080118|12255162|FG003|COMPLETED|Overall Study||30
11073389|NCT01080118|12255159|FG000|NOT COMPLETED|Overall Study||0
11073390|NCT01080118|12255160|FG001|NOT COMPLETED|Overall Study||0
11073391|NCT01080118|12255161|FG002|NOT COMPLETED|Overall Study||0
11073392|NCT01080118|12255162|FG003|NOT COMPLETED|Overall Study||0
11073393|NCT01080131|12255170|FG000|STARTED|Core Study (0- 12 Weeks)||112
11073394|NCT01080131|12255171|FG001|STARTED|Core Study (0- 12 Weeks)||114
11073395|NCT01080131|12255170|FG000|COMPLETED|Core Study (0- 12 Weeks)||99
11073396|NCT01080131|12255171|FG001|COMPLETED|Core Study (0- 12 Weeks)||103
11073397|NCT01080131|12255170|FG000|NOT COMPLETED|Core Study (0- 12 Weeks)||13
11073398|NCT01080131|12255171|FG001|NOT COMPLETED|Core Study (0- 12 Weeks)||11
11073399|NCT01080131|12255170|FG000|STARTED|Extension Study 1 (12 -24 Weeks)||84
11073400|NCT01080131|12255171|FG001|STARTED|Extension Study 1 (12 -24 Weeks)||76
11073401|NCT01080131|12255170|FG000|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
11073402|NCT01080131|12255171|FG001|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
11073403|NCT01080131|12255170|FG000|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
11073404|NCT01080131|12255171|FG001|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
11073405|NCT01080131|12255170|FG000|STARTED|Extension Study 2 (25-72 Weeks)||72
11073406|NCT01080131|12255171|FG001|STARTED|Extension Study 2 (25-72 Weeks)||65
11073407|NCT01080131|12255170|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
11073408|NCT01080131|12255171|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
11073409|NCT01080131|12255170|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||64
11073410|NCT01080131|12255171|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||54
11073411|NCT01080131|12255170|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
11073412|NCT01080131|12255171|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
11073413|NCT01080209|12255202|FG000|STARTED|Overall Study||28
11073414|NCT01080209|12255203|FG001|STARTED|Overall Study||53
11073415|NCT01080209|12255204|FG002|STARTED|Overall Study||33
11073416|NCT01080209|12255205|FG003|STARTED|Overall Study||42
11073417|NCT01080209|12255206|FG004|STARTED|Overall Study||6
11073418|NCT01080209|12255207|FG005|STARTED|Overall Study||2
11073419|NCT01080209|12255208|FG006|STARTED|Overall Study||51
11073420|NCT01080209|12255202|FG000|COMPLETED|Overall Study||22
11073421|NCT01080209|12255203|FG001|COMPLETED|Overall Study||42
11073422|NCT01080209|12255204|FG002|COMPLETED|Overall Study||28
11073423|NCT01080209|12255205|FG003|COMPLETED|Overall Study||37
11073424|NCT01080209|12255206|FG004|COMPLETED|Overall Study||6
11073425|NCT01080209|12255207|FG005|COMPLETED|Overall Study||2
11073426|NCT01080209|12255208|FG006|COMPLETED|Overall Study||44
11073427|NCT01080209|12255202|FG000|NOT COMPLETED|Overall Study||6
11073428|NCT01080209|12255203|FG001|NOT COMPLETED|Overall Study||11
11073429|NCT01080209|12255204|FG002|NOT COMPLETED|Overall Study||5
11073430|NCT01080209|12255205|FG003|NOT COMPLETED|Overall Study||5
11073431|NCT01080209|12255206|FG004|NOT COMPLETED|Overall Study||0
11073432|NCT01080209|12255207|FG005|NOT COMPLETED|Overall Study||0
11073433|NCT01080209|12255208|FG006|NOT COMPLETED|Overall Study||7
11073434|NCT01080248|12255224|FG000|STARTED|Overall Study||2
11073435|NCT01080248|12255224|FG000|COMPLETED|Overall Study||2
11073436|NCT01080248|12255224|FG000|NOT COMPLETED|Overall Study||0
11073437|NCT01080261|12255228|FG000|STARTED|Overall Study||60
11073438|NCT01080261|12255228|FG000|COMPLETED|Overall Study||60
11073439|NCT01080261|12255228|FG000|NOT COMPLETED|Overall Study||0
11073440|NCT01080300|12255234|FG000|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
11073441|NCT01080300|12255235|FG001|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
11073442|NCT01080300|12255234|FG000|COMPLETED|Overall Study||206
11073443|NCT01080300|12255235|FG001|COMPLETED|Overall Study||191
11073444|NCT01080300|12255234|FG000|NOT COMPLETED|Overall Study||94
11073445|NCT01080300|12255235|FG001|NOT COMPLETED|Overall Study||104
11073446|NCT01080326|12255243|FG000|STARTED|Overall Study||7
11073447|NCT01080326|12255243|FG000|COMPLETED|Overall Study||3
11073448|NCT01080326|12255243|FG000|NOT COMPLETED|Overall Study||4
11073449|NCT01080625|12255250|FG000|STARTED|Overall Study||31
11073450|NCT01080625|12255251|FG001|STARTED|Overall Study||33
11073451|NCT01080625|12255252|FG002|STARTED|Overall Study||32
11073452|NCT01080625|12255250|FG000|COMPLETED|Overall Study||31
11073453|NCT01080625|12255251|FG001|COMPLETED|Overall Study||31
11073454|NCT01080625|12255252|FG002|COMPLETED|Overall Study||31
11073455|NCT01080625|12255250|FG000|NOT COMPLETED|Overall Study||0
11073456|NCT01080625|12255251|FG001|NOT COMPLETED|Overall Study||2
11073457|NCT01080625|12255252|FG002|NOT COMPLETED|Overall Study||1
11073458|NCT01080677|12255263|FG000|STARTED|Overall Study||20
11073459|NCT01080677|12255264|FG001|STARTED|Overall Study||20
11073460|NCT01080677|12255265|FG002|STARTED|Overall Study||20
11073461|NCT01080677|12255263|FG000|COMPLETED|Overall Study||20
11073462|NCT01080677|12255264|FG001|COMPLETED|Overall Study||20
11073463|NCT01080677|12255265|FG002|COMPLETED|Overall Study||20
11073464|NCT01080677|12255263|FG000|NOT COMPLETED|Overall Study||0
11073465|NCT01080677|12255264|FG001|NOT COMPLETED|Overall Study||0
11073466|NCT01080677|12255265|FG002|NOT COMPLETED|Overall Study||0
11073467|NCT01080716|12255277|FG000|STARTED|Part 1||14
11073468|NCT01080716|12255278|FG001|STARTED|Part 1||6
11073469|NCT01080716|12255279|FG002|STARTED|Part 1||0
11073470|NCT01080716|12255280|FG003|STARTED|Part 1||0
11073471|NCT01080716|12255277|FG000|COMPLETED|Part 1||13
11073472|NCT01080716|12255278|FG001|COMPLETED|Part 1||6
11073473|NCT01080716|12255279|FG002|COMPLETED|Part 1||0
11073474|NCT01080716|12255280|FG003|COMPLETED|Part 1||0
11073475|NCT01080716|12255277|FG000|NOT COMPLETED|Part 1||1
11073476|NCT01080716|12255278|FG001|NOT COMPLETED|Part 1||0
11073477|NCT01080716|12255279|FG002|NOT COMPLETED|Part 1||0
11073478|NCT01080716|12255280|FG003|NOT COMPLETED|Part 1||0
11073479|NCT01080716|12255277|FG000|STARTED|Part 2||0
11073480|NCT01080716|12255278|FG001|STARTED|Part 2||0
11073481|NCT01080716|12255279|FG002|STARTED|Part 2||10
11073482|NCT01080716|12255280|FG003|STARTED|Part 2||10
11073483|NCT01080716|12255277|FG000|COMPLETED|Part 2||0
11073484|NCT01080716|12255278|FG001|COMPLETED|Part 2||0
11073485|NCT01080716|12255279|FG002|COMPLETED|Part 2||10
11073486|NCT01080716|12255280|FG003|COMPLETED|Part 2||10
11073487|NCT01080716|12255277|FG000|NOT COMPLETED|Part 2||0
11073488|NCT01080716|12255278|FG001|NOT COMPLETED|Part 2||0
11073489|NCT01080716|12255279|FG002|NOT COMPLETED|Part 2||0
11073490|NCT01080716|12255280|FG003|NOT COMPLETED|Part 2||0
11073491|NCT01080794|12255298|FG000|STARTED|Overall Study||20
11073492|NCT01080794|12255299|FG001|STARTED|Overall Study||14
11073493|NCT01080794|12255300|FG002|STARTED|Overall Study||12
11073494|NCT01080794|12255301|FG003|STARTED|Overall Study||15
11073495|NCT01080794|12255298|FG000|COMPLETED|Overall Study||15
11073496|NCT01080794|12255299|FG001|COMPLETED|Overall Study||12
11073497|NCT01080794|12255300|FG002|COMPLETED|Overall Study||10
11073498|NCT01080794|12255301|FG003|COMPLETED|Overall Study||13
11073499|NCT01080794|12255298|FG000|NOT COMPLETED|Overall Study||5
11073500|NCT01080794|12255299|FG001|NOT COMPLETED|Overall Study||2
11073501|NCT01080794|12255300|FG002|NOT COMPLETED|Overall Study||2
11073502|NCT01080794|12255301|FG003|NOT COMPLETED|Overall Study||2
11073503|NCT01080807|12255313|FG000|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
11073504|NCT01080807|12255314|FG001|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
11073505|NCT01080807|12255313|FG000|COMPLETED|Overall Study||158
11073506|NCT01080807|12255314|FG001|COMPLETED|Overall Study||167
11073507|NCT01080807|12255313|FG000|NOT COMPLETED|Overall Study||35
11073508|NCT01080807|12255314|FG001|NOT COMPLETED|Overall Study||23
11073509|NCT01080976|12255322|FG000|STARTED|Overall Study||5
11073510|NCT01080976|12255323|FG001|STARTED|Overall Study||5
11073511|NCT01080976|12255322|FG000|COMPLETED|Overall Study||5
11073512|NCT01080976|12255323|FG001|COMPLETED|Overall Study||5
11073513|NCT01080976|12255322|FG000|NOT COMPLETED|Overall Study||0
11073514|NCT01080976|12255323|FG001|NOT COMPLETED|Overall Study||0
11073515|NCT01081041|12255332|FG000|STARTED|Overall Study||33
11073516|NCT01081041|12255333|FG001|STARTED|Overall Study||81
11073517|NCT01081041|12255334|FG002|STARTED|Overall Study||73
11073518|NCT01081041|12255332|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
11073519|NCT01081041|12255333|FG001|Received at Least 1 Dose of Study Drug|Overall Study||77
11073520|NCT01081041|12255334|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71
11073521|NCT01081041|12255332|FG000|COMPLETED|Overall Study||33
11073522|NCT01081041|12255333|FG001|COMPLETED|Overall Study||77
11073523|NCT01081041|12255334|FG002|COMPLETED|Overall Study||71
11073524|NCT01081041|12255332|FG000|NOT COMPLETED|Overall Study||0
11073525|NCT01081041|12255333|FG001|NOT COMPLETED|Overall Study||4
11073526|NCT01081041|12255334|FG002|NOT COMPLETED|Overall Study||2
11073527|NCT01081132|12255349|FG000|STARTED|Overall Study||157
11073528|NCT01081132|12255350|FG001|STARTED|Overall Study||157
11073529|NCT01081132|12255349|FG000|COMPLETED|Overall Study||102
11073530|NCT01081132|12255350|FG001|COMPLETED|Overall Study||105
11073531|NCT01081132|12255349|FG000|NOT COMPLETED|Overall Study||55
11073532|NCT01081132|12255350|FG001|NOT COMPLETED|Overall Study||52
11073533|NCT01081145|12255356|FG000|STARTED|Open-Label Phase||528
11073534|NCT01081145|12255357|FG001|STARTED|Open-Label Phase||0
11073535|NCT01081145|12255356|FG000|COMPLETED|Open-Label Phase||316
11073536|NCT01081145|12255357|FG001|COMPLETED|Open-Label Phase||0
11073537|NCT01081145|12255356|FG000|NOT COMPLETED|Open-Label Phase||212
11073538|NCT01081145|12255357|FG001|NOT COMPLETED|Open-Label Phase||0
11073539|NCT01081145|12255356|FG000|STARTED|Double-Blind Randomized-Withdrawal Phase||157
11073540|NCT01081145|12255357|FG001|STARTED|Double-Blind Randomized-Withdrawal Phase||159
11073541|NCT01081145|12255356|FG000|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
11073542|NCT01081145|12255357|FG001|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
11073543|NCT01081145|12255356|FG000|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
11073544|NCT01081145|12255357|FG001|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
11073545|NCT01081249|12255365|FG000|STARTED|Overall Study||11
11073546|NCT01081249|12255366|FG001|STARTED|Overall Study||7
11073547|NCT01081249|12255365|FG000|First Psychotherapy Appointment (1 Day)|Overall Study||11
11073548|NCT01081249|12255366|FG001|First Psychotherapy Appointment (1 Day)|Overall Study||6
11073549|NCT01081249|12255365|FG000|Washout (5-10 Days)|Overall Study||11
11073550|NCT01081249|12255366|FG001|Washout (5-10 Days)|Overall Study||6
11073551|NCT01081249|12255365|FG000|Second Psychotherapy Appointment (1 Day)|Overall Study||11
11073552|NCT01081249|12255366|FG001|Second Psychotherapy Appointment (1 Day)|Overall Study||6
11073553|NCT01081249|12255365|FG000|COMPLETED|Overall Study||11
11073554|NCT01081249|12255366|FG001|COMPLETED|Overall Study||6
11073555|NCT01081249|12255365|FG000|NOT COMPLETED|Overall Study||0
11073556|NCT01081249|12255366|FG001|NOT COMPLETED|Overall Study||1
11073557|NCT01081301|12255372|FG000|STARTED|Overall Study||36
11073558|NCT01081301|12255372|FG000|COMPLETED|Overall Study||22
11073559|NCT01081301|12255372|FG000|NOT COMPLETED|Overall Study||14
11073560|NCT01081626|12255395|FG000|STARTED|Overall Study||155
11073561|NCT01081626|12255396|FG001|STARTED|Overall Study||155
11073562|NCT01081626|12255395|FG000|Assessed for Efficacy|Overall Study||122
11073563|NCT01081626|12255396|FG001|Assessed for Efficacy|Overall Study||125
11073564|NCT01081626|12255395|FG000|COMPLETED|Overall Study||95
11073565|NCT01081626|12255396|FG001|COMPLETED|Overall Study||94
11073566|NCT01081626|12255395|FG000|NOT COMPLETED|Overall Study||60
11073567|NCT01081626|12255396|FG001|NOT COMPLETED|Overall Study||61
11073568|NCT01081665|12255402|FG000|STARTED|Overall Study||237
11073569|NCT01081665|12255402|FG000|Full Analysis Set|Overall Study||237
11073570|NCT01081665|12255402|FG000|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
11073571|NCT01081665|12255402|FG000|COMPLETED|Overall Study||142
11073572|NCT01081665|12255402|FG000|NOT COMPLETED|Overall Study||95
11073573|NCT01081769|12255408|FG000|STARTED|Whole Intent-to-Treat||376
11073574|NCT01081769|12255409|FG001|STARTED|Whole Intent-to-Treat||388
11073575|NCT01081769|12255408|FG000|COMPLETED|Whole Intent-to-Treat||352
11073576|NCT01081769|12255409|FG001|COMPLETED|Whole Intent-to-Treat||363
11073577|NCT01081769|12255408|FG000|NOT COMPLETED|Whole Intent-to-Treat||24
11073578|NCT01081769|12255409|FG001|NOT COMPLETED|Whole Intent-to-Treat||25
11073579|NCT01081769|12255408|FG000|STARTED|CORE Intent-To-Treat||352
11073580|NCT01081769|12255409|FG001|STARTED|CORE Intent-To-Treat||363
11073581|NCT01081769|12255408|FG000|COMPLETED|CORE Intent-To-Treat||272
11073582|NCT01081769|12255409|FG001|COMPLETED|CORE Intent-To-Treat||266
11073583|NCT01081769|12255408|FG000|NOT COMPLETED|CORE Intent-To-Treat||80
11073584|NCT01081769|12255409|FG001|NOT COMPLETED|CORE Intent-To-Treat||97
11073585|NCT01081795|12255418|FG000|STARTED|Overall Study||130
11073586|NCT01081795|12255419|FG001|STARTED|Overall Study||130
11073587|NCT01081795|12255420|FG002|STARTED|Overall Study||127
11073588|NCT01081795|12255418|FG000|COMPLETED|Overall Study||97
11073589|NCT01081795|12255419|FG001|COMPLETED|Overall Study||95
11073590|NCT01081795|12255420|FG002|COMPLETED|Overall Study||97
11073591|NCT01081795|12255418|FG000|NOT COMPLETED|Overall Study||33
11073592|NCT01081795|12255419|FG001|NOT COMPLETED|Overall Study||35
11073593|NCT01081795|12255420|FG002|NOT COMPLETED|Overall Study||30
11073594|NCT01081834|12255433|FG000|STARTED|Core Period: Baseline to Week 26||192
11073595|NCT01081834|12255434|FG001|STARTED|Core Period: Baseline to Week 26||195
11073596|NCT01081834|12255435|FG002|STARTED|Core Period: Baseline to Week 26||197
11073597|NCT01081834|12255436|FG003|STARTED|Core Period: Baseline to Week 26||47
11073598|NCT01081834|12255437|FG004|STARTED|Core Period: Baseline to Week 26||44
11073599|NCT01081834|12255433|FG000|COMPLETED|Core Period: Baseline to Week 26||160
11073600|NCT01081834|12255434|FG001|COMPLETED|Core Period: Baseline to Week 26||172
11073601|NCT01081834|12255435|FG002|COMPLETED|Core Period: Baseline to Week 26||175
11073602|NCT01081834|12255436|FG003|COMPLETED|Core Period: Baseline to Week 26||40
11073603|NCT01081834|12255437|FG004|COMPLETED|Core Period: Baseline to Week 26||40
11073604|NCT01081834|12255433|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||32
11073605|NCT01081834|12255434|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||23
11073606|NCT01081834|12255435|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||22
11073607|NCT01081834|12255436|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||7
11073608|NCT01081834|12255437|FG004|NOT COMPLETED|Core Period: Baseline to Week 26||4
11073609|NCT01081834|12255433|FG000|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
11073610|NCT01081834|12255434|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
11073611|NCT01081834|12255435|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
11073612|NCT01081834|12255436|FG003|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
11073613|NCT01081834|12255437|FG004|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
11073614|NCT01081834|12255433|FG000|COMPLETED|Extension Period: Week 26 to Week 52||135
11073615|NCT01081834|12255434|FG001|COMPLETED|Extension Period: Week 26 to Week 52||152
11073616|NCT01081834|12255435|FG002|COMPLETED|Extension Period: Week 26 to Week 52||165
11073617|NCT01081834|12255436|FG003|COMPLETED|Extension Period: Week 26 to Week 52||0
11073618|NCT01081834|12255437|FG004|COMPLETED|Extension Period: Week 26 to Week 52||0
11073619|NCT01081834|12255433|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
11073620|NCT01081834|12255434|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
11073621|NCT01081834|12255435|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
11073622|NCT01081834|12255436|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
11073623|NCT01081834|12255437|FG004|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
11347393|NCT02991859|12544630|FG005|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347394|NCT02991859|12544631|FG006|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347395|NCT02991859|12544632|FG007|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347396|NCT02991859|12544633|FG008|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347397|NCT02991859|12544634|FG009|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347398|NCT02991859|12544635|FG010|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11073624|NCT01081873|12255456|FG000|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
11073625|NCT01081873|12255456|FG000|COMPLETED|Overall Study||2416
11073626|NCT01081873|12255456|FG000|NOT COMPLETED|Overall Study||298
11073627|NCT01081912|12255485|FG000|STARTED|Conversion/Titration||510
11073628|NCT01081912|12255486|FG001|STARTED|Conversion/Titration||0
11073629|NCT01081912|12255487|FG002|STARTED|Conversion/Titration||0
11073630|NCT01081912|12255485|FG000|COMPLETED|Conversion/Titration||302
11073631|NCT01081912|12255486|FG001|COMPLETED|Conversion/Titration||0
11073632|NCT01081912|12255487|FG002|COMPLETED|Conversion/Titration||0
11073633|NCT01081912|12255485|FG000|NOT COMPLETED|Conversion/Titration||208
11073634|NCT01081912|12255486|FG001|NOT COMPLETED|Conversion/Titration||0
11073635|NCT01081912|12255487|FG002|NOT COMPLETED|Conversion/Titration||0
11073636|NCT01081912|12255485|FG000|STARTED|Maintenance Treatment||0
11073637|NCT01081912|12255486|FG001|STARTED|Maintenance Treatment||151
11073638|NCT01081912|12255487|FG002|STARTED|Maintenance Treatment||151
11073639|NCT01081912|12255485|FG000|COMPLETED|Maintenance Treatment||0
11073640|NCT01081912|12255486|FG001|COMPLETED|Maintenance Treatment||124
11073641|NCT01081912|12255487|FG002|COMPLETED|Maintenance Treatment||59
11073642|NCT01081912|12255485|FG000|NOT COMPLETED|Maintenance Treatment||0
11073643|NCT01081912|12255486|FG001|NOT COMPLETED|Maintenance Treatment||27
11073644|NCT01081912|12255487|FG002|NOT COMPLETED|Maintenance Treatment||92
11073645|NCT01082081|12255497|FG000|STARTED|Overall Study||121
11073646|NCT01082081|12255498|FG001|STARTED|Overall Study||119
11073647|NCT01082081|12255499|FG002|STARTED|Overall Study||60
11073648|NCT01082081|12255497|FG000|COMPLETED|Overall Study||121
11073649|NCT01082081|12255498|FG001|COMPLETED|Overall Study||118
11073650|NCT01082081|12255499|FG002|COMPLETED|Overall Study||58
11073651|NCT01082081|12255497|FG000|NOT COMPLETED|Overall Study||0
11073652|NCT01082081|12255498|FG001|NOT COMPLETED|Overall Study||1
11073653|NCT01082081|12255499|FG002|NOT COMPLETED|Overall Study||2
11073654|NCT01082159|12255507|FG000|STARTED|Overall Study||55
11073655|NCT01082159|12255507|FG000|COMPLETED|Overall Study||46
11073656|NCT01082159|12255507|FG000|NOT COMPLETED|Overall Study||9
11073657|NCT01082328|12255512|FG000|STARTED|Overall Study||59
11073658|NCT01082328|12255512|FG000|COMPLETED|Overall Study||58
11073659|NCT01082328|12255512|FG000|NOT COMPLETED|Overall Study||1
11073660|NCT01082367|12255518|FG000|STARTED|Double-blind Period||26
11073661|NCT01082367|12255519|FG001|STARTED|Double-blind Period||25
11073662|NCT01082367|12255518|FG000|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
11073663|NCT01082367|12255519|FG001|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
11073664|NCT01082367|12255518|FG000|Stage 2:no tx|Double-blind Period||0
11073665|NCT01082367|12255519|FG001|Stage 2:no tx|Double-blind Period||0
11073666|NCT01082367|12255518|FG000|Entered OL TOBI|Double-blind Period||4
11073667|NCT01082367|12255519|FG001|Entered OL TOBI|Double-blind Period||18
11073668|NCT01082367|12255518|FG000|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
11073669|NCT01082367|12255519|FG001|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
11347399|NCT02991859|12544636|FG011|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347400|NCT02991859|12544637|FG012|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347401|NCT02991859|12544638|FG013|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347402|NCT02991859|12544639|FG014|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347403|NCT02991859|12544640|FG015|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347404|NCT02991859|12544641|FG016|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
11347405|NCT02991859|12544625|FG000|STARTED|Period1, Escalation Phase5, Upto Day35||2
11347406|NCT02991859|12544626|FG001|STARTED|Period1, Escalation Phase5, Upto Day35||2
11347407|NCT02991859|12544627|FG002|STARTED|Period1, Escalation Phase5, Upto Day35||2
11347408|NCT02991859|12544628|FG003|STARTED|Period1, Escalation Phase5, Upto Day35||2
11347409|NCT02991859|12544629|FG004|STARTED|Period1, Escalation Phase5, Upto Day35||2
11347410|NCT02991859|12544630|FG005|STARTED|Period1, Escalation Phase5, Upto Day35||2
11347411|NCT02991859|12544631|FG006|STARTED|Period1, Escalation Phase5, Upto Day35||2
11347412|NCT02991859|12544632|FG007|STARTED|Period1, Escalation Phase5, Upto Day35||2
11347413|NCT02991859|12544633|FG008|STARTED|Period1, Escalation Phase5, Upto Day35||2
11347414|NCT02991859|12544634|FG009|STARTED|Period1, Escalation Phase5, Upto Day35||2
11347415|NCT02991859|12544635|FG010|STARTED|Period1, Escalation Phase5, Upto Day35|1 participant did not enter Esc Phase 5, and was not withdrawn|1
11347416|NCT02991859|12544636|FG011|STARTED|Period1, Escalation Phase5, Upto Day35||2
11347417|NCT02991859|12544637|FG012|STARTED|Period1, Escalation Phase5, Upto Day35||6
11347418|NCT02991859|12544638|FG013|STARTED|Period1, Escalation Phase5, Upto Day35||6
11347419|NCT02991859|12544639|FG014|STARTED|Period1, Escalation Phase5, Upto Day35||6
11347420|NCT02991859|12544640|FG015|STARTED|Period1, Escalation Phase5, Upto Day35||3
11347421|NCT02991859|12544641|FG016|STARTED|Period1, Escalation Phase5, Upto Day35||3
11347422|NCT02991859|12544625|FG000|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
11347423|NCT02991859|12544626|FG001|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
11347424|NCT02991859|12544627|FG002|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
11347425|NCT02991859|12544628|FG003|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
11073670|NCT01082367|12255518|FG000|Stage 3: Cross-over (co) tx|Double-blind Period||13
11073671|NCT01082367|12255519|FG001|Stage 3: Cross-over (co) tx|Double-blind Period||6
11073672|NCT01082367|12255518|FG000|Stage 4:no tx for Patients Not in co|Double-blind Period||0
11073673|NCT01082367|12255519|FG001|Stage 4:no tx for Patients Not in co|Double-blind Period||0
11073674|NCT01082367|12255518|FG000|COMPLETED|Double-blind Period||21
11073675|NCT01082367|12255519|FG001|COMPLETED|Double-blind Period||12
11073676|NCT01082367|12255518|FG000|NOT COMPLETED|Double-blind Period||5
11073677|NCT01082367|12255519|FG001|NOT COMPLETED|Double-blind Period||13
11073678|NCT01082367|12255518|FG000|STARTED|Follow-up (F-U) Period||19
11073679|NCT01082367|12255519|FG001|STARTED|Follow-up (F-U) Period||10
11073680|NCT01082367|12255518|FG000|Treated in F-U|Follow-up (F-U) Period||5
11073681|NCT01082367|12255519|FG001|Treated in F-U|Follow-up (F-U) Period||5
11073682|NCT01082367|12255518|FG000|COMPLETED|Follow-up (F-U) Period||17
11073683|NCT01082367|12255519|FG001|COMPLETED|Follow-up (F-U) Period||9
11073684|NCT01082367|12255518|FG000|NOT COMPLETED|Follow-up (F-U) Period||2
11073685|NCT01082367|12255519|FG001|NOT COMPLETED|Follow-up (F-U) Period||1
11073686|NCT01082380|12255529|FG000|STARTED|Overall Study||6
11073687|NCT01082380|12255529|FG000|COMPLETED|Overall Study||6
11073688|NCT01082380|12255529|FG000|NOT COMPLETED|Overall Study||0
11073689|NCT01082575|12255533|FG000|STARTED|Overall Study||100
11073690|NCT01082575|12255533|FG000|COMPLETED|Overall Study||100
11073691|NCT01082575|12255533|FG000|NOT COMPLETED|Overall Study||0
11073692|NCT01082588|12255539|FG000|STARTED|Overall Study||30
11073693|NCT01082588|12255540|FG001|STARTED|Overall Study||30
11073694|NCT01082588|12255539|FG000|COMPLETED|Overall Study||24
11073695|NCT01082588|12255540|FG001|COMPLETED|Overall Study||25
11073696|NCT01082588|12255539|FG000|NOT COMPLETED|Overall Study||6
11073697|NCT01082588|12255540|FG001|NOT COMPLETED|Overall Study||5
11073698|NCT01082614|12255548|FG000|STARTED|Overall Study||23
11073699|NCT01082614|12255549|FG001|STARTED|Overall Study||23
11073700|NCT01082614|12255548|FG000|COMPLETED|Overall Study||20
11073701|NCT01082614|12255549|FG001|COMPLETED|Overall Study||18
11073702|NCT01082614|12255548|FG000|NOT COMPLETED|Overall Study||3
11073703|NCT01082614|12255549|FG001|NOT COMPLETED|Overall Study||5
11073704|NCT01082640|12255558|FG000|STARTED|Overall Study||32
11073705|NCT01082640|12255559|FG001|STARTED|Overall Study||32
11073706|NCT01082640|12255560|FG002|STARTED|Overall Study||32
11073707|NCT01082640|12255558|FG000|COMPLETED|Overall Study||15
11073708|NCT01082640|12255559|FG001|COMPLETED|Overall Study||17
11073709|NCT01082640|12255560|FG002|COMPLETED|Overall Study||24
11073710|NCT01082640|12255558|FG000|NOT COMPLETED|Overall Study||17
11073711|NCT01082640|12255559|FG001|NOT COMPLETED|Overall Study||15
11073712|NCT01082640|12255560|FG002|NOT COMPLETED|Overall Study||8
11073713|NCT01082874|12255575|FG000|STARTED|Overall Study||2499
11073714|NCT01082874|12255576|FG001|STARTED|Overall Study||2510
11073715|NCT01082874|12255577|FG002|STARTED|Overall Study||2499
11073716|NCT01082874|12255578|FG003|STARTED|Overall Study||2502
11073717|NCT01082874|12255575|FG000|COMPLETED|Overall Study||2488
11073718|NCT01082874|12255576|FG001|COMPLETED|Overall Study||2498
11073719|NCT01082874|12255577|FG002|COMPLETED|Overall Study||2488
11073720|NCT01082874|12255578|FG003|COMPLETED|Overall Study||2489
11073721|NCT01082874|12255575|FG000|NOT COMPLETED|Overall Study||11
11073722|NCT01082874|12255576|FG001|NOT COMPLETED|Overall Study||12
11073723|NCT01082874|12255577|FG002|NOT COMPLETED|Overall Study||11
11073724|NCT01082874|12255578|FG003|NOT COMPLETED|Overall Study||13
11073725|NCT01082939|12255588|FG000|STARTED|Overall Study||80
11073726|NCT01082939|12255588|FG000|COMPLETED|Overall Study||80
11073727|NCT01082939|12255588|FG000|NOT COMPLETED|Overall Study||0
11073728|NCT01082952|12255594|FG000|STARTED|Overall Study||6
11073729|NCT01082952|12255595|FG001|STARTED|Overall Study||6
11073730|NCT01082952|12255594|FG000|COMPLETED|Overall Study||6
11073731|NCT01082952|12255595|FG001|COMPLETED|Overall Study||6
11073732|NCT01082952|12255594|FG000|NOT COMPLETED|Overall Study||0
11073733|NCT01082952|12255595|FG001|NOT COMPLETED|Overall Study||0
11073734|NCT01082965|12255603|FG000|STARTED|Overall Study||10
11073735|NCT01082965|12255604|FG001|STARTED|Overall Study||8
11073736|NCT01082965|12255603|FG000|COMPLETED|Overall Study||9
11073737|NCT01082965|12255604|FG001|COMPLETED|Overall Study||6
11073738|NCT01082965|12255603|FG000|NOT COMPLETED|Overall Study||1
11073739|NCT01082965|12255604|FG001|NOT COMPLETED|Overall Study||2
11073740|NCT01083121|12255610|FG000|STARTED|Overall Study|Participants who were enrolled in the study|1779
11073741|NCT01083121|12255610|FG000|COMPLETED|Overall Study|Participants included in the analysis|1698
11073742|NCT01083121|12255610|FG000|NOT COMPLETED|Overall Study||81
11347426|NCT02991859|12544629|FG004|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
11073743|NCT01083160|12255618|FG000|STARTED|Overall Study||82
11073744|NCT01083160|12255618|FG000|Evaluable Population|Overall Study||71
11073745|NCT01083160|12255618|FG000|COMPLETED|Overall Study||81
11073746|NCT01083160|12255618|FG000|NOT COMPLETED|Overall Study||1
11073747|NCT01083173|12255622|FG000|STARTED|Main Surveillance: Safety Group||595
11073748|NCT01083173|12255623|FG001|STARTED|Main Surveillance: Safety Group||0
11073749|NCT01083173|12255622|FG000|COMPLETED|Main Surveillance: Safety Group||580
11073750|NCT01083173|12255623|FG001|COMPLETED|Main Surveillance: Safety Group||0
11073751|NCT01083173|12255622|FG000|NOT COMPLETED|Main Surveillance: Safety Group||15
11073752|NCT01083173|12255623|FG001|NOT COMPLETED|Main Surveillance: Safety Group||0
11073753|NCT01083173|12255622|FG000|STARTED|Main Surveillance: Effectiveness Group||580
11073754|NCT01083173|12255623|FG001|STARTED|Main Surveillance: Effectiveness Group||0
11073755|NCT01083173|12255622|FG000|COMPLETED|Main Surveillance: Effectiveness Group||198
11073756|NCT01083173|12255623|FG001|COMPLETED|Main Surveillance: Effectiveness Group||0
11073757|NCT01083173|12255622|FG000|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
11073758|NCT01083173|12255623|FG001|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
11347427|NCT02991859|12544630|FG005|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
11347428|NCT02991859|12544631|FG006|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
11347429|NCT02991859|12544632|FG007|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
11347430|NCT02991859|12544633|FG008|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
11347431|NCT02991859|12544634|FG009|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
11347432|NCT02991859|12544635|FG010|COMPLETED|Period1, Escalation Phase5, Upto Day35||1
11347433|NCT02991859|12544636|FG011|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
11347434|NCT02991859|12544637|FG012|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
11347435|NCT02991859|12544638|FG013|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
11347436|NCT02991859|12544639|FG014|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
11347437|NCT02991859|12544640|FG015|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
11347438|NCT02991859|12544641|FG016|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
11347439|NCT02991859|12544625|FG000|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347440|NCT02991859|12544626|FG001|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347441|NCT02991859|12544627|FG002|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347442|NCT02991859|12544628|FG003|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347443|NCT02991859|12544629|FG004|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347444|NCT02991859|12544630|FG005|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347445|NCT02991859|12544631|FG006|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347446|NCT02991859|12544632|FG007|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347447|NCT02991859|12544633|FG008|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347448|NCT02991859|12544634|FG009|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347449|NCT02991859|12544635|FG010|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347450|NCT02991859|12544636|FG011|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347451|NCT02991859|12544637|FG012|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347452|NCT02991859|12544638|FG013|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347453|NCT02991859|12544639|FG014|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347454|NCT02991859|12544640|FG015|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347455|NCT02991859|12544641|FG016|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
11347456|NCT02991859|12544625|FG000|STARTED|Wash Out, Up to Day 77||2
11347457|NCT02991859|12544626|FG001|STARTED|Wash Out, Up to Day 77||2
11347458|NCT02991859|12544627|FG002|STARTED|Wash Out, Up to Day 77||2
11347459|NCT02991859|12544628|FG003|STARTED|Wash Out, Up to Day 77||2
11347460|NCT02991859|12544629|FG004|STARTED|Wash Out, Up to Day 77||2
11347461|NCT02991859|12544630|FG005|STARTED|Wash Out, Up to Day 77||2
11347462|NCT02991859|12544631|FG006|STARTED|Wash Out, Up to Day 77||2
11347463|NCT02991859|12544632|FG007|STARTED|Wash Out, Up to Day 77||2
11347464|NCT02991859|12544633|FG008|STARTED|Wash Out, Up to Day 77||2
11347465|NCT02991859|12544634|FG009|STARTED|Wash Out, Up to Day 77||2
11347466|NCT02991859|12544635|FG010|STARTED|Wash Out, Up to Day 77||1
11347467|NCT02991859|12544636|FG011|STARTED|Wash Out, Up to Day 77||2
11347468|NCT02991859|12544637|FG012|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
11347469|NCT02991859|12544638|FG013|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
11347470|NCT02991859|12544639|FG014|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
11347471|NCT02991859|12544640|FG015|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
11347472|NCT02991859|12544641|FG016|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
11347473|NCT02991859|12544625|FG000|COMPLETED|Wash Out, Up to Day 77||2
11347474|NCT02991859|12544626|FG001|COMPLETED|Wash Out, Up to Day 77||2
11347475|NCT02991859|12544627|FG002|COMPLETED|Wash Out, Up to Day 77||2
11073759|NCT01083173|12255622|FG000|STARTED|Long-term Surveillance: Safety Group||0
11073760|NCT01083173|12255623|FG001|STARTED|Long-term Surveillance: Safety Group||595
11073761|NCT01083173|12255622|FG000|COMPLETED|Long-term Surveillance: Safety Group||0
11073762|NCT01083173|12255623|FG001|COMPLETED|Long-term Surveillance: Safety Group||479
11073763|NCT01083173|12255622|FG000|NOT COMPLETED|Long-term Surveillance: Safety Group||0
11073764|NCT01083173|12255623|FG001|NOT COMPLETED|Long-term Surveillance: Safety Group||116
11073765|NCT01083173|12255622|FG000|STARTED|Long-term Surveillance: Effectiveness Gr||0
11073766|NCT01083173|12255623|FG001|STARTED|Long-term Surveillance: Effectiveness Gr||479
11073767|NCT01083173|12255622|FG000|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
11073768|NCT01083173|12255623|FG001|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
11073769|NCT01083173|12255622|FG000|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
11073770|NCT01083173|12255623|FG001|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
11073771|NCT01083186|12255632|FG000|STARTED|Overall Study||500
11073772|NCT01083186|12255632|FG000|COMPLETED|Overall Study||406
11073773|NCT01083186|12255632|FG000|NOT COMPLETED|Overall Study||94
11073774|NCT01083199|12255656|FG000|STARTED|Overall Study||10
11347476|NCT02991859|12544628|FG003|COMPLETED|Wash Out, Up to Day 77||2
11347477|NCT02991859|12544629|FG004|COMPLETED|Wash Out, Up to Day 77||2
11073775|NCT01083199|12255656|FG000|COMPLETED|Overall Study||10
11073776|NCT01083199|12255656|FG000|NOT COMPLETED|Overall Study||0
11073777|NCT01083316|12255661|FG000|STARTED|Overall Study||35
11073778|NCT01083316|12255661|FG000|COMPLETED|Overall Study||32
11073779|NCT01083316|12255661|FG000|NOT COMPLETED|Overall Study||3
11347478|NCT02991859|12544630|FG005|COMPLETED|Wash Out, Up to Day 77||1
11347479|NCT02991859|12544631|FG006|COMPLETED|Wash Out, Up to Day 77||2
11347480|NCT02991859|12544632|FG007|COMPLETED|Wash Out, Up to Day 77||2
11206588|NCT01869075|12397653|FG002|NOT COMPLETED|Phase 0 (Baseline)||0
11206589|NCT01869075|12397654|FG003|NOT COMPLETED|Phase 0 (Baseline)||0
11206590|NCT01869075|12397655|FG004|NOT COMPLETED|Phase 0 (Baseline)||0
11206591|NCT01869075|12397656|FG005|NOT COMPLETED|Phase 0 (Baseline)||0
11206592|NCT01869075|12397651|FG000|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
11206593|NCT01869075|12397652|FG001|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
11206594|NCT01869075|12397653|FG002|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
11206595|NCT01869075|12397654|FG003|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
11206596|NCT01869075|12397655|FG004|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
11206597|NCT01869075|12397656|FG005|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
11206598|NCT01869075|12397651|FG000|COMPLETED|Phase 1||45
11206599|NCT01869075|12397652|FG001|COMPLETED|Phase 1||75
11206600|NCT01869075|12397653|FG002|COMPLETED|Phase 1||45
11206601|NCT01869075|12397654|FG003|COMPLETED|Phase 1||75
11206602|NCT01869075|12397655|FG004|COMPLETED|Phase 1||30
11206603|NCT01869075|12397656|FG005|COMPLETED|Phase 1||90
11206604|NCT01869075|12397651|FG000|NOT COMPLETED|Phase 1||0
11206605|NCT01869075|12397652|FG001|NOT COMPLETED|Phase 1||0
11206606|NCT01869075|12397653|FG002|NOT COMPLETED|Phase 1||0
11206607|NCT01869075|12397654|FG003|NOT COMPLETED|Phase 1||0
11206608|NCT01869075|12397655|FG004|NOT COMPLETED|Phase 1||0
11206609|NCT01869075|12397656|FG005|NOT COMPLETED|Phase 1||0
11206610|NCT01869075|12397651|FG000|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
11206611|NCT01869075|12397652|FG001|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
11206612|NCT01869075|12397653|FG002|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
11206613|NCT01869075|12397654|FG003|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
11206614|NCT01869075|12397655|FG004|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
11206615|NCT01869075|12397656|FG005|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
11206616|NCT01869075|12397651|FG000|COMPLETED|Phase 2||90
11206617|NCT01869075|12397652|FG001|COMPLETED|Phase 2||30
11206618|NCT01869075|12397653|FG002|COMPLETED|Phase 2||75
11073780|NCT01083368|12255668|FG000|STARTED|Dose Escalation Weeks 1-4||0
11073781|NCT01083368|12255669|FG001|STARTED|Dose Escalation Weeks 1-4||0
11073782|NCT01083368|12255670|FG002|STARTED|Dose Escalation Weeks 1-4||4
11073783|NCT01083368|12255671|FG003|STARTED|Dose Escalation Weeks 1-4||0
11073784|NCT01083368|12255668|FG000|Disease Progression|Dose Escalation Weeks 1-4||0
11073785|NCT01083368|12255669|FG001|Disease Progression|Dose Escalation Weeks 1-4||0
11073786|NCT01083368|12255670|FG002|Disease Progression|Dose Escalation Weeks 1-4||1
11073787|NCT01083368|12255671|FG003|Disease Progression|Dose Escalation Weeks 1-4||0
11073788|NCT01083368|12255668|FG000|COMPLETED|Dose Escalation Weeks 1-4||0
11073789|NCT01083368|12255669|FG001|COMPLETED|Dose Escalation Weeks 1-4||0
11073790|NCT01083368|12255670|FG002|COMPLETED|Dose Escalation Weeks 1-4||4
11073791|NCT01083368|12255671|FG003|COMPLETED|Dose Escalation Weeks 1-4||0
11073792|NCT01083368|12255668|FG000|NOT COMPLETED|Dose Escalation Weeks 1-4||0
11073793|NCT01083368|12255669|FG001|NOT COMPLETED|Dose Escalation Weeks 1-4||0
11073794|NCT01083368|12255670|FG002|NOT COMPLETED|Dose Escalation Weeks 1-4||0
11073795|NCT01083368|12255671|FG003|NOT COMPLETED|Dose Escalation Weeks 1-4||0
11073796|NCT01083368|12255668|FG000|STARTED|Dose Escalation Weeks 5-9||0
11073797|NCT01083368|12255669|FG001|STARTED|Dose Escalation Weeks 5-9||0
11073798|NCT01083368|12255670|FG002|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1
11073799|NCT01083368|12255671|FG003|STARTED|Dose Escalation Weeks 5-9||6
11073800|NCT01083368|12255668|FG000|COMPLETED|Dose Escalation Weeks 5-9||0
11073801|NCT01083368|12255669|FG001|COMPLETED|Dose Escalation Weeks 5-9||0
11073802|NCT01083368|12255670|FG002|COMPLETED|Dose Escalation Weeks 5-9||1
11073803|NCT01083368|12255671|FG003|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6
11347481|NCT02991859|12544633|FG008|COMPLETED|Wash Out, Up to Day 77||2
11347482|NCT02991859|12544634|FG009|COMPLETED|Wash Out, Up to Day 77||1
11347483|NCT02991859|12544635|FG010|COMPLETED|Wash Out, Up to Day 77||1
11347484|NCT02991859|12544636|FG011|COMPLETED|Wash Out, Up to Day 77||2
11347485|NCT02991859|12544637|FG012|COMPLETED|Wash Out, Up to Day 77||0
11347486|NCT02991859|12544638|FG013|COMPLETED|Wash Out, Up to Day 77||0
11347487|NCT02991859|12544639|FG014|COMPLETED|Wash Out, Up to Day 77||0
11347488|NCT02991859|12544640|FG015|COMPLETED|Wash Out, Up to Day 77||0
11347489|NCT02991859|12544641|FG016|COMPLETED|Wash Out, Up to Day 77||0
11347490|NCT02991859|12544625|FG000|NOT COMPLETED|Wash Out, Up to Day 77||0
11347491|NCT02991859|12544626|FG001|NOT COMPLETED|Wash Out, Up to Day 77||0
11347492|NCT02991859|12544627|FG002|NOT COMPLETED|Wash Out, Up to Day 77||0
11347493|NCT02991859|12544628|FG003|NOT COMPLETED|Wash Out, Up to Day 77||0
11347494|NCT02991859|12544629|FG004|NOT COMPLETED|Wash Out, Up to Day 77||0
11347495|NCT02991859|12544630|FG005|NOT COMPLETED|Wash Out, Up to Day 77||1
11347496|NCT02991859|12544631|FG006|NOT COMPLETED|Wash Out, Up to Day 77||0
11347497|NCT02991859|12544632|FG007|NOT COMPLETED|Wash Out, Up to Day 77||0
11073804|NCT01083368|12255668|FG000|NOT COMPLETED|Dose Escalation Weeks 5-9||0
11073805|NCT01083368|12255669|FG001|NOT COMPLETED|Dose Escalation Weeks 5-9||0
11073806|NCT01083368|12255670|FG002|NOT COMPLETED|Dose Escalation Weeks 5-9||0
11073807|NCT01083368|12255671|FG003|NOT COMPLETED|Dose Escalation Weeks 5-9||0
11073808|NCT01083368|12255668|FG000|STARTED|Phase II - Efficacy/Safety||0
11073809|NCT01083368|12255669|FG001|STARTED|Phase II - Efficacy/Safety||0
11073810|NCT01083368|12255670|FG002|STARTED|Phase II - Efficacy/Safety||0
11073811|NCT01083368|12255671|FG003|STARTED|Phase II - Efficacy/Safety||20
11073812|NCT01083368|12255668|FG000|COMPLETED|Phase II - Efficacy/Safety||0
11073813|NCT01083368|12255669|FG001|COMPLETED|Phase II - Efficacy/Safety||0
11073814|NCT01083368|12255670|FG002|COMPLETED|Phase II - Efficacy/Safety||0
11073815|NCT01083368|12255671|FG003|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20
11073816|NCT01083368|12255668|FG000|NOT COMPLETED|Phase II - Efficacy/Safety||0
11073817|NCT01083368|12255669|FG001|NOT COMPLETED|Phase II - Efficacy/Safety||0
11073818|NCT01083368|12255670|FG002|NOT COMPLETED|Phase II - Efficacy/Safety||0
11073819|NCT01083368|12255671|FG003|NOT COMPLETED|Phase II - Efficacy/Safety||0
11073820|NCT01083485|12255681|FG000|STARTED|Overall Study||70
11073821|NCT01083485|12255682|FG001|STARTED|Overall Study||67
11073822|NCT01083485|12255681|FG000|COMPLETED|Overall Study||63
11073823|NCT01083485|12255682|FG001|COMPLETED|Overall Study||64
11073824|NCT01083485|12255681|FG000|NOT COMPLETED|Overall Study||7
11073825|NCT01083485|12255682|FG001|NOT COMPLETED|Overall Study||3
11073826|NCT01083576|12255692|FG000|STARTED|Overall Study||15
11073827|NCT01083576|12255693|FG001|STARTED|Overall Study||15
11073828|NCT01083576|12255692|FG000|COMPLETED|Overall Study||9
11073829|NCT01083576|12255693|FG001|COMPLETED|Overall Study||14
11073830|NCT01083576|12255692|FG000|NOT COMPLETED|Overall Study||6
11073831|NCT01083576|12255693|FG001|NOT COMPLETED|Overall Study||1
11073832|NCT01083602|12255700|FG000|STARTED|Overall Study||55
11347498|NCT02991859|12544633|FG008|NOT COMPLETED|Wash Out, Up to Day 77||0
11347499|NCT02991859|12544634|FG009|NOT COMPLETED|Wash Out, Up to Day 77||1
11347500|NCT02991859|12544635|FG010|NOT COMPLETED|Wash Out, Up to Day 77||0
11347501|NCT02991859|12544636|FG011|NOT COMPLETED|Wash Out, Up to Day 77||0
11347502|NCT02991859|12544637|FG012|NOT COMPLETED|Wash Out, Up to Day 77||0
11347503|NCT02991859|12544638|FG013|NOT COMPLETED|Wash Out, Up to Day 77||0
11347504|NCT02991859|12544639|FG014|NOT COMPLETED|Wash Out, Up to Day 77||0
11347505|NCT02991859|12544640|FG015|NOT COMPLETED|Wash Out, Up to Day 77||0
11347506|NCT02991859|12544641|FG016|NOT COMPLETED|Wash Out, Up to Day 77||0
11347507|NCT02991859|12544625|FG000|STARTED|Period2, Escalation Phase1, Upto Day 84||2
11347508|NCT02991859|12544626|FG001|STARTED|Period2, Escalation Phase1, Upto Day 84||2
11347509|NCT02991859|12544627|FG002|STARTED|Period2, Escalation Phase1, Upto Day 84||2
11347510|NCT02991859|12544628|FG003|STARTED|Period2, Escalation Phase1, Upto Day 84||2
11347511|NCT02991859|12544629|FG004|STARTED|Period2, Escalation Phase1, Upto Day 84||2
11347512|NCT02991859|12544630|FG005|STARTED|Period2, Escalation Phase1, Upto Day 84||1
11347513|NCT02991859|12544631|FG006|STARTED|Period2, Escalation Phase1, Upto Day 84||2
11347514|NCT02991859|12544632|FG007|STARTED|Period2, Escalation Phase1, Upto Day 84||2
11347515|NCT02991859|12544633|FG008|STARTED|Period2, Escalation Phase1, Upto Day 84||2
11347516|NCT02991859|12544634|FG009|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par directly entered into Period 2, Esc 1|2
11347517|NCT02991859|12544635|FG010|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par cont in P2 Esc 1 insteadP1 Esc 5, was not withdrawn|2
11347518|NCT02991859|12544636|FG011|STARTED|Period2, Escalation Phase1, Upto Day 84||2
11347519|NCT02991859|12544637|FG012|STARTED|Period2, Escalation Phase1, Upto Day 84||0
11347520|NCT02991859|12544638|FG013|STARTED|Period2, Escalation Phase1, Upto Day 84||0
11347521|NCT02991859|12544639|FG014|STARTED|Period2, Escalation Phase1, Upto Day 84||0
11347522|NCT02991859|12544640|FG015|STARTED|Period2, Escalation Phase1, Upto Day 84||0
11347523|NCT02991859|12544641|FG016|STARTED|Period2, Escalation Phase1, Upto Day 84||0
11347524|NCT02991859|12544625|FG000|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
11347525|NCT02991859|12544626|FG001|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
11347526|NCT02991859|12544627|FG002|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
11073833|NCT01083602|12255700|FG000|COMPLETED|Overall Study||0
11073834|NCT01083602|12255700|FG000|NOT COMPLETED|Overall Study||55
11073835|NCT01083628|12255706|FG000|STARTED|Overall Study||45
11073836|NCT01083628|12255707|FG001|STARTED|Overall Study||40
11073837|NCT01083628|12255706|FG000|COMPLETED|Overall Study||45
11073838|NCT01083628|12255707|FG001|COMPLETED|Overall Study||40
11073839|NCT01083628|12255706|FG000|NOT COMPLETED|Overall Study||0
11073840|NCT01083628|12255707|FG001|NOT COMPLETED|Overall Study||0
11073841|NCT01083641|12255713|FG000|STARTED|Overall Study||17
11073842|NCT01083641|12255713|FG000|COMPLETED|Overall Study||15
11073843|NCT01083641|12255713|FG000|NOT COMPLETED|Overall Study||2
11073844|NCT01083654|12255719|FG000|STARTED|Overall Study||53
11073845|NCT01083654|12255720|FG001|STARTED|Overall Study||50
11073846|NCT01083654|12255719|FG000|COMPLETED|Overall Study||53
11073847|NCT01083654|12255720|FG001|COMPLETED|Overall Study||50
11073848|NCT01083654|12255719|FG000|NOT COMPLETED|Overall Study||0
11073849|NCT01083654|12255720|FG001|NOT COMPLETED|Overall Study||0
11073850|NCT01083667|12255726|FG000|STARTED|Overall Study|enrolled|32
11073851|NCT01083667|12255726|FG000|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
11073852|NCT01083667|12255726|FG000|NOT COMPLETED|Overall Study||10
11073853|NCT01083680|12255730|FG000|STARTED|Overall Study||4107
11073854|NCT01083680|12255730|FG000|Full Analysis Set (FAS), Efficacy|Overall Study||1621
11073855|NCT01083680|12255730|FG000|COMPLETED|Overall Study||263
11073856|NCT01083680|12255730|FG000|NOT COMPLETED|Overall Study||3844
11073857|NCT01083693|12255737|FG000|STARTED|Overall Study||93
11073858|NCT01083693|12255738|FG001|STARTED|Overall Study||28
11073859|NCT01083693|12255739|FG002|STARTED|Overall Study||40
11073860|NCT01083693|12255737|FG000|COMPLETED|Overall Study||73
11073861|NCT01083693|12255738|FG001|COMPLETED|Overall Study||22
11073862|NCT01083693|12255739|FG002|COMPLETED|Overall Study||33
11073863|NCT01083693|12255737|FG000|NOT COMPLETED|Overall Study||20
11073864|NCT01083693|12255738|FG001|NOT COMPLETED|Overall Study||6
11073865|NCT01083693|12255739|FG002|NOT COMPLETED|Overall Study||7
11073866|NCT01083706|12255751|FG000|STARTED|Overall Study||39
11073867|NCT01083706|12255751|FG000|COMPLETED|Overall Study||39
11073868|NCT01083706|12255751|FG000|NOT COMPLETED|Overall Study||0
11073869|NCT01083732|12255758|FG000|STARTED|Overall Study||6
11073870|NCT01083732|12255759|FG001|STARTED|Overall Study||9
11073871|NCT01083732|12255760|FG002|STARTED|Overall Study||3
11073872|NCT01083732|12255758|FG000|COMPLETED|Overall Study||6
11073873|NCT01083732|12255759|FG001|COMPLETED|Overall Study||9
11073874|NCT01083732|12255760|FG002|COMPLETED|Overall Study||3
11073875|NCT01083732|12255758|FG000|NOT COMPLETED|Overall Study||0
11073876|NCT01083732|12255759|FG001|NOT COMPLETED|Overall Study||0
11073877|NCT01083732|12255760|FG002|NOT COMPLETED|Overall Study||0
11073878|NCT01083758|12255771|FG000|STARTED|Overall Study||31
11073879|NCT01083758|12255771|FG000|COMPLETED|Overall Study||29
11073880|NCT01083758|12255771|FG000|NOT COMPLETED|Overall Study||2
11073881|NCT01083810|12255778|FG000|STARTED|Overall Study||137
11073882|NCT01083810|12255779|FG001|STARTED|Overall Study||92
11073883|NCT01083810|12255780|FG002|STARTED|Overall Study||55
11073884|NCT01083810|12255778|FG000|COMPLETED|Overall Study||72
11073885|NCT01083810|12255779|FG001|COMPLETED|Overall Study||47
11073886|NCT01083810|12255780|FG002|COMPLETED|Overall Study||35
11073887|NCT01083810|12255778|FG000|NOT COMPLETED|Overall Study||65
11073888|NCT01083810|12255779|FG001|NOT COMPLETED|Overall Study||45
11073889|NCT01083810|12255780|FG002|NOT COMPLETED|Overall Study||20
11073890|NCT01083849|12255788|FG000|STARTED|Overall Study||121
11073891|NCT01083849|12255789|FG001|STARTED|Overall Study||638
11073892|NCT01083849|12255788|FG000|COMPLETED|Overall Study||61
11073893|NCT01083849|12255789|FG001|COMPLETED|Overall Study||527
11073894|NCT01083849|12255788|FG000|NOT COMPLETED|Overall Study||60
11073895|NCT01083849|12255789|FG001|NOT COMPLETED|Overall Study||111
11073896|NCT01083901|12255801|FG000|STARTED|Overall Study||13
11073897|NCT01083901|12255802|FG001|STARTED|Overall Study||8
11073898|NCT01083901|12255803|FG002|STARTED|Overall Study||13
11073899|NCT01083901|12255801|FG000|COMPLETED|Overall Study||12
11073900|NCT01083901|12255802|FG001|COMPLETED|Overall Study||6
11073901|NCT01083901|12255803|FG002|COMPLETED|Overall Study||11
11073902|NCT01083901|12255801|FG000|NOT COMPLETED|Overall Study||1
11073903|NCT01083901|12255802|FG001|NOT COMPLETED|Overall Study||2
11073904|NCT01083901|12255803|FG002|NOT COMPLETED|Overall Study||2
11073905|NCT01083979|12255811|FG000|STARTED|Overall Study||1
11073906|NCT01083979|12255811|FG000|COMPLETED|Overall Study||1
11073907|NCT01083979|12255811|FG000|NOT COMPLETED|Overall Study||0
11073908|NCT01084005|12255817|FG000|STARTED|Overall Study||79
11073909|NCT01084005|12255818|FG001|STARTED|Overall Study||162
11073910|NCT01084005|12255817|FG000|COMPLETED|Overall Study||74
11073911|NCT01084005|12255818|FG001|COMPLETED|Overall Study||146
11073912|NCT01084005|12255817|FG000|NOT COMPLETED|Overall Study||5
11073913|NCT01084005|12255818|FG001|NOT COMPLETED|Overall Study||16
11073914|NCT01084083|12255824|FG000|STARTED|Overall Study||90
11073915|NCT01084083|12255824|FG000|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
11073916|NCT01084083|12255824|FG000|Eligible|Overall Study||81
11073917|NCT01084083|12255824|FG000|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
11073918|NCT01084083|12255824|FG000|CR to Induction Therapy|Overall Study||56
11073919|NCT01084083|12255824|FG000|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
11073920|NCT01084083|12255824|FG000|COMPLETED|Overall Study||78
11073921|NCT01084083|12255824|FG000|NOT COMPLETED|Overall Study||12
11073922|NCT01084135|12255833|FG000|STARTED|12 Week||4
11073923|NCT01084135|12255834|FG001|STARTED|12 Week||4
11073924|NCT01084135|12255833|FG000|COMPLETED|12 Week||4
11073925|NCT01084135|12255834|FG001|COMPLETED|12 Week||4
11073926|NCT01084135|12255833|FG000|NOT COMPLETED|12 Week||0
11073927|NCT01084135|12255834|FG001|NOT COMPLETED|12 Week||0
11073928|NCT01084135|12255833|FG000|STARTED|20 Week||12
11073929|NCT01084135|12255834|FG001|STARTED|20 Week||11
11073930|NCT01084135|12255833|FG000|COMPLETED|20 Week||12
11073931|NCT01084135|12255834|FG001|COMPLETED|20 Week||10
11073932|NCT01084135|12255833|FG000|NOT COMPLETED|20 Week||0
11073933|NCT01084135|12255834|FG001|NOT COMPLETED|20 Week||1
11073934|NCT01084148|12255844|FG000|STARTED|Overall Study||118
11073935|NCT01084148|12255845|FG001|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
11073936|NCT01084148|12255844|FG000|Treated Patients|Overall Study||118
11073937|NCT01084148|12255845|FG001|Treated Patients|Overall Study|Patients who received test product at least once|117
11073938|NCT01084148|12255844|FG000|COMPLETED|Overall Study||88
11073939|NCT01084148|12255845|FG001|COMPLETED|Overall Study||102
11073940|NCT01084148|12255844|FG000|NOT COMPLETED|Overall Study||30
11073941|NCT01084148|12255845|FG001|NOT COMPLETED|Overall Study||16
11073942|NCT01084174|12255855|FG000|STARTED|Overall Study||10
11073943|NCT01084174|12255856|FG001|STARTED|Overall Study||11
11073944|NCT01084174|12255855|FG000|COMPLETED|Overall Study||9
11073945|NCT01084174|12255856|FG001|COMPLETED|Overall Study||7
11073946|NCT01084174|12255855|FG000|NOT COMPLETED|Overall Study||1
11073947|NCT01084174|12255856|FG001|NOT COMPLETED|Overall Study||4
11073948|NCT01084239|12255864|FG000|STARTED|Randomization - Index Hospitalization||501
11073949|NCT01084239|12255865|FG001|STARTED|Randomization - Index Hospitalization||499
11073950|NCT01084239|12255864|FG000|COMPLETED|Randomization - Index Hospitalization||501
11073951|NCT01084239|12255865|FG001|COMPLETED|Randomization - Index Hospitalization||499
11073952|NCT01084239|12255864|FG000|NOT COMPLETED|Randomization - Index Hospitalization||0
11073953|NCT01084239|12255865|FG001|NOT COMPLETED|Randomization - Index Hospitalization||0
11206619|NCT01869075|12397654|FG003|COMPLETED|Phase 2||45
11347527|NCT02991859|12544628|FG003|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
11347528|NCT02991859|12544629|FG004|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
11347529|NCT02991859|12544630|FG005|COMPLETED|Period2, Escalation Phase1, Upto Day 84||1
11347530|NCT02991859|12544631|FG006|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
11347531|NCT02991859|12544632|FG007|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
11347532|NCT02991859|12544633|FG008|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
11347533|NCT02991859|12544634|FG009|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
11347534|NCT02991859|12544635|FG010|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
11347535|NCT02991859|12544636|FG011|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
11347536|NCT02991859|12544637|FG012|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347537|NCT02991859|12544638|FG013|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347538|NCT02991859|12544639|FG014|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347539|NCT02991859|12544640|FG015|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347540|NCT02991859|12544641|FG016|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347541|NCT02991859|12544625|FG000|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347542|NCT02991859|12544626|FG001|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347543|NCT02991859|12544627|FG002|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347544|NCT02991859|12544628|FG003|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347545|NCT02991859|12544629|FG004|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347546|NCT02991859|12544630|FG005|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347547|NCT02991859|12544631|FG006|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347548|NCT02991859|12544632|FG007|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347549|NCT02991859|12544633|FG008|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347550|NCT02991859|12544634|FG009|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347551|NCT02991859|12544635|FG010|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347552|NCT02991859|12544636|FG011|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347553|NCT02991859|12544637|FG012|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347554|NCT02991859|12544638|FG013|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347555|NCT02991859|12544639|FG014|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347556|NCT02991859|12544640|FG015|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347557|NCT02991859|12544641|FG016|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
11347558|NCT02991859|12544625|FG000|STARTED|Period2, Escalation Phase2, Upto Day 91||2
11347559|NCT02991859|12544626|FG001|STARTED|Period2, Escalation Phase2, Upto Day 91||2
11347560|NCT02991859|12544627|FG002|STARTED|Period2, Escalation Phase2, Upto Day 91||2
11347561|NCT02991859|12544628|FG003|STARTED|Period2, Escalation Phase2, Upto Day 91||2
11347562|NCT02991859|12544629|FG004|STARTED|Period2, Escalation Phase2, Upto Day 91||2
11347563|NCT02991859|12544630|FG005|STARTED|Period2, Escalation Phase2, Upto Day 91||1
11073954|NCT01084239|12255864|FG000|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
11073955|NCT01084239|12255865|FG001|STARTED|28-Day Follow-up||499
11073956|NCT01084239|12255864|FG000|COMPLETED|28-Day Follow-up||497
11073957|NCT01084239|12255865|FG001|COMPLETED|28-Day Follow-up||490
11073958|NCT01084239|12255864|FG000|NOT COMPLETED|28-Day Follow-up||4
11073959|NCT01084239|12255865|FG001|NOT COMPLETED|28-Day Follow-up||9
11073960|NCT01084265|12255873|FG000|STARTED|Overall Study||31
11073961|NCT01084265|12255873|FG000|COMPLETED|Overall Study||31
11073962|NCT01084265|12255873|FG000|NOT COMPLETED|Overall Study||0
11073963|NCT01084278|12255882|FG000|STARTED|Overall Study||8
11073964|NCT01084278|12255883|FG001|STARTED|Overall Study||8
11073965|NCT01084278|12255884|FG002|STARTED|Overall Study||8
11073966|NCT01084278|12255885|FG003|STARTED|Overall Study||8
11073967|NCT01084278|12255886|FG004|STARTED|Overall Study||8
11206620|NCT01869075|12397655|FG004|COMPLETED|Phase 2||75
11206621|NCT01869075|12397656|FG005|COMPLETED|Phase 2||45
11206622|NCT01869075|12397651|FG000|NOT COMPLETED|Phase 2||0
11206623|NCT01869075|12397652|FG001|NOT COMPLETED|Phase 2||0
11206624|NCT01869075|12397653|FG002|NOT COMPLETED|Phase 2||0
11206625|NCT01869075|12397654|FG003|NOT COMPLETED|Phase 2||0
11206626|NCT01869075|12397655|FG004|NOT COMPLETED|Phase 2||0
11206627|NCT01869075|12397656|FG005|NOT COMPLETED|Phase 2||0
11206628|NCT01869192|12397672|FG000|STARTED|Preoperative Chemotherapy to Surgery||37
11206629|NCT01869192|12397673|FG001|STARTED|Preoperative Chemotherapy to Surgery||35
11206630|NCT01869192|12397672|FG000|COMPLETED|Preoperative Chemotherapy to Surgery||35
11206631|NCT01869192|12397673|FG001|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
11206632|NCT01869192|12397672|FG000|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
11206633|NCT01869192|12397673|FG001|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
11206634|NCT01869192|12397672|FG000|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
11206635|NCT01869192|12397673|FG001|STARTED|Postoperative Chemotherapy||33
11206636|NCT01869192|12397672|FG000|COMPLETED|Postoperative Chemotherapy||32
11206637|NCT01869192|12397673|FG001|COMPLETED|Postoperative Chemotherapy||31
11206638|NCT01869192|12397672|FG000|NOT COMPLETED|Postoperative Chemotherapy||0
11206639|NCT01869192|12397673|FG001|NOT COMPLETED|Postoperative Chemotherapy||2
11206640|NCT01869348|12397681|FG000|STARTED|Overall Study||20
11206641|NCT01869348|12397682|FG001|STARTED|Overall Study||20
11206642|NCT01869348|12397681|FG000|COMPLETED|Overall Study||19
11206643|NCT01869348|12397682|FG001|COMPLETED|Overall Study||19
11206644|NCT01869348|12397681|FG000|NOT COMPLETED|Overall Study||1
11206645|NCT01869348|12397682|FG001|NOT COMPLETED|Overall Study||1
11206646|NCT01869374|12397690|FG000|STARTED|Overall Study||9
11206647|NCT01869374|12397691|FG001|STARTED|Overall Study||9
11206648|NCT01869374|12397690|FG000|COMPLETED|Overall Study||9
11206649|NCT01869374|12397691|FG001|COMPLETED|Overall Study||8
11206650|NCT01869374|12397690|FG000|NOT COMPLETED|Overall Study||0
11206651|NCT01869374|12397691|FG001|NOT COMPLETED|Overall Study||1
11206652|NCT01869439|12397697|FG000|STARTED|Overall Study||40
11206653|NCT01869439|12397697|FG000|COMPLETED|Overall Study||40
11206654|NCT01869439|12397697|FG000|NOT COMPLETED|Overall Study||0
11206655|NCT01869634|12397703|FG000|STARTED|Overall Study||20
11206656|NCT01869634|12397704|FG001|STARTED|Overall Study||17
11206657|NCT01869634|12397703|FG000|COMPLETED|Overall Study||18
11206658|NCT01869634|12397704|FG001|COMPLETED|Overall Study||17
11206659|NCT01869634|12397703|FG000|NOT COMPLETED|Overall Study||2
11206660|NCT01869634|12397704|FG001|NOT COMPLETED|Overall Study||0
11206661|NCT01869647|12397713|FG000|STARTED|Overall Study||66
11206662|NCT01869647|12397714|FG001|STARTED|Overall Study||136
11206663|NCT01869647|12397715|FG002|STARTED|Overall Study||62
11206664|NCT01869647|12397713|FG000|COMPLETED|Overall Study||65
11206665|NCT01869647|12397714|FG001|COMPLETED|Overall Study||130
11206666|NCT01869647|12397715|FG002|COMPLETED|Overall Study||62
11206667|NCT01869647|12397713|FG000|NOT COMPLETED|Overall Study||1
11206668|NCT01869647|12397714|FG001|NOT COMPLETED|Overall Study||6
11206669|NCT01869647|12397715|FG002|NOT COMPLETED|Overall Study||0
11206670|NCT01869686|12397723|FG000|STARTED|Overall Study||12
11206671|NCT01869686|12397723|FG000|COMPLETED|Overall Study||12
11206672|NCT01869686|12397723|FG000|NOT COMPLETED|Overall Study||0
11206673|NCT01869699|12397729|FG000|STARTED|Overall Study||21
11206674|NCT01869699|12397730|FG001|STARTED|Overall Study||20
11206675|NCT01869699|12397729|FG000|COMPLETED|Overall Study||20
11206676|NCT01869699|12397730|FG001|COMPLETED|Overall Study||20
11206677|NCT01869699|12397729|FG000|NOT COMPLETED|Overall Study||1
11206678|NCT01869699|12397730|FG001|NOT COMPLETED|Overall Study||0
11206679|NCT01869725|12397736|FG000|STARTED|Overall Study||68
11206680|NCT01869725|12397736|FG000|COMPLETED|Overall Study||64
11206681|NCT01869725|12397736|FG000|NOT COMPLETED|Overall Study||4
11206682|NCT01869764|12397742|FG000|STARTED|Overall Study||28
11206683|NCT01869764|12397743|FG001|STARTED|Overall Study||29
11206684|NCT01869764|12397742|FG000|COMPLETED|Overall Study||28
11206685|NCT01869764|12397743|FG001|COMPLETED|Overall Study||27
11206686|NCT01869764|12397742|FG000|NOT COMPLETED|Overall Study||0
11206687|NCT01869764|12397743|FG001|NOT COMPLETED|Overall Study||2
11206688|NCT01869777|12397749|FG000|STARTED|Overall Study||102
11206689|NCT01869777|12397749|FG000|COMPLETED|Overall Study||101
11206690|NCT01869777|12397749|FG000|NOT COMPLETED|Overall Study||1
11206691|NCT01869959|12397757|FG000|STARTED|Randomization Period||0
11206692|NCT01869959|12397758|FG001|STARTED|Randomization Period||0
11206693|NCT01869959|12397759|FG002|STARTED|Randomization Period||0
11206694|NCT01869959|12397760|FG003|STARTED|Randomization Period||0
11206695|NCT01869959|12397761|FG004|STARTED|Randomization Period||47
11206696|NCT01869959|12397757|FG000|COMPLETED|Randomization Period||0
11206697|NCT01869959|12397758|FG001|COMPLETED|Randomization Period||0
11206698|NCT01869959|12397759|FG002|COMPLETED|Randomization Period||0
11206699|NCT01869959|12397760|FG003|COMPLETED|Randomization Period||0
11073968|NCT01084278|12255882|FG000|COMPLETED|Overall Study||8
11073969|NCT01084278|12255883|FG001|COMPLETED|Overall Study||8
11073970|NCT01084278|12255884|FG002|COMPLETED|Overall Study||8
11073971|NCT01084278|12255885|FG003|COMPLETED|Overall Study||8
11073972|NCT01084278|12255886|FG004|COMPLETED|Overall Study||8
11073973|NCT01084278|12255882|FG000|NOT COMPLETED|Overall Study||0
11073974|NCT01084278|12255883|FG001|NOT COMPLETED|Overall Study||0
11073975|NCT01084278|12255884|FG002|NOT COMPLETED|Overall Study||0
11073976|NCT01084278|12255885|FG003|NOT COMPLETED|Overall Study||0
11073977|NCT01084278|12255886|FG004|NOT COMPLETED|Overall Study||0
11073978|NCT01084499|12255902|FG000|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13
11073979|NCT01084499|12255903|FG001|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13
11073980|NCT01084499|12255902|FG000|Washout (5 Weeks)|Overall Study||13
11073981|NCT01084499|12255903|FG001|Washout (5 Weeks)|Overall Study||13
11073982|NCT01084499|12255902|FG000|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13
11073983|NCT01084499|12255903|FG001|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13
11073984|NCT01084499|12255902|FG000|NOT COMPLETED|Overall Study||0
11073985|NCT01084499|12255903|FG001|NOT COMPLETED|Overall Study||0
11073986|NCT01084538|12255909|FG000|STARTED|Overall Study||181
11073987|NCT01084538|12255909|FG000|COMPLETED|Overall Study||113
11073988|NCT01084538|12255909|FG000|NOT COMPLETED|Overall Study||68
11073989|NCT01084551|12255916|FG000|STARTED|Overall Study||95
11073990|NCT01084551|12255917|FG001|STARTED|Overall Study||95
11073991|NCT01084551|12255918|FG002|STARTED|Overall Study||94
11073992|NCT01084551|12255916|FG000|COMPLETED|Overall Study||86
11073993|NCT01084551|12255917|FG001|COMPLETED|Overall Study||81
11073994|NCT01084551|12255918|FG002|COMPLETED|Overall Study||86
11073995|NCT01084551|12255916|FG000|NOT COMPLETED|Overall Study||9
11073996|NCT01084551|12255917|FG001|NOT COMPLETED|Overall Study||14
11073997|NCT01084551|12255918|FG002|NOT COMPLETED|Overall Study||8
11073998|NCT01084603|12255926|FG000|STARTED|Baseline||45
11073999|NCT01084603|12255926|FG000|COMPLETED|Baseline||43
11074000|NCT01084603|12255926|FG000|NOT COMPLETED|Baseline||2
11074001|NCT01084603|12255926|FG000|STARTED|NiQuitinTM Lozenge||43
11074002|NCT01084603|12255926|FG000|COMPLETED|NiQuitinTM Lozenge||42
11074003|NCT01084603|12255926|FG000|NOT COMPLETED|NiQuitinTM Lozenge||1
11074004|NCT01084603|12255926|FG000|STARTED|Washout Period 1||42
11074005|NCT01084603|12255926|FG000|COMPLETED|Washout Period 1||42
11074006|NCT01084603|12255926|FG000|NOT COMPLETED|Washout Period 1||0
11074007|NCT01084603|12255926|FG000|STARTED|Nicorette® Gum||42
11074008|NCT01084603|12255926|FG000|COMPLETED|Nicorette® Gum||41
11074009|NCT01084603|12255926|FG000|NOT COMPLETED|Nicorette® Gum||1
11074010|NCT01084603|12255926|FG000|STARTED|Washout Period 2||41
11074011|NCT01084603|12255926|FG000|COMPLETED|Washout Period 2||41
11074012|NCT01084603|12255926|FG000|NOT COMPLETED|Washout Period 2||0
11074013|NCT01084603|12255926|FG000|STARTED|Oral Nicotine 1||41
11074014|NCT01084603|12255926|FG000|COMPLETED|Oral Nicotine 1||40
11074015|NCT01084603|12255926|FG000|NOT COMPLETED|Oral Nicotine 1||1
11074016|NCT01084603|12255926|FG000|STARTED|Washout Period 3||40
11074017|NCT01084603|12255926|FG000|COMPLETED|Washout Period 3||40
11074018|NCT01084603|12255926|FG000|NOT COMPLETED|Washout Period 3||0
11074019|NCT01084603|12255926|FG000|STARTED|Oral Nicotine 2||40
11074020|NCT01084603|12255926|FG000|COMPLETED|Oral Nicotine 2||40
11074021|NCT01084603|12255926|FG000|NOT COMPLETED|Oral Nicotine 2||0
11074022|NCT01084603|12255926|FG000|STARTED|Washout Period 4||40
11074023|NCT01084603|12255926|FG000|COMPLETED|Washout Period 4||39
11074024|NCT01084603|12255926|FG000|NOT COMPLETED|Washout Period 4||1
11074025|NCT01084603|12255926|FG000|STARTED|Oral Nicotine 4||39
11074026|NCT01084603|12255926|FG000|COMPLETED|Oral Nicotine 4||39
11074027|NCT01084603|12255926|FG000|NOT COMPLETED|Oral Nicotine 4||0
11074028|NCT01084655|12255942|FG000|STARTED|Overall Study||6
11074029|NCT01084655|12255943|FG001|STARTED|Overall Study||8
11074030|NCT01084655|12255944|FG002|STARTED|Overall Study||24
11074031|NCT01084655|12255942|FG000|Treated|Overall Study||6
11074032|NCT01084655|12255943|FG001|Treated|Overall Study||8
11074033|NCT01084655|12255944|FG002|Treated|Overall Study||23
11074034|NCT01084655|12255942|FG000|COMPLETED|Overall Study||0
11074035|NCT01084655|12255943|FG001|COMPLETED|Overall Study||2
11074036|NCT01084655|12255944|FG002|COMPLETED|Overall Study||5
11074037|NCT01084655|12255942|FG000|NOT COMPLETED|Overall Study||6
11074038|NCT01084655|12255943|FG001|NOT COMPLETED|Overall Study||6
11074039|NCT01084655|12255944|FG002|NOT COMPLETED|Overall Study||19
11074040|NCT01084668|12255956|FG000|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
11074041|NCT01084668|12255956|FG000|COMPLETED|Overall Study||33
11074042|NCT01084668|12255956|FG000|NOT COMPLETED|Overall Study||9
11074043|NCT01084694|12255964|FG000|STARTED|Overall Study||50
11074044|NCT01084694|12255965|FG001|STARTED|Overall Study||50
11074045|NCT01084694|12255964|FG000|COMPLETED|Overall Study||44
11074046|NCT01084694|12255965|FG001|COMPLETED|Overall Study||30
11074047|NCT01084694|12255964|FG000|NOT COMPLETED|Overall Study||6
11074048|NCT01084694|12255965|FG001|NOT COMPLETED|Overall Study||20
11074049|NCT01084707|12255979|FG000|STARTED|Overall Study||40
11074050|NCT01084707|12255979|FG000|COMPLETED|Overall Study||34
11074051|NCT01084707|12255979|FG000|NOT COMPLETED|Overall Study||6
11074052|NCT01084759|12255991|FG000|STARTED|Overall Study||16
11074053|NCT01084759|12255991|FG000|COMPLETED|Overall Study||14
11074054|NCT01084759|12255991|FG000|NOT COMPLETED|Overall Study||2
11074055|NCT01084772|12255997|FG000|STARTED|Baseline||68
11074056|NCT01084772|12255998|FG001|STARTED|Baseline||66
11074057|NCT01084772|12255997|FG000|COMPLETED|Baseline||61
11074058|NCT01084772|12255998|FG001|COMPLETED|Baseline||60
11074059|NCT01084772|12255997|FG000|NOT COMPLETED|Baseline||7
11074060|NCT01084772|12255998|FG001|NOT COMPLETED|Baseline||6
11074061|NCT01084772|12255997|FG000|STARTED|3 Months||61
11074062|NCT01084772|12255998|FG001|STARTED|3 Months||60
11074063|NCT01084772|12255997|FG000|COMPLETED|3 Months||58
11074064|NCT01084772|12255998|FG001|COMPLETED|3 Months||58
11074065|NCT01084772|12255997|FG000|NOT COMPLETED|3 Months||3
11074066|NCT01084772|12255998|FG001|NOT COMPLETED|3 Months||2
11074067|NCT01084772|12255997|FG000|STARTED|1 Year||58
11074068|NCT01084772|12255998|FG001|STARTED|1 Year||58
11074069|NCT01084772|12255997|FG000|COMPLETED|1 Year||55
11074070|NCT01084772|12255998|FG001|COMPLETED|1 Year||50
11074071|NCT01084772|12255997|FG000|NOT COMPLETED|1 Year||3
11074072|NCT01084772|12255998|FG001|NOT COMPLETED|1 Year||8
11074073|NCT01084772|12255997|FG000|STARTED|2 Years||55
11074074|NCT01084772|12255998|FG001|STARTED|2 Years||50
11074075|NCT01084772|12255997|FG000|COMPLETED|2 Years||46
11074076|NCT01084772|12255998|FG001|COMPLETED|2 Years||46
11074077|NCT01084772|12255997|FG000|NOT COMPLETED|2 Years||9
11074078|NCT01084772|12255998|FG001|NOT COMPLETED|2 Years||4
11074079|NCT01085006|12256006|FG000|STARTED|Overall Study||50
11074080|NCT01085006|12256007|FG001|STARTED|Overall Study||50
11074081|NCT01085006|12256006|FG000|COMPLETED|Overall Study||50
11347564|NCT02991859|12544631|FG006|STARTED|Period2, Escalation Phase2, Upto Day 91||2
11347565|NCT02991859|12544632|FG007|STARTED|Period2, Escalation Phase2, Upto Day 91||2
11347566|NCT02991859|12544633|FG008|STARTED|Period2, Escalation Phase2, Upto Day 91||2
11347567|NCT02991859|12544634|FG009|STARTED|Period2, Escalation Phase2, Upto Day 91||2
11347568|NCT02991859|12544635|FG010|STARTED|Period2, Escalation Phase2, Upto Day 91||2
11347569|NCT02991859|12544636|FG011|STARTED|Period2, Escalation Phase2, Upto Day 91||2
11347570|NCT02991859|12544637|FG012|STARTED|Period2, Escalation Phase2, Upto Day 91||0
11074082|NCT01085006|12256007|FG001|COMPLETED|Overall Study||50
11074083|NCT01085006|12256006|FG000|NOT COMPLETED|Overall Study||0
11074084|NCT01085006|12256007|FG001|NOT COMPLETED|Overall Study||0
11074085|NCT01085045|12256013|FG000|STARTED|Part A||122
11074086|NCT01085045|12256013|FG000|GFF MDI 72/9.6mcg|Part A||40
11074087|NCT01085045|12256013|FG000|GFF MDI 36/9.6 µg (PT003)|Part A||42
11347571|NCT02991859|12544638|FG013|STARTED|Period2, Escalation Phase2, Upto Day 91||0
11074088|NCT01085045|12256013|FG000|GP MDI 36 µg (PT001)|Part A||40
11074089|NCT01085045|12256013|FG000|Spiriva 18 µg|Part A||58
11074090|NCT01085045|12256013|FG000|FF MDI 9.6 µg (PT005)|Part A||20
11074091|NCT01085045|12256013|FG000|FF MDI 7.2 µg (PT005)|Part A||21
11074092|NCT01085045|12256013|FG000|Placebo MDI|Part A||5
11074093|NCT01085045|12256013|FG000|Foradil 12 µg|Part A||14
11074094|NCT01085045|12256013|FG000|COMPLETED|Part A||104
11347572|NCT02991859|12544639|FG014|STARTED|Period2, Escalation Phase2, Upto Day 91||0
11347573|NCT02991859|12544640|FG015|STARTED|Period2, Escalation Phase2, Upto Day 91||0
11347574|NCT02991859|12544641|FG016|STARTED|Period2, Escalation Phase2, Upto Day 91||0
11347575|NCT02991859|12544625|FG000|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
11347576|NCT02991859|12544626|FG001|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
11347577|NCT02991859|12544627|FG002|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
11347578|NCT02991859|12544628|FG003|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
11347579|NCT02991859|12544629|FG004|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
11347580|NCT02991859|12544630|FG005|COMPLETED|Period2, Escalation Phase2, Upto Day 91||1
11347581|NCT02991859|12544631|FG006|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
11347582|NCT02991859|12544632|FG007|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
11347583|NCT02991859|12544633|FG008|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
11347584|NCT02991859|12544634|FG009|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
11347585|NCT02991859|12544635|FG010|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
11347586|NCT02991859|12544636|FG011|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
11347587|NCT02991859|12544637|FG012|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347588|NCT02991859|12544638|FG013|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347589|NCT02991859|12544639|FG014|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347590|NCT02991859|12544640|FG015|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347591|NCT02991859|12544641|FG016|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347592|NCT02991859|12544625|FG000|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347593|NCT02991859|12544626|FG001|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347594|NCT02991859|12544627|FG002|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347595|NCT02991859|12544628|FG003|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347596|NCT02991859|12544629|FG004|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347597|NCT02991859|12544630|FG005|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347598|NCT02991859|12544631|FG006|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347599|NCT02991859|12544632|FG007|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347600|NCT02991859|12544633|FG008|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347601|NCT02991859|12544634|FG009|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347602|NCT02991859|12544635|FG010|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347603|NCT02991859|12544636|FG011|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347604|NCT02991859|12544637|FG012|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347605|NCT02991859|12544638|FG013|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347606|NCT02991859|12544639|FG014|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347607|NCT02991859|12544640|FG015|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11074095|NCT01085045|12256013|FG000|NOT COMPLETED|Part A||18
11347608|NCT02991859|12544641|FG016|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
11347609|NCT02991859|12544625|FG000|STARTED|Period2, Escalation Phase3, Upto Day 98||2
11347610|NCT02991859|12544626|FG001|STARTED|Period2, Escalation Phase3, Upto Day 98||2
11347611|NCT02991859|12544627|FG002|STARTED|Period2, Escalation Phase3, Upto Day 98||2
11347612|NCT02991859|12544628|FG003|STARTED|Period2, Escalation Phase3, Upto Day 98||2
11347613|NCT02991859|12544629|FG004|STARTED|Period2, Escalation Phase3, Upto Day 98||2
11347614|NCT02991859|12544630|FG005|STARTED|Period2, Escalation Phase3, Upto Day 98||1
11347615|NCT02991859|12544631|FG006|STARTED|Period2, Escalation Phase3, Upto Day 98||2
11347616|NCT02991859|12544632|FG007|STARTED|Period2, Escalation Phase3, Upto Day 98||2
11347617|NCT02991859|12544633|FG008|STARTED|Period2, Escalation Phase3, Upto Day 98||2
11347618|NCT02991859|12544634|FG009|STARTED|Period2, Escalation Phase3, Upto Day 98||2
11347619|NCT02991859|12544635|FG010|STARTED|Period2, Escalation Phase3, Upto Day 98||2
11347620|NCT02991859|12544636|FG011|STARTED|Period2, Escalation Phase3, Upto Day 98||2
11347621|NCT02991859|12544637|FG012|STARTED|Period2, Escalation Phase3, Upto Day 98||0
11347622|NCT02991859|12544638|FG013|STARTED|Period2, Escalation Phase3, Upto Day 98||0
11347623|NCT02991859|12544639|FG014|STARTED|Period2, Escalation Phase3, Upto Day 98||0
11347624|NCT02991859|12544640|FG015|STARTED|Period2, Escalation Phase3, Upto Day 98||0
11347625|NCT02991859|12544641|FG016|STARTED|Period2, Escalation Phase3, Upto Day 98||0
11347626|NCT02991859|12544625|FG000|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
11347627|NCT02991859|12544626|FG001|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
11347628|NCT02991859|12544627|FG002|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
11347629|NCT02991859|12544628|FG003|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
11347630|NCT02991859|12544629|FG004|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
11347631|NCT02991859|12544630|FG005|COMPLETED|Period2, Escalation Phase3, Upto Day 98||1
11347632|NCT02991859|12544631|FG006|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
11347633|NCT02991859|12544632|FG007|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
11347634|NCT02991859|12544633|FG008|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
11347635|NCT02991859|12544634|FG009|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
11347636|NCT02991859|12544635|FG010|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
11347637|NCT02991859|12544636|FG011|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
11347638|NCT02991859|12544637|FG012|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347639|NCT02991859|12544638|FG013|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347640|NCT02991859|12544639|FG014|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347641|NCT02991859|12544640|FG015|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347642|NCT02991859|12544641|FG016|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11074096|NCT01085045|12256013|FG000|STARTED|Part B||104
11074097|NCT01085045|12256013|FG000|GFF MDI 72/9.6mcg (PT003)|Part B||0
11074098|NCT01085045|12256013|FG000|GFF MDI 36/9.6 µg|Part B||0
11074099|NCT01085045|12256013|FG000|Spiriva 18 µg|Part B||0
11074100|NCT01085045|12256013|FG000|FF MDI 9.6 µg (PT005)|Part B||43
11074101|NCT01085045|12256013|FG000|FF MDI 7.2 µg (PT005)|Part B||43
11074102|NCT01085045|12256013|FG000|Placebo MDI|Part B||47
11074103|NCT01085045|12256013|FG000|Foradil 12 µg|Part B||41
11074104|NCT01085045|12256013|FG000|GP MDI 36 µg (PT001)|Part B||0
11074105|NCT01085045|12256013|FG000|COMPLETED|Part B||89
11074106|NCT01085045|12256013|FG000|NOT COMPLETED|Part B||15
11074107|NCT01085136|12256033|FG000|STARTED|Part A||1154
11074108|NCT01085136|12256034|FG001|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
11074109|NCT01085136|12256035|FG002|STARTED|Part A||0
11074110|NCT01085136|12256033|FG000|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
11074111|NCT01085136|12256034|FG001|Randomized to Part B|Part A||0
11074112|NCT01085136|12256035|FG002|Randomized to Part B|Part A||0
11074113|NCT01085136|12256033|FG000|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
11074114|NCT01085136|12256034|FG001|COMPLETED|Part A||0
11074115|NCT01085136|12256035|FG002|COMPLETED|Part A||0
11074116|NCT01085136|12256033|FG000|NOT COMPLETED|Part A||323
11074117|NCT01085136|12256034|FG001|NOT COMPLETED|Part A||0
11074118|NCT01085136|12256035|FG002|NOT COMPLETED|Part A||0
11074119|NCT01085136|12256033|FG000|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
11074120|NCT01085136|12256034|FG001|STARTED|Part B||138
11074121|NCT01085136|12256035|FG002|STARTED|Part B||68
11074122|NCT01085136|12256033|FG000|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
11074123|NCT01085136|12256034|FG001|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
11074124|NCT01085136|12256035|FG002|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
11074125|NCT01085136|12256033|FG000|NOT COMPLETED|Part B||0
11074126|NCT01085136|12256034|FG001|NOT COMPLETED|Part B||51
11074127|NCT01085136|12256035|FG002|NOT COMPLETED|Part B||26
11074128|NCT01085201|12256050|FG000|STARTED|Overall Study||18
11074129|NCT01085201|12256051|FG001|STARTED|Overall Study||7
11074130|NCT01085201|12256052|FG002|STARTED|Overall Study||5
11074131|NCT01085201|12256053|FG003|STARTED|Overall Study||6
11074132|NCT01085201|12256054|FG004|STARTED|Overall Study||3
11074133|NCT01085201|12256050|FG000|COMPLETED|Overall Study||15
11074134|NCT01085201|12256051|FG001|COMPLETED|Overall Study||6
11074135|NCT01085201|12256052|FG002|COMPLETED|Overall Study||3
11074136|NCT01085201|12256053|FG003|COMPLETED|Overall Study||6
11074137|NCT01085201|12256054|FG004|COMPLETED|Overall Study||3
11074138|NCT01085201|12256050|FG000|NOT COMPLETED|Overall Study||3
11074139|NCT01085201|12256051|FG001|NOT COMPLETED|Overall Study||1
11074140|NCT01085201|12256052|FG002|NOT COMPLETED|Overall Study||2
11074141|NCT01085201|12256053|FG003|NOT COMPLETED|Overall Study||0
11074142|NCT01085201|12256054|FG004|NOT COMPLETED|Overall Study||0
11074143|NCT01085214|12256071|FG000|STARTED|Overall Study||37
11074144|NCT01085214|12256071|FG000|COMPLETED|Overall Study||36
11074145|NCT01085214|12256071|FG000|NOT COMPLETED|Overall Study||1
11074146|NCT01085318|12256077|FG000|STARTED|Overall Study||23
11074147|NCT01085318|12256078|FG001|STARTED|Overall Study||15
11074148|NCT01085318|12256077|FG000|COMPLETED|Overall Study||21
11074149|NCT01085318|12256078|FG001|COMPLETED|Overall Study||15
11074150|NCT01085318|12256077|FG000|NOT COMPLETED|Overall Study||2
11074151|NCT01085318|12256078|FG001|NOT COMPLETED|Overall Study||0
11074152|NCT01085331|12256086|FG000|STARTED|Overall Study||10
11074153|NCT01085331|12256087|FG001|STARTED|Overall Study||6
11074154|NCT01085331|12256086|FG000|COMPLETED|Overall Study||10
11074155|NCT01085331|12256087|FG001|COMPLETED|Overall Study||6
11074156|NCT01085331|12256086|FG000|NOT COMPLETED|Overall Study||0
11074157|NCT01085331|12256087|FG001|NOT COMPLETED|Overall Study||0
11074158|NCT01085344|12256097|FG000|STARTED|Overall Study||56
11074159|NCT01085344|12256097|FG000|COMPLETED|Overall Study||50
11074160|NCT01085344|12256097|FG000|NOT COMPLETED|Overall Study||6
11074161|NCT01085357|12256103|FG000|STARTED|Overall Study||374
11074162|NCT01085357|12256104|FG001|STARTED|Overall Study||131
11074163|NCT01085357|12256103|FG000|COMPLETED|Overall Study||355
11074164|NCT01085357|12256104|FG001|COMPLETED|Overall Study||125
11074165|NCT01085357|12256103|FG000|NOT COMPLETED|Overall Study||19
11074166|NCT01085357|12256104|FG001|NOT COMPLETED|Overall Study||6
11074167|NCT01085500|12256112|FG000|STARTED|Overall Study||26
11074168|NCT01085500|12256113|FG001|STARTED|Overall Study||24
11074169|NCT01085500|12256112|FG000|COMPLETED|Overall Study||26
11074170|NCT01085500|12256113|FG001|COMPLETED|Overall Study||24
11074171|NCT01085500|12256112|FG000|NOT COMPLETED|Overall Study||0
11074172|NCT01085500|12256113|FG001|NOT COMPLETED|Overall Study||0
11074173|NCT01085513|12256121|FG000|STARTED|Phase I - Development Phase||54
11074174|NCT01085513|12256122|FG001|STARTED|Phase I - Development Phase||52
11074175|NCT01085513|12256121|FG000|COMPLETED|Phase I - Development Phase|recruitment was premature terminated|54
11074176|NCT01085513|12256122|FG001|COMPLETED|Phase I - Development Phase||52
11074177|NCT01085513|12256121|FG000|NOT COMPLETED|Phase I - Development Phase||0
11074178|NCT01085513|12256122|FG001|NOT COMPLETED|Phase I - Development Phase||0
11074179|NCT01085513|12256121|FG000|STARTED|Phase II - Validation Phase||21
11074180|NCT01085513|12256122|FG001|STARTED|Phase II - Validation Phase||16
11074181|NCT01085513|12256121|FG000|COMPLETED|Phase II - Validation Phase||21
11074182|NCT01085513|12256122|FG001|COMPLETED|Phase II - Validation Phase||16
11074183|NCT01085513|12256121|FG000|NOT COMPLETED|Phase II - Validation Phase||0
11074184|NCT01085513|12256122|FG001|NOT COMPLETED|Phase II - Validation Phase||0
11074185|NCT01085539|12256128|FG000|STARTED|Sat Secs Off--No Alarm Evaluation||50
11074186|NCT01085539|12256128|FG000|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
11074187|NCT01085539|12256128|FG000|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
11074188|NCT01085539|12256128|FG000|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
11074189|NCT01085539|12256128|FG000|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
11074190|NCT01085539|12256128|FG000|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
11074191|NCT01085539|12256128|FG000|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
11074192|NCT01085539|12256128|FG000|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
11347643|NCT02991859|12544625|FG000|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347644|NCT02991859|12544626|FG001|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347645|NCT02991859|12544627|FG002|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347646|NCT02991859|12544628|FG003|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347647|NCT02991859|12544629|FG004|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347648|NCT02991859|12544630|FG005|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347649|NCT02991859|12544631|FG006|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347650|NCT02991859|12544632|FG007|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11074193|NCT01085539|12256128|FG000|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
11074194|NCT01085539|12256128|FG000|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
11074195|NCT01085539|12256128|FG000|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
11074196|NCT01085539|12256128|FG000|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
11074197|NCT01085539|12256128|FG000|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
11074198|NCT01085539|12256128|FG000|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
11074199|NCT01085539|12256128|FG000|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
11074200|NCT01085591|12256135|FG000|STARTED|Overall Study||69
11074201|NCT01085591|12256136|FG001|STARTED|Overall Study||71
11074202|NCT01085591|12256137|FG002|STARTED|Overall Study||70
11074203|NCT01085591|12256135|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
11074204|NCT01085591|12256136|FG001|Received at Least 1 Dose of Study Drug|Overall Study||69
11074205|NCT01085591|12256137|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70
11074206|NCT01085591|12256135|FG000|COMPLETED|Overall Study||66
11074207|NCT01085591|12256136|FG001|COMPLETED|Overall Study||65
11074208|NCT01085591|12256137|FG002|COMPLETED|Overall Study||63
11074209|NCT01085591|12256135|FG000|NOT COMPLETED|Overall Study||3
11074210|NCT01085591|12256136|FG001|NOT COMPLETED|Overall Study||6
11074211|NCT01085591|12256137|FG002|NOT COMPLETED|Overall Study||7
11074212|NCT01085630|12256148|FG000|STARTED|Overall Study||26
11074213|NCT01085630|12256149|FG001|STARTED|Overall Study||27
11074214|NCT01085630|12256148|FG000|COMPLETED|Overall Study||22
11074215|NCT01085630|12256149|FG001|COMPLETED|Overall Study||27
11074216|NCT01085630|12256148|FG000|NOT COMPLETED|Overall Study||4
11074217|NCT01085630|12256149|FG001|NOT COMPLETED|Overall Study||0
11074218|NCT01085682|12256157|FG000|STARTED|Overall Study||31
11074219|NCT01085682|12256158|FG001|STARTED|Overall Study||28
11074220|NCT01085682|12256157|FG000|COMPLETED|Overall Study||6
11074221|NCT01085682|12256158|FG001|COMPLETED|Overall Study||3
11074222|NCT01085682|12256157|FG000|NOT COMPLETED|Overall Study||25
11074223|NCT01085682|12256158|FG001|NOT COMPLETED|Overall Study||25
11074224|NCT01085734|12256166|FG000|STARTED|Overall Study||15
11074225|NCT01085734|12256167|FG001|STARTED|Overall Study||15
11074226|NCT01085734|12256166|FG000|COMPLETED|Overall Study||14
11074227|NCT01085734|12256167|FG001|COMPLETED|Overall Study||11
11074228|NCT01085734|12256166|FG000|NOT COMPLETED|Overall Study||1
11074229|NCT01085734|12256167|FG001|NOT COMPLETED|Overall Study||4
11074230|NCT01085760|12256178|FG000|STARTED|Overall Study||8
11074231|NCT01085760|12256179|FG001|STARTED|Overall Study||9
11074232|NCT01085760|12256180|FG002|STARTED|Overall Study||9
11074233|NCT01085760|12256181|FG003|STARTED|Overall Study||9
11074234|NCT01085760|12256178|FG000|COMPLETED|Overall Study||7
11074235|NCT01085760|12256179|FG001|COMPLETED|Overall Study||8
11074236|NCT01085760|12256180|FG002|COMPLETED|Overall Study||7
11074237|NCT01085760|12256181|FG003|COMPLETED|Overall Study||6
11074238|NCT01085760|12256178|FG000|NOT COMPLETED|Overall Study||1
11347651|NCT02991859|12544633|FG008|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347652|NCT02991859|12544634|FG009|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347653|NCT02991859|12544635|FG010|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11074239|NCT01085760|12256179|FG001|NOT COMPLETED|Overall Study||1
11347654|NCT02991859|12544636|FG011|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347655|NCT02991859|12544637|FG012|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347656|NCT02991859|12544638|FG013|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347657|NCT02991859|12544639|FG014|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347658|NCT02991859|12544640|FG015|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347659|NCT02991859|12544641|FG016|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
11347660|NCT02991859|12544625|FG000|STARTED|Period2, Escalation Phase4, Upto Day 105||2
11347661|NCT02991859|12544626|FG001|STARTED|Period2, Escalation Phase4, Upto Day 105||2
11347662|NCT02991859|12544627|FG002|STARTED|Period2, Escalation Phase4, Upto Day 105||2
11347663|NCT02991859|12544628|FG003|STARTED|Period2, Escalation Phase4, Upto Day 105||2
11074240|NCT01085760|12256180|FG002|NOT COMPLETED|Overall Study||2
11074241|NCT01085760|12256181|FG003|NOT COMPLETED|Overall Study||3
11074242|NCT01085786|12256193|FG000|STARTED|Overall Study||123
11074243|NCT01085786|12256194|FG001|STARTED|Overall Study||117
11074244|NCT01085786|12256193|FG000|COMPLETED|Overall Study||123
11074245|NCT01085786|12256194|FG001|COMPLETED|Overall Study||117
11074246|NCT01085786|12256193|FG000|NOT COMPLETED|Overall Study||0
11074247|NCT01085786|12256194|FG001|NOT COMPLETED|Overall Study||0
11074248|NCT01085812|12256200|FG000|STARTED|Open-Label Period||0
11074249|NCT01085812|12256201|FG001|STARTED|Open-Label Period||734
11074250|NCT01085812|12256200|FG000|COMPLETED|Open-Label Period||0
11074251|NCT01085812|12256201|FG001|COMPLETED|Open-Label Period||494
11074252|NCT01085812|12256200|FG000|NOT COMPLETED|Open-Label Period||0
11074253|NCT01085812|12256201|FG001|NOT COMPLETED|Open-Label Period||240
11074254|NCT01085812|12256200|FG000|STARTED|Double-Blind Period||113
11074255|NCT01085812|12256201|FG001|STARTED|Double-Blind Period||235
11074256|NCT01085812|12256200|FG000|COMPLETED|Double-Blind Period||92
11074257|NCT01085812|12256201|FG001|COMPLETED|Double-Blind Period||177
11074258|NCT01085812|12256200|FG000|NOT COMPLETED|Double-Blind Period||21
11074259|NCT01085812|12256201|FG001|NOT COMPLETED|Double-Blind Period||58
11074260|NCT01085812|12256200|FG000|STARTED|Double-blind Intent-to-treat Population||112
11074261|NCT01085812|12256201|FG001|STARTED|Double-blind Intent-to-treat Population||230
11074262|NCT01085812|12256200|FG000|COMPLETED|Double-blind Intent-to-treat Population||92
11074263|NCT01085812|12256201|FG001|COMPLETED|Double-blind Intent-to-treat Population||174
11074264|NCT01085812|12256200|FG000|NOT COMPLETED|Double-blind Intent-to-treat Population||20
11074265|NCT01085812|12256201|FG001|NOT COMPLETED|Double-blind Intent-to-treat Population||56
11074266|NCT01085825|12256210|FG000|STARTED|Overall Study|1st participant enrolled|252
11074267|NCT01085825|12256211|FG001|STARTED|Overall Study||248
11074268|NCT01085825|12256210|FG000|COMPLETED|Overall Study||251
11074269|NCT01085825|12256211|FG001|COMPLETED|Overall Study||247
11074270|NCT01085825|12256210|FG000|NOT COMPLETED|Overall Study||1
11347664|NCT02991859|12544629|FG004|STARTED|Period2, Escalation Phase4, Upto Day 105||2
11347665|NCT02991859|12544630|FG005|STARTED|Period2, Escalation Phase4, Upto Day 105||1
11347666|NCT02991859|12544631|FG006|STARTED|Period2, Escalation Phase4, Upto Day 105||2
11074271|NCT01085825|12256211|FG001|NOT COMPLETED|Overall Study||1
11074272|NCT01085903|12256219|FG000|STARTED|Overall Study||21
11074273|NCT01085903|12256220|FG001|STARTED|Overall Study||4
11074274|NCT01085903|12256221|FG002|STARTED|Overall Study||3
11347667|NCT02991859|12544632|FG007|STARTED|Period2, Escalation Phase4, Upto Day 105||2
11347668|NCT02991859|12544633|FG008|STARTED|Period2, Escalation Phase4, Upto Day 105||2
11347669|NCT02991859|12544634|FG009|STARTED|Period2, Escalation Phase4, Upto Day 105||2
11347670|NCT02991859|12544635|FG010|STARTED|Period2, Escalation Phase4, Upto Day 105||2
11347671|NCT02991859|12544636|FG011|STARTED|Period2, Escalation Phase4, Upto Day 105||2
11347672|NCT02991859|12544637|FG012|STARTED|Period2, Escalation Phase4, Upto Day 105||0
11347673|NCT02991859|12544638|FG013|STARTED|Period2, Escalation Phase4, Upto Day 105||0
11347674|NCT02991859|12544639|FG014|STARTED|Period2, Escalation Phase4, Upto Day 105||0
11347675|NCT02991859|12544640|FG015|STARTED|Period2, Escalation Phase4, Upto Day 105||0
11347676|NCT02991859|12544641|FG016|STARTED|Period2, Escalation Phase4, Upto Day 105||0
11347677|NCT02991859|12544625|FG000|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
11347678|NCT02991859|12544626|FG001|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
11347679|NCT02991859|12544627|FG002|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
11347680|NCT02991859|12544628|FG003|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
11347681|NCT02991859|12544629|FG004|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
11347682|NCT02991859|12544630|FG005|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
11347683|NCT02991859|12544631|FG006|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
11347684|NCT02991859|12544632|FG007|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
11074275|NCT01085903|12256219|FG000|COMPLETED|Overall Study||21
11347685|NCT02991859|12544633|FG008|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
11347686|NCT02991859|12544634|FG009|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
11347687|NCT02991859|12544635|FG010|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
11347688|NCT02991859|12544636|FG011|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
11347689|NCT02991859|12544637|FG012|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347690|NCT02991859|12544638|FG013|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347691|NCT02991859|12544639|FG014|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347692|NCT02991859|12544640|FG015|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347693|NCT02991859|12544641|FG016|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347694|NCT02991859|12544625|FG000|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11074276|NCT01085903|12256220|FG001|COMPLETED|Overall Study||4
11074277|NCT01085903|12256221|FG002|COMPLETED|Overall Study||3
11074278|NCT01085903|12256219|FG000|NOT COMPLETED|Overall Study||0
11074279|NCT01085903|12256220|FG001|NOT COMPLETED|Overall Study||0
11074280|NCT01085903|12256221|FG002|NOT COMPLETED|Overall Study||0
11074281|NCT01085968|12256242|FG000|STARTED|Overall Study||29
11074282|NCT01085968|12256243|FG001|STARTED|Overall Study||25
11074283|NCT01085968|12256242|FG000|COMPLETED|Overall Study||19
11074284|NCT01085968|12256243|FG001|COMPLETED|Overall Study||21
11074285|NCT01085968|12256242|FG000|NOT COMPLETED|Overall Study||10
11074286|NCT01085968|12256243|FG001|NOT COMPLETED|Overall Study||4
11074287|NCT01086033|12256249|FG000|STARTED|Overall Study||566
11074288|NCT01086033|12256249|FG000|COMPLETED|Overall Study||262
11074289|NCT01086033|12256249|FG000|NOT COMPLETED|Overall Study||304
11074290|NCT01086150|12256259|FG000|STARTED|Overall Study||11
11347695|NCT02991859|12544626|FG001|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347696|NCT02991859|12544627|FG002|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347697|NCT02991859|12544628|FG003|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11074291|NCT01086150|12256260|FG001|STARTED|Overall Study||27
11074292|NCT01086150|12256261|FG002|STARTED|Overall Study||13
11074293|NCT01086150|12256259|FG000|COMPLETED|Overall Study||11
11074294|NCT01086150|12256260|FG001|COMPLETED|Overall Study||21
11074295|NCT01086150|12256261|FG002|COMPLETED|Overall Study||12
11074296|NCT01086150|12256259|FG000|NOT COMPLETED|Overall Study||0
11074297|NCT01086150|12256260|FG001|NOT COMPLETED|Overall Study||6
11074298|NCT01086150|12256261|FG002|NOT COMPLETED|Overall Study||1
11074299|NCT01086215|12256273|FG000|STARTED|Overall Study||212
11074300|NCT01086215|12256274|FG001|STARTED|Overall Study||201
11074301|NCT01086215|12256275|FG002|STARTED|Overall Study||73
11074302|NCT01086215|12256276|FG003|STARTED|Overall Study||14
11074303|NCT01086215|12256273|FG000|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
11074304|NCT01086215|12256274|FG001|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
11074305|NCT01086215|12256275|FG002|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
11074306|NCT01086215|12256276|FG003|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
11074307|NCT01086215|12256273|FG000|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
11074308|NCT01086215|12256274|FG001|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
11074309|NCT01086215|12256275|FG002|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
11074310|NCT01086215|12256276|FG003|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
11074311|NCT01086215|12256273|FG000|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
11074312|NCT01086215|12256274|FG001|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
11074313|NCT01086215|12256275|FG002|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
11074314|NCT01086215|12256276|FG003|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
11074315|NCT01086215|12256273|FG000|COMPLETED|Overall Study||176
11074316|NCT01086215|12256274|FG001|COMPLETED|Overall Study||154
11074317|NCT01086215|12256275|FG002|COMPLETED|Overall Study||47
11074318|NCT01086215|12256276|FG003|COMPLETED|Overall Study||11
11074319|NCT01086215|12256273|FG000|NOT COMPLETED|Overall Study||36
11074320|NCT01086215|12256274|FG001|NOT COMPLETED|Overall Study||47
11074321|NCT01086215|12256275|FG002|NOT COMPLETED|Overall Study||26
11074322|NCT01086215|12256276|FG003|NOT COMPLETED|Overall Study||3
11074323|NCT01086228|12256286|FG000|STARTED|8 Month Follow-up|Analysis population|2009
11074324|NCT01086228|12256286|FG000|COMPLETED|8 Month Follow-up||1938
11074325|NCT01086228|12256286|FG000|NOT COMPLETED|8 Month Follow-up||71
11074326|NCT01086228|12256286|FG000|STARTED|1-year Follow-up||1938
11074327|NCT01086228|12256286|FG000|COMPLETED|1-year Follow-up||1894
11074328|NCT01086228|12256286|FG000|NOT COMPLETED|1-year Follow-up||44
11074329|NCT01086228|12256286|FG000|STARTED|2-year Follow-up||1894
11074330|NCT01086228|12256286|FG000|COMPLETED|2-year Follow-up||1834
11074331|NCT01086228|12256286|FG000|NOT COMPLETED|2-year Follow-up||60
11074332|NCT01086228|12256286|FG000|STARTED|3-year Follow-up||1834
11074333|NCT01086228|12256286|FG000|COMPLETED|3-year Follow-up||1767
11074334|NCT01086228|12256286|FG000|NOT COMPLETED|3-year Follow-up||67
11074335|NCT01086228|12256286|FG000|STARTED|4-year Follow-up||1767
11074336|NCT01086228|12256286|FG000|COMPLETED|4-year Follow-up||1664
11074337|NCT01086228|12256286|FG000|NOT COMPLETED|4-year Follow-up||103
11074338|NCT01086228|12256286|FG000|STARTED|5-year Follow-up||1664
11074339|NCT01086228|12256286|FG000|COMPLETED|5-year Follow-up||1012
11074340|NCT01086228|12256286|FG000|NOT COMPLETED|5-year Follow-up||652
11074341|NCT01086358|12256290|FG000|STARTED|First Intervention|30 subjects enrolled.|30
11074342|NCT01086358|12256291|FG001|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
11074343|NCT01086358|12256290|FG000|COMPLETED|First Intervention||21
11074344|NCT01086358|12256291|FG001|COMPLETED|First Intervention||24
11074345|NCT01086358|12256290|FG000|NOT COMPLETED|First Intervention||9
11347698|NCT02991859|12544629|FG004|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347699|NCT02991859|12544630|FG005|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11074346|NCT01086358|12256291|FG001|NOT COMPLETED|First Intervention||5
11074347|NCT01086358|12256290|FG000|STARTED|Second Intervention||21
11074348|NCT01086358|12256291|FG001|STARTED|Second Intervention||24
11074349|NCT01086358|12256290|FG000|COMPLETED|Second Intervention||17
11074350|NCT01086358|12256291|FG001|COMPLETED|Second Intervention||20
11074351|NCT01086358|12256290|FG000|NOT COMPLETED|Second Intervention||4
11074352|NCT01086358|12256291|FG001|NOT COMPLETED|Second Intervention||4
11074353|NCT01086384|12256299|FG000|STARTED|2-week Run-in Period||2183
11074354|NCT01086384|12256300|FG001|STARTED|2-week Run-in Period||0
11074355|NCT01086384|12256301|FG002|STARTED|2-week Run-in Period||0
11074356|NCT01086384|12256299|FG000|COMPLETED|2-week Run-in Period||2020
11347700|NCT02991859|12544631|FG006|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347701|NCT02991859|12544632|FG007|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347702|NCT02991859|12544633|FG008|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
11347703|NCT02991859|12544634|FG009|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347704|NCT02991859|12544635|FG010|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347705|NCT02991859|12544636|FG011|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347706|NCT02991859|12544637|FG012|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347707|NCT02991859|12544638|FG013|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347708|NCT02991859|12544639|FG014|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347709|NCT02991859|12544640|FG015|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347710|NCT02991859|12544641|FG016|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
11347711|NCT02991859|12544625|FG000|STARTED|Period2,Escalation Phase5,Upto Day 112||2
11074357|NCT01086384|12256300|FG001|COMPLETED|2-week Run-in Period||0
11074358|NCT01086384|12256301|FG002|COMPLETED|2-week Run-in Period||0
11074359|NCT01086384|12256299|FG000|NOT COMPLETED|2-week Run-in Period||163
11074360|NCT01086384|12256300|FG001|NOT COMPLETED|2-week Run-in Period||0
11074361|NCT01086384|12256301|FG002|NOT COMPLETED|2-week Run-in Period||0
11074362|NCT01086384|12256299|FG000|STARTED|Treatment Period||0
11074363|NCT01086384|12256300|FG001|STARTED|Treatment Period||1011
11074364|NCT01086384|12256301|FG002|STARTED|Treatment Period||1009
11074365|NCT01086384|12256299|FG000|COMPLETED|Treatment Period||0
11074366|NCT01086384|12256300|FG001|COMPLETED|Treatment Period||863
11074367|NCT01086384|12256301|FG002|COMPLETED|Treatment Period||885
11074368|NCT01086384|12256299|FG000|NOT COMPLETED|Treatment Period||0
11074369|NCT01086384|12256300|FG001|NOT COMPLETED|Treatment Period||148
11074370|NCT01086384|12256301|FG002|NOT COMPLETED|Treatment Period||124
11074371|NCT01086410|12256311|FG000|STARTED|Overall Study||58
11074372|NCT01086410|12256312|FG001|STARTED|Overall Study||56
11074373|NCT01086410|12256313|FG002|STARTED|Overall Study||56
11074374|NCT01086410|12256314|FG003|STARTED|Overall Study||15
11074375|NCT01086410|12256311|FG000|COMPLETED|Overall Study||55
11074376|NCT01086410|12256312|FG001|COMPLETED|Overall Study||54
11074377|NCT01086410|12256313|FG002|COMPLETED|Overall Study||55
11074378|NCT01086410|12256314|FG003|COMPLETED|Overall Study||13
11074379|NCT01086410|12256311|FG000|NOT COMPLETED|Overall Study||3
11074380|NCT01086410|12256312|FG001|NOT COMPLETED|Overall Study||2
11074381|NCT01086410|12256313|FG002|NOT COMPLETED|Overall Study||1
11074382|NCT01086410|12256314|FG003|NOT COMPLETED|Overall Study||2
11074383|NCT01086423|12256327|FG000|STARTED|Overall Study||330
11074384|NCT01086423|12256328|FG001|STARTED|Overall Study||324
11074385|NCT01086423|12256329|FG002|STARTED|Overall Study||330
11074386|NCT01086423|12256327|FG000|COMPLETED|Overall Study||320
11074387|NCT01086423|12256328|FG001|COMPLETED|Overall Study||321
11074388|NCT01086423|12256329|FG002|COMPLETED|Overall Study||321
11074389|NCT01086423|12256327|FG000|NOT COMPLETED|Overall Study||10
11074390|NCT01086423|12256328|FG001|NOT COMPLETED|Overall Study||3
11074391|NCT01086423|12256329|FG002|NOT COMPLETED|Overall Study||9
11074392|NCT01086475|12256339|FG000|STARTED|Overall Study||34
11074393|NCT01086475|12256340|FG001|STARTED|Overall Study||33
11074394|NCT01086475|12256339|FG000|COMPLETED|Overall Study||34
11074395|NCT01086475|12256340|FG001|COMPLETED|Overall Study||33
11074396|NCT01086475|12256339|FG000|NOT COMPLETED|Overall Study||0
11074397|NCT01086475|12256340|FG001|NOT COMPLETED|Overall Study||0
11074398|NCT01086540|12256348|FG000|STARTED|Overall Study||29
11074399|NCT01086540|12256349|FG001|STARTED|Overall Study||28
11074400|NCT01086540|12256348|FG000|COMPLETED|Overall Study||23
11074401|NCT01086540|12256349|FG001|COMPLETED|Overall Study||26
11074402|NCT01086540|12256348|FG000|NOT COMPLETED|Overall Study||6
11074403|NCT01086540|12256349|FG001|NOT COMPLETED|Overall Study||2
11074404|NCT01086605|12256357|FG000|STARTED|Overall Study||24
11074405|NCT01086605|12256358|FG001|STARTED|Overall Study||22
11074406|NCT01086605|12256357|FG000|COMPLETED|Overall Study||24
11074407|NCT01086605|12256358|FG001|COMPLETED|Overall Study||22
11074408|NCT01086605|12256357|FG000|NOT COMPLETED|Overall Study||0
11074409|NCT01086605|12256358|FG001|NOT COMPLETED|Overall Study||0
11074410|NCT01086761|12256370|FG000|STARTED|Overall Study||9
11074411|NCT01086761|12256371|FG001|STARTED|Overall Study||7
11074412|NCT01086761|12256372|FG002|STARTED|Overall Study||6
11074413|NCT01086761|12256373|FG003|STARTED|Overall Study||6
11074414|NCT01086761|12256374|FG004|STARTED|Overall Study||4
11074415|NCT01086761|12256375|FG005|STARTED|Overall Study||0
11074416|NCT01086761|12256370|FG000|COMPLETED|Overall Study||9
11074417|NCT01086761|12256371|FG001|COMPLETED|Overall Study||7
11074418|NCT01086761|12256372|FG002|COMPLETED|Overall Study||6
11074419|NCT01086761|12256373|FG003|COMPLETED|Overall Study||6
11074420|NCT01086761|12256374|FG004|COMPLETED|Overall Study||4
11074421|NCT01086761|12256375|FG005|COMPLETED|Overall Study||0
11074422|NCT01086761|12256370|FG000|NOT COMPLETED|Overall Study||0
11074423|NCT01086761|12256371|FG001|NOT COMPLETED|Overall Study||0
11074424|NCT01086761|12256372|FG002|NOT COMPLETED|Overall Study||0
11074425|NCT01086761|12256373|FG003|NOT COMPLETED|Overall Study||0
11074426|NCT01086761|12256374|FG004|NOT COMPLETED|Overall Study||0
11074427|NCT01086761|12256375|FG005|NOT COMPLETED|Overall Study||0
11074428|NCT01086852|12256388|FG000|STARTED|Overall Study||4
11074429|NCT01086852|12256388|FG000|COMPLETED|Overall Study||4
11074430|NCT01086852|12256388|FG000|NOT COMPLETED|Overall Study||0
11074431|NCT01086969|12256396|FG000|STARTED|Overall Study||100
11074432|NCT01086969|12256397|FG001|STARTED|Overall Study||100
11074433|NCT01086969|12256398|FG002|STARTED|Overall Study||100
11074434|NCT01086969|12256396|FG000|COMPLETED|Overall Study||99
11074435|NCT01086969|12256397|FG001|COMPLETED|Overall Study||98
11074436|NCT01086969|12256398|FG002|COMPLETED|Overall Study||100
11074437|NCT01086969|12256396|FG000|NOT COMPLETED|Overall Study||1
11074438|NCT01086969|12256397|FG001|NOT COMPLETED|Overall Study||2
11074439|NCT01086969|12256398|FG002|NOT COMPLETED|Overall Study||0
11074440|NCT01087489|12256406|FG000|STARTED|Overall Study||19
11074441|NCT01087489|12256407|FG001|STARTED|Overall Study||34
11074442|NCT01087489|12256406|FG000|COMPLETED|Overall Study||19
11074443|NCT01087489|12256407|FG001|COMPLETED|Overall Study||31
11074444|NCT01087489|12256406|FG000|NOT COMPLETED|Overall Study||0
11074445|NCT01087489|12256407|FG001|NOT COMPLETED|Overall Study||3
11074446|NCT01087502|12256415|FG000|STARTED|Up to Interim Analysis (Week 12)||123
11074447|NCT01087502|12256416|FG001|STARTED|Up to Interim Analysis (Week 12)||118
11074448|NCT01087502|12256415|FG000|COMPLETED|Up to Interim Analysis (Week 12)||114
11074449|NCT01087502|12256416|FG001|COMPLETED|Up to Interim Analysis (Week 12)||110
11074450|NCT01087502|12256415|FG000|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
11074451|NCT01087502|12256416|FG001|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
11074452|NCT01087502|12256415|FG000|STARTED|Up to Final Analysis (Week 52)||123
11074453|NCT01087502|12256416|FG001|STARTED|Up to Final Analysis (Week 52)||118
11074454|NCT01087502|12256415|FG000|COMPLETED|Up to Final Analysis (Week 52)||90
11074455|NCT01087502|12256416|FG001|COMPLETED|Up to Final Analysis (Week 52)||95
11074456|NCT01087502|12256415|FG000|NOT COMPLETED|Up to Final Analysis (Week 52)||33
11074457|NCT01087502|12256416|FG001|NOT COMPLETED|Up to Final Analysis (Week 52)||23
11074458|NCT01087528|12256424|FG000|STARTED|Overall Study||51
11074459|NCT01087528|12256424|FG000|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
11074460|NCT01087528|12256424|FG000|NOT COMPLETED|Overall Study||7
11074461|NCT01087541|12256432|FG000|STARTED|Overall Study||3307
11074462|NCT01087541|12256433|FG001|STARTED|Overall Study||3523
11074463|NCT01087541|12256432|FG000|COMPLETED|Overall Study||3307
11074464|NCT01087541|12256433|FG001|COMPLETED|Overall Study||3523
11074465|NCT01087541|12256432|FG000|NOT COMPLETED|Overall Study||0
11074466|NCT01087541|12256433|FG001|NOT COMPLETED|Overall Study||0
11074467|NCT01087723|12256441|FG000|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
11074468|NCT01087723|12256442|FG001|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
11074469|NCT01087723|12256441|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
11074470|NCT01087723|12256442|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
11074471|NCT01087723|12256441|FG000|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
11074472|NCT01087723|12256442|FG001|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
11074473|NCT01087723|12256441|FG000|NOT COMPLETED|Overall Study||14
11347712|NCT02991859|12544626|FG001|STARTED|Period2,Escalation Phase5,Upto Day 112||2
11347713|NCT02991859|12544627|FG002|STARTED|Period2,Escalation Phase5,Upto Day 112||2
11347714|NCT02991859|12544628|FG003|STARTED|Period2,Escalation Phase5,Upto Day 112||2
11347715|NCT02991859|12544629|FG004|STARTED|Period2,Escalation Phase5,Upto Day 112||2
11347716|NCT02991859|12544630|FG005|STARTED|Period2,Escalation Phase5,Upto Day 112||1
11347717|NCT02991859|12544631|FG006|STARTED|Period2,Escalation Phase5,Upto Day 112||2
11347718|NCT02991859|12544632|FG007|STARTED|Period2,Escalation Phase5,Upto Day 112||2
11347719|NCT02991859|12544633|FG008|STARTED|Period2,Escalation Phase5,Upto Day 112||1
11347720|NCT02991859|12544634|FG009|STARTED|Period2,Escalation Phase5,Upto Day 112||2
11347721|NCT02991859|12544635|FG010|STARTED|Period2,Escalation Phase5,Upto Day 112||2
11347722|NCT02991859|12544636|FG011|STARTED|Period2,Escalation Phase5,Upto Day 112||2
11347723|NCT02991859|12544637|FG012|STARTED|Period2,Escalation Phase5,Upto Day 112||0
11347724|NCT02991859|12544638|FG013|STARTED|Period2,Escalation Phase5,Upto Day 112||0
11347725|NCT02991859|12544639|FG014|STARTED|Period2,Escalation Phase5,Upto Day 112||0
11347726|NCT02991859|12544640|FG015|STARTED|Period2,Escalation Phase5,Upto Day 112||0
11074474|NCT01087723|12256442|FG001|NOT COMPLETED|Overall Study||20
11074475|NCT01087736|12256450|FG000|STARTED|Overall Study||14
11074476|NCT01087736|12256451|FG001|STARTED|Overall Study||16
11074477|NCT01087736|12256450|FG000|COMPLETED|Overall Study||13
11074478|NCT01087736|12256451|FG001|COMPLETED|Overall Study||14
11074479|NCT01087736|12256450|FG000|NOT COMPLETED|Overall Study||1
11347727|NCT02991859|12544641|FG016|STARTED|Period2,Escalation Phase5,Upto Day 112||0
11074480|NCT01087736|12256451|FG001|NOT COMPLETED|Overall Study||2
11074481|NCT01087762|12256460|FG000|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
11074482|NCT01087762|12256461|FG001|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
11074483|NCT01087762|12256462|FG002|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
11074484|NCT01087762|12256463|FG003|STARTED|Double Blind Period (Weeks 0-24)||0
11074485|NCT01087762|12256464|FG004|STARTED|Double Blind Period (Weeks 0-24)||0
11074486|NCT01087762|12256460|FG000|COMPLETED|Double Blind Period (Weeks 0-24)||95
11074487|NCT01087762|12256461|FG001|COMPLETED|Double Blind Period (Weeks 0-24)||105
11074488|NCT01087762|12256462|FG002|COMPLETED|Double Blind Period (Weeks 0-24)||98
11074489|NCT01087762|12256463|FG003|COMPLETED|Double Blind Period (Weeks 0-24)||0
11074490|NCT01087762|12256464|FG004|COMPLETED|Double Blind Period (Weeks 0-24)||0
11074491|NCT01087762|12256460|FG000|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
11074492|NCT01087762|12256461|FG001|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
11074493|NCT01087762|12256462|FG002|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
11074494|NCT01087762|12256463|FG003|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
11074495|NCT01087762|12256464|FG004|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
11074496|NCT01087762|12256460|FG000|STARTED|Open-Label Period (Weeks 48-204)||0
11074497|NCT01087762|12256461|FG001|STARTED|Open-Label Period (Weeks 48-204)||0
11074498|NCT01087762|12256462|FG002|STARTED|Open-Label Period (Weeks 48-204)||0
11074499|NCT01087762|12256463|FG003|STARTED|Open-Label Period (Weeks 48-204)||158
11074500|NCT01087762|12256464|FG004|STARTED|Open-Label Period (Weeks 48-204)||157
11074501|NCT01087762|12256460|FG000|COMPLETED|Open-Label Period (Weeks 48-204)||0
11074502|NCT01087762|12256461|FG001|COMPLETED|Open-Label Period (Weeks 48-204)||0
11074503|NCT01087762|12256462|FG002|COMPLETED|Open-Label Period (Weeks 48-204)||0
11074504|NCT01087762|12256463|FG003|COMPLETED|Open-Label Period (Weeks 48-204)||99
11074505|NCT01087762|12256464|FG004|COMPLETED|Open-Label Period (Weeks 48-204)||100
11074506|NCT01087762|12256460|FG000|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
11074507|NCT01087762|12256461|FG001|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
11074508|NCT01087762|12256462|FG002|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
11074509|NCT01087762|12256463|FG003|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
11074510|NCT01087762|12256464|FG004|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
11074511|NCT01087775|12256474|FG000|STARTED|Overall Study||25
11074512|NCT01087775|12256474|FG000|COMPLETED|Overall Study|2 subjects were found to be ineligible for the study|23
11074513|NCT01087775|12256474|FG000|NOT COMPLETED|Overall Study||2
11074514|NCT01087788|12256482|FG000|STARTED|24-weeks Double-blind Period||136
11074515|NCT01087788|12256483|FG001|STARTED|24-weeks Double-blind Period||138
11074516|NCT01087788|12256484|FG002|STARTED|24-weeks Double-blind Period||135
11074517|NCT01087788|12256482|FG000|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
11074518|NCT01087788|12256483|FG001|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
11074519|NCT01087788|12256484|FG002|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
11074520|NCT01087788|12256482|FG000|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
11074521|NCT01087788|12256483|FG001|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
11074522|NCT01087788|12256484|FG002|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
11074523|NCT01087788|12256482|FG000|COMPLETED|24-weeks Double-blind Period||120
11074524|NCT01087788|12256483|FG001|COMPLETED|24-weeks Double-blind Period||128
11074525|NCT01087788|12256484|FG002|COMPLETED|24-weeks Double-blind Period||120
11074526|NCT01087788|12256482|FG000|NOT COMPLETED|24-weeks Double-blind Period||16
11074527|NCT01087788|12256483|FG001|NOT COMPLETED|24-weeks Double-blind Period||10
11074528|NCT01087788|12256484|FG002|NOT COMPLETED|24-weeks Double-blind Period||15
11074529|NCT01087788|12256482|FG000|STARTED|24-weeks Dose-blind Period||120
11074530|NCT01087788|12256483|FG001|STARTED|24-weeks Dose-blind Period||128
11074531|NCT01087788|12256484|FG002|STARTED|24-weeks Dose-blind Period||120
11206700|NCT01869959|12397761|FG004|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
11206701|NCT01869959|12397757|FG000|NOT COMPLETED|Randomization Period||0
11206702|NCT01869959|12397758|FG001|NOT COMPLETED|Randomization Period||0
11206703|NCT01869959|12397759|FG002|NOT COMPLETED|Randomization Period||0
11347728|NCT02991859|12544625|FG000|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
11347729|NCT02991859|12544626|FG001|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
11074532|NCT01087788|12256482|FG000|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
11074533|NCT01087788|12256483|FG001|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
11074534|NCT01087788|12256484|FG002|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
11074535|NCT01087788|12256482|FG000|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
11074536|NCT01087788|12256483|FG001|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
11074537|NCT01087788|12256484|FG002|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
11074538|NCT01087788|12256482|FG000|COMPLETED|24-weeks Dose-blind Period||113
11347730|NCT02991859|12544627|FG002|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
11074539|NCT01087788|12256483|FG001|COMPLETED|24-weeks Dose-blind Period||123
11074540|NCT01087788|12256484|FG002|COMPLETED|24-weeks Dose-blind Period||114
11074541|NCT01087788|12256482|FG000|NOT COMPLETED|24-weeks Dose-blind Period||7
11074542|NCT01087788|12256483|FG001|NOT COMPLETED|24-weeks Dose-blind Period||5
11074543|NCT01087788|12256484|FG002|NOT COMPLETED|24-weeks Dose-blind Period||6
11074544|NCT01087788|12256482|FG000|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
11074545|NCT01087788|12256483|FG001|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
11074546|NCT01087788|12256484|FG002|STARTED|Open-Label Period (OL-P)||114
11074547|NCT01087788|12256482|FG000|COMPLETED|Open-Label Period (OL-P)||81
11074548|NCT01087788|12256483|FG001|COMPLETED|Open-Label Period (OL-P)||97
11074549|NCT01087788|12256484|FG002|COMPLETED|Open-Label Period (OL-P)||86
11074550|NCT01087788|12256482|FG000|NOT COMPLETED|Open-Label Period (OL-P)||30
11074551|NCT01087788|12256483|FG001|NOT COMPLETED|Open-Label Period (OL-P)||24
11074552|NCT01087788|12256484|FG002|NOT COMPLETED|Open-Label Period (OL-P)||28
11074553|NCT01087801|12256495|FG000|STARTED|Overall Study||30
11074554|NCT01087801|12256496|FG001|STARTED|Overall Study||34
11074555|NCT01087801|12256495|FG000|COMPLETED|Overall Study||26
11074556|NCT01087801|12256496|FG001|COMPLETED|Overall Study||29
11074557|NCT01087801|12256495|FG000|NOT COMPLETED|Overall Study||4
11074558|NCT01087801|12256496|FG001|NOT COMPLETED|Overall Study||5
11074559|NCT01087814|12256504|FG000|STARTED|First Intervention (5 Days)||8
11074560|NCT01087814|12256505|FG001|STARTED|First Intervention (5 Days)||7
11074561|NCT01087814|12256504|FG000|COMPLETED|First Intervention (5 Days)||5
11074562|NCT01087814|12256505|FG001|COMPLETED|First Intervention (5 Days)||6
11074563|NCT01087814|12256504|FG000|NOT COMPLETED|First Intervention (5 Days)||3
11074564|NCT01087814|12256505|FG001|NOT COMPLETED|First Intervention (5 Days)||1
11074565|NCT01087814|12256504|FG000|STARTED|Second Intervention (5 Days)||5
11074566|NCT01087814|12256505|FG001|STARTED|Second Intervention (5 Days)||6
11074567|NCT01087814|12256504|FG000|COMPLETED|Second Intervention (5 Days)||4
11074568|NCT01087814|12256505|FG001|COMPLETED|Second Intervention (5 Days)||6
11074569|NCT01087814|12256504|FG000|NOT COMPLETED|Second Intervention (5 Days)||1
11074570|NCT01087814|12256505|FG001|NOT COMPLETED|Second Intervention (5 Days)||0
11074571|NCT01087905|12256519|FG000|STARTED|Overall Study||119
11074572|NCT01087905|12256520|FG001|STARTED|Overall Study||126
11074573|NCT01087905|12256521|FG002|STARTED|Overall Study||123
11074574|NCT01087905|12256522|FG003|STARTED|Overall Study||122
11074575|NCT01087905|12256523|FG004|STARTED|Overall Study||122
11074576|NCT01087905|12256524|FG005|STARTED|Overall Study||127
11074577|NCT01087905|12256525|FG006|STARTED|Overall Study||121
11074578|NCT01087905|12256526|FG007|STARTED|Overall Study||127
11074579|NCT01087905|12256519|FG000|COMPLETED|Overall Study||90
11074580|NCT01087905|12256520|FG001|COMPLETED|Overall Study||94
11074581|NCT01087905|12256521|FG002|COMPLETED|Overall Study||101
11074582|NCT01087905|12256522|FG003|COMPLETED|Overall Study||86
11074583|NCT01087905|12256523|FG004|COMPLETED|Overall Study||91
11074584|NCT01087905|12256524|FG005|COMPLETED|Overall Study||99
11074585|NCT01087905|12256525|FG006|COMPLETED|Overall Study||98
11074586|NCT01087905|12256526|FG007|COMPLETED|Overall Study||98
11074587|NCT01087905|12256519|FG000|NOT COMPLETED|Overall Study||29
11074588|NCT01087905|12256520|FG001|NOT COMPLETED|Overall Study||32
11074589|NCT01087905|12256521|FG002|NOT COMPLETED|Overall Study||22
11074590|NCT01087905|12256522|FG003|NOT COMPLETED|Overall Study||36
11074591|NCT01087905|12256523|FG004|NOT COMPLETED|Overall Study||31
11074592|NCT01087905|12256524|FG005|NOT COMPLETED|Overall Study||28
11074593|NCT01087905|12256525|FG006|NOT COMPLETED|Overall Study||23
11074594|NCT01087905|12256526|FG007|NOT COMPLETED|Overall Study||29
11074595|NCT01087918|12256544|FG000|STARTED|Overall Study||5
11074596|NCT01087918|12256545|FG001|STARTED|Overall Study||4
11074597|NCT01087918|12256544|FG000|COMPLETED|Overall Study||5
11074598|NCT01087918|12256545|FG001|COMPLETED|Overall Study||4
11074599|NCT01087918|12256544|FG000|NOT COMPLETED|Overall Study||0
11074600|NCT01087918|12256545|FG001|NOT COMPLETED|Overall Study||0
11074601|NCT01087931|12256557|FG000|STARTED|Overall Study||20
11074602|NCT01087931|12256558|FG001|STARTED|Overall Study||20
11074603|NCT01087931|12256557|FG000|1st Follow up|Overall Study||20
11074604|NCT01087931|12256558|FG001|1st Follow up|Overall Study||19
11074605|NCT01087931|12256557|FG000|Final Follow up|Overall Study||19
11074606|NCT01087931|12256558|FG001|Final Follow up|Overall Study||17
11074607|NCT01087931|12256557|FG000|COMPLETED|Overall Study||20
11074608|NCT01087931|12256558|FG001|COMPLETED|Overall Study||20
11074609|NCT01087931|12256557|FG000|NOT COMPLETED|Overall Study||0
11074610|NCT01087931|12256558|FG001|NOT COMPLETED|Overall Study||0
11074611|NCT01087944|12256564|FG000|STARTED|Period 1 (Week 1-3)||30
11074612|NCT01087944|12256565|FG001|STARTED|Period 1 (Week 1-3)||30
11074613|NCT01087944|12256564|FG000|COMPLETED|Period 1 (Week 1-3)||29
11074614|NCT01087944|12256565|FG001|COMPLETED|Period 1 (Week 1-3)||30
11074615|NCT01087944|12256564|FG000|NOT COMPLETED|Period 1 (Week 1-3)||1
11074616|NCT01087944|12256565|FG001|NOT COMPLETED|Period 1 (Week 1-3)||0
11074617|NCT01087944|12256564|FG000|STARTED|Period 2 (Week 4-6)||29
11074618|NCT01087944|12256565|FG001|STARTED|Period 2 (Week 4-6)||30
11074619|NCT01087944|12256564|FG000|COMPLETED|Period 2 (Week 4-6)||29
11074620|NCT01087944|12256565|FG001|COMPLETED|Period 2 (Week 4-6)||28
11074621|NCT01087944|12256564|FG000|NOT COMPLETED|Period 2 (Week 4-6)||0
11074622|NCT01087944|12256565|FG001|NOT COMPLETED|Period 2 (Week 4-6)||2
11074623|NCT01087957|12256573|FG000|STARTED|Overall Study||253
11074624|NCT01087957|12256574|FG001|STARTED|Overall Study||242
11074625|NCT01087957|12256573|FG000|COMPLETED|Overall Study||212
11074626|NCT01087957|12256574|FG001|COMPLETED|Overall Study||187
11074627|NCT01087957|12256573|FG000|NOT COMPLETED|Overall Study||41
11074628|NCT01087957|12256574|FG001|NOT COMPLETED|Overall Study||55
11074629|NCT01087970|12256580|FG000|STARTED|Overall Study||69
11074630|NCT01087970|12256580|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||69
11074631|NCT01087970|12256580|FG000|Completed 6 Cycles|Overall Study||69
11074632|NCT01087970|12256580|FG000|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
11074633|NCT01087970|12256580|FG000|Received Carboplatin|Overall Study||63
11074634|NCT01087970|12256580|FG000|COMPLETED|Overall Study||67
11074635|NCT01087970|12256580|FG000|NOT COMPLETED|Overall Study||2
11074636|NCT01087996|12256587|FG000|STARTED|Overall Study||15
11074637|NCT01087996|12256588|FG001|STARTED|Overall Study||15
11074638|NCT01087996|12256587|FG000|COMPLETED|Overall Study||15
11074639|NCT01087996|12256588|FG001|COMPLETED|Overall Study||15
11074640|NCT01087996|12256587|FG000|NOT COMPLETED|Overall Study||0
11074641|NCT01087996|12256588|FG001|NOT COMPLETED|Overall Study||0
11074642|NCT01088048|12256604|FG000|STARTED|Overall Study||51
11074643|NCT01088048|12256605|FG001|STARTED|Overall Study||51
11074644|NCT01088048|12256606|FG002|STARTED|Overall Study||18
11074645|NCT01088048|12256607|FG003|STARTED|Overall Study||18
11074646|NCT01088048|12256608|FG004|STARTED|Overall Study||33
11074647|NCT01088048|12256609|FG005|STARTED|Overall Study||21
11074648|NCT01088048|12256610|FG006|STARTED|Overall Study||12
11074649|NCT01088048|12256611|FG007|STARTED|Overall Study||15
11074650|NCT01088048|12256612|FG008|STARTED|Overall Study||15
11074651|NCT01088048|12256613|FG009|STARTED|Overall Study||7
11074652|NCT01088048|12256604|FG000|Participants With CLL|Overall Study||19
11074653|NCT01088048|12256605|FG001|Participants With CLL|Overall Study||18
11074654|NCT01088048|12256606|FG002|Participants With CLL|Overall Study||0
11074655|NCT01088048|12256607|FG003|Participants With CLL|Overall Study||0
11074656|NCT01088048|12256608|FG004|Participants With CLL|Overall Study||15
11074657|NCT01088048|12256609|FG005|Participants With CLL|Overall Study||21
11074658|NCT01088048|12256610|FG006|Participants With CLL|Overall Study||12
11074659|NCT01088048|12256611|FG007|Participants With CLL|Overall Study||15
11074660|NCT01088048|12256612|FG008|Participants With CLL|Overall Study||14
11074661|NCT01088048|12256613|FG009|Participants With CLL|Overall Study||1
11074662|NCT01088048|12256604|FG000|Participants With Indolent NHL|Overall Study||32
11074663|NCT01088048|12256605|FG001|Participants With Indolent NHL|Overall Study||33
11074664|NCT01088048|12256606|FG002|Participants With Indolent NHL|Overall Study||0
11074665|NCT01088048|12256607|FG003|Participants With Indolent NHL|Overall Study||0
11074666|NCT01088048|12256608|FG004|Participants With Indolent NHL|Overall Study||14
11074667|NCT01088048|12256609|FG005|Participants With Indolent NHL|Overall Study||0
11074668|NCT01088048|12256610|FG006|Participants With Indolent NHL|Overall Study||0
11074669|NCT01088048|12256611|FG007|Participants With Indolent NHL|Overall Study||0
11074670|NCT01088048|12256612|FG008|Participants With Indolent NHL|Overall Study||1
11074671|NCT01088048|12256613|FG009|Participants With Indolent NHL|Overall Study||6
11074672|NCT01088048|12256604|FG000|Participants With MCL|Overall Study||0
11074673|NCT01088048|12256605|FG001|Participants With MCL|Overall Study||0
11074674|NCT01088048|12256606|FG002|Participants With MCL|Overall Study||18
11074675|NCT01088048|12256607|FG003|Participants With MCL|Overall Study||18
11074676|NCT01088048|12256608|FG004|Participants With MCL|Overall Study||4
11074677|NCT01088048|12256609|FG005|Participants With MCL|Overall Study||0
11074678|NCT01088048|12256610|FG006|Participants With MCL|Overall Study||0
11074679|NCT01088048|12256611|FG007|Participants With MCL|Overall Study||0
11074680|NCT01088048|12256612|FG008|Participants With MCL|Overall Study||0
11074681|NCT01088048|12256613|FG009|Participants With MCL|Overall Study||0
11074682|NCT01088048|12256604|FG000|COMPLETED|Overall Study||29
11074683|NCT01088048|12256605|FG001|COMPLETED|Overall Study||24
11074684|NCT01088048|12256606|FG002|COMPLETED|Overall Study||4
11074685|NCT01088048|12256607|FG003|COMPLETED|Overall Study||4
11074686|NCT01088048|12256608|FG004|COMPLETED|Overall Study||16
11074687|NCT01088048|12256609|FG005|COMPLETED|Overall Study||10
11074688|NCT01088048|12256610|FG006|COMPLETED|Overall Study||6
11074689|NCT01088048|12256611|FG007|COMPLETED|Overall Study||10
11074690|NCT01088048|12256612|FG008|COMPLETED|Overall Study||8
11074691|NCT01088048|12256613|FG009|COMPLETED|Overall Study||3
11074692|NCT01088048|12256604|FG000|NOT COMPLETED|Overall Study||22
11074693|NCT01088048|12256605|FG001|NOT COMPLETED|Overall Study||27
11074694|NCT01088048|12256606|FG002|NOT COMPLETED|Overall Study||14
11074695|NCT01088048|12256607|FG003|NOT COMPLETED|Overall Study||14
11074696|NCT01088048|12256608|FG004|NOT COMPLETED|Overall Study||17
11074697|NCT01088048|12256609|FG005|NOT COMPLETED|Overall Study||11
11074698|NCT01088048|12256610|FG006|NOT COMPLETED|Overall Study||6
11074699|NCT01088048|12256611|FG007|NOT COMPLETED|Overall Study||5
11074700|NCT01088048|12256612|FG008|NOT COMPLETED|Overall Study||7
11074701|NCT01088048|12256613|FG009|NOT COMPLETED|Overall Study||4
11074702|NCT01088243|12256648|FG000|STARTED|Overall Study||13
11074703|NCT01088243|12256649|FG001|STARTED|Overall Study||5
11074704|NCT01088243|12256648|FG000|COMPLETED|Overall Study||12
11074705|NCT01088243|12256649|FG001|COMPLETED|Overall Study||5
11074706|NCT01088243|12256648|FG000|NOT COMPLETED|Overall Study||1
11074707|NCT01088243|12256649|FG001|NOT COMPLETED|Overall Study||0
11074708|NCT01088295|12256655|FG000|STARTED|Overall Study||36
11074709|NCT01088295|12256655|FG000|COMPLETED|Overall Study||35
11074710|NCT01088295|12256655|FG000|NOT COMPLETED|Overall Study||1
11074711|NCT01088399|12256662|FG000|STARTED|Overall Study||8716
11074712|NCT01088399|12256663|FG001|STARTED|Overall Study||1655
11074713|NCT01088399|12256664|FG002|STARTED|Overall Study||302
11074714|NCT01088399|12256662|FG000|COMPLETED|Overall Study||1595
11074715|NCT01088399|12256663|FG001|COMPLETED|Overall Study||308
11074716|NCT01088399|12256664|FG002|COMPLETED|Overall Study||21
11074717|NCT01088399|12256662|FG000|NOT COMPLETED|Overall Study||7121
11074718|NCT01088399|12256663|FG001|NOT COMPLETED|Overall Study||1347
11074719|NCT01088399|12256664|FG002|NOT COMPLETED|Overall Study||281
11074720|NCT01088412|12256675|FG000|STARTED|Overall Study||22311
11074721|NCT01088412|12256676|FG001|STARTED|Overall Study||457
11074722|NCT01088412|12256677|FG002|STARTED|Overall Study||77
11074723|NCT01088412|12256675|FG000|Safety Modified Evaluable (SME)|Overall Study||22294
11074724|NCT01088412|12256676|FG001|Safety Modified Evaluable (SME)|Overall Study||456
11074725|NCT01088412|12256677|FG002|Safety Modified Evaluable (SME)|Overall Study||0
11074726|NCT01088412|12256675|FG000|SME With at Least 1 Follow Up (FU)|Overall Study||21178
11074727|NCT01088412|12256676|FG001|SME With at Least 1 Follow Up (FU)|Overall Study||306
11074728|NCT01088412|12256677|FG002|SME With at Least 1 Follow Up (FU)|Overall Study||0
11074729|NCT01088412|12256675|FG000|SME+ >= 1 FU and Unknown Arm|Overall Study||21177
11074730|NCT01088412|12256676|FG001|SME+ >= 1 FU and Unknown Arm|Overall Study||306
11074731|NCT01088412|12256677|FG002|SME+ >= 1 FU and Unknown Arm|Overall Study||40
11074732|NCT01088412|12256675|FG000|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556
11074733|NCT01088412|12256676|FG001|SME+ >= 1 FU and No Previous Cancer|Overall Study||192
11074734|NCT01088412|12256677|FG002|SME+ >= 1 FU and No Previous Cancer|Overall Study||0
11074735|NCT01088412|12256675|FG000|SME+ >= 1 FU and Previous Cancer|Overall Study||622
11074736|NCT01088412|12256676|FG001|SME+ >= 1 FU and Previous Cancer|Overall Study||114
11074737|NCT01088412|12256677|FG002|SME+ >= 1 FU and Previous Cancer|Overall Study||0
11074738|NCT01088412|12256675|FG000|COMPLETED|Overall Study||4294
11074739|NCT01088412|12256676|FG001|COMPLETED|Overall Study||21
11074740|NCT01088412|12256677|FG002|COMPLETED|Overall Study||5
11074741|NCT01088412|12256675|FG000|NOT COMPLETED|Overall Study||18017
11074742|NCT01088412|12256676|FG001|NOT COMPLETED|Overall Study||436
11074743|NCT01088412|12256677|FG002|NOT COMPLETED|Overall Study||72
11074744|NCT01088438|12256690|FG000|STARTED|Overall Study||94
11074745|NCT01088438|12256691|FG001|STARTED|Overall Study||95
11074746|NCT01088438|12256690|FG000|COMPLETED|Overall Study||65
11074747|NCT01088438|12256691|FG001|COMPLETED|Overall Study||59
11074748|NCT01088438|12256690|FG000|NOT COMPLETED|Overall Study||29
11074749|NCT01088438|12256691|FG001|NOT COMPLETED|Overall Study||36
11074750|NCT01088464|12256700|FG000|STARTED|Overall Study||3
11074751|NCT01088464|12256701|FG001|STARTED|Overall Study||6
11074752|NCT01088464|12256702|FG002|STARTED|Overall Study||6
11074753|NCT01088464|12256700|FG000|Received Any Quantity of Study Drug|Overall Study||3
11074754|NCT01088464|12256701|FG001|Received Any Quantity of Study Drug|Overall Study||6
11074755|NCT01088464|12256702|FG002|Received Any Quantity of Study Drug|Overall Study||6
11074756|NCT01088464|12256700|FG000|COMPLETED|Overall Study||3
11074757|NCT01088464|12256701|FG001|COMPLETED|Overall Study||6
11074758|NCT01088464|12256702|FG002|COMPLETED|Overall Study||6
11074759|NCT01088464|12256700|FG000|NOT COMPLETED|Overall Study||0
11074760|NCT01088464|12256701|FG001|NOT COMPLETED|Overall Study||0
11074761|NCT01088464|12256702|FG002|NOT COMPLETED|Overall Study||0
11074762|NCT01088503|12256713|FG000|STARTED|Overall Study||3123
11074763|NCT01088503|12256714|FG001|STARTED|Overall Study||8846
11074764|NCT01088503|12256715|FG002|STARTED|Overall Study||258
11074765|NCT01088503|12256713|FG000|COMPLETED|Overall Study||2941
11074766|NCT01088503|12256714|FG001|COMPLETED|Overall Study||8161
11074767|NCT01088503|12256715|FG002|COMPLETED|Overall Study||241
11074768|NCT01088503|12256713|FG000|NOT COMPLETED|Overall Study||182
11074769|NCT01088503|12256714|FG001|NOT COMPLETED|Overall Study||685
11074770|NCT01088503|12256715|FG002|NOT COMPLETED|Overall Study||17
11074771|NCT01088529|12256723|FG000|STARTED|Overall Study||44
11074772|NCT01088529|12256724|FG001|STARTED|Overall Study||22
11074773|NCT01088529|12256723|FG000|Received Treatment|Overall Study||44
11074774|NCT01088529|12256724|FG001|Received Treatment|Overall Study||21
11074775|NCT01088529|12256723|FG000|COMPLETED|Overall Study||44
11074776|NCT01088529|12256724|FG001|COMPLETED|Overall Study||21
11074777|NCT01088529|12256723|FG000|NOT COMPLETED|Overall Study||0
11074778|NCT01088529|12256724|FG001|NOT COMPLETED|Overall Study||1
11347731|NCT02991859|12544628|FG003|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
11347732|NCT02991859|12544629|FG004|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
11347733|NCT02991859|12544630|FG005|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
11347734|NCT02991859|12544631|FG006|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
11347735|NCT02991859|12544632|FG007|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
11347736|NCT02991859|12544633|FG008|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
11347737|NCT02991859|12544634|FG009|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
11347738|NCT02991859|12544635|FG010|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
11074779|NCT01088646|12256730|FG000|STARTED|Overall Study||25
11074780|NCT01088646|12256730|FG000|COMPLETED|Overall Study||25
11074781|NCT01088646|12256730|FG000|NOT COMPLETED|Overall Study||0
11347739|NCT02991859|12544636|FG011|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
11347740|NCT02991859|12544637|FG012|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347741|NCT02991859|12544638|FG013|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11074782|NCT01088672|12256735|FG000|STARTED|Overall Study||60
11074783|NCT01088672|12256735|FG000|COMPLETED|Overall Study||60
11074784|NCT01088672|12256735|FG000|NOT COMPLETED|Overall Study||0
11206704|NCT01869959|12397760|FG003|NOT COMPLETED|Randomization Period||0
11206705|NCT01869959|12397761|FG004|NOT COMPLETED|Randomization Period||1
11206706|NCT01869959|12397757|FG000|STARTED|Treatment Period||11
11206707|NCT01869959|12397758|FG001|STARTED|Treatment Period||10
11206708|NCT01869959|12397759|FG002|STARTED|Treatment Period||15
11206709|NCT01869959|12397760|FG003|STARTED|Treatment Period||10
11206710|NCT01869959|12397761|FG004|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
11206711|NCT01869959|12397757|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||11
11347742|NCT02991859|12544639|FG014|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347743|NCT02991859|12544640|FG015|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347744|NCT02991859|12544641|FG016|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347745|NCT02991859|12544625|FG000|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347746|NCT02991859|12544626|FG001|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347747|NCT02991859|12544627|FG002|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347748|NCT02991859|12544628|FG003|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347749|NCT02991859|12544629|FG004|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347750|NCT02991859|12544630|FG005|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347751|NCT02991859|12544631|FG006|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347752|NCT02991859|12544632|FG007|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347753|NCT02991859|12544633|FG008|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347754|NCT02991859|12544634|FG009|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347755|NCT02991859|12544635|FG010|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11074785|NCT01088711|12256743|FG000|STARTED|Overall Study||18
11074786|NCT01088711|12256744|FG001|STARTED|Overall Study||6
11074787|NCT01088711|12256745|FG002|STARTED|Overall Study||6
11074788|NCT01088711|12256746|FG003|STARTED|Overall Study||2
11074789|NCT01088711|12256743|FG000|COMPLETED|Overall Study||18
11074790|NCT01088711|12256744|FG001|COMPLETED|Overall Study||6
11074791|NCT01088711|12256745|FG002|COMPLETED|Overall Study||6
11074792|NCT01088711|12256746|FG003|COMPLETED|Overall Study||2
11074793|NCT01088711|12256743|FG000|NOT COMPLETED|Overall Study||0
11074794|NCT01088711|12256744|FG001|NOT COMPLETED|Overall Study||0
11074795|NCT01088711|12256745|FG002|NOT COMPLETED|Overall Study||0
11074796|NCT01088711|12256746|FG003|NOT COMPLETED|Overall Study||0
11074797|NCT01088984|12256760|FG000|STARTED|Phase 1||5
11074798|NCT01088984|12256761|FG001|STARTED|Phase 1||6
11074799|NCT01088984|12256760|FG000|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
11074800|NCT01088984|12256761|FG001|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
11074801|NCT01088984|12256760|FG000|NOT COMPLETED|Phase 1||5
11074802|NCT01088984|12256761|FG001|NOT COMPLETED|Phase 1||6
11074803|NCT01088984|12256760|FG000|STARTED|Phase 2||0
11074804|NCT01088984|12256761|FG001|STARTED|Phase 2||32
11074805|NCT01088984|12256760|FG000|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
11074806|NCT01088984|12256761|FG001|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
11074807|NCT01088984|12256760|FG000|NOT COMPLETED|Phase 2||0
11074808|NCT01088984|12256761|FG001|NOT COMPLETED|Phase 2||32
11074809|NCT01088997|12256772|FG000|STARTED|Overall Study||7
11074810|NCT01088997|12256773|FG001|STARTED|Overall Study||5
11074811|NCT01088997|12256772|FG000|COMPLETED|Overall Study||4
11074812|NCT01088997|12256773|FG001|COMPLETED|Overall Study||2
11074813|NCT01088997|12256772|FG000|NOT COMPLETED|Overall Study||3
11074814|NCT01088997|12256773|FG001|NOT COMPLETED|Overall Study||3
11074815|NCT01089023|12256782|FG000|STARTED|Overall Study||95
11074816|NCT01089023|12256782|FG000|COMPLETED|Overall Study||88
11074817|NCT01089023|12256782|FG000|NOT COMPLETED|Overall Study||7
11074818|NCT01089062|12256792|FG000|STARTED|Visit 2 (Randomization)||4
11074819|NCT01089062|12256793|FG001|STARTED|Visit 2 (Randomization)||4
11074820|NCT01089062|12256794|FG002|STARTED|Visit 2 (Randomization)||4
11074821|NCT01089062|12256795|FG003|STARTED|Visit 2 (Randomization)||4
11074822|NCT01089062|12256796|FG004|STARTED|Visit 2 (Randomization)||4
11074823|NCT01089062|12256797|FG005|STARTED|Visit 2 (Randomization)||4
11074824|NCT01089062|12256792|FG000|COMPLETED|Visit 2 (Randomization)||3
11074825|NCT01089062|12256793|FG001|COMPLETED|Visit 2 (Randomization)||3
11074826|NCT01089062|12256794|FG002|COMPLETED|Visit 2 (Randomization)||3
11074827|NCT01089062|12256795|FG003|COMPLETED|Visit 2 (Randomization)||4
11074828|NCT01089062|12256796|FG004|COMPLETED|Visit 2 (Randomization)||3
11074829|NCT01089062|12256797|FG005|COMPLETED|Visit 2 (Randomization)||3
11074830|NCT01089062|12256792|FG000|NOT COMPLETED|Visit 2 (Randomization)||1
11074831|NCT01089062|12256793|FG001|NOT COMPLETED|Visit 2 (Randomization)||1
11074832|NCT01089062|12256794|FG002|NOT COMPLETED|Visit 2 (Randomization)||1
11074833|NCT01089062|12256795|FG003|NOT COMPLETED|Visit 2 (Randomization)||0
11074834|NCT01089062|12256796|FG004|NOT COMPLETED|Visit 2 (Randomization)||1
11074835|NCT01089062|12256797|FG005|NOT COMPLETED|Visit 2 (Randomization)||1
11074836|NCT01089062|12256792|FG000|STARTED|Visit 3||3
11074837|NCT01089062|12256793|FG001|STARTED|Visit 3||3
11074838|NCT01089062|12256794|FG002|STARTED|Visit 3||3
11074839|NCT01089062|12256795|FG003|STARTED|Visit 3||4
11074840|NCT01089062|12256796|FG004|STARTED|Visit 3||3
11074841|NCT01089062|12256797|FG005|STARTED|Visit 3||3
11074842|NCT01089062|12256792|FG000|COMPLETED|Visit 3||3
11074843|NCT01089062|12256793|FG001|COMPLETED|Visit 3||3
11074844|NCT01089062|12256794|FG002|COMPLETED|Visit 3||3
11074845|NCT01089062|12256795|FG003|COMPLETED|Visit 3||3
11074846|NCT01089062|12256796|FG004|COMPLETED|Visit 3||3
11074847|NCT01089062|12256797|FG005|COMPLETED|Visit 3||3
11074848|NCT01089062|12256792|FG000|NOT COMPLETED|Visit 3||0
11074849|NCT01089062|12256793|FG001|NOT COMPLETED|Visit 3||0
11074850|NCT01089062|12256794|FG002|NOT COMPLETED|Visit 3||0
11074851|NCT01089062|12256795|FG003|NOT COMPLETED|Visit 3||1
11074852|NCT01089062|12256796|FG004|NOT COMPLETED|Visit 3||0
11074853|NCT01089062|12256797|FG005|NOT COMPLETED|Visit 3||0
11074854|NCT01089062|12256792|FG000|STARTED|Visit 4||3
11074855|NCT01089062|12256793|FG001|STARTED|Visit 4||3
11074856|NCT01089062|12256794|FG002|STARTED|Visit 4||3
11074857|NCT01089062|12256795|FG003|STARTED|Visit 4||3
11074858|NCT01089062|12256796|FG004|STARTED|Visit 4||3
11074859|NCT01089062|12256797|FG005|STARTED|Visit 4||3
11074860|NCT01089062|12256792|FG000|COMPLETED|Visit 4||3
11074861|NCT01089062|12256793|FG001|COMPLETED|Visit 4||3
11074862|NCT01089062|12256794|FG002|COMPLETED|Visit 4||3
11074863|NCT01089062|12256795|FG003|COMPLETED|Visit 4||3
11074864|NCT01089062|12256796|FG004|COMPLETED|Visit 4||3
11074865|NCT01089062|12256797|FG005|COMPLETED|Visit 4||3
11074866|NCT01089062|12256792|FG000|NOT COMPLETED|Visit 4||0
11074867|NCT01089062|12256793|FG001|NOT COMPLETED|Visit 4||0
11074868|NCT01089062|12256794|FG002|NOT COMPLETED|Visit 4||0
11074869|NCT01089062|12256795|FG003|NOT COMPLETED|Visit 4||0
11074870|NCT01089062|12256796|FG004|NOT COMPLETED|Visit 4||0
11074871|NCT01089062|12256797|FG005|NOT COMPLETED|Visit 4||0
11074872|NCT01089062|12256792|FG000|STARTED|Follow-up Visit (Final Visit)||3
11074873|NCT01089062|12256793|FG001|STARTED|Follow-up Visit (Final Visit)||3
11074874|NCT01089062|12256794|FG002|STARTED|Follow-up Visit (Final Visit)||3
11074875|NCT01089062|12256795|FG003|STARTED|Follow-up Visit (Final Visit)||3
11074876|NCT01089062|12256796|FG004|STARTED|Follow-up Visit (Final Visit)||3
11074877|NCT01089062|12256797|FG005|STARTED|Follow-up Visit (Final Visit)||3
11074878|NCT01089062|12256792|FG000|COMPLETED|Follow-up Visit (Final Visit)||3
11074879|NCT01089062|12256793|FG001|COMPLETED|Follow-up Visit (Final Visit)||3
11074880|NCT01089062|12256794|FG002|COMPLETED|Follow-up Visit (Final Visit)||3
11074881|NCT01089062|12256795|FG003|COMPLETED|Follow-up Visit (Final Visit)||3
11074882|NCT01089062|12256796|FG004|COMPLETED|Follow-up Visit (Final Visit)||3
11074883|NCT01089062|12256797|FG005|COMPLETED|Follow-up Visit (Final Visit)||3
11074884|NCT01089062|12256792|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0
11074885|NCT01089062|12256793|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0
11074886|NCT01089062|12256794|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0
11074887|NCT01089062|12256795|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0
11074888|NCT01089062|12256796|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0
11074889|NCT01089062|12256797|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0
11074890|NCT01089127|12256812|FG000|STARTED|Overall Study||92
11074891|NCT01089127|12256813|FG001|STARTED|Overall Study||91
11074892|NCT01089127|12256814|FG002|STARTED|Overall Study||94
11074893|NCT01089127|12256815|FG003|STARTED|Overall Study||92
11074894|NCT01089127|12256816|FG004|STARTED|Overall Study||92
11074895|NCT01089127|12256817|FG005|STARTED|Overall Study||91
11074896|NCT01089127|12256812|FG000|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
11074897|NCT01089127|12256813|FG001|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
11074898|NCT01089127|12256814|FG002|Exposed to Study Drug|Overall Study||94
11074899|NCT01089127|12256815|FG003|Exposed to Study Drug|Overall Study||92
11074900|NCT01089127|12256816|FG004|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
11074901|NCT01089127|12256817|FG005|Exposed to Study Drug|Overall Study||91
11074902|NCT01089127|12256812|FG000|COMPLETED|Overall Study||84
11074903|NCT01089127|12256813|FG001|COMPLETED|Overall Study||86
11074904|NCT01089127|12256814|FG002|COMPLETED|Overall Study||92
11074905|NCT01089127|12256815|FG003|COMPLETED|Overall Study||91
11074906|NCT01089127|12256816|FG004|COMPLETED|Overall Study||90
11074907|NCT01089127|12256817|FG005|COMPLETED|Overall Study||88
11074908|NCT01089127|12256812|FG000|NOT COMPLETED|Overall Study||8
11074909|NCT01089127|12256813|FG001|NOT COMPLETED|Overall Study||5
11074910|NCT01089127|12256814|FG002|NOT COMPLETED|Overall Study||2
11074911|NCT01089127|12256815|FG003|NOT COMPLETED|Overall Study||1
11074912|NCT01089127|12256816|FG004|NOT COMPLETED|Overall Study||2
11074913|NCT01089127|12256817|FG005|NOT COMPLETED|Overall Study||3
11074914|NCT01089231|12256835|FG000|STARTED|Overall Study||10
11074915|NCT01089231|12256836|FG001|STARTED|Overall Study||10
11074916|NCT01089231|12256837|FG002|STARTED|Overall Study||10
11074917|NCT01089231|12256838|FG003|STARTED|Overall Study||10
11074918|NCT01089231|12256835|FG000|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
11074919|NCT01089231|12256836|FG001|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
11074920|NCT01089231|12256837|FG002|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
11074921|NCT01089231|12256838|FG003|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
11074922|NCT01089231|12256835|FG000|NOT COMPLETED|Overall Study||4
11074923|NCT01089231|12256836|FG001|NOT COMPLETED|Overall Study||2
11074924|NCT01089231|12256837|FG002|NOT COMPLETED|Overall Study||2
11074925|NCT01089231|12256838|FG003|NOT COMPLETED|Overall Study||1
11074926|NCT01089361|12256850|FG000|STARTED|Overall Study||9
11074927|NCT01089361|12256851|FG001|STARTED|Overall Study||10
11074928|NCT01089361|12256850|FG000|COMPLETED|Overall Study||8
11074929|NCT01089361|12256851|FG001|COMPLETED|Overall Study||10
11074930|NCT01089361|12256850|FG000|NOT COMPLETED|Overall Study||1
11074931|NCT01089361|12256851|FG001|NOT COMPLETED|Overall Study||0
11074932|NCT01089413|12256862|FG000|STARTED|Overall Study||201
11074933|NCT01089413|12256862|FG000|Received Bevacizumab in First Line|Overall Study||199
11074934|NCT01089413|12256862|FG000|COMPLETED|Overall Study||0
11074935|NCT01089413|12256862|FG000|NOT COMPLETED|Overall Study||201
11074936|NCT01089504|12256874|FG000|STARTED|Overall Study||8
11074937|NCT01089504|12256875|FG001|STARTED|Overall Study||5
11074938|NCT01089504|12256874|FG000|COMPLETED|Overall Study||5
11074939|NCT01089504|12256875|FG001|COMPLETED|Overall Study||4
11074940|NCT01089504|12256874|FG000|NOT COMPLETED|Overall Study||3
11074941|NCT01089504|12256875|FG001|NOT COMPLETED|Overall Study||1
11074942|NCT01089517|12256884|FG000|STARTED|Overall Study||148
11074943|NCT01089517|12256885|FG001|STARTED|Overall Study||149
11347756|NCT02991859|12544636|FG011|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347757|NCT02991859|12544637|FG012|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347758|NCT02991859|12544638|FG013|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347759|NCT02991859|12544639|FG014|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347760|NCT02991859|12544640|FG015|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11347761|NCT02991859|12544641|FG016|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
11074944|NCT01089517|12256886|FG002|STARTED|Overall Study||152
11074945|NCT01089517|12256884|FG000|COMPLETED|Overall Study||144
11074946|NCT01089517|12256885|FG001|COMPLETED|Overall Study||144
11206712|NCT01869959|12397758|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||10
11206713|NCT01869959|12397759|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||15
11206714|NCT01869959|12397760|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||10
11074947|NCT01089517|12256886|FG002|COMPLETED|Overall Study||147
11074948|NCT01089517|12256884|FG000|NOT COMPLETED|Overall Study||4
11074949|NCT01089517|12256885|FG001|NOT COMPLETED|Overall Study||5
11074950|NCT01089517|12256886|FG002|NOT COMPLETED|Overall Study||5
11074951|NCT01089543|12256898|FG000|STARTED|Overall Study||84
11074952|NCT01089543|12256899|FG001|STARTED|Overall Study||85
11074953|NCT01089543|12256900|FG002|STARTED|Overall Study||84
11074954|NCT01089543|12256901|FG003|STARTED|Overall Study||85
11074955|NCT01089543|12256898|FG000|COMPLETED|Overall Study||81
11074956|NCT01089543|12256899|FG001|COMPLETED|Overall Study||81
11074957|NCT01089543|12256900|FG002|COMPLETED|Overall Study||81
11074958|NCT01089543|12256901|FG003|COMPLETED|Overall Study||83
11074959|NCT01089543|12256898|FG000|NOT COMPLETED|Overall Study||3
11074960|NCT01089543|12256899|FG001|NOT COMPLETED|Overall Study||4
11074961|NCT01089543|12256900|FG002|NOT COMPLETED|Overall Study||3
11074962|NCT01089543|12256901|FG003|NOT COMPLETED|Overall Study||2
11074963|NCT01089556|12256913|FG000|STARTED|Study Period II (Weeks 1-8)||404
11074964|NCT01089556|12256914|FG001|STARTED|Study Period II (Weeks 1-8)||407
11074965|NCT01089556|12256915|FG002|STARTED|Study Period II (Weeks 1-8)||0
11074966|NCT01089556|12256916|FG003|STARTED|Study Period II (Weeks 1-8)||0
11074967|NCT01089556|12256917|FG004|STARTED|Study Period II (Weeks 1-8)||0
11074968|NCT01089556|12256918|FG005|STARTED|Study Period II (Weeks 1-8)||0
11074969|NCT01089556|12256913|FG000|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
11074970|NCT01089556|12256914|FG001|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
11074971|NCT01089556|12256915|FG002|Safety Population|Study Period II (Weeks 1-8)||0
11074972|NCT01089556|12256916|FG003|Safety Population|Study Period II (Weeks 1-8)||0
11074973|NCT01089556|12256917|FG004|Safety Population|Study Period II (Weeks 1-8)||0
11074974|NCT01089556|12256918|FG005|Safety Population|Study Period II (Weeks 1-8)||0
11074975|NCT01089556|12256913|FG000|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
11074976|NCT01089556|12256914|FG001|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
11074977|NCT01089556|12256915|FG002|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
11074978|NCT01089556|12256916|FG003|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
11074979|NCT01089556|12256917|FG004|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
11074980|NCT01089556|12256918|FG005|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
11074981|NCT01089556|12256913|FG000|COMPLETED|Study Period II (Weeks 1-8)||333
11074982|NCT01089556|12256914|FG001|COMPLETED|Study Period II (Weeks 1-8)||333
11074983|NCT01089556|12256915|FG002|COMPLETED|Study Period II (Weeks 1-8)||0
11074984|NCT01089556|12256916|FG003|COMPLETED|Study Period II (Weeks 1-8)||0
11074985|NCT01089556|12256917|FG004|COMPLETED|Study Period II (Weeks 1-8)||0
11074986|NCT01089556|12256918|FG005|COMPLETED|Study Period II (Weeks 1-8)||0
11074987|NCT01089556|12256913|FG000|NOT COMPLETED|Study Period II (Weeks 1-8)||71
11074988|NCT01089556|12256914|FG001|NOT COMPLETED|Study Period II (Weeks 1-8)||74
11074989|NCT01089556|12256915|FG002|NOT COMPLETED|Study Period II (Weeks 1-8)||0
11074990|NCT01089556|12256916|FG003|NOT COMPLETED|Study Period II (Weeks 1-8)||0
11074991|NCT01089556|12256917|FG004|NOT COMPLETED|Study Period II (Weeks 1-8)||0
11074992|NCT01089556|12256918|FG005|NOT COMPLETED|Study Period II (Weeks 1-8)||0
11074993|NCT01089556|12256913|FG000|STARTED|Study Period III (Weeks 9-16)||0
11074994|NCT01089556|12256914|FG001|STARTED|Study Period III (Weeks 9-16)||0
11074995|NCT01089556|12256915|FG002|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
11074996|NCT01089556|12256916|FG003|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
11074997|NCT01089556|12256917|FG004|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
11074998|NCT01089556|12256918|FG005|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
11074999|NCT01089556|12256913|FG000|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
11075000|NCT01089556|12256914|FG001|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
11075001|NCT01089556|12256915|FG002|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
11075002|NCT01089556|12256916|FG003|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
11075003|NCT01089556|12256917|FG004|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
11075004|NCT01089556|12256918|FG005|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
11075005|NCT01089556|12256913|FG000|COMPLETED|Study Period III (Weeks 9-16)||0
11075006|NCT01089556|12256914|FG001|COMPLETED|Study Period III (Weeks 9-16)||0
11075007|NCT01089556|12256915|FG002|COMPLETED|Study Period III (Weeks 9-16)||60
11075008|NCT01089556|12256916|FG003|COMPLETED|Study Period III (Weeks 9-16)||66
11075009|NCT01089556|12256917|FG004|COMPLETED|Study Period III (Weeks 9-16)||83
11075010|NCT01089556|12256918|FG005|COMPLETED|Study Period III (Weeks 9-16)||92
11075011|NCT01089556|12256913|FG000|NOT COMPLETED|Study Period III (Weeks 9-16)||0
11075012|NCT01089556|12256914|FG001|NOT COMPLETED|Study Period III (Weeks 9-16)||0
11075013|NCT01089556|12256915|FG002|NOT COMPLETED|Study Period III (Weeks 9-16)||14
11075014|NCT01089556|12256916|FG003|NOT COMPLETED|Study Period III (Weeks 9-16)||9
11075015|NCT01089556|12256917|FG004|NOT COMPLETED|Study Period III (Weeks 9-16)||12
11075016|NCT01089556|12256918|FG005|NOT COMPLETED|Study Period III (Weeks 9-16)||7
11075017|NCT01089569|12256933|FG000|STARTED|Overall Study||20
11075018|NCT01089569|12256934|FG001|STARTED|Overall Study||20
11075019|NCT01089569|12256935|FG002|STARTED|Overall Study||20
11075020|NCT01089569|12256933|FG000|COMPLETED|Overall Study||16
11075021|NCT01089569|12256934|FG001|COMPLETED|Overall Study||17
11075022|NCT01089569|12256935|FG002|COMPLETED|Overall Study||16
11075023|NCT01089569|12256933|FG000|NOT COMPLETED|Overall Study||4
11075024|NCT01089569|12256934|FG001|NOT COMPLETED|Overall Study||3
11075025|NCT01089569|12256935|FG002|NOT COMPLETED|Overall Study||4
11075026|NCT01089582|12256943|FG000|STARTED|Overall Study||603
11075027|NCT01089582|12256943|FG000|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
11075028|NCT01089582|12256943|FG000|NOT COMPLETED|Overall Study||30
11075029|NCT01089595|12256949|FG000|STARTED|Overall Study||2
11075030|NCT01089595|12256950|FG001|STARTED|Overall Study||3
11075031|NCT01089595|12256949|FG000|COMPLETED|Overall Study||2
11075032|NCT01089595|12256950|FG001|COMPLETED|Overall Study||3
11075033|NCT01089595|12256949|FG000|NOT COMPLETED|Overall Study||0
11075034|NCT01089595|12256950|FG001|NOT COMPLETED|Overall Study||0
11075035|NCT01089608|12256960|FG000|STARTED|Overall Study||43
11075036|NCT01089608|12256961|FG001|STARTED|Overall Study||50
11075037|NCT01089608|12256960|FG000|COMPLETED|Overall Study||43
11075038|NCT01089608|12256961|FG001|COMPLETED|Overall Study||44
11075039|NCT01089608|12256960|FG000|NOT COMPLETED|Overall Study||0
11075040|NCT01089608|12256961|FG001|NOT COMPLETED|Overall Study||6
11075041|NCT01089647|12256969|FG000|STARTED|Overall Study||17
11075042|NCT01089647|12256970|FG001|STARTED|Overall Study||17
11075043|NCT01089647|12256969|FG000|COMPLETED|Overall Study||13
11075044|NCT01089647|12256970|FG001|COMPLETED|Overall Study||13
11075045|NCT01089647|12256969|FG000|NOT COMPLETED|Overall Study||4
11075046|NCT01089647|12256970|FG001|NOT COMPLETED|Overall Study||4
11075047|NCT01089725|12256981|FG000|STARTED|Overall Study||72
11075048|NCT01089725|12256982|FG001|STARTED|Overall Study||75
11075049|NCT01089725|12256983|FG002|STARTED|Overall Study||65
11075050|NCT01089725|12256984|FG003|STARTED|Overall Study||87
11075051|NCT01089725|12256985|FG004|STARTED|Overall Study||86
11075052|NCT01089725|12256981|FG000|Treated|Overall Study||72
11075053|NCT01089725|12256982|FG001|Treated|Overall Study||74
11075054|NCT01089725|12256983|FG002|Treated|Overall Study||63
11075055|NCT01089725|12256984|FG003|Treated|Overall Study||86
11075056|NCT01089725|12256985|FG004|Treated|Overall Study||84
11075057|NCT01089725|12256981|FG000|COMPLETED|Overall Study||6
11075058|NCT01089725|12256982|FG001|COMPLETED|Overall Study||7
11075059|NCT01089725|12256983|FG002|COMPLETED|Overall Study||4
11075060|NCT01089725|12256984|FG003|COMPLETED|Overall Study||8
11075061|NCT01089725|12256985|FG004|COMPLETED|Overall Study||6
11075062|NCT01089725|12256981|FG000|NOT COMPLETED|Overall Study||66
11075063|NCT01089725|12256982|FG001|NOT COMPLETED|Overall Study||68
11075064|NCT01089725|12256983|FG002|NOT COMPLETED|Overall Study||61
11075065|NCT01089725|12256984|FG003|NOT COMPLETED|Overall Study||79
11075066|NCT01089725|12256985|FG004|NOT COMPLETED|Overall Study||80
11075067|NCT01089751|12257003|FG000|STARTED|Overall Study||163
11075068|NCT01089751|12257004|FG001|STARTED|Overall Study||159
11075069|NCT01089751|12257003|FG000|COMPLETED|Overall Study||129
11075070|NCT01089751|12257004|FG001|COMPLETED|Overall Study||132
11075071|NCT01089751|12257003|FG000|NOT COMPLETED|Overall Study||34
11075072|NCT01089751|12257004|FG001|NOT COMPLETED|Overall Study||27
11075073|NCT01090011|12257010|FG000|STARTED|Overall Study||171
11075074|NCT01090011|12257010|FG000|COMPLETED|Overall Study||0
11075075|NCT01090011|12257010|FG000|NOT COMPLETED|Overall Study||171
11075076|NCT01090050|12257024|FG000|STARTED|Overall Study||16
11075077|NCT01090050|12257025|FG001|STARTED|Overall Study||12
11347762|NCT02991898|12544716|FG000|STARTED|Overall Study||3
11347763|NCT02991898|12544716|FG000|COMPLETED|Overall Study||3
11347764|NCT02991898|12544716|FG000|NOT COMPLETED|Overall Study||0
11347765|NCT02992067|12544720|FG000|STARTED|Overall Study||359
11347766|NCT02992067|12544720|FG000|COMPLETED|Overall Study||359
11347767|NCT02992067|12544720|FG000|NOT COMPLETED|Overall Study||0
11347768|NCT02992132|12544727|FG000|STARTED|Overall Study||40
11347769|NCT02992132|12544728|FG001|STARTED|Overall Study||35
11347770|NCT02992132|12544729|FG002|STARTED|Overall Study||36
11347771|NCT02992132|12544727|FG000|COMPLETED|Overall Study||27
11347772|NCT02992132|12544728|FG001|COMPLETED|Overall Study||27
11347773|NCT02992132|12544729|FG002|COMPLETED|Overall Study||29
11347774|NCT02992132|12544727|FG000|NOT COMPLETED|Overall Study||13
11347775|NCT02992132|12544728|FG001|NOT COMPLETED|Overall Study||8
11347776|NCT02992132|12544729|FG002|NOT COMPLETED|Overall Study||7
11347777|NCT02992197|12544739|FG000|STARTED|Overall Study||110
11347778|NCT02992197|12544740|FG001|STARTED|Overall Study||110
11347779|NCT02992197|12544739|FG000|COMPLETED|Overall Study||99
11347780|NCT02992197|12544740|FG001|COMPLETED|Overall Study||103
11347781|NCT02992197|12544739|FG000|NOT COMPLETED|Overall Study||11
11347782|NCT02992197|12544740|FG001|NOT COMPLETED|Overall Study||7
11347783|NCT02992236|12544748|FG000|STARTED|Overall Study||8
11347784|NCT02992236|12544749|FG001|STARTED|Overall Study||8
11347785|NCT02992236|12544748|FG000|COMPLETED|Overall Study||8
11347786|NCT02992236|12544749|FG001|COMPLETED|Overall Study||8
11347787|NCT02992236|12544748|FG000|NOT COMPLETED|Overall Study||0
11347788|NCT02992236|12544749|FG001|NOT COMPLETED|Overall Study||0
11347789|NCT02992288|12544763|FG000|STARTED|Overall Study||106
11347790|NCT02992288|12544764|FG001|STARTED|Overall Study||37
11347791|NCT02992288|12544765|FG002|STARTED|Overall Study||70
11347792|NCT02992288|12544766|FG003|STARTED|Overall Study||73
11347793|NCT02992288|12544767|FG004|STARTED|Overall Study||69
11347794|NCT02992288|12544768|FG005|STARTED|Overall Study||72
11347795|NCT02992288|12544763|FG000|Treated|Overall Study||106
11347796|NCT02992288|12544764|FG001|Treated|Overall Study||37
11347797|NCT02992288|12544765|FG002|Treated|Overall Study||70
11347798|NCT02992288|12544766|FG003|Treated|Overall Study||72
11347799|NCT02992288|12544767|FG004|Treated|Overall Study||69
11347800|NCT02992288|12544768|FG005|Treated|Overall Study||72
11347801|NCT02992288|12544763|FG000|COMPLETED|Overall Study||89
11347802|NCT02992288|12544764|FG001|COMPLETED|Overall Study||32
11347803|NCT02992288|12544765|FG002|COMPLETED|Overall Study||63
11347804|NCT02992288|12544766|FG003|COMPLETED|Overall Study||64
11347805|NCT02992288|12544767|FG004|COMPLETED|Overall Study||61
11347806|NCT02992288|12544768|FG005|COMPLETED|Overall Study||59
11347807|NCT02992288|12544763|FG000|NOT COMPLETED|Overall Study||17
11075078|NCT01090050|12257024|FG000|COMPLETED|Overall Study||15
11075079|NCT01090050|12257025|FG001|COMPLETED|Overall Study||5
11075080|NCT01090050|12257024|FG000|NOT COMPLETED|Overall Study||1
11075081|NCT01090050|12257025|FG001|NOT COMPLETED|Overall Study||7
11075082|NCT01090063|12257035|FG000|STARTED|Screen||28
11075083|NCT01090063|12257035|FG000|COMPLETED|Screen||24
11075084|NCT01090063|12257035|FG000|NOT COMPLETED|Screen||4
11075085|NCT01090063|12257035|FG000|STARTED|Treatment||24
11075086|NCT01090063|12257035|FG000|COMPLETED|Treatment||20
11075087|NCT01090063|12257035|FG000|NOT COMPLETED|Treatment||4
11075088|NCT01090076|12257051|FG000|STARTED|Overall Study||12
11347808|NCT02992288|12544764|FG001|NOT COMPLETED|Overall Study||5
11347809|NCT02992288|12544765|FG002|NOT COMPLETED|Overall Study||7
11347810|NCT02992288|12544766|FG003|NOT COMPLETED|Overall Study||9
11347811|NCT02992288|12544767|FG004|NOT COMPLETED|Overall Study||8
11347812|NCT02992288|12544768|FG005|NOT COMPLETED|Overall Study||13
11347813|NCT02992691|12544782|FG000|STARTED|Overall Study||56
11347814|NCT02992691|12544782|FG000|Received Test Product 1|Overall Study||55
11347815|NCT02992691|12544782|FG000|Received Test Product 2|Overall Study||55
11347816|NCT02992691|12544782|FG000|Received Test Product 3|Overall Study||52
11347817|NCT02992691|12544782|FG000|Received Positive Control|Overall Study||55
11347818|NCT02992691|12544782|FG000|Received Negative Control|Overall Study||55
11347819|NCT02992691|12544782|FG000|COMPLETED|Overall Study||53
11347820|NCT02992691|12544782|FG000|NOT COMPLETED|Overall Study||3
11347821|NCT02992899|12544799|FG000|STARTED|Overall Study||27
11347822|NCT02992899|12544800|FG001|STARTED|Overall Study||29
11347823|NCT02992899|12544799|FG000|COMPLETED|Overall Study||25
11347824|NCT02992899|12544800|FG001|COMPLETED|Overall Study||26
11347825|NCT02992899|12544799|FG000|NOT COMPLETED|Overall Study||2
11347826|NCT02992899|12544800|FG001|NOT COMPLETED|Overall Study||3
11347827|NCT02993224|12544806|FG000|STARTED|Core Phase - Period 1||148
11347828|NCT02993224|12544806|FG000|COMPLETED|Core Phase - Period 1||140
11347829|NCT02993224|12544806|FG000|NOT COMPLETED|Core Phase - Period 1||8
11347830|NCT02993224|12544806|FG000|STARTED|Core Phase- Period 2||140
11347831|NCT02993224|12544806|FG000|COMPLETED|Core Phase- Period 2||136
11347832|NCT02993224|12544806|FG000|NOT COMPLETED|Core Phase- Period 2||4
11347833|NCT02993224|12544806|FG000|STARTED|Extension Phase||116
11347834|NCT02993224|12544806|FG000|COMPLETED|Extension Phase||80
11347835|NCT02993224|12544806|FG000|NOT COMPLETED|Extension Phase||36
11347836|NCT02993250|12544814|FG000|STARTED|Overall Study||22
11347837|NCT02993250|12544815|FG001|STARTED|Overall Study||11
11347838|NCT02993250|12544814|FG000|COMPLETED|Overall Study||22
11347839|NCT02993250|12544815|FG001|COMPLETED|Overall Study||10
11347840|NCT02993250|12544814|FG000|NOT COMPLETED|Overall Study||0
11347841|NCT02993250|12544815|FG001|NOT COMPLETED|Overall Study||1
11347842|NCT02993302|12544823|FG000|STARTED|Overall Study||13
11347843|NCT02993302|12544824|FG001|STARTED|Overall Study||12
11347844|NCT02993302|12544823|FG000|COMPLETED|Overall Study||13
11347845|NCT02993302|12544824|FG001|COMPLETED|Overall Study||12
11075089|NCT01090076|12257052|FG001|STARTED|Overall Study||14
11075090|NCT01090076|12257051|FG000|COMPLETED|Overall Study||11
11347846|NCT02993302|12544823|FG000|NOT COMPLETED|Overall Study||0
11347847|NCT02993302|12544824|FG001|NOT COMPLETED|Overall Study||0
11075091|NCT01090076|12257052|FG001|COMPLETED|Overall Study||12
11347848|NCT02993445|12544832|FG000|STARTED|First Intervention (5 Minutes)||6
11347849|NCT02993445|12544833|FG001|STARTED|First Intervention (5 Minutes)||5
11347850|NCT02993445|12544832|FG000|COMPLETED|First Intervention (5 Minutes)||6
11347851|NCT02993445|12544833|FG001|COMPLETED|First Intervention (5 Minutes)||5
11347852|NCT02993445|12544832|FG000|NOT COMPLETED|First Intervention (5 Minutes)||0
11347853|NCT02993445|12544833|FG001|NOT COMPLETED|First Intervention (5 Minutes)||0
11347854|NCT02993445|12544832|FG000|STARTED|Washout (2 Weeks)||6
11347855|NCT02993445|12544833|FG001|STARTED|Washout (2 Weeks)||5
11347856|NCT02993445|12544832|FG000|COMPLETED|Washout (2 Weeks)||6
11347857|NCT02993445|12544833|FG001|COMPLETED|Washout (2 Weeks)||5
11347858|NCT02993445|12544832|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11347859|NCT02993445|12544833|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11347860|NCT02993445|12544832|FG000|STARTED|Second Intervention (5 Mins)||6
11347861|NCT02993445|12544833|FG001|STARTED|Second Intervention (5 Mins)||5
11347862|NCT02993445|12544832|FG000|COMPLETED|Second Intervention (5 Mins)||6
11347863|NCT02993445|12544833|FG001|COMPLETED|Second Intervention (5 Mins)||5
11075092|NCT01090076|12257051|FG000|NOT COMPLETED|Overall Study||1
11075093|NCT01090076|12257052|FG001|NOT COMPLETED|Overall Study||2
11075094|NCT01090102|12257062|FG000|STARTED|First 12 Weeks||15
11075095|NCT01090102|12257063|FG001|STARTED|First 12 Weeks||18
11075096|NCT01090102|12257062|FG000|COMPLETED|First 12 Weeks||11
11075097|NCT01090102|12257063|FG001|COMPLETED|First 12 Weeks||16
11075098|NCT01090102|12257062|FG000|NOT COMPLETED|First 12 Weeks||4
11347864|NCT02993445|12544832|FG000|NOT COMPLETED|Second Intervention (5 Mins)||0
11347865|NCT02993445|12544833|FG001|NOT COMPLETED|Second Intervention (5 Mins)||0
11347866|NCT02993471|12544839|FG000|STARTED|Period 1 (Drug Cocktail)||28
11347867|NCT02993471|12544839|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28
11347868|NCT02993471|12544839|FG000|COMPLETED|Period 1 (Drug Cocktail)||28
11347869|NCT02993471|12544839|FG000|NOT COMPLETED|Period 1 (Drug Cocktail)||0
11347870|NCT02993471|12544839|FG000|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28
11347871|NCT02993471|12544839|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27
11347872|NCT02993471|12544839|FG000|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26
11347873|NCT02993471|12544839|FG000|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2
11347874|NCT02993783|12544863|FG000|STARTED|Overall Study||8
11075099|NCT01090102|12257063|FG001|NOT COMPLETED|First 12 Weeks||2
11075100|NCT01090102|12257062|FG000|STARTED|Second 12 Weeks||11
11075101|NCT01090102|12257063|FG001|STARTED|Second 12 Weeks||16
11075102|NCT01090102|12257062|FG000|COMPLETED|Second 12 Weeks||11
11075103|NCT01090102|12257063|FG001|COMPLETED|Second 12 Weeks||15
11075104|NCT01090102|12257062|FG000|NOT COMPLETED|Second 12 Weeks||0
11075105|NCT01090102|12257063|FG001|NOT COMPLETED|Second 12 Weeks||1
11075106|NCT01090180|12257071|FG000|STARTED|Overall Study||33
11075107|NCT01090180|12257072|FG001|STARTED|Overall Study||29
11075108|NCT01090180|12257071|FG000|COMPLETED|Overall Study||22
11075109|NCT01090180|12257072|FG001|COMPLETED|Overall Study||21
11075110|NCT01090180|12257071|FG000|NOT COMPLETED|Overall Study||11
11075111|NCT01090180|12257072|FG001|NOT COMPLETED|Overall Study||8
11075112|NCT01090310|12257082|FG000|STARTED|Core Study||29
11075113|NCT01090310|12257083|FG001|STARTED|Core Study||31
11075114|NCT01090310|12257084|FG002|STARTED|Core Study||31
11075115|NCT01090310|12257085|FG003|STARTED|Core Study||34
11075116|NCT01090310|12257082|FG000|COMPLETED|Core Study||21
11075117|NCT01090310|12257083|FG001|COMPLETED|Core Study||20
11075118|NCT01090310|12257084|FG002|COMPLETED|Core Study||24
11075119|NCT01090310|12257085|FG003|COMPLETED|Core Study||27
11075120|NCT01090310|12257082|FG000|NOT COMPLETED|Core Study||8
11075121|NCT01090310|12257083|FG001|NOT COMPLETED|Core Study||11
11075122|NCT01090310|12257084|FG002|NOT COMPLETED|Core Study||7
11075123|NCT01090310|12257085|FG003|NOT COMPLETED|Core Study||7
11075124|NCT01090310|12257082|FG000|STARTED|Extension Study||17
11075125|NCT01090310|12257083|FG001|STARTED|Extension Study||16
11075126|NCT01090310|12257084|FG002|STARTED|Extension Study||16
11075127|NCT01090310|12257085|FG003|STARTED|Extension Study||21
11075128|NCT01090310|12257082|FG000|COMPLETED|Extension Study||3
11075129|NCT01090310|12257083|FG001|COMPLETED|Extension Study||0
11075130|NCT01090310|12257084|FG002|COMPLETED|Extension Study||1
11075131|NCT01090310|12257085|FG003|COMPLETED|Extension Study||1
11075132|NCT01090310|12257082|FG000|NOT COMPLETED|Extension Study||14
11075133|NCT01090310|12257083|FG001|NOT COMPLETED|Extension Study||16
11075134|NCT01090310|12257084|FG002|NOT COMPLETED|Extension Study||15
11075135|NCT01090310|12257085|FG003|NOT COMPLETED|Extension Study||20
11075136|NCT01090323|12257097|FG000|STARTED|Overall Study||132
11075137|NCT01090323|12257098|FG001|STARTED|Overall Study||53
11075138|NCT01090323|12257097|FG000|COMPLETED|Overall Study||43
11075139|NCT01090323|12257098|FG001|COMPLETED|Overall Study||19
11075140|NCT01090323|12257097|FG000|NOT COMPLETED|Overall Study||89
11075141|NCT01090323|12257098|FG001|NOT COMPLETED|Overall Study||34
11075142|NCT01090414|12257108|FG000|STARTED|Parent Studies||191
11075143|NCT01090414|12257109|FG001|STARTED|Parent Studies||241
11075144|NCT01090414|12257110|FG002|STARTED|Parent Studies||64
11075145|NCT01090414|12257111|FG003|STARTED|Parent Studies||18
11075146|NCT01090414|12257108|FG000|COMPLETED|Parent Studies||50
11075147|NCT01090414|12257109|FG001|COMPLETED|Parent Studies||114
11075148|NCT01090414|12257110|FG002|COMPLETED|Parent Studies||43
11075149|NCT01090414|12257111|FG003|COMPLETED|Parent Studies||5
11075150|NCT01090414|12257108|FG000|NOT COMPLETED|Parent Studies||141
11075151|NCT01090414|12257109|FG001|NOT COMPLETED|Parent Studies||127
11075152|NCT01090414|12257110|FG002|NOT COMPLETED|Parent Studies||21
11075153|NCT01090414|12257111|FG003|NOT COMPLETED|Parent Studies||13
11075154|NCT01090414|12257108|FG000|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48
11075155|NCT01090414|12257109|FG001|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108
11075156|NCT01090414|12257110|FG002|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41
11347875|NCT02993783|12544864|FG001|STARTED|Overall Study||9
11347876|NCT02993783|12544863|FG000|COMPLETED|Overall Study||2
11347877|NCT02993783|12544864|FG001|COMPLETED|Overall Study||0
11347878|NCT02993783|12544863|FG000|NOT COMPLETED|Overall Study||6
11347879|NCT02993783|12544864|FG001|NOT COMPLETED|Overall Study||9
11347880|NCT02994056|12544870|FG000|STARTED|Overall Study||32
11347881|NCT02994056|12544870|FG000|COMPLETED|Overall Study||23
11075157|NCT01090414|12257111|FG003|STARTED|Study 101-99||5
11075158|NCT01090414|12257108|FG000|COMPLETED|Study 101-99||0
11075159|NCT01090414|12257109|FG001|COMPLETED|Study 101-99||0
11075160|NCT01090414|12257110|FG002|COMPLETED|Study 101-99||0
11075161|NCT01090414|12257111|FG003|COMPLETED|Study 101-99||0
11075162|NCT01090414|12257108|FG000|NOT COMPLETED|Study 101-99||48
11075163|NCT01090414|12257109|FG001|NOT COMPLETED|Study 101-99||108
11075164|NCT01090414|12257110|FG002|NOT COMPLETED|Study 101-99||41
11075165|NCT01090414|12257111|FG003|NOT COMPLETED|Study 101-99||5
11075166|NCT01090427|12257136|FG000|STARTED|Controlled Period||37
11075167|NCT01090427|12257137|FG001|STARTED|Controlled Period||37
11075168|NCT01090427|12257138|FG002|STARTED|Controlled Period||36
11075169|NCT01090427|12257139|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
11075170|NCT01090427|12257140|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
11347882|NCT02994056|12544870|FG000|NOT COMPLETED|Overall Study||9
11347883|NCT02994108|12544885|FG000|STARTED|Intervention Messages||74
11347884|NCT02994108|12544886|FG001|STARTED|Intervention Messages||76
11075171|NCT01090427|12257141|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
11075172|NCT01090427|12257142|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
11075173|NCT01090427|12257136|FG000|COMPLETED|Controlled Period||37
11075174|NCT01090427|12257137|FG001|COMPLETED|Controlled Period||37
11075175|NCT01090427|12257138|FG002|COMPLETED|Controlled Period||36
11075176|NCT01090427|12257139|FG003|COMPLETED|Controlled Period||0
11075177|NCT01090427|12257140|FG004|COMPLETED|Controlled Period||0
11075178|NCT01090427|12257141|FG005|COMPLETED|Controlled Period||0
11075179|NCT01090427|12257142|FG006|COMPLETED|Controlled Period||0
11075180|NCT01090427|12257136|FG000|NOT COMPLETED|Controlled Period||0
11075181|NCT01090427|12257137|FG001|NOT COMPLETED|Controlled Period||0
11075182|NCT01090427|12257138|FG002|NOT COMPLETED|Controlled Period||0
11075183|NCT01090427|12257139|FG003|NOT COMPLETED|Controlled Period||0
11075184|NCT01090427|12257140|FG004|NOT COMPLETED|Controlled Period||0
11075185|NCT01090427|12257141|FG005|NOT COMPLETED|Controlled Period||0
11075186|NCT01090427|12257142|FG006|NOT COMPLETED|Controlled Period||0
11075187|NCT01090427|12257136|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
11075188|NCT01090427|12257137|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
11075189|NCT01090427|12257138|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
11075190|NCT01090427|12257139|FG003|STARTED|After Controlled Period||19
11075191|NCT01090427|12257140|FG004|STARTED|After Controlled Period||18
11075192|NCT01090427|12257141|FG005|STARTED|After Controlled Period||37
11075193|NCT01090427|12257142|FG006|STARTED|After Controlled Period||36
11075194|NCT01090427|12257136|FG000|COMPLETED|After Controlled Period||0
11075195|NCT01090427|12257137|FG001|COMPLETED|After Controlled Period||0
11075196|NCT01090427|12257138|FG002|COMPLETED|After Controlled Period||0
11075197|NCT01090427|12257139|FG003|COMPLETED|After Controlled Period||17
11075198|NCT01090427|12257140|FG004|COMPLETED|After Controlled Period||18
11075199|NCT01090427|12257141|FG005|COMPLETED|After Controlled Period||32
11075200|NCT01090427|12257142|FG006|COMPLETED|After Controlled Period||34
11075201|NCT01090427|12257136|FG000|NOT COMPLETED|After Controlled Period||0
11075202|NCT01090427|12257137|FG001|NOT COMPLETED|After Controlled Period||0
11075203|NCT01090427|12257138|FG002|NOT COMPLETED|After Controlled Period||0
11075204|NCT01090427|12257139|FG003|NOT COMPLETED|After Controlled Period||2
11075205|NCT01090427|12257140|FG004|NOT COMPLETED|After Controlled Period||0
11075206|NCT01090427|12257141|FG005|NOT COMPLETED|After Controlled Period||5
11075207|NCT01090427|12257142|FG006|NOT COMPLETED|After Controlled Period||2
11075208|NCT01090453|12257156|FG000|STARTED|Overall Study||238
11075209|NCT01090453|12257157|FG001|STARTED|Overall Study||242
11075210|NCT01090453|12257156|FG000|COMPLETED|Overall Study||225
11075211|NCT01090453|12257157|FG001|COMPLETED|Overall Study||228
11075212|NCT01090453|12257156|FG000|NOT COMPLETED|Overall Study||13
11347885|NCT02994108|12544885|FG000|COMPLETED|Intervention Messages||72
11347886|NCT02994108|12544886|FG001|COMPLETED|Intervention Messages||76
11347887|NCT02994108|12544885|FG000|NOT COMPLETED|Intervention Messages||2
11347888|NCT02994108|12544886|FG001|NOT COMPLETED|Intervention Messages||0
11347889|NCT02994108|12544885|FG000|STARTED|Phase 1 Assessment||72
11347890|NCT02994108|12544886|FG001|STARTED|Phase 1 Assessment||76
11347891|NCT02994108|12544885|FG000|COMPLETED|Phase 1 Assessment||67
11347892|NCT02994108|12544886|FG001|COMPLETED|Phase 1 Assessment||73
11347893|NCT02994108|12544885|FG000|NOT COMPLETED|Phase 1 Assessment||5
11347894|NCT02994108|12544886|FG001|NOT COMPLETED|Phase 1 Assessment||3
11347895|NCT02994108|12544885|FG000|STARTED|Phase 2 Assessment||72
11347896|NCT02994108|12544886|FG001|STARTED|Phase 2 Assessment||76
11347897|NCT02994108|12544885|FG000|COMPLETED|Phase 2 Assessment||63
11347898|NCT02994108|12544886|FG001|COMPLETED|Phase 2 Assessment||69
11347899|NCT02994108|12544885|FG000|NOT COMPLETED|Phase 2 Assessment||9
11075213|NCT01090453|12257157|FG001|NOT COMPLETED|Overall Study||14
11075214|NCT01090479|12257165|FG000|STARTED|Overall Study||50
11075215|NCT01090479|12257166|FG001|STARTED|Overall Study||50
11075216|NCT01090479|12257165|FG000|COMPLETED|Overall Study||50
11075217|NCT01090479|12257166|FG001|COMPLETED|Overall Study||50
11075218|NCT01090479|12257165|FG000|NOT COMPLETED|Overall Study||0
11075219|NCT01090479|12257166|FG001|NOT COMPLETED|Overall Study||0
11075220|NCT01090492|12257180|FG000|STARTED|First Intervention Period (4 Weeks)||27
11075221|NCT01090492|12257181|FG001|STARTED|First Intervention Period (4 Weeks)||29
11075222|NCT01090492|12257182|FG002|STARTED|First Intervention Period (4 Weeks)||29
11075223|NCT01090492|12257183|FG003|STARTED|First Intervention Period (4 Weeks)||28
11075224|NCT01090492|12257184|FG004|STARTED|First Intervention Period (4 Weeks)||33
11075225|NCT01090492|12257185|FG005|STARTED|First Intervention Period (4 Weeks)||32
11075226|NCT01090492|12257186|FG006|STARTED|First Intervention Period (4 Weeks)||32
11075227|NCT01090492|12257187|FG007|STARTED|First Intervention Period (4 Weeks)||33
11075228|NCT01090492|12257180|FG000|COMPLETED|First Intervention Period (4 Weeks)||26
11075229|NCT01090492|12257181|FG001|COMPLETED|First Intervention Period (4 Weeks)||24
11075230|NCT01090492|12257182|FG002|COMPLETED|First Intervention Period (4 Weeks)||26
11075231|NCT01090492|12257183|FG003|COMPLETED|First Intervention Period (4 Weeks)||22
11075232|NCT01090492|12257184|FG004|COMPLETED|First Intervention Period (4 Weeks)||29
11347900|NCT02994108|12544886|FG001|NOT COMPLETED|Phase 2 Assessment||7
11075233|NCT01090492|12257185|FG005|COMPLETED|First Intervention Period (4 Weeks)||30
11075234|NCT01090492|12257186|FG006|COMPLETED|First Intervention Period (4 Weeks)||31
11347901|NCT02994238|12544895|FG000|STARTED|Overall Study||125
11075235|NCT01090492|12257187|FG007|COMPLETED|First Intervention Period (4 Weeks)||27
11075236|NCT01090492|12257180|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||1
11075237|NCT01090492|12257181|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||5
11075238|NCT01090492|12257182|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||3
11075239|NCT01090492|12257183|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||6
11075240|NCT01090492|12257184|FG004|NOT COMPLETED|First Intervention Period (4 Weeks)||4
11075241|NCT01090492|12257185|FG005|NOT COMPLETED|First Intervention Period (4 Weeks)||2
11075242|NCT01090492|12257186|FG006|NOT COMPLETED|First Intervention Period (4 Weeks)||1
11075243|NCT01090492|12257187|FG007|NOT COMPLETED|First Intervention Period (4 Weeks)||6
11075244|NCT01090492|12257180|FG000|STARTED|Placebo Washout Period ( 2 Weeks)||26
11075245|NCT01090492|12257181|FG001|STARTED|Placebo Washout Period ( 2 Weeks)||24
11075246|NCT01090492|12257182|FG002|STARTED|Placebo Washout Period ( 2 Weeks)||26
11075247|NCT01090492|12257183|FG003|STARTED|Placebo Washout Period ( 2 Weeks)||22
11075248|NCT01090492|12257184|FG004|STARTED|Placebo Washout Period ( 2 Weeks)||29
11075249|NCT01090492|12257185|FG005|STARTED|Placebo Washout Period ( 2 Weeks)||30
11075250|NCT01090492|12257186|FG006|STARTED|Placebo Washout Period ( 2 Weeks)||31
11075251|NCT01090492|12257187|FG007|STARTED|Placebo Washout Period ( 2 Weeks)||27
11075252|NCT01090492|12257180|FG000|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
11075253|NCT01090492|12257181|FG001|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
11075254|NCT01090492|12257182|FG002|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
11075255|NCT01090492|12257183|FG003|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
11075256|NCT01090492|12257184|FG004|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
11075257|NCT01090492|12257185|FG005|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
11075258|NCT01090492|12257186|FG006|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
11075259|NCT01090492|12257187|FG007|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
11075260|NCT01090492|12257180|FG000|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
11075261|NCT01090492|12257181|FG001|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
11075262|NCT01090492|12257182|FG002|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
11075263|NCT01090492|12257183|FG003|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
11075264|NCT01090492|12257184|FG004|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
11075265|NCT01090492|12257185|FG005|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
11075266|NCT01090492|12257186|FG006|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
11075267|NCT01090492|12257187|FG007|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
11075268|NCT01090492|12257180|FG000|STARTED|Second Intervention Period (4 Weeks)||26
11075269|NCT01090492|12257181|FG001|STARTED|Second Intervention Period (4 Weeks)||24
11075270|NCT01090492|12257182|FG002|STARTED|Second Intervention Period (4 Weeks)||26
11075271|NCT01090492|12257183|FG003|STARTED|Second Intervention Period (4 Weeks)||22
11075272|NCT01090492|12257184|FG004|STARTED|Second Intervention Period (4 Weeks)||29
11075273|NCT01090492|12257185|FG005|STARTED|Second Intervention Period (4 Weeks)||30
11075274|NCT01090492|12257186|FG006|STARTED|Second Intervention Period (4 Weeks)||31
11075275|NCT01090492|12257187|FG007|STARTED|Second Intervention Period (4 Weeks)||27
11075276|NCT01090492|12257180|FG000|COMPLETED|Second Intervention Period (4 Weeks)||25
11075277|NCT01090492|12257181|FG001|COMPLETED|Second Intervention Period (4 Weeks)||22
11075278|NCT01090492|12257182|FG002|COMPLETED|Second Intervention Period (4 Weeks)||24
11075279|NCT01090492|12257183|FG003|COMPLETED|Second Intervention Period (4 Weeks)||22
11075280|NCT01090492|12257184|FG004|COMPLETED|Second Intervention Period (4 Weeks)||27
11075281|NCT01090492|12257185|FG005|COMPLETED|Second Intervention Period (4 Weeks)||29
11075282|NCT01090492|12257186|FG006|COMPLETED|Second Intervention Period (4 Weeks)||22
11075283|NCT01090492|12257187|FG007|COMPLETED|Second Intervention Period (4 Weeks)||25
11075284|NCT01090492|12257180|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
11075285|NCT01090492|12257181|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
11075286|NCT01090492|12257182|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
11075287|NCT01090492|12257183|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
11075288|NCT01090492|12257184|FG004|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
11075289|NCT01090492|12257185|FG005|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
11075290|NCT01090492|12257186|FG006|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
11075291|NCT01090492|12257187|FG007|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
11075292|NCT01090739|12257206|FG000|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
11075293|NCT01090739|12257206|FG000|COMPLETED|Enrollment||152
11075294|NCT01090739|12257206|FG000|NOT COMPLETED|Enrollment||55
11075295|NCT01090739|12257206|FG000|STARTED|12 Month Follow-up||152
11075296|NCT01090739|12257206|FG000|COMPLETED|12 Month Follow-up||147
11075297|NCT01090739|12257206|FG000|NOT COMPLETED|12 Month Follow-up||5
11075298|NCT01090739|12257206|FG000|STARTED|24 Month Follow-up||147
11075299|NCT01090739|12257206|FG000|COMPLETED|24 Month Follow-up||138
11075300|NCT01090739|12257206|FG000|NOT COMPLETED|24 Month Follow-up||9
11075301|NCT01090739|12257206|FG000|STARTED|36 Month Follow-up||138
11075302|NCT01090739|12257206|FG000|COMPLETED|36 Month Follow-up||115
11075303|NCT01090739|12257206|FG000|NOT COMPLETED|36 Month Follow-up||23
11075304|NCT01090752|12257213|FG000|STARTED|Overall Study||8
11075305|NCT01090752|12257214|FG001|STARTED|Overall Study||8
11075306|NCT01090752|12257213|FG000|COMPLETED|Overall Study||8
11075307|NCT01090752|12257214|FG001|COMPLETED|Overall Study||8
11075308|NCT01090752|12257213|FG000|NOT COMPLETED|Overall Study||0
11075309|NCT01090752|12257214|FG001|NOT COMPLETED|Overall Study||0
11075310|NCT01090765|12257226|FG000|STARTED|Overall Study||3
11075311|NCT01090765|12257227|FG001|STARTED|Overall Study||3
11075312|NCT01090765|12257228|FG002|STARTED|Overall Study||3
11075313|NCT01090765|12257229|FG003|STARTED|Overall Study||2
11075314|NCT01090765|12257230|FG004|STARTED|Overall Study||6
11075315|NCT01090765|12257231|FG005|STARTED|Overall Study||4
11075316|NCT01090765|12257226|FG000|COMPLETED|Overall Study||3
11075317|NCT01090765|12257227|FG001|COMPLETED|Overall Study||3
11075318|NCT01090765|12257228|FG002|COMPLETED|Overall Study||3
11075319|NCT01090765|12257229|FG003|COMPLETED|Overall Study||1
11075320|NCT01090765|12257230|FG004|COMPLETED|Overall Study||4
11075321|NCT01090765|12257231|FG005|COMPLETED|Overall Study||3
11075322|NCT01090765|12257226|FG000|NOT COMPLETED|Overall Study||0
11075323|NCT01090765|12257227|FG001|NOT COMPLETED|Overall Study||0
11075324|NCT01090765|12257228|FG002|NOT COMPLETED|Overall Study||0
11075325|NCT01090765|12257229|FG003|NOT COMPLETED|Overall Study||1
11075326|NCT01090765|12257230|FG004|NOT COMPLETED|Overall Study||2
11075327|NCT01090765|12257231|FG005|NOT COMPLETED|Overall Study||1
11075328|NCT01090921|12257246|FG000|STARTED|Overall Study||50
11075329|NCT01090921|12257246|FG000|COMPLETED|Overall Study||23
11075330|NCT01090921|12257246|FG000|NOT COMPLETED|Overall Study||27
11075331|NCT01090973|12257250|FG000|STARTED|Overall Study||1
11075332|NCT01090973|12257250|FG000|COMPLETED|Overall Study||0
11075333|NCT01090973|12257250|FG000|NOT COMPLETED|Overall Study||1
11075334|NCT01091103|12257254|FG000|STARTED|Overall Study||60
11075335|NCT01091103|12257254|FG000|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
11075336|NCT01091103|12257254|FG000|NOT COMPLETED|Overall Study||4
11075337|NCT01091116|12257265|FG000|STARTED|Overall Study||83
11075338|NCT01091116|12257266|FG001|STARTED|Overall Study||88
11075339|NCT01091116|12257267|FG002|STARTED|Overall Study||84
11075340|NCT01091116|12257268|FG003|STARTED|Overall Study||84
11075341|NCT01091116|12257269|FG004|STARTED|Overall Study||84
11075342|NCT01091116|12257265|FG000|COMPLETED|Overall Study||77
11075343|NCT01091116|12257266|FG001|COMPLETED|Overall Study||80
11075344|NCT01091116|12257267|FG002|COMPLETED|Overall Study||73
11347902|NCT02994238|12544896|FG001|STARTED|Overall Study||127
11347903|NCT02994238|12544895|FG000|COMPLETED|Overall Study||125
11075345|NCT01091116|12257268|FG003|COMPLETED|Overall Study||80
11075346|NCT01091116|12257269|FG004|COMPLETED|Overall Study||73
11075347|NCT01091116|12257265|FG000|NOT COMPLETED|Overall Study||6
11075348|NCT01091116|12257266|FG001|NOT COMPLETED|Overall Study||8
11075349|NCT01091116|12257267|FG002|NOT COMPLETED|Overall Study||11
11075350|NCT01091116|12257268|FG003|NOT COMPLETED|Overall Study||4
11075351|NCT01091116|12257269|FG004|NOT COMPLETED|Overall Study||11
11075352|NCT01091155|12257281|FG000|STARTED|Overall Study||288
11075353|NCT01091155|12257281|FG000|COMPLETED|Overall Study||279
11075354|NCT01091155|12257281|FG000|NOT COMPLETED|Overall Study||9
11347904|NCT02994238|12544896|FG001|COMPLETED|Overall Study||127
11347905|NCT02994238|12544895|FG000|NOT COMPLETED|Overall Study||0
11347906|NCT02994238|12544896|FG001|NOT COMPLETED|Overall Study||0
11347907|NCT02994394|12544904|FG000|STARTED|Period 1 (Days 1 to 3)||14
11347908|NCT02994394|12544905|FG001|STARTED|Period 1 (Days 1 to 3)||14
11347909|NCT02994394|12544906|FG002|STARTED|Period 1 (Days 1 to 3)||14
11347910|NCT02994394|12544907|FG003|STARTED|Period 1 (Days 1 to 3)||14
11347911|NCT02994394|12544908|FG004|STARTED|Period 1 (Days 1 to 3)||14
11347912|NCT02994394|12544909|FG005|STARTED|Period 1 (Days 1 to 3)||14
11347913|NCT02994394|12544904|FG000|COMPLETED|Period 1 (Days 1 to 3)||14
11347914|NCT02994394|12544905|FG001|COMPLETED|Period 1 (Days 1 to 3)||14
11347915|NCT02994394|12544906|FG002|COMPLETED|Period 1 (Days 1 to 3)||13
11347916|NCT02994394|12544907|FG003|COMPLETED|Period 1 (Days 1 to 3)||14
11347917|NCT02994394|12544908|FG004|COMPLETED|Period 1 (Days 1 to 3)||14
11347918|NCT02994394|12544909|FG005|COMPLETED|Period 1 (Days 1 to 3)||14
11347919|NCT02994394|12544904|FG000|NOT COMPLETED|Period 1 (Days 1 to 3)||0
11347920|NCT02994394|12544905|FG001|NOT COMPLETED|Period 1 (Days 1 to 3)||0
11347921|NCT02994394|12544906|FG002|NOT COMPLETED|Period 1 (Days 1 to 3)||1
11347922|NCT02994394|12544907|FG003|NOT COMPLETED|Period 1 (Days 1 to 3)||0
11347923|NCT02994394|12544908|FG004|NOT COMPLETED|Period 1 (Days 1 to 3)||0
11347924|NCT02994394|12544909|FG005|NOT COMPLETED|Period 1 (Days 1 to 3)||0
11347925|NCT02994394|12544904|FG000|STARTED|Period 2 (Days 4 to 6)||14
11075355|NCT01091168|12257287|FG000|STARTED|Overall Study||298
11075356|NCT01091168|12257288|FG001|STARTED|Overall Study||296
11075357|NCT01091168|12257287|FG000|COMPLETED|Overall Study||0
11075358|NCT01091168|12257288|FG001|COMPLETED|Overall Study||0
11075359|NCT01091168|12257287|FG000|NOT COMPLETED|Overall Study||298
11075360|NCT01091168|12257288|FG001|NOT COMPLETED|Overall Study||296
11075361|NCT01091246|12257297|FG000|STARTED|Overall Study||1385
11075362|NCT01091246|12257298|FG001|STARTED|Overall Study||464
11075363|NCT01091246|12257299|FG002|STARTED|Overall Study||463
11075364|NCT01091246|12257297|FG000|COMPLETED|Overall Study||1350
11075365|NCT01091246|12257298|FG001|COMPLETED|Overall Study||448
11075366|NCT01091246|12257299|FG002|COMPLETED|Overall Study||450
11075367|NCT01091246|12257297|FG000|NOT COMPLETED|Overall Study||35
11075368|NCT01091246|12257298|FG001|NOT COMPLETED|Overall Study||16
11075369|NCT01091246|12257299|FG002|NOT COMPLETED|Overall Study||13
11075370|NCT01091259|12257309|FG000|STARTED|Overall Study||29
11075371|NCT01091259|12257309|FG000|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
11075372|NCT01091259|12257309|FG000|NOT COMPLETED|Overall Study||5
11075373|NCT01091363|12257315|FG000|STARTED|Overall Study||55
11075374|NCT01091363|12257316|FG001|STARTED|Overall Study||54
11075375|NCT01091363|12257315|FG000|COMPLETED|Overall Study||42
11075376|NCT01091363|12257316|FG001|COMPLETED|Overall Study||37
11075377|NCT01091363|12257315|FG000|NOT COMPLETED|Overall Study||13
11075378|NCT01091363|12257316|FG001|NOT COMPLETED|Overall Study||17
11075379|NCT01091428|12257326|FG000|STARTED|Phase 1||38
11075380|NCT01091428|12257327|FG001|STARTED|Phase 1||11
11075381|NCT01091428|12257328|FG002|STARTED|Phase 1||0
11075382|NCT01091428|12257329|FG003|STARTED|Phase 1||0
11075383|NCT01091428|12257326|FG000|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
11075384|NCT01091428|12257327|FG001|COMPLETED|Phase 1||0
11075385|NCT01091428|12257328|FG002|COMPLETED|Phase 1||0
11075386|NCT01091428|12257329|FG003|COMPLETED|Phase 1||0
11075387|NCT01091428|12257326|FG000|NOT COMPLETED|Phase 1||38
11075388|NCT01091428|12257327|FG001|NOT COMPLETED|Phase 1||11
11075389|NCT01091428|12257328|FG002|NOT COMPLETED|Phase 1||0
11075390|NCT01091428|12257329|FG003|NOT COMPLETED|Phase 1||0
11075391|NCT01091428|12257326|FG000|STARTED|Phase 2||0
11075392|NCT01091428|12257327|FG001|STARTED|Phase 2||0
11075393|NCT01091428|12257328|FG002|STARTED|Phase 2||73
11075394|NCT01091428|12257329|FG003|STARTED|Phase 2||69
11075395|NCT01091428|12257326|FG000|COMPLETED|Phase 2||0
11075396|NCT01091428|12257327|FG001|COMPLETED|Phase 2||0
11075397|NCT01091428|12257328|FG002|COMPLETED|Phase 2||0
11075398|NCT01091428|12257329|FG003|COMPLETED|Phase 2||0
11075399|NCT01091428|12257326|FG000|NOT COMPLETED|Phase 2||0
11075400|NCT01091428|12257327|FG001|NOT COMPLETED|Phase 2||0
11075401|NCT01091428|12257328|FG002|NOT COMPLETED|Phase 2||73
11075402|NCT01091428|12257329|FG003|NOT COMPLETED|Phase 2||69
11075403|NCT01091454|12257348|FG000|STARTED|Overall Study||48
11075404|NCT01091454|12257348|FG000|COMPLETED|Overall Study||47
11075405|NCT01091454|12257348|FG000|NOT COMPLETED|Overall Study||1
11075406|NCT01091519|12257354|FG000|STARTED|Overall Study||346
11075407|NCT01091519|12257355|FG001|STARTED|Overall Study||435
11075408|NCT01091519|12257354|FG000|Treated|Overall Study||342
11075409|NCT01091519|12257355|FG001|Treated|Overall Study||431
11075410|NCT01091519|12257354|FG000|COMPLETED|Overall Study||291
11075411|NCT01091519|12257355|FG001|COMPLETED|Overall Study||362
11075412|NCT01091519|12257354|FG000|NOT COMPLETED|Overall Study||55
11075413|NCT01091519|12257355|FG001|NOT COMPLETED|Overall Study||73
11075414|NCT01091662|12257363|FG000|STARTED|Overall Study||58
11075415|NCT01091662|12257364|FG001|STARTED|Overall Study||114
11075416|NCT01091662|12257363|FG000|COMPLETED|Overall Study||41
11075417|NCT01091662|12257364|FG001|COMPLETED|Overall Study||80
11075418|NCT01091662|12257363|FG000|NOT COMPLETED|Overall Study||17
11075419|NCT01091662|12257364|FG001|NOT COMPLETED|Overall Study||34
11075420|NCT01091675|12257375|FG000|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
11075421|NCT01091675|12257375|FG000|COMPLETED|Overall Study||23
11075422|NCT01091675|12257375|FG000|NOT COMPLETED|Overall Study||34
11075423|NCT01091948|12257381|FG000|STARTED|Overall Study||37
11075424|NCT01091948|12257382|FG001|STARTED|Overall Study||38
11075425|NCT01091948|12257381|FG000|COMPLETED|Overall Study||37
11075426|NCT01091948|12257382|FG001|COMPLETED|Overall Study||38
11075427|NCT01091948|12257381|FG000|NOT COMPLETED|Overall Study||0
11075428|NCT01091948|12257382|FG001|NOT COMPLETED|Overall Study||0
11075429|NCT01091974|12257393|FG000|STARTED|Overall Study||24
11075430|NCT01091974|12257394|FG001|STARTED|Overall Study||23
11075431|NCT01091974|12257395|FG002|STARTED|Overall Study||25
11075432|NCT01091974|12257396|FG003|STARTED|Overall Study||24
11075433|NCT01091974|12257393|FG000|COMPLETED|Overall Study||19
11075434|NCT01091974|12257394|FG001|COMPLETED|Overall Study||18
11075435|NCT01091974|12257395|FG002|COMPLETED|Overall Study||19
11075436|NCT01091974|12257396|FG003|COMPLETED|Overall Study||17
11075437|NCT01091974|12257393|FG000|NOT COMPLETED|Overall Study||5
11075438|NCT01091974|12257394|FG001|NOT COMPLETED|Overall Study||5
11075439|NCT01091974|12257395|FG002|NOT COMPLETED|Overall Study||6
11075440|NCT01091974|12257396|FG003|NOT COMPLETED|Overall Study||7
11347926|NCT02994394|12544905|FG001|STARTED|Period 2 (Days 4 to 6)||14
11347927|NCT02994394|12544906|FG002|STARTED|Period 2 (Days 4 to 6)||13
11347928|NCT02994394|12544907|FG003|STARTED|Period 2 (Days 4 to 6)||14
11075441|NCT01092182|12257409|FG000|STARTED|Overall Study||15
11075442|NCT01092182|12257410|FG001|STARTED|Overall Study||98
11075443|NCT01092182|12257411|FG002|STARTED|Overall Study||81
11075444|NCT01092182|12257409|FG000|COMPLETED|Overall Study||14
11075445|NCT01092182|12257410|FG001|COMPLETED|Overall Study||80
11075446|NCT01092182|12257411|FG002|COMPLETED|Overall Study||53
11075447|NCT01092182|12257409|FG000|NOT COMPLETED|Overall Study||1
11075448|NCT01092182|12257410|FG001|NOT COMPLETED|Overall Study||18
11075449|NCT01092182|12257411|FG002|NOT COMPLETED|Overall Study||28
11075450|NCT01092195|12257422|FG000|STARTED|Overall Study||23
11075451|NCT01092195|12257423|FG001|STARTED|Overall Study||21
11075452|NCT01092195|12257424|FG002|STARTED|Overall Study||20
11075453|NCT01092195|12257422|FG000|COMPLETED|Overall Study||23
11075454|NCT01092195|12257423|FG001|COMPLETED|Overall Study||21
11075455|NCT01092195|12257424|FG002|COMPLETED|Overall Study||20
11075456|NCT01092195|12257422|FG000|NOT COMPLETED|Overall Study||0
11075457|NCT01092195|12257423|FG001|NOT COMPLETED|Overall Study||0
11075458|NCT01092195|12257424|FG002|NOT COMPLETED|Overall Study||0
11075459|NCT01092338|12257434|FG000|STARTED|Overall Study||22
11075460|NCT01092338|12257435|FG001|STARTED|Overall Study||22
11075461|NCT01092338|12257434|FG000|COMPLETED|Overall Study||21
11075462|NCT01092338|12257435|FG001|COMPLETED|Overall Study||21
11075463|NCT01092338|12257434|FG000|NOT COMPLETED|Overall Study||1
11075464|NCT01092338|12257435|FG001|NOT COMPLETED|Overall Study||1
11075465|NCT01092364|12257444|FG000|STARTED|Overall Study||122
11075466|NCT01092364|12257445|FG001|STARTED|Overall Study||120
11075467|NCT01092364|12257446|FG002|STARTED|Overall Study||123
11075468|NCT01092364|12257444|FG000|COMPLETED|Overall Study||104
11075469|NCT01092364|12257445|FG001|COMPLETED|Overall Study||104
11075470|NCT01092364|12257446|FG002|COMPLETED|Overall Study||105
11075471|NCT01092364|12257444|FG000|NOT COMPLETED|Overall Study||18
11075472|NCT01092364|12257445|FG001|NOT COMPLETED|Overall Study||16
11075473|NCT01092364|12257446|FG002|NOT COMPLETED|Overall Study||18
11075474|NCT01092416|12257454|FG000|STARTED|Enrollment||443
11075475|NCT01092416|12257454|FG000|COMPLETED|Enrollment||440
11075476|NCT01092416|12257454|FG000|NOT COMPLETED|Enrollment||3
11075477|NCT01092416|12257454|FG000|STARTED|30-Day Follow-up||440
11075478|NCT01092416|12257454|FG000|COMPLETED|30-Day Follow-up||430
11075479|NCT01092416|12257454|FG000|NOT COMPLETED|30-Day Follow-up||10
11075480|NCT01092416|12257454|FG000|STARTED|12-Month Follow-up||438
11075481|NCT01092416|12257454|FG000|COMPLETED|12-Month Follow-up||413
11075482|NCT01092416|12257454|FG000|NOT COMPLETED|12-Month Follow-up||25
11075483|NCT01092442|12257463|FG000|STARTED|Overall Study||80
11075484|NCT01092442|12257464|FG001|STARTED|Overall Study||60
11075485|NCT01092442|12257463|FG000|COMPLETED|Overall Study||80
11347929|NCT02994394|12544908|FG004|STARTED|Period 2 (Days 4 to 6)||14
11075486|NCT01092442|12257464|FG001|COMPLETED|Overall Study||60
11075487|NCT01092442|12257463|FG000|NOT COMPLETED|Overall Study||0
11075488|NCT01092442|12257464|FG001|NOT COMPLETED|Overall Study||0
11075489|NCT01092507|12257477|FG000|STARTED|Overall Study||149
11075490|NCT01092507|12257478|FG001|STARTED|Overall Study||150
11075491|NCT01092507|12257477|FG000|COMPLETED|Overall Study||147
11075492|NCT01092507|12257478|FG001|COMPLETED|Overall Study||150
11075493|NCT01092507|12257477|FG000|NOT COMPLETED|Overall Study||2
11075494|NCT01092507|12257478|FG001|NOT COMPLETED|Overall Study||0
11075495|NCT01092546|12257484|FG000|STARTED|Overall Study||16
11075496|NCT01092546|12257484|FG000|COMPLETED|Overall Study||12
11075497|NCT01092546|12257484|FG000|NOT COMPLETED|Overall Study||4
11075498|NCT01092559|12257488|FG000|STARTED|Overall Study||10
11075499|NCT01092559|12257488|FG000|COMPLETED|Overall Study||10
11075500|NCT01092559|12257488|FG000|NOT COMPLETED|Overall Study||0
11075501|NCT01092637|12257494|FG000|STARTED|Overall Study||145
11075502|NCT01092637|12257495|FG001|STARTED|Overall Study||135
11075503|NCT01092637|12257494|FG000|COMPLETED|Overall Study||98
11347930|NCT02994394|12544909|FG005|STARTED|Period 2 (Days 4 to 6)||14
11347931|NCT02994394|12544904|FG000|COMPLETED|Period 2 (Days 4 to 6)||14
11347932|NCT02994394|12544905|FG001|COMPLETED|Period 2 (Days 4 to 6)||13
11347933|NCT02994394|12544906|FG002|COMPLETED|Period 2 (Days 4 to 6)||13
11347934|NCT02994394|12544907|FG003|COMPLETED|Period 2 (Days 4 to 6)||14
11347935|NCT02994394|12544908|FG004|COMPLETED|Period 2 (Days 4 to 6)||13
11347936|NCT02994394|12544909|FG005|COMPLETED|Period 2 (Days 4 to 6)||14
11347937|NCT02994394|12544904|FG000|NOT COMPLETED|Period 2 (Days 4 to 6)||0
11347938|NCT02994394|12544905|FG001|NOT COMPLETED|Period 2 (Days 4 to 6)||1
11347939|NCT02994394|12544906|FG002|NOT COMPLETED|Period 2 (Days 4 to 6)||0
11347940|NCT02994394|12544907|FG003|NOT COMPLETED|Period 2 (Days 4 to 6)||0
11347941|NCT02994394|12544908|FG004|NOT COMPLETED|Period 2 (Days 4 to 6)||1
11075504|NCT01092637|12257495|FG001|COMPLETED|Overall Study||86
11075505|NCT01092637|12257494|FG000|NOT COMPLETED|Overall Study||47
11075506|NCT01092637|12257495|FG001|NOT COMPLETED|Overall Study||49
11075507|NCT01092663|12257504|FG000|STARTED|Overall Study||31
11075508|NCT01092663|12257505|FG001|STARTED|Overall Study||30
11075509|NCT01092663|12257504|FG000|COMPLETED|Overall Study||24
11075510|NCT01092663|12257505|FG001|COMPLETED|Overall Study||26
11075511|NCT01092663|12257504|FG000|NOT COMPLETED|Overall Study||7
11075512|NCT01092663|12257505|FG001|NOT COMPLETED|Overall Study||4
11075513|NCT01092676|12257518|FG000|STARTED|Overall Study||50
11075514|NCT01092676|12257519|FG001|STARTED|Overall Study||49
11075515|NCT01092676|12257518|FG000|COMPLETED|Overall Study||50
11075516|NCT01092676|12257519|FG001|COMPLETED|Overall Study||49
11075517|NCT01092676|12257518|FG000|NOT COMPLETED|Overall Study||0
11075518|NCT01092676|12257519|FG001|NOT COMPLETED|Overall Study||0
11075519|NCT01092702|12257525|FG000|STARTED|Overall Study||32
11075520|NCT01092702|12257525|FG000|COMPLETED|Overall Study||23
11075521|NCT01092702|12257525|FG000|NOT COMPLETED|Overall Study||9
11075522|NCT01092728|12257531|FG000|STARTED|Overall Study||4
11075523|NCT01092728|12257532|FG001|STARTED|Overall Study||14
11075524|NCT01092728|12257531|FG000|COMPLETED|Overall Study||0
11075525|NCT01092728|12257532|FG001|COMPLETED|Overall Study||0
11075526|NCT01092728|12257531|FG000|NOT COMPLETED|Overall Study||4
11075527|NCT01092728|12257532|FG001|NOT COMPLETED|Overall Study||14
11075528|NCT01092767|12257538|FG000|STARTED|Overall Study||50
11075529|NCT01092767|12257538|FG000|COMPLETED|Overall Study||45
11075530|NCT01092767|12257538|FG000|NOT COMPLETED|Overall Study||5
11075531|NCT01092780|12257542|FG000|STARTED|Treatment Period 1||14
11075532|NCT01092780|12257543|FG001|STARTED|Treatment Period 1||15
11075533|NCT01092780|12257544|FG002|STARTED|Treatment Period 1||14
11075534|NCT01092780|12257545|FG003|STARTED|Treatment Period 1||13
11075535|NCT01092780|12257542|FG000|COMPLETED|Treatment Period 1||14
11075536|NCT01092780|12257543|FG001|COMPLETED|Treatment Period 1||15
11075537|NCT01092780|12257544|FG002|COMPLETED|Treatment Period 1||14
11075538|NCT01092780|12257545|FG003|COMPLETED|Treatment Period 1||13
11075539|NCT01092780|12257542|FG000|NOT COMPLETED|Treatment Period 1||0
11347942|NCT02994394|12544909|FG005|NOT COMPLETED|Period 2 (Days 4 to 6)||0
11347943|NCT02994394|12544904|FG000|STARTED|Period 3 (Days 7 and 8)||14
11347944|NCT02994394|12544905|FG001|STARTED|Period 3 (Days 7 and 8)||13
11347945|NCT02994394|12544906|FG002|STARTED|Period 3 (Days 7 and 8)||13
11347946|NCT02994394|12544907|FG003|STARTED|Period 3 (Days 7 and 8)||14
11347947|NCT02994394|12544908|FG004|STARTED|Period 3 (Days 7 and 8)||13
11347948|NCT02994394|12544909|FG005|STARTED|Period 3 (Days 7 and 8)||14
11347949|NCT02994394|12544904|FG000|COMPLETED|Period 3 (Days 7 and 8)||14
11347950|NCT02994394|12544905|FG001|COMPLETED|Period 3 (Days 7 and 8)||13
11347951|NCT02994394|12544906|FG002|COMPLETED|Period 3 (Days 7 and 8)||13
11347952|NCT02994394|12544907|FG003|COMPLETED|Period 3 (Days 7 and 8)||14
11347953|NCT02994394|12544908|FG004|COMPLETED|Period 3 (Days 7 and 8)||13
11075540|NCT01092780|12257543|FG001|NOT COMPLETED|Treatment Period 1||0
11075541|NCT01092780|12257544|FG002|NOT COMPLETED|Treatment Period 1||0
11347954|NCT02994394|12544909|FG005|COMPLETED|Period 3 (Days 7 and 8)||14
11347955|NCT02994394|12544904|FG000|NOT COMPLETED|Period 3 (Days 7 and 8)||0
11347956|NCT02994394|12544905|FG001|NOT COMPLETED|Period 3 (Days 7 and 8)||0
11347957|NCT02994394|12544906|FG002|NOT COMPLETED|Period 3 (Days 7 and 8)||0
11347958|NCT02994394|12544907|FG003|NOT COMPLETED|Period 3 (Days 7 and 8)||0
11347959|NCT02994394|12544908|FG004|NOT COMPLETED|Period 3 (Days 7 and 8)||0
11347960|NCT02994394|12544909|FG005|NOT COMPLETED|Period 3 (Days 7 and 8)||0
11347961|NCT02994654|12544923|FG000|STARTED|Overall Study||12
11347962|NCT02994654|12544923|FG000|COMPLETED|Overall Study||11
11347963|NCT02994654|12544923|FG000|NOT COMPLETED|Overall Study||1
11347964|NCT02994732|12544928|FG000|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6
11347965|NCT02994732|12544928|FG000|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6
11347966|NCT02994732|12544928|FG000|NOT COMPLETED|Overall Study||0
11347967|NCT02994940|12544935|FG000|STARTED|Overall Study||37
11347968|NCT02994940|12544936|FG001|STARTED|Overall Study||37
11347969|NCT02994940|12544935|FG000|COMPLETED|Overall Study||30
11347970|NCT02994940|12544936|FG001|COMPLETED|Overall Study||36
11347971|NCT02994940|12544935|FG000|NOT COMPLETED|Overall Study||7
11347972|NCT02994940|12544936|FG001|NOT COMPLETED|Overall Study||1
11347973|NCT02994979|12544944|FG000|STARTED|Overall Study||114
11347974|NCT02994979|12544945|FG001|STARTED|Overall Study||105
11347975|NCT02994979|12544944|FG000|COMPLETED|Overall Study||114
11347976|NCT02994979|12544945|FG001|COMPLETED|Overall Study||105
11347977|NCT02994979|12544944|FG000|NOT COMPLETED|Overall Study||0
11347978|NCT02994979|12544945|FG001|NOT COMPLETED|Overall Study||0
11347979|NCT02995915|12544953|FG000|STARTED|Overall Study||30
11347980|NCT02995915|12544954|FG001|STARTED|Overall Study||15
11347981|NCT02995915|12544953|FG000|COMPLETED|Overall Study||30
11347982|NCT02995915|12544954|FG001|COMPLETED|Overall Study||15
11347983|NCT02995915|12544953|FG000|NOT COMPLETED|Overall Study||0
11347984|NCT02995915|12544954|FG001|NOT COMPLETED|Overall Study||0
11347985|NCT02995980|12544960|FG000|STARTED|Overall Study||128
11347986|NCT02995980|12544960|FG000|COMPLETED|Overall Study||114
11347987|NCT02995980|12544960|FG000|NOT COMPLETED|Overall Study||14
11347988|NCT02996097|12544965|FG000|STARTED|Overall Study||30
11347989|NCT02996097|12544966|FG001|STARTED|Overall Study||30
11347990|NCT02996097|12544965|FG000|Per Protocol Population|Overall Study||22
11347991|NCT02996097|12544966|FG001|Per Protocol Population|Overall Study||22
11347992|NCT02996097|12544965|FG000|COMPLETED|Overall Study||19
11347993|NCT02996097|12544966|FG001|COMPLETED|Overall Study||19
11347994|NCT02996097|12544965|FG000|NOT COMPLETED|Overall Study||11
11347995|NCT02996097|12544966|FG001|NOT COMPLETED|Overall Study||11
11347996|NCT02996448|12544971|FG000|STARTED|Overall Study||3
11347997|NCT02996448|12544971|FG000|COMPLETED|Overall Study||0
11347998|NCT02996448|12544971|FG000|NOT COMPLETED|Overall Study||3
11347999|NCT02996474|12544976|FG000|STARTED|Overall Study||10
11348000|NCT02996474|12544976|FG000|COMPLETED|Overall Study||5
11348001|NCT02996474|12544976|FG000|NOT COMPLETED|Overall Study||5
11348002|NCT02996500|12544986|FG000|STARTED|Overall Study||39
11348003|NCT02996500|12544987|FG001|STARTED|Overall Study||43
11348004|NCT02996500|12544988|FG002|STARTED|Overall Study||39
11348005|NCT02996500|12544989|FG003|STARTED|Overall Study||50
11348006|NCT02996500|12544990|FG004|STARTED|Overall Study||50
11348007|NCT02996500|12544991|FG005|STARTED|Overall Study||48
11348008|NCT02996500|12544986|FG000|COMPLETED|Overall Study||31
11348009|NCT02996500|12544987|FG001|COMPLETED|Overall Study||42
11348010|NCT02996500|12544988|FG002|COMPLETED|Overall Study||29
11348011|NCT02996500|12544989|FG003|COMPLETED|Overall Study||46
11348012|NCT02996500|12544990|FG004|COMPLETED|Overall Study||45
11348013|NCT02996500|12544991|FG005|COMPLETED|Overall Study||44
11348014|NCT02996500|12544986|FG000|NOT COMPLETED|Overall Study||8
11348015|NCT02996500|12544987|FG001|NOT COMPLETED|Overall Study||1
11348016|NCT02996500|12544988|FG002|NOT COMPLETED|Overall Study||10
11348017|NCT02996500|12544989|FG003|NOT COMPLETED|Overall Study||4
11348018|NCT02996500|12544990|FG004|NOT COMPLETED|Overall Study||5
11348019|NCT02996500|12544991|FG005|NOT COMPLETED|Overall Study||4
11075542|NCT01092780|12257545|FG003|NOT COMPLETED|Treatment Period 1||0
11075543|NCT01092780|12257542|FG000|STARTED|Washout Period 1||14
11075544|NCT01092780|12257543|FG001|STARTED|Washout Period 1||15
11075545|NCT01092780|12257544|FG002|STARTED|Washout Period 1||14
11075546|NCT01092780|12257545|FG003|STARTED|Washout Period 1||13
11075547|NCT01092780|12257542|FG000|COMPLETED|Washout Period 1||13
11075548|NCT01092780|12257543|FG001|COMPLETED|Washout Period 1||14
11075549|NCT01092780|12257544|FG002|COMPLETED|Washout Period 1||14
11075550|NCT01092780|12257545|FG003|COMPLETED|Washout Period 1||13
11075551|NCT01092780|12257542|FG000|NOT COMPLETED|Washout Period 1||1
11075552|NCT01092780|12257543|FG001|NOT COMPLETED|Washout Period 1||1
11075553|NCT01092780|12257544|FG002|NOT COMPLETED|Washout Period 1||0
11075554|NCT01092780|12257545|FG003|NOT COMPLETED|Washout Period 1||0
11075555|NCT01092780|12257542|FG000|STARTED|Treatment Period 2||13
11075556|NCT01092780|12257543|FG001|STARTED|Treatment Period 2||14
11075557|NCT01092780|12257544|FG002|STARTED|Treatment Period 2||14
11075558|NCT01092780|12257545|FG003|STARTED|Treatment Period 2||13
11075559|NCT01092780|12257542|FG000|COMPLETED|Treatment Period 2||13
11075560|NCT01092780|12257543|FG001|COMPLETED|Treatment Period 2||14
11075561|NCT01092780|12257544|FG002|COMPLETED|Treatment Period 2||14
11075562|NCT01092780|12257545|FG003|COMPLETED|Treatment Period 2||13
11075563|NCT01092780|12257542|FG000|NOT COMPLETED|Treatment Period 2||0
11075564|NCT01092780|12257543|FG001|NOT COMPLETED|Treatment Period 2||0
11075565|NCT01092780|12257544|FG002|NOT COMPLETED|Treatment Period 2||0
11075566|NCT01092780|12257545|FG003|NOT COMPLETED|Treatment Period 2||0
11075567|NCT01092780|12257542|FG000|STARTED|Washout Period 2||13
11075568|NCT01092780|12257543|FG001|STARTED|Washout Period 2||14
11075569|NCT01092780|12257544|FG002|STARTED|Washout Period 2||14
11075570|NCT01092780|12257545|FG003|STARTED|Washout Period 2||13
11075571|NCT01092780|12257542|FG000|COMPLETED|Washout Period 2||13
11075572|NCT01092780|12257543|FG001|COMPLETED|Washout Period 2||13
11075573|NCT01092780|12257544|FG002|COMPLETED|Washout Period 2||13
11075574|NCT01092780|12257545|FG003|COMPLETED|Washout Period 2||13
11075575|NCT01092780|12257542|FG000|NOT COMPLETED|Washout Period 2||0
11075576|NCT01092780|12257543|FG001|NOT COMPLETED|Washout Period 2||1
11075577|NCT01092780|12257544|FG002|NOT COMPLETED|Washout Period 2||1
11075578|NCT01092780|12257545|FG003|NOT COMPLETED|Washout Period 2||0
11075579|NCT01092780|12257542|FG000|STARTED|Treatment Period 3||13
11075580|NCT01092780|12257543|FG001|STARTED|Treatment Period 3||13
11075581|NCT01092780|12257544|FG002|STARTED|Treatment Period 3||13
11075582|NCT01092780|12257545|FG003|STARTED|Treatment Period 3||13
11075583|NCT01092780|12257542|FG000|COMPLETED|Treatment Period 3||13
11075584|NCT01092780|12257543|FG001|COMPLETED|Treatment Period 3||13
11075585|NCT01092780|12257544|FG002|COMPLETED|Treatment Period 3||13
11075586|NCT01092780|12257545|FG003|COMPLETED|Treatment Period 3||13
11075587|NCT01092780|12257542|FG000|NOT COMPLETED|Treatment Period 3||0
11075588|NCT01092780|12257543|FG001|NOT COMPLETED|Treatment Period 3||0
11075589|NCT01092780|12257544|FG002|NOT COMPLETED|Treatment Period 3||0
11075590|NCT01092780|12257545|FG003|NOT COMPLETED|Treatment Period 3||0
11075591|NCT01092780|12257542|FG000|STARTED|Washout Period 3||13
11075592|NCT01092780|12257543|FG001|STARTED|Washout Period 3||13
11075593|NCT01092780|12257544|FG002|STARTED|Washout Period 3||13
11075594|NCT01092780|12257545|FG003|STARTED|Washout Period 3||13
11075595|NCT01092780|12257542|FG000|COMPLETED|Washout Period 3||13
11075596|NCT01092780|12257543|FG001|COMPLETED|Washout Period 3||13
11075597|NCT01092780|12257544|FG002|COMPLETED|Washout Period 3||13
11075598|NCT01092780|12257545|FG003|COMPLETED|Washout Period 3||13
11075599|NCT01092780|12257542|FG000|NOT COMPLETED|Washout Period 3||0
11075600|NCT01092780|12257543|FG001|NOT COMPLETED|Washout Period 3||0
11075601|NCT01092780|12257544|FG002|NOT COMPLETED|Washout Period 3||0
11075602|NCT01092780|12257545|FG003|NOT COMPLETED|Washout Period 3||0
11075603|NCT01092780|12257542|FG000|STARTED|Treatment Period 4||13
11075604|NCT01092780|12257543|FG001|STARTED|Treatment Period 4||13
11075605|NCT01092780|12257544|FG002|STARTED|Treatment Period 4||13
11075606|NCT01092780|12257545|FG003|STARTED|Treatment Period 4||13
11075607|NCT01092780|12257542|FG000|COMPLETED|Treatment Period 4||13
11075608|NCT01092780|12257543|FG001|COMPLETED|Treatment Period 4||13
11075609|NCT01092780|12257544|FG002|COMPLETED|Treatment Period 4||13
11075610|NCT01092780|12257545|FG003|COMPLETED|Treatment Period 4||13
11075611|NCT01092780|12257542|FG000|NOT COMPLETED|Treatment Period 4||0
11075612|NCT01092780|12257543|FG001|NOT COMPLETED|Treatment Period 4||0
11075613|NCT01092780|12257544|FG002|NOT COMPLETED|Treatment Period 4||0
11075614|NCT01092780|12257545|FG003|NOT COMPLETED|Treatment Period 4||0
11075615|NCT01092832|12257557|FG000|STARTED|Overall Study||14
11075616|NCT01092832|12257558|FG001|STARTED|Overall Study||8
11075617|NCT01092832|12257557|FG000|COMPLETED|Overall Study||13
11075618|NCT01092832|12257558|FG001|COMPLETED|Overall Study||8
11075619|NCT01092832|12257557|FG000|NOT COMPLETED|Overall Study||1
11075620|NCT01092832|12257558|FG001|NOT COMPLETED|Overall Study||0
11075621|NCT01092910|12257564|FG000|STARTED|Overall Study||57
11075622|NCT01092910|12257564|FG000|4 Month Follow-up|Overall Study||54
11075623|NCT01092910|12257564|FG000|10 Month Follow-up|Overall Study||52
11075624|NCT01092910|12257564|FG000|COMPLETED|Overall Study||52
11075625|NCT01092910|12257564|FG000|NOT COMPLETED|Overall Study||5
11075626|NCT01092923|12257571|FG000|STARTED|Overall Study||10
11075627|NCT01092923|12257572|FG001|STARTED|Overall Study||10
11075628|NCT01092923|12257571|FG000|COMPLETED|Overall Study||10
11075629|NCT01092923|12257572|FG001|COMPLETED|Overall Study||10
11075630|NCT01092923|12257571|FG000|NOT COMPLETED|Overall Study||0
11075631|NCT01092923|12257572|FG001|NOT COMPLETED|Overall Study||0
11348020|NCT02996591|12545011|FG000|STARTED|Overall Study||18
11075632|NCT01093014|12257582|FG000|STARTED|Overall Study||12
11075633|NCT01093014|12257583|FG001|STARTED|Overall Study||9
11075634|NCT01093014|12257584|FG002|STARTED|Overall Study||12
11075635|NCT01093014|12257582|FG000|COMPLETED|Overall Study||12
11075636|NCT01093014|12257583|FG001|COMPLETED|Overall Study||9
11075637|NCT01093014|12257584|FG002|COMPLETED|Overall Study||12
11075638|NCT01093014|12257582|FG000|NOT COMPLETED|Overall Study||0
11075639|NCT01093014|12257583|FG001|NOT COMPLETED|Overall Study||0
11075640|NCT01093014|12257584|FG002|NOT COMPLETED|Overall Study||0
11075641|NCT01093027|12257597|FG000|STARTED|Visit 1||10
11075642|NCT01093027|12257598|FG001|STARTED|Visit 1||10
11075643|NCT01093027|12257597|FG000|COMPLETED|Visit 1||10
11075644|NCT01093027|12257598|FG001|COMPLETED|Visit 1||10
11075645|NCT01093027|12257597|FG000|NOT COMPLETED|Visit 1||0
11075646|NCT01093027|12257598|FG001|NOT COMPLETED|Visit 1||0
11075647|NCT01093027|12257597|FG000|STARTED|Visit 2||10
11075648|NCT01093027|12257598|FG001|STARTED|Visit 2||10
11075649|NCT01093027|12257597|FG000|COMPLETED|Visit 2||10
11075650|NCT01093027|12257598|FG001|COMPLETED|Visit 2||10
11075651|NCT01093027|12257597|FG000|NOT COMPLETED|Visit 2||0
11075652|NCT01093027|12257598|FG001|NOT COMPLETED|Visit 2||0
11075653|NCT01093183|12257604|FG000|STARTED|Overall Study||19
11075654|NCT01093183|12257605|FG001|STARTED|Overall Study||6
11075655|NCT01093183|12257604|FG000|COMPLETED|Overall Study||18
11075656|NCT01093183|12257605|FG001|COMPLETED|Overall Study||4
11348021|NCT02996591|12545012|FG001|STARTED|Overall Study||18
11075657|NCT01093183|12257604|FG000|NOT COMPLETED|Overall Study||1
11075658|NCT01093183|12257605|FG001|NOT COMPLETED|Overall Study||2
11075659|NCT01093222|12257609|FG000|STARTED|Overall Study||40
11075660|NCT01093222|12257609|FG000|Eligible and Began Protocol Therapy|Overall Study||34
11075661|NCT01093222|12257609|FG000|COMPLETED|Overall Study||0
11075662|NCT01093222|12257609|FG000|NOT COMPLETED|Overall Study||40
11075663|NCT01093417|12257615|FG000|STARTED|Overall Study||15
11075664|NCT01093417|12257616|FG001|STARTED|Overall Study||30
11075665|NCT01093417|12257615|FG000|COMPLETED|Overall Study||15
11075666|NCT01093417|12257616|FG001|COMPLETED|Overall Study||29
11075667|NCT01093417|12257615|FG000|NOT COMPLETED|Overall Study||0
11075668|NCT01093417|12257616|FG001|NOT COMPLETED|Overall Study||1
11075669|NCT01093469|12257625|FG000|STARTED|Overall Study||13
11075670|NCT01093469|12257626|FG001|STARTED|Overall Study||13
11075671|NCT01093469|12257627|FG002|STARTED|Overall Study||13
11075672|NCT01093469|12257625|FG000|COMPLETED|Overall Study||13
11075673|NCT01093469|12257626|FG001|COMPLETED|Overall Study||13
11075674|NCT01093469|12257627|FG002|COMPLETED|Overall Study||12
11075675|NCT01093469|12257625|FG000|NOT COMPLETED|Overall Study||0
11075676|NCT01093469|12257626|FG001|NOT COMPLETED|Overall Study||0
11075677|NCT01093469|12257627|FG002|NOT COMPLETED|Overall Study||1
11075678|NCT01093482|12257635|FG000|STARTED|Overall Study||8151
11075679|NCT01093482|12257635|FG000|COMPLETED|Overall Study||8151
11075680|NCT01093482|12257635|FG000|NOT COMPLETED|Overall Study||0
11075681|NCT01093521|12257639|FG000|STARTED|Overall Study||20
11075682|NCT01093521|12257639|FG000|COMPLETED|Overall Study||20
11075683|NCT01093521|12257639|FG000|NOT COMPLETED|Overall Study||0
11075684|NCT01093534|12257648|FG000|STARTED|Overall Study||186
11075685|NCT01093534|12257649|FG001|STARTED|Overall Study||183
11075686|NCT01093534|12257650|FG002|STARTED|Overall Study||178
11075687|NCT01093534|12257648|FG000|Received Study Treatment|Overall Study||186
11075688|NCT01093534|12257649|FG001|Received Study Treatment|Overall Study||182
11075689|NCT01093534|12257650|FG002|Received Study Treatment|Overall Study||175
11075690|NCT01093534|12257648|FG000|COMPLETED|Overall Study||176
11075691|NCT01093534|12257649|FG001|COMPLETED|Overall Study||167
11075692|NCT01093534|12257650|FG002|COMPLETED|Overall Study||169
11075693|NCT01093534|12257648|FG000|NOT COMPLETED|Overall Study||10
11075694|NCT01093534|12257649|FG001|NOT COMPLETED|Overall Study||16
11075695|NCT01093534|12257650|FG002|NOT COMPLETED|Overall Study||9
11075696|NCT01093586|12257659|FG000|STARTED|Overall Study||14
11075697|NCT01093586|12257659|FG000|COMPLETED|Overall Study||11
11075698|NCT01093586|12257659|FG000|NOT COMPLETED|Overall Study||3
11075699|NCT01093599|12257665|FG000|STARTED|Overall Study||91
11075700|NCT01093599|12257666|FG001|STARTED|Overall Study||105
11075701|NCT01093599|12257665|FG000|COMPLETED|Overall Study||59
11075702|NCT01093599|12257666|FG001|COMPLETED|Overall Study||59
11075703|NCT01093599|12257665|FG000|NOT COMPLETED|Overall Study||32
11075704|NCT01093599|12257666|FG001|NOT COMPLETED|Overall Study||46
11075705|NCT01093625|12257674|FG000|STARTED|Baseline and Dispensed||49
11075706|NCT01093625|12257675|FG001|STARTED|Baseline and Dispensed||49
11075707|NCT01093625|12257674|FG000|COMPLETED|Baseline and Dispensed||47
11075708|NCT01093625|12257675|FG001|COMPLETED|Baseline and Dispensed||49
11075709|NCT01093625|12257674|FG000|NOT COMPLETED|Baseline and Dispensed||2
11075710|NCT01093625|12257675|FG001|NOT COMPLETED|Baseline and Dispensed||0
11075711|NCT01093625|12257674|FG000|STARTED|2-Week Visit||47
11075712|NCT01093625|12257675|FG001|STARTED|2-Week Visit||49
11075713|NCT01093625|12257674|FG000|COMPLETED|2-Week Visit||46
11075714|NCT01093625|12257675|FG001|COMPLETED|2-Week Visit||49
11075715|NCT01093625|12257674|FG000|NOT COMPLETED|2-Week Visit||1
11075716|NCT01093625|12257675|FG001|NOT COMPLETED|2-Week Visit||0
11075717|NCT01093625|12257674|FG000|STARTED|1-Month Visit||46
11075718|NCT01093625|12257675|FG001|STARTED|1-Month Visit||49
11075719|NCT01093625|12257674|FG000|COMPLETED|1-Month Visit||44
11075720|NCT01093625|12257675|FG001|COMPLETED|1-Month Visit||49
11075721|NCT01093625|12257674|FG000|NOT COMPLETED|1-Month Visit||2
11075722|NCT01093625|12257675|FG001|NOT COMPLETED|1-Month Visit||0
11075723|NCT01093625|12257674|FG000|STARTED|3-Month Visit||44
11075724|NCT01093625|12257675|FG001|STARTED|3-Month Visit||49
11075725|NCT01093625|12257674|FG000|COMPLETED|3-Month Visit||42
11075726|NCT01093625|12257675|FG001|COMPLETED|3-Month Visit||49
11075727|NCT01093625|12257674|FG000|NOT COMPLETED|3-Month Visit||2
11075728|NCT01093625|12257675|FG001|NOT COMPLETED|3-Month Visit||0
11075729|NCT01093625|12257674|FG000|STARTED|6-Month Visit||42
11075730|NCT01093625|12257675|FG001|STARTED|6-Month Visit||49
11075731|NCT01093625|12257674|FG000|COMPLETED|6-Month Visit||34
11075732|NCT01093625|12257675|FG001|COMPLETED|6-Month Visit||40
11075733|NCT01093625|12257674|FG000|NOT COMPLETED|6-Month Visit||8
11075734|NCT01093625|12257675|FG001|NOT COMPLETED|6-Month Visit||9
11075735|NCT01093625|12257674|FG000|STARTED|1-Year Visit||34
11075736|NCT01093625|12257675|FG001|STARTED|1-Year Visit||40
11075737|NCT01093625|12257674|FG000|COMPLETED|1-Year Visit||29
11075738|NCT01093625|12257675|FG001|COMPLETED|1-Year Visit||37
11075739|NCT01093625|12257674|FG000|NOT COMPLETED|1-Year Visit||5
11075740|NCT01093625|12257675|FG001|NOT COMPLETED|1-Year Visit||3
11075741|NCT01093651|12257683|FG000|STARTED|Overall Study||10
11075742|NCT01093651|12257684|FG001|STARTED|Overall Study||10
11075743|NCT01093651|12257683|FG000|COMPLETED|Overall Study||10
11075744|NCT01093651|12257684|FG001|COMPLETED|Overall Study||10
11075745|NCT01093651|12257683|FG000|NOT COMPLETED|Overall Study||0
11075746|NCT01093651|12257684|FG001|NOT COMPLETED|Overall Study||0
11075747|NCT01093690|12257692|FG000|STARTED|Overall Study||83
11075748|NCT01093690|12257693|FG001|STARTED|Overall Study||79
11075749|NCT01093690|12257692|FG000|COMPLETED|Overall Study||83
11075750|NCT01093690|12257693|FG001|COMPLETED|Overall Study||79
11075751|NCT01093690|12257692|FG000|NOT COMPLETED|Overall Study||0
11075752|NCT01093690|12257693|FG001|NOT COMPLETED|Overall Study||0
11075753|NCT01093755|12257701|FG000|STARTED|Overall Study||16
11075754|NCT01093755|12257702|FG001|STARTED|Overall Study||14
11075755|NCT01093755|12257701|FG000|COMPLETED|Overall Study||13
11075756|NCT01093755|12257702|FG001|COMPLETED|Overall Study||10
11075757|NCT01093755|12257701|FG000|NOT COMPLETED|Overall Study||3
11075758|NCT01093755|12257702|FG001|NOT COMPLETED|Overall Study||4
11075759|NCT01093794|12257708|FG000|STARTED|Treatment Period 1||7
11075760|NCT01093794|12257709|FG001|STARTED|Treatment Period 1||7
11075761|NCT01093794|12257710|FG002|STARTED|Treatment Period 1||7
11075762|NCT01093794|12257711|FG003|STARTED|Treatment Period 1||7
11075763|NCT01093794|12257708|FG000|COMPLETED|Treatment Period 1||7
11075764|NCT01093794|12257709|FG001|COMPLETED|Treatment Period 1||7
11075765|NCT01093794|12257710|FG002|COMPLETED|Treatment Period 1||7
11075766|NCT01093794|12257711|FG003|COMPLETED|Treatment Period 1||7
11075767|NCT01093794|12257708|FG000|NOT COMPLETED|Treatment Period 1||0
11075768|NCT01093794|12257709|FG001|NOT COMPLETED|Treatment Period 1||0
11075769|NCT01093794|12257710|FG002|NOT COMPLETED|Treatment Period 1||0
11075770|NCT01093794|12257711|FG003|NOT COMPLETED|Treatment Period 1||0
11075771|NCT01093794|12257708|FG000|STARTED|Treatment Period 2||7
11075772|NCT01093794|12257709|FG001|STARTED|Treatment Period 2||7
11075773|NCT01093794|12257710|FG002|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
11075774|NCT01093794|12257711|FG003|STARTED|Treatment Period 2||7
11075775|NCT01093794|12257708|FG000|COMPLETED|Treatment Period 2||7
11075776|NCT01093794|12257709|FG001|COMPLETED|Treatment Period 2||7
11075777|NCT01093794|12257710|FG002|COMPLETED|Treatment Period 2||6
11075778|NCT01093794|12257711|FG003|COMPLETED|Treatment Period 2||7
11075779|NCT01093794|12257708|FG000|NOT COMPLETED|Treatment Period 2||0
11075780|NCT01093794|12257709|FG001|NOT COMPLETED|Treatment Period 2||0
11075781|NCT01093794|12257710|FG002|NOT COMPLETED|Treatment Period 2||0
11075782|NCT01093794|12257711|FG003|NOT COMPLETED|Treatment Period 2||0
11075783|NCT01093794|12257708|FG000|STARTED|Treatment Period 3||7
11075784|NCT01093794|12257709|FG001|STARTED|Treatment Period 3||7
11075785|NCT01093794|12257710|FG002|STARTED|Treatment Period 3||6
11075786|NCT01093794|12257711|FG003|STARTED|Treatment Period 3||7
11075787|NCT01093794|12257708|FG000|COMPLETED|Treatment Period 3||7
11075788|NCT01093794|12257709|FG001|COMPLETED|Treatment Period 3||7
11075789|NCT01093794|12257710|FG002|COMPLETED|Treatment Period 3||6
11075790|NCT01093794|12257711|FG003|COMPLETED|Treatment Period 3||7
11075791|NCT01093794|12257708|FG000|NOT COMPLETED|Treatment Period 3||0
11075792|NCT01093794|12257709|FG001|NOT COMPLETED|Treatment Period 3||0
11075793|NCT01093794|12257710|FG002|NOT COMPLETED|Treatment Period 3||0
11075794|NCT01093794|12257711|FG003|NOT COMPLETED|Treatment Period 3||0
11075795|NCT01093794|12257708|FG000|STARTED|Treatment Period 4||7
11075796|NCT01093794|12257709|FG001|STARTED|Treatment Period 4||7
11075797|NCT01093794|12257710|FG002|STARTED|Treatment Period 4||6
11075798|NCT01093794|12257711|FG003|STARTED|Treatment Period 4||7
11075799|NCT01093794|12257708|FG000|COMPLETED|Treatment Period 4||7
11075800|NCT01093794|12257709|FG001|COMPLETED|Treatment Period 4||7
11075801|NCT01093794|12257710|FG002|COMPLETED|Treatment Period 4||6
11075802|NCT01093794|12257711|FG003|COMPLETED|Treatment Period 4||7
11075803|NCT01093794|12257708|FG000|NOT COMPLETED|Treatment Period 4||0
11348022|NCT02996591|12545011|FG000|COMPLETED|Overall Study||18
11348023|NCT02996591|12545012|FG001|COMPLETED|Overall Study||18
11348024|NCT02996591|12545011|FG000|NOT COMPLETED|Overall Study||0
11348025|NCT02996591|12545012|FG001|NOT COMPLETED|Overall Study||0
11348026|NCT02996682|12545020|FG000|STARTED|Overall Study||51
11348027|NCT02996682|12545021|FG001|STARTED|Overall Study||51
11348028|NCT02996682|12545020|FG000|COMPLETED|Overall Study||51
11348029|NCT02996682|12545021|FG001|COMPLETED|Overall Study||48
11348030|NCT02996682|12545020|FG000|NOT COMPLETED|Overall Study||0
11348031|NCT02996682|12545021|FG001|NOT COMPLETED|Overall Study||3
11348032|NCT02996864|12545029|FG000|STARTED|Overall Study||150
11348033|NCT02996864|12545030|FG001|STARTED|Overall Study||150
11348034|NCT02996864|12545029|FG000|COMPLETED|Overall Study||142
11348035|NCT02996864|12545030|FG001|COMPLETED|Overall Study||136
11348036|NCT02996864|12545029|FG000|NOT COMPLETED|Overall Study||8
11348037|NCT02996864|12545030|FG001|NOT COMPLETED|Overall Study||14
11348038|NCT02996968|12545038|FG000|STARTED|Overall Study||79
11348039|NCT02996968|12545039|FG001|STARTED|Overall Study||79
11348040|NCT02996968|12545038|FG000|COMPLETED|Overall Study||78
11348041|NCT02996968|12545039|FG001|COMPLETED|Overall Study||79
11348042|NCT02996968|12545038|FG000|NOT COMPLETED|Overall Study||1
11348043|NCT02996968|12545039|FG001|NOT COMPLETED|Overall Study||0
11348044|NCT02997085|12545048|FG000|STARTED|Overall Study||34
11348045|NCT02997085|12545049|FG001|STARTED|Overall Study||35
11348046|NCT02997085|12545050|FG002|STARTED|Overall Study||34
11348047|NCT02997085|12545048|FG000|COMPLETED|Overall Study||34
11348048|NCT02997085|12545049|FG001|COMPLETED|Overall Study||35
11348049|NCT02997085|12545050|FG002|COMPLETED|Overall Study||34
11348050|NCT02997085|12545048|FG000|NOT COMPLETED|Overall Study||0
11348051|NCT02997085|12545049|FG001|NOT COMPLETED|Overall Study||0
11348052|NCT02997085|12545050|FG002|NOT COMPLETED|Overall Study||0
11348053|NCT02997163|12545061|FG000|STARTED|Overall Study||9
11075804|NCT01093794|12257709|FG001|NOT COMPLETED|Treatment Period 4||0
11075805|NCT01093794|12257710|FG002|NOT COMPLETED|Treatment Period 4||0
11075806|NCT01093794|12257711|FG003|NOT COMPLETED|Treatment Period 4||0
11348054|NCT02997163|12545062|FG001|STARTED|Overall Study||9
11348055|NCT02997163|12545063|FG002|STARTED|Overall Study||8
11075807|NCT01093885|12257721|FG000|STARTED|Overall Study||15
11075808|NCT01093885|12257721|FG000|COMPLETED|Overall Study||10
11075809|NCT01093885|12257721|FG000|NOT COMPLETED|Overall Study||5
11075810|NCT01093976|12257726|FG000|STARTED|Overall Study||14
11075811|NCT01093976|12257726|FG000|COMPLETED|Overall Study||14
11075812|NCT01093976|12257726|FG000|NOT COMPLETED|Overall Study||0
11075813|NCT01094106|12257732|FG000|STARTED|Overall Study||33
11075814|NCT01094106|12257733|FG001|STARTED|Overall Study||34
11075815|NCT01094106|12257732|FG000|COMPLETED|Overall Study||33
11075816|NCT01094106|12257733|FG001|COMPLETED|Overall Study||34
11075817|NCT01094106|12257732|FG000|NOT COMPLETED|Overall Study||0
11348056|NCT02997163|12545064|FG003|STARTED|Overall Study||8
11348057|NCT02997163|12545061|FG000|COMPLETED|Overall Study||8
11348058|NCT02997163|12545062|FG001|COMPLETED|Overall Study||9
11075818|NCT01094106|12257733|FG001|NOT COMPLETED|Overall Study||0
11075819|NCT01094119|12257741|FG000|STARTED|Overall Study||34
11075820|NCT01094119|12257742|FG001|STARTED|Overall Study||36
11075821|NCT01094119|12257741|FG000|COMPLETED|Overall Study||32
11075822|NCT01094119|12257742|FG001|COMPLETED|Overall Study||32
11075823|NCT01094119|12257741|FG000|NOT COMPLETED|Overall Study||2
11075824|NCT01094119|12257742|FG001|NOT COMPLETED|Overall Study||4
11075825|NCT01094171|12257748|FG000|STARTED|Overall Study||400
11075826|NCT01094171|12257748|FG000|COMPLETED|Overall Study||390
11075827|NCT01094171|12257748|FG000|NOT COMPLETED|Overall Study||10
11075828|NCT01094184|12257754|FG000|STARTED|Overall Study||36
11075829|NCT01094184|12257755|FG001|STARTED|Overall Study||13
11075830|NCT01094184|12257754|FG000|COMPLETED|Overall Study||1
11075831|NCT01094184|12257755|FG001|COMPLETED|Overall Study||2
11075832|NCT01094184|12257754|FG000|NOT COMPLETED|Overall Study||35
11075833|NCT01094184|12257755|FG001|NOT COMPLETED|Overall Study||11
11075834|NCT01094288|12257769|FG000|STARTED|Overall Study||6
11075835|NCT01094288|12257770|FG001|STARTED|Overall Study||15
11075836|NCT01094288|12257771|FG002|STARTED|Overall Study||5
11075837|NCT01094288|12257772|FG003|STARTED|Overall Study||3
11075838|NCT01094288|12257773|FG004|STARTED|Overall Study||2
11075839|NCT01094288|12257774|FG005|STARTED|Overall Study||4
11075840|NCT01094288|12257775|FG006|STARTED|Overall Study||2
11075841|NCT01094288|12257776|FG007|STARTED|Overall Study||4
11075842|NCT01094288|12257769|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|4
11075843|NCT01094288|12257770|FG001|COMPLETED|Overall Study||5
11075844|NCT01094288|12257771|FG002|COMPLETED|Overall Study||1
11075845|NCT01094288|12257772|FG003|COMPLETED|Overall Study||1
11075846|NCT01094288|12257773|FG004|COMPLETED|Overall Study||2
11075847|NCT01094288|12257774|FG005|COMPLETED|Overall Study||4
11075848|NCT01094288|12257775|FG006|COMPLETED|Overall Study||2
11075849|NCT01094288|12257776|FG007|COMPLETED|Overall Study||2
11075850|NCT01094288|12257769|FG000|NOT COMPLETED|Overall Study||2
11075851|NCT01094288|12257770|FG001|NOT COMPLETED|Overall Study||10
11075852|NCT01094288|12257771|FG002|NOT COMPLETED|Overall Study||4
11075853|NCT01094288|12257772|FG003|NOT COMPLETED|Overall Study||2
11075854|NCT01094288|12257773|FG004|NOT COMPLETED|Overall Study||0
11075855|NCT01094288|12257774|FG005|NOT COMPLETED|Overall Study||0
11075856|NCT01094288|12257775|FG006|NOT COMPLETED|Overall Study||0
11206715|NCT01869959|12397761|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0
11206716|NCT01869959|12397757|FG000|COMPLETED|Treatment Period||10
11206717|NCT01869959|12397758|FG001|COMPLETED|Treatment Period||8
11206718|NCT01869959|12397759|FG002|COMPLETED|Treatment Period||12
11206719|NCT01869959|12397760|FG003|COMPLETED|Treatment Period||8
11206720|NCT01869959|12397761|FG004|COMPLETED|Treatment Period||0
11206721|NCT01869959|12397757|FG000|NOT COMPLETED|Treatment Period||1
11206722|NCT01869959|12397758|FG001|NOT COMPLETED|Treatment Period||2
11206723|NCT01869959|12397759|FG002|NOT COMPLETED|Treatment Period||3
11206724|NCT01869959|12397760|FG003|NOT COMPLETED|Treatment Period||2
11206725|NCT01869959|12397761|FG004|NOT COMPLETED|Treatment Period||0
11206726|NCT01870076|12397775|FG000|STARTED|Overall Study||10
11206727|NCT01870076|12397776|FG001|STARTED|Overall Study||12
11206728|NCT01870076|12397777|FG002|STARTED|Overall Study||8
11206729|NCT01870076|12397778|FG003|STARTED|Overall Study||11
11206730|NCT01870076|12397775|FG000|COMPLETED|Overall Study||9
11206731|NCT01870076|12397776|FG001|COMPLETED|Overall Study||12
11206732|NCT01870076|12397777|FG002|COMPLETED|Overall Study||7
11206733|NCT01870076|12397778|FG003|COMPLETED|Overall Study||11
11206734|NCT01870076|12397775|FG000|NOT COMPLETED|Overall Study||1
11206735|NCT01870076|12397776|FG001|NOT COMPLETED|Overall Study||0
11206736|NCT01870076|12397777|FG002|NOT COMPLETED|Overall Study||1
11206737|NCT01870076|12397778|FG003|NOT COMPLETED|Overall Study||0
11206738|NCT01870297|12397795|FG000|STARTED|Overall Study||11
11206739|NCT01870297|12397796|FG001|STARTED|Overall Study||15
11206740|NCT01870297|12397797|FG002|STARTED|Overall Study||8
11206741|NCT01870297|12397798|FG003|STARTED|Overall Study||9
11206742|NCT01870297|12397799|FG004|STARTED|Overall Study||10
11206743|NCT01870297|12397800|FG005|STARTED|Overall Study||9
11206744|NCT01870297|12397801|FG006|STARTED|Overall Study||10
11206745|NCT01870297|12397795|FG000|COMPLETED|Overall Study||11
11206746|NCT01870297|12397796|FG001|COMPLETED|Overall Study||8
11206747|NCT01870297|12397797|FG002|COMPLETED|Overall Study||7
11206748|NCT01870297|12397798|FG003|COMPLETED|Overall Study||9
11206749|NCT01870297|12397799|FG004|COMPLETED|Overall Study||7
11206750|NCT01870297|12397800|FG005|COMPLETED|Overall Study||8
11206751|NCT01870297|12397801|FG006|COMPLETED|Overall Study||8
11206752|NCT01870297|12397795|FG000|NOT COMPLETED|Overall Study||0
11206753|NCT01870297|12397796|FG001|NOT COMPLETED|Overall Study||7
11206754|NCT01870297|12397797|FG002|NOT COMPLETED|Overall Study||1
11206755|NCT01870297|12397798|FG003|NOT COMPLETED|Overall Study||0
11206756|NCT01870297|12397799|FG004|NOT COMPLETED|Overall Study||3
11206757|NCT01870297|12397800|FG005|NOT COMPLETED|Overall Study||1
11206758|NCT01870297|12397801|FG006|NOT COMPLETED|Overall Study||2
11206759|NCT01870388|12397828|FG000|STARTED|Overall Study||8
11206760|NCT01870388|12397829|FG001|STARTED|Overall Study||8
11075857|NCT01094288|12257776|FG007|NOT COMPLETED|Overall Study||2
11075858|NCT01094301|12257798|FG000|STARTED|Trial Stage||28
11075859|NCT01094301|12257798|FG000|Subjects Who Received Smartpatch Lead|Trial Stage||28
11075860|NCT01094301|12257798|FG000|COMPLETED|Trial Stage||27
11075861|NCT01094301|12257798|FG000|NOT COMPLETED|Trial Stage||1
11075862|NCT01094301|12257798|FG000|STARTED|Implant Stage||13
11075863|NCT01094301|12257798|FG000|Met Criteria for Implant Stage|Implant Stage||7
11075864|NCT01094301|12257798|FG000|Subjects Who Received SPR IPG|Implant Stage||5
11075865|NCT01094301|12257798|FG000|COMPLETED|Implant Stage||5
11075866|NCT01094301|12257798|FG000|NOT COMPLETED|Implant Stage||8
11075867|NCT01094522|12257806|FG000|STARTED|Overall Study||20
11075868|NCT01094522|12257807|FG001|STARTED|Overall Study||20
11075869|NCT01094522|12257806|FG000|COMPLETED|Overall Study||20
11075870|NCT01094522|12257807|FG001|COMPLETED|Overall Study||20
11075871|NCT01094522|12257806|FG000|NOT COMPLETED|Overall Study||0
11075872|NCT01094522|12257807|FG001|NOT COMPLETED|Overall Study||0
11075873|NCT01094548|12257816|FG000|STARTED|Overall Study||17
11075874|NCT01094548|12257817|FG001|STARTED|Overall Study||17
11075875|NCT01094548|12257816|FG000|COMPLETED|Overall Study||17
11075876|NCT01094548|12257817|FG001|COMPLETED|Overall Study||17
11075877|NCT01094548|12257816|FG000|NOT COMPLETED|Overall Study||0
11075878|NCT01094548|12257817|FG001|NOT COMPLETED|Overall Study||0
11075879|NCT01094574|12257831|FG000|STARTED|Overall Study||1
11075880|NCT01094574|12257832|FG001|STARTED|Overall Study||1
11075881|NCT01094574|12257833|FG002|STARTED|Overall Study||2
11075882|NCT01094574|12257834|FG003|STARTED|Overall Study||2
11075883|NCT01094574|12257835|FG004|STARTED|Overall Study||2
11075884|NCT01094574|12257836|FG005|STARTED|Overall Study||2
11075885|NCT01094574|12257831|FG000|COMPLETED|Overall Study||1
11075886|NCT01094574|12257832|FG001|COMPLETED|Overall Study||1
11075887|NCT01094574|12257833|FG002|COMPLETED|Overall Study||2
11075888|NCT01094574|12257834|FG003|COMPLETED|Overall Study||2
11075889|NCT01094574|12257835|FG004|COMPLETED|Overall Study||2
11075890|NCT01094574|12257836|FG005|COMPLETED|Overall Study||2
11075891|NCT01094574|12257831|FG000|NOT COMPLETED|Overall Study||0
11075892|NCT01094574|12257832|FG001|NOT COMPLETED|Overall Study||0
11075893|NCT01094574|12257833|FG002|NOT COMPLETED|Overall Study||0
11075894|NCT01094574|12257834|FG003|NOT COMPLETED|Overall Study||0
11075895|NCT01094574|12257835|FG004|NOT COMPLETED|Overall Study||0
11075896|NCT01094574|12257836|FG005|NOT COMPLETED|Overall Study||0
11075897|NCT01094704|12257849|FG000|STARTED|Overall Study||8
11075898|NCT01094704|12257850|FG001|STARTED|Overall Study||8
11075899|NCT01094704|12257849|FG000|COMPLETED|Overall Study||8
11075900|NCT01094704|12257850|FG001|COMPLETED|Overall Study||8
11075901|NCT01094704|12257849|FG000|NOT COMPLETED|Overall Study||0
11075902|NCT01094704|12257850|FG001|NOT COMPLETED|Overall Study||0
11075903|NCT01094717|12257858|FG000|STARTED|Overall Study||3
11075904|NCT01094717|12257859|FG001|STARTED|Overall Study||10
11075905|NCT01094717|12257858|FG000|COMPLETED|Overall Study||3
11075906|NCT01094717|12257859|FG001|COMPLETED|Overall Study||10
11075907|NCT01094717|12257858|FG000|NOT COMPLETED|Overall Study||0
11075908|NCT01094717|12257859|FG001|NOT COMPLETED|Overall Study||0
11348059|NCT02997163|12545063|FG002|COMPLETED|Overall Study||8
11348060|NCT02997163|12545064|FG003|COMPLETED|Overall Study||7
11348061|NCT02997163|12545061|FG000|NOT COMPLETED|Overall Study||1
11348062|NCT02997163|12545062|FG001|NOT COMPLETED|Overall Study||0
11348063|NCT02997163|12545063|FG002|NOT COMPLETED|Overall Study||0
11348064|NCT02997163|12545064|FG003|NOT COMPLETED|Overall Study||1
11348065|NCT02997176|12545078|FG000|STARTED|Overall Study||7
11348066|NCT02997176|12545079|FG001|STARTED|Overall Study||10
11206761|NCT01870388|12397828|FG000|Received 1 Dose of Study Drug|Overall Study||8
11206762|NCT01870388|12397829|FG001|Received 1 Dose of Study Drug|Overall Study||8
11206763|NCT01870388|12397828|FG000|COMPLETED|Overall Study||8
11206764|NCT01870388|12397829|FG001|COMPLETED|Overall Study||8
11206765|NCT01870388|12397828|FG000|NOT COMPLETED|Overall Study||0
11206766|NCT01870388|12397829|FG001|NOT COMPLETED|Overall Study||0
11206767|NCT01870583|12397840|FG000|STARTED|Overall Study||467
11206768|NCT01870583|12397841|FG001|STARTED|Overall Study||474
11206769|NCT01870583|12397842|FG002|STARTED|Overall Study||463
11348067|NCT02997176|12545080|FG002|STARTED|Overall Study||5
11348068|NCT02997176|12545081|FG003|STARTED|Overall Study||16
11348069|NCT02997176|12545078|FG000|COMPLETED|Overall Study||6
11348070|NCT02997176|12545079|FG001|COMPLETED|Overall Study||8
11348071|NCT02997176|12545080|FG002|COMPLETED|Overall Study||3
11348072|NCT02997176|12545081|FG003|COMPLETED|Overall Study||5
11348073|NCT02997176|12545078|FG000|NOT COMPLETED|Overall Study||1
11348074|NCT02997176|12545079|FG001|NOT COMPLETED|Overall Study||2
11348075|NCT02997176|12545080|FG002|NOT COMPLETED|Overall Study||2
11348076|NCT02997176|12545081|FG003|NOT COMPLETED|Overall Study||11
11348077|NCT02997722|12545093|FG000|STARTED|Overall Study||3
11348078|NCT02997722|12545094|FG001|STARTED|Overall Study||1
11348079|NCT02997722|12545093|FG000|COMPLETED|Overall Study||3
11075909|NCT01094730|12257875|FG000|STARTED|Period 1 (14 Days)||92
11075910|NCT01094730|12257876|FG001|STARTED|Period 1 (14 Days)||88
11075911|NCT01094730|12257875|FG000|COMPLETED|Period 1 (14 Days)||90
11075912|NCT01094730|12257876|FG001|COMPLETED|Period 1 (14 Days)||86
11075913|NCT01094730|12257875|FG000|NOT COMPLETED|Period 1 (14 Days)||2
11075914|NCT01094730|12257876|FG001|NOT COMPLETED|Period 1 (14 Days)||2
11075915|NCT01094730|12257875|FG000|STARTED|Period 2 (14 Days)||90
11075916|NCT01094730|12257876|FG001|STARTED|Period 2 (14 Days)||86
11075917|NCT01094730|12257875|FG000|COMPLETED|Period 2 (14 Days)||87
11075918|NCT01094730|12257876|FG001|COMPLETED|Period 2 (14 Days)||84
11075919|NCT01094730|12257875|FG000|NOT COMPLETED|Period 2 (14 Days)||3
11075920|NCT01094730|12257876|FG001|NOT COMPLETED|Period 2 (14 Days)||2
11075921|NCT01094743|12257883|FG000|STARTED|Period 1||52
11075922|NCT01094743|12257883|FG000|COMPLETED|Period 1||50
11075923|NCT01094743|12257883|FG000|NOT COMPLETED|Period 1||2
11075924|NCT01094743|12257883|FG000|STARTED|Period 2||50
11075925|NCT01094743|12257883|FG000|COMPLETED|Period 2||50
11075926|NCT01094743|12257883|FG000|NOT COMPLETED|Period 2||0
11075927|NCT01094808|12257891|FG000|STARTED|Overall Study||21
11075928|NCT01094808|12257892|FG001|STARTED|Overall Study||20
11075929|NCT01094808|12257893|FG002|STARTED|Overall Study||21
11075930|NCT01094808|12257891|FG000|COMPLETED|Overall Study||20
11075931|NCT01094808|12257892|FG001|COMPLETED|Overall Study||19
11075932|NCT01094808|12257893|FG002|COMPLETED|Overall Study||21
11075933|NCT01094808|12257891|FG000|NOT COMPLETED|Overall Study||1
11075934|NCT01094808|12257892|FG001|NOT COMPLETED|Overall Study||1
11075935|NCT01094808|12257893|FG002|NOT COMPLETED|Overall Study||0
11075936|NCT01094886|12257901|FG000|STARTED|Overall Study||53
11075937|NCT01094886|12257901|FG000|COMPLETED|Overall Study||46
11075938|NCT01094886|12257901|FG000|NOT COMPLETED|Overall Study||7
11075939|NCT01095094|12257905|FG000|STARTED|Overall Study||19
11075940|NCT01095094|12257905|FG000|COMPLETED|Overall Study||16
11075941|NCT01095094|12257905|FG000|NOT COMPLETED|Overall Study||3
11075942|NCT01095497|12257911|FG000|STARTED|Intravenous CINRYZE||14
11075943|NCT01095497|12257912|FG001|STARTED|Intravenous CINRYZE||12
11075944|NCT01095497|12257911|FG000|COMPLETED|Intravenous CINRYZE||13
11075945|NCT01095497|12257912|FG001|COMPLETED|Intravenous CINRYZE||12
11348080|NCT02997722|12545094|FG001|COMPLETED|Overall Study||1
11348081|NCT02997722|12545093|FG000|NOT COMPLETED|Overall Study||0
11348082|NCT02997722|12545094|FG001|NOT COMPLETED|Overall Study||0
11348083|NCT02997735|12545102|FG000|STARTED|Overall Study||233
11348084|NCT02997735|12545103|FG001|STARTED|Overall Study||251
11348085|NCT02997735|12545102|FG000|COMPLETED|Overall Study||233
11348086|NCT02997735|12545103|FG001|COMPLETED|Overall Study||251
11348087|NCT02997735|12545102|FG000|NOT COMPLETED|Overall Study||0
11348088|NCT02997735|12545103|FG001|NOT COMPLETED|Overall Study||0
11348089|NCT02997904|12545111|FG000|STARTED|Overall Study||51
11348090|NCT02997904|12545112|FG001|STARTED|Overall Study||49
11348091|NCT02997904|12545111|FG000|COMPLETED|Overall Study||51
11348092|NCT02997904|12545112|FG001|COMPLETED|Overall Study||49
11348093|NCT02997904|12545111|FG000|NOT COMPLETED|Overall Study||0
11348094|NCT02997904|12545112|FG001|NOT COMPLETED|Overall Study||0
11348095|NCT02998021|12545124|FG000|STARTED|Overall Study||8
11348096|NCT02998021|12545125|FG001|STARTED|Overall Study||2
11075946|NCT01095497|12257911|FG000|NOT COMPLETED|Intravenous CINRYZE||1
11075947|NCT01095497|12257912|FG001|NOT COMPLETED|Intravenous CINRYZE||0
11075948|NCT01095497|12257911|FG000|STARTED|Subcutaneous CINRYZE||13
11075949|NCT01095497|12257912|FG001|STARTED|Subcutaneous CINRYZE||12
11075950|NCT01095497|12257911|FG000|COMPLETED|Subcutaneous CINRYZE||12
11075951|NCT01095497|12257912|FG001|COMPLETED|Subcutaneous CINRYZE||12
11075952|NCT01095497|12257911|FG000|NOT COMPLETED|Subcutaneous CINRYZE||1
11075953|NCT01095497|12257912|FG001|NOT COMPLETED|Subcutaneous CINRYZE||0
11075954|NCT01095510|12257926|FG000|STARTED|Overall Study||3
11075955|NCT01095510|12257927|FG001|STARTED|Overall Study||0
11075956|NCT01095510|12257928|FG002|STARTED|Overall Study||3
11075957|NCT01095510|12257929|FG003|STARTED|Overall Study||3
11075958|NCT01095510|12257926|FG000|COMPLETED|Overall Study||3
11075959|NCT01095510|12257927|FG001|COMPLETED|Overall Study||0
11075960|NCT01095510|12257928|FG002|COMPLETED|Overall Study||3
11075961|NCT01095510|12257929|FG003|COMPLETED|Overall Study||3
11075962|NCT01095510|12257926|FG000|NOT COMPLETED|Overall Study||0
11075963|NCT01095510|12257927|FG001|NOT COMPLETED|Overall Study||0
11348097|NCT02998021|12545124|FG000|COMPLETED|Overall Study||5
11348098|NCT02998021|12545125|FG001|COMPLETED|Overall Study||0
11348099|NCT02998021|12545124|FG000|NOT COMPLETED|Overall Study||3
11348100|NCT02998021|12545125|FG001|NOT COMPLETED|Overall Study||2
11348101|NCT02998151|12545131|FG000|STARTED|Overall Study||29
11348102|NCT02998151|12545131|FG000|Placebo|Overall Study|Two participants withdrew from the study before receiving placebo.|27
11348103|NCT02998151|12545131|FG000|Acamprosate|Overall Study|Every participant received acamprosate prior to acamprosate's discontinuance.|16
11348104|NCT02998151|12545131|FG000|Lovastatin|Overall Study|All participants received lovastatin.|29
11348105|NCT02998151|12545131|FG000|Minocycline|Overall Study|Two participants withdrew from the study before receiving minocycline.|27
11348106|NCT02998151|12545131|FG000|Baclofen|Overall Study|All 13 remaining participants received baclofen after acamprosate was discontinued. Five participants were re-enrolled to receive baclofen.|18
11348107|NCT02998151|12545131|FG000|COMPLETED|Overall Study|Acamprosate was discontinued mid-study due to undetectable serum levels and replaced with baclofen. Participants who already completed acamprosate were given the option to re-enroll and receive baclofen. Five participants received all 5 interventions; 26 received 4+ interventions.|5
11348108|NCT02998151|12545131|FG000|NOT COMPLETED|Overall Study||24
11348109|NCT02998541|12545146|FG000|STARTED|Overall Study||86
11348110|NCT02998541|12545147|FG001|STARTED|Overall Study||90
11348111|NCT02998541|12545148|FG002|STARTED|Overall Study||43
11348112|NCT02998541|12545146|FG000|COMPLETED|Overall Study||78
11348113|NCT02998541|12545147|FG001|COMPLETED|Overall Study||81
11348114|NCT02998541|12545148|FG002|COMPLETED|Overall Study||37
11348115|NCT02998541|12545146|FG000|NOT COMPLETED|Overall Study||8
11348116|NCT02998541|12545147|FG001|NOT COMPLETED|Overall Study||9
11348117|NCT02998541|12545148|FG002|NOT COMPLETED|Overall Study||6
11348118|NCT02998554|12545158|FG000|STARTED|Overall Study||79
11348119|NCT02998554|12545159|FG001|STARTED|Overall Study||77
11348120|NCT02998554|12545158|FG000|COMPLETED|Overall Study||68
11348121|NCT02998554|12545159|FG001|COMPLETED|Overall Study||66
11348122|NCT02998554|12545158|FG000|NOT COMPLETED|Overall Study||11
11348123|NCT02998554|12545159|FG001|NOT COMPLETED|Overall Study||11
11348124|NCT02998684|12545169|FG000|STARTED|Overall Study||7
11348125|NCT02998684|12545170|FG001|STARTED|Overall Study||7
11348126|NCT02998684|12545169|FG000|COMPLETED|Overall Study||4
11348127|NCT02998684|12545170|FG001|COMPLETED|Overall Study||6
11348128|NCT02998684|12545169|FG000|NOT COMPLETED|Overall Study||3
11348129|NCT02998684|12545170|FG001|NOT COMPLETED|Overall Study||1
11348130|NCT02998996|12545182|FG000|STARTED|Overall Study||36
11348131|NCT02998996|12545183|FG001|STARTED|Overall Study||35
11348132|NCT02998996|12545184|FG002|STARTED|Overall Study||36
11348133|NCT02998996|12545185|FG003|STARTED|Overall Study||18
11348134|NCT02998996|12545186|FG004|STARTED|Overall Study||18
11348135|NCT02998996|12545187|FG005|STARTED|Overall Study||19
11348136|NCT02998996|12545182|FG000|COMPLETED|Overall Study||36
11348137|NCT02998996|12545183|FG001|COMPLETED|Overall Study||34
11348138|NCT02998996|12545184|FG002|COMPLETED|Overall Study||35
11348139|NCT02998996|12545185|FG003|COMPLETED|Overall Study||18
11348140|NCT02998996|12545186|FG004|COMPLETED|Overall Study||17
11348141|NCT02998996|12545187|FG005|COMPLETED|Overall Study||19
11348142|NCT02998996|12545182|FG000|NOT COMPLETED|Overall Study||0
11075964|NCT01095510|12257928|FG002|NOT COMPLETED|Overall Study||0
11075965|NCT01095510|12257929|FG003|NOT COMPLETED|Overall Study||0
11075966|NCT01095653|12257940|FG000|STARTED|Overall Study||132
11075967|NCT01095653|12257941|FG001|STARTED|Overall Study||128
11075968|NCT01095653|12257942|FG002|STARTED|Overall Study||133
11075969|NCT01095653|12257940|FG000|COMPLETED|Overall Study||113
11075970|NCT01095653|12257941|FG001|COMPLETED|Overall Study||113
11075971|NCT01095653|12257942|FG002|COMPLETED|Overall Study||117
11075972|NCT01095653|12257940|FG000|NOT COMPLETED|Overall Study||19
11075973|NCT01095653|12257941|FG001|NOT COMPLETED|Overall Study||15
11075974|NCT01095653|12257942|FG002|NOT COMPLETED|Overall Study||16
11075975|NCT01095666|12257953|FG000|STARTED|Overall Study||145
11075976|NCT01095666|12257954|FG001|STARTED|Overall Study||147
11075977|NCT01095666|12257955|FG002|STARTED|Overall Study||152
11075978|NCT01095666|12257953|FG000|COMPLETED|Overall Study||128
11075979|NCT01095666|12257954|FG001|COMPLETED|Overall Study||136
11075980|NCT01095666|12257955|FG002|COMPLETED|Overall Study||145
11075981|NCT01095666|12257953|FG000|NOT COMPLETED|Overall Study||17
11075982|NCT01095666|12257954|FG001|NOT COMPLETED|Overall Study||11
11075983|NCT01095666|12257955|FG002|NOT COMPLETED|Overall Study||7
11075984|NCT01095757|12257963|FG000|STARTED|Overall Study||45
11075985|NCT01095757|12257963|FG000|COMPLETED|Overall Study||45
11075986|NCT01095757|12257963|FG000|NOT COMPLETED|Overall Study||0
11075987|NCT01095796|12257970|FG000|STARTED|Overall Study||353
11075988|NCT01095796|12257971|FG001|STARTED|Overall Study||354
11348143|NCT02998996|12545183|FG001|NOT COMPLETED|Overall Study||1
11348144|NCT02998996|12545184|FG002|NOT COMPLETED|Overall Study||1
11348145|NCT02998996|12545185|FG003|NOT COMPLETED|Overall Study||0
11348146|NCT02998996|12545186|FG004|NOT COMPLETED|Overall Study||1
11075989|NCT01095796|12257970|FG000|COMPLETED|Overall Study||58
11075990|NCT01095796|12257971|FG001|COMPLETED|Overall Study||65
11075991|NCT01095796|12257970|FG000|NOT COMPLETED|Overall Study||295
11075992|NCT01095796|12257971|FG001|NOT COMPLETED|Overall Study||289
11075993|NCT01095835|12257980|FG000|STARTED|Overall Study||51
11075994|NCT01095835|12257981|FG001|STARTED|Overall Study||52
11075995|NCT01095835|12257982|FG002|STARTED|Overall Study||25
11075996|NCT01095835|12257980|FG000|COMPLETED|Overall Study||41
11075997|NCT01095835|12257981|FG001|COMPLETED|Overall Study||40
11075998|NCT01095835|12257982|FG002|COMPLETED|Overall Study||17
11075999|NCT01095835|12257980|FG000|NOT COMPLETED|Overall Study||10
11076000|NCT01095835|12257981|FG001|NOT COMPLETED|Overall Study||12
11076001|NCT01095835|12257982|FG002|NOT COMPLETED|Overall Study||8
11076002|NCT01095887|12257991|FG000|STARTED|Overall Study||6
11076003|NCT01095887|12257991|FG000|COMPLETED|Overall Study||6
11076004|NCT01095887|12257991|FG000|NOT COMPLETED|Overall Study||0
11076005|NCT01095978|12257995|FG000|STARTED|Overall Study||2822
11076006|NCT01095978|12257995|FG000|COMPLETED|Overall Study||2819
11076007|NCT01095978|12257995|FG000|NOT COMPLETED|Overall Study||3
11076008|NCT01096017|12258001|FG000|STARTED|Treatment Period 1||12
11076009|NCT01096017|12258002|FG001|STARTED|Treatment Period 1||12
11076010|NCT01096017|12258001|FG000|COMPLETED|Treatment Period 1||12
11076011|NCT01096017|12258002|FG001|COMPLETED|Treatment Period 1||12
11076012|NCT01096017|12258001|FG000|NOT COMPLETED|Treatment Period 1||0
11076013|NCT01096017|12258002|FG001|NOT COMPLETED|Treatment Period 1||0
11076014|NCT01096017|12258001|FG000|STARTED|Washout 1 - 14 Days||12
11076015|NCT01096017|12258002|FG001|STARTED|Washout 1 - 14 Days||12
11076016|NCT01096017|12258001|FG000|COMPLETED|Washout 1 - 14 Days||12
11076017|NCT01096017|12258002|FG001|COMPLETED|Washout 1 - 14 Days||12
11076018|NCT01096017|12258001|FG000|NOT COMPLETED|Washout 1 - 14 Days||0
11076019|NCT01096017|12258002|FG001|NOT COMPLETED|Washout 1 - 14 Days||0
11076020|NCT01096017|12258001|FG000|STARTED|Treatment Period 2||12
11076021|NCT01096017|12258002|FG001|STARTED|Treatment Period 2||12
11076022|NCT01096017|12258001|FG000|COMPLETED|Treatment Period 2||11
11076023|NCT01096017|12258002|FG001|COMPLETED|Treatment Period 2||11
11076024|NCT01096017|12258001|FG000|NOT COMPLETED|Treatment Period 2||1
11076025|NCT01096017|12258002|FG001|NOT COMPLETED|Treatment Period 2||1
11076026|NCT01096056|12258010|FG000|STARTED|Overall Study||20
11076027|NCT01096056|12258011|FG001|STARTED|Overall Study||20
11076028|NCT01096056|12258010|FG000|Completed at Day 42|Overall Study||20
11076029|NCT01096056|12258011|FG001|Completed at Day 42|Overall Study||20
11076030|NCT01096056|12258010|FG000|COMPLETED|Overall Study||20
11076031|NCT01096056|12258011|FG001|COMPLETED|Overall Study||19
11076032|NCT01096056|12258010|FG000|NOT COMPLETED|Overall Study||0
11076033|NCT01096056|12258011|FG001|NOT COMPLETED|Overall Study||1
11076034|NCT01096160|12258027|FG000|STARTED|Overall Study||6
11076035|NCT01096160|12258028|FG001|STARTED|Overall Study||2
11076036|NCT01096160|12258029|FG002|STARTED|Overall Study||6
11076037|NCT01096160|12258030|FG003|STARTED|Overall Study||2
11076038|NCT01096160|12258031|FG004|STARTED|Overall Study||6
11076039|NCT01096160|12258032|FG005|STARTED|Overall Study||2
11076040|NCT01096160|12258033|FG006|STARTED|Overall Study||6
11076041|NCT01096160|12258034|FG007|STARTED|Overall Study||2
11076042|NCT01096160|12258035|FG008|STARTED|Overall Study||6
11076043|NCT01096160|12258036|FG009|STARTED|Overall Study||2
11076044|NCT01096160|12258027|FG000|COMPLETED|Overall Study||6
11076045|NCT01096160|12258028|FG001|COMPLETED|Overall Study||2
11076046|NCT01096160|12258029|FG002|COMPLETED|Overall Study||5
11076047|NCT01096160|12258030|FG003|COMPLETED|Overall Study||2
11076048|NCT01096160|12258031|FG004|COMPLETED|Overall Study||5
11076049|NCT01096160|12258032|FG005|COMPLETED|Overall Study||2
11076050|NCT01096160|12258033|FG006|COMPLETED|Overall Study||4
11076051|NCT01096160|12258034|FG007|COMPLETED|Overall Study||2
11076052|NCT01096160|12258035|FG008|COMPLETED|Overall Study||4
11076053|NCT01096160|12258036|FG009|COMPLETED|Overall Study||1
11348147|NCT02998996|12545187|FG005|NOT COMPLETED|Overall Study||0
11076054|NCT01096160|12258027|FG000|NOT COMPLETED|Overall Study||0
11076055|NCT01096160|12258028|FG001|NOT COMPLETED|Overall Study||0
11076056|NCT01096160|12258029|FG002|NOT COMPLETED|Overall Study||1
11076057|NCT01096160|12258030|FG003|NOT COMPLETED|Overall Study||0
11076058|NCT01096160|12258031|FG004|NOT COMPLETED|Overall Study||1
11076059|NCT01096160|12258032|FG005|NOT COMPLETED|Overall Study||0
11076060|NCT01096160|12258033|FG006|NOT COMPLETED|Overall Study||2
11076061|NCT01096160|12258034|FG007|NOT COMPLETED|Overall Study||0
11076062|NCT01096160|12258035|FG008|NOT COMPLETED|Overall Study||2
11076063|NCT01096160|12258036|FG009|NOT COMPLETED|Overall Study||1
11076064|NCT01096186|12258071|FG000|STARTED|Overall Study||617
11076065|NCT01096186|12258071|FG000|COMPLETED|Overall Study||567
11076066|NCT01096186|12258071|FG000|NOT COMPLETED|Overall Study||50
11076067|NCT01096290|12258077|FG000|STARTED|Overall Study||9
11076068|NCT01096290|12258078|FG001|STARTED|Overall Study||14
11076069|NCT01096290|12258077|FG000|COMPLETED|Overall Study||9
11076070|NCT01096290|12258078|FG001|COMPLETED|Overall Study||14
11076071|NCT01096290|12258077|FG000|NOT COMPLETED|Overall Study||0
11076072|NCT01096290|12258078|FG001|NOT COMPLETED|Overall Study||0
11076073|NCT01096316|12258086|FG000|STARTED|Overall Study||102
11076074|NCT01096316|12258087|FG001|STARTED|Overall Study||103
11076075|NCT01096316|12258086|FG000|COMPLETED|Overall Study||87
11076076|NCT01096316|12258087|FG001|COMPLETED|Overall Study||94
11076077|NCT01096316|12258086|FG000|NOT COMPLETED|Overall Study||15
11076078|NCT01096316|12258087|FG001|NOT COMPLETED|Overall Study||9
11076079|NCT01096342|12258093|FG000|STARTED|Overall Study||16
11076080|NCT01096342|12258093|FG000|COMPLETED|Overall Study||15
11076081|NCT01096342|12258093|FG000|NOT COMPLETED|Overall Study||1
11076082|NCT01096446|12258099|FG000|STARTED|Overall Study||12
11076083|NCT01096446|12258100|FG001|STARTED|Overall Study||10
11076084|NCT01096446|12258099|FG000|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
11076085|NCT01096446|12258100|FG001|COMPLETED|Overall Study||10
11076086|NCT01096446|12258099|FG000|NOT COMPLETED|Overall Study||3
11076087|NCT01096446|12258100|FG001|NOT COMPLETED|Overall Study||0
11348148|NCT02999100|12545207|FG000|STARTED|Part 1 (up to 15 Days)||9
11348149|NCT02999100|12545208|FG001|STARTED|Part 1 (up to 15 Days)||8
11348150|NCT02999100|12545209|FG002|STARTED|Part 1 (up to 15 Days)||0
11348151|NCT02999100|12545210|FG003|STARTED|Part 1 (up to 15 Days)||0
11348152|NCT02999100|12545211|FG004|STARTED|Part 1 (up to 15 Days)||0
11348153|NCT02999100|12545212|FG005|STARTED|Part 1 (up to 15 Days)||0
11348154|NCT02999100|12545207|FG000|COMPLETED|Part 1 (up to 15 Days)||9
11348155|NCT02999100|12545208|FG001|COMPLETED|Part 1 (up to 15 Days)||7
11348156|NCT02999100|12545209|FG002|COMPLETED|Part 1 (up to 15 Days)||0
11348157|NCT02999100|12545210|FG003|COMPLETED|Part 1 (up to 15 Days)||0
11348158|NCT02999100|12545211|FG004|COMPLETED|Part 1 (up to 15 Days)||0
11348159|NCT02999100|12545212|FG005|COMPLETED|Part 1 (up to 15 Days)||0
11348160|NCT02999100|12545207|FG000|NOT COMPLETED|Part 1 (up to 15 Days)||0
11348161|NCT02999100|12545208|FG001|NOT COMPLETED|Part 1 (up to 15 Days)||1
11348162|NCT02999100|12545209|FG002|NOT COMPLETED|Part 1 (up to 15 Days)||0
11348163|NCT02999100|12545210|FG003|NOT COMPLETED|Part 1 (up to 15 Days)||0
11348164|NCT02999100|12545211|FG004|NOT COMPLETED|Part 1 (up to 15 Days)||0
11348165|NCT02999100|12545212|FG005|NOT COMPLETED|Part 1 (up to 15 Days)||0
11348166|NCT02999100|12545207|FG000|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
11348167|NCT02999100|12545208|FG001|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
11348168|NCT02999100|12545209|FG002|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|5
11348169|NCT02999100|12545210|FG003|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
11348170|NCT02999100|12545211|FG004|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
11348171|NCT02999100|12545212|FG005|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
11348172|NCT02999100|12545207|FG000|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
11348173|NCT02999100|12545208|FG001|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
11348174|NCT02999100|12545209|FG002|COMPLETED|Part 2 (Day 1): Dosing Session 1||4
11348175|NCT02999100|12545210|FG003|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
11348176|NCT02999100|12545211|FG004|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
11348177|NCT02999100|12545212|FG005|COMPLETED|Part 2 (Day 1): Dosing Session 1||2
11348178|NCT02999100|12545207|FG000|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
11348179|NCT02999100|12545208|FG001|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
11348180|NCT02999100|12545209|FG002|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
11348181|NCT02999100|12545210|FG003|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
11348182|NCT02999100|12545211|FG004|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
11348183|NCT02999100|12545212|FG005|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
11348184|NCT02999100|12545207|FG000|STARTED|Part 2 (Day 14): Dosing Session 2||0
11348185|NCT02999100|12545208|FG001|STARTED|Part 2 (Day 14): Dosing Session 2||0
11348186|NCT02999100|12545209|FG002|STARTED|Part 2 (Day 14): Dosing Session 2||4
11076088|NCT01096550|12258107|FG000|STARTED|Overall Study||170
11076089|NCT01096550|12258108|FG001|STARTED|Overall Study||175
11348187|NCT02999100|12545210|FG003|STARTED|Part 2 (Day 14): Dosing Session 2||3
11076090|NCT01096550|12258107|FG000|COMPLETED|Overall Study||133
11076091|NCT01096550|12258108|FG001|COMPLETED|Overall Study||146
11076092|NCT01096550|12258107|FG000|NOT COMPLETED|Overall Study||37
11076093|NCT01096550|12258108|FG001|NOT COMPLETED|Overall Study||29
11076094|NCT01096589|12258118|FG000|STARTED|Overall Study||22
11076095|NCT01096589|12258119|FG001|STARTED|Overall Study||20
11076096|NCT01096589|12258120|FG002|STARTED|Overall Study||22
11076097|NCT01096589|12258121|FG003|STARTED|Overall Study||18
11076098|NCT01096589|12258118|FG000|COMPLETED|Overall Study||18
11076099|NCT01096589|12258119|FG001|COMPLETED|Overall Study||18
11076100|NCT01096589|12258120|FG002|COMPLETED|Overall Study||18
11076101|NCT01096589|12258121|FG003|COMPLETED|Overall Study||15
11076102|NCT01096589|12258118|FG000|NOT COMPLETED|Overall Study||4
11076103|NCT01096589|12258119|FG001|NOT COMPLETED|Overall Study||2
11076104|NCT01096589|12258120|FG002|NOT COMPLETED|Overall Study||4
11076105|NCT01096589|12258121|FG003|NOT COMPLETED|Overall Study||3
11076106|NCT01096667|12258140|FG000|STARTED|Overall Study||39
11076107|NCT01096667|12258141|FG001|STARTED|Overall Study||39
11076108|NCT01096667|12258142|FG002|STARTED|Overall Study||38
11076109|NCT01096667|12258143|FG003|STARTED|Overall Study||39
11076110|NCT01096667|12258144|FG004|STARTED|Overall Study||39
11076111|NCT01096667|12258140|FG000|Treated|Overall Study||38
11076112|NCT01096667|12258141|FG001|Treated|Overall Study||39
11076113|NCT01096667|12258142|FG002|Treated|Overall Study||38
11076114|NCT01096667|12258143|FG003|Treated|Overall Study||39
11076115|NCT01096667|12258144|FG004|Treated|Overall Study||39
11076116|NCT01096667|12258140|FG000|COMPLETED|Overall Study||36
11076117|NCT01096667|12258141|FG001|COMPLETED|Overall Study||37
11076118|NCT01096667|12258142|FG002|COMPLETED|Overall Study||36
11076119|NCT01096667|12258143|FG003|COMPLETED|Overall Study||36
11076120|NCT01096667|12258144|FG004|COMPLETED|Overall Study||39
11076121|NCT01096667|12258140|FG000|NOT COMPLETED|Overall Study||3
11076122|NCT01096667|12258141|FG001|NOT COMPLETED|Overall Study||2
11076123|NCT01096667|12258142|FG002|NOT COMPLETED|Overall Study||2
11076124|NCT01096667|12258143|FG003|NOT COMPLETED|Overall Study||3
11076125|NCT01096667|12258144|FG004|NOT COMPLETED|Overall Study||0
11076126|NCT01096680|12258162|FG000|STARTED|Overall Study||27
11076127|NCT01096680|12258163|FG001|STARTED|Overall Study||27
11076128|NCT01096680|12258164|FG002|STARTED|Overall Study||27
11076129|NCT01096680|12258165|FG003|STARTED|Overall Study||27
11076130|NCT01096680|12258166|FG004|STARTED|Overall Study||27
11076131|NCT01096680|12258162|FG000|COMPLETED|Overall Study||27
11076132|NCT01096680|12258163|FG001|COMPLETED|Overall Study||27
11076133|NCT01096680|12258164|FG002|COMPLETED|Overall Study||27
11076134|NCT01096680|12258165|FG003|COMPLETED|Overall Study||27
11076135|NCT01096680|12258166|FG004|COMPLETED|Overall Study||27
11076136|NCT01096680|12258162|FG000|NOT COMPLETED|Overall Study||0
11076137|NCT01096680|12258163|FG001|NOT COMPLETED|Overall Study||0
11076138|NCT01096680|12258164|FG002|NOT COMPLETED|Overall Study||0
11076139|NCT01096680|12258165|FG003|NOT COMPLETED|Overall Study||0
11076140|NCT01096680|12258166|FG004|NOT COMPLETED|Overall Study||0
11076141|NCT01096771|12258180|FG000|STARTED|Overall Study||7
11076142|NCT01096771|12258181|FG001|STARTED|Overall Study||7
11076143|NCT01096771|12258180|FG000|COMPLETED|Overall Study||7
11076144|NCT01096771|12258181|FG001|COMPLETED|Overall Study||7
11076145|NCT01096771|12258180|FG000|NOT COMPLETED|Overall Study||0
11076146|NCT01096771|12258181|FG001|NOT COMPLETED|Overall Study||0
11076147|NCT01096784|12258189|FG000|STARTED|Overall Study||61
11076148|NCT01096784|12258190|FG001|STARTED|Overall Study||60
11076149|NCT01096784|12258189|FG000|COMPLETED|Overall Study||46
11076150|NCT01096784|12258190|FG001|COMPLETED|Overall Study||46
11076151|NCT01096784|12258189|FG000|NOT COMPLETED|Overall Study||15
11076152|NCT01096784|12258190|FG001|NOT COMPLETED|Overall Study||14
11076153|NCT01096810|12258198|FG000|STARTED|Overall Study||20
11076154|NCT01096810|12258198|FG000|COMPLETED|Overall Study||20
11076155|NCT01096810|12258198|FG000|NOT COMPLETED|Overall Study||0
11076156|NCT01096823|12258204|FG000|STARTED|Overall Study||14
11076157|NCT01096823|12258205|FG001|STARTED|Overall Study||16
11076158|NCT01096823|12258204|FG000|COMPLETED|Overall Study||11
11076159|NCT01096823|12258205|FG001|COMPLETED|Overall Study||15
11076160|NCT01096823|12258204|FG000|NOT COMPLETED|Overall Study||3
11076161|NCT01096823|12258205|FG001|NOT COMPLETED|Overall Study||1
11076162|NCT01096849|12258214|FG000|STARTED|Overall Study||22
11076163|NCT01096849|12258215|FG001|STARTED|Overall Study||76
11076164|NCT01096849|12258216|FG002|STARTED|Overall Study||47
11076165|NCT01096849|12258214|FG000|COMPLETED|Overall Study||20
11076166|NCT01096849|12258215|FG001|COMPLETED|Overall Study||64
11076167|NCT01096849|12258216|FG002|COMPLETED|Overall Study||41
11076168|NCT01096849|12258214|FG000|NOT COMPLETED|Overall Study||2
11076169|NCT01096849|12258215|FG001|NOT COMPLETED|Overall Study||12
11076170|NCT01096849|12258216|FG002|NOT COMPLETED|Overall Study||6
11076171|NCT01096875|12258226|FG000|STARTED|Overall Study||30
11076172|NCT01096875|12258227|FG001|STARTED|Overall Study||30
11076173|NCT01096875|12258226|FG000|COMPLETED|Overall Study||30
11076174|NCT01096875|12258227|FG001|COMPLETED|Overall Study||29
11076175|NCT01096875|12258226|FG000|NOT COMPLETED|Overall Study||0
11076176|NCT01096875|12258227|FG001|NOT COMPLETED|Overall Study||1
11076177|NCT01096992|12258240|FG000|STARTED|Overall Study||6
11076178|NCT01096992|12258241|FG001|STARTED|Overall Study||3
11076179|NCT01096992|12258242|FG002|STARTED|Overall Study||6
11076180|NCT01096992|12258243|FG003|STARTED|Overall Study||6
11076181|NCT01096992|12258244|FG004|STARTED|Overall Study||30
11076182|NCT01096992|12258240|FG000|COMPLETED|Overall Study||6
11076183|NCT01096992|12258241|FG001|COMPLETED|Overall Study||3
11076184|NCT01096992|12258242|FG002|COMPLETED|Overall Study||6
11076185|NCT01096992|12258243|FG003|COMPLETED|Overall Study||6
11076186|NCT01096992|12258244|FG004|COMPLETED|Overall Study||30
11076187|NCT01096992|12258240|FG000|NOT COMPLETED|Overall Study||0
11076188|NCT01096992|12258241|FG001|NOT COMPLETED|Overall Study||0
11076189|NCT01096992|12258242|FG002|NOT COMPLETED|Overall Study||0
11076190|NCT01096992|12258243|FG003|NOT COMPLETED|Overall Study||0
11076191|NCT01096992|12258244|FG004|NOT COMPLETED|Overall Study||0
11076192|NCT01097044|12258259|FG000|STARTED|Overall Study||39
11076193|NCT01097044|12258260|FG001|STARTED|Overall Study||38
11076194|NCT01097044|12258259|FG000|COMPLETED|Overall Study||34
11076195|NCT01097044|12258260|FG001|COMPLETED|Overall Study||33
11076196|NCT01097044|12258259|FG000|NOT COMPLETED|Overall Study||5
11076197|NCT01097044|12258260|FG001|NOT COMPLETED|Overall Study||5
11076198|NCT01097057|12258268|FG000|STARTED|Overall Study||20
11076199|NCT01097057|12258268|FG000|COMPLETED|Overall Study||17
11076200|NCT01097057|12258268|FG000|NOT COMPLETED|Overall Study||3
11076201|NCT01097304|12258272|FG000|STARTED|Overall Study||36
11076202|NCT01097304|12258272|FG000|COMPLETED|Overall Study||29
11076203|NCT01097304|12258272|FG000|NOT COMPLETED|Overall Study||7
11076204|NCT01097330|12258279|FG000|STARTED|Overall Study||7
11076205|NCT01097330|12258280|FG001|STARTED|Overall Study||5
11076206|NCT01097330|12258279|FG000|COMPLETED|Overall Study||0
11076207|NCT01097330|12258280|FG001|COMPLETED|Overall Study||0
11076208|NCT01097330|12258279|FG000|NOT COMPLETED|Overall Study||7
11076209|NCT01097330|12258280|FG001|NOT COMPLETED|Overall Study||5
11076210|NCT01097343|12258286|FG000|STARTED|First Intervention- 30 Days||25
11076211|NCT01097343|12258287|FG001|STARTED|First Intervention- 30 Days||25
11076212|NCT01097343|12258286|FG000|COMPLETED|First Intervention- 30 Days||25
11076213|NCT01097343|12258287|FG001|COMPLETED|First Intervention- 30 Days||25
11076214|NCT01097343|12258286|FG000|NOT COMPLETED|First Intervention- 30 Days||0
11076215|NCT01097343|12258287|FG001|NOT COMPLETED|First Intervention- 30 Days||0
11076216|NCT01097343|12258286|FG000|STARTED|Second Intervention- 30 Days||25
11076217|NCT01097343|12258287|FG001|STARTED|Second Intervention- 30 Days||25
11076218|NCT01097343|12258286|FG000|COMPLETED|Second Intervention- 30 Days||25
11076219|NCT01097343|12258287|FG001|COMPLETED|Second Intervention- 30 Days||25
11076220|NCT01097343|12258286|FG000|NOT COMPLETED|Second Intervention- 30 Days||0
11076221|NCT01097343|12258287|FG001|NOT COMPLETED|Second Intervention- 30 Days||0
11076222|NCT01097395|12258295|FG000|STARTED|Overall Study||17
11076223|NCT01097395|12258296|FG001|STARTED|Overall Study||18
11076224|NCT01097395|12258295|FG000|COMPLETED|Overall Study||14
11076225|NCT01097395|12258296|FG001|COMPLETED|Overall Study||14
11076226|NCT01097395|12258295|FG000|NOT COMPLETED|Overall Study||3
11076227|NCT01097395|12258296|FG001|NOT COMPLETED|Overall Study||4
11076228|NCT01097421|12258302|FG000|STARTED|Overall Study||328
11076229|NCT01097421|12258302|FG000|COMPLETED|Overall Study||314
11076230|NCT01097421|12258302|FG000|NOT COMPLETED|Overall Study||14
11076231|NCT01097460|12258306|FG000|STARTED|Overall Study||16
11076232|NCT01097460|12258306|FG000|COMPLETED|Overall Study||16
11076233|NCT01097460|12258306|FG000|NOT COMPLETED|Overall Study||0
11076234|NCT01097577|12258312|FG000|STARTED|Overall Study||67
11076235|NCT01097577|12258313|FG001|STARTED|Overall Study||63
11076236|NCT01097577|12258312|FG000|COMPLETED|Overall Study||67
11076237|NCT01097577|12258313|FG001|COMPLETED|Overall Study||62
11076238|NCT01097577|12258312|FG000|NOT COMPLETED|Overall Study||0
11076239|NCT01097577|12258313|FG001|NOT COMPLETED|Overall Study||1
11076240|NCT01097616|12258322|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
11076241|NCT01097616|12258323|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
11076242|NCT01097616|12258324|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
11076243|NCT01097616|12258325|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
11076244|NCT01097616|12258326|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
11076245|NCT01097616|12258327|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
11076246|NCT01097616|12258328|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
11076247|NCT01097616|12258329|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
11076248|NCT01097616|12258322|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
11076249|NCT01097616|12258323|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
11076250|NCT01097616|12258324|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
11076251|NCT01097616|12258325|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
11076252|NCT01097616|12258326|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
11076253|NCT01097616|12258327|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
11076254|NCT01097616|12258328|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
11076255|NCT01097616|12258329|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
11076256|NCT01097616|12258322|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
11076257|NCT01097616|12258323|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
11076258|NCT01097616|12258324|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
11076259|NCT01097616|12258325|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076260|NCT01097616|12258326|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076261|NCT01097616|12258327|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076262|NCT01097616|12258328|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076263|NCT01097616|12258329|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076264|NCT01097616|12258322|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
11076265|NCT01097616|12258323|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
11076266|NCT01097616|12258324|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
11076267|NCT01097616|12258325|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076268|NCT01097616|12258326|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076269|NCT01097616|12258327|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076270|NCT01097616|12258328|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076271|NCT01097616|12258329|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076272|NCT01097616|12258322|FG000|STARTED|Optional DB EXT Phase||100
11076273|NCT01097616|12258323|FG001|STARTED|Optional DB EXT Phase||172
11076274|NCT01097616|12258324|FG002|STARTED|Optional DB EXT Phase||151
11076275|NCT01097616|12258325|FG003|STARTED|Optional DB EXT Phase||0
11076276|NCT01097616|12258326|FG004|STARTED|Optional DB EXT Phase||0
11076277|NCT01097616|12258327|FG005|STARTED|Optional DB EXT Phase||0
11076278|NCT01097616|12258328|FG006|STARTED|Optional DB EXT Phase||0
11076279|NCT01097616|12258329|FG007|STARTED|Optional DB EXT Phase||0
11076280|NCT01097616|12258322|FG000|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
11076281|NCT01097616|12258323|FG001|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
11076282|NCT01097616|12258324|FG002|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
11076283|NCT01097616|12258325|FG003|COMPLETED|Optional DB EXT Phase||0
11076284|NCT01097616|12258326|FG004|COMPLETED|Optional DB EXT Phase||0
11076285|NCT01097616|12258327|FG005|COMPLETED|Optional DB EXT Phase||0
11076286|NCT01097616|12258328|FG006|COMPLETED|Optional DB EXT Phase||0
11076287|NCT01097616|12258329|FG007|COMPLETED|Optional DB EXT Phase||0
11076288|NCT01097616|12258322|FG000|NOT COMPLETED|Optional DB EXT Phase||15
11076289|NCT01097616|12258323|FG001|NOT COMPLETED|Optional DB EXT Phase||21
11076290|NCT01097616|12258324|FG002|NOT COMPLETED|Optional DB EXT Phase||10
11076291|NCT01097616|12258325|FG003|NOT COMPLETED|Optional DB EXT Phase||0
11076292|NCT01097616|12258326|FG004|NOT COMPLETED|Optional DB EXT Phase||0
11076293|NCT01097616|12258327|FG005|NOT COMPLETED|Optional DB EXT Phase||0
11076294|NCT01097616|12258328|FG006|NOT COMPLETED|Optional DB EXT Phase||0
11076295|NCT01097616|12258329|FG007|NOT COMPLETED|Optional DB EXT Phase||0
11076296|NCT01097616|12258322|FG000|STARTED|DB RO Phase||0
11076297|NCT01097616|12258323|FG001|STARTED|DB RO Phase||0
11076298|NCT01097616|12258324|FG002|STARTED|DB RO Phase||0
11076299|NCT01097616|12258325|FG003|STARTED|DB RO Phase||101
11348188|NCT02999100|12545211|FG004|STARTED|Part 2 (Day 14): Dosing Session 2||3
11348189|NCT02999100|12545212|FG005|STARTED|Part 2 (Day 14): Dosing Session 2||2
11348190|NCT02999100|12545207|FG000|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
11348191|NCT02999100|12545208|FG001|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
11348192|NCT02999100|12545209|FG002|COMPLETED|Part 2 (Day 14): Dosing Session 2||4
11348193|NCT02999100|12545210|FG003|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
11348194|NCT02999100|12545211|FG004|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
11348195|NCT02999100|12545212|FG005|COMPLETED|Part 2 (Day 14): Dosing Session 2||2
11348196|NCT02999100|12545207|FG000|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
11348197|NCT02999100|12545208|FG001|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
11348198|NCT02999100|12545209|FG002|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
11076300|NCT01097616|12258326|FG004|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
11206770|NCT01870583|12397840|FG000|COMPLETED|Overall Study||456
11206771|NCT01870583|12397841|FG001|COMPLETED|Overall Study||456
11206772|NCT01870583|12397842|FG002|COMPLETED|Overall Study||455
11206773|NCT01870583|12397840|FG000|NOT COMPLETED|Overall Study||11
11206774|NCT01870583|12397841|FG001|NOT COMPLETED|Overall Study||18
11206775|NCT01870583|12397842|FG002|NOT COMPLETED|Overall Study||8
11206776|NCT01870596|12397852|FG000|STARTED|Overall Study||14
11206777|NCT01870596|12397853|FG001|STARTED|Overall Study||18
11206778|NCT01870596|12397852|FG000|COMPLETED|Overall Study||14
11206779|NCT01870596|12397853|FG001|COMPLETED|Overall Study||18
11206780|NCT01870596|12397852|FG000|NOT COMPLETED|Overall Study||0
11076301|NCT01097616|12258327|FG005|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
11076302|NCT01097616|12258328|FG006|STARTED|DB RO Phase||162
11076303|NCT01097616|12258329|FG007|STARTED|DB RO Phase||327
11076304|NCT01097616|12258322|FG000|COMPLETED|DB RO Phase||0
11076305|NCT01097616|12258323|FG001|COMPLETED|DB RO Phase||0
11076306|NCT01097616|12258324|FG002|COMPLETED|DB RO Phase||0
11076307|NCT01097616|12258325|FG003|COMPLETED|DB RO Phase||100
11076308|NCT01097616|12258326|FG004|COMPLETED|DB RO Phase||111
11076309|NCT01097616|12258327|FG005|COMPLETED|DB RO Phase||159
11076310|NCT01097616|12258328|FG006|COMPLETED|DB RO Phase||161
11076311|NCT01097616|12258329|FG007|COMPLETED|DB RO Phase||326
11076312|NCT01097616|12258322|FG000|NOT COMPLETED|DB RO Phase||0
11076313|NCT01097616|12258323|FG001|NOT COMPLETED|DB RO Phase||0
11076314|NCT01097616|12258324|FG002|NOT COMPLETED|DB RO Phase||0
11076315|NCT01097616|12258325|FG003|NOT COMPLETED|DB RO Phase||1
11076316|NCT01097616|12258326|FG004|NOT COMPLETED|DB RO Phase||1
11076317|NCT01097616|12258327|FG005|NOT COMPLETED|DB RO Phase||2
11076318|NCT01097616|12258328|FG006|NOT COMPLETED|DB RO Phase||1
11076319|NCT01097616|12258329|FG007|NOT COMPLETED|DB RO Phase||1
11076320|NCT01097629|12258358|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
11076321|NCT01097629|12258359|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
11076322|NCT01097629|12258360|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
11076323|NCT01097629|12258361|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
11076324|NCT01097629|12258362|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
11076325|NCT01097629|12258363|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
11076326|NCT01097629|12258364|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
11076327|NCT01097629|12258365|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
11076328|NCT01097629|12258358|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
11076329|NCT01097629|12258359|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
11076330|NCT01097629|12258360|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
11076331|NCT01097629|12258361|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
11076332|NCT01097629|12258362|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
11076333|NCT01097629|12258363|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
11076334|NCT01097629|12258364|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
11076335|NCT01097629|12258365|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
11348199|NCT02999100|12545210|FG003|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
11348200|NCT02999100|12545211|FG004|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
11348201|NCT02999100|12545212|FG005|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
11348202|NCT02999178|12545236|FG000|STARTED|Overall Study||332
11348203|NCT02999178|12545237|FG001|STARTED|Overall Study||331
11076336|NCT01097629|12258358|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
11076337|NCT01097629|12258359|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
11076338|NCT01097629|12258360|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
11076339|NCT01097629|12258361|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076340|NCT01097629|12258362|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076341|NCT01097629|12258363|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076342|NCT01097629|12258364|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076343|NCT01097629|12258365|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076344|NCT01097629|12258358|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
11076345|NCT01097629|12258359|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
11076346|NCT01097629|12258360|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
11076347|NCT01097629|12258361|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076348|NCT01097629|12258362|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076349|NCT01097629|12258363|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076350|NCT01097629|12258364|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076351|NCT01097629|12258365|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
11076352|NCT01097629|12258358|FG000|STARTED|DB RO Phase||0
11076353|NCT01097629|12258359|FG001|STARTED|DB RO Phase||0
11076354|NCT01097629|12258360|FG002|STARTED|DB RO Phase||0
11076355|NCT01097629|12258361|FG003|STARTED|DB RO Phase||97
11076356|NCT01097629|12258362|FG004|STARTED|DB RO Phase||108
11076357|NCT01097629|12258363|FG005|STARTED|DB RO Phase||173
11076358|NCT01097629|12258364|FG006|STARTED|DB RO Phase||171
11076359|NCT01097629|12258365|FG007|STARTED|DB RO Phase||327
11076360|NCT01097629|12258358|FG000|COMPLETED|DB RO Phase||0
11076361|NCT01097629|12258359|FG001|COMPLETED|DB RO Phase||0
11076362|NCT01097629|12258360|FG002|COMPLETED|DB RO Phase||0
11076363|NCT01097629|12258361|FG003|COMPLETED|DB RO Phase||96
11076364|NCT01097629|12258362|FG004|COMPLETED|DB RO Phase||108
11076365|NCT01097629|12258363|FG005|COMPLETED|DB RO Phase||172
11076366|NCT01097629|12258364|FG006|COMPLETED|DB RO Phase||168
11076367|NCT01097629|12258365|FG007|COMPLETED|DB RO Phase||326
11076368|NCT01097629|12258358|FG000|NOT COMPLETED|DB RO Phase||0
11076369|NCT01097629|12258359|FG001|NOT COMPLETED|DB RO Phase||0
11076370|NCT01097629|12258360|FG002|NOT COMPLETED|DB RO Phase||0
11076371|NCT01097629|12258361|FG003|NOT COMPLETED|DB RO Phase||1
11076372|NCT01097629|12258362|FG004|NOT COMPLETED|DB RO Phase||0
11076373|NCT01097629|12258363|FG005|NOT COMPLETED|DB RO Phase||1
11076374|NCT01097629|12258364|FG006|NOT COMPLETED|DB RO Phase||3
11076375|NCT01097629|12258365|FG007|NOT COMPLETED|DB RO Phase||1
11076376|NCT01097642|12258390|FG000|STARTED|Overall Study||15
11076377|NCT01097642|12258391|FG001|STARTED|Overall Study||25
11076378|NCT01097642|12258390|FG000|COMPLETED|Overall Study||15
11076379|NCT01097642|12258391|FG001|COMPLETED|Overall Study||25
11076380|NCT01097642|12258390|FG000|NOT COMPLETED|Overall Study||0
11076381|NCT01097642|12258391|FG001|NOT COMPLETED|Overall Study||0
11076382|NCT01097655|12258397|FG000|STARTED|Overall Study||3049
11076383|NCT01097655|12258397|FG000|COMPLETED|Overall Study|participants included for analysis|3039
11076384|NCT01097655|12258397|FG000|NOT COMPLETED|Overall Study||10
11076385|NCT01097668|12258403|FG000|STARTED|Overall Study||21
11076386|NCT01097668|12258404|FG001|STARTED|Overall Study||22
11076387|NCT01097668|12258403|FG000|Week 20|Overall Study|Patient evaluability time point = week 20|21
11076388|NCT01097668|12258404|FG001|Week 20|Overall Study|Patient evaluability time point = week 20|22
11076389|NCT01097668|12258403|FG000|Week 48|Overall Study||19
11076390|NCT01097668|12258404|FG001|Week 48|Overall Study||20
11076391|NCT01097668|12258403|FG000|COMPLETED|Overall Study||19
11076392|NCT01097668|12258404|FG001|COMPLETED|Overall Study||20
11076393|NCT01097668|12258403|FG000|NOT COMPLETED|Overall Study||2
11076394|NCT01097668|12258404|FG001|NOT COMPLETED|Overall Study||2
11076395|NCT01097694|12258416|FG000|STARTED|Overall Study||32
11076396|NCT01097694|12258417|FG001|STARTED|Overall Study||30
11076397|NCT01097694|12258416|FG000|COMPLETED|Overall Study||24
11076398|NCT01097694|12258417|FG001|COMPLETED|Overall Study||26
11076399|NCT01097694|12258416|FG000|NOT COMPLETED|Overall Study||8
11076400|NCT01097694|12258417|FG001|NOT COMPLETED|Overall Study||4
11076401|NCT01097707|12258428|FG000|STARTED|Overall Study||83
11076402|NCT01097707|12258429|FG001|STARTED|Overall Study||80
11076403|NCT01097707|12258430|FG002|STARTED|Overall Study||82
11076404|NCT01097707|12258431|FG003|STARTED|Overall Study||84
11076405|NCT01097707|12258432|FG004|STARTED|Overall Study||85
11076406|NCT01097707|12258428|FG000|COMPLETED|Overall Study||39
11076407|NCT01097707|12258429|FG001|COMPLETED|Overall Study||37
11076408|NCT01097707|12258430|FG002|COMPLETED|Overall Study||37
11076409|NCT01097707|12258431|FG003|COMPLETED|Overall Study||40
11076410|NCT01097707|12258432|FG004|COMPLETED|Overall Study||35
11076411|NCT01097707|12258428|FG000|NOT COMPLETED|Overall Study||44
11076412|NCT01097707|12258429|FG001|NOT COMPLETED|Overall Study||43
11076413|NCT01097707|12258430|FG002|NOT COMPLETED|Overall Study||45
11076414|NCT01097707|12258431|FG003|NOT COMPLETED|Overall Study||44
11076415|NCT01097707|12258432|FG004|NOT COMPLETED|Overall Study||50
11076416|NCT01097785|12258446|FG000|STARTED|Cycle 1 (30 Days)||6
11076417|NCT01097785|12258447|FG001|STARTED|Cycle 1 (30 Days)||6
11076418|NCT01097785|12258446|FG000|COMPLETED|Cycle 1 (30 Days)||6
11076419|NCT01097785|12258447|FG001|COMPLETED|Cycle 1 (30 Days)||6
11076420|NCT01097785|12258446|FG000|NOT COMPLETED|Cycle 1 (30 Days)||0
11076421|NCT01097785|12258447|FG001|NOT COMPLETED|Cycle 1 (30 Days)||0
11076422|NCT01097785|12258446|FG000|STARTED|Washout (2 Weeks)||6
11076423|NCT01097785|12258447|FG001|STARTED|Washout (2 Weeks)||6
11076424|NCT01097785|12258446|FG000|COMPLETED|Washout (2 Weeks)||6
11076425|NCT01097785|12258447|FG001|COMPLETED|Washout (2 Weeks)||6
11076426|NCT01097785|12258446|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11076427|NCT01097785|12258447|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11076428|NCT01097785|12258446|FG000|STARTED|Cycle 3 (30 Days)||6
11076429|NCT01097785|12258447|FG001|STARTED|Cycle 3 (30 Days)||6
11076430|NCT01097785|12258446|FG000|COMPLETED|Cycle 3 (30 Days)||6
11076431|NCT01097785|12258447|FG001|COMPLETED|Cycle 3 (30 Days)||6
11076432|NCT01097785|12258446|FG000|NOT COMPLETED|Cycle 3 (30 Days)||0
11076433|NCT01097785|12258447|FG001|NOT COMPLETED|Cycle 3 (30 Days)||0
11076434|NCT01097863|12258457|FG000|STARTED|Overall Study||90
11076435|NCT01097863|12258458|FG001|STARTED|Overall Study||98
11076436|NCT01097863|12258459|FG002|STARTED|Overall Study||91
11076437|NCT01097863|12258457|FG000|COMPLETED|Overall Study||89
11076438|NCT01097863|12258458|FG001|COMPLETED|Overall Study||98
11076439|NCT01097863|12258459|FG002|COMPLETED|Overall Study||89
11076440|NCT01097863|12258457|FG000|NOT COMPLETED|Overall Study||1
11076441|NCT01097863|12258458|FG001|NOT COMPLETED|Overall Study||0
11076442|NCT01097863|12258459|FG002|NOT COMPLETED|Overall Study||2
11076443|NCT01097915|12258470|FG000|STARTED|Overall Study||50
11076444|NCT01097915|12258471|FG001|STARTED|Overall Study||70
11076445|NCT01097915|12258472|FG002|STARTED|Overall Study||50
11076446|NCT01097915|12258470|FG000|COMPLETED|Overall Study||27
11076447|NCT01097915|12258471|FG001|COMPLETED|Overall Study||28
11076448|NCT01097915|12258472|FG002|COMPLETED|Overall Study||20
11076449|NCT01097915|12258470|FG000|NOT COMPLETED|Overall Study||23
11348204|NCT02999178|12545236|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|218
11076450|NCT01097915|12258471|FG001|NOT COMPLETED|Overall Study||42
11076451|NCT01097915|12258472|FG002|NOT COMPLETED|Overall Study||30
11076452|NCT01098006|12258491|FG000|STARTED|Overall Study||7
11076453|NCT01098006|12258492|FG001|STARTED|Overall Study||11
11076454|NCT01098006|12258493|FG002|STARTED|Overall Study||60
11076455|NCT01098006|12258494|FG003|STARTED|Overall Study||21
11076456|NCT01098006|12258491|FG000|COMPLETED|Overall Study||7
11076457|NCT01098006|12258492|FG001|COMPLETED|Overall Study||11
11076458|NCT01098006|12258493|FG002|COMPLETED|Overall Study||60
11076459|NCT01098006|12258494|FG003|COMPLETED|Overall Study||21
11076460|NCT01098006|12258491|FG000|NOT COMPLETED|Overall Study||0
11076461|NCT01098006|12258492|FG001|NOT COMPLETED|Overall Study||0
11076462|NCT01098006|12258493|FG002|NOT COMPLETED|Overall Study||0
11076463|NCT01098006|12258494|FG003|NOT COMPLETED|Overall Study||0
11076464|NCT01098097|12258504|FG000|STARTED|Overall Study||963
11076465|NCT01098097|12258504|FG000|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
11076466|NCT01098097|12258504|FG000|NOT COMPLETED|Overall Study||82
11076467|NCT01098162|12258508|FG000|STARTED|Overall Study||573
11076468|NCT01098162|12258508|FG000|COMPLETED|Overall Study||461
11076469|NCT01098162|12258508|FG000|NOT COMPLETED|Overall Study||112
11076470|NCT01098240|12258512|FG000|STARTED|Open-Label Phase||297
11076471|NCT01098240|12258513|FG001|STARTED|Open-Label Phase||0
11076472|NCT01098240|12258514|FG002|STARTED|Open-Label Phase||0
11076473|NCT01098240|12258512|FG000|COMPLETED|Open-Label Phase||162
11076474|NCT01098240|12258513|FG001|COMPLETED|Open-Label Phase||0
11076475|NCT01098240|12258514|FG002|COMPLETED|Open-Label Phase||0
11076476|NCT01098240|12258512|FG000|NOT COMPLETED|Open-Label Phase||135
11076477|NCT01098240|12258513|FG001|NOT COMPLETED|Open-Label Phase||0
11076478|NCT01098240|12258514|FG002|NOT COMPLETED|Open-Label Phase||0
11076479|NCT01098240|12258512|FG000|STARTED|Double-Blind Phase||0
11076480|NCT01098240|12258513|FG001|STARTED|Double-Blind Phase||77
11076481|NCT01098240|12258514|FG002|STARTED|Double-Blind Phase||85
11076482|NCT01098240|12258512|FG000|COMPLETED|Double-Blind Phase||0
11076483|NCT01098240|12258513|FG001|COMPLETED|Double-Blind Phase||60
11076484|NCT01098240|12258514|FG002|COMPLETED|Double-Blind Phase||63
11076485|NCT01098240|12258512|FG000|NOT COMPLETED|Double-Blind Phase||0
11076486|NCT01098240|12258513|FG001|NOT COMPLETED|Double-Blind Phase||17
11076487|NCT01098240|12258514|FG002|NOT COMPLETED|Double-Blind Phase||22
11076488|NCT01098253|12258523|FG000|STARTED|Overall Study||94
11076489|NCT01098253|12258524|FG001|STARTED|Overall Study||88
11076490|NCT01098253|12258523|FG000|COMPLETED|Overall Study||92
11076491|NCT01098253|12258524|FG001|COMPLETED|Overall Study||88
11076492|NCT01098253|12258523|FG000|NOT COMPLETED|Overall Study||2
11076493|NCT01098253|12258524|FG001|NOT COMPLETED|Overall Study||0
11076494|NCT01098266|12258532|FG000|STARTED|Overall Study||200
11076495|NCT01098266|12258533|FG001|STARTED|Overall Study||200
11076496|NCT01098266|12258532|FG000|COMPLETED|Overall Study||193
11076497|NCT01098266|12258533|FG001|COMPLETED|Overall Study||193
11076498|NCT01098266|12258532|FG000|NOT COMPLETED|Overall Study||7
11076499|NCT01098266|12258533|FG001|NOT COMPLETED|Overall Study||7
11076500|NCT01098305|12258541|FG000|STARTED|Overall Study||119
11076501|NCT01098305|12258542|FG001|STARTED|Overall Study||118
11076502|NCT01098305|12258541|FG000|COMPLETED|Overall Study||88
11076503|NCT01098305|12258542|FG001|COMPLETED|Overall Study||85
11076504|NCT01098305|12258541|FG000|NOT COMPLETED|Overall Study||31
11076505|NCT01098305|12258542|FG001|NOT COMPLETED|Overall Study||33
11076506|NCT01098318|12258551|FG000|STARTED|Overall Study||20
11076507|NCT01098318|12258552|FG001|STARTED|Overall Study||19
11076508|NCT01098318|12258553|FG002|STARTED|Overall Study||18
11076509|NCT01098318|12258551|FG000|COMPLETED|Overall Study||17
11076510|NCT01098318|12258552|FG001|COMPLETED|Overall Study||12
11076511|NCT01098318|12258553|FG002|COMPLETED|Overall Study||15
11076512|NCT01098318|12258551|FG000|NOT COMPLETED|Overall Study||3
11076513|NCT01098318|12258552|FG001|NOT COMPLETED|Overall Study||7
11076514|NCT01098318|12258553|FG002|NOT COMPLETED|Overall Study||3
11076515|NCT01098422|12258561|FG000|STARTED|Overall Study||10
11076516|NCT01098422|12258561|FG000|COMPLETED|Overall Study||9
11076517|NCT01098422|12258561|FG000|NOT COMPLETED|Overall Study||1
11076518|NCT01098461|12258569|FG000|STARTED|Treatment Period (TP) (16 Weeks)||53
11076519|NCT01098461|12258570|FG001|STARTED|Treatment Period (TP) (16 Weeks)||52
11076520|NCT01098461|12258571|FG002|STARTED|Treatment Period (TP) (16 Weeks)||54
11076521|NCT01098461|12258572|FG003|STARTED|Treatment Period (TP) (16 Weeks)||53
11076522|NCT01098461|12258569|FG000|COMPLETED|Treatment Period (TP) (16 Weeks)||41
11076523|NCT01098461|12258570|FG001|COMPLETED|Treatment Period (TP) (16 Weeks)||45
11076524|NCT01098461|12258571|FG002|COMPLETED|Treatment Period (TP) (16 Weeks)||53
11076525|NCT01098461|12258572|FG003|COMPLETED|Treatment Period (TP) (16 Weeks)||50
11076526|NCT01098461|12258569|FG000|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
11076527|NCT01098461|12258570|FG001|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
11076528|NCT01098461|12258571|FG002|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
11076529|NCT01098461|12258572|FG003|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
11076530|NCT01098461|12258569|FG000|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
11076531|NCT01098461|12258570|FG001|STARTED|Follow-up (FU) Period (8 Weeks)||52
11076532|NCT01098461|12258571|FG002|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
11076533|NCT01098461|12258572|FG003|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
11076534|NCT01098461|12258569|FG000|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
11076535|NCT01098461|12258570|FG001|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
11076536|NCT01098461|12258571|FG002|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
11076537|NCT01098461|12258572|FG003|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
11076538|NCT01098461|12258569|FG000|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
11076539|NCT01098461|12258570|FG001|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
11076540|NCT01098461|12258571|FG002|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
11076541|NCT01098461|12258572|FG003|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
11076542|NCT01098474|12258589|FG000|STARTED|Active Phase||50
11076543|NCT01098474|12258590|FG001|STARTED|Active Phase||50
11076544|NCT01098474|12258591|FG002|STARTED|Active Phase||50
11076545|NCT01098474|12258592|FG003|STARTED|Active Phase||49
11076546|NCT01098474|12258593|FG004|STARTED|Active Phase||52
11076547|NCT01098474|12258594|FG005|STARTED|Active Phase||49
11076548|NCT01098474|12258589|FG000|COMPLETED|Active Phase||48
11076549|NCT01098474|12258590|FG001|COMPLETED|Active Phase||49
11076550|NCT01098474|12258591|FG002|COMPLETED|Active Phase||45
11076551|NCT01098474|12258592|FG003|COMPLETED|Active Phase||49
11076552|NCT01098474|12258593|FG004|COMPLETED|Active Phase||52
11076553|NCT01098474|12258594|FG005|COMPLETED|Active Phase||49
11076554|NCT01098474|12258589|FG000|NOT COMPLETED|Active Phase||2
11076555|NCT01098474|12258590|FG001|NOT COMPLETED|Active Phase||1
11076556|NCT01098474|12258591|FG002|NOT COMPLETED|Active Phase||5
11076557|NCT01098474|12258592|FG003|NOT COMPLETED|Active Phase||0
11076558|NCT01098474|12258593|FG004|NOT COMPLETED|Active Phase||0
11076559|NCT01098474|12258594|FG005|NOT COMPLETED|Active Phase||0
11076560|NCT01098474|12258589|FG000|STARTED|Follow Up Phase||48
11076561|NCT01098474|12258590|FG001|STARTED|Follow Up Phase||49
11076562|NCT01098474|12258591|FG002|STARTED|Follow Up Phase||45
11076563|NCT01098474|12258592|FG003|STARTED|Follow Up Phase||49
11076564|NCT01098474|12258593|FG004|STARTED|Follow Up Phase||52
11076565|NCT01098474|12258594|FG005|STARTED|Follow Up Phase||49
11076566|NCT01098474|12258589|FG000|COMPLETED|Follow Up Phase||48
11076567|NCT01098474|12258590|FG001|COMPLETED|Follow Up Phase||49
11076568|NCT01098474|12258591|FG002|COMPLETED|Follow Up Phase||45
11076569|NCT01098474|12258592|FG003|COMPLETED|Follow Up Phase||47
11076570|NCT01098474|12258593|FG004|COMPLETED|Follow Up Phase||50
11076571|NCT01098474|12258594|FG005|COMPLETED|Follow Up Phase||44
11076572|NCT01098474|12258589|FG000|NOT COMPLETED|Follow Up Phase||0
11076573|NCT01098474|12258590|FG001|NOT COMPLETED|Follow Up Phase||0
11076574|NCT01098474|12258591|FG002|NOT COMPLETED|Follow Up Phase||0
11076575|NCT01098474|12258592|FG003|NOT COMPLETED|Follow Up Phase||2
11076576|NCT01098474|12258593|FG004|NOT COMPLETED|Follow Up Phase||2
11076577|NCT01098474|12258594|FG005|NOT COMPLETED|Follow Up Phase||5
11076578|NCT01098487|12258618|FG000|STARTED|Overall Study||162
11076579|NCT01098487|12258618|FG000|COMPLETED|Overall Study||118
11076580|NCT01098487|12258618|FG000|NOT COMPLETED|Overall Study||44
11076581|NCT01098500|12258622|FG000|STARTED|Overall Study||3800
11076582|NCT01098500|12258622|FG000|COMPLETED|Overall Study||3800
11076583|NCT01098500|12258622|FG000|NOT COMPLETED|Overall Study||0
11076584|NCT01098539|12258628|FG000|STARTED|Overall Study||249
11076585|NCT01098539|12258629|FG001|STARTED|Overall Study||246
11076586|NCT01098539|12258628|FG000|COMPLETED|Overall Study||198
11076587|NCT01098539|12258629|FG001|COMPLETED|Overall Study||178
11076588|NCT01098539|12258628|FG000|NOT COMPLETED|Overall Study||51
11076589|NCT01098539|12258629|FG001|NOT COMPLETED|Overall Study||68
11076590|NCT01098578|12258635|FG000|STARTED|Overall Study||20
11076591|NCT01098578|12258635|FG000|COMPLETED|Overall Study||20
11076592|NCT01098578|12258635|FG000|NOT COMPLETED|Overall Study||0
11076593|NCT01098747|12258645|FG000|STARTED|Overall Study||48
11076594|NCT01098747|12258646|FG001|STARTED|Overall Study||95
11076595|NCT01098747|12258647|FG002|STARTED|Overall Study||86
11076596|NCT01098747|12258648|FG003|STARTED|Overall Study||87
11076597|NCT01098747|12258645|FG000|COMPLETED|Overall Study||48
11076598|NCT01098747|12258646|FG001|COMPLETED|Overall Study||95
11076599|NCT01098747|12258647|FG002|COMPLETED|Overall Study||86
11076600|NCT01098747|12258648|FG003|COMPLETED|Overall Study||87
11076601|NCT01098747|12258645|FG000|NOT COMPLETED|Overall Study||0
11076602|NCT01098747|12258646|FG001|NOT COMPLETED|Overall Study||0
11076603|NCT01098747|12258647|FG002|NOT COMPLETED|Overall Study||0
11076604|NCT01098747|12258648|FG003|NOT COMPLETED|Overall Study||0
11076605|NCT01098812|12258660|FG000|STARTED|Overall Study||95
11076606|NCT01098812|12258661|FG001|STARTED|Overall Study||102
11076607|NCT01098812|12258662|FG002|STARTED|Overall Study||72
11076608|NCT01098812|12258660|FG000|COMPLETED|Overall Study||93
11076609|NCT01098812|12258661|FG001|COMPLETED|Overall Study||101
11076610|NCT01098812|12258662|FG002|COMPLETED|Overall Study||71
11076611|NCT01098812|12258660|FG000|NOT COMPLETED|Overall Study||2
11076612|NCT01098812|12258661|FG001|NOT COMPLETED|Overall Study||1
11076613|NCT01098812|12258662|FG002|NOT COMPLETED|Overall Study||1
11076614|NCT01098851|12258671|FG000|STARTED|Overall Study||11
11076615|NCT01098851|12258672|FG001|STARTED|Overall Study||10
11076616|NCT01098851|12258671|FG000|COMPLETED|Overall Study||10
11076617|NCT01098851|12258672|FG001|COMPLETED|Overall Study||10
11076618|NCT01098851|12258671|FG000|NOT COMPLETED|Overall Study||1
11076619|NCT01098851|12258672|FG001|NOT COMPLETED|Overall Study||0
11076620|NCT01099111|12258683|FG000|STARTED|Overall Study||50
11076621|NCT01099111|12258684|FG001|STARTED|Overall Study||50
11076622|NCT01099111|12258685|FG002|STARTED|Overall Study||46
11076623|NCT01099111|12258686|FG003|STARTED|Overall Study||29
11076624|NCT01099111|12258687|FG004|STARTED|Overall Study||50
11076625|NCT01099111|12258683|FG000|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
11076626|NCT01099111|12258684|FG001|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
11076627|NCT01099111|12258685|FG002|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
11076628|NCT01099111|12258686|FG003|COMPLETED|Overall Study||29
11076629|NCT01099111|12258687|FG004|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
11076630|NCT01099111|12258683|FG000|NOT COMPLETED|Overall Study||0
11076631|NCT01099111|12258684|FG001|NOT COMPLETED|Overall Study||0
11076632|NCT01099111|12258685|FG002|NOT COMPLETED|Overall Study||0
11076633|NCT01099111|12258686|FG003|NOT COMPLETED|Overall Study||0
11076634|NCT01099111|12258687|FG004|NOT COMPLETED|Overall Study||0
11076635|NCT01099202|12258701|FG000|STARTED|Overall Study||55
11076636|NCT01099202|12258702|FG001|STARTED|Overall Study||54
11076637|NCT01099202|12258701|FG000|COMPLETED|Overall Study||55
11076638|NCT01099202|12258702|FG001|COMPLETED|Overall Study||54
11076639|NCT01099202|12258701|FG000|NOT COMPLETED|Overall Study||0
11076640|NCT01099202|12258702|FG001|NOT COMPLETED|Overall Study||0
11076641|NCT01099215|12258711|FG000|STARTED|Overall Study||11
11076642|NCT01099215|12258712|FG001|STARTED|Overall Study||10
11076643|NCT01099215|12258711|FG000|COMPLETED|Overall Study||10
11076644|NCT01099215|12258712|FG001|COMPLETED|Overall Study||9
11076645|NCT01099215|12258711|FG000|NOT COMPLETED|Overall Study||1
11076646|NCT01099215|12258712|FG001|NOT COMPLETED|Overall Study||1
11076647|NCT01099267|12258718|FG000|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
11076648|NCT01099267|12258718|FG000|COMPLETED|MDS-003 Study||24
11076649|NCT01099267|12258718|FG000|NOT COMPLETED|MDS-003 Study||124
11076650|NCT01099267|12258718|FG000|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
11076651|NCT01099267|12258718|FG000|Informed Consent Given|MDS-009 Extension Follow-up||33
11076652|NCT01099267|12258718|FG000|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
11076653|NCT01099267|12258718|FG000|COMPLETED|MDS-009 Extension Follow-up||54
11076654|NCT01099267|12258718|FG000|NOT COMPLETED|MDS-009 Extension Follow-up||0
11076655|NCT01099358|12258722|FG000|STARTED|Overall Study||4
11076656|NCT01099358|12258723|FG001|STARTED|Overall Study||6
11076657|NCT01099358|12258724|FG002|STARTED|Overall Study||21
11076658|NCT01099358|12258725|FG003|STARTED|Overall Study||16
11076659|NCT01099358|12258722|FG000|Received at Least One Dose of Study Drug|Overall Study||3
11076660|NCT01099358|12258723|FG001|Received at Least One Dose of Study Drug|Overall Study||6
11076661|NCT01099358|12258724|FG002|Received at Least One Dose of Study Drug|Overall Study||20
11076662|NCT01099358|12258725|FG003|Received at Least One Dose of Study Drug|Overall Study||15
11076663|NCT01099358|12258722|FG000|COMPLETED|Overall Study||1
11348205|NCT02999178|12545237|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|231
11348206|NCT02999178|12545236|FG000|NOT COMPLETED|Overall Study||114
11348207|NCT02999178|12545237|FG001|NOT COMPLETED|Overall Study||100
11348208|NCT02999191|12545246|FG000|STARTED|Treatment Period 1 [1 Day]||6
11348209|NCT02999191|12545247|FG001|STARTED|Treatment Period 1 [1 Day]||6
11348210|NCT02999191|12545248|FG002|STARTED|Treatment Period 1 [1 Day]||6
11348211|NCT02999191|12545246|FG000|COMPLETED|Treatment Period 1 [1 Day]||6
11348212|NCT02999191|12545247|FG001|COMPLETED|Treatment Period 1 [1 Day]||6
11348213|NCT02999191|12545248|FG002|COMPLETED|Treatment Period 1 [1 Day]||6
11348214|NCT02999191|12545246|FG000|NOT COMPLETED|Treatment Period 1 [1 Day]||0
11348215|NCT02999191|12545247|FG001|NOT COMPLETED|Treatment Period 1 [1 Day]||0
11348216|NCT02999191|12545248|FG002|NOT COMPLETED|Treatment Period 1 [1 Day]||0
11348217|NCT02999191|12545246|FG000|STARTED|Wash-out Period 1 [21 Days]||6
11348218|NCT02999191|12545247|FG001|STARTED|Wash-out Period 1 [21 Days]||6
11348219|NCT02999191|12545248|FG002|STARTED|Wash-out Period 1 [21 Days]||6
11348220|NCT02999191|12545246|FG000|COMPLETED|Wash-out Period 1 [21 Days]||6
11348221|NCT02999191|12545247|FG001|COMPLETED|Wash-out Period 1 [21 Days]||5
11348222|NCT02999191|12545248|FG002|COMPLETED|Wash-out Period 1 [21 Days]||6
11348223|NCT02999191|12545246|FG000|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
11348224|NCT02999191|12545247|FG001|NOT COMPLETED|Wash-out Period 1 [21 Days]||1
11348225|NCT02999191|12545248|FG002|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
11348226|NCT02999191|12545246|FG000|STARTED|Treatment Period 2 [1 Day]||6
11348227|NCT02999191|12545247|FG001|STARTED|Treatment Period 2 [1 Day]||5
11348228|NCT02999191|12545248|FG002|STARTED|Treatment Period 2 [1 Day]||6
11348229|NCT02999191|12545246|FG000|COMPLETED|Treatment Period 2 [1 Day]||6
11348230|NCT02999191|12545247|FG001|COMPLETED|Treatment Period 2 [1 Day]||5
11348231|NCT02999191|12545248|FG002|COMPLETED|Treatment Period 2 [1 Day]||6
11348232|NCT02999191|12545246|FG000|NOT COMPLETED|Treatment Period 2 [1 Day]||0
11348233|NCT02999191|12545247|FG001|NOT COMPLETED|Treatment Period 2 [1 Day]||0
11348234|NCT02999191|12545248|FG002|NOT COMPLETED|Treatment Period 2 [1 Day]||0
11348235|NCT02999191|12545246|FG000|STARTED|Wash-out Period 2 [21 Days]||6
11348236|NCT02999191|12545247|FG001|STARTED|Wash-out Period 2 [21 Days]||5
11348237|NCT02999191|12545248|FG002|STARTED|Wash-out Period 2 [21 Days]||6
11348238|NCT02999191|12545246|FG000|COMPLETED|Wash-out Period 2 [21 Days]||6
11348239|NCT02999191|12545247|FG001|COMPLETED|Wash-out Period 2 [21 Days]||5
11348240|NCT02999191|12545248|FG002|COMPLETED|Wash-out Period 2 [21 Days]||6
11348241|NCT02999191|12545246|FG000|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
11348242|NCT02999191|12545247|FG001|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
11348243|NCT02999191|12545248|FG002|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
11348244|NCT02999191|12545246|FG000|STARTED|Treatment Period 3 [1 Day]||6
11348245|NCT02999191|12545247|FG001|STARTED|Treatment Period 3 [1 Day]||6
11348246|NCT02999191|12545248|FG002|STARTED|Treatment Period 3 [1 Day]||6
11348247|NCT02999191|12545246|FG000|COMPLETED|Treatment Period 3 [1 Day]||6
11348248|NCT02999191|12545247|FG001|COMPLETED|Treatment Period 3 [1 Day]||6
11348249|NCT02999191|12545248|FG002|COMPLETED|Treatment Period 3 [1 Day]||6
11348250|NCT02999191|12545246|FG000|NOT COMPLETED|Treatment Period 3 [1 Day]||0
11348251|NCT02999191|12545247|FG001|NOT COMPLETED|Treatment Period 3 [1 Day]||0
11348252|NCT02999191|12545248|FG002|NOT COMPLETED|Treatment Period 3 [1 Day]||0
11348253|NCT02999672|12545258|FG000|STARTED|Overall Study||13
11348254|NCT02999672|12545259|FG001|STARTED|Overall Study||7
11076664|NCT01099358|12258723|FG001|COMPLETED|Overall Study||5
11076665|NCT01099358|12258724|FG002|COMPLETED|Overall Study||13
11076666|NCT01099358|12258725|FG003|COMPLETED|Overall Study||12
11076667|NCT01099358|12258722|FG000|NOT COMPLETED|Overall Study||3
11348255|NCT02999672|12545258|FG000|COMPLETED|Overall Study||0
11076668|NCT01099358|12258723|FG001|NOT COMPLETED|Overall Study||1
11076669|NCT01099358|12258724|FG002|NOT COMPLETED|Overall Study||8
11076670|NCT01099358|12258725|FG003|NOT COMPLETED|Overall Study||4
11076671|NCT01099397|12258736|FG000|STARTED|Overall Study||39
11076672|NCT01099397|12258736|FG000|COMPLETED|Overall Study||26
11076673|NCT01099397|12258736|FG000|NOT COMPLETED|Overall Study||13
11076674|NCT01099449|12258744|FG000|STARTED|Overall Study||118
11076675|NCT01099449|12258745|FG001|STARTED|Overall Study||119
11076676|NCT01099449|12258746|FG002|STARTED|Overall Study||116
11076677|NCT01099449|12258744|FG000|COMPLETED|Overall Study||118
11076678|NCT01099449|12258745|FG001|COMPLETED|Overall Study||119
11076679|NCT01099449|12258746|FG002|COMPLETED|Overall Study||116
11076680|NCT01099449|12258744|FG000|NOT COMPLETED|Overall Study||0
11076681|NCT01099449|12258745|FG001|NOT COMPLETED|Overall Study||0
11076682|NCT01099449|12258746|FG002|NOT COMPLETED|Overall Study||0
11076683|NCT01099475|12258769|FG000|STARTED|Overall Study||10
11076684|NCT01099475|12258770|FG001|STARTED|Overall Study||10
11076685|NCT01099475|12258769|FG000|COMPLETED|Overall Study||10
11076686|NCT01099475|12258770|FG001|COMPLETED|Overall Study||10
11076687|NCT01099475|12258769|FG000|NOT COMPLETED|Overall Study||0
11076688|NCT01099475|12258770|FG001|NOT COMPLETED|Overall Study||0
11076689|NCT01099579|12258779|FG000|STARTED|Stage 1 (ATV Powder Formulation)||21
11076690|NCT01099579|12258780|FG001|STARTED|Stage 1 (ATV Powder Formulation)||19
11076691|NCT01099579|12258781|FG002|STARTED|Stage 1 (ATV Powder Formulation)||16
11076692|NCT01099579|12258779|FG000|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
11076693|NCT01099579|12258780|FG001|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
11076694|NCT01099579|12258781|FG002|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
11076695|NCT01099579|12258779|FG000|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
11076696|NCT01099579|12258780|FG001|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
11076697|NCT01099579|12258781|FG002|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
11076698|NCT01099579|12258779|FG000|STARTED|Stage 2 (ATV Capsule)||16
11076699|NCT01099579|12258780|FG001|STARTED|Stage 2 (ATV Capsule)||14
11076700|NCT01099579|12258781|FG002|STARTED|Stage 2 (ATV Capsule)||15
11076701|NCT01099579|12258779|FG000|COMPLETED|Stage 2 (ATV Capsule)||10
11076702|NCT01099579|12258780|FG001|COMPLETED|Stage 2 (ATV Capsule)||9
11076703|NCT01099579|12258781|FG002|COMPLETED|Stage 2 (ATV Capsule)||9
11076704|NCT01099579|12258779|FG000|NOT COMPLETED|Stage 2 (ATV Capsule)||6
11076705|NCT01099579|12258780|FG001|NOT COMPLETED|Stage 2 (ATV Capsule)||5
11076706|NCT01099579|12258781|FG002|NOT COMPLETED|Stage 2 (ATV Capsule)||6
11076707|NCT01099618|12258794|FG000|STARTED|Overall Study||17
11076708|NCT01099618|12258795|FG001|STARTED|Overall Study||16
11076709|NCT01099618|12258796|FG002|STARTED|Overall Study||15
11076710|NCT01099618|12258794|FG000|COMPLETED|Overall Study||17
11076711|NCT01099618|12258795|FG001|COMPLETED|Overall Study||16
11076712|NCT01099618|12258796|FG002|COMPLETED|Overall Study||15
11076713|NCT01099618|12258794|FG000|NOT COMPLETED|Overall Study||0
11076714|NCT01099618|12258795|FG001|NOT COMPLETED|Overall Study||0
11076715|NCT01099618|12258796|FG002|NOT COMPLETED|Overall Study||0
11076716|NCT01099631|12258810|FG000|STARTED|Overall Study||6
11076717|NCT01099631|12258811|FG001|STARTED|Overall Study||3
11076718|NCT01099631|12258812|FG002|STARTED|Overall Study||3
11076719|NCT01099631|12258813|FG003|STARTED|Overall Study||3
11076720|NCT01099631|12258814|FG004|STARTED|Overall Study||3
11076721|NCT01099631|12258815|FG005|STARTED|Overall Study||4
11076722|NCT01099631|12258810|FG000|COMPLETED|Overall Study||6
11076723|NCT01099631|12258811|FG001|COMPLETED|Overall Study||3
11076724|NCT01099631|12258812|FG002|COMPLETED|Overall Study||3
11076725|NCT01099631|12258813|FG003|COMPLETED|Overall Study||3
11076726|NCT01099631|12258814|FG004|COMPLETED|Overall Study||3
11076727|NCT01099631|12258815|FG005|COMPLETED|Overall Study||4
11076728|NCT01099631|12258810|FG000|NOT COMPLETED|Overall Study||0
11076729|NCT01099631|12258811|FG001|NOT COMPLETED|Overall Study||0
11076730|NCT01099631|12258812|FG002|NOT COMPLETED|Overall Study||0
11076731|NCT01099631|12258813|FG003|NOT COMPLETED|Overall Study||0
11076732|NCT01099631|12258814|FG004|NOT COMPLETED|Overall Study||0
11076733|NCT01099631|12258815|FG005|NOT COMPLETED|Overall Study||0
11076734|NCT01099709|12258835|FG000|STARTED|Period 1||42
11076735|NCT01099709|12258836|FG001|STARTED|Period 1||43
11076736|NCT01099709|12258835|FG000|COMPLETED|Period 1||41
11076737|NCT01099709|12258836|FG001|COMPLETED|Period 1||41
11076738|NCT01099709|12258835|FG000|NOT COMPLETED|Period 1||1
11076739|NCT01099709|12258836|FG001|NOT COMPLETED|Period 1||2
11076740|NCT01099709|12258835|FG000|STARTED|Period 2||41
11076741|NCT01099709|12258836|FG001|STARTED|Period 2||41
11076742|NCT01099709|12258835|FG000|COMPLETED|Period 2||41
11076743|NCT01099709|12258836|FG001|COMPLETED|Period 2||41
11076744|NCT01099709|12258835|FG000|NOT COMPLETED|Period 2||0
11076745|NCT01099709|12258836|FG001|NOT COMPLETED|Period 2||0
11076746|NCT01099761|12258847|FG000|STARTED|Overall Study||9
11076747|NCT01099761|12258848|FG001|STARTED|Overall Study||9
11076748|NCT01099761|12258849|FG002|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
11076749|NCT01099761|12258850|FG003|STARTED|Overall Study||6
11076750|NCT01099761|12258847|FG000|COMPLETED|Overall Study||9
11076751|NCT01099761|12258848|FG001|COMPLETED|Overall Study||9
11076752|NCT01099761|12258849|FG002|COMPLETED|Overall Study||0
11076753|NCT01099761|12258850|FG003|COMPLETED|Overall Study||6
11076754|NCT01099761|12258847|FG000|NOT COMPLETED|Overall Study||0
11076755|NCT01099761|12258848|FG001|NOT COMPLETED|Overall Study||0
11076756|NCT01099761|12258849|FG002|NOT COMPLETED|Overall Study||0
11076757|NCT01099761|12258850|FG003|NOT COMPLETED|Overall Study||0
11076758|NCT01099774|12258861|FG000|STARTED|Overall Study||302
11076759|NCT01099774|12258862|FG001|STARTED|Overall Study||295
11076760|NCT01099774|12258861|FG000|COMPLETED|Overall Study||296
11076761|NCT01099774|12258862|FG001|COMPLETED|Overall Study||289
11076762|NCT01099774|12258861|FG000|NOT COMPLETED|Overall Study||6
11076763|NCT01099774|12258862|FG001|NOT COMPLETED|Overall Study||6
11076764|NCT01099917|12258868|FG000|STARTED|Overall Study||45
11076765|NCT01099917|12258868|FG000|COMPLETED|Overall Study||18
11076766|NCT01099917|12258868|FG000|NOT COMPLETED|Overall Study||27
11076767|NCT01099969|12258876|FG000|STARTED|Overall Study||15
11076768|NCT01099969|12258877|FG001|STARTED|Overall Study||15
11348256|NCT02999672|12545259|FG001|COMPLETED|Overall Study||0
11348257|NCT02999672|12545258|FG000|NOT COMPLETED|Overall Study||13
11348258|NCT02999672|12545259|FG001|NOT COMPLETED|Overall Study||7
11348259|NCT02999763|12545265|FG000|STARTED|Overall Study||70
11348260|NCT02999763|12545265|FG000|COMPLETED|Overall Study||58
11348261|NCT02999763|12545265|FG000|NOT COMPLETED|Overall Study||12
11348262|NCT03000010|12545271|FG000|STARTED|Overall Study||21
11348263|NCT03000010|12545272|FG001|STARTED|Overall Study||20
11348264|NCT03000010|12545271|FG000|COMPLETED|Overall Study||21
11348265|NCT03000010|12545272|FG001|COMPLETED|Overall Study||20
11348266|NCT03000010|12545271|FG000|NOT COMPLETED|Overall Study||0
11348267|NCT03000010|12545272|FG001|NOT COMPLETED|Overall Study||0
11348268|NCT03000075|12545281|FG000|STARTED|Part A||58
11348269|NCT03000075|12545282|FG001|STARTED|Part A||58
11348270|NCT03000075|12545283|FG002|STARTED|Part A||55
11348271|NCT03000075|12545284|FG003|STARTED|Part A||0
11348272|NCT03000075|12545285|FG004|STARTED|Part A||0
11348273|NCT03000075|12545286|FG005|STARTED|Part A||0
11348274|NCT03000075|12545287|FG006|STARTED|Part A||0
11348275|NCT03000075|12545281|FG000|COMPLETED|Part A||54
11348276|NCT03000075|12545282|FG001|COMPLETED|Part A||58
11348277|NCT03000075|12545283|FG002|COMPLETED|Part A||55
11348278|NCT03000075|12545284|FG003|COMPLETED|Part A||0
11076769|NCT01099969|12258878|FG002|STARTED|Overall Study||15
11076770|NCT01099969|12258879|FG003|STARTED|Overall Study||15
11076771|NCT01099969|12258876|FG000|COMPLETED|Overall Study||15
11076772|NCT01099969|12258877|FG001|COMPLETED|Overall Study||15
11076773|NCT01099969|12258878|FG002|COMPLETED|Overall Study||15
11076774|NCT01099969|12258879|FG003|COMPLETED|Overall Study||15
11076775|NCT01099969|12258876|FG000|NOT COMPLETED|Overall Study||0
11076776|NCT01099969|12258877|FG001|NOT COMPLETED|Overall Study||0
11076777|NCT01099969|12258878|FG002|NOT COMPLETED|Overall Study||0
11076778|NCT01099969|12258879|FG003|NOT COMPLETED|Overall Study||0
11076779|NCT01100034|12258889|FG000|STARTED|Overall Study||72
11076780|NCT01100034|12258889|FG000|COMPLETED|Overall Study||29
11076781|NCT01100034|12258889|FG000|NOT COMPLETED|Overall Study||43
11076782|NCT01100073|12258893|FG000|STARTED|Overall Study|Baseline (Visit 1)|1699
11076783|NCT01100073|12258893|FG000|COMPLETED|Overall Study|End of study (Visit 3)|1599
11348279|NCT03000075|12545285|FG004|COMPLETED|Part A||0
11076784|NCT01100073|12258893|FG000|NOT COMPLETED|Overall Study||100
11076785|NCT01100086|12258897|FG000|STARTED|Period 1||43
11076786|NCT01100086|12258898|FG001|STARTED|Period 1||41
11076787|NCT01100086|12258897|FG000|COMPLETED|Period 1||42
11076788|NCT01100086|12258898|FG001|COMPLETED|Period 1||41
11076789|NCT01100086|12258897|FG000|NOT COMPLETED|Period 1||1
11076790|NCT01100086|12258898|FG001|NOT COMPLETED|Period 1||0
11076791|NCT01100086|12258897|FG000|STARTED|Period 2||42
11076792|NCT01100086|12258898|FG001|STARTED|Period 2||41
11076793|NCT01100086|12258897|FG000|COMPLETED|Period 2||42
11076794|NCT01100086|12258898|FG001|COMPLETED|Period 2||41
11076795|NCT01100086|12258897|FG000|NOT COMPLETED|Period 2||0
11076796|NCT01100086|12258898|FG001|NOT COMPLETED|Period 2||0
11076797|NCT01100112|12258904|FG000|STARTED|Overall Study||60
11076798|NCT01100112|12258904|FG000|COMPLETED|Overall Study||52
11076799|NCT01100112|12258904|FG000|NOT COMPLETED|Overall Study||8
11076800|NCT01100242|12258908|FG000|STARTED|Overall Study||17
11076801|NCT01100242|12258908|FG000|COMPLETED|Overall Study||17
11076802|NCT01100242|12258908|FG000|NOT COMPLETED|Overall Study||0
11076803|NCT01100255|12258914|FG000|STARTED|Overall Study||8
11076804|NCT01100255|12258915|FG001|STARTED|Overall Study||7
11076805|NCT01100255|12258914|FG000|COMPLETED|Overall Study||8
11076806|NCT01100255|12258915|FG001|COMPLETED|Overall Study||7
11076807|NCT01100255|12258914|FG000|NOT COMPLETED|Overall Study||0
11076808|NCT01100255|12258915|FG001|NOT COMPLETED|Overall Study||0
11076809|NCT01100268|12258921|FG000|STARTED|Overall Study||4
11076810|NCT01100268|12258921|FG000|COMPLETED|Overall Study||4
11076811|NCT01100268|12258921|FG000|NOT COMPLETED|Overall Study||0
11076812|NCT01100307|12258927|FG000|STARTED|Double Masked Phase (Up to Week 24)||123
11076813|NCT01100307|12258928|FG001|STARTED|Double Masked Phase (Up to Week 24)||120
11076814|NCT01100307|12258927|FG000|COMPLETED|Double Masked Phase (Up to Week 24)||117
11076815|NCT01100307|12258928|FG001|COMPLETED|Double Masked Phase (Up to Week 24)||116
11076816|NCT01100307|12258927|FG000|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
11076817|NCT01100307|12258928|FG001|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
11076818|NCT01100307|12258927|FG000|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
11076819|NCT01100307|12258928|FG001|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
11076820|NCT01100307|12258927|FG000|COMPLETED|Open Phase (Week 24 up to Week 54)||110
11076821|NCT01100307|12258928|FG001|COMPLETED|Open Phase (Week 24 up to Week 54)||99
11076822|NCT01100307|12258927|FG000|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
11076823|NCT01100307|12258928|FG001|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
11076824|NCT01100320|12258936|FG000|STARTED|Period 1||43
11076825|NCT01100320|12258937|FG001|STARTED|Period 1||45
11076826|NCT01100320|12258936|FG000|COMPLETED|Period 1||38
11076827|NCT01100320|12258937|FG001|COMPLETED|Period 1||38
11076828|NCT01100320|12258936|FG000|NOT COMPLETED|Period 1||5
11076829|NCT01100320|12258937|FG001|NOT COMPLETED|Period 1||7
11076830|NCT01100320|12258936|FG000|STARTED|Period 2||38
11076831|NCT01100320|12258937|FG001|STARTED|Period 2||38
11076832|NCT01100320|12258936|FG000|COMPLETED|Period 2||37
11076833|NCT01100320|12258937|FG001|COMPLETED|Period 2||37
11076834|NCT01100320|12258936|FG000|NOT COMPLETED|Period 2||1
11076835|NCT01100320|12258937|FG001|NOT COMPLETED|Period 2||1
11076836|NCT01100437|12258943|FG000|STARTED|Screening||4
11076837|NCT01100437|12258944|FG001|STARTED|Screening||2
11076838|NCT01100437|12258945|FG002|STARTED|Screening||8
11076839|NCT01100437|12258943|FG000|COMPLETED|Screening||4
11076840|NCT01100437|12258944|FG001|COMPLETED|Screening||2
11076841|NCT01100437|12258945|FG002|COMPLETED|Screening||8
11348280|NCT03000075|12545286|FG005|COMPLETED|Part A||0
11348281|NCT03000075|12545287|FG006|COMPLETED|Part A||0
11348282|NCT03000075|12545281|FG000|NOT COMPLETED|Part A||4
11348283|NCT03000075|12545282|FG001|NOT COMPLETED|Part A||0
11348284|NCT03000075|12545283|FG002|NOT COMPLETED|Part A||0
11348285|NCT03000075|12545284|FG003|NOT COMPLETED|Part A||0
11348286|NCT03000075|12545285|FG004|NOT COMPLETED|Part A||0
11348287|NCT03000075|12545286|FG005|NOT COMPLETED|Part A||0
11348288|NCT03000075|12545287|FG006|NOT COMPLETED|Part A||0
11348289|NCT03000075|12545281|FG000|STARTED|Part B||0
11348290|NCT03000075|12545282|FG001|STARTED|Part B||0
11076842|NCT01100437|12258943|FG000|NOT COMPLETED|Screening||0
11076843|NCT01100437|12258944|FG001|NOT COMPLETED|Screening||0
11076844|NCT01100437|12258945|FG002|NOT COMPLETED|Screening||0
11076845|NCT01100437|12258943|FG000|STARTED|Titration/Stabilization||4
11076846|NCT01100437|12258944|FG001|STARTED|Titration/Stabilization||2
11076847|NCT01100437|12258945|FG002|STARTED|Titration/Stabilization||8
11076848|NCT01100437|12258943|FG000|COMPLETED|Titration/Stabilization||4
11076849|NCT01100437|12258944|FG001|COMPLETED|Titration/Stabilization||2
11076850|NCT01100437|12258945|FG002|COMPLETED|Titration/Stabilization||2
11076851|NCT01100437|12258943|FG000|NOT COMPLETED|Titration/Stabilization||0
11076852|NCT01100437|12258944|FG001|NOT COMPLETED|Titration/Stabilization||0
11076853|NCT01100437|12258945|FG002|NOT COMPLETED|Titration/Stabilization||6
11348291|NCT03000075|12545283|FG002|STARTED|Part B||0
11076854|NCT01100437|12258943|FG000|STARTED|Maintenance||4
11076855|NCT01100437|12258944|FG001|STARTED|Maintenance||2
11076856|NCT01100437|12258945|FG002|STARTED|Maintenance||2
11076857|NCT01100437|12258943|FG000|COMPLETED|Maintenance||4
11076858|NCT01100437|12258944|FG001|COMPLETED|Maintenance||2
11076859|NCT01100437|12258945|FG002|COMPLETED|Maintenance||0
11076860|NCT01100437|12258943|FG000|NOT COMPLETED|Maintenance||0
11076861|NCT01100437|12258944|FG001|NOT COMPLETED|Maintenance||0
11076862|NCT01100437|12258945|FG002|NOT COMPLETED|Maintenance||2
11076863|NCT01100437|12258943|FG000|STARTED|Treatment 1||4
11076864|NCT01100437|12258944|FG001|STARTED|Treatment 1||2
11076865|NCT01100437|12258945|FG002|STARTED|Treatment 1||0
11076866|NCT01100437|12258943|FG000|COMPLETED|Treatment 1||4
11076867|NCT01100437|12258944|FG001|COMPLETED|Treatment 1||2
11076868|NCT01100437|12258945|FG002|COMPLETED|Treatment 1||0
11076869|NCT01100437|12258943|FG000|NOT COMPLETED|Treatment 1||0
11076870|NCT01100437|12258944|FG001|NOT COMPLETED|Treatment 1||0
11076871|NCT01100437|12258945|FG002|NOT COMPLETED|Treatment 1||0
11076872|NCT01100437|12258943|FG000|STARTED|Washout (4 Days)||4
11076873|NCT01100437|12258944|FG001|STARTED|Washout (4 Days)||2
11076874|NCT01100437|12258945|FG002|STARTED|Washout (4 Days)||0
11076875|NCT01100437|12258943|FG000|COMPLETED|Washout (4 Days)||4
11076876|NCT01100437|12258944|FG001|COMPLETED|Washout (4 Days)||2
11076877|NCT01100437|12258945|FG002|COMPLETED|Washout (4 Days)||0
11076878|NCT01100437|12258943|FG000|NOT COMPLETED|Washout (4 Days)||0
11076879|NCT01100437|12258944|FG001|NOT COMPLETED|Washout (4 Days)||0
11076880|NCT01100437|12258945|FG002|NOT COMPLETED|Washout (4 Days)||0
11076881|NCT01100437|12258943|FG000|STARTED|Treatment 2||4
11076882|NCT01100437|12258944|FG001|STARTED|Treatment 2||2
11076883|NCT01100437|12258945|FG002|STARTED|Treatment 2||0
11076884|NCT01100437|12258943|FG000|COMPLETED|Treatment 2||4
11076885|NCT01100437|12258944|FG001|COMPLETED|Treatment 2||2
11076886|NCT01100437|12258945|FG002|COMPLETED|Treatment 2||0
11076887|NCT01100437|12258943|FG000|NOT COMPLETED|Treatment 2||0
11076888|NCT01100437|12258944|FG001|NOT COMPLETED|Treatment 2||0
11076889|NCT01100437|12258945|FG002|NOT COMPLETED|Treatment 2||0
11076890|NCT01100502|12258956|FG000|STARTED|Overall Study||165
11076891|NCT01100502|12258957|FG001|STARTED|Overall Study||164
11348292|NCT03000075|12545284|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27
11348293|NCT03000075|12545285|FG004|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27
11348294|NCT03000075|12545286|FG005|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58
11348295|NCT03000075|12545287|FG006|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55
11348296|NCT03000075|12545281|FG000|COMPLETED|Part B||0
11348297|NCT03000075|12545282|FG001|COMPLETED|Part B||0
11348298|NCT03000075|12545283|FG002|COMPLETED|Part B||0
11348299|NCT03000075|12545284|FG003|COMPLETED|Part B||27
11348300|NCT03000075|12545285|FG004|COMPLETED|Part B||26
11348301|NCT03000075|12545286|FG005|COMPLETED|Part B||56
11348302|NCT03000075|12545287|FG006|COMPLETED|Part B||54
11348303|NCT03000075|12545281|FG000|NOT COMPLETED|Part B||0
11348304|NCT03000075|12545282|FG001|NOT COMPLETED|Part B||0
11348305|NCT03000075|12545283|FG002|NOT COMPLETED|Part B||0
11348306|NCT03000075|12545284|FG003|NOT COMPLETED|Part B||0
11348307|NCT03000075|12545285|FG004|NOT COMPLETED|Part B||1
11348308|NCT03000075|12545286|FG005|NOT COMPLETED|Part B||2
11348309|NCT03000075|12545287|FG006|NOT COMPLETED|Part B||1
11348310|NCT03000088|12545305|FG000|STARTED|Overall Study||70
11348311|NCT03000088|12545306|FG001|STARTED|Overall Study||70
11348312|NCT03000088|12545305|FG000|COMPLETED|Overall Study||70
11348313|NCT03000088|12545306|FG001|COMPLETED|Overall Study||70
11348314|NCT03000088|12545305|FG000|NOT COMPLETED|Overall Study||0
11348315|NCT03000088|12545306|FG001|NOT COMPLETED|Overall Study||0
11348316|NCT03000166|12545314|FG000|STARTED|Overall Study||25
11076892|NCT01100502|12258956|FG000|COMPLETED|Overall Study|Completed due to study closure by sponsor|89
11076893|NCT01100502|12258957|FG001|COMPLETED|Overall Study|Completed due to study closure by sponsor|70
11076894|NCT01100502|12258956|FG000|NOT COMPLETED|Overall Study||76
11076895|NCT01100502|12258957|FG001|NOT COMPLETED|Overall Study||94
11076896|NCT01100528|12258963|FG000|STARTED|Overall Study||38
11076897|NCT01100528|12258963|FG000|COMPLETED|Overall Study||35
11076898|NCT01100528|12258963|FG000|NOT COMPLETED|Overall Study||3
11076899|NCT01100567|12258969|FG000|STARTED|Overall Study||50
11076900|NCT01100567|12258970|FG001|STARTED|Overall Study||51
11206781|NCT01870596|12397853|FG001|NOT COMPLETED|Overall Study||0
11206782|NCT01870726|12397866|FG000|STARTED|Overall Study||5
11206783|NCT01870726|12397867|FG001|STARTED|Overall Study||6
11206784|NCT01870726|12397868|FG002|STARTED|Overall Study||4
11206785|NCT01870726|12397869|FG003|STARTED|Overall Study||6
11206786|NCT01870726|12397870|FG004|STARTED|Overall Study||7
11206787|NCT01870726|12397871|FG005|STARTED|Overall Study||5
11206788|NCT01870726|12397872|FG006|STARTED|Overall Study||10
11206789|NCT01870726|12397866|FG000|COMPLETED|Overall Study||0
11206790|NCT01870726|12397867|FG001|COMPLETED|Overall Study||0
11076901|NCT01100567|12258969|FG000|COMPLETED|Overall Study||38
11076902|NCT01100567|12258970|FG001|COMPLETED|Overall Study||35
11076903|NCT01100567|12258969|FG000|NOT COMPLETED|Overall Study||12
11076904|NCT01100567|12258970|FG001|NOT COMPLETED|Overall Study||16
11076905|NCT01100606|12258976|FG000|STARTED|First Treatment Period||8
11076906|NCT01100606|12258977|FG001|STARTED|First Treatment Period||7
11076907|NCT01100606|12258976|FG000|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
11076908|NCT01100606|12258977|FG001|COMPLETED|First Treatment Period||7
11076909|NCT01100606|12258976|FG000|NOT COMPLETED|First Treatment Period||0
11076910|NCT01100606|12258977|FG001|NOT COMPLETED|First Treatment Period||0
11076911|NCT01100606|12258976|FG000|STARTED|Second Treatment Period||8
11076912|NCT01100606|12258977|FG001|STARTED|Second Treatment Period||7
11076913|NCT01100606|12258976|FG000|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
11076914|NCT01100606|12258977|FG001|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
11076915|NCT01100606|12258976|FG000|NOT COMPLETED|Second Treatment Period||0
11076916|NCT01100606|12258977|FG001|NOT COMPLETED|Second Treatment Period||0
11206791|NCT01870726|12397868|FG002|COMPLETED|Overall Study||0
11206792|NCT01870726|12397869|FG003|COMPLETED|Overall Study||0
11206793|NCT01870726|12397870|FG004|COMPLETED|Overall Study||0
11206794|NCT01870726|12397871|FG005|COMPLETED|Overall Study||0
11206795|NCT01870726|12397872|FG006|COMPLETED|Overall Study||0
11206796|NCT01870726|12397866|FG000|NOT COMPLETED|Overall Study||5
11206797|NCT01870726|12397867|FG001|NOT COMPLETED|Overall Study||6
11206798|NCT01870726|12397868|FG002|NOT COMPLETED|Overall Study||4
11206799|NCT01870726|12397869|FG003|NOT COMPLETED|Overall Study||6
11206800|NCT01870726|12397870|FG004|NOT COMPLETED|Overall Study||7
11206801|NCT01870726|12397871|FG005|NOT COMPLETED|Overall Study||5
11206802|NCT01870726|12397872|FG006|NOT COMPLETED|Overall Study||10
11206803|NCT01870739|12397899|FG000|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
11206804|NCT01870739|12397900|FG001|STARTED|Single Drug Treatment (12 Weeks)||57
11206805|NCT01870739|12397899|FG000|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
11206806|NCT01870739|12397900|FG001|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
11206807|NCT01870739|12397899|FG000|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
11206808|NCT01870739|12397900|FG001|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
11206809|NCT01870739|12397899|FG000|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
11206810|NCT01870739|12397900|FG001|COMPLETED|Single Drug Treatment (12 Weeks)||53
11206811|NCT01870739|12397899|FG000|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
11206812|NCT01870739|12397900|FG001|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
11206813|NCT01870739|12397899|FG000|STARTED|Add-on Period (40 Weeks)||54
11206814|NCT01870739|12397900|FG001|STARTED|Add-on Period (40 Weeks)||53
11206815|NCT01870739|12397899|FG000|COMPLETED|Add-on Period (40 Weeks)||51
11206816|NCT01870739|12397900|FG001|COMPLETED|Add-on Period (40 Weeks)||51
11206817|NCT01870739|12397899|FG000|NOT COMPLETED|Add-on Period (40 Weeks)||3
11206818|NCT01870739|12397900|FG001|NOT COMPLETED|Add-on Period (40 Weeks)||2
11206819|NCT01870778|12397918|FG000|STARTED|Overall Study||3274
11206820|NCT01870778|12397919|FG001|STARTED|Overall Study||3271
11206821|NCT01870778|12397918|FG000|Safety Set|Overall Study||3257
11206822|NCT01870778|12397919|FG001|Safety Set|Overall Study||3248
11206823|NCT01870778|12397918|FG000|Full Analysis Set|Overall Study||3274
11206824|NCT01870778|12397919|FG001|Full Analysis Set|Overall Study||3271
11206825|NCT01870778|12397918|FG000|Biomarker Analysis Set|Overall Study||521
11206826|NCT01870778|12397919|FG001|Biomarker Analysis Set|Overall Study||510
11206827|NCT01870778|12397918|FG000|COMPLETED|Overall Study||3266
11206828|NCT01870778|12397919|FG001|COMPLETED|Overall Study||3262
11206829|NCT01870778|12397918|FG000|NOT COMPLETED|Overall Study||8
11206830|NCT01870778|12397919|FG001|NOT COMPLETED|Overall Study||9
11206831|NCT01870843|12397925|FG000|STARTED|Overall Study||261
11206832|NCT01870843|12397925|FG000|COMPLETED|Overall Study||208
11206833|NCT01870843|12397925|FG000|NOT COMPLETED|Overall Study||53
11206834|NCT01870856|12397931|FG000|STARTED|Overall Study||25
11206835|NCT01870856|12397932|FG001|STARTED|Overall Study||27
11206836|NCT01870856|12397931|FG000|COMPLETED|Overall Study||25
11206837|NCT01870856|12397932|FG001|COMPLETED|Overall Study||27
11206838|NCT01870856|12397931|FG000|NOT COMPLETED|Overall Study||0
11206839|NCT01870856|12397932|FG001|NOT COMPLETED|Overall Study||0
11206840|NCT01870869|12397944|FG000|STARTED|Overall Study||288
11206841|NCT01870869|12397945|FG001|STARTED|Overall Study||206
11206842|NCT01870869|12397946|FG002|STARTED|Overall Study||1222
11206843|NCT01870869|12397947|FG003|STARTED|Overall Study||235
11206844|NCT01870869|12397944|FG000|COMPLETED|Overall Study||260
11206845|NCT01870869|12397945|FG001|COMPLETED|Overall Study||192
11206846|NCT01870869|12397946|FG002|COMPLETED|Overall Study||1092
11348317|NCT03000166|12545315|FG001|STARTED|Overall Study||22
11348318|NCT03000166|12545314|FG000|COMPLETED|Overall Study||25
11206847|NCT01870869|12397947|FG003|COMPLETED|Overall Study||205
11206848|NCT01870869|12397944|FG000|NOT COMPLETED|Overall Study||28
11206849|NCT01870869|12397945|FG001|NOT COMPLETED|Overall Study||14
11206850|NCT01870869|12397946|FG002|NOT COMPLETED|Overall Study||130
11348319|NCT03000166|12545315|FG001|COMPLETED|Overall Study||19
11348320|NCT03000166|12545314|FG000|NOT COMPLETED|Overall Study||0
11348321|NCT03000166|12545315|FG001|NOT COMPLETED|Overall Study||3
11348322|NCT03000283|12545322|FG000|STARTED|Overall Study||7
11348323|NCT03000283|12545322|FG000|COMPLETED|Overall Study||7
11348324|NCT03000283|12545322|FG000|NOT COMPLETED|Overall Study||0
11348325|NCT03000309|12545326|FG000|STARTED|Overall Study||20
11348326|NCT03000309|12545326|FG000|COMPLETED|Overall Study||19
11348327|NCT03000309|12545326|FG000|NOT COMPLETED|Overall Study||1
11348328|NCT03000348|12545336|FG000|STARTED|Overall Study||17
11348329|NCT03000348|12545337|FG001|STARTED|Overall Study||11
11348330|NCT03000348|12545338|FG002|STARTED|Overall Study||15
11076917|NCT01100723|12258987|FG000|STARTED|Overall Study||92
11076918|NCT01100723|12258987|FG000|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
11076919|NCT01100723|12258987|FG000|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
11076920|NCT01100723|12258987|FG000|NOT COMPLETED|Overall Study||14
11076921|NCT01100762|12258992|FG000|STARTED|Overall Study||10
11076922|NCT01100762|12258992|FG000|COMPLETED|Overall Study||10
11076923|NCT01100762|12258992|FG000|NOT COMPLETED|Overall Study||0
11076924|NCT01100853|12259000|FG000|STARTED|Overall Study||51
11076925|NCT01100853|12259001|FG001|STARTED|Overall Study||49
11076926|NCT01100853|12259000|FG000|COMPLETED|Overall Study||24
11076927|NCT01100853|12259001|FG001|COMPLETED|Overall Study||26
11076928|NCT01100853|12259000|FG000|NOT COMPLETED|Overall Study||27
11076929|NCT01100853|12259001|FG001|NOT COMPLETED|Overall Study||23
11076930|NCT01100931|12259009|FG000|STARTED|Phase I||22
11076931|NCT01100931|12259010|FG001|STARTED|Phase I||0
11076932|NCT01100931|12259009|FG000|COMPLETED|Phase I||22
11076933|NCT01100931|12259010|FG001|COMPLETED|Phase I||0
11076934|NCT01100931|12259009|FG000|NOT COMPLETED|Phase I||0
11076935|NCT01100931|12259010|FG001|NOT COMPLETED|Phase I||0
11076936|NCT01100931|12259009|FG000|STARTED|Phase II||0
11076937|NCT01100931|12259010|FG001|STARTED|Phase II||19
11076938|NCT01100931|12259009|FG000|COMPLETED|Phase II||0
11076939|NCT01100931|12259010|FG001|COMPLETED|Phase II||19
11076940|NCT01100931|12259009|FG000|NOT COMPLETED|Phase II||0
11076941|NCT01100931|12259010|FG001|NOT COMPLETED|Phase II||0
11076942|NCT01100944|12259017|FG000|STARTED|Dose Escalation Phase 1 Dose Level 1||6
11076943|NCT01100944|12259018|FG001|STARTED|Dose Escalation Phase 1 Dose Level 1||0
11076944|NCT01100944|12259019|FG002|STARTED|Dose Escalation Phase 1 Dose Level 1||0
11076945|NCT01100944|12259017|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
11076946|NCT01100944|12259018|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
11076947|NCT01100944|12259019|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
11076948|NCT01100944|12259017|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
11076949|NCT01100944|12259018|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
11076950|NCT01100944|12259019|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
11076951|NCT01100944|12259017|FG000|STARTED|Dose Escalation Phase 1 Dose Level 2||0
11076952|NCT01100944|12259018|FG001|STARTED|Dose Escalation Phase 1 Dose Level 2||2
11076953|NCT01100944|12259019|FG002|STARTED|Dose Escalation Phase 1 Dose Level 2||0
11076954|NCT01100944|12259017|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
11076955|NCT01100944|12259018|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
11076956|NCT01100944|12259019|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
11076957|NCT01100944|12259017|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
11076958|NCT01100944|12259018|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
11076959|NCT01100944|12259019|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
11076960|NCT01100944|12259017|FG000|STARTED|Expansion Phase - Phase 2||0
11076961|NCT01100944|12259018|FG001|STARTED|Expansion Phase - Phase 2||0
11076962|NCT01100944|12259019|FG002|STARTED|Expansion Phase - Phase 2||18
11076963|NCT01100944|12259017|FG000|COMPLETED|Expansion Phase - Phase 2||0
11076964|NCT01100944|12259018|FG001|COMPLETED|Expansion Phase - Phase 2||0
11076965|NCT01100944|12259019|FG002|COMPLETED|Expansion Phase - Phase 2||18
11076966|NCT01100944|12259017|FG000|NOT COMPLETED|Expansion Phase - Phase 2||0
11076967|NCT01100944|12259018|FG001|NOT COMPLETED|Expansion Phase - Phase 2||0
11076968|NCT01100944|12259019|FG002|NOT COMPLETED|Expansion Phase - Phase 2||0
11076969|NCT01101022|12259042|FG000|STARTED|Overall Study||79
11076970|NCT01101022|12259043|FG001|STARTED|Overall Study||80
11076971|NCT01101022|12259042|FG000|COMPLETED|Overall Study||62
11076972|NCT01101022|12259043|FG001|COMPLETED|Overall Study||53
11206851|NCT01870869|12397947|FG003|NOT COMPLETED|Overall Study||30
11206852|NCT01870921|12397957|FG000|STARTED|Overall Study||2004
11348331|NCT03000348|12545339|FG003|STARTED|Overall Study||15
11206853|NCT01870921|12397957|FG000|COMPLETED|Overall Study||1914
11348332|NCT03000348|12545340|FG004|STARTED|Overall Study||16
11348333|NCT03000348|12545341|FG005|STARTED|Overall Study||15
11348334|NCT03000348|12545336|FG000|Day 14 Treatment Period|Overall Study||17
11348335|NCT03000348|12545337|FG001|Day 14 Treatment Period|Overall Study||10
11348336|NCT03000348|12545338|FG002|Day 14 Treatment Period|Overall Study||13
11348337|NCT03000348|12545339|FG003|Day 14 Treatment Period|Overall Study||14
11348338|NCT03000348|12545340|FG004|Day 14 Treatment Period|Overall Study||13
11348339|NCT03000348|12545341|FG005|Day 14 Treatment Period|Overall Study||14
11348340|NCT03000348|12545336|FG000|COMPLETED|Overall Study||14
11348341|NCT03000348|12545337|FG001|COMPLETED|Overall Study||7
11348342|NCT03000348|12545338|FG002|COMPLETED|Overall Study||11
11348343|NCT03000348|12545339|FG003|COMPLETED|Overall Study||12
11076973|NCT01101022|12259042|FG000|NOT COMPLETED|Overall Study||17
11076974|NCT01101022|12259043|FG001|NOT COMPLETED|Overall Study||27
11076975|NCT01101035|12259051|FG000|STARTED|Overall Study||3101
11076976|NCT01101035|12259052|FG001|STARTED|Overall Study||3097
11076977|NCT01101035|12259051|FG000|COMPLETED|Overall Study||1704
11076978|NCT01101035|12259052|FG001|COMPLETED|Overall Study||1706
11076979|NCT01101035|12259051|FG000|NOT COMPLETED|Overall Study||1397
11076980|NCT01101035|12259052|FG001|NOT COMPLETED|Overall Study||1391
11076981|NCT01101061|12259064|FG000|STARTED|Overall Study||6
11076982|NCT01101061|12259065|FG001|STARTED|Overall Study||6
11076983|NCT01101061|12259066|FG002|STARTED|Overall Study||7
11076984|NCT01101061|12259067|FG003|STARTED|Overall Study||6
11076985|NCT01101061|12259068|FG004|STARTED|Overall Study||2
11076986|NCT01101061|12259069|FG005|STARTED|Overall Study||4
11076987|NCT01101061|12259064|FG000|Received Study Drug|Overall Study||6
11076988|NCT01101061|12259065|FG001|Received Study Drug|Overall Study||6
11076989|NCT01101061|12259066|FG002|Received Study Drug|Overall Study||6
11076990|NCT01101061|12259067|FG003|Received Study Drug|Overall Study||6
11076991|NCT01101061|12259068|FG004|Received Study Drug|Overall Study||2
11076992|NCT01101061|12259069|FG005|Received Study Drug|Overall Study||4
11076993|NCT01101061|12259064|FG000|COMPLETED|Overall Study||6
11076994|NCT01101061|12259065|FG001|COMPLETED|Overall Study||6
11076995|NCT01101061|12259066|FG002|COMPLETED|Overall Study||6
11076996|NCT01101061|12259067|FG003|COMPLETED|Overall Study||6
11076997|NCT01101061|12259068|FG004|COMPLETED|Overall Study||2
11076998|NCT01101061|12259069|FG005|COMPLETED|Overall Study||4
11076999|NCT01101061|12259064|FG000|NOT COMPLETED|Overall Study||0
11077000|NCT01101061|12259065|FG001|NOT COMPLETED|Overall Study||0
11348344|NCT03000348|12545340|FG004|COMPLETED|Overall Study||11
11348345|NCT03000348|12545341|FG005|COMPLETED|Overall Study||13
11348346|NCT03000348|12545336|FG000|NOT COMPLETED|Overall Study||3
11348347|NCT03000348|12545337|FG001|NOT COMPLETED|Overall Study||4
11348348|NCT03000348|12545338|FG002|NOT COMPLETED|Overall Study||4
11348349|NCT03000348|12545339|FG003|NOT COMPLETED|Overall Study||3
11348350|NCT03000348|12545340|FG004|NOT COMPLETED|Overall Study||5
11348351|NCT03000348|12545341|FG005|NOT COMPLETED|Overall Study||2
11348352|NCT03000452|12545358|FG000|STARTED|Treatment Period||18
11348353|NCT03000452|12545358|FG000|COMPLETED|Treatment Period||0
11348354|NCT03000452|12545358|FG000|NOT COMPLETED|Treatment Period||18
11348355|NCT03000452|12545358|FG000|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
11348356|NCT03000452|12545358|FG000|COMPLETED|Follow-Up Period||10
11348357|NCT03000452|12545358|FG000|NOT COMPLETED|Follow-Up Period||7
11348358|NCT03000608|12545364|FG000|STARTED|Overall Study||46
11348359|NCT03000608|12545365|FG001|STARTED|Overall Study||23
11077001|NCT01101061|12259066|FG002|NOT COMPLETED|Overall Study||1
11077002|NCT01101061|12259067|FG003|NOT COMPLETED|Overall Study||0
11077003|NCT01101061|12259068|FG004|NOT COMPLETED|Overall Study||0
11077004|NCT01101061|12259069|FG005|NOT COMPLETED|Overall Study||0
11077005|NCT01101100|12259087|FG000|STARTED|Overall Study||181
11077006|NCT01101100|12259087|FG000|COMPLETED|Overall Study||126
11077007|NCT01101100|12259087|FG000|NOT COMPLETED|Overall Study||55
11077008|NCT01101165|12259092|FG000|STARTED|Period 1||47
11077009|NCT01101165|12259093|FG001|STARTED|Period 1||45
11077010|NCT01101165|12259092|FG000|COMPLETED|Period 1||45
11077011|NCT01101165|12259093|FG001|COMPLETED|Period 1||40
11077012|NCT01101165|12259092|FG000|NOT COMPLETED|Period 1||2
11077013|NCT01101165|12259093|FG001|NOT COMPLETED|Period 1||5
11077014|NCT01101165|12259092|FG000|STARTED|Period 2||45
11077015|NCT01101165|12259093|FG001|STARTED|Period 2||40
11077016|NCT01101165|12259092|FG000|COMPLETED|Period 2||41
11077017|NCT01101165|12259093|FG001|COMPLETED|Period 2||39
11077018|NCT01101165|12259092|FG000|NOT COMPLETED|Period 2||4
11077019|NCT01101165|12259093|FG001|NOT COMPLETED|Period 2||1
11077020|NCT01101178|12259099|FG000|STARTED|Period 1||40
11077021|NCT01101178|12259100|FG001|STARTED|Period 1||39
11077022|NCT01101178|12259099|FG000|COMPLETED|Period 1||36
11077023|NCT01101178|12259100|FG001|COMPLETED|Period 1||35
11077024|NCT01101178|12259099|FG000|NOT COMPLETED|Period 1||4
11077025|NCT01101178|12259100|FG001|NOT COMPLETED|Period 1||4
11077026|NCT01101178|12259099|FG000|STARTED|Period 2||36
11077027|NCT01101178|12259100|FG001|STARTED|Period 2||35
11077028|NCT01101178|12259099|FG000|COMPLETED|Period 2||36
11077029|NCT01101178|12259100|FG001|COMPLETED|Period 2||34
11077030|NCT01101178|12259099|FG000|NOT COMPLETED|Period 2||0
11077031|NCT01101178|12259100|FG001|NOT COMPLETED|Period 2||1
11077032|NCT01101191|12259107|FG000|STARTED|Period 1||42
11077033|NCT01101191|12259108|FG001|STARTED|Period 1||42
11077034|NCT01101191|12259107|FG000|COMPLETED|Period 1||40
11077035|NCT01101191|12259108|FG001|COMPLETED|Period 1||40
11077036|NCT01101191|12259107|FG000|NOT COMPLETED|Period 1||2
11077037|NCT01101191|12259108|FG001|NOT COMPLETED|Period 1||2
11077038|NCT01101191|12259107|FG000|STARTED|Period 2||40
11077039|NCT01101191|12259108|FG001|STARTED|Period 2||40
11077040|NCT01101191|12259107|FG000|COMPLETED|Period 2||40
11077041|NCT01101191|12259108|FG001|COMPLETED|Period 2||40
11077042|NCT01101191|12259107|FG000|NOT COMPLETED|Period 2||0
11077043|NCT01101191|12259108|FG001|NOT COMPLETED|Period 2||0
11077044|NCT01101308|12259115|FG000|STARTED|Period 1||27
11077045|NCT01101308|12259116|FG001|STARTED|Period 1||28
11348360|NCT03000608|12545364|FG000|COMPLETED|Overall Study||40
11348361|NCT03000608|12545365|FG001|COMPLETED|Overall Study||19
11348362|NCT03000608|12545364|FG000|NOT COMPLETED|Overall Study||6
11348363|NCT03000608|12545365|FG001|NOT COMPLETED|Overall Study||4
11348364|NCT03000673|12545375|FG000|STARTED|Overall Study||7
11077046|NCT01101308|12259115|FG000|COMPLETED|Period 1||24
11348365|NCT03000673|12545376|FG001|STARTED|Overall Study||9
11077047|NCT01101308|12259116|FG001|COMPLETED|Period 1||27
11077048|NCT01101308|12259115|FG000|NOT COMPLETED|Period 1||3
11077049|NCT01101308|12259116|FG001|NOT COMPLETED|Period 1||1
11077050|NCT01101308|12259115|FG000|STARTED|Period 2||24
11077051|NCT01101308|12259116|FG001|STARTED|Period 2||27
11077052|NCT01101308|12259115|FG000|COMPLETED|Period 2||24
11077053|NCT01101308|12259116|FG001|COMPLETED|Period 2||27
11077054|NCT01101308|12259115|FG000|NOT COMPLETED|Period 2||0
11077055|NCT01101308|12259116|FG001|NOT COMPLETED|Period 2||0
11077056|NCT01101321|12259123|FG000|STARTED|Period 1||30
11077057|NCT01101321|12259124|FG001|STARTED|Period 1||28
11077058|NCT01101321|12259123|FG000|COMPLETED|Period 1||26
11077059|NCT01101321|12259124|FG001|COMPLETED|Period 1||24
11077060|NCT01101321|12259123|FG000|NOT COMPLETED|Period 1||4
11077061|NCT01101321|12259124|FG001|NOT COMPLETED|Period 1||4
11077062|NCT01101321|12259123|FG000|STARTED|Period 2||26
11077063|NCT01101321|12259124|FG001|STARTED|Period 2||24
11077064|NCT01101321|12259123|FG000|COMPLETED|Period 2||26
11077065|NCT01101321|12259124|FG001|COMPLETED|Period 2||24
11077066|NCT01101321|12259123|FG000|NOT COMPLETED|Period 2||0
11077067|NCT01101321|12259124|FG001|NOT COMPLETED|Period 2||0
11077068|NCT01101334|12259132|FG000|STARTED|Overall Study||45
11077069|NCT01101334|12259133|FG001|STARTED|Overall Study||45
11077070|NCT01101334|12259132|FG000|Received Study Treatment|Overall Study||44
11077071|NCT01101334|12259133|FG001|Received Study Treatment|Overall Study||45
11077072|NCT01101334|12259132|FG000|COMPLETED|Overall Study||0
11077073|NCT01101334|12259133|FG001|COMPLETED|Overall Study||0
11077074|NCT01101334|12259132|FG000|NOT COMPLETED|Overall Study||45
11077075|NCT01101334|12259133|FG001|NOT COMPLETED|Overall Study||45
11077076|NCT01101477|12259142|FG000|STARTED|Overall Study||49
11077077|NCT01101477|12259143|FG001|STARTED|Overall Study||49
11077078|NCT01101477|12259144|FG002|STARTED|Overall Study||46
11077079|NCT01101477|12259142|FG000|COMPLETED|Overall Study||44
11077080|NCT01101477|12259143|FG001|COMPLETED|Overall Study||46
11077081|NCT01101477|12259144|FG002|COMPLETED|Overall Study||45
11077082|NCT01101477|12259142|FG000|NOT COMPLETED|Overall Study||5
11077083|NCT01101477|12259143|FG001|NOT COMPLETED|Overall Study||3
11077084|NCT01101477|12259144|FG002|NOT COMPLETED|Overall Study||1
11077085|NCT01101542|12259152|FG000|STARTED|Year 3 Surveillance Period||105
11077086|NCT01101542|12259152|FG000|COMPLETED|Year 3 Surveillance Period||94
11077087|NCT01101542|12259152|FG000|NOT COMPLETED|Year 3 Surveillance Period||11
11077088|NCT01101542|12259152|FG000|STARTED|Year 4 Surveillance Period||569
11077089|NCT01101542|12259152|FG000|COMPLETED|Year 4 Surveillance Period||282
11077090|NCT01101542|12259152|FG000|NOT COMPLETED|Year 4 Surveillance Period||287
11077091|NCT01101542|12259152|FG000|STARTED|Year 5 Surveillance Period||809
11077092|NCT01101542|12259152|FG000|COMPLETED|Year 5 Surveillance Period||668
11077093|NCT01101542|12259152|FG000|NOT COMPLETED|Year 5 Surveillance Period||141
11077094|NCT01101542|12259152|FG000|STARTED|Year 6 Surveillance Period||3091
11077095|NCT01101542|12259152|FG000|COMPLETED|Year 6 Surveillance Period||2100
11077096|NCT01101542|12259152|FG000|NOT COMPLETED|Year 6 Surveillance Period||991
11077097|NCT01101750|12259156|FG000|STARTED|Overall Study||25
11077098|NCT01101750|12259156|FG000|COMPLETED|Overall Study||9
11077099|NCT01101750|12259156|FG000|NOT COMPLETED|Overall Study||16
11077100|NCT01101841|12259162|FG000|STARTED|Overall Study||285
11077101|NCT01101841|12259163|FG001|STARTED|Overall Study||285
11077102|NCT01101841|12259162|FG000|COMPLETED|Overall Study||235
11077103|NCT01101841|12259163|FG001|COMPLETED|Overall Study||218
11077104|NCT01101841|12259162|FG000|NOT COMPLETED|Overall Study||50
11077105|NCT01101841|12259163|FG001|NOT COMPLETED|Overall Study||67
11077106|NCT01101867|12259172|FG000|STARTED|Overall Study||63
11077107|NCT01101867|12259173|FG001|STARTED|Overall Study||63
11077108|NCT01101867|12259172|FG000|COMPLETED|Overall Study||62
11077109|NCT01101867|12259173|FG001|COMPLETED|Overall Study||59
11077110|NCT01101867|12259172|FG000|NOT COMPLETED|Overall Study||1
11348366|NCT03000673|12545377|FG002|STARTED|Overall Study||7
11348367|NCT03000673|12545378|FG003|STARTED|Overall Study||9
11348368|NCT03000673|12545375|FG000|COMPLETED|Overall Study||6
11348369|NCT03000673|12545376|FG001|COMPLETED|Overall Study||9
11348370|NCT03000673|12545377|FG002|COMPLETED|Overall Study||7
11348371|NCT03000673|12545378|FG003|COMPLETED|Overall Study||9
11348372|NCT03000673|12545375|FG000|NOT COMPLETED|Overall Study||1
11348373|NCT03000673|12545376|FG001|NOT COMPLETED|Overall Study||0
11348374|NCT03000673|12545377|FG002|NOT COMPLETED|Overall Study||0
11348375|NCT03000673|12545378|FG003|NOT COMPLETED|Overall Study||0
11348376|NCT03000686|12545391|FG000|STARTED|Part 1, Period 1 (1 Day)||5
11077111|NCT01101867|12259173|FG001|NOT COMPLETED|Overall Study||4
11077112|NCT01101880|12259183|FG000|STARTED|Overall Study||50
11077113|NCT01101880|12259183|FG000|COMPLETED|Overall Study||50
11077114|NCT01101880|12259183|FG000|NOT COMPLETED|Overall Study||0
11077115|NCT01101958|12259189|FG000|STARTED|Overall Study||62
11077116|NCT01101958|12259190|FG001|STARTED|Overall Study||34
11077117|NCT01101958|12259189|FG000|COMPLETED|Overall Study||51
11077118|NCT01101958|12259190|FG001|COMPLETED|Overall Study||29
11077119|NCT01101958|12259189|FG000|NOT COMPLETED|Overall Study||11
11077120|NCT01101958|12259190|FG001|NOT COMPLETED|Overall Study||5
11077121|NCT01101971|12259196|FG000|STARTED|Overall Study||45
11077122|NCT01101971|12259196|FG000|COMPLETED|Overall Study||45
11077123|NCT01101971|12259196|FG000|NOT COMPLETED|Overall Study||0
11077124|NCT01101997|12259200|FG000|STARTED|Overall Study||60
11077125|NCT01101997|12259200|FG000|COMPLETED|Overall Study||58
11348377|NCT03000686|12545392|FG001|STARTED|Part 1, Period 1 (1 Day)||6
11348378|NCT03000686|12545393|FG002|STARTED|Part 1, Period 1 (1 Day)||0
11348379|NCT03000686|12545394|FG003|STARTED|Part 1, Period 1 (1 Day)||0
11077126|NCT01101997|12259200|FG000|NOT COMPLETED|Overall Study||2
11077127|NCT01102218|12259208|FG000|STARTED|Overall Study||24
11077128|NCT01102218|12259209|FG001|STARTED|Overall Study||24
11077129|NCT01102218|12259208|FG000|COMPLETED|Overall Study||13
11077130|NCT01102218|12259209|FG001|COMPLETED|Overall Study||14
11077131|NCT01102218|12259208|FG000|NOT COMPLETED|Overall Study||11
11077132|NCT01102218|12259209|FG001|NOT COMPLETED|Overall Study||10
11077133|NCT01102231|12259215|FG000|STARTED|Overall Study||106
11077134|NCT01102231|12259215|FG000|COMPLETED|Overall Study||91
11077135|NCT01102231|12259215|FG000|NOT COMPLETED|Overall Study||15
11077136|NCT01102257|12259222|FG000|STARTED|Overall Study||9
11077137|NCT01102257|12259223|FG001|STARTED|Overall Study||9
11077138|NCT01102257|12259222|FG000|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
11077139|NCT01102257|12259223|FG001|COMPLETED|Overall Study||9
11077140|NCT01102257|12259222|FG000|NOT COMPLETED|Overall Study||2
11077141|NCT01102257|12259223|FG001|NOT COMPLETED|Overall Study||0
11077142|NCT01102270|12259229|FG000|STARTED|Overall Study||8
11077143|NCT01102270|12259230|FG001|STARTED|Overall Study||9
11077144|NCT01102270|12259229|FG000|COMPLETED|Overall Study||8
11077145|NCT01102270|12259230|FG001|COMPLETED|Overall Study||9
11077146|NCT01102270|12259229|FG000|NOT COMPLETED|Overall Study||0
11077147|NCT01102270|12259230|FG001|NOT COMPLETED|Overall Study||0
11077148|NCT01102374|12259238|FG000|STARTED|Overall Study||55
11077149|NCT01102374|12259239|FG001|STARTED|Overall Study||52
11077150|NCT01102374|12259238|FG000|COMPLETED|Overall Study||39
11077151|NCT01102374|12259239|FG001|COMPLETED|Overall Study||33
11077152|NCT01102374|12259238|FG000|NOT COMPLETED|Overall Study||16
11077153|NCT01102374|12259239|FG001|NOT COMPLETED|Overall Study||19
11077154|NCT01102413|12259247|FG000|STARTED|Overall Study||233
11077155|NCT01102413|12259248|FG001|STARTED|Overall Study||118
11077156|NCT01102413|12259247|FG000|COMPLETED|Overall Study||208
11077157|NCT01102413|12259248|FG001|COMPLETED|Overall Study||106
11077158|NCT01102413|12259247|FG000|NOT COMPLETED|Overall Study||25
11077159|NCT01102413|12259248|FG001|NOT COMPLETED|Overall Study||12
11077160|NCT01102426|12259256|FG000|STARTED|Overall Study||171
11077161|NCT01102426|12259257|FG001|STARTED|Overall Study||84
11077162|NCT01102426|12259256|FG000|COMPLETED|Overall Study||6
11077163|NCT01102426|12259257|FG001|COMPLETED|Overall Study||3
11077164|NCT01102426|12259256|FG000|NOT COMPLETED|Overall Study||165
11077165|NCT01102426|12259257|FG001|NOT COMPLETED|Overall Study||81
11077166|NCT01102491|12259265|FG000|STARTED|Overall Study||71
11077167|NCT01102491|12259266|FG001|STARTED|Overall Study||71
11077168|NCT01102491|12259265|FG000|COMPLETED|Overall Study|11 patient excluded|60
11077169|NCT01102491|12259266|FG001|COMPLETED|Overall Study|12 patients were excluded|59
11077170|NCT01102491|12259265|FG000|NOT COMPLETED|Overall Study||11
11077171|NCT01102491|12259266|FG001|NOT COMPLETED|Overall Study||12
11077172|NCT01102738|12259272|FG000|STARTED|Overall Study||369
11077173|NCT01102738|12259272|FG000|COMPLETED|Overall Study||369
11077174|NCT01102738|12259272|FG000|NOT COMPLETED|Overall Study||0
11077175|NCT01102764|12259278|FG000|STARTED|Overall Study||64
11077176|NCT01102764|12259279|FG001|STARTED|Overall Study||68
11077177|NCT01102764|12259278|FG000|COMPLETED|Overall Study||43
11077178|NCT01102764|12259279|FG001|COMPLETED|Overall Study||55
11077179|NCT01102764|12259278|FG000|NOT COMPLETED|Overall Study||21
11077180|NCT01102764|12259279|FG001|NOT COMPLETED|Overall Study||13
11077181|NCT01102777|12259287|FG000|STARTED|Overall Study||84
11077182|NCT01102777|12259288|FG001|STARTED|Overall Study||155
11077183|NCT01102777|12259287|FG000|COMPLETED|Overall Study||75
11077184|NCT01102777|12259288|FG001|COMPLETED|Overall Study||139
11077185|NCT01102777|12259287|FG000|NOT COMPLETED|Overall Study||9
11077186|NCT01102777|12259288|FG001|NOT COMPLETED|Overall Study||16
11077187|NCT01102803|12259297|FG000|STARTED|Baseline to Post-Treatment||14
11077188|NCT01102803|12259298|FG001|STARTED|Baseline to Post-Treatment||15
11077189|NCT01102803|12259297|FG000|COMPLETED|Baseline to Post-Treatment||11
11077190|NCT01102803|12259298|FG001|COMPLETED|Baseline to Post-Treatment||15
11077191|NCT01102803|12259297|FG000|NOT COMPLETED|Baseline to Post-Treatment||3
11077192|NCT01102803|12259298|FG001|NOT COMPLETED|Baseline to Post-Treatment||0
11077193|NCT01102803|12259297|FG000|STARTED|Post to Follow-Up||11
11077194|NCT01102803|12259298|FG001|STARTED|Post to Follow-Up||15
11077195|NCT01102803|12259297|FG000|COMPLETED|Post to Follow-Up||10
11077196|NCT01102803|12259298|FG001|COMPLETED|Post to Follow-Up||12
11077197|NCT01102803|12259297|FG000|NOT COMPLETED|Post to Follow-Up||1
11077198|NCT01102803|12259298|FG001|NOT COMPLETED|Post to Follow-Up||3
11077199|NCT01102894|12259306|FG000|STARTED|Overall Study||10
11077200|NCT01102894|12259306|FG000|COMPLETED|Overall Study||10
11077201|NCT01102894|12259306|FG000|NOT COMPLETED|Overall Study||0
11077202|NCT01102972|12259314|FG000|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|199
11077203|NCT01102972|12259315|FG001|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|97
11077204|NCT01102972|12259314|FG000|Completed Week 24|Overall Study||180
11077205|NCT01102972|12259315|FG001|Completed Week 24|Overall Study||88
11077206|NCT01102972|12259314|FG000|COMPLETED|Overall Study|These participants completed Study Week 48.|170
11077207|NCT01102972|12259315|FG001|COMPLETED|Overall Study|These participants completed Study Week 48.|83
11077208|NCT01102972|12259314|FG000|NOT COMPLETED|Overall Study||29
11077209|NCT01102972|12259315|FG001|NOT COMPLETED|Overall Study||14
11077210|NCT01103063|12259323|FG000|STARTED|Overall Study||1446
11077211|NCT01103063|12259324|FG001|STARTED|Overall Study||1445
11348380|NCT03000686|12545391|FG000|COMPLETED|Part 1, Period 1 (1 Day)||5
11348381|NCT03000686|12545392|FG001|COMPLETED|Part 1, Period 1 (1 Day)||5
11348382|NCT03000686|12545393|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0
11348383|NCT03000686|12545394|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0
11348384|NCT03000686|12545391|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
11348385|NCT03000686|12545392|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||1
11348386|NCT03000686|12545393|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
11348387|NCT03000686|12545394|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
11348388|NCT03000686|12545391|FG000|STARTED|Part 1, Wash-out (Up to 14 Days)||5
11348389|NCT03000686|12545392|FG001|STARTED|Part 1, Wash-out (Up to 14 Days)||5
11348390|NCT03000686|12545393|FG002|STARTED|Part 1, Wash-out (Up to 14 Days)||0
11348391|NCT03000686|12545394|FG003|STARTED|Part 1, Wash-out (Up to 14 Days)||0
11077212|NCT01103063|12259323|FG000|COMPLETED|Overall Study||969
11077213|NCT01103063|12259324|FG001|COMPLETED|Overall Study||1024
11077214|NCT01103063|12259323|FG000|NOT COMPLETED|Overall Study||477
11077215|NCT01103063|12259324|FG001|NOT COMPLETED|Overall Study||421
11077216|NCT01103141|12259334|FG000|STARTED|Overall Study||67
11077217|NCT01103141|12259335|FG001|STARTED|Overall Study||76
11077218|NCT01103141|12259334|FG000|COMPLETED|Overall Study||65
11077219|NCT01103141|12259335|FG001|COMPLETED|Overall Study||74
11077220|NCT01103141|12259334|FG000|NOT COMPLETED|Overall Study||2
11077221|NCT01103141|12259335|FG001|NOT COMPLETED|Overall Study||2
11077222|NCT01103232|12259343|FG000|STARTED|Overall Study||13
11077223|NCT01103232|12259344|FG001|STARTED|Overall Study||13
11077224|NCT01103232|12259343|FG000|COMPLETED|Overall Study||12
11077225|NCT01103232|12259344|FG001|COMPLETED|Overall Study||11
11077226|NCT01103232|12259343|FG000|NOT COMPLETED|Overall Study||1
11077227|NCT01103232|12259344|FG001|NOT COMPLETED|Overall Study||2
11077228|NCT01103245|12259354|FG000|STARTED|Overall Study||13
11077229|NCT01103245|12259355|FG001|STARTED|Overall Study||7
11077230|NCT01103245|12259356|FG002|STARTED|Overall Study||12
11077231|NCT01103245|12259357|FG003|STARTED|Overall Study||6
11077232|NCT01103245|12259354|FG000|COMPLETED|Overall Study||10
11077233|NCT01103245|12259355|FG001|COMPLETED|Overall Study||5
11077234|NCT01103245|12259356|FG002|COMPLETED|Overall Study||8
11077235|NCT01103245|12259357|FG003|COMPLETED|Overall Study||6
11077236|NCT01103245|12259354|FG000|NOT COMPLETED|Overall Study||3
11077237|NCT01103245|12259355|FG001|NOT COMPLETED|Overall Study||2
11077238|NCT01103245|12259356|FG002|NOT COMPLETED|Overall Study||4
11077239|NCT01103245|12259357|FG003|NOT COMPLETED|Overall Study||0
11077240|NCT01103271|12259369|FG000|STARTED|Overall Study||11
11077241|NCT01103271|12259370|FG001|STARTED|Overall Study||9
11077242|NCT01103271|12259369|FG000|COMPLETED|Overall Study||10
11077243|NCT01103271|12259370|FG001|COMPLETED|Overall Study||5
11077244|NCT01103271|12259369|FG000|NOT COMPLETED|Overall Study||1
11077245|NCT01103271|12259370|FG001|NOT COMPLETED|Overall Study||4
11077246|NCT01103284|12259379|FG000|STARTED|Overall Study||236
11077247|NCT01103284|12259380|FG001|STARTED|Overall Study||239
11077248|NCT01103284|12259379|FG000|Treated|Overall Study||236
11077249|NCT01103284|12259380|FG001|Treated|Overall Study||238
11077250|NCT01103284|12259379|FG000|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
11077251|NCT01103284|12259380|FG001|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
11077252|NCT01103284|12259379|FG000|COMPLETED|Overall Study||194
11077253|NCT01103284|12259380|FG001|COMPLETED|Overall Study||195
11077254|NCT01103284|12259379|FG000|NOT COMPLETED|Overall Study||42
11077255|NCT01103284|12259380|FG001|NOT COMPLETED|Overall Study||44
11077256|NCT01103323|12259388|FG000|STARTED|Without/Before Drug Switch||505
11077257|NCT01103323|12259389|FG001|STARTED|Without/Before Drug Switch||255
11077258|NCT01103323|12259388|FG000|Participants Received Treatment|Without/Before Drug Switch||500
11077259|NCT01103323|12259389|FG001|Participants Received Treatment|Without/Before Drug Switch||253
11077260|NCT01103323|12259388|FG000|COMPLETED|Without/Before Drug Switch||429
11077261|NCT01103323|12259389|FG001|COMPLETED|Without/Before Drug Switch||237
11077262|NCT01103323|12259388|FG000|NOT COMPLETED|Without/Before Drug Switch||76
11077263|NCT01103323|12259389|FG001|NOT COMPLETED|Without/Before Drug Switch||18
11077264|NCT01103323|12259388|FG000|STARTED|Switched From Placebo to Regorafenib||0
11077265|NCT01103323|12259389|FG001|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
11077266|NCT01103323|12259388|FG000|COMPLETED|Switched From Placebo to Regorafenib||0
11077267|NCT01103323|12259389|FG001|COMPLETED|Switched From Placebo to Regorafenib||3
11077268|NCT01103323|12259388|FG000|NOT COMPLETED|Switched From Placebo to Regorafenib||0
11077269|NCT01103323|12259389|FG001|NOT COMPLETED|Switched From Placebo to Regorafenib||1
11077270|NCT01103362|12259396|FG000|STARTED|Overall Study||596
11077271|NCT01103362|12259396|FG000|COMPLETED|Overall Study||0
11077272|NCT01103362|12259396|FG000|NOT COMPLETED|Overall Study||596
11077273|NCT01103414|12259405|FG000|STARTED|Overall Study||72
11077274|NCT01103414|12259406|FG001|STARTED|Overall Study||71
11077275|NCT01103414|12259407|FG002|STARTED|Overall Study||71
11077276|NCT01103414|12259408|FG003|STARTED|Overall Study||71
11077277|NCT01103414|12259409|FG004|STARTED|Overall Study||71
11077278|NCT01103414|12259405|FG000|COMPLETED|Overall Study||59
11077279|NCT01103414|12259406|FG001|COMPLETED|Overall Study||62
11077280|NCT01103414|12259407|FG002|COMPLETED|Overall Study||56
11077281|NCT01103414|12259408|FG003|COMPLETED|Overall Study||64
11077282|NCT01103414|12259409|FG004|COMPLETED|Overall Study||56
11077283|NCT01103414|12259405|FG000|NOT COMPLETED|Overall Study||13
11077284|NCT01103414|12259406|FG001|NOT COMPLETED|Overall Study||9
11077285|NCT01103414|12259407|FG002|NOT COMPLETED|Overall Study||15
11077286|NCT01103414|12259408|FG003|NOT COMPLETED|Overall Study||7
11077287|NCT01103414|12259409|FG004|NOT COMPLETED|Overall Study||15
11077288|NCT01103440|12259423|FG000|STARTED|Overall Study||18
11077289|NCT01103440|12259424|FG001|STARTED|Overall Study||18
11077290|NCT01103440|12259423|FG000|COMPLETED|Overall Study||18
11077291|NCT01103440|12259424|FG001|COMPLETED|Overall Study||18
11077292|NCT01103440|12259423|FG000|NOT COMPLETED|Overall Study||0
11077293|NCT01103440|12259424|FG001|NOT COMPLETED|Overall Study||0
11077294|NCT01103466|12259430|FG000|STARTED|First Period (14 +/- 3 Days)||12
11077295|NCT01103466|12259431|FG001|STARTED|First Period (14 +/- 3 Days)||12
11077296|NCT01103466|12259432|FG002|STARTED|First Period (14 +/- 3 Days)||13
11077297|NCT01103466|12259430|FG000|COMPLETED|First Period (14 +/- 3 Days)||10
11077298|NCT01103466|12259431|FG001|COMPLETED|First Period (14 +/- 3 Days)||12
11077299|NCT01103466|12259432|FG002|COMPLETED|First Period (14 +/- 3 Days)||13
11077300|NCT01103466|12259430|FG000|NOT COMPLETED|First Period (14 +/- 3 Days)||2
11077301|NCT01103466|12259431|FG001|NOT COMPLETED|First Period (14 +/- 3 Days)||0
11077302|NCT01103466|12259432|FG002|NOT COMPLETED|First Period (14 +/- 3 Days)||0
11077303|NCT01103466|12259430|FG000|STARTED|Second Period (14 +/- 3 Days)||15
11077304|NCT01103466|12259431|FG001|STARTED|Second Period (14 +/- 3 Days)||13
11077305|NCT01103466|12259432|FG002|STARTED|Second Period (14 +/- 3 Days)||7
11077306|NCT01103466|12259430|FG000|COMPLETED|Second Period (14 +/- 3 Days)||13
11077307|NCT01103466|12259431|FG001|COMPLETED|Second Period (14 +/- 3 Days)||11
11077308|NCT01103466|12259432|FG002|COMPLETED|Second Period (14 +/- 3 Days)||6
11077309|NCT01103466|12259430|FG000|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
11077310|NCT01103466|12259431|FG001|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
11077311|NCT01103466|12259432|FG002|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
11077312|NCT01103466|12259430|FG000|STARTED|Third Period (14 +/- 3 Days)||8
11077313|NCT01103466|12259431|FG001|STARTED|Third Period (14 +/- 3 Days)||8
11077314|NCT01103466|12259432|FG002|STARTED|Third Period (14 +/- 3 Days)||14
11077315|NCT01103466|12259430|FG000|COMPLETED|Third Period (14 +/- 3 Days)||6
11077316|NCT01103466|12259431|FG001|COMPLETED|Third Period (14 +/- 3 Days)||8
11077317|NCT01103466|12259432|FG002|COMPLETED|Third Period (14 +/- 3 Days)||13
11077318|NCT01103466|12259430|FG000|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
11077319|NCT01103466|12259431|FG001|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
11077320|NCT01103466|12259432|FG002|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
11077321|NCT01103479|12259443|FG000|STARTED|Overall Study||168
11077322|NCT01103479|12259444|FG001|STARTED|Overall Study||210
11077323|NCT01103479|12259445|FG002|STARTED|Overall Study||188
11077324|NCT01103479|12259443|FG000|COMPLETED|Overall Study||163
11077325|NCT01103479|12259444|FG001|COMPLETED|Overall Study||201
11077326|NCT01103479|12259445|FG002|COMPLETED|Overall Study||174
11077327|NCT01103479|12259443|FG000|NOT COMPLETED|Overall Study||5
11077328|NCT01103479|12259444|FG001|NOT COMPLETED|Overall Study||9
11077329|NCT01103479|12259445|FG002|NOT COMPLETED|Overall Study||14
11077330|NCT01103492|12259454|FG000|STARTED|Overall Study||1
11077331|NCT01103492|12259454|FG000|COMPLETED|Overall Study||1
11077332|NCT01103492|12259454|FG000|NOT COMPLETED|Overall Study||0
11077333|NCT01103505|12259460|FG000|STARTED|Overall Study||763
11077334|NCT01103505|12259461|FG001|STARTED|Overall Study||757
11077335|NCT01103505|12259460|FG000|COMPLETED|Overall Study||739
11077336|NCT01103505|12259461|FG001|COMPLETED|Overall Study||737
11077337|NCT01103505|12259460|FG000|NOT COMPLETED|Overall Study||24
11077338|NCT01103505|12259461|FG001|NOT COMPLETED|Overall Study||20
11077339|NCT01103713|12259475|FG000|STARTED|Overall Study||168
11077340|NCT01103713|12259475|FG000|COMPLETED|Overall Study||155
11077341|NCT01103713|12259475|FG000|NOT COMPLETED|Overall Study||13
11077342|NCT01103778|12259482|FG000|STARTED|Overall Study||11
11077343|NCT01103778|12259482|FG000|COMPLETED|Overall Study||8
11077344|NCT01103778|12259482|FG000|NOT COMPLETED|Overall Study||3
11077345|NCT01103934|12259490|FG000|STARTED|Overall Study||17
11077346|NCT01103934|12259491|FG001|STARTED|Overall Study||18
11077347|NCT01103934|12259490|FG000|COMPLETED|Overall Study||17
11077348|NCT01103934|12259491|FG001|COMPLETED|Overall Study||18
11077349|NCT01103934|12259490|FG000|NOT COMPLETED|Overall Study||0
11077350|NCT01103934|12259491|FG001|NOT COMPLETED|Overall Study||0
11077351|NCT01103960|12259499|FG000|STARTED|Overall Study|Randomised and treated.|164
11077352|NCT01103960|12259500|FG001|STARTED|Overall Study|Randomised and treated.|160
11077353|NCT01103960|12259499|FG000|COMPLETED|Overall Study|Completed study medication.|159
11077354|NCT01103960|12259500|FG001|COMPLETED|Overall Study|Completed study medication.|158
11077355|NCT01103960|12259499|FG000|NOT COMPLETED|Overall Study||5
11077356|NCT01103960|12259500|FG001|NOT COMPLETED|Overall Study||2
11077357|NCT01103973|12259508|FG000|STARTED|Overall Study||51
11077358|NCT01103973|12259509|FG001|STARTED|Overall Study||46
11077359|NCT01103973|12259508|FG000|COMPLETED|Overall Study||51
11077360|NCT01103973|12259509|FG001|COMPLETED|Overall Study||46
11077361|NCT01103973|12259508|FG000|NOT COMPLETED|Overall Study||0
11077362|NCT01103973|12259509|FG001|NOT COMPLETED|Overall Study||0
11077363|NCT01104025|12259515|FG000|STARTED|Treatment Period||31
11077364|NCT01104025|12259515|FG000|COMPLETED|Treatment Period||25
11077365|NCT01104025|12259515|FG000|NOT COMPLETED|Treatment Period||6
11077366|NCT01104025|12259515|FG000|STARTED|Follow up Until BMT OR 6 Months||25
11077367|NCT01104025|12259515|FG000|COMPLETED|Follow up Until BMT OR 6 Months||22
11077368|NCT01104025|12259515|FG000|NOT COMPLETED|Follow up Until BMT OR 6 Months||3
11077369|NCT01104025|12259515|FG000|STARTED|Follow up Until Day 100 Post BMT|only 11 participants proceeded to BMT; 14 did not|11
11077370|NCT01104025|12259515|FG000|COMPLETED|Follow up Until Day 100 Post BMT||9
11077371|NCT01104025|12259515|FG000|NOT COMPLETED|Follow up Until Day 100 Post BMT||2
11077372|NCT01104090|12259521|FG000|STARTED|Overall Study||25
11077373|NCT01104090|12259522|FG001|STARTED|Overall Study||25
11077374|NCT01104090|12259521|FG000|COMPLETED|Overall Study||25
11077375|NCT01104090|12259522|FG001|COMPLETED|Overall Study||25
11077376|NCT01104090|12259521|FG000|NOT COMPLETED|Overall Study||0
11077377|NCT01104090|12259522|FG001|NOT COMPLETED|Overall Study||0
11077378|NCT01104103|12259532|FG000|STARTED|Overall Study||243
11077379|NCT01104103|12259533|FG001|STARTED|Overall Study||224
11077380|NCT01104103|12259532|FG000|COMPLETED|Overall Study||243
11077381|NCT01104103|12259533|FG001|COMPLETED|Overall Study||224
11077382|NCT01104103|12259532|FG000|NOT COMPLETED|Overall Study||0
11077383|NCT01104103|12259533|FG001|NOT COMPLETED|Overall Study||0
11077384|NCT01104155|12259541|FG000|STARTED|Overall Study||63
11077385|NCT01104155|12259542|FG001|STARTED|Overall Study||60
11077386|NCT01104155|12259541|FG000|COMPLETED|Overall Study||38
11077387|NCT01104155|12259542|FG001|COMPLETED|Overall Study||42
11077388|NCT01104155|12259541|FG000|NOT COMPLETED|Overall Study||25
11077389|NCT01104155|12259542|FG001|NOT COMPLETED|Overall Study||18
11077390|NCT01104207|12259550|FG000|STARTED|Overall Study||35
11077391|NCT01104207|12259551|FG001|STARTED|Overall Study||35
11077392|NCT01104207|12259550|FG000|COMPLETED|Overall Study||32
11077393|NCT01104207|12259551|FG001|COMPLETED|Overall Study||32
11077394|NCT01104207|12259550|FG000|NOT COMPLETED|Overall Study||3
11077395|NCT01104207|12259551|FG001|NOT COMPLETED|Overall Study||3
11077396|NCT01104246|12259557|FG000|STARTED|Overall Study||40
11077397|NCT01104246|12259557|FG000|Baseline Characteristics Measured|Overall Study||35
11077398|NCT01104246|12259557|FG000|COMPLETED|Overall Study||35
11077399|NCT01104246|12259557|FG000|NOT COMPLETED|Overall Study||5
11077400|NCT01104285|12259563|FG000|STARTED|Overall Study||112
11077401|NCT01104285|12259564|FG001|STARTED|Overall Study||86
11077402|NCT01104285|12259563|FG000|COMPLETED|Overall Study||112
11077403|NCT01104285|12259564|FG001|COMPLETED|Overall Study||86
11077404|NCT01104285|12259563|FG000|NOT COMPLETED|Overall Study||0
11077405|NCT01104285|12259564|FG001|NOT COMPLETED|Overall Study||0
11077406|NCT01104311|12259572|FG000|STARTED|Overall Study||66
11077407|NCT01104311|12259573|FG001|STARTED|Overall Study||66
11077408|NCT01104311|12259572|FG000|COMPLETED|Overall Study||56
11077409|NCT01104311|12259573|FG001|COMPLETED|Overall Study||54
11077410|NCT01104311|12259572|FG000|NOT COMPLETED|Overall Study||10
11077411|NCT01104311|12259573|FG001|NOT COMPLETED|Overall Study||12
11077412|NCT01104376|12259583|FG000|STARTED|Overall Study||89
11077413|NCT01104376|12259583|FG000|COMPLETED|Overall Study||61
11077414|NCT01104376|12259583|FG000|NOT COMPLETED|Overall Study||28
11077415|NCT01104402|12259589|FG000|STARTED|Overall Study||132
11077416|NCT01104402|12259590|FG001|STARTED|Overall Study||135
11077417|NCT01104402|12259589|FG000|COMPLETED|Overall Study||111
11077418|NCT01104402|12259590|FG001|COMPLETED|Overall Study||102
11077419|NCT01104402|12259589|FG000|NOT COMPLETED|Overall Study||21
11077420|NCT01104402|12259590|FG001|NOT COMPLETED|Overall Study||33
11077421|NCT01104415|12259596|FG000|STARTED|Core Phase||15
11077422|NCT01104415|12259597|FG001|STARTED|Core Phase||0
11077423|NCT01104415|12259596|FG000|COMPLETED|Core Phase||14
11077424|NCT01104415|12259597|FG001|COMPLETED|Core Phase||0
11077425|NCT01104415|12259596|FG000|NOT COMPLETED|Core Phase||1
11077426|NCT01104415|12259597|FG001|NOT COMPLETED|Core Phase||0
11077427|NCT01104415|12259596|FG000|STARTED|Extension Period||0
11077428|NCT01104415|12259597|FG001|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11
11077429|NCT01104415|12259596|FG000|COMPLETED|Extension Period||0
11077430|NCT01104415|12259597|FG001|COMPLETED|Extension Period||0
11077431|NCT01104415|12259596|FG000|NOT COMPLETED|Extension Period||0
11077432|NCT01104415|12259597|FG001|NOT COMPLETED|Extension Period||11
11077433|NCT01104493|12259606|FG000|STARTED|Overall Study||240
11077434|NCT01104493|12259607|FG001|STARTED|Overall Study||60
11077435|NCT01104493|12259606|FG000|COMPLETED|Overall Study||240
11077436|NCT01104493|12259607|FG001|COMPLETED|Overall Study||58
11077437|NCT01104493|12259606|FG000|NOT COMPLETED|Overall Study||0
11077438|NCT01104493|12259607|FG001|NOT COMPLETED|Overall Study||2
11077439|NCT01104545|12259616|FG000|STARTED|Overall Study||8
11077440|NCT01104545|12259617|FG001|STARTED|Overall Study||8
11077441|NCT01104545|12259618|FG002|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8
11077442|NCT01104545|12259616|FG000|COMPLETED|Overall Study||8
11077443|NCT01104545|12259617|FG001|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7
11077444|NCT01104545|12259618|FG002|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6
11077445|NCT01104545|12259616|FG000|NOT COMPLETED|Overall Study||0
11077446|NCT01104545|12259617|FG001|NOT COMPLETED|Overall Study||1
11077447|NCT01104545|12259618|FG002|NOT COMPLETED|Overall Study||2
11077448|NCT01104558|12259663|FG000|STARTED|Overall Study||100
11077449|NCT01104558|12259663|FG000|COMPLETED|Overall Study||83
11077450|NCT01104558|12259663|FG000|NOT COMPLETED|Overall Study||17
11077451|NCT01104584|12259667|FG000|STARTED|Overall Study|screened and enrolled|460
11077452|NCT01104584|12259667|FG000|Received Treatment|Overall Study|treatment started|439
11077453|NCT01104584|12259667|FG000|Fulfilled Requirements of FAS Population|Overall Study||397
11077454|NCT01104584|12259667|FG000|COMPLETED|Overall Study|study course completed|437
11077455|NCT01104584|12259667|FG000|NOT COMPLETED|Overall Study||23
11077456|NCT01104636|12259689|FG000|STARTED|Overall Study||1177
11077457|NCT01104636|12259689|FG000|COMPLETED|Overall Study||999
11077458|NCT01104636|12259689|FG000|NOT COMPLETED|Overall Study||178
11077459|NCT01104662|12259701|FG000|STARTED|Overall Study||20
11077460|NCT01104662|12259702|FG001|STARTED|Overall Study||21
11077461|NCT01104662|12259703|FG002|STARTED|Overall Study||5
11077462|NCT01104662|12259704|FG003|STARTED|Overall Study||4
11077463|NCT01104662|12259705|FG004|STARTED|Overall Study||15
11077464|NCT01104662|12259706|FG005|STARTED|Overall Study||16
11077465|NCT01104662|12259707|FG006|STARTED|Overall Study||5
11077466|NCT01104662|12259708|FG007|STARTED|Overall Study||6
11077467|NCT01104662|12259701|FG000|Received at Least 1 Dose of Study Drug|Overall Study||17
11077468|NCT01104662|12259702|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
11077469|NCT01104662|12259703|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
11077470|NCT01104662|12259704|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
11077471|NCT01104662|12259705|FG004|Received at Least 1 Dose of Study Drug|Overall Study||15
11077472|NCT01104662|12259706|FG005|Received at Least 1 Dose of Study Drug|Overall Study||15
11077473|NCT01104662|12259707|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
11077474|NCT01104662|12259708|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
11077475|NCT01104662|12259701|FG000|COMPLETED|Overall Study||10
11077476|NCT01104662|12259702|FG001|COMPLETED|Overall Study||11
11077477|NCT01104662|12259703|FG002|COMPLETED|Overall Study||4
11077478|NCT01104662|12259704|FG003|COMPLETED|Overall Study||3
11077479|NCT01104662|12259705|FG004|COMPLETED|Overall Study||14
11077480|NCT01104662|12259706|FG005|COMPLETED|Overall Study||12
11077481|NCT01104662|12259707|FG006|COMPLETED|Overall Study||5
11077482|NCT01104662|12259708|FG007|COMPLETED|Overall Study||6
11077483|NCT01104662|12259701|FG000|NOT COMPLETED|Overall Study||10
11077484|NCT01104662|12259702|FG001|NOT COMPLETED|Overall Study||10
11348392|NCT03000686|12545391|FG000|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
11348393|NCT03000686|12545392|FG001|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
11348394|NCT03000686|12545393|FG002|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
11348395|NCT03000686|12545394|FG003|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
11348396|NCT03000686|12545391|FG000|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
11348397|NCT03000686|12545392|FG001|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
11348398|NCT03000686|12545393|FG002|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
11077485|NCT01104662|12259703|FG002|NOT COMPLETED|Overall Study||1
11077486|NCT01104662|12259704|FG003|NOT COMPLETED|Overall Study||1
11077487|NCT01104662|12259705|FG004|NOT COMPLETED|Overall Study||1
11077488|NCT01104662|12259706|FG005|NOT COMPLETED|Overall Study||4
11077489|NCT01104662|12259707|FG006|NOT COMPLETED|Overall Study||0
11077490|NCT01104662|12259708|FG007|NOT COMPLETED|Overall Study||0
11077491|NCT01104701|12259731|FG000|STARTED|Overall Study||30
11077492|NCT01104701|12259732|FG001|STARTED|Overall Study||30
11077493|NCT01104701|12259733|FG002|STARTED|Overall Study||31
11077494|NCT01104701|12259734|FG003|STARTED|Overall Study||30
11077495|NCT01104701|12259731|FG000|COMPLETED|Overall Study||30
11077496|NCT01104701|12259732|FG001|COMPLETED|Overall Study||27
11077497|NCT01104701|12259733|FG002|COMPLETED|Overall Study||29
11077498|NCT01104701|12259734|FG003|COMPLETED|Overall Study||28
11077499|NCT01104701|12259731|FG000|NOT COMPLETED|Overall Study||0
11077500|NCT01104701|12259732|FG001|NOT COMPLETED|Overall Study||3
11077501|NCT01104701|12259733|FG002|NOT COMPLETED|Overall Study||2
11077502|NCT01104701|12259734|FG003|NOT COMPLETED|Overall Study||2
11077503|NCT01104766|12259748|FG000|STARTED|Overall Study||153
11077504|NCT01104766|12259749|FG001|STARTED|Overall Study||155
11077505|NCT01104766|12259750|FG002|STARTED|Overall Study||157
11077506|NCT01104766|12259751|FG003|STARTED|Overall Study||152
11077507|NCT01104766|12259748|FG000|COMPLETED|Overall Study||95
11077508|NCT01104766|12259749|FG001|COMPLETED|Overall Study||104
11077509|NCT01104766|12259750|FG002|COMPLETED|Overall Study||97
11077510|NCT01104766|12259751|FG003|COMPLETED|Overall Study||114
11077511|NCT01104766|12259748|FG000|NOT COMPLETED|Overall Study||58
11077512|NCT01104766|12259749|FG001|NOT COMPLETED|Overall Study||51
11077513|NCT01104766|12259750|FG002|NOT COMPLETED|Overall Study||60
11077514|NCT01104766|12259751|FG003|NOT COMPLETED|Overall Study||38
11077515|NCT01104779|12259764|FG000|STARTED|Overall Study||147
11077516|NCT01104779|12259765|FG001|STARTED|Overall Study||151
11077517|NCT01104779|12259766|FG002|STARTED|Overall Study||148
11077518|NCT01104779|12259764|FG000|COMPLETED|Overall Study||88
11077519|NCT01104779|12259765|FG001|COMPLETED|Overall Study||96
11077520|NCT01104779|12259766|FG002|COMPLETED|Overall Study||86
11077521|NCT01104779|12259764|FG000|NOT COMPLETED|Overall Study||59
11077522|NCT01104779|12259765|FG001|NOT COMPLETED|Overall Study||55
11077523|NCT01104779|12259766|FG002|NOT COMPLETED|Overall Study||62
11077524|NCT01104792|12259774|FG000|STARTED|Overall Study||752
11077525|NCT01104792|12259774|FG000|COMPLETED|Overall Study||226
11077526|NCT01104792|12259774|FG000|NOT COMPLETED|Overall Study||526
11077527|NCT01104870|12259781|FG000|STARTED|Overall Study||11
11077528|NCT01104870|12259782|FG001|STARTED|Overall Study||19
11077529|NCT01104870|12259783|FG002|STARTED|Overall Study||20
11077530|NCT01104870|12259781|FG000|COMPLETED|Overall Study||10
11077531|NCT01104870|12259782|FG001|COMPLETED|Overall Study||18
11077532|NCT01104870|12259783|FG002|COMPLETED|Overall Study||18
11077533|NCT01104870|12259781|FG000|NOT COMPLETED|Overall Study||1
11077534|NCT01104870|12259782|FG001|NOT COMPLETED|Overall Study||1
11077535|NCT01104870|12259783|FG002|NOT COMPLETED|Overall Study||2
11077536|NCT01105065|12259791|FG000|STARTED|Overall Study||23
11077537|NCT01105065|12259791|FG000|COMPLETED|Overall Study||17
11077538|NCT01105065|12259791|FG000|NOT COMPLETED|Overall Study||6
11077539|NCT01105091|12259799|FG000|STARTED|Overall Study||20
11077540|NCT01105091|12259800|FG001|STARTED|Overall Study||10
11077541|NCT01105091|12259799|FG000|COMPLETED|Overall Study||18
11077542|NCT01105091|12259800|FG001|COMPLETED|Overall Study||10
11077543|NCT01105091|12259799|FG000|NOT COMPLETED|Overall Study||2
11077544|NCT01105091|12259800|FG001|NOT COMPLETED|Overall Study||0
11077545|NCT01105117|12259810|FG000|STARTED|Overall Study||1
11077546|NCT01105117|12259811|FG001|STARTED|Overall Study||1
11077547|NCT01105117|12259810|FG000|COMPLETED|Overall Study||1
11077548|NCT01105117|12259811|FG001|COMPLETED|Overall Study||1
11077549|NCT01105117|12259810|FG000|NOT COMPLETED|Overall Study||0
11077550|NCT01105117|12259811|FG001|NOT COMPLETED|Overall Study||0
11077551|NCT01105130|12259820|FG000|STARTED|Overall Study||48
11077552|NCT01105130|12259821|FG001|STARTED|Overall Study||45
11077553|NCT01105130|12259822|FG002|STARTED|Overall Study||47
11077554|NCT01105130|12259820|FG000|COMPLETED|Overall Study||38
11077555|NCT01105130|12259821|FG001|COMPLETED|Overall Study||34
11077556|NCT01105130|12259822|FG002|COMPLETED|Overall Study||37
11077557|NCT01105130|12259820|FG000|NOT COMPLETED|Overall Study||10
11077558|NCT01105130|12259821|FG001|NOT COMPLETED|Overall Study||11
11077559|NCT01105130|12259822|FG002|NOT COMPLETED|Overall Study||10
11077560|NCT01105247|12259832|FG000|STARTED|Overall Study||116
11077561|NCT01105247|12259833|FG001|STARTED|Overall Study||16
11077562|NCT01105247|12259832|FG000|COMPLETED|Overall Study||79
11077563|NCT01105247|12259833|FG001|COMPLETED|Overall Study||16
11077564|NCT01105247|12259832|FG000|NOT COMPLETED|Overall Study||37
11077565|NCT01105247|12259833|FG001|NOT COMPLETED|Overall Study||0
11077566|NCT01105312|12259847|FG000|STARTED|Overall Study||16
11077567|NCT01105312|12259848|FG001|STARTED|Overall Study||6
11077568|NCT01105312|12259849|FG002|STARTED|Overall Study||6
11077569|NCT01105312|12259847|FG000|COMPLETED|Overall Study||13
11077570|NCT01105312|12259848|FG001|COMPLETED|Overall Study||6
11077571|NCT01105312|12259849|FG002|COMPLETED|Overall Study||6
11077572|NCT01105312|12259847|FG000|NOT COMPLETED|Overall Study||3
11077573|NCT01105312|12259848|FG001|NOT COMPLETED|Overall Study||0
11077574|NCT01105312|12259849|FG002|NOT COMPLETED|Overall Study||0
11077575|NCT01105377|12259859|FG000|STARTED|Overall Study||24
11077576|NCT01105377|12259860|FG001|STARTED|Overall Study||23
11077577|NCT01105377|12259859|FG000|COMPLETED|Overall Study||24
11077578|NCT01105377|12259860|FG001|COMPLETED|Overall Study||22
11077579|NCT01105377|12259859|FG000|NOT COMPLETED|Overall Study||0
11077580|NCT01105377|12259860|FG001|NOT COMPLETED|Overall Study||1
11077581|NCT01105533|12259866|FG000|STARTED|Overall Study||1
11077582|NCT01105533|12259867|FG001|STARTED|Overall Study||1
11077583|NCT01105533|12259868|FG002|STARTED|Overall Study||3
11077584|NCT01105533|12259869|FG003|STARTED|Overall Study||3
11077585|NCT01105533|12259870|FG004|STARTED|Overall Study||7
11348399|NCT03000686|12545394|FG003|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
11348400|NCT03000686|12545391|FG000|STARTED|Part 1, Period 2 (1 Day)||5
11348401|NCT03000686|12545392|FG001|STARTED|Part 1, Period 2 (1 Day)||5
11348402|NCT03000686|12545393|FG002|STARTED|Part 1, Period 2 (1 Day)||0
11348403|NCT03000686|12545394|FG003|STARTED|Part 1, Period 2 (1 Day)||0
11348404|NCT03000686|12545391|FG000|COMPLETED|Part 1, Period 2 (1 Day)||5
11348405|NCT03000686|12545392|FG001|COMPLETED|Part 1, Period 2 (1 Day)||5
11348406|NCT03000686|12545393|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0
11348407|NCT03000686|12545394|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0
11348408|NCT03000686|12545391|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
11348409|NCT03000686|12545392|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
11348410|NCT03000686|12545393|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
11348411|NCT03000686|12545394|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
11348412|NCT03000686|12545391|FG000|STARTED|Part 2, Period 1 (1 Day)||0
11348413|NCT03000686|12545392|FG001|STARTED|Part 2, Period 1 (1 Day)||0
11348414|NCT03000686|12545393|FG002|STARTED|Part 2, Period 1 (1 Day)||3
11348415|NCT03000686|12545394|FG003|STARTED|Part 2, Period 1 (1 Day)||3
11348416|NCT03000686|12545391|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0
11348417|NCT03000686|12545392|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0
11348418|NCT03000686|12545393|FG002|COMPLETED|Part 2, Period 1 (1 Day)||3
11348419|NCT03000686|12545394|FG003|COMPLETED|Part 2, Period 1 (1 Day)||3
11077586|NCT01105533|12259871|FG005|STARTED|Overall Study||7
11077587|NCT01105533|12259872|FG006|STARTED|Overall Study||8
11077588|NCT01105533|12259873|FG007|STARTED|Overall Study||4
11077589|NCT01105533|12259874|FG008|STARTED|Overall Study||12
11077590|NCT01105533|12259866|FG000|COMPLETED|Overall Study||0
11077591|NCT01105533|12259867|FG001|COMPLETED|Overall Study||0
11077592|NCT01105533|12259868|FG002|COMPLETED|Overall Study||0
11348420|NCT03000686|12545391|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
11348421|NCT03000686|12545392|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
11348422|NCT03000686|12545393|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
11077593|NCT01105533|12259869|FG003|COMPLETED|Overall Study||0
11077594|NCT01105533|12259870|FG004|COMPLETED|Overall Study||0
11077595|NCT01105533|12259871|FG005|COMPLETED|Overall Study||0
11077596|NCT01105533|12259872|FG006|COMPLETED|Overall Study||0
11077597|NCT01105533|12259873|FG007|COMPLETED|Overall Study||0
11077598|NCT01105533|12259874|FG008|COMPLETED|Overall Study||0
11077599|NCT01105533|12259866|FG000|NOT COMPLETED|Overall Study||1
11077600|NCT01105533|12259867|FG001|NOT COMPLETED|Overall Study||1
11077601|NCT01105533|12259868|FG002|NOT COMPLETED|Overall Study||3
11077602|NCT01105533|12259869|FG003|NOT COMPLETED|Overall Study||3
11077603|NCT01105533|12259870|FG004|NOT COMPLETED|Overall Study||7
11077604|NCT01105533|12259871|FG005|NOT COMPLETED|Overall Study||7
11077605|NCT01105533|12259872|FG006|NOT COMPLETED|Overall Study||8
11077606|NCT01105533|12259873|FG007|NOT COMPLETED|Overall Study||4
11077607|NCT01105533|12259874|FG008|NOT COMPLETED|Overall Study||12
11077608|NCT01105650|12259890|FG000|STARTED|Overall Study||3
11077609|NCT01105650|12259891|FG001|STARTED|Overall Study||3
11077610|NCT01105650|12259892|FG002|STARTED|Overall Study||7
11077611|NCT01105650|12259893|FG003|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
11077612|NCT01105650|12259890|FG000|COMPLETED|Overall Study||3
11077613|NCT01105650|12259891|FG001|COMPLETED|Overall Study||3
11077614|NCT01105650|12259892|FG002|COMPLETED|Overall Study||7
11077615|NCT01105650|12259893|FG003|COMPLETED|Overall Study||0
11077616|NCT01105650|12259890|FG000|NOT COMPLETED|Overall Study||0
11077617|NCT01105650|12259891|FG001|NOT COMPLETED|Overall Study||0
11077618|NCT01105650|12259892|FG002|NOT COMPLETED|Overall Study||0
11077619|NCT01105650|12259893|FG003|NOT COMPLETED|Overall Study||0
11077620|NCT01105702|12259901|FG000|STARTED|Overall Study||28
11077621|NCT01105702|12259901|FG000|COMPLETED|Overall Study||10
11077622|NCT01105702|12259901|FG000|NOT COMPLETED|Overall Study||18
11077623|NCT01105754|12259909|FG000|STARTED|Overall Study||319
11077624|NCT01105754|12259910|FG001|STARTED|Overall Study||319
11077625|NCT01105754|12259909|FG000|COMPLETED|Overall Study||304
11077626|NCT01105754|12259910|FG001|COMPLETED|Overall Study||307
11077627|NCT01105754|12259909|FG000|NOT COMPLETED|Overall Study||15
11077628|NCT01105754|12259910|FG001|NOT COMPLETED|Overall Study||12
11077629|NCT01105767|12259919|FG000|STARTED|Overall Study||9315
11077630|NCT01105767|12259920|FG001|STARTED|Overall Study||10864
11077631|NCT01105767|12259921|FG002|STARTED|Overall Study||10030
11077632|NCT01105767|12259919|FG000|COMPLETED|Overall Study||8155
11077633|NCT01105767|12259920|FG001|COMPLETED|Overall Study||9250
11077634|NCT01105767|12259921|FG002|COMPLETED|Overall Study||8846
11077635|NCT01105767|12259919|FG000|NOT COMPLETED|Overall Study||1160
11077636|NCT01105767|12259920|FG001|NOT COMPLETED|Overall Study||1614
11077637|NCT01105767|12259921|FG002|NOT COMPLETED|Overall Study||1184
11077638|NCT01105936|12259929|FG000|STARTED|Period 1||8
11077639|NCT01105936|12259930|FG001|STARTED|Period 1||8
11077640|NCT01105936|12259931|FG002|STARTED|Period 1||7
11077641|NCT01105936|12259932|FG003|STARTED|Period 1||8
11077642|NCT01105936|12259929|FG000|COMPLETED|Period 1||8
11077643|NCT01105936|12259930|FG001|COMPLETED|Period 1||8
11077644|NCT01105936|12259931|FG002|COMPLETED|Period 1||7
11077645|NCT01105936|12259932|FG003|COMPLETED|Period 1||7
11077646|NCT01105936|12259929|FG000|NOT COMPLETED|Period 1||0
11077647|NCT01105936|12259930|FG001|NOT COMPLETED|Period 1||0
11077648|NCT01105936|12259931|FG002|NOT COMPLETED|Period 1||0
11077649|NCT01105936|12259932|FG003|NOT COMPLETED|Period 1||1
11077650|NCT01105936|12259929|FG000|STARTED|Wash-out Period 1||8
11077651|NCT01105936|12259930|FG001|STARTED|Wash-out Period 1||8
11077652|NCT01105936|12259931|FG002|STARTED|Wash-out Period 1||7
11077653|NCT01105936|12259932|FG003|STARTED|Wash-out Period 1||7
11077654|NCT01105936|12259929|FG000|COMPLETED|Wash-out Period 1||8
11077655|NCT01105936|12259930|FG001|COMPLETED|Wash-out Period 1||8
11077656|NCT01105936|12259931|FG002|COMPLETED|Wash-out Period 1||7
11077657|NCT01105936|12259932|FG003|COMPLETED|Wash-out Period 1||7
11077658|NCT01105936|12259929|FG000|NOT COMPLETED|Wash-out Period 1||0
11077659|NCT01105936|12259930|FG001|NOT COMPLETED|Wash-out Period 1||0
11077660|NCT01105936|12259931|FG002|NOT COMPLETED|Wash-out Period 1||0
11077661|NCT01105936|12259932|FG003|NOT COMPLETED|Wash-out Period 1||0
11077662|NCT01105936|12259929|FG000|STARTED|Period 2||8
11077663|NCT01105936|12259930|FG001|STARTED|Period 2||8
11077664|NCT01105936|12259931|FG002|STARTED|Period 2||7
11348423|NCT03000686|12545394|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
11077665|NCT01105936|12259932|FG003|STARTED|Period 2||7
11077666|NCT01105936|12259929|FG000|COMPLETED|Period 2||7
11077667|NCT01105936|12259930|FG001|COMPLETED|Period 2||8
11077668|NCT01105936|12259931|FG002|COMPLETED|Period 2||7
11077669|NCT01105936|12259932|FG003|COMPLETED|Period 2||7
11077670|NCT01105936|12259929|FG000|NOT COMPLETED|Period 2||1
11077671|NCT01105936|12259930|FG001|NOT COMPLETED|Period 2||0
11077672|NCT01105936|12259931|FG002|NOT COMPLETED|Period 2||0
11077673|NCT01105936|12259932|FG003|NOT COMPLETED|Period 2||0
11077674|NCT01105936|12259929|FG000|STARTED|Wash-out Period 2||7
11077675|NCT01105936|12259930|FG001|STARTED|Wash-out Period 2||8
11077676|NCT01105936|12259931|FG002|STARTED|Wash-out Period 2||7
11077677|NCT01105936|12259932|FG003|STARTED|Wash-out Period 2||7
11077678|NCT01105936|12259929|FG000|COMPLETED|Wash-out Period 2||7
11077679|NCT01105936|12259930|FG001|COMPLETED|Wash-out Period 2||8
11077680|NCT01105936|12259931|FG002|COMPLETED|Wash-out Period 2||7
11077681|NCT01105936|12259932|FG003|COMPLETED|Wash-out Period 2||7
11077682|NCT01105936|12259929|FG000|NOT COMPLETED|Wash-out Period 2||0
11077683|NCT01105936|12259930|FG001|NOT COMPLETED|Wash-out Period 2||0
11077684|NCT01105936|12259931|FG002|NOT COMPLETED|Wash-out Period 2||0
11077685|NCT01105936|12259932|FG003|NOT COMPLETED|Wash-out Period 2||0
11077686|NCT01105936|12259929|FG000|STARTED|Period 3||7
11077687|NCT01105936|12259930|FG001|STARTED|Period 3||8
11077688|NCT01105936|12259931|FG002|STARTED|Period 3||7
11077689|NCT01105936|12259932|FG003|STARTED|Period 3||7
11077690|NCT01105936|12259929|FG000|COMPLETED|Period 3||7
11077691|NCT01105936|12259930|FG001|COMPLETED|Period 3||6
11077692|NCT01105936|12259931|FG002|COMPLETED|Period 3||7
11077693|NCT01105936|12259932|FG003|COMPLETED|Period 3||7
11077694|NCT01105936|12259929|FG000|NOT COMPLETED|Period 3||0
11077695|NCT01105936|12259930|FG001|NOT COMPLETED|Period 3||2
11077696|NCT01105936|12259931|FG002|NOT COMPLETED|Period 3||0
11077697|NCT01105936|12259932|FG003|NOT COMPLETED|Period 3||0
11077698|NCT01105975|12259951|FG000|STARTED|Overall Study||40
11077699|NCT01105975|12259952|FG001|STARTED|Overall Study||39
11077700|NCT01105975|12259953|FG002|STARTED|Overall Study||42
11077701|NCT01105975|12259954|FG003|STARTED|Overall Study||38
11077702|NCT01105975|12259955|FG004|STARTED|Overall Study||41
11077703|NCT01105975|12259956|FG005|STARTED|Overall Study||35
11077704|NCT01105975|12259957|FG006|STARTED|Overall Study||42
11077705|NCT01105975|12259958|FG007|STARTED|Overall Study||40
11077706|NCT01105975|12259959|FG008|STARTED|Overall Study||40
11077707|NCT01105975|12259960|FG009|STARTED|Overall Study||41
11077708|NCT01105975|12259951|FG000|Took at Least One Dose of Study Drug|Overall Study||40
11077709|NCT01105975|12259952|FG001|Took at Least One Dose of Study Drug|Overall Study||38
11077710|NCT01105975|12259953|FG002|Took at Least One Dose of Study Drug|Overall Study||40
11077711|NCT01105975|12259954|FG003|Took at Least One Dose of Study Drug|Overall Study||38
11077712|NCT01105975|12259955|FG004|Took at Least One Dose of Study Drug|Overall Study||41
11077713|NCT01105975|12259956|FG005|Took at Least One Dose of Study Drug|Overall Study||35
11077714|NCT01105975|12259957|FG006|Took at Least One Dose of Study Drug|Overall Study||41
11077715|NCT01105975|12259958|FG007|Took at Least One Dose of Study Drug|Overall Study||40
11077716|NCT01105975|12259959|FG008|Took at Least One Dose of Study Drug|Overall Study||39
11077717|NCT01105975|12259960|FG009|Took at Least One Dose of Study Drug|Overall Study||41
11077718|NCT01105975|12259951|FG000|COMPLETED|Overall Study||35
11077719|NCT01105975|12259952|FG001|COMPLETED|Overall Study||34
11077720|NCT01105975|12259953|FG002|COMPLETED|Overall Study||32
11077721|NCT01105975|12259954|FG003|COMPLETED|Overall Study||36
11077722|NCT01105975|12259955|FG004|COMPLETED|Overall Study||35
11077723|NCT01105975|12259956|FG005|COMPLETED|Overall Study||30
11348424|NCT03000686|12545391|FG000|STARTED|Part 2, Wash-out (Up to 14 Days)||0
11348425|NCT03000686|12545392|FG001|STARTED|Part 2, Wash-out (Up to 14 Days)||0
11348426|NCT03000686|12545393|FG002|STARTED|Part 2, Wash-out (Up to 14 Days)||3
11348427|NCT03000686|12545394|FG003|STARTED|Part 2, Wash-out (Up to 14 Days)||3
11348428|NCT03000686|12545391|FG000|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
11348429|NCT03000686|12545392|FG001|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
11348430|NCT03000686|12545393|FG002|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
11077724|NCT01105975|12259957|FG006|COMPLETED|Overall Study||34
11077725|NCT01105975|12259958|FG007|COMPLETED|Overall Study||33
11348431|NCT03000686|12545394|FG003|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
11348432|NCT03000686|12545391|FG000|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
11348433|NCT03000686|12545392|FG001|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
11348434|NCT03000686|12545393|FG002|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
11348435|NCT03000686|12545394|FG003|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
11348436|NCT03000686|12545391|FG000|STARTED|Part 2, Period 2 (1 Day)||0
11348437|NCT03000686|12545392|FG001|STARTED|Part 2, Period 2 (1 Day)||0
11348438|NCT03000686|12545393|FG002|STARTED|Part 2, Period 2 (1 Day)||3
11348439|NCT03000686|12545394|FG003|STARTED|Part 2, Period 2 (1 Day)||3
11348440|NCT03000686|12545391|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0
11348441|NCT03000686|12545392|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0
11077726|NCT01105975|12259959|FG008|COMPLETED|Overall Study||34
11077727|NCT01105975|12259960|FG009|COMPLETED|Overall Study||32
11077728|NCT01105975|12259951|FG000|NOT COMPLETED|Overall Study||5
11077729|NCT01105975|12259952|FG001|NOT COMPLETED|Overall Study||5
11077730|NCT01105975|12259953|FG002|NOT COMPLETED|Overall Study||10
11077731|NCT01105975|12259954|FG003|NOT COMPLETED|Overall Study||2
11077732|NCT01105975|12259955|FG004|NOT COMPLETED|Overall Study||6
11077733|NCT01105975|12259956|FG005|NOT COMPLETED|Overall Study||5
11077734|NCT01105975|12259957|FG006|NOT COMPLETED|Overall Study||8
11077735|NCT01105975|12259958|FG007|NOT COMPLETED|Overall Study||7
11077736|NCT01105975|12259959|FG008|NOT COMPLETED|Overall Study||6
11077737|NCT01105975|12259960|FG009|NOT COMPLETED|Overall Study||9
11077738|NCT01106014|12260003|FG000|STARTED|Overall Study||574
11077739|NCT01106014|12260004|FG001|STARTED|Overall Study||582
11077740|NCT01106014|12260003|FG000|COMPLETED|Overall Study||289
11077741|NCT01106014|12260004|FG001|COMPLETED|Overall Study||252
11077742|NCT01106014|12260003|FG000|NOT COMPLETED|Overall Study||285
11077743|NCT01106014|12260004|FG001|NOT COMPLETED|Overall Study||330
11077744|NCT01106027|12260010|FG000|STARTED|Overall Study||2
11077745|NCT01106027|12260010|FG000|COMPLETED|Overall Study||1
11077746|NCT01106027|12260010|FG000|NOT COMPLETED|Overall Study||1
11077747|NCT01106040|12260014|FG000|STARTED|Overall Study||163
11077748|NCT01106040|12260014|FG000|COMPLETED|Overall Study||152
11077749|NCT01106040|12260014|FG000|NOT COMPLETED|Overall Study||11
11077750|NCT01106092|12260023|FG000|STARTED|Overall Study||78
11077751|NCT01106092|12260024|FG001|STARTED|Overall Study||78
11077752|NCT01106092|12260025|FG002|STARTED|Overall Study||78
11077753|NCT01106092|12260026|FG003|STARTED|Overall Study||78
11077754|NCT01106092|12260023|FG000|COMPLETED|Overall Study||78
11077755|NCT01106092|12260024|FG001|COMPLETED|Overall Study||78
11077756|NCT01106092|12260025|FG002|COMPLETED|Overall Study||78
11077757|NCT01106092|12260026|FG003|COMPLETED|Overall Study||77
11077758|NCT01106092|12260023|FG000|NOT COMPLETED|Overall Study||0
11077759|NCT01106092|12260024|FG001|NOT COMPLETED|Overall Study||0
11077760|NCT01106092|12260025|FG002|NOT COMPLETED|Overall Study||0
11348442|NCT03000686|12545393|FG002|COMPLETED|Part 2, Period 2 (1 Day)||3
11348443|NCT03000686|12545394|FG003|COMPLETED|Part 2, Period 2 (1 Day)||3
11077761|NCT01106092|12260026|FG003|NOT COMPLETED|Overall Study||1
11077762|NCT01106157|12260038|FG000|STARTED|Overall Study||17
11077763|NCT01106157|12260039|FG001|STARTED|Overall Study||8
11077764|NCT01106157|12260038|FG000|COMPLETED|Overall Study||16
11077765|NCT01106157|12260039|FG001|COMPLETED|Overall Study||8
11077766|NCT01106157|12260038|FG000|NOT COMPLETED|Overall Study||1
11077767|NCT01106157|12260039|FG001|NOT COMPLETED|Overall Study||0
11077768|NCT01106248|12260045|FG000|STARTED|Overall Study||26
11077769|NCT01106248|12260045|FG000|COMPLETED|Overall Study||23
11077770|NCT01106248|12260045|FG000|NOT COMPLETED|Overall Study||3
11077771|NCT01106287|12260053|FG000|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
11077772|NCT01106287|12260054|FG001|STARTED|Overall Study||3
11077773|NCT01106287|12260055|FG002|STARTED|Overall Study||3
11077774|NCT01106287|12260056|FG003|STARTED|Overall Study||3
11077775|NCT01106287|12260053|FG000|COMPLETED|Overall Study||3
11077776|NCT01106287|12260054|FG001|COMPLETED|Overall Study||3
11077777|NCT01106287|12260055|FG002|COMPLETED|Overall Study||3
11077778|NCT01106287|12260056|FG003|COMPLETED|Overall Study||3
11077779|NCT01106287|12260053|FG000|NOT COMPLETED|Overall Study||1
11077780|NCT01106287|12260054|FG001|NOT COMPLETED|Overall Study||0
11077781|NCT01106287|12260055|FG002|NOT COMPLETED|Overall Study||0
11077782|NCT01106287|12260056|FG003|NOT COMPLETED|Overall Study||0
11206854|NCT01870921|12397957|FG000|NOT COMPLETED|Overall Study||90
11348444|NCT03000686|12545391|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
11348445|NCT03000686|12545392|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
11348446|NCT03000686|12545393|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
11348447|NCT03000686|12545394|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
11348448|NCT03001076|12545408|FG000|STARTED|Overall Study||88
11348449|NCT03001076|12545409|FG001|STARTED|Overall Study||181
11348450|NCT03001076|12545408|FG000|COMPLETED|Overall Study||81
11348451|NCT03001076|12545409|FG001|COMPLETED|Overall Study||176
11348452|NCT03001076|12545408|FG000|NOT COMPLETED|Overall Study||7
11348453|NCT03001076|12545409|FG001|NOT COMPLETED|Overall Study||5
11348454|NCT03001219|12545417|FG000|STARTED|Proof of Concept||37
11348455|NCT03001219|12545418|FG001|STARTED|Proof of Concept||72
11348456|NCT03001219|12545417|FG000|COMPLETED|Proof of Concept||35
11348457|NCT03001219|12545418|FG001|COMPLETED|Proof of Concept||65
11348458|NCT03001219|12545417|FG000|NOT COMPLETED|Proof of Concept||2
11348459|NCT03001219|12545418|FG001|NOT COMPLETED|Proof of Concept||7
11348460|NCT03001219|12545417|FG000|STARTED|Extension Period Analysis||9
11348461|NCT03001219|12545418|FG001|STARTED|Extension Period Analysis||97
11348462|NCT03001219|12545417|FG000|COMPLETED|Extension Period Analysis||4
11348463|NCT03001219|12545418|FG001|COMPLETED|Extension Period Analysis||52
11348464|NCT03001219|12545417|FG000|NOT COMPLETED|Extension Period Analysis||5
11348465|NCT03001219|12545418|FG001|NOT COMPLETED|Extension Period Analysis||45
11348466|NCT03001258|12545432|FG000|STARTED|Overall Study||765
11348467|NCT03001258|12545433|FG001|STARTED|Overall Study||751
11348468|NCT03001258|12545434|FG002|STARTED|Overall Study||485
11348469|NCT03001258|12545432|FG000|COMPLETED|Overall Study||765
11348470|NCT03001258|12545433|FG001|COMPLETED|Overall Study||751
11348471|NCT03001258|12545434|FG002|COMPLETED|Overall Study||485
11348472|NCT03001258|12545432|FG000|NOT COMPLETED|Overall Study||0
11348473|NCT03001258|12545433|FG001|NOT COMPLETED|Overall Study||0
11348474|NCT03001258|12545434|FG002|NOT COMPLETED|Overall Study||0
11348475|NCT03001453|12545444|FG000|STARTED|Overall Study||50
11206855|NCT01870973|12397963|FG000|STARTED|Overall Study||56
11206856|NCT01870973|12397964|FG001|STARTED|Overall Study||52
11206857|NCT01870973|12397963|FG000|COMPLETED|Overall Study||46
11206858|NCT01870973|12397964|FG001|COMPLETED|Overall Study||49
11206859|NCT01870973|12397963|FG000|NOT COMPLETED|Overall Study||10
11206860|NCT01870973|12397964|FG001|NOT COMPLETED|Overall Study||3
11206861|NCT01870999|12397973|FG000|STARTED|Overall Study||14
11206862|NCT01870999|12397974|FG001|STARTED|Overall Study||16
11206863|NCT01870999|12397975|FG002|STARTED|Overall Study||11
11348476|NCT03001453|12545445|FG001|STARTED|Overall Study||57
11348477|NCT03001453|12545444|FG000|COMPLETED|Overall Study||50
11348478|NCT03001453|12545445|FG001|COMPLETED|Overall Study||57
11348479|NCT03001453|12545444|FG000|NOT COMPLETED|Overall Study||0
11348480|NCT03001453|12545445|FG001|NOT COMPLETED|Overall Study||0
11348481|NCT03001557|12545456|FG000|STARTED|Core Phase||12
11348482|NCT03001557|12545457|FG001|STARTED|Core Phase||12
11348483|NCT03001557|12545458|FG002|STARTED|Core Phase||14
11348484|NCT03001557|12545459|FG003|STARTED|Core Phase||13
11348485|NCT03001557|12545460|FG004|STARTED|Core Phase||12
11348486|NCT03001557|12545461|FG005|STARTED|Core Phase||0
11348487|NCT03001557|12545462|FG006|STARTED|Core Phase||0
11348488|NCT03001557|12545463|FG007|STARTED|Core Phase||0
11348489|NCT03001557|12545456|FG000|Treated|Core Phase||12
11348490|NCT03001557|12545457|FG001|Treated|Core Phase||12
11348491|NCT03001557|12545458|FG002|Treated|Core Phase||13
11348492|NCT03001557|12545459|FG003|Treated|Core Phase||13
11348493|NCT03001557|12545460|FG004|Treated|Core Phase||12
11348494|NCT03001557|12545461|FG005|Treated|Core Phase||0
11348495|NCT03001557|12545462|FG006|Treated|Core Phase||0
11348496|NCT03001557|12545463|FG007|Treated|Core Phase||0
11348497|NCT03001557|12545456|FG000|COMPLETED|Core Phase||12
11348498|NCT03001557|12545457|FG001|COMPLETED|Core Phase||12
11348499|NCT03001557|12545458|FG002|COMPLETED|Core Phase||13
11348500|NCT03001557|12545459|FG003|COMPLETED|Core Phase||13
11348501|NCT03001557|12545460|FG004|COMPLETED|Core Phase||12
11348502|NCT03001557|12545461|FG005|COMPLETED|Core Phase||0
11348503|NCT03001557|12545462|FG006|COMPLETED|Core Phase||0
11348504|NCT03001557|12545463|FG007|COMPLETED|Core Phase||0
11348505|NCT03001557|12545456|FG000|NOT COMPLETED|Core Phase||0
11348506|NCT03001557|12545457|FG001|NOT COMPLETED|Core Phase||0
11348507|NCT03001557|12545458|FG002|NOT COMPLETED|Core Phase||1
11348508|NCT03001557|12545459|FG003|NOT COMPLETED|Core Phase||0
11348509|NCT03001557|12545460|FG004|NOT COMPLETED|Core Phase||0
11348510|NCT03001557|12545461|FG005|NOT COMPLETED|Core Phase||0
11348511|NCT03001557|12545462|FG006|NOT COMPLETED|Core Phase||0
11348512|NCT03001557|12545463|FG007|NOT COMPLETED|Core Phase||0
11348513|NCT03001557|12545456|FG000|STARTED|Extension Phase||0
11348514|NCT03001557|12545457|FG001|STARTED|Extension Phase||0
11348515|NCT03001557|12545458|FG002|STARTED|Extension Phase||0
11348516|NCT03001557|12545459|FG003|STARTED|Extension Phase||0
11348517|NCT03001557|12545460|FG004|STARTED|Extension Phase||0
11348518|NCT03001557|12545461|FG005|STARTED|Extension Phase||5
11348519|NCT03001557|12545462|FG006|STARTED|Extension Phase||14
11348520|NCT03001557|12545463|FG007|STARTED|Extension Phase||6
11348521|NCT03001557|12545456|FG000|COMPLETED|Extension Phase||0
11348522|NCT03001557|12545457|FG001|COMPLETED|Extension Phase||0
11348523|NCT03001557|12545458|FG002|COMPLETED|Extension Phase||0
11348524|NCT03001557|12545459|FG003|COMPLETED|Extension Phase||0
11348525|NCT03001557|12545460|FG004|COMPLETED|Extension Phase||0
11348526|NCT03001557|12545461|FG005|COMPLETED|Extension Phase||0
11348527|NCT03001557|12545462|FG006|COMPLETED|Extension Phase||0
11348528|NCT03001557|12545463|FG007|COMPLETED|Extension Phase||0
11348529|NCT03001557|12545456|FG000|NOT COMPLETED|Extension Phase||0
11348530|NCT03001557|12545457|FG001|NOT COMPLETED|Extension Phase||0
11348531|NCT03001557|12545458|FG002|NOT COMPLETED|Extension Phase||0
11348532|NCT03001557|12545459|FG003|NOT COMPLETED|Extension Phase||0
11348533|NCT03001557|12545460|FG004|NOT COMPLETED|Extension Phase||0
11348534|NCT03001557|12545461|FG005|NOT COMPLETED|Extension Phase||5
11348535|NCT03001557|12545462|FG006|NOT COMPLETED|Extension Phase||14
11348536|NCT03001557|12545463|FG007|NOT COMPLETED|Extension Phase||6
11348537|NCT03001674|12545487|FG000|STARTED|Overall Study||10
11348538|NCT03001674|12545488|FG001|STARTED|Overall Study||5
11348539|NCT03001674|12545487|FG000|COMPLETED|Overall Study||10
11348540|NCT03001674|12545488|FG001|COMPLETED|Overall Study||5
11348541|NCT03001674|12545487|FG000|NOT COMPLETED|Overall Study||0
11077783|NCT01106326|12260070|FG000|STARTED|Overall Study||30
11348542|NCT03001674|12545488|FG001|NOT COMPLETED|Overall Study||0
11348543|NCT03001778|12545496|FG000|STARTED|Overall Study||21
11348544|NCT03001778|12545497|FG001|STARTED|Overall Study||46
11348545|NCT03001778|12545496|FG000|COMPLETED|Overall Study||21
11348546|NCT03001778|12545497|FG001|COMPLETED|Overall Study||46
11348547|NCT03001778|12545496|FG000|NOT COMPLETED|Overall Study||0
11348548|NCT03001778|12545497|FG001|NOT COMPLETED|Overall Study||0
11348549|NCT03001843|12545505|FG000|STARTED|Overall Study||27
11348550|NCT03001843|12545506|FG001|STARTED|Overall Study||27
11348551|NCT03001843|12545505|FG000|COMPLETED|Overall Study||27
11077784|NCT01106326|12260070|FG000|COMPLETED|Overall Study||28
11348552|NCT03001843|12545506|FG001|COMPLETED|Overall Study||27
11348553|NCT03001843|12545505|FG000|NOT COMPLETED|Overall Study||0
11348554|NCT03001843|12545506|FG001|NOT COMPLETED|Overall Study||0
11348555|NCT03002012|12545514|FG000|STARTED|Overall Study||11
11077785|NCT01106326|12260070|FG000|NOT COMPLETED|Overall Study||2
11077786|NCT01106352|12260081|FG000|STARTED|Overall Study||7
11077787|NCT01106352|12260082|FG001|STARTED|Overall Study||3
11077788|NCT01106352|12260083|FG002|STARTED|Overall Study||7
11077789|NCT01106352|12260084|FG003|STARTED|Overall Study||36
11077790|NCT01106352|12260085|FG004|STARTED|Overall Study||17
11077791|NCT01106352|12260081|FG000|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
11077792|NCT01106352|12260082|FG001|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
11077793|NCT01106352|12260083|FG002|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
11077794|NCT01106352|12260084|FG003|Started Dose Escalation|Overall Study||0
11077795|NCT01106352|12260085|FG004|Started Dose Escalation|Overall Study||0
11077796|NCT01106352|12260081|FG000|Completed Dose Escalation|Overall Study||6
11077797|NCT01106352|12260082|FG001|Completed Dose Escalation|Overall Study||3
11077798|NCT01106352|12260083|FG002|Completed Dose Escalation|Overall Study||5
11077799|NCT01106352|12260084|FG003|Completed Dose Escalation|Overall Study||0
11077800|NCT01106352|12260085|FG004|Completed Dose Escalation|Overall Study||0
11077801|NCT01106352|12260081|FG000|Started Safety Cohort|Overall Study||0
11077802|NCT01106352|12260082|FG001|Started Safety Cohort|Overall Study||0
11077803|NCT01106352|12260083|FG002|Started Safety Cohort|Overall Study||0
11077804|NCT01106352|12260084|FG003|Started Safety Cohort|Overall Study||36
11077805|NCT01106352|12260085|FG004|Started Safety Cohort|Overall Study||17
11077806|NCT01106352|12260081|FG000|Treated Safety Cohort|Overall Study||0
11077807|NCT01106352|12260082|FG001|Treated Safety Cohort|Overall Study||0
11077808|NCT01106352|12260083|FG002|Treated Safety Cohort|Overall Study||0
11077809|NCT01106352|12260084|FG003|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
11348556|NCT03002012|12545515|FG001|STARTED|Overall Study||11
11348557|NCT03002012|12545514|FG000|COMPLETED|Overall Study||11
11348558|NCT03002012|12545515|FG001|COMPLETED|Overall Study||11
11348559|NCT03002012|12545514|FG000|NOT COMPLETED|Overall Study||0
11077810|NCT01106352|12260085|FG004|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
11077811|NCT01106352|12260081|FG000|Completed Safety Cohort|Overall Study||0
11077812|NCT01106352|12260082|FG001|Completed Safety Cohort|Overall Study||0
11077813|NCT01106352|12260083|FG002|Completed Safety Cohort|Overall Study||0
11077814|NCT01106352|12260084|FG003|Completed Safety Cohort|Overall Study||23
11077815|NCT01106352|12260085|FG004|Completed Safety Cohort|Overall Study||9
11077816|NCT01106352|12260081|FG000|COMPLETED|Overall Study||6
11077817|NCT01106352|12260082|FG001|COMPLETED|Overall Study||3
11077818|NCT01106352|12260083|FG002|COMPLETED|Overall Study||5
11077819|NCT01106352|12260084|FG003|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
11077820|NCT01106352|12260085|FG004|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
11077821|NCT01106352|12260081|FG000|NOT COMPLETED|Overall Study||1
11077822|NCT01106352|12260082|FG001|NOT COMPLETED|Overall Study||0
11077823|NCT01106352|12260083|FG002|NOT COMPLETED|Overall Study||2
11077824|NCT01106352|12260084|FG003|NOT COMPLETED|Overall Study||13
11077825|NCT01106352|12260085|FG004|NOT COMPLETED|Overall Study||8
11077826|NCT01106391|12260101|FG000|STARTED|Overall Study||60
11077827|NCT01106391|12260101|FG000|COMPLETED|Overall Study||60
11077828|NCT01106391|12260101|FG000|NOT COMPLETED|Overall Study||0
11077829|NCT01106404|12260107|FG000|STARTED|Period I (First 6 Weeks)||36
11077830|NCT01106404|12260108|FG001|STARTED|Period I (First 6 Weeks)||40
11077831|NCT01106404|12260107|FG000|COMPLETED|Period I (First 6 Weeks)||33
11077832|NCT01106404|12260108|FG001|COMPLETED|Period I (First 6 Weeks)||38
11077833|NCT01106404|12260107|FG000|NOT COMPLETED|Period I (First 6 Weeks)||3
11077834|NCT01106404|12260108|FG001|NOT COMPLETED|Period I (First 6 Weeks)||2
11077835|NCT01106404|12260107|FG000|STARTED|Period II (Second 6 Weeks)||33
11077836|NCT01106404|12260108|FG001|STARTED|Period II (Second 6 Weeks)||38
11077837|NCT01106404|12260107|FG000|COMPLETED|Period II (Second 6 Weeks)||33
11077838|NCT01106404|12260108|FG001|COMPLETED|Period II (Second 6 Weeks)||38
11077839|NCT01106404|12260107|FG000|NOT COMPLETED|Period II (Second 6 Weeks)||0
11077840|NCT01106404|12260108|FG001|NOT COMPLETED|Period II (Second 6 Weeks)||0
11206864|NCT01870999|12397973|FG000|Safety Population; Received Study Drug|Overall Study||14
11206865|NCT01870999|12397974|FG001|Safety Population; Received Study Drug|Overall Study||15
11206866|NCT01870999|12397975|FG002|Safety Population; Received Study Drug|Overall Study||10
11206867|NCT01870999|12397973|FG000|COMPLETED|Overall Study||10
11206868|NCT01870999|12397974|FG001|COMPLETED|Overall Study||8
11206869|NCT01870999|12397975|FG002|COMPLETED|Overall Study||4
11206870|NCT01870999|12397973|FG000|NOT COMPLETED|Overall Study||4
11206871|NCT01870999|12397974|FG001|NOT COMPLETED|Overall Study||8
11206872|NCT01870999|12397975|FG002|NOT COMPLETED|Overall Study||7
11206873|NCT01871077|12397983|FG000|STARTED|Overall Study||30
11206874|NCT01871077|12397983|FG000|COMPLETED|Overall Study||30
11206875|NCT01871077|12397983|FG000|NOT COMPLETED|Overall Study||0
11206876|NCT01871090|12397989|FG000|STARTED|Overall Study||35
11206877|NCT01871090|12397990|FG001|STARTED|Overall Study||48
11206878|NCT01871090|12397989|FG000|COMPLETED|Overall Study||33
11206879|NCT01871090|12397990|FG001|COMPLETED|Overall Study||25
11206880|NCT01871090|12397989|FG000|NOT COMPLETED|Overall Study||2
11206881|NCT01871090|12397990|FG001|NOT COMPLETED|Overall Study||23
11206882|NCT01871142|12397996|FG000|STARTED|Overall Study||12
11206883|NCT01871142|12397996|FG000|Received Placebo + Normoixa|Overall Study||11
11206884|NCT01871142|12397996|FG000|Received Placebo + Hypoxia|Overall Study||12
11206885|NCT01871142|12397996|FG000|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
11206886|NCT01871142|12397996|FG000|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
11206887|NCT01871142|12397996|FG000|COMPLETED|Overall Study||11
11206888|NCT01871142|12397996|FG000|NOT COMPLETED|Overall Study||1
11206889|NCT01871285|12398012|FG000|STARTED|First Intervention (1 Day)||18
11206890|NCT01871285|12398013|FG001|STARTED|First Intervention (1 Day)||15
11206891|NCT01871285|12398014|FG002|STARTED|First Intervention (1 Day)||4
11206892|NCT01871285|12398015|FG003|STARTED|First Intervention (1 Day)||2
11077841|NCT01106430|12260122|FG000|STARTED|Overall Study||133
11077842|NCT01106430|12260123|FG001|STARTED|Overall Study||134
11077843|NCT01106430|12260122|FG000|COMPLETED|Overall Study||100
11077844|NCT01106430|12260123|FG001|COMPLETED|Overall Study||101
11077845|NCT01106430|12260122|FG000|NOT COMPLETED|Overall Study||33
11077846|NCT01106430|12260123|FG001|NOT COMPLETED|Overall Study||33
11077847|NCT01106456|12260131|FG000|STARTED|Overall Study||243
11077848|NCT01106456|12260132|FG001|STARTED|Overall Study||220
11077849|NCT01106456|12260131|FG000|COMPLETED|Overall Study||140
11077850|NCT01106456|12260132|FG001|COMPLETED|Overall Study||96
11077851|NCT01106456|12260131|FG000|NOT COMPLETED|Overall Study||103
11077852|NCT01106456|12260132|FG001|NOT COMPLETED|Overall Study||124
11077853|NCT01106586|12260140|FG000|STARTED|Overall Study||353
11077854|NCT01106586|12260141|FG001|STARTED|Overall Study||355
11077855|NCT01106586|12260140|FG000|COMPLETED|Overall Study||68
11077856|NCT01106586|12260141|FG001|COMPLETED|Overall Study||70
11077857|NCT01106586|12260140|FG000|NOT COMPLETED|Overall Study||285
11077858|NCT01106586|12260141|FG001|NOT COMPLETED|Overall Study||285
11077859|NCT01106625|12260150|FG000|STARTED|Core Period: Baseline to Week 26||156
11077860|NCT01106625|12260151|FG001|STARTED|Core Period: Baseline to Week 26||157
11077861|NCT01106625|12260152|FG002|STARTED|Core Period: Baseline to Week 26||156
11077862|NCT01106625|12260150|FG000|COMPLETED|Core Period: Baseline to Week 26||123
11077863|NCT01106625|12260151|FG001|COMPLETED|Core Period: Baseline to Week 26||129
11077864|NCT01106625|12260152|FG002|COMPLETED|Core Period: Baseline to Week 26||129
11077865|NCT01106625|12260150|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||33
11077866|NCT01106625|12260151|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||28
11077867|NCT01106625|12260152|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||27
11077868|NCT01106625|12260150|FG000|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
11077869|NCT01106625|12260151|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
11077870|NCT01106625|12260152|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
11077871|NCT01106625|12260150|FG000|COMPLETED|Extension Period: Week 26 to Week 52||90
11077872|NCT01106625|12260151|FG001|COMPLETED|Extension Period: Week 26 to Week 52||109
11077873|NCT01106625|12260152|FG002|COMPLETED|Extension Period: Week 26 to Week 52||111
11077874|NCT01106625|12260150|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
11077875|NCT01106625|12260151|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
11077876|NCT01106625|12260152|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
11077877|NCT01106651|12260166|FG000|STARTED|Overall Study||237
11077878|NCT01106651|12260167|FG001|STARTED|Overall Study||241
11077879|NCT01106651|12260168|FG002|STARTED|Overall Study||236
11077880|NCT01106651|12260166|FG000|COMPLETED|Overall Study||158
11348560|NCT03002012|12545515|FG001|NOT COMPLETED|Overall Study||0
11348561|NCT03002038|12545523|FG000|STARTED|Overall Study||46
11348562|NCT03002038|12545524|FG001|STARTED|Overall Study||40
11348563|NCT03002038|12545523|FG000|COMPLETED|Overall Study||35
11348564|NCT03002038|12545524|FG001|COMPLETED|Overall Study||33
11348565|NCT03002038|12545523|FG000|NOT COMPLETED|Overall Study||11
11348566|NCT03002038|12545524|FG001|NOT COMPLETED|Overall Study||7
11077881|NCT01106651|12260167|FG001|COMPLETED|Overall Study||184
11077882|NCT01106651|12260168|FG002|COMPLETED|Overall Study||178
11077883|NCT01106651|12260166|FG000|NOT COMPLETED|Overall Study||79
11077884|NCT01106651|12260167|FG001|NOT COMPLETED|Overall Study||57
11077885|NCT01106651|12260168|FG002|NOT COMPLETED|Overall Study||58
11348567|NCT03002077|12545530|FG000|STARTED|Overall Study||617
11348568|NCT03002077|12545530|FG000|COMPLETED|Overall Study||179
11348569|NCT03002077|12545530|FG000|NOT COMPLETED|Overall Study||438
11348570|NCT03002194|12545534|FG000|STARTED|Overall Study||48
11077886|NCT01106677|12260183|FG000|STARTED|Core Period: Baseline to Week 26||183
11077887|NCT01106677|12260184|FG001|STARTED|Core Period: Baseline to Week 26||368
11077888|NCT01106677|12260185|FG002|STARTED|Core Period: Baseline to Week 26||367
11077889|NCT01106677|12260186|FG003|STARTED|Core Period: Baseline to Week 26||366
11077890|NCT01106677|12260183|FG000|COMPLETED|Core Period: Baseline to Week 26||155
11077891|NCT01106677|12260184|FG001|COMPLETED|Core Period: Baseline to Week 26||322
11077892|NCT01106677|12260185|FG002|COMPLETED|Core Period: Baseline to Week 26||323
11077893|NCT01106677|12260186|FG003|COMPLETED|Core Period: Baseline to Week 26||319
11077894|NCT01106677|12260183|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||28
11077895|NCT01106677|12260184|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||46
11077896|NCT01106677|12260185|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||44
11077897|NCT01106677|12260186|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||47
11077898|NCT01106677|12260183|FG000|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
11206893|NCT01871285|12398012|FG000|COMPLETED|First Intervention (1 Day)||17
11348571|NCT03002194|12545534|FG000|COMPLETED|Overall Study||38
11348572|NCT03002194|12545534|FG000|NOT COMPLETED|Overall Study||10
11348573|NCT03002311|12545540|FG000|STARTED|Overall Study||147
11348574|NCT03002311|12545541|FG001|STARTED|Overall Study||180
11348575|NCT03002311|12545540|FG000|COMPLETED|Overall Study||128
11348576|NCT03002311|12545541|FG001|COMPLETED|Overall Study||150
11348577|NCT03002311|12545540|FG000|NOT COMPLETED|Overall Study||19
11206894|NCT01871285|12398013|FG001|COMPLETED|First Intervention (1 Day)||14
11206895|NCT01871285|12398014|FG002|COMPLETED|First Intervention (1 Day)||3
11206896|NCT01871285|12398015|FG003|COMPLETED|First Intervention (1 Day)||2
11206897|NCT01871285|12398012|FG000|NOT COMPLETED|First Intervention (1 Day)||1
11206898|NCT01871285|12398013|FG001|NOT COMPLETED|First Intervention (1 Day)||1
11206899|NCT01871285|12398014|FG002|NOT COMPLETED|First Intervention (1 Day)||1
11206900|NCT01871285|12398015|FG003|NOT COMPLETED|First Intervention (1 Day)||0
11206901|NCT01871285|12398012|FG000|STARTED|Second Intervention (1 Day)||17
11206902|NCT01871285|12398013|FG001|STARTED|Second Intervention (1 Day)||14
11206903|NCT01871285|12398014|FG002|STARTED|Second Intervention (1 Day)||3
11206904|NCT01871285|12398015|FG003|STARTED|Second Intervention (1 Day)||2
11348578|NCT03002311|12545541|FG001|NOT COMPLETED|Overall Study||30
11348579|NCT03002454|12545547|FG000|STARTED|Overall Study||4
11348580|NCT03002454|12545547|FG000|COMPLETED|Overall Study||4
11348581|NCT03002454|12545547|FG000|NOT COMPLETED|Overall Study||0
11348582|NCT03002506|12545552|FG000|STARTED|Overall Study||6
11348583|NCT03002506|12545552|FG000|COMPLETED|Overall Study||6
11348584|NCT03002506|12545552|FG000|NOT COMPLETED|Overall Study||0
11348585|NCT03002610|12545559|FG000|STARTED|Overall Study||24
11348586|NCT03002610|12545560|FG001|STARTED|Overall Study||50
11348587|NCT03002610|12545561|FG002|STARTED|Overall Study||34
11348588|NCT03002610|12545559|FG000|COMPLETED|Overall Study||18
11077899|NCT01106677|12260184|FG001|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
11077900|NCT01106677|12260185|FG002|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
11077901|NCT01106677|12260186|FG003|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
11077902|NCT01106677|12260183|FG000|COMPLETED|Extension Period: Week 26 to Week 52||138
11077903|NCT01106677|12260184|FG001|COMPLETED|Extension Period: Week 26 to Week 52||298
11077904|NCT01106677|12260185|FG002|COMPLETED|Extension Period: Week 26 to Week 52||299
11077905|NCT01106677|12260186|FG003|COMPLETED|Extension Period: Week 26 to Week 52||285
11077906|NCT01106677|12260183|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
11077907|NCT01106677|12260184|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
11077908|NCT01106677|12260185|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
11077909|NCT01106677|12260186|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
11077910|NCT01106690|12260206|FG000|STARTED|Core Period: Baseline to Week 26||115
11077911|NCT01106690|12260207|FG001|STARTED|Core Period: Baseline to Week 26||113
11077912|NCT01106690|12260208|FG002|STARTED|Core Period: Baseline to Week 26||114
11077913|NCT01106690|12260206|FG000|COMPLETED|Core Period: Baseline to Week 26||91
11077914|NCT01106690|12260207|FG001|COMPLETED|Core Period: Baseline to Week 26||104
11077915|NCT01106690|12260208|FG002|COMPLETED|Core Period: Baseline to Week 26||101
11077916|NCT01106690|12260206|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||24
11077917|NCT01106690|12260207|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||9
11077918|NCT01106690|12260208|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||13
11077919|NCT01106690|12260206|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
11077920|NCT01106690|12260207|FG001|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
11077921|NCT01106690|12260208|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
11077922|NCT01106690|12260206|FG000|COMPLETED|Extension Period: Week 26 to Week 52||78
11077923|NCT01106690|12260207|FG001|COMPLETED|Extension Period: Week 26 to Week 52||96
11077924|NCT01106690|12260208|FG002|COMPLETED|Extension Period: Week 26 to Week 52||89
11077925|NCT01106690|12260206|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
11077926|NCT01106690|12260207|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
11077927|NCT01106690|12260208|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
11077928|NCT01106833|12260221|FG000|STARTED|Overall Study||74
11077929|NCT01106833|12260222|FG001|STARTED|Overall Study||77
11077930|NCT01106833|12260221|FG000|COMPLETED|Overall Study||74
11077931|NCT01106833|12260222|FG001|COMPLETED|Overall Study||77
11077932|NCT01106833|12260221|FG000|NOT COMPLETED|Overall Study||0
11077933|NCT01106833|12260222|FG001|NOT COMPLETED|Overall Study||0
11077934|NCT01106846|12260230|FG000|STARTED|Overall Study||12
11077935|NCT01106846|12260231|FG001|STARTED|Overall Study||10
11077936|NCT01106846|12260230|FG000|COMPLETED|Overall Study||12
11077937|NCT01106846|12260231|FG001|COMPLETED|Overall Study||9
11077938|NCT01106846|12260230|FG000|NOT COMPLETED|Overall Study||0
11077939|NCT01106846|12260231|FG001|NOT COMPLETED|Overall Study||1
11077940|NCT01106859|12260237|FG000|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
11077941|NCT01106859|12260237|FG000|COMPLETED|Overall Study||40
11077942|NCT01106859|12260237|FG000|NOT COMPLETED|Overall Study||0
11077943|NCT01106898|12260248|FG000|STARTED|Overall Study||100
11077944|NCT01106898|12260248|FG000|COMPLETED|Overall Study||94
11077945|NCT01106898|12260248|FG000|NOT COMPLETED|Overall Study||6
11077946|NCT01106911|12260252|FG000|STARTED|Overall Study||1085
11077947|NCT01106911|12260252|FG000|COMPLETED|Overall Study||1080
11077948|NCT01106911|12260252|FG000|NOT COMPLETED|Overall Study||5
11077949|NCT01106950|12260256|FG000|STARTED|Overall Study||15
11077950|NCT01106950|12260256|FG000|COMPLETED|Overall Study||15
11077951|NCT01106950|12260256|FG000|NOT COMPLETED|Overall Study||0
11077952|NCT01106976|12260262|FG000|STARTED|Overall Study||67
11077953|NCT01106976|12260262|FG000|COMPLETED|Overall Study||59
11077954|NCT01106976|12260262|FG000|NOT COMPLETED|Overall Study||8
11077955|NCT01107015|12260270|FG000|STARTED|Overall Study||62
11077956|NCT01107015|12260271|FG001|STARTED|Overall Study||38
11077957|NCT01107015|12260272|FG002|STARTED|Overall Study||33
11077958|NCT01107015|12260273|FG003|STARTED|Overall Study||80
11077959|NCT01107015|12260270|FG000|COMPLETED|Overall Study||56
11077960|NCT01107015|12260271|FG001|COMPLETED|Overall Study||23
11077961|NCT01107015|12260272|FG002|COMPLETED|Overall Study||22
11077962|NCT01107015|12260273|FG003|COMPLETED|Overall Study||62
11077963|NCT01107015|12260270|FG000|NOT COMPLETED|Overall Study||6
11077964|NCT01107015|12260271|FG001|NOT COMPLETED|Overall Study||15
11077965|NCT01107015|12260272|FG002|NOT COMPLETED|Overall Study||11
11077966|NCT01107015|12260273|FG003|NOT COMPLETED|Overall Study||18
11077967|NCT01107197|12260285|FG000|STARTED|Overall Study||99
11077968|NCT01107197|12260286|FG001|STARTED|Overall Study||101
11077969|NCT01107197|12260285|FG000|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
11077970|NCT01107197|12260286|FG001|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
11077971|NCT01107197|12260285|FG000|NOT COMPLETED|Overall Study||20
11077972|NCT01107197|12260286|FG001|NOT COMPLETED|Overall Study||23
11077973|NCT01107353|12260294|FG000|STARTED|Overall Study||20
11077974|NCT01107353|12260295|FG001|STARTED|Overall Study||20
11077975|NCT01107353|12260294|FG000|COMPLETED|Overall Study||19
11077976|NCT01107353|12260295|FG001|COMPLETED|Overall Study||20
11077977|NCT01107353|12260294|FG000|NOT COMPLETED|Overall Study||1
11077978|NCT01107353|12260295|FG001|NOT COMPLETED|Overall Study||0
11077979|NCT01107379|12260301|FG000|STARTED|Overall Study||203
11077980|NCT01107379|12260301|FG000|COMPLETED|Overall Study||182
11077981|NCT01107379|12260301|FG000|NOT COMPLETED|Overall Study||21
11077982|NCT01107392|12260307|FG000|STARTED|Overall Study||158
11077983|NCT01107392|12260308|FG001|STARTED|Overall Study||157
11077984|NCT01107392|12260307|FG000|COMPLETED|Overall Study||153
11077985|NCT01107392|12260308|FG001|COMPLETED|Overall Study||154
11077986|NCT01107392|12260307|FG000|NOT COMPLETED|Overall Study||5
11077987|NCT01107392|12260308|FG001|NOT COMPLETED|Overall Study||3
11077988|NCT01107405|12260319|FG000|STARTED|Overall Study||21
11077989|NCT01107405|12260320|FG001|STARTED|Overall Study||20
11077990|NCT01107405|12260321|FG002|STARTED|Overall Study||20
11077991|NCT01107405|12260322|FG003|STARTED|Overall Study||20
11077992|NCT01107405|12260323|FG004|STARTED|Overall Study||20
11077993|NCT01107405|12260319|FG000|COMPLETED|Overall Study||19
11077994|NCT01107405|12260320|FG001|COMPLETED|Overall Study||19
11077995|NCT01107405|12260321|FG002|COMPLETED|Overall Study||18
11077996|NCT01107405|12260322|FG003|COMPLETED|Overall Study||17
11077997|NCT01107405|12260323|FG004|COMPLETED|Overall Study||17
11077998|NCT01107405|12260319|FG000|NOT COMPLETED|Overall Study||2
11077999|NCT01107405|12260320|FG001|NOT COMPLETED|Overall Study||1
11078000|NCT01107405|12260321|FG002|NOT COMPLETED|Overall Study||2
11078001|NCT01107405|12260322|FG003|NOT COMPLETED|Overall Study||3
11078002|NCT01107405|12260323|FG004|NOT COMPLETED|Overall Study||3
11078003|NCT01107418|12260339|FG000|STARTED|Overall Study||52
11078004|NCT01107418|12260339|FG000|COMPLETED|Overall Study||0
11078005|NCT01107418|12260339|FG000|NOT COMPLETED|Overall Study||52
11078006|NCT01107444|12260356|FG000|STARTED|Overall Study||120
11078007|NCT01107444|12260357|FG001|STARTED|Overall Study||60
11078008|NCT01107444|12260356|FG000|Received At Least 1 Dose of Study Drug|Overall Study||114
11078009|NCT01107444|12260357|FG001|Received At Least 1 Dose of Study Drug|Overall Study||48
11078010|NCT01107444|12260356|FG000|COMPLETED|Overall Study||112
11078011|NCT01107444|12260357|FG001|COMPLETED|Overall Study||47
11078012|NCT01107444|12260356|FG000|NOT COMPLETED|Overall Study||8
11078013|NCT01107444|12260357|FG001|NOT COMPLETED|Overall Study||13
11078014|NCT01107457|12260371|FG000|STARTED|Part A||27
11078015|NCT01107457|12260372|FG001|STARTED|Part A||28
11078016|NCT01107457|12260373|FG002|STARTED|Part A||30
11078017|NCT01107457|12260374|FG003|STARTED|Part A||29
11348589|NCT03002610|12545560|FG001|COMPLETED|Overall Study||25
11348590|NCT03002610|12545561|FG002|COMPLETED|Overall Study||21
11348591|NCT03002610|12545559|FG000|NOT COMPLETED|Overall Study||6
11078018|NCT01107457|12260375|FG004|STARTED|Part A||28
11078019|NCT01107457|12260376|FG005|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
11078020|NCT01107457|12260371|FG000|Received at Least 1 Dose of Study Drug|Part A||27
11078021|NCT01107457|12260372|FG001|Received at Least 1 Dose of Study Drug|Part A||28
11078022|NCT01107457|12260373|FG002|Received at Least 1 Dose of Study Drug|Part A||30
11078023|NCT01107457|12260374|FG003|Received at Least 1 Dose of Study Drug|Part A||29
11078024|NCT01107457|12260375|FG004|Received at Least 1 Dose of Study Drug|Part A||28
11078025|NCT01107457|12260376|FG005|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
11078026|NCT01107457|12260371|FG000|COMPLETED|Part A||22
11078027|NCT01107457|12260372|FG001|COMPLETED|Part A||21
11078028|NCT01107457|12260373|FG002|COMPLETED|Part A||29
11078029|NCT01107457|12260374|FG003|COMPLETED|Part A||26
11078030|NCT01107457|12260375|FG004|COMPLETED|Part A||27
11078031|NCT01107457|12260376|FG005|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
11078032|NCT01107457|12260371|FG000|NOT COMPLETED|Part A||5
11078033|NCT01107457|12260372|FG001|NOT COMPLETED|Part A||7
11078034|NCT01107457|12260373|FG002|NOT COMPLETED|Part A||1
11078035|NCT01107457|12260374|FG003|NOT COMPLETED|Part A||3
11078036|NCT01107457|12260375|FG004|NOT COMPLETED|Part A||1
11078037|NCT01107457|12260376|FG005|NOT COMPLETED|Part A||0
11078038|NCT01107457|12260371|FG000|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
11078039|NCT01107457|12260372|FG001|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
11078040|NCT01107457|12260373|FG002|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
11078041|NCT01107457|12260374|FG003|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
11078042|NCT01107457|12260375|FG004|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
11078043|NCT01107457|12260376|FG005|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
11078044|NCT01107457|12260371|FG000|Completed Part B (Week 240)|Part B and C||0
11078045|NCT01107457|12260372|FG001|Completed Part B (Week 240)|Part B and C||0
11078046|NCT01107457|12260373|FG002|Completed Part B (Week 240)|Part B and C||0
11078047|NCT01107457|12260374|FG003|Completed Part B (Week 240)|Part B and C||0
11078048|NCT01107457|12260375|FG004|Completed Part B (Week 240)|Part B and C||0
11078049|NCT01107457|12260376|FG005|Completed Part B (Week 240)|Part B and C||74
11078050|NCT01107457|12260371|FG000|Completed Part C|Part B and C||0
11078051|NCT01107457|12260372|FG001|Completed Part C|Part B and C||0
11078052|NCT01107457|12260373|FG002|Completed Part C|Part B and C||0
11078053|NCT01107457|12260374|FG003|Completed Part C|Part B and C||0
11078054|NCT01107457|12260375|FG004|Completed Part C|Part B and C||0
11078055|NCT01107457|12260376|FG005|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
11078056|NCT01107457|12260371|FG000|Post Treatment Safety Visits|Part B and C||0
11078057|NCT01107457|12260372|FG001|Post Treatment Safety Visits|Part B and C||0
11078058|NCT01107457|12260373|FG002|Post Treatment Safety Visits|Part B and C||0
11078059|NCT01107457|12260374|FG003|Post Treatment Safety Visits|Part B and C||0
11078060|NCT01107457|12260375|FG004|Post Treatment Safety Visits|Part B and C||0
11078061|NCT01107457|12260376|FG005|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
11078062|NCT01107457|12260371|FG000|COMPLETED|Part B and C||0
11078063|NCT01107457|12260372|FG001|COMPLETED|Part B and C||0
11078064|NCT01107457|12260373|FG002|COMPLETED|Part B and C||0
11078065|NCT01107457|12260374|FG003|COMPLETED|Part B and C||0
11078066|NCT01107457|12260375|FG004|COMPLETED|Part B and C||0
11078067|NCT01107457|12260376|FG005|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
11078068|NCT01107457|12260371|FG000|NOT COMPLETED|Part B and C||0
11078069|NCT01107457|12260372|FG001|NOT COMPLETED|Part B and C||0
11078070|NCT01107457|12260373|FG002|NOT COMPLETED|Part B and C||0
11078071|NCT01107457|12260374|FG003|NOT COMPLETED|Part B and C||0
11078072|NCT01107457|12260375|FG004|NOT COMPLETED|Part B and C||0
11078073|NCT01107457|12260376|FG005|NOT COMPLETED|Part B and C||120
11078074|NCT01107535|12260394|FG000|STARTED|Overall Study||82
11078075|NCT01107535|12260394|FG000|Number of Participants Analyzed|Overall Study||82
11078076|NCT01107535|12260394|FG000|COMPLETED|Overall Study||77
11078077|NCT01107535|12260394|FG000|NOT COMPLETED|Overall Study||5
11078078|NCT01107665|12260398|FG000|STARTED|Overall Study||60
11078079|NCT01107665|12260398|FG000|COMPLETED|Overall Study||11
11078080|NCT01107665|12260398|FG000|NOT COMPLETED|Overall Study||49
11078081|NCT01107730|12260407|FG000|STARTED|Overall Study||11
11078082|NCT01107730|12260408|FG001|STARTED|Overall Study||11
11078083|NCT01107730|12260409|FG002|STARTED|Overall Study||11
11078084|NCT01107730|12260407|FG000|COMPLETED|Overall Study||11
11078085|NCT01107730|12260408|FG001|COMPLETED|Overall Study||11
11078086|NCT01107730|12260409|FG002|COMPLETED|Overall Study||11
11078087|NCT01107730|12260407|FG000|NOT COMPLETED|Overall Study||0
11078088|NCT01107730|12260408|FG001|NOT COMPLETED|Overall Study||0
11078089|NCT01107730|12260409|FG002|NOT COMPLETED|Overall Study||0
11078090|NCT01107743|12260417|FG000|STARTED|Overall Study||1291
11078091|NCT01107743|12260417|FG000|COMPLETED|Overall Study||1245
11348592|NCT03002610|12545560|FG001|NOT COMPLETED|Overall Study||25
11078092|NCT01107743|12260417|FG000|NOT COMPLETED|Overall Study||46
11078093|NCT01107834|12260468|FG000|STARTED|Overall Study||30
11078094|NCT01107834|12260469|FG001|STARTED|Overall Study||30
11078095|NCT01107834|12260468|FG000|COMPLETED|Overall Study||30
11078096|NCT01107834|12260469|FG001|COMPLETED|Overall Study||30
11078097|NCT01107834|12260468|FG000|NOT COMPLETED|Overall Study||0
11078098|NCT01107834|12260469|FG001|NOT COMPLETED|Overall Study||0
11078099|NCT01107886|12260477|FG000|STARTED|Overall Study|Randomized subjects|8280
11078100|NCT01107886|12260478|FG001|STARTED|Overall Study|Randomized subjects|8212
11078101|NCT01107886|12260477|FG000|COMPLETED|Overall Study|Completed subjects|8078
11078102|NCT01107886|12260478|FG001|COMPLETED|Overall Study|Completed subjects|7998
11078103|NCT01107886|12260477|FG000|NOT COMPLETED|Overall Study||202
11078104|NCT01107886|12260478|FG001|NOT COMPLETED|Overall Study||214
11078105|NCT01107899|12260487|FG000|STARTED|Overall Study||10
11348593|NCT03002610|12545561|FG002|NOT COMPLETED|Overall Study||13
11078106|NCT01107899|12260488|FG001|STARTED|Overall Study||10
11078107|NCT01107899|12260489|FG002|STARTED|Overall Study||9
11078108|NCT01107899|12260487|FG000|Received at Least One Dose of Study Drug|Overall Study||10
11078109|NCT01107899|12260488|FG001|Received at Least One Dose of Study Drug|Overall Study||10
11078110|NCT01107899|12260489|FG002|Received at Least One Dose of Study Drug|Overall Study||8
11078111|NCT01107899|12260487|FG000|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
11078112|NCT01107899|12260488|FG001|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
11078113|NCT01107899|12260489|FG002|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
11078114|NCT01107899|12260487|FG000|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
11078115|NCT01107899|12260488|FG001|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
11078116|NCT01107899|12260489|FG002|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
11078117|NCT01107899|12260487|FG000|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
11078118|NCT01107899|12260488|FG001|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
11206905|NCT01871285|12398012|FG000|COMPLETED|Second Intervention (1 Day)||17
11078119|NCT01107899|12260489|FG002|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
11078120|NCT01107899|12260487|FG000|COMPLETED|Overall Study||5
11078121|NCT01107899|12260488|FG001|COMPLETED|Overall Study||10
11078122|NCT01107899|12260489|FG002|COMPLETED|Overall Study||5
11078123|NCT01107899|12260487|FG000|NOT COMPLETED|Overall Study||5
11078124|NCT01107899|12260488|FG001|NOT COMPLETED|Overall Study||0
11078125|NCT01107899|12260489|FG002|NOT COMPLETED|Overall Study||4
11078126|NCT01107912|12260504|FG000|STARTED|Period 1||73
11078127|NCT01107912|12260505|FG001|STARTED|Period 1||0
11078128|NCT01107912|12260506|FG002|STARTED|Period 1||0
11078129|NCT01107912|12260507|FG003|STARTED|Period 1||0
11078130|NCT01107912|12260508|FG004|STARTED|Period 1||82
11078131|NCT01107912|12260509|FG005|STARTED|Period 1||0
11078132|NCT01107912|12260504|FG000|Received at Least 1 Dose of Study Drug|Period 1||73
11078133|NCT01107912|12260505|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
11078134|NCT01107912|12260506|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
11078135|NCT01107912|12260507|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
11078136|NCT01107912|12260508|FG004|Received at Least 1 Dose of Study Drug|Period 1||82
11078137|NCT01107912|12260509|FG005|Received at Least 1 Dose of Study Drug|Period 1||0
11078138|NCT01107912|12260504|FG000|COMPLETED|Period 1||72
11078139|NCT01107912|12260505|FG001|COMPLETED|Period 1||0
11078140|NCT01107912|12260506|FG002|COMPLETED|Period 1||0
11078141|NCT01107912|12260507|FG003|COMPLETED|Period 1||0
11078142|NCT01107912|12260508|FG004|COMPLETED|Period 1||79
11078143|NCT01107912|12260509|FG005|COMPLETED|Period 1||0
11078144|NCT01107912|12260504|FG000|NOT COMPLETED|Period 1||1
11078145|NCT01107912|12260505|FG001|NOT COMPLETED|Period 1||0
11078146|NCT01107912|12260506|FG002|NOT COMPLETED|Period 1||0
11078147|NCT01107912|12260507|FG003|NOT COMPLETED|Period 1||0
11078148|NCT01107912|12260508|FG004|NOT COMPLETED|Period 1||3
11078149|NCT01107912|12260509|FG005|NOT COMPLETED|Period 1||0
11078150|NCT01107912|12260504|FG000|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
11078151|NCT01107912|12260505|FG001|STARTED|Period 2||36
11078152|NCT01107912|12260506|FG002|STARTED|Period 2||36
11078153|NCT01107912|12260507|FG003|STARTED|Period 2||41
11078154|NCT01107912|12260508|FG004|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
11078155|NCT01107912|12260509|FG005|STARTED|Period 2||38
11078156|NCT01107912|12260504|FG000|COMPLETED|Period 2||0
11078157|NCT01107912|12260505|FG001|COMPLETED|Period 2||36
11078158|NCT01107912|12260506|FG002|COMPLETED|Period 2||35
11078159|NCT01107912|12260507|FG003|COMPLETED|Period 2||41
11078160|NCT01107912|12260508|FG004|COMPLETED|Period 2||0
11078161|NCT01107912|12260509|FG005|COMPLETED|Period 2||38
11078162|NCT01107912|12260504|FG000|NOT COMPLETED|Period 2||0
11078163|NCT01107912|12260505|FG001|NOT COMPLETED|Period 2||0
11078164|NCT01107912|12260506|FG002|NOT COMPLETED|Period 2||1
11078165|NCT01107912|12260507|FG003|NOT COMPLETED|Period 2||0
11078166|NCT01107912|12260508|FG004|NOT COMPLETED|Period 2||0
11078167|NCT01107912|12260509|FG005|NOT COMPLETED|Period 2||0
11078168|NCT01107912|12260504|FG000|STARTED|Period 3||0
11078169|NCT01107912|12260505|FG001|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
11078170|NCT01107912|12260506|FG002|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
11078171|NCT01107912|12260507|FG003|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
11078172|NCT01107912|12260508|FG004|STARTED|Period 3||0
11078173|NCT01107912|12260509|FG005|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
11078174|NCT01107912|12260504|FG000|COMPLETED|Period 3||0
11078175|NCT01107912|12260505|FG001|COMPLETED|Period 3||34
11078176|NCT01107912|12260506|FG002|COMPLETED|Period 3||35
11078177|NCT01107912|12260507|FG003|COMPLETED|Period 3||37
11078178|NCT01107912|12260508|FG004|COMPLETED|Period 3||0
11078179|NCT01107912|12260509|FG005|COMPLETED|Period 3||41
11078180|NCT01107912|12260504|FG000|NOT COMPLETED|Period 3||0
11078181|NCT01107912|12260505|FG001|NOT COMPLETED|Period 3||1
11078182|NCT01107912|12260506|FG002|NOT COMPLETED|Period 3||1
11078183|NCT01107912|12260507|FG003|NOT COMPLETED|Period 3||1
11078184|NCT01107912|12260508|FG004|NOT COMPLETED|Period 3||0
11078185|NCT01107912|12260509|FG005|NOT COMPLETED|Period 3||0
11078186|NCT01107925|12260528|FG000|STARTED|Period 1-Randomization up Through Day 12||34
11078187|NCT01107925|12260529|FG001|STARTED|Period 1-Randomization up Through Day 12||0
11078188|NCT01107925|12260530|FG002|STARTED|Period 1-Randomization up Through Day 12||0
11078189|NCT01107925|12260531|FG003|STARTED|Period 1-Randomization up Through Day 12||0
11078190|NCT01107925|12260532|FG004|STARTED|Period 1-Randomization up Through Day 12||38
11078191|NCT01107925|12260533|FG005|STARTED|Period 1-Randomization up Through Day 12||0
11078192|NCT01107925|12260528|FG000|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
11078193|NCT01107925|12260529|FG001|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
11078194|NCT01107925|12260530|FG002|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
11078195|NCT01107925|12260531|FG003|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
11078196|NCT01107925|12260532|FG004|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
11078197|NCT01107925|12260533|FG005|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
11078198|NCT01107925|12260528|FG000|COMPLETED|Period 1-Randomization up Through Day 12||33
11078199|NCT01107925|12260529|FG001|COMPLETED|Period 1-Randomization up Through Day 12||0
11078200|NCT01107925|12260530|FG002|COMPLETED|Period 1-Randomization up Through Day 12||0
11078201|NCT01107925|12260531|FG003|COMPLETED|Period 1-Randomization up Through Day 12||0
11078202|NCT01107925|12260532|FG004|COMPLETED|Period 1-Randomization up Through Day 12||37
11078203|NCT01107925|12260533|FG005|COMPLETED|Period 1-Randomization up Through Day 12||0
11078204|NCT01107925|12260528|FG000|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
11348594|NCT03002623|12545571|FG000|STARTED|Overall Study||4
11348595|NCT03002623|12545572|FG001|STARTED|Overall Study||3
11348596|NCT03002623|12545571|FG000|COMPLETED|Overall Study||2
11348597|NCT03002623|12545572|FG001|COMPLETED|Overall Study||2
11348598|NCT03002623|12545571|FG000|NOT COMPLETED|Overall Study||2
11348599|NCT03002623|12545572|FG001|NOT COMPLETED|Overall Study||1
11348600|NCT03002753|12545582|FG000|STARTED|First Randomization||10
11348601|NCT03002753|12545583|FG001|STARTED|First Randomization||12
11348602|NCT03002753|12545584|FG002|STARTED|First Randomization||21
11348603|NCT03002753|12545582|FG000|COMPLETED|First Randomization||9
11348604|NCT03002753|12545583|FG001|COMPLETED|First Randomization||11
11348605|NCT03002753|12545584|FG002|COMPLETED|First Randomization||21
11348606|NCT03002753|12545582|FG000|NOT COMPLETED|First Randomization||1
11348607|NCT03002753|12545583|FG001|NOT COMPLETED|First Randomization||1
11348608|NCT03002753|12545584|FG002|NOT COMPLETED|First Randomization||0
11078205|NCT01107925|12260529|FG001|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
11078206|NCT01107925|12260530|FG002|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
11078207|NCT01107925|12260531|FG003|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
11078208|NCT01107925|12260532|FG004|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
11078209|NCT01107925|12260533|FG005|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
11078210|NCT01107925|12260528|FG000|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
11078211|NCT01107925|12260529|FG001|STARTED|Period 2||16
11078212|NCT01107925|12260530|FG002|STARTED|Period 2||17
11078213|NCT01107925|12260531|FG003|STARTED|Period 2||20
11078214|NCT01107925|12260532|FG004|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
11078215|NCT01107925|12260533|FG005|STARTED|Period 2||17
11078216|NCT01107925|12260528|FG000|Took at Least 1 Dose of Study Drug|Period 2||0
11078217|NCT01107925|12260529|FG001|Took at Least 1 Dose of Study Drug|Period 2||16
11078218|NCT01107925|12260530|FG002|Took at Least 1 Dose of Study Drug|Period 2||17
11078219|NCT01107925|12260531|FG003|Took at Least 1 Dose of Study Drug|Period 2||20
11078220|NCT01107925|12260532|FG004|Took at Least 1 Dose of Study Drug|Period 2||0
11078221|NCT01107925|12260533|FG005|Took at Least 1 Dose of Study Drug|Period 2||17
11078222|NCT01107925|12260528|FG000|COMPLETED|Period 2||0
11078223|NCT01107925|12260529|FG001|COMPLETED|Period 2||15
11078224|NCT01107925|12260530|FG002|COMPLETED|Period 2||17
11078225|NCT01107925|12260531|FG003|COMPLETED|Period 2||20
11078226|NCT01107925|12260532|FG004|COMPLETED|Period 2||0
11078227|NCT01107925|12260533|FG005|COMPLETED|Period 2||16
11078228|NCT01107925|12260528|FG000|NOT COMPLETED|Period 2||0
11078229|NCT01107925|12260529|FG001|NOT COMPLETED|Period 2||1
11078230|NCT01107925|12260530|FG002|NOT COMPLETED|Period 2||0
11078231|NCT01107925|12260531|FG003|NOT COMPLETED|Period 2||0
11078232|NCT01107925|12260532|FG004|NOT COMPLETED|Period 2||0
11078233|NCT01107925|12260533|FG005|NOT COMPLETED|Period 2||1
11078234|NCT01107925|12260528|FG000|STARTED|Period 3||0
11078235|NCT01107925|12260529|FG001|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
11078236|NCT01107925|12260530|FG002|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
11078237|NCT01107925|12260531|FG003|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
11078238|NCT01107925|12260532|FG004|STARTED|Period 3||0
11078239|NCT01107925|12260533|FG005|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
11078240|NCT01107925|12260528|FG000|Took at Least 1 Dose of Study Drug|Period 3||0
11078241|NCT01107925|12260529|FG001|Took at Least 1 Dose of Study Drug|Period 3||17
11078242|NCT01107925|12260530|FG002|Took at Least 1 Dose of Study Drug|Period 3||15
11078243|NCT01107925|12260531|FG003|Took at Least 1 Dose of Study Drug|Period 3||16
11078244|NCT01107925|12260532|FG004|Took at Least 1 Dose of Study Drug|Period 3||0
11078245|NCT01107925|12260533|FG005|Took at Least 1 Dose of Study Drug|Period 3||20
11078246|NCT01107925|12260528|FG000|COMPLETED|Period 3||0
11078247|NCT01107925|12260529|FG001|COMPLETED|Period 3||17
11348609|NCT03002753|12545582|FG000|STARTED|Second Randomization (Re-randomization)||11
11348610|NCT03002753|12545583|FG001|STARTED|Second Randomization (Re-randomization)||10
11078248|NCT01107925|12260530|FG002|COMPLETED|Period 3||15
11078249|NCT01107925|12260531|FG003|COMPLETED|Period 3||16
11078250|NCT01107925|12260532|FG004|COMPLETED|Period 3||0
11078251|NCT01107925|12260533|FG005|COMPLETED|Period 3||20
11078252|NCT01107925|12260528|FG000|NOT COMPLETED|Period 3||0
11078253|NCT01107925|12260529|FG001|NOT COMPLETED|Period 3||0
11078254|NCT01107925|12260530|FG002|NOT COMPLETED|Period 3||0
11078255|NCT01107925|12260531|FG003|NOT COMPLETED|Period 3||0
11078256|NCT01107925|12260532|FG004|NOT COMPLETED|Period 3||0
11078257|NCT01107925|12260533|FG005|NOT COMPLETED|Period 3||0
11078258|NCT01107964|12260563|FG000|STARTED|Overall Study||13
11078259|NCT01107964|12260564|FG001|STARTED|Overall Study||14
11078260|NCT01107964|12260563|FG000|COMPLETED|Overall Study||12
11078261|NCT01107964|12260564|FG001|COMPLETED|Overall Study||13
11078262|NCT01107964|12260563|FG000|NOT COMPLETED|Overall Study||1
11078263|NCT01107964|12260564|FG001|NOT COMPLETED|Overall Study||1
11078264|NCT01108003|12260572|FG000|STARTED|Overall Study||4
11078265|NCT01108003|12260573|FG001|STARTED|Overall Study||3
11078266|NCT01108003|12260572|FG000|COMPLETED|Overall Study||4
11078267|NCT01108003|12260573|FG001|COMPLETED|Overall Study||3
11078268|NCT01108003|12260572|FG000|NOT COMPLETED|Overall Study||0
11078269|NCT01108003|12260573|FG001|NOT COMPLETED|Overall Study||0
11078270|NCT01108068|12260581|FG000|STARTED|Overall Study||10
11078271|NCT01108068|12260582|FG001|STARTED|Overall Study||16
11078272|NCT01108068|12260581|FG000|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
11078273|NCT01108068|12260582|FG001|COMPLETED|Overall Study||16
11078274|NCT01108068|12260581|FG000|NOT COMPLETED|Overall Study||6
11078275|NCT01108068|12260582|FG001|NOT COMPLETED|Overall Study||0
11078276|NCT01108081|12260593|FG000|STARTED|Overall Study||46
11078277|NCT01108081|12260594|FG001|STARTED|Overall Study||42
11078278|NCT01108081|12260595|FG002|STARTED|Overall Study||38
11078279|NCT01108081|12260596|FG003|STARTED|Overall Study||43
11078280|NCT01108081|12260593|FG000|COMPLETED|Overall Study||44
11078281|NCT01108081|12260594|FG001|COMPLETED|Overall Study||40
11078282|NCT01108081|12260595|FG002|COMPLETED|Overall Study||38
11078283|NCT01108081|12260596|FG003|COMPLETED|Overall Study||39
11078284|NCT01108081|12260593|FG000|NOT COMPLETED|Overall Study||2
11078285|NCT01108081|12260594|FG001|NOT COMPLETED|Overall Study||2
11078286|NCT01108081|12260595|FG002|NOT COMPLETED|Overall Study||0
11078287|NCT01108081|12260596|FG003|NOT COMPLETED|Overall Study||4
11078288|NCT01108094|12260610|FG000|STARTED|Overall Study||12
11078289|NCT01108094|12260611|FG001|STARTED|Overall Study||3
11078290|NCT01108094|12260612|FG002|STARTED|Overall Study||4
11078291|NCT01108094|12260613|FG003|STARTED|Overall Study||10
11078292|NCT01108094|12260610|FG000|COMPLETED|Overall Study||9
11078293|NCT01108094|12260611|FG001|COMPLETED|Overall Study||3
11078294|NCT01108094|12260612|FG002|COMPLETED|Overall Study||4
11078295|NCT01108094|12260613|FG003|COMPLETED|Overall Study||10
11078296|NCT01108094|12260610|FG000|NOT COMPLETED|Overall Study||3
11078297|NCT01108094|12260611|FG001|NOT COMPLETED|Overall Study||0
11078298|NCT01108094|12260612|FG002|NOT COMPLETED|Overall Study||0
11078299|NCT01108094|12260613|FG003|NOT COMPLETED|Overall Study||0
11078300|NCT01108185|12260626|FG000|STARTED|Overall Study||3181
11078301|NCT01108185|12260626|FG000|Per Protocol Population|Overall Study||3181
11078302|NCT01108185|12260626|FG000|COMPLETED|Overall Study||3154
11078303|NCT01108185|12260626|FG000|NOT COMPLETED|Overall Study||27
11078304|NCT01108237|12260632|FG000|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
11078305|NCT01108237|12260633|FG001|STARTED|Overall Study||101
11078306|NCT01108237|12260632|FG000|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
11078307|NCT01108237|12260633|FG001|COMPLETED|Overall Study||84
11078308|NCT01108237|12260632|FG000|NOT COMPLETED|Overall Study||9
11078309|NCT01108237|12260633|FG001|NOT COMPLETED|Overall Study||17
11078310|NCT01108263|12260641|FG000|STARTED|Overall Study||2
11078311|NCT01108263|12260642|FG001|STARTED|Overall Study||3
11078312|NCT01108263|12260641|FG000|COMPLETED|Overall Study||2
11078313|NCT01108263|12260642|FG001|COMPLETED|Overall Study||2
11078314|NCT01108263|12260641|FG000|NOT COMPLETED|Overall Study||0
11078315|NCT01108263|12260642|FG001|NOT COMPLETED|Overall Study||1
11078316|NCT01108341|12260648|FG000|STARTED|Overall Study||50
11078317|NCT01108341|12260648|FG000|Safety Set (Enrolled and Treated)|Overall Study||49
11078318|NCT01108341|12260648|FG000|COMPLETED|Overall Study||45
11078319|NCT01108341|12260648|FG000|NOT COMPLETED|Overall Study||5
11078320|NCT01108406|12260652|FG000|STARTED|Overall Study||22
11078321|NCT01108406|12260652|FG000|COMPLETED|Overall Study||22
11078322|NCT01108406|12260652|FG000|NOT COMPLETED|Overall Study||0
11078323|NCT01108445|12260660|FG000|STARTED|Overall Study||57
11078324|NCT01108445|12260661|FG001|STARTED|Overall Study||51
11078325|NCT01108445|12260660|FG000|COMPLETED|Overall Study||1
11078326|NCT01108445|12260661|FG001|COMPLETED|Overall Study||2
11078327|NCT01108445|12260660|FG000|NOT COMPLETED|Overall Study||56
11078328|NCT01108445|12260661|FG001|NOT COMPLETED|Overall Study||49
11078329|NCT01108458|12260667|FG000|STARTED|Overall Study||1
11078330|NCT01108458|12260667|FG000|COMPLETED|Overall Study||0
11078331|NCT01108458|12260667|FG000|NOT COMPLETED|Overall Study||1
11078332|NCT01108510|12260673|FG000|STARTED|Overall Study||349
11078333|NCT01108510|12260674|FG001|STARTED|Overall Study||349
11078334|NCT01108510|12260673|FG000|COMPLETED|Overall Study||70
11078335|NCT01108510|12260674|FG001|COMPLETED|Overall Study||81
11078336|NCT01108510|12260673|FG000|NOT COMPLETED|Overall Study||279
11078337|NCT01108510|12260674|FG001|NOT COMPLETED|Overall Study||268
11078338|NCT01108718|12260682|FG000|STARTED|Received First Intervention (2 Months)||5
11078339|NCT01108718|12260683|FG001|STARTED|Received First Intervention (2 Months)||7
11078340|NCT01108718|12260682|FG000|COMPLETED|Received First Intervention (2 Months)||5
11078341|NCT01108718|12260683|FG001|COMPLETED|Received First Intervention (2 Months)||7
11078342|NCT01108718|12260682|FG000|NOT COMPLETED|Received First Intervention (2 Months)||0
11078343|NCT01108718|12260683|FG001|NOT COMPLETED|Received First Intervention (2 Months)||0
11078344|NCT01108718|12260682|FG000|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
11078345|NCT01108718|12260683|FG001|STARTED|Received Second Intervention (2 Months)||7
11078346|NCT01108718|12260682|FG000|COMPLETED|Received Second Intervention (2 Months)||4
11078347|NCT01108718|12260683|FG001|COMPLETED|Received Second Intervention (2 Months)||7
11078348|NCT01108718|12260682|FG000|NOT COMPLETED|Received Second Intervention (2 Months)||1
11078349|NCT01108718|12260683|FG001|NOT COMPLETED|Received Second Intervention (2 Months)||0
11078350|NCT01108731|12260690|FG000|STARTED|Overall Study||17
11078351|NCT01108731|12260691|FG001|STARTED|Overall Study||17
11078352|NCT01108731|12260690|FG000|COMPLETED|Overall Study||13
11078353|NCT01108731|12260691|FG001|COMPLETED|Overall Study||13
11078354|NCT01108731|12260690|FG000|NOT COMPLETED|Overall Study||4
11078355|NCT01108731|12260691|FG001|NOT COMPLETED|Overall Study||4
11078356|NCT01108757|12260699|FG000|STARTED|Overall Study||26
11078357|NCT01108757|12260700|FG001|STARTED|Overall Study||26
11078358|NCT01108757|12260699|FG000|COMPLETED|Overall Study||26
11078359|NCT01108757|12260700|FG001|COMPLETED|Overall Study||26
11078360|NCT01108757|12260699|FG000|NOT COMPLETED|Overall Study||0
11078361|NCT01108757|12260700|FG001|NOT COMPLETED|Overall Study||0
11078362|NCT01108796|12260710|FG000|STARTED|Overall Study||774
11078363|NCT01108796|12260711|FG001|STARTED|Overall Study||1067
11078364|NCT01108796|12260710|FG000|COMPLETED|Overall Study||767
11078365|NCT01108796|12260711|FG001|COMPLETED|Overall Study||1060
11078366|NCT01108796|12260710|FG000|NOT COMPLETED|Overall Study||7
11078367|NCT01108796|12260711|FG001|NOT COMPLETED|Overall Study||7
11078368|NCT01108809|12260719|FG000|STARTED|Overall Study||295
11078369|NCT01108809|12260719|FG000|COMPLETED|Overall Study||291
11078370|NCT01108809|12260719|FG000|NOT COMPLETED|Overall Study||4
11078371|NCT01108835|12260726|FG000|STARTED|Overall Study||90
11078372|NCT01108835|12260727|FG001|STARTED|Overall Study||90
11078373|NCT01108835|12260726|FG000|COMPLETED|Overall Study||73
11078374|NCT01108835|12260727|FG001|COMPLETED|Overall Study||69
11078375|NCT01108835|12260726|FG000|NOT COMPLETED|Overall Study||17
11078376|NCT01108835|12260727|FG001|NOT COMPLETED|Overall Study||21
11078377|NCT01109056|12260736|FG000|STARTED|Overall Study||57
11078378|NCT01109056|12260737|FG001|STARTED|Overall Study||58
11078379|NCT01109056|12260736|FG000|COMPLETED|Overall Study||50
11078380|NCT01109056|12260737|FG001|COMPLETED|Overall Study||53
11078381|NCT01109056|12260736|FG000|NOT COMPLETED|Overall Study||7
11078382|NCT01109056|12260737|FG001|NOT COMPLETED|Overall Study||5
11078383|NCT01109069|12260743|FG000|STARTED|Overall Study||199
11078384|NCT01109069|12260743|FG000|COMPLETED|Overall Study||106
11078385|NCT01109069|12260743|FG000|NOT COMPLETED|Overall Study||93
11078386|NCT01109108|12260750|FG000|STARTED|Overall Study||4035
11078387|NCT01109108|12260751|FG001|STARTED|Overall Study||4755
11078388|NCT01109108|12260750|FG000|COMPLETED|Overall Study||4035
11078389|NCT01109108|12260751|FG001|COMPLETED|Overall Study||4755
11078390|NCT01109108|12260750|FG000|NOT COMPLETED|Overall Study||0
11078391|NCT01109108|12260751|FG001|NOT COMPLETED|Overall Study||0
11078392|NCT01109147|12260760|FG000|STARTED|Overall Study||17
11078393|NCT01109147|12260761|FG001|STARTED|Overall Study||14
11078394|NCT01109147|12260762|FG002|STARTED|Overall Study||36
11078395|NCT01109147|12260760|FG000|COMPLETED|Overall Study|2 have been excluded of the results|15
11078396|NCT01109147|12260761|FG001|COMPLETED|Overall Study|3 have been excluded of the results|11
11078397|NCT01109147|12260762|FG002|COMPLETED|Overall Study|10 have been excluded of the results|26
11078398|NCT01109147|12260760|FG000|NOT COMPLETED|Overall Study||2
11078399|NCT01109147|12260761|FG001|NOT COMPLETED|Overall Study||3
11078400|NCT01109147|12260762|FG002|NOT COMPLETED|Overall Study||10
11078401|NCT01109173|12260774|FG000|STARTED|Overall Study||851
11078402|NCT01109173|12260775|FG001|STARTED|Overall Study||845
11078403|NCT01109173|12260776|FG002|STARTED|Overall Study||211
11078404|NCT01109173|12260777|FG003|STARTED|Overall Study||213
11078405|NCT01109173|12260774|FG000|COMPLETED|Overall Study||763
11078406|NCT01109173|12260775|FG001|COMPLETED|Overall Study||759
11078407|NCT01109173|12260776|FG002|COMPLETED|Overall Study||110
11078408|NCT01109173|12260777|FG003|COMPLETED|Overall Study||120
11078409|NCT01109173|12260774|FG000|NOT COMPLETED|Overall Study||88
11078410|NCT01109173|12260775|FG001|NOT COMPLETED|Overall Study||86
11078411|NCT01109173|12260776|FG002|NOT COMPLETED|Overall Study||101
11078412|NCT01109173|12260777|FG003|NOT COMPLETED|Overall Study||93
11078413|NCT01109316|12260793|FG000|STARTED|Study Period 1||22
11078414|NCT01109316|12260794|FG001|STARTED|Study Period 1||22
11078415|NCT01109316|12260795|FG002|STARTED|Study Period 1||22
11078416|NCT01109316|12260796|FG003|STARTED|Study Period 1||22
11078417|NCT01109316|12260797|FG004|STARTED|Study Period 1||22
11078418|NCT01109316|12260798|FG005|STARTED|Study Period 1||22
11078419|NCT01109316|12260793|FG000|Received at Least One Dose of Study Drug|Study Period 1||22
11206906|NCT01871285|12398013|FG001|COMPLETED|Second Intervention (1 Day)||14
11078420|NCT01109316|12260794|FG001|Received at Least One Dose of Study Drug|Study Period 1||22
11078421|NCT01109316|12260795|FG002|Received at Least One Dose of Study Drug|Study Period 1||22
11078422|NCT01109316|12260796|FG003|Received at Least One Dose of Study Drug|Study Period 1||22
11078423|NCT01109316|12260797|FG004|Received at Least One Dose of Study Drug|Study Period 1||22
11078424|NCT01109316|12260798|FG005|Received at Least One Dose of Study Drug|Study Period 1||20
11078425|NCT01109316|12260793|FG000|COMPLETED|Study Period 1||22
11348611|NCT03002753|12545584|FG002|STARTED|Second Randomization (Re-randomization)||0
11348612|NCT03002753|12545582|FG000|COMPLETED|Second Randomization (Re-randomization)||11
11348613|NCT03002753|12545583|FG001|COMPLETED|Second Randomization (Re-randomization)||9
11348614|NCT03002753|12545584|FG002|COMPLETED|Second Randomization (Re-randomization)||0
11348615|NCT03002753|12545582|FG000|NOT COMPLETED|Second Randomization (Re-randomization)||0
11348616|NCT03002753|12545583|FG001|NOT COMPLETED|Second Randomization (Re-randomization)||1
11348617|NCT03002753|12545584|FG002|NOT COMPLETED|Second Randomization (Re-randomization)||0
11348618|NCT03002818|12545592|FG000|STARTED|Overall Study||41
11348619|NCT03002818|12545592|FG000|COMPLETED|Overall Study||40
11348620|NCT03002818|12545592|FG000|NOT COMPLETED|Overall Study||1
11348621|NCT03002974|12545599|FG000|STARTED|Overall Study||55
11348622|NCT03002974|12545600|FG001|STARTED|Overall Study||56
11348623|NCT03002974|12545601|FG002|STARTED|Overall Study||54
11348624|NCT03002974|12545599|FG000|Intention To Treat Populatio|Overall Study||55
11348625|NCT03002974|12545600|FG001|Intention To Treat Populatio|Overall Study||56
11348626|NCT03002974|12545601|FG002|Intention To Treat Populatio|Overall Study||54
11348627|NCT03002974|12545599|FG000|Safety Population|Overall Study||54
11348628|NCT03002974|12545600|FG001|Safety Population|Overall Study||55
11078426|NCT01109316|12260794|FG001|COMPLETED|Study Period 1||22
11348629|NCT03002974|12545601|FG002|Safety Population|Overall Study||52
11348630|NCT03002974|12545599|FG000|COMPLETED|Overall Study||35
11078427|NCT01109316|12260795|FG002|COMPLETED|Study Period 1||19
11078428|NCT01109316|12260796|FG003|COMPLETED|Study Period 1||21
11078429|NCT01109316|12260797|FG004|COMPLETED|Study Period 1||20
11078430|NCT01109316|12260798|FG005|COMPLETED|Study Period 1||20
11078431|NCT01109316|12260793|FG000|NOT COMPLETED|Study Period 1||0
11078432|NCT01109316|12260794|FG001|NOT COMPLETED|Study Period 1||0
11078433|NCT01109316|12260795|FG002|NOT COMPLETED|Study Period 1||3
11078434|NCT01109316|12260796|FG003|NOT COMPLETED|Study Period 1||1
11078435|NCT01109316|12260797|FG004|NOT COMPLETED|Study Period 1||2
11078436|NCT01109316|12260798|FG005|NOT COMPLETED|Study Period 1||2
11078437|NCT01109316|12260793|FG000|STARTED|Study Period 2||22
11078438|NCT01109316|12260794|FG001|STARTED|Study Period 2||22
11078439|NCT01109316|12260795|FG002|STARTED|Study Period 2||19
11078440|NCT01109316|12260796|FG003|STARTED|Study Period 2||21
11078441|NCT01109316|12260797|FG004|STARTED|Study Period 2||20
11078442|NCT01109316|12260798|FG005|STARTED|Study Period 2||20
11078443|NCT01109316|12260793|FG000|COMPLETED|Study Period 2||21
11078444|NCT01109316|12260794|FG001|COMPLETED|Study Period 2||21
11078445|NCT01109316|12260795|FG002|COMPLETED|Study Period 2||18
11078446|NCT01109316|12260796|FG003|COMPLETED|Study Period 2||20
11078447|NCT01109316|12260797|FG004|COMPLETED|Study Period 2||20
11078448|NCT01109316|12260798|FG005|COMPLETED|Study Period 2||19
11078449|NCT01109316|12260793|FG000|NOT COMPLETED|Study Period 2||1
11078450|NCT01109316|12260794|FG001|NOT COMPLETED|Study Period 2||1
11078451|NCT01109316|12260795|FG002|NOT COMPLETED|Study Period 2||1
11078452|NCT01109316|12260796|FG003|NOT COMPLETED|Study Period 2||1
11078453|NCT01109316|12260797|FG004|NOT COMPLETED|Study Period 2||0
11078454|NCT01109316|12260798|FG005|NOT COMPLETED|Study Period 2||1
11078455|NCT01109316|12260793|FG000|STARTED|Study Period 3||21
11078456|NCT01109316|12260794|FG001|STARTED|Study Period 3||21
11078457|NCT01109316|12260795|FG002|STARTED|Study Period 3||18
11078458|NCT01109316|12260796|FG003|STARTED|Study Period 3||20
11078459|NCT01109316|12260797|FG004|STARTED|Study Period 3||20
11078460|NCT01109316|12260798|FG005|STARTED|Study Period 3||19
11078461|NCT01109316|12260793|FG000|COMPLETED|Study Period 3||20
11078462|NCT01109316|12260794|FG001|COMPLETED|Study Period 3||21
11078463|NCT01109316|12260795|FG002|COMPLETED|Study Period 3||18
11078464|NCT01109316|12260796|FG003|COMPLETED|Study Period 3||20
11078465|NCT01109316|12260797|FG004|COMPLETED|Study Period 3||18
11078466|NCT01109316|12260798|FG005|COMPLETED|Study Period 3||19
11078467|NCT01109316|12260793|FG000|NOT COMPLETED|Study Period 3||1
11078468|NCT01109316|12260794|FG001|NOT COMPLETED|Study Period 3||0
11078469|NCT01109316|12260795|FG002|NOT COMPLETED|Study Period 3||0
11078470|NCT01109316|12260796|FG003|NOT COMPLETED|Study Period 3||0
11078471|NCT01109316|12260797|FG004|NOT COMPLETED|Study Period 3||2
11078472|NCT01109316|12260798|FG005|NOT COMPLETED|Study Period 3||0
11078473|NCT01109381|12260806|FG000|STARTED|Overall Study||33
11078474|NCT01109381|12260806|FG000|COMPLETED|Overall Study||31
11078475|NCT01109381|12260806|FG000|NOT COMPLETED|Overall Study||2
11078476|NCT01109524|12260812|FG000|STARTED|Overall Study||60
11078477|NCT01109524|12260812|FG000|COMPLETED|Overall Study||3
11078478|NCT01109524|12260812|FG000|NOT COMPLETED|Overall Study||57
11078479|NCT01109576|12260816|FG000|STARTED|Overall Study||13
11078480|NCT01109576|12260816|FG000|COMPLETED|Overall Study||12
11078481|NCT01109576|12260816|FG000|NOT COMPLETED|Overall Study||1
11078482|NCT01109602|12260823|FG000|STARTED|Overall Study||14
11078483|NCT01109602|12260824|FG001|STARTED|Overall Study||23
11078484|NCT01109602|12260825|FG002|STARTED|Overall Study||10
11078485|NCT01109602|12260823|FG000|COMPLETED|Overall Study||13
11078486|NCT01109602|12260824|FG001|COMPLETED|Overall Study||21
11078487|NCT01109602|12260825|FG002|COMPLETED|Overall Study||9
11078488|NCT01109602|12260823|FG000|NOT COMPLETED|Overall Study||1
11078489|NCT01109602|12260824|FG001|NOT COMPLETED|Overall Study||2
11078490|NCT01109602|12260825|FG002|NOT COMPLETED|Overall Study||1
11078491|NCT01109849|12260834|FG000|STARTED|Initial Randomization: ADHD Treatment||50
11078492|NCT01109849|12260835|FG001|STARTED|Initial Randomization: ADHD Treatment||180
11078493|NCT01109849|12260836|FG002|STARTED|Initial Randomization: ADHD Treatment||0
11078494|NCT01109849|12260837|FG003|STARTED|Initial Randomization: ADHD Treatment||0
11078495|NCT01109849|12260838|FG004|STARTED|Initial Randomization: ADHD Treatment||0
11078496|NCT01109849|12260834|FG000|COMPLETED|Initial Randomization: ADHD Treatment||32
11078497|NCT01109849|12260835|FG001|COMPLETED|Initial Randomization: ADHD Treatment||131
11078498|NCT01109849|12260836|FG002|COMPLETED|Initial Randomization: ADHD Treatment||0
11078499|NCT01109849|12260837|FG003|COMPLETED|Initial Randomization: ADHD Treatment||0
11078500|NCT01109849|12260838|FG004|COMPLETED|Initial Randomization: ADHD Treatment||0
11078501|NCT01109849|12260834|FG000|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
11078502|NCT01109849|12260835|FG001|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
11078503|NCT01109849|12260836|FG002|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
11078504|NCT01109849|12260837|FG003|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
11078505|NCT01109849|12260838|FG004|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
11078506|NCT01109849|12260834|FG000|STARTED|Adaptive Randomization: Weight Recovery||0
11078507|NCT01109849|12260835|FG001|STARTED|Adaptive Randomization: Weight Recovery||0
11078508|NCT01109849|12260836|FG002|STARTED|Adaptive Randomization: Weight Recovery||24
11078509|NCT01109849|12260837|FG003|STARTED|Adaptive Randomization: Weight Recovery||23
11078510|NCT01109849|12260838|FG004|STARTED|Adaptive Randomization: Weight Recovery||25
11078511|NCT01109849|12260834|FG000|COMPLETED|Adaptive Randomization: Weight Recovery||0
11078512|NCT01109849|12260835|FG001|COMPLETED|Adaptive Randomization: Weight Recovery||0
11078513|NCT01109849|12260836|FG002|COMPLETED|Adaptive Randomization: Weight Recovery||23
11078514|NCT01109849|12260837|FG003|COMPLETED|Adaptive Randomization: Weight Recovery||20
11078515|NCT01109849|12260838|FG004|COMPLETED|Adaptive Randomization: Weight Recovery||24
11078516|NCT01109849|12260834|FG000|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
11078517|NCT01109849|12260835|FG001|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
11078518|NCT01109849|12260836|FG002|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
11078519|NCT01109849|12260837|FG003|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
11078520|NCT01109849|12260838|FG004|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
11078521|NCT01109940|12260862|FG000|STARTED|Overall Study||21
11078522|NCT01109940|12260863|FG001|STARTED|Overall Study||8
11078523|NCT01109940|12260864|FG002|STARTED|Overall Study||7
11078524|NCT01109940|12260865|FG003|STARTED|Overall Study||3
11078525|NCT01109940|12260862|FG000|COMPLETED|Overall Study||13
11078526|NCT01109940|12260863|FG001|COMPLETED|Overall Study||6
11078527|NCT01109940|12260864|FG002|COMPLETED|Overall Study||6
11078528|NCT01109940|12260865|FG003|COMPLETED|Overall Study||3
11078529|NCT01109940|12260862|FG000|NOT COMPLETED|Overall Study||8
11078530|NCT01109940|12260863|FG001|NOT COMPLETED|Overall Study||2
11078531|NCT01109940|12260864|FG002|NOT COMPLETED|Overall Study||1
11078532|NCT01109940|12260865|FG003|NOT COMPLETED|Overall Study||0
11078533|NCT01109979|12260877|FG000|STARTED|Overall Study||12
11078534|NCT01109979|12260878|FG001|STARTED|Overall Study||12
11078535|NCT01109979|12260877|FG000|COMPLETED|Overall Study||10
11078536|NCT01109979|12260878|FG001|COMPLETED|Overall Study||11
11078537|NCT01109979|12260877|FG000|NOT COMPLETED|Overall Study||2
11078538|NCT01109979|12260878|FG001|NOT COMPLETED|Overall Study||1
11078539|NCT01109992|12260886|FG000|STARTED|Overall Study||11
11078540|NCT01109992|12260887|FG001|STARTED|Overall Study||32
11078541|NCT01109992|12260886|FG000|Subjects Enrolled|Overall Study||11
11078542|NCT01109992|12260887|FG001|Subjects Enrolled|Overall Study||32
11078543|NCT01109992|12260886|FG000|COMPLETED|Overall Study||11
11078544|NCT01109992|12260887|FG001|COMPLETED|Overall Study||30
11078545|NCT01109992|12260886|FG000|NOT COMPLETED|Overall Study||0
11078546|NCT01109992|12260887|FG001|NOT COMPLETED|Overall Study||2
11078547|NCT01110005|12260898|FG000|STARTED|Overall Study||157
11078548|NCT01110005|12260899|FG001|STARTED|Overall Study||161
11078549|NCT01110005|12260898|FG000|COMPLETED|Overall Study||153
11078550|NCT01110005|12260899|FG001|COMPLETED|Overall Study||156
11078551|NCT01110005|12260898|FG000|NOT COMPLETED|Overall Study||4
11078552|NCT01110005|12260899|FG001|NOT COMPLETED|Overall Study||5
11348631|NCT03002974|12545600|FG001|COMPLETED|Overall Study||40
11348632|NCT03002974|12545601|FG002|COMPLETED|Overall Study||36
11348633|NCT03002974|12545599|FG000|NOT COMPLETED|Overall Study||20
11348634|NCT03002974|12545600|FG001|NOT COMPLETED|Overall Study||16
11348635|NCT03002974|12545601|FG002|NOT COMPLETED|Overall Study||18
11348636|NCT03003000|12545612|FG000|STARTED|Overall Study||126
11348637|NCT03003000|12545613|FG001|STARTED|Overall Study||253
11078553|NCT01110135|12260905|FG000|STARTED|Overall Study||43
11078554|NCT01110135|12260905|FG000|COMPLETED|Overall Study||34
11078555|NCT01110135|12260905|FG000|NOT COMPLETED|Overall Study||9
11078556|NCT01110187|12260911|FG000|STARTED|Overall Study||7
11078557|NCT01110187|12260912|FG001|STARTED|Overall Study||4
11078558|NCT01110187|12260911|FG000|COMPLETED|Overall Study|completed 7 day treatment|7
11078559|NCT01110187|12260912|FG001|COMPLETED|Overall Study|completed 7 day treatment|4
11348638|NCT03003000|12545614|FG002|STARTED|Overall Study||256
11348639|NCT03003000|12545612|FG000|COMPLETED|Overall Study||121
11348640|NCT03003000|12545613|FG001|COMPLETED|Overall Study||249
11348641|NCT03003000|12545614|FG002|COMPLETED|Overall Study||251
11348642|NCT03003000|12545612|FG000|NOT COMPLETED|Overall Study||5
11348643|NCT03003000|12545613|FG001|NOT COMPLETED|Overall Study||4
11348644|NCT03003000|12545614|FG002|NOT COMPLETED|Overall Study||5
11078560|NCT01110187|12260911|FG000|NOT COMPLETED|Overall Study||0
11078561|NCT01110187|12260912|FG001|NOT COMPLETED|Overall Study||0
11078562|NCT01110200|12260922|FG000|STARTED|Overall Study||314
11078563|NCT01110200|12260923|FG001|STARTED|Overall Study||325
11078564|NCT01110200|12260922|FG000|COMPLETED|Overall Study||208
11078565|NCT01110200|12260923|FG001|COMPLETED|Overall Study||204
11078566|NCT01110200|12260922|FG000|NOT COMPLETED|Overall Study||106
11078567|NCT01110200|12260923|FG001|NOT COMPLETED|Overall Study||121
11078568|NCT01110239|12260933|FG000|STARTED|Sham Preconditioning||7
11078569|NCT01110239|12260934|FG001|STARTED|Sham Preconditioning||14
11078570|NCT01110239|12260935|FG002|STARTED|Sham Preconditioning||7
11078571|NCT01110239|12260936|FG003|STARTED|Sham Preconditioning||6
11078572|NCT01110239|12260933|FG000|COMPLETED|Sham Preconditioning||7
11078573|NCT01110239|12260934|FG001|COMPLETED|Sham Preconditioning||14
11078574|NCT01110239|12260935|FG002|COMPLETED|Sham Preconditioning||6
11078575|NCT01110239|12260936|FG003|COMPLETED|Sham Preconditioning||6
11078576|NCT01110239|12260933|FG000|NOT COMPLETED|Sham Preconditioning||0
11078577|NCT01110239|12260934|FG001|NOT COMPLETED|Sham Preconditioning||0
11078578|NCT01110239|12260935|FG002|NOT COMPLETED|Sham Preconditioning||1
11078579|NCT01110239|12260936|FG003|NOT COMPLETED|Sham Preconditioning||0
11078580|NCT01110239|12260933|FG000|STARTED|5 Min Ischemia||0
11078581|NCT01110239|12260934|FG001|STARTED|5 Min Ischemia||14
11078582|NCT01110239|12260935|FG002|STARTED|5 Min Ischemia||0
11078583|NCT01110239|12260936|FG003|STARTED|5 Min Ischemia||0
11078584|NCT01110239|12260933|FG000|COMPLETED|5 Min Ischemia||0
11078585|NCT01110239|12260934|FG001|COMPLETED|5 Min Ischemia||0
11078586|NCT01110239|12260935|FG002|COMPLETED|5 Min Ischemia||0
11078587|NCT01110239|12260936|FG003|COMPLETED|5 Min Ischemia||0
11078588|NCT01110239|12260933|FG000|NOT COMPLETED|5 Min Ischemia||0
11078589|NCT01110239|12260934|FG001|NOT COMPLETED|5 Min Ischemia||14
11078590|NCT01110239|12260935|FG002|NOT COMPLETED|5 Min Ischemia||0
11078591|NCT01110239|12260936|FG003|NOT COMPLETED|5 Min Ischemia||0
11078592|NCT01110239|12260933|FG000|STARTED|7.5 Min Ischemia||0
11078593|NCT01110239|12260934|FG001|STARTED|7.5 Min Ischemia||0
11078594|NCT01110239|12260935|FG002|STARTED|7.5 Min Ischemia||7
11078595|NCT01110239|12260936|FG003|STARTED|7.5 Min Ischemia||0
11078596|NCT01110239|12260933|FG000|COMPLETED|7.5 Min Ischemia||0
11078597|NCT01110239|12260934|FG001|COMPLETED|7.5 Min Ischemia||0
11078598|NCT01110239|12260935|FG002|COMPLETED|7.5 Min Ischemia||6
11348645|NCT03003390|12545624|FG000|STARTED|Overall Study||27
11348646|NCT03003390|12545625|FG001|STARTED|Overall Study||24
11348647|NCT03003390|12545624|FG000|COMPLETED|Overall Study||23
11348648|NCT03003390|12545625|FG001|COMPLETED|Overall Study||24
11348649|NCT03003390|12545624|FG000|NOT COMPLETED|Overall Study||4
11348650|NCT03003390|12545625|FG001|NOT COMPLETED|Overall Study||0
11348651|NCT03003494|12545636|FG000|STARTED|Overall Study||306
11348652|NCT03003494|12545636|FG000|COMPLETED|Overall Study||278
11348653|NCT03003494|12545636|FG000|NOT COMPLETED|Overall Study||28
11348654|NCT03003676|12545642|FG000|STARTED|Overall Study||9
11348655|NCT03003676|12545643|FG001|STARTED|Overall Study||12
11348656|NCT03003676|12545642|FG000|COMPLETED|Overall Study||3
11348657|NCT03003676|12545643|FG001|COMPLETED|Overall Study||4
11348658|NCT03003676|12545642|FG000|NOT COMPLETED|Overall Study||6
11348659|NCT03003676|12545643|FG001|NOT COMPLETED|Overall Study||8
11348660|NCT03003793|12545653|FG000|STARTED|Overall Study||16
11348661|NCT03003793|12545654|FG001|STARTED|Overall Study||16
11348662|NCT03003793|12545653|FG000|COMPLETED|Overall Study||16
11348663|NCT03003793|12545654|FG001|COMPLETED|Overall Study||16
11348664|NCT03003793|12545653|FG000|NOT COMPLETED|Overall Study||0
11348665|NCT03003793|12545654|FG001|NOT COMPLETED|Overall Study||0
11348666|NCT03003949|12545662|FG000|STARTED|Overall Study||40
11348667|NCT03003949|12545663|FG001|STARTED|Overall Study||42
11348668|NCT03003949|12545662|FG000|Week 8|Overall Study||40
11348669|NCT03003949|12545663|FG001|Week 8|Overall Study||42
11348670|NCT03003949|12545662|FG000|Week 16|Overall Study||38
11348671|NCT03003949|12545663|FG001|Week 16|Overall Study||35
11348672|NCT03003949|12545662|FG000|Week 20|Overall Study||35
11078599|NCT01110239|12260936|FG003|COMPLETED|7.5 Min Ischemia||0
11078600|NCT01110239|12260933|FG000|NOT COMPLETED|7.5 Min Ischemia||0
11078601|NCT01110239|12260934|FG001|NOT COMPLETED|7.5 Min Ischemia||0
11078602|NCT01110239|12260935|FG002|NOT COMPLETED|7.5 Min Ischemia||1
11078603|NCT01110239|12260936|FG003|NOT COMPLETED|7.5 Min Ischemia||0
11078604|NCT01110239|12260933|FG000|STARTED|10 Min Ischemia||0
11078605|NCT01110239|12260934|FG001|STARTED|10 Min Ischemia||0
11078606|NCT01110239|12260935|FG002|STARTED|10 Min Ischemia||0
11078607|NCT01110239|12260936|FG003|STARTED|10 Min Ischemia||6
11078608|NCT01110239|12260933|FG000|COMPLETED|10 Min Ischemia||0
11078609|NCT01110239|12260934|FG001|COMPLETED|10 Min Ischemia||0
11078610|NCT01110239|12260935|FG002|COMPLETED|10 Min Ischemia||0
11078611|NCT01110239|12260936|FG003|COMPLETED|10 Min Ischemia||6
11078612|NCT01110239|12260933|FG000|NOT COMPLETED|10 Min Ischemia||0
11078613|NCT01110239|12260934|FG001|NOT COMPLETED|10 Min Ischemia||0
11078614|NCT01110239|12260935|FG002|NOT COMPLETED|10 Min Ischemia||0
11078615|NCT01110239|12260936|FG003|NOT COMPLETED|10 Min Ischemia||0
11078616|NCT01110252|12260947|FG000|STARTED|Pre-procedure (Stem Cells Infusion)||4
11078617|NCT01110252|12260947|FG000|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
11078618|NCT01110252|12260947|FG000|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
11078619|NCT01110252|12260947|FG000|STARTED|Post-procedure (Stem Cells Infusion)||4
11078620|NCT01110252|12260947|FG000|COMPLETED|Post-procedure (Stem Cells Infusion)||4
11078621|NCT01110252|12260947|FG000|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
11078622|NCT01110330|12260955|FG000|STARTED|Overall Study||119
11078623|NCT01110330|12260956|FG001|STARTED|Overall Study||230
11078624|NCT01110330|12260957|FG002|STARTED|Overall Study||234
11078625|NCT01110330|12260955|FG000|Positive Baseline Culture Set|Overall Study||56
11078626|NCT01110330|12260956|FG001|Positive Baseline Culture Set|Overall Study||111
11078627|NCT01110330|12260957|FG002|Positive Baseline Culture Set|Overall Study||114
11078628|NCT01110330|12260955|FG000|COMPLETED|Overall Study||104
11078629|NCT01110330|12260956|FG001|COMPLETED|Overall Study||207
11078630|NCT01110330|12260957|FG002|COMPLETED|Overall Study||208
11078631|NCT01110330|12260955|FG000|NOT COMPLETED|Overall Study||15
11078632|NCT01110330|12260956|FG001|NOT COMPLETED|Overall Study||23
11078633|NCT01110330|12260957|FG002|NOT COMPLETED|Overall Study||26
11078634|NCT01110382|12260967|FG000|STARTED|Overall Study||31
11078635|NCT01110382|12260968|FG001|STARTED|Overall Study||10
11078636|NCT01110382|12260967|FG000|COMPLETED|Overall Study||31
11078637|NCT01110382|12260968|FG001|COMPLETED|Overall Study||8
11078638|NCT01110382|12260967|FG000|NOT COMPLETED|Overall Study||0
11078639|NCT01110382|12260968|FG001|NOT COMPLETED|Overall Study||2
11078640|NCT01110395|12260974|FG000|STARTED|Overall Study||15
11078641|NCT01110395|12260974|FG000|COMPLETED|Overall Study||15
11078642|NCT01110395|12260974|FG000|NOT COMPLETED|Overall Study||0
11078643|NCT01110408|12260980|FG000|STARTED|Overall Study||31
11078644|NCT01110408|12260981|FG001|STARTED|Overall Study||10
11078645|NCT01110408|12260980|FG000|COMPLETED|Overall Study||30
11348673|NCT03003949|12545663|FG001|Week 20|Overall Study||33
11348674|NCT03003949|12545662|FG000|Week 24|Overall Study||35
11348675|NCT03003949|12545663|FG001|Week 24|Overall Study||32
11348676|NCT03003949|12545662|FG000|COMPLETED|Overall Study||35
11348677|NCT03003949|12545663|FG001|COMPLETED|Overall Study||32
11348678|NCT03003949|12545662|FG000|NOT COMPLETED|Overall Study||5
11078646|NCT01110408|12260981|FG001|COMPLETED|Overall Study||10
11078647|NCT01110408|12260980|FG000|NOT COMPLETED|Overall Study||1
11078648|NCT01110408|12260981|FG001|NOT COMPLETED|Overall Study||0
11078649|NCT01110421|12260989|FG000|STARTED|Overall Study||5
11078650|NCT01110421|12260990|FG001|STARTED|Overall Study||2
11078651|NCT01110421|12260989|FG000|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
11348679|NCT03003949|12545663|FG001|NOT COMPLETED|Overall Study||10
11348680|NCT03004469|12545672|FG000|STARTED|Overall Study||189
11348681|NCT03004469|12545673|FG001|STARTED|Overall Study||184
11348682|NCT03004469|12545674|FG002|STARTED|Overall Study||85
11348683|NCT03004469|12545672|FG000|COMPLETED|Overall Study||128
11348684|NCT03004469|12545673|FG001|COMPLETED|Overall Study||135
11348685|NCT03004469|12545674|FG002|COMPLETED|Overall Study||60
11348686|NCT03004469|12545672|FG000|NOT COMPLETED|Overall Study||61
11348687|NCT03004469|12545673|FG001|NOT COMPLETED|Overall Study||49
11348688|NCT03004469|12545674|FG002|NOT COMPLETED|Overall Study||25
11348689|NCT03004534|12545683|FG000|STARTED|Overall Study||36
11348690|NCT03004534|12545683|FG000|COMPLETED|Overall Study||36
11348691|NCT03004534|12545683|FG000|NOT COMPLETED|Overall Study||0
11348692|NCT03004638|12545693|FG000|STARTED|Overall Study||6
11348693|NCT03004638|12545694|FG001|STARTED|Overall Study||6
11348694|NCT03004638|12545695|FG002|STARTED|Overall Study||6
11348695|NCT03004638|12545696|FG003|STARTED|Overall Study||6
11348696|NCT03004638|12545697|FG004|STARTED|Overall Study||1
11348697|NCT03004638|12545698|FG005|STARTED|Overall Study||7
11078652|NCT01110421|12260990|FG001|COMPLETED|Overall Study||2
11078653|NCT01110421|12260989|FG000|NOT COMPLETED|Overall Study||0
11078654|NCT01110421|12260990|FG001|NOT COMPLETED|Overall Study||0
11078655|NCT01110434|12260998|FG000|STARTED|Overall Study||40
11078656|NCT01110434|12260999|FG001|STARTED|Overall Study||26
11078657|NCT01110434|12260998|FG000|COMPLETED|Overall Study||29
11348698|NCT03004638|12545693|FG000|COMPLETED|Overall Study||6
11348699|NCT03004638|12545694|FG001|COMPLETED|Overall Study||6
11348700|NCT03004638|12545695|FG002|COMPLETED|Overall Study||6
11348701|NCT03004638|12545696|FG003|COMPLETED|Overall Study||6
11348702|NCT03004638|12545697|FG004|COMPLETED|Overall Study||1
11348703|NCT03004638|12545698|FG005|COMPLETED|Overall Study||7
11348704|NCT03004638|12545693|FG000|NOT COMPLETED|Overall Study||0
11348705|NCT03004638|12545694|FG001|NOT COMPLETED|Overall Study||0
11348706|NCT03004638|12545695|FG002|NOT COMPLETED|Overall Study||0
11348707|NCT03004638|12545696|FG003|NOT COMPLETED|Overall Study||0
11348708|NCT03004638|12545697|FG004|NOT COMPLETED|Overall Study||0
11348709|NCT03004638|12545698|FG005|NOT COMPLETED|Overall Study||0
11348710|NCT03004846|12545719|FG000|STARTED|Part A (Up to 14 Weeks)||8
11348711|NCT03004846|12545720|FG001|STARTED|Part A (Up to 14 Weeks)||0
11348712|NCT03004846|12545721|FG002|STARTED|Part A (Up to 14 Weeks)||0
11348713|NCT03004846|12545719|FG000|COMPLETED|Part A (Up to 14 Weeks)||8
11348714|NCT03004846|12545720|FG001|COMPLETED|Part A (Up to 14 Weeks)||0
11348715|NCT03004846|12545721|FG002|COMPLETED|Part A (Up to 14 Weeks)||0
11348716|NCT03004846|12545719|FG000|NOT COMPLETED|Part A (Up to 14 Weeks)||0
11348717|NCT03004846|12545720|FG001|NOT COMPLETED|Part A (Up to 14 Weeks)||0
11348718|NCT03004846|12545721|FG002|NOT COMPLETED|Part A (Up to 14 Weeks)||0
11348719|NCT03004846|12545719|FG000|STARTED|Part B (Up to 14 Weeks)||0
11348720|NCT03004846|12545720|FG001|STARTED|Part B (Up to 14 Weeks)||0
11348721|NCT03004846|12545721|FG002|STARTED|Part B (Up to 14 Weeks)||0
11348722|NCT03004846|12545719|FG000|COMPLETED|Part B (Up to 14 Weeks)||0
11348723|NCT03004846|12545720|FG001|COMPLETED|Part B (Up to 14 Weeks)||0
11348724|NCT03004846|12545721|FG002|COMPLETED|Part B (Up to 14 Weeks)||0
11348725|NCT03004846|12545719|FG000|NOT COMPLETED|Part B (Up to 14 Weeks)||0
11348726|NCT03004846|12545720|FG001|NOT COMPLETED|Part B (Up to 14 Weeks)||0
11078658|NCT01110434|12260999|FG001|COMPLETED|Overall Study||20
11078659|NCT01110434|12260998|FG000|NOT COMPLETED|Overall Study||11
11348727|NCT03004846|12545721|FG002|NOT COMPLETED|Part B (Up to 14 Weeks)||0
11348728|NCT03004911|12545732|FG000|STARTED|Overall Study||20
11348729|NCT03004911|12545733|FG001|STARTED|Overall Study||20
11348730|NCT03004911|12545732|FG000|COMPLETED|Overall Study||19
11348731|NCT03004911|12545733|FG001|COMPLETED|Overall Study||17
11348732|NCT03004911|12545732|FG000|NOT COMPLETED|Overall Study||1
11348733|NCT03004911|12545733|FG001|NOT COMPLETED|Overall Study||3
11348734|NCT03004924|12545742|FG000|STARTED|Overall Study||324
11348735|NCT03004924|12545743|FG001|STARTED|Overall Study||108
11348736|NCT03004924|12545744|FG002|STARTED|Overall Study||321
11348737|NCT03004924|12545742|FG000|COMPLETED|Overall Study||297
11348738|NCT03004924|12545743|FG001|COMPLETED|Overall Study||94
11078660|NCT01110434|12260999|FG001|NOT COMPLETED|Overall Study||6
11078661|NCT01110499|12261013|FG000|STARTED|Overall Study||14
11078662|NCT01110499|12261014|FG001|STARTED|Overall Study||14
11078663|NCT01110499|12261015|FG002|STARTED|Overall Study||14
11078664|NCT01110499|12261016|FG003|STARTED|Overall Study||14
11078665|NCT01110499|12261017|FG004|STARTED|Overall Study||14
11078666|NCT01110499|12261018|FG005|STARTED|Overall Study||14
11078667|NCT01110499|12261019|FG006|STARTED|Overall Study||39
11078668|NCT01110499|12261020|FG007|STARTED|Overall Study||40
11078669|NCT01110499|12261013|FG000|COMPLETED|Overall Study||14
11078670|NCT01110499|12261014|FG001|COMPLETED|Overall Study||14
11078671|NCT01110499|12261015|FG002|COMPLETED|Overall Study||14
11078672|NCT01110499|12261016|FG003|COMPLETED|Overall Study||14
11078673|NCT01110499|12261017|FG004|COMPLETED|Overall Study||14
11078674|NCT01110499|12261018|FG005|COMPLETED|Overall Study||14
11078675|NCT01110499|12261019|FG006|COMPLETED|Overall Study||39
11078676|NCT01110499|12261020|FG007|COMPLETED|Overall Study||40
11078677|NCT01110499|12261013|FG000|NOT COMPLETED|Overall Study||0
11078678|NCT01110499|12261014|FG001|NOT COMPLETED|Overall Study||0
11078679|NCT01110499|12261015|FG002|NOT COMPLETED|Overall Study||0
11078680|NCT01110499|12261016|FG003|NOT COMPLETED|Overall Study||0
11078681|NCT01110499|12261017|FG004|NOT COMPLETED|Overall Study||0
11078682|NCT01110499|12261018|FG005|NOT COMPLETED|Overall Study||0
11078683|NCT01110499|12261019|FG006|NOT COMPLETED|Overall Study||0
11078684|NCT01110499|12261020|FG007|NOT COMPLETED|Overall Study||0
11078685|NCT01110707|12261042|FG000|STARTED|Overall Study||63
11078686|NCT01110707|12261043|FG001|STARTED|Overall Study||68
11078687|NCT01110707|12261042|FG000|COMPLETED|Overall Study||63
11078688|NCT01110707|12261043|FG001|COMPLETED|Overall Study||65
11078689|NCT01110707|12261042|FG000|NOT COMPLETED|Overall Study||0
11078690|NCT01110707|12261043|FG001|NOT COMPLETED|Overall Study||3
11078691|NCT01110876|12261052|FG000|STARTED|Overall Study|One received 400 mg Erlotinib dose as result of enzyme inducing anticonvulsants (EIACs)|13
11078692|NCT01110876|12261053|FG001|STARTED|Overall Study||5
11078693|NCT01110876|12261052|FG000|COMPLETED|Overall Study||13
11078694|NCT01110876|12261053|FG001|COMPLETED|Overall Study||5
11078695|NCT01110876|12261052|FG000|NOT COMPLETED|Overall Study||0
11078696|NCT01110876|12261053|FG001|NOT COMPLETED|Overall Study||0
11078697|NCT01110915|12261062|FG000|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
11078698|NCT01110915|12261063|FG001|STARTED|Overall Study|Subjects being randomized to the Control group.|86
11078699|NCT01110915|12261062|FG000|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
11078700|NCT01110915|12261063|FG001|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
11078701|NCT01110915|12261062|FG000|NOT COMPLETED|Overall Study||10
11078702|NCT01110915|12261063|FG001|NOT COMPLETED|Overall Study||2
11078703|NCT01110967|12261070|FG000|STARTED|Overall Study||40
11078704|NCT01110967|12261070|FG000|Surgery|Overall Study||40
11078705|NCT01110967|12261070|FG000|1 Month Follow up|Overall Study||26
11078706|NCT01110967|12261070|FG000|3 Months Follow up|Overall Study||28
11078707|NCT01110967|12261070|FG000|6 Months Follow up|Overall Study||24
11078708|NCT01110967|12261070|FG000|12 Months Follow up|Overall Study||31
11078709|NCT01110967|12261070|FG000|COMPLETED|Overall Study||31
11078710|NCT01110967|12261070|FG000|NOT COMPLETED|Overall Study||9
11078711|NCT01111058|12261076|FG000|STARTED|Overall Study||28
11078712|NCT01111058|12261077|FG001|STARTED|Overall Study||24
11078713|NCT01111058|12261076|FG000|COMPLETED|Overall Study||28
11078714|NCT01111058|12261077|FG001|COMPLETED|Overall Study||24
11078715|NCT01111058|12261076|FG000|NOT COMPLETED|Overall Study||0
11078716|NCT01111058|12261077|FG001|NOT COMPLETED|Overall Study||0
11078717|NCT01111123|12261085|FG000|STARTED|Open- Label Phase||55
11078718|NCT01111123|12261086|FG001|STARTED|Open- Label Phase||0
11078719|NCT01111123|12261085|FG000|COMPLETED|Open- Label Phase||41
11078720|NCT01111123|12261086|FG001|COMPLETED|Open- Label Phase||0
11078721|NCT01111123|12261085|FG000|NOT COMPLETED|Open- Label Phase||14
11078722|NCT01111123|12261086|FG001|NOT COMPLETED|Open- Label Phase||0
11078723|NCT01111123|12261085|FG000|STARTED|Maintenance Phase||21
11078724|NCT01111123|12261086|FG001|STARTED|Maintenance Phase||20
11078725|NCT01111123|12261085|FG000|COMPLETED|Maintenance Phase||21
11078726|NCT01111123|12261086|FG001|COMPLETED|Maintenance Phase||18
11078727|NCT01111123|12261085|FG000|NOT COMPLETED|Maintenance Phase||0
11078728|NCT01111123|12261086|FG001|NOT COMPLETED|Maintenance Phase||2
11078729|NCT01111149|12261097|FG000|STARTED|Overall Study||9
11078730|NCT01111149|12261098|FG001|STARTED|Overall Study||6
11078731|NCT01111149|12261099|FG002|STARTED|Overall Study||9
11078732|NCT01111149|12261097|FG000|COMPLETED|Overall Study||7
11078733|NCT01111149|12261098|FG001|COMPLETED|Overall Study||5
11078734|NCT01111149|12261099|FG002|COMPLETED|Overall Study||5
11078735|NCT01111149|12261097|FG000|NOT COMPLETED|Overall Study||2
11078736|NCT01111149|12261098|FG001|NOT COMPLETED|Overall Study||1
11078737|NCT01111149|12261099|FG002|NOT COMPLETED|Overall Study||4
11078738|NCT01111162|12261107|FG000|STARTED|Overall Study||120
11078739|NCT01111162|12261107|FG000|COMPLETED|Overall Study||120
11078740|NCT01111162|12261107|FG000|NOT COMPLETED|Overall Study||0
11078741|NCT01111240|12261112|FG000|STARTED|Overall Study||4635
11078742|NCT01111240|12261112|FG000|COMPLETED|Overall Study||3569
11078743|NCT01111240|12261112|FG000|NOT COMPLETED|Overall Study||1066
11078744|NCT01111292|12261118|FG000|STARTED|Randomization||3
11078745|NCT01111292|12261119|FG001|STARTED|Randomization||2
11078746|NCT01111292|12261118|FG000|COMPLETED|Randomization||3
11078747|NCT01111292|12261119|FG001|COMPLETED|Randomization||2
11078748|NCT01111292|12261118|FG000|NOT COMPLETED|Randomization||0
11078749|NCT01111292|12261119|FG001|NOT COMPLETED|Randomization||0
11078750|NCT01111292|12261118|FG000|STARTED|Treatment||3
11078751|NCT01111292|12261119|FG001|STARTED|Treatment||2
11078752|NCT01111292|12261118|FG000|COMPLETED|Treatment||2
11078753|NCT01111292|12261119|FG001|COMPLETED|Treatment||1
11078754|NCT01111292|12261118|FG000|NOT COMPLETED|Treatment||1
11078755|NCT01111292|12261119|FG001|NOT COMPLETED|Treatment||1
11078756|NCT01111292|12261118|FG000|STARTED|Post Treatment Biopsy||2
11078757|NCT01111292|12261119|FG001|STARTED|Post Treatment Biopsy||1
11078758|NCT01111292|12261118|FG000|COMPLETED|Post Treatment Biopsy||2
11078759|NCT01111292|12261119|FG001|COMPLETED|Post Treatment Biopsy||1
11078760|NCT01111292|12261118|FG000|NOT COMPLETED|Post Treatment Biopsy||0
11078761|NCT01111292|12261119|FG001|NOT COMPLETED|Post Treatment Biopsy||0
11078762|NCT01111292|12261118|FG000|STARTED|Follow-Up||2
11078763|NCT01111292|12261119|FG001|STARTED|Follow-Up||1
11078764|NCT01111292|12261118|FG000|COMPLETED|Follow-Up||2
11078765|NCT01111292|12261119|FG001|COMPLETED|Follow-Up||1
11078766|NCT01111292|12261118|FG000|NOT COMPLETED|Follow-Up||0
11078767|NCT01111292|12261119|FG001|NOT COMPLETED|Follow-Up||0
11078768|NCT01111318|12261129|FG000|STARTED|Overall Study||12
11078769|NCT01111318|12261130|FG001|STARTED|Overall Study||8
11078770|NCT01111318|12261131|FG002|STARTED|Overall Study||8
11078771|NCT01111318|12261132|FG003|STARTED|Overall Study||8
11078772|NCT01111318|12261129|FG000|COMPLETED|Overall Study||12
11078773|NCT01111318|12261130|FG001|COMPLETED|Overall Study||8
11078774|NCT01111318|12261131|FG002|COMPLETED|Overall Study||8
11078775|NCT01111318|12261132|FG003|COMPLETED|Overall Study||8
11078776|NCT01111318|12261129|FG000|NOT COMPLETED|Overall Study||0
11078777|NCT01111318|12261130|FG001|NOT COMPLETED|Overall Study||0
11078778|NCT01111318|12261131|FG002|NOT COMPLETED|Overall Study||0
11078779|NCT01111318|12261132|FG003|NOT COMPLETED|Overall Study||0
11078780|NCT01111331|12261142|FG000|STARTED|Overall Study||9
11078781|NCT01111331|12261143|FG001|STARTED|Overall Study||9
11078782|NCT01111331|12261142|FG000|COMPLETED|Overall Study||9
11078783|NCT01111331|12261143|FG001|COMPLETED|Overall Study||9
11078784|NCT01111331|12261142|FG000|NOT COMPLETED|Overall Study||0
11078785|NCT01111331|12261143|FG001|NOT COMPLETED|Overall Study||0
11078786|NCT01111370|12261153|FG000|STARTED|Overall Study||60
11078787|NCT01111370|12261153|FG000|COMPLETED|Overall Study||58
11078788|NCT01111370|12261153|FG000|NOT COMPLETED|Overall Study||2
11078789|NCT01111461|12261157|FG000|STARTED|Overall Study||133
11078790|NCT01111461|12261157|FG000|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
11078791|NCT01111461|12261157|FG000|NOT COMPLETED|Overall Study||51
11078792|NCT01111474|12261161|FG000|STARTED|Overall Study|593 teeth from 74 participants: 296 teeth treated with cyanoacrylate and 297 teeth with LILT|74
11078793|NCT01111474|12261161|FG000|COMPLETED|Overall Study|434 teeth from 62 participants: 218 teeth teated with cyanoacrylate and 216 teeth with LILT|62
11078794|NCT01111474|12261161|FG000|NOT COMPLETED|Overall Study||12
11078795|NCT01111526|12261167|FG000|STARTED|Overall Study||4
11078796|NCT01111526|12261168|FG001|STARTED|Overall Study||8
11078797|NCT01111526|12261169|FG002|STARTED|Overall Study||10
11078798|NCT01111526|12261167|FG000|COMPLETED|Overall Study||4
11078799|NCT01111526|12261168|FG001|COMPLETED|Overall Study||7
11078800|NCT01111526|12261169|FG002|COMPLETED|Overall Study||8
11078801|NCT01111526|12261167|FG000|NOT COMPLETED|Overall Study||0
11078802|NCT01111526|12261168|FG001|NOT COMPLETED|Overall Study||1
11078803|NCT01111526|12261169|FG002|NOT COMPLETED|Overall Study||2
11078804|NCT01111539|12261173|FG000|STARTED|Phase B (Day 1 to Week 8)||211
11078805|NCT01111539|12261174|FG001|STARTED|Phase B (Day 1 to Week 8)||0
11078806|NCT01111539|12261175|FG002|STARTED|Phase B (Day 1 to Week 8)||0
11078807|NCT01111539|12261176|FG003|STARTED|Phase B (Day 1 to Week 8)||0
11078808|NCT01111539|12261177|FG004|STARTED|Phase B (Day 1 to Week 8)||0
11078809|NCT01111539|12261173|FG000|COMPLETED|Phase B (Day 1 to Week 8)||129
11078810|NCT01111539|12261174|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0
11348739|NCT03004924|12545744|FG002|COMPLETED|Overall Study||293
11348740|NCT03004924|12545742|FG000|NOT COMPLETED|Overall Study||27
11348741|NCT03004924|12545743|FG001|NOT COMPLETED|Overall Study||14
11348742|NCT03004924|12545744|FG002|NOT COMPLETED|Overall Study||28
11348743|NCT03005041|12545753|FG000|STARTED|Period 1||28
11348744|NCT03005041|12545754|FG001|STARTED|Period 1||27
11348745|NCT03005041|12545753|FG000|COMPLETED|Period 1||28
11348746|NCT03005041|12545754|FG001|COMPLETED|Period 1||27
11348747|NCT03005041|12545753|FG000|NOT COMPLETED|Period 1||0
11348748|NCT03005041|12545754|FG001|NOT COMPLETED|Period 1||0
11348749|NCT03005041|12545753|FG000|STARTED|Washout Period 1||28
11348750|NCT03005041|12545754|FG001|STARTED|Washout Period 1||27
11348751|NCT03005041|12545753|FG000|COMPLETED|Washout Period 1||28
11348752|NCT03005041|12545754|FG001|COMPLETED|Washout Period 1||27
11348753|NCT03005041|12545753|FG000|NOT COMPLETED|Washout Period 1||0
11348754|NCT03005041|12545754|FG001|NOT COMPLETED|Washout Period 1||0
11348755|NCT03005041|12545753|FG000|STARTED|Period 2||28
11348756|NCT03005041|12545754|FG001|STARTED|Period 2||27
11348757|NCT03005041|12545753|FG000|COMPLETED|Period 2||28
11078811|NCT01111539|12261175|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0
11348758|NCT03005041|12545754|FG001|COMPLETED|Period 2||27
11348759|NCT03005041|12545753|FG000|NOT COMPLETED|Period 2||0
11348760|NCT03005041|12545754|FG001|NOT COMPLETED|Period 2||0
11078812|NCT01111539|12261176|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0
11078813|NCT01111539|12261177|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0
11078814|NCT01111539|12261173|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||82
11078815|NCT01111539|12261174|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
11078816|NCT01111539|12261175|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
11078817|NCT01111539|12261176|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
11078818|NCT01111539|12261177|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
11078819|NCT01111539|12261173|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0
11078820|NCT01111539|12261174|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||45
11078821|NCT01111539|12261175|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
11078822|NCT01111539|12261176|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
11078823|NCT01111539|12261177|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
11078824|NCT01111539|12261173|FG000|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||0
11078825|NCT01111539|12261174|FG001|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||45
11078826|NCT01111539|12261175|FG002|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
11078827|NCT01111539|12261176|FG003|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||27
11078828|NCT01111539|12261177|FG004|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
11078829|NCT01111539|12261173|FG000|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||0
11078830|NCT01111539|12261174|FG001|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||45
11078831|NCT01111539|12261175|FG002|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
11078832|NCT01111539|12261176|FG003|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||27
11078833|NCT01111539|12261177|FG004|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
11078834|NCT01111539|12261173|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
11078835|NCT01111539|12261174|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||38
11078836|NCT01111539|12261175|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||22
11078837|NCT01111539|12261176|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||20
11078838|NCT01111539|12261177|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18
11078839|NCT01111539|12261173|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
11078840|NCT01111539|12261174|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||7
11078841|NCT01111539|12261175|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||6
11078842|NCT01111539|12261176|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||8
11078843|NCT01111539|12261177|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||10
11078844|NCT01111552|12261187|FG000|STARTED|Phase B (Day 1 to Week 8)||237
11078845|NCT01111552|12261188|FG001|STARTED|Phase B (Day 1 to Week 8)||0
11078846|NCT01111552|12261189|FG002|STARTED|Phase B (Day 1 to Week 8)||0
11078847|NCT01111552|12261190|FG003|STARTED|Phase B (Day 1 to Week 8)||0
11078848|NCT01111552|12261191|FG004|STARTED|Phase B (Day 1 to Week 8)||0
11078849|NCT01111552|12261187|FG000|COMPLETED|Phase B (Day 1 to Week 8)||120
11078850|NCT01111552|12261188|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0
11078851|NCT01111552|12261189|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0
11078852|NCT01111552|12261190|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0
11078853|NCT01111552|12261191|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0
11078854|NCT01111552|12261187|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||117
11078855|NCT01111552|12261188|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
11078856|NCT01111552|12261189|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
11078857|NCT01111552|12261190|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
11078858|NCT01111552|12261191|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
11078859|NCT01111552|12261187|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0
11078860|NCT01111552|12261188|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||54
11078861|NCT01111552|12261189|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||22
11078862|NCT01111552|12261190|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||21
11078863|NCT01111552|12261191|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||23
11078864|NCT01111552|12261187|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
11078865|NCT01111552|12261188|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||45
11078866|NCT01111552|12261189|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17
11078867|NCT01111552|12261190|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17
11078868|NCT01111552|12261191|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18
11078869|NCT01111552|12261187|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
11078870|NCT01111552|12261188|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||9
11078871|NCT01111552|12261189|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5
11078872|NCT01111552|12261190|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||4
11078873|NCT01111552|12261191|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5
11206907|NCT01871285|12398014|FG002|COMPLETED|Second Intervention (1 Day)||3
11206908|NCT01871285|12398015|FG003|COMPLETED|Second Intervention (1 Day)||2
11206909|NCT01871285|12398012|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11206910|NCT01871285|12398013|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11206911|NCT01871285|12398014|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11206912|NCT01871285|12398015|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
11206913|NCT01871402|12398027|FG000|STARTED|Overall Study||110
11206914|NCT01871402|12398028|FG001|STARTED|Overall Study||111
11206915|NCT01871402|12398027|FG000|COMPLETED|Overall Study||109
11206916|NCT01871402|12398028|FG001|COMPLETED|Overall Study||108
11206917|NCT01871402|12398027|FG000|NOT COMPLETED|Overall Study||1
11206918|NCT01871402|12398028|FG001|NOT COMPLETED|Overall Study||3
11206919|NCT01871441|12398034|FG000|STARTED|Overall Study||4
11206920|NCT01871441|12398034|FG000|COMPLETED|Overall Study||4
11206921|NCT01871441|12398034|FG000|NOT COMPLETED|Overall Study||0
11206922|NCT01871506|12398041|FG000|STARTED|Overall Study||150
11206923|NCT01871506|12398042|FG001|STARTED|Overall Study||153
11206924|NCT01871506|12398041|FG000|COMPLETED|Overall Study||150
11206925|NCT01871506|12398042|FG001|COMPLETED|Overall Study||153
11206926|NCT01871506|12398041|FG000|NOT COMPLETED|Overall Study||0
11206927|NCT01871506|12398042|FG001|NOT COMPLETED|Overall Study||0
11206928|NCT01871519|12398061|FG000|STARTED|Overall Study||350
11206929|NCT01871519|12398061|FG000|COMPLETED|Overall Study||260
11206930|NCT01871519|12398061|FG000|NOT COMPLETED|Overall Study||90
11206931|NCT01871532|12398068|FG000|STARTED|Overall Study||12
11206932|NCT01871532|12398069|FG001|STARTED|Overall Study||12
11206933|NCT01871532|12398068|FG000|Subjects Received hCG Treatment|Overall Study||11
11206934|NCT01871532|12398069|FG001|Subjects Received hCG Treatment|Overall Study||9
11206935|NCT01871532|12398068|FG000|COMPLETED|Overall Study||11
11206936|NCT01871532|12398069|FG001|COMPLETED|Overall Study||10
11206937|NCT01871532|12398068|FG000|NOT COMPLETED|Overall Study||1
11206938|NCT01871532|12398069|FG001|NOT COMPLETED|Overall Study||2
11206939|NCT01871545|12398077|FG000|STARTED|Overall Study||73
11206940|NCT01871545|12398078|FG001|STARTED|Overall Study||11
11206941|NCT01871545|12398077|FG000|COMPLETED|Overall Study||56
11206942|NCT01871545|12398078|FG001|COMPLETED|Overall Study||8
11206943|NCT01871545|12398077|FG000|NOT COMPLETED|Overall Study||17
11206944|NCT01871545|12398078|FG001|NOT COMPLETED|Overall Study||3
11206945|NCT01871558|12398089|FG000|STARTED|Overall Study||21
11206946|NCT01871558|12398090|FG001|STARTED|Overall Study||21
11206947|NCT01871558|12398089|FG000|COMPLETED|Overall Study||18
11206948|NCT01871558|12398090|FG001|COMPLETED|Overall Study||19
11206949|NCT01871558|12398089|FG000|NOT COMPLETED|Overall Study||3
11206950|NCT01871558|12398090|FG001|NOT COMPLETED|Overall Study||2
11206951|NCT01871805|12398102|FG000|STARTED|Phase I||7
11206952|NCT01871805|12398103|FG001|STARTED|Phase I||7
11206953|NCT01871805|12398104|FG002|STARTED|Phase I||13
11206954|NCT01871805|12398105|FG003|STARTED|Phase I||7
11206955|NCT01871805|12398106|FG004|STARTED|Phase I||13
11206956|NCT01871805|12398107|FG005|STARTED|Phase I||0
11206957|NCT01871805|12398102|FG000|COMPLETED|Phase I||0
11206958|NCT01871805|12398103|FG001|COMPLETED|Phase I||0
11206959|NCT01871805|12398104|FG002|COMPLETED|Phase I||0
11206960|NCT01871805|12398105|FG003|COMPLETED|Phase I||0
11206961|NCT01871805|12398106|FG004|COMPLETED|Phase I||0
11206962|NCT01871805|12398107|FG005|COMPLETED|Phase I||0
11206963|NCT01871805|12398102|FG000|NOT COMPLETED|Phase I||7
11206964|NCT01871805|12398103|FG001|NOT COMPLETED|Phase I||7
11206965|NCT01871805|12398104|FG002|NOT COMPLETED|Phase I||13
11206966|NCT01871805|12398105|FG003|NOT COMPLETED|Phase I||7
11206967|NCT01871805|12398106|FG004|NOT COMPLETED|Phase I||13
11206968|NCT01871805|12398107|FG005|NOT COMPLETED|Phase I||0
11206969|NCT01871805|12398102|FG000|STARTED|Phase II||0
11206970|NCT01871805|12398103|FG001|STARTED|Phase II||0
11206971|NCT01871805|12398104|FG002|STARTED|Phase II||0
11206972|NCT01871805|12398105|FG003|STARTED|Phase II||0
11206973|NCT01871805|12398106|FG004|STARTED|Phase II||0
11206974|NCT01871805|12398107|FG005|STARTED|Phase II||87
11206975|NCT01871805|12398102|FG000|COMPLETED|Phase II||0
11206976|NCT01871805|12398103|FG001|COMPLETED|Phase II||0
11078874|NCT01111604|12261204|FG000|STARTED|Overall Study||54
11078875|NCT01111604|12261205|FG001|STARTED|Overall Study||52
11078876|NCT01111604|12261206|FG002|STARTED|Overall Study||52
11078877|NCT01111604|12261204|FG000|Received at Least One Dose of Study Drug|Overall Study||49
11078878|NCT01111604|12261205|FG001|Received at Least One Dose of Study Drug|Overall Study||52
11078879|NCT01111604|12261206|FG002|Received at Least One Dose of Study Drug|Overall Study||52
11078880|NCT01111604|12261204|FG000|COMPLETED|Overall Study||46
11078881|NCT01111604|12261205|FG001|COMPLETED|Overall Study||52
11078882|NCT01111604|12261206|FG002|COMPLETED|Overall Study||49
11078883|NCT01111604|12261204|FG000|NOT COMPLETED|Overall Study||8
11078884|NCT01111604|12261205|FG001|NOT COMPLETED|Overall Study||0
11078885|NCT01111604|12261206|FG002|NOT COMPLETED|Overall Study||3
11078886|NCT01111825|12261236|FG000|STARTED|Overall Study||8
11078887|NCT01111825|12261237|FG001|STARTED|Overall Study||6
11078888|NCT01111825|12261238|FG002|STARTED|Overall Study||37
11078889|NCT01111825|12261239|FG003|STARTED|Overall Study||48
11078890|NCT01111825|12261236|FG000|COMPLETED|Overall Study||5
11078891|NCT01111825|12261237|FG001|COMPLETED|Overall Study||5
11078892|NCT01111825|12261238|FG002|COMPLETED|Overall Study||29
11078893|NCT01111825|12261239|FG003|COMPLETED|Overall Study||27
11078894|NCT01111825|12261236|FG000|NOT COMPLETED|Overall Study||3
11078895|NCT01111825|12261237|FG001|NOT COMPLETED|Overall Study||1
11078896|NCT01111825|12261238|FG002|NOT COMPLETED|Overall Study||8
11078897|NCT01111825|12261239|FG003|NOT COMPLETED|Overall Study||21
11078898|NCT01111838|12261249|FG000|STARTED|Overall Study||22
11078899|NCT01111838|12261249|FG000|COMPLETED|Overall Study||15
11078900|NCT01111838|12261249|FG000|NOT COMPLETED|Overall Study||7
11078901|NCT01111851|12261255|FG000|STARTED|Overall Study||8
11078902|NCT01111851|12261256|FG001|STARTED|Overall Study||8
11078903|NCT01111851|12261255|FG000|COMPLETED|Overall Study||6
11078904|NCT01111851|12261256|FG001|COMPLETED|Overall Study||8
11078905|NCT01111851|12261255|FG000|NOT COMPLETED|Overall Study||2
11078906|NCT01111851|12261256|FG001|NOT COMPLETED|Overall Study||0
11078907|NCT01112059|12261264|FG000|STARTED|Overall Study||20
11078908|NCT01112059|12261265|FG001|STARTED|Overall Study||20
11078909|NCT01112059|12261264|FG000|COMPLETED|Overall Study||19
11078910|NCT01112059|12261265|FG001|COMPLETED|Overall Study||20
11078911|NCT01112059|12261264|FG000|NOT COMPLETED|Overall Study||1
11078912|NCT01112059|12261265|FG001|NOT COMPLETED|Overall Study||0
11078913|NCT01112228|12261274|FG000|STARTED|Overall Study||600
11078914|NCT01112228|12261274|FG000|COMPLETED|Overall Study||600
11078915|NCT01112228|12261274|FG000|NOT COMPLETED|Overall Study||0
11078916|NCT01112241|12261280|FG000|STARTED|Overall Study||17
11078917|NCT01112241|12261280|FG000|COMPLETED|Overall Study||17
11348761|NCT03005054|12545760|FG000|STARTED|Overall Study||3
11348762|NCT03005054|12545760|FG000|COMPLETED|Overall Study||3
11348763|NCT03005054|12545760|FG000|NOT COMPLETED|Overall Study||0
11348764|NCT03005067|12545766|FG000|STARTED|Overall Study||90
11348765|NCT03005067|12545767|FG001|STARTED|Overall Study||81
11348766|NCT03005067|12545766|FG000|COMPLETED|Overall Study||80
11348767|NCT03005067|12545767|FG001|COMPLETED|Overall Study||74
11348768|NCT03005067|12545766|FG000|NOT COMPLETED|Overall Study||10
11348769|NCT03005067|12545767|FG001|NOT COMPLETED|Overall Study||7
11348770|NCT03005106|12545773|FG000|STARTED|Overall Study||71
11348771|NCT03005106|12545773|FG000|Completed Month 3 Visit|Overall Study||64
11348772|NCT03005106|12545773|FG000|Completed Month 12 Visit|Overall Study||51
11348773|NCT03005106|12545773|FG000|COMPLETED|Overall Study||51
11348774|NCT03005106|12545773|FG000|NOT COMPLETED|Overall Study||20
11348775|NCT03005288|12545779|FG000|STARTED|Overall Study||39
11078918|NCT01112241|12261280|FG000|NOT COMPLETED|Overall Study||0
11078919|NCT01112267|12261286|FG000|STARTED|Overall Study||126
11078920|NCT01112267|12261287|FG001|STARTED|Overall Study||122
11078921|NCT01112267|12261286|FG000|Treated|Overall Study||125
11078922|NCT01112267|12261287|FG001|Treated|Overall Study||120
11078923|NCT01112267|12261286|FG000|COMPLETED|Overall Study||92
11078924|NCT01112267|12261287|FG001|COMPLETED|Overall Study||104
11078925|NCT01112267|12261286|FG000|NOT COMPLETED|Overall Study||34
11348776|NCT03005288|12545780|FG001|STARTED|Overall Study||39
11348777|NCT03005288|12545779|FG000|Safety Analysis Set|Overall Study||37
11348778|NCT03005288|12545780|FG001|Safety Analysis Set|Overall Study||38
11348779|NCT03005288|12545779|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
11348780|NCT03005288|12545780|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|PK samples were only obtained and evaluated for subjects treated with BYM338.|0
11348781|NCT03005288|12545779|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
11348782|NCT03005288|12545780|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|Two subjects were excluded due to protocol deviations.|36
11348783|NCT03005288|12545779|FG000|COMPLETED|Overall Study||27
11348784|NCT03005288|12545780|FG001|COMPLETED|Overall Study||31
11348785|NCT03005288|12545779|FG000|NOT COMPLETED|Overall Study||12
11348786|NCT03005288|12545780|FG001|NOT COMPLETED|Overall Study||8
11348787|NCT03006341|12545790|FG000|STARTED|Overall Study||26199
11348788|NCT03006341|12545791|FG001|STARTED|Overall Study||70071
11348789|NCT03006341|12545792|FG002|STARTED|Overall Study||32595
11348790|NCT03006341|12545793|FG003|STARTED|Overall Study||11322
11348791|NCT03006341|12545790|FG000|COMPLETED|Overall Study||1130
11348792|NCT03006341|12545791|FG001|COMPLETED|Overall Study||2566
11348793|NCT03006341|12545792|FG002|COMPLETED|Overall Study||1602
11348794|NCT03006341|12545793|FG003|COMPLETED|Overall Study||637
11348795|NCT03006341|12545790|FG000|NOT COMPLETED|Overall Study||25069
11348796|NCT03006341|12545791|FG001|NOT COMPLETED|Overall Study||67505
11348797|NCT03006341|12545792|FG002|NOT COMPLETED|Overall Study||30993
11348798|NCT03006341|12545793|FG003|NOT COMPLETED|Overall Study||10685
11348799|NCT03006393|12545803|FG000|STARTED|Overall Study||21
11348800|NCT03006393|12545804|FG001|STARTED|Overall Study||21
11348801|NCT03006393|12545803|FG000|COMPLETED|Overall Study||20
11348802|NCT03006393|12545804|FG001|COMPLETED|Overall Study||18
11348803|NCT03006393|12545803|FG000|NOT COMPLETED|Overall Study||1
11348804|NCT03006393|12545804|FG001|NOT COMPLETED|Overall Study||3
11348805|NCT03006458|12545810|FG000|STARTED|First Intervention||14
11348806|NCT03006458|12545811|FG001|STARTED|First Intervention||10
11348807|NCT03006458|12545810|FG000|COMPLETED|First Intervention||14
11348808|NCT03006458|12545811|FG001|COMPLETED|First Intervention||7
11348809|NCT03006458|12545810|FG000|NOT COMPLETED|First Intervention||0
11348810|NCT03006458|12545811|FG001|NOT COMPLETED|First Intervention||3
11348811|NCT03006458|12545810|FG000|STARTED|Second Intervention||14
11348812|NCT03006458|12545811|FG001|STARTED|Second Intervention||10
11348813|NCT03006458|12545810|FG000|COMPLETED|Second Intervention||14
11348814|NCT03006458|12545811|FG001|COMPLETED|Second Intervention||10
11348815|NCT03006458|12545810|FG000|NOT COMPLETED|Second Intervention||0
11078926|NCT01112267|12261287|FG001|NOT COMPLETED|Overall Study||18
11348816|NCT03006458|12545811|FG001|NOT COMPLETED|Second Intervention||0
11348817|NCT03006471|12545819|FG000|STARTED|Overall Study||15
11348818|NCT03006471|12545820|FG001|STARTED|Overall Study||15
11348819|NCT03006471|12545819|FG000|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
11348820|NCT03006471|12545820|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
11348821|NCT03006471|12545819|FG000|NOT COMPLETED|Overall Study||2
11348822|NCT03006471|12545820|FG001|NOT COMPLETED|Overall Study||2
11348823|NCT03006562|12545828|FG000|STARTED|Overall Study||251
11348824|NCT03006562|12545829|FG001|STARTED|Overall Study||250
11348825|NCT03006562|12545828|FG000|Voluntary Ultrasound at 30 Days|Overall Study||141
11348826|NCT03006562|12545829|FG001|Voluntary Ultrasound at 30 Days|Overall Study||137
11348827|NCT03006562|12545828|FG000|COMPLETED|Overall Study||251
11348828|NCT03006562|12545829|FG001|COMPLETED|Overall Study||249
11348829|NCT03006562|12545828|FG000|NOT COMPLETED|Overall Study||0
11348830|NCT03006562|12545829|FG001|NOT COMPLETED|Overall Study||1
11348831|NCT03006887|12545835|FG000|STARTED|Overall Study||6
11348832|NCT03006887|12545835|FG000|COMPLETED|Overall Study||5
11078927|NCT01112293|12261293|FG000|STARTED|Overall Study||14
11078928|NCT01112293|12261293|FG000|COMPLETED|Overall Study||14
11078929|NCT01112293|12261293|FG000|NOT COMPLETED|Overall Study||0
11078930|NCT01112358|12261299|FG000|STARTED|Overall Study||25
11078931|NCT01112358|12261300|FG001|STARTED|Overall Study||33
11206977|NCT01871805|12398104|FG002|COMPLETED|Phase II||0
11206978|NCT01871805|12398105|FG003|COMPLETED|Phase II||0
11206979|NCT01871805|12398106|FG004|COMPLETED|Phase II||0
11206980|NCT01871805|12398107|FG005|COMPLETED|Phase II||0
11206981|NCT01871805|12398102|FG000|NOT COMPLETED|Phase II||0
11206982|NCT01871805|12398103|FG001|NOT COMPLETED|Phase II||0
11206983|NCT01871805|12398104|FG002|NOT COMPLETED|Phase II||0
11206984|NCT01871805|12398105|FG003|NOT COMPLETED|Phase II||0
11206985|NCT01871805|12398106|FG004|NOT COMPLETED|Phase II||0
11206986|NCT01871805|12398107|FG005|NOT COMPLETED|Phase II||87
11206987|NCT01871870|12398138|FG000|STARTED|Overall Study||20
11206988|NCT01871870|12398138|FG000|COMPLETED|Overall Study||11
11206989|NCT01871870|12398138|FG000|NOT COMPLETED|Overall Study||9
11206990|NCT01872078|12398146|FG000|STARTED|Overall Study||16
11206991|NCT01872078|12398147|FG001|STARTED|Overall Study||15
11206992|NCT01872078|12398148|FG002|STARTED|Overall Study||17
11206993|NCT01872078|12398149|FG003|STARTED|Overall Study||17
11206994|NCT01872078|12398146|FG000|COMPLETED|Overall Study||16
11206995|NCT01872078|12398147|FG001|COMPLETED|Overall Study||15
11206996|NCT01872078|12398148|FG002|COMPLETED|Overall Study||14
11206997|NCT01872078|12398149|FG003|COMPLETED|Overall Study||15
11206998|NCT01872078|12398146|FG000|NOT COMPLETED|Overall Study||0
11206999|NCT01872078|12398147|FG001|NOT COMPLETED|Overall Study||0
11207000|NCT01872078|12398148|FG002|NOT COMPLETED|Overall Study||3
11207001|NCT01872078|12398149|FG003|NOT COMPLETED|Overall Study||2
11207002|NCT01872325|12398161|FG000|STARTED|Overall Study||689
11207003|NCT01872325|12398162|FG001|STARTED|Overall Study||387
11207004|NCT01872325|12398161|FG000|COMPLETED|Overall Study||689
11207005|NCT01872325|12398162|FG001|COMPLETED|Overall Study||387
11207006|NCT01872325|12398161|FG000|NOT COMPLETED|Overall Study||0
11207007|NCT01872325|12398162|FG001|NOT COMPLETED|Overall Study||0
11207008|NCT01872338|12398170|FG000|STARTED|Overall Study||66
11207009|NCT01872338|12398171|FG001|STARTED|Overall Study||69
11207010|NCT01872338|12398170|FG000|COMPLETED|Overall Study||46
11207011|NCT01872338|12398171|FG001|COMPLETED|Overall Study||69
11207012|NCT01872338|12398170|FG000|NOT COMPLETED|Overall Study||20
11207013|NCT01872338|12398171|FG001|NOT COMPLETED|Overall Study||0
11207014|NCT01872611|12398179|FG000|STARTED|Overall Study||301
11207015|NCT01872611|12398180|FG001|STARTED|Overall Study||304
11207016|NCT01872611|12398179|FG000|Randomized|Overall Study||301
11207017|NCT01872611|12398180|FG001|Randomized|Overall Study||304
11348833|NCT03006887|12545835|FG000|NOT COMPLETED|Overall Study||1
11078932|NCT01112358|12261299|FG000|COMPLETED|Overall Study||25
11078933|NCT01112358|12261300|FG001|COMPLETED|Overall Study||33
11078934|NCT01112358|12261299|FG000|NOT COMPLETED|Overall Study||0
11078935|NCT01112358|12261300|FG001|NOT COMPLETED|Overall Study||0
11078936|NCT01112514|12261306|FG000|STARTED|Overall Study||4
11078937|NCT01112514|12261306|FG000|COMPLETED|Overall Study||3
11078938|NCT01112514|12261306|FG000|NOT COMPLETED|Overall Study||1
11207018|NCT01872611|12398179|FG000|Treated (Safety Analysis Set)|Overall Study||293
11207019|NCT01872611|12398180|FG001|Treated (Safety Analysis Set)|Overall Study||295
11207020|NCT01872611|12398179|FG000|Full Analysis Set|Overall Study||289
11207021|NCT01872611|12398180|FG001|Full Analysis Set|Overall Study||293
11207022|NCT01872611|12398179|FG000|COMPLETED|Overall Study||277
11207023|NCT01872611|12398180|FG001|COMPLETED|Overall Study||292
11207024|NCT01872611|12398179|FG000|NOT COMPLETED|Overall Study||24
11207025|NCT01872611|12398180|FG001|NOT COMPLETED|Overall Study||12
11207026|NCT01872689|12398192|FG000|STARTED|Double-Blind/Placebo-Controlled Period||76
11207027|NCT01872689|12398193|FG001|STARTED|Double-Blind/Placebo-Controlled Period||78
11207028|NCT01872689|12398194|FG002|STARTED|Double-Blind/Placebo-Controlled Period||177
11207029|NCT01872689|12398195|FG003|STARTED|Double-Blind/Placebo-Controlled Period||174
11207030|NCT01872689|12398192|FG000|COMPLETED|Double-Blind/Placebo-Controlled Period||56
11207031|NCT01872689|12398193|FG001|COMPLETED|Double-Blind/Placebo-Controlled Period||58
11207032|NCT01872689|12398194|FG002|COMPLETED|Double-Blind/Placebo-Controlled Period||129
11207033|NCT01872689|12398195|FG003|COMPLETED|Double-Blind/Placebo-Controlled Period||136
11207034|NCT01872689|12398192|FG000|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
11207035|NCT01872689|12398193|FG001|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
11207036|NCT01872689|12398194|FG002|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
11207037|NCT01872689|12398195|FG003|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
11207038|NCT01872689|12398192|FG000|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
11207039|NCT01872689|12398193|FG001|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
11207040|NCT01872689|12398194|FG002|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
11207041|NCT01872689|12398195|FG003|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
11207042|NCT01872689|12398192|FG000|COMPLETED|Open-Label Period (Only For Monotherapy)||31
11207043|NCT01872689|12398193|FG001|COMPLETED|Open-Label Period (Only For Monotherapy)||33
11207044|NCT01872689|12398194|FG002|COMPLETED|Open-Label Period (Only For Monotherapy)||0
11207045|NCT01872689|12398195|FG003|COMPLETED|Open-Label Period (Only For Monotherapy)||0
11207046|NCT01872689|12398192|FG000|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
11078939|NCT01112579|12261312|FG000|STARTED|Overall Study||42
11078940|NCT01112579|12261313|FG001|STARTED|Overall Study||24
11078941|NCT01112579|12261312|FG000|COMPLETED|Overall Study||41
11078942|NCT01112579|12261313|FG001|COMPLETED|Overall Study||21
11078943|NCT01112579|12261312|FG000|NOT COMPLETED|Overall Study||1
11078944|NCT01112579|12261313|FG001|NOT COMPLETED|Overall Study||3
11078945|NCT01112670|12261319|FG000|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
11078946|NCT01112670|12261320|FG001|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
11078947|NCT01112670|12261321|FG002|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
11078948|NCT01112670|12261322|FG003|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
11078949|NCT01112670|12261323|FG004|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
11078950|NCT01112670|12261324|FG005|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
11078951|NCT01112670|12261319|FG000|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
11078952|NCT01112670|12261320|FG001|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
11078953|NCT01112670|12261321|FG002|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
11078954|NCT01112670|12261322|FG003|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
11078955|NCT01112670|12261323|FG004|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
11078956|NCT01112670|12261324|FG005|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
11078957|NCT01112670|12261319|FG000|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
11078958|NCT01112670|12261320|FG001|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
11078959|NCT01112670|12261321|FG002|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
11078960|NCT01112670|12261322|FG003|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
11078961|NCT01112670|12261323|FG004|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
11078962|NCT01112670|12261324|FG005|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
11078963|NCT01112670|12261319|FG000|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
11078964|NCT01112670|12261320|FG001|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
11078965|NCT01112670|12261321|FG002|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
11078966|NCT01112670|12261322|FG003|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
11078967|NCT01112670|12261323|FG004|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
11078968|NCT01112670|12261324|FG005|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
11078969|NCT01112670|12261319|FG000|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
11078970|NCT01112670|12261320|FG001|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
11078971|NCT01112670|12261321|FG002|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
11078972|NCT01112670|12261322|FG003|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
11078973|NCT01112670|12261323|FG004|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
11078974|NCT01112670|12261324|FG005|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
11078975|NCT01112670|12261319|FG000|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
11078976|NCT01112670|12261320|FG001|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
11078977|NCT01112670|12261321|FG002|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
11078978|NCT01112670|12261322|FG003|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
11078979|NCT01112670|12261323|FG004|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
11078980|NCT01112670|12261324|FG005|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
11078981|NCT01112683|12261333|FG000|STARTED|Overall Study||19
11078982|NCT01112683|12261334|FG001|STARTED|Overall Study||20
11078983|NCT01112683|12261333|FG000|COMPLETED|Overall Study||18
11078984|NCT01112683|12261334|FG001|COMPLETED|Overall Study||19
11078985|NCT01112683|12261333|FG000|NOT COMPLETED|Overall Study||1
11078986|NCT01112683|12261334|FG001|NOT COMPLETED|Overall Study||1
11078987|NCT01112696|12261340|FG000|STARTED|Overall Study||100
11078988|NCT01112696|12261340|FG000|COMPLETED|Overall Study||98
11078989|NCT01112696|12261340|FG000|NOT COMPLETED|Overall Study||2
11078990|NCT01112735|12261347|FG000|STARTED|Overall Study||20
11078991|NCT01112735|12261348|FG001|STARTED|Overall Study||20
11078992|NCT01112735|12261347|FG000|COMPLETED|Overall Study||20
11078993|NCT01112735|12261348|FG001|COMPLETED|Overall Study||20
11078994|NCT01112735|12261347|FG000|NOT COMPLETED|Overall Study||0
11078995|NCT01112735|12261348|FG001|NOT COMPLETED|Overall Study||0
11078996|NCT01112865|12261354|FG000|STARTED|First Intervention||59
11078997|NCT01112865|12261355|FG001|STARTED|First Intervention||61
11078998|NCT01112865|12261354|FG000|COMPLETED|First Intervention||59
11078999|NCT01112865|12261355|FG001|COMPLETED|First Intervention||61
11079000|NCT01112865|12261354|FG000|NOT COMPLETED|First Intervention||0
11079001|NCT01112865|12261355|FG001|NOT COMPLETED|First Intervention||0
11079002|NCT01112865|12261354|FG000|STARTED|Second Intervention||59
11079003|NCT01112865|12261355|FG001|STARTED|Second Intervention||61
11079004|NCT01112865|12261354|FG000|COMPLETED|Second Intervention||59
11079005|NCT01112865|12261355|FG001|COMPLETED|Second Intervention||61
11079006|NCT01112865|12261354|FG000|NOT COMPLETED|Second Intervention||0
11079007|NCT01112865|12261355|FG001|NOT COMPLETED|Second Intervention||0
11079008|NCT01112917|12261361|FG000|STARTED|Overall Study||96
11079009|NCT01112917|12261362|FG001|STARTED|Overall Study||53
11079010|NCT01112917|12261361|FG000|COMPLETED|Overall Study||89
11079011|NCT01112917|12261362|FG001|COMPLETED|Overall Study||38
11079012|NCT01112917|12261361|FG000|NOT COMPLETED|Overall Study||7
11079013|NCT01112917|12261362|FG001|NOT COMPLETED|Overall Study||15
11079014|NCT01112982|12261366|FG000|STARTED|Overall Study||74
11079015|NCT01112982|12261366|FG000|COMPLETED|Overall Study||72
11079016|NCT01112982|12261366|FG000|NOT COMPLETED|Overall Study||2
11079017|NCT01113008|12261375|FG000|STARTED|Overall Study||133
11079018|NCT01113008|12261376|FG001|STARTED|Overall Study||133
11079019|NCT01113008|12261375|FG000|COMPLETED|Overall Study||133
11079020|NCT01113008|12261376|FG001|COMPLETED|Overall Study||133
11079021|NCT01113008|12261375|FG000|NOT COMPLETED|Overall Study||0
11079022|NCT01113008|12261376|FG001|NOT COMPLETED|Overall Study||0
11079023|NCT01113385|12261382|FG000|STARTED|Overall Study||7
11079024|NCT01113385|12261382|FG000|COMPLETED|Overall Study||7
11079025|NCT01113385|12261382|FG000|NOT COMPLETED|Overall Study||0
11079026|NCT01113398|12261386|FG000|STARTED|Overall Study||36
11079027|NCT01113398|12261386|FG000|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
11079028|NCT01113398|12261386|FG000|NOT COMPLETED|Overall Study||0
11079029|NCT01113463|12261390|FG000|STARTED|Overall Study||17
11079030|NCT01113463|12261390|FG000|COMPLETED|Overall Study||12
11079031|NCT01113463|12261390|FG000|NOT COMPLETED|Overall Study||5
11079032|NCT01113502|12261399|FG000|STARTED|Overall Study||4
11079033|NCT01113502|12261400|FG001|STARTED|Overall Study||3
11079034|NCT01113502|12261401|FG002|STARTED|Overall Study||7
11079035|NCT01113502|12261402|FG003|STARTED|Overall Study||9
11079036|NCT01113502|12261403|FG004|STARTED|Overall Study||21
11079037|NCT01113502|12261399|FG000|COMPLETED|Overall Study||3
11079038|NCT01113502|12261400|FG001|COMPLETED|Overall Study||3
11079039|NCT01113502|12261401|FG002|COMPLETED|Overall Study||3
11079040|NCT01113502|12261402|FG003|COMPLETED|Overall Study||6
11079041|NCT01113502|12261403|FG004|COMPLETED|Overall Study||21
11079042|NCT01113502|12261399|FG000|NOT COMPLETED|Overall Study||1
11079043|NCT01113502|12261400|FG001|NOT COMPLETED|Overall Study||0
11079044|NCT01113502|12261401|FG002|NOT COMPLETED|Overall Study||4
11079045|NCT01113502|12261402|FG003|NOT COMPLETED|Overall Study||3
11079046|NCT01113502|12261403|FG004|NOT COMPLETED|Overall Study||0
11079047|NCT01113541|12261416|FG000|STARTED|Overall Study||13
11079048|NCT01113541|12261416|FG000|COMPLETED|Overall Study||0
11079049|NCT01113541|12261416|FG000|NOT COMPLETED|Overall Study||13
11079050|NCT01113580|12261422|FG000|STARTED|Overall Study||60
11079051|NCT01113580|12261423|FG001|STARTED|Overall Study||60
11079052|NCT01113580|12261422|FG000|COMPLETED|Overall Study||59
11079053|NCT01113580|12261423|FG001|COMPLETED|Overall Study||60
11079054|NCT01113580|12261422|FG000|NOT COMPLETED|Overall Study||1
11079055|NCT01113580|12261423|FG001|NOT COMPLETED|Overall Study||0
11079056|NCT01113632|12261431|FG000|STARTED|Overall Study||33
11079057|NCT01113632|12261432|FG001|STARTED|Overall Study||44
11079058|NCT01113632|12261431|FG000|COMPLETED|Overall Study||2
11079059|NCT01113632|12261432|FG001|COMPLETED|Overall Study||19
11079060|NCT01113632|12261431|FG000|NOT COMPLETED|Overall Study||31
11079061|NCT01113632|12261432|FG001|NOT COMPLETED|Overall Study||25
11079062|NCT01113710|12261438|FG000|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
11079063|NCT01113710|12261438|FG000|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
11079064|NCT01113710|12261438|FG000|NOT COMPLETED|Overall Study||269
11079065|NCT01113723|12261444|FG000|STARTED|Overall Study||70
11079066|NCT01113723|12261445|FG001|STARTED|Overall Study||70
11079067|NCT01113723|12261444|FG000|COMPLETED|Overall Study||70
11079068|NCT01113723|12261445|FG001|COMPLETED|Overall Study||70
11079069|NCT01113723|12261444|FG000|NOT COMPLETED|Overall Study||0
11079070|NCT01113723|12261445|FG001|NOT COMPLETED|Overall Study||0
11079071|NCT01113749|12261455|FG000|STARTED|Overall Study||127
11079072|NCT01113749|12261456|FG001|STARTED|Overall Study||129
11079073|NCT01113749|12261455|FG000|COMPLETED|Overall Study||126
11079074|NCT01113749|12261456|FG001|COMPLETED|Overall Study||127
11079075|NCT01113749|12261455|FG000|NOT COMPLETED|Overall Study||1
11079076|NCT01113749|12261456|FG001|NOT COMPLETED|Overall Study||2
11079077|NCT01113801|12261466|FG000|STARTED|Overall Study||103
11079078|NCT01113801|12261467|FG001|STARTED|Overall Study||105
11079079|NCT01113801|12261468|FG002|STARTED|Overall Study||103
11079080|NCT01113801|12261469|FG003|STARTED|Overall Study||106
11079081|NCT01113801|12261466|FG000|Received at Least One Dose of Drug|Overall Study||103
11079082|NCT01113801|12261467|FG001|Received at Least One Dose of Drug|Overall Study||105
11079083|NCT01113801|12261468|FG002|Received at Least One Dose of Drug|Overall Study||103
11079084|NCT01113801|12261469|FG003|Received at Least One Dose of Drug|Overall Study||105
11079085|NCT01113801|12261466|FG000|COMPLETED|Overall Study||62
11079086|NCT01113801|12261467|FG001|COMPLETED|Overall Study||65
11079087|NCT01113801|12261468|FG002|COMPLETED|Overall Study||66
11079088|NCT01113801|12261469|FG003|COMPLETED|Overall Study||65
11079089|NCT01113801|12261466|FG000|NOT COMPLETED|Overall Study||41
11079090|NCT01113801|12261467|FG001|NOT COMPLETED|Overall Study||40
11079091|NCT01113801|12261468|FG002|NOT COMPLETED|Overall Study||37
11079092|NCT01113801|12261469|FG003|NOT COMPLETED|Overall Study||41
11079093|NCT01113879|12261481|FG000|STARTED|Period 1: Block 1||7
11079094|NCT01113879|12261482|FG001|STARTED|Period 1: Block 1||2
11079095|NCT01113879|12261481|FG000|COMPLETED|Period 1: Block 1||5
11079096|NCT01113879|12261482|FG001|COMPLETED|Period 1: Block 1||2
11079097|NCT01113879|12261481|FG000|NOT COMPLETED|Period 1: Block 1||2
11079098|NCT01113879|12261482|FG001|NOT COMPLETED|Period 1: Block 1||0
11079099|NCT01113879|12261481|FG000|STARTED|Period 2: Block 2||5
11079100|NCT01113879|12261482|FG001|STARTED|Period 2: Block 2||2
11079101|NCT01113879|12261481|FG000|COMPLETED|Period 2: Block 2||5
11079102|NCT01113879|12261482|FG001|COMPLETED|Period 2: Block 2||2
11079103|NCT01113879|12261481|FG000|NOT COMPLETED|Period 2: Block 2||0
11079104|NCT01113879|12261482|FG001|NOT COMPLETED|Period 2: Block 2||0
11079105|NCT01113892|12261492|FG000|STARTED|Overall Study||101
11079106|NCT01113892|12261493|FG001|STARTED|Overall Study||106
11079107|NCT01113892|12261492|FG000|COMPLETED|Overall Study||87
11079108|NCT01113892|12261493|FG001|COMPLETED|Overall Study||90
11079109|NCT01113892|12261492|FG000|NOT COMPLETED|Overall Study||14
11079110|NCT01113892|12261493|FG001|NOT COMPLETED|Overall Study||16
11079111|NCT01113931|12261501|FG000|STARTED|Overall Study||247
11079112|NCT01113931|12261502|FG001|STARTED|Overall Study||248
11079113|NCT01113931|12261501|FG000|Safety Population|Overall Study|1 subject did not take any study medication|246
11079114|NCT01113931|12261502|FG001|Safety Population|Overall Study||248
11079115|NCT01113931|12261501|FG000|mITT Population|Overall Study||188
11079116|NCT01113931|12261502|FG001|mITT Population|Overall Study||190
11079117|NCT01113931|12261501|FG000|COMPLETED|Overall Study||228
11079118|NCT01113931|12261502|FG001|COMPLETED|Overall Study||231
11079119|NCT01113931|12261501|FG000|NOT COMPLETED|Overall Study||19
11079120|NCT01113931|12261502|FG001|NOT COMPLETED|Overall Study||17
11079121|NCT01113983|12261510|FG000|STARTED|Overall Study||37
11079122|NCT01113983|12261511|FG001|STARTED|Overall Study||27
11079123|NCT01113983|12261510|FG000|COMPLETED|Overall Study||12
11079124|NCT01113983|12261511|FG001|COMPLETED|Overall Study||10
11079125|NCT01113983|12261510|FG000|NOT COMPLETED|Overall Study||25
11079126|NCT01113983|12261511|FG001|NOT COMPLETED|Overall Study||17
11079127|NCT01114334|12261519|FG000|STARTED|Overall Study||88
11079128|NCT01114334|12261520|FG001|STARTED|Overall Study||80
11079129|NCT01114334|12261519|FG000|COMPLETED|Overall Study||67
11079130|NCT01114334|12261520|FG001|COMPLETED|Overall Study||58
11079131|NCT01114334|12261519|FG000|NOT COMPLETED|Overall Study||21
11079132|NCT01114334|12261520|FG001|NOT COMPLETED|Overall Study||22
11079133|NCT01114360|12261527|FG000|STARTED|Intervention 1 (4 Weeks)||18
11079134|NCT01114360|12261528|FG001|STARTED|Intervention 1 (4 Weeks)||19
11079135|NCT01114360|12261527|FG000|COMPLETED|Intervention 1 (4 Weeks)||18
11079136|NCT01114360|12261528|FG001|COMPLETED|Intervention 1 (4 Weeks)||18
11079137|NCT01114360|12261527|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||0
11079138|NCT01114360|12261528|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||1
11348834|NCT03007225|12545841|FG000|STARTED|Overall Study|Followed up for at least 6 months after DEB TACE|25
11079139|NCT01114360|12261527|FG000|STARTED|Intervention 2 (4 Weeks)||18
11079140|NCT01114360|12261528|FG001|STARTED|Intervention 2 (4 Weeks)||18
11348835|NCT03007225|12545842|FG001|STARTED|Overall Study|followed up for at least 6 months after TACE|25
11348836|NCT03007225|12545841|FG000|COMPLETED|Overall Study||25
11348837|NCT03007225|12545842|FG001|COMPLETED|Overall Study||25
11348838|NCT03007225|12545841|FG000|NOT COMPLETED|Overall Study||0
11348839|NCT03007225|12545842|FG001|NOT COMPLETED|Overall Study||0
11348840|NCT03007394|12545850|FG000|STARTED|Overall Study||118
11079141|NCT01114360|12261527|FG000|COMPLETED|Intervention 2 (4 Weeks)||18
11079142|NCT01114360|12261528|FG001|COMPLETED|Intervention 2 (4 Weeks)||18
11079143|NCT01114360|12261527|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0
11079144|NCT01114360|12261528|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||0
11079145|NCT01114373|12261548|FG000|STARTED|Intervention 1 (4 Weeks)||21
11079146|NCT01114373|12261549|FG001|STARTED|Intervention 1 (4 Weeks)||19
11079147|NCT01114373|12261548|FG000|COMPLETED|Intervention 1 (4 Weeks)||18
11079148|NCT01114373|12261549|FG001|COMPLETED|Intervention 1 (4 Weeks)||19
11079149|NCT01114373|12261548|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||3
11079150|NCT01114373|12261549|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||0
11079151|NCT01114373|12261548|FG000|STARTED|Intervention 2 (4 Weeks)||18
11079152|NCT01114373|12261549|FG001|STARTED|Intervention 2 (4 Weeks)||19
11079153|NCT01114373|12261548|FG000|COMPLETED|Intervention 2 (4 Weeks)||18
11079154|NCT01114373|12261549|FG001|COMPLETED|Intervention 2 (4 Weeks)||18
11079155|NCT01114373|12261548|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0
11079156|NCT01114373|12261549|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||1
11079157|NCT01114438|12261559|FG000|STARTED|Overall Study||45
11079158|NCT01114438|12261559|FG000|COMPLETED|Overall Study||31
11079159|NCT01114438|12261559|FG000|NOT COMPLETED|Overall Study||14
11079160|NCT01114503|12261568|FG000|STARTED|Overall Study||2
11079161|NCT01114503|12261568|FG000|COMPLETED|Overall Study||2
11079162|NCT01114503|12261568|FG000|NOT COMPLETED|Overall Study||0
11079163|NCT01114516|12261574|FG000|STARTED|Overall Study||26
11079164|NCT01114516|12261575|FG001|STARTED|Overall Study||27
11079165|NCT01114516|12261574|FG000|COMPLETED|Overall Study||24
11079166|NCT01114516|12261575|FG001|COMPLETED|Overall Study||26
11079167|NCT01114516|12261574|FG000|NOT COMPLETED|Overall Study||2
11079168|NCT01114516|12261575|FG001|NOT COMPLETED|Overall Study||1
11079169|NCT01114529|12261584|FG000|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
11079170|NCT01114529|12261585|FG001|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
11079171|NCT01114529|12261586|FG002|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
11348841|NCT03007394|12545851|FG001|STARTED|Overall Study||154
11348842|NCT03007394|12545850|FG000|COMPLETED|Overall Study||91
11348843|NCT03007394|12545851|FG001|COMPLETED|Overall Study||91
11348844|NCT03007394|12545850|FG000|NOT COMPLETED|Overall Study||27
11348845|NCT03007394|12545851|FG001|NOT COMPLETED|Overall Study||63
11348846|NCT03007472|12545857|FG000|STARTED|Overall Study||96
11348847|NCT03007472|12545857|FG000|COMPLETED|Overall Study||91
11348848|NCT03007472|12545857|FG000|NOT COMPLETED|Overall Study||5
11348849|NCT03007953|12545863|FG000|STARTED|Overall Study||73
11348850|NCT03007953|12545864|FG001|STARTED|Overall Study||78
11348851|NCT03007953|12545863|FG000|COMPLETED|Overall Study||57
11348852|NCT03007953|12545864|FG001|COMPLETED|Overall Study||65
11348853|NCT03007953|12545863|FG000|NOT COMPLETED|Overall Study||16
11348854|NCT03007953|12545864|FG001|NOT COMPLETED|Overall Study||13
11348855|NCT03007966|12545872|FG000|STARTED|Overall Study||30
11348856|NCT03007966|12545873|FG001|STARTED|Overall Study||30
11348857|NCT03007966|12545872|FG000|COMPLETED|Overall Study||29
11348858|NCT03007966|12545873|FG001|COMPLETED|Overall Study||30
11348859|NCT03007966|12545872|FG000|NOT COMPLETED|Overall Study||1
11348860|NCT03007966|12545873|FG001|NOT COMPLETED|Overall Study||0
11348861|NCT03008070|12545883|FG000|STARTED|Overall Study||83
11348862|NCT03008070|12545884|FG001|STARTED|Overall Study||83
11348863|NCT03008070|12545885|FG002|STARTED|Overall Study||81
11348864|NCT03008070|12545883|FG000|COMPLETED|Overall Study||77
11348865|NCT03008070|12545884|FG001|COMPLETED|Overall Study||77
11348866|NCT03008070|12545885|FG002|COMPLETED|Overall Study||74
11348867|NCT03008070|12545883|FG000|NOT COMPLETED|Overall Study||6
11348868|NCT03008070|12545884|FG001|NOT COMPLETED|Overall Study||6
11348869|NCT03008070|12545885|FG002|NOT COMPLETED|Overall Study||7
11348870|NCT03008174|12545897|FG000|STARTED|Overall Study||10
11348871|NCT03008174|12545898|FG001|STARTED|Overall Study||10
11348872|NCT03008174|12545897|FG000|COMPLETED|Overall Study||7
11348873|NCT03008174|12545898|FG001|COMPLETED|Overall Study||6
11348874|NCT03008174|12545897|FG000|NOT COMPLETED|Overall Study||3
11348875|NCT03008174|12545898|FG001|NOT COMPLETED|Overall Study||4
11348876|NCT03008213|12545904|FG000|STARTED|Overall Study||1
11348877|NCT03008213|12545904|FG000|COMPLETED|Overall Study||1
11348878|NCT03008213|12545904|FG000|NOT COMPLETED|Overall Study||0
11348879|NCT03008460|12545910|FG000|STARTED|Overall Study||126
11348880|NCT03008460|12545911|FG001|STARTED|Overall Study||124
11348881|NCT03008460|12545910|FG000|COMPLETED|Overall Study||119
11348882|NCT03008460|12545911|FG001|COMPLETED|Overall Study||110
11348883|NCT03008460|12545910|FG000|NOT COMPLETED|Overall Study||7
11348884|NCT03008460|12545911|FG001|NOT COMPLETED|Overall Study||14
11348885|NCT03008590|12545919|FG000|STARTED|Overall Study||14
11348886|NCT03008590|12545920|FG001|STARTED|Overall Study||15
11348887|NCT03008590|12545919|FG000|COMPLETED|Overall Study||11
11348888|NCT03008590|12545920|FG001|COMPLETED|Overall Study||12
11348889|NCT03008590|12545919|FG000|NOT COMPLETED|Overall Study||3
11348890|NCT03008590|12545920|FG001|NOT COMPLETED|Overall Study||3
11348891|NCT03008707|12545928|FG000|STARTED|Overall Study||28
11348892|NCT03008707|12545929|FG001|STARTED|Overall Study||38
11348893|NCT03008707|12545928|FG000|COMPLETED|Overall Study||28
11348894|NCT03008707|12545929|FG001|COMPLETED|Overall Study||38
11348895|NCT03008707|12545928|FG000|NOT COMPLETED|Overall Study||0
11348896|NCT03008707|12545929|FG001|NOT COMPLETED|Overall Study||0
11348897|NCT03008837|12545937|FG000|STARTED|Overall Study||12
11348898|NCT03008837|12545938|FG001|STARTED|Overall Study||9
11348899|NCT03008837|12545937|FG000|COMPLETED|Overall Study||9
11348900|NCT03008837|12545938|FG001|COMPLETED|Overall Study||5
11348901|NCT03008837|12545937|FG000|NOT COMPLETED|Overall Study||3
11348902|NCT03008837|12545938|FG001|NOT COMPLETED|Overall Study||4
11348903|NCT03008889|12545949|FG000|STARTED|Overall Study||1
11348904|NCT03008889|12545950|FG001|STARTED|Overall Study||1
11348905|NCT03008889|12545949|FG000|COMPLETED|Overall Study||1
11348906|NCT03008889|12545950|FG001|COMPLETED|Overall Study||1
11079172|NCT01114529|12261584|FG000|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
11079173|NCT01114529|12261585|FG001|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
11348907|NCT03008889|12545949|FG000|NOT COMPLETED|Overall Study||0
11348908|NCT03008889|12545950|FG001|NOT COMPLETED|Overall Study||0
11079174|NCT01114529|12261586|FG002|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
11079175|NCT01114529|12261584|FG000|NOT COMPLETED|Completed Study Medication at Month 24||124
11079176|NCT01114529|12261585|FG001|NOT COMPLETED|Completed Study Medication at Month 24||41
11079177|NCT01114529|12261586|FG002|NOT COMPLETED|Completed Study Medication at Month 24||32
11079178|NCT01114529|12261584|FG000|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
11079179|NCT01114529|12261585|FG001|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
11079180|NCT01114529|12261586|FG002|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
11079181|NCT01114529|12261584|FG000|COMPLETED|Completed Study Phase at Month 24|at month 24|313
11079182|NCT01114529|12261585|FG001|COMPLETED|Completed Study Phase at Month 24|at month 24|215
11079183|NCT01114529|12261586|FG002|COMPLETED|Completed Study Phase at Month 24|at month 24|111
11079184|NCT01114529|12261584|FG000|NOT COMPLETED|Completed Study Phase at Month 24||40
11079185|NCT01114529|12261585|FG001|NOT COMPLETED|Completed Study Phase at Month 24||16
11079186|NCT01114529|12261586|FG002|NOT COMPLETED|Completed Study Phase at Month 24||14
11079187|NCT01114555|12261596|FG000|STARTED|Overall Study||34
11079188|NCT01114555|12261596|FG000|COMPLETED|Overall Study||34
11079189|NCT01114555|12261596|FG000|NOT COMPLETED|Overall Study||0
11079190|NCT01114581|12261602|FG000|STARTED|Overall Study||19
11079191|NCT01114581|12261603|FG001|STARTED|Overall Study||19
11079192|NCT01114581|12261602|FG000|COMPLETED|Overall Study||19
11079193|NCT01114581|12261603|FG001|COMPLETED|Overall Study||19
11079194|NCT01114581|12261602|FG000|NOT COMPLETED|Overall Study||0
11079195|NCT01114581|12261603|FG001|NOT COMPLETED|Overall Study||0
11079196|NCT01114620|12261609|FG000|STARTED|Overall Study||50
11079197|NCT01114620|12261609|FG000|COMPLETED|Overall Study||50
11079198|NCT01114620|12261609|FG000|NOT COMPLETED|Overall Study||0
11079199|NCT01114646|12261615|FG000|STARTED|Overall Study||66
11079200|NCT01114646|12261616|FG001|STARTED|Overall Study||64
11079201|NCT01114646|12261615|FG000|COMPLETED|Overall Study||63
11079202|NCT01114646|12261616|FG001|COMPLETED|Overall Study||62
11079203|NCT01114646|12261615|FG000|NOT COMPLETED|Overall Study||3
11079204|NCT01114646|12261616|FG001|NOT COMPLETED|Overall Study||2
11079205|NCT01114672|12261624|FG000|STARTED|Overall Study||25
11079206|NCT01114672|12261625|FG001|STARTED|Overall Study||25
11079207|NCT01114672|12261624|FG000|COMPLETED|Overall Study||21
11079208|NCT01114672|12261625|FG001|COMPLETED|Overall Study||23
11079209|NCT01114672|12261624|FG000|NOT COMPLETED|Overall Study||4
11079210|NCT01114672|12261625|FG001|NOT COMPLETED|Overall Study||2
11079211|NCT01114724|12261631|FG000|STARTED|Overall Study||50
11079212|NCT01114724|12261631|FG000|COMPLETED|Overall Study||40
11079213|NCT01114724|12261631|FG000|NOT COMPLETED|Overall Study||10
11079214|NCT01114737|12261638|FG000|STARTED|Randomized Treatment Period||108
11079215|NCT01114737|12261639|FG001|STARTED|Randomized Treatment Period||98
11079216|NCT01114737|12261638|FG000|COMPLETED|Randomized Treatment Period||105
11079217|NCT01114737|12261639|FG001|COMPLETED|Randomized Treatment Period||97
11079218|NCT01114737|12261638|FG000|NOT COMPLETED|Randomized Treatment Period||3
11079219|NCT01114737|12261639|FG001|NOT COMPLETED|Randomized Treatment Period||1
11079220|NCT01114737|12261638|FG000|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
11079221|NCT01114737|12261639|FG001|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
11079222|NCT01114737|12261638|FG000|COMPLETED|Open-Label Treatment Period||100
11079223|NCT01114737|12261639|FG001|COMPLETED|Open-Label Treatment Period||95
11079224|NCT01114737|12261638|FG000|NOT COMPLETED|Open-Label Treatment Period||5
11079225|NCT01114737|12261639|FG001|NOT COMPLETED|Open-Label Treatment Period||2
11079226|NCT01114828|12261658|FG000|STARTED|Overall Study||19
11079227|NCT01114828|12261659|FG001|STARTED|Overall Study||21
11079228|NCT01114828|12261658|FG000|COMPLETED|Overall Study||16
11079229|NCT01114828|12261659|FG001|COMPLETED|Overall Study||17
11079230|NCT01114828|12261658|FG000|NOT COMPLETED|Overall Study||3
11079231|NCT01114828|12261659|FG001|NOT COMPLETED|Overall Study||4
11079232|NCT01114880|12261667|FG000|STARTED|Period 1 (Week 0 to Week 12)||229
11079233|NCT01114880|12261668|FG001|STARTED|Period 1 (Week 0 to Week 12)||115
11079234|NCT01114880|12261667|FG000|COMPLETED|Period 1 (Week 0 to Week 12)||224
11079235|NCT01114880|12261668|FG001|COMPLETED|Period 1 (Week 0 to Week 12)||113
11079236|NCT01114880|12261667|FG000|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
11079237|NCT01114880|12261668|FG001|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
11079238|NCT01114880|12261667|FG000|STARTED|Period 2 (Week 12 to Week 24)||224
11079239|NCT01114880|12261668|FG001|STARTED|Period 2 (Week 12 to Week 24)||113
11079240|NCT01114880|12261667|FG000|COMPLETED|Period 2 (Week 12 to Week 24)||221
11079241|NCT01114880|12261668|FG001|COMPLETED|Period 2 (Week 12 to Week 24)||111
11079242|NCT01114880|12261667|FG000|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
11079243|NCT01114880|12261668|FG001|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
11079244|NCT01114893|12261681|FG000|STARTED|Overall Study||14
11079245|NCT01114893|12261682|FG001|STARTED|Overall Study||14
11079246|NCT01114893|12261683|FG002|STARTED|Overall Study||14
11079247|NCT01114893|12261684|FG003|STARTED|Overall Study||13
11079248|NCT01114893|12261685|FG004|STARTED|Overall Study||12
11079249|NCT01114893|12261681|FG000|COMPLETED|Overall Study||14
11079250|NCT01114893|12261682|FG001|COMPLETED|Overall Study||14
11079251|NCT01114893|12261683|FG002|COMPLETED|Overall Study||14
11079252|NCT01114893|12261684|FG003|COMPLETED|Overall Study||13
11079253|NCT01114893|12261685|FG004|COMPLETED|Overall Study||12
11079254|NCT01114893|12261681|FG000|NOT COMPLETED|Overall Study||0
11079255|NCT01114893|12261682|FG001|NOT COMPLETED|Overall Study||0
11079256|NCT01114893|12261683|FG002|NOT COMPLETED|Overall Study||0
11079257|NCT01114893|12261684|FG003|NOT COMPLETED|Overall Study||0
11079258|NCT01114893|12261685|FG004|NOT COMPLETED|Overall Study||0
11079259|NCT01114945|12261701|FG000|STARTED|Overall Study||30
11079260|NCT01114945|12261702|FG001|STARTED|Overall Study||30
11079261|NCT01114945|12261703|FG002|STARTED|Overall Study||30
11079262|NCT01114945|12261704|FG003|STARTED|Overall Study||31
11079263|NCT01114945|12261701|FG000|COMPLETED|Overall Study||30
11079264|NCT01114945|12261702|FG001|COMPLETED|Overall Study||30
11079265|NCT01114945|12261703|FG002|COMPLETED|Overall Study||30
11079266|NCT01114945|12261704|FG003|COMPLETED|Overall Study||31
11079267|NCT01114945|12261701|FG000|NOT COMPLETED|Overall Study||0
11079268|NCT01114945|12261702|FG001|NOT COMPLETED|Overall Study||0
11079269|NCT01114945|12261703|FG002|NOT COMPLETED|Overall Study||0
11079270|NCT01114945|12261704|FG003|NOT COMPLETED|Overall Study||0
11079271|NCT01114971|12261718|FG000|STARTED|Overall Study||25
11079272|NCT01114971|12261719|FG001|STARTED|Overall Study||25
11079273|NCT01114971|12261720|FG002|STARTED|Overall Study||25
11079274|NCT01114971|12261718|FG000|COMPLETED|Overall Study||25
11079275|NCT01114971|12261719|FG001|COMPLETED|Overall Study||25
11079276|NCT01114971|12261720|FG002|COMPLETED|Overall Study||25
11079277|NCT01114971|12261718|FG000|NOT COMPLETED|Overall Study||0
11079278|NCT01114971|12261719|FG001|NOT COMPLETED|Overall Study||0
11079279|NCT01114971|12261720|FG002|NOT COMPLETED|Overall Study||0
11079280|NCT01114997|12261731|FG000|STARTED|Overall Study||11
11079281|NCT01114997|12261732|FG001|STARTED|Overall Study||10
11079282|NCT01114997|12261733|FG002|STARTED|Overall Study||11
11079283|NCT01114997|12261731|FG000|COMPLETED|Overall Study||11
11079284|NCT01114997|12261732|FG001|COMPLETED|Overall Study||10
11079285|NCT01114997|12261733|FG002|COMPLETED|Overall Study||11
11079286|NCT01114997|12261731|FG000|NOT COMPLETED|Overall Study||0
11079287|NCT01114997|12261732|FG001|NOT COMPLETED|Overall Study||0
11079288|NCT01114997|12261733|FG002|NOT COMPLETED|Overall Study||0
11079289|NCT01115101|12261744|FG000|STARTED|Overall Study||113
11079290|NCT01115101|12261745|FG001|STARTED|Overall Study||126
11079291|NCT01115101|12261744|FG000|COMPLETED|Overall Study||113
11079292|NCT01115101|12261745|FG001|COMPLETED|Overall Study||126
11079293|NCT01115101|12261744|FG000|NOT COMPLETED|Overall Study||0
11079294|NCT01115101|12261745|FG001|NOT COMPLETED|Overall Study||0
11079295|NCT01115166|12261751|FG000|STARTED|Overall Study||10
11079296|NCT01115166|12261751|FG000|COMPLETED|Overall Study||10
11079297|NCT01115166|12261751|FG000|NOT COMPLETED|Overall Study||0
11079298|NCT01115231|12261757|FG000|STARTED|Overall Study||133
11079299|NCT01115231|12261758|FG001|STARTED|Overall Study||90
11079300|NCT01115231|12261757|FG000|COMPLETED|Overall Study||133
11079301|NCT01115231|12261758|FG001|COMPLETED|Overall Study||90
11079302|NCT01115231|12261757|FG000|NOT COMPLETED|Overall Study||0
11079303|NCT01115231|12261758|FG001|NOT COMPLETED|Overall Study||0
11079304|NCT01115309|12261765|FG000|STARTED|Procedure Safety (1-Month)||175
11079305|NCT01115309|12261765|FG000|COMPLETED|Procedure Safety (1-Month)||172
11079306|NCT01115309|12261765|FG000|NOT COMPLETED|Procedure Safety (1-Month)||3
11079307|NCT01115309|12261765|FG000|STARTED|Long-term Follow-up||50
11079308|NCT01115309|12261765|FG000|6-Month Follow-up|Long-term Follow-up||46
11079309|NCT01115309|12261765|FG000|12-Month Follow-up|Long-term Follow-up||44
11079310|NCT01115309|12261765|FG000|COMPLETED|Long-term Follow-up||44
11079311|NCT01115309|12261765|FG000|NOT COMPLETED|Long-term Follow-up||6
11079312|NCT01115452|12261770|FG000|STARTED|Overall Study||32
11079313|NCT01115452|12261770|FG000|COMPLETED|Overall Study||32
11079314|NCT01115452|12261770|FG000|NOT COMPLETED|Overall Study||0
11079315|NCT01115491|12261778|FG000|STARTED|Overall Study||32
11079316|NCT01115491|12261778|FG000|COMPLETED|Overall Study||2
11079317|NCT01115491|12261778|FG000|NOT COMPLETED|Overall Study||30
11079318|NCT01115517|12261784|FG000|STARTED|Overall Study||18
11079319|NCT01115517|12261785|FG001|STARTED|Overall Study||21
11079320|NCT01115517|12261784|FG000|COMPLETED|Overall Study||14
11079321|NCT01115517|12261785|FG001|COMPLETED|Overall Study||16
11079322|NCT01115517|12261784|FG000|NOT COMPLETED|Overall Study||4
11079323|NCT01115517|12261785|FG001|NOT COMPLETED|Overall Study||5
11079324|NCT01115556|12261793|FG000|STARTED|Overall Study||7
11079325|NCT01115556|12261794|FG001|STARTED|Overall Study||2
11079326|NCT01115556|12261793|FG000|COMPLETED|Overall Study||7
11079327|NCT01115556|12261794|FG001|COMPLETED|Overall Study||2
11079328|NCT01115556|12261793|FG000|NOT COMPLETED|Overall Study||0
11079329|NCT01115556|12261794|FG001|NOT COMPLETED|Overall Study||0
11079330|NCT01115569|12261802|FG000|STARTED|Conversion/Titration Phase||638
11079331|NCT01115569|12261803|FG001|STARTED|Conversion/Titration Phase||0
11079332|NCT01115569|12261802|FG000|COMPLETED|Conversion/Titration Phase||424
11079333|NCT01115569|12261803|FG001|COMPLETED|Conversion/Titration Phase||0
11079334|NCT01115569|12261802|FG000|NOT COMPLETED|Conversion/Titration Phase||214
11079335|NCT01115569|12261803|FG001|NOT COMPLETED|Conversion/Titration Phase||0
11079336|NCT01115569|12261802|FG000|STARTED|Maintenance Phase||0
11079337|NCT01115569|12261803|FG001|STARTED|Maintenance Phase||424
11079338|NCT01115569|12261802|FG000|COMPLETED|Maintenance Phase||0
11079339|NCT01115569|12261803|FG001|COMPLETED|Maintenance Phase||285
11079340|NCT01115569|12261802|FG000|NOT COMPLETED|Maintenance Phase||0
11079341|NCT01115569|12261803|FG001|NOT COMPLETED|Maintenance Phase||139
11079342|NCT01115582|12261808|FG000|STARTED|Overall Study||16
11079343|NCT01115582|12261808|FG000|COMPLETED|Overall Study||16
11079344|NCT01115582|12261808|FG000|NOT COMPLETED|Overall Study||0
11079345|NCT01115660|12261814|FG000|STARTED|Overall Study||20
11079346|NCT01115660|12261815|FG001|STARTED|Overall Study||10
11079347|NCT01115660|12261814|FG000|COMPLETED|Overall Study||19
11079348|NCT01115660|12261815|FG001|COMPLETED|Overall Study||10
11079349|NCT01115660|12261814|FG000|NOT COMPLETED|Overall Study||1
11079350|NCT01115660|12261815|FG001|NOT COMPLETED|Overall Study||0
11079351|NCT01115673|12261824|FG000|STARTED|Overall Study||239
11079352|NCT01115673|12261825|FG001|STARTED|Overall Study||241
11079353|NCT01115673|12261826|FG002|STARTED|Overall Study||60
11079354|NCT01115673|12261824|FG000|COMPLETED|Overall Study||239
11079355|NCT01115673|12261825|FG001|COMPLETED|Overall Study||241
11079356|NCT01115673|12261826|FG002|COMPLETED|Overall Study||60
11079357|NCT01115673|12261824|FG000|NOT COMPLETED|Overall Study||0
11079358|NCT01115673|12261825|FG001|NOT COMPLETED|Overall Study||0
11079359|NCT01115673|12261826|FG002|NOT COMPLETED|Overall Study||0
11079360|NCT01115738|12261837|FG000|STARTED|Overall Study||110
11079361|NCT01115738|12261838|FG001|STARTED|Overall Study||83
11079362|NCT01115738|12261839|FG002|STARTED|Overall Study||89
11079363|NCT01115738|12261837|FG000|Received Any Treatment|Overall Study||109
11079364|NCT01115738|12261838|FG001|Received Any Treatment|Overall Study||79
11079365|NCT01115738|12261839|FG002|Received Any Treatment|Overall Study||88
11079366|NCT01115738|12261837|FG000|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
11079367|NCT01115738|12261838|FG001|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
11079368|NCT01115738|12261839|FG002|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
11079369|NCT01115738|12261837|FG000|COMPLETED|Overall Study||85
11079370|NCT01115738|12261838|FG001|COMPLETED|Overall Study||62
11079371|NCT01115738|12261839|FG002|COMPLETED|Overall Study||62
11079372|NCT01115738|12261837|FG000|NOT COMPLETED|Overall Study||25
11079373|NCT01115738|12261838|FG001|NOT COMPLETED|Overall Study||21
11079374|NCT01115738|12261839|FG002|NOT COMPLETED|Overall Study||27
11079375|NCT01115803|12261862|FG000|STARTED|Overall Study||4
11079376|NCT01115803|12261863|FG001|STARTED|Overall Study||5
11079377|NCT01115803|12261864|FG002|STARTED|Overall Study||3
11079378|NCT01115803|12261865|FG003|STARTED|Overall Study||5
11079379|NCT01115803|12261866|FG004|STARTED|Overall Study||3
11348909|NCT03008915|12545957|FG000|STARTED|Treatment 1||8
11348910|NCT03008915|12545958|FG001|STARTED|Treatment 1||7
11348911|NCT03008915|12545957|FG000|COMPLETED|Treatment 1||8
11348912|NCT03008915|12545958|FG001|COMPLETED|Treatment 1||6
11348913|NCT03008915|12545957|FG000|NOT COMPLETED|Treatment 1||0
11348914|NCT03008915|12545958|FG001|NOT COMPLETED|Treatment 1||1
11348915|NCT03008915|12545957|FG000|STARTED|Treatment 2||8
11348916|NCT03008915|12545958|FG001|STARTED|Treatment 2||6
11348917|NCT03008915|12545957|FG000|COMPLETED|Treatment 2||8
11348918|NCT03008915|12545958|FG001|COMPLETED|Treatment 2||6
11348919|NCT03008915|12545957|FG000|NOT COMPLETED|Treatment 2||0
11348920|NCT03008915|12545958|FG001|NOT COMPLETED|Treatment 2||0
11348921|NCT03009162|12545967|FG000|STARTED|Overall Study||8
11348922|NCT03009162|12545968|FG001|STARTED|Overall Study||8
11348923|NCT03009162|12545967|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
11079380|NCT01115803|12261867|FG005|STARTED|Overall Study||3
11079381|NCT01115803|12261868|FG006|STARTED|Overall Study||6
11079382|NCT01115803|12261862|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
11348924|NCT03009162|12545968|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
11348925|NCT03009162|12545967|FG000|COMPLETED|Overall Study||8
11348926|NCT03009162|12545968|FG001|COMPLETED|Overall Study||8
11079383|NCT01115803|12261863|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
11079384|NCT01115803|12261864|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
11079385|NCT01115803|12261865|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
11079386|NCT01115803|12261866|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
11079387|NCT01115803|12261867|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
11079388|NCT01115803|12261868|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
11079389|NCT01115803|12261862|FG000|COMPLETED|Overall Study||4
11079390|NCT01115803|12261863|FG001|COMPLETED|Overall Study||5
11079391|NCT01115803|12261864|FG002|COMPLETED|Overall Study||2
11079392|NCT01115803|12261865|FG003|COMPLETED|Overall Study||5
11079393|NCT01115803|12261866|FG004|COMPLETED|Overall Study||3
11079394|NCT01115803|12261867|FG005|COMPLETED|Overall Study||3
11079395|NCT01115803|12261868|FG006|COMPLETED|Overall Study||4
11079396|NCT01115803|12261862|FG000|NOT COMPLETED|Overall Study||0
11079397|NCT01115803|12261863|FG001|NOT COMPLETED|Overall Study||0
11079398|NCT01115803|12261864|FG002|NOT COMPLETED|Overall Study||1
11079399|NCT01115803|12261865|FG003|NOT COMPLETED|Overall Study||0
11079400|NCT01115803|12261866|FG004|NOT COMPLETED|Overall Study||0
11079401|NCT01115803|12261867|FG005|NOT COMPLETED|Overall Study||0
11079402|NCT01115803|12261868|FG006|NOT COMPLETED|Overall Study||2
11079403|NCT01115855|12261891|FG000|STARTED|Overall Study||111
11079404|NCT01115855|12261892|FG001|STARTED|Overall Study||110
11079405|NCT01115855|12261891|FG000|COMPLETED|Overall Study||75
11079406|NCT01115855|12261892|FG001|COMPLETED|Overall Study||74
11079407|NCT01115855|12261891|FG000|NOT COMPLETED|Overall Study||36
11079408|NCT01115855|12261892|FG001|NOT COMPLETED|Overall Study||36
11079409|NCT01115933|12261898|FG000|STARTED|Overall Study||65
11079410|NCT01115933|12261898|FG000|COMPLETED|Overall Study||64
11079411|NCT01115933|12261898|FG000|NOT COMPLETED|Overall Study||1
11079412|NCT01115998|12261957|FG000|STARTED|Overall Study||17
11079413|NCT01115998|12261958|FG001|STARTED|Overall Study||17
11079414|NCT01115998|12261957|FG000|COMPLETED|Overall Study||11
11079415|NCT01115998|12261958|FG001|COMPLETED|Overall Study||11
11079416|NCT01115998|12261957|FG000|NOT COMPLETED|Overall Study||6
11079417|NCT01115998|12261958|FG001|NOT COMPLETED|Overall Study||6
11079418|NCT01116024|12261964|FG000|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
11079419|NCT01116024|12261964|FG000|COMPLETED|Overall Study|Patient Enrollment stop date|96
11079420|NCT01116024|12261964|FG000|NOT COMPLETED|Overall Study||52
11348927|NCT03009162|12545967|FG000|NOT COMPLETED|Overall Study||0
11348928|NCT03009162|12545968|FG001|NOT COMPLETED|Overall Study||0
11348929|NCT03009396|12545974|FG000|STARTED|Overall Study||16
11348930|NCT03009396|12545975|FG001|STARTED|Overall Study||38
11348931|NCT03009396|12545974|FG000|COMPLETED|Overall Study||9
11348932|NCT03009396|12545975|FG001|COMPLETED|Overall Study||21
11348933|NCT03009396|12545974|FG000|NOT COMPLETED|Overall Study||7
11348934|NCT03009396|12545975|FG001|NOT COMPLETED|Overall Study||17
11348935|NCT03010137|12545984|FG000|STARTED|Overall Study||15
11348936|NCT03010137|12545985|FG001|STARTED|Overall Study||15
11348937|NCT03010137|12545984|FG000|COMPLETED|Overall Study||15
11348938|NCT03010137|12545985|FG001|COMPLETED|Overall Study||15
11348939|NCT03010137|12545984|FG000|NOT COMPLETED|Overall Study||0
11348940|NCT03010137|12545985|FG001|NOT COMPLETED|Overall Study||0
11348941|NCT03010254|12545993|FG000|STARTED|Overall Study||159
11348942|NCT03010254|12545994|FG001|STARTED|Overall Study||123
11348943|NCT03010254|12545993|FG000|Attempted Implantation|Overall Study||156
11348944|NCT03010254|12545994|FG001|Attempted Implantation|Overall Study||120
11348945|NCT03010254|12545993|FG000|Successful Implantation|Overall Study||156
11348946|NCT03010254|12545994|FG001|Successful Implantation|Overall Study||120
11348947|NCT03010254|12545993|FG000|COMPLETED|Overall Study||152
11348948|NCT03010254|12545994|FG001|COMPLETED|Overall Study||118
11348949|NCT03010254|12545993|FG000|NOT COMPLETED|Overall Study||7
11348950|NCT03010254|12545994|FG001|NOT COMPLETED|Overall Study||5
11348951|NCT03010462|12546009|FG000|STARTED|Overall Study||31
11348952|NCT03010462|12546010|FG001|STARTED|Overall Study||29
11348953|NCT03010462|12546009|FG000|COMPLETED|Overall Study|1 subject withdrew consent before baseline visit. 2 subjects completed treatment but were lost during follow-up|28
11348954|NCT03010462|12546010|FG001|COMPLETED|Overall Study|1 subject withdrew consent prior to baseline visit|28
11348955|NCT03010462|12546009|FG000|NOT COMPLETED|Overall Study||3
11348956|NCT03010462|12546010|FG001|NOT COMPLETED|Overall Study||1
11348957|NCT03010488|12546018|FG000|STARTED|Overall Study||22
11348958|NCT03010488|12546019|FG001|STARTED|Overall Study||22
11348959|NCT03010488|12546018|FG000|COMPLETED|Overall Study||17
11079421|NCT01116037|12261990|FG000|STARTED|Overall Study||26
11348960|NCT03010488|12546019|FG001|COMPLETED|Overall Study||15
11079422|NCT01116037|12261990|FG000|COMPLETED|Overall Study||1
11079423|NCT01116037|12261990|FG000|NOT COMPLETED|Overall Study||25
11079424|NCT01116102|12262002|FG000|STARTED|Overall Study||2
11079425|NCT01116102|12262003|FG001|STARTED|Overall Study||3
11079426|NCT01116102|12262004|FG002|STARTED|Overall Study||3
11348961|NCT03010488|12546018|FG000|NOT COMPLETED|Overall Study||5
11079427|NCT01116102|12262005|FG003|STARTED|Overall Study||3
11079428|NCT01116102|12262006|FG004|STARTED|Overall Study||2
11079429|NCT01116102|12262007|FG005|STARTED|Overall Study||2
11079430|NCT01116102|12262008|FG006|STARTED|Overall Study||2
11079431|NCT01116102|12262009|FG007|STARTED|Overall Study||3
11079432|NCT01116102|12262002|FG000|COMPLETED|Overall Study||2
11079433|NCT01116102|12262003|FG001|COMPLETED|Overall Study||3
11079434|NCT01116102|12262004|FG002|COMPLETED|Overall Study||3
11079435|NCT01116102|12262005|FG003|COMPLETED|Overall Study||3
11079436|NCT01116102|12262006|FG004|COMPLETED|Overall Study||2
11079437|NCT01116102|12262007|FG005|COMPLETED|Overall Study||2
11079438|NCT01116102|12262008|FG006|COMPLETED|Overall Study||2
11079439|NCT01116102|12262009|FG007|COMPLETED|Overall Study||3
11079440|NCT01116102|12262002|FG000|NOT COMPLETED|Overall Study||0
11079441|NCT01116102|12262003|FG001|NOT COMPLETED|Overall Study||0
11079442|NCT01116102|12262004|FG002|NOT COMPLETED|Overall Study||0
11079443|NCT01116102|12262005|FG003|NOT COMPLETED|Overall Study||0
11079444|NCT01116102|12262006|FG004|NOT COMPLETED|Overall Study||0
11079445|NCT01116102|12262007|FG005|NOT COMPLETED|Overall Study||0
11079446|NCT01116102|12262008|FG006|NOT COMPLETED|Overall Study||0
11079447|NCT01116102|12262009|FG007|NOT COMPLETED|Overall Study||0
11079448|NCT01116401|12262027|FG000|STARTED|Overall Study||29
11079449|NCT01116401|12262027|FG000|COMPLETED|Overall Study||29
11079450|NCT01116401|12262027|FG000|NOT COMPLETED|Overall Study||0
11079451|NCT01116427|12262033|FG000|STARTED|Core Phase||44
11079452|NCT01116427|12262034|FG001|STARTED|Core Phase||21
11079453|NCT01116427|12262033|FG000|COMPLETED|Core Phase||39
11079454|NCT01116427|12262034|FG001|COMPLETED|Core Phase||20
11079455|NCT01116427|12262033|FG000|NOT COMPLETED|Core Phase||5
11079456|NCT01116427|12262034|FG001|NOT COMPLETED|Core Phase||1
11079457|NCT01116427|12262033|FG000|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
11079458|NCT01116427|12262034|FG001|STARTED|Extension Phase||20
11079459|NCT01116427|12262033|FG000|COMPLETED|Extension Phase||29
11079460|NCT01116427|12262034|FG001|COMPLETED|Extension Phase||18
11079461|NCT01116427|12262033|FG000|NOT COMPLETED|Extension Phase||9
11079462|NCT01116427|12262034|FG001|NOT COMPLETED|Extension Phase||2
11079463|NCT01116440|12262046|FG000|STARTED|Treatment||11
11079464|NCT01116440|12262047|FG001|STARTED|Treatment||16
11079465|NCT01116440|12262046|FG000|COMPLETED|Treatment||8
11079466|NCT01116440|12262047|FG001|COMPLETED|Treatment||9
11079467|NCT01116440|12262046|FG000|NOT COMPLETED|Treatment||3
11079468|NCT01116440|12262047|FG001|NOT COMPLETED|Treatment||7
11079469|NCT01116440|12262046|FG000|STARTED|Withdrawal||8
11079470|NCT01116440|12262047|FG001|STARTED|Withdrawal||9
11079471|NCT01116440|12262046|FG000|COMPLETED|Withdrawal||8
11079472|NCT01116440|12262047|FG001|COMPLETED|Withdrawal||7
11079473|NCT01116440|12262046|FG000|NOT COMPLETED|Withdrawal||0
11079474|NCT01116440|12262047|FG001|NOT COMPLETED|Withdrawal||2
11079475|NCT01116440|12262046|FG000|STARTED|Follow-up||8
11079476|NCT01116440|12262047|FG001|STARTED|Follow-up||7
11079477|NCT01116440|12262046|FG000|COMPLETED|Follow-up||8
11079478|NCT01116440|12262047|FG001|COMPLETED|Follow-up||5
11079479|NCT01116440|12262046|FG000|NOT COMPLETED|Follow-up||0
11079480|NCT01116440|12262047|FG001|NOT COMPLETED|Follow-up||2
11079481|NCT01116466|12262055|FG000|STARTED|Overall Study||5
11079482|NCT01116466|12262055|FG000|COMPLETED|Overall Study||5
11079483|NCT01116466|12262055|FG000|NOT COMPLETED|Overall Study||0
11079484|NCT01116544|12262062|FG000|STARTED|Overall Study||23
11079485|NCT01116544|12262063|FG001|STARTED|Overall Study||23
11079486|NCT01116544|12262062|FG000|COMPLETED|Overall Study||21
11079487|NCT01116544|12262063|FG001|COMPLETED|Overall Study||22
11079488|NCT01116544|12262062|FG000|NOT COMPLETED|Overall Study||2
11079489|NCT01116544|12262063|FG001|NOT COMPLETED|Overall Study||1
11079490|NCT01116661|12262069|FG000|STARTED|Overall Study||199
11079491|NCT01116661|12262069|FG000|COMPLETED|Overall Study||197
11079492|NCT01116661|12262069|FG000|NOT COMPLETED|Overall Study||2
11079493|NCT01116687|12262073|FG000|STARTED|Overall Study||37
11079494|NCT01116687|12262073|FG000|COMPLETED|Overall Study||33
11079495|NCT01116687|12262073|FG000|NOT COMPLETED|Overall Study||4
11079496|NCT01116739|12262079|FG000|STARTED|Overall Study||1056
11079497|NCT01116739|12262080|FG001|STARTED|Overall Study||1004
11079498|NCT01116739|12262079|FG000|COMPLETED|Overall Study||926
11079499|NCT01116739|12262080|FG001|COMPLETED|Overall Study||868
11079500|NCT01116739|12262079|FG000|NOT COMPLETED|Overall Study||130
11079501|NCT01116739|12262080|FG001|NOT COMPLETED|Overall Study||136
11079502|NCT01116882|12262088|FG000|STARTED|30-day||2774
11079503|NCT01116882|12262089|FG001|STARTED|30-day||917
11079504|NCT01116882|12262088|FG000|COMPLETED|30-day||2706
11079505|NCT01116882|12262089|FG001|COMPLETED|30-day||886
11079506|NCT01116882|12262088|FG000|NOT COMPLETED|30-day||68
11079507|NCT01116882|12262089|FG001|NOT COMPLETED|30-day||31
11079508|NCT01116882|12262088|FG000|STARTED|12-month||2706
11079509|NCT01116882|12262089|FG001|STARTED|12-month||886
11079510|NCT01116882|12262088|FG000|COMPLETED|12-month||2439
11079511|NCT01116882|12262089|FG001|COMPLETED|12-month||787
11348962|NCT03010488|12546019|FG001|NOT COMPLETED|Overall Study||7
11348963|NCT03010501|12546025|FG000|STARTED|Study Week 1||9
11348964|NCT03010501|12546026|FG001|STARTED|Study Week 1||15
11079512|NCT01116882|12262088|FG000|NOT COMPLETED|12-month||267
11079513|NCT01116882|12262089|FG001|NOT COMPLETED|12-month||99
11079514|NCT01116895|12262102|FG000|STARTED|Overall Study||16
11079515|NCT01116895|12262103|FG001|STARTED|Overall Study||15
11079516|NCT01116895|12262104|FG002|STARTED|Overall Study||18
11079517|NCT01116895|12262105|FG003|STARTED|Overall Study||14
11079518|NCT01116895|12262102|FG000|COMPLETED|Overall Study||12
11079519|NCT01116895|12262103|FG001|COMPLETED|Overall Study||8
11079520|NCT01116895|12262104|FG002|COMPLETED|Overall Study||14
11079521|NCT01116895|12262105|FG003|COMPLETED|Overall Study||11
11079522|NCT01116895|12262102|FG000|NOT COMPLETED|Overall Study||4
11079523|NCT01116895|12262103|FG001|NOT COMPLETED|Overall Study||7
11079524|NCT01116895|12262104|FG002|NOT COMPLETED|Overall Study||4
11079525|NCT01116895|12262105|FG003|NOT COMPLETED|Overall Study||3
11079526|NCT01116921|12262117|FG000|STARTED|Overall Study||53
11079527|NCT01116921|12262118|FG001|STARTED|Overall Study||50
11079528|NCT01116921|12262117|FG000|COMPLETED|Overall Study||53
11079529|NCT01116921|12262118|FG001|COMPLETED|Overall Study||50
11079530|NCT01116921|12262117|FG000|NOT COMPLETED|Overall Study||0
11079531|NCT01116921|12262118|FG001|NOT COMPLETED|Overall Study||0
11079532|NCT01116934|12262126|FG000|STARTED|Overall Study||8
11079533|NCT01116934|12262127|FG001|STARTED|Overall Study||9
11079534|NCT01116934|12262126|FG000|COMPLETED|Overall Study||8
11079535|NCT01116934|12262127|FG001|COMPLETED|Overall Study||9
11079536|NCT01116934|12262126|FG000|NOT COMPLETED|Overall Study||0
11079537|NCT01116934|12262127|FG001|NOT COMPLETED|Overall Study||0
11079538|NCT01116986|12262165|FG000|STARTED|Overall Study||24
11079539|NCT01116986|12262166|FG001|STARTED|Overall Study||19
11079540|NCT01116986|12262167|FG002|STARTED|Overall Study||18
11079541|NCT01116986|12262168|FG003|STARTED|Overall Study||22
11079542|NCT01116986|12262169|FG004|STARTED|Overall Study||24
11079543|NCT01116986|12262170|FG005|STARTED|Overall Study||22
11079544|NCT01116986|12262171|FG006|STARTED|Overall Study||22
11079545|NCT01116986|12262172|FG007|STARTED|Overall Study||22
11079546|NCT01116986|12262173|FG008|STARTED|Overall Study||20
11079547|NCT01116986|12262174|FG009|STARTED|Overall Study||23
11079548|NCT01116986|12262175|FG010|STARTED|Overall Study||19
11079549|NCT01116986|12262176|FG011|STARTED|Overall Study||20
11079550|NCT01116986|12262177|FG012|STARTED|Overall Study||17
11079551|NCT01116986|12262178|FG013|STARTED|Overall Study||19
11079552|NCT01116986|12262179|FG014|STARTED|Overall Study||17
11079553|NCT01116986|12262180|FG015|STARTED|Overall Study||21
11079554|NCT01116986|12262181|FG016|STARTED|Overall Study||16
11079555|NCT01116986|12262182|FG017|STARTED|Overall Study||24
11079556|NCT01116986|12262183|FG018|STARTED|Overall Study||23
11079557|NCT01116986|12262184|FG019|STARTED|Overall Study||15
11079558|NCT01116986|12262185|FG020|STARTED|Overall Study||24
11079559|NCT01116986|12262186|FG021|STARTED|Overall Study||20
11079560|NCT01116986|12262187|FG022|STARTED|Overall Study||23
11079561|NCT01116986|12262188|FG023|STARTED|Overall Study||21
11079562|NCT01116986|12262189|FG024|STARTED|Overall Study||18
11079563|NCT01116986|12262190|FG025|STARTED|Overall Study||19
11079564|NCT01116986|12262191|FG026|STARTED|Overall Study||18
11079565|NCT01116986|12262192|FG027|STARTED|Overall Study||19
11079566|NCT01116986|12262193|FG028|STARTED|Overall Study||17
11079567|NCT01116986|12262194|FG029|STARTED|Overall Study||17
11079568|NCT01116986|12262195|FG030|STARTED|Overall Study||17
11079569|NCT01116986|12262196|FG031|STARTED|Overall Study||17
11079570|NCT01116986|12262165|FG000|COMPLETED|Overall Study||22
11079571|NCT01116986|12262166|FG001|COMPLETED|Overall Study||16
11079572|NCT01116986|12262167|FG002|COMPLETED|Overall Study||16
11079573|NCT01116986|12262168|FG003|COMPLETED|Overall Study||20
11079574|NCT01116986|12262169|FG004|COMPLETED|Overall Study||20
11079575|NCT01116986|12262170|FG005|COMPLETED|Overall Study||20
11079576|NCT01116986|12262171|FG006|COMPLETED|Overall Study||20
11079577|NCT01116986|12262172|FG007|COMPLETED|Overall Study||20
11079578|NCT01116986|12262173|FG008|COMPLETED|Overall Study||19
11079579|NCT01116986|12262174|FG009|COMPLETED|Overall Study||19
11079580|NCT01116986|12262175|FG010|COMPLETED|Overall Study||18
11079581|NCT01116986|12262176|FG011|COMPLETED|Overall Study||20
11079582|NCT01116986|12262177|FG012|COMPLETED|Overall Study||16
11079583|NCT01116986|12262178|FG013|COMPLETED|Overall Study||16
11079584|NCT01116986|12262179|FG014|COMPLETED|Overall Study||17
11079585|NCT01116986|12262180|FG015|COMPLETED|Overall Study||15
11079586|NCT01116986|12262181|FG016|COMPLETED|Overall Study||13
11079587|NCT01116986|12262182|FG017|COMPLETED|Overall Study||19
11079588|NCT01116986|12262183|FG018|COMPLETED|Overall Study||20
11079589|NCT01116986|12262184|FG019|COMPLETED|Overall Study||13
11079590|NCT01116986|12262185|FG020|COMPLETED|Overall Study||22
11079591|NCT01116986|12262186|FG021|COMPLETED|Overall Study||18
11079592|NCT01116986|12262187|FG022|COMPLETED|Overall Study||19
11079593|NCT01116986|12262188|FG023|COMPLETED|Overall Study||19
11079594|NCT01116986|12262189|FG024|COMPLETED|Overall Study||15
11079595|NCT01116986|12262190|FG025|COMPLETED|Overall Study||19
11079596|NCT01116986|12262191|FG026|COMPLETED|Overall Study||14
11079597|NCT01116986|12262192|FG027|COMPLETED|Overall Study||18
11079598|NCT01116986|12262193|FG028|COMPLETED|Overall Study||17
11079599|NCT01116986|12262194|FG029|COMPLETED|Overall Study||17
11079600|NCT01116986|12262195|FG030|COMPLETED|Overall Study||16
11079601|NCT01116986|12262196|FG031|COMPLETED|Overall Study||14
11079602|NCT01116986|12262165|FG000|NOT COMPLETED|Overall Study||2
11079603|NCT01116986|12262166|FG001|NOT COMPLETED|Overall Study||3
11079604|NCT01116986|12262167|FG002|NOT COMPLETED|Overall Study||2
11079605|NCT01116986|12262168|FG003|NOT COMPLETED|Overall Study||2
11079606|NCT01116986|12262169|FG004|NOT COMPLETED|Overall Study||4
11079607|NCT01116986|12262170|FG005|NOT COMPLETED|Overall Study||2
11079608|NCT01116986|12262171|FG006|NOT COMPLETED|Overall Study||2
11079609|NCT01116986|12262172|FG007|NOT COMPLETED|Overall Study||2
11079610|NCT01116986|12262173|FG008|NOT COMPLETED|Overall Study||1
11079611|NCT01116986|12262174|FG009|NOT COMPLETED|Overall Study||4
11079612|NCT01116986|12262175|FG010|NOT COMPLETED|Overall Study||1
11079613|NCT01116986|12262176|FG011|NOT COMPLETED|Overall Study||0
11079614|NCT01116986|12262177|FG012|NOT COMPLETED|Overall Study||1
11079615|NCT01116986|12262178|FG013|NOT COMPLETED|Overall Study||3
11079616|NCT01116986|12262179|FG014|NOT COMPLETED|Overall Study||0
11079617|NCT01116986|12262180|FG015|NOT COMPLETED|Overall Study||6
11079618|NCT01116986|12262181|FG016|NOT COMPLETED|Overall Study||3
11079619|NCT01116986|12262182|FG017|NOT COMPLETED|Overall Study||5
11079620|NCT01116986|12262183|FG018|NOT COMPLETED|Overall Study||3
11079621|NCT01116986|12262184|FG019|NOT COMPLETED|Overall Study||2
11348965|NCT03010501|12546027|FG002|STARTED|Study Week 1||7
11348966|NCT03010501|12546028|FG003|STARTED|Study Week 1||7
11348967|NCT03010501|12546029|FG004|STARTED|Study Week 1||7
11348968|NCT03010501|12546030|FG005|STARTED|Study Week 1||11
11348969|NCT03010501|12546025|FG000|COMPLETED|Study Week 1||7
11348970|NCT03010501|12546026|FG001|COMPLETED|Study Week 1||14
11348971|NCT03010501|12546027|FG002|COMPLETED|Study Week 1||7
11348972|NCT03010501|12546028|FG003|COMPLETED|Study Week 1||5
11348973|NCT03010501|12546029|FG004|COMPLETED|Study Week 1||7
11348974|NCT03010501|12546030|FG005|COMPLETED|Study Week 1||11
11348975|NCT03010501|12546025|FG000|NOT COMPLETED|Study Week 1||2
11348976|NCT03010501|12546026|FG001|NOT COMPLETED|Study Week 1||1
11348977|NCT03010501|12546027|FG002|NOT COMPLETED|Study Week 1||0
11348978|NCT03010501|12546028|FG003|NOT COMPLETED|Study Week 1||2
11348979|NCT03010501|12546029|FG004|NOT COMPLETED|Study Week 1||0
11348980|NCT03010501|12546030|FG005|NOT COMPLETED|Study Week 1||0
11348981|NCT03010501|12546025|FG000|STARTED|Study Week 2||7
11348982|NCT03010501|12546026|FG001|STARTED|Study Week 2||14
11348983|NCT03010501|12546027|FG002|STARTED|Study Week 2||7
11348984|NCT03010501|12546028|FG003|STARTED|Study Week 2||5
11348985|NCT03010501|12546029|FG004|STARTED|Study Week 2||7
11348986|NCT03010501|12546030|FG005|STARTED|Study Week 2||11
11348987|NCT03010501|12546025|FG000|COMPLETED|Study Week 2||7
11348988|NCT03010501|12546026|FG001|COMPLETED|Study Week 2||14
11348989|NCT03010501|12546027|FG002|COMPLETED|Study Week 2||7
11348990|NCT03010501|12546028|FG003|COMPLETED|Study Week 2||5
11348991|NCT03010501|12546029|FG004|COMPLETED|Study Week 2||7
11348992|NCT03010501|12546030|FG005|COMPLETED|Study Week 2||11
11348993|NCT03010501|12546025|FG000|NOT COMPLETED|Study Week 2||0
11348994|NCT03010501|12546026|FG001|NOT COMPLETED|Study Week 2||0
11348995|NCT03010501|12546027|FG002|NOT COMPLETED|Study Week 2||0
11348996|NCT03010501|12546028|FG003|NOT COMPLETED|Study Week 2||0
11348997|NCT03010501|12546029|FG004|NOT COMPLETED|Study Week 2||0
11348998|NCT03010501|12546030|FG005|NOT COMPLETED|Study Week 2||0
11348999|NCT03010501|12546025|FG000|STARTED|Study Week 3||7
11349000|NCT03010501|12546026|FG001|STARTED|Study Week 3||14
11349001|NCT03010501|12546027|FG002|STARTED|Study Week 3||7
11349002|NCT03010501|12546028|FG003|STARTED|Study Week 3||5
11349003|NCT03010501|12546029|FG004|STARTED|Study Week 3||7
11349004|NCT03010501|12546030|FG005|STARTED|Study Week 3||11
11349005|NCT03010501|12546025|FG000|COMPLETED|Study Week 3||7
11349006|NCT03010501|12546026|FG001|COMPLETED|Study Week 3||14
11349007|NCT03010501|12546027|FG002|COMPLETED|Study Week 3||7
11349008|NCT03010501|12546028|FG003|COMPLETED|Study Week 3||4
11349009|NCT03010501|12546029|FG004|COMPLETED|Study Week 3||7
11349010|NCT03010501|12546030|FG005|COMPLETED|Study Week 3||11
11349011|NCT03010501|12546025|FG000|NOT COMPLETED|Study Week 3||0
11349012|NCT03010501|12546026|FG001|NOT COMPLETED|Study Week 3||0
11349013|NCT03010501|12546027|FG002|NOT COMPLETED|Study Week 3||0
11349014|NCT03010501|12546028|FG003|NOT COMPLETED|Study Week 3||1
11349015|NCT03010501|12546029|FG004|NOT COMPLETED|Study Week 3||0
11349016|NCT03010501|12546030|FG005|NOT COMPLETED|Study Week 3||0
11349017|NCT03010631|12546042|FG000|STARTED|Cohort 1||18
11349018|NCT03010631|12546043|FG001|STARTED|Cohort 1||17
11349019|NCT03010631|12546044|FG002|STARTED|Cohort 1||0
11349020|NCT03010631|12546045|FG003|STARTED|Cohort 1||0
11349021|NCT03010631|12546042|FG000|COMPLETED|Cohort 1||14
11349022|NCT03010631|12546043|FG001|COMPLETED|Cohort 1||17
11079622|NCT01116986|12262185|FG020|NOT COMPLETED|Overall Study||2
11079623|NCT01116986|12262186|FG021|NOT COMPLETED|Overall Study||2
11079624|NCT01116986|12262187|FG022|NOT COMPLETED|Overall Study||4
11079625|NCT01116986|12262188|FG023|NOT COMPLETED|Overall Study||2
11349023|NCT03010631|12546044|FG002|COMPLETED|Cohort 1||0
11349024|NCT03010631|12546045|FG003|COMPLETED|Cohort 1||0
11079626|NCT01116986|12262189|FG024|NOT COMPLETED|Overall Study||3
11079627|NCT01116986|12262190|FG025|NOT COMPLETED|Overall Study||0
11079628|NCT01116986|12262191|FG026|NOT COMPLETED|Overall Study||4
11079629|NCT01116986|12262192|FG027|NOT COMPLETED|Overall Study||1
11079630|NCT01116986|12262193|FG028|NOT COMPLETED|Overall Study||0
11079631|NCT01116986|12262194|FG029|NOT COMPLETED|Overall Study||0
11079632|NCT01116986|12262195|FG030|NOT COMPLETED|Overall Study||1
11079633|NCT01116986|12262196|FG031|NOT COMPLETED|Overall Study||3
11079634|NCT01117012|12262218|FG000|STARTED|Overall Study||89
11079635|NCT01117012|12262219|FG001|STARTED|Overall Study||103
11079636|NCT01117012|12262218|FG000|COMPLETED|Overall Study||81
11079637|NCT01117012|12262219|FG001|COMPLETED|Overall Study||98
11079638|NCT01117012|12262218|FG000|NOT COMPLETED|Overall Study||8
11079639|NCT01117012|12262219|FG001|NOT COMPLETED|Overall Study||5
11079640|NCT01117051|12262227|FG000|STARTED|Overall Study||86
11079641|NCT01117051|12262228|FG001|STARTED|Overall Study||88
11079642|NCT01117051|12262227|FG000|COMPLETED|Overall Study||73
11079643|NCT01117051|12262228|FG001|COMPLETED|Overall Study||77
11079644|NCT01117051|12262227|FG000|NOT COMPLETED|Overall Study||13
11079645|NCT01117051|12262228|FG001|NOT COMPLETED|Overall Study||11
11079646|NCT01117090|12262235|FG000|STARTED|Overall Study||47
11079647|NCT01117090|12262235|FG000|COMPLETED|Overall Study||47
11079648|NCT01117090|12262235|FG000|NOT COMPLETED|Overall Study||0
11079649|NCT01117181|12262248|FG000|STARTED|Overall Study||29
11079650|NCT01117181|12262249|FG001|STARTED|Overall Study||31
11079651|NCT01117181|12262248|FG000|COMPLETED|Overall Study||28
11079652|NCT01117181|12262249|FG001|COMPLETED|Overall Study||29
11079653|NCT01117181|12262248|FG000|NOT COMPLETED|Overall Study||1
11079654|NCT01117181|12262249|FG001|NOT COMPLETED|Overall Study||2
11079655|NCT01117311|12262257|FG000|STARTED|Lead-in Mixed Meal 1||3
11079656|NCT01117311|12262258|FG001|STARTED|Lead-in Mixed Meal 1||4
11079657|NCT01117311|12262257|FG000|COMPLETED|Lead-in Mixed Meal 1||3
11079658|NCT01117311|12262258|FG001|COMPLETED|Lead-in Mixed Meal 1||4
11079659|NCT01117311|12262257|FG000|NOT COMPLETED|Lead-in Mixed Meal 1||0
11079660|NCT01117311|12262258|FG001|NOT COMPLETED|Lead-in Mixed Meal 1||0
11079661|NCT01117311|12262257|FG000|STARTED|First Intervention - Mixed Meal 2||3
11079662|NCT01117311|12262258|FG001|STARTED|First Intervention - Mixed Meal 2||4
11079663|NCT01117311|12262257|FG000|COMPLETED|First Intervention - Mixed Meal 2||3
11079664|NCT01117311|12262258|FG001|COMPLETED|First Intervention - Mixed Meal 2||4
11079665|NCT01117311|12262257|FG000|NOT COMPLETED|First Intervention - Mixed Meal 2||0
11079666|NCT01117311|12262258|FG001|NOT COMPLETED|First Intervention - Mixed Meal 2||0
11079667|NCT01117311|12262257|FG000|STARTED|Second Intervention - Mixed Meal 3||3
11079668|NCT01117311|12262258|FG001|STARTED|Second Intervention - Mixed Meal 3||4
11079669|NCT01117311|12262257|FG000|COMPLETED|Second Intervention - Mixed Meal 3||3
11079670|NCT01117311|12262258|FG001|COMPLETED|Second Intervention - Mixed Meal 3||4
11079671|NCT01117311|12262257|FG000|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
11079672|NCT01117311|12262258|FG001|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
11079673|NCT01117337|12262266|FG000|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
11079674|NCT01117337|12262267|FG001|STARTED|Overall Study||52
11079675|NCT01117337|12262266|FG000|Underwent Surgery|Overall Study|52 patients underwent surgery|52
11079676|NCT01117337|12262267|FG001|Underwent Surgery|Overall Study||52
11079677|NCT01117337|12262266|FG000|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
11079678|NCT01117337|12262267|FG001|COMPLETED|Overall Study||52
11079679|NCT01117337|12262266|FG000|NOT COMPLETED|Overall Study||4
11349025|NCT03010631|12546042|FG000|NOT COMPLETED|Cohort 1||4
11349026|NCT03010631|12546043|FG001|NOT COMPLETED|Cohort 1||0
11349027|NCT03010631|12546044|FG002|NOT COMPLETED|Cohort 1||0
11349028|NCT03010631|12546045|FG003|NOT COMPLETED|Cohort 1||0
11349029|NCT03010631|12546042|FG000|STARTED|Cohort 2||0
11079680|NCT01117337|12262267|FG001|NOT COMPLETED|Overall Study||0
11079681|NCT01117350|12262275|FG000|STARTED|Comparative Period|STARTED: randomized|489
11079682|NCT01117350|12262276|FG001|STARTED|Comparative Period||489
11349030|NCT03010631|12546043|FG001|STARTED|Cohort 2||0
11349031|NCT03010631|12546044|FG002|STARTED|Cohort 2|New participants were enrolled for Cohort 2|7
11349032|NCT03010631|12546045|FG003|STARTED|Cohort 2||7
11349033|NCT03010631|12546042|FG000|COMPLETED|Cohort 2||0
11349034|NCT03010631|12546043|FG001|COMPLETED|Cohort 2||0
11349035|NCT03010631|12546044|FG002|COMPLETED|Cohort 2||7
11349036|NCT03010631|12546045|FG003|COMPLETED|Cohort 2||7
11349037|NCT03010631|12546042|FG000|NOT COMPLETED|Cohort 2||0
11079683|NCT01117350|12262275|FG000|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
11079684|NCT01117350|12262276|FG001|TREATED = Safety Population|Comparative Period||481
11079685|NCT01117350|12262275|FG000|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
11079686|NCT01117350|12262276|FG001|mITT Population|Comparative Period||470
11079687|NCT01117350|12262275|FG000|COMPLETED|Comparative Period||447
11079688|NCT01117350|12262276|FG001|COMPLETED|Comparative Period||414
11079689|NCT01117350|12262275|FG000|NOT COMPLETED|Comparative Period||42
11079690|NCT01117350|12262276|FG001|NOT COMPLETED|Comparative Period||75
11079691|NCT01117350|12262275|FG000|STARTED|Extension Period||0
11079692|NCT01117350|12262276|FG001|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
11349038|NCT03010631|12546043|FG001|NOT COMPLETED|Cohort 2||0
11349039|NCT03010631|12546044|FG002|NOT COMPLETED|Cohort 2||0
11349040|NCT03010631|12546045|FG003|NOT COMPLETED|Cohort 2||0
11349041|NCT03010683|12546061|FG000|STARTED|Overall Study||30
11349042|NCT03010683|12546062|FG001|STARTED|Overall Study||30
11349043|NCT03010683|12546061|FG000|COMPLETED|Overall Study||30
11349044|NCT03010683|12546062|FG001|COMPLETED|Overall Study||30
11349045|NCT03010683|12546061|FG000|NOT COMPLETED|Overall Study||0
11349046|NCT03010683|12546062|FG001|NOT COMPLETED|Overall Study||0
11349047|NCT03010800|12546070|FG000|STARTED|Initial Assignment||4
11349048|NCT03010800|12546071|FG001|STARTED|Initial Assignment||4
11349049|NCT03010800|12546070|FG000|COMPLETED|Initial Assignment||4
11349050|NCT03010800|12546071|FG001|COMPLETED|Initial Assignment||4
11349051|NCT03010800|12546070|FG000|NOT COMPLETED|Initial Assignment||0
11349052|NCT03010800|12546071|FG001|NOT COMPLETED|Initial Assignment||0
11349053|NCT03010800|12546070|FG000|STARTED|Cross Over||4
11349054|NCT03010800|12546071|FG001|STARTED|Cross Over||4
11349055|NCT03010800|12546070|FG000|COMPLETED|Cross Over||4
11349056|NCT03010800|12546071|FG001|COMPLETED|Cross Over||4
11349057|NCT03010800|12546070|FG000|NOT COMPLETED|Cross Over||0
11349058|NCT03010800|12546071|FG001|NOT COMPLETED|Cross Over||0
11079693|NCT01117350|12262275|FG000|TREATED = Safety Population (Extension)|Extension Period||0
11079694|NCT01117350|12262276|FG001|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
11349059|NCT03011099|12546079|FG000|STARTED|Overall Study||6
11349060|NCT03011099|12546080|FG001|STARTED|Overall Study||5
11349061|NCT03011099|12546079|FG000|COMPLETED|Overall Study||6
11079695|NCT01117350|12262275|FG000|mITT Population (Extension)|Extension Period||0
11079696|NCT01117350|12262276|FG001|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
11079697|NCT01117350|12262275|FG000|COMPLETED|Extension Period||0
11079698|NCT01117350|12262276|FG001|COMPLETED|Extension Period||147
11079699|NCT01117350|12262275|FG000|NOT COMPLETED|Extension Period||0
11079700|NCT01117350|12262276|FG001|NOT COMPLETED|Extension Period||63
11079701|NCT01117428|12262291|FG000|STARTED|Overall Study|"0.4 mg/kg=1~0.75 mg/kg=1~1.5 mg/kg=3~3 mg/kg=3~6 mg/kg=3~9 mg/kg=6~12 mg/kg=3"|20
11079702|NCT01117428|12262292|FG001|STARTED|Overall Study||29
11079703|NCT01117428|12262293|FG002|STARTED|Overall Study||13
11079704|NCT01117428|12262294|FG003|STARTED|Overall Study||12
11079705|NCT01117428|12262295|FG004|STARTED|Overall Study||17
11079706|NCT01117428|12262296|FG005|STARTED|Overall Study||20
11079707|NCT01117428|12262291|FG000|COMPLETED|Overall Study||0
11079708|NCT01117428|12262292|FG001|COMPLETED|Overall Study||0
11079709|NCT01117428|12262293|FG002|COMPLETED|Overall Study||0
11079710|NCT01117428|12262294|FG003|COMPLETED|Overall Study||0
11079711|NCT01117428|12262295|FG004|COMPLETED|Overall Study||0
11079712|NCT01117428|12262296|FG005|COMPLETED|Overall Study||0
11079713|NCT01117428|12262291|FG000|NOT COMPLETED|Overall Study||20
11079714|NCT01117428|12262292|FG001|NOT COMPLETED|Overall Study||29
11079715|NCT01117428|12262293|FG002|NOT COMPLETED|Overall Study||13
11079716|NCT01117428|12262294|FG003|NOT COMPLETED|Overall Study||12
11079717|NCT01117428|12262295|FG004|NOT COMPLETED|Overall Study||17
11079718|NCT01117428|12262296|FG005|NOT COMPLETED|Overall Study||20
11079719|NCT01117454|12262314|FG000|STARTED|Overall Study||6
11079720|NCT01117454|12262315|FG001|STARTED|Overall Study||8
11079721|NCT01117454|12262314|FG000|COMPLETED|Overall Study||6
11079722|NCT01117454|12262315|FG001|COMPLETED|Overall Study||7
11079723|NCT01117454|12262314|FG000|NOT COMPLETED|Overall Study||0
11079724|NCT01117454|12262315|FG001|NOT COMPLETED|Overall Study||1
11079725|NCT01117480|12262321|FG000|STARTED|Overall Study||1013
11079726|NCT01117480|12262321|FG000|COMPLETED|Overall Study||985
11079727|NCT01117480|12262321|FG000|NOT COMPLETED|Overall Study||28
11079728|NCT01117623|12262333|FG000|STARTED|Overall Study||3
11079729|NCT01117623|12262334|FG001|STARTED|Overall Study||8
11079730|NCT01117623|12262335|FG002|STARTED|Overall Study||11
11079731|NCT01117623|12262336|FG003|STARTED|Overall Study||6
11079732|NCT01117623|12262337|FG004|STARTED|Overall Study||10
11079733|NCT01117623|12262338|FG005|STARTED|Overall Study||16
11079734|NCT01117623|12262339|FG006|STARTED|Overall Study||6
11079735|NCT01117623|12262340|FG007|STARTED|Overall Study||26
11079736|NCT01117623|12262333|FG000|ITT Efficacy Analysis Population|Overall Study||3
11079737|NCT01117623|12262334|FG001|ITT Efficacy Analysis Population|Overall Study||8
11079738|NCT01117623|12262335|FG002|ITT Efficacy Analysis Population|Overall Study||11
11079739|NCT01117623|12262336|FG003|ITT Efficacy Analysis Population|Overall Study||5
11079740|NCT01117623|12262337|FG004|ITT Efficacy Analysis Population|Overall Study||10
11079741|NCT01117623|12262338|FG005|ITT Efficacy Analysis Population|Overall Study||16
11079742|NCT01117623|12262339|FG006|ITT Efficacy Analysis Population|Overall Study||6
11079743|NCT01117623|12262340|FG007|ITT Efficacy Analysis Population|Overall Study||22
11079744|NCT01117623|12262333|FG000|PK Population|Overall Study||3
11079745|NCT01117623|12262334|FG001|PK Population|Overall Study||8
11079746|NCT01117623|12262335|FG002|PK Population|Overall Study||10
11079747|NCT01117623|12262336|FG003|PK Population|Overall Study||6
11079748|NCT01117623|12262337|FG004|PK Population|Overall Study||10
11079749|NCT01117623|12262338|FG005|PK Population|Overall Study||14
11079750|NCT01117623|12262339|FG006|PK Population|Overall Study||6
11079751|NCT01117623|12262340|FG007|PK Population|Overall Study||24
11079752|NCT01117623|12262333|FG000|COMPLETED|Overall Study||0
11079753|NCT01117623|12262334|FG001|COMPLETED|Overall Study||0
11079754|NCT01117623|12262335|FG002|COMPLETED|Overall Study||0
11079755|NCT01117623|12262336|FG003|COMPLETED|Overall Study||0
11079756|NCT01117623|12262337|FG004|COMPLETED|Overall Study||0
11079757|NCT01117623|12262338|FG005|COMPLETED|Overall Study||0
11079758|NCT01117623|12262339|FG006|COMPLETED|Overall Study||0
11079759|NCT01117623|12262340|FG007|COMPLETED|Overall Study||0
11079760|NCT01117623|12262333|FG000|NOT COMPLETED|Overall Study||3
11079761|NCT01117623|12262334|FG001|NOT COMPLETED|Overall Study||8
11079762|NCT01117623|12262335|FG002|NOT COMPLETED|Overall Study||11
11079763|NCT01117623|12262336|FG003|NOT COMPLETED|Overall Study||6
11079764|NCT01117623|12262337|FG004|NOT COMPLETED|Overall Study||10
11079765|NCT01117623|12262338|FG005|NOT COMPLETED|Overall Study||16
11079766|NCT01117623|12262339|FG006|NOT COMPLETED|Overall Study||6
11079767|NCT01117623|12262340|FG007|NOT COMPLETED|Overall Study||26
11079768|NCT01117727|12262360|FG000|STARTED|Overall Study||1
11079769|NCT01117727|12262360|FG000|COMPLETED|Overall Study||1
11079770|NCT01117727|12262360|FG000|NOT COMPLETED|Overall Study||0
11207047|NCT01872689|12398193|FG001|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
11207048|NCT01872689|12398194|FG002|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
11207049|NCT01872689|12398195|FG003|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
11207050|NCT01872819|12398208|FG000|STARTED|Overall Study||14
11207051|NCT01872819|12398208|FG000|COMPLETED|Overall Study||14
11207052|NCT01872819|12398208|FG000|NOT COMPLETED|Overall Study||0
11207053|NCT01872910|12398219|FG000|STARTED|Overall Study||30
11207054|NCT01872910|12398220|FG001|STARTED|Overall Study||31
11207055|NCT01872910|12398221|FG002|STARTED|Overall Study||30
11207056|NCT01872910|12398222|FG003|STARTED|Overall Study||15
11207057|NCT01872910|12398223|FG004|STARTED|Overall Study||15
11207058|NCT01872910|12398224|FG005|STARTED|Overall Study||3
11207059|NCT01872910|12398219|FG000|Received Any Study Drug|Overall Study||30
11207060|NCT01872910|12398220|FG001|Received Any Study Drug|Overall Study||31
11207061|NCT01872910|12398221|FG002|Received Any Study Drug|Overall Study||30
11207062|NCT01872910|12398222|FG003|Received Any Study Drug|Overall Study||15
11207063|NCT01872910|12398223|FG004|Received Any Study Drug|Overall Study||15
11207064|NCT01872910|12398224|FG005|Received Any Study Drug|Overall Study||3
11207065|NCT01872910|12398219|FG000|COMPLETED|Overall Study||28
11207066|NCT01872910|12398220|FG001|COMPLETED|Overall Study||31
11207067|NCT01872910|12398221|FG002|COMPLETED|Overall Study||28
11207068|NCT01872910|12398222|FG003|COMPLETED|Overall Study||15
11207069|NCT01872910|12398223|FG004|COMPLETED|Overall Study||15
11207070|NCT01872910|12398224|FG005|COMPLETED|Overall Study||3
11207071|NCT01872910|12398219|FG000|NOT COMPLETED|Overall Study||2
11207072|NCT01872910|12398220|FG001|NOT COMPLETED|Overall Study||0
11207073|NCT01872910|12398221|FG002|NOT COMPLETED|Overall Study||2
11207074|NCT01872910|12398222|FG003|NOT COMPLETED|Overall Study||0
11207075|NCT01872910|12398223|FG004|NOT COMPLETED|Overall Study||0
11207076|NCT01872910|12398224|FG005|NOT COMPLETED|Overall Study||0
11207077|NCT01873287|12398239|FG000|STARTED|Overall Study||2006
11207078|NCT01873287|12398240|FG001|STARTED|Overall Study||1057
11207079|NCT01873287|12398239|FG000|COMPLETED|Overall Study||1701
11207080|NCT01873287|12398240|FG001|COMPLETED|Overall Study||883
11207081|NCT01873287|12398239|FG000|NOT COMPLETED|Overall Study||305
11207082|NCT01873287|12398240|FG001|NOT COMPLETED|Overall Study||174
11207083|NCT01873417|12398248|FG000|STARTED|Overall Study||237
11207084|NCT01873417|12398248|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
11207085|NCT01873417|12398248|FG000|COMPLETED|Overall Study||202
11207086|NCT01873417|12398248|FG000|NOT COMPLETED|Overall Study||35
11207087|NCT01873495|12398252|FG000|STARTED|Overall Study||7
11207088|NCT01873495|12398252|FG000|COMPLETED|Overall Study||0
11207089|NCT01873495|12398252|FG000|NOT COMPLETED|Overall Study||7
11207090|NCT01873586|12398256|FG000|STARTED|Overall Study||29
11207091|NCT01873586|12398256|FG000|COMPLETED|Overall Study||26
11207092|NCT01873586|12398256|FG000|NOT COMPLETED|Overall Study||3
11207093|NCT01873729|12398263|FG000|STARTED|Overall Study||3
11207094|NCT01873729|12398263|FG000|COMPLETED|Overall Study||2
11207095|NCT01873729|12398263|FG000|NOT COMPLETED|Overall Study||1
11207096|NCT01873742|12398269|FG000|STARTED|Overall Study||165
11207097|NCT01873742|12398270|FG001|STARTED|Overall Study||163
11207098|NCT01873742|12398269|FG000|COMPLETED|Overall Study||97
11207099|NCT01873742|12398270|FG001|COMPLETED|Overall Study||87
11207100|NCT01873742|12398269|FG000|NOT COMPLETED|Overall Study||68
11207101|NCT01873742|12398270|FG001|NOT COMPLETED|Overall Study||76
11207102|NCT01873846|12398276|FG000|STARTED|Overall Study||400
11207103|NCT01873846|12398276|FG000|Eligble Participants Dispensed Lenses|Overall Study||396
11207104|NCT01873846|12398276|FG000|COMPLETED|Overall Study||388
11207105|NCT01873846|12398276|FG000|NOT COMPLETED|Overall Study||12
11207106|NCT01873859|12398282|FG000|STARTED|Overall Study||83
11207107|NCT01873859|12398283|FG001|STARTED|Overall Study||83
11207108|NCT01873859|12398282|FG000|COMPLETED|Overall Study||83
11207109|NCT01873859|12398283|FG001|COMPLETED|Overall Study||79
11207110|NCT01873859|12398282|FG000|NOT COMPLETED|Overall Study||0
11207111|NCT01873859|12398283|FG001|NOT COMPLETED|Overall Study||4
11207112|NCT01873950|12398290|FG000|STARTED|Period 1||5
11207113|NCT01873950|12398291|FG001|STARTED|Period 1||4
11207114|NCT01873950|12398292|FG002|STARTED|Period 1||5
11207115|NCT01873950|12398293|FG003|STARTED|Period 1||4
11207116|NCT01873950|12398294|FG004|STARTED|Period 1||4
11207117|NCT01873950|12398290|FG000|COMPLETED|Period 1||5
11207118|NCT01873950|12398291|FG001|COMPLETED|Period 1||4
11207119|NCT01873950|12398292|FG002|COMPLETED|Period 1||5
11207120|NCT01873950|12398293|FG003|COMPLETED|Period 1||4
11207121|NCT01873950|12398294|FG004|COMPLETED|Period 1||4
11207122|NCT01873950|12398290|FG000|NOT COMPLETED|Period 1||0
11207123|NCT01873950|12398291|FG001|NOT COMPLETED|Period 1||0
11207124|NCT01873950|12398292|FG002|NOT COMPLETED|Period 1||0
11207125|NCT01873950|12398293|FG003|NOT COMPLETED|Period 1||0
11207126|NCT01873950|12398294|FG004|NOT COMPLETED|Period 1||0
11207127|NCT01873950|12398290|FG000|STARTED|Period 2||5
11079771|NCT01117766|12262365|FG000|STARTED|First Intervention||14
11079772|NCT01117766|12262366|FG001|STARTED|First Intervention||17
11079773|NCT01117766|12262365|FG000|Received Treatment|First Intervention||14
11079774|NCT01117766|12262366|FG001|Received Treatment|First Intervention||17
11079775|NCT01117766|12262365|FG000|COMPLETED|First Intervention||13
11079776|NCT01117766|12262366|FG001|COMPLETED|First Intervention||16
11079777|NCT01117766|12262365|FG000|NOT COMPLETED|First Intervention||1
11079778|NCT01117766|12262366|FG001|NOT COMPLETED|First Intervention||1
11079779|NCT01117766|12262365|FG000|STARTED|Washout Period||13
11079780|NCT01117766|12262366|FG001|STARTED|Washout Period||16
11079781|NCT01117766|12262365|FG000|COMPLETED|Washout Period||13
11079782|NCT01117766|12262366|FG001|COMPLETED|Washout Period||14
11079783|NCT01117766|12262365|FG000|NOT COMPLETED|Washout Period||0
11079784|NCT01117766|12262366|FG001|NOT COMPLETED|Washout Period||2
11079785|NCT01117766|12262365|FG000|STARTED|Second Intervention||13
11079786|NCT01117766|12262366|FG001|STARTED|Second Intervention||14
11079787|NCT01117766|12262365|FG000|COMPLETED|Second Intervention||11
11079788|NCT01117766|12262366|FG001|COMPLETED|Second Intervention||9
11079789|NCT01117766|12262365|FG000|NOT COMPLETED|Second Intervention||2
11079790|NCT01117766|12262366|FG001|NOT COMPLETED|Second Intervention||5
11079791|NCT01117792|12262372|FG000|STARTED|Overall Study||55
11079792|NCT01117792|12262372|FG000|COMPLETED|Overall Study||51
11079793|NCT01117792|12262372|FG000|NOT COMPLETED|Overall Study||4
11079794|NCT01117857|12262376|FG000|STARTED|Overall Study||22
11079795|NCT01117857|12262376|FG000|COMPLETED|Overall Study||13
11079796|NCT01117857|12262376|FG000|NOT COMPLETED|Overall Study||9
11079797|NCT01117870|12262382|FG000|STARTED|Overall Study||15
11079798|NCT01117870|12262383|FG001|STARTED|Overall Study||16
11079799|NCT01117870|12262382|FG000|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
11079800|NCT01117870|12262383|FG001|COMPLETED|Overall Study||16
11079801|NCT01117870|12262382|FG000|NOT COMPLETED|Overall Study||1
11079802|NCT01117870|12262383|FG001|NOT COMPLETED|Overall Study||0
11079803|NCT01117948|12262395|FG000|STARTED|Double Blind||111
11079804|NCT01117948|12262396|FG001|STARTED|Double Blind||108
11079805|NCT01117948|12262395|FG000|COMPLETED|Double Blind||93
11079806|NCT01117948|12262396|FG001|COMPLETED|Double Blind||98
11079807|NCT01117948|12262395|FG000|NOT COMPLETED|Double Blind||18
11079808|NCT01117948|12262396|FG001|NOT COMPLETED|Double Blind||10
11079809|NCT01117948|12262395|FG000|STARTED|Open Label||93
11079810|NCT01117948|12262396|FG001|STARTED|Open Label||98
11079811|NCT01117948|12262395|FG000|COMPLETED|Open Label||41
11079812|NCT01117948|12262396|FG001|COMPLETED|Open Label||51
11079813|NCT01117948|12262395|FG000|NOT COMPLETED|Open Label||52
11079814|NCT01117948|12262396|FG001|NOT COMPLETED|Open Label||47
11079815|NCT01117987|12262404|FG000|STARTED|Overall Study||66
11079816|NCT01117987|12262405|FG001|STARTED|Overall Study||78
11079817|NCT01117987|12262404|FG000|COMPLETED|Overall Study||5
11079818|NCT01117987|12262405|FG001|COMPLETED|Overall Study||4
11079819|NCT01117987|12262404|FG000|NOT COMPLETED|Overall Study||61
11079820|NCT01117987|12262405|FG001|NOT COMPLETED|Overall Study||74
11079821|NCT01118052|12262411|FG000|STARTED|Overall Study||22
11079822|NCT01118052|12262411|FG000|COMPLETED|Overall Study||20
11079823|NCT01118052|12262411|FG000|NOT COMPLETED|Overall Study||2
11079824|NCT01118091|12262423|FG000|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
11079825|NCT01118091|12262424|FG001|STARTED|Overall Study||5
11079826|NCT01118091|12262423|FG000|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
11079827|NCT01118091|12262424|FG001|COMPLETED|Overall Study||5
11079828|NCT01118091|12262423|FG000|NOT COMPLETED|Overall Study||0
11079829|NCT01118091|12262424|FG001|NOT COMPLETED|Overall Study||0
11079830|NCT01118117|12262432|FG000|STARTED|Overall Study||261
11079831|NCT01118117|12262433|FG001|STARTED|Overall Study||15
11079832|NCT01118117|12262432|FG000|COMPLETED|Overall Study||240
11079833|NCT01118117|12262433|FG001|COMPLETED|Overall Study||15
11079834|NCT01118117|12262432|FG000|NOT COMPLETED|Overall Study||21
11207128|NCT01873950|12398291|FG001|STARTED|Period 2||4
11207129|NCT01873950|12398292|FG002|STARTED|Period 2||4
11207130|NCT01873950|12398293|FG003|STARTED|Period 2||4
11207131|NCT01873950|12398294|FG004|STARTED|Period 2||5
11207132|NCT01873950|12398290|FG000|COMPLETED|Period 2||5
11207133|NCT01873950|12398291|FG001|COMPLETED|Period 2||4
11207134|NCT01873950|12398292|FG002|COMPLETED|Period 2||4
11207135|NCT01873950|12398293|FG003|COMPLETED|Period 2||4
11207136|NCT01873950|12398294|FG004|COMPLETED|Period 2||5
11207137|NCT01873950|12398290|FG000|NOT COMPLETED|Period 2||0
11207138|NCT01873950|12398291|FG001|NOT COMPLETED|Period 2||0
11207139|NCT01873950|12398292|FG002|NOT COMPLETED|Period 2||0
11207140|NCT01873950|12398293|FG003|NOT COMPLETED|Period 2||0
11207141|NCT01873950|12398294|FG004|NOT COMPLETED|Period 2||0
11207142|NCT01873950|12398290|FG000|STARTED|Period 3||4
11207143|NCT01873950|12398291|FG001|STARTED|Period 3||4
11207144|NCT01873950|12398292|FG002|STARTED|Period 3||5
11207145|NCT01873950|12398293|FG003|STARTED|Period 3||5
11207146|NCT01873950|12398294|FG004|STARTED|Period 3||4
11207147|NCT01873950|12398290|FG000|COMPLETED|Period 3||4
11207148|NCT01873950|12398291|FG001|COMPLETED|Period 3||4
11207149|NCT01873950|12398292|FG002|COMPLETED|Period 3||5
11207150|NCT01873950|12398293|FG003|COMPLETED|Period 3||5
11207151|NCT01873950|12398294|FG004|COMPLETED|Period 3||4
11207152|NCT01873950|12398290|FG000|NOT COMPLETED|Period 3||0
11207153|NCT01873950|12398291|FG001|NOT COMPLETED|Period 3||0
11207154|NCT01873950|12398292|FG002|NOT COMPLETED|Period 3||0
11207155|NCT01873950|12398293|FG003|NOT COMPLETED|Period 3||0
11207156|NCT01873950|12398294|FG004|NOT COMPLETED|Period 3||0
11207157|NCT01873950|12398290|FG000|STARTED|Period 4||4
11207158|NCT01873950|12398291|FG001|STARTED|Period 4||5
11207159|NCT01873950|12398292|FG002|STARTED|Period 4||4
11207160|NCT01873950|12398293|FG003|STARTED|Period 4||4
11207161|NCT01873950|12398294|FG004|STARTED|Period 4||5
11207162|NCT01873950|12398290|FG000|COMPLETED|Period 4||4
11207163|NCT01873950|12398291|FG001|COMPLETED|Period 4||5
11207164|NCT01873950|12398292|FG002|COMPLETED|Period 4||4
11207165|NCT01873950|12398293|FG003|COMPLETED|Period 4||4
11207166|NCT01873950|12398294|FG004|COMPLETED|Period 4||5
11207167|NCT01873950|12398290|FG000|NOT COMPLETED|Period 4||0
11207168|NCT01873950|12398291|FG001|NOT COMPLETED|Period 4||0
11207169|NCT01873950|12398292|FG002|NOT COMPLETED|Period 4||0
11207170|NCT01873950|12398293|FG003|NOT COMPLETED|Period 4||0
11207171|NCT01873950|12398294|FG004|NOT COMPLETED|Period 4||0
11207172|NCT01873950|12398290|FG000|STARTED|Period 5||4
11079835|NCT01118117|12262433|FG001|NOT COMPLETED|Overall Study||0
11079836|NCT01118143|12262441|FG000|STARTED|Overall Study||64
11079837|NCT01118143|12262442|FG001|STARTED|Overall Study||69
11079838|NCT01118143|12262441|FG000|COMPLETED|Overall Study||62
11079839|NCT01118143|12262442|FG001|COMPLETED|Overall Study||64
11079840|NCT01118143|12262441|FG000|NOT COMPLETED|Overall Study||2
11079841|NCT01118143|12262442|FG001|NOT COMPLETED|Overall Study||5
11079842|NCT01118221|12262452|FG000|STARTED|Overall Study||14
11079843|NCT01118221|12262453|FG001|STARTED|Overall Study||11
11079844|NCT01118221|12262452|FG000|COMPLETED|Overall Study||11
11079845|NCT01118221|12262453|FG001|COMPLETED|Overall Study||10
11079846|NCT01118221|12262452|FG000|NOT COMPLETED|Overall Study||3
11079847|NCT01118221|12262453|FG001|NOT COMPLETED|Overall Study||1
11079848|NCT01118273|12262469|FG000|STARTED|Overall Study||27
11079849|NCT01118273|12262470|FG001|STARTED|Overall Study||27
11079850|NCT01118273|12262471|FG002|STARTED|Overall Study||27
11079851|NCT01118273|12262472|FG003|STARTED|Overall Study||27
11079852|NCT01118273|12262473|FG004|STARTED|Overall Study||27
11079853|NCT01118273|12262474|FG005|STARTED|Overall Study||27
11079854|NCT01118273|12262469|FG000|COMPLETED|Overall Study||27
11079855|NCT01118273|12262470|FG001|COMPLETED|Overall Study||27
11079856|NCT01118273|12262471|FG002|COMPLETED|Overall Study||27
11079857|NCT01118273|12262472|FG003|COMPLETED|Overall Study||27
11079858|NCT01118273|12262473|FG004|COMPLETED|Overall Study||27
11079859|NCT01118273|12262474|FG005|COMPLETED|Overall Study||27
11079860|NCT01118273|12262469|FG000|NOT COMPLETED|Overall Study||0
11079861|NCT01118273|12262470|FG001|NOT COMPLETED|Overall Study||0
11079862|NCT01118273|12262471|FG002|NOT COMPLETED|Overall Study||0
11079863|NCT01118273|12262472|FG003|NOT COMPLETED|Overall Study||0
11079864|NCT01118273|12262473|FG004|NOT COMPLETED|Overall Study||0
11079865|NCT01118273|12262474|FG005|NOT COMPLETED|Overall Study||0
11079866|NCT01118299|12262490|FG000|STARTED|Overall Study||68
11079867|NCT01118299|12262491|FG001|STARTED|Overall Study||29
11079868|NCT01118299|12262490|FG000|COMPLETED|Overall Study||45
11079869|NCT01118299|12262491|FG001|COMPLETED|Overall Study||0
11079870|NCT01118299|12262490|FG000|NOT COMPLETED|Overall Study||23
11079871|NCT01118299|12262491|FG001|NOT COMPLETED|Overall Study||29
11079872|NCT01118312|12262498|FG000|STARTED|Overall Study||189
11079873|NCT01118312|12262499|FG001|STARTED|Overall Study||199
11079874|NCT01118312|12262498|FG000|COMPLETED|Overall Study||155
11079875|NCT01118312|12262499|FG001|COMPLETED|Overall Study||164
11079876|NCT01118312|12262498|FG000|NOT COMPLETED|Overall Study||34
11079877|NCT01118312|12262499|FG001|NOT COMPLETED|Overall Study||35
11079878|NCT01118325|12262508|FG000|STARTED|Overall Study||50
11079879|NCT01118325|12262509|FG001|STARTED|Overall Study||43
11079880|NCT01118325|12262510|FG002|STARTED|Overall Study||46
11079881|NCT01118325|12262508|FG000|COMPLETED|Overall Study||49
11079882|NCT01118325|12262509|FG001|COMPLETED|Overall Study||43
11079883|NCT01118325|12262510|FG002|COMPLETED|Overall Study||45
11079884|NCT01118325|12262508|FG000|NOT COMPLETED|Overall Study||1
11079885|NCT01118325|12262509|FG001|NOT COMPLETED|Overall Study||0
11079886|NCT01118325|12262510|FG002|NOT COMPLETED|Overall Study||1
11079887|NCT01118338|12262533|FG000|STARTED|Overall Study||185
11079888|NCT01118338|12262534|FG001|STARTED|Overall Study||183
11079889|NCT01118338|12262533|FG000|COMPLETED|Overall Study||182
11079890|NCT01118338|12262534|FG001|COMPLETED|Overall Study||174
11079891|NCT01118338|12262533|FG000|NOT COMPLETED|Overall Study||3
11079892|NCT01118338|12262534|FG001|NOT COMPLETED|Overall Study||9
11079893|NCT01118351|12262540|FG000|STARTED|Overall Study||19
11079894|NCT01118351|12262540|FG000|COMPLETED|Overall Study||15
11079895|NCT01118351|12262540|FG000|NOT COMPLETED|Overall Study||4
11079896|NCT01118377|12262544|FG000|STARTED|Overall Study||45
11079897|NCT01118377|12262544|FG000|COMPLETED|Overall Study||3
11079898|NCT01118377|12262544|FG000|NOT COMPLETED|Overall Study||42
11079899|NCT01118455|12262550|FG000|STARTED|Baseline [Visits 1 & 2]||66
11079900|NCT01118455|12262551|FG001|STARTED|Baseline [Visits 1 & 2]||69
11079901|NCT01118455|12262550|FG000|Actual Patients Treated|Baseline [Visits 1 & 2]||65
11079902|NCT01118455|12262551|FG001|Actual Patients Treated|Baseline [Visits 1 & 2]||69
11079903|NCT01118455|12262550|FG000|COMPLETED|Baseline [Visits 1 & 2]||65
11079904|NCT01118455|12262551|FG001|COMPLETED|Baseline [Visits 1 & 2]||69
11079905|NCT01118455|12262550|FG000|NOT COMPLETED|Baseline [Visits 1 & 2]||1
11079906|NCT01118455|12262551|FG001|NOT COMPLETED|Baseline [Visits 1 & 2]||0
11079907|NCT01118455|12262550|FG000|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
11207173|NCT01873950|12398291|FG001|STARTED|Period 5||5
11207174|NCT01873950|12398292|FG002|STARTED|Period 5||4
11207175|NCT01873950|12398293|FG003|STARTED|Period 5||4
11079908|NCT01118455|12262551|FG001|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
11079909|NCT01118455|12262550|FG000|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
11079910|NCT01118455|12262551|FG001|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
11079911|NCT01118455|12262550|FG000|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
11079912|NCT01118455|12262551|FG001|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
11079913|NCT01118520|12262568|FG000|STARTED|Overall Study||73
11079914|NCT01118520|12262569|FG001|STARTED|Overall Study||72
11079915|NCT01118520|12262570|FG002|STARTED|Overall Study||79
11079916|NCT01118520|12262568|FG000|COMPLETED|Overall Study||53
11079917|NCT01118520|12262569|FG001|COMPLETED|Overall Study||49
11079918|NCT01118520|12262570|FG002|COMPLETED|Overall Study||59
11079919|NCT01118520|12262568|FG000|NOT COMPLETED|Overall Study||20
11079920|NCT01118520|12262569|FG001|NOT COMPLETED|Overall Study||23
11079921|NCT01118520|12262570|FG002|NOT COMPLETED|Overall Study||20
11079922|NCT01118624|12262578|FG000|STARTED|Overall Study||22
11079923|NCT01118624|12262578|FG000|COMPLETED|Overall Study||0
11079924|NCT01118624|12262578|FG000|NOT COMPLETED|Overall Study||22
11079925|NCT01118663|12262584|FG000|STARTED|Overall Study||7
11079926|NCT01118663|12262585|FG001|STARTED|Overall Study||10
11079927|NCT01118663|12262584|FG000|COMPLETED|Overall Study||5
11079928|NCT01118663|12262585|FG001|COMPLETED|Overall Study||8
11079929|NCT01118663|12262584|FG000|NOT COMPLETED|Overall Study||2
11079930|NCT01118663|12262585|FG001|NOT COMPLETED|Overall Study||2
11079931|NCT01118715|12262593|FG000|STARTED|Overall Study||68
11079932|NCT01118715|12262594|FG001|STARTED|Overall Study||60
11079933|NCT01118715|12262593|FG000|COMPLETED|Overall Study||68
11079934|NCT01118715|12262594|FG001|COMPLETED|Overall Study||60
11079935|NCT01118715|12262593|FG000|NOT COMPLETED|Overall Study||0
11079936|NCT01118715|12262594|FG001|NOT COMPLETED|Overall Study||0
11079937|NCT01118728|12262621|FG000|STARTED|Overall Study||223
11079938|NCT01118728|12262621|FG000|COMPLETED|Overall Study||0
11079939|NCT01118728|12262621|FG000|NOT COMPLETED|Overall Study||223
11079940|NCT01118741|12262627|FG000|STARTED|Overall Study||9
11079941|NCT01118741|12262628|FG001|STARTED|Overall Study||10
11079942|NCT01118741|12262627|FG000|COMPLETED|Overall Study||9
11079943|NCT01118741|12262628|FG001|COMPLETED|Overall Study||10
11079944|NCT01118741|12262627|FG000|NOT COMPLETED|Overall Study||0
11079945|NCT01118741|12262628|FG001|NOT COMPLETED|Overall Study||0
11079946|NCT01118780|12262638|FG000|STARTED|Overall Study||151
11079947|NCT01118780|12262639|FG001|STARTED|Overall Study||140
11079948|NCT01118780|12262638|FG000|COMPLETED|Overall Study||115
11079949|NCT01118780|12262639|FG001|COMPLETED|Overall Study||105
11079950|NCT01118780|12262638|FG000|NOT COMPLETED|Overall Study||36
11079951|NCT01118780|12262639|FG001|NOT COMPLETED|Overall Study||35
11079952|NCT01118845|12262648|FG000|STARTED|Overall Study||59
11079953|NCT01118845|12262648|FG000|COMPLETED|Overall Study||17
11079954|NCT01118845|12262648|FG000|NOT COMPLETED|Overall Study||42
11079955|NCT01118949|12262652|FG000|STARTED|Overall Study||49
11079956|NCT01118949|12262652|FG000|COMPLETED|Overall Study||40
11079957|NCT01118949|12262652|FG000|NOT COMPLETED|Overall Study||9
11079958|NCT01118962|12262656|FG000|STARTED|Overall Study||39
11079959|NCT01118962|12262656|FG000|COMPLETED|Overall Study||29
11079960|NCT01118962|12262656|FG000|NOT COMPLETED|Overall Study||10
11079961|NCT01118975|12262662|FG000|STARTED|Overall Study||9
11079962|NCT01118975|12262663|FG001|STARTED|Overall Study||3
11079963|NCT01118975|12262662|FG000|COMPLETED|Overall Study||9
11079964|NCT01118975|12262663|FG001|COMPLETED|Overall Study||2
11079965|NCT01118975|12262662|FG000|NOT COMPLETED|Overall Study||0
11079966|NCT01118975|12262663|FG001|NOT COMPLETED|Overall Study||1
11079967|NCT01118988|12262672|FG000|STARTED|Overall Study||16
11079968|NCT01118988|12262673|FG001|STARTED|Overall Study||4
11079969|NCT01118988|12262674|FG002|STARTED|Overall Study||7
11079970|NCT01118988|12262672|FG000|COMPLETED|Overall Study||11
11079971|NCT01118988|12262673|FG001|COMPLETED|Overall Study||3
11079972|NCT01118988|12262674|FG002|COMPLETED|Overall Study||3
11079973|NCT01118988|12262672|FG000|NOT COMPLETED|Overall Study||5
11079974|NCT01118988|12262673|FG001|NOT COMPLETED|Overall Study||1
11079975|NCT01118988|12262674|FG002|NOT COMPLETED|Overall Study||4
11079976|NCT01119001|12262681|FG000|STARTED|Overall Study||13
11079977|NCT01119001|12262681|FG000|COMPLETED|Overall Study||11
11079978|NCT01119001|12262681|FG000|NOT COMPLETED|Overall Study||2
11079979|NCT01119040|12262687|FG000|STARTED|Overall Study||1
11079980|NCT01119040|12262687|FG000|COMPLETED|Overall Study||0
11079981|NCT01119040|12262687|FG000|NOT COMPLETED|Overall Study||1
11079982|NCT01119105|12262694|FG000|STARTED|Overall Study||70
11079983|NCT01119105|12262695|FG001|STARTED|Overall Study||72
11079984|NCT01119105|12262696|FG002|STARTED|Overall Study||68
11079985|NCT01119105|12262694|FG000|COMPLETED|Overall Study||66
11079986|NCT01119105|12262695|FG001|COMPLETED|Overall Study||66
11079987|NCT01119105|12262696|FG002|COMPLETED|Overall Study||60
11079988|NCT01119105|12262694|FG000|NOT COMPLETED|Overall Study||4
11079989|NCT01119105|12262695|FG001|NOT COMPLETED|Overall Study||6
11079990|NCT01119105|12262696|FG002|NOT COMPLETED|Overall Study||8
11079991|NCT01119118|12262704|FG000|STARTED|Overall Study||6
11079992|NCT01119118|12262704|FG000|COMPLETED|Overall Study||5
11079993|NCT01119118|12262704|FG000|NOT COMPLETED|Overall Study||1
11079994|NCT01119131|12262711|FG000|STARTED|Overall Study||10
11079995|NCT01119131|12262712|FG001|STARTED|Overall Study||28
11079996|NCT01119131|12262713|FG002|STARTED|Overall Study||30
11079997|NCT01119131|12262711|FG000|COMPLETED|Overall Study||8
11079998|NCT01119131|12262712|FG001|COMPLETED|Overall Study||27
11079999|NCT01119131|12262713|FG002|COMPLETED|Overall Study||24
11080000|NCT01119131|12262711|FG000|NOT COMPLETED|Overall Study||2
11080001|NCT01119131|12262712|FG001|NOT COMPLETED|Overall Study||1
11080002|NCT01119131|12262713|FG002|NOT COMPLETED|Overall Study||6
11080003|NCT01119222|12262721|FG000|STARTED|Overall Study||5
11080004|NCT01119222|12262722|FG001|STARTED|Overall Study||5
11080005|NCT01119222|12262723|FG002|STARTED|Overall Study||5
11080006|NCT01119222|12262724|FG003|STARTED|Overall Study||4
11080007|NCT01119222|12262721|FG000|COMPLETED|Overall Study||5
11080008|NCT01119222|12262722|FG001|COMPLETED|Overall Study||5
11080009|NCT01119222|12262723|FG002|COMPLETED|Overall Study||5
11080010|NCT01119222|12262724|FG003|COMPLETED|Overall Study||4
11080011|NCT01119222|12262721|FG000|NOT COMPLETED|Overall Study||0
11080012|NCT01119222|12262722|FG001|NOT COMPLETED|Overall Study||0
11080013|NCT01119222|12262723|FG002|NOT COMPLETED|Overall Study||0
11080014|NCT01119222|12262724|FG003|NOT COMPLETED|Overall Study||0
11080015|NCT01119248|12262737|FG000|STARTED|Overall Study||120
11080016|NCT01119248|12262737|FG000|COMPLETED|Overall Study||115
11080017|NCT01119248|12262737|FG000|NOT COMPLETED|Overall Study||5
11080018|NCT01119287|12262748|FG000|STARTED|Overall Study||26
11080019|NCT01119287|12262749|FG001|STARTED|Overall Study||24
11080020|NCT01119287|12262750|FG002|STARTED|Overall Study||26
11080021|NCT01119287|12262751|FG003|STARTED|Overall Study||31
11080022|NCT01119287|12262752|FG004|STARTED|Overall Study||31
11080023|NCT01119287|12262753|FG005|STARTED|Overall Study||32
11080024|NCT01119287|12262748|FG000|COMPLETED|Overall Study||26
11080025|NCT01119287|12262749|FG001|COMPLETED|Overall Study||24
11080026|NCT01119287|12262750|FG002|COMPLETED|Overall Study||24
11080027|NCT01119287|12262751|FG003|COMPLETED|Overall Study||29
11080028|NCT01119287|12262752|FG004|COMPLETED|Overall Study||30
11080029|NCT01119287|12262753|FG005|COMPLETED|Overall Study||32
11080030|NCT01119287|12262748|FG000|NOT COMPLETED|Overall Study||0
11080031|NCT01119287|12262749|FG001|NOT COMPLETED|Overall Study||0
11080032|NCT01119287|12262750|FG002|NOT COMPLETED|Overall Study||2
11080033|NCT01119287|12262751|FG003|NOT COMPLETED|Overall Study||2
11080034|NCT01119287|12262752|FG004|NOT COMPLETED|Overall Study||1
11080035|NCT01119287|12262753|FG005|NOT COMPLETED|Overall Study||0
11080036|NCT01119443|12262767|FG000|STARTED|Up-titration Period (10 Days)||14
11080037|NCT01119443|12262768|FG001|STARTED|Up-titration Period (10 Days)||14
11080038|NCT01119443|12262767|FG000|COMPLETED|Up-titration Period (10 Days)||14
11080039|NCT01119443|12262768|FG001|COMPLETED|Up-titration Period (10 Days)||14
11080040|NCT01119443|12262767|FG000|NOT COMPLETED|Up-titration Period (10 Days)||0
11080041|NCT01119443|12262768|FG001|NOT COMPLETED|Up-titration Period (10 Days)||0
11080042|NCT01119443|12262767|FG000|STARTED|Crossover Period 1 (5 Days)||14
11080043|NCT01119443|12262768|FG001|STARTED|Crossover Period 1 (5 Days)||14
11080044|NCT01119443|12262767|FG000|COMPLETED|Crossover Period 1 (5 Days)||14
11080045|NCT01119443|12262768|FG001|COMPLETED|Crossover Period 1 (5 Days)||13
11080046|NCT01119443|12262767|FG000|NOT COMPLETED|Crossover Period 1 (5 Days)||0
11080047|NCT01119443|12262768|FG001|NOT COMPLETED|Crossover Period 1 (5 Days)||1
11080048|NCT01119443|12262767|FG000|STARTED|Crossover Period 2 (5 Days)||14
11080049|NCT01119443|12262768|FG001|STARTED|Crossover Period 2 (5 Days)||13
11080050|NCT01119443|12262767|FG000|COMPLETED|Crossover Period 2 (5 Days)||14
11080051|NCT01119443|12262768|FG001|COMPLETED|Crossover Period 2 (5 Days)||13
11080052|NCT01119443|12262767|FG000|NOT COMPLETED|Crossover Period 2 (5 Days)||0
11080053|NCT01119443|12262768|FG001|NOT COMPLETED|Crossover Period 2 (5 Days)||0
11080054|NCT01119443|12262767|FG000|STARTED|Crossover Period 3 (5 Days)||14
11080055|NCT01119443|12262768|FG001|STARTED|Crossover Period 3 (5 Days)||13
11080056|NCT01119443|12262767|FG000|COMPLETED|Crossover Period 3 (5 Days)||14
11080057|NCT01119443|12262768|FG001|COMPLETED|Crossover Period 3 (5 Days)||13
11080058|NCT01119443|12262767|FG000|NOT COMPLETED|Crossover Period 3 (5 Days)||0
11080059|NCT01119443|12262768|FG001|NOT COMPLETED|Crossover Period 3 (5 Days)||0
11080060|NCT01119443|12262767|FG000|STARTED|Crossover Period 4 (5 Days)||14
11080061|NCT01119443|12262768|FG001|STARTED|Crossover Period 4 (5 Days)||13
11080062|NCT01119443|12262767|FG000|COMPLETED|Crossover Period 4 (5 Days)||14
11080063|NCT01119443|12262768|FG001|COMPLETED|Crossover Period 4 (5 Days)||13
11080064|NCT01119443|12262767|FG000|NOT COMPLETED|Crossover Period 4 (5 Days)||0
11080065|NCT01119443|12262768|FG001|NOT COMPLETED|Crossover Period 4 (5 Days)||0
11080066|NCT01119443|12262767|FG000|STARTED|Down-titration Period (1 Day)||14
11080067|NCT01119443|12262768|FG001|STARTED|Down-titration Period (1 Day)||13
11080068|NCT01119443|12262767|FG000|COMPLETED|Down-titration Period (1 Day)||14
11080069|NCT01119443|12262768|FG001|COMPLETED|Down-titration Period (1 Day)||13
11080070|NCT01119443|12262767|FG000|NOT COMPLETED|Down-titration Period (1 Day)||0
11080071|NCT01119443|12262768|FG001|NOT COMPLETED|Down-titration Period (1 Day)||0
11080072|NCT01119443|12262767|FG000|STARTED|End of Study (All Patients)||14
11080073|NCT01119443|12262768|FG001|STARTED|End of Study (All Patients)||14
11080074|NCT01119443|12262767|FG000|COMPLETED|End of Study (All Patients)||14
11080075|NCT01119443|12262768|FG001|COMPLETED|End of Study (All Patients)||14
11080076|NCT01119443|12262767|FG000|NOT COMPLETED|End of Study (All Patients)||0
11080077|NCT01119443|12262768|FG001|NOT COMPLETED|End of Study (All Patients)||0
11080078|NCT01119456|12262785|FG000|STARTED|Overall Study||7
11080079|NCT01119456|12262786|FG001|STARTED|Overall Study||3
11080080|NCT01119456|12262787|FG002|STARTED|Overall Study||3
11080081|NCT01119456|12262788|FG003|STARTED|Overall Study||13
11080082|NCT01119456|12262789|FG004|STARTED|Overall Study||4
11080083|NCT01119456|12262790|FG005|STARTED|Overall Study||3
11080084|NCT01119456|12262791|FG006|STARTED|Overall Study||3
11080085|NCT01119456|12262792|FG007|STARTED|Overall Study||3
11080086|NCT01119456|12262785|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
11080087|NCT01119456|12262786|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
11080088|NCT01119456|12262787|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
11080089|NCT01119456|12262788|FG003|Received at Least 1 Dose of Study Drug|Overall Study||13
11080090|NCT01119456|12262789|FG004|Received at Least 1 Dose of Study Drug|Overall Study||4
11080091|NCT01119456|12262790|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
11080092|NCT01119456|12262791|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
11080093|NCT01119456|12262792|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
11080094|NCT01119456|12262785|FG000|COMPLETED|Overall Study||7
11080095|NCT01119456|12262786|FG001|COMPLETED|Overall Study||3
11080096|NCT01119456|12262787|FG002|COMPLETED|Overall Study||3
11080097|NCT01119456|12262788|FG003|COMPLETED|Overall Study||13
11080098|NCT01119456|12262789|FG004|COMPLETED|Overall Study||4
11080099|NCT01119456|12262790|FG005|COMPLETED|Overall Study||3
11080100|NCT01119456|12262791|FG006|COMPLETED|Overall Study||3
11080101|NCT01119456|12262792|FG007|COMPLETED|Overall Study||3
11080102|NCT01119456|12262785|FG000|NOT COMPLETED|Overall Study||0
11080103|NCT01119456|12262786|FG001|NOT COMPLETED|Overall Study||0
11080104|NCT01119456|12262787|FG002|NOT COMPLETED|Overall Study||0
11080105|NCT01119456|12262788|FG003|NOT COMPLETED|Overall Study||0
11080106|NCT01119456|12262789|FG004|NOT COMPLETED|Overall Study||0
11080107|NCT01119456|12262790|FG005|NOT COMPLETED|Overall Study||0
11080108|NCT01119456|12262791|FG006|NOT COMPLETED|Overall Study||0
11080109|NCT01119456|12262792|FG007|NOT COMPLETED|Overall Study||0
11080110|NCT01119508|12262817|FG000|STARTED|Overall Study||64
11080111|NCT01119508|12262817|FG000|Received Four Induction Doses|Overall Study||45
11080112|NCT01119508|12262817|FG000|Received Fifth Consolidation Dose week12|Overall Study||32
11080113|NCT01119508|12262817|FG000|COMPLETED|Overall Study||5
11080114|NCT01119508|12262817|FG000|NOT COMPLETED|Overall Study||59
11080115|NCT01119625|12262823|FG000|STARTED|Overall Study||118
11080116|NCT01119625|12262824|FG001|STARTED|Overall Study||120
11080117|NCT01119625|12262823|FG000|COMPLETED|Overall Study||115
11080118|NCT01119625|12262824|FG001|COMPLETED|Overall Study||116
11080119|NCT01119625|12262823|FG000|NOT COMPLETED|Overall Study||3
11080120|NCT01119625|12262824|FG001|NOT COMPLETED|Overall Study||4
11080121|NCT01119703|12262832|FG000|STARTED|Overall Study||30
11080122|NCT01119703|12262833|FG001|STARTED|Overall Study||144
11080123|NCT01119703|12262832|FG000|COMPLETED|Overall Study||30
11080124|NCT01119703|12262833|FG001|COMPLETED|Overall Study||143
11080125|NCT01119703|12262832|FG000|NOT COMPLETED|Overall Study||0
11080126|NCT01119703|12262833|FG001|NOT COMPLETED|Overall Study||1
11080127|NCT01119716|12262838|FG000|STARTED|Overall Study||4658
11349062|NCT03011099|12546080|FG001|COMPLETED|Overall Study||3
11349063|NCT03011099|12546079|FG000|NOT COMPLETED|Overall Study||0
11349064|NCT03011099|12546080|FG001|NOT COMPLETED|Overall Study||2
11349065|NCT03011333|12546095|FG000|STARTED|Overall Study||12
11349066|NCT03011333|12546096|FG001|STARTED|Overall Study||27
11349067|NCT03011333|12546097|FG002|STARTED|Overall Study||25
11349068|NCT03011333|12546098|FG003|STARTED|Overall Study||47
11349069|NCT03011333|12546099|FG004|STARTED|Overall Study||50
11349070|NCT03011333|12546100|FG005|STARTED|Overall Study||41
11349071|NCT03011333|12546101|FG006|STARTED|Overall Study||41
11349072|NCT03011333|12546095|FG000|COMPLETED|Overall Study||12
11349073|NCT03011333|12546096|FG001|COMPLETED|Overall Study||26
11349074|NCT03011333|12546097|FG002|COMPLETED|Overall Study||25
11349075|NCT03011333|12546098|FG003|COMPLETED|Overall Study||46
11349076|NCT03011333|12546099|FG004|COMPLETED|Overall Study||46
11349077|NCT03011333|12546100|FG005|COMPLETED|Overall Study||37
11349078|NCT03011333|12546101|FG006|COMPLETED|Overall Study||36
11349079|NCT03011333|12546095|FG000|NOT COMPLETED|Overall Study||0
11349080|NCT03011333|12546096|FG001|NOT COMPLETED|Overall Study||1
11349081|NCT03011333|12546097|FG002|NOT COMPLETED|Overall Study||0
11349082|NCT03011333|12546098|FG003|NOT COMPLETED|Overall Study||1
11349083|NCT03011333|12546099|FG004|NOT COMPLETED|Overall Study||4
11349084|NCT03011333|12546100|FG005|NOT COMPLETED|Overall Study||4
11349085|NCT03011333|12546101|FG006|NOT COMPLETED|Overall Study||5
11349086|NCT03011840|12546119|FG000|STARTED|Overall Study||232
11349087|NCT03011840|12546120|FG001|STARTED|Overall Study||217
11349088|NCT03011840|12546119|FG000|COMPLETED|Overall Study||232
11349089|NCT03011840|12546120|FG001|COMPLETED|Overall Study||196
11349090|NCT03011840|12546119|FG000|NOT COMPLETED|Overall Study||0
11349091|NCT03011840|12546120|FG001|NOT COMPLETED|Overall Study||21
11349092|NCT03011892|12546132|FG000|STARTED|Double Blind (DB) Period||52
11349093|NCT03011892|12546133|FG001|STARTED|Double Blind (DB) Period||51
11349094|NCT03011892|12546134|FG002|STARTED|Double Blind (DB) Period||51
11349095|NCT03011892|12546135|FG003|STARTED|Double Blind (DB) Period||51
11349096|NCT03011892|12546136|FG004|STARTED|Double Blind (DB) Period||52
11349097|NCT03011892|12546137|FG005|STARTED|Double Blind (DB) Period||50
11349098|NCT03011892|12546138|FG006|STARTED|Double Blind (DB) Period||0
11080128|NCT01119716|12262838|FG000|COMPLETED|Overall Study||4658
11080129|NCT01119716|12262838|FG000|NOT COMPLETED|Overall Study||0
11080130|NCT01119755|12262846|FG000|STARTED|Overall Study||80
11080131|NCT01119755|12262846|FG000|COMPLETED|Overall Study||80
11349099|NCT03011892|12546139|FG007|STARTED|Double Blind (DB) Period||0
11349100|NCT03011892|12546140|FG008|STARTED|Double Blind (DB) Period||0
11349101|NCT03011892|12546141|FG009|STARTED|Double Blind (DB) Period||0
11349102|NCT03011892|12546142|FG010|STARTED|Double Blind (DB) Period||0
11349103|NCT03011892|12546143|FG011|STARTED|Double Blind (DB) Period||0
11080132|NCT01119755|12262846|FG000|NOT COMPLETED|Overall Study||0
11080133|NCT01119768|12262852|FG000|STARTED|Treatment Period||154
11080134|NCT01119768|12262853|FG001|STARTED|Treatment Period||151
11349104|NCT03011892|12546132|FG000|Treated in DB Period|Double Blind (DB) Period||52
11349105|NCT03011892|12546133|FG001|Treated in DB Period|Double Blind (DB) Period||51
11080135|NCT01119768|12262852|FG000|COMPLETED|Treatment Period||136
11080136|NCT01119768|12262853|FG001|COMPLETED|Treatment Period||126
11080137|NCT01119768|12262852|FG000|NOT COMPLETED|Treatment Period||18
11080138|NCT01119768|12262853|FG001|NOT COMPLETED|Treatment Period||25
11080139|NCT01119768|12262852|FG000|STARTED|Follow-up||136
11080140|NCT01119768|12262853|FG001|STARTED|Follow-up||124
11080141|NCT01119768|12262852|FG000|COMPLETED|Follow-up||135
11080142|NCT01119768|12262853|FG001|COMPLETED|Follow-up||122
11080143|NCT01119768|12262852|FG000|NOT COMPLETED|Follow-up||1
11080144|NCT01119768|12262853|FG001|NOT COMPLETED|Follow-up||2
11080145|NCT01119794|12262859|FG000|STARTED|Overall Study||10
11080146|NCT01119794|12262859|FG000|COMPLETED|Overall Study||10
11080147|NCT01119794|12262859|FG000|NOT COMPLETED|Overall Study||0
11080148|NCT01119846|12262866|FG000|STARTED|Overall Study||13
11080149|NCT01119846|12262867|FG001|STARTED|Overall Study||4
11080150|NCT01119846|12262868|FG002|STARTED|Overall Study||83
11080151|NCT01119846|12262866|FG000|COMPLETED|Overall Study||11
11080152|NCT01119846|12262867|FG001|COMPLETED|Overall Study||4
11080153|NCT01119846|12262868|FG002|COMPLETED|Overall Study||72
11080154|NCT01119846|12262866|FG000|NOT COMPLETED|Overall Study||2
11080155|NCT01119846|12262867|FG001|NOT COMPLETED|Overall Study||0
11080156|NCT01119846|12262868|FG002|NOT COMPLETED|Overall Study||11
11080157|NCT01119859|12262905|FG000|STARTED|Overall Study||163
11080158|NCT01119859|12262906|FG001|STARTED|Overall Study||163
11080159|NCT01119859|12262905|FG000|COMPLETED|Overall Study||139
11080160|NCT01119859|12262906|FG001|COMPLETED|Overall Study||133
11080161|NCT01119859|12262905|FG000|NOT COMPLETED|Overall Study||24
11080162|NCT01119859|12262906|FG001|NOT COMPLETED|Overall Study||30
11080163|NCT01119898|12262914|FG000|STARTED|Overall Study||131
11080164|NCT01119898|12262915|FG001|STARTED|Overall Study||129
11080165|NCT01119898|12262914|FG000|Received Study Drug (mITT)|Overall Study||130
11080166|NCT01119898|12262915|FG001|Received Study Drug (mITT)|Overall Study||129
11080167|NCT01119898|12262914|FG000|COMPLETED|Overall Study||123
11080168|NCT01119898|12262915|FG001|COMPLETED|Overall Study||117
11080169|NCT01119898|12262914|FG000|NOT COMPLETED|Overall Study||8
11080170|NCT01119898|12262915|FG001|NOT COMPLETED|Overall Study||12
11080171|NCT01119937|12262923|FG000|STARTED|Overall Study||123
11080172|NCT01119937|12262924|FG001|STARTED|Overall Study||40
11080173|NCT01119937|12262923|FG000|COMPLETED|Overall Study||104
11080174|NCT01119937|12262924|FG001|COMPLETED|Overall Study||33
11080175|NCT01119937|12262923|FG000|NOT COMPLETED|Overall Study||19
11080176|NCT01119937|12262924|FG001|NOT COMPLETED|Overall Study||7
11080177|NCT01119950|12262930|FG000|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
11080178|NCT01119950|12262930|FG000|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
11080179|NCT01119950|12262930|FG000|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
11080180|NCT01119950|12262930|FG000|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
11080181|NCT01119950|12262930|FG000|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
11080182|NCT01119950|12262930|FG000|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
11080183|NCT01119950|12262930|FG000|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
11080184|NCT01119950|12262930|FG000|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
11080185|NCT01119950|12262930|FG000|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
11080186|NCT01119950|12262930|FG000|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
11080187|NCT01119950|12262930|FG000|NOT COMPLETED|Overall Study||47
11080188|NCT01119963|12262958|FG000|STARTED|Overall Study||74
11080189|NCT01119963|12262959|FG001|STARTED|Overall Study||78
11080190|NCT01119963|12262958|FG000|COMPLETED|Overall Study||73
11080191|NCT01119963|12262959|FG001|COMPLETED|Overall Study||77
11080192|NCT01119963|12262958|FG000|NOT COMPLETED|Overall Study||1
11080193|NCT01119963|12262959|FG001|NOT COMPLETED|Overall Study||1
11080194|NCT01120028|12262971|FG000|STARTED|Period 1: Alemtuzumab or Basiliximab||426
11080195|NCT01120028|12262972|FG001|STARTED|Period 1: Alemtuzumab or Basiliximab||426
11080196|NCT01120028|12262973|FG002|STARTED|Period 1: Alemtuzumab or Basiliximab||0
11080197|NCT01120028|12262974|FG003|STARTED|Period 1: Alemtuzumab or Basiliximab||0
11080198|NCT01120028|12262971|FG000|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412
11080199|NCT01120028|12262972|FG001|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403
11080200|NCT01120028|12262973|FG002|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
11080201|NCT01120028|12262974|FG003|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
11080202|NCT01120028|12262971|FG000|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14
11080203|NCT01120028|12262972|FG001|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23
11080204|NCT01120028|12262973|FG002|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
11080205|NCT01120028|12262974|FG003|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
11080206|NCT01120028|12262971|FG000|STARTED|Period 2: Tacrolimus or Sirolimus||0
11080207|NCT01120028|12262972|FG001|STARTED|Period 2: Tacrolimus or Sirolimus||0
11080208|NCT01120028|12262973|FG002|STARTED|Period 2: Tacrolimus or Sirolimus||197
11080209|NCT01120028|12262974|FG003|STARTED|Period 2: Tacrolimus or Sirolimus||197
11080210|NCT01120028|12262971|FG000|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
11080211|NCT01120028|12262972|FG001|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
11080212|NCT01120028|12262973|FG002|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
11080213|NCT01120028|12262974|FG003|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
11080214|NCT01120028|12262971|FG000|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
11080215|NCT01120028|12262972|FG001|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
11080216|NCT01120028|12262973|FG002|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
11080217|NCT01120028|12262974|FG003|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
11080218|NCT01120067|12262987|FG000|STARTED|Overall Study||12
11080219|NCT01120067|12262988|FG001|STARTED|Overall Study||11
11080220|NCT01120067|12262987|FG000|COMPLETED|Overall Study||7
11080221|NCT01120067|12262988|FG001|COMPLETED|Overall Study||10
11080222|NCT01120067|12262987|FG000|NOT COMPLETED|Overall Study||5
11080223|NCT01120067|12262988|FG001|NOT COMPLETED|Overall Study||1
11080224|NCT01120093|12262994|FG000|STARTED|Treatment Period 1||18
11080225|NCT01120093|12262995|FG001|STARTED|Treatment Period 1||14
11080226|NCT01120093|12262996|FG002|STARTED|Treatment Period 1||17
11080227|NCT01120093|12262997|FG003|STARTED|Treatment Period 1||14
11080228|NCT01120093|12262998|FG004|STARTED|Treatment Period 1||16
11080229|NCT01120093|12262994|FG000|COMPLETED|Treatment Period 1||18
11080230|NCT01120093|12262995|FG001|COMPLETED|Treatment Period 1||13
11080231|NCT01120093|12262996|FG002|COMPLETED|Treatment Period 1||16
11080232|NCT01120093|12262997|FG003|COMPLETED|Treatment Period 1||14
11080233|NCT01120093|12262998|FG004|COMPLETED|Treatment Period 1||15
11080234|NCT01120093|12262994|FG000|NOT COMPLETED|Treatment Period 1||0
11080235|NCT01120093|12262995|FG001|NOT COMPLETED|Treatment Period 1||1
11080236|NCT01120093|12262996|FG002|NOT COMPLETED|Treatment Period 1||1
11080237|NCT01120093|12262997|FG003|NOT COMPLETED|Treatment Period 1||0
11080238|NCT01120093|12262998|FG004|NOT COMPLETED|Treatment Period 1||1
11080239|NCT01120093|12262994|FG000|STARTED|Treatment Period 2||18
11080240|NCT01120093|12262995|FG001|STARTED|Treatment Period 2||13
11080241|NCT01120093|12262996|FG002|STARTED|Treatment Period 2||16
11080242|NCT01120093|12262997|FG003|STARTED|Treatment Period 2||14
11080243|NCT01120093|12262998|FG004|STARTED|Treatment Period 2||15
11080244|NCT01120093|12262994|FG000|COMPLETED|Treatment Period 2||18
11080245|NCT01120093|12262995|FG001|COMPLETED|Treatment Period 2||13
11080246|NCT01120093|12262996|FG002|COMPLETED|Treatment Period 2||16
11080247|NCT01120093|12262997|FG003|COMPLETED|Treatment Period 2||13
11080248|NCT01120093|12262998|FG004|COMPLETED|Treatment Period 2||14
11080249|NCT01120093|12262994|FG000|NOT COMPLETED|Treatment Period 2||0
11080250|NCT01120093|12262995|FG001|NOT COMPLETED|Treatment Period 2||0
11080251|NCT01120093|12262996|FG002|NOT COMPLETED|Treatment Period 2||0
11080252|NCT01120093|12262997|FG003|NOT COMPLETED|Treatment Period 2||1
11080253|NCT01120093|12262998|FG004|NOT COMPLETED|Treatment Period 2||1
11080254|NCT01120093|12262994|FG000|STARTED|Treatment Period 3||18
11080255|NCT01120093|12262995|FG001|STARTED|Treatment Period 3||13
11080256|NCT01120093|12262996|FG002|STARTED|Treatment Period 3||16
11080257|NCT01120093|12262997|FG003|STARTED|Treatment Period 3||13
11080258|NCT01120093|12262998|FG004|STARTED|Treatment Period 3||14
11080259|NCT01120093|12262994|FG000|COMPLETED|Treatment Period 3||18
11080260|NCT01120093|12262995|FG001|COMPLETED|Treatment Period 3||13
11080261|NCT01120093|12262996|FG002|COMPLETED|Treatment Period 3||15
11080262|NCT01120093|12262997|FG003|COMPLETED|Treatment Period 3||12
11080263|NCT01120093|12262998|FG004|COMPLETED|Treatment Period 3||13
11080264|NCT01120093|12262994|FG000|NOT COMPLETED|Treatment Period 3||0
11080265|NCT01120093|12262995|FG001|NOT COMPLETED|Treatment Period 3||0
11080266|NCT01120093|12262996|FG002|NOT COMPLETED|Treatment Period 3||1
11080267|NCT01120093|12262997|FG003|NOT COMPLETED|Treatment Period 3||1
11080268|NCT01120093|12262998|FG004|NOT COMPLETED|Treatment Period 3||1
11080269|NCT01120093|12262994|FG000|STARTED|Treatment Period 4||18
11080270|NCT01120093|12262995|FG001|STARTED|Treatment Period 4||13
11080271|NCT01120093|12262996|FG002|STARTED|Treatment Period 4||15
11080272|NCT01120093|12262997|FG003|STARTED|Treatment Period 4||12
11080273|NCT01120093|12262998|FG004|STARTED|Treatment Period 4||13
11080274|NCT01120093|12262994|FG000|COMPLETED|Treatment Period 4||17
11080275|NCT01120093|12262995|FG001|COMPLETED|Treatment Period 4||13
11080276|NCT01120093|12262996|FG002|COMPLETED|Treatment Period 4||15
11080277|NCT01120093|12262997|FG003|COMPLETED|Treatment Period 4||12
11080278|NCT01120093|12262998|FG004|COMPLETED|Treatment Period 4||13
11080279|NCT01120093|12262994|FG000|NOT COMPLETED|Treatment Period 4||1
11080280|NCT01120093|12262995|FG001|NOT COMPLETED|Treatment Period 4||0
11080281|NCT01120093|12262996|FG002|NOT COMPLETED|Treatment Period 4||0
11080282|NCT01120093|12262997|FG003|NOT COMPLETED|Treatment Period 4||0
11080283|NCT01120093|12262998|FG004|NOT COMPLETED|Treatment Period 4||0
11080284|NCT01120093|12262994|FG000|STARTED|Treatment Period 5||17
11080285|NCT01120093|12262995|FG001|STARTED|Treatment Period 5||13
11080286|NCT01120093|12262996|FG002|STARTED|Treatment Period 5||15
11080287|NCT01120093|12262997|FG003|STARTED|Treatment Period 5||12
11080288|NCT01120093|12262998|FG004|STARTED|Treatment Period 5||13
11080289|NCT01120093|12262994|FG000|COMPLETED|Treatment Period 5||17
11080290|NCT01120093|12262995|FG001|COMPLETED|Treatment Period 5||12
11080291|NCT01120093|12262996|FG002|COMPLETED|Treatment Period 5||15
11080292|NCT01120093|12262997|FG003|COMPLETED|Treatment Period 5||11
11080293|NCT01120093|12262998|FG004|COMPLETED|Treatment Period 5||13
11080294|NCT01120093|12262994|FG000|NOT COMPLETED|Treatment Period 5||0
11080295|NCT01120093|12262995|FG001|NOT COMPLETED|Treatment Period 5||1
11080296|NCT01120093|12262996|FG002|NOT COMPLETED|Treatment Period 5||0
11080297|NCT01120093|12262997|FG003|NOT COMPLETED|Treatment Period 5||1
11080298|NCT01120093|12262998|FG004|NOT COMPLETED|Treatment Period 5||0
11080299|NCT01120184|12263013|FG000|STARTED|Overall Study||365
11080300|NCT01120184|12263014|FG001|STARTED|Overall Study||367
11080301|NCT01120184|12263015|FG002|STARTED|Overall Study||363
11080302|NCT01120184|12263013|FG000|Treated|Overall Study||355
11349106|NCT03011892|12546134|FG002|Treated in DB Period|Double Blind (DB) Period||51
11349107|NCT03011892|12546135|FG003|Treated in DB Period|Double Blind (DB) Period||51
11349108|NCT03011892|12546136|FG004|Treated in DB Period|Double Blind (DB) Period||51
11349109|NCT03011892|12546137|FG005|Treated in DB Period|Double Blind (DB) Period||50
11349110|NCT03011892|12546138|FG006|Treated in DB Period|Double Blind (DB) Period||0
11349111|NCT03011892|12546139|FG007|Treated in DB Period|Double Blind (DB) Period||0
11349112|NCT03011892|12546140|FG008|Treated in DB Period|Double Blind (DB) Period||0
11349113|NCT03011892|12546141|FG009|Treated in DB Period|Double Blind (DB) Period||0
11349114|NCT03011892|12546142|FG010|Treated in DB Period|Double Blind (DB) Period||0
11349115|NCT03011892|12546143|FG011|Treated in DB Period|Double Blind (DB) Period||0
11349116|NCT03011892|12546132|FG000|Completed Treatment Through Week 4|Double Blind (DB) Period||44
11349117|NCT03011892|12546133|FG001|Completed Treatment Through Week 4|Double Blind (DB) Period||46
11349118|NCT03011892|12546134|FG002|Completed Treatment Through Week 4|Double Blind (DB) Period||48
11349119|NCT03011892|12546135|FG003|Completed Treatment Through Week 4|Double Blind (DB) Period||47
11349120|NCT03011892|12546136|FG004|Completed Treatment Through Week 4|Double Blind (DB) Period||49
11349121|NCT03011892|12546137|FG005|Completed Treatment Through Week 4|Double Blind (DB) Period||49
11349122|NCT03011892|12546138|FG006|Completed Treatment Through Week 4|Double Blind (DB) Period||0
11349123|NCT03011892|12546139|FG007|Completed Treatment Through Week 4|Double Blind (DB) Period||0
11349124|NCT03011892|12546140|FG008|Completed Treatment Through Week 4|Double Blind (DB) Period||0
11349125|NCT03011892|12546141|FG009|Completed Treatment Through Week 4|Double Blind (DB) Period||0
11349126|NCT03011892|12546142|FG010|Completed Treatment Through Week 4|Double Blind (DB) Period||0
11349127|NCT03011892|12546143|FG011|Completed Treatment Through Week 4|Double Blind (DB) Period||0
11349128|NCT03011892|12546132|FG000|COMPLETED|Double Blind (DB) Period||41
11349129|NCT03011892|12546133|FG001|COMPLETED|Double Blind (DB) Period||41
11349130|NCT03011892|12546134|FG002|COMPLETED|Double Blind (DB) Period||45
11349131|NCT03011892|12546135|FG003|COMPLETED|Double Blind (DB) Period||44
11349132|NCT03011892|12546136|FG004|COMPLETED|Double Blind (DB) Period||45
11349133|NCT03011892|12546137|FG005|COMPLETED|Double Blind (DB) Period||45
11349134|NCT03011892|12546138|FG006|COMPLETED|Double Blind (DB) Period||0
11349135|NCT03011892|12546139|FG007|COMPLETED|Double Blind (DB) Period||0
11349136|NCT03011892|12546140|FG008|COMPLETED|Double Blind (DB) Period||0
11349137|NCT03011892|12546141|FG009|COMPLETED|Double Blind (DB) Period||0
11349138|NCT03011892|12546142|FG010|COMPLETED|Double Blind (DB) Period||0
11349139|NCT03011892|12546143|FG011|COMPLETED|Double Blind (DB) Period||0
11349140|NCT03011892|12546132|FG000|NOT COMPLETED|Double Blind (DB) Period||11
11349141|NCT03011892|12546133|FG001|NOT COMPLETED|Double Blind (DB) Period||10
11349142|NCT03011892|12546134|FG002|NOT COMPLETED|Double Blind (DB) Period||6
11349143|NCT03011892|12546135|FG003|NOT COMPLETED|Double Blind (DB) Period||7
11349144|NCT03011892|12546136|FG004|NOT COMPLETED|Double Blind (DB) Period||7
11349145|NCT03011892|12546137|FG005|NOT COMPLETED|Double Blind (DB) Period||5
11349146|NCT03011892|12546138|FG006|NOT COMPLETED|Double Blind (DB) Period||0
11349147|NCT03011892|12546139|FG007|NOT COMPLETED|Double Blind (DB) Period||0
11349148|NCT03011892|12546140|FG008|NOT COMPLETED|Double Blind (DB) Period||0
11349149|NCT03011892|12546141|FG009|NOT COMPLETED|Double Blind (DB) Period||0
11349150|NCT03011892|12546142|FG010|NOT COMPLETED|Double Blind (DB) Period||0
11349151|NCT03011892|12546143|FG011|NOT COMPLETED|Double Blind (DB) Period||0
11349152|NCT03011892|12546132|FG000|STARTED|Open Label (OL) Period||0
11349153|NCT03011892|12546133|FG001|STARTED|Open Label (OL) Period||0
11349154|NCT03011892|12546134|FG002|STARTED|Open Label (OL) Period||0
11080303|NCT01120184|12263014|FG001|Treated|Overall Study||365
11080304|NCT01120184|12263015|FG002|Treated|Overall Study||360
11080305|NCT01120184|12263013|FG000|COMPLETED|Overall Study||0
11080306|NCT01120184|12263014|FG001|COMPLETED|Overall Study||0
11080307|NCT01120184|12263015|FG002|COMPLETED|Overall Study||0
11080308|NCT01120184|12263013|FG000|NOT COMPLETED|Overall Study||365
11080309|NCT01120184|12263014|FG001|NOT COMPLETED|Overall Study||367
11080310|NCT01120184|12263015|FG002|NOT COMPLETED|Overall Study||363
11080311|NCT01120197|12263025|FG000|STARTED|Overall Study||47
11080312|NCT01120197|12263026|FG001|STARTED|Overall Study||42
11080313|NCT01120197|12263025|FG000|COMPLETED|Overall Study||38
11080314|NCT01120197|12263026|FG001|COMPLETED|Overall Study||32
11080315|NCT01120197|12263025|FG000|NOT COMPLETED|Overall Study||9
11080316|NCT01120197|12263026|FG001|NOT COMPLETED|Overall Study||10
11080317|NCT01120210|12263035|FG000|STARTED|MAIN INFUSION||16
11349155|NCT03011892|12546135|FG003|STARTED|Open Label (OL) Period||0
11080318|NCT01120210|12263036|FG001|STARTED|MAIN INFUSION||46
11349156|NCT03011892|12546136|FG004|STARTED|Open Label (OL) Period||0
11080319|NCT01120210|12263035|FG000|COMPLETED|MAIN INFUSION||15
11080320|NCT01120210|12263036|FG001|COMPLETED|MAIN INFUSION||45
11080321|NCT01120210|12263035|FG000|NOT COMPLETED|MAIN INFUSION||1
11080322|NCT01120210|12263036|FG001|NOT COMPLETED|MAIN INFUSION||1
11080323|NCT01120210|12263035|FG000|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
11080324|NCT01120210|12263036|FG001|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
11080325|NCT01120210|12263035|FG000|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
11080326|NCT01120210|12263036|FG001|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
11080327|NCT01120210|12263035|FG000|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
11080328|NCT01120210|12263036|FG001|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
11080329|NCT01120223|12263042|FG000|STARTED|Overall Study||78
11080330|NCT01120223|12263042|FG000|COMPLETED|Overall Study||74
11080331|NCT01120223|12263042|FG000|NOT COMPLETED|Overall Study||4
11080332|NCT01120236|12263048|FG000|STARTED|Overall Study||105
11080333|NCT01120236|12263049|FG001|STARTED|Overall Study||106
11080334|NCT01120236|12263048|FG000|Ineligble|Overall Study||0
11080335|NCT01120236|12263049|FG001|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
11080336|NCT01120236|12263048|FG000|COMPLETED|Overall Study||105
11080337|NCT01120236|12263049|FG001|COMPLETED|Overall Study||105
11080338|NCT01120236|12263048|FG000|NOT COMPLETED|Overall Study||0
11080339|NCT01120236|12263049|FG001|NOT COMPLETED|Overall Study||1
11080340|NCT01120275|12263063|FG000|STARTED|Overall Study||36
11080341|NCT01120275|12263063|FG000|Eligible and Treated|Overall Study||32
11080342|NCT01120275|12263063|FG000|COMPLETED|Overall Study||0
11080343|NCT01120275|12263063|FG000|NOT COMPLETED|Overall Study||36
11080344|NCT01120379|12263068|FG000|STARTED|One Year Timepoint||5020
11080345|NCT01120379|12263068|FG000|COMPLETED|One Year Timepoint||4742
11080346|NCT01120379|12263068|FG000|NOT COMPLETED|One Year Timepoint||278
11080347|NCT01120379|12263068|FG000|STARTED|Two Year Timepoint||4742
11080348|NCT01120379|12263068|FG000|COMPLETED|Two Year Timepoint||4505
11080349|NCT01120379|12263068|FG000|NOT COMPLETED|Two Year Timepoint||237
11080350|NCT01120379|12263068|FG000|STARTED|Three Year Timepoint||4505
11080351|NCT01120379|12263068|FG000|COMPLETED|Three Year Timepoint||4291
11080352|NCT01120379|12263068|FG000|NOT COMPLETED|Three Year Timepoint||214
11080353|NCT01120379|12263068|FG000|STARTED|Four Year Timepoint||4291
11080354|NCT01120379|12263068|FG000|COMPLETED|Four Year Timepoint||3923
11349157|NCT03011892|12546137|FG005|STARTED|Open Label (OL) Period||0
11349158|NCT03011892|12546138|FG006|STARTED|Open Label (OL) Period||41
11080355|NCT01120379|12263068|FG000|NOT COMPLETED|Four Year Timepoint||368
11080356|NCT01120405|12263074|FG000|STARTED|Overall Study||298
11080357|NCT01120405|12263075|FG001|STARTED|Overall Study||302
11080358|NCT01120405|12263074|FG000|COMPLETED|Overall Study||271
11080359|NCT01120405|12263075|FG001|COMPLETED|Overall Study||269
11080360|NCT01120405|12263074|FG000|NOT COMPLETED|Overall Study||27
11080361|NCT01120405|12263075|FG001|NOT COMPLETED|Overall Study||33
11349159|NCT03011892|12546139|FG007|STARTED|Open Label (OL) Period||40
11349160|NCT03011892|12546140|FG008|STARTED|Open Label (OL) Period||45
11349161|NCT03011892|12546141|FG009|STARTED|Open Label (OL) Period||41
11349162|NCT03011892|12546142|FG010|STARTED|Open Label (OL) Period||42
11349163|NCT03011892|12546143|FG011|STARTED|Open Label (OL) Period||43
11349164|NCT03011892|12546132|FG000|COMPLETED|Open Label (OL) Period||0
11080362|NCT01120600|12263085|FG000|STARTED|Overall Study||147
11080363|NCT01120600|12263086|FG001|STARTED|Overall Study||147
11080364|NCT01120600|12263085|FG000|Treated|Overall Study||146
11080365|NCT01120600|12263086|FG001|Treated|Overall Study||146
11349165|NCT03011892|12546133|FG001|COMPLETED|Open Label (OL) Period||0
11080366|NCT01120600|12263085|FG000|COMPLETED|Overall Study||128
11080367|NCT01120600|12263086|FG001|COMPLETED|Overall Study||115
11080368|NCT01120600|12263085|FG000|NOT COMPLETED|Overall Study||19
11080369|NCT01120600|12263086|FG001|NOT COMPLETED|Overall Study||32
11080370|NCT01120626|12263094|FG000|STARTED|Overall Study||20
11080371|NCT01120626|12263095|FG001|STARTED|Overall Study||22
11080372|NCT01120626|12263094|FG000|COMPLETED|Overall Study||19
11080373|NCT01120626|12263095|FG001|COMPLETED|Overall Study||22
11080374|NCT01120626|12263094|FG000|NOT COMPLETED|Overall Study||1
11080375|NCT01120626|12263095|FG001|NOT COMPLETED|Overall Study||0
11080376|NCT01120639|12263105|FG000|STARTED|Overall Study||6
11080377|NCT01120639|12263106|FG001|STARTED|Overall Study||6
11080378|NCT01120639|12263107|FG002|STARTED|Overall Study||6
11080379|NCT01120639|12263108|FG003|STARTED|Overall Study||12
11080380|NCT01120639|12263105|FG000|COMPLETED|Overall Study||6
11080381|NCT01120639|12263106|FG001|COMPLETED|Overall Study||6
11080382|NCT01120639|12263107|FG002|COMPLETED|Overall Study||6
11080383|NCT01120639|12263108|FG003|COMPLETED|Overall Study||12
11080384|NCT01120639|12263105|FG000|NOT COMPLETED|Overall Study||0
11080385|NCT01120639|12263106|FG001|NOT COMPLETED|Overall Study||0
11080386|NCT01120639|12263107|FG002|NOT COMPLETED|Overall Study||0
11080387|NCT01120639|12263108|FG003|NOT COMPLETED|Overall Study||0
11080388|NCT01120691|12263121|FG000|STARTED|Overall Study||741
11080389|NCT01120691|12263122|FG001|STARTED|Overall Study||741
11080390|NCT01120691|12263123|FG002|STARTED|Overall Study||742
11080391|NCT01120691|12263121|FG000|Full Analysis Set (FAS)|Overall Study||736
11349166|NCT03011892|12546134|FG002|COMPLETED|Open Label (OL) Period||0
11349167|NCT03011892|12546135|FG003|COMPLETED|Open Label (OL) Period||0
11349168|NCT03011892|12546136|FG004|COMPLETED|Open Label (OL) Period||0
11349169|NCT03011892|12546137|FG005|COMPLETED|Open Label (OL) Period||0
11349170|NCT03011892|12546138|FG006|COMPLETED|Open Label (OL) Period||34
11349171|NCT03011892|12546139|FG007|COMPLETED|Open Label (OL) Period||37
11080392|NCT01120691|12263122|FG001|Full Analysis Set (FAS)|Overall Study||739
11080393|NCT01120691|12263123|FG002|Full Analysis Set (FAS)|Overall Study||739
11080394|NCT01120691|12263121|FG000|Safety Set (SAF)|Overall Study||736
11080395|NCT01120691|12263122|FG001|Safety Set (SAF)|Overall Study||740
11349172|NCT03011892|12546140|FG008|COMPLETED|Open Label (OL) Period||43
11349173|NCT03011892|12546141|FG009|COMPLETED|Open Label (OL) Period||41
11080396|NCT01120691|12263123|FG002|Safety Set (SAF)|Overall Study||739
11080397|NCT01120691|12263121|FG000|Modified Safety Set (mSAF)|Overall Study||729
11080398|NCT01120691|12263122|FG001|Modified Safety Set (mSAF)|Overall Study||740
11080399|NCT01120691|12263123|FG002|Modified Safety Set (mSAF)|Overall Study||737
11080400|NCT01120691|12263121|FG000|Modified Full Analysis Set (mFAS)|Overall Study||729
11080401|NCT01120691|12263122|FG001|Modified Full Analysis Set (mFAS)|Overall Study||739
11080402|NCT01120691|12263123|FG002|Modified Full Analysis Set (mFAS)|Overall Study||737
11080403|NCT01120691|12263121|FG000|COMPLETED|Overall Study||570
11080404|NCT01120691|12263122|FG001|COMPLETED|Overall Study||538
11080405|NCT01120691|12263123|FG002|COMPLETED|Overall Study||559
11080406|NCT01120691|12263121|FG000|NOT COMPLETED|Overall Study||171
11080407|NCT01120691|12263122|FG001|NOT COMPLETED|Overall Study||203
11080408|NCT01120691|12263123|FG002|NOT COMPLETED|Overall Study||183
11080409|NCT01120704|12263167|FG000|STARTED|Overall Study||13
11080410|NCT01120704|12263168|FG001|STARTED|Overall Study||17
11080411|NCT01120704|12263169|FG002|STARTED|Overall Study||14
11080412|NCT01120704|12263170|FG003|STARTED|Overall Study||19
11080413|NCT01120704|12263171|FG004|STARTED|Overall Study||16
11080414|NCT01120704|12263172|FG005|STARTED|Overall Study||19
11080415|NCT01120704|12263173|FG006|STARTED|Overall Study||15
11080416|NCT01120704|12263174|FG007|STARTED|Overall Study||15
11080417|NCT01120704|12263175|FG008|STARTED|Overall Study||22
11080418|NCT01120704|12263176|FG009|STARTED|Overall Study||20
11080419|NCT01120704|12263177|FG010|STARTED|Overall Study||17
11080420|NCT01120704|12263178|FG011|STARTED|Overall Study||16
11080421|NCT01120704|12263179|FG012|STARTED|Overall Study||17
11080422|NCT01120704|12263180|FG013|STARTED|Overall Study||19
11080423|NCT01120704|12263181|FG014|STARTED|Overall Study||18
11080424|NCT01120704|12263182|FG015|STARTED|Overall Study||18
11080425|NCT01120704|12263183|FG016|STARTED|Overall Study||14
11080426|NCT01120704|12263184|FG017|STARTED|Overall Study||16
11080427|NCT01120704|12263185|FG018|STARTED|Overall Study||17
11349174|NCT03011892|12546142|FG010|COMPLETED|Open Label (OL) Period||40
11349175|NCT03011892|12546143|FG011|COMPLETED|Open Label (OL) Period||40
11349176|NCT03011892|12546132|FG000|NOT COMPLETED|Open Label (OL) Period||0
11349177|NCT03011892|12546133|FG001|NOT COMPLETED|Open Label (OL) Period||0
11349178|NCT03011892|12546134|FG002|NOT COMPLETED|Open Label (OL) Period||0
11349179|NCT03011892|12546135|FG003|NOT COMPLETED|Open Label (OL) Period||0
11349180|NCT03011892|12546136|FG004|NOT COMPLETED|Open Label (OL) Period||0
11349181|NCT03011892|12546137|FG005|NOT COMPLETED|Open Label (OL) Period||0
11080428|NCT01120704|12263186|FG019|STARTED|Overall Study||18
11080429|NCT01120704|12263187|FG020|STARTED|Overall Study||17
11349182|NCT03011892|12546138|FG006|NOT COMPLETED|Open Label (OL) Period||7
11349183|NCT03011892|12546139|FG007|NOT COMPLETED|Open Label (OL) Period||3
11080430|NCT01120704|12263188|FG021|STARTED|Overall Study||16
11080431|NCT01120704|12263189|FG022|STARTED|Overall Study||21
11080432|NCT01120704|12263190|FG023|STARTED|Overall Study||16
11080433|NCT01120704|12263191|FG024|STARTED|Overall Study||18
11080434|NCT01120704|12263192|FG025|STARTED|Overall Study||14
11080435|NCT01120704|12263193|FG026|STARTED|Overall Study||18
11080436|NCT01120704|12263194|FG027|STARTED|Overall Study||18
11080437|NCT01120704|12263195|FG028|STARTED|Overall Study||19
11080438|NCT01120704|12263196|FG029|STARTED|Overall Study||15
11080439|NCT01120704|12263197|FG030|STARTED|Overall Study||14
11080440|NCT01120704|12263198|FG031|STARTED|Overall Study||18
11080441|NCT01120704|12263167|FG000|COMPLETED|Overall Study||10
11080442|NCT01120704|12263168|FG001|COMPLETED|Overall Study||13
11080443|NCT01120704|12263169|FG002|COMPLETED|Overall Study||13
11080444|NCT01120704|12263170|FG003|COMPLETED|Overall Study||15
11080445|NCT01120704|12263171|FG004|COMPLETED|Overall Study||14
11080446|NCT01120704|12263172|FG005|COMPLETED|Overall Study||18
11080447|NCT01120704|12263173|FG006|COMPLETED|Overall Study||12
11080448|NCT01120704|12263174|FG007|COMPLETED|Overall Study||13
11080449|NCT01120704|12263175|FG008|COMPLETED|Overall Study||19
11080450|NCT01120704|12263176|FG009|COMPLETED|Overall Study||19
11080451|NCT01120704|12263177|FG010|COMPLETED|Overall Study||16
11080452|NCT01120704|12263178|FG011|COMPLETED|Overall Study||14
11080453|NCT01120704|12263179|FG012|COMPLETED|Overall Study||14
11080454|NCT01120704|12263180|FG013|COMPLETED|Overall Study||15
11080455|NCT01120704|12263181|FG014|COMPLETED|Overall Study||17
11080456|NCT01120704|12263182|FG015|COMPLETED|Overall Study||16
11080457|NCT01120704|12263183|FG016|COMPLETED|Overall Study||13
11080458|NCT01120704|12263184|FG017|COMPLETED|Overall Study||16
11080459|NCT01120704|12263185|FG018|COMPLETED|Overall Study||15
11080460|NCT01120704|12263186|FG019|COMPLETED|Overall Study||15
11080461|NCT01120704|12263187|FG020|COMPLETED|Overall Study||14
11080462|NCT01120704|12263188|FG021|COMPLETED|Overall Study||16
11080463|NCT01120704|12263189|FG022|COMPLETED|Overall Study||17
11080464|NCT01120704|12263190|FG023|COMPLETED|Overall Study||13
11080465|NCT01120704|12263191|FG024|COMPLETED|Overall Study||16
11080466|NCT01120704|12263192|FG025|COMPLETED|Overall Study||14
11080467|NCT01120704|12263193|FG026|COMPLETED|Overall Study||15
11080468|NCT01120704|12263194|FG027|COMPLETED|Overall Study||16
11080469|NCT01120704|12263195|FG028|COMPLETED|Overall Study||14
11080470|NCT01120704|12263196|FG029|COMPLETED|Overall Study||12
11080471|NCT01120704|12263197|FG030|COMPLETED|Overall Study||12
11080472|NCT01120704|12263198|FG031|COMPLETED|Overall Study||17
11080473|NCT01120704|12263167|FG000|NOT COMPLETED|Overall Study||3
11080474|NCT01120704|12263168|FG001|NOT COMPLETED|Overall Study||4
11080475|NCT01120704|12263169|FG002|NOT COMPLETED|Overall Study||1
11080476|NCT01120704|12263170|FG003|NOT COMPLETED|Overall Study||4
11080477|NCT01120704|12263171|FG004|NOT COMPLETED|Overall Study||2
11080478|NCT01120704|12263172|FG005|NOT COMPLETED|Overall Study||1
11080479|NCT01120704|12263173|FG006|NOT COMPLETED|Overall Study||3
11080480|NCT01120704|12263174|FG007|NOT COMPLETED|Overall Study||2
11080481|NCT01120704|12263175|FG008|NOT COMPLETED|Overall Study||3
11080482|NCT01120704|12263176|FG009|NOT COMPLETED|Overall Study||1
11080483|NCT01120704|12263177|FG010|NOT COMPLETED|Overall Study||1
11349184|NCT03011892|12546140|FG008|NOT COMPLETED|Open Label (OL) Period||2
11349185|NCT03011892|12546141|FG009|NOT COMPLETED|Open Label (OL) Period||0
11349186|NCT03011892|12546142|FG010|NOT COMPLETED|Open Label (OL) Period||2
11349187|NCT03011892|12546143|FG011|NOT COMPLETED|Open Label (OL) Period||3
11349188|NCT03012061|12546173|FG000|STARTED|Overall Study||143
11080484|NCT01120704|12263178|FG011|NOT COMPLETED|Overall Study||2
11080485|NCT01120704|12263179|FG012|NOT COMPLETED|Overall Study||3
11080486|NCT01120704|12263180|FG013|NOT COMPLETED|Overall Study||4
11080487|NCT01120704|12263181|FG014|NOT COMPLETED|Overall Study||1
11080488|NCT01120704|12263182|FG015|NOT COMPLETED|Overall Study||2
11080489|NCT01120704|12263183|FG016|NOT COMPLETED|Overall Study||1
11080490|NCT01120704|12263184|FG017|NOT COMPLETED|Overall Study||0
11080491|NCT01120704|12263185|FG018|NOT COMPLETED|Overall Study||2
11080492|NCT01120704|12263186|FG019|NOT COMPLETED|Overall Study||3
11080493|NCT01120704|12263187|FG020|NOT COMPLETED|Overall Study||3
11080494|NCT01120704|12263188|FG021|NOT COMPLETED|Overall Study||0
11080495|NCT01120704|12263189|FG022|NOT COMPLETED|Overall Study||4
11080496|NCT01120704|12263190|FG023|NOT COMPLETED|Overall Study||3
11080497|NCT01120704|12263191|FG024|NOT COMPLETED|Overall Study||2
11080498|NCT01120704|12263192|FG025|NOT COMPLETED|Overall Study||0
11080499|NCT01120704|12263193|FG026|NOT COMPLETED|Overall Study||3
11080500|NCT01120704|12263194|FG027|NOT COMPLETED|Overall Study||2
11080501|NCT01120704|12263195|FG028|NOT COMPLETED|Overall Study||5
11080502|NCT01120704|12263196|FG029|NOT COMPLETED|Overall Study||3
11080503|NCT01120704|12263197|FG030|NOT COMPLETED|Overall Study||2
11080504|NCT01120704|12263198|FG031|NOT COMPLETED|Overall Study||1
11080505|NCT01120717|12263214|FG000|STARTED|Overall Study||226
11080506|NCT01120717|12263215|FG001|STARTED|Overall Study||113
11080507|NCT01120717|12263214|FG000|Safety Population: Received Study Drug|Overall Study||225
11080508|NCT01120717|12263215|FG001|Safety Population: Received Study Drug|Overall Study||113
11080509|NCT01120717|12263214|FG000|COMPLETED|Overall Study||194
11080510|NCT01120717|12263215|FG001|COMPLETED|Overall Study||89
11080511|NCT01120717|12263214|FG000|NOT COMPLETED|Overall Study||32
11080512|NCT01120717|12263215|FG001|NOT COMPLETED|Overall Study||24
11080513|NCT01120756|12263223|FG000|STARTED|Overall Study||21
11080514|NCT01120756|12263224|FG001|STARTED|Overall Study||14
11080515|NCT01120756|12263223|FG000|COMPLETED|Overall Study||20
11080516|NCT01120756|12263224|FG001|COMPLETED|Overall Study||13
11080517|NCT01120756|12263223|FG000|NOT COMPLETED|Overall Study||1
11080518|NCT01120756|12263224|FG001|NOT COMPLETED|Overall Study||1
11080519|NCT01120782|12263230|FG000|STARTED|Overall Study||45
11080520|NCT01120782|12263230|FG000|COMPLETED|Overall Study||34
11080521|NCT01120782|12263230|FG000|NOT COMPLETED|Overall Study||11
11080522|NCT01120808|12263234|FG000|STARTED|Overall Study||136
11080523|NCT01120808|12263234|FG000|COMPLETED|Overall Study||90
11080524|NCT01120808|12263234|FG000|NOT COMPLETED|Overall Study||46
11080525|NCT01120834|12263238|FG000|STARTED|Overall Study||18
11080526|NCT01120834|12263238|FG000|COMPLETED|Overall Study||18
11080527|NCT01120834|12263238|FG000|NOT COMPLETED|Overall Study||0
11080528|NCT01120899|12263242|FG000|STARTED|Overall Study||6
11080529|NCT01120899|12263242|FG000|Month 6|Overall Study||5
11080530|NCT01120899|12263242|FG000|Month 12|Overall Study||3
11080531|NCT01120899|12263242|FG000|Month 18|Overall Study||3
11080532|NCT01120899|12263242|FG000|COMPLETED|Overall Study||3
11080533|NCT01120899|12263242|FG000|NOT COMPLETED|Overall Study||3
11080534|NCT01120990|12263246|FG000|STARTED|Overall Study||51
11080535|NCT01120990|12263246|FG000|COMPLETED|Overall Study||51
11080536|NCT01120990|12263246|FG000|NOT COMPLETED|Overall Study||0
11080537|NCT01121146|12263252|FG000|STARTED|Overall Study||116
11080538|NCT01121146|12263253|FG001|STARTED|Overall Study||114
11080539|NCT01121146|12263252|FG000|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
11080540|NCT01121146|12263253|FG001|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
11080541|NCT01121146|12263252|FG000|NOT COMPLETED|Overall Study||26
11080542|NCT01121146|12263253|FG001|NOT COMPLETED|Overall Study||42
11080543|NCT01121172|12263262|FG000|STARTED|Overall Study||90
11080544|NCT01121172|12263263|FG001|STARTED|Overall Study||90
11080545|NCT01121172|12263262|FG000|COMPLETED|Overall Study||90
11080546|NCT01121172|12263263|FG001|COMPLETED|Overall Study||90
11080547|NCT01121172|12263262|FG000|NOT COMPLETED|Overall Study||0
11349189|NCT03012061|12546174|FG001|STARTED|Overall Study||139
11349190|NCT03012061|12546175|FG002|STARTED|Overall Study||139
11349191|NCT03012061|12546173|FG000|COMPLETED|Overall Study||137
11349192|NCT03012061|12546174|FG001|COMPLETED|Overall Study||130
11349193|NCT03012061|12546175|FG002|COMPLETED|Overall Study||131
11349194|NCT03012061|12546173|FG000|NOT COMPLETED|Overall Study||6
11349195|NCT03012061|12546174|FG001|NOT COMPLETED|Overall Study||9
11349196|NCT03012061|12546175|FG002|NOT COMPLETED|Overall Study||8
11349197|NCT03012191|12546186|FG000|STARTED|Overall Study||2
11349198|NCT03012191|12546187|FG001|STARTED|Overall Study||2
11349199|NCT03012191|12546188|FG002|STARTED|Overall Study||2
11349200|NCT03012191|12546186|FG000|COMPLETED|Overall Study||2
11349201|NCT03012191|12546187|FG001|COMPLETED|Overall Study||2
11349202|NCT03012191|12546188|FG002|COMPLETED|Overall Study||2
11349203|NCT03012191|12546186|FG000|NOT COMPLETED|Overall Study||0
11349204|NCT03012191|12546187|FG001|NOT COMPLETED|Overall Study||0
11349205|NCT03012191|12546188|FG002|NOT COMPLETED|Overall Study||0
11349206|NCT03012334|12546207|FG000|STARTED|Period 1||9
11349207|NCT03012334|12546208|FG001|STARTED|Period 1||9
11349208|NCT03012334|12546209|FG002|STARTED|Period 1||9
11080548|NCT01121172|12263263|FG001|NOT COMPLETED|Overall Study||0
11080549|NCT01121185|12263272|FG000|STARTED|Overall Study||7
11080550|NCT01121185|12263273|FG001|STARTED|Overall Study||6
11080551|NCT01121185|12263272|FG000|Infused|Overall Study||7
11080552|NCT01121185|12263273|FG001|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
11080553|NCT01121185|12263272|FG000|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
11080554|NCT01121185|12263273|FG001|Transplanted|Overall Study||5
11080555|NCT01121185|12263272|FG000|COMPLETED|Overall Study||6
11080556|NCT01121185|12263273|FG001|COMPLETED|Overall Study||5
11080557|NCT01121185|12263272|FG000|NOT COMPLETED|Overall Study||1
11080558|NCT01121185|12263273|FG001|NOT COMPLETED|Overall Study||1
11080559|NCT01121211|12263281|FG000|STARTED|Overall Study||43
11349209|NCT03012334|12546210|FG003|STARTED|Period 1||9
11349210|NCT03012334|12546211|FG004|STARTED|Period 1||9
11349211|NCT03012334|12546212|FG005|STARTED|Period 1||9
11349212|NCT03012334|12546213|FG006|STARTED|Period 1||9
11349213|NCT03012334|12546214|FG007|STARTED|Period 1||9
11349214|NCT03012334|12546215|FG008|STARTED|Period 1||9
11349215|NCT03012334|12546216|FG009|STARTED|Period 1||9
11349216|NCT03012334|12546207|FG000|COMPLETED|Period 1||9
11349217|NCT03012334|12546208|FG001|COMPLETED|Period 1||9
11349218|NCT03012334|12546209|FG002|COMPLETED|Period 1||9
11080560|NCT01121211|12263282|FG001|STARTED|Overall Study||47
11080561|NCT01121211|12263281|FG000|COMPLETED|Overall Study||32
11080562|NCT01121211|12263282|FG001|COMPLETED|Overall Study||35
11080563|NCT01121211|12263281|FG000|NOT COMPLETED|Overall Study||11
11080564|NCT01121211|12263282|FG001|NOT COMPLETED|Overall Study||12
11080565|NCT01121250|12263291|FG000|STARTED|Overall Study||76
11080566|NCT01121250|12263292|FG001|STARTED|Overall Study||76
11080567|NCT01121250|12263293|FG002|STARTED|Overall Study||76
11080568|NCT01121250|12263291|FG000|COMPLETED|Overall Study||76
11080569|NCT01121250|12263292|FG001|COMPLETED|Overall Study||76
11080570|NCT01121250|12263293|FG002|COMPLETED|Overall Study||75
11080571|NCT01121250|12263291|FG000|NOT COMPLETED|Overall Study||0
11080572|NCT01121250|12263292|FG001|NOT COMPLETED|Overall Study||0
11080573|NCT01121250|12263293|FG002|NOT COMPLETED|Overall Study||1
11080574|NCT01121263|12263303|FG000|STARTED|Overall Study||200
11080575|NCT01121263|12263304|FG001|STARTED|Overall Study||98
11080576|NCT01121263|12263303|FG000|COMPLETED|Overall Study||175
11080577|NCT01121263|12263304|FG001|COMPLETED|Overall Study||83
11080578|NCT01121263|12263303|FG000|NOT COMPLETED|Overall Study||25
11080579|NCT01121263|12263304|FG001|NOT COMPLETED|Overall Study||15
11080580|NCT01121393|12263314|FG000|STARTED|Overall Study|Randomised|242
11080581|NCT01121393|12263315|FG001|STARTED|Overall Study|Randomised|122
11080582|NCT01121393|12263314|FG000|Treated|Overall Study|Treated|239
11080583|NCT01121393|12263315|FG001|Treated|Overall Study|Treated|113
11080584|NCT01121393|12263314|FG000|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
11080585|NCT01121393|12263315|FG001|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
11080586|NCT01121393|12263314|FG000|NOT COMPLETED|Overall Study||242
11080587|NCT01121393|12263315|FG001|NOT COMPLETED|Overall Study||84
11080588|NCT01121406|12263329|FG000|STARTED|Overall Study||55
11080589|NCT01121406|12263330|FG001|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
11080590|NCT01121406|12263329|FG000|COMPLETED|Overall Study||0
11080591|NCT01121406|12263330|FG001|COMPLETED|Overall Study||0
11080592|NCT01121406|12263329|FG000|NOT COMPLETED|Overall Study||55
11080593|NCT01121406|12263330|FG001|NOT COMPLETED|Overall Study||55
11349219|NCT03012334|12546210|FG003|COMPLETED|Period 1||9
11349220|NCT03012334|12546211|FG004|COMPLETED|Period 1||9
11349221|NCT03012334|12546212|FG005|COMPLETED|Period 1||9
11349222|NCT03012334|12546213|FG006|COMPLETED|Period 1||9
11349223|NCT03012334|12546214|FG007|COMPLETED|Period 1||9
11349224|NCT03012334|12546215|FG008|COMPLETED|Period 1||9
11349225|NCT03012334|12546216|FG009|COMPLETED|Period 1||8
11349226|NCT03012334|12546207|FG000|NOT COMPLETED|Period 1||0
11349227|NCT03012334|12546208|FG001|NOT COMPLETED|Period 1||0
11349228|NCT03012334|12546209|FG002|NOT COMPLETED|Period 1||0
11349229|NCT03012334|12546210|FG003|NOT COMPLETED|Period 1||0
11349230|NCT03012334|12546211|FG004|NOT COMPLETED|Period 1||0
11349231|NCT03012334|12546212|FG005|NOT COMPLETED|Period 1||0
11349232|NCT03012334|12546213|FG006|NOT COMPLETED|Period 1||0
11349233|NCT03012334|12546214|FG007|NOT COMPLETED|Period 1||0
11349234|NCT03012334|12546215|FG008|NOT COMPLETED|Period 1||0
11349235|NCT03012334|12546216|FG009|NOT COMPLETED|Period 1||1
11349236|NCT03012334|12546207|FG000|STARTED|Period 2||9
11349237|NCT03012334|12546208|FG001|STARTED|Period 2||9
11349238|NCT03012334|12546209|FG002|STARTED|Period 2||9
11349239|NCT03012334|12546210|FG003|STARTED|Period 2||9
11349240|NCT03012334|12546211|FG004|STARTED|Period 2||9
11349241|NCT03012334|12546212|FG005|STARTED|Period 2||9
11349242|NCT03012334|12546213|FG006|STARTED|Period 2||9
11349243|NCT03012334|12546214|FG007|STARTED|Period 2||9
11349244|NCT03012334|12546215|FG008|STARTED|Period 2||9
11349245|NCT03012334|12546216|FG009|STARTED|Period 2||8
11349246|NCT03012334|12546207|FG000|COMPLETED|Period 2||9
11349247|NCT03012334|12546208|FG001|COMPLETED|Period 2||8
11349248|NCT03012334|12546209|FG002|COMPLETED|Period 2||8
11349249|NCT03012334|12546210|FG003|COMPLETED|Period 2||9
11349250|NCT03012334|12546211|FG004|COMPLETED|Period 2||9
11349251|NCT03012334|12546212|FG005|COMPLETED|Period 2||9
11349252|NCT03012334|12546213|FG006|COMPLETED|Period 2||9
11349253|NCT03012334|12546214|FG007|COMPLETED|Period 2||8
11349254|NCT03012334|12546215|FG008|COMPLETED|Period 2||9
11349255|NCT03012334|12546216|FG009|COMPLETED|Period 2||8
11349256|NCT03012334|12546207|FG000|NOT COMPLETED|Period 2||0
11349257|NCT03012334|12546208|FG001|NOT COMPLETED|Period 2||1
11349258|NCT03012334|12546209|FG002|NOT COMPLETED|Period 2||1
11349259|NCT03012334|12546210|FG003|NOT COMPLETED|Period 2||0
11349260|NCT03012334|12546211|FG004|NOT COMPLETED|Period 2||0
11349261|NCT03012334|12546212|FG005|NOT COMPLETED|Period 2||0
11349262|NCT03012334|12546213|FG006|NOT COMPLETED|Period 2||0
11349263|NCT03012334|12546214|FG007|NOT COMPLETED|Period 2||1
11080594|NCT01121484|12263341|FG000|STARTED|Overall Study||218
11349264|NCT03012334|12546215|FG008|NOT COMPLETED|Period 2||0
11349265|NCT03012334|12546216|FG009|NOT COMPLETED|Period 2||0
11349266|NCT03012334|12546207|FG000|STARTED|Period 3||9
11349267|NCT03012334|12546208|FG001|STARTED|Period 3||8
11349268|NCT03012334|12546209|FG002|STARTED|Period 3||8
11349269|NCT03012334|12546210|FG003|STARTED|Period 3||9
11349270|NCT03012334|12546211|FG004|STARTED|Period 3||9
11349271|NCT03012334|12546212|FG005|STARTED|Period 3||9
11349272|NCT03012334|12546213|FG006|STARTED|Period 3||9
11349273|NCT03012334|12546214|FG007|STARTED|Period 3||8
11349274|NCT03012334|12546215|FG008|STARTED|Period 3||9
11349275|NCT03012334|12546216|FG009|STARTED|Period 3||8
11349276|NCT03012334|12546207|FG000|COMPLETED|Period 3||9
11080595|NCT01121484|12263342|FG001|STARTED|Overall Study||221
11080596|NCT01121484|12263341|FG000|Treated|Overall Study||217
11080597|NCT01121484|12263342|FG001|Treated|Overall Study||217
11080598|NCT01121484|12263341|FG000|COMPLETED|Overall Study||185
11080599|NCT01121484|12263342|FG001|COMPLETED|Overall Study||178
11080600|NCT01121484|12263341|FG000|NOT COMPLETED|Overall Study||33
11080601|NCT01121484|12263342|FG001|NOT COMPLETED|Overall Study||43
11080602|NCT01121536|12263348|FG000|STARTED|Overall Study||867
11080603|NCT01121536|12263348|FG000|Safety Population|Overall Study|Participants treated|863
11080604|NCT01121536|12263348|FG000|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
11080605|NCT01121536|12263348|FG000|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
11080606|NCT01121536|12263348|FG000|NOT COMPLETED|Overall Study||361
11080607|NCT01121549|12263352|FG000|STARTED|Overall Study||378
11080608|NCT01121549|12263352|FG000|COMPLETED|Overall Study||31
11080609|NCT01121549|12263352|FG000|NOT COMPLETED|Overall Study||347
11080610|NCT01121562|12263356|FG000|STARTED|Overall Study||12
11080611|NCT01121562|12263356|FG000|COMPLETED|Overall Study||0
11080612|NCT01121562|12263356|FG000|NOT COMPLETED|Overall Study||12
11080613|NCT01121575|12263366|FG000|STARTED|Overall Study||14
11080614|NCT01121575|12263367|FG001|STARTED|Overall Study||6
11080615|NCT01121575|12263368|FG002|STARTED|Overall Study||7
11080616|NCT01121575|12263369|FG003|STARTED|Overall Study||6
11080617|NCT01121575|12263370|FG004|STARTED|Overall Study||25
11080618|NCT01121575|12263371|FG005|STARTED|Overall Study||12
11080619|NCT01121575|12263366|FG000|Treated|Overall Study||14
11080620|NCT01121575|12263367|FG001|Treated|Overall Study||6
11080621|NCT01121575|12263368|FG002|Treated|Overall Study||7
11080622|NCT01121575|12263369|FG003|Treated|Overall Study||6
11080623|NCT01121575|12263370|FG004|Treated|Overall Study||25
11080624|NCT01121575|12263371|FG005|Treated|Overall Study||12
11080625|NCT01121575|12263366|FG000|COMPLETED|Overall Study||0
11080626|NCT01121575|12263367|FG001|COMPLETED|Overall Study||0
11080627|NCT01121575|12263368|FG002|COMPLETED|Overall Study||0
11080628|NCT01121575|12263369|FG003|COMPLETED|Overall Study||0
11080629|NCT01121575|12263370|FG004|COMPLETED|Overall Study||0
11080630|NCT01121575|12263371|FG005|COMPLETED|Overall Study||0
11080631|NCT01121575|12263366|FG000|NOT COMPLETED|Overall Study||14
11080632|NCT01121575|12263367|FG001|NOT COMPLETED|Overall Study||6
11080633|NCT01121575|12263368|FG002|NOT COMPLETED|Overall Study||7
11080634|NCT01121575|12263369|FG003|NOT COMPLETED|Overall Study||6
11080635|NCT01121575|12263370|FG004|NOT COMPLETED|Overall Study||25
11080636|NCT01121575|12263371|FG005|NOT COMPLETED|Overall Study||12
11080637|NCT01121666|12263392|FG000|STARTED|Overall Study||249
11080638|NCT01121666|12263393|FG001|STARTED|Overall Study||123
11080639|NCT01121666|12263392|FG000|COMPLETED|Overall Study||220
11080640|NCT01121666|12263393|FG001|COMPLETED|Overall Study||113
11080641|NCT01121666|12263392|FG000|NOT COMPLETED|Overall Study||29
11080642|NCT01121666|12263393|FG001|NOT COMPLETED|Overall Study||10
11080643|NCT01121757|12263401|FG000|STARTED|First Drug||6
11080644|NCT01121757|12263402|FG001|STARTED|First Drug||3
11080645|NCT01121757|12263401|FG000|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
11080646|NCT01121757|12263402|FG001|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
11080647|NCT01121757|12263401|FG000|NOT COMPLETED|First Drug||1
11080648|NCT01121757|12263402|FG001|NOT COMPLETED|First Drug||2
11080649|NCT01121757|12263401|FG000|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
11080650|NCT01121757|12263402|FG001|STARTED|Second Drug||1
11080651|NCT01121757|12263401|FG000|COMPLETED|Second Drug||4
11080652|NCT01121757|12263402|FG001|COMPLETED|Second Drug||1
11080653|NCT01121757|12263401|FG000|NOT COMPLETED|Second Drug||0
11080654|NCT01121757|12263402|FG001|NOT COMPLETED|Second Drug||0
11080655|NCT01121757|12263401|FG000|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
11080656|NCT01121757|12263402|FG001|STARTED|Combination||1
11080657|NCT01121757|12263401|FG000|COMPLETED|Combination||0
11080658|NCT01121757|12263402|FG001|COMPLETED|Combination||0
11080659|NCT01121757|12263401|FG000|NOT COMPLETED|Combination||2
11080660|NCT01121757|12263402|FG001|NOT COMPLETED|Combination||1
11080661|NCT01121900|12263410|FG000|STARTED|First Intervention Period||13
11080662|NCT01121900|12263411|FG001|STARTED|First Intervention Period||13
11080663|NCT01121900|12263410|FG000|COMPLETED|First Intervention Period||12
11080664|NCT01121900|12263411|FG001|COMPLETED|First Intervention Period||12
11080665|NCT01121900|12263410|FG000|NOT COMPLETED|First Intervention Period||1
11080666|NCT01121900|12263411|FG001|NOT COMPLETED|First Intervention Period||1
11080667|NCT01121900|12263410|FG000|STARTED|Washout Period of 7 Days||12
11349277|NCT03012334|12546208|FG001|COMPLETED|Period 3||8
11349278|NCT03012334|12546209|FG002|COMPLETED|Period 3||8
11349279|NCT03012334|12546210|FG003|COMPLETED|Period 3||9
11349280|NCT03012334|12546211|FG004|COMPLETED|Period 3||9
11349281|NCT03012334|12546212|FG005|COMPLETED|Period 3||9
11080668|NCT01121900|12263411|FG001|STARTED|Washout Period of 7 Days||12
11080669|NCT01121900|12263410|FG000|COMPLETED|Washout Period of 7 Days||12
11080670|NCT01121900|12263411|FG001|COMPLETED|Washout Period of 7 Days||11
11080671|NCT01121900|12263410|FG000|NOT COMPLETED|Washout Period of 7 Days||0
11080672|NCT01121900|12263411|FG001|NOT COMPLETED|Washout Period of 7 Days||1
11349282|NCT03012334|12546213|FG006|COMPLETED|Period 3||9
11349283|NCT03012334|12546214|FG007|COMPLETED|Period 3||8
11349284|NCT03012334|12546215|FG008|COMPLETED|Period 3||9
11349285|NCT03012334|12546216|FG009|COMPLETED|Period 3||8
11080673|NCT01121900|12263410|FG000|STARTED|Second Intervention Period||12
11080674|NCT01121900|12263411|FG001|STARTED|Second Intervention Period||11
11080675|NCT01121900|12263410|FG000|COMPLETED|Second Intervention Period||12
11080676|NCT01121900|12263411|FG001|COMPLETED|Second Intervention Period||11
11080677|NCT01121900|12263410|FG000|NOT COMPLETED|Second Intervention Period||0
11080678|NCT01121900|12263411|FG001|NOT COMPLETED|Second Intervention Period||0
11080679|NCT01121913|12263417|FG000|STARTED|First Intervention Period||6
11080680|NCT01121913|12263418|FG001|STARTED|First Intervention Period||6
11080681|NCT01121913|12263419|FG002|STARTED|First Intervention Period||6
11080682|NCT01121913|12263420|FG003|STARTED|First Intervention Period||6
11080683|NCT01121913|12263417|FG000|COMPLETED|First Intervention Period||6
11080684|NCT01121913|12263418|FG001|COMPLETED|First Intervention Period||6
11080685|NCT01121913|12263419|FG002|COMPLETED|First Intervention Period||5
11080686|NCT01121913|12263420|FG003|COMPLETED|First Intervention Period||6
11080687|NCT01121913|12263417|FG000|NOT COMPLETED|First Intervention Period||0
11080688|NCT01121913|12263418|FG001|NOT COMPLETED|First Intervention Period||0
11080689|NCT01121913|12263419|FG002|NOT COMPLETED|First Intervention Period||1
11080690|NCT01121913|12263420|FG003|NOT COMPLETED|First Intervention Period||0
11080691|NCT01121913|12263417|FG000|STARTED|First Washout Period||6
11080692|NCT01121913|12263418|FG001|STARTED|First Washout Period||6
11080693|NCT01121913|12263419|FG002|STARTED|First Washout Period||5
11080694|NCT01121913|12263420|FG003|STARTED|First Washout Period||6
11080695|NCT01121913|12263417|FG000|COMPLETED|First Washout Period||5
11080696|NCT01121913|12263418|FG001|COMPLETED|First Washout Period||6
11080697|NCT01121913|12263419|FG002|COMPLETED|First Washout Period||5
11080698|NCT01121913|12263420|FG003|COMPLETED|First Washout Period||6
11080699|NCT01121913|12263417|FG000|NOT COMPLETED|First Washout Period||1
11080700|NCT01121913|12263418|FG001|NOT COMPLETED|First Washout Period||0
11080701|NCT01121913|12263419|FG002|NOT COMPLETED|First Washout Period||0
11080702|NCT01121913|12263420|FG003|NOT COMPLETED|First Washout Period||0
11080703|NCT01121913|12263417|FG000|STARTED|Second Intervention Period||5
11080704|NCT01121913|12263418|FG001|STARTED|Second Intervention Period||6
11080705|NCT01121913|12263419|FG002|STARTED|Second Intervention Period||5
11080706|NCT01121913|12263420|FG003|STARTED|Second Intervention Period||6
11080707|NCT01121913|12263417|FG000|COMPLETED|Second Intervention Period||5
11080708|NCT01121913|12263418|FG001|COMPLETED|Second Intervention Period||6
11080709|NCT01121913|12263419|FG002|COMPLETED|Second Intervention Period||4
11080710|NCT01121913|12263420|FG003|COMPLETED|Second Intervention Period||6
11080711|NCT01121913|12263417|FG000|NOT COMPLETED|Second Intervention Period||0
11080712|NCT01121913|12263418|FG001|NOT COMPLETED|Second Intervention Period||0
11080713|NCT01121913|12263419|FG002|NOT COMPLETED|Second Intervention Period||1
11080714|NCT01121913|12263420|FG003|NOT COMPLETED|Second Intervention Period||0
11080715|NCT01121913|12263417|FG000|STARTED|Second Washout Period||5
11080716|NCT01121913|12263418|FG001|STARTED|Second Washout Period||6
11080717|NCT01121913|12263419|FG002|STARTED|Second Washout Period||4
11080718|NCT01121913|12263420|FG003|STARTED|Second Washout Period||6
11080719|NCT01121913|12263417|FG000|COMPLETED|Second Washout Period||5
11080720|NCT01121913|12263418|FG001|COMPLETED|Second Washout Period||6
11080721|NCT01121913|12263419|FG002|COMPLETED|Second Washout Period||3
11080722|NCT01121913|12263420|FG003|COMPLETED|Second Washout Period||6
11080723|NCT01121913|12263417|FG000|NOT COMPLETED|Second Washout Period||0
11080724|NCT01121913|12263418|FG001|NOT COMPLETED|Second Washout Period||0
11080725|NCT01121913|12263419|FG002|NOT COMPLETED|Second Washout Period||1
11080726|NCT01121913|12263420|FG003|NOT COMPLETED|Second Washout Period||0
11080727|NCT01121913|12263417|FG000|STARTED|Third Intervention Period||5
11080728|NCT01121913|12263418|FG001|STARTED|Third Intervention Period||6
11080729|NCT01121913|12263419|FG002|STARTED|Third Intervention Period||3
11080730|NCT01121913|12263420|FG003|STARTED|Third Intervention Period||6
11080731|NCT01121913|12263417|FG000|COMPLETED|Third Intervention Period||5
11080732|NCT01121913|12263418|FG001|COMPLETED|Third Intervention Period||6
11080733|NCT01121913|12263419|FG002|COMPLETED|Third Intervention Period||3
11080734|NCT01121913|12263420|FG003|COMPLETED|Third Intervention Period||6
11080735|NCT01121913|12263417|FG000|NOT COMPLETED|Third Intervention Period||0
11080736|NCT01121913|12263418|FG001|NOT COMPLETED|Third Intervention Period||0
11080737|NCT01121913|12263419|FG002|NOT COMPLETED|Third Intervention Period||0
11080738|NCT01121913|12263420|FG003|NOT COMPLETED|Third Intervention Period||0
11080739|NCT01121913|12263417|FG000|STARTED|Third Washout Period||5
11080740|NCT01121913|12263418|FG001|STARTED|Third Washout Period||6
11080741|NCT01121913|12263419|FG002|STARTED|Third Washout Period||3
11080742|NCT01121913|12263420|FG003|STARTED|Third Washout Period||6
11080743|NCT01121913|12263417|FG000|COMPLETED|Third Washout Period||4
11080744|NCT01121913|12263418|FG001|COMPLETED|Third Washout Period||6
11080745|NCT01121913|12263419|FG002|COMPLETED|Third Washout Period||3
11080746|NCT01121913|12263420|FG003|COMPLETED|Third Washout Period||6
11080747|NCT01121913|12263417|FG000|NOT COMPLETED|Third Washout Period||1
11080748|NCT01121913|12263418|FG001|NOT COMPLETED|Third Washout Period||0
11080749|NCT01121913|12263419|FG002|NOT COMPLETED|Third Washout Period||0
11080750|NCT01121913|12263420|FG003|NOT COMPLETED|Third Washout Period||0
11080751|NCT01121913|12263417|FG000|STARTED|Fourth Intervention Period||4
11080752|NCT01121913|12263418|FG001|STARTED|Fourth Intervention Period||6
11080753|NCT01121913|12263419|FG002|STARTED|Fourth Intervention Period||3
11080754|NCT01121913|12263420|FG003|STARTED|Fourth Intervention Period||6
11080755|NCT01121913|12263417|FG000|COMPLETED|Fourth Intervention Period||4
11080756|NCT01121913|12263418|FG001|COMPLETED|Fourth Intervention Period||6
11080757|NCT01121913|12263419|FG002|COMPLETED|Fourth Intervention Period||3
11080758|NCT01121913|12263420|FG003|COMPLETED|Fourth Intervention Period||6
11080759|NCT01121913|12263417|FG000|NOT COMPLETED|Fourth Intervention Period||0
11080760|NCT01121913|12263418|FG001|NOT COMPLETED|Fourth Intervention Period||0
11080761|NCT01121913|12263419|FG002|NOT COMPLETED|Fourth Intervention Period||0
11080762|NCT01121913|12263420|FG003|NOT COMPLETED|Fourth Intervention Period||0
11080763|NCT01121926|12263430|FG000|STARTED|First Intervention Period||15
11349286|NCT03012334|12546207|FG000|NOT COMPLETED|Period 3||0
11349287|NCT03012334|12546208|FG001|NOT COMPLETED|Period 3||0
11349288|NCT03012334|12546209|FG002|NOT COMPLETED|Period 3||0
11349289|NCT03012334|12546210|FG003|NOT COMPLETED|Period 3||0
11349290|NCT03012334|12546211|FG004|NOT COMPLETED|Period 3||0
11349291|NCT03012334|12546212|FG005|NOT COMPLETED|Period 3||0
11349292|NCT03012334|12546213|FG006|NOT COMPLETED|Period 3||0
11349293|NCT03012334|12546214|FG007|NOT COMPLETED|Period 3||0
11349294|NCT03012334|12546215|FG008|NOT COMPLETED|Period 3||0
11349295|NCT03012334|12546216|FG009|NOT COMPLETED|Period 3||0
11349296|NCT03012334|12546207|FG000|STARTED|Period 4||9
11080764|NCT01121926|12263431|FG001|STARTED|First Intervention Period||15
11080765|NCT01121926|12263430|FG000|COMPLETED|First Intervention Period||14
11080766|NCT01121926|12263431|FG001|COMPLETED|First Intervention Period||15
11080767|NCT01121926|12263430|FG000|NOT COMPLETED|First Intervention Period||1
11080768|NCT01121926|12263431|FG001|NOT COMPLETED|First Intervention Period||0
11080769|NCT01121926|12263430|FG000|STARTED|Washout Period||14
11080770|NCT01121926|12263431|FG001|STARTED|Washout Period||15
11080771|NCT01121926|12263430|FG000|COMPLETED|Washout Period||14
11080772|NCT01121926|12263431|FG001|COMPLETED|Washout Period||13
11080773|NCT01121926|12263430|FG000|NOT COMPLETED|Washout Period||0
11080774|NCT01121926|12263431|FG001|NOT COMPLETED|Washout Period||2
11080775|NCT01121926|12263430|FG000|STARTED|Second Intervention Period||14
11080776|NCT01121926|12263431|FG001|STARTED|Second Intervention Period||13
11080777|NCT01121926|12263430|FG000|COMPLETED|Second Intervention Period||14
11080778|NCT01121926|12263431|FG001|COMPLETED|Second Intervention Period||13
11080779|NCT01121926|12263430|FG000|NOT COMPLETED|Second Intervention Period||0
11080780|NCT01121926|12263431|FG001|NOT COMPLETED|Second Intervention Period||0
11080781|NCT01121939|12263437|FG000|STARTED|Overall Study||43
11080782|NCT01121939|12263437|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
11080783|NCT01121939|12263437|FG000|NOT COMPLETED|Overall Study||43
11080784|NCT01121991|12263444|FG000|STARTED|Overall Study|Number of participants treated|52
11080785|NCT01121991|12263444|FG000|COMPLETED|Overall Study||46
11080786|NCT01121991|12263444|FG000|NOT COMPLETED|Overall Study||6
11080787|NCT01122030|12263455|FG000|STARTED|Overall Study||18
11080788|NCT01122030|12263456|FG001|STARTED|Overall Study||9
11080789|NCT01122030|12263457|FG002|STARTED|Overall Study||9
11080790|NCT01122030|12263458|FG003|STARTED|Overall Study||9
11080791|NCT01122030|12263459|FG004|STARTED|Overall Study||9
11080792|NCT01122030|12263460|FG005|STARTED|Overall Study||9
11080793|NCT01122030|12263461|FG006|STARTED|Overall Study||9
11080794|NCT01122030|12263455|FG000|Received Treatment|Overall Study||18
11080795|NCT01122030|12263456|FG001|Received Treatment|Overall Study||9
11080796|NCT01122030|12263457|FG002|Received Treatment|Overall Study||9
11080797|NCT01122030|12263458|FG003|Received Treatment|Overall Study||9
11080798|NCT01122030|12263459|FG004|Received Treatment|Overall Study||9
11080799|NCT01122030|12263460|FG005|Received Treatment|Overall Study||9
11080800|NCT01122030|12263461|FG006|Received Treatment|Overall Study||9
11080801|NCT01122030|12263455|FG000|COMPLETED|Overall Study||18
11080802|NCT01122030|12263456|FG001|COMPLETED|Overall Study||9
11080803|NCT01122030|12263457|FG002|COMPLETED|Overall Study||9
11080804|NCT01122030|12263458|FG003|COMPLETED|Overall Study||9
11080805|NCT01122030|12263459|FG004|COMPLETED|Overall Study||9
11080806|NCT01122030|12263460|FG005|COMPLETED|Overall Study||9
11080807|NCT01122030|12263461|FG006|COMPLETED|Overall Study||9
11080808|NCT01122030|12263455|FG000|NOT COMPLETED|Overall Study||0
11080809|NCT01122030|12263456|FG001|NOT COMPLETED|Overall Study||0
11080810|NCT01122030|12263457|FG002|NOT COMPLETED|Overall Study||0
11080811|NCT01122030|12263458|FG003|NOT COMPLETED|Overall Study||0
11080812|NCT01122030|12263459|FG004|NOT COMPLETED|Overall Study||0
11080813|NCT01122030|12263460|FG005|NOT COMPLETED|Overall Study||0
11080814|NCT01122030|12263461|FG006|NOT COMPLETED|Overall Study||0
11080815|NCT01122108|12263483|FG000|STARTED|Overall Study||21
11080816|NCT01122108|12263484|FG001|STARTED|Overall Study||21
11080817|NCT01122108|12263483|FG000|COMPLETED|Overall Study||21
11080818|NCT01122108|12263484|FG001|COMPLETED|Overall Study||21
11080819|NCT01122108|12263483|FG000|NOT COMPLETED|Overall Study||0
11080820|NCT01122108|12263484|FG001|NOT COMPLETED|Overall Study||0
11080821|NCT01122160|12263492|FG000|STARTED|First Intervention (7 Days)||6
11080822|NCT01122160|12263493|FG001|STARTED|First Intervention (7 Days)||5
11080823|NCT01122160|12263492|FG000|COMPLETED|First Intervention (7 Days)||6
11349297|NCT03012334|12546208|FG001|STARTED|Period 4||8
11349298|NCT03012334|12546209|FG002|STARTED|Period 4||8
11349299|NCT03012334|12546210|FG003|STARTED|Period 4||9
11349300|NCT03012334|12546211|FG004|STARTED|Period 4||9
11349301|NCT03012334|12546212|FG005|STARTED|Period 4||9
11080824|NCT01122160|12263493|FG001|COMPLETED|First Intervention (7 Days)||5
11080825|NCT01122160|12263492|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11080826|NCT01122160|12263493|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11080827|NCT01122160|12263492|FG000|STARTED|Washout (7-14 Days)||6
11080828|NCT01122160|12263493|FG001|STARTED|Washout (7-14 Days)||5
11080829|NCT01122160|12263492|FG000|COMPLETED|Washout (7-14 Days)||6
11080830|NCT01122160|12263493|FG001|COMPLETED|Washout (7-14 Days)||5
11080831|NCT01122160|12263492|FG000|NOT COMPLETED|Washout (7-14 Days)||0
11080832|NCT01122160|12263493|FG001|NOT COMPLETED|Washout (7-14 Days)||0
11080833|NCT01122160|12263492|FG000|STARTED|Second Intervention (7 Days)||6
11080834|NCT01122160|12263493|FG001|STARTED|Second Intervention (7 Days)||5
11080835|NCT01122160|12263492|FG000|COMPLETED|Second Intervention (7 Days)||6
11080836|NCT01122160|12263493|FG001|COMPLETED|Second Intervention (7 Days)||5
11080837|NCT01122160|12263492|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
11080838|NCT01122160|12263493|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11207176|NCT01873950|12398294|FG004|STARTED|Period 5||4
11207177|NCT01873950|12398290|FG000|COMPLETED|Period 5||4
11207178|NCT01873950|12398291|FG001|COMPLETED|Period 5||5
11207179|NCT01873950|12398292|FG002|COMPLETED|Period 5||4
11207180|NCT01873950|12398293|FG003|COMPLETED|Period 5||3
11207181|NCT01873950|12398294|FG004|COMPLETED|Period 5||4
11207182|NCT01873950|12398290|FG000|NOT COMPLETED|Period 5||0
11207183|NCT01873950|12398291|FG001|NOT COMPLETED|Period 5||0
11207184|NCT01873950|12398292|FG002|NOT COMPLETED|Period 5||0
11207185|NCT01873950|12398293|FG003|NOT COMPLETED|Period 5||1
11207186|NCT01873950|12398294|FG004|NOT COMPLETED|Period 5||0
11207187|NCT01873989|12398310|FG000|STARTED|Overall Study||8
11207188|NCT01873989|12398311|FG001|STARTED|Overall Study||7
11207189|NCT01873989|12398310|FG000|COMPLETED|Overall Study||7
11207190|NCT01873989|12398311|FG001|COMPLETED|Overall Study||6
11207191|NCT01873989|12398310|FG000|NOT COMPLETED|Overall Study||1
11207192|NCT01873989|12398311|FG001|NOT COMPLETED|Overall Study||1
11349302|NCT03012334|12546213|FG006|STARTED|Period 4||9
11349303|NCT03012334|12546214|FG007|STARTED|Period 4||8
11349304|NCT03012334|12546215|FG008|STARTED|Period 4||9
11349305|NCT03012334|12546216|FG009|STARTED|Period 4||8
11349306|NCT03012334|12546207|FG000|COMPLETED|Period 4||9
11349307|NCT03012334|12546208|FG001|COMPLETED|Period 4||8
11349308|NCT03012334|12546209|FG002|COMPLETED|Period 4||8
11349309|NCT03012334|12546210|FG003|COMPLETED|Period 4||9
11349310|NCT03012334|12546211|FG004|COMPLETED|Period 4||9
11349311|NCT03012334|12546212|FG005|COMPLETED|Period 4||9
11349312|NCT03012334|12546213|FG006|COMPLETED|Period 4||8
11349313|NCT03012334|12546214|FG007|COMPLETED|Period 4||8
11349314|NCT03012334|12546215|FG008|COMPLETED|Period 4||8
11349315|NCT03012334|12546216|FG009|COMPLETED|Period 4||8
11349316|NCT03012334|12546207|FG000|NOT COMPLETED|Period 4||0
11349317|NCT03012334|12546208|FG001|NOT COMPLETED|Period 4||0
11349318|NCT03012334|12546209|FG002|NOT COMPLETED|Period 4||0
11349319|NCT03012334|12546210|FG003|NOT COMPLETED|Period 4||0
11349320|NCT03012334|12546211|FG004|NOT COMPLETED|Period 4||0
11349321|NCT03012334|12546212|FG005|NOT COMPLETED|Period 4||0
11349322|NCT03012334|12546213|FG006|NOT COMPLETED|Period 4||1
11349323|NCT03012334|12546214|FG007|NOT COMPLETED|Period 4||0
11349324|NCT03012334|12546215|FG008|NOT COMPLETED|Period 4||1
11349325|NCT03012334|12546216|FG009|NOT COMPLETED|Period 4||0
11349326|NCT03012334|12546207|FG000|STARTED|Period 5||9
11349327|NCT03012334|12546208|FG001|STARTED|Period 5||8
11349328|NCT03012334|12546209|FG002|STARTED|Period 5||8
11349329|NCT03012334|12546210|FG003|STARTED|Period 5||9
11349330|NCT03012334|12546211|FG004|STARTED|Period 5||9
11349331|NCT03012334|12546212|FG005|STARTED|Period 5||9
11349332|NCT03012334|12546213|FG006|STARTED|Period 5||8
11349333|NCT03012334|12546214|FG007|STARTED|Period 5||8
11349334|NCT03012334|12546215|FG008|STARTED|Period 5||8
11349335|NCT03012334|12546216|FG009|STARTED|Period 5||8
11349336|NCT03012334|12546207|FG000|COMPLETED|Period 5||9
11349337|NCT03012334|12546208|FG001|COMPLETED|Period 5||8
11349338|NCT03012334|12546209|FG002|COMPLETED|Period 5||8
11349339|NCT03012334|12546210|FG003|COMPLETED|Period 5||9
11349340|NCT03012334|12546211|FG004|COMPLETED|Period 5||9
11349341|NCT03012334|12546212|FG005|COMPLETED|Period 5||9
11349342|NCT03012334|12546213|FG006|COMPLETED|Period 5||8
11349343|NCT03012334|12546214|FG007|COMPLETED|Period 5||8
11349344|NCT03012334|12546215|FG008|COMPLETED|Period 5||8
11349345|NCT03012334|12546216|FG009|COMPLETED|Period 5||8
11349346|NCT03012334|12546207|FG000|NOT COMPLETED|Period 5||0
11349347|NCT03012334|12546208|FG001|NOT COMPLETED|Period 5||0
11349348|NCT03012334|12546209|FG002|NOT COMPLETED|Period 5||0
11349349|NCT03012334|12546210|FG003|NOT COMPLETED|Period 5||0
11349350|NCT03012334|12546211|FG004|NOT COMPLETED|Period 5||0
11349351|NCT03012334|12546212|FG005|NOT COMPLETED|Period 5||0
11349352|NCT03012334|12546213|FG006|NOT COMPLETED|Period 5||0
11349353|NCT03012334|12546214|FG007|NOT COMPLETED|Period 5||0
11349354|NCT03012334|12546215|FG008|NOT COMPLETED|Period 5||0
11349355|NCT03012334|12546216|FG009|NOT COMPLETED|Period 5||0
11349356|NCT03012477|12546229|FG000|STARTED|Overall Study||34
11349357|NCT03012477|12546229|FG000|COMPLETED|Overall Study||34
11349358|NCT03012477|12546229|FG000|NOT COMPLETED|Overall Study||0
11349359|NCT03012594|12546233|FG000|STARTED|Overall Study||12
11349360|NCT03012594|12546233|FG000|COMPLETED|Overall Study||9
11349361|NCT03012594|12546233|FG000|NOT COMPLETED|Overall Study||3
11349362|NCT03012828|12546243|FG000|STARTED|Overall Study||10
11349363|NCT03012828|12546244|FG001|STARTED|Overall Study||10
11349364|NCT03012828|12546245|FG002|STARTED|Overall Study||10
11080839|NCT01122173|12263499|FG000|STARTED|Overall Study||150
11080840|NCT01122173|12263499|FG000|COMPLETED|Overall Study||141
11080841|NCT01122173|12263499|FG000|NOT COMPLETED|Overall Study||9
11080842|NCT01122238|12263520|FG000|STARTED|Overall Study||30
11080843|NCT01122238|12263521|FG001|STARTED|Overall Study||37
11080844|NCT01122238|12263522|FG002|STARTED|Overall Study||33
11080845|NCT01122238|12263523|FG003|STARTED|Overall Study||33
11080846|NCT01122238|12263524|FG004|STARTED|Overall Study||33
11080847|NCT01122238|12263525|FG005|STARTED|Overall Study||32
11080848|NCT01122238|12263526|FG006|STARTED|Overall Study||35
11080849|NCT01122238|12263527|FG007|STARTED|Overall Study||32
11080850|NCT01122238|12263528|FG008|STARTED|Overall Study||32
11080851|NCT01122238|12263529|FG009|STARTED|Overall Study||34
11080852|NCT01122238|12263530|FG010|STARTED|Overall Study||32
11080853|NCT01122238|12263531|FG011|STARTED|Overall Study||33
11080854|NCT01122238|12263532|FG012|STARTED|Overall Study||30
11080855|NCT01122238|12263533|FG013|STARTED|Overall Study||32
11080856|NCT01122238|12263534|FG014|STARTED|Overall Study||28
11080857|NCT01122238|12263535|FG015|STARTED|Overall Study||31
11080858|NCT01122238|12263520|FG000|COMPLETED|Overall Study||28
11080859|NCT01122238|12263521|FG001|COMPLETED|Overall Study||36
11080860|NCT01122238|12263522|FG002|COMPLETED|Overall Study||28
11080861|NCT01122238|12263523|FG003|COMPLETED|Overall Study||33
11080862|NCT01122238|12263524|FG004|COMPLETED|Overall Study||33
11207193|NCT01874054|12398317|FG000|STARTED|Overall Study||55
11207194|NCT01874054|12398317|FG000|Completed ≥2 Cycles of Combo Treatment|Overall Study||53
11207195|NCT01874054|12398317|FG000|Completed 16 Cycles of BV Treatment|Overall Study||17
11207196|NCT01874054|12398317|FG000|COMPLETED|Overall Study||0
11207197|NCT01874054|12398317|FG000|NOT COMPLETED|Overall Study||55
11207198|NCT01874119|12398321|FG000|STARTED|First Intervention (6 Days)||8
11207199|NCT01874119|12398322|FG001|STARTED|First Intervention (6 Days)||5
11207200|NCT01874119|12398321|FG000|COMPLETED|First Intervention (6 Days)||7
11207201|NCT01874119|12398322|FG001|COMPLETED|First Intervention (6 Days)||5
11207202|NCT01874119|12398321|FG000|NOT COMPLETED|First Intervention (6 Days)||1
11207203|NCT01874119|12398322|FG001|NOT COMPLETED|First Intervention (6 Days)||0
11207204|NCT01874119|12398321|FG000|STARTED|Washout (7 Days)||7
11207205|NCT01874119|12398322|FG001|STARTED|Washout (7 Days)||5
11207206|NCT01874119|12398321|FG000|COMPLETED|Washout (7 Days)||4
11207207|NCT01874119|12398322|FG001|COMPLETED|Washout (7 Days)||3
11207208|NCT01874119|12398321|FG000|NOT COMPLETED|Washout (7 Days)||3
11207209|NCT01874119|12398322|FG001|NOT COMPLETED|Washout (7 Days)||2
11207210|NCT01874119|12398321|FG000|STARTED|Second Intervention (6 Days)||4
11207211|NCT01874119|12398322|FG001|STARTED|Second Intervention (6 Days)||3
11207212|NCT01874119|12398321|FG000|COMPLETED|Second Intervention (6 Days)||4
11207213|NCT01874119|12398322|FG001|COMPLETED|Second Intervention (6 Days)||3
11207214|NCT01874119|12398321|FG000|NOT COMPLETED|Second Intervention (6 Days)||0
11207215|NCT01874119|12398322|FG001|NOT COMPLETED|Second Intervention (6 Days)||0
11207216|NCT01874132|12398331|FG000|STARTED|Overall Study||22
11207217|NCT01874132|12398332|FG001|STARTED|Overall Study||22
11207218|NCT01874132|12398333|FG002|STARTED|Overall Study||22
11207219|NCT01874132|12398331|FG000|COMPLETED|Overall Study||18
11207220|NCT01874132|12398332|FG001|COMPLETED|Overall Study||18
11207221|NCT01874132|12398333|FG002|COMPLETED|Overall Study||19
11207222|NCT01874132|12398331|FG000|NOT COMPLETED|Overall Study||4
11207223|NCT01874132|12398332|FG001|NOT COMPLETED|Overall Study||4
11207224|NCT01874132|12398333|FG002|NOT COMPLETED|Overall Study||3
11207225|NCT01874145|12398343|FG000|STARTED|Core Period||101
11207226|NCT01874145|12398344|FG001|STARTED|Core Period||108
11207227|NCT01874145|12398343|FG000|Full Analysis Set|Core Period||100
11207228|NCT01874145|12398344|FG001|Full Analysis Set|Core Period||108
11207229|NCT01874145|12398343|FG000|COMPLETED|Core Period||98
11207230|NCT01874145|12398344|FG001|COMPLETED|Core Period||101
11207231|NCT01874145|12398343|FG000|NOT COMPLETED|Core Period||3
11207232|NCT01874145|12398344|FG001|NOT COMPLETED|Core Period||7
11207233|NCT01874145|12398343|FG000|STARTED|Extension Period|Switchers|97
11207234|NCT01874145|12398344|FG001|STARTED|Extension Period|Non-Switchers|101
11207235|NCT01874145|12398343|FG000|Full Analysis Set|Extension Period||95
11207236|NCT01874145|12398344|FG001|Full Analysis Set|Extension Period||101
11207237|NCT01874145|12398343|FG000|COMPLETED|Extension Period||91
11207238|NCT01874145|12398344|FG001|COMPLETED|Extension Period||97
11207239|NCT01874145|12398343|FG000|NOT COMPLETED|Extension Period||6
11207240|NCT01874145|12398344|FG001|NOT COMPLETED|Extension Period||4
11207241|NCT01874262|12398356|FG000|STARTED|Overall Study||91
11207242|NCT01874262|12398357|FG001|STARTED|Overall Study||83
11080863|NCT01122238|12263525|FG005|COMPLETED|Overall Study||31
11080864|NCT01122238|12263526|FG006|COMPLETED|Overall Study||34
11080865|NCT01122238|12263527|FG007|COMPLETED|Overall Study||32
11080866|NCT01122238|12263528|FG008|COMPLETED|Overall Study||31
11080867|NCT01122238|12263529|FG009|COMPLETED|Overall Study||33
11080868|NCT01122238|12263530|FG010|COMPLETED|Overall Study||32
11080869|NCT01122238|12263531|FG011|COMPLETED|Overall Study||31
11080870|NCT01122238|12263532|FG012|COMPLETED|Overall Study||28
11080871|NCT01122238|12263533|FG013|COMPLETED|Overall Study||31
11080872|NCT01122238|12263534|FG014|COMPLETED|Overall Study||28
11080873|NCT01122238|12263535|FG015|COMPLETED|Overall Study||31
11080874|NCT01122238|12263520|FG000|NOT COMPLETED|Overall Study||2
11080875|NCT01122238|12263521|FG001|NOT COMPLETED|Overall Study||1
11080876|NCT01122238|12263522|FG002|NOT COMPLETED|Overall Study||5
11349365|NCT03012828|12546246|FG003|STARTED|Overall Study||10
11349366|NCT03012828|12546247|FG004|STARTED|Overall Study||10
11349367|NCT03012828|12546248|FG005|STARTED|Overall Study||10
11349368|NCT03012828|12546243|FG000|COMPLETED|Overall Study||9
11349369|NCT03012828|12546244|FG001|COMPLETED|Overall Study||10
11349370|NCT03012828|12546245|FG002|COMPLETED|Overall Study||8
11349371|NCT03012828|12546246|FG003|COMPLETED|Overall Study||10
11349372|NCT03012828|12546247|FG004|COMPLETED|Overall Study||8
11349373|NCT03012828|12546248|FG005|COMPLETED|Overall Study||8
11349374|NCT03012828|12546243|FG000|NOT COMPLETED|Overall Study||1
11349375|NCT03012828|12546244|FG001|NOT COMPLETED|Overall Study||0
11349376|NCT03012828|12546245|FG002|NOT COMPLETED|Overall Study||2
11349377|NCT03012828|12546246|FG003|NOT COMPLETED|Overall Study||0
11080877|NCT01122238|12263523|FG003|NOT COMPLETED|Overall Study||0
11080878|NCT01122238|12263524|FG004|NOT COMPLETED|Overall Study||0
11080879|NCT01122238|12263525|FG005|NOT COMPLETED|Overall Study||1
11080880|NCT01122238|12263526|FG006|NOT COMPLETED|Overall Study||1
11080881|NCT01122238|12263527|FG007|NOT COMPLETED|Overall Study||0
11080882|NCT01122238|12263528|FG008|NOT COMPLETED|Overall Study||1
11080883|NCT01122238|12263529|FG009|NOT COMPLETED|Overall Study||1
11080884|NCT01122238|12263530|FG010|NOT COMPLETED|Overall Study||0
11080885|NCT01122238|12263531|FG011|NOT COMPLETED|Overall Study||2
11080886|NCT01122238|12263532|FG012|NOT COMPLETED|Overall Study||2
11080887|NCT01122238|12263533|FG013|NOT COMPLETED|Overall Study||1
11349378|NCT03012828|12546247|FG004|NOT COMPLETED|Overall Study||2
11349379|NCT03012828|12546248|FG005|NOT COMPLETED|Overall Study||2
11080888|NCT01122238|12263534|FG014|NOT COMPLETED|Overall Study||0
11080889|NCT01122238|12263535|FG015|NOT COMPLETED|Overall Study||0
11080890|NCT01122264|12263552|FG000|STARTED|Overall Study||252
11080891|NCT01122264|12263553|FG001|STARTED|Overall Study||257
11080892|NCT01122264|12263554|FG002|STARTED|Overall Study||261
11080893|NCT01122264|12263552|FG000|Received at Least 1 Dose of Study Drug|Overall Study||250
11080894|NCT01122264|12263553|FG001|Received at Least 1 Dose of Study Drug|Overall Study||257
11080895|NCT01122264|12263554|FG002|Received at Least 1 Dose of Study Drug|Overall Study||260
11080896|NCT01122264|12263552|FG000|COMPLETED|Overall Study||220
11080897|NCT01122264|12263553|FG001|COMPLETED|Overall Study||228
11080898|NCT01122264|12263554|FG002|COMPLETED|Overall Study||214
11080899|NCT01122264|12263552|FG000|NOT COMPLETED|Overall Study||32
11080900|NCT01122264|12263553|FG001|NOT COMPLETED|Overall Study||29
11080901|NCT01122264|12263554|FG002|NOT COMPLETED|Overall Study||47
11080902|NCT01122316|12263566|FG000|STARTED|Overall Study||10
11080903|NCT01122316|12263566|FG000|COMPLETED|Overall Study||8
11080904|NCT01122316|12263566|FG000|NOT COMPLETED|Overall Study||2
11080905|NCT01122394|12263572|FG000|STARTED|Overall Study||66
11080906|NCT01122394|12263573|FG001|STARTED|Overall Study||74
11080907|NCT01122394|12263572|FG000|COMPLETED|Overall Study||63
11080908|NCT01122394|12263573|FG001|COMPLETED|Overall Study||70
11080909|NCT01122394|12263572|FG000|NOT COMPLETED|Overall Study||3
11080910|NCT01122394|12263573|FG001|NOT COMPLETED|Overall Study||4
11080911|NCT01122446|12263583|FG000|STARTED|Overall Study||25
11080912|NCT01122446|12263584|FG001|STARTED|Overall Study||25
11080913|NCT01122446|12263583|FG000|COMPLETED|Overall Study||25
11080914|NCT01122446|12263584|FG001|COMPLETED|Overall Study||25
11080915|NCT01122446|12263583|FG000|NOT COMPLETED|Overall Study||0
11080916|NCT01122446|12263584|FG001|NOT COMPLETED|Overall Study||0
11080917|NCT01122576|12263593|FG000|STARTED|Pre-Cataract Surgery||26
11080918|NCT01122576|12263594|FG001|STARTED|Pre-Cataract Surgery||26
11080919|NCT01122576|12263595|FG002|STARTED|Pre-Cataract Surgery||26
11080920|NCT01122576|12263593|FG000|COMPLETED|Pre-Cataract Surgery||26
11080921|NCT01122576|12263594|FG001|COMPLETED|Pre-Cataract Surgery||25
11080922|NCT01122576|12263595|FG002|COMPLETED|Pre-Cataract Surgery||24
11080923|NCT01122576|12263593|FG000|NOT COMPLETED|Pre-Cataract Surgery||0
11080924|NCT01122576|12263594|FG001|NOT COMPLETED|Pre-Cataract Surgery||1
11080925|NCT01122576|12263595|FG002|NOT COMPLETED|Pre-Cataract Surgery||2
11080926|NCT01122576|12263593|FG000|STARTED|Post-Cataract Surgery||26
11080927|NCT01122576|12263594|FG001|STARTED|Post-Cataract Surgery||25
11080928|NCT01122576|12263595|FG002|STARTED|Post-Cataract Surgery||24
11349380|NCT03012841|12546264|FG000|STARTED|Overall Study||165
11349381|NCT03012841|12546265|FG001|STARTED|Overall Study||21
11349382|NCT03012841|12546264|FG000|COMPLETED|Overall Study||145
11349383|NCT03012841|12546265|FG001|COMPLETED|Overall Study||0
11349384|NCT03012841|12546264|FG000|NOT COMPLETED|Overall Study||20
11349385|NCT03012841|12546265|FG001|NOT COMPLETED|Overall Study||21
11349386|NCT03013985|12546272|FG000|STARTED|Overall Study||108
11349387|NCT03013985|12546273|FG001|STARTED|Overall Study||103
11349388|NCT03013985|12546272|FG000|COMPLETED|Overall Study||92
11349389|NCT03013985|12546273|FG001|COMPLETED|Overall Study||84
11349390|NCT03013985|12546272|FG000|NOT COMPLETED|Overall Study||16
11349391|NCT03013985|12546273|FG001|NOT COMPLETED|Overall Study||19
11349392|NCT03014011|12546279|FG000|STARTED|First Intervention||14
11349393|NCT03014011|12546280|FG001|STARTED|First Intervention||13
11349394|NCT03014011|12546279|FG000|COMPLETED|First Intervention||13
11349395|NCT03014011|12546280|FG001|COMPLETED|First Intervention||13
11349396|NCT03014011|12546279|FG000|NOT COMPLETED|First Intervention||1
11349397|NCT03014011|12546280|FG001|NOT COMPLETED|First Intervention||0
11349398|NCT03014011|12546279|FG000|STARTED|Washout||13
11349399|NCT03014011|12546280|FG001|STARTED|Washout||13
11349400|NCT03014011|12546279|FG000|COMPLETED|Washout||12
11349401|NCT03014011|12546280|FG001|COMPLETED|Washout||13
11080929|NCT01122576|12263593|FG000|COMPLETED|Post-Cataract Surgery||26
11080930|NCT01122576|12263594|FG001|COMPLETED|Post-Cataract Surgery||25
11080931|NCT01122576|12263595|FG002|COMPLETED|Post-Cataract Surgery||22
11080932|NCT01122576|12263593|FG000|NOT COMPLETED|Post-Cataract Surgery||0
11080933|NCT01122576|12263594|FG001|NOT COMPLETED|Post-Cataract Surgery||0
11349402|NCT03014011|12546279|FG000|NOT COMPLETED|Washout||1
11349403|NCT03014011|12546280|FG001|NOT COMPLETED|Washout||0
11349404|NCT03014011|12546279|FG000|STARTED|Second Intervention||12
11349405|NCT03014011|12546280|FG001|STARTED|Second Intervention||13
11080934|NCT01122576|12263595|FG002|NOT COMPLETED|Post-Cataract Surgery||2
11080935|NCT01122680|12263606|FG000|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
11080936|NCT01122680|12263607|FG001|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
11349406|NCT03014011|12546279|FG000|COMPLETED|Second Intervention||12
11080937|NCT01122680|12263608|FG002|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
11349407|NCT03014011|12546280|FG001|COMPLETED|Second Intervention||13
11080938|NCT01122680|12263609|FG003|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
11080939|NCT01122680|12263606|FG000|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
11080940|NCT01122680|12263607|FG001|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
11080941|NCT01122680|12263608|FG002|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
11080942|NCT01122680|12263609|FG003|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
11080943|NCT01122680|12263606|FG000|NOT COMPLETED|Period 1 (4 Weeks)||3
11080944|NCT01122680|12263607|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
11080945|NCT01122680|12263608|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0
11080946|NCT01122680|12263609|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
11080947|NCT01122680|12263606|FG000|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
11080948|NCT01122680|12263607|FG001|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
11080949|NCT01122680|12263608|FG002|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
11080950|NCT01122680|12263609|FG003|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
11080951|NCT01122680|12263606|FG000|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
11080952|NCT01122680|12263607|FG001|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
11080953|NCT01122680|12263608|FG002|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
11080954|NCT01122680|12263609|FG003|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
11080955|NCT01122680|12263606|FG000|NOT COMPLETED|Period 2 (4 Weeks)||1
11080956|NCT01122680|12263607|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
11080957|NCT01122680|12263608|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
11080958|NCT01122680|12263609|FG003|NOT COMPLETED|Period 2 (4 Weeks)||1
11080959|NCT01122680|12263606|FG000|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
11080960|NCT01122680|12263607|FG001|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
11080961|NCT01122680|12263608|FG002|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
11080962|NCT01122680|12263609|FG003|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
11080963|NCT01122680|12263606|FG000|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
11080964|NCT01122680|12263607|FG001|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
11080965|NCT01122680|12263608|FG002|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
11080966|NCT01122680|12263609|FG003|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
11080967|NCT01122680|12263606|FG000|NOT COMPLETED|Period 3 (4 Weeks)||1
11080968|NCT01122680|12263607|FG001|NOT COMPLETED|Period 3 (4 Weeks)||1
11080969|NCT01122680|12263608|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
11080970|NCT01122680|12263609|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
11080971|NCT01122849|12263622|FG000|STARTED|Overall Study||20
11080972|NCT01122849|12263623|FG001|STARTED|Overall Study||21
11080973|NCT01122849|12263624|FG002|STARTED|Overall Study||20
11080974|NCT01122849|12263622|FG000|COMPLETED|Overall Study||20
11080975|NCT01122849|12263623|FG001|COMPLETED|Overall Study||21
11080976|NCT01122849|12263624|FG002|COMPLETED|Overall Study||20
11080977|NCT01122849|12263622|FG000|NOT COMPLETED|Overall Study||0
11080978|NCT01122849|12263623|FG001|NOT COMPLETED|Overall Study||0
11080979|NCT01122849|12263624|FG002|NOT COMPLETED|Overall Study||0
11080980|NCT01122862|12263642|FG000|STARTED|Period 1||8
11080981|NCT01122862|12263643|FG001|STARTED|Period 1||8
11080982|NCT01122862|12263644|FG002|STARTED|Period 1||7
11080983|NCT01122862|12263642|FG000|COMPLETED|Period 1||8
11080984|NCT01122862|12263643|FG001|COMPLETED|Period 1||7
11080985|NCT01122862|12263644|FG002|COMPLETED|Period 1||7
11080986|NCT01122862|12263642|FG000|NOT COMPLETED|Period 1||0
11080987|NCT01122862|12263643|FG001|NOT COMPLETED|Period 1||1
11080988|NCT01122862|12263644|FG002|NOT COMPLETED|Period 1||0
11080989|NCT01122862|12263642|FG000|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
11080990|NCT01122862|12263643|FG001|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
11080991|NCT01122862|12263644|FG002|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
11080992|NCT01122862|12263642|FG000|COMPLETED|Period 2||8
11080993|NCT01122862|12263643|FG001|COMPLETED|Period 2||7
11080994|NCT01122862|12263644|FG002|COMPLETED|Period 2||6
11080995|NCT01122862|12263642|FG000|NOT COMPLETED|Period 2||0
11080996|NCT01122862|12263643|FG001|NOT COMPLETED|Period 2||0
11080997|NCT01122862|12263644|FG002|NOT COMPLETED|Period 2||1
11080998|NCT01122862|12263642|FG000|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
11080999|NCT01122862|12263643|FG001|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
11081000|NCT01122862|12263644|FG002|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
11081001|NCT01122862|12263642|FG000|COMPLETED|Period 3||6
11081002|NCT01122862|12263643|FG001|COMPLETED|Period 3||7
11081003|NCT01122862|12263644|FG002|COMPLETED|Period 3||8
11081004|NCT01122862|12263642|FG000|NOT COMPLETED|Period 3||0
11081005|NCT01122862|12263643|FG001|NOT COMPLETED|Period 3||0
11081006|NCT01122862|12263644|FG002|NOT COMPLETED|Period 3||0
11081007|NCT01122901|12263655|FG000|STARTED|Overall Study||40
11081008|NCT01122901|12263656|FG001|STARTED|Overall Study||7
11081009|NCT01122901|12263655|FG000|COMPLETED|Overall Study||40
11081010|NCT01122901|12263656|FG001|COMPLETED|Overall Study||7
11081011|NCT01122901|12263655|FG000|NOT COMPLETED|Overall Study||0
11081012|NCT01122901|12263656|FG001|NOT COMPLETED|Overall Study||0
11081013|NCT01122927|12263667|FG000|STARTED|Period 1 - Conversion Phase||297
11081014|NCT01122927|12263668|FG001|STARTED|Period 1 - Conversion Phase||0
11081015|NCT01122927|12263667|FG000|COMPLETED|Period 1 - Conversion Phase||283
11081016|NCT01122927|12263668|FG001|COMPLETED|Period 1 - Conversion Phase||0
11081017|NCT01122927|12263667|FG000|NOT COMPLETED|Period 1 - Conversion Phase||14
11081018|NCT01122927|12263668|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0
11081019|NCT01122927|12263667|FG000|STARTED|Period 2- Open-label Treatment Phase||0
11081020|NCT01122927|12263668|FG001|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
11081021|NCT01122927|12263667|FG000|COMPLETED|Period 2- Open-label Treatment Phase||0
11081022|NCT01122927|12263668|FG001|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
11081023|NCT01122927|12263667|FG000|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
11081024|NCT01122927|12263668|FG001|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
11081025|NCT01123070|12263682|FG000|STARTED|Part A Cohort 1 Open Label Period||3
11081026|NCT01123070|12263683|FG001|STARTED|Part A Cohort 1 Open Label Period||0
11081027|NCT01123070|12263684|FG002|STARTED|Part A Cohort 1 Open Label Period||0
11081028|NCT01123070|12263685|FG003|STARTED|Part A Cohort 1 Open Label Period||0
11081029|NCT01123070|12263682|FG000|COMPLETED|Part A Cohort 1 Open Label Period||3
11081030|NCT01123070|12263683|FG001|COMPLETED|Part A Cohort 1 Open Label Period||0
11081031|NCT01123070|12263684|FG002|COMPLETED|Part A Cohort 1 Open Label Period||0
11081032|NCT01123070|12263685|FG003|COMPLETED|Part A Cohort 1 Open Label Period||0
11081033|NCT01123070|12263682|FG000|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
11081034|NCT01123070|12263683|FG001|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
11081035|NCT01123070|12263684|FG002|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
11081036|NCT01123070|12263685|FG003|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
11081037|NCT01123070|12263682|FG000|STARTED|Part A Cohort 2 Open Label Period||0
11081038|NCT01123070|12263683|FG001|STARTED|Part A Cohort 2 Open Label Period||3
11081039|NCT01123070|12263684|FG002|STARTED|Part A Cohort 2 Open Label Period||0
11081040|NCT01123070|12263685|FG003|STARTED|Part A Cohort 2 Open Label Period||0
11081041|NCT01123070|12263682|FG000|COMPLETED|Part A Cohort 2 Open Label Period||0
11081042|NCT01123070|12263683|FG001|COMPLETED|Part A Cohort 2 Open Label Period||3
11081043|NCT01123070|12263684|FG002|COMPLETED|Part A Cohort 2 Open Label Period||0
11081044|NCT01123070|12263685|FG003|COMPLETED|Part A Cohort 2 Open Label Period||0
11081045|NCT01123070|12263682|FG000|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
11081046|NCT01123070|12263683|FG001|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
11081047|NCT01123070|12263684|FG002|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
11081048|NCT01123070|12263685|FG003|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
11081049|NCT01123070|12263682|FG000|STARTED|Part B Double Blind Period||0
11081050|NCT01123070|12263683|FG001|STARTED|Part B Double Blind Period||0
11081051|NCT01123070|12263684|FG002|STARTED|Part B Double Blind Period||25
11081052|NCT01123070|12263685|FG003|STARTED|Part B Double Blind Period||23
11081053|NCT01123070|12263682|FG000|COMPLETED|Part B Double Blind Period||0
11081054|NCT01123070|12263683|FG001|COMPLETED|Part B Double Blind Period||0
11081055|NCT01123070|12263684|FG002|COMPLETED|Part B Double Blind Period||21
11081056|NCT01123070|12263685|FG003|COMPLETED|Part B Double Blind Period||20
11081057|NCT01123070|12263682|FG000|NOT COMPLETED|Part B Double Blind Period||0
11081058|NCT01123070|12263683|FG001|NOT COMPLETED|Part B Double Blind Period||0
11081059|NCT01123070|12263684|FG002|NOT COMPLETED|Part B Double Blind Period||4
11081060|NCT01123070|12263685|FG003|NOT COMPLETED|Part B Double Blind Period||3
11081061|NCT01123083|12263698|FG000|STARTED|Overall Study||61
11081062|NCT01123083|12263699|FG001|STARTED|Overall Study||118
11081063|NCT01123083|12263698|FG000|COMPLETED|Overall Study||50
11081064|NCT01123083|12263699|FG001|COMPLETED|Overall Study||103
11081065|NCT01123083|12263698|FG000|NOT COMPLETED|Overall Study||11
11081066|NCT01123083|12263699|FG001|NOT COMPLETED|Overall Study||15
11081067|NCT01123148|12263705|FG000|STARTED|Overall Study||14
11081068|NCT01123148|12263705|FG000|BCI Calibration >50% Accuracy|Overall Study||13
11081069|NCT01123148|12263705|FG000|COMPLETED|Overall Study||12
11081070|NCT01123148|12263705|FG000|NOT COMPLETED|Overall Study||2
11081071|NCT01123161|12263711|FG000|STARTED|Overall Study||57
11081072|NCT01123161|12263712|FG001|STARTED|Overall Study||63
11081073|NCT01123161|12263711|FG000|COMPLETED|Overall Study||55
11081074|NCT01123161|12263712|FG001|COMPLETED|Overall Study||63
11081075|NCT01123161|12263711|FG000|NOT COMPLETED|Overall Study||2
11081076|NCT01123161|12263712|FG001|NOT COMPLETED|Overall Study||0
11081077|NCT01123200|12263721|FG000|STARTED|Overall Study||1
11081078|NCT01123200|12263721|FG000|COMPLETED|Overall Study||0
11081079|NCT01123200|12263721|FG000|NOT COMPLETED|Overall Study||1
11081080|NCT01123356|12263725|FG000|STARTED|Overall Study||21
11081081|NCT01123356|12263725|FG000|COMPLETED|Overall Study||14
11081082|NCT01123356|12263725|FG000|NOT COMPLETED|Overall Study||7
11081083|NCT01123382|12263732|FG000|STARTED|Overall Study||13
11081084|NCT01123382|12263733|FG001|STARTED|Overall Study||12
11081085|NCT01123382|12263732|FG000|Received Intervention|Overall Study||12
11081086|NCT01123382|12263733|FG001|Received Intervention|Overall Study||10
11081087|NCT01123382|12263732|FG000|COMPLETED|Overall Study||11
11081088|NCT01123382|12263733|FG001|COMPLETED|Overall Study||6
11081089|NCT01123382|12263732|FG000|NOT COMPLETED|Overall Study||2
11081090|NCT01123382|12263733|FG001|NOT COMPLETED|Overall Study||6
11081091|NCT01123395|12263739|FG000|STARTED|Period 1||8
11081092|NCT01123395|12263740|FG001|STARTED|Period 1||8
11081093|NCT01123395|12263739|FG000|COMPLETED|Period 1||8
11081094|NCT01123395|12263740|FG001|COMPLETED|Period 1||8
11081095|NCT01123395|12263739|FG000|NOT COMPLETED|Period 1||0
11081096|NCT01123395|12263740|FG001|NOT COMPLETED|Period 1||0
11081097|NCT01123395|12263739|FG000|STARTED|Washout Period of 14 Days||8
11081098|NCT01123395|12263740|FG001|STARTED|Washout Period of 14 Days||8
11081099|NCT01123395|12263739|FG000|COMPLETED|Washout Period of 14 Days||8
11081100|NCT01123395|12263740|FG001|COMPLETED|Washout Period of 14 Days||7
11081101|NCT01123395|12263739|FG000|NOT COMPLETED|Washout Period of 14 Days||0
11081102|NCT01123395|12263740|FG001|NOT COMPLETED|Washout Period of 14 Days||1
11081103|NCT01123395|12263739|FG000|STARTED|Period 2||8
11081104|NCT01123395|12263740|FG001|STARTED|Period 2||7
11081105|NCT01123395|12263739|FG000|COMPLETED|Period 2||8
11081106|NCT01123395|12263740|FG001|COMPLETED|Period 2||7
11081107|NCT01123395|12263739|FG000|NOT COMPLETED|Period 2||0
11081108|NCT01123395|12263740|FG001|NOT COMPLETED|Period 2||0
11081109|NCT01123512|12263748|FG000|STARTED|Overall Study||153
11081110|NCT01123512|12263749|FG001|STARTED|Overall Study||147
11081111|NCT01123512|12263748|FG000|COMPLETED|Overall Study||127
11081112|NCT01123512|12263749|FG001|COMPLETED|Overall Study||126
11081113|NCT01123512|12263748|FG000|NOT COMPLETED|Overall Study||26
11081114|NCT01123512|12263749|FG001|NOT COMPLETED|Overall Study||21
11081115|NCT01123642|12263755|FG000|STARTED|Overall Study||345
11081116|NCT01123642|12263755|FG000|COMPLETED|Overall Study||277
11081117|NCT01123642|12263755|FG000|NOT COMPLETED|Overall Study||68
11081118|NCT01123655|12263762|FG000|STARTED|Overall Study||10
11081119|NCT01123655|12263763|FG001|STARTED|Overall Study||4
11081120|NCT01123655|12263764|FG002|STARTED|Overall Study||8
11081121|NCT01123655|12263762|FG000|COMPLETED|Overall Study||9
11081122|NCT01123655|12263763|FG001|COMPLETED|Overall Study||3
11081123|NCT01123655|12263764|FG002|COMPLETED|Overall Study||7
11081124|NCT01123655|12263762|FG000|NOT COMPLETED|Overall Study||1
11081125|NCT01123655|12263763|FG001|NOT COMPLETED|Overall Study||1
11081126|NCT01123655|12263764|FG002|NOT COMPLETED|Overall Study||1
11081127|NCT01123889|12263772|FG000|STARTED|Overall Study||5
11081128|NCT01123889|12263773|FG001|STARTED|Overall Study||7
11081129|NCT01123889|12263772|FG000|COMPLETED|Overall Study||2
11081130|NCT01123889|12263773|FG001|COMPLETED|Overall Study||6
11081131|NCT01123889|12263772|FG000|NOT COMPLETED|Overall Study||3
11081132|NCT01123889|12263773|FG001|NOT COMPLETED|Overall Study||1
11081133|NCT01123928|12263781|FG000|STARTED|Overall Study||212
11081134|NCT01123928|12263782|FG001|STARTED|Overall Study||222
11081135|NCT01123928|12263781|FG000|COMPLETED|Overall Study||212
11081136|NCT01123928|12263782|FG001|COMPLETED|Overall Study||222
11081137|NCT01123928|12263781|FG000|NOT COMPLETED|Overall Study||0
11081138|NCT01123928|12263782|FG001|NOT COMPLETED|Overall Study||0
11081139|NCT01123941|12263790|FG000|STARTED|Overall Study||25
11081140|NCT01123941|12263791|FG001|STARTED|Overall Study||25
11081141|NCT01123941|12263790|FG000|COMPLETED|Overall Study||23
11081142|NCT01123941|12263791|FG001|COMPLETED|Overall Study||24
11081143|NCT01123941|12263790|FG000|NOT COMPLETED|Overall Study||2
11081144|NCT01123941|12263791|FG001|NOT COMPLETED|Overall Study||1
11081145|NCT01123980|12263799|FG000|STARTED|Overall Study||261
11081146|NCT01123980|12263800|FG001|STARTED|Overall Study||260
11081147|NCT01123980|12263799|FG000|COMPLETED|Overall Study||242
11081148|NCT01123980|12263800|FG001|COMPLETED|Overall Study||236
11081149|NCT01123980|12263799|FG000|NOT COMPLETED|Overall Study||19
11081150|NCT01123980|12263800|FG001|NOT COMPLETED|Overall Study||24
11081151|NCT01124006|12263809|FG000|STARTED|Overall Study||10
11081152|NCT01124006|12263810|FG001|STARTED|Overall Study||10
11081153|NCT01124006|12263811|FG002|STARTED|Overall Study||4
11081154|NCT01124006|12263809|FG000|COMPLETED|Overall Study||7
11081155|NCT01124006|12263810|FG001|COMPLETED|Overall Study||8
11081156|NCT01124006|12263811|FG002|COMPLETED|Overall Study||2
11081157|NCT01124006|12263809|FG000|NOT COMPLETED|Overall Study||3
11081158|NCT01124006|12263810|FG001|NOT COMPLETED|Overall Study||2
11081159|NCT01124006|12263811|FG002|NOT COMPLETED|Overall Study||2
11081160|NCT01124045|12263821|FG000|STARTED|Overall Study||39
11081161|NCT01124045|12263822|FG001|STARTED|Overall Study||40
11081162|NCT01124045|12263821|FG000|COMPLETED|Overall Study||39
11081163|NCT01124045|12263822|FG001|COMPLETED|Overall Study||37
11081164|NCT01124045|12263821|FG000|NOT COMPLETED|Overall Study||0
11081165|NCT01124045|12263822|FG001|NOT COMPLETED|Overall Study||3
11081166|NCT01124097|12263832|FG000|STARTED|Overall Study||60
11081167|NCT01124097|12263833|FG001|STARTED|Overall Study||60
11081168|NCT01124097|12263834|FG002|STARTED|Overall Study||60
11081169|NCT01124097|12263835|FG003|STARTED|Overall Study||60
11081170|NCT01124097|12263832|FG000|Safety Population|Overall Study||60
11081171|NCT01124097|12263833|FG001|Safety Population|Overall Study||60
11081172|NCT01124097|12263834|FG002|Safety Population|Overall Study||60
11081173|NCT01124097|12263835|FG003|Safety Population|Overall Study||60
11081174|NCT01124097|12263832|FG000|Efficacy Population|Overall Study||52
11081175|NCT01124097|12263833|FG001|Efficacy Population|Overall Study||53
11081176|NCT01124097|12263834|FG002|Efficacy Population|Overall Study||53
11081177|NCT01124097|12263835|FG003|Efficacy Population|Overall Study||51
11081178|NCT01124097|12263832|FG000|COMPLETED|Overall Study||26
11081179|NCT01124097|12263833|FG001|COMPLETED|Overall Study||38
11081180|NCT01124097|12263834|FG002|COMPLETED|Overall Study||40
11081181|NCT01124097|12263835|FG003|COMPLETED|Overall Study||46
11081182|NCT01124097|12263832|FG000|NOT COMPLETED|Overall Study||34
11081183|NCT01124097|12263833|FG001|NOT COMPLETED|Overall Study||22
11081184|NCT01124097|12263834|FG002|NOT COMPLETED|Overall Study||20
11081185|NCT01124097|12263835|FG003|NOT COMPLETED|Overall Study||14
11081186|NCT01124149|12263845|FG000|STARTED|Acute Phase||722
11081187|NCT01124149|12263845|FG000|COMPLETED|Acute Phase||639
11081188|NCT01124149|12263845|FG000|NOT COMPLETED|Acute Phase||83
11081189|NCT01124149|12263845|FG000|STARTED|Maintenance Phase||469
11081190|NCT01124149|12263845|FG000|COMPLETED|Maintenance Phase||373
11081191|NCT01124149|12263845|FG000|NOT COMPLETED|Maintenance Phase||96
11081192|NCT01124162|12263854|FG000|STARTED|First Intervention||40
11081193|NCT01124162|12263855|FG001|STARTED|First Intervention||40
11081194|NCT01124162|12263854|FG000|COMPLETED|First Intervention||38
11081195|NCT01124162|12263855|FG001|COMPLETED|First Intervention||40
11081196|NCT01124162|12263854|FG000|NOT COMPLETED|First Intervention||2
11081197|NCT01124162|12263855|FG001|NOT COMPLETED|First Intervention||0
11081198|NCT01124162|12263854|FG000|STARTED|Washout of 7 Days||38
11081199|NCT01124162|12263855|FG001|STARTED|Washout of 7 Days||40
11081200|NCT01124162|12263854|FG000|COMPLETED|Washout of 7 Days||37
11349408|NCT03014011|12546279|FG000|NOT COMPLETED|Second Intervention||0
11349409|NCT03014011|12546280|FG001|NOT COMPLETED|Second Intervention||0
11349410|NCT03014180|12546286|FG000|STARTED|Overall Study||60
11349411|NCT03014180|12546286|FG000|COMPLETED|Overall Study||58
11349412|NCT03014180|12546286|FG000|NOT COMPLETED|Overall Study||2
11349413|NCT03014206|12546294|FG000|STARTED|Overall Study||696
11349414|NCT03014206|12546294|FG000|COMPLETED|Overall Study||684
11349415|NCT03014206|12546294|FG000|NOT COMPLETED|Overall Study||12
11349416|NCT03014453|12546298|FG000|STARTED|Overall Study||187
11349417|NCT03014453|12546298|FG000|COMPLETED|Overall Study||116
11349418|NCT03014453|12546298|FG000|NOT COMPLETED|Overall Study||71
11349419|NCT03014479|12546304|FG000|STARTED|Overall Study||110
11349420|NCT03014479|12546305|FG001|STARTED|Overall Study||109
11349421|NCT03014479|12546304|FG000|COMPLETED|Overall Study||110
11349422|NCT03014479|12546305|FG001|COMPLETED|Overall Study||105
11349423|NCT03014479|12546304|FG000|NOT COMPLETED|Overall Study||0
11349424|NCT03014479|12546305|FG001|NOT COMPLETED|Overall Study||4
11349425|NCT03014492|12546313|FG000|STARTED|Overall Study||44
11349426|NCT03014492|12546314|FG001|STARTED|Overall Study||28
11349427|NCT03014492|12546313|FG000|COMPLETED|Overall Study||44
11349428|NCT03014492|12546314|FG001|COMPLETED|Overall Study||28
11349429|NCT03014492|12546313|FG000|NOT COMPLETED|Overall Study||0
11349430|NCT03014492|12546314|FG001|NOT COMPLETED|Overall Study||0
11349431|NCT03014674|12546323|FG000|STARTED|Overall Study||85
11349432|NCT03014674|12546324|FG001|STARTED|Overall Study||79
11349433|NCT03014674|12546325|FG002|STARTED|Overall Study||80
11349434|NCT03014674|12546323|FG000|COMPLETED|Overall Study||84
11349435|NCT03014674|12546324|FG001|COMPLETED|Overall Study||79
11349436|NCT03014674|12546325|FG002|COMPLETED|Overall Study||80
11349437|NCT03014674|12546323|FG000|NOT COMPLETED|Overall Study||1
11349438|NCT03014674|12546324|FG001|NOT COMPLETED|Overall Study||0
11349439|NCT03014674|12546325|FG002|NOT COMPLETED|Overall Study||0
11349440|NCT03014700|12546335|FG000|STARTED|Overall Study||30
11349441|NCT03014700|12546336|FG001|STARTED|Overall Study||30
11081201|NCT01124162|12263855|FG001|COMPLETED|Washout of 7 Days||40
11081202|NCT01124162|12263854|FG000|NOT COMPLETED|Washout of 7 Days||1
11081203|NCT01124162|12263855|FG001|NOT COMPLETED|Washout of 7 Days||0
11349442|NCT03014700|12546335|FG000|COMPLETED|Overall Study||25
11349443|NCT03014700|12546336|FG001|COMPLETED|Overall Study||29
11349444|NCT03014700|12546335|FG000|NOT COMPLETED|Overall Study||5
11349445|NCT03014700|12546336|FG001|NOT COMPLETED|Overall Study||1
11349446|NCT03015116|12546345|FG000|STARTED|Overall Study||38
11349447|NCT03015116|12546346|FG001|STARTED|Overall Study||38
11349448|NCT03015116|12546347|FG002|STARTED|Overall Study||38
11349449|NCT03015116|12546345|FG000|COMPLETED|Overall Study||31
11349450|NCT03015116|12546346|FG001|COMPLETED|Overall Study||36
11081204|NCT01124162|12263854|FG000|STARTED|Second Intervention||37
11081205|NCT01124162|12263855|FG001|STARTED|Second Intervention||40
11349451|NCT03015116|12546347|FG002|COMPLETED|Overall Study||36
11349452|NCT03015116|12546345|FG000|NOT COMPLETED|Overall Study||7
11081206|NCT01124162|12263854|FG000|COMPLETED|Second Intervention||37
11081207|NCT01124162|12263855|FG001|COMPLETED|Second Intervention||40
11081208|NCT01124162|12263854|FG000|NOT COMPLETED|Second Intervention||0
11081209|NCT01124162|12263855|FG001|NOT COMPLETED|Second Intervention||0
11081210|NCT01124175|12263863|FG000|STARTED|First Intervention||40
11349453|NCT03015116|12546346|FG001|NOT COMPLETED|Overall Study||2
11349454|NCT03015116|12546347|FG002|NOT COMPLETED|Overall Study||2
11349455|NCT03015181|12546364|FG000|STARTED|Overall Study||4
11349456|NCT03015181|12546365|FG001|STARTED|Overall Study||3
11349457|NCT03015181|12546366|FG002|STARTED|Overall Study||3
11349458|NCT03015181|12546367|FG003|STARTED|Overall Study||3
11349459|NCT03015181|12546368|FG004|STARTED|Overall Study||3
11349460|NCT03015181|12546369|FG005|STARTED|Overall Study||5
11349461|NCT03015181|12546370|FG006|STARTED|Overall Study||5
11349462|NCT03015181|12546364|FG000|Received VRC07-523LS Per Protocol|Overall Study||3
11349463|NCT03015181|12546365|FG001|Received VRC07-523LS Per Protocol|Overall Study||3
11349464|NCT03015181|12546366|FG002|Received VRC07-523LS Per Protocol|Overall Study||3
11349465|NCT03015181|12546367|FG003|Received VRC07-523LS Per Protocol|Overall Study||3
11349466|NCT03015181|12546368|FG004|Received VRC07-523LS Per Protocol|Overall Study||3
11349467|NCT03015181|12546369|FG005|Received VRC07-523LS Per Protocol|Overall Study||4
11349468|NCT03015181|12546370|FG006|Received VRC07-523LS Per Protocol|Overall Study||4
11349469|NCT03015181|12546364|FG000|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1
11349470|NCT03015181|12546365|FG001|Discontinued VRC07-523LS Administrations|Overall Study||0
11349471|NCT03015181|12546366|FG002|Discontinued VRC07-523LS Administrations|Overall Study||0
11349472|NCT03015181|12546367|FG003|Discontinued VRC07-523LS Administrations|Overall Study||0
11349473|NCT03015181|12546368|FG004|Discontinued VRC07-523LS Administrations|Overall Study||0
11349474|NCT03015181|12546369|FG005|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1
11349475|NCT03015181|12546370|FG006|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1
11349476|NCT03015181|12546364|FG000|COMPLETED|Overall Study||3
11349477|NCT03015181|12546365|FG001|COMPLETED|Overall Study||3
11349478|NCT03015181|12546366|FG002|COMPLETED|Overall Study||3
11349479|NCT03015181|12546367|FG003|COMPLETED|Overall Study||3
11349480|NCT03015181|12546368|FG004|COMPLETED|Overall Study||3
11349481|NCT03015181|12546369|FG005|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4
11349482|NCT03015181|12546370|FG006|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4
11349483|NCT03015181|12546364|FG000|NOT COMPLETED|Overall Study||1
11349484|NCT03015181|12546365|FG001|NOT COMPLETED|Overall Study||0
11349485|NCT03015181|12546366|FG002|NOT COMPLETED|Overall Study||0
11349486|NCT03015181|12546367|FG003|NOT COMPLETED|Overall Study||0
11349487|NCT03015181|12546368|FG004|NOT COMPLETED|Overall Study||0
11349488|NCT03015181|12546369|FG005|NOT COMPLETED|Overall Study||1
11349489|NCT03015181|12546370|FG006|NOT COMPLETED|Overall Study||1
11349490|NCT03015220|12546410|FG000|STARTED|Overall Study||131
11349491|NCT03015220|12546411|FG001|STARTED|Overall Study||132
11349492|NCT03015220|12546412|FG002|STARTED|Overall Study||130
11349493|NCT03015220|12546413|FG003|STARTED|Overall Study||65
11349494|NCT03015220|12546410|FG000|Full Analysis Set (FAS)|Overall Study||131
11349495|NCT03015220|12546411|FG001|Full Analysis Set (FAS)|Overall Study||132
11349496|NCT03015220|12546412|FG002|Full Analysis Set (FAS)|Overall Study||130
11349497|NCT03015220|12546413|FG003|Full Analysis Set (FAS)|Overall Study||65
11349498|NCT03015220|12546410|FG000|Safety Analysis Set (SAS)|Overall Study||131
11349499|NCT03015220|12546411|FG001|Safety Analysis Set (SAS)|Overall Study||132
11349500|NCT03015220|12546412|FG002|Safety Analysis Set (SAS)|Overall Study||130
11349501|NCT03015220|12546413|FG003|Safety Analysis Set (SAS)|Overall Study||65
11349502|NCT03015220|12546410|FG000|COMPLETED|Overall Study||128
11349503|NCT03015220|12546411|FG001|COMPLETED|Overall Study||130
11349504|NCT03015220|12546412|FG002|COMPLETED|Overall Study||127
11349505|NCT03015220|12546413|FG003|COMPLETED|Overall Study||63
11349506|NCT03015220|12546410|FG000|NOT COMPLETED|Overall Study||3
11349507|NCT03015220|12546411|FG001|NOT COMPLETED|Overall Study||2
11349508|NCT03015220|12546412|FG002|NOT COMPLETED|Overall Study||3
11349509|NCT03015220|12546413|FG003|NOT COMPLETED|Overall Study||2
11349510|NCT03015363|12546423|FG000|STARTED|Overall Study||37
11349511|NCT03015363|12546423|FG000|COMPLETED|Overall Study||20
11349512|NCT03015363|12546423|FG000|NOT COMPLETED|Overall Study||17
11349513|NCT03015532|12546435|FG000|STARTED|Overall Study||20
11349514|NCT03015532|12546436|FG001|STARTED|Overall Study||22
11349515|NCT03015532|12546437|FG002|STARTED|Overall Study||11
11349516|NCT03015532|12546438|FG003|STARTED|Overall Study||10
11349517|NCT03015532|12546439|FG004|STARTED|Overall Study||58
11349518|NCT03015532|12546440|FG005|STARTED|Overall Study||56
11349519|NCT03015532|12546441|FG006|STARTED|Overall Study||53
11349520|NCT03015532|12546442|FG007|STARTED|Overall Study||55
11349521|NCT03015532|12546435|FG000|COMPLETED|Overall Study||20
11349522|NCT03015532|12546436|FG001|COMPLETED|Overall Study||22
11349523|NCT03015532|12546437|FG002|COMPLETED|Overall Study||11
11081211|NCT01124175|12263864|FG001|STARTED|First Intervention||40
11081212|NCT01124175|12263863|FG000|COMPLETED|First Intervention||40
11081213|NCT01124175|12263864|FG001|COMPLETED|First Intervention||40
11081214|NCT01124175|12263863|FG000|NOT COMPLETED|First Intervention||0
11081215|NCT01124175|12263864|FG001|NOT COMPLETED|First Intervention||0
11081216|NCT01124175|12263863|FG000|STARTED|Washout of 7 Days||40
11081217|NCT01124175|12263864|FG001|STARTED|Washout of 7 Days||40
11081218|NCT01124175|12263863|FG000|COMPLETED|Washout of 7 Days||40
11081219|NCT01124175|12263864|FG001|COMPLETED|Washout of 7 Days||38
11081220|NCT01124175|12263863|FG000|NOT COMPLETED|Washout of 7 Days||0
11081221|NCT01124175|12263864|FG001|NOT COMPLETED|Washout of 7 Days||2
11081222|NCT01124175|12263863|FG000|STARTED|Second Intervention||40
11081223|NCT01124175|12263864|FG001|STARTED|Second Intervention||38
11081224|NCT01124175|12263863|FG000|COMPLETED|Second Intervention||40
11081225|NCT01124175|12263864|FG001|COMPLETED|Second Intervention||38
11081226|NCT01124175|12263863|FG000|NOT COMPLETED|Second Intervention||0
11081227|NCT01124175|12263864|FG001|NOT COMPLETED|Second Intervention||0
11081228|NCT01124188|12263872|FG000|STARTED|Overall Study||68
11081229|NCT01124188|12263873|FG001|STARTED|Overall Study||71
11081230|NCT01124188|12263872|FG000|COMPLETED|Overall Study||60
11081231|NCT01124188|12263873|FG001|COMPLETED|Overall Study||65
11081232|NCT01124188|12263872|FG000|NOT COMPLETED|Overall Study||8
11081233|NCT01124188|12263873|FG001|NOT COMPLETED|Overall Study||6
11081234|NCT01124292|12263882|FG000|STARTED|Overall Study||16
11081235|NCT01124292|12263883|FG001|STARTED|Overall Study||24
11081236|NCT01124292|12263884|FG002|STARTED|Overall Study||21
11081237|NCT01124292|12263882|FG000|COMPLETED|Overall Study||14
11081238|NCT01124292|12263883|FG001|COMPLETED|Overall Study||9
11081239|NCT01124292|12263884|FG002|COMPLETED|Overall Study||11
11081240|NCT01124292|12263882|FG000|NOT COMPLETED|Overall Study||2
11081241|NCT01124292|12263883|FG001|NOT COMPLETED|Overall Study||15
11081242|NCT01124292|12263884|FG002|NOT COMPLETED|Overall Study||10
11081243|NCT01124305|12263897|FG000|STARTED|Overall Study||34
11081244|NCT01124305|12263898|FG001|STARTED|Overall Study||36
11081245|NCT01124305|12263897|FG000|COMPLETED|Overall Study||26
11081246|NCT01124305|12263898|FG001|COMPLETED|Overall Study||26
11081247|NCT01124305|12263897|FG000|NOT COMPLETED|Overall Study||8
11081248|NCT01124305|12263898|FG001|NOT COMPLETED|Overall Study||10
11081249|NCT01124370|12263904|FG000|STARTED|Overall Study|Underwent implant attempt|57
11081250|NCT01124370|12263904|FG000|Successfully Implanted|Overall Study||50
11081251|NCT01124370|12263904|FG000|Therapy Initiated|Overall Study||48
11081252|NCT01124370|12263904|FG000|3 Month Visit|Overall Study|Defines evaluable population|47
11081253|NCT01124370|12263904|FG000|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
11081254|NCT01124370|12263904|FG000|NOT COMPLETED|Overall Study||20
11081255|NCT01124422|12263910|FG000|STARTED|4-Week Open-label Run-in Phase||338
11081256|NCT01124422|12263911|FG001|STARTED|4-Week Open-label Run-in Phase||0
11081257|NCT01124422|12263912|FG002|STARTED|4-Week Open-label Run-in Phase||0
11081258|NCT01124422|12263910|FG000|COMPLETED|4-Week Open-label Run-in Phase||255
11081259|NCT01124422|12263911|FG001|COMPLETED|4-Week Open-label Run-in Phase||0
11081260|NCT01124422|12263912|FG002|COMPLETED|4-Week Open-label Run-in Phase||0
11081261|NCT01124422|12263910|FG000|NOT COMPLETED|4-Week Open-label Run-in Phase||83
11081262|NCT01124422|12263911|FG001|NOT COMPLETED|4-Week Open-label Run-in Phase||0
11081263|NCT01124422|12263912|FG002|NOT COMPLETED|4-Week Open-label Run-in Phase||0
11081264|NCT01124422|12263910|FG000|STARTED|4-Week Double-blind Treatment Phase||0
11081265|NCT01124422|12263911|FG001|STARTED|4-Week Double-blind Treatment Phase||131
11081266|NCT01124422|12263912|FG002|STARTED|4-Week Double-blind Treatment Phase||124
11081267|NCT01124422|12263910|FG000|COMPLETED|4-Week Double-blind Treatment Phase||0
11081268|NCT01124422|12263911|FG001|COMPLETED|4-Week Double-blind Treatment Phase||120
11081269|NCT01124422|12263912|FG002|COMPLETED|4-Week Double-blind Treatment Phase||115
11081270|NCT01124422|12263910|FG000|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
11081271|NCT01124422|12263911|FG001|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
11081272|NCT01124422|12263912|FG002|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
11081273|NCT01124448|12263921|FG000|STARTED|Overall Study||25
11081274|NCT01124448|12263922|FG001|STARTED|Overall Study||15
11081275|NCT01124448|12263921|FG000|COMPLETED|Overall Study||23
11081276|NCT01124448|12263922|FG001|COMPLETED|Overall Study||12
11081277|NCT01124448|12263921|FG000|NOT COMPLETED|Overall Study||2
11081278|NCT01124448|12263922|FG001|NOT COMPLETED|Overall Study||3
11081279|NCT01124604|12263930|FG000|STARTED|Overall Study||60
11081280|NCT01124604|12263931|FG001|STARTED|Overall Study||31
11081281|NCT01124604|12263930|FG000|COMPLETED|Overall Study||45
11081282|NCT01124604|12263931|FG001|COMPLETED|Overall Study||29
11081283|NCT01124604|12263930|FG000|NOT COMPLETED|Overall Study||15
11081284|NCT01124604|12263931|FG001|NOT COMPLETED|Overall Study||2
11081285|NCT01124617|12263939|FG000|STARTED|Overall Study||60
11081286|NCT01124617|12263940|FG001|STARTED|Overall Study||31
11081287|NCT01124617|12263939|FG000|COMPLETED|Overall Study||41
11081288|NCT01124617|12263940|FG001|COMPLETED|Overall Study||25
11081289|NCT01124617|12263939|FG000|NOT COMPLETED|Overall Study||19
11081290|NCT01124617|12263940|FG001|NOT COMPLETED|Overall Study||6
11081291|NCT01124643|12263946|FG000|STARTED|Overall Study||35
11081292|NCT01124643|12263946|FG000|COMPLETED|Overall Study||34
11081293|NCT01124643|12263946|FG000|NOT COMPLETED|Overall Study||1
11081294|NCT01124734|12263950|FG000|STARTED|Overall Study||17
11081295|NCT01124734|12263950|FG000|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17
11081296|NCT01124734|12263950|FG000|Initiation of Course 1 Cycle 2|Overall Study||17
11081297|NCT01124734|12263950|FG000|COMPLETED|Overall Study|Closed to accrual|0
11081298|NCT01124734|12263950|FG000|NOT COMPLETED|Overall Study||17
11081299|NCT01124786|12263961|FG000|STARTED|Overall Study||182
11081300|NCT01124786|12263962|FG001|STARTED|Overall Study||185
11081301|NCT01124786|12263961|FG000|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
11081302|NCT01124786|12263962|FG001|Intent-to-Treat (ITT) Population|Overall Study||185
11081303|NCT01124786|12263961|FG000|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
11081304|NCT01124786|12263962|FG001|Safety Population|Overall Study||181
11349524|NCT03015532|12546438|FG003|COMPLETED|Overall Study||10
11349525|NCT03015532|12546439|FG004|COMPLETED|Overall Study||58
11349526|NCT03015532|12546440|FG005|COMPLETED|Overall Study||54
11349527|NCT03015532|12546441|FG006|COMPLETED|Overall Study||51
11349528|NCT03015532|12546442|FG007|COMPLETED|Overall Study||55
11081305|NCT01124786|12263961|FG000|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
11349529|NCT03015532|12546435|FG000|NOT COMPLETED|Overall Study||0
11349530|NCT03015532|12546436|FG001|NOT COMPLETED|Overall Study||0
11349531|NCT03015532|12546437|FG002|NOT COMPLETED|Overall Study||0
11349532|NCT03015532|12546438|FG003|NOT COMPLETED|Overall Study||0
11349533|NCT03015532|12546439|FG004|NOT COMPLETED|Overall Study||0
11349534|NCT03015532|12546440|FG005|NOT COMPLETED|Overall Study||2
11349535|NCT03015532|12546441|FG006|NOT COMPLETED|Overall Study||2
11349536|NCT03015532|12546442|FG007|NOT COMPLETED|Overall Study||0
11349537|NCT03015649|12546462|FG000|STARTED|Overall Study||34
11349538|NCT03015649|12546462|FG000|COMPLETED|Overall Study||34
11349539|NCT03015649|12546462|FG000|NOT COMPLETED|Overall Study||0
11349540|NCT03015961|12546468|FG000|STARTED|Overall Study||18
11349541|NCT03015961|12546469|FG001|STARTED|Overall Study||20
11349542|NCT03015961|12546468|FG000|COMPLETED|Overall Study||18
11349543|NCT03015961|12546469|FG001|COMPLETED|Overall Study||18
11349544|NCT03015961|12546468|FG000|NOT COMPLETED|Overall Study||0
11349545|NCT03015961|12546469|FG001|NOT COMPLETED|Overall Study||2
11349546|NCT03016078|12546475|FG000|STARTED|Overall Study||21
11349547|NCT03016078|12546475|FG000|COMPLETED|Overall Study||19
11349548|NCT03016078|12546475|FG000|NOT COMPLETED|Overall Study||2
11349549|NCT03016325|12546487|FG000|STARTED|Treatment Period||48
11349550|NCT03016325|12546488|FG001|STARTED|Treatment Period||49
11349551|NCT03016325|12546489|FG002|STARTED|Treatment Period||71
11349552|NCT03016325|12546490|FG003|STARTED|Treatment Period||71
11349553|NCT03016325|12546491|FG004|STARTED|Treatment Period||72
11349554|NCT03016325|12546492|FG005|STARTED|Treatment Period||6
11349555|NCT03016325|12546493|FG006|STARTED|Treatment Period||6
11349556|NCT03016325|12546494|FG007|STARTED|Treatment Period||6
11349557|NCT03016325|12546487|FG000|COMPLETED|Treatment Period||48
11349558|NCT03016325|12546488|FG001|COMPLETED|Treatment Period||48
11349559|NCT03016325|12546489|FG002|COMPLETED|Treatment Period||70
11349560|NCT03016325|12546490|FG003|COMPLETED|Treatment Period||71
11349561|NCT03016325|12546491|FG004|COMPLETED|Treatment Period||70
11349562|NCT03016325|12546492|FG005|COMPLETED|Treatment Period||6
11349563|NCT03016325|12546493|FG006|COMPLETED|Treatment Period||6
11349564|NCT03016325|12546494|FG007|COMPLETED|Treatment Period||6
11349565|NCT03016325|12546487|FG000|NOT COMPLETED|Treatment Period||0
11349566|NCT03016325|12546488|FG001|NOT COMPLETED|Treatment Period||1
11349567|NCT03016325|12546489|FG002|NOT COMPLETED|Treatment Period||1
11349568|NCT03016325|12546490|FG003|NOT COMPLETED|Treatment Period||0
11349569|NCT03016325|12546491|FG004|NOT COMPLETED|Treatment Period||2
11349570|NCT03016325|12546492|FG005|NOT COMPLETED|Treatment Period||0
11349571|NCT03016325|12546493|FG006|NOT COMPLETED|Treatment Period||0
11349572|NCT03016325|12546494|FG007|NOT COMPLETED|Treatment Period||0
11349573|NCT03016325|12546487|FG000|STARTED|32-Day Follow-Up Period||48
11349574|NCT03016325|12546488|FG001|STARTED|32-Day Follow-Up Period||49
11349575|NCT03016325|12546489|FG002|STARTED|32-Day Follow-Up Period||71
11349576|NCT03016325|12546490|FG003|STARTED|32-Day Follow-Up Period||71
11349577|NCT03016325|12546491|FG004|STARTED|32-Day Follow-Up Period||72
11349578|NCT03016325|12546492|FG005|STARTED|32-Day Follow-Up Period||6
11349579|NCT03016325|12546493|FG006|STARTED|32-Day Follow-Up Period||6
11349580|NCT03016325|12546494|FG007|STARTED|32-Day Follow-Up Period||6
11349581|NCT03016325|12546487|FG000|COMPLETED|32-Day Follow-Up Period||44
11349582|NCT03016325|12546488|FG001|COMPLETED|32-Day Follow-Up Period||47
11349583|NCT03016325|12546489|FG002|COMPLETED|32-Day Follow-Up Period||62
11349584|NCT03016325|12546490|FG003|COMPLETED|32-Day Follow-Up Period||63
11349585|NCT03016325|12546491|FG004|COMPLETED|32-Day Follow-Up Period||64
11349586|NCT03016325|12546492|FG005|COMPLETED|32-Day Follow-Up Period||6
11349587|NCT03016325|12546493|FG006|COMPLETED|32-Day Follow-Up Period||5
11349588|NCT03016325|12546494|FG007|COMPLETED|32-Day Follow-Up Period||6
11349589|NCT03016325|12546487|FG000|NOT COMPLETED|32-Day Follow-Up Period||4
11349590|NCT03016325|12546488|FG001|NOT COMPLETED|32-Day Follow-Up Period||2
11349591|NCT03016325|12546489|FG002|NOT COMPLETED|32-Day Follow-Up Period||9
11349592|NCT03016325|12546490|FG003|NOT COMPLETED|32-Day Follow-Up Period||8
11349593|NCT03016325|12546491|FG004|NOT COMPLETED|32-Day Follow-Up Period||8
11349594|NCT03016325|12546492|FG005|NOT COMPLETED|32-Day Follow-Up Period||0
11349595|NCT03016325|12546493|FG006|NOT COMPLETED|32-Day Follow-Up Period||1
11349596|NCT03016325|12546494|FG007|NOT COMPLETED|32-Day Follow-Up Period||0
11349597|NCT03016325|12546487|FG000|STARTED|182-Day Follow-Up Period||48
11349598|NCT03016325|12546488|FG001|STARTED|182-Day Follow-Up Period||49
11349599|NCT03016325|12546489|FG002|STARTED|182-Day Follow-Up Period||71
11349600|NCT03016325|12546490|FG003|STARTED|182-Day Follow-Up Period||71
11349601|NCT03016325|12546491|FG004|STARTED|182-Day Follow-Up Period||72
11349602|NCT03016325|12546492|FG005|STARTED|182-Day Follow-Up Period||6
11349603|NCT03016325|12546493|FG006|STARTED|182-Day Follow-Up Period||6
11349604|NCT03016325|12546494|FG007|STARTED|182-Day Follow-Up Period||6
11349605|NCT03016325|12546487|FG000|COMPLETED|182-Day Follow-Up Period||44
11349606|NCT03016325|12546488|FG001|COMPLETED|182-Day Follow-Up Period||45
11081306|NCT01124786|12263962|FG001|Tumor Evaluable Population|Overall Study||180
11081307|NCT01124786|12263961|FG000|COMPLETED|Overall Study||178
11081308|NCT01124786|12263962|FG001|COMPLETED|Overall Study||180
11081309|NCT01124786|12263961|FG000|NOT COMPLETED|Overall Study||4
11081310|NCT01124786|12263962|FG001|NOT COMPLETED|Overall Study||5
11081311|NCT01124838|12263970|FG000|STARTED|Overall Study||130
11081312|NCT01124838|12263971|FG001|STARTED|Overall Study||131
11081313|NCT01124838|12263970|FG000|Enrolled in Main Study|Overall Study||114
11081314|NCT01124838|12263971|FG001|Enrolled in Main Study|Overall Study||115
11081315|NCT01124838|12263970|FG000|Enrolled in Japan Sub-study|Overall Study||16
11081316|NCT01124838|12263971|FG001|Enrolled in Japan Sub-study|Overall Study||16
11081317|NCT01124838|12263970|FG000|COMPLETED|Overall Study||112
11081318|NCT01124838|12263971|FG001|COMPLETED|Overall Study||116
11081319|NCT01124838|12263970|FG000|NOT COMPLETED|Overall Study||18
11081320|NCT01124838|12263971|FG001|NOT COMPLETED|Overall Study||15
11081321|NCT01124864|12263985|FG000|STARTED|Overall Study||28
11081322|NCT01124864|12263986|FG001|STARTED|Overall Study||35
11081323|NCT01124864|12263987|FG002|STARTED|Overall Study||34
11081324|NCT01124864|12263988|FG003|STARTED|Overall Study||22
11081325|NCT01124864|12263989|FG004|STARTED|Overall Study||31
11081326|NCT01124864|12263990|FG005|STARTED|Overall Study||3
11081327|NCT01124864|12263985|FG000|COMPLETED|Overall Study||0
11081328|NCT01124864|12263986|FG001|COMPLETED|Overall Study||0
11081329|NCT01124864|12263987|FG002|COMPLETED|Overall Study||0
11081330|NCT01124864|12263988|FG003|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
11081331|NCT01124864|12263989|FG004|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
11081332|NCT01124864|12263990|FG005|COMPLETED|Overall Study||0
11081333|NCT01124864|12263985|FG000|NOT COMPLETED|Overall Study||28
11081334|NCT01124864|12263986|FG001|NOT COMPLETED|Overall Study||35
11081335|NCT01124864|12263987|FG002|NOT COMPLETED|Overall Study||34
11081336|NCT01124864|12263988|FG003|NOT COMPLETED|Overall Study||21
11081337|NCT01124864|12263989|FG004|NOT COMPLETED|Overall Study||30
11081338|NCT01124864|12263990|FG005|NOT COMPLETED|Overall Study||3
11081339|NCT01124916|12264008|FG000|STARTED|Overall Study||38
11081340|NCT01124916|12264009|FG001|STARTED|Overall Study||40
11081341|NCT01124916|12264008|FG000|COMPLETED|Overall Study||35
11081342|NCT01124916|12264009|FG001|COMPLETED|Overall Study||38
11081343|NCT01124916|12264008|FG000|NOT COMPLETED|Overall Study||3
11081344|NCT01124916|12264009|FG001|NOT COMPLETED|Overall Study||2
11081345|NCT01124955|12264017|FG000|STARTED|Overall Study||40
11081346|NCT01124955|12264018|FG001|STARTED|Overall Study||40
11081347|NCT01124955|12264017|FG000|COMPLETED|Overall Study||40
11081348|NCT01124955|12264018|FG001|COMPLETED|Overall Study||40
11081349|NCT01124955|12264017|FG000|NOT COMPLETED|Overall Study||0
11081350|NCT01124955|12264018|FG001|NOT COMPLETED|Overall Study||0
11081351|NCT01125046|12264024|FG000|STARTED|First 6 Months of Treatment||50
11081352|NCT01125046|12264024|FG000|COMPLETED|First 6 Months of Treatment||36
11081353|NCT01125046|12264024|FG000|NOT COMPLETED|First 6 Months of Treatment||14
11081354|NCT01125046|12264024|FG000|STARTED|Continued Treatment After 6 Months||36
11081355|NCT01125046|12264024|FG000|COMPLETED|Continued Treatment After 6 Months||33
11081356|NCT01125046|12264024|FG000|NOT COMPLETED|Continued Treatment After 6 Months||3
11081357|NCT01125046|12264024|FG000|STARTED|Follow-up/Data Cut Off Point||49
11081358|NCT01125046|12264024|FG000|COMPLETED|Follow-up/Data Cut Off Point||16
11081359|NCT01125046|12264024|FG000|NOT COMPLETED|Follow-up/Data Cut Off Point||33
11081360|NCT01125098|12264030|FG000|STARTED|Overall Study||91
11081361|NCT01125098|12264031|FG001|STARTED|Overall Study||90
11081362|NCT01125098|12264030|FG000|COMPLETED|Overall Study||88
11081363|NCT01125098|12264031|FG001|COMPLETED|Overall Study||90
11081364|NCT01125098|12264030|FG000|NOT COMPLETED|Overall Study||3
11081365|NCT01125098|12264031|FG001|NOT COMPLETED|Overall Study||0
11081366|NCT01125163|12264039|FG000|STARTED|Overall Study||76
11081367|NCT01125163|12264040|FG001|STARTED|Overall Study||74
11081368|NCT01125163|12264039|FG000|COMPLETED|Overall Study||76
11081369|NCT01125163|12264040|FG001|COMPLETED|Overall Study||74
11081370|NCT01125163|12264039|FG000|NOT COMPLETED|Overall Study||0
11081371|NCT01125163|12264040|FG001|NOT COMPLETED|Overall Study||0
11081372|NCT01125189|12264050|FG000|STARTED|Treatment Period||159
11081373|NCT01125189|12264051|FG001|STARTED|Treatment Period||158
11081374|NCT01125189|12264052|FG002|STARTED|Treatment Period||78
11081375|NCT01125189|12264050|FG000|COMPLETED|Treatment Period||128
11081376|NCT01125189|12264051|FG001|COMPLETED|Treatment Period||123
11081377|NCT01125189|12264052|FG002|COMPLETED|Treatment Period||37
11081378|NCT01125189|12264050|FG000|NOT COMPLETED|Treatment Period||31
11081379|NCT01125189|12264051|FG001|NOT COMPLETED|Treatment Period||35
11081380|NCT01125189|12264052|FG002|NOT COMPLETED|Treatment Period||41
11081381|NCT01125189|12264050|FG000|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
11081382|NCT01125189|12264051|FG001|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
11081383|NCT01125189|12264052|FG002|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
11081384|NCT01125189|12264050|FG000|COMPLETED|Follow up Period||132
11081385|NCT01125189|12264051|FG001|COMPLETED|Follow up Period||138
11081386|NCT01125189|12264052|FG002|COMPLETED|Follow up Period||58
11081387|NCT01125189|12264050|FG000|NOT COMPLETED|Follow up Period||20
11081388|NCT01125189|12264051|FG001|NOT COMPLETED|Follow up Period||15
11081389|NCT01125189|12264052|FG002|NOT COMPLETED|Follow up Period||16
11081390|NCT01125202|12264065|FG000|STARTED|Overall Study||93
11081391|NCT01125202|12264066|FG001|STARTED|Overall Study||86
11081392|NCT01125202|12264065|FG000|COMPLETED|Overall Study||81
11081393|NCT01125202|12264066|FG001|COMPLETED|Overall Study||79
11081394|NCT01125202|12264065|FG000|NOT COMPLETED|Overall Study||12
11081395|NCT01125202|12264066|FG001|NOT COMPLETED|Overall Study||7
11081396|NCT01125293|12264078|FG000|STARTED|Overall Study||3
11081397|NCT01125293|12264079|FG001|STARTED|Overall Study||3
11081398|NCT01125293|12264080|FG002|STARTED|Overall Study||4
11081399|NCT01125293|12264081|FG003|STARTED|Overall Study||3
11081400|NCT01125293|12264082|FG004|STARTED|Overall Study|Per protocol, a 10 patient expansion cohort is used to confirm the MTD determined in Stage B .|10
11081401|NCT01125293|12264083|FG005|STARTED|Overall Study||23
11081402|NCT01125293|12264078|FG000|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
11081403|NCT01125293|12264079|FG001|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
11081404|NCT01125293|12264080|FG002|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
11081405|NCT01125293|12264081|FG003|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
11081406|NCT01125293|12264082|FG004|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase I dose expansion cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
11081407|NCT01125293|12264083|FG005|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase II cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
11081408|NCT01125293|12264078|FG000|COMPLETED|Overall Study||0
11081409|NCT01125293|12264079|FG001|COMPLETED|Overall Study||0
11081410|NCT01125293|12264080|FG002|COMPLETED|Overall Study||0
11081411|NCT01125293|12264081|FG003|COMPLETED|Overall Study||0
11081412|NCT01125293|12264082|FG004|COMPLETED|Overall Study||0
11081413|NCT01125293|12264083|FG005|COMPLETED|Overall Study||0
11081414|NCT01125293|12264078|FG000|NOT COMPLETED|Overall Study||3
11081415|NCT01125293|12264079|FG001|NOT COMPLETED|Overall Study||3
11081416|NCT01125293|12264080|FG002|NOT COMPLETED|Overall Study||4
11081417|NCT01125293|12264081|FG003|NOT COMPLETED|Overall Study||3
11081418|NCT01125293|12264082|FG004|NOT COMPLETED|Overall Study||10
11081419|NCT01125293|12264083|FG005|NOT COMPLETED|Overall Study||23
11081420|NCT01125358|12264104|FG000|STARTED|Overall Study||21
11081421|NCT01125358|12264105|FG001|STARTED|Overall Study||21
11081422|NCT01125358|12264106|FG002|STARTED|Overall Study||20
11081423|NCT01125358|12264107|FG003|STARTED|Overall Study||20
11081424|NCT01125358|12264104|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
11081425|NCT01125358|12264105|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21
11081426|NCT01125358|12264106|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
11081427|NCT01125358|12264107|FG003|Received at Least 1 Dose of Study Drug|Overall Study||20
11081428|NCT01125358|12264104|FG000|Placebo Responder|Overall Study||1
11081429|NCT01125358|12264105|FG001|Placebo Responder|Overall Study||0
11081430|NCT01125358|12264106|FG002|Placebo Responder|Overall Study||0
11081431|NCT01125358|12264107|FG003|Placebo Responder|Overall Study||0
11081432|NCT01125358|12264104|FG000|COMPLETED|Overall Study||9
11081433|NCT01125358|12264105|FG001|COMPLETED|Overall Study||17
11081434|NCT01125358|12264106|FG002|COMPLETED|Overall Study||11
11081435|NCT01125358|12264107|FG003|COMPLETED|Overall Study||12
11081436|NCT01125358|12264104|FG000|NOT COMPLETED|Overall Study||12
11081437|NCT01125358|12264105|FG001|NOT COMPLETED|Overall Study||4
11081438|NCT01125358|12264106|FG002|NOT COMPLETED|Overall Study||9
11081439|NCT01125358|12264107|FG003|NOT COMPLETED|Overall Study||8
11207243|NCT01874262|12398356|FG000|Not Correctly Randomised|Overall Study||2
11207244|NCT01874262|12398357|FG001|Not Correctly Randomised|Overall Study||0
11207245|NCT01874262|12398356|FG000|Not Included Due to Tehnical Issues|Overall Study||3
11207246|NCT01874262|12398357|FG001|Not Included Due to Tehnical Issues|Overall Study||3
11207247|NCT01874262|12398356|FG000|COMPLETED|Overall Study||86
11207248|NCT01874262|12398357|FG001|COMPLETED|Overall Study||80
11207249|NCT01874262|12398356|FG000|NOT COMPLETED|Overall Study||5
11207250|NCT01874262|12398357|FG001|NOT COMPLETED|Overall Study||3
11207251|NCT01874275|12398365|FG000|STARTED|Overall Study||4
11207252|NCT01874275|12398366|FG001|STARTED|Overall Study||2
11207253|NCT01874275|12398365|FG000|COMPLETED|Overall Study||3
11207254|NCT01874275|12398366|FG001|COMPLETED|Overall Study||2
11207255|NCT01874275|12398365|FG000|NOT COMPLETED|Overall Study||1
11207256|NCT01874275|12398366|FG001|NOT COMPLETED|Overall Study||0
11207257|NCT01874288|12398383|FG000|STARTED|Overall Study||3
11207258|NCT01874288|12398384|FG001|STARTED|Overall Study||3
11207259|NCT01874288|12398385|FG002|STARTED|Overall Study||9
11207260|NCT01874288|12398386|FG003|STARTED|Overall Study||7
11207261|NCT01874288|12398387|FG004|STARTED|Overall Study||2
11207262|NCT01874288|12398383|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11207263|NCT01874288|12398384|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
11207264|NCT01874288|12398385|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
11207265|NCT01874288|12398386|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
11207266|NCT01874288|12398387|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2
11207267|NCT01874288|12398383|FG000|COMPLETED|Overall Study||0
11207268|NCT01874288|12398384|FG001|COMPLETED|Overall Study||3
11207269|NCT01874288|12398385|FG002|COMPLETED|Overall Study||4
11207270|NCT01874288|12398386|FG003|COMPLETED|Overall Study||0
11207271|NCT01874288|12398387|FG004|COMPLETED|Overall Study||0
11207272|NCT01874288|12398383|FG000|NOT COMPLETED|Overall Study||3
11207273|NCT01874288|12398384|FG001|NOT COMPLETED|Overall Study||0
11207274|NCT01874288|12398385|FG002|NOT COMPLETED|Overall Study||5
11207275|NCT01874288|12398386|FG003|NOT COMPLETED|Overall Study||7
11207276|NCT01874288|12398387|FG004|NOT COMPLETED|Overall Study||2
11207277|NCT01874340|12398404|FG000|STARTED|Overall Study||6
11207278|NCT01874340|12398405|FG001|STARTED|Overall Study||8
11207279|NCT01874340|12398406|FG002|STARTED|Overall Study||8
11207280|NCT01874340|12398407|FG003|STARTED|Overall Study||6
11207281|NCT01874340|12398404|FG000|COMPLETED|Overall Study||0
11207282|NCT01874340|12398405|FG001|COMPLETED|Overall Study||0
11081440|NCT04733664|12264117|FG000|STARTED|Overall Study||10
11081441|NCT04733664|12264117|FG000|COMPLETED|Overall Study||10
11081442|NCT04733664|12264117|FG000|NOT COMPLETED|Overall Study||0
11081443|NCT04573322|12264125|FG000|STARTED|Overall Study||6
11081444|NCT04573322|12264126|FG001|STARTED|Overall Study||6
11081445|NCT04573322|12264127|FG002|STARTED|Overall Study||7
11081446|NCT04573322|12264128|FG003|STARTED|Overall Study||6
11081447|NCT04573322|12264125|FG000|COMPLETED|Overall Study||5
11081448|NCT04573322|12264126|FG001|COMPLETED|Overall Study||4
11081449|NCT04573322|12264127|FG002|COMPLETED|Overall Study||5
11081450|NCT04573322|12264128|FG003|COMPLETED|Overall Study||3
11081451|NCT04573322|12264125|FG000|NOT COMPLETED|Overall Study||1
11081452|NCT04573322|12264126|FG001|NOT COMPLETED|Overall Study||2
11081453|NCT04573322|12264127|FG002|NOT COMPLETED|Overall Study||2
11081454|NCT04573322|12264128|FG003|NOT COMPLETED|Overall Study||3
11081455|NCT04374565|12264138|FG000|STARTED|Overall Study||29
11081456|NCT04374565|12264138|FG000|COMPLETED|Overall Study||29
11081457|NCT04374565|12264138|FG000|NOT COMPLETED|Overall Study||0
11081458|NCT04364737|12264144|FG000|STARTED|Overall Study||468
11081459|NCT04364737|12264145|FG001|STARTED|Overall Study||473
11081460|NCT04364737|12264144|FG000|COMPLETED|Overall Study||463
11081461|NCT04364737|12264145|FG001|COMPLETED|Overall Study||463
11081462|NCT04364737|12264144|FG000|NOT COMPLETED|Overall Study||5
11081463|NCT04364737|12264145|FG001|NOT COMPLETED|Overall Study||10
11081464|NCT04354155|12264151|FG000|STARTED|Overall Study||40
11081465|NCT04354155|12264151|FG000|COMPLETED|Overall Study||38
11081466|NCT04354155|12264151|FG000|NOT COMPLETED|Overall Study||2
11081467|NCT04085367|12264157|FG000|STARTED|Overall Study||364
11081468|NCT04085367|12264158|FG001|STARTED|Overall Study||193
11081469|NCT04085367|12264157|FG000|COMPLETED|Overall Study||344
11081470|NCT04085367|12264158|FG001|COMPLETED|Overall Study||185
11081471|NCT04085367|12264157|FG000|NOT COMPLETED|Overall Study||20
11081472|NCT04085367|12264158|FG001|NOT COMPLETED|Overall Study||8
11081473|NCT03884270|12264164|FG000|STARTED|Overall Study||23
11081474|NCT03884270|12264164|FG000|COMPLETED|Overall Study||22
11081475|NCT03884270|12264164|FG000|NOT COMPLETED|Overall Study||1
11207283|NCT01874340|12398406|FG002|COMPLETED|Overall Study||0
11207284|NCT01874340|12398407|FG003|COMPLETED|Overall Study||1
11207285|NCT01874340|12398404|FG000|NOT COMPLETED|Overall Study||6
11207286|NCT01874340|12398405|FG001|NOT COMPLETED|Overall Study||8
11207287|NCT01874340|12398406|FG002|NOT COMPLETED|Overall Study||8
11207288|NCT01874340|12398407|FG003|NOT COMPLETED|Overall Study||5
11207289|NCT01874392|12398417|FG000|STARTED|Overall Study||9
11207290|NCT01874392|12398417|FG000|COMPLETED|Overall Study||9
11207291|NCT01874392|12398417|FG000|NOT COMPLETED|Overall Study||0
11207292|NCT01874431|12398429|FG000|STARTED|Overall Study||96
11207293|NCT01874431|12398430|FG001|STARTED|Overall Study||92
11207294|NCT01874431|12398431|FG002|STARTED|Overall Study||100
11207295|NCT01874431|12398432|FG003|STARTED|Overall Study||98
11207296|NCT01874431|12398433|FG004|STARTED|Overall Study||98
11207297|NCT01874431|12398434|FG005|STARTED|Overall Study||125
11207298|NCT01874431|12398435|FG006|STARTED|Overall Study||120
11207299|NCT01874431|12398436|FG007|STARTED|Overall Study||94
11207300|NCT01874431|12398429|FG000|Participants Received Treatment|Overall Study||96
11207301|NCT01874431|12398430|FG001|Participants Received Treatment|Overall Study||92
11207302|NCT01874431|12398431|FG002|Participants Received Treatment|Overall Study||100
11207303|NCT01874431|12398432|FG003|Participants Received Treatment|Overall Study||97
11207304|NCT01874431|12398433|FG004|Participants Received Treatment|Overall Study||98
11207305|NCT01874431|12398434|FG005|Participants Received Treatment|Overall Study||125
11207306|NCT01874431|12398435|FG006|Participants Received Treatment|Overall Study||119
11207307|NCT01874431|12398436|FG007|Participants Received Treatment|Overall Study||94
11207308|NCT01874431|12398429|FG000|COMPLETED|Overall Study||90
11207309|NCT01874431|12398430|FG001|COMPLETED|Overall Study||87
11207310|NCT01874431|12398431|FG002|COMPLETED|Overall Study||90
11207311|NCT01874431|12398432|FG003|COMPLETED|Overall Study||91
11207312|NCT01874431|12398433|FG004|COMPLETED|Overall Study||90
11207313|NCT01874431|12398434|FG005|COMPLETED|Overall Study||114
11207314|NCT01874431|12398435|FG006|COMPLETED|Overall Study||112
11207315|NCT01874431|12398436|FG007|COMPLETED|Overall Study||90
11207316|NCT01874431|12398429|FG000|NOT COMPLETED|Overall Study||6
11207317|NCT01874431|12398430|FG001|NOT COMPLETED|Overall Study||5
11207318|NCT01874431|12398431|FG002|NOT COMPLETED|Overall Study||10
11207319|NCT01874431|12398432|FG003|NOT COMPLETED|Overall Study||7
11207320|NCT01874431|12398433|FG004|NOT COMPLETED|Overall Study||8
11207321|NCT01874431|12398434|FG005|NOT COMPLETED|Overall Study||11
11207322|NCT01874431|12398435|FG006|NOT COMPLETED|Overall Study||8
11207323|NCT01874431|12398436|FG007|NOT COMPLETED|Overall Study||4
11207324|NCT01874535|12398456|FG000|STARTED|Overall Study||207
11207325|NCT01874535|12398457|FG001|STARTED|Overall Study||201
11207326|NCT01874535|12398456|FG000|COMPLETED|Overall Study||152
11207327|NCT01874535|12398457|FG001|COMPLETED|Overall Study||157
11207328|NCT01874535|12398456|FG000|NOT COMPLETED|Overall Study||55
11207329|NCT01874535|12398457|FG001|NOT COMPLETED|Overall Study||44
11207330|NCT01874665|12398465|FG000|STARTED|Overall Study||30
11207331|NCT01874665|12398466|FG001|STARTED|Overall Study||15
11207332|NCT01874665|12398465|FG000|COMPLETED|Overall Study||0
11207333|NCT01874665|12398466|FG001|COMPLETED|Overall Study||0
11207334|NCT01874665|12398465|FG000|NOT COMPLETED|Overall Study||30
11207335|NCT01874665|12398466|FG001|NOT COMPLETED|Overall Study||15
11207336|NCT01874756|12398477|FG000|STARTED|Overall Study||29
11207337|NCT01874756|12398478|FG001|STARTED|Overall Study||10
11081476|NCT03621696|12264172|FG000|STARTED|Overall Study||21
11081477|NCT03621696|12264173|FG001|STARTED|Overall Study||31
11081478|NCT03621696|12264174|FG002|STARTED|Overall Study||6
11081479|NCT03621696|12264175|FG003|STARTED|Overall Study||5
11081480|NCT03621696|12264172|FG000|COMPLETED|Overall Study||20
11081481|NCT03621696|12264173|FG001|COMPLETED|Overall Study||30
11081482|NCT03621696|12264174|FG002|COMPLETED|Overall Study||4
11081483|NCT03621696|12264175|FG003|COMPLETED|Overall Study||0
11081484|NCT03621696|12264172|FG000|NOT COMPLETED|Overall Study||1
11081485|NCT03621696|12264173|FG001|NOT COMPLETED|Overall Study||1
11081486|NCT03621696|12264174|FG002|NOT COMPLETED|Overall Study||2
11081487|NCT03621696|12264175|FG003|NOT COMPLETED|Overall Study||5
11081488|NCT03544268|12264185|FG000|STARTED|Overall Study||5
11081489|NCT03544268|12264186|FG001|STARTED|Overall Study||15
11081490|NCT03544268|12264185|FG000|COMPLETED|Overall Study||3
11081491|NCT03544268|12264186|FG001|COMPLETED|Overall Study||15
11081492|NCT03544268|12264185|FG000|NOT COMPLETED|Overall Study||2
11081493|NCT03544268|12264186|FG001|NOT COMPLETED|Overall Study||0
11081494|NCT03421197|12264196|FG000|STARTED|Overall Study||105
11081495|NCT03421197|12264197|FG001|STARTED|Overall Study||107
11081496|NCT03421197|12264198|FG002|STARTED|Overall Study||107
11081497|NCT03421197|12264199|FG003|STARTED|Overall Study||107
11081498|NCT03421197|12264196|FG000|COMPLETED|Overall Study||67
11081499|NCT03421197|12264197|FG001|COMPLETED|Overall Study||68
11081500|NCT03421197|12264198|FG002|COMPLETED|Overall Study||56
11081501|NCT03421197|12264199|FG003|COMPLETED|Overall Study||62
11081502|NCT03421197|12264196|FG000|NOT COMPLETED|Overall Study||38
11081503|NCT03421197|12264197|FG001|NOT COMPLETED|Overall Study||39
11081504|NCT03421197|12264198|FG002|NOT COMPLETED|Overall Study||51
11081505|NCT03421197|12264199|FG003|NOT COMPLETED|Overall Study||45
11081506|NCT03371108|12264211|FG000|STARTED|Safety Analysis Set||284
11081507|NCT03371108|12264212|FG001|STARTED|Safety Analysis Set||283
11081508|NCT03371108|12264211|FG000|COMPLETED|Safety Analysis Set||281
11081509|NCT03371108|12264212|FG001|COMPLETED|Safety Analysis Set||282
11081510|NCT03371108|12264211|FG000|NOT COMPLETED|Safety Analysis Set||3
11081511|NCT03371108|12264212|FG001|NOT COMPLETED|Safety Analysis Set||1
11081512|NCT03371108|12264211|FG000|STARTED|Completers||281
11081513|NCT03371108|12264212|FG001|STARTED|Completers||282
11081514|NCT03371108|12264211|FG000|COMPLETED|Completers||259
11081515|NCT03371108|12264212|FG001|COMPLETED|Completers||256
11081516|NCT03371108|12264211|FG000|NOT COMPLETED|Completers||22
11081517|NCT03371108|12264212|FG001|NOT COMPLETED|Completers||26
11081518|NCT03112993|12264220|FG000|STARTED|Overall Study||19
11081519|NCT03112993|12264221|FG001|STARTED|Overall Study||21
11081520|NCT03112993|12264220|FG000|COMPLETED|Overall Study||19
11081521|NCT03112993|12264221|FG001|COMPLETED|Overall Study||21
11081522|NCT03112993|12264220|FG000|NOT COMPLETED|Overall Study||0
11081523|NCT03112993|12264221|FG001|NOT COMPLETED|Overall Study||0
11081524|NCT03088137|12264231|FG000|STARTED|Overall Study||55
11081525|NCT03088137|12264232|FG001|STARTED|Overall Study||55
11081526|NCT03088137|12264231|FG000|COMPLETED|Overall Study||55
11081527|NCT03088137|12264232|FG001|COMPLETED|Overall Study||55
11081528|NCT03088137|12264231|FG000|NOT COMPLETED|Overall Study||0
11081529|NCT03088137|12264232|FG001|NOT COMPLETED|Overall Study||0
11081530|NCT03038438|12264238|FG000|STARTED|Overall Study||200
11081531|NCT03038438|12264238|FG000|30-Day Follow-Up|Overall Study||198
11081532|NCT03038438|12264238|FG000|6-Month Follow-up|Overall Study||193
11081533|NCT03038438|12264238|FG000|12-Month Follow-up|Overall Study||191
11081534|NCT03038438|12264238|FG000|24-Month Follow-up|Overall Study||148
11081535|NCT03038438|12264238|FG000|COMPLETED|Overall Study||148
11081536|NCT03038438|12264238|FG000|NOT COMPLETED|Overall Study||52
11081537|NCT02951481|12264244|FG000|STARTED|Overall Study||231
11081538|NCT02951481|12264245|FG001|STARTED|Overall Study||172
11081539|NCT02951481|12264244|FG000|COMPLETED|Overall Study||231
11081540|NCT02951481|12264245|FG001|COMPLETED|Overall Study||172
11081541|NCT02951481|12264244|FG000|NOT COMPLETED|Overall Study||0
11081542|NCT02951481|12264245|FG001|NOT COMPLETED|Overall Study||0
11207338|NCT01874756|12398479|FG002|STARTED|Overall Study||29
11207339|NCT01874756|12398480|FG003|STARTED|Overall Study||27
11207340|NCT01874756|12398477|FG000|COMPLETED|Overall Study||28
11207341|NCT01874756|12398478|FG001|COMPLETED|Overall Study||10
11207342|NCT01874756|12398479|FG002|COMPLETED|Overall Study||27
11207343|NCT01874756|12398480|FG003|COMPLETED|Overall Study||21
11207344|NCT01874756|12398477|FG000|NOT COMPLETED|Overall Study||1
11207345|NCT01874756|12398478|FG001|NOT COMPLETED|Overall Study||0
11207346|NCT01874756|12398479|FG002|NOT COMPLETED|Overall Study||2
11207347|NCT01874756|12398480|FG003|NOT COMPLETED|Overall Study||6
11207348|NCT01874951|12398492|FG000|STARTED|Overall Study||6
11207349|NCT01874951|12398493|FG001|STARTED|Overall Study||6
11207350|NCT01874951|12398492|FG000|COMPLETED|Overall Study||6
11207351|NCT01874951|12398493|FG001|COMPLETED|Overall Study||6
11207352|NCT01874951|12398492|FG000|NOT COMPLETED|Overall Study||0
11207353|NCT01874951|12398493|FG001|NOT COMPLETED|Overall Study||0
11207354|NCT01875159|12398504|FG000|STARTED|Overall Study||45
11081543|NCT02451943|12264253|FG000|STARTED|Overall Study||258
11081544|NCT02451943|12264254|FG001|STARTED|Overall Study||251
11081545|NCT02451943|12264253|FG000|Received at Least One Dose of Study Drug|Overall Study||257
11081546|NCT02451943|12264254|FG001|Received at Least One Dose of Study Drug|Overall Study||249
11081547|NCT02451943|12264253|FG000|Leiomyosarcoma (LMS) Population|Overall Study||119
11081548|NCT02451943|12264254|FG001|Leiomyosarcoma (LMS) Population|Overall Study||115
11081549|NCT02451943|12264253|FG000|COMPLETED|Overall Study||238
11081550|NCT02451943|12264254|FG001|COMPLETED|Overall Study||227
11081551|NCT02451943|12264253|FG000|NOT COMPLETED|Overall Study||20
11081552|NCT02451943|12264254|FG001|NOT COMPLETED|Overall Study||24
11081553|NCT02198794|12264260|FG000|STARTED|Part A: Open-Label (158 Weeks)||337
11081554|NCT02198794|12264261|FG001|STARTED|Part A: Open-Label (158 Weeks)||0
11081555|NCT02198794|12264262|FG002|STARTED|Part A: Open-Label (158 Weeks)||0
11081556|NCT02198794|12264263|FG003|STARTED|Part A: Open-Label (158 Weeks)||0
11081557|NCT02198794|12264260|FG000|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||337
11081558|NCT02198794|12264261|FG001|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
11081559|NCT02198794|12264262|FG002|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
11081560|NCT02198794|12264263|FG003|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
11081561|NCT02198794|12264260|FG000|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||337
11081562|NCT02198794|12264261|FG001|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
11081563|NCT02198794|12264262|FG002|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
11081564|NCT02198794|12264263|FG003|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
11081565|NCT02198794|12264260|FG000|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||195
11081566|NCT02198794|12264261|FG001|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
11081567|NCT02198794|12264262|FG002|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
11081568|NCT02198794|12264263|FG003|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
11081569|NCT02198794|12264260|FG000|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||142
11081570|NCT02198794|12264261|FG001|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
11081571|NCT02198794|12264262|FG002|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
11081572|NCT02198794|12264263|FG003|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
11081573|NCT02198794|12264260|FG000|COMPLETED|Part A: Open-Label (158 Weeks)||32
11081574|NCT02198794|12264261|FG001|COMPLETED|Part A: Open-Label (158 Weeks)||0
11081575|NCT02198794|12264262|FG002|COMPLETED|Part A: Open-Label (158 Weeks)||0
11081576|NCT02198794|12264263|FG003|COMPLETED|Part A: Open-Label (158 Weeks)||0
11081577|NCT02198794|12264260|FG000|NOT COMPLETED|Part A: Open-Label (158 Weeks)||305
11081578|NCT02198794|12264261|FG001|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
11081579|NCT02198794|12264262|FG002|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
11081580|NCT02198794|12264263|FG003|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
11081581|NCT02198794|12264260|FG000|STARTED|Part B: Randomized (13 Weeks)||0
11081582|NCT02198794|12264261|FG001|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
11081583|NCT02198794|12264262|FG002|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
11081584|NCT02198794|12264263|FG003|STARTED|Part B: Randomized (13 Weeks)||0
11081585|NCT02198794|12264260|FG000|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
11081586|NCT02198794|12264261|FG001|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||63
11081587|NCT02198794|12264262|FG002|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||65
11081588|NCT02198794|12264263|FG003|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
11081589|NCT02198794|12264260|FG000|COMPLETED|Part B: Randomized (13 Weeks)||0
11081590|NCT02198794|12264261|FG001|COMPLETED|Part B: Randomized (13 Weeks)||66
11081591|NCT02198794|12264262|FG002|COMPLETED|Part B: Randomized (13 Weeks)||68
11081592|NCT02198794|12264263|FG003|COMPLETED|Part B: Randomized (13 Weeks)||0
11081593|NCT02198794|12264260|FG000|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
11081594|NCT02198794|12264261|FG001|NOT COMPLETED|Part B: Randomized (13 Weeks)||5
11081595|NCT02198794|12264262|FG002|NOT COMPLETED|Part B: Randomized (13 Weeks)||3
11081596|NCT02198794|12264263|FG003|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
11081597|NCT02198794|12264260|FG000|STARTED|Part C: Safety Assessment (52 Weeks)||0
11081598|NCT02198794|12264261|FG001|STARTED|Part C: Safety Assessment (52 Weeks)||0
11081599|NCT02198794|12264262|FG002|STARTED|Part C: Safety Assessment (52 Weeks)||0
11081600|NCT02198794|12264263|FG003|STARTED|Part C: Safety Assessment (52 Weeks)||80
11081601|NCT02198794|12264260|FG000|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
11081602|NCT02198794|12264261|FG001|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
11081603|NCT02198794|12264262|FG002|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
11081604|NCT02198794|12264263|FG003|COMPLETED|Part C: Safety Assessment (52 Weeks)||73
11081605|NCT02198794|12264260|FG000|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
11081606|NCT02198794|12264261|FG001|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
11081607|NCT02198794|12264262|FG002|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
11081608|NCT02198794|12264263|FG003|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||7
11081609|NCT01877655|12264274|FG000|STARTED|Overall Study||263
11081610|NCT01877655|12264275|FG001|STARTED|Overall Study||251
11081611|NCT01877655|12264274|FG000|Received Treatment|Overall Study||255
11081612|NCT01877655|12264275|FG001|Received Treatment|Overall Study||246
11081613|NCT01877655|12264274|FG000|COMPLETED|Overall Study||165
11081614|NCT01877655|12264275|FG001|COMPLETED|Overall Study||154
11081615|NCT01877655|12264274|FG000|NOT COMPLETED|Overall Study||98
11081616|NCT01877655|12264275|FG001|NOT COMPLETED|Overall Study||97
11081617|NCT00308685|12264283|FG000|STARTED|Overall Study||50
11081618|NCT00308685|12264284|FG001|STARTED|Overall Study||45
11081619|NCT00308685|12264283|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
11081620|NCT00308685|12264284|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45
11081621|NCT00308685|12264283|FG000|COMPLETED|Overall Study||47
11081622|NCT00308685|12264284|FG001|COMPLETED|Overall Study||40
11081623|NCT00308685|12264283|FG000|NOT COMPLETED|Overall Study||3
11081624|NCT00308685|12264284|FG001|NOT COMPLETED|Overall Study||5
11081625|NCT01125514|12264290|FG000|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
11081626|NCT01125514|12264290|FG000|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
11081627|NCT01125514|12264290|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
11081628|NCT01125514|12264290|FG000|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
11081629|NCT01125514|12264290|FG000|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
11081630|NCT01125514|12264290|FG000|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
11081631|NCT01125514|12264290|FG000|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
11081632|NCT01125514|12264290|FG000|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
11081633|NCT01125514|12264290|FG000|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
11081634|NCT01125514|12264290|FG000|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
11081635|NCT01125514|12264290|FG000|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
11081636|NCT01125566|12264306|FG000|STARTED|Patients Before the Switch (26Apr2013)||339
11081637|NCT01125566|12264307|FG001|STARTED|Patients Before the Switch (26Apr2013)||169
11081638|NCT01125566|12264308|FG002|STARTED|Patients Before the Switch (26Apr2013)||0
11081639|NCT01125566|12264306|FG000|Treated|Patients Before the Switch (26Apr2013)||337
11081640|NCT01125566|12264307|FG001|Treated|Patients Before the Switch (26Apr2013)||169
11081641|NCT01125566|12264308|FG002|Treated|Patients Before the Switch (26Apr2013)||0
11081642|NCT01125566|12264306|FG000|COMPLETED|Patients Before the Switch (26Apr2013)||74
11081643|NCT01125566|12264307|FG001|COMPLETED|Patients Before the Switch (26Apr2013)||0
11081644|NCT01125566|12264308|FG002|COMPLETED|Patients Before the Switch (26Apr2013)||0
11081645|NCT01125566|12264306|FG000|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265
11081646|NCT01125566|12264307|FG001|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169
11081647|NCT01125566|12264308|FG002|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
11081648|NCT01125566|12264306|FG000|STARTED|Patients Who Switched From AV to TV||0
11081649|NCT01125566|12264307|FG001|STARTED|Patients Who Switched From AV to TV||0
11081650|NCT01125566|12264308|FG002|STARTED|Patients Who Switched From AV to TV||75
11081651|NCT01125566|12264306|FG000|COMPLETED|Patients Who Switched From AV to TV||0
11081652|NCT01125566|12264307|FG001|COMPLETED|Patients Who Switched From AV to TV||0
11081653|NCT01125566|12264308|FG002|COMPLETED|Patients Who Switched From AV to TV||2
11081654|NCT01125566|12264306|FG000|NOT COMPLETED|Patients Who Switched From AV to TV||0
11081655|NCT01125566|12264307|FG001|NOT COMPLETED|Patients Who Switched From AV to TV||0
11081656|NCT01125566|12264308|FG002|NOT COMPLETED|Patients Who Switched From AV to TV||73
11081657|NCT01125605|12264315|FG000|STARTED|Overall Study|started = had baseline values|325
11081658|NCT01125605|12264315|FG000|Safety|Overall Study|1 patient was only analysed for safety|326
11081659|NCT01125605|12264315|FG000|COMPLETED|Overall Study||325
11081660|NCT01125605|12264315|FG000|NOT COMPLETED|Overall Study||0
11081661|NCT01125722|12264334|FG000|STARTED|Overall Study||37
11081662|NCT01125722|12264335|FG001|STARTED|Overall Study||37
11081663|NCT01125722|12264334|FG000|COMPLETED|Overall Study||34
11081664|NCT01125722|12264335|FG001|COMPLETED|Overall Study||36
11081665|NCT01125722|12264334|FG000|NOT COMPLETED|Overall Study||3
11081666|NCT01125722|12264335|FG001|NOT COMPLETED|Overall Study||1
11081667|NCT01125748|12264343|FG000|STARTED|Overall Study||88
11081668|NCT01125748|12264344|FG001|STARTED|Overall Study||88
11081669|NCT01125748|12264343|FG000|COMPLETED|Overall Study||78
11081670|NCT01125748|12264344|FG001|COMPLETED|Overall Study||74
11081671|NCT01125748|12264343|FG000|NOT COMPLETED|Overall Study||10
11081672|NCT01125748|12264344|FG001|NOT COMPLETED|Overall Study||14
11081673|NCT01125774|12264352|FG000|STARTED|Overall Study|Randomized|3018
11081674|NCT01125774|12264353|FG001|STARTED|Overall Study|Randomized|1502
11081675|NCT01125774|12264354|FG002|STARTED|Overall Study|Unique participants randomized|22
11081676|NCT01125774|12264355|FG003|STARTED|Overall Study|Unique participants randomized|6
11081677|NCT01125774|12264352|FG000|Treated|Overall Study||2638
11207355|NCT01875159|12398505|FG001|STARTED|Overall Study||53
11207356|NCT01875159|12398504|FG000|COMPLETED|Overall Study||42
11207357|NCT01875159|12398505|FG001|COMPLETED|Overall Study||53
11207358|NCT01875159|12398504|FG000|NOT COMPLETED|Overall Study||3
11207359|NCT01875159|12398505|FG001|NOT COMPLETED|Overall Study||0
11207360|NCT01875237|12398513|FG000|STARTED|Overall Study||2
11207361|NCT01875237|12398514|FG001|STARTED|Overall Study||1
11207362|NCT01875237|12398513|FG000|COMPLETED|Overall Study||0
11207363|NCT01875237|12398514|FG001|COMPLETED|Overall Study||1
11207364|NCT01875237|12398513|FG000|NOT COMPLETED|Overall Study||2
11207365|NCT01875237|12398514|FG001|NOT COMPLETED|Overall Study||0
11207366|NCT01875250|12398524|FG000|STARTED|Overall Study||19
11207367|NCT01875250|12398525|FG001|STARTED|Overall Study||19
11207368|NCT01875250|12398524|FG000|COMPLETED|Overall Study||17
11349607|NCT03016325|12546489|FG002|COMPLETED|182-Day Follow-Up Period||60
11349608|NCT03016325|12546490|FG003|COMPLETED|182-Day Follow-Up Period||58
11349609|NCT03016325|12546491|FG004|COMPLETED|182-Day Follow-Up Period||60
11349610|NCT03016325|12546492|FG005|COMPLETED|182-Day Follow-Up Period||1
11349611|NCT03016325|12546493|FG006|COMPLETED|182-Day Follow-Up Period||2
11349612|NCT03016325|12546494|FG007|COMPLETED|182-Day Follow-Up Period||1
11349613|NCT03016325|12546487|FG000|NOT COMPLETED|182-Day Follow-Up Period||4
11349614|NCT03016325|12546488|FG001|NOT COMPLETED|182-Day Follow-Up Period||4
11349615|NCT03016325|12546489|FG002|NOT COMPLETED|182-Day Follow-Up Period||11
11349616|NCT03016325|12546490|FG003|NOT COMPLETED|182-Day Follow-Up Period||13
11349617|NCT03016325|12546491|FG004|NOT COMPLETED|182-Day Follow-Up Period||12
11349618|NCT03016325|12546492|FG005|NOT COMPLETED|182-Day Follow-Up Period||5
11349619|NCT03016325|12546493|FG006|NOT COMPLETED|182-Day Follow-Up Period||4
11349620|NCT03016325|12546494|FG007|NOT COMPLETED|182-Day Follow-Up Period||5
11349621|NCT03016403|12546519|FG000|STARTED|Baseline||139
11349622|NCT03016403|12546520|FG001|STARTED|Baseline||147
11349623|NCT03016403|12546521|FG002|STARTED|Baseline||118
11349624|NCT03016403|12546522|FG003|STARTED|Baseline||131
11349625|NCT03016403|12546519|FG000|COMPLETED|Baseline||123
11349626|NCT03016403|12546520|FG001|COMPLETED|Baseline||120
11349627|NCT03016403|12546521|FG002|COMPLETED|Baseline||107
11349628|NCT03016403|12546522|FG003|COMPLETED|Baseline||97
11349629|NCT03016403|12546519|FG000|NOT COMPLETED|Baseline||16
11349630|NCT03016403|12546520|FG001|NOT COMPLETED|Baseline||27
11349631|NCT03016403|12546521|FG002|NOT COMPLETED|Baseline||11
11349632|NCT03016403|12546522|FG003|NOT COMPLETED|Baseline||34
11349633|NCT03016403|12546519|FG000|STARTED|6-week Follow-up|Anyone who had at least 1 follow-up after baseline.|123
11349634|NCT03016403|12546520|FG001|STARTED|6-week Follow-up||120
11349635|NCT03016403|12546521|FG002|STARTED|6-week Follow-up||107
11349636|NCT03016403|12546522|FG003|STARTED|6-week Follow-up||97
11349637|NCT03016403|12546519|FG000|COMPLETED|6-week Follow-up||120
11081678|NCT01125774|12264353|FG001|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
11081679|NCT01125774|12264354|FG002|Treated|Overall Study|Received telcagepant|21
11081680|NCT01125774|12264355|FG003|Treated|Overall Study||5
11081681|NCT01125774|12264352|FG000|COMPLETED|Overall Study||1893
11207369|NCT01875250|12398525|FG001|COMPLETED|Overall Study||19
11207370|NCT01875250|12398524|FG000|NOT COMPLETED|Overall Study||2
11207371|NCT01875250|12398525|FG001|NOT COMPLETED|Overall Study||0
11207372|NCT01875367|12398535|FG000|STARTED|Overall Study||81
11207373|NCT01875367|12398536|FG001|STARTED|Overall Study||85
11207374|NCT01875367|12398535|FG000|COMPLETED|Overall Study||76
11207375|NCT01875367|12398536|FG001|COMPLETED|Overall Study||83
11207376|NCT01875367|12398535|FG000|NOT COMPLETED|Overall Study||5
11207377|NCT01875367|12398536|FG001|NOT COMPLETED|Overall Study||2
11207378|NCT01875445|12398548|FG000|STARTED|Overall Study||19
11207379|NCT01875445|12398549|FG001|STARTED|Overall Study||19
11207380|NCT01875445|12398548|FG000|COMPLETED|Overall Study||12
11207381|NCT01875445|12398549|FG001|COMPLETED|Overall Study||19
11207382|NCT01875445|12398548|FG000|NOT COMPLETED|Overall Study||7
11207383|NCT01875445|12398549|FG001|NOT COMPLETED|Overall Study||0
11207384|NCT01875471|12398557|FG000|STARTED|Overall Study||137
11207385|NCT01875471|12398558|FG001|STARTED|Overall Study||138
11207386|NCT01875471|12398557|FG000|Completed Per Protocol|Overall Study||127
11207387|NCT01875471|12398558|FG001|Completed Per Protocol|Overall Study||123
11349638|NCT03016403|12546520|FG001|COMPLETED|6-week Follow-up||107
11349639|NCT03016403|12546521|FG002|COMPLETED|6-week Follow-up||103
11349640|NCT03016403|12546522|FG003|COMPLETED|6-week Follow-up||88
11081682|NCT01125774|12264353|FG001|COMPLETED|Overall Study||948
11081683|NCT01125774|12264354|FG002|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
11349641|NCT03016403|12546519|FG000|NOT COMPLETED|6-week Follow-up||3
11349642|NCT03016403|12546520|FG001|NOT COMPLETED|6-week Follow-up||13
11349643|NCT03016403|12546521|FG002|NOT COMPLETED|6-week Follow-up||4
11349644|NCT03016403|12546522|FG003|NOT COMPLETED|6-week Follow-up||9
11349645|NCT03016403|12546519|FG000|STARTED|3-month Follow-up and 6-month Follow-up||120
11349646|NCT03016403|12546520|FG001|STARTED|3-month Follow-up and 6-month Follow-up||107
11349647|NCT03016403|12546521|FG002|STARTED|3-month Follow-up and 6-month Follow-up||103
11349648|NCT03016403|12546522|FG003|STARTED|3-month Follow-up and 6-month Follow-up||88
11349649|NCT03016403|12546519|FG000|COMPLETED|3-month Follow-up and 6-month Follow-up||108
11349650|NCT03016403|12546520|FG001|COMPLETED|3-month Follow-up and 6-month Follow-up||96
11349651|NCT03016403|12546521|FG002|COMPLETED|3-month Follow-up and 6-month Follow-up||95
11349652|NCT03016403|12546522|FG003|COMPLETED|3-month Follow-up and 6-month Follow-up||81
11349653|NCT03016403|12546519|FG000|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||12
11349654|NCT03016403|12546520|FG001|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||11
11349655|NCT03016403|12546521|FG002|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||8
11349656|NCT03016403|12546522|FG003|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||7
11349657|NCT03016598|12546536|FG000|STARTED|Overall Study||18
11349658|NCT03016598|12546537|FG001|STARTED|Overall Study||22
11349659|NCT03016598|12546536|FG000|COMPLETED|Overall Study||18
11349660|NCT03016598|12546537|FG001|COMPLETED|Overall Study||20
11349661|NCT03016598|12546536|FG000|NOT COMPLETED|Overall Study||0
11349662|NCT03016598|12546537|FG001|NOT COMPLETED|Overall Study||2
11349663|NCT03017079|12546545|FG000|STARTED|Overall Study||20
11349664|NCT03017079|12546546|FG001|STARTED|Overall Study||20
11349665|NCT03017079|12546545|FG000|COMPLETED|Overall Study||14
11349666|NCT03017079|12546546|FG001|COMPLETED|Overall Study||14
11349667|NCT03017079|12546545|FG000|NOT COMPLETED|Overall Study||6
11081684|NCT01125774|12264355|FG003|COMPLETED|Overall Study|Completed study at least once|3
11081685|NCT01125774|12264352|FG000|NOT COMPLETED|Overall Study||1125
11349668|NCT03017079|12546546|FG001|NOT COMPLETED|Overall Study||6
11349669|NCT03017235|12546561|FG000|STARTED|Overall Study||456
11349670|NCT03017235|12546562|FG001|STARTED|Overall Study||461
11349671|NCT03017235|12546561|FG000|COMPLETED|Overall Study||444
11349672|NCT03017235|12546562|FG001|COMPLETED|Overall Study||447
11349673|NCT03017235|12546561|FG000|NOT COMPLETED|Overall Study||12
11349674|NCT03017235|12546562|FG001|NOT COMPLETED|Overall Study||14
11349675|NCT03017261|12546568|FG000|STARTED|6 Week Follow up||115
11349676|NCT03017261|12546568|FG000|COMPLETED|6 Week Follow up||115
11349677|NCT03017261|12546568|FG000|NOT COMPLETED|6 Week Follow up||0
11349678|NCT03017261|12546568|FG000|STARTED|3 Month Follow up||115
11349679|NCT03017261|12546568|FG000|COMPLETED|3 Month Follow up|1 failed to compete 3M imaging so only 114 have 3M data for tibial slope and KSS Objective Score.|115
11349680|NCT03017261|12546568|FG000|NOT COMPLETED|3 Month Follow up||0
11349681|NCT03017261|12546568|FG000|STARTED|6 Month Follow up||115
11349682|NCT03017261|12546568|FG000|COMPLETED|6 Month Follow up||106
11349683|NCT03017261|12546568|FG000|NOT COMPLETED|6 Month Follow up||9
11349684|NCT03017261|12546568|FG000|STARTED|12 Month Follow up||106
11349685|NCT03017261|12546568|FG000|COMPLETED|12 Month Follow up|1 failed to compete 12M imaging so only 58 have 12M data for KSS Objective Score.|59
11349686|NCT03017261|12546568|FG000|NOT COMPLETED|12 Month Follow up||47
11349687|NCT03017508|12546574|FG000|STARTED|Overall Study||12
11349688|NCT03017508|12546575|FG001|STARTED|Overall Study||10
11349689|NCT03017508|12546574|FG000|First Intervention (1 Day)|Overall Study||12
11349690|NCT03017508|12546575|FG001|First Intervention (1 Day)|Overall Study||10
11349691|NCT03017508|12546574|FG000|Washout (2-10 Days)|Overall Study||12
11349692|NCT03017508|12546575|FG001|Washout (2-10 Days)|Overall Study||10
11349693|NCT03017508|12546574|FG000|Second Intervention (1 Day)|Overall Study||12
11349694|NCT03017508|12546575|FG001|Second Intervention (1 Day)|Overall Study||10
11349695|NCT03017508|12546574|FG000|COMPLETED|Overall Study||12
11349696|NCT03017508|12546575|FG001|COMPLETED|Overall Study||10
11349697|NCT03017508|12546574|FG000|NOT COMPLETED|Overall Study||0
11349698|NCT03017508|12546575|FG001|NOT COMPLETED|Overall Study||0
11349699|NCT03017612|12546581|FG000|STARTED|Overall Study||13
11349700|NCT03017612|12546581|FG000|COMPLETED|Overall Study||11
11349701|NCT03017612|12546581|FG000|NOT COMPLETED|Overall Study||2
11349702|NCT03017846|12546585|FG000|STARTED|Overall Study||30
11349703|NCT03017846|12546585|FG000|COMPLETED|Overall Study||25
11349704|NCT03017846|12546585|FG000|NOT COMPLETED|Overall Study||5
11349705|NCT03017924|12546593|FG000|STARTED|Overall Study||12
11349706|NCT03017924|12546594|FG001|STARTED|Overall Study||11
11349707|NCT03017924|12546593|FG000|COMPLETED|Overall Study||10
11349708|NCT03017924|12546594|FG001|COMPLETED|Overall Study||8
11081686|NCT01125774|12264353|FG001|NOT COMPLETED|Overall Study||554
11081687|NCT01125774|12264354|FG002|NOT COMPLETED|Overall Study||9
11081688|NCT01125774|12264355|FG003|NOT COMPLETED|Overall Study||3
11081689|NCT01125800|12264366|FG000|STARTED|Phase I||11
11081690|NCT01125800|12264367|FG001|STARTED|Phase I||16
11081691|NCT01125800|12264368|FG002|STARTED|Phase I||11
11081692|NCT01125800|12264369|FG003|STARTED|Phase I||21
11081693|NCT01125800|12264370|FG004|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
11081694|NCT01125800|12264366|FG000|COMPLETED|Phase I||3
11081695|NCT01125800|12264367|FG001|COMPLETED|Phase I||7
11081696|NCT01125800|12264368|FG002|COMPLETED|Phase I||7
11081697|NCT01125800|12264369|FG003|COMPLETED|Phase I||10
11081698|NCT01125800|12264370|FG004|COMPLETED|Phase I||0
11081699|NCT01125800|12264366|FG000|NOT COMPLETED|Phase I||8
11081700|NCT01125800|12264367|FG001|NOT COMPLETED|Phase I||9
11081701|NCT01125800|12264368|FG002|NOT COMPLETED|Phase I||4
11081702|NCT01125800|12264369|FG003|NOT COMPLETED|Phase I||11
11081703|NCT01125800|12264370|FG004|NOT COMPLETED|Phase I||0
11081704|NCT01125800|12264366|FG000|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
11081705|NCT01125800|12264367|FG001|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
11081706|NCT01125800|12264368|FG002|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
11081707|NCT01125800|12264369|FG003|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
11081708|NCT01125800|12264370|FG004|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
11081709|NCT01125800|12264366|FG000|COMPLETED|Phase II||0
11081710|NCT01125800|12264367|FG001|COMPLETED|Phase II||0
11081711|NCT01125800|12264368|FG002|COMPLETED|Phase II||0
11081712|NCT01125800|12264369|FG003|COMPLETED|Phase II||0
11081713|NCT01125800|12264370|FG004|COMPLETED|Phase II||5
11207388|NCT01875471|12398557|FG000|COMPLETED|Overall Study||136
11207389|NCT01875471|12398558|FG001|COMPLETED|Overall Study||137
11207390|NCT01875471|12398557|FG000|NOT COMPLETED|Overall Study||1
11207391|NCT01875471|12398558|FG001|NOT COMPLETED|Overall Study||1
11207392|NCT01875510|12398566|FG000|STARTED|Overall Study||40
11207393|NCT01875510|12398567|FG001|STARTED|Overall Study||40
11207394|NCT01875510|12398566|FG000|COMPLETED|Overall Study||40
11207395|NCT01875510|12398567|FG001|COMPLETED|Overall Study||40
11207396|NCT01875510|12398566|FG000|NOT COMPLETED|Overall Study||0
11207397|NCT01875510|12398567|FG001|NOT COMPLETED|Overall Study||0
11207398|NCT01875731|12398575|FG000|STARTED|Overall Study||34
11207399|NCT01875731|12398576|FG001|STARTED|Overall Study||32
11207400|NCT01875731|12398575|FG000|COMPLETED|Overall Study||33
11207401|NCT01875731|12398576|FG001|COMPLETED|Overall Study||32
11207402|NCT01875731|12398575|FG000|NOT COMPLETED|Overall Study||1
11207403|NCT01875731|12398576|FG001|NOT COMPLETED|Overall Study||0
11207404|NCT01875783|12398582|FG000|STARTED|Overall Study||385
11207405|NCT01875783|12398582|FG000|COMPLETED|Overall Study||385
11207406|NCT01875783|12398582|FG000|NOT COMPLETED|Overall Study||0
11207407|NCT01875848|12398590|FG000|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
11207408|NCT01875848|12398591|FG001|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
11207409|NCT01875848|12398590|FG000|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
11207410|NCT01875848|12398591|FG001|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
11207411|NCT01875848|12398590|FG000|NOT COMPLETED|Overall Study||2
11207412|NCT01875848|12398591|FG001|NOT COMPLETED|Overall Study||0
11207413|NCT01875861|12398599|FG000|STARTED|Pre-implementation||4779
11207414|NCT01875861|12398600|FG001|STARTED|Pre-implementation||3714
11207415|NCT01875861|12398599|FG000|COMPLETED|Pre-implementation||4779
11207416|NCT01875861|12398600|FG001|COMPLETED|Pre-implementation||3714
11207417|NCT01875861|12398599|FG000|NOT COMPLETED|Pre-implementation||0
11349709|NCT03017924|12546593|FG000|NOT COMPLETED|Overall Study||2
11349710|NCT03017924|12546594|FG001|NOT COMPLETED|Overall Study||3
11349711|NCT03017937|12546602|FG000|STARTED|Overall Study||155
11349712|NCT03017937|12546602|FG000|COMPLETED|Overall Study||155
11207418|NCT01875861|12398600|FG001|NOT COMPLETED|Pre-implementation||0
11207419|NCT01875861|12398599|FG000|STARTED|Implementation||4546
11207420|NCT01875861|12398600|FG001|STARTED|Implementation||3444
11207421|NCT01875861|12398599|FG000|COMPLETED|Implementation||4546
11207422|NCT01875861|12398600|FG001|COMPLETED|Implementation||3444
11207423|NCT01875861|12398599|FG000|NOT COMPLETED|Implementation||0
11207424|NCT01875861|12398600|FG001|NOT COMPLETED|Implementation||0
11207425|NCT01875861|12398599|FG000|STARTED|Sustainability||4306
11207426|NCT01875861|12398600|FG001|STARTED|Sustainability||3444
11207427|NCT01875861|12398599|FG000|COMPLETED|Sustainability||4306
11207428|NCT01875861|12398600|FG001|COMPLETED|Sustainability||3444
11207429|NCT01875861|12398599|FG000|NOT COMPLETED|Sustainability||0
11207430|NCT01875861|12398600|FG001|NOT COMPLETED|Sustainability||0
11207431|NCT01875874|12398607|FG000|STARTED|Overall Study||8
11207432|NCT01875874|12398607|FG000|COMPLETED|Overall Study||5
11207433|NCT01875874|12398607|FG000|NOT COMPLETED|Overall Study||3
11207434|NCT01875978|12398614|FG000|STARTED|Study 4weeks||20
11207435|NCT01875978|12398615|FG001|STARTED|Study 4weeks||20
11207436|NCT01875978|12398614|FG000|COMPLETED|Study 4weeks||20
11207437|NCT01875978|12398615|FG001|COMPLETED|Study 4weeks||20
11207438|NCT01875978|12398614|FG000|NOT COMPLETED|Study 4weeks||0
11207439|NCT01875978|12398615|FG001|NOT COMPLETED|Study 4weeks||0
11207440|NCT01875978|12398614|FG000|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
11349713|NCT03017937|12546602|FG000|NOT COMPLETED|Overall Study||0
11349714|NCT03018028|12546612|FG000|STARTED|Overall Study||49
11081714|NCT01125800|12264366|FG000|NOT COMPLETED|Phase II||0
11081715|NCT01125800|12264367|FG001|NOT COMPLETED|Phase II||0
11081716|NCT01125800|12264368|FG002|NOT COMPLETED|Phase II||0
11081717|NCT01125800|12264369|FG003|NOT COMPLETED|Phase II||1
11081718|NCT01125800|12264370|FG004|NOT COMPLETED|Phase II||11
11081719|NCT01125813|12264385|FG000|STARTED|Overall Study||36
11081720|NCT01125813|12264385|FG000|COMPLETED|Overall Study||30
11081721|NCT01125813|12264385|FG000|NOT COMPLETED|Overall Study||6
11081722|NCT01125917|12264389|FG000|STARTED|Overall Study||354
11081723|NCT01125917|12264389|FG000|COMPLETED|Overall Study||15
11081724|NCT01125917|12264389|FG000|NOT COMPLETED|Overall Study||339
11081725|NCT01125930|12264395|FG000|STARTED|Overall Study||22
11081726|NCT01125930|12264396|FG001|STARTED|Overall Study||46
11081727|NCT01125930|12264395|FG000|COMPLETED|Overall Study||21
11081728|NCT01125930|12264396|FG001|COMPLETED|Overall Study||36
11081729|NCT01125930|12264395|FG000|NOT COMPLETED|Overall Study||1
11081730|NCT01125930|12264396|FG001|NOT COMPLETED|Overall Study||10
11081731|NCT01126060|12264420|FG000|STARTED|Overall Study||40
11081732|NCT01126060|12264421|FG001|STARTED|Overall Study||40
11081733|NCT01126060|12264420|FG000|COMPLETED|Overall Study||40
11081734|NCT01126060|12264421|FG001|COMPLETED|Overall Study||38
11081735|NCT01126060|12264420|FG000|NOT COMPLETED|Overall Study||0
11081736|NCT01126060|12264421|FG001|NOT COMPLETED|Overall Study||2
11081737|NCT01126099|12264429|FG000|STARTED|Double Blind Phase||11
11081738|NCT01126099|12264430|FG001|STARTED|Double Blind Phase||9
11081739|NCT01126099|12264429|FG000|COMPLETED|Double Blind Phase||7
11081740|NCT01126099|12264430|FG001|COMPLETED|Double Blind Phase||7
11081741|NCT01126099|12264429|FG000|NOT COMPLETED|Double Blind Phase||4
11081742|NCT01126099|12264430|FG001|NOT COMPLETED|Double Blind Phase||2
11081743|NCT01126099|12264429|FG000|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
11081744|NCT01126099|12264430|FG001|STARTED|Open-label Extension||7
11081745|NCT01126099|12264429|FG000|COMPLETED|Open-label Extension||4
11081746|NCT01126099|12264430|FG001|COMPLETED|Open-label Extension||6
11081747|NCT01126099|12264429|FG000|NOT COMPLETED|Open-label Extension||1
11081748|NCT01126099|12264430|FG001|NOT COMPLETED|Open-label Extension||1
11081749|NCT01126268|12264436|FG000|STARTED|Overall Study||38
11081750|NCT01126268|12264436|FG000|COMPLETED|Overall Study||37
11081751|NCT01126268|12264436|FG000|NOT COMPLETED|Overall Study||1
11081752|NCT01126359|12264440|FG000|STARTED|First Intervention (20-minutes)||5
11081753|NCT01126359|12264441|FG001|STARTED|First Intervention (20-minutes)||6
11081754|NCT01126359|12264440|FG000|COMPLETED|First Intervention (20-minutes)||5
11081755|NCT01126359|12264441|FG001|COMPLETED|First Intervention (20-minutes)||5
11081756|NCT01126359|12264440|FG000|NOT COMPLETED|First Intervention (20-minutes)||0
11081757|NCT01126359|12264441|FG001|NOT COMPLETED|First Intervention (20-minutes)||1
11081758|NCT01126359|12264440|FG000|STARTED|Dressing Replacement/Healing (48-hours)||5
11081759|NCT01126359|12264441|FG001|STARTED|Dressing Replacement/Healing (48-hours)||5
11081760|NCT01126359|12264440|FG000|COMPLETED|Dressing Replacement/Healing (48-hours)||5
11081761|NCT01126359|12264441|FG001|COMPLETED|Dressing Replacement/Healing (48-hours)||5
11081762|NCT01126359|12264440|FG000|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
11081763|NCT01126359|12264441|FG001|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
11081764|NCT01126359|12264440|FG000|STARTED|Second Intervention (20-minutes)||5
11081765|NCT01126359|12264441|FG001|STARTED|Second Intervention (20-minutes)||5
11081766|NCT01126359|12264440|FG000|COMPLETED|Second Intervention (20-minutes)||5
11081767|NCT01126359|12264441|FG001|COMPLETED|Second Intervention (20-minutes)||5
11081768|NCT01126359|12264440|FG000|NOT COMPLETED|Second Intervention (20-minutes)||0
11081769|NCT01126359|12264441|FG001|NOT COMPLETED|Second Intervention (20-minutes)||0
11081770|NCT01126424|12264457|FG000|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
11081771|NCT01126424|12264458|FG001|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
11081772|NCT01126424|12264459|FG002|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
11081773|NCT01126424|12264460|FG003|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
11081774|NCT01126424|12264461|FG004|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
11081775|NCT01126424|12264462|FG005|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
11081776|NCT01126424|12264457|FG000|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
11081777|NCT01126424|12264458|FG001|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
11081778|NCT01126424|12264459|FG002|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
11081779|NCT01126424|12264460|FG003|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
11081780|NCT01126424|12264461|FG004|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
11081781|NCT01126424|12264462|FG005|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
11081782|NCT01126424|12264457|FG000|COMPLETED|Overall Study||3
11081783|NCT01126424|12264458|FG001|COMPLETED|Overall Study||4
11081784|NCT01126424|12264459|FG002|COMPLETED|Overall Study||4
11081785|NCT01126424|12264460|FG003|COMPLETED|Overall Study||3
11081786|NCT01126424|12264461|FG004|COMPLETED|Overall Study||2
11081787|NCT01126424|12264462|FG005|COMPLETED|Overall Study||4
11081788|NCT01126424|12264457|FG000|NOT COMPLETED|Overall Study||0
11081789|NCT01126424|12264458|FG001|NOT COMPLETED|Overall Study||0
11081790|NCT01126424|12264459|FG002|NOT COMPLETED|Overall Study||1
11081791|NCT01126424|12264460|FG003|NOT COMPLETED|Overall Study||3
11081792|NCT01126424|12264461|FG004|NOT COMPLETED|Overall Study||2
11081793|NCT01126424|12264462|FG005|NOT COMPLETED|Overall Study||0
11081794|NCT01126437|12264473|FG000|STARTED|Overall Study||5741
11081795|NCT01126437|12264474|FG001|STARTED|Overall Study||5729
11081796|NCT01126437|12264475|FG002|STARTED|Overall Study||5713
11081797|NCT01126437|12264473|FG000|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
11081798|NCT01126437|12264474|FG001|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
11081799|NCT01126437|12264475|FG002|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
11081800|NCT01126437|12264473|FG000|NOT COMPLETED|Overall Study||1341
11081801|NCT01126437|12264474|FG001|NOT COMPLETED|Overall Study||1330
11081802|NCT01126437|12264475|FG002|NOT COMPLETED|Overall Study||1313
11081803|NCT01126541|12264486|FG000|STARTED|Overall Study||70
11081804|NCT01126541|12264487|FG001|STARTED|Overall Study||73
11081805|NCT01126541|12264488|FG002|STARTED|Overall Study||81
11081806|NCT01126541|12264486|FG000|COMPLETED|Overall Study||60
11081807|NCT01126541|12264487|FG001|COMPLETED|Overall Study||61
11081808|NCT01126541|12264488|FG002|COMPLETED|Overall Study||55
11081809|NCT01126541|12264486|FG000|NOT COMPLETED|Overall Study||10
11081810|NCT01126541|12264487|FG001|NOT COMPLETED|Overall Study||12
11081811|NCT01126541|12264488|FG002|NOT COMPLETED|Overall Study||26
11081812|NCT01126580|12264501|FG000|STARTED|Overall Study||269
11081813|NCT01126580|12264502|FG001|STARTED|Overall Study||270
11081814|NCT01126580|12264503|FG002|STARTED|Overall Study||268
11081815|NCT01126580|12264501|FG000|Received at Least 1 Dose of Study Drug|Overall Study||269
11081816|NCT01126580|12264502|FG001|Received at Least 1 Dose of Study Drug|Overall Study||270
11081817|NCT01126580|12264503|FG002|Received at Least 1 Dose of Study Drug|Overall Study||268
11081818|NCT01126580|12264501|FG000|Completed 26 Weeks|Overall Study||233
11081819|NCT01126580|12264502|FG001|Completed 26 Weeks|Overall Study||242
11081820|NCT01126580|12264503|FG002|Completed 26 Weeks|Overall Study||226
11081821|NCT01126580|12264501|FG000|COMPLETED|Overall Study||220
11081822|NCT01126580|12264502|FG001|COMPLETED|Overall Study||218
11081823|NCT01126580|12264503|FG002|COMPLETED|Overall Study||213
11081824|NCT01126580|12264501|FG000|NOT COMPLETED|Overall Study||49
11081825|NCT01126580|12264502|FG001|NOT COMPLETED|Overall Study||52
11081826|NCT01126580|12264503|FG002|NOT COMPLETED|Overall Study||55
11081827|NCT01126593|12264515|FG000|STARTED|Overall Study||33
11081828|NCT01126593|12264516|FG001|STARTED|Overall Study||29
11081829|NCT01126593|12264517|FG002|STARTED|Overall Study||34
11081830|NCT01126593|12264515|FG000|COMPLETED|Overall Study||29
11081831|NCT01126593|12264516|FG001|COMPLETED|Overall Study||27
11081832|NCT01126593|12264517|FG002|COMPLETED|Overall Study||32
11081833|NCT01126593|12264515|FG000|NOT COMPLETED|Overall Study||4
11081834|NCT01126593|12264516|FG001|NOT COMPLETED|Overall Study||2
11081835|NCT01126593|12264517|FG002|NOT COMPLETED|Overall Study||2
11081836|NCT01126619|12264525|FG000|STARTED|Overall Study||103
11081837|NCT01126619|12264525|FG000|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
11081838|NCT01126619|12264525|FG000|NOT COMPLETED|Overall Study||17
11081839|NCT01126671|12264533|FG000|STARTED|Overall Study||26
11081840|NCT01126671|12264534|FG001|STARTED|Overall Study||30
11081841|NCT01126671|12264533|FG000|COMPLETED|Overall Study||24
11081842|NCT01126671|12264534|FG001|COMPLETED|Overall Study||29
11081843|NCT01126671|12264533|FG000|NOT COMPLETED|Overall Study||2
11081844|NCT01126671|12264534|FG001|NOT COMPLETED|Overall Study||1
11081845|NCT01126723|12264544|FG000|STARTED|Overall Study||35
11081846|NCT01126723|12264545|FG001|STARTED|Overall Study||31
11081847|NCT01126723|12264544|FG000|COMPLETED|Overall Study||29
11081848|NCT01126723|12264545|FG001|COMPLETED|Overall Study||28
11081849|NCT01126723|12264544|FG000|NOT COMPLETED|Overall Study||6
11081850|NCT01126723|12264545|FG001|NOT COMPLETED|Overall Study||3
11081851|NCT01127061|12264553|FG000|STARTED|Overall Study||67
11081852|NCT01127061|12264554|FG001|STARTED|Overall Study||69
11081853|NCT01127061|12264553|FG000|COMPLETED|Overall Study||57
11081854|NCT01127061|12264554|FG001|COMPLETED|Overall Study||56
11081855|NCT01127061|12264553|FG000|NOT COMPLETED|Overall Study||10
11081856|NCT01127061|12264554|FG001|NOT COMPLETED|Overall Study||13
11081857|NCT01127087|12264562|FG000|STARTED|Overall Study||8
11081858|NCT01127087|12264563|FG001|STARTED|Overall Study||2
11081859|NCT01127087|12264562|FG000|COMPLETED|Overall Study||8
11081860|NCT01127087|12264563|FG001|COMPLETED|Overall Study||2
11081861|NCT01127087|12264562|FG000|NOT COMPLETED|Overall Study||0
11081862|NCT01127087|12264563|FG001|NOT COMPLETED|Overall Study||0
11081863|NCT01127139|12264571|FG000|STARTED|Overall Study||3828
11081864|NCT01127139|12264571|FG000|Number of Participants Analyzed|Overall Study||3828
11081865|NCT01127139|12264571|FG000|COMPLETED|Overall Study||3771
11081866|NCT01127139|12264571|FG000|NOT COMPLETED|Overall Study||57
11081867|NCT01127165|12264580|FG000|STARTED|Overall Study||65
11081868|NCT01127165|12264581|FG001|STARTED|Overall Study||60
11081869|NCT01127165|12264580|FG000|COMPLETED|Overall Study||49
11081870|NCT01127165|12264581|FG001|COMPLETED|Overall Study||41
11081871|NCT01127165|12264580|FG000|NOT COMPLETED|Overall Study||16
11081872|NCT01127165|12264581|FG001|NOT COMPLETED|Overall Study||19
11349715|NCT03018028|12546613|FG001|STARTED|Overall Study||49
11349716|NCT03018028|12546614|FG002|STARTED|Overall Study||48
11349717|NCT03018028|12546615|FG003|STARTED|Overall Study||48
11349718|NCT03018028|12546616|FG004|STARTED|Overall Study||49
11349719|NCT03018028|12546612|FG000|Full Analysis Set (FAS)|Overall Study||49
11349720|NCT03018028|12546613|FG001|Full Analysis Set (FAS)|Overall Study||49
11081873|NCT01127321|12264592|FG000|STARTED|Overall Study||3
11081874|NCT01127321|12264593|FG001|STARTED|Overall Study||1
11081875|NCT01127321|12264594|FG002|STARTED|Overall Study||1
11081876|NCT01127321|12264595|FG003|STARTED|Overall Study||7
11081877|NCT01127321|12264596|FG004|STARTED|Overall Study||5
11081878|NCT01127321|12264592|FG000|COMPLETED|Overall Study||3
11349721|NCT03018028|12546614|FG002|Full Analysis Set (FAS)|Overall Study||48
11349722|NCT03018028|12546615|FG003|Full Analysis Set (FAS)|Overall Study||48
11349723|NCT03018028|12546616|FG004|Full Analysis Set (FAS)|Overall Study||49
11349724|NCT03018028|12546612|FG000|Safety Analysis Set (SAS)|Overall Study||49
11349725|NCT03018028|12546613|FG001|Safety Analysis Set (SAS)|Overall Study||49
11349726|NCT03018028|12546614|FG002|Safety Analysis Set (SAS)|Overall Study||48
11349727|NCT03018028|12546615|FG003|Safety Analysis Set (SAS)|Overall Study||48
11349728|NCT03018028|12546616|FG004|Safety Analysis Set (SAS)|Overall Study||49
11349729|NCT03018028|12546612|FG000|COMPLETED|Overall Study||46
11349730|NCT03018028|12546613|FG001|COMPLETED|Overall Study||49
11349731|NCT03018028|12546614|FG002|COMPLETED|Overall Study||47
11349732|NCT03018028|12546615|FG003|COMPLETED|Overall Study||46
11349733|NCT03018028|12546616|FG004|COMPLETED|Overall Study||49
11349734|NCT03018028|12546612|FG000|NOT COMPLETED|Overall Study||3
11349735|NCT03018028|12546613|FG001|NOT COMPLETED|Overall Study||0
11349736|NCT03018028|12546614|FG002|NOT COMPLETED|Overall Study||1
11349737|NCT03018028|12546615|FG003|NOT COMPLETED|Overall Study||2
11349738|NCT03018028|12546616|FG004|NOT COMPLETED|Overall Study||0
11349739|NCT03018106|12546630|FG000|STARTED|Overall Study||0
11349740|NCT03018106|12546631|FG001|STARTED|Overall Study||1
11349741|NCT03018106|12546630|FG000|COMPLETED|Overall Study||0
11349742|NCT03018106|12546631|FG001|COMPLETED|Overall Study||0
11349743|NCT03018106|12546630|FG000|NOT COMPLETED|Overall Study||0
11349744|NCT03018106|12546631|FG001|NOT COMPLETED|Overall Study||1
11349745|NCT03018223|12546635|FG000|STARTED|Overall Study||32
11349746|NCT03018223|12546635|FG000|COMPLETED|Overall Study||32
11349747|NCT03018223|12546635|FG000|NOT COMPLETED|Overall Study||0
11349748|NCT03018249|12546641|FG000|STARTED|Overall Study||25
11349749|NCT03018249|12546642|FG001|STARTED|Overall Study||25
11349750|NCT03018249|12546641|FG000|COMPLETED|Overall Study||23
11349751|NCT03018249|12546642|FG001|COMPLETED|Overall Study||23
11349752|NCT03018249|12546641|FG000|NOT COMPLETED|Overall Study||2
11349753|NCT03018249|12546642|FG001|NOT COMPLETED|Overall Study||2
11349754|NCT03018340|12546650|FG000|STARTED|Overall Study||52
11349755|NCT03018340|12546651|FG001|STARTED|Overall Study||155
11081879|NCT01127321|12264593|FG001|COMPLETED|Overall Study||1
11081880|NCT01127321|12264594|FG002|COMPLETED|Overall Study||1
11081881|NCT01127321|12264595|FG003|COMPLETED|Overall Study||7
11081882|NCT01127321|12264596|FG004|COMPLETED|Overall Study||5
11081883|NCT01127321|12264592|FG000|NOT COMPLETED|Overall Study||0
11081884|NCT01127321|12264593|FG001|NOT COMPLETED|Overall Study||0
11081885|NCT01127321|12264594|FG002|NOT COMPLETED|Overall Study||0
11081886|NCT01127321|12264595|FG003|NOT COMPLETED|Overall Study||0
11081887|NCT01127321|12264596|FG004|NOT COMPLETED|Overall Study||0
11349756|NCT03018340|12546650|FG000|COMPLETED|Overall Study||44
11349757|NCT03018340|12546651|FG001|COMPLETED|Overall Study||125
11349758|NCT03018340|12546650|FG000|NOT COMPLETED|Overall Study||8
11349759|NCT03018340|12546651|FG001|NOT COMPLETED|Overall Study||30
11349760|NCT03018691|12546664|FG000|STARTED|Overall Study||24
11081888|NCT01127373|12264608|FG000|STARTED|Overall Study||116
11081889|NCT01127373|12264608|FG000|COMPLETED|Overall Study||104
11081890|NCT01127373|12264608|FG000|NOT COMPLETED|Overall Study||12
11081891|NCT01127438|12264618|FG000|STARTED|Overall Study||25
11081892|NCT01127438|12264619|FG001|STARTED|Overall Study||25
11081893|NCT01127438|12264620|FG002|STARTED|Overall Study||26
11081894|NCT01127438|12264621|FG003|STARTED|Overall Study||24
11081895|NCT01127438|12264622|FG004|STARTED|Overall Study||28
11081896|NCT01127438|12264623|FG005|STARTED|Overall Study||25
11081897|NCT01127438|12264618|FG000|COMPLETED|Overall Study||25
11081898|NCT01127438|12264619|FG001|COMPLETED|Overall Study||25
11081899|NCT01127438|12264620|FG002|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
11081900|NCT01127438|12264621|FG003|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
11081901|NCT01127438|12264622|FG004|COMPLETED|Overall Study||28
11081902|NCT01127438|12264623|FG005|COMPLETED|Overall Study||25
11081903|NCT01127438|12264618|FG000|NOT COMPLETED|Overall Study||0
11081904|NCT01127438|12264619|FG001|NOT COMPLETED|Overall Study||0
11081905|NCT01127438|12264620|FG002|NOT COMPLETED|Overall Study||0
11081906|NCT01127438|12264621|FG003|NOT COMPLETED|Overall Study||0
11081907|NCT01127438|12264622|FG004|NOT COMPLETED|Overall Study||0
11081908|NCT01127438|12264623|FG005|NOT COMPLETED|Overall Study||0
11081909|NCT01127581|12264635|FG000|STARTED|Overall Study||678
11081910|NCT01127581|12264636|FG001|STARTED|Overall Study||680
11081911|NCT01127581|12264635|FG000|COMPLETED|Overall Study||678
11081912|NCT01127581|12264636|FG001|COMPLETED|Overall Study||680
11081913|NCT01127581|12264635|FG000|NOT COMPLETED|Overall Study||0
11081914|NCT01127581|12264636|FG001|NOT COMPLETED|Overall Study||0
11081915|NCT01127607|12264644|FG000|STARTED|Phase I (Within Subjects)||14
11081916|NCT01127607|12264645|FG001|STARTED|Phase I (Within Subjects)||13
11081917|NCT01127607|12264644|FG000|COMPLETED|Phase I (Within Subjects)||14
11081918|NCT01127607|12264645|FG001|COMPLETED|Phase I (Within Subjects)||13
11081919|NCT01127607|12264644|FG000|NOT COMPLETED|Phase I (Within Subjects)||0
11081920|NCT01127607|12264645|FG001|NOT COMPLETED|Phase I (Within Subjects)||0
11081921|NCT01127607|12264644|FG000|STARTED|Phase II (Between Subjects)||14
11081922|NCT01127607|12264645|FG001|STARTED|Phase II (Between Subjects)||13
11081923|NCT01127607|12264644|FG000|COMPLETED|Phase II (Between Subjects)||13
11081924|NCT01127607|12264645|FG001|COMPLETED|Phase II (Between Subjects)||11
11081925|NCT01127607|12264644|FG000|NOT COMPLETED|Phase II (Between Subjects)||1
11081926|NCT01127607|12264645|FG001|NOT COMPLETED|Phase II (Between Subjects)||2
11081927|NCT01127633|12264670|FG000|STARTED|Overall Study||723
11081928|NCT01127633|12264671|FG001|STARTED|Overall Study||734
11081929|NCT01127633|12264670|FG000|Received at Least 1 Dose of Study Drug|Overall Study||723
11081930|NCT01127633|12264671|FG001|Received at Least 1 Dose of Study Drug|Overall Study||734
11081931|NCT01127633|12264670|FG000|COMPLETED|Overall Study||70
11081932|NCT01127633|12264671|FG001|COMPLETED|Overall Study||61
11081933|NCT01127633|12264670|FG000|NOT COMPLETED|Overall Study||653
11081934|NCT01127633|12264671|FG001|NOT COMPLETED|Overall Study||673
11081935|NCT01127646|12264679|FG000|STARTED|Overall Study||15
11081936|NCT01127646|12264680|FG001|STARTED|Overall Study||8
11081937|NCT01127646|12264679|FG000|COMPLETED|Overall Study||14
11081938|NCT01127646|12264680|FG001|COMPLETED|Overall Study||7
11081939|NCT01127646|12264679|FG000|NOT COMPLETED|Overall Study||1
11081940|NCT01127646|12264680|FG001|NOT COMPLETED|Overall Study||1
11081941|NCT01127659|12264694|FG000|STARTED|Overall Study||22
11081942|NCT01127659|12264695|FG001|STARTED|Overall Study||22
11081943|NCT01127659|12264696|FG002|STARTED|Overall Study||12
11081944|NCT01127659|12264697|FG003|STARTED|Overall Study||10
11081945|NCT01127659|12264698|FG004|STARTED|Overall Study||50
11081946|NCT01127659|12264699|FG005|STARTED|Overall Study||21
11349761|NCT03018691|12546665|FG001|STARTED|Overall Study||25
11349762|NCT03018691|12546666|FG002|STARTED|Overall Study||24
11349763|NCT03018691|12546664|FG000|COMPLETED|Overall Study||22
11349764|NCT03018691|12546665|FG001|COMPLETED|Overall Study||24
11349765|NCT03018691|12546666|FG002|COMPLETED|Overall Study||17
11349766|NCT03018691|12546664|FG000|NOT COMPLETED|Overall Study||2
11349767|NCT03018691|12546665|FG001|NOT COMPLETED|Overall Study||1
11081947|NCT01127659|12264694|FG000|COMPLETED|Overall Study||20
11081948|NCT01127659|12264695|FG001|COMPLETED|Overall Study||14
11081949|NCT01127659|12264696|FG002|COMPLETED|Overall Study||10
11081950|NCT01127659|12264697|FG003|COMPLETED|Overall Study||6
11081951|NCT01127659|12264698|FG004|COMPLETED|Overall Study||50
11081952|NCT01127659|12264699|FG005|COMPLETED|Overall Study||21
11081953|NCT01127659|12264694|FG000|NOT COMPLETED|Overall Study||2
11081954|NCT01127659|12264695|FG001|NOT COMPLETED|Overall Study||8
11081955|NCT01127659|12264696|FG002|NOT COMPLETED|Overall Study||2
11081956|NCT01127659|12264697|FG003|NOT COMPLETED|Overall Study||4
11081957|NCT01127659|12264698|FG004|NOT COMPLETED|Overall Study||0
11081958|NCT01127659|12264699|FG005|NOT COMPLETED|Overall Study||0
11081959|NCT01127737|12264715|FG000|STARTED|Overall Study||37
11081960|NCT01127737|12264716|FG001|STARTED|Overall Study||38
11081961|NCT01127737|12264715|FG000|COMPLETED|Overall Study||37
11081962|NCT01127737|12264716|FG001|COMPLETED|Overall Study||38
11081963|NCT01127737|12264715|FG000|NOT COMPLETED|Overall Study||0
11081964|NCT01127737|12264716|FG001|NOT COMPLETED|Overall Study||0
11081965|NCT01127763|12264722|FG000|STARTED|Overall Study||25
11081966|NCT01127763|12264722|FG000|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
11081967|NCT01127763|12264722|FG000|NOT COMPLETED|Overall Study||5
11081968|NCT01127893|12264730|FG000|STARTED|Overall Study||1
11081969|NCT01127893|12264730|FG000|COMPLETED|Overall Study||0
11081970|NCT01127893|12264730|FG000|NOT COMPLETED|Overall Study||1
11081971|NCT01128049|12264737|FG000|STARTED|Overall Study||5
11081972|NCT01128049|12264738|FG001|STARTED|Overall Study||5
11081973|NCT01128049|12264739|FG002|STARTED|Overall Study||5
11081974|NCT01128049|12264737|FG000|COMPLETED|Overall Study||5
11081975|NCT01128049|12264738|FG001|COMPLETED|Overall Study||5
11081976|NCT01128049|12264739|FG002|COMPLETED|Overall Study||5
11081977|NCT01128049|12264737|FG000|NOT COMPLETED|Overall Study||0
11081978|NCT01128049|12264738|FG001|NOT COMPLETED|Overall Study||0
11081979|NCT01128049|12264739|FG002|NOT COMPLETED|Overall Study||0
11081980|NCT01128153|12264749|FG000|STARTED|Overall Study|Randomised|129
11081981|NCT01128153|12264750|FG001|STARTED|Overall Study|Randomised|128
11081982|NCT01128153|12264749|FG000|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
11081983|NCT01128153|12264750|FG001|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
11081984|NCT01128153|12264749|FG000|COMPLETED|Overall Study|Completed 24 weeks|113
11081985|NCT01128153|12264750|FG001|COMPLETED|Overall Study|Completed 24 weeks|113
11081986|NCT01128153|12264749|FG000|NOT COMPLETED|Overall Study||16
11081987|NCT01128153|12264750|FG001|NOT COMPLETED|Overall Study||15
11081988|NCT01128179|12264758|FG000|STARTED|Overall Study||23
11081989|NCT01128179|12264759|FG001|STARTED|Overall Study||12
11081990|NCT01128179|12264758|FG000|COMPLETED|Overall Study||21
11081991|NCT01128179|12264759|FG001|COMPLETED|Overall Study||12
11081992|NCT01128179|12264758|FG000|NOT COMPLETED|Overall Study||2
11081993|NCT01128179|12264759|FG001|NOT COMPLETED|Overall Study||0
11081994|NCT01128192|12264767|FG000|STARTED|Overall Study||19
11081995|NCT01128192|12264768|FG001|STARTED|Overall Study||19
11081996|NCT01128192|12264769|FG002|STARTED|Overall Study||7
11081997|NCT01128192|12264767|FG000|COMPLETED|Overall Study||19
11081998|NCT01128192|12264768|FG001|COMPLETED|Overall Study||19
11081999|NCT01128192|12264769|FG002|COMPLETED|Overall Study||7
11082000|NCT01128192|12264767|FG000|NOT COMPLETED|Overall Study||0
11082001|NCT01128192|12264768|FG001|NOT COMPLETED|Overall Study||0
11082002|NCT01128192|12264769|FG002|NOT COMPLETED|Overall Study||0
11082003|NCT01128244|12264780|FG000|STARTED|Overall Study||13
11082004|NCT01128244|12264780|FG000|COMPLETED|Overall Study||10
11082005|NCT01128244|12264780|FG000|NOT COMPLETED|Overall Study||3
11082006|NCT01128270|12264788|FG000|STARTED|Environment Chloral Hydrate and DCA (1A)||7
11082007|NCT01128270|12264788|FG000|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
11082008|NCT01128270|12264788|FG000|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
11082009|NCT01128270|12264788|FG000|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
11082010|NCT01128270|12264788|FG000|COMPLETED|Environmental Chloral Hydrate (1B)||8
11082011|NCT01128270|12264788|FG000|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
11082012|NCT01128270|12264788|FG000|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
11082013|NCT01128270|12264788|FG000|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
11082014|NCT01128270|12264788|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
11082015|NCT01128270|12264788|FG000|STARTED|Therapeutic Chloral Hydrate (2B)||8
11082016|NCT01128270|12264788|FG000|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
11082017|NCT01128270|12264788|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
11082018|NCT01128296|12264800|FG000|STARTED|Overall Study||1
11082019|NCT01128296|12264801|FG001|STARTED|Overall Study||1
11082020|NCT01128296|12264802|FG002|STARTED|Overall Study||1
11082021|NCT01128296|12264803|FG003|STARTED|Overall Study||1
11082022|NCT01128296|12264804|FG004|STARTED|Overall Study||1
11082023|NCT01128296|12264805|FG005|STARTED|Overall Study||26
11082024|NCT01128296|12264800|FG000|COMPLETED|Overall Study||1
11349768|NCT03018691|12546666|FG002|NOT COMPLETED|Overall Study||7
11082025|NCT01128296|12264801|FG001|COMPLETED|Overall Study||1
11082026|NCT01128296|12264802|FG002|COMPLETED|Overall Study||1
11082027|NCT01128296|12264803|FG003|COMPLETED|Overall Study||1
11082028|NCT01128296|12264804|FG004|COMPLETED|Overall Study||1
11082029|NCT01128296|12264805|FG005|COMPLETED|Overall Study||21
11082030|NCT01128296|12264800|FG000|NOT COMPLETED|Overall Study||0
11082031|NCT01128296|12264801|FG001|NOT COMPLETED|Overall Study||0
11082032|NCT01128296|12264802|FG002|NOT COMPLETED|Overall Study||0
11082033|NCT01128296|12264803|FG003|NOT COMPLETED|Overall Study||0
11082034|NCT01128296|12264804|FG004|NOT COMPLETED|Overall Study||0
11082035|NCT01128296|12264805|FG005|NOT COMPLETED|Overall Study||5
11082036|NCT01128361|12264818|FG000|STARTED|Overall Study||39
11082037|NCT01128361|12264819|FG001|STARTED|Overall Study||37
11082038|NCT01128361|12264818|FG000|COMPLETED|Overall Study||34
11082039|NCT01128361|12264819|FG001|COMPLETED|Overall Study||34
11082040|NCT01128361|12264818|FG000|NOT COMPLETED|Overall Study||5
11082041|NCT01128361|12264819|FG001|NOT COMPLETED|Overall Study||3
11082042|NCT01128387|12264827|FG000|STARTED|Overall Study||5
11082043|NCT01128387|12264828|FG001|STARTED|Overall Study||6
11082044|NCT01128387|12264827|FG000|COMPLETED|Overall Study||5
11082045|NCT01128387|12264828|FG001|COMPLETED|Overall Study||5
11082046|NCT01128387|12264827|FG000|NOT COMPLETED|Overall Study||0
11082047|NCT01128387|12264828|FG001|NOT COMPLETED|Overall Study||1
11082048|NCT01128400|12264837|FG000|STARTED|Overall Study||8
11082049|NCT01128400|12264838|FG001|STARTED|Overall Study||9
11082050|NCT01128400|12264839|FG002|STARTED|Overall Study||23
11082051|NCT01128400|12264837|FG000|COMPLETED|Overall Study||6
11082052|NCT01128400|12264838|FG001|COMPLETED|Overall Study||8
11082053|NCT01128400|12264839|FG002|COMPLETED|Overall Study||7
11082054|NCT01128400|12264837|FG000|NOT COMPLETED|Overall Study||2
11082055|NCT01128400|12264838|FG001|NOT COMPLETED|Overall Study||1
11082056|NCT01128400|12264839|FG002|NOT COMPLETED|Overall Study||16
11082057|NCT01128413|12264849|FG000|STARTED|Overall Study||11
11082058|NCT01128413|12264850|FG001|STARTED|Overall Study||11
11082059|NCT01128413|12264849|FG000|COMPLETED|Overall Study||7
11082060|NCT01128413|12264850|FG001|COMPLETED|Overall Study||10
11082061|NCT01128413|12264849|FG000|NOT COMPLETED|Overall Study||4
11082062|NCT01128413|12264850|FG001|NOT COMPLETED|Overall Study||1
11082063|NCT01128426|12264856|FG000|STARTED|Overall Study||53902
11082064|NCT01128426|12264856|FG000|COMPLETED|Overall Study||53902
11082065|NCT01128426|12264856|FG000|NOT COMPLETED|Overall Study||0
11082066|NCT01128543|12264862|FG000|STARTED|Overall Study||29
11082067|NCT01128543|12264862|FG000|COMPLETED|Overall Study||25
11082068|NCT01128543|12264862|FG000|NOT COMPLETED|Overall Study||4
11082069|NCT01128569|12264866|FG000|STARTED|Treatment Period 1||9
11082070|NCT01128569|12264867|FG001|STARTED|Treatment Period 1||8
11082071|NCT01128569|12264868|FG002|STARTED|Treatment Period 1||9
11082072|NCT01128569|12264869|FG003|STARTED|Treatment Period 1||8
11082073|NCT01128569|12264870|FG004|STARTED|Treatment Period 1||9
11082074|NCT01128569|12264871|FG005|STARTED|Treatment Period 1||9
11082075|NCT01128569|12264866|FG000|COMPLETED|Treatment Period 1||9
11082076|NCT01128569|12264867|FG001|COMPLETED|Treatment Period 1||8
11082077|NCT01128569|12264868|FG002|COMPLETED|Treatment Period 1||9
11082078|NCT01128569|12264869|FG003|COMPLETED|Treatment Period 1||8
11082079|NCT01128569|12264870|FG004|COMPLETED|Treatment Period 1||9
11082080|NCT01128569|12264871|FG005|COMPLETED|Treatment Period 1||9
11082081|NCT01128569|12264866|FG000|NOT COMPLETED|Treatment Period 1||0
11082082|NCT01128569|12264867|FG001|NOT COMPLETED|Treatment Period 1||0
11082083|NCT01128569|12264868|FG002|NOT COMPLETED|Treatment Period 1||0
11082084|NCT01128569|12264869|FG003|NOT COMPLETED|Treatment Period 1||0
11082085|NCT01128569|12264870|FG004|NOT COMPLETED|Treatment Period 1||0
11082086|NCT01128569|12264871|FG005|NOT COMPLETED|Treatment Period 1||0
11082087|NCT01128569|12264866|FG000|STARTED|Washout Period 1||9
11082088|NCT01128569|12264867|FG001|STARTED|Washout Period 1||8
11082089|NCT01128569|12264868|FG002|STARTED|Washout Period 1||9
11082090|NCT01128569|12264869|FG003|STARTED|Washout Period 1||8
11082091|NCT01128569|12264870|FG004|STARTED|Washout Period 1||9
11082092|NCT01128569|12264871|FG005|STARTED|Washout Period 1||9
11082093|NCT01128569|12264866|FG000|COMPLETED|Washout Period 1||9
11082094|NCT01128569|12264867|FG001|COMPLETED|Washout Period 1||8
11082095|NCT01128569|12264868|FG002|COMPLETED|Washout Period 1||8
11082096|NCT01128569|12264869|FG003|COMPLETED|Washout Period 1||8
11082097|NCT01128569|12264870|FG004|COMPLETED|Washout Period 1||9
11082098|NCT01128569|12264871|FG005|COMPLETED|Washout Period 1||9
11082099|NCT01128569|12264866|FG000|NOT COMPLETED|Washout Period 1||0
11082100|NCT01128569|12264867|FG001|NOT COMPLETED|Washout Period 1||0
11082101|NCT01128569|12264868|FG002|NOT COMPLETED|Washout Period 1||1
11082102|NCT01128569|12264869|FG003|NOT COMPLETED|Washout Period 1||0
11082103|NCT01128569|12264870|FG004|NOT COMPLETED|Washout Period 1||0
11082104|NCT01128569|12264871|FG005|NOT COMPLETED|Washout Period 1||0
11082105|NCT01128569|12264866|FG000|STARTED|Treatment Period 2||9
11082106|NCT01128569|12264867|FG001|STARTED|Treatment Period 2||8
11082107|NCT01128569|12264868|FG002|STARTED|Treatment Period 2||8
11082108|NCT01128569|12264869|FG003|STARTED|Treatment Period 2||8
11082109|NCT01128569|12264870|FG004|STARTED|Treatment Period 2||9
11082110|NCT01128569|12264871|FG005|STARTED|Treatment Period 2||9
11082111|NCT01128569|12264866|FG000|COMPLETED|Treatment Period 2||9
11082112|NCT01128569|12264867|FG001|COMPLETED|Treatment Period 2||7
11082113|NCT01128569|12264868|FG002|COMPLETED|Treatment Period 2||8
11082114|NCT01128569|12264869|FG003|COMPLETED|Treatment Period 2||8
11082115|NCT01128569|12264870|FG004|COMPLETED|Treatment Period 2||9
11082116|NCT01128569|12264871|FG005|COMPLETED|Treatment Period 2||9
11082117|NCT01128569|12264866|FG000|NOT COMPLETED|Treatment Period 2||0
11082118|NCT01128569|12264867|FG001|NOT COMPLETED|Treatment Period 2||1
11082119|NCT01128569|12264868|FG002|NOT COMPLETED|Treatment Period 2||0
11082120|NCT01128569|12264869|FG003|NOT COMPLETED|Treatment Period 2||0
11082121|NCT01128569|12264870|FG004|NOT COMPLETED|Treatment Period 2||0
11082122|NCT01128569|12264871|FG005|NOT COMPLETED|Treatment Period 2||0
11082123|NCT01128569|12264866|FG000|STARTED|Washout Period 2||9
11082124|NCT01128569|12264867|FG001|STARTED|Washout Period 2||7
11082125|NCT01128569|12264868|FG002|STARTED|Washout Period 2||8
11082126|NCT01128569|12264869|FG003|STARTED|Washout Period 2||8
11082127|NCT01128569|12264870|FG004|STARTED|Washout Period 2||9
11082128|NCT01128569|12264871|FG005|STARTED|Washout Period 2||9
11082129|NCT01128569|12264866|FG000|COMPLETED|Washout Period 2||9
11082130|NCT01128569|12264867|FG001|COMPLETED|Washout Period 2||7
11082131|NCT01128569|12264868|FG002|COMPLETED|Washout Period 2||8
11082132|NCT01128569|12264869|FG003|COMPLETED|Washout Period 2||8
11082133|NCT01128569|12264870|FG004|COMPLETED|Washout Period 2||9
11082134|NCT01128569|12264871|FG005|COMPLETED|Washout Period 2||9
11082135|NCT01128569|12264866|FG000|NOT COMPLETED|Washout Period 2||0
11082136|NCT01128569|12264867|FG001|NOT COMPLETED|Washout Period 2||0
11082137|NCT01128569|12264868|FG002|NOT COMPLETED|Washout Period 2||0
11082138|NCT01128569|12264869|FG003|NOT COMPLETED|Washout Period 2||0
11082139|NCT01128569|12264870|FG004|NOT COMPLETED|Washout Period 2||0
11082140|NCT01128569|12264871|FG005|NOT COMPLETED|Washout Period 2||0
11082141|NCT01128569|12264866|FG000|STARTED|Treatment Period 3||9
11082142|NCT01128569|12264867|FG001|STARTED|Treatment Period 3||7
11082143|NCT01128569|12264868|FG002|STARTED|Treatment Period 3||8
11082144|NCT01128569|12264869|FG003|STARTED|Treatment Period 3||8
11082145|NCT01128569|12264870|FG004|STARTED|Treatment Period 3||9
11082146|NCT01128569|12264871|FG005|STARTED|Treatment Period 3||9
11082147|NCT01128569|12264866|FG000|COMPLETED|Treatment Period 3||9
11082148|NCT01128569|12264867|FG001|COMPLETED|Treatment Period 3||7
11082149|NCT01128569|12264868|FG002|COMPLETED|Treatment Period 3||8
11082150|NCT01128569|12264869|FG003|COMPLETED|Treatment Period 3||8
11082151|NCT01128569|12264870|FG004|COMPLETED|Treatment Period 3||9
11082152|NCT01128569|12264871|FG005|COMPLETED|Treatment Period 3||9
11082153|NCT01128569|12264866|FG000|NOT COMPLETED|Treatment Period 3||0
11082154|NCT01128569|12264867|FG001|NOT COMPLETED|Treatment Period 3||0
11082155|NCT01128569|12264868|FG002|NOT COMPLETED|Treatment Period 3||0
11082156|NCT01128569|12264869|FG003|NOT COMPLETED|Treatment Period 3||0
11082157|NCT01128569|12264870|FG004|NOT COMPLETED|Treatment Period 3||0
11082158|NCT01128569|12264871|FG005|NOT COMPLETED|Treatment Period 3||0
11082159|NCT01128595|12264879|FG000|STARTED|Treatment Period 1||7
11082160|NCT01128595|12264880|FG001|STARTED|Treatment Period 1||6
11082161|NCT01128595|12264881|FG002|STARTED|Treatment Period 1||7
11082162|NCT01128595|12264882|FG003|STARTED|Treatment Period 1||7
11082163|NCT01128595|12264879|FG000|COMPLETED|Treatment Period 1||7
11082164|NCT01128595|12264880|FG001|COMPLETED|Treatment Period 1||6
11082165|NCT01128595|12264881|FG002|COMPLETED|Treatment Period 1||7
11082166|NCT01128595|12264882|FG003|COMPLETED|Treatment Period 1||7
11082167|NCT01128595|12264879|FG000|NOT COMPLETED|Treatment Period 1||0
11082168|NCT01128595|12264880|FG001|NOT COMPLETED|Treatment Period 1||0
11082169|NCT01128595|12264881|FG002|NOT COMPLETED|Treatment Period 1||0
11082170|NCT01128595|12264882|FG003|NOT COMPLETED|Treatment Period 1||0
11082171|NCT01128595|12264879|FG000|STARTED|Washout Period 1||7
11082172|NCT01128595|12264880|FG001|STARTED|Washout Period 1||6
11082173|NCT01128595|12264881|FG002|STARTED|Washout Period 1||7
11082174|NCT01128595|12264882|FG003|STARTED|Washout Period 1||7
11082175|NCT01128595|12264879|FG000|COMPLETED|Washout Period 1||7
11082176|NCT01128595|12264880|FG001|COMPLETED|Washout Period 1||6
11082177|NCT01128595|12264881|FG002|COMPLETED|Washout Period 1||7
11082178|NCT01128595|12264882|FG003|COMPLETED|Washout Period 1||7
11082179|NCT01128595|12264879|FG000|NOT COMPLETED|Washout Period 1||0
11082180|NCT01128595|12264880|FG001|NOT COMPLETED|Washout Period 1||0
11082181|NCT01128595|12264881|FG002|NOT COMPLETED|Washout Period 1||0
11082182|NCT01128595|12264882|FG003|NOT COMPLETED|Washout Period 1||0
11082183|NCT01128595|12264879|FG000|STARTED|Treatment Period 2||7
11082184|NCT01128595|12264880|FG001|STARTED|Treatment Period 2||6
11082185|NCT01128595|12264881|FG002|STARTED|Treatment Period 2||7
11082186|NCT01128595|12264882|FG003|STARTED|Treatment Period 2||7
11082187|NCT01128595|12264879|FG000|COMPLETED|Treatment Period 2||7
11082188|NCT01128595|12264880|FG001|COMPLETED|Treatment Period 2||6
11082189|NCT01128595|12264881|FG002|COMPLETED|Treatment Period 2||7
11082190|NCT01128595|12264882|FG003|COMPLETED|Treatment Period 2||7
11082191|NCT01128595|12264879|FG000|NOT COMPLETED|Treatment Period 2||0
11082192|NCT01128595|12264880|FG001|NOT COMPLETED|Treatment Period 2||0
11082193|NCT01128595|12264881|FG002|NOT COMPLETED|Treatment Period 2||0
11082194|NCT01128595|12264882|FG003|NOT COMPLETED|Treatment Period 2||0
11082195|NCT01128595|12264879|FG000|STARTED|Washout Period 2||7
11082196|NCT01128595|12264880|FG001|STARTED|Washout Period 2||6
11082197|NCT01128595|12264881|FG002|STARTED|Washout Period 2||7
11082198|NCT01128595|12264882|FG003|STARTED|Washout Period 2||7
11082199|NCT01128595|12264879|FG000|COMPLETED|Washout Period 2||7
11082200|NCT01128595|12264880|FG001|COMPLETED|Washout Period 2||6
11082201|NCT01128595|12264881|FG002|COMPLETED|Washout Period 2||7
11082202|NCT01128595|12264882|FG003|COMPLETED|Washout Period 2||7
11082203|NCT01128595|12264879|FG000|NOT COMPLETED|Washout Period 2||0
11082204|NCT01128595|12264880|FG001|NOT COMPLETED|Washout Period 2||0
11082205|NCT01128595|12264881|FG002|NOT COMPLETED|Washout Period 2||0
11082206|NCT01128595|12264882|FG003|NOT COMPLETED|Washout Period 2||0
11082207|NCT01128595|12264879|FG000|STARTED|Treatment Period 3||7
11082208|NCT01128595|12264880|FG001|STARTED|Treatment Period 3||6
11082209|NCT01128595|12264881|FG002|STARTED|Treatment Period 3||7
11082210|NCT01128595|12264882|FG003|STARTED|Treatment Period 3||7
11082211|NCT01128595|12264879|FG000|COMPLETED|Treatment Period 3||7
11082212|NCT01128595|12264880|FG001|COMPLETED|Treatment Period 3||5
11082213|NCT01128595|12264881|FG002|COMPLETED|Treatment Period 3||7
11082214|NCT01128595|12264882|FG003|COMPLETED|Treatment Period 3||7
11082215|NCT01128595|12264879|FG000|NOT COMPLETED|Treatment Period 3||0
11082216|NCT01128595|12264880|FG001|NOT COMPLETED|Treatment Period 3||1
11082217|NCT01128595|12264881|FG002|NOT COMPLETED|Treatment Period 3||0
11082218|NCT01128595|12264882|FG003|NOT COMPLETED|Treatment Period 3||0
11082219|NCT01128595|12264879|FG000|STARTED|Washout Period 3||7
11082220|NCT01128595|12264880|FG001|STARTED|Washout Period 3||5
11082221|NCT01128595|12264881|FG002|STARTED|Washout Period 3||7
11082222|NCT01128595|12264882|FG003|STARTED|Washout Period 3||7
11082223|NCT01128595|12264879|FG000|COMPLETED|Washout Period 3||7
11082224|NCT01128595|12264880|FG001|COMPLETED|Washout Period 3||5
11082225|NCT01128595|12264881|FG002|COMPLETED|Washout Period 3||7
11082226|NCT01128595|12264882|FG003|COMPLETED|Washout Period 3||7
11082227|NCT01128595|12264879|FG000|NOT COMPLETED|Washout Period 3||0
11082228|NCT01128595|12264880|FG001|NOT COMPLETED|Washout Period 3||0
11082229|NCT01128595|12264881|FG002|NOT COMPLETED|Washout Period 3||0
11082230|NCT01128595|12264882|FG003|NOT COMPLETED|Washout Period 3||0
11082231|NCT01128595|12264879|FG000|STARTED|Treatment Period 4||7
11082232|NCT01128595|12264880|FG001|STARTED|Treatment Period 4||5
11082233|NCT01128595|12264881|FG002|STARTED|Treatment Period 4||7
11082234|NCT01128595|12264882|FG003|STARTED|Treatment Period 4||7
11349769|NCT03018925|12546676|FG000|STARTED|Overall Study||15
11349770|NCT03018925|12546676|FG000|COMPLETED|Overall Study||15
11349771|NCT03018925|12546676|FG000|NOT COMPLETED|Overall Study||0
11349772|NCT03018938|12546703|FG000|STARTED|Overall Study||404
11349773|NCT03018938|12546704|FG001|STARTED|Overall Study||410
11349774|NCT03018938|12546703|FG000|Received at Least 1 Dose of Study Drug|Overall Study||404
11349775|NCT03018938|12546704|FG001|Received at Least 1 Dose of Study Drug|Overall Study||410
11349776|NCT03018938|12546703|FG000|COMPLETED|Overall Study||338
11349777|NCT03018938|12546704|FG001|COMPLETED|Overall Study||325
11349778|NCT03018938|12546703|FG000|NOT COMPLETED|Overall Study||66
11349779|NCT03018938|12546704|FG001|NOT COMPLETED|Overall Study||85
11349780|NCT03019055|12546714|FG000|STARTED|Overall Study||0
11349781|NCT03019055|12546715|FG001|STARTED|Overall Study||3
11349782|NCT03019055|12546716|FG002|STARTED|Overall Study||3
11349783|NCT03019055|12546717|FG003|STARTED|Overall Study||20
11349784|NCT03019055|12546714|FG000|COMPLETED|Overall Study||0
11349785|NCT03019055|12546715|FG001|COMPLETED|Overall Study||3
11349786|NCT03019055|12546716|FG002|COMPLETED|Overall Study||3
11349787|NCT03019055|12546717|FG003|COMPLETED|Overall Study||20
11349788|NCT03019055|12546714|FG000|NOT COMPLETED|Overall Study||0
11349789|NCT03019055|12546715|FG001|NOT COMPLETED|Overall Study||0
11349790|NCT03019055|12546716|FG002|NOT COMPLETED|Overall Study||0
11349791|NCT03019055|12546717|FG003|NOT COMPLETED|Overall Study||0
11349792|NCT03019107|12546729|FG000|STARTED|Overall Study||1
11349793|NCT03019107|12546730|FG001|STARTED|Overall Study||0
11349794|NCT03019107|12546729|FG000|COMPLETED|Overall Study||1
11349795|NCT03019107|12546730|FG001|COMPLETED|Overall Study||0
11349796|NCT03019107|12546729|FG000|NOT COMPLETED|Overall Study||0
11349797|NCT03019107|12546730|FG001|NOT COMPLETED|Overall Study||0
11349798|NCT03019289|12546745|FG000|STARTED|Overall Study||5
11349799|NCT03019289|12546746|FG001|STARTED|Overall Study||1
11349800|NCT03019289|12546747|FG002|STARTED|Overall Study||3
11349801|NCT03019289|12546748|FG003|STARTED|Overall Study||2
11349802|NCT03019289|12546749|FG004|STARTED|Overall Study||1
11349803|NCT03019289|12546750|FG005|STARTED|Overall Study||1
11349804|NCT03019289|12546751|FG006|STARTED|Overall Study||3
11349805|NCT03019289|12546752|FG007|STARTED|Overall Study||4
11349806|NCT03019289|12546753|FG008|STARTED|Overall Study||3
11349807|NCT03019289|12546745|FG000|COMPLETED|Overall Study||3
11349808|NCT03019289|12546746|FG001|COMPLETED|Overall Study||1
11349809|NCT03019289|12546747|FG002|COMPLETED|Overall Study||3
11349810|NCT03019289|12546748|FG003|COMPLETED|Overall Study||2
11349811|NCT03019289|12546749|FG004|COMPLETED|Overall Study||1
11349812|NCT03019289|12546750|FG005|COMPLETED|Overall Study||1
11349813|NCT03019289|12546751|FG006|COMPLETED|Overall Study||3
11349814|NCT03019289|12546752|FG007|COMPLETED|Overall Study||4
11349815|NCT03019289|12546753|FG008|COMPLETED|Overall Study||2
11349816|NCT03019289|12546745|FG000|NOT COMPLETED|Overall Study||2
11349817|NCT03019289|12546746|FG001|NOT COMPLETED|Overall Study||0
11349818|NCT03019289|12546747|FG002|NOT COMPLETED|Overall Study||0
11349819|NCT03019289|12546748|FG003|NOT COMPLETED|Overall Study||0
11349820|NCT03019289|12546749|FG004|NOT COMPLETED|Overall Study||0
11349821|NCT03019289|12546750|FG005|NOT COMPLETED|Overall Study||0
11349822|NCT03019289|12546751|FG006|NOT COMPLETED|Overall Study||0
11349823|NCT03019289|12546752|FG007|NOT COMPLETED|Overall Study||0
11349824|NCT03019289|12546753|FG008|NOT COMPLETED|Overall Study||1
11349825|NCT03019458|12546776|FG000|STARTED|Overall Study||24
11349826|NCT03019458|12546777|FG001|STARTED|Overall Study||26
11349827|NCT03019458|12546776|FG000|COMPLETED|Overall Study||24
11082235|NCT01128595|12264879|FG000|COMPLETED|Treatment Period 4||7
11349828|NCT03019458|12546777|FG001|COMPLETED|Overall Study||25
11082236|NCT01128595|12264880|FG001|COMPLETED|Treatment Period 4||5
11082237|NCT01128595|12264881|FG002|COMPLETED|Treatment Period 4||7
11082238|NCT01128595|12264882|FG003|COMPLETED|Treatment Period 4||7
11082239|NCT01128595|12264879|FG000|NOT COMPLETED|Treatment Period 4||0
11082240|NCT01128595|12264880|FG001|NOT COMPLETED|Treatment Period 4||0
11082241|NCT01128595|12264881|FG002|NOT COMPLETED|Treatment Period 4||0
11082242|NCT01128595|12264882|FG003|NOT COMPLETED|Treatment Period 4||0
11082243|NCT01128621|12264895|FG000|STARTED|Part A: GSK1292263 300 mg||6
11082244|NCT01128621|12264896|FG001|STARTED|Part A: GSK1292263 300 mg||0
11082245|NCT01128621|12264895|FG000|COMPLETED|Part A: GSK1292263 300 mg||6
11082246|NCT01128621|12264896|FG001|COMPLETED|Part A: GSK1292263 300 mg||0
11082247|NCT01128621|12264895|FG000|NOT COMPLETED|Part A: GSK1292263 300 mg||0
11082248|NCT01128621|12264896|FG001|NOT COMPLETED|Part A: GSK1292263 300 mg||0
11082249|NCT01128621|12264895|FG000|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
11082250|NCT01128621|12264896|FG001|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
11349829|NCT03019458|12546776|FG000|NOT COMPLETED|Overall Study||0
11082251|NCT01128621|12264895|FG000|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
11349830|NCT03019458|12546777|FG001|NOT COMPLETED|Overall Study||1
11349831|NCT03019549|12546785|FG000|STARTED|Period 1||42
11349832|NCT03019549|12546785|FG000|Received 1 Dose of Study Drug|Period 1||42
11349833|NCT03019549|12546785|FG000|COMPLETED|Period 1||42
11349834|NCT03019549|12546785|FG000|NOT COMPLETED|Period 1||0
11349835|NCT03019549|12546785|FG000|STARTED|Washout||42
11349836|NCT03019549|12546785|FG000|COMPLETED|Washout||31
11082252|NCT01128621|12264896|FG001|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
11082253|NCT01128621|12264895|FG000|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
11082254|NCT01128621|12264896|FG001|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
11082255|NCT01128738|12264920|FG000|STARTED|First Treatment Phase (TP)||78
11082256|NCT01128738|12264921|FG001|STARTED|First Treatment Phase (TP)||74
11082257|NCT01128738|12264920|FG000|COMPLETED|First Treatment Phase (TP)||74
11082258|NCT01128738|12264921|FG001|COMPLETED|First Treatment Phase (TP)||73
11082259|NCT01128738|12264920|FG000|NOT COMPLETED|First Treatment Phase (TP)||4
11082260|NCT01128738|12264921|FG001|NOT COMPLETED|First Treatment Phase (TP)||1
11082261|NCT01128738|12264920|FG000|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
11082262|NCT01128738|12264921|FG001|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
11082263|NCT01128738|12264920|FG000|COMPLETED|Second TP||34
11082264|NCT01128738|12264921|FG001|COMPLETED|Second TP||63
11082265|NCT01128738|12264920|FG000|NOT COMPLETED|Second TP||0
11082266|NCT01128738|12264921|FG001|NOT COMPLETED|Second TP||3
11082267|NCT01128829|12264928|FG000|STARTED|Overall Study||6
11082268|NCT01128829|12264929|FG001|STARTED|Overall Study||11
11082269|NCT01128829|12264928|FG000|COMPLETED|Overall Study||6
11082270|NCT01128829|12264929|FG001|COMPLETED|Overall Study||11
11082271|NCT01128829|12264928|FG000|NOT COMPLETED|Overall Study||0
11082272|NCT01128829|12264929|FG001|NOT COMPLETED|Overall Study||0
11082273|NCT01128842|12264933|FG000|STARTED|Overall Study||7
11082274|NCT01128842|12264933|FG000|COMPLETED|Overall Study||0
11082275|NCT01128842|12264933|FG000|NOT COMPLETED|Overall Study||7
11082276|NCT01128894|12264940|FG000|STARTED|Overall Study||404
11082277|NCT01128894|12264941|FG001|STARTED|Overall Study||408
11082278|NCT01128894|12264940|FG000|COMPLETED|Overall Study||346
11082279|NCT01128894|12264941|FG001|COMPLETED|Overall Study||340
11082280|NCT01128894|12264940|FG000|NOT COMPLETED|Overall Study||58
11082281|NCT01128894|12264941|FG001|NOT COMPLETED|Overall Study||68
11082282|NCT01128946|12264947|FG000|STARTED|Period I||20
11082283|NCT01128946|12264948|FG001|STARTED|Period I||21
11082284|NCT01128946|12264949|FG002|STARTED|Period I||21
11082285|NCT01128946|12264950|FG003|STARTED|Period I||21
11082286|NCT01128946|12264947|FG000|COMPLETED|Period I||20
11082287|NCT01128946|12264948|FG001|COMPLETED|Period I||20
11082288|NCT01128946|12264949|FG002|COMPLETED|Period I||20
11082289|NCT01128946|12264950|FG003|COMPLETED|Period I||20
11082290|NCT01128946|12264947|FG000|NOT COMPLETED|Period I||0
11082291|NCT01128946|12264948|FG001|NOT COMPLETED|Period I||1
11082292|NCT01128946|12264949|FG002|NOT COMPLETED|Period I||1
11082293|NCT01128946|12264950|FG003|NOT COMPLETED|Period I||1
11082294|NCT01128946|12264947|FG000|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
11082295|NCT01128946|12264948|FG001|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
11082296|NCT01128946|12264949|FG002|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
11082297|NCT01128946|12264950|FG003|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
11082298|NCT01128946|12264947|FG000|COMPLETED|Period II||20
11082299|NCT01128946|12264948|FG001|COMPLETED|Period II||19
11082300|NCT01128946|12264949|FG002|COMPLETED|Period II||20
11082301|NCT01128946|12264950|FG003|COMPLETED|Period II||19
11082302|NCT01128946|12264947|FG000|NOT COMPLETED|Period II||0
11082303|NCT01128946|12264948|FG001|NOT COMPLETED|Period II||1
11082304|NCT01128946|12264949|FG002|NOT COMPLETED|Period II||0
11082305|NCT01128946|12264950|FG003|NOT COMPLETED|Period II||1
11082306|NCT01128946|12264947|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
11082307|NCT01128946|12264948|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
11082308|NCT01128946|12264949|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
11082309|NCT01128946|12264950|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
11082310|NCT01128946|12264947|FG000|COMPLETED|Period III||19
11082311|NCT01128946|12264948|FG001|COMPLETED|Period III||19
11082312|NCT01128946|12264949|FG002|COMPLETED|Period III||20
11082313|NCT01128946|12264950|FG003|COMPLETED|Period III||19
11082314|NCT01128946|12264947|FG000|NOT COMPLETED|Period III||1
11082315|NCT01128946|12264948|FG001|NOT COMPLETED|Period III||0
11082316|NCT01128946|12264949|FG002|NOT COMPLETED|Period III||0
11082317|NCT01128946|12264950|FG003|NOT COMPLETED|Period III||0
11082318|NCT01128946|12264947|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
11082319|NCT01128946|12264948|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
11082320|NCT01128946|12264949|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
11082321|NCT01128946|12264950|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
11082322|NCT01128946|12264947|FG000|COMPLETED|Period IV||19
11082323|NCT01128946|12264948|FG001|COMPLETED|Period IV||20
11082324|NCT01128946|12264949|FG002|COMPLETED|Period IV||19
11082325|NCT01128946|12264950|FG003|COMPLETED|Period IV||19
11082326|NCT01128946|12264947|FG000|NOT COMPLETED|Period IV||0
11082327|NCT01128946|12264948|FG001|NOT COMPLETED|Period IV||0
11082328|NCT01128946|12264949|FG002|NOT COMPLETED|Period IV||0
11082329|NCT01128946|12264950|FG003|NOT COMPLETED|Period IV||0
11082330|NCT01128959|12264961|FG000|STARTED|Lead in Period||108
11082331|NCT01128959|12264961|FG000|COMPLETED|Lead in Period||105
11082332|NCT01128959|12264961|FG000|NOT COMPLETED|Lead in Period||3
11082333|NCT01128959|12264961|FG000|STARTED|Treatment Period||105
11082334|NCT01128959|12264961|FG000|COMPLETED|Treatment Period||101
11082335|NCT01128959|12264961|FG000|NOT COMPLETED|Treatment Period||4
11082336|NCT01128972|12264967|FG000|STARTED|Period I||7
11082337|NCT01128972|12264968|FG001|STARTED|Period I||7
11082338|NCT01128972|12264969|FG002|STARTED|Period I||7
11082339|NCT01128972|12264970|FG003|STARTED|Period I||7
11082340|NCT01128972|12264971|FG004|STARTED|Period I||8
11082341|NCT01128972|12264967|FG000|COMPLETED|Period I||7
11082342|NCT01128972|12264968|FG001|COMPLETED|Period I||7
11082343|NCT01128972|12264969|FG002|COMPLETED|Period I||7
11082344|NCT01128972|12264970|FG003|COMPLETED|Period I||7
11082345|NCT01128972|12264971|FG004|COMPLETED|Period I||8
11082346|NCT01128972|12264967|FG000|NOT COMPLETED|Period I||0
11082347|NCT01128972|12264968|FG001|NOT COMPLETED|Period I||0
11082348|NCT01128972|12264969|FG002|NOT COMPLETED|Period I||0
11082349|NCT01128972|12264970|FG003|NOT COMPLETED|Period I||0
11082350|NCT01128972|12264971|FG004|NOT COMPLETED|Period I||0
11082351|NCT01128972|12264967|FG000|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
11082352|NCT01128972|12264968|FG001|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
11082353|NCT01128972|12264969|FG002|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
11082354|NCT01128972|12264970|FG003|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
11082355|NCT01128972|12264971|FG004|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
11082356|NCT01128972|12264967|FG000|COMPLETED|Period II||7
11082357|NCT01128972|12264968|FG001|COMPLETED|Period II||7
11082358|NCT01128972|12264969|FG002|COMPLETED|Period II||7
11082359|NCT01128972|12264970|FG003|COMPLETED|Period II||8
11082360|NCT01128972|12264971|FG004|COMPLETED|Period II||7
11082361|NCT01128972|12264967|FG000|NOT COMPLETED|Period II||0
11082362|NCT01128972|12264968|FG001|NOT COMPLETED|Period II||0
11082363|NCT01128972|12264969|FG002|NOT COMPLETED|Period II||0
11082364|NCT01128972|12264970|FG003|NOT COMPLETED|Period II||0
11082365|NCT01128972|12264971|FG004|NOT COMPLETED|Period II||0
11082366|NCT01128972|12264967|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
11082367|NCT01128972|12264968|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
11082368|NCT01128972|12264969|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
11082369|NCT01128972|12264970|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
11082370|NCT01128972|12264971|FG004|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
11082371|NCT01128972|12264967|FG000|COMPLETED|Period III||7
11082372|NCT01128972|12264968|FG001|COMPLETED|Period III||7
11082373|NCT01128972|12264969|FG002|COMPLETED|Period III||8
11082374|NCT01128972|12264970|FG003|COMPLETED|Period III||7
11082375|NCT01128972|12264971|FG004|COMPLETED|Period III||7
11082376|NCT01128972|12264967|FG000|NOT COMPLETED|Period III||0
11082377|NCT01128972|12264968|FG001|NOT COMPLETED|Period III||0
11082378|NCT01128972|12264969|FG002|NOT COMPLETED|Period III||0
11082379|NCT01128972|12264970|FG003|NOT COMPLETED|Period III||0
11082380|NCT01128972|12264971|FG004|NOT COMPLETED|Period III||0
11082381|NCT01128972|12264967|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
11349837|NCT03019549|12546785|FG000|NOT COMPLETED|Washout||11
11082382|NCT01128972|12264968|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
11082383|NCT01128972|12264969|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
11082384|NCT01128972|12264970|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
11082385|NCT01128972|12264971|FG004|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
11082386|NCT01128972|12264967|FG000|COMPLETED|Period IV||7
11082387|NCT01128972|12264968|FG001|COMPLETED|Period IV||8
11082388|NCT01128972|12264969|FG002|COMPLETED|Period IV||7
11082389|NCT01128972|12264970|FG003|COMPLETED|Period IV||7
11082390|NCT01128972|12264971|FG004|COMPLETED|Period IV||7
11082391|NCT01128972|12264967|FG000|NOT COMPLETED|Period IV||0
11082392|NCT01128972|12264968|FG001|NOT COMPLETED|Period IV||0
11082393|NCT01128972|12264969|FG002|NOT COMPLETED|Period IV||0
11082394|NCT01128972|12264970|FG003|NOT COMPLETED|Period IV||0
11082395|NCT01128972|12264971|FG004|NOT COMPLETED|Period IV||0
11082396|NCT01128972|12264967|FG000|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
11082397|NCT01128972|12264968|FG001|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
11082398|NCT01128972|12264969|FG002|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
11082399|NCT01128972|12264970|FG003|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
11082400|NCT01128972|12264971|FG004|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
11082401|NCT01128972|12264967|FG000|COMPLETED|Period V||8
11082402|NCT01128972|12264968|FG001|COMPLETED|Period V||7
11082403|NCT01128972|12264969|FG002|COMPLETED|Period V||7
11082404|NCT01128972|12264970|FG003|COMPLETED|Period V||7
11082405|NCT01128972|12264971|FG004|COMPLETED|Period V||7
11082406|NCT01128972|12264967|FG000|NOT COMPLETED|Period V||0
11082407|NCT01128972|12264968|FG001|NOT COMPLETED|Period V||0
11349838|NCT03019549|12546785|FG000|STARTED|Period 2||31
11349839|NCT03019549|12546785|FG000|Received at Least 1 Dose of Study Drug|Period 2||29
11349840|NCT03019549|12546785|FG000|COMPLETED|Period 2||26
11349841|NCT03019549|12546785|FG000|NOT COMPLETED|Period 2||5
11349842|NCT03019627|12546796|FG000|STARTED|Overall Study||100
11349843|NCT03019627|12546797|FG001|STARTED|Overall Study||50
11349844|NCT03019627|12546796|FG000|COMPLETED|Overall Study||85
11349845|NCT03019627|12546797|FG001|COMPLETED|Overall Study||42
11349846|NCT03019627|12546796|FG000|NOT COMPLETED|Overall Study||15
11349847|NCT03019627|12546797|FG001|NOT COMPLETED|Overall Study||8
11349848|NCT03019744|12546805|FG000|STARTED|Overall Study||38
11349849|NCT03019744|12546806|FG001|STARTED|Overall Study||44
11349850|NCT03019744|12546805|FG000|COMPLETED|Overall Study||32
11349851|NCT03019744|12546806|FG001|COMPLETED|Overall Study||36
11349852|NCT03019744|12546805|FG000|NOT COMPLETED|Overall Study||6
11349853|NCT03019744|12546806|FG001|NOT COMPLETED|Overall Study||8
11349854|NCT03019783|12546814|FG000|STARTED|Overall Study||29
11349855|NCT03019783|12546815|FG001|STARTED|Overall Study||31
11349856|NCT03019783|12546814|FG000|COMPLETED|Overall Study||29
11349857|NCT03019783|12546815|FG001|COMPLETED|Overall Study||31
11349858|NCT03019783|12546814|FG000|NOT COMPLETED|Overall Study||0
11349859|NCT03019783|12546815|FG001|NOT COMPLETED|Overall Study||0
11349860|NCT03019796|12546821|FG000|STARTED|First Intervention Drug Tests||20
11349861|NCT03019796|12546822|FG001|STARTED|First Intervention Drug Tests||20
11349862|NCT03019796|12546821|FG000|COMPLETED|First Intervention Drug Tests||20
11349863|NCT03019796|12546822|FG001|COMPLETED|First Intervention Drug Tests||20
11082408|NCT01128972|12264969|FG002|NOT COMPLETED|Period V||0
11082409|NCT01128972|12264970|FG003|NOT COMPLETED|Period V||0
11082410|NCT01128972|12264971|FG004|NOT COMPLETED|Period V||0
11082411|NCT01129024|12264989|FG000|STARTED|Overall Study||19
11082412|NCT01129024|12264989|FG000|COMPLETED|Overall Study||0
11082413|NCT01129024|12264989|FG000|NOT COMPLETED|Overall Study||19
11082414|NCT01129102|12264996|FG000|STARTED|Overall Study||110
11082415|NCT01129102|12264997|FG001|STARTED|Overall Study||50
11082416|NCT01129102|12264998|FG002|STARTED|Overall Study||55
11082417|NCT01129102|12264996|FG000|COMPLETED|Overall Study||102
11082418|NCT01129102|12264997|FG001|COMPLETED|Overall Study||44
11349864|NCT03019796|12546821|FG000|NOT COMPLETED|First Intervention Drug Tests||0
11349865|NCT03019796|12546822|FG001|NOT COMPLETED|First Intervention Drug Tests||0
11349866|NCT03019796|12546821|FG000|STARTED|Second Intervention Training (4 Months)||20
11082419|NCT01129102|12264998|FG002|COMPLETED|Overall Study||48
11082420|NCT01129102|12264996|FG000|NOT COMPLETED|Overall Study||8
11082421|NCT01129102|12264997|FG001|NOT COMPLETED|Overall Study||6
11082422|NCT01129102|12264998|FG002|NOT COMPLETED|Overall Study||7
11207441|NCT01875978|12398615|FG001|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
11207442|NCT01875978|12398614|FG000|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
11207443|NCT01875978|12398615|FG001|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
11207444|NCT01875978|12398614|FG000|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
11207445|NCT01875978|12398615|FG001|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
11207446|NCT01875991|12398625|FG000|STARTED|Overall Study||108
11207447|NCT01875991|12398626|FG001|STARTED|Overall Study||109
11207448|NCT01875991|12398625|FG000|Received Etanercept in Period 1|Overall Study||108
11207449|NCT01875991|12398626|FG001|Received Etanercept in Period 1|Overall Study||108
11207450|NCT01875991|12398625|FG000|Received Etanercept in Period 2|Overall Study||102
11207451|NCT01875991|12398626|FG001|Received Etanercept in Period 2|Overall Study||103
11207452|NCT01875991|12398625|FG000|COMPLETED|Overall Study||101
11207453|NCT01875991|12398626|FG001|COMPLETED|Overall Study||103
11207454|NCT01875991|12398625|FG000|NOT COMPLETED|Overall Study||7
11207455|NCT01875991|12398626|FG001|NOT COMPLETED|Overall Study||6
11207456|NCT01876043|12398635|FG000|STARTED|Overall Study||24
11207457|NCT01876043|12398635|FG000|Interim Analysis Population|Overall Study||17
11207458|NCT01876043|12398635|FG000|COMPLETED|Overall Study||22
11207459|NCT01876043|12398635|FG000|NOT COMPLETED|Overall Study||2
11207460|NCT01876082|12398641|FG000|STARTED|Overall Study||48
11207461|NCT01876082|12398642|FG001|STARTED|Overall Study||24
11207462|NCT01876082|12398641|FG000|Safety Population|Overall Study||48
11207463|NCT01876082|12398642|FG001|Safety Population|Overall Study|2 patients did not start control treatment|22
11207464|NCT01876082|12398641|FG000|COMPLETED|Overall Study||46
11207465|NCT01876082|12398642|FG001|COMPLETED|Overall Study||20
11207466|NCT01876082|12398641|FG000|NOT COMPLETED|Overall Study||2
11207467|NCT01876082|12398642|FG001|NOT COMPLETED|Overall Study||4
11207468|NCT01876212|12398650|FG000|STARTED|Overall Study||9
11207469|NCT01876212|12398651|FG001|STARTED|Overall Study||6
11207470|NCT01876212|12398650|FG000|COMPLETED|Overall Study||9
11207471|NCT01876212|12398651|FG001|COMPLETED|Overall Study||6
11207472|NCT01876212|12398650|FG000|NOT COMPLETED|Overall Study||0
11207473|NCT01876212|12398651|FG001|NOT COMPLETED|Overall Study||0
11207474|NCT01876251|12398660|FG000|STARTED|Overall Study||15
11207475|NCT01876251|12398661|FG001|STARTED|Overall Study||3
11207476|NCT01876251|12398662|FG002|STARTED|Overall Study||11
11207477|NCT01876251|12398660|FG000|COMPLETED|Overall Study||0
11207478|NCT01876251|12398661|FG001|COMPLETED|Overall Study||0
11207479|NCT01876251|12398662|FG002|COMPLETED|Overall Study||0
11207480|NCT01876251|12398660|FG000|NOT COMPLETED|Overall Study||15
11207481|NCT01876251|12398661|FG001|NOT COMPLETED|Overall Study||3
11207482|NCT01876251|12398662|FG002|NOT COMPLETED|Overall Study||11
11207483|NCT01876329|12398674|FG000|STARTED|Overall Study||45
11207484|NCT01876329|12398675|FG001|STARTED|Overall Study||36
11207485|NCT01876329|12398676|FG002|STARTED|Overall Study||44
11207486|NCT01876329|12398674|FG000|COMPLETED|Overall Study||45
11207487|NCT01876329|12398675|FG001|COMPLETED|Overall Study||36
11207488|NCT01876329|12398676|FG002|COMPLETED|Overall Study||44
11207489|NCT01876329|12398674|FG000|NOT COMPLETED|Overall Study||0
11207490|NCT01876329|12398675|FG001|NOT COMPLETED|Overall Study||0
11207491|NCT01876329|12398676|FG002|NOT COMPLETED|Overall Study||0
11207492|NCT01876368|12398686|FG000|STARTED|Overall Study||188
11207493|NCT01876368|12398687|FG001|STARTED|Overall Study||188
11207494|NCT01876368|12398686|FG000|Full Analysis Set (FAS)|Overall Study||188
11207495|NCT01876368|12398687|FG001|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
11207496|NCT01876368|12398686|FG000|Safety Set (SAF)|Overall Study||188
11207497|NCT01876368|12398687|FG001|Safety Set (SAF)|Overall Study||187
11207498|NCT01876368|12398686|FG000|COMPLETED|Overall Study||179
11207499|NCT01876368|12398687|FG001|COMPLETED|Overall Study||175
11207500|NCT01876368|12398686|FG000|NOT COMPLETED|Overall Study||9
11207501|NCT01876368|12398687|FG001|NOT COMPLETED|Overall Study||13
11207502|NCT01876381|12398693|FG000|STARTED|Overall Study||23
11207503|NCT01876381|12398693|FG000|COMPLETED|Overall Study||16
11207504|NCT01876381|12398693|FG000|NOT COMPLETED|Overall Study||7
11207505|NCT01876420|12398697|FG000|STARTED|Overall Study||60
11207506|NCT01876420|12398697|FG000|COMPLETED|Overall Study||59
11207507|NCT01876420|12398697|FG000|NOT COMPLETED|Overall Study||1
11207508|NCT01876446|12398703|FG000|STARTED|Overall Study||20
11207509|NCT01876446|12398704|FG001|STARTED|Overall Study||18
11207510|NCT01876446|12398703|FG000|COMPLETED|Overall Study||18
11207511|NCT01876446|12398704|FG001|COMPLETED|Overall Study||12
11207512|NCT01876446|12398703|FG000|NOT COMPLETED|Overall Study||2
11207513|NCT01876446|12398704|FG001|NOT COMPLETED|Overall Study||6
11207514|NCT01876485|12398712|FG000|STARTED|Overall Study||140
11207515|NCT01876485|12398713|FG001|STARTED|Overall Study||140
11207516|NCT01876485|12398712|FG000|Post-Intervention|Overall Study||125
11207517|NCT01876485|12398713|FG001|Post-Intervention|Overall Study||129
11207518|NCT01876485|12398712|FG000|Maintenance|Overall Study||116
11207519|NCT01876485|12398713|FG001|Maintenance|Overall Study||114
11207520|NCT01876485|12398712|FG000|COMPLETED|Overall Study||116
11207521|NCT01876485|12398713|FG001|COMPLETED|Overall Study||114
11207522|NCT01876485|12398712|FG000|NOT COMPLETED|Overall Study||24
11082423|NCT01129115|12265009|FG000|STARTED|Overall Study||25
11082424|NCT01129115|12265010|FG001|STARTED|Overall Study||25
11082425|NCT01129115|12265011|FG002|STARTED|Overall Study||27
11082426|NCT01129115|12265012|FG003|STARTED|Overall Study||24
11082427|NCT01129115|12265009|FG000|COMPLETED|Overall Study||23
11082428|NCT01129115|12265010|FG001|COMPLETED|Overall Study||18
11082429|NCT01129115|12265011|FG002|COMPLETED|Overall Study||21
11082430|NCT01129115|12265012|FG003|COMPLETED|Overall Study||15
11082431|NCT01129115|12265009|FG000|NOT COMPLETED|Overall Study||2
11082432|NCT01129115|12265010|FG001|NOT COMPLETED|Overall Study||7
11082433|NCT01129115|12265011|FG002|NOT COMPLETED|Overall Study||6
11082434|NCT01129115|12265012|FG003|NOT COMPLETED|Overall Study||9
11082435|NCT01129128|12265025|FG000|STARTED|Overall Study||22
11082436|NCT01129128|12265026|FG001|STARTED|Overall Study||22
11082437|NCT01129128|12265027|FG002|STARTED|Overall Study||23
11082438|NCT01129128|12265025|FG000|COMPLETED|Overall Study||19
11082439|NCT01129128|12265026|FG001|COMPLETED|Overall Study||18
11082440|NCT01129128|12265027|FG002|COMPLETED|Overall Study||19
11082441|NCT01129128|12265025|FG000|NOT COMPLETED|Overall Study||3
11349867|NCT03019796|12546822|FG001|STARTED|Second Intervention Training (4 Months)||20
11349868|NCT03019796|12546821|FG000|COMPLETED|Second Intervention Training (4 Months)||19
11349869|NCT03019796|12546822|FG001|COMPLETED|Second Intervention Training (4 Months)||19
11349870|NCT03019796|12546821|FG000|NOT COMPLETED|Second Intervention Training (4 Months)||1
11349871|NCT03019796|12546822|FG001|NOT COMPLETED|Second Intervention Training (4 Months)||1
11349872|NCT03019796|12546821|FG000|STARTED|Third Intervention Drug Test||19
11082442|NCT01129128|12265026|FG001|NOT COMPLETED|Overall Study||4
11349873|NCT03019796|12546822|FG001|STARTED|Third Intervention Drug Test||19
11349874|NCT03019796|12546821|FG000|COMPLETED|Third Intervention Drug Test||19
11349875|NCT03019796|12546822|FG001|COMPLETED|Third Intervention Drug Test||19
11349876|NCT03019796|12546821|FG000|NOT COMPLETED|Third Intervention Drug Test||0
11349877|NCT03019796|12546822|FG001|NOT COMPLETED|Third Intervention Drug Test||0
11349878|NCT03019887|12546829|FG000|STARTED|Overall Study||139
11349879|NCT03019887|12546829|FG000|COMPLETED|Overall Study||130
11349880|NCT03019887|12546829|FG000|NOT COMPLETED|Overall Study||9
11349881|NCT03019939|12546833|FG000|STARTED|Overall Study||65
11082443|NCT01129128|12265027|FG002|NOT COMPLETED|Overall Study||4
11082444|NCT01129141|12265037|FG000|STARTED|Overall Study||101
11082445|NCT01129141|12265038|FG001|STARTED|Overall Study||104
11082446|NCT01129141|12265037|FG000|COMPLETED|Overall Study||86
11082447|NCT01129141|12265038|FG001|COMPLETED|Overall Study||91
11082448|NCT01129141|12265037|FG000|NOT COMPLETED|Overall Study||15
11082449|NCT01129141|12265038|FG001|NOT COMPLETED|Overall Study||13
11082450|NCT01129206|12265044|FG000|STARTED|Overall Study||6
11082451|NCT01129206|12265044|FG000|COMPLETED|Overall Study||6
11082452|NCT01129206|12265044|FG000|NOT COMPLETED|Overall Study||0
11082453|NCT01129245|12265053|FG000|STARTED|Control Cycle (no Celecoxib or Placebo)||10
11082454|NCT01129245|12265054|FG001|STARTED|Control Cycle (no Celecoxib or Placebo)||10
11082455|NCT01129245|12265053|FG000|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
11082456|NCT01129245|12265054|FG001|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
11082457|NCT01129245|12265053|FG000|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
11082458|NCT01129245|12265054|FG001|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
11082459|NCT01129245|12265053|FG000|STARTED|Treatment Cycle 1||10
11082460|NCT01129245|12265054|FG001|STARTED|Treatment Cycle 1||10
11082461|NCT01129245|12265053|FG000|COMPLETED|Treatment Cycle 1||10
11082462|NCT01129245|12265054|FG001|COMPLETED|Treatment Cycle 1||10
11082463|NCT01129245|12265053|FG000|NOT COMPLETED|Treatment Cycle 1||0
11082464|NCT01129245|12265054|FG001|NOT COMPLETED|Treatment Cycle 1||0
11349882|NCT03019939|12546833|FG000|COMPLETED|Overall Study||65
11349883|NCT03019939|12546833|FG000|NOT COMPLETED|Overall Study||0
11349884|NCT03019965|12546839|FG000|STARTED|Overall Study||211
11082465|NCT01129245|12265053|FG000|STARTED|Washout Cycle||10
11082466|NCT01129245|12265054|FG001|STARTED|Washout Cycle||10
11082467|NCT01129245|12265053|FG000|COMPLETED|Washout Cycle||10
11082468|NCT01129245|12265054|FG001|COMPLETED|Washout Cycle||10
11082469|NCT01129245|12265053|FG000|NOT COMPLETED|Washout Cycle||0
11082470|NCT01129245|12265054|FG001|NOT COMPLETED|Washout Cycle||0
11082471|NCT01129245|12265053|FG000|STARTED|Treatment Cycle 2||10
11082472|NCT01129245|12265054|FG001|STARTED|Treatment Cycle 2||10
11082473|NCT01129245|12265053|FG000|COMPLETED|Treatment Cycle 2||10
11082474|NCT01129245|12265054|FG001|COMPLETED|Treatment Cycle 2||10
11082475|NCT01129245|12265053|FG000|NOT COMPLETED|Treatment Cycle 2||0
11082476|NCT01129245|12265054|FG001|NOT COMPLETED|Treatment Cycle 2||0
11082477|NCT01129284|12265066|FG000|STARTED|Overall Study||5
11082478|NCT01129284|12265067|FG001|STARTED|Overall Study||5
11082479|NCT01129284|12265068|FG002|STARTED|Overall Study||5
11082480|NCT01129284|12265066|FG000|COMPLETED|Overall Study||3
11082481|NCT01129284|12265067|FG001|COMPLETED|Overall Study||5
11082482|NCT01129284|12265068|FG002|COMPLETED|Overall Study||4
11082483|NCT01129284|12265066|FG000|NOT COMPLETED|Overall Study||2
11082484|NCT01129284|12265067|FG001|NOT COMPLETED|Overall Study||0
11082485|NCT01129284|12265068|FG002|NOT COMPLETED|Overall Study||1
11082486|NCT01129336|12265078|FG000|STARTED|Overall Study||15
11082487|NCT01129336|12265079|FG001|STARTED|Overall Study||29
11349885|NCT03019965|12546840|FG001|STARTED|Overall Study||215
11349886|NCT03019965|12546839|FG000|COMPLETED|Overall Study||201
11349887|NCT03019965|12546840|FG001|COMPLETED|Overall Study||202
11349888|NCT03019965|12546839|FG000|NOT COMPLETED|Overall Study||10
11349889|NCT03019965|12546840|FG001|NOT COMPLETED|Overall Study||13
11349890|NCT03020004|12546846|FG000|STARTED|Overall Study||70
11349891|NCT03020004|12546846|FG000|COMPLETED|Overall Study||69
11349892|NCT03020004|12546846|FG000|NOT COMPLETED|Overall Study||1
11349893|NCT03020069|12546852|FG000|STARTED|Overall Study||9
11349894|NCT03020069|12546853|FG001|STARTED|Overall Study||4
11349895|NCT03020069|12546852|FG000|COMPLETED|Overall Study||9
11349896|NCT03020069|12546853|FG001|COMPLETED|Overall Study||3
11349897|NCT03020069|12546852|FG000|NOT COMPLETED|Overall Study||0
11349898|NCT03020069|12546853|FG001|NOT COMPLETED|Overall Study||1
11349899|NCT03020082|12546859|FG000|STARTED|Overall Study||141
11349900|NCT03020082|12546859|FG000|COMPLETED|Overall Study||138
11349901|NCT03020082|12546859|FG000|NOT COMPLETED|Overall Study||3
11349902|NCT03020095|12546863|FG000|STARTED|Overall Study||38
11349903|NCT03020095|12546863|FG000|COMPLETED|Overall Study||37
11349904|NCT03020095|12546863|FG000|NOT COMPLETED|Overall Study||1
11349905|NCT03020407|12546869|FG000|STARTED|Overall Study||105
11349906|NCT03020407|12546870|FG001|STARTED|Overall Study||106
11349907|NCT03020407|12546869|FG000|COMPLETED|Overall Study||101
11349908|NCT03020407|12546870|FG001|COMPLETED|Overall Study||101
11349909|NCT03020407|12546869|FG000|NOT COMPLETED|Overall Study||4
11349910|NCT03020407|12546870|FG001|NOT COMPLETED|Overall Study||5
11349911|NCT03020472|12546876|FG000|STARTED|Overall Study||6
11349912|NCT03020472|12546876|FG000|COMPLETED|Overall Study||6
11082488|NCT01129336|12265078|FG000|Completed Treatment|Overall Study||1
11082489|NCT01129336|12265079|FG001|Completed Treatment|Overall Study||3
11082490|NCT01129336|12265078|FG000|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
11082491|NCT01129336|12265079|FG001|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
11082492|NCT01129336|12265078|FG000|NOT COMPLETED|Overall Study||12
11082493|NCT01129336|12265079|FG001|NOT COMPLETED|Overall Study||16
11082494|NCT01129440|12265087|FG000|STARTED|Overall Study||297
11082495|NCT01129440|12265088|FG001|STARTED|Overall Study||300
11082496|NCT01129440|12265087|FG000|12 Month Follow-up|Overall Study||249
11082497|NCT01129440|12265088|FG001|12 Month Follow-up|Overall Study||256
11082498|NCT01129440|12265087|FG000|24 Month Follow-up|Overall Study||239
11082499|NCT01129440|12265088|FG001|24 Month Follow-up|Overall Study||258
11082500|NCT01129440|12265087|FG000|COMPLETED|Overall Study||246
11082501|NCT01129440|12265088|FG001|COMPLETED|Overall Study||258
11082502|NCT01129440|12265087|FG000|NOT COMPLETED|Overall Study||51
11082503|NCT01129440|12265088|FG001|NOT COMPLETED|Overall Study||42
11082504|NCT01129531|12265098|FG000|STARTED|Treatment Cycle 1||84
11082505|NCT01129531|12265099|FG001|STARTED|Treatment Cycle 1||84
11082506|NCT01129531|12265100|FG002|STARTED|Treatment Cycle 1||126
11082507|NCT01129531|12265098|FG000|COMPLETED|Treatment Cycle 1||80
11082508|NCT01129531|12265099|FG001|COMPLETED|Treatment Cycle 1||78
11082509|NCT01129531|12265100|FG002|COMPLETED|Treatment Cycle 1||110
11082510|NCT01129531|12265098|FG000|NOT COMPLETED|Treatment Cycle 1||4
11082511|NCT01129531|12265099|FG001|NOT COMPLETED|Treatment Cycle 1||6
11082512|NCT01129531|12265100|FG002|NOT COMPLETED|Treatment Cycle 1||16
11082513|NCT01129531|12265098|FG000|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
11082514|NCT01129531|12265099|FG001|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
11207523|NCT01876485|12398713|FG001|NOT COMPLETED|Overall Study||26
11207524|NCT01876511|12398722|FG000|STARTED|Overall Study||41
11207525|NCT01876511|12398723|FG001|STARTED|Overall Study||25
11207526|NCT01876511|12398724|FG002|STARTED|Overall Study||47
11207527|NCT01876511|12398722|FG000|Stages 1 and 2|Overall Study||24
11207528|NCT01876511|12398723|FG001|Stages 1 and 2|Overall Study||25
11207529|NCT01876511|12398724|FG002|Stages 1 and 2|Overall Study||21
11207530|NCT01876511|12398722|FG000|COMPLETED|Overall Study||18
11207531|NCT01876511|12398723|FG001|COMPLETED|Overall Study||0
11207532|NCT01876511|12398724|FG002|COMPLETED|Overall Study||16
11207533|NCT01876511|12398722|FG000|NOT COMPLETED|Overall Study||23
11207534|NCT01876511|12398723|FG001|NOT COMPLETED|Overall Study||25
11207535|NCT01876511|12398724|FG002|NOT COMPLETED|Overall Study||31
11207536|NCT01876706|12398734|FG000|STARTED|Overall Study||51
11207537|NCT01876706|12398734|FG000|1 Month|Overall Study||51
11207538|NCT01876706|12398734|FG000|3 Months|Overall Study||51
11207539|NCT01876706|12398734|FG000|6 Months|Overall Study||46
11207540|NCT01876706|12398734|FG000|12 Months|Overall Study||42
11207541|NCT01876706|12398734|FG000|24 Months|Overall Study||35
11207542|NCT01876706|12398734|FG000|36 Months|Overall Study||32
11207543|NCT01876706|12398734|FG000|48 Months|Overall Study||31
11207544|NCT01876706|12398734|FG000|60 Months|Overall Study||26
11207545|NCT01876706|12398734|FG000|COMPLETED|Overall Study||26
11207546|NCT01876706|12398734|FG000|NOT COMPLETED|Overall Study||25
11207547|NCT01876732|12398738|FG000|STARTED|Overall Study||132
11207548|NCT01876732|12398738|FG000|COMPLETED|Overall Study||57
11207549|NCT01876732|12398738|FG000|NOT COMPLETED|Overall Study||75
11082515|NCT01129531|12265100|FG002|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
11082516|NCT01129531|12265098|FG000|COMPLETED|Treatment Cycle 2||88
11082517|NCT01129531|12265099|FG001|COMPLETED|Treatment Cycle 2||92
11082518|NCT01129531|12265100|FG002|COMPLETED|Treatment Cycle 2||74
11082519|NCT01129531|12265098|FG000|NOT COMPLETED|Treatment Cycle 2||6
11082520|NCT01129531|12265099|FG001|NOT COMPLETED|Treatment Cycle 2||3
11082521|NCT01129531|12265100|FG002|NOT COMPLETED|Treatment Cycle 2||5
11082522|NCT01129557|12265115|FG000|STARTED|Overall Study||15
11082523|NCT01129557|12265116|FG001|STARTED|Overall Study||17
11082524|NCT01129557|12265117|FG002|STARTED|Overall Study||14
11082525|NCT01129557|12265115|FG000|COMPLETED|Overall Study||11
11082526|NCT01129557|12265116|FG001|COMPLETED|Overall Study||12
11082527|NCT01129557|12265117|FG002|COMPLETED|Overall Study||10
11082528|NCT01129557|12265115|FG000|NOT COMPLETED|Overall Study||4
11082529|NCT01129557|12265116|FG001|NOT COMPLETED|Overall Study||5
11082530|NCT01129557|12265117|FG002|NOT COMPLETED|Overall Study||4
11082531|NCT01129583|12265138|FG000|STARTED|Overall Study||9
11082532|NCT01129583|12265139|FG001|STARTED|Overall Study||9
11082533|NCT01129583|12265138|FG000|COMPLETED|Overall Study||6
11082534|NCT01129583|12265139|FG001|COMPLETED|Overall Study||7
11082535|NCT01129583|12265138|FG000|NOT COMPLETED|Overall Study||3
11082536|NCT01129583|12265139|FG001|NOT COMPLETED|Overall Study||2
11082537|NCT01129609|12265145|FG000|STARTED|Overall Study||20
11082538|NCT01129609|12265145|FG000|COMPLETED|Overall Study||18
11082539|NCT01129609|12265145|FG000|NOT COMPLETED|Overall Study||2
11082540|NCT01129622|12265149|FG000|STARTED|Overall Study||16
11082541|NCT01129622|12265149|FG000|COMPLETED|Overall Study||14
11082542|NCT01129622|12265149|FG000|NOT COMPLETED|Overall Study||2
11082543|NCT01129765|12265154|FG000|STARTED|Overall Study||30
11082544|NCT01129765|12265154|FG000|COMPLETED|Overall Study||30
11082545|NCT01129765|12265154|FG000|NOT COMPLETED|Overall Study||0
11082546|NCT01129778|12265158|FG000|STARTED|Overall Study||22
11082547|NCT01129778|12265158|FG000|COMPLETED|Overall Study||15
11082548|NCT01129778|12265158|FG000|NOT COMPLETED|Overall Study||7
11082549|NCT01129804|12265164|FG000|STARTED|Overall Study||96
11082550|NCT01129804|12265165|FG001|STARTED|Overall Study||97
11082551|NCT01129804|12265164|FG000|COMPLETED|Overall Study||64
11082552|NCT01129804|12265165|FG001|COMPLETED|Overall Study||66
11082553|NCT01129804|12265164|FG000|NOT COMPLETED|Overall Study||32
11082554|NCT01129804|12265165|FG001|NOT COMPLETED|Overall Study||31
11082555|NCT01129882|12265171|FG000|STARTED|Overall Study||709
11082556|NCT01129882|12265171|FG000|Received at Least 1 Dose of Study Drug|Overall Study||709
11082557|NCT01129882|12265171|FG000|COMPLETED|Overall Study||431
11082558|NCT01129882|12265171|FG000|NOT COMPLETED|Overall Study||278
11082559|NCT01129921|12265177|FG000|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
11082560|NCT01129921|12265178|FG001|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
11082561|NCT01129921|12265177|FG000|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
11082562|NCT01129921|12265178|FG001|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
11082563|NCT01129921|12265177|FG000|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
11082564|NCT01129921|12265178|FG001|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
11082565|NCT01129921|12265177|FG000|STARTED|After Sham Cross-over to Mild, One Year||20
11082566|NCT01129921|12265178|FG001|STARTED|After Sham Cross-over to Mild, One Year||20
11082567|NCT01129921|12265177|FG000|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
11082568|NCT01129921|12265178|FG001|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
11082569|NCT01129921|12265177|FG000|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
11082570|NCT01129921|12265178|FG001|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
11082571|NCT01129960|12265192|FG000|STARTED|Overall Study||84
11207550|NCT01876784|12398745|FG000|STARTED|Overall Study||119
11207551|NCT01876784|12398746|FG001|STARTED|Overall Study||119
11207552|NCT01876784|12398745|FG000|Treated|Overall Study||117
11207553|NCT01876784|12398746|FG001|Treated|Overall Study||118
11207554|NCT01876784|12398745|FG000|COMPLETED|Overall Study||0
11207555|NCT01876784|12398746|FG001|COMPLETED|Overall Study||0
11207556|NCT01876784|12398745|FG000|NOT COMPLETED|Overall Study||119
11207557|NCT01876784|12398746|FG001|NOT COMPLETED|Overall Study||119
11207558|NCT01876810|12398752|FG000|STARTED|Overall Study||14
11207559|NCT01876810|12398753|FG001|STARTED|Overall Study||14
11207560|NCT01876810|12398752|FG000|COMPLETED|Overall Study||14
11207561|NCT01876810|12398753|FG001|COMPLETED|Overall Study||13
11207562|NCT01876810|12398752|FG000|NOT COMPLETED|Overall Study||0
11207563|NCT01876810|12398753|FG001|NOT COMPLETED|Overall Study||1
11207564|NCT01876823|12398762|FG000|STARTED|Overall Study||35
11207565|NCT01876823|12398762|FG000|COMPLETED|Overall Study||26
11082572|NCT01129960|12265193|FG001|STARTED|Overall Study||83
11082573|NCT01129960|12265194|FG002|STARTED|Overall Study||82
11082574|NCT01129960|12265195|FG003|STARTED|Overall Study||83
11207566|NCT01876823|12398762|FG000|NOT COMPLETED|Overall Study||9
11082575|NCT01129960|12265192|FG000|Safety|Overall Study||84
11082576|NCT01129960|12265193|FG001|Safety|Overall Study||83
11082577|NCT01129960|12265194|FG002|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
11082578|NCT01129960|12265195|FG003|Safety|Overall Study||82
11082579|NCT01129960|12265192|FG000|Intent-to-Treat|Overall Study||84
11082580|NCT01129960|12265193|FG001|Intent-to-Treat|Overall Study||83
11082581|NCT01129960|12265194|FG002|Intent-to-Treat|Overall Study||82
11082582|NCT01129960|12265195|FG003|Intent-to-Treat|Overall Study||83
11082583|NCT01129960|12265192|FG000|Per-Protocol|Overall Study||34
11207567|NCT01876901|12398768|FG000|STARTED|Overall Study||65
11207568|NCT01876901|12398769|FG001|STARTED|Overall Study||59
11207569|NCT01876901|12398768|FG000|COMPLETED|Overall Study||48
11207570|NCT01876901|12398769|FG001|COMPLETED|Overall Study||52
11207571|NCT01876901|12398768|FG000|NOT COMPLETED|Overall Study||17
11207572|NCT01876901|12398769|FG001|NOT COMPLETED|Overall Study||7
11207573|NCT01876979|12398778|FG000|STARTED|Overall Study||2
11207574|NCT01876979|12398779|FG001|STARTED|Overall Study||3
11207575|NCT01876979|12398778|FG000|COMPLETED|Overall Study||0
11207576|NCT01876979|12398779|FG001|COMPLETED|Overall Study||0
11207577|NCT01876979|12398778|FG000|NOT COMPLETED|Overall Study||2
11207578|NCT01876979|12398779|FG001|NOT COMPLETED|Overall Study||3
11082584|NCT01129960|12265193|FG001|Per-Protocol|Overall Study||52
11082585|NCT01129960|12265194|FG002|Per-Protocol|Overall Study||49
11082586|NCT01129960|12265195|FG003|Per-Protocol|Overall Study||55
11082587|NCT01129960|12265192|FG000|Full Analysis Set (FAS|Overall Study||71
11082588|NCT01129960|12265193|FG001|Full Analysis Set (FAS|Overall Study||67
11082589|NCT01129960|12265194|FG002|Full Analysis Set (FAS|Overall Study||68
11082590|NCT01129960|12265195|FG003|Full Analysis Set (FAS|Overall Study||71
11082591|NCT01129960|12265192|FG000|COMPLETED|Overall Study||54
11082592|NCT01129960|12265193|FG001|COMPLETED|Overall Study||61
11082593|NCT01129960|12265194|FG002|COMPLETED|Overall Study||56
11082594|NCT01129960|12265195|FG003|COMPLETED|Overall Study||70
11082595|NCT01129960|12265192|FG000|NOT COMPLETED|Overall Study||30
11082596|NCT01129960|12265193|FG001|NOT COMPLETED|Overall Study||22
11082597|NCT01129960|12265194|FG002|NOT COMPLETED|Overall Study||26
11082598|NCT01129960|12265195|FG003|NOT COMPLETED|Overall Study||13
11082599|NCT01130051|12265205|FG000|STARTED|Period 1||8
11082600|NCT01130051|12265206|FG001|STARTED|Period 1||8
11082601|NCT01130051|12265205|FG000|COMPLETED|Period 1||8
11082602|NCT01130051|12265206|FG001|COMPLETED|Period 1||8
11082603|NCT01130051|12265205|FG000|NOT COMPLETED|Period 1||0
11082604|NCT01130051|12265206|FG001|NOT COMPLETED|Period 1||0
11082605|NCT01130051|12265205|FG000|STARTED|Washout Period of 14 Days||8
11082606|NCT01130051|12265206|FG001|STARTED|Washout Period of 14 Days||8
11082607|NCT01130051|12265205|FG000|COMPLETED|Washout Period of 14 Days||7
11082608|NCT01130051|12265206|FG001|COMPLETED|Washout Period of 14 Days||6
11082609|NCT01130051|12265205|FG000|NOT COMPLETED|Washout Period of 14 Days||1
11082610|NCT01130051|12265206|FG001|NOT COMPLETED|Washout Period of 14 Days||2
11082611|NCT01130051|12265205|FG000|STARTED|Period 2||7
11082612|NCT01130051|12265206|FG001|STARTED|Period 2||6
11349913|NCT03020472|12546876|FG000|NOT COMPLETED|Overall Study||0
11349914|NCT03020498|12546883|FG000|STARTED|Overall Study||14
11349915|NCT03020498|12546884|FG001|STARTED|Overall Study||41
11349916|NCT03020498|12546885|FG002|STARTED|Overall Study||36
11349917|NCT03020498|12546883|FG000|COMPLETED|Overall Study||14
11349918|NCT03020498|12546884|FG001|COMPLETED|Overall Study||38
11349919|NCT03020498|12546885|FG002|COMPLETED|Overall Study||36
11349920|NCT03020498|12546883|FG000|NOT COMPLETED|Overall Study||0
11082613|NCT01130051|12265205|FG000|COMPLETED|Period 2||7
11082614|NCT01130051|12265206|FG001|COMPLETED|Period 2||6
11082615|NCT01130051|12265205|FG000|NOT COMPLETED|Period 2||0
11082616|NCT01130051|12265206|FG001|NOT COMPLETED|Period 2||0
11082617|NCT01130103|12265214|FG000|STARTED|Randomized Treatment||19
11082618|NCT01130103|12265215|FG001|STARTED|Randomized Treatment||18
11082619|NCT01130103|12265214|FG000|COMPLETED|Randomized Treatment||13
11082620|NCT01130103|12265215|FG001|COMPLETED|Randomized Treatment||13
11082621|NCT01130103|12265214|FG000|NOT COMPLETED|Randomized Treatment||6
11082622|NCT01130103|12265215|FG001|NOT COMPLETED|Randomized Treatment||5
11082623|NCT01130103|12265214|FG000|STARTED|Maintenance Treatment||13
11082624|NCT01130103|12265215|FG001|STARTED|Maintenance Treatment||13
11082625|NCT01130103|12265214|FG000|COMPLETED|Maintenance Treatment||11
11082626|NCT01130103|12265215|FG001|COMPLETED|Maintenance Treatment||11
11082627|NCT01130103|12265214|FG000|NOT COMPLETED|Maintenance Treatment||2
11082628|NCT01130103|12265215|FG001|NOT COMPLETED|Maintenance Treatment||2
11082629|NCT01130168|12265221|FG000|STARTED|Period 1||6
11082630|NCT01130168|12265222|FG001|STARTED|Period 1||7
11082631|NCT01130168|12265223|FG002|STARTED|Period 1||6
11082632|NCT01130168|12265224|FG003|STARTED|Period 1||8
11082633|NCT01130168|12265225|FG004|STARTED|Period 1||5
11082634|NCT01130168|12265226|FG005|STARTED|Period 1||6
11082635|NCT01130168|12265221|FG000|COMPLETED|Period 1||6
11082636|NCT01130168|12265222|FG001|COMPLETED|Period 1||6
11082637|NCT01130168|12265223|FG002|COMPLETED|Period 1||5
11082638|NCT01130168|12265224|FG003|COMPLETED|Period 1||5
11349921|NCT03020498|12546884|FG001|NOT COMPLETED|Overall Study||3
11349922|NCT03020498|12546885|FG002|NOT COMPLETED|Overall Study||0
11082639|NCT01130168|12265225|FG004|COMPLETED|Period 1||5
11082640|NCT01130168|12265226|FG005|COMPLETED|Period 1||6
11082641|NCT01130168|12265221|FG000|NOT COMPLETED|Period 1||0
11082642|NCT01130168|12265222|FG001|NOT COMPLETED|Period 1||1
11082643|NCT01130168|12265223|FG002|NOT COMPLETED|Period 1||1
11082644|NCT01130168|12265224|FG003|NOT COMPLETED|Period 1||3
11082645|NCT01130168|12265225|FG004|NOT COMPLETED|Period 1||0
11082646|NCT01130168|12265226|FG005|NOT COMPLETED|Period 1||0
11082647|NCT01130168|12265221|FG000|STARTED|Period 2||6
11082648|NCT01130168|12265222|FG001|STARTED|Period 2||6
11082649|NCT01130168|12265223|FG002|STARTED|Period 2||5
11082650|NCT01130168|12265224|FG003|STARTED|Period 2||5
11082651|NCT01130168|12265225|FG004|STARTED|Period 2||5
11082652|NCT01130168|12265226|FG005|STARTED|Period 2||6
11082653|NCT01130168|12265221|FG000|COMPLETED|Period 2||6
11082654|NCT01130168|12265222|FG001|COMPLETED|Period 2||6
11082655|NCT01130168|12265223|FG002|COMPLETED|Period 2||5
11082656|NCT01130168|12265224|FG003|COMPLETED|Period 2||5
11082657|NCT01130168|12265225|FG004|COMPLETED|Period 2||5
11082658|NCT01130168|12265226|FG005|COMPLETED|Period 2||6
11082659|NCT01130168|12265221|FG000|NOT COMPLETED|Period 2||0
11082660|NCT01130168|12265222|FG001|NOT COMPLETED|Period 2||0
11082661|NCT01130168|12265223|FG002|NOT COMPLETED|Period 2||0
11082662|NCT01130168|12265224|FG003|NOT COMPLETED|Period 2||0
11082663|NCT01130168|12265225|FG004|NOT COMPLETED|Period 2||0
11082664|NCT01130168|12265226|FG005|NOT COMPLETED|Period 2||0
11082665|NCT01130168|12265221|FG000|STARTED|Period 3||6
11082666|NCT01130168|12265222|FG001|STARTED|Period 3||6
11082667|NCT01130168|12265223|FG002|STARTED|Period 3||5
11082668|NCT01130168|12265224|FG003|STARTED|Period 3||5
11082669|NCT01130168|12265225|FG004|STARTED|Period 3||5
11082670|NCT01130168|12265226|FG005|STARTED|Period 3||6
11082671|NCT01130168|12265221|FG000|COMPLETED|Period 3||6
11082672|NCT01130168|12265222|FG001|COMPLETED|Period 3||6
11082673|NCT01130168|12265223|FG002|COMPLETED|Period 3||5
11082674|NCT01130168|12265224|FG003|COMPLETED|Period 3||5
11082675|NCT01130168|12265225|FG004|COMPLETED|Period 3||5
11082676|NCT01130168|12265226|FG005|COMPLETED|Period 3||6
11082677|NCT01130168|12265221|FG000|NOT COMPLETED|Period 3||0
11082678|NCT01130168|12265222|FG001|NOT COMPLETED|Period 3||0
11082679|NCT01130168|12265223|FG002|NOT COMPLETED|Period 3||0
11082680|NCT01130168|12265224|FG003|NOT COMPLETED|Period 3||0
11082681|NCT01130168|12265225|FG004|NOT COMPLETED|Period 3||0
11082682|NCT01130168|12265226|FG005|NOT COMPLETED|Period 3||0
11082683|NCT01130272|12265240|FG000|STARTED|Overall Study||107
11082684|NCT01130272|12265241|FG001|STARTED|Overall Study||173
11082685|NCT01130272|12265242|FG002|STARTED|Overall Study||169
11082686|NCT01130272|12265243|FG003|STARTED|Overall Study||171
11082687|NCT01130272|12265244|FG004|STARTED|Overall Study||169
11082688|NCT01130272|12265240|FG000|Safety Analysis Set: as Randomized|Overall Study||105
11082689|NCT01130272|12265241|FG001|Safety Analysis Set: as Randomized|Overall Study||171
11082690|NCT01130272|12265242|FG002|Safety Analysis Set: as Randomized|Overall Study||166
11082691|NCT01130272|12265243|FG003|Safety Analysis Set: as Randomized|Overall Study||167
11082692|NCT01130272|12265244|FG004|Safety Analysis Set: as Randomized|Overall Study||162
11082693|NCT01130272|12265240|FG000|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105
11082694|NCT01130272|12265241|FG001|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170
11082695|NCT01130272|12265242|FG002|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165
11082696|NCT01130272|12265243|FG003|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172
11082697|NCT01130272|12265244|FG004|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159
11082698|NCT01130272|12265240|FG000|COMPLETED|Overall Study||48
11082699|NCT01130272|12265241|FG001|COMPLETED|Overall Study||131
11082700|NCT01130272|12265242|FG002|COMPLETED|Overall Study||121
11082701|NCT01130272|12265243|FG003|COMPLETED|Overall Study||103
11082702|NCT01130272|12265244|FG004|COMPLETED|Overall Study||117
11082703|NCT01130272|12265240|FG000|NOT COMPLETED|Overall Study||59
11082704|NCT01130272|12265241|FG001|NOT COMPLETED|Overall Study||42
11082705|NCT01130272|12265242|FG002|NOT COMPLETED|Overall Study||48
11082706|NCT01130272|12265243|FG003|NOT COMPLETED|Overall Study||68
11082707|NCT01130272|12265244|FG004|NOT COMPLETED|Overall Study||52
11082708|NCT01130337|12265256|FG000|STARTED|Overall Study||36
11082709|NCT01130337|12265256|FG000|COMPLETED|Overall Study||22
11082710|NCT01130337|12265256|FG000|NOT COMPLETED|Overall Study||14
11082711|NCT01130493|12265260|FG000|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
11082712|NCT01130493|12265261|FG001|STARTED|Open-label Dose Conversion to IPX066||0
11082713|NCT01130493|12265262|FG002|STARTED|Open-label Dose Conversion to IPX066||0
11082714|NCT01130493|12265260|FG000|COMPLETED|Open-label Dose Conversion to IPX066||91
11082715|NCT01130493|12265261|FG001|COMPLETED|Open-label Dose Conversion to IPX066||0
11082716|NCT01130493|12265262|FG002|COMPLETED|Open-label Dose Conversion to IPX066||0
11082717|NCT01130493|12265260|FG000|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
11082718|NCT01130493|12265261|FG001|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
11082719|NCT01130493|12265262|FG002|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
11082720|NCT01130493|12265260|FG000|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
11082721|NCT01130493|12265261|FG001|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
11082722|NCT01130493|12265262|FG002|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
11082723|NCT01130493|12265260|FG000|COMPLETED|Part 1: Double-blind Treatment Period 1||0
11082724|NCT01130493|12265261|FG001|COMPLETED|Part 1: Double-blind Treatment Period 1||46
11082725|NCT01130493|12265262|FG002|COMPLETED|Part 1: Double-blind Treatment Period 1||43
11082726|NCT01130493|12265260|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
11082727|NCT01130493|12265261|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
11082728|NCT01130493|12265262|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
11082729|NCT01130493|12265260|FG000|STARTED|Part 1: Open-Label IPX066 Washout||0
11082730|NCT01130493|12265261|FG001|STARTED|Part 1: Open-Label IPX066 Washout||46
11082731|NCT01130493|12265262|FG002|STARTED|Part 1: Open-Label IPX066 Washout||43
11082732|NCT01130493|12265260|FG000|COMPLETED|Part 1: Open-Label IPX066 Washout||0
11082733|NCT01130493|12265261|FG001|COMPLETED|Part 1: Open-Label IPX066 Washout||45
11082734|NCT01130493|12265262|FG002|COMPLETED|Part 1: Open-Label IPX066 Washout||41
11082735|NCT01130493|12265260|FG000|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
11082736|NCT01130493|12265261|FG001|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
11082737|NCT01130493|12265262|FG002|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
11082738|NCT01130493|12265260|FG000|STARTED|Part 1: Double-blind Treatment Period 2||0
11082739|NCT01130493|12265261|FG001|STARTED|Part 1: Double-blind Treatment Period 2||45
11082740|NCT01130493|12265262|FG002|STARTED|Part 1: Double-blind Treatment Period 2||41
11082741|NCT01130493|12265260|FG000|COMPLETED|Part 1: Double-blind Treatment Period 2||0
11082742|NCT01130493|12265261|FG001|COMPLETED|Part 1: Double-blind Treatment Period 2||45
11082743|NCT01130493|12265262|FG002|COMPLETED|Part 1: Double-blind Treatment Period 2||39
11082744|NCT01130493|12265260|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
11082745|NCT01130493|12265261|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
11082746|NCT01130493|12265262|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
11082747|NCT01130493|12265260|FG000|STARTED|Part 2: OLE||0
11082748|NCT01130493|12265261|FG001|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
11082749|NCT01130493|12265262|FG002|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
11082750|NCT01130493|12265260|FG000|COMPLETED|Part 2: OLE||0
11082751|NCT01130493|12265261|FG001|COMPLETED|Part 2: OLE||36
11082752|NCT01130493|12265262|FG002|COMPLETED|Part 2: OLE||30
11082753|NCT01130493|12265260|FG000|NOT COMPLETED|Part 2: OLE||0
11082754|NCT01130493|12265261|FG001|NOT COMPLETED|Part 2: OLE||3
11082755|NCT01130493|12265262|FG002|NOT COMPLETED|Part 2: OLE||5
11082756|NCT01130532|12265276|FG000|STARTED|Period III (Weeks 0-12)||207
11082757|NCT01130532|12265277|FG001|STARTED|Period III (Weeks 0-12)||207
11082758|NCT01130532|12265278|FG002|STARTED|Period III (Weeks 0-12)||209
11082759|NCT01130532|12265279|FG003|STARTED|Period III (Weeks 0-12)||0
11082760|NCT01130532|12265276|FG000|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
11082761|NCT01130532|12265277|FG001|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
11082762|NCT01130532|12265278|FG002|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
11082763|NCT01130532|12265279|FG003|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
11082764|NCT01130532|12265276|FG000|COMPLETED|Period III (Weeks 0-12)||186
11349923|NCT03020524|12546896|FG000|STARTED|Overall Study||3
11349924|NCT03020524|12546897|FG001|STARTED|Overall Study||3
11349925|NCT03020524|12546898|FG002|STARTED|Overall Study||3
11349926|NCT03020524|12546896|FG000|COMPLETED|Overall Study||3
11349927|NCT03020524|12546897|FG001|COMPLETED|Overall Study||3
11349928|NCT03020524|12546898|FG002|COMPLETED|Overall Study||3
11349929|NCT03020524|12546896|FG000|NOT COMPLETED|Overall Study||0
11349930|NCT03020524|12546897|FG001|NOT COMPLETED|Overall Study||0
11349931|NCT03020524|12546898|FG002|NOT COMPLETED|Overall Study||0
11349932|NCT03020537|12546908|FG000|STARTED|Overall Study||1
11349933|NCT03020537|12546909|FG001|STARTED|Overall Study||7
11082765|NCT01130532|12265277|FG001|COMPLETED|Period III (Weeks 0-12)||189
11082766|NCT01130532|12265278|FG002|COMPLETED|Period III (Weeks 0-12)||190
11082767|NCT01130532|12265279|FG003|COMPLETED|Period III (Weeks 0-12)||0
11082768|NCT01130532|12265276|FG000|NOT COMPLETED|Period III (Weeks 0-12)||21
11082769|NCT01130532|12265277|FG001|NOT COMPLETED|Period III (Weeks 0-12)||18
11349934|NCT03020537|12546908|FG000|COMPLETED|Overall Study||1
11082770|NCT01130532|12265278|FG002|NOT COMPLETED|Period III (Weeks 0-12)||19
11082771|NCT01130532|12265279|FG003|NOT COMPLETED|Period III (Weeks 0-12)||0
11082772|NCT01130532|12265276|FG000|STARTED|Period IV (Weeks 13-16)||0
11082773|NCT01130532|12265277|FG001|STARTED|Period IV (Weeks 13-16)||0
11349935|NCT03020537|12546909|FG001|COMPLETED|Overall Study||7
11082774|NCT01130532|12265278|FG002|STARTED|Period IV (Weeks 13-16)||0
11082775|NCT01130532|12265279|FG003|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
11082776|NCT01130532|12265276|FG000|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
11082777|NCT01130532|12265277|FG001|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
11082778|NCT01130532|12265278|FG002|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
11082779|NCT01130532|12265279|FG003|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
11082780|NCT01130532|12265276|FG000|COMPLETED|Period IV (Weeks 13-16)||0
11082781|NCT01130532|12265277|FG001|COMPLETED|Period IV (Weeks 13-16)||0
11082782|NCT01130532|12265278|FG002|COMPLETED|Period IV (Weeks 13-16)||0
11082783|NCT01130532|12265279|FG003|COMPLETED|Period IV (Weeks 13-16)||552
11082784|NCT01130532|12265276|FG000|NOT COMPLETED|Period IV (Weeks 13-16)||0
11082785|NCT01130532|12265277|FG001|NOT COMPLETED|Period IV (Weeks 13-16)||0
11082786|NCT01130532|12265278|FG002|NOT COMPLETED|Period IV (Weeks 13-16)||0
11082787|NCT01130532|12265279|FG003|NOT COMPLETED|Period IV (Weeks 13-16)||10
11082788|NCT01130597|12265291|FG000|STARTED|Overall Study||63
11082789|NCT01130597|12265291|FG000|COMPLETED|Overall Study||56
11082790|NCT01130597|12265291|FG000|NOT COMPLETED|Overall Study||7
11082791|NCT01130740|12265297|FG000|STARTED|Overall Study||149
11082792|NCT01130740|12265298|FG001|STARTED|Overall Study||151
11082793|NCT01130740|12265297|FG000|COMPLETED|Overall Study||137
11082794|NCT01130740|12265298|FG001|COMPLETED|Overall Study||136
11082795|NCT01130740|12265297|FG000|NOT COMPLETED|Overall Study||12
11082796|NCT01130740|12265298|FG001|NOT COMPLETED|Overall Study||15
11082797|NCT01130831|12265304|FG000|STARTED|Overall Study||66
11082798|NCT01130831|12265304|FG000|COMPLETED|Overall Study||52
11082799|NCT01130831|12265304|FG000|NOT COMPLETED|Overall Study||14
11082800|NCT01130844|12265323|FG000|STARTED|Overall Study||21
11082801|NCT01130844|12265324|FG001|STARTED|Overall Study||22
11082802|NCT01130844|12265325|FG002|STARTED|Overall Study||9
11082803|NCT01130844|12265323|FG000|COMPLETED|Overall Study||21
11082804|NCT01130844|12265324|FG001|COMPLETED|Overall Study||22
11082805|NCT01130844|12265325|FG002|COMPLETED|Overall Study||9
11082806|NCT01130844|12265323|FG000|NOT COMPLETED|Overall Study||0
11082807|NCT01130844|12265324|FG001|NOT COMPLETED|Overall Study||0
11082808|NCT01130844|12265325|FG002|NOT COMPLETED|Overall Study||0
11082809|NCT01130883|12265336|FG000|STARTED|Overall Study||3130
11082810|NCT01130883|12265336|FG000|Participants Analyzed|Overall Study||3128
11082811|NCT01130883|12265336|FG000|COMPLETED|Overall Study||3120
11082812|NCT01130883|12265336|FG000|NOT COMPLETED|Overall Study||10
11082813|NCT01130896|12265340|FG000|STARTED|Overall Study||1509
11082814|NCT01130896|12265340|FG000|COMPLETED|Overall Study||1509
11082815|NCT01130896|12265340|FG000|NOT COMPLETED|Overall Study||0
11082816|NCT01130974|12265346|FG000|STARTED|Overall Study||100
11082817|NCT01130974|12265347|FG001|STARTED|Overall Study||100
11082818|NCT01130974|12265346|FG000|COMPLETED|Overall Study||85
11082819|NCT01130974|12265347|FG001|COMPLETED|Overall Study||87
11082820|NCT01130974|12265346|FG000|NOT COMPLETED|Overall Study||15
11082821|NCT01130974|12265347|FG001|NOT COMPLETED|Overall Study||13
11082822|NCT01131052|12265356|FG000|STARTED|Overall Study||75
11082823|NCT01131052|12265357|FG001|STARTED|Overall Study||75
11082824|NCT01131052|12265356|FG000|COMPLETED|Overall Study||75
11082825|NCT01131052|12265357|FG001|COMPLETED|Overall Study||75
11082826|NCT01131052|12265356|FG000|NOT COMPLETED|Overall Study||0
11082827|NCT01131052|12265357|FG001|NOT COMPLETED|Overall Study||0
11082828|NCT01131065|12265363|FG000|STARTED|Overall Study||15
11082829|NCT01131065|12265363|FG000|COMPLETED|Overall Study||15
11082830|NCT01131065|12265363|FG000|NOT COMPLETED|Overall Study||0
11082831|NCT01131078|12265370|FG000|STARTED|Overall Study||101
11082832|NCT01131078|12265371|FG001|STARTED|Overall Study||102
11082833|NCT01131078|12265372|FG002|STARTED|Overall Study||103
11082834|NCT01131078|12265370|FG000|COMPLETED|Overall Study||0
11082835|NCT01131078|12265371|FG001|COMPLETED|Overall Study||1
11082836|NCT01131078|12265372|FG002|COMPLETED|Overall Study||1
11349936|NCT03020537|12546908|FG000|NOT COMPLETED|Overall Study||0
11349937|NCT03020537|12546909|FG001|NOT COMPLETED|Overall Study||0
11349938|NCT03020550|12546917|FG000|STARTED|Overall Study||8
11349939|NCT03020550|12546918|FG001|STARTED|Overall Study||16
11082837|NCT01131078|12265370|FG000|NOT COMPLETED|Overall Study||101
11082838|NCT01131078|12265371|FG001|NOT COMPLETED|Overall Study||101
11082839|NCT01131078|12265372|FG002|NOT COMPLETED|Overall Study||102
11082840|NCT01131104|12265382|FG000|STARTED|Overall Study||345
11082841|NCT01131104|12265382|FG000|Study Set|Overall Study||344
11082842|NCT01131104|12265382|FG000|Adjudication-Confirmed NAION Set|Overall Study||279
11082843|NCT01131104|12265382|FG000|30-Day Analysis Set|Overall Study||24
11082844|NCT01131104|12265382|FG000|42-Day Analysis Set|Overall Study||28
11082845|NCT01131104|12265382|FG000|12-Month Analysis Set|Overall Study||26
11082846|NCT01131104|12265382|FG000|COMPLETED|Overall Study||332
11082847|NCT01131104|12265382|FG000|NOT COMPLETED|Overall Study||13
11082848|NCT01131130|12265386|FG000|STARTED|Period 1 - Baseline||118
11082849|NCT01131130|12265386|FG000|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
11082850|NCT01131130|12265386|FG000|NOT COMPLETED|Period 1 - Baseline||1
11082851|NCT01131130|12265386|FG000|STARTED|Period 2 - Crossover||117
11082852|NCT01131130|12265386|FG000|COMPLETED|Period 2 - Crossover||117
11082853|NCT01131130|12265386|FG000|NOT COMPLETED|Period 2 - Crossover||0
11082854|NCT01131130|12265386|FG000|STARTED|Period 3- Crossover||117
11082855|NCT01131130|12265386|FG000|COMPLETED|Period 3- Crossover||116
11082856|NCT01131130|12265386|FG000|NOT COMPLETED|Period 3- Crossover||1
11082857|NCT01131260|12265396|FG000|STARTED|Overall Study||5532
11082858|NCT01131260|12265397|FG001|STARTED|Overall Study||5576
11082859|NCT01131260|12265396|FG000|COMPLETED|Overall Study||5488
11082860|NCT01131260|12265397|FG001|COMPLETED|Overall Study||5529
11082861|NCT01131260|12265396|FG000|NOT COMPLETED|Overall Study||44
11082862|NCT01131260|12265397|FG001|NOT COMPLETED|Overall Study||47
11082863|NCT01131299|12265405|FG000|STARTED|Overall Study||42
11082864|NCT01131299|12265406|FG001|STARTED|Overall Study||44
11349940|NCT03020550|12546917|FG000|COMPLETED|Overall Study||8
11349941|NCT03020550|12546918|FG001|COMPLETED|Overall Study||16
11349942|NCT03020550|12546917|FG000|NOT COMPLETED|Overall Study||0
11349943|NCT03020550|12546918|FG001|NOT COMPLETED|Overall Study||0
11349944|NCT03020576|12546926|FG000|STARTED|Overall Study||15
11082865|NCT01131299|12265405|FG000|COMPLETED|Overall Study||38
11082866|NCT01131299|12265406|FG001|COMPLETED|Overall Study||37
11082867|NCT01131299|12265405|FG000|NOT COMPLETED|Overall Study||4
11082868|NCT01131299|12265406|FG001|NOT COMPLETED|Overall Study||7
11082869|NCT01131312|12265414|FG000|STARTED|Overall Study||1839
11082870|NCT01131312|12265415|FG001|STARTED|Overall Study||1385
11082871|NCT01131312|12265416|FG002|STARTED|Overall Study||1836
11082872|NCT01131312|12265414|FG000|COMPLETED|Overall Study||1414
11082873|NCT01131312|12265415|FG001|COMPLETED|Overall Study||1156
11082874|NCT01131312|12265416|FG002|COMPLETED|Overall Study||1485
11082875|NCT01131312|12265414|FG000|NOT COMPLETED|Overall Study||425
11082876|NCT01131312|12265415|FG001|NOT COMPLETED|Overall Study||229
11082877|NCT01131312|12265416|FG002|NOT COMPLETED|Overall Study||351
11082878|NCT01131325|12265424|FG000|STARTED|Overall Study||3
11082879|NCT01131325|12265424|FG000|COMPLETED|Overall Study||0
11082880|NCT01131325|12265424|FG000|NOT COMPLETED|Overall Study||3
11082881|NCT01131351|12265430|FG000|STARTED|Overall Study||5
11082882|NCT01131351|12265431|FG001|STARTED|Overall Study||5
11082883|NCT01131351|12265430|FG000|COMPLETED|Overall Study||5
11082884|NCT01131351|12265431|FG001|COMPLETED|Overall Study||2
11082885|NCT01131351|12265430|FG000|NOT COMPLETED|Overall Study||0
11082886|NCT01131351|12265431|FG001|NOT COMPLETED|Overall Study||3
11082887|NCT01131494|12265437|FG000|STARTED|Overall Study||17
11082888|NCT01131494|12265437|FG000|COMPLETED|Overall Study||15
11082889|NCT01131494|12265437|FG000|NOT COMPLETED|Overall Study||2
11082890|NCT01131507|12265442|FG000|STARTED|Overall Study||15
11082891|NCT01131507|12265442|FG000|COMPLETED|Overall Study||12
11082892|NCT01131507|12265442|FG000|NOT COMPLETED|Overall Study||3
11082893|NCT01131520|12265448|FG000|STARTED|Overall Study||180
11082894|NCT01131520|12265449|FG001|STARTED|Overall Study||180
11082895|NCT01131520|12265448|FG000|COMPLETED|Overall Study||179
11082896|NCT01131520|12265449|FG001|COMPLETED|Overall Study||176
11082897|NCT01131520|12265448|FG000|NOT COMPLETED|Overall Study||1
11082898|NCT01131520|12265449|FG001|NOT COMPLETED|Overall Study||4
11082899|NCT01131585|12265457|FG000|STARTED|Overall Study||85
11082900|NCT01131585|12265458|FG001|STARTED|Overall Study||43
11082901|NCT01131585|12265457|FG000|COMPLETED|Overall Study||0
11082902|NCT01131585|12265458|FG001|COMPLETED|Overall Study||0
11082903|NCT01131585|12265457|FG000|NOT COMPLETED|Overall Study||85
11082904|NCT01131585|12265458|FG001|NOT COMPLETED|Overall Study||43
11082905|NCT01131676|12265467|FG000|STARTED|Discontinuation From Treatment|Randomised|2337
11082906|NCT01131676|12265468|FG001|STARTED|Discontinuation From Treatment|Randomised|2347
11082907|NCT01131676|12265469|FG002|STARTED|Discontinuation From Treatment|Randomised|2344
11082908|NCT01131676|12265467|FG000|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
11082909|NCT01131676|12265468|FG001|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
11082910|NCT01131676|12265469|FG002|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
11082911|NCT01131676|12265467|FG000|NOT COMPLETED|Discontinuation From Treatment||687
11082912|NCT01131676|12265468|FG001|NOT COMPLETED|Discontinuation From Treatment||557
11349945|NCT03020576|12546927|FG001|STARTED|Overall Study||16
11349946|NCT03020576|12546926|FG000|COMPLETED|Overall Study||14
11082913|NCT01131676|12265469|FG002|NOT COMPLETED|Discontinuation From Treatment||544
11082914|NCT01131676|12265467|FG000|STARTED|Discontinuation From Study (Treated Set)||2333
11082915|NCT01131676|12265468|FG001|STARTED|Discontinuation From Study (Treated Set)||2345
11082916|NCT01131676|12265469|FG002|STARTED|Discontinuation From Study (Treated Set)||2342
11082917|NCT01131676|12265467|FG000|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
11082918|NCT01131676|12265468|FG001|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
11082919|NCT01131676|12265469|FG002|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
11082920|NCT01131676|12265467|FG000|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
11082921|NCT01131676|12265468|FG001|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
11082922|NCT01131676|12265469|FG002|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
11082923|NCT01131676|12265467|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
11082924|NCT01131676|12265468|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
11082925|NCT01131676|12265469|FG002|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
11082926|NCT01132118|12265480|FG000|STARTED|First Intervention (8 Weeks)||15
11082927|NCT01132118|12265481|FG001|STARTED|First Intervention (8 Weeks)||15
11082928|NCT01132118|12265480|FG000|COMPLETED|First Intervention (8 Weeks)||12
11082929|NCT01132118|12265481|FG001|COMPLETED|First Intervention (8 Weeks)||12
11082930|NCT01132118|12265480|FG000|NOT COMPLETED|First Intervention (8 Weeks)||3
11082931|NCT01132118|12265481|FG001|NOT COMPLETED|First Intervention (8 Weeks)||3
11082932|NCT01132118|12265480|FG000|STARTED|Second Intervention (8 Weeks)||12
11082933|NCT01132118|12265481|FG001|STARTED|Second Intervention (8 Weeks)||12
11082934|NCT01132118|12265480|FG000|COMPLETED|Second Intervention (8 Weeks)||12
11082935|NCT01132118|12265481|FG001|COMPLETED|Second Intervention (8 Weeks)||11
11082936|NCT01132118|12265480|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
11082937|NCT01132118|12265481|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||1
11082938|NCT01132144|12265489|FG000|STARTED|Overall Study||79
11082939|NCT01132144|12265490|FG001|STARTED|Overall Study||79
11082940|NCT01132144|12265489|FG000|COMPLETED|Overall Study||79
11082941|NCT01132144|12265490|FG001|COMPLETED|Overall Study||79
11082942|NCT01132144|12265489|FG000|NOT COMPLETED|Overall Study||0
11082943|NCT01132144|12265490|FG001|NOT COMPLETED|Overall Study||0
11082944|NCT01132313|12265510|FG000|STARTED|Overall Study||17
11082945|NCT01132313|12265511|FG001|STARTED|Overall Study||17
11082946|NCT01132313|12265512|FG002|STARTED|Overall Study||81
11082947|NCT01132313|12265513|FG003|STARTED|Overall Study||80
11349947|NCT03020576|12546927|FG001|COMPLETED|Overall Study||14
11349948|NCT03020576|12546926|FG000|NOT COMPLETED|Overall Study||1
11349949|NCT03020576|12546927|FG001|NOT COMPLETED|Overall Study||2
11349950|NCT03020615|12546936|FG000|STARTED|Overall Study||26
11349951|NCT03020615|12546937|FG001|STARTED|Overall Study||25
11349952|NCT03020615|12546938|FG002|STARTED|Overall Study||7
11349953|NCT03020615|12546936|FG000|COMPLETED|Overall Study||19
11349954|NCT03020615|12546937|FG001|COMPLETED|Overall Study||23
11349955|NCT03020615|12546938|FG002|COMPLETED|Overall Study||0
11082948|NCT01132313|12265514|FG004|STARTED|Overall Study||79
11082949|NCT01132313|12265515|FG005|STARTED|Overall Study||79
11082950|NCT01132313|12265516|FG006|STARTED|Overall Study||49
11082951|NCT01132313|12265517|FG007|STARTED|Overall Study||32
11082952|NCT01132313|12265518|FG008|STARTED|Overall Study||26
11082953|NCT01132313|12265519|FG009|STARTED|Overall Study||25
11082954|NCT01132313|12265520|FG010|STARTED|Overall Study||1
11082955|NCT01132313|12265521|FG011|STARTED|Overall Study||2
11082956|NCT01132313|12265510|FG000|COMPLETED|Overall Study||14
11082957|NCT01132313|12265511|FG001|COMPLETED|Overall Study||17
11082958|NCT01132313|12265512|FG002|COMPLETED|Overall Study||61
11082959|NCT01132313|12265513|FG003|COMPLETED|Overall Study||48
11082960|NCT01132313|12265514|FG004|COMPLETED|Overall Study||34
11082961|NCT01132313|12265515|FG005|COMPLETED|Overall Study||54
11082962|NCT01132313|12265516|FG006|COMPLETED|Overall Study||19
11082963|NCT01132313|12265517|FG007|COMPLETED|Overall Study||24
11082964|NCT01132313|12265518|FG008|COMPLETED|Overall Study||5
11082965|NCT01132313|12265519|FG009|COMPLETED|Overall Study||5
11082966|NCT01132313|12265520|FG010|COMPLETED|Overall Study||0
11082967|NCT01132313|12265521|FG011|COMPLETED|Overall Study||2
11082968|NCT01132313|12265510|FG000|NOT COMPLETED|Overall Study||3
11082969|NCT01132313|12265511|FG001|NOT COMPLETED|Overall Study||0
11082970|NCT01132313|12265512|FG002|NOT COMPLETED|Overall Study||20
11082971|NCT01132313|12265513|FG003|NOT COMPLETED|Overall Study||32
11082972|NCT01132313|12265514|FG004|NOT COMPLETED|Overall Study||45
11082973|NCT01132313|12265515|FG005|NOT COMPLETED|Overall Study||25
11082974|NCT01132313|12265516|FG006|NOT COMPLETED|Overall Study||30
11082975|NCT01132313|12265517|FG007|NOT COMPLETED|Overall Study||8
11082976|NCT01132313|12265518|FG008|NOT COMPLETED|Overall Study||21
11349956|NCT03020615|12546936|FG000|NOT COMPLETED|Overall Study||7
11349957|NCT03020615|12546937|FG001|NOT COMPLETED|Overall Study||2
11082977|NCT01132313|12265519|FG009|NOT COMPLETED|Overall Study||20
11082978|NCT01132313|12265520|FG010|NOT COMPLETED|Overall Study||1
11082979|NCT01132313|12265521|FG011|NOT COMPLETED|Overall Study||0
11082980|NCT01132326|12265552|FG000|STARTED|Overall Study||350
11082981|NCT01132326|12265552|FG000|COMPLETED|Overall Study||132
11082982|NCT01132326|12265552|FG000|NOT COMPLETED|Overall Study||218
11082983|NCT01132378|12265556|FG000|STARTED|Overall Study||40
11082984|NCT01132378|12265556|FG000|COMPLETED|Overall Study||40
11082985|NCT01132378|12265556|FG000|NOT COMPLETED|Overall Study||0
11082986|NCT01132482|12265563|FG000|STARTED|Overall Study||13
11082987|NCT01132482|12265564|FG001|STARTED|Overall Study||6
11082988|NCT01132482|12265563|FG000|COMPLETED|Overall Study||12
11082989|NCT01132482|12265564|FG001|COMPLETED|Overall Study||6
11082990|NCT01132482|12265563|FG000|NOT COMPLETED|Overall Study||1
11082991|NCT01132482|12265564|FG001|NOT COMPLETED|Overall Study||0
11082992|NCT01132495|12265574|FG000|STARTED|Overall Study||447
11082993|NCT01132495|12265575|FG001|STARTED|Overall Study||441
11082994|NCT01132495|12265576|FG002|STARTED|Overall Study||166
11082995|NCT01132495|12265577|FG003|STARTED|Overall Study||116
11082996|NCT01132495|12265574|FG000|COMPLETED|Overall Study||407
11082997|NCT01132495|12265575|FG001|COMPLETED|Overall Study||403
11082998|NCT01132495|12265576|FG002|COMPLETED|Overall Study||146
11082999|NCT01132495|12265577|FG003|COMPLETED|Overall Study||104
11083000|NCT01132495|12265574|FG000|NOT COMPLETED|Overall Study||40
11083001|NCT01132495|12265575|FG001|NOT COMPLETED|Overall Study||38
11083002|NCT01132495|12265576|FG002|NOT COMPLETED|Overall Study||20
11083003|NCT01132495|12265577|FG003|NOT COMPLETED|Overall Study||12
11083004|NCT01132508|12265588|FG000|STARTED|Overall Study||33
11083005|NCT01132508|12265588|FG000|Treated at Baseline|Overall Study||33
11083006|NCT01132508|12265588|FG000|6 Weeks|Overall Study||33
11083007|NCT01132508|12265588|FG000|12 Weeks|Overall Study||33
11083008|NCT01132508|12265588|FG000|26 Weeks|Overall Study||33
11083009|NCT01132508|12265588|FG000|52 Weeks|Overall Study||30
11083010|NCT01132508|12265588|FG000|78 Weeks|Overall Study||28
11083011|NCT01132508|12265588|FG000|104 Weeks|Overall Study||27
11083012|NCT01132508|12265588|FG000|COMPLETED|Overall Study||24
11083013|NCT01132508|12265588|FG000|NOT COMPLETED|Overall Study||9
11083014|NCT01132547|12265594|FG000|STARTED|Overall Study||9
11083015|NCT01132547|12265595|FG001|STARTED|Overall Study||13
11083016|NCT01132547|12265594|FG000|COMPLETED|Overall Study||5
11083017|NCT01132547|12265595|FG001|COMPLETED|Overall Study||12
11083018|NCT01132547|12265594|FG000|NOT COMPLETED|Overall Study||4
11083019|NCT01132547|12265595|FG001|NOT COMPLETED|Overall Study||1
11083020|NCT01132612|12265604|FG000|STARTED|Overall Study||46
11083021|NCT01132612|12265605|FG001|STARTED|Overall Study||42
11083022|NCT01132612|12265606|FG002|STARTED|Overall Study||187
11083023|NCT01132612|12265604|FG000|COMPLETED|Overall Study||6
11083024|NCT01132612|12265605|FG001|COMPLETED|Overall Study||7
11083025|NCT01132612|12265606|FG002|COMPLETED|Overall Study||17
11083026|NCT01132612|12265604|FG000|NOT COMPLETED|Overall Study||40
11083027|NCT01132612|12265605|FG001|NOT COMPLETED|Overall Study||35
11083028|NCT01132612|12265606|FG002|NOT COMPLETED|Overall Study||170
11083029|NCT01132651|12265616|FG000|STARTED|Overall Study||4
11083030|NCT01132651|12265617|FG001|STARTED|Overall Study||5
11083031|NCT01132651|12265616|FG000|COMPLETED|Overall Study||3
11083032|NCT01132651|12265617|FG001|COMPLETED|Overall Study||4
11083033|NCT01132651|12265616|FG000|NOT COMPLETED|Overall Study||1
11083034|NCT01132651|12265617|FG001|NOT COMPLETED|Overall Study||1
11083035|NCT01132664|12265628|FG000|STARTED|Phase lb||5
11083036|NCT01132664|12265629|FG001|STARTED|Phase lb||12
11083037|NCT01132664|12265630|FG002|STARTED|Phase lb||0
11083038|NCT01132664|12265631|FG003|STARTED|Phase lb||0
11083039|NCT01132664|12265632|FG004|STARTED|Phase lb||0
11083040|NCT01132664|12265628|FG000|COMPLETED|Phase lb||0
11083041|NCT01132664|12265629|FG001|COMPLETED|Phase lb||0
11083042|NCT01132664|12265630|FG002|COMPLETED|Phase lb||0
11083043|NCT01132664|12265631|FG003|COMPLETED|Phase lb||0
11083044|NCT01132664|12265632|FG004|COMPLETED|Phase lb||0
11083045|NCT01132664|12265628|FG000|NOT COMPLETED|Phase lb||5
11083046|NCT01132664|12265629|FG001|NOT COMPLETED|Phase lb||12
11083047|NCT01132664|12265630|FG002|NOT COMPLETED|Phase lb||0
11083048|NCT01132664|12265631|FG003|NOT COMPLETED|Phase lb||0
11083049|NCT01132664|12265632|FG004|NOT COMPLETED|Phase lb||0
11083050|NCT01132664|12265628|FG000|STARTED|Phase ll||0
11083051|NCT01132664|12265629|FG001|STARTED|Phase ll||0
11083052|NCT01132664|12265630|FG002|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
11083053|NCT01132664|12265631|FG003|STARTED|Phase ll||0
11083054|NCT01132664|12265632|FG004|STARTED|Phase ll||0
11083055|NCT01132664|12265628|FG000|COMPLETED|Phase ll||0
11083056|NCT01132664|12265629|FG001|COMPLETED|Phase ll||0
11083057|NCT01132664|12265630|FG002|COMPLETED|Phase ll||0
11083058|NCT01132664|12265631|FG003|COMPLETED|Phase ll||0
11083059|NCT01132664|12265632|FG004|COMPLETED|Phase ll||0
11083060|NCT01132664|12265628|FG000|NOT COMPLETED|Phase ll||0
11083061|NCT01132664|12265629|FG001|NOT COMPLETED|Phase ll||0
11083062|NCT01132664|12265630|FG002|NOT COMPLETED|Phase ll||50
11083063|NCT01132664|12265631|FG003|NOT COMPLETED|Phase ll||0
11083064|NCT01132664|12265632|FG004|NOT COMPLETED|Phase ll||0
11083065|NCT01132664|12265628|FG000|STARTED|BM Cohort||0
11083066|NCT01132664|12265629|FG001|STARTED|BM Cohort||0
11083067|NCT01132664|12265630|FG002|STARTED|BM Cohort||0
11083068|NCT01132664|12265631|FG003|STARTED|BM Cohort||3
11083069|NCT01132664|12265632|FG004|STARTED|BM Cohort||6
11083070|NCT01132664|12265628|FG000|COMPLETED|BM Cohort||0
11083071|NCT01132664|12265629|FG001|COMPLETED|BM Cohort||0
11083072|NCT01132664|12265630|FG002|COMPLETED|BM Cohort||0
11083073|NCT01132664|12265631|FG003|COMPLETED|BM Cohort||0
11083074|NCT01132664|12265632|FG004|COMPLETED|BM Cohort||0
11083075|NCT01132664|12265628|FG000|NOT COMPLETED|BM Cohort||0
11083076|NCT01132664|12265629|FG001|NOT COMPLETED|BM Cohort||0
11083077|NCT01132664|12265630|FG002|NOT COMPLETED|BM Cohort||0
11083078|NCT01132664|12265631|FG003|NOT COMPLETED|BM Cohort||3
11083079|NCT01132664|12265632|FG004|NOT COMPLETED|BM Cohort||6
11083080|NCT01132690|12265646|FG000|STARTED|Overall Study||6
11083081|NCT01132690|12265647|FG001|STARTED|Overall Study||5
11083082|NCT01132690|12265646|FG000|COMPLETED|Overall Study||6
11083083|NCT01132690|12265647|FG001|COMPLETED|Overall Study||5
11083084|NCT01132690|12265646|FG000|NOT COMPLETED|Overall Study||0
11083085|NCT01132690|12265647|FG001|NOT COMPLETED|Overall Study||0
11083086|NCT01132755|12265653|FG000|STARTED|Overall Study||112
11083087|NCT01132755|12265653|FG000|COMPLETED|Overall Study||70
11083088|NCT01132755|12265653|FG000|NOT COMPLETED|Overall Study||42
11083089|NCT01132807|12265657|FG000|STARTED|Initial ABVD Treatment (2 Cycles)||15
11083090|NCT01132807|12265658|FG001|STARTED|Initial ABVD Treatment (2 Cycles)||135
11083091|NCT01132807|12265659|FG002|STARTED|Initial ABVD Treatment (2 Cycles)||14
11083092|NCT01132807|12265657|FG000|COMPLETED|Initial ABVD Treatment (2 Cycles)||0
11083093|NCT01132807|12265658|FG001|COMPLETED|Initial ABVD Treatment (2 Cycles)||135
11083094|NCT01132807|12265659|FG002|COMPLETED|Initial ABVD Treatment (2 Cycles)||14
11083095|NCT01132807|12265657|FG000|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||15
11083096|NCT01132807|12265658|FG001|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
11083097|NCT01132807|12265659|FG002|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
11083098|NCT01132807|12265657|FG000|STARTED|Post-Cycle 2 PET Assessment||0
11083099|NCT01132807|12265658|FG001|STARTED|Post-Cycle 2 PET Assessment||135
11083100|NCT01132807|12265659|FG002|STARTED|Post-Cycle 2 PET Assessment||14
11083101|NCT01132807|12265657|FG000|COMPLETED|Post-Cycle 2 PET Assessment||0
11083102|NCT01132807|12265658|FG001|COMPLETED|Post-Cycle 2 PET Assessment||135
11083103|NCT01132807|12265659|FG002|COMPLETED|Post-Cycle 2 PET Assessment||14
11083104|NCT01132807|12265657|FG000|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
11083105|NCT01132807|12265658|FG001|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
11083106|NCT01132807|12265659|FG002|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
11083107|NCT01132820|12265667|FG000|STARTED|Overall Study||53
11083108|NCT01132820|12265667|FG000|COMPLETED|Overall Study||48
11083109|NCT01132820|12265667|FG000|NOT COMPLETED|Overall Study||5
11083110|NCT01132846|12265674|FG000|STARTED|Overall Study||122
11083111|NCT01132846|12265675|FG001|STARTED|Overall Study||119
11083112|NCT01132846|12265676|FG002|STARTED|Overall Study||119
11083113|NCT01132846|12265674|FG000|COMPLETED|Overall Study||106
11083114|NCT01132846|12265675|FG001|COMPLETED|Overall Study||101
11083115|NCT01132846|12265676|FG002|COMPLETED|Overall Study||108
11083116|NCT01132846|12265674|FG000|NOT COMPLETED|Overall Study||16
11083117|NCT01132846|12265675|FG001|NOT COMPLETED|Overall Study||18
11083118|NCT01132846|12265676|FG002|NOT COMPLETED|Overall Study||11
11083119|NCT01133067|12265686|FG000|STARTED|Overall Study||200
11083120|NCT01133067|12265686|FG000|COMPLETED|Overall Study||61
11083121|NCT01133067|12265686|FG000|NOT COMPLETED|Overall Study||139
11083122|NCT01133158|12265690|FG000|STARTED|Overall Study||60
11083123|NCT01133158|12265690|FG000|COMPLETED|Overall Study||43
11083124|NCT01133158|12265690|FG000|NOT COMPLETED|Overall Study||17
11083125|NCT01133171|12265699|FG000|STARTED|Overall Study||25
11083126|NCT01133171|12265700|FG001|STARTED|Overall Study||27
11083127|NCT01133171|12265701|FG002|STARTED|Overall Study||25
11083128|NCT01133171|12265699|FG000|COMPLETED|Overall Study||24
11083129|NCT01133171|12265700|FG001|COMPLETED|Overall Study||25
11083130|NCT01133171|12265701|FG002|COMPLETED|Overall Study||25
11083131|NCT01133171|12265699|FG000|NOT COMPLETED|Overall Study||1
11083132|NCT01133171|12265700|FG001|NOT COMPLETED|Overall Study||2
11083133|NCT01133171|12265701|FG002|NOT COMPLETED|Overall Study||0
11083134|NCT01133275|12265709|FG000|STARTED|Overall Study||28
11083135|NCT01133275|12265709|FG000|COMPLETED|Overall Study||26
11083136|NCT01133275|12265709|FG000|NOT COMPLETED|Overall Study||2
11083137|NCT01133379|12265716|FG000|STARTED|Overall Study||58
11083138|NCT01133379|12265717|FG001|STARTED|Overall Study||58
11083139|NCT01133379|12265718|FG002|STARTED|Overall Study||58
11083140|NCT01133379|12265716|FG000|COMPLETED|Overall Study||57
11083141|NCT01133379|12265717|FG001|COMPLETED|Overall Study||56
11083142|NCT01133379|12265718|FG002|COMPLETED|Overall Study||56
11083143|NCT01133379|12265716|FG000|NOT COMPLETED|Overall Study||1
11083144|NCT01133379|12265717|FG001|NOT COMPLETED|Overall Study||2
11083145|NCT01133379|12265718|FG002|NOT COMPLETED|Overall Study||2
11083146|NCT01133392|12265728|FG000|STARTED|First Intervention (1 Day )||20
11083147|NCT01133392|12265729|FG001|STARTED|First Intervention (1 Day )||18
11083148|NCT01133392|12265728|FG000|COMPLETED|First Intervention (1 Day )||20
11083149|NCT01133392|12265729|FG001|COMPLETED|First Intervention (1 Day )||18
11083150|NCT01133392|12265728|FG000|NOT COMPLETED|First Intervention (1 Day )||0
11083151|NCT01133392|12265729|FG001|NOT COMPLETED|First Intervention (1 Day )||0
11083152|NCT01133392|12265728|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
11083153|NCT01133392|12265729|FG001|STARTED|Interval Between Dosing (4-7 Days)||18
11083154|NCT01133392|12265728|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
11083155|NCT01133392|12265729|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17
11083156|NCT01133392|12265728|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
11083157|NCT01133392|12265729|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
11083158|NCT01133392|12265728|FG000|STARTED|Second Intervention (1 Day)||20
11083159|NCT01133392|12265729|FG001|STARTED|Second Intervention (1 Day)||17
11083160|NCT01133392|12265728|FG000|COMPLETED|Second Intervention (1 Day)||20
11083161|NCT01133392|12265729|FG001|COMPLETED|Second Intervention (1 Day)||17
11083162|NCT01133392|12265728|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11083163|NCT01133392|12265729|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11083164|NCT01133392|12265728|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
11083165|NCT01133392|12265729|FG001|STARTED|Interval Between Dosing (4-7 Days)||17
11083166|NCT01133392|12265728|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
11083167|NCT01133392|12265729|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17
11083168|NCT01133392|12265728|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
11083169|NCT01133392|12265729|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
11083170|NCT01133392|12265728|FG000|STARTED|Third Intervention (1 Day)||20
11083171|NCT01133392|12265729|FG001|STARTED|Third Intervention (1 Day)||17
11083172|NCT01133392|12265728|FG000|COMPLETED|Third Intervention (1 Day)||20
11083173|NCT01133392|12265729|FG001|COMPLETED|Third Intervention (1 Day)||17
11083174|NCT01133392|12265728|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11083175|NCT01133392|12265729|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11083176|NCT01133392|12265728|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
11083177|NCT01133392|12265729|FG001|STARTED|Interval Between Dosing (4-7 Days)||17
11083178|NCT01133392|12265728|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
11083179|NCT01133392|12265729|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||16
11083180|NCT01133392|12265728|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
11083181|NCT01133392|12265729|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
11083182|NCT01133392|12265728|FG000|STARTED|Fourth Intervention (1 Day)||20
11083183|NCT01133392|12265729|FG001|STARTED|Fourth Intervention (1 Day)||16
11083184|NCT01133392|12265728|FG000|COMPLETED|Fourth Intervention (1 Day)||20
11083185|NCT01133392|12265729|FG001|COMPLETED|Fourth Intervention (1 Day)||16
11083186|NCT01133392|12265728|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
11083187|NCT01133392|12265729|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
11083188|NCT01133405|12265745|FG000|STARTED|Period 1||3
11083189|NCT01133405|12265746|FG001|STARTED|Period 1||6
11083190|NCT01133405|12265747|FG002|STARTED|Period 1||5
11083191|NCT01133405|12265748|FG003|STARTED|Period 1||5
11083192|NCT01133405|12265749|FG004|STARTED|Period 1||3
11083193|NCT01133405|12265750|FG005|STARTED|Period 1||5
11083194|NCT01133405|12265751|FG006|STARTED|Period 1||5
11083195|NCT01133405|12265752|FG007|STARTED|Period 1||2
11083196|NCT01133405|12265753|FG008|STARTED|Period 1||4
11083197|NCT01133405|12265754|FG009|STARTED|Period 1||2
11083198|NCT01133405|12265745|FG000|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2
11083199|NCT01133405|12265746|FG001|Safety Analysis Population|Period 1||6
11083200|NCT01133405|12265747|FG002|Safety Analysis Population|Period 1||5
11083201|NCT01133405|12265748|FG003|Safety Analysis Population|Period 1||5
11083202|NCT01133405|12265749|FG004|Safety Analysis Population|Period 1||3
11083203|NCT01133405|12265750|FG005|Safety Analysis Population|Period 1||5
11083204|NCT01133405|12265751|FG006|Safety Analysis Population|Period 1||5
11083205|NCT01133405|12265752|FG007|Safety Analysis Population|Period 1||2
11083206|NCT01133405|12265753|FG008|Safety Analysis Population|Period 1||4
11083207|NCT01133405|12265754|FG009|Safety Analysis Population|Period 1||2
11083208|NCT01133405|12265745|FG000|Received at Least 1 Dose of Drug|Period 1||2
11083209|NCT01133405|12265746|FG001|Received at Least 1 Dose of Drug|Period 1||4
11083210|NCT01133405|12265747|FG002|Received at Least 1 Dose of Drug|Period 1||4
11083211|NCT01133405|12265748|FG003|Received at Least 1 Dose of Drug|Period 1||3
11083212|NCT01133405|12265749|FG004|Received at Least 1 Dose of Drug|Period 1||3
11083213|NCT01133405|12265750|FG005|Received at Least 1 Dose of Drug|Period 1||4
11083214|NCT01133405|12265751|FG006|Received at Least 1 Dose of Drug|Period 1||4
11083215|NCT01133405|12265752|FG007|Received at Least 1 Dose of Drug|Period 1||2
11083216|NCT01133405|12265753|FG008|Received at Least 1 Dose of Drug|Period 1||4
11083217|NCT01133405|12265754|FG009|Received at Least 1 Dose of Drug|Period 1||2
11349958|NCT03020615|12546938|FG002|NOT COMPLETED|Overall Study||7
11349959|NCT03020641|12546951|FG000|STARTED|Overall Study||50
11349960|NCT03020641|12546952|FG001|STARTED|Overall Study||50
11349961|NCT03020641|12546951|FG000|COMPLETED|Overall Study||48
11349962|NCT03020641|12546952|FG001|COMPLETED|Overall Study||47
11349963|NCT03020641|12546951|FG000|NOT COMPLETED|Overall Study||2
11349964|NCT03020641|12546952|FG001|NOT COMPLETED|Overall Study||3
11349965|NCT03020719|12546963|FG000|STARTED|Overall Study||30
11349966|NCT03020719|12546964|FG001|STARTED|Overall Study||30
11349967|NCT03020719|12546963|FG000|COMPLETED|Overall Study||30
11349968|NCT03020719|12546964|FG001|COMPLETED|Overall Study||28
11349969|NCT03020719|12546963|FG000|NOT COMPLETED|Overall Study||0
11349970|NCT03020719|12546964|FG001|NOT COMPLETED|Overall Study||2
11349971|NCT03020745|12546978|FG000|STARTED|Part 1 (Up to 60 Days)||3
11349972|NCT03020745|12546979|FG001|STARTED|Part 1 (Up to 60 Days)||3
11083218|NCT01133405|12265745|FG000|COMPLETED|Period 1||2
11083219|NCT01133405|12265746|FG001|COMPLETED|Period 1||3
11083220|NCT01133405|12265747|FG002|COMPLETED|Period 1||4
11083221|NCT01133405|12265748|FG003|COMPLETED|Period 1||1
11083222|NCT01133405|12265749|FG004|COMPLETED|Period 1||3
11083223|NCT01133405|12265750|FG005|COMPLETED|Period 1||3
11083224|NCT01133405|12265751|FG006|COMPLETED|Period 1||4
11083225|NCT01133405|12265752|FG007|COMPLETED|Period 1||2
11083226|NCT01133405|12265753|FG008|COMPLETED|Period 1||4
11083227|NCT01133405|12265754|FG009|COMPLETED|Period 1||2
11083228|NCT01133405|12265745|FG000|NOT COMPLETED|Period 1||1
11083229|NCT01133405|12265746|FG001|NOT COMPLETED|Period 1||3
11083230|NCT01133405|12265747|FG002|NOT COMPLETED|Period 1||1
11083231|NCT01133405|12265748|FG003|NOT COMPLETED|Period 1||4
11083232|NCT01133405|12265749|FG004|NOT COMPLETED|Period 1||0
11083233|NCT01133405|12265750|FG005|NOT COMPLETED|Period 1||2
11083234|NCT01133405|12265751|FG006|NOT COMPLETED|Period 1||1
11083235|NCT01133405|12265752|FG007|NOT COMPLETED|Period 1||0
11083236|NCT01133405|12265753|FG008|NOT COMPLETED|Period 1||0
11083237|NCT01133405|12265754|FG009|NOT COMPLETED|Period 1||0
11083238|NCT01133405|12265745|FG000|STARTED|Period 2||2
11083239|NCT01133405|12265746|FG001|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4
11083240|NCT01133405|12265747|FG002|STARTED|Period 2||4
11083241|NCT01133405|12265748|FG003|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3
11083242|NCT01133405|12265749|FG004|STARTED|Period 2||3
11083243|NCT01133405|12265750|FG005|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4
11083244|NCT01133405|12265751|FG006|STARTED|Period 2|Cohort C was planned only for single period.|0
11083245|NCT01133405|12265752|FG007|STARTED|Period 2|Cohort C was planned only for single period.|0
11083246|NCT01133405|12265753|FG008|STARTED|Period 2|Cohort D was planned only for single period.|0
11083247|NCT01133405|12265754|FG009|STARTED|Period 2|Cohort D was planned only for single period.|0
11083248|NCT01133405|12265745|FG000|Received at Least 1 Dose of Study Drug|Period 2||2
11083249|NCT01133405|12265746|FG001|Received at Least 1 Dose of Study Drug|Period 2||4
11083250|NCT01133405|12265747|FG002|Received at Least 1 Dose of Study Drug|Period 2||4
11083251|NCT01133405|12265748|FG003|Received at Least 1 Dose of Study Drug|Period 2||3
11083252|NCT01133405|12265749|FG004|Received at Least 1 Dose of Study Drug|Period 2||3
11083253|NCT01133405|12265750|FG005|Received at Least 1 Dose of Study Drug|Period 2||4
11083254|NCT01133405|12265751|FG006|Received at Least 1 Dose of Study Drug|Period 2||0
11083255|NCT01133405|12265752|FG007|Received at Least 1 Dose of Study Drug|Period 2||0
11083256|NCT01133405|12265753|FG008|Received at Least 1 Dose of Study Drug|Period 2||0
11083257|NCT01133405|12265754|FG009|Received at Least 1 Dose of Study Drug|Period 2||0
11083258|NCT01133405|12265745|FG000|COMPLETED|Period 2||2
11083259|NCT01133405|12265746|FG001|COMPLETED|Period 2||3
11083260|NCT01133405|12265747|FG002|COMPLETED|Period 2||3
11083261|NCT01133405|12265748|FG003|COMPLETED|Period 2||2
11083262|NCT01133405|12265749|FG004|COMPLETED|Period 2||3
11083263|NCT01133405|12265750|FG005|COMPLETED|Period 2||2
11083264|NCT01133405|12265751|FG006|COMPLETED|Period 2||0
11083265|NCT01133405|12265752|FG007|COMPLETED|Period 2||0
11083266|NCT01133405|12265753|FG008|COMPLETED|Period 2||0
11083267|NCT01133405|12265754|FG009|COMPLETED|Period 2||0
11083268|NCT01133405|12265745|FG000|NOT COMPLETED|Period 2||0
11083269|NCT01133405|12265746|FG001|NOT COMPLETED|Period 2||1
11083270|NCT01133405|12265747|FG002|NOT COMPLETED|Period 2||1
11083271|NCT01133405|12265748|FG003|NOT COMPLETED|Period 2||1
11083272|NCT01133405|12265749|FG004|NOT COMPLETED|Period 2||0
11083273|NCT01133405|12265750|FG005|NOT COMPLETED|Period 2||2
11083274|NCT01133405|12265751|FG006|NOT COMPLETED|Period 2||0
11083275|NCT01133405|12265752|FG007|NOT COMPLETED|Period 2||0
11083276|NCT01133405|12265753|FG008|NOT COMPLETED|Period 2||0
11083277|NCT01133405|12265754|FG009|NOT COMPLETED|Period 2||0
11083278|NCT01133405|12265745|FG000|STARTED|Period 3||2
11083279|NCT01133405|12265746|FG001|STARTED|Period 3|One participant started and received placebo only in period 3.|4
11083280|NCT01133405|12265747|FG002|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4
11083281|NCT01133405|12265748|FG003|STARTED|Period 3||2
11083282|NCT01133405|12265749|FG004|STARTED|Period 3||3
11083283|NCT01133405|12265750|FG005|STARTED|Period 3||2
11083284|NCT01133405|12265751|FG006|STARTED|Period 3||0
11083285|NCT01133405|12265752|FG007|STARTED|Period 3||0
11083286|NCT01133405|12265753|FG008|STARTED|Period 3||0
11083287|NCT01133405|12265754|FG009|STARTED|Period 3||0
11083288|NCT01133405|12265745|FG000|Received at Least 1 Dose of Study Drug|Period 3||2
11083289|NCT01133405|12265746|FG001|Received at Least 1 Dose of Study Drug|Period 3||4
11083290|NCT01133405|12265747|FG002|Received at Least 1 Dose of Study Drug|Period 3||4
11083291|NCT01133405|12265748|FG003|Received at Least 1 Dose of Study Drug|Period 3||2
11083292|NCT01133405|12265749|FG004|Received at Least 1 Dose of Study Drug|Period 3||3
11083293|NCT01133405|12265750|FG005|Received at Least 1 Dose of Study Drug|Period 3||2
11083294|NCT01133405|12265751|FG006|Received at Least 1 Dose of Study Drug|Period 3||0
11083295|NCT01133405|12265752|FG007|Received at Least 1 Dose of Study Drug|Period 3||0
11083296|NCT01133405|12265753|FG008|Received at Least 1 Dose of Study Drug|Period 3||0
11083297|NCT01133405|12265754|FG009|Received at Least 1 Dose of Study Drug|Period 3||0
11083298|NCT01133405|12265745|FG000|COMPLETED|Period 3||2
11083299|NCT01133405|12265746|FG001|COMPLETED|Period 3||4
11083300|NCT01133405|12265747|FG002|COMPLETED|Period 3||4
11083301|NCT01133405|12265748|FG003|COMPLETED|Period 3||2
11083302|NCT01133405|12265749|FG004|COMPLETED|Period 3||3
11083303|NCT01133405|12265750|FG005|COMPLETED|Period 3||2
11083304|NCT01133405|12265751|FG006|COMPLETED|Period 3||0
11083305|NCT01133405|12265752|FG007|COMPLETED|Period 3||0
11083306|NCT01133405|12265753|FG008|COMPLETED|Period 3||0
11083307|NCT01133405|12265754|FG009|COMPLETED|Period 3||0
11083308|NCT01133405|12265745|FG000|NOT COMPLETED|Period 3||0
11083309|NCT01133405|12265746|FG001|NOT COMPLETED|Period 3||0
11083310|NCT01133405|12265747|FG002|NOT COMPLETED|Period 3||0
11083311|NCT01133405|12265748|FG003|NOT COMPLETED|Period 3||0
11083312|NCT01133405|12265749|FG004|NOT COMPLETED|Period 3||0
11083313|NCT01133405|12265750|FG005|NOT COMPLETED|Period 3||0
11083314|NCT01133405|12265751|FG006|NOT COMPLETED|Period 3||0
11083315|NCT01133405|12265752|FG007|NOT COMPLETED|Period 3||0
11083316|NCT01133405|12265753|FG008|NOT COMPLETED|Period 3||0
11083317|NCT01133405|12265754|FG009|NOT COMPLETED|Period 3||0
11083318|NCT01133418|12265786|FG000|STARTED|Overall Study||34
11083319|NCT01133418|12265787|FG001|STARTED|Overall Study||38
11083320|NCT01133418|12265786|FG000|COMPLETED|Overall Study||29
11083321|NCT01133418|12265787|FG001|COMPLETED|Overall Study||32
11083322|NCT01133418|12265786|FG000|NOT COMPLETED|Overall Study||5
11083323|NCT01133418|12265787|FG001|NOT COMPLETED|Overall Study||6
11083324|NCT01133522|12265803|FG000|STARTED|Overall Study||10
11083325|NCT01133522|12265804|FG001|STARTED|Overall Study||7
11083326|NCT01133522|12265805|FG002|STARTED|Overall Study||6
11083327|NCT01133522|12265806|FG003|STARTED|Overall Study||7
11083328|NCT01133522|12265807|FG004|STARTED|Overall Study||7
11083329|NCT01133522|12265808|FG005|STARTED|Overall Study||6
11083330|NCT01133522|12265809|FG006|STARTED|Overall Study||2
11083331|NCT01133522|12265810|FG007|STARTED|Overall Study||9
11083332|NCT01133522|12265811|FG008|STARTED|Overall Study||2
11083333|NCT01133522|12265812|FG009|STARTED|Overall Study||4
11083334|NCT01133522|12265803|FG000|Received Treatment|Overall Study||10
11083335|NCT01133522|12265804|FG001|Received Treatment|Overall Study||6
11083336|NCT01133522|12265805|FG002|Received Treatment|Overall Study||6
11083337|NCT01133522|12265806|FG003|Received Treatment|Overall Study||6
11083338|NCT01133522|12265807|FG004|Received Treatment|Overall Study||6
11083339|NCT01133522|12265808|FG005|Received Treatment|Overall Study||6
11083340|NCT01133522|12265809|FG006|Received Treatment|Overall Study||2
11083341|NCT01133522|12265810|FG007|Received Treatment|Overall Study||9
11083342|NCT01133522|12265811|FG008|Received Treatment|Overall Study||2
11083343|NCT01133522|12265812|FG009|Received Treatment|Overall Study||4
11083344|NCT01133522|12265803|FG000|COMPLETED|Overall Study||10
11083345|NCT01133522|12265804|FG001|COMPLETED|Overall Study||6
11083346|NCT01133522|12265805|FG002|COMPLETED|Overall Study||6
11083347|NCT01133522|12265806|FG003|COMPLETED|Overall Study||6
11083348|NCT01133522|12265807|FG004|COMPLETED|Overall Study||6
11083349|NCT01133522|12265808|FG005|COMPLETED|Overall Study||6
11083350|NCT01133522|12265809|FG006|COMPLETED|Overall Study||2
11083351|NCT01133522|12265810|FG007|COMPLETED|Overall Study||9
11083352|NCT01133522|12265811|FG008|COMPLETED|Overall Study||2
11083353|NCT01133522|12265812|FG009|COMPLETED|Overall Study||4
11083354|NCT01133522|12265803|FG000|NOT COMPLETED|Overall Study||0
11083355|NCT01133522|12265804|FG001|NOT COMPLETED|Overall Study||1
11083356|NCT01133522|12265805|FG002|NOT COMPLETED|Overall Study||0
11083357|NCT01133522|12265806|FG003|NOT COMPLETED|Overall Study||1
11083358|NCT01133522|12265807|FG004|NOT COMPLETED|Overall Study||1
11083359|NCT01133522|12265808|FG005|NOT COMPLETED|Overall Study||0
11083360|NCT01133522|12265809|FG006|NOT COMPLETED|Overall Study||0
11083361|NCT01133522|12265810|FG007|NOT COMPLETED|Overall Study||0
11083362|NCT01133522|12265811|FG008|NOT COMPLETED|Overall Study||0
11083363|NCT01133522|12265812|FG009|NOT COMPLETED|Overall Study||0
11083364|NCT01133626|12265844|FG000|STARTED|Overall Study||50
11083365|NCT01133626|12265845|FG001|STARTED|Overall Study||46
11083366|NCT01133626|12265846|FG002|STARTED|Overall Study||11
11083367|NCT01133626|12265844|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
11083368|NCT01133626|12265845|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
11083369|NCT01133626|12265846|FG002|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
11083370|NCT01133626|12265844|FG000|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
11083371|NCT01133626|12265845|FG001|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
11083372|NCT01133626|12265846|FG002|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
11083373|NCT01133626|12265844|FG000|COMPLETED|Overall Study||49
11083374|NCT01133626|12265845|FG001|COMPLETED|Overall Study||41
11083375|NCT01133626|12265846|FG002|COMPLETED|Overall Study||9
11083376|NCT01133626|12265844|FG000|NOT COMPLETED|Overall Study||1
11083377|NCT01133626|12265845|FG001|NOT COMPLETED|Overall Study||5
11083378|NCT01133626|12265846|FG002|NOT COMPLETED|Overall Study||2
11083379|NCT01133665|12265854|FG000|STARTED|Overall Study||42
11083380|NCT01133665|12265854|FG000|COMPLETED|Overall Study||40
11083381|NCT01133665|12265854|FG000|NOT COMPLETED|Overall Study||2
11083382|NCT01133678|12265860|FG000|STARTED|Overall Study||25
11083383|NCT01133678|12265861|FG001|STARTED|Overall Study||25
11083384|NCT01133678|12265860|FG000|COMPLETED|Overall Study||24
11083385|NCT01133678|12265861|FG001|COMPLETED|Overall Study||24
11083386|NCT01133678|12265860|FG000|NOT COMPLETED|Overall Study||1
11083387|NCT01133678|12265861|FG001|NOT COMPLETED|Overall Study||1
11083388|NCT01133704|12265869|FG000|STARTED|Overall Study||65
11083389|NCT01133704|12265870|FG001|STARTED|Overall Study||33
11083390|NCT01133704|12265869|FG000|COMPLETED|Overall Study|(including 3 year follow-up)|16
11083391|NCT01133704|12265870|FG001|COMPLETED|Overall Study|(including 3 year follow-up)|7
11083392|NCT01133704|12265869|FG000|NOT COMPLETED|Overall Study||49
11083393|NCT01133704|12265870|FG001|NOT COMPLETED|Overall Study||26
11083394|NCT01133756|12265879|FG000|STARTED|Overall Study||2
11083395|NCT01133756|12265880|FG001|STARTED|Overall Study||3
11083396|NCT01133756|12265881|FG002|STARTED|Overall Study||2
11083397|NCT01133756|12265879|FG000|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
11083398|NCT01133756|12265880|FG001|Completed 6 Cycles|Overall Study||0
11083399|NCT01133756|12265881|FG002|Completed 6 Cycles|Overall Study||0
11083400|NCT01133756|12265879|FG000|COMPLETED|Overall Study||0
11083401|NCT01133756|12265880|FG001|COMPLETED|Overall Study||0
11083402|NCT01133756|12265881|FG002|COMPLETED|Overall Study||0
11083403|NCT01133756|12265879|FG000|NOT COMPLETED|Overall Study||2
11083404|NCT01133756|12265880|FG001|NOT COMPLETED|Overall Study||3
11083405|NCT01133756|12265881|FG002|NOT COMPLETED|Overall Study||2
11083406|NCT01133821|12265891|FG000|STARTED|Overall Study||45
11083407|NCT01133821|12265892|FG001|STARTED|Overall Study||47
11083408|NCT01133821|12265891|FG000|COMPLETED|Overall Study||27
11083409|NCT01133821|12265892|FG001|COMPLETED|Overall Study||28
11083410|NCT01133821|12265891|FG000|NOT COMPLETED|Overall Study||18
11083411|NCT01133821|12265892|FG001|NOT COMPLETED|Overall Study||19
11083412|NCT01133847|12265901|FG000|STARTED|Active Treatment Phase (Weeks 1-16)||78
11083413|NCT01133847|12265902|FG001|STARTED|Active Treatment Phase (Weeks 1-16)||74
11083414|NCT01133847|12265903|FG002|STARTED|Active Treatment Phase (Weeks 1-16)||70
11083415|NCT01133847|12265901|FG000|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
11083416|NCT01133847|12265902|FG001|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
11083417|NCT01133847|12265903|FG002|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
11083418|NCT01133847|12265901|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
11083419|NCT01133847|12265902|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
11083420|NCT01133847|12265903|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
11083421|NCT01133847|12265901|FG000|STARTED|Follow-Up Phase||73
11083422|NCT01133847|12265902|FG001|STARTED|Follow-Up Phase||73
11083423|NCT01133847|12265903|FG002|STARTED|Follow-Up Phase||67
11083424|NCT01133847|12265901|FG000|COMPLETED|Follow-Up Phase||72
11083425|NCT01133847|12265902|FG001|COMPLETED|Follow-Up Phase||70
11083426|NCT01133847|12265903|FG002|COMPLETED|Follow-Up Phase||60
11083427|NCT01133847|12265901|FG000|NOT COMPLETED|Follow-Up Phase||1
11083428|NCT01133847|12265902|FG001|NOT COMPLETED|Follow-Up Phase||3
11083429|NCT01133847|12265903|FG002|NOT COMPLETED|Follow-Up Phase||7
11083430|NCT01133860|12265912|FG000|STARTED|Overall Study||12
11083431|NCT01133860|12265912|FG000|COMPLETED|Overall Study||12
11083432|NCT01133860|12265912|FG000|NOT COMPLETED|Overall Study||0
11083433|NCT01133977|12265922|FG000|STARTED|Overall Study|Treated|3
11083434|NCT01133977|12265923|FG001|STARTED|Overall Study|Treated|7
11083435|NCT01133977|12265924|FG002|STARTED|Overall Study|Treated|6
11083436|NCT01133977|12265925|FG003|STARTED|Overall Study|Treated|42
11083437|NCT01133977|12265926|FG004|STARTED|Overall Study|Treated|39
11083438|NCT01133977|12265922|FG000|COMPLETED|Overall Study||0
11083439|NCT01133977|12265923|FG001|COMPLETED|Overall Study||0
11083440|NCT01133977|12265924|FG002|COMPLETED|Overall Study||0
11083441|NCT01133977|12265925|FG003|COMPLETED|Overall Study||3
11083442|NCT01133977|12265926|FG004|COMPLETED|Overall Study||1
11083443|NCT01133977|12265922|FG000|NOT COMPLETED|Overall Study||3
11083444|NCT01133977|12265923|FG001|NOT COMPLETED|Overall Study||7
11083445|NCT01133977|12265924|FG002|NOT COMPLETED|Overall Study||6
11083446|NCT01133977|12265925|FG003|NOT COMPLETED|Overall Study||39
11083447|NCT01133977|12265926|FG004|NOT COMPLETED|Overall Study||38
11083448|NCT01134016|12265941|FG000|STARTED|Overall Study||13
11083449|NCT01134016|12265941|FG000|COMPLETED|Overall Study||10
11083450|NCT01134016|12265941|FG000|NOT COMPLETED|Overall Study||3
11083451|NCT01134042|12265977|FG000|STARTED|Overall Study||194
11083452|NCT01134042|12265978|FG001|STARTED|Overall Study||197
11083453|NCT01134042|12265979|FG002|STARTED|Overall Study||195
11083454|NCT01134042|12265977|FG000|COMPLETED|Overall Study||146
11083455|NCT01134042|12265978|FG001|COMPLETED|Overall Study||169
11083456|NCT01134042|12265979|FG002|COMPLETED|Overall Study||161
11083457|NCT01134042|12265977|FG000|NOT COMPLETED|Overall Study||48
11083458|NCT01134042|12265978|FG001|NOT COMPLETED|Overall Study||28
11083459|NCT01134042|12265979|FG002|NOT COMPLETED|Overall Study||34
11083460|NCT01134055|12265995|FG000|STARTED|Overall Study||73
11083461|NCT01134055|12265996|FG001|STARTED|Overall Study||72
11083462|NCT01134055|12265997|FG002|STARTED|Overall Study||74
11083463|NCT01134055|12265998|FG003|STARTED|Overall Study||73
11083464|NCT01134055|12265999|FG004|STARTED|Overall Study||73
11083465|NCT01134055|12266000|FG005|STARTED|Overall Study||72
11083466|NCT01134055|12266001|FG006|STARTED|Overall Study||73
11083467|NCT01134055|12265995|FG000|COMPLETED|Overall Study||65
11083468|NCT01134055|12265996|FG001|COMPLETED|Overall Study||66
11083469|NCT01134055|12265997|FG002|COMPLETED|Overall Study||71
11083470|NCT01134055|12265998|FG003|COMPLETED|Overall Study||67
11083471|NCT01134055|12265999|FG004|COMPLETED|Overall Study||67
11083472|NCT01134055|12266000|FG005|COMPLETED|Overall Study||65
11083473|NCT01134055|12266001|FG006|COMPLETED|Overall Study||62
11083474|NCT01134055|12265995|FG000|NOT COMPLETED|Overall Study||8
11083475|NCT01134055|12265996|FG001|NOT COMPLETED|Overall Study||6
11083476|NCT01134055|12265997|FG002|NOT COMPLETED|Overall Study||3
11083477|NCT01134055|12265998|FG003|NOT COMPLETED|Overall Study||6
11083478|NCT01134055|12265999|FG004|NOT COMPLETED|Overall Study||6
11083479|NCT01134055|12266000|FG005|NOT COMPLETED|Overall Study||7
11083480|NCT01134055|12266001|FG006|NOT COMPLETED|Overall Study||11
11083481|NCT01134081|12266023|FG000|STARTED|Overall Study||44
11083482|NCT01134081|12266023|FG000|COMPLETED|Overall Study||44
11083483|NCT01134081|12266023|FG000|NOT COMPLETED|Overall Study||0
11083484|NCT01134107|12266033|FG000|STARTED|Period 1-First Treatment Intervention||67
11349973|NCT03020745|12546980|FG002|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
11349974|NCT03020745|12546981|FG003|STARTED|Part 1 (Up to 60 Days)||6
11349975|NCT03020745|12546982|FG004|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
11349976|NCT03020745|12546983|FG005|STARTED|Part 1 (Up to 60 Days)||0
11349977|NCT03020745|12546984|FG006|STARTED|Part 1 (Up to 60 Days)||0
11349978|NCT03020745|12546985|FG007|STARTED|Part 1 (Up to 60 Days)||0
11349979|NCT03020745|12546986|FG008|STARTED|Part 1 (Up to 60 Days)||0
11349980|NCT03020745|12546987|FG009|STARTED|Part 1 (Up to 60 Days)||0
11349981|NCT03020745|12546978|FG000|COMPLETED|Part 1 (Up to 60 Days)||3
11349982|NCT03020745|12546979|FG001|COMPLETED|Part 1 (Up to 60 Days)||3
11349983|NCT03020745|12546980|FG002|COMPLETED|Part 1 (Up to 60 Days)||0
11349984|NCT03020745|12546981|FG003|COMPLETED|Part 1 (Up to 60 Days)||6
11349985|NCT03020745|12546982|FG004|COMPLETED|Part 1 (Up to 60 Days)||0
11083485|NCT01134107|12266034|FG001|STARTED|Period 1-First Treatment Intervention||66
11083486|NCT01134107|12266033|FG000|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
11083487|NCT01134107|12266034|FG001|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
11083488|NCT01134107|12266033|FG000|COMPLETED|Period 1-First Treatment Intervention||61
11083489|NCT01134107|12266034|FG001|COMPLETED|Period 1-First Treatment Intervention||61
11083490|NCT01134107|12266033|FG000|NOT COMPLETED|Period 1-First Treatment Intervention||6
11083491|NCT01134107|12266034|FG001|NOT COMPLETED|Period 1-First Treatment Intervention||5
11083492|NCT01134107|12266033|FG000|STARTED|Period 2-Second Treatment Intervention||61
11083493|NCT01134107|12266034|FG001|STARTED|Period 2-Second Treatment Intervention||61
11083494|NCT01134107|12266033|FG000|COMPLETED|Period 2-Second Treatment Intervention||57
11083495|NCT01134107|12266034|FG001|COMPLETED|Period 2-Second Treatment Intervention||61
11083496|NCT01134107|12266033|FG000|NOT COMPLETED|Period 2-Second Treatment Intervention||4
11083497|NCT01134107|12266034|FG001|NOT COMPLETED|Period 2-Second Treatment Intervention||0
11349986|NCT03020745|12546983|FG005|COMPLETED|Part 1 (Up to 60 Days)||0
11349987|NCT03020745|12546984|FG006|COMPLETED|Part 1 (Up to 60 Days)||0
11349988|NCT03020745|12546985|FG007|COMPLETED|Part 1 (Up to 60 Days)||0
11349989|NCT03020745|12546986|FG008|COMPLETED|Part 1 (Up to 60 Days)||0
11349990|NCT03020745|12546987|FG009|COMPLETED|Part 1 (Up to 60 Days)||0
11349991|NCT03020745|12546978|FG000|NOT COMPLETED|Part 1 (Up to 60 Days)||0
11349992|NCT03020745|12546979|FG001|NOT COMPLETED|Part 1 (Up to 60 Days)||0
11083498|NCT01134198|12266042|FG000|STARTED|Phase 1||16
11083499|NCT01134198|12266043|FG001|STARTED|Phase 1||13
11083500|NCT01134198|12266042|FG000|COMPLETED|Phase 1||9
11083501|NCT01134198|12266043|FG001|COMPLETED|Phase 1||11
11083502|NCT01134198|12266042|FG000|NOT COMPLETED|Phase 1||7
11083503|NCT01134198|12266043|FG001|NOT COMPLETED|Phase 1||2
11083504|NCT01134198|12266042|FG000|STARTED|Phase 2||9
11083505|NCT01134198|12266043|FG001|STARTED|Phase 2||11
11083506|NCT01134198|12266042|FG000|COMPLETED|Phase 2||9
11083507|NCT01134198|12266043|FG001|COMPLETED|Phase 2||7
11083508|NCT01134198|12266042|FG000|NOT COMPLETED|Phase 2||0
11083509|NCT01134198|12266043|FG001|NOT COMPLETED|Phase 2||4
11083510|NCT01134263|12266054|FG000|STARTED|Overall Study||164
11083511|NCT01134263|12266055|FG001|STARTED|Overall Study||163
11083512|NCT01134263|12266056|FG002|STARTED|Overall Study||163
11083513|NCT01134263|12266057|FG003|STARTED|Overall Study||168
11349993|NCT03020745|12546980|FG002|NOT COMPLETED|Part 1 (Up to 60 Days)||0
11349994|NCT03020745|12546981|FG003|NOT COMPLETED|Part 1 (Up to 60 Days)||0
11349995|NCT03020745|12546982|FG004|NOT COMPLETED|Part 1 (Up to 60 Days)||0
11349996|NCT03020745|12546983|FG005|NOT COMPLETED|Part 1 (Up to 60 Days)||0
11349997|NCT03020745|12546984|FG006|NOT COMPLETED|Part 1 (Up to 60 Days)||0
11349998|NCT03020745|12546985|FG007|NOT COMPLETED|Part 1 (Up to 60 Days)||0
11349999|NCT03020745|12546986|FG008|NOT COMPLETED|Part 1 (Up to 60 Days)||0
11350000|NCT03020745|12546987|FG009|NOT COMPLETED|Part 1 (Up to 60 Days)||0
11350001|NCT03020745|12546978|FG000|STARTED|Part 2 (Up to 169 Days)||0
11350002|NCT03020745|12546979|FG001|STARTED|Part 2 (Up to 169 Days)||0
11350003|NCT03020745|12546980|FG002|STARTED|Part 2 (Up to 169 Days)||0
11350004|NCT03020745|12546981|FG003|STARTED|Part 2 (Up to 169 Days)||0
11350005|NCT03020745|12546982|FG004|STARTED|Part 2 (Up to 169 Days)||0
11350006|NCT03020745|12546983|FG005|STARTED|Part 2 (Up to 169 Days)||10
11350007|NCT03020745|12546984|FG006|STARTED|Part 2 (Up to 169 Days)||6
11350008|NCT03020745|12546985|FG007|STARTED|Part 2 (Up to 169 Days)||20
11350009|NCT03020745|12546986|FG008|STARTED|Part 2 (Up to 169 Days)||15
11350010|NCT03020745|12546987|FG009|STARTED|Part 2 (Up to 169 Days)||15
11350011|NCT03020745|12546978|FG000|COMPLETED|Part 2 (Up to 169 Days)||0
11350012|NCT03020745|12546979|FG001|COMPLETED|Part 2 (Up to 169 Days)||0
11350013|NCT03020745|12546980|FG002|COMPLETED|Part 2 (Up to 169 Days)||0
11350014|NCT03020745|12546981|FG003|COMPLETED|Part 2 (Up to 169 Days)||0
11350015|NCT03020745|12546982|FG004|COMPLETED|Part 2 (Up to 169 Days)||0
11350016|NCT03020745|12546983|FG005|COMPLETED|Part 2 (Up to 169 Days)||10
11350017|NCT03020745|12546984|FG006|COMPLETED|Part 2 (Up to 169 Days)||6
11350018|NCT03020745|12546985|FG007|COMPLETED|Part 2 (Up to 169 Days)||19
11350019|NCT03020745|12546986|FG008|COMPLETED|Part 2 (Up to 169 Days)||14
11350020|NCT03020745|12546987|FG009|COMPLETED|Part 2 (Up to 169 Days)||15
11350021|NCT03020745|12546978|FG000|NOT COMPLETED|Part 2 (Up to 169 Days)||0
11350022|NCT03020745|12546979|FG001|NOT COMPLETED|Part 2 (Up to 169 Days)||0
11350023|NCT03020745|12546980|FG002|NOT COMPLETED|Part 2 (Up to 169 Days)||0
11350024|NCT03020745|12546981|FG003|NOT COMPLETED|Part 2 (Up to 169 Days)||0
11350025|NCT03020745|12546982|FG004|NOT COMPLETED|Part 2 (Up to 169 Days)||0
11083514|NCT01134263|12266058|FG004|STARTED|Overall Study||57
11350026|NCT03020745|12546983|FG005|NOT COMPLETED|Part 2 (Up to 169 Days)||0
11083515|NCT01134263|12266054|FG000|Received Vaccination 1|Overall Study||163
11350027|NCT03020745|12546984|FG006|NOT COMPLETED|Part 2 (Up to 169 Days)||0
11350028|NCT03020745|12546985|FG007|NOT COMPLETED|Part 2 (Up to 169 Days)||1
11350029|NCT03020745|12546986|FG008|NOT COMPLETED|Part 2 (Up to 169 Days)||1
11350030|NCT03020745|12546987|FG009|NOT COMPLETED|Part 2 (Up to 169 Days)||0
11350031|NCT03020745|12546978|FG000|STARTED|Part 2:Optional FU (Up to 450 Days)||0
11350032|NCT03020745|12546979|FG001|STARTED|Part 2:Optional FU (Up to 450 Days)||0
11350033|NCT03020745|12546980|FG002|STARTED|Part 2:Optional FU (Up to 450 Days)||0
11350034|NCT03020745|12546981|FG003|STARTED|Part 2:Optional FU (Up to 450 Days)||0
11350035|NCT03020745|12546982|FG004|STARTED|Part 2:Optional FU (Up to 450 Days)||0
11350036|NCT03020745|12546983|FG005|STARTED|Part 2:Optional FU (Up to 450 Days)||10
11350037|NCT03020745|12546984|FG006|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant didn't enter into optional follow-up period.|5
11350038|NCT03020745|12546985|FG007|STARTED|Part 2:Optional FU (Up to 450 Days)|2 participants didn't enter into optional follow-up period.|17
11083516|NCT01134263|12266055|FG001|Received Vaccination 1|Overall Study||162
11083517|NCT01134263|12266056|FG002|Received Vaccination 1|Overall Study||163
11083518|NCT01134263|12266057|FG003|Received Vaccination 1|Overall Study||167
11083519|NCT01134263|12266058|FG004|Received Vaccination 1|Overall Study||57
11083520|NCT01134263|12266054|FG000|Received Vaccination 2|Overall Study||151
11083521|NCT01134263|12266055|FG001|Received Vaccination 2|Overall Study||152
11083522|NCT01134263|12266056|FG002|Received Vaccination 2|Overall Study||139
11083523|NCT01134263|12266057|FG003|Received Vaccination 2|Overall Study||154
11083524|NCT01134263|12266058|FG004|Received Vaccination 2|Overall Study||53
11083525|NCT01134263|12266054|FG000|Received Vaccination 3|Overall Study||140
11083526|NCT01134263|12266055|FG001|Received Vaccination 3|Overall Study||145
11083527|NCT01134263|12266056|FG002|Received Vaccination 3|Overall Study||134
11083528|NCT01134263|12266057|FG003|Received Vaccination 3|Overall Study||151
11083529|NCT01134263|12266058|FG004|Received Vaccination 3|Overall Study||49
11083530|NCT01134263|12266054|FG000|Safety Population|Overall Study||163
11083531|NCT01134263|12266055|FG001|Safety Population|Overall Study||161
11083532|NCT01134263|12266056|FG002|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164
11083533|NCT01134263|12266057|FG003|Safety Population|Overall Study||167
11083534|NCT01134263|12266058|FG004|Safety Population|Overall Study||57
11083535|NCT01134263|12266054|FG000|COMPLETED|Overall Study||140
11083536|NCT01134263|12266055|FG001|COMPLETED|Overall Study||143
11083537|NCT01134263|12266056|FG002|COMPLETED|Overall Study||134
11083538|NCT01134263|12266057|FG003|COMPLETED|Overall Study||149
11083539|NCT01134263|12266058|FG004|COMPLETED|Overall Study||48
11083540|NCT01134263|12266054|FG000|NOT COMPLETED|Overall Study||24
11083541|NCT01134263|12266055|FG001|NOT COMPLETED|Overall Study||20
11350039|NCT03020745|12546986|FG008|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant did not enter into optional follow-up period|13
11350040|NCT03020745|12546987|FG009|STARTED|Part 2:Optional FU (Up to 450 Days)||15
11350041|NCT03020745|12546978|FG000|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
11350042|NCT03020745|12546979|FG001|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
11350043|NCT03020745|12546980|FG002|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
11350044|NCT03020745|12546981|FG003|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
11350045|NCT03020745|12546982|FG004|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
11350046|NCT03020745|12546983|FG005|COMPLETED|Part 2:Optional FU (Up to 450 Days)||9
11350047|NCT03020745|12546984|FG006|COMPLETED|Part 2:Optional FU (Up to 450 Days)||5
11350048|NCT03020745|12546985|FG007|COMPLETED|Part 2:Optional FU (Up to 450 Days)||17
11350049|NCT03020745|12546986|FG008|COMPLETED|Part 2:Optional FU (Up to 450 Days)||10
11350050|NCT03020745|12546987|FG009|COMPLETED|Part 2:Optional FU (Up to 450 Days)||15
11350051|NCT03020745|12546978|FG000|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
11350052|NCT03020745|12546979|FG001|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
11350053|NCT03020745|12546980|FG002|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
11350054|NCT03020745|12546981|FG003|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
11350055|NCT03020745|12546982|FG004|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
11350056|NCT03020745|12546983|FG005|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||1
11350057|NCT03020745|12546984|FG006|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
11350058|NCT03020745|12546985|FG007|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
11350059|NCT03020745|12546986|FG008|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||3
11350060|NCT03020745|12546987|FG009|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
11350061|NCT03020888|12547011|FG000|STARTED|Overall Study||120
11350062|NCT03020888|12547011|FG000|COMPLETED|Overall Study||107
11350063|NCT03020888|12547011|FG000|NOT COMPLETED|Overall Study||13
11350064|NCT03020966|12547017|FG000|STARTED|Overall Study||77
11083542|NCT01134263|12266056|FG002|NOT COMPLETED|Overall Study||29
11083543|NCT01134263|12266057|FG003|NOT COMPLETED|Overall Study||19
11083544|NCT01134263|12266058|FG004|NOT COMPLETED|Overall Study||9
11083545|NCT01134276|12266078|FG000|STARTED|Overall Study||104
11083546|NCT01134276|12266079|FG001|STARTED|Overall Study||107
11083547|NCT01134276|12266078|FG000|COMPLETED|Overall Study||104
11083548|NCT01134276|12266079|FG001|COMPLETED|Overall Study||107
11083549|NCT01134276|12266078|FG000|NOT COMPLETED|Overall Study||0
11083550|NCT01134276|12266079|FG001|NOT COMPLETED|Overall Study||0
11083551|NCT01134315|12266090|FG000|STARTED|Overall Study||21
11083552|NCT01134315|12266091|FG001|STARTED|Overall Study||40
11083553|NCT01134315|12266090|FG000|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
11083554|NCT01134315|12266091|FG001|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
11083555|NCT01134315|12266090|FG000|NOT COMPLETED|Overall Study||9
11083556|NCT01134315|12266091|FG001|NOT COMPLETED|Overall Study||19
11083557|NCT01134328|12266101|FG000|STARTED|Overall Study||21
11083558|NCT01134328|12266102|FG001|STARTED|Overall Study||21
11083559|NCT01134328|12266103|FG002|STARTED|Overall Study||20
11083560|NCT01134328|12266104|FG003|STARTED|Overall Study||21
11083561|NCT01134328|12266101|FG000|COMPLETED|Overall Study||19
11083562|NCT01134328|12266102|FG001|COMPLETED|Overall Study||18
11083563|NCT01134328|12266103|FG002|COMPLETED|Overall Study||17
11083564|NCT01134328|12266104|FG003|COMPLETED|Overall Study||17
11083565|NCT01134328|12266101|FG000|NOT COMPLETED|Overall Study||2
11083566|NCT01134328|12266102|FG001|NOT COMPLETED|Overall Study||3
11083567|NCT01134328|12266103|FG002|NOT COMPLETED|Overall Study||3
11083568|NCT01134328|12266104|FG003|NOT COMPLETED|Overall Study||4
11083569|NCT01134393|12266114|FG000|STARTED|Overall Study|Entered and treated.|501
11083570|NCT01134393|12266114|FG000|COMPLETED|Overall Study|Completed trial medication.|449
11083571|NCT01134393|12266114|FG000|NOT COMPLETED|Overall Study||52
11083572|NCT01134510|12266121|FG000|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
11083573|NCT01134510|12266122|FG001|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
11083574|NCT01134510|12266121|FG000|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
11083575|NCT01134510|12266122|FG001|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
11083576|NCT01134510|12266121|FG000|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
11083577|NCT01134510|12266122|FG001|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
11083578|NCT01134510|12266121|FG000|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
11083579|NCT01134510|12266122|FG001|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
11083580|NCT01134510|12266121|FG000|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
11083581|NCT01134510|12266122|FG001|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
11083582|NCT01134510|12266121|FG000|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
11083583|NCT01134510|12266122|FG001|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
11083584|NCT01134510|12266121|FG000|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
11083585|NCT01134510|12266122|FG001|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
11083586|NCT01134510|12266121|FG000|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
11083587|NCT01134510|12266122|FG001|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
11083588|NCT01134510|12266121|FG000|Month 1|Overall Study||10
11083589|NCT01134510|12266122|FG001|Month 1|Overall Study||10
11083590|NCT01134510|12266121|FG000|Month 3|Overall Study||10
11083591|NCT01134510|12266122|FG001|Month 3|Overall Study||9
11083592|NCT01134510|12266121|FG000|COMPLETED|Overall Study||10
11083593|NCT01134510|12266122|FG001|COMPLETED|Overall Study||9
11083594|NCT01134510|12266121|FG000|NOT COMPLETED|Overall Study||0
11083595|NCT01134510|12266122|FG001|NOT COMPLETED|Overall Study||1
11083596|NCT01129011|12266133|FG000|STARTED|Overall Study|Safety, Intent-to-Treat population|210
11083597|NCT01129011|12266134|FG001|STARTED|Overall Study|Safety, Intent-to-Treat population|210
11083598|NCT01129011|12266133|FG000|COMPLETED|Overall Study||151
11083599|NCT01129011|12266134|FG001|COMPLETED|Overall Study||153
11083600|NCT01129011|12266133|FG000|NOT COMPLETED|Overall Study||59
11083601|NCT01129011|12266134|FG001|NOT COMPLETED|Overall Study||57
11083602|NCT01134549|12266145|FG000|STARTED|Overall Study||8
11083603|NCT01134549|12266146|FG001|STARTED|Overall Study||6
11083604|NCT01134549|12266147|FG002|STARTED|Overall Study||6
11083605|NCT01134549|12266148|FG003|STARTED|Overall Study||6
11083606|NCT01134549|12266149|FG004|STARTED|Overall Study||6
11207579|NCT01876992|12398787|FG000|STARTED|Overall Study||5
11207580|NCT01876992|12398788|FG001|STARTED|Overall Study||5
11207581|NCT01876992|12398787|FG000|COMPLETED|Overall Study||5
11207582|NCT01876992|12398788|FG001|COMPLETED|Overall Study||5
11207583|NCT01876992|12398787|FG000|NOT COMPLETED|Overall Study||0
11083607|NCT01134549|12266145|FG000|COMPLETED|Overall Study||8
11083608|NCT01134549|12266146|FG001|COMPLETED|Overall Study||6
11083609|NCT01134549|12266147|FG002|COMPLETED|Overall Study||6
11083610|NCT01134549|12266148|FG003|COMPLETED|Overall Study||6
11083611|NCT01134549|12266149|FG004|COMPLETED|Overall Study||6
11207584|NCT01876992|12398788|FG001|NOT COMPLETED|Overall Study||0
11207585|NCT01877083|12398795|FG000|STARTED|Treatment Phase||25
11207586|NCT01877083|12398795|FG000|COMPLETED|Treatment Phase||5
11207587|NCT01877083|12398795|FG000|NOT COMPLETED|Treatment Phase||20
11207588|NCT01877083|12398795|FG000|STARTED|Extension Phase||5
11207589|NCT01877083|12398795|FG000|COMPLETED|Extension Phase||0
11207590|NCT01877083|12398795|FG000|NOT COMPLETED|Extension Phase||5
11207591|NCT01877148|12398801|FG000|STARTED|Overall Study||6
11207592|NCT01877148|12398802|FG001|STARTED|Overall Study||6
11083612|NCT01134549|12266145|FG000|NOT COMPLETED|Overall Study||0
11083613|NCT01134549|12266146|FG001|NOT COMPLETED|Overall Study||0
11083614|NCT01134549|12266147|FG002|NOT COMPLETED|Overall Study||0
11083615|NCT01134549|12266148|FG003|NOT COMPLETED|Overall Study||0
11083616|NCT01134549|12266149|FG004|NOT COMPLETED|Overall Study||0
11083617|NCT01134562|12266171|FG000|STARTED|Overall Study||4
11083618|NCT01134562|12266172|FG001|STARTED|Overall Study||4
11083619|NCT01134562|12266173|FG002|STARTED|Overall Study||4
11083620|NCT01134562|12266174|FG003|STARTED|Overall Study||8
11083621|NCT01134562|12266175|FG004|STARTED|Overall Study||8
11083622|NCT01134562|12266171|FG000|COMPLETED|Overall Study||4
11083623|NCT01134562|12266172|FG001|COMPLETED|Overall Study||3
11083624|NCT01134562|12266173|FG002|COMPLETED|Overall Study||4
11083625|NCT01134562|12266174|FG003|COMPLETED|Overall Study||8
11083626|NCT01134562|12266175|FG004|COMPLETED|Overall Study||8
11083627|NCT01134562|12266171|FG000|NOT COMPLETED|Overall Study||0
11083628|NCT01134562|12266172|FG001|NOT COMPLETED|Overall Study||1
11083629|NCT01134562|12266173|FG002|NOT COMPLETED|Overall Study||0
11083630|NCT01134562|12266174|FG003|NOT COMPLETED|Overall Study||0
11083631|NCT01134562|12266175|FG004|NOT COMPLETED|Overall Study||0
11083632|NCT01134575|12266198|FG000|STARTED|Overall Study||3
11083633|NCT01134575|12266199|FG001|STARTED|Overall Study||45
11083634|NCT01134575|12266200|FG002|STARTED|Overall Study||42
11083635|NCT01134575|12266198|FG000|COMPLETED|Overall Study||3
11083636|NCT01134575|12266199|FG001|COMPLETED|Overall Study||45
11083637|NCT01134575|12266200|FG002|COMPLETED|Overall Study||42
11083638|NCT01134575|12266198|FG000|NOT COMPLETED|Overall Study||0
11083639|NCT01134575|12266199|FG001|NOT COMPLETED|Overall Study||0
11083640|NCT01134575|12266200|FG002|NOT COMPLETED|Overall Study||0
11083641|NCT01134627|12266210|FG000|STARTED|Overall Study|Number of participants treated.|149
11083642|NCT01134627|12266211|FG001|STARTED|Overall Study|Number of participants treated.|155
11083643|NCT01134627|12266210|FG000|COMPLETED|Overall Study||80
11083644|NCT01134627|12266211|FG001|COMPLETED|Overall Study||88
11083645|NCT01134627|12266210|FG000|NOT COMPLETED|Overall Study||69
11083646|NCT01134627|12266211|FG001|NOT COMPLETED|Overall Study||67
11207593|NCT01877148|12398801|FG000|COMPLETED|Overall Study||5
11207594|NCT01877148|12398802|FG001|COMPLETED|Overall Study||5
11207595|NCT01877148|12398801|FG000|NOT COMPLETED|Overall Study||1
11207596|NCT01877148|12398802|FG001|NOT COMPLETED|Overall Study||1
11207597|NCT01877161|12398808|FG000|STARTED|First Session of Stimulation||12
11207598|NCT01877161|12398808|FG000|COMPLETED|First Session of Stimulation||12
11207599|NCT01877161|12398808|FG000|NOT COMPLETED|First Session of Stimulation||0
11207600|NCT01877161|12398808|FG000|STARTED|Washout (at Least 3 Days)||12
11207601|NCT01877161|12398808|FG000|COMPLETED|Washout (at Least 3 Days)||12
11207602|NCT01877161|12398808|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
11207603|NCT01877161|12398808|FG000|STARTED|Second Session of Stimulation||12
11207604|NCT01877161|12398808|FG000|COMPLETED|Second Session of Stimulation||12
11207605|NCT01877161|12398808|FG000|NOT COMPLETED|Second Session of Stimulation||0
11207606|NCT01877161|12398808|FG000|STARTED|Washout (at Least 3 Days)||12
11207607|NCT01877161|12398808|FG000|COMPLETED|Washout (at Least 3 Days)||12
11207608|NCT01877161|12398808|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
11207609|NCT01877161|12398808|FG000|STARTED|Third Session of Stimulation||12
11207610|NCT01877161|12398808|FG000|COMPLETED|Third Session of Stimulation||12
11207611|NCT01877161|12398808|FG000|NOT COMPLETED|Third Session of Stimulation||0
11207612|NCT01877187|12398816|FG000|STARTED|Overall Study|21 HCC, 18 non-HCC|39
11207613|NCT01877187|12398816|FG000|Completed 30 Day f/u|Overall Study|18 HCC, 17 non-HCC|35
11207614|NCT01877187|12398816|FG000|Completed 90 Day f/u|Overall Study|11 HCC, 9 non-HCC|20
11207615|NCT01877187|12398816|FG000|COMPLETED|Overall Study|10 HCC, 7 non-HCC|17
11207616|NCT01877187|12398816|FG000|NOT COMPLETED|Overall Study||22
11207617|NCT01877239|12398823|FG000|STARTED|Overall Study||111
11207618|NCT01877239|12398823|FG000|Treated|Overall Study||76
11207619|NCT01877239|12398823|FG000|COMPLETED|Overall Study||61
11207620|NCT01877239|12398823|FG000|NOT COMPLETED|Overall Study||50
11207621|NCT01877265|12398827|FG000|STARTED|Treatment Period 1||3
11207622|NCT01877265|12398828|FG001|STARTED|Treatment Period 1||3
11207623|NCT01877265|12398829|FG002|STARTED|Treatment Period 1||3
11083647|NCT01134705|12266219|FG000|STARTED|Overall Study||236
11083648|NCT01134705|12266220|FG001|STARTED|Overall Study||238
11083649|NCT01134705|12266219|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
11083650|NCT01134705|12266220|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
11083651|NCT01134705|12266219|FG000|COMPLETED|Overall Study||221
11083652|NCT01134705|12266220|FG001|COMPLETED|Overall Study||216
11083653|NCT01134705|12266219|FG000|NOT COMPLETED|Overall Study||15
11083654|NCT01134705|12266220|FG001|NOT COMPLETED|Overall Study||22
11083655|NCT01134731|12266229|FG000|STARTED|Overall Study||23
11083656|NCT01134731|12266230|FG001|STARTED|Overall Study||21
11083657|NCT01134731|12266231|FG002|STARTED|Overall Study||10
11083658|NCT01134731|12266229|FG000|COMPLETED|Overall Study||10
11083659|NCT01134731|12266230|FG001|COMPLETED|Overall Study||10
11083660|NCT01134731|12266231|FG002|COMPLETED|Overall Study||2
11350065|NCT03020966|12547018|FG001|STARTED|Overall Study||77
11350066|NCT03020966|12547017|FG000|COMPLETED|Overall Study||75
11350067|NCT03020966|12547018|FG001|COMPLETED|Overall Study||77
11350068|NCT03020966|12547017|FG000|NOT COMPLETED|Overall Study||2
11350069|NCT03020966|12547018|FG001|NOT COMPLETED|Overall Study||0
11350070|NCT03020992|12547024|FG000|STARTED|Overall Study||89
11350071|NCT03020992|12547024|FG000|COMPLETED|Overall Study||83
11083661|NCT01134731|12266229|FG000|NOT COMPLETED|Overall Study||13
11083662|NCT01134731|12266230|FG001|NOT COMPLETED|Overall Study||11
11083663|NCT01134731|12266231|FG002|NOT COMPLETED|Overall Study||8
11350072|NCT03020992|12547024|FG000|NOT COMPLETED|Overall Study||6
11083664|NCT01134783|12266242|FG000|STARTED|Overall Study||224
11083665|NCT01134783|12266243|FG001|STARTED|Overall Study||217
11083666|NCT01134783|12266242|FG000|COMPLETED|Overall Study||188
11083667|NCT01134783|12266243|FG001|COMPLETED|Overall Study||180
11083668|NCT01134783|12266242|FG000|NOT COMPLETED|Overall Study||36
11083669|NCT01134783|12266243|FG001|NOT COMPLETED|Overall Study||37
11083670|NCT01134887|12266257|FG000|STARTED|Overall Study||9
11083671|NCT01134887|12266258|FG001|STARTED|Overall Study||11
11083672|NCT01134887|12266259|FG002|STARTED|Overall Study||5
11083673|NCT01134887|12266260|FG003|STARTED|Overall Study||5
11083674|NCT01134887|12266257|FG000|COMPLETED|Overall Study||9
11083675|NCT01134887|12266258|FG001|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
11083676|NCT01134887|12266259|FG002|COMPLETED|Overall Study||5
11083677|NCT01134887|12266260|FG003|COMPLETED|Overall Study||5
11083678|NCT01134887|12266257|FG000|NOT COMPLETED|Overall Study||0
11083679|NCT01134887|12266258|FG001|NOT COMPLETED|Overall Study||4
11083680|NCT01134887|12266259|FG002|NOT COMPLETED|Overall Study||0
11083681|NCT01134887|12266260|FG003|NOT COMPLETED|Overall Study||0
11083682|NCT01134900|12266270|FG000|STARTED|Overall Study||200
11083683|NCT01134900|12266271|FG001|STARTED|Overall Study||196
11083684|NCT01134900|12266270|FG000|COMPLETED|Overall Study||200
11083685|NCT01134900|12266271|FG001|COMPLETED|Overall Study||196
11083686|NCT01134900|12266270|FG000|NOT COMPLETED|Overall Study||0
11083687|NCT01134900|12266271|FG001|NOT COMPLETED|Overall Study||0
11083688|NCT01134939|12266285|FG000|STARTED|Overall Study||59
11083689|NCT01134939|12266286|FG001|STARTED|Overall Study||42
11083690|NCT01134939|12266287|FG002|STARTED|Overall Study||51
11083691|NCT01134939|12266288|FG003|STARTED|Overall Study||46
11083692|NCT01134939|12266289|FG004|STARTED|Overall Study||33
11083693|NCT01134939|12266290|FG005|STARTED|Overall Study||14
11083694|NCT01134939|12266291|FG006|STARTED|Overall Study||19
11083695|NCT01134939|12266292|FG007|STARTED|Overall Study||1
11083696|NCT01134939|12266285|FG000|COMPLETED|Overall Study||42
11083697|NCT01134939|12266286|FG001|COMPLETED|Overall Study||24
11083698|NCT01134939|12266287|FG002|COMPLETED|Overall Study||41
11083699|NCT01134939|12266288|FG003|COMPLETED|Overall Study||32
11083700|NCT01134939|12266289|FG004|COMPLETED|Overall Study||23
11083701|NCT01134939|12266290|FG005|COMPLETED|Overall Study||5
11083702|NCT01134939|12266291|FG006|COMPLETED|Overall Study||10
11083703|NCT01134939|12266292|FG007|COMPLETED|Overall Study||1
11083704|NCT01134939|12266285|FG000|NOT COMPLETED|Overall Study||17
11083705|NCT01134939|12266286|FG001|NOT COMPLETED|Overall Study||18
11083706|NCT01134939|12266287|FG002|NOT COMPLETED|Overall Study||10
11083707|NCT01134939|12266288|FG003|NOT COMPLETED|Overall Study||14
11083708|NCT01134939|12266289|FG004|NOT COMPLETED|Overall Study||10
11083709|NCT01134939|12266290|FG005|NOT COMPLETED|Overall Study||9
11083710|NCT01134939|12266291|FG006|NOT COMPLETED|Overall Study||9
11083711|NCT01134939|12266292|FG007|NOT COMPLETED|Overall Study||0
11083712|NCT01134952|12266306|FG000|STARTED|Overall Study||11
11083713|NCT01134952|12266306|FG000|COMPLETED|Overall Study||11
11083714|NCT01134952|12266306|FG000|NOT COMPLETED|Overall Study||0
11083715|NCT01135017|12266316|FG000|STARTED|Overall Study||55
11083716|NCT01135017|12266317|FG001|STARTED|Overall Study||57
11083717|NCT01135017|12266316|FG000|Treated|Overall Study||55
11083718|NCT01135017|12266317|FG001|Treated|Overall Study||57
11083719|NCT01135017|12266316|FG000|Evaluable for Efficacy|Overall Study||55
11083720|NCT01135017|12266317|FG001|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
11083721|NCT01135017|12266316|FG000|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
11083722|NCT01135017|12266317|FG001|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
11083723|NCT01135017|12266316|FG000|NOT COMPLETED|Overall Study||6
11083724|NCT01135017|12266317|FG001|NOT COMPLETED|Overall Study||12
11083725|NCT01135069|12266326|FG000|STARTED|Overall Study||205
11083726|NCT01135069|12266327|FG001|STARTED|Overall Study||209
11083727|NCT01135069|12266328|FG002|STARTED|Overall Study||66
11083728|NCT01135069|12266326|FG000|COMPLETED|Overall Study||169
11083729|NCT01135069|12266327|FG001|COMPLETED|Overall Study||177
11083730|NCT01135069|12266328|FG002|COMPLETED|Overall Study||56
11083731|NCT01135069|12266326|FG000|NOT COMPLETED|Overall Study||36
11083732|NCT01135069|12266327|FG001|NOT COMPLETED|Overall Study||32
11083733|NCT01135069|12266328|FG002|NOT COMPLETED|Overall Study||10
11083734|NCT01135095|12266336|FG000|STARTED|Overall Study||101
11083735|NCT01135095|12266336|FG000|COMPLETED|Overall Study||101
11083736|NCT01135095|12266336|FG000|NOT COMPLETED|Overall Study||0
11083737|NCT01135186|12266340|FG000|STARTED|Overall Study||9
11083738|NCT01135186|12266340|FG000|COMPLETED|Overall Study||9
11083739|NCT01135186|12266340|FG000|NOT COMPLETED|Overall Study||0
11083740|NCT01135329|12266346|FG000|STARTED|Overall Study||15
11083741|NCT01135329|12266346|FG000|COMPLETED|Overall Study||15
11083742|NCT01135329|12266346|FG000|NOT COMPLETED|Overall Study||0
11083743|NCT01135368|12266351|FG000|STARTED|Overall Study||506
11083744|NCT01135368|12266351|FG000|COMPLETED|Overall Study||255
11083745|NCT01135368|12266351|FG000|NOT COMPLETED|Overall Study||251
11083746|NCT01135381|12266393|FG000|STARTED|Overall Study||189
11083747|NCT01135381|12266394|FG001|STARTED|Overall Study||185
11083748|NCT01135381|12266395|FG002|STARTED|Overall Study||69
11083749|NCT01135381|12266396|FG003|STARTED|Overall Study||68
11083750|NCT01135381|12266393|FG000|COMPLETED|Overall Study||168
11083751|NCT01135381|12266394|FG001|COMPLETED|Overall Study||178
11083752|NCT01135381|12266395|FG002|COMPLETED|Overall Study||65
11083753|NCT01135381|12266396|FG003|COMPLETED|Overall Study||67
11083754|NCT01135381|12266393|FG000|NOT COMPLETED|Overall Study||21
11083755|NCT01135381|12266394|FG001|NOT COMPLETED|Overall Study||7
11083756|NCT01135381|12266395|FG002|NOT COMPLETED|Overall Study||4
11083757|NCT01135381|12266396|FG003|NOT COMPLETED|Overall Study||1
11083758|NCT01135394|12266406|FG000|STARTED|Screening||114
11083759|NCT01135394|12266406|FG000|COMPLETED|Screening||81
11083760|NCT01135394|12266406|FG000|NOT COMPLETED|Screening||33
11083761|NCT01135394|12266406|FG000|STARTED|Baseline Assessment||81
11083762|NCT01135394|12266406|FG000|COMPLETED|Baseline Assessment||66
11083763|NCT01135394|12266406|FG000|NOT COMPLETED|Baseline Assessment||15
11083764|NCT01135394|12266406|FG000|STARTED|Study Treatment||66
11083765|NCT01135394|12266406|FG000|COMPLETED|Study Treatment||62
11083766|NCT01135394|12266406|FG000|NOT COMPLETED|Study Treatment||4
11083767|NCT01135420|12266412|FG000|STARTED|Overall Study||199
11083768|NCT01135420|12266413|FG001|STARTED|Overall Study||207
11083769|NCT01135420|12266412|FG000|COMPLETED|Overall Study||155
11083770|NCT01135420|12266413|FG001|COMPLETED|Overall Study||175
11083771|NCT01135420|12266412|FG000|NOT COMPLETED|Overall Study||44
11083772|NCT01135420|12266413|FG001|NOT COMPLETED|Overall Study||32
11083773|NCT01135498|12266419|FG000|STARTED|Overall Study||90
11083774|NCT01135498|12266419|FG000|COMPLETED|Overall Study||0
11083775|NCT01135498|12266419|FG000|NOT COMPLETED|Overall Study||90
11083776|NCT01135511|12266433|FG000|STARTED|Overall Study||41
11083777|NCT01135511|12266434|FG001|STARTED|Overall Study||42
11083778|NCT01135511|12266435|FG002|STARTED|Overall Study||41
11083779|NCT01135511|12266436|FG003|STARTED|Overall Study||40
11083780|NCT01135511|12266437|FG004|STARTED|Overall Study||39
11083781|NCT01135511|12266438|FG005|STARTED|Overall Study||21
11083782|NCT01135511|12266439|FG006|STARTED|Overall Study||19
11083783|NCT01135511|12266440|FG007|STARTED|Overall Study||21
11083784|NCT01135511|12266441|FG008|STARTED|Overall Study||21
11083785|NCT01135511|12266433|FG000|COMPLETED|Overall Study||41
11083786|NCT01135511|12266434|FG001|COMPLETED|Overall Study||39
11083787|NCT01135511|12266435|FG002|COMPLETED|Overall Study||33
11083788|NCT01135511|12266436|FG003|COMPLETED|Overall Study||37
11083789|NCT01135511|12266437|FG004|COMPLETED|Overall Study||38
11083790|NCT01135511|12266438|FG005|COMPLETED|Overall Study||20
11083791|NCT01135511|12266439|FG006|COMPLETED|Overall Study||18
11083792|NCT01135511|12266440|FG007|COMPLETED|Overall Study||20
11083793|NCT01135511|12266441|FG008|COMPLETED|Overall Study||20
11083794|NCT01135511|12266433|FG000|NOT COMPLETED|Overall Study||0
11083795|NCT01135511|12266434|FG001|NOT COMPLETED|Overall Study||3
11083796|NCT01135511|12266435|FG002|NOT COMPLETED|Overall Study||8
11083797|NCT01135511|12266436|FG003|NOT COMPLETED|Overall Study||3
11083798|NCT01135511|12266437|FG004|NOT COMPLETED|Overall Study||1
11083799|NCT01135511|12266438|FG005|NOT COMPLETED|Overall Study||1
11083800|NCT01135511|12266439|FG006|NOT COMPLETED|Overall Study||1
11083801|NCT01135511|12266440|FG007|NOT COMPLETED|Overall Study||1
11083802|NCT01135511|12266441|FG008|NOT COMPLETED|Overall Study||1
11083803|NCT01135524|12266461|FG000|STARTED|Overall Study||196
11083804|NCT01135524|12266461|FG000|COMPLETED|Overall Study||0
11083805|NCT01135524|12266461|FG000|NOT COMPLETED|Overall Study||196
11083806|NCT01135537|12266465|FG000|STARTED|Overall Study||30
11083807|NCT01135537|12266465|FG000|COMPLETED|Overall Study||17
11083808|NCT01135537|12266465|FG000|NOT COMPLETED|Overall Study||13
11083809|NCT01135914|12266472|FG000|STARTED|Overall Study||78
11083810|NCT01135914|12266473|FG001|STARTED|Overall Study||80
11083811|NCT01135914|12266474|FG002|STARTED|Overall Study||81
11083812|NCT01135914|12266472|FG000|Intent to Treat (ITT) Population|Overall Study||73
11083813|NCT01135914|12266473|FG001|Intent to Treat (ITT) Population|Overall Study||75
11083814|NCT01135914|12266474|FG002|Intent to Treat (ITT) Population|Overall Study||72
11083815|NCT01135914|12266472|FG000|Safety Population|Overall Study||73
11083816|NCT01135914|12266473|FG001|Safety Population|Overall Study||75
11083817|NCT01135914|12266474|FG002|Safety Population|Overall Study||74
11083818|NCT01135914|12266472|FG000|COMPLETED|Overall Study||74
11083819|NCT01135914|12266473|FG001|COMPLETED|Overall Study||75
11083820|NCT01135914|12266474|FG002|COMPLETED|Overall Study||59
11350073|NCT03021005|12547031|FG000|STARTED|Overall Study||102
11350074|NCT03021005|12547032|FG001|STARTED|Overall Study||98
11350075|NCT03021005|12547031|FG000|COMPLETED|Overall Study||63
11350076|NCT03021005|12547032|FG001|COMPLETED|Overall Study||72
11350077|NCT03021005|12547031|FG000|NOT COMPLETED|Overall Study||39
11350078|NCT03021005|12547032|FG001|NOT COMPLETED|Overall Study||26
11350079|NCT03021018|12547041|FG000|STARTED|Overall Study||16
11350080|NCT03021018|12547042|FG001|STARTED|Overall Study||15
11350081|NCT03021018|12547043|FG002|STARTED|Overall Study||15
11350082|NCT03021018|12547041|FG000|COMPLETED|Overall Study||14
11350083|NCT03021018|12547042|FG001|COMPLETED|Overall Study||15
11350084|NCT03021018|12547043|FG002|COMPLETED|Overall Study||15
11350085|NCT03021018|12547041|FG000|NOT COMPLETED|Overall Study||2
11350086|NCT03021018|12547042|FG001|NOT COMPLETED|Overall Study||0
11350087|NCT03021018|12547043|FG002|NOT COMPLETED|Overall Study||0
11350088|NCT03021187|12547055|FG000|STARTED|Overall Study||184
11350089|NCT03021187|12547056|FG001|STARTED|Overall Study||182
11350090|NCT03021187|12547057|FG002|STARTED|Overall Study||181
11350091|NCT03021187|12547058|FG003|STARTED|Overall Study||184
11350092|NCT03021187|12547055|FG000|Exposed|Overall Study||184
11350093|NCT03021187|12547056|FG001|Exposed|Overall Study||181
11350094|NCT03021187|12547057|FG002|Exposed|Overall Study||181
11350095|NCT03021187|12547058|FG003|Exposed|Overall Study||184
11350096|NCT03021187|12547055|FG000|Full Analysis Set (FAS)|Overall Study||184
11350097|NCT03021187|12547056|FG001|Full Analysis Set (FAS)|Overall Study||182
11350098|NCT03021187|12547057|FG002|Full Analysis Set (FAS)|Overall Study||181
11350099|NCT03021187|12547058|FG003|Full Analysis Set (FAS)|Overall Study||184
11350100|NCT03021187|12547055|FG000|Safety Analysis Set (SAS)|Overall Study||184
11350101|NCT03021187|12547056|FG001|Safety Analysis Set (SAS)|Overall Study||181
11350102|NCT03021187|12547057|FG002|Safety Analysis Set (SAS)|Overall Study||181
11350103|NCT03021187|12547058|FG003|Safety Analysis Set (SAS)|Overall Study||184
11350104|NCT03021187|12547055|FG000|COMPLETED|Overall Study||174
11350105|NCT03021187|12547056|FG001|COMPLETED|Overall Study||173
11350106|NCT03021187|12547057|FG002|COMPLETED|Overall Study||175
11350107|NCT03021187|12547058|FG003|COMPLETED|Overall Study||175
11350108|NCT03021187|12547055|FG000|NOT COMPLETED|Overall Study||10
11350109|NCT03021187|12547056|FG001|NOT COMPLETED|Overall Study||9
11083821|NCT01135914|12266472|FG000|NOT COMPLETED|Overall Study||4
11083822|NCT01135914|12266473|FG001|NOT COMPLETED|Overall Study||5
11083823|NCT01135914|12266474|FG002|NOT COMPLETED|Overall Study||22
11083824|NCT01135992|12266482|FG000|STARTED|Overall Study||143
11083825|NCT01135992|12266482|FG000|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
11350110|NCT03021187|12547057|FG002|NOT COMPLETED|Overall Study||6
11350111|NCT03021187|12547058|FG003|NOT COMPLETED|Overall Study||9
11350112|NCT03021265|12547068|FG000|STARTED|Overall Study||676
11083826|NCT01135992|12266482|FG000|Full Analysis Set|Overall Study||129
11083827|NCT01135992|12266482|FG000|COMPLETED|Overall Study||122
11083828|NCT01135992|12266482|FG000|NOT COMPLETED|Overall Study||21
11083829|NCT01136174|12266490|FG000|STARTED|Overall Study||12
11083830|NCT01136174|12266491|FG001|STARTED|Overall Study||6
11083831|NCT01136174|12266492|FG002|STARTED|Overall Study||8
11083832|NCT01136174|12266493|FG003|STARTED|Overall Study||24
11083833|NCT01136174|12266490|FG000|COMPLETED|Overall Study||12
11083834|NCT01136174|12266491|FG001|COMPLETED|Overall Study||6
11350113|NCT03021265|12547068|FG000|COMPLETED|Overall Study||554
11350114|NCT03021265|12547068|FG000|NOT COMPLETED|Overall Study||122
11350115|NCT03021304|12547072|FG000|STARTED|Overall Study||56
11083835|NCT01136174|12266492|FG002|COMPLETED|Overall Study||8
11083836|NCT01136174|12266493|FG003|COMPLETED|Overall Study||20
11083837|NCT01136174|12266490|FG000|NOT COMPLETED|Overall Study||0
11083838|NCT01136174|12266491|FG001|NOT COMPLETED|Overall Study||0
11083839|NCT01136174|12266492|FG002|NOT COMPLETED|Overall Study||0
11083840|NCT01136174|12266493|FG003|NOT COMPLETED|Overall Study||4
11083841|NCT01136226|12266512|FG000|STARTED|Overall Study||42
11083842|NCT01136226|12266512|FG000|COMPLETED|Overall Study||29
11083843|NCT01136226|12266512|FG000|NOT COMPLETED|Overall Study||13
11083844|NCT01136291|12266519|FG000|STARTED|Overall Study||40
11083845|NCT01136291|12266520|FG001|STARTED|Overall Study||42
11083846|NCT01136291|12266519|FG000|Follow|Overall Study||40
11083847|NCT01136291|12266520|FG001|Follow|Overall Study||42
11083848|NCT01136291|12266519|FG000|COMPLETED|Overall Study||39
11083849|NCT01136291|12266520|FG001|COMPLETED|Overall Study||41
11083850|NCT01136291|12266519|FG000|NOT COMPLETED|Overall Study||1
11083851|NCT01136291|12266520|FG001|NOT COMPLETED|Overall Study||1
11083852|NCT01136356|12266526|FG000|STARTED|First Intervention||6
11083853|NCT01136356|12266527|FG001|STARTED|First Intervention||6
11083854|NCT01136356|12266526|FG000|COMPLETED|First Intervention||6
11083855|NCT01136356|12266527|FG001|COMPLETED|First Intervention||6
11083856|NCT01136356|12266526|FG000|NOT COMPLETED|First Intervention||0
11083857|NCT01136356|12266527|FG001|NOT COMPLETED|First Intervention||0
11083858|NCT01136356|12266526|FG000|STARTED|First 18-day Withdrawal||6
11083859|NCT01136356|12266527|FG001|STARTED|First 18-day Withdrawal||6
11083860|NCT01136356|12266526|FG000|COMPLETED|First 18-day Withdrawal||2
11083861|NCT01136356|12266527|FG001|COMPLETED|First 18-day Withdrawal||6
11083862|NCT01136356|12266526|FG000|NOT COMPLETED|First 18-day Withdrawal||4
11083863|NCT01136356|12266527|FG001|NOT COMPLETED|First 18-day Withdrawal||0
11083864|NCT01136356|12266526|FG000|STARTED|Second Intervention||2
11083865|NCT01136356|12266527|FG001|STARTED|Second Intervention||6
11083866|NCT01136356|12266526|FG000|COMPLETED|Second Intervention||2
11083867|NCT01136356|12266527|FG001|COMPLETED|Second Intervention||6
11083868|NCT01136356|12266526|FG000|NOT COMPLETED|Second Intervention||0
11083869|NCT01136356|12266527|FG001|NOT COMPLETED|Second Intervention||0
11083870|NCT01136356|12266526|FG000|STARTED|Second 18-day Withdrawal||2
11083871|NCT01136356|12266527|FG001|STARTED|Second 18-day Withdrawal||6
11083872|NCT01136356|12266526|FG000|COMPLETED|Second 18-day Withdrawal||2
11083873|NCT01136356|12266527|FG001|COMPLETED|Second 18-day Withdrawal||5
11083874|NCT01136356|12266526|FG000|NOT COMPLETED|Second 18-day Withdrawal||0
11083875|NCT01136356|12266527|FG001|NOT COMPLETED|Second 18-day Withdrawal||1
11083876|NCT01136382|12266534|FG000|STARTED|Overall Study||152
11083877|NCT01136382|12266535|FG001|STARTED|Overall Study||152
11083878|NCT01136382|12266534|FG000|COMPLETED|Overall Study||92
11083879|NCT01136382|12266535|FG001|COMPLETED|Overall Study||121
11350116|NCT03021304|12547072|FG000|COMPLETED|Overall Study||55
11350117|NCT03021304|12547072|FG000|NOT COMPLETED|Overall Study||1
11350118|NCT03021343|12547078|FG000|STARTED|Overall Study||179
11350119|NCT03021343|12547079|FG001|STARTED|Overall Study||181
11350120|NCT03021343|12547078|FG000|COMPLETED|Overall Study||174
11350121|NCT03021343|12547079|FG001|COMPLETED|Overall Study||174
11350122|NCT03021343|12547078|FG000|NOT COMPLETED|Overall Study||5
11350123|NCT03021343|12547079|FG001|NOT COMPLETED|Overall Study||7
11350124|NCT03021499|12547087|FG000|STARTED|Overall Study||179
11350125|NCT03021499|12547088|FG001|STARTED|Overall Study||178
11350126|NCT03021499|12547087|FG000|Week 24|Overall Study||167
11350127|NCT03021499|12547088|FG001|Week 24|Overall Study||162
11350128|NCT03021499|12547087|FG000|Week 52|Overall Study||162
11083880|NCT01136382|12266534|FG000|NOT COMPLETED|Overall Study||60
11083881|NCT01136382|12266535|FG001|NOT COMPLETED|Overall Study||31
11083882|NCT01136408|12266544|FG000|STARTED|Overall Study||46
11083883|NCT01136408|12266545|FG001|STARTED|Overall Study||58
11083884|NCT01136408|12266546|FG002|STARTED|Overall Study||62
11083885|NCT01136408|12266544|FG000|COMPLETED|Overall Study||41
11083886|NCT01136408|12266545|FG001|COMPLETED|Overall Study||49
11083887|NCT01136408|12266546|FG002|COMPLETED|Overall Study||57
11083888|NCT01136408|12266544|FG000|NOT COMPLETED|Overall Study||5
11083889|NCT01136408|12266545|FG001|NOT COMPLETED|Overall Study||9
11083890|NCT01136408|12266546|FG002|NOT COMPLETED|Overall Study||5
11083891|NCT01136486|12266558|FG000|STARTED|Overall Study||56
11083892|NCT01136486|12266558|FG000|COMPLETED|Overall Study||56
11083893|NCT01136486|12266558|FG000|NOT COMPLETED|Overall Study||0
11083894|NCT01136655|12266562|FG000|STARTED|BUD 160/FM 2.25 (1 Dose)||54
11083895|NCT01136655|12266562|FG000|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
11083896|NCT01136655|12266562|FG000|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
11083897|NCT01136655|12266562|FG000|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
11083898|NCT01136655|12266562|FG000|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
11083899|NCT01136655|12266562|FG000|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
11083900|NCT01136655|12266562|FG000|STARTED|BUD 160/FM 4.5 (1 Dose)||53
11083901|NCT01136655|12266562|FG000|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
11083902|NCT01136655|12266562|FG000|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
11083903|NCT01136655|12266562|FG000|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
11083904|NCT01136655|12266562|FG000|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
11083905|NCT01136655|12266562|FG000|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
11083906|NCT01136655|12266562|FG000|STARTED|BUD 160/FM 9.0 (1 Dose)||53
11083907|NCT01136655|12266562|FG000|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
11350129|NCT03021499|12547088|FG001|Week 52|Overall Study||147
11350130|NCT03021499|12547087|FG000|COMPLETED|Overall Study||163
11350131|NCT03021499|12547088|FG001|COMPLETED|Overall Study||147
11083908|NCT01136655|12266562|FG000|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
11083909|NCT01136655|12266562|FG000|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
11083910|NCT01136655|12266562|FG000|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
11083911|NCT01136655|12266562|FG000|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
11083912|NCT01136655|12266562|FG000|STARTED|BUD 160 (1 Dose)||51
11083913|NCT01136655|12266562|FG000|COMPLETED|BUD 160 (1 Dose)||51
11083914|NCT01136655|12266562|FG000|NOT COMPLETED|BUD 160 (1 Dose)||0
11083915|NCT01136655|12266562|FG000|STARTED|Washout After BUD 160 (7 Days)||51
11083916|NCT01136655|12266562|FG000|COMPLETED|Washout After BUD 160 (7 Days)||51
11083917|NCT01136655|12266562|FG000|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
11083918|NCT01136655|12266562|FG000|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
11083919|NCT01136655|12266562|FG000|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
11083920|NCT01136655|12266562|FG000|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
11083921|NCT01136655|12266562|FG000|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
11083922|NCT01136655|12266562|FG000|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
11083923|NCT01136655|12266562|FG000|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
11083924|NCT01136733|12266582|FG000|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7
11083925|NCT01136733|12266583|FG001|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11
11083926|NCT01136733|12266584|FG002|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2
11083927|NCT01136733|12266585|FG003|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0
11083928|NCT01136733|12266586|FG004|STARTED|Phase 1b||0
11083929|NCT01136733|12266587|FG005|STARTED|Phase 1b||0
11083930|NCT01136733|12266588|FG006|STARTED|Phase 1b||0
11083931|NCT01136733|12266582|FG000|COMPLETED|Phase 1b||6
11083932|NCT01136733|12266583|FG001|COMPLETED|Phase 1b||6
11083933|NCT01136733|12266584|FG002|COMPLETED|Phase 1b||0
11083934|NCT01136733|12266585|FG003|COMPLETED|Phase 1b||0
11083935|NCT01136733|12266586|FG004|COMPLETED|Phase 1b||0
11083936|NCT01136733|12266587|FG005|COMPLETED|Phase 1b||0
11083937|NCT01136733|12266588|FG006|COMPLETED|Phase 1b||0
11083938|NCT01136733|12266582|FG000|NOT COMPLETED|Phase 1b||1
11083939|NCT01136733|12266583|FG001|NOT COMPLETED|Phase 1b||5
11083940|NCT01136733|12266584|FG002|NOT COMPLETED|Phase 1b||2
11083941|NCT01136733|12266585|FG003|NOT COMPLETED|Phase 1b||0
11083942|NCT01136733|12266586|FG004|NOT COMPLETED|Phase 1b||0
11083943|NCT01136733|12266587|FG005|NOT COMPLETED|Phase 1b||0
11083944|NCT01136733|12266588|FG006|NOT COMPLETED|Phase 1b||0
11083945|NCT01136733|12266582|FG000|STARTED|Phase 2||0
11083946|NCT01136733|12266583|FG001|STARTED|Phase 2||0
11083947|NCT01136733|12266584|FG002|STARTED|Phase 2||0
11083948|NCT01136733|12266585|FG003|STARTED|Phase 2||0
11083949|NCT01136733|12266586|FG004|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51
11083950|NCT01136733|12266587|FG005|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52
11083951|NCT01136733|12266588|FG006|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50
11083952|NCT01136733|12266582|FG000|COMPLETED|Phase 2||0
11083953|NCT01136733|12266583|FG001|COMPLETED|Phase 2||0
11083954|NCT01136733|12266584|FG002|COMPLETED|Phase 2||0
11083955|NCT01136733|12266585|FG003|COMPLETED|Phase 2||0
11083956|NCT01136733|12266586|FG004|COMPLETED|Phase 2||0
11083957|NCT01136733|12266587|FG005|COMPLETED|Phase 2||0
11083958|NCT01136733|12266588|FG006|COMPLETED|Phase 2||0
11083959|NCT01136733|12266582|FG000|NOT COMPLETED|Phase 2||0
11083960|NCT01136733|12266583|FG001|NOT COMPLETED|Phase 2||0
11083961|NCT01136733|12266584|FG002|NOT COMPLETED|Phase 2||0
11083962|NCT01136733|12266585|FG003|NOT COMPLETED|Phase 2||0
11083963|NCT01136733|12266586|FG004|NOT COMPLETED|Phase 2||51
11083964|NCT01136733|12266587|FG005|NOT COMPLETED|Phase 2||52
11083965|NCT01136733|12266588|FG006|NOT COMPLETED|Phase 2||50
11083966|NCT01136746|12266620|FG000|STARTED|Overall Study||9
11083967|NCT01136746|12266621|FG001|STARTED|Overall Study||7
11083968|NCT01136746|12266620|FG000|COMPLETED|Overall Study||6
11083969|NCT01136746|12266621|FG001|COMPLETED|Overall Study||4
11083970|NCT01136746|12266620|FG000|NOT COMPLETED|Overall Study||3
11083971|NCT01136746|12266621|FG001|NOT COMPLETED|Overall Study||3
11083972|NCT01136772|12266629|FG000|STARTED|Overall Study||157
11083973|NCT01136772|12266630|FG001|STARTED|Overall Study||154
11083974|NCT01136772|12266629|FG000|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
11083975|NCT01136772|12266630|FG001|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
11083976|NCT01136772|12266629|FG000|COMPLETED|Overall Study||41
11083977|NCT01136772|12266630|FG001|COMPLETED|Overall Study||44
11083978|NCT01136772|12266629|FG000|NOT COMPLETED|Overall Study||116
11083979|NCT01136772|12266630|FG001|NOT COMPLETED|Overall Study||110
11083980|NCT01136785|12266638|FG000|STARTED|Overall Study||15
11083981|NCT01136785|12266639|FG001|STARTED|Overall Study||7
11083982|NCT01136785|12266638|FG000|COMPLETED|Overall Study||13
11083983|NCT01136785|12266639|FG001|COMPLETED|Overall Study||6
11083984|NCT01136785|12266638|FG000|NOT COMPLETED|Overall Study||2
11083985|NCT01136785|12266639|FG001|NOT COMPLETED|Overall Study||1
11083986|NCT01136798|12266651|FG000|STARTED|Overall Study||10
11083987|NCT01136798|12266652|FG001|STARTED|Overall Study||8
11083988|NCT01136798|12266651|FG000|COMPLETED|Overall Study||10
11083989|NCT01136798|12266652|FG001|COMPLETED|Overall Study||8
11083990|NCT01136798|12266651|FG000|NOT COMPLETED|Overall Study||0
11083991|NCT01136798|12266652|FG001|NOT COMPLETED|Overall Study||0
11083992|NCT01136876|12266660|FG000|STARTED|Overall Study||28
11083993|NCT01136876|12266661|FG001|STARTED|Overall Study||29
11083994|NCT01136876|12266660|FG000|COMPLETED|Overall Study||23
11083995|NCT01136876|12266661|FG001|COMPLETED|Overall Study||18
11083996|NCT01136876|12266660|FG000|NOT COMPLETED|Overall Study||5
11083997|NCT01136876|12266661|FG001|NOT COMPLETED|Overall Study||11
11083998|NCT01136915|12266671|FG000|STARTED|Overall Study||8
11083999|NCT01136915|12266672|FG001|STARTED|Overall Study||7
11084000|NCT01136915|12266671|FG000|COMPLETED|Overall Study||6
11084001|NCT01136915|12266672|FG001|COMPLETED|Overall Study||6
11084002|NCT01136915|12266671|FG000|NOT COMPLETED|Overall Study||2
11084003|NCT01136915|12266672|FG001|NOT COMPLETED|Overall Study||1
11084004|NCT01136954|12266682|FG000|STARTED|Overall Study||72
11084005|NCT01136954|12266683|FG001|STARTED|Overall Study||72
11084006|NCT01136954|12266682|FG000|COMPLETED|Overall Study||48
11084007|NCT01136954|12266683|FG001|COMPLETED|Overall Study||51
11084008|NCT01136954|12266682|FG000|NOT COMPLETED|Overall Study||24
11084009|NCT01136954|12266683|FG001|NOT COMPLETED|Overall Study||21
11084010|NCT01137006|12266697|FG000|STARTED|Overall Study||3
11084011|NCT01137006|12266698|FG001|STARTED|Overall Study||3
11084012|NCT01137006|12266699|FG002|STARTED|Overall Study||8
11084013|NCT01137006|12266700|FG003|STARTED|Overall Study||3
11084014|NCT01137006|12266701|FG004|STARTED|Overall Study||3
11084015|NCT01137006|12266702|FG005|STARTED|Overall Study||4
11084016|NCT01137006|12266703|FG006|STARTED|Overall Study||3
11084017|NCT01137006|12266697|FG000|Completed at Least 1 Treatment Cycle|Overall Study||3
11350132|NCT03021499|12547087|FG000|NOT COMPLETED|Overall Study||16
11350133|NCT03021499|12547088|FG001|NOT COMPLETED|Overall Study||31
11350134|NCT03021538|12547098|FG000|STARTED|Overall Study||6
11350135|NCT03021538|12547099|FG001|STARTED|Overall Study||7
11350136|NCT03021538|12547098|FG000|COMPLETED|Overall Study||6
11350137|NCT03021538|12547099|FG001|COMPLETED|Overall Study||7
11350138|NCT03021538|12547098|FG000|NOT COMPLETED|Overall Study||0
11350139|NCT03021538|12547099|FG001|NOT COMPLETED|Overall Study||0
11350140|NCT03021564|12547107|FG000|STARTED|Overall Study||120
11350141|NCT03021564|12547108|FG001|STARTED|Overall Study||557
11350142|NCT03021564|12547107|FG000|COMPLETED|Overall Study||36
11350143|NCT03021564|12547108|FG001|COMPLETED|Overall Study||89
11350144|NCT03021564|12547107|FG000|NOT COMPLETED|Overall Study||84
11350145|NCT03021564|12547108|FG001|NOT COMPLETED|Overall Study||468
11350146|NCT03021668|12547120|FG000|STARTED|Overall Study||62
11350147|NCT03021668|12547121|FG001|STARTED|Overall Study||62
11350148|NCT03021668|12547120|FG000|COMPLETED|Overall Study||62
11350149|NCT03021668|12547121|FG001|COMPLETED|Overall Study||61
11350150|NCT03021668|12547120|FG000|NOT COMPLETED|Overall Study||0
11350151|NCT03021668|12547121|FG001|NOT COMPLETED|Overall Study||1
11350152|NCT03021759|12547130|FG000|STARTED|Overall Study||1566
11350153|NCT03021759|12547131|FG001|STARTED|Overall Study||1743
11350154|NCT03021759|12547132|FG002|STARTED|Overall Study||1465
11350155|NCT03021759|12547130|FG000|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566
11350156|NCT03021759|12547131|FG001|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743
11350157|NCT03021759|12547132|FG002|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465
11350158|NCT03021759|12547130|FG000|NOT COMPLETED|Overall Study||0
11350159|NCT03021759|12547131|FG001|NOT COMPLETED|Overall Study||0
11350160|NCT03021759|12547132|FG002|NOT COMPLETED|Overall Study||0
11350161|NCT03022045|12547142|FG000|STARTED|Overall Study||9
11350162|NCT03022045|12547143|FG001|STARTED|Overall Study||8
11350163|NCT03022045|12547142|FG000|COMPLETED|Overall Study||8
11350164|NCT03022045|12547143|FG001|COMPLETED|Overall Study||6
11350165|NCT03022045|12547142|FG000|NOT COMPLETED|Overall Study||1
11350166|NCT03022045|12547143|FG001|NOT COMPLETED|Overall Study||2
11350167|NCT03022084|12547155|FG000|STARTED|Overall Study||29
11350168|NCT03022084|12547156|FG001|STARTED|Overall Study||32
11350169|NCT03022084|12547155|FG000|COMPLETED|Overall Study||27
11350170|NCT03022084|12547156|FG001|COMPLETED|Overall Study||29
11350171|NCT03022084|12547155|FG000|NOT COMPLETED|Overall Study||2
11350172|NCT03022084|12547156|FG001|NOT COMPLETED|Overall Study||3
11350173|NCT03022370|12547166|FG000|STARTED|Overall Study||677
11350174|NCT03022370|12547167|FG001|STARTED|Overall Study||674
11350175|NCT03022370|12547166|FG000|COMPLETED|Overall Study||497
11350176|NCT03022370|12547167|FG001|COMPLETED|Overall Study||553
11350177|NCT03022370|12547166|FG000|NOT COMPLETED|Overall Study||180
11350178|NCT03022370|12547167|FG001|NOT COMPLETED|Overall Study||121
11350179|NCT03022396|12547183|FG000|STARTED|Overall Study||16
11350180|NCT03022396|12547184|FG001|STARTED|Overall Study||14
11350181|NCT03022396|12547185|FG002|STARTED|Overall Study||10
11350182|NCT03022396|12547186|FG003|STARTED|Overall Study||20
11350183|NCT03022396|12547187|FG004|STARTED|Overall Study||14
11350184|NCT03022396|12547188|FG005|STARTED|Overall Study||8
11350185|NCT03022396|12547183|FG000|COMPLETED|Overall Study||16
11084018|NCT01137006|12266698|FG001|Completed at Least 1 Treatment Cycle|Overall Study||3
11350186|NCT03022396|12547184|FG001|COMPLETED|Overall Study||14
11350187|NCT03022396|12547185|FG002|COMPLETED|Overall Study||10
11350188|NCT03022396|12547186|FG003|COMPLETED|Overall Study||20
11350189|NCT03022396|12547187|FG004|COMPLETED|Overall Study||14
11350190|NCT03022396|12547188|FG005|COMPLETED|Overall Study||8
11350191|NCT03022396|12547183|FG000|NOT COMPLETED|Overall Study||0
11350192|NCT03022396|12547184|FG001|NOT COMPLETED|Overall Study||0
11350193|NCT03022396|12547185|FG002|NOT COMPLETED|Overall Study||0
11350194|NCT03022396|12547186|FG003|NOT COMPLETED|Overall Study||0
11350195|NCT03022396|12547187|FG004|NOT COMPLETED|Overall Study||0
11350196|NCT03022396|12547188|FG005|NOT COMPLETED|Overall Study||0
11350197|NCT03022422|12547208|FG000|STARTED|Overall Study||8
11350198|NCT03022422|12547209|FG001|STARTED|Overall Study||10
11350199|NCT03022422|12547210|FG002|STARTED|Overall Study||23
11350200|NCT03022422|12547211|FG003|STARTED|Overall Study||12
11350201|NCT03022422|12547212|FG004|STARTED|Overall Study||5
11350202|NCT03022422|12547213|FG005|STARTED|Overall Study||5
11350203|NCT03022422|12547208|FG000|COMPLETED|Overall Study||8
11350204|NCT03022422|12547209|FG001|COMPLETED|Overall Study||10
11350205|NCT03022422|12547210|FG002|COMPLETED|Overall Study||20
11350206|NCT03022422|12547211|FG003|COMPLETED|Overall Study||12
11350207|NCT03022422|12547212|FG004|COMPLETED|Overall Study||5
11350208|NCT03022422|12547213|FG005|COMPLETED|Overall Study||5
11350209|NCT03022422|12547208|FG000|NOT COMPLETED|Overall Study||0
11350210|NCT03022422|12547209|FG001|NOT COMPLETED|Overall Study||0
11350211|NCT03022422|12547210|FG002|NOT COMPLETED|Overall Study||3
11350212|NCT03022422|12547211|FG003|NOT COMPLETED|Overall Study||0
11350213|NCT03022422|12547212|FG004|NOT COMPLETED|Overall Study||0
11350214|NCT03022422|12547213|FG005|NOT COMPLETED|Overall Study||0
11350215|NCT03022435|12547234|FG000|STARTED|Overall Study||5
11350216|NCT03022435|12547235|FG001|STARTED|Overall Study||5
11350217|NCT03022435|12547236|FG002|STARTED|Overall Study||6
11350218|NCT03022435|12547237|FG003|STARTED|Overall Study||3
11350219|NCT03022435|12547238|FG004|STARTED|Overall Study||3
11350220|NCT03022435|12547234|FG000|COMPLETED|Overall Study||5
11350221|NCT03022435|12547235|FG001|COMPLETED|Overall Study||5
11350222|NCT03022435|12547236|FG002|COMPLETED|Overall Study||6
11350223|NCT03022435|12547237|FG003|COMPLETED|Overall Study||3
11350224|NCT03022435|12547238|FG004|COMPLETED|Overall Study||3
11350225|NCT03022435|12547234|FG000|NOT COMPLETED|Overall Study||0
11350226|NCT03022435|12547235|FG001|NOT COMPLETED|Overall Study||0
11350227|NCT03022435|12547236|FG002|NOT COMPLETED|Overall Study||0
11350228|NCT03022435|12547237|FG003|NOT COMPLETED|Overall Study||0
11350229|NCT03022435|12547238|FG004|NOT COMPLETED|Overall Study||0
11350230|NCT03022526|12547255|FG000|STARTED|Overall Study||31
11350231|NCT03022526|12547256|FG001|STARTED|Overall Study||30
11350232|NCT03022526|12547255|FG000|COMPLETED|Overall Study||21
11350233|NCT03022526|12547256|FG001|COMPLETED|Overall Study||25
11350234|NCT03022526|12547255|FG000|NOT COMPLETED|Overall Study||10
11350235|NCT03022526|12547256|FG001|NOT COMPLETED|Overall Study||5
11350236|NCT03022617|12547262|FG000|STARTED|Overall Study||12
11350237|NCT03022617|12547262|FG000|COMPLETED|Overall Study||6
11350238|NCT03022617|12547262|FG000|NOT COMPLETED|Overall Study||6
11350239|NCT03022630|12547268|FG000|STARTED|Overall Study||31
11350240|NCT03022630|12547269|FG001|STARTED|Overall Study||32
11350241|NCT03022630|12547268|FG000|COMPLETED|Overall Study||22
11350242|NCT03022630|12547269|FG001|COMPLETED|Overall Study||20
11350243|NCT03022630|12547268|FG000|NOT COMPLETED|Overall Study||9
11350244|NCT03022630|12547269|FG001|NOT COMPLETED|Overall Study||12
11350245|NCT03022799|12547293|FG000|STARTED|Overall Study||6
11350246|NCT03022799|12547294|FG001|STARTED|Overall Study||6
11350247|NCT03022799|12547295|FG002|STARTED|Overall Study||6
11350248|NCT03022799|12547296|FG003|STARTED|Overall Study||6
11350249|NCT03022799|12547297|FG004|STARTED|Overall Study||6
11350250|NCT03022799|12547298|FG005|STARTED|Overall Study||6
11350251|NCT03022799|12547299|FG006|STARTED|Overall Study||12
11350252|NCT03022799|12547300|FG007|STARTED|Overall Study||6
11350253|NCT03022799|12547301|FG008|STARTED|Overall Study||6
11350254|NCT03022799|12547302|FG009|STARTED|Overall Study||6
11350255|NCT03022799|12547303|FG010|STARTED|Overall Study||6
11350256|NCT03022799|12547304|FG011|STARTED|Overall Study||6
11350257|NCT03022799|12547305|FG012|STARTED|Overall Study||10
11350258|NCT03022799|12547293|FG000|COMPLETED|Overall Study||6
11350259|NCT03022799|12547294|FG001|COMPLETED|Overall Study||6
11350260|NCT03022799|12547295|FG002|COMPLETED|Overall Study||6
11350261|NCT03022799|12547296|FG003|COMPLETED|Overall Study||6
11350262|NCT03022799|12547297|FG004|COMPLETED|Overall Study||6
11350263|NCT03022799|12547298|FG005|COMPLETED|Overall Study||6
11350264|NCT03022799|12547299|FG006|COMPLETED|Overall Study||12
11350265|NCT03022799|12547300|FG007|COMPLETED|Overall Study||6
11350266|NCT03022799|12547301|FG008|COMPLETED|Overall Study||6
11350267|NCT03022799|12547302|FG009|COMPLETED|Overall Study||5
11350268|NCT03022799|12547303|FG010|COMPLETED|Overall Study||5
11350269|NCT03022799|12547304|FG011|COMPLETED|Overall Study||6
11350270|NCT03022799|12547305|FG012|COMPLETED|Overall Study||10
11350271|NCT03022799|12547293|FG000|NOT COMPLETED|Overall Study||0
11350272|NCT03022799|12547294|FG001|NOT COMPLETED|Overall Study||0
11350273|NCT03022799|12547295|FG002|NOT COMPLETED|Overall Study||0
11350274|NCT03022799|12547296|FG003|NOT COMPLETED|Overall Study||0
11350275|NCT03022799|12547297|FG004|NOT COMPLETED|Overall Study||0
11350276|NCT03022799|12547298|FG005|NOT COMPLETED|Overall Study||0
11350277|NCT03022799|12547299|FG006|NOT COMPLETED|Overall Study||0
11350278|NCT03022799|12547300|FG007|NOT COMPLETED|Overall Study||0
11350279|NCT03022799|12547301|FG008|NOT COMPLETED|Overall Study||0
11350280|NCT03022799|12547302|FG009|NOT COMPLETED|Overall Study||1
11350281|NCT03022799|12547303|FG010|NOT COMPLETED|Overall Study||1
11350282|NCT03022799|12547304|FG011|NOT COMPLETED|Overall Study||0
11350283|NCT03022799|12547305|FG012|NOT COMPLETED|Overall Study||0
11350284|NCT03022916|12547350|FG000|STARTED|Overall Study||5
11350285|NCT03022916|12547351|FG001|STARTED|Overall Study||5
11350286|NCT03022916|12547352|FG002|STARTED|Overall Study||5
11350287|NCT03022916|12547353|FG003|STARTED|Overall Study||5
11350288|NCT03022916|12547350|FG000|Nail Polish|Overall Study||5
11350289|NCT03022916|12547351|FG001|Nail Polish|Overall Study||5
11350290|NCT03022916|12547352|FG002|Nail Polish|Overall Study||5
11350291|NCT03022916|12547353|FG003|Nail Polish|Overall Study||5
11350292|NCT03022916|12547350|FG000|Nail Polish, Base Coat|Overall Study||5
11350293|NCT03022916|12547351|FG001|Nail Polish, Base Coat|Overall Study||5
11350294|NCT03022916|12547352|FG002|Nail Polish, Base Coat|Overall Study||5
11350295|NCT03022916|12547353|FG003|Nail Polish, Base Coat|Overall Study||5
11350296|NCT03022916|12547350|FG000|Nail Polish, Top Coat|Overall Study||5
11350297|NCT03022916|12547351|FG001|Nail Polish, Top Coat|Overall Study||5
11350298|NCT03022916|12547352|FG002|Nail Polish, Top Coat|Overall Study||5
11350299|NCT03022916|12547353|FG003|Nail Polish, Top Coat|Overall Study||5
11350300|NCT03022916|12547350|FG000|COMPLETED|Overall Study||5
11350301|NCT03022916|12547351|FG001|COMPLETED|Overall Study||5
11350302|NCT03022916|12547352|FG002|COMPLETED|Overall Study||5
11350303|NCT03022916|12547353|FG003|COMPLETED|Overall Study||5
11350304|NCT03022916|12547350|FG000|NOT COMPLETED|Overall Study||0
11350305|NCT03022916|12547351|FG001|NOT COMPLETED|Overall Study||0
11350306|NCT03022916|12547352|FG002|NOT COMPLETED|Overall Study||0
11350307|NCT03022916|12547353|FG003|NOT COMPLETED|Overall Study||0
11350308|NCT03022981|12547363|FG000|STARTED|Overall Study||102
11350309|NCT03022981|12547364|FG001|STARTED|Overall Study||73
11350310|NCT03022981|12547365|FG002|STARTED|Overall Study||41
11350311|NCT03022981|12547363|FG000|Participated in PK Lead-in (PKL) Phase|Overall Study|All 17 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|17
11350312|NCT03022981|12547364|FG001|Participated in PK Lead-in (PKL) Phase|Overall Study|All 20 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|20
11350313|NCT03022981|12547365|FG002|Participated in PK Lead-in (PKL) Phase|Overall Study|All 19 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|19
11350314|NCT03022981|12547363|FG000|COMPLETED|Overall Study||96
11350315|NCT03022981|12547364|FG001|COMPLETED|Overall Study||69
11350316|NCT03022981|12547365|FG002|COMPLETED|Overall Study||35
11350317|NCT03022981|12547363|FG000|NOT COMPLETED|Overall Study||6
11350318|NCT03022981|12547364|FG001|NOT COMPLETED|Overall Study||4
11350319|NCT03022981|12547365|FG002|NOT COMPLETED|Overall Study||6
11350320|NCT03023137|12547385|FG000|STARTED|Overall Study||178
11350321|NCT03023137|12547386|FG001|STARTED|Overall Study||171
11350322|NCT03023137|12547385|FG000|COMPLETED|Overall Study||174
11350323|NCT03023137|12547386|FG001|COMPLETED|Overall Study||162
11350324|NCT03023137|12547385|FG000|NOT COMPLETED|Overall Study||4
11350325|NCT03023137|12547386|FG001|NOT COMPLETED|Overall Study||9
11350326|NCT03023176|12547393|FG000|STARTED|Overall Study||20
11350327|NCT03023176|12547393|FG000|COMPLETED|Overall Study||20
11350328|NCT03023176|12547393|FG000|NOT COMPLETED|Overall Study||0
11350329|NCT03023397|12547400|FG000|STARTED|Run-In||8
11350330|NCT03023397|12547401|FG001|STARTED|Run-In||3
11350331|NCT03023397|12547402|FG002|STARTED|Run-In||1
11350332|NCT03023397|12547400|FG000|COMPLETED|Run-In||6
11350333|NCT03023397|12547401|FG001|COMPLETED|Run-In||3
11350334|NCT03023397|12547402|FG002|COMPLETED|Run-In||1
11350335|NCT03023397|12547400|FG000|NOT COMPLETED|Run-In||2
11350336|NCT03023397|12547401|FG001|NOT COMPLETED|Run-In||0
11350337|NCT03023397|12547402|FG002|NOT COMPLETED|Run-In||0
11350338|NCT03023397|12547400|FG000|STARTED|Main Study||6
11350339|NCT03023397|12547401|FG001|STARTED|Main Study||3
11350340|NCT03023397|12547402|FG002|STARTED|Main Study||1
11350341|NCT03023397|12547400|FG000|COMPLETED|Main Study||6
11350342|NCT03023397|12547401|FG001|COMPLETED|Main Study||3
11350343|NCT03023397|12547402|FG002|COMPLETED|Main Study||1
11350344|NCT03023397|12547400|FG000|NOT COMPLETED|Main Study||0
11350345|NCT03023397|12547401|FG001|NOT COMPLETED|Main Study||0
11350346|NCT03023397|12547402|FG002|NOT COMPLETED|Main Study||0
11350347|NCT03023423|12547414|FG000|STARTED|Overall Study||7
11350348|NCT03023423|12547415|FG001|STARTED|Overall Study||46
11350349|NCT03023423|12547416|FG002|STARTED|Overall Study||46
11350350|NCT03023423|12547414|FG000|Treated|Overall Study||7
11350351|NCT03023423|12547415|FG001|Treated|Overall Study||44
11350352|NCT03023423|12547416|FG002|Treated|Overall Study||44
11350353|NCT03023423|12547414|FG000|Crossover From Atezo to Dara + Atezo|Overall Study||0
11350354|NCT03023423|12547415|FG001|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8
11350355|NCT03023423|12547416|FG002|Crossover From Atezo to Dara + Atezo|Overall Study||0
11350356|NCT03023423|12547414|FG000|COMPLETED|Overall Study||0
11350357|NCT03023423|12547415|FG001|COMPLETED|Overall Study||0
11350358|NCT03023423|12547416|FG002|COMPLETED|Overall Study||0
11350359|NCT03023423|12547414|FG000|NOT COMPLETED|Overall Study||7
11350360|NCT03023423|12547415|FG001|NOT COMPLETED|Overall Study||46
11350361|NCT03023423|12547416|FG002|NOT COMPLETED|Overall Study||46
11350362|NCT03023488|12547428|FG000|STARTED|Overall Study||46
11350363|NCT03023488|12547428|FG000|COMPLETED|Overall Study||46
11350364|NCT03023488|12547428|FG000|NOT COMPLETED|Overall Study||0
11350365|NCT03023553|12547440|FG000|STARTED|Overall Study||4
11350366|NCT03023553|12547441|FG001|STARTED|Overall Study||9
11350367|NCT03023553|12547440|FG000|COMPLETED|Overall Study||4
11350368|NCT03023553|12547441|FG001|COMPLETED|Overall Study||8
11350369|NCT03023553|12547440|FG000|NOT COMPLETED|Overall Study||0
11350370|NCT03023553|12547441|FG001|NOT COMPLETED|Overall Study||1
11350371|NCT03023683|12547449|FG000|STARTED|Overall Study||0
11350372|NCT03023683|12547450|FG001|STARTED|Overall Study||18
11350373|NCT03023683|12547449|FG000|COMPLETED|Overall Study||0
11350374|NCT03023683|12547450|FG001|COMPLETED|Overall Study||17
11350375|NCT03023683|12547449|FG000|NOT COMPLETED|Overall Study||0
11350376|NCT03023683|12547450|FG001|NOT COMPLETED|Overall Study||1
11350377|NCT03023709|12547458|FG000|STARTED|Overall Study||3
11350378|NCT03023709|12547459|FG001|STARTED|Overall Study||0
11350379|NCT03023709|12547458|FG000|COMPLETED|Overall Study||3
11350380|NCT03023709|12547459|FG001|COMPLETED|Overall Study||0
11350381|NCT03023709|12547458|FG000|NOT COMPLETED|Overall Study||0
11350382|NCT03023709|12547459|FG001|NOT COMPLETED|Overall Study||0
11350383|NCT03023722|12547467|FG000|STARTED|Overall Study||18
11350384|NCT03023722|12547467|FG000|COMPLETED|Overall Study||14
11350385|NCT03023722|12547467|FG000|NOT COMPLETED|Overall Study||4
11350386|NCT03023826|12547471|FG000|STARTED|Period 1||4
11350387|NCT03023826|12547472|FG001|STARTED|Period 1||4
11350388|NCT03023826|12547473|FG002|STARTED|Period 1||5
11350389|NCT03023826|12547474|FG003|STARTED|Period 1||4
11350390|NCT03023826|12547475|FG004|STARTED|Period 1||4
11350391|NCT03023826|12547476|FG005|STARTED|Period 1||5
11350392|NCT03023826|12547471|FG000|Received at Least One Dose of Study Drug|Period 1||4
11350393|NCT03023826|12547472|FG001|Received at Least One Dose of Study Drug|Period 1||4
11350394|NCT03023826|12547473|FG002|Received at Least One Dose of Study Drug|Period 1||5
11350395|NCT03023826|12547474|FG003|Received at Least One Dose of Study Drug|Period 1||4
11350396|NCT03023826|12547475|FG004|Received at Least One Dose of Study Drug|Period 1||4
11350397|NCT03023826|12547476|FG005|Received at Least One Dose of Study Drug|Period 1||5
11350398|NCT03023826|12547471|FG000|COMPLETED|Period 1||4
11350399|NCT03023826|12547472|FG001|COMPLETED|Period 1||4
11350400|NCT03023826|12547473|FG002|COMPLETED|Period 1||5
11350401|NCT03023826|12547474|FG003|COMPLETED|Period 1||4
11350402|NCT03023826|12547475|FG004|COMPLETED|Period 1||3
11350403|NCT03023826|12547476|FG005|COMPLETED|Period 1||5
11350404|NCT03023826|12547471|FG000|NOT COMPLETED|Period 1||0
11350405|NCT03023826|12547472|FG001|NOT COMPLETED|Period 1||0
11350406|NCT03023826|12547473|FG002|NOT COMPLETED|Period 1||0
11350407|NCT03023826|12547474|FG003|NOT COMPLETED|Period 1||0
11350408|NCT03023826|12547475|FG004|NOT COMPLETED|Period 1||1
11350409|NCT03023826|12547476|FG005|NOT COMPLETED|Period 1||0
11350410|NCT03023826|12547471|FG000|STARTED|Period 2||4
11350411|NCT03023826|12547472|FG001|STARTED|Period 2||4
11350412|NCT03023826|12547473|FG002|STARTED|Period 2||5
11350413|NCT03023826|12547474|FG003|STARTED|Period 2||4
11350414|NCT03023826|12547475|FG004|STARTED|Period 2||3
11350415|NCT03023826|12547476|FG005|STARTED|Period 2||5
11350416|NCT03023826|12547471|FG000|COMPLETED|Period 2||4
11084019|NCT01137006|12266699|FG002|Completed at Least 1 Treatment Cycle|Overall Study||8
11084020|NCT01137006|12266700|FG003|Completed at Least 1 Treatment Cycle|Overall Study||3
11084021|NCT01137006|12266701|FG004|Completed at Least 1 Treatment Cycle|Overall Study||3
11084022|NCT01137006|12266702|FG005|Completed at Least 1 Treatment Cycle|Overall Study||4
11084023|NCT01137006|12266703|FG006|Completed at Least 1 Treatment Cycle|Overall Study||3
11084024|NCT01137006|12266697|FG000|COMPLETED|Overall Study||3
11084025|NCT01137006|12266698|FG001|COMPLETED|Overall Study||3
11084026|NCT01137006|12266699|FG002|COMPLETED|Overall Study||8
11084027|NCT01137006|12266700|FG003|COMPLETED|Overall Study||3
11084028|NCT01137006|12266701|FG004|COMPLETED|Overall Study||3
11084029|NCT01137006|12266702|FG005|COMPLETED|Overall Study||4
11084030|NCT01137006|12266703|FG006|COMPLETED|Overall Study||3
11350417|NCT03023826|12547472|FG001|COMPLETED|Period 2||4
11350418|NCT03023826|12547473|FG002|COMPLETED|Period 2||5
11350419|NCT03023826|12547474|FG003|COMPLETED|Period 2||4
11350420|NCT03023826|12547475|FG004|COMPLETED|Period 2||3
11350421|NCT03023826|12547476|FG005|COMPLETED|Period 2||5
11350422|NCT03023826|12547471|FG000|NOT COMPLETED|Period 2||0
11350423|NCT03023826|12547472|FG001|NOT COMPLETED|Period 2||0
11350424|NCT03023826|12547473|FG002|NOT COMPLETED|Period 2||0
11350425|NCT03023826|12547474|FG003|NOT COMPLETED|Period 2||0
11350426|NCT03023826|12547475|FG004|NOT COMPLETED|Period 2||0
11350427|NCT03023826|12547476|FG005|NOT COMPLETED|Period 2||0
11350428|NCT03023826|12547471|FG000|STARTED|Period 3||4
11350429|NCT03023826|12547472|FG001|STARTED|Period 3||4
11350430|NCT03023826|12547473|FG002|STARTED|Period 3||5
11350431|NCT03023826|12547474|FG003|STARTED|Period 3||4
11350432|NCT03023826|12547475|FG004|STARTED|Period 3||3
11350433|NCT03023826|12547476|FG005|STARTED|Period 3||5
11350434|NCT03023826|12547471|FG000|COMPLETED|Period 3||4
11350435|NCT03023826|12547472|FG001|COMPLETED|Period 3||4
11350436|NCT03023826|12547473|FG002|COMPLETED|Period 3||5
11350437|NCT03023826|12547474|FG003|COMPLETED|Period 3||4
11350438|NCT03023826|12547475|FG004|COMPLETED|Period 3||3
11350439|NCT03023826|12547476|FG005|COMPLETED|Period 3||5
11350440|NCT03023826|12547471|FG000|NOT COMPLETED|Period 3||0
11350441|NCT03023826|12547472|FG001|NOT COMPLETED|Period 3||0
11350442|NCT03023826|12547473|FG002|NOT COMPLETED|Period 3||0
11350443|NCT03023826|12547474|FG003|NOT COMPLETED|Period 3||0
11350444|NCT03023826|12547475|FG004|NOT COMPLETED|Period 3||0
11350445|NCT03023826|12547476|FG005|NOT COMPLETED|Period 3||0
11350446|NCT03023878|12547484|FG000|STARTED|Pre-Study Run-In Period||47
11350447|NCT03023878|12547484|FG000|COMPLETED|Pre-Study Run-In Period||30
11350448|NCT03023878|12547484|FG000|NOT COMPLETED|Pre-Study Run-In Period||17
11350449|NCT03023878|12547484|FG000|STARTED|Between Run-In and Treatment Periods||30
11084031|NCT01137006|12266697|FG000|NOT COMPLETED|Overall Study||0
11350450|NCT03023878|12547484|FG000|COMPLETED|Between Run-In and Treatment Periods||28
11350451|NCT03023878|12547484|FG000|NOT COMPLETED|Between Run-In and Treatment Periods||2
11350452|NCT03023878|12547484|FG000|STARTED|Treatment Period||28
11350453|NCT03023878|12547484|FG000|Started Cycle 1|Treatment Period||28
11350454|NCT03023878|12547484|FG000|Started Cycle 2|Treatment Period||11
11350455|NCT03023878|12547484|FG000|COMPLETED|Treatment Period||25
11350456|NCT03023878|12547484|FG000|NOT COMPLETED|Treatment Period||3
11350457|NCT03023878|12547484|FG000|STARTED|Long Term Follow-Up Period||28
11350458|NCT03023878|12547484|FG000|COMPLETED|Long Term Follow-Up Period||26
11350459|NCT03023878|12547484|FG000|NOT COMPLETED|Long Term Follow-Up Period||2
11350460|NCT03023891|12547488|FG000|STARTED|Overall Study||18
11350461|NCT03023891|12547488|FG000|COMPLETED|Overall Study||18
11350462|NCT03023891|12547488|FG000|NOT COMPLETED|Overall Study||0
11350463|NCT03024112|12547494|FG000|STARTED|Overall Study||25
11350464|NCT03024112|12547495|FG001|STARTED|Overall Study||26
11350465|NCT03024112|12547494|FG000|COMPLETED|Overall Study||18
11350466|NCT03024112|12547495|FG001|COMPLETED|Overall Study||26
11350467|NCT03024112|12547494|FG000|NOT COMPLETED|Overall Study||7
11350468|NCT03024112|12547495|FG001|NOT COMPLETED|Overall Study||0
11350469|NCT03024606|12547503|FG000|STARTED|Overall Study||23
11350470|NCT03024606|12547504|FG001|STARTED|Overall Study||26
11350471|NCT03024606|12547503|FG000|COMPLETED|Overall Study||14
11350472|NCT03024606|12547504|FG001|COMPLETED|Overall Study||16
11350473|NCT03024606|12547503|FG000|NOT COMPLETED|Overall Study||9
11350474|NCT03024606|12547504|FG001|NOT COMPLETED|Overall Study||10
11350475|NCT03024970|12547510|FG000|STARTED|First Intervention||34
11350476|NCT03024970|12547511|FG001|STARTED|First Intervention||38
11350477|NCT03024970|12547510|FG000|COMPLETED|First Intervention||33
11350478|NCT03024970|12547511|FG001|COMPLETED|First Intervention||38
11350479|NCT03024970|12547510|FG000|NOT COMPLETED|First Intervention||1
11350480|NCT03024970|12547511|FG001|NOT COMPLETED|First Intervention||0
11350481|NCT03024970|12547510|FG000|STARTED|Second Intervention||33
11350482|NCT03024970|12547511|FG001|STARTED|Second Intervention||38
11350483|NCT03024970|12547510|FG000|COMPLETED|Second Intervention||32
11350484|NCT03024970|12547511|FG001|COMPLETED|Second Intervention||38
11350485|NCT03024970|12547510|FG000|NOT COMPLETED|Second Intervention||1
11350486|NCT03024970|12547511|FG001|NOT COMPLETED|Second Intervention||0
11350487|NCT03025217|12547517|FG000|STARTED|Overall Study||31
11350488|NCT03025217|12547517|FG000|COMPLETED|Overall Study||27
11350489|NCT03025217|12547517|FG000|NOT COMPLETED|Overall Study||4
11350490|NCT03025945|12547523|FG000|STARTED|Overall Study||331
11350491|NCT03025945|12547524|FG001|STARTED|Overall Study||331
11350492|NCT03025945|12547523|FG000|COMPLETED|Overall Study||331
11350493|NCT03025945|12547524|FG001|COMPLETED|Overall Study||331
11350494|NCT03025945|12547523|FG000|NOT COMPLETED|Overall Study||0
11350495|NCT03025945|12547524|FG001|NOT COMPLETED|Overall Study||0
11350496|NCT03026075|12547530|FG000|STARTED|Overall Study||47
11350497|NCT03026075|12547530|FG000|COMPLETED|Overall Study||46
11350498|NCT03026075|12547530|FG000|NOT COMPLETED|Overall Study||1
11350499|NCT03026088|12547534|FG000|STARTED|Overall Study||20
11350500|NCT03026088|12547534|FG000|COMPLETED|Overall Study||0
11350501|NCT03026088|12547534|FG000|NOT COMPLETED|Overall Study||20
11350502|NCT03026166|12547540|FG000|STARTED|Overall Study||30
11350503|NCT03026166|12547541|FG001|STARTED|Overall Study||12
11350504|NCT03026166|12547540|FG000|COMPLETED|Overall Study||0
11350505|NCT03026166|12547541|FG001|COMPLETED|Overall Study||0
11350506|NCT03026166|12547540|FG000|NOT COMPLETED|Overall Study||30
11350507|NCT03026166|12547541|FG001|NOT COMPLETED|Overall Study||12
11350508|NCT03026257|12547553|FG000|STARTED|Overall Study||60
11350509|NCT03026257|12547554|FG001|STARTED|Overall Study||64
11350510|NCT03026257|12547555|FG002|STARTED|Overall Study||34
11350511|NCT03026257|12547556|FG003|STARTED|Overall Study||25
11350512|NCT03026257|12547557|FG004|STARTED|Overall Study||23
11350513|NCT03026257|12547558|FG005|STARTED|Overall Study||46
11350514|NCT03026257|12547553|FG000|Treated|Overall Study||58
11350515|NCT03026257|12547554|FG001|Treated|Overall Study||65
11350516|NCT03026257|12547555|FG002|Treated|Overall Study||35
11350517|NCT03026257|12547556|FG003|Treated|Overall Study||24
11350518|NCT03026257|12547557|FG004|Treated|Overall Study||23
11350519|NCT03026257|12547558|FG005|Treated|Overall Study||47
11350520|NCT03026257|12547553|FG000|COMPLETED|Overall Study||54
11350521|NCT03026257|12547554|FG001|COMPLETED|Overall Study||63
11350522|NCT03026257|12547555|FG002|COMPLETED|Overall Study||34
11350523|NCT03026257|12547556|FG003|COMPLETED|Overall Study||24
11350524|NCT03026257|12547557|FG004|COMPLETED|Overall Study||22
11350525|NCT03026257|12547558|FG005|COMPLETED|Overall Study||46
11350526|NCT03026257|12547553|FG000|NOT COMPLETED|Overall Study||6
11350527|NCT03026257|12547554|FG001|NOT COMPLETED|Overall Study||1
11350528|NCT03026257|12547555|FG002|NOT COMPLETED|Overall Study||0
11350529|NCT03026257|12547556|FG003|NOT COMPLETED|Overall Study||1
11350530|NCT03026257|12547557|FG004|NOT COMPLETED|Overall Study||1
11350531|NCT03026257|12547558|FG005|NOT COMPLETED|Overall Study||0
11350532|NCT03026283|12547572|FG000|STARTED|CCTA Diagnosis||586
11350533|NCT03026283|12547573|FG001|STARTED|CCTA Diagnosis||0
11350534|NCT03026283|12547574|FG002|STARTED|CCTA Diagnosis||0
11350535|NCT03026283|12547575|FG003|STARTED|CCTA Diagnosis||0
11350536|NCT03026283|12547576|FG004|STARTED|CCTA Diagnosis||0
11350537|NCT03026283|12547577|FG005|STARTED|CCTA Diagnosis||0
11350538|NCT03026283|12547578|FG006|STARTED|CCTA Diagnosis||0
11350539|NCT03026283|12547579|FG007|STARTED|CCTA Diagnosis||0
11350540|NCT03026283|12547572|FG000|COMPLETED|CCTA Diagnosis||572
11350541|NCT03026283|12547573|FG001|COMPLETED|CCTA Diagnosis||0
11350542|NCT03026283|12547574|FG002|COMPLETED|CCTA Diagnosis||0
11350543|NCT03026283|12547575|FG003|COMPLETED|CCTA Diagnosis||0
11350544|NCT03026283|12547576|FG004|COMPLETED|CCTA Diagnosis||0
11350545|NCT03026283|12547577|FG005|COMPLETED|CCTA Diagnosis||0
11350546|NCT03026283|12547578|FG006|COMPLETED|CCTA Diagnosis||0
11350547|NCT03026283|12547579|FG007|COMPLETED|CCTA Diagnosis||0
11350548|NCT03026283|12547572|FG000|NOT COMPLETED|CCTA Diagnosis||14
11350549|NCT03026283|12547573|FG001|NOT COMPLETED|CCTA Diagnosis||0
11350550|NCT03026283|12547574|FG002|NOT COMPLETED|CCTA Diagnosis||0
11350551|NCT03026283|12547575|FG003|NOT COMPLETED|CCTA Diagnosis||0
11350552|NCT03026283|12547576|FG004|NOT COMPLETED|CCTA Diagnosis||0
11350553|NCT03026283|12547577|FG005|NOT COMPLETED|CCTA Diagnosis||0
11350554|NCT03026283|12547578|FG006|NOT COMPLETED|CCTA Diagnosis||0
11350555|NCT03026283|12547579|FG007|NOT COMPLETED|CCTA Diagnosis||0
11350556|NCT03026283|12547572|FG000|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
11350557|NCT03026283|12547573|FG001|STARTED|Optimal Medical Care/FFR-CT Diagnosis||289
11350558|NCT03026283|12547574|FG002|STARTED|Optimal Medical Care/FFR-CT Diagnosis||280
11350559|NCT03026283|12547575|FG003|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
11350560|NCT03026283|12547576|FG004|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
11350561|NCT03026283|12547577|FG005|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
11350562|NCT03026283|12547578|FG006|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
11350563|NCT03026283|12547579|FG007|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
11350564|NCT03026283|12547572|FG000|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
11350565|NCT03026283|12547573|FG001|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||286
11350566|NCT03026283|12547574|FG002|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||265
11350567|NCT03026283|12547575|FG003|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
11350568|NCT03026283|12547576|FG004|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
11350569|NCT03026283|12547577|FG005|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
11350570|NCT03026283|12547578|FG006|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
11350571|NCT03026283|12547579|FG007|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
11350572|NCT03026283|12547572|FG000|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
11350573|NCT03026283|12547573|FG001|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||3
11350574|NCT03026283|12547574|FG002|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||15
11350575|NCT03026283|12547575|FG003|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
11350576|NCT03026283|12547576|FG004|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
11350577|NCT03026283|12547577|FG005|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
11350578|NCT03026283|12547578|FG006|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
11350579|NCT03026283|12547579|FG007|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
11350580|NCT03026283|12547572|FG000|STARTED|Optimal Care/Stress Test/ICA||0
11350581|NCT03026283|12547573|FG001|STARTED|Optimal Care/Stress Test/ICA||0
11350582|NCT03026283|12547574|FG002|STARTED|Optimal Care/Stress Test/ICA||0
11350583|NCT03026283|12547575|FG003|STARTED|Optimal Care/Stress Test/ICA||128
11350584|NCT03026283|12547576|FG004|STARTED|Optimal Care/Stress Test/ICA||52
11350585|NCT03026283|12547577|FG005|STARTED|Optimal Care/Stress Test/ICA||101
11350586|NCT03026283|12547578|FG006|STARTED|Optimal Care/Stress Test/ICA||0
11350587|NCT03026283|12547579|FG007|STARTED|Optimal Care/Stress Test/ICA||0
11350588|NCT03026283|12547572|FG000|COMPLETED|Optimal Care/Stress Test/ICA||0
11350589|NCT03026283|12547573|FG001|COMPLETED|Optimal Care/Stress Test/ICA||0
11350590|NCT03026283|12547574|FG002|COMPLETED|Optimal Care/Stress Test/ICA||0
11084032|NCT01137006|12266698|FG001|NOT COMPLETED|Overall Study||0
11350591|NCT03026283|12547575|FG003|COMPLETED|Optimal Care/Stress Test/ICA||108
11350592|NCT03026283|12547576|FG004|COMPLETED|Optimal Care/Stress Test/ICA||14
11350593|NCT03026283|12547577|FG005|COMPLETED|Optimal Care/Stress Test/ICA||73
11350594|NCT03026283|12547578|FG006|COMPLETED|Optimal Care/Stress Test/ICA||0
11084033|NCT01137006|12266699|FG002|NOT COMPLETED|Overall Study||0
11084034|NCT01137006|12266700|FG003|NOT COMPLETED|Overall Study||0
11084035|NCT01137006|12266701|FG004|NOT COMPLETED|Overall Study||0
11084036|NCT01137006|12266702|FG005|NOT COMPLETED|Overall Study||0
11084037|NCT01137006|12266703|FG006|NOT COMPLETED|Overall Study||0
11084038|NCT01137032|12266720|FG000|STARTED|Overall Study||19
11084039|NCT01137032|12266720|FG000|COMPLETED|Overall Study||19
11084040|NCT01137032|12266720|FG000|NOT COMPLETED|Overall Study||0
11084041|NCT01137071|12266724|FG000|STARTED|Overall Study|all patients considered eligible were included on the study|29
11084042|NCT01137071|12266724|FG000|COMPLETED|Overall Study|Of the eligible patients|15
11084043|NCT01137071|12266724|FG000|NOT COMPLETED|Overall Study||14
11084044|NCT01137110|12266735|FG000|STARTED|Overall Study||35
11084045|NCT01137110|12266736|FG001|STARTED|Overall Study||49
11084046|NCT01137110|12266735|FG000|COMPLETED|Overall Study||34
11084047|NCT01137110|12266736|FG001|COMPLETED|Overall Study||49
11084048|NCT01137110|12266735|FG000|NOT COMPLETED|Overall Study||1
11084049|NCT01137110|12266736|FG001|NOT COMPLETED|Overall Study||0
11350595|NCT03026283|12547579|FG007|COMPLETED|Optimal Care/Stress Test/ICA||0
11084050|NCT01137292|12266742|FG000|STARTED|Overall Study||177
11350596|NCT03026283|12547572|FG000|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
11350597|NCT03026283|12547573|FG001|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
11350598|NCT03026283|12547574|FG002|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
11350599|NCT03026283|12547575|FG003|NOT COMPLETED|Optimal Care/Stress Test/ICA||20
11084051|NCT01137292|12266742|FG000|COMPLETED|Overall Study||123
11350600|NCT03026283|12547576|FG004|NOT COMPLETED|Optimal Care/Stress Test/ICA||38
11350601|NCT03026283|12547577|FG005|NOT COMPLETED|Optimal Care/Stress Test/ICA||28
11350602|NCT03026283|12547578|FG006|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
11350603|NCT03026283|12547579|FG007|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
11350604|NCT03026283|12547572|FG000|STARTED|Optimal Care/ICA Diagnostic Cath||0
11350605|NCT03026283|12547573|FG001|STARTED|Optimal Care/ICA Diagnostic Cath||0
11350606|NCT03026283|12547574|FG002|STARTED|Optimal Care/ICA Diagnostic Cath||0
11350607|NCT03026283|12547575|FG003|STARTED|Optimal Care/ICA Diagnostic Cath||0
11350608|NCT03026283|12547576|FG004|STARTED|Optimal Care/ICA Diagnostic Cath||0
11350609|NCT03026283|12547577|FG005|STARTED|Optimal Care/ICA Diagnostic Cath||0
11350610|NCT03026283|12547578|FG006|STARTED|Optimal Care/ICA Diagnostic Cath||21
11350611|NCT03026283|12547579|FG007|STARTED|Optimal Care/ICA Diagnostic Cath||0
11350612|NCT03026283|12547572|FG000|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11350613|NCT03026283|12547573|FG001|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11350614|NCT03026283|12547574|FG002|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11350615|NCT03026283|12547575|FG003|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11350616|NCT03026283|12547576|FG004|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11350617|NCT03026283|12547577|FG005|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11350618|NCT03026283|12547578|FG006|COMPLETED|Optimal Care/ICA Diagnostic Cath||21
11350619|NCT03026283|12547579|FG007|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11350620|NCT03026283|12547572|FG000|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11084052|NCT01137292|12266742|FG000|NOT COMPLETED|Overall Study||54
11084053|NCT01137370|12266748|FG000|STARTED|Overall Study||116
11084054|NCT01137370|12266749|FG001|STARTED|Overall Study||87
11084055|NCT01137370|12266748|FG000|COMPLETED|Overall Study||116
11084056|NCT01137370|12266749|FG001|COMPLETED|Overall Study||87
11084057|NCT01137370|12266748|FG000|NOT COMPLETED|Overall Study||0
11084058|NCT01137370|12266749|FG001|NOT COMPLETED|Overall Study||0
11084059|NCT01137396|12266757|FG000|STARTED|Overall Study||30
11084060|NCT01137396|12266758|FG001|STARTED|Overall Study||27
11084061|NCT01137396|12266757|FG000|COMPLETED|Overall Study||22
11084062|NCT01137396|12266758|FG001|COMPLETED|Overall Study||25
11084063|NCT01137396|12266757|FG000|NOT COMPLETED|Overall Study||8
11084064|NCT01137396|12266758|FG001|NOT COMPLETED|Overall Study||2
11084065|NCT01137474|12266768|FG000|STARTED|Overall Study||311
11350621|NCT03026283|12547573|FG001|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11350622|NCT03026283|12547574|FG002|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11350623|NCT03026283|12547575|FG003|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11350624|NCT03026283|12547576|FG004|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11350625|NCT03026283|12547577|FG005|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11350626|NCT03026283|12547578|FG006|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11350627|NCT03026283|12547579|FG007|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
11350628|NCT03026530|12547594|FG000|STARTED|Overall Study||100
11350629|NCT03026530|12547595|FG001|STARTED|Overall Study||100
11350630|NCT03026530|12547594|FG000|COMPLETED|Overall Study||79
11350631|NCT03026530|12547595|FG001|COMPLETED|Overall Study||71
11350632|NCT03026530|12547594|FG000|NOT COMPLETED|Overall Study||21
11084066|NCT01137474|12266769|FG001|STARTED|Overall Study||166
11084067|NCT01137474|12266770|FG002|STARTED|Overall Study||165
11084068|NCT01137474|12266771|FG003|STARTED|Overall Study||302
11084069|NCT01137474|12266768|FG000|Received Treatment|Overall Study||311
11084070|NCT01137474|12266769|FG001|Received Treatment|Overall Study||166
11084071|NCT01137474|12266770|FG002|Received Treatment|Overall Study||165
11084072|NCT01137474|12266771|FG003|Received Treatment|Overall Study||302
11084073|NCT01137474|12266768|FG000|COMPLETED|Overall Study||287
11084074|NCT01137474|12266769|FG001|COMPLETED|Overall Study||154
11084075|NCT01137474|12266770|FG002|COMPLETED|Overall Study||158
11084076|NCT01137474|12266771|FG003|COMPLETED|Overall Study||281
11084077|NCT01137474|12266768|FG000|NOT COMPLETED|Overall Study||24
11084078|NCT01137474|12266769|FG001|NOT COMPLETED|Overall Study||12
11084079|NCT01137474|12266770|FG002|NOT COMPLETED|Overall Study||7
11084080|NCT01137474|12266771|FG003|NOT COMPLETED|Overall Study||21
11084081|NCT01137539|12266781|FG000|STARTED|Overall Study||50
11084082|NCT01137539|12266781|FG000|COMPLETED|Overall Study||50
11084083|NCT01137539|12266781|FG000|NOT COMPLETED|Overall Study||0
11084084|NCT01137578|12266785|FG000|STARTED|Overall Study||77
11084085|NCT01137578|12266786|FG001|STARTED|Overall Study||14
11084086|NCT01137578|12266787|FG002|STARTED|Overall Study||43
11084087|NCT01137578|12266785|FG000|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
11084088|NCT01137578|12266786|FG001|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
11084089|NCT01137578|12266787|FG002|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
11084090|NCT01137578|12266785|FG000|NOT COMPLETED|Overall Study||16
11084091|NCT01137578|12266786|FG001|NOT COMPLETED|Overall Study||2
11084092|NCT01137578|12266787|FG002|NOT COMPLETED|Overall Study||6
11084093|NCT01137682|12266818|FG000|STARTED|Overall Study||65
11084094|NCT01137682|12266819|FG001|STARTED|Overall Study||65
11084095|NCT01137682|12266820|FG002|STARTED|Overall Study||68
11084096|NCT01137682|12266818|FG000|Not Treated|Overall Study||2
11084097|NCT01137682|12266819|FG001|Not Treated|Overall Study||2
11084098|NCT01137682|12266820|FG002|Not Treated|Overall Study||1
11084099|NCT01137682|12266818|FG000|Treated|Overall Study||63
11084100|NCT01137682|12266819|FG001|Treated|Overall Study||63
11084101|NCT01137682|12266820|FG002|Treated|Overall Study||67
11084102|NCT01137682|12266818|FG000|Completed 24-Week Core Phase|Overall Study||59
11084103|NCT01137682|12266819|FG001|Completed 24-Week Core Phase|Overall Study||57
11084104|NCT01137682|12266820|FG002|Completed 24-Week Core Phase|Overall Study||65
11084105|NCT01137682|12266818|FG000|Not Continuing Into Extension|Overall Study||2
11084106|NCT01137682|12266819|FG001|Not Continuing Into Extension|Overall Study||3
11084107|NCT01137682|12266820|FG002|Not Continuing Into Extension|Overall Study||2
11350633|NCT03026530|12547595|FG001|NOT COMPLETED|Overall Study||29
11350634|NCT03026556|12547604|FG000|STARTED|Overall Study||12763
11350635|NCT03026556|12547605|FG001|STARTED|Overall Study||17177
11350636|NCT03026556|12547606|FG002|STARTED|Overall Study||12594
11350637|NCT03026556|12547604|FG000|COMPLETED|Overall Study||12763
11350638|NCT03026556|12547605|FG001|COMPLETED|Overall Study||17177
11350639|NCT03026556|12547606|FG002|COMPLETED|Overall Study||12594
11350640|NCT03026556|12547604|FG000|NOT COMPLETED|Overall Study||0
11350641|NCT03026556|12547605|FG001|NOT COMPLETED|Overall Study||0
11350642|NCT03026556|12547606|FG002|NOT COMPLETED|Overall Study||0
11350643|NCT03026777|12547617|FG000|STARTED|Overall Study||168
11350644|NCT03026777|12547618|FG001|STARTED|Overall Study||169
11350645|NCT03026777|12547617|FG000|COMPLETED|Overall Study||168
11350646|NCT03026777|12547618|FG001|COMPLETED|Overall Study||169
11350647|NCT03026777|12547617|FG000|NOT COMPLETED|Overall Study||0
11350648|NCT03026777|12547618|FG001|NOT COMPLETED|Overall Study||0
11350649|NCT03026803|12547624|FG000|STARTED|Overall Study||4
11350650|NCT03026803|12547624|FG000|COMPLETED|Overall Study||4
11350651|NCT03026803|12547624|FG000|NOT COMPLETED|Overall Study||0
11350652|NCT03027466|12547632|FG000|STARTED|Overall Study||2027
11350653|NCT03027466|12547633|FG001|STARTED|Overall Study||1984
11350654|NCT03027466|12547634|FG002|STARTED|Overall Study||1903
11350655|NCT03027466|12547635|FG003|STARTED|Overall Study||1985
11350656|NCT03027466|12547632|FG000|COMPLETED|Overall Study||158
11350657|NCT03027466|12547633|FG001|COMPLETED|Overall Study||165
11084108|NCT01137682|12266818|FG000|Continuing Into Extension|Overall Study||57
11084109|NCT01137682|12266819|FG001|Continuing Into Extension|Overall Study||54
11084110|NCT01137682|12266820|FG002|Continuing Into Extension|Overall Study||63
11084111|NCT01137682|12266818|FG000|Safety Set - CORE|Overall Study|2 patients never received drug.|63
11084112|NCT01137682|12266819|FG001|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
11084113|NCT01137682|12266820|FG002|Safety Set - CORE|Overall Study|2 patients never received drug.|66
11084114|NCT01137682|12266818|FG000|Safety Set - Extension|Overall Study||57
11084115|NCT01137682|12266819|FG001|Safety Set - Extension|Overall Study||54
11084116|NCT01137682|12266820|FG002|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
11084117|NCT01137682|12266818|FG000|COMPLETED|Overall Study||28
11084118|NCT01137682|12266819|FG001|COMPLETED|Overall Study||25
11084119|NCT01137682|12266820|FG002|COMPLETED|Overall Study||34
11084120|NCT01137682|12266818|FG000|NOT COMPLETED|Overall Study||37
11084121|NCT01137682|12266819|FG001|NOT COMPLETED|Overall Study||40
11084122|NCT01137682|12266820|FG002|NOT COMPLETED|Overall Study||34
11084123|NCT01137786|12266834|FG000|STARTED|Overall Study||25
11084124|NCT01137786|12266835|FG001|STARTED|Overall Study||24
11084125|NCT01137786|12266834|FG000|COMPLETED|Overall Study||24
11084126|NCT01137786|12266835|FG001|COMPLETED|Overall Study||21
11084127|NCT01137786|12266834|FG000|NOT COMPLETED|Overall Study||1
11084128|NCT01137786|12266835|FG001|NOT COMPLETED|Overall Study||3
11084129|NCT01137812|12266845|FG000|STARTED|Overall Study||377
11084130|NCT01137812|12266846|FG001|STARTED|Overall Study||378
11084131|NCT01137812|12266845|FG000|COMPLETED|Overall Study||254
11084132|NCT01137812|12266846|FG001|COMPLETED|Overall Study||210
11084133|NCT01137812|12266845|FG000|NOT COMPLETED|Overall Study||123
11084134|NCT01137812|12266846|FG001|NOT COMPLETED|Overall Study||168
11084135|NCT01137890|12266854|FG000|STARTED|Overall Study||14
11084136|NCT01137890|12266855|FG001|STARTED|Overall Study||5
11084137|NCT01137890|12266854|FG000|COMPLETED|Overall Study||8
11084138|NCT01137890|12266855|FG001|COMPLETED|Overall Study||2
11084139|NCT01137890|12266854|FG000|NOT COMPLETED|Overall Study||6
11084140|NCT01137890|12266855|FG001|NOT COMPLETED|Overall Study||3
11084141|NCT01138007|12266910|FG000|STARTED|Overall Study||187
11084142|NCT01138007|12266911|FG001|STARTED|Overall Study||190
11084143|NCT01138007|12266912|FG002|STARTED|Overall Study||192
11084144|NCT01138007|12266910|FG000|COMPLETED|Overall Study||165
11084145|NCT01138007|12266911|FG001|COMPLETED|Overall Study||160
11084146|NCT01138007|12266912|FG002|COMPLETED|Overall Study||144
11084147|NCT01138007|12266910|FG000|NOT COMPLETED|Overall Study||22
11084148|NCT01138007|12266911|FG001|NOT COMPLETED|Overall Study||30
11084149|NCT01138007|12266912|FG002|NOT COMPLETED|Overall Study||48
11350658|NCT03027466|12547634|FG002|COMPLETED|Overall Study||160
11350659|NCT03027466|12547635|FG003|COMPLETED|Overall Study||164
11084150|NCT01138046|12266922|FG000|STARTED|Overall Study||12
11084151|NCT01138046|12266922|FG000|COMPLETED|Overall Study||6
11084152|NCT01138046|12266922|FG000|NOT COMPLETED|Overall Study||6
11350660|NCT03027466|12547632|FG000|NOT COMPLETED|Overall Study||1869
11350661|NCT03027466|12547633|FG001|NOT COMPLETED|Overall Study||1819
11350662|NCT03027466|12547634|FG002|NOT COMPLETED|Overall Study||1743
11084153|NCT01138098|12266928|FG000|STARTED|Overall Study||95
11084154|NCT01138098|12266929|FG001|STARTED|Overall Study||90
11084155|NCT01138098|12266928|FG000|COMPLETED|Overall Study||95
11084156|NCT01138098|12266929|FG001|COMPLETED|Overall Study||90
11084157|NCT01138098|12266928|FG000|NOT COMPLETED|Overall Study||0
11084158|NCT01138098|12266929|FG001|NOT COMPLETED|Overall Study||0
11084159|NCT01138111|12266935|FG000|STARTED|Overall Study||45
11084160|NCT01138111|12266935|FG000|COMPLETED|Overall Study||36
11084161|NCT01138111|12266935|FG000|NOT COMPLETED|Overall Study||9
11084162|NCT01138124|12266968|FG000|STARTED|Overall Study||3149
11084163|NCT01138124|12266969|FG001|STARTED|Overall Study||30026
11084164|NCT01138124|12266970|FG002|STARTED|Overall Study||1981
11350663|NCT03027466|12547635|FG003|NOT COMPLETED|Overall Study||1821
11350664|NCT03027557|12547648|FG000|STARTED|Overall Study||15
11350665|NCT03027557|12547649|FG001|STARTED|Overall Study||16
11350666|NCT03027557|12547650|FG002|STARTED|Overall Study||15
11350667|NCT03027557|12547648|FG000|COMPLETED|Overall Study||14
11350668|NCT03027557|12547649|FG001|COMPLETED|Overall Study||16
11350669|NCT03027557|12547650|FG002|COMPLETED|Overall Study||15
11350670|NCT03027557|12547648|FG000|NOT COMPLETED|Overall Study||1
11350671|NCT03027557|12547649|FG001|NOT COMPLETED|Overall Study||0
11350672|NCT03027557|12547650|FG002|NOT COMPLETED|Overall Study||0
11350673|NCT03027661|12547660|FG000|STARTED|Overall Study||20
11350674|NCT03027661|12547661|FG001|STARTED|Overall Study||21
11350675|NCT03027661|12547660|FG000|COMPLETED|Overall Study||20
11350676|NCT03027661|12547661|FG001|COMPLETED|Overall Study||21
11350677|NCT03027661|12547660|FG000|NOT COMPLETED|Overall Study||0
11350678|NCT03027661|12547661|FG001|NOT COMPLETED|Overall Study||0
11350679|NCT03028012|12547670|FG000|STARTED|Overall Study||4
11350680|NCT03028012|12547671|FG001|STARTED|Overall Study||3
11350681|NCT03028012|12547672|FG002|STARTED|Overall Study||3
11350682|NCT03028012|12547670|FG000|COMPLETED|Overall Study||2
11350683|NCT03028012|12547671|FG001|COMPLETED|Overall Study||0
11350684|NCT03028012|12547672|FG002|COMPLETED|Overall Study||0
11350685|NCT03028012|12547670|FG000|NOT COMPLETED|Overall Study||2
11350686|NCT03028012|12547671|FG001|NOT COMPLETED|Overall Study||3
11350687|NCT03028012|12547672|FG002|NOT COMPLETED|Overall Study||3
11350688|NCT03028025|12547683|FG000|STARTED|Overall Study||90
11350689|NCT03028025|12547684|FG001|STARTED|Overall Study||94
11350690|NCT03028025|12547683|FG000|COMPLETED|Overall Study||87
11350691|NCT03028025|12547684|FG001|COMPLETED|Overall Study||93
11350692|NCT03028025|12547683|FG000|NOT COMPLETED|Overall Study||3
11350693|NCT03028025|12547684|FG001|NOT COMPLETED|Overall Study||1
11350694|NCT03028103|12547692|FG000|STARTED|Overall Study||16
11350695|NCT03028103|12547693|FG001|STARTED|Overall Study||16
11350696|NCT03028103|12547692|FG000|COMPLETED|Overall Study||16
11350697|NCT03028103|12547693|FG001|COMPLETED|Overall Study||16
11350698|NCT03028103|12547692|FG000|NOT COMPLETED|Overall Study||0
11350699|NCT03028103|12547693|FG001|NOT COMPLETED|Overall Study||0
11350700|NCT03028129|12547705|FG000|STARTED|Overall Study||258
11350701|NCT03028129|12547706|FG001|STARTED|Overall Study||209
11350702|NCT03028129|12547705|FG000|COMPLETED|Overall Study||132
11350703|NCT03028129|12547706|FG001|COMPLETED|Overall Study||122
11350704|NCT03028129|12547705|FG000|NOT COMPLETED|Overall Study||126
11350705|NCT03028129|12547706|FG001|NOT COMPLETED|Overall Study||87
11350706|NCT03028142|12547712|FG000|STARTED|Overall Study||5
11350707|NCT03028142|12547713|FG001|STARTED|Overall Study||5
11350708|NCT03028142|12547714|FG002|STARTED|Overall Study||6
11350709|NCT03028142|12547715|FG003|STARTED|Overall Study||4
11350710|NCT03028142|12547716|FG004|STARTED|Overall Study||6
11350711|NCT03028142|12547717|FG005|STARTED|Overall Study||4
11350712|NCT03028142|12547712|FG000|COMPLETED|Overall Study||4
11350713|NCT03028142|12547713|FG001|COMPLETED|Overall Study||4
11350714|NCT03028142|12547714|FG002|COMPLETED|Overall Study||6
11350715|NCT03028142|12547715|FG003|COMPLETED|Overall Study||4
11350716|NCT03028142|12547716|FG004|COMPLETED|Overall Study||5
11350717|NCT03028142|12547717|FG005|COMPLETED|Overall Study||3
11350718|NCT03028142|12547712|FG000|NOT COMPLETED|Overall Study||1
11350719|NCT03028142|12547713|FG001|NOT COMPLETED|Overall Study||1
11350720|NCT03028142|12547714|FG002|NOT COMPLETED|Overall Study||0
11350721|NCT03028142|12547715|FG003|NOT COMPLETED|Overall Study||0
11350722|NCT03028142|12547716|FG004|NOT COMPLETED|Overall Study||1
11350723|NCT03028142|12547717|FG005|NOT COMPLETED|Overall Study||1
11350724|NCT03028220|12547728|FG000|STARTED|Overall Study||20
11350725|NCT03028220|12547729|FG001|STARTED|Overall Study||20
11350726|NCT03028220|12547728|FG000|COMPLETED|Overall Study||20
11350727|NCT03028220|12547729|FG001|COMPLETED|Overall Study||20
11350728|NCT03028220|12547728|FG000|NOT COMPLETED|Overall Study||0
11084165|NCT01138124|12266971|FG003|STARTED|Overall Study||19046
11084166|NCT01138124|12266968|FG000|COMPLETED|Overall Study||3149
11084167|NCT01138124|12266969|FG001|COMPLETED|Overall Study||30026
11084168|NCT01138124|12266970|FG002|COMPLETED|Overall Study||1981
11084169|NCT01138124|12266971|FG003|COMPLETED|Overall Study||19046
11084170|NCT01138124|12266968|FG000|NOT COMPLETED|Overall Study||0
11350729|NCT03028220|12547729|FG001|NOT COMPLETED|Overall Study||0
11350730|NCT03028324|12547735|FG000|STARTED|Overall Study||4
11350731|NCT03028324|12547735|FG000|COMPLETED|Overall Study||4
11350732|NCT03028324|12547735|FG000|NOT COMPLETED|Overall Study||0
11350733|NCT03028363|12547741|FG000|STARTED|Overall Study||498
11350734|NCT03028363|12547742|FG001|STARTED|Overall Study||261
11350735|NCT03028363|12547741|FG000|COMPLETED|Overall Study||420
11350736|NCT03028363|12547742|FG001|COMPLETED|Overall Study||228
11350737|NCT03028363|12547741|FG000|NOT COMPLETED|Overall Study||78
11350738|NCT03028363|12547742|FG001|NOT COMPLETED|Overall Study||33
11350739|NCT03028415|12547750|FG000|STARTED|Overall Study||39
11350740|NCT03028415|12547751|FG001|STARTED|Overall Study||17
11350741|NCT03028415|12547750|FG000|Modified Intention-to-treat (mITT) Population|Overall Study||39
11350742|NCT03028415|12547751|FG001|Modified Intention-to-treat (mITT) Population|Overall Study||17
11084171|NCT01138124|12266969|FG001|NOT COMPLETED|Overall Study||0
11084172|NCT01138124|12266970|FG002|NOT COMPLETED|Overall Study||0
11084173|NCT01138124|12266971|FG003|NOT COMPLETED|Overall Study||0
11084174|NCT01138150|12266981|FG000|STARTED|Overall Study||18
11084175|NCT01138150|12266982|FG001|STARTED|Overall Study||18
11084176|NCT01138150|12266981|FG000|COMPLETED|Overall Study||17
11084177|NCT01138150|12266982|FG001|COMPLETED|Overall Study||17
11084178|NCT01138150|12266981|FG000|NOT COMPLETED|Overall Study||1
11084179|NCT01138150|12266982|FG001|NOT COMPLETED|Overall Study||1
11084180|NCT01138475|12267001|FG000|STARTED|Overall Study||16
11350743|NCT03028415|12547750|FG000|COMPLETED|Overall Study||31
11084181|NCT01138475|12267002|FG001|STARTED|Overall Study||16
11084182|NCT01138475|12267003|FG002|STARTED|Overall Study||17
11084183|NCT01138475|12267001|FG000|COMPLETED|Overall Study||16
11084184|NCT01138475|12267002|FG001|COMPLETED|Overall Study||16
11084185|NCT01138475|12267003|FG002|COMPLETED|Overall Study||17
11084186|NCT01138475|12267001|FG000|NOT COMPLETED|Overall Study||0
11084187|NCT01138475|12267002|FG001|NOT COMPLETED|Overall Study||0
11084188|NCT01138475|12267003|FG002|NOT COMPLETED|Overall Study||0
11084189|NCT01138501|12267017|FG000|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
11084190|NCT01138501|12267017|FG000|Exposed|Overall Study||63
11084191|NCT01138501|12267017|FG000|COMPLETED|Overall Study||60
11084192|NCT01138501|12267017|FG000|NOT COMPLETED|Overall Study||5
11084193|NCT01138514|12267024|FG000|STARTED|Overall Study||522
11084194|NCT01138514|12267025|FG001|STARTED|Overall Study||516
11084195|NCT01138514|12267026|FG002|STARTED|Overall Study||517
11084196|NCT01138514|12267024|FG000|COMPLETED|Overall Study||474
11084197|NCT01138514|12267025|FG001|COMPLETED|Overall Study||463
11084198|NCT01138514|12267026|FG002|COMPLETED|Overall Study||424
11084199|NCT01138514|12267024|FG000|NOT COMPLETED|Overall Study||48
11084200|NCT01138514|12267025|FG001|NOT COMPLETED|Overall Study||53
11084201|NCT01138514|12267026|FG002|NOT COMPLETED|Overall Study||93
11084202|NCT01138657|12267037|FG000|STARTED|Overall Study||120
11084203|NCT01138657|12267038|FG001|STARTED|Overall Study||119
11084204|NCT01138657|12267037|FG000|Enrolled in Main Study|Overall Study||112
11084205|NCT01138657|12267038|FG001|Enrolled in Main Study|Overall Study||111
11084206|NCT01138657|12267037|FG000|Enrolled in Japan Sub-study|Overall Study||8
11084207|NCT01138657|12267038|FG001|Enrolled in Japan Sub-study|Overall Study||8
11084208|NCT01138657|12267037|FG000|COMPLETED|Overall Study||112
11084209|NCT01138657|12267038|FG001|COMPLETED|Overall Study||101
11084210|NCT01138657|12267037|FG000|NOT COMPLETED|Overall Study||8
11084211|NCT01138657|12267038|FG001|NOT COMPLETED|Overall Study||18
11084212|NCT01138735|12267048|FG000|STARTED|Overall Study||142
11084213|NCT01138735|12267049|FG001|STARTED|Overall Study||143
11084214|NCT01138735|12267048|FG000|COMPLETED|Overall Study||134
11350744|NCT03028415|12547751|FG001|COMPLETED|Overall Study||14
11350745|NCT03028415|12547750|FG000|NOT COMPLETED|Overall Study||8
11350746|NCT03028415|12547751|FG001|NOT COMPLETED|Overall Study||3
11350747|NCT03028467|12547762|FG000|STARTED|Overall Study||4
11350748|NCT03028467|12547763|FG001|STARTED|Overall Study||3
11350749|NCT03028467|12547764|FG002|STARTED|Overall Study||4
11350750|NCT03028467|12547765|FG003|STARTED|Overall Study||4
11350751|NCT03028467|12547762|FG000|COMPLETED|Overall Study||4
11350752|NCT03028467|12547763|FG001|COMPLETED|Overall Study||3
11350753|NCT03028467|12547764|FG002|COMPLETED|Overall Study||4
11350754|NCT03028467|12547765|FG003|COMPLETED|Overall Study||4
11350755|NCT03028467|12547762|FG000|NOT COMPLETED|Overall Study||0
11350756|NCT03028467|12547763|FG001|NOT COMPLETED|Overall Study||0
11084215|NCT01138735|12267049|FG001|COMPLETED|Overall Study||126
11084216|NCT01138735|12267048|FG000|NOT COMPLETED|Overall Study||8
11084217|NCT01138735|12267049|FG001|NOT COMPLETED|Overall Study||17
11084218|NCT01138826|12267055|FG000|STARTED|First Intervention Period||3
11084219|NCT01138826|12267056|FG001|STARTED|First Intervention Period||3
11084220|NCT01138826|12267057|FG002|STARTED|First Intervention Period||3
11084221|NCT01138826|12267058|FG003|STARTED|First Intervention Period||3
11084222|NCT01138826|12267059|FG004|STARTED|First Intervention Period||3
11084223|NCT01138826|12267060|FG005|STARTED|First Intervention Period||3
11084224|NCT01138826|12267055|FG000|COMPLETED|First Intervention Period||3
11350757|NCT03028467|12547764|FG002|NOT COMPLETED|Overall Study||0
11084225|NCT01138826|12267056|FG001|COMPLETED|First Intervention Period||3
11350758|NCT03028467|12547765|FG003|NOT COMPLETED|Overall Study||0
11350759|NCT03028636|12547778|FG000|STARTED|Overall Study||17
11350760|NCT03028636|12547778|FG000|COMPLETED|Overall Study||11
11350761|NCT03028636|12547778|FG000|NOT COMPLETED|Overall Study||6
11350762|NCT03028870|12547791|FG000|STARTED|Overall Study||74
11350763|NCT03028870|12547792|FG001|STARTED|Overall Study||67
11350764|NCT03028870|12547793|FG002|STARTED|Overall Study||76
11350765|NCT03028870|12547794|FG003|STARTED|Overall Study||74
11350766|NCT03028870|12547791|FG000|COMPLETED|Overall Study||57
11350767|NCT03028870|12547792|FG001|COMPLETED|Overall Study||57
11350768|NCT03028870|12547793|FG002|COMPLETED|Overall Study||60
11350769|NCT03028870|12547794|FG003|COMPLETED|Overall Study||65
11350770|NCT03028870|12547791|FG000|NOT COMPLETED|Overall Study||17
11350771|NCT03028870|12547792|FG001|NOT COMPLETED|Overall Study||10
11350772|NCT03028870|12547793|FG002|NOT COMPLETED|Overall Study||16
11350773|NCT03028870|12547794|FG003|NOT COMPLETED|Overall Study||9
11350774|NCT03028974|12547809|FG000|STARTED|2014-2015||1
11350775|NCT03028974|12547810|FG001|STARTED|2014-2015||0
11350776|NCT03028974|12547811|FG002|STARTED|2014-2015||0
11350777|NCT03028974|12547812|FG003|STARTED|2014-2015||3
11350778|NCT03028974|12547813|FG004|STARTED|2014-2015||0
11350779|NCT03028974|12547814|FG005|STARTED|2014-2015||11
11350780|NCT03028974|12547815|FG006|STARTED|2014-2015||13
11350781|NCT03028974|12547809|FG000|COMPLETED|2014-2015||1
11350782|NCT03028974|12547810|FG001|COMPLETED|2014-2015||0
11350783|NCT03028974|12547811|FG002|COMPLETED|2014-2015||0
11350784|NCT03028974|12547812|FG003|COMPLETED|2014-2015||3
11350785|NCT03028974|12547813|FG004|COMPLETED|2014-2015||0
11350786|NCT03028974|12547814|FG005|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
11350787|NCT03028974|12547815|FG006|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
11350788|NCT03028974|12547809|FG000|NOT COMPLETED|2014-2015||0
11350789|NCT03028974|12547810|FG001|NOT COMPLETED|2014-2015||0
11350790|NCT03028974|12547811|FG002|NOT COMPLETED|2014-2015||0
11350791|NCT03028974|12547812|FG003|NOT COMPLETED|2014-2015||0
11350792|NCT03028974|12547813|FG004|NOT COMPLETED|2014-2015||0
11350793|NCT03028974|12547814|FG005|NOT COMPLETED|2014-2015||0
11350794|NCT03028974|12547815|FG006|NOT COMPLETED|2014-2015||0
11350795|NCT03028974|12547809|FG000|STARTED|2015-2016||0
11350796|NCT03028974|12547810|FG001|STARTED|2015-2016||0
11350797|NCT03028974|12547811|FG002|STARTED|2015-2016||0
11350798|NCT03028974|12547812|FG003|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
11350799|NCT03028974|12547813|FG004|STARTED|2015-2016||0
11350800|NCT03028974|12547814|FG005|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
11350801|NCT03028974|12547815|FG006|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
11350802|NCT03028974|12547809|FG000|COMPLETED|2015-2016||0
11350803|NCT03028974|12547810|FG001|COMPLETED|2015-2016||0
11350804|NCT03028974|12547811|FG002|COMPLETED|2015-2016||0
11350805|NCT03028974|12547812|FG003|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
11350806|NCT03028974|12547813|FG004|COMPLETED|2015-2016||0
11350807|NCT03028974|12547814|FG005|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
11350808|NCT03028974|12547815|FG006|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
11350809|NCT03028974|12547809|FG000|NOT COMPLETED|2015-2016||0
11350810|NCT03028974|12547810|FG001|NOT COMPLETED|2015-2016||0
11350811|NCT03028974|12547811|FG002|NOT COMPLETED|2015-2016||0
11350812|NCT03028974|12547812|FG003|NOT COMPLETED|2015-2016||0
11350813|NCT03028974|12547813|FG004|NOT COMPLETED|2015-2016||0
11350814|NCT03028974|12547814|FG005|NOT COMPLETED|2015-2016||0
11350815|NCT03028974|12547815|FG006|NOT COMPLETED|2015-2016||0
11350816|NCT03028974|12547809|FG000|STARTED|2016-2017||0
11084226|NCT01138826|12267057|FG002|COMPLETED|First Intervention Period||3
11350817|NCT03028974|12547810|FG001|STARTED|2016-2017||0
11350818|NCT03028974|12547811|FG002|STARTED|2016-2017||0
11350819|NCT03028974|12547812|FG003|STARTED|2016-2017|1 new participant was enrolled.|4
11350820|NCT03028974|12547813|FG004|STARTED|2016-2017|2 new participants were enrolled.|2
11084227|NCT01138826|12267058|FG003|COMPLETED|First Intervention Period||3
11084228|NCT01138826|12267059|FG004|COMPLETED|First Intervention Period||3
11084229|NCT01138826|12267060|FG005|COMPLETED|First Intervention Period||3
11350821|NCT03028974|12547814|FG005|STARTED|2016-2017||0
11350822|NCT03028974|12547815|FG006|STARTED|2016-2017|18 new participants were enrolled.|18
11350823|NCT03028974|12547809|FG000|COMPLETED|2016-2017||0
11350824|NCT03028974|12547810|FG001|COMPLETED|2016-2017||0
11350825|NCT03028974|12547811|FG002|COMPLETED|2016-2017||0
11350826|NCT03028974|12547812|FG003|COMPLETED|2016-2017||4
11350827|NCT03028974|12547813|FG004|COMPLETED|2016-2017|2 participants did not continue to the next period|2
11350828|NCT03028974|12547814|FG005|COMPLETED|2016-2017||0
11350829|NCT03028974|12547815|FG006|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
11084230|NCT01138826|12267055|FG000|NOT COMPLETED|First Intervention Period||0
11084231|NCT01138826|12267056|FG001|NOT COMPLETED|First Intervention Period||0
11084232|NCT01138826|12267057|FG002|NOT COMPLETED|First Intervention Period||0
11084233|NCT01138826|12267058|FG003|NOT COMPLETED|First Intervention Period||0
11084234|NCT01138826|12267059|FG004|NOT COMPLETED|First Intervention Period||0
11084235|NCT01138826|12267060|FG005|NOT COMPLETED|First Intervention Period||0
11084236|NCT01138826|12267055|FG000|STARTED|Washout Period I (of 16 Days)||3
11084237|NCT01138826|12267056|FG001|STARTED|Washout Period I (of 16 Days)||3
11084238|NCT01138826|12267057|FG002|STARTED|Washout Period I (of 16 Days)||3
11350830|NCT03028974|12547809|FG000|NOT COMPLETED|2016-2017||0
11084239|NCT01138826|12267058|FG003|STARTED|Washout Period I (of 16 Days)||3
11084240|NCT01138826|12267059|FG004|STARTED|Washout Period I (of 16 Days)||3
11084241|NCT01138826|12267060|FG005|STARTED|Washout Period I (of 16 Days)||3
11084242|NCT01138826|12267055|FG000|COMPLETED|Washout Period I (of 16 Days)||2
11084243|NCT01138826|12267056|FG001|COMPLETED|Washout Period I (of 16 Days)||2
11084244|NCT01138826|12267057|FG002|COMPLETED|Washout Period I (of 16 Days)||3
11084245|NCT01138826|12267058|FG003|COMPLETED|Washout Period I (of 16 Days)||3
11084246|NCT01138826|12267059|FG004|COMPLETED|Washout Period I (of 16 Days)||2
11084247|NCT01138826|12267060|FG005|COMPLETED|Washout Period I (of 16 Days)||3
11084248|NCT01138826|12267055|FG000|NOT COMPLETED|Washout Period I (of 16 Days)||1
11084249|NCT01138826|12267056|FG001|NOT COMPLETED|Washout Period I (of 16 Days)||1
11084250|NCT01138826|12267057|FG002|NOT COMPLETED|Washout Period I (of 16 Days)||0
11084251|NCT01138826|12267058|FG003|NOT COMPLETED|Washout Period I (of 16 Days)||0
11084252|NCT01138826|12267059|FG004|NOT COMPLETED|Washout Period I (of 16 Days)||1
11084253|NCT01138826|12267060|FG005|NOT COMPLETED|Washout Period I (of 16 Days)||0
11084254|NCT01138826|12267055|FG000|STARTED|Second Intervention Period||2
11084255|NCT01138826|12267056|FG001|STARTED|Second Intervention Period||2
11084256|NCT01138826|12267057|FG002|STARTED|Second Intervention Period||3
11084257|NCT01138826|12267058|FG003|STARTED|Second Intervention Period||3
11350831|NCT03028974|12547810|FG001|NOT COMPLETED|2016-2017||0
11350832|NCT03028974|12547811|FG002|NOT COMPLETED|2016-2017||0
11350833|NCT03028974|12547812|FG003|NOT COMPLETED|2016-2017||0
11350834|NCT03028974|12547813|FG004|NOT COMPLETED|2016-2017||0
11350835|NCT03028974|12547814|FG005|NOT COMPLETED|2016-2017||0
11350836|NCT03028974|12547815|FG006|NOT COMPLETED|2016-2017||0
11350837|NCT03028974|12547809|FG000|STARTED|2017-2018||0
11350838|NCT03028974|12547810|FG001|STARTED|2017-2018||0
11350839|NCT03028974|12547811|FG002|STARTED|2017-2018||0
11350840|NCT03028974|12547812|FG003|STARTED|2017-2018||5
11350841|NCT03028974|12547813|FG004|STARTED|2017-2018||0
11350842|NCT03028974|12547814|FG005|STARTED|2017-2018||0
11350843|NCT03028974|12547815|FG006|STARTED|2017-2018|5 new participants were enrolled.|5
11350844|NCT03028974|12547809|FG000|COMPLETED|2017-2018||0
11350845|NCT03028974|12547810|FG001|COMPLETED|2017-2018||0
11350846|NCT03028974|12547811|FG002|COMPLETED|2017-2018||0
11350847|NCT03028974|12547812|FG003|COMPLETED|2017-2018||5
11350848|NCT03028974|12547813|FG004|COMPLETED|2017-2018||0
11350849|NCT03028974|12547814|FG005|COMPLETED|2017-2018||0
11350850|NCT03028974|12547815|FG006|COMPLETED|2017-2018||5
11350851|NCT03028974|12547809|FG000|NOT COMPLETED|2017-2018||0
11350852|NCT03028974|12547810|FG001|NOT COMPLETED|2017-2018||0
11350853|NCT03028974|12547811|FG002|NOT COMPLETED|2017-2018||0
11350854|NCT03028974|12547812|FG003|NOT COMPLETED|2017-2018||0
11350855|NCT03028974|12547813|FG004|NOT COMPLETED|2017-2018||0
11350856|NCT03028974|12547814|FG005|NOT COMPLETED|2017-2018||0
11350857|NCT03028974|12547815|FG006|NOT COMPLETED|2017-2018||0
11350858|NCT03028987|12547830|FG000|STARTED|Overall Study||5
11350859|NCT03028987|12547831|FG001|STARTED|Overall Study||5
11350860|NCT03028987|12547830|FG000|COMPLETED|Overall Study||5
11350861|NCT03028987|12547831|FG001|COMPLETED|Overall Study||5
11350862|NCT03028987|12547830|FG000|NOT COMPLETED|Overall Study||0
11350863|NCT03028987|12547831|FG001|NOT COMPLETED|Overall Study||0
11350864|NCT03029091|12547839|FG000|STARTED|Overall Study||8
11350865|NCT03029091|12547840|FG001|STARTED|Overall Study||7
11350866|NCT03029091|12547839|FG000|COMPLETED|Overall Study||8
11350867|NCT03029091|12547840|FG001|COMPLETED|Overall Study||7
11350868|NCT03029091|12547839|FG000|NOT COMPLETED|Overall Study||0
11350869|NCT03029091|12547840|FG001|NOT COMPLETED|Overall Study||0
11350870|NCT03029143|12547848|FG000|STARTED|Lead-in Period (6 Weeks)||278
11350871|NCT03029143|12547849|FG001|STARTED|Lead-in Period (6 Weeks)||0
11350872|NCT03029143|12547850|FG002|STARTED|Lead-in Period (6 Weeks)||0
11350873|NCT03029143|12547848|FG000|COMPLETED|Lead-in Period (6 Weeks)||109
11350874|NCT03029143|12547849|FG001|COMPLETED|Lead-in Period (6 Weeks)||0
11350875|NCT03029143|12547850|FG002|COMPLETED|Lead-in Period (6 Weeks)||0
11350876|NCT03029143|12547848|FG000|NOT COMPLETED|Lead-in Period (6 Weeks)||169
11350877|NCT03029143|12547849|FG001|NOT COMPLETED|Lead-in Period (6 Weeks)||0
11350878|NCT03029143|12547850|FG002|NOT COMPLETED|Lead-in Period (6 Weeks)||0
11350879|NCT03029143|12547848|FG000|STARTED|Randomized Treatment Period (24 Weeks)||0
11350880|NCT03029143|12547849|FG001|STARTED|Randomized Treatment Period (24 Weeks)||54
11350881|NCT03029143|12547850|FG002|STARTED|Randomized Treatment Period (24 Weeks)||55
11350882|NCT03029143|12547848|FG000|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0
11350883|NCT03029143|12547849|FG001|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)|One participant was randomized to Randomized Treatment Period: Standard Treatment Arm, but was not treated and was thus included in the Lead-in failure vedolizumab arm for the Safety Analysis Set (N=170).|1
11350884|NCT03029143|12547850|FG002|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0
11350885|NCT03029143|12547848|FG000|Safety Population|Randomized Treatment Period (24 Weeks)||0
11350886|NCT03029143|12547849|FG001|Safety Population|Randomized Treatment Period (24 Weeks)||53
11350887|NCT03029143|12547850|FG002|Safety Population|Randomized Treatment Period (24 Weeks)|Regimen A = 28 Regimen B = 27|55
11350888|NCT03029143|12547848|FG000|COMPLETED|Randomized Treatment Period (24 Weeks)||0
11350889|NCT03029143|12547849|FG001|COMPLETED|Randomized Treatment Period (24 Weeks)||31
11350890|NCT03029143|12547850|FG002|COMPLETED|Randomized Treatment Period (24 Weeks)||31
11350891|NCT03029143|12547848|FG000|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||0
11350892|NCT03029143|12547849|FG001|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||23
11350893|NCT03029143|12547850|FG002|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||24
11350894|NCT03029208|12547861|FG000|STARTED|Overall Study||157
11350895|NCT03029208|12547862|FG001|STARTED|Overall Study||155
11350896|NCT03029208|12547861|FG000|COMPLETED|Overall Study||155
11350897|NCT03029208|12547862|FG001|COMPLETED|Overall Study||151
11350898|NCT03029208|12547861|FG000|NOT COMPLETED|Overall Study||2
11350899|NCT03029208|12547862|FG001|NOT COMPLETED|Overall Study||4
11350900|NCT03029247|12547879|FG000|STARTED|Acute Challenge 1 (Day 1)||45
11350901|NCT03029247|12547880|FG001|STARTED|Acute Challenge 1 (Day 1)||43
11350902|NCT03029247|12547879|FG000|COMPLETED|Acute Challenge 1 (Day 1)||45
11350903|NCT03029247|12547880|FG001|COMPLETED|Acute Challenge 1 (Day 1)||43
11350904|NCT03029247|12547879|FG000|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
11350905|NCT03029247|12547880|FG001|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
11350906|NCT03029247|12547879|FG000|STARTED|Hgb Maintenance Phase (8 Weeks)||45
11350907|NCT03029247|12547880|FG001|STARTED|Hgb Maintenance Phase (8 Weeks)||43
11350908|NCT03029247|12547879|FG000|COMPLETED|Hgb Maintenance Phase (8 Weeks)||32
11350909|NCT03029247|12547880|FG001|COMPLETED|Hgb Maintenance Phase (8 Weeks)||36
11350910|NCT03029247|12547879|FG000|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||13
11350911|NCT03029247|12547880|FG001|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||7
11350912|NCT03029247|12547879|FG000|STARTED|Acute Challenge 2 (Day 57)||32
11350913|NCT03029247|12547880|FG001|STARTED|Acute Challenge 2 (Day 57)||36
11350914|NCT03029247|12547879|FG000|COMPLETED|Acute Challenge 2 (Day 57)||32
11350915|NCT03029247|12547880|FG001|COMPLETED|Acute Challenge 2 (Day 57)||36
11350916|NCT03029247|12547879|FG000|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
11350917|NCT03029247|12547880|FG001|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
11350918|NCT03029247|12547879|FG000|STARTED|Follow-up Period (14 Days)||32
11350919|NCT03029247|12547880|FG001|STARTED|Follow-up Period (14 Days)||36
11350920|NCT03029247|12547879|FG000|COMPLETED|Follow-up Period (14 Days)||32
11350921|NCT03029247|12547880|FG001|COMPLETED|Follow-up Period (14 Days)||36
11350922|NCT03029247|12547879|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0
11350923|NCT03029247|12547880|FG001|NOT COMPLETED|Follow-up Period (14 Days)||0
11350924|NCT03029585|12547888|FG000|STARTED|Overall Study||7
11350925|NCT03029585|12547889|FG001|STARTED|Overall Study||3
11350926|NCT03029585|12547888|FG000|COMPLETED|Overall Study||5
11350927|NCT03029585|12547889|FG001|COMPLETED|Overall Study||2
11350928|NCT03029585|12547888|FG000|NOT COMPLETED|Overall Study||2
11350929|NCT03029585|12547889|FG001|NOT COMPLETED|Overall Study||1
11350930|NCT03029624|12547895|FG000|STARTED|Overall Study||46
11350931|NCT03029624|12547895|FG000|Primary Endpoint (3 Months)|Overall Study||44
11350932|NCT03029624|12547895|FG000|COMPLETED|Overall Study||41
11350933|NCT03029624|12547895|FG000|NOT COMPLETED|Overall Study||5
11350934|NCT03029650|12547901|FG000|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
11350935|NCT03029650|12547902|FG001|STARTED|First Intervention (3 - 6 Days)||12
11350936|NCT03029650|12547901|FG000|COMPLETED|First Intervention (3 - 6 Days)||14
11350937|NCT03029650|12547902|FG001|COMPLETED|First Intervention (3 - 6 Days)||12
11350938|NCT03029650|12547901|FG000|NOT COMPLETED|First Intervention (3 - 6 Days)||0
11350939|NCT03029650|12547902|FG001|NOT COMPLETED|First Intervention (3 - 6 Days)||0
11350940|NCT03029650|12547901|FG000|STARTED|Washout (1 Week)||14
11350941|NCT03029650|12547902|FG001|STARTED|Washout (1 Week)||12
11350942|NCT03029650|12547901|FG000|COMPLETED|Washout (1 Week)||13
11084258|NCT01138826|12267059|FG004|STARTED|Second Intervention Period||2
11084259|NCT01138826|12267060|FG005|STARTED|Second Intervention Period||3
11084260|NCT01138826|12267055|FG000|COMPLETED|Second Intervention Period||2
11084261|NCT01138826|12267056|FG001|COMPLETED|Second Intervention Period||2
11084262|NCT01138826|12267057|FG002|COMPLETED|Second Intervention Period||3
11084263|NCT01138826|12267058|FG003|COMPLETED|Second Intervention Period||3
11084264|NCT01138826|12267059|FG004|COMPLETED|Second Intervention Period||2
11084265|NCT01138826|12267060|FG005|COMPLETED|Second Intervention Period||3
11084266|NCT01138826|12267055|FG000|NOT COMPLETED|Second Intervention Period||0
11084267|NCT01138826|12267056|FG001|NOT COMPLETED|Second Intervention Period||0
11084268|NCT01138826|12267057|FG002|NOT COMPLETED|Second Intervention Period||0
11084269|NCT01138826|12267058|FG003|NOT COMPLETED|Second Intervention Period||0
11084270|NCT01138826|12267059|FG004|NOT COMPLETED|Second Intervention Period||0
11084271|NCT01138826|12267060|FG005|NOT COMPLETED|Second Intervention Period||0
11084272|NCT01138826|12267055|FG000|STARTED|Washout Period II (of 16 Days)||2
11084273|NCT01138826|12267056|FG001|STARTED|Washout Period II (of 16 Days)||2
11084274|NCT01138826|12267057|FG002|STARTED|Washout Period II (of 16 Days)||3
11084275|NCT01138826|12267058|FG003|STARTED|Washout Period II (of 16 Days)||3
11084276|NCT01138826|12267059|FG004|STARTED|Washout Period II (of 16 Days)||2
11084277|NCT01138826|12267060|FG005|STARTED|Washout Period II (of 16 Days)||3
11084278|NCT01138826|12267055|FG000|COMPLETED|Washout Period II (of 16 Days)||2
11084279|NCT01138826|12267056|FG001|COMPLETED|Washout Period II (of 16 Days)||2
11084280|NCT01138826|12267057|FG002|COMPLETED|Washout Period II (of 16 Days)||3
11084281|NCT01138826|12267058|FG003|COMPLETED|Washout Period II (of 16 Days)||3
11084282|NCT01138826|12267059|FG004|COMPLETED|Washout Period II (of 16 Days)||2
11084283|NCT01138826|12267060|FG005|COMPLETED|Washout Period II (of 16 Days)||3
11084284|NCT01138826|12267055|FG000|NOT COMPLETED|Washout Period II (of 16 Days)||0
11084285|NCT01138826|12267056|FG001|NOT COMPLETED|Washout Period II (of 16 Days)||0
11084286|NCT01138826|12267057|FG002|NOT COMPLETED|Washout Period II (of 16 Days)||0
11084287|NCT01138826|12267058|FG003|NOT COMPLETED|Washout Period II (of 16 Days)||0
11084288|NCT01138826|12267059|FG004|NOT COMPLETED|Washout Period II (of 16 Days)||0
11207624|NCT01877265|12398830|FG003|STARTED|Treatment Period 1||3
11207625|NCT01877265|12398831|FG004|STARTED|Treatment Period 1||3
11207626|NCT01877265|12398832|FG005|STARTED|Treatment Period 1||3
11207627|NCT01877265|12398827|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||3
11207628|NCT01877265|12398828|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||3
11207629|NCT01877265|12398829|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||3
11207630|NCT01877265|12398830|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||3
11207631|NCT01877265|12398831|FG004|Received at Least One Dose of Study Drug|Treatment Period 1||3
11207632|NCT01877265|12398832|FG005|Received at Least One Dose of Study Drug|Treatment Period 1||3
11207633|NCT01877265|12398827|FG000|COMPLETED|Treatment Period 1||3
11207634|NCT01877265|12398828|FG001|COMPLETED|Treatment Period 1||3
11207635|NCT01877265|12398829|FG002|COMPLETED|Treatment Period 1||2
11207636|NCT01877265|12398830|FG003|COMPLETED|Treatment Period 1||3
11207637|NCT01877265|12398831|FG004|COMPLETED|Treatment Period 1||3
11207638|NCT01877265|12398832|FG005|COMPLETED|Treatment Period 1||3
11207639|NCT01877265|12398827|FG000|NOT COMPLETED|Treatment Period 1||0
11207640|NCT01877265|12398828|FG001|NOT COMPLETED|Treatment Period 1||0
11207641|NCT01877265|12398829|FG002|NOT COMPLETED|Treatment Period 1||1
11207642|NCT01877265|12398830|FG003|NOT COMPLETED|Treatment Period 1||0
11207643|NCT01877265|12398831|FG004|NOT COMPLETED|Treatment Period 1||0
11207644|NCT01877265|12398832|FG005|NOT COMPLETED|Treatment Period 1||0
11207645|NCT01877265|12398827|FG000|STARTED|Washout Period 1 (at Least 14 Days)||3
11084289|NCT01138826|12267060|FG005|NOT COMPLETED|Washout Period II (of 16 Days)||0
11084290|NCT01138826|12267055|FG000|STARTED|Third Intervention Period||2
11084291|NCT01138826|12267056|FG001|STARTED|Third Intervention Period||2
11084292|NCT01138826|12267057|FG002|STARTED|Third Intervention Period||3
11084293|NCT01138826|12267058|FG003|STARTED|Third Intervention Period||3
11084294|NCT01138826|12267059|FG004|STARTED|Third Intervention Period||2
11084295|NCT01138826|12267060|FG005|STARTED|Third Intervention Period||3
11084296|NCT01138826|12267055|FG000|COMPLETED|Third Intervention Period||2
11084297|NCT01138826|12267056|FG001|COMPLETED|Third Intervention Period||2
11084298|NCT01138826|12267057|FG002|COMPLETED|Third Intervention Period||3
11084299|NCT01138826|12267058|FG003|COMPLETED|Third Intervention Period||3
11084300|NCT01138826|12267059|FG004|COMPLETED|Third Intervention Period||2
11084301|NCT01138826|12267060|FG005|COMPLETED|Third Intervention Period||3
11084302|NCT01138826|12267055|FG000|NOT COMPLETED|Third Intervention Period||0
11084303|NCT01138826|12267056|FG001|NOT COMPLETED|Third Intervention Period||0
11084304|NCT01138826|12267057|FG002|NOT COMPLETED|Third Intervention Period||0
11084305|NCT01138826|12267058|FG003|NOT COMPLETED|Third Intervention Period||0
11084306|NCT01138826|12267059|FG004|NOT COMPLETED|Third Intervention Period||0
11084307|NCT01138826|12267060|FG005|NOT COMPLETED|Third Intervention Period||0
11084308|NCT01138917|12267068|FG000|STARTED|Overall Study||101
11084309|NCT01138917|12267068|FG000|COMPLETED|Overall Study||77
11084310|NCT01138917|12267068|FG000|NOT COMPLETED|Overall Study||24
11084311|NCT01138969|12267078|FG000|STARTED|Overall Study||83
11084312|NCT01138969|12267079|FG001|STARTED|Overall Study||82
11084313|NCT01138969|12267078|FG000|COMPLETED|Overall Study||83
11084314|NCT01138969|12267079|FG001|COMPLETED|Overall Study||82
11084315|NCT01138969|12267078|FG000|NOT COMPLETED|Overall Study||0
11084316|NCT01138969|12267079|FG001|NOT COMPLETED|Overall Study||0
11084317|NCT01138995|12267087|FG000|STARTED|Overall Study||98
11084318|NCT01138995|12267088|FG001|STARTED|Overall Study||99
11084319|NCT01138995|12267087|FG000|COMPLETED|Overall Study||88
11084320|NCT01138995|12267088|FG001|COMPLETED|Overall Study||74
11084321|NCT01138995|12267087|FG000|NOT COMPLETED|Overall Study||10
11084322|NCT01138995|12267088|FG001|NOT COMPLETED|Overall Study||25
11084323|NCT01139021|12267101|FG000|STARTED|Overall Study||152
11084324|NCT01139021|12267102|FG001|STARTED|Overall Study||153
11084325|NCT01139021|12267103|FG002|STARTED|Overall Study||67
11084326|NCT01139021|12267104|FG003|STARTED|Overall Study||19
11084327|NCT01139021|12267105|FG004|STARTED|Overall Study||116
11084328|NCT01139021|12267106|FG005|STARTED|Overall Study||1
11084329|NCT01139021|12267101|FG000|COMPLETED|Overall Study||151
11084330|NCT01139021|12267102|FG001|COMPLETED|Overall Study||153
11084331|NCT01139021|12267103|FG002|COMPLETED|Overall Study||67
11084332|NCT01139021|12267104|FG003|COMPLETED|Overall Study||18
11084333|NCT01139021|12267105|FG004|COMPLETED|Overall Study||107
11084334|NCT01139021|12267106|FG005|COMPLETED|Overall Study||1
11084335|NCT01139021|12267101|FG000|NOT COMPLETED|Overall Study||1
11084336|NCT01139021|12267102|FG001|NOT COMPLETED|Overall Study||0
11084337|NCT01139021|12267103|FG002|NOT COMPLETED|Overall Study||0
11084338|NCT01139021|12267104|FG003|NOT COMPLETED|Overall Study||1
11084339|NCT01139021|12267105|FG004|NOT COMPLETED|Overall Study||9
11084340|NCT01139021|12267106|FG005|NOT COMPLETED|Overall Study||0
11084341|NCT01139164|12267124|FG000|STARTED|Overall Study||4
11084342|NCT01139164|12267125|FG001|STARTED|Overall Study||67
11084343|NCT01139164|12267126|FG002|STARTED|Overall Study||7
11084344|NCT01139164|12267124|FG000|COMPLETED|Overall Study||4
11084345|NCT01139164|12267125|FG001|COMPLETED|Overall Study||65
11084346|NCT01139164|12267126|FG002|COMPLETED|Overall Study||7
11084347|NCT01139164|12267124|FG000|NOT COMPLETED|Overall Study||0
11084348|NCT01139164|12267125|FG001|NOT COMPLETED|Overall Study||2
11084349|NCT01139164|12267126|FG002|NOT COMPLETED|Overall Study||0
11084350|NCT01139190|12267136|FG000|STARTED|Overall Study||38
11084351|NCT01139190|12267137|FG001|STARTED|Overall Study||39
11084352|NCT01139190|12267136|FG000|COMPLETED|Overall Study||38
11084353|NCT01139190|12267137|FG001|COMPLETED|Overall Study||38
11084354|NCT01139190|12267136|FG000|NOT COMPLETED|Overall Study||0
11084355|NCT01139190|12267137|FG001|NOT COMPLETED|Overall Study||1
11084356|NCT01139411|12267145|FG000|STARTED|Overall Study||26
11084357|NCT01139411|12267146|FG001|STARTED|Overall Study||23
11084358|NCT01139411|12267145|FG000|COMPLETED|Overall Study||24
11084359|NCT01139411|12267146|FG001|COMPLETED|Overall Study||19
11084360|NCT01139411|12267145|FG000|NOT COMPLETED|Overall Study||2
11084361|NCT01139411|12267146|FG001|NOT COMPLETED|Overall Study||4
11084362|NCT01139450|12267157|FG000|STARTED|Overall Study||302
11084363|NCT01139450|12267158|FG001|STARTED|Overall Study||297
11084364|NCT01139450|12267159|FG002|STARTED|Overall Study||300
11084365|NCT01139450|12267157|FG000|COMPLETED|Overall Study||275
11084366|NCT01139450|12267158|FG001|COMPLETED|Overall Study||272
11084367|NCT01139450|12267159|FG002|COMPLETED|Overall Study||262
11084368|NCT01139450|12267157|FG000|NOT COMPLETED|Overall Study||27
11084369|NCT01139450|12267158|FG001|NOT COMPLETED|Overall Study||25
11084370|NCT01139450|12267159|FG002|NOT COMPLETED|Overall Study||38
11084371|NCT01139515|12267167|FG000|STARTED|First Intervention Period||4
11084372|NCT01139515|12267168|FG001|STARTED|First Intervention Period||4
11084373|NCT01139515|12267169|FG002|STARTED|First Intervention Period||4
11084374|NCT01139515|12267170|FG003|STARTED|First Intervention Period||4
11084375|NCT01139515|12267167|FG000|COMPLETED|First Intervention Period||4
11084376|NCT01139515|12267168|FG001|COMPLETED|First Intervention Period||4
11084377|NCT01139515|12267169|FG002|COMPLETED|First Intervention Period||4
11084378|NCT01139515|12267170|FG003|COMPLETED|First Intervention Period||4
11084379|NCT01139515|12267167|FG000|NOT COMPLETED|First Intervention Period||0
11084380|NCT01139515|12267168|FG001|NOT COMPLETED|First Intervention Period||0
11084381|NCT01139515|12267169|FG002|NOT COMPLETED|First Intervention Period||0
11084382|NCT01139515|12267170|FG003|NOT COMPLETED|First Intervention Period||0
11084383|NCT01139515|12267167|FG000|STARTED|Washout Period I (46hrs)||4
11084384|NCT01139515|12267168|FG001|STARTED|Washout Period I (46hrs)||4
11084385|NCT01139515|12267169|FG002|STARTED|Washout Period I (46hrs)||4
11084386|NCT01139515|12267170|FG003|STARTED|Washout Period I (46hrs)||4
11084387|NCT01139515|12267167|FG000|COMPLETED|Washout Period I (46hrs)||4
11084388|NCT01139515|12267168|FG001|COMPLETED|Washout Period I (46hrs)||4
11084389|NCT01139515|12267169|FG002|COMPLETED|Washout Period I (46hrs)||4
11084390|NCT01139515|12267170|FG003|COMPLETED|Washout Period I (46hrs)||4
11084391|NCT01139515|12267167|FG000|NOT COMPLETED|Washout Period I (46hrs)||0
11084392|NCT01139515|12267168|FG001|NOT COMPLETED|Washout Period I (46hrs)||0
11084393|NCT01139515|12267169|FG002|NOT COMPLETED|Washout Period I (46hrs)||0
11084394|NCT01139515|12267170|FG003|NOT COMPLETED|Washout Period I (46hrs)||0
11084395|NCT01139515|12267167|FG000|STARTED|Second Intervention Period||4
11084396|NCT01139515|12267168|FG001|STARTED|Second Intervention Period||4
11084397|NCT01139515|12267169|FG002|STARTED|Second Intervention Period||4
11084398|NCT01139515|12267170|FG003|STARTED|Second Intervention Period||4
11084399|NCT01139515|12267167|FG000|COMPLETED|Second Intervention Period||4
11084400|NCT01139515|12267168|FG001|COMPLETED|Second Intervention Period||4
11084401|NCT01139515|12267169|FG002|COMPLETED|Second Intervention Period||4
11084402|NCT01139515|12267170|FG003|COMPLETED|Second Intervention Period||4
11084403|NCT01139515|12267167|FG000|NOT COMPLETED|Second Intervention Period||0
11084404|NCT01139515|12267168|FG001|NOT COMPLETED|Second Intervention Period||0
11084405|NCT01139515|12267169|FG002|NOT COMPLETED|Second Intervention Period||0
11084406|NCT01139515|12267170|FG003|NOT COMPLETED|Second Intervention Period||0
11084407|NCT01139515|12267167|FG000|STARTED|Washout Period 2 (46 Hrs)||4
11084408|NCT01139515|12267168|FG001|STARTED|Washout Period 2 (46 Hrs)||4
11084409|NCT01139515|12267169|FG002|STARTED|Washout Period 2 (46 Hrs)||4
11084410|NCT01139515|12267170|FG003|STARTED|Washout Period 2 (46 Hrs)||4
11084411|NCT01139515|12267167|FG000|COMPLETED|Washout Period 2 (46 Hrs)||4
11084412|NCT01139515|12267168|FG001|COMPLETED|Washout Period 2 (46 Hrs)||4
11084413|NCT01139515|12267169|FG002|COMPLETED|Washout Period 2 (46 Hrs)||4
11084414|NCT01139515|12267170|FG003|COMPLETED|Washout Period 2 (46 Hrs)||4
11084415|NCT01139515|12267167|FG000|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
11084416|NCT01139515|12267168|FG001|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
11084417|NCT01139515|12267169|FG002|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
11084418|NCT01139515|12267170|FG003|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
11084419|NCT01139515|12267167|FG000|STARTED|Third Intervention Period||4
11084420|NCT01139515|12267168|FG001|STARTED|Third Intervention Period||4
11084421|NCT01139515|12267169|FG002|STARTED|Third Intervention Period||4
11084422|NCT01139515|12267170|FG003|STARTED|Third Intervention Period||4
11084423|NCT01139515|12267167|FG000|COMPLETED|Third Intervention Period||4
11084424|NCT01139515|12267168|FG001|COMPLETED|Third Intervention Period||4
11084425|NCT01139515|12267169|FG002|COMPLETED|Third Intervention Period||4
11084426|NCT01139515|12267170|FG003|COMPLETED|Third Intervention Period||4
11084427|NCT01139515|12267167|FG000|NOT COMPLETED|Third Intervention Period||0
11084428|NCT01139515|12267168|FG001|NOT COMPLETED|Third Intervention Period||0
11084429|NCT01139515|12267169|FG002|NOT COMPLETED|Third Intervention Period||0
11084430|NCT01139515|12267170|FG003|NOT COMPLETED|Third Intervention Period||0
11084431|NCT01139515|12267167|FG000|STARTED|Washout Period 3 (46 Hrs)||4
11084432|NCT01139515|12267168|FG001|STARTED|Washout Period 3 (46 Hrs)||4
11084433|NCT01139515|12267169|FG002|STARTED|Washout Period 3 (46 Hrs)||4
11084434|NCT01139515|12267170|FG003|STARTED|Washout Period 3 (46 Hrs)||4
11084435|NCT01139515|12267167|FG000|COMPLETED|Washout Period 3 (46 Hrs)||4
11084436|NCT01139515|12267168|FG001|COMPLETED|Washout Period 3 (46 Hrs)||4
11084437|NCT01139515|12267169|FG002|COMPLETED|Washout Period 3 (46 Hrs)||4
11084438|NCT01139515|12267170|FG003|COMPLETED|Washout Period 3 (46 Hrs)||4
11084439|NCT01139515|12267167|FG000|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
11350943|NCT03029650|12547902|FG001|COMPLETED|Washout (1 Week)||10
11350944|NCT03029650|12547901|FG000|NOT COMPLETED|Washout (1 Week)||1
11350945|NCT03029650|12547902|FG001|NOT COMPLETED|Washout (1 Week)||2
11350946|NCT03029650|12547901|FG000|STARTED|2nd Intervention (3 - 6 Days)||13
11350947|NCT03029650|12547902|FG001|STARTED|2nd Intervention (3 - 6 Days)||10
11350948|NCT03029650|12547901|FG000|COMPLETED|2nd Intervention (3 - 6 Days)||13
11350949|NCT03029650|12547902|FG001|COMPLETED|2nd Intervention (3 - 6 Days)||10
11084440|NCT01139515|12267168|FG001|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
11084441|NCT01139515|12267169|FG002|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
11084442|NCT01139515|12267170|FG003|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
11084443|NCT01139515|12267167|FG000|STARTED|Fourth Intervention Period||4
11084444|NCT01139515|12267168|FG001|STARTED|Fourth Intervention Period||4
11084445|NCT01139515|12267169|FG002|STARTED|Fourth Intervention Period||4
11084446|NCT01139515|12267170|FG003|STARTED|Fourth Intervention Period||4
11084447|NCT01139515|12267167|FG000|COMPLETED|Fourth Intervention Period||4
11084448|NCT01139515|12267168|FG001|COMPLETED|Fourth Intervention Period||4
11084449|NCT01139515|12267169|FG002|COMPLETED|Fourth Intervention Period||4
11084450|NCT01139515|12267170|FG003|COMPLETED|Fourth Intervention Period||4
11084451|NCT01139515|12267167|FG000|NOT COMPLETED|Fourth Intervention Period||0
11084452|NCT01139515|12267168|FG001|NOT COMPLETED|Fourth Intervention Period||0
11084453|NCT01139515|12267169|FG002|NOT COMPLETED|Fourth Intervention Period||0
11084454|NCT01139515|12267170|FG003|NOT COMPLETED|Fourth Intervention Period||0
11084455|NCT01139580|12267182|FG000|STARTED|Overall Study||181
11084456|NCT01139580|12267183|FG001|STARTED|Overall Study||182
11084457|NCT01139580|12267182|FG000|COMPLETED|Overall Study||158
11084458|NCT01139580|12267183|FG001|COMPLETED|Overall Study||164
11084459|NCT01139580|12267182|FG000|NOT COMPLETED|Overall Study||23
11084460|NCT01139580|12267183|FG001|NOT COMPLETED|Overall Study||18
11084461|NCT01139658|12267191|FG000|STARTED|Overall Study||747
11084462|NCT01139658|12267192|FG001|STARTED|Overall Study||929
11084463|NCT01139658|12267191|FG000|COMPLETED|Overall Study||691
11084464|NCT01139658|12267192|FG001|COMPLETED|Overall Study||816
11084465|NCT01139658|12267191|FG000|NOT COMPLETED|Overall Study||56
11084466|NCT01139658|12267192|FG001|NOT COMPLETED|Overall Study||113
11084467|NCT01139762|12267200|FG000|STARTED|Washout and Placebo Lead-In Period||1070
11084468|NCT01139762|12267201|FG001|STARTED|Washout and Placebo Lead-In Period||0
11084469|NCT01139762|12267202|FG002|STARTED|Washout and Placebo Lead-In Period||0
11084470|NCT01139762|12267200|FG000|COMPLETED|Washout and Placebo Lead-In Period||696
11084471|NCT01139762|12267201|FG001|COMPLETED|Washout and Placebo Lead-In Period||0
11084472|NCT01139762|12267202|FG002|COMPLETED|Washout and Placebo Lead-In Period||0
11084473|NCT01139762|12267200|FG000|NOT COMPLETED|Washout and Placebo Lead-In Period||374
11084474|NCT01139762|12267201|FG001|NOT COMPLETED|Washout and Placebo Lead-In Period||0
11084475|NCT01139762|12267202|FG002|NOT COMPLETED|Washout and Placebo Lead-In Period||0
11084476|NCT01139762|12267200|FG000|STARTED|Double-Blind Randomized Active Treatment||0
11084477|NCT01139762|12267201|FG001|STARTED|Double-Blind Randomized Active Treatment||346
11350950|NCT03029650|12547901|FG000|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
11350951|NCT03029650|12547902|FG001|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
11350952|NCT03029715|12547914|FG000|STARTED|Overall Study||50
11350953|NCT03029715|12547915|FG001|STARTED|Overall Study||50
11350954|NCT03029715|12547914|FG000|COMPLETED|Overall Study||50
11084478|NCT01139762|12267202|FG002|STARTED|Double-Blind Randomized Active Treatment||350
11084479|NCT01139762|12267200|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
11084480|NCT01139762|12267201|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
11084481|NCT01139762|12267202|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
11084482|NCT01139762|12267200|FG000|COMPLETED|Double-Blind Randomized Active Treatment||0
11084483|NCT01139762|12267201|FG001|COMPLETED|Double-Blind Randomized Active Treatment||306
11084484|NCT01139762|12267202|FG002|COMPLETED|Double-Blind Randomized Active Treatment||286
11084485|NCT01139762|12267200|FG000|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
11084486|NCT01139762|12267201|FG001|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
11084487|NCT01139762|12267202|FG002|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
11084488|NCT01139775|12267212|FG000|STARTED|Overall Study||14
11084489|NCT01139775|12267213|FG001|STARTED|Overall Study||39
11084490|NCT01139775|12267214|FG002|STARTED|Overall Study||23
11084491|NCT01139775|12267212|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14
11084492|NCT01139775|12267213|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
11084493|NCT01139775|12267214|FG002|Received at Least 1 Dose of Study Drug|Overall Study||22
11084494|NCT01139775|12267212|FG000|COMPLETED|Overall Study||13
11084495|NCT01139775|12267213|FG001|COMPLETED|Overall Study||26
11084496|NCT01139775|12267214|FG002|COMPLETED|Overall Study||17
11084497|NCT01139775|12267212|FG000|NOT COMPLETED|Overall Study||1
11084498|NCT01139775|12267213|FG001|NOT COMPLETED|Overall Study||13
11084499|NCT01139775|12267214|FG002|NOT COMPLETED|Overall Study||6
11084500|NCT01139801|12267226|FG000|STARTED|Overall Study||25
11084501|NCT01139801|12267227|FG001|STARTED|Overall Study||25
11084502|NCT01139801|12267226|FG000|COMPLETED|Overall Study||25
11084503|NCT01139801|12267227|FG001|COMPLETED|Overall Study||25
11084504|NCT01139801|12267226|FG000|NOT COMPLETED|Overall Study||0
11084505|NCT01139801|12267227|FG001|NOT COMPLETED|Overall Study||0
11084506|NCT01139814|12267233|FG000|STARTED|Overall Study||181
11084507|NCT01139814|12267233|FG000|COMPLETED|Overall Study||181
11084508|NCT01139814|12267233|FG000|NOT COMPLETED|Overall Study||0
11084509|NCT01139879|12267238|FG000|STARTED|Overall Study||10
11084510|NCT01139879|12267238|FG000|COMPLETED|Overall Study||10
11084511|NCT01139879|12267238|FG000|NOT COMPLETED|Overall Study||0
11084512|NCT01140061|12267254|FG000|STARTED|Part I|Includes 1 replacement participant|7
11084513|NCT01140061|12267255|FG001|STARTED|Part I||2
11084514|NCT01140061|12267256|FG002|STARTED|Part I||0
11084515|NCT01140061|12267257|FG003|STARTED|Part I||0
11084516|NCT01140061|12267258|FG004|STARTED|Part I||0
11084517|NCT01140061|12267259|FG005|STARTED|Part I||0
11084518|NCT01140061|12267260|FG006|STARTED|Part I||0
11084519|NCT01140061|12267261|FG007|STARTED|Part I||0
11084520|NCT01140061|12267262|FG008|STARTED|Part I||0
11084521|NCT01140061|12267263|FG009|STARTED|Part I||0
11084522|NCT01140061|12267254|FG000|COMPLETED|Part I||6
11084523|NCT01140061|12267255|FG001|COMPLETED|Part I||2
11084524|NCT01140061|12267256|FG002|COMPLETED|Part I||0
11084525|NCT01140061|12267257|FG003|COMPLETED|Part I||0
11084526|NCT01140061|12267258|FG004|COMPLETED|Part I||0
11084527|NCT01140061|12267259|FG005|COMPLETED|Part I||0
11084528|NCT01140061|12267260|FG006|COMPLETED|Part I||0
11084529|NCT01140061|12267261|FG007|COMPLETED|Part I||0
11084530|NCT01140061|12267262|FG008|COMPLETED|Part I||0
11084531|NCT01140061|12267263|FG009|COMPLETED|Part I||0
11084532|NCT01140061|12267254|FG000|NOT COMPLETED|Part I||1
11084533|NCT01140061|12267255|FG001|NOT COMPLETED|Part I||0
11084534|NCT01140061|12267256|FG002|NOT COMPLETED|Part I||0
11084535|NCT01140061|12267257|FG003|NOT COMPLETED|Part I||0
11084536|NCT01140061|12267258|FG004|NOT COMPLETED|Part I||0
11084537|NCT01140061|12267259|FG005|NOT COMPLETED|Part I||0
11084538|NCT01140061|12267260|FG006|NOT COMPLETED|Part I||0
11084539|NCT01140061|12267261|FG007|NOT COMPLETED|Part I||0
11084540|NCT01140061|12267262|FG008|NOT COMPLETED|Part I||0
11084541|NCT01140061|12267263|FG009|NOT COMPLETED|Part I||0
11084542|NCT01140061|12267254|FG000|STARTED|Part II||0
11084543|NCT01140061|12267255|FG001|STARTED|Part II||0
11084544|NCT01140061|12267256|FG002|STARTED|Part II||6
11084545|NCT01140061|12267257|FG003|STARTED|Part II||2
11084546|NCT01140061|12267258|FG004|STARTED|Part II||6
11084547|NCT01140061|12267259|FG005|STARTED|Part II||2
11084548|NCT01140061|12267260|FG006|STARTED|Part II||6
11084549|NCT01140061|12267261|FG007|STARTED|Part II||2
11084550|NCT01140061|12267262|FG008|STARTED|Part II||0
11084551|NCT01140061|12267263|FG009|STARTED|Part II||0
11084552|NCT01140061|12267254|FG000|COMPLETED|Part II||0
11084553|NCT01140061|12267255|FG001|COMPLETED|Part II||0
11084554|NCT01140061|12267256|FG002|COMPLETED|Part II||6
11084555|NCT01140061|12267257|FG003|COMPLETED|Part II||2
11084556|NCT01140061|12267258|FG004|COMPLETED|Part II||6
11084557|NCT01140061|12267259|FG005|COMPLETED|Part II||2
11084558|NCT01140061|12267260|FG006|COMPLETED|Part II||6
11084559|NCT01140061|12267261|FG007|COMPLETED|Part II||2
11084560|NCT01140061|12267262|FG008|COMPLETED|Part II||0
11084561|NCT01140061|12267263|FG009|COMPLETED|Part II||0
11084562|NCT01140061|12267254|FG000|NOT COMPLETED|Part II||0
11084563|NCT01140061|12267255|FG001|NOT COMPLETED|Part II||0
11084564|NCT01140061|12267256|FG002|NOT COMPLETED|Part II||0
11084565|NCT01140061|12267257|FG003|NOT COMPLETED|Part II||0
11084566|NCT01140061|12267258|FG004|NOT COMPLETED|Part II||0
11084567|NCT01140061|12267259|FG005|NOT COMPLETED|Part II||0
11084568|NCT01140061|12267260|FG006|NOT COMPLETED|Part II||0
11084569|NCT01140061|12267261|FG007|NOT COMPLETED|Part II||0
11084570|NCT01140061|12267262|FG008|NOT COMPLETED|Part II||0
11084571|NCT01140061|12267263|FG009|NOT COMPLETED|Part II||0
11084572|NCT01140061|12267254|FG000|STARTED|Part III||0
11084573|NCT01140061|12267255|FG001|STARTED|Part III||0
11084574|NCT01140061|12267256|FG002|STARTED|Part III||0
11084575|NCT01140061|12267257|FG003|STARTED|Part III||0
11084576|NCT01140061|12267258|FG004|STARTED|Part III||0
11084577|NCT01140061|12267259|FG005|STARTED|Part III||0
11084578|NCT01140061|12267260|FG006|STARTED|Part III||0
11084579|NCT01140061|12267261|FG007|STARTED|Part III||0
11084580|NCT01140061|12267262|FG008|STARTED|Part III||7
11084581|NCT01140061|12267263|FG009|STARTED|Part III|Includes 1 replacement participant|2
11084582|NCT01140061|12267254|FG000|COMPLETED|Part III||0
11084583|NCT01140061|12267255|FG001|COMPLETED|Part III||0
11084584|NCT01140061|12267256|FG002|COMPLETED|Part III||0
11084585|NCT01140061|12267257|FG003|COMPLETED|Part III||0
11084586|NCT01140061|12267258|FG004|COMPLETED|Part III||0
11084587|NCT01140061|12267259|FG005|COMPLETED|Part III||0
11084588|NCT01140061|12267260|FG006|COMPLETED|Part III||0
11084589|NCT01140061|12267261|FG007|COMPLETED|Part III||0
11084590|NCT01140061|12267262|FG008|COMPLETED|Part III||7
11084591|NCT01140061|12267263|FG009|COMPLETED|Part III||2
11084592|NCT01140061|12267254|FG000|NOT COMPLETED|Part III||0
11084593|NCT01140061|12267255|FG001|NOT COMPLETED|Part III||0
11084594|NCT01140061|12267256|FG002|NOT COMPLETED|Part III||0
11084595|NCT01140061|12267257|FG003|NOT COMPLETED|Part III||0
11350955|NCT03029715|12547915|FG001|COMPLETED|Overall Study||50
11350956|NCT03029715|12547914|FG000|NOT COMPLETED|Overall Study||0
11350957|NCT03029715|12547915|FG001|NOT COMPLETED|Overall Study||0
11350958|NCT03029819|12547923|FG000|STARTED|Overall Study||33
11350959|NCT03029819|12547924|FG001|STARTED|Overall Study||39
11350960|NCT03029819|12547923|FG000|COMPLETED|Overall Study||30
11350961|NCT03029819|12547924|FG001|COMPLETED|Overall Study||33
11350962|NCT03029819|12547923|FG000|NOT COMPLETED|Overall Study||3
11350963|NCT03029819|12547924|FG001|NOT COMPLETED|Overall Study||6
11350964|NCT03029988|12547933|FG000|STARTED|Overall Study||3
11350965|NCT03029988|12547933|FG000|COMPLETED|Overall Study||3
11350966|NCT03029988|12547933|FG000|NOT COMPLETED|Overall Study||0
11350967|NCT03030599|12547938|FG000|STARTED|Open Label Treatment and Titration||201
11350968|NCT03030599|12547939|FG001|STARTED|Open Label Treatment and Titration||0
11350969|NCT03030599|12547940|FG002|STARTED|Open Label Treatment and Titration||0
11350970|NCT03030599|12547938|FG000|COMPLETED|Open Label Treatment and Titration||155
11350971|NCT03030599|12547939|FG001|COMPLETED|Open Label Treatment and Titration||0
11350972|NCT03030599|12547940|FG002|COMPLETED|Open Label Treatment and Titration||0
11350973|NCT03030599|12547938|FG000|NOT COMPLETED|Open Label Treatment and Titration||46
11350974|NCT03030599|12547939|FG001|NOT COMPLETED|Open Label Treatment and Titration||0
11350975|NCT03030599|12547940|FG002|NOT COMPLETED|Open Label Treatment and Titration||0
11350976|NCT03030599|12547938|FG000|STARTED|Stable Dose|149 subjects of the 201 entered the Stable Dose Period. Of those subjects, 136 were randomized.|149
11350977|NCT03030599|12547939|FG001|STARTED|Stable Dose||0
11350978|NCT03030599|12547940|FG002|STARTED|Stable Dose||0
11350979|NCT03030599|12547938|FG000|COMPLETED|Stable Dose||144
11350980|NCT03030599|12547939|FG001|COMPLETED|Stable Dose||0
11350981|NCT03030599|12547940|FG002|COMPLETED|Stable Dose||0
11350982|NCT03030599|12547938|FG000|NOT COMPLETED|Stable Dose||5
11350983|NCT03030599|12547939|FG001|NOT COMPLETED|Stable Dose||0
11350984|NCT03030599|12547940|FG002|NOT COMPLETED|Stable Dose||0
11350985|NCT03030599|12547938|FG000|STARTED|Double Blind Randomized Withdrawal||0
11350986|NCT03030599|12547939|FG001|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|69
11350987|NCT03030599|12547940|FG002|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|67
11350988|NCT03030599|12547938|FG000|COMPLETED|Double Blind Randomized Withdrawal||0
11084596|NCT01140061|12267258|FG004|NOT COMPLETED|Part III||0
11084597|NCT01140061|12267259|FG005|NOT COMPLETED|Part III||0
11084598|NCT01140061|12267260|FG006|NOT COMPLETED|Part III||0
11084599|NCT01140061|12267261|FG007|NOT COMPLETED|Part III||0
11084600|NCT01140061|12267262|FG008|NOT COMPLETED|Part III||0
11084601|NCT01140061|12267263|FG009|NOT COMPLETED|Part III||0
11084602|NCT01140061|12267254|FG000|STARTED|Extension||0
11084603|NCT01140061|12267255|FG001|STARTED|Extension||0
11084604|NCT01140061|12267256|FG002|STARTED|Extension||0
11084605|NCT01140061|12267257|FG003|STARTED|Extension||0
11084606|NCT01140061|12267258|FG004|STARTED|Extension||0
11084607|NCT01140061|12267259|FG005|STARTED|Extension||0
11084608|NCT01140061|12267260|FG006|STARTED|Extension||0
11084609|NCT01140061|12267261|FG007|STARTED|Extension||0
11084610|NCT01140061|12267262|FG008|STARTED|Extension||7
11084611|NCT01140061|12267263|FG009|STARTED|Extension||2
11084612|NCT01140061|12267254|FG000|COMPLETED|Extension||0
11084613|NCT01140061|12267255|FG001|COMPLETED|Extension||0
11084614|NCT01140061|12267256|FG002|COMPLETED|Extension||0
11084615|NCT01140061|12267257|FG003|COMPLETED|Extension||0
11084616|NCT01140061|12267258|FG004|COMPLETED|Extension||0
11084617|NCT01140061|12267259|FG005|COMPLETED|Extension||0
11084618|NCT01140061|12267260|FG006|COMPLETED|Extension||0
11084619|NCT01140061|12267261|FG007|COMPLETED|Extension||0
11084620|NCT01140061|12267262|FG008|COMPLETED|Extension||7
11084621|NCT01140061|12267263|FG009|COMPLETED|Extension||1
11084622|NCT01140061|12267254|FG000|NOT COMPLETED|Extension||0
11084623|NCT01140061|12267255|FG001|NOT COMPLETED|Extension||0
11084624|NCT01140061|12267256|FG002|NOT COMPLETED|Extension||0
11084625|NCT01140061|12267257|FG003|NOT COMPLETED|Extension||0
11084626|NCT01140061|12267258|FG004|NOT COMPLETED|Extension||0
11084627|NCT01140061|12267259|FG005|NOT COMPLETED|Extension||0
11084628|NCT01140061|12267260|FG006|NOT COMPLETED|Extension||0
11084629|NCT01140061|12267261|FG007|NOT COMPLETED|Extension||0
11084630|NCT01140061|12267262|FG008|NOT COMPLETED|Extension||0
11084631|NCT01140061|12267263|FG009|NOT COMPLETED|Extension||1
11084632|NCT01140191|12267278|FG000|STARTED|Overall Study||1
11084633|NCT01140191|12267278|FG000|COMPLETED|Overall Study||1
11084634|NCT01140191|12267278|FG000|NOT COMPLETED|Overall Study||0
11084635|NCT01140295|12267284|FG000|STARTED|Overall Study||17
11084636|NCT01140295|12267285|FG001|STARTED|Overall Study||16
11084637|NCT01140295|12267284|FG000|COMPLETED|Overall Study||16
11084638|NCT01140295|12267285|FG001|COMPLETED|Overall Study||14
11084639|NCT01140295|12267284|FG000|NOT COMPLETED|Overall Study||1
11084640|NCT01140295|12267285|FG001|NOT COMPLETED|Overall Study||2
11084641|NCT01140347|12267295|FG000|STARTED|Overall Study||283
11084642|NCT01140347|12267296|FG001|STARTED|Overall Study||282
11084643|NCT01140347|12267295|FG000|Received at Least 1 Dose of Study Drug|Overall Study||277
11084644|NCT01140347|12267296|FG001|Received at Least 1 Dose of Study Drug|Overall Study||276
11084645|NCT01140347|12267295|FG000|COMPLETED|Overall Study||265
11084646|NCT01140347|12267296|FG001|COMPLETED|Overall Study||268
11084647|NCT01140347|12267295|FG000|NOT COMPLETED|Overall Study||18
11084648|NCT01140347|12267296|FG001|NOT COMPLETED|Overall Study||14
11084649|NCT01140360|12267302|FG000|STARTED|Overall Study||21
11084650|NCT01140360|12267302|FG000|COMPLETED|Overall Study||15
11084651|NCT01140360|12267302|FG000|NOT COMPLETED|Overall Study||6
11084652|NCT01140477|12267308|FG000|STARTED|Overall Study||153
11084653|NCT01140477|12267309|FG001|STARTED|Overall Study||76
11084654|NCT01140477|12267308|FG000|COMPLETED|Overall Study||145
11084655|NCT01140477|12267309|FG001|COMPLETED|Overall Study||70
11084656|NCT01140477|12267308|FG000|NOT COMPLETED|Overall Study||8
11084657|NCT01140477|12267309|FG001|NOT COMPLETED|Overall Study||6
11084658|NCT01140503|12267315|FG000|STARTED|Overall Study||5
11084659|NCT01140503|12267315|FG000|COMPLETED|Overall Study||4
11084660|NCT01140503|12267315|FG000|NOT COMPLETED|Overall Study||1
11084661|NCT01140568|12267319|FG000|STARTED|Overall Study||38
11084662|NCT01140568|12267319|FG000|Screen Fail|Overall Study||4
11084663|NCT01140568|12267319|FG000|Treated With Study Drug|Overall Study||34
11084664|NCT01140568|12267319|FG000|COMPLETED|Overall Study||2
11084665|NCT01140568|12267319|FG000|NOT COMPLETED|Overall Study||36
11084666|NCT01140646|12267323|FG000|STARTED|Overall Study||43
11084667|NCT01140646|12267323|FG000|COMPLETED|Overall Study||34
11084668|NCT01140646|12267323|FG000|NOT COMPLETED|Overall Study||9
11084669|NCT01140815|12267329|FG000|STARTED|Overall Study||25
11084670|NCT01140815|12267330|FG001|STARTED|Overall Study||25
11350989|NCT03030599|12547939|FG001|COMPLETED|Double Blind Randomized Withdrawal||69
11350990|NCT03030599|12547940|FG002|COMPLETED|Double Blind Randomized Withdrawal||59
11350991|NCT03030599|12547938|FG000|NOT COMPLETED|Double Blind Randomized Withdrawal||0
11350992|NCT03030599|12547939|FG001|NOT COMPLETED|Double Blind Randomized Withdrawal||0
11350993|NCT03030599|12547940|FG002|NOT COMPLETED|Double Blind Randomized Withdrawal||8
11350994|NCT03030599|12547938|FG000|STARTED|Open-label Extension||74
11350995|NCT03030599|12547939|FG001|STARTED|Open-label Extension||0
11350996|NCT03030599|12547940|FG002|STARTED|Open-label Extension||0
11350997|NCT03030599|12547938|FG000|COMPLETED|Open-label Extension||67
11350998|NCT03030599|12547939|FG001|COMPLETED|Open-label Extension||0
11350999|NCT03030599|12547940|FG002|COMPLETED|Open-label Extension||0
11351000|NCT03030599|12547938|FG000|NOT COMPLETED|Open-label Extension||7
11351001|NCT03030599|12547939|FG001|NOT COMPLETED|Open-label Extension||0
11351002|NCT03030599|12547940|FG002|NOT COMPLETED|Open-label Extension||0
11351003|NCT03030638|12547954|FG000|STARTED|Overall Study||1386
11351004|NCT03030638|12547955|FG001|STARTED|Overall Study||1841
11351005|NCT03030638|12547956|FG002|STARTED|Overall Study||1712
11351006|NCT03030638|12547957|FG003|STARTED|Overall Study||6406
11351007|NCT03030638|12547958|FG004|STARTED|Overall Study||696
11351008|NCT03030638|12547959|FG005|STARTED|Overall Study||1592
11351009|NCT03030638|12547960|FG006|STARTED|Overall Study||364
11351010|NCT03030638|12547961|FG007|STARTED|Overall Study||127
11351011|NCT03030638|12547954|FG000|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372
11351012|NCT03030638|12547955|FG001|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636
11351013|NCT03030638|12547956|FG002|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
11351014|NCT03030638|12547957|FG003|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
11084671|NCT01140815|12267329|FG000|COMPLETED|Overall Study||25
11084672|NCT01140815|12267330|FG001|COMPLETED|Overall Study||25
11351015|NCT03030638|12547958|FG004|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
11351016|NCT03030638|12547959|FG005|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
11351017|NCT03030638|12547960|FG006|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
11351018|NCT03030638|12547961|FG007|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
11351019|NCT03030638|12547954|FG000|COMPLETED|Overall Study||1386
11351020|NCT03030638|12547955|FG001|COMPLETED|Overall Study||1841
11351021|NCT03030638|12547956|FG002|COMPLETED|Overall Study||1712
11351022|NCT03030638|12547957|FG003|COMPLETED|Overall Study||6406
11084673|NCT01140815|12267329|FG000|NOT COMPLETED|Overall Study||0
11084674|NCT01140815|12267330|FG001|NOT COMPLETED|Overall Study||0
11084675|NCT01140880|12267340|FG000|STARTED|Overall Study||70
11084676|NCT01140880|12267341|FG001|STARTED|Overall Study||100
11084677|NCT01140880|12267340|FG000|COMPLETED|Overall Study||56
11084678|NCT01140880|12267341|FG001|COMPLETED|Overall Study||56
11084679|NCT01140880|12267340|FG000|NOT COMPLETED|Overall Study||14
11084680|NCT01140880|12267341|FG001|NOT COMPLETED|Overall Study||44
11084681|NCT01140906|12267351|FG000|STARTED|Overall Study||158
11084682|NCT01140906|12267352|FG001|STARTED|Overall Study||151
11084683|NCT01140906|12267353|FG002|STARTED|Overall Study||151
11084684|NCT01140906|12267354|FG003|STARTED|Overall Study||147
11084685|NCT01140906|12267351|FG000|COMPLETED|Overall Study||133
11084686|NCT01140906|12267352|FG001|COMPLETED|Overall Study||117
11084687|NCT01140906|12267353|FG002|COMPLETED|Overall Study||125
11084688|NCT01140906|12267354|FG003|COMPLETED|Overall Study||131
11084689|NCT01140906|12267351|FG000|NOT COMPLETED|Overall Study||25
11084690|NCT01140906|12267352|FG001|NOT COMPLETED|Overall Study||34
11084691|NCT01140906|12267353|FG002|NOT COMPLETED|Overall Study||26
11084692|NCT01140906|12267354|FG003|NOT COMPLETED|Overall Study||16
11084693|NCT01141049|12267366|FG000|STARTED|Overall Study||19
11084694|NCT01141049|12267367|FG001|STARTED|Overall Study||21
11084695|NCT01141049|12267366|FG000|COMPLETED|Overall Study||14
11084696|NCT01141049|12267367|FG001|COMPLETED|Overall Study||13
11084697|NCT01141049|12267366|FG000|NOT COMPLETED|Overall Study||5
11084698|NCT01141049|12267367|FG001|NOT COMPLETED|Overall Study||8
11084699|NCT01141075|12267373|FG000|STARTED|Cycle 1||11
11084700|NCT01141075|12267373|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||11
11084701|NCT01141075|12267373|FG000|COMPLETED|Cycle 1||11
11084702|NCT01141075|12267373|FG000|NOT COMPLETED|Cycle 1||0
11084703|NCT01141075|12267373|FG000|STARTED|Cycle 2||11
11084704|NCT01141075|12267373|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||11
11084705|NCT01141075|12267373|FG000|COMPLETED|Cycle 2||11
11084706|NCT01141075|12267373|FG000|NOT COMPLETED|Cycle 2||0
11084707|NCT01141205|12267379|FG000|STARTED|Overall Study||18
11084708|NCT01141205|12267380|FG001|STARTED|Overall Study||5
11084709|NCT01141205|12267379|FG000|COMPLETED|Overall Study||15
11084710|NCT01141205|12267380|FG001|COMPLETED|Overall Study||3
11084711|NCT01141205|12267379|FG000|NOT COMPLETED|Overall Study||3
11084712|NCT01141205|12267380|FG001|NOT COMPLETED|Overall Study||2
11084713|NCT01141283|12267390|FG000|STARTED|Overall Study||290
11084714|NCT01141283|12267390|FG000|COMPLETED|Overall Study||202
11084715|NCT01141283|12267390|FG000|NOT COMPLETED|Overall Study||88
11084716|NCT01141374|12267397|FG000|STARTED|Overall Study||26
11084717|NCT01141374|12267398|FG001|STARTED|Overall Study||27
11084718|NCT01141374|12267399|FG002|STARTED|Overall Study||22
11084719|NCT01141374|12267397|FG000|COMPLETED|Overall Study||26
11084720|NCT01141374|12267398|FG001|COMPLETED|Overall Study||27
11084721|NCT01141374|12267399|FG002|COMPLETED|Overall Study||22
11084722|NCT01141374|12267397|FG000|NOT COMPLETED|Overall Study||0
11084723|NCT01141374|12267398|FG001|NOT COMPLETED|Overall Study||0
11084724|NCT01141374|12267399|FG002|NOT COMPLETED|Overall Study||0
11084725|NCT01141478|12267411|FG000|STARTED|Overall Study||4
11084726|NCT01141478|12267412|FG001|STARTED|Overall Study||4
11084727|NCT01141478|12267411|FG000|COMPLETED|Overall Study||3
11084728|NCT01141478|12267412|FG001|COMPLETED|Overall Study||3
11084729|NCT01141478|12267411|FG000|NOT COMPLETED|Overall Study||1
11084730|NCT01141478|12267412|FG001|NOT COMPLETED|Overall Study||1
11084731|NCT01141491|12267420|FG000|STARTED|Overall Study||68
11084732|NCT01141491|12267421|FG001|STARTED|Overall Study||68
11084733|NCT01141491|12267420|FG000|COMPLETED|Overall Study||20
11084734|NCT01141491|12267421|FG001|COMPLETED|Overall Study||21
11084735|NCT01141491|12267420|FG000|NOT COMPLETED|Overall Study||48
11084736|NCT01141491|12267421|FG001|NOT COMPLETED|Overall Study||47
11084737|NCT01141569|12267427|FG000|STARTED|Overall Study||12
11084738|NCT01141569|12267427|FG000|COMPLETED|Overall Study||12
11084739|NCT01141569|12267427|FG000|NOT COMPLETED|Overall Study||0
11207646|NCT01877265|12398828|FG001|STARTED|Washout Period 1 (at Least 14 Days)||3
11207647|NCT01877265|12398829|FG002|STARTED|Washout Period 1 (at Least 14 Days)||2
11207648|NCT01877265|12398830|FG003|STARTED|Washout Period 1 (at Least 14 Days)||3
11207649|NCT01877265|12398831|FG004|STARTED|Washout Period 1 (at Least 14 Days)||3
11207650|NCT01877265|12398832|FG005|STARTED|Washout Period 1 (at Least 14 Days)||3
11207651|NCT01877265|12398827|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||3
11207652|NCT01877265|12398828|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||3
11207653|NCT01877265|12398829|FG002|COMPLETED|Washout Period 1 (at Least 14 Days)||2
11207654|NCT01877265|12398830|FG003|COMPLETED|Washout Period 1 (at Least 14 Days)||3
11207655|NCT01877265|12398831|FG004|COMPLETED|Washout Period 1 (at Least 14 Days)||3
11207656|NCT01877265|12398832|FG005|COMPLETED|Washout Period 1 (at Least 14 Days)||3
11207657|NCT01877265|12398827|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
11207658|NCT01877265|12398828|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
11207659|NCT01877265|12398829|FG002|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
11084740|NCT01141595|12267431|FG000|STARTED|Overall Study||10
11084741|NCT01141595|12267431|FG000|COMPLETED|Overall Study||8
11084742|NCT01141595|12267431|FG000|NOT COMPLETED|Overall Study||2
11084743|NCT01141608|12267437|FG000|STARTED|Overall Study||152
11084744|NCT01141608|12267438|FG001|STARTED|Overall Study||150
11084745|NCT01141608|12267437|FG000|COMPLETED|Overall Study||152
11084746|NCT01141608|12267438|FG001|COMPLETED|Overall Study||150
11084747|NCT01141608|12267437|FG000|NOT COMPLETED|Overall Study||0
11084748|NCT01141608|12267438|FG001|NOT COMPLETED|Overall Study||0
11084749|NCT01141647|12267444|FG000|STARTED|Overall Study||213
11084750|NCT01141647|12267444|FG000|COMPLETED|Overall Study||167
11084751|NCT01141647|12267444|FG000|NOT COMPLETED|Overall Study||46
11351023|NCT03030638|12547958|FG004|COMPLETED|Overall Study||696
11351024|NCT03030638|12547959|FG005|COMPLETED|Overall Study||1592
11351025|NCT03030638|12547960|FG006|COMPLETED|Overall Study||364
11084752|NCT01141660|12267455|FG000|STARTED|Overall Study||71
11084753|NCT01141660|12267456|FG001|STARTED|Overall Study||60
11084754|NCT01141660|12267455|FG000|COMPLETED|Overall Study||71
11084755|NCT01141660|12267456|FG001|COMPLETED|Overall Study||48
11084756|NCT01141660|12267455|FG000|NOT COMPLETED|Overall Study||0
11084757|NCT01141660|12267456|FG001|NOT COMPLETED|Overall Study||12
11084758|NCT01141725|12267462|FG000|STARTED|Overall Study||3
11084759|NCT01141725|12267463|FG001|STARTED|Overall Study||33
11084760|NCT01141725|12267464|FG002|STARTED|Overall Study||3
11084761|NCT01141725|12267462|FG000|COMPLETED|Overall Study||3
11084762|NCT01141725|12267463|FG001|COMPLETED|Overall Study||33
11084763|NCT01141725|12267464|FG002|COMPLETED|Overall Study||3
11084764|NCT01141725|12267462|FG000|NOT COMPLETED|Overall Study||0
11084765|NCT01141725|12267463|FG001|NOT COMPLETED|Overall Study||0
11084766|NCT01141725|12267464|FG002|NOT COMPLETED|Overall Study||0
11351026|NCT03030638|12547961|FG007|COMPLETED|Overall Study||127
11084767|NCT01141907|12267473|FG000|STARTED|Overall Study||6
11084768|NCT01141907|12267474|FG001|STARTED|Overall Study||5
11084769|NCT01141907|12267473|FG000|COMPLETED|Overall Study||6
11084770|NCT01141907|12267474|FG001|COMPLETED|Overall Study||5
11084771|NCT01141907|12267473|FG000|NOT COMPLETED|Overall Study||0
11084772|NCT01141907|12267474|FG001|NOT COMPLETED|Overall Study||0
11084773|NCT01142089|12267482|FG000|STARTED|Overall Study||65
11084774|NCT01142089|12267483|FG001|STARTED|Overall Study||199
11351027|NCT03030638|12547954|FG000|NOT COMPLETED|Overall Study||0
11084775|NCT01142089|12267482|FG000|COMPLETED|Overall Study||53
11084776|NCT01142089|12267483|FG001|COMPLETED|Overall Study||178
11084777|NCT01142089|12267482|FG000|NOT COMPLETED|Overall Study||12
11084778|NCT01142089|12267483|FG001|NOT COMPLETED|Overall Study||21
11084779|NCT01142115|12267489|FG000|STARTED|First Intervention||21
11084780|NCT01142115|12267490|FG001|STARTED|First Intervention||20
11084781|NCT01142115|12267489|FG000|COMPLETED|First Intervention||19
11084782|NCT01142115|12267490|FG001|COMPLETED|First Intervention||19
11084783|NCT01142115|12267489|FG000|NOT COMPLETED|First Intervention||2
11084784|NCT01142115|12267490|FG001|NOT COMPLETED|First Intervention||1
11084785|NCT01142115|12267489|FG000|STARTED|Second Intervention||19
11084786|NCT01142115|12267490|FG001|STARTED|Second Intervention||19
11084787|NCT01142115|12267489|FG000|COMPLETED|Second Intervention||19
11084788|NCT01142115|12267490|FG001|COMPLETED|Second Intervention||19
11084789|NCT01142115|12267489|FG000|NOT COMPLETED|Second Intervention||0
11084790|NCT01142115|12267490|FG001|NOT COMPLETED|Second Intervention||0
11084791|NCT01142193|12267497|FG000|STARTED|Overall Study||124
11084792|NCT01142193|12267498|FG001|STARTED|Overall Study||125
11084793|NCT01142193|12267497|FG000|COMPLETED|Overall Study||103
11084794|NCT01142193|12267498|FG001|COMPLETED|Overall Study||114
11084795|NCT01142193|12267497|FG000|NOT COMPLETED|Overall Study||21
11084796|NCT01142193|12267498|FG001|NOT COMPLETED|Overall Study||11
11084797|NCT01142232|12267509|FG000|STARTED|Overall Study||3
11084798|NCT01142232|12267510|FG001|STARTED|Overall Study||4
11084799|NCT01142232|12267511|FG002|STARTED|Overall Study||3
11084800|NCT01142232|12267512|FG003|STARTED|Overall Study||6
11084801|NCT01142232|12267513|FG004|STARTED|Overall Study||44
11084802|NCT01142232|12267509|FG000|COMPLETED|Overall Study||0
11084803|NCT01142232|12267510|FG001|COMPLETED|Overall Study||0
11084804|NCT01142232|12267511|FG002|COMPLETED|Overall Study||0
11084805|NCT01142232|12267512|FG003|COMPLETED|Overall Study||1
11084806|NCT01142232|12267513|FG004|COMPLETED|Overall Study||10
11084807|NCT01142232|12267509|FG000|NOT COMPLETED|Overall Study||3
11084808|NCT01142232|12267510|FG001|NOT COMPLETED|Overall Study||4
11084809|NCT01142232|12267511|FG002|NOT COMPLETED|Overall Study||3
11084810|NCT01142232|12267512|FG003|NOT COMPLETED|Overall Study||5
11084811|NCT01142232|12267513|FG004|NOT COMPLETED|Overall Study||34
11084812|NCT01142297|12267525|FG000|STARTED|Overall Study||24
11084813|NCT01142297|12267525|FG000|COMPLETED|Overall Study||18
11084814|NCT01142297|12267525|FG000|NOT COMPLETED|Overall Study||6
11084815|NCT01142310|12267534|FG000|STARTED|Overall Study||26
11084816|NCT01142310|12267535|FG001|STARTED|Overall Study||28
11084817|NCT01142310|12267534|FG000|COMPLETED|Overall Study||17
11084818|NCT01142310|12267535|FG001|COMPLETED|Overall Study||16
11084819|NCT01142310|12267534|FG000|NOT COMPLETED|Overall Study||9
11084820|NCT01142310|12267535|FG001|NOT COMPLETED|Overall Study||12
11084821|NCT01142323|12267541|FG000|STARTED|Overall Study||8
11084822|NCT01142323|12267541|FG000|COMPLETED|Overall Study||8
11084823|NCT01142323|12267541|FG000|NOT COMPLETED|Overall Study||0
11084824|NCT01142336|12267549|FG000|STARTED|Overall Study||26
11084825|NCT01142336|12267550|FG001|STARTED|Overall Study||23
11084826|NCT01142336|12267549|FG000|COMPLETED|Overall Study||25
11084827|NCT01142336|12267550|FG001|COMPLETED|Overall Study||21
11084828|NCT01142336|12267549|FG000|NOT COMPLETED|Overall Study||1
11084829|NCT01142336|12267550|FG001|NOT COMPLETED|Overall Study||2
11084830|NCT01142466|12267561|FG000|STARTED|Overall Study||15
11084831|NCT01142466|12267562|FG001|STARTED|Overall Study||15
11084832|NCT01142466|12267561|FG000|COMPLETED|Overall Study||12
11084833|NCT01142466|12267562|FG001|COMPLETED|Overall Study||13
11084834|NCT01142466|12267561|FG000|NOT COMPLETED|Overall Study||3
11084835|NCT01142466|12267562|FG001|NOT COMPLETED|Overall Study||2
11084836|NCT01142661|12267568|FG000|STARTED|Overall Study||9
11084837|NCT01142661|12267568|FG000|COMPLETED|Overall Study||5
11084838|NCT01142661|12267568|FG000|NOT COMPLETED|Overall Study||4
11084839|NCT01142726|12267575|FG000|STARTED|Treatment Phase: Day 1 Through Month 12||119
11084840|NCT01142726|12267576|FG001|STARTED|Treatment Phase: Day 1 Through Month 12||116
11084841|NCT01142726|12267577|FG002|STARTED|Treatment Phase: Day 1 Through Month 12||116
11084842|NCT01142726|12267575|FG000|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
11084843|NCT01142726|12267576|FG001|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
11084844|NCT01142726|12267577|FG002|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
11084845|NCT01142726|12267575|FG000|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
11084846|NCT01142726|12267576|FG001|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
11084847|NCT01142726|12267577|FG002|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
11351028|NCT03030638|12547955|FG001|NOT COMPLETED|Overall Study||0
11084848|NCT01142726|12267575|FG000|STARTED|Withdrawal Phase: Months 12 up to 24||84
11084849|NCT01142726|12267576|FG001|STARTED|Withdrawal Phase: Months 12 up to 24||66
11084850|NCT01142726|12267577|FG002|STARTED|Withdrawal Phase: Months 12 up to 24||75
11084851|NCT01142726|12267575|FG000|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
11084852|NCT01142726|12267576|FG001|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
11084853|NCT01142726|12267577|FG002|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
11084854|NCT01142726|12267575|FG000|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
11084855|NCT01142726|12267576|FG001|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
11084856|NCT01142726|12267577|FG002|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
11084857|NCT01142726|12267575|FG000|STARTED|Re-Exposure Phase: Months 24 up to 30||55
11084858|NCT01142726|12267576|FG001|STARTED|Re-Exposure Phase: Months 24 up to 30||48
11084859|NCT01142726|12267577|FG002|STARTED|Re-Exposure Phase: Months 24 up to 30||43
11084860|NCT01142726|12267575|FG000|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
11084861|NCT01142726|12267576|FG001|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
11351029|NCT03030638|12547956|FG002|NOT COMPLETED|Overall Study||0
11351030|NCT03030638|12547957|FG003|NOT COMPLETED|Overall Study||0
11351031|NCT03030638|12547958|FG004|NOT COMPLETED|Overall Study||0
11084862|NCT01142726|12267577|FG002|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
11084863|NCT01142726|12267575|FG000|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
11084864|NCT01142726|12267576|FG001|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
11084865|NCT01142726|12267577|FG002|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
11084866|NCT01142791|12267593|FG000|STARTED|Overall Study||115
11084867|NCT01142791|12267594|FG001|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6
11084868|NCT01142791|12267593|FG000|Safety|Overall Study||115
11084869|NCT01142791|12267594|FG001|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6
11084870|NCT01142791|12267593|FG000|COMPLETED|Overall Study||108
11084871|NCT01142791|12267594|FG001|COMPLETED|Overall Study||0
11084872|NCT01142791|12267593|FG000|NOT COMPLETED|Overall Study||7
11084873|NCT01142791|12267594|FG001|NOT COMPLETED|Overall Study||6
11084874|NCT01142908|12267600|FG000|STARTED|Overall Study||215
11084875|NCT01142908|12267601|FG001|STARTED|Overall Study||213
11084876|NCT01142908|12267600|FG000|6 Month f/u|Overall Study||188
11084877|NCT01142908|12267601|FG001|6 Month f/u|Overall Study||196
11084878|NCT01142908|12267600|FG000|COMPLETED|Overall Study||183
11084879|NCT01142908|12267601|FG001|COMPLETED|Overall Study||191
11084880|NCT01142908|12267600|FG000|NOT COMPLETED|Overall Study||32
11084881|NCT01142908|12267601|FG001|NOT COMPLETED|Overall Study||22
11084882|NCT01142947|12267607|FG000|STARTED|Overall Study||362
11084883|NCT01142947|12267607|FG000|COMPLETED|Overall Study||244
11084884|NCT01142947|12267607|FG000|NOT COMPLETED|Overall Study||118
11084885|NCT01143051|12267617|FG000|STARTED|Visit 1||4
11084886|NCT01143051|12267618|FG001|STARTED|Visit 1||4
11084887|NCT01143051|12267619|FG002|STARTED|Visit 1||4
11084888|NCT01143051|12267620|FG003|STARTED|Visit 1||4
11084889|NCT01143051|12267621|FG004|STARTED|Visit 1||4
11084890|NCT01143051|12267622|FG005|STARTED|Visit 1||4
11084891|NCT01143051|12267617|FG000|COMPLETED|Visit 1||4
11084892|NCT01143051|12267618|FG001|COMPLETED|Visit 1||4
11084893|NCT01143051|12267619|FG002|COMPLETED|Visit 1||4
11084894|NCT01143051|12267620|FG003|COMPLETED|Visit 1||4
11084895|NCT01143051|12267621|FG004|COMPLETED|Visit 1||4
11084896|NCT01143051|12267622|FG005|COMPLETED|Visit 1||4
11084897|NCT01143051|12267617|FG000|NOT COMPLETED|Visit 1||0
11084898|NCT01143051|12267618|FG001|NOT COMPLETED|Visit 1||0
11084899|NCT01143051|12267619|FG002|NOT COMPLETED|Visit 1||0
11084900|NCT01143051|12267620|FG003|NOT COMPLETED|Visit 1||0
11084901|NCT01143051|12267621|FG004|NOT COMPLETED|Visit 1||0
11084902|NCT01143051|12267622|FG005|NOT COMPLETED|Visit 1||0
11084903|NCT01143051|12267617|FG000|STARTED|3-14 Day Washout||4
11084904|NCT01143051|12267618|FG001|STARTED|3-14 Day Washout||4
11084905|NCT01143051|12267619|FG002|STARTED|3-14 Day Washout||4
11084906|NCT01143051|12267620|FG003|STARTED|3-14 Day Washout||4
11084907|NCT01143051|12267621|FG004|STARTED|3-14 Day Washout||4
11084908|NCT01143051|12267622|FG005|STARTED|3-14 Day Washout||4
11084909|NCT01143051|12267617|FG000|COMPLETED|3-14 Day Washout||4
11084910|NCT01143051|12267618|FG001|COMPLETED|3-14 Day Washout||4
11084911|NCT01143051|12267619|FG002|COMPLETED|3-14 Day Washout||3
11084912|NCT01143051|12267620|FG003|COMPLETED|3-14 Day Washout||4
11084913|NCT01143051|12267621|FG004|COMPLETED|3-14 Day Washout||4
11084914|NCT01143051|12267622|FG005|COMPLETED|3-14 Day Washout||4
11084915|NCT01143051|12267617|FG000|NOT COMPLETED|3-14 Day Washout||0
11084916|NCT01143051|12267618|FG001|NOT COMPLETED|3-14 Day Washout||0
11084917|NCT01143051|12267619|FG002|NOT COMPLETED|3-14 Day Washout||1
11084918|NCT01143051|12267620|FG003|NOT COMPLETED|3-14 Day Washout||0
11351032|NCT03030638|12547959|FG005|NOT COMPLETED|Overall Study||0
11351033|NCT03030638|12547960|FG006|NOT COMPLETED|Overall Study||0
11351034|NCT03030638|12547961|FG007|NOT COMPLETED|Overall Study||0
11351035|NCT03030989|12547983|FG000|STARTED|Overall Study||21
11351036|NCT03030989|12547984|FG001|STARTED|Overall Study||29
11351037|NCT03030989|12547983|FG000|COMPLETED|Overall Study||9
11084919|NCT01143051|12267621|FG004|NOT COMPLETED|3-14 Day Washout||0
11084920|NCT01143051|12267622|FG005|NOT COMPLETED|3-14 Day Washout||0
11084921|NCT01143051|12267617|FG000|STARTED|Visit 2||4
11084922|NCT01143051|12267618|FG001|STARTED|Visit 2||4
11084923|NCT01143051|12267619|FG002|STARTED|Visit 2||3
11084924|NCT01143051|12267620|FG003|STARTED|Visit 2||4
11084925|NCT01143051|12267621|FG004|STARTED|Visit 2||4
11084926|NCT01143051|12267622|FG005|STARTED|Visit 2||4
11084927|NCT01143051|12267617|FG000|COMPLETED|Visit 2||4
11084928|NCT01143051|12267618|FG001|COMPLETED|Visit 2||4
11084929|NCT01143051|12267619|FG002|COMPLETED|Visit 2||3
11084930|NCT01143051|12267620|FG003|COMPLETED|Visit 2||4
11084931|NCT01143051|12267621|FG004|COMPLETED|Visit 2||4
11084932|NCT01143051|12267622|FG005|COMPLETED|Visit 2||4
11084933|NCT01143051|12267617|FG000|NOT COMPLETED|Visit 2||0
11084934|NCT01143051|12267618|FG001|NOT COMPLETED|Visit 2||0
11084935|NCT01143051|12267619|FG002|NOT COMPLETED|Visit 2||0
11084936|NCT01143051|12267620|FG003|NOT COMPLETED|Visit 2||0
11084937|NCT01143051|12267621|FG004|NOT COMPLETED|Visit 2||0
11084938|NCT01143051|12267622|FG005|NOT COMPLETED|Visit 2||0
11207660|NCT01877265|12398830|FG003|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
11207661|NCT01877265|12398831|FG004|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
11207662|NCT01877265|12398832|FG005|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
11207663|NCT01877265|12398827|FG000|STARTED|Treatment Period 2||3
11207664|NCT01877265|12398828|FG001|STARTED|Treatment Period 2||3
11207665|NCT01877265|12398829|FG002|STARTED|Treatment Period 2||2
11207666|NCT01877265|12398830|FG003|STARTED|Treatment Period 2||3
11207667|NCT01877265|12398831|FG004|STARTED|Treatment Period 2||3
11207668|NCT01877265|12398832|FG005|STARTED|Treatment Period 2||3
11207669|NCT01877265|12398827|FG000|Received at Least One Dose of Study Drug|Treatment Period 2||3
11207670|NCT01877265|12398828|FG001|Received at Least One Dose of Study Drug|Treatment Period 2||3
11207671|NCT01877265|12398829|FG002|Received at Least One Dose of Study Drug|Treatment Period 2||2
11207672|NCT01877265|12398830|FG003|Received at Least One Dose of Study Drug|Treatment Period 2||3
11207673|NCT01877265|12398831|FG004|Received at Least One Dose of Study Drug|Treatment Period 2||3
11207674|NCT01877265|12398832|FG005|Received at Least One Dose of Study Drug|Treatment Period 2||3
11207675|NCT01877265|12398827|FG000|COMPLETED|Treatment Period 2||3
11207676|NCT01877265|12398828|FG001|COMPLETED|Treatment Period 2||3
11207677|NCT01877265|12398829|FG002|COMPLETED|Treatment Period 2||2
11207678|NCT01877265|12398830|FG003|COMPLETED|Treatment Period 2||3
11207679|NCT01877265|12398831|FG004|COMPLETED|Treatment Period 2||3
11207680|NCT01877265|12398832|FG005|COMPLETED|Treatment Period 2||3
11207681|NCT01877265|12398827|FG000|NOT COMPLETED|Treatment Period 2||0
11207682|NCT01877265|12398828|FG001|NOT COMPLETED|Treatment Period 2||0
11207683|NCT01877265|12398829|FG002|NOT COMPLETED|Treatment Period 2||0
11207684|NCT01877265|12398830|FG003|NOT COMPLETED|Treatment Period 2||0
11207685|NCT01877265|12398831|FG004|NOT COMPLETED|Treatment Period 2||0
11207686|NCT01877265|12398832|FG005|NOT COMPLETED|Treatment Period 2||0
11207687|NCT01877265|12398827|FG000|STARTED|Washout Period 2 (at Least 14 Days)||3
11207688|NCT01877265|12398828|FG001|STARTED|Washout Period 2 (at Least 14 Days)||3
11207689|NCT01877265|12398829|FG002|STARTED|Washout Period 2 (at Least 14 Days)||2
11207690|NCT01877265|12398830|FG003|STARTED|Washout Period 2 (at Least 14 Days)||3
11207691|NCT01877265|12398831|FG004|STARTED|Washout Period 2 (at Least 14 Days)||3
11207692|NCT01877265|12398832|FG005|STARTED|Washout Period 2 (at Least 14 Days)||3
11207693|NCT01877265|12398827|FG000|COMPLETED|Washout Period 2 (at Least 14 Days)||3
11351038|NCT03030989|12547984|FG001|COMPLETED|Overall Study||15
11351039|NCT03030989|12547983|FG000|NOT COMPLETED|Overall Study||12
11351040|NCT03030989|12547984|FG001|NOT COMPLETED|Overall Study||14
11351041|NCT03031431|12547990|FG000|STARTED|Overall Study||130
11351042|NCT03031431|12547990|FG000|COMPLETED|Overall Study||129
11351043|NCT03031431|12547990|FG000|NOT COMPLETED|Overall Study||1
11351044|NCT03031496|12547994|FG000|STARTED|Period 1||21
11351045|NCT03031496|12547995|FG001|STARTED|Period 1||21
11351046|NCT03031496|12547994|FG000|COMPLETED|Period 1||19
11351047|NCT03031496|12547995|FG001|COMPLETED|Period 1||19
11084939|NCT01143051|12267617|FG000|STARTED|3-14 Day Washout||4
11084940|NCT01143051|12267618|FG001|STARTED|3-14 Day Washout||4
11084941|NCT01143051|12267619|FG002|STARTED|3-14 Day Washout||3
11084942|NCT01143051|12267620|FG003|STARTED|3-14 Day Washout||4
11084943|NCT01143051|12267621|FG004|STARTED|3-14 Day Washout||4
11084944|NCT01143051|12267622|FG005|STARTED|3-14 Day Washout||4
11084945|NCT01143051|12267617|FG000|COMPLETED|3-14 Day Washout||4
11084946|NCT01143051|12267618|FG001|COMPLETED|3-14 Day Washout||4
11084947|NCT01143051|12267619|FG002|COMPLETED|3-14 Day Washout||3
11084948|NCT01143051|12267620|FG003|COMPLETED|3-14 Day Washout||4
11084949|NCT01143051|12267621|FG004|COMPLETED|3-14 Day Washout||4
11084950|NCT01143051|12267622|FG005|COMPLETED|3-14 Day Washout||3
11084951|NCT01143051|12267617|FG000|NOT COMPLETED|3-14 Day Washout||0
11351048|NCT03031496|12547994|FG000|NOT COMPLETED|Period 1||2
11084952|NCT01143051|12267618|FG001|NOT COMPLETED|3-14 Day Washout||0
11084953|NCT01143051|12267619|FG002|NOT COMPLETED|3-14 Day Washout||0
11084954|NCT01143051|12267620|FG003|NOT COMPLETED|3-14 Day Washout||0
11084955|NCT01143051|12267621|FG004|NOT COMPLETED|3-14 Day Washout||0
11084956|NCT01143051|12267622|FG005|NOT COMPLETED|3-14 Day Washout||1
11084957|NCT01143051|12267617|FG000|STARTED|Visit 3||4
11084958|NCT01143051|12267618|FG001|STARTED|Visit 3||4
11084959|NCT01143051|12267619|FG002|STARTED|Visit 3||3
11084960|NCT01143051|12267620|FG003|STARTED|Visit 3||4
11084961|NCT01143051|12267621|FG004|STARTED|Visit 3||4
11084962|NCT01143051|12267622|FG005|STARTED|Visit 3||3
11084963|NCT01143051|12267617|FG000|COMPLETED|Visit 3||4
11084964|NCT01143051|12267618|FG001|COMPLETED|Visit 3||4
11084965|NCT01143051|12267619|FG002|COMPLETED|Visit 3||3
11084966|NCT01143051|12267620|FG003|COMPLETED|Visit 3||4
11084967|NCT01143051|12267621|FG004|COMPLETED|Visit 3||4
11084968|NCT01143051|12267622|FG005|COMPLETED|Visit 3||3
11084969|NCT01143051|12267617|FG000|NOT COMPLETED|Visit 3||0
11084970|NCT01143051|12267618|FG001|NOT COMPLETED|Visit 3||0
11084971|NCT01143051|12267619|FG002|NOT COMPLETED|Visit 3||0
11084972|NCT01143051|12267620|FG003|NOT COMPLETED|Visit 3||0
11084973|NCT01143051|12267621|FG004|NOT COMPLETED|Visit 3||0
11084974|NCT01143051|12267622|FG005|NOT COMPLETED|Visit 3||0
11084975|NCT01143077|12267635|FG000|STARTED|Overall Study||74
11084976|NCT01143077|12267636|FG001|STARTED|Overall Study||88
11084977|NCT01143077|12267637|FG002|STARTED|Overall Study||82
11084978|NCT01143077|12267635|FG000|COMPLETED|Overall Study||58
11084979|NCT01143077|12267636|FG001|COMPLETED|Overall Study||73
11084980|NCT01143077|12267637|FG002|COMPLETED|Overall Study||67
11084981|NCT01143077|12267635|FG000|NOT COMPLETED|Overall Study||16
11084982|NCT01143077|12267636|FG001|NOT COMPLETED|Overall Study||15
11084983|NCT01143077|12267637|FG002|NOT COMPLETED|Overall Study||15
11084984|NCT01143090|12267645|FG000|STARTED|Overall Study||149
11084985|NCT01143090|12267645|FG000|COMPLETED|Overall Study||98
11084986|NCT01143090|12267645|FG000|NOT COMPLETED|Overall Study||51
11084987|NCT01143142|12267651|FG000|STARTED|Overall Study||36
11084988|NCT01143142|12267652|FG001|STARTED|Overall Study||34
11084989|NCT01143142|12267651|FG000|COMPLETED|Overall Study||36
11084990|NCT01143142|12267652|FG001|COMPLETED|Overall Study||34
11084991|NCT01143142|12267651|FG000|NOT COMPLETED|Overall Study||0
11084992|NCT01143142|12267652|FG001|NOT COMPLETED|Overall Study||0
11084993|NCT01143181|12267662|FG000|STARTED|Overall Study||30
11084994|NCT01143181|12267663|FG001|STARTED|Overall Study||38
11084995|NCT01143181|12267664|FG002|STARTED|Overall Study||102
11084996|NCT01143181|12267665|FG003|STARTED|Overall Study||40
11084997|NCT01143181|12267662|FG000|COMPLETED|Overall Study||14
11084998|NCT01143181|12267663|FG001|COMPLETED|Overall Study||22
11084999|NCT01143181|12267664|FG002|COMPLETED|Overall Study||58
11085000|NCT01143181|12267665|FG003|COMPLETED|Overall Study||17
11085001|NCT01143181|12267662|FG000|NOT COMPLETED|Overall Study||16
11085002|NCT01143181|12267663|FG001|NOT COMPLETED|Overall Study||16
11085003|NCT01143181|12267664|FG002|NOT COMPLETED|Overall Study||44
11085004|NCT01143181|12267665|FG003|NOT COMPLETED|Overall Study||23
11085005|NCT01143207|12267675|FG000|STARTED|Overall Study||26
11085006|NCT01143207|12267675|FG000|COMPLETED|Overall Study||24
11085007|NCT01143207|12267675|FG000|NOT COMPLETED|Overall Study||2
11085008|NCT01143259|12267681|FG000|STARTED|Overall Study||136
11085009|NCT01143259|12267682|FG001|STARTED|Overall Study||138
11085010|NCT01143259|12267681|FG000|COMPLETED|Overall Study||113
11085011|NCT01143259|12267682|FG001|COMPLETED|Overall Study||118
11085012|NCT01143259|12267681|FG000|NOT COMPLETED|Overall Study||23
11085013|NCT01143259|12267682|FG001|NOT COMPLETED|Overall Study||20
11085014|NCT01143272|12267690|FG000|STARTED|Overall Study||246
11351049|NCT03031496|12547995|FG001|NOT COMPLETED|Period 1||2
11351050|NCT03031496|12547994|FG000|STARTED|Period 2||19
11351051|NCT03031496|12547995|FG001|STARTED|Period 2||19
11351052|NCT03031496|12547994|FG000|COMPLETED|Period 2||19
11351053|NCT03031496|12547995|FG001|COMPLETED|Period 2||19
11351054|NCT03031496|12547994|FG000|NOT COMPLETED|Period 2||0
11351055|NCT03031496|12547995|FG001|NOT COMPLETED|Period 2||0
11351056|NCT03031678|12548001|FG000|STARTED|Overall Study||50
11351057|NCT03031678|12548001|FG000|EAS Test Condition Complete|Overall Study||39
11351058|NCT03031678|12548001|FG000|CI Alone Test Condition Complete|Overall Study||10
11351059|NCT03031678|12548001|FG000|COMPLETED|Overall Study||49
11351060|NCT03031678|12548001|FG000|NOT COMPLETED|Overall Study||1
11351061|NCT03031795|12548011|FG000|STARTED|Overall Study||35
11351062|NCT03031795|12548012|FG001|STARTED|Overall Study||36
11351063|NCT03031795|12548011|FG000|COMPLETED|Overall Study||35
11351064|NCT03031795|12548012|FG001|COMPLETED|Overall Study||35
11351065|NCT03031795|12548011|FG000|NOT COMPLETED|Overall Study||0
11351066|NCT03031795|12548012|FG001|NOT COMPLETED|Overall Study||1
11351067|NCT03031899|12548018|FG000|STARTED|Overall Study||27
11351068|NCT03031899|12548018|FG000|COMPLETED|Overall Study||25
11351069|NCT03031899|12548018|FG000|NOT COMPLETED|Overall Study||2
11351070|NCT03031938|12548028|FG000|STARTED|Overall Study||2
11351071|NCT03031938|12548029|FG001|STARTED|Overall Study||2
11351072|NCT03031938|12548028|FG000|COMPLETED|Overall Study||1
11351073|NCT03031938|12548029|FG001|COMPLETED|Overall Study||2
11351074|NCT03031938|12548028|FG000|NOT COMPLETED|Overall Study||1
11351075|NCT03031938|12548029|FG001|NOT COMPLETED|Overall Study||0
11351076|NCT03032263|12548037|FG000|STARTED|Overall Study||6
11351077|NCT03032263|12548038|FG001|STARTED|Overall Study||6
11085015|NCT01143272|12267691|FG001|STARTED|Overall Study||231
11085016|NCT01143272|12267690|FG000|COMPLETED|Overall Study||246
11085017|NCT01143272|12267691|FG001|COMPLETED|Overall Study||231
11085018|NCT01143272|12267690|FG000|NOT COMPLETED|Overall Study||0
11085019|NCT01143272|12267691|FG001|NOT COMPLETED|Overall Study||0
11085020|NCT01143324|12267697|FG000|STARTED|Overall Study||252
11085021|NCT01143324|12267697|FG000|COMPLETED|Overall Study||233
11085022|NCT01143324|12267697|FG000|NOT COMPLETED|Overall Study||19
11085023|NCT01143337|12267703|FG000|STARTED|Overall Study||49
11351078|NCT03032263|12548037|FG000|COMPLETED|Overall Study||6
11351079|NCT03032263|12548038|FG001|COMPLETED|Overall Study||6
11351080|NCT03032263|12548037|FG000|NOT COMPLETED|Overall Study||0
11351081|NCT03032263|12548038|FG001|NOT COMPLETED|Overall Study||0
11351082|NCT03032380|12548046|FG000|STARTED|Overall Study||148
11351083|NCT03032380|12548047|FG001|STARTED|Overall Study||152
11351084|NCT03032380|12548046|FG000|Received Treatment|Overall Study||148
11351085|NCT03032380|12548047|FG001|Received Treatment|Overall Study||150
11351086|NCT03032380|12548046|FG000|COMPLETED|Overall Study||106
11351087|NCT03032380|12548047|FG001|COMPLETED|Overall Study||112
11351088|NCT03032380|12548046|FG000|NOT COMPLETED|Overall Study||42
11351089|NCT03032380|12548047|FG001|NOT COMPLETED|Overall Study||40
11351090|NCT03032393|12548055|FG000|STARTED|Overall Study||15
11351091|NCT03032393|12548056|FG001|STARTED|Overall Study||15
11351092|NCT03032393|12548055|FG000|COMPLETED|Overall Study||15
11351093|NCT03032393|12548056|FG001|COMPLETED|Overall Study||15
11351094|NCT03032393|12548055|FG000|NOT COMPLETED|Overall Study||0
11351095|NCT03032393|12548056|FG001|NOT COMPLETED|Overall Study||0
11351096|NCT03032523|12548064|FG000|STARTED|Overall Study||15
11351097|NCT03032523|12548065|FG001|STARTED|Overall Study||6
11351098|NCT03032523|12548064|FG000|COMPLETED|Overall Study||12
11351099|NCT03032523|12548065|FG001|COMPLETED|Overall Study||4
11351100|NCT03032523|12548064|FG000|NOT COMPLETED|Overall Study||3
11351101|NCT03032523|12548065|FG001|NOT COMPLETED|Overall Study||2
11085024|NCT01143337|12267704|FG001|STARTED|Overall Study||50
11085025|NCT01143337|12267705|FG002|STARTED|Overall Study||13
11085026|NCT01143337|12267703|FG000|COMPLETED|Overall Study||39
11085027|NCT01143337|12267704|FG001|COMPLETED|Overall Study||39
11085028|NCT01143337|12267705|FG002|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
11085029|NCT01143337|12267703|FG000|NOT COMPLETED|Overall Study||10
11085030|NCT01143337|12267704|FG001|NOT COMPLETED|Overall Study||11
11085031|NCT01143337|12267705|FG002|NOT COMPLETED|Overall Study||12
11085032|NCT01143389|12267713|FG000|STARTED|Overall Study||253
11085033|NCT01143389|12267714|FG001|STARTED|Overall Study||257
11085034|NCT01143389|12267713|FG000|COMPLETED|Overall Study||227
11085035|NCT01143389|12267714|FG001|COMPLETED|Overall Study||232
11085036|NCT01143389|12267713|FG000|NOT COMPLETED|Overall Study||26
11085037|NCT01143389|12267714|FG001|NOT COMPLETED|Overall Study||25
11085038|NCT01143402|12267723|FG000|STARTED|Overall Study||51
11085039|NCT01143402|12267724|FG001|STARTED|Overall Study||50
11085040|NCT01143402|12267725|FG002|STARTED|Overall Study||19
11085041|NCT01143402|12267723|FG000|COMPLETED|Overall Study||50
11085042|NCT01143402|12267724|FG001|COMPLETED|Overall Study||49
11085043|NCT01143402|12267725|FG002|COMPLETED|Overall Study||18
11085044|NCT01143402|12267723|FG000|NOT COMPLETED|Overall Study||1
11085045|NCT01143402|12267724|FG001|NOT COMPLETED|Overall Study||1
11085046|NCT01143402|12267725|FG002|NOT COMPLETED|Overall Study||1
11085047|NCT01143610|12267734|FG000|STARTED|Overall Study||7
11085048|NCT01143610|12267735|FG001|STARTED|Overall Study||8
11085049|NCT01143610|12267734|FG000|COMPLETED|Overall Study||7
11085050|NCT01143610|12267735|FG001|COMPLETED|Overall Study||8
11085051|NCT01143610|12267734|FG000|NOT COMPLETED|Overall Study||0
11085052|NCT01143610|12267735|FG001|NOT COMPLETED|Overall Study||0
11085053|NCT01143636|12267744|FG000|STARTED|Overall Study||6
11085054|NCT01143636|12267745|FG001|STARTED|Overall Study||5
11085055|NCT01143636|12267746|FG002|STARTED|Overall Study||8
11085056|NCT01143636|12267747|FG003|STARTED|Overall Study||7
11085057|NCT01143636|12267744|FG000|COMPLETED|Overall Study||5
11085058|NCT01143636|12267745|FG001|COMPLETED|Overall Study||4
11085059|NCT01143636|12267746|FG002|COMPLETED|Overall Study||8
11085060|NCT01143636|12267747|FG003|COMPLETED|Overall Study||7
11085061|NCT01143636|12267744|FG000|NOT COMPLETED|Overall Study||1
11085062|NCT01143636|12267745|FG001|NOT COMPLETED|Overall Study||1
11085063|NCT01143636|12267746|FG002|NOT COMPLETED|Overall Study||0
11085064|NCT01143636|12267747|FG003|NOT COMPLETED|Overall Study||0
11085065|NCT01143649|12267762|FG000|STARTED|Overall Study||7
11085066|NCT01143649|12267763|FG001|STARTED|Overall Study||7
11085067|NCT01143649|12267764|FG002|STARTED|Overall Study||10
11085068|NCT01143649|12267765|FG003|STARTED|Overall Study||10
11085069|NCT01143649|12267766|FG004|STARTED|Overall Study||5
11085070|NCT01143649|12267767|FG005|STARTED|Overall Study||5
11085071|NCT01143649|12267762|FG000|COMPLETED|Overall Study||7
11085072|NCT01143649|12267763|FG001|COMPLETED|Overall Study||7
11085073|NCT01143649|12267764|FG002|COMPLETED|Overall Study||10
11085074|NCT01143649|12267765|FG003|COMPLETED|Overall Study||10
11085075|NCT01143649|12267766|FG004|COMPLETED|Overall Study||4
11085076|NCT01143649|12267767|FG005|COMPLETED|Overall Study||3
11085077|NCT01143649|12267762|FG000|NOT COMPLETED|Overall Study||0
11085078|NCT01143649|12267763|FG001|NOT COMPLETED|Overall Study||0
11085079|NCT01143649|12267764|FG002|NOT COMPLETED|Overall Study||0
11085080|NCT01143649|12267765|FG003|NOT COMPLETED|Overall Study||0
11085081|NCT01143649|12267766|FG004|NOT COMPLETED|Overall Study||1
11085082|NCT01143649|12267767|FG005|NOT COMPLETED|Overall Study||2
11085083|NCT01143688|12267781|FG000|STARTED|Overall Study||39
11085084|NCT01143688|12267781|FG000|COMPLETED|Overall Study||39
11085085|NCT01143688|12267781|FG000|NOT COMPLETED|Overall Study||0
11085086|NCT01143701|12267793|FG000|STARTED|Overall Study||258
11085087|NCT01143701|12267794|FG001|STARTED|Overall Study||319
11085088|NCT01143701|12267793|FG000|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
11085089|NCT01143701|12267794|FG001|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
11085090|NCT01143701|12267793|FG000|NOT COMPLETED|Overall Study||23
11085091|NCT01143701|12267794|FG001|NOT COMPLETED|Overall Study||32
11085092|NCT01143714|12267802|FG000|STARTED|Overall Study||29
11085093|NCT01143714|12267803|FG001|STARTED|Overall Study||28
11085094|NCT01143714|12267802|FG000|COMPLETED|Overall Study||22
11085095|NCT01143714|12267803|FG001|COMPLETED|Overall Study||25
11085096|NCT01143714|12267802|FG000|NOT COMPLETED|Overall Study||7
11085097|NCT01143714|12267803|FG001|NOT COMPLETED|Overall Study||3
11085098|NCT01143727|12267811|FG000|STARTED|Overall Study||9
11085099|NCT01143727|12267812|FG001|STARTED|Overall Study||8
11085100|NCT01143727|12267811|FG000|COMPLETED|Overall Study||9
11085101|NCT01143727|12267812|FG001|COMPLETED|Overall Study||8
11085102|NCT01143727|12267811|FG000|NOT COMPLETED|Overall Study||0
11085103|NCT01143727|12267812|FG001|NOT COMPLETED|Overall Study||0
11085104|NCT01143766|12267820|FG000|STARTED|Overall Study||25
11085105|NCT01143766|12267821|FG001|STARTED|Overall Study||31
11085106|NCT01143766|12267820|FG000|COMPLETED|Overall Study||25
11085107|NCT01143766|12267821|FG001|COMPLETED|Overall Study||31
11085108|NCT01143766|12267820|FG000|NOT COMPLETED|Overall Study||0
11085109|NCT01143766|12267821|FG001|NOT COMPLETED|Overall Study||0
11085110|NCT01143792|12267832|FG000|STARTED|Overall Study||93
11085111|NCT01143792|12267833|FG001|STARTED|Overall Study||86
11085112|NCT01143792|12267834|FG002|STARTED|Overall Study||91
11085113|NCT01143792|12267832|FG000|COMPLETED|Overall Study||93
11085114|NCT01143792|12267833|FG001|COMPLETED|Overall Study||86
11085115|NCT01143792|12267834|FG002|COMPLETED|Overall Study||91
11085116|NCT01143792|12267832|FG000|NOT COMPLETED|Overall Study||0
11085117|NCT01143792|12267833|FG001|NOT COMPLETED|Overall Study||0
11085118|NCT01143792|12267834|FG002|NOT COMPLETED|Overall Study||0
11085119|NCT01143818|12267853|FG000|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
11085120|NCT01143818|12267853|FG000|COMPLETED|Overall Study||799
11085121|NCT01143818|12267853|FG000|NOT COMPLETED|Overall Study||250
11085122|NCT01143870|12267860|FG000|STARTED|Overall Study||58
11085123|NCT01143870|12267861|FG001|STARTED|Overall Study||58
11085124|NCT01143870|12267862|FG002|STARTED|Overall Study||61
11085125|NCT01143870|12267860|FG000|Post-intervention Survey|Overall Study||53
11085126|NCT01143870|12267861|FG001|Post-intervention Survey|Overall Study||50
11085127|NCT01143870|12267862|FG002|Post-intervention Survey|Overall Study||61
11085128|NCT01143870|12267860|FG000|Had Available 6-month A1C|Overall Study||27
11085129|NCT01143870|12267861|FG001|Had Available 6-month A1C|Overall Study||29
11085130|NCT01143870|12267862|FG002|Had Available 6-month A1C|Overall Study||31
11085131|NCT01143870|12267860|FG000|A1C Imputed|Overall Study||31
11085132|NCT01143870|12267861|FG001|A1C Imputed|Overall Study||29
11085133|NCT01143870|12267862|FG002|A1C Imputed|Overall Study||30
11085134|NCT01143870|12267860|FG000|COMPLETED|Overall Study||58
11085135|NCT01143870|12267861|FG001|COMPLETED|Overall Study||58
11085136|NCT01143870|12267862|FG002|COMPLETED|Overall Study||61
11085137|NCT01143870|12267860|FG000|NOT COMPLETED|Overall Study||0
11085138|NCT01143870|12267861|FG001|NOT COMPLETED|Overall Study||0
11085139|NCT01143870|12267862|FG002|NOT COMPLETED|Overall Study||0
11085140|NCT01143883|12267872|FG000|STARTED|Overall Study||55
11085141|NCT01143883|12267873|FG001|STARTED|Overall Study||55
11085142|NCT01143883|12267872|FG000|COMPLETED|Overall Study||55
11085143|NCT01143883|12267873|FG001|COMPLETED|Overall Study||55
11085144|NCT01143883|12267872|FG000|NOT COMPLETED|Overall Study||0
11085145|NCT01143883|12267873|FG001|NOT COMPLETED|Overall Study||0
11085146|NCT01143896|12267881|FG000|STARTED|Overall Study||156
11085147|NCT01143896|12267882|FG001|STARTED|Overall Study||153
11085148|NCT01143896|12267881|FG000|COMPLETED|Overall Study||114
11085149|NCT01143896|12267882|FG001|COMPLETED|Overall Study||128
11085150|NCT01143896|12267881|FG000|NOT COMPLETED|Overall Study||42
11085151|NCT01143896|12267882|FG001|NOT COMPLETED|Overall Study||25
11085152|NCT01144026|12267891|FG000|STARTED|Overall Study||10
11085153|NCT01144026|12267892|FG001|STARTED|Overall Study||5
11085154|NCT01144026|12267891|FG000|COMPLETED|Overall Study||10
11085155|NCT01144026|12267892|FG001|COMPLETED|Overall Study||5
11085156|NCT01144026|12267891|FG000|NOT COMPLETED|Overall Study||0
11085157|NCT01144026|12267892|FG001|NOT COMPLETED|Overall Study||0
11085158|NCT01144052|12267900|FG000|STARTED|Overall Study||10
11085159|NCT01144052|12267901|FG001|STARTED|Overall Study||9
11085160|NCT01144052|12267900|FG000|COMPLETED|Overall Study||9
11085161|NCT01144052|12267901|FG001|COMPLETED|Overall Study||8
11085162|NCT01144052|12267900|FG000|NOT COMPLETED|Overall Study||1
11085163|NCT01144052|12267901|FG001|NOT COMPLETED|Overall Study||1
11085164|NCT01144143|12267912|FG000|STARTED|Overall Study||8
11085165|NCT01144143|12267913|FG001|STARTED|Overall Study||4
11085166|NCT01144143|12267914|FG002|STARTED|Overall Study||4
11085167|NCT01144143|12267912|FG000|COMPLETED|Overall Study||8
11085168|NCT01144143|12267913|FG001|COMPLETED|Overall Study||4
11085169|NCT01144143|12267914|FG002|COMPLETED|Overall Study||4
11085170|NCT01144143|12267912|FG000|NOT COMPLETED|Overall Study||0
11085171|NCT01144143|12267913|FG001|NOT COMPLETED|Overall Study||0
11085172|NCT01144143|12267914|FG002|NOT COMPLETED|Overall Study||0
11085173|NCT01144182|12267928|FG000|STARTED|Overall Study||68
11085174|NCT01144182|12267929|FG001|STARTED|Overall Study||68
11085175|NCT01144182|12267928|FG000|COMPLETED|Overall Study||51
11085176|NCT01144182|12267929|FG001|COMPLETED|Overall Study||47
11085177|NCT01144182|12267928|FG000|NOT COMPLETED|Overall Study||17
11085178|NCT01144182|12267929|FG001|NOT COMPLETED|Overall Study||21
11085179|NCT01144286|12267940|FG000|STARTED|Overall Study||57
11085180|NCT01144286|12267941|FG001|STARTED|Overall Study||58
11085181|NCT01144286|12267942|FG002|STARTED|Overall Study||58
11085182|NCT01144286|12267943|FG003|STARTED|Overall Study||56
11085183|NCT01144286|12267940|FG000|COMPLETED|Overall Study||57
11085184|NCT01144286|12267941|FG001|COMPLETED|Overall Study||58
11085185|NCT01144286|12267942|FG002|COMPLETED|Overall Study||58
11085186|NCT01144286|12267943|FG003|COMPLETED|Overall Study||56
11085187|NCT01144286|12267940|FG000|NOT COMPLETED|Overall Study||0
11085188|NCT01144286|12267941|FG001|NOT COMPLETED|Overall Study||0
11085189|NCT01144286|12267942|FG002|NOT COMPLETED|Overall Study||0
11085190|NCT01144286|12267943|FG003|NOT COMPLETED|Overall Study||0
11085191|NCT01144299|12267955|FG000|STARTED|Overall Study||60
11085192|NCT01144299|12267956|FG001|STARTED|Overall Study||54
11085193|NCT01144299|12267955|FG000|COMPLETED|Overall Study||58
11085194|NCT01144299|12267956|FG001|COMPLETED|Overall Study||54
11085195|NCT01144299|12267955|FG000|NOT COMPLETED|Overall Study||2
11085196|NCT01144299|12267956|FG001|NOT COMPLETED|Overall Study||0
11085197|NCT01144338|12267964|FG000|STARTED|Overall Study||7396
11085198|NCT01144338|12267965|FG001|STARTED|Overall Study||7356
11085199|NCT01144338|12267964|FG000|COMPLETED|Overall Study||7093
11085200|NCT01144338|12267965|FG001|COMPLETED|Overall Study||7094
11085201|NCT01144338|12267964|FG000|NOT COMPLETED|Overall Study||303
11085202|NCT01144338|12267965|FG001|NOT COMPLETED|Overall Study||262
11085203|NCT01144364|12267973|FG000|STARTED|Induction Phase||234
11085204|NCT01144364|12267974|FG001|STARTED|Induction Phase||0
11085205|NCT01144364|12267975|FG002|STARTED|Induction Phase||0
11085206|NCT01144364|12267973|FG000|COMPLETED|Induction Phase||202
11085207|NCT01144364|12267974|FG001|COMPLETED|Induction Phase||0
11085208|NCT01144364|12267975|FG002|COMPLETED|Induction Phase||0
11085209|NCT01144364|12267973|FG000|NOT COMPLETED|Induction Phase||32
11085210|NCT01144364|12267974|FG001|NOT COMPLETED|Induction Phase||0
11085211|NCT01144364|12267975|FG002|NOT COMPLETED|Induction Phase||0
11085212|NCT01144364|12267973|FG000|STARTED|Follow-Up/Maintenance Phase||0
11085213|NCT01144364|12267974|FG001|STARTED|Follow-Up/Maintenance Phase||101
11085214|NCT01144364|12267975|FG002|STARTED|Follow-Up/Maintenance Phase||101
11085215|NCT01144364|12267973|FG000|COMPLETED|Follow-Up/Maintenance Phase||0
11085216|NCT01144364|12267974|FG001|COMPLETED|Follow-Up/Maintenance Phase||66
11085217|NCT01144364|12267975|FG002|COMPLETED|Follow-Up/Maintenance Phase||60
11085218|NCT01144364|12267973|FG000|NOT COMPLETED|Follow-Up/Maintenance Phase||0
11085219|NCT01144364|12267974|FG001|NOT COMPLETED|Follow-Up/Maintenance Phase||35
11085220|NCT01144364|12267975|FG002|NOT COMPLETED|Follow-Up/Maintenance Phase||41
11085221|NCT01144377|12267990|FG000|STARTED|52 Week Treatment Period||31
11085222|NCT01144377|12267991|FG001|STARTED|52 Week Treatment Period||30
11085223|NCT01144377|12267992|FG002|STARTED|52 Week Treatment Period||30
11085224|NCT01144377|12267993|FG003|STARTED|52 Week Treatment Period||26
11085225|NCT01144377|12267994|FG004|STARTED|52 Week Treatment Period||37
11085226|NCT01144377|12267990|FG000|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
11085227|NCT01144377|12267991|FG001|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
11085228|NCT01144377|12267992|FG002|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
11085229|NCT01144377|12267993|FG003|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
11085230|NCT01144377|12267994|FG004|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
11085231|NCT01144377|12267990|FG000|COMPLETED|52 Week Treatment Period||26
11085232|NCT01144377|12267991|FG001|COMPLETED|52 Week Treatment Period||29
11085233|NCT01144377|12267992|FG002|COMPLETED|52 Week Treatment Period||25
11085234|NCT01144377|12267993|FG003|COMPLETED|52 Week Treatment Period||22
11085235|NCT01144377|12267994|FG004|COMPLETED|52 Week Treatment Period||34
11085236|NCT01144377|12267990|FG000|NOT COMPLETED|52 Week Treatment Period||5
11085237|NCT01144377|12267991|FG001|NOT COMPLETED|52 Week Treatment Period||1
11085238|NCT01144377|12267992|FG002|NOT COMPLETED|52 Week Treatment Period||5
11085239|NCT01144377|12267993|FG003|NOT COMPLETED|52 Week Treatment Period||4
11085240|NCT01144377|12267994|FG004|NOT COMPLETED|52 Week Treatment Period||3
11085241|NCT01144377|12267990|FG000|STARTED|12 Week Safety Follow-up Period||26
11085242|NCT01144377|12267991|FG001|STARTED|12 Week Safety Follow-up Period||29
11085243|NCT01144377|12267992|FG002|STARTED|12 Week Safety Follow-up Period||25
11085244|NCT01144377|12267993|FG003|STARTED|12 Week Safety Follow-up Period||22
11085245|NCT01144377|12267994|FG004|STARTED|12 Week Safety Follow-up Period||34
11085246|NCT01144377|12267990|FG000|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
11085247|NCT01144377|12267991|FG001|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
11085248|NCT01144377|12267992|FG002|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
11085249|NCT01144377|12267993|FG003|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
11085250|NCT01144377|12267994|FG004|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
11085251|NCT01144377|12267990|FG000|NOT COMPLETED|12 Week Safety Follow-up Period||0
11085252|NCT01144377|12267991|FG001|NOT COMPLETED|12 Week Safety Follow-up Period||0
11085253|NCT01144377|12267992|FG002|NOT COMPLETED|12 Week Safety Follow-up Period||0
11085254|NCT01144377|12267993|FG003|NOT COMPLETED|12 Week Safety Follow-up Period||0
11085255|NCT01144377|12267994|FG004|NOT COMPLETED|12 Week Safety Follow-up Period||0
11085256|NCT01144377|12267990|FG000|STARTED|Optional 40 Week Safety Follow-up Period||22
11085257|NCT01144377|12267991|FG001|STARTED|Optional 40 Week Safety Follow-up Period||25
11085258|NCT01144377|12267992|FG002|STARTED|Optional 40 Week Safety Follow-up Period||23
11085259|NCT01144377|12267993|FG003|STARTED|Optional 40 Week Safety Follow-up Period||3
11085260|NCT01144377|12267994|FG004|STARTED|Optional 40 Week Safety Follow-up Period||23
11085261|NCT01144377|12267990|FG000|COMPLETED|Optional 40 Week Safety Follow-up Period||21
11085262|NCT01144377|12267991|FG001|COMPLETED|Optional 40 Week Safety Follow-up Period||24
11085263|NCT01144377|12267992|FG002|COMPLETED|Optional 40 Week Safety Follow-up Period||23
11085264|NCT01144377|12267993|FG003|COMPLETED|Optional 40 Week Safety Follow-up Period||3
11085265|NCT01144377|12267994|FG004|COMPLETED|Optional 40 Week Safety Follow-up Period||21
11351102|NCT03032965|12548074|FG000|STARTED|Overall Study||61
11351103|NCT03032965|12548075|FG001|STARTED|Overall Study||68
11351104|NCT03032965|12548074|FG000|COMPLETED|Overall Study||61
11351105|NCT03032965|12548075|FG001|COMPLETED|Overall Study||68
11351106|NCT03032965|12548074|FG000|NOT COMPLETED|Overall Study||0
11351107|NCT03032965|12548075|FG001|NOT COMPLETED|Overall Study||0
11351108|NCT03033108|12548084|FG000|STARTED|Overall Study||7
11085266|NCT01144377|12267990|FG000|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
11351109|NCT03033108|12548085|FG001|STARTED|Overall Study||9
11351110|NCT03033108|12548086|FG002|STARTED|Overall Study||7
11085267|NCT01144377|12267991|FG001|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
11085268|NCT01144377|12267992|FG002|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
11085269|NCT01144377|12267993|FG003|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
11085270|NCT01144377|12267994|FG004|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
11085271|NCT01144403|12268008|FG000|STARTED|Overall Study||8
11085272|NCT01144403|12268008|FG000|COMPLETED|Overall Study||3
11085273|NCT01144403|12268008|FG000|NOT COMPLETED|Overall Study||5
11085274|NCT01144442|12268013|FG000|STARTED|Overall Study||10
11085275|NCT01144442|12268013|FG000|COMPLETED|Overall Study||10
11085276|NCT01144442|12268013|FG000|NOT COMPLETED|Overall Study||0
11085277|NCT01144455|12268020|FG000|STARTED|Overall Study||69
11085278|NCT01144455|12268021|FG001|STARTED|Overall Study||71
11085279|NCT01144455|12268022|FG002|STARTED|Overall Study||74
11085280|NCT01144455|12268020|FG000|COMPLETED|Overall Study||19
11085281|NCT01144455|12268021|FG001|COMPLETED|Overall Study||29
11085282|NCT01144455|12268022|FG002|COMPLETED|Overall Study||38
11085283|NCT01144455|12268020|FG000|NOT COMPLETED|Overall Study||50
11085284|NCT01144455|12268021|FG001|NOT COMPLETED|Overall Study||42
11085285|NCT01144455|12268022|FG002|NOT COMPLETED|Overall Study||36
11085286|NCT01144494|12268030|FG000|STARTED|Overall Study||15
11085287|NCT01144494|12268031|FG001|STARTED|Overall Study||18
11085288|NCT01144494|12268030|FG000|COMPLETED|Overall Study||15
11085289|NCT01144494|12268031|FG001|COMPLETED|Overall Study||14
11085290|NCT01144494|12268030|FG000|NOT COMPLETED|Overall Study||0
11085291|NCT01144494|12268031|FG001|NOT COMPLETED|Overall Study||4
11085292|NCT01144598|12268042|FG000|STARTED|Overall Study||356
11085293|NCT01144598|12268042|FG000|Analysis Population|Overall Study||356
11085294|NCT01144598|12268042|FG000|COMPLETED|Overall Study||356
11085295|NCT01144598|12268042|FG000|NOT COMPLETED|Overall Study||0
11085296|NCT01144624|12268049|FG000|STARTED|Overall Study||7
11085297|NCT01144624|12268050|FG001|STARTED|Overall Study||7
11085298|NCT01144624|12268051|FG002|STARTED|Overall Study||6
11085299|NCT01144624|12268049|FG000|Received Treatment|Overall Study||7
11085300|NCT01144624|12268050|FG001|Received Treatment|Overall Study||7
11085301|NCT01144624|12268051|FG002|Received Treatment|Overall Study||6
11085302|NCT01144624|12268049|FG000|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
11085303|NCT01144624|12268050|FG001|Completed Treatment|Overall Study||7
11085304|NCT01144624|12268051|FG002|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
11085305|NCT01144624|12268049|FG000|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
11085306|NCT01144624|12268050|FG001|COMPLETED|Overall Study||7
11085307|NCT01144624|12268051|FG002|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
11085308|NCT01144624|12268049|FG000|NOT COMPLETED|Overall Study||0
11351111|NCT03033108|12548084|FG000|COMPLETED|Overall Study||7
11351112|NCT03033108|12548085|FG001|COMPLETED|Overall Study||8
11085309|NCT01144624|12268050|FG001|NOT COMPLETED|Overall Study||0
11085310|NCT01144624|12268051|FG002|NOT COMPLETED|Overall Study||0
11085311|NCT01144637|12268063|FG000|STARTED|Overall Study||999
11085312|NCT01144637|12268064|FG001|STARTED|Overall Study||1005
11085313|NCT01144637|12268065|FG002|STARTED|Overall Study||999
11085314|NCT01144637|12268066|FG003|STARTED|Overall Study||1002
11085315|NCT01144637|12268063|FG000|COMPLETED|Overall Study||925
11085316|NCT01144637|12268064|FG001|COMPLETED|Overall Study||929
11085317|NCT01144637|12268065|FG002|COMPLETED|Overall Study||939
11085318|NCT01144637|12268066|FG003|COMPLETED|Overall Study||946
11085319|NCT01144637|12268063|FG000|NOT COMPLETED|Overall Study||74
11085320|NCT01144637|12268064|FG001|NOT COMPLETED|Overall Study||76
11085321|NCT01144637|12268065|FG002|NOT COMPLETED|Overall Study||60
11085322|NCT01144637|12268066|FG003|NOT COMPLETED|Overall Study||56
11085323|NCT01144663|12268080|FG000|STARTED|Primary Vaccination Phase||528
11085324|NCT01144663|12268081|FG001|STARTED|Primary Vaccination Phase||524
11085325|NCT01144663|12268082|FG002|STARTED|Primary Vaccination Phase||516
11085326|NCT01144663|12268083|FG003|STARTED|Primary Vaccination Phase||527
11085327|NCT01144663|12268080|FG000|COMPLETED|Primary Vaccination Phase||508
11085328|NCT01144663|12268081|FG001|COMPLETED|Primary Vaccination Phase||517
11085329|NCT01144663|12268082|FG002|COMPLETED|Primary Vaccination Phase||508
11085330|NCT01144663|12268083|FG003|COMPLETED|Primary Vaccination Phase||509
11085331|NCT01144663|12268080|FG000|NOT COMPLETED|Primary Vaccination Phase||20
11085332|NCT01144663|12268081|FG001|NOT COMPLETED|Primary Vaccination Phase||7
11085333|NCT01144663|12268082|FG002|NOT COMPLETED|Primary Vaccination Phase||8
11085334|NCT01144663|12268083|FG003|NOT COMPLETED|Primary Vaccination Phase||18
11085335|NCT01144663|12268080|FG000|STARTED|Booster Vaccination Phase||497
11085336|NCT01144663|12268081|FG001|STARTED|Booster Vaccination Phase||511
11085337|NCT01144663|12268082|FG002|STARTED|Booster Vaccination Phase||503
11085338|NCT01144663|12268083|FG003|STARTED|Booster Vaccination Phase||506
11085339|NCT01144663|12268080|FG000|COMPLETED|Booster Vaccination Phase||494
11085340|NCT01144663|12268081|FG001|COMPLETED|Booster Vaccination Phase||509
11085341|NCT01144663|12268082|FG002|COMPLETED|Booster Vaccination Phase||498
11085342|NCT01144663|12268083|FG003|COMPLETED|Booster Vaccination Phase||505
11085343|NCT01144663|12268080|FG000|NOT COMPLETED|Booster Vaccination Phase||3
11085344|NCT01144663|12268081|FG001|NOT COMPLETED|Booster Vaccination Phase||2
11085345|NCT01144663|12268082|FG002|NOT COMPLETED|Booster Vaccination Phase||5
11085346|NCT01144663|12268083|FG003|NOT COMPLETED|Booster Vaccination Phase||1
11085347|NCT01144663|12268080|FG000|STARTED|Extended Safety Follow-Up (ESFU)||497
11085348|NCT01144663|12268081|FG001|STARTED|Extended Safety Follow-Up (ESFU)||511
11085349|NCT01144663|12268082|FG002|STARTED|Extended Safety Follow-Up (ESFU)||503
11085350|NCT01144663|12268083|FG003|STARTED|Extended Safety Follow-Up (ESFU)||506
11085351|NCT01144663|12268080|FG000|COMPLETED|Extended Safety Follow-Up (ESFU)||492
11085352|NCT01144663|12268081|FG001|COMPLETED|Extended Safety Follow-Up (ESFU)||502
11085353|NCT01144663|12268082|FG002|COMPLETED|Extended Safety Follow-Up (ESFU)||496
11085354|NCT01144663|12268083|FG003|COMPLETED|Extended Safety Follow-Up (ESFU)||505
11085355|NCT01144663|12268080|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5
11085356|NCT01144663|12268081|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9
11085357|NCT01144663|12268082|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7
11085358|NCT01144663|12268083|FG003|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1
11085359|NCT01144715|12268095|FG000|STARTED|Overall Study||51
11085360|NCT01144715|12268096|FG001|STARTED|Overall Study||48
11085361|NCT01144715|12268095|FG000|COMPLETED|Overall Study||47
11085362|NCT01144715|12268096|FG001|COMPLETED|Overall Study||45
11085363|NCT01144715|12268095|FG000|NOT COMPLETED|Overall Study||4
11085364|NCT01144715|12268096|FG001|NOT COMPLETED|Overall Study||3
11085365|NCT01144949|12268104|FG000|STARTED|Overall Study||119
11085366|NCT01144949|12268105|FG001|STARTED|Overall Study||120
11085367|NCT01144949|12268104|FG000|COMPLETED|Overall Study||108
11085368|NCT01144949|12268105|FG001|COMPLETED|Overall Study||106
11085369|NCT01144949|12268104|FG000|NOT COMPLETED|Overall Study||11
11085370|NCT01144949|12268105|FG001|NOT COMPLETED|Overall Study||14
11085371|NCT01145001|12268115|FG000|STARTED|Overall Study||36
11085372|NCT01145001|12268116|FG001|STARTED|Overall Study||37
11085373|NCT01145001|12268117|FG002|STARTED|Overall Study||44
11085374|NCT01145001|12268118|FG003|STARTED|Overall Study||37
11085375|NCT01145001|12268115|FG000|COMPLETED|Overall Study||28
11085376|NCT01145001|12268116|FG001|COMPLETED|Overall Study||31
11085377|NCT01145001|12268117|FG002|COMPLETED|Overall Study||39
11085378|NCT01145001|12268118|FG003|COMPLETED|Overall Study||31
11085379|NCT01145001|12268115|FG000|NOT COMPLETED|Overall Study||8
11085380|NCT01145001|12268116|FG001|NOT COMPLETED|Overall Study||6
11085381|NCT01145001|12268117|FG002|NOT COMPLETED|Overall Study||5
11085382|NCT01145001|12268118|FG003|NOT COMPLETED|Overall Study||6
11085383|NCT01145053|12268128|FG000|STARTED|Overall Study||341
11085384|NCT01145053|12268128|FG000|COMPLETED|Overall Study||248
11085385|NCT01145053|12268128|FG000|NOT COMPLETED|Overall Study||93
11085386|NCT01145066|12268135|FG000|STARTED|Overall Study||26
11085387|NCT01145066|12268136|FG001|STARTED|Overall Study||20
11085388|NCT01145066|12268137|FG002|STARTED|Overall Study||25
11085389|NCT01145066|12268135|FG000|COMPLETED|Overall Study||22
11085390|NCT01145066|12268136|FG001|COMPLETED|Overall Study||16
11085391|NCT01145066|12268137|FG002|COMPLETED|Overall Study||21
11085392|NCT01145066|12268135|FG000|NOT COMPLETED|Overall Study||4
11351113|NCT03033108|12548086|FG002|COMPLETED|Overall Study||7
11085393|NCT01145066|12268136|FG001|NOT COMPLETED|Overall Study||4
11085394|NCT01145066|12268137|FG002|NOT COMPLETED|Overall Study||4
11085395|NCT01145183|12268149|FG000|STARTED|Overall Study||21
11085396|NCT01145183|12268150|FG001|STARTED|Overall Study||26
11085397|NCT01145183|12268151|FG002|STARTED|Overall Study||19
11085398|NCT01145183|12268152|FG003|STARTED|Overall Study||10
11085399|NCT01145183|12268149|FG000|COMPLETED|Overall Study||21
11085400|NCT01145183|12268150|FG001|COMPLETED|Overall Study||26
11085401|NCT01145183|12268151|FG002|COMPLETED|Overall Study||19
11085402|NCT01145183|12268152|FG003|COMPLETED|Overall Study||10
11085403|NCT01145183|12268149|FG000|NOT COMPLETED|Overall Study||0
11085404|NCT01145183|12268150|FG001|NOT COMPLETED|Overall Study||0
11085405|NCT01145183|12268151|FG002|NOT COMPLETED|Overall Study||0
11085406|NCT01145183|12268152|FG003|NOT COMPLETED|Overall Study||0
11085407|NCT01145222|12268166|FG000|STARTED|Overall Study||40
11085408|NCT01145222|12268167|FG001|STARTED|Overall Study||40
11085409|NCT01145222|12268168|FG002|STARTED|Overall Study||41
11085410|NCT01145222|12268169|FG003|STARTED|Overall Study||41
11085411|NCT01145222|12268166|FG000|Safety Population|Overall Study||40
11085412|NCT01145222|12268167|FG001|Safety Population|Overall Study||40
11085413|NCT01145222|12268168|FG002|Safety Population|Overall Study||40
11085414|NCT01145222|12268169|FG003|Safety Population|Overall Study||41
11085415|NCT01145222|12268166|FG000|Intention to Treat (ITT) Population|Overall Study||40
11085416|NCT01145222|12268167|FG001|Intention to Treat (ITT) Population|Overall Study||40
11085417|NCT01145222|12268168|FG002|Intention to Treat (ITT) Population|Overall Study||40
11085418|NCT01145222|12268169|FG003|Intention to Treat (ITT) Population|Overall Study||40
11085419|NCT01145222|12268166|FG000|COMPLETED|Overall Study||40
11085420|NCT01145222|12268167|FG001|COMPLETED|Overall Study||40
11085421|NCT01145222|12268168|FG002|COMPLETED|Overall Study||40
11085422|NCT01145222|12268169|FG003|COMPLETED|Overall Study||40
11085423|NCT01145222|12268166|FG000|NOT COMPLETED|Overall Study||0
11085424|NCT01145222|12268167|FG001|NOT COMPLETED|Overall Study||0
11085425|NCT01145222|12268168|FG002|NOT COMPLETED|Overall Study||1
11085426|NCT01145222|12268169|FG003|NOT COMPLETED|Overall Study||1
11085427|NCT01145352|12268179|FG000|STARTED|Overall Study||113
11085428|NCT01145352|12268179|FG000|COMPLETED|Overall Study||102
11085429|NCT01145352|12268179|FG000|NOT COMPLETED|Overall Study||11
11085430|NCT01145391|12268185|FG000|STARTED|Overall Study||293
11085431|NCT01145391|12268186|FG001|STARTED|Overall Study||298
11085432|NCT01145391|12268185|FG000|9 Months Post-randomization|Overall Study||293
11085433|NCT01145391|12268186|FG001|9 Months Post-randomization|Overall Study||298
11085434|NCT01145391|12268185|FG000|COMPLETED|Overall Study||293
11085435|NCT01145391|12268186|FG001|COMPLETED|Overall Study||298
11085436|NCT01145391|12268185|FG000|NOT COMPLETED|Overall Study||0
11085437|NCT01145391|12268186|FG001|NOT COMPLETED|Overall Study||0
11085438|NCT01145417|12268196|FG000|STARTED|Overall Study||108
11085439|NCT01145417|12268197|FG001|STARTED|Overall Study||109
11085440|NCT01145417|12268196|FG000|COMPLETED|Overall Study||67
11085441|NCT01145417|12268197|FG001|COMPLETED|Overall Study||62
11085442|NCT01145417|12268196|FG000|NOT COMPLETED|Overall Study||41
11085443|NCT01145417|12268197|FG001|NOT COMPLETED|Overall Study||47
11085444|NCT01145482|12268205|FG000|STARTED|First Intervention (1 Day)||6
11085445|NCT01145482|12268206|FG001|STARTED|First Intervention (1 Day)||6
11085446|NCT01145482|12268205|FG000|COMPLETED|First Intervention (1 Day)||6
11085447|NCT01145482|12268206|FG001|COMPLETED|First Intervention (1 Day)||5
11085448|NCT01145482|12268205|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11085449|NCT01145482|12268206|FG001|NOT COMPLETED|First Intervention (1 Day)||1
11085450|NCT01145482|12268205|FG000|STARTED|Second Intervention (1 Day)||5
11085451|NCT01145482|12268206|FG001|STARTED|Second Intervention (1 Day)||6
11085452|NCT01145482|12268205|FG000|COMPLETED|Second Intervention (1 Day)||5
11085453|NCT01145482|12268206|FG001|COMPLETED|Second Intervention (1 Day)||6
11085454|NCT01145482|12268205|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11085455|NCT01145482|12268206|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11085456|NCT01145508|12268214|FG000|STARTED|Overall Study||7
11085457|NCT01145508|12268215|FG001|STARTED|Overall Study||3
11085458|NCT01145508|12268214|FG000|Treated|Overall Study||6
11085459|NCT01145508|12268215|FG001|Treated|Overall Study||2
11085460|NCT01145508|12268214|FG000|COMPLETED|Overall Study||2
11085461|NCT01145508|12268215|FG001|COMPLETED|Overall Study||1
11085462|NCT01145508|12268214|FG000|NOT COMPLETED|Overall Study||5
11085463|NCT01145508|12268215|FG001|NOT COMPLETED|Overall Study||2
11085464|NCT01145547|12268221|FG000|STARTED|Overall Study||4
11085465|NCT01145547|12268222|FG001|STARTED|Overall Study||3
11085466|NCT01145547|12268221|FG000|COMPLETED|Overall Study||4
11085467|NCT01145547|12268222|FG001|COMPLETED|Overall Study||3
11085468|NCT01145547|12268221|FG000|NOT COMPLETED|Overall Study||0
11085469|NCT01145547|12268222|FG001|NOT COMPLETED|Overall Study||0
11085470|NCT01145560|12268231|FG000|STARTED|Overall Study||100
11085471|NCT01145560|12268232|FG001|STARTED|Overall Study||100
11085472|NCT01145560|12268233|FG002|STARTED|Overall Study||100
11085473|NCT01145560|12268231|FG000|Received Treatment|Overall Study||99
11085474|NCT01145560|12268232|FG001|Received Treatment|Overall Study||98
11085475|NCT01145560|12268233|FG002|Received Treatment|Overall Study||99
11085476|NCT01145560|12268231|FG000|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
11085477|NCT01145560|12268232|FG001|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
11085478|NCT01145560|12268233|FG002|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
11351114|NCT03033108|12548084|FG000|NOT COMPLETED|Overall Study||0
11085479|NCT01145560|12268231|FG000|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
11085480|NCT01145560|12268232|FG001|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
11085481|NCT01145560|12268233|FG002|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
11085482|NCT01145560|12268231|FG000|NOT COMPLETED|Overall Study||4
11085483|NCT01145560|12268232|FG001|NOT COMPLETED|Overall Study||4
11085484|NCT01145560|12268233|FG002|NOT COMPLETED|Overall Study||2
11085485|NCT01145625|12268243|FG000|STARTED|Overall Study||161
11085486|NCT01145625|12268244|FG001|STARTED|Overall Study||161
11085487|NCT01145625|12268243|FG000|COMPLETED|Overall Study||137
11085488|NCT01145625|12268244|FG001|COMPLETED|Overall Study||130
11085489|NCT01145625|12268243|FG000|NOT COMPLETED|Overall Study||24
11085490|NCT01145625|12268244|FG001|NOT COMPLETED|Overall Study||31
11085491|NCT01145638|12268252|FG000|STARTED|Overall Study||231
11085492|NCT01145638|12268253|FG001|STARTED|Overall Study||119
11085493|NCT01145638|12268252|FG000|COMPLETED|Overall Study||141
11085494|NCT01145638|12268253|FG001|COMPLETED|Overall Study||62
11085495|NCT01145638|12268252|FG000|NOT COMPLETED|Overall Study||90
11085496|NCT01145638|12268253|FG001|NOT COMPLETED|Overall Study||57
11085497|NCT01145755|12268262|FG000|STARTED|Overall Study||40
11085498|NCT01145755|12268263|FG001|STARTED|Overall Study||47
11085499|NCT01145755|12268264|FG002|STARTED|Overall Study||44
11085500|NCT01145755|12268262|FG000|COMPLETED|Overall Study||20
11085501|NCT01145755|12268263|FG001|COMPLETED|Overall Study||19
11085502|NCT01145755|12268264|FG002|COMPLETED|Overall Study||19
11085503|NCT01145755|12268262|FG000|NOT COMPLETED|Overall Study||20
11085504|NCT01145755|12268263|FG001|NOT COMPLETED|Overall Study||28
11085505|NCT01145755|12268264|FG002|NOT COMPLETED|Overall Study||25
11085506|NCT01145833|12268274|FG000|STARTED|Overall Study||25
11085507|NCT01145833|12268275|FG001|STARTED|Overall Study||25
11085508|NCT01145833|12268274|FG000|COMPLETED|Overall Study||22
11085509|NCT01145833|12268275|FG001|COMPLETED|Overall Study||25
11085510|NCT01145833|12268274|FG000|NOT COMPLETED|Overall Study||3
11085511|NCT01145833|12268275|FG001|NOT COMPLETED|Overall Study||0
11085512|NCT01145885|12268281|FG000|STARTED|Overall Study||7
11085513|NCT01145885|12268281|FG000|COMPLETED|Overall Study||0
11085514|NCT01145885|12268281|FG000|NOT COMPLETED|Overall Study||7
11085515|NCT01145898|12268293|FG000|STARTED|6-month Treatment||12
11085516|NCT01145898|12268294|FG001|STARTED|6-month Treatment||44
11085517|NCT01145898|12268293|FG000|COMPLETED|6-month Treatment||12
11085518|NCT01145898|12268294|FG001|COMPLETED|6-month Treatment||44
11085519|NCT01145898|12268293|FG000|NOT COMPLETED|6-month Treatment||0
11085520|NCT01145898|12268294|FG001|NOT COMPLETED|6-month Treatment||0
11085521|NCT01145898|12268293|FG000|STARTED|3-year Treatment||12
11085522|NCT01145898|12268294|FG001|STARTED|3-year Treatment||44
11085523|NCT01145898|12268293|FG000|COMPLETED|3-year Treatment||9
11085524|NCT01145898|12268294|FG001|COMPLETED|3-year Treatment||28
11085525|NCT01145898|12268293|FG000|NOT COMPLETED|3-year Treatment||3
11085526|NCT01145898|12268294|FG001|NOT COMPLETED|3-year Treatment||16
11085527|NCT01146054|12268299|FG000|STARTED|Overall Study||59
11085528|NCT01146054|12268299|FG000|COMPLETED|Overall Study||49
11085529|NCT01146054|12268299|FG000|NOT COMPLETED|Overall Study||10
11085530|NCT01146288|12268305|FG000|STARTED|First Intervention(1 Day)||7
11085531|NCT01146288|12268306|FG001|STARTED|First Intervention(1 Day)||6
11085532|NCT01146288|12268305|FG000|COMPLETED|First Intervention(1 Day)||7
11085533|NCT01146288|12268306|FG001|COMPLETED|First Intervention(1 Day)||5
11085534|NCT01146288|12268305|FG000|NOT COMPLETED|First Intervention(1 Day)||0
11351115|NCT03033108|12548085|FG001|NOT COMPLETED|Overall Study||1
11351116|NCT03033108|12548086|FG002|NOT COMPLETED|Overall Study||0
11351117|NCT03033134|12548096|FG000|STARTED|Overall Study||42
11351118|NCT03033134|12548097|FG001|STARTED|Overall Study||12
11351119|NCT03033134|12548096|FG000|6-month Primary Endpoints|Overall Study||42
11351120|NCT03033134|12548097|FG001|6-month Primary Endpoints|Overall Study||12
11351121|NCT03033134|12548096|FG000|COMPLETED|Overall Study||0
11351122|NCT03033134|12548097|FG001|COMPLETED|Overall Study||0
11085535|NCT01146288|12268306|FG001|NOT COMPLETED|First Intervention(1 Day)||1
11085536|NCT01146288|12268305|FG000|STARTED|Second Intervention (1 Day)||7
11085537|NCT01146288|12268306|FG001|STARTED|Second Intervention (1 Day)||5
11085538|NCT01146288|12268305|FG000|COMPLETED|Second Intervention (1 Day)||7
11085539|NCT01146288|12268306|FG001|COMPLETED|Second Intervention (1 Day)||5
11085540|NCT01146288|12268305|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11085541|NCT01146288|12268306|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11085542|NCT01146379|12268317|FG000|STARTED|Overall Study||21
11085543|NCT01146379|12268318|FG001|STARTED|Overall Study||22
11085544|NCT01146379|12268319|FG002|STARTED|Overall Study||21
11085545|NCT01146379|12268320|FG003|STARTED|Overall Study||21
11085546|NCT01146379|12268317|FG000|COMPLETED|Overall Study||20
11085547|NCT01146379|12268318|FG001|COMPLETED|Overall Study||21
11085548|NCT01146379|12268319|FG002|COMPLETED|Overall Study||21
11085549|NCT01146379|12268320|FG003|COMPLETED|Overall Study||20
11085550|NCT01146379|12268317|FG000|NOT COMPLETED|Overall Study||1
11085551|NCT01146379|12268318|FG001|NOT COMPLETED|Overall Study||1
11085552|NCT01146379|12268319|FG002|NOT COMPLETED|Overall Study||0
11085553|NCT01146379|12268320|FG003|NOT COMPLETED|Overall Study||1
11085554|NCT01146457|12268335|FG000|STARTED|Overall Study||19
11351123|NCT03033134|12548096|FG000|NOT COMPLETED|Overall Study||42
11085555|NCT01146457|12268336|FG001|STARTED|Overall Study||17
11085556|NCT01146457|12268337|FG002|STARTED|Overall Study||21
11085557|NCT01146457|12268338|FG003|STARTED|Overall Study||13
11085558|NCT01146457|12268339|FG004|STARTED|Overall Study||13
11085559|NCT01146457|12268335|FG000|COMPLETED|Overall Study||19
11085560|NCT01146457|12268336|FG001|COMPLETED|Overall Study||17
11085561|NCT01146457|12268337|FG002|COMPLETED|Overall Study||20
11085562|NCT01146457|12268338|FG003|COMPLETED|Overall Study||13
11085563|NCT01146457|12268339|FG004|COMPLETED|Overall Study||13
11085564|NCT01146457|12268335|FG000|NOT COMPLETED|Overall Study||0
11085565|NCT01146457|12268336|FG001|NOT COMPLETED|Overall Study||0
11085566|NCT01146457|12268337|FG002|NOT COMPLETED|Overall Study||1
11085567|NCT01146457|12268338|FG003|NOT COMPLETED|Overall Study||0
11085568|NCT01146457|12268339|FG004|NOT COMPLETED|Overall Study||0
11085569|NCT01146496|12268353|FG000|STARTED|Overall Study||114168
11085570|NCT01146496|12268354|FG001|STARTED|Overall Study||109693
11085571|NCT01146496|12268353|FG000|COMPLETED|Overall Study||114168
11085572|NCT01146496|12268354|FG001|COMPLETED|Overall Study||109693
11085573|NCT01146496|12268353|FG000|NOT COMPLETED|Overall Study||0
11085574|NCT01146496|12268354|FG001|NOT COMPLETED|Overall Study||0
11085575|NCT01146561|12268361|FG000|STARTED|Overall Study||2
11085576|NCT01146561|12268361|FG000|COMPLETED|Overall Study||0
11085577|NCT01146561|12268361|FG000|NOT COMPLETED|Overall Study||2
11085578|NCT01146600|12268367|FG000|STARTED|Period 1 (Weeks 1 & 2)||13
11085579|NCT01146600|12268368|FG001|STARTED|Period 1 (Weeks 1 & 2)||10
11085580|NCT01146600|12268367|FG000|COMPLETED|Period 1 (Weeks 1 & 2)||10
11085581|NCT01146600|12268368|FG001|COMPLETED|Period 1 (Weeks 1 & 2)||10
11085582|NCT01146600|12268367|FG000|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
11085583|NCT01146600|12268368|FG001|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
11085584|NCT01146600|12268367|FG000|STARTED|Washout (Week 3)||10
11085585|NCT01146600|12268368|FG001|STARTED|Washout (Week 3)||10
11085586|NCT01146600|12268367|FG000|COMPLETED|Washout (Week 3)||10
11085587|NCT01146600|12268368|FG001|COMPLETED|Washout (Week 3)||10
11085588|NCT01146600|12268367|FG000|NOT COMPLETED|Washout (Week 3)||0
11085589|NCT01146600|12268368|FG001|NOT COMPLETED|Washout (Week 3)||0
11085590|NCT01146600|12268367|FG000|STARTED|Period 2 (Weeks 4 & 5)||10
11085591|NCT01146600|12268368|FG001|STARTED|Period 2 (Weeks 4 & 5)||10
11085592|NCT01146600|12268367|FG000|COMPLETED|Period 2 (Weeks 4 & 5)||10
11085593|NCT01146600|12268368|FG001|COMPLETED|Period 2 (Weeks 4 & 5)||10
11085594|NCT01146600|12268367|FG000|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
11085595|NCT01146600|12268368|FG001|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
11085596|NCT01146613|12268377|FG000|STARTED|Overall Study||99
11085597|NCT01146613|12268378|FG001|STARTED|Overall Study||101
11085598|NCT01146613|12268377|FG000|COMPLETED|Overall Study||92
11085599|NCT01146613|12268378|FG001|COMPLETED|Overall Study||89
11085600|NCT01146613|12268377|FG000|NOT COMPLETED|Overall Study||7
11085601|NCT01146613|12268378|FG001|NOT COMPLETED|Overall Study||12
11085602|NCT01146665|12268386|FG000|STARTED|Overall Study||18
11085603|NCT01146665|12268387|FG001|STARTED|Overall Study||26
11085604|NCT01146665|12268386|FG000|1-month Post-ED Discharge (Follow-up)|Overall Study||9
11085605|NCT01146665|12268387|FG001|1-month Post-ED Discharge (Follow-up)|Overall Study||12
11085606|NCT01146665|12268386|FG000|3-month Post-ED Discharge (Follow-up)|Overall Study||8
11085607|NCT01146665|12268387|FG001|3-month Post-ED Discharge (Follow-up)|Overall Study||10
11085608|NCT01146665|12268386|FG000|COMPLETED|Overall Study||8
11085609|NCT01146665|12268387|FG001|COMPLETED|Overall Study||10
11085610|NCT01146665|12268386|FG000|NOT COMPLETED|Overall Study||10
11085611|NCT01146665|12268387|FG001|NOT COMPLETED|Overall Study||16
11085612|NCT01146704|12268404|FG000|STARTED|Overall Study||16
11085613|NCT01146704|12268405|FG001|STARTED|Overall Study||15
11085614|NCT01146704|12268404|FG000|COMPLETED|Overall Study||16
11085615|NCT01146704|12268405|FG001|COMPLETED|Overall Study||15
11085616|NCT01146704|12268404|FG000|NOT COMPLETED|Overall Study||0
11085617|NCT01146704|12268405|FG001|NOT COMPLETED|Overall Study||0
11085618|NCT01146782|12268411|FG000|STARTED|Screening Cohort||367
11085619|NCT01146782|12268411|FG000|COMPLETED|Screening Cohort||146
11085620|NCT01146782|12268411|FG000|NOT COMPLETED|Screening Cohort||221
11085621|NCT01146782|12268411|FG000|STARTED|Safety Cohort||146
11085622|NCT01146782|12268411|FG000|COMPLETED|Safety Cohort||63
11085623|NCT01146782|12268411|FG000|NOT COMPLETED|Safety Cohort||83
11085624|NCT01146782|12268411|FG000|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
11085625|NCT01146782|12268411|FG000|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
11085626|NCT01146782|12268411|FG000|NOT COMPLETED|Primary Endpoint Cohort||6
11085627|NCT01146795|12268416|FG000|STARTED|Overall Study||32
11085628|NCT01146795|12268416|FG000|COMPLETED|Overall Study||12
11085629|NCT01146795|12268416|FG000|NOT COMPLETED|Overall Study||20
11085630|NCT01146808|12268420|FG000|STARTED|Overall Study||16
11085631|NCT01146808|12268420|FG000|COMPLETED|Overall Study||16
11085632|NCT01146808|12268420|FG000|NOT COMPLETED|Overall Study||0
11085633|NCT01146834|12268429|FG000|STARTED|Overall Study||20
11085634|NCT01146834|12268430|FG001|STARTED|Overall Study||4
11085635|NCT01146834|12268431|FG002|STARTED|Overall Study||23
11085636|NCT01146834|12268432|FG003|STARTED|Overall Study||0
11085637|NCT01146834|12268433|FG004|STARTED|Overall Study||0
11085638|NCT01146834|12268429|FG000|COMPLETED|Overall Study||17
11085639|NCT01146834|12268430|FG001|COMPLETED|Overall Study||4
11085640|NCT01146834|12268431|FG002|COMPLETED|Overall Study||21
11085641|NCT01146834|12268432|FG003|COMPLETED|Overall Study||0
11085642|NCT01146834|12268433|FG004|COMPLETED|Overall Study||0
11085643|NCT01146834|12268429|FG000|NOT COMPLETED|Overall Study||3
11085644|NCT01146834|12268430|FG001|NOT COMPLETED|Overall Study||0
11085645|NCT01146834|12268431|FG002|NOT COMPLETED|Overall Study||2
11085646|NCT01146834|12268432|FG003|NOT COMPLETED|Overall Study||0
11085647|NCT01146834|12268433|FG004|NOT COMPLETED|Overall Study||0
11085648|NCT01146860|12268447|FG000|STARTED|Overall Study||194
11085649|NCT01146860|12268448|FG001|STARTED|Overall Study||192
11085650|NCT01146860|12268447|FG000|COMPLETED|Overall Study||194
11085651|NCT01146860|12268448|FG001|COMPLETED|Overall Study||191
11085652|NCT01146860|12268447|FG000|NOT COMPLETED|Overall Study||0
11085653|NCT01146860|12268448|FG001|NOT COMPLETED|Overall Study||1
11085654|NCT01146873|12268456|FG000|STARTED|Overall Study||148
11085655|NCT01146873|12268457|FG001|STARTED|Overall Study||150
11085656|NCT01146873|12268456|FG000|COMPLETED|Overall Study||148
11085657|NCT01146873|12268457|FG001|COMPLETED|Overall Study||144
11085658|NCT01146873|12268456|FG000|NOT COMPLETED|Overall Study||0
11085659|NCT01146873|12268457|FG001|NOT COMPLETED|Overall Study||6
11085660|NCT01146912|12268470|FG000|STARTED|Overall Study||4607
11085661|NCT01146912|12268471|FG001|STARTED|Overall Study||4606
11085662|NCT01146912|12268472|FG002|STARTED|Overall Study||593
11085663|NCT01146912|12268473|FG003|STARTED|Overall Study||594
11085664|NCT01146912|12268474|FG004|STARTED|Overall Study||1821
11085665|NCT01146912|12268475|FG005|STARTED|Overall Study||1821
11085666|NCT01146912|12268476|FG006|STARTED|Overall Study||1820
11085667|NCT01146912|12268477|FG007|STARTED|Overall Study||14675
11085668|NCT01146912|12268470|FG000|COMPLETED|Overall Study||3790
11085669|NCT01146912|12268471|FG001|COMPLETED|Overall Study||3784
11085670|NCT01146912|12268472|FG002|COMPLETED|Overall Study||576
11085671|NCT01146912|12268473|FG003|COMPLETED|Overall Study||577
11085672|NCT01146912|12268474|FG004|COMPLETED|Overall Study||1780
11085673|NCT01146912|12268475|FG005|COMPLETED|Overall Study||1760
11085674|NCT01146912|12268476|FG006|COMPLETED|Overall Study||1764
11085675|NCT01146912|12268477|FG007|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
11085676|NCT01146912|12268470|FG000|NOT COMPLETED|Overall Study||817
11085677|NCT01146912|12268471|FG001|NOT COMPLETED|Overall Study||822
11085678|NCT01146912|12268472|FG002|NOT COMPLETED|Overall Study||17
11085679|NCT01146912|12268473|FG003|NOT COMPLETED|Overall Study||17
11085680|NCT01146912|12268474|FG004|NOT COMPLETED|Overall Study||41
11085681|NCT01146912|12268475|FG005|NOT COMPLETED|Overall Study||61
11085682|NCT01146912|12268476|FG006|NOT COMPLETED|Overall Study||56
11085683|NCT01146912|12268477|FG007|NOT COMPLETED|Overall Study||0
11085684|NCT01146951|12268498|FG000|STARTED|Overall Study||29
11085685|NCT01146951|12268499|FG001|STARTED|Overall Study||30
11085686|NCT01146951|12268498|FG000|COMPLETED|Overall Study||25
11085687|NCT01146951|12268499|FG001|COMPLETED|Overall Study||29
11085688|NCT01146951|12268498|FG000|NOT COMPLETED|Overall Study||4
11085689|NCT01146951|12268499|FG001|NOT COMPLETED|Overall Study||1
11207694|NCT01877265|12398828|FG001|COMPLETED|Washout Period 2 (at Least 14 Days)||3
11207695|NCT01877265|12398829|FG002|COMPLETED|Washout Period 2 (at Least 14 Days)||2
11207696|NCT01877265|12398830|FG003|COMPLETED|Washout Period 2 (at Least 14 Days)||3
11207697|NCT01877265|12398831|FG004|COMPLETED|Washout Period 2 (at Least 14 Days)||3
11207698|NCT01877265|12398832|FG005|COMPLETED|Washout Period 2 (at Least 14 Days)||2
11207699|NCT01877265|12398827|FG000|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
11207700|NCT01877265|12398828|FG001|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
11085690|NCT01147055|12268505|FG000|STARTED|First Intervention Period||15
11085691|NCT01147055|12268506|FG001|STARTED|First Intervention Period||0
11085692|NCT01147055|12268505|FG000|COMPLETED|First Intervention Period||14
11085693|NCT01147055|12268506|FG001|COMPLETED|First Intervention Period||0
11085694|NCT01147055|12268505|FG000|NOT COMPLETED|First Intervention Period||1
11085695|NCT01147055|12268506|FG001|NOT COMPLETED|First Intervention Period||0
11085696|NCT01147055|12268505|FG000|STARTED|Washout Period (at Least 14 Days)||14
11085697|NCT01147055|12268506|FG001|STARTED|Washout Period (at Least 14 Days)||0
11085698|NCT01147055|12268505|FG000|COMPLETED|Washout Period (at Least 14 Days)||14
11085699|NCT01147055|12268506|FG001|COMPLETED|Washout Period (at Least 14 Days)||0
11085700|NCT01147055|12268505|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11085701|NCT01147055|12268506|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11085702|NCT01147055|12268505|FG000|STARTED|Second Intervention Period||0
11085703|NCT01147055|12268506|FG001|STARTED|Second Intervention Period||14
11085704|NCT01147055|12268505|FG000|COMPLETED|Second Intervention Period||0
11085705|NCT01147055|12268506|FG001|COMPLETED|Second Intervention Period||14
11085706|NCT01147055|12268505|FG000|NOT COMPLETED|Second Intervention Period||0
11085707|NCT01147055|12268506|FG001|NOT COMPLETED|Second Intervention Period||0
11085708|NCT01147068|12268519|FG000|STARTED|Subjects That Received 1st Dose||60
11085709|NCT01147068|12268520|FG001|STARTED|Subjects That Received 1st Dose||57
11085710|NCT01147068|12268521|FG002|STARTED|Subjects That Received 1st Dose||55
11085711|NCT01147068|12268522|FG003|STARTED|Subjects That Received 1st Dose||56
11085712|NCT01147068|12268523|FG004|STARTED|Subjects That Received 1st Dose||56
11085713|NCT01147068|12268524|FG005|STARTED|Subjects That Received 1st Dose||53
11085714|NCT01147068|12268525|FG006|STARTED|Subjects That Received 1st Dose||55
11085715|NCT01147068|12268519|FG000|COMPLETED|Subjects That Received 1st Dose||60
11085716|NCT01147068|12268520|FG001|COMPLETED|Subjects That Received 1st Dose||57
11085717|NCT01147068|12268521|FG002|COMPLETED|Subjects That Received 1st Dose||55
11085718|NCT01147068|12268522|FG003|COMPLETED|Subjects That Received 1st Dose||56
11085719|NCT01147068|12268523|FG004|COMPLETED|Subjects That Received 1st Dose||56
11085720|NCT01147068|12268524|FG005|COMPLETED|Subjects That Received 1st Dose||53
11085721|NCT01147068|12268525|FG006|COMPLETED|Subjects That Received 1st Dose||55
11085722|NCT01147068|12268519|FG000|NOT COMPLETED|Subjects That Received 1st Dose||0
11085723|NCT01147068|12268520|FG001|NOT COMPLETED|Subjects That Received 1st Dose||0
11085724|NCT01147068|12268521|FG002|NOT COMPLETED|Subjects That Received 1st Dose||0
11085725|NCT01147068|12268522|FG003|NOT COMPLETED|Subjects That Received 1st Dose||0
11085726|NCT01147068|12268523|FG004|NOT COMPLETED|Subjects That Received 1st Dose||0
11085727|NCT01147068|12268524|FG005|NOT COMPLETED|Subjects That Received 1st Dose||0
11085728|NCT01147068|12268525|FG006|NOT COMPLETED|Subjects That Received 1st Dose||0
11085729|NCT01147068|12268519|FG000|STARTED|Subjects That Received 2nd Dose||60
11085730|NCT01147068|12268520|FG001|STARTED|Subjects That Received 2nd Dose||57
11085731|NCT01147068|12268521|FG002|STARTED|Subjects That Received 2nd Dose||55
11085732|NCT01147068|12268522|FG003|STARTED|Subjects That Received 2nd Dose||56
11085733|NCT01147068|12268523|FG004|STARTED|Subjects That Received 2nd Dose||56
11085734|NCT01147068|12268524|FG005|STARTED|Subjects That Received 2nd Dose||53
11085735|NCT01147068|12268525|FG006|STARTED|Subjects That Received 2nd Dose||55
11085736|NCT01147068|12268519|FG000|COMPLETED|Subjects That Received 2nd Dose||59
11085737|NCT01147068|12268520|FG001|COMPLETED|Subjects That Received 2nd Dose||52
11085738|NCT01147068|12268521|FG002|COMPLETED|Subjects That Received 2nd Dose||52
11085739|NCT01147068|12268522|FG003|COMPLETED|Subjects That Received 2nd Dose||56
11085740|NCT01147068|12268523|FG004|COMPLETED|Subjects That Received 2nd Dose||55
11085741|NCT01147068|12268524|FG005|COMPLETED|Subjects That Received 2nd Dose||51
11085742|NCT01147068|12268525|FG006|COMPLETED|Subjects That Received 2nd Dose||55
11085743|NCT01147068|12268519|FG000|NOT COMPLETED|Subjects That Received 2nd Dose||1
11085744|NCT01147068|12268520|FG001|NOT COMPLETED|Subjects That Received 2nd Dose||5
11085745|NCT01147068|12268521|FG002|NOT COMPLETED|Subjects That Received 2nd Dose||3
11085746|NCT01147068|12268522|FG003|NOT COMPLETED|Subjects That Received 2nd Dose||0
11085747|NCT01147068|12268523|FG004|NOT COMPLETED|Subjects That Received 2nd Dose||1
11085748|NCT01147068|12268524|FG005|NOT COMPLETED|Subjects That Received 2nd Dose||2
11085749|NCT01147068|12268525|FG006|NOT COMPLETED|Subjects That Received 2nd Dose||0
11085750|NCT01147068|12268519|FG000|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
11085751|NCT01147068|12268520|FG001|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
11085752|NCT01147068|12268521|FG002|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
11085753|NCT01147068|12268522|FG003|STARTED|Subjects That Completed Safety Follow-up||56
11085754|NCT01147068|12268523|FG004|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
11085755|NCT01147068|12268524|FG005|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
11085756|NCT01147068|12268525|FG006|STARTED|Subjects That Completed Safety Follow-up||55
11085757|NCT01147068|12268519|FG000|COMPLETED|Subjects That Completed Safety Follow-up||59
11085758|NCT01147068|12268520|FG001|COMPLETED|Subjects That Completed Safety Follow-up||56
11085759|NCT01147068|12268521|FG002|COMPLETED|Subjects That Completed Safety Follow-up||55
11085760|NCT01147068|12268522|FG003|COMPLETED|Subjects That Completed Safety Follow-up||54
11085761|NCT01147068|12268523|FG004|COMPLETED|Subjects That Completed Safety Follow-up||56
11085762|NCT01147068|12268524|FG005|COMPLETED|Subjects That Completed Safety Follow-up||52
11085763|NCT01147068|12268525|FG006|COMPLETED|Subjects That Completed Safety Follow-up||54
11085764|NCT01147068|12268519|FG000|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
11085765|NCT01147068|12268520|FG001|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
11085766|NCT01147068|12268521|FG002|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
11085767|NCT01147068|12268522|FG003|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
11085768|NCT01147068|12268523|FG004|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
11085769|NCT01147068|12268524|FG005|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
11085770|NCT01147068|12268525|FG006|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
11085771|NCT01147107|12268543|FG000|STARTED|Overall Study||39
11085772|NCT01147107|12268544|FG001|STARTED|Overall Study||41
11085773|NCT01147107|12268543|FG000|COMPLETED|Overall Study||33
11085774|NCT01147107|12268544|FG001|COMPLETED|Overall Study||40
11085775|NCT01147107|12268543|FG000|NOT COMPLETED|Overall Study||6
11085776|NCT01147107|12268544|FG001|NOT COMPLETED|Overall Study||1
11085777|NCT01147172|12268550|FG000|STARTED|Overall Study||100
11085778|NCT01147172|12268550|FG000|COMPLETED|Overall Study||96
11085779|NCT01147172|12268550|FG000|NOT COMPLETED|Overall Study||4
11085780|NCT01147250|12268558|FG000|STARTED|Overall Study||3034
11085781|NCT01147250|12268559|FG001|STARTED|Overall Study||3034
11085782|NCT01147250|12268558|FG000|Treated|Overall Study||3032
11085783|NCT01147250|12268559|FG001|Treated|Overall Study||3031
11085784|NCT01147250|12268558|FG000|COMPLETED|Overall Study||2924
11085785|NCT01147250|12268559|FG001|COMPLETED|Overall Study||2929
11085786|NCT01147250|12268558|FG000|NOT COMPLETED|Overall Study||110
11085787|NCT01147250|12268559|FG001|NOT COMPLETED|Overall Study||105
11085788|NCT01147302|12268567|FG000|STARTED|Overall Study||9
11085789|NCT01147302|12268568|FG001|STARTED|Overall Study||9
11085790|NCT01147302|12268567|FG000|COMPLETED|Overall Study||9
11085791|NCT01147302|12268568|FG001|COMPLETED|Overall Study||9
11085792|NCT01147302|12268567|FG000|NOT COMPLETED|Overall Study||0
11085793|NCT01147302|12268568|FG001|NOT COMPLETED|Overall Study||0
11085794|NCT01147341|12268576|FG000|STARTED|Double Blind Period||27
11085795|NCT01147341|12268577|FG001|STARTED|Double Blind Period||10
11085796|NCT01147341|12268576|FG000|COMPLETED|Double Blind Period||26
11085797|NCT01147341|12268577|FG001|COMPLETED|Double Blind Period||8
11085798|NCT01147341|12268576|FG000|NOT COMPLETED|Double Blind Period||1
11085799|NCT01147341|12268577|FG001|NOT COMPLETED|Double Blind Period||2
11085800|NCT01147341|12268576|FG000|STARTED|Open Label Period||26
11085801|NCT01147341|12268577|FG001|STARTED|Open Label Period||8
11085802|NCT01147341|12268576|FG000|COMPLETED|Open Label Period||22
11085803|NCT01147341|12268577|FG001|COMPLETED|Open Label Period||8
11085804|NCT01147341|12268576|FG000|NOT COMPLETED|Open Label Period||4
11085805|NCT01147341|12268577|FG001|NOT COMPLETED|Open Label Period||0
11085806|NCT01147380|12268585|FG000|STARTED|Overall Study||6
11085807|NCT01147380|12268586|FG001|STARTED|Overall Study||12
11085808|NCT01147380|12268585|FG000|COMPLETED|Overall Study||6
11085809|NCT01147380|12268586|FG001|COMPLETED|Overall Study||12
11085810|NCT01147380|12268585|FG000|NOT COMPLETED|Overall Study||0
11085811|NCT01147380|12268586|FG001|NOT COMPLETED|Overall Study||0
11085812|NCT01147406|12268600|FG000|STARTED|Overall Study||6
11085813|NCT01147406|12268601|FG001|STARTED|Overall Study||12
11085814|NCT01147406|12268602|FG002|STARTED|Overall Study||1
11085815|NCT01147406|12268603|FG003|STARTED|Overall Study||6
11085816|NCT01147406|12268604|FG004|STARTED|Overall Study||6
11085817|NCT01147406|12268605|FG005|STARTED|Overall Study||10
11085818|NCT01147406|12268600|FG000|COMPLETED|Overall Study||6
11085819|NCT01147406|12268601|FG001|COMPLETED|Overall Study||12
11085820|NCT01147406|12268602|FG002|COMPLETED|Overall Study||1
11085821|NCT01147406|12268603|FG003|COMPLETED|Overall Study||6
11085822|NCT01147406|12268604|FG004|COMPLETED|Overall Study||6
11085823|NCT01147406|12268605|FG005|COMPLETED|Overall Study||10
11085824|NCT01147406|12268600|FG000|NOT COMPLETED|Overall Study||0
11085825|NCT01147406|12268601|FG001|NOT COMPLETED|Overall Study||0
11085826|NCT01147406|12268602|FG002|NOT COMPLETED|Overall Study||0
11085827|NCT01147406|12268603|FG003|NOT COMPLETED|Overall Study||0
11085828|NCT01147406|12268604|FG004|NOT COMPLETED|Overall Study||0
11085829|NCT01147406|12268605|FG005|NOT COMPLETED|Overall Study||0
11085830|NCT01147458|12268620|FG000|STARTED|First Intervention||48
11085831|NCT01147458|12268621|FG001|STARTED|First Intervention||47
11085832|NCT01147458|12268622|FG002|STARTED|First Intervention||47
11085833|NCT01147458|12268623|FG003|STARTED|First Intervention||48
11085834|NCT01147458|12268620|FG000|COMPLETED|First Intervention||34
11085835|NCT01147458|12268621|FG001|COMPLETED|First Intervention||31
11085836|NCT01147458|12268622|FG002|COMPLETED|First Intervention||35
11085837|NCT01147458|12268623|FG003|COMPLETED|First Intervention||34
11085838|NCT01147458|12268620|FG000|NOT COMPLETED|First Intervention||14
11085839|NCT01147458|12268621|FG001|NOT COMPLETED|First Intervention||16
11085840|NCT01147458|12268622|FG002|NOT COMPLETED|First Intervention||12
11085841|NCT01147458|12268623|FG003|NOT COMPLETED|First Intervention||14
11085842|NCT01147458|12268620|FG000|STARTED|Washout Period of 2 Weeks||34
11085843|NCT01147458|12268621|FG001|STARTED|Washout Period of 2 Weeks||31
11085844|NCT01147458|12268622|FG002|STARTED|Washout Period of 2 Weeks||35
11085845|NCT01147458|12268623|FG003|STARTED|Washout Period of 2 Weeks||34
11085846|NCT01147458|12268620|FG000|COMPLETED|Washout Period of 2 Weeks||34
11085847|NCT01147458|12268621|FG001|COMPLETED|Washout Period of 2 Weeks||31
11085848|NCT01147458|12268622|FG002|COMPLETED|Washout Period of 2 Weeks||35
11085849|NCT01147458|12268623|FG003|COMPLETED|Washout Period of 2 Weeks||34
11085850|NCT01147458|12268620|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
11085851|NCT01147458|12268621|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
11085852|NCT01147458|12268622|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
11085853|NCT01147458|12268623|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
11085854|NCT01147458|12268620|FG000|STARTED|Second Intervention||34
11085855|NCT01147458|12268621|FG001|STARTED|Second Intervention||31
11085856|NCT01147458|12268622|FG002|STARTED|Second Intervention||35
11085857|NCT01147458|12268623|FG003|STARTED|Second Intervention||34
11085858|NCT01147458|12268620|FG000|COMPLETED|Second Intervention||25
11085859|NCT01147458|12268621|FG001|COMPLETED|Second Intervention||24
11085860|NCT01147458|12268622|FG002|COMPLETED|Second Intervention||27
11085861|NCT01147458|12268623|FG003|COMPLETED|Second Intervention||30
11085862|NCT01147458|12268620|FG000|NOT COMPLETED|Second Intervention||9
11085863|NCT01147458|12268621|FG001|NOT COMPLETED|Second Intervention||7
11085864|NCT01147458|12268622|FG002|NOT COMPLETED|Second Intervention||8
11085865|NCT01147458|12268623|FG003|NOT COMPLETED|Second Intervention||4
11085866|NCT01147471|12268637|FG000|STARTED|Through Initial Hospital Discharge||13
11085867|NCT01147471|12268638|FG001|STARTED|Through Initial Hospital Discharge||11
11085868|NCT01147471|12268637|FG000|COMPLETED|Through Initial Hospital Discharge||13
11085869|NCT01147471|12268638|FG001|COMPLETED|Through Initial Hospital Discharge||11
11085870|NCT01147471|12268637|FG000|NOT COMPLETED|Through Initial Hospital Discharge||0
11085871|NCT01147471|12268638|FG001|NOT COMPLETED|Through Initial Hospital Discharge||0
11085872|NCT01147471|12268637|FG000|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
11085873|NCT01147471|12268638|FG001|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
11085874|NCT01147471|12268637|FG000|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
11085875|NCT01147471|12268638|FG001|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
11085876|NCT01147471|12268637|FG000|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
11085877|NCT01147471|12268638|FG001|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
11085878|NCT01147471|12268637|FG000|STARTED|3 Month Follow Up||13
11085879|NCT01147471|12268638|FG001|STARTED|3 Month Follow Up||8
11085880|NCT01147471|12268637|FG000|COMPLETED|3 Month Follow Up||12
11085881|NCT01147471|12268638|FG001|COMPLETED|3 Month Follow Up||6
11085882|NCT01147471|12268637|FG000|NOT COMPLETED|3 Month Follow Up||1
11085883|NCT01147471|12268638|FG001|NOT COMPLETED|3 Month Follow Up||2
11085884|NCT01147471|12268637|FG000|STARTED|6 Month Follow Up||12
11085885|NCT01147471|12268638|FG001|STARTED|6 Month Follow Up||6
11085886|NCT01147471|12268637|FG000|COMPLETED|6 Month Follow Up||8
11085887|NCT01147471|12268638|FG001|COMPLETED|6 Month Follow Up||4
11085888|NCT01147471|12268637|FG000|NOT COMPLETED|6 Month Follow Up||4
11085889|NCT01147471|12268638|FG001|NOT COMPLETED|6 Month Follow Up||2
11085890|NCT01147497|12268646|FG000|STARTED|Overall Study||37
11085891|NCT01147497|12268647|FG001|STARTED|Overall Study||36
11085892|NCT01147497|12268646|FG000|COMPLETED|Overall Study||35
11085893|NCT01147497|12268647|FG001|COMPLETED|Overall Study||36
11085894|NCT01147497|12268646|FG000|NOT COMPLETED|Overall Study||2
11085895|NCT01147497|12268647|FG001|NOT COMPLETED|Overall Study||0
11085896|NCT01147601|12268655|FG000|STARTED|Overall Study||5
11085897|NCT01147601|12268656|FG001|STARTED|Overall Study||1
11085898|NCT01147601|12268655|FG000|COMPLETED|Overall Study||2
11085899|NCT01147601|12268656|FG001|COMPLETED|Overall Study||1
11085900|NCT01147601|12268655|FG000|NOT COMPLETED|Overall Study||3
11085901|NCT01147601|12268656|FG001|NOT COMPLETED|Overall Study||0
11085902|NCT01147627|12268665|FG000|STARTED|Overall Study||142
11085903|NCT01147627|12268666|FG001|STARTED|Overall Study||138
11085904|NCT01147627|12268667|FG002|STARTED|Overall Study||136
11085905|NCT01147627|12268665|FG000|COMPLETED|Overall Study||110
11085906|NCT01147627|12268666|FG001|COMPLETED|Overall Study||114
11085907|NCT01147627|12268667|FG002|COMPLETED|Overall Study||118
11085908|NCT01147627|12268665|FG000|NOT COMPLETED|Overall Study||32
11207701|NCT01877265|12398829|FG002|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
11085909|NCT01147627|12268666|FG001|NOT COMPLETED|Overall Study||24
11085910|NCT01147627|12268667|FG002|NOT COMPLETED|Overall Study||18
11085911|NCT01147640|12268677|FG000|STARTED|Overall Study||83
11085912|NCT01147640|12268678|FG001|STARTED|Overall Study||39
11085913|NCT01147640|12268677|FG000|COMPLETED|Overall Study||78
11085914|NCT01147640|12268678|FG001|COMPLETED|Overall Study||38
11085915|NCT01147640|12268677|FG000|NOT COMPLETED|Overall Study||5
11085916|NCT01147640|12268678|FG001|NOT COMPLETED|Overall Study||1
11085917|NCT01147744|12268691|FG000|STARTED|Overall Study||100
11085918|NCT01147744|12268692|FG001|STARTED|Overall Study||99
11085919|NCT01147744|12268693|FG002|STARTED|Overall Study||100
11085920|NCT01147744|12268694|FG003|STARTED|Overall Study||100
11085921|NCT01147744|12268695|FG004|STARTED|Overall Study||101
11085922|NCT01147744|12268696|FG005|STARTED|Overall Study||103
11085923|NCT01147744|12268697|FG006|STARTED|Overall Study||97
11085924|NCT01147744|12268691|FG000|COMPLETED|Overall Study||71
11085925|NCT01147744|12268692|FG001|COMPLETED|Overall Study||76
11085926|NCT01147744|12268693|FG002|COMPLETED|Overall Study||82
11085927|NCT01147744|12268694|FG003|COMPLETED|Overall Study||82
11085928|NCT01147744|12268695|FG004|COMPLETED|Overall Study||76
11085929|NCT01147744|12268696|FG005|COMPLETED|Overall Study||83
11085930|NCT01147744|12268697|FG006|COMPLETED|Overall Study||78
11085931|NCT01147744|12268691|FG000|NOT COMPLETED|Overall Study||29
11207702|NCT01877265|12398830|FG003|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
11207703|NCT01877265|12398831|FG004|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
11207704|NCT01877265|12398832|FG005|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
11207705|NCT01877265|12398827|FG000|STARTED|Treatment Period 3||3
11207706|NCT01877265|12398828|FG001|STARTED|Treatment Period 3||3
11207707|NCT01877265|12398829|FG002|STARTED|Treatment Period 3||2
11207708|NCT01877265|12398830|FG003|STARTED|Treatment Period 3||3
11207709|NCT01877265|12398831|FG004|STARTED|Treatment Period 3||3
11207710|NCT01877265|12398832|FG005|STARTED|Treatment Period 3||2
11207711|NCT01877265|12398827|FG000|Received at Least One Dose of Study Drug|Treatment Period 3||3
11207712|NCT01877265|12398828|FG001|Received at Least One Dose of Study Drug|Treatment Period 3||3
11207713|NCT01877265|12398829|FG002|Received at Least One Dose of Study Drug|Treatment Period 3||2
11207714|NCT01877265|12398830|FG003|Received at Least One Dose of Study Drug|Treatment Period 3||3
11207715|NCT01877265|12398831|FG004|Received at Least One Dose of Study Drug|Treatment Period 3||3
11207716|NCT01877265|12398832|FG005|Received at Least One Dose of Study Drug|Treatment Period 3||2
11207717|NCT01877265|12398827|FG000|COMPLETED|Treatment Period 3||2
11207718|NCT01877265|12398828|FG001|COMPLETED|Treatment Period 3||3
11207719|NCT01877265|12398829|FG002|COMPLETED|Treatment Period 3||2
11207720|NCT01877265|12398830|FG003|COMPLETED|Treatment Period 3||3
11207721|NCT01877265|12398831|FG004|COMPLETED|Treatment Period 3||3
11207722|NCT01877265|12398832|FG005|COMPLETED|Treatment Period 3||2
11207723|NCT01877265|12398827|FG000|NOT COMPLETED|Treatment Period 3||1
11207724|NCT01877265|12398828|FG001|NOT COMPLETED|Treatment Period 3||0
11207725|NCT01877265|12398829|FG002|NOT COMPLETED|Treatment Period 3||0
11207726|NCT01877265|12398830|FG003|NOT COMPLETED|Treatment Period 3||0
11207727|NCT01877265|12398831|FG004|NOT COMPLETED|Treatment Period 3||0
11085932|NCT01147744|12268692|FG001|NOT COMPLETED|Overall Study||23
11085933|NCT01147744|12268693|FG002|NOT COMPLETED|Overall Study||18
11085934|NCT01147744|12268694|FG003|NOT COMPLETED|Overall Study||18
11085935|NCT01147744|12268695|FG004|NOT COMPLETED|Overall Study||25
11085936|NCT01147744|12268696|FG005|NOT COMPLETED|Overall Study||20
11085937|NCT01147744|12268697|FG006|NOT COMPLETED|Overall Study||19
11085938|NCT01147809|12268725|FG000|STARTED|Phase I (168 Days)||3
11085939|NCT01147809|12268726|FG001|STARTED|Phase I (168 Days)||9
11085940|NCT01147809|12268727|FG002|STARTED|Phase I (168 Days)||4
11085941|NCT01147809|12268728|FG003|STARTED|Phase I (168 Days)||10
11085942|NCT01147809|12268729|FG004|STARTED|Phase I (168 Days)||0
11085943|NCT01147809|12268730|FG005|STARTED|Phase I (168 Days)||0
11085944|NCT01147809|12268725|FG000|COMPLETED|Phase I (168 Days)||2
11085945|NCT01147809|12268726|FG001|COMPLETED|Phase I (168 Days)||8
11085946|NCT01147809|12268727|FG002|COMPLETED|Phase I (168 Days)||2
11085947|NCT01147809|12268728|FG003|COMPLETED|Phase I (168 Days)||5
11085948|NCT01147809|12268729|FG004|COMPLETED|Phase I (168 Days)||0
11085949|NCT01147809|12268730|FG005|COMPLETED|Phase I (168 Days)||0
11085950|NCT01147809|12268725|FG000|NOT COMPLETED|Phase I (168 Days)||1
11085951|NCT01147809|12268726|FG001|NOT COMPLETED|Phase I (168 Days)||1
11085952|NCT01147809|12268727|FG002|NOT COMPLETED|Phase I (168 Days)||2
11085953|NCT01147809|12268728|FG003|NOT COMPLETED|Phase I (168 Days)||5
11085954|NCT01147809|12268729|FG004|NOT COMPLETED|Phase I (168 Days)||0
11085955|NCT01147809|12268730|FG005|NOT COMPLETED|Phase I (168 Days)||0
11085956|NCT01147809|12268725|FG000|STARTED|Phase II (168 Days)||0
11085957|NCT01147809|12268726|FG001|STARTED|Phase II (168 Days)||0
11085958|NCT01147809|12268727|FG002|STARTED|Phase II (168 Days)||0
11085959|NCT01147809|12268728|FG003|STARTED|Phase II (168 Days)||0
11085960|NCT01147809|12268729|FG004|STARTED|Phase II (168 Days)||23
11085961|NCT01147809|12268730|FG005|STARTED|Phase II (168 Days)||52
11085962|NCT01147809|12268725|FG000|Ongoing|Phase II (168 Days)||0
11085963|NCT01147809|12268726|FG001|Ongoing|Phase II (168 Days)||0
11085964|NCT01147809|12268727|FG002|Ongoing|Phase II (168 Days)||0
11085965|NCT01147809|12268728|FG003|Ongoing|Phase II (168 Days)||0
11085966|NCT01147809|12268729|FG004|Ongoing|Phase II (168 Days)||1
11085967|NCT01147809|12268730|FG005|Ongoing|Phase II (168 Days)||0
11085968|NCT01147809|12268725|FG000|COMPLETED|Phase II (168 Days)||0
11085969|NCT01147809|12268726|FG001|COMPLETED|Phase II (168 Days)||0
11085970|NCT01147809|12268727|FG002|COMPLETED|Phase II (168 Days)||0
11085971|NCT01147809|12268728|FG003|COMPLETED|Phase II (168 Days)||0
11085972|NCT01147809|12268729|FG004|COMPLETED|Phase II (168 Days)||7
11085973|NCT01147809|12268730|FG005|COMPLETED|Phase II (168 Days)||19
11085974|NCT01147809|12268725|FG000|NOT COMPLETED|Phase II (168 Days)||0
11085975|NCT01147809|12268726|FG001|NOT COMPLETED|Phase II (168 Days)||0
11085976|NCT01147809|12268727|FG002|NOT COMPLETED|Phase II (168 Days)||0
11085977|NCT01147809|12268728|FG003|NOT COMPLETED|Phase II (168 Days)||0
11085978|NCT01147809|12268729|FG004|NOT COMPLETED|Phase II (168 Days)||16
11085979|NCT01147809|12268730|FG005|NOT COMPLETED|Phase II (168 Days)||33
11085980|NCT01147848|12268747|FG000|STARTED|Run-in Period||1564
11085981|NCT01147848|12268748|FG001|STARTED|Run-in Period||0
11085982|NCT01147848|12268749|FG002|STARTED|Run-in Period||0
11085983|NCT01147848|12268747|FG000|COMPLETED|Run-in Period||806
11085984|NCT01147848|12268748|FG001|COMPLETED|Run-in Period||0
11085985|NCT01147848|12268749|FG002|COMPLETED|Run-in Period||0
11207728|NCT01877265|12398832|FG005|NOT COMPLETED|Treatment Period 3||0
11085986|NCT01147848|12268747|FG000|NOT COMPLETED|Run-in Period||758
11085987|NCT01147848|12268748|FG001|NOT COMPLETED|Run-in Period||0
11085988|NCT01147848|12268749|FG002|NOT COMPLETED|Run-in Period||0
11085989|NCT01147848|12268747|FG000|STARTED|Randomized Phase||0
11085990|NCT01147848|12268748|FG001|STARTED|Randomized Phase||403
11085991|NCT01147848|12268749|FG002|STARTED|Randomized Phase||403
11085992|NCT01147848|12268747|FG000|COMPLETED|Randomized Phase||0
11085993|NCT01147848|12268748|FG001|COMPLETED|Randomized Phase||358
11085994|NCT01147848|12268749|FG002|COMPLETED|Randomized Phase||357
11085995|NCT01147848|12268747|FG000|NOT COMPLETED|Randomized Phase||0
11085996|NCT01147848|12268748|FG001|NOT COMPLETED|Randomized Phase||45
11085997|NCT01147848|12268749|FG002|NOT COMPLETED|Randomized Phase||46
11085998|NCT01147874|12268756|FG000|STARTED|Overall Study||1013
11085999|NCT01147874|12268756|FG000|COMPLETED|Overall Study||946
11086000|NCT01147874|12268756|FG000|NOT COMPLETED|Overall Study||67
11086001|NCT01147900|12268763|FG000|STARTED|At Year 8.5||54
11086002|NCT01147900|12268764|FG001|STARTED|At Year 8.5||60
11086003|NCT01147900|12268765|FG002|STARTED|At Year 8.5||66
11086004|NCT01147900|12268763|FG000|COMPLETED|At Year 8.5||54
11086005|NCT01147900|12268764|FG001|COMPLETED|At Year 8.5||60
11086006|NCT01147900|12268765|FG002|COMPLETED|At Year 8.5||66
11086007|NCT01147900|12268763|FG000|NOT COMPLETED|At Year 8.5||0
11086008|NCT01147900|12268764|FG001|NOT COMPLETED|At Year 8.5||0
11086009|NCT01147900|12268765|FG002|NOT COMPLETED|At Year 8.5||0
11086010|NCT01147900|12268763|FG000|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
11086011|NCT01147900|12268764|FG001|STARTED|At Year 10||60
11086012|NCT01147900|12268765|FG002|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
11086013|NCT01147900|12268763|FG000|COMPLETED|At Year 10||55
11086014|NCT01147900|12268764|FG001|COMPLETED|At Year 10||59
11086015|NCT01147900|12268765|FG002|COMPLETED|At Year 10||62
11086016|NCT01147900|12268763|FG000|NOT COMPLETED|At Year 10||0
11086017|NCT01147900|12268764|FG001|NOT COMPLETED|At Year 10||1
11086018|NCT01147900|12268765|FG002|NOT COMPLETED|At Year 10||0
11086019|NCT01147926|12268775|FG000|STARTED|Overall Study||187
11086020|NCT01147926|12268776|FG001|STARTED|Overall Study||187
11086021|NCT01147926|12268775|FG000|COMPLETED|Overall Study||160
11086022|NCT01147926|12268776|FG001|COMPLETED|Overall Study||158
11086023|NCT01147926|12268775|FG000|NOT COMPLETED|Overall Study||27
11086024|NCT01147926|12268776|FG001|NOT COMPLETED|Overall Study||29
11086025|NCT01148017|12268786|FG000|STARTED|Overall Study||214
11086026|NCT01148017|12268787|FG001|STARTED|Overall Study||121
11086027|NCT01148017|12268788|FG002|STARTED|Overall Study||53
11086028|NCT01148017|12268789|FG003|STARTED|Overall Study||45
11086029|NCT01148017|12268786|FG000|COMPLETED|Overall Study||134
11086030|NCT01148017|12268787|FG001|COMPLETED|Overall Study||87
11086031|NCT01148017|12268788|FG002|COMPLETED|Overall Study||53
11086032|NCT01148017|12268789|FG003|COMPLETED|Overall Study||45
11086033|NCT01148017|12268786|FG000|NOT COMPLETED|Overall Study||80
11086034|NCT01148017|12268787|FG001|NOT COMPLETED|Overall Study||34
11086035|NCT01148017|12268788|FG002|NOT COMPLETED|Overall Study||0
11086036|NCT01148017|12268789|FG003|NOT COMPLETED|Overall Study||0
11086037|NCT01148225|12268800|FG000|STARTED|Overall Study||424
11086038|NCT01148225|12268800|FG000|COMPLETED|Overall Study||239
11086039|NCT01148225|12268800|FG000|NOT COMPLETED|Overall Study||185
11086040|NCT01148420|12268807|FG000|STARTED|Overall Study||48
11086041|NCT01148420|12268807|FG000|COMPLETED|Overall Study||48
11086042|NCT01148420|12268807|FG000|NOT COMPLETED|Overall Study||0
11086043|NCT01148459|12268814|FG000|STARTED|Overall Study||99
11086044|NCT01148459|12268815|FG001|STARTED|Overall Study||101
11086045|NCT01148459|12268814|FG000|COMPLETED|Overall Study||87
11086046|NCT01148459|12268815|FG001|COMPLETED|Overall Study||90
11086047|NCT01148459|12268814|FG000|NOT COMPLETED|Overall Study||12
11086048|NCT01148459|12268815|FG001|NOT COMPLETED|Overall Study||11
11086049|NCT01148511|12268823|FG000|STARTED|Exposed to Study Drug||99
11086050|NCT01148511|12268824|FG001|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
11086051|NCT01148511|12268825|FG002|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
11086052|NCT01148511|12268823|FG000|COMPLETED|Exposed to Study Drug||93
11086053|NCT01148511|12268824|FG001|COMPLETED|Exposed to Study Drug||0
11086054|NCT01148511|12268825|FG002|COMPLETED|Exposed to Study Drug||0
11086055|NCT01148511|12268823|FG000|NOT COMPLETED|Exposed to Study Drug||6
11086056|NCT01148511|12268824|FG001|NOT COMPLETED|Exposed to Study Drug||0
11086057|NCT01148511|12268825|FG002|NOT COMPLETED|Exposed to Study Drug||0
11086058|NCT01148511|12268823|FG000|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
11086059|NCT01148511|12268824|FG001|STARTED|Randomized||48
11086060|NCT01148511|12268825|FG002|STARTED|Randomized||45
11086061|NCT01148511|12268823|FG000|COMPLETED|Randomized||0
11086062|NCT01148511|12268824|FG001|COMPLETED|Randomized||38
11086063|NCT01148511|12268825|FG002|COMPLETED|Randomized||39
11086064|NCT01148511|12268823|FG000|NOT COMPLETED|Randomized||0
11086065|NCT01148511|12268824|FG001|NOT COMPLETED|Randomized||10
11086066|NCT01148511|12268825|FG002|NOT COMPLETED|Randomized||6
11086067|NCT01148524|12268841|FG000|STARTED|Overall Study||49
11086068|NCT01148524|12268842|FG001|STARTED|Overall Study||95
11086069|NCT01148524|12268843|FG002|STARTED|Overall Study||53
11086070|NCT01148524|12268844|FG003|STARTED|Overall Study||102
11086071|NCT01148524|12268845|FG004|STARTED|Overall Study||57
11086072|NCT01148524|12268846|FG005|STARTED|Overall Study||106
11086073|NCT01148524|12268847|FG006|STARTED|Overall Study||153
11086074|NCT01148524|12268848|FG007|STARTED|Overall Study||51
11086075|NCT01148524|12268849|FG008|STARTED|Overall Study||151
11086076|NCT01148524|12268841|FG000|COMPLETED|Overall Study||49
11086077|NCT01148524|12268842|FG001|COMPLETED|Overall Study||95
11086078|NCT01148524|12268843|FG002|COMPLETED|Overall Study||53
11086079|NCT01148524|12268844|FG003|COMPLETED|Overall Study||102
11086080|NCT01148524|12268845|FG004|COMPLETED|Overall Study||57
11086081|NCT01148524|12268846|FG005|COMPLETED|Overall Study||106
11086082|NCT01148524|12268847|FG006|COMPLETED|Overall Study||153
11086083|NCT01148524|12268848|FG007|COMPLETED|Overall Study||51
11086084|NCT01148524|12268849|FG008|COMPLETED|Overall Study||151
11086085|NCT01148524|12268841|FG000|NOT COMPLETED|Overall Study||0
11086086|NCT01148524|12268842|FG001|NOT COMPLETED|Overall Study||0
11086087|NCT01148524|12268843|FG002|NOT COMPLETED|Overall Study||0
11086088|NCT01148524|12268844|FG003|NOT COMPLETED|Overall Study||0
11086089|NCT01148524|12268845|FG004|NOT COMPLETED|Overall Study||0
11086090|NCT01148524|12268846|FG005|NOT COMPLETED|Overall Study||0
11086091|NCT01148524|12268847|FG006|NOT COMPLETED|Overall Study||0
11086092|NCT01148524|12268848|FG007|NOT COMPLETED|Overall Study||0
11086093|NCT01148524|12268849|FG008|NOT COMPLETED|Overall Study||0
11086094|NCT01148537|12268872|FG000|STARTED|Overall Study||44
11086095|NCT01148537|12268873|FG001|STARTED|Overall Study||44
11086096|NCT01148537|12268874|FG002|STARTED|Overall Study||44
11086097|NCT01148537|12268872|FG000|COMPLETED|Overall Study||41
11086098|NCT01148537|12268873|FG001|COMPLETED|Overall Study||44
11086099|NCT01148537|12268874|FG002|COMPLETED|Overall Study||41
11086100|NCT01148537|12268872|FG000|NOT COMPLETED|Overall Study||3
11086101|NCT01148537|12268873|FG001|NOT COMPLETED|Overall Study||0
11086102|NCT01148537|12268874|FG002|NOT COMPLETED|Overall Study||3
11086103|NCT01148563|12268885|FG000|STARTED|Overall Study||69
11086104|NCT01148563|12268886|FG001|STARTED|Overall Study||67
11086105|NCT01148563|12268885|FG000|COMPLETED|Overall Study||40
11086106|NCT01148563|12268886|FG001|COMPLETED|Overall Study||37
11086107|NCT01148563|12268885|FG000|NOT COMPLETED|Overall Study||29
11086108|NCT01148563|12268886|FG001|NOT COMPLETED|Overall Study||30
11086109|NCT01148693|12268895|FG000|STARTED|Overall Study||70
11086110|NCT01148693|12268896|FG001|STARTED|Overall Study||67
11086111|NCT01148693|12268895|FG000|COMPLETED|Overall Study||57
11086112|NCT01148693|12268896|FG001|COMPLETED|Overall Study||57
11086113|NCT01148693|12268895|FG000|NOT COMPLETED|Overall Study||13
11086114|NCT01148693|12268896|FG001|NOT COMPLETED|Overall Study||10
11086115|NCT01148745|12268902|FG000|STARTED|Overall Study||15
11086116|NCT01148745|12268902|FG000|COMPLETED|Overall Study||15
11086117|NCT01148745|12268902|FG000|NOT COMPLETED|Overall Study||0
11086118|NCT01148771|12268910|FG000|STARTED|First Intervention||6
11086119|NCT01148771|12268911|FG001|STARTED|First Intervention||6
11086120|NCT01148771|12268910|FG000|COMPLETED|First Intervention||6
11086121|NCT01148771|12268911|FG001|COMPLETED|First Intervention||6
11086122|NCT01148771|12268910|FG000|NOT COMPLETED|First Intervention||0
11086123|NCT01148771|12268911|FG001|NOT COMPLETED|First Intervention||0
11086124|NCT01148771|12268910|FG000|STARTED|Washout Period||6
11086125|NCT01148771|12268911|FG001|STARTED|Washout Period||6
11086126|NCT01148771|12268910|FG000|COMPLETED|Washout Period||6
11086127|NCT01148771|12268911|FG001|COMPLETED|Washout Period||5
11351124|NCT03033134|12548097|FG001|NOT COMPLETED|Overall Study||12
11351125|NCT03033394|12548105|FG000|STARTED|Completed Sampling||65
11086128|NCT01148771|12268910|FG000|NOT COMPLETED|Washout Period||0
11086129|NCT01148771|12268911|FG001|NOT COMPLETED|Washout Period||1
11086130|NCT01148771|12268910|FG000|STARTED|Second Intervention||6
11086131|NCT01148771|12268911|FG001|STARTED|Second Intervention||5
11086132|NCT01148771|12268910|FG000|COMPLETED|Second Intervention||6
11086133|NCT01148771|12268911|FG001|COMPLETED|Second Intervention||5
11086134|NCT01148771|12268910|FG000|NOT COMPLETED|Second Intervention||0
11086135|NCT01148771|12268911|FG001|NOT COMPLETED|Second Intervention||0
11086136|NCT01148810|12268923|FG000|STARTED|Overall Study||8
11086137|NCT01148810|12268924|FG001|STARTED|Overall Study||10
11086138|NCT01148810|12268923|FG000|COMPLETED|Overall Study||7
11086139|NCT01148810|12268924|FG001|COMPLETED|Overall Study||5
11086140|NCT01148810|12268923|FG000|NOT COMPLETED|Overall Study||1
11086141|NCT01148810|12268924|FG001|NOT COMPLETED|Overall Study||5
11086142|NCT01148836|12268933|FG000|STARTED|Overall Study|Enrollment completed|8
11086143|NCT01148836|12268934|FG001|STARTED|Overall Study||10
11086144|NCT01148836|12268933|FG000|COMPLETED|Overall Study|Enrollment completed|7
11086145|NCT01148836|12268934|FG001|COMPLETED|Overall Study||8
11086146|NCT01148836|12268933|FG000|NOT COMPLETED|Overall Study||1
11086147|NCT01148836|12268934|FG001|NOT COMPLETED|Overall Study||2
11086148|NCT01148862|12268940|FG000|STARTED|First Intervention||25
11086149|NCT01148862|12268941|FG001|STARTED|First Intervention||25
11086150|NCT01148862|12268940|FG000|COMPLETED|First Intervention||25
11086151|NCT01148862|12268941|FG001|COMPLETED|First Intervention||25
11086152|NCT01148862|12268940|FG000|NOT COMPLETED|First Intervention||0
11086153|NCT01148862|12268941|FG001|NOT COMPLETED|First Intervention||0
11086154|NCT01148862|12268940|FG000|STARTED|Washout Period of 2 Weeks||25
11086155|NCT01148862|12268941|FG001|STARTED|Washout Period of 2 Weeks||25
11086156|NCT01148862|12268940|FG000|COMPLETED|Washout Period of 2 Weeks||25
11086157|NCT01148862|12268941|FG001|COMPLETED|Washout Period of 2 Weeks||25
11086158|NCT01148862|12268940|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
11086159|NCT01148862|12268941|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
11086160|NCT01148862|12268940|FG000|STARTED|Second Intervention||25
11086161|NCT01148862|12268941|FG001|STARTED|Second Intervention||25
11086162|NCT01148862|12268940|FG000|COMPLETED|Second Intervention||25
11086163|NCT01148862|12268941|FG001|COMPLETED|Second Intervention||23
11086164|NCT01148862|12268940|FG000|NOT COMPLETED|Second Intervention||0
11086165|NCT01148862|12268941|FG001|NOT COMPLETED|Second Intervention||2
11086166|NCT01148940|12268949|FG000|STARTED|Overall Study||7
11086167|NCT01148940|12268950|FG001|STARTED|Overall Study||27
11086168|NCT01148940|12268951|FG002|STARTED|Overall Study||0
11086169|NCT01148940|12268949|FG000|COMPLETED|Overall Study||7
11086170|NCT01148940|12268950|FG001|COMPLETED|Overall Study||27
11086171|NCT01148940|12268951|FG002|COMPLETED|Overall Study||0
11086172|NCT01148940|12268949|FG000|NOT COMPLETED|Overall Study||0
11086173|NCT01148940|12268950|FG001|NOT COMPLETED|Overall Study||0
11351126|NCT03033394|12548105|FG000|COMPLETED|Completed Sampling||65
11086174|NCT01148940|12268951|FG002|NOT COMPLETED|Overall Study||0
11086175|NCT01148979|12268961|FG000|STARTED|Overall Study||13
11086176|NCT01148979|12268962|FG001|STARTED|Overall Study||16
11086177|NCT01148979|12268961|FG000|COMPLETED|Overall Study||13
11086178|NCT01148979|12268962|FG001|COMPLETED|Overall Study||15
11086179|NCT01148979|12268961|FG000|NOT COMPLETED|Overall Study||0
11086180|NCT01148979|12268962|FG001|NOT COMPLETED|Overall Study||1
11086181|NCT01149057|12268968|FG000|STARTED|Overall Study||145
11086182|NCT01149057|12268968|FG000|COMPLETED|Overall Study||88
11086183|NCT01149057|12268968|FG000|NOT COMPLETED|Overall Study||57
11086184|NCT01149096|12268974|FG000|STARTED|Overall Study||6
11086185|NCT01149096|12268975|FG001|STARTED|Overall Study||7
11086186|NCT01149096|12268974|FG000|COMPLETED|Overall Study||6
11086187|NCT01149096|12268975|FG001|COMPLETED|Overall Study||6
11086188|NCT01149096|12268974|FG000|NOT COMPLETED|Overall Study||0
11086189|NCT01149096|12268975|FG001|NOT COMPLETED|Overall Study||1
11086190|NCT01149148|12268984|FG000|STARTED|Overall Study||12
11086191|NCT01149148|12268985|FG001|STARTED|Overall Study||13
11086192|NCT01149148|12268984|FG000|COMPLETED|Overall Study||10
11086193|NCT01149148|12268985|FG001|COMPLETED|Overall Study||11
11086194|NCT01149148|12268984|FG000|NOT COMPLETED|Overall Study||2
11086195|NCT01149148|12268985|FG001|NOT COMPLETED|Overall Study||2
11086196|NCT01149343|12268996|FG000|STARTED|Overall Study||20
11086197|NCT01149343|12268997|FG001|STARTED|Overall Study||24
11086198|NCT01149343|12268998|FG002|STARTED|Overall Study||22
11086199|NCT01149343|12268999|FG003|STARTED|Overall Study||40
11086200|NCT01149343|12268996|FG000|COMPLETED|Overall Study||0
11086201|NCT01149343|12268997|FG001|COMPLETED|Overall Study||0
11086202|NCT01149343|12268998|FG002|COMPLETED|Overall Study||0
11086203|NCT01149343|12268999|FG003|COMPLETED|Overall Study||0
11086204|NCT01149343|12268996|FG000|NOT COMPLETED|Overall Study||20
11086205|NCT01149343|12268997|FG001|NOT COMPLETED|Overall Study||24
11086206|NCT01149343|12268998|FG002|NOT COMPLETED|Overall Study||22
11086207|NCT01149343|12268999|FG003|NOT COMPLETED|Overall Study||40
11086208|NCT01149369|12269015|FG000|STARTED|Overall Study||63
11086209|NCT01149369|12269016|FG001|STARTED|Overall Study||63
11086210|NCT01149369|12269015|FG000|COMPLETED|Overall Study||57
11086211|NCT01149369|12269016|FG001|COMPLETED|Overall Study||60
11086212|NCT01149369|12269015|FG000|NOT COMPLETED|Overall Study||6
11086213|NCT01149369|12269016|FG001|NOT COMPLETED|Overall Study||3
11086214|NCT01149421|12269025|FG000|STARTED|Overall Study||251
11086215|NCT01149421|12269026|FG001|STARTED|Overall Study||254
11086216|NCT01149421|12269027|FG002|STARTED|Overall Study||250
11086217|NCT01149421|12269025|FG000|Received at Least One Dose of Study Drug|Overall Study||251
11086218|NCT01149421|12269026|FG001|Received at Least One Dose of Study Drug|Overall Study||254
11086219|NCT01149421|12269027|FG002|Received at Least One Dose of Study Drug|Overall Study||250
11086220|NCT01149421|12269025|FG000|COMPLETED|Overall Study||199
11086221|NCT01149421|12269026|FG001|COMPLETED|Overall Study||225
11086222|NCT01149421|12269027|FG002|COMPLETED|Overall Study||206
11086223|NCT01149421|12269025|FG000|NOT COMPLETED|Overall Study||52
11086224|NCT01149421|12269026|FG001|NOT COMPLETED|Overall Study||29
11086225|NCT01149421|12269027|FG002|NOT COMPLETED|Overall Study||44
11086226|NCT01149434|12269037|FG000|STARTED|Overall Study||4
11086227|NCT01149434|12269038|FG001|STARTED|Overall Study||15
11086228|NCT01149434|12269037|FG000|COMPLETED|Overall Study||4
11086229|NCT01149434|12269038|FG001|COMPLETED|Overall Study||10
11086230|NCT01149434|12269037|FG000|NOT COMPLETED|Overall Study||0
11086231|NCT01149434|12269038|FG001|NOT COMPLETED|Overall Study||5
11086232|NCT01149460|12269047|FG000|STARTED|Overall Study||18
11086233|NCT01149460|12269048|FG001|STARTED|Overall Study||18
11086234|NCT01149460|12269047|FG000|COMPLETED|Overall Study||18
11086235|NCT01149460|12269048|FG001|COMPLETED|Overall Study||16
11086236|NCT01149460|12269047|FG000|NOT COMPLETED|Overall Study||0
11086237|NCT01149460|12269048|FG001|NOT COMPLETED|Overall Study||2
11086238|NCT01149473|12269056|FG000|STARTED|First Intervention||40
11086239|NCT01149473|12269057|FG001|STARTED|First Intervention||40
11086240|NCT01149473|12269056|FG000|COMPLETED|First Intervention||39
11086241|NCT01149473|12269057|FG001|COMPLETED|First Intervention||39
11086242|NCT01149473|12269056|FG000|NOT COMPLETED|First Intervention||1
11086243|NCT01149473|12269057|FG001|NOT COMPLETED|First Intervention||1
11086244|NCT01149473|12269056|FG000|STARTED|Washout of 7 Days||39
11086245|NCT01149473|12269057|FG001|STARTED|Washout of 7 Days||39
11086246|NCT01149473|12269056|FG000|COMPLETED|Washout of 7 Days||38
11086247|NCT01149473|12269057|FG001|COMPLETED|Washout of 7 Days||38
11086248|NCT01149473|12269056|FG000|NOT COMPLETED|Washout of 7 Days||1
11086249|NCT01149473|12269057|FG001|NOT COMPLETED|Washout of 7 Days||1
11086250|NCT01149473|12269056|FG000|STARTED|Second Intervention||38
11086251|NCT01149473|12269057|FG001|STARTED|Second Intervention||38
11086252|NCT01149473|12269056|FG000|COMPLETED|Second Intervention||38
11086253|NCT01149473|12269057|FG001|COMPLETED|Second Intervention||38
11086254|NCT01149473|12269056|FG000|NOT COMPLETED|Second Intervention||0
11086255|NCT01149473|12269057|FG001|NOT COMPLETED|Second Intervention||0
11086256|NCT01149486|12269065|FG000|STARTED|First Intervention||10
11086257|NCT01149486|12269066|FG001|STARTED|First Intervention||10
11086258|NCT01149486|12269065|FG000|COMPLETED|First Intervention||10
11086259|NCT01149486|12269066|FG001|COMPLETED|First Intervention||9
11086260|NCT01149486|12269065|FG000|NOT COMPLETED|First Intervention||0
11086261|NCT01149486|12269066|FG001|NOT COMPLETED|First Intervention||1
11086262|NCT01149486|12269065|FG000|STARTED|Washout of 7 Days||10
11086263|NCT01149486|12269066|FG001|STARTED|Washout of 7 Days||9
11086264|NCT01149486|12269065|FG000|COMPLETED|Washout of 7 Days||10
11086265|NCT01149486|12269066|FG001|COMPLETED|Washout of 7 Days||9
11086266|NCT01149486|12269065|FG000|NOT COMPLETED|Washout of 7 Days||0
11086267|NCT01149486|12269066|FG001|NOT COMPLETED|Washout of 7 Days||0
11086268|NCT01149486|12269065|FG000|STARTED|Second Intervention||10
11086269|NCT01149486|12269066|FG001|STARTED|Second Intervention||9
11086270|NCT01149486|12269065|FG000|COMPLETED|Second Intervention||10
11086271|NCT01149486|12269066|FG001|COMPLETED|Second Intervention||9
11086272|NCT01149486|12269065|FG000|NOT COMPLETED|Second Intervention||0
11086273|NCT01149486|12269066|FG001|NOT COMPLETED|Second Intervention||0
11086274|NCT01149512|12269072|FG000|STARTED|Overall Study||178
11086275|NCT01149512|12269072|FG000|COMPLETED|Overall Study||178
11086276|NCT01149512|12269072|FG000|NOT COMPLETED|Overall Study||0
11086277|NCT01149538|12269078|FG000|STARTED|Overall Study||31
11086278|NCT01149538|12269079|FG001|STARTED|Overall Study||29
11086279|NCT01149538|12269078|FG000|COMPLETED|Overall Study||26
11086280|NCT01149538|12269079|FG001|COMPLETED|Overall Study||25
11086281|NCT01149538|12269078|FG000|NOT COMPLETED|Overall Study||5
11086282|NCT01149538|12269079|FG001|NOT COMPLETED|Overall Study||4
11086283|NCT01149616|12269087|FG000|STARTED|Overall Study||41
11086284|NCT01149616|12269088|FG001|STARTED|Overall Study||41
11086285|NCT01149616|12269087|FG000|COMPLETED|Overall Study||41
11086286|NCT01149616|12269088|FG001|COMPLETED|Overall Study||41
11086287|NCT01149616|12269087|FG000|NOT COMPLETED|Overall Study||0
11086288|NCT01149616|12269088|FG001|NOT COMPLETED|Overall Study||0
11086289|NCT01149655|12269098|FG000|STARTED|Period 1 - Conversion Phase||186
11086290|NCT01149655|12269099|FG001|STARTED|Period 1 - Conversion Phase||0
11086291|NCT01149655|12269100|FG002|STARTED|Period 1 - Conversion Phase||0
11086292|NCT01149655|12269101|FG003|STARTED|Period 1 - Conversion Phase||0
11086293|NCT01149655|12269098|FG000|COMPLETED|Period 1 - Conversion Phase||168
11086294|NCT01149655|12269099|FG001|COMPLETED|Period 1 - Conversion Phase||0
11086295|NCT01149655|12269100|FG002|COMPLETED|Period 1 - Conversion Phase||0
11086296|NCT01149655|12269101|FG003|COMPLETED|Period 1 - Conversion Phase||0
11086297|NCT01149655|12269098|FG000|NOT COMPLETED|Period 1 - Conversion Phase||18
11086298|NCT01149655|12269099|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0
11086299|NCT01149655|12269100|FG002|NOT COMPLETED|Period 1 - Conversion Phase||0
11086300|NCT01149655|12269101|FG003|NOT COMPLETED|Period 1 - Conversion Phase||0
11086301|NCT01149655|12269098|FG000|STARTED|Period 2-Stabilization Phase||0
11086302|NCT01149655|12269099|FG001|STARTED|Period 2-Stabilization Phase||183
11086303|NCT01149655|12269100|FG002|STARTED|Period 2-Stabilization Phase||0
11086304|NCT01149655|12269101|FG003|STARTED|Period 2-Stabilization Phase||0
11086305|NCT01149655|12269098|FG000|COMPLETED|Period 2-Stabilization Phase||0
11086306|NCT01149655|12269099|FG001|COMPLETED|Period 2-Stabilization Phase||146
11086307|NCT01149655|12269100|FG002|COMPLETED|Period 2-Stabilization Phase||0
11086308|NCT01149655|12269101|FG003|COMPLETED|Period 2-Stabilization Phase||0
11086309|NCT01149655|12269098|FG000|NOT COMPLETED|Period 2-Stabilization Phase||0
11086310|NCT01149655|12269099|FG001|NOT COMPLETED|Period 2-Stabilization Phase||37
11086311|NCT01149655|12269100|FG002|NOT COMPLETED|Period 2-Stabilization Phase||0
11086312|NCT01149655|12269101|FG003|NOT COMPLETED|Period 2-Stabilization Phase||0
11086313|NCT01149655|12269098|FG000|STARTED|Period 3-DB Maintenance Phase||0
11086314|NCT01149655|12269099|FG001|STARTED|Period 3-DB Maintenance Phase||0
11086315|NCT01149655|12269100|FG002|STARTED|Period 3-DB Maintenance Phase||98
11086316|NCT01149655|12269101|FG003|STARTED|Period 3-DB Maintenance Phase||48
11086317|NCT01149655|12269098|FG000|COMPLETED|Period 3-DB Maintenance Phase||0
11086318|NCT01149655|12269099|FG001|COMPLETED|Period 3-DB Maintenance Phase||0
11086319|NCT01149655|12269100|FG002|COMPLETED|Period 3-DB Maintenance Phase||15
11086320|NCT01149655|12269101|FG003|COMPLETED|Period 3-DB Maintenance Phase||6
11086321|NCT01149655|12269098|FG000|NOT COMPLETED|Period 3-DB Maintenance Phase||0
11086322|NCT01149655|12269099|FG001|NOT COMPLETED|Period 3-DB Maintenance Phase||0
11086323|NCT01149655|12269100|FG002|NOT COMPLETED|Period 3-DB Maintenance Phase||83
11086324|NCT01149655|12269101|FG003|NOT COMPLETED|Period 3-DB Maintenance Phase||42
11086325|NCT01149681|12269109|FG000|STARTED|Overall Study||12
11086326|NCT01149681|12269109|FG000|COMPLETED|Overall Study||0
11086327|NCT01149681|12269109|FG000|NOT COMPLETED|Overall Study||12
11086328|NCT01149733|12269116|FG000|STARTED|Overall Study||16
11086329|NCT01149733|12269117|FG001|STARTED|Overall Study||16
11086330|NCT01149733|12269116|FG000|COMPLETED|Overall Study||16
11086331|NCT01149733|12269117|FG001|COMPLETED|Overall Study||16
11086332|NCT01149733|12269116|FG000|NOT COMPLETED|Overall Study||0
11086333|NCT01149733|12269117|FG001|NOT COMPLETED|Overall Study||0
11086334|NCT01149759|12269123|FG000|STARTED|Overall Study||9
11086335|NCT01149759|12269123|FG000|COMPLETED|Overall Study||9
11086336|NCT01149759|12269123|FG000|NOT COMPLETED|Overall Study||0
11086337|NCT01149772|12269129|FG000|STARTED|Overall Study||180
11086338|NCT01149772|12269130|FG001|STARTED|Overall Study||122
11086339|NCT01149772|12269129|FG000|COMPLETED|Overall Study||132
11086340|NCT01149772|12269130|FG001|COMPLETED|Overall Study||101
11086341|NCT01149772|12269129|FG000|NOT COMPLETED|Overall Study||48
11086342|NCT01149772|12269130|FG001|NOT COMPLETED|Overall Study||21
11086343|NCT01149785|12269138|FG000|STARTED|First Intervention||15
11086344|NCT01149785|12269139|FG001|STARTED|First Intervention||0
11086345|NCT01149785|12269138|FG000|COMPLETED|First Intervention||15
11086346|NCT01149785|12269139|FG001|COMPLETED|First Intervention||0
11086347|NCT01149785|12269138|FG000|NOT COMPLETED|First Intervention||0
11086348|NCT01149785|12269139|FG001|NOT COMPLETED|First Intervention||0
11086349|NCT01149785|12269138|FG000|STARTED|Washout Period of at Least 14 Days||15
11086350|NCT01149785|12269139|FG001|STARTED|Washout Period of at Least 14 Days||0
11086351|NCT01149785|12269138|FG000|COMPLETED|Washout Period of at Least 14 Days||15
11086352|NCT01149785|12269139|FG001|COMPLETED|Washout Period of at Least 14 Days||0
11086353|NCT01149785|12269138|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
11086354|NCT01149785|12269139|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0
11086355|NCT01149785|12269138|FG000|STARTED|Second Intervention||0
11086356|NCT01149785|12269139|FG001|STARTED|Second Intervention||15
11086357|NCT01149785|12269138|FG000|COMPLETED|Second Intervention||0
11086358|NCT01149785|12269139|FG001|COMPLETED|Second Intervention||15
11086359|NCT01149785|12269138|FG000|NOT COMPLETED|Second Intervention||0
11086360|NCT01149785|12269139|FG001|NOT COMPLETED|Second Intervention||0
11086361|NCT01149863|12269145|FG000|STARTED|Overall Study||34
11086362|NCT01149863|12269145|FG000|COMPLETED|Overall Study||31
11086363|NCT01149863|12269145|FG000|NOT COMPLETED|Overall Study||3
11086364|NCT01149876|12269153|FG000|STARTED|Overall Study||21
11086365|NCT01149876|12269154|FG001|STARTED|Overall Study||20
11086366|NCT01149876|12269155|FG002|STARTED|Overall Study||21
11086367|NCT01149876|12269156|FG003|STARTED|Overall Study||18
11086368|NCT01149876|12269153|FG000|COMPLETED|Overall Study||20
11351127|NCT03033394|12548105|FG000|NOT COMPLETED|Completed Sampling||0
11351128|NCT03033394|12548105|FG000|STARTED|Completed Pharmacokinetic Analysis||65
11351129|NCT03033394|12548105|FG000|COMPLETED|Completed Pharmacokinetic Analysis||59
11351130|NCT03033394|12548105|FG000|NOT COMPLETED|Completed Pharmacokinetic Analysis||6
11351131|NCT03033394|12548105|FG000|STARTED|Completed Final Analysis||59
11351132|NCT03033394|12548105|FG000|COMPLETED|Completed Final Analysis||58
11351133|NCT03033394|12548105|FG000|NOT COMPLETED|Completed Final Analysis||1
11351134|NCT03033511|12548116|FG000|STARTED|Overall Study||376
11351135|NCT03033511|12548117|FG001|STARTED|Overall Study||372
11351136|NCT03033511|12548116|FG000|COMPLETED|Overall Study||376
11351137|NCT03033511|12548117|FG001|COMPLETED|Overall Study||372
11351138|NCT03033511|12548116|FG000|NOT COMPLETED|Overall Study||0
11351139|NCT03033511|12548117|FG001|NOT COMPLETED|Overall Study||0
11351140|NCT03033745|12548126|FG000|STARTED|Overall Study||15
11351141|NCT03033745|12548127|FG001|STARTED|Overall Study||18
11351142|NCT03033745|12548128|FG002|STARTED|Overall Study||16
11351143|NCT03033745|12548126|FG000|COMPLETED|Overall Study||14
11351144|NCT03033745|12548127|FG001|COMPLETED|Overall Study||17
11351145|NCT03033745|12548128|FG002|COMPLETED|Overall Study||14
11351146|NCT03033745|12548126|FG000|NOT COMPLETED|Overall Study||1
11351147|NCT03033745|12548127|FG001|NOT COMPLETED|Overall Study||1
11351148|NCT03033745|12548128|FG002|NOT COMPLETED|Overall Study||2
11351149|NCT03033784|12548145|FG000|STARTED|Overall Study||9
11351150|NCT03033784|12548146|FG001|STARTED|Overall Study||2
11351151|NCT03033784|12548147|FG002|STARTED|Overall Study||4
11351152|NCT03033784|12548148|FG003|STARTED|Overall Study||4
11351153|NCT03033784|12548149|FG004|STARTED|Overall Study||3
11351154|NCT03033784|12548150|FG005|STARTED|Overall Study||2
11351155|NCT03033784|12548151|FG006|STARTED|Overall Study||2
11351156|NCT03033784|12548152|FG007|STARTED|Overall Study||2
11351157|NCT03033784|12548153|FG008|STARTED|Overall Study||1
11351158|NCT03033784|12548154|FG009|STARTED|Overall Study||1
11351159|NCT03033784|12548155|FG010|STARTED|Overall Study||1
11351160|NCT03033784|12548156|FG011|STARTED|Overall Study||1
11351161|NCT03033784|12548157|FG012|STARTED|Overall Study||19
11351162|NCT03033784|12548145|FG000|Clinical Visit 2|Overall Study||9
11086369|NCT01149876|12269154|FG001|COMPLETED|Overall Study||20
11086370|NCT01149876|12269155|FG002|COMPLETED|Overall Study||20
11086371|NCT01149876|12269156|FG003|COMPLETED|Overall Study||18
11086372|NCT01149876|12269153|FG000|NOT COMPLETED|Overall Study||1
11086373|NCT01149876|12269154|FG001|NOT COMPLETED|Overall Study||0
11086374|NCT01149876|12269155|FG002|NOT COMPLETED|Overall Study||1
11086375|NCT01149876|12269156|FG003|NOT COMPLETED|Overall Study||0
11086376|NCT01150097|12269170|FG000|STARTED|Months 24 to 36 Post-transplantation||106
11086377|NCT01150097|12269171|FG001|STARTED|Months 24 to 36 Post-transplantation||51
11086378|NCT01150097|12269172|FG002|STARTED|Months 24 to 36 Post-transplantation||125
11086379|NCT01150097|12269170|FG000|COMPLETED|Months 24 to 36 Post-transplantation||96
11086380|NCT01150097|12269171|FG001|COMPLETED|Months 24 to 36 Post-transplantation||49
11086381|NCT01150097|12269172|FG002|COMPLETED|Months 24 to 36 Post-transplantation||117
11086382|NCT01150097|12269170|FG000|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
11086383|NCT01150097|12269171|FG001|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
11086384|NCT01150097|12269172|FG002|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
11086385|NCT01150097|12269170|FG000|STARTED|Months 24 to 48 Post-transplantation||106
11086386|NCT01150097|12269171|FG001|STARTED|Months 24 to 48 Post-transplantation||51
11086387|NCT01150097|12269172|FG002|STARTED|Months 24 to 48 Post-transplantation||0
11086388|NCT01150097|12269170|FG000|COMPLETED|Months 24 to 48 Post-transplantation||95
11086389|NCT01150097|12269171|FG001|COMPLETED|Months 24 to 48 Post-transplantation||47
11351163|NCT03033784|12548146|FG001|Clinical Visit 2|Overall Study||2
11351164|NCT03033784|12548147|FG002|Clinical Visit 2|Overall Study||4
11351165|NCT03033784|12548148|FG003|Clinical Visit 2|Overall Study||4
11086390|NCT01150097|12269172|FG002|COMPLETED|Months 24 to 48 Post-transplantation||0
11086391|NCT01150097|12269170|FG000|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
11086392|NCT01150097|12269171|FG001|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
11086393|NCT01150097|12269172|FG002|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
11086394|NCT01150123|12269200|FG000|STARTED|Overall Study||40
11086395|NCT01150123|12269201|FG001|STARTED|Overall Study||40
11086396|NCT01150123|12269202|FG002|STARTED|Overall Study||39
11086397|NCT01150123|12269203|FG003|STARTED|Overall Study||40
11086398|NCT01150123|12269204|FG004|STARTED|Overall Study||40
11086399|NCT01150123|12269205|FG005|STARTED|Overall Study||40
11086400|NCT01150123|12269206|FG006|STARTED|Overall Study||39
11086401|NCT01150123|12269207|FG007|STARTED|Overall Study||40
11086402|NCT01150123|12269208|FG008|STARTED|Overall Study||20
11086403|NCT01150123|12269209|FG009|STARTED|Overall Study||40
11086404|NCT01150123|12269210|FG010|STARTED|Overall Study||40
11086405|NCT01150123|12269211|FG011|STARTED|Overall Study||40
11086406|NCT01150123|12269212|FG012|STARTED|Overall Study||40
11086407|NCT01150123|12269213|FG013|STARTED|Overall Study||40
11086408|NCT01150123|12269214|FG014|STARTED|Overall Study||40
11086409|NCT01150123|12269215|FG015|STARTED|Overall Study||40
11086410|NCT01150123|12269216|FG016|STARTED|Overall Study||40
11086411|NCT01150123|12269217|FG017|STARTED|Overall Study||20
11086412|NCT01150123|12269200|FG000|COMPLETED|Overall Study||37
11086413|NCT01150123|12269201|FG001|COMPLETED|Overall Study||38
11086414|NCT01150123|12269202|FG002|COMPLETED|Overall Study||35
11086415|NCT01150123|12269203|FG003|COMPLETED|Overall Study||37
11086416|NCT01150123|12269204|FG004|COMPLETED|Overall Study||37
11086417|NCT01150123|12269205|FG005|COMPLETED|Overall Study||34
11086418|NCT01150123|12269206|FG006|COMPLETED|Overall Study||39
11086419|NCT01150123|12269207|FG007|COMPLETED|Overall Study||37
11086420|NCT01150123|12269208|FG008|COMPLETED|Overall Study||15
11086421|NCT01150123|12269209|FG009|COMPLETED|Overall Study||39
11086422|NCT01150123|12269210|FG010|COMPLETED|Overall Study||38
11086423|NCT01150123|12269211|FG011|COMPLETED|Overall Study||39
11086424|NCT01150123|12269212|FG012|COMPLETED|Overall Study||37
11086425|NCT01150123|12269213|FG013|COMPLETED|Overall Study||40
11086426|NCT01150123|12269214|FG014|COMPLETED|Overall Study||40
11086427|NCT01150123|12269215|FG015|COMPLETED|Overall Study||39
11086428|NCT01150123|12269216|FG016|COMPLETED|Overall Study||40
11086429|NCT01150123|12269217|FG017|COMPLETED|Overall Study||19
11086430|NCT01150123|12269200|FG000|NOT COMPLETED|Overall Study||3
11086431|NCT01150123|12269201|FG001|NOT COMPLETED|Overall Study||2
11086432|NCT01150123|12269202|FG002|NOT COMPLETED|Overall Study||4
11086433|NCT01150123|12269203|FG003|NOT COMPLETED|Overall Study||3
11086434|NCT01150123|12269204|FG004|NOT COMPLETED|Overall Study||3
11086435|NCT01150123|12269205|FG005|NOT COMPLETED|Overall Study||6
11351166|NCT03033784|12548149|FG004|Clinical Visit 2|Overall Study||3
11351167|NCT03033784|12548150|FG005|Clinical Visit 2|Overall Study||2
11351168|NCT03033784|12548151|FG006|Clinical Visit 2|Overall Study||2
11351169|NCT03033784|12548152|FG007|Clinical Visit 2|Overall Study||2
11086436|NCT01150123|12269206|FG006|NOT COMPLETED|Overall Study||0
11086437|NCT01150123|12269207|FG007|NOT COMPLETED|Overall Study||3
11086438|NCT01150123|12269208|FG008|NOT COMPLETED|Overall Study||5
11086439|NCT01150123|12269209|FG009|NOT COMPLETED|Overall Study||1
11086440|NCT01150123|12269210|FG010|NOT COMPLETED|Overall Study||2
11086441|NCT01150123|12269211|FG011|NOT COMPLETED|Overall Study||1
11086442|NCT01150123|12269212|FG012|NOT COMPLETED|Overall Study||3
11086443|NCT01150123|12269213|FG013|NOT COMPLETED|Overall Study||0
11086444|NCT01150123|12269214|FG014|NOT COMPLETED|Overall Study||0
11086445|NCT01150123|12269215|FG015|NOT COMPLETED|Overall Study||1
11086446|NCT01150123|12269216|FG016|NOT COMPLETED|Overall Study||0
11086447|NCT01150123|12269217|FG017|NOT COMPLETED|Overall Study||1
11086448|NCT01150357|12269277|FG000|STARTED|Dose Response Phase (Phase 1)||108
11086449|NCT01150357|12269278|FG001|STARTED|Dose Response Phase (Phase 1)||54
11207729|NCT01877278|12398845|FG000|STARTED|Overall Study||33
11207730|NCT01877278|12398846|FG001|STARTED|Overall Study||33
11207731|NCT01877278|12398845|FG000|COMPLETED|Overall Study||30
11207732|NCT01877278|12398846|FG001|COMPLETED|Overall Study||30
11086450|NCT01150357|12269279|FG002|STARTED|Dose Response Phase (Phase 1)||105
11086451|NCT01150357|12269277|FG000|COMPLETED|Dose Response Phase (Phase 1)||107
11086452|NCT01150357|12269278|FG001|COMPLETED|Dose Response Phase (Phase 1)||51
11086453|NCT01150357|12269279|FG002|COMPLETED|Dose Response Phase (Phase 1)||102
11086454|NCT01150357|12269277|FG000|NOT COMPLETED|Dose Response Phase (Phase 1)||1
11086455|NCT01150357|12269278|FG001|NOT COMPLETED|Dose Response Phase (Phase 1)||3
11086456|NCT01150357|12269279|FG002|NOT COMPLETED|Dose Response Phase (Phase 1)||3
11086457|NCT01150357|12269277|FG000|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
11086458|NCT01150357|12269278|FG001|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
11086459|NCT01150357|12269279|FG002|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
11086460|NCT01150357|12269277|FG000|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
11086461|NCT01150357|12269278|FG001|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
11086462|NCT01150357|12269279|FG002|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
11086463|NCT01150357|12269277|FG000|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
11086464|NCT01150357|12269278|FG001|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
11086465|NCT01150357|12269279|FG002|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
11086466|NCT01150357|12269277|FG000|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
11086467|NCT01150357|12269278|FG001|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
11086468|NCT01150357|12269279|FG002|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
11086469|NCT01150357|12269277|FG000|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
11086470|NCT01150357|12269278|FG001|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
11086471|NCT01150357|12269279|FG002|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
11086472|NCT01150357|12269277|FG000|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
11086473|NCT01150357|12269278|FG001|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
11086474|NCT01150357|12269279|FG002|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
11086475|NCT01150357|12269277|FG000|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
11351170|NCT03033784|12548153|FG008|Clinical Visit 2|Overall Study||1
11351171|NCT03033784|12548154|FG009|Clinical Visit 2|Overall Study||1
11351172|NCT03033784|12548155|FG010|Clinical Visit 2|Overall Study||1
11086476|NCT01150357|12269278|FG001|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
11086477|NCT01150357|12269279|FG002|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
11086478|NCT01150461|12269301|FG000|STARTED|Overall Study||11
11086479|NCT01150461|12269302|FG001|STARTED|Overall Study||9
11086480|NCT01150461|12269301|FG000|COMPLETED|Overall Study||11
11086481|NCT01150461|12269302|FG001|COMPLETED|Overall Study||9
11086482|NCT01150461|12269301|FG000|NOT COMPLETED|Overall Study||0
11086483|NCT01150461|12269302|FG001|NOT COMPLETED|Overall Study||0
11086484|NCT01150474|12269310|FG000|STARTED|Overall Study||51
11086485|NCT01150474|12269311|FG001|STARTED|Overall Study||52
11086486|NCT01150474|12269310|FG000|COMPLETED|Overall Study||41
11086487|NCT01150474|12269311|FG001|COMPLETED|Overall Study||49
11086488|NCT01150474|12269310|FG000|NOT COMPLETED|Overall Study||10
11086489|NCT01150474|12269311|FG001|NOT COMPLETED|Overall Study||3
11086490|NCT01150500|12269317|FG000|STARTED|Overall Study||65
11086491|NCT01150500|12269317|FG000|COMPLETED|Overall Study||0
11086492|NCT01150500|12269317|FG000|NOT COMPLETED|Overall Study||65
11086493|NCT01150760|12269323|FG000|STARTED|Overall Study||3525
11086494|NCT01150760|12269324|FG001|STARTED|Overall Study||3525
11086495|NCT01150760|12269323|FG000|COMPLETED|Overall Study||3525
11086496|NCT01150760|12269324|FG001|COMPLETED|Overall Study||3525
11086497|NCT01150760|12269323|FG000|NOT COMPLETED|Overall Study||0
11086498|NCT01150760|12269324|FG001|NOT COMPLETED|Overall Study||0
11086499|NCT01150838|12269335|FG000|STARTED|Overall Study||19
11086500|NCT01150838|12269336|FG001|STARTED|Overall Study||26
11086501|NCT01150838|12269337|FG002|STARTED|Overall Study||24
11086502|NCT01150838|12269338|FG003|STARTED|Overall Study||15
11086503|NCT01150838|12269339|FG004|STARTED|Overall Study||16
11086504|NCT01150838|12269340|FG005|STARTED|Overall Study||2
11086505|NCT01150838|12269335|FG000|COMPLETED|Overall Study||19
11086506|NCT01150838|12269336|FG001|COMPLETED|Overall Study||26
11086507|NCT01150838|12269337|FG002|COMPLETED|Overall Study||24
11086508|NCT01150838|12269338|FG003|COMPLETED|Overall Study||15
11086509|NCT01150838|12269339|FG004|COMPLETED|Overall Study||16
11086510|NCT01150838|12269340|FG005|COMPLETED|Overall Study||2
11086511|NCT01150838|12269335|FG000|NOT COMPLETED|Overall Study||0
11086512|NCT01150838|12269336|FG001|NOT COMPLETED|Overall Study||0
11086513|NCT01150838|12269337|FG002|NOT COMPLETED|Overall Study||0
11086514|NCT01150838|12269338|FG003|NOT COMPLETED|Overall Study||0
11086515|NCT01150838|12269339|FG004|NOT COMPLETED|Overall Study||0
11086516|NCT01150838|12269340|FG005|NOT COMPLETED|Overall Study||0
11086517|NCT01150903|12269350|FG000|STARTED|Overall Study||24708
11086518|NCT01150903|12269351|FG001|STARTED|Overall Study||74124
11086519|NCT01150903|12269350|FG000|COMPLETED|Overall Study||24708
11086520|NCT01150903|12269351|FG001|COMPLETED|Overall Study||74124
11086521|NCT01150903|12269350|FG000|NOT COMPLETED|Overall Study||0
11086522|NCT01150903|12269351|FG001|NOT COMPLETED|Overall Study||0
11086523|NCT01150981|12269359|FG000|STARTED|Overall Study||20
11086524|NCT01150981|12269360|FG001|STARTED|Overall Study||15
11086525|NCT01150981|12269359|FG000|COMPLETED|Overall Study||16
11086526|NCT01150981|12269360|FG001|COMPLETED|Overall Study||13
11086527|NCT01150981|12269359|FG000|NOT COMPLETED|Overall Study||4
11086528|NCT01150981|12269360|FG001|NOT COMPLETED|Overall Study||2
11086529|NCT01151020|12269366|FG000|STARTED|Overall Study||110
11086530|NCT01151020|12269366|FG000|30-day|Overall Study||110
11086531|NCT01151020|12269366|FG000|COMPLETED|Overall Study||56
11086532|NCT01151020|12269366|FG000|NOT COMPLETED|Overall Study||54
11086533|NCT01151046|12269372|FG000|STARTED|Overall Study||59
11086534|NCT01151046|12269373|FG001|STARTED|Overall Study||59
11086535|NCT01151046|12269372|FG000|COMPLETED|Overall Study||56
11086536|NCT01151046|12269373|FG001|COMPLETED|Overall Study||59
11086537|NCT01151046|12269372|FG000|NOT COMPLETED|Overall Study||3
11086538|NCT01151046|12269373|FG001|NOT COMPLETED|Overall Study||0
11351173|NCT03033784|12548156|FG011|Clinical Visit 2|Overall Study||1
11351174|NCT03033784|12548157|FG012|Clinical Visit 2|Overall Study||17
11351175|NCT03033784|12548145|FG000|Clinical Visit 3|Overall Study||9
11351176|NCT03033784|12548146|FG001|Clinical Visit 3|Overall Study||1
11351177|NCT03033784|12548147|FG002|Clinical Visit 3|Overall Study||4
11351178|NCT03033784|12548148|FG003|Clinical Visit 3|Overall Study||4
11351179|NCT03033784|12548149|FG004|Clinical Visit 3|Overall Study||3
11351180|NCT03033784|12548150|FG005|Clinical Visit 3|Overall Study||2
11351181|NCT03033784|12548151|FG006|Clinical Visit 3|Overall Study||2
11351182|NCT03033784|12548152|FG007|Clinical Visit 3|Overall Study||2
11351183|NCT03033784|12548153|FG008|Clinical Visit 3|Overall Study||1
11351184|NCT03033784|12548154|FG009|Clinical Visit 3|Overall Study||1
11351185|NCT03033784|12548155|FG010|Clinical Visit 3|Overall Study||1
11351186|NCT03033784|12548156|FG011|Clinical Visit 3|Overall Study||1
11351187|NCT03033784|12548157|FG012|Clinical Visit 3|Overall Study||0
11351188|NCT03033784|12548145|FG000|Clinical Visit 4|Overall Study||9
11351189|NCT03033784|12548146|FG001|Clinical Visit 4|Overall Study||1
11351190|NCT03033784|12548147|FG002|Clinical Visit 4|Overall Study||4
11351191|NCT03033784|12548148|FG003|Clinical Visit 4|Overall Study||4
11351192|NCT03033784|12548149|FG004|Clinical Visit 4|Overall Study||3
11351193|NCT03033784|12548150|FG005|Clinical Visit 4|Overall Study||2
11351194|NCT03033784|12548151|FG006|Clinical Visit 4|Overall Study||2
11351195|NCT03033784|12548152|FG007|Clinical Visit 4|Overall Study||2
11351196|NCT03033784|12548153|FG008|Clinical Visit 4|Overall Study||1
11351197|NCT03033784|12548154|FG009|Clinical Visit 4|Overall Study||1
11351198|NCT03033784|12548155|FG010|Clinical Visit 4|Overall Study||1
11351199|NCT03033784|12548156|FG011|Clinical Visit 4|Overall Study||1
11351200|NCT03033784|12548157|FG012|Clinical Visit 4|Overall Study||0
11351201|NCT03033784|12548145|FG000|COMPLETED|Overall Study||9
11351202|NCT03033784|12548146|FG001|COMPLETED|Overall Study||1
11351203|NCT03033784|12548147|FG002|COMPLETED|Overall Study||4
11351204|NCT03033784|12548148|FG003|COMPLETED|Overall Study||4
11351205|NCT03033784|12548149|FG004|COMPLETED|Overall Study||3
11351206|NCT03033784|12548150|FG005|COMPLETED|Overall Study||2
11351207|NCT03033784|12548151|FG006|COMPLETED|Overall Study||2
11086539|NCT01151085|12269383|FG000|STARTED|Overall Study||1002
11086540|NCT01151085|12269383|FG000|COMPLETED|Overall Study||946
11086541|NCT01151085|12269383|FG000|NOT COMPLETED|Overall Study||56
11086542|NCT01151098|12269394|FG000|STARTED|Overall Study|Extension Safety Population|189
11086543|NCT01151098|12269394|FG000|COMPLETED|Overall Study||72
11086544|NCT01151098|12269394|FG000|NOT COMPLETED|Overall Study||117
11086545|NCT01151137|12269400|FG000|STARTED|Overall Study||1617
11351208|NCT03033784|12548152|FG007|COMPLETED|Overall Study||2
11351209|NCT03033784|12548153|FG008|COMPLETED|Overall Study||1
11351210|NCT03033784|12548154|FG009|COMPLETED|Overall Study||1
11351211|NCT03033784|12548155|FG010|COMPLETED|Overall Study||1
11086546|NCT01151137|12269401|FG001|STARTED|Overall Study||1619
11086547|NCT01151137|12269400|FG000|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
11086548|NCT01151137|12269401|FG001|Treated|Overall Study||1613
11086549|NCT01151137|12269400|FG000|Discontinued Treatment|Overall Study||171
11086550|NCT01151137|12269401|FG001|Discontinued Treatment|Overall Study||342
11086551|NCT01151137|12269400|FG000|COMPLETED|Overall Study||1601
11351212|NCT03033784|12548156|FG011|COMPLETED|Overall Study||1
11351213|NCT03033784|12548157|FG012|COMPLETED|Overall Study||17
11351214|NCT03033784|12548145|FG000|NOT COMPLETED|Overall Study||0
11351215|NCT03033784|12548146|FG001|NOT COMPLETED|Overall Study||1
11351216|NCT03033784|12548147|FG002|NOT COMPLETED|Overall Study||0
11086552|NCT01151137|12269401|FG001|COMPLETED|Overall Study||1591
11086553|NCT01151137|12269400|FG000|NOT COMPLETED|Overall Study||16
11086554|NCT01151137|12269401|FG001|NOT COMPLETED|Overall Study||28
11086555|NCT01151189|12269409|FG000|STARTED|Overall Study||326
11086556|NCT01151189|12269410|FG001|STARTED|Overall Study||324
11086557|NCT01151189|12269409|FG000|Received Vaccine|Overall Study||325
11086558|NCT01151189|12269410|FG001|Received Vaccine|Overall Study||324
11086559|NCT01151189|12269409|FG000|COMPLETED|Overall Study||311
11086560|NCT01151189|12269410|FG001|COMPLETED|Overall Study||314
11086561|NCT01151189|12269409|FG000|NOT COMPLETED|Overall Study||15
11086562|NCT01151189|12269410|FG001|NOT COMPLETED|Overall Study||10
11086563|NCT01151215|12269419|FG000|STARTED|Overall Study||120
11086564|NCT01151215|12269420|FG001|STARTED|Overall Study||118
11086565|NCT01151215|12269421|FG002|STARTED|Overall Study||121
11086566|NCT01151215|12269419|FG000|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
11086567|NCT01151215|12269420|FG001|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
11086568|NCT01151215|12269421|FG002|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
11086569|NCT01151215|12269419|FG000|NOT COMPLETED|Overall Study||20
11086570|NCT01151215|12269420|FG001|NOT COMPLETED|Overall Study||23
11086571|NCT01151215|12269421|FG002|NOT COMPLETED|Overall Study||19
11086572|NCT01151280|12269429|FG000|STARTED|Overall Study||10
11086573|NCT01151280|12269429|FG000|COMPLETED|Overall Study||6
11086574|NCT01151280|12269429|FG000|NOT COMPLETED|Overall Study||4
11086575|NCT01151345|12269433|FG000|STARTED|First Intervention Period||13
11086576|NCT01151345|12269434|FG001|STARTED|First Intervention Period||13
11086577|NCT01151345|12269433|FG000|Treated|First Intervention Period||13
11086578|NCT01151345|12269434|FG001|Treated|First Intervention Period||12
11086579|NCT01151345|12269433|FG000|COMPLETED|First Intervention Period||13
11086580|NCT01151345|12269434|FG001|COMPLETED|First Intervention Period||12
11086581|NCT01151345|12269433|FG000|NOT COMPLETED|First Intervention Period||0
11086582|NCT01151345|12269434|FG001|NOT COMPLETED|First Intervention Period||1
11086583|NCT01151345|12269433|FG000|STARTED|Wash-out Period (7 Days)||13
11351217|NCT03033784|12548148|FG003|NOT COMPLETED|Overall Study||0
11351218|NCT03033784|12548149|FG004|NOT COMPLETED|Overall Study||0
11351219|NCT03033784|12548150|FG005|NOT COMPLETED|Overall Study||0
11086584|NCT01151345|12269434|FG001|STARTED|Wash-out Period (7 Days)||12
11086585|NCT01151345|12269433|FG000|COMPLETED|Wash-out Period (7 Days)||13
11086586|NCT01151345|12269434|FG001|COMPLETED|Wash-out Period (7 Days)||12
11086587|NCT01151345|12269433|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0
11086588|NCT01151345|12269434|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0
11086589|NCT01151345|12269433|FG000|STARTED|Second Intervention Period||13
11086590|NCT01151345|12269434|FG001|STARTED|Second Intervention Period||12
11086591|NCT01151345|12269433|FG000|COMPLETED|Second Intervention Period||13
11086592|NCT01151345|12269434|FG001|COMPLETED|Second Intervention Period||12
11086593|NCT01151345|12269433|FG000|NOT COMPLETED|Second Intervention Period||0
11086594|NCT01151345|12269434|FG001|NOT COMPLETED|Second Intervention Period||0
11086595|NCT01151371|12269443|FG000|STARTED|Overall Study||149
11086596|NCT01151371|12269444|FG001|STARTED|Overall Study||150
11086597|NCT01151371|12269445|FG002|STARTED|Overall Study||153
11086598|NCT01151371|12269443|FG000|COMPLETED|Overall Study||144
11086599|NCT01151371|12269444|FG001|COMPLETED|Overall Study||149
11086600|NCT01151371|12269445|FG002|COMPLETED|Overall Study||146
11086601|NCT01151371|12269443|FG000|NOT COMPLETED|Overall Study||5
11086602|NCT01151371|12269444|FG001|NOT COMPLETED|Overall Study||1
11086603|NCT01151371|12269445|FG002|NOT COMPLETED|Overall Study||7
11086604|NCT01151410|12269455|FG000|STARTED|Overall Study||104
11086605|NCT01151410|12269456|FG001|STARTED|Overall Study||104
11086606|NCT01151410|12269455|FG000|Safety Set (SAF)|Overall Study||105
11351220|NCT03033784|12548151|FG006|NOT COMPLETED|Overall Study||0
11086607|NCT01151410|12269456|FG001|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
11086608|NCT01151410|12269455|FG000|COMPLETED|Overall Study||93
11086609|NCT01151410|12269456|FG001|COMPLETED|Overall Study||89
11086610|NCT01151410|12269455|FG000|NOT COMPLETED|Overall Study||11
11086611|NCT01151410|12269456|FG001|NOT COMPLETED|Overall Study||15
11086612|NCT01151423|12269464|FG000|STARTED|Overall Study||36
11086613|NCT01151423|12269465|FG001|STARTED|Overall Study||39
11086614|NCT01151423|12269464|FG000|Received Study Drug|Overall Study||35
11086615|NCT01151423|12269465|FG001|Received Study Drug|Overall Study||37
11086616|NCT01151423|12269464|FG000|COMPLETED|Overall Study||20
11086617|NCT01151423|12269465|FG001|COMPLETED|Overall Study||21
11086618|NCT01151423|12269464|FG000|NOT COMPLETED|Overall Study||16
11086619|NCT01151423|12269465|FG001|NOT COMPLETED|Overall Study||18
11086620|NCT01151436|12269471|FG000|STARTED|Overall Study||77
11086621|NCT01151436|12269471|FG000|COMPLETED|Overall Study||76
11086622|NCT01151436|12269471|FG000|NOT COMPLETED|Overall Study||1
11086623|NCT01151449|12269475|FG000|STARTED|Overall Study||6
11086624|NCT01151449|12269475|FG000|COMPLETED|Overall Study||6
11086625|NCT01151449|12269475|FG000|NOT COMPLETED|Overall Study||0
11086626|NCT01151540|12269479|FG000|STARTED|Overall Study||54
11086627|NCT01151540|12269479|FG000|COMPLETED|Overall Study||41
11086628|NCT01151540|12269479|FG000|NOT COMPLETED|Overall Study||13
11086629|NCT01151579|12269485|FG000|STARTED|Overall Study||58
11086630|NCT01151579|12269486|FG001|STARTED|Overall Study||31
11086631|NCT01151579|12269485|FG000|COMPLETED|Overall Study||46
11086632|NCT01151579|12269486|FG001|COMPLETED|Overall Study||24
11086633|NCT01151579|12269485|FG000|NOT COMPLETED|Overall Study||12
11086634|NCT01151579|12269486|FG001|NOT COMPLETED|Overall Study||7
11086635|NCT01151618|12269492|FG000|STARTED|Overall Study||22
11086636|NCT01151618|12269492|FG000|COMPLETED|Overall Study||13
11086637|NCT01151618|12269492|FG000|NOT COMPLETED|Overall Study||9
11086638|NCT01151761|12269496|FG000|STARTED|Overall Study||2
11086639|NCT01151761|12269496|FG000|COMPLETED|Overall Study||2
11086640|NCT01151761|12269496|FG000|NOT COMPLETED|Overall Study||0
11086641|NCT01151813|12269500|FG000|STARTED|Period 1||8
11086642|NCT01151813|12269501|FG001|STARTED|Period 1||7
11086643|NCT01151813|12269500|FG000|COMPLETED|Period 1||8
11086644|NCT01151813|12269501|FG001|COMPLETED|Period 1||7
11086645|NCT01151813|12269500|FG000|NOT COMPLETED|Period 1||0
11086646|NCT01151813|12269501|FG001|NOT COMPLETED|Period 1||0
11086647|NCT01151813|12269500|FG000|STARTED|Period 2||8
11351221|NCT03033784|12548152|FG007|NOT COMPLETED|Overall Study||0
11086648|NCT01151813|12269501|FG001|STARTED|Period 2||7
11086649|NCT01151813|12269500|FG000|COMPLETED|Period 2||8
11086650|NCT01151813|12269501|FG001|COMPLETED|Period 2||7
11086651|NCT01151813|12269500|FG000|NOT COMPLETED|Period 2||0
11086652|NCT01151813|12269501|FG001|NOT COMPLETED|Period 2||0
11086653|NCT01151852|12269510|FG000|STARTED|Overall Study||41
11086654|NCT01151852|12269511|FG001|STARTED|Overall Study||40
11086655|NCT01151852|12269510|FG000|COMPLETED|Overall Study||41
11086656|NCT01151852|12269511|FG001|COMPLETED|Overall Study||40
11086657|NCT01151852|12269510|FG000|NOT COMPLETED|Overall Study||0
11086658|NCT01151852|12269511|FG001|NOT COMPLETED|Overall Study||0
11086659|NCT01152021|12269519|FG000|STARTED|Overall Study||8
11086660|NCT01152021|12269520|FG001|STARTED|Overall Study||7
11086661|NCT01152021|12269519|FG000|COMPLETED|Overall Study||2
11086662|NCT01152021|12269520|FG001|COMPLETED|Overall Study||1
11086663|NCT01152021|12269519|FG000|NOT COMPLETED|Overall Study||6
11086664|NCT01152021|12269520|FG001|NOT COMPLETED|Overall Study||6
11086665|NCT01152112|12269530|FG000|STARTED|Overall Study||42
11086666|NCT01152112|12269531|FG001|STARTED|Overall Study||32
11086667|NCT01152112|12269530|FG000|COMPLETED|Overall Study||42
11086668|NCT01152112|12269531|FG001|COMPLETED|Overall Study||32
11086669|NCT01152112|12269530|FG000|NOT COMPLETED|Overall Study||0
11086670|NCT01152112|12269531|FG001|NOT COMPLETED|Overall Study||0
11086671|NCT01152190|12269539|FG000|STARTED|Overall Study||50
11086672|NCT01152190|12269540|FG001|STARTED|Overall Study||47
11086673|NCT01152190|12269539|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
11086674|NCT01152190|12269540|FG001|Received at Least 1 Dose of Study Drug|Overall Study||47
11086675|NCT01152190|12269539|FG000|COMPLETED|Overall Study||45
11086676|NCT01152190|12269540|FG001|COMPLETED|Overall Study||39
11086677|NCT01152190|12269539|FG000|NOT COMPLETED|Overall Study||5
11086678|NCT01152190|12269540|FG001|NOT COMPLETED|Overall Study||8
11086679|NCT01152294|12269548|FG000|STARTED|Overall Study||213
11086680|NCT01152294|12269549|FG001|STARTED|Overall Study||188
11086681|NCT01152294|12269548|FG000|COMPLETED|Overall Study||213
11086682|NCT01152294|12269549|FG001|COMPLETED|Overall Study||188
11086683|NCT01152294|12269548|FG000|NOT COMPLETED|Overall Study||0
11086684|NCT01152294|12269549|FG001|NOT COMPLETED|Overall Study||0
11086685|NCT01152307|12269557|FG000|STARTED|Overall Study||191
11086686|NCT01152307|12269558|FG001|STARTED|Overall Study||214
11086687|NCT01152307|12269557|FG000|COMPLETED|Overall Study||191
11086688|NCT01152307|12269558|FG001|COMPLETED|Overall Study||214
11086689|NCT01152307|12269557|FG000|NOT COMPLETED|Overall Study||0
11086690|NCT01152307|12269558|FG001|NOT COMPLETED|Overall Study||0
11086691|NCT01152359|12269566|FG000|STARTED|Overall Study||105
11086692|NCT01152359|12269567|FG001|STARTED|Overall Study||102
11086693|NCT01152359|12269566|FG000|COMPLETED|Overall Study||81
11086694|NCT01152359|12269567|FG001|COMPLETED|Overall Study||80
11086695|NCT01152359|12269566|FG000|NOT COMPLETED|Overall Study||24
11086696|NCT01152359|12269567|FG001|NOT COMPLETED|Overall Study||22
11086697|NCT01152385|12269577|FG000|STARTED|Overall Study||55
11086698|NCT01152385|12269578|FG001|STARTED|Overall Study||58
11086699|NCT01152385|12269579|FG002|STARTED|Overall Study||56
11086700|NCT01152385|12269580|FG003|STARTED|Overall Study||55
11086701|NCT01152385|12269577|FG000|COMPLETED|Overall Study||46
11086702|NCT01152385|12269578|FG001|COMPLETED|Overall Study||52
11086703|NCT01152385|12269579|FG002|COMPLETED|Overall Study||51
11086704|NCT01152385|12269580|FG003|COMPLETED|Overall Study||50
11086705|NCT01152385|12269577|FG000|NOT COMPLETED|Overall Study||9
11086706|NCT01152385|12269578|FG001|NOT COMPLETED|Overall Study||6
11086707|NCT01152385|12269579|FG002|NOT COMPLETED|Overall Study||5
11086708|NCT01152385|12269580|FG003|NOT COMPLETED|Overall Study||5
11086709|NCT01152437|12269597|FG000|STARTED|Overall Study|randomised|36
11086710|NCT01152437|12269598|FG001|STARTED|Overall Study|randomised|15
11086711|NCT01152437|12269599|FG002|STARTED|Overall Study|entered|43
11086712|NCT01152437|12269597|FG000|COMPLETED|Overall Study||0
11086713|NCT01152437|12269598|FG001|COMPLETED|Overall Study||0
11086714|NCT01152437|12269599|FG002|COMPLETED|Overall Study||0
11086715|NCT01152437|12269597|FG000|NOT COMPLETED|Overall Study||36
11086716|NCT01152437|12269598|FG001|NOT COMPLETED|Overall Study||15
11086717|NCT01152437|12269599|FG002|NOT COMPLETED|Overall Study||43
11086718|NCT01152450|12269609|FG000|STARTED|Period 1 (4 Weeks)||15
11086719|NCT01152450|12269610|FG001|STARTED|Period 1 (4 Weeks)||16
11086720|NCT01152450|12269611|FG002|STARTED|Period 1 (4 Weeks)||17
11086721|NCT01152450|12269612|FG003|STARTED|Period 1 (4 Weeks)||15
11086722|NCT01152450|12269613|FG004|STARTED|Period 1 (4 Weeks)||18
11086723|NCT01152450|12269614|FG005|STARTED|Period 1 (4 Weeks)||13
11086724|NCT01152450|12269609|FG000|COMPLETED|Period 1 (4 Weeks)||15
11086725|NCT01152450|12269610|FG001|COMPLETED|Period 1 (4 Weeks)||15
11086726|NCT01152450|12269611|FG002|COMPLETED|Period 1 (4 Weeks)||16
11086727|NCT01152450|12269612|FG003|COMPLETED|Period 1 (4 Weeks)||15
11086728|NCT01152450|12269613|FG004|COMPLETED|Period 1 (4 Weeks)||16
11086729|NCT01152450|12269614|FG005|COMPLETED|Period 1 (4 Weeks)||12
11086730|NCT01152450|12269609|FG000|NOT COMPLETED|Period 1 (4 Weeks)||0
11086731|NCT01152450|12269610|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
11086732|NCT01152450|12269611|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1
11086733|NCT01152450|12269612|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
11086734|NCT01152450|12269613|FG004|NOT COMPLETED|Period 1 (4 Weeks)||2
11086735|NCT01152450|12269614|FG005|NOT COMPLETED|Period 1 (4 Weeks)||1
11086736|NCT01152450|12269609|FG000|STARTED|Period 2 (4 Weeks)||15
11086737|NCT01152450|12269610|FG001|STARTED|Period 2 (4 Weeks)||15
11086738|NCT01152450|12269611|FG002|STARTED|Period 2 (4 Weeks)||16
11086739|NCT01152450|12269612|FG003|STARTED|Period 2 (4 Weeks)||15
11086740|NCT01152450|12269613|FG004|STARTED|Period 2 (4 Weeks)||16
11086741|NCT01152450|12269614|FG005|STARTED|Period 2 (4 Weeks)||12
11086742|NCT01152450|12269609|FG000|COMPLETED|Period 2 (4 Weeks)||15
11086743|NCT01152450|12269610|FG001|COMPLETED|Period 2 (4 Weeks)||15
11086744|NCT01152450|12269611|FG002|COMPLETED|Period 2 (4 Weeks)||16
11086745|NCT01152450|12269612|FG003|COMPLETED|Period 2 (4 Weeks)||15
11086746|NCT01152450|12269613|FG004|COMPLETED|Period 2 (4 Weeks)||16
11086747|NCT01152450|12269614|FG005|COMPLETED|Period 2 (4 Weeks)||12
11086748|NCT01152450|12269609|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
11086749|NCT01152450|12269610|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
11086750|NCT01152450|12269611|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
11086751|NCT01152450|12269612|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
11086752|NCT01152450|12269613|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0
11086753|NCT01152450|12269614|FG005|NOT COMPLETED|Period 2 (4 Weeks)||0
11086754|NCT01152450|12269609|FG000|STARTED|Period 3 (4 Weeks)||15
11086755|NCT01152450|12269610|FG001|STARTED|Period 3 (4 Weeks)||15
11086756|NCT01152450|12269611|FG002|STARTED|Period 3 (4 Weeks)||16
11086757|NCT01152450|12269612|FG003|STARTED|Period 3 (4 Weeks)||15
11086758|NCT01152450|12269613|FG004|STARTED|Period 3 (4 Weeks)||16
11086759|NCT01152450|12269614|FG005|STARTED|Period 3 (4 Weeks)||12
11086760|NCT01152450|12269609|FG000|COMPLETED|Period 3 (4 Weeks)||15
11086761|NCT01152450|12269610|FG001|COMPLETED|Period 3 (4 Weeks)||15
11086762|NCT01152450|12269611|FG002|COMPLETED|Period 3 (4 Weeks)||16
11086763|NCT01152450|12269612|FG003|COMPLETED|Period 3 (4 Weeks)||15
11086764|NCT01152450|12269613|FG004|COMPLETED|Period 3 (4 Weeks)||16
11086765|NCT01152450|12269614|FG005|COMPLETED|Period 3 (4 Weeks)||12
11086766|NCT01152450|12269609|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
11086767|NCT01152450|12269610|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
11086768|NCT01152450|12269611|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
11086769|NCT01152450|12269612|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
11086770|NCT01152450|12269613|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0
11086771|NCT01152450|12269614|FG005|NOT COMPLETED|Period 3 (4 Weeks)||0
11086772|NCT01152515|12269624|FG000|STARTED|Overall Study||25
11086773|NCT01152515|12269625|FG001|STARTED|Overall Study||25
11086774|NCT01152515|12269624|FG000|COMPLETED|Overall Study||25
11086775|NCT01152515|12269625|FG001|COMPLETED|Overall Study||25
11086776|NCT01152515|12269624|FG000|NOT COMPLETED|Overall Study||0
11086777|NCT01152515|12269625|FG001|NOT COMPLETED|Overall Study||0
11086778|NCT01152554|12269633|FG000|STARTED|Overall Study||610
11086779|NCT01152554|12269634|FG001|STARTED|Overall Study||203
11086780|NCT01152554|12269633|FG000|Received Treatment|Overall Study||607
11086781|NCT01152554|12269634|FG001|Received Treatment|Overall Study||201
11086782|NCT01152554|12269633|FG000|COMPLETED|Overall Study||276
11086783|NCT01152554|12269634|FG001|COMPLETED|Overall Study||92
11086784|NCT01152554|12269633|FG000|NOT COMPLETED|Overall Study||334
11086785|NCT01152554|12269634|FG001|NOT COMPLETED|Overall Study||111
11086786|NCT01152580|12269642|FG000|STARTED|Overall Study||5
11086787|NCT01152580|12269643|FG001|STARTED|Overall Study||14
11086788|NCT01152580|12269642|FG000|COMPLETED|Overall Study||5
11086789|NCT01152580|12269643|FG001|COMPLETED|Overall Study||13
11086790|NCT01152580|12269642|FG000|NOT COMPLETED|Overall Study||0
11086791|NCT01152580|12269643|FG001|NOT COMPLETED|Overall Study||1
11207733|NCT01877278|12398845|FG000|NOT COMPLETED|Overall Study||3
11207734|NCT01877278|12398846|FG001|NOT COMPLETED|Overall Study||3
11207735|NCT01877408|12398854|FG000|STARTED|Overall Study||50
11207736|NCT01877408|12398855|FG001|STARTED|Overall Study||100
11207737|NCT01877408|12398854|FG000|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
11207738|NCT01877408|12398855|FG001|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
11207739|NCT01877408|12398854|FG000|NOT COMPLETED|Overall Study||0
11207740|NCT01877408|12398855|FG001|NOT COMPLETED|Overall Study||2
11207741|NCT01877421|12398894|FG000|STARTED|Phase 1||2
11207742|NCT01877421|12398895|FG001|STARTED|Phase 1||1
11207743|NCT01877421|12398896|FG002|STARTED|Phase 1||4
11207744|NCT01877421|12398897|FG003|STARTED|Phase 1||2
11207745|NCT01877421|12398898|FG004|STARTED|Phase 1||4
11207746|NCT01877421|12398899|FG005|STARTED|Phase 1||2
11207747|NCT01877421|12398900|FG006|STARTED|Phase 1||4
11207748|NCT01877421|12398901|FG007|STARTED|Phase 1||2
11207749|NCT01877421|12398902|FG008|STARTED|Phase 1||7
11207750|NCT01877421|12398903|FG009|STARTED|Phase 1||3
11207751|NCT01877421|12398904|FG010|STARTED|Phase 1||7
11207752|NCT01877421|12398905|FG011|STARTED|Phase 1||3
11207753|NCT01877421|12398906|FG012|STARTED|Phase 1||7
11207754|NCT01877421|12398907|FG013|STARTED|Phase 1||3
11207755|NCT01877421|12398908|FG014|STARTED|Phase 1||7
11207756|NCT01877421|12398909|FG015|STARTED|Phase 1||3
11207757|NCT01877421|12398910|FG016|STARTED|Phase 1||7
11207758|NCT01877421|12398911|FG017|STARTED|Phase 1||3
11207759|NCT01877421|12398894|FG000|COMPLETED|Phase 1||2
11207760|NCT01877421|12398895|FG001|COMPLETED|Phase 1||1
11207761|NCT01877421|12398896|FG002|COMPLETED|Phase 1||4
11207762|NCT01877421|12398897|FG003|COMPLETED|Phase 1||2
11207763|NCT01877421|12398898|FG004|COMPLETED|Phase 1||4
11207764|NCT01877421|12398899|FG005|COMPLETED|Phase 1||2
11207765|NCT01877421|12398900|FG006|COMPLETED|Phase 1||4
11207766|NCT01877421|12398901|FG007|COMPLETED|Phase 1||2
11207767|NCT01877421|12398902|FG008|COMPLETED|Phase 1||7
11207768|NCT01877421|12398903|FG009|COMPLETED|Phase 1||3
11207769|NCT01877421|12398904|FG010|COMPLETED|Phase 1||7
11207770|NCT01877421|12398905|FG011|COMPLETED|Phase 1||3
11207771|NCT01877421|12398906|FG012|COMPLETED|Phase 1||7
11207772|NCT01877421|12398907|FG013|COMPLETED|Phase 1||3
11207773|NCT01877421|12398908|FG014|COMPLETED|Phase 1||7
11207774|NCT01877421|12398909|FG015|COMPLETED|Phase 1||3
11207775|NCT01877421|12398910|FG016|COMPLETED|Phase 1||7
11207776|NCT01877421|12398911|FG017|COMPLETED|Phase 1||3
11207777|NCT01877421|12398894|FG000|NOT COMPLETED|Phase 1||0
11207778|NCT01877421|12398895|FG001|NOT COMPLETED|Phase 1||0
11207779|NCT01877421|12398896|FG002|NOT COMPLETED|Phase 1||0
11207780|NCT01877421|12398897|FG003|NOT COMPLETED|Phase 1||0
11207781|NCT01877421|12398898|FG004|NOT COMPLETED|Phase 1||0
11207782|NCT01877421|12398899|FG005|NOT COMPLETED|Phase 1||0
11207783|NCT01877421|12398900|FG006|NOT COMPLETED|Phase 1||0
11207784|NCT01877421|12398901|FG007|NOT COMPLETED|Phase 1||0
11207785|NCT01877421|12398902|FG008|NOT COMPLETED|Phase 1||0
11207786|NCT01877421|12398903|FG009|NOT COMPLETED|Phase 1||0
11207787|NCT01877421|12398904|FG010|NOT COMPLETED|Phase 1||0
11207788|NCT01877421|12398905|FG011|NOT COMPLETED|Phase 1||0
11207789|NCT01877421|12398906|FG012|NOT COMPLETED|Phase 1||0
11207790|NCT01877421|12398907|FG013|NOT COMPLETED|Phase 1||0
11207791|NCT01877421|12398908|FG014|NOT COMPLETED|Phase 1||0
11207792|NCT01877421|12398909|FG015|NOT COMPLETED|Phase 1||0
11207793|NCT01877421|12398910|FG016|NOT COMPLETED|Phase 1||0
11207794|NCT01877421|12398911|FG017|NOT COMPLETED|Phase 1||0
11207795|NCT01877421|12398894|FG000|STARTED|Phase 2||0
11086792|NCT01152697|12269649|FG000|STARTED|Overall Study||30
11086793|NCT01152697|12269649|FG000|COMPLETED|Overall Study||11
11086794|NCT01152697|12269649|FG000|NOT COMPLETED|Overall Study||19
11086795|NCT01152788|12269655|FG000|STARTED|Overall Study||32
11086796|NCT01152788|12269656|FG001|STARTED|Overall Study||32
11086797|NCT01152788|12269655|FG000|COMPLETED|Overall Study||32
11086798|NCT01152788|12269656|FG001|COMPLETED|Overall Study||28
11086799|NCT01152788|12269655|FG000|NOT COMPLETED|Overall Study||0
11086800|NCT01152788|12269656|FG001|NOT COMPLETED|Overall Study||4
11086801|NCT01152814|12269662|FG000|STARTED|Overall Study||64
11086802|NCT01152814|12269662|FG000|COMPLETED|Overall Study||62
11086803|NCT01152814|12269662|FG000|NOT COMPLETED|Overall Study||2
11086804|NCT01152996|12269666|FG000|STARTED|Overall Study||1075
11086805|NCT01152996|12269666|FG000|Treated|Overall Study||1073
11086806|NCT01152996|12269666|FG000|COMPLETED|Overall Study||538
11086807|NCT01152996|12269666|FG000|NOT COMPLETED|Overall Study||537
11086808|NCT01153009|12269674|FG000|STARTED|Overall Study||161
11086809|NCT01153009|12269675|FG001|STARTED|Overall Study||147
11086810|NCT01153009|12269676|FG002|STARTED|Overall Study||154
11086811|NCT01153009|12269677|FG003|STARTED|Overall Study||152
11086812|NCT01153009|12269674|FG000|Treated|Overall Study||159
11086813|NCT01153009|12269675|FG001|Treated|Overall Study||147
11086814|NCT01153009|12269676|FG002|Treated|Overall Study||154
11086815|NCT01153009|12269677|FG003|Treated|Overall Study||150
11086816|NCT01153009|12269674|FG000|COMPLETED|Overall Study||129
11086817|NCT01153009|12269675|FG001|COMPLETED|Overall Study||113
11086818|NCT01153009|12269676|FG002|COMPLETED|Overall Study||113
11086819|NCT01153009|12269677|FG003|COMPLETED|Overall Study||115
11086820|NCT01153009|12269674|FG000|NOT COMPLETED|Overall Study||32
11086821|NCT01153009|12269675|FG001|NOT COMPLETED|Overall Study||34
11086822|NCT01153009|12269676|FG002|NOT COMPLETED|Overall Study||41
11086823|NCT01153009|12269677|FG003|NOT COMPLETED|Overall Study||37
11086824|NCT01153269|12269687|FG000|STARTED|Overall Study||33
11086825|NCT01153269|12269687|FG000|Participants Analyzed|Overall Study||33
11086826|NCT01153269|12269687|FG000|COMPLETED|Overall Study||31
11086827|NCT01153269|12269687|FG000|NOT COMPLETED|Overall Study||2
11086828|NCT01153321|12269696|FG000|STARTED|Overall Study||22
11086829|NCT01153321|12269697|FG001|STARTED|Overall Study||22
11086830|NCT01153321|12269696|FG000|COMPLETED|Overall Study||21
11086831|NCT01153321|12269697|FG001|COMPLETED|Overall Study||19
11086832|NCT01153321|12269696|FG000|NOT COMPLETED|Overall Study||1
11086833|NCT01153321|12269697|FG001|NOT COMPLETED|Overall Study||3
11086834|NCT01153347|12269707|FG000|STARTED|Overall Study||160
11086835|NCT01153347|12269708|FG001|STARTED|Overall Study||160
11086836|NCT01153347|12269709|FG002|STARTED|Overall Study||160
11086837|NCT01153347|12269710|FG003|STARTED|Overall Study||161
11086838|NCT01153347|12269707|FG000|Received Treatment|Overall Study||160
11086839|NCT01153347|12269708|FG001|Received Treatment|Overall Study||158
11086840|NCT01153347|12269709|FG002|Received Treatment|Overall Study||158
11086841|NCT01153347|12269710|FG003|Received Treatment|Overall Study||160
11086842|NCT01153347|12269707|FG000|COMPLETED|Overall Study||127
11086843|NCT01153347|12269708|FG001|COMPLETED|Overall Study||116
11086844|NCT01153347|12269709|FG002|COMPLETED|Overall Study||110
11086845|NCT01153347|12269710|FG003|COMPLETED|Overall Study||129
11086846|NCT01153347|12269707|FG000|NOT COMPLETED|Overall Study||33
11086847|NCT01153347|12269708|FG001|NOT COMPLETED|Overall Study||44
11086848|NCT01153347|12269709|FG002|NOT COMPLETED|Overall Study||50
11086849|NCT01153347|12269710|FG003|NOT COMPLETED|Overall Study||32
11086850|NCT01153425|12269722|FG000|STARTED|Overall Study||16
11086851|NCT01153425|12269723|FG001|STARTED|Overall Study||17
11086852|NCT01153425|12269722|FG000|COMPLETED|Overall Study||13
11086853|NCT01153425|12269723|FG001|COMPLETED|Overall Study||14
11086854|NCT01153425|12269722|FG000|NOT COMPLETED|Overall Study||3
11086855|NCT01153425|12269723|FG001|NOT COMPLETED|Overall Study||3
11086856|NCT01153503|12269733|FG000|STARTED|Overall Study||25
11086857|NCT01153503|12269734|FG001|STARTED|Overall Study||25
11086858|NCT01153503|12269735|FG002|STARTED|Overall Study||25
11086859|NCT01153503|12269733|FG000|COMPLETED|Overall Study||25
11086860|NCT01153503|12269734|FG001|COMPLETED|Overall Study||24
11086861|NCT01153503|12269735|FG002|COMPLETED|Overall Study||25
11086862|NCT01153503|12269733|FG000|NOT COMPLETED|Overall Study||0
11086863|NCT01153503|12269734|FG001|NOT COMPLETED|Overall Study||1
11086864|NCT01153503|12269735|FG002|NOT COMPLETED|Overall Study||0
11086865|NCT01153516|12269745|FG000|STARTED|Overall Study||12
11086866|NCT01153516|12269746|FG001|STARTED|Overall Study||10
11086867|NCT01153516|12269745|FG000|COMPLETED|Overall Study||10
11086868|NCT01153516|12269746|FG001|COMPLETED|Overall Study||10
11086869|NCT01153516|12269745|FG000|NOT COMPLETED|Overall Study||2
11086870|NCT01153516|12269746|FG001|NOT COMPLETED|Overall Study||0
11086871|NCT01153581|12269752|FG000|STARTED|Overall Study||109
11086872|NCT01153581|12269752|FG000|COMPLETED|Overall Study||109
11086873|NCT01153581|12269752|FG000|NOT COMPLETED|Overall Study||0
11086874|NCT01153620|12269764|FG000|STARTED|Overall Study||30
11086875|NCT01153620|12269765|FG001|STARTED|Overall Study|30 patients (31 wounds)|30
11086876|NCT01153620|12269764|FG000|COMPLETED|Overall Study||30
11086877|NCT01153620|12269765|FG001|COMPLETED|Overall Study|30 patients (31 wounds)|30
11086878|NCT01153620|12269764|FG000|NOT COMPLETED|Overall Study||0
11086879|NCT01153620|12269765|FG001|NOT COMPLETED|Overall Study||0
11086880|NCT01153633|12269773|FG000|STARTED|Overall Study||17
11086881|NCT01153633|12269774|FG001|STARTED|Overall Study||17
11086882|NCT01153633|12269773|FG000|COMPLETED|Overall Study||13
11086883|NCT01153633|12269774|FG001|COMPLETED|Overall Study||13
11086884|NCT01153633|12269773|FG000|NOT COMPLETED|Overall Study||4
11086885|NCT01153633|12269774|FG001|NOT COMPLETED|Overall Study||4
11086886|NCT01153672|12269782|FG000|STARTED|Overall Study||8
11086887|NCT01153672|12269782|FG000|COMPLETED|Overall Study||6
11086888|NCT01153672|12269782|FG000|NOT COMPLETED|Overall Study||2
11086889|NCT01153685|12269788|FG000|STARTED|Overall Study||50
11086890|NCT01153685|12269789|FG001|STARTED|Overall Study||70
11086891|NCT01153685|12269788|FG000|COMPLETED|Overall Study||50
11086892|NCT01153685|12269789|FG001|COMPLETED|Overall Study||70
11086893|NCT01153685|12269788|FG000|NOT COMPLETED|Overall Study||0
11086894|NCT01153685|12269789|FG001|NOT COMPLETED|Overall Study||0
11086895|NCT01153698|12269795|FG000|STARTED|Overall Study|Entered and treated.|168
11086896|NCT01153698|12269795|FG000|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
11086897|NCT01153698|12269795|FG000|NOT COMPLETED|Overall Study||29
11086898|NCT01153711|12269800|FG000|STARTED|Overall Study||32
11086899|NCT01153711|12269800|FG000|COMPLETED|Overall Study||32
11086900|NCT01153711|12269800|FG000|NOT COMPLETED|Overall Study||0
11086901|NCT01153724|12269806|FG000|STARTED|Treatment Period 1||35
11086902|NCT01153724|12269806|FG000|COMPLETED|Treatment Period 1||34
11086903|NCT01153724|12269806|FG000|NOT COMPLETED|Treatment Period 1||1
11086904|NCT01153724|12269806|FG000|STARTED|Treatment Period 2||34
11086905|NCT01153724|12269806|FG000|COMPLETED|Treatment Period 2||32
11086906|NCT01153724|12269806|FG000|NOT COMPLETED|Treatment Period 2||2
11086907|NCT01153763|12269812|FG000|STARTED|Overall Study||92
11086908|NCT01153763|12269812|FG000|COMPLETED|Overall Study||71
11086909|NCT01153763|12269812|FG000|NOT COMPLETED|Overall Study||21
11086910|NCT01153815|12269818|FG000|STARTED|Overall Study||83
11086911|NCT01153815|12269819|FG001|STARTED|Overall Study||87
11086912|NCT01153815|12269818|FG000|COMPLETED|Overall Study||74
11086913|NCT01153815|12269819|FG001|COMPLETED|Overall Study||82
11086914|NCT01153815|12269818|FG000|NOT COMPLETED|Overall Study||9
11086915|NCT01153815|12269819|FG001|NOT COMPLETED|Overall Study||5
11086916|NCT01153841|12269827|FG000|STARTED|Overall Study||199
11086917|NCT01153841|12269828|FG001|STARTED|Overall Study||99
11086918|NCT01153841|12269827|FG000|COMPLETED|Overall Study||193
11086919|NCT01153841|12269828|FG001|COMPLETED|Overall Study||99
11086920|NCT01153841|12269827|FG000|NOT COMPLETED|Overall Study||6
11086921|NCT01153841|12269828|FG001|NOT COMPLETED|Overall Study||0
11086922|NCT01153893|12269836|FG000|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
11086923|NCT01153893|12269837|FG001|STARTED|Overall Study||36
11086924|NCT01153893|12269836|FG000|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
11086925|NCT01153893|12269837|FG001|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
11086926|NCT01153893|12269836|FG000|NOT COMPLETED|Overall Study||1
11086927|NCT01153893|12269837|FG001|NOT COMPLETED|Overall Study||0
11086928|NCT01153958|12269845|FG000|STARTED|Overall Study||66
11086929|NCT01153958|12269846|FG001|STARTED|Overall Study||67
11086930|NCT01153958|12269845|FG000|COMPLETED|Overall Study||30
11086931|NCT01153958|12269846|FG001|COMPLETED|Overall Study||35
11086932|NCT01153958|12269845|FG000|NOT COMPLETED|Overall Study||36
11086933|NCT01153958|12269846|FG001|NOT COMPLETED|Overall Study||32
11086934|NCT01153971|12269852|FG000|STARTED|Induction Phase (Months 1 to 7 of Study)||47
11086935|NCT01153971|12269852|FG000|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
11086936|NCT01153971|12269852|FG000|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
11086937|NCT01153971|12269852|FG000|STARTED|Maintenance Phase (Months 8-16 of Study)||44
11351222|NCT03033784|12548153|FG008|NOT COMPLETED|Overall Study||0
11351223|NCT03033784|12548154|FG009|NOT COMPLETED|Overall Study||0
11086938|NCT01153971|12269852|FG000|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
11086939|NCT01153971|12269852|FG000|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
11086940|NCT01153971|12269852|FG000|STARTED|Follow-up (Months 17-40 of Study)||41
11086941|NCT01153971|12269852|FG000|COMPLETED|Follow-up (Months 17-40 of Study)||37
11086942|NCT01153971|12269852|FG000|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
11086943|NCT01153984|12269856|FG000|STARTED|Overall Study||23
11086944|NCT01153984|12269856|FG000|COMPLETED|Overall Study||21
11086945|NCT01153984|12269856|FG000|NOT COMPLETED|Overall Study||2
11086946|NCT01154010|12269862|FG000|STARTED|Overall Study||9
11086947|NCT01154010|12269863|FG001|STARTED|Overall Study||9
11086948|NCT01154010|12269862|FG000|COMPLETED|Overall Study||9
11086949|NCT01154010|12269863|FG001|COMPLETED|Overall Study||8
11086950|NCT01154010|12269862|FG000|NOT COMPLETED|Overall Study||0
11086951|NCT01154010|12269863|FG001|NOT COMPLETED|Overall Study||1
11086952|NCT01154088|12269872|FG000|STARTED|Overall Study||390
11086953|NCT01154088|12269873|FG001|STARTED|Overall Study||390
11086954|NCT01154088|12269874|FG002|STARTED|Overall Study||390
11086955|NCT01154088|12269872|FG000|COMPLETED|Overall Study||386
11086956|NCT01154088|12269873|FG001|COMPLETED|Overall Study||384
11086957|NCT01154088|12269874|FG002|COMPLETED|Overall Study||383
11086958|NCT01154088|12269872|FG000|NOT COMPLETED|Overall Study||4
11086959|NCT01154088|12269873|FG001|NOT COMPLETED|Overall Study||6
11086960|NCT01154088|12269874|FG002|NOT COMPLETED|Overall Study||7
11086961|NCT01154101|12269888|FG000|STARTED|Overall Study||7
11086962|NCT01154101|12269889|FG001|STARTED|Overall Study||9
11086963|NCT01154101|12269890|FG002|STARTED|Overall Study||12
11086964|NCT01154101|12269891|FG003|STARTED|Overall Study||11
11086965|NCT01154101|12269892|FG004|STARTED|Overall Study||1
11086966|NCT01154101|12269888|FG000|COMPLETED|Overall Study||7
11086967|NCT01154101|12269889|FG001|COMPLETED|Overall Study||5
11086968|NCT01154101|12269890|FG002|COMPLETED|Overall Study||9
11351224|NCT03033784|12548155|FG010|NOT COMPLETED|Overall Study||0
11086969|NCT01154101|12269891|FG003|COMPLETED|Overall Study||9
11086970|NCT01154101|12269892|FG004|COMPLETED|Overall Study||0
11086971|NCT01154101|12269888|FG000|NOT COMPLETED|Overall Study||0
11086972|NCT01154101|12269889|FG001|NOT COMPLETED|Overall Study||4
11086973|NCT01154101|12269890|FG002|NOT COMPLETED|Overall Study||3
11086974|NCT01154101|12269891|FG003|NOT COMPLETED|Overall Study||2
11086975|NCT01154101|12269892|FG004|NOT COMPLETED|Overall Study||1
11086976|NCT01154127|12269911|FG000|STARTED|Period 1 (21 Days)||55
11086977|NCT01154127|12269912|FG001|STARTED|Period 1 (21 Days)||53
11086978|NCT01154127|12269911|FG000|COMPLETED|Period 1 (21 Days)||52
11086979|NCT01154127|12269912|FG001|COMPLETED|Period 1 (21 Days)||47
11086980|NCT01154127|12269911|FG000|NOT COMPLETED|Period 1 (21 Days)||3
11086981|NCT01154127|12269912|FG001|NOT COMPLETED|Period 1 (21 Days)||6
11086982|NCT01154127|12269911|FG000|STARTED|Washout (14 - 28 Days)||52
11086983|NCT01154127|12269912|FG001|STARTED|Washout (14 - 28 Days)||47
11086984|NCT01154127|12269911|FG000|COMPLETED|Washout (14 - 28 Days)||49
11086985|NCT01154127|12269912|FG001|COMPLETED|Washout (14 - 28 Days)||47
11086986|NCT01154127|12269911|FG000|NOT COMPLETED|Washout (14 - 28 Days)||3
11086987|NCT01154127|12269912|FG001|NOT COMPLETED|Washout (14 - 28 Days)||0
11086988|NCT01154127|12269911|FG000|STARTED|Period 2 (21 Days)||49
11086989|NCT01154127|12269912|FG001|STARTED|Period 2 (21 Days)||47
11086990|NCT01154127|12269911|FG000|COMPLETED|Period 2 (21 Days)||49
11086991|NCT01154127|12269912|FG001|COMPLETED|Period 2 (21 Days)||46
11086992|NCT01154127|12269911|FG000|NOT COMPLETED|Period 2 (21 Days)||0
11086993|NCT01154127|12269912|FG001|NOT COMPLETED|Period 2 (21 Days)||1
11086994|NCT01154140|12269920|FG000|STARTED|Overall Study||172
11086995|NCT01154140|12269921|FG001|STARTED|Overall Study||171
11086996|NCT01154140|12269920|FG000|Treated|Overall Study||171
11086997|NCT01154140|12269921|FG001|Treated|Overall Study||169
11086998|NCT01154140|12269920|FG000|COMPLETED|Overall Study||81
11086999|NCT01154140|12269921|FG001|COMPLETED|Overall Study||69
11087000|NCT01154140|12269920|FG000|NOT COMPLETED|Overall Study||91
11087001|NCT01154140|12269921|FG001|NOT COMPLETED|Overall Study||102
11087002|NCT01154153|12269929|FG000|STARTED|Overall Study||71
11087003|NCT01154153|12269930|FG001|STARTED|Overall Study||69
11087004|NCT01154153|12269929|FG000|COMPLETED|Overall Study||66
11087005|NCT01154153|12269930|FG001|COMPLETED|Overall Study||66
11087006|NCT01154153|12269929|FG000|NOT COMPLETED|Overall Study||5
11087007|NCT01154153|12269930|FG001|NOT COMPLETED|Overall Study||3
11087008|NCT01154166|12269938|FG000|STARTED|Overall Study||169
11087009|NCT01154166|12269939|FG001|STARTED|Overall Study||175
11207796|NCT01877421|12398895|FG001|STARTED|Phase 2||0
11087010|NCT01154166|12269938|FG000|COMPLETED|Overall Study||135
11087011|NCT01154166|12269939|FG001|COMPLETED|Overall Study||163
11087012|NCT01154166|12269938|FG000|NOT COMPLETED|Overall Study||34
11087013|NCT01154166|12269939|FG001|NOT COMPLETED|Overall Study||12
11087014|NCT01154192|12269948|FG000|STARTED|Overall Study||14
11087015|NCT01154192|12269949|FG001|STARTED|Overall Study||10
11087016|NCT01154192|12269950|FG002|STARTED|Overall Study||0
11087017|NCT01154192|12269948|FG000|COMPLETED|Overall Study||14
11087018|NCT01154192|12269949|FG001|COMPLETED|Overall Study||10
11087019|NCT01154192|12269950|FG002|COMPLETED|Overall Study||0
11087020|NCT01154192|12269948|FG000|NOT COMPLETED|Overall Study||0
11087021|NCT01154192|12269949|FG001|NOT COMPLETED|Overall Study||0
11087022|NCT01154192|12269950|FG002|NOT COMPLETED|Overall Study||0
11087023|NCT01154218|12269959|FG000|STARTED|First Intervention Period||9
11087024|NCT01154218|12269960|FG001|STARTED|First Intervention Period||9
11087025|NCT01154218|12269961|FG002|STARTED|First Intervention Period||9
11087026|NCT01154218|12269962|FG003|STARTED|First Intervention Period||9
11087027|NCT01154218|12269959|FG000|COMPLETED|First Intervention Period||9
11087028|NCT01154218|12269960|FG001|COMPLETED|First Intervention Period||9
11087029|NCT01154218|12269961|FG002|COMPLETED|First Intervention Period||9
11087030|NCT01154218|12269962|FG003|COMPLETED|First Intervention Period||9
11087031|NCT01154218|12269959|FG000|NOT COMPLETED|First Intervention Period||0
11087032|NCT01154218|12269960|FG001|NOT COMPLETED|First Intervention Period||0
11087033|NCT01154218|12269961|FG002|NOT COMPLETED|First Intervention Period||0
11087034|NCT01154218|12269962|FG003|NOT COMPLETED|First Intervention Period||0
11087035|NCT01154218|12269959|FG000|STARTED|Washout Period (at Least 14 Days)||9
11087036|NCT01154218|12269960|FG001|STARTED|Washout Period (at Least 14 Days)||9
11087037|NCT01154218|12269961|FG002|STARTED|Washout Period (at Least 14 Days)||9
11087038|NCT01154218|12269962|FG003|STARTED|Washout Period (at Least 14 Days)||9
11087039|NCT01154218|12269959|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
11087040|NCT01154218|12269960|FG001|COMPLETED|Washout Period (at Least 14 Days)||9
11087041|NCT01154218|12269961|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
11087042|NCT01154218|12269962|FG003|COMPLETED|Washout Period (at Least 14 Days)||9
11087043|NCT01154218|12269959|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11087044|NCT01154218|12269960|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11087045|NCT01154218|12269961|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11087046|NCT01154218|12269962|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11087047|NCT01154218|12269959|FG000|STARTED|Second Intervention Period||9
11087048|NCT01154218|12269960|FG001|STARTED|Second Intervention Period||9
11087049|NCT01154218|12269961|FG002|STARTED|Second Intervention Period||9
11087050|NCT01154218|12269962|FG003|STARTED|Second Intervention Period||9
11087051|NCT01154218|12269959|FG000|COMPLETED|Second Intervention Period||9
11087052|NCT01154218|12269960|FG001|COMPLETED|Second Intervention Period||9
11087053|NCT01154218|12269961|FG002|COMPLETED|Second Intervention Period||9
11087054|NCT01154218|12269962|FG003|COMPLETED|Second Intervention Period||9
11087055|NCT01154218|12269959|FG000|NOT COMPLETED|Second Intervention Period||0
11087056|NCT01154218|12269960|FG001|NOT COMPLETED|Second Intervention Period||0
11087057|NCT01154218|12269961|FG002|NOT COMPLETED|Second Intervention Period||0
11087058|NCT01154218|12269962|FG003|NOT COMPLETED|Second Intervention Period||0
11087059|NCT01154218|12269959|FG000|STARTED|Washout Period (at Least 14 Days)||9
11087060|NCT01154218|12269960|FG001|STARTED|Washout Period (at Least 14 Days)||9
11087061|NCT01154218|12269961|FG002|STARTED|Washout Period (at Least 14 Days)||9
11087062|NCT01154218|12269962|FG003|STARTED|Washout Period (at Least 14 Days)||9
11087063|NCT01154218|12269959|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
11087064|NCT01154218|12269960|FG001|COMPLETED|Washout Period (at Least 14 Days)||9
11087065|NCT01154218|12269961|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
11087066|NCT01154218|12269962|FG003|COMPLETED|Washout Period (at Least 14 Days)||9
11087067|NCT01154218|12269959|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11087068|NCT01154218|12269960|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11087069|NCT01154218|12269961|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11087070|NCT01154218|12269962|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11087071|NCT01154218|12269959|FG000|STARTED|Third Intervention Period||9
11087072|NCT01154218|12269960|FG001|STARTED|Third Intervention Period||9
11087073|NCT01154218|12269961|FG002|STARTED|Third Intervention Period||9
11087074|NCT01154218|12269962|FG003|STARTED|Third Intervention Period||9
11087075|NCT01154218|12269959|FG000|COMPLETED|Third Intervention Period||9
11087076|NCT01154218|12269960|FG001|COMPLETED|Third Intervention Period||8
11087077|NCT01154218|12269961|FG002|COMPLETED|Third Intervention Period||9
11087078|NCT01154218|12269962|FG003|COMPLETED|Third Intervention Period||9
11087079|NCT01154218|12269959|FG000|NOT COMPLETED|Third Intervention Period||0
11087080|NCT01154218|12269960|FG001|NOT COMPLETED|Third Intervention Period||1
11087081|NCT01154218|12269961|FG002|NOT COMPLETED|Third Intervention Period||0
11087082|NCT01154218|12269962|FG003|NOT COMPLETED|Third Intervention Period||0
11087083|NCT01154218|12269959|FG000|STARTED|Washout Period (at Least 14 Days)||9
11207797|NCT01877421|12398896|FG002|STARTED|Phase 2||4
11087084|NCT01154218|12269960|FG001|STARTED|Washout Period (at Least 14 Days)||8
11087085|NCT01154218|12269961|FG002|STARTED|Washout Period (at Least 14 Days)||9
11087086|NCT01154218|12269962|FG003|STARTED|Washout Period (at Least 14 Days)||9
11087087|NCT01154218|12269959|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
11087088|NCT01154218|12269960|FG001|COMPLETED|Washout Period (at Least 14 Days)||8
11087089|NCT01154218|12269961|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
11087090|NCT01154218|12269962|FG003|COMPLETED|Washout Period (at Least 14 Days)||8
11087091|NCT01154218|12269959|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11087092|NCT01154218|12269960|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11087093|NCT01154218|12269961|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11087094|NCT01154218|12269962|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||1
11087095|NCT01154218|12269959|FG000|STARTED|Fourth Intervention Period||9
11087096|NCT01154218|12269960|FG001|STARTED|Fourth Intervention Period||8
11087097|NCT01154218|12269961|FG002|STARTED|Fourth Intervention Period||9
11087098|NCT01154218|12269962|FG003|STARTED|Fourth Intervention Period||8
11087099|NCT01154218|12269959|FG000|COMPLETED|Fourth Intervention Period||8
11087100|NCT01154218|12269960|FG001|COMPLETED|Fourth Intervention Period||8
11087101|NCT01154218|12269961|FG002|COMPLETED|Fourth Intervention Period||9
11087102|NCT01154218|12269962|FG003|COMPLETED|Fourth Intervention Period||8
11087103|NCT01154218|12269959|FG000|NOT COMPLETED|Fourth Intervention Period||1
11087104|NCT01154218|12269960|FG001|NOT COMPLETED|Fourth Intervention Period||0
11087105|NCT01154218|12269961|FG002|NOT COMPLETED|Fourth Intervention Period||0
11087106|NCT01154218|12269962|FG003|NOT COMPLETED|Fourth Intervention Period||0
11087107|NCT01154231|12269972|FG000|STARTED|Overall Study||314
11087108|NCT01154231|12269972|FG000|COMPLETED|Overall Study||312
11087109|NCT01154231|12269972|FG000|NOT COMPLETED|Overall Study||2
11087110|NCT01154283|12269978|FG000|STARTED|0-6 Weeks||14
11087111|NCT01154283|12269979|FG001|STARTED|0-6 Weeks||14
11087112|NCT01154283|12269978|FG000|COMPLETED|0-6 Weeks||7
11087113|NCT01154283|12269979|FG001|COMPLETED|0-6 Weeks||11
11087114|NCT01154283|12269978|FG000|NOT COMPLETED|0-6 Weeks||7
11087115|NCT01154283|12269979|FG001|NOT COMPLETED|0-6 Weeks||3
11087116|NCT01154283|12269978|FG000|STARTED|7-12 Weeks||7
11087117|NCT01154283|12269979|FG001|STARTED|7-12 Weeks||11
11087118|NCT01154283|12269978|FG000|COMPLETED|7-12 Weeks||6
11087119|NCT01154283|12269979|FG001|COMPLETED|7-12 Weeks||10
11087120|NCT01154283|12269978|FG000|NOT COMPLETED|7-12 Weeks||1
11087121|NCT01154283|12269979|FG001|NOT COMPLETED|7-12 Weeks||1
11087122|NCT01154296|12269987|FG000|STARTED|Randomization and Intervention||2505
11087123|NCT01154296|12269988|FG001|STARTED|Randomization and Intervention||2507
11087124|NCT01154296|12269987|FG000|COMPLETED|Randomization and Intervention||2500
11087125|NCT01154296|12269988|FG001|COMPLETED|Randomization and Intervention||2505
11087126|NCT01154296|12269987|FG000|NOT COMPLETED|Randomization and Intervention||5
11087127|NCT01154296|12269988|FG001|NOT COMPLETED|Randomization and Intervention||2
11087128|NCT01154296|12269987|FG000|STARTED|6-month Follow-up||2505
11087129|NCT01154296|12269988|FG001|STARTED|6-month Follow-up||2507
11087130|NCT01154296|12269987|FG000|COMPLETED|6-month Follow-up||2177
11087131|NCT01154296|12269988|FG001|COMPLETED|6-month Follow-up||2179
11087132|NCT01154296|12269987|FG000|NOT COMPLETED|6-month Follow-up||328
11087133|NCT01154296|12269988|FG001|NOT COMPLETED|6-month Follow-up||328
11087134|NCT01154322|12269994|FG000|STARTED|Overall Study||16
11087135|NCT01154322|12269994|FG000|COMPLETED|Overall Study||14
11087136|NCT01154322|12269994|FG000|NOT COMPLETED|Overall Study||2
11087137|NCT01154452|12270003|FG000|STARTED|Phase Ib||6
11087138|NCT01154452|12270004|FG001|STARTED|Phase Ib||4
11087139|NCT01154452|12270005|FG002|STARTED|Phase Ib||0
11087140|NCT01154452|12270006|FG003|STARTED|Phase Ib||0
11087141|NCT01154452|12270003|FG000|COMPLETED|Phase Ib||3
11087142|NCT01154452|12270004|FG001|COMPLETED|Phase Ib||3
11087143|NCT01154452|12270005|FG002|COMPLETED|Phase Ib||0
11087144|NCT01154452|12270006|FG003|COMPLETED|Phase Ib||0
11087145|NCT01154452|12270003|FG000|NOT COMPLETED|Phase Ib||3
11087146|NCT01154452|12270004|FG001|NOT COMPLETED|Phase Ib||1
11087147|NCT01154452|12270005|FG002|NOT COMPLETED|Phase Ib||0
11087148|NCT01154452|12270006|FG003|NOT COMPLETED|Phase Ib||0
11087149|NCT01154452|12270003|FG000|STARTED|Phase II||0
11087150|NCT01154452|12270004|FG001|STARTED|Phase II||0
11087151|NCT01154452|12270005|FG002|STARTED|Phase II||35
11087152|NCT01154452|12270006|FG003|STARTED|Phase II||33
11087153|NCT01154452|12270003|FG000|COMPLETED|Phase II||0
11351225|NCT03033784|12548156|FG011|NOT COMPLETED|Overall Study||0
11351226|NCT03033784|12548157|FG012|NOT COMPLETED|Overall Study||2
11351227|NCT03034044|12548168|FG000|STARTED|Overall Study||106
11351228|NCT03034044|12548168|FG000|Received Xyntha|Overall Study||105
11351229|NCT03034044|12548168|FG000|COMPLETED|Overall Study||105
11351230|NCT03034044|12548168|FG000|NOT COMPLETED|Overall Study||1
11351231|NCT03034057|12548172|FG000|STARTED|Overall Study||169
11351232|NCT03034057|12548172|FG000|COMPLETED|Overall Study||114
11351233|NCT03034057|12548172|FG000|NOT COMPLETED|Overall Study||55
11351234|NCT03034135|12548176|FG000|STARTED|Overall Study||23
11351235|NCT03034135|12548176|FG000|COMPLETED|Overall Study||21
11351236|NCT03034135|12548176|FG000|NOT COMPLETED|Overall Study||2
11351237|NCT03034460|12548182|FG000|STARTED|Overall Study||48
11351238|NCT03034460|12548183|FG001|STARTED|Overall Study||22
11351239|NCT03034460|12548182|FG000|COMPLETED|Overall Study||45
11351240|NCT03034460|12548183|FG001|COMPLETED|Overall Study||19
11351241|NCT03034460|12548182|FG000|NOT COMPLETED|Overall Study||3
11351242|NCT03034460|12548183|FG001|NOT COMPLETED|Overall Study||3
11351243|NCT03034577|12548195|FG000|STARTED|Overall Study||175
11351244|NCT03034577|12548196|FG001|STARTED|Overall Study||175
11351245|NCT03034577|12548195|FG000|COMPLETED|Overall Study||144
11351246|NCT03034577|12548196|FG001|COMPLETED|Overall Study||140
11351247|NCT03034577|12548195|FG000|NOT COMPLETED|Overall Study||31
11351248|NCT03034577|12548196|FG001|NOT COMPLETED|Overall Study||35
11351249|NCT03034772|12548206|FG000|STARTED|Overall Study||27
11351250|NCT03034772|12548207|FG001|STARTED|Overall Study||25
11351251|NCT03034772|12548206|FG000|COMPLETED|Overall Study||27
11087154|NCT01154452|12270004|FG001|COMPLETED|Phase II||0
11087155|NCT01154452|12270005|FG002|COMPLETED|Phase II||30
11087156|NCT01154452|12270006|FG003|COMPLETED|Phase II||27
11087157|NCT01154452|12270003|FG000|NOT COMPLETED|Phase II||0
11087158|NCT01154452|12270004|FG001|NOT COMPLETED|Phase II||0
11087159|NCT01154452|12270005|FG002|NOT COMPLETED|Phase II||5
11087160|NCT01154452|12270006|FG003|NOT COMPLETED|Phase II||6
11087161|NCT01154634|12270023|FG000|STARTED|Period 1 - First Intervention||4
11087162|NCT01154634|12270024|FG001|STARTED|Period 1 - First Intervention||7
11087163|NCT01154634|12270025|FG002|STARTED|Period 1 - First Intervention||4
11087164|NCT01154634|12270026|FG003|STARTED|Period 1 - First Intervention||5
11351252|NCT03034772|12548207|FG001|COMPLETED|Overall Study||23
11351253|NCT03034772|12548206|FG000|NOT COMPLETED|Overall Study||0
11351254|NCT03034772|12548207|FG001|NOT COMPLETED|Overall Study||2
11351255|NCT03034915|12548216|FG000|STARTED|Overall Study||812
11351256|NCT03034915|12548217|FG001|STARTED|Overall Study||804
11351257|NCT03034915|12548218|FG002|STARTED|Overall Study||809
11351258|NCT03034915|12548216|FG000|COMPLETED|Overall Study||717
11351259|NCT03034915|12548217|FG001|COMPLETED|Overall Study||650
11351260|NCT03034915|12548218|FG002|COMPLETED|Overall Study||683
11351261|NCT03034915|12548216|FG000|NOT COMPLETED|Overall Study||95
11351262|NCT03034915|12548217|FG001|NOT COMPLETED|Overall Study||154
11351263|NCT03034915|12548218|FG002|NOT COMPLETED|Overall Study||126
11351264|NCT03034928|12548226|FG000|STARTED|Period 1, First 2 Hours of Wear||8
11351265|NCT03034928|12548227|FG001|STARTED|Period 1, First 2 Hours of Wear||8
11351266|NCT03034928|12548228|FG002|STARTED|Period 1, First 2 Hours of Wear||9
11351267|NCT03034928|12548229|FG003|STARTED|Period 1, First 2 Hours of Wear||8
11351268|NCT03034928|12548226|FG000|COMPLETED|Period 1, First 2 Hours of Wear||8
11351269|NCT03034928|12548227|FG001|COMPLETED|Period 1, First 2 Hours of Wear||8
11351270|NCT03034928|12548228|FG002|COMPLETED|Period 1, First 2 Hours of Wear||9
11351271|NCT03034928|12548229|FG003|COMPLETED|Period 1, First 2 Hours of Wear||8
11351272|NCT03034928|12548226|FG000|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
11351273|NCT03034928|12548227|FG001|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
11351274|NCT03034928|12548228|FG002|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
11351275|NCT03034928|12548229|FG003|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
11351276|NCT03034928|12548226|FG000|STARTED|Washout Period Between Lens Wear||8
11351277|NCT03034928|12548227|FG001|STARTED|Washout Period Between Lens Wear||8
11351278|NCT03034928|12548228|FG002|STARTED|Washout Period Between Lens Wear||9
11351279|NCT03034928|12548229|FG003|STARTED|Washout Period Between Lens Wear||8
11351280|NCT03034928|12548226|FG000|COMPLETED|Washout Period Between Lens Wear||8
11351281|NCT03034928|12548227|FG001|COMPLETED|Washout Period Between Lens Wear||8
11351282|NCT03034928|12548228|FG002|COMPLETED|Washout Period Between Lens Wear||9
11087165|NCT01154634|12270023|FG000|COMPLETED|Period 1 - First Intervention||4
11087166|NCT01154634|12270024|FG001|COMPLETED|Period 1 - First Intervention||7
11087167|NCT01154634|12270025|FG002|COMPLETED|Period 1 - First Intervention||4
11087168|NCT01154634|12270026|FG003|COMPLETED|Period 1 - First Intervention||5
11087169|NCT01154634|12270023|FG000|NOT COMPLETED|Period 1 - First Intervention||0
11087170|NCT01154634|12270024|FG001|NOT COMPLETED|Period 1 - First Intervention||0
11087171|NCT01154634|12270025|FG002|NOT COMPLETED|Period 1 - First Intervention||0
11087172|NCT01154634|12270026|FG003|NOT COMPLETED|Period 1 - First Intervention||0
11087173|NCT01154634|12270023|FG000|STARTED|Period 2 - Washout||4
11087174|NCT01154634|12270024|FG001|STARTED|Period 2 - Washout||7
11087175|NCT01154634|12270025|FG002|STARTED|Period 2 - Washout||4
11087176|NCT01154634|12270026|FG003|STARTED|Period 2 - Washout||5
11087177|NCT01154634|12270023|FG000|COMPLETED|Period 2 - Washout||4
11087178|NCT01154634|12270024|FG001|COMPLETED|Period 2 - Washout||7
11087179|NCT01154634|12270025|FG002|COMPLETED|Period 2 - Washout||4
11087180|NCT01154634|12270026|FG003|COMPLETED|Period 2 - Washout||5
11087181|NCT01154634|12270023|FG000|NOT COMPLETED|Period 2 - Washout||0
11087182|NCT01154634|12270024|FG001|NOT COMPLETED|Period 2 - Washout||0
11087183|NCT01154634|12270025|FG002|NOT COMPLETED|Period 2 - Washout||0
11351283|NCT03034928|12548229|FG003|COMPLETED|Washout Period Between Lens Wear||8
11351284|NCT03034928|12548226|FG000|NOT COMPLETED|Washout Period Between Lens Wear||0
11351285|NCT03034928|12548227|FG001|NOT COMPLETED|Washout Period Between Lens Wear||0
11087184|NCT01154634|12270026|FG003|NOT COMPLETED|Period 2 - Washout||0
11087185|NCT01154634|12270023|FG000|STARTED|Period 3- Second Intervention||4
11087186|NCT01154634|12270024|FG001|STARTED|Period 3- Second Intervention||7
11087187|NCT01154634|12270025|FG002|STARTED|Period 3- Second Intervention||4
11087188|NCT01154634|12270026|FG003|STARTED|Period 3- Second Intervention||5
11087189|NCT01154634|12270023|FG000|COMPLETED|Period 3- Second Intervention||4
11087190|NCT01154634|12270024|FG001|COMPLETED|Period 3- Second Intervention||7
11087191|NCT01154634|12270025|FG002|COMPLETED|Period 3- Second Intervention||4
11087192|NCT01154634|12270026|FG003|COMPLETED|Period 3- Second Intervention||5
11087193|NCT01154634|12270023|FG000|NOT COMPLETED|Period 3- Second Intervention||0
11087194|NCT01154634|12270024|FG001|NOT COMPLETED|Period 3- Second Intervention||0
11087195|NCT01154634|12270025|FG002|NOT COMPLETED|Period 3- Second Intervention||0
11087196|NCT01154634|12270026|FG003|NOT COMPLETED|Period 3- Second Intervention||0
11087197|NCT01154634|12270023|FG000|STARTED|Period 4 - Washout||4
11087198|NCT01154634|12270024|FG001|STARTED|Period 4 - Washout||7
11087199|NCT01154634|12270025|FG002|STARTED|Period 4 - Washout||4
11087200|NCT01154634|12270026|FG003|STARTED|Period 4 - Washout||5
11087201|NCT01154634|12270023|FG000|COMPLETED|Period 4 - Washout||4
11087202|NCT01154634|12270024|FG001|COMPLETED|Period 4 - Washout||7
11087203|NCT01154634|12270025|FG002|COMPLETED|Period 4 - Washout||4
11087204|NCT01154634|12270026|FG003|COMPLETED|Period 4 - Washout||5
11087205|NCT01154634|12270023|FG000|NOT COMPLETED|Period 4 - Washout||0
11087206|NCT01154634|12270024|FG001|NOT COMPLETED|Period 4 - Washout||0
11087207|NCT01154634|12270025|FG002|NOT COMPLETED|Period 4 - Washout||0
11087208|NCT01154634|12270026|FG003|NOT COMPLETED|Period 4 - Washout||0
11087209|NCT01154634|12270023|FG000|STARTED|Period 5 - Third Intervention||4
11087210|NCT01154634|12270024|FG001|STARTED|Period 5 - Third Intervention||7
11087211|NCT01154634|12270025|FG002|STARTED|Period 5 - Third Intervention||4
11087212|NCT01154634|12270026|FG003|STARTED|Period 5 - Third Intervention||5
11087213|NCT01154634|12270023|FG000|COMPLETED|Period 5 - Third Intervention||4
11087214|NCT01154634|12270024|FG001|COMPLETED|Period 5 - Third Intervention||7
11087215|NCT01154634|12270025|FG002|COMPLETED|Period 5 - Third Intervention||4
11087216|NCT01154634|12270026|FG003|COMPLETED|Period 5 - Third Intervention||5
11087217|NCT01154634|12270023|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
11087218|NCT01154634|12270024|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
11087219|NCT01154634|12270025|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
11087220|NCT01154634|12270026|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
11087221|NCT01154634|12270023|FG000|STARTED|Period 6 - Washout||4
11087222|NCT01154634|12270024|FG001|STARTED|Period 6 - Washout||7
11087223|NCT01154634|12270025|FG002|STARTED|Period 6 - Washout||4
11087224|NCT01154634|12270026|FG003|STARTED|Period 6 - Washout||5
11087225|NCT01154634|12270023|FG000|COMPLETED|Period 6 - Washout||4
11087226|NCT01154634|12270024|FG001|COMPLETED|Period 6 - Washout||7
11087227|NCT01154634|12270025|FG002|COMPLETED|Period 6 - Washout||4
11087228|NCT01154634|12270026|FG003|COMPLETED|Period 6 - Washout||5
11087229|NCT01154634|12270023|FG000|NOT COMPLETED|Period 6 - Washout||0
11087230|NCT01154634|12270024|FG001|NOT COMPLETED|Period 6 - Washout||0
11087231|NCT01154634|12270025|FG002|NOT COMPLETED|Period 6 - Washout||0
11087232|NCT01154634|12270026|FG003|NOT COMPLETED|Period 6 - Washout||0
11087233|NCT01154634|12270023|FG000|STARTED|Period 7 - Fourth Intervention||4
11087234|NCT01154634|12270024|FG001|STARTED|Period 7 - Fourth Intervention||7
11087235|NCT01154634|12270025|FG002|STARTED|Period 7 - Fourth Intervention||4
11087236|NCT01154634|12270026|FG003|STARTED|Period 7 - Fourth Intervention||5
11087237|NCT01154634|12270023|FG000|COMPLETED|Period 7 - Fourth Intervention||4
11087238|NCT01154634|12270024|FG001|COMPLETED|Period 7 - Fourth Intervention||7
11087239|NCT01154634|12270025|FG002|COMPLETED|Period 7 - Fourth Intervention||4
11087240|NCT01154634|12270026|FG003|COMPLETED|Period 7 - Fourth Intervention||5
11087241|NCT01154634|12270023|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0
11087242|NCT01154634|12270024|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0
11087243|NCT01154634|12270025|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0
11087244|NCT01154634|12270026|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0
11087245|NCT01154673|12270038|FG000|STARTED|Overall Study||16
11087246|NCT01154673|12270039|FG001|STARTED|Overall Study||16
11087247|NCT01154673|12270038|FG000|COMPLETED|Overall Study||14
11087248|NCT01154673|12270039|FG001|COMPLETED|Overall Study||16
11087249|NCT01154673|12270038|FG000|NOT COMPLETED|Overall Study||2
11087250|NCT01154673|12270039|FG001|NOT COMPLETED|Overall Study||0
11087251|NCT01154699|12270047|FG000|STARTED|First Intervention (4 Weeks)||13
11087252|NCT01154699|12270048|FG001|STARTED|First Intervention (4 Weeks)||8
11087253|NCT01154699|12270047|FG000|Subjects With Asthma Only|First Intervention (4 Weeks)||7
11087254|NCT01154699|12270048|FG001|Subjects With Asthma Only|First Intervention (4 Weeks)||6
11087255|NCT01154699|12270047|FG000|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
11087256|NCT01154699|12270048|FG001|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
11087257|NCT01154699|12270047|FG000|COMPLETED|First Intervention (4 Weeks)||13
11087258|NCT01154699|12270048|FG001|COMPLETED|First Intervention (4 Weeks)||8
11087259|NCT01154699|12270047|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
11087260|NCT01154699|12270048|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
11087261|NCT01154699|12270047|FG000|STARTED|Washout Period (4 Weeks)||13
11087262|NCT01154699|12270048|FG001|STARTED|Washout Period (4 Weeks)||8
11087263|NCT01154699|12270047|FG000|Subjects With Asthma Only|Washout Period (4 Weeks)||7
11087264|NCT01154699|12270048|FG001|Subjects With Asthma Only|Washout Period (4 Weeks)||6
11087265|NCT01154699|12270047|FG000|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
11087266|NCT01154699|12270048|FG001|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
11087267|NCT01154699|12270047|FG000|COMPLETED|Washout Period (4 Weeks)||13
11087268|NCT01154699|12270048|FG001|COMPLETED|Washout Period (4 Weeks)||8
11087269|NCT01154699|12270047|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0
11087270|NCT01154699|12270048|FG001|NOT COMPLETED|Washout Period (4 Weeks)||0
11087271|NCT01154699|12270047|FG000|STARTED|Second Intervention||13
11087272|NCT01154699|12270048|FG001|STARTED|Second Intervention||8
11087273|NCT01154699|12270047|FG000|Subjects With Asthma Only|Second Intervention||7
11087274|NCT01154699|12270048|FG001|Subjects With Asthma Only|Second Intervention||6
11087275|NCT01154699|12270047|FG000|Subjects With Asthma + OSA|Second Intervention||6
11087276|NCT01154699|12270048|FG001|Subjects With Asthma + OSA|Second Intervention||2
11087277|NCT01154699|12270047|FG000|COMPLETED|Second Intervention||13
11087278|NCT01154699|12270048|FG001|COMPLETED|Second Intervention||8
11087279|NCT01154699|12270047|FG000|NOT COMPLETED|Second Intervention||0
11087280|NCT01154699|12270048|FG001|NOT COMPLETED|Second Intervention||0
11087281|NCT01154751|12270056|FG000|STARTED|6-month Follow-up||109
11087282|NCT01154751|12270056|FG000|COMPLETED|6-month Follow-up||98
11087283|NCT01154751|12270056|FG000|NOT COMPLETED|6-month Follow-up||11
11087284|NCT01154751|12270056|FG000|STARTED|1-year Follow-up||98
11087285|NCT01154751|12270056|FG000|COMPLETED|1-year Follow-up||93
11087286|NCT01154751|12270056|FG000|NOT COMPLETED|1-year Follow-up||5
11087287|NCT01154751|12270056|FG000|STARTED|2-year Follow-up||93
11087288|NCT01154751|12270056|FG000|COMPLETED|2-year Follow-up||83
11087289|NCT01154751|12270056|FG000|NOT COMPLETED|2-year Follow-up||10
11087290|NCT01154751|12270056|FG000|STARTED|3-year Follow-up||83
11087291|NCT01154751|12270056|FG000|COMPLETED|3-year Follow-up||34
11087292|NCT01154751|12270056|FG000|NOT COMPLETED|3-year Follow-up||49
11087293|NCT01154816|12270072|FG000|STARTED|Overall Study||20
11087294|NCT01154816|12270073|FG001|STARTED|Overall Study||12
11087295|NCT01154816|12270074|FG002|STARTED|Overall Study||10
11087296|NCT01154816|12270075|FG003|STARTED|Overall Study||10
11087297|NCT01154816|12270076|FG004|STARTED|Overall Study||10
11087298|NCT01154816|12270077|FG005|STARTED|Overall Study||8
11087299|NCT01154816|12270078|FG006|STARTED|Overall Study||6
11087300|NCT01154816|12270079|FG007|STARTED|Overall Study||7
11087301|NCT01154816|12270080|FG008|STARTED|Overall Study||10
11087302|NCT01154816|12270081|FG009|STARTED|Overall Study||10
11087303|NCT01154816|12270082|FG010|STARTED|Overall Study||11
11087304|NCT01154816|12270083|FG011|STARTED|Overall Study||4
11087305|NCT01154816|12270072|FG000|COMPLETED|Overall Study||0
11087306|NCT01154816|12270073|FG001|COMPLETED|Overall Study||2
11087307|NCT01154816|12270074|FG002|COMPLETED|Overall Study||0
11087308|NCT01154816|12270075|FG003|COMPLETED|Overall Study||0
11087309|NCT01154816|12270076|FG004|COMPLETED|Overall Study||0
11087310|NCT01154816|12270077|FG005|COMPLETED|Overall Study||0
11087311|NCT01154816|12270078|FG006|COMPLETED|Overall Study||0
11087312|NCT01154816|12270079|FG007|COMPLETED|Overall Study||0
11087313|NCT01154816|12270080|FG008|COMPLETED|Overall Study||1
11087314|NCT01154816|12270081|FG009|COMPLETED|Overall Study||0
11087315|NCT01154816|12270082|FG010|COMPLETED|Overall Study||0
11087316|NCT01154816|12270083|FG011|COMPLETED|Overall Study||0
11087317|NCT01154816|12270072|FG000|NOT COMPLETED|Overall Study||20
11087318|NCT01154816|12270073|FG001|NOT COMPLETED|Overall Study||10
11087319|NCT01154816|12270074|FG002|NOT COMPLETED|Overall Study||10
11087320|NCT01154816|12270075|FG003|NOT COMPLETED|Overall Study||10
11087321|NCT01154816|12270076|FG004|NOT COMPLETED|Overall Study||10
11087322|NCT01154816|12270077|FG005|NOT COMPLETED|Overall Study||8
11087323|NCT01154816|12270078|FG006|NOT COMPLETED|Overall Study||6
11087324|NCT01154816|12270079|FG007|NOT COMPLETED|Overall Study||7
11087325|NCT01154816|12270080|FG008|NOT COMPLETED|Overall Study||9
11087326|NCT01154816|12270081|FG009|NOT COMPLETED|Overall Study||10
11087327|NCT01154816|12270082|FG010|NOT COMPLETED|Overall Study||11
11087328|NCT01154816|12270083|FG011|NOT COMPLETED|Overall Study||4
11087329|NCT01154985|12270114|FG000|STARTED|Overall Study|Randomized|75
11087330|NCT01154985|12270115|FG001|STARTED|Overall Study|Randomized|82
11087331|NCT01154985|12270116|FG002|STARTED|Overall Study|Randomized|86
11087332|NCT01154985|12270114|FG000|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
11087333|NCT01154985|12270115|FG001|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
11087334|NCT01154985|12270116|FG002|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
11087335|NCT01154985|12270114|FG000|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
11087336|NCT01154985|12270115|FG001|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
11087337|NCT01154985|12270116|FG002|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
11087338|NCT01154985|12270114|FG000|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
11087339|NCT01154985|12270115|FG001|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
11087340|NCT01154985|12270116|FG002|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
11087341|NCT01154985|12270114|FG000|COMPLETED|Overall Study||58
11087342|NCT01154985|12270115|FG001|COMPLETED|Overall Study||55
11087343|NCT01154985|12270116|FG002|COMPLETED|Overall Study||68
11087344|NCT01154985|12270114|FG000|NOT COMPLETED|Overall Study||17
11087345|NCT01154985|12270115|FG001|NOT COMPLETED|Overall Study||27
11087346|NCT01154985|12270116|FG002|NOT COMPLETED|Overall Study||18
11087347|NCT01155011|12270126|FG000|STARTED|Baseline to 6 Months||151
11087348|NCT01155011|12270127|FG001|STARTED|Baseline to 6 Months||156
11087349|NCT01155011|12270126|FG000|COMPLETED|Baseline to 6 Months||129
11087350|NCT01155011|12270127|FG001|COMPLETED|Baseline to 6 Months||131
11087351|NCT01155011|12270126|FG000|NOT COMPLETED|Baseline to 6 Months||22
11087352|NCT01155011|12270127|FG001|NOT COMPLETED|Baseline to 6 Months||25
11087353|NCT01155011|12270126|FG000|STARTED|6 to 12 Months||129
11087354|NCT01155011|12270127|FG001|STARTED|6 to 12 Months||131
11087355|NCT01155011|12270126|FG000|COMPLETED|6 to 12 Months||120
11087356|NCT01155011|12270127|FG001|COMPLETED|6 to 12 Months||121
11087357|NCT01155011|12270126|FG000|NOT COMPLETED|6 to 12 Months||9
11087358|NCT01155011|12270127|FG001|NOT COMPLETED|6 to 12 Months||10
11087359|NCT01155024|12270137|FG000|STARTED|First Socket Intervention Fitting||5
11087360|NCT01155024|12270138|FG001|STARTED|First Socket Intervention Fitting||5
11087361|NCT01155024|12270137|FG000|COMPLETED|First Socket Intervention Fitting||5
11087362|NCT01155024|12270138|FG001|COMPLETED|First Socket Intervention Fitting||5
11087363|NCT01155024|12270137|FG000|NOT COMPLETED|First Socket Intervention Fitting||0
11087364|NCT01155024|12270138|FG001|NOT COMPLETED|First Socket Intervention Fitting||0
11087365|NCT01155024|12270137|FG000|STARTED|Second Socket Intervention Fitting||5
11087366|NCT01155024|12270138|FG001|STARTED|Second Socket Intervention Fitting||5
11087367|NCT01155024|12270137|FG000|COMPLETED|Second Socket Intervention Fitting||5
11087368|NCT01155024|12270138|FG001|COMPLETED|Second Socket Intervention Fitting||5
11087369|NCT01155024|12270137|FG000|NOT COMPLETED|Second Socket Intervention Fitting||0
11087370|NCT01155024|12270138|FG001|NOT COMPLETED|Second Socket Intervention Fitting||0
11087371|NCT01155024|12270137|FG000|STARTED|Direct Manufactured Socket 3 Month Trial||0
11087372|NCT01155024|12270138|FG001|STARTED|Direct Manufactured Socket 3 Month Trial||10
11087373|NCT01155024|12270137|FG000|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
11087374|NCT01155024|12270138|FG001|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
11087375|NCT01155024|12270137|FG000|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
11087376|NCT01155024|12270138|FG001|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
11087377|NCT01155050|12270149|FG000|STARTED|Overall Study||50
11087378|NCT01155050|12270150|FG001|STARTED|Overall Study||51
11087379|NCT01155050|12270151|FG002|STARTED|Overall Study||52
11087380|NCT01155050|12270152|FG003|STARTED|Overall Study||49
11087381|NCT01155050|12270149|FG000|COMPLETED|Overall Study||35
11087382|NCT01155050|12270150|FG001|COMPLETED|Overall Study||31
11087383|NCT01155050|12270151|FG002|COMPLETED|Overall Study||33
11087384|NCT01155050|12270152|FG003|COMPLETED|Overall Study||27
11087385|NCT01155050|12270149|FG000|NOT COMPLETED|Overall Study||15
11087386|NCT01155050|12270150|FG001|NOT COMPLETED|Overall Study||20
11087387|NCT01155050|12270151|FG002|NOT COMPLETED|Overall Study||19
11087388|NCT01155050|12270152|FG003|NOT COMPLETED|Overall Study||22
11087389|NCT01155063|12270162|FG000|STARTED|Overall Study||89
11087390|NCT01155063|12270162|FG000|COMPLETED|Overall Study||0
11087391|NCT01155063|12270162|FG000|NOT COMPLETED|Overall Study||89
11087392|NCT01155141|12270166|FG000|STARTED|Overall Study||16
11087393|NCT01155141|12270166|FG000|COMPLETED|Overall Study||14
11087394|NCT01155141|12270166|FG000|NOT COMPLETED|Overall Study||2
11087395|NCT01155154|12270173|FG000|STARTED|Overall Study||25
11087396|NCT01155154|12270174|FG001|STARTED|Overall Study||24
11087397|NCT01155154|12270175|FG002|STARTED|Overall Study||24
11087398|NCT01155154|12270173|FG000|COMPLETED|Overall Study||25
11087399|NCT01155154|12270174|FG001|COMPLETED|Overall Study||24
11087400|NCT01155154|12270175|FG002|COMPLETED|Overall Study||24
11087401|NCT01155154|12270173|FG000|NOT COMPLETED|Overall Study||0
11087402|NCT01155154|12270174|FG001|NOT COMPLETED|Overall Study||0
11087403|NCT01155154|12270175|FG002|NOT COMPLETED|Overall Study||0
11087404|NCT01155167|12270185|FG000|STARTED|Overall Study||43
11087405|NCT01155167|12270186|FG001|STARTED|Overall Study||43
11087406|NCT01155167|12270185|FG000|COMPLETED|Overall Study||40
11087407|NCT01155167|12270186|FG001|COMPLETED|Overall Study||43
11087408|NCT01155167|12270185|FG000|NOT COMPLETED|Overall Study||3
11207798|NCT01877421|12398897|FG003|STARTED|Phase 2||2
11207799|NCT01877421|12398898|FG004|STARTED|Phase 2||7
11207800|NCT01877421|12398899|FG005|STARTED|Phase 2||3
11207801|NCT01877421|12398900|FG006|STARTED|Phase 2||7
11207802|NCT01877421|12398901|FG007|STARTED|Phase 2||2
11087409|NCT01155167|12270186|FG001|NOT COMPLETED|Overall Study||0
11087410|NCT01155180|12270194|FG000|STARTED|Overall Study||18
11087411|NCT01155180|12270195|FG001|STARTED|Overall Study||6
11087412|NCT01155180|12270194|FG000|COMPLETED|Overall Study||18
11087413|NCT01155180|12270195|FG001|COMPLETED|Overall Study||6
11087414|NCT01155180|12270194|FG000|NOT COMPLETED|Overall Study||0
11087415|NCT01155180|12270195|FG001|NOT COMPLETED|Overall Study||0
11087416|NCT01155193|12270205|FG000|STARTED|Overall Study||10924
11087417|NCT01155193|12270206|FG001|STARTED|Overall Study||3818
11207803|NCT01877421|12398902|FG008|STARTED|Phase 2||6
11207804|NCT01877421|12398903|FG009|STARTED|Phase 2||3
11207805|NCT01877421|12398904|FG010|STARTED|Phase 2||7
11087418|NCT01155193|12270207|FG002|STARTED|Overall Study||2260
11087419|NCT01155193|12270208|FG003|STARTED|Overall Study||13802
11087420|NCT01155193|12270205|FG000|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
11087421|NCT01155193|12270206|FG001|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
11087422|NCT01155193|12270207|FG002|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
11087423|NCT01155193|12270208|FG003|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
11087424|NCT01155193|12270205|FG000|NOT COMPLETED|Overall Study||238
11087425|NCT01155193|12270206|FG001|NOT COMPLETED|Overall Study||13
11087426|NCT01155193|12270207|FG002|NOT COMPLETED|Overall Study||12
11087427|NCT01155193|12270208|FG003|NOT COMPLETED|Overall Study||91
11087428|NCT01155219|12270225|FG000|STARTED|Overall Study||77
11087429|NCT01155219|12270226|FG001|STARTED|Overall Study||73
11087430|NCT01155219|12270225|FG000|COMPLETED|Overall Study||73
11087431|NCT01155219|12270226|FG001|COMPLETED|Overall Study||70
11087432|NCT01155219|12270225|FG000|NOT COMPLETED|Overall Study||4
11087433|NCT01155219|12270226|FG001|NOT COMPLETED|Overall Study||3
11087434|NCT01155284|12270234|FG000|STARTED|Overall Study||47
11087435|NCT01155284|12270235|FG001|STARTED|Overall Study||23
11087436|NCT01155284|12270234|FG000|COMPLETED|Overall Study||40
11087437|NCT01155284|12270235|FG001|COMPLETED|Overall Study||18
11087438|NCT01155284|12270234|FG000|NOT COMPLETED|Overall Study||7
11087439|NCT01155284|12270235|FG001|NOT COMPLETED|Overall Study||5
11087440|NCT01155323|12270243|FG000|STARTED|First Intervention||60
11087441|NCT01155323|12270244|FG001|STARTED|First Intervention||58
11087442|NCT01155323|12270243|FG000|COMPLETED|First Intervention||59
11087443|NCT01155323|12270244|FG001|COMPLETED|First Intervention||57
11087444|NCT01155323|12270243|FG000|NOT COMPLETED|First Intervention||1
11087445|NCT01155323|12270244|FG001|NOT COMPLETED|First Intervention||1
11087446|NCT01155323|12270243|FG000|STARTED|Second Intervention||59
11087447|NCT01155323|12270244|FG001|STARTED|Second Intervention||57
11087448|NCT01155323|12270243|FG000|COMPLETED|Second Intervention||58
11087449|NCT01155323|12270244|FG001|COMPLETED|Second Intervention||56
11087450|NCT01155323|12270243|FG000|NOT COMPLETED|Second Intervention||1
11087451|NCT01155323|12270244|FG001|NOT COMPLETED|Second Intervention||1
11087452|NCT01155336|12270252|FG000|STARTED|Overall Study|We did not complete the study.|0
11087453|NCT01155336|12270253|FG001|STARTED|Overall Study|We did not complete the study.|4
11087454|NCT01155336|12270252|FG000|COMPLETED|Overall Study|We did not complete the study.|0
11087455|NCT01155336|12270253|FG001|COMPLETED|Overall Study|We did not complete the study.|4
11087456|NCT01155336|12270252|FG000|NOT COMPLETED|Overall Study||0
11087457|NCT01155336|12270253|FG001|NOT COMPLETED|Overall Study||0
11087458|NCT01155466|12270264|FG000|STARTED|Overall Study||156
11087459|NCT01155466|12270265|FG001|STARTED|Overall Study||155
11087460|NCT01155466|12270266|FG002|STARTED|Overall Study||156
11087461|NCT01155466|12270267|FG003|STARTED|Overall Study||155
11087462|NCT01155466|12270268|FG004|STARTED|Overall Study||156
11087463|NCT01155466|12270264|FG000|Treated|Overall Study||154
11087464|NCT01155466|12270265|FG001|Treated|Overall Study||153
11087465|NCT01155466|12270266|FG002|Treated|Overall Study||153
11087466|NCT01155466|12270267|FG003|Treated|Overall Study||155
11087467|NCT01155466|12270268|FG004|Treated|Overall Study||154
11087468|NCT01155466|12270264|FG000|COMPLETED|Overall Study|Completed treatment phase|134
11207806|NCT01877421|12398905|FG011|STARTED|Phase 2||3
11207807|NCT01877421|12398906|FG012|STARTED|Phase 2||7
11207808|NCT01877421|12398907|FG013|STARTED|Phase 2||3
11207809|NCT01877421|12398908|FG014|STARTED|Phase 2||7
11207810|NCT01877421|12398909|FG015|STARTED|Phase 2||3
11207811|NCT01877421|12398910|FG016|STARTED|Phase 2||0
11351286|NCT03034928|12548228|FG002|NOT COMPLETED|Washout Period Between Lens Wear||0
11351287|NCT03034928|12548229|FG003|NOT COMPLETED|Washout Period Between Lens Wear||0
11351288|NCT03034928|12548226|FG000|STARTED|Period 2, Second 2 Hours of Wear||8
11351289|NCT03034928|12548227|FG001|STARTED|Period 2, Second 2 Hours of Wear||8
11351290|NCT03034928|12548228|FG002|STARTED|Period 2, Second 2 Hours of Wear||9
11351291|NCT03034928|12548229|FG003|STARTED|Period 2, Second 2 Hours of Wear||8
11351292|NCT03034928|12548226|FG000|COMPLETED|Period 2, Second 2 Hours of Wear||8
11351293|NCT03034928|12548227|FG001|COMPLETED|Period 2, Second 2 Hours of Wear||8
11351294|NCT03034928|12548228|FG002|COMPLETED|Period 2, Second 2 Hours of Wear||9
11351295|NCT03034928|12548229|FG003|COMPLETED|Period 2, Second 2 Hours of Wear||8
11351296|NCT03034928|12548226|FG000|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
11207812|NCT01877421|12398911|FG017|STARTED|Phase 2||0
11207813|NCT01877421|12398894|FG000|COMPLETED|Phase 2||0
11207814|NCT01877421|12398895|FG001|COMPLETED|Phase 2||0
11351297|NCT03034928|12548227|FG001|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
11351298|NCT03034928|12548228|FG002|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
11351299|NCT03034928|12548229|FG003|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
11351300|NCT03034954|12548240|FG000|STARTED|Overall Study||21
11351301|NCT03034954|12548241|FG001|STARTED|Overall Study||21
11351302|NCT03034954|12548240|FG000|COMPLETED|Overall Study||20
11351303|NCT03034954|12548241|FG001|COMPLETED|Overall Study||21
11351304|NCT03034954|12548240|FG000|NOT COMPLETED|Overall Study||1
11351305|NCT03034954|12548241|FG001|NOT COMPLETED|Overall Study||0
11351306|NCT03034967|12548253|FG000|STARTED|Overall Study||102
11087469|NCT01155466|12270265|FG001|COMPLETED|Overall Study|Completed treatment phase|130
11087470|NCT01155466|12270266|FG002|COMPLETED|Overall Study|Completed treatment phase|136
11087471|NCT01155466|12270267|FG003|COMPLETED|Overall Study|Completed treatment phase|134
11087472|NCT01155466|12270268|FG004|COMPLETED|Overall Study|Completed treatment phase|129
11087473|NCT01155466|12270264|FG000|NOT COMPLETED|Overall Study||22
11087474|NCT01155466|12270265|FG001|NOT COMPLETED|Overall Study||25
11087475|NCT01155466|12270266|FG002|NOT COMPLETED|Overall Study||20
11087476|NCT01155466|12270267|FG003|NOT COMPLETED|Overall Study||21
11087477|NCT01155466|12270268|FG004|NOT COMPLETED|Overall Study||27
11087478|NCT01155479|12270285|FG000|STARTED|Part I||204
11087479|NCT01155479|12270286|FG001|STARTED|Part I||204
11087480|NCT01155479|12270287|FG002|STARTED|Part I||206
11087481|NCT01155479|12270288|FG003|STARTED|Part I||204
11087482|NCT01155479|12270289|FG004|STARTED|Part I||204
11087483|NCT01155479|12270285|FG000|Treated|Part I||200
11087484|NCT01155479|12270286|FG001|Treated|Part I||202
11087485|NCT01155479|12270287|FG002|Treated|Part I||204
11087486|NCT01155479|12270288|FG003|Treated|Part I||198
11087487|NCT01155479|12270289|FG004|Treated|Part I||203
11087488|NCT01155479|12270285|FG000|COMPLETED|Part I||166
11087489|NCT01155479|12270286|FG001|COMPLETED|Part I||177
11087490|NCT01155479|12270287|FG002|COMPLETED|Part I||167
11087491|NCT01155479|12270288|FG003|COMPLETED|Part I||177
11087492|NCT01155479|12270289|FG004|COMPLETED|Part I||181
11087493|NCT01155479|12270285|FG000|NOT COMPLETED|Part I||38
11087494|NCT01155479|12270286|FG001|NOT COMPLETED|Part I||27
11087495|NCT01155479|12270287|FG002|NOT COMPLETED|Part I||39
11087496|NCT01155479|12270288|FG003|NOT COMPLETED|Part I||27
11087497|NCT01155479|12270289|FG004|NOT COMPLETED|Part I||23
11087498|NCT01155479|12270285|FG000|STARTED|Part II||166
11087499|NCT01155479|12270286|FG001|STARTED|Part II||177
11087500|NCT01155479|12270287|FG002|STARTED|Part II||167
11087501|NCT01155479|12270288|FG003|STARTED|Part II||177
11087502|NCT01155479|12270289|FG004|STARTED|Part II||181
11087503|NCT01155479|12270285|FG000|COMPLETED|Part II||107
11087504|NCT01155479|12270286|FG001|COMPLETED|Part II||116
11087505|NCT01155479|12270287|FG002|COMPLETED|Part II||109
11087506|NCT01155479|12270288|FG003|COMPLETED|Part II||127
11087507|NCT01155479|12270289|FG004|COMPLETED|Part II||126
11087508|NCT01155479|12270285|FG000|NOT COMPLETED|Part II||59
11087509|NCT01155479|12270286|FG001|NOT COMPLETED|Part II||61
11087510|NCT01155479|12270287|FG002|NOT COMPLETED|Part II||58
11087511|NCT01155479|12270288|FG003|NOT COMPLETED|Part II||50
11087512|NCT01155479|12270289|FG004|NOT COMPLETED|Part II||55
11087513|NCT01155531|12270321|FG000|STARTED|Overall Study||10
11087514|NCT01155531|12270322|FG001|STARTED|Overall Study||10
11087515|NCT01155531|12270323|FG002|STARTED|Overall Study||10
11087516|NCT01155531|12270324|FG003|STARTED|Overall Study||10
11087517|NCT01155531|12270321|FG000|COMPLETED|Overall Study||9
11087518|NCT01155531|12270322|FG001|COMPLETED|Overall Study||10
11087519|NCT01155531|12270323|FG002|COMPLETED|Overall Study||8
11087520|NCT01155531|12270324|FG003|COMPLETED|Overall Study||9
11087521|NCT01155531|12270321|FG000|NOT COMPLETED|Overall Study||1
11087522|NCT01155531|12270322|FG001|NOT COMPLETED|Overall Study||0
11087523|NCT01155531|12270323|FG002|NOT COMPLETED|Overall Study||2
11087524|NCT01155531|12270324|FG003|NOT COMPLETED|Overall Study||1
11087525|NCT01155570|12270334|FG000|STARTED|Overall Study|Safety Analysis Population|734
11087526|NCT01155570|12270334|FG000|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
11087527|NCT01155570|12270334|FG000|COMPLETED|Overall Study||592
11087528|NCT01155570|12270334|FG000|NOT COMPLETED|Overall Study||142
11087529|NCT01155583|12270349|FG000|STARTED|Phase I||3
11087530|NCT01155583|12270350|FG001|STARTED|Phase I||3
11087531|NCT01155583|12270351|FG002|STARTED|Phase I||4
11087532|NCT01155583|12270352|FG003|STARTED|Phase I||6
11087533|NCT01155583|12270353|FG004|STARTED|Phase I||7
11087534|NCT01155583|12270354|FG005|STARTED|Phase I||0
11087535|NCT01155583|12270355|FG006|STARTED|Phase I||3
11087536|NCT01155583|12270356|FG007|STARTED|Phase I||8
11087537|NCT01155583|12270357|FG008|STARTED|Phase I||0
11207815|NCT01877421|12398896|FG002|COMPLETED|Phase 2||4
11087538|NCT01155583|12270349|FG000|COMPLETED|Phase I||3
11087539|NCT01155583|12270350|FG001|COMPLETED|Phase I||3
11087540|NCT01155583|12270351|FG002|COMPLETED|Phase I||4
11087541|NCT01155583|12270352|FG003|COMPLETED|Phase I||6
11087542|NCT01155583|12270353|FG004|COMPLETED|Phase I||6
11087543|NCT01155583|12270354|FG005|COMPLETED|Phase I||0
11087544|NCT01155583|12270355|FG006|COMPLETED|Phase I||3
11087545|NCT01155583|12270356|FG007|COMPLETED|Phase I||5
11087546|NCT01155583|12270357|FG008|COMPLETED|Phase I||0
11087547|NCT01155583|12270349|FG000|NOT COMPLETED|Phase I||0
11087548|NCT01155583|12270350|FG001|NOT COMPLETED|Phase I||0
11087549|NCT01155583|12270351|FG002|NOT COMPLETED|Phase I||0
11087550|NCT01155583|12270352|FG003|NOT COMPLETED|Phase I||0
11087551|NCT01155583|12270353|FG004|NOT COMPLETED|Phase I||1
11087552|NCT01155583|12270354|FG005|NOT COMPLETED|Phase I||0
11087553|NCT01155583|12270355|FG006|NOT COMPLETED|Phase I||0
11087554|NCT01155583|12270356|FG007|NOT COMPLETED|Phase I||3
11087555|NCT01155583|12270357|FG008|NOT COMPLETED|Phase I||0
11087556|NCT01155583|12270349|FG000|STARTED|Phase II - Expansion Phase||0
11087557|NCT01155583|12270350|FG001|STARTED|Phase II - Expansion Phase||0
11087558|NCT01155583|12270351|FG002|STARTED|Phase II - Expansion Phase||0
11087559|NCT01155583|12270352|FG003|STARTED|Phase II - Expansion Phase||0
11087560|NCT01155583|12270353|FG004|STARTED|Phase II - Expansion Phase||0
11087561|NCT01155583|12270354|FG005|STARTED|Phase II - Expansion Phase||0
11087562|NCT01155583|12270355|FG006|STARTED|Phase II - Expansion Phase||0
11087563|NCT01155583|12270356|FG007|STARTED|Phase II - Expansion Phase||0
11087564|NCT01155583|12270357|FG008|STARTED|Phase II - Expansion Phase||11
11087565|NCT01155583|12270349|FG000|COMPLETED|Phase II - Expansion Phase||0
11087566|NCT01155583|12270350|FG001|COMPLETED|Phase II - Expansion Phase||0
11087567|NCT01155583|12270351|FG002|COMPLETED|Phase II - Expansion Phase||0
11087568|NCT01155583|12270352|FG003|COMPLETED|Phase II - Expansion Phase||0
11087569|NCT01155583|12270353|FG004|COMPLETED|Phase II - Expansion Phase||0
11087570|NCT01155583|12270354|FG005|COMPLETED|Phase II - Expansion Phase||0
11087571|NCT01155583|12270355|FG006|COMPLETED|Phase II - Expansion Phase||0
11087572|NCT01155583|12270356|FG007|COMPLETED|Phase II - Expansion Phase||0
11087573|NCT01155583|12270357|FG008|COMPLETED|Phase II - Expansion Phase||11
11087574|NCT01155583|12270349|FG000|NOT COMPLETED|Phase II - Expansion Phase||0
11087575|NCT01155583|12270350|FG001|NOT COMPLETED|Phase II - Expansion Phase||0
11087576|NCT01155583|12270351|FG002|NOT COMPLETED|Phase II - Expansion Phase||0
11087577|NCT01155583|12270352|FG003|NOT COMPLETED|Phase II - Expansion Phase||0
11087578|NCT01155583|12270353|FG004|NOT COMPLETED|Phase II - Expansion Phase||0
11087579|NCT01155583|12270354|FG005|NOT COMPLETED|Phase II - Expansion Phase||0
11087580|NCT01155583|12270355|FG006|NOT COMPLETED|Phase II - Expansion Phase||0
11087581|NCT01155583|12270356|FG007|NOT COMPLETED|Phase II - Expansion Phase||0
11087582|NCT01155583|12270357|FG008|NOT COMPLETED|Phase II - Expansion Phase||0
11087583|NCT01155661|12270373|FG000|STARTED|Overall Study||608
11087584|NCT01155661|12270373|FG000|COMPLETED|Overall Study||328
11087585|NCT01155661|12270373|FG000|NOT COMPLETED|Overall Study||280
11087586|NCT01155726|12270379|FG000|STARTED|Period 1, 3 Days (Masked)||24
11087587|NCT01155726|12270380|FG001|STARTED|Period 1, 3 Days (Masked)||20
11087588|NCT01155726|12270381|FG002|STARTED|Period 1, 3 Days (Masked)||30
11087589|NCT01155726|12270382|FG003|STARTED|Period 1, 3 Days (Masked)||25
11087590|NCT01155726|12270379|FG000|COMPLETED|Period 1, 3 Days (Masked)||23
11087591|NCT01155726|12270380|FG001|COMPLETED|Period 1, 3 Days (Masked)||20
11087592|NCT01155726|12270381|FG002|COMPLETED|Period 1, 3 Days (Masked)||28
11087593|NCT01155726|12270382|FG003|COMPLETED|Period 1, 3 Days (Masked)||25
11087594|NCT01155726|12270379|FG000|NOT COMPLETED|Period 1, 3 Days (Masked)||1
11087595|NCT01155726|12270380|FG001|NOT COMPLETED|Period 1, 3 Days (Masked)||0
11087596|NCT01155726|12270381|FG002|NOT COMPLETED|Period 1, 3 Days (Masked)||2
11087597|NCT01155726|12270382|FG003|NOT COMPLETED|Period 1, 3 Days (Masked)||0
11087598|NCT01155726|12270379|FG000|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
11087599|NCT01155726|12270380|FG001|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
11087600|NCT01155726|12270381|FG002|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
11087601|NCT01155726|12270382|FG003|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
11087602|NCT01155726|12270379|FG000|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
11087603|NCT01155726|12270380|FG001|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
11087604|NCT01155726|12270381|FG002|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
11087605|NCT01155726|12270382|FG003|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
11087606|NCT01155726|12270379|FG000|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
11087607|NCT01155726|12270380|FG001|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
11087608|NCT01155726|12270381|FG002|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
11087609|NCT01155726|12270382|FG003|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
11087610|NCT01155778|12270407|FG000|STARTED|Overall Study||4
11087611|NCT01155778|12270408|FG001|STARTED|Overall Study||4
11351307|NCT03034967|12548254|FG001|STARTED|Overall Study||102
11351308|NCT03034967|12548255|FG002|STARTED|Overall Study||103
11351309|NCT03034967|12548256|FG003|STARTED|Overall Study||103
11351310|NCT03034967|12548257|FG004|STARTED|Overall Study||102
11087612|NCT01155778|12270409|FG002|STARTED|Overall Study||4
11087613|NCT01155778|12270407|FG000|COMPLETED|Overall Study||4
11087614|NCT01155778|12270408|FG001|COMPLETED|Overall Study||4
11087615|NCT01155778|12270409|FG002|COMPLETED|Overall Study||4
11087616|NCT01155778|12270407|FG000|NOT COMPLETED|Overall Study||0
11087617|NCT01155778|12270408|FG001|NOT COMPLETED|Overall Study||0
11087618|NCT01155778|12270409|FG002|NOT COMPLETED|Overall Study||0
11087619|NCT01155830|12270420|FG000|STARTED|Overall Study||0
11087620|NCT01155830|12270421|FG001|STARTED|Overall Study||0
11087621|NCT01155830|12270422|FG002|STARTED|Overall Study||21
11087622|NCT01155830|12270420|FG000|COMPLETED|Overall Study||0
11087623|NCT01155830|12270421|FG001|COMPLETED|Overall Study||0
11087624|NCT01155830|12270422|FG002|COMPLETED|Overall Study||21
11087625|NCT01155830|12270420|FG000|NOT COMPLETED|Overall Study||0
11087626|NCT01155830|12270421|FG001|NOT COMPLETED|Overall Study||0
11087627|NCT01155830|12270422|FG002|NOT COMPLETED|Overall Study||0
11087628|NCT01155869|12270432|FG000|STARTED|Overall Study||3
11087629|NCT01155869|12270433|FG001|STARTED|Overall Study||4
11087630|NCT01155869|12270432|FG000|COMPLETED|Overall Study||0
11087631|NCT01155869|12270433|FG001|COMPLETED|Overall Study||3
11087632|NCT01155869|12270432|FG000|NOT COMPLETED|Overall Study||3
11087633|NCT01155869|12270433|FG001|NOT COMPLETED|Overall Study||1
11087634|NCT01155999|12270441|FG000|STARTED|Overall Study||146
11087635|NCT01155999|12270442|FG001|STARTED|Overall Study||140
11087636|NCT01155999|12270441|FG000|COMPLETED|Overall Study||139
11087637|NCT01155999|12270442|FG001|COMPLETED|Overall Study||136
11087638|NCT01155999|12270441|FG000|NOT COMPLETED|Overall Study||7
11087639|NCT01155999|12270442|FG001|NOT COMPLETED|Overall Study||4
11087640|NCT01156012|12270450|FG000|STARTED|Overall Study||213
11087641|NCT01156012|12270451|FG001|STARTED|Overall Study||189
11087642|NCT01156012|12270450|FG000|COMPLETED|Overall Study||206
11087643|NCT01156012|12270451|FG001|COMPLETED|Overall Study||186
11351311|NCT03034967|12548258|FG005|STARTED|Overall Study||102
11351312|NCT03034967|12548253|FG000|COMPLETED|Overall Study||88
11087644|NCT01156012|12270450|FG000|NOT COMPLETED|Overall Study||7
11087645|NCT01156012|12270451|FG001|NOT COMPLETED|Overall Study||3
11087646|NCT01156051|12270459|FG000|STARTED|Overall Study||12
11087647|NCT01156051|12270460|FG001|STARTED|Overall Study||17
11087648|NCT01156051|12270459|FG000|COMPLETED|Overall Study||11
11087649|NCT01156051|12270460|FG001|COMPLETED|Overall Study||16
11087650|NCT01156051|12270459|FG000|NOT COMPLETED|Overall Study||1
11087651|NCT01156051|12270460|FG001|NOT COMPLETED|Overall Study||1
11351313|NCT03034967|12548254|FG001|COMPLETED|Overall Study||97
11087652|NCT01156116|12270468|FG000|STARTED|Overall Study||26
11087653|NCT01156116|12270469|FG001|STARTED|Overall Study||13
11087654|NCT01156116|12270468|FG000|COMPLETED|Overall Study||21
11087655|NCT01156116|12270469|FG001|COMPLETED|Overall Study||12
11087656|NCT01156116|12270468|FG000|NOT COMPLETED|Overall Study||5
11087657|NCT01156116|12270469|FG001|NOT COMPLETED|Overall Study||1
11087658|NCT01156142|12270477|FG000|STARTED|Overall Study||77
11087659|NCT01156142|12270478|FG001|STARTED|Overall Study||78
11087660|NCT01156142|12270477|FG000|COMPLETED|Overall Study||69
11087661|NCT01156142|12270478|FG001|COMPLETED|Overall Study||71
11087662|NCT01156142|12270477|FG000|NOT COMPLETED|Overall Study||8
11087663|NCT01156142|12270478|FG001|NOT COMPLETED|Overall Study||7
11087664|NCT01156311|12270486|FG000|STARTED|2-Month Monotherapy Period||59
11087665|NCT01156311|12270487|FG001|STARTED|2-Month Monotherapy Period||49
11087666|NCT01156311|12270488|FG002|STARTED|2-Month Monotherapy Period||0
11087667|NCT01156311|12270489|FG003|STARTED|2-Month Monotherapy Period||0
11087668|NCT01156311|12270486|FG000|COMPLETED|2-Month Monotherapy Period||57
11087669|NCT01156311|12270487|FG001|COMPLETED|2-Month Monotherapy Period||47
11087670|NCT01156311|12270488|FG002|COMPLETED|2-Month Monotherapy Period||0
11087671|NCT01156311|12270489|FG003|COMPLETED|2-Month Monotherapy Period||0
11087672|NCT01156311|12270486|FG000|NOT COMPLETED|2-Month Monotherapy Period||2
11087673|NCT01156311|12270487|FG001|NOT COMPLETED|2-Month Monotherapy Period||2
11087674|NCT01156311|12270488|FG002|NOT COMPLETED|2-Month Monotherapy Period||0
11087675|NCT01156311|12270489|FG003|NOT COMPLETED|2-Month Monotherapy Period||0
11087676|NCT01156311|12270486|FG000|STARTED|6-month Add-on Therapy Period||0
11087677|NCT01156311|12270487|FG001|STARTED|6-month Add-on Therapy Period||0
11087678|NCT01156311|12270488|FG002|STARTED|6-month Add-on Therapy Period||57
11087679|NCT01156311|12270489|FG003|STARTED|6-month Add-on Therapy Period||47
11087680|NCT01156311|12270486|FG000|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
11087681|NCT01156311|12270487|FG001|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
11087682|NCT01156311|12270488|FG002|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
11087683|NCT01156311|12270489|FG003|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
11087684|NCT01156311|12270486|FG000|COMPLETED|6-month Add-on Therapy Period||0
11087685|NCT01156311|12270487|FG001|COMPLETED|6-month Add-on Therapy Period||0
11087686|NCT01156311|12270488|FG002|COMPLETED|6-month Add-on Therapy Period||45
11087687|NCT01156311|12270489|FG003|COMPLETED|6-month Add-on Therapy Period||37
11087688|NCT01156311|12270486|FG000|NOT COMPLETED|6-month Add-on Therapy Period||0
11087689|NCT01156311|12270487|FG001|NOT COMPLETED|6-month Add-on Therapy Period||0
11087690|NCT01156311|12270488|FG002|NOT COMPLETED|6-month Add-on Therapy Period||12
11087691|NCT01156311|12270489|FG003|NOT COMPLETED|6-month Add-on Therapy Period||10
11087692|NCT01156363|12270500|FG000|STARTED|Overall Study||86
11087693|NCT01156363|12270500|FG000|COMPLETED|Overall Study||64
11087694|NCT01156363|12270500|FG000|NOT COMPLETED|Overall Study||22
11087695|NCT01156376|12270514|FG000|STARTED|Overall Study||27
11087696|NCT01156376|12270515|FG001|STARTED|Overall Study||26
11087697|NCT01156376|12270516|FG002|STARTED|Overall Study||27
11087698|NCT01156376|12270514|FG000|COMPLETED|Overall Study||26
11087699|NCT01156376|12270515|FG001|COMPLETED|Overall Study||26
11087700|NCT01156376|12270516|FG002|COMPLETED|Overall Study||23
11351314|NCT03034967|12548255|FG002|COMPLETED|Overall Study||90
11351315|NCT03034967|12548256|FG003|COMPLETED|Overall Study||92
11351316|NCT03034967|12548257|FG004|COMPLETED|Overall Study||88
11351317|NCT03034967|12548258|FG005|COMPLETED|Overall Study||87
11351318|NCT03034967|12548253|FG000|NOT COMPLETED|Overall Study||14
11351319|NCT03034967|12548254|FG001|NOT COMPLETED|Overall Study||5
11351320|NCT03034967|12548255|FG002|NOT COMPLETED|Overall Study||13
11351321|NCT03034967|12548256|FG003|NOT COMPLETED|Overall Study||11
11351322|NCT03034967|12548257|FG004|NOT COMPLETED|Overall Study||14
11351323|NCT03034967|12548258|FG005|NOT COMPLETED|Overall Study||15
11351324|NCT03035032|12548277|FG000|STARTED|Overall Study||107
11351325|NCT03035032|12548277|FG000|COMPLETED|Overall Study||64
11087701|NCT01156376|12270514|FG000|NOT COMPLETED|Overall Study||1
11087702|NCT01156376|12270515|FG001|NOT COMPLETED|Overall Study||0
11087703|NCT01156376|12270516|FG002|NOT COMPLETED|Overall Study||4
11087704|NCT01156480|12270526|FG000|STARTED|Overall Study||0
11351326|NCT03035032|12548277|FG000|NOT COMPLETED|Overall Study||43
11351327|NCT03035318|12548286|FG000|STARTED|Overall Study||24
11351328|NCT03035318|12548287|FG001|STARTED|Overall Study||25
11351329|NCT03035318|12548288|FG002|STARTED|Overall Study||25
11351330|NCT03035318|12548289|FG003|STARTED|Overall Study||25
11351331|NCT03035318|12548290|FG004|STARTED|Overall Study||27
11351332|NCT03035318|12548286|FG000|COMPLETED|Overall Study||22
11351333|NCT03035318|12548287|FG001|COMPLETED|Overall Study||21
11351334|NCT03035318|12548288|FG002|COMPLETED|Overall Study||21
11351335|NCT03035318|12548289|FG003|COMPLETED|Overall Study||23
11087705|NCT01156480|12270527|FG001|STARTED|Overall Study||2
11087706|NCT01156480|12270526|FG000|COMPLETED|Overall Study||0
11087707|NCT01156480|12270527|FG001|COMPLETED|Overall Study||1
11087708|NCT01156480|12270526|FG000|NOT COMPLETED|Overall Study||0
11087709|NCT01156480|12270527|FG001|NOT COMPLETED|Overall Study||1
11087710|NCT01156532|12270535|FG000|STARTED|Overall Study||30
11087711|NCT01156532|12270535|FG000|COMPLETED|Overall Study||28
11087712|NCT01156532|12270535|FG000|NOT COMPLETED|Overall Study||2
11087713|NCT01156571|12270541|FG000|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
11087714|NCT01156571|12270542|FG001|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
11087715|NCT01156571|12270541|FG000|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
11087716|NCT01156571|12270542|FG001|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
11087717|NCT01156571|12270541|FG000|NOT COMPLETED|Overall Study||17
11087718|NCT01156571|12270542|FG001|NOT COMPLETED|Overall Study||19
11087719|NCT01156597|12270550|FG000|STARTED|Overall Study||16
11087720|NCT01156597|12270551|FG001|STARTED|Overall Study||14
11087721|NCT01156597|12270550|FG000|COMPLETED|Overall Study||13
11087722|NCT01156597|12270551|FG001|COMPLETED|Overall Study||13
11087723|NCT01156597|12270550|FG000|NOT COMPLETED|Overall Study||3
11087724|NCT01156597|12270551|FG001|NOT COMPLETED|Overall Study||1
11087725|NCT01156675|12270561|FG000|STARTED|Overall Study||107
11087726|NCT01156675|12270562|FG001|STARTED|Overall Study||106
11087727|NCT01156675|12270563|FG002|STARTED|Overall Study||2
11087728|NCT01156675|12270561|FG000|COMPLETED|Overall Study||73
11087729|NCT01156675|12270562|FG001|COMPLETED|Overall Study||81
11087730|NCT01156675|12270563|FG002|COMPLETED|Overall Study||0
11087731|NCT01156675|12270561|FG000|NOT COMPLETED|Overall Study||34
11087732|NCT01156675|12270562|FG001|NOT COMPLETED|Overall Study||25
11087733|NCT01156675|12270563|FG002|NOT COMPLETED|Overall Study||2
11087734|NCT01156701|12270572|FG000|STARTED|Overall Study||257
11087735|NCT01156701|12270573|FG001|STARTED|Overall Study||1007
11087736|NCT01156701|12270574|FG002|STARTED|Overall Study||163716
11087737|NCT01156701|12270575|FG003|STARTED|Overall Study||6725
11087738|NCT01156701|12270572|FG000|COMPLETED|Overall Study||257
11087739|NCT01156701|12270573|FG001|COMPLETED|Overall Study||1007
11087740|NCT01156701|12270574|FG002|COMPLETED|Overall Study||163716
11087741|NCT01156701|12270575|FG003|COMPLETED|Overall Study||6725
11087742|NCT01156701|12270572|FG000|NOT COMPLETED|Overall Study||0
11087743|NCT01156701|12270573|FG001|NOT COMPLETED|Overall Study||0
11087744|NCT01156701|12270574|FG002|NOT COMPLETED|Overall Study||0
11087745|NCT01156701|12270575|FG003|NOT COMPLETED|Overall Study||0
11087746|NCT01156714|12270588|FG000|STARTED|Overall Study||20
11087747|NCT01156714|12270589|FG001|STARTED|Overall Study||19
11087748|NCT01156714|12270590|FG002|STARTED|Overall Study||20
11087749|NCT01156714|12270588|FG000|COMPLETED|Overall Study||11
11087750|NCT01156714|12270589|FG001|COMPLETED|Overall Study||15
11087751|NCT01156714|12270590|FG002|COMPLETED|Overall Study||17
11087752|NCT01156714|12270588|FG000|NOT COMPLETED|Overall Study||9
11087753|NCT01156714|12270589|FG001|NOT COMPLETED|Overall Study||4
11087754|NCT01156714|12270590|FG002|NOT COMPLETED|Overall Study||3
11087755|NCT01156792|12270601|FG000|STARTED|Overall Study||162
11087756|NCT01156792|12270601|FG000|COMPLETED|Overall Study||93
11087757|NCT01156792|12270601|FG000|NOT COMPLETED|Overall Study||69
11087758|NCT01156805|12270618|FG000|STARTED|Overall Study||237
11087759|NCT01156805|12270619|FG001|STARTED|Overall Study||272
11087760|NCT01156805|12270618|FG000|COMPLETED|Overall Study||181
11087761|NCT01156805|12270619|FG001|COMPLETED|Overall Study||216
11087762|NCT01156805|12270618|FG000|NOT COMPLETED|Overall Study||56
11087763|NCT01156805|12270619|FG001|NOT COMPLETED|Overall Study||56
11087764|NCT01156844|12270629|FG000|STARTED|Overall Study|Randomized participants.|48
11087765|NCT01156844|12270630|FG001|STARTED|Overall Study||48
11087766|NCT01156844|12270631|FG002|STARTED|Overall Study||48
11087767|NCT01156844|12270632|FG003|STARTED|Overall Study||47
11087768|NCT01156844|12270629|FG000|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
11087769|NCT01156844|12270630|FG001|PD & Safety Sets: Received Study Drug|Overall Study||47
11087770|NCT01156844|12270631|FG002|PD & Safety Sets: Received Study Drug|Overall Study||48
11087771|NCT01156844|12270632|FG003|PD & Safety Sets: Received Study Drug|Overall Study||46
11087772|NCT01156844|12270629|FG000|COMPLETED|Overall Study||46
11087773|NCT01156844|12270630|FG001|COMPLETED|Overall Study||46
11087774|NCT01156844|12270631|FG002|COMPLETED|Overall Study||42
11087775|NCT01156844|12270632|FG003|COMPLETED|Overall Study||41
11087776|NCT01156844|12270629|FG000|NOT COMPLETED|Overall Study||2
11087777|NCT01156844|12270630|FG001|NOT COMPLETED|Overall Study||2
11087778|NCT01156844|12270631|FG002|NOT COMPLETED|Overall Study||6
11087779|NCT01156844|12270632|FG003|NOT COMPLETED|Overall Study||6
11087780|NCT01156987|12270647|FG000|STARTED|Overall Study||8
11087781|NCT01156987|12270648|FG001|STARTED|Overall Study||23
11087782|NCT01156987|12270647|FG000|COMPLETED|Overall Study||8
11087783|NCT01156987|12270648|FG001|COMPLETED|Overall Study||12
11087784|NCT01156987|12270647|FG000|NOT COMPLETED|Overall Study||0
11087785|NCT01156987|12270648|FG001|NOT COMPLETED|Overall Study||11
11087786|NCT01157065|12270656|FG000|STARTED|Overall Study||38
11087787|NCT01157065|12270657|FG001|STARTED|Overall Study||11
11087788|NCT01157065|12270656|FG000|COMPLETED|Overall Study||38
11087789|NCT01157065|12270657|FG001|COMPLETED|Overall Study||10
11087790|NCT01157065|12270656|FG000|NOT COMPLETED|Overall Study||0
11087791|NCT01157065|12270657|FG001|NOT COMPLETED|Overall Study||1
11087792|NCT01157078|12270665|FG000|STARTED|Overall Study||159
11087793|NCT01157078|12270666|FG001|STARTED|Overall Study||160
11087794|NCT01157078|12270665|FG000|Received Treatment|Overall Study||157
11087795|NCT01157078|12270666|FG001|Received Treatment|Overall Study||159
11087796|NCT01157078|12270665|FG000|COMPLETED|Overall Study||124
11087797|NCT01157078|12270666|FG001|COMPLETED|Overall Study||124
11087798|NCT01157078|12270665|FG000|NOT COMPLETED|Overall Study||35
11087799|NCT01157078|12270666|FG001|NOT COMPLETED|Overall Study||36
11087800|NCT01157117|12270675|FG000|STARTED|Overall Study||28
11087801|NCT01157117|12270676|FG001|STARTED|Overall Study||29
11087802|NCT01157117|12270677|FG002|STARTED|Overall Study||20
11087803|NCT01157117|12270675|FG000|Began Omalizumab or Placebo Dosing|Overall Study||27
11087804|NCT01157117|12270676|FG001|Began Omalizumab or Placebo Dosing|Overall Study||28
11087805|NCT01157117|12270677|FG002|Began Omalizumab or Placebo Dosing|Overall Study||0
11087806|NCT01157117|12270675|FG000|Began Milk OIT Dosing at Month 4|Overall Study||27
11087807|NCT01157117|12270676|FG001|Began Milk OIT Dosing at Month 4|Overall Study||28
11087808|NCT01157117|12270677|FG002|Began Milk OIT Dosing at Month 4|Overall Study||0
11087809|NCT01157117|12270675|FG000|Reached Milk OIT Maintenance Dosing|Overall Study||26
11087810|NCT01157117|12270676|FG001|Reached Milk OIT Maintenance Dosing|Overall Study||26
11087811|NCT01157117|12270677|FG002|Reached Milk OIT Maintenance Dosing|Overall Study||0
11087812|NCT01157117|12270675|FG000|Unblinded at Month 16|Overall Study||26
11087813|NCT01157117|12270676|FG001|Unblinded at Month 16|Overall Study||26
11087814|NCT01157117|12270677|FG002|Unblinded at Month 16|Overall Study||0
11087815|NCT01157117|12270675|FG000|Completed Month 28 Desensitization OFC|Overall Study||26
11087816|NCT01157117|12270676|FG001|Completed Month 28 Desensitization OFC|Overall Study||24
11087817|NCT01157117|12270677|FG002|Completed Month 28 Desensitization OFC|Overall Study||0
11087818|NCT01157117|12270675|FG000|Discontinued Milk OIT at Month 30|Overall Study||24
11087819|NCT01157117|12270676|FG001|Discontinued Milk OIT at Month 30|Overall Study||20
11087820|NCT01157117|12270677|FG002|Discontinued Milk OIT at Month 30|Overall Study||0
11087821|NCT01157117|12270675|FG000|Completed Month 32 Tolerance OFC|Overall Study||24
11087822|NCT01157117|12270676|FG001|Completed Month 32 Tolerance OFC|Overall Study||20
11087823|NCT01157117|12270677|FG002|Completed Month 32 Tolerance OFC|Overall Study||0
11087824|NCT01157117|12270675|FG000|Completed Final Month 38 Study Visit|Overall Study||19
11087825|NCT01157117|12270676|FG001|Completed Final Month 38 Study Visit|Overall Study||18
11087826|NCT01157117|12270677|FG002|Completed Final Month 38 Study Visit|Overall Study||3
11087827|NCT01157117|12270675|FG000|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
11087828|NCT01157117|12270676|FG001|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
11087829|NCT01157117|12270677|FG002|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
11087830|NCT01157117|12270675|FG000|NOT COMPLETED|Overall Study||9
11087831|NCT01157117|12270676|FG001|NOT COMPLETED|Overall Study||11
11087832|NCT01157117|12270677|FG002|NOT COMPLETED|Overall Study||15
11087833|NCT01157169|12270687|FG000|STARTED|First Intervention||20
11087834|NCT01157169|12270688|FG001|STARTED|First Intervention||20
11087835|NCT01157169|12270687|FG000|COMPLETED|First Intervention||16
11087836|NCT01157169|12270688|FG001|COMPLETED|First Intervention||18
11087837|NCT01157169|12270687|FG000|NOT COMPLETED|First Intervention||4
11087838|NCT01157169|12270688|FG001|NOT COMPLETED|First Intervention||2
11087839|NCT01157169|12270687|FG000|STARTED|Washout of 10 Days||16
11087840|NCT01157169|12270688|FG001|STARTED|Washout of 10 Days||18
11087841|NCT01157169|12270687|FG000|COMPLETED|Washout of 10 Days||16
11087842|NCT01157169|12270688|FG001|COMPLETED|Washout of 10 Days||18
11087843|NCT01157169|12270687|FG000|NOT COMPLETED|Washout of 10 Days||0
11087844|NCT01157169|12270688|FG001|NOT COMPLETED|Washout of 10 Days||0
11087845|NCT01157169|12270687|FG000|STARTED|Second Intervention||16
11087846|NCT01157169|12270688|FG001|STARTED|Second Intervention||18
11087847|NCT01157169|12270687|FG000|COMPLETED|Second Intervention||16
11087848|NCT01157169|12270688|FG001|COMPLETED|Second Intervention||17
11087849|NCT01157169|12270687|FG000|NOT COMPLETED|Second Intervention||0
11087850|NCT01157169|12270688|FG001|NOT COMPLETED|Second Intervention||1
11087851|NCT01157182|12270696|FG000|STARTED|First Intervention||18
11087852|NCT01157182|12270697|FG001|STARTED|First Intervention||18
11087853|NCT01157182|12270696|FG000|COMPLETED|First Intervention||18
11087854|NCT01157182|12270697|FG001|COMPLETED|First Intervention||18
11087855|NCT01157182|12270696|FG000|NOT COMPLETED|First Intervention||0
11087856|NCT01157182|12270697|FG001|NOT COMPLETED|First Intervention||0
11087857|NCT01157182|12270696|FG000|STARTED|Washout of 28 Days||18
11087858|NCT01157182|12270697|FG001|STARTED|Washout of 28 Days||18
11087859|NCT01157182|12270696|FG000|COMPLETED|Washout of 28 Days||16
11087860|NCT01157182|12270697|FG001|COMPLETED|Washout of 28 Days||18
11087861|NCT01157182|12270696|FG000|NOT COMPLETED|Washout of 28 Days||2
11087862|NCT01157182|12270697|FG001|NOT COMPLETED|Washout of 28 Days||0
11087863|NCT01157182|12270696|FG000|STARTED|Second Intervention||16
11087864|NCT01157182|12270697|FG001|STARTED|Second Intervention||18
11087865|NCT01157182|12270696|FG000|COMPLETED|Second Intervention||16
11087866|NCT01157182|12270697|FG001|COMPLETED|Second Intervention||18
11087867|NCT01157182|12270696|FG000|NOT COMPLETED|Second Intervention||0
11087868|NCT01157182|12270697|FG001|NOT COMPLETED|Second Intervention||0
11087869|NCT01157234|12270705|FG000|STARTED|Overall Study||15
11087870|NCT01157234|12270706|FG001|STARTED|Overall Study||15
11087871|NCT01157234|12270705|FG000|COMPLETED|Overall Study||14
11087872|NCT01157234|12270706|FG001|COMPLETED|Overall Study||15
11087873|NCT01157234|12270705|FG000|NOT COMPLETED|Overall Study||1
11087874|NCT01157234|12270706|FG001|NOT COMPLETED|Overall Study||0
11087875|NCT01157351|12270721|FG000|STARTED|Overall Study||230
11087876|NCT01157351|12270722|FG001|STARTED|Overall Study||220
11087877|NCT01157351|12270721|FG000|Treated|Overall Study||226
11087878|NCT01157351|12270722|FG001|Treated|Overall Study||218
11087879|NCT01157351|12270721|FG000|COMPLETED|Overall Study||93
11087880|NCT01157351|12270722|FG001|COMPLETED|Overall Study||88
11087881|NCT01157351|12270721|FG000|NOT COMPLETED|Overall Study||137
11087882|NCT01157351|12270722|FG001|NOT COMPLETED|Overall Study||132
11087883|NCT01157364|12270734|FG000|STARTED|Overall Study||15
11087884|NCT01157364|12270735|FG001|STARTED|Overall Study||21
11087885|NCT01157364|12270736|FG002|STARTED|Overall Study||21
11087886|NCT01157364|12270737|FG003|STARTED|Overall Study||18
11087887|NCT01157364|12270738|FG004|STARTED|Overall Study||11
11087888|NCT01157364|12270739|FG005|STARTED|Overall Study||23
11087889|NCT01157364|12270734|FG000|COMPLETED|Overall Study||13
11087890|NCT01157364|12270735|FG001|COMPLETED|Overall Study||17
11087891|NCT01157364|12270736|FG002|COMPLETED|Overall Study||17
11087892|NCT01157364|12270737|FG003|COMPLETED|Overall Study||16
11087893|NCT01157364|12270738|FG004|COMPLETED|Overall Study||9
11087894|NCT01157364|12270739|FG005|COMPLETED|Overall Study||22
11087895|NCT01157364|12270734|FG000|NOT COMPLETED|Overall Study||2
11087896|NCT01157364|12270735|FG001|NOT COMPLETED|Overall Study||4
11087897|NCT01157364|12270736|FG002|NOT COMPLETED|Overall Study||4
11087898|NCT01157364|12270737|FG003|NOT COMPLETED|Overall Study||2
11087899|NCT01157364|12270738|FG004|NOT COMPLETED|Overall Study||2
11087900|NCT01157364|12270739|FG005|NOT COMPLETED|Overall Study||1
11087901|NCT01157377|12270760|FG000|STARTED|Overall Study||23
11087902|NCT01157377|12270761|FG001|STARTED|Overall Study||23
11087903|NCT01157377|12270762|FG002|STARTED|Overall Study||27
11087904|NCT01157377|12270763|FG003|STARTED|Overall Study||15
11087905|NCT01157377|12270764|FG004|STARTED|Overall Study||20
11087906|NCT01157377|12270765|FG005|STARTED|Overall Study||19
11087907|NCT01157377|12270766|FG006|STARTED|Overall Study||29
11087908|NCT01157377|12270760|FG000|COMPLETED|Overall Study||21
11087909|NCT01157377|12270761|FG001|COMPLETED|Overall Study||20
11087910|NCT01157377|12270762|FG002|COMPLETED|Overall Study||26
11087911|NCT01157377|12270763|FG003|COMPLETED|Overall Study||14
11087912|NCT01157377|12270764|FG004|COMPLETED|Overall Study||18
11087913|NCT01157377|12270765|FG005|COMPLETED|Overall Study||16
11087914|NCT01157377|12270766|FG006|COMPLETED|Overall Study||27
11087915|NCT01157377|12270760|FG000|NOT COMPLETED|Overall Study||2
11087916|NCT01157377|12270761|FG001|NOT COMPLETED|Overall Study||3
11087917|NCT01157377|12270762|FG002|NOT COMPLETED|Overall Study||1
11087918|NCT01157377|12270763|FG003|NOT COMPLETED|Overall Study||1
11087919|NCT01157377|12270764|FG004|NOT COMPLETED|Overall Study||2
11087920|NCT01157377|12270765|FG005|NOT COMPLETED|Overall Study||3
11087921|NCT01157377|12270766|FG006|NOT COMPLETED|Overall Study||2
11087922|NCT01157416|12270784|FG000|STARTED|Overall Study||17
11087923|NCT01157416|12270785|FG001|STARTED|Overall Study||16
11087924|NCT01157416|12270784|FG000|COMPLETED|Overall Study||15
11087925|NCT01157416|12270785|FG001|COMPLETED|Overall Study||16
11087926|NCT01157416|12270784|FG000|NOT COMPLETED|Overall Study||2
11087927|NCT01157416|12270785|FG001|NOT COMPLETED|Overall Study||0
11087928|NCT01157429|12270793|FG000|STARTED|Overall Study||12
11087929|NCT01157429|12270794|FG001|STARTED|Overall Study||12
11087930|NCT01157429|12270793|FG000|COMPLETED|Overall Study||8
11087931|NCT01157429|12270794|FG001|COMPLETED|Overall Study||8
11087932|NCT01157429|12270793|FG000|NOT COMPLETED|Overall Study||4
11087933|NCT01157429|12270794|FG001|NOT COMPLETED|Overall Study||4
11087934|NCT01157676|12270802|FG000|STARTED|Enrollment||174
11087935|NCT01157676|12270803|FG001|STARTED|Enrollment||176
11087936|NCT01157676|12270802|FG000|COMPLETED|Enrollment||174
11087937|NCT01157676|12270803|FG001|COMPLETED|Enrollment||176
11087938|NCT01157676|12270802|FG000|NOT COMPLETED|Enrollment||0
11087939|NCT01157676|12270803|FG001|NOT COMPLETED|Enrollment||0
11087940|NCT01157676|12270802|FG000|STARTED|Randomization||174
11087941|NCT01157676|12270803|FG001|STARTED|Randomization||176
11087942|NCT01157676|12270802|FG000|COMPLETED|Randomization||153
11087943|NCT01157676|12270803|FG001|COMPLETED|Randomization||159
11087944|NCT01157676|12270802|FG000|NOT COMPLETED|Randomization||21
11087945|NCT01157676|12270803|FG001|NOT COMPLETED|Randomization||17
11351336|NCT03035318|12548290|FG004|COMPLETED|Overall Study||20
11351337|NCT03035318|12548286|FG000|NOT COMPLETED|Overall Study||2
11351338|NCT03035318|12548287|FG001|NOT COMPLETED|Overall Study||4
11351339|NCT03035318|12548288|FG002|NOT COMPLETED|Overall Study||4
11351340|NCT03035318|12548289|FG003|NOT COMPLETED|Overall Study||2
11351341|NCT03035318|12548290|FG004|NOT COMPLETED|Overall Study||7
11351342|NCT03035487|12548302|FG000|STARTED|Overall Study||9
11351343|NCT03035487|12548302|FG000|COMPLETED|Overall Study||9
11351344|NCT03035487|12548302|FG000|NOT COMPLETED|Overall Study||0
11351345|NCT03035708|12548308|FG000|STARTED|Overall Study||23
11351346|NCT03035708|12548309|FG001|STARTED|Overall Study||24
11351347|NCT03035708|12548308|FG000|COMPLETED|Overall Study||19
11351348|NCT03035708|12548309|FG001|COMPLETED|Overall Study||13
11351349|NCT03035708|12548308|FG000|NOT COMPLETED|Overall Study||4
11351350|NCT03035708|12548309|FG001|NOT COMPLETED|Overall Study||11
11351351|NCT03035760|12548322|FG000|STARTED|First Intervention - 10/7 Days Follow-up||8
11351352|NCT03035760|12548323|FG001|STARTED|First Intervention - 10/7 Days Follow-up||8
11351353|NCT03035760|12548324|FG002|STARTED|First Intervention - 10/7 Days Follow-up||8
11351354|NCT03035760|12548325|FG003|STARTED|First Intervention - 10/7 Days Follow-up||6
11087946|NCT01157676|12270802|FG000|STARTED|Surgery||153
11087947|NCT01157676|12270803|FG001|STARTED|Surgery||159
11351355|NCT03035760|12548326|FG004|STARTED|First Intervention - 10/7 Days Follow-up||6
11087948|NCT01157676|12270802|FG000|COMPLETED|Surgery||152
11087949|NCT01157676|12270803|FG001|COMPLETED|Surgery|advanced disease=2, inadequate visualization=1, inability to tolerate position=1, colonic mass=1.|150
11087950|NCT01157676|12270802|FG000|NOT COMPLETED|Surgery||1
11087951|NCT01157676|12270803|FG001|NOT COMPLETED|Surgery||9
11207816|NCT01877421|12398897|FG003|COMPLETED|Phase 2||2
11207817|NCT01877421|12398898|FG004|COMPLETED|Phase 2||7
11207818|NCT01877421|12398899|FG005|COMPLETED|Phase 2||3
11207819|NCT01877421|12398900|FG006|COMPLETED|Phase 2||6
11207820|NCT01877421|12398901|FG007|COMPLETED|Phase 2||2
11207821|NCT01877421|12398902|FG008|COMPLETED|Phase 2||5
11207822|NCT01877421|12398903|FG009|COMPLETED|Phase 2||3
11207823|NCT01877421|12398904|FG010|COMPLETED|Phase 2||5
11207824|NCT01877421|12398905|FG011|COMPLETED|Phase 2||3
11207825|NCT01877421|12398906|FG012|COMPLETED|Phase 2||6
11207826|NCT01877421|12398907|FG013|COMPLETED|Phase 2||3
11207827|NCT01877421|12398908|FG014|COMPLETED|Phase 2||7
11207828|NCT01877421|12398909|FG015|COMPLETED|Phase 2||2
11207829|NCT01877421|12398910|FG016|COMPLETED|Phase 2||0
11207830|NCT01877421|12398911|FG017|COMPLETED|Phase 2||0
11207831|NCT01877421|12398894|FG000|NOT COMPLETED|Phase 2||0
11207832|NCT01877421|12398895|FG001|NOT COMPLETED|Phase 2||0
11207833|NCT01877421|12398896|FG002|NOT COMPLETED|Phase 2||0
11207834|NCT01877421|12398897|FG003|NOT COMPLETED|Phase 2||0
11207835|NCT01877421|12398898|FG004|NOT COMPLETED|Phase 2||0
11207836|NCT01877421|12398899|FG005|NOT COMPLETED|Phase 2||0
11207837|NCT01877421|12398900|FG006|NOT COMPLETED|Phase 2||1
11207838|NCT01877421|12398901|FG007|NOT COMPLETED|Phase 2||0
11207839|NCT01877421|12398902|FG008|NOT COMPLETED|Phase 2||1
11207840|NCT01877421|12398903|FG009|NOT COMPLETED|Phase 2||0
11207841|NCT01877421|12398904|FG010|NOT COMPLETED|Phase 2||2
11207842|NCT01877421|12398905|FG011|NOT COMPLETED|Phase 2||0
11207843|NCT01877421|12398906|FG012|NOT COMPLETED|Phase 2||1
11207844|NCT01877421|12398907|FG013|NOT COMPLETED|Phase 2||0
11207845|NCT01877421|12398908|FG014|NOT COMPLETED|Phase 2||0
11207846|NCT01877421|12398909|FG015|NOT COMPLETED|Phase 2||1
11207847|NCT01877421|12398910|FG016|NOT COMPLETED|Phase 2||0
11207848|NCT01877421|12398911|FG017|NOT COMPLETED|Phase 2||0
11207849|NCT01877538|12398991|FG000|STARTED|Overall Study||7
11207850|NCT01877538|12398991|FG000|COMPLETED|Overall Study||7
11207851|NCT01877538|12398991|FG000|NOT COMPLETED|Overall Study||0
11207852|NCT01877551|12398997|FG000|STARTED|Overall Study||13
11207853|NCT01877551|12398998|FG001|STARTED|Overall Study||14
11207854|NCT01877551|12398997|FG000|COMPLETED|Overall Study||13
11207855|NCT01877551|12398998|FG001|COMPLETED|Overall Study||13
11207856|NCT01877551|12398997|FG000|NOT COMPLETED|Overall Study||0
11207857|NCT01877551|12398998|FG001|NOT COMPLETED|Overall Study||1
11207858|NCT01877642|12399006|FG000|STARTED|Overall Study||4
11207859|NCT01877642|12399007|FG001|STARTED|Overall Study||3
11207860|NCT01877642|12399008|FG002|STARTED|Overall Study||3
11207861|NCT01877642|12399009|FG003|STARTED|Overall Study||3
11207862|NCT01877642|12399010|FG004|STARTED|Overall Study||3
11207863|NCT01877642|12399011|FG005|STARTED|Overall Study||3
11207864|NCT01877642|12399012|FG006|STARTED|Overall Study||3
11207865|NCT01877642|12399006|FG000|COMPLETED|Overall Study||4
11207866|NCT01877642|12399007|FG001|COMPLETED|Overall Study||3
11207867|NCT01877642|12399008|FG002|COMPLETED|Overall Study||3
11207868|NCT01877642|12399009|FG003|COMPLETED|Overall Study||3
11207869|NCT01877642|12399010|FG004|COMPLETED|Overall Study||3
11207870|NCT01877642|12399011|FG005|COMPLETED|Overall Study||3
11207871|NCT01877642|12399012|FG006|COMPLETED|Overall Study||3
11207872|NCT01877642|12399006|FG000|NOT COMPLETED|Overall Study||0
11207873|NCT01877642|12399007|FG001|NOT COMPLETED|Overall Study||0
11207874|NCT01877642|12399008|FG002|NOT COMPLETED|Overall Study||0
11207875|NCT01877642|12399009|FG003|NOT COMPLETED|Overall Study||0
11207876|NCT01877642|12399010|FG004|NOT COMPLETED|Overall Study||0
11207877|NCT01877642|12399011|FG005|NOT COMPLETED|Overall Study||0
11207878|NCT01877642|12399012|FG006|NOT COMPLETED|Overall Study||0
11207879|NCT01877668|12399026|FG000|STARTED|Overall Study|Received treatment|107
11207880|NCT01877668|12399027|FG001|STARTED|Overall Study|Received treatment|104
11207881|NCT01877668|12399028|FG002|STARTED|Overall Study|Received treatment|106
11351356|NCT03035760|12548322|FG000|COMPLETED|First Intervention - 10/7 Days Follow-up||8
11351357|NCT03035760|12548323|FG001|COMPLETED|First Intervention - 10/7 Days Follow-up||8
11351358|NCT03035760|12548324|FG002|COMPLETED|First Intervention - 10/7 Days Follow-up||8
11351359|NCT03035760|12548325|FG003|COMPLETED|First Intervention - 10/7 Days Follow-up||6
11351360|NCT03035760|12548326|FG004|COMPLETED|First Intervention - 10/7 Days Follow-up||6
11351361|NCT03035760|12548322|FG000|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
11351362|NCT03035760|12548323|FG001|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
11351363|NCT03035760|12548324|FG002|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
11351364|NCT03035760|12548325|FG003|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
11351365|NCT03035760|12548326|FG004|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
11351366|NCT03035760|12548322|FG000|STARTED|Second Intervention - 7 Days Follow-up||0
11351367|NCT03035760|12548323|FG001|STARTED|Second Intervention - 7 Days Follow-up||0
11351368|NCT03035760|12548324|FG002|STARTED|Second Intervention - 7 Days Follow-up||0
11351369|NCT03035760|12548325|FG003|STARTED|Second Intervention - 7 Days Follow-up||6
11351370|NCT03035760|12548326|FG004|STARTED|Second Intervention - 7 Days Follow-up||6
11087952|NCT01157845|12270815|FG000|STARTED|Overall Study||165
11087953|NCT01157845|12270815|FG000|COMPLETED|Overall Study||130
11087954|NCT01157845|12270815|FG000|NOT COMPLETED|Overall Study||35
11087955|NCT01157897|12270823|FG000|STARTED|Overall Study||10
11087956|NCT01157897|12270824|FG001|STARTED|Overall Study||10
11087957|NCT01157897|12270825|FG002|STARTED|Overall Study||10
11087958|NCT01157897|12270826|FG003|STARTED|Overall Study||6
11087959|NCT01157897|12270823|FG000|COMPLETED|Overall Study||8
11087960|NCT01157897|12270824|FG001|COMPLETED|Overall Study||8
11087961|NCT01157897|12270825|FG002|COMPLETED|Overall Study||10
11087962|NCT01157897|12270826|FG003|COMPLETED|Overall Study||5
11087963|NCT01157897|12270823|FG000|NOT COMPLETED|Overall Study||2
11087964|NCT01157897|12270824|FG001|NOT COMPLETED|Overall Study||2
11087965|NCT01157897|12270825|FG002|NOT COMPLETED|Overall Study||0
11087966|NCT01157897|12270826|FG003|NOT COMPLETED|Overall Study||1
11087967|NCT01158118|12270838|FG000|STARTED|Overall Study||24
11087968|NCT01158118|12270839|FG001|STARTED|Overall Study||24
11087969|NCT01158118|12270838|FG000|COMPLETED|Overall Study||23
11087970|NCT01158118|12270839|FG001|COMPLETED|Overall Study||21
11087971|NCT01158118|12270838|FG000|NOT COMPLETED|Overall Study||1
11087972|NCT01158118|12270839|FG001|NOT COMPLETED|Overall Study||3
11087973|NCT01158157|12270845|FG000|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25
11087974|NCT01158157|12270845|FG000|COMPLETED|Overall Study||25
11087975|NCT01158157|12270845|FG000|NOT COMPLETED|Overall Study||0
11087976|NCT01158222|12270849|FG000|STARTED|Overall Study||37
11087977|NCT01158222|12270849|FG000|COMPLETED|Overall Study||20
11087978|NCT01158222|12270849|FG000|NOT COMPLETED|Overall Study||17
11087979|NCT01158261|12270853|FG000|STARTED|Overall Study||300
11087980|NCT01158261|12270853|FG000|COMPLETED|Overall Study||283
11087981|NCT01158261|12270853|FG000|NOT COMPLETED|Overall Study||17
11087982|NCT01158378|12270859|FG000|STARTED|Overall Study||124
11087983|NCT01158378|12270860|FG001|STARTED|Overall Study||126
11087984|NCT01158378|12270859|FG000|COMPLETED|Overall Study||114
11087985|NCT01158378|12270860|FG001|COMPLETED|Overall Study||117
11087986|NCT01158378|12270859|FG000|NOT COMPLETED|Overall Study||10
11087987|NCT01158378|12270860|FG001|NOT COMPLETED|Overall Study||9
11087988|NCT01158404|12270875|FG000|STARTED|Overall Study||3
11087989|NCT01158404|12270876|FG001|STARTED|Overall Study||4
11087990|NCT01158404|12270877|FG002|STARTED|Overall Study||3
11087991|NCT01158404|12270878|FG003|STARTED|Overall Study||3
11087992|NCT01158404|12270879|FG004|STARTED|Overall Study||6
11087993|NCT01158404|12270880|FG005|STARTED|Overall Study||5
11087994|NCT01158404|12270881|FG006|STARTED|Overall Study||3
11087995|NCT01158404|12270882|FG007|STARTED|Overall Study||8
11087996|NCT01158404|12270875|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11087997|NCT01158404|12270876|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
11087998|NCT01158404|12270877|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
11087999|NCT01158404|12270878|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
11088000|NCT01158404|12270879|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
11088001|NCT01158404|12270880|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
11088002|NCT01158404|12270881|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
11088003|NCT01158404|12270882|FG007|Received at Least 1 Dose of Study Drug|Overall Study||8
11088004|NCT01158404|12270875|FG000|COMPLETED|Overall Study||3
11088005|NCT01158404|12270876|FG001|COMPLETED|Overall Study||3
11088006|NCT01158404|12270877|FG002|COMPLETED|Overall Study||3
11088007|NCT01158404|12270878|FG003|COMPLETED|Overall Study||3
11088008|NCT01158404|12270879|FG004|COMPLETED|Overall Study||3
11088009|NCT01158404|12270880|FG005|COMPLETED|Overall Study||4
11088010|NCT01158404|12270881|FG006|COMPLETED|Overall Study||2
11088011|NCT01158404|12270882|FG007|COMPLETED|Overall Study||6
11088012|NCT01158404|12270875|FG000|NOT COMPLETED|Overall Study||0
11088013|NCT01158404|12270876|FG001|NOT COMPLETED|Overall Study||1
11088014|NCT01158404|12270877|FG002|NOT COMPLETED|Overall Study||0
11088015|NCT01158404|12270878|FG003|NOT COMPLETED|Overall Study||0
11088016|NCT01158404|12270879|FG004|NOT COMPLETED|Overall Study||3
11088017|NCT01158404|12270880|FG005|NOT COMPLETED|Overall Study||1
11088018|NCT01158404|12270881|FG006|NOT COMPLETED|Overall Study||1
11088019|NCT01158404|12270882|FG007|NOT COMPLETED|Overall Study||2
11088020|NCT01158521|12270902|FG000|STARTED|Overall Study||25
11088021|NCT01158521|12270902|FG000|COMPLETED|Overall Study||25
11088022|NCT01158521|12270902|FG000|NOT COMPLETED|Overall Study||0
11088023|NCT01158534|12270908|FG000|STARTED|Overall Study||17
11088024|NCT01158534|12270908|FG000|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
11088025|NCT01158534|12270908|FG000|NOT COMPLETED|Overall Study||3
11088026|NCT01158573|12270916|FG000|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
11088027|NCT01158573|12270917|FG001|STARTED|Overall Study||30
11088028|NCT01158573|12270918|FG002|STARTED|Overall Study||29
11088029|NCT01158573|12270919|FG003|STARTED|Overall Study||28
11088030|NCT01158573|12270916|FG000|COMPLETED|Overall Study|Study completed at 117 subjects.|30
11088031|NCT01158573|12270917|FG001|COMPLETED|Overall Study||30
11088032|NCT01158573|12270918|FG002|COMPLETED|Overall Study||29
11088033|NCT01158573|12270919|FG003|COMPLETED|Overall Study||28
11088034|NCT01158573|12270916|FG000|NOT COMPLETED|Overall Study||0
11088035|NCT01158573|12270917|FG001|NOT COMPLETED|Overall Study||0
11088036|NCT01158573|12270918|FG002|NOT COMPLETED|Overall Study||0
11088037|NCT01158573|12270919|FG003|NOT COMPLETED|Overall Study||0
11088038|NCT01158651|12270929|FG000|STARTED|Overall Study||23
11088039|NCT01158651|12270929|FG000|COMPLETED|Overall Study||22
11088040|NCT01158651|12270929|FG000|NOT COMPLETED|Overall Study||1
11088041|NCT01158703|12270935|FG000|STARTED|Overall Study||12
11088042|NCT01158703|12270936|FG001|STARTED|Overall Study||8
11088043|NCT01158703|12270935|FG000|COMPLETED|Overall Study||12
11088044|NCT01158703|12270936|FG001|COMPLETED|Overall Study||8
11088045|NCT01158703|12270935|FG000|NOT COMPLETED|Overall Study||0
11088046|NCT01158703|12270936|FG001|NOT COMPLETED|Overall Study||0
11088047|NCT01158716|12270944|FG000|STARTED|Overall Study||48
11088048|NCT01158716|12270945|FG001|STARTED|Overall Study||48
11088049|NCT01158716|12270944|FG000|COMPLETED|Overall Study||47
11088050|NCT01158716|12270945|FG001|COMPLETED|Overall Study||47
11088051|NCT01158716|12270944|FG000|NOT COMPLETED|Overall Study||1
11088052|NCT01158716|12270945|FG001|NOT COMPLETED|Overall Study||1
11088053|NCT01158820|12270953|FG000|STARTED|Overall Study||25
11088054|NCT01158820|12270954|FG001|STARTED|Overall Study||25
11088055|NCT01158820|12270953|FG000|COMPLETED|Overall Study||25
11088056|NCT01158820|12270954|FG001|COMPLETED|Overall Study||25
11088057|NCT01158820|12270953|FG000|NOT COMPLETED|Overall Study||0
11088058|NCT01158820|12270954|FG001|NOT COMPLETED|Overall Study||0
11088059|NCT01158885|12270961|FG000|STARTED|Treatment Course 1||2
11088060|NCT01158885|12270961|FG000|COMPLETED|Treatment Course 1||2
11088061|NCT01158885|12270961|FG000|NOT COMPLETED|Treatment Course 1||0
11088062|NCT01158885|12270961|FG000|STARTED|Treatment Course 2|Neither of the patients that were treated on Treatment Course 1 were eligible to proceed to Course 2|0
11088063|NCT01158885|12270961|FG000|COMPLETED|Treatment Course 2||0
11088064|NCT01158885|12270961|FG000|NOT COMPLETED|Treatment Course 2||0
11088065|NCT01158924|12270967|FG000|STARTED|Overall Study||14
11088066|NCT01158924|12270968|FG001|STARTED|Overall Study||26
11088067|NCT01158924|12270967|FG000|COMPLETED|Overall Study||13
11088068|NCT01158924|12270968|FG001|COMPLETED|Overall Study||23
11088069|NCT01158924|12270967|FG000|NOT COMPLETED|Overall Study||1
11088070|NCT01158924|12270968|FG001|NOT COMPLETED|Overall Study||3
11088071|NCT01158950|12270974|FG000|STARTED|1st Intervention (1 Day)||13
11088072|NCT01158950|12270975|FG001|STARTED|1st Intervention (1 Day)||13
11088073|NCT01158950|12270974|FG000|Data Collected|1st Intervention (1 Day)||12
11088074|NCT01158950|12270975|FG001|Data Collected|1st Intervention (1 Day)||11
11088075|NCT01158950|12270974|FG000|COMPLETED|1st Intervention (1 Day)||12
11088076|NCT01158950|12270975|FG001|COMPLETED|1st Intervention (1 Day)||11
11088077|NCT01158950|12270974|FG000|NOT COMPLETED|1st Intervention (1 Day)||1
11088078|NCT01158950|12270975|FG001|NOT COMPLETED|1st Intervention (1 Day)||2
11088079|NCT01158950|12270974|FG000|STARTED|Washout (1 Week)||12
11088080|NCT01158950|12270975|FG001|STARTED|Washout (1 Week)||11
11088081|NCT01158950|12270974|FG000|COMPLETED|Washout (1 Week)||12
11088082|NCT01158950|12270975|FG001|COMPLETED|Washout (1 Week)||11
11088083|NCT01158950|12270974|FG000|NOT COMPLETED|Washout (1 Week)||0
11088084|NCT01158950|12270975|FG001|NOT COMPLETED|Washout (1 Week)||0
11088085|NCT01158950|12270974|FG000|STARTED|2nd Intervention (1 Day)||12
11088086|NCT01158950|12270975|FG001|STARTED|2nd Intervention (1 Day)||11
11088087|NCT01158950|12270974|FG000|COMPLETED|2nd Intervention (1 Day)||12
11088088|NCT01158950|12270975|FG001|COMPLETED|2nd Intervention (1 Day)||11
11088089|NCT01158950|12270974|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0
11088090|NCT01158950|12270975|FG001|NOT COMPLETED|2nd Intervention (1 Day)||0
11088091|NCT01158976|12270982|FG000|STARTED|Overall Study||43
11088092|NCT01158976|12270983|FG001|STARTED|Overall Study||21
11088093|NCT01158976|12270982|FG000|COMPLETED|Overall Study||34
11088094|NCT01158976|12270983|FG001|COMPLETED|Overall Study||17
11088095|NCT01158976|12270982|FG000|NOT COMPLETED|Overall Study||9
11088096|NCT01158976|12270983|FG001|NOT COMPLETED|Overall Study||4
11088097|NCT01159015|12270991|FG000|STARTED|Overall Study||357
11088098|NCT01159015|12270992|FG001|STARTED|Overall Study||177
11088099|NCT01159015|12270991|FG000|COMPLETED|Overall Study||339
11088100|NCT01159015|12270992|FG001|COMPLETED|Overall Study||170
11088101|NCT01159015|12270991|FG000|NOT COMPLETED|Overall Study||18
11088102|NCT01159015|12270992|FG001|NOT COMPLETED|Overall Study||7
11088103|NCT01159054|12270998|FG000|STARTED|Overall Study||22
11088104|NCT01159054|12270998|FG000|COMPLETED|Overall Study||2
11088105|NCT01159054|12270998|FG000|NOT COMPLETED|Overall Study||20
11088106|NCT01159067|12271002|FG000|STARTED|Overall Study||1
11088107|NCT01159067|12271002|FG000|COMPLETED|Overall Study||1
11088108|NCT01159067|12271002|FG000|NOT COMPLETED|Overall Study||0
11088109|NCT01159171|12271006|FG000|STARTED|Overall Study||50
11088110|NCT01159171|12271006|FG000|COMPLETED|Overall Study||0
11088111|NCT01159171|12271006|FG000|NOT COMPLETED|Overall Study||50
11088112|NCT01159262|12271014|FG000|STARTED|Overall Study||14
11088113|NCT01159262|12271015|FG001|STARTED|Overall Study||14
11088114|NCT01159262|12271016|FG002|STARTED|Overall Study||8
11088115|NCT01159262|12271014|FG000|COMPLETED|Overall Study||14
11088116|NCT01159262|12271015|FG001|COMPLETED|Overall Study||14
11088117|NCT01159262|12271016|FG002|COMPLETED|Overall Study||8
11088118|NCT01159262|12271014|FG000|NOT COMPLETED|Overall Study||0
11088119|NCT01159262|12271015|FG001|NOT COMPLETED|Overall Study||0
11088120|NCT01159262|12271016|FG002|NOT COMPLETED|Overall Study||0
11088121|NCT01159431|12271026|FG000|STARTED|Overall Study||25
11088122|NCT01159431|12271027|FG001|STARTED|Overall Study||25
11088123|NCT01159431|12271026|FG000|COMPLETED|Overall Study||23
11088124|NCT01159431|12271027|FG001|COMPLETED|Overall Study||19
11088125|NCT01159431|12271026|FG000|NOT COMPLETED|Overall Study||2
11088126|NCT01159431|12271027|FG001|NOT COMPLETED|Overall Study||6
11088127|NCT01159535|12271043|FG000|STARTED|Overall Study||103
11088128|NCT01159535|12271044|FG001|STARTED|Overall Study||88
11088129|NCT01159535|12271045|FG002|STARTED|Overall Study||95
11088130|NCT01159535|12271043|FG000|COMPLETED|Overall Study||79
11088131|NCT01159535|12271044|FG001|COMPLETED|Overall Study||64
11088132|NCT01159535|12271045|FG002|COMPLETED|Overall Study||64
11088133|NCT01159535|12271043|FG000|NOT COMPLETED|Overall Study||24
11088134|NCT01159535|12271044|FG001|NOT COMPLETED|Overall Study||24
11088135|NCT01159535|12271045|FG002|NOT COMPLETED|Overall Study||31
11088136|NCT01159574|12271053|FG000|STARTED|Treatment Phase||121
11088137|NCT01159574|12271053|FG000|COMPLETED|Treatment Phase||100
11088138|NCT01159574|12271053|FG000|NOT COMPLETED|Treatment Phase||21
11088139|NCT01159574|12271053|FG000|STARTED|Follow Up Phase||112
11088140|NCT01159574|12271053|FG000|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
11088141|NCT01159574|12271053|FG000|NOT COMPLETED|Follow Up Phase||20
11088142|NCT01159600|12271065|FG000|STARTED|Overall Study||207
11088143|NCT01159600|12271066|FG001|STARTED|Overall Study||217
11088144|NCT01159600|12271067|FG002|STARTED|Overall Study||214
11088145|NCT01159600|12271068|FG003|STARTED|Overall Study||69
11088146|NCT01159600|12271069|FG004|STARTED|Overall Study||225
11088147|NCT01159600|12271070|FG005|STARTED|Overall Study||226
11088148|NCT01159600|12271071|FG006|STARTED|Overall Study||218
11088149|NCT01159600|12271072|FG007|STARTED|Overall Study||103
11088150|NCT01159600|12271065|FG000|COMPLETED|Overall Study||186
11088151|NCT01159600|12271066|FG001|COMPLETED|Overall Study||209
11088152|NCT01159600|12271067|FG002|COMPLETED|Overall Study||196
11088153|NCT01159600|12271068|FG003|COMPLETED|Overall Study||58
11088154|NCT01159600|12271069|FG004|COMPLETED|Overall Study||201
11088155|NCT01159600|12271070|FG005|COMPLETED|Overall Study||208
11088156|NCT01159600|12271071|FG006|COMPLETED|Overall Study||199
11088157|NCT01159600|12271072|FG007|COMPLETED|Overall Study||85
11088158|NCT01159600|12271065|FG000|NOT COMPLETED|Overall Study||21
11088159|NCT01159600|12271066|FG001|NOT COMPLETED|Overall Study||8
11088160|NCT01159600|12271067|FG002|NOT COMPLETED|Overall Study||18
11088161|NCT01159600|12271068|FG003|NOT COMPLETED|Overall Study||11
11088162|NCT01159600|12271069|FG004|NOT COMPLETED|Overall Study||24
11088163|NCT01159600|12271070|FG005|NOT COMPLETED|Overall Study||18
11088164|NCT01159600|12271071|FG006|NOT COMPLETED|Overall Study||19
11088165|NCT01159600|12271072|FG007|NOT COMPLETED|Overall Study||18
11088166|NCT01159665|12271097|FG000|STARTED|Overall Study||9
11088167|NCT01159665|12271098|FG001|STARTED|Overall Study||9
11088168|NCT01159665|12271099|FG002|STARTED|Overall Study||8
11088169|NCT01159665|12271100|FG003|STARTED|Overall Study||4
11088170|NCT01159665|12271101|FG004|STARTED|Overall Study||4
11088171|NCT01159665|12271102|FG005|STARTED|Overall Study||4
11088172|NCT01159665|12271097|FG000|COMPLETED|Overall Study||9
11088173|NCT01159665|12271098|FG001|COMPLETED|Overall Study||8
11088174|NCT01159665|12271099|FG002|COMPLETED|Overall Study||8
11088175|NCT01159665|12271100|FG003|COMPLETED|Overall Study||4
11088176|NCT01159665|12271101|FG004|COMPLETED|Overall Study||4
11088177|NCT01159665|12271102|FG005|COMPLETED|Overall Study||4
11088178|NCT01159665|12271097|FG000|NOT COMPLETED|Overall Study||0
11088179|NCT01159665|12271098|FG001|NOT COMPLETED|Overall Study||1
11088180|NCT01159665|12271099|FG002|NOT COMPLETED|Overall Study||0
11088181|NCT01159665|12271100|FG003|NOT COMPLETED|Overall Study||0
11088182|NCT01159665|12271101|FG004|NOT COMPLETED|Overall Study||0
11088183|NCT01159665|12271102|FG005|NOT COMPLETED|Overall Study||0
11088184|NCT01159691|12271116|FG000|STARTED|Overall Study||76
11088185|NCT01159691|12271116|FG000|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
11088186|NCT01159691|12271116|FG000|NOT COMPLETED|Overall Study||22
11088187|NCT01159743|12271122|FG000|STARTED|Overall Study||237
11088188|NCT01159743|12271123|FG001|STARTED|Overall Study||109
11088189|NCT01159743|12271122|FG000|COMPLETED|Overall Study||237
11088190|NCT01159743|12271123|FG001|COMPLETED|Overall Study||109
11088191|NCT01159743|12271122|FG000|NOT COMPLETED|Overall Study||0
11088192|NCT01159743|12271123|FG001|NOT COMPLETED|Overall Study||0
11088193|NCT01159769|12271129|FG000|STARTED|Overall Study||215
11088194|NCT01159769|12271129|FG000|COMPLETED|Overall Study||214
11088195|NCT01159769|12271129|FG000|NOT COMPLETED|Overall Study||1
11088196|NCT01159912|12271136|FG000|STARTED|Overall Study||115
11088197|NCT01159912|12271137|FG001|STARTED|Overall Study||114
11088198|NCT01159912|12271138|FG002|STARTED|Overall Study||114
11088199|NCT01159912|12271136|FG000|COMPLETED|Overall Study||75
11088200|NCT01159912|12271137|FG001|COMPLETED|Overall Study||92
11088201|NCT01159912|12271138|FG002|COMPLETED|Overall Study||88
11088202|NCT01159912|12271136|FG000|NOT COMPLETED|Overall Study||40
11088203|NCT01159912|12271137|FG001|NOT COMPLETED|Overall Study||22
11088204|NCT01159912|12271138|FG002|NOT COMPLETED|Overall Study||26
11088205|NCT01159938|12271149|FG000|STARTED|First Study Period||26
11088206|NCT01159938|12271150|FG001|STARTED|First Study Period||11
11088207|NCT01159938|12271151|FG002|STARTED|First Study Period||11
11088208|NCT01159938|12271152|FG003|STARTED|First Study Period||12
11088209|NCT01159938|12271153|FG004|STARTED|First Study Period||12
11088210|NCT01159938|12271149|FG000|Received at Least 1 Dose of Study Drug|First Study Period||0
11088211|NCT01159938|12271150|FG001|Received at Least 1 Dose of Study Drug|First Study Period||11
11088212|NCT01159938|12271151|FG002|Received at Least 1 Dose of Study Drug|First Study Period||11
11088213|NCT01159938|12271152|FG003|Received at Least 1 Dose of Study Drug|First Study Period||12
11088214|NCT01159938|12271153|FG004|Received at Least 1 Dose of Study Drug|First Study Period||12
11088215|NCT01159938|12271149|FG000|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
11088216|NCT01159938|12271150|FG001|Safety and Efficacy Analysis Population|First Study Period||11
11088217|NCT01159938|12271151|FG002|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
11088218|NCT01159938|12271152|FG003|Safety and Efficacy Analysis Population|First Study Period||12
11088219|NCT01159938|12271153|FG004|Safety and Efficacy Analysis Population|First Study Period||12
11088220|NCT01159938|12271149|FG000|COMPLETED|First Study Period||26
11088221|NCT01159938|12271150|FG001|COMPLETED|First Study Period||11
11088222|NCT01159938|12271151|FG002|COMPLETED|First Study Period||10
11088223|NCT01159938|12271152|FG003|COMPLETED|First Study Period||12
11088224|NCT01159938|12271153|FG004|COMPLETED|First Study Period||12
11088225|NCT01159938|12271149|FG000|NOT COMPLETED|First Study Period||0
11088226|NCT01159938|12271150|FG001|NOT COMPLETED|First Study Period||0
11088227|NCT01159938|12271151|FG002|NOT COMPLETED|First Study Period||1
11088228|NCT01159938|12271152|FG003|NOT COMPLETED|First Study Period||0
11088229|NCT01159938|12271153|FG004|NOT COMPLETED|First Study Period||0
11088230|NCT01159938|12271149|FG000|STARTED|Second Study Period||0
11088231|NCT01159938|12271150|FG001|STARTED|Second Study Period||11
11088232|NCT01159938|12271151|FG002|STARTED|Second Study Period||10
11088233|NCT01159938|12271152|FG003|STARTED|Second Study Period||12
11088234|NCT01159938|12271153|FG004|STARTED|Second Study Period||12
11088235|NCT01159938|12271149|FG000|COMPLETED|Second Study Period||0
11088236|NCT01159938|12271150|FG001|COMPLETED|Second Study Period||11
11088237|NCT01159938|12271151|FG002|COMPLETED|Second Study Period||10
11088238|NCT01159938|12271152|FG003|COMPLETED|Second Study Period||12
11088239|NCT01159938|12271153|FG004|COMPLETED|Second Study Period||12
11088240|NCT01159938|12271149|FG000|NOT COMPLETED|Second Study Period||0
11088241|NCT01159938|12271150|FG001|NOT COMPLETED|Second Study Period||0
11088242|NCT01159938|12271151|FG002|NOT COMPLETED|Second Study Period||0
11088243|NCT01159938|12271152|FG003|NOT COMPLETED|Second Study Period||0
11088244|NCT01159938|12271153|FG004|NOT COMPLETED|Second Study Period||0
11088245|NCT01160198|12271177|FG000|STARTED|Overall Study||89
11088246|NCT01160198|12271178|FG001|STARTED|Overall Study||91
11088247|NCT01160198|12271179|FG002|STARTED|Overall Study||90
11088248|NCT01160198|12271177|FG000|COMPLETED|Overall Study||87
11088249|NCT01160198|12271178|FG001|COMPLETED|Overall Study||88
11088250|NCT01160198|12271179|FG002|COMPLETED|Overall Study||89
11088251|NCT01160198|12271177|FG000|NOT COMPLETED|Overall Study||2
11088252|NCT01160198|12271178|FG001|NOT COMPLETED|Overall Study||3
11088253|NCT01160198|12271179|FG002|NOT COMPLETED|Overall Study||1
11088254|NCT01160237|12271190|FG000|STARTED|Overall Study||4
11088255|NCT01160237|12271191|FG001|STARTED|Overall Study||3
11088256|NCT01160237|12271192|FG002|STARTED|Overall Study||0
11088257|NCT01160237|12271190|FG000|COMPLETED|Overall Study||4
11088258|NCT01160237|12271191|FG001|COMPLETED|Overall Study||3
11088259|NCT01160237|12271192|FG002|COMPLETED|Overall Study||0
11088260|NCT01160237|12271190|FG000|NOT COMPLETED|Overall Study||0
11088261|NCT01160237|12271191|FG001|NOT COMPLETED|Overall Study||0
11088262|NCT01160237|12271192|FG002|NOT COMPLETED|Overall Study||0
11088263|NCT01160289|12271205|FG000|STARTED|Screening, Washout, and Lead-In Period||894
11088264|NCT01160289|12271206|FG001|STARTED|Screening, Washout, and Lead-In Period||0
11088265|NCT01160289|12271207|FG002|STARTED|Screening, Washout, and Lead-In Period||0
11088266|NCT01160289|12271208|FG003|STARTED|Screening, Washout, and Lead-In Period||0
11088267|NCT01160289|12271209|FG004|STARTED|Screening, Washout, and Lead-In Period||0
11088268|NCT01160289|12271210|FG005|STARTED|Screening, Washout, and Lead-In Period||0
11088269|NCT01160289|12271205|FG000|COMPLETED|Screening, Washout, and Lead-In Period||410
11088270|NCT01160289|12271206|FG001|COMPLETED|Screening, Washout, and Lead-In Period||0
11088271|NCT01160289|12271207|FG002|COMPLETED|Screening, Washout, and Lead-In Period||0
11088272|NCT01160289|12271208|FG003|COMPLETED|Screening, Washout, and Lead-In Period||0
11088273|NCT01160289|12271209|FG004|COMPLETED|Screening, Washout, and Lead-In Period||0
11088274|NCT01160289|12271210|FG005|COMPLETED|Screening, Washout, and Lead-In Period||0
11088275|NCT01160289|12271205|FG000|NOT COMPLETED|Screening, Washout, and Lead-In Period||484
11088276|NCT01160289|12271206|FG001|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
11088277|NCT01160289|12271207|FG002|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
11088278|NCT01160289|12271208|FG003|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
11088279|NCT01160289|12271209|FG004|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
11088280|NCT01160289|12271210|FG005|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
11088281|NCT01160289|12271205|FG000|STARTED|Post-Randomization Period||0
11088282|NCT01160289|12271206|FG001|STARTED|Post-Randomization Period||85
11088283|NCT01160289|12271207|FG002|STARTED|Post-Randomization Period||97
11088284|NCT01160289|12271208|FG003|STARTED|Post-Randomization Period||52
11088285|NCT01160289|12271209|FG004|STARTED|Post-Randomization Period||89
11088286|NCT01160289|12271210|FG005|STARTED|Post-Randomization Period||87
11088287|NCT01160289|12271205|FG000|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0
11088288|NCT01160289|12271206|FG001|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85
11088289|NCT01160289|12271207|FG002|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97
11207882|NCT01877668|12399029|FG003|STARTED|Overall Study|Received treatment|52
11088290|NCT01160289|12271208|FG003|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52
11088291|NCT01160289|12271209|FG004|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89
11088292|NCT01160289|12271210|FG005|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87
11088293|NCT01160289|12271205|FG000|COMPLETED|Post-Randomization Period||0
11088294|NCT01160289|12271206|FG001|COMPLETED|Post-Randomization Period||65
11088295|NCT01160289|12271207|FG002|COMPLETED|Post-Randomization Period||73
11088296|NCT01160289|12271208|FG003|COMPLETED|Post-Randomization Period||31
11088297|NCT01160289|12271209|FG004|COMPLETED|Post-Randomization Period||80
11088298|NCT01160289|12271210|FG005|COMPLETED|Post-Randomization Period||73
11088299|NCT01160289|12271205|FG000|NOT COMPLETED|Post-Randomization Period||0
11088300|NCT01160289|12271206|FG001|NOT COMPLETED|Post-Randomization Period||20
11088301|NCT01160289|12271207|FG002|NOT COMPLETED|Post-Randomization Period||24
11088302|NCT01160289|12271208|FG003|NOT COMPLETED|Post-Randomization Period||21
11088303|NCT01160289|12271209|FG004|NOT COMPLETED|Post-Randomization Period||9
11088304|NCT01160289|12271210|FG005|NOT COMPLETED|Post-Randomization Period||14
11088305|NCT01160354|12271226|FG000|STARTED|Overall Study||3
11088306|NCT01160354|12271227|FG001|STARTED|Overall Study||4
11088307|NCT01160354|12271228|FG002|STARTED|Overall Study||15
11088308|NCT01160354|12271226|FG000|COMPLETED|Overall Study||3
11088309|NCT01160354|12271227|FG001|COMPLETED|Overall Study||3
11088310|NCT01160354|12271228|FG002|COMPLETED|Overall Study||14
11088311|NCT01160354|12271226|FG000|NOT COMPLETED|Overall Study||0
11088312|NCT01160354|12271227|FG001|NOT COMPLETED|Overall Study||1
11088313|NCT01160354|12271228|FG002|NOT COMPLETED|Overall Study||1
11088314|NCT01160380|12271238|FG000|STARTED|Overall Study||25
11088315|NCT01160380|12271239|FG001|STARTED|Overall Study||25
11088316|NCT01160380|12271238|FG000|COMPLETED|Overall Study||17
11088317|NCT01160380|12271239|FG001|COMPLETED|Overall Study||20
11351371|NCT03035760|12548322|FG000|COMPLETED|Second Intervention - 7 Days Follow-up||0
11351372|NCT03035760|12548323|FG001|COMPLETED|Second Intervention - 7 Days Follow-up||0
11351373|NCT03035760|12548324|FG002|COMPLETED|Second Intervention - 7 Days Follow-up||0
11351374|NCT03035760|12548325|FG003|COMPLETED|Second Intervention - 7 Days Follow-up||6
11351375|NCT03035760|12548326|FG004|COMPLETED|Second Intervention - 7 Days Follow-up||6
11351376|NCT03035760|12548322|FG000|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
11351377|NCT03035760|12548323|FG001|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
11351378|NCT03035760|12548324|FG002|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
11351379|NCT03035760|12548325|FG003|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
11351380|NCT03035760|12548326|FG004|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
11351381|NCT03035864|12548341|FG000|STARTED|Treatment Period||120
11088318|NCT01160380|12271238|FG000|NOT COMPLETED|Overall Study||8
11088319|NCT01160380|12271239|FG001|NOT COMPLETED|Overall Study||5
11088320|NCT01160445|12271247|FG000|STARTED|Overall Study||7
11088321|NCT01160445|12271248|FG001|STARTED|Overall Study||2
11088322|NCT01160445|12271247|FG000|COMPLETED|Overall Study||7
11088323|NCT01160445|12271248|FG001|COMPLETED|Overall Study||2
11088324|NCT01160445|12271247|FG000|NOT COMPLETED|Overall Study||0
11088325|NCT01160445|12271248|FG001|NOT COMPLETED|Overall Study||0
11088326|NCT01160458|12271254|FG000|STARTED|Overall Study||20
11088327|NCT01160458|12271254|FG000|COMPLETED|Overall Study||20
11088328|NCT01160458|12271254|FG000|NOT COMPLETED|Overall Study||0
11088329|NCT01160484|12271258|FG000|STARTED|Overall Study||40
11088330|NCT01160484|12271258|FG000|COMPLETED|Overall Study||22
11088331|NCT01160484|12271258|FG000|NOT COMPLETED|Overall Study||18
11088332|NCT01160614|12271264|FG000|STARTED|Overall Study||5
11088333|NCT01160614|12271265|FG001|STARTED|Overall Study||25
11088334|NCT01160614|12271264|FG000|COMPLETED|Overall Study||5
11088335|NCT01160614|12271265|FG001|COMPLETED|Overall Study||23
11088336|NCT01160614|12271264|FG000|NOT COMPLETED|Overall Study||0
11088337|NCT01160614|12271265|FG001|NOT COMPLETED|Overall Study||2
11088338|NCT01160640|12271291|FG000|STARTED|Overall Study||117
11088339|NCT01160640|12271292|FG001|STARTED|Overall Study||116
11088340|NCT01160640|12271291|FG000|COMPLETED|Overall Study||113
11088341|NCT01160640|12271292|FG001|COMPLETED|Overall Study||110
11088342|NCT01160640|12271291|FG000|NOT COMPLETED|Overall Study||4
11088343|NCT01160640|12271292|FG001|NOT COMPLETED|Overall Study||6
11088344|NCT01160744|12271304|FG000|STARTED|Overall Study||71
11088345|NCT01160744|12271305|FG001|STARTED|Overall Study||69
11088346|NCT01160744|12271306|FG002|STARTED|Overall Study||69
11088347|NCT01160744|12271307|FG003|STARTED|Overall Study||71
11088348|NCT01160744|12271304|FG000|Received Study Drug|Overall Study||69
11088349|NCT01160744|12271305|FG001|Received Study Drug|Overall Study||67
11088350|NCT01160744|12271306|FG002|Received Study Drug|Overall Study||63
11088351|NCT01160744|12271307|FG003|Received Study Drug|Overall Study||71
11088352|NCT01160744|12271304|FG000|COMPLETED|Overall Study||60
11088353|NCT01160744|12271305|FG001|COMPLETED|Overall Study||64
11088354|NCT01160744|12271306|FG002|COMPLETED|Overall Study||62
11088355|NCT01160744|12271307|FG003|COMPLETED|Overall Study||67
11088356|NCT01160744|12271304|FG000|NOT COMPLETED|Overall Study||11
11088357|NCT01160744|12271305|FG001|NOT COMPLETED|Overall Study||5
11088358|NCT01160744|12271306|FG002|NOT COMPLETED|Overall Study||7
11088359|NCT01160744|12271307|FG003|NOT COMPLETED|Overall Study||4
11088360|NCT01160770|12271319|FG000|STARTED|Overall Study||267
11088361|NCT01160770|12271319|FG000|COMPLETED|Overall Study||188
11088362|NCT01160770|12271319|FG000|NOT COMPLETED|Overall Study||79
11088363|NCT01160822|12271330|FG000|STARTED|Overall Study||6
11088364|NCT01160822|12271331|FG001|STARTED|Overall Study||7
11088365|NCT01160822|12271332|FG002|STARTED|Overall Study||6
11088366|NCT01160822|12271333|FG003|STARTED|Overall Study||5
11088367|NCT01160822|12271334|FG004|STARTED|Overall Study||45
11088368|NCT01160822|12271335|FG005|STARTED|Overall Study||47
11088369|NCT01160822|12271336|FG006|STARTED|Overall Study||53
11088370|NCT01160822|12271330|FG000|COMPLETED|Overall Study||6
11088371|NCT01160822|12271331|FG001|COMPLETED|Overall Study||7
11088372|NCT01160822|12271332|FG002|COMPLETED|Overall Study||6
11088373|NCT01160822|12271333|FG003|COMPLETED|Overall Study||5
11088374|NCT01160822|12271334|FG004|COMPLETED|Overall Study||36
11207883|NCT01877668|12399030|FG004|STARTED|Overall Study|Received treatment|53
11351382|NCT03035864|12548342|FG001|STARTED|Treatment Period||60
11351383|NCT03035864|12548341|FG000|COMPLETED|Treatment Period||116
11351384|NCT03035864|12548342|FG001|COMPLETED|Treatment Period||59
11351385|NCT03035864|12548341|FG000|NOT COMPLETED|Treatment Period||4
11088375|NCT01160822|12271335|FG005|COMPLETED|Overall Study||40
11088376|NCT01160822|12271336|FG006|COMPLETED|Overall Study||44
11088377|NCT01160822|12271330|FG000|NOT COMPLETED|Overall Study||0
11088378|NCT01160822|12271331|FG001|NOT COMPLETED|Overall Study||0
11088379|NCT01160822|12271332|FG002|NOT COMPLETED|Overall Study||0
11088380|NCT01160822|12271333|FG003|NOT COMPLETED|Overall Study||0
11088381|NCT01160822|12271334|FG004|NOT COMPLETED|Overall Study||9
11088382|NCT01160822|12271335|FG005|NOT COMPLETED|Overall Study||7
11088383|NCT01160822|12271336|FG006|NOT COMPLETED|Overall Study||9
11088384|NCT01160848|12271355|FG000|STARTED|Overall Study||12
11088385|NCT01160848|12271356|FG001|STARTED|Overall Study||8
11088386|NCT01160848|12271355|FG000|COMPLETED|Overall Study||12
11088387|NCT01160848|12271356|FG001|COMPLETED|Overall Study||8
11088388|NCT01160848|12271355|FG000|NOT COMPLETED|Overall Study||0
11088389|NCT01160848|12271356|FG001|NOT COMPLETED|Overall Study||0
11088390|NCT01161043|12271366|FG000|STARTED|Overall Study||83
11088391|NCT01161043|12271366|FG000|COMPLETED|Overall Study||80
11088392|NCT01161043|12271366|FG000|NOT COMPLETED|Overall Study||3
11088393|NCT01161121|12271370|FG000|STARTED|Overall Study||46
11088394|NCT01161121|12271370|FG000|COMPLETED|Overall Study||46
11088395|NCT01161121|12271370|FG000|NOT COMPLETED|Overall Study||0
11088396|NCT01161160|12271381|FG000|STARTED|Overall Study||76
11088397|NCT01161160|12271382|FG001|STARTED|Overall Study||75
11088398|NCT01161160|12271383|FG002|STARTED|Overall Study||58
11088399|NCT01161160|12271381|FG000|COMPLETED|Overall Study||76
11088400|NCT01161160|12271382|FG001|COMPLETED|Overall Study||75
11088401|NCT01161160|12271383|FG002|COMPLETED|Overall Study||58
11088402|NCT01161160|12271381|FG000|NOT COMPLETED|Overall Study||0
11088403|NCT01161160|12271382|FG001|NOT COMPLETED|Overall Study||0
11088404|NCT01161160|12271383|FG002|NOT COMPLETED|Overall Study||0
11088405|NCT01161173|12271391|FG000|STARTED|Overall Study||347
11088406|NCT01161173|12271391|FG000|COMPLETED|Overall Study||0
11088407|NCT01161173|12271391|FG000|NOT COMPLETED|Overall Study||347
11088408|NCT01161225|12271398|FG000|STARTED|Overall Study||59
11088409|NCT01161225|12271399|FG001|STARTED|Overall Study||53
11088410|NCT01161225|12271400|FG002|STARTED|Overall Study||14
11088411|NCT01161225|12271398|FG000|COMPLETED|Overall Study||45
11088412|NCT01161225|12271399|FG001|COMPLETED|Overall Study||44
11088413|NCT01161225|12271400|FG002|COMPLETED|Overall Study||12
11088414|NCT01161225|12271398|FG000|NOT COMPLETED|Overall Study||14
11088415|NCT01161225|12271399|FG001|NOT COMPLETED|Overall Study||9
11088416|NCT01161225|12271400|FG002|NOT COMPLETED|Overall Study||2
11088417|NCT01161329|12271414|FG000|STARTED|Overall Study||33
11088418|NCT01161329|12271415|FG001|STARTED|Overall Study||34
11088419|NCT01161329|12271414|FG000|COMPLETED|Overall Study||29
11088420|NCT01161329|12271415|FG001|COMPLETED|Overall Study||24
11088421|NCT01161329|12271414|FG000|NOT COMPLETED|Overall Study||4
11088422|NCT01161329|12271415|FG001|NOT COMPLETED|Overall Study||10
11088423|NCT01161407|12271424|FG000|STARTED|Overall Study||6
11088424|NCT01161407|12271425|FG001|STARTED|Overall Study||6
11088425|NCT01161407|12271424|FG000|COMPLETED|Overall Study||3
11088426|NCT01161407|12271425|FG001|COMPLETED|Overall Study||5
11088427|NCT01161407|12271424|FG000|NOT COMPLETED|Overall Study||3
11088428|NCT01161407|12271425|FG001|NOT COMPLETED|Overall Study||1
11088429|NCT01161420|12271431|FG000|STARTED|Inspire Therapy||126
11088430|NCT01161420|12271431|FG000|COMPLETED|Inspire Therapy||124
11088431|NCT01161420|12271431|FG000|NOT COMPLETED|Inspire Therapy||2
11088432|NCT01161420|12271431|FG000|STARTED|Withdrawal Study - Maintenance||23
11088433|NCT01161420|12271431|FG000|COMPLETED|Withdrawal Study - Maintenance||23
11088434|NCT01161420|12271431|FG000|NOT COMPLETED|Withdrawal Study - Maintenance||0
11088435|NCT01161420|12271431|FG000|STARTED|Withdrawal Study - Withdrawal||23
11088436|NCT01161420|12271431|FG000|COMPLETED|Withdrawal Study - Withdrawal||23
11088437|NCT01161420|12271431|FG000|NOT COMPLETED|Withdrawal Study - Withdrawal||0
11088438|NCT01161446|12271443|FG000|STARTED|Overall Study||116
11088439|NCT01161446|12271444|FG001|STARTED|Overall Study||114
11088440|NCT01161446|12271443|FG000|COMPLETED|Overall Study||98
11088441|NCT01161446|12271444|FG001|COMPLETED|Overall Study||99
11088442|NCT01161446|12271443|FG000|NOT COMPLETED|Overall Study||18
11088443|NCT01161446|12271444|FG001|NOT COMPLETED|Overall Study||15
11088444|NCT01161472|12271450|FG000|STARTED|First Intervention Period||5
11088445|NCT01161472|12271451|FG001|STARTED|First Intervention Period||5
11088446|NCT01161472|12271452|FG002|STARTED|First Intervention Period||5
11088447|NCT01161472|12271453|FG003|STARTED|First Intervention Period||5
11088448|NCT01161472|12271450|FG000|Treated|First Intervention Period||5
11088449|NCT01161472|12271451|FG001|Treated|First Intervention Period||5
11088450|NCT01161472|12271452|FG002|Treated|First Intervention Period||5
11207884|NCT01877668|12399026|FG000|COMPLETED|Overall Study||96
11207885|NCT01877668|12399027|FG001|COMPLETED|Overall Study||96
11088451|NCT01161472|12271453|FG003|Treated|First Intervention Period||5
11088452|NCT01161472|12271450|FG000|COMPLETED|First Intervention Period||5
11088453|NCT01161472|12271451|FG001|COMPLETED|First Intervention Period||5
11088454|NCT01161472|12271452|FG002|COMPLETED|First Intervention Period||5
11088455|NCT01161472|12271453|FG003|COMPLETED|First Intervention Period||5
11088456|NCT01161472|12271450|FG000|NOT COMPLETED|First Intervention Period||0
11088457|NCT01161472|12271451|FG001|NOT COMPLETED|First Intervention Period||0
11088458|NCT01161472|12271452|FG002|NOT COMPLETED|First Intervention Period||0
11088459|NCT01161472|12271453|FG003|NOT COMPLETED|First Intervention Period||0
11088460|NCT01161472|12271450|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5
11088461|NCT01161472|12271451|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
11088462|NCT01161472|12271452|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
11088463|NCT01161472|12271453|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
11088464|NCT01161472|12271450|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
11088465|NCT01161472|12271451|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
11088466|NCT01161472|12271452|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
11088467|NCT01161472|12271453|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
11088468|NCT01161472|12271450|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
11088469|NCT01161472|12271451|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
11088470|NCT01161472|12271452|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
11088471|NCT01161472|12271453|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
11088472|NCT01161472|12271450|FG000|STARTED|Second Intervention Period||5
11088473|NCT01161472|12271451|FG001|STARTED|Second Intervention Period||5
11088474|NCT01161472|12271452|FG002|STARTED|Second Intervention Period||5
11088475|NCT01161472|12271453|FG003|STARTED|Second Intervention Period||5
11088476|NCT01161472|12271450|FG000|COMPLETED|Second Intervention Period||5
11088477|NCT01161472|12271451|FG001|COMPLETED|Second Intervention Period||5
11088478|NCT01161472|12271452|FG002|COMPLETED|Second Intervention Period||5
11088479|NCT01161472|12271453|FG003|COMPLETED|Second Intervention Period||5
11088480|NCT01161472|12271450|FG000|NOT COMPLETED|Second Intervention Period||0
11088481|NCT01161472|12271451|FG001|NOT COMPLETED|Second Intervention Period||0
11088482|NCT01161472|12271452|FG002|NOT COMPLETED|Second Intervention Period||0
11088483|NCT01161472|12271453|FG003|NOT COMPLETED|Second Intervention Period||0
11088484|NCT01161472|12271450|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5
11088485|NCT01161472|12271451|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
11088486|NCT01161472|12271452|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
11088487|NCT01161472|12271453|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
11088488|NCT01161472|12271450|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
11088489|NCT01161472|12271451|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
11088490|NCT01161472|12271452|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
11088491|NCT01161472|12271453|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
11088492|NCT01161472|12271450|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
11088493|NCT01161472|12271451|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
11088494|NCT01161472|12271452|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
11088495|NCT01161472|12271453|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
11088496|NCT01161472|12271450|FG000|STARTED|Third Intervention Period||4
11088497|NCT01161472|12271451|FG001|STARTED|Third Intervention Period||5
11088498|NCT01161472|12271452|FG002|STARTED|Third Intervention Period||5
11088499|NCT01161472|12271453|FG003|STARTED|Third Intervention Period||5
11088500|NCT01161472|12271450|FG000|COMPLETED|Third Intervention Period||4
11088501|NCT01161472|12271451|FG001|COMPLETED|Third Intervention Period||5
11088502|NCT01161472|12271452|FG002|COMPLETED|Third Intervention Period||5
11088503|NCT01161472|12271453|FG003|COMPLETED|Third Intervention Period||5
11088504|NCT01161472|12271450|FG000|NOT COMPLETED|Third Intervention Period||0
11088505|NCT01161472|12271451|FG001|NOT COMPLETED|Third Intervention Period||0
11088506|NCT01161472|12271452|FG002|NOT COMPLETED|Third Intervention Period||0
11088507|NCT01161472|12271453|FG003|NOT COMPLETED|Third Intervention Period||0
11088508|NCT01161472|12271450|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||4
11088509|NCT01161472|12271451|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
11088510|NCT01161472|12271452|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
11088511|NCT01161472|12271453|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
11088512|NCT01161472|12271450|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
11088513|NCT01161472|12271451|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
11088514|NCT01161472|12271452|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
11088515|NCT01161472|12271453|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
11088516|NCT01161472|12271450|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
11088517|NCT01161472|12271451|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
11088518|NCT01161472|12271452|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
11088519|NCT01161472|12271453|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
11088520|NCT01161472|12271450|FG000|STARTED|Fourth Intervention Period||4
11088521|NCT01161472|12271451|FG001|STARTED|Fourth Intervention Period||5
11088522|NCT01161472|12271452|FG002|STARTED|Fourth Intervention Period||5
11088523|NCT01161472|12271453|FG003|STARTED|Fourth Intervention Period||5
11088524|NCT01161472|12271450|FG000|COMPLETED|Fourth Intervention Period||4
11088525|NCT01161472|12271451|FG001|COMPLETED|Fourth Intervention Period||5
11088526|NCT01161472|12271452|FG002|COMPLETED|Fourth Intervention Period||5
11088527|NCT01161472|12271453|FG003|COMPLETED|Fourth Intervention Period||5
11088528|NCT01161472|12271450|FG000|NOT COMPLETED|Fourth Intervention Period||0
11088529|NCT01161472|12271451|FG001|NOT COMPLETED|Fourth Intervention Period||0
11088530|NCT01161472|12271452|FG002|NOT COMPLETED|Fourth Intervention Period||0
11088531|NCT01161472|12271453|FG003|NOT COMPLETED|Fourth Intervention Period||0
11088532|NCT01161498|12271465|FG000|STARTED|Overall Study||3
11088533|NCT01161498|12271466|FG001|STARTED|Overall Study||2
11088534|NCT01161498|12271465|FG000|COMPLETED|Overall Study||3
11088535|NCT01161498|12271466|FG001|COMPLETED|Overall Study||1
11088536|NCT01161498|12271465|FG000|NOT COMPLETED|Overall Study||0
11088537|NCT01161498|12271466|FG001|NOT COMPLETED|Overall Study||1
11088538|NCT01161524|12271474|FG000|STARTED|Core Study (23 Weeks)||85
11088539|NCT01161524|12271475|FG001|STARTED|Core Study (23 Weeks)||48
11088540|NCT01161524|12271476|FG002|STARTED|Core Study (23 Weeks)||0
11088541|NCT01161524|12271474|FG000|COMPLETED|Core Study (23 Weeks)||76
11088542|NCT01161524|12271475|FG001|COMPLETED|Core Study (23 Weeks)||43
11088543|NCT01161524|12271476|FG002|COMPLETED|Core Study (23 Weeks)||0
11088544|NCT01161524|12271474|FG000|NOT COMPLETED|Core Study (23 Weeks)||9
11088545|NCT01161524|12271475|FG001|NOT COMPLETED|Core Study (23 Weeks)||5
11088546|NCT01161524|12271476|FG002|NOT COMPLETED|Core Study (23 Weeks)||0
11351386|NCT03035864|12548342|FG001|NOT COMPLETED|Treatment Period||1
11351387|NCT03035864|12548341|FG000|STARTED|Follow-up Period||116
11351388|NCT03035864|12548342|FG001|STARTED|Follow-up Period||59
11351389|NCT03035864|12548341|FG000|COMPLETED|Follow-up Period||105
11351390|NCT03035864|12548342|FG001|COMPLETED|Follow-up Period||55
11351391|NCT03035864|12548341|FG000|NOT COMPLETED|Follow-up Period||11
11351392|NCT03035864|12548342|FG001|NOT COMPLETED|Follow-up Period||4
11351393|NCT03035916|12548351|FG000|STARTED|Overall Study||30
11351394|NCT03035916|12548352|FG001|STARTED|Overall Study||30
11351395|NCT03035916|12548353|FG002|STARTED|Overall Study||31
11351396|NCT03035916|12548351|FG000|COMPLETED|Overall Study||30
11351397|NCT03035916|12548352|FG001|COMPLETED|Overall Study||28
11351398|NCT03035916|12548353|FG002|COMPLETED|Overall Study||31
11351399|NCT03035916|12548351|FG000|NOT COMPLETED|Overall Study||0
11351400|NCT03035916|12548352|FG001|NOT COMPLETED|Overall Study||2
11351401|NCT03035916|12548353|FG002|NOT COMPLETED|Overall Study||0
11351402|NCT03035929|12548361|FG000|STARTED|Overall Study||10
11088547|NCT01161524|12271474|FG000|STARTED|Extension Phase (Approximately 83 Weeks)||0
11088548|NCT01161524|12271475|FG001|STARTED|Extension Phase (Approximately 83 Weeks)||0
11088549|NCT01161524|12271476|FG002|STARTED|Extension Phase (Approximately 83 Weeks)||114
11088550|NCT01161524|12271474|FG000|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
11088551|NCT01161524|12271475|FG001|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
11088552|NCT01161524|12271476|FG002|COMPLETED|Extension Phase (Approximately 83 Weeks)||90
11088553|NCT01161524|12271474|FG000|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
11088554|NCT01161524|12271475|FG001|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
11088555|NCT01161524|12271476|FG002|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24
11088556|NCT01161537|12271485|FG000|STARTED|Part A||8
11088557|NCT01161537|12271485|FG000|COMPLETED|Part A||8
11088558|NCT01161537|12271485|FG000|NOT COMPLETED|Part A||0
11088559|NCT01161537|12271485|FG000|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
11088560|NCT01161537|12271485|FG000|COMPLETED|Part B||7
11088561|NCT01161537|12271485|FG000|NOT COMPLETED|Part B||2
11088562|NCT01161563|12271496|FG000|STARTED|Overall Study||63
11088563|NCT01161563|12271497|FG001|STARTED|Overall Study||55
11351403|NCT03035929|12548361|FG000|COMPLETED|Overall Study||10
11351404|NCT03035929|12548361|FG000|NOT COMPLETED|Overall Study||0
11351405|NCT03035942|12548369|FG000|STARTED|Overall Study||45
11088564|NCT01161563|12271496|FG000|COMPLETED|Overall Study||58
11088565|NCT01161563|12271497|FG001|COMPLETED|Overall Study||49
11088566|NCT01161563|12271496|FG000|NOT COMPLETED|Overall Study||5
11088567|NCT01161563|12271497|FG001|NOT COMPLETED|Overall Study||6
11088568|NCT01161628|12271503|FG000|STARTED|Overall Study||25
11088569|NCT01161628|12271503|FG000|COMPLETED|Overall Study||17
11088570|NCT01161628|12271503|FG000|NOT COMPLETED|Overall Study||8
11088571|NCT01161771|12271507|FG000|STARTED|Overall Study||32
11088572|NCT01161771|12271507|FG000|COMPLETED|Overall Study||32
11088573|NCT01161771|12271507|FG000|NOT COMPLETED|Overall Study||0
11088574|NCT01161862|12271513|FG000|STARTED|Overall Study||12
11088575|NCT01161862|12271514|FG001|STARTED|Overall Study||12
11088576|NCT01161862|12271513|FG000|COMPLETED|Overall Study||12
11088577|NCT01161862|12271514|FG001|COMPLETED|Overall Study||12
11088578|NCT01161862|12271513|FG000|NOT COMPLETED|Overall Study||0
11088579|NCT01161862|12271514|FG001|NOT COMPLETED|Overall Study||0
11088580|NCT01162005|12271525|FG000|STARTED|Overall Study||44
11088581|NCT01162005|12271526|FG001|STARTED|Overall Study||33
11088582|NCT01162005|12271525|FG000|COMPLETED|Overall Study||44
11088583|NCT01162005|12271526|FG001|COMPLETED|Overall Study||33
11088584|NCT01162005|12271525|FG000|NOT COMPLETED|Overall Study||0
11088585|NCT01162005|12271526|FG001|NOT COMPLETED|Overall Study||0
11088586|NCT01162096|12271534|FG000|STARTED|Overall Study||34
11088587|NCT01162096|12271534|FG000|COMPLETED|Overall Study||34
11088588|NCT01162096|12271534|FG000|NOT COMPLETED|Overall Study||0
11088589|NCT01162122|12271541|FG000|STARTED|Overall Study||3552
11088590|NCT01162122|12271542|FG001|STARTED|Overall Study||3552
11088591|NCT01162122|12271541|FG000|Vaccinated|Overall Study||3541
11088592|NCT01162122|12271542|FG001|Vaccinated|Overall Study||3541
11088593|NCT01162122|12271541|FG000|COMPLETED|Overall Study||3361
11088594|NCT01162122|12271542|FG001|COMPLETED|Overall Study||3356
11088595|NCT01162122|12271541|FG000|NOT COMPLETED|Overall Study||191
11088596|NCT01162122|12271542|FG001|NOT COMPLETED|Overall Study||196
11088597|NCT01162135|12271551|FG000|STARTED|Overall Study||16
11088598|NCT01162135|12271551|FG000|COMPLETED|Overall Study||13
11088599|NCT01162135|12271551|FG000|NOT COMPLETED|Overall Study||3
11088600|NCT01162239|12271559|FG000|STARTED|Treatment Phase||55
11088601|NCT01162239|12271560|FG001|STARTED|Treatment Phase||54
11088602|NCT01162239|12271561|FG002|STARTED|Treatment Phase||52
11088603|NCT01162239|12271562|FG003|STARTED|Treatment Phase||55
11088604|NCT01162239|12271559|FG000|Week 12|Treatment Phase||50
11088605|NCT01162239|12271560|FG001|Week 12|Treatment Phase||51
11088606|NCT01162239|12271561|FG002|Week 12|Treatment Phase||49
11088607|NCT01162239|12271562|FG003|Week 12|Treatment Phase||53
11088608|NCT01162239|12271559|FG000|Week 24|Treatment Phase||51
11088609|NCT01162239|12271560|FG001|Week 24|Treatment Phase||48
11088610|NCT01162239|12271561|FG002|Week 24|Treatment Phase||48
11088611|NCT01162239|12271562|FG003|Week 24|Treatment Phase||50
11088612|NCT01162239|12271559|FG000|Week 52|Treatment Phase||49
11088613|NCT01162239|12271560|FG001|Week 52|Treatment Phase||47
11088614|NCT01162239|12271561|FG002|Week 52|Treatment Phase||48
11088615|NCT01162239|12271562|FG003|Week 52|Treatment Phase||50
11088616|NCT01162239|12271559|FG000|COMPLETED|Treatment Phase||49
11088617|NCT01162239|12271560|FG001|COMPLETED|Treatment Phase||47
11088618|NCT01162239|12271561|FG002|COMPLETED|Treatment Phase||48
11088619|NCT01162239|12271562|FG003|COMPLETED|Treatment Phase||50
11088620|NCT01162239|12271559|FG000|NOT COMPLETED|Treatment Phase||6
11088621|NCT01162239|12271560|FG001|NOT COMPLETED|Treatment Phase||7
11088622|NCT01162239|12271561|FG002|NOT COMPLETED|Treatment Phase||4
11088623|NCT01162239|12271562|FG003|NOT COMPLETED|Treatment Phase||5
11088624|NCT01162239|12271559|FG000|STARTED|Extended Follow-up||47
11088625|NCT01162239|12271560|FG001|STARTED|Extended Follow-up||45
11088626|NCT01162239|12271561|FG002|STARTED|Extended Follow-up||45
11088627|NCT01162239|12271562|FG003|STARTED|Extended Follow-up||47
11088628|NCT01162239|12271559|FG000|COMPLETED|Extended Follow-up||39
11088629|NCT01162239|12271560|FG001|COMPLETED|Extended Follow-up||32
11207886|NCT01877668|12399028|FG002|COMPLETED|Overall Study||94
11088630|NCT01162239|12271561|FG002|COMPLETED|Extended Follow-up||37
11088631|NCT01162239|12271562|FG003|COMPLETED|Extended Follow-up||41
11088632|NCT01162239|12271559|FG000|NOT COMPLETED|Extended Follow-up||8
11088633|NCT01162239|12271560|FG001|NOT COMPLETED|Extended Follow-up||13
11088634|NCT01162239|12271561|FG002|NOT COMPLETED|Extended Follow-up||8
11088635|NCT01162239|12271562|FG003|NOT COMPLETED|Extended Follow-up||6
11088636|NCT01162317|12271575|FG000|STARTED|Overall Study||30
11088637|NCT01162317|12271576|FG001|STARTED|Overall Study||30
11088638|NCT01162317|12271575|FG000|COMPLETED|Overall Study||27
11088639|NCT01162317|12271576|FG001|COMPLETED|Overall Study||28
11088640|NCT01162317|12271575|FG000|NOT COMPLETED|Overall Study||3
11088641|NCT01162317|12271576|FG001|NOT COMPLETED|Overall Study||2
11088642|NCT01162343|12271582|FG000|STARTED|Overall Study||498
11207887|NCT01877668|12399029|FG003|COMPLETED|Overall Study||44
11207888|NCT01877668|12399030|FG004|COMPLETED|Overall Study||43
11207889|NCT01877668|12399026|FG000|NOT COMPLETED|Overall Study||11
11207890|NCT01877668|12399027|FG001|NOT COMPLETED|Overall Study||8
11207891|NCT01877668|12399028|FG002|NOT COMPLETED|Overall Study||12
11207892|NCT01877668|12399029|FG003|NOT COMPLETED|Overall Study||8
11207893|NCT01877668|12399030|FG004|NOT COMPLETED|Overall Study||10
11207894|NCT01877720|12399046|FG000|STARTED|Overall Study||8
11207895|NCT01877720|12399047|FG001|STARTED|Overall Study||8
11207896|NCT01877720|12399046|FG000|1st Intervention|Overall Study||7
11207897|NCT01877720|12399047|FG001|1st Intervention|Overall Study||8
11207898|NCT01877720|12399046|FG000|2nd Intervention|Overall Study||7
11207899|NCT01877720|12399047|FG001|2nd Intervention|Overall Study||8
11207900|NCT01877720|12399046|FG000|COMPLETED|Overall Study||7
11088643|NCT01162343|12271582|FG000|COMPLETED|Overall Study||406
11088644|NCT01162343|12271582|FG000|NOT COMPLETED|Overall Study||92
11088645|NCT01162421|12271588|FG000|STARTED|Overall Study||37
11088646|NCT01162421|12271589|FG001|STARTED|Overall Study||40
11088647|NCT01162421|12271588|FG000|COMPLETED|Overall Study||29
11088648|NCT01162421|12271589|FG001|COMPLETED|Overall Study||27
11207901|NCT01877720|12399047|FG001|COMPLETED|Overall Study||8
11207902|NCT01877720|12399046|FG000|NOT COMPLETED|Overall Study||1
11207903|NCT01877720|12399047|FG001|NOT COMPLETED|Overall Study||0
11207904|NCT01877915|12399055|FG000|STARTED|Overall Study||2507
11207905|NCT01877915|12399056|FG001|STARTED|Overall Study||2515
11207906|NCT01877915|12399055|FG000|COMPLETED|Overall Study||2453
11207907|NCT01877915|12399056|FG001|COMPLETED|Overall Study||2447
11207908|NCT01877915|12399055|FG000|NOT COMPLETED|Overall Study||54
11207909|NCT01877915|12399056|FG001|NOT COMPLETED|Overall Study||68
11207910|NCT01877941|12399062|FG000|STARTED|Overall Study||39
11207911|NCT01877941|12399062|FG000|COMPLETED|Overall Study||39
11207912|NCT01877941|12399062|FG000|NOT COMPLETED|Overall Study||0
11207913|NCT01878006|12399067|FG000|STARTED|Study Session 1||5
11207914|NCT01878006|12399068|FG001|STARTED|Study Session 1||5
11207915|NCT01878006|12399067|FG000|COMPLETED|Study Session 1||5
11207916|NCT01878006|12399068|FG001|COMPLETED|Study Session 1||5
11207917|NCT01878006|12399067|FG000|NOT COMPLETED|Study Session 1||0
11207918|NCT01878006|12399068|FG001|NOT COMPLETED|Study Session 1||0
11207919|NCT01878006|12399067|FG000|STARTED|Study Session 2||5
11207920|NCT01878006|12399068|FG001|STARTED|Study Session 2||5
11207921|NCT01878006|12399067|FG000|COMPLETED|Study Session 2||5
11207922|NCT01878006|12399068|FG001|COMPLETED|Study Session 2||5
11207923|NCT01878006|12399067|FG000|NOT COMPLETED|Study Session 2||0
11207924|NCT01878006|12399068|FG001|NOT COMPLETED|Study Session 2||0
11207925|NCT01878084|12399074|FG000|STARTED|Overall Study||9
11207926|NCT01878084|12399074|FG000|Test(Received TAMP Bioglass) s|Overall Study||7
11207927|NCT01878084|12399074|FG000|Control (Sockets Were Left Empty)|Overall Study||7
11207928|NCT01878084|12399074|FG000|COMPLETED|Overall Study||7
11207929|NCT01878084|12399074|FG000|NOT COMPLETED|Overall Study||2
11207930|NCT01878097|12399081|FG000|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
11207931|NCT01878097|12399082|FG001|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
11207932|NCT01878097|12399081|FG000|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
11207933|NCT01878097|12399082|FG001|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
11207934|NCT01878097|12399081|FG000|NOT COMPLETED|Baseline||2497
11207935|NCT01878097|12399082|FG001|NOT COMPLETED|Baseline||1800
11088649|NCT01162421|12271588|FG000|NOT COMPLETED|Overall Study||8
11088650|NCT01162421|12271589|FG001|NOT COMPLETED|Overall Study||13
11088651|NCT01162473|12271597|FG000|STARTED|Overall Study||8
11088652|NCT01162473|12271598|FG001|STARTED|Overall Study||17
11088653|NCT01162473|12271597|FG000|COMPLETED|Overall Study||6
11088654|NCT01162473|12271598|FG001|COMPLETED|Overall Study||12
11088655|NCT01162473|12271597|FG000|NOT COMPLETED|Overall Study||2
11088656|NCT01162473|12271598|FG001|NOT COMPLETED|Overall Study||5
11088657|NCT01162486|12271609|FG000|STARTED|Overall Study||8
11088658|NCT01162486|12271610|FG001|STARTED|Overall Study||6
11088659|NCT01162486|12271611|FG002|STARTED|Overall Study||6
11088660|NCT01162486|12271612|FG003|STARTED|Overall Study||7
11088661|NCT01162486|12271613|FG004|STARTED|Overall Study||6
11088662|NCT01162486|12271609|FG000|Took at Least One Dose Study Drug|Overall Study||8
11088663|NCT01162486|12271610|FG001|Took at Least One Dose Study Drug|Overall Study||6
11088664|NCT01162486|12271611|FG002|Took at Least One Dose Study Drug|Overall Study||6
11088665|NCT01162486|12271612|FG003|Took at Least One Dose Study Drug|Overall Study||7
11088666|NCT01162486|12271613|FG004|Took at Least One Dose Study Drug|Overall Study||6
11088667|NCT01162486|12271609|FG000|COMPLETED|Overall Study||6
11088668|NCT01162486|12271610|FG001|COMPLETED|Overall Study||6
11088669|NCT01162486|12271611|FG002|COMPLETED|Overall Study||5
11088670|NCT01162486|12271612|FG003|COMPLETED|Overall Study||6
11088671|NCT01162486|12271613|FG004|COMPLETED|Overall Study||6
11088672|NCT01162486|12271609|FG000|NOT COMPLETED|Overall Study||2
11088673|NCT01162486|12271610|FG001|NOT COMPLETED|Overall Study||0
11088674|NCT01162486|12271611|FG002|NOT COMPLETED|Overall Study||1
11088675|NCT01162486|12271612|FG003|NOT COMPLETED|Overall Study||1
11088676|NCT01162486|12271613|FG004|NOT COMPLETED|Overall Study||0
11088677|NCT01162499|12271629|FG000|STARTED|Intervention 1 (4 Hours)||3
11088678|NCT01162499|12271630|FG001|STARTED|Intervention 1 (4 Hours)||4
11088679|NCT01162499|12271629|FG000|Received Intervention|Intervention 1 (4 Hours)||3
11088680|NCT01162499|12271630|FG001|Received Intervention|Intervention 1 (4 Hours)||3
11088681|NCT01162499|12271629|FG000|COMPLETED|Intervention 1 (4 Hours)||3
11088682|NCT01162499|12271630|FG001|COMPLETED|Intervention 1 (4 Hours)||3
11088683|NCT01162499|12271629|FG000|NOT COMPLETED|Intervention 1 (4 Hours)||0
11088684|NCT01162499|12271630|FG001|NOT COMPLETED|Intervention 1 (4 Hours)||1
11088685|NCT01162499|12271629|FG000|STARTED|Intervention 2 (4 Hours)||3
11088686|NCT01162499|12271630|FG001|STARTED|Intervention 2 (4 Hours)||3
11088687|NCT01162499|12271629|FG000|COMPLETED|Intervention 2 (4 Hours)||3
11088688|NCT01162499|12271630|FG001|COMPLETED|Intervention 2 (4 Hours)||3
11088689|NCT01162499|12271629|FG000|NOT COMPLETED|Intervention 2 (4 Hours)||0
11088690|NCT01162499|12271630|FG001|NOT COMPLETED|Intervention 2 (4 Hours)||0
11088691|NCT01162551|12271638|FG000|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3
11088692|NCT01162551|12271638|FG000|COMPLETED|Overall Study||3
11088693|NCT01162551|12271638|FG000|NOT COMPLETED|Overall Study||0
11088694|NCT01162733|12271644|FG000|STARTED|Overall Study||49
11088695|NCT01162733|12271645|FG001|STARTED|Overall Study||50
11207936|NCT01878097|12399081|FG000|STARTED|Implementation Year 1||11742
11207937|NCT01878097|12399082|FG001|STARTED|Implementation Year 1||9866
11207938|NCT01878097|12399081|FG000|COMPLETED|Implementation Year 1||8540
11207939|NCT01878097|12399082|FG001|COMPLETED|Implementation Year 1||7317
11207940|NCT01878097|12399081|FG000|NOT COMPLETED|Implementation Year 1||3202
11088696|NCT01162733|12271644|FG000|COMPLETED|Overall Study||22
11088697|NCT01162733|12271645|FG001|COMPLETED|Overall Study||25
11088698|NCT01162733|12271644|FG000|NOT COMPLETED|Overall Study||27
11088699|NCT01162733|12271645|FG001|NOT COMPLETED|Overall Study||25
11088700|NCT01162863|12271654|FG000|STARTED|Overall Study||18
11088701|NCT01162863|12271655|FG001|STARTED|Overall Study||17
11088702|NCT01162863|12271656|FG002|STARTED|Overall Study||17
11088703|NCT01162863|12271654|FG000|COMPLETED|Overall Study||17
11088704|NCT01162863|12271655|FG001|COMPLETED|Overall Study||16
11088705|NCT01162863|12271656|FG002|COMPLETED|Overall Study||17
11088706|NCT01162863|12271654|FG000|NOT COMPLETED|Overall Study||1
11088707|NCT01162863|12271655|FG001|NOT COMPLETED|Overall Study||1
11088708|NCT01162863|12271656|FG002|NOT COMPLETED|Overall Study||0
11088709|NCT01163032|12271667|FG000|STARTED|Randomization Phase||42
11088710|NCT01163032|12271668|FG001|STARTED|Randomization Phase||42
11088711|NCT01163032|12271669|FG002|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
11088712|NCT01163032|12271667|FG000|COMPLETED|Randomization Phase||32
11088713|NCT01163032|12271668|FG001|COMPLETED|Randomization Phase||30
11088714|NCT01163032|12271669|FG002|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
11088715|NCT01163032|12271667|FG000|NOT COMPLETED|Randomization Phase||10
11088716|NCT01163032|12271668|FG001|NOT COMPLETED|Randomization Phase||12
11088717|NCT01163032|12271669|FG002|NOT COMPLETED|Randomization Phase||0
11088718|NCT01163032|12271667|FG000|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
11088719|NCT01163032|12271668|FG001|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
11088720|NCT01163032|12271669|FG002|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
11088721|NCT01163032|12271667|FG000|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
11088722|NCT01163032|12271668|FG001|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
11088723|NCT01163032|12271669|FG002|COMPLETED|Open Label Extension Phase||39
11088724|NCT01163032|12271667|FG000|NOT COMPLETED|Open Label Extension Phase||0
11088725|NCT01163032|12271668|FG001|NOT COMPLETED|Open Label Extension Phase||0
11088726|NCT01163032|12271669|FG002|NOT COMPLETED|Open Label Extension Phase||16
11088727|NCT01163097|12271680|FG000|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
11088728|NCT01163097|12271681|FG001|STARTED|Overall Study||16
11088729|NCT01163097|12271682|FG002|STARTED|Overall Study||8
11088730|NCT01163097|12271680|FG000|COMPLETED|Overall Study||14
11088731|NCT01163097|12271681|FG001|COMPLETED|Overall Study||16
11088732|NCT01163097|12271682|FG002|COMPLETED|Overall Study||8
11088733|NCT01163097|12271680|FG000|NOT COMPLETED|Overall Study||6
11088734|NCT01163097|12271681|FG001|NOT COMPLETED|Overall Study||0
11088735|NCT01163097|12271682|FG002|NOT COMPLETED|Overall Study||0
11088736|NCT01163149|12271695|FG000|STARTED|Primary Treatment Period||7
11088737|NCT01163149|12271696|FG001|STARTED|Primary Treatment Period||6
11088738|NCT01163149|12271697|FG002|STARTED|Primary Treatment Period||6
11351406|NCT03035942|12548370|FG001|STARTED|Overall Study||45
11351407|NCT03035942|12548371|FG002|STARTED|Overall Study||45
11088739|NCT01163149|12271695|FG000|COMPLETED|Primary Treatment Period||7
11088740|NCT01163149|12271696|FG001|COMPLETED|Primary Treatment Period||6
11088741|NCT01163149|12271697|FG002|COMPLETED|Primary Treatment Period||6
11088742|NCT01163149|12271695|FG000|NOT COMPLETED|Primary Treatment Period||0
11088743|NCT01163149|12271696|FG001|NOT COMPLETED|Primary Treatment Period||0
11088744|NCT01163149|12271697|FG002|NOT COMPLETED|Primary Treatment Period||0
11088745|NCT01163149|12271695|FG000|STARTED|Extension Treatment Period||7
11088746|NCT01163149|12271696|FG001|STARTED|Extension Treatment Period||6
11088747|NCT01163149|12271697|FG002|STARTED|Extension Treatment Period||6
11088748|NCT01163149|12271695|FG000|COMPLETED|Extension Treatment Period||5
11088749|NCT01163149|12271696|FG001|COMPLETED|Extension Treatment Period||5
11088750|NCT01163149|12271697|FG002|COMPLETED|Extension Treatment Period||4
11088751|NCT01163149|12271695|FG000|NOT COMPLETED|Extension Treatment Period||2
11088752|NCT01163149|12271696|FG001|NOT COMPLETED|Extension Treatment Period||1
11088753|NCT01163149|12271697|FG002|NOT COMPLETED|Extension Treatment Period||2
11088754|NCT01163162|12271719|FG000|STARTED|Overall Study||16
11351408|NCT03035942|12548369|FG000|COMPLETED|Overall Study||37
11351409|NCT03035942|12548370|FG001|COMPLETED|Overall Study||41
11351410|NCT03035942|12548371|FG002|COMPLETED|Overall Study||40
11351411|NCT03035942|12548369|FG000|NOT COMPLETED|Overall Study||8
11351412|NCT03035942|12548370|FG001|NOT COMPLETED|Overall Study||4
11351413|NCT03035942|12548371|FG002|NOT COMPLETED|Overall Study||5
11351414|NCT03035955|12548383|FG000|STARTED|Overall Study||10
11351415|NCT03035955|12548384|FG001|STARTED|Overall Study||10
11088755|NCT01163162|12271719|FG000|COMPLETED|Overall Study||16
11088756|NCT01163162|12271719|FG000|NOT COMPLETED|Overall Study||0
11088757|NCT01163214|12271725|FG000|STARTED|Overall Study||79
11088758|NCT01163214|12271726|FG001|STARTED|Overall Study||81
11088759|NCT01163214|12271725|FG000|COMPLETED|Overall Study||79
11088760|NCT01163214|12271726|FG001|COMPLETED|Overall Study||81
11088761|NCT01163214|12271725|FG000|NOT COMPLETED|Overall Study||0
11088762|NCT01163214|12271726|FG001|NOT COMPLETED|Overall Study||0
11088763|NCT01163253|12271734|FG000|STARTED|Overall Study||2281
11088764|NCT01163253|12271735|FG001|STARTED|Overall Study||586
11088765|NCT01163253|12271734|FG000|COMPLETED|Overall Study||0
11088766|NCT01163253|12271735|FG001|COMPLETED|Overall Study||0
11088767|NCT01163253|12271734|FG000|NOT COMPLETED|Overall Study||2281
11088768|NCT01163253|12271735|FG001|NOT COMPLETED|Overall Study||586
11088769|NCT01163266|12271744|FG000|STARTED|Overall Study||157
11088770|NCT01163266|12271745|FG001|STARTED|Overall Study||155
11088771|NCT01163266|12271746|FG002|STARTED|Overall Study||150
11088772|NCT01163266|12271744|FG000|Treated|Overall Study||157
11088773|NCT01163266|12271745|FG001|Treated|Overall Study||155
11088774|NCT01163266|12271746|FG002|Treated|Overall Study||150
11088775|NCT01163266|12271744|FG000|COMPLETED|Overall Study||139
11088776|NCT01163266|12271745|FG001|COMPLETED|Overall Study||124
11088777|NCT01163266|12271746|FG002|COMPLETED|Overall Study||122
11088778|NCT01163266|12271744|FG000|NOT COMPLETED|Overall Study||18
11088779|NCT01163266|12271745|FG001|NOT COMPLETED|Overall Study||31
11088780|NCT01163266|12271746|FG002|NOT COMPLETED|Overall Study||28
11088781|NCT01163279|12271756|FG000|STARTED|Overall Study||10
11088782|NCT01163279|12271757|FG001|STARTED|Overall Study||9
11088783|NCT01163279|12271756|FG000|COMPLETED|Overall Study||8
11088784|NCT01163279|12271757|FG001|COMPLETED|Overall Study||9
11088785|NCT01163279|12271756|FG000|NOT COMPLETED|Overall Study||2
11088786|NCT01163279|12271757|FG001|NOT COMPLETED|Overall Study||0
11088787|NCT01163292|12271766|FG000|STARTED|Overall Study||106
11088788|NCT01163292|12271767|FG001|STARTED|Overall Study||114
11088789|NCT01163292|12271766|FG000|COMPLETED|Overall Study||65
11088790|NCT01163292|12271767|FG001|COMPLETED|Overall Study||92
11088791|NCT01163292|12271766|FG000|NOT COMPLETED|Overall Study||41
11088792|NCT01163292|12271767|FG001|NOT COMPLETED|Overall Study||22
11088793|NCT01163318|12271773|FG000|STARTED|Overall Study||552
11088794|NCT01163318|12271773|FG000|COMPLETED|Overall Study||284
11088795|NCT01163318|12271773|FG000|NOT COMPLETED|Overall Study||268
11088796|NCT01163461|12271777|FG000|STARTED|Overall Study||14
11088797|NCT01163461|12271778|FG001|STARTED|Overall Study||14
11088798|NCT01163461|12271777|FG000|COMPLETED|Overall Study||14
11088799|NCT01163461|12271778|FG001|COMPLETED|Overall Study||14
11088800|NCT01163461|12271777|FG000|NOT COMPLETED|Overall Study||0
11088801|NCT01163461|12271778|FG001|NOT COMPLETED|Overall Study||0
11088802|NCT01163474|12271782|FG000|STARTED|Overall Study||40
11088803|NCT01163474|12271782|FG000|COMPLETED|Overall Study||24
11088804|NCT01163474|12271782|FG000|NOT COMPLETED|Overall Study||16
11088805|NCT01163604|12271791|FG000|STARTED|Overall Study|August 2010|58
11088806|NCT01163604|12271792|FG001|STARTED|Overall Study|August 2010|56
11088807|NCT01163604|12271791|FG000|COMPLETED|Overall Study|August 2011|58
11088808|NCT01163604|12271792|FG001|COMPLETED|Overall Study|August 2011|56
11088809|NCT01163604|12271791|FG000|NOT COMPLETED|Overall Study||0
11088810|NCT01163604|12271792|FG001|NOT COMPLETED|Overall Study||0
11088811|NCT01163617|12271798|FG000|STARTED|Phase A (User Experience), Weeks 0 and 2||19
11088812|NCT01163617|12271799|FG001|STARTED|Phase A (User Experience), Weeks 0 and 2||23
11088813|NCT01163617|12271800|FG002|STARTED|Phase A (User Experience), Weeks 0 and 2||21
11088814|NCT01163617|12271801|FG003|STARTED|Phase A (User Experience), Weeks 0 and 2||21
11088815|NCT01163617|12271802|FG004|STARTED|Phase A (User Experience), Weeks 0 and 2||0
11088816|NCT01163617|12271803|FG005|STARTED|Phase A (User Experience), Weeks 0 and 2||0
11088817|NCT01163617|12271804|FG006|STARTED|Phase A (User Experience), Weeks 0 and 2||0
11088818|NCT01163617|12271805|FG007|STARTED|Phase A (User Experience), Weeks 0 and 2||0
11088819|NCT01163617|12271798|FG000|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
11088820|NCT01163617|12271799|FG001|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
11088821|NCT01163617|12271800|FG002|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
11088822|NCT01163617|12271801|FG003|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
11088823|NCT01163617|12271802|FG004|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
11088824|NCT01163617|12271803|FG005|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
11088825|NCT01163617|12271804|FG006|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
11088826|NCT01163617|12271805|FG007|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
11088827|NCT01163617|12271798|FG000|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
11088828|NCT01163617|12271799|FG001|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
11088829|NCT01163617|12271800|FG002|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
11088830|NCT01163617|12271801|FG003|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
11088831|NCT01163617|12271802|FG004|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
11088832|NCT01163617|12271803|FG005|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
11088833|NCT01163617|12271804|FG006|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
11088834|NCT01163617|12271805|FG007|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
11088835|NCT01163617|12271798|FG000|STARTED|Phase B (Injection Time), Week 4||0
11088836|NCT01163617|12271799|FG001|STARTED|Phase B (Injection Time), Week 4||0
11088837|NCT01163617|12271800|FG002|STARTED|Phase B (Injection Time), Week 4||0
11088838|NCT01163617|12271801|FG003|STARTED|Phase B (Injection Time), Week 4||0
11088839|NCT01163617|12271802|FG004|STARTED|Phase B (Injection Time), Week 4||18
11088840|NCT01163617|12271803|FG005|STARTED|Phase B (Injection Time), Week 4||27
11088841|NCT01163617|12271804|FG006|STARTED|Phase B (Injection Time), Week 4||16
11088842|NCT01163617|12271805|FG007|STARTED|Phase B (Injection Time), Week 4||20
11088843|NCT01163617|12271798|FG000|COMPLETED|Phase B (Injection Time), Week 4||0
11088844|NCT01163617|12271799|FG001|COMPLETED|Phase B (Injection Time), Week 4||0
11088845|NCT01163617|12271800|FG002|COMPLETED|Phase B (Injection Time), Week 4||0
11088846|NCT01163617|12271801|FG003|COMPLETED|Phase B (Injection Time), Week 4||0
11088847|NCT01163617|12271802|FG004|COMPLETED|Phase B (Injection Time), Week 4||18
11088848|NCT01163617|12271803|FG005|COMPLETED|Phase B (Injection Time), Week 4||27
11088849|NCT01163617|12271804|FG006|COMPLETED|Phase B (Injection Time), Week 4||16
11088850|NCT01163617|12271805|FG007|COMPLETED|Phase B (Injection Time), Week 4||20
11088851|NCT01163617|12271798|FG000|NOT COMPLETED|Phase B (Injection Time), Week 4||0
11088852|NCT01163617|12271799|FG001|NOT COMPLETED|Phase B (Injection Time), Week 4||0
11088853|NCT01163617|12271800|FG002|NOT COMPLETED|Phase B (Injection Time), Week 4||0
11088854|NCT01163617|12271801|FG003|NOT COMPLETED|Phase B (Injection Time), Week 4||0
11088855|NCT01163617|12271802|FG004|NOT COMPLETED|Phase B (Injection Time), Week 4||0
11088856|NCT01163617|12271803|FG005|NOT COMPLETED|Phase B (Injection Time), Week 4||0
11088857|NCT01163617|12271804|FG006|NOT COMPLETED|Phase B (Injection Time), Week 4||0
11088858|NCT01163617|12271805|FG007|NOT COMPLETED|Phase B (Injection Time), Week 4||0
11088859|NCT01163643|12271831|FG000|STARTED|Overall Study||68
11088860|NCT01163643|12271832|FG001|STARTED|Overall Study||37
11088861|NCT01163643|12271833|FG002|STARTED|Overall Study||35
11088862|NCT01163643|12271834|FG003|STARTED|Overall Study||74
11088863|NCT01163643|12271835|FG004|STARTED|Overall Study||69
11088864|NCT01163643|12271836|FG005|STARTED|Overall Study||73
11088865|NCT01163643|12271831|FG000|COMPLETED|Overall Study||62
11088866|NCT01163643|12271832|FG001|COMPLETED|Overall Study||35
11088867|NCT01163643|12271833|FG002|COMPLETED|Overall Study||33
11088868|NCT01163643|12271834|FG003|COMPLETED|Overall Study||69
11088869|NCT01163643|12271835|FG004|COMPLETED|Overall Study||61
11088870|NCT01163643|12271836|FG005|COMPLETED|Overall Study||66
11088871|NCT01163643|12271831|FG000|NOT COMPLETED|Overall Study||6
11088872|NCT01163643|12271832|FG001|NOT COMPLETED|Overall Study||2
11088873|NCT01163643|12271833|FG002|NOT COMPLETED|Overall Study||2
11088874|NCT01163643|12271834|FG003|NOT COMPLETED|Overall Study||5
11088875|NCT01163643|12271835|FG004|NOT COMPLETED|Overall Study||8
11088876|NCT01163643|12271836|FG005|NOT COMPLETED|Overall Study||7
11088877|NCT01163656|12271852|FG000|STARTED|Overall Study||33
11088878|NCT01163656|12271853|FG001|STARTED|Overall Study||33
11088879|NCT01163656|12271852|FG000|COMPLETED|Overall Study||30
11088880|NCT01163656|12271853|FG001|COMPLETED|Overall Study||30
11088881|NCT01163656|12271852|FG000|NOT COMPLETED|Overall Study||3
11088882|NCT01163656|12271853|FG001|NOT COMPLETED|Overall Study||3
11088883|NCT01163721|12271861|FG000|STARTED|Overall Study||39
11088884|NCT01163721|12271862|FG001|STARTED|Overall Study||41
11088885|NCT01163721|12271861|FG000|COMPLETED|Overall Study||31
11088886|NCT01163721|12271862|FG001|COMPLETED|Overall Study||29
11088887|NCT01163721|12271861|FG000|NOT COMPLETED|Overall Study||8
11088888|NCT01163721|12271862|FG001|NOT COMPLETED|Overall Study||12
11088889|NCT01163747|12271870|FG000|STARTED|Overall Study||31
11088890|NCT01163747|12271871|FG001|STARTED|Overall Study||60
11088891|NCT01163747|12271870|FG000|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
11088892|NCT01163747|12271871|FG001|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
11088893|NCT01163747|12271870|FG000|COMPLETED|Overall Study||25
11088894|NCT01163747|12271871|FG001|COMPLETED|Overall Study||49
11088895|NCT01163747|12271870|FG000|NOT COMPLETED|Overall Study||6
11088896|NCT01163747|12271871|FG001|NOT COMPLETED|Overall Study||11
11088897|NCT01163760|12271877|FG000|STARTED|Period 1 (Fit)||12
11088898|NCT01163760|12271878|FG001|STARTED|Period 1 (Fit)||13
11088899|NCT01163760|12271879|FG002|STARTED|Period 1 (Fit)||13
11088900|NCT01163760|12271880|FG003|STARTED|Period 1 (Fit)||12
11088901|NCT01163760|12271877|FG000|COMPLETED|Period 1 (Fit)||12
11088902|NCT01163760|12271878|FG001|COMPLETED|Period 1 (Fit)||13
11088903|NCT01163760|12271879|FG002|COMPLETED|Period 1 (Fit)||13
11088904|NCT01163760|12271880|FG003|COMPLETED|Period 1 (Fit)||12
11088905|NCT01163760|12271877|FG000|NOT COMPLETED|Period 1 (Fit)||0
11088906|NCT01163760|12271878|FG001|NOT COMPLETED|Period 1 (Fit)||0
11088907|NCT01163760|12271879|FG002|NOT COMPLETED|Period 1 (Fit)||0
11088908|NCT01163760|12271880|FG003|NOT COMPLETED|Period 1 (Fit)||0
11088909|NCT01163760|12271877|FG000|STARTED|Period 2 (Follow-up)||12
11088910|NCT01163760|12271878|FG001|STARTED|Period 2 (Follow-up)||13
11088911|NCT01163760|12271879|FG002|STARTED|Period 2 (Follow-up)||13
11088912|NCT01163760|12271880|FG003|STARTED|Period 2 (Follow-up)||12
11088913|NCT01163760|12271877|FG000|COMPLETED|Period 2 (Follow-up)||12
11088914|NCT01163760|12271878|FG001|COMPLETED|Period 2 (Follow-up)||13
11088915|NCT01163760|12271879|FG002|COMPLETED|Period 2 (Follow-up)||13
11088916|NCT01163760|12271880|FG003|COMPLETED|Period 2 (Follow-up)||12
11088917|NCT01163760|12271877|FG000|NOT COMPLETED|Period 2 (Follow-up)||0
11088918|NCT01163760|12271878|FG001|NOT COMPLETED|Period 2 (Follow-up)||0
11088919|NCT01163760|12271879|FG002|NOT COMPLETED|Period 2 (Follow-up)||0
11088920|NCT01163760|12271880|FG003|NOT COMPLETED|Period 2 (Follow-up)||0
11088921|NCT01163760|12271877|FG000|STARTED|Period 3 (Fit)||12
11088922|NCT01163760|12271878|FG001|STARTED|Period 3 (Fit)||13
11088923|NCT01163760|12271879|FG002|STARTED|Period 3 (Fit)||13
11088924|NCT01163760|12271880|FG003|STARTED|Period 3 (Fit)||12
11088925|NCT01163760|12271877|FG000|COMPLETED|Period 3 (Fit)||12
11088926|NCT01163760|12271878|FG001|COMPLETED|Period 3 (Fit)||13
11088927|NCT01163760|12271879|FG002|COMPLETED|Period 3 (Fit)||13
11088928|NCT01163760|12271880|FG003|COMPLETED|Period 3 (Fit)||12
11088929|NCT01163760|12271877|FG000|NOT COMPLETED|Period 3 (Fit)||0
11088930|NCT01163760|12271878|FG001|NOT COMPLETED|Period 3 (Fit)||0
11088931|NCT01163760|12271879|FG002|NOT COMPLETED|Period 3 (Fit)||0
11088932|NCT01163760|12271880|FG003|NOT COMPLETED|Period 3 (Fit)||0
11088933|NCT01163760|12271877|FG000|STARTED|Period 4 (Follow-up)||12
11088934|NCT01163760|12271878|FG001|STARTED|Period 4 (Follow-up)||13
11088935|NCT01163760|12271879|FG002|STARTED|Period 4 (Follow-up)||13
11088936|NCT01163760|12271880|FG003|STARTED|Period 4 (Follow-up)||12
11088937|NCT01163760|12271877|FG000|COMPLETED|Period 4 (Follow-up)||12
11088938|NCT01163760|12271878|FG001|COMPLETED|Period 4 (Follow-up)||13
11088939|NCT01163760|12271879|FG002|COMPLETED|Period 4 (Follow-up)||13
11088940|NCT01163760|12271880|FG003|COMPLETED|Period 4 (Follow-up)||12
11088941|NCT01163760|12271877|FG000|NOT COMPLETED|Period 4 (Follow-up)||0
11351416|NCT03035955|12548383|FG000|COMPLETED|Overall Study||9
11351417|NCT03035955|12548384|FG001|COMPLETED|Overall Study||9
11351418|NCT03035955|12548383|FG000|NOT COMPLETED|Overall Study||1
11351419|NCT03035955|12548384|FG001|NOT COMPLETED|Overall Study||1
11351420|NCT03036072|12548392|FG000|STARTED|Overall Study||12
11351421|NCT03036072|12548393|FG001|STARTED|Overall Study||13
11351422|NCT03036072|12548392|FG000|COMPLETED|Overall Study||12
11351423|NCT03036072|12548393|FG001|COMPLETED|Overall Study||10
11351424|NCT03036072|12548392|FG000|NOT COMPLETED|Overall Study||0
11351425|NCT03036072|12548393|FG001|NOT COMPLETED|Overall Study||3
11351426|NCT03036124|12548401|FG000|STARTED|Overall Study||2373
11351427|NCT03036124|12548402|FG001|STARTED|Overall Study||2371
11351428|NCT03036124|12548401|FG000|COMPLETED|Overall Study||2368
11088942|NCT01163760|12271878|FG001|NOT COMPLETED|Period 4 (Follow-up)||0
11088943|NCT01163760|12271879|FG002|NOT COMPLETED|Period 4 (Follow-up)||0
11088944|NCT01163760|12271880|FG003|NOT COMPLETED|Period 4 (Follow-up)||0
11088945|NCT01163786|12271888|FG000|STARTED|Treatment With Bortezomib||17
11088946|NCT01163786|12271888|FG000|Completed 1st Cycle|Treatment With Bortezomib||17
11088947|NCT01163786|12271888|FG000|Completed 2nd Cycle|Treatment With Bortezomib|One patient completed cycle 2 but missed one dose of Bortezomib.|14
11088948|NCT01163786|12271888|FG000|COMPLETED|Treatment With Bortezomib||14
11088949|NCT01163786|12271888|FG000|NOT COMPLETED|Treatment With Bortezomib||3
11088950|NCT01163786|12271888|FG000|STARTED|Completed Follow up (Visit 9 and 10)||14
11088951|NCT01163786|12271888|FG000|Completed Week 12 Follow up (Visit 9)|Completed Follow up (Visit 9 and 10)||14
11088952|NCT01163786|12271888|FG000|Completed Week 18 Follow up (Visit 10)|Completed Follow up (Visit 9 and 10)||13
11088953|NCT01163786|12271888|FG000|COMPLETED|Completed Follow up (Visit 9 and 10)||13
11088954|NCT01163786|12271888|FG000|NOT COMPLETED|Completed Follow up (Visit 9 and 10)||1
11088955|NCT01163851|12271894|FG000|STARTED|Overall Study||13
11351429|NCT03036124|12548402|FG001|COMPLETED|Overall Study||2365
11351430|NCT03036124|12548401|FG000|NOT COMPLETED|Overall Study||5
11351431|NCT03036124|12548402|FG001|NOT COMPLETED|Overall Study||6
11351432|NCT03036150|12548410|FG000|STARTED|Overall Study||2152
11088956|NCT01163851|12271895|FG001|STARTED|Overall Study||12
11088957|NCT01163851|12271894|FG000|Treated|Overall Study||12
11088958|NCT01163851|12271895|FG001|Treated|Overall Study||12
11088959|NCT01163851|12271894|FG000|COMPLETED|Overall Study||12
11088960|NCT01163851|12271895|FG001|COMPLETED|Overall Study||11
11088961|NCT01163851|12271894|FG000|NOT COMPLETED|Overall Study||1
11088962|NCT01163851|12271895|FG001|NOT COMPLETED|Overall Study||1
11207941|NCT01878097|12399082|FG001|NOT COMPLETED|Implementation Year 1||2549
11207942|NCT01878097|12399081|FG000|STARTED|Implementation Year 2||11567
11207943|NCT01878097|12399082|FG001|STARTED|Implementation Year 2||9611
11207944|NCT01878097|12399081|FG000|COMPLETED|Implementation Year 2||8286
11207945|NCT01878097|12399082|FG001|COMPLETED|Implementation Year 2||6770
11207946|NCT01878097|12399081|FG000|NOT COMPLETED|Implementation Year 2||3281
11207947|NCT01878097|12399082|FG001|NOT COMPLETED|Implementation Year 2||2841
11207948|NCT01878097|12399081|FG000|STARTED|Implementation Year 3||10540
11207949|NCT01878097|12399082|FG001|STARTED|Implementation Year 3||9750
11207950|NCT01878097|12399081|FG000|COMPLETED|Implementation Year 3||7046
11207951|NCT01878097|12399082|FG001|COMPLETED|Implementation Year 3||6770
11207952|NCT01878097|12399081|FG000|NOT COMPLETED|Implementation Year 3||3494
11207953|NCT01878097|12399082|FG001|NOT COMPLETED|Implementation Year 3||2980
11207954|NCT01878097|12399081|FG000|STARTED|Implementation Year 4||10585
11207955|NCT01878097|12399082|FG001|STARTED|Implementation Year 4||9614
11207956|NCT01878097|12399081|FG000|COMPLETED|Implementation Year 4||6981
11207957|NCT01878097|12399082|FG001|COMPLETED|Implementation Year 4||6607
11207958|NCT01878097|12399081|FG000|NOT COMPLETED|Implementation Year 4||3604
11207959|NCT01878097|12399082|FG001|NOT COMPLETED|Implementation Year 4||3007
11207960|NCT01878149|12399090|FG000|STARTED|Overall Study||21
11207961|NCT01878149|12399091|FG001|STARTED|Overall Study||17
11207962|NCT01878149|12399090|FG000|COMPLETED|Overall Study||19
11207963|NCT01878149|12399091|FG001|COMPLETED|Overall Study||15
11207964|NCT01878149|12399090|FG000|NOT COMPLETED|Overall Study||2
11207965|NCT01878149|12399091|FG001|NOT COMPLETED|Overall Study||2
11207966|NCT01878175|12399097|FG000|STARTED|Overall Study||15
11207967|NCT01878175|12399097|FG000|COMPLETED|Overall Study||13
11207968|NCT01878175|12399097|FG000|NOT COMPLETED|Overall Study||2
11207969|NCT01878214|12399104|FG000|STARTED|Overall Study||223
11207970|NCT01878214|12399105|FG001|STARTED|Overall Study||219
11207971|NCT01878214|12399104|FG000|COMPLETED|Overall Study||170
11207972|NCT01878214|12399105|FG001|COMPLETED|Overall Study||175
11207973|NCT01878214|12399104|FG000|NOT COMPLETED|Overall Study||53
11207974|NCT01878214|12399105|FG001|NOT COMPLETED|Overall Study||44
11207975|NCT01878253|12399111|FG000|STARTED|Overall Study||95
11207976|NCT01878253|12399111|FG000|Pre-Operative|Overall Study||95
11207977|NCT01878253|12399111|FG000|6 Weeks|Overall Study||95
11207978|NCT01878253|12399111|FG000|6 Months|Overall Study||90
11207979|NCT01878253|12399111|FG000|1 Year|Overall Study||88
11207980|NCT01878253|12399111|FG000|2 Year|Overall Study||86
11207981|NCT01878253|12399111|FG000|COMPLETED|Overall Study||86
11207982|NCT01878253|12399111|FG000|NOT COMPLETED|Overall Study||9
11207983|NCT01878292|12399123|FG000|STARTED|Randomized||174
11207984|NCT01878292|12399124|FG001|STARTED|Randomized||175
11207985|NCT01878292|12399125|FG002|STARTED|Randomized||180
11207986|NCT01878292|12399123|FG000|COMPLETED|Randomized||171
11207987|NCT01878292|12399124|FG001|COMPLETED|Randomized||175
11207988|NCT01878292|12399125|FG002|COMPLETED|Randomized||180
11207989|NCT01878292|12399123|FG000|NOT COMPLETED|Randomized||3
11207990|NCT01878292|12399124|FG001|NOT COMPLETED|Randomized||0
11207991|NCT01878292|12399125|FG002|NOT COMPLETED|Randomized||0
11207992|NCT01878292|12399123|FG000|STARTED|Double-blind Treatment Period||171
11207993|NCT01878292|12399124|FG001|STARTED|Double-blind Treatment Period||175
11207994|NCT01878292|12399125|FG002|STARTED|Double-blind Treatment Period||180
11207995|NCT01878292|12399123|FG000|COMPLETED|Double-blind Treatment Period||142
11207996|NCT01878292|12399124|FG001|COMPLETED|Double-blind Treatment Period||149
11207997|NCT01878292|12399125|FG002|COMPLETED|Double-blind Treatment Period||161
11207998|NCT01878292|12399123|FG000|NOT COMPLETED|Double-blind Treatment Period||29
11207999|NCT01878292|12399124|FG001|NOT COMPLETED|Double-blind Treatment Period||26
11208000|NCT01878292|12399125|FG002|NOT COMPLETED|Double-blind Treatment Period||19
11208001|NCT01878292|12399123|FG000|STARTED|Double-blind Down-Taper Period||127
11208002|NCT01878292|12399124|FG001|STARTED|Double-blind Down-Taper Period||140
11088963|NCT01163916|12271904|FG000|STARTED|Overall Study||126
11088964|NCT01163916|12271905|FG001|STARTED|Overall Study||35
11088965|NCT01163916|12271906|FG002|STARTED|Overall Study||91
11088966|NCT01163916|12271904|FG000|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
11088967|NCT01163916|12271905|FG001|Safety Population|Overall Study||35
11088968|NCT01163916|12271906|FG002|Safety Population|Overall Study||91
11088969|NCT01163916|12271904|FG000|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
11088970|NCT01163916|12271905|FG001|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
11088971|NCT01163916|12271906|FG002|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
11088972|NCT01163916|12271904|FG000|NOT COMPLETED|Overall Study||30
11088973|NCT01163916|12271905|FG001|NOT COMPLETED|Overall Study||4
11088974|NCT01163916|12271906|FG002|NOT COMPLETED|Overall Study||20
11088975|NCT01163955|12271921|FG000|STARTED|Overall Study||26
11088976|NCT01163955|12271922|FG001|STARTED|Overall Study||30
11088977|NCT01163955|12271921|FG000|COMPLETED|Overall Study||26
11088978|NCT01163955|12271922|FG001|COMPLETED|Overall Study||26
11088979|NCT01163955|12271921|FG000|NOT COMPLETED|Overall Study||0
11088980|NCT01163955|12271922|FG001|NOT COMPLETED|Overall Study||4
11088981|NCT01164007|12271928|FG000|STARTED|Overall Study||40
11088982|NCT01164007|12271928|FG000|Treated|Overall Study||37
11088983|NCT01164007|12271928|FG000|COMPLETED|Overall Study||0
11088984|NCT01164007|12271928|FG000|NOT COMPLETED|Overall Study||40
11088985|NCT01164098|12271934|FG000|STARTED|Overall Study||15
11088986|NCT01164098|12271935|FG001|STARTED|Overall Study||15
11088987|NCT01164098|12271934|FG000|COMPLETED|Overall Study||15
11088988|NCT01164098|12271935|FG001|COMPLETED|Overall Study||15
11088989|NCT01164098|12271934|FG000|NOT COMPLETED|Overall Study||0
11088990|NCT01164098|12271935|FG001|NOT COMPLETED|Overall Study||0
11088991|NCT01164137|12271943|FG000|STARTED|Overall Study||80
11088992|NCT01164137|12271944|FG001|STARTED|Overall Study||76
11088993|NCT01164137|12271943|FG000|COMPLETED|Overall Study||77
11088994|NCT01164137|12271944|FG001|COMPLETED|Overall Study||76
11088995|NCT01164137|12271943|FG000|NOT COMPLETED|Overall Study||3
11088996|NCT01164137|12271944|FG001|NOT COMPLETED|Overall Study||0
11088997|NCT01164475|12271952|FG000|STARTED|Overall Study||30
11088998|NCT01164475|12271953|FG001|STARTED|Overall Study||31
11088999|NCT01164475|12271952|FG000|COMPLETED|Overall Study||28
11089000|NCT01164475|12271953|FG001|COMPLETED|Overall Study||29
11351433|NCT03036150|12548411|FG001|STARTED|Overall Study||2152
11351434|NCT03036150|12548410|FG000|COMPLETED|Overall Study||2142
11351435|NCT03036150|12548411|FG001|COMPLETED|Overall Study||2147
11351436|NCT03036150|12548410|FG000|NOT COMPLETED|Overall Study||10
11351437|NCT03036150|12548411|FG001|NOT COMPLETED|Overall Study||5
11351438|NCT03036163|12548424|FG000|STARTED|Overall Study||6
11351439|NCT03036163|12548425|FG001|STARTED|Overall Study||6
11351440|NCT03036163|12548426|FG002|STARTED|Overall Study||6
11351441|NCT03036163|12548427|FG003|STARTED|Overall Study||6
11351442|NCT03036163|12548428|FG004|STARTED|Overall Study||6
11351443|NCT03036163|12548429|FG005|STARTED|Overall Study||5
11351444|NCT03036163|12548430|FG006|STARTED|Overall Study||5
11351445|NCT03036163|12548424|FG000|COMPLETED|Overall Study||6
11351446|NCT03036163|12548425|FG001|COMPLETED|Overall Study||6
11351447|NCT03036163|12548426|FG002|COMPLETED|Overall Study||6
11351448|NCT03036163|12548427|FG003|COMPLETED|Overall Study||6
11351449|NCT03036163|12548428|FG004|COMPLETED|Overall Study||6
11351450|NCT03036163|12548429|FG005|COMPLETED|Overall Study||5
11089001|NCT01164475|12271952|FG000|NOT COMPLETED|Overall Study||2
11089002|NCT01164475|12271953|FG001|NOT COMPLETED|Overall Study||2
11089003|NCT01164501|12271962|FG000|STARTED|Overall Study||321
11089004|NCT01164501|12271963|FG001|STARTED|Overall Study||98
11089005|NCT01164501|12271964|FG002|STARTED|Overall Study||322
11089006|NCT01164501|12271962|FG000|COMPLETED|Overall Study||278
11089007|NCT01164501|12271963|FG001|COMPLETED|Overall Study||88
11089008|NCT01164501|12271964|FG002|COMPLETED|Overall Study||280
11089009|NCT01164501|12271962|FG000|NOT COMPLETED|Overall Study||43
11089010|NCT01164501|12271963|FG001|NOT COMPLETED|Overall Study||10
11089011|NCT01164501|12271964|FG002|NOT COMPLETED|Overall Study||42
11089012|NCT01164579|12271977|FG000|STARTED|Overall Study||36
11089013|NCT01164579|12271978|FG001|STARTED|Overall Study||36
11089014|NCT01164579|12271979|FG002|STARTED|Overall Study||37
11089015|NCT01164579|12271977|FG000|COMPLETED|Overall Study||28
11089016|NCT01164579|12271978|FG001|COMPLETED|Overall Study||27
11089017|NCT01164579|12271979|FG002|COMPLETED|Overall Study||21
11089018|NCT01164579|12271977|FG000|NOT COMPLETED|Overall Study||8
11089019|NCT01164579|12271978|FG001|NOT COMPLETED|Overall Study||9
11089020|NCT01164579|12271979|FG002|NOT COMPLETED|Overall Study||16
11089021|NCT01164644|12271990|FG000|STARTED|Overall Study||12
11089022|NCT01164644|12271991|FG001|STARTED|Overall Study||14
11089023|NCT01164644|12271990|FG000|COMPLETED|Overall Study||9
11089024|NCT01164644|12271991|FG001|COMPLETED|Overall Study||13
11089025|NCT01164644|12271990|FG000|NOT COMPLETED|Overall Study||3
11089026|NCT01164644|12271991|FG001|NOT COMPLETED|Overall Study||1
11089027|NCT01164722|12271999|FG000|STARTED|Overall Study||60
11089028|NCT01164722|12272000|FG001|STARTED|Overall Study||60
11089029|NCT01164722|12271999|FG000|COMPLETED|Overall Study||42
11089030|NCT01164722|12272000|FG001|COMPLETED|Overall Study||45
11089031|NCT01164722|12271999|FG000|NOT COMPLETED|Overall Study||18
11089032|NCT01164722|12272000|FG001|NOT COMPLETED|Overall Study||15
11089033|NCT01164865|12272008|FG000|STARTED|Overall Study||39
11089034|NCT01164865|12272009|FG001|STARTED|Overall Study||39
11089035|NCT01164865|12272008|FG000|COMPLETED|Overall Study||37
11089036|NCT01164865|12272009|FG001|COMPLETED|Overall Study||38
11089037|NCT01164865|12272008|FG000|NOT COMPLETED|Overall Study||2
11089038|NCT01164865|12272009|FG001|NOT COMPLETED|Overall Study||1
11089039|NCT01164891|12272015|FG000|STARTED|Overall Study||7
11089040|NCT01164891|12272015|FG000|COMPLETED|Overall Study||1
11089041|NCT01164891|12272015|FG000|NOT COMPLETED|Overall Study||6
11089042|NCT01164956|12272020|FG000|STARTED|Overall Study||1
11089043|NCT01164956|12272021|FG001|STARTED|Overall Study||1
11089044|NCT01164956|12272022|FG002|STARTED|Overall Study||1
11089045|NCT01164956|12272020|FG000|Evaluable for pedsFACIT-F Score Change|Overall Study||0
11089046|NCT01164956|12272021|FG001|Evaluable for pedsFACIT-F Score Change|Overall Study||1
11089047|NCT01164956|12272022|FG002|Evaluable for pedsFACIT-F Score Change|Overall Study||0
11089048|NCT01164956|12272020|FG000|COMPLETED|Overall Study||0
11089049|NCT01164956|12272021|FG001|COMPLETED|Overall Study||1
11089050|NCT01164956|12272022|FG002|COMPLETED|Overall Study||0
11089051|NCT01164956|12272020|FG000|NOT COMPLETED|Overall Study||1
11089052|NCT01164956|12272021|FG001|NOT COMPLETED|Overall Study||0
11089053|NCT01164956|12272022|FG002|NOT COMPLETED|Overall Study||1
11089054|NCT01165021|12272030|FG000|STARTED|Overall Study||19
11089055|NCT01165021|12272030|FG000|≥1 Dose Chemo|Overall Study||19
11089056|NCT01165021|12272030|FG000|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
11089057|NCT01165021|12272030|FG000|3 Cycles of Chemo, Then Surgery|Overall Study||15
11089058|NCT01165021|12272030|FG000|COMPLETED|Overall Study||18
11089059|NCT01165021|12272030|FG000|NOT COMPLETED|Overall Study||1
11089060|NCT01165047|12272034|FG000|STARTED|Overall Study||10
11089061|NCT01165047|12272034|FG000|COMPLETED|Overall Study||10
11089062|NCT01165047|12272034|FG000|NOT COMPLETED|Overall Study||0
11089063|NCT01165112|12272038|FG000|STARTED|Overall Study||48
11089064|NCT01165112|12272038|FG000|COMPLETED|Overall Study||48
11089065|NCT01165112|12272038|FG000|NOT COMPLETED|Overall Study||0
11089066|NCT01165138|12272045|FG000|STARTED|Overall Study||0
11089067|NCT01165138|12272046|FG001|STARTED|Overall Study||203
11089068|NCT01165138|12272047|FG002|STARTED|Overall Study||205
11089069|NCT01165138|12272048|FG003|STARTED|Overall Study||201
11089070|NCT01165138|12272045|FG000|COMPLETED|Overall Study||0
11089071|NCT01165138|12272046|FG001|COMPLETED|Overall Study||151
11089072|NCT01165138|12272047|FG002|COMPLETED|Overall Study||185
11089073|NCT01165138|12272048|FG003|COMPLETED|Overall Study||179
11089074|NCT01165138|12272045|FG000|NOT COMPLETED|Overall Study||0
11089075|NCT01165138|12272046|FG001|NOT COMPLETED|Overall Study||52
11089076|NCT01165138|12272047|FG002|NOT COMPLETED|Overall Study||20
11089077|NCT01165138|12272048|FG003|NOT COMPLETED|Overall Study||22
11089078|NCT01165177|12272058|FG000|STARTED|Overall Study||7695
11089079|NCT01165177|12272059|FG001|STARTED|Overall Study||7710
11089080|NCT01165177|12272058|FG000|COMPLETED|Overall Study||6773
11089081|NCT01165177|12272059|FG001|COMPLETED|Overall Study||6808
11089082|NCT01165177|12272058|FG000|NOT COMPLETED|Overall Study||922
11089083|NCT01165177|12272059|FG001|NOT COMPLETED|Overall Study||902
11089084|NCT01165203|12272075|FG000|STARTED|Active Phase||74
11089085|NCT01165203|12272076|FG001|STARTED|Active Phase||49
11089086|NCT01165203|12272075|FG000|COMPLETED|Active Phase||69
11089087|NCT01165203|12272076|FG001|COMPLETED|Active Phase||47
11089088|NCT01165203|12272075|FG000|NOT COMPLETED|Active Phase||5
11089089|NCT01165203|12272076|FG001|NOT COMPLETED|Active Phase||2
11089090|NCT01165203|12272075|FG000|STARTED|Extended Safety Follow-up Phase||74
11089091|NCT01165203|12272076|FG001|STARTED|Extended Safety Follow-up Phase||49
11089092|NCT01165203|12272075|FG000|COMPLETED|Extended Safety Follow-up Phase||67
11089093|NCT01165203|12272076|FG001|COMPLETED|Extended Safety Follow-up Phase||45
11089094|NCT01165203|12272075|FG000|NOT COMPLETED|Extended Safety Follow-up Phase||7
11089095|NCT01165203|12272076|FG001|NOT COMPLETED|Extended Safety Follow-up Phase||4
11089096|NCT01165216|12272091|FG000|STARTED|Overall Study|Participants who received any study drug|8
11089097|NCT01165216|12272092|FG001|STARTED|Overall Study|Participants who received any study drug|7
11089098|NCT01165216|12272091|FG000|Received at Least 1 Dose of Ipilimumab|Overall Study||6
11089099|NCT01165216|12272092|FG001|Received at Least 1 Dose of Ipilimumab|Overall Study||6
11089100|NCT01165216|12272091|FG000|COMPLETED|Overall Study|Completed=still on study drug|0
11089101|NCT01165216|12272092|FG001|COMPLETED|Overall Study|Completed=still on study drug|0
11089102|NCT01165216|12272091|FG000|NOT COMPLETED|Overall Study||8
11089103|NCT01165216|12272092|FG001|NOT COMPLETED|Overall Study||7
11089104|NCT01165229|12272102|FG000|STARTED|Overall Study||6950
11089105|NCT01165229|12272103|FG001|STARTED|Overall Study||6950
11089106|NCT01165229|12272102|FG000|COMPLETED|Overall Study||5770
11089107|NCT01165229|12272103|FG001|COMPLETED|Overall Study||5760
11089108|NCT01165229|12272102|FG000|NOT COMPLETED|Overall Study||1180
11089109|NCT01165229|12272103|FG001|NOT COMPLETED|Overall Study||1190
11089110|NCT01165242|12272142|FG000|STARTED|Overall Study||337
11089111|NCT01165242|12272143|FG001|STARTED|Overall Study||336
11089112|NCT01165242|12272144|FG002|STARTED|Overall Study||338
11089113|NCT01165242|12272142|FG000|COMPLETED|Overall Study||327
11089114|NCT01165242|12272143|FG001|COMPLETED|Overall Study||326
11089115|NCT01165242|12272144|FG002|COMPLETED|Overall Study||324
11089116|NCT01165242|12272142|FG000|NOT COMPLETED|Overall Study||10
11089117|NCT01165242|12272143|FG001|NOT COMPLETED|Overall Study||10
11089118|NCT01165242|12272144|FG002|NOT COMPLETED|Overall Study||14
11089119|NCT01165281|12272156|FG000|STARTED|Overall Study||168
11089120|NCT01165281|12272157|FG001|STARTED|Overall Study||172
11089121|NCT01165281|12272156|FG000|COMPLETED|Overall Study||110
11089122|NCT01165281|12272157|FG001|COMPLETED|Overall Study||121
11089123|NCT01165281|12272156|FG000|NOT COMPLETED|Overall Study||58
11089124|NCT01165281|12272157|FG001|NOT COMPLETED|Overall Study||51
11089125|NCT01165307|12272165|FG000|STARTED|Overall Study||33
11089126|NCT01165307|12272166|FG001|STARTED|Overall Study||34
11089127|NCT01165307|12272165|FG000|COMPLETED|Overall Study||19
11089128|NCT01165307|12272166|FG001|COMPLETED|Overall Study||31
11089129|NCT01165307|12272165|FG000|NOT COMPLETED|Overall Study||14
11089130|NCT01165307|12272166|FG001|NOT COMPLETED|Overall Study||3
11089131|NCT01165320|12272174|FG000|STARTED|Overall Study||12
11089132|NCT01165320|12272175|FG001|STARTED|Overall Study||8
11089133|NCT01165320|12272176|FG002|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
11089134|NCT01165320|12272174|FG000|COMPLETED|Overall Study||9
11089135|NCT01165320|12272175|FG001|COMPLETED|Overall Study||4
11089136|NCT01165320|12272176|FG002|COMPLETED|Overall Study||0
11089137|NCT01165320|12272174|FG000|NOT COMPLETED|Overall Study||3
11089138|NCT01165320|12272175|FG001|NOT COMPLETED|Overall Study||4
11089139|NCT01165320|12272176|FG002|NOT COMPLETED|Overall Study||0
11089140|NCT01165541|12272182|FG000|STARTED|Quetiapine XR Monotherapy||20
11089141|NCT01165541|12272182|FG000|COMPLETED|Quetiapine XR Monotherapy||16
11089142|NCT01165541|12272182|FG000|NOT COMPLETED|Quetiapine XR Monotherapy||4
11089143|NCT01165541|12272182|FG000|STARTED|Quetiapine XR and Mirtazepine||16
11089144|NCT01165541|12272182|FG000|COMPLETED|Quetiapine XR and Mirtazepine||11
11089145|NCT01165541|12272182|FG000|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
11089146|NCT01165554|12272188|FG000|STARTED|Overall Study|This was the number of subjects that started the study.|203
11089147|NCT01165554|12272188|FG000|COMPLETED|Overall Study||180
11089148|NCT01165554|12272188|FG000|NOT COMPLETED|Overall Study||23
11089149|NCT01165684|12272197|FG000|STARTED|Overall Study||201
11089150|NCT01165684|12272198|FG001|STARTED|Overall Study||200
11089151|NCT01165684|12272197|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
11089152|NCT01165684|12272198|FG001|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
11089153|NCT01165684|12272197|FG000|COMPLETED|Overall Study||173
11089154|NCT01165684|12272198|FG001|COMPLETED|Overall Study||148
11089155|NCT01165684|12272197|FG000|NOT COMPLETED|Overall Study||28
11089156|NCT01165684|12272198|FG001|NOT COMPLETED|Overall Study||52
11089157|NCT01165775|12272204|FG000|STARTED|Overall Study||17
11089158|NCT01165775|12272204|FG000|COMPLETED|Overall Study||15
11089159|NCT01165775|12272204|FG000|NOT COMPLETED|Overall Study||2
11089160|NCT01165840|12272212|FG000|STARTED|Overall Study||36
11089161|NCT01165840|12272212|FG000|COMPLETED|Overall Study||36
11089162|NCT01165840|12272212|FG000|NOT COMPLETED|Overall Study||0
11089163|NCT01165983|12272218|FG000|STARTED|Overall Study||51
11089164|NCT01165983|12272219|FG001|STARTED|Overall Study||49
11089165|NCT01165983|12272218|FG000|COMPLETED|Overall Study||46
11089166|NCT01165983|12272219|FG001|COMPLETED|Overall Study||42
11089167|NCT01165983|12272218|FG000|NOT COMPLETED|Overall Study||5
11089168|NCT01165983|12272219|FG001|NOT COMPLETED|Overall Study||7
11089169|NCT01165996|12272227|FG000|STARTED|Overall Study||25
11089170|NCT01165996|12272227|FG000|Induction Phase|Overall Study||25
11089171|NCT01165996|12272227|FG000|Maintenance Phase|Overall Study||23
11089172|NCT01165996|12272227|FG000|COMPLETED|Overall Study||23
11089173|NCT01165996|12272227|FG000|NOT COMPLETED|Overall Study||2
11089174|NCT01166126|12272232|FG000|STARTED|Overall Study||4
11089175|NCT01166126|12272232|FG000|COMPLETED|Overall Study||4
11089176|NCT01166126|12272232|FG000|NOT COMPLETED|Overall Study||0
11089177|NCT01166139|12272236|FG000|STARTED|Overall Study||10
11089178|NCT01166139|12272236|FG000|COMPLETED|Overall Study||7
11089179|NCT01166139|12272236|FG000|NOT COMPLETED|Overall Study||3
11089180|NCT01166230|12272242|FG000|STARTED|Overall Study||280
11089181|NCT01166230|12272243|FG001|STARTED|Overall Study||271
11089182|NCT01166230|12272242|FG000|COMPLETED|Overall Study||261
11089183|NCT01166230|12272243|FG001|COMPLETED|Overall Study||255
11089184|NCT01166230|12272242|FG000|NOT COMPLETED|Overall Study||19
11089185|NCT01166230|12272243|FG001|NOT COMPLETED|Overall Study||16
11089186|NCT01166282|12272251|FG000|STARTED|Double-blind Period||15
11089187|NCT01166282|12272252|FG001|STARTED|Double-blind Period||31
11089188|NCT01166282|12272253|FG002|STARTED|Double-blind Period||0
11089189|NCT01166282|12272251|FG000|COMPLETED|Double-blind Period||15
11089190|NCT01166282|12272252|FG001|COMPLETED|Double-blind Period||31
11089191|NCT01166282|12272253|FG002|COMPLETED|Double-blind Period||0
11089192|NCT01166282|12272251|FG000|NOT COMPLETED|Double-blind Period||0
11089193|NCT01166282|12272252|FG001|NOT COMPLETED|Double-blind Period||0
11089194|NCT01166282|12272253|FG002|NOT COMPLETED|Double-blind Period||0
11089195|NCT01166282|12272251|FG000|STARTED|Open-label Period||0
11089196|NCT01166282|12272252|FG001|STARTED|Open-label Period||0
11089197|NCT01166282|12272253|FG002|STARTED|Open-label Period||46
11089198|NCT01166282|12272251|FG000|COMPLETED|Open-label Period||0
11089199|NCT01166282|12272252|FG001|COMPLETED|Open-label Period||0
11089200|NCT01166282|12272253|FG002|COMPLETED|Open-label Period||29
11089201|NCT01166282|12272251|FG000|NOT COMPLETED|Open-label Period||0
11089202|NCT01166282|12272252|FG001|NOT COMPLETED|Open-label Period||0
11089203|NCT01166282|12272253|FG002|NOT COMPLETED|Open-label Period||17
11089204|NCT01166347|12272263|FG000|STARTED|Overall Study||297
11089205|NCT01166347|12272264|FG001|STARTED|Overall Study||149
11089206|NCT01166347|12272263|FG000|COMPLETED|Overall Study||295
11089207|NCT01166347|12272264|FG001|COMPLETED|Overall Study||148
11089208|NCT01166347|12272263|FG000|NOT COMPLETED|Overall Study||2
11089209|NCT01166347|12272264|FG001|NOT COMPLETED|Overall Study||1
11089210|NCT01166373|12272274|FG000|STARTED|Overall Study||95
11089211|NCT01166373|12272275|FG001|STARTED|Overall Study||91
11089212|NCT01166373|12272276|FG002|STARTED|Overall Study||91
11089213|NCT01166373|12272277|FG003|STARTED|Overall Study||97
11089214|NCT01166373|12272274|FG000|Completed OPTIMAL Year 2 Visit|Overall Study||81
11089215|NCT01166373|12272275|FG001|Completed OPTIMAL Year 2 Visit|Overall Study||80
11089216|NCT01166373|12272276|FG002|Completed OPTIMAL Year 2 Visit|Overall Study||79
11089217|NCT01166373|12272277|FG003|Completed OPTIMAL Year 2 Visit|Overall Study||87
11089218|NCT01166373|12272274|FG000|Randomized to Video|Overall Study||32
11089219|NCT01166373|12272275|FG001|Randomized to Video|Overall Study||43
11089220|NCT01166373|12272276|FG002|Randomized to Video|Overall Study||38
11089221|NCT01166373|12272277|FG003|Randomized to Video|Overall Study||40
11089222|NCT01166373|12272274|FG000|Randomized to No Video|Overall Study||45
11089223|NCT01166373|12272275|FG001|Randomized to No Video|Overall Study||30
11089224|NCT01166373|12272276|FG002|Randomized to No Video|Overall Study||34
11089225|NCT01166373|12272277|FG003|Randomized to No Video|Overall Study||42
11089226|NCT01166373|12272274|FG000|Consented to Participate E-OPTIMAL|Overall Study||72
11089227|NCT01166373|12272275|FG001|Consented to Participate E-OPTIMAL|Overall Study||66
11089228|NCT01166373|12272276|FG002|Consented to Participate E-OPTIMAL|Overall Study||69
11089229|NCT01166373|12272277|FG003|Consented to Participate E-OPTIMAL|Overall Study||78
11089230|NCT01166373|12272274|FG000|Completed E-OPTIMAL Year 3 Visit|Overall Study||70
11089231|NCT01166373|12272275|FG001|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
11089232|NCT01166373|12272276|FG002|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
11089233|NCT01166373|12272277|FG003|Completed E-OPTIMAL Year 3 Visit|Overall Study||77
11089234|NCT01166373|12272274|FG000|Completed E-OPTIMAL Year 4 Visit|Overall Study||67
11089235|NCT01166373|12272275|FG001|Completed E-OPTIMAL Year 4 Visit|Overall Study||61
11089236|NCT01166373|12272276|FG002|Completed E-OPTIMAL Year 4 Visit|Overall Study||63
11089237|NCT01166373|12272277|FG003|Completed E-OPTIMAL Year 4 Visit|Overall Study||68
11089238|NCT01166373|12272274|FG000|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
11089239|NCT01166373|12272275|FG001|Completed E-OPTIMAL Year 5 Visit|Overall Study||56
11089240|NCT01166373|12272276|FG002|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
11089241|NCT01166373|12272277|FG003|Completed E-OPTIMAL Year 5 Visit|Overall Study||64
11089242|NCT01166373|12272274|FG000|COMPLETED|Overall Study||90
11089243|NCT01166373|12272275|FG001|COMPLETED|Overall Study||87
11089244|NCT01166373|12272276|FG002|COMPLETED|Overall Study||87
11089245|NCT01166373|12272277|FG003|COMPLETED|Overall Study||92
11089246|NCT01166373|12272274|FG000|NOT COMPLETED|Overall Study||5
11089247|NCT01166373|12272275|FG001|NOT COMPLETED|Overall Study||4
11089248|NCT01166373|12272276|FG002|NOT COMPLETED|Overall Study||4
11089249|NCT01166373|12272277|FG003|NOT COMPLETED|Overall Study||5
11089250|NCT01166438|12272291|FG000|STARTED|Double-blind Phase: 1st 6 Months||122
11089251|NCT01166438|12272292|FG001|STARTED|Double-blind Phase: 1st 6 Months||127
11089252|NCT01166438|12272291|FG000|Treated|Double-blind Phase: 1st 6 Months||121
11089253|NCT01166438|12272292|FG001|Treated|Double-blind Phase: 1st 6 Months||126
11089254|NCT01166438|12272291|FG000|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
11089255|NCT01166438|12272292|FG001|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
11089256|NCT01166438|12272291|FG000|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
11089257|NCT01166438|12272292|FG001|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
11089258|NCT01166438|12272291|FG000|STARTED|Off Treatment Follow-up Phase||85
11089259|NCT01166438|12272292|FG001|STARTED|Off Treatment Follow-up Phase||89
11089260|NCT01166438|12272291|FG000|COMPLETED|Off Treatment Follow-up Phase||51
11089261|NCT01166438|12272292|FG001|COMPLETED|Off Treatment Follow-up Phase||33
11089262|NCT01166438|12272291|FG000|NOT COMPLETED|Off Treatment Follow-up Phase||34
11089263|NCT01166438|12272292|FG001|NOT COMPLETED|Off Treatment Follow-up Phase||56
11089264|NCT01166568|12272302|FG000|STARTED|Deferred Implantation- Randomized||0
11089265|NCT01166568|12272303|FG001|STARTED|Deferred Implantation- Randomized||0
11089266|NCT01166568|12272304|FG002|STARTED|Deferred Implantation- Randomized||16
11089267|NCT01166568|12272302|FG000|COMPLETED|Deferred Implantation- Randomized||0
11089268|NCT01166568|12272303|FG001|COMPLETED|Deferred Implantation- Randomized||0
11089269|NCT01166568|12272304|FG002|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
11089270|NCT01166568|12272302|FG000|NOT COMPLETED|Deferred Implantation- Randomized||0
11089271|NCT01166568|12272303|FG001|NOT COMPLETED|Deferred Implantation- Randomized||0
11089272|NCT01166568|12272304|FG002|NOT COMPLETED|Deferred Implantation- Randomized||1
11089273|NCT01166568|12272302|FG000|STARTED|Implantation- Nonrandomized & Randomized||288
11089274|NCT01166568|12272303|FG001|STARTED|Implantation- Nonrandomized & Randomized||33
11089275|NCT01166568|12272304|FG002|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
11089276|NCT01166568|12272302|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||274
11089277|NCT01166568|12272303|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||32
11089278|NCT01166568|12272304|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
11089279|NCT01166568|12272302|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
11089280|NCT01166568|12272303|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
11089281|NCT01166568|12272304|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
11089282|NCT01166646|12272312|FG000|STARTED|Overall Study||21
11089283|NCT01166646|12272313|FG001|STARTED|Overall Study||22
11089284|NCT01166646|12272312|FG000|COMPLETED|Overall Study||20
11089285|NCT01166646|12272313|FG001|COMPLETED|Overall Study||21
11089286|NCT01166646|12272312|FG000|NOT COMPLETED|Overall Study||1
11089287|NCT01166646|12272313|FG001|NOT COMPLETED|Overall Study||1
11089288|NCT01166659|12272319|FG000|STARTED|Overall Study||48
11089289|NCT01166659|12272319|FG000|COMPLETED|Overall Study||35
11089290|NCT01166659|12272319|FG000|NOT COMPLETED|Overall Study||13
11089291|NCT01166750|12272326|FG000|STARTED|Overall Study||10
11089292|NCT01166750|12272327|FG001|STARTED|Overall Study||13
11089293|NCT01166750|12272326|FG000|COMPLETED|Overall Study||9
11089294|NCT01166750|12272327|FG001|COMPLETED|Overall Study||13
11089295|NCT01166750|12272326|FG000|NOT COMPLETED|Overall Study||1
11089296|NCT01166750|12272327|FG001|NOT COMPLETED|Overall Study||0
11089297|NCT01166763|12272333|FG000|STARTED|Overall Study||30
11089298|NCT01166763|12272333|FG000|COMPLETED|Overall Study||27
11089299|NCT01166763|12272333|FG000|NOT COMPLETED|Overall Study||3
11089300|NCT01166945|12272339|FG000|STARTED|Randomized||51
11089301|NCT01166945|12272340|FG001|STARTED|Randomized||47
11089302|NCT01166945|12272339|FG000|COMPLETED|Randomized||47
11089303|NCT01166945|12272340|FG001|COMPLETED|Randomized||43
11089304|NCT01166945|12272339|FG000|NOT COMPLETED|Randomized||4
11089305|NCT01166945|12272340|FG001|NOT COMPLETED|Randomized||4
11089306|NCT01166945|12272339|FG000|STARTED|Day 5||47
11089307|NCT01166945|12272340|FG001|STARTED|Day 5||43
11089308|NCT01166945|12272339|FG000|COMPLETED|Day 5||47
11089309|NCT01166945|12272340|FG001|COMPLETED|Day 5||43
11089310|NCT01166945|12272339|FG000|NOT COMPLETED|Day 5||0
11089311|NCT01166945|12272340|FG001|NOT COMPLETED|Day 5||0
11089312|NCT01166945|12272339|FG000|STARTED|Day 10||47
11089313|NCT01166945|12272340|FG001|STARTED|Day 10||43
11089314|NCT01166945|12272339|FG000|COMPLETED|Day 10||44
11089315|NCT01166945|12272340|FG001|COMPLETED|Day 10||41
11089316|NCT01166945|12272339|FG000|NOT COMPLETED|Day 10||3
11089317|NCT01166945|12272340|FG001|NOT COMPLETED|Day 10||2
11089318|NCT01166945|12272339|FG000|STARTED|Day 15||44
11089319|NCT01166945|12272340|FG001|STARTED|Day 15||41
11089320|NCT01166945|12272339|FG000|COMPLETED|Day 15||42
11089321|NCT01166945|12272340|FG001|COMPLETED|Day 15||40
11089322|NCT01166945|12272339|FG000|NOT COMPLETED|Day 15||2
11089323|NCT01166945|12272340|FG001|NOT COMPLETED|Day 15||1
11089324|NCT01166945|12272339|FG000|STARTED|Day 20||42
11089325|NCT01166945|12272340|FG001|STARTED|Day 20||40
11089326|NCT01166945|12272339|FG000|COMPLETED|Day 20||42
11089327|NCT01166945|12272340|FG001|COMPLETED|Day 20||40
11089328|NCT01166945|12272339|FG000|NOT COMPLETED|Day 20||0
11089329|NCT01166945|12272340|FG001|NOT COMPLETED|Day 20||0
11089330|NCT01166945|12272339|FG000|STARTED|Day 30||42
11089331|NCT01166945|12272340|FG001|STARTED|Day 30||40
11089332|NCT01166945|12272339|FG000|COMPLETED|Day 30||38
11089333|NCT01166945|12272340|FG001|COMPLETED|Day 30||37
11089334|NCT01166945|12272339|FG000|NOT COMPLETED|Day 30||4
11089335|NCT01166945|12272340|FG001|NOT COMPLETED|Day 30||3
11089336|NCT01166958|12272350|FG000|STARTED|Overall Study||13
11089337|NCT01166958|12272351|FG001|STARTED|Overall Study||13
11089338|NCT01166958|12272350|FG000|COMPLETED|Overall Study||12
11089339|NCT01166958|12272351|FG001|COMPLETED|Overall Study||13
11089340|NCT01166958|12272350|FG000|NOT COMPLETED|Overall Study||1
11089341|NCT01166958|12272351|FG001|NOT COMPLETED|Overall Study||0
11089342|NCT01166971|12272359|FG000|STARTED|Overall Study||33
11089343|NCT01166971|12272360|FG001|STARTED|Overall Study||31
11089344|NCT01166971|12272359|FG000|COMPLETED|Overall Study||32
11089345|NCT01166971|12272360|FG001|COMPLETED|Overall Study||30
11089346|NCT01166971|12272359|FG000|NOT COMPLETED|Overall Study||1
11089347|NCT01166971|12272360|FG001|NOT COMPLETED|Overall Study||1
11089348|NCT01166984|12272371|FG000|STARTED|Overall Study||5
11089349|NCT01166984|12272372|FG001|STARTED|Overall Study||5
11089350|NCT01166984|12272373|FG002|STARTED|Overall Study||5
11089351|NCT01166984|12272374|FG003|STARTED|Overall Study||5
11089352|NCT01166984|12272375|FG004|STARTED|Overall Study||5
11089353|NCT01166984|12272371|FG000|COMPLETED|Overall Study||5
11089354|NCT01166984|12272372|FG001|COMPLETED|Overall Study||5
11089355|NCT01166984|12272373|FG002|COMPLETED|Overall Study||5
11089356|NCT01166984|12272374|FG003|COMPLETED|Overall Study||5
11089357|NCT01166984|12272375|FG004|COMPLETED|Overall Study||5
11089358|NCT01166984|12272371|FG000|NOT COMPLETED|Overall Study||0
11089359|NCT01166984|12272372|FG001|NOT COMPLETED|Overall Study||0
11089360|NCT01166984|12272373|FG002|NOT COMPLETED|Overall Study||0
11089361|NCT01166984|12272374|FG003|NOT COMPLETED|Overall Study||0
11089362|NCT01166984|12272375|FG004|NOT COMPLETED|Overall Study||0
11089363|NCT01166997|12272399|FG000|STARTED|Overall Study||29
11089364|NCT01166997|12272400|FG001|STARTED|Overall Study||30
11089365|NCT01166997|12272399|FG000|COMPLETED|Overall Study||27
11089366|NCT01166997|12272400|FG001|COMPLETED|Overall Study||30
11089367|NCT01166997|12272399|FG000|NOT COMPLETED|Overall Study||2
11089368|NCT01166997|12272400|FG001|NOT COMPLETED|Overall Study||0
11089369|NCT01167023|12272410|FG000|STARTED|Overall Study||0
11089370|NCT01167023|12272411|FG001|STARTED|Overall Study||21
11089371|NCT01167023|12272412|FG002|STARTED|Overall Study||41
11089372|NCT01167023|12272410|FG000|Received at Least 1 Dose of Study Drug|Overall Study||0
11089373|NCT01167023|12272411|FG001|Received at Least 1 Dose of Study Drug|Overall Study||19
11089374|NCT01167023|12272412|FG002|Received at Least 1 Dose of Study Drug|Overall Study||41
11089375|NCT01167023|12272410|FG000|COMPLETED|Overall Study||0
11089376|NCT01167023|12272411|FG001|COMPLETED|Overall Study||18
11089377|NCT01167023|12272412|FG002|COMPLETED|Overall Study||39
11089378|NCT01167023|12272410|FG000|NOT COMPLETED|Overall Study||0
11089379|NCT01167023|12272411|FG001|NOT COMPLETED|Overall Study||3
11089380|NCT01167023|12272412|FG002|NOT COMPLETED|Overall Study||2
11089381|NCT01167140|12272418|FG000|STARTED|Overall Study||42
11089382|NCT01167140|12272418|FG000|COMPLETED|Overall Study||41
11089383|NCT01167140|12272418|FG000|NOT COMPLETED|Overall Study||1
11089384|NCT01167153|12272424|FG000|STARTED|Overall Study||282
11089385|NCT01167153|12272425|FG001|STARTED|Overall Study||282
11089386|NCT01167153|12272424|FG000|Intention to Treat (ITT)|Overall Study||272
11089387|NCT01167153|12272425|FG001|Intention to Treat (ITT)|Overall Study||268
11089388|NCT01167153|12272424|FG000|COMPLETED|Overall Study||264
11089389|NCT01167153|12272425|FG001|COMPLETED|Overall Study||249
11089390|NCT01167153|12272424|FG000|NOT COMPLETED|Overall Study||18
11089391|NCT01167153|12272425|FG001|NOT COMPLETED|Overall Study||33
11089392|NCT01167179|12272433|FG000|STARTED|Overall Study||80
11089393|NCT01167179|12272434|FG001|STARTED|Overall Study||80
11089394|NCT01167179|12272433|FG000|COMPLETED|Overall Study||65
11089395|NCT01167179|12272434|FG001|COMPLETED|Overall Study||59
11089396|NCT01167179|12272433|FG000|NOT COMPLETED|Overall Study||15
11089397|NCT01167179|12272434|FG001|NOT COMPLETED|Overall Study||21
11089398|NCT01167192|12272440|FG000|STARTED|Overall Study||10
11089399|NCT01167192|12272440|FG000|COMPLETED|Overall Study||6
11089400|NCT01167192|12272440|FG000|NOT COMPLETED|Overall Study||4
11089401|NCT01167257|12272446|FG000|STARTED|Overall Study||31
11089402|NCT01167257|12272447|FG001|STARTED|Overall Study||31
11089403|NCT01167257|12272446|FG000|COMPLETED|Overall Study||28
11089404|NCT01167257|12272447|FG001|COMPLETED|Overall Study||28
11089405|NCT01167257|12272446|FG000|NOT COMPLETED|Overall Study||3
11089406|NCT01167257|12272447|FG001|NOT COMPLETED|Overall Study||3
11089407|NCT01167426|12272457|FG000|STARTED|Overall Study||148
11089408|NCT01167426|12272457|FG000|COMPLETED|Overall Study||138
11089409|NCT01167426|12272457|FG000|NOT COMPLETED|Overall Study||10
11089410|NCT01167452|12272462|FG000|STARTED|Overall Study||36
11089411|NCT01167452|12272462|FG000|COMPLETED|Overall Study||36
11089412|NCT01167452|12272462|FG000|NOT COMPLETED|Overall Study||0
11089413|NCT01167504|12272467|FG000|STARTED|Overall Study||15
11089414|NCT01167504|12272467|FG000|COMPLETED|Overall Study||12
11089415|NCT01167504|12272467|FG000|NOT COMPLETED|Overall Study||3
11089416|NCT01167569|12272473|FG000|STARTED|Overall Study||28
11089417|NCT01167569|12272474|FG001|STARTED|Overall Study||29
11089418|NCT01167569|12272473|FG000|COMPLETED|Overall Study||27
11089419|NCT01167569|12272474|FG001|COMPLETED|Overall Study||27
11089420|NCT01167569|12272473|FG000|NOT COMPLETED|Overall Study||1
11089421|NCT01167569|12272474|FG001|NOT COMPLETED|Overall Study||2
11089422|NCT01167582|12272484|FG000|STARTED|Overall Study||55
11351451|NCT03036163|12548430|FG006|COMPLETED|Overall Study||5
11351452|NCT03036163|12548424|FG000|NOT COMPLETED|Overall Study||0
11351453|NCT03036163|12548425|FG001|NOT COMPLETED|Overall Study||0
11351454|NCT03036163|12548426|FG002|NOT COMPLETED|Overall Study||0
11351455|NCT03036163|12548427|FG003|NOT COMPLETED|Overall Study||0
11351456|NCT03036163|12548428|FG004|NOT COMPLETED|Overall Study||0
11351457|NCT03036163|12548429|FG005|NOT COMPLETED|Overall Study||0
11351458|NCT03036163|12548430|FG006|NOT COMPLETED|Overall Study||0
11351459|NCT03036215|12548448|FG000|STARTED|Overall Study||41
11351460|NCT03036215|12548449|FG001|STARTED|Overall Study||39
11351461|NCT03036215|12548448|FG000|COMPLETED|Overall Study||39
11351462|NCT03036215|12548449|FG001|COMPLETED|Overall Study||36
11351463|NCT03036215|12548448|FG000|NOT COMPLETED|Overall Study||2
11351464|NCT03036215|12548449|FG001|NOT COMPLETED|Overall Study||3
11351465|NCT03036293|12548462|FG000|STARTED|Overall Study||127
11351466|NCT03036293|12548463|FG001|STARTED|Overall Study||67
11351467|NCT03036293|12548464|FG002|STARTED|Overall Study||131
11351468|NCT03036293|12548465|FG003|STARTED|Overall Study||65
11351469|NCT03036293|12548462|FG000|COMPLETED|Overall Study||126
11351470|NCT03036293|12548463|FG001|COMPLETED|Overall Study||64
11351471|NCT03036293|12548464|FG002|COMPLETED|Overall Study||130
11351472|NCT03036293|12548465|FG003|COMPLETED|Overall Study||64
11089423|NCT01167582|12272485|FG001|STARTED|Overall Study||55
11089424|NCT01167582|12272484|FG000|COMPLETED|Overall Study||55
11089425|NCT01167582|12272485|FG001|COMPLETED|Overall Study||54
11089426|NCT01167582|12272484|FG000|NOT COMPLETED|Overall Study||0
11089427|NCT01167582|12272485|FG001|NOT COMPLETED|Overall Study||1
11089428|NCT01167595|12272493|FG000|STARTED|Overall Study||522
11089429|NCT01167595|12272494|FG001|STARTED|Overall Study||537
11089430|NCT01167595|12272493|FG000|COMPLETED|Overall Study||522
11089431|NCT01167595|12272494|FG001|COMPLETED|Overall Study||537
11089432|NCT01167595|12272493|FG000|NOT COMPLETED|Overall Study||0
11089433|NCT01167595|12272494|FG001|NOT COMPLETED|Overall Study||0
11089434|NCT01167608|12272500|FG000|STARTED|Overall Study||883
11089435|NCT01167608|12272500|FG000|COMPLETED|Overall Study||769
11089436|NCT01167608|12272500|FG000|NOT COMPLETED|Overall Study||114
11089437|NCT01167634|12272509|FG000|STARTED|Overall Study||33
11089438|NCT01167634|12272510|FG001|STARTED|Overall Study||33
11089439|NCT01167634|12272511|FG002|STARTED|Overall Study||33
11089440|NCT01167634|12272512|FG003|STARTED|Overall Study||33
11089441|NCT01167634|12272509|FG000|COMPLETED|Overall Study||31
11089442|NCT01167634|12272510|FG001|COMPLETED|Overall Study||29
11089443|NCT01167634|12272511|FG002|COMPLETED|Overall Study||30
11089444|NCT01167634|12272512|FG003|COMPLETED|Overall Study||29
11089445|NCT01167634|12272509|FG000|NOT COMPLETED|Overall Study||2
11089446|NCT01167634|12272510|FG001|NOT COMPLETED|Overall Study||4
11089447|NCT01167634|12272511|FG002|NOT COMPLETED|Overall Study||3
11089448|NCT01167634|12272512|FG003|NOT COMPLETED|Overall Study||4
11089449|NCT01167829|12272522|FG000|STARTED|Overall Study||12
11089450|NCT01167829|12272522|FG000|COMPLETED|Overall Study||12
11089451|NCT01167829|12272522|FG000|NOT COMPLETED|Overall Study||0
11089452|NCT01167881|12272530|FG000|STARTED|Overall Study||769
11089453|NCT01167881|12272531|FG001|STARTED|Overall Study||780
11089454|NCT01167881|12272530|FG000|Completed After 2 Years Treatment|Overall Study||95
11089455|NCT01167881|12272531|FG001|Completed After 2 Years Treatment|Overall Study||127
11089456|NCT01167881|12272530|FG000|Completed After 4 Years Treatment|Overall Study||515
11089457|NCT01167881|12272531|FG001|Completed After 4 Years Treatment|Overall Study||462
11089458|NCT01167881|12272530|FG000|COMPLETED|Overall Study||610
11089459|NCT01167881|12272531|FG001|COMPLETED|Overall Study||589
11089460|NCT01167881|12272530|FG000|NOT COMPLETED|Overall Study||159
11089461|NCT01167881|12272531|FG001|NOT COMPLETED|Overall Study||191
11089462|NCT01167907|12272539|FG000|STARTED|Overall Study||17
11089463|NCT01167907|12272540|FG001|STARTED|Overall Study||15
11089464|NCT01167907|12272539|FG000|COMPLETED|Overall Study||15
11089465|NCT01167907|12272540|FG001|COMPLETED|Overall Study||14
11351473|NCT03036293|12548462|FG000|NOT COMPLETED|Overall Study||1
11351474|NCT03036293|12548463|FG001|NOT COMPLETED|Overall Study||3
11351475|NCT03036293|12548464|FG002|NOT COMPLETED|Overall Study||1
11351476|NCT03036293|12548465|FG003|NOT COMPLETED|Overall Study||1
11351477|NCT03036384|12548477|FG000|STARTED|Overall Study||4
11089466|NCT01167907|12272539|FG000|NOT COMPLETED|Overall Study||2
11089467|NCT01167907|12272540|FG001|NOT COMPLETED|Overall Study||1
11089468|NCT01168024|12272548|FG000|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
11089469|NCT01168024|12272549|FG001|STARTED|Overall Study||3
11089470|NCT01168024|12272548|FG000|COMPLETED|Overall Study||13
11089471|NCT01168024|12272549|FG001|COMPLETED|Overall Study||3
11089472|NCT01168024|12272548|FG000|NOT COMPLETED|Overall Study||0
11089473|NCT01168024|12272549|FG001|NOT COMPLETED|Overall Study||0
11089474|NCT01168232|12272555|FG000|STARTED|Overall Study||42
11089475|NCT01168232|12272555|FG000|COMPLETED|Overall Study|Eligible and treated patients|34
11089476|NCT01168232|12272555|FG000|NOT COMPLETED|Overall Study||8
11089477|NCT01168349|12272559|FG000|STARTED|Overall Study||1055
11089478|NCT01168349|12272559|FG000|COMPLETED|Overall Study||754
11089479|NCT01168349|12272559|FG000|NOT COMPLETED|Overall Study||301
11089480|NCT01168401|12272590|FG000|STARTED|Overall Study||10
11089481|NCT01168401|12272591|FG001|STARTED|Overall Study||10
11089482|NCT01168401|12272592|FG002|STARTED|Overall Study||10
11089483|NCT01168401|12272593|FG003|STARTED|Overall Study||9
11089484|NCT01168401|12272594|FG004|STARTED|Overall Study||9
11351478|NCT03036384|12548478|FG001|STARTED|Overall Study||4
11089485|NCT01168401|12272595|FG005|STARTED|Overall Study||9
11089486|NCT01168401|12272596|FG006|STARTED|Overall Study||10
11089487|NCT01168401|12272597|FG007|STARTED|Overall Study||10
11089488|NCT01168401|12272598|FG008|STARTED|Overall Study||9
11089489|NCT01168401|12272599|FG009|STARTED|Overall Study||8
11089490|NCT01168401|12272600|FG010|STARTED|Overall Study||8
11089491|NCT01168401|12272590|FG000|COMPLETED|Overall Study||9
11089492|NCT01168401|12272591|FG001|COMPLETED|Overall Study||9
11089493|NCT01168401|12272592|FG002|COMPLETED|Overall Study||8
11089494|NCT01168401|12272593|FG003|COMPLETED|Overall Study||7
11089495|NCT01168401|12272594|FG004|COMPLETED|Overall Study||9
11089496|NCT01168401|12272595|FG005|COMPLETED|Overall Study||9
11089497|NCT01168401|12272596|FG006|COMPLETED|Overall Study||10
11089498|NCT01168401|12272597|FG007|COMPLETED|Overall Study||10
11089499|NCT01168401|12272598|FG008|COMPLETED|Overall Study||9
11089500|NCT01168401|12272599|FG009|COMPLETED|Overall Study||8
11089501|NCT01168401|12272600|FG010|COMPLETED|Overall Study||8
11089502|NCT01168401|12272590|FG000|NOT COMPLETED|Overall Study||1
11089503|NCT01168401|12272591|FG001|NOT COMPLETED|Overall Study||1
11089504|NCT01168401|12272592|FG002|NOT COMPLETED|Overall Study||2
11089505|NCT01168401|12272593|FG003|NOT COMPLETED|Overall Study||2
11089506|NCT01168401|12272594|FG004|NOT COMPLETED|Overall Study||0
11089507|NCT01168401|12272595|FG005|NOT COMPLETED|Overall Study||0
11089508|NCT01168401|12272596|FG006|NOT COMPLETED|Overall Study||0
11089509|NCT01168401|12272597|FG007|NOT COMPLETED|Overall Study||0
11089510|NCT01168401|12272598|FG008|NOT COMPLETED|Overall Study||0
11089511|NCT01168401|12272599|FG009|NOT COMPLETED|Overall Study||0
11089512|NCT01168401|12272600|FG010|NOT COMPLETED|Overall Study||0
11089513|NCT01168427|12272624|FG000|STARTED|Overall Study||66
11089514|NCT01168427|12272624|FG000|COMPLETED|Overall Study||65
11089515|NCT01168427|12272624|FG000|NOT COMPLETED|Overall Study||1
11089516|NCT01168596|12272630|FG000|STARTED|Overall Study||16
11089517|NCT01168596|12272631|FG001|STARTED|Overall Study||14
11089518|NCT01168596|12272630|FG000|COMPLETED|Overall Study||13
11089519|NCT01168596|12272631|FG001|COMPLETED|Overall Study||13
11089520|NCT01168596|12272630|FG000|NOT COMPLETED|Overall Study||3
11089521|NCT01168596|12272631|FG001|NOT COMPLETED|Overall Study||1
11089522|NCT01168674|12272637|FG000|STARTED|Overall Study||25
11089523|NCT01168674|12272638|FG001|STARTED|Overall Study||24
11089524|NCT01168674|12272637|FG000|COMPLETED|Overall Study||25
11089525|NCT01168674|12272638|FG001|COMPLETED|Overall Study||24
11089526|NCT01168674|12272637|FG000|NOT COMPLETED|Overall Study||0
11089527|NCT01168674|12272638|FG001|NOT COMPLETED|Overall Study||0
11089528|NCT01168687|12272647|FG000|STARTED|Overall Study||23
11089529|NCT01168687|12272648|FG001|STARTED|Overall Study||23
11089530|NCT01168687|12272647|FG000|COMPLETED|Overall Study||23
11089531|NCT01168687|12272648|FG001|COMPLETED|Overall Study||23
11089532|NCT01168687|12272647|FG000|NOT COMPLETED|Overall Study||0
11089533|NCT01168687|12272648|FG001|NOT COMPLETED|Overall Study||0
11089534|NCT01168726|12272657|FG000|STARTED|Overall Study||111
11089535|NCT01168726|12272658|FG001|STARTED|Overall Study||121
11089536|NCT01168726|12272659|FG002|STARTED|Overall Study||133
11089537|NCT01168726|12272657|FG000|COMPLETED|Overall Study||103
11089538|NCT01168726|12272658|FG001|COMPLETED|Overall Study||112
11089539|NCT01168726|12272659|FG002|COMPLETED|Overall Study||128
11089540|NCT01168726|12272657|FG000|NOT COMPLETED|Overall Study||8
11089541|NCT01168726|12272658|FG001|NOT COMPLETED|Overall Study||9
11089542|NCT01168726|12272659|FG002|NOT COMPLETED|Overall Study||5
11089543|NCT01168856|12272669|FG000|STARTED|Overall Study||176
11089544|NCT01168856|12272670|FG001|STARTED|Overall Study||558
11351479|NCT03036384|12548479|FG002|STARTED|Overall Study||4
11351480|NCT03036384|12548480|FG003|STARTED|Overall Study||4
11351481|NCT03036384|12548481|FG004|STARTED|Overall Study||4
11351482|NCT03036384|12548482|FG005|STARTED|Overall Study||4
11351483|NCT03036384|12548483|FG006|STARTED|Overall Study||4
11351484|NCT03036384|12548484|FG007|STARTED|Overall Study||4
11089545|NCT01168856|12272669|FG000|COMPLETED|Overall Study||158
11089546|NCT01168856|12272670|FG001|COMPLETED|Overall Study||215
11089547|NCT01168856|12272669|FG000|NOT COMPLETED|Overall Study||18
11089548|NCT01168856|12272670|FG001|NOT COMPLETED|Overall Study||343
11089549|NCT01168908|12272683|FG000|STARTED|Double Blind, Placebo Controlled||10
11089550|NCT01168908|12272684|FG001|STARTED|Double Blind, Placebo Controlled||10
11089551|NCT01168908|12272683|FG000|COMPLETED|Double Blind, Placebo Controlled||7
11089552|NCT01168908|12272684|FG001|COMPLETED|Double Blind, Placebo Controlled||8
11089553|NCT01168908|12272683|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||3
11089554|NCT01168908|12272684|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||2
11089555|NCT01168908|12272683|FG000|STARTED|Open Label||7
11089556|NCT01168908|12272684|FG001|STARTED|Open Label||8
11089557|NCT01168908|12272683|FG000|COMPLETED|Open Label||6
11089558|NCT01168908|12272684|FG001|COMPLETED|Open Label||7
11089559|NCT01168908|12272683|FG000|NOT COMPLETED|Open Label||1
11089560|NCT01168908|12272684|FG001|NOT COMPLETED|Open Label||1
11089561|NCT01168934|12272690|FG000|STARTED|First Intervention Period||7
11089562|NCT01168934|12272691|FG001|STARTED|First Intervention Period||7
11089563|NCT01168934|12272690|FG000|COMPLETED|First Intervention Period||7
11089564|NCT01168934|12272691|FG001|COMPLETED|First Intervention Period||7
11089565|NCT01168934|12272690|FG000|NOT COMPLETED|First Intervention Period||0
11089566|NCT01168934|12272691|FG001|NOT COMPLETED|First Intervention Period||0
11089567|NCT01168934|12272690|FG000|STARTED|Washout Period (at Least 14 Days)||7
11089568|NCT01168934|12272691|FG001|STARTED|Washout Period (at Least 14 Days)||7
11089569|NCT01168934|12272690|FG000|COMPLETED|Washout Period (at Least 14 Days)||7
11089570|NCT01168934|12272691|FG001|COMPLETED|Washout Period (at Least 14 Days)||7
11089571|NCT01168934|12272690|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11208003|NCT01878292|12399125|FG002|STARTED|Double-blind Down-Taper Period||146
11208004|NCT01878292|12399123|FG000|COMPLETED|Double-blind Down-Taper Period||122
11208005|NCT01878292|12399124|FG001|COMPLETED|Double-blind Down-Taper Period||132
11208006|NCT01878292|12399125|FG002|COMPLETED|Double-blind Down-Taper Period||142
11208007|NCT01878292|12399123|FG000|NOT COMPLETED|Double-blind Down-Taper Period||5
11208008|NCT01878292|12399124|FG001|NOT COMPLETED|Double-blind Down-Taper Period||8
11208009|NCT01878292|12399125|FG002|NOT COMPLETED|Double-blind Down-Taper Period||4
11208010|NCT01878383|12399135|FG000|STARTED|Overall Study||50
11208011|NCT01878383|12399136|FG001|STARTED|Overall Study||12500
11208012|NCT01878383|12399135|FG000|COMPLETED|Overall Study||50
11208013|NCT01878383|12399136|FG001|COMPLETED|Overall Study||11001
11208014|NCT01878383|12399135|FG000|NOT COMPLETED|Overall Study||0
11208015|NCT01878383|12399136|FG001|NOT COMPLETED|Overall Study||1499
11208016|NCT01878526|12399144|FG000|STARTED|Overall Study||40
11208017|NCT01878526|12399145|FG001|STARTED|Overall Study||40
11208018|NCT01878526|12399144|FG000|COMPLETED|Overall Study||37
11208019|NCT01878526|12399145|FG001|COMPLETED|Overall Study||38
11208020|NCT01878526|12399144|FG000|NOT COMPLETED|Overall Study||3
11208021|NCT01878526|12399145|FG001|NOT COMPLETED|Overall Study||2
11208022|NCT01878604|12399152|FG000|STARTED|Overall Study||5
11208023|NCT01878604|12399152|FG000|COMPLETED|Overall Study||5
11208024|NCT01878604|12399152|FG000|NOT COMPLETED|Overall Study||0
11089572|NCT01168934|12272691|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
11089573|NCT01168934|12272690|FG000|STARTED|Second Intervention Period||7
11089574|NCT01168934|12272691|FG001|STARTED|Second Intervention Period||7
11089575|NCT01168934|12272690|FG000|COMPLETED|Second Intervention Period||7
11089576|NCT01168934|12272691|FG001|COMPLETED|Second Intervention Period||7
11089577|NCT01168934|12272690|FG000|NOT COMPLETED|Second Intervention Period||0
11089578|NCT01168934|12272691|FG001|NOT COMPLETED|Second Intervention Period||0
11089579|NCT01168973|12272700|FG000|STARTED|Overall Study||628
11089580|NCT01168973|12272701|FG001|STARTED|Overall Study||625
11089581|NCT01168973|12272700|FG000|Received Any Quantity of Any Study Drug|Overall Study||624
11089582|NCT01168973|12272701|FG001|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
11089583|NCT01168973|12272700|FG000|COMPLETED|Overall Study||15
11089584|NCT01168973|12272701|FG001|COMPLETED|Overall Study||14
11089585|NCT01168973|12272700|FG000|NOT COMPLETED|Overall Study||613
11089586|NCT01168973|12272701|FG001|NOT COMPLETED|Overall Study||611
11089587|NCT01168986|12272710|FG000|STARTED|Overall Study||20
11089588|NCT01168986|12272711|FG001|STARTED|Overall Study||21
11089589|NCT01168986|12272712|FG002|STARTED|Overall Study||21
11089590|NCT01168986|12272710|FG000|COMPLETED|Overall Study||18
11089591|NCT01168986|12272711|FG001|COMPLETED|Overall Study||20
11089592|NCT01168986|12272712|FG002|COMPLETED|Overall Study||21
11089593|NCT01168986|12272710|FG000|NOT COMPLETED|Overall Study||2
11089594|NCT01168986|12272711|FG001|NOT COMPLETED|Overall Study||1
11089595|NCT01168986|12272712|FG002|NOT COMPLETED|Overall Study||0
11089596|NCT01168999|12272724|FG000|STARTED|Overall Study||28
11089597|NCT01168999|12272725|FG001|STARTED|Overall Study||27
11089598|NCT01168999|12272726|FG002|STARTED|Overall Study||27
11089599|NCT01168999|12272727|FG003|STARTED|Overall Study||28
11089600|NCT01168999|12272724|FG000|COMPLETED|Overall Study||26
11089601|NCT01168999|12272725|FG001|COMPLETED|Overall Study||26
11089602|NCT01168999|12272726|FG002|COMPLETED|Overall Study||27
11089603|NCT01168999|12272727|FG003|COMPLETED|Overall Study||28
11089604|NCT01168999|12272724|FG000|NOT COMPLETED|Overall Study||2
11089605|NCT01168999|12272725|FG001|NOT COMPLETED|Overall Study||1
11089606|NCT01168999|12272726|FG002|NOT COMPLETED|Overall Study||0
11089607|NCT01168999|12272727|FG003|NOT COMPLETED|Overall Study||0
11089608|NCT01169038|12272737|FG000|STARTED|Overall Study||15
11089609|NCT01169038|12272737|FG000|COMPLETED|Overall Study||8
11089610|NCT01169038|12272737|FG000|NOT COMPLETED|Overall Study||7
11089611|NCT01169064|12272743|FG000|STARTED|Overall Study||239
11089612|NCT01169064|12272744|FG001|STARTED|Overall Study||236
11089613|NCT01169064|12272743|FG000|COMPLETED|Overall Study||239
11089614|NCT01169064|12272744|FG001|COMPLETED|Overall Study||236
11089615|NCT01169064|12272743|FG000|NOT COMPLETED|Overall Study||0
11089616|NCT01169064|12272744|FG001|NOT COMPLETED|Overall Study||0
11089617|NCT01169103|12272754|FG000|STARTED|Overall Study||11
11089618|NCT01169103|12272755|FG001|STARTED|Overall Study||11
11089619|NCT01169103|12272754|FG000|COMPLETED|Overall Study||5
11089620|NCT01169103|12272755|FG001|COMPLETED|Overall Study||7
11089621|NCT01169103|12272754|FG000|NOT COMPLETED|Overall Study||6
11089622|NCT01169103|12272755|FG001|NOT COMPLETED|Overall Study||4
11089623|NCT01169311|12272761|FG000|STARTED|Overall Study||27
11351485|NCT03036384|12548485|FG008|STARTED|Overall Study||4
11351486|NCT03036384|12548486|FG009|STARTED|Overall Study||4
11351487|NCT03036384|12548477|FG000|COMPLETED|Overall Study||4
11351488|NCT03036384|12548478|FG001|COMPLETED|Overall Study||4
11351489|NCT03036384|12548479|FG002|COMPLETED|Overall Study||4
11351490|NCT03036384|12548480|FG003|COMPLETED|Overall Study||4
11351491|NCT03036384|12548481|FG004|COMPLETED|Overall Study||4
11351492|NCT03036384|12548482|FG005|COMPLETED|Overall Study||4
11351493|NCT03036384|12548483|FG006|COMPLETED|Overall Study||4
11351494|NCT03036384|12548484|FG007|COMPLETED|Overall Study||4
11351495|NCT03036384|12548485|FG008|COMPLETED|Overall Study||4
11351496|NCT03036384|12548486|FG009|COMPLETED|Overall Study||4
11351497|NCT03036384|12548477|FG000|NOT COMPLETED|Overall Study||0
11351498|NCT03036384|12548478|FG001|NOT COMPLETED|Overall Study||0
11351499|NCT03036384|12548479|FG002|NOT COMPLETED|Overall Study||0
11351500|NCT03036384|12548480|FG003|NOT COMPLETED|Overall Study||0
11351501|NCT03036384|12548481|FG004|NOT COMPLETED|Overall Study||0
11351502|NCT03036384|12548482|FG005|NOT COMPLETED|Overall Study||0
11089624|NCT01169311|12272761|FG000|COMPLETED|Overall Study||27
11089625|NCT01169311|12272761|FG000|NOT COMPLETED|Overall Study||0
11089626|NCT01169337|12272769|FG000|STARTED|Overall Study||44
11089627|NCT01169337|12272770|FG001|STARTED|Overall Study||90
11089628|NCT01169337|12272771|FG002|STARTED|Overall Study||92
11089629|NCT01169337|12272769|FG000|Received Treatment/Observation|Overall Study||44
11089630|NCT01169337|12272770|FG001|Received Treatment/Observation|Overall Study||88
11089631|NCT01169337|12272771|FG002|Received Treatment/Observation|Overall Study||86
11089632|NCT01169337|12272769|FG000|COMPLETED|Overall Study||0
11351503|NCT03036384|12548483|FG006|NOT COMPLETED|Overall Study||0
11351504|NCT03036384|12548484|FG007|NOT COMPLETED|Overall Study||0
11351505|NCT03036384|12548485|FG008|NOT COMPLETED|Overall Study||0
11089633|NCT01169337|12272770|FG001|COMPLETED|Overall Study||0
11089634|NCT01169337|12272771|FG002|COMPLETED|Overall Study||86
11089635|NCT01169337|12272769|FG000|NOT COMPLETED|Overall Study||44
11089636|NCT01169337|12272770|FG001|NOT COMPLETED|Overall Study||90
11089637|NCT01169337|12272771|FG002|NOT COMPLETED|Overall Study||6
11089638|NCT01169350|12272779|FG000|STARTED|Overall Study||8
11089639|NCT01169350|12272779|FG000|COMPLETED|Overall Study||3
11089640|NCT01169350|12272779|FG000|NOT COMPLETED|Overall Study||5
11089641|NCT01169467|12272785|FG000|STARTED|Overall Study||44
11089642|NCT01169467|12272786|FG001|STARTED|Overall Study||40
11089643|NCT01169467|12272785|FG000|COMPLETED|Overall Study||37
11089644|NCT01169467|12272786|FG001|COMPLETED|Overall Study||36
11089645|NCT01169467|12272785|FG000|NOT COMPLETED|Overall Study||7
11089646|NCT01169467|12272786|FG001|NOT COMPLETED|Overall Study||4
11089647|NCT01169493|12272798|FG000|STARTED|Period 1 (6 Months)||2
11089648|NCT01169493|12272799|FG001|STARTED|Period 1 (6 Months)||4
11089649|NCT01169493|12272800|FG002|STARTED|Period 1 (6 Months)||5
11089650|NCT01169493|12272801|FG003|STARTED|Period 1 (6 Months)||0
11089651|NCT01169493|12272802|FG004|STARTED|Period 1 (6 Months)||0
11089652|NCT01169493|12272803|FG005|STARTED|Period 1 (6 Months)||5
11089653|NCT01169493|12272798|FG000|COMPLETED|Period 1 (6 Months)||2
11089654|NCT01169493|12272799|FG001|COMPLETED|Period 1 (6 Months)||3
11089655|NCT01169493|12272800|FG002|COMPLETED|Period 1 (6 Months)||3
11089656|NCT01169493|12272801|FG003|COMPLETED|Period 1 (6 Months)||0
11089657|NCT01169493|12272802|FG004|COMPLETED|Period 1 (6 Months)||0
11089658|NCT01169493|12272803|FG005|COMPLETED|Period 1 (6 Months)||2
11089659|NCT01169493|12272798|FG000|NOT COMPLETED|Period 1 (6 Months)||0
11089660|NCT01169493|12272799|FG001|NOT COMPLETED|Period 1 (6 Months)||1
11089661|NCT01169493|12272800|FG002|NOT COMPLETED|Period 1 (6 Months)||2
11089662|NCT01169493|12272801|FG003|NOT COMPLETED|Period 1 (6 Months)||0
11089663|NCT01169493|12272802|FG004|NOT COMPLETED|Period 1 (6 Months)||0
11089664|NCT01169493|12272803|FG005|NOT COMPLETED|Period 1 (6 Months)||3
11089665|NCT01169493|12272798|FG000|STARTED|Period 2 (6 Months)||2
11089666|NCT01169493|12272799|FG001|STARTED|Period 2 (6 Months)||3
11089667|NCT01169493|12272800|FG002|STARTED|Period 2 (6 Months)||3
11089668|NCT01169493|12272801|FG003|STARTED|Period 2 (6 Months)||0
11089669|NCT01169493|12272802|FG004|STARTED|Period 2 (6 Months)||0
11089670|NCT01169493|12272803|FG005|STARTED|Period 2 (6 Months)||2
11089671|NCT01169493|12272798|FG000|COMPLETED|Period 2 (6 Months)||2
11089672|NCT01169493|12272799|FG001|COMPLETED|Period 2 (6 Months)||3
11089673|NCT01169493|12272800|FG002|COMPLETED|Period 2 (6 Months)||3
11089674|NCT01169493|12272801|FG003|COMPLETED|Period 2 (6 Months)||0
11089675|NCT01169493|12272802|FG004|COMPLETED|Period 2 (6 Months)||0
11089676|NCT01169493|12272803|FG005|COMPLETED|Period 2 (6 Months)||2
11089677|NCT01169493|12272798|FG000|NOT COMPLETED|Period 2 (6 Months)||0
11089678|NCT01169493|12272799|FG001|NOT COMPLETED|Period 2 (6 Months)||0
11089679|NCT01169493|12272800|FG002|NOT COMPLETED|Period 2 (6 Months)||0
11089680|NCT01169493|12272801|FG003|NOT COMPLETED|Period 2 (6 Months)||0
11089681|NCT01169493|12272802|FG004|NOT COMPLETED|Period 2 (6 Months)||0
11089682|NCT01169493|12272803|FG005|NOT COMPLETED|Period 2 (6 Months)||0
11089683|NCT01169493|12272798|FG000|STARTED|Period 3 (6 Months)||2
11089684|NCT01169493|12272799|FG001|STARTED|Period 3 (6 Months)||3
11089685|NCT01169493|12272800|FG002|STARTED|Period 3 (6 Months)||3
11089686|NCT01169493|12272801|FG003|STARTED|Period 3 (6 Months)||0
11089687|NCT01169493|12272802|FG004|STARTED|Period 3 (6 Months)||0
11089688|NCT01169493|12272803|FG005|STARTED|Period 3 (6 Months)||2
11089689|NCT01169493|12272798|FG000|COMPLETED|Period 3 (6 Months)||2
11089690|NCT01169493|12272799|FG001|COMPLETED|Period 3 (6 Months)||1
11089691|NCT01169493|12272800|FG002|COMPLETED|Period 3 (6 Months)||2
11089692|NCT01169493|12272801|FG003|COMPLETED|Period 3 (6 Months)||0
11089693|NCT01169493|12272802|FG004|COMPLETED|Period 3 (6 Months)||0
11089694|NCT01169493|12272803|FG005|COMPLETED|Period 3 (6 Months)||2
11089695|NCT01169493|12272798|FG000|NOT COMPLETED|Period 3 (6 Months)||0
11089696|NCT01169493|12272799|FG001|NOT COMPLETED|Period 3 (6 Months)||2
11089697|NCT01169493|12272800|FG002|NOT COMPLETED|Period 3 (6 Months)||1
11089698|NCT01169493|12272801|FG003|NOT COMPLETED|Period 3 (6 Months)||0
11089699|NCT01169493|12272802|FG004|NOT COMPLETED|Period 3 (6 Months)||0
11089700|NCT01169493|12272803|FG005|NOT COMPLETED|Period 3 (6 Months)||0
11089701|NCT01169519|12272811|FG000|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
11089702|NCT01169519|12272811|FG000|COMPLETED|Overall Study||21
11089703|NCT01169519|12272811|FG000|NOT COMPLETED|Overall Study||0
11089704|NCT01169532|12272823|FG000|STARTED|Overall Study||16
11089705|NCT01169532|12272823|FG000|COMPLETED|Overall Study||15
11089706|NCT01169532|12272823|FG000|NOT COMPLETED|Overall Study||1
11089707|NCT01169558|12272827|FG000|STARTED|Overall Study||162
11089708|NCT01169558|12272827|FG000|COMPLETED|Overall Study||6
11089709|NCT01169558|12272827|FG000|NOT COMPLETED|Overall Study||156
11089710|NCT01169636|12272836|FG000|STARTED|Overall Study||3
11089711|NCT01169636|12272837|FG001|STARTED|Overall Study||6
11089712|NCT01169636|12272838|FG002|STARTED|Overall Study||20
11089713|NCT01169636|12272839|FG003|STARTED|Overall Study||13
11089714|NCT01169636|12272840|FG004|STARTED|Overall Study||14
11089715|NCT01169636|12272836|FG000|COMPLETED|Overall Study||3
11089716|NCT01169636|12272837|FG001|COMPLETED|Overall Study||6
11089717|NCT01169636|12272838|FG002|COMPLETED|Overall Study||17
11089718|NCT01169636|12272839|FG003|COMPLETED|Overall Study||12
11089719|NCT01169636|12272840|FG004|COMPLETED|Overall Study||11
11089720|NCT01169636|12272836|FG000|NOT COMPLETED|Overall Study||0
11089721|NCT01169636|12272837|FG001|NOT COMPLETED|Overall Study||0
11089722|NCT01169636|12272838|FG002|NOT COMPLETED|Overall Study||3
11089723|NCT01169636|12272839|FG003|NOT COMPLETED|Overall Study||1
11089724|NCT01169636|12272840|FG004|NOT COMPLETED|Overall Study||3
11089725|NCT01169649|12272850|FG000|STARTED|Overall Study||11
11089726|NCT01169649|12272850|FG000|COMPLETED|Overall Study||8
11089727|NCT01169649|12272850|FG000|NOT COMPLETED|Overall Study||3
11089728|NCT01169675|12272859|FG000|STARTED|Overall Study||20
11089729|NCT01169675|12272860|FG001|STARTED|Overall Study||3
11089730|NCT01169675|12272861|FG002|STARTED|Overall Study||7
11089731|NCT01169675|12272862|FG003|STARTED|Overall Study||17
11089732|NCT01169675|12272863|FG004|STARTED|Overall Study||6
11089733|NCT01169675|12272859|FG000|COMPLETED|Overall Study||0
11089734|NCT01169675|12272860|FG001|COMPLETED|Overall Study||0
11089735|NCT01169675|12272861|FG002|COMPLETED|Overall Study||0
11089736|NCT01169675|12272862|FG003|COMPLETED|Overall Study||0
11089737|NCT01169675|12272863|FG004|COMPLETED|Overall Study||0
11089738|NCT01169675|12272859|FG000|NOT COMPLETED|Overall Study||20
11089739|NCT01169675|12272860|FG001|NOT COMPLETED|Overall Study||3
11089740|NCT01169675|12272861|FG002|NOT COMPLETED|Overall Study||7
11089741|NCT01169675|12272862|FG003|NOT COMPLETED|Overall Study||17
11089742|NCT01169675|12272863|FG004|NOT COMPLETED|Overall Study||6
11089743|NCT01169701|12272877|FG000|STARTED|Overall Study||36
11089744|NCT01169701|12272878|FG001|STARTED|Overall Study||35
11089745|NCT01169701|12272877|FG000|Safety Set|Overall Study||36
11089746|NCT01169701|12272878|FG001|Safety Set|Overall Study||35
11089747|NCT01169701|12272877|FG000|Intent to Treat (ITT) Set|Overall Study||32
11089748|NCT01169701|12272878|FG001|Intent to Treat (ITT) Set|Overall Study||28
11089749|NCT01169701|12272877|FG000|COMPLETED|Overall Study||31
11089750|NCT01169701|12272878|FG001|COMPLETED|Overall Study||25
11089751|NCT01169701|12272877|FG000|NOT COMPLETED|Overall Study||5
11089752|NCT01169701|12272878|FG001|NOT COMPLETED|Overall Study||10
11089753|NCT01169779|12272886|FG000|STARTED|Overall Study|Randomized.|195
11089754|NCT01169779|12272887|FG001|STARTED|Overall Study||196
11089755|NCT01169779|12272886|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
11089756|NCT01169779|12272887|FG001|Treated/Safety Population|Overall Study||196
11089757|NCT01169779|12272886|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
11089758|NCT01169779|12272887|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||195
11089759|NCT01169779|12272886|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
11089760|NCT01169779|12272887|FG001|Subgroup for Standardized Meal Test|Overall Study||121
11089761|NCT01169779|12272886|FG000|COMPLETED|Overall Study||184
11089762|NCT01169779|12272887|FG001|COMPLETED|Overall Study||179
11089763|NCT01169779|12272886|FG000|NOT COMPLETED|Overall Study||11
11089764|NCT01169779|12272887|FG001|NOT COMPLETED|Overall Study||17
11089765|NCT01169844|12272895|FG000|STARTED|Overall Study||19
11089766|NCT01169844|12272896|FG001|STARTED|Overall Study||9
11089767|NCT01169844|12272895|FG000|COMPLETED|Overall Study||14
11089768|NCT01169844|12272896|FG001|COMPLETED|Overall Study||8
11089769|NCT01169844|12272895|FG000|NOT COMPLETED|Overall Study||5
11089770|NCT01169844|12272896|FG001|NOT COMPLETED|Overall Study||1
11089771|NCT01169987|12272902|FG000|STARTED|Overall Study||191
11089772|NCT01169987|12272902|FG000|COMPLETED|Overall Study||160
11089773|NCT01169987|12272902|FG000|NOT COMPLETED|Overall Study||31
11089774|NCT01170039|12272914|FG000|STARTED|Overall Study||37
11089775|NCT01170039|12272915|FG001|STARTED|Overall Study||39
11089776|NCT01170039|12272914|FG000|COMPLETED|Overall Study||29
11089777|NCT01170039|12272915|FG001|COMPLETED|Overall Study||33
11089778|NCT01170039|12272914|FG000|NOT COMPLETED|Overall Study||8
11089779|NCT01170039|12272915|FG001|NOT COMPLETED|Overall Study||6
11208025|NCT01878656|12399159|FG000|STARTED|Overall Study||72
11208026|NCT01878656|12399160|FG001|STARTED|Overall Study||72
11208027|NCT01878656|12399159|FG000|COMPLETED|Overall Study||72
11208028|NCT01878656|12399160|FG001|COMPLETED|Overall Study||72
11208029|NCT01878656|12399159|FG000|NOT COMPLETED|Overall Study||0
11208030|NCT01878656|12399160|FG001|NOT COMPLETED|Overall Study||0
11208031|NCT01878799|12399168|FG000|STARTED|Overall Study||37
11208032|NCT01878799|12399169|FG001|STARTED|Overall Study||13
11208033|NCT01878799|12399168|FG000|COMPLETED|Overall Study||36
11208034|NCT01878799|12399169|FG001|COMPLETED|Overall Study||13
11208035|NCT01878799|12399168|FG000|NOT COMPLETED|Overall Study||1
11208036|NCT01878799|12399169|FG001|NOT COMPLETED|Overall Study||0
11208037|NCT01878812|12399177|FG000|STARTED|Overall Study||60
11208038|NCT01878812|12399178|FG001|STARTED|Overall Study||57
11208039|NCT01878812|12399177|FG000|COMPLETED|Overall Study||60
11208040|NCT01878812|12399178|FG001|COMPLETED|Overall Study||57
11208041|NCT01878812|12399177|FG000|NOT COMPLETED|Overall Study||0
11208042|NCT01878812|12399178|FG001|NOT COMPLETED|Overall Study||0
11208043|NCT01878825|12399186|FG000|STARTED|Overall Study||60
11208044|NCT01878825|12399187|FG001|STARTED|Overall Study||60
11208045|NCT01878825|12399186|FG000|COMPLETED|Overall Study||60
11208046|NCT01878825|12399187|FG001|COMPLETED|Overall Study||60
11208047|NCT01878825|12399186|FG000|NOT COMPLETED|Overall Study||0
11208048|NCT01878825|12399187|FG001|NOT COMPLETED|Overall Study||0
11208049|NCT01878890|12399206|FG000|STARTED|Overall Study||5
11351506|NCT03036384|12548486|FG009|NOT COMPLETED|Overall Study||0
11208050|NCT01878890|12399207|FG001|STARTED|Overall Study||11
11208051|NCT01878890|12399208|FG002|STARTED|Overall Study||4
11208052|NCT01878890|12399209|FG003|STARTED|Overall Study||5
11208053|NCT01878890|12399206|FG000|COMPLETED|Overall Study||5
11208054|NCT01878890|12399207|FG001|COMPLETED|Overall Study||10
11208055|NCT01878890|12399208|FG002|COMPLETED|Overall Study||4
11208056|NCT01878890|12399209|FG003|COMPLETED|Overall Study||5
11208057|NCT01878890|12399206|FG000|NOT COMPLETED|Overall Study||0
11208058|NCT01878890|12399207|FG001|NOT COMPLETED|Overall Study||1
11208059|NCT01878890|12399208|FG002|NOT COMPLETED|Overall Study||0
11208060|NCT01878890|12399209|FG003|NOT COMPLETED|Overall Study||0
11208061|NCT01879059|12399220|FG000|STARTED|Overall Study||13
11208062|NCT01879059|12399220|FG000|COMPLETED|Overall Study||13
11208063|NCT01879059|12399220|FG000|NOT COMPLETED|Overall Study||0
11208064|NCT01879072|12399224|FG000|STARTED|Overall Study||1860
11208065|NCT01879072|12399224|FG000|COMPLETED|Overall Study||1709
11208066|NCT01879072|12399224|FG000|NOT COMPLETED|Overall Study||151
11208067|NCT01879176|12399230|FG000|STARTED|Overall Study||24
11208068|NCT01879176|12399231|FG001|STARTED|Overall Study||22
11208069|NCT01879176|12399230|FG000|COMPLETED|Overall Study||16
11208070|NCT01879176|12399231|FG001|COMPLETED|Overall Study||16
11208071|NCT01879176|12399230|FG000|NOT COMPLETED|Overall Study||8
11208072|NCT01879176|12399231|FG001|NOT COMPLETED|Overall Study||6
11208073|NCT01879319|12399239|FG000|STARTED|Overall Study||82
11208074|NCT01879319|12399240|FG001|STARTED|Overall Study||82
11208075|NCT01879319|12399239|FG000|Received Treatment|Overall Study||82
11208076|NCT01879319|12399240|FG001|Received Treatment|Overall Study||82
11208077|NCT01879319|12399239|FG000|COMPLETED|Overall Study||80
11208078|NCT01879319|12399240|FG001|COMPLETED|Overall Study||77
11208079|NCT01879319|12399239|FG000|NOT COMPLETED|Overall Study||2
11208080|NCT01879319|12399240|FG001|NOT COMPLETED|Overall Study||5
11351507|NCT03036813|12548507|FG000|STARTED|Overall Study||92
11351508|NCT03036813|12548508|FG001|STARTED|Overall Study||90
11351509|NCT03036813|12548509|FG002|STARTED|Overall Study||92
11351510|NCT03036813|12548507|FG000|COMPLETED|Overall Study||70
11351511|NCT03036813|12548508|FG001|COMPLETED|Overall Study||63
11351512|NCT03036813|12548509|FG002|COMPLETED|Overall Study||66
11351513|NCT03036813|12548507|FG000|NOT COMPLETED|Overall Study||22
11351514|NCT03036813|12548508|FG001|NOT COMPLETED|Overall Study||27
11351515|NCT03036813|12548509|FG002|NOT COMPLETED|Overall Study||26
11089780|NCT01170065|12272924|FG000|STARTED|Overall Study||37
11089781|NCT01170065|12272925|FG001|STARTED|Overall Study||126
11089782|NCT01170065|12272926|FG002|STARTED|Overall Study||35
11089783|NCT01170065|12272924|FG000|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
11089784|NCT01170065|12272925|FG001|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|34
11089785|NCT01170065|12272926|FG002|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
11089786|NCT01170065|12272924|FG000|NOT COMPLETED|Overall Study||28
11089787|NCT01170065|12272925|FG001|NOT COMPLETED|Overall Study||92
11089788|NCT01170065|12272926|FG002|NOT COMPLETED|Overall Study||26
11089789|NCT01170091|12272934|FG000|STARTED|Overall Study||651
11089790|NCT01170091|12272934|FG000|COMPLETED|Overall Study||627
11089791|NCT01170091|12272934|FG000|NOT COMPLETED|Overall Study||24
11089792|NCT01170117|12272940|FG000|STARTED|Overall Study||77
11089793|NCT01170117|12272941|FG001|STARTED|Overall Study||75
11208081|NCT01879332|12399249|FG000|STARTED|Overall Study||6
11208082|NCT01879332|12399250|FG001|STARTED|Overall Study||6
11208083|NCT01879332|12399251|FG002|STARTED|Overall Study||4
11208084|NCT01879332|12399249|FG000|COMPLETED|Overall Study||0
11208085|NCT01879332|12399250|FG001|COMPLETED|Overall Study||0
11208086|NCT01879332|12399251|FG002|COMPLETED|Overall Study||0
11208087|NCT01879332|12399249|FG000|NOT COMPLETED|Overall Study||6
11208088|NCT01879332|12399250|FG001|NOT COMPLETED|Overall Study||6
11208089|NCT01879332|12399251|FG002|NOT COMPLETED|Overall Study||4
11208090|NCT01879345|12399262|FG000|STARTED|Single-dose Period||6
11208091|NCT01879345|12399263|FG001|STARTED|Single-dose Period||6
11208092|NCT01879345|12399264|FG002|STARTED|Single-dose Period||6
11208093|NCT01879345|12399262|FG000|COMPLETED|Single-dose Period||6
11208094|NCT01879345|12399263|FG001|COMPLETED|Single-dose Period||6
11208095|NCT01879345|12399264|FG002|COMPLETED|Single-dose Period||6
11208096|NCT01879345|12399262|FG000|NOT COMPLETED|Single-dose Period||0
11208097|NCT01879345|12399263|FG001|NOT COMPLETED|Single-dose Period||0
11208098|NCT01879345|12399264|FG002|NOT COMPLETED|Single-dose Period||0
11208099|NCT01879345|12399262|FG000|STARTED|7-day Multiple-dose Period||6
11208100|NCT01879345|12399263|FG001|STARTED|7-day Multiple-dose Period||6
11208101|NCT01879345|12399264|FG002|STARTED|7-day Multiple-dose Period||6
11208102|NCT01879345|12399262|FG000|COMPLETED|7-day Multiple-dose Period||6
11208103|NCT01879345|12399263|FG001|COMPLETED|7-day Multiple-dose Period||6
11208104|NCT01879345|12399264|FG002|COMPLETED|7-day Multiple-dose Period||6
11208105|NCT01879345|12399262|FG000|NOT COMPLETED|7-day Multiple-dose Period||0
11208106|NCT01879345|12399263|FG001|NOT COMPLETED|7-day Multiple-dose Period||0
11208107|NCT01879345|12399264|FG002|NOT COMPLETED|7-day Multiple-dose Period||0
11208108|NCT01879371|12399280|FG000|STARTED|Overall Study||6
11208109|NCT01879371|12399281|FG001|STARTED|Overall Study||6
11208110|NCT01879371|12399282|FG002|STARTED|Overall Study||6
11208111|NCT01879371|12399283|FG003|STARTED|Overall Study||6
11208112|NCT01879371|12399284|FG004|STARTED|Overall Study||6
11208113|NCT01879371|12399285|FG005|STARTED|Overall Study||6
11208114|NCT01879371|12399280|FG000|COMPLETED|Overall Study||6
11208115|NCT01879371|12399281|FG001|COMPLETED|Overall Study||6
11208116|NCT01879371|12399282|FG002|COMPLETED|Overall Study||6
11208117|NCT01879371|12399283|FG003|COMPLETED|Overall Study||6
11208118|NCT01879371|12399284|FG004|COMPLETED|Overall Study||6
11208119|NCT01879371|12399285|FG005|COMPLETED|Overall Study||6
11208120|NCT01879371|12399280|FG000|NOT COMPLETED|Overall Study||0
11208121|NCT01879371|12399281|FG001|NOT COMPLETED|Overall Study||0
11208122|NCT01879371|12399282|FG002|NOT COMPLETED|Overall Study||0
11208123|NCT01879371|12399283|FG003|NOT COMPLETED|Overall Study||0
11208124|NCT01879371|12399284|FG004|NOT COMPLETED|Overall Study||0
11208125|NCT01879371|12399285|FG005|NOT COMPLETED|Overall Study||0
11208126|NCT01879410|12399295|FG000|STARTED|Overall Study||350
11208127|NCT01879410|12399296|FG001|STARTED|Overall Study||350
11208128|NCT01879410|12399295|FG000|Intent-to-Treat Population|Overall Study||349
11208129|NCT01879410|12399296|FG001|Intent-to-Treat Population|Overall Study||348
11208130|NCT01879410|12399295|FG000|COMPLETED|Overall Study||326
11208131|NCT01879410|12399296|FG001|COMPLETED|Overall Study||312
11208132|NCT01879410|12399295|FG000|NOT COMPLETED|Overall Study||24
11208133|NCT01879410|12399296|FG001|NOT COMPLETED|Overall Study||38
11208134|NCT01879540|12399302|FG000|STARTED|Overall Study||63
11208135|NCT01879540|12399302|FG000|COMPLETED|Overall Study||63
11208136|NCT01879540|12399302|FG000|NOT COMPLETED|Overall Study||0
11208137|NCT01879553|12399308|FG000|STARTED|Overall Study||63
11208138|NCT01879553|12399309|FG001|STARTED|Overall Study||63
11208139|NCT01879553|12399308|FG000|COMPLETED|Overall Study||62
11089794|NCT01170117|12272940|FG000|COMPLETED|Overall Study||47
11089795|NCT01170117|12272941|FG001|COMPLETED|Overall Study||55
11089796|NCT01170117|12272940|FG000|NOT COMPLETED|Overall Study||30
11089797|NCT01170117|12272941|FG001|NOT COMPLETED|Overall Study||20
11089798|NCT01170208|12272950|FG000|STARTED|Overall Study||20
11089799|NCT01170208|12272951|FG001|STARTED|Overall Study||20
11089800|NCT01170208|12272952|FG002|STARTED|Overall Study||6
11089801|NCT01170208|12272950|FG000|COMPLETED|Overall Study||14
11089802|NCT01170208|12272951|FG001|COMPLETED|Overall Study||20
11089803|NCT01170208|12272952|FG002|COMPLETED|Overall Study||4
11089804|NCT01170208|12272950|FG000|NOT COMPLETED|Overall Study||6
11089805|NCT01170208|12272951|FG001|NOT COMPLETED|Overall Study||0
11089806|NCT01170208|12272952|FG002|NOT COMPLETED|Overall Study||2
11089807|NCT01170221|12272965|FG000|STARTED|Overall Study||332
11089808|NCT01170221|12272966|FG001|STARTED|Overall Study||335
11089809|NCT01170221|12272965|FG000|COMPLETED|Overall Study||299
11089810|NCT01170221|12272966|FG001|COMPLETED|Overall Study||307
11089811|NCT01170221|12272965|FG000|NOT COMPLETED|Overall Study||33
11089812|NCT01170221|12272966|FG001|NOT COMPLETED|Overall Study||28
11089813|NCT01170247|12272974|FG000|STARTED|Overall Study||2
11089814|NCT01170247|12272975|FG001|STARTED|Overall Study||1
11089815|NCT01170247|12272974|FG000|COMPLETED|Overall Study||2
11089816|NCT01170247|12272975|FG001|COMPLETED|Overall Study||1
11089817|NCT01170247|12272974|FG000|NOT COMPLETED|Overall Study||0
11089818|NCT01170247|12272975|FG001|NOT COMPLETED|Overall Study||0
11089819|NCT01170273|12272983|FG000|STARTED|Overall Study||64
11089820|NCT01170273|12272984|FG001|STARTED|Overall Study||66
11089821|NCT01170273|12272983|FG000|COMPLETED|Overall Study||56
11089822|NCT01170273|12272984|FG001|COMPLETED|Overall Study||57
11089823|NCT01170273|12272983|FG000|NOT COMPLETED|Overall Study||8
11089824|NCT01170273|12272984|FG001|NOT COMPLETED|Overall Study||9
11089825|NCT01170364|12272992|FG000|STARTED|Overall Study||8
11089826|NCT01170364|12272993|FG001|STARTED|Overall Study||6
11089827|NCT01170364|12272992|FG000|COMPLETED|Overall Study||4
11089828|NCT01170364|12272993|FG001|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
11089829|NCT01170364|12272992|FG000|NOT COMPLETED|Overall Study||4
11089830|NCT01170364|12272993|FG001|NOT COMPLETED|Overall Study||1
11089831|NCT01170390|12273001|FG000|STARTED|Oral Contraceptives||32
11089832|NCT01170390|12273002|FG001|STARTED|Oral Contraceptives||0
11089833|NCT01170390|12273003|FG002|STARTED|Oral Contraceptives||0
11089834|NCT01170390|12273001|FG000|COMPLETED|Oral Contraceptives||31
11089835|NCT01170390|12273002|FG001|COMPLETED|Oral Contraceptives||0
11089836|NCT01170390|12273003|FG002|COMPLETED|Oral Contraceptives||0
11089837|NCT01170390|12273001|FG000|NOT COMPLETED|Oral Contraceptives||1
11089838|NCT01170390|12273002|FG001|NOT COMPLETED|Oral Contraceptives||0
11089839|NCT01170390|12273003|FG002|NOT COMPLETED|Oral Contraceptives||0
11089840|NCT01170390|12273001|FG000|STARTED|Randomized Treatment||0
11089841|NCT01170390|12273002|FG001|STARTED|Randomized Treatment||17
11089842|NCT01170390|12273003|FG002|STARTED|Randomized Treatment||15
11089843|NCT01170390|12273001|FG000|COMPLETED|Randomized Treatment||0
11089844|NCT01170390|12273002|FG001|COMPLETED|Randomized Treatment||16
11089845|NCT01170390|12273003|FG002|COMPLETED|Randomized Treatment||15
11089846|NCT01170390|12273001|FG000|NOT COMPLETED|Randomized Treatment||0
11089847|NCT01170390|12273002|FG001|NOT COMPLETED|Randomized Treatment||1
11089848|NCT01170390|12273003|FG002|NOT COMPLETED|Randomized Treatment||0
11089849|NCT01170533|12273011|FG000|STARTED|Omeprazole Cross-over||20
11089850|NCT01170533|12273012|FG001|STARTED|Omeprazole Cross-over||0
11089851|NCT01170533|12273011|FG000|COMPLETED|Omeprazole Cross-over||20
11089852|NCT01170533|12273012|FG001|COMPLETED|Omeprazole Cross-over||0
11089853|NCT01170533|12273011|FG000|NOT COMPLETED|Omeprazole Cross-over||0
11089854|NCT01170533|12273012|FG001|NOT COMPLETED|Omeprazole Cross-over||0
11089855|NCT01170533|12273011|FG000|STARTED|Pantoprazole Cross-over||0
11089856|NCT01170533|12273012|FG001|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
11089857|NCT01170533|12273011|FG000|COMPLETED|Pantoprazole Cross-over||0
11089858|NCT01170533|12273012|FG001|COMPLETED|Pantoprazole Cross-over||20
11089859|NCT01170533|12273011|FG000|NOT COMPLETED|Pantoprazole Cross-over||0
11089860|NCT01170533|12273012|FG001|NOT COMPLETED|Pantoprazole Cross-over||0
11089861|NCT01170546|12273026|FG000|STARTED|Overall Study||7
11089862|NCT01170546|12273027|FG001|STARTED|Overall Study||7
11089863|NCT01170546|12273028|FG002|STARTED|Overall Study||6
11089864|NCT01170546|12273029|FG003|STARTED|Overall Study||8
11089865|NCT01170546|12273026|FG000|COMPLETED|Overall Study||7
11089866|NCT01170546|12273027|FG001|COMPLETED|Overall Study||7
11089867|NCT01170546|12273028|FG002|COMPLETED|Overall Study||6
11089868|NCT01170546|12273029|FG003|COMPLETED|Overall Study||8
11089869|NCT01170546|12273026|FG000|NOT COMPLETED|Overall Study||0
11089870|NCT01170546|12273027|FG001|NOT COMPLETED|Overall Study||0
11089871|NCT01170546|12273028|FG002|NOT COMPLETED|Overall Study||0
11089872|NCT01170546|12273029|FG003|NOT COMPLETED|Overall Study||0
11089873|NCT01170598|12273039|FG000|STARTED|Overall Study||35
11089874|NCT01170598|12273039|FG000|COMPLETED|Overall Study||29
11089875|NCT01170598|12273039|FG000|NOT COMPLETED|Overall Study||6
11089876|NCT01170663|12273045|FG000|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
11089877|NCT01170663|12273046|FG001|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
11089878|NCT01170663|12273045|FG000|Received Any Treatment (Safety Pop)|Overall Study||327
11089879|NCT01170663|12273046|FG001|Received Any Treatment (Safety Pop)|Overall Study||329
11089880|NCT01170663|12273045|FG000|COMPLETED|Overall Study||316
11089881|NCT01170663|12273046|FG001|COMPLETED|Overall Study||315
11089882|NCT01170663|12273045|FG000|NOT COMPLETED|Overall Study||14
11089883|NCT01170663|12273046|FG001|NOT COMPLETED|Overall Study||20
11089884|NCT01170715|12273052|FG000|STARTED|Overall Study||21
11089885|NCT01170715|12273052|FG000|COMPLETED|Overall Study||14
11089886|NCT01170715|12273052|FG000|NOT COMPLETED|Overall Study||7
11089887|NCT01170754|12273058|FG000|STARTED|Overall Study||66
11089888|NCT01170754|12273059|FG001|STARTED|Overall Study||70
11089889|NCT01170754|12273058|FG000|COMPLETED|Overall Study||66
11089890|NCT01170754|12273059|FG001|COMPLETED|Overall Study||70
11089891|NCT01170754|12273058|FG000|NOT COMPLETED|Overall Study||0
11089892|NCT01170754|12273059|FG001|NOT COMPLETED|Overall Study||0
11089893|NCT01170884|12273069|FG000|STARTED|Overall Study||59
11089894|NCT01170884|12273070|FG001|STARTED|Overall Study||62
11089895|NCT01170884|12273069|FG000|COMPLETED|Overall Study||54
11089896|NCT01170884|12273070|FG001|COMPLETED|Overall Study||60
11089897|NCT01170884|12273069|FG000|NOT COMPLETED|Overall Study||5
11089898|NCT01170884|12273070|FG001|NOT COMPLETED|Overall Study||2
11089899|NCT01170949|12273078|FG000|STARTED|Overall Study||50
11089900|NCT01170949|12273079|FG001|STARTED|Overall Study||26
11089901|NCT01170949|12273078|FG000|COMPLETED|Overall Study||43
11089902|NCT01170949|12273079|FG001|COMPLETED|Overall Study||22
11089903|NCT01170949|12273078|FG000|NOT COMPLETED|Overall Study||7
11089904|NCT01170949|12273079|FG001|NOT COMPLETED|Overall Study||4
11089905|NCT01170962|12273088|FG000|STARTED|Treatment Period||203
11089906|NCT01170962|12273089|FG001|STARTED|Treatment Period||199
11089907|NCT01170962|12273090|FG002|STARTED|Treatment Period||17
11089908|NCT01170962|12273088|FG000|No PDR|Treatment Period||145
11089909|NCT01170962|12273089|FG001|No PDR|Treatment Period||127
11089910|NCT01170962|12273090|FG002|No PDR|Treatment Period||17
11089911|NCT01170962|12273088|FG000|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||30
11089912|NCT01170962|12273089|FG001|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||36
11089913|NCT01170962|12273090|FG002|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||0
11089914|NCT01170962|12273088|FG000|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||28
11089915|NCT01170962|12273089|FG001|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||36
11089916|NCT01170962|12273090|FG002|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||0
11089917|NCT01170962|12273088|FG000|COMPLETED|Treatment Period||76
11089918|NCT01170962|12273089|FG001|COMPLETED|Treatment Period||88
11089919|NCT01170962|12273090|FG002|COMPLETED|Treatment Period||5
11089920|NCT01170962|12273088|FG000|NOT COMPLETED|Treatment Period||127
11089921|NCT01170962|12273089|FG001|NOT COMPLETED|Treatment Period||111
11089922|NCT01170962|12273090|FG002|NOT COMPLETED|Treatment Period||12
11089923|NCT01170962|12273088|FG000|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
11089924|NCT01170962|12273089|FG001|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
11089925|NCT01170962|12273090|FG002|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
11089926|NCT01170962|12273088|FG000|COMPLETED|Follow up Period||159
11089927|NCT01170962|12273089|FG001|COMPLETED|Follow up Period||165
11089928|NCT01170962|12273090|FG002|COMPLETED|Follow up Period||9
11089929|NCT01170962|12273088|FG000|NOT COMPLETED|Follow up Period||39
11089930|NCT01170962|12273089|FG001|NOT COMPLETED|Follow up Period||27
11089931|NCT01170962|12273090|FG002|NOT COMPLETED|Follow up Period||6
11089932|NCT01171118|12273107|FG000|STARTED|Overall Study||10
11089933|NCT01171118|12273107|FG000|COMPLETED|Overall Study||10
11089934|NCT01171118|12273107|FG000|NOT COMPLETED|Overall Study||0
11089935|NCT01171183|12273119|FG000|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
11089936|NCT01171183|12273120|FG001|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
11089937|NCT01171183|12273119|FG000|COMPLETED|Residential Facility (Weeks 1-2)||13
11089938|NCT01171183|12273120|FG001|COMPLETED|Residential Facility (Weeks 1-2)||10
11089939|NCT01171183|12273119|FG000|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
11089940|NCT01171183|12273120|FG001|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
11089941|NCT01171183|12273119|FG000|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
11089942|NCT01171183|12273120|FG001|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
11089943|NCT01171183|12273119|FG000|COMPLETED|Outpatient Participation (Weeks 3-10)||2
11089944|NCT01171183|12273120|FG001|COMPLETED|Outpatient Participation (Weeks 3-10)||4
11089945|NCT01171183|12273119|FG000|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
11089946|NCT01171183|12273120|FG001|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
11089947|NCT01171521|12273126|FG000|STARTED|Overall Study||6
11089948|NCT01171521|12273126|FG000|COMPLETED|Overall Study||0
11089949|NCT01171521|12273126|FG000|NOT COMPLETED|Overall Study||6
11089950|NCT01171612|12273130|FG000|STARTED|Overall Study||483
11089951|NCT01171612|12273130|FG000|COMPLETED|Overall Study||432
11089952|NCT01171612|12273130|FG000|NOT COMPLETED|Overall Study||51
11089953|NCT01171625|12273137|FG000|STARTED|Overall Study||283
11089954|NCT01171625|12273137|FG000|Subjects Implanted With Device|Overall Study||258
11089955|NCT01171625|12273137|FG000|COMPLETED|Overall Study||103
11089956|NCT01171625|12273137|FG000|NOT COMPLETED|Overall Study||180
11089957|NCT01171677|12273151|FG000|STARTED|Overall Study||17
11089958|NCT01171677|12273152|FG001|STARTED|Overall Study||15
11089959|NCT01171677|12273151|FG000|COMPLETED|Overall Study||11
11089960|NCT01171677|12273152|FG001|COMPLETED|Overall Study||12
11089961|NCT01171677|12273151|FG000|NOT COMPLETED|Overall Study||6
11089962|NCT01171677|12273152|FG001|NOT COMPLETED|Overall Study||3
11089963|NCT01171690|12273160|FG000|STARTED|Overall Study||5
11089964|NCT01171690|12273161|FG001|STARTED|Overall Study||5
11089965|NCT01171690|12273160|FG000|COMPLETED|Overall Study||5
11089966|NCT01171690|12273161|FG001|COMPLETED|Overall Study||5
11089967|NCT01171690|12273160|FG000|NOT COMPLETED|Overall Study||0
11089968|NCT01171690|12273161|FG001|NOT COMPLETED|Overall Study||0
11089969|NCT01171794|12273169|FG000|STARTED|Overall Study||47
11089970|NCT01171794|12273170|FG001|STARTED|Overall Study||42
11089971|NCT01171794|12273169|FG000|COMPLETED|Overall Study||44
11089972|NCT01171794|12273170|FG001|COMPLETED|Overall Study||42
11089973|NCT01171794|12273169|FG000|NOT COMPLETED|Overall Study||3
11089974|NCT01171794|12273170|FG001|NOT COMPLETED|Overall Study||0
11089975|NCT01171820|12273178|FG000|STARTED|Overall Study||106
11089976|NCT01171820|12273179|FG001|STARTED|Overall Study||218
11089977|NCT01171820|12273178|FG000|COMPLETED|Overall Study||100
11089978|NCT01171820|12273179|FG001|COMPLETED|Overall Study||212
11089979|NCT01171820|12273178|FG000|NOT COMPLETED|Overall Study||6
11089980|NCT01171820|12273179|FG001|NOT COMPLETED|Overall Study||6
11089981|NCT01171924|12273187|FG000|STARTED|Overall Study||23
11089982|NCT01171924|12273188|FG001|STARTED|Overall Study||23
11089983|NCT01171924|12273187|FG000|COMPLETED|Overall Study||0
11089984|NCT01171924|12273188|FG001|COMPLETED|Overall Study||0
11089985|NCT01171924|12273187|FG000|NOT COMPLETED|Overall Study||23
11089986|NCT01171924|12273188|FG001|NOT COMPLETED|Overall Study||23
11089987|NCT01171963|12273196|FG000|STARTED|Overall Study||1666
11089988|NCT01171963|12273197|FG001|STARTED|Overall Study||1667
11089989|NCT01171963|12273196|FG000|COMPLETED|Overall Study||1518
11089990|NCT01171963|12273197|FG001|COMPLETED|Overall Study||1499
11089991|NCT01171963|12273196|FG000|NOT COMPLETED|Overall Study||148
11089992|NCT01171963|12273197|FG001|NOT COMPLETED|Overall Study||168
11089993|NCT01171976|12273209|FG000|STARTED|Overall Study||121
11089994|NCT01171976|12273210|FG001|STARTED|Overall Study||128
11089995|NCT01171976|12273211|FG002|STARTED|Overall Study||123
11089996|NCT01171976|12273209|FG000|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
11089997|NCT01171976|12273210|FG001|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
11089998|NCT01171976|12273211|FG002|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
11089999|NCT01171976|12273209|FG000|COMPLETED|Overall Study||107
11090000|NCT01171976|12273210|FG001|COMPLETED|Overall Study||117
11090001|NCT01171976|12273211|FG002|COMPLETED|Overall Study||108
11090002|NCT01171976|12273209|FG000|NOT COMPLETED|Overall Study||14
11090003|NCT01171976|12273210|FG001|NOT COMPLETED|Overall Study||11
11090004|NCT01171976|12273211|FG002|NOT COMPLETED|Overall Study||15
11090005|NCT01171989|12273222|FG000|STARTED|Overall Study||137
11090006|NCT01171989|12273223|FG001|STARTED|Overall Study||133
11090007|NCT01171989|12273224|FG002|STARTED|Overall Study||121
11090008|NCT01171989|12273222|FG000|COMPLETED|Overall Study||137
11090009|NCT01171989|12273223|FG001|COMPLETED|Overall Study||133
11090010|NCT01171989|12273224|FG002|COMPLETED|Overall Study||120
11090011|NCT01171989|12273222|FG000|NOT COMPLETED|Overall Study||0
11090012|NCT01171989|12273223|FG001|NOT COMPLETED|Overall Study||0
11090013|NCT01171989|12273224|FG002|NOT COMPLETED|Overall Study||1
11090014|NCT01172067|12273234|FG000|STARTED|Overall Study||200
11090015|NCT01172067|12273235|FG001|STARTED|Overall Study||200
11090016|NCT01172067|12273234|FG000|COMPLETED|Overall Study||153
11090017|NCT01172067|12273235|FG001|COMPLETED|Overall Study||163
11090018|NCT01172067|12273234|FG000|NOT COMPLETED|Overall Study||47
11090019|NCT01172067|12273235|FG001|NOT COMPLETED|Overall Study||37
11090020|NCT01172145|12273243|FG000|STARTED|Overall Study||11
11090021|NCT01172145|12273244|FG001|STARTED|Overall Study||11
11090022|NCT01172145|12273243|FG000|COMPLETED|Overall Study||11
11090023|NCT01172145|12273244|FG001|COMPLETED|Overall Study||11
11090024|NCT01172145|12273243|FG000|NOT COMPLETED|Overall Study||0
11090025|NCT01172145|12273244|FG001|NOT COMPLETED|Overall Study||0
11090026|NCT01172184|12273250|FG000|STARTED|Overall Study||111
11090027|NCT01172184|12273250|FG000|COMPLETED|Overall Study||111
11090028|NCT01172184|12273250|FG000|NOT COMPLETED|Overall Study||0
11090029|NCT01172197|12273256|FG000|STARTED|Overall Study||7
11090030|NCT01172197|12273257|FG001|STARTED|Overall Study||7
11090031|NCT01172197|12273256|FG000|COMPLETED|Overall Study||7
11090032|NCT01172197|12273257|FG001|COMPLETED|Overall Study||7
11090033|NCT01172197|12273256|FG000|NOT COMPLETED|Overall Study||0
11090034|NCT01172197|12273257|FG001|NOT COMPLETED|Overall Study||0
11090035|NCT01172275|12273265|FG000|STARTED|Overall Study||5
11090036|NCT01172275|12273266|FG001|STARTED|Overall Study||6
11090037|NCT01172275|12273265|FG000|COMPLETED|Overall Study||3
11090038|NCT01172275|12273266|FG001|COMPLETED|Overall Study||6
11090039|NCT01172275|12273265|FG000|NOT COMPLETED|Overall Study||2
11090040|NCT01172275|12273266|FG001|NOT COMPLETED|Overall Study||0
11090041|NCT01172288|12273274|FG000|STARTED|Overall Study||17
11090042|NCT01172288|12273275|FG001|STARTED|Overall Study||14
11090043|NCT01172288|12273274|FG000|COMPLETED|Overall Study||16
11090044|NCT01172288|12273275|FG001|COMPLETED|Overall Study||13
11090045|NCT01172288|12273274|FG000|NOT COMPLETED|Overall Study||1
11090046|NCT01172288|12273275|FG001|NOT COMPLETED|Overall Study||1
11090047|NCT01172353|12273283|FG000|STARTED|Overall Study||150
11090048|NCT01172353|12273284|FG001|STARTED|Overall Study||151
11090049|NCT01172353|12273283|FG000|COMPLETED|Overall Study||150
11090050|NCT01172353|12273284|FG001|COMPLETED|Overall Study||151
11090051|NCT01172353|12273283|FG000|NOT COMPLETED|Overall Study||0
11090052|NCT01172353|12273284|FG001|NOT COMPLETED|Overall Study||0
11090053|NCT01172418|12273292|FG000|STARTED|Overall Study||100
11090054|NCT01172418|12273293|FG001|STARTED|Overall Study||100
11090055|NCT01172418|12273292|FG000|COMPLETED|Overall Study||100
11090056|NCT01172418|12273293|FG001|COMPLETED|Overall Study||100
11090057|NCT01172418|12273292|FG000|NOT COMPLETED|Overall Study||0
11090058|NCT01172418|12273293|FG001|NOT COMPLETED|Overall Study||0
11090059|NCT01172522|12273303|FG000|STARTED|Overall Study||15
11090060|NCT01172522|12273304|FG001|STARTED|Overall Study||15
11090061|NCT01172522|12273303|FG000|COMPLETED|Overall Study||15
11090062|NCT01172522|12273304|FG001|COMPLETED|Overall Study||15
11090063|NCT01172522|12273303|FG000|NOT COMPLETED|Overall Study||0
11090064|NCT01172522|12273304|FG001|NOT COMPLETED|Overall Study||0
11090065|NCT01172535|12273309|FG000|STARTED|Overall Study||97
11090066|NCT01172535|12273309|FG000|COMPLETED|Overall Study||89
11090067|NCT01172535|12273309|FG000|NOT COMPLETED|Overall Study||8
11090068|NCT01172600|12273318|FG000|STARTED|Overall Study||39
11090069|NCT01172600|12273319|FG001|STARTED|Overall Study||39
11090070|NCT01172600|12273318|FG000|COMPLETED|Overall Study||39
11090071|NCT01172600|12273319|FG001|COMPLETED|Overall Study||39
11090072|NCT01172600|12273318|FG000|NOT COMPLETED|Overall Study||0
11090073|NCT01172600|12273319|FG001|NOT COMPLETED|Overall Study||0
11090074|NCT01172639|12273330|FG000|STARTED|Overall Study||98
11090075|NCT01172639|12273331|FG001|STARTED|Overall Study||98
11090076|NCT01172639|12273332|FG002|STARTED|Overall Study||93
11090077|NCT01172639|12273333|FG003|STARTED|Overall Study||43
11090078|NCT01172639|12273334|FG004|STARTED|Overall Study||47
11090079|NCT01172639|12273330|FG000|Week 16|Overall Study||94
11090080|NCT01172639|12273331|FG001|Week 16|Overall Study||96
11090081|NCT01172639|12273332|FG002|Week 16|Overall Study||91
11090082|NCT01172639|12273333|FG003|Week 16|Overall Study||39
11090083|NCT01172639|12273334|FG004|Week 16|Overall Study||47
11090084|NCT01172639|12273330|FG000|Week 52|Overall Study||89
11090085|NCT01172639|12273331|FG001|Week 52|Overall Study||89
11090086|NCT01172639|12273332|FG002|Week 52|Overall Study||88
11090087|NCT01172639|12273333|FG003|Week 52|Overall Study||38
11090088|NCT01172639|12273334|FG004|Week 52|Overall Study||45
11090089|NCT01172639|12273330|FG000|COMPLETED|Overall Study||85
11090090|NCT01172639|12273331|FG001|COMPLETED|Overall Study||87
11090091|NCT01172639|12273332|FG002|COMPLETED|Overall Study||77
11090092|NCT01172639|12273333|FG003|COMPLETED|Overall Study||32
11351516|NCT03036839|12548523|FG000|STARTED|Overall Study||45
11351517|NCT03036839|12548524|FG001|STARTED|Overall Study||31
11090093|NCT01172639|12273334|FG004|COMPLETED|Overall Study||41
11090094|NCT01172639|12273330|FG000|NOT COMPLETED|Overall Study||13
11090095|NCT01172639|12273331|FG001|NOT COMPLETED|Overall Study||11
11090096|NCT01172639|12273332|FG002|NOT COMPLETED|Overall Study||16
11090097|NCT01172639|12273333|FG003|NOT COMPLETED|Overall Study||11
11090098|NCT01172639|12273334|FG004|NOT COMPLETED|Overall Study||6
11351518|NCT03036839|12548525|FG002|STARTED|Overall Study||19
11351519|NCT03036839|12548523|FG000|COMPLETED|Overall Study||42
11351520|NCT03036839|12548524|FG001|COMPLETED|Overall Study||31
11351521|NCT03036839|12548525|FG002|COMPLETED|Overall Study||14
11090099|NCT01172808|12273350|FG000|STARTED|Overall Study|Entered and Treated|269
11090100|NCT01172808|12273351|FG001|STARTED|Overall Study|Entered and Treated|262
11090101|NCT01172808|12273352|FG002|STARTED|Overall Study|Entered and Treated|264
11090102|NCT01172808|12273353|FG003|STARTED|Overall Study|Entered and Treated|275
11090103|NCT01172808|12273350|FG000|COMPLETED|Overall Study||248
11090104|NCT01172808|12273351|FG001|COMPLETED|Overall Study||249
11090105|NCT01172808|12273352|FG002|COMPLETED|Overall Study||241
11090106|NCT01172808|12273353|FG003|COMPLETED|Overall Study||260
11090107|NCT01172808|12273350|FG000|NOT COMPLETED|Overall Study||21
11090108|NCT01172808|12273351|FG001|NOT COMPLETED|Overall Study||13
11090109|NCT01172808|12273352|FG002|NOT COMPLETED|Overall Study||23
11090110|NCT01172808|12273353|FG003|NOT COMPLETED|Overall Study||15
11351522|NCT03036839|12548523|FG000|NOT COMPLETED|Overall Study||3
11090111|NCT01172821|12273367|FG000|STARTED|Overall Study|Entered and Treated|254
11090112|NCT01172821|12273368|FG001|STARTED|Overall Study|Entered and Treated|257
11090113|NCT01172821|12273369|FG002|STARTED|Overall Study|Entered and Treated|253
11090114|NCT01172821|12273370|FG003|STARTED|Overall Study|Entered and Treated|266
11090115|NCT01172821|12273367|FG000|COMPLETED|Overall Study||240
11090116|NCT01172821|12273368|FG001|COMPLETED|Overall Study||245
11090117|NCT01172821|12273369|FG002|COMPLETED|Overall Study||240
11090118|NCT01172821|12273370|FG003|COMPLETED|Overall Study||249
11090119|NCT01172821|12273367|FG000|NOT COMPLETED|Overall Study||14
11090120|NCT01172821|12273368|FG001|NOT COMPLETED|Overall Study||12
11090121|NCT01172821|12273369|FG002|NOT COMPLETED|Overall Study||13
11090122|NCT01172821|12273370|FG003|NOT COMPLETED|Overall Study||17
11090123|NCT01172847|12273380|FG000|STARTED|Overall Study||24
11090124|NCT01172847|12273380|FG000|Oseltamivir|Overall Study||24
11090125|NCT01172847|12273380|FG000|Rimantadine|Overall Study||22
11090126|NCT01172847|12273380|FG000|Oseltamivir + Rimantadine|Overall Study||21
11090127|NCT01172847|12273380|FG000|COMPLETED|Overall Study||21
11090128|NCT01172847|12273380|FG000|NOT COMPLETED|Overall Study||3
11090129|NCT01172873|12273392|FG000|STARTED|Overall Study||11
11090130|NCT01172873|12273393|FG001|STARTED|Overall Study||5
11090131|NCT01172873|12273392|FG000|COMPLETED|Overall Study||8
11090132|NCT01172873|12273393|FG001|COMPLETED|Overall Study||3
11090133|NCT01172873|12273392|FG000|NOT COMPLETED|Overall Study||3
11090134|NCT01172873|12273393|FG001|NOT COMPLETED|Overall Study||2
11090135|NCT01172938|12273402|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||168
11090136|NCT01172938|12273403|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||168
11351523|NCT03036839|12548524|FG001|NOT COMPLETED|Overall Study||0
11351524|NCT03036839|12548525|FG002|NOT COMPLETED|Overall Study||5
11351525|NCT03036852|12548539|FG000|STARTED|Overall Study||59
11351526|NCT03036852|12548539|FG000|COMPLETED|Overall Study||53
11351527|NCT03036852|12548539|FG000|NOT COMPLETED|Overall Study||6
11351528|NCT03037203|12548553|FG000|STARTED|Overall Study||28
11351529|NCT03037203|12548554|FG001|STARTED|Overall Study||28
11351530|NCT03037203|12548555|FG002|STARTED|Overall Study||10
11351531|NCT03037203|12548553|FG000|COMPLETED|Overall Study||27
11351532|NCT03037203|12548554|FG001|COMPLETED|Overall Study||26
11351533|NCT03037203|12548555|FG002|COMPLETED|Overall Study||9
11351534|NCT03037203|12548553|FG000|NOT COMPLETED|Overall Study||1
11351535|NCT03037203|12548554|FG001|NOT COMPLETED|Overall Study||2
11351536|NCT03037203|12548555|FG002|NOT COMPLETED|Overall Study||1
11351537|NCT03037281|12548575|FG000|STARTED|Overall Study||6
11351538|NCT03037281|12548576|FG001|STARTED|Overall Study||8
11351539|NCT03037281|12548575|FG000|COMPLETED|Overall Study||6
11351540|NCT03037281|12548576|FG001|COMPLETED|Overall Study||8
11351541|NCT03037281|12548575|FG000|NOT COMPLETED|Overall Study||0
11351542|NCT03037281|12548576|FG001|NOT COMPLETED|Overall Study||0
11351543|NCT03037307|12548587|FG000|STARTED|Period 1||7
11351544|NCT03037307|12548588|FG001|STARTED|Period 1||7
11351545|NCT03037307|12548589|FG002|STARTED|Period 1||8
11090137|NCT01172938|12273404|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||168
11090138|NCT01172938|12273405|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0
11090139|NCT01172938|12273406|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0
11090140|NCT01172938|12273407|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0
11090141|NCT01172938|12273408|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0
11090142|NCT01172938|12273409|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0
11090143|NCT01172938|12273410|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0
11090144|NCT01172938|12273402|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
11090145|NCT01172938|12273403|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
11090146|NCT01172938|12273404|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
11090147|NCT01172938|12273405|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
11090148|NCT01172938|12273406|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
11090149|NCT01172938|12273407|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
11090150|NCT01172938|12273408|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
11090151|NCT01172938|12273409|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
11090152|NCT01172938|12273410|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
11090153|NCT01172938|12273402|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
11090154|NCT01172938|12273403|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
11090155|NCT01172938|12273404|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
11090156|NCT01172938|12273405|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
11090157|NCT01172938|12273406|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
11090158|NCT01172938|12273407|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
11090159|NCT01172938|12273408|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
11090160|NCT01172938|12273409|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
11090161|NCT01172938|12273410|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
11090162|NCT01172938|12273402|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
11090163|NCT01172938|12273403|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
11090164|NCT01172938|12273404|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
11090165|NCT01172938|12273405|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
11090166|NCT01172938|12273406|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
11090167|NCT01172938|12273407|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
11090168|NCT01172938|12273408|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
11090169|NCT01172938|12273409|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
11090170|NCT01172938|12273410|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
11090171|NCT01172938|12273402|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
11090172|NCT01172938|12273403|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
11090173|NCT01172938|12273404|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
11090174|NCT01172938|12273405|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11090175|NCT01172938|12273406|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11090176|NCT01172938|12273407|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11090177|NCT01172938|12273408|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11090178|NCT01172938|12273409|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11090179|NCT01172938|12273410|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11090180|NCT01172938|12273402|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
11208140|NCT01879553|12399309|FG001|COMPLETED|Overall Study||63
11090181|NCT01172938|12273403|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
11090182|NCT01172938|12273404|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
11090183|NCT01172938|12273405|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11090184|NCT01172938|12273406|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11090185|NCT01172938|12273407|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11090186|NCT01172938|12273408|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11090187|NCT01172938|12273409|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11090188|NCT01172938|12273410|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
11090189|NCT01172938|12273402|FG000|STARTED|Active Treatment Phase (Weeks 25-52)||0
11090190|NCT01172938|12273403|FG001|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
11090191|NCT01172938|12273404|FG002|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
11090192|NCT01172938|12273405|FG003|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
11090193|NCT01172938|12273406|FG004|STARTED|Active Treatment Phase (Weeks 25-52)||23
11090194|NCT01172938|12273407|FG005|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
11090195|NCT01172938|12273408|FG006|STARTED|Active Treatment Phase (Weeks 25-52)||24
11090196|NCT01172938|12273409|FG007|STARTED|Active Treatment Phase (Weeks 25-52)||0
11090197|NCT01172938|12273410|FG008|STARTED|Active Treatment Phase (Weeks 25-52)||0
11090198|NCT01172938|12273402|FG000|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
11090199|NCT01172938|12273403|FG001|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
11090200|NCT01172938|12273404|FG002|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
11090201|NCT01172938|12273405|FG003|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
11090202|NCT01172938|12273406|FG004|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
11090203|NCT01172938|12273407|FG005|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
11090204|NCT01172938|12273408|FG006|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
11090205|NCT01172938|12273409|FG007|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
11090206|NCT01172938|12273410|FG008|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
11090207|NCT01172938|12273402|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
11090208|NCT01172938|12273403|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
11090209|NCT01172938|12273404|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
11090210|NCT01172938|12273405|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
11090211|NCT01172938|12273406|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
11090212|NCT01172938|12273407|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
11090213|NCT01172938|12273408|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
11090214|NCT01172938|12273409|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
11090215|NCT01172938|12273410|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
11090216|NCT01172938|12273402|FG000|STARTED|Active-Treatment Phase (Weeks 52-104)||0
11090217|NCT01172938|12273403|FG001|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
11090218|NCT01172938|12273404|FG002|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
11090219|NCT01172938|12273405|FG003|STARTED|Active-Treatment Phase (Weeks 52-104)||0
11090220|NCT01172938|12273406|FG004|STARTED|Active-Treatment Phase (Weeks 52-104)||0
11090221|NCT01172938|12273407|FG005|STARTED|Active-Treatment Phase (Weeks 52-104)||0
11090222|NCT01172938|12273408|FG006|STARTED|Active-Treatment Phase (Weeks 52-104)||0
11090223|NCT01172938|12273409|FG007|STARTED|Active-Treatment Phase (Weeks 52-104)||61
11090224|NCT01172938|12273410|FG008|STARTED|Active-Treatment Phase (Weeks 52-104)||49
11090225|NCT01172938|12273402|FG000|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
11090226|NCT01172938|12273403|FG001|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
11090227|NCT01172938|12273404|FG002|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
11090228|NCT01172938|12273405|FG003|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
11090229|NCT01172938|12273406|FG004|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
11090230|NCT01172938|12273407|FG005|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
11090231|NCT01172938|12273408|FG006|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
11090232|NCT01172938|12273409|FG007|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
11090233|NCT01172938|12273410|FG008|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
11090234|NCT01172938|12273402|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
11090235|NCT01172938|12273403|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
11090236|NCT01172938|12273404|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
11090237|NCT01172938|12273405|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
11090238|NCT01172938|12273406|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
11090239|NCT01172938|12273407|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
11090240|NCT01172938|12273408|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
11090241|NCT01172938|12273409|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
11090242|NCT01172938|12273410|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
11090243|NCT01172938|12273402|FG000|STARTED|Active-Treatment Phase Weeks (104-156)||0
11090244|NCT01172938|12273403|FG001|STARTED|Active-Treatment Phase Weeks (104-156)||95
11090245|NCT01172938|12273404|FG002|STARTED|Active-Treatment Phase Weeks (104-156)||100
11090246|NCT01172938|12273405|FG003|STARTED|Active-Treatment Phase Weeks (104-156)||0
11090247|NCT01172938|12273406|FG004|STARTED|Active-Treatment Phase Weeks (104-156)||0
11090248|NCT01172938|12273407|FG005|STARTED|Active-Treatment Phase Weeks (104-156)||0
11090249|NCT01172938|12273408|FG006|STARTED|Active-Treatment Phase Weeks (104-156)||0
11090250|NCT01172938|12273409|FG007|STARTED|Active-Treatment Phase Weeks (104-156)||46
11090251|NCT01172938|12273410|FG008|STARTED|Active-Treatment Phase Weeks (104-156)||45
11090252|NCT01172938|12273402|FG000|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
11090253|NCT01172938|12273403|FG001|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
11090254|NCT01172938|12273404|FG002|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
11090255|NCT01172938|12273405|FG003|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
11090256|NCT01172938|12273406|FG004|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
11090257|NCT01172938|12273407|FG005|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
11090258|NCT01172938|12273408|FG006|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
11090259|NCT01172938|12273409|FG007|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
11090260|NCT01172938|12273410|FG008|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
11090261|NCT01172938|12273402|FG000|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
11090262|NCT01172938|12273403|FG001|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
11090263|NCT01172938|12273404|FG002|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
11090264|NCT01172938|12273405|FG003|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
11090265|NCT01172938|12273406|FG004|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
11090266|NCT01172938|12273407|FG005|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
11090267|NCT01172938|12273408|FG006|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
11090268|NCT01172938|12273409|FG007|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
11090269|NCT01172938|12273410|FG008|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
11090270|NCT01172938|12273402|FG000|STARTED|Active-Treatment Phase (Weeks 156-208)||0
11090271|NCT01172938|12273403|FG001|STARTED|Active-Treatment Phase (Weeks 156-208)||84
11090272|NCT01172938|12273404|FG002|STARTED|Active-Treatment Phase (Weeks 156-208)||93
11090273|NCT01172938|12273405|FG003|STARTED|Active-Treatment Phase (Weeks 156-208)||0
11090274|NCT01172938|12273406|FG004|STARTED|Active-Treatment Phase (Weeks 156-208)||0
11090275|NCT01172938|12273407|FG005|STARTED|Active-Treatment Phase (Weeks 156-208)||0
11090276|NCT01172938|12273408|FG006|STARTED|Active-Treatment Phase (Weeks 156-208)||0
11090277|NCT01172938|12273409|FG007|STARTED|Active-Treatment Phase (Weeks 156-208)||41
11090278|NCT01172938|12273410|FG008|STARTED|Active-Treatment Phase (Weeks 156-208)||41
11090279|NCT01172938|12273402|FG000|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
11090280|NCT01172938|12273403|FG001|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
11090281|NCT01172938|12273404|FG002|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
11090282|NCT01172938|12273405|FG003|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
11090283|NCT01172938|12273406|FG004|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
11090284|NCT01172938|12273407|FG005|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
11090285|NCT01172938|12273408|FG006|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
11090286|NCT01172938|12273409|FG007|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
11090287|NCT01172938|12273410|FG008|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
11090288|NCT01172938|12273402|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
11090289|NCT01172938|12273403|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
11090290|NCT01172938|12273404|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
11090291|NCT01172938|12273405|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
11090292|NCT01172938|12273406|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
11090293|NCT01172938|12273407|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
11090294|NCT01172938|12273408|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
11090295|NCT01172938|12273409|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
11090296|NCT01172938|12273410|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
11090297|NCT01172938|12273402|FG000|STARTED|Active-Treatment Phase (Weeks 208-260)||0
11090298|NCT01172938|12273403|FG001|STARTED|Active-Treatment Phase (Weeks 208-260)||75
11090299|NCT01172938|12273404|FG002|STARTED|Active-Treatment Phase (Weeks 208-260)||88
11090300|NCT01172938|12273405|FG003|STARTED|Active-Treatment Phase (Weeks 208-260)||0
11090301|NCT01172938|12273406|FG004|STARTED|Active-Treatment Phase (Weeks 208-260)||0
11090302|NCT01172938|12273407|FG005|STARTED|Active-Treatment Phase (Weeks 208-260)||0
11090303|NCT01172938|12273408|FG006|STARTED|Active-Treatment Phase (Weeks 208-260)||0
11090304|NCT01172938|12273409|FG007|STARTED|Active-Treatment Phase (Weeks 208-260)||32
11090305|NCT01172938|12273410|FG008|STARTED|Active-Treatment Phase (Weeks 208-260)||34
11090306|NCT01172938|12273402|FG000|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
11090307|NCT01172938|12273403|FG001|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
11090308|NCT01172938|12273404|FG002|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
11090309|NCT01172938|12273405|FG003|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
11090310|NCT01172938|12273406|FG004|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
11090311|NCT01172938|12273407|FG005|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
11090312|NCT01172938|12273408|FG006|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
11090313|NCT01172938|12273409|FG007|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
11090314|NCT01172938|12273410|FG008|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
11090315|NCT01172938|12273402|FG000|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
11090316|NCT01172938|12273403|FG001|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
11090317|NCT01172938|12273404|FG002|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
11090318|NCT01172938|12273405|FG003|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
11090319|NCT01172938|12273406|FG004|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
11090320|NCT01172938|12273407|FG005|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
11090321|NCT01172938|12273408|FG006|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
11090322|NCT01172938|12273409|FG007|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
11090323|NCT01172938|12273410|FG008|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
11090324|NCT01172938|12273402|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
11090325|NCT01172938|12273403|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
11090326|NCT01172938|12273404|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
11090327|NCT01172938|12273405|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
11090328|NCT01172938|12273406|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
11090329|NCT01172938|12273407|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
11090330|NCT01172938|12273408|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
11090331|NCT01172938|12273409|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
11090332|NCT01172938|12273410|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
11090333|NCT01173016|12273428|FG000|STARTED|Overall Study||11
11090334|NCT01173016|12273428|FG000|COMPLETED|Overall Study||10
11090335|NCT01173016|12273428|FG000|NOT COMPLETED|Overall Study||1
11090336|NCT01173029|12273434|FG000|STARTED|Overall Study||61
11090337|NCT01173029|12273435|FG001|STARTED|Overall Study||31
11090338|NCT01173029|12273434|FG000|COMPLETED|Overall Study||61
11090339|NCT01173029|12273435|FG001|COMPLETED|Overall Study||31
11090340|NCT01173029|12273434|FG000|NOT COMPLETED|Overall Study||0
11090341|NCT01173029|12273435|FG001|NOT COMPLETED|Overall Study||0
11090342|NCT01173055|12273452|FG000|STARTED|Period 1 - Day 1 to 49||10
11090343|NCT01173055|12273453|FG001|STARTED|Period 1 - Day 1 to 49||12
11090344|NCT01173055|12273452|FG000|COMPLETED|Period 1 - Day 1 to 49||8
11090345|NCT01173055|12273453|FG001|COMPLETED|Period 1 - Day 1 to 49||10
11090346|NCT01173055|12273452|FG000|NOT COMPLETED|Period 1 - Day 1 to 49||2
11090347|NCT01173055|12273453|FG001|NOT COMPLETED|Period 1 - Day 1 to 49||2
11090348|NCT01173055|12273452|FG000|STARTED|Placebo Washout Period - Day 50 to 63||8
11090349|NCT01173055|12273453|FG001|STARTED|Placebo Washout Period - Day 50 to 63||10
11090350|NCT01173055|12273452|FG000|COMPLETED|Placebo Washout Period - Day 50 to 63||8
11090351|NCT01173055|12273453|FG001|COMPLETED|Placebo Washout Period - Day 50 to 63||10
11090352|NCT01173055|12273452|FG000|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
11090353|NCT01173055|12273453|FG001|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
11090354|NCT01173055|12273452|FG000|STARTED|Period 2 - Day 64 to 112||8
11090355|NCT01173055|12273453|FG001|STARTED|Period 2 - Day 64 to 112||10
11090356|NCT01173055|12273452|FG000|COMPLETED|Period 2 - Day 64 to 112||8
11090357|NCT01173055|12273453|FG001|COMPLETED|Period 2 - Day 64 to 112||9
11090358|NCT01173055|12273452|FG000|NOT COMPLETED|Period 2 - Day 64 to 112||0
11090359|NCT01173055|12273453|FG001|NOT COMPLETED|Period 2 - Day 64 to 112||1
11090360|NCT01173120|12273459|FG000|STARTED|Overall Study||62
11090361|NCT01173120|12273459|FG000|Switched Back to Main Study|Overall Study||57
11090362|NCT01173120|12273459|FG000|Discontinued ACP Substudy and Main Study|Overall Study||5
11090363|NCT01173120|12273459|FG000|COMPLETED|Overall Study||0
11090364|NCT01173120|12273459|FG000|NOT COMPLETED|Overall Study||62
11090365|NCT01173159|12273465|FG000|STARTED|Overall Study||10
11090366|NCT01173159|12273465|FG000|COMPLETED|Overall Study||10
11090367|NCT01173159|12273465|FG000|NOT COMPLETED|Overall Study||0
11090368|NCT01173211|12273475|FG000|STARTED|Overall Study||48
11090369|NCT01173211|12273476|FG001|STARTED|Overall Study||45
11090370|NCT01173211|12273477|FG002|STARTED|Overall Study||46
11090371|NCT01173211|12273478|FG003|STARTED|Overall Study||15
11090372|NCT01173211|12273479|FG004|STARTED|Overall Study||16
11090373|NCT01173211|12273480|FG005|STARTED|Overall Study||13
11090374|NCT01173211|12273475|FG000|COMPLETED|Overall Study||46
11090375|NCT01173211|12273476|FG001|COMPLETED|Overall Study||44
11090376|NCT01173211|12273477|FG002|COMPLETED|Overall Study||44
11090377|NCT01173211|12273478|FG003|COMPLETED|Overall Study||15
11090378|NCT01173211|12273479|FG004|COMPLETED|Overall Study||16
11090379|NCT01173211|12273480|FG005|COMPLETED|Overall Study||13
11090380|NCT01173211|12273475|FG000|NOT COMPLETED|Overall Study||2
11090381|NCT01173211|12273476|FG001|NOT COMPLETED|Overall Study||1
11090382|NCT01173211|12273477|FG002|NOT COMPLETED|Overall Study||2
11090383|NCT01173211|12273478|FG003|NOT COMPLETED|Overall Study||0
11090384|NCT01173211|12273479|FG004|NOT COMPLETED|Overall Study||0
11090385|NCT01173211|12273480|FG005|NOT COMPLETED|Overall Study||0
11090386|NCT01173471|12273498|FG000|STARTED|Overall Study|Randomized|6
11090387|NCT01173471|12273499|FG001|STARTED|Overall Study|Randomized|7
11090388|NCT01173471|12273500|FG002|STARTED|Overall Study|Randomized|18
11090389|NCT01173471|12273501|FG003|STARTED|Overall Study|Randomized|19
11090390|NCT01173471|12273498|FG000|Received Treatment|Overall Study||6
11090391|NCT01173471|12273499|FG001|Received Treatment|Overall Study||7
11090392|NCT01173471|12273500|FG002|Received Treatment|Overall Study||18
11090393|NCT01173471|12273501|FG003|Received Treatment|Overall Study||19
11090394|NCT01173471|12273498|FG000|Completed Treatment|Overall Study||4
11090395|NCT01173471|12273499|FG001|Completed Treatment|Overall Study||7
11090396|NCT01173471|12273500|FG002|Completed Treatment|Overall Study||15
11090397|NCT01173471|12273501|FG003|Completed Treatment|Overall Study||18
11090398|NCT01173471|12273498|FG000|COMPLETED|Overall Study|Completed study|4
11090399|NCT01173471|12273499|FG001|COMPLETED|Overall Study|Completed study|7
11090400|NCT01173471|12273500|FG002|COMPLETED|Overall Study|Completed study|15
11090401|NCT01173471|12273501|FG003|COMPLETED|Overall Study|Completed study|18
11090402|NCT01173471|12273498|FG000|NOT COMPLETED|Overall Study||2
11090403|NCT01173471|12273499|FG001|NOT COMPLETED|Overall Study||0
11090404|NCT01173471|12273500|FG002|NOT COMPLETED|Overall Study||3
11090405|NCT01173471|12273501|FG003|NOT COMPLETED|Overall Study||1
11090406|NCT01173523|12273513|FG000|STARTED|Overall Study||13
11090407|NCT01173523|12273514|FG001|STARTED|Overall Study||12
11090408|NCT01173523|12273513|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
11090409|NCT01173523|12273514|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
11090410|NCT01173523|12273513|FG000|NOT COMPLETED|Overall Study||13
11090411|NCT01173523|12273514|FG001|NOT COMPLETED|Overall Study||12
11090412|NCT01173601|12273524|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
11090413|NCT01173601|12273525|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
11090414|NCT01173601|12273526|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
11090415|NCT01173601|12273527|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
11090416|NCT01173601|12273528|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0
11090417|NCT01173601|12273524|FG000|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
11090418|NCT01173601|12273525|FG001|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
11090419|NCT01173601|12273526|FG002|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
11090420|NCT01173601|12273527|FG003|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
11090421|NCT01173601|12273528|FG004|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
11090422|NCT01173601|12273524|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
11090423|NCT01173601|12273525|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11090424|NCT01173601|12273526|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11090425|NCT01173601|12273527|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11090426|NCT01173601|12273528|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11090427|NCT01173601|12273524|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
11090428|NCT01173601|12273525|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11090429|NCT01173601|12273526|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11090430|NCT01173601|12273527|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11090431|NCT01173601|12273528|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11090432|NCT01173601|12273524|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11090433|NCT01173601|12273525|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
11090434|NCT01173601|12273526|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
11090435|NCT01173601|12273527|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
11090436|NCT01173601|12273528|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
11090437|NCT01173601|12273524|FG000|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11090438|NCT01173601|12273525|FG001|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
11090439|NCT01173601|12273526|FG002|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
11090440|NCT01173601|12273527|FG003|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11090441|NCT01173601|12273528|FG004|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11090442|NCT01173601|12273524|FG000|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11090443|NCT01173601|12273525|FG001|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
11090444|NCT01173601|12273526|FG002|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
11090445|NCT01173601|12273527|FG003|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
11090446|NCT01173601|12273528|FG004|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
11090447|NCT01173601|12273524|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11090448|NCT01173601|12273525|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
11090449|NCT01173601|12273526|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
11090450|NCT01173601|12273527|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
11090451|NCT01173601|12273528|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
11090452|NCT01173601|12273524|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11090453|NCT01173601|12273525|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
11090454|NCT01173601|12273526|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
11090455|NCT01173601|12273527|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
11090456|NCT01173601|12273528|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
11090457|NCT01173653|12273548|FG000|STARTED|Overall Study||109
11090458|NCT01173653|12273549|FG001|STARTED|Overall Study||90
11090459|NCT01173653|12273548|FG000|COMPLETED|Overall Study||56
11090460|NCT01173653|12273549|FG001|COMPLETED|Overall Study||49
11090461|NCT01173653|12273548|FG000|NOT COMPLETED|Overall Study||53
11090462|NCT01173653|12273549|FG001|NOT COMPLETED|Overall Study||41
11090463|NCT01173679|12273555|FG000|STARTED|Overall Study||10
11090464|NCT01173679|12273555|FG000|COMPLETED|Overall Study||9
11090465|NCT01173679|12273555|FG000|NOT COMPLETED|Overall Study||1
11090466|NCT01173692|12273562|FG000|STARTED|Overall Study||22
11090467|NCT01173692|12273563|FG001|STARTED|Overall Study||25
11090468|NCT01173692|12273562|FG000|COMPLETED|Overall Study||20
11090469|NCT01173692|12273563|FG001|COMPLETED|Overall Study||20
11090470|NCT01173692|12273562|FG000|NOT COMPLETED|Overall Study||2
11090471|NCT01173692|12273563|FG001|NOT COMPLETED|Overall Study||5
11351546|NCT03037307|12548590|FG003|STARTED|Period 1||7
11351547|NCT03037307|12548591|FG004|STARTED|Period 1||7
11351548|NCT03037307|12548592|FG005|STARTED|Period 1||8
11351549|NCT03037307|12548587|FG000|COMPLETED|Period 1||7
11351550|NCT03037307|12548588|FG001|COMPLETED|Period 1||7
11351551|NCT03037307|12548589|FG002|COMPLETED|Period 1||8
11351552|NCT03037307|12548590|FG003|COMPLETED|Period 1||6
11351553|NCT03037307|12548591|FG004|COMPLETED|Period 1||7
11351554|NCT03037307|12548592|FG005|COMPLETED|Period 1||8
11090472|NCT01173718|12273569|FG000|STARTED|Overall Study||138
11090473|NCT01173718|12273569|FG000|COMPLETED|Overall Study||94
11090474|NCT01173718|12273569|FG000|NOT COMPLETED|Overall Study||44
11090475|NCT01173848|12273575|FG000|STARTED|Overall Study||8
11090476|NCT01173848|12273576|FG001|STARTED|Overall Study||11
11090477|NCT01173848|12273575|FG000|COMPLETED|Overall Study||4
11090478|NCT01173848|12273576|FG001|COMPLETED|Overall Study||3
11090479|NCT01173848|12273575|FG000|NOT COMPLETED|Overall Study||4
11090480|NCT01173848|12273576|FG001|NOT COMPLETED|Overall Study||8
11090481|NCT01173874|12273583|FG000|STARTED|Overall Study||56
11090482|NCT01173874|12273584|FG001|STARTED|Overall Study||64
11090483|NCT01173874|12273583|FG000|COMPLETED|Overall Study||33
11090484|NCT01173874|12273584|FG001|COMPLETED|Overall Study||41
11090485|NCT01173874|12273583|FG000|NOT COMPLETED|Overall Study||23
11090486|NCT01173874|12273584|FG001|NOT COMPLETED|Overall Study||23
11090487|NCT01174004|12273592|FG000|STARTED|Overall Study||94
11090488|NCT01174004|12273593|FG001|STARTED|Overall Study||105
11090489|NCT01174004|12273592|FG000|COMPLETED|Overall Study||87
11090490|NCT01174004|12273593|FG001|COMPLETED|Overall Study||89
11090491|NCT01174004|12273592|FG000|NOT COMPLETED|Overall Study||7
11090492|NCT01174004|12273593|FG001|NOT COMPLETED|Overall Study||16
11090493|NCT01174030|12273604|FG000|STARTED|Overall Study||53
11090494|NCT01174030|12273605|FG001|STARTED|Overall Study||54
11090495|NCT01174030|12273606|FG002|STARTED|Overall Study||54
11090496|NCT01174030|12273607|FG003|STARTED|Overall Study||55
11090497|NCT01174030|12273608|FG004|STARTED|Overall Study||53
11090498|NCT01174030|12273604|FG000|COMPLETED|Overall Study||51
11090499|NCT01174030|12273605|FG001|COMPLETED|Overall Study||52
11090500|NCT01174030|12273606|FG002|COMPLETED|Overall Study||52
11090501|NCT01174030|12273607|FG003|COMPLETED|Overall Study||53
11090502|NCT01174030|12273608|FG004|COMPLETED|Overall Study||52
11090503|NCT01174030|12273604|FG000|NOT COMPLETED|Overall Study||2
11090504|NCT01174030|12273605|FG001|NOT COMPLETED|Overall Study||2
11090505|NCT01174030|12273606|FG002|NOT COMPLETED|Overall Study||2
11090506|NCT01174030|12273607|FG003|NOT COMPLETED|Overall Study||2
11090507|NCT01174030|12273608|FG004|NOT COMPLETED|Overall Study||1
11090508|NCT01174043|12273620|FG000|STARTED|Overall Study||11
11090509|NCT01174043|12273620|FG000|COMPLETED|Overall Study||0
11090510|NCT01174043|12273620|FG000|NOT COMPLETED|Overall Study||11
11090511|NCT01174082|12273626|FG000|STARTED|Overall Study||1
11090512|NCT01174082|12273627|FG001|STARTED|Overall Study||1
11090513|NCT01174082|12273626|FG000|COMPLETED|Overall Study||1
11090514|NCT01174082|12273627|FG001|COMPLETED|Overall Study||1
11090515|NCT01174082|12273626|FG000|NOT COMPLETED|Overall Study||0
11090516|NCT01174082|12273627|FG001|NOT COMPLETED|Overall Study||0
11090517|NCT01174160|12273635|FG000|STARTED|Overall Study||61
11090518|NCT01174160|12273636|FG001|STARTED|Overall Study||62
11090519|NCT01174160|12273635|FG000|Discontinued Pre Dose|Overall Study||6
11090520|NCT01174160|12273636|FG001|Discontinued Pre Dose|Overall Study||6
11090521|NCT01174160|12273635|FG000|Dosed|Overall Study||55
11090522|NCT01174160|12273636|FG001|Dosed|Overall Study||56
11090523|NCT01174160|12273635|FG000|Discontinued Post Dose|Overall Study||2
11090524|NCT01174160|12273636|FG001|Discontinued Post Dose|Overall Study||0
11090525|NCT01174160|12273635|FG000|COMPLETED|Overall Study||53
11090526|NCT01174160|12273636|FG001|COMPLETED|Overall Study||56
11090527|NCT01174160|12273635|FG000|NOT COMPLETED|Overall Study||8
11090528|NCT01174160|12273636|FG001|NOT COMPLETED|Overall Study||6
11090529|NCT01174173|12273642|FG000|STARTED|Overall Study||11
11090530|NCT01174173|12273642|FG000|COMPLETED|Overall Study||10
11090531|NCT01174173|12273642|FG000|NOT COMPLETED|Overall Study||1
11090532|NCT01174186|12273649|FG000|STARTED|Overall Study|Patients were included over three years|15
11090533|NCT01174186|12273650|FG001|STARTED|Overall Study||15
11090534|NCT01174186|12273649|FG000|COMPLETED|Overall Study||15
11090535|NCT01174186|12273650|FG001|COMPLETED|Overall Study||12
11090536|NCT01174186|12273649|FG000|NOT COMPLETED|Overall Study||0
11090537|NCT01174186|12273650|FG001|NOT COMPLETED|Overall Study||3
11090538|NCT01174238|12273656|FG000|STARTED|Overall Study||38
11090539|NCT01174238|12273656|FG000|Participants That Underwent FLT-PET Scan|Overall Study||6
11090540|NCT01174238|12273656|FG000|COMPLETED|Overall Study||36
11090541|NCT01174238|12273656|FG000|NOT COMPLETED|Overall Study||2
11090542|NCT01174264|12273666|FG000|STARTED|Single Dose Pharmacokinetics||23
11090543|NCT01174264|12273667|FG001|STARTED|Single Dose Pharmacokinetics||20
11090544|NCT01174264|12273668|FG002|STARTED|Single Dose Pharmacokinetics||20
11090545|NCT01174264|12273666|FG000|COMPLETED|Single Dose Pharmacokinetics||22
11090546|NCT01174264|12273667|FG001|COMPLETED|Single Dose Pharmacokinetics||20
11090547|NCT01174264|12273668|FG002|COMPLETED|Single Dose Pharmacokinetics||18
11090548|NCT01174264|12273666|FG000|NOT COMPLETED|Single Dose Pharmacokinetics||1
11090549|NCT01174264|12273667|FG001|NOT COMPLETED|Single Dose Pharmacokinetics||0
11090550|NCT01174264|12273668|FG002|NOT COMPLETED|Single Dose Pharmacokinetics||2
11090551|NCT01174264|12273666|FG000|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
11090552|NCT01174264|12273667|FG001|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
11090553|NCT01174264|12273668|FG002|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
11090554|NCT01174264|12273666|FG000|COMPLETED|Steady-state Pharmacokinetics||25
11090555|NCT01174264|12273667|FG001|COMPLETED|Steady-state Pharmacokinetics||0
11090556|NCT01174264|12273668|FG002|COMPLETED|Steady-state Pharmacokinetics||27
11090557|NCT01174264|12273666|FG000|NOT COMPLETED|Steady-state Pharmacokinetics||6
11090558|NCT01174264|12273667|FG001|NOT COMPLETED|Steady-state Pharmacokinetics||0
11090559|NCT01174264|12273668|FG002|NOT COMPLETED|Steady-state Pharmacokinetics||2
11090560|NCT01174342|12273676|FG000|STARTED|Overall Study||30
11090561|NCT01174342|12273676|FG000|COMPLETED|Overall Study||26
11090562|NCT01174342|12273676|FG000|NOT COMPLETED|Overall Study||4
11090563|NCT01174446|12273680|FG000|STARTED|Part 1 -Pharmacokinetic Crossover||14
11090564|NCT01174446|12273681|FG001|STARTED|Part 1 -Pharmacokinetic Crossover||14
11090565|NCT01174446|12273682|FG002|STARTED|Part 1 -Pharmacokinetic Crossover||0
11090566|NCT01174446|12273683|FG003|STARTED|Part 1 -Pharmacokinetic Crossover||0
11090567|NCT01174446|12273680|FG000|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
11090568|NCT01174446|12273681|FG001|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
11090569|NCT01174446|12273682|FG002|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
11090570|NCT01174446|12273683|FG003|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
11090571|NCT01174446|12273680|FG000|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
11090572|NCT01174446|12273681|FG001|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
11090573|NCT01174446|12273682|FG002|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
11090574|NCT01174446|12273683|FG003|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
11090575|NCT01174446|12273680|FG000|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
11090576|NCT01174446|12273681|FG001|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
11090577|NCT01174446|12273682|FG002|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
11090578|NCT01174446|12273683|FG003|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
11090579|NCT01174446|12273680|FG000|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
11090580|NCT01174446|12273681|FG001|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
11090581|NCT01174446|12273682|FG002|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
11090582|NCT01174446|12273683|FG003|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
11090583|NCT01174446|12273680|FG000|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
11090584|NCT01174446|12273681|FG001|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
11090585|NCT01174446|12273682|FG002|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
11090586|NCT01174446|12273683|FG003|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
11090587|NCT01174446|12273680|FG000|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
11090588|NCT01174446|12273681|FG001|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
11090589|NCT01174446|12273682|FG002|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
11090590|NCT01174446|12273683|FG003|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
11090591|NCT01174446|12273680|FG000|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
11090592|NCT01174446|12273681|FG001|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
11090593|NCT01174446|12273682|FG002|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
11090594|NCT01174446|12273683|FG003|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
11090595|NCT01174446|12273680|FG000|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
11090596|NCT01174446|12273681|FG001|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
11090597|NCT01174446|12273682|FG002|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
11090598|NCT01174446|12273683|FG003|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
11090599|NCT01174459|12273730|FG000|STARTED|Overall Study|Registered patients|571
11090600|NCT01174459|12273730|FG000|COMPLETED|Overall Study|Case report form (CRF) collected|566
11090601|NCT01174459|12273730|FG000|NOT COMPLETED|Overall Study||5
11090602|NCT01174550|12273736|FG000|STARTED|Overall Study||5007
11090603|NCT01174550|12273737|FG001|STARTED|Overall Study||4996
11090604|NCT01174550|12273736|FG000|COMPLETED|Overall Study||3737
11090605|NCT01174550|12273737|FG001|COMPLETED|Overall Study||4123
11090606|NCT01174550|12273736|FG000|NOT COMPLETED|Overall Study||1270
11090607|NCT01174550|12273737|FG001|NOT COMPLETED|Overall Study||873
11090608|NCT01174576|12273743|FG000|STARTED|Overall Study|All participants received all interventions without exception.|16
11090609|NCT01174576|12273743|FG000|COMPLETED|Overall Study||16
11090610|NCT01174576|12273743|FG000|NOT COMPLETED|Overall Study||0
11090611|NCT01174784|12273756|FG000|STARTED|Overall Study||88
11090612|NCT01174784|12273756|FG000|COMPLETED|Overall Study|While 88 subjects did complete the procedure, 4 were considered screen failures post-procedure.|84
11090613|NCT01174784|12273756|FG000|NOT COMPLETED|Overall Study||4
11090614|NCT01174823|12273763|FG000|STARTED|Overall Study||122
11090615|NCT01174823|12273764|FG001|STARTED|Overall Study||123
11090616|NCT01174823|12273763|FG000|COMPLETED|Overall Study||115
11090617|NCT01174823|12273764|FG001|COMPLETED|Overall Study||119
11090618|NCT01174823|12273763|FG000|NOT COMPLETED|Overall Study||7
11090619|NCT01174823|12273764|FG001|NOT COMPLETED|Overall Study||4
11090620|NCT01175005|12273770|FG000|STARTED|Overall Study||62
11090621|NCT01175005|12273770|FG000|COMPLETED|Overall Study||62
11090622|NCT01175005|12273770|FG000|NOT COMPLETED|Overall Study||0
11090623|NCT01175018|12273777|FG000|STARTED|Overall Study||15
11090624|NCT01175018|12273778|FG001|STARTED|Overall Study||15
11090625|NCT01175018|12273777|FG000|COMPLETED|Overall Study||12
11090626|NCT01175018|12273778|FG001|COMPLETED|Overall Study||14
11090627|NCT01175018|12273777|FG000|NOT COMPLETED|Overall Study||3
11090628|NCT01175018|12273778|FG001|NOT COMPLETED|Overall Study||1
11090629|NCT01175031|12273786|FG000|STARTED|Overall Study||45
11090630|NCT01175031|12273786|FG000|COMPLETED|Overall Study||45
11090631|NCT01175031|12273786|FG000|NOT COMPLETED|Overall Study||0
11090632|NCT01175083|12273800|FG000|STARTED|Primary Epoch||50
11090633|NCT01175083|12273801|FG001|STARTED|Primary Epoch||50
11090634|NCT01175083|12273802|FG002|STARTED|Primary Epoch||50
11090635|NCT01175083|12273803|FG003|STARTED|Primary Epoch||50
11090636|NCT01175083|12273804|FG004|STARTED|Primary Epoch||50
11090637|NCT01175083|12273805|FG005|STARTED|Primary Epoch||50
11090638|NCT01175083|12273800|FG000|COMPLETED|Primary Epoch||50
11090639|NCT01175083|12273801|FG001|COMPLETED|Primary Epoch||50
11090640|NCT01175083|12273802|FG002|COMPLETED|Primary Epoch||50
11090641|NCT01175083|12273803|FG003|COMPLETED|Primary Epoch||50
11090642|NCT01175083|12273804|FG004|COMPLETED|Primary Epoch||50
11090643|NCT01175083|12273805|FG005|COMPLETED|Primary Epoch||47
11090644|NCT01175083|12273800|FG000|NOT COMPLETED|Primary Epoch||0
11090645|NCT01175083|12273801|FG001|NOT COMPLETED|Primary Epoch||0
11090646|NCT01175083|12273802|FG002|NOT COMPLETED|Primary Epoch||0
11090647|NCT01175083|12273803|FG003|NOT COMPLETED|Primary Epoch||0
11090648|NCT01175083|12273804|FG004|NOT COMPLETED|Primary Epoch||0
11090649|NCT01175083|12273805|FG005|NOT COMPLETED|Primary Epoch||3
11090650|NCT01175083|12273800|FG000|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
11090651|NCT01175083|12273801|FG001|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
11090652|NCT01175083|12273802|FG002|STARTED|Booster Epoch||50
11090653|NCT01175083|12273803|FG003|STARTED|Booster Epoch||50
11090654|NCT01175083|12273804|FG004|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
11090655|NCT01175083|12273805|FG005|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
11090656|NCT01175083|12273800|FG000|COMPLETED|Booster Epoch||49
11090657|NCT01175083|12273801|FG001|COMPLETED|Booster Epoch||49
11090658|NCT01175083|12273802|FG002|COMPLETED|Booster Epoch||49
11090659|NCT01175083|12273803|FG003|COMPLETED|Booster Epoch||49
11090660|NCT01175083|12273804|FG004|COMPLETED|Booster Epoch||0
11090661|NCT01175083|12273805|FG005|COMPLETED|Booster Epoch||0
11090662|NCT01175083|12273800|FG000|NOT COMPLETED|Booster Epoch||0
11090663|NCT01175083|12273801|FG001|NOT COMPLETED|Booster Epoch||0
11090664|NCT01175083|12273802|FG002|NOT COMPLETED|Booster Epoch||1
11090665|NCT01175083|12273803|FG003|NOT COMPLETED|Booster Epoch||1
11090666|NCT01175083|12273804|FG004|NOT COMPLETED|Booster Epoch||0
11090667|NCT01175083|12273805|FG005|NOT COMPLETED|Booster Epoch||0
11090668|NCT01175135|12273827|FG000|STARTED|Overall Study||74
11090669|NCT01175135|12273828|FG001|STARTED|Overall Study||74
11090670|NCT01175135|12273829|FG002|STARTED|Overall Study||37
11090671|NCT01175135|12273830|FG003|STARTED|Overall Study||74
11090672|NCT01175135|12273827|FG000|Treated|Overall Study||74
11090673|NCT01175135|12273828|FG001|Treated|Overall Study||74
11090674|NCT01175135|12273829|FG002|Treated|Overall Study||36
11090675|NCT01175135|12273830|FG003|Treated|Overall Study||74
11090676|NCT01175135|12273827|FG000|Analyzed for Efficacy|Overall Study||74
11090677|NCT01175135|12273828|FG001|Analyzed for Efficacy|Overall Study||73
11090678|NCT01175135|12273829|FG002|Analyzed for Efficacy|Overall Study||34
11090679|NCT01175135|12273830|FG003|Analyzed for Efficacy|Overall Study||73
11090680|NCT01175135|12273827|FG000|COMPLETED|Overall Study||58
11090681|NCT01175135|12273828|FG001|COMPLETED|Overall Study||52
11090682|NCT01175135|12273829|FG002|COMPLETED|Overall Study||25
11090683|NCT01175135|12273830|FG003|COMPLETED|Overall Study||60
11090684|NCT01175135|12273827|FG000|NOT COMPLETED|Overall Study||16
11090685|NCT01175135|12273828|FG001|NOT COMPLETED|Overall Study||22
11090686|NCT01175135|12273829|FG002|NOT COMPLETED|Overall Study||12
11090687|NCT01175135|12273830|FG003|NOT COMPLETED|Overall Study||14
11090688|NCT01175148|12273842|FG000|STARTED|Overall Study||30
11090689|NCT01175148|12273843|FG001|STARTED|Overall Study||30
11090690|NCT01175148|12273842|FG000|COMPLETED|Overall Study||30
11090691|NCT01175148|12273843|FG001|COMPLETED|Overall Study||30
11090692|NCT01175148|12273842|FG000|NOT COMPLETED|Overall Study||0
11090693|NCT01175148|12273843|FG001|NOT COMPLETED|Overall Study||0
11090694|NCT01175213|12273852|FG000|STARTED|IGSC, 10%/rHuPH20||63
11090695|NCT01175213|12273853|FG001|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
11090696|NCT01175213|12273852|FG000|COMPLETED|IGSC, 10%/rHuPH20||48
11090697|NCT01175213|12273853|FG001|COMPLETED|IGSC, 10%/rHuPH20||3
11090698|NCT01175213|12273852|FG000|NOT COMPLETED|IGSC, 10%/rHuPH20||15
11090699|NCT01175213|12273853|FG001|NOT COMPLETED|IGSC, 10%/rHuPH20||0
11090700|NCT01175213|12273852|FG000|STARTED|Safety Follow-up||48
11090701|NCT01175213|12273853|FG001|STARTED|Safety Follow-up||3
11090702|NCT01175213|12273852|FG000|COMPLETED|Safety Follow-up||47
11090703|NCT01175213|12273853|FG001|COMPLETED|Safety Follow-up||3
11090704|NCT01175213|12273852|FG000|NOT COMPLETED|Safety Follow-up||1
11090705|NCT01175213|12273853|FG001|NOT COMPLETED|Safety Follow-up||0
11090706|NCT01175226|12273864|FG000|STARTED|Overall Study||155
11090707|NCT01175226|12273865|FG001|STARTED|Overall Study||145
11090708|NCT01175226|12273864|FG000|COMPLETED|Overall Study||144
11090709|NCT01175226|12273865|FG001|COMPLETED|Overall Study||140
11090710|NCT01175226|12273864|FG000|NOT COMPLETED|Overall Study||11
11090711|NCT01175226|12273865|FG001|NOT COMPLETED|Overall Study||5
11090712|NCT01175317|12273873|FG000|STARTED|Overall Study||27
11090713|NCT01175317|12273874|FG001|STARTED|Overall Study||31
11090714|NCT01175317|12273873|FG000|COMPLETED|Overall Study||27
11090715|NCT01175317|12273874|FG001|COMPLETED|Overall Study||31
11090716|NCT01175317|12273873|FG000|NOT COMPLETED|Overall Study||0
11090717|NCT01175317|12273874|FG001|NOT COMPLETED|Overall Study||0
11090718|NCT01175343|12273880|FG000|STARTED|Overall Study||44
11090719|NCT01175343|12273880|FG000|COMPLETED|Overall Study||44
11090720|NCT01175343|12273880|FG000|NOT COMPLETED|Overall Study||0
11090721|NCT01175369|12273886|FG000|STARTED|Overall Study||265
11090722|NCT01175369|12273887|FG001|STARTED|Overall Study||265
11090723|NCT01175369|12273886|FG000|COMPLETED|Overall Study||263
11090724|NCT01175369|12273887|FG001|COMPLETED|Overall Study||260
11090725|NCT01175369|12273886|FG000|NOT COMPLETED|Overall Study||2
11090726|NCT01175369|12273887|FG001|NOT COMPLETED|Overall Study||5
11090727|NCT01175382|12273896|FG000|STARTED|Overall Study||71
11090728|NCT01175382|12273897|FG001|STARTED|Overall Study||68
11090729|NCT01175382|12273898|FG002|STARTED|Overall Study||65
11090730|NCT01175382|12273896|FG000|COMPLETED|Overall Study||63
11351555|NCT03037307|12548587|FG000|NOT COMPLETED|Period 1||0
11351556|NCT03037307|12548588|FG001|NOT COMPLETED|Period 1||0
11351557|NCT03037307|12548589|FG002|NOT COMPLETED|Period 1||0
11351558|NCT03037307|12548590|FG003|NOT COMPLETED|Period 1||1
11351559|NCT03037307|12548591|FG004|NOT COMPLETED|Period 1||0
11351560|NCT03037307|12548592|FG005|NOT COMPLETED|Period 1||0
11351561|NCT03037307|12548587|FG000|STARTED|Wash Out Period 1||7
11351562|NCT03037307|12548588|FG001|STARTED|Wash Out Period 1||7
11351563|NCT03037307|12548589|FG002|STARTED|Wash Out Period 1||8
11351564|NCT03037307|12548590|FG003|STARTED|Wash Out Period 1||6
11351565|NCT03037307|12548591|FG004|STARTED|Wash Out Period 1||7
11351566|NCT03037307|12548592|FG005|STARTED|Wash Out Period 1||8
11351567|NCT03037307|12548587|FG000|COMPLETED|Wash Out Period 1||7
11351568|NCT03037307|12548588|FG001|COMPLETED|Wash Out Period 1||7
11090731|NCT01175382|12273897|FG001|COMPLETED|Overall Study||61
11090732|NCT01175382|12273898|FG002|COMPLETED|Overall Study||59
11090733|NCT01175382|12273896|FG000|NOT COMPLETED|Overall Study||8
11090734|NCT01175382|12273897|FG001|NOT COMPLETED|Overall Study||7
11090735|NCT01175382|12273898|FG002|NOT COMPLETED|Overall Study||6
11090736|NCT01175395|12273906|FG000|STARTED|Overall Study||10
11090737|NCT01175395|12273906|FG000|COMPLETED|Overall Study||10
11090738|NCT01175395|12273906|FG000|NOT COMPLETED|Overall Study||0
11090739|NCT01175434|12273912|FG000|STARTED|Overall Study||48
11090740|NCT01175434|12273913|FG001|STARTED|Overall Study||51
11090741|NCT01175434|12273912|FG000|COMPLETED|Overall Study||48
11090742|NCT01175434|12273913|FG001|COMPLETED|Overall Study||51
11090743|NCT01175434|12273912|FG000|NOT COMPLETED|Overall Study||0
11090744|NCT01175434|12273913|FG001|NOT COMPLETED|Overall Study||0
11090745|NCT01175473|12273921|FG000|STARTED|Overall Study|Randomized and treated.|77
11090746|NCT01175473|12273922|FG001|STARTED|Overall Study||71
11208141|NCT01879553|12399308|FG000|NOT COMPLETED|Overall Study||1
11090747|NCT01175473|12273921|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
11090748|NCT01175473|12273922|FG001|Safety Population|Overall Study||71
11090749|NCT01175473|12273921|FG000|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
11090750|NCT01175473|12273922|FG001|Pharmacodynamic (PD) Population|Overall Study||68
11090751|NCT01175473|12273921|FG000|COMPLETED|Overall Study||75
11090752|NCT01175473|12273922|FG001|COMPLETED|Overall Study||69
11090753|NCT01175473|12273921|FG000|NOT COMPLETED|Overall Study||2
11090754|NCT01175473|12273922|FG001|NOT COMPLETED|Overall Study||2
11090755|NCT01175590|12273930|FG000|STARTED|Overall Study||347
11090756|NCT01175590|12273931|FG001|STARTED|Overall Study||171
11090757|NCT01175590|12273930|FG000|Modified Intent to Treat Population|Overall Study||212
11090758|NCT01175590|12273931|FG001|Modified Intent to Treat Population|Overall Study||87
11090759|NCT01175590|12273930|FG000|Safety Population|Overall Study||344
11090760|NCT01175590|12273931|FG001|Safety Population|Overall Study||170
11090761|NCT01175590|12273930|FG000|COMPLETED|Overall Study||335
11090762|NCT01175590|12273931|FG001|COMPLETED|Overall Study||161
11090763|NCT01175590|12273930|FG000|NOT COMPLETED|Overall Study||12
11090764|NCT01175590|12273931|FG001|NOT COMPLETED|Overall Study||10
11090765|NCT01175668|12273940|FG000|STARTED|Overall Study||34
11090766|NCT01175668|12273941|FG001|STARTED|Overall Study||34
11090767|NCT01175668|12273940|FG000|COMPLETED|Overall Study||32
11351569|NCT03037307|12548589|FG002|COMPLETED|Wash Out Period 1||8
11351570|NCT03037307|12548590|FG003|COMPLETED|Wash Out Period 1||6
11090768|NCT01175668|12273941|FG001|COMPLETED|Overall Study||34
11090769|NCT01175668|12273940|FG000|NOT COMPLETED|Overall Study||2
11090770|NCT01175668|12273941|FG001|NOT COMPLETED|Overall Study||0
11090771|NCT01175707|12273949|FG000|STARTED|Overall Study||40
11090772|NCT01175707|12273950|FG001|STARTED|Overall Study||40
11090773|NCT01175707|12273949|FG000|COMPLETED|Overall Study||36
11090774|NCT01175707|12273950|FG001|COMPLETED|Overall Study||34
11090775|NCT01175707|12273949|FG000|NOT COMPLETED|Overall Study||4
11090776|NCT01175707|12273950|FG001|NOT COMPLETED|Overall Study||6
11090777|NCT01175798|12273959|FG000|STARTED|Overall Study||34
11090778|NCT01175798|12273960|FG001|STARTED|Overall Study||62
11090779|NCT01175798|12273959|FG000|COMPLETED|Overall Study||27
11090780|NCT01175798|12273960|FG001|COMPLETED|Overall Study||41
11090781|NCT01175798|12273959|FG000|NOT COMPLETED|Overall Study||7
11090782|NCT01175798|12273960|FG001|NOT COMPLETED|Overall Study||21
11090783|NCT01175811|12273968|FG000|STARTED|Overall Study||199
11090784|NCT01175811|12273969|FG001|STARTED|Overall Study||203
11090785|NCT01175811|12273968|FG000|Received at Least 1 Dose of Study Drug|Overall Study||197
11090786|NCT01175811|12273969|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202
11090787|NCT01175811|12273968|FG000|COMPLETED|Overall Study||183
11090788|NCT01175811|12273969|FG001|COMPLETED|Overall Study||189
11090789|NCT01175811|12273968|FG000|NOT COMPLETED|Overall Study||16
11090790|NCT01175811|12273969|FG001|NOT COMPLETED|Overall Study||14
11090791|NCT01175824|12273977|FG000|STARTED|Overall Study||236
11090792|NCT01175824|12273978|FG001|STARTED|Overall Study||242
11090793|NCT01175824|12273977|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236
11090794|NCT01175824|12273978|FG001|Received at Least 1 Dose of Study Drug|Overall Study||240
11090795|NCT01175824|12273977|FG000|COMPLETED|Overall Study||220
11090796|NCT01175824|12273978|FG001|COMPLETED|Overall Study||220
11090797|NCT01175824|12273977|FG000|NOT COMPLETED|Overall Study||16
11090798|NCT01175824|12273978|FG001|NOT COMPLETED|Overall Study||22
11208142|NCT01879553|12399309|FG001|NOT COMPLETED|Overall Study||0
11208143|NCT01879579|12399318|FG000|STARTED|Overall Study||33
11208144|NCT01879579|12399319|FG001|STARTED|Overall Study||28
11208145|NCT01879579|12399318|FG000|COMPLETED|Overall Study||28
11208146|NCT01879579|12399319|FG001|COMPLETED|Overall Study||26
11208147|NCT01879579|12399318|FG000|NOT COMPLETED|Overall Study||5
11208148|NCT01879579|12399319|FG001|NOT COMPLETED|Overall Study||2
11208149|NCT01879618|12399328|FG000|STARTED|Overall Study||152
11208150|NCT01879618|12399328|FG000|COMPLETED|Overall Study||131
11208151|NCT01879618|12399328|FG000|NOT COMPLETED|Overall Study||21
11351571|NCT03037307|12548591|FG004|COMPLETED|Wash Out Period 1||7
11351572|NCT03037307|12548592|FG005|COMPLETED|Wash Out Period 1||8
11090799|NCT01175850|12273986|FG000|STARTED|IN.PACT SFA I Phase||99
11090800|NCT01175850|12273987|FG001|STARTED|IN.PACT SFA I Phase||51
11090801|NCT01175850|12273986|FG000|COMPLETED|IN.PACT SFA I Phase||88
11090802|NCT01175850|12273987|FG001|COMPLETED|IN.PACT SFA I Phase||49
11090803|NCT01175850|12273986|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11
11090804|NCT01175850|12273987|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2
11090805|NCT01175850|12273986|FG000|STARTED|IN.PACT SFA II Phase||121
11090806|NCT01175850|12273987|FG001|STARTED|IN.PACT SFA II Phase||60
11090807|NCT01175850|12273986|FG000|COMPLETED|IN.PACT SFA II Phase||109
11090808|NCT01175850|12273987|FG001|COMPLETED|IN.PACT SFA II Phase||55
11090809|NCT01175850|12273986|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12
11090810|NCT01175850|12273987|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5
11090811|NCT01175902|12273996|FG000|STARTED|Overall Study||22
11090812|NCT01175902|12273997|FG001|STARTED|Overall Study||22
11090813|NCT01175902|12273996|FG000|COMPLETED|Overall Study||22
11090814|NCT01175902|12273997|FG001|COMPLETED|Overall Study||22
11090815|NCT01175902|12273996|FG000|NOT COMPLETED|Overall Study||0
11090816|NCT01175902|12273997|FG001|NOT COMPLETED|Overall Study||0
11090817|NCT01175980|12274005|FG000|STARTED|Overall Study||30
11351573|NCT03037307|12548587|FG000|NOT COMPLETED|Wash Out Period 1||0
11351574|NCT03037307|12548588|FG001|NOT COMPLETED|Wash Out Period 1||0
11351575|NCT03037307|12548589|FG002|NOT COMPLETED|Wash Out Period 1||0
11351576|NCT03037307|12548590|FG003|NOT COMPLETED|Wash Out Period 1||0
11351577|NCT03037307|12548591|FG004|NOT COMPLETED|Wash Out Period 1||0
11351578|NCT03037307|12548592|FG005|NOT COMPLETED|Wash Out Period 1||0
11351579|NCT03037307|12548587|FG000|STARTED|Period 2||7
11351580|NCT03037307|12548588|FG001|STARTED|Period 2||7
11351581|NCT03037307|12548589|FG002|STARTED|Period 2||8
11351582|NCT03037307|12548590|FG003|STARTED|Period 2||6
11090818|NCT01175980|12274005|FG000|COMPLETED|Overall Study||30
11090819|NCT01175980|12274005|FG000|NOT COMPLETED|Overall Study||0
11090820|NCT01176032|12274011|FG000|STARTED|Overall Study|"Started indicates randomized and safety population"|37
11090821|NCT01176032|12274012|FG001|STARTED|Overall Study||37
11090822|NCT01176032|12274011|FG000|Intention-to-treat (ITT) Population|Overall Study||32
11090823|NCT01176032|12274012|FG001|Intention-to-treat (ITT) Population|Overall Study||37
11090824|NCT01176032|12274011|FG000|COMPLETED|Overall Study||31
11090825|NCT01176032|12274012|FG001|COMPLETED|Overall Study||36
11090826|NCT01176032|12274011|FG000|NOT COMPLETED|Overall Study||6
11090827|NCT01176032|12274012|FG001|NOT COMPLETED|Overall Study||1
11090828|NCT01176058|12274025|FG000|STARTED|Overall Study||9
11090829|NCT01176058|12274026|FG001|STARTED|Overall Study||8
11090830|NCT01176058|12274025|FG000|COMPLETED|Overall Study||5
11090831|NCT01176058|12274026|FG001|COMPLETED|Overall Study||5
11090832|NCT01176058|12274025|FG000|NOT COMPLETED|Overall Study||4
11090833|NCT01176058|12274026|FG001|NOT COMPLETED|Overall Study||3
11090834|NCT01176240|12274036|FG000|STARTED|Study 306A||24
11090835|NCT01176240|12274037|FG001|STARTED|Study 306A||27
11090836|NCT01176240|12274036|FG000|COMPLETED|Study 306A||21
11090837|NCT01176240|12274037|FG001|COMPLETED|Study 306A||24
11090838|NCT01176240|12274036|FG000|NOT COMPLETED|Study 306A||3
11351583|NCT03037307|12548591|FG004|STARTED|Period 2||7
11351584|NCT03037307|12548592|FG005|STARTED|Period 2||8
11351585|NCT03037307|12548587|FG000|COMPLETED|Period 2||7
11351586|NCT03037307|12548588|FG001|COMPLETED|Period 2||7
11090839|NCT01176240|12274037|FG001|NOT COMPLETED|Study 306A||3
11090840|NCT01176240|12274036|FG000|STARTED|Study 306B||89
11090841|NCT01176240|12274037|FG001|STARTED|Study 306B||85
11090842|NCT01176240|12274036|FG000|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
11090843|NCT01176240|12274037|FG001|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
11090844|NCT01176240|12274036|FG000|1 wk of Stable Dosing and Visit 4|Study 306B||69
11090845|NCT01176240|12274037|FG001|1 wk of Stable Dosing and Visit 4|Study 306B||78
11090846|NCT01176240|12274036|FG000|2 wk of Stable Dosing and Visit 5|Study 306B||68
11090847|NCT01176240|12274037|FG001|2 wk of Stable Dosing and Visit 5|Study 306B||75
11090848|NCT01176240|12274036|FG000|4 wk of Stable Dosing and Visit 6|Study 306B||67
11090849|NCT01176240|12274037|FG001|4 wk of Stable Dosing and Visit 6|Study 306B||73
11090850|NCT01176240|12274036|FG000|COMPLETED|Study 306B||63
11090851|NCT01176240|12274037|FG001|COMPLETED|Study 306B||68
11090852|NCT01176240|12274036|FG000|NOT COMPLETED|Study 306B||26
11090853|NCT01176240|12274037|FG001|NOT COMPLETED|Study 306B||17
11090854|NCT01176266|12274043|FG000|STARTED|Overall Study||69
11090855|NCT01176266|12274043|FG000|COMPLETED|Overall Study||60
11090856|NCT01176266|12274043|FG000|NOT COMPLETED|Overall Study||9
11090857|NCT01176292|12274053|FG000|STARTED|Overall Study||71
11090858|NCT01176292|12274054|FG001|STARTED|Overall Study||71
11090859|NCT01176292|12274053|FG000|COMPLETED|Overall Study||66
11351587|NCT03037307|12548589|FG002|COMPLETED|Period 2||8
11351588|NCT03037307|12548590|FG003|COMPLETED|Period 2||6
11351589|NCT03037307|12548591|FG004|COMPLETED|Period 2||7
11351590|NCT03037307|12548592|FG005|COMPLETED|Period 2||8
11351591|NCT03037307|12548587|FG000|NOT COMPLETED|Period 2||0
11351592|NCT03037307|12548588|FG001|NOT COMPLETED|Period 2||0
11351593|NCT03037307|12548589|FG002|NOT COMPLETED|Period 2||0
11090860|NCT01176292|12274054|FG001|COMPLETED|Overall Study||62
11351594|NCT03037307|12548590|FG003|NOT COMPLETED|Period 2||0
11351595|NCT03037307|12548591|FG004|NOT COMPLETED|Period 2||0
11351596|NCT03037307|12548592|FG005|NOT COMPLETED|Period 2||0
11351597|NCT03037307|12548587|FG000|STARTED|Wash Out Period 2||7
11351598|NCT03037307|12548588|FG001|STARTED|Wash Out Period 2||7
11351599|NCT03037307|12548589|FG002|STARTED|Wash Out Period 2||8
11351600|NCT03037307|12548590|FG003|STARTED|Wash Out Period 2||6
11351601|NCT03037307|12548591|FG004|STARTED|Wash Out Period 2||7
11351602|NCT03037307|12548592|FG005|STARTED|Wash Out Period 2||8
11351603|NCT03037307|12548587|FG000|COMPLETED|Wash Out Period 2||7
11351604|NCT03037307|12548588|FG001|COMPLETED|Wash Out Period 2||7
11351605|NCT03037307|12548589|FG002|COMPLETED|Wash Out Period 2||8
11351606|NCT03037307|12548590|FG003|COMPLETED|Wash Out Period 2||6
11351607|NCT03037307|12548591|FG004|COMPLETED|Wash Out Period 2||7
11351608|NCT03037307|12548592|FG005|COMPLETED|Wash Out Period 2||8
11351609|NCT03037307|12548587|FG000|NOT COMPLETED|Wash Out Period 2||0
11351610|NCT03037307|12548588|FG001|NOT COMPLETED|Wash Out Period 2||0
11351611|NCT03037307|12548589|FG002|NOT COMPLETED|Wash Out Period 2||0
11351612|NCT03037307|12548590|FG003|NOT COMPLETED|Wash Out Period 2||0
11351613|NCT03037307|12548591|FG004|NOT COMPLETED|Wash Out Period 2||0
11351614|NCT03037307|12548592|FG005|NOT COMPLETED|Wash Out Period 2||0
11351615|NCT03037307|12548587|FG000|STARTED|Period 3||7
11351616|NCT03037307|12548588|FG001|STARTED|Period 3||7
11351617|NCT03037307|12548589|FG002|STARTED|Period 3||8
11351618|NCT03037307|12548590|FG003|STARTED|Period 3||6
11351619|NCT03037307|12548591|FG004|STARTED|Period 3||7
11090861|NCT01176292|12274053|FG000|NOT COMPLETED|Overall Study||5
11090862|NCT01176292|12274054|FG001|NOT COMPLETED|Overall Study||9
11090863|NCT01176435|12274063|FG000|STARTED|Overall Study||15
11090864|NCT01176435|12274064|FG001|STARTED|Overall Study||15
11351620|NCT03037307|12548592|FG005|STARTED|Period 3||8
11351621|NCT03037307|12548587|FG000|COMPLETED|Period 3||7
11351622|NCT03037307|12548588|FG001|COMPLETED|Period 3||7
11351623|NCT03037307|12548589|FG002|COMPLETED|Period 3||8
11351624|NCT03037307|12548590|FG003|COMPLETED|Period 3||6
11351625|NCT03037307|12548591|FG004|COMPLETED|Period 3||7
11351626|NCT03037307|12548592|FG005|COMPLETED|Period 3||8
11090865|NCT01176435|12274065|FG002|STARTED|Overall Study||15
11090866|NCT01176435|12274063|FG000|COMPLETED|Overall Study||15
11090867|NCT01176435|12274064|FG001|COMPLETED|Overall Study||15
11090868|NCT01176435|12274065|FG002|COMPLETED|Overall Study||15
11090869|NCT01176435|12274063|FG000|NOT COMPLETED|Overall Study||0
11090870|NCT01176435|12274064|FG001|NOT COMPLETED|Overall Study||0
11090871|NCT01176435|12274065|FG002|NOT COMPLETED|Overall Study||0
11090872|NCT01176448|12274073|FG000|STARTED|Overall Study||6
11090873|NCT01176448|12274073|FG000|COMPLETED|Overall Study||6
11090874|NCT01176448|12274073|FG000|NOT COMPLETED|Overall Study||0
11090875|NCT01176565|12274083|FG000|STARTED|Overall Study||500
11090876|NCT01176565|12274084|FG001|STARTED|Overall Study||500
11090877|NCT01176565|12274083|FG000|COMPLETED|Overall Study||480
11090878|NCT01176565|12274084|FG001|COMPLETED|Overall Study||481
11090879|NCT01176565|12274083|FG000|NOT COMPLETED|Overall Study||20
11090880|NCT01176565|12274084|FG001|NOT COMPLETED|Overall Study||19
11090881|NCT01176591|12274092|FG000|STARTED|Session 1||10
11090882|NCT01176591|12274093|FG001|STARTED|Session 1||3
11090883|NCT01176591|12274092|FG000|COMPLETED|Session 1||10
11090884|NCT01176591|12274093|FG001|COMPLETED|Session 1||3
11090885|NCT01176591|12274092|FG000|NOT COMPLETED|Session 1||0
11090886|NCT01176591|12274093|FG001|NOT COMPLETED|Session 1||0
11090887|NCT01176591|12274092|FG000|STARTED|Session 2||10
11090888|NCT01176591|12274093|FG001|STARTED|Session 2||3
11090889|NCT01176591|12274092|FG000|COMPLETED|Session 2||10
11090890|NCT01176591|12274093|FG001|COMPLETED|Session 2||3
11090891|NCT01176591|12274092|FG000|NOT COMPLETED|Session 2||0
11090892|NCT01176591|12274093|FG001|NOT COMPLETED|Session 2||0
11090893|NCT01176617|12274103|FG000|STARTED|1 - 6 Months (Ron-randomized)||0
11090894|NCT01176617|12274104|FG001|STARTED|1 - 6 Months (Ron-randomized)||0
11090895|NCT01176617|12274105|FG002|STARTED|1 - 6 Months (Ron-randomized)||38
11090896|NCT01176617|12274103|FG000|COMPLETED|1 - 6 Months (Ron-randomized)||0
11090897|NCT01176617|12274104|FG001|COMPLETED|1 - 6 Months (Ron-randomized)||0
11090898|NCT01176617|12274105|FG002|COMPLETED|1 - 6 Months (Ron-randomized)||38
11090899|NCT01176617|12274103|FG000|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
11090900|NCT01176617|12274104|FG001|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
11090901|NCT01176617|12274105|FG002|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
11090902|NCT01176617|12274103|FG000|STARTED|6 - 12 Months (Randomized)||18
11090903|NCT01176617|12274104|FG001|STARTED|6 - 12 Months (Randomized)||20
11090904|NCT01176617|12274105|FG002|STARTED|6 - 12 Months (Randomized)||0
11090905|NCT01176617|12274103|FG000|COMPLETED|6 - 12 Months (Randomized)||13
11090906|NCT01176617|12274104|FG001|COMPLETED|6 - 12 Months (Randomized)||20
11090907|NCT01176617|12274105|FG002|COMPLETED|6 - 12 Months (Randomized)||0
11351627|NCT03037307|12548587|FG000|NOT COMPLETED|Period 3||0
11090908|NCT01176617|12274103|FG000|NOT COMPLETED|6 - 12 Months (Randomized)||5
11090909|NCT01176617|12274104|FG001|NOT COMPLETED|6 - 12 Months (Randomized)||0
11090910|NCT01176617|12274105|FG002|NOT COMPLETED|6 - 12 Months (Randomized)||0
11090911|NCT01176773|12274113|FG000|STARTED|Overall Study||62
11090912|NCT01176773|12274113|FG000|COMPLETED|Overall Study||59
11090913|NCT01176773|12274113|FG000|NOT COMPLETED|Overall Study||3
11090914|NCT01176877|12274118|FG000|STARTED|Overall Study||40
11090915|NCT01176877|12274118|FG000|COMPLETED|Overall Study||31
11090916|NCT01176877|12274118|FG000|NOT COMPLETED|Overall Study||9
11090917|NCT01176916|12274123|FG000|STARTED|Overall Study||564
11090918|NCT01176916|12274123|FG000|Treated|Overall Study||558
11090919|NCT01176916|12274123|FG000|Assigne But Not Treated|Overall Study||6
11090920|NCT01176916|12274123|FG000|COMPLETED|Overall Study||397
11090921|NCT01176916|12274123|FG000|NOT COMPLETED|Overall Study||167
11090922|NCT01176955|12274129|FG000|STARTED|Overall Study||10
11090923|NCT01176955|12274130|FG001|STARTED|Overall Study||10
11090924|NCT01176955|12274129|FG000|COMPLETED|Overall Study||7
11090925|NCT01176955|12274130|FG001|COMPLETED|Overall Study||8
11090926|NCT01176955|12274129|FG000|NOT COMPLETED|Overall Study||3
11090927|NCT01176955|12274130|FG001|NOT COMPLETED|Overall Study||2
11090928|NCT01176968|12274141|FG000|STARTED|Overall Study||506
11090929|NCT01176968|12274142|FG001|STARTED|Overall Study||506
11090930|NCT01176968|12274141|FG000|Treated|Overall Study||505
11090931|NCT01176968|12274142|FG001|Treated|Overall Study||505
11090932|NCT01176968|12274141|FG000|COMPLETED|Overall Study||422
11090933|NCT01176968|12274142|FG001|COMPLETED|Overall Study||424
11090934|NCT01176968|12274141|FG000|NOT COMPLETED|Overall Study||84
11090935|NCT01176968|12274142|FG001|NOT COMPLETED|Overall Study||82
11090936|NCT01176981|12274148|FG000|STARTED|Overall Study||6
11090937|NCT01176981|12274148|FG000|COMPLETED|Overall Study||6
11090938|NCT01176981|12274148|FG000|NOT COMPLETED|Overall Study||0
11090939|NCT01177007|12274152|FG000|STARTED|Overall Study||50
11090940|NCT01177007|12274152|FG000|Completed First Y90 Treatment|Overall Study||50
11090941|NCT01177007|12274152|FG000|Completed First Clinical and Imaging|Overall Study||43
11090942|NCT01177007|12274152|FG000|COMPLETED|Overall Study||12
11090943|NCT01177007|12274152|FG000|NOT COMPLETED|Overall Study||38
11090944|NCT01177059|12274158|FG000|STARTED|Overall Study||68
11090945|NCT01177059|12274158|FG000|COMPLETED|Overall Study||18
11090946|NCT01177059|12274158|FG000|NOT COMPLETED|Overall Study||50
11090947|NCT01177098|12274164|FG000|STARTED|Overall Study||278
11090948|NCT01177098|12274165|FG001|STARTED|Overall Study||283
11090949|NCT01177098|12274164|FG000|COMPLETED|Overall Study||269
11090950|NCT01177098|12274165|FG001|COMPLETED|Overall Study||271
11090951|NCT01177098|12274164|FG000|NOT COMPLETED|Overall Study||9
11090952|NCT01177098|12274165|FG001|NOT COMPLETED|Overall Study||12
11090953|NCT01177137|12274174|FG000|STARTED|Overall Study||51
11090954|NCT01177137|12274175|FG001|STARTED|Overall Study||51
11090955|NCT01177137|12274176|FG002|STARTED|Overall Study||49
11090956|NCT01177137|12274174|FG000|COMPLETED|Overall Study||41
11090957|NCT01177137|12274175|FG001|COMPLETED|Overall Study||41
11090958|NCT01177137|12274176|FG002|COMPLETED|Overall Study||47
11090959|NCT01177137|12274174|FG000|NOT COMPLETED|Overall Study||10
11090960|NCT01177137|12274175|FG001|NOT COMPLETED|Overall Study||10
11090961|NCT01177137|12274176|FG002|NOT COMPLETED|Overall Study||2
11090962|NCT01177189|12274189|FG000|STARTED|Overall Study||42
11090963|NCT01177189|12274190|FG001|STARTED|Overall Study||45
11090964|NCT01177189|12274189|FG000|COMPLETED|Overall Study||42
11090965|NCT01177189|12274190|FG001|COMPLETED|Overall Study||45
11090966|NCT01177189|12274189|FG000|NOT COMPLETED|Overall Study||0
11090967|NCT01177189|12274190|FG001|NOT COMPLETED|Overall Study||0
11090968|NCT01177228|12274200|FG000|STARTED|Overall Study||9
11090969|NCT01177228|12274201|FG001|STARTED|Overall Study||13
11208152|NCT01879683|12399332|FG000|STARTED|Overall Study||10
11208153|NCT01879683|12399332|FG000|COMPLETED|Overall Study||9
11208154|NCT01879683|12399332|FG000|NOT COMPLETED|Overall Study||1
11208155|NCT01879722|12399346|FG000|STARTED|Overall Study||7
11208156|NCT01879722|12399347|FG001|STARTED|Overall Study||8
11208157|NCT01879722|12399348|FG002|STARTED|Overall Study||7
11208158|NCT01879722|12399349|FG003|STARTED|Overall Study||8
11208159|NCT01879722|12399350|FG004|STARTED|Overall Study||8
11208160|NCT01879722|12399351|FG005|STARTED|Overall Study||9
11208161|NCT01879722|12399352|FG006|STARTED|Overall Study||8
11208162|NCT01879722|12399353|FG007|STARTED|Overall Study||8
11208163|NCT01879722|12399354|FG008|STARTED|Overall Study||8
11208164|NCT01879722|12399355|FG009|STARTED|Overall Study||6
11208165|NCT01879722|12399346|FG000|COMPLETED|Overall Study||7
11208166|NCT01879722|12399347|FG001|COMPLETED|Overall Study||7
11208167|NCT01879722|12399348|FG002|COMPLETED|Overall Study||7
11208168|NCT01879722|12399349|FG003|COMPLETED|Overall Study||7
11208169|NCT01879722|12399350|FG004|COMPLETED|Overall Study||7
11208170|NCT01879722|12399351|FG005|COMPLETED|Overall Study||9
11208171|NCT01879722|12399352|FG006|COMPLETED|Overall Study||8
11351628|NCT03037307|12548588|FG001|NOT COMPLETED|Period 3||0
11351629|NCT03037307|12548589|FG002|NOT COMPLETED|Period 3||0
11351630|NCT03037307|12548590|FG003|NOT COMPLETED|Period 3||0
11351631|NCT03037307|12548591|FG004|NOT COMPLETED|Period 3||0
11351632|NCT03037307|12548592|FG005|NOT COMPLETED|Period 3||0
11351633|NCT03037489|12548603|FG000|STARTED|Overall Study||46
11351634|NCT03037489|12548604|FG001|STARTED|Overall Study||4
11351635|NCT03037489|12548603|FG000|COMPLETED|Overall Study||39
11351636|NCT03037489|12548604|FG001|COMPLETED|Overall Study||4
11351637|NCT03037489|12548603|FG000|NOT COMPLETED|Overall Study||7
11351638|NCT03037489|12548604|FG001|NOT COMPLETED|Overall Study||0
11351639|NCT03037541|12548612|FG000|STARTED|Overall Study||30
11351640|NCT03037541|12548613|FG001|STARTED|Overall Study||30
11351641|NCT03037541|12548612|FG000|COMPLETED|Overall Study||30
11351642|NCT03037541|12548613|FG001|COMPLETED|Overall Study||30
11351643|NCT03037541|12548612|FG000|NOT COMPLETED|Overall Study||0
11351644|NCT03037541|12548613|FG001|NOT COMPLETED|Overall Study||0
11351645|NCT03037580|12548621|FG000|STARTED|Overall Study||41
11351646|NCT03037580|12548622|FG001|STARTED|Overall Study||43
11351647|NCT03037580|12548621|FG000|COMPLETED|Overall Study||25
11351648|NCT03037580|12548622|FG001|COMPLETED|Overall Study||27
11351649|NCT03037580|12548621|FG000|NOT COMPLETED|Overall Study||16
11090970|NCT01177228|12274202|FG002|STARTED|Overall Study||14
11090971|NCT01177228|12274203|FG003|STARTED|Overall Study||11
11090972|NCT01177228|12274200|FG000|Received Treatment|Overall Study||9
11090973|NCT01177228|12274201|FG001|Received Treatment|Overall Study||12
11090974|NCT01177228|12274202|FG002|Received Treatment|Overall Study||14
11351650|NCT03037580|12548622|FG001|NOT COMPLETED|Overall Study||16
11351651|NCT03037619|12548630|FG000|STARTED|Overall Study||8
11351652|NCT03037619|12548631|FG001|STARTED|Overall Study|8 participants and 7 buddies|15
11351653|NCT03037619|12548630|FG000|COMPLETED|Overall Study||8
11351654|NCT03037619|12548631|FG001|COMPLETED|Overall Study|7 participants and 7 buddies|14
11090975|NCT01177228|12274203|FG003|Received Treatment|Overall Study||11
11090976|NCT01177228|12274200|FG000|COMPLETED|Overall Study||8
11090977|NCT01177228|12274201|FG001|COMPLETED|Overall Study||11
11090978|NCT01177228|12274202|FG002|COMPLETED|Overall Study||14
11090979|NCT01177228|12274203|FG003|COMPLETED|Overall Study||11
11090980|NCT01177228|12274200|FG000|NOT COMPLETED|Overall Study||1
11090981|NCT01177228|12274201|FG001|NOT COMPLETED|Overall Study||2
11090982|NCT01177228|12274202|FG002|NOT COMPLETED|Overall Study||0
11090983|NCT01177228|12274203|FG003|NOT COMPLETED|Overall Study||0
11090984|NCT01177293|12274218|FG000|STARTED|First Intervention Period||7
11090985|NCT01177293|12274219|FG001|STARTED|First Intervention Period||7
11090986|NCT01177293|12274218|FG000|COMPLETED|First Intervention Period||7
11090987|NCT01177293|12274219|FG001|COMPLETED|First Intervention Period||7
11090988|NCT01177293|12274218|FG000|NOT COMPLETED|First Intervention Period||0
11090989|NCT01177293|12274219|FG001|NOT COMPLETED|First Intervention Period||0
11090990|NCT01177293|12274218|FG000|STARTED|Washout Period (of 14 Days)||7
11090991|NCT01177293|12274219|FG001|STARTED|Washout Period (of 14 Days)||7
11090992|NCT01177293|12274218|FG000|COMPLETED|Washout Period (of 14 Days)||7
11090993|NCT01177293|12274219|FG001|COMPLETED|Washout Period (of 14 Days)||6
11090994|NCT01177293|12274218|FG000|NOT COMPLETED|Washout Period (of 14 Days)||0
11090995|NCT01177293|12274219|FG001|NOT COMPLETED|Washout Period (of 14 Days)||1
11090996|NCT01177293|12274218|FG000|STARTED|Second Intervention Period||7
11090997|NCT01177293|12274219|FG001|STARTED|Second Intervention Period||6
11090998|NCT01177293|12274218|FG000|COMPLETED|Second Intervention Period||7
11090999|NCT01177293|12274219|FG001|COMPLETED|Second Intervention Period||6
11351655|NCT03037619|12548630|FG000|NOT COMPLETED|Overall Study||0
11351656|NCT03037619|12548631|FG001|NOT COMPLETED|Overall Study||1
11351657|NCT03037905|12548639|FG000|STARTED|Overall Study||50
11351658|NCT03037905|12548640|FG001|STARTED|Overall Study||50
11351659|NCT03037905|12548639|FG000|COMPLETED|Overall Study||50
11351660|NCT03037905|12548640|FG001|COMPLETED|Overall Study||50
11091000|NCT01177293|12274218|FG000|NOT COMPLETED|Second Intervention Period||0
11091001|NCT01177293|12274219|FG001|NOT COMPLETED|Second Intervention Period||0
11091002|NCT01177384|12274227|FG000|STARTED|Overall Study||191
11091003|NCT01177384|12274228|FG001|STARTED|Overall Study|Includes the second randomization of a participant|190
11091004|NCT01177384|12274227|FG000|COMPLETED|Overall Study||177
11091005|NCT01177384|12274228|FG001|COMPLETED|Overall Study||164
11091006|NCT01177384|12274227|FG000|NOT COMPLETED|Overall Study||14
11091007|NCT01177384|12274228|FG001|NOT COMPLETED|Overall Study||26
11091008|NCT01177410|12274237|FG000|STARTED|Overall Study||51
11091009|NCT01177410|12274238|FG001|STARTED|Overall Study||47
11091010|NCT01177410|12274239|FG002|STARTED|Overall Study||50
11091011|NCT01177410|12274237|FG000|COMPLETED|Overall Study||50
11091012|NCT01177410|12274238|FG001|COMPLETED|Overall Study||40
11091013|NCT01177410|12274239|FG002|COMPLETED|Overall Study||45
11091014|NCT01177410|12274237|FG000|NOT COMPLETED|Overall Study||1
11091015|NCT01177410|12274238|FG001|NOT COMPLETED|Overall Study||7
11091016|NCT01177410|12274239|FG002|NOT COMPLETED|Overall Study||5
11091017|NCT01177553|12274249|FG000|STARTED|Overall Study||3
11091018|NCT01177553|12274250|FG001|STARTED|Overall Study||2
11091019|NCT01177553|12274249|FG000|COMPLETED|Overall Study|data as of March 2009|2
11091020|NCT01177553|12274250|FG001|COMPLETED|Overall Study|data as of March 2009|2
11091021|NCT01177553|12274249|FG000|NOT COMPLETED|Overall Study||1
11091022|NCT01177553|12274250|FG001|NOT COMPLETED|Overall Study||0
11091023|NCT01177670|12274256|FG000|STARTED|Overall Study||169
11091024|NCT01177670|12274256|FG000|COMPLETED|Overall Study||0
11091025|NCT01177670|12274256|FG000|NOT COMPLETED|Overall Study||169
11091026|NCT01177709|12274260|FG000|STARTED|Overall Study||12
11091027|NCT01177709|12274260|FG000|COMPLETED|Overall Study||12
11091028|NCT01177709|12274260|FG000|NOT COMPLETED|Overall Study||0
11091029|NCT01177722|12274268|FG000|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
11091030|NCT01177722|12274269|FG001|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
11091031|NCT01177722|12274270|FG002|STARTED|Overall Study||342
11091032|NCT01177722|12274271|FG003|STARTED|Overall Study||345
11091033|NCT01177722|12274268|FG000|COMPLETED|Overall Study||331
11091034|NCT01177722|12274269|FG001|COMPLETED|Overall Study||334
11351661|NCT03037905|12548639|FG000|NOT COMPLETED|Overall Study||0
11091035|NCT01177722|12274270|FG002|COMPLETED|Overall Study||333
11091036|NCT01177722|12274271|FG003|COMPLETED|Overall Study||338
11091037|NCT01177722|12274268|FG000|NOT COMPLETED|Overall Study||13
11091038|NCT01177722|12274269|FG001|NOT COMPLETED|Overall Study||10
11091039|NCT01177722|12274270|FG002|NOT COMPLETED|Overall Study||9
11091040|NCT01177722|12274271|FG003|NOT COMPLETED|Overall Study||7
11091041|NCT01177735|12274282|FG000|STARTED|Overall Study||71
11091042|NCT01177735|12274282|FG000|COMPLETED|Overall Study||0
11091043|NCT01177735|12274282|FG000|NOT COMPLETED|Overall Study||71
11091044|NCT01177787|12274286|FG000|STARTED|Clinical Efficacy of Cryolipolysis||28
11091045|NCT01177787|12274286|FG000|COMPLETED|Clinical Efficacy of Cryolipolysis||28
11091046|NCT01177787|12274286|FG000|NOT COMPLETED|Clinical Efficacy of Cryolipolysis||0
11091047|NCT01177787|12274286|FG000|STARTED|Cryolipolysis on Thigh||28
11091048|NCT01177787|12274286|FG000|COMPLETED|Cryolipolysis on Thigh||14
11091049|NCT01177787|12274286|FG000|NOT COMPLETED|Cryolipolysis on Thigh||14
11091050|NCT01177800|12274300|FG000|STARTED|Overall Study||84
11091051|NCT01177800|12274301|FG001|STARTED|Overall Study||45
11091052|NCT01177800|12274300|FG000|COMPLETED|Overall Study||74
11091053|NCT01177800|12274301|FG001|COMPLETED|Overall Study||40
11091054|NCT01177800|12274300|FG000|NOT COMPLETED|Overall Study||10
11091055|NCT01177800|12274301|FG001|NOT COMPLETED|Overall Study||5
11091056|NCT01177813|12274312|FG000|STARTED|Overall Study||228
11091057|NCT01177813|12274313|FG001|STARTED|Overall Study||224
11091058|NCT01177813|12274314|FG002|STARTED|Overall Study||224
11091059|NCT01177813|12274315|FG003|STARTED|Overall Study||223
11091060|NCT01177813|12274316|FG004|STARTED|Overall Study||87
11091061|NCT01177813|12274312|FG000|COMPLETED|Overall Study||187
11091062|NCT01177813|12274313|FG001|COMPLETED|Overall Study||206
11091063|NCT01177813|12274314|FG002|COMPLETED|Overall Study||204
11091064|NCT01177813|12274315|FG003|COMPLETED|Overall Study||206
11091065|NCT01177813|12274316|FG004|COMPLETED|Overall Study||78
11091066|NCT01177813|12274312|FG000|NOT COMPLETED|Overall Study||41
11091067|NCT01177813|12274313|FG001|NOT COMPLETED|Overall Study||18
11091068|NCT01177813|12274314|FG002|NOT COMPLETED|Overall Study||20
11091069|NCT01177813|12274315|FG003|NOT COMPLETED|Overall Study||17
11091070|NCT01177813|12274316|FG004|NOT COMPLETED|Overall Study||9
11091071|NCT01177943|12274330|FG000|STARTED|First Intervention||21
11091072|NCT01177943|12274331|FG001|STARTED|First Intervention||21
11091073|NCT01177943|12274330|FG000|COMPLETED|First Intervention||19
11091074|NCT01177943|12274331|FG001|COMPLETED|First Intervention||21
11091075|NCT01177943|12274330|FG000|NOT COMPLETED|First Intervention||2
11091076|NCT01177943|12274331|FG001|NOT COMPLETED|First Intervention||0
11091077|NCT01177943|12274330|FG000|STARTED|Second Intervention||19
11091078|NCT01177943|12274331|FG001|STARTED|Second Intervention||21
11091079|NCT01177943|12274330|FG000|COMPLETED|Second Intervention||19
11091080|NCT01177943|12274331|FG001|COMPLETED|Second Intervention||21
11091081|NCT01177943|12274330|FG000|NOT COMPLETED|Second Intervention||0
11091082|NCT01177943|12274331|FG001|NOT COMPLETED|Second Intervention||0
11091083|NCT01177956|12274337|FG000|STARTED|Overall Study||68
11091084|NCT01177956|12274337|FG000|COMPLETED|Overall Study||68
11091085|NCT01177956|12274337|FG000|NOT COMPLETED|Overall Study||0
11091086|NCT01177969|12274344|FG000|STARTED|Overall Study||19
11091087|NCT01177969|12274345|FG001|STARTED|Overall Study||14
11091088|NCT01177969|12274344|FG000|COMPLETED|Overall Study||16
11091089|NCT01177969|12274345|FG001|COMPLETED|Overall Study||11
11091090|NCT01177969|12274344|FG000|NOT COMPLETED|Overall Study||3
11091091|NCT01177969|12274345|FG001|NOT COMPLETED|Overall Study||3
11091092|NCT01178073|12274354|FG000|STARTED|Overall Study||302
11091093|NCT01178073|12274355|FG001|STARTED|Overall Study||152
11091094|NCT01178073|12274356|FG002|STARTED|Overall Study||151
11091095|NCT01178073|12274354|FG000|COMPLETED|Overall Study||240
11091096|NCT01178073|12274355|FG001|COMPLETED|Overall Study||108
11091097|NCT01178073|12274356|FG002|COMPLETED|Overall Study||105
11091098|NCT01178073|12274354|FG000|NOT COMPLETED|Overall Study||62
11091099|NCT01178073|12274355|FG001|NOT COMPLETED|Overall Study||44
11091100|NCT01178073|12274356|FG002|NOT COMPLETED|Overall Study||46
11091101|NCT01178086|12274367|FG000|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
11091102|NCT01178086|12274367|FG000|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
11091103|NCT01178086|12274367|FG000|COMPLETED|Overall Study||349
11091104|NCT01178086|12274367|FG000|NOT COMPLETED|Overall Study||332
11091105|NCT01178099|12274377|FG000|STARTED|Overall Study||13
11091106|NCT01178099|12274378|FG001|STARTED|Overall Study||13
11091107|NCT01178099|12274377|FG000|COMPLETED|Overall Study||13
11091108|NCT01178099|12274378|FG001|COMPLETED|Overall Study||12
11091109|NCT01178099|12274377|FG000|NOT COMPLETED|Overall Study||0
11091110|NCT01178099|12274378|FG001|NOT COMPLETED|Overall Study||1
11091111|NCT01178125|12274388|FG000|STARTED|Overall Study|Number enrolled.|2858
11091112|NCT01178125|12274388|FG000|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
11091113|NCT01178125|12274388|FG000|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
11091114|NCT01178125|12274388|FG000|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
11091115|NCT01178125|12274388|FG000|COMPLETED|Overall Study||1680
11351662|NCT03037905|12548640|FG001|NOT COMPLETED|Overall Study||0
11351663|NCT03037983|12548650|FG000|STARTED|Overall Study||5
11091116|NCT01178125|12274388|FG000|NOT COMPLETED|Overall Study||1178
11091117|NCT01178138|12274397|FG000|STARTED|Overall Study||24
11091118|NCT01178138|12274397|FG000|Completed 6 Sessions|Overall Study||1
11091119|NCT01178138|12274397|FG000|Completed 5 Sessions|Overall Study||1
11091120|NCT01178138|12274397|FG000|Completed 3 Sessions|Overall Study||1
11091121|NCT01178138|12274397|FG000|COMPLETED|Overall Study||1
11091122|NCT01178138|12274397|FG000|NOT COMPLETED|Overall Study||23
11091123|NCT01178216|12274406|FG000|STARTED|Overall Study||41
11091124|NCT01178216|12274406|FG000|COMPLETED|Overall Study||39
11091125|NCT01178216|12274406|FG000|NOT COMPLETED|Overall Study||2
11091126|NCT01178268|12274412|FG000|STARTED|Overall Study||367
11091127|NCT01178268|12274413|FG001|STARTED|Overall Study||121
11091128|NCT01178268|12274412|FG000|COMPLETED|Overall Study||360
11091129|NCT01178268|12274413|FG001|COMPLETED|Overall Study||120
11091130|NCT01178268|12274412|FG000|NOT COMPLETED|Overall Study||7
11091131|NCT01178268|12274413|FG001|NOT COMPLETED|Overall Study||1
11091132|NCT01178281|12274422|FG000|STARTED|Overall Study||168
11091133|NCT01178281|12274423|FG001|STARTED|Overall Study||84
11091134|NCT01178281|12274424|FG002|STARTED|Overall Study||15
11091135|NCT01178281|12274422|FG000|Received Study Drug|Overall Study||167
11091136|NCT01178281|12274423|FG001|Received Study Drug|Overall Study||83
11091137|NCT01178281|12274424|FG002|Received Study Drug|Overall Study||15
11091138|NCT01178281|12274422|FG000|COMPLETED|Overall Study||168
11091139|NCT01178281|12274423|FG001|COMPLETED|Overall Study||84
11091140|NCT01178281|12274424|FG002|COMPLETED|Overall Study||15
11091141|NCT01178281|12274422|FG000|NOT COMPLETED|Overall Study||0
11091142|NCT01178281|12274423|FG001|NOT COMPLETED|Overall Study||0
11091143|NCT01178281|12274424|FG002|NOT COMPLETED|Overall Study||0
11091144|NCT01178294|12274434|FG000|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
11091145|NCT01178294|12274434|FG000|COMPLETED|Overall Study||18
11091146|NCT01178294|12274434|FG000|NOT COMPLETED|Overall Study||11
11091147|NCT01178333|12274441|FG000|STARTED|Overall Study||71
11091148|NCT01178333|12274442|FG001|STARTED|Overall Study||284
11091149|NCT01178333|12274443|FG002|STARTED|Overall Study||87
11091150|NCT01178333|12274441|FG000|COMPLETED|Overall Study||71
11091151|NCT01178333|12274442|FG001|COMPLETED|Overall Study||284
11091152|NCT01178333|12274443|FG002|COMPLETED|Overall Study||87
11091153|NCT01178333|12274441|FG000|NOT COMPLETED|Overall Study||0
11091154|NCT01178333|12274442|FG001|NOT COMPLETED|Overall Study||0
11091155|NCT01178333|12274443|FG002|NOT COMPLETED|Overall Study||0
11091156|NCT01178385|12274455|FG000|STARTED|Overall Study||24
11091157|NCT01178385|12274456|FG001|STARTED|Overall Study||21
11091158|NCT01178385|12274455|FG000|COMPLETED|Overall Study||22
11091159|NCT01178385|12274456|FG001|COMPLETED|Overall Study||21
11091160|NCT01178385|12274455|FG000|NOT COMPLETED|Overall Study||2
11091161|NCT01178385|12274456|FG001|NOT COMPLETED|Overall Study||0
11091162|NCT01178411|12274462|FG000|STARTED|Overall Study||60
11091163|NCT01178411|12274462|FG000|COMPLETED|Overall Study||0
11091164|NCT01178411|12274462|FG000|NOT COMPLETED|Overall Study||60
11091165|NCT01178528|12274469|FG000|STARTED|Overall Study||41
11091166|NCT01178528|12274470|FG001|STARTED|Overall Study||38
11091167|NCT01178528|12274471|FG002|STARTED|Overall Study||42
11091168|NCT01178528|12274469|FG000|COMPLETED|Overall Study||41
11091169|NCT01178528|12274470|FG001|COMPLETED|Overall Study||38
11091170|NCT01178528|12274471|FG002|COMPLETED|Overall Study||42
11091171|NCT01178528|12274469|FG000|NOT COMPLETED|Overall Study||0
11091172|NCT01178528|12274470|FG001|NOT COMPLETED|Overall Study||0
11091173|NCT01178528|12274471|FG002|NOT COMPLETED|Overall Study||0
11091174|NCT01178671|12274482|FG000|STARTED|Overall Study||18
11091175|NCT01178671|12274483|FG001|STARTED|Overall Study||18
11091176|NCT01178671|12274482|FG000|COMPLETED|Overall Study||6
11091177|NCT01178671|12274483|FG001|COMPLETED|Overall Study||3
11091178|NCT01178671|12274482|FG000|NOT COMPLETED|Overall Study||12
11091179|NCT01178671|12274483|FG001|NOT COMPLETED|Overall Study||15
11091180|NCT01178762|12274489|FG000|STARTED|Overall Study||42
11351664|NCT03037983|12548651|FG001|STARTED|Overall Study||4
11351665|NCT03037983|12548650|FG000|COMPLETED|Overall Study||5
11351666|NCT03037983|12548651|FG001|COMPLETED|Overall Study||4
11091181|NCT01178762|12274489|FG000|COMPLETED|Overall Study||27
11091182|NCT01178762|12274489|FG000|NOT COMPLETED|Overall Study||15
11091183|NCT01178827|12274496|FG000|STARTED|Overall Study||6
11091184|NCT01178827|12274497|FG001|STARTED|Overall Study||10
11091185|NCT01178827|12274498|FG002|STARTED|Overall Study||4
11091186|NCT01178827|12274496|FG000|COMPLETED|Overall Study||6
11091187|NCT01178827|12274497|FG001|COMPLETED|Overall Study||10
11091188|NCT01178827|12274498|FG002|COMPLETED|Overall Study||4
11091189|NCT01178827|12274496|FG000|NOT COMPLETED|Overall Study||0
11351667|NCT03037983|12548650|FG000|NOT COMPLETED|Overall Study||0
11351668|NCT03037983|12548651|FG001|NOT COMPLETED|Overall Study||0
11351669|NCT03038113|12548671|FG000|STARTED|Overall Study||8
11091190|NCT01178827|12274497|FG001|NOT COMPLETED|Overall Study||0
11091191|NCT01178827|12274498|FG002|NOT COMPLETED|Overall Study||0
11351670|NCT03038113|12548672|FG001|STARTED|Overall Study||8
11351671|NCT03038113|12548673|FG002|STARTED|Overall Study||8
11351672|NCT03038113|12548674|FG003|STARTED|Overall Study||8
11351673|NCT03038113|12548675|FG004|STARTED|Overall Study||8
11351674|NCT03038113|12548676|FG005|STARTED|Overall Study||8
11351675|NCT03038113|12548677|FG006|STARTED|Overall Study||12
11351676|NCT03038113|12548678|FG007|STARTED|Overall Study||6
11351677|NCT03038113|12548679|FG008|STARTED|Overall Study||7
11351678|NCT03038113|12548680|FG009|STARTED|Overall Study||6
11351679|NCT03038113|12548681|FG010|STARTED|Overall Study||14
11351680|NCT03038113|12548682|FG011|STARTED|Overall Study||7
11351681|NCT03038113|12548683|FG012|STARTED|Overall Study||4
11351682|NCT03038113|12548684|FG013|STARTED|Overall Study||15
11351683|NCT03038113|12548671|FG000|COMPLETED|Overall Study||8
11351684|NCT03038113|12548672|FG001|COMPLETED|Overall Study||8
11351685|NCT03038113|12548673|FG002|COMPLETED|Overall Study||7
11351686|NCT03038113|12548674|FG003|COMPLETED|Overall Study||8
11351687|NCT03038113|12548675|FG004|COMPLETED|Overall Study||8
11351688|NCT03038113|12548676|FG005|COMPLETED|Overall Study||8
11351689|NCT03038113|12548677|FG006|COMPLETED|Overall Study||11
11351690|NCT03038113|12548678|FG007|COMPLETED|Overall Study||6
11351691|NCT03038113|12548679|FG008|COMPLETED|Overall Study||7
11351692|NCT03038113|12548680|FG009|COMPLETED|Overall Study||6
11351693|NCT03038113|12548681|FG010|COMPLETED|Overall Study||14
11351694|NCT03038113|12548682|FG011|COMPLETED|Overall Study||7
11351695|NCT03038113|12548683|FG012|COMPLETED|Overall Study||4
11351696|NCT03038113|12548684|FG013|COMPLETED|Overall Study||14
11091192|NCT01178853|12274508|FG000|STARTED|Period 1 (Warfarin Titration)||24
11091193|NCT01178853|12274509|FG001|STARTED|Period 1 (Warfarin Titration)||24
11091194|NCT01178853|12274508|FG000|COMPLETED|Period 1 (Warfarin Titration)||23
11091195|NCT01178853|12274509|FG001|COMPLETED|Period 1 (Warfarin Titration)||22
11091196|NCT01178853|12274508|FG000|NOT COMPLETED|Period 1 (Warfarin Titration)||1
11091197|NCT01178853|12274509|FG001|NOT COMPLETED|Period 1 (Warfarin Titration)||2
11091198|NCT01178853|12274508|FG000|STARTED|Period 2 (Warfarin + Study Drug)||23
11091199|NCT01178853|12274509|FG001|STARTED|Period 2 (Warfarin + Study Drug)||22
11091200|NCT01178853|12274508|FG000|COMPLETED|Period 2 (Warfarin + Study Drug)||22
11091201|NCT01178853|12274509|FG001|COMPLETED|Period 2 (Warfarin + Study Drug)||22
11091202|NCT01178853|12274508|FG000|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
11091203|NCT01178853|12274509|FG001|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
11091204|NCT01178853|12274508|FG000|STARTED|Period 3 (Warfarin Titration)||22
11091205|NCT01178853|12274509|FG001|STARTED|Period 3 (Warfarin Titration)||22
11091206|NCT01178853|12274508|FG000|COMPLETED|Period 3 (Warfarin Titration)||21
11091207|NCT01178853|12274509|FG001|COMPLETED|Period 3 (Warfarin Titration)||22
11091208|NCT01178853|12274508|FG000|NOT COMPLETED|Period 3 (Warfarin Titration)||1
11091209|NCT01178853|12274509|FG001|NOT COMPLETED|Period 3 (Warfarin Titration)||0
11091210|NCT01178853|12274508|FG000|STARTED|Period 4 (Warfarin + Study Drug)||21
11091211|NCT01178853|12274509|FG001|STARTED|Period 4 (Warfarin + Study Drug)||22
11091212|NCT01178853|12274508|FG000|COMPLETED|Period 4 (Warfarin + Study Drug)||21
11091213|NCT01178853|12274509|FG001|COMPLETED|Period 4 (Warfarin + Study Drug)||19
11091214|NCT01178853|12274508|FG000|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
11091215|NCT01178853|12274509|FG001|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
11091216|NCT01178944|12274515|FG000|STARTED|Overall Study||35
11091217|NCT01178944|12274515|FG000|COMPLETED|Overall Study||35
11091218|NCT01178944|12274515|FG000|NOT COMPLETED|Overall Study||0
11091219|NCT01179048|12274521|FG000|STARTED|Overall Study||4668
11091220|NCT01179048|12274522|FG001|STARTED|Overall Study||4672
11091221|NCT01179048|12274521|FG000|COMPLETED|Overall Study||4529
11091222|NCT01179048|12274522|FG001|COMPLETED|Overall Study||4513
11091223|NCT01179048|12274521|FG000|NOT COMPLETED|Overall Study||139
11091224|NCT01179048|12274522|FG001|NOT COMPLETED|Overall Study||159
11091225|NCT01179113|12274530|FG000|STARTED|Overall Study||17
11091226|NCT01179113|12274531|FG001|STARTED|Overall Study||16
11091227|NCT01179113|12274530|FG000|COMPLETED|Overall Study||17
11091228|NCT01179113|12274531|FG001|COMPLETED|Overall Study||16
11091229|NCT01179113|12274530|FG000|NOT COMPLETED|Overall Study||0
11091230|NCT01179113|12274531|FG001|NOT COMPLETED|Overall Study||0
11091231|NCT01179191|12274537|FG000|STARTED|Titration Phase (up to 6 Weeks)||684
11091232|NCT01179191|12274537|FG000|COMPLETED|Titration Phase (up to 6 Weeks)||351
11091233|NCT01179191|12274537|FG000|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
11091234|NCT01179191|12274537|FG000|STARTED|Maintenance Phase (8 Weeks)||351
11351697|NCT03038113|12548671|FG000|NOT COMPLETED|Overall Study||0
11351698|NCT03038113|12548672|FG001|NOT COMPLETED|Overall Study||0
11351699|NCT03038113|12548673|FG002|NOT COMPLETED|Overall Study||1
11351700|NCT03038113|12548674|FG003|NOT COMPLETED|Overall Study||0
11351701|NCT03038113|12548675|FG004|NOT COMPLETED|Overall Study||0
11351702|NCT03038113|12548676|FG005|NOT COMPLETED|Overall Study||0
11351703|NCT03038113|12548677|FG006|NOT COMPLETED|Overall Study||1
11091235|NCT01179191|12274537|FG000|COMPLETED|Maintenance Phase (8 Weeks)||234
11091236|NCT01179191|12274537|FG000|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
11091237|NCT01179217|12274543|FG000|STARTED|Overall Study||152
11091238|NCT01179217|12274544|FG001|STARTED|Overall Study||78
11091239|NCT01179217|12274543|FG000|COMPLETED|Overall Study||97
11091240|NCT01179217|12274544|FG001|COMPLETED|Overall Study||59
11091241|NCT01179217|12274543|FG000|NOT COMPLETED|Overall Study||55
11091242|NCT01179217|12274544|FG001|NOT COMPLETED|Overall Study||19
11091243|NCT01179334|12274554|FG000|STARTED|Treatment Period||12
11091244|NCT01179334|12274555|FG001|STARTED|Treatment Period||6
11091245|NCT01179334|12274554|FG000|Participants Received Treatment|Treatment Period||12
11091246|NCT01179334|12274555|FG001|Participants Received Treatment|Treatment Period||6
11091247|NCT01179334|12274554|FG000|COMPLETED|Treatment Period||11
11091248|NCT01179334|12274555|FG001|COMPLETED|Treatment Period||6
11091249|NCT01179334|12274554|FG000|NOT COMPLETED|Treatment Period||1
11091250|NCT01179334|12274555|FG001|NOT COMPLETED|Treatment Period||0
11091251|NCT01179334|12274554|FG000|STARTED|Long-term Extension (LTE) Period||11
11091252|NCT01179334|12274555|FG001|STARTED|Long-term Extension (LTE) Period||6
11091253|NCT01179334|12274554|FG000|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
11091254|NCT01179334|12274555|FG001|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
11091255|NCT01179334|12274554|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||11
11091256|NCT01179334|12274555|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||6
11091257|NCT01179347|12274563|FG000|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
11091258|NCT01179347|12274564|FG001|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
11091259|NCT01179347|12274563|FG000|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
11091260|NCT01179347|12274564|FG001|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
11091261|NCT01179347|12274563|FG000|NOT COMPLETED|Double-blind Period (12 Weeks)||8
11091262|NCT01179347|12274564|FG001|NOT COMPLETED|Double-blind Period (12 Weeks)||14
11091263|NCT01179347|12274563|FG000|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
11091264|NCT01179347|12274564|FG001|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
11091265|NCT01179347|12274563|FG000|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
11091266|NCT01179347|12274564|FG001|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
11091267|NCT01179347|12274563|FG000|NOT COMPLETED|Open-label Period (12 Weeks)||15
11091268|NCT01179347|12274564|FG001|NOT COMPLETED|Open-label Period (12 Weeks)||16
11091269|NCT01179477|12274572|FG000|STARTED|Overall Study||1930
11091270|NCT01179477|12274572|FG000|COMPLETED|Overall Study||843
11091271|NCT01179477|12274572|FG000|NOT COMPLETED|Overall Study||1087
11091272|NCT01179490|12274576|FG000|STARTED|Overall Study||5
11091273|NCT01179490|12274576|FG000|COMPLETED|Overall Study||5
11091274|NCT01179490|12274576|FG000|NOT COMPLETED|Overall Study||0
11091275|NCT01179516|12274583|FG000|STARTED|Overall Study||160
11091276|NCT01179516|12274584|FG001|STARTED|Overall Study||157
11091277|NCT01179516|12274585|FG002|STARTED|Overall Study||152
11091278|NCT01179516|12274583|FG000|Treated|Overall Study||160
11091279|NCT01179516|12274584|FG001|Treated|Overall Study||154
11091280|NCT01179516|12274585|FG002|Treated|Overall Study||151
11091281|NCT01179516|12274583|FG000|COMPLETED|Overall Study||133
11091282|NCT01179516|12274584|FG001|COMPLETED|Overall Study||131
11091283|NCT01179516|12274585|FG002|COMPLETED|Overall Study||121
11091284|NCT01179516|12274583|FG000|NOT COMPLETED|Overall Study||27
11091285|NCT01179516|12274584|FG001|NOT COMPLETED|Overall Study||26
11091286|NCT01179516|12274585|FG002|NOT COMPLETED|Overall Study||31
11091287|NCT01179568|12274597|FG000|STARTED|Overall Study||101
11091288|NCT01179568|12274598|FG001|STARTED|Overall Study||99
11091289|NCT01179568|12274599|FG002|STARTED|Overall Study||99
11091290|NCT01179568|12274600|FG003|STARTED|Overall Study||96
11091291|NCT01179568|12274597|FG000|Completed Week 12 Assessment|Overall Study||69
11091292|NCT01179568|12274598|FG001|Completed Week 12 Assessment|Overall Study||69
11091293|NCT01179568|12274599|FG002|Completed Week 12 Assessment|Overall Study||76
11091294|NCT01179568|12274600|FG003|Completed Week 12 Assessment|Overall Study||75
11091295|NCT01179568|12274597|FG000|COMPLETED|Overall Study||73
11091296|NCT01179568|12274598|FG001|COMPLETED|Overall Study||61
11091297|NCT01179568|12274599|FG002|COMPLETED|Overall Study||76
11091298|NCT01179568|12274600|FG003|COMPLETED|Overall Study||76
11091299|NCT01179568|12274597|FG000|NOT COMPLETED|Overall Study||28
11091300|NCT01179568|12274598|FG001|NOT COMPLETED|Overall Study||38
11091301|NCT01179568|12274599|FG002|NOT COMPLETED|Overall Study||23
11091302|NCT01179568|12274600|FG003|NOT COMPLETED|Overall Study||20
11091303|NCT01179672|12274615|FG000|STARTED|Overall Study||203
11091304|NCT01179672|12274616|FG001|STARTED|Overall Study||202
11091305|NCT01179672|12274615|FG000|Received at Least 1 Dose of Study Drug|Overall Study||202
11091306|NCT01179672|12274616|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202
11091307|NCT01179672|12274615|FG000|Entered Taper|Overall Study||181
11091308|NCT01179672|12274616|FG001|Entered Taper|Overall Study||177
11091309|NCT01179672|12274615|FG000|COMPLETED|Overall Study||173
11091310|NCT01179672|12274616|FG001|COMPLETED|Overall Study||176
11091311|NCT01179672|12274615|FG000|NOT COMPLETED|Overall Study||30
11091312|NCT01179672|12274616|FG001|NOT COMPLETED|Overall Study||26
11091313|NCT01179919|12274626|FG000|STARTED|Overall Study||21
11091314|NCT01179919|12274626|FG000|COMPLETED|Overall Study||19
11091315|NCT01179919|12274626|FG000|NOT COMPLETED|Overall Study||2
11091316|NCT01179984|12274630|FG000|STARTED|Overall Study||76
11091317|NCT01179984|12274630|FG000|COMPLETED|Overall Study||58
11091318|NCT01179984|12274630|FG000|NOT COMPLETED|Overall Study||18
11091319|NCT01180036|12274637|FG000|STARTED|Overall Study||65
11091320|NCT01180036|12274638|FG001|STARTED|Overall Study||65
11091321|NCT01180036|12274637|FG000|COMPLETED|Overall Study||65
11091322|NCT01180036|12274638|FG001|COMPLETED|Overall Study||65
11091323|NCT01180036|12274637|FG000|NOT COMPLETED|Overall Study||0
11091324|NCT01180036|12274638|FG001|NOT COMPLETED|Overall Study||0
11091325|NCT01180049|12274648|FG000|STARTED|Overall Study||53
11091326|NCT01180049|12274649|FG001|STARTED|Overall Study||48
11091327|NCT01180049|12274648|FG000|COMPLETED|Overall Study||0
11091328|NCT01180049|12274649|FG001|COMPLETED|Overall Study||0
11091329|NCT01180049|12274648|FG000|NOT COMPLETED|Overall Study||53
11351704|NCT03038113|12548678|FG007|NOT COMPLETED|Overall Study||0
11351705|NCT03038113|12548679|FG008|NOT COMPLETED|Overall Study||0
11351706|NCT03038113|12548680|FG009|NOT COMPLETED|Overall Study||0
11351707|NCT03038113|12548681|FG010|NOT COMPLETED|Overall Study||0
11091330|NCT01180049|12274649|FG001|NOT COMPLETED|Overall Study||48
11091331|NCT01180127|12274659|FG000|STARTED|Overall Study||10
11091332|NCT01180127|12274660|FG001|STARTED|Overall Study||11
11091333|NCT01180127|12274661|FG002|STARTED|Overall Study||10
11091334|NCT01180127|12274662|FG003|STARTED|Overall Study||10
11091335|NCT01180127|12274659|FG000|COMPLETED|Overall Study||8
11091336|NCT01180127|12274660|FG001|COMPLETED|Overall Study||11
11091337|NCT01180127|12274661|FG002|COMPLETED|Overall Study||9
11091338|NCT01180127|12274662|FG003|COMPLETED|Overall Study||9
11091339|NCT01180127|12274659|FG000|NOT COMPLETED|Overall Study||2
11091340|NCT01180127|12274660|FG001|NOT COMPLETED|Overall Study||0
11091341|NCT01180127|12274661|FG002|NOT COMPLETED|Overall Study||1
11091342|NCT01180127|12274662|FG003|NOT COMPLETED|Overall Study||1
11091343|NCT01180244|12274678|FG000|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
11091344|NCT01180244|12274679|FG001|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
11091345|NCT01180244|12274678|FG000|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
11091346|NCT01180244|12274679|FG001|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
11091347|NCT01180244|12274678|FG000|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
11091348|NCT01180244|12274679|FG001|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
11091349|NCT01180244|12274678|FG000|NOT COMPLETED|Overall Study||6
11091350|NCT01180244|12274679|FG001|NOT COMPLETED|Overall Study||8
11091351|NCT01180296|12274687|FG000|STARTED|Overall Study||20
11091352|NCT01180296|12274688|FG001|STARTED|Overall Study||16
11091353|NCT01180296|12274687|FG000|COMPLETED|Overall Study||19
11091354|NCT01180296|12274688|FG001|COMPLETED|Overall Study||14
11091355|NCT01180296|12274687|FG000|NOT COMPLETED|Overall Study||1
11091356|NCT01180296|12274688|FG001|NOT COMPLETED|Overall Study||2
11091357|NCT01180400|12274698|FG000|STARTED|Overall Study||147
11091358|NCT01180400|12274699|FG001|STARTED|Overall Study||148
11091359|NCT01180400|12274698|FG000|Received Treatment|Overall Study||147
11091360|NCT01180400|12274699|FG001|Received Treatment|Overall Study||146
11091361|NCT01180400|12274698|FG000|COMPLETED|Overall Study||122
11091362|NCT01180400|12274699|FG001|COMPLETED|Overall Study||121
11091363|NCT01180400|12274698|FG000|NOT COMPLETED|Overall Study||25
11091364|NCT01180400|12274699|FG001|NOT COMPLETED|Overall Study||27
11091365|NCT01180478|12274707|FG000|STARTED|Overall Study||484
11091366|NCT01180478|12274708|FG001|STARTED|Overall Study||481
11091367|NCT01180478|12274707|FG000|COMPLETED|Overall Study||303
11091368|NCT01180478|12274708|FG001|COMPLETED|Overall Study||293
11091369|NCT01180478|12274707|FG000|NOT COMPLETED|Overall Study||181
11091370|NCT01180478|12274708|FG001|NOT COMPLETED|Overall Study||188
11091371|NCT01180647|12274718|FG000|STARTED|Overall Study||17
11091372|NCT01180647|12274719|FG001|STARTED|Overall Study||17
11091373|NCT01180647|12274718|FG000|COMPLETED|Overall Study||12
11091374|NCT01180647|12274719|FG001|COMPLETED|Overall Study||11
11091375|NCT01180647|12274718|FG000|NOT COMPLETED|Overall Study||5
11091376|NCT01180647|12274719|FG001|NOT COMPLETED|Overall Study||6
11091377|NCT01180660|12274727|FG000|STARTED|Overall Study||25
11091378|NCT01180660|12274728|FG001|STARTED|Overall Study||26
11091379|NCT01180660|12274727|FG000|COMPLETED|Overall Study||24
11091380|NCT01180660|12274728|FG001|COMPLETED|Overall Study||26
11091381|NCT01180660|12274727|FG000|NOT COMPLETED|Overall Study||1
11091382|NCT01180660|12274728|FG001|NOT COMPLETED|Overall Study||0
11091383|NCT01180777|12274734|FG000|STARTED|Overall Study||92
11091384|NCT01180777|12274734|FG000|COMPLETED|Overall Study||80
11091385|NCT01180777|12274734|FG000|NOT COMPLETED|Overall Study||12
11091386|NCT01180790|12274747|FG000|STARTED|Overall Study||16
11091387|NCT01180790|12274748|FG001|STARTED|Overall Study||16
11091388|NCT01180790|12274749|FG002|STARTED|Overall Study||17
11091389|NCT01180790|12274750|FG003|STARTED|Overall Study||15
11091390|NCT01180790|12274751|FG004|STARTED|Overall Study||19
11091391|NCT01180790|12274752|FG005|STARTED|Overall Study||20
11091392|NCT01180790|12274753|FG006|STARTED|Overall Study||19
11091393|NCT01180790|12274747|FG000|COMPLETED|Overall Study||7
11091394|NCT01180790|12274748|FG001|COMPLETED|Overall Study||11
11091395|NCT01180790|12274749|FG002|COMPLETED|Overall Study||4
11091396|NCT01180790|12274750|FG003|COMPLETED|Overall Study||6
11091397|NCT01180790|12274751|FG004|COMPLETED|Overall Study||14
11091398|NCT01180790|12274752|FG005|COMPLETED|Overall Study||13
11091399|NCT01180790|12274753|FG006|COMPLETED|Overall Study||18
11091400|NCT01180790|12274747|FG000|NOT COMPLETED|Overall Study||9
11351708|NCT03038113|12548682|FG011|NOT COMPLETED|Overall Study||0
11091401|NCT01180790|12274748|FG001|NOT COMPLETED|Overall Study||5
11091402|NCT01180790|12274749|FG002|NOT COMPLETED|Overall Study||13
11091403|NCT01180790|12274750|FG003|NOT COMPLETED|Overall Study||9
11091404|NCT01180790|12274751|FG004|NOT COMPLETED|Overall Study||5
11091405|NCT01180790|12274752|FG005|NOT COMPLETED|Overall Study||7
11091406|NCT01180790|12274753|FG006|NOT COMPLETED|Overall Study||1
11091407|NCT01180894|12274799|FG000|STARTED|Overall Study||75
11091408|NCT01180894|12274800|FG001|STARTED|Overall Study||75
11091409|NCT01180894|12274799|FG000|COMPLETED|Overall Study||75
11091410|NCT01180894|12274800|FG001|COMPLETED|Overall Study||75
11091411|NCT01180894|12274799|FG000|NOT COMPLETED|Overall Study||0
11091412|NCT01180894|12274800|FG001|NOT COMPLETED|Overall Study||0
11091413|NCT01180985|12274808|FG000|STARTED|Period 1 (7 +/- Days)||27
11091414|NCT01180985|12274809|FG001|STARTED|Period 1 (7 +/- Days)||26
11091415|NCT01180985|12274808|FG000|COMPLETED|Period 1 (7 +/- Days)||27
11091416|NCT01180985|12274809|FG001|COMPLETED|Period 1 (7 +/- Days)||26
11091417|NCT01180985|12274808|FG000|NOT COMPLETED|Period 1 (7 +/- Days)||0
11091418|NCT01180985|12274809|FG001|NOT COMPLETED|Period 1 (7 +/- Days)||0
11091419|NCT01180985|12274808|FG000|STARTED|Period 2 (7 +/- 1 Days)||27
11091420|NCT01180985|12274809|FG001|STARTED|Period 2 (7 +/- 1 Days)||26
11091421|NCT01180985|12274808|FG000|COMPLETED|Period 2 (7 +/- 1 Days)||26
11091422|NCT01180985|12274809|FG001|COMPLETED|Period 2 (7 +/- 1 Days)||26
11091423|NCT01180985|12274808|FG000|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
11091424|NCT01180985|12274809|FG001|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
11091425|NCT01180998|12274819|FG000|STARTED|Overall Study||67
11091426|NCT01180998|12274820|FG001|STARTED|Overall Study||72
11091427|NCT01180998|12274821|FG002|STARTED|Overall Study||61
11091428|NCT01180998|12274819|FG000|COMPLETED|Overall Study||63
11091429|NCT01180998|12274820|FG001|COMPLETED|Overall Study||68
11091430|NCT01180998|12274821|FG002|COMPLETED|Overall Study||51
11091431|NCT01180998|12274819|FG000|NOT COMPLETED|Overall Study||4
11091432|NCT01180998|12274820|FG001|NOT COMPLETED|Overall Study||4
11091433|NCT01180998|12274821|FG002|NOT COMPLETED|Overall Study||10
11091434|NCT01181011|12274830|FG000|STARTED|Overall Study||28
11091435|NCT01181011|12274830|FG000|Received Telmisartan 80mg|Overall Study||27
11091436|NCT01181011|12274830|FG000|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
11091437|NCT01181011|12274830|FG000|Received Amlodipine 5mg|Overall Study||26
11091438|NCT01181011|12274830|FG000|COMPLETED|Overall Study||25
11091439|NCT01181011|12274830|FG000|NOT COMPLETED|Overall Study||3
11208172|NCT01879722|12399353|FG007|COMPLETED|Overall Study||7
11208173|NCT01879722|12399354|FG008|COMPLETED|Overall Study||6
11208174|NCT01879722|12399355|FG009|COMPLETED|Overall Study||6
11208175|NCT01879722|12399346|FG000|NOT COMPLETED|Overall Study||0
11208176|NCT01879722|12399347|FG001|NOT COMPLETED|Overall Study||1
11208177|NCT01879722|12399348|FG002|NOT COMPLETED|Overall Study||0
11208178|NCT01879722|12399349|FG003|NOT COMPLETED|Overall Study||1
11208179|NCT01879722|12399350|FG004|NOT COMPLETED|Overall Study||1
11208180|NCT01879722|12399351|FG005|NOT COMPLETED|Overall Study||0
11208181|NCT01879722|12399352|FG006|NOT COMPLETED|Overall Study||0
11351709|NCT03038113|12548683|FG012|NOT COMPLETED|Overall Study||0
11208182|NCT01879722|12399353|FG007|NOT COMPLETED|Overall Study||1
11351710|NCT03038113|12548684|FG013|NOT COMPLETED|Overall Study||1
11351711|NCT03038126|12548733|FG000|STARTED|Overall Study||63
11351712|NCT03038126|12548734|FG001|STARTED|Overall Study||55
11351713|NCT03038126|12548733|FG000|COMPLETED|Overall Study||54
11351714|NCT03038126|12548734|FG001|COMPLETED|Overall Study||51
11351715|NCT03038126|12548733|FG000|NOT COMPLETED|Overall Study||9
11351716|NCT03038126|12548734|FG001|NOT COMPLETED|Overall Study||4
11351717|NCT03038308|12548740|FG000|STARTED|Overall Study||15
11351718|NCT03038308|12548740|FG000|COMPLETED|Overall Study||11
11351719|NCT03038308|12548740|FG000|NOT COMPLETED|Overall Study||4
11351720|NCT03038399|12548748|FG000|STARTED|Overall Study||11
11351721|NCT03038399|12548749|FG001|STARTED|Overall Study||12
11351722|NCT03038399|12548750|FG002|STARTED|Overall Study||12
11351723|NCT03038399|12548751|FG003|STARTED|Overall Study||11
11351724|NCT03038399|12548748|FG000|COMPLETED|Overall Study||10
11351725|NCT03038399|12548749|FG001|COMPLETED|Overall Study||11
11351726|NCT03038399|12548750|FG002|COMPLETED|Overall Study||11
11351727|NCT03038399|12548751|FG003|COMPLETED|Overall Study|Subjects escalated from lower dose groups|9
11091440|NCT01181050|12274841|FG000|STARTED|Overall Study||41
11091441|NCT01181050|12274842|FG001|STARTED|Overall Study||22
11091442|NCT01181050|12274841|FG000|COMPLETED|Overall Study||41
11091443|NCT01181050|12274842|FG001|COMPLETED|Overall Study||22
11091444|NCT01181050|12274841|FG000|NOT COMPLETED|Overall Study||0
11091445|NCT01181050|12274842|FG001|NOT COMPLETED|Overall Study||0
11091446|NCT01181076|12274850|FG000|STARTED|Overall Study||59
11091447|NCT01181076|12274851|FG001|STARTED|Overall Study||60
11091448|NCT01181076|12274850|FG000|COMPLETED|Overall Study||40
11091449|NCT01181076|12274851|FG001|COMPLETED|Overall Study|As determined|48
11091450|NCT01181076|12274850|FG000|NOT COMPLETED|Overall Study||19
11091451|NCT01181076|12274851|FG001|NOT COMPLETED|Overall Study||12
11091452|NCT01181102|12274859|FG000|STARTED|Overall Study||360
11091453|NCT01181102|12274860|FG001|STARTED|Overall Study||356
11091454|NCT01181102|12274859|FG000|Safety Analysis Set|Overall Study||354
11091455|NCT01181102|12274860|FG001|Safety Analysis Set|Overall Study||349
11091456|NCT01181102|12274859|FG000|Efficacy Analysis Population|Overall Study||299
11091457|NCT01181102|12274860|FG001|Efficacy Analysis Population|Overall Study||295
11091458|NCT01181102|12274859|FG000|COMPLETED|Overall Study||309
11091459|NCT01181102|12274860|FG001|COMPLETED|Overall Study||310
11091460|NCT01181102|12274859|FG000|NOT COMPLETED|Overall Study||51
11091461|NCT01181102|12274860|FG001|NOT COMPLETED|Overall Study||46
11091462|NCT01181128|12274869|FG000|STARTED|Overall Study||118
11091463|NCT01181128|12274870|FG001|STARTED|Overall Study||24
11091464|NCT01181128|12274871|FG002|STARTED|Overall Study||23
11091465|NCT01181128|12274869|FG000|Pharmacokinetic (PK) Subgroup|Overall Study||30
11091466|NCT01181128|12274870|FG001|Pharmacokinetic (PK) Subgroup|Overall Study||0
11091467|NCT01181128|12274871|FG002|Pharmacokinetic (PK) Subgroup|Overall Study||0
11091468|NCT01181128|12274869|FG000|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
11091469|NCT01181128|12274870|FG001|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
11091470|NCT01181128|12274871|FG002|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
11091471|NCT01181128|12274869|FG000|COMPLETED|Overall Study||112
11091472|NCT01181128|12274870|FG001|COMPLETED|Overall Study||19
11091473|NCT01181128|12274871|FG002|COMPLETED|Overall Study||22
11091474|NCT01181128|12274869|FG000|NOT COMPLETED|Overall Study||6
11091475|NCT01181128|12274870|FG001|NOT COMPLETED|Overall Study||5
11091476|NCT01181128|12274871|FG002|NOT COMPLETED|Overall Study||1
11091477|NCT01181141|12274893|FG000|STARTED|Overall Study||62
11091478|NCT01181141|12274894|FG001|STARTED|Overall Study||30
11091479|NCT01181141|12274893|FG000|Safety Analysis Population|Overall Study||59
11351728|NCT03038399|12548748|FG000|NOT COMPLETED|Overall Study||1
11351729|NCT03038399|12548749|FG001|NOT COMPLETED|Overall Study||1
11351730|NCT03038399|12548750|FG002|NOT COMPLETED|Overall Study||1
11351731|NCT03038399|12548751|FG003|NOT COMPLETED|Overall Study||2
11351732|NCT03038620|12548765|FG000|STARTED|Overall Study||92
11351733|NCT03038620|12548766|FG001|STARTED|Overall Study||93
11351734|NCT03038620|12548765|FG000|COMPLETED|Overall Study||73
11351735|NCT03038620|12548766|FG001|COMPLETED|Overall Study||55
11351736|NCT03038620|12548765|FG000|NOT COMPLETED|Overall Study||19
11351737|NCT03038620|12548766|FG001|NOT COMPLETED|Overall Study||38
11351738|NCT03038815|12548774|FG000|STARTED|Controll Condition, 1 Hour||10
11351739|NCT03038815|12548775|FG001|STARTED|Controll Condition, 1 Hour||10
11091480|NCT01181141|12274894|FG001|Safety Analysis Population|Overall Study||29
11091481|NCT01181141|12274893|FG000|COMPLETED|Overall Study||50
11091482|NCT01181141|12274894|FG001|COMPLETED|Overall Study||26
11091483|NCT01181141|12274893|FG000|NOT COMPLETED|Overall Study||12
11091484|NCT01181141|12274894|FG001|NOT COMPLETED|Overall Study||4
11091485|NCT01181167|12274902|FG000|STARTED|Overall Study||307
11091486|NCT01181167|12274903|FG001|STARTED|Overall Study||303
11091487|NCT01181167|12274902|FG000|Efficacy Analysis Population|Overall Study||255
11091488|NCT01181167|12274903|FG001|Efficacy Analysis Population|Overall Study||248
11091489|NCT01181167|12274902|FG000|COMPLETED|Overall Study||284
11091490|NCT01181167|12274903|FG001|COMPLETED|Overall Study||271
11091491|NCT01181167|12274902|FG000|NOT COMPLETED|Overall Study||23
11091492|NCT01181167|12274903|FG001|NOT COMPLETED|Overall Study||32
11091493|NCT01181258|12274909|FG000|STARTED|Overall Study||16
11091494|NCT01181258|12274909|FG000|COMPLETED|Overall Study||16
11091495|NCT01181258|12274909|FG000|NOT COMPLETED|Overall Study||0
11091496|NCT01181271|12274913|FG000|STARTED|Autologous Transplant||42
11091497|NCT01181271|12274913|FG000|COMPLETED|Autologous Transplant||42
11091498|NCT01181271|12274913|FG000|NOT COMPLETED|Autologous Transplant||0
11091499|NCT01181271|12274913|FG000|STARTED|Evaluation for Allogeneic Transplant||42
11091500|NCT01181271|12274913|FG000|COMPLETED|Evaluation for Allogeneic Transplant||29
11091501|NCT01181271|12274913|FG000|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
11091502|NCT01181271|12274913|FG000|STARTED|Allogeneic Transplant||29
11091503|NCT01181271|12274913|FG000|COMPLETED|Allogeneic Transplant||29
11091504|NCT01181271|12274913|FG000|NOT COMPLETED|Allogeneic Transplant||0
11091505|NCT01181323|12274921|FG000|STARTED|Overall Study||124
11091506|NCT01181323|12274922|FG001|STARTED|Overall Study||124
11091507|NCT01181323|12274923|FG002|STARTED|Overall Study||124
11091508|NCT01181323|12274924|FG003|STARTED|Overall Study||125
11091509|NCT01181323|12274921|FG000|COMPLETED|Overall Study||123
11091510|NCT01181323|12274922|FG001|COMPLETED|Overall Study||121
11091511|NCT01181323|12274923|FG002|COMPLETED|Overall Study||123
11091512|NCT01181323|12274924|FG003|COMPLETED|Overall Study||122
11091513|NCT01181323|12274921|FG000|NOT COMPLETED|Overall Study||1
11091514|NCT01181323|12274922|FG001|NOT COMPLETED|Overall Study||3
11091515|NCT01181323|12274923|FG002|NOT COMPLETED|Overall Study||1
11091516|NCT01181323|12274924|FG003|NOT COMPLETED|Overall Study||3
11091517|NCT01181349|12274946|FG000|STARTED|Overall Study||350
11091518|NCT01181349|12274946|FG000|COMPLETED|Overall Study||350
11091519|NCT01181349|12274946|FG000|NOT COMPLETED|Overall Study||0
11091520|NCT01181479|12274954|FG000|STARTED|Subjects Receive AG200-15 or Lessina||1129
11091521|NCT01181479|12274955|FG001|STARTED|Subjects Receive AG200-15 or Lessina||375
11091522|NCT01181479|12274956|FG002|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
11091523|NCT01181479|12274954|FG000|COMPLETED|Subjects Receive AG200-15 or Lessina||485
11091524|NCT01181479|12274955|FG001|COMPLETED|Subjects Receive AG200-15 or Lessina||249
11091525|NCT01181479|12274956|FG002|COMPLETED|Subjects Receive AG200-15 or Lessina||0
11091526|NCT01181479|12274954|FG000|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
11091527|NCT01181479|12274955|FG001|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
11091528|NCT01181479|12274956|FG002|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
11091529|NCT01181479|12274954|FG000|STARTED|Crossover Subjects Recieve AG200-15||0
11091530|NCT01181479|12274955|FG001|STARTED|Crossover Subjects Recieve AG200-15||0
11091531|NCT01181479|12274956|FG002|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
11091532|NCT01181479|12274954|FG000|COMPLETED|Crossover Subjects Recieve AG200-15||0
11091533|NCT01181479|12274955|FG001|COMPLETED|Crossover Subjects Recieve AG200-15||0
11091534|NCT01181479|12274956|FG002|COMPLETED|Crossover Subjects Recieve AG200-15||150
11091535|NCT01181479|12274954|FG000|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
11091536|NCT01181479|12274955|FG001|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
11091537|NCT01181479|12274956|FG002|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
11091538|NCT01181492|12274971|FG000|STARTED|Overall Study||103
11091539|NCT01181492|12274972|FG001|STARTED|Overall Study||66
11091540|NCT01181492|12274973|FG002|STARTED|Overall Study||7
11091541|NCT01181492|12274971|FG000|COMPLETED|Overall Study||103
11091542|NCT01181492|12274972|FG001|COMPLETED|Overall Study||66
11091543|NCT01181492|12274973|FG002|COMPLETED|Overall Study||7
11091544|NCT01181492|12274971|FG000|NOT COMPLETED|Overall Study||0
11091545|NCT01181492|12274972|FG001|NOT COMPLETED|Overall Study||0
11091546|NCT01181492|12274973|FG002|NOT COMPLETED|Overall Study||0
11091547|NCT01181531|12274983|FG000|STARTED|Overall Study|Subjects are randomized after washout.|157
11091548|NCT01181531|12274984|FG001|STARTED|Overall Study|Subjects are randomized after washout.|155
11091549|NCT01181531|12274983|FG000|Received Investigational Product|Overall Study||155
11091550|NCT01181531|12274984|FG001|Received Investigational Product|Overall Study||153
11091551|NCT01181531|12274983|FG000|COMPLETED|Overall Study||96
11091552|NCT01181531|12274984|FG001|COMPLETED|Overall Study||102
11091553|NCT01181531|12274983|FG000|NOT COMPLETED|Overall Study||61
11091554|NCT01181531|12274984|FG001|NOT COMPLETED|Overall Study||53
11091555|NCT01181596|12274990|FG000|STARTED|Overall Study||31
11091556|NCT01181596|12274990|FG000|COMPLETED|Overall Study||31
11091557|NCT01181596|12274990|FG000|NOT COMPLETED|Overall Study||0
11091558|NCT01181609|12274995|FG000|STARTED|Overall Study||54
11091559|NCT01181609|12274995|FG000|COMPLETED|Overall Study||1
11091560|NCT01181609|12274995|FG000|NOT COMPLETED|Overall Study||53
11208183|NCT01879722|12399354|FG008|NOT COMPLETED|Overall Study||2
11208184|NCT01879722|12399355|FG009|NOT COMPLETED|Overall Study||0
11351740|NCT03038815|12548774|FG000|COMPLETED|Controll Condition, 1 Hour||10
11351741|NCT03038815|12548775|FG001|COMPLETED|Controll Condition, 1 Hour||10
11351742|NCT03038815|12548774|FG000|NOT COMPLETED|Controll Condition, 1 Hour||0
11351743|NCT03038815|12548775|FG001|NOT COMPLETED|Controll Condition, 1 Hour||0
11351744|NCT03038815|12548774|FG000|STARTED|Intervention 1, 1 Hour||10
11351745|NCT03038815|12548775|FG001|STARTED|Intervention 1, 1 Hour||10
11351746|NCT03038815|12548774|FG000|COMPLETED|Intervention 1, 1 Hour||10
11351747|NCT03038815|12548775|FG001|COMPLETED|Intervention 1, 1 Hour||10
11351748|NCT03038815|12548774|FG000|NOT COMPLETED|Intervention 1, 1 Hour||0
11351749|NCT03038815|12548775|FG001|NOT COMPLETED|Intervention 1, 1 Hour||0
11351750|NCT03038815|12548774|FG000|STARTED|Intervention 2, 1 Hour||10
11351751|NCT03038815|12548775|FG001|STARTED|Intervention 2, 1 Hour||10
11351752|NCT03038815|12548774|FG000|COMPLETED|Intervention 2, 1 Hour||10
11351753|NCT03038815|12548775|FG001|COMPLETED|Intervention 2, 1 Hour||10
11351754|NCT03038815|12548774|FG000|NOT COMPLETED|Intervention 2, 1 Hour||0
11351755|NCT03038815|12548775|FG001|NOT COMPLETED|Intervention 2, 1 Hour||0
11351756|NCT03038867|12548784|FG000|STARTED|Overall Study||37
11351757|NCT03038867|12548785|FG001|STARTED|Overall Study||32
11351758|NCT03038867|12548784|FG000|COMPLETED|Overall Study||37
11351759|NCT03038867|12548785|FG001|COMPLETED|Overall Study||32
11351760|NCT03038867|12548784|FG000|NOT COMPLETED|Overall Study||0
11351761|NCT03038867|12548785|FG001|NOT COMPLETED|Overall Study||0
11351762|NCT03038880|12548794|FG000|STARTED|Overall Study||24
11351763|NCT03038880|12548795|FG001|STARTED|Overall Study||31
11351764|NCT03038880|12548796|FG002|STARTED|Overall Study||16
11351765|NCT03038880|12548794|FG000|COMPLETED|Overall Study||21
11351766|NCT03038880|12548795|FG001|COMPLETED|Overall Study||28
11351767|NCT03038880|12548796|FG002|COMPLETED|Overall Study||16
11351768|NCT03038880|12548794|FG000|NOT COMPLETED|Overall Study||3
11351769|NCT03038880|12548795|FG001|NOT COMPLETED|Overall Study||3
11351770|NCT03038880|12548796|FG002|NOT COMPLETED|Overall Study||0
11351771|NCT03039023|12548809|FG000|STARTED|Overall Study||19
11351772|NCT03039023|12548810|FG001|STARTED|Overall Study||20
11351773|NCT03039023|12548811|FG002|STARTED|Overall Study||17
11351774|NCT03039023|12548812|FG003|STARTED|Overall Study||20
11351775|NCT03039023|12548813|FG004|STARTED|Overall Study||10
11351776|NCT03039023|12548809|FG000|COMPLETED|Overall Study||18
11351777|NCT03039023|12548810|FG001|COMPLETED|Overall Study||20
11351778|NCT03039023|12548811|FG002|COMPLETED|Overall Study||16
11351779|NCT03039023|12548812|FG003|COMPLETED|Overall Study||18
11351780|NCT03039023|12548813|FG004|COMPLETED|Overall Study||10
11351781|NCT03039023|12548809|FG000|NOT COMPLETED|Overall Study||1
11351782|NCT03039023|12548810|FG001|NOT COMPLETED|Overall Study||0
11091561|NCT01181674|12275002|FG000|STARTED|Overall Study||28
11091562|NCT01181674|12275003|FG001|STARTED|Overall Study||27
11091563|NCT01181674|12275004|FG002|STARTED|Overall Study||28
11091564|NCT01181674|12275002|FG000|COMPLETED|Overall Study||28
11091565|NCT01181674|12275003|FG001|COMPLETED|Overall Study||27
11091566|NCT01181674|12275004|FG002|COMPLETED|Overall Study|28 included in analyses|26
11091567|NCT01181674|12275002|FG000|NOT COMPLETED|Overall Study||0
11091568|NCT01181674|12275003|FG001|NOT COMPLETED|Overall Study||0
11091569|NCT01181674|12275004|FG002|NOT COMPLETED|Overall Study||2
11091570|NCT01181726|12275014|FG000|STARTED|First Intervention||20
11091571|NCT01181726|12275015|FG001|STARTED|First Intervention||20
11091572|NCT01181726|12275014|FG000|COMPLETED|First Intervention||19
11091573|NCT01181726|12275015|FG001|COMPLETED|First Intervention||20
11091574|NCT01181726|12275014|FG000|NOT COMPLETED|First Intervention||1
11091575|NCT01181726|12275015|FG001|NOT COMPLETED|First Intervention||0
11091576|NCT01181726|12275014|FG000|STARTED|Washout of 28 Days||19
11091577|NCT01181726|12275015|FG001|STARTED|Washout of 28 Days||20
11091578|NCT01181726|12275014|FG000|COMPLETED|Washout of 28 Days||19
11091579|NCT01181726|12275015|FG001|COMPLETED|Washout of 28 Days||20
11091580|NCT01181726|12275014|FG000|NOT COMPLETED|Washout of 28 Days||0
11091581|NCT01181726|12275015|FG001|NOT COMPLETED|Washout of 28 Days||0
11091582|NCT01181726|12275014|FG000|STARTED|Second Intervention||19
11091583|NCT01181726|12275015|FG001|STARTED|Second Intervention||20
11091584|NCT01181726|12275014|FG000|COMPLETED|Second Intervention||19
11091585|NCT01181726|12275015|FG001|COMPLETED|Second Intervention||20
11091586|NCT01181726|12275014|FG000|NOT COMPLETED|Second Intervention||0
11091587|NCT01181726|12275015|FG001|NOT COMPLETED|Second Intervention||0
11091588|NCT01181804|12275025|FG000|STARTED|Period 1, Fed (Part 1)||30
11091589|NCT01181804|12275026|FG001|STARTED|Period 1, Fed (Part 1)||30
11091590|NCT01181804|12275027|FG002|STARTED|Period 1, Fed (Part 1)||0
11091591|NCT01181804|12275028|FG003|STARTED|Period 1, Fed (Part 1)||0
11091592|NCT01181804|12275025|FG000|COMPLETED|Period 1, Fed (Part 1)||30
11091593|NCT01181804|12275026|FG001|COMPLETED|Period 1, Fed (Part 1)||30
11091594|NCT01181804|12275027|FG002|COMPLETED|Period 1, Fed (Part 1)||0
11091595|NCT01181804|12275028|FG003|COMPLETED|Period 1, Fed (Part 1)||0
11091596|NCT01181804|12275025|FG000|NOT COMPLETED|Period 1, Fed (Part 1)||0
11091597|NCT01181804|12275026|FG001|NOT COMPLETED|Period 1, Fed (Part 1)||0
11091598|NCT01181804|12275027|FG002|NOT COMPLETED|Period 1, Fed (Part 1)||0
11091599|NCT01181804|12275028|FG003|NOT COMPLETED|Period 1, Fed (Part 1)||0
11091600|NCT01181804|12275025|FG000|STARTED|Period 2, Fed (Part 1)||30
11091601|NCT01181804|12275026|FG001|STARTED|Period 2, Fed (Part 1)||30
11091602|NCT01181804|12275027|FG002|STARTED|Period 2, Fed (Part 1)||0
11091603|NCT01181804|12275028|FG003|STARTED|Period 2, Fed (Part 1)||0
11091604|NCT01181804|12275025|FG000|COMPLETED|Period 2, Fed (Part 1)||30
11091605|NCT01181804|12275026|FG001|COMPLETED|Period 2, Fed (Part 1)||30
11091606|NCT01181804|12275027|FG002|COMPLETED|Period 2, Fed (Part 1)||0
11091607|NCT01181804|12275028|FG003|COMPLETED|Period 2, Fed (Part 1)||0
11351783|NCT03039023|12548811|FG002|NOT COMPLETED|Overall Study||1
11351784|NCT03039023|12548812|FG003|NOT COMPLETED|Overall Study||2
11351785|NCT03039023|12548813|FG004|NOT COMPLETED|Overall Study||0
11351786|NCT03039088|12548827|FG000|STARTED|Overall Study||192
11351787|NCT03039088|12548828|FG001|STARTED|Overall Study||316
11351788|NCT03039088|12548827|FG000|COMPLETED|Overall Study||192
11351789|NCT03039088|12548828|FG001|COMPLETED|Overall Study||316
11351790|NCT03039088|12548827|FG000|NOT COMPLETED|Overall Study||0
11091608|NCT01181804|12275025|FG000|NOT COMPLETED|Period 2, Fed (Part 1)||0
11091609|NCT01181804|12275026|FG001|NOT COMPLETED|Period 2, Fed (Part 1)||0
11091610|NCT01181804|12275027|FG002|NOT COMPLETED|Period 2, Fed (Part 1)||0
11091611|NCT01181804|12275028|FG003|NOT COMPLETED|Period 2, Fed (Part 1)||0
11091612|NCT01181804|12275025|FG000|STARTED|Period 3, Fasted (Part 2)||0
11091613|NCT01181804|12275026|FG001|STARTED|Period 3, Fasted (Part 2)||0
11091614|NCT01181804|12275027|FG002|STARTED|Period 3, Fasted (Part 2)||59
11091615|NCT01181804|12275028|FG003|STARTED|Period 3, Fasted (Part 2)||58
11091616|NCT01181804|12275025|FG000|COMPLETED|Period 3, Fasted (Part 2)||0
11091617|NCT01181804|12275026|FG001|COMPLETED|Period 3, Fasted (Part 2)||0
11091618|NCT01181804|12275027|FG002|COMPLETED|Period 3, Fasted (Part 2)||59
11091619|NCT01181804|12275028|FG003|COMPLETED|Period 3, Fasted (Part 2)||58
11091620|NCT01181804|12275025|FG000|NOT COMPLETED|Period 3, Fasted (Part 2)||0
11091621|NCT01181804|12275026|FG001|NOT COMPLETED|Period 3, Fasted (Part 2)||0
11091622|NCT01181804|12275027|FG002|NOT COMPLETED|Period 3, Fasted (Part 2)||0
11091623|NCT01181804|12275028|FG003|NOT COMPLETED|Period 3, Fasted (Part 2)||0
11091624|NCT01181804|12275025|FG000|STARTED|Period 4, Fasted (Part 2)||0
11091625|NCT01181804|12275026|FG001|STARTED|Period 4, Fasted (Part 2)||0
11091626|NCT01181804|12275027|FG002|STARTED|Period 4, Fasted (Part 2)||59
11091627|NCT01181804|12275028|FG003|STARTED|Period 4, Fasted (Part 2)||58
11091628|NCT01181804|12275025|FG000|COMPLETED|Period 4, Fasted (Part 2)||0
11091629|NCT01181804|12275026|FG001|COMPLETED|Period 4, Fasted (Part 2)||0
11091630|NCT01181804|12275027|FG002|COMPLETED|Period 4, Fasted (Part 2)||58
11091631|NCT01181804|12275028|FG003|COMPLETED|Period 4, Fasted (Part 2)||58
11091632|NCT01181804|12275025|FG000|NOT COMPLETED|Period 4, Fasted (Part 2)||0
11091633|NCT01181804|12275026|FG001|NOT COMPLETED|Period 4, Fasted (Part 2)||0
11091634|NCT01181804|12275027|FG002|NOT COMPLETED|Period 4, Fasted (Part 2)||1
11091635|NCT01181804|12275028|FG003|NOT COMPLETED|Period 4, Fasted (Part 2)||0
11091636|NCT01181895|12275041|FG000|STARTED|Overall Study||116
11091637|NCT01181895|12275042|FG001|STARTED|Overall Study||115
11351791|NCT03039088|12548828|FG001|NOT COMPLETED|Overall Study||0
11351792|NCT03039179|12548836|FG000|STARTED|Overall Study||38
11091638|NCT01181895|12275043|FG002|STARTED|Overall Study||116
11091639|NCT01181895|12275041|FG000|COMPLETED|Overall Study||99
11091640|NCT01181895|12275042|FG001|COMPLETED|Overall Study||101
11091641|NCT01181895|12275043|FG002|COMPLETED|Overall Study||98
11091642|NCT01181895|12275041|FG000|NOT COMPLETED|Overall Study||17
11091643|NCT01181895|12275042|FG001|NOT COMPLETED|Overall Study||14
11091644|NCT01181895|12275043|FG002|NOT COMPLETED|Overall Study||18
11091645|NCT01181947|12275051|FG000|STARTED|Overall Study||100
11091646|NCT01181947|12275051|FG000|COMPLETED|Overall Study||100
11091647|NCT01181947|12275051|FG000|NOT COMPLETED|Overall Study||0
11091648|NCT01181986|12275058|FG000|STARTED|Phase 1||19
11091649|NCT01181986|12275059|FG001|STARTED|Phase 1||23
11091650|NCT01181986|12275060|FG002|STARTED|Phase 1||34
11091651|NCT01181986|12275058|FG000|Saline+Exenatide|Phase 1|N/A for this arm|0
11091652|NCT01181986|12275059|FG001|Saline+Exenatide|Phase 1|N/A for this arm|0
11091653|NCT01181986|12275060|FG002|Saline+Exenatide|Phase 1||32
11091654|NCT01181986|12275058|FG000|Saline+Placebo|Phase 1|N/A for this arm|0
11091655|NCT01181986|12275059|FG001|Saline+Placebo|Phase 1|N/A for this arm|0
11091656|NCT01181986|12275060|FG002|Saline+Placebo|Phase 1||33
11091657|NCT01181986|12275058|FG000|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
11091658|NCT01181986|12275059|FG001|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
11091659|NCT01181986|12275060|FG002|Exendin-9+Exenatide|Phase 1||33
11091660|NCT01181986|12275058|FG000|COMPLETED|Phase 1||18
11091661|NCT01181986|12275059|FG001|COMPLETED|Phase 1||22
11091662|NCT01181986|12275060|FG002|COMPLETED|Phase 1||32
11091663|NCT01181986|12275058|FG000|NOT COMPLETED|Phase 1||1
11091664|NCT01181986|12275059|FG001|NOT COMPLETED|Phase 1||1
11091665|NCT01181986|12275060|FG002|NOT COMPLETED|Phase 1||2
11091666|NCT01181986|12275058|FG000|STARTED|Phase 2||18
11091667|NCT01181986|12275059|FG001|STARTED|Phase 2||22
11091668|NCT01181986|12275060|FG002|STARTED|Phase 2|N/A for Sub-study 2|0
11091669|NCT01181986|12275058|FG000|COMPLETED|Phase 2||18
11091670|NCT01181986|12275059|FG001|COMPLETED|Phase 2||18
11091671|NCT01181986|12275060|FG002|COMPLETED|Phase 2||0
11091672|NCT01181986|12275058|FG000|NOT COMPLETED|Phase 2||0
11091673|NCT01181986|12275059|FG001|NOT COMPLETED|Phase 2||4
11091674|NCT01181986|12275060|FG002|NOT COMPLETED|Phase 2||0
11091675|NCT01182103|12275076|FG000|STARTED|Overall Study||48
11091676|NCT01182103|12275077|FG001|STARTED|Overall Study||62
11091677|NCT01182103|12275076|FG000|COMPLETED|Overall Study||48
11091678|NCT01182103|12275077|FG001|COMPLETED|Overall Study||62
11091679|NCT01182103|12275076|FG000|NOT COMPLETED|Overall Study||0
11091680|NCT01182103|12275077|FG001|NOT COMPLETED|Overall Study||0
11091681|NCT01182181|12275088|FG000|STARTED|First Intervention||11
11091682|NCT01182181|12275089|FG001|STARTED|First Intervention||11
11091683|NCT01182181|12275088|FG000|COMPLETED|First Intervention||10
11091684|NCT01182181|12275089|FG001|COMPLETED|First Intervention||11
11091685|NCT01182181|12275088|FG000|NOT COMPLETED|First Intervention||1
11091686|NCT01182181|12275089|FG001|NOT COMPLETED|First Intervention||0
11091687|NCT01182181|12275088|FG000|STARTED|Washout of 21 Days||10
11091688|NCT01182181|12275089|FG001|STARTED|Washout of 21 Days||11
11091689|NCT01182181|12275088|FG000|COMPLETED|Washout of 21 Days||10
11091690|NCT01182181|12275089|FG001|COMPLETED|Washout of 21 Days||10
11091691|NCT01182181|12275088|FG000|NOT COMPLETED|Washout of 21 Days||0
11091692|NCT01182181|12275089|FG001|NOT COMPLETED|Washout of 21 Days||1
11091693|NCT01182181|12275088|FG000|STARTED|Second Intervention||10
11091694|NCT01182181|12275089|FG001|STARTED|Second Intervention||10
11091695|NCT01182181|12275088|FG000|COMPLETED|Second Intervention||10
11091696|NCT01182181|12275089|FG001|COMPLETED|Second Intervention||10
11091697|NCT01182181|12275088|FG000|NOT COMPLETED|Second Intervention||0
11091698|NCT01182181|12275089|FG001|NOT COMPLETED|Second Intervention||0
11091699|NCT01182194|12275097|FG000|STARTED|First Intervention||16
11091700|NCT01182194|12275098|FG001|STARTED|First Intervention||16
11091701|NCT01182194|12275097|FG000|COMPLETED|First Intervention||16
11091702|NCT01182194|12275098|FG001|COMPLETED|First Intervention||16
11091703|NCT01182194|12275097|FG000|NOT COMPLETED|First Intervention||0
11091704|NCT01182194|12275098|FG001|NOT COMPLETED|First Intervention||0
11091705|NCT01182194|12275097|FG000|STARTED|Washout of 28 Days||16
11091706|NCT01182194|12275098|FG001|STARTED|Washout of 28 Days||16
11091707|NCT01182194|12275097|FG000|COMPLETED|Washout of 28 Days||15
11091708|NCT01182194|12275098|FG001|COMPLETED|Washout of 28 Days||16
11091709|NCT01182194|12275097|FG000|NOT COMPLETED|Washout of 28 Days||1
11091710|NCT01182194|12275098|FG001|NOT COMPLETED|Washout of 28 Days||0
11091711|NCT01182194|12275097|FG000|STARTED|Second Intervention||15
11091712|NCT01182194|12275098|FG001|STARTED|Second Intervention||16
11091713|NCT01182194|12275097|FG000|COMPLETED|Second Intervention||15
11091714|NCT01182194|12275098|FG001|COMPLETED|Second Intervention||16
11091715|NCT01182194|12275097|FG000|NOT COMPLETED|Second Intervention||0
11091716|NCT01182194|12275098|FG001|NOT COMPLETED|Second Intervention||0
11091717|NCT01182207|12275106|FG000|STARTED|First Intervention||18
11091718|NCT01182207|12275107|FG001|STARTED|First Intervention||15
11091719|NCT01182207|12275106|FG000|COMPLETED|First Intervention||18
11091720|NCT01182207|12275107|FG001|COMPLETED|First Intervention||14
11091721|NCT01182207|12275106|FG000|NOT COMPLETED|First Intervention||0
11091722|NCT01182207|12275107|FG001|NOT COMPLETED|First Intervention||1
11091723|NCT01182207|12275106|FG000|STARTED|Washout of 28 Days||18
11091724|NCT01182207|12275107|FG001|STARTED|Washout of 28 Days||14
11091725|NCT01182207|12275106|FG000|COMPLETED|Washout of 28 Days||18
11091726|NCT01182207|12275107|FG001|COMPLETED|Washout of 28 Days||14
11091727|NCT01182207|12275106|FG000|NOT COMPLETED|Washout of 28 Days||0
11091728|NCT01182207|12275107|FG001|NOT COMPLETED|Washout of 28 Days||0
11091729|NCT01182207|12275106|FG000|STARTED|Second Intervention||18
11091730|NCT01182207|12275107|FG001|STARTED|Second Intervention||14
11091731|NCT01182207|12275106|FG000|COMPLETED|Second Intervention||17
11091732|NCT01182207|12275107|FG001|COMPLETED|Second Intervention||14
11091733|NCT01182207|12275106|FG000|NOT COMPLETED|Second Intervention||1
11091734|NCT01182207|12275107|FG001|NOT COMPLETED|Second Intervention||0
11091735|NCT01182285|12275113|FG000|STARTED|First Intervention Week 1-10||13
11091736|NCT01182285|12275114|FG001|STARTED|First Intervention Week 1-10||0
11091737|NCT01182285|12275115|FG002|STARTED|First Intervention Week 1-10||0
11091738|NCT01182285|12275113|FG000|COMPLETED|First Intervention Week 1-10||10
11091739|NCT01182285|12275114|FG001|COMPLETED|First Intervention Week 1-10||0
11091740|NCT01182285|12275115|FG002|COMPLETED|First Intervention Week 1-10||0
11091741|NCT01182285|12275113|FG000|NOT COMPLETED|First Intervention Week 1-10||3
11091742|NCT01182285|12275114|FG001|NOT COMPLETED|First Intervention Week 1-10||0
11091743|NCT01182285|12275115|FG002|NOT COMPLETED|First Intervention Week 1-10||0
11091744|NCT01182285|12275113|FG000|STARTED|Second Intervention Week 11-17||0
11091745|NCT01182285|12275114|FG001|STARTED|Second Intervention Week 11-17||0
11091746|NCT01182285|12275115|FG002|STARTED|Second Intervention Week 11-17||0
11091747|NCT01182285|12275113|FG000|COMPLETED|Second Intervention Week 11-17||0
11091748|NCT01182285|12275114|FG001|COMPLETED|Second Intervention Week 11-17||0
11091749|NCT01182285|12275115|FG002|COMPLETED|Second Intervention Week 11-17||0
11091750|NCT01182285|12275113|FG000|NOT COMPLETED|Second Intervention Week 11-17||0
11091751|NCT01182285|12275114|FG001|NOT COMPLETED|Second Intervention Week 11-17||0
11091752|NCT01182285|12275115|FG002|NOT COMPLETED|Second Intervention Week 11-17||0
11091753|NCT01182285|12275113|FG000|STARTED|Third Intervention Week 11-52||0
11091754|NCT01182285|12275114|FG001|STARTED|Third Intervention Week 11-52||0
11091755|NCT01182285|12275115|FG002|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
11091756|NCT01182285|12275113|FG000|COMPLETED|Third Intervention Week 11-52||0
11091757|NCT01182285|12275114|FG001|COMPLETED|Third Intervention Week 11-52||0
11091758|NCT01182285|12275115|FG002|COMPLETED|Third Intervention Week 11-52||0
11091759|NCT01182285|12275113|FG000|NOT COMPLETED|Third Intervention Week 11-52||0
11091760|NCT01182285|12275114|FG001|NOT COMPLETED|Third Intervention Week 11-52||0
11091761|NCT01182285|12275115|FG002|NOT COMPLETED|Third Intervention Week 11-52||8
11091762|NCT01182298|12275122|FG000|STARTED|Overall Study||10
11091763|NCT01182298|12275122|FG000|COMPLETED|Overall Study||4
11091764|NCT01182298|12275122|FG000|NOT COMPLETED|Overall Study||6
11091765|NCT01182337|12275128|FG000|STARTED|Overall Study||22
11091766|NCT01182337|12275129|FG001|STARTED|Overall Study||9
11091767|NCT01182337|12275128|FG000|COMPLETED|Overall Study||19
11091768|NCT01182337|12275129|FG001|COMPLETED|Overall Study||7
11091769|NCT01182337|12275128|FG000|NOT COMPLETED|Overall Study||3
11091770|NCT01182337|12275129|FG001|NOT COMPLETED|Overall Study||2
11091771|NCT01182350|12275136|FG000|STARTED|Overall Study||30
11091772|NCT01182350|12275137|FG001|STARTED|Overall Study||14
11091773|NCT01182350|12275138|FG002|STARTED|Overall Study||3
11091774|NCT01182350|12275139|FG003|STARTED|Overall Study||3
11091775|NCT01182350|12275140|FG004|STARTED|Overall Study||3
11091776|NCT01182350|12275136|FG000|Underwent Stereotactic Biopsy|Overall Study||30
11091777|NCT01182350|12275137|FG001|Underwent Stereotactic Biopsy|Overall Study||14
11091778|NCT01182350|12275138|FG002|Underwent Stereotactic Biopsy|Overall Study||3
11091779|NCT01182350|12275139|FG003|Underwent Stereotactic Biopsy|Overall Study||3
11091780|NCT01182350|12275140|FG004|Underwent Stereotactic Biopsy|Overall Study||0
11091781|NCT01182350|12275136|FG000|Started Assigned Chemoradiation|Overall Study||27
11091782|NCT01182350|12275137|FG001|Started Assigned Chemoradiation|Overall Study||14
11091783|NCT01182350|12275138|FG002|Started Assigned Chemoradiation|Overall Study||2
11091784|NCT01182350|12275139|FG003|Started Assigned Chemoradiation|Overall Study||2
11091785|NCT01182350|12275140|FG004|Started Assigned Chemoradiation|Overall Study||0
11091786|NCT01182350|12275136|FG000|COMPLETED|Overall Study||3
11091787|NCT01182350|12275137|FG001|COMPLETED|Overall Study||0
11091788|NCT01182350|12275138|FG002|COMPLETED|Overall Study||0
11091789|NCT01182350|12275139|FG003|COMPLETED|Overall Study||0
11091790|NCT01182350|12275140|FG004|COMPLETED|Overall Study||0
11091791|NCT01182350|12275136|FG000|NOT COMPLETED|Overall Study||27
11091792|NCT01182350|12275137|FG001|NOT COMPLETED|Overall Study||14
11091793|NCT01182350|12275138|FG002|NOT COMPLETED|Overall Study||3
11091794|NCT01182350|12275139|FG003|NOT COMPLETED|Overall Study||3
11091795|NCT01182350|12275140|FG004|NOT COMPLETED|Overall Study||3
11091796|NCT01182376|12275158|FG000|STARTED|Overall Study||15
11091797|NCT01182376|12275159|FG001|STARTED|Overall Study||18
11091798|NCT01182376|12275158|FG000|COMPLETED|Overall Study||4
11091799|NCT01182376|12275159|FG001|COMPLETED|Overall Study||13
11091800|NCT01182376|12275158|FG000|NOT COMPLETED|Overall Study||11
11091801|NCT01182376|12275159|FG001|NOT COMPLETED|Overall Study||5
11091802|NCT01182415|12275165|FG000|STARTED|Overall Study||30
11091803|NCT01182415|12275165|FG000|COMPLETED|Overall Study||29
11091804|NCT01182415|12275165|FG000|NOT COMPLETED|Overall Study||1
11091805|NCT01182428|12275171|FG000|STARTED|Overall Study||304
11091806|NCT01182428|12275172|FG001|STARTED|Overall Study||151
11091807|NCT01182428|12275171|FG000|COMPLETED|Overall Study||293
11091808|NCT01182428|12275172|FG001|COMPLETED|Overall Study||150
11091809|NCT01182428|12275171|FG000|NOT COMPLETED|Overall Study||11
11091810|NCT01182428|12275172|FG001|NOT COMPLETED|Overall Study||1
11091811|NCT01182441|12275180|FG000|STARTED|Overall Study||269
11091812|NCT01182441|12275181|FG001|STARTED|Overall Study||138
11091813|NCT01182441|12275180|FG000|COMPLETED|Overall Study||49
11091814|NCT01182441|12275181|FG001|COMPLETED|Overall Study||19
11091815|NCT01182441|12275180|FG000|NOT COMPLETED|Overall Study||220
11091816|NCT01182441|12275181|FG001|NOT COMPLETED|Overall Study||119
11091817|NCT01182480|12275187|FG000|STARTED|Overall Study||47
11091818|NCT01182480|12275187|FG000|COMPLETED|Overall Study||47
11091819|NCT01182480|12275187|FG000|NOT COMPLETED|Overall Study||0
11091820|NCT01182493|12275193|FG000|STARTED|Overall Study||168
11091821|NCT01182493|12275194|FG001|STARTED|Overall Study||163
11091822|NCT01182493|12275193|FG000|COMPLETED|Overall Study||152
11091823|NCT01182493|12275194|FG001|COMPLETED|Overall Study||156
11091824|NCT01182493|12275193|FG000|NOT COMPLETED|Overall Study||16
11091825|NCT01182493|12275194|FG001|NOT COMPLETED|Overall Study||7
11091826|NCT01182675|12275202|FG000|STARTED|Overall Study||7
11091827|NCT01182675|12275203|FG001|STARTED|Overall Study||0
11091828|NCT01182675|12275202|FG000|COMPLETED|Overall Study||7
11091829|NCT01182675|12275203|FG001|COMPLETED|Overall Study||0
11091830|NCT01182675|12275202|FG000|NOT COMPLETED|Overall Study||0
11091831|NCT01182675|12275203|FG001|NOT COMPLETED|Overall Study||0
11091832|NCT01182805|12275211|FG000|STARTED|Overall Study||50
11091833|NCT01182805|12275211|FG000|COMPLETED|Overall Study||50
11091834|NCT01182805|12275211|FG000|NOT COMPLETED|Overall Study||0
11091835|NCT01182844|12275219|FG000|STARTED|Overall Study||15
11091836|NCT01182844|12275220|FG001|STARTED|Overall Study||15
11091837|NCT01182844|12275219|FG000|COMPLETED|Overall Study||15
11091838|NCT01182844|12275220|FG001|COMPLETED|Overall Study||13
11091839|NCT01182844|12275219|FG000|NOT COMPLETED|Overall Study||0
11091840|NCT01182844|12275220|FG001|NOT COMPLETED|Overall Study||2
11091841|NCT01183013|12275233|FG000|STARTED|Overall Study||131
11091842|NCT01183013|12275234|FG001|STARTED|Overall Study||140
11091843|NCT01183013|12275235|FG002|STARTED|Overall Study||138
11091844|NCT01183013|12275236|FG003|STARTED|Overall Study||135
11091845|NCT01183013|12275237|FG004|STARTED|Overall Study||126
11091846|NCT01183013|12275238|FG005|STARTED|Overall Study||133
11091847|NCT01183013|12275239|FG006|STARTED|Overall Study||133
11091848|NCT01183013|12275233|FG000|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
11091849|NCT01183013|12275234|FG001|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
11091850|NCT01183013|12275235|FG002|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
11091851|NCT01183013|12275236|FG003|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
11091852|NCT01183013|12275237|FG004|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
11091853|NCT01183013|12275238|FG005|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
11091854|NCT01183013|12275239|FG006|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
11091855|NCT01183013|12275233|FG000|NOT COMPLETED|Overall Study||45
11091856|NCT01183013|12275234|FG001|NOT COMPLETED|Overall Study||39
11091857|NCT01183013|12275235|FG002|NOT COMPLETED|Overall Study||41
11091858|NCT01183013|12275236|FG003|NOT COMPLETED|Overall Study||30
11091859|NCT01183013|12275237|FG004|NOT COMPLETED|Overall Study||36
11091860|NCT01183013|12275238|FG005|NOT COMPLETED|Overall Study||45
11091861|NCT01183013|12275239|FG006|NOT COMPLETED|Overall Study||37
11091862|NCT01183065|12275256|FG000|STARTED|Overall Study||13
11091863|NCT01183065|12275256|FG000|COMPLETED|Overall Study||12
11091864|NCT01183065|12275256|FG000|NOT COMPLETED|Overall Study||1
11091865|NCT01183104|12275262|FG000|STARTED|Overall Study||153
11091866|NCT01183104|12275263|FG001|STARTED|Overall Study||152
11091867|NCT01183104|12275262|FG000|Received Study Drug|Overall Study||148
11091868|NCT01183104|12275263|FG001|Received Study Drug|Overall Study||143
11091869|NCT01183104|12275262|FG000|Continued Treatment for 12 Weeks|Overall Study||143
11091870|NCT01183104|12275263|FG001|Continued Treatment for 12 Weeks|Overall Study||129
11091871|NCT01183104|12275262|FG000|Completed 52-week Treatment|Overall Study||119
11091872|NCT01183104|12275263|FG001|Completed 52-week Treatment|Overall Study||111
11091873|NCT01183104|12275262|FG000|Enrolled in Extension Study|Overall Study||80
11091874|NCT01183104|12275263|FG001|Enrolled in Extension Study|Overall Study||61
11091875|NCT01183104|12275262|FG000|COMPLETED|Overall Study||76
11091876|NCT01183104|12275263|FG001|COMPLETED|Overall Study||60
11091877|NCT01183104|12275262|FG000|NOT COMPLETED|Overall Study||77
11091878|NCT01183104|12275263|FG001|NOT COMPLETED|Overall Study||92
11091879|NCT01183143|12275269|FG000|STARTED|Overall Study||215
11091880|NCT01183143|12275269|FG000|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
11091881|NCT01183143|12275269|FG000|COMPLETED|Overall Study||65
11091882|NCT01183143|12275269|FG000|NOT COMPLETED|Overall Study||150
11091883|NCT01183169|12275277|FG000|STARTED|Main Phase||121
11091884|NCT01183169|12275278|FG001|STARTED|Main Phase||115
11091885|NCT01183169|12275279|FG002|STARTED|Main Phase||59
11091886|NCT01183169|12275280|FG003|STARTED|Main Phase||55
11091887|NCT01183169|12275281|FG004|STARTED|Main Phase||109
11091888|NCT01183169|12275282|FG005|STARTED|Main Phase||0
11091889|NCT01183169|12275283|FG006|STARTED|Main Phase||0
11091890|NCT01183169|12275277|FG000|Completed Treatment|Main Phase||72
11091891|NCT01183169|12275278|FG001|Completed Treatment|Main Phase||78
11091892|NCT01183169|12275279|FG002|Completed Treatment|Main Phase||17
11091893|NCT01183169|12275280|FG003|Completed Treatment|Main Phase||17
11091894|NCT01183169|12275281|FG004|Completed Treatment|Main Phase||77
11091895|NCT01183169|12275282|FG005|Completed Treatment|Main Phase||0
11091896|NCT01183169|12275283|FG006|Completed Treatment|Main Phase||0
11091897|NCT01183169|12275277|FG000|Switched to ALV|Main Phase||0
11091898|NCT01183169|12275278|FG001|Switched to ALV|Main Phase||0
11351793|NCT03039179|12548837|FG001|STARTED|Overall Study||42
11351794|NCT03039179|12548836|FG000|COMPLETED|Overall Study||38
11091899|NCT01183169|12275279|FG002|Switched to ALV|Main Phase||35
11091900|NCT01183169|12275280|FG003|Switched to ALV|Main Phase||30
11091901|NCT01183169|12275281|FG004|Switched to ALV|Main Phase||0
11091902|NCT01183169|12275282|FG005|Switched to ALV|Main Phase||0
11091903|NCT01183169|12275283|FG006|Switched to ALV|Main Phase||0
11091904|NCT01183169|12275277|FG000|COMPLETED|Main Phase||94
11091905|NCT01183169|12275278|FG001|COMPLETED|Main Phase||93
11091906|NCT01183169|12275279|FG002|COMPLETED|Main Phase||18
11091907|NCT01183169|12275280|FG003|COMPLETED|Main Phase||18
11091908|NCT01183169|12275281|FG004|COMPLETED|Main Phase||83
11351795|NCT03039179|12548837|FG001|COMPLETED|Overall Study||42
11091909|NCT01183169|12275282|FG005|COMPLETED|Main Phase||0
11091910|NCT01183169|12275283|FG006|COMPLETED|Main Phase||0
11091911|NCT01183169|12275277|FG000|NOT COMPLETED|Main Phase||27
11091912|NCT01183169|12275278|FG001|NOT COMPLETED|Main Phase||22
11091913|NCT01183169|12275279|FG002|NOT COMPLETED|Main Phase||41
11091914|NCT01183169|12275280|FG003|NOT COMPLETED|Main Phase||37
11091915|NCT01183169|12275281|FG004|NOT COMPLETED|Main Phase||26
11091916|NCT01183169|12275282|FG005|NOT COMPLETED|Main Phase||0
11091917|NCT01183169|12275283|FG006|NOT COMPLETED|Main Phase||0
11091918|NCT01183169|12275277|FG000|STARTED|Post-switch Phase|Not a post-switch group|0
11091919|NCT01183169|12275278|FG001|STARTED|Post-switch Phase|Not a post-switch group|0
11091920|NCT01183169|12275279|FG002|STARTED|Post-switch Phase|Not a post-switch group|0
11091921|NCT01183169|12275280|FG003|STARTED|Post-switch Phase|Not a post-switch group|0
11091922|NCT01183169|12275281|FG004|STARTED|Post-switch Phase|Not a post-switch group|0
11091923|NCT01183169|12275282|FG005|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
11091924|NCT01183169|12275283|FG006|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
11091925|NCT01183169|12275277|FG000|Completed Treatment|Post-switch Phase||0
11091926|NCT01183169|12275278|FG001|Completed Treatment|Post-switch Phase||0
11091927|NCT01183169|12275279|FG002|Completed Treatment|Post-switch Phase||0
11091928|NCT01183169|12275280|FG003|Completed Treatment|Post-switch Phase||0
11091929|NCT01183169|12275281|FG004|Completed Treatment|Post-switch Phase||0
11091930|NCT01183169|12275282|FG005|Completed Treatment|Post-switch Phase||12
11091931|NCT01183169|12275283|FG006|Completed Treatment|Post-switch Phase||13
11091932|NCT01183169|12275277|FG000|COMPLETED|Post-switch Phase||0
11091933|NCT01183169|12275278|FG001|COMPLETED|Post-switch Phase||0
11091934|NCT01183169|12275279|FG002|COMPLETED|Post-switch Phase||0
11091935|NCT01183169|12275280|FG003|COMPLETED|Post-switch Phase||0
11091936|NCT01183169|12275281|FG004|COMPLETED|Post-switch Phase||0
11091937|NCT01183169|12275282|FG005|COMPLETED|Post-switch Phase||21
11091938|NCT01183169|12275283|FG006|COMPLETED|Post-switch Phase||21
11091939|NCT01183169|12275277|FG000|NOT COMPLETED|Post-switch Phase||0
11091940|NCT01183169|12275278|FG001|NOT COMPLETED|Post-switch Phase||0
11091941|NCT01183169|12275279|FG002|NOT COMPLETED|Post-switch Phase||0
11091942|NCT01183169|12275280|FG003|NOT COMPLETED|Post-switch Phase||0
11091943|NCT01183169|12275281|FG004|NOT COMPLETED|Post-switch Phase||0
11091944|NCT01183169|12275282|FG005|NOT COMPLETED|Post-switch Phase||14
11091945|NCT01183169|12275283|FG006|NOT COMPLETED|Post-switch Phase||9
11091946|NCT01183234|12275303|FG000|STARTED|First Intervention||14
11091947|NCT01183234|12275304|FG001|STARTED|First Intervention||14
11091948|NCT01183234|12275303|FG000|COMPLETED|First Intervention||13
11091949|NCT01183234|12275304|FG001|COMPLETED|First Intervention||14
11091950|NCT01183234|12275303|FG000|NOT COMPLETED|First Intervention||1
11091951|NCT01183234|12275304|FG001|NOT COMPLETED|First Intervention||0
11091952|NCT01183234|12275303|FG000|STARTED|Washout||13
11091953|NCT01183234|12275304|FG001|STARTED|Washout||14
11091954|NCT01183234|12275303|FG000|COMPLETED|Washout||13
11091955|NCT01183234|12275304|FG001|COMPLETED|Washout||14
11091956|NCT01183234|12275303|FG000|NOT COMPLETED|Washout||0
11091957|NCT01183234|12275304|FG001|NOT COMPLETED|Washout||0
11091958|NCT01183234|12275303|FG000|STARTED|Second Intervention||13
11091959|NCT01183234|12275304|FG001|STARTED|Second Intervention||14
11091960|NCT01183234|12275303|FG000|COMPLETED|Second Intervention||13
11091961|NCT01183234|12275304|FG001|COMPLETED|Second Intervention||14
11091962|NCT01183234|12275303|FG000|NOT COMPLETED|Second Intervention||0
11091963|NCT01183234|12275304|FG001|NOT COMPLETED|Second Intervention||0
11091964|NCT01183260|12275312|FG000|STARTED|Overall Study||14
11091965|NCT01183260|12275313|FG001|STARTED|Overall Study||11
11091966|NCT01183260|12275312|FG000|COMPLETED|Overall Study||10
11091967|NCT01183260|12275313|FG001|COMPLETED|Overall Study||9
11091968|NCT01183260|12275312|FG000|NOT COMPLETED|Overall Study||4
11091969|NCT01183260|12275313|FG001|NOT COMPLETED|Overall Study||2
11091970|NCT01183312|12275321|FG000|STARTED|First Intervention Day||5
11091971|NCT01183312|12275322|FG001|STARTED|First Intervention Day||5
11091972|NCT01183312|12275321|FG000|COMPLETED|First Intervention Day||5
11091973|NCT01183312|12275322|FG001|COMPLETED|First Intervention Day||5
11091974|NCT01183312|12275321|FG000|NOT COMPLETED|First Intervention Day||0
11091975|NCT01183312|12275322|FG001|NOT COMPLETED|First Intervention Day||0
11091976|NCT01183312|12275321|FG000|STARTED|Washout Period of at Least 1 Week||5
11091977|NCT01183312|12275322|FG001|STARTED|Washout Period of at Least 1 Week||5
11091978|NCT01183312|12275321|FG000|COMPLETED|Washout Period of at Least 1 Week||5
11091979|NCT01183312|12275322|FG001|COMPLETED|Washout Period of at Least 1 Week||5
11091980|NCT01183312|12275321|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0
11091981|NCT01183312|12275322|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0
11091982|NCT01183312|12275321|FG000|STARTED|Second Intervention Day||5
11091983|NCT01183312|12275322|FG001|STARTED|Second Intervention Day||5
11091984|NCT01183312|12275321|FG000|COMPLETED|Second Intervention Day||5
11091985|NCT01183312|12275322|FG001|COMPLETED|Second Intervention Day||5
11091986|NCT01183312|12275321|FG000|NOT COMPLETED|Second Intervention Day||0
11091987|NCT01183312|12275322|FG001|NOT COMPLETED|Second Intervention Day||0
11091988|NCT01183390|12275330|FG000|STARTED|First Intervention||11
11091989|NCT01183390|12275331|FG001|STARTED|First Intervention||11
11091990|NCT01183390|12275330|FG000|COMPLETED|First Intervention||11
11091991|NCT01183390|12275331|FG001|COMPLETED|First Intervention||10
11091992|NCT01183390|12275330|FG000|NOT COMPLETED|First Intervention||0
11091993|NCT01183390|12275331|FG001|NOT COMPLETED|First Intervention||1
11091994|NCT01183390|12275330|FG000|STARTED|Washout of 21 Days||11
11091995|NCT01183390|12275331|FG001|STARTED|Washout of 21 Days||10
11091996|NCT01183390|12275330|FG000|COMPLETED|Washout of 21 Days||11
11091997|NCT01183390|12275331|FG001|COMPLETED|Washout of 21 Days||10
11091998|NCT01183390|12275330|FG000|NOT COMPLETED|Washout of 21 Days||0
11091999|NCT01183390|12275331|FG001|NOT COMPLETED|Washout of 21 Days||0
11092000|NCT01183390|12275330|FG000|STARTED|Second Intervention||11
11092001|NCT01183390|12275331|FG001|STARTED|Second Intervention||10
11092002|NCT01183390|12275330|FG000|COMPLETED|Second Intervention||11
11092003|NCT01183390|12275331|FG001|COMPLETED|Second Intervention||10
11092004|NCT01183390|12275330|FG000|NOT COMPLETED|Second Intervention||0
11092005|NCT01183390|12275331|FG001|NOT COMPLETED|Second Intervention||0
11092006|NCT01183481|12275337|FG000|STARTED|Overall Study||19
11092007|NCT01183481|12275337|FG000|COMPLETED|Overall Study||19
11092008|NCT01183481|12275337|FG000|NOT COMPLETED|Overall Study||0
11092009|NCT01183533|12275342|FG000|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
11092010|NCT01183533|12275342|FG000|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
11092011|NCT01183533|12275342|FG000|NOT COMPLETED|Overall Study||0
11092012|NCT01183546|12275346|FG000|STARTED|Overall Study||53
11092013|NCT01183546|12275346|FG000|COMPLETED|Overall Study||53
11092014|NCT01183546|12275346|FG000|NOT COMPLETED|Overall Study||0
11092015|NCT01183559|12275351|FG000|STARTED|Overall Study||9
11092016|NCT01183559|12275351|FG000|COMPLETED|Overall Study||9
11092017|NCT01183559|12275351|FG000|NOT COMPLETED|Overall Study||0
11092018|NCT01183650|12275358|FG000|STARTED|Overall Study||12
11092019|NCT01183650|12275359|FG001|STARTED|Overall Study||12
11092020|NCT01183650|12275358|FG000|COMPLETED|Overall Study||12
11092021|NCT01183650|12275359|FG001|COMPLETED|Overall Study||12
11092022|NCT01183650|12275358|FG000|NOT COMPLETED|Overall Study||0
11092023|NCT01183650|12275359|FG001|NOT COMPLETED|Overall Study||0
11092024|NCT01183689|12275368|FG000|STARTED|Overall Study||202
11092025|NCT01183689|12275369|FG001|STARTED|Overall Study||200
11092026|NCT01183689|12275370|FG002|STARTED|Overall Study||197
11092027|NCT01183689|12275368|FG000|Month 4 Visit|Overall Study||197
11092028|NCT01183689|12275369|FG001|Month 4 Visit|Overall Study||192
11092029|NCT01183689|12275370|FG002|Month 4 Visit|Overall Study||187
11092030|NCT01183689|12275368|FG000|Year 1 Visit|Overall Study||187
11092031|NCT01183689|12275369|FG001|Year 1 Visit|Overall Study||172
11092032|NCT01183689|12275370|FG002|Year 1 Visit|Overall Study||183
11092033|NCT01183689|12275368|FG000|Year 2 Visit|Overall Study||178
11092034|NCT01183689|12275369|FG001|Year 2 Visit|Overall Study||172
11092035|NCT01183689|12275370|FG002|Year 2 Visit|Overall Study||174
11092036|NCT01183689|12275368|FG000|Year 3 Visit|Overall Study||139
11092037|NCT01183689|12275369|FG001|Year 3 Visit|Overall Study||125
11092038|NCT01183689|12275370|FG002|Year 3 Visit|Overall Study||126
11092039|NCT01183689|12275368|FG000|Year 4 Visit|Overall Study||38
11092040|NCT01183689|12275369|FG001|Year 4 Visit|Overall Study||33
11092041|NCT01183689|12275370|FG002|Year 4 Visit|Overall Study||30
11092042|NCT01183689|12275368|FG000|COMPLETED|Overall Study||202
11092043|NCT01183689|12275369|FG001|COMPLETED|Overall Study||200
11092044|NCT01183689|12275370|FG002|COMPLETED|Overall Study||197
11092045|NCT01183689|12275368|FG000|NOT COMPLETED|Overall Study||0
11092046|NCT01183689|12275369|FG001|NOT COMPLETED|Overall Study||0
11092047|NCT01183689|12275370|FG002|NOT COMPLETED|Overall Study||0
11092048|NCT01183728|12275380|FG000|STARTED|Overall Study||12
11092049|NCT01183728|12275380|FG000|COMPLETED|Overall Study||12
11092050|NCT01183728|12275380|FG000|NOT COMPLETED|Overall Study||0
11092051|NCT01183780|12275386|FG000|STARTED|Overall Study||536
11092052|NCT01183780|12275387|FG001|STARTED|Overall Study||536
11092053|NCT01183780|12275386|FG000|Received at Least 1 Dose of Study Drug|Overall Study||528
11092054|NCT01183780|12275387|FG001|Received at Least 1 Dose of Study Drug|Overall Study||529
11092055|NCT01183780|12275386|FG000|COMPLETED|Overall Study||505
11092056|NCT01183780|12275387|FG001|COMPLETED|Overall Study||511
11092057|NCT01183780|12275386|FG000|NOT COMPLETED|Overall Study||31
11092058|NCT01183780|12275387|FG001|NOT COMPLETED|Overall Study||25
11092059|NCT01183858|12275395|FG000|STARTED|Overall Study||154
11092060|NCT01183858|12275396|FG001|STARTED|Overall Study||159
11092061|NCT01183858|12275395|FG000|Safety Population|Overall Study||154
11092062|NCT01183858|12275396|FG001|Safety Population|Overall Study||158
11092063|NCT01183858|12275395|FG000|COMPLETED|Overall Study||1
11092064|NCT01183858|12275396|FG001|COMPLETED|Overall Study||3
11092065|NCT01183858|12275395|FG000|NOT COMPLETED|Overall Study||153
11092066|NCT01183858|12275396|FG001|NOT COMPLETED|Overall Study||156
11092067|NCT01183923|12275402|FG000|STARTED|Intervention 1 (7 Days)||1
11092068|NCT01183923|12275403|FG001|STARTED|Intervention 1 (7 Days)||0
11092069|NCT01183923|12275402|FG000|COMPLETED|Intervention 1 (7 Days)||1
11092070|NCT01183923|12275403|FG001|COMPLETED|Intervention 1 (7 Days)||0
11092071|NCT01183923|12275402|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0
11092072|NCT01183923|12275403|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0
11092073|NCT01183923|12275402|FG000|STARTED|Washout (14 Days)||1
11092074|NCT01183923|12275403|FG001|STARTED|Washout (14 Days)||0
11092075|NCT01183923|12275402|FG000|COMPLETED|Washout (14 Days)||1
11092076|NCT01183923|12275403|FG001|COMPLETED|Washout (14 Days)||0
11092077|NCT01183923|12275402|FG000|NOT COMPLETED|Washout (14 Days)||0
11092078|NCT01183923|12275403|FG001|NOT COMPLETED|Washout (14 Days)||0
11092079|NCT01183923|12275402|FG000|STARTED|Intervention 2 (7 Days)||1
11092080|NCT01183923|12275403|FG001|STARTED|Intervention 2 (7 Days)||0
11092081|NCT01183923|12275402|FG000|COMPLETED|Intervention 2 (7 Days)||1
11092082|NCT01183923|12275403|FG001|COMPLETED|Intervention 2 (7 Days)||0
11092083|NCT01183923|12275402|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0
11092084|NCT01183923|12275403|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0
11092085|NCT01183975|12275408|FG000|STARTED|Overall Study||517
11092086|NCT01183975|12275408|FG000|COMPLETED|Overall Study||444
11092087|NCT01183975|12275408|FG000|NOT COMPLETED|Overall Study||73
11092088|NCT01184014|12275414|FG000|STARTED|Overall Study||35
11092089|NCT01184014|12275415|FG001|STARTED|Overall Study||37
11092090|NCT01184014|12275414|FG000|COMPLETED|Overall Study||30
11092091|NCT01184014|12275415|FG001|COMPLETED|Overall Study||31
11092092|NCT01184014|12275414|FG000|NOT COMPLETED|Overall Study||5
11092093|NCT01184014|12275415|FG001|NOT COMPLETED|Overall Study||6
11092094|NCT01184053|12275421|FG000|STARTED|Overall Study||3
11092095|NCT01184053|12275421|FG000|COMPLETED|Overall Study||0
11092096|NCT01184053|12275421|FG000|NOT COMPLETED|Overall Study||3
11092097|NCT01184079|12275428|FG000|STARTED|Overall Study||111
11092098|NCT01184079|12275429|FG001|STARTED|Overall Study||109
11092099|NCT01184079|12275428|FG000|Dose 2|Overall Study||110
11092100|NCT01184079|12275429|FG001|Dose 2|Overall Study||108
11092101|NCT01184079|12275428|FG000|Dose 3|Overall Study||101
11092102|NCT01184079|12275429|FG001|Dose 3|Overall Study||107
11092103|NCT01184079|12275428|FG000|Final Blood Draw|Overall Study||97
11092104|NCT01184079|12275429|FG001|Final Blood Draw|Overall Study||107
11092105|NCT01184079|12275428|FG000|COMPLETED|Overall Study||97
11092106|NCT01184079|12275429|FG001|COMPLETED|Overall Study||107
11092107|NCT01184079|12275428|FG000|NOT COMPLETED|Overall Study||14
11092108|NCT01184079|12275429|FG001|NOT COMPLETED|Overall Study||2
11092109|NCT01184118|12275437|FG000|STARTED|Overall Study||36
11092110|NCT01184118|12275437|FG000|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
11092111|NCT01184118|12275437|FG000|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
11092112|NCT01184118|12275437|FG000|FP MDI as Indicated (2 Weeks)|Overall Study||18
11092113|NCT01184118|12275437|FG000|COMPLETED|Overall Study||18
11092114|NCT01184118|12275437|FG000|NOT COMPLETED|Overall Study||18
11092115|NCT01184326|12275444|FG000|STARTED|Overall Study||3
11092116|NCT01184326|12275445|FG001|STARTED|Overall Study||6
11092117|NCT01184326|12275446|FG002|STARTED|Overall Study||14
11092118|NCT01184326|12275444|FG000|COMPLETED|Overall Study||0
11092119|NCT01184326|12275445|FG001|COMPLETED|Overall Study||0
11092120|NCT01184326|12275446|FG002|COMPLETED|Overall Study||0
11092121|NCT01184326|12275444|FG000|NOT COMPLETED|Overall Study||3
11092122|NCT01184326|12275445|FG001|NOT COMPLETED|Overall Study||6
11092123|NCT01184326|12275446|FG002|NOT COMPLETED|Overall Study||14
11092124|NCT01184417|12275459|FG000|STARTED|Overall Study||51
11092125|NCT01184417|12275460|FG001|STARTED|Overall Study||51
11092126|NCT01184417|12275459|FG000|COMPLETED|Overall Study||51
11092127|NCT01184417|12275460|FG001|COMPLETED|Overall Study||51
11092128|NCT01184417|12275459|FG000|NOT COMPLETED|Overall Study||0
11092129|NCT01184417|12275460|FG001|NOT COMPLETED|Overall Study||0
11092130|NCT01184508|12275468|FG000|STARTED|Overall Study||45
11092131|NCT01184508|12275469|FG001|STARTED|Overall Study||42
11092132|NCT01184508|12275468|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45
11092133|NCT01184508|12275469|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
11092134|NCT01184508|12275468|FG000|COMPLETED|Overall Study||29
11092135|NCT01184508|12275469|FG001|COMPLETED|Overall Study||27
11092136|NCT01184508|12275468|FG000|NOT COMPLETED|Overall Study||16
11092137|NCT01184508|12275469|FG001|NOT COMPLETED|Overall Study||15
11092138|NCT01184755|12275479|FG000|STARTED|Overall Study||126
11092139|NCT01184755|12275480|FG001|STARTED|Overall Study||65
11092140|NCT01184755|12275481|FG002|STARTED|Overall Study||62
11092141|NCT01184755|12275479|FG000|COMPLETED|Overall Study||101
11092142|NCT01184755|12275480|FG001|COMPLETED|Overall Study||54
11092143|NCT01184755|12275481|FG002|COMPLETED|Overall Study||56
11092144|NCT01184755|12275479|FG000|NOT COMPLETED|Overall Study||25
11092145|NCT01184755|12275480|FG001|NOT COMPLETED|Overall Study||11
11092146|NCT01184755|12275481|FG002|NOT COMPLETED|Overall Study||6
11092147|NCT01184846|12275489|FG000|STARTED|Overall Study||28
11092148|NCT01184846|12275489|FG000|COMPLETED|Overall Study||25
11092149|NCT01184846|12275489|FG000|NOT COMPLETED|Overall Study||3
11092150|NCT01184859|12275500|FG000|STARTED|Period 1: Single Dose||23
11092151|NCT01184859|12275501|FG001|STARTED|Period 1: Single Dose||25
11092152|NCT01184859|12275502|FG002|STARTED|Period 1: Single Dose||22
11092153|NCT01184859|12275503|FG003|STARTED|Period 1: Single Dose||22
11092154|NCT01184859|12275504|FG004|STARTED|Period 1: Single Dose||24
11092155|NCT01184859|12275500|FG000|Full Analysis Set (FAS)|Period 1: Single Dose||23
11092156|NCT01184859|12275501|FG001|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
11092157|NCT01184859|12275502|FG002|Full Analysis Set (FAS)|Period 1: Single Dose||22
11092158|NCT01184859|12275503|FG003|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
11092159|NCT01184859|12275504|FG004|Full Analysis Set (FAS)|Period 1: Single Dose||24
11092160|NCT01184859|12275500|FG000|Per Protocol (PP)|Period 1: Single Dose||23
11092161|NCT01184859|12275501|FG001|Per Protocol (PP)|Period 1: Single Dose||23
11092162|NCT01184859|12275502|FG002|Per Protocol (PP)|Period 1: Single Dose||22
11092163|NCT01184859|12275503|FG003|Per Protocol (PP)|Period 1: Single Dose||21
11092164|NCT01184859|12275504|FG004|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
11092165|NCT01184859|12275500|FG000|COMPLETED|Period 1: Single Dose||23
11092166|NCT01184859|12275501|FG001|COMPLETED|Period 1: Single Dose||23
11092167|NCT01184859|12275502|FG002|COMPLETED|Period 1: Single Dose||22
11092168|NCT01184859|12275503|FG003|COMPLETED|Period 1: Single Dose||22
11092169|NCT01184859|12275504|FG004|COMPLETED|Period 1: Single Dose||23
11092170|NCT01184859|12275500|FG000|NOT COMPLETED|Period 1: Single Dose||0
11092171|NCT01184859|12275501|FG001|NOT COMPLETED|Period 1: Single Dose||2
11092172|NCT01184859|12275502|FG002|NOT COMPLETED|Period 1: Single Dose||0
11092173|NCT01184859|12275503|FG003|NOT COMPLETED|Period 1: Single Dose||0
11092174|NCT01184859|12275504|FG004|NOT COMPLETED|Period 1: Single Dose||1
11092175|NCT01184859|12275500|FG000|STARTED|Washout Period||23
11092176|NCT01184859|12275501|FG001|STARTED|Washout Period||23
11092177|NCT01184859|12275502|FG002|STARTED|Washout Period||22
11092178|NCT01184859|12275503|FG003|STARTED|Washout Period||22
11092179|NCT01184859|12275504|FG004|STARTED|Washout Period||23
11092180|NCT01184859|12275500|FG000|COMPLETED|Washout Period||23
11092181|NCT01184859|12275501|FG001|COMPLETED|Washout Period||23
11092182|NCT01184859|12275502|FG002|COMPLETED|Washout Period||22
11092183|NCT01184859|12275503|FG003|COMPLETED|Washout Period||22
11092184|NCT01184859|12275504|FG004|COMPLETED|Washout Period||23
11092185|NCT01184859|12275500|FG000|NOT COMPLETED|Washout Period||0
11092186|NCT01184859|12275501|FG001|NOT COMPLETED|Washout Period||0
11092187|NCT01184859|12275502|FG002|NOT COMPLETED|Washout Period||0
11092188|NCT01184859|12275503|FG003|NOT COMPLETED|Washout Period||0
11092189|NCT01184859|12275504|FG004|NOT COMPLETED|Washout Period||0
11092190|NCT01184859|12275500|FG000|STARTED|Period 2: Daily Dose for 28 Days||23
11092191|NCT01184859|12275501|FG001|STARTED|Period 2: Daily Dose for 28 Days||23
11092192|NCT01184859|12275502|FG002|STARTED|Period 2: Daily Dose for 28 Days||22
11092193|NCT01184859|12275503|FG003|STARTED|Period 2: Daily Dose for 28 Days||22
11092194|NCT01184859|12275504|FG004|STARTED|Period 2: Daily Dose for 28 Days||23
11092195|NCT01184859|12275500|FG000|COMPLETED|Period 2: Daily Dose for 28 Days||22
11092196|NCT01184859|12275501|FG001|COMPLETED|Period 2: Daily Dose for 28 Days||23
11092197|NCT01184859|12275502|FG002|COMPLETED|Period 2: Daily Dose for 28 Days||22
11092198|NCT01184859|12275503|FG003|COMPLETED|Period 2: Daily Dose for 28 Days||22
11092199|NCT01184859|12275504|FG004|COMPLETED|Period 2: Daily Dose for 28 Days||22
11092200|NCT01184859|12275500|FG000|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
11092201|NCT01184859|12275501|FG001|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
11092202|NCT01184859|12275502|FG002|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
11092203|NCT01184859|12275503|FG003|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
11092204|NCT01184859|12275504|FG004|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
11092205|NCT01184872|12275523|FG000|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
11092206|NCT01184872|12275524|FG001|STARTED|Overall Study||39
11351796|NCT03039179|12548836|FG000|NOT COMPLETED|Overall Study||0
11092207|NCT01184872|12275523|FG000|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
11351797|NCT03039179|12548837|FG001|NOT COMPLETED|Overall Study||0
11092208|NCT01184872|12275524|FG001|Safety Set|Overall Study||40
11092209|NCT01184872|12275523|FG000|Clinical Evaluable Set (CES)|Overall Study||73
11092210|NCT01184872|12275524|FG001|Clinical Evaluable Set (CES)|Overall Study||30
11092211|NCT01184872|12275523|FG000|Microbiologically Evaluable Set (MES)|Overall Study||65
11092212|NCT01184872|12275524|FG001|Microbiologically Evaluable Set (MES)|Overall Study||27
11092213|NCT01184872|12275523|FG000|COMPLETED|Overall Study||71
11092214|NCT01184872|12275524|FG001|COMPLETED|Overall Study||31
11092215|NCT01184872|12275523|FG000|NOT COMPLETED|Overall Study||10
11092216|NCT01184872|12275524|FG001|NOT COMPLETED|Overall Study||8
11092217|NCT01184885|12275530|FG000|STARTED|Overall Study||7
11092218|NCT01184885|12275530|FG000|COMPLETED|Overall Study||7
11092219|NCT01184885|12275530|FG000|NOT COMPLETED|Overall Study||0
11092220|NCT01184898|12275535|FG000|STARTED|Overall Study||36
11092221|NCT01184898|12275535|FG000|COMPLETED|Overall Study||36
11092222|NCT01184898|12275535|FG000|NOT COMPLETED|Overall Study||0
11092223|NCT01184989|12275539|FG000|STARTED|Overall Study|Treated Patients|112
11092224|NCT01184989|12275539|FG000|COMPLETED|Overall Study||100
11092225|NCT01184989|12275539|FG000|NOT COMPLETED|Overall Study||12
11092226|NCT01185028|12275543|FG000|STARTED|Overall Study||8
11092227|NCT01185028|12275543|FG000|COMPLETED|Overall Study||4
11092228|NCT01185028|12275543|FG000|NOT COMPLETED|Overall Study||4
11092229|NCT01185080|12275550|FG000|STARTED|Overall Study||50
11092230|NCT01185080|12275551|FG001|STARTED|Overall Study||16
11092231|NCT01185080|12275552|FG002|STARTED|Overall Study||17
11092232|NCT01185080|12275550|FG000|COMPLETED|Overall Study||49
11092233|NCT01185080|12275551|FG001|COMPLETED|Overall Study||15
11092234|NCT01185080|12275552|FG002|COMPLETED|Overall Study||16
11092235|NCT01185080|12275550|FG000|NOT COMPLETED|Overall Study||1
11092236|NCT01185080|12275551|FG001|NOT COMPLETED|Overall Study||1
11092237|NCT01185080|12275552|FG002|NOT COMPLETED|Overall Study||1
11092238|NCT01185171|12275560|FG000|STARTED|Induction Chemotherapy||59
11092239|NCT01185171|12275560|FG000|COMPLETED|Induction Chemotherapy||57
11092240|NCT01185171|12275560|FG000|NOT COMPLETED|Induction Chemotherapy||2
11351798|NCT03039192|12548845|FG000|STARTED|Overall Study||112
11092241|NCT01185171|12275560|FG000|STARTED|Concurrent Chemo and Radiation Treatment||69
11092242|NCT01185171|12275560|FG000|COMPLETED|Concurrent Chemo and Radiation Treatment||66
11092243|NCT01185171|12275560|FG000|NOT COMPLETED|Concurrent Chemo and Radiation Treatment||3
11092244|NCT01185171|12275560|FG000|STARTED|Maintenance||60
11092245|NCT01185171|12275560|FG000|COMPLETED|Maintenance||48
11092246|NCT01185171|12275560|FG000|NOT COMPLETED|Maintenance||12
11092247|NCT01185249|12275564|FG000|STARTED|Overall Study|Total number of patients consented to participate.|66
11092248|NCT01185249|12275564|FG000|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
11092249|NCT01185249|12275564|FG000|NOT COMPLETED|Overall Study||42
11092250|NCT01185288|12275571|FG000|STARTED|Overall Study||154
11092251|NCT01185288|12275572|FG001|STARTED|Overall Study||155
11092252|NCT01185288|12275571|FG000|COMPLETED|Overall Study||135
11092253|NCT01185288|12275572|FG001|COMPLETED|Overall Study||139
11092254|NCT01185288|12275571|FG000|NOT COMPLETED|Overall Study||19
11092255|NCT01185288|12275572|FG001|NOT COMPLETED|Overall Study||16
11092256|NCT01185301|12275582|FG000|STARTED|Overall Study||98
11092257|NCT01185301|12275583|FG001|STARTED|Overall Study||100
11092258|NCT01185301|12275584|FG002|STARTED|Overall Study||99
11092259|NCT01185301|12275585|FG003|STARTED|Overall Study||98
11092260|NCT01185301|12275582|FG000|COMPLETED|Overall Study||83
11092261|NCT01185301|12275583|FG001|COMPLETED|Overall Study||93
11092262|NCT01185301|12275584|FG002|COMPLETED|Overall Study||93
11092263|NCT01185301|12275585|FG003|COMPLETED|Overall Study||89
11092264|NCT01185301|12275582|FG000|NOT COMPLETED|Overall Study||15
11092265|NCT01185301|12275583|FG001|NOT COMPLETED|Overall Study||7
11092266|NCT01185301|12275584|FG002|NOT COMPLETED|Overall Study||6
11092267|NCT01185301|12275585|FG003|NOT COMPLETED|Overall Study||9
11092268|NCT01185340|12275598|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
11092269|NCT01185340|12275599|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
11092270|NCT01185340|12275600|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
11092271|NCT01185340|12275601|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
11092272|NCT01185340|12275598|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
11092273|NCT01185340|12275599|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
11092274|NCT01185340|12275600|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
11092275|NCT01185340|12275601|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
11092276|NCT01185340|12275598|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
11092277|NCT01185340|12275599|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11092278|NCT01185340|12275600|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11092279|NCT01185340|12275601|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11092280|NCT01185340|12275598|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
11092281|NCT01185340|12275599|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11092282|NCT01185340|12275600|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11092283|NCT01185340|12275601|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11092284|NCT01185340|12275598|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11092285|NCT01185340|12275599|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
11092286|NCT01185340|12275600|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
11092287|NCT01185340|12275601|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
11092288|NCT01185340|12275598|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11092289|NCT01185340|12275599|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
11092290|NCT01185340|12275600|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
11092291|NCT01185340|12275601|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
11092292|NCT01185340|12275598|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11092293|NCT01185340|12275599|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
11092294|NCT01185340|12275600|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
11092295|NCT01185340|12275601|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
11092296|NCT01185340|12275598|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11092297|NCT01185340|12275599|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
11092298|NCT01185340|12275600|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
11092299|NCT01185340|12275601|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
11092300|NCT01185353|12275618|FG000|STARTED|Part A (Weeks 0 Through 12)||49
11092301|NCT01185353|12275619|FG001|STARTED|Part A (Weeks 0 Through 12)||52
11092302|NCT01185353|12275620|FG002|STARTED|Part A (Weeks 0 Through 12)||52
11092303|NCT01185353|12275621|FG003|STARTED|Part A (Weeks 0 Through 12)||50
11092304|NCT01185353|12275622|FG004|STARTED|Part A (Weeks 0 Through 12)||98
11092305|NCT01185353|12275623|FG005|STARTED|Part A (Weeks 0 Through 12)||0
11092306|NCT01185353|12275624|FG006|STARTED|Part A (Weeks 0 Through 12)||0
11092307|NCT01185353|12275625|FG007|STARTED|Part A (Weeks 0 Through 12)||0
11092308|NCT01185353|12275626|FG008|STARTED|Part A (Weeks 0 Through 12)||0
11092309|NCT01185353|12275627|FG009|STARTED|Part A (Weeks 0 Through 12)||0
11351799|NCT03039192|12548846|FG001|STARTED|Overall Study||114
11351800|NCT03039192|12548845|FG000|Treated|Overall Study||112
11351801|NCT03039192|12548846|FG001|Treated|Overall Study||113
11351802|NCT03039192|12548845|FG000|COMPLETED|Overall Study||80
11351803|NCT03039192|12548846|FG001|COMPLETED|Overall Study||84
11351804|NCT03039192|12548845|FG000|NOT COMPLETED|Overall Study||32
11092310|NCT01185353|12275618|FG000|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
11092311|NCT01185353|12275619|FG001|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
11092312|NCT01185353|12275620|FG002|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
11092313|NCT01185353|12275621|FG003|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
11092314|NCT01185353|12275622|FG004|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
11092315|NCT01185353|12275623|FG005|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
11092316|NCT01185353|12275624|FG006|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
11092317|NCT01185353|12275625|FG007|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
11092318|NCT01185353|12275626|FG008|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
11092319|NCT01185353|12275627|FG009|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
11092320|NCT01185353|12275618|FG000|COMPLETED|Part A (Weeks 0 Through 12)||44
11092321|NCT01185353|12275619|FG001|COMPLETED|Part A (Weeks 0 Through 12)||51
11092322|NCT01185353|12275620|FG002|COMPLETED|Part A (Weeks 0 Through 12)||50
11092323|NCT01185353|12275621|FG003|COMPLETED|Part A (Weeks 0 Through 12)||49
11092324|NCT01185353|12275622|FG004|COMPLETED|Part A (Weeks 0 Through 12)||82
11351805|NCT03039192|12548846|FG001|NOT COMPLETED|Overall Study||30
11351806|NCT03039283|12548852|FG000|STARTED|Overall Study||162
11351807|NCT03039283|12548852|FG000|COMPLETED|Overall Study||160
11351808|NCT03039283|12548852|FG000|NOT COMPLETED|Overall Study||2
11351809|NCT03039543|12548858|FG000|STARTED|Overall Study||54
11351810|NCT03039543|12548859|FG001|STARTED|Overall Study||54
11351811|NCT03039543|12548858|FG000|COMPLETED|Overall Study||53
11351812|NCT03039543|12548859|FG001|COMPLETED|Overall Study||51
11351813|NCT03039543|12548858|FG000|NOT COMPLETED|Overall Study||1
11351814|NCT03039543|12548859|FG001|NOT COMPLETED|Overall Study||3
11351815|NCT03039569|12548867|FG000|STARTED|Overall Study||40
11351816|NCT03039569|12548868|FG001|STARTED|Overall Study||39
11351817|NCT03039569|12548867|FG000|COMPLETED|Overall Study||35
11351818|NCT03039569|12548868|FG001|COMPLETED|Overall Study||35
11092325|NCT01185353|12275623|FG005|COMPLETED|Part A (Weeks 0 Through 12)||0
11092326|NCT01185353|12275624|FG006|COMPLETED|Part A (Weeks 0 Through 12)||0
11092327|NCT01185353|12275625|FG007|COMPLETED|Part A (Weeks 0 Through 12)||0
11092328|NCT01185353|12275626|FG008|COMPLETED|Part A (Weeks 0 Through 12)||0
11092329|NCT01185353|12275627|FG009|COMPLETED|Part A (Weeks 0 Through 12)||0
11092330|NCT01185353|12275618|FG000|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
11092331|NCT01185353|12275619|FG001|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
11092332|NCT01185353|12275620|FG002|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
11092333|NCT01185353|12275621|FG003|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
11092334|NCT01185353|12275622|FG004|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
11092335|NCT01185353|12275623|FG005|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
11092336|NCT01185353|12275624|FG006|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
11092337|NCT01185353|12275625|FG007|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
11092338|NCT01185353|12275626|FG008|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
11092339|NCT01185353|12275627|FG009|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
11092340|NCT01185353|12275618|FG000|STARTED|Part B (Weeks 12 Through 24)||0
11092341|NCT01185353|12275619|FG001|STARTED|Part B (Weeks 12 Through 24)||51
11092342|NCT01185353|12275620|FG002|STARTED|Part B (Weeks 12 Through 24)||50
11092343|NCT01185353|12275621|FG003|STARTED|Part B (Weeks 12 Through 24)||49
11092344|NCT01185353|12275622|FG004|STARTED|Part B (Weeks 12 Through 24)||0
11092345|NCT01185353|12275623|FG005|STARTED|Part B (Weeks 12 Through 24)||63
11092346|NCT01185353|12275624|FG006|STARTED|Part B (Weeks 12 Through 24)||63
11092347|NCT01185353|12275625|FG007|STARTED|Part B (Weeks 12 Through 24)||0
11092348|NCT01185353|12275626|FG008|STARTED|Part B (Weeks 12 Through 24)||0
11092349|NCT01185353|12275627|FG009|STARTED|Part B (Weeks 12 Through 24)||0
11092350|NCT01185353|12275618|FG000|COMPLETED|Part B (Weeks 12 Through 24)||0
11092351|NCT01185353|12275619|FG001|COMPLETED|Part B (Weeks 12 Through 24)||50
11092352|NCT01185353|12275620|FG002|COMPLETED|Part B (Weeks 12 Through 24)||48
11092353|NCT01185353|12275621|FG003|COMPLETED|Part B (Weeks 12 Through 24)||45
11092354|NCT01185353|12275622|FG004|COMPLETED|Part B (Weeks 12 Through 24)||0
11092355|NCT01185353|12275623|FG005|COMPLETED|Part B (Weeks 12 Through 24)||59
11092356|NCT01185353|12275624|FG006|COMPLETED|Part B (Weeks 12 Through 24)||57
11092357|NCT01185353|12275625|FG007|COMPLETED|Part B (Weeks 12 Through 24)||0
11092358|NCT01185353|12275626|FG008|COMPLETED|Part B (Weeks 12 Through 24)||0
11092359|NCT01185353|12275627|FG009|COMPLETED|Part B (Weeks 12 Through 24)||0
11092360|NCT01185353|12275618|FG000|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
11092361|NCT01185353|12275619|FG001|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
11092362|NCT01185353|12275620|FG002|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
11092363|NCT01185353|12275621|FG003|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
11092364|NCT01185353|12275622|FG004|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
11092365|NCT01185353|12275623|FG005|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
11092366|NCT01185353|12275624|FG006|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
11092367|NCT01185353|12275625|FG007|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
11092368|NCT01185353|12275626|FG008|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
11092369|NCT01185353|12275627|FG009|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
11092370|NCT01185353|12275618|FG000|STARTED|Part C (Weeks 24 Through 76)||0
11092371|NCT01185353|12275619|FG001|STARTED|Part C (Weeks 24 Through 76)||0
11092372|NCT01185353|12275620|FG002|STARTED|Part C (Weeks 24 Through 76)||0
11092373|NCT01185353|12275621|FG003|STARTED|Part C (Weeks 24 Through 76)||0
11092374|NCT01185353|12275622|FG004|STARTED|Part C (Weeks 24 Through 76)||0
11092375|NCT01185353|12275623|FG005|STARTED|Part C (Weeks 24 Through 76)||0
11092376|NCT01185353|12275624|FG006|STARTED|Part C (Weeks 24 Through 76)||0
11092377|NCT01185353|12275625|FG007|STARTED|Part C (Weeks 24 Through 76)||108
11092378|NCT01185353|12275626|FG008|STARTED|Part C (Weeks 24 Through 76)||61
11092379|NCT01185353|12275627|FG009|STARTED|Part C (Weeks 24 Through 76)||32
11092380|NCT01185353|12275618|FG000|COMPLETED|Part C (Weeks 24 Through 76)||0
11092381|NCT01185353|12275619|FG001|COMPLETED|Part C (Weeks 24 Through 76)||0
11092382|NCT01185353|12275620|FG002|COMPLETED|Part C (Weeks 24 Through 76)||0
11092383|NCT01185353|12275621|FG003|COMPLETED|Part C (Weeks 24 Through 76)||0
11092384|NCT01185353|12275622|FG004|COMPLETED|Part C (Weeks 24 Through 76)||0
11092385|NCT01185353|12275623|FG005|COMPLETED|Part C (Weeks 24 Through 76)||0
11092386|NCT01185353|12275624|FG006|COMPLETED|Part C (Weeks 24 Through 76)||0
11092387|NCT01185353|12275625|FG007|COMPLETED|Part C (Weeks 24 Through 76)||92
11092388|NCT01185353|12275626|FG008|COMPLETED|Part C (Weeks 24 Through 76)||53
11092389|NCT01185353|12275627|FG009|COMPLETED|Part C (Weeks 24 Through 76)||24
11092390|NCT01185353|12275618|FG000|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
11092391|NCT01185353|12275619|FG001|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
11092392|NCT01185353|12275620|FG002|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
11092393|NCT01185353|12275621|FG003|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
11092394|NCT01185353|12275622|FG004|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
11092395|NCT01185353|12275623|FG005|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
11092396|NCT01185353|12275624|FG006|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
11092397|NCT01185353|12275625|FG007|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
11092398|NCT01185353|12275626|FG008|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
11092399|NCT01185353|12275627|FG009|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
11092400|NCT01185353|12275618|FG000|STARTED|Part D (Weeks 76 Through 128)||0
11092401|NCT01185353|12275619|FG001|STARTED|Part D (Weeks 76 Through 128)||0
11092402|NCT01185353|12275620|FG002|STARTED|Part D (Weeks 76 Through 128)||0
11208185|NCT04838054|12399382|FG000|STARTED|Overall Study||29
11208186|NCT04838054|12399383|FG001|STARTED|Overall Study||28
11208187|NCT04838054|12399382|FG000|COMPLETED|Overall Study||27
11208188|NCT04838054|12399383|FG001|COMPLETED|Overall Study||28
11208189|NCT04838054|12399382|FG000|NOT COMPLETED|Overall Study||2
11208190|NCT04838054|12399383|FG001|NOT COMPLETED|Overall Study||0
11208191|NCT04495829|12399389|FG000|STARTED|Overall Study||70
11208192|NCT04495829|12399389|FG000|COMPLETED|Overall Study||65
11208193|NCT04495829|12399389|FG000|NOT COMPLETED|Overall Study||5
11351819|NCT03039569|12548867|FG000|NOT COMPLETED|Overall Study||5
11351820|NCT03039569|12548868|FG001|NOT COMPLETED|Overall Study||4
11351821|NCT03039621|12548877|FG000|STARTED|Overall Study||143
11351822|NCT03039621|12548878|FG001|STARTED|Overall Study||144
11351823|NCT03039621|12548877|FG000|COMPLETED|Overall Study||131
11351824|NCT03039621|12548878|FG001|COMPLETED|Overall Study||128
11351825|NCT03039621|12548877|FG000|NOT COMPLETED|Overall Study||12
11351826|NCT03039621|12548878|FG001|NOT COMPLETED|Overall Study||16
11351827|NCT03039686|12548887|FG000|STARTED|Double-blind Period||56
11351828|NCT03039686|12548888|FG001|STARTED|Double-blind Period||55
11351829|NCT03039686|12548889|FG002|STARTED|Double-blind Period||55
11092403|NCT01185353|12275621|FG003|STARTED|Part D (Weeks 76 Through 128)||0
11092404|NCT01185353|12275622|FG004|STARTED|Part D (Weeks 76 Through 128)||0
11092405|NCT01185353|12275623|FG005|STARTED|Part D (Weeks 76 Through 128)||0
11092406|NCT01185353|12275624|FG006|STARTED|Part D (Weeks 76 Through 128)||0
11092407|NCT01185353|12275625|FG007|STARTED|Part D (Weeks 76 Through 128)||79
11092408|NCT01185353|12275626|FG008|STARTED|Part D (Weeks 76 Through 128)||47
11092409|NCT01185353|12275627|FG009|STARTED|Part D (Weeks 76 Through 128)||18
11092410|NCT01185353|12275618|FG000|COMPLETED|Part D (Weeks 76 Through 128)||0
11092411|NCT01185353|12275619|FG001|COMPLETED|Part D (Weeks 76 Through 128)||0
11092412|NCT01185353|12275620|FG002|COMPLETED|Part D (Weeks 76 Through 128)||0
11092413|NCT01185353|12275621|FG003|COMPLETED|Part D (Weeks 76 Through 128)||0
11092414|NCT01185353|12275622|FG004|COMPLETED|Part D (Weeks 76 Through 128)||0
11092415|NCT01185353|12275623|FG005|COMPLETED|Part D (Weeks 76 Through 128)||0
11092416|NCT01185353|12275624|FG006|COMPLETED|Part D (Weeks 76 Through 128)||0
11092417|NCT01185353|12275625|FG007|COMPLETED|Part D (Weeks 76 Through 128)||76
11092418|NCT01185353|12275626|FG008|COMPLETED|Part D (Weeks 76 Through 128)||40
11092419|NCT01185353|12275627|FG009|COMPLETED|Part D (Weeks 76 Through 128)||17
11092420|NCT01185353|12275618|FG000|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
11092421|NCT01185353|12275619|FG001|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
11092422|NCT01185353|12275620|FG002|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
11092423|NCT01185353|12275621|FG003|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
11092424|NCT01185353|12275622|FG004|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
11092425|NCT01185353|12275623|FG005|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
11092426|NCT01185353|12275624|FG006|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
11092427|NCT01185353|12275625|FG007|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
11092428|NCT01185353|12275626|FG008|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
11092429|NCT01185353|12275627|FG009|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
11092430|NCT01185366|12275668|FG000|STARTED|First Line Therapy||38
11092431|NCT01185366|12275669|FG001|STARTED|First Line Therapy||34
11092432|NCT01185366|12275668|FG000|Received 1st Drug|First Line Therapy||36
11092433|NCT01185366|12275669|FG001|Received 1st Drug|First Line Therapy||33
11092434|NCT01185366|12275668|FG000|COMPLETED|First Line Therapy||35
11092435|NCT01185366|12275669|FG001|COMPLETED|First Line Therapy||33
11092436|NCT01185366|12275668|FG000|NOT COMPLETED|First Line Therapy||3
11092437|NCT01185366|12275669|FG001|NOT COMPLETED|First Line Therapy||1
11092438|NCT01185366|12275668|FG000|STARTED|Crossover to Second Line Therapy||35
11092439|NCT01185366|12275669|FG001|STARTED|Crossover to Second Line Therapy||33
11092440|NCT01185366|12275668|FG000|Received Crossover Drug|Crossover to Second Line Therapy||21
11092441|NCT01185366|12275669|FG001|Received Crossover Drug|Crossover to Second Line Therapy||23
11092442|NCT01185366|12275668|FG000|COMPLETED|Crossover to Second Line Therapy||21
11092443|NCT01185366|12275669|FG001|COMPLETED|Crossover to Second Line Therapy||23
11092444|NCT01185366|12275668|FG000|NOT COMPLETED|Crossover to Second Line Therapy||14
11092445|NCT01185366|12275669|FG001|NOT COMPLETED|Crossover to Second Line Therapy||10
11092446|NCT01185509|12275679|FG000|STARTED|Overall Study||11
11092447|NCT01185509|12275680|FG001|STARTED|Overall Study||20
11092448|NCT01185509|12275679|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
11092449|NCT01185509|12275680|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
11092450|NCT01185509|12275679|FG000|NOT COMPLETED|Overall Study||11
11092451|NCT01185509|12275680|FG001|NOT COMPLETED|Overall Study||20
11092452|NCT01185522|12275687|FG000|STARTED|Overall Study||693
11092453|NCT01185522|12275687|FG000|COMPLETED|Overall Study||585
11092454|NCT01185522|12275687|FG000|NOT COMPLETED|Overall Study||108
11092455|NCT01185548|12275692|FG000|STARTED|Period 1 : Tolbutamide||4
11092456|NCT01185548|12275692|FG000|COMPLETED|Period 1 : Tolbutamide||4
11092457|NCT01185548|12275692|FG000|NOT COMPLETED|Period 1 : Tolbutamide||0
11092458|NCT01185548|12275692|FG000|STARTED|Period 2: Tasisulam and Tolbutamide||4
11092459|NCT01185548|12275692|FG000|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
11092460|NCT01185548|12275692|FG000|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
11092461|NCT01185548|12275692|FG000|STARTED|Period 3: Tasisulam and Tolbutamide||2
11092462|NCT01185548|12275692|FG000|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
11092463|NCT01185548|12275692|FG000|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
11092464|NCT01185561|12275707|FG000|STARTED|Overall Study||36
11092465|NCT01185561|12275708|FG001|STARTED|Overall Study||38
11092466|NCT01185561|12275707|FG000|COMPLETED|Overall Study||34
11092467|NCT01185561|12275708|FG001|COMPLETED|Overall Study||26
11092468|NCT01185561|12275707|FG000|NOT COMPLETED|Overall Study||2
11092469|NCT01185561|12275708|FG001|NOT COMPLETED|Overall Study||12
11092470|NCT01185600|12275716|FG000|STARTED|Overall Study||73
11092471|NCT01185600|12275717|FG001|STARTED|Overall Study||104
11092472|NCT01185600|12275716|FG000|COMPLETED|Overall Study||41
11092473|NCT01185600|12275717|FG001|COMPLETED|Overall Study||59
11092474|NCT01185600|12275716|FG000|NOT COMPLETED|Overall Study||32
11092475|NCT01185600|12275717|FG001|NOT COMPLETED|Overall Study||45
11092476|NCT01185639|12275726|FG000|STARTED|Overall Study||29
11092477|NCT01185639|12275726|FG000|COMPLETED|Overall Study||27
11092478|NCT01185639|12275726|FG000|NOT COMPLETED|Overall Study||2
11092479|NCT01185704|12275732|FG000|STARTED|Overall Study||68
11092480|NCT01185704|12275733|FG001|STARTED|Overall Study||68
11092481|NCT01185704|12275732|FG000|Treated|Overall Study||65
11092482|NCT01185704|12275733|FG001|Treated|Overall Study||65
11092483|NCT01185704|12275732|FG000|COMPLETED|Overall Study||55
11092484|NCT01185704|12275733|FG001|COMPLETED|Overall Study||60
11092485|NCT01185704|12275732|FG000|NOT COMPLETED|Overall Study||13
11092486|NCT01185704|12275733|FG001|NOT COMPLETED|Overall Study||8
11092487|NCT01185782|12275741|FG000|STARTED|Overall Study||129
11092488|NCT01185782|12275742|FG001|STARTED|Overall Study||136
11092489|NCT01185782|12275741|FG000|Treated|Overall Study||129
11092490|NCT01185782|12275742|FG001|Treated|Overall Study||132
11092491|NCT01185782|12275741|FG000|COMPLETED|Overall Study||123
11092492|NCT01185782|12275742|FG001|COMPLETED|Overall Study||125
11092493|NCT01185782|12275741|FG000|NOT COMPLETED|Overall Study||6
11092494|NCT01185782|12275742|FG001|NOT COMPLETED|Overall Study||11
11092495|NCT01185821|12275753|FG000|STARTED|Overall Study||33
11092496|NCT01185821|12275754|FG001|STARTED|Overall Study||29
11351830|NCT03039686|12548887|FG000|COMPLETED|Double-blind Period||29
11351831|NCT03039686|12548888|FG001|COMPLETED|Double-blind Period||26
11351832|NCT03039686|12548889|FG002|COMPLETED|Double-blind Period||32
11351833|NCT03039686|12548887|FG000|NOT COMPLETED|Double-blind Period||27
11351834|NCT03039686|12548888|FG001|NOT COMPLETED|Double-blind Period||29
11351835|NCT03039686|12548889|FG002|NOT COMPLETED|Double-blind Period||23
11351836|NCT03039686|12548887|FG000|STARTED|Open Label Period|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
11351837|NCT03039686|12548888|FG001|STARTED|Open Label Period|14 DB placebo participants switched to the RO Low Dose for the open-label phase.|38
11351838|NCT03039686|12548889|FG002|STARTED|Open Label Period|13 DB placebo participants switched to the RO High Dose for the open-label phase.|42
11351839|NCT03039686|12548887|FG000|Completed DB, Did Not Start OL|Open Label Period||2
11351840|NCT03039686|12548888|FG001|Completed DB, Did Not Start OL|Open Label Period||2
11351841|NCT03039686|12548889|FG002|Completed DB, Did Not Start OL|Open Label Period||3
11351842|NCT03039686|12548887|FG000|COMPLETED|Open Label Period||0
11351843|NCT03039686|12548888|FG001|COMPLETED|Open Label Period||0
11351844|NCT03039686|12548889|FG002|COMPLETED|Open Label Period||0
11351845|NCT03039686|12548887|FG000|NOT COMPLETED|Open Label Period||0
11351846|NCT03039686|12548888|FG001|NOT COMPLETED|Open Label Period||38
11351847|NCT03039686|12548889|FG002|NOT COMPLETED|Open Label Period||42
11092497|NCT01185821|12275755|FG002|STARTED|Overall Study||43
11092498|NCT01185821|12275756|FG003|STARTED|Overall Study||29
11092499|NCT01185821|12275757|FG004|STARTED|Overall Study||50
11351848|NCT03039699|12548909|FG000|STARTED|Overall Study||127
11351849|NCT03039699|12548910|FG001|STARTED|Overall Study||132
11351850|NCT03039699|12548909|FG000|COMPLETED|Overall Study||105
11351851|NCT03039699|12548910|FG001|COMPLETED|Overall Study||97
11351852|NCT03039699|12548909|FG000|NOT COMPLETED|Overall Study||22
11351853|NCT03039699|12548910|FG001|NOT COMPLETED|Overall Study||35
11092500|NCT01185821|12275753|FG000|Patients With Washout|Overall Study||33
11092501|NCT01185821|12275754|FG001|Patients With Washout|Overall Study||29
11092502|NCT01185821|12275755|FG002|Patients With Washout|Overall Study||39
11092503|NCT01185821|12275756|FG003|Patients With Washout|Overall Study||29
11092504|NCT01185821|12275757|FG004|Patients With Washout|Overall Study||33
11092505|NCT01185821|12275753|FG000|Patients Without Washout|Overall Study||0
11092506|NCT01185821|12275754|FG001|Patients Without Washout|Overall Study||0
11092507|NCT01185821|12275755|FG002|Patients Without Washout|Overall Study||4
11092508|NCT01185821|12275756|FG003|Patients Without Washout|Overall Study||0
11092509|NCT01185821|12275757|FG004|Patients Without Washout|Overall Study||17
11092510|NCT01185821|12275753|FG000|Patients on Placebo in Core|Overall Study||8
11092511|NCT01185821|12275754|FG001|Patients on Placebo in Core|Overall Study||7
11092512|NCT01185821|12275755|FG002|Patients on Placebo in Core|Overall Study||9
11092513|NCT01185821|12275756|FG003|Patients on Placebo in Core|Overall Study||8
11092514|NCT01185821|12275757|FG004|Patients on Placebo in Core|Overall Study||2
11092515|NCT01185821|12275753|FG000|COMPLETED|Overall Study||26
11351854|NCT03039738|12548918|FG000|STARTED|Overall Study||206
11351855|NCT03039738|12548919|FG001|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0
11351856|NCT03039738|12548918|FG000|COMPLETED|Overall Study||152
11351857|NCT03039738|12548919|FG001|COMPLETED|Overall Study||0
11351858|NCT03039738|12548918|FG000|NOT COMPLETED|Overall Study||54
11351859|NCT03039738|12548919|FG001|NOT COMPLETED|Overall Study||0
11351860|NCT03040011|12548928|FG000|STARTED|Received Randomized Study Intervention||25
11092516|NCT01185821|12275754|FG001|COMPLETED|Overall Study||20
11092517|NCT01185821|12275755|FG002|COMPLETED|Overall Study||33
11092518|NCT01185821|12275756|FG003|COMPLETED|Overall Study||23
11092519|NCT01185821|12275757|FG004|COMPLETED|Overall Study||26
11092520|NCT01185821|12275753|FG000|NOT COMPLETED|Overall Study||7
11092521|NCT01185821|12275754|FG001|NOT COMPLETED|Overall Study||9
11092522|NCT01185821|12275755|FG002|NOT COMPLETED|Overall Study||10
11092523|NCT01185821|12275756|FG003|NOT COMPLETED|Overall Study||6
11092524|NCT01185821|12275757|FG004|NOT COMPLETED|Overall Study||24
11092525|NCT01185834|12275771|FG000|STARTED|Overall Study||118
11092526|NCT01185834|12275771|FG000|COMPLETED|Overall Study||104
11092527|NCT01185834|12275771|FG000|NOT COMPLETED|Overall Study||14
11092528|NCT01185964|12275778|FG000|STARTED|Phase 1b and Phase 2||15
11092529|NCT01185964|12275779|FG001|STARTED|Phase 1b and Phase 2||66
11092530|NCT01185964|12275780|FG002|STARTED|Phase 1b and Phase 2||67
11092531|NCT01185964|12275781|FG003|STARTED|Phase 1b and Phase 2||0
11351861|NCT03040011|12548929|FG001|STARTED|Received Randomized Study Intervention||25
11351862|NCT03040011|12548930|FG002|STARTED|Received Randomized Study Intervention||25
11351863|NCT03040011|12548928|FG000|COMPLETED|Received Randomized Study Intervention||25
11092532|NCT01185964|12275778|FG000|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
11092533|NCT01185964|12275779|FG001|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
11092534|NCT01185964|12275780|FG002|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
11092535|NCT01185964|12275781|FG003|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
11092536|NCT01185964|12275778|FG000|COMPLETED|Phase 1b and Phase 2||13
11092537|NCT01185964|12275779|FG001|COMPLETED|Phase 1b and Phase 2||56
11092538|NCT01185964|12275780|FG002|COMPLETED|Phase 1b and Phase 2||58
11092539|NCT01185964|12275781|FG003|COMPLETED|Phase 1b and Phase 2||0
11092540|NCT01185964|12275778|FG000|NOT COMPLETED|Phase 1b and Phase 2||2
11092541|NCT01185964|12275779|FG001|NOT COMPLETED|Phase 1b and Phase 2||10
11092542|NCT01185964|12275780|FG002|NOT COMPLETED|Phase 1b and Phase 2||9
11092543|NCT01185964|12275781|FG003|NOT COMPLETED|Phase 1b and Phase 2||0
11092544|NCT01185964|12275778|FG000|STARTED|Optional Olaratumab Monotherapy on Dox||0
11092545|NCT01185964|12275779|FG001|STARTED|Optional Olaratumab Monotherapy on Dox||0
11092546|NCT01185964|12275780|FG002|STARTED|Optional Olaratumab Monotherapy on Dox||0
11092547|NCT01185964|12275781|FG003|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
11092548|NCT01185964|12275778|FG000|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
11092549|NCT01185964|12275779|FG001|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
11092550|NCT01185964|12275780|FG002|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
11092551|NCT01185964|12275781|FG003|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
11092552|NCT01185964|12275778|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
11092553|NCT01185964|12275779|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
11092554|NCT01185964|12275780|FG002|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
11092555|NCT01185964|12275781|FG003|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
11092556|NCT01186250|12275799|FG000|STARTED|Overall Study||9
11092557|NCT01186250|12275800|FG001|STARTED|Overall Study||9
11092558|NCT01186250|12275799|FG000|COMPLETED|Overall Study||8
11092559|NCT01186250|12275800|FG001|COMPLETED|Overall Study||9
11092560|NCT01186250|12275799|FG000|NOT COMPLETED|Overall Study||1
11092561|NCT01186250|12275800|FG001|NOT COMPLETED|Overall Study||0
11092562|NCT01186328|12275806|FG000|STARTED|Overall Study||6
11092563|NCT01186328|12275807|FG001|STARTED|Overall Study||0
11092564|NCT01186328|12275808|FG002|STARTED|Overall Study||0
11092565|NCT01186328|12275806|FG000|COMPLETED|Overall Study||5
11092566|NCT01186328|12275807|FG001|COMPLETED|Overall Study||0
11092567|NCT01186328|12275808|FG002|COMPLETED|Overall Study||0
11092568|NCT01186328|12275806|FG000|NOT COMPLETED|Overall Study||1
11092569|NCT01186328|12275807|FG001|NOT COMPLETED|Overall Study||0
11092570|NCT01186328|12275808|FG002|NOT COMPLETED|Overall Study||0
11092571|NCT01186406|12275813|FG000|STARTED|Overall Study||41
11092572|NCT01186406|12275813|FG000|COMPLETED|Overall Study||41
11092573|NCT01186406|12275813|FG000|NOT COMPLETED|Overall Study||0
11092574|NCT01186419|12275819|FG000|STARTED|Overall Study||24
11092575|NCT01186419|12275820|FG001|STARTED|Overall Study||27
11092576|NCT01186419|12275819|FG000|COMPLETED|Overall Study||17
11092577|NCT01186419|12275820|FG001|COMPLETED|Overall Study||18
11092578|NCT01186419|12275819|FG000|NOT COMPLETED|Overall Study||7
11092579|NCT01186419|12275820|FG001|NOT COMPLETED|Overall Study||9
11092580|NCT01186458|12275825|FG000|STARTED|Overall Study||4
11092581|NCT01186458|12275825|FG000|COMPLETED|Overall Study||3
11092582|NCT01186458|12275825|FG000|NOT COMPLETED|Overall Study||1
11092583|NCT01186562|12275831|FG000|STARTED|Overall Study||54
11092584|NCT01186562|12275832|FG001|STARTED|Overall Study||29
11092585|NCT01186562|12275831|FG000|COMPLETED|Overall Study||50
11092586|NCT01186562|12275832|FG001|COMPLETED|Overall Study||27
11092587|NCT01186562|12275831|FG000|NOT COMPLETED|Overall Study||4
11092588|NCT01186562|12275832|FG001|NOT COMPLETED|Overall Study||2
11092589|NCT01186692|12275838|FG000|STARTED|Overall Study||131
11092590|NCT01186692|12275838|FG000|COMPLETED|Overall Study||99
11092591|NCT01186692|12275838|FG000|NOT COMPLETED|Overall Study||32
11092592|NCT01186705|12275846|FG000|STARTED|Overall Study||1
11092593|NCT01186705|12275846|FG000|COMPLETED|Overall Study||1
11092594|NCT01186705|12275846|FG000|NOT COMPLETED|Overall Study||0
11092595|NCT01186744|12275856|FG000|STARTED|Overall Study||218
11092596|NCT01186744|12275857|FG001|STARTED|Overall Study||157
11092597|NCT01186744|12275858|FG002|STARTED|Overall Study||31
11092598|NCT01186744|12275859|FG003|STARTED|Overall Study||82
11092599|NCT01186744|12275860|FG004|STARTED|Overall Study||45
11092600|NCT01186744|12275861|FG005|STARTED|Overall Study||133
11092601|NCT01186744|12275856|FG000|COMPLETED|Overall Study||10
11092602|NCT01186744|12275857|FG001|COMPLETED|Overall Study||5
11092603|NCT01186744|12275858|FG002|COMPLETED|Overall Study||25
11092604|NCT01186744|12275859|FG003|COMPLETED|Overall Study||70
11092605|NCT01186744|12275860|FG004|COMPLETED|Overall Study||39
11092606|NCT01186744|12275861|FG005|COMPLETED|Overall Study||107
11092607|NCT01186744|12275856|FG000|NOT COMPLETED|Overall Study||208
11092608|NCT01186744|12275857|FG001|NOT COMPLETED|Overall Study||152
11092609|NCT01186744|12275858|FG002|NOT COMPLETED|Overall Study||6
11092610|NCT01186744|12275859|FG003|NOT COMPLETED|Overall Study||12
11092611|NCT01186744|12275860|FG004|NOT COMPLETED|Overall Study||6
11092612|NCT01186744|12275861|FG005|NOT COMPLETED|Overall Study||26
11092613|NCT01186770|12275900|FG000|STARTED|Overall Study||201
11092614|NCT01186770|12275901|FG001|STARTED|Overall Study||202
11092615|NCT01186770|12275902|FG002|STARTED|Overall Study||200
11092616|NCT01186770|12275903|FG003|STARTED|Overall Study||201
11092617|NCT01186770|12275900|FG000|Intent-to-treat (ITT Population)|Overall Study||201
11092618|NCT01186770|12275901|FG001|Intent-to-treat (ITT Population)|Overall Study||201
11092619|NCT01186770|12275902|FG002|Intent-to-treat (ITT Population)|Overall Study||200
11092620|NCT01186770|12275903|FG003|Intent-to-treat (ITT Population)|Overall Study||201
11092621|NCT01186770|12275900|FG000|COMPLETED|Overall Study||160
11092622|NCT01186770|12275901|FG001|COMPLETED|Overall Study||156
11092623|NCT01186770|12275902|FG002|COMPLETED|Overall Study||148
11092624|NCT01186770|12275903|FG003|COMPLETED|Overall Study||143
11092625|NCT01186770|12275900|FG000|NOT COMPLETED|Overall Study||41
11092626|NCT01186770|12275901|FG001|NOT COMPLETED|Overall Study||46
11092627|NCT01186770|12275902|FG002|NOT COMPLETED|Overall Study||52
11092628|NCT01186770|12275903|FG003|NOT COMPLETED|Overall Study||58
11092629|NCT01186796|12275915|FG000|STARTED|Overall Study||14
11092630|NCT01186796|12275916|FG001|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
11092631|NCT01186796|12275915|FG000|COMPLETED|Overall Study||10
11092632|NCT01186796|12275916|FG001|COMPLETED|Overall Study||14
11092633|NCT01186796|12275915|FG000|NOT COMPLETED|Overall Study||4
11092634|NCT01186796|12275916|FG001|NOT COMPLETED|Overall Study||2
11092635|NCT01186809|12275922|FG000|STARTED|Overall Study||73
11092636|NCT01186809|12275922|FG000|COMPLETED|Overall Study||43
11092637|NCT01186809|12275922|FG000|NOT COMPLETED|Overall Study||30
11092638|NCT01186939|12275926|FG000|STARTED|Overall Study||40
11092639|NCT01186939|12275926|FG000|COMPLETED|Overall Study||0
11092640|NCT01186939|12275926|FG000|NOT COMPLETED|Overall Study||40
11092641|NCT01186978|12275930|FG000|STARTED|Overall Study||63
11092642|NCT01186978|12275930|FG000|COMPLETED|Overall Study||62
11092643|NCT01186978|12275930|FG000|NOT COMPLETED|Overall Study||1
11092644|NCT01187004|12275936|FG000|STARTED|Overall Study||20
11092645|NCT01187004|12275937|FG001|STARTED|Overall Study||144
11092646|NCT01187004|12275936|FG000|COMPLETED|Overall Study||20
11092647|NCT01187004|12275937|FG001|COMPLETED|Overall Study||144
11092648|NCT01187004|12275936|FG000|NOT COMPLETED|Overall Study||0
11092649|NCT01187004|12275937|FG001|NOT COMPLETED|Overall Study||0
11092650|NCT01187017|12275944|FG000|STARTED|Overall Study||1
11092651|NCT01187017|12275944|FG000|COMPLETED|Overall Study||1
11092652|NCT01187017|12275944|FG000|NOT COMPLETED|Overall Study||0
11092653|NCT01187043|12275955|FG000|STARTED|Overall Study||12
11092654|NCT01187043|12275956|FG001|STARTED|Overall Study||10
11092655|NCT01187043|12275957|FG002|STARTED|Overall Study||12
11092656|NCT01187043|12275958|FG003|STARTED|Overall Study||12
11092657|NCT01187043|12275959|FG004|STARTED|Overall Study||12
11092658|NCT01187043|12275955|FG000|COMPLETED|Overall Study||11
11092659|NCT01187043|12275956|FG001|COMPLETED|Overall Study||10
11092660|NCT01187043|12275957|FG002|COMPLETED|Overall Study||8
11092661|NCT01187043|12275958|FG003|COMPLETED|Overall Study||12
11092662|NCT01187043|12275959|FG004|COMPLETED|Overall Study||10
11092663|NCT01187043|12275955|FG000|NOT COMPLETED|Overall Study||1
11092664|NCT01187043|12275956|FG001|NOT COMPLETED|Overall Study||0
11092665|NCT01187043|12275957|FG002|NOT COMPLETED|Overall Study||4
11092666|NCT01187043|12275958|FG003|NOT COMPLETED|Overall Study||0
11092667|NCT01187043|12275959|FG004|NOT COMPLETED|Overall Study||2
11092668|NCT01187095|12275973|FG000|STARTED|Overall Study||153
11092669|NCT01187095|12275974|FG001|STARTED|Overall Study||142
11092670|NCT01187095|12275973|FG000|COMPLETED|Overall Study||108
11092671|NCT01187095|12275974|FG001|COMPLETED|Overall Study||108
11092672|NCT01187095|12275973|FG000|NOT COMPLETED|Overall Study||45
11092673|NCT01187095|12275974|FG001|NOT COMPLETED|Overall Study||34
11092674|NCT01187329|12275982|FG000|STARTED|Overall Study||50
11092675|NCT01187329|12275983|FG001|STARTED|Overall Study||50
11092676|NCT01187329|12275982|FG000|COMPLETED|Overall Study||49
11092677|NCT01187329|12275983|FG001|COMPLETED|Overall Study||48
11092678|NCT01187329|12275982|FG000|NOT COMPLETED|Overall Study||1
11092679|NCT01187329|12275983|FG001|NOT COMPLETED|Overall Study||2
11092680|NCT01187355|12275991|FG000|STARTED|Overall Study||294
11092681|NCT01187355|12275992|FG001|STARTED|Overall Study||297
11092682|NCT01187355|12275991|FG000|COMPLETED|Overall Study||276
11092683|NCT01187355|12275992|FG001|COMPLETED|Overall Study||277
11092684|NCT01187355|12275991|FG000|NOT COMPLETED|Overall Study||18
11092685|NCT01187355|12275992|FG001|NOT COMPLETED|Overall Study||20
11092686|NCT01187381|12275998|FG000|STARTED|Overall Study||250
11092687|NCT01187381|12275998|FG000|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
11092688|NCT01187381|12275998|FG000|NOT COMPLETED|Overall Study||0
11092689|NCT01187407|12276006|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
11092690|NCT01187407|12276007|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
11092691|NCT01187407|12276008|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
11092692|NCT01187407|12276009|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
11092693|NCT01187407|12276010|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0
11092694|NCT01187407|12276006|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
11092695|NCT01187407|12276007|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
11092696|NCT01187407|12276008|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
11092697|NCT01187407|12276009|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
11092698|NCT01187407|12276010|FG004|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
11092699|NCT01187407|12276006|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
11092700|NCT01187407|12276007|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11092701|NCT01187407|12276008|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11092702|NCT01187407|12276009|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11092703|NCT01187407|12276010|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11092704|NCT01187407|12276006|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
11092705|NCT01187407|12276007|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11092706|NCT01187407|12276008|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11092707|NCT01187407|12276009|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11092708|NCT01187407|12276010|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
11092709|NCT01187407|12276006|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11092710|NCT01187407|12276007|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
11092711|NCT01187407|12276008|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
11092712|NCT01187407|12276009|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
11092713|NCT01187407|12276010|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
11092714|NCT01187407|12276006|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11092715|NCT01187407|12276007|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
11092716|NCT01187407|12276008|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
11092717|NCT01187407|12276009|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
11092718|NCT01187407|12276010|FG004|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
11092719|NCT01187407|12276006|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11092720|NCT01187407|12276007|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
11092721|NCT01187407|12276008|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
11092722|NCT01187407|12276009|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
11092723|NCT01187407|12276010|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
11092724|NCT01187407|12276006|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
11092725|NCT01187407|12276007|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
11092726|NCT01187407|12276008|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
11092727|NCT01187407|12276009|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
11092728|NCT01187407|12276010|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
11092729|NCT01187446|12276029|FG000|STARTED|Overall Study||14
11092730|NCT01187446|12276030|FG001|STARTED|Overall Study||14
11092731|NCT01187446|12276029|FG000|COMPLETED|Overall Study||14
11092732|NCT01187446|12276030|FG001|COMPLETED|Overall Study||13
11092733|NCT01187446|12276029|FG000|NOT COMPLETED|Overall Study||0
11092734|NCT01187446|12276030|FG001|NOT COMPLETED|Overall Study||1
11208194|NCT03861052|12399397|FG000|STARTED|Overall Study||159
11208195|NCT03861052|12399398|FG001|STARTED|Overall Study||158
11208196|NCT03861052|12399399|FG002|STARTED|Overall Study||160
11208197|NCT03861052|12399400|FG003|STARTED|Overall Study||159
11208198|NCT03861052|12399397|FG000|Received at Least One Dose of Study Drug|Overall Study||159
11208199|NCT03861052|12399398|FG001|Received at Least One Dose of Study Drug|Overall Study||158
11208200|NCT03861052|12399399|FG002|Received at Least One Dose of Study Drug|Overall Study||160
11208201|NCT03861052|12399400|FG003|Received at Least One Dose of Study Drug|Overall Study||159
11208202|NCT03861052|12399397|FG000|COMPLETED|Overall Study||155
11208203|NCT03861052|12399398|FG001|COMPLETED|Overall Study||151
11208204|NCT03861052|12399399|FG002|COMPLETED|Overall Study||155
11208205|NCT03861052|12399400|FG003|COMPLETED|Overall Study||154
11208206|NCT03861052|12399397|FG000|NOT COMPLETED|Overall Study||4
11208207|NCT03861052|12399398|FG001|NOT COMPLETED|Overall Study||7
11208208|NCT03861052|12399399|FG002|NOT COMPLETED|Overall Study||5
11208209|NCT03861052|12399400|FG003|NOT COMPLETED|Overall Study||5
11208210|NCT03846453|12399417|FG000|STARTED|Placebo Run-in (14 Days)||1108
11208211|NCT03846453|12399418|FG001|STARTED|Placebo Run-in (14 Days)|Participants in this group were randomized after they completed the placebo run-in period.|0
11208212|NCT03846453|12399419|FG002|STARTED|Placebo Run-in (14 Days)|Participants in this group were randomized after they completed the placebo run-in period.|0
11208213|NCT03846453|12399417|FG000|COMPLETED|Placebo Run-in (14 Days)||637
11208214|NCT03846453|12399418|FG001|COMPLETED|Placebo Run-in (14 Days)||0
11208215|NCT03846453|12399419|FG002|COMPLETED|Placebo Run-in (14 Days)||0
11208216|NCT03846453|12399417|FG000|NOT COMPLETED|Placebo Run-in (14 Days)||471
11208217|NCT03846453|12399418|FG001|NOT COMPLETED|Placebo Run-in (14 Days)||0
11208218|NCT03846453|12399419|FG002|NOT COMPLETED|Placebo Run-in (14 Days)||0
11351864|NCT03040011|12548929|FG001|COMPLETED|Received Randomized Study Intervention||25
11351865|NCT03040011|12548930|FG002|COMPLETED|Received Randomized Study Intervention||25
11092735|NCT01187498|12276038|FG000|STARTED|Overall Study||73
11092736|NCT01187498|12276039|FG001|STARTED|Overall Study||70
11092737|NCT01187498|12276038|FG000|COMPLETED|Overall Study||64
11092738|NCT01187498|12276039|FG001|COMPLETED|Overall Study||60
11092739|NCT01187498|12276038|FG000|NOT COMPLETED|Overall Study||9
11092740|NCT01187498|12276039|FG001|NOT COMPLETED|Overall Study||10
11092741|NCT01187511|12276047|FG000|STARTED|Overall Study||22
11092742|NCT01187511|12276048|FG001|STARTED|Overall Study||22
11092743|NCT01187511|12276047|FG000|COMPLETED|Overall Study||14
11092744|NCT01187511|12276048|FG001|COMPLETED|Overall Study||21
11092745|NCT01187511|12276047|FG000|NOT COMPLETED|Overall Study||8
11092746|NCT01187511|12276048|FG001|NOT COMPLETED|Overall Study||1
11092747|NCT01187550|12276056|FG000|STARTED|Overall Study||183
11092748|NCT01187550|12276057|FG001|STARTED|Overall Study||30
11092749|NCT01187550|12276056|FG000|Treated|Overall Study||175
11092750|NCT01187550|12276057|FG001|Treated|Overall Study||30
11092751|NCT01187550|12276056|FG000|COMPLETED|Overall Study||169
11092752|NCT01187550|12276057|FG001|COMPLETED|Overall Study||29
11092753|NCT01187550|12276056|FG000|NOT COMPLETED|Overall Study||14
11092754|NCT01187550|12276057|FG001|NOT COMPLETED|Overall Study||1
11092755|NCT01187771|12276065|FG000|STARTED|Overall Study||28
11092756|NCT01187771|12276066|FG001|STARTED|Overall Study||21
11092757|NCT01187771|12276065|FG000|COMPLETED|Overall Study||25
11092758|NCT01187771|12276066|FG001|COMPLETED|Overall Study||18
11092759|NCT01187771|12276065|FG000|NOT COMPLETED|Overall Study||3
11092760|NCT01187771|12276066|FG001|NOT COMPLETED|Overall Study||3
11092761|NCT01187901|12276076|FG000|STARTED|Overall Study||46
11092762|NCT01187901|12276077|FG001|STARTED|Overall Study||46
11092763|NCT01187901|12276076|FG000|COMPLETED|Overall Study||37
11092764|NCT01187901|12276077|FG001|COMPLETED|Overall Study||36
11092765|NCT01187901|12276076|FG000|NOT COMPLETED|Overall Study||9
11092766|NCT01187901|12276077|FG001|NOT COMPLETED|Overall Study||10
11092767|NCT01187914|12276083|FG000|STARTED|Overall Study||40
11092768|NCT01187914|12276083|FG000|COMPLETED|Overall Study||40
11092769|NCT01187914|12276083|FG000|NOT COMPLETED|Overall Study||0
11092770|NCT01187953|12276089|FG000|STARTED|Overall Study||268
11092771|NCT01187953|12276090|FG001|STARTED|Overall Study||275
11092772|NCT01187953|12276089|FG000|Dosed|Overall Study||266
11092773|NCT01187953|12276090|FG001|Dosed|Overall Study||271
11092774|NCT01187953|12276089|FG000|COMPLETED|Overall Study||253
11092775|NCT01187953|12276090|FG001|COMPLETED|Overall Study||254
11092776|NCT01187953|12276089|FG000|NOT COMPLETED|Overall Study||15
11092777|NCT01187953|12276090|FG001|NOT COMPLETED|Overall Study||21
11092778|NCT01188109|12276096|FG000|STARTED|Overall Study||22
11092779|NCT01188109|12276096|FG000|COMPLETED|Overall Study||22
11092780|NCT01188109|12276096|FG000|NOT COMPLETED|Overall Study||0
11092781|NCT01188226|12276100|FG000|STARTED|Overall Study||10
11092782|NCT01188226|12276100|FG000|COMPLETED|Overall Study||6
11092783|NCT01188226|12276100|FG000|NOT COMPLETED|Overall Study||4
11092784|NCT01188343|12276117|FG000|STARTED|Overall Study||102
11092785|NCT01188343|12276118|FG001|STARTED|Overall Study||219
11092786|NCT01188343|12276119|FG002|STARTED|Overall Study||221
11092787|NCT01188343|12276117|FG000|COMPLETED|Overall Study||101
11092788|NCT01188343|12276118|FG001|COMPLETED|Overall Study||193
11092789|NCT01188343|12276119|FG002|COMPLETED|Overall Study||220
11092790|NCT01188343|12276117|FG000|NOT COMPLETED|Overall Study||1
11092791|NCT01188343|12276118|FG001|NOT COMPLETED|Overall Study||26
11092792|NCT01188343|12276119|FG002|NOT COMPLETED|Overall Study||1
11092793|NCT01188369|12276132|FG000|STARTED|Overall Study||10
11092794|NCT01188369|12276133|FG001|STARTED|Overall Study||10
11092795|NCT01188369|12276132|FG000|COMPLETED|Overall Study||10
11092796|NCT01188369|12276133|FG001|COMPLETED|Overall Study||10
11092797|NCT01188369|12276132|FG000|NOT COMPLETED|Overall Study||0
11092798|NCT01188369|12276133|FG001|NOT COMPLETED|Overall Study||0
11092799|NCT01188421|12276142|FG000|STARTED|Overall Study||31
11092800|NCT01188421|12276143|FG001|STARTED|Overall Study||36
11092801|NCT01188421|12276144|FG002|STARTED|Overall Study||36
11092802|NCT01188421|12276142|FG000|COMPLETED|Overall Study||28
11092803|NCT01188421|12276143|FG001|COMPLETED|Overall Study||26
11092804|NCT01188421|12276144|FG002|COMPLETED|Overall Study||22
11092805|NCT01188421|12276142|FG000|NOT COMPLETED|Overall Study||3
11092806|NCT01188421|12276143|FG001|NOT COMPLETED|Overall Study||10
11092807|NCT01188421|12276144|FG002|NOT COMPLETED|Overall Study||14
11092808|NCT01188447|12276152|FG000|STARTED|Overall Study||4034
11092809|NCT01188447|12276152|FG000|COMPLETED|Overall Study||4034
11092810|NCT01188447|12276152|FG000|NOT COMPLETED|Overall Study||0
11092811|NCT01188460|12276159|FG000|STARTED|Overall Study||25
11092812|NCT01188460|12276160|FG001|STARTED|Overall Study||23
11092813|NCT01188460|12276159|FG000|COMPLETED|Overall Study||25
11092814|NCT01188460|12276160|FG001|COMPLETED|Overall Study||23
11092815|NCT01188460|12276159|FG000|NOT COMPLETED|Overall Study||0
11351866|NCT03040011|12548928|FG000|NOT COMPLETED|Received Randomized Study Intervention||0
11092816|NCT01188460|12276160|FG001|NOT COMPLETED|Overall Study||0
11092817|NCT01188499|12276171|FG000|STARTED|Overall Study||24
11092818|NCT01188499|12276172|FG001|STARTED|Overall Study||83
11092819|NCT01188499|12276173|FG002|STARTED|Overall Study||33
11092820|NCT01188499|12276174|FG003|STARTED|Overall Study||18
11092821|NCT01188499|12276175|FG004|STARTED|Overall Study||18
11092822|NCT01188499|12276171|FG000|COMPLETED|Overall Study||24
11092823|NCT01188499|12276172|FG001|COMPLETED|Overall Study||83
11092824|NCT01188499|12276173|FG002|COMPLETED|Overall Study||33
11092825|NCT01188499|12276174|FG003|COMPLETED|Overall Study||18
11092826|NCT01188499|12276175|FG004|COMPLETED|Overall Study||18
11092827|NCT01188499|12276171|FG000|NOT COMPLETED|Overall Study||0
11351867|NCT03040011|12548929|FG001|NOT COMPLETED|Received Randomized Study Intervention||0
11351868|NCT03040011|12548930|FG002|NOT COMPLETED|Received Randomized Study Intervention||0
11351869|NCT03040011|12548928|FG000|STARTED|Primary Outcome Follow Up||25
11351870|NCT03040011|12548929|FG001|STARTED|Primary Outcome Follow Up||25
11351871|NCT03040011|12548930|FG002|STARTED|Primary Outcome Follow Up||25
11351872|NCT03040011|12548928|FG000|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for four patients|21
11351873|NCT03040011|12548929|FG001|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
11351874|NCT03040011|12548930|FG002|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
11351875|NCT03040011|12548928|FG000|NOT COMPLETED|Primary Outcome Follow Up||4
11351876|NCT03040011|12548929|FG001|NOT COMPLETED|Primary Outcome Follow Up||1
11351877|NCT03040011|12548930|FG002|NOT COMPLETED|Primary Outcome Follow Up||1
11351878|NCT03040024|12548941|FG000|STARTED|Overall Study||21
11351879|NCT03040024|12548942|FG001|STARTED|Overall Study||26
11351880|NCT03040024|12548943|FG002|STARTED|Overall Study||24
11351881|NCT03040024|12548941|FG000|COMPLETED|Overall Study||21
11351882|NCT03040024|12548942|FG001|COMPLETED|Overall Study||24
11351883|NCT03040024|12548943|FG002|COMPLETED|Overall Study||23
11351884|NCT03040024|12548941|FG000|NOT COMPLETED|Overall Study||0
11351885|NCT03040024|12548942|FG001|NOT COMPLETED|Overall Study||2
11351886|NCT03040024|12548943|FG002|NOT COMPLETED|Overall Study||1
11351887|NCT03040154|12548953|FG000|STARTED|Overall Study||110
11351888|NCT03040154|12548954|FG001|STARTED|Overall Study||105
11351889|NCT03040154|12548953|FG000|COMPLETED|Overall Study||110
11351890|NCT03040154|12548954|FG001|COMPLETED|Overall Study||105
11351891|NCT03040154|12548953|FG000|NOT COMPLETED|Overall Study||0
11351892|NCT03040154|12548954|FG001|NOT COMPLETED|Overall Study||0
11351893|NCT03040336|12548962|FG000|STARTED|Overall Study||10
11351894|NCT03040336|12548963|FG001|STARTED|Overall Study||7
11351895|NCT03040336|12548962|FG000|COMPLETED|Overall Study||7
11351896|NCT03040336|12548963|FG001|COMPLETED|Overall Study||4
11351897|NCT03040336|12548962|FG000|NOT COMPLETED|Overall Study||3
11092828|NCT01188499|12276172|FG001|NOT COMPLETED|Overall Study||0
11092829|NCT01188499|12276173|FG002|NOT COMPLETED|Overall Study||0
11092830|NCT01188499|12276174|FG003|NOT COMPLETED|Overall Study||0
11092831|NCT01188499|12276175|FG004|NOT COMPLETED|Overall Study||0
11092832|NCT01188538|12276189|FG000|STARTED|Overall Study||20
11351898|NCT03040336|12548963|FG001|NOT COMPLETED|Overall Study||3
11351899|NCT03040362|12548970|FG000|STARTED|Overall Study||8
11351900|NCT03040362|12548970|FG000|Received at Least 1dose of Study Drug|Overall Study||8
11351901|NCT03040362|12548970|FG000|COMPLETED|Overall Study||8
11351902|NCT03040362|12548970|FG000|NOT COMPLETED|Overall Study||0
11092833|NCT01188538|12276190|FG001|STARTED|Overall Study||20
11092834|NCT01188538|12276189|FG000|COMPLETED|Overall Study||20
11092835|NCT01188538|12276190|FG001|COMPLETED|Overall Study||19
11092836|NCT01188538|12276189|FG000|NOT COMPLETED|Overall Study||0
11092837|NCT01188538|12276190|FG001|NOT COMPLETED|Overall Study||1
11092838|NCT01188551|12276202|FG000|STARTED|Overall Study||25
11092839|NCT01188551|12276203|FG001|STARTED|Overall Study||25
11092840|NCT01188551|12276204|FG002|STARTED|Overall Study||25
11092841|NCT01188551|12276205|FG003|STARTED|Overall Study||25
11092842|NCT01188551|12276202|FG000|COMPLETED|Overall Study||24
11092843|NCT01188551|12276203|FG001|COMPLETED|Overall Study||25
11092844|NCT01188551|12276204|FG002|COMPLETED|Overall Study||25
11092845|NCT01188551|12276205|FG003|COMPLETED|Overall Study||25
11092846|NCT01188551|12276202|FG000|NOT COMPLETED|Overall Study||1
11092847|NCT01188551|12276203|FG001|NOT COMPLETED|Overall Study||0
11092848|NCT01188551|12276204|FG002|NOT COMPLETED|Overall Study||0
11092849|NCT01188551|12276205|FG003|NOT COMPLETED|Overall Study||0
11092850|NCT01188564|12276217|FG000|STARTED|Double-blind Phase||44
11092851|NCT01188564|12276218|FG001|STARTED|Double-blind Phase||31
11092852|NCT01188564|12276217|FG000|COMPLETED|Double-blind Phase||43
11092853|NCT01188564|12276218|FG001|COMPLETED|Double-blind Phase||31
11092854|NCT01188564|12276217|FG000|NOT COMPLETED|Double-blind Phase||1
11092855|NCT01188564|12276218|FG001|NOT COMPLETED|Double-blind Phase||0
11092856|NCT01188564|12276217|FG000|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
11092857|NCT01188564|12276218|FG001|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
11092858|NCT01188564|12276217|FG000|COMPLETED|Open Label Phase||24
11092859|NCT01188564|12276218|FG001|COMPLETED|Open Label Phase||20
11092860|NCT01188564|12276217|FG000|NOT COMPLETED|Open Label Phase||0
11092861|NCT01188564|12276218|FG001|NOT COMPLETED|Open Label Phase||0
11092862|NCT01188577|12276226|FG000|STARTED|Visit 1||11
11092863|NCT01188577|12276227|FG001|STARTED|Visit 1||12
11092864|NCT01188577|12276226|FG000|COMPLETED|Visit 1||11
11092865|NCT01188577|12276227|FG001|COMPLETED|Visit 1||12
11092866|NCT01188577|12276226|FG000|NOT COMPLETED|Visit 1||0
11092867|NCT01188577|12276227|FG001|NOT COMPLETED|Visit 1||0
11092868|NCT01188577|12276226|FG000|STARTED|3-14 Day Washout||11
11092869|NCT01188577|12276227|FG001|STARTED|3-14 Day Washout||12
11092870|NCT01188577|12276226|FG000|COMPLETED|3-14 Day Washout||11
11092871|NCT01188577|12276227|FG001|COMPLETED|3-14 Day Washout||12
11092872|NCT01188577|12276226|FG000|NOT COMPLETED|3-14 Day Washout||0
11092873|NCT01188577|12276227|FG001|NOT COMPLETED|3-14 Day Washout||0
11092874|NCT01188577|12276226|FG000|STARTED|Visit 2||11
11092875|NCT01188577|12276227|FG001|STARTED|Visit 2||12
11092876|NCT01188577|12276226|FG000|COMPLETED|Visit 2||11
11092877|NCT01188577|12276227|FG001|COMPLETED|Visit 2||12
11092878|NCT01188577|12276226|FG000|NOT COMPLETED|Visit 2||0
11092879|NCT01188577|12276227|FG001|NOT COMPLETED|Visit 2||0
11092880|NCT01188603|12276233|FG000|STARTED|Overall Study||24
11092881|NCT01188603|12276233|FG000|COMPLETED|Overall Study||24
11092882|NCT01188603|12276233|FG000|NOT COMPLETED|Overall Study||0
11092883|NCT01188655|12276237|FG000|STARTED|Overall Study||89
11092884|NCT01188655|12276237|FG000|COMPLETED|Overall Study||76
11092885|NCT01188655|12276237|FG000|NOT COMPLETED|Overall Study||13
11092886|NCT01188668|12276241|FG000|STARTED|Period 1: ARIP Alone||38
11092887|NCT01188668|12276241|FG000|COMPLETED|Period 1: ARIP Alone||36
11092888|NCT01188668|12276241|FG000|NOT COMPLETED|Period 1: ARIP Alone||2
11092889|NCT01188668|12276241|FG000|STARTED|Period 2: Coadministration ARIP + DVS SR||36
11092890|NCT01188668|12276241|FG000|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
11092891|NCT01188668|12276241|FG000|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
11351903|NCT03040414|12548976|FG000|STARTED|Overall Study||57
11351904|NCT03040414|12548977|FG001|STARTED|Overall Study||56
11092892|NCT01188681|12276252|FG000|STARTED|Overall Study||6
11092893|NCT01188681|12276253|FG001|STARTED|Overall Study||6
11092894|NCT01188681|12276254|FG002|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
11092895|NCT01188681|12276255|FG003|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
11092896|NCT01188681|12276252|FG000|COMPLETED|Overall Study||6
11092897|NCT01188681|12276253|FG001|COMPLETED|Overall Study||6
11092898|NCT01188681|12276254|FG002|COMPLETED|Overall Study||32
11092899|NCT01188681|12276255|FG003|COMPLETED|Overall Study||33
11092900|NCT01188681|12276252|FG000|NOT COMPLETED|Overall Study||0
11092901|NCT01188681|12276253|FG001|NOT COMPLETED|Overall Study||0
11351905|NCT03040414|12548976|FG000|Completed Period 1|Overall Study||56
11092902|NCT01188681|12276254|FG002|NOT COMPLETED|Overall Study||1
11092903|NCT01188681|12276255|FG003|NOT COMPLETED|Overall Study||1
11092904|NCT01188694|12276272|FG000|STARTED|Overall Study||15
11092905|NCT01188694|12276273|FG001|STARTED|Overall Study||16
11092906|NCT01188694|12276274|FG002|STARTED|Overall Study||11
11092907|NCT01188694|12276272|FG000|COMPLETED|Overall Study||10
11092908|NCT01188694|12276273|FG001|COMPLETED|Overall Study||15
11092909|NCT01188694|12276274|FG002|COMPLETED|Overall Study||10
11092910|NCT01188694|12276272|FG000|NOT COMPLETED|Overall Study||5
11092911|NCT01188694|12276273|FG001|NOT COMPLETED|Overall Study||1
11092912|NCT01188694|12276274|FG002|NOT COMPLETED|Overall Study||1
11092913|NCT01188772|12276286|FG000|STARTED|Overall Study||48
11092914|NCT01188772|12276287|FG001|STARTED|Overall Study||48
11092915|NCT01188772|12276288|FG002|STARTED|Overall Study||26
11092916|NCT01188772|12276289|FG003|STARTED|Overall Study||25
11092917|NCT01188772|12276286|FG000|Randomized and Treated|Overall Study||48
11092918|NCT01188772|12276287|FG001|Randomized and Treated|Overall Study||47
11092919|NCT01188772|12276288|FG002|Randomized and Treated|Overall Study||26
11092920|NCT01188772|12276289|FG003|Randomized and Treated|Overall Study||25
11092921|NCT01188772|12276286|FG000|COMPLETED|Overall Study||43
11092922|NCT01188772|12276287|FG001|COMPLETED|Overall Study||45
11092923|NCT01188772|12276288|FG002|COMPLETED|Overall Study||15
11092924|NCT01188772|12276289|FG003|COMPLETED|Overall Study||24
11092925|NCT01188772|12276286|FG000|NOT COMPLETED|Overall Study||5
11092926|NCT01188772|12276287|FG001|NOT COMPLETED|Overall Study||3
11092927|NCT01188772|12276288|FG002|NOT COMPLETED|Overall Study||11
11092928|NCT01188772|12276289|FG003|NOT COMPLETED|Overall Study||1
11092929|NCT01188811|12276304|FG000|STARTED|Overall Study||28
11092930|NCT01188811|12276305|FG001|STARTED|Overall Study||26
11092931|NCT01188811|12276304|FG000|COMPLETED|Overall Study||22
11092932|NCT01188811|12276305|FG001|COMPLETED|Overall Study||24
11092933|NCT01188811|12276304|FG000|NOT COMPLETED|Overall Study||6
11092934|NCT01188811|12276305|FG001|NOT COMPLETED|Overall Study||2
11092935|NCT01188876|12276311|FG000|STARTED|Overall Study||50
11092936|NCT01188876|12276311|FG000|COMPLETED|Overall Study||50
11092937|NCT01188876|12276311|FG000|NOT COMPLETED|Overall Study||0
11092938|NCT01188928|12276319|FG000|STARTED|Overall Study||482
11092939|NCT01188928|12276320|FG001|STARTED|Overall Study||479
11092940|NCT01188928|12276321|FG002|STARTED|Overall Study||96
11092941|NCT01188928|12276322|FG003|STARTED|Overall Study||95
11092942|NCT01188928|12276319|FG000|COMPLETED|Overall Study||444
11092943|NCT01188928|12276320|FG001|COMPLETED|Overall Study||417
11092944|NCT01188928|12276321|FG002|COMPLETED|Overall Study||82
11092945|NCT01188928|12276322|FG003|COMPLETED|Overall Study||77
11092946|NCT01188928|12276319|FG000|NOT COMPLETED|Overall Study||38
11092947|NCT01188928|12276320|FG001|NOT COMPLETED|Overall Study||62
11092948|NCT01188928|12276321|FG002|NOT COMPLETED|Overall Study||14
11092949|NCT01188928|12276322|FG003|NOT COMPLETED|Overall Study||18
11092950|NCT01188967|12276334|FG000|STARTED|Overall Study||10
11092951|NCT01188967|12276335|FG001|STARTED|Overall Study||8
11092952|NCT01188967|12276334|FG000|COMPLETED|Overall Study||5
11092953|NCT01188967|12276335|FG001|COMPLETED|Overall Study||4
11092954|NCT01188967|12276334|FG000|NOT COMPLETED|Overall Study||5
11092955|NCT01188967|12276335|FG001|NOT COMPLETED|Overall Study||4
11092956|NCT01189032|12276346|FG000|STARTED|Overall Study||94
11092957|NCT01189032|12276347|FG001|STARTED|Overall Study||96
11092958|NCT01189032|12276348|FG002|STARTED|Overall Study||96
11092959|NCT01189032|12276346|FG000|COMPLETED|Overall Study||89
11092960|NCT01189032|12276347|FG001|COMPLETED|Overall Study||89
11092961|NCT01189032|12276348|FG002|COMPLETED|Overall Study||90
11351906|NCT03040414|12548977|FG001|Completed Period 1|Overall Study||55
11092962|NCT01189032|12276346|FG000|NOT COMPLETED|Overall Study||5
11351907|NCT03040414|12548976|FG000|Started Period 2|Overall Study||56
11351908|NCT03040414|12548977|FG001|Started Period 2|Overall Study||55
11351909|NCT03040414|12548976|FG000|COMPLETED|Overall Study||56
11351910|NCT03040414|12548977|FG001|COMPLETED|Overall Study||55
11351911|NCT03040414|12548976|FG000|NOT COMPLETED|Overall Study||1
11351912|NCT03040414|12548977|FG001|NOT COMPLETED|Overall Study||1
11351913|NCT03040427|12548986|FG000|STARTED|Overall Study||2
11351914|NCT03040427|12548987|FG001|STARTED|Overall Study||6
11351915|NCT03040427|12548988|FG002|STARTED|Overall Study||4
11351916|NCT03040427|12548986|FG000|COMPLETED|Overall Study||2
11351917|NCT03040427|12548987|FG001|COMPLETED|Overall Study||6
11351918|NCT03040427|12548988|FG002|COMPLETED|Overall Study||4
11351919|NCT03040427|12548986|FG000|NOT COMPLETED|Overall Study||0
11351920|NCT03040427|12548987|FG001|NOT COMPLETED|Overall Study||0
11351921|NCT03040427|12548988|FG002|NOT COMPLETED|Overall Study||0
11351922|NCT03040466|12548998|FG000|STARTED|Overall Study||65
11351923|NCT03040466|12548999|FG001|STARTED|Overall Study||115
11351924|NCT03040466|12548998|FG000|COMPLETED|Overall Study||65
11351925|NCT03040466|12548999|FG001|COMPLETED|Overall Study||115
11351926|NCT03040466|12548998|FG000|NOT COMPLETED|Overall Study||0
11351927|NCT03040466|12548999|FG001|NOT COMPLETED|Overall Study||0
11351928|NCT03040479|12549008|FG000|STARTED|Overall Study||8
11351929|NCT03040479|12549009|FG001|STARTED|Overall Study||8
11351930|NCT03040479|12549010|FG002|STARTED|Overall Study||8
11351931|NCT03040479|12549008|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
11351932|NCT03040479|12549009|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
11351933|NCT03040479|12549010|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
11351934|NCT03040479|12549008|FG000|COMPLETED|Overall Study||8
11351935|NCT03040479|12549009|FG001|COMPLETED|Overall Study||8
11351936|NCT03040479|12549010|FG002|COMPLETED|Overall Study||8
11351937|NCT03040479|12549008|FG000|NOT COMPLETED|Overall Study||0
11351938|NCT03040479|12549009|FG001|NOT COMPLETED|Overall Study||0
11351939|NCT03040479|12549010|FG002|NOT COMPLETED|Overall Study||0
11351940|NCT03040674|12549020|FG000|STARTED|Overall Study||489
11351941|NCT03040674|12549020|FG000|Participants Completing 3 Month Survey|Overall Study||351
11351942|NCT03040674|12549020|FG000|Participants Completing 6 Month Survey|Overall Study||241
11351943|NCT03040674|12549020|FG000|COMPLETED|Overall Study||241
11351944|NCT03040674|12549020|FG000|NOT COMPLETED|Overall Study||248
11351945|NCT03040687|12549028|FG000|STARTED|Overall Study||20
11351946|NCT03040687|12549029|FG001|STARTED|Overall Study||20
11092963|NCT01189032|12276347|FG001|NOT COMPLETED|Overall Study||7
11092964|NCT01189032|12276348|FG002|NOT COMPLETED|Overall Study||6
11092965|NCT01189110|12276358|FG000|STARTED|Overall Study|September, 2010|64
11092966|NCT01189110|12276359|FG001|STARTED|Overall Study||61
11092967|NCT01189110|12276358|FG000|COMPLETED|Overall Study|February, 2011|64
11092968|NCT01189110|12276359|FG001|COMPLETED|Overall Study||61
11092969|NCT01189110|12276358|FG000|NOT COMPLETED|Overall Study||0
11092970|NCT01189110|12276359|FG001|NOT COMPLETED|Overall Study||0
11092971|NCT01189123|12276367|FG000|STARTED|Overall Study||52
11092972|NCT01189123|12276368|FG001|STARTED|Overall Study||53
11092973|NCT01189123|12276367|FG000|COMPLETED|Overall Study||50
11092974|NCT01189123|12276368|FG001|COMPLETED|Overall Study||47
11351947|NCT03040687|12549030|FG002|STARTED|Overall Study||20
11351948|NCT03040687|12549028|FG000|COMPLETED|Overall Study||19
11351949|NCT03040687|12549029|FG001|COMPLETED|Overall Study||20
11351950|NCT03040687|12549030|FG002|COMPLETED|Overall Study||20
11351951|NCT03040687|12549028|FG000|NOT COMPLETED|Overall Study||1
11351952|NCT03040687|12549029|FG001|NOT COMPLETED|Overall Study||0
11351953|NCT03040687|12549030|FG002|NOT COMPLETED|Overall Study||0
11351954|NCT03040713|12549038|FG000|STARTED|Overall Study||16
11351955|NCT03040713|12549038|FG000|COMPLETED|Overall Study||13
11351956|NCT03040713|12549038|FG000|NOT COMPLETED|Overall Study||3
11351957|NCT03040804|12549042|FG000|STARTED|Overall Study||2
11092975|NCT01189123|12276367|FG000|NOT COMPLETED|Overall Study||2
11092976|NCT01189123|12276368|FG001|NOT COMPLETED|Overall Study||6
11092977|NCT01189136|12276376|FG000|STARTED|Overall Study||42
11092978|NCT01189136|12276377|FG001|STARTED|Overall Study||42
11092979|NCT01189136|12276376|FG000|COMPLETED|Overall Study||42
11092980|NCT01189136|12276377|FG001|COMPLETED|Overall Study||42
11092981|NCT01189136|12276376|FG000|NOT COMPLETED|Overall Study||0
11092982|NCT01189136|12276377|FG001|NOT COMPLETED|Overall Study||0
11092983|NCT01189201|12276383|FG000|STARTED|Overall Study||42
11092984|NCT01189201|12276383|FG000|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
11092985|NCT01189201|12276383|FG000|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
11092986|NCT01189201|12276383|FG000|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
11092987|NCT01189201|12276383|FG000|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
11351958|NCT03040804|12549042|FG000|COMPLETED|Overall Study||2
11351959|NCT03040804|12549042|FG000|NOT COMPLETED|Overall Study||0
11351960|NCT03040986|12549048|FG000|STARTED|Overall Study||6
11092988|NCT01189201|12276383|FG000|COMPLETED|Overall Study||41
11092989|NCT01189201|12276383|FG000|NOT COMPLETED|Overall Study||1
11092990|NCT01189240|12276398|FG000|STARTED|Overall Study||4
11092991|NCT01189240|12276399|FG001|STARTED|Overall Study||6
11092992|NCT01189240|12276400|FG002|STARTED|Overall Study||3
11092993|NCT01189240|12276398|FG000|COMPLETED|Overall Study||4
11092994|NCT01189240|12276399|FG001|COMPLETED|Overall Study||6
11092995|NCT01189240|12276400|FG002|COMPLETED|Overall Study||3
11092996|NCT01189240|12276398|FG000|NOT COMPLETED|Overall Study||0
11092997|NCT01189240|12276399|FG001|NOT COMPLETED|Overall Study||0
11092998|NCT01189240|12276400|FG002|NOT COMPLETED|Overall Study||0
11092999|NCT01189266|12276413|FG000|STARTED|Overall Study||6
11093000|NCT01189266|12276414|FG001|STARTED|Overall Study||6
11093001|NCT01189266|12276415|FG002|STARTED|Overall Study||67
11093002|NCT01189266|12276413|FG000|COMPLETED|Overall Study||0
11093003|NCT01189266|12276414|FG001|COMPLETED|Overall Study||0
11093004|NCT01189266|12276415|FG002|COMPLETED|Overall Study||2
11093005|NCT01189266|12276413|FG000|NOT COMPLETED|Overall Study||6
11093006|NCT01189266|12276414|FG001|NOT COMPLETED|Overall Study||6
11093007|NCT01189266|12276415|FG002|NOT COMPLETED|Overall Study||65
11093008|NCT01189279|12276427|FG000|STARTED|Overall Study||14
11093009|NCT01189279|12276428|FG001|STARTED|Overall Study||14
11093010|NCT01189279|12276429|FG002|STARTED|Overall Study||14
11093011|NCT01189279|12276427|FG000|COMPLETED|Overall Study||13
11093012|NCT01189279|12276428|FG001|COMPLETED|Overall Study||14
11093013|NCT01189279|12276429|FG002|COMPLETED|Overall Study||13
11093014|NCT01189279|12276427|FG000|NOT COMPLETED|Overall Study||1
11093015|NCT01189279|12276428|FG001|NOT COMPLETED|Overall Study||0
11093016|NCT01189279|12276429|FG002|NOT COMPLETED|Overall Study||1
11093017|NCT01189292|12276439|FG000|STARTED|Intention to Treat Analysis||76
11093018|NCT01189292|12276440|FG001|STARTED|Intention to Treat Analysis||76
11093019|NCT01189292|12276439|FG000|COMPLETED|Intention to Treat Analysis||76
11093020|NCT01189292|12276440|FG001|COMPLETED|Intention to Treat Analysis||76
11093021|NCT01189292|12276439|FG000|NOT COMPLETED|Intention to Treat Analysis||0
11093022|NCT01189292|12276440|FG001|NOT COMPLETED|Intention to Treat Analysis||0
11093023|NCT01189292|12276439|FG000|STARTED|Per Protocol Analysis||76
11093024|NCT01189292|12276440|FG001|STARTED|Per Protocol Analysis||76
11093025|NCT01189292|12276439|FG000|COMPLETED|Per Protocol Analysis||65
11093026|NCT01189292|12276440|FG001|COMPLETED|Per Protocol Analysis||60
11093027|NCT01189292|12276439|FG000|NOT COMPLETED|Per Protocol Analysis||11
11093028|NCT01189292|12276440|FG001|NOT COMPLETED|Per Protocol Analysis||16
11093029|NCT01189370|12276446|FG000|STARTED|Dose Level 1||25
11093030|NCT01189370|12276447|FG001|STARTED|Dose Level 1||0
11093031|NCT01189370|12276448|FG002|STARTED|Dose Level 1||0
11093032|NCT01189370|12276446|FG000|COMPLETED|Dose Level 1||16
11093033|NCT01189370|12276447|FG001|COMPLETED|Dose Level 1||0
11093034|NCT01189370|12276448|FG002|COMPLETED|Dose Level 1||0
11093035|NCT01189370|12276446|FG000|NOT COMPLETED|Dose Level 1||9
11093036|NCT01189370|12276447|FG001|NOT COMPLETED|Dose Level 1||0
11093037|NCT01189370|12276448|FG002|NOT COMPLETED|Dose Level 1||0
11093038|NCT01189370|12276446|FG000|STARTED|Dose Level 2||0
11093039|NCT01189370|12276447|FG001|STARTED|Dose Level 2||16
11093040|NCT01189370|12276448|FG002|STARTED|Dose Level 2||0
11093041|NCT01189370|12276446|FG000|COMPLETED|Dose Level 2||0
11093042|NCT01189370|12276447|FG001|COMPLETED|Dose Level 2||12
11093043|NCT01189370|12276448|FG002|COMPLETED|Dose Level 2||0
11093044|NCT01189370|12276446|FG000|NOT COMPLETED|Dose Level 2||0
11093045|NCT01189370|12276447|FG001|NOT COMPLETED|Dose Level 2||4
11093046|NCT01189370|12276448|FG002|NOT COMPLETED|Dose Level 2||0
11093047|NCT01189370|12276446|FG000|STARTED|Dose Level 3||0
11093048|NCT01189370|12276447|FG001|STARTED|Dose Level 3||0
11093049|NCT01189370|12276448|FG002|STARTED|Dose Level 3||12
11093050|NCT01189370|12276446|FG000|COMPLETED|Dose Level 3||0
11093051|NCT01189370|12276447|FG001|COMPLETED|Dose Level 3||0
11093052|NCT01189370|12276448|FG002|COMPLETED|Dose Level 3||6
11093053|NCT01189370|12276446|FG000|NOT COMPLETED|Dose Level 3||0
11093054|NCT01189370|12276447|FG001|NOT COMPLETED|Dose Level 3||0
11093055|NCT01189370|12276448|FG002|NOT COMPLETED|Dose Level 3||6
11093056|NCT01189409|12276457|FG000|STARTED|First 3 Weeks||37
11093057|NCT01189409|12276458|FG001|STARTED|First 3 Weeks||33
11093058|NCT01189409|12276457|FG000|COMPLETED|First 3 Weeks||19
11093059|NCT01189409|12276458|FG001|COMPLETED|First 3 Weeks||23
11093060|NCT01189409|12276457|FG000|NOT COMPLETED|First 3 Weeks||18
11093061|NCT01189409|12276458|FG001|NOT COMPLETED|First 3 Weeks||10
11093062|NCT01189409|12276457|FG000|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
11093063|NCT01189409|12276458|FG001|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
11093064|NCT01189409|12276457|FG000|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
11093065|NCT01189409|12276458|FG001|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
11093066|NCT01189409|12276457|FG000|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
11093067|NCT01189409|12276458|FG001|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
11093068|NCT01189461|12276471|FG000|STARTED|Overall Study||46
11093069|NCT01189461|12276471|FG000|COMPLETED|Overall Study||12
11093070|NCT01189461|12276471|FG000|NOT COMPLETED|Overall Study||34
11093071|NCT01189487|12276475|FG000|STARTED|Overall Study|Treated participants|47
11093072|NCT01189487|12276475|FG000|COMPLETED|Overall Study||44
11093073|NCT01189487|12276475|FG000|NOT COMPLETED|Overall Study||3
11093074|NCT01189500|12276479|FG000|STARTED|Period 1: TAMOX Alone||30
11093075|NCT01189500|12276479|FG000|COMPLETED|Period 1: TAMOX Alone||29
11093076|NCT01189500|12276479|FG000|NOT COMPLETED|Period 1: TAMOX Alone||1
11093077|NCT01189500|12276479|FG000|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
11093078|NCT01189500|12276479|FG000|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
11093079|NCT01189500|12276479|FG000|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
11093080|NCT01189604|12276493|FG000|STARTED|Overall Study||21
11093081|NCT01189604|12276494|FG001|STARTED|Overall Study||21
11093082|NCT01189604|12276495|FG002|STARTED|Overall Study||20
11093083|NCT01189604|12276496|FG003|STARTED|Overall Study||20
11093084|NCT01189604|12276497|FG004|STARTED|Overall Study||20
11093085|NCT01189604|12276498|FG005|STARTED|Overall Study||11
11093086|NCT01189604|12276499|FG006|STARTED|Overall Study||10
11093087|NCT01189604|12276493|FG000|Administered Study Drug|Overall Study||20
11093088|NCT01189604|12276494|FG001|Administered Study Drug|Overall Study||20
11093089|NCT01189604|12276495|FG002|Administered Study Drug|Overall Study||20
11093090|NCT01189604|12276496|FG003|Administered Study Drug|Overall Study||20
11093091|NCT01189604|12276497|FG004|Administered Study Drug|Overall Study||20
11093092|NCT01189604|12276498|FG005|Administered Study Drug|Overall Study||10
11093093|NCT01189604|12276499|FG006|Administered Study Drug|Overall Study||10
11093094|NCT01189604|12276493|FG000|COMPLETED|Overall Study||20
11093095|NCT01189604|12276494|FG001|COMPLETED|Overall Study||20
11093096|NCT01189604|12276495|FG002|COMPLETED|Overall Study||20
11093097|NCT01189604|12276496|FG003|COMPLETED|Overall Study||20
11093098|NCT01189604|12276497|FG004|COMPLETED|Overall Study||18
11093099|NCT01189604|12276498|FG005|COMPLETED|Overall Study||10
11093100|NCT01189604|12276499|FG006|COMPLETED|Overall Study||9
11093101|NCT01189604|12276493|FG000|NOT COMPLETED|Overall Study||1
11093102|NCT01189604|12276494|FG001|NOT COMPLETED|Overall Study||1
11093103|NCT01189604|12276495|FG002|NOT COMPLETED|Overall Study||0
11093104|NCT01189604|12276496|FG003|NOT COMPLETED|Overall Study||0
11093105|NCT01189604|12276497|FG004|NOT COMPLETED|Overall Study||2
11093106|NCT01189604|12276498|FG005|NOT COMPLETED|Overall Study||1
11093107|NCT01189604|12276499|FG006|NOT COMPLETED|Overall Study||1
11093108|NCT01189617|12276517|FG000|STARTED|Overall Study||35
11093109|NCT01189617|12276518|FG001|STARTED|Overall Study||35
11093110|NCT01189617|12276517|FG000|COMPLETED|Overall Study||35
11093111|NCT01189617|12276518|FG001|COMPLETED|Overall Study||35
11093112|NCT01189617|12276517|FG000|NOT COMPLETED|Overall Study||0
11093113|NCT01189617|12276518|FG001|NOT COMPLETED|Overall Study||0
11093114|NCT01189747|12276526|FG000|STARTED|Overall Study||222
11093115|NCT01189747|12276527|FG001|STARTED|Overall Study||224
11093116|NCT01189747|12276526|FG000|COMPLETED|Overall Study||210
11093117|NCT01189747|12276527|FG001|COMPLETED|Overall Study||206
11093118|NCT01189747|12276526|FG000|NOT COMPLETED|Overall Study||12
11093119|NCT01189747|12276527|FG001|NOT COMPLETED|Overall Study||18
11093120|NCT01189760|12276536|FG000|STARTED|Overall Study||305
11093121|NCT01189760|12276537|FG001|STARTED|Overall Study||306
11093122|NCT01189760|12276538|FG002|STARTED|Overall Study||306
11093123|NCT01189760|12276536|FG000|COMPLETED|Overall Study||291
11093124|NCT01189760|12276537|FG001|COMPLETED|Overall Study||283
11093125|NCT01189760|12276538|FG002|COMPLETED|Overall Study||255
11093126|NCT01189760|12276536|FG000|NOT COMPLETED|Overall Study||14
11093127|NCT01189760|12276537|FG001|NOT COMPLETED|Overall Study||23
11093128|NCT01189760|12276538|FG002|NOT COMPLETED|Overall Study||51
11093129|NCT01189812|12276548|FG000|STARTED|Overall Study||40
11093130|NCT01189812|12276549|FG001|STARTED|Overall Study||40
11093131|NCT01189812|12276548|FG000|COMPLETED|Overall Study||32
11093132|NCT01189812|12276549|FG001|COMPLETED|Overall Study||32
11093133|NCT01189812|12276548|FG000|NOT COMPLETED|Overall Study||8
11093134|NCT01189812|12276549|FG001|NOT COMPLETED|Overall Study||8
11093135|NCT01189890|12276557|FG000|STARTED|Overall Study||241
11093136|NCT01189890|12276558|FG001|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
11093137|NCT01189890|12276557|FG000|COMPLETED|Overall Study||204
11093138|NCT01189890|12276558|FG001|COMPLETED|Overall Study||200
11093139|NCT01189890|12276557|FG000|NOT COMPLETED|Overall Study||37
11093140|NCT01189890|12276558|FG001|NOT COMPLETED|Overall Study||39
11093141|NCT01190007|12276564|FG000|STARTED|Overall Study|Treated|159
11093142|NCT01190007|12276564|FG000|COMPLETED|Overall Study||145
11093143|NCT01190007|12276564|FG000|NOT COMPLETED|Overall Study||14
11093144|NCT01190020|12276570|FG000|STARTED|Overall Study||29
11093145|NCT01190020|12276571|FG001|STARTED|Overall Study||12
11093146|NCT01190020|12276570|FG000|COMPLETED|Overall Study||22
11093147|NCT01190020|12276571|FG001|COMPLETED|Overall Study||12
11093148|NCT01190020|12276570|FG000|NOT COMPLETED|Overall Study||7
11351961|NCT03040986|12549049|FG001|STARTED|Overall Study||2
11351962|NCT03040986|12549048|FG000|COMPLETED|Overall Study||0
11351963|NCT03040986|12549049|FG001|COMPLETED|Overall Study||0
11351964|NCT03040986|12549048|FG000|NOT COMPLETED|Overall Study||6
11351965|NCT03040986|12549049|FG001|NOT COMPLETED|Overall Study||2
11351966|NCT03041025|12549060|FG000|STARTED|Overall Study||8
11351967|NCT03041025|12549061|FG001|STARTED|Overall Study||3
11351968|NCT03041025|12549062|FG002|STARTED|Overall Study||24
11351969|NCT03041025|12549060|FG000|COMPLETED|Overall Study||7
11351970|NCT03041025|12549061|FG001|COMPLETED|Overall Study||3
11093149|NCT01190020|12276571|FG001|NOT COMPLETED|Overall Study||0
11093150|NCT01190085|12276580|FG000|STARTED|Overall Study||13
11093151|NCT01190085|12276581|FG001|STARTED|Overall Study||14
11093152|NCT01190085|12276582|FG002|STARTED|Overall Study||18
11093153|NCT01190085|12276580|FG000|COMPLETED|Overall Study||13
11093154|NCT01190085|12276581|FG001|COMPLETED|Overall Study||14
11093155|NCT01190085|12276582|FG002|COMPLETED|Overall Study||18
11093156|NCT01190085|12276580|FG000|NOT COMPLETED|Overall Study||0
11093157|NCT01190085|12276581|FG001|NOT COMPLETED|Overall Study||0
11093158|NCT01190085|12276582|FG002|NOT COMPLETED|Overall Study||0
11093159|NCT01190098|12276592|FG000|STARTED|Overall Study||42
11093160|NCT01190098|12276593|FG001|STARTED|Overall Study||10
11093161|NCT01190098|12276592|FG000|COMPLETED|Overall Study||39
11093162|NCT01190098|12276593|FG001|COMPLETED|Overall Study||8
11093163|NCT01190098|12276592|FG000|NOT COMPLETED|Overall Study||3
11093164|NCT01190098|12276593|FG001|NOT COMPLETED|Overall Study||2
11093165|NCT01190124|12276602|FG000|STARTED|Overall Study||107
11093166|NCT01190124|12276603|FG001|STARTED|Overall Study||24
11093167|NCT01190124|12276604|FG002|STARTED|Overall Study||20
11093168|NCT01190124|12276602|FG000|COMPLETED|Overall Study||90
11093169|NCT01190124|12276603|FG001|COMPLETED|Overall Study||24
11093170|NCT01190124|12276604|FG002|COMPLETED|Overall Study||19
11093171|NCT01190124|12276602|FG000|NOT COMPLETED|Overall Study||17
11093172|NCT01190124|12276603|FG001|NOT COMPLETED|Overall Study||0
11093173|NCT01190124|12276604|FG002|NOT COMPLETED|Overall Study||1
11093174|NCT01190150|12276617|FG000|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
11093175|NCT01190150|12276618|FG001|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
11093176|NCT01190150|12276617|FG000|COMPLETED|First Treatment||10
11093177|NCT01190150|12276618|FG001|COMPLETED|First Treatment||9
11093178|NCT01190150|12276617|FG000|NOT COMPLETED|First Treatment||1
11093179|NCT01190150|12276618|FG001|NOT COMPLETED|First Treatment||0
11093180|NCT01190150|12276617|FG000|STARTED|Washout||10
11093181|NCT01190150|12276618|FG001|STARTED|Washout||9
11093182|NCT01190150|12276617|FG000|COMPLETED|Washout||10
11093183|NCT01190150|12276618|FG001|COMPLETED|Washout||7
11093184|NCT01190150|12276617|FG000|NOT COMPLETED|Washout||0
11093185|NCT01190150|12276618|FG001|NOT COMPLETED|Washout||2
11093186|NCT01190150|12276617|FG000|STARTED|Second Treatment||10
11093187|NCT01190150|12276618|FG001|STARTED|Second Treatment||7
11093188|NCT01190150|12276617|FG000|COMPLETED|Second Treatment||10
11093189|NCT01190150|12276618|FG001|COMPLETED|Second Treatment||7
11093190|NCT01190150|12276617|FG000|NOT COMPLETED|Second Treatment||0
11093191|NCT01190150|12276618|FG001|NOT COMPLETED|Second Treatment||0
11093192|NCT01190176|12276624|FG000|STARTED|Overall Study||32
11093193|NCT01190176|12276624|FG000|COMPLETED|Overall Study||30
11093194|NCT01190176|12276624|FG000|NOT COMPLETED|Overall Study||2
11093195|NCT01190189|12276628|FG000|STARTED|Overall Study||137
11093196|NCT01190189|12276628|FG000|COMPLETED|Overall Study||131
11093197|NCT01190189|12276628|FG000|NOT COMPLETED|Overall Study||6
11093198|NCT01190215|12276634|FG000|STARTED|Up to Day 28||38
11093199|NCT01190215|12276635|FG001|STARTED|Up to Day 28||39
11093200|NCT01190215|12276634|FG000|COMPLETED|Up to Day 28||38
11093201|NCT01190215|12276635|FG001|COMPLETED|Up to Day 28||39
11093202|NCT01190215|12276634|FG000|NOT COMPLETED|Up to Day 28||0
11093203|NCT01190215|12276635|FG001|NOT COMPLETED|Up to Day 28||0
11093204|NCT01190215|12276634|FG000|STARTED|Up to Month 6||38
11093205|NCT01190215|12276635|FG001|STARTED|Up to Month 6||39
11093206|NCT01190215|12276634|FG000|COMPLETED|Up to Month 6||36
11093207|NCT01190215|12276635|FG001|COMPLETED|Up to Month 6||39
11093208|NCT01190215|12276634|FG000|NOT COMPLETED|Up to Month 6||2
11093209|NCT01190215|12276635|FG001|NOT COMPLETED|Up to Month 6||0
11093210|NCT01190410|12276643|FG000|STARTED|Overall Study||4
11093211|NCT01190410|12276644|FG001|STARTED|Overall Study||12
11093212|NCT01190410|12276643|FG000|Re-Induction|Overall Study||0
11093213|NCT01190410|12276644|FG001|Re-Induction|Overall Study||2
11093214|NCT01190410|12276643|FG000|COMPLETED|Overall Study||3
11093215|NCT01190410|12276644|FG001|COMPLETED|Overall Study||3
11093216|NCT01190410|12276643|FG000|NOT COMPLETED|Overall Study||1
11093217|NCT01190410|12276644|FG001|NOT COMPLETED|Overall Study||9
11093218|NCT01190436|12276656|FG000|STARTED|Overall Study||125
11093219|NCT01190436|12276656|FG000|COMPLETED|Overall Study||86
11093220|NCT01190436|12276656|FG000|NOT COMPLETED|Overall Study||39
11093221|NCT01190449|12276663|FG000|STARTED|Overall Study||15
11093222|NCT01190449|12276664|FG001|STARTED|Overall Study||36
11093223|NCT01190449|12276663|FG000|COMPLETED|Overall Study||15
11093224|NCT01190449|12276664|FG001|COMPLETED|Overall Study||32
11093225|NCT01190449|12276663|FG000|NOT COMPLETED|Overall Study||0
11093226|NCT01190449|12276664|FG001|NOT COMPLETED|Overall Study||4
11093227|NCT01190475|12276673|FG000|STARTED|Overall Study||2
11093228|NCT01190475|12276674|FG001|STARTED|Overall Study||2
11093229|NCT01190475|12276675|FG002|STARTED|Overall Study||2
11093230|NCT01190475|12276673|FG000|COMPLETED|Overall Study||2
11093231|NCT01190475|12276674|FG001|COMPLETED|Overall Study||2
11093232|NCT01190475|12276675|FG002|COMPLETED|Overall Study||1
11093233|NCT01190475|12276673|FG000|NOT COMPLETED|Overall Study||0
11093234|NCT01190475|12276674|FG001|NOT COMPLETED|Overall Study||0
11093235|NCT01190475|12276675|FG002|NOT COMPLETED|Overall Study||1
11093236|NCT01190514|12276685|FG000|STARTED|First Intervention (Period 1)||11
11093237|NCT01190514|12276686|FG001|STARTED|First Intervention (Period 1)||10
11093238|NCT01190514|12276687|FG002|STARTED|First Intervention (Period 1)||10
11093239|NCT01190514|12276688|FG003|STARTED|First Intervention (Period 1)||10
11093240|NCT01190514|12276685|FG000|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
11093241|NCT01190514|12276686|FG001|COMPLETED|First Intervention (Period 1)||10
11093242|NCT01190514|12276687|FG002|COMPLETED|First Intervention (Period 1)||10
11093243|NCT01190514|12276688|FG003|COMPLETED|First Intervention (Period 1)||10
11093244|NCT01190514|12276685|FG000|NOT COMPLETED|First Intervention (Period 1)||1
11093245|NCT01190514|12276686|FG001|NOT COMPLETED|First Intervention (Period 1)||0
11093246|NCT01190514|12276687|FG002|NOT COMPLETED|First Intervention (Period 1)||0
11093247|NCT01190514|12276688|FG003|NOT COMPLETED|First Intervention (Period 1)||0
11093248|NCT01190514|12276685|FG000|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
11093249|NCT01190514|12276686|FG001|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
11093250|NCT01190514|12276687|FG002|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
11093251|NCT01190514|12276688|FG003|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
11093252|NCT01190514|12276685|FG000|COMPLETED|Second Intervention (Period 2)||10
11093253|NCT01190514|12276686|FG001|COMPLETED|Second Intervention (Period 2)||10
11093254|NCT01190514|12276687|FG002|COMPLETED|Second Intervention (Period 2)||10
11093255|NCT01190514|12276688|FG003|COMPLETED|Second Intervention (Period 2)||10
11093256|NCT01190514|12276685|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
11093257|NCT01190514|12276686|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
11093258|NCT01190514|12276687|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
11093259|NCT01190514|12276688|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
11093260|NCT01190514|12276685|FG000|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
11093261|NCT01190514|12276686|FG001|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
11093262|NCT01190514|12276687|FG002|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
11093263|NCT01190514|12276688|FG003|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
11093264|NCT01190514|12276685|FG000|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
11093265|NCT01190514|12276686|FG001|COMPLETED|Third Intervention (Period 3)||10
11093266|NCT01190514|12276687|FG002|COMPLETED|Third Intervention (Period 3)||10
11093267|NCT01190514|12276688|FG003|COMPLETED|Third Intervention (Period 3)||10
11093268|NCT01190514|12276685|FG000|NOT COMPLETED|Third Intervention (Period 3)||1
11351971|NCT03041025|12549062|FG002|COMPLETED|Overall Study||22
11351972|NCT03041025|12549060|FG000|NOT COMPLETED|Overall Study||1
11351973|NCT03041025|12549061|FG001|NOT COMPLETED|Overall Study||0
11351974|NCT03041025|12549062|FG002|NOT COMPLETED|Overall Study||2
11351975|NCT03041038|12549075|FG000|STARTED|Overall Study||11
11351976|NCT03041038|12549076|FG001|STARTED|Overall Study||9
11351977|NCT03041038|12549075|FG000|Week 16|Overall Study||10
11351978|NCT03041038|12549076|FG001|Week 16|Overall Study||8
11351979|NCT03041038|12549075|FG000|Week 32|Overall Study||9
11351980|NCT03041038|12549076|FG001|Week 32|Overall Study||8
11093269|NCT01190514|12276686|FG001|NOT COMPLETED|Third Intervention (Period 3)||0
11093270|NCT01190514|12276687|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
11093271|NCT01190514|12276688|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
11093272|NCT01190514|12276685|FG000|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
11093273|NCT01190514|12276686|FG001|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
11093274|NCT01190514|12276687|FG002|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
11351981|NCT03041038|12549075|FG000|COMPLETED|Overall Study||5
11351982|NCT03041038|12549076|FG001|COMPLETED|Overall Study||7
11351983|NCT03041038|12549075|FG000|NOT COMPLETED|Overall Study||6
11351984|NCT03041038|12549076|FG001|NOT COMPLETED|Overall Study||2
11351985|NCT03041090|12549086|FG000|STARTED|Overall Study||109
11093275|NCT01190514|12276688|FG003|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
11093276|NCT01190514|12276685|FG000|COMPLETED|Fourth Intervention (Period 4)||9
11093277|NCT01190514|12276686|FG001|COMPLETED|Fourth Intervention (Period 4)||10
11093278|NCT01190514|12276687|FG002|COMPLETED|Fourth Intervention (Period 4)||10
11093279|NCT01190514|12276688|FG003|COMPLETED|Fourth Intervention (Period 4)||10
11093280|NCT01190514|12276685|FG000|NOT COMPLETED|Fourth Intervention (Period 4)||0
11093281|NCT01190514|12276686|FG001|NOT COMPLETED|Fourth Intervention (Period 4)||0
11093282|NCT01190514|12276687|FG002|NOT COMPLETED|Fourth Intervention (Period 4)||0
11093283|NCT01190514|12276688|FG003|NOT COMPLETED|Fourth Intervention (Period 4)||0
11093284|NCT01190527|12276698|FG000|STARTED|Overall Study||42
11093285|NCT01190527|12276698|FG000|COMPLETED|Overall Study||42
11093286|NCT01190527|12276698|FG000|NOT COMPLETED|Overall Study||0
11093287|NCT01190566|12276704|FG000|STARTED|Overall Study||6
11093288|NCT01190566|12276705|FG001|STARTED|Overall Study||42
11093289|NCT01190566|12276704|FG000|COMPLETED|Overall Study||6
11093290|NCT01190566|12276705|FG001|COMPLETED|Overall Study||42
11093291|NCT01190566|12276704|FG000|NOT COMPLETED|Overall Study||0
11093292|NCT01190566|12276705|FG001|NOT COMPLETED|Overall Study||0
11093293|NCT01190813|12276714|FG000|STARTED|Overall Study||90
11093294|NCT01190813|12276715|FG001|STARTED|Overall Study||49
11093295|NCT01190813|12276714|FG000|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
11093296|NCT01190813|12276715|FG001|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
11093297|NCT01190813|12276714|FG000|4-week Visit|Overall Study|0 missed, 1 dropped|88
11093298|NCT01190813|12276715|FG001|4-week Visit|Overall Study|1 missed, 1 dropped|47
11093299|NCT01190813|12276714|FG000|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
11093300|NCT01190813|12276715|FG001|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
11093301|NCT01190813|12276714|FG000|10-week Visit|Overall Study|0 missed, 0 dropped|88
11093302|NCT01190813|12276715|FG001|10-week Visit|Overall Study|0 dropped, 0 missed|48
11093303|NCT01190813|12276714|FG000|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
11093304|NCT01190813|12276715|FG001|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
11351986|NCT03041090|12549087|FG001|STARTED|Overall Study||24
11351987|NCT03041090|12549086|FG000|COMPLETED|Overall Study||109
11093305|NCT01190813|12276714|FG000|16-week Visit|Overall Study|1 dropped|87
11093306|NCT01190813|12276715|FG001|16-week Visit|Overall Study|2 dropped|46
11093307|NCT01190813|12276714|FG000|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
11093308|NCT01190813|12276715|FG001|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
11093309|NCT01190813|12276714|FG000|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
11093310|NCT01190813|12276715|FG001|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
11093311|NCT01190813|12276714|FG000|26-week Visit|Overall Study|0 missed, 0 dropped|86
11093312|NCT01190813|12276715|FG001|26-week Visit|Overall Study|0 missed, 0 dropped|45
11093313|NCT01190813|12276714|FG000|COMPLETED|Overall Study||86
11093314|NCT01190813|12276715|FG001|COMPLETED|Overall Study||45
11093315|NCT01190813|12276714|FG000|NOT COMPLETED|Overall Study||4
11093316|NCT01190813|12276715|FG001|NOT COMPLETED|Overall Study||4
11093317|NCT01190839|12276723|FG000|STARTED|Overall Study||150
11093318|NCT01190839|12276724|FG001|STARTED|Overall Study||147
11093319|NCT01190839|12276723|FG000|Treated|Overall Study||148
11093320|NCT01190839|12276724|FG001|Treated|Overall Study||143
11093321|NCT01190839|12276723|FG000|COMPLETED|Overall Study||0
11093322|NCT01190839|12276724|FG001|COMPLETED|Overall Study||0
11093323|NCT01190839|12276723|FG000|NOT COMPLETED|Overall Study||150
11093324|NCT01190839|12276724|FG001|NOT COMPLETED|Overall Study||147
11093325|NCT01190865|12276732|FG000|STARTED|Overall Study||28
11093326|NCT01190865|12276732|FG000|COMPLETED|Overall Study||25
11093327|NCT01190865|12276732|FG000|NOT COMPLETED|Overall Study||3
11093328|NCT01190878|12276740|FG000|STARTED|Overall Study||40
11093329|NCT01190878|12276741|FG001|STARTED|Overall Study||45
11093330|NCT01190878|12276742|FG002|STARTED|Overall Study||42
11093331|NCT01190878|12276743|FG003|STARTED|Overall Study||42
11093332|NCT01190878|12276740|FG000|COMPLETED|Overall Study||37
11093333|NCT01190878|12276741|FG001|COMPLETED|Overall Study||42
11093334|NCT01190878|12276742|FG002|COMPLETED|Overall Study||37
11093335|NCT01190878|12276743|FG003|COMPLETED|Overall Study||22
11093336|NCT01190878|12276740|FG000|NOT COMPLETED|Overall Study||3
11093337|NCT01190878|12276741|FG001|NOT COMPLETED|Overall Study||3
11093338|NCT01190878|12276742|FG002|NOT COMPLETED|Overall Study||5
11093339|NCT01190878|12276743|FG003|NOT COMPLETED|Overall Study||20
11093340|NCT01190891|12276755|FG000|STARTED|Overall Study||52
11093341|NCT01190891|12276756|FG001|STARTED|Overall Study||52
11093342|NCT01190891|12276755|FG000|COMPLETED|Overall Study||46
11093343|NCT01190891|12276756|FG001|COMPLETED|Overall Study||52
11093344|NCT01190891|12276755|FG000|NOT COMPLETED|Overall Study||6
11093345|NCT01190891|12276756|FG001|NOT COMPLETED|Overall Study||0
11093346|NCT01191008|12276762|FG000|STARTED|Overall Study||633
11093347|NCT01191008|12276762|FG000|COMPLETED|Overall Study||618
11093348|NCT01191008|12276762|FG000|NOT COMPLETED|Overall Study||15
11093349|NCT01191086|12276766|FG000|STARTED|Overall Study||210
11093350|NCT01191086|12276766|FG000|COMPLETED|Overall Study||148
11093351|NCT01191086|12276766|FG000|NOT COMPLETED|Overall Study||62
11093352|NCT01191190|12276770|FG000|STARTED|Overall Study||21
11093353|NCT01191190|12276770|FG000|COMPLETED|Overall Study||20
11093354|NCT01191190|12276770|FG000|NOT COMPLETED|Overall Study||1
11093355|NCT01191242|12276774|FG000|STARTED|Overall Study||31
11093356|NCT01191242|12276774|FG000|COMPLETED|Overall Study||31
11093357|NCT01191242|12276774|FG000|NOT COMPLETED|Overall Study||0
11093358|NCT01191255|12276782|FG000|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
11093359|NCT01191255|12276783|FG001|STARTED|Safety Assessment Period||292
11093360|NCT01191255|12276784|FG002|STARTED|Safety Assessment Period||0
11093361|NCT01191255|12276785|FG003|STARTED|Safety Assessment Period||0
11093362|NCT01191255|12276782|FG000|Safety Population|Safety Assessment Period||149
11093363|NCT01191255|12276783|FG001|Safety Population|Safety Assessment Period||289
11093364|NCT01191255|12276784|FG002|Safety Population|Safety Assessment Period||0
11093365|NCT01191255|12276785|FG003|Safety Population|Safety Assessment Period||0
11093366|NCT01191255|12276782|FG000|COMPLETED|Safety Assessment Period||111
11093367|NCT01191255|12276783|FG001|COMPLETED|Safety Assessment Period||193
11093368|NCT01191255|12276784|FG002|COMPLETED|Safety Assessment Period||0
11093369|NCT01191255|12276785|FG003|COMPLETED|Safety Assessment Period||0
11093370|NCT01191255|12276782|FG000|NOT COMPLETED|Safety Assessment Period||38
11093371|NCT01191255|12276783|FG001|NOT COMPLETED|Safety Assessment Period||99
11093372|NCT01191255|12276784|FG002|NOT COMPLETED|Safety Assessment Period||0
11093373|NCT01191255|12276785|FG003|NOT COMPLETED|Safety Assessment Period||0
11093374|NCT01191255|12276782|FG000|STARTED|Efficacy Assessment Period||0
11093375|NCT01191255|12276783|FG001|STARTED|Efficacy Assessment Period||0
11093376|NCT01191255|12276784|FG002|STARTED|Efficacy Assessment Period||96
11093377|NCT01191255|12276785|FG003|STARTED|Efficacy Assessment Period||96
11093378|NCT01191255|12276782|FG000|COMPLETED|Efficacy Assessment Period||0
11093379|NCT01191255|12276783|FG001|COMPLETED|Efficacy Assessment Period||0
11093380|NCT01191255|12276784|FG002|COMPLETED|Efficacy Assessment Period||70
11093381|NCT01191255|12276785|FG003|COMPLETED|Efficacy Assessment Period||90
11093382|NCT01191255|12276782|FG000|NOT COMPLETED|Efficacy Assessment Period||0
11093383|NCT01191255|12276783|FG001|NOT COMPLETED|Efficacy Assessment Period||0
11093384|NCT01191255|12276784|FG002|NOT COMPLETED|Efficacy Assessment Period||26
11093385|NCT01191255|12276785|FG003|NOT COMPLETED|Efficacy Assessment Period||6
11093386|NCT01191268|12276798|FG000|STARTED|Overall Study||295
11093387|NCT01191268|12276799|FG001|STARTED|Overall Study||293
11093388|NCT01191268|12276800|FG002|STARTED|Overall Study||296
11093389|NCT01191268|12276798|FG000|Received at Least One Dose of Study Drug|Overall Study||295
11093390|NCT01191268|12276799|FG001|Received at Least One Dose of Study Drug|Overall Study||293
11093391|NCT01191268|12276800|FG002|Received at Least One Dose of Study Drug|Overall Study||296
11093392|NCT01191268|12276798|FG000|COMPLETED|Overall Study||237
11093393|NCT01191268|12276799|FG001|COMPLETED|Overall Study||238
11093394|NCT01191268|12276800|FG002|COMPLETED|Overall Study||244
11093395|NCT01191268|12276798|FG000|NOT COMPLETED|Overall Study||58
11093396|NCT01191268|12276799|FG001|NOT COMPLETED|Overall Study||55
11093397|NCT01191268|12276800|FG002|NOT COMPLETED|Overall Study||52
11093398|NCT01191320|12276812|FG000|STARTED|Overall Study||43
11093399|NCT01191320|12276813|FG001|STARTED|Overall Study||38
11093400|NCT01191320|12276814|FG002|STARTED|Overall Study||38
11093401|NCT01191320|12276812|FG000|COMPLETED|Overall Study||36
11093402|NCT01191320|12276813|FG001|COMPLETED|Overall Study||32
11093403|NCT01191320|12276814|FG002|COMPLETED|Overall Study||31
11093404|NCT01191320|12276812|FG000|NOT COMPLETED|Overall Study||7
11093405|NCT01191320|12276813|FG001|NOT COMPLETED|Overall Study||6
11093406|NCT01191320|12276814|FG002|NOT COMPLETED|Overall Study||7
11093407|NCT01191333|12276824|FG000|STARTED|Overall Study||81
11093408|NCT01191333|12276825|FG001|STARTED|Overall Study||83
11093409|NCT01191333|12276824|FG000|COMPLETED|Overall Study||60
11093410|NCT01191333|12276825|FG001|COMPLETED|Overall Study||65
11093411|NCT01191333|12276824|FG000|NOT COMPLETED|Overall Study||21
11093412|NCT01191333|12276825|FG001|NOT COMPLETED|Overall Study||18
11093413|NCT01191398|12276834|FG000|STARTED|Overall Study||17
11093414|NCT01191398|12276835|FG001|STARTED|Overall Study||17
11093415|NCT01191398|12276836|FG002|STARTED|Overall Study||18
11093416|NCT01191398|12276834|FG000|COMPLETED|Overall Study||17
11093417|NCT01191398|12276835|FG001|COMPLETED|Overall Study||17
11093418|NCT01191398|12276836|FG002|COMPLETED|Overall Study||18
11093419|NCT01191398|12276834|FG000|NOT COMPLETED|Overall Study||0
11093420|NCT01191398|12276835|FG001|NOT COMPLETED|Overall Study||0
11093421|NCT01191398|12276836|FG002|NOT COMPLETED|Overall Study||0
11093422|NCT01191411|12276847|FG000|STARTED|Overall Study||1593
11093423|NCT01191411|12276848|FG001|STARTED|Overall Study||479
11093424|NCT01191411|12276849|FG002|STARTED|Overall Study||3898
11093425|NCT01191411|12276847|FG000|COMPLETED|Overall Study||648
11093426|NCT01191411|12276848|FG001|COMPLETED|Overall Study||118
11093427|NCT01191411|12276849|FG002|COMPLETED|Overall Study||471
11093428|NCT01191411|12276847|FG000|NOT COMPLETED|Overall Study||945
11093429|NCT01191411|12276848|FG001|NOT COMPLETED|Overall Study||361
11093430|NCT01191411|12276849|FG002|NOT COMPLETED|Overall Study||3427
11093431|NCT01191476|12276860|FG000|STARTED|Overall Study||112
11093432|NCT01191476|12276861|FG001|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
11093433|NCT01191476|12276862|FG002|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
11093434|NCT01191476|12276860|FG000|COMPLETED|Overall Study||109
11093435|NCT01191476|12276861|FG001|COMPLETED|Overall Study||107
11093436|NCT01191476|12276862|FG002|COMPLETED|Overall Study||111
11093437|NCT01191476|12276860|FG000|NOT COMPLETED|Overall Study||3
11093438|NCT01191476|12276861|FG001|NOT COMPLETED|Overall Study||4
11093439|NCT01191476|12276862|FG002|NOT COMPLETED|Overall Study||0
11093440|NCT01191541|12276874|FG000|STARTED|All the Patients||30
11093441|NCT01191541|12276875|FG001|STARTED|All the Patients||35
11093442|NCT01191541|12276874|FG000|COMPLETED|All the Patients||30
11093443|NCT01191541|12276875|FG001|COMPLETED|All the Patients||35
11093444|NCT01191541|12276874|FG000|NOT COMPLETED|All the Patients||0
11093445|NCT01191541|12276875|FG001|NOT COMPLETED|All the Patients||0
11093446|NCT01191541|12276874|FG000|STARTED|the Randomized Patients||30
11093447|NCT01191541|12276875|FG001|STARTED|the Randomized Patients||35
11093448|NCT01191541|12276874|FG000|COMPLETED|the Randomized Patients||30
11093449|NCT01191541|12276875|FG001|COMPLETED|the Randomized Patients||35
11093450|NCT01191541|12276874|FG000|NOT COMPLETED|the Randomized Patients||0
11093451|NCT01191541|12276875|FG001|NOT COMPLETED|the Randomized Patients||0
11093452|NCT01191723|12276891|FG000|STARTED|Overall Study||9
11093453|NCT01191723|12276892|FG001|STARTED|Overall Study||9
11351988|NCT03041090|12549087|FG001|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21
11351989|NCT03041090|12549086|FG000|NOT COMPLETED|Overall Study||0
11351990|NCT03041090|12549087|FG001|NOT COMPLETED|Overall Study||3
11351991|NCT03041116|12549095|FG000|STARTED|Double-blind||41
11093454|NCT01191723|12276893|FG002|STARTED|Overall Study||9
11093455|NCT01191723|12276894|FG003|STARTED|Overall Study||9
11093456|NCT01191723|12276895|FG004|STARTED|Overall Study||9
11093457|NCT01191723|12276896|FG005|STARTED|Overall Study||9
11093458|NCT01191723|12276891|FG000|COMPLETED|Overall Study||9
11093459|NCT01191723|12276892|FG001|COMPLETED|Overall Study||9
11093460|NCT01191723|12276893|FG002|COMPLETED|Overall Study||9
11093461|NCT01191723|12276894|FG003|COMPLETED|Overall Study||9
11093462|NCT01191723|12276895|FG004|COMPLETED|Overall Study||9
11093463|NCT01191723|12276896|FG005|COMPLETED|Overall Study||9
11093464|NCT01191723|12276891|FG000|NOT COMPLETED|Overall Study||0
11093465|NCT01191723|12276892|FG001|NOT COMPLETED|Overall Study||0
11093466|NCT01191723|12276893|FG002|NOT COMPLETED|Overall Study||0
11093467|NCT01191723|12276894|FG003|NOT COMPLETED|Overall Study||0
11093468|NCT01191723|12276895|FG004|NOT COMPLETED|Overall Study||0
11093469|NCT01191723|12276896|FG005|NOT COMPLETED|Overall Study||0
11093470|NCT01191736|12276912|FG000|STARTED|Overall Study||51
11093471|NCT01191736|12276913|FG001|STARTED|Overall Study||47
11093472|NCT01191736|12276914|FG002|STARTED|Overall Study||49
11093473|NCT01191736|12276915|FG003|STARTED|Overall Study||46
11093474|NCT01191736|12276916|FG004|STARTED|Overall Study||48
11093475|NCT01191736|12276917|FG005|STARTED|Overall Study||50
11093476|NCT01191736|12276918|FG006|STARTED|Overall Study||45
11093477|NCT01191736|12276912|FG000|COMPLETED|Overall Study||51
11093478|NCT01191736|12276913|FG001|COMPLETED|Overall Study||47
11093479|NCT01191736|12276914|FG002|COMPLETED|Overall Study||49
11093480|NCT01191736|12276915|FG003|COMPLETED|Overall Study||46
11093481|NCT01191736|12276916|FG004|COMPLETED|Overall Study||48
11093482|NCT01191736|12276917|FG005|COMPLETED|Overall Study||50
11093483|NCT01191736|12276918|FG006|COMPLETED|Overall Study||45
11093484|NCT01191736|12276912|FG000|NOT COMPLETED|Overall Study||0
11093485|NCT01191736|12276913|FG001|NOT COMPLETED|Overall Study||0
11351992|NCT03041116|12549096|FG001|STARTED|Double-blind||43
11093486|NCT01191736|12276914|FG002|NOT COMPLETED|Overall Study||0
11093487|NCT01191736|12276915|FG003|NOT COMPLETED|Overall Study||0
11351993|NCT03041116|12549095|FG000|Received at Least 1 Dose of Study Drug|Double-blind||41
11351994|NCT03041116|12549096|FG001|Received at Least 1 Dose of Study Drug|Double-blind||43
11093488|NCT01191736|12276916|FG004|NOT COMPLETED|Overall Study||0
11093489|NCT01191736|12276917|FG005|NOT COMPLETED|Overall Study||0
11093490|NCT01191736|12276918|FG006|NOT COMPLETED|Overall Study||0
11093491|NCT01191749|12276934|FG000|STARTED|Overall Study||7
11093492|NCT01191749|12276934|FG000|COMPLETED|Overall Study||7
11093493|NCT01191749|12276934|FG000|NOT COMPLETED|Overall Study||0
11093494|NCT01191762|12276940|FG000|STARTED|Overall Study||15
11093495|NCT01191762|12276941|FG001|STARTED|Overall Study||15
11093496|NCT01191762|12276940|FG000|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
11093497|NCT01191762|12276941|FG001|COMPLETED|Overall Study||15
11093498|NCT01191762|12276940|FG000|NOT COMPLETED|Overall Study||1
11093499|NCT01191762|12276941|FG001|NOT COMPLETED|Overall Study||0
11093500|NCT01191788|12276949|FG000|STARTED|Overall Study||140
11093501|NCT01191788|12276950|FG001|STARTED|Overall Study||159
11351995|NCT03041116|12549095|FG000|COMPLETED|Double-blind||41
11351996|NCT03041116|12549096|FG001|COMPLETED|Double-blind||37
11351997|NCT03041116|12549095|FG000|NOT COMPLETED|Double-blind||0
11351998|NCT03041116|12549096|FG001|NOT COMPLETED|Double-blind||6
11351999|NCT03041116|12549095|FG000|STARTED|Open-label||41
11352000|NCT03041116|12549096|FG001|STARTED|Open-label||37
11352001|NCT03041116|12549095|FG000|Received At Least 1 Dose of Study Drug|Open-label||41
11352002|NCT03041116|12549096|FG001|Received At Least 1 Dose of Study Drug|Open-label||37
11352003|NCT03041116|12549095|FG000|COMPLETED|Open-label||0
11352004|NCT03041116|12549096|FG001|COMPLETED|Open-label||0
11352005|NCT03041116|12549095|FG000|NOT COMPLETED|Open-label||41
11352006|NCT03041116|12549096|FG001|NOT COMPLETED|Open-label||37
11352007|NCT03041298|12549106|FG000|STARTED|Overall Study||1537
11352008|NCT03041298|12549106|FG000|COMPLETED|Overall Study||1537
11352009|NCT03041298|12549106|FG000|NOT COMPLETED|Overall Study||0
11352010|NCT03041441|12549110|FG000|STARTED|Overall Study||5
11352011|NCT03041441|12549110|FG000|COMPLETED|Overall Study||3
11352012|NCT03041441|12549110|FG000|NOT COMPLETED|Overall Study||2
11352013|NCT03041636|12549115|FG000|STARTED|Overall Study||1
11352014|NCT03041636|12549115|FG000|COMPLETED|Overall Study||1
11352015|NCT03041636|12549115|FG000|NOT COMPLETED|Overall Study||0
11352016|NCT03041792|12549121|FG000|STARTED|Overall Study||32
11352017|NCT03041792|12549122|FG001|STARTED|Overall Study||29
11352018|NCT03041792|12549121|FG000|Received Treatment|Overall Study||32
11352019|NCT03041792|12549122|FG001|Received Treatment|Overall Study||28
11352020|NCT03041792|12549121|FG000|COMPLETED|Overall Study||28
11352021|NCT03041792|12549122|FG001|COMPLETED|Overall Study||26
11352022|NCT03041792|12549121|FG000|NOT COMPLETED|Overall Study||4
11352023|NCT03041792|12549122|FG001|NOT COMPLETED|Overall Study||3
11352024|NCT03041896|12549132|FG000|STARTED|Overall Study||1486
11352025|NCT03041896|12549133|FG001|STARTED|Overall Study||1009
11352026|NCT03041896|12549134|FG002|STARTED|Overall Study||2299
11352027|NCT03041896|12549135|FG003|STARTED|Overall Study||256
11352028|NCT03041896|12549132|FG000|COMPLETED|Overall Study||1486
11352029|NCT03041896|12549133|FG001|COMPLETED|Overall Study||1009
11352030|NCT03041896|12549134|FG002|COMPLETED|Overall Study||2236
11352031|NCT03041896|12549135|FG003|COMPLETED|Overall Study||253
11352032|NCT03041896|12549132|FG000|NOT COMPLETED|Overall Study||0
11352033|NCT03041896|12549133|FG001|NOT COMPLETED|Overall Study||0
11352034|NCT03041896|12549134|FG002|NOT COMPLETED|Overall Study||63
11352035|NCT03041896|12549135|FG003|NOT COMPLETED|Overall Study||3
11352036|NCT03041909|12549152|FG000|STARTED|Overall Study||3
11352037|NCT03041909|12549153|FG001|STARTED|Overall Study||1
11352038|NCT03041909|12549154|FG002|STARTED|Overall Study||1
11352039|NCT03041909|12549152|FG000|COMPLETED|Overall Study||3
11352040|NCT03041909|12549153|FG001|COMPLETED|Overall Study||1
11352041|NCT03041909|12549154|FG002|COMPLETED|Overall Study||1
11352042|NCT03041909|12549152|FG000|NOT COMPLETED|Overall Study||0
11352043|NCT03041909|12549153|FG001|NOT COMPLETED|Overall Study||0
11352044|NCT03041909|12549154|FG002|NOT COMPLETED|Overall Study||0
11352045|NCT03042299|12549164|FG000|STARTED|Intervention Period 1 (6 Days)||7
11352046|NCT03042299|12549165|FG001|STARTED|Intervention Period 1 (6 Days)||7
11352047|NCT03042299|12549164|FG000|COMPLETED|Intervention Period 1 (6 Days)||7
11352048|NCT03042299|12549165|FG001|COMPLETED|Intervention Period 1 (6 Days)||7
11352049|NCT03042299|12549164|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
11093502|NCT01191788|12276949|FG000|COMPLETED|Overall Study|Completed 3-month followup|119
11093503|NCT01191788|12276950|FG001|COMPLETED|Overall Study|Completed 3-month followup|137
11093504|NCT01191788|12276949|FG000|NOT COMPLETED|Overall Study||21
11093505|NCT01191788|12276950|FG001|NOT COMPLETED|Overall Study||22
11093506|NCT01191801|12276959|FG000|STARTED|Overall Study||356
11093507|NCT01191801|12276960|FG001|STARTED|Overall Study||355
11093508|NCT01191801|12276959|FG000|COMPLETED|Overall Study||40
11093509|NCT01191801|12276960|FG001|COMPLETED|Overall Study||18
11093510|NCT01191801|12276959|FG000|NOT COMPLETED|Overall Study||316
11093511|NCT01191801|12276960|FG001|NOT COMPLETED|Overall Study||337
11093512|NCT01191827|12276968|FG000|STARTED|Overall Study||20
11093513|NCT01191827|12276969|FG001|STARTED|Overall Study||20
11093514|NCT01191827|12276968|FG000|COMPLETED|Overall Study||20
11093515|NCT01191827|12276969|FG001|COMPLETED|Overall Study||20
11093516|NCT01191827|12276968|FG000|NOT COMPLETED|Overall Study||0
11093517|NCT01191827|12276969|FG001|NOT COMPLETED|Overall Study||0
11093518|NCT01191840|12276977|FG000|STARTED|Overall Study||254
11093519|NCT01191840|12276978|FG001|STARTED|Overall Study||255
11093520|NCT01191840|12276977|FG000|COMPLETED|Overall Study||240
11093521|NCT01191840|12276978|FG001|COMPLETED|Overall Study||240
11093522|NCT01191840|12276977|FG000|NOT COMPLETED|Overall Study||14
11093523|NCT01191840|12276978|FG001|NOT COMPLETED|Overall Study||15
11093524|NCT01191944|12276986|FG000|STARTED|Overall Study|Treated titration/maintenance|234
11093525|NCT01191944|12276987|FG001|STARTED|Overall Study|Treated titration/maintenance|239
11093526|NCT01191944|12276986|FG000|COMPLETED|Overall Study|Completed titration/maintenance|217
11093527|NCT01191944|12276987|FG001|COMPLETED|Overall Study|Completed titration/maintenance|220
11093528|NCT01191944|12276986|FG000|NOT COMPLETED|Overall Study||17
11093529|NCT01191944|12276987|FG001|NOT COMPLETED|Overall Study||19
11093530|NCT01192022|12276997|FG000|STARTED|Overall Study||114
11093531|NCT01192022|12276998|FG001|STARTED|Overall Study||110
11093532|NCT01192022|12276999|FG002|STARTED|Overall Study||8
11093533|NCT01192022|12277000|FG003|STARTED|Overall Study||9
11093534|NCT01192022|12277001|FG004|STARTED|Overall Study||12
11093535|NCT01192022|12276997|FG000|Safety Population-Received Treatment|Overall Study||114
11093536|NCT01192022|12276998|FG001|Safety Population-Received Treatment|Overall Study||109
11093537|NCT01192022|12276999|FG002|Safety Population-Received Treatment|Overall Study||8
11093538|NCT01192022|12277000|FG003|Safety Population-Received Treatment|Overall Study||9
11093539|NCT01192022|12277001|FG004|Safety Population-Received Treatment|Overall Study||12
11093540|NCT01192022|12276997|FG000|COMPLETED|Overall Study||101
11093541|NCT01192022|12276998|FG001|COMPLETED|Overall Study||99
11093542|NCT01192022|12276999|FG002|COMPLETED|Overall Study||7
11093543|NCT01192022|12277000|FG003|COMPLETED|Overall Study||7
11093544|NCT01192022|12277001|FG004|COMPLETED|Overall Study||11
11093545|NCT01192022|12276997|FG000|NOT COMPLETED|Overall Study||13
11093546|NCT01192022|12276998|FG001|NOT COMPLETED|Overall Study||11
11093547|NCT01192022|12276999|FG002|NOT COMPLETED|Overall Study||1
11093548|NCT01192022|12277000|FG003|NOT COMPLETED|Overall Study||2
11093549|NCT01192022|12277001|FG004|NOT COMPLETED|Overall Study||1
11093550|NCT01192100|12277012|FG000|STARTED|Overall Study||6
11352050|NCT03042299|12549165|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
11352051|NCT03042299|12549164|FG000|STARTED|Washout Period (at Least 6 Days)||7
11352052|NCT03042299|12549165|FG001|STARTED|Washout Period (at Least 6 Days)||7
11352053|NCT03042299|12549164|FG000|COMPLETED|Washout Period (at Least 6 Days)||7
11352054|NCT03042299|12549165|FG001|COMPLETED|Washout Period (at Least 6 Days)||7
11093551|NCT01192100|12277013|FG001|STARTED|Overall Study||4
11093552|NCT01192100|12277014|FG002|STARTED|Overall Study||3
11093553|NCT01192100|12277015|FG003|STARTED|Overall Study||4
11093554|NCT01192100|12277016|FG004|STARTED|Overall Study||3
11093555|NCT01192100|12277017|FG005|STARTED|Overall Study||2
11093556|NCT01192100|12277012|FG000|Began 1st Intervention Week|Overall Study||6
11093557|NCT01192100|12277013|FG001|Began 1st Intervention Week|Overall Study||4
11093558|NCT01192100|12277014|FG002|Began 1st Intervention Week|Overall Study||3
11093559|NCT01192100|12277015|FG003|Began 1st Intervention Week|Overall Study||4
11093560|NCT01192100|12277016|FG004|Began 1st Intervention Week|Overall Study||3
11093561|NCT01192100|12277017|FG005|Began 1st Intervention Week|Overall Study||2
11093562|NCT01192100|12277012|FG000|Began 2nd Intervention Week|Overall Study||6
11093563|NCT01192100|12277013|FG001|Began 2nd Intervention Week|Overall Study||4
11093564|NCT01192100|12277014|FG002|Began 2nd Intervention Week|Overall Study||3
11093565|NCT01192100|12277015|FG003|Began 2nd Intervention Week|Overall Study||3
11093566|NCT01192100|12277016|FG004|Began 2nd Intervention Week|Overall Study||2
11093567|NCT01192100|12277017|FG005|Began 2nd Intervention Week|Overall Study||2
11093568|NCT01192100|12277012|FG000|Began 3rd Intervention Week|Overall Study||6
11093569|NCT01192100|12277013|FG001|Began 3rd Intervention Week|Overall Study||4
11093570|NCT01192100|12277014|FG002|Began 3rd Intervention Week|Overall Study||3
11093571|NCT01192100|12277015|FG003|Began 3rd Intervention Week|Overall Study||3
11093572|NCT01192100|12277016|FG004|Began 3rd Intervention Week|Overall Study||2
11352055|NCT03042299|12549164|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0
11352056|NCT03042299|12549165|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||0
11352057|NCT03042299|12549164|FG000|STARTED|Intervention Period 2 (6 Days)||7
11352058|NCT03042299|12549165|FG001|STARTED|Intervention Period 2 (6 Days)||7
11352059|NCT03042299|12549164|FG000|COMPLETED|Intervention Period 2 (6 Days)||7
11352060|NCT03042299|12549165|FG001|COMPLETED|Intervention Period 2 (6 Days)||7
11352061|NCT03042299|12549164|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
11352062|NCT03042299|12549165|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
11352063|NCT03042312|12549173|FG000|STARTED|Overall Study||28
11352064|NCT03042312|12549174|FG001|STARTED|Overall Study||43
11352065|NCT03042312|12549173|FG000|Safety Population|Overall Study||23
11352066|NCT03042312|12549174|FG001|Safety Population|Overall Study||41
11352067|NCT03042312|12549173|FG000|COMPLETED|Overall Study||18
11352068|NCT03042312|12549174|FG001|COMPLETED|Overall Study||31
11352069|NCT03042312|12549173|FG000|NOT COMPLETED|Overall Study||10
11352070|NCT03042312|12549174|FG001|NOT COMPLETED|Overall Study||12
11352071|NCT03042559|12549182|FG000|STARTED|Overall Study||22
11352072|NCT03042559|12549183|FG001|STARTED|Overall Study||21
11352073|NCT03042559|12549182|FG000|COMPLETED|Overall Study||21
11352074|NCT03042559|12549183|FG001|COMPLETED|Overall Study||20
11352075|NCT03042559|12549182|FG000|NOT COMPLETED|Overall Study||1
11352076|NCT03042559|12549183|FG001|NOT COMPLETED|Overall Study||1
11352077|NCT03042702|12549189|FG000|STARTED|Overall Study||2
11352078|NCT03042702|12549189|FG000|COMPLETED|Overall Study||2
11352079|NCT03042702|12549189|FG000|NOT COMPLETED|Overall Study||0
11352080|NCT03042715|12549194|FG000|STARTED|Overall Study||6
11352081|NCT03042715|12549194|FG000|COMPLETED|Overall Study||5
11352082|NCT03042715|12549194|FG000|NOT COMPLETED|Overall Study||1
11352083|NCT03042767|12549200|FG000|STARTED|Overall Study||12
11352084|NCT03042767|12549201|FG001|STARTED|Overall Study||13
11352085|NCT03042767|12549200|FG000|COMPLETED|Overall Study||11
11352086|NCT03042767|12549201|FG001|COMPLETED|Overall Study||11
11352087|NCT03042767|12549200|FG000|NOT COMPLETED|Overall Study||1
11352088|NCT03042767|12549201|FG001|NOT COMPLETED|Overall Study||2
11352089|NCT03042910|12549207|FG000|STARTED|Overall Study||38
11352090|NCT03042910|12549207|FG000|Treated|Overall Study||37
11352091|NCT03042910|12549207|FG000|COMPLETED|Overall Study||31
11352092|NCT03042910|12549207|FG000|NOT COMPLETED|Overall Study||7
11352093|NCT03043079|12549214|FG000|STARTED|Overall Study||21
11352094|NCT03043079|12549215|FG001|STARTED|Overall Study||14
11352095|NCT03043079|12549216|FG002|STARTED|Overall Study||10
11352096|NCT03043079|12549214|FG000|COMPLETED|Overall Study||21
11093573|NCT01192100|12277017|FG005|Began 3rd Intervention Week|Overall Study||2
11093574|NCT01192100|12277012|FG000|COMPLETED|Overall Study||6
11093575|NCT01192100|12277013|FG001|COMPLETED|Overall Study||4
11093576|NCT01192100|12277014|FG002|COMPLETED|Overall Study||3
11093577|NCT01192100|12277015|FG003|COMPLETED|Overall Study||3
11093578|NCT01192100|12277016|FG004|COMPLETED|Overall Study||2
11093579|NCT01192100|12277017|FG005|COMPLETED|Overall Study||2
11093580|NCT01192100|12277012|FG000|NOT COMPLETED|Overall Study||0
11093581|NCT01192100|12277013|FG001|NOT COMPLETED|Overall Study||0
11093582|NCT01192100|12277014|FG002|NOT COMPLETED|Overall Study||0
11093583|NCT01192100|12277015|FG003|NOT COMPLETED|Overall Study||1
11093584|NCT01192100|12277016|FG004|NOT COMPLETED|Overall Study||1
11093585|NCT01192100|12277017|FG005|NOT COMPLETED|Overall Study||0
11093586|NCT01192126|12277027|FG000|STARTED|First Intervention (1 Week)||51
11093587|NCT01192126|12277028|FG001|STARTED|First Intervention (1 Week)||51
11093588|NCT01192126|12277027|FG000|COMPLETED|First Intervention (1 Week)||49
11093589|NCT01192126|12277028|FG001|COMPLETED|First Intervention (1 Week)||50
11093590|NCT01192126|12277027|FG000|NOT COMPLETED|First Intervention (1 Week)||2
11093591|NCT01192126|12277028|FG001|NOT COMPLETED|First Intervention (1 Week)||1
11093592|NCT01192126|12277027|FG000|STARTED|Second Intervention (1 Week)||49
11093593|NCT01192126|12277028|FG001|STARTED|Second Intervention (1 Week)||50
11093594|NCT01192126|12277027|FG000|COMPLETED|Second Intervention (1 Week)||49
11093595|NCT01192126|12277028|FG001|COMPLETED|Second Intervention (1 Week)||50
11093596|NCT01192126|12277027|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
11093597|NCT01192126|12277028|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
11093598|NCT01192139|12277034|FG000|STARTED|Period 1||5
11093599|NCT01192139|12277035|FG001|STARTED|Period 1||5
11093600|NCT01192139|12277036|FG002|STARTED|Period 1||5
11093601|NCT01192139|12277037|FG003|STARTED|Period 1||5
11093602|NCT01192139|12277038|FG004|STARTED|Period 1||5
11093603|NCT01192139|12277039|FG005|STARTED|Period 1||5
11093604|NCT01192139|12277034|FG000|COMPLETED|Period 1||5
11093605|NCT01192139|12277035|FG001|COMPLETED|Period 1||5
11093606|NCT01192139|12277036|FG002|COMPLETED|Period 1||5
11093607|NCT01192139|12277037|FG003|COMPLETED|Period 1||5
11093608|NCT01192139|12277038|FG004|COMPLETED|Period 1||5
11093609|NCT01192139|12277039|FG005|COMPLETED|Period 1||5
11093610|NCT01192139|12277034|FG000|NOT COMPLETED|Period 1||0
11093611|NCT01192139|12277035|FG001|NOT COMPLETED|Period 1||0
11093612|NCT01192139|12277036|FG002|NOT COMPLETED|Period 1||0
11093613|NCT01192139|12277037|FG003|NOT COMPLETED|Period 1||0
11093614|NCT01192139|12277038|FG004|NOT COMPLETED|Period 1||0
11093615|NCT01192139|12277039|FG005|NOT COMPLETED|Period 1||0
11093616|NCT01192139|12277034|FG000|STARTED|Period 2||5
11093617|NCT01192139|12277035|FG001|STARTED|Period 2||5
11093618|NCT01192139|12277036|FG002|STARTED|Period 2||5
11093619|NCT01192139|12277037|FG003|STARTED|Period 2||5
11093620|NCT01192139|12277038|FG004|STARTED|Period 2||5
11093621|NCT01192139|12277039|FG005|STARTED|Period 2||5
11093622|NCT01192139|12277034|FG000|COMPLETED|Period 2||5
11093623|NCT01192139|12277035|FG001|COMPLETED|Period 2||5
11093624|NCT01192139|12277036|FG002|COMPLETED|Period 2||5
11093625|NCT01192139|12277037|FG003|COMPLETED|Period 2||5
11093626|NCT01192139|12277038|FG004|COMPLETED|Period 2||5
11093627|NCT01192139|12277039|FG005|COMPLETED|Period 2||5
11093628|NCT01192139|12277034|FG000|NOT COMPLETED|Period 2||0
11093629|NCT01192139|12277035|FG001|NOT COMPLETED|Period 2||0
11093630|NCT01192139|12277036|FG002|NOT COMPLETED|Period 2||0
11093631|NCT01192139|12277037|FG003|NOT COMPLETED|Period 2||0
11093632|NCT01192139|12277038|FG004|NOT COMPLETED|Period 2||0
11093633|NCT01192139|12277039|FG005|NOT COMPLETED|Period 2||0
11093634|NCT01192139|12277034|FG000|STARTED|Period 3||5
11093635|NCT01192139|12277035|FG001|STARTED|Period 3||5
11093636|NCT01192139|12277036|FG002|STARTED|Period 3||5
11093637|NCT01192139|12277037|FG003|STARTED|Period 3||5
11093638|NCT01192139|12277038|FG004|STARTED|Period 3||5
11093639|NCT01192139|12277039|FG005|STARTED|Period 3||5
11093640|NCT01192139|12277034|FG000|COMPLETED|Period 3||5
11093641|NCT01192139|12277035|FG001|COMPLETED|Period 3||5
11093642|NCT01192139|12277036|FG002|COMPLETED|Period 3||5
11093643|NCT01192139|12277037|FG003|COMPLETED|Period 3||5
11093644|NCT01192139|12277038|FG004|COMPLETED|Period 3||5
11093645|NCT01192139|12277039|FG005|COMPLETED|Period 3||5
11093646|NCT01192139|12277034|FG000|NOT COMPLETED|Period 3||0
11093647|NCT01192139|12277035|FG001|NOT COMPLETED|Period 3||0
11093648|NCT01192139|12277036|FG002|NOT COMPLETED|Period 3||0
11093649|NCT01192139|12277037|FG003|NOT COMPLETED|Period 3||0
11093650|NCT01192139|12277038|FG004|NOT COMPLETED|Period 3||0
11093651|NCT01192139|12277039|FG005|NOT COMPLETED|Period 3||0
11093652|NCT01192152|12277047|FG000|STARTED|Period 1||15
11093653|NCT01192152|12277048|FG001|STARTED|Period 1||15
11093654|NCT01192152|12277047|FG000|COMPLETED|Period 1||15
11093655|NCT01192152|12277048|FG001|COMPLETED|Period 1||14
11093656|NCT01192152|12277047|FG000|NOT COMPLETED|Period 1||0
11093657|NCT01192152|12277048|FG001|NOT COMPLETED|Period 1||1
11093658|NCT01192152|12277047|FG000|STARTED|Period 2||15
11093659|NCT01192152|12277048|FG001|STARTED|Period 2||14
11093660|NCT01192152|12277047|FG000|COMPLETED|Period 2||15
11093661|NCT01192152|12277048|FG001|COMPLETED|Period 2||14
11093662|NCT01192152|12277047|FG000|NOT COMPLETED|Period 2||0
11093663|NCT01192152|12277048|FG001|NOT COMPLETED|Period 2||0
11093664|NCT01192152|12277047|FG000|STARTED|Period 3||15
11093665|NCT01192152|12277048|FG001|STARTED|Period 3||0
11093666|NCT01192152|12277047|FG000|COMPLETED|Period 3||14
11093667|NCT01192152|12277048|FG001|COMPLETED|Period 3||0
11093668|NCT01192152|12277047|FG000|NOT COMPLETED|Period 3||1
11093669|NCT01192152|12277048|FG001|NOT COMPLETED|Period 3||0
11093670|NCT01192178|12277058|FG000|STARTED|Overall Study||171
11093671|NCT01192178|12277059|FG001|STARTED|Overall Study||168
11093672|NCT01192178|12277058|FG000|COMPLETED|Overall Study||147
11093673|NCT01192178|12277059|FG001|COMPLETED|Overall Study||145
11093674|NCT01192178|12277058|FG000|NOT COMPLETED|Overall Study||24
11093675|NCT01192178|12277059|FG001|NOT COMPLETED|Overall Study||23
11093676|NCT01192191|12277069|FG000|STARTED|Overall Study||60
11093677|NCT01192191|12277070|FG001|STARTED|Overall Study||127
11093678|NCT01192191|12277069|FG000|COMPLETED|Overall Study||49
11093679|NCT01192191|12277070|FG001|COMPLETED|Overall Study||106
11093680|NCT01192191|12277069|FG000|NOT COMPLETED|Overall Study||11
11093681|NCT01192191|12277070|FG001|NOT COMPLETED|Overall Study||21
11093682|NCT01192204|12277078|FG000|STARTED|Overall Study||23
11093683|NCT01192204|12277079|FG001|STARTED|Overall Study||18
11093684|NCT01192204|12277078|FG000|COMPLETED|Overall Study||22
11093685|NCT01192204|12277079|FG001|COMPLETED|Overall Study||18
11093686|NCT01192204|12277078|FG000|NOT COMPLETED|Overall Study||1
11093687|NCT01192204|12277079|FG001|NOT COMPLETED|Overall Study||0
11093688|NCT01192282|12277089|FG000|STARTED|Overall Study||156
11093689|NCT01192282|12277089|FG000|COMPLETED|Overall Study||156
11093690|NCT01192282|12277089|FG000|NOT COMPLETED|Overall Study||0
11208219|NCT03846453|12399417|FG000|STARTED|Randomized Treatment Period (Days 57±3)|All participants who completed the placebo run-in period and qualified were randomized to either 0.25% HL036 Ophthalmic Solution group or placebo group.|0
11208220|NCT03846453|12399418|FG001|STARTED|Randomized Treatment Period (Days 57±3)||318
11208221|NCT03846453|12399419|FG002|STARTED|Randomized Treatment Period (Days 57±3)||319
11208222|NCT03846453|12399417|FG000|COMPLETED|Randomized Treatment Period (Days 57±3)||0
11208223|NCT03846453|12399418|FG001|COMPLETED|Randomized Treatment Period (Days 57±3)||291
11208224|NCT03846453|12399419|FG002|COMPLETED|Randomized Treatment Period (Days 57±3)||294
11208225|NCT03846453|12399417|FG000|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||0
11208226|NCT03846453|12399418|FG001|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||27
11093691|NCT01192295|12277104|FG000|STARTED|Overall Study||27
11093692|NCT01192295|12277105|FG001|STARTED|Overall Study||128
11093693|NCT01192295|12277104|FG000|COMPLETED|Overall Study||17
11093694|NCT01192295|12277105|FG001|COMPLETED|Overall Study||105
11093695|NCT01192295|12277104|FG000|NOT COMPLETED|Overall Study||10
11093696|NCT01192295|12277105|FG001|NOT COMPLETED|Overall Study||23
11093697|NCT01192347|12277113|FG000|STARTED|Overall Study||175
11093698|NCT01192347|12277113|FG000|COMPLETED|Overall Study||163
11093699|NCT01192347|12277113|FG000|NOT COMPLETED|Overall Study||12
11093700|NCT01192399|12277117|FG000|STARTED|Overall Study||29
11093701|NCT01192399|12277117|FG000|COMPLETED|Overall Study||27
11093702|NCT01192399|12277117|FG000|NOT COMPLETED|Overall Study||2
11093703|NCT01192412|12277123|FG000|STARTED|Overall Study||497
11093704|NCT01192412|12277124|FG001|STARTED|Overall Study||490
11093705|NCT01192412|12277123|FG000|COMPLETED|Overall Study||493
11093706|NCT01192412|12277124|FG001|COMPLETED|Overall Study||488
11093707|NCT01192412|12277123|FG000|NOT COMPLETED|Overall Study||4
11093708|NCT01192412|12277124|FG001|NOT COMPLETED|Overall Study||2
11093709|NCT01192516|12277133|FG000|STARTED|Overall Study|Indicates number of people initially randomized to group|66
11093710|NCT01192516|12277134|FG001|STARTED|Overall Study|Indicates number of people initially randomized to group|66
11093711|NCT01192516|12277135|FG002|STARTED|Overall Study|Indicates number of people initially randomized to group|63
11093712|NCT01192516|12277133|FG000|COMPLETED|Overall Study||46
11093713|NCT01192516|12277134|FG001|COMPLETED|Overall Study||49
11093714|NCT01192516|12277135|FG002|COMPLETED|Overall Study||55
11093715|NCT01192516|12277133|FG000|NOT COMPLETED|Overall Study||20
11093716|NCT01192516|12277134|FG001|NOT COMPLETED|Overall Study||17
11093717|NCT01192516|12277135|FG002|NOT COMPLETED|Overall Study||8
11093718|NCT01192542|12277147|FG000|STARTED|Period 1||18
11093719|NCT01192542|12277148|FG001|STARTED|Period 1||20
11093720|NCT01192542|12277147|FG000|COMPLETED|Period 1||18
11093721|NCT01192542|12277148|FG001|COMPLETED|Period 1||20
11093722|NCT01192542|12277147|FG000|NOT COMPLETED|Period 1||0
11093723|NCT01192542|12277148|FG001|NOT COMPLETED|Period 1||0
11093724|NCT01192542|12277147|FG000|STARTED|Period 2||18
11093725|NCT01192542|12277148|FG001|STARTED|Period 2||20
11093726|NCT01192542|12277147|FG000|COMPLETED|Period 2||18
11093727|NCT01192542|12277148|FG001|COMPLETED|Period 2||20
11093728|NCT01192542|12277147|FG000|NOT COMPLETED|Period 2||0
11093729|NCT01192542|12277148|FG001|NOT COMPLETED|Period 2||0
11093730|NCT01192815|12277156|FG000|STARTED|Overall Study||2
11093731|NCT01192815|12277156|FG000|COMPLETED|Overall Study||0
11093732|NCT01192815|12277156|FG000|NOT COMPLETED|Overall Study||2
11093733|NCT01192828|12277160|FG000|STARTED|Overall Study||14
11093734|NCT01192828|12277160|FG000|COMPLETED|Overall Study||14
11093735|NCT01192828|12277160|FG000|NOT COMPLETED|Overall Study||0
11093736|NCT01193010|12277168|FG000|STARTED|Overall Study||20
11093737|NCT01193010|12277169|FG001|STARTED|Overall Study||20
11093738|NCT01193010|12277168|FG000|COMPLETED|Overall Study||17
11093739|NCT01193010|12277169|FG001|COMPLETED|Overall Study||20
11093740|NCT01193010|12277168|FG000|NOT COMPLETED|Overall Study||3
11093741|NCT01193010|12277169|FG001|NOT COMPLETED|Overall Study||0
11093742|NCT01193049|12277175|FG000|STARTED|Period 1: Placebo Run-In||5
11093743|NCT01193049|12277176|FG001|STARTED|Period 1: Placebo Run-In||6
11093744|NCT01193049|12277175|FG000|COMPLETED|Period 1: Placebo Run-In||5
11093745|NCT01193049|12277176|FG001|COMPLETED|Period 1: Placebo Run-In||6
11093746|NCT01193049|12277175|FG000|NOT COMPLETED|Period 1: Placebo Run-In||0
11093747|NCT01193049|12277176|FG001|NOT COMPLETED|Period 1: Placebo Run-In||0
11093748|NCT01193049|12277175|FG000|STARTED|Washout 1 : 21 Day Washout||5
11093749|NCT01193049|12277176|FG001|STARTED|Washout 1 : 21 Day Washout||6
11093750|NCT01193049|12277175|FG000|COMPLETED|Washout 1 : 21 Day Washout||5
11093751|NCT01193049|12277176|FG001|COMPLETED|Washout 1 : 21 Day Washout||6
11093752|NCT01193049|12277175|FG000|NOT COMPLETED|Washout 1 : 21 Day Washout||0
11093753|NCT01193049|12277176|FG001|NOT COMPLETED|Washout 1 : 21 Day Washout||0
11352097|NCT03043079|12549215|FG001|COMPLETED|Overall Study||14
11352098|NCT03043079|12549216|FG002|COMPLETED|Overall Study||10
11352099|NCT03043079|12549214|FG000|NOT COMPLETED|Overall Study||0
11352100|NCT03043079|12549215|FG001|NOT COMPLETED|Overall Study||0
11352101|NCT03043079|12549216|FG002|NOT COMPLETED|Overall Study||0
11352102|NCT03043105|12549225|FG000|STARTED|Overall Study||25
11352103|NCT03043105|12549225|FG000|COMPLETED|Overall Study||25
11352104|NCT03043105|12549225|FG000|NOT COMPLETED|Overall Study||0
11352105|NCT03043274|12549231|FG000|STARTED|Overall Study||13
11352106|NCT03043274|12549232|FG001|STARTED|Overall Study||10
11352107|NCT03043274|12549231|FG000|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|13
11352108|NCT03043274|12549232|FG001|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|9
11352109|NCT03043274|12549231|FG000|NOT COMPLETED|Overall Study||0
11352110|NCT03043274|12549232|FG001|NOT COMPLETED|Overall Study||1
11352111|NCT03043365|12549240|FG000|STARTED|Weeks 0 to Week 8||20
11093754|NCT01193049|12277175|FG000|STARTED|Period 2 : Double Blind Crossover||5
11093755|NCT01193049|12277176|FG001|STARTED|Period 2 : Double Blind Crossover||6
11093756|NCT01193049|12277175|FG000|COMPLETED|Period 2 : Double Blind Crossover||5
11093757|NCT01193049|12277176|FG001|COMPLETED|Period 2 : Double Blind Crossover||6
11093758|NCT01193049|12277175|FG000|NOT COMPLETED|Period 2 : Double Blind Crossover||0
11093759|NCT01193049|12277176|FG001|NOT COMPLETED|Period 2 : Double Blind Crossover||0
11093760|NCT01193049|12277175|FG000|STARTED|Washout 2 : 21 Day Washout||5
11093761|NCT01193049|12277176|FG001|STARTED|Washout 2 : 21 Day Washout||6
11093762|NCT01193049|12277175|FG000|COMPLETED|Washout 2 : 21 Day Washout||5
11093763|NCT01193049|12277176|FG001|COMPLETED|Washout 2 : 21 Day Washout||6
11093764|NCT01193049|12277175|FG000|NOT COMPLETED|Washout 2 : 21 Day Washout||0
11093765|NCT01193049|12277176|FG001|NOT COMPLETED|Washout 2 : 21 Day Washout||0
11093766|NCT01193049|12277175|FG000|STARTED|Period 3 : Double Blind Crossover||5
11093767|NCT01193049|12277176|FG001|STARTED|Period 3 : Double Blind Crossover||6
11093768|NCT01193049|12277175|FG000|COMPLETED|Period 3 : Double Blind Crossover||5
11093769|NCT01193049|12277176|FG001|COMPLETED|Period 3 : Double Blind Crossover||6
11093770|NCT01193049|12277175|FG000|NOT COMPLETED|Period 3 : Double Blind Crossover||0
11352112|NCT03043365|12549241|FG001|STARTED|Weeks 0 to Week 8||17
11352113|NCT03043365|12549240|FG000|COMPLETED|Weeks 0 to Week 8||17
11352114|NCT03043365|12549241|FG001|COMPLETED|Weeks 0 to Week 8||14
11352115|NCT03043365|12549240|FG000|NOT COMPLETED|Weeks 0 to Week 8||3
11352116|NCT03043365|12549241|FG001|NOT COMPLETED|Weeks 0 to Week 8||3
11093771|NCT01193049|12277176|FG001|NOT COMPLETED|Period 3 : Double Blind Crossover||0
11093772|NCT01193101|12277186|FG000|STARTED|Overall Study||100
11093773|NCT01193101|12277187|FG001|STARTED|Overall Study||101
11093774|NCT01193101|12277188|FG002|STARTED|Overall Study||96
11093775|NCT01193101|12277189|FG003|STARTED|Overall Study||92
11093776|NCT01193101|12277186|FG000|Full Analysis Set|Overall Study||100
11093777|NCT01193101|12277187|FG001|Full Analysis Set|Overall Study||101
11093778|NCT01193101|12277188|FG002|Full Analysis Set|Overall Study||96
11093779|NCT01193101|12277189|FG003|Full Analysis Set|Overall Study||92
11093780|NCT01193101|12277186|FG000|Placebo Withdrawal Set|Overall Study||95
11093781|NCT01193101|12277187|FG001|Placebo Withdrawal Set|Overall Study||94
11093782|NCT01193101|12277188|FG002|Placebo Withdrawal Set|Overall Study||93
11093783|NCT01193101|12277189|FG003|Placebo Withdrawal Set|Overall Study||80
11093784|NCT01193101|12277186|FG000|COMPLETED|Overall Study||95
11093785|NCT01193101|12277187|FG001|COMPLETED|Overall Study||94
11093786|NCT01193101|12277188|FG002|COMPLETED|Overall Study||93
11093787|NCT01193101|12277189|FG003|COMPLETED|Overall Study||80
11093788|NCT01193101|12277186|FG000|NOT COMPLETED|Overall Study||5
11093789|NCT01193101|12277187|FG001|NOT COMPLETED|Overall Study||7
11093790|NCT01193101|12277188|FG002|NOT COMPLETED|Overall Study||3
11093791|NCT01193101|12277189|FG003|NOT COMPLETED|Overall Study||12
11093792|NCT01193114|12277201|FG000|STARTED|Overall Study||30
11093793|NCT01193114|12277202|FG001|STARTED|Overall Study||30
11093794|NCT01193114|12277201|FG000|COMPLETED|Overall Study||30
11093795|NCT01193114|12277202|FG001|COMPLETED|Overall Study||30
11093796|NCT01193114|12277201|FG000|NOT COMPLETED|Overall Study||0
11093797|NCT01193114|12277202|FG001|NOT COMPLETED|Overall Study||0
11093798|NCT01193127|12277212|FG000|STARTED|Randomized||57
11093799|NCT01193127|12277213|FG001|STARTED|Randomized||54
11093800|NCT01193127|12277214|FG002|STARTED|Randomized||55
11093801|NCT01193127|12277215|FG003|STARTED|Randomized||57
11093802|NCT01193127|12277212|FG000|COMPLETED|Randomized||57
11093803|NCT01193127|12277213|FG001|COMPLETED|Randomized||54
11093804|NCT01193127|12277214|FG002|COMPLETED|Randomized||55
11093805|NCT01193127|12277215|FG003|COMPLETED|Randomized||56
11093806|NCT01193127|12277212|FG000|NOT COMPLETED|Randomized||0
11093807|NCT01193127|12277213|FG001|NOT COMPLETED|Randomized||0
11093808|NCT01193127|12277214|FG002|NOT COMPLETED|Randomized||0
11093809|NCT01193127|12277215|FG003|NOT COMPLETED|Randomized||1
11093810|NCT01193127|12277212|FG000|STARTED|Treated||57
11093811|NCT01193127|12277213|FG001|STARTED|Treated||54
11093812|NCT01193127|12277214|FG002|STARTED|Treated||55
11093813|NCT01193127|12277215|FG003|STARTED|Treated||56
11093814|NCT01193127|12277212|FG000|COMPLETED|Treated||57
11093815|NCT01193127|12277213|FG001|COMPLETED|Treated||54
11093816|NCT01193127|12277214|FG002|COMPLETED|Treated||55
11093817|NCT01193127|12277215|FG003|COMPLETED|Treated||55
11093818|NCT01193127|12277212|FG000|NOT COMPLETED|Treated||0
11093819|NCT01193127|12277213|FG001|NOT COMPLETED|Treated||0
11093820|NCT01193127|12277214|FG002|NOT COMPLETED|Treated||0
11093821|NCT01193127|12277215|FG003|NOT COMPLETED|Treated||1
11093822|NCT01193153|12277227|FG000|STARTED|Open-label Lead in Period||667
11093823|NCT01193153|12277228|FG001|STARTED|Open-label Lead in Period||0
11093824|NCT01193153|12277227|FG000|COMPLETED|Open-label Lead in Period||432
11093825|NCT01193153|12277228|FG001|COMPLETED|Open-label Lead in Period||0
11093826|NCT01193153|12277227|FG000|NOT COMPLETED|Open-label Lead in Period||235
11093827|NCT01193153|12277228|FG001|NOT COMPLETED|Open-label Lead in Period||0
11093828|NCT01193153|12277227|FG000|STARTED|Open-label Stabilization Period||432
11093829|NCT01193153|12277228|FG001|STARTED|Open-label Stabilization Period||0
11093830|NCT01193153|12277227|FG000|COMPLETED|Open-label Stabilization Period||334
11093831|NCT01193153|12277228|FG001|COMPLETED|Open-label Stabilization Period||0
11093832|NCT01193153|12277227|FG000|NOT COMPLETED|Open-label Stabilization Period||98
11093833|NCT01193153|12277228|FG001|NOT COMPLETED|Open-label Stabilization Period||0
11093834|NCT01193153|12277227|FG000|STARTED|Double Blind Relapse Prevention Period||164
11093835|NCT01193153|12277228|FG001|STARTED|Double Blind Relapse Prevention Period||170
11093836|NCT01193153|12277227|FG000|COMPLETED|Double Blind Relapse Prevention Period||100
11093837|NCT01193153|12277228|FG001|COMPLETED|Double Blind Relapse Prevention Period||65
11352117|NCT03043365|12549240|FG000|STARTED|Week 8 to Week 16 - Washout Period||17
11093838|NCT01193153|12277227|FG000|NOT COMPLETED|Double Blind Relapse Prevention Period||64
11093839|NCT01193153|12277228|FG001|NOT COMPLETED|Double Blind Relapse Prevention Period||105
11093840|NCT01193218|12277242|FG000|STARTED|0-12 Weeks|It is actually placebo group|109
11093841|NCT01193218|12277243|FG001|STARTED|0-12 Weeks|It is actually N/A|0
11093842|NCT01193218|12277244|FG002|STARTED|0-12 Weeks|It is actually empa 5mg group|110
11093843|NCT01193218|12277245|FG003|STARTED|0-12 Weeks|It is actually N/A|0
11093844|NCT01193218|12277246|FG004|STARTED|0-12 Weeks||109
11093845|NCT01193218|12277247|FG005|STARTED|0-12 Weeks||109
11093846|NCT01193218|12277248|FG006|STARTED|0-12 Weeks|It is actually empa 50mg group|110
11093847|NCT01193218|12277249|FG007|STARTED|0-12 Weeks|It is actually N/A|0
11093848|NCT01193218|12277242|FG000|COMPLETED|0-12 Weeks||100
11093849|NCT01193218|12277243|FG001|COMPLETED|0-12 Weeks||0
11093850|NCT01193218|12277244|FG002|COMPLETED|0-12 Weeks||107
11093851|NCT01193218|12277245|FG003|COMPLETED|0-12 Weeks||0
11093852|NCT01193218|12277246|FG004|COMPLETED|0-12 Weeks||108
11093853|NCT01193218|12277247|FG005|COMPLETED|0-12 Weeks||106
11093854|NCT01193218|12277248|FG006|COMPLETED|0-12 Weeks||107
11093855|NCT01193218|12277249|FG007|COMPLETED|0-12 Weeks||0
11093856|NCT01193218|12277242|FG000|NOT COMPLETED|0-12 Weeks||9
11093857|NCT01193218|12277243|FG001|NOT COMPLETED|0-12 Weeks||0
11093858|NCT01193218|12277244|FG002|NOT COMPLETED|0-12 Weeks||3
11093859|NCT01193218|12277245|FG003|NOT COMPLETED|0-12 Weeks||0
11093860|NCT01193218|12277246|FG004|NOT COMPLETED|0-12 Weeks||1
11093861|NCT01193218|12277247|FG005|NOT COMPLETED|0-12 Weeks||3
11093862|NCT01193218|12277248|FG006|NOT COMPLETED|0-12 Weeks||3
11093863|NCT01193218|12277249|FG007|NOT COMPLETED|0-12 Weeks||0
11093864|NCT01193218|12277242|FG000|STARTED|12-52 Weeks||50
11093865|NCT01193218|12277243|FG001|STARTED|12-52 Weeks||50
11093866|NCT01193218|12277244|FG002|STARTED|12-52 Weeks||54
11093867|NCT01193218|12277245|FG003|STARTED|12-52 Weeks||53
11093868|NCT01193218|12277246|FG004|STARTED|12-52 Weeks||108
11093869|NCT01193218|12277247|FG005|STARTED|12-52 Weeks||106
11093870|NCT01193218|12277248|FG006|STARTED|12-52 Weeks||54
11093871|NCT01193218|12277249|FG007|STARTED|12-52 Weeks||53
11093872|NCT01193218|12277242|FG000|COMPLETED|12-52 Weeks||45
11093873|NCT01193218|12277243|FG001|COMPLETED|12-52 Weeks||50
11093874|NCT01193218|12277244|FG002|COMPLETED|12-52 Weeks||50
11093875|NCT01193218|12277245|FG003|COMPLETED|12-52 Weeks||50
11093876|NCT01193218|12277246|FG004|COMPLETED|12-52 Weeks||104
11093877|NCT01193218|12277247|FG005|COMPLETED|12-52 Weeks||101
11093878|NCT01193218|12277248|FG006|COMPLETED|12-52 Weeks||51
11093879|NCT01193218|12277249|FG007|COMPLETED|12-52 Weeks||49
11093880|NCT01193218|12277242|FG000|NOT COMPLETED|12-52 Weeks||5
11093881|NCT01193218|12277243|FG001|NOT COMPLETED|12-52 Weeks||0
11093882|NCT01193218|12277244|FG002|NOT COMPLETED|12-52 Weeks||4
11093883|NCT01193218|12277245|FG003|NOT COMPLETED|12-52 Weeks||3
11093884|NCT01193218|12277246|FG004|NOT COMPLETED|12-52 Weeks||4
11093885|NCT01193218|12277247|FG005|NOT COMPLETED|12-52 Weeks||5
11093886|NCT01193218|12277248|FG006|NOT COMPLETED|12-52 Weeks||3
11093887|NCT01193218|12277249|FG007|NOT COMPLETED|12-52 Weeks||4
11093888|NCT01193244|12277267|FG000|STARTED|Overall Study||779
11093889|NCT01193244|12277268|FG001|STARTED|Overall Study||781
11093890|NCT01193244|12277267|FG000|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
11093891|NCT01193244|12277268|FG001|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
11093892|NCT01193244|12277267|FG000|COMPLETED|Overall Study||391
11093893|NCT01193244|12277268|FG001|COMPLETED|Overall Study||391
11093894|NCT01193244|12277267|FG000|NOT COMPLETED|Overall Study||388
11093895|NCT01193244|12277268|FG001|NOT COMPLETED|Overall Study||390
11093896|NCT01193257|12277276|FG000|STARTED|Overall Study||365
11093897|NCT01193257|12277277|FG001|STARTED|Overall Study||734
11093898|NCT01193257|12277276|FG000|Treated|Overall Study||363
11093899|NCT01193257|12277277|FG001|Treated|Overall Study||732
11093900|NCT01193257|12277276|FG000|COMPLETED|Overall Study||0
11093901|NCT01193257|12277277|FG001|COMPLETED|Overall Study||0
11093902|NCT01193257|12277276|FG000|NOT COMPLETED|Overall Study||365
11093903|NCT01193257|12277277|FG001|NOT COMPLETED|Overall Study||734
11093904|NCT01193283|12277283|FG000|STARTED|Overall Study||22
11093905|NCT01193283|12277283|FG000|COMPLETED|Overall Study||21
11093906|NCT01193283|12277283|FG000|NOT COMPLETED|Overall Study||1
11093907|NCT01193335|12277289|FG000|STARTED|Infant Series||100
11093908|NCT01193335|12277290|FG001|STARTED|Infant Series||100
11093909|NCT01193335|12277289|FG000|COMPLETED|Infant Series||100
11093910|NCT01193335|12277290|FG001|COMPLETED|Infant Series||100
11093911|NCT01193335|12277289|FG000|NOT COMPLETED|Infant Series||0
11093912|NCT01193335|12277290|FG001|NOT COMPLETED|Infant Series||0
11093913|NCT01193335|12277289|FG000|STARTED|After Infant Series||100
11093914|NCT01193335|12277290|FG001|STARTED|After Infant Series||100
11093915|NCT01193335|12277289|FG000|COMPLETED|After Infant Series||99
11093916|NCT01193335|12277290|FG001|COMPLETED|After Infant Series||97
11093917|NCT01193335|12277289|FG000|NOT COMPLETED|After Infant Series||1
11093918|NCT01193335|12277290|FG001|NOT COMPLETED|After Infant Series||3
11093919|NCT01193335|12277289|FG000|STARTED|Toddler Dose||99
11093920|NCT01193335|12277290|FG001|STARTED|Toddler Dose||97
11093921|NCT01193335|12277289|FG000|COMPLETED|Toddler Dose||99
11093922|NCT01193335|12277290|FG001|COMPLETED|Toddler Dose||97
11093923|NCT01193335|12277289|FG000|NOT COMPLETED|Toddler Dose||0
11093924|NCT01193335|12277290|FG001|NOT COMPLETED|Toddler Dose||0
11093925|NCT01193335|12277289|FG000|STARTED|1-Year Follow-up||99
11093926|NCT01193335|12277290|FG001|STARTED|1-Year Follow-up||97
11093927|NCT01193335|12277289|FG000|COMPLETED|1-Year Follow-up||88
11093928|NCT01193335|12277290|FG001|COMPLETED|1-Year Follow-up||88
11093929|NCT01193335|12277289|FG000|NOT COMPLETED|1-Year Follow-up||11
11093930|NCT01193335|12277290|FG001|NOT COMPLETED|1-Year Follow-up||9
11093931|NCT01193335|12277289|FG000|STARTED|2-Year Follow-up||88
11093932|NCT01193335|12277290|FG001|STARTED|2-Year Follow-up||88
11093933|NCT01193335|12277289|FG000|COMPLETED|2-Year Follow-up||81
11093934|NCT01193335|12277290|FG001|COMPLETED|2-Year Follow-up||80
11093935|NCT01193335|12277289|FG000|NOT COMPLETED|2-Year Follow-up||7
11093936|NCT01193335|12277290|FG001|NOT COMPLETED|2-Year Follow-up||8
11093937|NCT01193348|12277312|FG000|STARTED|Screening Period||27
11093938|NCT01193348|12277312|FG000|COMPLETED|Screening Period||22
11093939|NCT01193348|12277312|FG000|NOT COMPLETED|Screening Period||5
11093940|NCT01193348|12277312|FG000|STARTED|Treatment Period (26 Weeks)||22
11093941|NCT01193348|12277312|FG000|COMPLETED|Treatment Period (26 Weeks)||19
11093942|NCT01193348|12277312|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||3
11093943|NCT01193348|12277312|FG000|STARTED|Extension Treatment Period||17
11093944|NCT01193348|12277312|FG000|COMPLETED|Extension Treatment Period||16
11093945|NCT01193348|12277312|FG000|NOT COMPLETED|Extension Treatment Period||1
11093946|NCT01193348|12277312|FG000|STARTED|Post Treatment Period (Patients Who Disc||10
11093947|NCT01193348|12277312|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||8
11093948|NCT01193348|12277312|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
11093949|NCT01193517|12277324|FG000|STARTED|Overall Study||3
11093950|NCT01193517|12277325|FG001|STARTED|Overall Study||12
11093951|NCT01193517|12277326|FG002|STARTED|Overall Study||11
11093952|NCT01193517|12277324|FG000|COMPLETED|Overall Study||2
11093953|NCT01193517|12277325|FG001|COMPLETED|Overall Study||12
11093954|NCT01193517|12277326|FG002|COMPLETED|Overall Study||11
11093955|NCT01193517|12277324|FG000|NOT COMPLETED|Overall Study||1
11093956|NCT01193517|12277325|FG001|NOT COMPLETED|Overall Study||0
11093957|NCT01193517|12277326|FG002|NOT COMPLETED|Overall Study||0
11093958|NCT01193582|12277339|FG000|STARTED|Vaccination Series||100
11093959|NCT01193582|12277340|FG001|STARTED|Vaccination Series||101
11093960|NCT01193582|12277341|FG002|STARTED|Vaccination Series||125
11093961|NCT01193582|12277342|FG003|STARTED|Vaccination Series||180
11093962|NCT01193582|12277339|FG000|Vaccinated Dose 1|Vaccination Series||100
11093963|NCT01193582|12277340|FG001|Vaccinated Dose 1|Vaccination Series||100
11093964|NCT01193582|12277341|FG002|Vaccinated Dose 1|Vaccination Series||125
11093965|NCT01193582|12277342|FG003|Vaccinated Dose 1|Vaccination Series||180
11093966|NCT01193582|12277339|FG000|Vaccinated Dose 2|Vaccination Series||92
11093967|NCT01193582|12277340|FG001|Vaccinated Dose 2|Vaccination Series||91
11093968|NCT01193582|12277341|FG002|Vaccinated Dose 2|Vaccination Series||118
11093969|NCT01193582|12277342|FG003|Vaccinated Dose 2|Vaccination Series||0
11093970|NCT01193582|12277339|FG000|Vaccinated Dose 3|Vaccination Series||90
11093971|NCT01193582|12277340|FG001|Vaccinated Dose 3|Vaccination Series||89
11093972|NCT01193582|12277341|FG002|Vaccinated Dose 3|Vaccination Series||0
11093973|NCT01193582|12277342|FG003|Vaccinated Dose 3|Vaccination Series||0
11093974|NCT01193582|12277339|FG000|Vaccinated Dose 4|Vaccination Series||90
11093975|NCT01193582|12277340|FG001|Vaccinated Dose 4|Vaccination Series||0
11093976|NCT01193582|12277341|FG002|Vaccinated Dose 4|Vaccination Series||0
11093977|NCT01193582|12277342|FG003|Vaccinated Dose 4|Vaccination Series||0
11093978|NCT01193582|12277339|FG000|COMPLETED|Vaccination Series||89
11093979|NCT01193582|12277340|FG001|COMPLETED|Vaccination Series||88
11093980|NCT01193582|12277341|FG002|COMPLETED|Vaccination Series||117
11093981|NCT01193582|12277342|FG003|COMPLETED|Vaccination Series||177
11093982|NCT01193582|12277339|FG000|NOT COMPLETED|Vaccination Series||11
11093983|NCT01193582|12277340|FG001|NOT COMPLETED|Vaccination Series||13
11093984|NCT01193582|12277341|FG002|NOT COMPLETED|Vaccination Series||8
11093985|NCT01193582|12277342|FG003|NOT COMPLETED|Vaccination Series||3
11093986|NCT01193582|12277339|FG000|STARTED|12 Month Follow-up||89
11093987|NCT01193582|12277340|FG001|STARTED|12 Month Follow-up||88
11093988|NCT01193582|12277341|FG002|STARTED|12 Month Follow-up||117
11093989|NCT01193582|12277342|FG003|STARTED|12 Month Follow-up||177
11093990|NCT01193582|12277339|FG000|COMPLETED|12 Month Follow-up||83
11093991|NCT01193582|12277340|FG001|COMPLETED|12 Month Follow-up||88
11093992|NCT01193582|12277341|FG002|COMPLETED|12 Month Follow-up||113
11093993|NCT01193582|12277342|FG003|COMPLETED|12 Month Follow-up||166
11093994|NCT01193582|12277339|FG000|NOT COMPLETED|12 Month Follow-up||6
11093995|NCT01193582|12277340|FG001|NOT COMPLETED|12 Month Follow-up||0
11093996|NCT01193582|12277341|FG002|NOT COMPLETED|12 Month Follow-up||4
11093997|NCT01193582|12277342|FG003|NOT COMPLETED|12 Month Follow-up||11
11093998|NCT01193608|12277360|FG000|STARTED|Overall Study||6
11093999|NCT01193608|12277361|FG001|STARTED|Overall Study||6
11094000|NCT01193608|12277362|FG002|STARTED|Overall Study||16
11094001|NCT01193608|12277363|FG003|STARTED|Overall Study||17
11094002|NCT01193608|12277364|FG004|STARTED|Overall Study||24
11094003|NCT01193608|12277365|FG005|STARTED|Overall Study||19
11094004|NCT01193608|12277360|FG000|COMPLETED|Overall Study||6
11094005|NCT01193608|12277361|FG001|COMPLETED|Overall Study||4
11094006|NCT01193608|12277362|FG002|COMPLETED|Overall Study||14
11094007|NCT01193608|12277363|FG003|COMPLETED|Overall Study||14
11208227|NCT03846453|12399419|FG002|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||25
11208228|NCT03605862|12399429|FG000|STARTED|Overall Study||872
11208229|NCT03605862|12399430|FG001|STARTED|Overall Study||884
11208230|NCT03605862|12399429|FG000|COMPLETED|Overall Study||844
11208231|NCT03605862|12399430|FG001|COMPLETED|Overall Study||858
11208232|NCT03605862|12399429|FG000|NOT COMPLETED|Overall Study||28
11208233|NCT03605862|12399430|FG001|NOT COMPLETED|Overall Study||26
11208234|NCT03541252|12399437|FG000|STARTED|Overall Study||20
11208235|NCT03541252|12399437|FG000|COMPLETED|Overall Study||19
11208236|NCT03541252|12399437|FG000|NOT COMPLETED|Overall Study||1
11208237|NCT03401112|12399446|FG000|STARTED|Overall Study||15
11208238|NCT03401112|12399447|FG001|STARTED|Overall Study||26
11208239|NCT03401112|12399448|FG002|STARTED|Overall Study||22
11208240|NCT03401112|12399449|FG003|STARTED|Overall Study||27
11208241|NCT03401112|12399450|FG004|STARTED|Overall Study||10
11208242|NCT03401112|12399446|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
11208243|NCT03401112|12399447|FG001|Received at Least 1 Dose of Study Drug|Overall Study||26
11208244|NCT03401112|12399448|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
11208245|NCT03401112|12399449|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25
11208246|NCT03401112|12399450|FG004|Received at Least 1 Dose of Study Drug|Overall Study||10
11208247|NCT03401112|12399446|FG000|COMPLETED|Overall Study||10
11208248|NCT03401112|12399447|FG001|COMPLETED|Overall Study||19
11208249|NCT03401112|12399448|FG002|COMPLETED|Overall Study||11
11208250|NCT03401112|12399449|FG003|COMPLETED|Overall Study||21
11208251|NCT03401112|12399450|FG004|COMPLETED|Overall Study||10
11208252|NCT03401112|12399446|FG000|NOT COMPLETED|Overall Study||5
11208253|NCT03401112|12399447|FG001|NOT COMPLETED|Overall Study||7
11208254|NCT03401112|12399448|FG002|NOT COMPLETED|Overall Study||11
11208255|NCT03401112|12399449|FG003|NOT COMPLETED|Overall Study||6
11208256|NCT03401112|12399450|FG004|NOT COMPLETED|Overall Study||0
11208257|NCT03362112|12399477|FG000|STARTED|Overall Study||1713
11208258|NCT03362112|12399477|FG000|COMPLETED|Overall Study||1622
11208259|NCT03362112|12399477|FG000|NOT COMPLETED|Overall Study||91
11352118|NCT03043365|12549241|FG001|STARTED|Week 8 to Week 16 - Washout Period||14
11352119|NCT03043365|12549240|FG000|COMPLETED|Week 8 to Week 16 - Washout Period||16
11352120|NCT03043365|12549241|FG001|COMPLETED|Week 8 to Week 16 - Washout Period||14
11352121|NCT03043365|12549240|FG000|NOT COMPLETED|Week 8 to Week 16 - Washout Period||1
11094008|NCT01193608|12277364|FG004|COMPLETED|Overall Study||19
11094009|NCT01193608|12277365|FG005|COMPLETED|Overall Study||17
11094010|NCT01193608|12277360|FG000|NOT COMPLETED|Overall Study||0
11094011|NCT01193608|12277361|FG001|NOT COMPLETED|Overall Study||2
11094012|NCT01193608|12277362|FG002|NOT COMPLETED|Overall Study||2
11094013|NCT01193608|12277363|FG003|NOT COMPLETED|Overall Study||3
11094014|NCT01193608|12277364|FG004|NOT COMPLETED|Overall Study||5
11094015|NCT01193608|12277365|FG005|NOT COMPLETED|Overall Study||2
11094016|NCT01193660|12277387|FG000|STARTED|Overall Study||35
11094017|NCT01193660|12277388|FG001|STARTED|Overall Study||36
11094018|NCT01193660|12277389|FG002|STARTED|Overall Study||34
11094019|NCT01193660|12277387|FG000|COMPLETED|Overall Study||31
11094020|NCT01193660|12277388|FG001|COMPLETED|Overall Study||33
11094021|NCT01193660|12277389|FG002|COMPLETED|Overall Study||32
11094022|NCT01193660|12277387|FG000|NOT COMPLETED|Overall Study||4
11094023|NCT01193660|12277388|FG001|NOT COMPLETED|Overall Study||3
11094024|NCT01193660|12277389|FG002|NOT COMPLETED|Overall Study||2
11094025|NCT01193686|12277399|FG000|STARTED|Overall Study||15
11094026|NCT01193686|12277400|FG001|STARTED|Overall Study||9
11094027|NCT01193686|12277399|FG000|Completed Baseline Assessment|Overall Study||15
11094028|NCT01193686|12277400|FG001|Completed Baseline Assessment|Overall Study||9
11094029|NCT01193686|12277399|FG000|Completed Mentor Training|Overall Study||9
11094030|NCT01193686|12277400|FG001|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
11094031|NCT01193686|12277399|FG000|Completed Visits and Final Assessment|Overall Study||8
11094032|NCT01193686|12277400|FG001|Completed Visits and Final Assessment|Overall Study||8
11094033|NCT01193686|12277399|FG000|COMPLETED|Overall Study||8
11094034|NCT01193686|12277400|FG001|COMPLETED|Overall Study||8
11094035|NCT01193686|12277399|FG000|NOT COMPLETED|Overall Study||7
11094036|NCT01193686|12277400|FG001|NOT COMPLETED|Overall Study||1
11094037|NCT01193868|12277407|FG000|STARTED|Overall Study||6
11094038|NCT01193868|12277407|FG000|COMPLETED|Overall Study||6
11094039|NCT01193868|12277407|FG000|NOT COMPLETED|Overall Study||0
11094040|NCT01193907|12277415|FG000|STARTED|Overall Study||22
11094041|NCT01193907|12277416|FG001|STARTED|Overall Study||22
11094042|NCT01193907|12277417|FG002|STARTED|Overall Study||22
11094043|NCT01193907|12277418|FG003|STARTED|Overall Study||22
11094044|NCT01193907|12277415|FG000|COMPLETED|Overall Study||21
11094045|NCT01193907|12277416|FG001|COMPLETED|Overall Study||22
11094046|NCT01193907|12277417|FG002|COMPLETED|Overall Study||22
11094047|NCT01193907|12277418|FG003|COMPLETED|Overall Study||21
11094048|NCT01193907|12277415|FG000|NOT COMPLETED|Overall Study||1
11352122|NCT03043365|12549241|FG001|NOT COMPLETED|Week 8 to Week 16 - Washout Period||0
11352123|NCT03043365|12549240|FG000|STARTED|Week 16 to Week 24||16
11352124|NCT03043365|12549241|FG001|STARTED|Week 16 to Week 24||14
11352125|NCT03043365|12549240|FG000|COMPLETED|Week 16 to Week 24||16
11352126|NCT03043365|12549241|FG001|COMPLETED|Week 16 to Week 24||14
11352127|NCT03043365|12549240|FG000|NOT COMPLETED|Week 16 to Week 24||0
11352128|NCT03043365|12549241|FG001|NOT COMPLETED|Week 16 to Week 24||0
11094049|NCT01193907|12277416|FG001|NOT COMPLETED|Overall Study||0
11094050|NCT01193907|12277417|FG002|NOT COMPLETED|Overall Study||0
11094051|NCT01193907|12277418|FG003|NOT COMPLETED|Overall Study||1
11094052|NCT01193920|12277438|FG000|STARTED|Overall Study||40
11094053|NCT01193920|12277439|FG001|STARTED|Overall Study||20
11094054|NCT01193920|12277440|FG002|STARTED|Overall Study||80
11094055|NCT01193920|12277441|FG003|STARTED|Overall Study||80
11094056|NCT01193920|12277442|FG004|STARTED|Overall Study||80
11094057|NCT01193920|12277443|FG005|STARTED|Overall Study||80
11094058|NCT01193920|12277444|FG006|STARTED|Overall Study||80
11094059|NCT01193920|12277445|FG007|STARTED|Overall Study||80
11094060|NCT01193920|12277446|FG008|STARTED|Overall Study||76
11094061|NCT01193920|12277447|FG009|STARTED|Overall Study||81
11094062|NCT01193920|12277438|FG000|COMPLETED|Overall Study||37
11094063|NCT01193920|12277439|FG001|COMPLETED|Overall Study||20
11094064|NCT01193920|12277440|FG002|COMPLETED|Overall Study||74
11094065|NCT01193920|12277441|FG003|COMPLETED|Overall Study||76
11094066|NCT01193920|12277442|FG004|COMPLETED|Overall Study||74
11094067|NCT01193920|12277443|FG005|COMPLETED|Overall Study||76
11094068|NCT01193920|12277444|FG006|COMPLETED|Overall Study||74
11094069|NCT01193920|12277445|FG007|COMPLETED|Overall Study||76
11094070|NCT01193920|12277446|FG008|COMPLETED|Overall Study||71
11094071|NCT01193920|12277447|FG009|COMPLETED|Overall Study||74
11094072|NCT01193920|12277438|FG000|NOT COMPLETED|Overall Study||3
11094073|NCT01193920|12277439|FG001|NOT COMPLETED|Overall Study||0
11094074|NCT01193920|12277440|FG002|NOT COMPLETED|Overall Study||6
11094075|NCT01193920|12277441|FG003|NOT COMPLETED|Overall Study||4
11094076|NCT01193920|12277442|FG004|NOT COMPLETED|Overall Study||6
11094077|NCT01193920|12277443|FG005|NOT COMPLETED|Overall Study||4
11094078|NCT01193920|12277444|FG006|NOT COMPLETED|Overall Study||6
11094079|NCT01193920|12277445|FG007|NOT COMPLETED|Overall Study||4
11094080|NCT01193920|12277446|FG008|NOT COMPLETED|Overall Study||5
11094081|NCT01193920|12277447|FG009|NOT COMPLETED|Overall Study||7
11094082|NCT01194089|12277472|FG000|STARTED|Overall Study||42
11094083|NCT01194089|12277473|FG001|STARTED|Overall Study||47
11094084|NCT01194089|12277472|FG000|COMPLETED|Overall Study||42
11094085|NCT01194089|12277473|FG001|COMPLETED|Overall Study||47
11094086|NCT01194089|12277472|FG000|NOT COMPLETED|Overall Study||0
11094087|NCT01194089|12277473|FG001|NOT COMPLETED|Overall Study||0
11094088|NCT01194154|12277481|FG000|STARTED|Overall Study||117
11094089|NCT01194154|12277482|FG001|STARTED|Overall Study||124
11094090|NCT01194154|12277481|FG000|Full Analysis Set|Overall Study||115
11094091|NCT01194154|12277482|FG001|Full Analysis Set|Overall Study||120
11094092|NCT01194154|12277481|FG000|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
11094093|NCT01194154|12277482|FG001|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
11094094|NCT01194154|12277481|FG000|COMPLETED|Overall Study||68
11094095|NCT01194154|12277482|FG001|COMPLETED|Overall Study||91
11094096|NCT01194154|12277481|FG000|NOT COMPLETED|Overall Study||49
11094097|NCT01194154|12277482|FG001|NOT COMPLETED|Overall Study||33
11094098|NCT01194245|12277495|FG000|STARTED|Titration Period (4 to 6 Weeks)||135
11094099|NCT01194245|12277496|FG001|STARTED|Titration Period (4 to 6 Weeks)||0
11094100|NCT01194245|12277497|FG002|STARTED|Titration Period (4 to 6 Weeks)||0
11094101|NCT01194245|12277498|FG003|STARTED|Titration Period (4 to 6 Weeks)||0
11094102|NCT01194245|12277499|FG004|STARTED|Titration Period (4 to 6 Weeks)||0
11094103|NCT01194245|12277495|FG000|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
11094104|NCT01194245|12277496|FG001|COMPLETED|Titration Period (4 to 6 Weeks)||0
11094105|NCT01194245|12277497|FG002|COMPLETED|Titration Period (4 to 6 Weeks)||0
11094106|NCT01194245|12277498|FG003|COMPLETED|Titration Period (4 to 6 Weeks)||0
11094107|NCT01194245|12277499|FG004|COMPLETED|Titration Period (4 to 6 Weeks)||0
11094108|NCT01194245|12277495|FG000|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
11094109|NCT01194245|12277496|FG001|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
11094110|NCT01194245|12277497|FG002|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
11094111|NCT01194245|12277498|FG003|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
11094112|NCT01194245|12277499|FG004|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
11094113|NCT01194245|12277495|FG000|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
11094114|NCT01194245|12277496|FG001|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
11094115|NCT01194245|12277497|FG002|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
11094116|NCT01194245|12277498|FG003|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
11094117|NCT01194245|12277499|FG004|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
11094118|NCT01194245|12277495|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
11094119|NCT01194245|12277496|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
11094120|NCT01194245|12277497|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
11094121|NCT01194245|12277498|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
11094122|NCT01194245|12277499|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
11094123|NCT01194245|12277495|FG000|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
11094124|NCT01194245|12277496|FG001|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
11094125|NCT01194245|12277497|FG002|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
11094126|NCT01194245|12277498|FG003|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
11094127|NCT01194245|12277499|FG004|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
11094128|NCT01194245|12277495|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
11094129|NCT01194245|12277496|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
11094130|NCT01194245|12277497|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
11094131|NCT01194245|12277498|FG003|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
11094132|NCT01194245|12277499|FG004|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
11094133|NCT01194245|12277495|FG000|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
11094134|NCT01194245|12277496|FG001|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
11094135|NCT01194245|12277497|FG002|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
11094136|NCT01194245|12277498|FG003|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
11094137|NCT01194245|12277499|FG004|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
11094138|NCT01194245|12277495|FG000|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
11094139|NCT01194245|12277496|FG001|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
11094140|NCT01194245|12277497|FG002|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
11094141|NCT01194245|12277498|FG003|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
11094142|NCT01194245|12277499|FG004|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
11094143|NCT01194245|12277495|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
11094144|NCT01194245|12277496|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
11094145|NCT01194245|12277497|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
11094146|NCT01194245|12277498|FG003|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
11094147|NCT01194245|12277499|FG004|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
11094148|NCT01194258|12277508|FG000|STARTED|Titration Period||132
11094149|NCT01194258|12277509|FG001|STARTED|Titration Period||0
11094150|NCT01194258|12277510|FG002|STARTED|Titration Period||0
11094151|NCT01194258|12277511|FG003|STARTED|Titration Period||0
11094152|NCT01194258|12277512|FG004|STARTED|Titration Period||0
11094153|NCT01194258|12277508|FG000|COMPLETED|Titration Period||121
11094154|NCT01194258|12277509|FG001|COMPLETED|Titration Period||0
11094155|NCT01194258|12277510|FG002|COMPLETED|Titration Period||0
11094156|NCT01194258|12277511|FG003|COMPLETED|Titration Period||0
11094157|NCT01194258|12277512|FG004|COMPLETED|Titration Period||0
11094158|NCT01194258|12277508|FG000|NOT COMPLETED|Titration Period||11
11094159|NCT01194258|12277509|FG001|NOT COMPLETED|Titration Period||0
11094160|NCT01194258|12277510|FG002|NOT COMPLETED|Titration Period||0
11094161|NCT01194258|12277511|FG003|NOT COMPLETED|Titration Period||0
11094162|NCT01194258|12277512|FG004|NOT COMPLETED|Titration Period||0
11094163|NCT01194258|12277508|FG000|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
11094164|NCT01194258|12277509|FG001|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
11094165|NCT01194258|12277510|FG002|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
11094166|NCT01194258|12277511|FG003|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
11094167|NCT01194258|12277512|FG004|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
11094168|NCT01194258|12277508|FG000|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
11094169|NCT01194258|12277509|FG001|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
11094170|NCT01194258|12277510|FG002|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
11094171|NCT01194258|12277511|FG003|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
11094172|NCT01194258|12277512|FG004|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
11094173|NCT01194258|12277508|FG000|COMPLETED|Period 1 (12 Weeks)||0
11094174|NCT01194258|12277509|FG001|COMPLETED|Period 1 (12 Weeks)||29
11094175|NCT01194258|12277510|FG002|COMPLETED|Period 1 (12 Weeks)||30
11094176|NCT01194258|12277511|FG003|COMPLETED|Period 1 (12 Weeks)||29
11094177|NCT01194258|12277512|FG004|COMPLETED|Period 1 (12 Weeks)||32
11094178|NCT01194258|12277508|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
11094179|NCT01194258|12277509|FG001|NOT COMPLETED|Period 1 (12 Weeks)||0
11094180|NCT01194258|12277510|FG002|NOT COMPLETED|Period 1 (12 Weeks)||0
11094181|NCT01194258|12277511|FG003|NOT COMPLETED|Period 1 (12 Weeks)||0
11094182|NCT01194258|12277512|FG004|NOT COMPLETED|Period 1 (12 Weeks)||1
11094183|NCT01194258|12277508|FG000|STARTED|Period 2 (12 Weeks)||0
11094184|NCT01194258|12277509|FG001|STARTED|Period 2 (12 Weeks)||29
11094185|NCT01194258|12277510|FG002|STARTED|Period 2 (12 Weeks)||30
11094186|NCT01194258|12277511|FG003|STARTED|Period 2 (12 Weeks)||29
11094187|NCT01194258|12277512|FG004|STARTED|Period 2 (12 Weeks)||32
11094188|NCT01194258|12277508|FG000|COMPLETED|Period 2 (12 Weeks)||0
11094189|NCT01194258|12277509|FG001|COMPLETED|Period 2 (12 Weeks)||27
11094190|NCT01194258|12277510|FG002|COMPLETED|Period 2 (12 Weeks)||29
11094191|NCT01194258|12277511|FG003|COMPLETED|Period 2 (12 Weeks)||29
11094192|NCT01194258|12277512|FG004|COMPLETED|Period 2 (12 Weeks)||30
11094193|NCT01194258|12277508|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
11094194|NCT01194258|12277509|FG001|NOT COMPLETED|Period 2 (12 Weeks)||2
11094195|NCT01194258|12277510|FG002|NOT COMPLETED|Period 2 (12 Weeks)||1
11094196|NCT01194258|12277511|FG003|NOT COMPLETED|Period 2 (12 Weeks)||0
11094197|NCT01194258|12277512|FG004|NOT COMPLETED|Period 2 (12 Weeks)||2
11094198|NCT01194271|12277523|FG000|STARTED|Overall Study||19
11094199|NCT01194271|12277523|FG000|COMPLETED|Overall Study||16
11094200|NCT01194271|12277523|FG000|NOT COMPLETED|Overall Study||3
11094201|NCT01194297|12277529|FG000|STARTED|Overall Study||2
11094202|NCT01194297|12277530|FG001|STARTED|Overall Study||1
11094203|NCT01194297|12277529|FG000|COMPLETED|Overall Study||2
11094204|NCT01194297|12277530|FG001|COMPLETED|Overall Study||1
11094205|NCT01194297|12277529|FG000|NOT COMPLETED|Overall Study||0
11094206|NCT01194297|12277530|FG001|NOT COMPLETED|Overall Study||0
11094207|NCT01194414|12277538|FG000|STARTED|24 Weeks Double Blind Period||631
11094208|NCT01194414|12277539|FG001|STARTED|24 Weeks Double Blind Period||631
11094209|NCT01194414|12277540|FG002|STARTED|24 Weeks Double Blind Period||0
11094210|NCT01194414|12277541|FG003|STARTED|24 Weeks Double Blind Period||0
11094211|NCT01194414|12277538|FG000|Per Protocol Population|24 Weeks Double Blind Period||558
11094212|NCT01194414|12277539|FG001|Per Protocol Population|24 Weeks Double Blind Period||537
11094213|NCT01194414|12277540|FG002|Per Protocol Population|24 Weeks Double Blind Period||0
11094214|NCT01194414|12277541|FG003|Per Protocol Population|24 Weeks Double Blind Period||0
11094215|NCT01194414|12277538|FG000|COMPLETED|24 Weeks Double Blind Period||572
11094216|NCT01194414|12277539|FG001|COMPLETED|24 Weeks Double Blind Period||564
11094217|NCT01194414|12277540|FG002|COMPLETED|24 Weeks Double Blind Period||0
11094218|NCT01194414|12277541|FG003|COMPLETED|24 Weeks Double Blind Period||0
11094219|NCT01194414|12277538|FG000|NOT COMPLETED|24 Weeks Double Blind Period||59
11094220|NCT01194414|12277539|FG001|NOT COMPLETED|24 Weeks Double Blind Period||67
11094221|NCT01194414|12277540|FG002|NOT COMPLETED|24 Weeks Double Blind Period||0
11094222|NCT01194414|12277541|FG003|NOT COMPLETED|24 Weeks Double Blind Period||0
11094223|NCT01194414|12277538|FG000|STARTED|72 Weeks Open Label Extension||524
11094224|NCT01194414|12277539|FG001|STARTED|72 Weeks Open Label Extension||377
11094225|NCT01194414|12277540|FG002|STARTED|72 Weeks Open Label Extension||48
11094226|NCT01194414|12277541|FG003|STARTED|72 Weeks Open Label Extension||186
11094227|NCT01194414|12277538|FG000|COMPLETED|72 Weeks Open Label Extension||445
11094228|NCT01194414|12277539|FG001|COMPLETED|72 Weeks Open Label Extension||311
11094229|NCT01194414|12277540|FG002|COMPLETED|72 Weeks Open Label Extension||40
11094230|NCT01194414|12277541|FG003|COMPLETED|72 Weeks Open Label Extension||160
11094231|NCT01194414|12277538|FG000|NOT COMPLETED|72 Weeks Open Label Extension||79
11094232|NCT01194414|12277539|FG001|NOT COMPLETED|72 Weeks Open Label Extension||66
11094233|NCT01194414|12277540|FG002|NOT COMPLETED|72 Weeks Open Label Extension||8
11094234|NCT01194414|12277541|FG003|NOT COMPLETED|72 Weeks Open Label Extension||26
11094235|NCT01194440|12277553|FG000|STARTED|Baseline (First Dose)||59
11094236|NCT01194440|12277553|FG000|COMPLETED|Baseline (First Dose)||52
11094237|NCT01194440|12277553|FG000|NOT COMPLETED|Baseline (First Dose)||7
11094238|NCT01194440|12277553|FG000|STARTED|6-months (2nd Dose)||52
11094239|NCT01194440|12277553|FG000|COMPLETED|6-months (2nd Dose)||48
11094240|NCT01194440|12277553|FG000|NOT COMPLETED|6-months (2nd Dose)||4
11094241|NCT01194453|12277560|FG000|STARTED|Overall Study||144
11094242|NCT01194453|12277561|FG001|STARTED|Overall Study||144
11094243|NCT01194453|12277560|FG000|COMPLETED|Overall Study||127
11094244|NCT01194453|12277561|FG001|COMPLETED|Overall Study||127
11094245|NCT01194453|12277560|FG000|NOT COMPLETED|Overall Study||17
11094246|NCT01194453|12277561|FG001|NOT COMPLETED|Overall Study||17
11094247|NCT01194466|12277567|FG000|STARTED|Overall Study||14
11094248|NCT01194466|12277568|FG001|STARTED|Overall Study||14
11094249|NCT01194466|12277569|FG002|STARTED|Overall Study||13
11094250|NCT01194466|12277567|FG000|COMPLETED|Overall Study||14
11094251|NCT01194466|12277568|FG001|COMPLETED|Overall Study||14
11094252|NCT01194466|12277569|FG002|COMPLETED|Overall Study||13
11094253|NCT01194466|12277567|FG000|NOT COMPLETED|Overall Study||0
11094254|NCT01194466|12277568|FG001|NOT COMPLETED|Overall Study||0
11352129|NCT03043534|12549251|FG000|STARTED|Overall Study||15
11352130|NCT03043534|12549252|FG001|STARTED|Overall Study||14
11352131|NCT03043534|12549251|FG000|COMPLETED|Overall Study||15
11094255|NCT01194466|12277569|FG002|NOT COMPLETED|Overall Study||0
11094256|NCT01194479|12277579|FG000|STARTED|Overall Study||3
11094257|NCT01194479|12277580|FG001|STARTED|Overall Study||4
11094258|NCT01194479|12277581|FG002|STARTED|Overall Study||2
11094259|NCT01194479|12277582|FG003|STARTED|Overall Study||5
11094260|NCT01194479|12277579|FG000|Cross-over at Second Visit|Overall Study||3
11352132|NCT03043534|12549252|FG001|COMPLETED|Overall Study||14
11352133|NCT03043534|12549251|FG000|NOT COMPLETED|Overall Study||0
11352134|NCT03043534|12549252|FG001|NOT COMPLETED|Overall Study||0
11094261|NCT01194479|12277580|FG001|Cross-over at Second Visit|Overall Study||4
11094262|NCT01194479|12277581|FG002|Cross-over at Second Visit|Overall Study||2
11094263|NCT01194479|12277582|FG003|Cross-over at Second Visit|Overall Study||5
11094264|NCT01194479|12277579|FG000|COMPLETED|Overall Study||3
11094265|NCT01194479|12277580|FG001|COMPLETED|Overall Study||4
11094266|NCT01194479|12277581|FG002|COMPLETED|Overall Study||2
11094267|NCT01194479|12277582|FG003|COMPLETED|Overall Study||5
11094268|NCT01194479|12277579|FG000|NOT COMPLETED|Overall Study||0
11094269|NCT01194479|12277580|FG001|NOT COMPLETED|Overall Study||0
11094270|NCT01194479|12277581|FG002|NOT COMPLETED|Overall Study||0
11094271|NCT01194479|12277582|FG003|NOT COMPLETED|Overall Study||0
11094272|NCT01194531|12277594|FG000|STARTED|Overall Study||29
11094273|NCT01194531|12277595|FG001|STARTED|Overall Study||30
11094274|NCT01194531|12277594|FG000|COMPLETED|Overall Study||24
11094275|NCT01194531|12277595|FG001|COMPLETED|Overall Study||27
11094276|NCT01194531|12277594|FG000|NOT COMPLETED|Overall Study||5
11094277|NCT01194531|12277595|FG001|NOT COMPLETED|Overall Study||3
11094278|NCT01194674|12277601|FG000|STARTED|Overall Study||2
11352135|NCT03043560|12549260|FG000|STARTED|Overall Study||21
11352136|NCT03043560|12549261|FG001|STARTED|Overall Study||24
11352137|NCT03043560|12549260|FG000|COMPLETED|Overall Study||20
11352138|NCT03043560|12549261|FG001|COMPLETED|Overall Study||21
11352139|NCT03043560|12549260|FG000|NOT COMPLETED|Overall Study||1
11352140|NCT03043560|12549261|FG001|NOT COMPLETED|Overall Study||3
11352141|NCT03043651|12549267|FG000|STARTED|Overall Study||48
11352142|NCT03043651|12549267|FG000|COMPLETED|Overall Study||0
11094279|NCT01194674|12277601|FG000|COMPLETED|Overall Study||2
11094280|NCT01194674|12277601|FG000|NOT COMPLETED|Overall Study||0
11094281|NCT01194804|12277606|FG000|STARTED|Overall Study||27
11094282|NCT01194804|12277606|FG000|COMPLETED|Overall Study||26
11094283|NCT01194804|12277606|FG000|NOT COMPLETED|Overall Study||1
11352143|NCT03043651|12549267|FG000|NOT COMPLETED|Overall Study||48
11352144|NCT03043885|12549275|FG000|STARTED|Overall Study||10
11352145|NCT03043885|12549276|FG001|STARTED|Overall Study||10
11352146|NCT03043885|12549277|FG002|STARTED|Overall Study||10
11352147|NCT03043885|12549278|FG003|STARTED|Overall Study||10
11352148|NCT03043885|12549275|FG000|COMPLETED|Overall Study||10
11352149|NCT03043885|12549276|FG001|COMPLETED|Overall Study||10
11352150|NCT03043885|12549277|FG002|COMPLETED|Overall Study||10
11352151|NCT03043885|12549278|FG003|COMPLETED|Overall Study||10
11352152|NCT03043885|12549275|FG000|NOT COMPLETED|Overall Study||0
11352153|NCT03043885|12549276|FG001|NOT COMPLETED|Overall Study||0
11094284|NCT01194830|12277612|FG000|STARTED|Overall Study||124
11094285|NCT01194830|12277613|FG001|STARTED|Overall Study||110
11094286|NCT01194830|12277612|FG000|COMPLETED|Overall Study||88
11094287|NCT01194830|12277613|FG001|COMPLETED|Overall Study||83
11094288|NCT01194830|12277612|FG000|NOT COMPLETED|Overall Study||36
11094289|NCT01194830|12277613|FG001|NOT COMPLETED|Overall Study||27
11094290|NCT01194869|12277619|FG000|STARTED|Overall Study||25
11094291|NCT01194869|12277619|FG000|COMPLETED|Overall Study||21
11094292|NCT01194869|12277619|FG000|NOT COMPLETED|Overall Study||4
11094293|NCT01194973|12277623|FG000|STARTED|Screening Period||44
11094294|NCT01194973|12277623|FG000|COMPLETED|Screening Period||41
11094295|NCT01194973|12277623|FG000|NOT COMPLETED|Screening Period||3
11352154|NCT03043885|12549277|FG002|NOT COMPLETED|Overall Study||0
11352155|NCT03043885|12549278|FG003|NOT COMPLETED|Overall Study||0
11094296|NCT01194973|12277623|FG000|STARTED|26 Week Treatment Period||41
11094297|NCT01194973|12277623|FG000|COMPLETED|26 Week Treatment Period||38
11094298|NCT01194973|12277623|FG000|NOT COMPLETED|26 Week Treatment Period||3
11094299|NCT01194999|12277627|FG000|STARTED|Overall Study||132
11094300|NCT01194999|12277627|FG000|COMPLETED|Overall Study||115
11094301|NCT01194999|12277627|FG000|NOT COMPLETED|Overall Study||17
11094302|NCT01195025|12277631|FG000|STARTED|First Intervention A||2
11094303|NCT01195025|12277632|FG001|STARTED|First Intervention A||3
11094304|NCT01195025|12277633|FG002|STARTED|First Intervention A||2
11094305|NCT01195025|12277634|FG003|STARTED|First Intervention A||2
11094306|NCT01195025|12277635|FG004|STARTED|First Intervention A||1
11094307|NCT01195025|12277631|FG000|COMPLETED|First Intervention A||2
11094308|NCT01195025|12277632|FG001|COMPLETED|First Intervention A||3
11094309|NCT01195025|12277633|FG002|COMPLETED|First Intervention A||2
11094310|NCT01195025|12277634|FG003|COMPLETED|First Intervention A||2
11094311|NCT01195025|12277635|FG004|COMPLETED|First Intervention A||1
11094312|NCT01195025|12277631|FG000|NOT COMPLETED|First Intervention A||0
11094313|NCT01195025|12277632|FG001|NOT COMPLETED|First Intervention A||0
11094314|NCT01195025|12277633|FG002|NOT COMPLETED|First Intervention A||0
11094315|NCT01195025|12277634|FG003|NOT COMPLETED|First Intervention A||0
11094316|NCT01195025|12277635|FG004|NOT COMPLETED|First Intervention A||0
11094317|NCT01195025|12277631|FG000|STARTED|Second Intervention B||2
11094318|NCT01195025|12277632|FG001|STARTED|Second Intervention B||3
11094319|NCT01195025|12277633|FG002|STARTED|Second Intervention B||2
11094320|NCT01195025|12277634|FG003|STARTED|Second Intervention B||2
11094321|NCT01195025|12277635|FG004|STARTED|Second Intervention B||1
11094322|NCT01195025|12277631|FG000|COMPLETED|Second Intervention B||2
11094323|NCT01195025|12277632|FG001|COMPLETED|Second Intervention B||3
11094324|NCT01195025|12277633|FG002|COMPLETED|Second Intervention B||2
11094325|NCT01195025|12277634|FG003|COMPLETED|Second Intervention B||2
11094326|NCT01195025|12277635|FG004|COMPLETED|Second Intervention B||1
11094327|NCT01195025|12277631|FG000|NOT COMPLETED|Second Intervention B||0
11094328|NCT01195025|12277632|FG001|NOT COMPLETED|Second Intervention B||0
11094329|NCT01195025|12277633|FG002|NOT COMPLETED|Second Intervention B||0
11094330|NCT01195025|12277634|FG003|NOT COMPLETED|Second Intervention B||0
11094331|NCT01195025|12277635|FG004|NOT COMPLETED|Second Intervention B||0
11094332|NCT01195025|12277631|FG000|STARTED|Third Intervention C||2
11094333|NCT01195025|12277632|FG001|STARTED|Third Intervention C||3
11094334|NCT01195025|12277633|FG002|STARTED|Third Intervention C||2
11094335|NCT01195025|12277634|FG003|STARTED|Third Intervention C||2
11094336|NCT01195025|12277635|FG004|STARTED|Third Intervention C||1
11094337|NCT01195025|12277631|FG000|COMPLETED|Third Intervention C||2
11094338|NCT01195025|12277632|FG001|COMPLETED|Third Intervention C||3
11094339|NCT01195025|12277633|FG002|COMPLETED|Third Intervention C||2
11094340|NCT01195025|12277634|FG003|COMPLETED|Third Intervention C||2
11094341|NCT01195025|12277635|FG004|COMPLETED|Third Intervention C||1
11094342|NCT01195025|12277631|FG000|NOT COMPLETED|Third Intervention C||0
11094343|NCT01195025|12277632|FG001|NOT COMPLETED|Third Intervention C||0
11094344|NCT01195025|12277633|FG002|NOT COMPLETED|Third Intervention C||0
11094345|NCT01195025|12277634|FG003|NOT COMPLETED|Third Intervention C||0
11094346|NCT01195025|12277635|FG004|NOT COMPLETED|Third Intervention C||0
11094347|NCT01195090|12277643|FG000|STARTED|Overall Study||60
11094348|NCT01195090|12277644|FG001|STARTED|Overall Study||60
11094349|NCT01195090|12277643|FG000|COMPLETED|Overall Study||54
11094350|NCT01195090|12277644|FG001|COMPLETED|Overall Study||52
11094351|NCT01195090|12277643|FG000|NOT COMPLETED|Overall Study||6
11094352|NCT01195090|12277644|FG001|NOT COMPLETED|Overall Study||8
11094353|NCT01195103|12277653|FG000|STARTED|Overall Study||6
11094354|NCT01195103|12277654|FG001|STARTED|Overall Study||2
11094355|NCT01195103|12277655|FG002|STARTED|Overall Study||5
11094356|NCT01195103|12277653|FG000|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
11094357|NCT01195103|12277654|FG001|COMPLETED|Overall Study||2
11094358|NCT01195103|12277655|FG002|COMPLETED|Overall Study||5
11094359|NCT01195103|12277653|FG000|NOT COMPLETED|Overall Study||1
11094360|NCT01195103|12277654|FG001|NOT COMPLETED|Overall Study||0
11094361|NCT01195103|12277655|FG002|NOT COMPLETED|Overall Study||0
11094362|NCT01195116|12277665|FG000|STARTED|Overall Study||21
11094363|NCT01195116|12277666|FG001|STARTED|Overall Study||20
11094364|NCT01195116|12277665|FG000|COMPLETED|Overall Study||21
11094365|NCT01195116|12277666|FG001|COMPLETED|Overall Study||20
11094366|NCT01195116|12277665|FG000|NOT COMPLETED|Overall Study||0
11094367|NCT01195116|12277666|FG001|NOT COMPLETED|Overall Study||0
11094368|NCT01195272|12277672|FG000|STARTED|Overall Study||21
11094369|NCT01195272|12277672|FG000|COMPLETED|Overall Study||17
11094370|NCT01195272|12277672|FG000|NOT COMPLETED|Overall Study||4
11094371|NCT01195363|12277678|FG000|STARTED|Overall Study||15
11094372|NCT01195363|12277679|FG001|STARTED|Overall Study||13
11094373|NCT01195363|12277678|FG000|COMPLETED|Overall Study||4
11094374|NCT01195363|12277679|FG001|COMPLETED|Overall Study||4
11094375|NCT01195363|12277678|FG000|NOT COMPLETED|Overall Study||11
11094376|NCT01195363|12277679|FG001|NOT COMPLETED|Overall Study||9
11094377|NCT01195415|12277685|FG000|STARTED|Overall Study||25
11094378|NCT01195415|12277685|FG000|COMPLETED|Overall Study||23
11094379|NCT01195415|12277685|FG000|NOT COMPLETED|Overall Study||2
11094380|NCT01195467|12277689|FG000|STARTED|Overall Study||40
11094381|NCT01195467|12277689|FG000|COMPLETED|Overall Study||30
11094382|NCT01195467|12277689|FG000|NOT COMPLETED|Overall Study||10
11094383|NCT01195545|12277693|FG000|STARTED|Overall Study||20
11094384|NCT01195545|12277693|FG000|COMPLETED|Overall Study||16
11094385|NCT01195545|12277693|FG000|NOT COMPLETED|Overall Study||4
11094386|NCT01195584|12277700|FG000|STARTED|Overall Study||20
11094387|NCT01195584|12277701|FG001|STARTED|Overall Study||25
11094388|NCT01195584|12277702|FG002|STARTED|Overall Study||27
11094389|NCT01195584|12277700|FG000|COMPLETED|Overall Study||20
11094390|NCT01195584|12277701|FG001|COMPLETED|Overall Study||25
11094391|NCT01195584|12277702|FG002|COMPLETED|Overall Study||27
11094392|NCT01195584|12277700|FG000|NOT COMPLETED|Overall Study||0
11094393|NCT01195584|12277701|FG001|NOT COMPLETED|Overall Study||0
11094394|NCT01195584|12277702|FG002|NOT COMPLETED|Overall Study||0
11094395|NCT01195597|12277712|FG000|STARTED|Overall Study||40
11094396|NCT01195597|12277712|FG000|COMPLETED|Overall Study||27
11094397|NCT01195597|12277712|FG000|NOT COMPLETED|Overall Study||13
11094398|NCT01195623|12277718|FG000|STARTED|Overall Study|166 legs total operated|148
11094399|NCT01195623|12277719|FG001|STARTED|Overall Study|177 legs total operated|145
11094400|NCT01195623|12277718|FG000|COMPLETED|Overall Study|127 legs|113
11094401|NCT01195623|12277719|FG001|COMPLETED|Overall Study|129 legs|108
11094402|NCT01195623|12277718|FG000|NOT COMPLETED|Overall Study||35
11094403|NCT01195623|12277719|FG001|NOT COMPLETED|Overall Study||37
11094404|NCT01195636|12277727|FG000|STARTED|First Intervention (3 Weeks)||35
11094405|NCT01195636|12277728|FG001|STARTED|First Intervention (3 Weeks)||35
11094406|NCT01195636|12277727|FG000|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
11094407|NCT01195636|12277728|FG001|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
11094408|NCT01195636|12277727|FG000|COMPLETED|First Intervention (3 Weeks)||30
11094409|NCT01195636|12277728|FG001|COMPLETED|First Intervention (3 Weeks)||32
11094410|NCT01195636|12277727|FG000|NOT COMPLETED|First Intervention (3 Weeks)||5
11094411|NCT01195636|12277728|FG001|NOT COMPLETED|First Intervention (3 Weeks)||3
11094412|NCT01195636|12277727|FG000|STARTED|Washout Period (2 Weeks)||30
11094413|NCT01195636|12277728|FG001|STARTED|Washout Period (2 Weeks)||32
11094414|NCT01195636|12277727|FG000|COMPLETED|Washout Period (2 Weeks)||28
11094415|NCT01195636|12277728|FG001|COMPLETED|Washout Period (2 Weeks)||29
11094416|NCT01195636|12277727|FG000|NOT COMPLETED|Washout Period (2 Weeks)||2
11094417|NCT01195636|12277728|FG001|NOT COMPLETED|Washout Period (2 Weeks)||3
11094418|NCT01195636|12277727|FG000|STARTED|Second Intervention (3 Weeks)||28
11094419|NCT01195636|12277728|FG001|STARTED|Second Intervention (3 Weeks)||29
11094420|NCT01195636|12277727|FG000|COMPLETED|Second Intervention (3 Weeks)||27
11094421|NCT01195636|12277728|FG001|COMPLETED|Second Intervention (3 Weeks)||27
11094422|NCT01195636|12277727|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
11208260|NCT03158298|12399481|FG000|STARTED|Overall Study||82
11094423|NCT01195636|12277728|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||2
11094424|NCT01195662|12277737|FG000|STARTED|Double Blind Treatment Period||224
11094425|NCT01195662|12277738|FG001|STARTED|Double Blind Treatment Period||225
11094426|NCT01195662|12277739|FG002|STARTED|Double Blind Treatment Period||133
11094427|NCT01195662|12277737|FG000|COMPLETED|Double Blind Treatment Period||202
11094428|NCT01195662|12277738|FG001|COMPLETED|Double Blind Treatment Period||211
11094429|NCT01195662|12277739|FG002|COMPLETED|Double Blind Treatment Period||119
11094430|NCT01195662|12277737|FG000|NOT COMPLETED|Double Blind Treatment Period||22
11094431|NCT01195662|12277738|FG001|NOT COMPLETED|Double Blind Treatment Period||14
11094432|NCT01195662|12277739|FG002|NOT COMPLETED|Double Blind Treatment Period||14
11094433|NCT01195662|12277737|FG000|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
11094434|NCT01195662|12277738|FG001|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
11094435|NCT01195662|12277739|FG002|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
11094436|NCT01195662|12277737|FG000|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
11094437|NCT01195662|12277738|FG001|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
11094438|NCT01195662|12277739|FG002|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
11094439|NCT01195662|12277737|FG000|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
11094440|NCT01195662|12277738|FG001|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
11094441|NCT01195662|12277739|FG002|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
11094442|NCT01195675|12277748|FG000|STARTED|Overall Study||30
11094443|NCT01195675|12277748|FG000|Received Empa 25mg|Overall Study||28
11094444|NCT01195675|12277748|FG000|Received Empa 200mg|Overall Study||30
11094445|NCT01195675|12277748|FG000|Received Moxifloxacin|Overall Study||29
11094446|NCT01195675|12277748|FG000|Received Placebo 1|Overall Study||29
11094447|NCT01195675|12277748|FG000|Received Placebo 2|Overall Study||28
11094448|NCT01195675|12277748|FG000|COMPLETED|Overall Study||27
11352156|NCT03044028|12549291|FG000|STARTED|Overall Study||22
11352157|NCT03044028|12549292|FG001|STARTED|Overall Study||22
11352158|NCT03044028|12549293|FG002|STARTED|Overall Study||22
11352159|NCT03044028|12549291|FG000|COMPLETED|Overall Study||12
11352160|NCT03044028|12549292|FG001|COMPLETED|Overall Study||12
11352161|NCT03044028|12549293|FG002|COMPLETED|Overall Study||22
11352162|NCT03044028|12549291|FG000|NOT COMPLETED|Overall Study||10
11352163|NCT03044028|12549292|FG001|NOT COMPLETED|Overall Study||10
11352164|NCT03044028|12549293|FG002|NOT COMPLETED|Overall Study||0
11352165|NCT03044106|12549302|FG000|STARTED|Visit 1||22
11352166|NCT03044106|12549303|FG001|STARTED|Visit 1||22
11352167|NCT03044106|12549302|FG000|COMPLETED|Visit 1||22
11094449|NCT01195675|12277748|FG000|NOT COMPLETED|Overall Study||3
11094450|NCT01195701|12277765|FG000|STARTED|Overall Study||10
11094451|NCT01195701|12277766|FG001|STARTED|Overall Study||25
11094452|NCT01195701|12277765|FG000|COMPLETED|Overall Study||10
11094453|NCT01195701|12277766|FG001|COMPLETED|Overall Study||20
11094454|NCT01195701|12277765|FG000|NOT COMPLETED|Overall Study||0
11094455|NCT01195701|12277766|FG001|NOT COMPLETED|Overall Study||5
11094456|NCT01195779|12277786|FG000|STARTED|Overall Study||0
11094457|NCT01195779|12277787|FG001|STARTED|Overall Study||0
11094458|NCT01195779|12277788|FG002|STARTED|Overall Study||0
11094459|NCT01195779|12277789|FG003|STARTED|Overall Study||0
11094460|NCT01195779|12277790|FG004|STARTED|Overall Study||1
11094461|NCT01195779|12277791|FG005|STARTED|Overall Study||0
11094462|NCT01195779|12277792|FG006|STARTED|Overall Study||0
11094463|NCT01195779|12277793|FG007|STARTED|Overall Study||1
11094464|NCT01195779|12277794|FG008|STARTED|Overall Study||0
11094465|NCT01195779|12277795|FG009|STARTED|Overall Study||0
11094466|NCT01195779|12277796|FG010|STARTED|Overall Study||0
11094467|NCT01195779|12277797|FG011|STARTED|Overall Study||1
11094468|NCT01195779|12277798|FG012|STARTED|Overall Study||0
11094469|NCT01195779|12277799|FG013|STARTED|Overall Study||1
11094470|NCT01195779|12277786|FG000|COMPLETED|Overall Study||0
11094471|NCT01195779|12277787|FG001|COMPLETED|Overall Study||0
11094472|NCT01195779|12277788|FG002|COMPLETED|Overall Study||0
11094473|NCT01195779|12277789|FG003|COMPLETED|Overall Study||0
11094474|NCT01195779|12277790|FG004|COMPLETED|Overall Study||1
11094475|NCT01195779|12277791|FG005|COMPLETED|Overall Study||0
11094476|NCT01195779|12277792|FG006|COMPLETED|Overall Study||0
11094477|NCT01195779|12277793|FG007|COMPLETED|Overall Study||1
11094478|NCT01195779|12277794|FG008|COMPLETED|Overall Study||0
11094479|NCT01195779|12277795|FG009|COMPLETED|Overall Study||0
11094480|NCT01195779|12277796|FG010|COMPLETED|Overall Study||0
11094481|NCT01195779|12277797|FG011|COMPLETED|Overall Study||1
11094482|NCT01195779|12277798|FG012|COMPLETED|Overall Study||0
11094483|NCT01195779|12277799|FG013|COMPLETED|Overall Study||1
11094484|NCT01195779|12277786|FG000|NOT COMPLETED|Overall Study||0
11094485|NCT01195779|12277787|FG001|NOT COMPLETED|Overall Study||0
11094486|NCT01195779|12277788|FG002|NOT COMPLETED|Overall Study||0
11094487|NCT01195779|12277789|FG003|NOT COMPLETED|Overall Study||0
11094488|NCT01195779|12277790|FG004|NOT COMPLETED|Overall Study||0
11094489|NCT01195779|12277791|FG005|NOT COMPLETED|Overall Study||0
11094490|NCT01195779|12277792|FG006|NOT COMPLETED|Overall Study||0
11094491|NCT01195779|12277793|FG007|NOT COMPLETED|Overall Study||0
11094492|NCT01195779|12277794|FG008|NOT COMPLETED|Overall Study||0
11094493|NCT01195779|12277795|FG009|NOT COMPLETED|Overall Study||0
11094494|NCT01195779|12277796|FG010|NOT COMPLETED|Overall Study||0
11094495|NCT01195779|12277797|FG011|NOT COMPLETED|Overall Study||0
11094496|NCT01195779|12277798|FG012|NOT COMPLETED|Overall Study||0
11094497|NCT01195779|12277799|FG013|NOT COMPLETED|Overall Study||0
11094498|NCT01195831|12277831|FG000|STARTED|Overall Study||120
11094499|NCT01195831|12277832|FG001|STARTED|Overall Study||124
11094500|NCT01195831|12277831|FG000|COMPLETED|Overall Study||112
11094501|NCT01195831|12277832|FG001|COMPLETED|Overall Study||114
11094502|NCT01195831|12277831|FG000|NOT COMPLETED|Overall Study||8
11094503|NCT01195831|12277832|FG001|NOT COMPLETED|Overall Study||10
11094504|NCT01195844|12277838|FG000|STARTED|Overall Study||230
11094505|NCT01195844|12277838|FG000|COMPLETED|Overall Study||190
11094506|NCT01195844|12277838|FG000|NOT COMPLETED|Overall Study||40
11094507|NCT01195883|12277854|FG000|STARTED|Overall Study||553
11094508|NCT01195883|12277855|FG001|STARTED|Overall Study||549
11094509|NCT01195883|12277854|FG000|COMPLETED|Overall Study||534
11094510|NCT01195883|12277855|FG001|COMPLETED|Overall Study||523
11094511|NCT01195883|12277854|FG000|NOT COMPLETED|Overall Study||19
11094512|NCT01195883|12277855|FG001|NOT COMPLETED|Overall Study||26
11094513|NCT01195922|12277861|FG000|STARTED|Overall Study||16
11094514|NCT01195922|12277861|FG000|COMPLETED|Overall Study||16
11094515|NCT01195922|12277861|FG000|NOT COMPLETED|Overall Study||0
11094516|NCT01195948|12277868|FG000|STARTED|Overall Study||10
11094517|NCT01195948|12277869|FG001|STARTED|Overall Study||10
11094518|NCT01195948|12277870|FG002|STARTED|Overall Study||11
11094519|NCT01195948|12277868|FG000|Week 24|Overall Study||10
11094520|NCT01195948|12277869|FG001|Week 24|Overall Study||10
11094521|NCT01195948|12277870|FG002|Week 24|Overall Study||10
11094522|NCT01195948|12277868|FG000|COMPLETED|Overall Study||10
11094523|NCT01195948|12277869|FG001|COMPLETED|Overall Study||9
11094524|NCT01195948|12277870|FG002|COMPLETED|Overall Study||9
11094525|NCT01195948|12277868|FG000|NOT COMPLETED|Overall Study||0
11094526|NCT01195948|12277869|FG001|NOT COMPLETED|Overall Study||1
11094527|NCT01195948|12277870|FG002|NOT COMPLETED|Overall Study||2
11094528|NCT01196026|12277887|FG000|STARTED|Overall Study||10
11094529|NCT01196026|12277888|FG001|STARTED|Overall Study||44
11094530|NCT01196026|12277889|FG002|STARTED|Overall Study||23
11094531|NCT01196026|12277890|FG003|STARTED|Overall Study||10
11094532|NCT01196026|12277891|FG004|STARTED|Overall Study||43
11094533|NCT01196026|12277892|FG005|STARTED|Overall Study||24
11094534|NCT01196026|12277887|FG000|Completed at Day 28|Overall Study||9
11094535|NCT01196026|12277888|FG001|Completed at Day 28|Overall Study||41
11094536|NCT01196026|12277889|FG002|Completed at Day 28|Overall Study||23
11094537|NCT01196026|12277890|FG003|Completed at Day 28|Overall Study||10
11094538|NCT01196026|12277891|FG004|Completed at Day 28|Overall Study||42
11094539|NCT01196026|12277892|FG005|Completed at Day 28|Overall Study||24
11094540|NCT01196026|12277887|FG000|COMPLETED|Overall Study||9
11094541|NCT01196026|12277888|FG001|COMPLETED|Overall Study||36
11094542|NCT01196026|12277889|FG002|COMPLETED|Overall Study||23
11094543|NCT01196026|12277890|FG003|COMPLETED|Overall Study||10
11094544|NCT01196026|12277891|FG004|COMPLETED|Overall Study||42
11094545|NCT01196026|12277892|FG005|COMPLETED|Overall Study||24
11094546|NCT01196026|12277887|FG000|NOT COMPLETED|Overall Study||1
11094547|NCT01196026|12277888|FG001|NOT COMPLETED|Overall Study||8
11094548|NCT01196026|12277889|FG002|NOT COMPLETED|Overall Study||0
11094549|NCT01196026|12277890|FG003|NOT COMPLETED|Overall Study||0
11094550|NCT01196026|12277891|FG004|NOT COMPLETED|Overall Study||1
11094551|NCT01196026|12277892|FG005|NOT COMPLETED|Overall Study||0
11094552|NCT01196052|12277908|FG000|STARTED|Overall Study||153
11094553|NCT01196052|12277908|FG000|Received Trastuzumab Emtansine|Overall Study||148
11094554|NCT01196052|12277908|FG000|COMPLETED|Overall Study||130
11094555|NCT01196052|12277908|FG000|NOT COMPLETED|Overall Study||23
11094556|NCT01196078|12277914|FG000|STARTED|Overall Study||57
11094557|NCT01196078|12277915|FG001|STARTED|Overall Study||57
11094558|NCT01196078|12277914|FG000|COMPLETED|Overall Study||24
11094559|NCT01196078|12277915|FG001|COMPLETED|Overall Study||20
11094560|NCT01196078|12277914|FG000|NOT COMPLETED|Overall Study||33
11094561|NCT01196078|12277915|FG001|NOT COMPLETED|Overall Study||37
11094562|NCT01196091|12277924|FG000|STARTED|Overall Study||387
11094563|NCT01196091|12277925|FG001|STARTED|Overall Study||389
11094564|NCT01196091|12277926|FG002|STARTED|Overall Study||388
11094565|NCT01196091|12277924|FG000|Received at Least 1 Dose of Study Drug|Overall Study||386
11094566|NCT01196091|12277925|FG001|Received at Least 1 Dose of Study Drug|Overall Study||389
11094567|NCT01196091|12277926|FG002|Received at Least 1 Dose of Study Drug|Overall Study||387
11094568|NCT01196091|12277924|FG000|ITT-Received Drug and Excluded Sites|Overall Study||381
11094569|NCT01196091|12277925|FG001|ITT-Received Drug and Excluded Sites|Overall Study||378
11094570|NCT01196091|12277926|FG002|ITT-Received Drug and Excluded Sites|Overall Study||379
11094571|NCT01196091|12277924|FG000|Follow-Up|Overall Study||103
11094572|NCT01196091|12277925|FG001|Follow-Up|Overall Study||105
11094573|NCT01196091|12277926|FG002|Follow-Up|Overall Study||128
11094574|NCT01196091|12277924|FG000|COMPLETED|Overall Study||299
11094575|NCT01196091|12277925|FG001|COMPLETED|Overall Study||291
11094576|NCT01196091|12277926|FG002|COMPLETED|Overall Study||284
11094577|NCT01196091|12277924|FG000|NOT COMPLETED|Overall Study||88
11094578|NCT01196091|12277925|FG001|NOT COMPLETED|Overall Study||98
11094579|NCT01196091|12277926|FG002|NOT COMPLETED|Overall Study||104
11094580|NCT01196104|12277941|FG000|STARTED|Overall Study||19
11352168|NCT03044106|12549303|FG001|COMPLETED|Visit 1||22
11352169|NCT03044106|12549302|FG000|NOT COMPLETED|Visit 1||0
11352170|NCT03044106|12549303|FG001|NOT COMPLETED|Visit 1||0
11094581|NCT01196104|12277942|FG001|STARTED|Overall Study||20
11094582|NCT01196104|12277941|FG000|COMPLETED|Overall Study||15
11094583|NCT01196104|12277942|FG001|COMPLETED|Overall Study||15
11352171|NCT03044106|12549302|FG000|STARTED|Washout (1 Week)||22
11094584|NCT01196104|12277941|FG000|NOT COMPLETED|Overall Study||4
11094585|NCT01196104|12277942|FG001|NOT COMPLETED|Overall Study||5
11094586|NCT01196117|12277950|FG000|STARTED|Placebo, Then CPAP||18
11352172|NCT03044106|12549303|FG001|STARTED|Washout (1 Week)||22
11094587|NCT01196117|12277951|FG001|STARTED|Placebo, Then CPAP||0
11094588|NCT01196117|12277950|FG000|COMPLETED|Placebo, Then CPAP||18
11094589|NCT01196117|12277951|FG001|COMPLETED|Placebo, Then CPAP||0
11094590|NCT01196117|12277950|FG000|NOT COMPLETED|Placebo, Then CPAP||0
11094591|NCT01196117|12277951|FG001|NOT COMPLETED|Placebo, Then CPAP||0
11094592|NCT01196117|12277950|FG000|STARTED|CPAP||0
11094593|NCT01196117|12277951|FG001|STARTED|CPAP||18
11094594|NCT01196117|12277950|FG000|COMPLETED|CPAP||0
11094595|NCT01196117|12277951|FG001|COMPLETED|CPAP||18
11094596|NCT01196117|12277950|FG000|NOT COMPLETED|CPAP||0
11094597|NCT01196117|12277951|FG001|NOT COMPLETED|CPAP||0
11094598|NCT01196377|12277965|FG000|STARTED|Overall Study||4
11094599|NCT01196377|12277966|FG001|STARTED|Overall Study||4
11094600|NCT01196377|12277967|FG002|STARTED|Overall Study||4
11094601|NCT01196377|12277968|FG003|STARTED|Overall Study||4
11094602|NCT01196377|12277965|FG000|COMPLETED|Overall Study||4
11094603|NCT01196377|12277966|FG001|COMPLETED|Overall Study||4
11094604|NCT01196377|12277967|FG002|COMPLETED|Overall Study||4
11094605|NCT01196377|12277968|FG003|COMPLETED|Overall Study||4
11094606|NCT01196377|12277965|FG000|NOT COMPLETED|Overall Study||0
11094607|NCT01196377|12277966|FG001|NOT COMPLETED|Overall Study||0
11094608|NCT01196377|12277967|FG002|NOT COMPLETED|Overall Study||0
11094609|NCT01196377|12277968|FG003|NOT COMPLETED|Overall Study||0
11094610|NCT01196416|12277978|FG000|STARTED|Overall Study||14
11094611|NCT01196416|12277978|FG000|COMPLETED|Overall Study||12
11094612|NCT01196416|12277978|FG000|NOT COMPLETED|Overall Study||2
11094613|NCT01196429|12277984|FG000|STARTED|Overall Study||45
11094614|NCT01196429|12277985|FG001|STARTED|Overall Study||45
11094615|NCT01196429|12277984|FG000|COMPLETED|Overall Study||42
11094616|NCT01196429|12277985|FG001|COMPLETED|Overall Study||45
11094617|NCT01196429|12277984|FG000|NOT COMPLETED|Overall Study||3
11094618|NCT01196429|12277985|FG001|NOT COMPLETED|Overall Study||0
11094619|NCT01196442|12277993|FG000|STARTED|Overall Study||39
11094620|NCT01196442|12277993|FG000|COMPLETED|Overall Study||39
11094621|NCT01196442|12277993|FG000|NOT COMPLETED|Overall Study||0
11094622|NCT01196533|12277998|FG000|STARTED|Overall Study||94
11094623|NCT01196533|12277998|FG000|COMPLETED|Overall Study||94
11094624|NCT01196533|12277998|FG000|NOT COMPLETED|Overall Study||0
11094625|NCT01196741|12278004|FG000|STARTED|Overall Study||71
11094626|NCT01196741|12278005|FG001|STARTED|Overall Study||36
11094627|NCT01196741|12278004|FG000|COMPLETED|Overall Study||11
11094628|NCT01196741|12278005|FG001|COMPLETED|Overall Study||8
11094629|NCT01196741|12278004|FG000|NOT COMPLETED|Overall Study||60
11094630|NCT01196741|12278005|FG001|NOT COMPLETED|Overall Study||28
11094631|NCT01196793|12278011|FG000|STARTED|Overall Study||108
11094632|NCT01196793|12278011|FG000|COMPLETED|Overall Study||108
11094633|NCT01196793|12278011|FG000|NOT COMPLETED|Overall Study||0
11094634|NCT01196819|12278017|FG000|STARTED|Overall Study||231
11094635|NCT01196819|12278018|FG001|STARTED|Overall Study||227
11094636|NCT01196819|12278017|FG000|COMPLETED|Overall Study||225
11094637|NCT01196819|12278018|FG001|COMPLETED|Overall Study||227
11094638|NCT01196819|12278017|FG000|NOT COMPLETED|Overall Study||6
11094639|NCT01196819|12278018|FG001|NOT COMPLETED|Overall Study||0
11094640|NCT01196871|12278030|FG000|STARTED|Stage 1: Period 1||5
11094641|NCT01196871|12278031|FG001|STARTED|Stage 1: Period 1||3
11094642|NCT01196871|12278032|FG002|STARTED|Stage 1: Period 1||4
11094643|NCT01196871|12278033|FG003|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
11094644|NCT01196871|12278034|FG004|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
11094645|NCT01196871|12278035|FG005|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
11094646|NCT01196871|12278030|FG000|PK Population|Stage 1: Period 1||5
11094647|NCT01196871|12278031|FG001|PK Population|Stage 1: Period 1||3
11094648|NCT01196871|12278032|FG002|PK Population|Stage 1: Period 1||4
11094649|NCT01196871|12278033|FG003|PK Population|Stage 1: Period 1||0
11094650|NCT01196871|12278034|FG004|PK Population|Stage 1: Period 1||0
11094651|NCT01196871|12278035|FG005|PK Population|Stage 1: Period 1||0
11094652|NCT01196871|12278030|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
11094653|NCT01196871|12278031|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
11094654|NCT01196871|12278032|FG002|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
11094655|NCT01196871|12278033|FG003|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
11094656|NCT01196871|12278034|FG004|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
11094657|NCT01196871|12278035|FG005|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
11094658|NCT01196871|12278030|FG000|COMPLETED|Stage 1: Period 1||5
11094659|NCT01196871|12278031|FG001|COMPLETED|Stage 1: Period 1||3
11094660|NCT01196871|12278032|FG002|COMPLETED|Stage 1: Period 1||4
11094661|NCT01196871|12278033|FG003|COMPLETED|Stage 1: Period 1||0
11094662|NCT01196871|12278034|FG004|COMPLETED|Stage 1: Period 1||0
11094663|NCT01196871|12278035|FG005|COMPLETED|Stage 1: Period 1||0
11094664|NCT01196871|12278030|FG000|NOT COMPLETED|Stage 1: Period 1||0
11094665|NCT01196871|12278031|FG001|NOT COMPLETED|Stage 1: Period 1||0
11094666|NCT01196871|12278032|FG002|NOT COMPLETED|Stage 1: Period 1||0
11094667|NCT01196871|12278033|FG003|NOT COMPLETED|Stage 1: Period 1||0
11094668|NCT01196871|12278034|FG004|NOT COMPLETED|Stage 1: Period 1||0
11094669|NCT01196871|12278035|FG005|NOT COMPLETED|Stage 1: Period 1||0
11094670|NCT01196871|12278030|FG000|STARTED|Stage 1: Period 2||5
11094671|NCT01196871|12278031|FG001|STARTED|Stage 1: Period 2||3
11094672|NCT01196871|12278032|FG002|STARTED|Stage 1: Period 2||4
11094673|NCT01196871|12278033|FG003|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
11094674|NCT01196871|12278034|FG004|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
11094675|NCT01196871|12278035|FG005|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
11094676|NCT01196871|12278030|FG000|PK Population|Stage 1: Period 2||5
11094677|NCT01196871|12278031|FG001|PK Population|Stage 1: Period 2||3
11094678|NCT01196871|12278032|FG002|PK Population|Stage 1: Period 2||4
11094679|NCT01196871|12278033|FG003|PK Population|Stage 1: Period 2||0
11094680|NCT01196871|12278034|FG004|PK Population|Stage 1: Period 2||0
11094681|NCT01196871|12278035|FG005|PK Population|Stage 1: Period 2||0
11094682|NCT01196871|12278030|FG000|COMPLETED|Stage 1: Period 2||5
11094683|NCT01196871|12278031|FG001|COMPLETED|Stage 1: Period 2||3
11094684|NCT01196871|12278032|FG002|COMPLETED|Stage 1: Period 2||4
11208261|NCT03158298|12399481|FG000|COMPLETED|Overall Study||82
11094685|NCT01196871|12278033|FG003|COMPLETED|Stage 1: Period 2||0
11094686|NCT01196871|12278034|FG004|COMPLETED|Stage 1: Period 2||0
11094687|NCT01196871|12278035|FG005|COMPLETED|Stage 1: Period 2||0
11094688|NCT01196871|12278030|FG000|NOT COMPLETED|Stage 1: Period 2||0
11094689|NCT01196871|12278031|FG001|NOT COMPLETED|Stage 1: Period 2||0
11094690|NCT01196871|12278032|FG002|NOT COMPLETED|Stage 1: Period 2||0
11094691|NCT01196871|12278033|FG003|NOT COMPLETED|Stage 1: Period 2||0
11094692|NCT01196871|12278034|FG004|NOT COMPLETED|Stage 1: Period 2||0
11094693|NCT01196871|12278035|FG005|NOT COMPLETED|Stage 1: Period 2||0
11094694|NCT01196871|12278030|FG000|STARTED|Stage 1: Period 3||5
11094695|NCT01196871|12278031|FG001|STARTED|Stage 1: Period 3||3
11094696|NCT01196871|12278032|FG002|STARTED|Stage 1: Period 3||4
11094697|NCT01196871|12278033|FG003|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
11094698|NCT01196871|12278034|FG004|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
11094699|NCT01196871|12278035|FG005|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
11094700|NCT01196871|12278030|FG000|COMPLETED|Stage 1: Period 3||5
11094701|NCT01196871|12278031|FG001|COMPLETED|Stage 1: Period 3||3
11094702|NCT01196871|12278032|FG002|COMPLETED|Stage 1: Period 3||4
11094703|NCT01196871|12278033|FG003|COMPLETED|Stage 1: Period 3||0
11094704|NCT01196871|12278034|FG004|COMPLETED|Stage 1: Period 3||0
11094705|NCT01196871|12278035|FG005|COMPLETED|Stage 1: Period 3||0
11094706|NCT01196871|12278030|FG000|NOT COMPLETED|Stage 1: Period 3||0
11094707|NCT01196871|12278031|FG001|NOT COMPLETED|Stage 1: Period 3||0
11094708|NCT01196871|12278032|FG002|NOT COMPLETED|Stage 1: Period 3||0
11094709|NCT01196871|12278033|FG003|NOT COMPLETED|Stage 1: Period 3||0
11094710|NCT01196871|12278034|FG004|NOT COMPLETED|Stage 1: Period 3||0
11094711|NCT01196871|12278035|FG005|NOT COMPLETED|Stage 1: Period 3||0
11094712|NCT01196871|12278030|FG000|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
11094713|NCT01196871|12278031|FG001|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
11094714|NCT01196871|12278032|FG002|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
11094715|NCT01196871|12278033|FG003|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
11094716|NCT01196871|12278034|FG004|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
11094717|NCT01196871|12278035|FG005|STARTED|Stage 2: Period 1||4
11352173|NCT03044106|12549302|FG000|COMPLETED|Washout (1 Week)||22
11352174|NCT03044106|12549303|FG001|COMPLETED|Washout (1 Week)||20
11352175|NCT03044106|12549302|FG000|NOT COMPLETED|Washout (1 Week)||0
11352176|NCT03044106|12549303|FG001|NOT COMPLETED|Washout (1 Week)||2
11352177|NCT03044106|12549302|FG000|STARTED|Visit 2||22
11352178|NCT03044106|12549303|FG001|STARTED|Visit 2||20
11352179|NCT03044106|12549302|FG000|COMPLETED|Visit 2||22
11352180|NCT03044106|12549303|FG001|COMPLETED|Visit 2||20
11352181|NCT03044106|12549302|FG000|NOT COMPLETED|Visit 2||0
11352182|NCT03044106|12549303|FG001|NOT COMPLETED|Visit 2||0
11352183|NCT03044197|12549318|FG000|STARTED|Overall Study||12
11352184|NCT03044197|12549319|FG001|STARTED|Overall Study||12
11352185|NCT03044197|12549318|FG000|COMPLETED|Overall Study||9
11352186|NCT03044197|12549319|FG001|COMPLETED|Overall Study||11
11352187|NCT03044197|12549318|FG000|NOT COMPLETED|Overall Study||3
11352188|NCT03044197|12549319|FG001|NOT COMPLETED|Overall Study||1
11352189|NCT03044249|12549327|FG000|STARTED|Overall Study||42
11352190|NCT03044249|12549328|FG001|STARTED|Overall Study||39
11352191|NCT03044249|12549327|FG000|Received at Least One Dose of Study Drug|Overall Study||42
11352192|NCT03044249|12549328|FG001|Received at Least One Dose of Study Drug|Overall Study||39
11352193|NCT03044249|12549327|FG000|COMPLETED|Overall Study||32
11352194|NCT03044249|12549328|FG001|COMPLETED|Overall Study||25
11352195|NCT03044249|12549327|FG000|NOT COMPLETED|Overall Study||10
11094718|NCT01196871|12278030|FG000|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
11352196|NCT03044249|12549328|FG001|NOT COMPLETED|Overall Study||14
11094719|NCT01196871|12278031|FG001|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
11094720|NCT01196871|12278032|FG002|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
11094721|NCT01196871|12278033|FG003|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
11094722|NCT01196871|12278034|FG004|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
11094723|NCT01196871|12278035|FG005|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
11094724|NCT01196871|12278030|FG000|PK Population|Stage 2: Period 1||0
11094725|NCT01196871|12278031|FG001|PK Population|Stage 2: Period 1||0
11094726|NCT01196871|12278032|FG002|PK Population|Stage 2: Period 1||0
11094727|NCT01196871|12278033|FG003|PK Population|Stage 2: Period 1||1
11094728|NCT01196871|12278034|FG004|PK Population|Stage 2: Period 1||5
11094729|NCT01196871|12278035|FG005|PK Population|Stage 2: Period 1||4
11094730|NCT01196871|12278030|FG000|COMPLETED|Stage 2: Period 1||0
11094731|NCT01196871|12278031|FG001|COMPLETED|Stage 2: Period 1||0
11094732|NCT01196871|12278032|FG002|COMPLETED|Stage 2: Period 1||0
11094733|NCT01196871|12278033|FG003|COMPLETED|Stage 2: Period 1||2
11094734|NCT01196871|12278034|FG004|COMPLETED|Stage 2: Period 1||5
11094735|NCT01196871|12278035|FG005|COMPLETED|Stage 2: Period 1||4
11094736|NCT01196871|12278030|FG000|NOT COMPLETED|Stage 2: Period 1||0
11094737|NCT01196871|12278031|FG001|NOT COMPLETED|Stage 2: Period 1||0
11094738|NCT01196871|12278032|FG002|NOT COMPLETED|Stage 2: Period 1||0
11094739|NCT01196871|12278033|FG003|NOT COMPLETED|Stage 2: Period 1||0
11094740|NCT01196871|12278034|FG004|NOT COMPLETED|Stage 2: Period 1||0
11094741|NCT01196871|12278035|FG005|NOT COMPLETED|Stage 2: Period 1||0
11094742|NCT01196871|12278030|FG000|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
11094743|NCT01196871|12278031|FG001|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
11094744|NCT01196871|12278032|FG002|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
11094745|NCT01196871|12278033|FG003|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
11094746|NCT01196871|12278034|FG004|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
11094747|NCT01196871|12278035|FG005|STARTED|Stage 2: Period 2||4
11094748|NCT01196871|12278030|FG000|PK Population|Stage 2: Period 2||0
11094749|NCT01196871|12278031|FG001|PK Population|Stage 2: Period 2||0
11094750|NCT01196871|12278032|FG002|PK Population|Stage 2: Period 2||0
11094751|NCT01196871|12278033|FG003|PK Population|Stage 2: Period 2||1
11094752|NCT01196871|12278034|FG004|PK Population|Stage 2: Period 2||6
11094753|NCT01196871|12278035|FG005|PK Population|Stage 2: Period 2||4
11094754|NCT01196871|12278030|FG000|COMPLETED|Stage 2: Period 2||0
11094755|NCT01196871|12278031|FG001|COMPLETED|Stage 2: Period 2||0
11094756|NCT01196871|12278032|FG002|COMPLETED|Stage 2: Period 2||0
11094757|NCT01196871|12278033|FG003|COMPLETED|Stage 2: Period 2||1
11094758|NCT01196871|12278034|FG004|COMPLETED|Stage 2: Period 2||6
11094759|NCT01196871|12278035|FG005|COMPLETED|Stage 2: Period 2||4
11094760|NCT01196871|12278030|FG000|NOT COMPLETED|Stage 2: Period 2||0
11094761|NCT01196871|12278031|FG001|NOT COMPLETED|Stage 2: Period 2||0
11094762|NCT01196871|12278032|FG002|NOT COMPLETED|Stage 2: Period 2||0
11094763|NCT01196871|12278033|FG003|NOT COMPLETED|Stage 2: Period 2||0
11094764|NCT01196871|12278034|FG004|NOT COMPLETED|Stage 2: Period 2||0
11094765|NCT01196871|12278035|FG005|NOT COMPLETED|Stage 2: Period 2||0
11094766|NCT01196923|12278058|FG000|STARTED|Overall Study||20
11094767|NCT01196923|12278058|FG000|COMPLETED|Overall Study||20
11094768|NCT01196923|12278058|FG000|NOT COMPLETED|Overall Study||0
11094769|NCT01196975|12278067|FG000|STARTED|Overall Study||423
11094770|NCT01196975|12278068|FG001|STARTED|Overall Study||424
11094771|NCT01196975|12278069|FG002|STARTED|Overall Study||425
11094772|NCT01196975|12278070|FG003|STARTED|Overall Study||213
11094773|NCT01196975|12278071|FG004|STARTED|Overall Study||218
11094774|NCT01196975|12278067|FG000|COMPLETED|Overall Study||408
11094775|NCT01196975|12278068|FG001|COMPLETED|Overall Study||415
11094776|NCT01196975|12278069|FG002|COMPLETED|Overall Study||420
11094777|NCT01196975|12278070|FG003|COMPLETED|Overall Study||207
11094778|NCT01196975|12278071|FG004|COMPLETED|Overall Study||205
11094779|NCT01196975|12278067|FG000|NOT COMPLETED|Overall Study||15
11094780|NCT01196975|12278068|FG001|NOT COMPLETED|Overall Study||9
11094781|NCT01196975|12278069|FG002|NOT COMPLETED|Overall Study||5
11094782|NCT01196975|12278070|FG003|NOT COMPLETED|Overall Study||6
11094783|NCT01196975|12278071|FG004|NOT COMPLETED|Overall Study||13
11094784|NCT01196988|12278110|FG000|STARTED|Overall Study||915
11094785|NCT01196988|12278111|FG001|STARTED|Overall Study||912
11094786|NCT01196988|12278112|FG002|STARTED|Overall Study||911
11094787|NCT01196988|12278113|FG003|STARTED|Overall Study||277
11094788|NCT01196988|12278110|FG000|COMPLETED|Overall Study||891
11094789|NCT01196988|12278111|FG001|COMPLETED|Overall Study||880
11094790|NCT01196988|12278112|FG002|COMPLETED|Overall Study||886
11094791|NCT01196988|12278113|FG003|COMPLETED|Overall Study||276
11094792|NCT01196988|12278110|FG000|NOT COMPLETED|Overall Study||24
11094793|NCT01196988|12278111|FG001|NOT COMPLETED|Overall Study||32
11094794|NCT01196988|12278112|FG002|NOT COMPLETED|Overall Study||25
11352197|NCT03044353|12549342|FG000|STARTED|Overall Study||6
11094795|NCT01196988|12278113|FG003|NOT COMPLETED|Overall Study||1
11094796|NCT01197300|12278126|FG000|STARTED|Overall Study||10
11094797|NCT01197300|12278127|FG001|STARTED|Overall Study||15
11094798|NCT01197300|12278126|FG000|COMPLETED|Overall Study||10
11094799|NCT01197300|12278127|FG001|COMPLETED|Overall Study||13
11094800|NCT01197300|12278126|FG000|NOT COMPLETED|Overall Study||0
11094801|NCT01197300|12278127|FG001|NOT COMPLETED|Overall Study||2
11094802|NCT01197326|12278135|FG000|STARTED|Overall Study||205
11094803|NCT01197326|12278136|FG001|STARTED|Overall Study||209
11094804|NCT01197326|12278135|FG000|COMPLETED|Overall Study||205
11094805|NCT01197326|12278136|FG001|COMPLETED|Overall Study||209
11094806|NCT01197326|12278135|FG000|NOT COMPLETED|Overall Study||0
11094807|NCT01197326|12278136|FG001|NOT COMPLETED|Overall Study||0
11094808|NCT01197378|12278144|FG000|STARTED|Overall Study||60
11094809|NCT01197378|12278144|FG000|Received Treatment|Overall Study||59
11094810|NCT01197378|12278144|FG000|COMPLETED|Overall Study||53
11094811|NCT01197378|12278144|FG000|NOT COMPLETED|Overall Study||7
11094812|NCT01197417|12278150|FG000|STARTED|Overall Study||104
11094813|NCT01197417|12278151|FG001|STARTED|Overall Study||104
11094814|NCT01197417|12278150|FG000|Received Study Drug|Overall Study||101
11094815|NCT01197417|12278151|FG001|Received Study Drug|Overall Study||103
11094816|NCT01197417|12278150|FG000|COMPLETED|Overall Study||96
11094817|NCT01197417|12278151|FG001|COMPLETED|Overall Study||86
11094818|NCT01197417|12278150|FG000|NOT COMPLETED|Overall Study||8
11094819|NCT01197417|12278151|FG001|NOT COMPLETED|Overall Study||18
11094820|NCT01197456|12278159|FG000|STARTED|Overall Study||171
11094821|NCT01197456|12278160|FG001|STARTED|Overall Study||61
11094822|NCT01197456|12278159|FG000|COMPLETED|Overall Study||171
11094823|NCT01197456|12278160|FG001|COMPLETED|Overall Study||61
11094824|NCT01197456|12278159|FG000|NOT COMPLETED|Overall Study||0
11094825|NCT01197456|12278160|FG001|NOT COMPLETED|Overall Study||0
11094826|NCT01197495|12278168|FG000|STARTED|Overall Study||157
11094827|NCT01197495|12278169|FG001|STARTED|Overall Study||56
11094828|NCT01197495|12278168|FG000|COMPLETED|Overall Study||144
11094829|NCT01197495|12278169|FG001|COMPLETED|Overall Study||49
11094830|NCT01197495|12278168|FG000|NOT COMPLETED|Overall Study||13
11094831|NCT01197495|12278169|FG001|NOT COMPLETED|Overall Study||7
11094832|NCT01197508|12278179|FG000|STARTED|Overall Study||174
11094833|NCT01197508|12278180|FG001|STARTED|Overall Study||174
11094834|NCT01197508|12278181|FG002|STARTED|Overall Study||174
11094835|NCT01197508|12278182|FG003|STARTED|Overall Study||174
11094836|NCT01197508|12278179|FG000|Received Treatment|Overall Study||174
11094837|NCT01197508|12278180|FG001|Received Treatment|Overall Study||174
11094838|NCT01197508|12278181|FG002|Received Treatment|Overall Study||171
11094839|NCT01197508|12278182|FG003|Received Treatment|Overall Study||174
11094840|NCT01197508|12278179|FG000|COMPLETED|Overall Study||151
11094841|NCT01197508|12278180|FG001|COMPLETED|Overall Study||144
11094842|NCT01197508|12278181|FG002|COMPLETED|Overall Study||125
11094843|NCT01197508|12278182|FG003|COMPLETED|Overall Study||158
11094844|NCT01197508|12278179|FG000|NOT COMPLETED|Overall Study||23
11094845|NCT01197508|12278180|FG001|NOT COMPLETED|Overall Study||30
11094846|NCT01197508|12278181|FG002|NOT COMPLETED|Overall Study||49
11094847|NCT01197508|12278182|FG003|NOT COMPLETED|Overall Study||16
11094848|NCT01197521|12278195|FG000|STARTED|Overall Study|Patients who received treatment|310
11094849|NCT01197521|12278196|FG001|STARTED|Overall Study|Patients who received treatment|304
11094850|NCT01197521|12278197|FG002|STARTED|Overall Study|Patients who received treatment|304
11094851|NCT01197521|12278195|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
11094852|NCT01197521|12278196|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
11094853|NCT01197521|12278197|FG002|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
11094854|NCT01197521|12278195|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
11094855|NCT01197521|12278196|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
11094856|NCT01197521|12278197|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
11094857|NCT01197521|12278195|FG000|NOT COMPLETED|Overall Study||103
11094858|NCT01197521|12278196|FG001|NOT COMPLETED|Overall Study||113
11094859|NCT01197521|12278197|FG002|NOT COMPLETED|Overall Study||143
11094860|NCT01197534|12278211|FG000|STARTED|Overall Study|Patients who received treatment|308
11094861|NCT01197534|12278212|FG001|STARTED|Overall Study|Patients who received treatment|298
11094862|NCT01197534|12278213|FG002|STARTED|Overall Study|Patients who received treatment|302
11094863|NCT01197534|12278211|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
11094864|NCT01197534|12278212|FG001|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
11094865|NCT01197534|12278213|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
11094866|NCT01197534|12278211|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
11094867|NCT01197534|12278212|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
11094868|NCT01197534|12278213|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
11094869|NCT01197534|12278211|FG000|NOT COMPLETED|Overall Study||134
11094870|NCT01197534|12278212|FG001|NOT COMPLETED|Overall Study||130
11094871|NCT01197534|12278213|FG002|NOT COMPLETED|Overall Study||173
11094872|NCT01197547|12278224|FG000|STARTED|Overall Study||1014
11094873|NCT01197547|12278224|FG000|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
11094874|NCT01197547|12278224|FG000|NOT COMPLETED|Overall Study||22
11094875|NCT01197560|12278230|FG000|STARTED|Overall Study|This is the intent to treat population|54
11094876|NCT01197560|12278231|FG001|STARTED|Overall Study|This is the intent to treat population|57
11094877|NCT01197560|12278230|FG000|Received ≥ One Dose Study Drug|Overall Study||54
11094878|NCT01197560|12278231|FG001|Received ≥ One Dose Study Drug|Overall Study||55
11094879|NCT01197560|12278230|FG000|Lenalidomide Crossover|Overall Study||0
11094880|NCT01197560|12278231|FG001|Lenalidomide Crossover|Overall Study||29
11094881|NCT01197560|12278230|FG000|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14
11094882|NCT01197560|12278231|FG001|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0
11094883|NCT01197560|12278230|FG000|COMPLETED|Overall Study||0
11094884|NCT01197560|12278231|FG001|COMPLETED|Overall Study||4
11094885|NCT01197560|12278230|FG000|NOT COMPLETED|Overall Study||54
11094886|NCT01197560|12278231|FG001|NOT COMPLETED|Overall Study||53
11094887|NCT01197573|12278242|FG000|STARTED|Overall Study||33
11094888|NCT01197573|12278243|FG001|STARTED|Overall Study||46
11094889|NCT01197573|12278244|FG002|STARTED|Overall Study||12
11094890|NCT01197573|12278245|FG003|STARTED|Overall Study||12
11094891|NCT01197573|12278242|FG000|COMPLETED|Overall Study||33
11094892|NCT01197573|12278243|FG001|COMPLETED|Overall Study||46
11094893|NCT01197573|12278244|FG002|COMPLETED|Overall Study||12
11094894|NCT01197573|12278245|FG003|COMPLETED|Overall Study||12
11094895|NCT01197573|12278242|FG000|NOT COMPLETED|Overall Study||0
11094896|NCT01197573|12278243|FG001|NOT COMPLETED|Overall Study||0
11094897|NCT01197573|12278244|FG002|NOT COMPLETED|Overall Study||0
11094898|NCT01197573|12278245|FG003|NOT COMPLETED|Overall Study||0
11094899|NCT01197612|12278255|FG000|STARTED|Overall Study||18
11094900|NCT01197612|12278255|FG000|Week 3|Overall Study||16
11094901|NCT01197612|12278255|FG000|Returned for Week 24|Overall Study||6
11094902|NCT01197612|12278255|FG000|COMPLETED|Overall Study||6
11094903|NCT01197612|12278255|FG000|NOT COMPLETED|Overall Study||12
11094904|NCT01197755|12278265|FG000|STARTED|Overall Study|Patients who received treatment|105
11094905|NCT01197755|12278266|FG001|STARTED|Overall Study|Patients who received treatment|108
11094906|NCT01197755|12278267|FG002|STARTED|Overall Study|Patients who received treatment|109
11352198|NCT03044353|12549343|FG001|STARTED|Overall Study||1
11352199|NCT03044353|12549344|FG002|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0
11094907|NCT01197755|12278265|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
11094908|NCT01197755|12278266|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
11094909|NCT01197755|12278267|FG002|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
11094910|NCT01197755|12278265|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
11094911|NCT01197755|12278266|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
11094912|NCT01197755|12278267|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
11094913|NCT01197755|12278265|FG000|NOT COMPLETED|Overall Study||38
11094914|NCT01197755|12278266|FG001|NOT COMPLETED|Overall Study||43
11094915|NCT01197755|12278267|FG002|NOT COMPLETED|Overall Study||54
11208262|NCT03158298|12399481|FG000|NOT COMPLETED|Overall Study||0
11208263|NCT03041701|12399488|FG000|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||7
11208264|NCT03041701|12399489|FG001|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||6
11208265|NCT03041701|12399490|FG002|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||0
11208266|NCT03041701|12399488|FG000|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||6
11208267|NCT03041701|12399489|FG001|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||5
11208268|NCT03041701|12399490|FG002|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||0
11208269|NCT03041701|12399488|FG000|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||1
11208270|NCT03041701|12399489|FG001|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||1
11208271|NCT03041701|12399490|FG002|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||0
11208272|NCT03041701|12399488|FG000|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
11208273|NCT03041701|12399489|FG001|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
11208274|NCT03041701|12399490|FG002|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||1
11208275|NCT03041701|12399488|FG000|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
11208276|NCT03041701|12399489|FG001|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
11208277|NCT03041701|12399490|FG002|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
11208278|NCT03041701|12399488|FG000|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
11208279|NCT03041701|12399489|FG001|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
11208280|NCT03041701|12399490|FG002|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||1
11208281|NCT03000179|12399501|FG000|STARTED|Overall Study||8
11208282|NCT03000179|12399501|FG000|COMPLETED|Overall Study||6
11208283|NCT03000179|12399501|FG000|NOT COMPLETED|Overall Study||2
11208284|NCT02876835|12399507|FG000|STARTED|Run-in Period: Placebo (Week-4 to Day 1)||1937
11208285|NCT02876835|12399508|FG001|STARTED|Run-in Period: Placebo (Week-4 to Day 1)||1935
11208286|NCT02876835|12399507|FG000|COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||1937
11208287|NCT02876835|12399508|FG001|COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||1935
11208288|NCT02876835|12399507|FG000|NOT COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||0
11208289|NCT02876835|12399508|FG001|NOT COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||0
11208290|NCT02876835|12399507|FG000|STARTED|Treatment Period (51.1 Month)||1937
11208291|NCT02876835|12399508|FG001|STARTED|Treatment Period (51.1 Month)||1935
11208292|NCT02876835|12399507|FG000|COMPLETED|Treatment Period (51.1 Month)||1873
11094916|NCT01197794|12278284|FG000|STARTED|Overall Study||164
11094917|NCT01197794|12278285|FG001|STARTED|Overall Study|Two participants did not receive study treatment|161
11094918|NCT01197794|12278286|FG002|STARTED|Overall Study|Two participants did not receive study treatment|166
11094919|NCT01197794|12278287|FG003|STARTED|Overall Study||164
11094920|NCT01197794|12278288|FG004|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
11094921|NCT01197794|12278289|FG005|STARTED|Overall Study||163
11094922|NCT01197794|12278290|FG006|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
11094923|NCT01197794|12278284|FG000|COMPLETED|Overall Study||148
11094924|NCT01197794|12278285|FG001|COMPLETED|Overall Study||146
11094925|NCT01197794|12278286|FG002|COMPLETED|Overall Study||153
11094926|NCT01197794|12278287|FG003|COMPLETED|Overall Study||152
11094927|NCT01197794|12278288|FG004|COMPLETED|Overall Study||149
11094928|NCT01197794|12278289|FG005|COMPLETED|Overall Study||144
11094929|NCT01197794|12278290|FG006|COMPLETED|Overall Study||142
11094930|NCT01197794|12278284|FG000|NOT COMPLETED|Overall Study||16
11094931|NCT01197794|12278285|FG001|NOT COMPLETED|Overall Study||15
11094932|NCT01197794|12278286|FG002|NOT COMPLETED|Overall Study||13
11094933|NCT01197794|12278287|FG003|NOT COMPLETED|Overall Study||12
11094934|NCT01197794|12278288|FG004|NOT COMPLETED|Overall Study||14
11094935|NCT01197794|12278289|FG005|NOT COMPLETED|Overall Study||19
11094936|NCT01197794|12278290|FG006|NOT COMPLETED|Overall Study||21
11094937|NCT01197833|12278310|FG000|STARTED|Overall Study||38
11094938|NCT01197833|12278311|FG001|STARTED|Overall Study||39
11094939|NCT01197833|12278312|FG002|STARTED|Overall Study||40
11094940|NCT01197833|12278310|FG000|COMPLETED|Overall Study||38
11094941|NCT01197833|12278311|FG001|COMPLETED|Overall Study||39
11094942|NCT01197833|12278312|FG002|COMPLETED|Overall Study||40
11094943|NCT01197833|12278310|FG000|NOT COMPLETED|Overall Study||0
11094944|NCT01197833|12278311|FG001|NOT COMPLETED|Overall Study||0
11094945|NCT01197833|12278312|FG002|NOT COMPLETED|Overall Study||0
11094946|NCT01197898|12278322|FG000|STARTED|Overall Study||5
11094947|NCT01197898|12278323|FG001|STARTED|Overall Study||5
11094948|NCT01197898|12278322|FG000|COMPLETED|Overall Study||5
11094949|NCT01197898|12278323|FG001|COMPLETED|Overall Study||5
11094950|NCT01197898|12278322|FG000|NOT COMPLETED|Overall Study||0
11094951|NCT01197898|12278323|FG001|NOT COMPLETED|Overall Study||0
11094952|NCT01197911|12278332|FG000|STARTED|Overall Study||18
11094953|NCT01197911|12278333|FG001|STARTED|Overall Study||10
11094954|NCT01197911|12278334|FG002|STARTED|Overall Study||10
11094955|NCT01197911|12278332|FG000|COMPLETED|Overall Study||18
11094956|NCT01197911|12278333|FG001|COMPLETED|Overall Study||10
11094957|NCT01197911|12278334|FG002|COMPLETED|Overall Study||9
11094958|NCT01197911|12278332|FG000|NOT COMPLETED|Overall Study||0
11094959|NCT01197911|12278333|FG001|NOT COMPLETED|Overall Study||0
11094960|NCT01197911|12278334|FG002|NOT COMPLETED|Overall Study||1
11094961|NCT01198002|12278346|FG000|STARTED|Treatment Period 1 (Weeks 0-52)||345
11094962|NCT01198002|12278347|FG001|STARTED|Treatment Period 1 (Weeks 0-52)||347
11094963|NCT01198002|12278348|FG002|STARTED|Treatment Period 1 (Weeks 0-52)||349
11094964|NCT01198002|12278346|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
11094965|NCT01198002|12278347|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
11094966|NCT01198002|12278348|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
11094967|NCT01198002|12278346|FG000|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
11094968|NCT01198002|12278347|FG001|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
11094969|NCT01198002|12278348|FG002|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
11094970|NCT01198002|12278346|FG000|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
11094971|NCT01198002|12278347|FG001|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
11094972|NCT01198002|12278348|FG002|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
11094973|NCT01198002|12278346|FG000|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
11094974|NCT01198002|12278347|FG001|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
11094975|NCT01198002|12278348|FG002|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
11094976|NCT01198002|12278346|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
11094977|NCT01198002|12278347|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
11094978|NCT01198002|12278348|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
11094979|NCT01198002|12278346|FG000|STARTED|Treatment Period 2 (Weeks 52-100)||70
11094980|NCT01198002|12278347|FG001|STARTED|Treatment Period 2 (Weeks 52-100)||73
11094981|NCT01198002|12278348|FG002|STARTED|Treatment Period 2 (Weeks 52-100)||80
11094982|NCT01198002|12278346|FG000|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
11094983|NCT01198002|12278347|FG001|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
11094984|NCT01198002|12278348|FG002|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
11094985|NCT01198002|12278346|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
11094986|NCT01198002|12278347|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
11094987|NCT01198002|12278348|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
11094988|NCT01198028|12278378|FG000|STARTED|Overall Study||39
11094989|NCT01198028|12278378|FG000|COMPLETED|Overall Study||29
11094990|NCT01198028|12278378|FG000|NOT COMPLETED|Overall Study||10
11094991|NCT01198132|12278384|FG000|STARTED|Overall Study||63
11094992|NCT01198132|12278385|FG001|STARTED|Overall Study||66
11094993|NCT01198132|12278384|FG000|COMPLETED|Overall Study||45
11094994|NCT01198132|12278385|FG001|COMPLETED|Overall Study||45
11094995|NCT01198132|12278384|FG000|NOT COMPLETED|Overall Study||18
11094996|NCT01198132|12278385|FG001|NOT COMPLETED|Overall Study||21
11094997|NCT01198145|12278395|FG000|STARTED|Overall Study||44
11094998|NCT01198145|12278396|FG001|STARTED|Overall Study||43
11094999|NCT01198145|12278395|FG000|COMPLETED|Overall Study||43
11095000|NCT01198145|12278396|FG001|COMPLETED|Overall Study||42
11095001|NCT01198145|12278395|FG000|NOT COMPLETED|Overall Study||1
11095002|NCT01198145|12278396|FG001|NOT COMPLETED|Overall Study||1
11095003|NCT01198158|12278405|FG000|STARTED|Overall Study||41
11095004|NCT01198158|12278406|FG001|STARTED|Overall Study||36
11095005|NCT01198158|12278405|FG000|COMPLETED|Overall Study||41
11095006|NCT01198158|12278406|FG001|COMPLETED|Overall Study||36
11095007|NCT01198158|12278405|FG000|NOT COMPLETED|Overall Study||0
11095008|NCT01198158|12278406|FG001|NOT COMPLETED|Overall Study||0
11095009|NCT01198275|12278414|FG000|STARTED|Overall Study||100
11095010|NCT01198275|12278415|FG001|STARTED|Overall Study||99
11095011|NCT01198275|12278414|FG000|COMPLETED|Overall Study||94
11095012|NCT01198275|12278415|FG001|COMPLETED|Overall Study||94
11095013|NCT01198275|12278414|FG000|NOT COMPLETED|Overall Study||6
11095014|NCT01198275|12278415|FG001|NOT COMPLETED|Overall Study||5
11095015|NCT01198327|12278421|FG000|STARTED|Overall Study||66
11095016|NCT01198327|12278421|FG000|COMPLETED|Overall Study||56
11095017|NCT01198327|12278421|FG000|NOT COMPLETED|Overall Study||10
11095018|NCT01198366|12278434|FG000|STARTED|Overall Study||52
11095019|NCT01198366|12278435|FG001|STARTED|Overall Study||51
11095020|NCT01198366|12278436|FG002|STARTED|Overall Study||51
11095021|NCT01198366|12278437|FG003|STARTED|Overall Study||52
11095022|NCT01198366|12278438|FG004|STARTED|Overall Study||140
11095023|NCT01198366|12278439|FG005|STARTED|Overall Study||141
11095024|NCT01198366|12278434|FG000|COMPLETED|Overall Study||40
11095025|NCT01198366|12278435|FG001|COMPLETED|Overall Study||44
11095026|NCT01198366|12278436|FG002|COMPLETED|Overall Study||43
11095027|NCT01198366|12278437|FG003|COMPLETED|Overall Study||47
11095028|NCT01198366|12278438|FG004|COMPLETED|Overall Study||125
11095029|NCT01198366|12278439|FG005|COMPLETED|Overall Study||128
11095030|NCT01198366|12278434|FG000|NOT COMPLETED|Overall Study||12
11095031|NCT01198366|12278435|FG001|NOT COMPLETED|Overall Study||7
11095032|NCT01198366|12278436|FG002|NOT COMPLETED|Overall Study||8
11095033|NCT01198366|12278437|FG003|NOT COMPLETED|Overall Study||5
11095034|NCT01198366|12278438|FG004|NOT COMPLETED|Overall Study||15
11095035|NCT01198366|12278439|FG005|NOT COMPLETED|Overall Study||13
11095036|NCT01198470|12278453|FG000|STARTED|Overall Study||20
11095037|NCT01198470|12278453|FG000|COMPLETED|Overall Study||18
11095038|NCT01198470|12278453|FG000|NOT COMPLETED|Overall Study||2
11095039|NCT01198509|12278463|FG000|STARTED|Overall Study||5
11095040|NCT01198509|12278464|FG001|STARTED|Overall Study||10
11095041|NCT01198509|12278465|FG002|STARTED|Overall Study||19
11095042|NCT01198509|12278466|FG003|STARTED|Overall Study||66
11095043|NCT01198509|12278467|FG004|STARTED|Overall Study||20
11095044|NCT01198509|12278468|FG005|STARTED|Overall Study||58
11095045|NCT01198509|12278463|FG000|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
11095046|NCT01198509|12278464|FG001|COMPLETED|Overall Study||10
11095047|NCT01198509|12278465|FG002|COMPLETED|Overall Study||19
11095048|NCT01198509|12278466|FG003|COMPLETED|Overall Study||66
11095049|NCT01198509|12278467|FG004|COMPLETED|Overall Study||20
11095050|NCT01198509|12278468|FG005|COMPLETED|Overall Study||58
11095051|NCT01198509|12278463|FG000|NOT COMPLETED|Overall Study||1
11095052|NCT01198509|12278464|FG001|NOT COMPLETED|Overall Study||0
11095053|NCT01198509|12278465|FG002|NOT COMPLETED|Overall Study||0
11095054|NCT01198509|12278466|FG003|NOT COMPLETED|Overall Study||0
11095055|NCT01198509|12278467|FG004|NOT COMPLETED|Overall Study||0
11095056|NCT01198509|12278468|FG005|NOT COMPLETED|Overall Study||0
11095057|NCT01198574|12278484|FG000|STARTED|Overall Study||98
11095058|NCT01198574|12278485|FG001|STARTED|Overall Study||102
11095059|NCT01198574|12278486|FG002|STARTED|Overall Study||100
11095060|NCT01198574|12278487|FG003|STARTED|Overall Study||102
11095061|NCT01198574|12278484|FG000|COMPLETED|Overall Study||94
11095062|NCT01198574|12278485|FG001|COMPLETED|Overall Study||101
11095063|NCT01198574|12278486|FG002|COMPLETED|Overall Study||99
11095064|NCT01198574|12278487|FG003|COMPLETED|Overall Study||98
11095065|NCT01198574|12278484|FG000|NOT COMPLETED|Overall Study||4
11095066|NCT01198574|12278485|FG001|NOT COMPLETED|Overall Study||1
11095067|NCT01198574|12278486|FG002|NOT COMPLETED|Overall Study||1
11095068|NCT01198574|12278487|FG003|NOT COMPLETED|Overall Study||4
11095069|NCT01198587|12278501|FG000|STARTED|Overall Study||31
11095070|NCT01198587|12278502|FG001|STARTED|Overall Study||5
11095071|NCT01198587|12278503|FG002|STARTED|Overall Study||30
11095072|NCT01198587|12278504|FG003|STARTED|Overall Study||5
11095073|NCT01198587|12278501|FG000|COMPLETED|Overall Study||23
11095074|NCT01198587|12278502|FG001|COMPLETED|Overall Study||5
11095075|NCT01198587|12278503|FG002|COMPLETED|Overall Study||21
11095076|NCT01198587|12278504|FG003|COMPLETED|Overall Study||5
11095077|NCT01198587|12278501|FG000|NOT COMPLETED|Overall Study||8
11095078|NCT01198587|12278502|FG001|NOT COMPLETED|Overall Study||0
11095079|NCT01198587|12278503|FG002|NOT COMPLETED|Overall Study||9
11095080|NCT01198587|12278504|FG003|NOT COMPLETED|Overall Study||0
11095081|NCT01198600|12278519|FG000|STARTED|Phase 1: Period One, 30 Days of Wear||35
11095082|NCT01198600|12278520|FG001|STARTED|Phase 1: Period One, 30 Days of Wear||37
11095083|NCT01198600|12278521|FG002|STARTED|Phase 1: Period One, 30 Days of Wear||0
11095084|NCT01198600|12278522|FG003|STARTED|Phase 1: Period One, 30 Days of Wear||0
11095085|NCT01198600|12278519|FG000|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
11095086|NCT01198600|12278520|FG001|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
11095087|NCT01198600|12278521|FG002|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
11095088|NCT01198600|12278522|FG003|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
11095089|NCT01198600|12278519|FG000|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
11095090|NCT01198600|12278520|FG001|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
11095091|NCT01198600|12278521|FG002|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
11095092|NCT01198600|12278522|FG003|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
11095093|NCT01198600|12278519|FG000|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
11095094|NCT01198600|12278520|FG001|STARTED|Phase 1: Period Two, 30 Days of Wear||36
11095095|NCT01198600|12278521|FG002|STARTED|Phase 1: Period Two, 30 Days of Wear||0
11095096|NCT01198600|12278522|FG003|STARTED|Phase 1: Period Two, 30 Days of Wear||0
11095097|NCT01198600|12278519|FG000|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
11095098|NCT01198600|12278520|FG001|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
11095099|NCT01198600|12278521|FG002|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
11095100|NCT01198600|12278522|FG003|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
11095101|NCT01198600|12278519|FG000|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
11095102|NCT01198600|12278520|FG001|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
11095103|NCT01198600|12278521|FG002|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
11095104|NCT01198600|12278522|FG003|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
11095105|NCT01198600|12278519|FG000|STARTED|Phase 2: 56 Days of Wear||0
11095106|NCT01198600|12278520|FG001|STARTED|Phase 2: 56 Days of Wear||0
11095107|NCT01198600|12278521|FG002|STARTED|Phase 2: 56 Days of Wear||67
11095108|NCT01198600|12278522|FG003|STARTED|Phase 2: 56 Days of Wear||0
11095109|NCT01198600|12278519|FG000|COMPLETED|Phase 2: 56 Days of Wear||0
11095110|NCT01198600|12278520|FG001|COMPLETED|Phase 2: 56 Days of Wear||0
11095111|NCT01198600|12278521|FG002|COMPLETED|Phase 2: 56 Days of Wear||62
11095112|NCT01198600|12278522|FG003|COMPLETED|Phase 2: 56 Days of Wear||0
11095113|NCT01198600|12278519|FG000|NOT COMPLETED|Phase 2: 56 Days of Wear||0
11095114|NCT01198600|12278520|FG001|NOT COMPLETED|Phase 2: 56 Days of Wear||0
11095115|NCT01198600|12278521|FG002|NOT COMPLETED|Phase 2: 56 Days of Wear||5
11095116|NCT01198600|12278522|FG003|NOT COMPLETED|Phase 2: 56 Days of Wear||0
11095117|NCT01198600|12278519|FG000|STARTED|Phase 3: 43 Days of Wear||0
11095118|NCT01198600|12278520|FG001|STARTED|Phase 3: 43 Days of Wear||0
11095119|NCT01198600|12278521|FG002|STARTED|Phase 3: 43 Days of Wear||0
11095120|NCT01198600|12278522|FG003|STARTED|Phase 3: 43 Days of Wear||38
11095121|NCT01198600|12278519|FG000|COMPLETED|Phase 3: 43 Days of Wear||0
11095122|NCT01198600|12278520|FG001|COMPLETED|Phase 3: 43 Days of Wear||0
11095123|NCT01198600|12278521|FG002|COMPLETED|Phase 3: 43 Days of Wear||0
11095124|NCT01198600|12278522|FG003|COMPLETED|Phase 3: 43 Days of Wear||38
11095125|NCT01198600|12278519|FG000|NOT COMPLETED|Phase 3: 43 Days of Wear||0
11095126|NCT01198600|12278520|FG001|NOT COMPLETED|Phase 3: 43 Days of Wear||0
11095127|NCT01198600|12278521|FG002|NOT COMPLETED|Phase 3: 43 Days of Wear||0
11095128|NCT01198600|12278522|FG003|NOT COMPLETED|Phase 3: 43 Days of Wear||0
11352200|NCT03044353|12549342|FG000|COMPLETED|Overall Study||6
11352201|NCT03044353|12549343|FG001|COMPLETED|Overall Study||0
11352202|NCT03044353|12549344|FG002|COMPLETED|Overall Study||0
11352203|NCT03044353|12549342|FG000|NOT COMPLETED|Overall Study||0
11352204|NCT03044353|12549343|FG001|NOT COMPLETED|Overall Study||1
11352205|NCT03044353|12549344|FG002|NOT COMPLETED|Overall Study||0
11352206|NCT03044418|12549351|FG000|STARTED|Overall Study||30
11352207|NCT03044418|12549351|FG000|COMPLETED|Overall Study||30
11352208|NCT03044418|12549351|FG000|NOT COMPLETED|Overall Study||0
11352209|NCT03044431|12549355|FG000|STARTED|Overall Study||207
11352210|NCT03044431|12549355|FG000|COMPLETED|Overall Study||148
11352211|NCT03044431|12549355|FG000|NOT COMPLETED|Overall Study||59
11352212|NCT03044574|12549361|FG000|STARTED|Overall Study||204
11352213|NCT03044574|12549362|FG001|STARTED|Overall Study||203
11352214|NCT03044574|12549361|FG000|Inpatient Period|Overall Study||204
11352215|NCT03044574|12549362|FG001|Inpatient Period|Overall Study||203
11352216|NCT03044574|12549361|FG000|30 Days After Surgery|Overall Study||193
11352217|NCT03044574|12549362|FG001|30 Days After Surgery|Overall Study||194
11352218|NCT03044574|12549361|FG000|180 Days After Surgery|Overall Study||167
11352219|NCT03044574|12549362|FG001|180 Days After Surgery|Overall Study||158
11352220|NCT03044574|12549361|FG000|COMPLETED|Overall Study||167
11352221|NCT03044574|12549362|FG001|COMPLETED|Overall Study||158
11352222|NCT03044574|12549361|FG000|NOT COMPLETED|Overall Study||37
11095129|NCT01198691|12278532|FG000|STARTED|Completed Surgery -Received Intervention||50
11352223|NCT03044574|12549362|FG001|NOT COMPLETED|Overall Study||45
11352224|NCT03044691|12549370|FG000|STARTED|Overall Study||0
11352225|NCT03044691|12549371|FG001|STARTED|Overall Study||84
11095130|NCT01198691|12278533|FG001|STARTED|Completed Surgery -Received Intervention||50
11095131|NCT01198691|12278532|FG000|COMPLETED|Completed Surgery -Received Intervention||50
11095132|NCT01198691|12278533|FG001|COMPLETED|Completed Surgery -Received Intervention||50
11095133|NCT01198691|12278532|FG000|NOT COMPLETED|Completed Surgery -Received Intervention||0
11095134|NCT01198691|12278533|FG001|NOT COMPLETED|Completed Surgery -Received Intervention||0
11095135|NCT01198691|12278532|FG000|STARTED|Completed VAS Score Postop Day 1||50
11095136|NCT01198691|12278533|FG001|STARTED|Completed VAS Score Postop Day 1||50
11095137|NCT01198691|12278532|FG000|COMPLETED|Completed VAS Score Postop Day 1||47
11095138|NCT01198691|12278533|FG001|COMPLETED|Completed VAS Score Postop Day 1||46
11095139|NCT01198691|12278532|FG000|NOT COMPLETED|Completed VAS Score Postop Day 1||3
11095140|NCT01198691|12278533|FG001|NOT COMPLETED|Completed VAS Score Postop Day 1||4
11095141|NCT01198691|12278532|FG000|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
11095142|NCT01198691|12278533|FG001|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
11095143|NCT01198691|12278532|FG000|COMPLETED|Completed VAS Score at Discharge||45
11095144|NCT01198691|12278533|FG001|COMPLETED|Completed VAS Score at Discharge||44
11095145|NCT01198691|12278532|FG000|NOT COMPLETED|Completed VAS Score at Discharge||5
11095146|NCT01198691|12278533|FG001|NOT COMPLETED|Completed VAS Score at Discharge||6
11095147|NCT01198691|12278532|FG000|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
11095148|NCT01198691|12278533|FG001|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
11095149|NCT01198691|12278532|FG000|COMPLETED|Survey Prior to Discharge||18
11095150|NCT01198691|12278533|FG001|COMPLETED|Survey Prior to Discharge||17
11095151|NCT01198691|12278532|FG000|NOT COMPLETED|Survey Prior to Discharge||32
11095152|NCT01198691|12278533|FG001|NOT COMPLETED|Survey Prior to Discharge||33
11095153|NCT01198691|12278532|FG000|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
11095154|NCT01198691|12278533|FG001|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
11095155|NCT01198691|12278532|FG000|COMPLETED|6 Week Post-partum Survey||21
11095156|NCT01198691|12278533|FG001|COMPLETED|6 Week Post-partum Survey||26
11095157|NCT01198691|12278532|FG000|NOT COMPLETED|6 Week Post-partum Survey||29
11095158|NCT01198691|12278533|FG001|NOT COMPLETED|6 Week Post-partum Survey||24
11095159|NCT01198756|12278543|FG000|STARTED|Overall Study||932
11095160|NCT01198756|12278544|FG001|STARTED|Overall Study||929
11095161|NCT01198756|12278545|FG002|STARTED|Overall Study||932
11095162|NCT01198756|12278546|FG003|STARTED|Overall Study||301
11095163|NCT01198756|12278543|FG000|COMPLETED|Overall Study||894
11095164|NCT01198756|12278544|FG001|COMPLETED|Overall Study||889
11095165|NCT01198756|12278545|FG002|COMPLETED|Overall Study||902
11095166|NCT01198756|12278546|FG003|COMPLETED|Overall Study||275
11095167|NCT01198756|12278543|FG000|NOT COMPLETED|Overall Study||38
11095168|NCT01198756|12278544|FG001|NOT COMPLETED|Overall Study||40
11095169|NCT01198756|12278545|FG002|NOT COMPLETED|Overall Study||30
11095170|NCT01198756|12278546|FG003|NOT COMPLETED|Overall Study||26
11095171|NCT01198769|12278563|FG000|STARTED|Overall Study||15
11095172|NCT01198769|12278563|FG000|COMPLETED|Overall Study||15
11095173|NCT01198769|12278563|FG000|NOT COMPLETED|Overall Study||0
11095174|NCT01198795|12278567|FG000|STARTED|Overall Study||162
11095175|NCT01198795|12278567|FG000|COMPLETED|Overall Study||80
11095176|NCT01198795|12278567|FG000|NOT COMPLETED|Overall Study||82
11095177|NCT01198873|12278573|FG000|STARTED|Overall Study||41
11095178|NCT01198873|12278574|FG001|STARTED|Overall Study||35
11095179|NCT01198873|12278573|FG000|Treated|Overall Study||41
11095180|NCT01198873|12278574|FG001|Treated|Overall Study||35
11095181|NCT01198873|12278573|FG000|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
11095182|NCT01198873|12278574|FG001|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
11095183|NCT01198873|12278573|FG000|COMPLETED|Overall Study||4
11095184|NCT01198873|12278574|FG001|COMPLETED|Overall Study||3
11095185|NCT01198873|12278573|FG000|NOT COMPLETED|Overall Study||37
11095186|NCT01198873|12278574|FG001|NOT COMPLETED|Overall Study||32
11095187|NCT01198977|12278582|FG000|STARTED|Overall Study||31
11095188|NCT01198977|12278583|FG001|STARTED|Overall Study||33
11095189|NCT01198977|12278582|FG000|COMPLETED|Overall Study||30
11095190|NCT01198977|12278583|FG001|COMPLETED|Overall Study||33
11095191|NCT01198977|12278582|FG000|NOT COMPLETED|Overall Study||1
11095192|NCT01198977|12278583|FG001|NOT COMPLETED|Overall Study||0
11095193|NCT01199016|12278591|FG000|STARTED|Overall Study||239
11095194|NCT01199016|12278591|FG000|Treated|Overall Study||236
11095195|NCT01199016|12278591|FG000|COMPLETED|Overall Study||162
11095196|NCT01199016|12278591|FG000|NOT COMPLETED|Overall Study||77
11095197|NCT01199042|12278595|FG000|STARTED|Sleep Laboratory (3 Nights)||29
11095198|NCT01199042|12278595|FG000|COMPLETED|Sleep Laboratory (3 Nights)||27
11095199|NCT01199042|12278595|FG000|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
11095200|NCT01199042|12278595|FG000|STARTED|At Home (3 Months)||27
11095201|NCT01199042|12278595|FG000|COMPLETED|At Home (3 Months)||26
11095202|NCT01199042|12278595|FG000|NOT COMPLETED|At Home (3 Months)||1
11095203|NCT01199055|12278607|FG000|STARTED|Overall Study||3
11095204|NCT01199055|12278608|FG001|STARTED|Overall Study||4
11095205|NCT01199055|12278609|FG002|STARTED|Overall Study||9
11095206|NCT01199055|12278607|FG000|COMPLETED|Overall Study||1
11095207|NCT01199055|12278608|FG001|COMPLETED|Overall Study||1
11095208|NCT01199055|12278609|FG002|COMPLETED|Overall Study||5
11095209|NCT01199055|12278607|FG000|NOT COMPLETED|Overall Study||2
11095210|NCT01199055|12278608|FG001|NOT COMPLETED|Overall Study||3
11095211|NCT01199055|12278609|FG002|NOT COMPLETED|Overall Study||4
11095212|NCT01199068|12278622|FG000|STARTED|Overall Study||3
11095213|NCT01199068|12278623|FG001|STARTED|Overall Study||3
11095214|NCT01199068|12278624|FG002|STARTED|Overall Study||9
11095215|NCT01199068|12278622|FG000|Received Treatment|Overall Study||3
11095216|NCT01199068|12278623|FG001|Received Treatment|Overall Study||3
11095217|NCT01199068|12278624|FG002|Received Treatment|Overall Study||8
11095218|NCT01199068|12278622|FG000|COMPLETED|Overall Study||0
11095219|NCT01199068|12278623|FG001|COMPLETED|Overall Study||0
11095220|NCT01199068|12278624|FG002|COMPLETED|Overall Study||0
11095221|NCT01199068|12278622|FG000|NOT COMPLETED|Overall Study||3
11095222|NCT01199068|12278623|FG001|NOT COMPLETED|Overall Study||3
11095223|NCT01199068|12278624|FG002|NOT COMPLETED|Overall Study||9
11095224|NCT01199146|12278639|FG000|STARTED|Overall Study||42
11095225|NCT01199146|12278639|FG000|COMPLETED|Overall Study||39
11095226|NCT01199146|12278639|FG000|NOT COMPLETED|Overall Study||3
11095227|NCT01199198|12278645|FG000|STARTED|Overall Study||24
11095228|NCT01199198|12278646|FG001|STARTED|Overall Study||24
11095229|NCT01199198|12278645|FG000|COMPLETED|Overall Study||17
11095230|NCT01199198|12278646|FG001|COMPLETED|Overall Study||13
11095231|NCT01199198|12278645|FG000|NOT COMPLETED|Overall Study||7
11095232|NCT01199198|12278646|FG001|NOT COMPLETED|Overall Study||11
11095233|NCT01199237|12278654|FG000|STARTED|Overall Study||41
11095234|NCT01199237|12278655|FG001|STARTED|Overall Study||40
11095235|NCT01199237|12278654|FG000|COMPLETED|Overall Study||41
11095236|NCT01199237|12278655|FG001|COMPLETED|Overall Study||40
11095237|NCT01199237|12278654|FG000|NOT COMPLETED|Overall Study||0
11095238|NCT01199237|12278655|FG001|NOT COMPLETED|Overall Study||0
11095239|NCT01199263|12278665|FG000|STARTED|Overall Study||54
11095240|NCT01199263|12278666|FG001|STARTED|Overall Study||54
11095241|NCT01199263|12278665|FG000|COMPLETED|Overall Study||48
11095242|NCT01199263|12278666|FG001|COMPLETED|Overall Study||52
11095243|NCT01199263|12278665|FG000|NOT COMPLETED|Overall Study||6
11095244|NCT01199263|12278666|FG001|NOT COMPLETED|Overall Study||2
11095245|NCT01199289|12278678|FG000|STARTED|Overall Study||77
11095246|NCT01199289|12278679|FG001|STARTED|Overall Study||75
11095247|NCT01199289|12278680|FG002|STARTED|Overall Study||76
11095248|NCT01199289|12278681|FG003|STARTED|Overall Study||77
11095249|NCT01199289|12278678|FG000|Participants Who Received Study Treatment|Overall Study||76
11095250|NCT01199289|12278679|FG001|Participants Who Received Study Treatment|Overall Study||74
11095251|NCT01199289|12278680|FG002|Participants Who Received Study Treatment|Overall Study||76
11095252|NCT01199289|12278681|FG003|Participants Who Received Study Treatment|Overall Study||76
11095253|NCT01199289|12278678|FG000|COMPLETED|Overall Study||68
11095254|NCT01199289|12278679|FG001|COMPLETED|Overall Study||68
11095255|NCT01199289|12278680|FG002|COMPLETED|Overall Study||71
11095256|NCT01199289|12278681|FG003|COMPLETED|Overall Study||65
11095257|NCT01199289|12278678|FG000|NOT COMPLETED|Overall Study||9
11095258|NCT01199289|12278679|FG001|NOT COMPLETED|Overall Study||7
11095259|NCT01199289|12278680|FG002|NOT COMPLETED|Overall Study||5
11095260|NCT01199289|12278681|FG003|NOT COMPLETED|Overall Study||12
11095261|NCT01199471|12278694|FG000|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
11095262|NCT01199471|12278694|FG000|COMPLETED|Overall Study||3994
11095263|NCT01199471|12278694|FG000|NOT COMPLETED|Overall Study||6
11095264|NCT01199575|12278699|FG000|STARTED|Overall Study||30
11095265|NCT01199575|12278699|FG000|COMPLETED|Overall Study||25
11095266|NCT01199575|12278699|FG000|NOT COMPLETED|Overall Study||5
11095267|NCT01199601|12278706|FG000|STARTED|Overall Study|Control Group|422
11095268|NCT01199601|12278707|FG001|STARTED|Overall Study|Intervention Group|422
11095269|NCT01199601|12278706|FG000|COMPLETED|Overall Study||353
11095270|NCT01199601|12278707|FG001|COMPLETED|Overall Study||344
11095271|NCT01199601|12278706|FG000|NOT COMPLETED|Overall Study||69
11095272|NCT01199601|12278707|FG001|NOT COMPLETED|Overall Study||78
11095273|NCT01199705|12278713|FG000|STARTED|IVIG Treatment||25
11095274|NCT01199705|12278713|FG000|COMPLETED|IVIG Treatment||25
11095275|NCT01199705|12278713|FG000|NOT COMPLETED|IVIG Treatment||0
11095276|NCT01199705|12278713|FG000|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
11095277|NCT01199705|12278713|FG000|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
11095278|NCT01199705|12278713|FG000|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
11095279|NCT01199705|12278713|FG000|STARTED|SCIG Treatment (Efficacy)||24
11095280|NCT01199705|12278713|FG000|COMPLETED|SCIG Treatment (Efficacy)||24
11095281|NCT01199705|12278713|FG000|NOT COMPLETED|SCIG Treatment (Efficacy)||0
11095282|NCT01199731|12278731|FG000|STARTED|Overall Study||9
11095283|NCT01199731|12278732|FG001|STARTED|Overall Study||11
11095284|NCT01199731|12278733|FG002|STARTED|Overall Study||10
11095285|NCT01199731|12278731|FG000|COMPLETED|Overall Study||0
11095286|NCT01199731|12278732|FG001|COMPLETED|Overall Study||0
11095287|NCT01199731|12278733|FG002|COMPLETED|Overall Study||0
11095288|NCT01199731|12278731|FG000|NOT COMPLETED|Overall Study||9
11095289|NCT01199731|12278732|FG001|NOT COMPLETED|Overall Study||11
11095290|NCT01199731|12278733|FG002|NOT COMPLETED|Overall Study||10
11095291|NCT01199744|12278741|FG000|STARTED|Overall Study||1575
11095292|NCT01199744|12278741|FG000|COMPLETED|Overall Study||1575
11095293|NCT01199744|12278741|FG000|NOT COMPLETED|Overall Study||0
11095294|NCT01199822|12278748|FG000|STARTED|Overall Study||3
11095295|NCT01199822|12278749|FG001|STARTED|Overall Study||7
11095296|NCT01199822|12278750|FG002|STARTED|Overall Study||6
11095297|NCT01199822|12278748|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11095298|NCT01199822|12278749|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
11095299|NCT01199822|12278750|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11095300|NCT01199822|12278748|FG000|COMPLETED|Overall Study||3
11095301|NCT01199822|12278749|FG001|COMPLETED|Overall Study||6
11095302|NCT01199822|12278750|FG002|COMPLETED|Overall Study||6
11095303|NCT01199822|12278748|FG000|NOT COMPLETED|Overall Study||0
11095304|NCT01199822|12278749|FG001|NOT COMPLETED|Overall Study||1
11095305|NCT01199822|12278750|FG002|NOT COMPLETED|Overall Study||0
11095306|NCT01199848|12278765|FG000|STARTED|Placebo Arm||29
11095307|NCT01199848|12278765|FG000|COMPLETED|Placebo Arm||21
11095308|NCT01199848|12278765|FG000|NOT COMPLETED|Placebo Arm||8
11095309|NCT01199848|12278765|FG000|STARTED|10g STR Arm||21
11095310|NCT01199848|12278765|FG000|COMPLETED|10g STR Arm||21
11095311|NCT01199848|12278765|FG000|NOT COMPLETED|10g STR Arm||0
11095312|NCT01199848|12278765|FG000|STARTED|20G STRB Arm||21
11095313|NCT01199848|12278765|FG000|COMPLETED|20G STRB Arm||21
11095314|NCT01199848|12278765|FG000|NOT COMPLETED|20G STRB Arm||0
11095315|NCT01199848|12278765|FG000|STARTED|40G STRB Arm||21
11352226|NCT03044691|12549370|FG000|COMPLETED|Overall Study||0
11352227|NCT03044691|12549371|FG001|COMPLETED|Overall Study||84
11352228|NCT03044691|12549370|FG000|NOT COMPLETED|Overall Study||0
11352229|NCT03044691|12549371|FG001|NOT COMPLETED|Overall Study||0
11352230|NCT03044730|12549377|FG000|STARTED|3 Cycles of Pembro + Capecitab||30
11352231|NCT03044730|12549377|FG000|Attempted Cycle 1|3 Cycles of Pembro + Capecitab||30
11352232|NCT03044730|12549377|FG000|Attempted Cycle 2|3 Cycles of Pembro + Capecitab||28
11352233|NCT03044730|12549377|FG000|Attempted Cycle 3|3 Cycles of Pembro + Capecitab||26
11352234|NCT03044730|12549377|FG000|COMPLETED|3 Cycles of Pembro + Capecitab||26
11352235|NCT03044730|12549377|FG000|NOT COMPLETED|3 Cycles of Pembro + Capecitab||4
11352236|NCT03044730|12549377|FG000|STARTED|Cycles 4 and Beyond||26
11352237|NCT03044730|12549377|FG000|Assessed for Cycle 4|Cycles 4 and Beyond||26
11352238|NCT03044730|12549377|FG000|Started Cycle 4|Cycles 4 and Beyond||20
11352239|NCT03044730|12549377|FG000|Went on to Cycle 5 and Beyond|Cycles 4 and Beyond||16
11352240|NCT03044730|12549377|FG000|COMPLETED|Cycles 4 and Beyond||16
11352241|NCT03044730|12549377|FG000|NOT COMPLETED|Cycles 4 and Beyond||10
11352242|NCT03044730|12549377|FG000|STARTED|On Follow-up for 2 Years||29
11352243|NCT03044730|12549377|FG000|COMPLETED|On Follow-up for 2 Years||4
11352244|NCT03044730|12549377|FG000|NOT COMPLETED|On Follow-up for 2 Years||25
11352245|NCT03044886|12549385|FG000|STARTED|Overall Study||120
11352246|NCT03044886|12549386|FG001|STARTED|Overall Study||120
11352247|NCT03044886|12549387|FG002|STARTED|Overall Study||120
11352248|NCT03044886|12549385|FG000|COMPLETED|Overall Study||105
11352249|NCT03044886|12549386|FG001|COMPLETED|Overall Study||110
11352250|NCT03044886|12549387|FG002|COMPLETED|Overall Study||108
11352251|NCT03044886|12549385|FG000|NOT COMPLETED|Overall Study||15
11352252|NCT03044886|12549386|FG001|NOT COMPLETED|Overall Study||10
11352253|NCT03044886|12549387|FG002|NOT COMPLETED|Overall Study||12
11095316|NCT01199848|12278765|FG000|COMPLETED|40G STRB Arm||21
11352254|NCT03045081|12549397|FG000|STARTED|Overall Study||51
11352255|NCT03045081|12549398|FG001|STARTED|Overall Study||48
11352256|NCT03045081|12549397|FG000|COMPLETED|Overall Study||45
11352257|NCT03045081|12549398|FG001|COMPLETED|Overall Study||37
11352258|NCT03045081|12549397|FG000|NOT COMPLETED|Overall Study||6
11352259|NCT03045081|12549398|FG001|NOT COMPLETED|Overall Study||11
11352260|NCT03045302|12549404|FG000|STARTED|Overall Study||4
11352261|NCT03045302|12549404|FG000|COMPLETED|Overall Study||3
11352262|NCT03045302|12549404|FG000|NOT COMPLETED|Overall Study||1
11352263|NCT03045328|12549408|FG000|STARTED|Overall Study||22
11352264|NCT03045328|12549408|FG000|COMPLETED|Overall Study||20
11352265|NCT03045328|12549408|FG000|NOT COMPLETED|Overall Study||2
11095317|NCT01199848|12278765|FG000|NOT COMPLETED|40G STRB Arm||0
11095318|NCT01199861|12278777|FG000|STARTED|Overall Study||95
11095319|NCT01199861|12278778|FG001|STARTED|Overall Study||43
11095320|NCT01199861|12278777|FG000|COMPLETED|Overall Study||93
11095321|NCT01199861|12278778|FG001|COMPLETED|Overall Study||43
11095322|NCT01199861|12278777|FG000|NOT COMPLETED|Overall Study||2
11095323|NCT01199861|12278778|FG001|NOT COMPLETED|Overall Study||0
11095324|NCT01199926|12278786|FG000|STARTED|Overall Study||17
11095325|NCT01199926|12278787|FG001|STARTED|Overall Study||17
11095326|NCT01199926|12278786|FG000|COMPLETED|Overall Study||10
11095327|NCT01199926|12278787|FG001|COMPLETED|Overall Study||13
11095328|NCT01199926|12278786|FG000|NOT COMPLETED|Overall Study||7
11095329|NCT01199926|12278787|FG001|NOT COMPLETED|Overall Study||4
11095330|NCT01199939|12278793|FG000|STARTED|Overall Study|Number of enrolled participants|54
11095331|NCT01199939|12278793|FG000|COMPLETED|Overall Study||41
11095332|NCT01199939|12278793|FG000|NOT COMPLETED|Overall Study||13
11095333|NCT01199952|12278799|FG000|STARTED|Overall Study||103
11095334|NCT01199952|12278800|FG001|STARTED|Overall Study||104
11095335|NCT01199952|12278799|FG000|COMPLETED|Overall Study||51
11095336|NCT01199952|12278800|FG001|COMPLETED|Overall Study||59
11095337|NCT01199952|12278799|FG000|NOT COMPLETED|Overall Study||52
11095338|NCT01199952|12278800|FG001|NOT COMPLETED|Overall Study||45
11095339|NCT01199965|12278809|FG000|STARTED|Overall Study||23
11095340|NCT01199965|12278810|FG001|STARTED|Overall Study||24
11095341|NCT01199965|12278809|FG000|COMPLETED|Overall Study||22
11095342|NCT01199965|12278810|FG001|COMPLETED|Overall Study||24
11095343|NCT01199965|12278809|FG000|NOT COMPLETED|Overall Study||1
11095344|NCT01199965|12278810|FG001|NOT COMPLETED|Overall Study||0
11095345|NCT01200030|12278827|FG000|STARTED|Overall Study||12
11095346|NCT01200030|12278828|FG001|STARTED|Overall Study||13
11095347|NCT01200030|12278829|FG002|STARTED|Overall Study||12
11095348|NCT01200030|12278827|FG000|COMPLETED|Overall Study||12
11095349|NCT01200030|12278828|FG001|COMPLETED|Overall Study||13
11095350|NCT01200030|12278829|FG002|COMPLETED|Overall Study||12
11095351|NCT01200030|12278827|FG000|NOT COMPLETED|Overall Study||0
11095352|NCT01200030|12278828|FG001|NOT COMPLETED|Overall Study||0
11095353|NCT01200030|12278829|FG002|NOT COMPLETED|Overall Study||0
11095354|NCT01200069|12278839|FG000|STARTED|Overall Study||8
11095355|NCT01200069|12278840|FG001|STARTED|Overall Study||6
11095356|NCT01200069|12278839|FG000|COMPLETED|Overall Study||8
11095357|NCT01200069|12278840|FG001|COMPLETED|Overall Study||5
11095358|NCT01200069|12278839|FG000|NOT COMPLETED|Overall Study||0
11095359|NCT01200069|12278840|FG001|NOT COMPLETED|Overall Study||1
11095360|NCT01200160|12278889|FG000|STARTED|Overall Study||128
11095361|NCT01200160|12278889|FG000|COMPLETED|Overall Study||66
11095362|NCT01200160|12278889|FG000|NOT COMPLETED|Overall Study||62
11095363|NCT01200238|12278895|FG000|STARTED|Overall Study||7
11095364|NCT01200238|12278896|FG001|STARTED|Overall Study||10
11095365|NCT01200238|12278895|FG000|COMPLETED|Overall Study||0
11095366|NCT01200238|12278896|FG001|COMPLETED|Overall Study||0
11095367|NCT01200238|12278895|FG000|NOT COMPLETED|Overall Study||7
11095368|NCT01200238|12278896|FG001|NOT COMPLETED|Overall Study||10
11095369|NCT01200290|12278902|FG000|STARTED|Treatment Period||18
11095370|NCT01200290|12278902|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||18
11095371|NCT01200290|12278902|FG000|COMPLETED|Treatment Period||17
11095372|NCT01200290|12278902|FG000|NOT COMPLETED|Treatment Period||1
11095373|NCT01200290|12278902|FG000|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
11095374|NCT01200290|12278902|FG000|COMPLETED|Post-Treatment Follow-Up Period||16
11095375|NCT01200290|12278902|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2
11095376|NCT01200329|12278906|FG000|STARTED|Overall Study||81
11095377|NCT01200329|12278906|FG000|COMPLETED|Overall Study||78
11095378|NCT01200329|12278906|FG000|NOT COMPLETED|Overall Study||3
11095379|NCT01200342|12278910|FG000|STARTED|Overall Study||7
11095380|NCT01200342|12278910|FG000|COMPLETED|Overall Study||6
11095381|NCT01200342|12278910|FG000|NOT COMPLETED|Overall Study||1
11095382|NCT01200355|12278916|FG000|STARTED|Overall Study||58
11095383|NCT01200355|12278917|FG001|STARTED|Overall Study||55
11095384|NCT01200355|12278916|FG000|COMPLETED|Overall Study||51
11095385|NCT01200355|12278917|FG001|COMPLETED|Overall Study||53
11095386|NCT01200355|12278916|FG000|NOT COMPLETED|Overall Study||7
11095387|NCT01200355|12278917|FG001|NOT COMPLETED|Overall Study||2
11095388|NCT01200368|12278926|FG000|STARTED|Infant Series||183
11095389|NCT01200368|12278927|FG001|STARTED|Infant Series||184
11095390|NCT01200368|12278928|FG002|STARTED|Infant Series||184
11095391|NCT01200368|12278926|FG000|Vaccinated Dose 1|Infant Series||183
11095392|NCT01200368|12278927|FG001|Vaccinated Dose 1|Infant Series||183
11095393|NCT01200368|12278928|FG002|Vaccinated Dose 1|Infant Series||183
11095394|NCT01200368|12278926|FG000|Vaccinated Dose 2|Infant Series||183
11095395|NCT01200368|12278927|FG001|Vaccinated Dose 2|Infant Series||182
11095396|NCT01200368|12278928|FG002|Vaccinated Dose 2|Infant Series||183
11095397|NCT01200368|12278926|FG000|Vaccinated Dose 3|Infant Series||181
11095398|NCT01200368|12278927|FG001|Vaccinated Dose 3|Infant Series||178
11095399|NCT01200368|12278928|FG002|Vaccinated Dose 3|Infant Series||182
11095400|NCT01200368|12278926|FG000|COMPLETED|Infant Series||180
11095401|NCT01200368|12278927|FG001|COMPLETED|Infant Series||178
11095402|NCT01200368|12278928|FG002|COMPLETED|Infant Series||178
11095403|NCT01200368|12278926|FG000|NOT COMPLETED|Infant Series||3
11095404|NCT01200368|12278927|FG001|NOT COMPLETED|Infant Series||6
11095405|NCT01200368|12278928|FG002|NOT COMPLETED|Infant Series||6
11095406|NCT01200368|12278926|FG000|STARTED|After Infant Series||180
11095407|NCT01200368|12278927|FG001|STARTED|After Infant Series||178
11095408|NCT01200368|12278928|FG002|STARTED|After Infant Series||178
11095409|NCT01200368|12278926|FG000|COMPLETED|After Infant Series||162
11095410|NCT01200368|12278927|FG001|COMPLETED|After Infant Series||162
11095411|NCT01200368|12278928|FG002|COMPLETED|After Infant Series||169
11095412|NCT01200368|12278926|FG000|NOT COMPLETED|After Infant Series||18
11095413|NCT01200368|12278927|FG001|NOT COMPLETED|After Infant Series||16
11095414|NCT01200368|12278928|FG002|NOT COMPLETED|After Infant Series||9
11095415|NCT01200368|12278926|FG000|STARTED|Toddler Dose||162
11095416|NCT01200368|12278927|FG001|STARTED|Toddler Dose||162
11095417|NCT01200368|12278928|FG002|STARTED|Toddler Dose||169
11095418|NCT01200368|12278926|FG000|COMPLETED|Toddler Dose||162
11095419|NCT01200368|12278927|FG001|COMPLETED|Toddler Dose||159
11095420|NCT01200368|12278928|FG002|COMPLETED|Toddler Dose||168
11095421|NCT01200368|12278926|FG000|NOT COMPLETED|Toddler Dose||0
11095422|NCT01200368|12278927|FG001|NOT COMPLETED|Toddler Dose||3
11095423|NCT01200368|12278928|FG002|NOT COMPLETED|Toddler Dose||1
11095424|NCT01200394|12278945|FG000|STARTED|Overall Study||64
11095425|NCT01200394|12278946|FG001|STARTED|Overall Study||192
11352266|NCT03045809|12549412|FG000|STARTED|Overall Study||705
11352267|NCT03045809|12549412|FG000|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51
11352268|NCT03045809|12549412|FG000|COMPLETED|Overall Study||705
11352269|NCT03045809|12549412|FG000|NOT COMPLETED|Overall Study||0
11352270|NCT03045861|12549422|FG000|STARTED|Part A (Up to 10 Days)||0
11352271|NCT03045861|12549423|FG001|STARTED|Part A (Up to 10 Days)||0
11352272|NCT03045861|12549424|FG002|STARTED|Part A (Up to 10 Days)||10
11352273|NCT03045861|12549425|FG003|STARTED|Part A (Up to 10 Days)||0
11352274|NCT03045861|12549422|FG000|COMPLETED|Part A (Up to 10 Days)||0
11352275|NCT03045861|12549423|FG001|COMPLETED|Part A (Up to 10 Days)||0
11095426|NCT01200394|12278945|FG000|COMPLETED|Overall Study||62
11095427|NCT01200394|12278946|FG001|COMPLETED|Overall Study||164
11095428|NCT01200394|12278945|FG000|NOT COMPLETED|Overall Study||2
11095429|NCT01200394|12278946|FG001|NOT COMPLETED|Overall Study||28
11095430|NCT01200407|12278953|FG000|STARTED|Overall Study||615
11095431|NCT01200407|12278953|FG000|COMPLETED|Overall Study||533
11095432|NCT01200407|12278953|FG000|NOT COMPLETED|Overall Study||82
11095433|NCT01200433|12278959|FG000|STARTED|Overall Study||21
11095434|NCT01200433|12278960|FG001|STARTED|Overall Study||23
11095435|NCT01200433|12278959|FG000|COMPLETED|Overall Study||21
11095436|NCT01200433|12278960|FG001|COMPLETED|Overall Study||23
11095437|NCT01200433|12278959|FG000|NOT COMPLETED|Overall Study||0
11095438|NCT01200433|12278960|FG001|NOT COMPLETED|Overall Study||0
11095439|NCT01200485|12278966|FG000|STARTED|Cycle 1: Rasburicase Alone Delivery|Of 55 participants screened, only 52 treated.|55
11095440|NCT01200485|12278967|FG001|STARTED|Cycle 1: Rasburicase Alone Delivery||0
11095441|NCT01200485|12278968|FG002|STARTED|Cycle 1: Rasburicase Alone Delivery||0
11095442|NCT01200485|12278966|FG000|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52
11095443|NCT01200485|12278967|FG001|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
11095444|NCT01200485|12278968|FG002|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
11208293|NCT02876835|12399508|FG001|COMPLETED|Treatment Period (51.1 Month)||1870
11095445|NCT01200485|12278966|FG000|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3
11095446|NCT01200485|12278967|FG001|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
11095447|NCT01200485|12278968|FG002|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
11095448|NCT01200485|12278966|FG000|STARTED|Cycle 2: Randomization|Of 55 enrolled on study, 52 participants were treated in Cycle 1, only 46 randomized to Cycle 2|0
11095449|NCT01200485|12278967|FG001|STARTED|Cycle 2: Randomization|Six not randomized: Methemoglobinemia-1, Kidney failure-2, Chemotherapy changed-2, Not evaluable-1|21
11095450|NCT01200485|12278968|FG002|STARTED|Cycle 2: Randomization||25
11095451|NCT01200485|12278966|FG000|COMPLETED|Cycle 2: Randomization||0
11095452|NCT01200485|12278967|FG001|COMPLETED|Cycle 2: Randomization||21
11095453|NCT01200485|12278968|FG002|COMPLETED|Cycle 2: Randomization||25
11095454|NCT01200485|12278966|FG000|NOT COMPLETED|Cycle 2: Randomization||0
11095455|NCT01200485|12278967|FG001|NOT COMPLETED|Cycle 2: Randomization||0
11095456|NCT01200485|12278968|FG002|NOT COMPLETED|Cycle 2: Randomization||0
11095457|NCT01200498|12278975|FG000|STARTED|Overall Study||22
11095458|NCT01200498|12278975|FG000|COMPLETED|Overall Study||22
11095459|NCT01200498|12278975|FG000|NOT COMPLETED|Overall Study||0
11095460|NCT01200511|12278979|FG000|STARTED|Overall Study||49
11095461|NCT01200511|12278979|FG000|COMPLETED|Overall Study||44
11095462|NCT01200511|12278979|FG000|NOT COMPLETED|Overall Study||5
11095463|NCT01200524|12278988|FG000|STARTED|Overall Study||41
11095464|NCT01200524|12278989|FG001|STARTED|Overall Study||48
11095465|NCT01200524|12278990|FG002|STARTED|Overall Study||44
11095466|NCT01200524|12278988|FG000|COMPLETED|Overall Study||39
11095467|NCT01200524|12278989|FG001|COMPLETED|Overall Study||47
11208294|NCT02876835|12399507|FG000|NOT COMPLETED|Treatment Period (51.1 Month)||64
11208295|NCT02876835|12399508|FG001|NOT COMPLETED|Treatment Period (51.1 Month)||65
11208296|NCT02482389|12399515|FG000|STARTED|Overall Study||3
11208297|NCT02482389|12399515|FG000|COMPLETED|Overall Study||3
11208298|NCT02482389|12399515|FG000|NOT COMPLETED|Overall Study||0
11208299|NCT02232282|12399521|FG000|STARTED|Overall Study||10
11208300|NCT02232282|12399522|FG001|STARTED|Overall Study||12
11208301|NCT02232282|12399521|FG000|COMPLETED|Overall Study||10
11208302|NCT02232282|12399522|FG001|COMPLETED|Overall Study||11
11208303|NCT02232282|12399521|FG000|NOT COMPLETED|Overall Study||0
11208304|NCT02232282|12399522|FG001|NOT COMPLETED|Overall Study||1
11208305|NCT01492361|12399534|FG000|STARTED|Overall Study||4089
11208306|NCT01492361|12399535|FG001|STARTED|Overall Study||4090
11095468|NCT01200524|12278990|FG002|COMPLETED|Overall Study||40
11095469|NCT01200524|12278988|FG000|NOT COMPLETED|Overall Study||2
11095470|NCT01200524|12278989|FG001|NOT COMPLETED|Overall Study||1
11095471|NCT01200524|12278990|FG002|NOT COMPLETED|Overall Study||4
11095472|NCT01200589|12279000|FG000|STARTED|Overall Study||219
11095473|NCT01200589|12279001|FG001|STARTED|Overall Study||219
11095474|NCT01200589|12279000|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||219
11095475|NCT01200589|12279001|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||219
11095476|NCT01200589|12279000|FG000|Safety Set|Overall Study||217
11095477|NCT01200589|12279001|FG001|Safety Set|Overall Study||218
11095478|NCT01200589|12279000|FG000|COMPLETED|Overall Study||29
11095479|NCT01200589|12279001|FG001|COMPLETED|Overall Study||30
11095480|NCT01200589|12279000|FG000|NOT COMPLETED|Overall Study||190
11095481|NCT01200589|12279001|FG001|NOT COMPLETED|Overall Study||189
11095482|NCT01200758|12279009|FG000|STARTED|Stage I||64
11095483|NCT01200758|12279010|FG001|STARTED|Stage I||63
11095484|NCT01200758|12279011|FG002|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
11095485|NCT01200758|12279012|FG003|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
11095486|NCT01200758|12279009|FG000|COMPLETED|Stage I|Participants completed treatment period.|46
11095487|NCT01200758|12279010|FG001|COMPLETED|Stage I|Participants completed treatment period.|46
11095488|NCT01200758|12279011|FG002|COMPLETED|Stage I||0
11095489|NCT01200758|12279012|FG003|COMPLETED|Stage I||0
11095490|NCT01200758|12279009|FG000|NOT COMPLETED|Stage I||18
11095491|NCT01200758|12279010|FG001|NOT COMPLETED|Stage I||17
11095492|NCT01200758|12279011|FG002|NOT COMPLETED|Stage I||0
11095493|NCT01200758|12279012|FG003|NOT COMPLETED|Stage I||0
11095494|NCT01200758|12279009|FG000|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
11095495|NCT01200758|12279010|FG001|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
11095496|NCT01200758|12279011|FG002|STARTED|Stage 2||141
11095497|NCT01200758|12279012|FG003|STARTED|Stage 2||142
11095498|NCT01200758|12279009|FG000|COMPLETED|Stage 2||0
11095499|NCT01200758|12279010|FG001|COMPLETED|Stage 2||0
11095500|NCT01200758|12279011|FG002|COMPLETED|Stage 2|Participants completed treatment period.|100
11095501|NCT01200758|12279012|FG003|COMPLETED|Stage 2|Participants completed treatment period.|92
11095502|NCT01200758|12279009|FG000|NOT COMPLETED|Stage 2||0
11095503|NCT01200758|12279010|FG001|NOT COMPLETED|Stage 2||0
11095504|NCT01200758|12279011|FG002|NOT COMPLETED|Stage 2||41
11095505|NCT01200758|12279012|FG003|NOT COMPLETED|Stage 2||50
11095506|NCT01200797|12279024|FG000|STARTED|Overall Study||19
11095507|NCT01200797|12279024|FG000|COMPLETED|Overall Study||0
11095508|NCT01200797|12279024|FG000|NOT COMPLETED|Overall Study||19
11095509|NCT01200810|12279031|FG000|STARTED|Overall Study||5
11095510|NCT01200810|12279032|FG001|STARTED|Overall Study||5
11095511|NCT01200810|12279031|FG000|COMPLETED|Overall Study||0
11095512|NCT01200810|12279032|FG001|COMPLETED|Overall Study||0
11095513|NCT01200810|12279031|FG000|NOT COMPLETED|Overall Study||5
11095514|NCT01200810|12279032|FG001|NOT COMPLETED|Overall Study||5
11095515|NCT01200875|12279038|FG000|STARTED|Overall Study||25
11095516|NCT01200875|12279038|FG000|COMPLETED|Overall Study||25
11095517|NCT01200875|12279038|FG000|NOT COMPLETED|Overall Study||0
11095518|NCT01200992|12279044|FG000|STARTED|Overall Study||39
11095519|NCT01200992|12279045|FG001|STARTED|Overall Study||45
11095520|NCT01200992|12279044|FG000|COMPLETED|Overall Study||2
11095521|NCT01200992|12279045|FG001|COMPLETED|Overall Study||4
11095522|NCT01200992|12279044|FG000|NOT COMPLETED|Overall Study||37
11095523|NCT01200992|12279045|FG001|NOT COMPLETED|Overall Study||41
11095524|NCT01201057|12279057|FG000|STARTED|Overall Study||34
11095525|NCT01201057|12279058|FG001|STARTED|Overall Study||33
11095526|NCT01201057|12279059|FG002|STARTED|Overall Study||32
11095527|NCT01201057|12279060|FG003|STARTED|Overall Study||33
11095528|NCT01201057|12279057|FG000|COMPLETED|Overall Study||32
11095529|NCT01201057|12279058|FG001|COMPLETED|Overall Study||29
11095530|NCT01201057|12279059|FG002|COMPLETED|Overall Study||27
11095531|NCT01201057|12279060|FG003|COMPLETED|Overall Study||29
11095532|NCT01201057|12279057|FG000|NOT COMPLETED|Overall Study||2
11095533|NCT01201057|12279058|FG001|NOT COMPLETED|Overall Study||4
11095534|NCT01201057|12279059|FG002|NOT COMPLETED|Overall Study||5
11095535|NCT01201057|12279060|FG003|NOT COMPLETED|Overall Study||4
11095536|NCT01201265|12279070|FG000|STARTED|Overall Study||40
11095537|NCT01201265|12279070|FG000|COMPLETED|Overall Study||2
11095538|NCT01201265|12279070|FG000|NOT COMPLETED|Overall Study||38
11095539|NCT01201317|12279077|FG000|STARTED|Overall Study||48
11095540|NCT01201317|12279078|FG001|STARTED|Overall Study||45
11095541|NCT01201317|12279079|FG002|STARTED|Overall Study||41
11095542|NCT01201317|12279077|FG000|COMPLETED|Overall Study||39
11095543|NCT01201317|12279078|FG001|COMPLETED|Overall Study||38
11095544|NCT01201317|12279079|FG002|COMPLETED|Overall Study||33
11095545|NCT01201317|12279077|FG000|NOT COMPLETED|Overall Study||9
11095546|NCT01201317|12279078|FG001|NOT COMPLETED|Overall Study||7
11095547|NCT01201317|12279079|FG002|NOT COMPLETED|Overall Study||8
11095548|NCT01201343|12279087|FG000|STARTED|Overall Study||79
11095549|NCT01201343|12279087|FG000|Treated|Overall Study||76
11095550|NCT01201343|12279087|FG000|COMPLETED|Overall Study||60
11095551|NCT01201343|12279087|FG000|NOT COMPLETED|Overall Study||19
11095552|NCT01201356|12279091|FG000|STARTED|Overall Study||4125
11095553|NCT01201356|12279091|FG000|Safety Set|Overall Study||4083
11095554|NCT01201356|12279091|FG000|Fingolimod Full Analysis Set|Overall Study||4046
11095555|NCT01201356|12279091|FG000|COMPLETED|Overall Study||3481
11095556|NCT01201356|12279091|FG000|NOT COMPLETED|Overall Study||644
11095557|NCT01201486|12279095|FG000|STARTED|Overall Study||6781
11095558|NCT01201486|12279095|FG000|COMPLETED|Overall Study||6781
11095559|NCT01201486|12279095|FG000|NOT COMPLETED|Overall Study||0
11095560|NCT01201629|12279101|FG000|STARTED|Overall Study||8
11095561|NCT01201629|12279102|FG001|STARTED|Overall Study||8
11095562|NCT01201629|12279101|FG000|COMPLETED|Overall Study||8
11095563|NCT01201629|12279102|FG001|COMPLETED|Overall Study||8
11095564|NCT01201629|12279101|FG000|NOT COMPLETED|Overall Study||0
11095565|NCT01201629|12279102|FG001|NOT COMPLETED|Overall Study||0
11095566|NCT01201759|12279110|FG000|STARTED|Visit 1 Wash-in ( Untreated)||10
11095567|NCT01201759|12279111|FG001|STARTED|Visit 1 Wash-in ( Untreated)||8
11095568|NCT01201759|12279110|FG000|COMPLETED|Visit 1 Wash-in ( Untreated)||8
11095569|NCT01201759|12279111|FG001|COMPLETED|Visit 1 Wash-in ( Untreated)||7
11095570|NCT01201759|12279110|FG000|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
11095571|NCT01201759|12279111|FG001|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
11095572|NCT01201759|12279110|FG000|STARTED|Visit 2||8
11095573|NCT01201759|12279111|FG001|STARTED|Visit 2||7
11095574|NCT01201759|12279110|FG000|COMPLETED|Visit 2||8
11095575|NCT01201759|12279111|FG001|COMPLETED|Visit 2||7
11095576|NCT01201759|12279110|FG000|NOT COMPLETED|Visit 2||0
11095577|NCT01201759|12279111|FG001|NOT COMPLETED|Visit 2||0
11095578|NCT01201759|12279110|FG000|STARTED|Visit 3 - Washout||8
11095579|NCT01201759|12279111|FG001|STARTED|Visit 3 - Washout||7
11095580|NCT01201759|12279110|FG000|COMPLETED|Visit 3 - Washout||7
11095581|NCT01201759|12279111|FG001|COMPLETED|Visit 3 - Washout||4
11095582|NCT01201759|12279110|FG000|NOT COMPLETED|Visit 3 - Washout||1
11095583|NCT01201759|12279111|FG001|NOT COMPLETED|Visit 3 - Washout||3
11095584|NCT01201759|12279110|FG000|STARTED|Visit 4 Crossover||7
11095585|NCT01201759|12279111|FG001|STARTED|Visit 4 Crossover||4
11095586|NCT01201759|12279110|FG000|COMPLETED|Visit 4 Crossover||7
11095587|NCT01201759|12279111|FG001|COMPLETED|Visit 4 Crossover||3
11095588|NCT01201759|12279110|FG000|NOT COMPLETED|Visit 4 Crossover||0
11095589|NCT01201759|12279111|FG001|NOT COMPLETED|Visit 4 Crossover||1
11095590|NCT01201759|12279110|FG000|STARTED|Visit 5||7
11095591|NCT01201759|12279111|FG001|STARTED|Visit 5||3
11095592|NCT01201759|12279110|FG000|COMPLETED|Visit 5||7
11095593|NCT01201759|12279111|FG001|COMPLETED|Visit 5||3
11095594|NCT01201759|12279110|FG000|NOT COMPLETED|Visit 5||0
11095595|NCT01201759|12279111|FG001|NOT COMPLETED|Visit 5||0
11095596|NCT01201772|12279122|FG000|STARTED|Overall Study||23
11095597|NCT01201772|12279123|FG001|STARTED|Overall Study||21
11095598|NCT01201772|12279124|FG002|STARTED|Overall Study||21
11095599|NCT01201772|12279122|FG000|COMPLETED|Overall Study||22
11095600|NCT01201772|12279123|FG001|COMPLETED|Overall Study||21
11095601|NCT01201772|12279124|FG002|COMPLETED|Overall Study||21
11095602|NCT01201772|12279122|FG000|NOT COMPLETED|Overall Study||1
11095603|NCT01201772|12279123|FG001|NOT COMPLETED|Overall Study||0
11095604|NCT01201772|12279124|FG002|NOT COMPLETED|Overall Study||0
11095605|NCT01201785|12279130|FG000|STARTED|Overall Study||36
11095606|NCT01201785|12279130|FG000|COMPLETED|Overall Study||20
11095607|NCT01201785|12279130|FG000|NOT COMPLETED|Overall Study||16
11095608|NCT01201798|12279136|FG000|STARTED|Overall Study||56
11095609|NCT01201798|12279137|FG001|STARTED|Overall Study||54
11095610|NCT01201798|12279136|FG000|COMPLETED|Overall Study||47
11095611|NCT01201798|12279137|FG001|COMPLETED|Overall Study||39
11095612|NCT01201798|12279136|FG000|NOT COMPLETED|Overall Study||9
11095613|NCT01201798|12279137|FG001|NOT COMPLETED|Overall Study||15
11095614|NCT01201811|12279143|FG000|STARTED|Overall Study||44
11095615|NCT01201811|12279143|FG000|COMPLETED|Overall Study||25
11095616|NCT01201811|12279143|FG000|NOT COMPLETED|Overall Study||19
11095617|NCT01201850|12279147|FG000|STARTED|Overall Study||7
11095618|NCT01201850|12279147|FG000|COMPLETED|Overall Study||3
11095619|NCT01201850|12279147|FG000|NOT COMPLETED|Overall Study||4
11095620|NCT01201863|12279154|FG000|STARTED|Overall Study||12
11095621|NCT01201863|12279155|FG001|STARTED|Overall Study||10
11095622|NCT01201863|12279156|FG002|STARTED|Overall Study||24
11095623|NCT01201863|12279154|FG000|COMPLETED|Overall Study||11
11095624|NCT01201863|12279155|FG001|COMPLETED|Overall Study||6
11095625|NCT01201863|12279156|FG002|COMPLETED|Overall Study||18
11095626|NCT01201863|12279154|FG000|NOT COMPLETED|Overall Study||1
11095627|NCT01201863|12279155|FG001|NOT COMPLETED|Overall Study||4
11095628|NCT01201863|12279156|FG002|NOT COMPLETED|Overall Study||6
11095629|NCT01201915|12279167|FG000|STARTED|Overall Study||24
11095630|NCT01201915|12279168|FG001|STARTED|Overall Study||25
11095631|NCT01201915|12279169|FG002|STARTED|Overall Study||25
11095632|NCT01201915|12279167|FG000|COMPLETED|Overall Study||16
11095633|NCT01201915|12279168|FG001|COMPLETED|Overall Study||14
11095634|NCT01201915|12279169|FG002|COMPLETED|Overall Study||19
11095635|NCT01201915|12279167|FG000|NOT COMPLETED|Overall Study||8
11095636|NCT01201915|12279168|FG001|NOT COMPLETED|Overall Study||11
11095637|NCT01201915|12279169|FG002|NOT COMPLETED|Overall Study||6
11095638|NCT01201967|12279179|FG000|STARTED|Overall Study||92
11095639|NCT01201967|12279180|FG001|STARTED|Overall Study||91
11095640|NCT01201967|12279179|FG000|COMPLETED|Overall Study||86
11095641|NCT01201967|12279180|FG001|COMPLETED|Overall Study||86
11095642|NCT01201967|12279179|FG000|NOT COMPLETED|Overall Study||6
11095643|NCT01201967|12279180|FG001|NOT COMPLETED|Overall Study||5
11095644|NCT01202071|12279187|FG000|STARTED|Overall Study||6
11095645|NCT01202071|12279188|FG001|STARTED|Overall Study||6
11095646|NCT01202071|12279189|FG002|STARTED|Overall Study||6
11095647|NCT01202071|12279190|FG003|STARTED|Overall Study||6
11095648|NCT01202071|12279187|FG000|COMPLETED|Overall Study||6
11095649|NCT01202071|12279188|FG001|COMPLETED|Overall Study||6
11095650|NCT01202071|12279189|FG002|COMPLETED|Overall Study||6
11095651|NCT01202071|12279190|FG003|COMPLETED|Overall Study||6
11095652|NCT01202071|12279187|FG000|NOT COMPLETED|Overall Study||0
11095653|NCT01202071|12279188|FG001|NOT COMPLETED|Overall Study||0
11095654|NCT01202071|12279189|FG002|NOT COMPLETED|Overall Study||0
11095655|NCT01202071|12279190|FG003|NOT COMPLETED|Overall Study||0
11095656|NCT01202162|12279202|FG000|STARTED|Overall Study||43
11095657|NCT01202162|12279203|FG001|STARTED|Overall Study||42
11095658|NCT01202162|12279202|FG000|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
11095659|NCT01202162|12279203|FG001|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
11095660|NCT01202162|12279202|FG000|NOT COMPLETED|Overall Study||3
11095661|NCT01202162|12279203|FG001|NOT COMPLETED|Overall Study||2
11095662|NCT01202175|12279211|FG000|STARTED|Overall Study||50
11095663|NCT01202175|12279211|FG000|Nebivolol|Overall Study||25
11095664|NCT01202175|12279211|FG000|Pacebo|Overall Study||25
11095665|NCT01202175|12279211|FG000|COMPLETED|Overall Study||45
11095666|NCT01202175|12279211|FG000|NOT COMPLETED|Overall Study||5
11208307|NCT01492361|12399534|FG000|Completed Final Visit|Overall Study||3419
11208308|NCT01492361|12399535|FG001|Completed Final Visit|Overall Study||3335
11208309|NCT01492361|12399534|FG000|Death Before Final Visit|Overall Study||265
11208310|NCT01492361|12399535|FG001|Death Before Final Visit|Overall Study||295
11095667|NCT01202188|12279221|FG000|STARTED|Overall Study||475
11095668|NCT01202188|12279222|FG001|STARTED|Overall Study||477
11095669|NCT01202188|12279223|FG002|STARTED|Overall Study||475
11095670|NCT01202188|12279224|FG003|STARTED|Overall Study||483
11095671|NCT01202188|12279225|FG004|STARTED|Overall Study||234
11095672|NCT01202188|12279221|FG000|Safety Set; Received Study Drug|Overall Study||474
11095673|NCT01202188|12279222|FG001|Safety Set; Received Study Drug|Overall Study||476
11095674|NCT01202188|12279223|FG002|Safety Set; Received Study Drug|Overall Study||473
11095675|NCT01202188|12279224|FG003|Safety Set; Received Study Drug|Overall Study||480
11095676|NCT01202188|12279225|FG004|Safety Set; Received Study Drug|Overall Study||232
11095677|NCT01202188|12279221|FG000|COMPLETED|Overall Study||437
11095678|NCT01202188|12279222|FG001|COMPLETED|Overall Study||421
11208311|NCT01492361|12399534|FG000|COMPLETED|Overall Study||3684
11208312|NCT01492361|12399535|FG001|COMPLETED|Overall Study||3630
11208313|NCT01492361|12399534|FG000|NOT COMPLETED|Overall Study||405
11208314|NCT01492361|12399535|FG001|NOT COMPLETED|Overall Study||460
11208315|NCT01296711|12399549|FG000|STARTED|Overall Study||20
11208316|NCT01296711|12399550|FG001|STARTED|Overall Study||20
11208317|NCT01296711|12399551|FG002|STARTED|Overall Study||21
11208318|NCT01296711|12399552|FG003|STARTED|Overall Study||20
11208319|NCT01296711|12399553|FG004|STARTED|Overall Study||17
11208320|NCT01296711|12399554|FG005|STARTED|Overall Study||16
11208321|NCT01296711|12399555|FG006|STARTED|Overall Study||40
11208322|NCT01296711|12399556|FG007|STARTED|Overall Study||36
11208323|NCT01296711|12399549|FG000|COMPLETED|Overall Study||4
11208324|NCT01296711|12399550|FG001|COMPLETED|Overall Study||12
11095679|NCT01202188|12279223|FG002|COMPLETED|Overall Study||422
11095680|NCT01202188|12279224|FG003|COMPLETED|Overall Study||441
11208325|NCT01296711|12399551|FG002|COMPLETED|Overall Study||8
11208326|NCT01296711|12399552|FG003|COMPLETED|Overall Study||7
11208327|NCT01296711|12399553|FG004|COMPLETED|Overall Study||7
11208328|NCT01296711|12399554|FG005|COMPLETED|Overall Study||5
11208329|NCT01296711|12399555|FG006|COMPLETED|Overall Study||9
11208330|NCT01296711|12399556|FG007|COMPLETED|Overall Study||15
11208331|NCT01296711|12399549|FG000|NOT COMPLETED|Overall Study||16
11208332|NCT01296711|12399550|FG001|NOT COMPLETED|Overall Study||8
11208333|NCT01296711|12399551|FG002|NOT COMPLETED|Overall Study||13
11208334|NCT01296711|12399552|FG003|NOT COMPLETED|Overall Study||13
11208335|NCT01296711|12399553|FG004|NOT COMPLETED|Overall Study||10
11208336|NCT01296711|12399554|FG005|NOT COMPLETED|Overall Study||11
11208337|NCT01296711|12399555|FG006|NOT COMPLETED|Overall Study||31
11208338|NCT01296711|12399556|FG007|NOT COMPLETED|Overall Study||21
11352276|NCT03045861|12549424|FG002|COMPLETED|Part A (Up to 10 Days)||10
11352277|NCT03045861|12549425|FG003|COMPLETED|Part A (Up to 10 Days)||0
11352278|NCT03045861|12549422|FG000|NOT COMPLETED|Part A (Up to 10 Days)||0
11352279|NCT03045861|12549423|FG001|NOT COMPLETED|Part A (Up to 10 Days)||0
11352280|NCT03045861|12549424|FG002|NOT COMPLETED|Part A (Up to 10 Days)||0
11352281|NCT03045861|12549425|FG003|NOT COMPLETED|Part A (Up to 10 Days)||0
11352282|NCT03045861|12549422|FG000|STARTED|Part B (Up to 10 Days)||7
11352283|NCT03045861|12549423|FG001|STARTED|Part B (Up to 10 Days)||8
11352284|NCT03045861|12549424|FG002|STARTED|Part B (Up to 10 Days)||0
11095681|NCT01202188|12279225|FG004|COMPLETED|Overall Study||189
11352285|NCT03045861|12549425|FG003|STARTED|Part B (Up to 10 Days)||8
11352286|NCT03045861|12549422|FG000|COMPLETED|Part B (Up to 10 Days)||7
11352287|NCT03045861|12549423|FG001|COMPLETED|Part B (Up to 10 Days)||8
11352288|NCT03045861|12549424|FG002|COMPLETED|Part B (Up to 10 Days)||0
11352289|NCT03045861|12549425|FG003|COMPLETED|Part B (Up to 10 Days)||8
11352290|NCT03045861|12549422|FG000|NOT COMPLETED|Part B (Up to 10 Days)||0
11352291|NCT03045861|12549423|FG001|NOT COMPLETED|Part B (Up to 10 Days)||0
11352292|NCT03045861|12549424|FG002|NOT COMPLETED|Part B (Up to 10 Days)||0
11352293|NCT03045861|12549425|FG003|NOT COMPLETED|Part B (Up to 10 Days)||0
11352294|NCT03045887|12549446|FG000|STARTED|Part A, Period (1 Day)||7
11352295|NCT03045887|12549447|FG001|STARTED|Part A, Period (1 Day)||4
11352296|NCT03045887|12549448|FG002|STARTED|Part A, Period (1 Day)||5
11095682|NCT01202188|12279221|FG000|NOT COMPLETED|Overall Study||38
11095683|NCT01202188|12279222|FG001|NOT COMPLETED|Overall Study||56
11095684|NCT01202188|12279223|FG002|NOT COMPLETED|Overall Study||53
11095685|NCT01202188|12279224|FG003|NOT COMPLETED|Overall Study||42
11095686|NCT01202188|12279225|FG004|NOT COMPLETED|Overall Study||45
11095687|NCT01202227|12279243|FG000|STARTED|Overall Study|Treated|103
11095688|NCT01202227|12279243|FG000|COMPLETED|Overall Study||84
11095689|NCT01202227|12279243|FG000|NOT COMPLETED|Overall Study||19
11095690|NCT01202253|12279247|FG000|STARTED|Overall Study||50
11095691|NCT01202253|12279247|FG000|COMPLETED|Overall Study||50
11095692|NCT01202253|12279247|FG000|NOT COMPLETED|Overall Study||0
11095693|NCT01202279|12279253|FG000|STARTED|Overall Study||591
11095694|NCT01202279|12279254|FG001|STARTED|Overall Study||588
11095695|NCT01202279|12279253|FG000|COMPLETED|Overall Study||554
11095696|NCT01202279|12279254|FG001|COMPLETED|Overall Study||561
11095697|NCT01202279|12279253|FG000|NOT COMPLETED|Overall Study||37
11095698|NCT01202279|12279254|FG001|NOT COMPLETED|Overall Study||27
11095699|NCT01202409|12279260|FG000|STARTED|Overall Study||19
11095700|NCT01202409|12279260|FG000|COMPLETED|Overall Study||11
11095701|NCT01202409|12279260|FG000|NOT COMPLETED|Overall Study||8
11095702|NCT01202565|12279264|FG000|STARTED|Overall Study||506
11095703|NCT01202565|12279264|FG000|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
11095704|NCT01202565|12279264|FG000|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
11352297|NCT03045887|12549449|FG003|STARTED|Part A, Period (1 Day)||5
11352298|NCT03045887|12549450|FG004|STARTED|Part A, Period (1 Day)||4
11352299|NCT03045887|12549451|FG005|STARTED|Part A, Period (1 Day)||4
11352300|NCT03045887|12549452|FG006|STARTED|Part A, Period (1 Day)||4
11352301|NCT03045887|12549453|FG007|STARTED|Part A, Period (1 Day)||4
11352302|NCT03045887|12549454|FG008|STARTED|Part A, Period (1 Day)||0
11352303|NCT03045887|12549455|FG009|STARTED|Part A, Period (1 Day)||0
11352304|NCT03045887|12549446|FG000|COMPLETED|Part A, Period (1 Day)||7
11352305|NCT03045887|12549447|FG001|COMPLETED|Part A, Period (1 Day)||4
11095705|NCT01202565|12279264|FG000|NOT COMPLETED|Overall Study||67
11095706|NCT01202578|12279268|FG000|STARTED|Overall Study||53
11095707|NCT01202578|12279268|FG000|COMPLETED|Overall Study||53
11095708|NCT01202578|12279268|FG000|NOT COMPLETED|Overall Study||0
11095709|NCT01202591|12279278|FG000|STARTED|Overall Study||5
11095710|NCT01202591|12279279|FG001|STARTED|Overall Study||5
11095711|NCT01202591|12279280|FG002|STARTED|Overall Study||12
11095712|NCT01202591|12279281|FG003|STARTED|Overall Study||9
11095713|NCT01202591|12279282|FG004|STARTED|Overall Study||5
11095714|NCT01202591|12279283|FG005|STARTED|Overall Study||4
11095715|NCT01202591|12279278|FG000|COMPLETED|Overall Study||0
11095716|NCT01202591|12279279|FG001|COMPLETED|Overall Study||0
11095717|NCT01202591|12279280|FG002|COMPLETED|Overall Study||1
11208339|NCT00084656|12399577|FG000|STARTED|Overall Study||25
11208340|NCT00084656|12399578|FG001|STARTED|Overall Study||25
11208341|NCT00084656|12399579|FG002|STARTED|Overall Study||26
11208342|NCT00084656|12399577|FG000|COMPLETED|Overall Study||0
11208343|NCT00084656|12399578|FG001|COMPLETED|Overall Study||0
11208344|NCT00084656|12399579|FG002|COMPLETED|Overall Study||0
11208345|NCT00084656|12399577|FG000|NOT COMPLETED|Overall Study||25
11208346|NCT00084656|12399578|FG001|NOT COMPLETED|Overall Study||25
11208347|NCT00084656|12399579|FG002|NOT COMPLETED|Overall Study||26
11208348|NCT01879735|12399591|FG000|STARTED|Overall Study||6
11208349|NCT01879735|12399592|FG001|STARTED|Overall Study||16
11208350|NCT01879735|12399591|FG000|COMPLETED|Overall Study||6
11208351|NCT01879735|12399592|FG001|COMPLETED|Overall Study||16
11208352|NCT01879735|12399591|FG000|NOT COMPLETED|Overall Study||0
11208353|NCT01879735|12399592|FG001|NOT COMPLETED|Overall Study||0
11208354|NCT01879800|12399600|FG000|STARTED|Overall Study||14
11208355|NCT01879800|12399601|FG001|STARTED|Overall Study||30
11208356|NCT01879800|12399600|FG000|COMPLETED|Overall Study||14
11208357|NCT01879800|12399601|FG001|COMPLETED|Overall Study||26
11208358|NCT01879800|12399600|FG000|NOT COMPLETED|Overall Study||0
11208359|NCT01879800|12399601|FG001|NOT COMPLETED|Overall Study||4
11208360|NCT01879826|12399609|FG000|STARTED|Overall Study||41
11208361|NCT01879826|12399610|FG001|STARTED|Overall Study||40
11208362|NCT01879826|12399609|FG000|COMPLETED|Overall Study||41
11208363|NCT01879826|12399610|FG001|COMPLETED|Overall Study||40
11208364|NCT01879826|12399609|FG000|NOT COMPLETED|Overall Study||0
11208365|NCT01879826|12399610|FG001|NOT COMPLETED|Overall Study||0
11208366|NCT01879852|12399618|FG000|STARTED|Overall Study||14
11208367|NCT01879852|12399619|FG001|STARTED|Overall Study||13
11208368|NCT01879852|12399618|FG000|COMPLETED|Overall Study||12
11208369|NCT01879852|12399619|FG001|COMPLETED|Overall Study||13
11208370|NCT01879852|12399618|FG000|NOT COMPLETED|Overall Study||2
11208371|NCT01879852|12399619|FG001|NOT COMPLETED|Overall Study||0
11208372|NCT01880047|12399629|FG000|STARTED|Weeks 0-2||17
11208373|NCT01880047|12399630|FG001|STARTED|Weeks 0-2||9
11208374|NCT01880047|12399631|FG002|STARTED|Weeks 0-2||5
11208375|NCT01880047|12399632|FG003|STARTED|Weeks 0-2||3
11208376|NCT01880047|12399629|FG000|COMPLETED|Weeks 0-2||17
11208377|NCT01880047|12399630|FG001|COMPLETED|Weeks 0-2||8
11208378|NCT01880047|12399631|FG002|COMPLETED|Weeks 0-2||4
11208379|NCT01880047|12399632|FG003|COMPLETED|Weeks 0-2||2
11208380|NCT01880047|12399629|FG000|NOT COMPLETED|Weeks 0-2||0
11208381|NCT01880047|12399630|FG001|NOT COMPLETED|Weeks 0-2||1
11208382|NCT01880047|12399631|FG002|NOT COMPLETED|Weeks 0-2||1
11208383|NCT01880047|12399632|FG003|NOT COMPLETED|Weeks 0-2||1
11208384|NCT01880047|12399629|FG000|STARTED|Weeks 3-4||17
11208385|NCT01880047|12399630|FG001|STARTED|Weeks 3-4||8
11208386|NCT01880047|12399631|FG002|STARTED|Weeks 3-4||4
11208387|NCT01880047|12399632|FG003|STARTED|Weeks 3-4||2
11208388|NCT01880047|12399629|FG000|COMPLETED|Weeks 3-4||17
11208389|NCT01880047|12399630|FG001|COMPLETED|Weeks 3-4||7
11208390|NCT01880047|12399631|FG002|COMPLETED|Weeks 3-4||4
11208391|NCT01880047|12399632|FG003|COMPLETED|Weeks 3-4||2
11208392|NCT01880047|12399629|FG000|NOT COMPLETED|Weeks 3-4||0
11208393|NCT01880047|12399630|FG001|NOT COMPLETED|Weeks 3-4||1
11208394|NCT01880047|12399631|FG002|NOT COMPLETED|Weeks 3-4||0
11208395|NCT01880047|12399632|FG003|NOT COMPLETED|Weeks 3-4||0
11208396|NCT01880047|12399629|FG000|STARTED|Weeks 5-8||17
11208397|NCT01880047|12399630|FG001|STARTED|Weeks 5-8||7
11208398|NCT01880047|12399631|FG002|STARTED|Weeks 5-8||4
11208399|NCT01880047|12399632|FG003|STARTED|Weeks 5-8||2
11208400|NCT01880047|12399629|FG000|COMPLETED|Weeks 5-8||15
11208401|NCT01880047|12399630|FG001|COMPLETED|Weeks 5-8||6
11208402|NCT01880047|12399631|FG002|COMPLETED|Weeks 5-8||4
11208403|NCT01880047|12399632|FG003|COMPLETED|Weeks 5-8||2
11208404|NCT01880047|12399629|FG000|NOT COMPLETED|Weeks 5-8||2
11208405|NCT01880047|12399630|FG001|NOT COMPLETED|Weeks 5-8||1
11095718|NCT01202591|12279281|FG003|COMPLETED|Overall Study||2
11208406|NCT01880047|12399631|FG002|NOT COMPLETED|Weeks 5-8||0
11208407|NCT01880047|12399632|FG003|NOT COMPLETED|Weeks 5-8||0
11208408|NCT01880047|12399629|FG000|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15
11208409|NCT01880047|12399630|FG001|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6
11208410|NCT01880047|12399631|FG002|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4
11208411|NCT01880047|12399632|FG003|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2
11208412|NCT01880047|12399629|FG000|COMPLETED|Extension Phase - 18 Months||6
11208413|NCT01880047|12399630|FG001|COMPLETED|Extension Phase - 18 Months||3
11208414|NCT01880047|12399631|FG002|COMPLETED|Extension Phase - 18 Months||3
11208415|NCT01880047|12399632|FG003|COMPLETED|Extension Phase - 18 Months||0
11352306|NCT03045887|12549448|FG002|COMPLETED|Part A, Period (1 Day)||5
11352307|NCT03045887|12549449|FG003|COMPLETED|Part A, Period (1 Day)||5
11352308|NCT03045887|12549450|FG004|COMPLETED|Part A, Period (1 Day)||4
11352309|NCT03045887|12549451|FG005|COMPLETED|Part A, Period (1 Day)||4
11352310|NCT03045887|12549452|FG006|COMPLETED|Part A, Period (1 Day)||4
11352311|NCT03045887|12549453|FG007|COMPLETED|Part A, Period (1 Day)||4
11095719|NCT01202591|12279282|FG004|COMPLETED|Overall Study||0
11095720|NCT01202591|12279283|FG005|COMPLETED|Overall Study||0
11095721|NCT01202591|12279278|FG000|NOT COMPLETED|Overall Study||5
11095722|NCT01202591|12279279|FG001|NOT COMPLETED|Overall Study||5
11095723|NCT01202591|12279280|FG002|NOT COMPLETED|Overall Study||11
11095724|NCT01202591|12279281|FG003|NOT COMPLETED|Overall Study||7
11095725|NCT01202591|12279282|FG004|NOT COMPLETED|Overall Study||5
11095726|NCT01202591|12279283|FG005|NOT COMPLETED|Overall Study||4
11095727|NCT01202643|12279299|FG000|STARTED|Period 1||6
11095728|NCT01202643|12279300|FG001|STARTED|Period 1||6
11095729|NCT01202643|12279299|FG000|COMPLETED|Period 1||6
11095730|NCT01202643|12279300|FG001|COMPLETED|Period 1||6
11095731|NCT01202643|12279299|FG000|NOT COMPLETED|Period 1||0
11095732|NCT01202643|12279300|FG001|NOT COMPLETED|Period 1||0
11095733|NCT01202643|12279299|FG000|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
11095734|NCT01202643|12279300|FG001|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
11095735|NCT01202643|12279299|FG000|COMPLETED|Crossover Cycle||1
11095736|NCT01202643|12279300|FG001|COMPLETED|Crossover Cycle||2
11095737|NCT01202643|12279299|FG000|NOT COMPLETED|Crossover Cycle||0
11095738|NCT01202643|12279300|FG001|NOT COMPLETED|Crossover Cycle||0
11095739|NCT01202656|12279308|FG000|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
11095740|NCT01202656|12279309|FG001|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
11095741|NCT01202656|12279308|FG000|COMPLETED|Cycle 1||67
11095742|NCT01202656|12279309|FG001|COMPLETED|Cycle 1||62
11095743|NCT01202656|12279308|FG000|NOT COMPLETED|Cycle 1||0
11095744|NCT01202656|12279309|FG001|NOT COMPLETED|Cycle 1||0
11095745|NCT01202656|12279308|FG000|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
11095746|NCT01202656|12279309|FG001|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
11095747|NCT01202656|12279308|FG000|COMPLETED|CrossoverCycle||18
11095748|NCT01202656|12279309|FG001|COMPLETED|CrossoverCycle||14
11095749|NCT01202656|12279308|FG000|NOT COMPLETED|CrossoverCycle||0
11095750|NCT01202656|12279309|FG001|NOT COMPLETED|CrossoverCycle||0
11095751|NCT01202721|12279319|FG000|STARTED|Overall Study||18
11095752|NCT01202721|12279320|FG001|STARTED|Overall Study||26
11095753|NCT01202721|12279321|FG002|STARTED|Overall Study||14
11095754|NCT01202721|12279322|FG003|STARTED|Overall Study||27
11095755|NCT01202721|12279319|FG000|COMPLETED|Overall Study||18
11095756|NCT01202721|12279320|FG001|COMPLETED|Overall Study||26
11095757|NCT01202721|12279321|FG002|COMPLETED|Overall Study||14
11095758|NCT01202721|12279322|FG003|COMPLETED|Overall Study||27
11095759|NCT01202721|12279319|FG000|NOT COMPLETED|Overall Study||0
11208416|NCT01880047|12399629|FG000|NOT COMPLETED|Extension Phase - 18 Months||9
11208417|NCT01880047|12399630|FG001|NOT COMPLETED|Extension Phase - 18 Months||3
11208418|NCT01880047|12399631|FG002|NOT COMPLETED|Extension Phase - 18 Months||1
11208419|NCT01880047|12399632|FG003|NOT COMPLETED|Extension Phase - 18 Months||2
11208420|NCT01880073|12399649|FG000|STARTED|Overall Study||24
11208421|NCT01880073|12399649|FG000|COMPLETED|Overall Study||24
11208422|NCT01880073|12399649|FG000|NOT COMPLETED|Overall Study||0
11208423|NCT01880086|12399655|FG000|STARTED|Overall Study||6
11208424|NCT01880086|12399656|FG001|STARTED|Overall Study||7
11352312|NCT03045887|12549454|FG008|COMPLETED|Part A, Period (1 Day)||0
11352313|NCT03045887|12549455|FG009|COMPLETED|Part A, Period (1 Day)||0
11352314|NCT03045887|12549446|FG000|NOT COMPLETED|Part A, Period (1 Day)||0
11352315|NCT03045887|12549447|FG001|NOT COMPLETED|Part A, Period (1 Day)||0
11352316|NCT03045887|12549448|FG002|NOT COMPLETED|Part A, Period (1 Day)||0
11352317|NCT03045887|12549449|FG003|NOT COMPLETED|Part A, Period (1 Day)||0
11208425|NCT01880086|12399655|FG000|COMPLETED|Overall Study||5
11208426|NCT01880086|12399656|FG001|COMPLETED|Overall Study||6
11208427|NCT01880086|12399655|FG000|NOT COMPLETED|Overall Study||1
11208428|NCT01880086|12399656|FG001|NOT COMPLETED|Overall Study||1
11208429|NCT01880099|12399665|FG000|STARTED|Overall Study||17
11208430|NCT01880099|12399666|FG001|STARTED|Overall Study||21
11208431|NCT01880099|12399667|FG002|STARTED|Overall Study||22
11208432|NCT01880099|12399665|FG000|COMPLETED|Overall Study||9
11208433|NCT01880099|12399666|FG001|COMPLETED|Overall Study||11
11208434|NCT01880099|12399667|FG002|COMPLETED|Overall Study||15
11208435|NCT01880099|12399665|FG000|NOT COMPLETED|Overall Study||8
11208436|NCT01880099|12399666|FG001|NOT COMPLETED|Overall Study||10
11208437|NCT01880099|12399667|FG002|NOT COMPLETED|Overall Study||7
11208438|NCT01880320|12399678|FG000|STARTED|Overall Study||217
11208439|NCT01880320|12399679|FG001|STARTED|Overall Study||217
11208440|NCT01880320|12399680|FG002|STARTED|Overall Study||69
11208441|NCT01880320|12399678|FG000|COMPLETED|Overall Study||197
11208442|NCT01880320|12399679|FG001|COMPLETED|Overall Study||192
11208443|NCT01880320|12399680|FG002|COMPLETED|Overall Study||61
11208444|NCT01880320|12399678|FG000|NOT COMPLETED|Overall Study||20
11208445|NCT01880320|12399679|FG001|NOT COMPLETED|Overall Study||25
11208446|NCT01880320|12399680|FG002|NOT COMPLETED|Overall Study||8
11208447|NCT01880424|12399690|FG000|STARTED|Overall Study||417
11208448|NCT01880424|12399691|FG001|STARTED|Overall Study||422
11208449|NCT01880424|12399690|FG000|COMPLETED|Overall Study||384
11208450|NCT01880424|12399691|FG001|COMPLETED|Overall Study||367
11208451|NCT01880424|12399690|FG000|NOT COMPLETED|Overall Study||33
11208452|NCT01880424|12399691|FG001|NOT COMPLETED|Overall Study||55
11095760|NCT01202721|12279320|FG001|NOT COMPLETED|Overall Study||0
11095761|NCT01202721|12279321|FG002|NOT COMPLETED|Overall Study||0
11095762|NCT01202721|12279322|FG003|NOT COMPLETED|Overall Study||0
11095763|NCT01202747|12279334|FG000|STARTED|Overall Study||50
11095764|NCT01202747|12279334|FG000|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
11095765|NCT01202747|12279334|FG000|NOT COMPLETED|Overall Study||1
11095766|NCT01202760|12279341|FG000|STARTED|Overall Study||379
11095767|NCT01202760|12279342|FG001|STARTED|Overall Study||374
11095768|NCT01202760|12279343|FG002|STARTED|Overall Study||251
11095769|NCT01202760|12279341|FG000|Received at Least One Dose of Study Drug|Overall Study||379
11095770|NCT01202760|12279342|FG001|Received at Least One Dose of Study Drug|Overall Study||371
11095771|NCT01202760|12279343|FG002|Received at Least One Dose of Study Drug|Overall Study||250
11095772|NCT01202760|12279341|FG000|COMPLETED|Overall Study||332
11095773|NCT01202760|12279342|FG001|COMPLETED|Overall Study||322
11208453|NCT01880437|12399700|FG000|STARTED|Overall Study||15
11208454|NCT01880437|12399701|FG001|STARTED|Overall Study||4
11208455|NCT01880437|12399702|FG002|STARTED|Overall Study||19
11208456|NCT01880437|12399700|FG000|COMPLETED|Overall Study||0
11208457|NCT01880437|12399701|FG001|COMPLETED|Overall Study||0
11208458|NCT01880437|12399702|FG002|COMPLETED|Overall Study||0
11095774|NCT01202760|12279343|FG002|COMPLETED|Overall Study||216
11095775|NCT01202760|12279341|FG000|NOT COMPLETED|Overall Study||47
11095776|NCT01202760|12279342|FG001|NOT COMPLETED|Overall Study||52
11095777|NCT01202760|12279343|FG002|NOT COMPLETED|Overall Study||35
11095778|NCT01202773|12279366|FG000|STARTED|Overall Study||153
11095779|NCT01202773|12279367|FG001|STARTED|Overall Study||148
11095780|NCT01202773|12279368|FG002|STARTED|Overall Study||155
11095781|NCT01202773|12279366|FG000|Received at Least 1 Dose of Study Drug|Overall Study||153
11095782|NCT01202773|12279367|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147
11095783|NCT01202773|12279368|FG002|Received at Least 1 Dose of Study Drug|Overall Study||154
11095784|NCT01202773|12279366|FG000|Week 16 NR|Overall Study||23
11095785|NCT01202773|12279367|FG001|Week 16 NR|Overall Study||33
11095786|NCT01202773|12279368|FG002|Week 16 NR|Overall Study||37
11095787|NCT01202773|12279366|FG000|Post-Treatment Follow-Up Population|Overall Study||46
11095788|NCT01202773|12279367|FG001|Post-Treatment Follow-Up Population|Overall Study||36
11095789|NCT01202773|12279368|FG002|Post-Treatment Follow-Up Population|Overall Study||51
11095790|NCT01202773|12279366|FG000|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
11208459|NCT01880437|12399700|FG000|NOT COMPLETED|Overall Study||15
11208460|NCT01880437|12399701|FG001|NOT COMPLETED|Overall Study||4
11208461|NCT01880437|12399702|FG002|NOT COMPLETED|Overall Study||19
11208462|NCT01880515|12399714|FG000|STARTED|Overall Study||53
11208463|NCT01880515|12399715|FG001|STARTED|Overall Study||54
11208464|NCT01880515|12399714|FG000|COMPLETED|Overall Study||45
11208465|NCT01880515|12399715|FG001|COMPLETED|Overall Study||45
11208466|NCT01880515|12399714|FG000|NOT COMPLETED|Overall Study||8
11208467|NCT01880515|12399715|FG001|NOT COMPLETED|Overall Study||9
11208468|NCT01880528|12399724|FG000|STARTED|Overall Study||12
11208469|NCT01880528|12399725|FG001|STARTED|Overall Study||11
11208470|NCT01880528|12399724|FG000|COMPLETED|Overall Study||11
11208471|NCT01880528|12399725|FG001|COMPLETED|Overall Study||10
11208472|NCT01880528|12399724|FG000|NOT COMPLETED|Overall Study||1
11208473|NCT01880528|12399725|FG001|NOT COMPLETED|Overall Study||1
11208474|NCT01880554|12399731|FG000|STARTED|Overall Study|Patients enrolled in the study|68
11208475|NCT01880554|12399731|FG000|Population Eligible|Overall Study||58
11208476|NCT01880554|12399731|FG000|Population Eligible and Assessable|Overall Study||54
11208477|NCT01880554|12399731|FG000|COMPLETED|Overall Study|Patients eligible and assessable according to two-stage Simon's design (primary outcome)|52
11208478|NCT01880554|12399731|FG000|NOT COMPLETED|Overall Study||16
11208479|NCT01880593|12399738|FG000|STARTED|Overall Study||18
11208480|NCT01880593|12399739|FG001|STARTED|Overall Study||16
11208481|NCT01880593|12399738|FG000|COMPLETED|Overall Study||10
11208482|NCT01880593|12399739|FG001|COMPLETED|Overall Study||10
11208483|NCT01880593|12399738|FG000|NOT COMPLETED|Overall Study||8
11208484|NCT01880593|12399739|FG001|NOT COMPLETED|Overall Study||6
11208485|NCT01880697|12399747|FG000|STARTED|Overall Study||63
11208486|NCT01880697|12399748|FG001|STARTED|Overall Study||63
11208487|NCT01880697|12399747|FG000|COMPLETED|Overall Study||63
11208488|NCT01880697|12399748|FG001|COMPLETED|Overall Study||62
11208489|NCT01880697|12399747|FG000|NOT COMPLETED|Overall Study||0
11208490|NCT01880697|12399748|FG001|NOT COMPLETED|Overall Study||1
11208491|NCT01880723|12399756|FG000|STARTED|Overall Study||16
11208492|NCT01880723|12399757|FG001|STARTED|Overall Study||16
11208493|NCT01880723|12399756|FG000|COMPLETED|Overall Study||16
11208494|NCT01880723|12399757|FG001|COMPLETED|Overall Study||16
11208495|NCT01880723|12399756|FG000|NOT COMPLETED|Overall Study||0
11208496|NCT01880723|12399757|FG001|NOT COMPLETED|Overall Study||0
11208497|NCT01880736|12399767|FG000|STARTED|Overall Study||114
11208498|NCT01880736|12399768|FG001|STARTED|Overall Study||115
11208499|NCT01880736|12399769|FG002|STARTED|Overall Study||115
11208500|NCT01880736|12399770|FG003|STARTED|Overall Study||114
11208501|NCT01880736|12399767|FG000|COMPLETED|Overall Study||113
11208502|NCT01880736|12399768|FG001|COMPLETED|Overall Study||113
11208503|NCT01880736|12399769|FG002|COMPLETED|Overall Study||114
11208504|NCT01880736|12399770|FG003|COMPLETED|Overall Study||108
11208505|NCT01880736|12399767|FG000|NOT COMPLETED|Overall Study||1
11208506|NCT01880736|12399768|FG001|NOT COMPLETED|Overall Study||2
11208507|NCT01880736|12399769|FG002|NOT COMPLETED|Overall Study||1
11208508|NCT01880736|12399770|FG003|NOT COMPLETED|Overall Study||6
11208509|NCT01880840|12399782|FG000|STARTED|Overall Study||95
11208510|NCT01880840|12399783|FG001|STARTED|Overall Study||96
11208511|NCT01880840|12399782|FG000|COMPLETED|Overall Study||87
11208512|NCT01880840|12399783|FG001|COMPLETED|Overall Study||91
11208513|NCT01880840|12399782|FG000|NOT COMPLETED|Overall Study||8
11208514|NCT01880840|12399783|FG001|NOT COMPLETED|Overall Study||5
11208515|NCT01881009|12399791|FG000|STARTED|Inpatient Safety Testing (22 Hours)||16
11095791|NCT01202773|12279367|FG001|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
11095792|NCT01202773|12279368|FG002|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
11095793|NCT01202773|12279366|FG000|NOT COMPLETED|Overall Study||57
11095794|NCT01202773|12279367|FG001|NOT COMPLETED|Overall Study||43
11095795|NCT01202773|12279368|FG002|NOT COMPLETED|Overall Study||55
11208516|NCT01881009|12399792|FG001|STARTED|Inpatient Safety Testing (22 Hours)||0
11208517|NCT01881009|12399791|FG000|COMPLETED|Inpatient Safety Testing (22 Hours)||16
11208518|NCT01881009|12399792|FG001|COMPLETED|Inpatient Safety Testing (22 Hours)||0
11208519|NCT01881009|12399791|FG000|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
11208520|NCT01881009|12399792|FG001|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
11208521|NCT01881009|12399791|FG000|STARTED|Summer Camp Session (6 Days)||0
11208522|NCT01881009|12399792|FG001|STARTED|Summer Camp Session (6 Days)||22
11208523|NCT01881009|12399791|FG000|COMPLETED|Summer Camp Session (6 Days)||0
11208524|NCT01881009|12399792|FG001|COMPLETED|Summer Camp Session (6 Days)||21
11208525|NCT01881009|12399791|FG000|NOT COMPLETED|Summer Camp Session (6 Days)||0
11208526|NCT01881009|12399792|FG001|NOT COMPLETED|Summer Camp Session (6 Days)||1
11208527|NCT01881087|12399802|FG000|STARTED|Overall Study||60
11208528|NCT01881087|12399803|FG001|STARTED|Overall Study||61
11208529|NCT01881087|12399804|FG002|STARTED|Overall Study||62
11208530|NCT01881087|12399802|FG000|COMPLETED|Overall Study||59
11208531|NCT01881087|12399803|FG001|COMPLETED|Overall Study||61
11208532|NCT01881087|12399804|FG002|COMPLETED|Overall Study||60
11208533|NCT01881087|12399802|FG000|NOT COMPLETED|Overall Study||1
11208534|NCT01881087|12399803|FG001|NOT COMPLETED|Overall Study||0
11208535|NCT01881087|12399804|FG002|NOT COMPLETED|Overall Study||2
11208536|NCT01881113|12399814|FG000|STARTED|Overall Study||51
11208537|NCT01881113|12399815|FG001|STARTED|Overall Study||50
11208538|NCT01881113|12399814|FG000|COMPLETED|Overall Study||43
11208539|NCT01881113|12399815|FG001|COMPLETED|Overall Study||44
11208540|NCT01881113|12399814|FG000|NOT COMPLETED|Overall Study||8
11208541|NCT01881113|12399815|FG001|NOT COMPLETED|Overall Study||6
11208542|NCT01881126|12399823|FG000|STARTED|Overall Study||47
11208543|NCT01881126|12399824|FG001|STARTED|Overall Study||46
11208544|NCT01881126|12399823|FG000|COMPLETED|Overall Study||46
11208545|NCT01881126|12399824|FG001|COMPLETED|Overall Study||44
11208546|NCT01881126|12399823|FG000|NOT COMPLETED|Overall Study||1
11208547|NCT01881126|12399824|FG001|NOT COMPLETED|Overall Study||2
11208548|NCT01881230|12399833|FG000|STARTED|Overall Study||61
11208549|NCT01881230|12399834|FG001|STARTED|Overall Study||64
11208550|NCT01881230|12399835|FG002|STARTED|Overall Study||66
11208551|NCT01881230|12399833|FG000|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
11208552|NCT01881230|12399834|FG001|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
11208553|NCT01881230|12399835|FG002|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
11208554|NCT01881230|12399833|FG000|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
11208555|NCT01881230|12399834|FG001|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
11208556|NCT01881230|12399835|FG002|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
11208557|NCT01881230|12399833|FG000|COMPLETED|Overall Study|Not applicable according to the study design|0
11208558|NCT01881230|12399834|FG001|COMPLETED|Overall Study|Not applicable according to the study design|0
11208559|NCT01881230|12399835|FG002|COMPLETED|Overall Study|Not applicable according to the study design|0
11208560|NCT01881230|12399833|FG000|NOT COMPLETED|Overall Study||61
11208561|NCT01881230|12399834|FG001|NOT COMPLETED|Overall Study||64
11208562|NCT01881230|12399835|FG002|NOT COMPLETED|Overall Study||66
11208563|NCT01881373|12399846|FG000|STARTED|Baseline|Cross-sectional sample|1517
11095796|NCT01202877|12279389|FG000|STARTED|Overall Study||6
11095797|NCT01202877|12279390|FG001|STARTED|Overall Study||8
11095798|NCT01202877|12279391|FG002|STARTED|Overall Study||40
11095799|NCT01202877|12279389|FG000|COMPLETED|Overall Study||6
11095800|NCT01202877|12279390|FG001|COMPLETED|Overall Study||7
11095801|NCT01202877|12279391|FG002|COMPLETED|Overall Study||34
11208564|NCT01881373|12399847|FG001|STARTED|Baseline|Cross-sectional sample|1491
11208565|NCT01881373|12399848|FG002|STARTED|Baseline|Cross-sectional sample|1321
11208566|NCT01881373|12399846|FG000|COMPLETED|Baseline|Cross-sectional sample|1517
11208567|NCT01881373|12399847|FG001|COMPLETED|Baseline|Cross-sectional sample|1491
11208568|NCT01881373|12399848|FG002|COMPLETED|Baseline|Cross-sectional sample|1321
11208569|NCT01881373|12399846|FG000|NOT COMPLETED|Baseline||0
11208570|NCT01881373|12399847|FG001|NOT COMPLETED|Baseline||0
11208571|NCT01881373|12399848|FG002|NOT COMPLETED|Baseline||0
11208572|NCT01881373|12399846|FG000|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
11208573|NCT01881373|12399847|FG001|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
11208574|NCT01881373|12399848|FG002|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
11208575|NCT01881373|12399846|FG000|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
11208576|NCT01881373|12399847|FG001|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
11208577|NCT01881373|12399848|FG002|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
11208578|NCT01881373|12399846|FG000|NOT COMPLETED|24 Months||0
11208579|NCT01881373|12399847|FG001|NOT COMPLETED|24 Months||0
11208580|NCT01881373|12399848|FG002|NOT COMPLETED|24 Months||0
11208581|NCT01881412|12399862|FG000|STARTED|Overall Study||59
11208582|NCT01881412|12399863|FG001|STARTED|Overall Study||59
11208583|NCT01881412|12399862|FG000|COMPLETED|Overall Study||49
11208584|NCT01881412|12399863|FG001|COMPLETED|Overall Study||57
11208585|NCT01881412|12399862|FG000|NOT COMPLETED|Overall Study||10
11208586|NCT01881412|12399863|FG001|NOT COMPLETED|Overall Study||2
11208587|NCT01881620|12399869|FG000|STARTED|Overall Study||109
11208588|NCT01881620|12399869|FG000|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105
11208589|NCT01881620|12399869|FG000|NOT COMPLETED|Overall Study||4
11208590|NCT01881737|12399873|FG000|STARTED|Overall Study|This is a pilot study|15
11208591|NCT01881737|12399873|FG000|Number Screened|Overall Study||15
11208592|NCT01881737|12399873|FG000|COMPLETED|Overall Study||10
11208593|NCT01881737|12399873|FG000|NOT COMPLETED|Overall Study||5
11208594|NCT01881750|12399881|FG000|STARTED|Overall Study||27
11208595|NCT01881750|12399882|FG001|STARTED|Overall Study||26
11208596|NCT01881750|12399881|FG000|COMPLETED|Overall Study||25
11208597|NCT01881750|12399882|FG001|COMPLETED|Overall Study||22
11208598|NCT01881750|12399881|FG000|NOT COMPLETED|Overall Study||2
11208599|NCT01881750|12399882|FG001|NOT COMPLETED|Overall Study||4
11208600|NCT01881776|12399893|FG000|STARTED|Overall Study||24
11208601|NCT01881776|12399894|FG001|STARTED|Overall Study||24
11208602|NCT01881776|12399895|FG002|STARTED|Overall Study||22
11208603|NCT01881776|12399893|FG000|COMPLETED|Overall Study||23
11208604|NCT01881776|12399894|FG001|COMPLETED|Overall Study||20
11208605|NCT01881776|12399895|FG002|COMPLETED|Overall Study||20
11208606|NCT01881776|12399893|FG000|NOT COMPLETED|Overall Study||1
11208607|NCT01881776|12399894|FG001|NOT COMPLETED|Overall Study||4
11208608|NCT01881776|12399895|FG002|NOT COMPLETED|Overall Study||2
11208609|NCT01881789|12399909|FG000|STARTED|Overall Study||3
11208610|NCT01881789|12399910|FG001|STARTED|Overall Study||7
11208611|NCT01881789|12399911|FG002|STARTED|Overall Study||3
11208612|NCT01881789|12399912|FG003|STARTED|Overall Study||3
11208613|NCT01881789|12399913|FG004|STARTED|Overall Study||2
11208614|NCT01881789|12399914|FG005|STARTED|Overall Study||3
11208615|NCT01881789|12399909|FG000|COMPLETED|Overall Study||0
11208616|NCT01881789|12399910|FG001|COMPLETED|Overall Study||0
11208617|NCT01881789|12399911|FG002|COMPLETED|Overall Study||0
11208618|NCT01881789|12399912|FG003|COMPLETED|Overall Study||0
11208619|NCT01881789|12399913|FG004|COMPLETED|Overall Study||0
11208620|NCT01881789|12399914|FG005|COMPLETED|Overall Study||0
11208621|NCT01881789|12399909|FG000|NOT COMPLETED|Overall Study||3
11208622|NCT01881789|12399910|FG001|NOT COMPLETED|Overall Study||7
11208623|NCT01881789|12399911|FG002|NOT COMPLETED|Overall Study||3
11208624|NCT01881789|12399912|FG003|NOT COMPLETED|Overall Study||3
11208625|NCT01881789|12399913|FG004|NOT COMPLETED|Overall Study||2
11208626|NCT01881789|12399914|FG005|NOT COMPLETED|Overall Study||3
11208627|NCT01881828|12399931|FG000|STARTED|Overall Study|23 excluded at randomization from enrollment|71
11208628|NCT01881828|12399932|FG001|STARTED|Overall Study|23 excluded from randomization from enrollment|69
11208629|NCT01881828|12399931|FG000|COMPLETED|Overall Study||71
11208630|NCT01881828|12399932|FG001|COMPLETED|Overall Study||69
11352318|NCT03045887|12549450|FG004|NOT COMPLETED|Part A, Period (1 Day)||0
11352319|NCT03045887|12549451|FG005|NOT COMPLETED|Part A, Period (1 Day)||0
11352320|NCT03045887|12549452|FG006|NOT COMPLETED|Part A, Period (1 Day)||0
11095802|NCT01202877|12279389|FG000|NOT COMPLETED|Overall Study||0
11095803|NCT01202877|12279390|FG001|NOT COMPLETED|Overall Study||1
11095804|NCT01202877|12279391|FG002|NOT COMPLETED|Overall Study||6
11208631|NCT01881828|12399931|FG000|NOT COMPLETED|Overall Study||0
11208632|NCT01881828|12399932|FG001|NOT COMPLETED|Overall Study||0
11208633|NCT01881867|12399940|FG000|STARTED|Overall Study||26
11208634|NCT01881867|12399941|FG001|STARTED|Overall Study||28
11208635|NCT01881867|12399940|FG000|COMPLETED|Overall Study||14
11208636|NCT01881867|12399941|FG001|COMPLETED|Overall Study||15
11208637|NCT01881867|12399940|FG000|NOT COMPLETED|Overall Study||12
11352321|NCT03045887|12549453|FG007|NOT COMPLETED|Part A, Period (1 Day)||0
11352322|NCT03045887|12549454|FG008|NOT COMPLETED|Part A, Period (1 Day)||0
11352323|NCT03045887|12549455|FG009|NOT COMPLETED|Part A, Period (1 Day)||0
11352324|NCT03045887|12549446|FG000|STARTED|Part A,Washout Period 1(4 Weeks)||7
11208638|NCT01881867|12399941|FG001|NOT COMPLETED|Overall Study||13
11208639|NCT01882062|12399949|FG000|STARTED|Overall Study|16th of may 2013|10
11208640|NCT01882062|12399949|FG000|COMPLETED|Overall Study|18th of july 2013|10
11208641|NCT01882062|12399949|FG000|NOT COMPLETED|Overall Study||0
11352325|NCT03045887|12549447|FG001|STARTED|Part A,Washout Period 1(4 Weeks)||4
11208642|NCT01882088|12399953|FG000|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35
11208643|NCT01882088|12399953|FG000|COMPLETED|Overall Study||30
11208644|NCT01882088|12399953|FG000|NOT COMPLETED|Overall Study||5
11208645|NCT01882257|12399960|FG000|STARTED|Study Origination to Beginning Therapy||11
11208646|NCT01882257|12399961|FG001|STARTED|Study Origination to Beginning Therapy||40
11208647|NCT01882257|12399962|FG002|STARTED|Study Origination to Beginning Therapy||23
11208648|NCT01882257|12399960|FG000|Started Therapy Using Device|Study Origination to Beginning Therapy||11
11208649|NCT01882257|12399961|FG001|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
11208650|NCT01882257|12399962|FG002|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
11208651|NCT01882257|12399960|FG000|COMPLETED|Study Origination to Beginning Therapy||11
11208652|NCT01882257|12399961|FG001|COMPLETED|Study Origination to Beginning Therapy||38
11208653|NCT01882257|12399962|FG002|COMPLETED|Study Origination to Beginning Therapy||22
11208654|NCT01882257|12399960|FG000|NOT COMPLETED|Study Origination to Beginning Therapy||0
11208655|NCT01882257|12399961|FG001|NOT COMPLETED|Study Origination to Beginning Therapy||2
11208656|NCT01882257|12399962|FG002|NOT COMPLETED|Study Origination to Beginning Therapy||1
11208657|NCT01882257|12399960|FG000|STARTED|Therapy Portion of Study (12 Months)||11
11208658|NCT01882257|12399961|FG001|STARTED|Therapy Portion of Study (12 Months)||38
11208659|NCT01882257|12399962|FG002|STARTED|Therapy Portion of Study (12 Months)||22
11208660|NCT01882257|12399960|FG000|COMPLETED|Therapy Portion of Study (12 Months)||11
11208661|NCT01882257|12399961|FG001|COMPLETED|Therapy Portion of Study (12 Months)||27
11208662|NCT01882257|12399962|FG002|COMPLETED|Therapy Portion of Study (12 Months)||18
11208663|NCT01882257|12399960|FG000|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
11208664|NCT01882257|12399961|FG001|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
11208665|NCT01882257|12399962|FG002|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
11208666|NCT01882413|12399969|FG000|STARTED|Overall Study||204
11208667|NCT01882413|12399969|FG000|COMPLETED|Overall Study||204
11208668|NCT01882413|12399969|FG000|NOT COMPLETED|Overall Study||0
11208669|NCT01882439|12399977|FG000|STARTED|Overall Study|Received treatment|131
11208670|NCT01882439|12399978|FG001|STARTED|Overall Study|Received treatment|132
11208671|NCT01882439|12399979|FG002|STARTED|Overall Study|Received treatment|66
11208672|NCT01882439|12399980|FG003|STARTED|Overall Study|Received treatment|65
11208673|NCT01882439|12399977|FG000|COMPLETED|Overall Study||122
11208674|NCT01882439|12399978|FG001|COMPLETED|Overall Study||111
11208675|NCT01882439|12399979|FG002|COMPLETED|Overall Study||56
11208676|NCT01882439|12399980|FG003|COMPLETED|Overall Study||56
11208677|NCT01882439|12399977|FG000|NOT COMPLETED|Overall Study||9
11208678|NCT01882439|12399978|FG001|NOT COMPLETED|Overall Study||21
11208679|NCT01882439|12399979|FG002|NOT COMPLETED|Overall Study||10
11208680|NCT01882439|12399980|FG003|NOT COMPLETED|Overall Study||9
11208681|NCT01882465|12399995|FG000|STARTED|Period 1||6
11208682|NCT01882465|12399996|FG001|STARTED|Period 1||6
11208683|NCT01882465|12399997|FG002|STARTED|Period 1||5
11208684|NCT01882465|12399998|FG003|STARTED|Period 1||6
11208685|NCT01882465|12399999|FG004|STARTED|Period 1||5
11208686|NCT01882465|12400000|FG005|STARTED|Period 1||5
11208687|NCT01882465|12400001|FG006|STARTED|Period 1||1
11208688|NCT01882465|12399995|FG000|COMPLETED|Period 1||6
11208689|NCT01882465|12399996|FG001|COMPLETED|Period 1||6
11208690|NCT01882465|12399997|FG002|COMPLETED|Period 1||5
11208691|NCT01882465|12399998|FG003|COMPLETED|Period 1||5
11208692|NCT01882465|12399999|FG004|COMPLETED|Period 1||5
11208693|NCT01882465|12400000|FG005|COMPLETED|Period 1||5
11208694|NCT01882465|12400001|FG006|COMPLETED|Period 1||0
11208695|NCT01882465|12399995|FG000|NOT COMPLETED|Period 1||0
11208696|NCT01882465|12399996|FG001|NOT COMPLETED|Period 1||0
11208697|NCT01882465|12399997|FG002|NOT COMPLETED|Period 1||0
11352326|NCT03045887|12549448|FG002|STARTED|Part A,Washout Period 1(4 Weeks)||5
11352327|NCT03045887|12549449|FG003|STARTED|Part A,Washout Period 1(4 Weeks)||5
11352328|NCT03045887|12549450|FG004|STARTED|Part A,Washout Period 1(4 Weeks)||4
11208698|NCT01882465|12399998|FG003|NOT COMPLETED|Period 1||1
11208699|NCT01882465|12399999|FG004|NOT COMPLETED|Period 1||0
11208700|NCT01882465|12400000|FG005|NOT COMPLETED|Period 1||0
11208701|NCT01882465|12400001|FG006|NOT COMPLETED|Period 1||1
11208702|NCT01882465|12399995|FG000|STARTED|Period 2||6
11208703|NCT01882465|12399996|FG001|STARTED|Period 2||6
11208704|NCT01882465|12399997|FG002|STARTED|Period 2||5
11208705|NCT01882465|12399998|FG003|STARTED|Period 2||5
11208706|NCT01882465|12399999|FG004|STARTED|Period 2||5
11208707|NCT01882465|12400000|FG005|STARTED|Period 2||5
11208708|NCT01882465|12400001|FG006|STARTED|Period 2||0
11208709|NCT01882465|12399995|FG000|COMPLETED|Period 2||6
11208710|NCT01882465|12399996|FG001|COMPLETED|Period 2||6
11208711|NCT01882465|12399997|FG002|COMPLETED|Period 2||5
11208712|NCT01882465|12399998|FG003|COMPLETED|Period 2||5
11208713|NCT01882465|12399999|FG004|COMPLETED|Period 2||4
11208714|NCT01882465|12400000|FG005|COMPLETED|Period 2||5
11208715|NCT01882465|12400001|FG006|COMPLETED|Period 2||0
11208716|NCT01882465|12399995|FG000|NOT COMPLETED|Period 2||0
11208717|NCT01882465|12399996|FG001|NOT COMPLETED|Period 2||0
11208718|NCT01882465|12399997|FG002|NOT COMPLETED|Period 2||0
11208719|NCT01882465|12399998|FG003|NOT COMPLETED|Period 2||0
11208720|NCT01882465|12399999|FG004|NOT COMPLETED|Period 2||1
11208721|NCT01882465|12400000|FG005|NOT COMPLETED|Period 2||0
11208722|NCT01882465|12400001|FG006|NOT COMPLETED|Period 2||0
11208723|NCT01882465|12399995|FG000|STARTED|Period 3||6
11208724|NCT01882465|12399996|FG001|STARTED|Period 3||6
11208725|NCT01882465|12399997|FG002|STARTED|Period 3||5
11208726|NCT01882465|12399998|FG003|STARTED|Period 3||5
11208727|NCT01882465|12399999|FG004|STARTED|Period 3||4
11208728|NCT01882465|12400000|FG005|STARTED|Period 3||5
11208729|NCT01882465|12400001|FG006|STARTED|Period 3||0
11208730|NCT01882465|12399995|FG000|COMPLETED|Period 3||6
11208731|NCT01882465|12399996|FG001|COMPLETED|Period 3||6
11208732|NCT01882465|12399997|FG002|COMPLETED|Period 3||5
11208733|NCT01882465|12399998|FG003|COMPLETED|Period 3||5
11208734|NCT01882465|12399999|FG004|COMPLETED|Period 3||4
11208735|NCT01882465|12400000|FG005|COMPLETED|Period 3||5
11208736|NCT01882465|12400001|FG006|COMPLETED|Period 3||0
11208737|NCT01882465|12399995|FG000|NOT COMPLETED|Period 3||0
11208738|NCT01882465|12399996|FG001|NOT COMPLETED|Period 3||0
11208739|NCT01882465|12399997|FG002|NOT COMPLETED|Period 3||0
11208740|NCT01882465|12399998|FG003|NOT COMPLETED|Period 3||0
11208741|NCT01882465|12399999|FG004|NOT COMPLETED|Period 3||0
11208742|NCT01882465|12400000|FG005|NOT COMPLETED|Period 3||0
11208743|NCT01882465|12400001|FG006|NOT COMPLETED|Period 3||0
11208744|NCT01882543|12400011|FG000|STARTED|Overall Study||37
11208745|NCT01882543|12400012|FG001|STARTED|Overall Study||32
11208746|NCT01882543|12400011|FG000|COMPLETED|Overall Study||33
11208747|NCT01882543|12400012|FG001|COMPLETED|Overall Study||29
11208748|NCT01882543|12400011|FG000|NOT COMPLETED|Overall Study||4
11208749|NCT01882543|12400012|FG001|NOT COMPLETED|Overall Study||3
11208750|NCT01882647|12400021|FG000|STARTED|Overall Study||110
11208751|NCT01882647|12400022|FG001|STARTED|Overall Study||112
11208752|NCT01882647|12400021|FG000|COMPLETED|Overall Study||108
11208753|NCT01882647|12400022|FG001|COMPLETED|Overall Study||106
11208754|NCT01882647|12400021|FG000|NOT COMPLETED|Overall Study||2
11208755|NCT01882647|12400022|FG001|NOT COMPLETED|Overall Study||6
11208756|NCT01882725|12400028|FG000|STARTED|Overall Study||14
11208757|NCT01882725|12400028|FG000|COMPLETED|Overall Study||14
11208758|NCT01882725|12400028|FG000|NOT COMPLETED|Overall Study||0
11208759|NCT01882764|12400034|FG000|STARTED|Overall Study||47
11208760|NCT01882764|12400035|FG001|STARTED|Overall Study||19
11208761|NCT01882764|12400034|FG000|COMPLETED|Overall Study||0
11208762|NCT01882764|12400035|FG001|COMPLETED|Overall Study||1
11208763|NCT01882764|12400034|FG000|NOT COMPLETED|Overall Study||47
11208764|NCT01882764|12400035|FG001|NOT COMPLETED|Overall Study||18
11208765|NCT01882803|12400041|FG000|STARTED|Overall Study||129
11208766|NCT01882803|12400041|FG000|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
11208767|NCT01882803|12400041|FG000|NOT COMPLETED|Overall Study||94
11208768|NCT01882829|12400046|FG000|STARTED|Overall Study||20
11208769|NCT01882829|12400046|FG000|COMPLETED|Overall Study||14
11208770|NCT01882829|12400046|FG000|NOT COMPLETED|Overall Study||6
11208771|NCT01882868|12400050|FG000|STARTED|Overall Study||62
11208772|NCT01882868|12400050|FG000|COMPLETED|Overall Study||62
11095805|NCT01202903|12279401|FG000|STARTED|Overall Study||308
11095806|NCT01202903|12279402|FG001|STARTED|Overall Study||308
11095807|NCT01202903|12279401|FG000|Full Analysis Set|Overall Study||306
11208773|NCT01882868|12400050|FG000|NOT COMPLETED|Overall Study||0
11208774|NCT01882907|12400056|FG000|STARTED|Overall Study||117
11208775|NCT01882907|12400057|FG001|STARTED|Overall Study||111
11208776|NCT01882907|12400056|FG000|COMPLETED|Overall Study||103
11208777|NCT01882907|12400057|FG001|COMPLETED|Overall Study||83
11208778|NCT01882907|12400056|FG000|NOT COMPLETED|Overall Study||14
11208779|NCT01882907|12400057|FG001|NOT COMPLETED|Overall Study||28
11208780|NCT01882985|12400065|FG000|STARTED|Overall Study||14
11208781|NCT01882985|12400065|FG000|COMPLETED|Overall Study||12
11095808|NCT01202903|12279402|FG001|Full Analysis Set|Overall Study||302
11095809|NCT01202903|12279401|FG000|Safety Set*|Overall Study||310
11095810|NCT01202903|12279402|FG001|Safety Set*|Overall Study||299
11095811|NCT01202903|12279401|FG000|COMPLETED|Overall Study||297
11095812|NCT01202903|12279402|FG001|COMPLETED|Overall Study||292
11095813|NCT01202903|12279401|FG000|NOT COMPLETED|Overall Study||11
11095814|NCT01202903|12279402|FG001|NOT COMPLETED|Overall Study||16
11095815|NCT01202955|12279410|FG000|STARTED|Period 1: 10 Days||9
11095816|NCT01202955|12279411|FG001|STARTED|Period 1: 10 Days||10
11095817|NCT01202955|12279410|FG000|COMPLETED|Period 1: 10 Days||9
11208782|NCT01882985|12400065|FG000|NOT COMPLETED|Overall Study||2
11208783|NCT01883141|12400069|FG000|STARTED|Overall Study||31
11208784|NCT01883141|12400069|FG000|Passing Eligibility|Overall Study||30
11208785|NCT01883141|12400069|FG000|EP Study Performed|Overall Study||30
11208786|NCT01883141|12400069|FG000|Usable EP Data|Overall Study||26
11208787|NCT01883141|12400069|FG000|BiV Pacing-Distal|Overall Study||24
11208788|NCT01883141|12400069|FG000|BiV Pacing-Mid|Overall Study||25
11208789|NCT01883141|12400069|FG000|BiV Pacing-Standard Therapy|Overall Study||26
11208790|NCT01883141|12400069|FG000|Multispot-pacing|Overall Study||24
11208791|NCT01883141|12400069|FG000|BiV Pacing-Anterior|Overall Study||23
11208792|NCT01883141|12400069|FG000|Biv Pacing-Posterior|Overall Study||22
11208793|NCT01883141|12400069|FG000|Multivein|Overall Study||23
11208794|NCT01883141|12400069|FG000|COMPLETED|Overall Study|Exit form with exit reason available|31
11208795|NCT01883141|12400069|FG000|NOT COMPLETED|Overall Study||0
11208796|NCT01883362|12400075|FG000|STARTED|Treatment||30
11208797|NCT01883362|12400076|FG001|STARTED|Treatment||30
11208798|NCT01883362|12400075|FG000|COMPLETED|Treatment||14
11208799|NCT01883362|12400076|FG001|COMPLETED|Treatment||16
11208800|NCT01883362|12400075|FG000|NOT COMPLETED|Treatment||16
11208801|NCT01883362|12400076|FG001|NOT COMPLETED|Treatment||14
11208802|NCT01883362|12400075|FG000|STARTED|Post Treatment Follow-up||26
11095818|NCT01202955|12279411|FG001|COMPLETED|Period 1: 10 Days||8
11095819|NCT01202955|12279410|FG000|NOT COMPLETED|Period 1: 10 Days||0
11095820|NCT01202955|12279411|FG001|NOT COMPLETED|Period 1: 10 Days||2
11095821|NCT01202955|12279410|FG000|STARTED|Period 2: 7 Days (Wash-Out)||9
11095822|NCT01202955|12279411|FG001|STARTED|Period 2: 7 Days (Wash-Out)||8
11095823|NCT01202955|12279410|FG000|COMPLETED|Period 2: 7 Days (Wash-Out)||9
11095824|NCT01202955|12279411|FG001|COMPLETED|Period 2: 7 Days (Wash-Out)||8
11095825|NCT01202955|12279410|FG000|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
11095826|NCT01202955|12279411|FG001|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
11095827|NCT01202955|12279410|FG000|STARTED|Period 3: 10 Days||9
11095828|NCT01202955|12279411|FG001|STARTED|Period 3: 10 Days||8
11095829|NCT01202955|12279410|FG000|COMPLETED|Period 3: 10 Days||9
11095830|NCT01202955|12279411|FG001|COMPLETED|Period 3: 10 Days||8
11095831|NCT01202955|12279410|FG000|NOT COMPLETED|Period 3: 10 Days||0
11095832|NCT01202955|12279411|FG001|NOT COMPLETED|Period 3: 10 Days||0
11095833|NCT01202994|12279417|FG000|STARTED|Overall Study||27
11095834|NCT01202994|12279417|FG000|COMPLETED|Overall Study||27
11095835|NCT01202994|12279417|FG000|NOT COMPLETED|Overall Study||0
11095836|NCT01203046|12279424|FG000|STARTED|Overall Study||28
11095837|NCT01203046|12279425|FG001|STARTED|Overall Study||28
11095838|NCT01203046|12279424|FG000|COMPLETED|Overall Study||28
11208803|NCT01883362|12400076|FG001|STARTED|Post Treatment Follow-up||27
11208804|NCT01883362|12400075|FG000|COMPLETED|Post Treatment Follow-up||10
11208805|NCT01883362|12400076|FG001|COMPLETED|Post Treatment Follow-up||13
11208806|NCT01883362|12400075|FG000|NOT COMPLETED|Post Treatment Follow-up||16
11208807|NCT01883362|12400076|FG001|NOT COMPLETED|Post Treatment Follow-up||14
11208808|NCT01883427|12400088|FG000|STARTED|Overall Study||20
11352329|NCT03045887|12549451|FG005|STARTED|Part A,Washout Period 1(4 Weeks)||4
11352330|NCT03045887|12549452|FG006|STARTED|Part A,Washout Period 1(4 Weeks)||4
11352331|NCT03045887|12549453|FG007|STARTED|Part A,Washout Period 1(4 Weeks)||4
11352332|NCT03045887|12549454|FG008|STARTED|Part A,Washout Period 1(4 Weeks)||0
11352333|NCT03045887|12549455|FG009|STARTED|Part A,Washout Period 1(4 Weeks)||0
11352334|NCT03045887|12549446|FG000|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
11352335|NCT03045887|12549447|FG001|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
11352336|NCT03045887|12549448|FG002|COMPLETED|Part A,Washout Period 1(4 Weeks)||5
11352337|NCT03045887|12549449|FG003|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
11352338|NCT03045887|12549450|FG004|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
11352339|NCT03045887|12549451|FG005|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
11095839|NCT01203046|12279425|FG001|COMPLETED|Overall Study||28
11095840|NCT01203046|12279424|FG000|NOT COMPLETED|Overall Study||0
11095841|NCT01203046|12279425|FG001|NOT COMPLETED|Overall Study||0
11095842|NCT01203072|12279438|FG000|STARTED|Overall Study||105
11095843|NCT01203072|12279439|FG001|STARTED|Overall Study||106
11095844|NCT01203072|12279440|FG002|STARTED|Overall Study||104
11095845|NCT01203072|12279441|FG003|STARTED|Overall Study||106
11095846|NCT01203072|12279442|FG004|STARTED|Overall Study||102
11095847|NCT01203072|12279438|FG000|COMPLETED|Overall Study||95
11095848|NCT01203072|12279439|FG001|COMPLETED|Overall Study||100
11095849|NCT01203072|12279440|FG002|COMPLETED|Overall Study||101
11095850|NCT01203072|12279441|FG003|COMPLETED|Overall Study||100
11095851|NCT01203072|12279442|FG004|COMPLETED|Overall Study||96
11095852|NCT01203072|12279438|FG000|NOT COMPLETED|Overall Study||10
11208809|NCT01883427|12400089|FG001|STARTED|Overall Study||20
11208810|NCT01883427|12400088|FG000|COMPLETED|Overall Study||20
11208811|NCT01883427|12400089|FG001|COMPLETED|Overall Study||20
11208812|NCT01883427|12400088|FG000|NOT COMPLETED|Overall Study||0
11208813|NCT01883427|12400089|FG001|NOT COMPLETED|Overall Study||0
11208814|NCT01883440|12400097|FG000|STARTED|Overall Study||45
11208815|NCT01883440|12400098|FG001|STARTED|Overall Study||45
11208816|NCT01883440|12400097|FG000|COMPLETED|Overall Study||42
11208817|NCT01883440|12400098|FG001|COMPLETED|Overall Study||45
11208818|NCT01883440|12400097|FG000|NOT COMPLETED|Overall Study||3
11208819|NCT01883440|12400098|FG001|NOT COMPLETED|Overall Study||0
11208820|NCT01883453|12400107|FG000|STARTED|Overall Study||73
11208821|NCT01883453|12400108|FG001|STARTED|Overall Study||73
11208822|NCT01883453|12400107|FG000|COMPLETED|Overall Study||48
11095853|NCT01203072|12279439|FG001|NOT COMPLETED|Overall Study||6
11208823|NCT01883453|12400108|FG001|COMPLETED|Overall Study||50
11208824|NCT01883453|12400107|FG000|NOT COMPLETED|Overall Study||25
11208825|NCT01883453|12400108|FG001|NOT COMPLETED|Overall Study||23
11208826|NCT01883492|12400116|FG000|STARTED|Overall Study||75
11208827|NCT01883492|12400117|FG001|STARTED|Overall Study||78
11208828|NCT01883492|12400116|FG000|COMPLETED|Overall Study||62
11208829|NCT01883492|12400117|FG001|COMPLETED|Overall Study||67
11208830|NCT01883492|12400116|FG000|NOT COMPLETED|Overall Study||13
11208831|NCT01883492|12400117|FG001|NOT COMPLETED|Overall Study||11
11208832|NCT01883635|12400125|FG000|STARTED|Overall Study||24
11208833|NCT01883635|12400126|FG001|STARTED|Overall Study||20
11208834|NCT01883635|12400125|FG000|COMPLETED|Overall Study||20
11208835|NCT01883635|12400126|FG001|COMPLETED|Overall Study||20
11208836|NCT01883635|12400125|FG000|NOT COMPLETED|Overall Study||4
11208837|NCT01883635|12400126|FG001|NOT COMPLETED|Overall Study||0
11208838|NCT01883856|12400136|FG000|STARTED|Overall Study||26
11208839|NCT01883856|12400137|FG001|STARTED|Overall Study||26
11208840|NCT01883856|12400136|FG000|COMPLETED|Overall Study||26
11208841|NCT01883856|12400137|FG001|COMPLETED|Overall Study||26
11208842|NCT01883856|12400136|FG000|NOT COMPLETED|Overall Study||0
11208843|NCT01883856|12400137|FG001|NOT COMPLETED|Overall Study||0
11208844|NCT01883895|12400143|FG000|STARTED|Overall Study||34
11208845|NCT01883895|12400143|FG000|COMPLETED|Overall Study||32
11208846|NCT01883895|12400143|FG000|NOT COMPLETED|Overall Study||2
11208847|NCT01883986|12400149|FG000|STARTED|Overall Study|Allocated to intervention arm|20
11208848|NCT01883986|12400150|FG001|STARTED|Overall Study|Allocated to usual care arm|20
11208849|NCT01883986|12400149|FG000|Did Not Complete Study|Overall Study||3
11208850|NCT01883986|12400150|FG001|Did Not Complete Study|Overall Study|Did not completed study|1
11208851|NCT01883986|12400149|FG000|COMPLETED|Overall Study|Received allocated intervention|17
11208852|NCT01883986|12400150|FG001|COMPLETED|Overall Study|Completed study|19
11208853|NCT01883986|12400149|FG000|NOT COMPLETED|Overall Study||3
11208854|NCT01883986|12400150|FG001|NOT COMPLETED|Overall Study||1
11208855|NCT01883999|12400156|FG000|STARTED|Overall Study||64
11208856|NCT01883999|12400156|FG000|COMPLETED|Overall Study||61
11208857|NCT01883999|12400156|FG000|NOT COMPLETED|Overall Study||3
11208858|NCT01884025|12400162|FG000|STARTED|Overall Study||13
11208859|NCT01884025|12400163|FG001|STARTED|Overall Study||14
11095854|NCT01203072|12279440|FG002|NOT COMPLETED|Overall Study||3
11095855|NCT01203072|12279441|FG003|NOT COMPLETED|Overall Study||6
11095856|NCT01203072|12279442|FG004|NOT COMPLETED|Overall Study||6
11095857|NCT01203098|12279457|FG000|STARTED|Overall Study||89
11095858|NCT01203098|12279458|FG001|STARTED|Overall Study||86
11095859|NCT01203098|12279459|FG002|STARTED|Overall Study||89
11095860|NCT01203098|12279457|FG000|Safety Analysis Dataset|Overall Study||89
11095861|NCT01203098|12279458|FG001|Safety Analysis Dataset|Overall Study||85
11095862|NCT01203098|12279459|FG002|Safety Analysis Dataset|Overall Study||87
11095863|NCT01203098|12279457|FG000|COMPLETED|Overall Study||83
11095864|NCT01203098|12279458|FG001|COMPLETED|Overall Study||82
11095865|NCT01203098|12279459|FG002|COMPLETED|Overall Study||78
11095866|NCT01203098|12279457|FG000|NOT COMPLETED|Overall Study||6
11095867|NCT01203098|12279458|FG001|NOT COMPLETED|Overall Study||4
11095868|NCT01203098|12279459|FG002|NOT COMPLETED|Overall Study||11
11095869|NCT01203189|12279470|FG000|STARTED|First 4 Weeks Treatment||10
11095870|NCT01203189|12279471|FG001|STARTED|First 4 Weeks Treatment||10
11095871|NCT01203189|12279472|FG002|STARTED|First 4 Weeks Treatment||3
11095872|NCT01203189|12279470|FG000|COMPLETED|First 4 Weeks Treatment||8
11095873|NCT01203189|12279471|FG001|COMPLETED|First 4 Weeks Treatment||8
11095874|NCT01203189|12279472|FG002|COMPLETED|First 4 Weeks Treatment||3
11095875|NCT01203189|12279470|FG000|NOT COMPLETED|First 4 Weeks Treatment||2
11095876|NCT01203189|12279471|FG001|NOT COMPLETED|First 4 Weeks Treatment||2
11095877|NCT01203189|12279472|FG002|NOT COMPLETED|First 4 Weeks Treatment||0
11095878|NCT01203189|12279470|FG000|STARTED|Cross Over Period 4 Weeks Treatment||0
11095879|NCT01203189|12279471|FG001|STARTED|Cross Over Period 4 Weeks Treatment||0
11095880|NCT01203189|12279472|FG002|STARTED|Cross Over Period 4 Weeks Treatment||3
11095881|NCT01203189|12279470|FG000|COMPLETED|Cross Over Period 4 Weeks Treatment||0
11095882|NCT01203189|12279471|FG001|COMPLETED|Cross Over Period 4 Weeks Treatment||0
11095883|NCT01203189|12279472|FG002|COMPLETED|Cross Over Period 4 Weeks Treatment||3
11095884|NCT01203189|12279470|FG000|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
11095885|NCT01203189|12279471|FG001|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
11095886|NCT01203189|12279472|FG002|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
11095887|NCT01203319|12279483|FG000|STARTED|Overall Study||434
11095888|NCT01203319|12279484|FG001|STARTED|Overall Study||435
11095889|NCT01203319|12279485|FG002|STARTED|Overall Study||222
11095890|NCT01203319|12279483|FG000|COMPLETED|Overall Study||428
11095891|NCT01203319|12279484|FG001|COMPLETED|Overall Study||426
11095892|NCT01203319|12279485|FG002|COMPLETED|Overall Study||217
11095893|NCT01203319|12279483|FG000|NOT COMPLETED|Overall Study||6
11095894|NCT01203319|12279484|FG001|NOT COMPLETED|Overall Study||9
11095895|NCT01203319|12279485|FG002|NOT COMPLETED|Overall Study||5
11095896|NCT01203644|12279495|FG000|STARTED|Overall Study||26
11095897|NCT01203644|12279496|FG001|STARTED|Overall Study||50
11095898|NCT01203644|12279495|FG000|COMPLETED|Overall Study||26
11095899|NCT01203644|12279496|FG001|COMPLETED|Overall Study||50
11095900|NCT01203644|12279495|FG000|NOT COMPLETED|Overall Study||0
11095901|NCT01203644|12279496|FG001|NOT COMPLETED|Overall Study||0
11208860|NCT01884025|12400162|FG000|COMPLETED|Overall Study||10
11208861|NCT01884025|12400163|FG001|COMPLETED|Overall Study||10
11208862|NCT01884025|12400162|FG000|NOT COMPLETED|Overall Study||3
11208863|NCT01884025|12400163|FG001|NOT COMPLETED|Overall Study||4
11208864|NCT01884064|12400171|FG000|STARTED|Overall Study||12
11208865|NCT01884064|12400172|FG001|STARTED|Overall Study||5
11208866|NCT01884064|12400171|FG000|COMPLETED|Overall Study||12
11208867|NCT01884064|12400172|FG001|COMPLETED|Overall Study||5
11208868|NCT01884064|12400171|FG000|NOT COMPLETED|Overall Study||0
11208869|NCT01884064|12400172|FG001|NOT COMPLETED|Overall Study||0
11208870|NCT01884311|12400178|FG000|STARTED|Overall Study||38
11208871|NCT01884311|12400178|FG000|COMPLETED|Overall Study||33
11208872|NCT01884311|12400178|FG000|NOT COMPLETED|Overall Study||5
11208873|NCT01884337|12400187|FG000|STARTED|Treatment||326
11208874|NCT01884337|12400188|FG001|STARTED|Treatment||172
11208875|NCT01884337|12400187|FG000|Continuing Into Follow-up Period|Treatment||324
11095902|NCT01203774|12279505|FG000|STARTED|Overall Study||21
11095903|NCT01203774|12279506|FG001|STARTED|Overall Study||10
11095904|NCT01203774|12279505|FG000|COMPLETED|Overall Study||21
11095905|NCT01203774|12279506|FG001|COMPLETED|Overall Study||10
11208876|NCT01884337|12400188|FG001|Continuing Into Follow-up Period|Treatment||171
11208877|NCT01884337|12400187|FG000|COMPLETED|Treatment||322
11208878|NCT01884337|12400188|FG001|COMPLETED|Treatment||170
11095906|NCT01203774|12279505|FG000|NOT COMPLETED|Overall Study||0
11095907|NCT01203774|12279506|FG001|NOT COMPLETED|Overall Study||0
11095908|NCT01203787|12279514|FG000|STARTED|Overall Study||63
11095909|NCT01203787|12279515|FG001|STARTED|Overall Study||57
11095910|NCT01203787|12279514|FG000|COMPLETED|Overall Study||32
11095911|NCT01203787|12279515|FG001|COMPLETED|Overall Study||30
11095912|NCT01203787|12279514|FG000|NOT COMPLETED|Overall Study||31
11095913|NCT01203787|12279515|FG001|NOT COMPLETED|Overall Study||27
11095914|NCT01203826|12279525|FG000|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
11095915|NCT01203826|12279526|FG001|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
11095916|NCT01203826|12279525|FG000|COMPLETED|Overall Study||6
11095917|NCT01203826|12279526|FG001|COMPLETED|Overall Study||6
11095918|NCT01203826|12279525|FG000|NOT COMPLETED|Overall Study||0
11095919|NCT01203826|12279526|FG001|NOT COMPLETED|Overall Study||0
11095920|NCT01203852|12279532|FG000|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
11095921|NCT01203852|12279532|FG000|COMPLETED|Metoprolol 8 Weeks||369
11095922|NCT01203852|12279532|FG000|NOT COMPLETED|Metoprolol 8 Weeks||470
11095923|NCT01203852|12279532|FG000|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
11095924|NCT01203852|12279532|FG000|COMPLETED|Washout 2 Weeks||282
11095925|NCT01203852|12279532|FG000|NOT COMPLETED|Washout 2 Weeks||46
11095926|NCT01203852|12279532|FG000|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
11095927|NCT01203852|12279532|FG000|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
11095928|NCT01203852|12279532|FG000|COMPLETED|Chlorthalidone 8 Weeks||328
11095929|NCT01203852|12279532|FG000|NOT COMPLETED|Chlorthalidone 8 Weeks||0
11095930|NCT01203878|12279542|FG000|STARTED|Overall Study||9
11095931|NCT01203878|12279543|FG001|STARTED|Overall Study||9
11095932|NCT01203878|12279544|FG002|STARTED|Overall Study||3
11095933|NCT01203878|12279542|FG000|COMPLETED|Overall Study||9
11095934|NCT01203878|12279543|FG001|COMPLETED|Overall Study||9
11095935|NCT01203878|12279544|FG002|COMPLETED|Overall Study||0
11095936|NCT01203878|12279542|FG000|NOT COMPLETED|Overall Study||0
11095937|NCT01203878|12279543|FG001|NOT COMPLETED|Overall Study||0
11095938|NCT01203878|12279544|FG002|NOT COMPLETED|Overall Study||3
11095939|NCT01203917|12279551|FG000|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
11095940|NCT01203917|12279551|FG000|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
11095941|NCT01203917|12279551|FG000|NOT COMPLETED|Overall Study||36
11095942|NCT01203930|12279557|FG000|STARTED|Overall Study||64
11095943|NCT01203930|12279558|FG001|STARTED|Overall Study||41
11095944|NCT01203930|12279557|FG000|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
11095945|NCT01203930|12279558|FG001|COMPLETED|Overall Study||0
11095946|NCT01203930|12279557|FG000|NOT COMPLETED|Overall Study||21
11095947|NCT01203930|12279558|FG001|NOT COMPLETED|Overall Study||41
11095948|NCT01203956|12279566|FG000|STARTED|First Two-week Period||15
11095949|NCT01203956|12279567|FG001|STARTED|First Two-week Period||13
11095950|NCT01203956|12279566|FG000|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
11095951|NCT01203956|12279567|FG001|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
11095952|NCT01203956|12279566|FG000|NOT COMPLETED|First Two-week Period||0
11095953|NCT01203956|12279567|FG001|NOT COMPLETED|First Two-week Period||0
11095954|NCT01203956|12279566|FG000|STARTED|Second Two-week Period||15
11095955|NCT01203956|12279567|FG001|STARTED|Second Two-week Period||13
11095956|NCT01203956|12279566|FG000|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
11095957|NCT01203956|12279567|FG001|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
11095958|NCT01203956|12279566|FG000|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
11095959|NCT01203956|12279567|FG001|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
11095960|NCT01203956|12279566|FG000|NOT COMPLETED|Second Two-week Period||5
11095961|NCT01203956|12279567|FG001|NOT COMPLETED|Second Two-week Period||6
11095962|NCT01204203|12279574|FG000|STARTED|Overall Study||8
11095963|NCT01204203|12279574|FG000|COMPLETED|Overall Study||8
11095964|NCT01204203|12279574|FG000|NOT COMPLETED|Overall Study||0
11095965|NCT01204255|12279578|FG000|STARTED|Overall Study||11
11095966|NCT01204255|12279578|FG000|COMPLETED|Overall Study||10
11095967|NCT01204255|12279578|FG000|NOT COMPLETED|Overall Study||1
11095968|NCT01204294|12279589|FG000|STARTED|Overall Study||82
11095969|NCT01204294|12279590|FG001|STARTED|Overall Study||66
11095970|NCT01204294|12279591|FG002|STARTED|Overall Study||74
11095971|NCT01204294|12279592|FG003|STARTED|Overall Study||143
11095972|NCT01204294|12279593|FG004|STARTED|Overall Study||85
11095973|NCT01204294|12279594|FG005|STARTED|Overall Study||63
11095974|NCT01204294|12279595|FG006|STARTED|Overall Study||61
11095975|NCT01204294|12279589|FG000|COMPLETED|Overall Study||79
11208879|NCT01884337|12400187|FG000|NOT COMPLETED|Treatment||4
11208880|NCT01884337|12400188|FG001|NOT COMPLETED|Treatment||2
11208881|NCT01884337|12400187|FG000|STARTED|Follow-up Period||324
11208882|NCT01884337|12400188|FG001|STARTED|Follow-up Period||171
11208883|NCT01884337|12400187|FG000|COMPLETED|Follow-up Period||323
11208884|NCT01884337|12400188|FG001|COMPLETED|Follow-up Period||170
11208885|NCT01884337|12400187|FG000|NOT COMPLETED|Follow-up Period||1
11208886|NCT01884337|12400188|FG001|NOT COMPLETED|Follow-up Period||1
11208887|NCT01884350|12400196|FG000|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583
11208888|NCT01884350|12400197|FG001|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579
11208889|NCT01884350|12400198|FG002|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0
11208890|NCT01884350|12400196|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604
11208891|NCT01884350|12400197|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558
11208892|NCT01884350|12400198|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0
11208893|NCT01884350|12400196|FG000|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529
11208894|NCT01884350|12400197|FG001|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525
11208895|NCT01884350|12400198|FG002|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
11208896|NCT01884350|12400196|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
11208897|NCT01884350|12400197|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
11208898|NCT01884350|12400198|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
11095976|NCT01204294|12279590|FG001|COMPLETED|Overall Study||58
11095977|NCT01204294|12279591|FG002|COMPLETED|Overall Study||69
11095978|NCT01204294|12279592|FG003|COMPLETED|Overall Study||132
11095979|NCT01204294|12279593|FG004|COMPLETED|Overall Study||83
11095980|NCT01204294|12279594|FG005|COMPLETED|Overall Study||58
11095981|NCT01204294|12279595|FG006|COMPLETED|Overall Study||59
11095982|NCT01204294|12279589|FG000|NOT COMPLETED|Overall Study||3
11095983|NCT01204294|12279590|FG001|NOT COMPLETED|Overall Study||8
11095984|NCT01204294|12279591|FG002|NOT COMPLETED|Overall Study||5
11095985|NCT01204294|12279592|FG003|NOT COMPLETED|Overall Study||11
11095986|NCT01204294|12279593|FG004|NOT COMPLETED|Overall Study||2
11095987|NCT01204294|12279594|FG005|NOT COMPLETED|Overall Study||5
11095988|NCT01204294|12279595|FG006|NOT COMPLETED|Overall Study||2
11095989|NCT01204398|12279611|FG000|STARTED|Overall Study|Entered and treated.|27
11095990|NCT01204398|12279611|FG000|COMPLETED|Overall Study|Completed trial medication.|26
11095991|NCT01204398|12279611|FG000|NOT COMPLETED|Overall Study||1
11095992|NCT01204658|12279619|FG000|STARTED|Primary Phase||146
11095993|NCT01204658|12279620|FG001|STARTED|Primary Phase||142
11095994|NCT01204658|12279621|FG002|STARTED|Primary Phase||145
11095995|NCT01204658|12279622|FG003|STARTED|Primary Phase||142
11095996|NCT01204658|12279619|FG000|COMPLETED|Primary Phase||146
11095997|NCT01204658|12279620|FG001|COMPLETED|Primary Phase||142
11095998|NCT01204658|12279621|FG002|COMPLETED|Primary Phase||144
11095999|NCT01204658|12279622|FG003|COMPLETED|Primary Phase||142
11096000|NCT01204658|12279619|FG000|NOT COMPLETED|Primary Phase||0
11096001|NCT01204658|12279620|FG001|NOT COMPLETED|Primary Phase||0
11096002|NCT01204658|12279621|FG002|NOT COMPLETED|Primary Phase||1
11096003|NCT01204658|12279622|FG003|NOT COMPLETED|Primary Phase||0
11096004|NCT01204658|12279619|FG000|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
11096005|NCT01204658|12279620|FG001|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
11096006|NCT01204658|12279621|FG002|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
11096007|NCT01204658|12279622|FG003|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
11096008|NCT01204658|12279619|FG000|COMPLETED|Booster Phase||144
11096009|NCT01204658|12279620|FG001|COMPLETED|Booster Phase||140
11096010|NCT01204658|12279621|FG002|COMPLETED|Booster Phase||140
11096011|NCT01204658|12279622|FG003|COMPLETED|Booster Phase||140
11096012|NCT01204658|12279619|FG000|NOT COMPLETED|Booster Phase||0
11096013|NCT01204658|12279620|FG001|NOT COMPLETED|Booster Phase||0
11096014|NCT01204658|12279621|FG002|NOT COMPLETED|Booster Phase||0
11096015|NCT01204658|12279622|FG003|NOT COMPLETED|Booster Phase||0
11096016|NCT01204671|12279640|FG000|STARTED|Overall Study||1012
11096017|NCT01204671|12279641|FG001|STARTED|Overall Study||1013
11096018|NCT01204671|12279642|FG002|STARTED|Overall Study||1011
11096019|NCT01204671|12279643|FG003|STARTED|Overall Study||1010
11096020|NCT01204671|12279644|FG004|STARTED|Overall Study||610
11096021|NCT01204671|12279640|FG000|COMPLETED|Overall Study||998
11096022|NCT01204671|12279641|FG001|COMPLETED|Overall Study||998
11096023|NCT01204671|12279642|FG002|COMPLETED|Overall Study||998
11096024|NCT01204671|12279643|FG003|COMPLETED|Overall Study||997
11096025|NCT01204671|12279644|FG004|COMPLETED|Overall Study||606
11096026|NCT01204671|12279640|FG000|NOT COMPLETED|Overall Study||14
11096027|NCT01204671|12279641|FG001|NOT COMPLETED|Overall Study||15
11096028|NCT01204671|12279642|FG002|NOT COMPLETED|Overall Study||13
11096029|NCT01204671|12279643|FG003|NOT COMPLETED|Overall Study||13
11096030|NCT01204671|12279644|FG004|NOT COMPLETED|Overall Study||4
11096031|NCT01204697|12279662|FG000|STARTED|Overall Study||36
11208899|NCT01884350|12400196|FG000|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583
11352340|NCT03045887|12549452|FG006|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
11352341|NCT03045887|12549453|FG007|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
11352342|NCT03045887|12549454|FG008|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
11352343|NCT03045887|12549455|FG009|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
11352344|NCT03045887|12549446|FG000|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3
11352345|NCT03045887|12549447|FG001|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
11352346|NCT03045887|12549448|FG002|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
11352347|NCT03045887|12549449|FG003|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1
11352348|NCT03045887|12549450|FG004|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
11352349|NCT03045887|12549451|FG005|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
11352350|NCT03045887|12549452|FG006|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
11096032|NCT01204697|12279663|FG001|STARTED|Overall Study||38
11096033|NCT01204697|12279662|FG000|Treated|Overall Study||36
11096034|NCT01204697|12279663|FG001|Treated|Overall Study||37
11096035|NCT01204697|12279662|FG000|COMPLETED|Overall Study||5
11096036|NCT01204697|12279663|FG001|COMPLETED|Overall Study||2
11096037|NCT01204697|12279662|FG000|NOT COMPLETED|Overall Study||31
11096038|NCT01204697|12279663|FG001|NOT COMPLETED|Overall Study||36
11096039|NCT01204710|12279671|FG000|STARTED|Randomization Treatment||63
11096040|NCT01204710|12279672|FG001|STARTED|Randomization Treatment||60
11096041|NCT01204710|12279671|FG000|Received ≥1 Dose of Study Drug|Randomization Treatment||62
11096042|NCT01204710|12279672|FG001|Received ≥1 Dose of Study Drug|Randomization Treatment||59
11096043|NCT01204710|12279671|FG000|COMPLETED|Randomization Treatment||49
11096044|NCT01204710|12279672|FG001|COMPLETED|Randomization Treatment||47
11096045|NCT01204710|12279671|FG000|NOT COMPLETED|Randomization Treatment||14
11096046|NCT01204710|12279672|FG001|NOT COMPLETED|Randomization Treatment||13
11096047|NCT01204710|12279671|FG000|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
11096048|NCT01204710|12279672|FG001|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
11096049|NCT01204710|12279671|FG000|COMPLETED|Optional Olaratumab Monotherapy||0
11096050|NCT01204710|12279672|FG001|COMPLETED|Optional Olaratumab Monotherapy||16
11096051|NCT01204710|12279671|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy||0
11096052|NCT01204710|12279672|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy||3
11096053|NCT01204736|12279689|FG000|STARTED|Overall Study||4
11096054|NCT01204736|12279690|FG001|STARTED|Overall Study||5
11096055|NCT01204736|12279691|FG002|STARTED|Overall Study||3
11096056|NCT01204736|12279692|FG003|STARTED|Overall Study||2
11096057|NCT01204736|12279689|FG000|COMPLETED|Overall Study||4
11096058|NCT01204736|12279690|FG001|COMPLETED|Overall Study||5
11096059|NCT01204736|12279691|FG002|COMPLETED|Overall Study||3
11096060|NCT01204736|12279692|FG003|COMPLETED|Overall Study||2
11096061|NCT01204736|12279689|FG000|NOT COMPLETED|Overall Study||0
11096062|NCT01204736|12279690|FG001|NOT COMPLETED|Overall Study||0
11096063|NCT01204736|12279691|FG002|NOT COMPLETED|Overall Study||0
11096064|NCT01204736|12279692|FG003|NOT COMPLETED|Overall Study||0
11096065|NCT01204775|12279704|FG000|STARTED|Overall Study||4
11096066|NCT01204775|12279705|FG001|STARTED|Overall Study||4
11096067|NCT01204775|12279704|FG000|Double-blind Treatment Period|Overall Study||4
11096068|NCT01204775|12279705|FG001|Double-blind Treatment Period|Overall Study||4
11096069|NCT01204775|12279704|FG000|COMPLETED|Overall Study||3
11096070|NCT01204775|12279705|FG001|COMPLETED|Overall Study||3
11096071|NCT01204775|12279704|FG000|NOT COMPLETED|Overall Study||1
11096072|NCT01204775|12279705|FG001|NOT COMPLETED|Overall Study||1
11096073|NCT01204853|12279711|FG000|STARTED|Overall Study||2
11096074|NCT01204853|12279711|FG000|COMPLETED|Overall Study||2
11096075|NCT01204853|12279711|FG000|NOT COMPLETED|Overall Study||0
11096076|NCT01204905|12279715|FG000|STARTED|Overall Study||7
11096077|NCT01204905|12279715|FG000|COMPLETED|Overall Study||5
11096078|NCT01204905|12279715|FG000|NOT COMPLETED|Overall Study||2
11096079|NCT01204918|12279722|FG000|STARTED|Overall Study||25
11096080|NCT01204918|12279723|FG001|STARTED|Overall Study||39
11096081|NCT01204918|12279724|FG002|STARTED|Overall Study||40
11096082|NCT01204918|12279722|FG000|Stage 1 Begin|Overall Study||25
11096083|NCT01204918|12279723|FG001|Stage 1 Begin|Overall Study||39
11096084|NCT01204918|12279724|FG002|Stage 1 Begin|Overall Study||40
11096085|NCT01204918|12279722|FG000|Stage 1 End|Overall Study||22
11096086|NCT01204918|12279723|FG001|Stage 1 End|Overall Study||35
11096087|NCT01204918|12279724|FG002|Stage 1 End|Overall Study||36
11096088|NCT01204918|12279722|FG000|Stage 2 Begin|Overall Study||22
11096089|NCT01204918|12279723|FG001|Stage 2 Begin|Overall Study||35
11096090|NCT01204918|12279724|FG002|Stage 2 Begin|Overall Study||36
11096091|NCT01204918|12279722|FG000|Stage 2 End|Overall Study||21
11208900|NCT01884350|12400197|FG001|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263
11208901|NCT01884350|12400198|FG002|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261
11208902|NCT01884350|12400196|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604
11208903|NCT01884350|12400197|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308
11208904|NCT01884350|12400198|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223
11208905|NCT01884350|12400196|FG000|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503
11208906|NCT01884350|12400197|FG001|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
11208907|NCT01884350|12400198|FG002|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
11208908|NCT01884350|12400196|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80
11208909|NCT01884350|12400197|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13
11208910|NCT01884350|12400198|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11
11208911|NCT01884519|12400210|FG000|STARTED|Overall Study||60
11208912|NCT01884519|12400211|FG001|STARTED|Overall Study||60
11208913|NCT01884519|12400210|FG000|COMPLETED|Overall Study||60
11208914|NCT01884519|12400211|FG001|COMPLETED|Overall Study||60
11208915|NCT01884519|12400210|FG000|NOT COMPLETED|Overall Study||0
11208916|NCT01884519|12400211|FG001|NOT COMPLETED|Overall Study||0
11096092|NCT01204918|12279723|FG001|Stage 2 End|Overall Study||29
11096093|NCT01204918|12279724|FG002|Stage 2 End|Overall Study||35
11208917|NCT01884545|12400229|FG000|STARTED|Overall Study||50
11208918|NCT01884545|12400230|FG001|STARTED|Overall Study||49
11096094|NCT01204918|12279722|FG000|COMPLETED|Overall Study||21
11208919|NCT01884545|12400231|FG002|STARTED|Overall Study||49
11208920|NCT01884545|12400232|FG003|STARTED|Overall Study||52
11208921|NCT01884545|12400229|FG000|COMPLETED|Overall Study||37
11208922|NCT01884545|12400230|FG001|COMPLETED|Overall Study||31
11208923|NCT01884545|12400231|FG002|COMPLETED|Overall Study||35
11208924|NCT01884545|12400232|FG003|COMPLETED|Overall Study||43
11208925|NCT01884545|12400229|FG000|NOT COMPLETED|Overall Study||13
11208926|NCT01884545|12400230|FG001|NOT COMPLETED|Overall Study||18
11208927|NCT01884545|12400231|FG002|NOT COMPLETED|Overall Study||14
11208928|NCT01884545|12400232|FG003|NOT COMPLETED|Overall Study||9
11208929|NCT01884571|12400242|FG000|STARTED|Overall Study||31
11208930|NCT01884571|12400242|FG000|COMPLETED|Overall Study||23
11208931|NCT01884571|12400242|FG000|NOT COMPLETED|Overall Study||8
11208932|NCT01884597|12400249|FG000|STARTED|Overall Study||5
11208933|NCT01884597|12400250|FG001|STARTED|Overall Study||3
11096095|NCT01204918|12279723|FG001|COMPLETED|Overall Study||29
11096096|NCT01204918|12279724|FG002|COMPLETED|Overall Study||35
11096097|NCT01204918|12279722|FG000|NOT COMPLETED|Overall Study||4
11096098|NCT01204918|12279723|FG001|NOT COMPLETED|Overall Study||10
11208934|NCT01884597|12400251|FG002|STARTED|Overall Study||16
11208935|NCT01884597|12400249|FG000|COMPLETED|Overall Study||4
11208936|NCT01884597|12400250|FG001|COMPLETED|Overall Study||2
11208937|NCT01884597|12400251|FG002|COMPLETED|Overall Study||15
11208938|NCT01884597|12400249|FG000|NOT COMPLETED|Overall Study||1
11208939|NCT01884597|12400250|FG001|NOT COMPLETED|Overall Study||1
11208940|NCT01884597|12400251|FG002|NOT COMPLETED|Overall Study||1
11208941|NCT01884675|12400267|FG000|STARTED|Overall Study||16
11208942|NCT01884675|12400268|FG001|STARTED|Overall Study||17
11208943|NCT01884675|12400267|FG000|COMPLETED|Overall Study||13
11208944|NCT01884675|12400268|FG001|COMPLETED|Overall Study||15
11208945|NCT01884675|12400267|FG000|NOT COMPLETED|Overall Study||3
11096099|NCT01204918|12279724|FG002|NOT COMPLETED|Overall Study||5
11096100|NCT01205035|12279734|FG000|STARTED|Overall Study||3
11208946|NCT01884675|12400268|FG001|NOT COMPLETED|Overall Study||2
11208947|NCT01884688|12400276|FG000|STARTED|Overall Study||3
11208948|NCT01884688|12400276|FG000|COMPLETED|Overall Study||1
11208949|NCT01884688|12400276|FG000|NOT COMPLETED|Overall Study||2
11208950|NCT01884844|12400282|FG000|STARTED|Overall Study||16
11208951|NCT01884844|12400283|FG001|STARTED|Overall Study||17
11208952|NCT01884844|12400282|FG000|COMPLETED|Overall Study||13
11208953|NCT01884844|12400283|FG001|COMPLETED|Overall Study||12
11208954|NCT01884844|12400282|FG000|NOT COMPLETED|Overall Study||3
11208955|NCT01884844|12400283|FG001|NOT COMPLETED|Overall Study||5
11208956|NCT01885000|12400291|FG000|STARTED|Overall Study||48
11208957|NCT01885000|12400292|FG001|STARTED|Overall Study||44
11208958|NCT01885000|12400291|FG000|COMPLETED|Overall Study||46
11208959|NCT01885000|12400292|FG001|COMPLETED|Overall Study||42
11208960|NCT01885000|12400291|FG000|NOT COMPLETED|Overall Study||2
11208961|NCT01885000|12400292|FG001|NOT COMPLETED|Overall Study||2
11208962|NCT01885104|12400300|FG000|STARTED|Overall Study||31
11208963|NCT01885104|12400301|FG001|STARTED|Overall Study||34
11208964|NCT01885104|12400300|FG000|COMPLETED|Overall Study||29
11208965|NCT01885104|12400301|FG001|COMPLETED|Overall Study||33
11208966|NCT01885104|12400300|FG000|NOT COMPLETED|Overall Study||2
11208967|NCT01885104|12400301|FG001|NOT COMPLETED|Overall Study||1
11208968|NCT01885117|12400309|FG000|STARTED|Overall Study||61
11208969|NCT01885117|12400310|FG001|STARTED|Overall Study||64
11208970|NCT01885117|12400309|FG000|COMPLETED|Overall Study||61
11208971|NCT01885117|12400310|FG001|COMPLETED|Overall Study||64
11208972|NCT01885117|12400309|FG000|NOT COMPLETED|Overall Study||0
11208973|NCT01885117|12400310|FG001|NOT COMPLETED|Overall Study||0
11208974|NCT01885182|12400318|FG000|STARTED|Overall Study||117
11208975|NCT01885182|12400319|FG001|STARTED|Overall Study||115
11208976|NCT01885182|12400318|FG000|Safety Population|Overall Study||114
11208977|NCT01885182|12400319|FG001|Safety Population|Overall Study||111
11208978|NCT01885182|12400318|FG000|FAP Population|Overall Study||107
11208979|NCT01885182|12400319|FG001|FAP Population|Overall Study||106
11208980|NCT01885182|12400318|FG000|COMPLETED|Overall Study||83
11208981|NCT01885182|12400319|FG001|COMPLETED|Overall Study||93
11208982|NCT01885182|12400318|FG000|NOT COMPLETED|Overall Study||34
11208983|NCT01885182|12400319|FG001|NOT COMPLETED|Overall Study||22
11208984|NCT01885195|12400327|FG000|STARTED|Overall Study||110
11208985|NCT01885195|12400327|FG000|COMPLETED|Overall Study||0
11208986|NCT01885195|12400327|FG000|NOT COMPLETED|Overall Study||110
11208987|NCT01885208|12400333|FG000|STARTED|Overall Study||406
11208988|NCT01885208|12400334|FG001|STARTED|Overall Study||407
11208989|NCT01885208|12400333|FG000|Exposed|Overall Study||404
11208990|NCT01885208|12400334|FG001|Exposed|Overall Study||405
11208991|NCT01885208|12400333|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
11208992|NCT01885208|12400334|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
11208993|NCT01885208|12400333|FG000|COMPLETED|Overall Study||374
11208994|NCT01885208|12400334|FG001|COMPLETED|Overall Study||369
11208995|NCT01885208|12400333|FG000|NOT COMPLETED|Overall Study||32
11208996|NCT01885208|12400334|FG001|NOT COMPLETED|Overall Study||38
11208997|NCT01885559|12400342|FG000|STARTED|Overall Study||242
11208998|NCT01885559|12400343|FG001|STARTED|Overall Study||244
11208999|NCT01885559|12400342|FG000|COMPLETED|Overall Study||218
11209000|NCT01885559|12400343|FG001|COMPLETED|Overall Study||208
11209001|NCT01885559|12400342|FG000|NOT COMPLETED|Overall Study||24
11209002|NCT01885559|12400343|FG001|NOT COMPLETED|Overall Study||36
11209003|NCT01885871|12400349|FG000|STARTED|Overall Study||20
11209004|NCT01885871|12400349|FG000|COMPLETED|Overall Study||20
11096101|NCT01205035|12279735|FG001|STARTED|Overall Study||3
11096102|NCT01205035|12279734|FG000|COMPLETED|Overall Study||1
11096103|NCT01205035|12279735|FG001|COMPLETED|Overall Study||3
11096104|NCT01205035|12279734|FG000|NOT COMPLETED|Overall Study||2
11096105|NCT01205035|12279735|FG001|NOT COMPLETED|Overall Study||0
11209005|NCT01885871|12400349|FG000|NOT COMPLETED|Overall Study||0
11209006|NCT01885897|12400359|FG000|STARTED|Overall Study||6
11209007|NCT01885897|12400360|FG001|STARTED|Overall Study||3
11209008|NCT01885897|12400361|FG002|STARTED|Overall Study||4
11209009|NCT01885897|12400362|FG003|STARTED|Overall Study||3
11209010|NCT01885897|12400363|FG004|STARTED|Overall Study||8
11209011|NCT01885897|12400364|FG005|STARTED|Overall Study||9
11209012|NCT01885897|12400359|FG000|COMPLETED|Overall Study||6
11209013|NCT01885897|12400360|FG001|COMPLETED|Overall Study||3
11209014|NCT01885897|12400361|FG002|COMPLETED|Overall Study||4
11209015|NCT01885897|12400362|FG003|COMPLETED|Overall Study||3
11209016|NCT01885897|12400363|FG004|COMPLETED|Overall Study||8
11209017|NCT01885897|12400364|FG005|COMPLETED|Overall Study||9
11209018|NCT01885897|12400359|FG000|NOT COMPLETED|Overall Study||0
11209019|NCT01885897|12400360|FG001|NOT COMPLETED|Overall Study||0
11209020|NCT01885897|12400361|FG002|NOT COMPLETED|Overall Study||0
11209021|NCT01885897|12400362|FG003|NOT COMPLETED|Overall Study||0
11209022|NCT01885897|12400363|FG004|NOT COMPLETED|Overall Study||0
11209023|NCT01885897|12400364|FG005|NOT COMPLETED|Overall Study||0
11209024|NCT01885910|12400378|FG000|STARTED|Overall Study||32
11096106|NCT01205126|12279743|FG000|STARTED|Titration Phase||130
11096107|NCT01205126|12279744|FG001|STARTED|Titration Phase||130
11096108|NCT01205126|12279743|FG000|COMPLETED|Titration Phase||107
11096109|NCT01205126|12279744|FG001|COMPLETED|Titration Phase||111
11096110|NCT01205126|12279743|FG000|NOT COMPLETED|Titration Phase||23
11096111|NCT01205126|12279744|FG001|NOT COMPLETED|Titration Phase||19
11209025|NCT01885910|12400378|FG000|COMPLETED|Overall Study||24
11209026|NCT01885910|12400378|FG000|NOT COMPLETED|Overall Study||8
11209027|NCT01885936|12400386|FG000|STARTED|Overall Study||8
11209028|NCT01885936|12400387|FG001|STARTED|Overall Study||5
11209029|NCT01885936|12400386|FG000|COMPLETED|Overall Study||7
11209030|NCT01885936|12400387|FG001|COMPLETED|Overall Study||5
11209031|NCT01885936|12400386|FG000|NOT COMPLETED|Overall Study||1
11209032|NCT01885936|12400387|FG001|NOT COMPLETED|Overall Study||0
11209033|NCT01886105|12400393|FG000|STARTED|Overall Study||4
11209034|NCT01886105|12400393|FG000|COMPLETED|Overall Study||1
11209035|NCT01886105|12400393|FG000|NOT COMPLETED|Overall Study||3
11209036|NCT01886235|12400398|FG000|STARTED|Overall Study||10
11209037|NCT01886235|12400398|FG000|COMPLETED|Overall Study||10
11209038|NCT01886235|12400398|FG000|NOT COMPLETED|Overall Study||0
11209039|NCT01886287|12400402|FG000|STARTED|Overall Study||2
11209040|NCT01886287|12400402|FG000|COMPLETED|Overall Study||0
11209041|NCT01886287|12400402|FG000|NOT COMPLETED|Overall Study||2
11209042|NCT01886300|12400406|FG000|STARTED|Overall Study||16
11209043|NCT01886300|12400406|FG000|COMPLETED|Overall Study||0
11209044|NCT01886300|12400406|FG000|NOT COMPLETED|Overall Study||16
11209045|NCT01886313|12400412|FG000|STARTED|Overall Study||6
11209046|NCT01886313|12400413|FG001|STARTED|Overall Study||5
11209047|NCT01886313|12400412|FG000|COMPLETED|Overall Study||5
11209048|NCT01886313|12400413|FG001|COMPLETED|Overall Study||4
11209049|NCT01886313|12400412|FG000|NOT COMPLETED|Overall Study||1
11209050|NCT01886313|12400413|FG001|NOT COMPLETED|Overall Study||1
11209051|NCT01886378|12400419|FG000|STARTED|Overall Study||29
11209052|NCT01886378|12400419|FG000|Completed 24 Weeks of UX007 Treatment|Overall Study||25
11209053|NCT01886378|12400419|FG000|COMPLETED|Overall Study||24
11209054|NCT01886378|12400419|FG000|NOT COMPLETED|Overall Study||5
11209055|NCT01886690|12400425|FG000|STARTED|Overall Study||75
11209056|NCT01886690|12400426|FG001|STARTED|Overall Study||73
11096112|NCT01205126|12279743|FG000|STARTED|Between Titration & Maintenance Phase||107
11096113|NCT01205126|12279744|FG001|STARTED|Between Titration & Maintenance Phase||111
11096114|NCT01205126|12279743|FG000|COMPLETED|Between Titration & Maintenance Phase||107
11096115|NCT01205126|12279744|FG001|COMPLETED|Between Titration & Maintenance Phase||107
11096116|NCT01205126|12279743|FG000|NOT COMPLETED|Between Titration & Maintenance Phase||0
11096117|NCT01205126|12279744|FG001|NOT COMPLETED|Between Titration & Maintenance Phase||4
11096118|NCT01205126|12279743|FG000|STARTED|Maintenance Phase||107
11096119|NCT01205126|12279744|FG001|STARTED|Maintenance Phase||107
11096120|NCT01205126|12279743|FG000|COMPLETED|Maintenance Phase||70
11096121|NCT01205126|12279744|FG001|COMPLETED|Maintenance Phase||67
11209057|NCT01886690|12400425|FG000|COMPLETED|Overall Study||75
11209058|NCT01886690|12400426|FG001|COMPLETED|Overall Study||71
11209059|NCT01886690|12400425|FG000|NOT COMPLETED|Overall Study||0
11209060|NCT01886690|12400426|FG001|NOT COMPLETED|Overall Study||2
11209061|NCT01886716|12400436|FG000|STARTED|Week 1||24
11209062|NCT01886716|12400437|FG001|STARTED|Week 1||20
11209063|NCT01886716|12400438|FG002|STARTED|Week 1||22
11209064|NCT01886716|12400439|FG003|STARTED|Week 1||20
11209065|NCT01886716|12400436|FG000|COMPLETED|Week 1||24
11209066|NCT01886716|12400437|FG001|COMPLETED|Week 1||20
11209067|NCT01886716|12400438|FG002|COMPLETED|Week 1||20
11209068|NCT01886716|12400439|FG003|COMPLETED|Week 1||18
11209069|NCT01886716|12400436|FG000|NOT COMPLETED|Week 1||0
11209070|NCT01886716|12400437|FG001|NOT COMPLETED|Week 1||0
11209071|NCT01886716|12400438|FG002|NOT COMPLETED|Week 1||2
11209072|NCT01886716|12400439|FG003|NOT COMPLETED|Week 1||2
11209073|NCT01886716|12400436|FG000|STARTED|Week 2||24
11209074|NCT01886716|12400437|FG001|STARTED|Week 2||20
11209075|NCT01886716|12400438|FG002|STARTED|Week 2||20
11209076|NCT01886716|12400439|FG003|STARTED|Week 2||18
11209077|NCT01886716|12400436|FG000|COMPLETED|Week 2||21
11209078|NCT01886716|12400437|FG001|COMPLETED|Week 2||18
11209079|NCT01886716|12400438|FG002|COMPLETED|Week 2||19
11209080|NCT01886716|12400439|FG003|COMPLETED|Week 2||15
11209081|NCT01886716|12400436|FG000|NOT COMPLETED|Week 2||3
11209082|NCT01886716|12400437|FG001|NOT COMPLETED|Week 2||2
11209083|NCT01886716|12400438|FG002|NOT COMPLETED|Week 2||1
11209084|NCT01886716|12400439|FG003|NOT COMPLETED|Week 2||3
11209085|NCT01886716|12400436|FG000|STARTED|Week 3||21
11209086|NCT01886716|12400437|FG001|STARTED|Week 3||18
11209087|NCT01886716|12400438|FG002|STARTED|Week 3||19
11209088|NCT01886716|12400439|FG003|STARTED|Week 3||15
11096122|NCT01205126|12279743|FG000|NOT COMPLETED|Maintenance Phase||37
11209089|NCT01886716|12400436|FG000|COMPLETED|Week 3||20
11209090|NCT01886716|12400437|FG001|COMPLETED|Week 3||17
11209091|NCT01886716|12400438|FG002|COMPLETED|Week 3||19
11209092|NCT01886716|12400439|FG003|COMPLETED|Week 3||14
11209093|NCT01886716|12400436|FG000|NOT COMPLETED|Week 3||1
11209094|NCT01886716|12400437|FG001|NOT COMPLETED|Week 3||1
11209095|NCT01886716|12400438|FG002|NOT COMPLETED|Week 3||0
11209096|NCT01886716|12400439|FG003|NOT COMPLETED|Week 3||1
11209097|NCT01886716|12400436|FG000|STARTED|Week 4||20
11209098|NCT01886716|12400437|FG001|STARTED|Week 4||17
11209099|NCT01886716|12400438|FG002|STARTED|Week 4||19
11209100|NCT01886716|12400439|FG003|STARTED|Week 4||14
11209101|NCT01886716|12400436|FG000|COMPLETED|Week 4||20
11209102|NCT01886716|12400437|FG001|COMPLETED|Week 4||17
11209103|NCT01886716|12400438|FG002|COMPLETED|Week 4||19
11209104|NCT01886716|12400439|FG003|COMPLETED|Week 4||14
11209105|NCT01886716|12400436|FG000|NOT COMPLETED|Week 4||0
11209106|NCT01886716|12400437|FG001|NOT COMPLETED|Week 4||0
11209107|NCT01886716|12400438|FG002|NOT COMPLETED|Week 4||0
11209108|NCT01886716|12400439|FG003|NOT COMPLETED|Week 4||0
11209109|NCT01886716|12400436|FG000|STARTED|1-Week Post Follow-Up||20
11209110|NCT01886716|12400437|FG001|STARTED|1-Week Post Follow-Up||17
11209111|NCT01886716|12400438|FG002|STARTED|1-Week Post Follow-Up||19
11209112|NCT01886716|12400439|FG003|STARTED|1-Week Post Follow-Up||14
11209113|NCT01886716|12400436|FG000|COMPLETED|1-Week Post Follow-Up||20
11209114|NCT01886716|12400437|FG001|COMPLETED|1-Week Post Follow-Up||17
11209115|NCT01886716|12400438|FG002|COMPLETED|1-Week Post Follow-Up||19
11209116|NCT01886716|12400439|FG003|COMPLETED|1-Week Post Follow-Up||14
11209117|NCT01886716|12400436|FG000|NOT COMPLETED|1-Week Post Follow-Up||0
11209118|NCT01886716|12400437|FG001|NOT COMPLETED|1-Week Post Follow-Up||0
11209119|NCT01886716|12400438|FG002|NOT COMPLETED|1-Week Post Follow-Up||0
11209120|NCT01886716|12400439|FG003|NOT COMPLETED|1-Week Post Follow-Up||0
11209121|NCT01886716|12400436|FG000|STARTED|1-Month Post Follow-Up||20
11209122|NCT01886716|12400437|FG001|STARTED|1-Month Post Follow-Up||17
11209123|NCT01886716|12400438|FG002|STARTED|1-Month Post Follow-Up||19
11209124|NCT01886716|12400439|FG003|STARTED|1-Month Post Follow-Up||14
11209125|NCT01886716|12400436|FG000|COMPLETED|1-Month Post Follow-Up||20
11209126|NCT01886716|12400437|FG001|COMPLETED|1-Month Post Follow-Up||17
11209127|NCT01886716|12400438|FG002|COMPLETED|1-Month Post Follow-Up||19
11209128|NCT01886716|12400439|FG003|COMPLETED|1-Month Post Follow-Up||14
11209129|NCT01886716|12400436|FG000|NOT COMPLETED|1-Month Post Follow-Up||0
11209130|NCT01886716|12400437|FG001|NOT COMPLETED|1-Month Post Follow-Up||0
11209131|NCT01886716|12400438|FG002|NOT COMPLETED|1-Month Post Follow-Up||0
11209132|NCT01886716|12400439|FG003|NOT COMPLETED|1-Month Post Follow-Up||0
11209133|NCT01886781|12400451|FG000|STARTED|Overall Study||54
11209134|NCT01886781|12400452|FG001|STARTED|Overall Study||27
11209135|NCT01886781|12400451|FG000|COMPLETED|Overall Study||40
11209136|NCT01886781|12400452|FG001|COMPLETED|Overall Study||25
11209137|NCT01886781|12400451|FG000|NOT COMPLETED|Overall Study||14
11209138|NCT01886781|12400452|FG001|NOT COMPLETED|Overall Study||2
11209139|NCT01886807|12400461|FG000|STARTED|Overall Study||164
11209140|NCT01886807|12400462|FG001|STARTED|Overall Study||155
11209141|NCT01886807|12400463|FG002|STARTED|Overall Study||163
11209142|NCT01886807|12400461|FG000|COMPLETED|Overall Study||159
11209143|NCT01886807|12400462|FG001|COMPLETED|Overall Study||145
11209144|NCT01886807|12400463|FG002|COMPLETED|Overall Study||153
11209145|NCT01886807|12400461|FG000|NOT COMPLETED|Overall Study||5
11209146|NCT01886807|12400462|FG001|NOT COMPLETED|Overall Study||10
11209147|NCT01886807|12400463|FG002|NOT COMPLETED|Overall Study||10
11209148|NCT01886833|12400474|FG000|STARTED|Overall Study||420
11209149|NCT01886833|12400474|FG000|COMPLETED|Overall Study||216
11209150|NCT01886833|12400474|FG000|NOT COMPLETED|Overall Study||204
11209151|NCT01886937|12400483|FG000|STARTED|Overall Study||7
11209152|NCT01886937|12400484|FG001|STARTED|Overall Study||6
11209153|NCT01886937|12400483|FG000|COMPLETED|Overall Study||7
11209154|NCT01886937|12400484|FG001|COMPLETED|Overall Study||6
11209155|NCT01886937|12400483|FG000|NOT COMPLETED|Overall Study||0
11209156|NCT01886937|12400484|FG001|NOT COMPLETED|Overall Study||0
11209157|NCT01887132|12400490|FG000|STARTED|Overall Study||4
11209158|NCT01887132|12400490|FG000|COMPLETED|Overall Study||4
11209159|NCT01887132|12400490|FG000|NOT COMPLETED|Overall Study||0
11209160|NCT01887171|12400496|FG000|STARTED|Overall Study||43
11209161|NCT01887171|12400497|FG001|STARTED|Overall Study||43
11209162|NCT01887171|12400496|FG000|COMPLETED|Overall Study||43
11209163|NCT01887171|12400497|FG001|COMPLETED|Overall Study||43
11209164|NCT01887171|12400496|FG000|NOT COMPLETED|Overall Study||0
11209165|NCT01887171|12400497|FG001|NOT COMPLETED|Overall Study||0
11209166|NCT01887210|12400505|FG000|STARTED|Overall Study||33
11209167|NCT01887210|12400506|FG001|STARTED|Overall Study||33
11209168|NCT01887210|12400505|FG000|COMPLETED|Overall Study||32
11209169|NCT01887210|12400506|FG001|COMPLETED|Overall Study||29
11209170|NCT01887210|12400505|FG000|NOT COMPLETED|Overall Study||1
11209171|NCT01887210|12400506|FG001|NOT COMPLETED|Overall Study||4
11209172|NCT01887327|12400515|FG000|STARTED|Overall Study||30
11209173|NCT01887327|12400516|FG001|STARTED|Overall Study||31
11209174|NCT01887327|12400517|FG002|STARTED|Overall Study||30
11209175|NCT01887327|12400515|FG000|COMPLETED|Overall Study||29
11209176|NCT01887327|12400516|FG001|COMPLETED|Overall Study||27
11209177|NCT01887327|12400517|FG002|COMPLETED|Overall Study||27
11209178|NCT01887327|12400515|FG000|NOT COMPLETED|Overall Study||1
11209179|NCT01887327|12400516|FG001|NOT COMPLETED|Overall Study||4
11209180|NCT01887327|12400517|FG002|NOT COMPLETED|Overall Study||3
11209181|NCT01887353|12400528|FG000|STARTED|Overall Study||4
11209182|NCT01887353|12400529|FG001|STARTED|Overall Study||4
11209183|NCT01887353|12400528|FG000|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
11209184|NCT01887353|12400529|FG001|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
11209185|NCT01887353|12400528|FG000|NOT COMPLETED|Overall Study||4
11209186|NCT01887353|12400529|FG001|NOT COMPLETED|Overall Study||3
11209187|NCT01887418|12400538|FG000|STARTED|Overall Study||15
11209188|NCT01887418|12400539|FG001|STARTED|Overall Study||14
11209189|NCT01887418|12400540|FG002|STARTED|Overall Study||10
11209190|NCT01887418|12400538|FG000|COMPLETED|Overall Study||15
11209191|NCT01887418|12400539|FG001|COMPLETED|Overall Study||14
11209192|NCT01887418|12400540|FG002|COMPLETED|Overall Study||9
11209193|NCT01887418|12400538|FG000|NOT COMPLETED|Overall Study||0
11209194|NCT01887418|12400539|FG001|NOT COMPLETED|Overall Study||0
11209195|NCT01887418|12400540|FG002|NOT COMPLETED|Overall Study||1
11209196|NCT01887470|12400552|FG000|STARTED|Overall Study||10
11209197|NCT01887470|12400553|FG001|STARTED|Overall Study||10
11209198|NCT01887470|12400554|FG002|STARTED|Overall Study||10
11209199|NCT01887470|12400555|FG003|STARTED|Overall Study||10
11209200|NCT01887470|12400552|FG000|COMPLETED|Overall Study||10
11209201|NCT01887470|12400553|FG001|COMPLETED|Overall Study||10
11209202|NCT01887470|12400554|FG002|COMPLETED|Overall Study||10
11209203|NCT01887470|12400555|FG003|COMPLETED|Overall Study||10
11209204|NCT01887470|12400552|FG000|NOT COMPLETED|Overall Study||0
11209205|NCT01887470|12400553|FG001|NOT COMPLETED|Overall Study||0
11209206|NCT01887470|12400554|FG002|NOT COMPLETED|Overall Study||0
11209207|NCT01887470|12400555|FG003|NOT COMPLETED|Overall Study||0
11209208|NCT01887587|12400565|FG000|STARTED|Overall Study||5
11209209|NCT01887587|12400565|FG000|COMPLETED|Overall Study||5
11209210|NCT01887587|12400565|FG000|NOT COMPLETED|Overall Study||0
11209211|NCT01887600|12400572|FG000|STARTED|Overall Study||391
11209212|NCT01887600|12400573|FG001|STARTED|Overall Study||203
11209213|NCT01887600|12400572|FG000|Treatment Received|Overall Study||391
11209214|NCT01887600|12400573|FG001|Treatment Received|Overall Study||203
11209215|NCT01887600|12400572|FG000|COMPLETED|Overall Study||245
11209216|NCT01887600|12400573|FG001|COMPLETED|Overall Study||89
11209217|NCT01887600|12400572|FG000|NOT COMPLETED|Overall Study||146
11209218|NCT01887600|12400573|FG001|NOT COMPLETED|Overall Study||114
11209219|NCT01887678|12400582|FG000|STARTED|Overall Study||119
11209220|NCT01887678|12400583|FG001|STARTED|Overall Study||113
11209221|NCT01887678|12400582|FG000|COMPLETED|Overall Study||102
11209222|NCT01887678|12400583|FG001|COMPLETED|Overall Study||85
11209223|NCT01887678|12400582|FG000|NOT COMPLETED|Overall Study||17
11209224|NCT01887678|12400583|FG001|NOT COMPLETED|Overall Study||28
11209225|NCT01887717|12400591|FG000|STARTED|Overall Study||17
11209226|NCT01887717|12400592|FG001|STARTED|Overall Study||19
11209227|NCT01887717|12400591|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
11209228|NCT01887717|12400592|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
11209229|NCT01887717|12400591|FG000|COMPLETED|Overall Study||11
11209230|NCT01887717|12400592|FG001|COMPLETED|Overall Study||8
11209231|NCT01887717|12400591|FG000|NOT COMPLETED|Overall Study||6
11209232|NCT01887717|12400592|FG001|NOT COMPLETED|Overall Study||11
11209233|NCT01887990|12400602|FG000|STARTED|Overall Study||7
11209234|NCT01887990|12400603|FG001|STARTED|Overall Study||7
11209235|NCT01887990|12400604|FG002|STARTED|Overall Study||2
11209236|NCT01887990|12400605|FG003|STARTED|Overall Study||2
11209237|NCT01887990|12400602|FG000|COMPLETED|Overall Study||7
11209238|NCT01887990|12400603|FG001|COMPLETED|Overall Study||7
11209239|NCT01887990|12400604|FG002|COMPLETED|Overall Study||2
11209240|NCT01887990|12400605|FG003|COMPLETED|Overall Study||2
11209241|NCT01887990|12400602|FG000|NOT COMPLETED|Overall Study||0
11209242|NCT01887990|12400603|FG001|NOT COMPLETED|Overall Study||0
11209243|NCT01887990|12400604|FG002|NOT COMPLETED|Overall Study||0
11209244|NCT01887990|12400605|FG003|NOT COMPLETED|Overall Study||0
11209245|NCT01888003|12400620|FG000|STARTED|Overall Study||5
11209246|NCT01888003|12400621|FG001|STARTED|Overall Study||6
11209247|NCT01888003|12400622|FG002|STARTED|Overall Study||40
11096123|NCT01205126|12279744|FG001|NOT COMPLETED|Maintenance Phase||40
11096124|NCT01205152|12279750|FG000|STARTED|Overall Study||10
11096125|NCT01205152|12279750|FG000|COMPLETED|Overall Study||9
11096126|NCT01205152|12279750|FG000|NOT COMPLETED|Overall Study||1
11096127|NCT01205165|12279756|FG000|STARTED|Overall Study||104
11096128|NCT01205165|12279756|FG000|COMPLETED|Overall Study||102
11096129|NCT01205165|12279756|FG000|NOT COMPLETED|Overall Study||2
11096130|NCT01205230|12279763|FG000|STARTED|Overall Study||21
11096131|NCT01205230|12279764|FG001|STARTED|Overall Study||13
11096132|NCT01205230|12279763|FG000|Combination Therapy|Overall Study||21
11096133|NCT01205230|12279764|FG001|Combination Therapy|Overall Study||13
11096134|NCT01205230|12279763|FG000|COMPLETED|Overall Study||16
11096135|NCT01205230|12279764|FG001|COMPLETED|Overall Study||13
11096136|NCT01205230|12279763|FG000|NOT COMPLETED|Overall Study||5
11096137|NCT01205230|12279764|FG001|NOT COMPLETED|Overall Study||0
11096138|NCT01205269|12279775|FG000|STARTED|Period 1 - First Intervention||4
11096139|NCT01205269|12279776|FG001|STARTED|Period 1 - First Intervention||4
11209248|NCT01888003|12400620|FG000|COMPLETED|Overall Study||0
11209249|NCT01888003|12400621|FG001|COMPLETED|Overall Study||0
11209250|NCT01888003|12400622|FG002|COMPLETED|Overall Study||0
11209251|NCT01888003|12400620|FG000|NOT COMPLETED|Overall Study||5
11209252|NCT01888003|12400621|FG001|NOT COMPLETED|Overall Study||6
11209253|NCT01888003|12400622|FG002|NOT COMPLETED|Overall Study||40
11209254|NCT01888367|12400633|FG000|STARTED|Overall Study||296
11209255|NCT01888367|12400634|FG001|STARTED|Overall Study||71
11209256|NCT01888367|12400635|FG002|STARTED|Overall Study||78
11209257|NCT01888367|12400633|FG000|COMPLETED|Overall Study||288
11352351|NCT03045887|12549453|FG007|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
11352352|NCT03045887|12549454|FG008|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
11352353|NCT03045887|12549455|FG009|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
11352354|NCT03045887|12549446|FG000|STARTED|Part A, Period 2 (1 Day)||4
11209258|NCT01888367|12400634|FG001|COMPLETED|Overall Study||66
11209259|NCT01888367|12400635|FG002|COMPLETED|Overall Study||73
11209260|NCT01888367|12400633|FG000|NOT COMPLETED|Overall Study||8
11209261|NCT01888367|12400634|FG001|NOT COMPLETED|Overall Study||5
11209262|NCT01888367|12400635|FG002|NOT COMPLETED|Overall Study||5
11352355|NCT03045887|12549447|FG001|STARTED|Part A, Period 2 (1 Day)||4
11352356|NCT03045887|12549448|FG002|STARTED|Part A, Period 2 (1 Day)||5
11352357|NCT03045887|12549449|FG003|STARTED|Part A, Period 2 (1 Day)||4
11096140|NCT01205269|12279777|FG002|STARTED|Period 1 - First Intervention||4
11096141|NCT01205269|12279778|FG003|STARTED|Period 1 - First Intervention||6
11096142|NCT01205269|12279779|FG004|STARTED|Period 1 - First Intervention||5
11096143|NCT01205269|12279780|FG005|STARTED|Period 1 - First Intervention||5
11096144|NCT01205269|12279775|FG000|COMPLETED|Period 1 - First Intervention||4
11096145|NCT01205269|12279776|FG001|COMPLETED|Period 1 - First Intervention||4
11096146|NCT01205269|12279777|FG002|COMPLETED|Period 1 - First Intervention||4
11096147|NCT01205269|12279778|FG003|COMPLETED|Period 1 - First Intervention||6
11096148|NCT01205269|12279779|FG004|COMPLETED|Period 1 - First Intervention||5
11096149|NCT01205269|12279780|FG005|COMPLETED|Period 1 - First Intervention||5
11096150|NCT01205269|12279775|FG000|NOT COMPLETED|Period 1 - First Intervention||0
11096151|NCT01205269|12279776|FG001|NOT COMPLETED|Period 1 - First Intervention||0
11096152|NCT01205269|12279777|FG002|NOT COMPLETED|Period 1 - First Intervention||0
11096153|NCT01205269|12279778|FG003|NOT COMPLETED|Period 1 - First Intervention||0
11096154|NCT01205269|12279779|FG004|NOT COMPLETED|Period 1 - First Intervention||0
11096155|NCT01205269|12279780|FG005|NOT COMPLETED|Period 1 - First Intervention||0
11096156|NCT01205269|12279775|FG000|STARTED|Period 2 - Washout||4
11096157|NCT01205269|12279776|FG001|STARTED|Period 2 - Washout||4
11096158|NCT01205269|12279777|FG002|STARTED|Period 2 - Washout||4
11096159|NCT01205269|12279778|FG003|STARTED|Period 2 - Washout||6
11096160|NCT01205269|12279779|FG004|STARTED|Period 2 - Washout||5
11096161|NCT01205269|12279780|FG005|STARTED|Period 2 - Washout||5
11096162|NCT01205269|12279775|FG000|COMPLETED|Period 2 - Washout||4
11096163|NCT01205269|12279776|FG001|COMPLETED|Period 2 - Washout||4
11096164|NCT01205269|12279777|FG002|COMPLETED|Period 2 - Washout||4
11096165|NCT01205269|12279778|FG003|COMPLETED|Period 2 - Washout||6
11096166|NCT01205269|12279779|FG004|COMPLETED|Period 2 - Washout||5
11096167|NCT01205269|12279780|FG005|COMPLETED|Period 2 - Washout||5
11096168|NCT01205269|12279775|FG000|NOT COMPLETED|Period 2 - Washout||0
11096169|NCT01205269|12279776|FG001|NOT COMPLETED|Period 2 - Washout||0
11096170|NCT01205269|12279777|FG002|NOT COMPLETED|Period 2 - Washout||0
11096171|NCT01205269|12279778|FG003|NOT COMPLETED|Period 2 - Washout||0
11096172|NCT01205269|12279779|FG004|NOT COMPLETED|Period 2 - Washout||0
11096173|NCT01205269|12279780|FG005|NOT COMPLETED|Period 2 - Washout||0
11096174|NCT01205269|12279775|FG000|STARTED|Period 3 - Second Intervention||4
11096175|NCT01205269|12279776|FG001|STARTED|Period 3 - Second Intervention||4
11096176|NCT01205269|12279777|FG002|STARTED|Period 3 - Second Intervention||4
11096177|NCT01205269|12279778|FG003|STARTED|Period 3 - Second Intervention||6
11096178|NCT01205269|12279779|FG004|STARTED|Period 3 - Second Intervention||5
11209263|NCT01888432|12400645|FG000|STARTED|12-month Analysis (FAS)||142
11209264|NCT01888432|12400646|FG001|STARTED|12-month Analysis (FAS)||142
11209265|NCT01888432|12400645|FG000|COMPLETED|12-month Analysis (FAS)||131
11209266|NCT01888432|12400646|FG001|COMPLETED|12-month Analysis (FAS)||133
11209267|NCT01888432|12400645|FG000|NOT COMPLETED|12-month Analysis (FAS)||11
11209268|NCT01888432|12400646|FG001|NOT COMPLETED|12-month Analysis (FAS)||9
11209269|NCT01888432|12400645|FG000|STARTED|24-month Analysis (FAS)||142
11209270|NCT01888432|12400646|FG001|STARTED|24-month Analysis (FAS)||142
11209271|NCT01888432|12400645|FG000|COMPLETED|24-month Analysis (FAS)||125
11209272|NCT01888432|12400646|FG001|COMPLETED|24-month Analysis (FAS)||125
11209273|NCT01888432|12400645|FG000|NOT COMPLETED|24-month Analysis (FAS)||17
11209274|NCT01888432|12400646|FG001|NOT COMPLETED|24-month Analysis (FAS)||17
11209275|NCT01888432|12400645|FG000|STARTED|36-month Analysis (Extension)||13
11209276|NCT01888432|12400646|FG001|STARTED|36-month Analysis (Extension)||5
11209277|NCT01888432|12400645|FG000|COMPLETED|36-month Analysis (Extension)||12
11209278|NCT01888432|12400646|FG001|COMPLETED|36-month Analysis (Extension)||5
11209279|NCT01888432|12400645|FG000|NOT COMPLETED|36-month Analysis (Extension)||1
11209280|NCT01888432|12400646|FG001|NOT COMPLETED|36-month Analysis (Extension)||0
11209281|NCT01888484|12400654|FG000|STARTED|Overall Study||12
11096179|NCT01205269|12279780|FG005|STARTED|Period 3 - Second Intervention||5
11096180|NCT01205269|12279775|FG000|COMPLETED|Period 3 - Second Intervention||4
11096181|NCT01205269|12279776|FG001|COMPLETED|Period 3 - Second Intervention||4
11096182|NCT01205269|12279777|FG002|COMPLETED|Period 3 - Second Intervention||4
11096183|NCT01205269|12279778|FG003|COMPLETED|Period 3 - Second Intervention||6
11096184|NCT01205269|12279779|FG004|COMPLETED|Period 3 - Second Intervention||5
11096185|NCT01205269|12279780|FG005|COMPLETED|Period 3 - Second Intervention||5
11096186|NCT01205269|12279775|FG000|NOT COMPLETED|Period 3 - Second Intervention||0
11209282|NCT01888484|12400655|FG001|STARTED|Overall Study||14
11209283|NCT01888484|12400656|FG002|STARTED|Overall Study||12
11209284|NCT01888484|12400657|FG003|STARTED|Overall Study||37
11209285|NCT01888484|12400654|FG000|COMPLETED|Overall Study||12
11209286|NCT01888484|12400655|FG001|COMPLETED|Overall Study||14
11209287|NCT01888484|12400656|FG002|COMPLETED|Overall Study||8
11209288|NCT01888484|12400657|FG003|COMPLETED|Overall Study||34
11209289|NCT01888484|12400654|FG000|NOT COMPLETED|Overall Study||0
11209290|NCT01888484|12400655|FG001|NOT COMPLETED|Overall Study||0
11209291|NCT01888484|12400656|FG002|NOT COMPLETED|Overall Study||4
11209292|NCT01888484|12400657|FG003|NOT COMPLETED|Overall Study||3
11209293|NCT01888497|12400662|FG000|STARTED|First Intervention Period||13
11209294|NCT01888497|12400663|FG001|STARTED|First Intervention Period||14
11209295|NCT01888497|12400664|FG002|STARTED|First Intervention Period||15
11209296|NCT01888497|12400665|FG003|STARTED|First Intervention Period||17
11209297|NCT01888497|12400662|FG000|COMPLETED|First Intervention Period||13
11209298|NCT01888497|12400663|FG001|COMPLETED|First Intervention Period||14
11209299|NCT01888497|12400664|FG002|COMPLETED|First Intervention Period||15
11209300|NCT01888497|12400665|FG003|COMPLETED|First Intervention Period||17
11209301|NCT01888497|12400662|FG000|NOT COMPLETED|First Intervention Period||0
11209302|NCT01888497|12400663|FG001|NOT COMPLETED|First Intervention Period||0
11209303|NCT01888497|12400664|FG002|NOT COMPLETED|First Intervention Period||0
11209304|NCT01888497|12400665|FG003|NOT COMPLETED|First Intervention Period||0
11209305|NCT01888497|12400662|FG000|STARTED|Washout Period 1||13
11209306|NCT01888497|12400663|FG001|STARTED|Washout Period 1||14
11209307|NCT01888497|12400664|FG002|STARTED|Washout Period 1||15
11209308|NCT01888497|12400665|FG003|STARTED|Washout Period 1||17
11209309|NCT01888497|12400662|FG000|COMPLETED|Washout Period 1||13
11209310|NCT01888497|12400663|FG001|COMPLETED|Washout Period 1||14
11209311|NCT01888497|12400664|FG002|COMPLETED|Washout Period 1||14
11209312|NCT01888497|12400665|FG003|COMPLETED|Washout Period 1||16
11209313|NCT01888497|12400662|FG000|NOT COMPLETED|Washout Period 1||0
11209314|NCT01888497|12400663|FG001|NOT COMPLETED|Washout Period 1||0
11209315|NCT01888497|12400664|FG002|NOT COMPLETED|Washout Period 1||1
11209316|NCT01888497|12400665|FG003|NOT COMPLETED|Washout Period 1||1
11209317|NCT01888497|12400662|FG000|STARTED|Second Intervention Period||13
11209318|NCT01888497|12400663|FG001|STARTED|Second Intervention Period||14
11209319|NCT01888497|12400664|FG002|STARTED|Second Intervention Period||14
11209320|NCT01888497|12400665|FG003|STARTED|Second Intervention Period||16
11209321|NCT01888497|12400662|FG000|COMPLETED|Second Intervention Period||13
11209322|NCT01888497|12400663|FG001|COMPLETED|Second Intervention Period||14
11209323|NCT01888497|12400664|FG002|COMPLETED|Second Intervention Period||14
11209324|NCT01888497|12400665|FG003|COMPLETED|Second Intervention Period||16
11209325|NCT01888497|12400662|FG000|NOT COMPLETED|Second Intervention Period||0
11209326|NCT01888497|12400663|FG001|NOT COMPLETED|Second Intervention Period||0
11209327|NCT01888497|12400664|FG002|NOT COMPLETED|Second Intervention Period||0
11209328|NCT01888497|12400665|FG003|NOT COMPLETED|Second Intervention Period||0
11209329|NCT01888497|12400662|FG000|STARTED|Washout Period 2||13
11209330|NCT01888497|12400663|FG001|STARTED|Washout Period 2||14
11209331|NCT01888497|12400664|FG002|STARTED|Washout Period 2||14
11209332|NCT01888497|12400665|FG003|STARTED|Washout Period 2||16
11209333|NCT01888497|12400662|FG000|COMPLETED|Washout Period 2||13
11209334|NCT01888497|12400663|FG001|COMPLETED|Washout Period 2||14
11209335|NCT01888497|12400664|FG002|COMPLETED|Washout Period 2||14
11209336|NCT01888497|12400665|FG003|COMPLETED|Washout Period 2||14
11209337|NCT01888497|12400662|FG000|NOT COMPLETED|Washout Period 2||0
11209338|NCT01888497|12400663|FG001|NOT COMPLETED|Washout Period 2||0
11209339|NCT01888497|12400664|FG002|NOT COMPLETED|Washout Period 2||0
11209340|NCT01888497|12400665|FG003|NOT COMPLETED|Washout Period 2||2
11209341|NCT01888497|12400662|FG000|STARTED|Third Intervention Period||13
11209342|NCT01888497|12400663|FG001|STARTED|Third Intervention Period||14
11209343|NCT01888497|12400664|FG002|STARTED|Third Intervention Period||14
11209344|NCT01888497|12400665|FG003|STARTED|Third Intervention Period||14
11209345|NCT01888497|12400662|FG000|COMPLETED|Third Intervention Period||13
11209346|NCT01888497|12400663|FG001|COMPLETED|Third Intervention Period||14
11209347|NCT01888497|12400664|FG002|COMPLETED|Third Intervention Period||14
11209348|NCT01888497|12400665|FG003|COMPLETED|Third Intervention Period||14
11209349|NCT01888497|12400662|FG000|NOT COMPLETED|Third Intervention Period||0
11209350|NCT01888497|12400663|FG001|NOT COMPLETED|Third Intervention Period||0
11209351|NCT01888497|12400664|FG002|NOT COMPLETED|Third Intervention Period||0
11209352|NCT01888497|12400665|FG003|NOT COMPLETED|Third Intervention Period||0
11209353|NCT01888497|12400662|FG000|STARTED|Washout Period 3||13
11209354|NCT01888497|12400663|FG001|STARTED|Washout Period 3||14
11209355|NCT01888497|12400664|FG002|STARTED|Washout Period 3||14
11209356|NCT01888497|12400665|FG003|STARTED|Washout Period 3||14
11209357|NCT01888497|12400662|FG000|COMPLETED|Washout Period 3||13
11209358|NCT01888497|12400663|FG001|COMPLETED|Washout Period 3||14
11209359|NCT01888497|12400664|FG002|COMPLETED|Washout Period 3||14
11209360|NCT01888497|12400665|FG003|COMPLETED|Washout Period 3||14
11209361|NCT01888497|12400662|FG000|NOT COMPLETED|Washout Period 3||0
11209362|NCT01888497|12400663|FG001|NOT COMPLETED|Washout Period 3||0
11209363|NCT01888497|12400664|FG002|NOT COMPLETED|Washout Period 3||0
11209364|NCT01888497|12400665|FG003|NOT COMPLETED|Washout Period 3||0
11209365|NCT01888497|12400662|FG000|STARTED|Fourth Intervention Period||13
11209366|NCT01888497|12400663|FG001|STARTED|Fourth Intervention Period||14
11209367|NCT01888497|12400664|FG002|STARTED|Fourth Intervention Period||14
11209368|NCT01888497|12400665|FG003|STARTED|Fourth Intervention Period||14
11209369|NCT01888497|12400662|FG000|COMPLETED|Fourth Intervention Period||13
11209370|NCT01888497|12400663|FG001|COMPLETED|Fourth Intervention Period||14
11209371|NCT01888497|12400664|FG002|COMPLETED|Fourth Intervention Period||14
11209372|NCT01888497|12400665|FG003|COMPLETED|Fourth Intervention Period||14
11209373|NCT01888497|12400662|FG000|NOT COMPLETED|Fourth Intervention Period||0
11209374|NCT01888497|12400663|FG001|NOT COMPLETED|Fourth Intervention Period||0
11209375|NCT01888497|12400664|FG002|NOT COMPLETED|Fourth Intervention Period||0
11209376|NCT01888497|12400665|FG003|NOT COMPLETED|Fourth Intervention Period||0
11209377|NCT01888640|12400678|FG000|STARTED|Overall Study||103
11209378|NCT01888640|12400679|FG001|STARTED|Overall Study||99
11209379|NCT01888640|12400680|FG002|STARTED|Overall Study||99
11209380|NCT01888640|12400678|FG000|COMPLETED|Overall Study||76
11209381|NCT01888640|12400679|FG001|COMPLETED|Overall Study||68
11209382|NCT01888640|12400680|FG002|COMPLETED|Overall Study||94
11209383|NCT01888640|12400678|FG000|NOT COMPLETED|Overall Study||27
11209384|NCT01888640|12400679|FG001|NOT COMPLETED|Overall Study||31
11209385|NCT01888640|12400680|FG002|NOT COMPLETED|Overall Study||5
11209386|NCT01888874|12400698|FG000|STARTED|Period 1 (Baseline up to Week 12)||86
11209387|NCT01888874|12400699|FG001|STARTED|Period 1 (Baseline up to Week 12)||82
11209388|NCT01888874|12400700|FG002|STARTED|Period 1 (Baseline up to Week 12)||85
11209389|NCT01888874|12400701|FG003|STARTED|Period 1 (Baseline up to Week 12)||86
11209390|NCT01888874|12400702|FG004|STARTED|Period 1 (Baseline up to Week 12)||86
11209391|NCT01888874|12400703|FG005|STARTED|Period 1 (Baseline up to Week 12)||85
11209392|NCT01888874|12400704|FG006|STARTED|Period 1 (Baseline up to Week 12)||84
11209393|NCT01888874|12400698|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||83
11209394|NCT01888874|12400699|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||76
11209395|NCT01888874|12400700|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||78
11209396|NCT01888874|12400701|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||80
11209397|NCT01888874|12400702|FG004|COMPLETED|Period 1 (Baseline up to Week 12)||77
11209398|NCT01888874|12400703|FG005|COMPLETED|Period 1 (Baseline up to Week 12)||80
11209399|NCT01888874|12400704|FG006|COMPLETED|Period 1 (Baseline up to Week 12)||83
11209400|NCT01888874|12400698|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
11209401|NCT01888874|12400699|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
11209402|NCT01888874|12400700|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
11209403|NCT01888874|12400701|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
11209404|NCT01888874|12400702|FG004|NOT COMPLETED|Period 1 (Baseline up to Week 12)||9
11209405|NCT01888874|12400703|FG005|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
11209406|NCT01888874|12400704|FG006|NOT COMPLETED|Period 1 (Baseline up to Week 12)||1
11209407|NCT01888874|12400698|FG000|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo group moved to 100 mg QD(15 participants) and 50 mg BID(15 participants).|53
11209408|NCT01888874|12400699|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (19 participants).|57
11209409|NCT01888874|12400700|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 50 mg QD (19 participants) moved to 100 mg QD group.|112
11209410|NCT01888874|12400701|FG003|STARTED|Period 2 (Week 13 to Week 24)||80
11209411|NCT01888874|12400702|FG004|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 25 mg BID group moved to 50 mg BID group (17 participants).|60
11209412|NCT01888874|12400703|FG005|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 25 mg BID(17 participants) moved to 50 mg BID group.|112
11209413|NCT01888874|12400704|FG006|STARTED|Period 2 (Week 13 to Week 24)||83
11209414|NCT01888874|12400698|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||50
11209415|NCT01888874|12400699|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||55
11209416|NCT01888874|12400700|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||104
11209417|NCT01888874|12400701|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||78
11209418|NCT01888874|12400702|FG004|COMPLETED|Period 2 (Week 13 to Week 24)||57
11209419|NCT01888874|12400703|FG005|COMPLETED|Period 2 (Week 13 to Week 24)||109
11096187|NCT01205269|12279776|FG001|NOT COMPLETED|Period 3 - Second Intervention||0
11096188|NCT01205269|12279777|FG002|NOT COMPLETED|Period 3 - Second Intervention||0
11096189|NCT01205269|12279778|FG003|NOT COMPLETED|Period 3 - Second Intervention||0
11096190|NCT01205269|12279779|FG004|NOT COMPLETED|Period 3 - Second Intervention||0
11096191|NCT01205269|12279780|FG005|NOT COMPLETED|Period 3 - Second Intervention||0
11096192|NCT01205269|12279775|FG000|STARTED|Period 4 - Washout||4
11209420|NCT01888874|12400704|FG006|COMPLETED|Period 2 (Week 13 to Week 24)||80
11209421|NCT01888874|12400698|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
11209422|NCT01888874|12400699|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
11209423|NCT01888874|12400700|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||8
11209424|NCT01888874|12400701|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
11209425|NCT01888874|12400702|FG004|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
11209426|NCT01888874|12400703|FG005|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
11209427|NCT01888874|12400704|FG006|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
11209428|NCT01888900|12400723|FG000|STARTED|Overall Study||22
11209429|NCT01888900|12400724|FG001|STARTED|Overall Study||13
11209430|NCT01888900|12400723|FG000|COMPLETED|Overall Study||22
11209431|NCT01888900|12400724|FG001|COMPLETED|Overall Study||11
11209432|NCT01888900|12400723|FG000|NOT COMPLETED|Overall Study||0
11209433|NCT01888900|12400724|FG001|NOT COMPLETED|Overall Study||2
11209434|NCT01888952|12400732|FG000|STARTED|Overall Study||10
11209435|NCT01888952|12400732|FG000|COMPLETED|Overall Study||10
11209436|NCT01888952|12400732|FG000|NOT COMPLETED|Overall Study||0
11209437|NCT01888965|12400736|FG000|STARTED|Overall Study||9
11209438|NCT01888965|12400736|FG000|COMPLETED|Overall Study||0
11209439|NCT01888965|12400736|FG000|NOT COMPLETED|Overall Study||9
11209440|NCT01889069|12400742|FG000|STARTED|Overall Study||158
11209441|NCT01889069|12400742|FG000|COMPLETED|Overall Study||113
11096193|NCT01205269|12279776|FG001|STARTED|Period 4 - Washout||4
11096194|NCT01205269|12279777|FG002|STARTED|Period 4 - Washout||4
11209442|NCT01889069|12400742|FG000|NOT COMPLETED|Overall Study||45
11209443|NCT01889251|12400754|FG000|STARTED|Overall Study||115
11209444|NCT01889251|12400755|FG001|STARTED|Overall Study||57
11209445|NCT01889251|12400754|FG000|COMPLETED|Overall Study||114
11209446|NCT01889251|12400755|FG001|COMPLETED|Overall Study||57
11209447|NCT01889251|12400754|FG000|NOT COMPLETED|Overall Study||1
11209448|NCT01889251|12400755|FG001|NOT COMPLETED|Overall Study||0
11209449|NCT01889355|12400761|FG000|STARTED|Overall Study||115
11209450|NCT01889355|12400761|FG000|COMPLETED|Overall Study||113
11209451|NCT01889355|12400761|FG000|NOT COMPLETED|Overall Study||2
11209452|NCT01889563|12400767|FG000|STARTED|Overall Study||17
11209453|NCT01889563|12400768|FG001|STARTED|Overall Study||15
11209454|NCT01889563|12400767|FG000|COMPLETED|Overall Study||10
11209455|NCT01889563|12400768|FG001|COMPLETED|Overall Study||10
11209456|NCT01889563|12400767|FG000|NOT COMPLETED|Overall Study||7
11209457|NCT01889563|12400768|FG001|NOT COMPLETED|Overall Study||5
11209458|NCT01889602|12400777|FG000|STARTED|First Intervention||20
11209459|NCT01889602|12400778|FG001|STARTED|First Intervention||20
11209460|NCT01889602|12400779|FG002|STARTED|First Intervention||20
11209461|NCT01889602|12400777|FG000|COMPLETED|First Intervention||19
11209462|NCT01889602|12400778|FG001|COMPLETED|First Intervention||17
11209463|NCT01889602|12400779|FG002|COMPLETED|First Intervention||18
11209464|NCT01889602|12400777|FG000|NOT COMPLETED|First Intervention||1
11209465|NCT01889602|12400778|FG001|NOT COMPLETED|First Intervention||3
11209466|NCT01889602|12400779|FG002|NOT COMPLETED|First Intervention||2
11209467|NCT01889602|12400777|FG000|STARTED|First Washout Period of at Least 2 Weeks||19
11209468|NCT01889602|12400778|FG001|STARTED|First Washout Period of at Least 2 Weeks||17
11209469|NCT01889602|12400779|FG002|STARTED|First Washout Period of at Least 2 Weeks||18
11209470|NCT01889602|12400777|FG000|COMPLETED|First Washout Period of at Least 2 Weeks||19
11209471|NCT01889602|12400778|FG001|COMPLETED|First Washout Period of at Least 2 Weeks||17
11209472|NCT01889602|12400779|FG002|COMPLETED|First Washout Period of at Least 2 Weeks||18
11209473|NCT01889602|12400777|FG000|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
11209474|NCT01889602|12400778|FG001|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
11209475|NCT01889602|12400779|FG002|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
11096195|NCT01205269|12279778|FG003|STARTED|Period 4 - Washout||6
11209476|NCT01889602|12400777|FG000|STARTED|Second Intervention||19
11209477|NCT01889602|12400778|FG001|STARTED|Second Intervention||17
11209478|NCT01889602|12400779|FG002|STARTED|Second Intervention||18
11209479|NCT01889602|12400777|FG000|COMPLETED|Second Intervention||18
11209480|NCT01889602|12400778|FG001|COMPLETED|Second Intervention||17
11209481|NCT01889602|12400779|FG002|COMPLETED|Second Intervention||16
11209482|NCT01889602|12400777|FG000|NOT COMPLETED|Second Intervention||1
11209483|NCT01889602|12400778|FG001|NOT COMPLETED|Second Intervention||0
11209484|NCT01889602|12400779|FG002|NOT COMPLETED|Second Intervention||2
11209485|NCT01889602|12400777|FG000|STARTED|Second Washout Period of at Least 2 Week||18
11209486|NCT01889602|12400778|FG001|STARTED|Second Washout Period of at Least 2 Week||17
11209487|NCT01889602|12400779|FG002|STARTED|Second Washout Period of at Least 2 Week||16
11209488|NCT01889602|12400777|FG000|COMPLETED|Second Washout Period of at Least 2 Week||18
11209489|NCT01889602|12400778|FG001|COMPLETED|Second Washout Period of at Least 2 Week||17
11209490|NCT01889602|12400779|FG002|COMPLETED|Second Washout Period of at Least 2 Week||16
11209491|NCT01889602|12400777|FG000|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
11209492|NCT01889602|12400778|FG001|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
11209493|NCT01889602|12400779|FG002|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
11209494|NCT01889602|12400777|FG000|STARTED|Third Intervention||18
11209495|NCT01889602|12400778|FG001|STARTED|Third Intervention||17
11209496|NCT01889602|12400779|FG002|STARTED|Third Intervention||16
11209497|NCT01889602|12400777|FG000|COMPLETED|Third Intervention||15
11209498|NCT01889602|12400778|FG001|COMPLETED|Third Intervention||15
11209499|NCT01889602|12400779|FG002|COMPLETED|Third Intervention||16
11209500|NCT01889602|12400777|FG000|NOT COMPLETED|Third Intervention||3
11209501|NCT01889602|12400778|FG001|NOT COMPLETED|Third Intervention||2
11209502|NCT01889602|12400779|FG002|NOT COMPLETED|Third Intervention||0
11209503|NCT01889602|12400777|FG000|STARTED|Third Washout Period of at Least 2 Weeks||15
11209504|NCT01889602|12400778|FG001|STARTED|Third Washout Period of at Least 2 Weeks||15
11209505|NCT01889602|12400779|FG002|STARTED|Third Washout Period of at Least 2 Weeks||16
11209506|NCT01889602|12400777|FG000|COMPLETED|Third Washout Period of at Least 2 Weeks||15
11209507|NCT01889602|12400778|FG001|COMPLETED|Third Washout Period of at Least 2 Weeks||15
11209508|NCT01889602|12400779|FG002|COMPLETED|Third Washout Period of at Least 2 Weeks||16
11209509|NCT01889602|12400777|FG000|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
11209510|NCT01889602|12400778|FG001|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
11209511|NCT01889602|12400779|FG002|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
11209512|NCT01889667|12400798|FG000|STARTED|Overall Study||10
11209513|NCT01889667|12400799|FG001|STARTED|Overall Study||10
11209514|NCT01889667|12400800|FG002|STARTED|Overall Study||10
11209515|NCT01889667|12400798|FG000|COMPLETED|Overall Study||10
11209516|NCT01889667|12400799|FG001|COMPLETED|Overall Study||10
11209517|NCT01889667|12400800|FG002|COMPLETED|Overall Study||10
11209518|NCT01889667|12400798|FG000|NOT COMPLETED|Overall Study||0
11209519|NCT01889667|12400799|FG001|NOT COMPLETED|Overall Study||0
11209520|NCT01889667|12400800|FG002|NOT COMPLETED|Overall Study||0
11209521|NCT01889797|12400812|FG000|STARTED|Overall Study||16
11209522|NCT01889797|12400813|FG001|STARTED|Overall Study||16
11209523|NCT01889797|12400812|FG000|COMPLETED|Overall Study||16
11209524|NCT01889797|12400813|FG001|COMPLETED|Overall Study||16
11209525|NCT01889797|12400812|FG000|NOT COMPLETED|Overall Study||0
11209526|NCT01889797|12400813|FG001|NOT COMPLETED|Overall Study||0
11209527|NCT01889862|12400819|FG000|STARTED|Part 1 (Up to 13 Weeks)||86
11209528|NCT01889862|12400820|FG001|STARTED|Part 1 (Up to 13 Weeks)||0
11209529|NCT01889862|12400821|FG002|STARTED|Part 1 (Up to 13 Weeks)||78
11209530|NCT01889862|12400822|FG003|STARTED|Part 1 (Up to 13 Weeks)||0
11209531|NCT01889862|12400823|FG004|STARTED|Part 1 (Up to 13 Weeks)||0
11209532|NCT01889862|12400819|FG000|COMPLETED|Part 1 (Up to 13 Weeks)|Out of 164, total 12 subjects have not completed Part 1.|74
11209533|NCT01889862|12400820|FG001|COMPLETED|Part 1 (Up to 13 Weeks)||0
11209534|NCT01889862|12400821|FG002|COMPLETED|Part 1 (Up to 13 Weeks)||78
11209535|NCT01889862|12400822|FG003|COMPLETED|Part 1 (Up to 13 Weeks)||0
11209536|NCT01889862|12400823|FG004|COMPLETED|Part 1 (Up to 13 Weeks)||0
11096196|NCT01205269|12279779|FG004|STARTED|Period 4 - Washout||5
11096197|NCT01205269|12279780|FG005|STARTED|Period 4 - Washout||5
11096198|NCT01205269|12279775|FG000|COMPLETED|Period 4 - Washout||4
11096199|NCT01205269|12279776|FG001|COMPLETED|Period 4 - Washout||4
11096200|NCT01205269|12279777|FG002|COMPLETED|Period 4 - Washout||4
11096201|NCT01205269|12279778|FG003|COMPLETED|Period 4 - Washout||5
11096202|NCT01205269|12279779|FG004|COMPLETED|Period 4 - Washout||5
11096203|NCT01205269|12279780|FG005|COMPLETED|Period 4 - Washout||5
11096204|NCT01205269|12279775|FG000|NOT COMPLETED|Period 4 - Washout||0
11096205|NCT01205269|12279776|FG001|NOT COMPLETED|Period 4 - Washout||0
11096206|NCT01205269|12279777|FG002|NOT COMPLETED|Period 4 - Washout||0
11096207|NCT01205269|12279778|FG003|NOT COMPLETED|Period 4 - Washout||1
11096208|NCT01205269|12279779|FG004|NOT COMPLETED|Period 4 - Washout||0
11096209|NCT01205269|12279780|FG005|NOT COMPLETED|Period 4 - Washout||0
11096210|NCT01205269|12279775|FG000|STARTED|Period 5 - Third Intervention||4
11096211|NCT01205269|12279776|FG001|STARTED|Period 5 - Third Intervention||4
11096212|NCT01205269|12279777|FG002|STARTED|Period 5 - Third Intervention||4
11096213|NCT01205269|12279778|FG003|STARTED|Period 5 - Third Intervention||5
11096214|NCT01205269|12279779|FG004|STARTED|Period 5 - Third Intervention||5
11096215|NCT01205269|12279780|FG005|STARTED|Period 5 - Third Intervention||5
11096216|NCT01205269|12279775|FG000|COMPLETED|Period 5 - Third Intervention||4
11096217|NCT01205269|12279776|FG001|COMPLETED|Period 5 - Third Intervention||4
11096218|NCT01205269|12279777|FG002|COMPLETED|Period 5 - Third Intervention||4
11096219|NCT01205269|12279778|FG003|COMPLETED|Period 5 - Third Intervention||5
11096220|NCT01205269|12279779|FG004|COMPLETED|Period 5 - Third Intervention||5
11096221|NCT01205269|12279780|FG005|COMPLETED|Period 5 - Third Intervention||5
11096222|NCT01205269|12279775|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
11096223|NCT01205269|12279776|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
11096224|NCT01205269|12279777|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
11096225|NCT01205269|12279778|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
11096226|NCT01205269|12279779|FG004|NOT COMPLETED|Period 5 - Third Intervention||0
11096227|NCT01205269|12279780|FG005|NOT COMPLETED|Period 5 - Third Intervention||0
11096228|NCT01205399|12279788|FG000|STARTED|Overall Study||78
11096229|NCT01205399|12279788|FG000|COMPLETED|Overall Study||78
11096230|NCT01205399|12279788|FG000|NOT COMPLETED|Overall Study||0
11096231|NCT01205438|12279795|FG000|STARTED|Overall Study||372
11096232|NCT01205438|12279796|FG001|STARTED|Overall Study||376
11096233|NCT01205438|12279797|FG002|STARTED|Overall Study||376
11096234|NCT01205438|12279795|FG000|Received At Least One Dose of Study Drug|Overall Study||371
11096235|NCT01205438|12279796|FG001|Received At Least One Dose of Study Drug|Overall Study||374
11096236|NCT01205438|12279797|FG002|Received At Least One Dose of Study Drug|Overall Study||376
11096237|NCT01205438|12279795|FG000|Participated in Follow Up|Overall Study||72
11096238|NCT01205438|12279796|FG001|Participated in Follow Up|Overall Study||78
11096239|NCT01205438|12279797|FG002|Participated in Follow Up|Overall Study||66
11096240|NCT01205438|12279795|FG000|COMPLETED|Overall Study||295
11096241|NCT01205438|12279796|FG001|COMPLETED|Overall Study||289
11096242|NCT01205438|12279797|FG002|COMPLETED|Overall Study||288
11096243|NCT01205438|12279795|FG000|NOT COMPLETED|Overall Study||77
11096244|NCT01205438|12279796|FG001|NOT COMPLETED|Overall Study||87
11096245|NCT01205438|12279797|FG002|NOT COMPLETED|Overall Study||88
11096246|NCT01205451|12279810|FG000|STARTED|Overall Study||53
11096247|NCT01205451|12279811|FG001|STARTED|Overall Study||56
11096248|NCT01205451|12279810|FG000|COMPLETED|Overall Study||47
11096249|NCT01205451|12279811|FG001|COMPLETED|Overall Study||46
11096250|NCT01205451|12279810|FG000|NOT COMPLETED|Overall Study||6
11096251|NCT01205451|12279811|FG001|NOT COMPLETED|Overall Study||10
11096252|NCT01205503|12279819|FG000|STARTED|First Intervention (1st Cycle)||16
11096253|NCT01205503|12279820|FG001|STARTED|First Intervention (1st Cycle)||16
11096254|NCT01205503|12279819|FG000|COMPLETED|First Intervention (1st Cycle)||16
11096255|NCT01205503|12279820|FG001|COMPLETED|First Intervention (1st Cycle)||16
11096256|NCT01205503|12279819|FG000|NOT COMPLETED|First Intervention (1st Cycle)||0
11096257|NCT01205503|12279820|FG001|NOT COMPLETED|First Intervention (1st Cycle)||0
11096258|NCT01205503|12279819|FG000|STARTED|Second Intervention (2nd Cycle)||16
11096259|NCT01205503|12279820|FG001|STARTED|Second Intervention (2nd Cycle)||16
11096260|NCT01205503|12279819|FG000|COMPLETED|Second Intervention (2nd Cycle)||16
11096261|NCT01205503|12279820|FG001|COMPLETED|Second Intervention (2nd Cycle)||16
11096262|NCT01205503|12279819|FG000|NOT COMPLETED|Second Intervention (2nd Cycle)||0
11096263|NCT01205503|12279820|FG001|NOT COMPLETED|Second Intervention (2nd Cycle)||0
11096264|NCT01205529|12279826|FG000|STARTED|Overall Study||161
11096265|NCT01205529|12279826|FG000|COMPLETED|Overall Study||106
11096266|NCT01205529|12279826|FG000|NOT COMPLETED|Overall Study||55
11096267|NCT01205568|12279830|FG000|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
11096268|NCT01205568|12279831|FG001|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
11209537|NCT01889862|12400819|FG000|NOT COMPLETED|Part 1 (Up to 13 Weeks)||12
11209538|NCT01889862|12400820|FG001|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
11096269|NCT01205568|12279830|FG000|COMPLETED|Overall Study||65
11096270|NCT01205568|12279831|FG001|COMPLETED|Overall Study||47
11096271|NCT01205568|12279830|FG000|NOT COMPLETED|Overall Study||0
11096272|NCT01205568|12279831|FG001|NOT COMPLETED|Overall Study||0
11096273|NCT01205581|12279841|FG000|STARTED|Overall Study||14
11096274|NCT01205581|12279842|FG001|STARTED|Overall Study||13
11096275|NCT01205581|12279843|FG002|STARTED|Overall Study||8
11096276|NCT01205581|12279844|FG003|STARTED|Overall Study||9
11096277|NCT01205581|12279845|FG004|STARTED|Overall Study||20
11096278|NCT01205581|12279846|FG005|STARTED|Overall Study||20
11096279|NCT01205581|12279841|FG000|COMPLETED|Overall Study||13
11096280|NCT01205581|12279842|FG001|COMPLETED|Overall Study||13
11096281|NCT01205581|12279843|FG002|COMPLETED|Overall Study||8
11096282|NCT01205581|12279844|FG003|COMPLETED|Overall Study||9
11096283|NCT01205581|12279845|FG004|COMPLETED|Overall Study||20
11096284|NCT01205581|12279846|FG005|COMPLETED|Overall Study||20
11096285|NCT01205581|12279841|FG000|NOT COMPLETED|Overall Study||1
11096286|NCT01205581|12279842|FG001|NOT COMPLETED|Overall Study||0
11096287|NCT01205581|12279843|FG002|NOT COMPLETED|Overall Study||0
11096288|NCT01205581|12279844|FG003|NOT COMPLETED|Overall Study||0
11096289|NCT01205581|12279845|FG004|NOT COMPLETED|Overall Study||0
11096290|NCT01205581|12279846|FG005|NOT COMPLETED|Overall Study||0
11096291|NCT01205646|12279877|FG000|STARTED|Overall Study||11
11096292|NCT01205646|12279877|FG000|COMPLETED|Overall Study||11
11096293|NCT01205646|12279877|FG000|NOT COMPLETED|Overall Study||0
11096294|NCT01205685|12279881|FG000|STARTED|Overall Study||11
11096295|NCT01205685|12279881|FG000|COMPLETED|Overall Study||0
11096296|NCT01205685|12279881|FG000|NOT COMPLETED|Overall Study||11
11096297|NCT01205776|12279887|FG000|STARTED|Overall Study||948
11096298|NCT01205776|12279888|FG001|STARTED|Overall Study||957
11096299|NCT01205776|12279887|FG000|COMPLETED|Overall Study||884
11096300|NCT01205776|12279888|FG001|COMPLETED|Overall Study||862
11096301|NCT01205776|12279887|FG000|NOT COMPLETED|Overall Study||64
11096302|NCT01205776|12279888|FG001|NOT COMPLETED|Overall Study||95
11096303|NCT01205828|12279894|FG000|STARTED|Overall Study||16
11096304|NCT01205828|12279894|FG000|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
11096305|NCT01205828|12279894|FG000|NOT COMPLETED|Overall Study||0
11096306|NCT01206062|12279901|FG000|STARTED|Overall Study||4678
11096307|NCT01206062|12279902|FG001|STARTED|Overall Study||4683
11096308|NCT01206062|12279901|FG000|COMPLETED|Overall Study||4678
11096309|NCT01206062|12279902|FG001|COMPLETED|Overall Study||4683
11096310|NCT01206062|12279901|FG000|NOT COMPLETED|Overall Study||0
11096311|NCT01206062|12279902|FG001|NOT COMPLETED|Overall Study||0
11096312|NCT01206140|12279912|FG000|STARTED|Overall Study||35
11096313|NCT01206140|12279913|FG001|STARTED|Overall Study||35
11096314|NCT01206140|12279912|FG000|COMPLETED|Overall Study||34
11096315|NCT01206140|12279913|FG001|COMPLETED|Overall Study||35
11096316|NCT01206140|12279912|FG000|NOT COMPLETED|Overall Study||1
11096317|NCT01206140|12279913|FG001|NOT COMPLETED|Overall Study||0
11096318|NCT01206166|12279921|FG000|STARTED|Overall Study||73
11096319|NCT01206166|12279922|FG001|STARTED|Overall Study||52
11096320|NCT01206166|12279921|FG000|COMPLETED|Overall Study||71
11096321|NCT01206166|12279922|FG001|COMPLETED|Overall Study||49
11096322|NCT01206166|12279921|FG000|NOT COMPLETED|Overall Study||2
11096323|NCT01206166|12279922|FG001|NOT COMPLETED|Overall Study||3
11096324|NCT01206322|12279933|FG000|STARTED|Overall Study||4
11096325|NCT01206322|12279934|FG001|STARTED|Overall Study||11
11096326|NCT01206322|12279935|FG002|STARTED|Overall Study||9
11096327|NCT01206322|12279936|FG003|STARTED|Overall Study||6
11096328|NCT01206322|12279933|FG000|COMPLETED|Overall Study||4
11096329|NCT01206322|12279934|FG001|COMPLETED|Overall Study||11
11096330|NCT01206322|12279935|FG002|COMPLETED|Overall Study||9
11096331|NCT01206322|12279936|FG003|COMPLETED|Overall Study||5
11096332|NCT01206322|12279933|FG000|NOT COMPLETED|Overall Study||0
11096333|NCT01206322|12279934|FG001|NOT COMPLETED|Overall Study||0
11096334|NCT01206322|12279935|FG002|NOT COMPLETED|Overall Study||0
11096335|NCT01206322|12279936|FG003|NOT COMPLETED|Overall Study||1
11096336|NCT01206387|12279948|FG000|STARTED|Overall Study||60
11096337|NCT01206387|12279949|FG001|STARTED|Overall Study||60
11096338|NCT01206387|12279948|FG000|COMPLETED|Overall Study||59
11096339|NCT01206387|12279949|FG001|COMPLETED|Overall Study||60
11096340|NCT01206387|12279948|FG000|NOT COMPLETED|Overall Study||1
11096341|NCT01206387|12279949|FG001|NOT COMPLETED|Overall Study||0
11096342|NCT01206452|12279957|FG000|STARTED|Overall Study||30
11096343|NCT01206452|12279958|FG001|STARTED|Overall Study||30
11096344|NCT01206452|12279957|FG000|COMPLETED|Overall Study||30
11096345|NCT01206452|12279958|FG001|COMPLETED|Overall Study||30
11096346|NCT01206452|12279957|FG000|NOT COMPLETED|Overall Study||0
11096347|NCT01206452|12279958|FG001|NOT COMPLETED|Overall Study||0
11096348|NCT01206465|12279964|FG000|STARTED|Overall Study||3
11096349|NCT01206465|12279965|FG001|STARTED|Overall Study||6
11096350|NCT01206465|12279966|FG002|STARTED|Overall Study||6
11096351|NCT01206465|12279967|FG003|STARTED|Overall Study||6
11096352|NCT01206465|12279968|FG004|STARTED|Overall Study||6
11096353|NCT01206465|12279964|FG000|COMPLETED|Overall Study||3
11096354|NCT01206465|12279965|FG001|COMPLETED|Overall Study||6
11096355|NCT01206465|12279966|FG002|COMPLETED|Overall Study||6
11096356|NCT01206465|12279967|FG003|COMPLETED|Overall Study||6
11096357|NCT01206465|12279968|FG004|COMPLETED|Overall Study||6
11096358|NCT01206465|12279964|FG000|NOT COMPLETED|Overall Study||0
11096359|NCT01206465|12279965|FG001|NOT COMPLETED|Overall Study||0
11096360|NCT01206465|12279966|FG002|NOT COMPLETED|Overall Study||0
11096361|NCT01206465|12279967|FG003|NOT COMPLETED|Overall Study||0
11096362|NCT01206465|12279968|FG004|NOT COMPLETED|Overall Study||0
11096363|NCT01206478|12279986|FG000|STARTED|Overall Study||9
11096364|NCT01206478|12279987|FG001|STARTED|Overall Study||12
11096365|NCT01206478|12279986|FG000|COMPLETED|Overall Study||7
11096366|NCT01206478|12279987|FG001|COMPLETED|Overall Study||7
11096367|NCT01206478|12279986|FG000|NOT COMPLETED|Overall Study||2
11096368|NCT01206478|12279987|FG001|NOT COMPLETED|Overall Study||5
11096369|NCT01206582|12279995|FG000|STARTED|Overall Study||11
11096370|NCT01206582|12279996|FG001|STARTED|Overall Study||9
11209539|NCT01889862|12400821|FG002|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
11209540|NCT01889862|12400822|FG003|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
11209541|NCT01889862|12400823|FG004|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
11209542|NCT01889862|12400819|FG000|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|34
11209543|NCT01889862|12400820|FG001|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|15
11209544|NCT01889862|12400821|FG002|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|32
11209545|NCT01889862|12400822|FG003|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|14
11209546|NCT01889862|12400823|FG004|STARTED|Part 2 (8 Weeks)||0
11209547|NCT01889862|12400819|FG000|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
11209548|NCT01889862|12400820|FG001|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
11209549|NCT01889862|12400821|FG002|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
11209550|NCT01889862|12400822|FG003|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
11209551|NCT01889862|12400823|FG004|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||0
11209552|NCT01889862|12400819|FG000|COMPLETED|Part 2 (8 Weeks)||34
11209553|NCT01889862|12400820|FG001|COMPLETED|Part 2 (8 Weeks)||15
11209554|NCT01889862|12400821|FG002|COMPLETED|Part 2 (8 Weeks)||31
11209555|NCT01889862|12400822|FG003|COMPLETED|Part 2 (8 Weeks)||14
11209556|NCT01889862|12400823|FG004|COMPLETED|Part 2 (8 Weeks)||0
11209557|NCT01889862|12400819|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0
11209558|NCT01889862|12400820|FG001|NOT COMPLETED|Part 2 (8 Weeks)||0
11209559|NCT01889862|12400821|FG002|NOT COMPLETED|Part 2 (8 Weeks)||1
11209560|NCT01889862|12400822|FG003|NOT COMPLETED|Part 2 (8 Weeks)||0
11209561|NCT01889862|12400823|FG004|NOT COMPLETED|Part 2 (8 Weeks)||0
11209562|NCT01889862|12400819|FG000|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|48
11209563|NCT01889862|12400820|FG001|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|0
11209564|NCT01889862|12400821|FG002|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|41
11209565|NCT01889862|12400822|FG003|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|0
11209566|NCT01889862|12400823|FG004|STARTED|Part 3A/B (6 Week)||0
11209567|NCT01889862|12400819|FG000|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||34
11352358|NCT03045887|12549450|FG004|STARTED|Part A, Period 2 (1 Day)||4
11352359|NCT03045887|12549451|FG005|STARTED|Part A, Period 2 (1 Day)||4
11096371|NCT01206582|12279995|FG000|COMPLETED|Overall Study||9
11096372|NCT01206582|12279996|FG001|COMPLETED|Overall Study||7
11096373|NCT01206582|12279995|FG000|NOT COMPLETED|Overall Study||2
11096374|NCT01206582|12279996|FG001|NOT COMPLETED|Overall Study||2
11096375|NCT01206595|12280004|FG000|STARTED|Overall Study||38
11096376|NCT01206595|12280005|FG001|STARTED|Overall Study||20
11096377|NCT01206595|12280004|FG000|COMPLETED|Overall Study||38
11096378|NCT01206595|12280005|FG001|COMPLETED|Overall Study||20
11096379|NCT01206595|12280004|FG000|NOT COMPLETED|Overall Study||0
11096380|NCT01206595|12280005|FG001|NOT COMPLETED|Overall Study||0
11209568|NCT01889862|12400820|FG001|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
11209569|NCT01889862|12400821|FG002|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||26
11209570|NCT01889862|12400822|FG003|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
11209571|NCT01889862|12400823|FG004|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
11209572|NCT01889862|12400819|FG000|COMPLETED|Part 3A/B (6 Week)||48
11209573|NCT01889862|12400820|FG001|COMPLETED|Part 3A/B (6 Week)||0
11209574|NCT01889862|12400821|FG002|COMPLETED|Part 3A/B (6 Week)||41
11209575|NCT01889862|12400822|FG003|COMPLETED|Part 3A/B (6 Week)||0
11209576|NCT01889862|12400823|FG004|COMPLETED|Part 3A/B (6 Week)||0
11096381|NCT01206608|12280015|FG000|STARTED|Overall Study||20
11096382|NCT01206608|12280016|FG001|STARTED|Overall Study||20
11096383|NCT01206608|12280015|FG000|COMPLETED|Overall Study||20
11096384|NCT01206608|12280016|FG001|COMPLETED|Overall Study||20
11096385|NCT01206608|12280015|FG000|NOT COMPLETED|Overall Study||0
11096386|NCT01206608|12280016|FG001|NOT COMPLETED|Overall Study||0
11096387|NCT01206660|12280024|FG000|STARTED|Overall Study||60
11096388|NCT01206660|12280025|FG001|STARTED|Overall Study||60
11096389|NCT01206660|12280024|FG000|COMPLETED|Overall Study||60
11096390|NCT01206660|12280025|FG001|COMPLETED|Overall Study||60
11096391|NCT01206660|12280024|FG000|NOT COMPLETED|Overall Study||0
11096392|NCT01206660|12280025|FG001|NOT COMPLETED|Overall Study||0
11096393|NCT01206738|12280034|FG000|STARTED|Overall Study||63
11096394|NCT01206738|12280035|FG001|STARTED|Overall Study||74
11096395|NCT01206738|12280036|FG002|STARTED|Overall Study||61
11096396|NCT01206738|12280034|FG000|COMPLETED|Overall Study||40
11096397|NCT01206738|12280035|FG001|COMPLETED|Overall Study||49
11096398|NCT01206738|12280036|FG002|COMPLETED|Overall Study||42
11096399|NCT01206738|12280034|FG000|NOT COMPLETED|Overall Study||23
11096400|NCT01206738|12280035|FG001|NOT COMPLETED|Overall Study||25
11096401|NCT01206738|12280036|FG002|NOT COMPLETED|Overall Study||19
11096402|NCT01206764|12280046|FG000|STARTED|Overall Study||142
11096403|NCT01206764|12280046|FG000|COMPLETED|Overall Study||4
11096404|NCT01206764|12280046|FG000|NOT COMPLETED|Overall Study||138
11096405|NCT01206777|12280050|FG000|STARTED|Overall Study||52
11096406|NCT01206777|12280050|FG000|Discontinued Trial and Deemed Ineligible|Overall Study||2
11096407|NCT01206777|12280050|FG000|COMPLETED|Overall Study||50
11096408|NCT01206777|12280050|FG000|NOT COMPLETED|Overall Study||2
11096409|NCT01206816|12280061|FG000|STARTED|Overall Study|Started=Treated|3
11096410|NCT01206816|12280062|FG001|STARTED|Overall Study|Started=Treated|3
11096411|NCT01206816|12280063|FG002|STARTED|Overall Study|Started=Treated|20
11096412|NCT01206816|12280064|FG003|STARTED|Overall Study|Started=Treated|3
11096413|NCT01206816|12280065|FG004|STARTED|Overall Study|Started=Treated|3
11096414|NCT01206816|12280066|FG005|STARTED|Overall Study|Started=Treated|19
11096415|NCT01206816|12280067|FG006|STARTED|Overall Study|Started=Treated|6
11096416|NCT01206816|12280061|FG000|COMPLETED|Overall Study||0
11096417|NCT01206816|12280062|FG001|COMPLETED|Overall Study||0
11096418|NCT01206816|12280063|FG002|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,'DLT' from aftb|0
11096419|NCT01206816|12280064|FG003|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, 'Other AE' from aftb|0
11096420|NCT01206816|12280065|FG004|COMPLETED|Overall Study||0
11096421|NCT01206816|12280066|FG005|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, 'Other AE' from aftb|0
11096422|NCT01206816|12280067|FG006|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,'PD' from aftb.|0
11096423|NCT01206816|12280061|FG000|NOT COMPLETED|Overall Study||3
11096424|NCT01206816|12280062|FG001|NOT COMPLETED|Overall Study||3
11096425|NCT01206816|12280063|FG002|NOT COMPLETED|Overall Study||20
11096426|NCT01206816|12280064|FG003|NOT COMPLETED|Overall Study||3
11096427|NCT01206816|12280065|FG004|NOT COMPLETED|Overall Study||3
11096428|NCT01206816|12280066|FG005|NOT COMPLETED|Overall Study||19
11096429|NCT01206816|12280067|FG006|NOT COMPLETED|Overall Study||6
11096430|NCT01207219|12280090|FG000|STARTED|Overall Study||45
11096431|NCT01207219|12280091|FG001|STARTED|Overall Study||40
11209577|NCT01889862|12400819|FG000|NOT COMPLETED|Part 3A/B (6 Week)||0
11209578|NCT01889862|12400820|FG001|NOT COMPLETED|Part 3A/B (6 Week)||0
11209579|NCT01889862|12400821|FG002|NOT COMPLETED|Part 3A/B (6 Week)||0
11209580|NCT01889862|12400822|FG003|NOT COMPLETED|Part 3A/B (6 Week)||0
11209581|NCT01889862|12400823|FG004|NOT COMPLETED|Part 3A/B (6 Week)||0
11209582|NCT01889862|12400819|FG000|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
11209583|NCT01889862|12400820|FG001|STARTED|Part 4 (Up to 274 Weeks)||0
11209584|NCT01889862|12400821|FG002|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
11209585|NCT01889862|12400822|FG003|STARTED|Part 4 (Up to 274 Weeks)||0
11209586|NCT01889862|12400823|FG004|STARTED|Part 4 (Up to 274 Weeks)|Total of 202 subjects from 165-301, Part 1, 2, 3 entered Part 4 to receive dose of up to 60mg/kg.|202
11209587|NCT01889862|12400819|FG000|COMPLETED|Part 4 (Up to 274 Weeks)||0
11209588|NCT01889862|12400820|FG001|COMPLETED|Part 4 (Up to 274 Weeks)||0
11209589|NCT01889862|12400821|FG002|COMPLETED|Part 4 (Up to 274 Weeks)||0
11209590|NCT01889862|12400822|FG003|COMPLETED|Part 4 (Up to 274 Weeks)||0
11209591|NCT01889862|12400823|FG004|COMPLETED|Part 4 (Up to 274 Weeks)||172
11209592|NCT01889862|12400819|FG000|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
11209593|NCT01889862|12400820|FG001|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
11209594|NCT01889862|12400821|FG002|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
11209595|NCT01889862|12400822|FG003|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
11209596|NCT01889862|12400823|FG004|NOT COMPLETED|Part 4 (Up to 274 Weeks)||30
11209597|NCT01890031|12400853|FG000|STARTED|Overall Study||50
11209598|NCT01890031|12400854|FG001|STARTED|Overall Study||50
11209599|NCT01890031|12400855|FG002|STARTED|Overall Study||12
11209600|NCT01890031|12400856|FG003|STARTED|Overall Study||11
11209601|NCT01890031|12400857|FG004|STARTED|Overall Study||8
11209602|NCT01890031|12400853|FG000|COMPLETED|Overall Study||50
11209603|NCT01890031|12400854|FG001|COMPLETED|Overall Study||50
11209604|NCT01890031|12400855|FG002|COMPLETED|Overall Study||12
11209605|NCT01890031|12400856|FG003|COMPLETED|Overall Study||11
11209606|NCT01890031|12400857|FG004|COMPLETED|Overall Study||8
11209607|NCT01890031|12400853|FG000|NOT COMPLETED|Overall Study||0
11209608|NCT01890031|12400854|FG001|NOT COMPLETED|Overall Study||0
11209609|NCT01890031|12400855|FG002|NOT COMPLETED|Overall Study||0
11209610|NCT01890031|12400856|FG003|NOT COMPLETED|Overall Study||0
11209611|NCT01890031|12400857|FG004|NOT COMPLETED|Overall Study||0
11209612|NCT01890109|12400871|FG000|STARTED|Overall Study||52
11209613|NCT01890109|12400872|FG001|STARTED|Overall Study||51
11209614|NCT01890109|12400871|FG000|Received Study Treatment|Overall Study||52
11209615|NCT01890109|12400872|FG001|Received Study Treatment|Overall Study||50
11209616|NCT01890109|12400871|FG000|COMPLETED|Overall Study||51
11209617|NCT01890109|12400872|FG001|COMPLETED|Overall Study||46
11209618|NCT01890109|12400871|FG000|NOT COMPLETED|Overall Study||1
11209619|NCT01890109|12400872|FG001|NOT COMPLETED|Overall Study||5
11209620|NCT01890122|12400883|FG000|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
11209621|NCT01890122|12400884|FG001|STARTED|Overall Study||163
11209622|NCT01890122|12400885|FG002|STARTED|Overall Study||159
11209623|NCT01890122|12400886|FG003|STARTED|Overall Study||163
11209624|NCT01890122|12400883|FG000|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
11209625|NCT01890122|12400884|FG001|Treated|Overall Study||162
11209626|NCT01890122|12400885|FG002|Treated|Overall Study||159
11209627|NCT01890122|12400886|FG003|Treated|Overall Study||163
11209628|NCT01890122|12400883|FG000|COMPLETED|Overall Study||135
11209629|NCT01890122|12400884|FG001|COMPLETED|Overall Study||126
11209630|NCT01890122|12400885|FG002|COMPLETED|Overall Study||146
11209631|NCT01890122|12400886|FG003|COMPLETED|Overall Study||104
11209632|NCT01890122|12400883|FG000|NOT COMPLETED|Overall Study||27
11209633|NCT01890122|12400884|FG001|NOT COMPLETED|Overall Study||37
11209634|NCT01890122|12400885|FG002|NOT COMPLETED|Overall Study||13
11209635|NCT01890122|12400886|FG003|NOT COMPLETED|Overall Study||59
11209636|NCT01890148|12400896|FG000|STARTED|Overall Study||5
11209637|NCT01890148|12400896|FG000|COMPLETED|Overall Study||4
11209638|NCT01890148|12400896|FG000|NOT COMPLETED|Overall Study||1
11209639|NCT01890226|12400902|FG000|STARTED|Overall Study||155
11209640|NCT01890226|12400903|FG001|STARTED|Overall Study||156
11209641|NCT01890226|12400902|FG000|COMPLETED|Overall Study||155
11209642|NCT01890226|12400903|FG001|COMPLETED|Overall Study||156
11209643|NCT01890226|12400902|FG000|NOT COMPLETED|Overall Study||0
11209644|NCT01890226|12400903|FG001|NOT COMPLETED|Overall Study||0
11209645|NCT01890265|12400915|FG000|STARTED|Overall Study||50
11209646|NCT01890265|12400916|FG001|STARTED|Overall Study||53
11209647|NCT01890265|12400917|FG002|STARTED|Overall Study||24
11209648|NCT01890265|12400918|FG003|STARTED|Overall Study||12
11209649|NCT01890265|12400919|FG004|STARTED|Overall Study||15
11209650|NCT01890265|12400920|FG005|STARTED|Overall Study||6
11209651|NCT01890265|12400915|FG000|Safety Population|Overall Study||50
11209652|NCT01890265|12400916|FG001|Safety Population|Overall Study||53
11209653|NCT01890265|12400917|FG002|Safety Population|Overall Study||24
11209654|NCT01890265|12400918|FG003|Safety Population|Overall Study||12
11209655|NCT01890265|12400919|FG004|Safety Population|Overall Study||15
11209656|NCT01890265|12400920|FG005|Safety Population|Overall Study||6
11209657|NCT01890265|12400915|FG000|Intent-to-Treat (ITT) Population|Overall Study||50
11209658|NCT01890265|12400916|FG001|Intent-to-Treat (ITT) Population|Overall Study||51
11209659|NCT01890265|12400917|FG002|Intent-to-Treat (ITT) Population|Overall Study||24
11209660|NCT01890265|12400918|FG003|Intent-to-Treat (ITT) Population|Overall Study||12
11209661|NCT01890265|12400919|FG004|Intent-to-Treat (ITT) Population|Overall Study||15
11209662|NCT01890265|12400920|FG005|Intent-to-Treat (ITT) Population|Overall Study||6
11209663|NCT01890265|12400915|FG000|COMPLETED|Overall Study||40
11209664|NCT01890265|12400916|FG001|COMPLETED|Overall Study||40
11209665|NCT01890265|12400917|FG002|COMPLETED|Overall Study||20
11209666|NCT01890265|12400918|FG003|COMPLETED|Overall Study||12
11209667|NCT01890265|12400919|FG004|COMPLETED|Overall Study||13
11209668|NCT01890265|12400920|FG005|COMPLETED|Overall Study||6
11209669|NCT01890265|12400915|FG000|NOT COMPLETED|Overall Study||10
11209670|NCT01890265|12400916|FG001|NOT COMPLETED|Overall Study||13
11209671|NCT01890265|12400917|FG002|NOT COMPLETED|Overall Study||4
11209672|NCT01890265|12400918|FG003|NOT COMPLETED|Overall Study||0
11209673|NCT01890265|12400919|FG004|NOT COMPLETED|Overall Study||2
11209674|NCT01890265|12400920|FG005|NOT COMPLETED|Overall Study||0
11209675|NCT01890343|12400933|FG000|STARTED|Overall Study||8
11209676|NCT01890343|12400934|FG001|STARTED|Overall Study||10
11209677|NCT01890343|12400935|FG002|STARTED|Overall Study||10
11209678|NCT01890343|12400933|FG000|COMPLETED|Overall Study||8
11209679|NCT01890343|12400934|FG001|COMPLETED|Overall Study||10
11209680|NCT01890343|12400935|FG002|COMPLETED|Overall Study||10
11209681|NCT01890343|12400933|FG000|NOT COMPLETED|Overall Study||0
11209682|NCT01890343|12400934|FG001|NOT COMPLETED|Overall Study||0
11209683|NCT01890343|12400935|FG002|NOT COMPLETED|Overall Study||0
11209684|NCT01890421|12400943|FG000|STARTED|Overall Study||426
11209685|NCT01890421|12400943|FG000|COMPLETED|Overall Study||415
11209686|NCT01890421|12400943|FG000|NOT COMPLETED|Overall Study||11
11209687|NCT01890434|12400947|FG000|STARTED|Overall Study||478
11209688|NCT01890434|12400947|FG000|Evaluated for Efficacy|Overall Study||389
11209689|NCT01890434|12400947|FG000|COMPLETED|Overall Study||458
11209690|NCT01890434|12400947|FG000|NOT COMPLETED|Overall Study||20
11209691|NCT01890473|12400953|FG000|STARTED|Overall Study||111
11209692|NCT01890473|12400954|FG001|STARTED|Overall Study||113
11209693|NCT01890473|12400953|FG000|COMPLETED|Overall Study||109
11209694|NCT01890473|12400954|FG001|COMPLETED|Overall Study||113
11209695|NCT01890473|12400953|FG000|NOT COMPLETED|Overall Study||2
11209696|NCT01890473|12400954|FG001|NOT COMPLETED|Overall Study||0
11209697|NCT01890512|12400962|FG000|STARTED|Overall Study||20
11209698|NCT01890512|12400962|FG000|COMPLETED|Overall Study||17
11209699|NCT01890512|12400962|FG000|NOT COMPLETED|Overall Study||3
11209700|NCT01890642|12400969|FG000|STARTED|Overall Study||56
11209701|NCT01890642|12400970|FG001|STARTED|Overall Study||53
11209702|NCT01890642|12400971|FG002|STARTED|Overall Study||96
11209703|NCT01890642|12400969|FG000|COMPLETED|Overall Study||56
11209704|NCT01890642|12400970|FG001|COMPLETED|Overall Study||53
11209705|NCT01890642|12400971|FG002|COMPLETED|Overall Study||96
11209706|NCT01890642|12400969|FG000|NOT COMPLETED|Overall Study||0
11209707|NCT01890642|12400970|FG001|NOT COMPLETED|Overall Study||0
11209708|NCT01890642|12400971|FG002|NOT COMPLETED|Overall Study||0
11209709|NCT01890707|12400981|FG000|STARTED|Overall Study||11
11209710|NCT01890707|12400982|FG001|STARTED|Overall Study||8
11209711|NCT01890707|12400981|FG000|COMPLETED|Overall Study||10
11209712|NCT01890707|12400982|FG001|COMPLETED|Overall Study||7
11209713|NCT01890707|12400981|FG000|NOT COMPLETED|Overall Study||1
11209714|NCT01890707|12400982|FG001|NOT COMPLETED|Overall Study||1
11209715|NCT01890746|12400990|FG000|STARTED|Overall Study||74
11209716|NCT01890746|12400991|FG001|STARTED|Overall Study||74
11209717|NCT01890746|12400990|FG000|COMPLETED|Overall Study||22
11209718|NCT01890746|12400991|FG001|COMPLETED|Overall Study||33
11209719|NCT01890746|12400990|FG000|NOT COMPLETED|Overall Study||52
11209720|NCT01890746|12400991|FG001|NOT COMPLETED|Overall Study||41
11209721|NCT01890785|12401003|FG000|STARTED|First Intervention||5
11209722|NCT01890785|12401004|FG001|STARTED|First Intervention||5
11209723|NCT01890785|12401005|FG002|STARTED|First Intervention||5
11209724|NCT01890785|12401006|FG003|STARTED|First Intervention||5
11209725|NCT01890785|12401007|FG004|STARTED|First Intervention||5
11209726|NCT01890785|12401008|FG005|STARTED|First Intervention||5
11209727|NCT01890785|12401003|FG000|COMPLETED|First Intervention||5
11209728|NCT01890785|12401004|FG001|COMPLETED|First Intervention||5
11209729|NCT01890785|12401005|FG002|COMPLETED|First Intervention||5
11209730|NCT01890785|12401006|FG003|COMPLETED|First Intervention||5
11209731|NCT01890785|12401007|FG004|COMPLETED|First Intervention||5
11209732|NCT01890785|12401008|FG005|COMPLETED|First Intervention||5
11209733|NCT01890785|12401003|FG000|NOT COMPLETED|First Intervention||0
11209734|NCT01890785|12401004|FG001|NOT COMPLETED|First Intervention||0
11209735|NCT01890785|12401005|FG002|NOT COMPLETED|First Intervention||0
11209736|NCT01890785|12401006|FG003|NOT COMPLETED|First Intervention||0
11209737|NCT01890785|12401007|FG004|NOT COMPLETED|First Intervention||0
11209738|NCT01890785|12401008|FG005|NOT COMPLETED|First Intervention||0
11096432|NCT01207219|12280092|FG002|STARTED|Overall Study||39
11096433|NCT01207219|12280090|FG000|Included in ITT Analysis|Overall Study||40
11096434|NCT01207219|12280091|FG001|Included in ITT Analysis|Overall Study||37
11096435|NCT01207219|12280092|FG002|Included in ITT Analysis|Overall Study||38
11096436|NCT01207219|12280090|FG000|COMPLETED|Overall Study||34
11096437|NCT01207219|12280091|FG001|COMPLETED|Overall Study||29
11096438|NCT01207219|12280092|FG002|COMPLETED|Overall Study||32
11096439|NCT01207219|12280090|FG000|NOT COMPLETED|Overall Study||11
11096440|NCT01207219|12280091|FG001|NOT COMPLETED|Overall Study||11
11096441|NCT01207219|12280092|FG002|NOT COMPLETED|Overall Study||7
11096442|NCT01207388|12280100|FG000|STARTED|Overall Study||116
11096443|NCT01207388|12280100|FG000|COMPLETED|Overall Study||48
11096444|NCT01207388|12280100|FG000|NOT COMPLETED|Overall Study||68
11096445|NCT01207401|12280114|FG000|STARTED|Overall Study||26
11096446|NCT01207401|12280115|FG001|STARTED|Overall Study||24
11096447|NCT01207401|12280114|FG000|COMPLETED|Overall Study||26
11096448|NCT01207401|12280115|FG001|COMPLETED|Overall Study||24
11096449|NCT01207401|12280114|FG000|NOT COMPLETED|Overall Study||0
11096450|NCT01207401|12280115|FG001|NOT COMPLETED|Overall Study||0
11096451|NCT01207414|12280123|FG000|STARTED|Overall Study|Includes 1 patient randomized in error.|241
11096452|NCT01207414|12280124|FG001|STARTED|Overall Study||260
11209739|NCT01890785|12401003|FG000|STARTED|Second Intervention||5
11096453|NCT01207414|12280123|FG000|Safety Population: Received Study Drug|Overall Study||240
11096454|NCT01207414|12280124|FG001|Safety Population: Received Study Drug|Overall Study||260
11096455|NCT01207414|12280123|FG000|COMPLETED|Overall Study||168
11096456|NCT01207414|12280124|FG001|COMPLETED|Overall Study||178
11096457|NCT01207414|12280123|FG000|NOT COMPLETED|Overall Study||73
11096458|NCT01207414|12280124|FG001|NOT COMPLETED|Overall Study||82
11096459|NCT01207427|12280133|FG000|STARTED|Run-in Placebo Period||43
11096460|NCT01207427|12280134|FG001|STARTED|Run-in Placebo Period||45
11096461|NCT01207427|12280135|FG002|STARTED|Run-in Placebo Period||43
11096462|NCT01207427|12280133|FG000|COMPLETED|Run-in Placebo Period||43
11096463|NCT01207427|12280134|FG001|COMPLETED|Run-in Placebo Period||45
11096464|NCT01207427|12280135|FG002|COMPLETED|Run-in Placebo Period||43
11096465|NCT01207427|12280133|FG000|NOT COMPLETED|Run-in Placebo Period||0
11096466|NCT01207427|12280134|FG001|NOT COMPLETED|Run-in Placebo Period||0
11096467|NCT01207427|12280135|FG002|NOT COMPLETED|Run-in Placebo Period||0
11209740|NCT01890785|12401004|FG001|STARTED|Second Intervention||5
11209741|NCT01890785|12401005|FG002|STARTED|Second Intervention||5
11209742|NCT01890785|12401006|FG003|STARTED|Second Intervention||5
11209743|NCT01890785|12401007|FG004|STARTED|Second Intervention||5
11209744|NCT01890785|12401008|FG005|STARTED|Second Intervention||5
11209745|NCT01890785|12401003|FG000|COMPLETED|Second Intervention||5
11209746|NCT01890785|12401004|FG001|COMPLETED|Second Intervention||5
11209747|NCT01890785|12401005|FG002|COMPLETED|Second Intervention||5
11209748|NCT01890785|12401006|FG003|COMPLETED|Second Intervention||5
11209749|NCT01890785|12401007|FG004|COMPLETED|Second Intervention||5
11209750|NCT01890785|12401008|FG005|COMPLETED|Second Intervention||5
11209751|NCT01890785|12401003|FG000|NOT COMPLETED|Second Intervention||0
11209752|NCT01890785|12401004|FG001|NOT COMPLETED|Second Intervention||0
11209753|NCT01890785|12401005|FG002|NOT COMPLETED|Second Intervention||0
11209754|NCT01890785|12401006|FG003|NOT COMPLETED|Second Intervention||0
11209755|NCT01890785|12401007|FG004|NOT COMPLETED|Second Intervention||0
11209756|NCT01890785|12401008|FG005|NOT COMPLETED|Second Intervention||0
11209757|NCT01890785|12401003|FG000|STARTED|Third Intervention||5
11209758|NCT01890785|12401004|FG001|STARTED|Third Intervention||5
11209759|NCT01890785|12401005|FG002|STARTED|Third Intervention||5
11209760|NCT01890785|12401006|FG003|STARTED|Third Intervention||5
11209761|NCT01890785|12401007|FG004|STARTED|Third Intervention||5
11209762|NCT01890785|12401008|FG005|STARTED|Third Intervention||5
11209763|NCT01890785|12401003|FG000|COMPLETED|Third Intervention||5
11209764|NCT01890785|12401004|FG001|COMPLETED|Third Intervention||4
11209765|NCT01890785|12401005|FG002|COMPLETED|Third Intervention||5
11209766|NCT01890785|12401006|FG003|COMPLETED|Third Intervention||5
11209767|NCT01890785|12401007|FG004|COMPLETED|Third Intervention||5
11209768|NCT01890785|12401008|FG005|COMPLETED|Third Intervention||5
11209769|NCT01890785|12401003|FG000|NOT COMPLETED|Third Intervention||0
11209770|NCT01890785|12401004|FG001|NOT COMPLETED|Third Intervention||1
11209771|NCT01890785|12401005|FG002|NOT COMPLETED|Third Intervention||0
11209772|NCT01890785|12401006|FG003|NOT COMPLETED|Third Intervention||0
11209773|NCT01890785|12401007|FG004|NOT COMPLETED|Third Intervention||0
11209774|NCT01890785|12401008|FG005|NOT COMPLETED|Third Intervention||0
11209775|NCT01890915|12401019|FG000|STARTED|Overall Study||11
11209776|NCT01890915|12401020|FG001|STARTED|Overall Study||10
11209777|NCT01890915|12401019|FG000|COMPLETED|Overall Study||8
11209778|NCT01890915|12401020|FG001|COMPLETED|Overall Study||9
11209779|NCT01890915|12401019|FG000|NOT COMPLETED|Overall Study||3
11209780|NCT01890915|12401020|FG001|NOT COMPLETED|Overall Study||1
11209781|NCT01890967|12401032|FG000|STARTED|Overall Study||88
11209782|NCT01890967|12401033|FG001|STARTED|Overall Study||88
11209783|NCT01890967|12401034|FG002|STARTED|Overall Study||88
11209784|NCT01890967|12401035|FG003|STARTED|Overall Study||88
11209785|NCT01890967|12401036|FG004|STARTED|Overall Study||87
11209786|NCT01890967|12401037|FG005|STARTED|Overall Study||88
11209787|NCT01890967|12401032|FG000|Received at Least One Dose of Study Drug|Overall Study||87
11209788|NCT01890967|12401033|FG001|Received at Least One Dose of Study Drug|Overall Study||87
11209789|NCT01890967|12401034|FG002|Received at Least One Dose of Study Drug|Overall Study||86
11209790|NCT01890967|12401035|FG003|Received at Least One Dose of Study Drug|Overall Study||86
11209791|NCT01890967|12401036|FG004|Received at Least One Dose of Study Drug|Overall Study||86
11209792|NCT01890967|12401037|FG005|Received at Least One Dose of Study Drug|Overall Study||87
11209793|NCT01890967|12401032|FG000|COMPLETED|Overall Study||78
11209794|NCT01890967|12401033|FG001|COMPLETED|Overall Study||77
11209795|NCT01890967|12401034|FG002|COMPLETED|Overall Study||78
11209796|NCT01890967|12401035|FG003|COMPLETED|Overall Study||77
11209797|NCT01890967|12401036|FG004|COMPLETED|Overall Study||77
11209798|NCT01890967|12401037|FG005|COMPLETED|Overall Study||75
11209799|NCT01890967|12401032|FG000|NOT COMPLETED|Overall Study||10
11209800|NCT01890967|12401033|FG001|NOT COMPLETED|Overall Study||11
11209801|NCT01890967|12401034|FG002|NOT COMPLETED|Overall Study||10
11209802|NCT01890967|12401035|FG003|NOT COMPLETED|Overall Study||11
11209803|NCT01890967|12401036|FG004|NOT COMPLETED|Overall Study||10
11209804|NCT01890967|12401037|FG005|NOT COMPLETED|Overall Study||13
11096468|NCT01207427|12280133|FG000|STARTED|Double-blind Treatment Period||43
11209805|NCT01891305|12401060|FG000|STARTED|Overall Study||12
11209806|NCT01891305|12401061|FG001|STARTED|Overall Study||12
11209807|NCT01891305|12401062|FG002|STARTED|Overall Study||14
11209808|NCT01891305|12401063|FG003|STARTED|Overall Study||12
11209809|NCT01891305|12401060|FG000|COMPLETED|Overall Study||9
11209810|NCT01891305|12401061|FG001|COMPLETED|Overall Study||11
11209811|NCT01891305|12401062|FG002|COMPLETED|Overall Study||11
11209812|NCT01891305|12401063|FG003|COMPLETED|Overall Study||12
11209813|NCT01891305|12401060|FG000|NOT COMPLETED|Overall Study||3
11209814|NCT01891305|12401061|FG001|NOT COMPLETED|Overall Study||1
11209815|NCT01891305|12401062|FG002|NOT COMPLETED|Overall Study||3
11209816|NCT01891305|12401063|FG003|NOT COMPLETED|Overall Study||0
11209817|NCT01891331|12401077|FG000|STARTED|Overall Study||14
11209818|NCT01891331|12401078|FG001|STARTED|Overall Study||12
11209819|NCT01891331|12401079|FG002|STARTED|Overall Study||14
11209820|NCT01891331|12401080|FG003|STARTED|Overall Study||15
11209821|NCT01891331|12401077|FG000|COMPLETED|Overall Study||12
11209822|NCT01891331|12401078|FG001|COMPLETED|Overall Study||10
11209823|NCT01891331|12401079|FG002|COMPLETED|Overall Study||13
11209824|NCT01891331|12401080|FG003|COMPLETED|Overall Study||13
11209825|NCT01891331|12401077|FG000|NOT COMPLETED|Overall Study||2
11209826|NCT01891331|12401078|FG001|NOT COMPLETED|Overall Study||2
11209827|NCT01891331|12401079|FG002|NOT COMPLETED|Overall Study||1
11209828|NCT01891331|12401080|FG003|NOT COMPLETED|Overall Study||2
11209829|NCT01891357|12401090|FG000|STARTED|Overall Study||64
11209830|NCT01891357|12401090|FG000|COMPLETED|Overall Study||61
11209831|NCT01891357|12401090|FG000|NOT COMPLETED|Overall Study||3
11209832|NCT01891669|12401104|FG000|STARTED|Overall Study||2
11209833|NCT01891669|12401105|FG001|STARTED|Overall Study||2
11209834|NCT01891669|12401106|FG002|STARTED|Overall Study||2
11209835|NCT01891669|12401107|FG003|STARTED|Overall Study||2
11209836|NCT01891669|12401108|FG004|STARTED|Overall Study||2
11209837|NCT01891669|12401109|FG005|STARTED|Overall Study||2
11209838|NCT01891669|12401110|FG006|STARTED|Overall Study||2
11209839|NCT01891669|12401111|FG007|STARTED|Overall Study||6
11209840|NCT01891669|12401112|FG008|STARTED|Overall Study||3
11209841|NCT01891669|12401113|FG009|STARTED|Overall Study||3
11209842|NCT01891669|12401104|FG000|COMPLETED|Overall Study||0
11209843|NCT01891669|12401105|FG001|COMPLETED|Overall Study||1
11209844|NCT01891669|12401106|FG002|COMPLETED|Overall Study||2
11209845|NCT01891669|12401107|FG003|COMPLETED|Overall Study||2
11209846|NCT01891669|12401108|FG004|COMPLETED|Overall Study||2
11209847|NCT01891669|12401109|FG005|COMPLETED|Overall Study||2
11209848|NCT01891669|12401110|FG006|COMPLETED|Overall Study||1
11209849|NCT01891669|12401111|FG007|COMPLETED|Overall Study||2
11209850|NCT01891669|12401112|FG008|COMPLETED|Overall Study||2
11209851|NCT01891669|12401113|FG009|COMPLETED|Overall Study||1
11209852|NCT01891669|12401104|FG000|NOT COMPLETED|Overall Study||2
11209853|NCT01891669|12401105|FG001|NOT COMPLETED|Overall Study||1
11209854|NCT01891669|12401106|FG002|NOT COMPLETED|Overall Study||0
11209855|NCT01891669|12401107|FG003|NOT COMPLETED|Overall Study||0
11209856|NCT01891669|12401108|FG004|NOT COMPLETED|Overall Study||0
11209857|NCT01891669|12401109|FG005|NOT COMPLETED|Overall Study||0
11209858|NCT01891669|12401110|FG006|NOT COMPLETED|Overall Study||1
11209859|NCT01891669|12401111|FG007|NOT COMPLETED|Overall Study||4
11209860|NCT01891669|12401112|FG008|NOT COMPLETED|Overall Study||1
11209861|NCT01891669|12401113|FG009|NOT COMPLETED|Overall Study||2
11209862|NCT01891721|12401147|FG000|STARTED|Overall Study||39
11209863|NCT01891721|12401148|FG001|STARTED|Overall Study||40
11209864|NCT01891721|12401149|FG002|STARTED|Overall Study||20
11209865|NCT01891721|12401147|FG000|COMPLETED|Overall Study||29
11209866|NCT01891721|12401148|FG001|COMPLETED|Overall Study||35
11209867|NCT01891721|12401149|FG002|COMPLETED|Overall Study||19
11209868|NCT01891721|12401147|FG000|NOT COMPLETED|Overall Study||10
11209869|NCT01891721|12401148|FG001|NOT COMPLETED|Overall Study||5
11209870|NCT01891721|12401149|FG002|NOT COMPLETED|Overall Study||1
11209871|NCT01891734|12401159|FG000|STARTED|Overall Study||17
11209872|NCT01891734|12401160|FG001|STARTED|Overall Study||16
11209873|NCT01891734|12401159|FG000|COMPLETED|Overall Study||14
11209874|NCT01891734|12401160|FG001|COMPLETED|Overall Study||13
11209875|NCT01891734|12401159|FG000|NOT COMPLETED|Overall Study||3
11209876|NCT01891734|12401160|FG001|NOT COMPLETED|Overall Study||3
11209877|NCT01891864|12401170|FG000|STARTED|Treatment Period 1||264
11209878|NCT01891864|12401171|FG001|STARTED|Treatment Period 1||267
11209879|NCT01891864|12401172|FG002|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
11209880|NCT01891864|12401173|FG003|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
11209881|NCT01891864|12401174|FG004|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
11209882|NCT01891864|12401175|FG005|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
11209883|NCT01891864|12401170|FG000|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
11209884|NCT01891864|12401171|FG001|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
11209885|NCT01891864|12401172|FG002|COMPLETED|Treatment Period 1||0
11209886|NCT01891864|12401173|FG003|COMPLETED|Treatment Period 1||0
11209887|NCT01891864|12401174|FG004|COMPLETED|Treatment Period 1||0
11209888|NCT01891864|12401175|FG005|COMPLETED|Treatment Period 1||0
11209889|NCT01891864|12401170|FG000|NOT COMPLETED|Treatment Period 1||8
11209890|NCT01891864|12401171|FG001|NOT COMPLETED|Treatment Period 1||12
11209891|NCT01891864|12401172|FG002|NOT COMPLETED|Treatment Period 1||0
11209892|NCT01891864|12401173|FG003|NOT COMPLETED|Treatment Period 1||0
11209893|NCT01891864|12401174|FG004|NOT COMPLETED|Treatment Period 1||0
11209894|NCT01891864|12401175|FG005|NOT COMPLETED|Treatment Period 1||0
11209895|NCT01891864|12401170|FG000|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
11209896|NCT01891864|12401171|FG001|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
11209897|NCT01891864|12401172|FG002|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
11209898|NCT01891864|12401173|FG003|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
11209899|NCT01891864|12401174|FG004|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
11209900|NCT01891864|12401175|FG005|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
11209901|NCT01891864|12401170|FG000|COMPLETED|Treatment Period 2||0
11209902|NCT01891864|12401171|FG001|COMPLETED|Treatment Period 2||0
11209903|NCT01891864|12401172|FG002|COMPLETED|Treatment Period 2||143
11209904|NCT01891864|12401173|FG003|COMPLETED|Treatment Period 2||142
11209905|NCT01891864|12401174|FG004|COMPLETED|Treatment Period 2||96
11209906|NCT01891864|12401175|FG005|COMPLETED|Treatment Period 2||91
11209907|NCT01891864|12401170|FG000|NOT COMPLETED|Treatment Period 2||0
11209908|NCT01891864|12401171|FG001|NOT COMPLETED|Treatment Period 2||0
11209909|NCT01891864|12401172|FG002|NOT COMPLETED|Treatment Period 2||7
11209910|NCT01891864|12401173|FG003|NOT COMPLETED|Treatment Period 2||9
11209911|NCT01891864|12401174|FG004|NOT COMPLETED|Treatment Period 2||4
11209912|NCT01891864|12401175|FG005|NOT COMPLETED|Treatment Period 2||5
11209913|NCT01891864|12401170|FG000|STARTED|Extension Period||0
11209914|NCT01891864|12401171|FG001|STARTED|Extension Period||0
11209915|NCT01891864|12401172|FG002|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
11209916|NCT01891864|12401173|FG003|STARTED|Extension Period||142
11209917|NCT01891864|12401174|FG004|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
11209918|NCT01891864|12401175|FG005|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
11209919|NCT01891864|12401170|FG000|COMPLETED|Extension Period||0
11209920|NCT01891864|12401171|FG001|COMPLETED|Extension Period||0
11209921|NCT01891864|12401172|FG002|COMPLETED|Extension Period||132
11209922|NCT01891864|12401173|FG003|COMPLETED|Extension Period||137
11209923|NCT01891864|12401174|FG004|COMPLETED|Extension Period||88
11209924|NCT01891864|12401175|FG005|COMPLETED|Extension Period||90
11209925|NCT01891864|12401170|FG000|NOT COMPLETED|Extension Period||0
11209926|NCT01891864|12401171|FG001|NOT COMPLETED|Extension Period||0
11209927|NCT01891864|12401172|FG002|NOT COMPLETED|Extension Period||8
11209928|NCT01891864|12401173|FG003|NOT COMPLETED|Extension Period||5
11209929|NCT01891864|12401174|FG004|NOT COMPLETED|Extension Period||7
11209930|NCT01891864|12401175|FG005|NOT COMPLETED|Extension Period||0
11209931|NCT01891890|12401190|FG000|STARTED|Overall Study||24
11209932|NCT01891890|12401191|FG001|STARTED|Overall Study||27
11209933|NCT01891890|12401192|FG002|STARTED|Overall Study||21
11209934|NCT01891890|12401190|FG000|COMPLETED|Overall Study||17
11209935|NCT01891890|12401191|FG001|COMPLETED|Overall Study||24
11209936|NCT01891890|12401192|FG002|COMPLETED|Overall Study||14
11209937|NCT01891890|12401190|FG000|NOT COMPLETED|Overall Study||7
11209938|NCT01891890|12401191|FG001|NOT COMPLETED|Overall Study||3
11209939|NCT01891890|12401192|FG002|NOT COMPLETED|Overall Study||7
11209940|NCT01891968|12401200|FG000|STARTED|Overall Study||15
11209941|NCT01891968|12401200|FG000|COMPLETED|Overall Study||15
11209942|NCT01891968|12401200|FG000|NOT COMPLETED|Overall Study||0
11209943|NCT01892007|12401206|FG000|STARTED|Overall Study||27
11209944|NCT01892007|12401207|FG001|STARTED|Overall Study||30
11209945|NCT01892007|12401206|FG000|COMPLETED|Overall Study||27
11209946|NCT01892007|12401207|FG001|COMPLETED|Overall Study||30
11209947|NCT01892007|12401206|FG000|NOT COMPLETED|Overall Study||0
11209948|NCT01892007|12401207|FG001|NOT COMPLETED|Overall Study||0
11209949|NCT01892020|12401213|FG000|STARTED|Period 1||81
11209950|NCT01892020|12401214|FG001|STARTED|Period 1||80
11209951|NCT01892020|12401213|FG000|COMPLETED|Period 1||78
11209952|NCT01892020|12401214|FG001|COMPLETED|Period 1||74
11209953|NCT01892020|12401213|FG000|NOT COMPLETED|Period 1||3
11209954|NCT01892020|12401214|FG001|NOT COMPLETED|Period 1||6
11209955|NCT01892020|12401213|FG000|STARTED|Period 2||78
11096469|NCT01207427|12280134|FG001|STARTED|Double-blind Treatment Period||45
11096470|NCT01207427|12280135|FG002|STARTED|Double-blind Treatment Period||43
11352360|NCT03045887|12549452|FG006|STARTED|Part A, Period 2 (1 Day)||4
11352361|NCT03045887|12549453|FG007|STARTED|Part A, Period 2 (1 Day)||4
11352362|NCT03045887|12549454|FG008|STARTED|Part A, Period 2 (1 Day)||0
11352363|NCT03045887|12549455|FG009|STARTED|Part A, Period 2 (1 Day)||0
11352364|NCT03045887|12549446|FG000|COMPLETED|Part A, Period 2 (1 Day)||3
11352365|NCT03045887|12549447|FG001|COMPLETED|Part A, Period 2 (1 Day)||4
11352366|NCT03045887|12549448|FG002|COMPLETED|Part A, Period 2 (1 Day)||5
11352367|NCT03045887|12549449|FG003|COMPLETED|Part A, Period 2 (1 Day)||4
11352368|NCT03045887|12549450|FG004|COMPLETED|Part A, Period 2 (1 Day)||4
11352369|NCT03045887|12549451|FG005|COMPLETED|Part A, Period 2 (1 Day)||4
11352370|NCT03045887|12549452|FG006|COMPLETED|Part A, Period 2 (1 Day)||4
11352371|NCT03045887|12549453|FG007|COMPLETED|Part A, Period 2 (1 Day)||4
11352372|NCT03045887|12549454|FG008|COMPLETED|Part A, Period 2 (1 Day)||0
11352373|NCT03045887|12549455|FG009|COMPLETED|Part A, Period 2 (1 Day)||0
11352374|NCT03045887|12549446|FG000|NOT COMPLETED|Part A, Period 2 (1 Day)||1
11352375|NCT03045887|12549447|FG001|NOT COMPLETED|Part A, Period 2 (1 Day)||0
11352376|NCT03045887|12549448|FG002|NOT COMPLETED|Part A, Period 2 (1 Day)||0
11352377|NCT03045887|12549449|FG003|NOT COMPLETED|Part A, Period 2 (1 Day)||0
11352378|NCT03045887|12549450|FG004|NOT COMPLETED|Part A, Period 2 (1 Day)||0
11096471|NCT01207427|12280133|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
11096472|NCT01207427|12280134|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
11096473|NCT01207427|12280135|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
11096474|NCT01207427|12280133|FG000|COMPLETED|Double-blind Treatment Period||40
11096475|NCT01207427|12280134|FG001|COMPLETED|Double-blind Treatment Period||43
11096476|NCT01207427|12280135|FG002|COMPLETED|Double-blind Treatment Period||41
11096477|NCT01207427|12280133|FG000|NOT COMPLETED|Double-blind Treatment Period||3
11096478|NCT01207427|12280134|FG001|NOT COMPLETED|Double-blind Treatment Period||2
11096479|NCT01207427|12280135|FG002|NOT COMPLETED|Double-blind Treatment Period||2
11096480|NCT01207427|12280133|FG000|STARTED|Run-out Placebo Period||40
11096481|NCT01207427|12280134|FG001|STARTED|Run-out Placebo Period||43
11096482|NCT01207427|12280135|FG002|STARTED|Run-out Placebo Period||41
11096483|NCT01207427|12280133|FG000|COMPLETED|Run-out Placebo Period||40
11096484|NCT01207427|12280134|FG001|COMPLETED|Run-out Placebo Period||43
11096485|NCT01207427|12280135|FG002|COMPLETED|Run-out Placebo Period||41
11209956|NCT01892020|12401214|FG001|STARTED|Period 2||74
11209957|NCT01892020|12401213|FG000|COMPLETED|Period 2||77
11209958|NCT01892020|12401214|FG001|COMPLETED|Period 2||74
11209959|NCT01892020|12401213|FG000|NOT COMPLETED|Period 2||1
11352379|NCT03045887|12549451|FG005|NOT COMPLETED|Part A, Period 2 (1 Day)||0
11209960|NCT01892020|12401214|FG001|NOT COMPLETED|Period 2||0
11209961|NCT01892163|12401222|FG000|STARTED|Overall Study||50
11209962|NCT01892163|12401223|FG001|STARTED|Overall Study||50
11352380|NCT03045887|12549452|FG006|NOT COMPLETED|Part A, Period 2 (1 Day)||0
11352381|NCT03045887|12549453|FG007|NOT COMPLETED|Part A, Period 2 (1 Day)||0
11352382|NCT03045887|12549454|FG008|NOT COMPLETED|Part A, Period 2 (1 Day)||0
11352383|NCT03045887|12549455|FG009|NOT COMPLETED|Part A, Period 2 (1 Day)||0
11352384|NCT03045887|12549446|FG000|STARTED|Part A,Washout Period 2 (4 Weeks)||3
11352385|NCT03045887|12549447|FG001|STARTED|Part A,Washout Period 2 (4 Weeks)||4
11352386|NCT03045887|12549448|FG002|STARTED|Part A,Washout Period 2 (4 Weeks)||5
11352387|NCT03045887|12549449|FG003|STARTED|Part A,Washout Period 2 (4 Weeks)||4
11352388|NCT03045887|12549450|FG004|STARTED|Part A,Washout Period 2 (4 Weeks)||4
11352389|NCT03045887|12549451|FG005|STARTED|Part A,Washout Period 2 (4 Weeks)||4
11209963|NCT01892163|12401222|FG000|COMPLETED|Overall Study||48
11209964|NCT01892163|12401223|FG001|COMPLETED|Overall Study||49
11209965|NCT01892163|12401222|FG000|NOT COMPLETED|Overall Study||2
11209966|NCT01892163|12401223|FG001|NOT COMPLETED|Overall Study||1
11209967|NCT01892189|12401238|FG000|STARTED|First Intervention Period (1 Day)||3
11209968|NCT01892189|12401239|FG001|STARTED|First Intervention Period (1 Day)||3
11209969|NCT01892189|12401240|FG002|STARTED|First Intervention Period (1 Day)||3
11352390|NCT03045887|12549452|FG006|STARTED|Part A,Washout Period 2 (4 Weeks)||4
11352391|NCT03045887|12549453|FG007|STARTED|Part A,Washout Period 2 (4 Weeks)||4
11352392|NCT03045887|12549454|FG008|STARTED|Part A,Washout Period 2 (4 Weeks)||0
11352393|NCT03045887|12549455|FG009|STARTED|Part A,Washout Period 2 (4 Weeks)||0
11352394|NCT03045887|12549446|FG000|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3
11352395|NCT03045887|12549447|FG001|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
11352396|NCT03045887|12549448|FG002|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
11352397|NCT03045887|12549449|FG003|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
11352398|NCT03045887|12549450|FG004|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
11352399|NCT03045887|12549451|FG005|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
11352400|NCT03045887|12549452|FG006|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
11352401|NCT03045887|12549453|FG007|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
11352402|NCT03045887|12549454|FG008|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
11352403|NCT03045887|12549455|FG009|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
11352404|NCT03045887|12549446|FG000|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
11352405|NCT03045887|12549447|FG001|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
11209970|NCT01892189|12401241|FG003|STARTED|First Intervention Period (1 Day)||3
11209971|NCT01892189|12401242|FG004|STARTED|First Intervention Period (1 Day)||3
11352406|NCT03045887|12549448|FG002|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1
11352407|NCT03045887|12549449|FG003|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
11209972|NCT01892189|12401243|FG005|STARTED|First Intervention Period (1 Day)||3
11209973|NCT01892189|12401244|FG006|STARTED|First Intervention Period (1 Day)||3
11209974|NCT01892189|12401245|FG007|STARTED|First Intervention Period (1 Day)||3
11209975|NCT01892189|12401246|FG008|STARTED|First Intervention Period (1 Day)||3
11209976|NCT01892189|12401238|FG000|COMPLETED|First Intervention Period (1 Day)||3
11209977|NCT01892189|12401239|FG001|COMPLETED|First Intervention Period (1 Day)||3
11209978|NCT01892189|12401240|FG002|COMPLETED|First Intervention Period (1 Day)||3
11209979|NCT01892189|12401241|FG003|COMPLETED|First Intervention Period (1 Day)||3
11209980|NCT01892189|12401242|FG004|COMPLETED|First Intervention Period (1 Day)||3
11209981|NCT01892189|12401243|FG005|COMPLETED|First Intervention Period (1 Day)||3
11209982|NCT01892189|12401244|FG006|COMPLETED|First Intervention Period (1 Day)||3
11209983|NCT01892189|12401245|FG007|COMPLETED|First Intervention Period (1 Day)||3
11209984|NCT01892189|12401246|FG008|COMPLETED|First Intervention Period (1 Day)||3
11209985|NCT01892189|12401238|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
11209986|NCT01892189|12401239|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
11209987|NCT01892189|12401240|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0
11209988|NCT01892189|12401241|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0
11209989|NCT01892189|12401242|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0
11209990|NCT01892189|12401243|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0
11209991|NCT01892189|12401244|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0
11209992|NCT01892189|12401245|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0
11209993|NCT01892189|12401246|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0
11209994|NCT01892189|12401238|FG000|STARTED|Washout Period 1 (7 Days)||3
11209995|NCT01892189|12401239|FG001|STARTED|Washout Period 1 (7 Days)||3
11209996|NCT01892189|12401240|FG002|STARTED|Washout Period 1 (7 Days)||3
11209997|NCT01892189|12401241|FG003|STARTED|Washout Period 1 (7 Days)||3
11209998|NCT01892189|12401242|FG004|STARTED|Washout Period 1 (7 Days)||3
11209999|NCT01892189|12401243|FG005|STARTED|Washout Period 1 (7 Days)||3
11210000|NCT01892189|12401244|FG006|STARTED|Washout Period 1 (7 Days)||3
11210001|NCT01892189|12401245|FG007|STARTED|Washout Period 1 (7 Days)||3
11210002|NCT01892189|12401246|FG008|STARTED|Washout Period 1 (7 Days)||3
11210003|NCT01892189|12401238|FG000|COMPLETED|Washout Period 1 (7 Days)||3
11210004|NCT01892189|12401239|FG001|COMPLETED|Washout Period 1 (7 Days)||3
11210005|NCT01892189|12401240|FG002|COMPLETED|Washout Period 1 (7 Days)||1
11210006|NCT01892189|12401241|FG003|COMPLETED|Washout Period 1 (7 Days)||2
11210007|NCT01892189|12401242|FG004|COMPLETED|Washout Period 1 (7 Days)||3
11210008|NCT01892189|12401243|FG005|COMPLETED|Washout Period 1 (7 Days)||2
11210009|NCT01892189|12401244|FG006|COMPLETED|Washout Period 1 (7 Days)||2
11210010|NCT01892189|12401245|FG007|COMPLETED|Washout Period 1 (7 Days)||3
11210011|NCT01892189|12401246|FG008|COMPLETED|Washout Period 1 (7 Days)||1
11210012|NCT01892189|12401238|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
11210013|NCT01892189|12401239|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
11210014|NCT01892189|12401240|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||2
11210015|NCT01892189|12401241|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
11210016|NCT01892189|12401242|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
11210017|NCT01892189|12401243|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1
11210018|NCT01892189|12401244|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||1
11210019|NCT01892189|12401245|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
11210020|NCT01892189|12401246|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||2
11210021|NCT01892189|12401238|FG000|STARTED|Second Intervention Period (1 Day)||3
11210022|NCT01892189|12401239|FG001|STARTED|Second Intervention Period (1 Day)||3
11210023|NCT01892189|12401240|FG002|STARTED|Second Intervention Period (1 Day)||1
11210024|NCT01892189|12401241|FG003|STARTED|Second Intervention Period (1 Day)||2
11210025|NCT01892189|12401242|FG004|STARTED|Second Intervention Period (1 Day)||3
11210026|NCT01892189|12401243|FG005|STARTED|Second Intervention Period (1 Day)||2
11210027|NCT01892189|12401244|FG006|STARTED|Second Intervention Period (1 Day)||2
11096486|NCT01207427|12280133|FG000|NOT COMPLETED|Run-out Placebo Period||0
11096487|NCT01207427|12280134|FG001|NOT COMPLETED|Run-out Placebo Period||0
11096488|NCT01207427|12280135|FG002|NOT COMPLETED|Run-out Placebo Period||0
11096489|NCT01207440|12280150|FG000|STARTED|Overall Study||203
11096490|NCT01207440|12280151|FG001|STARTED|Overall Study||64
11096491|NCT01207440|12280152|FG002|STARTED|Overall Study||65
11096492|NCT01207440|12280153|FG003|STARTED|Overall Study||18
11096493|NCT01207440|12280154|FG004|STARTED|Overall Study||48
11096494|NCT01207440|12280155|FG005|STARTED|Overall Study||46
11096495|NCT01207440|12280156|FG006|STARTED|Overall Study||5
11096496|NCT01207440|12280150|FG000|COMPLETED|Overall Study||0
11096497|NCT01207440|12280151|FG001|COMPLETED|Overall Study||0
11096498|NCT01207440|12280152|FG002|COMPLETED|Overall Study||0
11096499|NCT01207440|12280153|FG003|COMPLETED|Overall Study||0
11096500|NCT01207440|12280154|FG004|COMPLETED|Overall Study||0
11096501|NCT01207440|12280155|FG005|COMPLETED|Overall Study||0
11096502|NCT01207440|12280156|FG006|COMPLETED|Overall Study||0
11096503|NCT01207440|12280150|FG000|NOT COMPLETED|Overall Study||203
11096504|NCT01207440|12280151|FG001|NOT COMPLETED|Overall Study||64
11096505|NCT01207440|12280152|FG002|NOT COMPLETED|Overall Study||65
11096506|NCT01207440|12280153|FG003|NOT COMPLETED|Overall Study||18
11096507|NCT01207440|12280154|FG004|NOT COMPLETED|Overall Study||48
11210028|NCT01892189|12401245|FG007|STARTED|Second Intervention Period (1 Day)||3
11210029|NCT01892189|12401246|FG008|STARTED|Second Intervention Period (1 Day)||1
11210030|NCT01892189|12401238|FG000|COMPLETED|Second Intervention Period (1 Day)||3
11210031|NCT01892189|12401239|FG001|COMPLETED|Second Intervention Period (1 Day)||3
11210032|NCT01892189|12401240|FG002|COMPLETED|Second Intervention Period (1 Day)||1
11210033|NCT01892189|12401241|FG003|COMPLETED|Second Intervention Period (1 Day)||2
11210034|NCT01892189|12401242|FG004|COMPLETED|Second Intervention Period (1 Day)||3
11210035|NCT01892189|12401243|FG005|COMPLETED|Second Intervention Period (1 Day)||2
11210036|NCT01892189|12401244|FG006|COMPLETED|Second Intervention Period (1 Day)||2
11210037|NCT01892189|12401245|FG007|COMPLETED|Second Intervention Period (1 Day)||3
11210038|NCT01892189|12401246|FG008|COMPLETED|Second Intervention Period (1 Day)||1
11210039|NCT01892189|12401238|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
11210040|NCT01892189|12401239|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
11210041|NCT01892189|12401240|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0
11210042|NCT01892189|12401241|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0
11210043|NCT01892189|12401242|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0
11210044|NCT01892189|12401243|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0
11210045|NCT01892189|12401244|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0
11210046|NCT01892189|12401245|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0
11210047|NCT01892189|12401246|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0
11210048|NCT01892189|12401238|FG000|STARTED|Washout Period 2 (7 Days)||3
11210049|NCT01892189|12401239|FG001|STARTED|Washout Period 2 (7 Days)||3
11210050|NCT01892189|12401240|FG002|STARTED|Washout Period 2 (7 Days)||1
11210051|NCT01892189|12401241|FG003|STARTED|Washout Period 2 (7 Days)||2
11210052|NCT01892189|12401242|FG004|STARTED|Washout Period 2 (7 Days)||3
11210053|NCT01892189|12401243|FG005|STARTED|Washout Period 2 (7 Days)||2
11210054|NCT01892189|12401244|FG006|STARTED|Washout Period 2 (7 Days)||2
11210055|NCT01892189|12401245|FG007|STARTED|Washout Period 2 (7 Days)||3
11210056|NCT01892189|12401246|FG008|STARTED|Washout Period 2 (7 Days)||1
11210057|NCT01892189|12401238|FG000|COMPLETED|Washout Period 2 (7 Days)||3
11210058|NCT01892189|12401239|FG001|COMPLETED|Washout Period 2 (7 Days)||3
11210059|NCT01892189|12401240|FG002|COMPLETED|Washout Period 2 (7 Days)||1
11210060|NCT01892189|12401241|FG003|COMPLETED|Washout Period 2 (7 Days)||2
11210061|NCT01892189|12401242|FG004|COMPLETED|Washout Period 2 (7 Days)||3
11210062|NCT01892189|12401243|FG005|COMPLETED|Washout Period 2 (7 Days)||2
11210063|NCT01892189|12401244|FG006|COMPLETED|Washout Period 2 (7 Days)||2
11210064|NCT01892189|12401245|FG007|COMPLETED|Washout Period 2 (7 Days)||3
11210065|NCT01892189|12401246|FG008|COMPLETED|Washout Period 2 (7 Days)||1
11210066|NCT01892189|12401238|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
11210067|NCT01892189|12401239|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
11210068|NCT01892189|12401240|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
11210069|NCT01892189|12401241|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
11210070|NCT01892189|12401242|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
11210071|NCT01892189|12401243|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
11210072|NCT01892189|12401244|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
11210073|NCT01892189|12401245|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
11210074|NCT01892189|12401246|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
11210075|NCT01892189|12401238|FG000|STARTED|Third Intervention Period (1 Day)||3
11210076|NCT01892189|12401239|FG001|STARTED|Third Intervention Period (1 Day)||3
11210077|NCT01892189|12401240|FG002|STARTED|Third Intervention Period (1 Day)||1
11210078|NCT01892189|12401241|FG003|STARTED|Third Intervention Period (1 Day)||2
11210079|NCT01892189|12401242|FG004|STARTED|Third Intervention Period (1 Day)||3
11210080|NCT01892189|12401243|FG005|STARTED|Third Intervention Period (1 Day)||2
11210081|NCT01892189|12401244|FG006|STARTED|Third Intervention Period (1 Day)||2
11210082|NCT01892189|12401245|FG007|STARTED|Third Intervention Period (1 Day)||3
11210083|NCT01892189|12401246|FG008|STARTED|Third Intervention Period (1 Day)||1
11210084|NCT01892189|12401238|FG000|COMPLETED|Third Intervention Period (1 Day)||3
11210085|NCT01892189|12401239|FG001|COMPLETED|Third Intervention Period (1 Day)||3
11210086|NCT01892189|12401240|FG002|COMPLETED|Third Intervention Period (1 Day)||1
11210087|NCT01892189|12401241|FG003|COMPLETED|Third Intervention Period (1 Day)||2
11210088|NCT01892189|12401242|FG004|COMPLETED|Third Intervention Period (1 Day)||3
11210089|NCT01892189|12401243|FG005|COMPLETED|Third Intervention Period (1 Day)||2
11210090|NCT01892189|12401244|FG006|COMPLETED|Third Intervention Period (1 Day)||2
11210091|NCT01892189|12401245|FG007|COMPLETED|Third Intervention Period (1 Day)||3
11210092|NCT01892189|12401246|FG008|COMPLETED|Third Intervention Period (1 Day)||1
11210093|NCT01892189|12401238|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0
11210094|NCT01892189|12401239|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0
11210095|NCT01892189|12401240|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0
11210096|NCT01892189|12401241|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0
11210097|NCT01892189|12401242|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0
11210098|NCT01892189|12401243|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0
11210099|NCT01892189|12401244|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0
11210100|NCT01892189|12401245|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0
11210101|NCT01892189|12401246|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0
11210102|NCT01892267|12401263|FG000|STARTED|Overall Study||9
11210103|NCT01892267|12401264|FG001|STARTED|Overall Study||10
11210104|NCT01892267|12401263|FG000|COMPLETED|Overall Study||9
11210105|NCT01892267|12401264|FG001|COMPLETED|Overall Study||10
11210106|NCT01892267|12401263|FG000|NOT COMPLETED|Overall Study||0
11210107|NCT01892267|12401264|FG001|NOT COMPLETED|Overall Study||0
11210108|NCT01892293|12401270|FG000|STARTED|Overall Study||6
11210109|NCT01892293|12401270|FG000|Received T-cell|Overall Study||2
11210110|NCT01892293|12401270|FG000|COMPLETED|Overall Study||2
11210111|NCT01892293|12401270|FG000|NOT COMPLETED|Overall Study||4
11210112|NCT01892306|12401276|FG000|STARTED|Overall Study||13
11210113|NCT01892306|12401277|FG001|STARTED|Overall Study||16
11210114|NCT01892306|12401276|FG000|COMPLETED|Overall Study||8
11210115|NCT01892306|12401277|FG001|COMPLETED|Overall Study||10
11210116|NCT01892306|12401276|FG000|NOT COMPLETED|Overall Study||5
11210117|NCT01892306|12401277|FG001|NOT COMPLETED|Overall Study||6
11210118|NCT01892345|12401285|FG000|STARTED|Overall Study||96
11210119|NCT01892345|12401286|FG001|STARTED|Overall Study||47
11210120|NCT01892345|12401285|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||96
11210121|NCT01892345|12401286|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||47
11210122|NCT01892345|12401285|FG000|COMPLETED|Overall Study||80
11210123|NCT01892345|12401286|FG001|COMPLETED|Overall Study||44
11210124|NCT01892345|12401285|FG000|NOT COMPLETED|Overall Study||16
11210125|NCT01892345|12401286|FG001|NOT COMPLETED|Overall Study||3
11210126|NCT01892436|12401296|FG000|STARTED|Overall Study||147
11210127|NCT01892436|12401297|FG001|STARTED|Overall Study||161
11210128|NCT01892436|12401298|FG002|STARTED|Overall Study||74
11210129|NCT01892436|12401299|FG003|STARTED|Overall Study||75
11210130|NCT01892436|12401296|FG000|COMPLETED|Overall Study||124
11210131|NCT01892436|12401297|FG001|COMPLETED|Overall Study||132
11210132|NCT01892436|12401298|FG002|COMPLETED|Overall Study||63
11210133|NCT01892436|12401299|FG003|COMPLETED|Overall Study||61
11210134|NCT01892436|12401296|FG000|NOT COMPLETED|Overall Study||23
11210135|NCT01892436|12401297|FG001|NOT COMPLETED|Overall Study||29
11210136|NCT01892436|12401298|FG002|NOT COMPLETED|Overall Study||11
11210137|NCT01892436|12401299|FG003|NOT COMPLETED|Overall Study||14
11210138|NCT01892501|12401309|FG000|STARTED|Overall Study||75
11210139|NCT01892501|12401309|FG000|Group A : Biopsy Surgically Possible|Overall Study||72
11210140|NCT01892501|12401309|FG000|Group B : Biopsy Not Surgically Possible|Overall Study||3
11210141|NCT01892501|12401309|FG000|COMPLETED|Overall Study||47
11210142|NCT01892501|12401309|FG000|NOT COMPLETED|Overall Study||28
11210143|NCT01892540|12401316|FG000|STARTED|Overall Study||15
11210144|NCT01892540|12401317|FG001|STARTED|Overall Study||0
11210145|NCT01892540|12401318|FG002|STARTED|Overall Study||28
11210146|NCT01892540|12401316|FG000|COMPLETED|Overall Study||15
11210147|NCT01892540|12401317|FG001|COMPLETED|Overall Study||0
11210148|NCT01892540|12401318|FG002|COMPLETED|Overall Study||25
11210149|NCT01892540|12401316|FG000|NOT COMPLETED|Overall Study||0
11210150|NCT01892540|12401317|FG001|NOT COMPLETED|Overall Study||0
11210151|NCT01892540|12401318|FG002|NOT COMPLETED|Overall Study||3
11210152|NCT01892709|12401326|FG000|STARTED|Overall Study||215
11210153|NCT01892709|12401326|FG000|COMPLETED|Overall Study||215
11210154|NCT01892709|12401326|FG000|NOT COMPLETED|Overall Study||0
11210155|NCT01892865|12401336|FG000|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
11210156|NCT01892865|12401337|FG001|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
11210157|NCT01892865|12401336|FG000|COMPLETED|Overall Study||356
11210158|NCT01892865|12401337|FG001|COMPLETED|Overall Study||379
11210159|NCT01892865|12401336|FG000|NOT COMPLETED|Overall Study||0
11210160|NCT01892865|12401337|FG001|NOT COMPLETED|Overall Study||0
11210161|NCT01893203|12401343|FG000|STARTED|Overall Study||14
11210162|NCT01893203|12401343|FG000|COMPLETED|Overall Study||13
11210163|NCT01893203|12401343|FG000|NOT COMPLETED|Overall Study||1
11210164|NCT01893281|12401347|FG000|STARTED|Overall Study||78
11210165|NCT01893281|12401347|FG000|Received at Least 1 Dose of Study Drug|Overall Study||78
11210166|NCT01893281|12401347|FG000|COMPLETED|Overall Study||75
11210167|NCT01893281|12401347|FG000|NOT COMPLETED|Overall Study||3
11210168|NCT01893346|12401355|FG000|STARTED|Overall Study||11
11210169|NCT01893346|12401356|FG001|STARTED|Overall Study||8
11210170|NCT01893346|12401357|FG002|STARTED|Overall Study||8
11210171|NCT01893346|12401358|FG003|STARTED|Overall Study||8
11210172|NCT01893346|12401355|FG000|Patients Who Received Full Infusion|Overall Study||8
11210173|NCT01893346|12401356|FG001|Patients Who Received Full Infusion|Overall Study||8
11210174|NCT01893346|12401357|FG002|Patients Who Received Full Infusion|Overall Study||8
11210175|NCT01893346|12401358|FG003|Patients Who Received Full Infusion|Overall Study||8
11210176|NCT01893346|12401355|FG000|COMPLETED|Overall Study||8
11210177|NCT01893346|12401356|FG001|COMPLETED|Overall Study||7
11210178|NCT01893346|12401357|FG002|COMPLETED|Overall Study||8
11210179|NCT01893346|12401358|FG003|COMPLETED|Overall Study||8
11210180|NCT01893346|12401355|FG000|NOT COMPLETED|Overall Study||3
11210181|NCT01893346|12401356|FG001|NOT COMPLETED|Overall Study||1
11210182|NCT01893346|12401357|FG002|NOT COMPLETED|Overall Study||0
11210183|NCT01893346|12401358|FG003|NOT COMPLETED|Overall Study||0
11210184|NCT01893372|12401370|FG000|STARTED|Overall Study||7
11210185|NCT01893372|12401371|FG001|STARTED|Overall Study||22
11210186|NCT01893372|12401370|FG000|COMPLETED|Overall Study||7
11210187|NCT01893372|12401371|FG001|COMPLETED|Overall Study||22
11352408|NCT03045887|12549450|FG004|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
11352409|NCT03045887|12549451|FG005|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
11352410|NCT03045887|12549452|FG006|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
11352411|NCT03045887|12549453|FG007|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
11352412|NCT03045887|12549454|FG008|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
11352413|NCT03045887|12549455|FG009|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
11210188|NCT01893372|12401370|FG000|NOT COMPLETED|Overall Study||0
11210189|NCT01893372|12401371|FG001|NOT COMPLETED|Overall Study||0
11210190|NCT01893411|12401380|FG000|STARTED|Overall Study||156
11210191|NCT01893411|12401381|FG001|STARTED|Overall Study||77
11210192|NCT01893411|12401382|FG002|STARTED|Overall Study||78
11210193|NCT01893411|12401380|FG000|COMPLETED|Overall Study||139
11210194|NCT01893411|12401381|FG001|COMPLETED|Overall Study||70
11210195|NCT01893411|12401382|FG002|COMPLETED|Overall Study||69
11210196|NCT01893411|12401380|FG000|NOT COMPLETED|Overall Study||17
11210197|NCT01893411|12401381|FG001|NOT COMPLETED|Overall Study||7
11210198|NCT01893411|12401382|FG002|NOT COMPLETED|Overall Study||9
11210199|NCT01893632|12401392|FG000|STARTED|Overall Study||1
11210200|NCT01893632|12401393|FG001|STARTED|Overall Study||1
11210201|NCT01893632|12401392|FG000|COMPLETED|Overall Study||1
11210202|NCT01893632|12401393|FG001|COMPLETED|Overall Study||1
11210203|NCT01893632|12401392|FG000|NOT COMPLETED|Overall Study||0
11210204|NCT01893632|12401393|FG001|NOT COMPLETED|Overall Study||0
11210205|NCT01893801|12401399|FG000|STARTED|Overall Study||25
11210206|NCT01893801|12401399|FG000|COMPLETED|Overall Study||25
11210207|NCT01893801|12401399|FG000|NOT COMPLETED|Overall Study||0
11210208|NCT01893827|12401407|FG000|STARTED|Overall Study||117
11210209|NCT01893827|12401408|FG001|STARTED|Overall Study||120
11210210|NCT01893827|12401407|FG000|COMPLETED|Overall Study||98
11210211|NCT01893827|12401408|FG001|COMPLETED|Overall Study||94
11210212|NCT01893827|12401407|FG000|NOT COMPLETED|Overall Study||19
11210213|NCT01893827|12401408|FG001|NOT COMPLETED|Overall Study||26
11210214|NCT01893879|12401416|FG000|STARTED|Overall Study||7
11210215|NCT01893879|12401417|FG001|STARTED|Overall Study||7
11210216|NCT01893879|12401416|FG000|COMPLETED|Overall Study||5
11210217|NCT01893879|12401417|FG001|COMPLETED|Overall Study||4
11210218|NCT01893879|12401416|FG000|NOT COMPLETED|Overall Study||2
11210219|NCT01893879|12401417|FG001|NOT COMPLETED|Overall Study||3
11210220|NCT01893905|12401425|FG000|STARTED|Overall Study||80
11210221|NCT01893905|12401426|FG001|STARTED|Overall Study||78
11210222|NCT01893905|12401425|FG000|COMPLETED|Overall Study||55
11210223|NCT01893905|12401426|FG001|COMPLETED|Overall Study||64
11210224|NCT01893905|12401425|FG000|NOT COMPLETED|Overall Study||25
11210225|NCT01893905|12401426|FG001|NOT COMPLETED|Overall Study||14
11210226|NCT01893983|12401434|FG000|STARTED|Overall Study||140
11210227|NCT01893983|12401435|FG001|STARTED|Overall Study||140
11210228|NCT01893983|12401434|FG000|COMPLETED|Overall Study||130
11210229|NCT01893983|12401435|FG001|COMPLETED|Overall Study||134
11210230|NCT01893983|12401434|FG000|NOT COMPLETED|Overall Study||10
11210231|NCT01893983|12401435|FG001|NOT COMPLETED|Overall Study||6
11210232|NCT01894022|12401443|FG000|STARTED|Overall Study||9
11210233|NCT01894022|12401444|FG001|STARTED|Overall Study||10
11096508|NCT01207440|12280155|FG005|NOT COMPLETED|Overall Study||46
11096509|NCT01207440|12280156|FG006|NOT COMPLETED|Overall Study||5
11096510|NCT01207453|12280180|FG000|STARTED|First Intervention||23
11096511|NCT01207453|12280181|FG001|STARTED|First Intervention||18
11096512|NCT01207453|12280180|FG000|COMPLETED|First Intervention||21
11096513|NCT01207453|12280181|FG001|COMPLETED|First Intervention||17
11096514|NCT01207453|12280180|FG000|NOT COMPLETED|First Intervention||2
11096515|NCT01207453|12280181|FG001|NOT COMPLETED|First Intervention||1
11096516|NCT01207453|12280180|FG000|STARTED|Washout||21
11096517|NCT01207453|12280181|FG001|STARTED|Washout||17
11096518|NCT01207453|12280180|FG000|COMPLETED|Washout||19
11096519|NCT01207453|12280181|FG001|COMPLETED|Washout||17
11096520|NCT01207453|12280180|FG000|NOT COMPLETED|Washout||2
11096521|NCT01207453|12280181|FG001|NOT COMPLETED|Washout||0
11096522|NCT01207453|12280180|FG000|STARTED|2nd Intervention||19
11096523|NCT01207453|12280181|FG001|STARTED|2nd Intervention||17
11096524|NCT01207453|12280180|FG000|COMPLETED|2nd Intervention||17
11096525|NCT01207453|12280181|FG001|COMPLETED|2nd Intervention||15
11096526|NCT01207453|12280180|FG000|NOT COMPLETED|2nd Intervention||2
11096527|NCT01207453|12280181|FG001|NOT COMPLETED|2nd Intervention||2
11096528|NCT01207466|12280190|FG000|STARTED|Period 1, One Week of Wear||46
11096529|NCT01207466|12280191|FG001|STARTED|Period 1, One Week of Wear||48
11096530|NCT01207466|12280190|FG000|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
11210234|NCT01894022|12401443|FG000|COMPLETED|Overall Study||0
11210235|NCT01894022|12401444|FG001|COMPLETED|Overall Study||0
11210236|NCT01894022|12401443|FG000|NOT COMPLETED|Overall Study||9
11210237|NCT01894022|12401444|FG001|NOT COMPLETED|Overall Study||10
11210238|NCT01894087|12401453|FG000|STARTED|Overall Study||102
11210239|NCT01894087|12401454|FG001|STARTED|Overall Study||102
11210240|NCT01894087|12401453|FG000|COMPLETED|Overall Study||96
11210241|NCT01894087|12401454|FG001|COMPLETED|Overall Study||102
11210242|NCT01894087|12401453|FG000|NOT COMPLETED|Overall Study||6
11210243|NCT01894087|12401454|FG001|NOT COMPLETED|Overall Study||0
11210244|NCT01894100|12401462|FG000|STARTED|Overall Study||15
11210245|NCT01894100|12401463|FG001|STARTED|Overall Study||15
11210246|NCT01894100|12401462|FG000|COMPLETED|Overall Study||12
11210247|NCT01894100|12401463|FG001|COMPLETED|Overall Study||14
11210248|NCT01894100|12401462|FG000|NOT COMPLETED|Overall Study||3
11096531|NCT01207466|12280191|FG001|COMPLETED|Period 1, One Week of Wear||48
11096532|NCT01207466|12280190|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
11096533|NCT01207466|12280191|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
11096534|NCT01207466|12280190|FG000|STARTED|Period 2, One Week of Wear||45
11096535|NCT01207466|12280191|FG001|STARTED|Period 2, One Week of Wear||48
11096536|NCT01207466|12280190|FG000|COMPLETED|Period 2, One Week of Wear||45
11096537|NCT01207466|12280191|FG001|COMPLETED|Period 2, One Week of Wear||48
11096538|NCT01207466|12280190|FG000|NOT COMPLETED|Period 2, One Week of Wear||0
11096539|NCT01207466|12280191|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
11096540|NCT01207570|12280199|FG000|STARTED|The First Stage (Before Crossover)||23
11096541|NCT01207570|12280200|FG001|STARTED|The First Stage (Before Crossover)||31
11096542|NCT01207570|12280199|FG000|COMPLETED|The First Stage (Before Crossover)||23
11096543|NCT01207570|12280200|FG001|COMPLETED|The First Stage (Before Crossover)||31
11096544|NCT01207570|12280199|FG000|NOT COMPLETED|The First Stage (Before Crossover)||0
11096545|NCT01207570|12280200|FG001|NOT COMPLETED|The First Stage (Before Crossover)||0
11096546|NCT01207570|12280199|FG000|STARTED|The Second Stage (After Crossover)||31
11096547|NCT01207570|12280200|FG001|STARTED|The Second Stage (After Crossover)||23
11096548|NCT01207570|12280199|FG000|COMPLETED|The Second Stage (After Crossover)||31
11096549|NCT01207570|12280200|FG001|COMPLETED|The Second Stage (After Crossover)||23
11096550|NCT01207570|12280199|FG000|NOT COMPLETED|The Second Stage (After Crossover)||0
11096551|NCT01207570|12280200|FG001|NOT COMPLETED|The Second Stage (After Crossover)||0
11096552|NCT01207583|12280211|FG000|STARTED|Overall Study||14
11096553|NCT01207583|12280212|FG001|STARTED|Overall Study||31
11096554|NCT01207583|12280213|FG002|STARTED|Overall Study||55
11096555|NCT01207583|12280211|FG000|Dose 1|Overall Study||14
11096556|NCT01207583|12280212|FG001|Dose 1|Overall Study||31
11096557|NCT01207583|12280213|FG002|Dose 1|Overall Study||55
11096558|NCT01207583|12280211|FG000|Dose 2|Overall Study||13
11096559|NCT01207583|12280212|FG001|Dose 2|Overall Study||29
11096560|NCT01207583|12280213|FG002|Dose 2|Overall Study||54
11096561|NCT01207583|12280211|FG000|Dose 3|Overall Study||13
11096562|NCT01207583|12280212|FG001|Dose 3|Overall Study||27
11096563|NCT01207583|12280213|FG002|Dose 3|Overall Study||0
11096564|NCT01207583|12280211|FG000|Dose 4|Overall Study||7
11096565|NCT01207583|12280212|FG001|Dose 4|Overall Study||0
11096566|NCT01207583|12280213|FG002|Dose 4|Overall Study||0
11096567|NCT01207583|12280211|FG000|COMPLETED|Overall Study||13
11210249|NCT01894100|12401463|FG001|NOT COMPLETED|Overall Study||1
11210250|NCT01894152|12401469|FG000|STARTED|Overall Study||2002
11210251|NCT01894152|12401469|FG000|COMPLETED|Overall Study||1851
11210252|NCT01894152|12401469|FG000|NOT COMPLETED|Overall Study||151
11210253|NCT01894178|12401475|FG000|STARTED|Overall Study||30
11210254|NCT01894178|12401476|FG001|STARTED|Overall Study||30
11210255|NCT01894178|12401475|FG000|COMPLETED|Overall Study||30
11210256|NCT01894178|12401476|FG001|COMPLETED|Overall Study||30
11210257|NCT01894178|12401475|FG000|NOT COMPLETED|Overall Study||0
11210258|NCT01894178|12401476|FG001|NOT COMPLETED|Overall Study||0
11210259|NCT01894230|12401484|FG000|STARTED|Overall Study||83
11210260|NCT01894230|12401485|FG001|STARTED|Overall Study||76
11210261|NCT01894230|12401484|FG000|COMPLETED|Overall Study||76
11210262|NCT01894230|12401485|FG001|COMPLETED|Overall Study||69
11210263|NCT01894230|12401484|FG000|NOT COMPLETED|Overall Study||7
11210264|NCT01894230|12401485|FG001|NOT COMPLETED|Overall Study||7
11210265|NCT01894243|12401494|FG000|STARTED|Overall Study||13
11210266|NCT01894243|12401495|FG001|STARTED|Overall Study||10
11210267|NCT01894243|12401496|FG002|STARTED|Overall Study||8
11210268|NCT01894243|12401494|FG000|Completed Treatment in Part A|Overall Study||13
11210269|NCT01894243|12401495|FG001|Completed Treatment in Part A|Overall Study||10
11210270|NCT01894243|12401496|FG002|Completed Treatment in Part A|Overall Study||8
11096568|NCT01207583|12280212|FG001|COMPLETED|Overall Study||26
11096569|NCT01207583|12280213|FG002|COMPLETED|Overall Study||54
11096570|NCT01207583|12280211|FG000|NOT COMPLETED|Overall Study||1
11096571|NCT01207583|12280212|FG001|NOT COMPLETED|Overall Study||5
11096572|NCT01207583|12280213|FG002|NOT COMPLETED|Overall Study||1
11210271|NCT01894243|12401494|FG000|Ongoing Into Part B|Overall Study||13
11210272|NCT01894243|12401495|FG001|Ongoing Into Part B|Overall Study||10
11210273|NCT01894243|12401496|FG002|Ongoing Into Part B|Overall Study||8
11096573|NCT01207596|12280234|FG000|STARTED|Overall Study||30
11096574|NCT01207596|12280234|FG000|COMPLETED|Overall Study||21
11096575|NCT01207596|12280234|FG000|NOT COMPLETED|Overall Study||9
11096576|NCT01207648|12280238|FG000|STARTED|Overall Study||307
11096577|NCT01207648|12280238|FG000|COMPLETED|Overall Study||307
11096578|NCT01207648|12280238|FG000|NOT COMPLETED|Overall Study||0
11096579|NCT01207687|12280242|FG000|STARTED|Overall Study||14
11210274|NCT01894243|12401494|FG000|COMPLETED|Overall Study||0
11210275|NCT01894243|12401495|FG001|COMPLETED|Overall Study||0
11210276|NCT01894243|12401496|FG002|COMPLETED|Overall Study||0
11210277|NCT01894243|12401494|FG000|NOT COMPLETED|Overall Study||13
11210278|NCT01894243|12401495|FG001|NOT COMPLETED|Overall Study||10
11210279|NCT01894243|12401496|FG002|NOT COMPLETED|Overall Study||8
11210280|NCT01894256|12401514|FG000|STARTED|Part A||15
11210281|NCT01894256|12401515|FG001|STARTED|Part A||15
11210282|NCT01894256|12401516|FG002|STARTED|Part A||14
11210283|NCT01894256|12401514|FG000|COMPLETED|Part A||15
11210284|NCT01894256|12401515|FG001|COMPLETED|Part A||14
11210285|NCT01894256|12401516|FG002|COMPLETED|Part A||14
11210286|NCT01894256|12401514|FG000|NOT COMPLETED|Part A||0
11210287|NCT01894256|12401515|FG001|NOT COMPLETED|Part A||1
11210288|NCT01894256|12401516|FG002|NOT COMPLETED|Part A||0
11210289|NCT01894256|12401514|FG000|STARTED|Part B||15
11210290|NCT01894256|12401515|FG001|STARTED|Part B||14
11210291|NCT01894256|12401516|FG002|STARTED|Part B||14
11210292|NCT01894256|12401514|FG000|COMPLETED|Part B||0
11210293|NCT01894256|12401515|FG001|COMPLETED|Part B||0
11210294|NCT01894256|12401516|FG002|COMPLETED|Part B||0
11210295|NCT01894256|12401514|FG000|NOT COMPLETED|Part B||15
11210296|NCT01894256|12401515|FG001|NOT COMPLETED|Part B||14
11210297|NCT01894256|12401516|FG002|NOT COMPLETED|Part B||14
11210298|NCT01894477|12401529|FG000|STARTED|Overall Study||35
11210299|NCT01894477|12401530|FG001|STARTED|Overall Study||67
11210300|NCT01894477|12401529|FG000|COMPLETED|Overall Study||35
11210301|NCT01894477|12401530|FG001|COMPLETED|Overall Study||65
11210302|NCT01894477|12401529|FG000|NOT COMPLETED|Overall Study||0
11210303|NCT01894477|12401530|FG001|NOT COMPLETED|Overall Study||2
11096580|NCT01207687|12280242|FG000|COMPLETED|Overall Study||12
11096581|NCT01207687|12280242|FG000|NOT COMPLETED|Overall Study||2
11096582|NCT01207752|12280254|FG000|STARTED|Overall Study||35
11096583|NCT01207752|12280255|FG001|STARTED|Overall Study||34
11096584|NCT01207752|12280254|FG000|COMPLETED|Overall Study||33
11096585|NCT01207752|12280255|FG001|COMPLETED|Overall Study||27
11096586|NCT01207752|12280254|FG000|NOT COMPLETED|Overall Study||2
11096587|NCT01207752|12280255|FG001|NOT COMPLETED|Overall Study||7
11096588|NCT01207765|12280261|FG000|STARTED|Overall Study||8
11096589|NCT01207765|12280261|FG000|COMPLETED|Overall Study||8
11096590|NCT01207765|12280261|FG000|NOT COMPLETED|Overall Study||0
11096591|NCT01207908|12280267|FG000|STARTED|Overall Study||22
11096592|NCT01207908|12280268|FG001|STARTED|Overall Study||22
11096593|NCT01207908|12280267|FG000|COMPLETED|Overall Study||17
11096594|NCT01207908|12280268|FG001|COMPLETED|Overall Study||21
11096595|NCT01207908|12280267|FG000|NOT COMPLETED|Overall Study||5
11096596|NCT01207908|12280268|FG001|NOT COMPLETED|Overall Study||1
11096597|NCT01207934|12280277|FG000|STARTED|Overall Study||6
11096598|NCT01207934|12280278|FG001|STARTED|Overall Study||6
11096599|NCT01207934|12280279|FG002|STARTED|Overall Study||6
11096600|NCT01207934|12280277|FG000|COMPLETED|Overall Study||6
11096601|NCT01207934|12280278|FG001|COMPLETED|Overall Study||6
11210304|NCT01894503|12401536|FG000|STARTED|Overall Study||5
11210305|NCT01894503|12401536|FG000|COMPLETED|Overall Study||5
11096602|NCT01207934|12280279|FG002|COMPLETED|Overall Study||6
11096603|NCT01207934|12280277|FG000|NOT COMPLETED|Overall Study||0
11096604|NCT01207934|12280278|FG001|NOT COMPLETED|Overall Study||0
11352414|NCT03045887|12549446|FG000|STARTED|Part A, Period 3 (1 Day)||3
11352415|NCT03045887|12549447|FG001|STARTED|Part A, Period 3 (1 Day)||4
11352416|NCT03045887|12549448|FG002|STARTED|Part A, Period 3 (1 Day)||4
11352417|NCT03045887|12549449|FG003|STARTED|Part A, Period 3 (1 Day)||2
11352418|NCT03045887|12549450|FG004|STARTED|Part A, Period 3 (1 Day)||4
11352419|NCT03045887|12549451|FG005|STARTED|Part A, Period 3 (1 Day)||4
11352420|NCT03045887|12549452|FG006|STARTED|Part A, Period 3 (1 Day)||4
11352421|NCT03045887|12549453|FG007|STARTED|Part A, Period 3 (1 Day)||4
11352422|NCT03045887|12549454|FG008|STARTED|Part A, Period 3 (1 Day)||0
11352423|NCT03045887|12549455|FG009|STARTED|Part A, Period 3 (1 Day)||0
11352424|NCT03045887|12549446|FG000|COMPLETED|Part A, Period 3 (1 Day)||3
11352425|NCT03045887|12549447|FG001|COMPLETED|Part A, Period 3 (1 Day)||4
11352426|NCT03045887|12549448|FG002|COMPLETED|Part A, Period 3 (1 Day)||4
11352427|NCT03045887|12549449|FG003|COMPLETED|Part A, Period 3 (1 Day)||2
11210306|NCT01894503|12401536|FG000|NOT COMPLETED|Overall Study||0
11210307|NCT01894516|12401545|FG000|STARTED|Period 1 (Baseline up to Week 12)||72
11210308|NCT01894516|12401546|FG001|STARTED|Period 1 (Baseline up to Week 12)||72
11210309|NCT01894516|12401547|FG002|STARTED|Period 1 (Baseline up to Week 12)||70
11210310|NCT01894516|12401548|FG003|STARTED|Period 1 (Baseline up to Week 12)||69
11210311|NCT01894516|12401545|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||65
11210312|NCT01894516|12401546|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||67
11210313|NCT01894516|12401547|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||67
11210314|NCT01894516|12401548|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||66
11210315|NCT01894516|12401545|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
11210316|NCT01894516|12401546|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
11210317|NCT01894516|12401547|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
11210318|NCT01894516|12401548|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
11210319|NCT01894516|12401545|FG000|STARTED|Period 2 (Week 13 to Week 24)|All participants from Placebo moved to 100 mg QD (65 participants) group.|0
11210320|NCT01894516|12401546|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (15 participants).|52
11210321|NCT01894516|12401547|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(65 participants) and 50 mg QD (15 participants) moved to 100 mg QD group.|147
11210322|NCT01894516|12401548|FG003|STARTED|Period 2 (Week 13 to Week 24)||66
11210323|NCT01894516|12401545|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||0
11210324|NCT01894516|12401546|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||50
11210325|NCT01894516|12401547|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||142
11210326|NCT01894516|12401548|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||65
11210327|NCT01894516|12401545|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||0
11210328|NCT01894516|12401546|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
11096605|NCT01207934|12280279|FG002|NOT COMPLETED|Overall Study||0
11096606|NCT01208038|12280287|FG000|STARTED|Overall Study||22
11096607|NCT01208038|12280287|FG000|COMPLETED|Overall Study|Patient withdrew before commencing study drug|21
11210329|NCT01894516|12401547|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||5
11210330|NCT01894516|12401548|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||1
11210331|NCT01894555|12401562|FG000|STARTED|Overall Study||33
11210332|NCT01894555|12401562|FG000|COMPLETED|Overall Study||33
11210333|NCT01894555|12401562|FG000|NOT COMPLETED|Overall Study||0
11210334|NCT01894568|12401568|FG000|STARTED|Overall Study||192
11210335|NCT01894568|12401569|FG001|STARTED|Overall Study||196
11210336|NCT01894568|12401568|FG000|Received at Least 1 Dose of Study Drug|Overall Study||192
11210337|NCT01894568|12401569|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
11210338|NCT01894568|12401568|FG000|COMPLETED|Overall Study||182
11210339|NCT01894568|12401569|FG001|COMPLETED|Overall Study||186
11210340|NCT01894568|12401568|FG000|NOT COMPLETED|Overall Study||10
11210341|NCT01894568|12401569|FG001|NOT COMPLETED|Overall Study||10
11210342|NCT01894581|12401578|FG000|STARTED|Overall Study||20
11210343|NCT01894581|12401579|FG001|STARTED|Overall Study||19
11210344|NCT01894581|12401578|FG000|COMPLETED|Overall Study||15
11210345|NCT01894581|12401579|FG001|COMPLETED|Overall Study||12
11210346|NCT01894581|12401578|FG000|NOT COMPLETED|Overall Study||5
11210347|NCT01894581|12401579|FG001|NOT COMPLETED|Overall Study||7
11210348|NCT01894607|12401585|FG000|STARTED|Overall Study||11
11210349|NCT01894607|12401585|FG000|COMPLETED|Overall Study||10
11210350|NCT01894607|12401585|FG000|NOT COMPLETED|Overall Study||1
11210351|NCT01894620|12401591|FG000|STARTED|Overall Study||6
11210352|NCT01894620|12401592|FG001|STARTED|Overall Study||5
11210353|NCT01894620|12401591|FG000|COMPLETED|Overall Study||6
11210354|NCT01894620|12401592|FG001|COMPLETED|Overall Study||4
11210355|NCT01894620|12401591|FG000|NOT COMPLETED|Overall Study||0
11352428|NCT03045887|12549450|FG004|COMPLETED|Part A, Period 3 (1 Day)||4
11352429|NCT03045887|12549451|FG005|COMPLETED|Part A, Period 3 (1 Day)||4
11352430|NCT03045887|12549452|FG006|COMPLETED|Part A, Period 3 (1 Day)||4
11210356|NCT01894620|12401592|FG001|NOT COMPLETED|Overall Study||1
11210357|NCT01894672|12401600|FG000|STARTED|Overall Study||7
11210358|NCT01894672|12401600|FG000|COMPLETED|Overall Study||7
11210359|NCT01894672|12401600|FG000|NOT COMPLETED|Overall Study||0
11210360|NCT01894776|12401605|FG000|STARTED|Overall Study||15
11210361|NCT01894776|12401605|FG000|COMPLETED|Overall Study||14
11210362|NCT01894776|12401605|FG000|NOT COMPLETED|Overall Study||1
11210363|NCT01894841|12401611|FG000|STARTED|Overall Study||52
11210364|NCT01894841|12401612|FG001|STARTED|Overall Study||53
11210365|NCT01894841|12401611|FG000|COMPLETED|Overall Study||34
11210366|NCT01894841|12401612|FG001|COMPLETED|Overall Study||44
11210367|NCT01894841|12401611|FG000|NOT COMPLETED|Overall Study||18
11210368|NCT01894841|12401612|FG001|NOT COMPLETED|Overall Study||9
11210369|NCT01894906|12401624|FG000|STARTED|Overall Study||6
11210370|NCT01894906|12401625|FG001|STARTED|Overall Study||6
11210371|NCT01894906|12401624|FG000|Treatment A|Overall Study||6
11210372|NCT01894906|12401625|FG001|Treatment A|Overall Study||6
11210373|NCT01894906|12401624|FG000|Treatment B|Overall Study||6
11210374|NCT01894906|12401625|FG001|Treatment B|Overall Study||6
11210375|NCT01894906|12401624|FG000|Treatment C|Overall Study||6
11210376|NCT01894906|12401625|FG001|Treatment C|Overall Study||6
11210377|NCT01894906|12401624|FG000|Treatment D|Overall Study||6
11210378|NCT01894906|12401625|FG001|Treatment D|Overall Study||6
11210379|NCT01894906|12401624|FG000|Treatment E|Overall Study||6
11210380|NCT01894906|12401625|FG001|Treatment E|Overall Study||6
11210381|NCT01894906|12401624|FG000|Treatment F|Overall Study||6
11210382|NCT01894906|12401625|FG001|Treatment F|Overall Study||6
11210383|NCT01894906|12401624|FG000|COMPLETED|Overall Study||6
11210384|NCT01894906|12401625|FG001|COMPLETED|Overall Study||6
11210385|NCT01894906|12401624|FG000|NOT COMPLETED|Overall Study||0
11210386|NCT01894906|12401625|FG001|NOT COMPLETED|Overall Study||0
11210387|NCT01894919|12401656|FG000|STARTED|Overall Study||98
11210388|NCT01894919|12401657|FG001|STARTED|Overall Study||47
11210389|NCT01894919|12401658|FG002|STARTED|Overall Study||89
11210390|NCT01894919|12401659|FG003|STARTED|Overall Study||43
11210391|NCT01894919|12401660|FG004|STARTED|Overall Study||81
11210392|NCT01894919|12401661|FG005|STARTED|Overall Study||39
11210393|NCT01894919|12401662|FG006|STARTED|Overall Study||32
11210394|NCT01894919|12401663|FG007|STARTED|Overall Study||36
11210395|NCT01894919|12401664|FG008|STARTED|Overall Study||91
11210396|NCT01894919|12401665|FG009|STARTED|Overall Study||90
11210397|NCT01894919|12401666|FG010|STARTED|Overall Study||100
11210398|NCT01894919|12401667|FG011|STARTED|Overall Study||55
11210399|NCT01894919|12401668|FG012|STARTED|Overall Study||50
11210400|NCT01894919|12401656|FG000|COMPLETED|Overall Study||96
11210401|NCT01894919|12401657|FG001|COMPLETED|Overall Study||47
11210402|NCT01894919|12401658|FG002|COMPLETED|Overall Study||89
11210403|NCT01894919|12401659|FG003|COMPLETED|Overall Study||43
11210404|NCT01894919|12401660|FG004|COMPLETED|Overall Study||78
11210405|NCT01894919|12401661|FG005|COMPLETED|Overall Study||39
11210406|NCT01894919|12401662|FG006|COMPLETED|Overall Study||32
11210407|NCT01894919|12401663|FG007|COMPLETED|Overall Study||36
11210408|NCT01894919|12401664|FG008|COMPLETED|Overall Study||91
11210409|NCT01894919|12401665|FG009|COMPLETED|Overall Study||89
11210410|NCT01894919|12401666|FG010|COMPLETED|Overall Study||98
11352431|NCT03045887|12549453|FG007|COMPLETED|Part A, Period 3 (1 Day)||4
11352432|NCT03045887|12549454|FG008|COMPLETED|Part A, Period 3 (1 Day)||0
11352433|NCT03045887|12549455|FG009|COMPLETED|Part A, Period 3 (1 Day)||0
11352434|NCT03045887|12549446|FG000|NOT COMPLETED|Part A, Period 3 (1 Day)||0
11352435|NCT03045887|12549447|FG001|NOT COMPLETED|Part A, Period 3 (1 Day)||0
11352436|NCT03045887|12549448|FG002|NOT COMPLETED|Part A, Period 3 (1 Day)||0
11210411|NCT01894919|12401667|FG011|COMPLETED|Overall Study||55
11210412|NCT01894919|12401668|FG012|COMPLETED|Overall Study||50
11210413|NCT01894919|12401656|FG000|NOT COMPLETED|Overall Study||2
11210414|NCT01894919|12401657|FG001|NOT COMPLETED|Overall Study||0
11210415|NCT01894919|12401658|FG002|NOT COMPLETED|Overall Study||0
11210416|NCT01894919|12401659|FG003|NOT COMPLETED|Overall Study||0
11210417|NCT01894919|12401660|FG004|NOT COMPLETED|Overall Study||3
11210418|NCT01894919|12401661|FG005|NOT COMPLETED|Overall Study||0
11210419|NCT01894919|12401662|FG006|NOT COMPLETED|Overall Study||0
11210420|NCT01894919|12401663|FG007|NOT COMPLETED|Overall Study||0
11210421|NCT01894919|12401664|FG008|NOT COMPLETED|Overall Study||0
11210422|NCT01894919|12401665|FG009|NOT COMPLETED|Overall Study||1
11210423|NCT01894919|12401666|FG010|NOT COMPLETED|Overall Study||2
11210424|NCT01894919|12401667|FG011|NOT COMPLETED|Overall Study||0
11210425|NCT01894919|12401668|FG012|NOT COMPLETED|Overall Study||0
11210426|NCT01894984|12401712|FG000|STARTED|Overall Study||396
11210427|NCT01894984|12401713|FG001|STARTED|Overall Study||244
11210428|NCT01894984|12401712|FG000|COMPLETED|Overall Study||82
11210429|NCT01894984|12401713|FG001|COMPLETED|Overall Study||69
11210430|NCT01894984|12401712|FG000|NOT COMPLETED|Overall Study||314
11210431|NCT01894984|12401713|FG001|NOT COMPLETED|Overall Study||175
11210432|NCT01895036|12401719|FG000|STARTED|Overall Study||6
11210433|NCT01895036|12401719|FG000|COMPLETED|Overall Study||6
11210434|NCT01895036|12401719|FG000|NOT COMPLETED|Overall Study||0
11210435|NCT01895062|12401725|FG000|STARTED|Overall Study||30
11210436|NCT01895062|12401726|FG001|STARTED|Overall Study||24
11210437|NCT01895062|12401725|FG000|COMPLETED|Overall Study||30
11210438|NCT01895062|12401726|FG001|COMPLETED|Overall Study||24
11210439|NCT01895062|12401725|FG000|NOT COMPLETED|Overall Study||0
11210440|NCT01895062|12401726|FG001|NOT COMPLETED|Overall Study||0
11352437|NCT03045887|12549449|FG003|NOT COMPLETED|Part A, Period 3 (1 Day)||0
11352438|NCT03045887|12549450|FG004|NOT COMPLETED|Part A, Period 3 (1 Day)||0
11352439|NCT03045887|12549451|FG005|NOT COMPLETED|Part A, Period 3 (1 Day)||0
11352440|NCT03045887|12549452|FG006|NOT COMPLETED|Part A, Period 3 (1 Day)||0
11352441|NCT03045887|12549453|FG007|NOT COMPLETED|Part A, Period 3 (1 Day)||0
11352442|NCT03045887|12549454|FG008|NOT COMPLETED|Part A, Period 3 (1 Day)||0
11352443|NCT03045887|12549455|FG009|NOT COMPLETED|Part A, Period 3 (1 Day)||0
11352444|NCT03045887|12549446|FG000|STARTED|Part B (14 Days)||0
11352445|NCT03045887|12549447|FG001|STARTED|Part B (14 Days)||0
11352446|NCT03045887|12549448|FG002|STARTED|Part B (14 Days)||0
11352447|NCT03045887|12549449|FG003|STARTED|Part B (14 Days)||0
11352448|NCT03045887|12549450|FG004|STARTED|Part B (14 Days)||0
11352449|NCT03045887|12549451|FG005|STARTED|Part B (14 Days)||0
11352450|NCT03045887|12549452|FG006|STARTED|Part B (14 Days)||0
11352451|NCT03045887|12549453|FG007|STARTED|Part B (14 Days)||0
11352452|NCT03045887|12549454|FG008|STARTED|Part B (14 Days)||3
11352453|NCT03045887|12549455|FG009|STARTED|Part B (14 Days)||9
11352454|NCT03045887|12549446|FG000|COMPLETED|Part B (14 Days)||0
11352455|NCT03045887|12549447|FG001|COMPLETED|Part B (14 Days)||0
11352456|NCT03045887|12549448|FG002|COMPLETED|Part B (14 Days)||0
11352457|NCT03045887|12549449|FG003|COMPLETED|Part B (14 Days)||0
11352458|NCT03045887|12549450|FG004|COMPLETED|Part B (14 Days)||0
11352459|NCT03045887|12549451|FG005|COMPLETED|Part B (14 Days)||0
11352460|NCT03045887|12549452|FG006|COMPLETED|Part B (14 Days)||0
11352461|NCT03045887|12549453|FG007|COMPLETED|Part B (14 Days)||0
11352462|NCT03045887|12549454|FG008|COMPLETED|Part B (14 Days)||3
11352463|NCT03045887|12549455|FG009|COMPLETED|Part B (14 Days)||9
11352464|NCT03045887|12549446|FG000|NOT COMPLETED|Part B (14 Days)||0
11352465|NCT03045887|12549447|FG001|NOT COMPLETED|Part B (14 Days)||0
11352466|NCT03045887|12549448|FG002|NOT COMPLETED|Part B (14 Days)||0
11352467|NCT03045887|12549449|FG003|NOT COMPLETED|Part B (14 Days)||0
11352468|NCT03045887|12549450|FG004|NOT COMPLETED|Part B (14 Days)||0
11352469|NCT03045887|12549451|FG005|NOT COMPLETED|Part B (14 Days)||0
11352470|NCT03045887|12549452|FG006|NOT COMPLETED|Part B (14 Days)||0
11352471|NCT03045887|12549453|FG007|NOT COMPLETED|Part B (14 Days)||0
11352472|NCT03045887|12549454|FG008|NOT COMPLETED|Part B (14 Days)||0
11352473|NCT03045887|12549455|FG009|NOT COMPLETED|Part B (14 Days)||0
11352474|NCT03045926|12549482|FG000|STARTED|Overall Study||35
11352475|NCT03045926|12549482|FG000|COMPLETED|Overall Study||35
11352476|NCT03045926|12549482|FG000|NOT COMPLETED|Overall Study||0
11352477|NCT03046056|12549489|FG000|STARTED|Overall Study||28
11352478|NCT03046056|12549490|FG001|STARTED|Overall Study||32
11352479|NCT03046056|12549491|FG002|STARTED|Overall Study||18
11352480|NCT03046056|12549489|FG000|COMPLETED|Overall Study||16
11352481|NCT03046056|12549490|FG001|COMPLETED|Overall Study||16
11352482|NCT03046056|12549491|FG002|COMPLETED|Overall Study||11
11352483|NCT03046056|12549489|FG000|NOT COMPLETED|Overall Study||12
11352484|NCT03046056|12549490|FG001|NOT COMPLETED|Overall Study||16
11352485|NCT03046056|12549491|FG002|NOT COMPLETED|Overall Study||7
11352486|NCT03046212|12549501|FG000|STARTED|Overall Study||15
11352487|NCT03046212|12549502|FG001|STARTED|Overall Study||15
11352488|NCT03046212|12549501|FG000|COMPLETED|Overall Study||15
11352489|NCT03046212|12549502|FG001|COMPLETED|Overall Study||15
11352490|NCT03046212|12549501|FG000|NOT COMPLETED|Overall Study||0
11352491|NCT03046212|12549502|FG001|NOT COMPLETED|Overall Study||0
11352492|NCT03046225|12549510|FG000|STARTED|Overall Study||13
11352493|NCT03046225|12549511|FG001|STARTED|Overall Study||13
11352494|NCT03046225|12549510|FG000|COMPLETED|Overall Study||13
11352495|NCT03046225|12549511|FG001|COMPLETED|Overall Study||13
11210441|NCT01895088|12401732|FG000|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
11210442|NCT01895088|12401732|FG000|COMPLETED|Overall Study||253
11210443|NCT01895088|12401732|FG000|NOT COMPLETED|Overall Study||18
11210444|NCT01895101|12401739|FG000|STARTED|Overall Study||250
11210445|NCT01895101|12401740|FG001|STARTED|Overall Study||250
11210446|NCT01895101|12401741|FG002|STARTED|Overall Study||250
11210447|NCT01895101|12401739|FG000|COMPLETED|Overall Study||249
11210448|NCT01895101|12401740|FG001|COMPLETED|Overall Study||245
11210449|NCT01895101|12401741|FG002|COMPLETED|Overall Study||245
11210450|NCT01895101|12401739|FG000|NOT COMPLETED|Overall Study||1
11210451|NCT01895101|12401740|FG001|NOT COMPLETED|Overall Study||5
11210452|NCT01895101|12401741|FG002|NOT COMPLETED|Overall Study||5
11210453|NCT01895127|12401751|FG000|STARTED|Screening||4
11210454|NCT01895127|12401752|FG001|STARTED|Screening||7
11210455|NCT01895127|12401751|FG000|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
11210456|NCT01895127|12401752|FG001|COMPLETED|Screening||7
11210457|NCT01895127|12401751|FG000|NOT COMPLETED|Screening||0
11210458|NCT01895127|12401752|FG001|NOT COMPLETED|Screening||0
11210459|NCT01895127|12401751|FG000|STARTED|Treatment Period (Week 0-Month 3)||3
11210460|NCT01895127|12401752|FG001|STARTED|Treatment Period (Week 0-Month 3)||7
11210461|NCT01895127|12401751|FG000|COMPLETED|Treatment Period (Week 0-Month 3)||3
11210462|NCT01895127|12401752|FG001|COMPLETED|Treatment Period (Week 0-Month 3)||7
11210463|NCT01895127|12401751|FG000|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
11352496|NCT03046225|12549510|FG000|NOT COMPLETED|Overall Study||0
11352497|NCT03046225|12549511|FG001|NOT COMPLETED|Overall Study||0
11352498|NCT03046446|12549517|FG000|STARTED|Overall Study||208
11352499|NCT03046446|12549517|FG000|Second Injection|Overall Study||179
11352500|NCT03046446|12549517|FG000|Completed at Week 12|Overall Study||10
11352501|NCT03046446|12549517|FG000|Completed at Week 24|Overall Study||6
11352502|NCT03046446|12549517|FG000|Completed at Week 52|Overall Study||133
11210464|NCT01895127|12401752|FG001|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
11210465|NCT01895127|12401751|FG000|STARTED|Month 3 Follow-up & Biopsy||3
11210466|NCT01895127|12401752|FG001|STARTED|Month 3 Follow-up & Biopsy||7
11210467|NCT01895127|12401751|FG000|COMPLETED|Month 3 Follow-up & Biopsy||3
11210468|NCT01895127|12401752|FG001|COMPLETED|Month 3 Follow-up & Biopsy||7
11210469|NCT01895127|12401751|FG000|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
11210470|NCT01895127|12401752|FG001|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
11210471|NCT01895127|12401751|FG000|STARTED|Long Term Follow-up (Month 3-12)||3
11210472|NCT01895127|12401752|FG001|STARTED|Long Term Follow-up (Month 3-12)||7
11210473|NCT01895127|12401751|FG000|COMPLETED|Long Term Follow-up (Month 3-12)||1
11210474|NCT01895127|12401752|FG001|COMPLETED|Long Term Follow-up (Month 3-12)||4
11210475|NCT01895127|12401751|FG000|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
11210476|NCT01895127|12401752|FG001|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
11210477|NCT01895270|12401761|FG000|STARTED|Study Medications Induction (W1-4)||11
11210478|NCT01895270|12401762|FG001|STARTED|Study Medications Induction (W1-4)||14
11210479|NCT01895270|12401761|FG000|COMPLETED|Study Medications Induction (W1-4)||5
11210480|NCT01895270|12401762|FG001|COMPLETED|Study Medications Induction (W1-4)||8
11210481|NCT01895270|12401761|FG000|NOT COMPLETED|Study Medications Induction (W1-4)||6
11210482|NCT01895270|12401762|FG001|NOT COMPLETED|Study Medications Induction (W1-4)||6
11210483|NCT01895270|12401761|FG000|STARTED|Buprenorphine Taper (W5 to W6D3)||5
11210484|NCT01895270|12401762|FG001|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
11210485|NCT01895270|12401761|FG000|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
11210486|NCT01895270|12401762|FG001|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
11210487|NCT01895270|12401761|FG000|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
11210488|NCT01895270|12401762|FG001|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
11210489|NCT01895270|12401761|FG000|STARTED|Isradipine Taper (W7-8)||2
11210490|NCT01895270|12401762|FG001|STARTED|Isradipine Taper (W7-8)||2
11210491|NCT01895270|12401761|FG000|COMPLETED|Isradipine Taper (W7-8)||2
11210492|NCT01895270|12401762|FG001|COMPLETED|Isradipine Taper (W7-8)||0
11210493|NCT01895270|12401761|FG000|NOT COMPLETED|Isradipine Taper (W7-8)||0
11210494|NCT01895270|12401762|FG001|NOT COMPLETED|Isradipine Taper (W7-8)||2
11210495|NCT01895309|12401770|FG000|STARTED|Overall Study||299
11210496|NCT01895309|12401771|FG001|STARTED|Overall Study||297
11210497|NCT01895309|12401770|FG000|COMPLETED|Overall Study||259
11210498|NCT01895309|12401771|FG001|COMPLETED|Overall Study||246
11210499|NCT01895309|12401770|FG000|NOT COMPLETED|Overall Study||40
11210500|NCT01895309|12401771|FG001|NOT COMPLETED|Overall Study||51
11210501|NCT01895322|12401781|FG000|STARTED|Overall Study||20
11210502|NCT01895322|12401781|FG000|COMPLETED|Overall Study||7
11210503|NCT01895322|12401781|FG000|NOT COMPLETED|Overall Study||13
11210504|NCT01895335|12401786|FG000|STARTED|Overall Study||1001
11210505|NCT01895335|12401786|FG000|Treated|Overall Study||1000
11210506|NCT01895335|12401786|FG000|COMPLETED|Overall Study||786
11210507|NCT01895335|12401786|FG000|NOT COMPLETED|Overall Study||215
11210508|NCT01895361|12401793|FG000|STARTED|Overall Study||67
11210509|NCT01895361|12401794|FG001|STARTED|Overall Study||66
11210510|NCT01895361|12401795|FG002|STARTED|Overall Study||65
11210511|NCT01895361|12401793|FG000|COMPLETED|Overall Study||43
11210512|NCT01895361|12401794|FG001|COMPLETED|Overall Study||45
11210513|NCT01895361|12401795|FG002|COMPLETED|Overall Study||41
11210514|NCT01895361|12401793|FG000|NOT COMPLETED|Overall Study||24
11210515|NCT01895361|12401794|FG001|NOT COMPLETED|Overall Study||21
11210516|NCT01895361|12401795|FG002|NOT COMPLETED|Overall Study||24
11210517|NCT01895452|12401805|FG000|STARTED|Overall Study||65
11210518|NCT01895452|12401806|FG001|STARTED|Overall Study||226
11210519|NCT01895452|12401805|FG000|COMPLETED|Overall Study||61
11210520|NCT01895452|12401806|FG001|COMPLETED|Overall Study||198
11210521|NCT01895452|12401805|FG000|NOT COMPLETED|Overall Study||4
11210522|NCT01895452|12401806|FG001|NOT COMPLETED|Overall Study||28
11210523|NCT01895543|12401812|FG000|STARTED|Overall Study||411
11210524|NCT01895543|12401812|FG000|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
11210525|NCT01895543|12401812|FG000|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
11210526|NCT01895543|12401812|FG000|COMPLETED|Overall Study||282
11210527|NCT01895543|12401812|FG000|NOT COMPLETED|Overall Study||129
11210528|NCT01895608|12401820|FG000|STARTED|Overall Study||10
11210529|NCT01895608|12401821|FG001|STARTED|Overall Study||7
11210530|NCT01895608|12401822|FG002|STARTED|Overall Study||11
11210531|NCT01895608|12401823|FG003|STARTED|Overall Study||6
11210532|NCT01895608|12401820|FG000|COMPLETED|Overall Study||10
11210533|NCT01895608|12401821|FG001|COMPLETED|Overall Study||6
11210534|NCT01895608|12401822|FG002|COMPLETED|Overall Study||8
11210535|NCT01895608|12401823|FG003|COMPLETED|Overall Study||6
11210536|NCT01895608|12401820|FG000|NOT COMPLETED|Overall Study||0
11210537|NCT01895608|12401821|FG001|NOT COMPLETED|Overall Study||1
11210538|NCT01895608|12401822|FG002|NOT COMPLETED|Overall Study||3
11210539|NCT01895608|12401823|FG003|NOT COMPLETED|Overall Study||0
11210540|NCT01895634|12401833|FG000|STARTED|Overall Study||49
11210541|NCT01895634|12401833|FG000|COMPLETED|Overall Study||46
11210542|NCT01895634|12401833|FG000|NOT COMPLETED|Overall Study||3
11210543|NCT01895647|12401840|FG000|STARTED|Overall Study||8
11210544|NCT01895647|12401841|FG001|STARTED|Overall Study||10
11210545|NCT01895647|12401842|FG002|STARTED|Overall Study||7
11210546|NCT01895647|12401840|FG000|COMPLETED|Overall Study||8
11210547|NCT01895647|12401841|FG001|COMPLETED|Overall Study||10
11210548|NCT01895647|12401842|FG002|COMPLETED|Overall Study||7
11210549|NCT01895647|12401840|FG000|NOT COMPLETED|Overall Study||0
11352503|NCT03046446|12549517|FG000|COMPLETED|Overall Study||149
11352504|NCT03046446|12549517|FG000|NOT COMPLETED|Overall Study||59
11352505|NCT03046472|12549523|FG000|STARTED|Overall Study||33
11352506|NCT03046472|12549524|FG001|STARTED|Overall Study||17
11352507|NCT03046472|12549523|FG000|COMPLETED|Overall Study||33
11352508|NCT03046472|12549524|FG001|COMPLETED|Overall Study||17
11210550|NCT01895647|12401841|FG001|NOT COMPLETED|Overall Study||0
11210551|NCT01895647|12401842|FG002|NOT COMPLETED|Overall Study||0
11210552|NCT01895777|12401852|FG000|STARTED|Overall Study||177
11210553|NCT01895777|12401853|FG001|STARTED|Overall Study||90
11210554|NCT01895777|12401852|FG000|Treated|Overall Study||176
11210555|NCT01895777|12401853|FG001|Treated|Overall Study||90
11210556|NCT01895777|12401852|FG000|COMPLETED|Overall Study||168
11210557|NCT01895777|12401853|FG001|COMPLETED|Overall Study||85
11210558|NCT01895777|12401852|FG000|NOT COMPLETED|Overall Study||9
11210559|NCT01895777|12401853|FG001|NOT COMPLETED|Overall Study||5
11210560|NCT01895855|12401864|FG000|STARTED|Overall Study||95
11210561|NCT01895855|12401865|FG001|STARTED|Overall Study||102
11210562|NCT01895855|12401864|FG000|COMPLETED|Overall Study||95
11210563|NCT01895855|12401865|FG001|COMPLETED|Overall Study||102
11210564|NCT01895855|12401864|FG000|NOT COMPLETED|Overall Study||0
11210565|NCT01895855|12401865|FG001|NOT COMPLETED|Overall Study||0
11210566|NCT01895946|12401877|FG000|STARTED|Overall Study||18
11210567|NCT01895946|12401878|FG001|STARTED|Overall Study||12
11210568|NCT01895946|12401877|FG000|COMPLETED|Overall Study||18
11210569|NCT01895946|12401878|FG001|COMPLETED|Overall Study||12
11210570|NCT01895946|12401877|FG000|NOT COMPLETED|Overall Study||0
11210571|NCT01895946|12401878|FG001|NOT COMPLETED|Overall Study||0
11210572|NCT01895972|12401884|FG000|STARTED|Overall Study||130
11210573|NCT01895972|12401884|FG000|COMPLETED|Overall Study||121
11210574|NCT01895972|12401884|FG000|NOT COMPLETED|Overall Study||9
11210575|NCT01896050|12401890|FG000|STARTED|Overall Study||93
11210576|NCT01896050|12401891|FG001|STARTED|Overall Study||22
11210577|NCT01896050|12401890|FG000|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
11210578|NCT01896050|12401891|FG001|COMPLETED|Overall Study||20
11210579|NCT01896050|12401890|FG000|NOT COMPLETED|Overall Study||38
11210580|NCT01896050|12401891|FG001|NOT COMPLETED|Overall Study||2
11210581|NCT01896115|12401901|FG000|STARTED|Overall Study||16
11210582|NCT01896115|12401902|FG001|STARTED|Overall Study||24
11210583|NCT01896115|12401901|FG000|Phase 1 Short PW|Overall Study||15
11210584|NCT01896115|12401902|FG001|Phase 1 Short PW|Overall Study||0
11210585|NCT01896115|12401901|FG000|Phase 1 Conventional PW|Overall Study||15
11210586|NCT01896115|12401902|FG001|Phase 1 Conventional PW|Overall Study||0
11210587|NCT01896115|12401901|FG000|Phase 1 Dorsal Steering|Overall Study||15
11210588|NCT01896115|12401902|FG001|Phase 1 Dorsal Steering|Overall Study||0
11210589|NCT01896115|12401901|FG000|Phase 1 Ventral Steering|Overall Study||15
11210590|NCT01896115|12401902|FG001|Phase 1 Ventral Steering|Overall Study||0
11210591|NCT01896115|12401901|FG000|Phase 2 Single Contact|Overall Study||0
11210592|NCT01896115|12401902|FG001|Phase 2 Single Contact|Overall Study||24
11210593|NCT01896115|12401901|FG000|Phase 2 Steering|Overall Study||0
11210594|NCT01896115|12401902|FG001|Phase 2 Steering|Overall Study||24
11210595|NCT01896115|12401901|FG000|COMPLETED|Overall Study||15
11352509|NCT03046472|12549523|FG000|NOT COMPLETED|Overall Study||0
11352510|NCT03046472|12549524|FG001|NOT COMPLETED|Overall Study||0
11096608|NCT01208038|12280287|FG000|NOT COMPLETED|Overall Study||1
11352511|NCT03046966|12549532|FG000|STARTED|Overall Study||51
11210596|NCT01896115|12401902|FG001|COMPLETED|Overall Study||24
11210597|NCT01896115|12401901|FG000|NOT COMPLETED|Overall Study||1
11210598|NCT01896115|12401902|FG001|NOT COMPLETED|Overall Study||0
11210599|NCT01896128|12401915|FG000|STARTED|Overall Study||8
11210600|NCT01896128|12401916|FG001|STARTED|Overall Study||11
11352512|NCT03046966|12549533|FG001|STARTED|Overall Study||51
11352513|NCT03046966|12549532|FG000|COMPLETED|Overall Study||51
11352514|NCT03046966|12549533|FG001|COMPLETED|Overall Study||51
11352515|NCT03046966|12549532|FG000|NOT COMPLETED|Overall Study||0
11352516|NCT03046966|12549533|FG001|NOT COMPLETED|Overall Study||0
11352517|NCT03047174|12549541|FG000|STARTED|Overall Study||28
11210601|NCT01896128|12401915|FG000|COMPLETED|Overall Study||5
11210602|NCT01896128|12401916|FG001|COMPLETED|Overall Study||8
11210603|NCT01896128|12401915|FG000|NOT COMPLETED|Overall Study||3
11210604|NCT01896128|12401916|FG001|NOT COMPLETED|Overall Study||3
11210605|NCT01896193|12401926|FG000|STARTED|Overall Study||62
11210606|NCT01896193|12401927|FG001|STARTED|Overall Study||65
11210607|NCT01896193|12401926|FG000|COMPLETED|Overall Study||41
11210608|NCT01896193|12401927|FG001|COMPLETED|Overall Study||53
11210609|NCT01896193|12401926|FG000|NOT COMPLETED|Overall Study||21
11096609|NCT01208051|12280296|FG000|STARTED|Total Enrollment||4
11096610|NCT01208051|12280297|FG001|STARTED|Total Enrollment||7
11096611|NCT01208051|12280298|FG002|STARTED|Total Enrollment||6
11096612|NCT01208051|12280299|FG003|STARTED|Total Enrollment||39
11096613|NCT01208051|12280300|FG004|STARTED|Total Enrollment||71
11096614|NCT01208051|12280296|FG000|COMPLETED|Total Enrollment||4
11096615|NCT01208051|12280297|FG001|COMPLETED|Total Enrollment||6
11096616|NCT01208051|12280298|FG002|COMPLETED|Total Enrollment||5
11096617|NCT01208051|12280299|FG003|COMPLETED|Total Enrollment||39
11096618|NCT01208051|12280300|FG004|COMPLETED|Total Enrollment||69
11096619|NCT01208051|12280296|FG000|NOT COMPLETED|Total Enrollment||0
11096620|NCT01208051|12280297|FG001|NOT COMPLETED|Total Enrollment||1
11096621|NCT01208051|12280298|FG002|NOT COMPLETED|Total Enrollment||1
11096622|NCT01208051|12280299|FG003|NOT COMPLETED|Total Enrollment||0
11096623|NCT01208051|12280300|FG004|NOT COMPLETED|Total Enrollment||2
11096624|NCT01208051|12280296|FG000|STARTED|Interim Futility Analysis||0
11096625|NCT01208051|12280297|FG001|STARTED|Interim Futility Analysis||0
11096626|NCT01208051|12280298|FG002|STARTED|Interim Futility Analysis||0
11096627|NCT01208051|12280299|FG003|STARTED|Interim Futility Analysis||39
11096628|NCT01208051|12280300|FG004|STARTED|Interim Futility Analysis||68
11096629|NCT01208051|12280296|FG000|COMPLETED|Interim Futility Analysis||0
11096630|NCT01208051|12280297|FG001|COMPLETED|Interim Futility Analysis||0
11096631|NCT01208051|12280298|FG002|COMPLETED|Interim Futility Analysis||0
11096632|NCT01208051|12280299|FG003|COMPLETED|Interim Futility Analysis||39
11096633|NCT01208051|12280300|FG004|COMPLETED|Interim Futility Analysis||68
11096634|NCT01208051|12280296|FG000|NOT COMPLETED|Interim Futility Analysis||0
11096635|NCT01208051|12280297|FG001|NOT COMPLETED|Interim Futility Analysis||0
11096636|NCT01208051|12280298|FG002|NOT COMPLETED|Interim Futility Analysis||0
11096637|NCT01208051|12280299|FG003|NOT COMPLETED|Interim Futility Analysis||0
11096638|NCT01208051|12280300|FG004|NOT COMPLETED|Interim Futility Analysis||0
11096639|NCT01208051|12280296|FG000|STARTED|After Crossover to Cediranib Only||0
11096640|NCT01208051|12280297|FG001|STARTED|After Crossover to Cediranib Only||0
11096641|NCT01208051|12280298|FG002|STARTED|After Crossover to Cediranib Only||0
11096642|NCT01208051|12280299|FG003|STARTED|After Crossover to Cediranib Only||39
11096643|NCT01208051|12280300|FG004|STARTED|After Crossover to Cediranib Only|One patient entered while futility analysis was ongoing.|69
11096644|NCT01208051|12280296|FG000|COMPLETED|After Crossover to Cediranib Only||0
11096645|NCT01208051|12280297|FG001|COMPLETED|After Crossover to Cediranib Only||0
11096646|NCT01208051|12280298|FG002|COMPLETED|After Crossover to Cediranib Only||0
11096647|NCT01208051|12280299|FG003|COMPLETED|After Crossover to Cediranib Only||39
11096648|NCT01208051|12280300|FG004|COMPLETED|After Crossover to Cediranib Only||69
11096649|NCT01208051|12280296|FG000|NOT COMPLETED|After Crossover to Cediranib Only||0
11096650|NCT01208051|12280297|FG001|NOT COMPLETED|After Crossover to Cediranib Only||0
11096651|NCT01208051|12280298|FG002|NOT COMPLETED|After Crossover to Cediranib Only||0
11096652|NCT01208051|12280299|FG003|NOT COMPLETED|After Crossover to Cediranib Only||0
11096653|NCT01208051|12280300|FG004|NOT COMPLETED|After Crossover to Cediranib Only||0
11096654|NCT01208103|12280316|FG000|STARTED|Overall Study||30
11096655|NCT01208103|12280316|FG000|COMPLETED|Overall Study||28
11096656|NCT01208103|12280316|FG000|NOT COMPLETED|Overall Study||2
11096657|NCT01208220|12280323|FG000|STARTED|Overall Study||1
11096658|NCT01208220|12280324|FG001|STARTED|Overall Study||1
11096659|NCT01208220|12280323|FG000|COMPLETED|Overall Study||1
11096660|NCT01208220|12280324|FG001|COMPLETED|Overall Study||1
11096661|NCT01208220|12280323|FG000|NOT COMPLETED|Overall Study||0
11096662|NCT01208220|12280324|FG001|NOT COMPLETED|Overall Study||0
11096663|NCT01208233|12280336|FG000|STARTED|Overall Study||11
11096664|NCT01208233|12280337|FG001|STARTED|Overall Study||9
11210610|NCT01896193|12401927|FG001|NOT COMPLETED|Overall Study||12
11096665|NCT01208233|12280338|FG002|STARTED|Overall Study||11
11096666|NCT01208233|12280339|FG003|STARTED|Overall Study||10
11096667|NCT01208233|12280340|FG004|STARTED|Overall Study||70
11096668|NCT01208233|12280341|FG005|STARTED|Overall Study||67
11096669|NCT01208233|12280336|FG000|COMPLETED|Overall Study||6
11096670|NCT01208233|12280337|FG001|COMPLETED|Overall Study||6
11096671|NCT01208233|12280338|FG002|COMPLETED|Overall Study||7
11096672|NCT01208233|12280339|FG003|COMPLETED|Overall Study||9
11096673|NCT01208233|12280340|FG004|COMPLETED|Overall Study||46
11096674|NCT01208233|12280341|FG005|COMPLETED|Overall Study||46
11096675|NCT01208233|12280336|FG000|NOT COMPLETED|Overall Study||5
11096676|NCT01208233|12280337|FG001|NOT COMPLETED|Overall Study||3
11210611|NCT01896206|12401935|FG000|STARTED|Overall Study||21
11210612|NCT01896206|12401935|FG000|COMPLETED|Overall Study||21
11210613|NCT01896206|12401935|FG000|NOT COMPLETED|Overall Study||0
11210614|NCT01896232|12401941|FG000|STARTED|Overall Study||343
11210615|NCT01896232|12401942|FG001|STARTED|Overall Study||340
11210616|NCT01896232|12401941|FG000|Received Treatment|Overall Study||341
11210617|NCT01896232|12401942|FG001|Received Treatment|Overall Study||338
11210618|NCT01896232|12401941|FG000|COMPLETED|Overall Study||294
11210619|NCT01896232|12401942|FG001|COMPLETED|Overall Study||287
11210620|NCT01896232|12401941|FG000|NOT COMPLETED|Overall Study||49
11210621|NCT01896232|12401942|FG001|NOT COMPLETED|Overall Study||53
11210622|NCT01896271|12401948|FG000|STARTED|Overall Study||30
11210623|NCT01896271|12401948|FG000|COMPLETED|Overall Study||20
11210624|NCT01896271|12401948|FG000|NOT COMPLETED|Overall Study||10
11210625|NCT01896297|12401952|FG000|STARTED|Overall Study||60
11210626|NCT01896297|12401952|FG000|COMPLETED|Overall Study||59
11210627|NCT01896297|12401952|FG000|NOT COMPLETED|Overall Study||1
11210628|NCT01896544|12401959|FG000|STARTED|Overall Study||10
11210629|NCT01896544|12401960|FG001|STARTED|Overall Study||10
11210630|NCT01896544|12401961|FG002|STARTED|Overall Study||10
11210631|NCT01896544|12401959|FG000|COMPLETED|Overall Study||10
11210632|NCT01896544|12401960|FG001|COMPLETED|Overall Study||10
11210633|NCT01896544|12401961|FG002|COMPLETED|Overall Study||10
11210634|NCT01896544|12401959|FG000|NOT COMPLETED|Overall Study||0
11210635|NCT01896544|12401960|FG001|NOT COMPLETED|Overall Study||0
11210636|NCT01896544|12401961|FG002|NOT COMPLETED|Overall Study||0
11210637|NCT01896557|12401974|FG000|STARTED|Clopidogrel Alone||44
11210638|NCT01896557|12401975|FG001|STARTED|Clopidogrel Alone||48
11210639|NCT01896557|12401974|FG000|COMPLETED|Clopidogrel Alone||43
11210640|NCT01896557|12401975|FG001|COMPLETED|Clopidogrel Alone||48
11210641|NCT01896557|12401974|FG000|NOT COMPLETED|Clopidogrel Alone||1
11210642|NCT01896557|12401975|FG001|NOT COMPLETED|Clopidogrel Alone||0
11210643|NCT01896557|12401974|FG000|STARTED|Clopidogrel + GI Protector||43
11210644|NCT01896557|12401975|FG001|STARTED|Clopidogrel + GI Protector||48
11210645|NCT01896557|12401974|FG000|COMPLETED|Clopidogrel + GI Protector||41
11210646|NCT01896557|12401975|FG001|COMPLETED|Clopidogrel + GI Protector||44
11210647|NCT01896557|12401974|FG000|NOT COMPLETED|Clopidogrel + GI Protector||2
11210648|NCT01896557|12401975|FG001|NOT COMPLETED|Clopidogrel + GI Protector||4
11210649|NCT01896687|12401983|FG000|STARTED|Overall Study||15
11210650|NCT01896687|12401984|FG001|STARTED|Overall Study||15
11210651|NCT01896687|12401983|FG000|COMPLETED|Overall Study||15
11210652|NCT01896687|12401984|FG001|COMPLETED|Overall Study||15
11210653|NCT01896687|12401983|FG000|NOT COMPLETED|Overall Study||0
11210654|NCT01896687|12401984|FG001|NOT COMPLETED|Overall Study||0
11210655|NCT01896700|12401992|FG000|STARTED|Overall Study||12
11210656|NCT01896700|12401993|FG001|STARTED|Overall Study||12
11210657|NCT01896700|12401992|FG000|COMPLETED|Overall Study||8
11210658|NCT01896700|12401993|FG001|COMPLETED|Overall Study||6
11210659|NCT01896700|12401992|FG000|NOT COMPLETED|Overall Study||4
11210660|NCT01896700|12401993|FG001|NOT COMPLETED|Overall Study||6
11210661|NCT01896726|12401999|FG000|STARTED|Treatment Period 1 (Days 1-22)||20
11210662|NCT01896726|12401999|FG000|Received Microgynon|Treatment Period 1 (Days 1-22)||20
11210663|NCT01896726|12401999|FG000|COMPLETED|Treatment Period 1 (Days 1-22)||20
11210664|NCT01896726|12401999|FG000|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
11210665|NCT01896726|12401999|FG000|STARTED|Treatment Period 2 (Days 23-31)||20
11210666|NCT01896726|12401999|FG000|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
11096677|NCT01208233|12280338|FG002|NOT COMPLETED|Overall Study||4
11096678|NCT01208233|12280339|FG003|NOT COMPLETED|Overall Study||1
11210667|NCT01896726|12401999|FG000|Received Microgynon|Treatment Period 2 (Days 23-31)||18
11210668|NCT01896726|12401999|FG000|COMPLETED|Treatment Period 2 (Days 23-31)||18
11210669|NCT01896726|12401999|FG000|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
11210670|NCT01896856|12402012|FG000|STARTED|Overall Study||6
11210671|NCT01896856|12402013|FG001|STARTED|Overall Study||3
11210672|NCT01896856|12402014|FG002|STARTED|Overall Study||7
11210673|NCT01896856|12402015|FG003|STARTED|Overall Study||6
11210674|NCT01896856|12402016|FG004|STARTED|Overall Study||62
11210675|NCT01896856|12402017|FG005|STARTED|Overall Study||34
11210676|NCT01896856|12402012|FG000|COMPLETED|Overall Study||6
11210677|NCT01896856|12402013|FG001|COMPLETED|Overall Study||3
11210678|NCT01896856|12402014|FG002|COMPLETED|Overall Study||6
11210679|NCT01896856|12402015|FG003|COMPLETED|Overall Study||6
11210680|NCT01896856|12402016|FG004|COMPLETED|Overall Study||62
11210681|NCT01896856|12402017|FG005|COMPLETED|Overall Study||34
11210682|NCT01896856|12402012|FG000|NOT COMPLETED|Overall Study||0
11210683|NCT01896856|12402013|FG001|NOT COMPLETED|Overall Study||0
11210684|NCT01896856|12402014|FG002|NOT COMPLETED|Overall Study||1
11210685|NCT01896856|12402015|FG003|NOT COMPLETED|Overall Study||0
11210686|NCT01896856|12402016|FG004|NOT COMPLETED|Overall Study||0
11210687|NCT01896856|12402017|FG005|NOT COMPLETED|Overall Study||0
11210688|NCT01896869|12402034|FG000|STARTED|Overall Study||41
11210689|NCT01896869|12402035|FG001|STARTED|Overall Study||42
11210690|NCT01896869|12402034|FG000|COMPLETED|Overall Study||40
11210691|NCT01896869|12402035|FG001|COMPLETED|Overall Study||36
11210692|NCT01896869|12402034|FG000|NOT COMPLETED|Overall Study||1
11210693|NCT01896869|12402035|FG001|NOT COMPLETED|Overall Study||6
11210694|NCT01896895|12402046|FG000|STARTED|Double-blind MP||20
11210695|NCT01896895|12402047|FG001|STARTED|Double-blind MP||22
11210696|NCT01896895|12402048|FG002|STARTED|Double-blind MP||19
11210697|NCT01896895|12402049|FG003|STARTED|Double-blind MP||0
11210698|NCT01896895|12402046|FG000|COMPLETED|Double-blind MP||19
11210699|NCT01896895|12402047|FG001|COMPLETED|Double-blind MP||20
11210700|NCT01896895|12402048|FG002|COMPLETED|Double-blind MP||16
11210701|NCT01896895|12402049|FG003|COMPLETED|Double-blind MP||0
11210702|NCT01896895|12402046|FG000|NOT COMPLETED|Double-blind MP||1
11210703|NCT01896895|12402047|FG001|NOT COMPLETED|Double-blind MP||2
11210704|NCT01896895|12402048|FG002|NOT COMPLETED|Double-blind MP||3
11210705|NCT01896895|12402049|FG003|NOT COMPLETED|Double-blind MP||0
11210706|NCT01896895|12402046|FG000|STARTED|OLEX Period||0
11210707|NCT01896895|12402047|FG001|STARTED|OLEX Period||0
11210708|NCT01896895|12402048|FG002|STARTED|OLEX Period||0
11210709|NCT01896895|12402049|FG003|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
11210710|NCT01896895|12402046|FG000|COMPLETED|OLEX Period||0
11210711|NCT01896895|12402047|FG001|COMPLETED|OLEX Period||0
11210712|NCT01896895|12402048|FG002|COMPLETED|OLEX Period||0
11210713|NCT01896895|12402049|FG003|COMPLETED|OLEX Period||39
11210714|NCT01896895|12402046|FG000|NOT COMPLETED|OLEX Period||0
11210715|NCT01896895|12402047|FG001|NOT COMPLETED|OLEX Period||0
11210716|NCT01896895|12402048|FG002|NOT COMPLETED|OLEX Period||0
11210717|NCT01896895|12402049|FG003|NOT COMPLETED|OLEX Period||0
11210718|NCT01896921|12402058|FG000|STARTED|Overall Study||7
11210719|NCT01896921|12402058|FG000|COMPLETED|Overall Study||5
11210720|NCT01896921|12402058|FG000|NOT COMPLETED|Overall Study||2
11210721|NCT01896934|12402062|FG000|STARTED|Overall Study||21
11210722|NCT01896934|12402062|FG000|COMPLETED|Overall Study||19
11210723|NCT01896934|12402062|FG000|NOT COMPLETED|Overall Study||2
11210724|NCT01896986|12402068|FG000|STARTED|Overall Study||14
11210725|NCT01896986|12402069|FG001|STARTED|Overall Study||23
11210726|NCT01896986|12402068|FG000|COMPLETED|Overall Study||0
11210727|NCT01896986|12402069|FG001|COMPLETED|Overall Study||0
11210728|NCT01896986|12402068|FG000|NOT COMPLETED|Overall Study||14
11210729|NCT01896986|12402069|FG001|NOT COMPLETED|Overall Study||23
11210730|NCT01897025|12402077|FG000|STARTED|Overall Study||10
11210731|NCT01897025|12402078|FG001|STARTED|Overall Study||9
11210732|NCT01897025|12402077|FG000|COMPLETED|Overall Study||10
11210733|NCT01897025|12402078|FG001|COMPLETED|Overall Study||9
11210734|NCT01897025|12402077|FG000|NOT COMPLETED|Overall Study||0
11210735|NCT01897025|12402078|FG001|NOT COMPLETED|Overall Study||0
11210736|NCT01897077|12402086|FG000|STARTED|Overall Study||0
11210737|NCT01897077|12402087|FG001|STARTED|Overall Study||5
11210738|NCT01897077|12402086|FG000|COMPLETED|Overall Study||0
11210739|NCT01897077|12402087|FG001|COMPLETED|Overall Study||5
11210740|NCT01897077|12402086|FG000|NOT COMPLETED|Overall Study||0
11210741|NCT01897077|12402087|FG001|NOT COMPLETED|Overall Study||0
11352518|NCT03047174|12549542|FG001|STARTED|Overall Study||29
11352519|NCT03047174|12549541|FG000|COMPLETED|Overall Study||9
11352520|NCT03047174|12549542|FG001|COMPLETED|Overall Study||27
11352521|NCT03047174|12549541|FG000|NOT COMPLETED|Overall Study||19
11352522|NCT03047174|12549542|FG001|NOT COMPLETED|Overall Study||2
11352523|NCT03047447|12549565|FG000|STARTED|Overall Study||10
11352524|NCT03047447|12549566|FG001|STARTED|Overall Study||10
11352525|NCT03047447|12549567|FG002|STARTED|Overall Study||10
11352526|NCT03047447|12549565|FG000|COMPLETED|Overall Study||10
11210742|NCT01897233|12402093|FG000|STARTED|Part A (14 Days)||10
11210743|NCT01897233|12402093|FG000|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
11210744|NCT01897233|12402093|FG000|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
11210745|NCT01897233|12402093|FG000|COMPLETED|Part A (14 Days)||10
11210746|NCT01897233|12402093|FG000|NOT COMPLETED|Part A (14 Days)||0
11210747|NCT01897233|12402093|FG000|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
11210748|NCT01897233|12402093|FG000|COMPLETED|Part B (24 Weeks)||54
11210749|NCT01897233|12402093|FG000|NOT COMPLETED|Part B (24 Weeks)||4
11210750|NCT01897285|12402101|FG000|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
11210751|NCT01897285|12402101|FG000|COMPLETED|Overall Study||20
11210752|NCT01897285|12402101|FG000|NOT COMPLETED|Overall Study||0
11210753|NCT01897402|12402109|FG000|STARTED|Overall Study||265
11210754|NCT01897402|12402110|FG001|STARTED|Overall Study||260
11210755|NCT01897402|12402109|FG000|COMPLETED|Overall Study||246
11210756|NCT01897402|12402110|FG001|COMPLETED|Overall Study||244
11210757|NCT01897402|12402109|FG000|NOT COMPLETED|Overall Study||19
11210758|NCT01897402|12402110|FG001|NOT COMPLETED|Overall Study||16
11210759|NCT01897493|12402122|FG000|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
11210760|NCT01897493|12402122|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
11210761|NCT01897493|12402122|FG000|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
11210762|NCT01897493|12402122|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
11210763|NCT01897493|12402122|FG000|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
11210764|NCT01897493|12402122|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
11210765|NCT01897493|12402122|FG000|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
11210766|NCT01897493|12402122|FG000|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
11210767|NCT01897532|12402131|FG000|STARTED|Discontinuation From Treatment||3492
11210768|NCT01897532|12402132|FG001|STARTED|Discontinuation From Treatment||3499
11210769|NCT01897532|12402131|FG000|Treated|Discontinuation From Treatment||3485
11210770|NCT01897532|12402132|FG001|Treated|Discontinuation From Treatment||3494
11210771|NCT01897532|12402131|FG000|COMPLETED|Discontinuation From Treatment||2530
11210772|NCT01897532|12402132|FG001|COMPLETED|Discontinuation From Treatment||2660
11210773|NCT01897532|12402131|FG000|NOT COMPLETED|Discontinuation From Treatment||962
11210774|NCT01897532|12402132|FG001|NOT COMPLETED|Discontinuation From Treatment||839
11210775|NCT01897532|12402131|FG000|STARTED|Discontinuation From Trial||3492
11210776|NCT01897532|12402132|FG001|STARTED|Discontinuation From Trial||3499
11210777|NCT01897532|12402131|FG000|Treated|Discontinuation From Trial||3485
11096679|NCT01208233|12280340|FG004|NOT COMPLETED|Overall Study||24
11096680|NCT01208233|12280341|FG005|NOT COMPLETED|Overall Study||21
11096681|NCT01208324|12280365|FG000|STARTED|Pre-randomization of Patch||14
11096682|NCT01208324|12280366|FG001|STARTED|Pre-randomization of Patch||15
11096683|NCT01208324|12280367|FG002|STARTED|Pre-randomization of Patch||10
11096684|NCT01208324|12280368|FG003|STARTED|Pre-randomization of Patch||8
11096685|NCT01208324|12280365|FG000|Test Day 1|Pre-randomization of Patch||14
11096686|NCT01208324|12280366|FG001|Test Day 1|Pre-randomization of Patch||15
11096687|NCT01208324|12280367|FG002|Test Day 1|Pre-randomization of Patch||10
11096688|NCT01208324|12280368|FG003|Test Day 1|Pre-randomization of Patch||8
11096689|NCT01208324|12280365|FG000|Test Day 2|Pre-randomization of Patch||14
11096690|NCT01208324|12280366|FG001|Test Day 2|Pre-randomization of Patch||15
11096691|NCT01208324|12280367|FG002|Test Day 2|Pre-randomization of Patch||8
11096692|NCT01208324|12280368|FG003|Test Day 2|Pre-randomization of Patch||5
11096693|NCT01208324|12280365|FG000|COMPLETED|Pre-randomization of Patch||14
11096694|NCT01208324|12280366|FG001|COMPLETED|Pre-randomization of Patch||15
11096695|NCT01208324|12280367|FG002|COMPLETED|Pre-randomization of Patch||8
11096696|NCT01208324|12280368|FG003|COMPLETED|Pre-randomization of Patch||5
11096697|NCT01208324|12280365|FG000|NOT COMPLETED|Pre-randomization of Patch||0
11096698|NCT01208324|12280366|FG001|NOT COMPLETED|Pre-randomization of Patch||0
11096699|NCT01208324|12280367|FG002|NOT COMPLETED|Pre-randomization of Patch||2
11210778|NCT01897532|12402132|FG001|Treated|Discontinuation From Trial||3494
11210779|NCT01897532|12402131|FG000|COMPLETED|Discontinuation From Trial||3430
11210780|NCT01897532|12402132|FG001|COMPLETED|Discontinuation From Trial||3458
11210781|NCT01897532|12402131|FG000|NOT COMPLETED|Discontinuation From Trial||62
11210782|NCT01897532|12402132|FG001|NOT COMPLETED|Discontinuation From Trial||41
11210783|NCT01897714|12402144|FG000|STARTED|Phase I (Dose Escalation)||4
11210784|NCT01897714|12402145|FG001|STARTED|Phase I (Dose Escalation)||7
11210785|NCT01897714|12402146|FG002|STARTED|Phase I (Dose Escalation)||6
11210786|NCT01897714|12402147|FG003|STARTED|Phase I (Dose Escalation)||6
11210787|NCT01897714|12402148|FG004|STARTED|Phase I (Dose Escalation)||0
11210788|NCT01897714|12402149|FG005|STARTED|Phase I (Dose Escalation)||0
11210789|NCT01897714|12402144|FG000|COMPLETED|Phase I (Dose Escalation)||1
11210790|NCT01897714|12402145|FG001|COMPLETED|Phase I (Dose Escalation)||0
11210791|NCT01897714|12402146|FG002|COMPLETED|Phase I (Dose Escalation)||1
11210792|NCT01897714|12402147|FG003|COMPLETED|Phase I (Dose Escalation)||0
11210793|NCT01897714|12402148|FG004|COMPLETED|Phase I (Dose Escalation)||0
11210794|NCT01897714|12402149|FG005|COMPLETED|Phase I (Dose Escalation)||0
11210795|NCT01897714|12402144|FG000|NOT COMPLETED|Phase I (Dose Escalation)||3
11210796|NCT01897714|12402145|FG001|NOT COMPLETED|Phase I (Dose Escalation)||7
11210797|NCT01897714|12402146|FG002|NOT COMPLETED|Phase I (Dose Escalation)||5
11210798|NCT01897714|12402147|FG003|NOT COMPLETED|Phase I (Dose Escalation)||6
11210799|NCT01897714|12402148|FG004|NOT COMPLETED|Phase I (Dose Escalation)||0
11210800|NCT01897714|12402149|FG005|NOT COMPLETED|Phase I (Dose Escalation)||0
11210801|NCT01897714|12402144|FG000|STARTED|Phase II (MTD)||0
11210802|NCT01897714|12402145|FG001|STARTED|Phase II (MTD)||0
11210803|NCT01897714|12402146|FG002|STARTED|Phase II (MTD)||0
11210804|NCT01897714|12402147|FG003|STARTED|Phase II (MTD)||0
11210805|NCT01897714|12402148|FG004|STARTED|Phase II (MTD)|6 patients were entered from the Phase I: Melflufen 40 mg + Dexamethasone arm.|45
11210806|NCT01897714|12402149|FG005|STARTED|Phase II (MTD)||13
11210807|NCT01897714|12402144|FG000|COMPLETED|Phase II (MTD)||0
11210808|NCT01897714|12402145|FG001|COMPLETED|Phase II (MTD)||0
11210809|NCT01897714|12402146|FG002|COMPLETED|Phase II (MTD)||0
11210810|NCT01897714|12402147|FG003|COMPLETED|Phase II (MTD)||0
11210811|NCT01897714|12402148|FG004|COMPLETED|Phase II (MTD)||15
11210812|NCT01897714|12402149|FG005|COMPLETED|Phase II (MTD)||2
11210813|NCT01897714|12402144|FG000|NOT COMPLETED|Phase II (MTD)||0
11210814|NCT01897714|12402145|FG001|NOT COMPLETED|Phase II (MTD)||0
11210815|NCT01897714|12402146|FG002|NOT COMPLETED|Phase II (MTD)||0
11352527|NCT03047447|12549566|FG001|COMPLETED|Overall Study||10
11352528|NCT03047447|12549567|FG002|COMPLETED|Overall Study||10
11096700|NCT01208324|12280368|FG003|NOT COMPLETED|Pre-randomization of Patch||3
11096701|NCT01208324|12280365|FG000|STARTED|Post-randomization of Patch||14
11352529|NCT03047447|12549565|FG000|NOT COMPLETED|Overall Study||0
11352530|NCT03047447|12549566|FG001|NOT COMPLETED|Overall Study||0
11352531|NCT03047447|12549567|FG002|NOT COMPLETED|Overall Study||0
11352532|NCT03047551|12549580|FG000|STARTED|Overall Study||319
11352533|NCT03047551|12549581|FG001|STARTED|Overall Study||315
11352534|NCT03047551|12549580|FG000|COMPLETED|Overall Study||317
11352535|NCT03047551|12549581|FG001|COMPLETED|Overall Study||312
11352536|NCT03047551|12549580|FG000|NOT COMPLETED|Overall Study||2
11352537|NCT03047551|12549581|FG001|NOT COMPLETED|Overall Study||3
11352538|NCT03047720|12549589|FG000|STARTED|First Intervention (6weeks)||12
11352539|NCT03047720|12549590|FG001|STARTED|First Intervention (6weeks)||0
11096702|NCT01208324|12280366|FG001|STARTED|Post-randomization of Patch||15
11096703|NCT01208324|12280367|FG002|STARTED|Post-randomization of Patch||8
11210816|NCT01897714|12402147|FG003|NOT COMPLETED|Phase II (MTD)||0
11210817|NCT01897714|12402148|FG004|NOT COMPLETED|Phase II (MTD)||30
11210818|NCT01897714|12402149|FG005|NOT COMPLETED|Phase II (MTD)||11
11352540|NCT03047720|12549589|FG000|COMPLETED|First Intervention (6weeks)||5
11352541|NCT03047720|12549590|FG001|COMPLETED|First Intervention (6weeks)||0
11352542|NCT03047720|12549589|FG000|NOT COMPLETED|First Intervention (6weeks)||7
11210819|NCT01897727|12402167|FG000|STARTED|Overall Study||8
11210820|NCT01897727|12402168|FG001|STARTED|Overall Study||9
11210821|NCT01897727|12402167|FG000|COMPLETED|Overall Study||8
11210822|NCT01897727|12402168|FG001|COMPLETED|Overall Study||8
11210823|NCT01897727|12402167|FG000|NOT COMPLETED|Overall Study||0
11210824|NCT01897727|12402168|FG001|NOT COMPLETED|Overall Study||1
11210825|NCT01897766|12402174|FG000|STARTED|Overall Study||482
11210826|NCT01897766|12402174|FG000|COMPLETED|Overall Study||482
11210827|NCT01897766|12402174|FG000|NOT COMPLETED|Overall Study||0
11210828|NCT01897792|12402180|FG000|STARTED|Overall Study||6
11210829|NCT01897792|12402181|FG001|STARTED|Overall Study||5
11210830|NCT01897792|12402180|FG000|COMPLETED|Overall Study||6
11210831|NCT01897792|12402181|FG001|COMPLETED|Overall Study||5
11210832|NCT01897792|12402180|FG000|NOT COMPLETED|Overall Study||0
11210833|NCT01897792|12402181|FG001|NOT COMPLETED|Overall Study||0
11210834|NCT01897896|12402193|FG000|STARTED|Overall Study||82
11210835|NCT01897896|12402194|FG001|STARTED|Overall Study||37
11096704|NCT01208324|12280368|FG003|STARTED|Post-randomization of Patch||5
11096705|NCT01208324|12280365|FG000|Test Day 3|Post-randomization of Patch||13
11096706|NCT01208324|12280366|FG001|Test Day 3|Post-randomization of Patch||15
11096707|NCT01208324|12280367|FG002|Test Day 3|Post-randomization of Patch||8
11096708|NCT01208324|12280368|FG003|Test Day 3|Post-randomization of Patch||5
11096709|NCT01208324|12280365|FG000|Test Day 4|Post-randomization of Patch||13
11096710|NCT01208324|12280366|FG001|Test Day 4|Post-randomization of Patch||15
11096711|NCT01208324|12280367|FG002|Test Day 4|Post-randomization of Patch||8
11096712|NCT01208324|12280368|FG003|Test Day 4|Post-randomization of Patch||5
11096713|NCT01208324|12280365|FG000|COMPLETED|Post-randomization of Patch||13
11210836|NCT01897896|12402193|FG000|COMPLETED|Overall Study||56
11210837|NCT01897896|12402194|FG001|COMPLETED|Overall Study||25
11210838|NCT01897896|12402193|FG000|NOT COMPLETED|Overall Study||26
11210839|NCT01897896|12402194|FG001|NOT COMPLETED|Overall Study||12
11210840|NCT01898013|12402204|FG000|STARTED|Visit 3 (Randomization Visit)||45
11210841|NCT01898013|12402205|FG001|STARTED|Visit 3 (Randomization Visit)||49
11210842|NCT01898013|12402204|FG000|COMPLETED|Visit 3 (Randomization Visit)||45
11210843|NCT01898013|12402205|FG001|COMPLETED|Visit 3 (Randomization Visit)||49
11210844|NCT01898013|12402204|FG000|NOT COMPLETED|Visit 3 (Randomization Visit)||0
11210845|NCT01898013|12402205|FG001|NOT COMPLETED|Visit 3 (Randomization Visit)||0
11210846|NCT01898013|12402204|FG000|STARTED|Visit 4||45
11210847|NCT01898013|12402205|FG001|STARTED|Visit 4||49
11210848|NCT01898013|12402204|FG000|COMPLETED|Visit 4||45
11210849|NCT01898013|12402205|FG001|COMPLETED|Visit 4||48
11210850|NCT01898013|12402204|FG000|NOT COMPLETED|Visit 4||0
11210851|NCT01898013|12402205|FG001|NOT COMPLETED|Visit 4||1
11210852|NCT01898013|12402204|FG000|STARTED|Visit 5||45
11210853|NCT01898013|12402205|FG001|STARTED|Visit 5||48
11210854|NCT01898013|12402204|FG000|COMPLETED|Visit 5||44
11210855|NCT01898013|12402205|FG001|COMPLETED|Visit 5||47
11210856|NCT01898013|12402204|FG000|NOT COMPLETED|Visit 5||1
11210857|NCT01898013|12402205|FG001|NOT COMPLETED|Visit 5||1
11210858|NCT01898013|12402204|FG000|STARTED|Visit 6||44
11210859|NCT01898013|12402205|FG001|STARTED|Visit 6||47
11210860|NCT01898013|12402204|FG000|COMPLETED|Visit 6||41
11210861|NCT01898013|12402205|FG001|COMPLETED|Visit 6||42
11210862|NCT01898013|12402204|FG000|NOT COMPLETED|Visit 6||3
11210863|NCT01898013|12402205|FG001|NOT COMPLETED|Visit 6||5
11210864|NCT01898078|12402213|FG000|STARTED|Overall Study||13
11210865|NCT01898078|12402214|FG001|STARTED|Overall Study||13
11210866|NCT01898078|12402213|FG000|COMPLETED|Overall Study|Completed treatment|7
11210867|NCT01898078|12402214|FG001|COMPLETED|Overall Study|Completed treatment|5
11210868|NCT01898078|12402213|FG000|NOT COMPLETED|Overall Study||6
11210869|NCT01898078|12402214|FG001|NOT COMPLETED|Overall Study||8
11210870|NCT01898091|12402224|FG000|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
11210871|NCT01898091|12402225|FG001|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
11210872|NCT01898091|12402224|FG000|COMPLETED|Overall Study||23
11210873|NCT01898091|12402225|FG001|COMPLETED|Overall Study||19
11210874|NCT01898091|12402224|FG000|NOT COMPLETED|Overall Study||2
11210875|NCT01898091|12402225|FG001|NOT COMPLETED|Overall Study||6
11210876|NCT01898130|12402231|FG000|STARTED|Treatment||27
11210877|NCT01898130|12402231|FG000|Reached 1st Response/2 Cycles|Treatment||24
11210878|NCT01898130|12402231|FG000|Went on to Start Cycle 3|Treatment||21
11210879|NCT01898130|12402231|FG000|COMPLETED|Treatment||21
11210880|NCT01898130|12402231|FG000|NOT COMPLETED|Treatment||6
11210881|NCT01898130|12402231|FG000|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27
11210882|NCT01898130|12402231|FG000|COMPLETED|Follow up Until PD or Death||26
11210883|NCT01898130|12402231|FG000|NOT COMPLETED|Follow up Until PD or Death||1
11210884|NCT01898195|12402238|FG000|STARTED|Varenicline Adherence||53
11210885|NCT01898195|12402239|FG001|STARTED|Varenicline Adherence||54
11210886|NCT01898195|12402240|FG002|STARTED|Varenicline Adherence||51
11210887|NCT01898195|12402238|FG000|COMPLETED|Varenicline Adherence||18
11210888|NCT01898195|12402239|FG001|COMPLETED|Varenicline Adherence||16
11210889|NCT01898195|12402240|FG002|COMPLETED|Varenicline Adherence||15
11210890|NCT01898195|12402238|FG000|NOT COMPLETED|Varenicline Adherence||35
11210891|NCT01898195|12402239|FG001|NOT COMPLETED|Varenicline Adherence||38
11210892|NCT01898195|12402240|FG002|NOT COMPLETED|Varenicline Adherence||36
11210893|NCT01898195|12402238|FG000|STARTED|Smoking Abstinence||53
11210894|NCT01898195|12402239|FG001|STARTED|Smoking Abstinence||54
11210895|NCT01898195|12402240|FG002|STARTED|Smoking Abstinence||51
11210896|NCT01898195|12402238|FG000|COMPLETED|Smoking Abstinence||18
11210897|NCT01898195|12402239|FG001|COMPLETED|Smoking Abstinence||16
11210898|NCT01898195|12402240|FG002|COMPLETED|Smoking Abstinence||15
11210899|NCT01898195|12402238|FG000|NOT COMPLETED|Smoking Abstinence||35
11210900|NCT01898195|12402239|FG001|NOT COMPLETED|Smoking Abstinence||38
11210901|NCT01898195|12402240|FG002|NOT COMPLETED|Smoking Abstinence||36
11210902|NCT01898208|12402251|FG000|STARTED|Overall Study||247
11210903|NCT01898208|12402252|FG001|STARTED|Overall Study||247
11210904|NCT01898208|12402253|FG002|STARTED|Overall Study||249
11210905|NCT01898208|12402251|FG000|COMPLETED|Overall Study||207
11210906|NCT01898208|12402252|FG001|COMPLETED|Overall Study||198
11210907|NCT01898208|12402253|FG002|COMPLETED|Overall Study||212
11210908|NCT01898208|12402251|FG000|NOT COMPLETED|Overall Study||40
11210909|NCT01898208|12402252|FG001|NOT COMPLETED|Overall Study||49
11210910|NCT01898208|12402253|FG002|NOT COMPLETED|Overall Study||37
11210911|NCT01898286|12402261|FG000|STARTED|Overall Study||38
11210912|NCT01898286|12402261|FG000|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
11210913|NCT01898286|12402261|FG000|NOT COMPLETED|Overall Study||3
11210914|NCT01898299|12402267|FG000|STARTED|Post Treatment (One Week)||47
11210915|NCT01898299|12402268|FG001|STARTED|Post Treatment (One Week)||42
11210916|NCT01898299|12402267|FG000|COMPLETED|Post Treatment (One Week)||47
11210917|NCT01898299|12402268|FG001|COMPLETED|Post Treatment (One Week)||42
11210918|NCT01898299|12402267|FG000|NOT COMPLETED|Post Treatment (One Week)||0
11210919|NCT01898299|12402268|FG001|NOT COMPLETED|Post Treatment (One Week)||0
11210920|NCT01898299|12402267|FG000|STARTED|Post Treatment (One Month)||47
11210921|NCT01898299|12402268|FG001|STARTED|Post Treatment (One Month)||42
11210922|NCT01898299|12402267|FG000|COMPLETED|Post Treatment (One Month)||44
11210923|NCT01898299|12402268|FG001|COMPLETED|Post Treatment (One Month)||38
11210924|NCT01898299|12402267|FG000|NOT COMPLETED|Post Treatment (One Month)||3
11210925|NCT01898299|12402268|FG001|NOT COMPLETED|Post Treatment (One Month)||4
11096714|NCT01208324|12280366|FG001|COMPLETED|Post-randomization of Patch||15
11096715|NCT01208324|12280367|FG002|COMPLETED|Post-randomization of Patch||8
11096716|NCT01208324|12280368|FG003|COMPLETED|Post-randomization of Patch||5
11096717|NCT01208324|12280365|FG000|NOT COMPLETED|Post-randomization of Patch||1
11096718|NCT01208324|12280366|FG001|NOT COMPLETED|Post-randomization of Patch||0
11096719|NCT01208324|12280367|FG002|NOT COMPLETED|Post-randomization of Patch||0
11096720|NCT01208324|12280368|FG003|NOT COMPLETED|Post-randomization of Patch||0
11096721|NCT01208337|12280378|FG000|STARTED|Overall Study||23
11096722|NCT01208337|12280378|FG000|One-year Follow-up|Overall Study||23
11096723|NCT01208337|12280378|FG000|Five-year Follow-up|Overall Study||20
11096724|NCT01208337|12280378|FG000|COMPLETED|Overall Study||20
11096725|NCT01208337|12280378|FG000|NOT COMPLETED|Overall Study||3
11096726|NCT01208402|12280384|FG000|STARTED|Overall Study||31
11096727|NCT01208402|12280385|FG001|STARTED|Overall Study||28
11096728|NCT01208402|12280384|FG000|COMPLETED|Overall Study||30
11096729|NCT01208402|12280385|FG001|COMPLETED|Overall Study||28
11096730|NCT01208402|12280384|FG000|NOT COMPLETED|Overall Study||1
11096731|NCT01208402|12280385|FG001|NOT COMPLETED|Overall Study||0
11096732|NCT01208415|12280391|FG000|STARTED|Overall Study||40
11096733|NCT01208415|12280391|FG000|6 Months|Overall Study||37
11096734|NCT01208415|12280391|FG000|COMPLETED|Overall Study||0
11096735|NCT01208415|12280391|FG000|NOT COMPLETED|Overall Study||40
11096736|NCT01208870|12280397|FG000|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
11096737|NCT01208870|12280398|FG001|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
11096738|NCT01208870|12280397|FG000|Pilot 1|Overall Study||20
11096739|NCT01208870|12280398|FG001|Pilot 1|Overall Study||22
11096740|NCT01208870|12280397|FG000|Pilot 2|Overall Study||26
11096741|NCT01208870|12280398|FG001|Pilot 2|Overall Study||22
11096742|NCT01208870|12280397|FG000|COMPLETED|Overall Study||44
11096743|NCT01208870|12280398|FG001|COMPLETED|Overall Study||36
11096744|NCT01208870|12280397|FG000|NOT COMPLETED|Overall Study||2
11096745|NCT01208870|12280398|FG001|NOT COMPLETED|Overall Study||8
11096746|NCT01208922|12280408|FG000|STARTED|Overall Study||420
11096747|NCT01208922|12280409|FG001|STARTED|Overall Study||415
11096748|NCT01208922|12280408|FG000|COMPLETED|Overall Study||409
11096749|NCT01208922|12280409|FG001|COMPLETED|Overall Study||405
11096750|NCT01208922|12280408|FG000|NOT COMPLETED|Overall Study||11
11096751|NCT01208922|12280409|FG001|NOT COMPLETED|Overall Study||10
11096752|NCT01208961|12280415|FG000|STARTED|Low-Fat Period I||27
11096753|NCT01208961|12280416|FG001|STARTED|Low-Fat Period I||27
11096754|NCT01208961|12280415|FG000|COMPLETED|Low-Fat Period I||27
11096755|NCT01208961|12280416|FG001|COMPLETED|Low-Fat Period I||27
11096756|NCT01208961|12280415|FG000|NOT COMPLETED|Low-Fat Period I||0
11096757|NCT01208961|12280416|FG001|NOT COMPLETED|Low-Fat Period I||0
11096758|NCT01208961|12280415|FG000|STARTED|Low-Fat Period II||26
11096759|NCT01208961|12280416|FG001|STARTED|Low-Fat Period II||27
11096760|NCT01208961|12280415|FG000|COMPLETED|Low-Fat Period II||26
11096761|NCT01208961|12280416|FG001|COMPLETED|Low-Fat Period II||27
11096762|NCT01208961|12280415|FG000|NOT COMPLETED|Low-Fat Period II||0
11096763|NCT01208961|12280416|FG001|NOT COMPLETED|Low-Fat Period II||0
11210926|NCT01898403|12402274|FG000|STARTED|Overall Study||50
11210927|NCT01898403|12402274|FG000|COMPLETED|Overall Study||50
11210928|NCT01898403|12402274|FG000|NOT COMPLETED|Overall Study||0
11210929|NCT01898429|12402280|FG000|STARTED|Phase 1||5
11210930|NCT01898429|12402281|FG001|STARTED|Phase 1||0
11210931|NCT01898429|12402282|FG002|STARTED|Phase 1||0
11210932|NCT01898429|12402280|FG000|COMPLETED|Phase 1||5
11210933|NCT01898429|12402281|FG001|COMPLETED|Phase 1||0
11210934|NCT01898429|12402282|FG002|COMPLETED|Phase 1||0
11210935|NCT01898429|12402280|FG000|NOT COMPLETED|Phase 1||0
11210936|NCT01898429|12402281|FG001|NOT COMPLETED|Phase 1||0
11210937|NCT01898429|12402282|FG002|NOT COMPLETED|Phase 1||0
11210938|NCT01898429|12402280|FG000|STARTED|Phase 2||0
11210939|NCT01898429|12402281|FG001|STARTED|Phase 2||5
11210940|NCT01898429|12402282|FG002|STARTED|Phase 2||0
11210941|NCT01898429|12402280|FG000|COMPLETED|Phase 2||0
11210942|NCT01898429|12402281|FG001|COMPLETED|Phase 2||5
11210943|NCT01898429|12402282|FG002|COMPLETED|Phase 2||0
11210944|NCT01898429|12402280|FG000|NOT COMPLETED|Phase 2||0
11210945|NCT01898429|12402281|FG001|NOT COMPLETED|Phase 2||0
11210946|NCT01898429|12402282|FG002|NOT COMPLETED|Phase 2||0
11210947|NCT01898429|12402280|FG000|STARTED|Phase 3||0
11210948|NCT01898429|12402281|FG001|STARTED|Phase 3||0
11210949|NCT01898429|12402282|FG002|STARTED|Phase 3||5
11210950|NCT01898429|12402280|FG000|COMPLETED|Phase 3||0
11210951|NCT01898429|12402281|FG001|COMPLETED|Phase 3||0
11210952|NCT01898429|12402282|FG002|COMPLETED|Phase 3||5
11210953|NCT01898429|12402280|FG000|NOT COMPLETED|Phase 3||0
11210954|NCT01898429|12402281|FG001|NOT COMPLETED|Phase 3||0
11210955|NCT01898429|12402282|FG002|NOT COMPLETED|Phase 3||0
11210956|NCT01898442|12402289|FG000|STARTED|Overall Study||17
11210957|NCT01898442|12402290|FG001|STARTED|Overall Study||17
11210958|NCT01898442|12402291|FG002|STARTED|Overall Study||18
11210959|NCT01898442|12402289|FG000|COMPLETED|Overall Study||16
11210960|NCT01898442|12402290|FG001|COMPLETED|Overall Study||15
11210961|NCT01898442|12402291|FG002|COMPLETED|Overall Study||15
11210962|NCT01898442|12402289|FG000|NOT COMPLETED|Overall Study||1
11210963|NCT01898442|12402290|FG001|NOT COMPLETED|Overall Study||2
11210964|NCT01898442|12402291|FG002|NOT COMPLETED|Overall Study||3
11210965|NCT01898598|12402301|FG000|STARTED|Overall Study||12
11210966|NCT01898598|12402302|FG001|STARTED|Overall Study||6
11210967|NCT01898598|12402301|FG000|Treated|Overall Study||11
11210968|NCT01898598|12402302|FG001|Treated|Overall Study||5
11210969|NCT01898598|12402301|FG000|COMPLETED|Overall Study||8
11210970|NCT01898598|12402302|FG001|COMPLETED|Overall Study||4
11210971|NCT01898598|12402301|FG000|NOT COMPLETED|Overall Study||4
11210972|NCT01898598|12402302|FG001|NOT COMPLETED|Overall Study||2
11210973|NCT01898611|12402310|FG000|STARTED|Overall Study||5
11210974|NCT01898611|12402311|FG001|STARTED|Overall Study||11
11210975|NCT01898611|12402310|FG000|COMPLETED|Overall Study||5
11210976|NCT01898611|12402311|FG001|COMPLETED|Overall Study||10
11210977|NCT01898611|12402310|FG000|NOT COMPLETED|Overall Study||0
11096764|NCT01208961|12280415|FG000|STARTED|High-Fat Period III||26
11096765|NCT01208961|12280416|FG001|STARTED|High-Fat Period III||26
11096766|NCT01208961|12280415|FG000|COMPLETED|High-Fat Period III||25
11096767|NCT01208961|12280416|FG001|COMPLETED|High-Fat Period III||26
11096768|NCT01208961|12280415|FG000|NOT COMPLETED|High-Fat Period III||1
11096769|NCT01208961|12280416|FG001|NOT COMPLETED|High-Fat Period III||0
11096770|NCT01208961|12280415|FG000|STARTED|High-Fat Period IV||25
11096771|NCT01208961|12280416|FG001|STARTED|High-Fat Period IV||26
11096772|NCT01208961|12280415|FG000|COMPLETED|High-Fat Period IV||25
11096773|NCT01208961|12280416|FG001|COMPLETED|High-Fat Period IV||26
11096774|NCT01208961|12280415|FG000|NOT COMPLETED|High-Fat Period IV||0
11096775|NCT01208961|12280416|FG001|NOT COMPLETED|High-Fat Period IV||0
11096776|NCT01209078|12280423|FG000|STARTED|Overall Study||57
11096777|NCT01209078|12280424|FG001|STARTED|Overall Study||27
11096778|NCT01209078|12280423|FG000|COMPLETED|Overall Study||41
11096779|NCT01209078|12280424|FG001|COMPLETED|Overall Study||24
11096780|NCT01209078|12280423|FG000|NOT COMPLETED|Overall Study||16
11096781|NCT01209078|12280424|FG001|NOT COMPLETED|Overall Study||3
11096782|NCT01209143|12280434|FG000|STARTED|Overall Study||24
11096783|NCT01209143|12280435|FG001|STARTED|Overall Study||28
11096784|NCT01209143|12280434|FG000|COMPLETED|Overall Study||5
11096785|NCT01209143|12280435|FG001|COMPLETED|Overall Study||8
11096786|NCT01209143|12280434|FG000|NOT COMPLETED|Overall Study||19
11096787|NCT01209143|12280435|FG001|NOT COMPLETED|Overall Study||20
11096788|NCT01209195|12280443|FG000|STARTED|Overall Study||7
11096789|NCT01209195|12280444|FG001|STARTED|Overall Study||3
11096790|NCT01209195|12280445|FG002|STARTED|Overall Study||6
11096791|NCT01209195|12280446|FG003|STARTED|Overall Study||6
11096792|NCT01209195|12280447|FG004|STARTED|Overall Study||6
11096793|NCT01209195|12280448|FG005|STARTED|Overall Study||13
11096794|NCT01209195|12280443|FG000|COMPLETED|Overall Study||7
11096795|NCT01209195|12280444|FG001|COMPLETED|Overall Study||3
11210978|NCT01898611|12402311|FG001|NOT COMPLETED|Overall Study||1
11210979|NCT01898689|12402319|FG000|STARTED|Overall Study||10
11210980|NCT01898689|12402320|FG001|STARTED|Overall Study||14
11210981|NCT01898689|12402319|FG000|COMPLETED|Overall Study||10
11210982|NCT01898689|12402320|FG001|COMPLETED|Overall Study||14
11096796|NCT01209195|12280445|FG002|COMPLETED|Overall Study||6
11096797|NCT01209195|12280446|FG003|COMPLETED|Overall Study||6
11096798|NCT01209195|12280447|FG004|COMPLETED|Overall Study||6
11096799|NCT01209195|12280448|FG005|COMPLETED|Overall Study||13
11096800|NCT01209195|12280443|FG000|NOT COMPLETED|Overall Study||0
11096801|NCT01209195|12280444|FG001|NOT COMPLETED|Overall Study||0
11096802|NCT01209195|12280445|FG002|NOT COMPLETED|Overall Study||0
11096803|NCT01209195|12280446|FG003|NOT COMPLETED|Overall Study||0
11096804|NCT01209195|12280447|FG004|NOT COMPLETED|Overall Study||0
11096805|NCT01209195|12280448|FG005|NOT COMPLETED|Overall Study||0
11096806|NCT01209234|12280466|FG000|STARTED|Overall Study||1070
11096807|NCT01209234|12280467|FG001|STARTED|Overall Study||1070
11096808|NCT01209234|12280466|FG000|COMPLETED|Overall Study||1058
11096809|NCT01209234|12280467|FG001|COMPLETED|Overall Study||1063
11096810|NCT01209234|12280466|FG000|NOT COMPLETED|Overall Study||12
11096811|NCT01209234|12280467|FG001|NOT COMPLETED|Overall Study||7
11096812|NCT01209260|12280475|FG000|STARTED|Overall Study||36
11096813|NCT01209260|12280476|FG001|STARTED|Overall Study||36
11096814|NCT01209260|12280475|FG000|COMPLETED|Overall Study||36
11096815|NCT01209260|12280476|FG001|COMPLETED|Overall Study||36
11096816|NCT01209260|12280475|FG000|NOT COMPLETED|Overall Study||0
11096817|NCT01209260|12280476|FG001|NOT COMPLETED|Overall Study||0
11096818|NCT01209286|12280487|FG000|STARTED|Overall Study||7
11096819|NCT01209286|12280488|FG001|STARTED|Overall Study||23
11096820|NCT01209286|12280489|FG002|STARTED|Overall Study||6
11096821|NCT01209286|12280487|FG000|COMPLETED|Overall Study||2
11096822|NCT01209286|12280488|FG001|COMPLETED|Overall Study||13
11210983|NCT01898689|12402319|FG000|NOT COMPLETED|Overall Study||0
11210984|NCT01898689|12402320|FG001|NOT COMPLETED|Overall Study||0
11210985|NCT01898754|12402330|FG000|STARTED|Overall Study||494
11210986|NCT01898754|12402331|FG001|STARTED|Overall Study||497
11210987|NCT01898754|12402330|FG000|COMPLETED|Overall Study||400
11210988|NCT01898754|12402331|FG001|COMPLETED|Overall Study||403
11210989|NCT01898754|12402330|FG000|NOT COMPLETED|Overall Study||94
11210990|NCT01898754|12402331|FG001|NOT COMPLETED|Overall Study||94
11210991|NCT01898806|12402337|FG000|STARTED|Overall Study||11
11210992|NCT01898806|12402337|FG000|COMPLETED|Overall Study||8
11210993|NCT01898806|12402337|FG000|NOT COMPLETED|Overall Study||3
11210994|NCT01898884|12402346|FG000|STARTED|Single Dose Period||8
11210995|NCT01898884|12402347|FG001|STARTED|Single Dose Period||6
11210996|NCT01898884|12402348|FG002|STARTED|Single Dose Period||6
11210997|NCT01898884|12402349|FG003|STARTED|Single Dose Period||6
11210998|NCT01898884|12402350|FG004|STARTED|Single Dose Period||6
11210999|NCT01898884|12402351|FG005|STARTED|Single Dose Period||0
11211000|NCT01898884|12402352|FG006|STARTED|Single Dose Period||0
11096823|NCT01209286|12280489|FG002|COMPLETED|Overall Study||3
11096824|NCT01209286|12280487|FG000|NOT COMPLETED|Overall Study||5
11096825|NCT01209286|12280488|FG001|NOT COMPLETED|Overall Study||10
11096826|NCT01209286|12280489|FG002|NOT COMPLETED|Overall Study||3
11096827|NCT01209325|12280506|FG000|STARTED|Overall Study||149
11096828|NCT01209325|12280506|FG000|Eligible|Overall Study||145
11096829|NCT01209325|12280506|FG000|Received First Vaccine Injection|Overall Study||144
11096830|NCT01209325|12280506|FG000|Received Second Vaccine Injection|Overall Study||141
11211001|NCT01898884|12402353|FG007|STARTED|Single Dose Period||0
11211002|NCT01898884|12402354|FG008|STARTED|Single Dose Period||0
11211003|NCT01898884|12402346|FG000|COMPLETED|Single Dose Period||8
11211004|NCT01898884|12402347|FG001|COMPLETED|Single Dose Period||6
11211005|NCT01898884|12402348|FG002|COMPLETED|Single Dose Period||6
11211006|NCT01898884|12402349|FG003|COMPLETED|Single Dose Period||6
11211007|NCT01898884|12402350|FG004|COMPLETED|Single Dose Period||6
11211008|NCT01898884|12402351|FG005|COMPLETED|Single Dose Period||0
11211009|NCT01898884|12402352|FG006|COMPLETED|Single Dose Period||0
11211010|NCT01898884|12402353|FG007|COMPLETED|Single Dose Period||0
11211011|NCT01898884|12402354|FG008|COMPLETED|Single Dose Period||0
11211012|NCT01898884|12402346|FG000|NOT COMPLETED|Single Dose Period||0
11211013|NCT01898884|12402347|FG001|NOT COMPLETED|Single Dose Period||0
11211014|NCT01898884|12402348|FG002|NOT COMPLETED|Single Dose Period||0
11211015|NCT01898884|12402349|FG003|NOT COMPLETED|Single Dose Period||0
11211016|NCT01898884|12402350|FG004|NOT COMPLETED|Single Dose Period||0
11211017|NCT01898884|12402351|FG005|NOT COMPLETED|Single Dose Period||0
11211018|NCT01898884|12402352|FG006|NOT COMPLETED|Single Dose Period||0
11211019|NCT01898884|12402353|FG007|NOT COMPLETED|Single Dose Period||0
11096831|NCT01209325|12280506|FG000|Received Third Vaccine Infjection|Overall Study||138
11096832|NCT01209325|12280506|FG000|Returned After Week 28|Overall Study||124
11211020|NCT01898884|12402354|FG008|NOT COMPLETED|Single Dose Period||0
11211021|NCT01898884|12402346|FG000|STARTED|Multiple Dose Period||0
11211022|NCT01898884|12402347|FG001|STARTED|Multiple Dose Period||0
11211023|NCT01898884|12402348|FG002|STARTED|Multiple Dose Period||0
11211024|NCT01898884|12402349|FG003|STARTED|Multiple Dose Period||0
11211025|NCT01898884|12402350|FG004|STARTED|Multiple Dose Period||0
11211026|NCT01898884|12402351|FG005|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
11211027|NCT01898884|12402352|FG006|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
11211028|NCT01898884|12402353|FG007|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
11352543|NCT03047720|12549590|FG001|NOT COMPLETED|First Intervention (6weeks)||0
11096833|NCT01209325|12280506|FG000|COMPLETED|Overall Study||106
11096834|NCT01209325|12280506|FG000|NOT COMPLETED|Overall Study||43
11211029|NCT01898884|12402354|FG008|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
11211030|NCT01898884|12402346|FG000|Treated|Multiple Dose Period||0
11211031|NCT01898884|12402347|FG001|Treated|Multiple Dose Period||0
11211032|NCT01898884|12402348|FG002|Treated|Multiple Dose Period||0
11211033|NCT01898884|12402349|FG003|Treated|Multiple Dose Period||0
11211034|NCT01898884|12402350|FG004|Treated|Multiple Dose Period||0
11211035|NCT01898884|12402351|FG005|Treated|Multiple Dose Period||6
11211036|NCT01898884|12402352|FG006|Treated|Multiple Dose Period||6
11211037|NCT01898884|12402353|FG007|Treated|Multiple Dose Period||6
11211038|NCT01898884|12402354|FG008|Treated|Multiple Dose Period||5
11211039|NCT01898884|12402346|FG000|COMPLETED|Multiple Dose Period||0
11211040|NCT01898884|12402347|FG001|COMPLETED|Multiple Dose Period||0
11211041|NCT01898884|12402348|FG002|COMPLETED|Multiple Dose Period||0
11211042|NCT01898884|12402349|FG003|COMPLETED|Multiple Dose Period||0
11211043|NCT01898884|12402350|FG004|COMPLETED|Multiple Dose Period||0
11211044|NCT01898884|12402351|FG005|COMPLETED|Multiple Dose Period||6
11211045|NCT01898884|12402352|FG006|COMPLETED|Multiple Dose Period||5
11211046|NCT01898884|12402353|FG007|COMPLETED|Multiple Dose Period||6
11211047|NCT01898884|12402354|FG008|COMPLETED|Multiple Dose Period||5
11211048|NCT01898884|12402346|FG000|NOT COMPLETED|Multiple Dose Period||0
11211049|NCT01898884|12402347|FG001|NOT COMPLETED|Multiple Dose Period||0
11211050|NCT01898884|12402348|FG002|NOT COMPLETED|Multiple Dose Period||0
11096835|NCT01209442|12280532|FG000|STARTED|Overall Study||30
11096836|NCT01209442|12280532|FG000|COMPLETED|Overall Study||30
11096837|NCT01209442|12280532|FG000|NOT COMPLETED|Overall Study||0
11096838|NCT01209598|12280538|FG000|STARTED|Overall Study||30
11096839|NCT01209598|12280539|FG001|STARTED|Overall Study||60
11096840|NCT01209598|12280538|FG000|COMPLETED|Overall Study||29
11096841|NCT01209598|12280539|FG001|COMPLETED|Overall Study||60
11096842|NCT01209598|12280538|FG000|NOT COMPLETED|Overall Study||1
11096843|NCT01209598|12280539|FG001|NOT COMPLETED|Overall Study||0
11096844|NCT01209624|12280546|FG000|STARTED|Overall Study||902
11096845|NCT01209624|12280546|FG000|Per Protocol Population|Overall Study||469
11096846|NCT01209624|12280546|FG000|COMPLETED|Overall Study||576
11096847|NCT01209624|12280546|FG000|NOT COMPLETED|Overall Study||326
11096848|NCT01209689|12280552|FG000|STARTED|Overall Study||91
11096849|NCT01209689|12280553|FG001|STARTED|Overall Study||22
11096850|NCT01209689|12280552|FG000|COMPLETED|Overall Study||0
11096851|NCT01209689|12280553|FG001|COMPLETED|Overall Study||0
11096852|NCT01209689|12280552|FG000|NOT COMPLETED|Overall Study||91
11096853|NCT01209689|12280553|FG001|NOT COMPLETED|Overall Study||22
11211051|NCT01898884|12402349|FG003|NOT COMPLETED|Multiple Dose Period||0
11211052|NCT01898884|12402350|FG004|NOT COMPLETED|Multiple Dose Period||0
11211053|NCT01898884|12402351|FG005|NOT COMPLETED|Multiple Dose Period||0
11211054|NCT01898884|12402352|FG006|NOT COMPLETED|Multiple Dose Period||1
11211055|NCT01898884|12402353|FG007|NOT COMPLETED|Multiple Dose Period||0
11211056|NCT01898884|12402354|FG008|NOT COMPLETED|Multiple Dose Period||1
11211057|NCT01898923|12402392|FG000|STARTED|Overall Study||122
11211058|NCT01898923|12402393|FG001|STARTED|Overall Study||114
11211059|NCT01898923|12402392|FG000|COMPLETED|Overall Study||106
11211060|NCT01898923|12402393|FG001|COMPLETED|Overall Study||93
11211061|NCT01898923|12402392|FG000|NOT COMPLETED|Overall Study||16
11211062|NCT01898923|12402393|FG001|NOT COMPLETED|Overall Study||21
11211063|NCT01899053|12402413|FG000|STARTED|Overall Study||7
11211064|NCT01899053|12402414|FG001|STARTED|Overall Study||3
11211065|NCT01899053|12402415|FG002|STARTED|Overall Study||7
11211066|NCT01899053|12402416|FG003|STARTED|Overall Study||3
11211067|NCT01899053|12402417|FG004|STARTED|Overall Study||6
11211068|NCT01899053|12402418|FG005|STARTED|Overall Study||3
11211069|NCT01899053|12402419|FG006|STARTED|Overall Study||3
11096854|NCT01209702|12280561|FG000|STARTED|Overall Study||51
11211070|NCT01899053|12402420|FG007|STARTED|Overall Study||3
11211071|NCT01899053|12402421|FG008|STARTED|Overall Study||6
11211072|NCT01899053|12402422|FG009|STARTED|Overall Study||3
11096855|NCT01209702|12280562|FG001|STARTED|Overall Study||51
11096856|NCT01209702|12280563|FG002|STARTED|Overall Study||51
11096857|NCT01209702|12280564|FG003|STARTED|Overall Study||153
11096858|NCT01209702|12280561|FG000|Treated|Overall Study||51
11096859|NCT01209702|12280562|FG001|Treated|Overall Study||51
11211073|NCT01899053|12402423|FG010|STARTED|Overall Study||16
11211074|NCT01899053|12402424|FG011|STARTED|Overall Study||7
11211075|NCT01899053|12402425|FG012|STARTED|Overall Study||14
11211076|NCT01899053|12402426|FG013|STARTED|Overall Study||20
11211077|NCT01899053|12402413|FG000|COMPLETED|Overall Study||0
11211078|NCT01899053|12402414|FG001|COMPLETED|Overall Study||0
11211079|NCT01899053|12402415|FG002|COMPLETED|Overall Study||0
11211080|NCT01899053|12402416|FG003|COMPLETED|Overall Study||0
11211081|NCT01899053|12402417|FG004|COMPLETED|Overall Study||0
11211082|NCT01899053|12402418|FG005|COMPLETED|Overall Study||0
11211083|NCT01899053|12402419|FG006|COMPLETED|Overall Study||0
11211084|NCT01899053|12402420|FG007|COMPLETED|Overall Study||0
11211085|NCT01899053|12402421|FG008|COMPLETED|Overall Study||0
11211086|NCT01899053|12402422|FG009|COMPLETED|Overall Study||0
11211087|NCT01899053|12402423|FG010|COMPLETED|Overall Study||0
11211088|NCT01899053|12402424|FG011|COMPLETED|Overall Study||0
11211089|NCT01899053|12402425|FG012|COMPLETED|Overall Study||0
11211090|NCT01899053|12402426|FG013|COMPLETED|Overall Study||0
11211091|NCT01899053|12402413|FG000|NOT COMPLETED|Overall Study||7
11211092|NCT01899053|12402414|FG001|NOT COMPLETED|Overall Study||3
11211093|NCT01899053|12402415|FG002|NOT COMPLETED|Overall Study||7
11211094|NCT01899053|12402416|FG003|NOT COMPLETED|Overall Study||3
11211095|NCT01899053|12402417|FG004|NOT COMPLETED|Overall Study||6
11096860|NCT01209702|12280563|FG002|Treated|Overall Study||51
11211096|NCT01899053|12402418|FG005|NOT COMPLETED|Overall Study||3
11211097|NCT01899053|12402419|FG006|NOT COMPLETED|Overall Study||3
11211098|NCT01899053|12402420|FG007|NOT COMPLETED|Overall Study||3
11211099|NCT01899053|12402421|FG008|NOT COMPLETED|Overall Study||6
11211100|NCT01899053|12402422|FG009|NOT COMPLETED|Overall Study||3
11211101|NCT01899053|12402423|FG010|NOT COMPLETED|Overall Study||16
11211102|NCT01899053|12402424|FG011|NOT COMPLETED|Overall Study||7
11211103|NCT01899053|12402425|FG012|NOT COMPLETED|Overall Study||14
11211104|NCT01899053|12402426|FG013|NOT COMPLETED|Overall Study||20
11211105|NCT01899300|12402458|FG000|STARTED|Overall Study||1
11211106|NCT01899300|12402459|FG001|STARTED|Overall Study||0
11211107|NCT01899300|12402458|FG000|COMPLETED|Overall Study||1
11096861|NCT01209702|12280564|FG003|Treated|Overall Study||152
11096862|NCT01209702|12280561|FG000|Escape or Switched to Tocilizumab|Overall Study||51
11096863|NCT01209702|12280562|FG001|Escape or Switched to Tocilizumab|Overall Study||0
11096864|NCT01209702|12280563|FG002|Escape or Switched to Tocilizumab|Overall Study||6
11096865|NCT01209702|12280564|FG003|Escape or Switched to Tocilizumab|Overall Study||0
11096866|NCT01209702|12280561|FG000|Completed 12 Weeks Treatment|Overall Study||50
11096867|NCT01209702|12280562|FG001|Completed 12 Weeks Treatment|Overall Study||48
11096868|NCT01209702|12280563|FG002|Completed 12 Weeks Treatment|Overall Study||12
11096869|NCT01209702|12280564|FG003|Completed 12 Weeks Treatment|Overall Study||59
11096870|NCT01209702|12280561|FG000|Completed 24 Weeks Treatment|Overall Study||19
11096871|NCT01209702|12280562|FG001|Completed 24 Weeks Treatment|Overall Study||28
11096872|NCT01209702|12280563|FG002|Completed 24 Weeks Treatment|Overall Study||3
11096873|NCT01209702|12280564|FG003|Completed 24 Weeks Treatment|Overall Study||10
11211108|NCT01899300|12402459|FG001|COMPLETED|Overall Study||0
11211109|NCT01899300|12402458|FG000|NOT COMPLETED|Overall Study||0
11211110|NCT01899300|12402459|FG001|NOT COMPLETED|Overall Study||0
11211111|NCT01899677|12402467|FG000|STARTED|Overall Study||35
11211112|NCT01899677|12402468|FG001|STARTED|Overall Study||35
11211113|NCT01899677|12402467|FG000|COMPLETED|Overall Study||25
11211114|NCT01899677|12402468|FG001|COMPLETED|Overall Study||28
11211115|NCT01899677|12402467|FG000|NOT COMPLETED|Overall Study||10
11211116|NCT01899677|12402468|FG001|NOT COMPLETED|Overall Study||7
11211117|NCT01899742|12402476|FG000|STARTED|Overall Study||247
11211118|NCT01899742|12402477|FG001|STARTED|Overall Study||247
11211119|NCT01899742|12402476|FG000|COMPLETED|Overall Study||230
11211120|NCT01899742|12402477|FG001|COMPLETED|Overall Study||231
11211121|NCT01899742|12402476|FG000|NOT COMPLETED|Overall Study||17
11211122|NCT01899742|12402477|FG001|NOT COMPLETED|Overall Study||16
11211123|NCT01899768|12402483|FG000|STARTED|Part A||16
11211124|NCT01899768|12402483|FG000|COMPLETED|Part A||13
11211125|NCT01899768|12402483|FG000|NOT COMPLETED|Part A||3
11211126|NCT01899768|12402483|FG000|STARTED|Part B||13
11211127|NCT01899768|12402483|FG000|COMPLETED|Part B||11
11211128|NCT01899768|12402483|FG000|NOT COMPLETED|Part B||2
11211129|NCT01899768|12402483|FG000|STARTED|Part C||11
11211130|NCT01899768|12402483|FG000|COMPLETED|Part C||11
11211131|NCT01899768|12402483|FG000|NOT COMPLETED|Part C||0
11211132|NCT01899911|12402491|FG000|STARTED|Overall Study||12
11211133|NCT01899911|12402491|FG000|COMPLETED|Overall Study||12
11211134|NCT01899911|12402491|FG000|NOT COMPLETED|Overall Study||0
11211135|NCT01900054|12402495|FG000|STARTED|Overall Study||58
11211136|NCT01900054|12402495|FG000|COMPLETED|Overall Study||56
11211137|NCT01900054|12402495|FG000|NOT COMPLETED|Overall Study||2
11211138|NCT01900067|12402501|FG000|STARTED|Overall Study||134
11211139|NCT01900067|12402502|FG001|STARTED|Overall Study||137
11211140|NCT01900067|12402501|FG000|COMPLETED|Overall Study||122
11211141|NCT01900067|12402502|FG001|COMPLETED|Overall Study||124
11211142|NCT01900067|12402501|FG000|NOT COMPLETED|Overall Study||12
11211143|NCT01900067|12402502|FG001|NOT COMPLETED|Overall Study||13
11211144|NCT01900249|12402511|FG000|STARTED|Overall Study||67
11211145|NCT01900249|12402512|FG001|STARTED|Overall Study||68
11211146|NCT01900249|12402513|FG002|STARTED|Overall Study||69
11211147|NCT01900249|12402511|FG000|COMPLETED|Overall Study||64
11211148|NCT01900249|12402512|FG001|COMPLETED|Overall Study||63
11211149|NCT01900249|12402513|FG002|COMPLETED|Overall Study||65
11211150|NCT01900249|12402511|FG000|NOT COMPLETED|Overall Study||3
11211151|NCT01900249|12402512|FG001|NOT COMPLETED|Overall Study||5
11211152|NCT01900249|12402513|FG002|NOT COMPLETED|Overall Study||4
11211153|NCT01900314|12402523|FG000|STARTED|Overall Study||20
11211154|NCT01900314|12402524|FG001|STARTED|Overall Study||20
11211155|NCT01900314|12402523|FG000|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
11211156|NCT01900314|12402524|FG001|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
11211157|NCT01900314|12402523|FG000|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
11211158|NCT01900314|12402524|FG001|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
11211159|NCT01900314|12402523|FG000|NOT COMPLETED|Overall Study||4
11211160|NCT01900314|12402524|FG001|NOT COMPLETED|Overall Study||4
11211161|NCT01900392|12402534|FG000|STARTED|Overall Study||39
11211162|NCT01900392|12402535|FG001|STARTED|Overall Study||75
11211163|NCT01900392|12402536|FG002|STARTED|Overall Study||77
11211164|NCT01900392|12402534|FG000|COMPLETED|Overall Study||38
11211165|NCT01900392|12402535|FG001|COMPLETED|Overall Study||74
11211166|NCT01900392|12402536|FG002|COMPLETED|Overall Study||77
11211167|NCT01900392|12402534|FG000|NOT COMPLETED|Overall Study||1
11211168|NCT01900392|12402535|FG001|NOT COMPLETED|Overall Study||1
11211169|NCT01900392|12402536|FG002|NOT COMPLETED|Overall Study||0
11211170|NCT01900431|12402546|FG000|STARTED|Principal Treatment Period (Part A)||20
11211171|NCT01900431|12402547|FG001|STARTED|Principal Treatment Period (Part A)||38
11211172|NCT01900431|12402548|FG002|STARTED|Principal Treatment Period (Part A)||0
11352544|NCT03047720|12549589|FG000|STARTED|Second Intervention (6weeks)||0
11211173|NCT01900431|12402546|FG000|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
11211174|NCT01900431|12402547|FG001|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
11211175|NCT01900431|12402548|FG002|COMPLETED|Principal Treatment Period (Part A)||0
11211176|NCT01900431|12402546|FG000|NOT COMPLETED|Principal Treatment Period (Part A)||7
11211177|NCT01900431|12402547|FG001|NOT COMPLETED|Principal Treatment Period (Part A)||10
11211178|NCT01900431|12402548|FG002|NOT COMPLETED|Principal Treatment Period (Part A)||0
11211179|NCT01900431|12402546|FG000|STARTED|Extended Treatment Period (Part B)||8
11211180|NCT01900431|12402547|FG001|STARTED|Extended Treatment Period (Part B)||22
11211181|NCT01900431|12402548|FG002|STARTED|Extended Treatment Period (Part B)||0
11211182|NCT01900431|12402546|FG000|COMPLETED|Extended Treatment Period (Part B)||7
11211183|NCT01900431|12402547|FG001|COMPLETED|Extended Treatment Period (Part B)||12
11211184|NCT01900431|12402548|FG002|COMPLETED|Extended Treatment Period (Part B)||0
11211185|NCT01900431|12402546|FG000|NOT COMPLETED|Extended Treatment Period (Part B)||1
11211186|NCT01900431|12402547|FG001|NOT COMPLETED|Extended Treatment Period (Part B)||10
11211187|NCT01900431|12402548|FG002|NOT COMPLETED|Extended Treatment Period (Part B)||0
11211188|NCT01900431|12402546|FG000|STARTED|Open-Label Treatment Period (Part C)||0
11211189|NCT01900431|12402547|FG001|STARTED|Open-Label Treatment Period (Part C)||0
11211190|NCT01900431|12402548|FG002|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
11211191|NCT01900431|12402546|FG000|COMPLETED|Open-Label Treatment Period (Part C)||0
11211192|NCT01900431|12402547|FG001|COMPLETED|Open-Label Treatment Period (Part C)||0
11211193|NCT01900431|12402548|FG002|COMPLETED|Open-Label Treatment Period (Part C)||13
11211194|NCT01900431|12402546|FG000|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
11211195|NCT01900431|12402547|FG001|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
11211196|NCT01900431|12402548|FG002|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
11211197|NCT01900561|12402558|FG000|STARTED|Overall Study||278
11211198|NCT01900561|12402559|FG001|STARTED|Overall Study||278
11211199|NCT01900561|12402558|FG000|COMPLETED|Overall Study||261
11211200|NCT01900561|12402559|FG001|COMPLETED|Overall Study||269
11211201|NCT01900561|12402558|FG000|NOT COMPLETED|Overall Study||17
11211202|NCT01900561|12402559|FG001|NOT COMPLETED|Overall Study||9
11211203|NCT01900652|12402567|FG000|STARTED|Overall Study||83
11211204|NCT01900652|12402568|FG001|STARTED|Overall Study||28
11211205|NCT01900652|12402567|FG000|Post-Erlotinib Progression Tumor Sample|Overall Study||66
11211206|NCT01900652|12402568|FG001|Post-Erlotinib Progression Tumor Sample|Overall Study||23
11211207|NCT01900652|12402567|FG000|COMPLETED|Overall Study||75
11211208|NCT01900652|12402568|FG001|COMPLETED|Overall Study||25
11211209|NCT01900652|12402567|FG000|NOT COMPLETED|Overall Study||8
11211210|NCT01900652|12402568|FG001|NOT COMPLETED|Overall Study||3
11211211|NCT01900665|12402581|FG000|STARTED|Placebo Controlled Period||1057
11211212|NCT01900665|12402582|FG001|STARTED|Placebo Controlled Period||1072
11211213|NCT01900665|12402581|FG000|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
11211214|NCT01900665|12402582|FG001|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
11211215|NCT01900665|12402581|FG000|COMPLETED|Placebo Controlled Period||914
11211216|NCT01900665|12402582|FG001|COMPLETED|Placebo Controlled Period||908
11211217|NCT01900665|12402581|FG000|NOT COMPLETED|Placebo Controlled Period||143
11211218|NCT01900665|12402582|FG001|NOT COMPLETED|Placebo Controlled Period||164
11211219|NCT01900665|12402581|FG000|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
11211220|NCT01900665|12402582|FG001|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
11211221|NCT01900665|12402581|FG000|COMPLETED|Open Label Period||0
11211222|NCT01900665|12402582|FG001|COMPLETED|Open Label Period||0
11211223|NCT01900665|12402581|FG000|NOT COMPLETED|Open Label Period||881
11211224|NCT01900665|12402582|FG001|NOT COMPLETED|Open Label Period||859
11211225|NCT01900704|12402594|FG000|STARTED|Overall Study||270
11211226|NCT01900704|12402595|FG001|STARTED|Overall Study||270
11211227|NCT01900704|12402596|FG002|STARTED|Overall Study||270
11211228|NCT01900704|12402594|FG000|COMPLETED|Overall Study||229
11211229|NCT01900704|12402595|FG001|COMPLETED|Overall Study||235
11211230|NCT01900704|12402596|FG002|COMPLETED|Overall Study||237
11211231|NCT01900704|12402594|FG000|NOT COMPLETED|Overall Study||41
11211232|NCT01900704|12402595|FG001|NOT COMPLETED|Overall Study||35
11211233|NCT01900704|12402596|FG002|NOT COMPLETED|Overall Study||33
11211234|NCT01900899|12402607|FG000|STARTED|Overall Study||159
11211235|NCT01900899|12402608|FG001|STARTED|Overall Study||25
11211236|NCT01900899|12402607|FG000|COMPLETED|Overall Study||150
11211237|NCT01900899|12402608|FG001|COMPLETED|Overall Study||24
11211238|NCT01900899|12402607|FG000|NOT COMPLETED|Overall Study||9
11211239|NCT01900899|12402608|FG001|NOT COMPLETED|Overall Study||1
11211240|NCT01901055|12402616|FG000|STARTED|Randomization But Not Titrated||49
11211241|NCT01901055|12402617|FG001|STARTED|Randomization But Not Titrated||49
11211242|NCT01901055|12402616|FG000|COMPLETED|Randomization But Not Titrated||48
11211243|NCT01901055|12402617|FG001|COMPLETED|Randomization But Not Titrated||47
11211244|NCT01901055|12402616|FG000|NOT COMPLETED|Randomization But Not Titrated||1
11211245|NCT01901055|12402617|FG001|NOT COMPLETED|Randomization But Not Titrated||2
11211246|NCT01901055|12402616|FG000|STARTED|Started Protocol to Week 6||48
11211247|NCT01901055|12402617|FG001|STARTED|Started Protocol to Week 6||47
11211248|NCT01901055|12402616|FG000|COMPLETED|Started Protocol to Week 6||45
11211249|NCT01901055|12402617|FG001|COMPLETED|Started Protocol to Week 6||43
11211250|NCT01901055|12402616|FG000|NOT COMPLETED|Started Protocol to Week 6||3
11211251|NCT01901055|12402617|FG001|NOT COMPLETED|Started Protocol to Week 6||4
11211252|NCT01901055|12402616|FG000|STARTED|Week 12 Assessment||45
11211253|NCT01901055|12402617|FG001|STARTED|Week 12 Assessment||43
11211254|NCT01901055|12402616|FG000|COMPLETED|Week 12 Assessment||44
11211255|NCT01901055|12402617|FG001|COMPLETED|Week 12 Assessment||39
11211256|NCT01901055|12402616|FG000|NOT COMPLETED|Week 12 Assessment||1
11211257|NCT01901055|12402617|FG001|NOT COMPLETED|Week 12 Assessment||4
11211258|NCT01901055|12402616|FG000|STARTED|Week 24||44
11211259|NCT01901055|12402617|FG001|STARTED|Week 24||39
11096874|NCT01209702|12280561|FG000|COMPLETED|Overall Study||0
11096875|NCT01209702|12280562|FG001|COMPLETED|Overall Study||0
11096876|NCT01209702|12280563|FG002|COMPLETED|Overall Study||0
11096877|NCT01209702|12280564|FG003|COMPLETED|Overall Study||0
11096878|NCT01209702|12280561|FG000|NOT COMPLETED|Overall Study||51
11096879|NCT01209702|12280562|FG001|NOT COMPLETED|Overall Study||51
11096880|NCT01209702|12280563|FG002|NOT COMPLETED|Overall Study||51
11211260|NCT01901055|12402616|FG000|COMPLETED|Week 24||30
11211261|NCT01901055|12402617|FG001|COMPLETED|Week 24||20
11211262|NCT01901055|12402616|FG000|NOT COMPLETED|Week 24||14
11211263|NCT01901055|12402617|FG001|NOT COMPLETED|Week 24||19
11211264|NCT01901055|12402616|FG000|STARTED|Week 36||30
11211265|NCT01901055|12402617|FG001|STARTED|Week 36||20
11211266|NCT01901055|12402616|FG000|COMPLETED|Week 36||30
11211267|NCT01901055|12402617|FG001|COMPLETED|Week 36||15
11211268|NCT01901055|12402616|FG000|NOT COMPLETED|Week 36||0
11211269|NCT01901055|12402617|FG001|NOT COMPLETED|Week 36||5
11211270|NCT01901146|12402628|FG000|STARTED|Neoadjuvant Phase||364
11211271|NCT01901146|12402629|FG001|STARTED|Neoadjuvant Phase||361
11211272|NCT01901146|12402630|FG002|STARTED|Neoadjuvant Phase||0
11211273|NCT01901146|12402631|FG003|STARTED|Neoadjuvant Phase||0
11211274|NCT01901146|12402632|FG004|STARTED|Neoadjuvant Phase||0
11211275|NCT01901146|12402628|FG000|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358
11211276|NCT01901146|12402629|FG001|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347
11211277|NCT01901146|12402630|FG002|COMPLETED|Neoadjuvant Phase||0
11211278|NCT01901146|12402631|FG003|COMPLETED|Neoadjuvant Phase||0
11211279|NCT01901146|12402632|FG004|COMPLETED|Neoadjuvant Phase||0
11211280|NCT01901146|12402628|FG000|NOT COMPLETED|Neoadjuvant Phase||6
11211281|NCT01901146|12402629|FG001|NOT COMPLETED|Neoadjuvant Phase||14
11211282|NCT01901146|12402630|FG002|NOT COMPLETED|Neoadjuvant Phase||0
11211283|NCT01901146|12402631|FG003|NOT COMPLETED|Neoadjuvant Phase||0
11211284|NCT01901146|12402632|FG004|NOT COMPLETED|Neoadjuvant Phase||0
11211285|NCT01901146|12402628|FG000|STARTED|Adjuvant Phase||0
11211286|NCT01901146|12402629|FG001|STARTED|Adjuvant Phase||0
11211287|NCT01901146|12402630|FG002|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349
11211288|NCT01901146|12402631|FG003|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171
11211289|NCT01901146|12402632|FG004|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171
11211290|NCT01901146|12402628|FG000|COMPLETED|Adjuvant Phase||0
11211291|NCT01901146|12402629|FG001|COMPLETED|Adjuvant Phase||0
11211292|NCT01901146|12402630|FG002|COMPLETED|Adjuvant Phase||323
11211293|NCT01901146|12402631|FG003|COMPLETED|Adjuvant Phase||164
11211294|NCT01901146|12402632|FG004|COMPLETED|Adjuvant Phase||157
11211295|NCT01901146|12402628|FG000|NOT COMPLETED|Adjuvant Phase||0
11211296|NCT01901146|12402629|FG001|NOT COMPLETED|Adjuvant Phase||0
11211297|NCT01901146|12402630|FG002|NOT COMPLETED|Adjuvant Phase||26
11211298|NCT01901146|12402631|FG003|NOT COMPLETED|Adjuvant Phase||7
11096881|NCT01209702|12280564|FG003|NOT COMPLETED|Overall Study||153
11096882|NCT01209780|12280587|FG000|STARTED|Overall Study||1042
11096883|NCT01209780|12280588|FG001|STARTED|Overall Study||485
11096884|NCT01209780|12280589|FG002|STARTED|Overall Study||48
11096885|NCT01209780|12280590|FG003|STARTED|Overall Study||817
11211299|NCT01901146|12402632|FG004|NOT COMPLETED|Adjuvant Phase||14
11211300|NCT01901185|12402641|FG000|STARTED|Overall Study||77
11211301|NCT01901185|12402641|FG000|Received Etanercept With Autoinjector A|Overall Study||75
11211302|NCT01901185|12402641|FG000|COMPLETED|Overall Study||75
11211303|NCT01901185|12402641|FG000|NOT COMPLETED|Overall Study||2
11211304|NCT01901211|12402647|FG000|STARTED|First Ten-week Period||6
11211305|NCT01901211|12402648|FG001|STARTED|First Ten-week Period||5
11211306|NCT01901211|12402647|FG000|COMPLETED|First Ten-week Period||6
11211307|NCT01901211|12402648|FG001|COMPLETED|First Ten-week Period||5
11211308|NCT01901211|12402647|FG000|NOT COMPLETED|First Ten-week Period||0
11211309|NCT01901211|12402648|FG001|NOT COMPLETED|First Ten-week Period||0
11211310|NCT01901211|12402647|FG000|STARTED|Washout (6 Weeks)||6
11211311|NCT01901211|12402648|FG001|STARTED|Washout (6 Weeks)||5
11211312|NCT01901211|12402647|FG000|COMPLETED|Washout (6 Weeks)||6
11211313|NCT01901211|12402648|FG001|COMPLETED|Washout (6 Weeks)||5
11211314|NCT01901211|12402647|FG000|NOT COMPLETED|Washout (6 Weeks)||0
11211315|NCT01901211|12402648|FG001|NOT COMPLETED|Washout (6 Weeks)||0
11211316|NCT01901211|12402647|FG000|STARTED|Second Ten-week Period||6
11211317|NCT01901211|12402648|FG001|STARTED|Second Ten-week Period||5
11211318|NCT01901211|12402647|FG000|COMPLETED|Second Ten-week Period||6
11211319|NCT01901211|12402648|FG001|COMPLETED|Second Ten-week Period||5
11211320|NCT01901211|12402647|FG000|NOT COMPLETED|Second Ten-week Period||0
11211321|NCT01901211|12402648|FG001|NOT COMPLETED|Second Ten-week Period||0
11211322|NCT01901250|12402656|FG000|STARTED|Overall Study||260
11211323|NCT01901250|12402657|FG001|STARTED|Overall Study||265
11211324|NCT01901250|12402656|FG000|End of Kidergarten|Overall Study||215
11211325|NCT01901250|12402657|FG001|End of Kidergarten|Overall Study||212
11211326|NCT01901250|12402656|FG000|Start of 1st Grade|Overall Study||173
11211327|NCT01901250|12402657|FG001|Start of 1st Grade|Overall Study||176
11211328|NCT01901250|12402656|FG000|End of 1st Grade|Overall Study||143
11211329|NCT01901250|12402657|FG001|End of 1st Grade|Overall Study||151
11211330|NCT01901250|12402656|FG000|COMPLETED|Overall Study||122
11211331|NCT01901250|12402657|FG001|COMPLETED|Overall Study||139
11211332|NCT01901250|12402656|FG000|NOT COMPLETED|Overall Study||138
11211333|NCT01901250|12402657|FG001|NOT COMPLETED|Overall Study||126
11211334|NCT01901302|12402665|FG000|STARTED|Overall Study||31
11211335|NCT01901302|12402666|FG001|STARTED|Overall Study||30
11211336|NCT01901302|12402665|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
11211337|NCT01901302|12402666|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30
11211338|NCT01901302|12402665|FG000|COMPLETED|Overall Study||4
11211339|NCT01901302|12402666|FG001|COMPLETED|Overall Study||7
11211340|NCT01901302|12402665|FG000|NOT COMPLETED|Overall Study||27
11211341|NCT01901302|12402666|FG001|NOT COMPLETED|Overall Study||23
11211342|NCT01901328|12402674|FG000|STARTED|Overall Study||26
11211343|NCT01901328|12402675|FG001|STARTED|Overall Study||23
11211344|NCT01901328|12402674|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
11211345|NCT01901328|12402675|FG001|Received at Least 1 Dose of Study Drug|Overall Study||23
11211346|NCT01901328|12402674|FG000|COMPLETED|Overall Study||4
11211347|NCT01901328|12402675|FG001|COMPLETED|Overall Study||2
11211348|NCT01901328|12402674|FG000|NOT COMPLETED|Overall Study||22
11211349|NCT01901328|12402675|FG001|NOT COMPLETED|Overall Study||21
11211350|NCT01901341|12402684|FG000|STARTED|Overall Study||22
11211351|NCT01901341|12402685|FG001|STARTED|Overall Study||22
11211352|NCT01901341|12402684|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
11211353|NCT01901341|12402685|FG001|Received at Least 1 Dose of Study Drug|Overall Study||22
11211354|NCT01901341|12402684|FG000|COMPLETED|Overall Study||2
11211355|NCT01901341|12402685|FG001|COMPLETED|Overall Study||1
11211356|NCT01901341|12402684|FG000|NOT COMPLETED|Overall Study||20
11211357|NCT01901341|12402685|FG001|NOT COMPLETED|Overall Study||21
11211358|NCT01901393|12402694|FG000|STARTED|Overall Study||51
11211359|NCT01901393|12402695|FG001|STARTED|Overall Study||49
11211360|NCT01901393|12402694|FG000|COMPLETED|Overall Study||50
11211361|NCT01901393|12402695|FG001|COMPLETED|Overall Study||49
11096886|NCT01209780|12280591|FG004|STARTED|Overall Study||412
11096887|NCT01209780|12280587|FG000|COMPLETED|Overall Study||1016
11096888|NCT01209780|12280588|FG001|COMPLETED|Overall Study||467
11096889|NCT01209780|12280589|FG002|COMPLETED|Overall Study||44
11096890|NCT01209780|12280590|FG003|COMPLETED|Overall Study||807
11096891|NCT01209780|12280591|FG004|COMPLETED|Overall Study||407
11096892|NCT01209780|12280587|FG000|NOT COMPLETED|Overall Study||26
11096893|NCT01209780|12280588|FG001|NOT COMPLETED|Overall Study||18
11096894|NCT01209780|12280589|FG002|NOT COMPLETED|Overall Study||4
11096895|NCT01209780|12280590|FG003|NOT COMPLETED|Overall Study||10
11096896|NCT01209780|12280591|FG004|NOT COMPLETED|Overall Study||5
11211362|NCT01901393|12402694|FG000|NOT COMPLETED|Overall Study||1
11211363|NCT01901393|12402695|FG001|NOT COMPLETED|Overall Study||0
11211364|NCT01901419|12402703|FG000|STARTED|Overall Study||40
11211365|NCT01901419|12402704|FG001|STARTED|Overall Study||40
11211366|NCT01901419|12402703|FG000|COMPLETED|Overall Study||32
11211367|NCT01901419|12402704|FG001|COMPLETED|Overall Study||31
11211368|NCT01901419|12402703|FG000|NOT COMPLETED|Overall Study||8
11211369|NCT01901419|12402704|FG001|NOT COMPLETED|Overall Study||9
11211370|NCT01901575|12402710|FG000|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
11211371|NCT01901575|12402710|FG000|COMPLETED|Overall Study||16
11211372|NCT01901575|12402710|FG000|NOT COMPLETED|Overall Study||0
11211373|NCT01901588|12402717|FG000|STARTED|Overall Study||32
11211374|NCT01901588|12402718|FG001|STARTED|Overall Study||31
11211375|NCT01901588|12402717|FG000|COMPLETED|Overall Study||32
11211376|NCT01901588|12402718|FG001|COMPLETED|Overall Study||31
11211377|NCT01901588|12402717|FG000|NOT COMPLETED|Overall Study||0
11211378|NCT01901588|12402718|FG001|NOT COMPLETED|Overall Study||0
11211379|NCT01901614|12402726|FG000|STARTED|Overall Study||3
11211380|NCT01901614|12402727|FG001|STARTED|Overall Study||2
11211381|NCT01901614|12402726|FG000|COMPLETED|Overall Study||1
11211382|NCT01901614|12402727|FG001|COMPLETED|Overall Study||1
11211383|NCT01901614|12402726|FG000|NOT COMPLETED|Overall Study||2
11211384|NCT01901614|12402727|FG001|NOT COMPLETED|Overall Study||1
11211385|NCT01901653|12402746|FG000|STARTED|Overall Study||3
11211386|NCT01901653|12402747|FG001|STARTED|Overall Study||1
11211387|NCT01901653|12402748|FG002|STARTED|Overall Study||11
11211388|NCT01901653|12402749|FG003|STARTED|Overall Study||3
11211389|NCT01901653|12402750|FG004|STARTED|Overall Study||2
11211390|NCT01901653|12402751|FG005|STARTED|Overall Study||3
11211391|NCT01901653|12402752|FG006|STARTED|Overall Study||7
11211392|NCT01901653|12402753|FG007|STARTED|Overall Study||10
11211393|NCT01901653|12402754|FG008|STARTED|Overall Study||1
11211394|NCT01901653|12402755|FG009|STARTED|Overall Study||18
11211395|NCT01901653|12402756|FG010|STARTED|Overall Study||2
11211396|NCT01901653|12402757|FG011|STARTED|Overall Study||16
11211397|NCT01901653|12402758|FG012|STARTED|Overall Study||5
11211398|NCT01901653|12402746|FG000|COMPLETED|Overall Study||0
11211399|NCT01901653|12402747|FG001|COMPLETED|Overall Study||0
11211400|NCT01901653|12402748|FG002|COMPLETED|Overall Study||0
11211401|NCT01901653|12402749|FG003|COMPLETED|Overall Study||0
11211402|NCT01901653|12402750|FG004|COMPLETED|Overall Study||0
11211403|NCT01901653|12402751|FG005|COMPLETED|Overall Study||0
11211404|NCT01901653|12402752|FG006|COMPLETED|Overall Study||0
11211405|NCT01901653|12402753|FG007|COMPLETED|Overall Study||0
11211406|NCT01901653|12402754|FG008|COMPLETED|Overall Study||0
11211407|NCT01901653|12402755|FG009|COMPLETED|Overall Study||0
11211408|NCT01901653|12402756|FG010|COMPLETED|Overall Study||0
11211409|NCT01901653|12402757|FG011|COMPLETED|Overall Study||0
11211410|NCT01901653|12402758|FG012|COMPLETED|Overall Study||0
11211411|NCT01901653|12402746|FG000|NOT COMPLETED|Overall Study||3
11211412|NCT01901653|12402747|FG001|NOT COMPLETED|Overall Study||1
11211413|NCT01901653|12402748|FG002|NOT COMPLETED|Overall Study||11
11211414|NCT01901653|12402749|FG003|NOT COMPLETED|Overall Study||3
11211415|NCT01901653|12402750|FG004|NOT COMPLETED|Overall Study||2
11096897|NCT01209832|12280604|FG000|STARTED|Period 1||11
11096898|NCT01209832|12280604|FG000|Received At Least 1 Dose of Study Drug|Period 1||10
11096899|NCT01209832|12280604|FG000|COMPLETED|Period 1||10
11096900|NCT01209832|12280604|FG000|NOT COMPLETED|Period 1||1
11211416|NCT01901653|12402751|FG005|NOT COMPLETED|Overall Study||3
11211417|NCT01901653|12402752|FG006|NOT COMPLETED|Overall Study||7
11211418|NCT01901653|12402753|FG007|NOT COMPLETED|Overall Study||10
11211419|NCT01901653|12402754|FG008|NOT COMPLETED|Overall Study||1
11211420|NCT01901653|12402755|FG009|NOT COMPLETED|Overall Study||18
11211421|NCT01901653|12402756|FG010|NOT COMPLETED|Overall Study||2
11211422|NCT01901653|12402757|FG011|NOT COMPLETED|Overall Study||16
11211423|NCT01901653|12402758|FG012|NOT COMPLETED|Overall Study||5
11211424|NCT01901809|12402788|FG000|STARTED|Overall Study||19
11211425|NCT01901809|12402789|FG001|STARTED|Overall Study||23
11211426|NCT01901809|12402790|FG002|STARTED|Overall Study||24
11211427|NCT01901809|12402791|FG003|STARTED|Overall Study||24
11211428|NCT01901809|12402788|FG000|COMPLETED|Overall Study||19
11211429|NCT01901809|12402789|FG001|COMPLETED|Overall Study||23
11211430|NCT01901809|12402790|FG002|COMPLETED|Overall Study||21
11211431|NCT01901809|12402791|FG003|COMPLETED|Overall Study||22
11211432|NCT01901809|12402788|FG000|NOT COMPLETED|Overall Study||0
11211433|NCT01901809|12402789|FG001|NOT COMPLETED|Overall Study||0
11211434|NCT01901809|12402790|FG002|NOT COMPLETED|Overall Study||3
11211435|NCT01901809|12402791|FG003|NOT COMPLETED|Overall Study||2
11211436|NCT01901848|12402807|FG000|STARTED|Randomized and Treated||25
11211437|NCT01901848|12402808|FG001|STARTED|Randomized and Treated||25
11211438|NCT01901848|12402807|FG000|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
11211439|NCT01901848|12402808|FG001|COMPLETED|Randomized and Treated||19
11211440|NCT01901848|12402807|FG000|NOT COMPLETED|Randomized and Treated||3
11211441|NCT01901848|12402808|FG001|NOT COMPLETED|Randomized and Treated||6
11211442|NCT01901848|12402807|FG000|STARTED|Removed From Analyses||22
11211443|NCT01901848|12402808|FG001|STARTED|Removed From Analyses||19
11211444|NCT01901848|12402807|FG000|COMPLETED|Removed From Analyses||12
11211445|NCT01901848|12402808|FG001|COMPLETED|Removed From Analyses||19
11211446|NCT01901848|12402807|FG000|NOT COMPLETED|Removed From Analyses||10
11211447|NCT01901848|12402808|FG001|NOT COMPLETED|Removed From Analyses||0
11211448|NCT01901874|12402814|FG000|STARTED|Procedure||312
11211449|NCT01901874|12402814|FG000|COMPLETED|Procedure||312
11211450|NCT01901874|12402814|FG000|NOT COMPLETED|Procedure||0
11211451|NCT01901874|12402814|FG000|STARTED|Screening Committee Retrospective Review||312
11211452|NCT01901874|12402814|FG000|COMPLETED|Screening Committee Retrospective Review||265
11211453|NCT01901874|12402814|FG000|NOT COMPLETED|Screening Committee Retrospective Review||47
11211454|NCT01901874|12402814|FG000|STARTED|30-Day MAE Evaluation||265
11211455|NCT01901874|12402814|FG000|COMPLETED|30-Day MAE Evaluation||264
11211456|NCT01901874|12402814|FG000|NOT COMPLETED|30-Day MAE Evaluation||1
11211457|NCT01901874|12402814|FG000|STARTED|1-Year (365-Day) MAE Evaluation||264
11211458|NCT01901874|12402814|FG000|COMPLETED|1-Year (365-Day) MAE Evaluation||244
11211459|NCT01901874|12402814|FG000|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20
11352545|NCT03047720|12549590|FG001|STARTED|Second Intervention (6weeks)||0
11352546|NCT03047720|12549589|FG000|COMPLETED|Second Intervention (6weeks)||0
11352547|NCT03047720|12549590|FG001|COMPLETED|Second Intervention (6weeks)||0
11352548|NCT03047720|12549589|FG000|NOT COMPLETED|Second Intervention (6weeks)||0
11352549|NCT03047720|12549590|FG001|NOT COMPLETED|Second Intervention (6weeks)||0
11352550|NCT03047980|12549596|FG000|STARTED|Overall Study||10
11352551|NCT03047980|12549596|FG000|COMPLETED|Overall Study||9
11352552|NCT03047980|12549596|FG000|NOT COMPLETED|Overall Study||1
11352553|NCT03048006|12549600|FG000|STARTED|Overall Study||44456
11352554|NCT03048006|12549600|FG000|COMPLETED|Overall Study||44456
11352555|NCT03048006|12549600|FG000|NOT COMPLETED|Overall Study||0
11352556|NCT03048058|12549606|FG000|STARTED|Overall Study||10
11352557|NCT03048058|12549607|FG001|STARTED|Overall Study||10
11352558|NCT03048058|12549606|FG000|COMPLETED|Overall Study||6
11352559|NCT03048058|12549607|FG001|COMPLETED|Overall Study||6
11352560|NCT03048058|12549606|FG000|NOT COMPLETED|Overall Study||4
11352561|NCT03048058|12549607|FG001|NOT COMPLETED|Overall Study||4
11352562|NCT03048383|12549616|FG000|STARTED|Overall Study||28
11352563|NCT03048383|12549617|FG001|STARTED|Overall Study||21
11352564|NCT03048383|12549618|FG002|STARTED|Overall Study||22
11352565|NCT03048383|12549616|FG000|COMPLETED|Overall Study||15
11352566|NCT03048383|12549617|FG001|COMPLETED|Overall Study||13
11352567|NCT03048383|12549618|FG002|COMPLETED|Overall Study||10
11352568|NCT03048383|12549616|FG000|NOT COMPLETED|Overall Study||13
11352569|NCT03048383|12549617|FG001|NOT COMPLETED|Overall Study||8
11352570|NCT03048383|12549618|FG002|NOT COMPLETED|Overall Study||12
11352571|NCT03048500|12549626|FG000|STARTED|2 Cycles of Treatment||17
11352572|NCT03048500|12549626|FG000|Attempted 1st Cycle|2 Cycles of Treatment||17
11352573|NCT03048500|12549626|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||16
11352574|NCT03048500|12549626|FG000|COMPLETED|2 Cycles of Treatment||16
11352575|NCT03048500|12549626|FG000|NOT COMPLETED|2 Cycles of Treatment||1
11352576|NCT03048500|12549626|FG000|STARTED|Reached 1st Response/Continued Treatment||16
11352577|NCT03048500|12549626|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||16
11211460|NCT01902004|12402820|FG000|STARTED|Overall Study||48
11211461|NCT01902004|12402821|FG001|STARTED|Overall Study||47
11211462|NCT01902004|12402820|FG000|COMPLETED|Overall Study||33
11211463|NCT01902004|12402821|FG001|COMPLETED|Overall Study||29
11211464|NCT01902004|12402820|FG000|NOT COMPLETED|Overall Study||15
11211465|NCT01902004|12402821|FG001|NOT COMPLETED|Overall Study||18
11211466|NCT01902134|12402833|FG000|STARTED|Overall Study||159
11211467|NCT01902134|12402834|FG001|STARTED|Overall Study||161
11096901|NCT01209832|12280604|FG000|STARTED|Period 2||10
11096902|NCT01209832|12280604|FG000|COMPLETED|Period 2||9
11096903|NCT01209832|12280604|FG000|NOT COMPLETED|Period 2||1
11096904|NCT01209832|12280604|FG000|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4
11096905|NCT01209832|12280604|FG000|COMPLETED|Maintenance Period 1 (M1)||4
11096906|NCT01209832|12280604|FG000|NOT COMPLETED|Maintenance Period 1 (M1)||0
11096907|NCT01209832|12280604|FG000|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3
11096908|NCT01209832|12280604|FG000|COMPLETED|Maintenance Period 2 (M1)||3
11096909|NCT01209832|12280604|FG000|NOT COMPLETED|Maintenance Period 2 (M1)||0
11096910|NCT01210001|12280618|FG000|STARTED|Overall Study||166
11096911|NCT01210001|12280619|FG001|STARTED|Overall Study||165
11096912|NCT01210001|12280620|FG002|STARTED|Overall Study||168
11096913|NCT01210001|12280618|FG000|COMPLETED|Overall Study||147
11096914|NCT01210001|12280619|FG001|COMPLETED|Overall Study||154
11096915|NCT01210001|12280620|FG002|COMPLETED|Overall Study||156
11096916|NCT01210001|12280618|FG000|NOT COMPLETED|Overall Study||19
11096917|NCT01210001|12280619|FG001|NOT COMPLETED|Overall Study||11
11096918|NCT01210001|12280620|FG002|NOT COMPLETED|Overall Study||12
11096919|NCT01210079|12280630|FG000|STARTED|Overall Study||10
11096920|NCT01210079|12280631|FG001|STARTED|Overall Study||16
11096921|NCT01210079|12280630|FG000|COMPLETED|Overall Study||10
11096922|NCT01210079|12280631|FG001|COMPLETED|Overall Study||16
11211468|NCT01902134|12402835|FG002|STARTED|Overall Study||160
11211469|NCT01902134|12402836|FG003|STARTED|Overall Study||54
11096923|NCT01210079|12280630|FG000|NOT COMPLETED|Overall Study||0
11096924|NCT01210079|12280631|FG001|NOT COMPLETED|Overall Study||0
11096925|NCT01210118|12280639|FG000|STARTED|Overall Study||45
11096926|NCT01210118|12280640|FG001|STARTED|Overall Study||47
11096927|NCT01210118|12280639|FG000|COMPLETED|Overall Study||42
11211470|NCT01902134|12402837|FG004|STARTED|Overall Study||53
11096928|NCT01210118|12280640|FG001|COMPLETED|Overall Study||42
11096929|NCT01210118|12280639|FG000|NOT COMPLETED|Overall Study||3
11096930|NCT01210118|12280640|FG001|NOT COMPLETED|Overall Study||5
11211471|NCT01902134|12402838|FG005|STARTED|Overall Study||54
11352578|NCT03048500|12549626|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||9
11352579|NCT03048500|12549626|FG000|COMPLETED|Reached 1st Response/Continued Treatment||9
11352580|NCT03048500|12549626|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||7
11352581|NCT03048500|12549626|FG000|STARTED|Follow up for 3 Years|1 patient died whilst on study.|16
11352582|NCT03048500|12549626|FG000|COMPLETED|Follow up for 3 Years||0
11211472|NCT01902134|12402833|FG000|Single-dose Phase|Overall Study||159
11211473|NCT01902134|12402834|FG001|Single-dose Phase|Overall Study||161
11211474|NCT01902134|12402835|FG002|Single-dose Phase|Overall Study||160
11211475|NCT01902134|12402836|FG003|Single-dose Phase|Overall Study||54
11211476|NCT01902134|12402837|FG004|Single-dose Phase|Overall Study||53
11211477|NCT01902134|12402838|FG005|Single-dose Phase|Overall Study||54
11211478|NCT01902134|12402833|FG000|Multiple-dose Phase|Overall Study||159
11211479|NCT01902134|12402834|FG001|Multiple-dose Phase|Overall Study||160
11211480|NCT01902134|12402835|FG002|Multiple-dose Phase|Overall Study||160
11211481|NCT01902134|12402836|FG003|Multiple-dose Phase|Overall Study||54
11211482|NCT01902134|12402837|FG004|Multiple-dose Phase|Overall Study||53
11211483|NCT01902134|12402838|FG005|Multiple-dose Phase|Overall Study||52
11211484|NCT01902134|12402833|FG000|COMPLETED|Overall Study||151
11211485|NCT01902134|12402834|FG001|COMPLETED|Overall Study||150
11211486|NCT01902134|12402835|FG002|COMPLETED|Overall Study||145
11211487|NCT01902134|12402836|FG003|COMPLETED|Overall Study||52
11211488|NCT01902134|12402837|FG004|COMPLETED|Overall Study||46
11211489|NCT01902134|12402838|FG005|COMPLETED|Overall Study||45
11211490|NCT01902134|12402833|FG000|NOT COMPLETED|Overall Study||8
11211491|NCT01902134|12402834|FG001|NOT COMPLETED|Overall Study||11
11211492|NCT01902134|12402835|FG002|NOT COMPLETED|Overall Study||15
11211493|NCT01902134|12402836|FG003|NOT COMPLETED|Overall Study||2
11211494|NCT01902134|12402837|FG004|NOT COMPLETED|Overall Study||7
11211495|NCT01902134|12402838|FG005|NOT COMPLETED|Overall Study||9
11211496|NCT01902303|12402856|FG000|STARTED|Overall Study|Allocated to placebo|77
11211497|NCT01902303|12402857|FG001|STARTED|Overall Study|Allocated to active treatment|81
11211498|NCT01902303|12402856|FG000|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
11211499|NCT01902303|12402857|FG001|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
11211500|NCT01902303|12402856|FG000|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
11211501|NCT01902303|12402857|FG001|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
11211502|NCT01902303|12402856|FG000|NOT COMPLETED|Overall Study||23
11096931|NCT01210144|12280651|FG000|STARTED|Overall Study||13
11096932|NCT01210144|12280652|FG001|STARTED|Overall Study||11
11096933|NCT01210144|12280651|FG000|COMPLETED|Overall Study||10
11096934|NCT01210144|12280652|FG001|COMPLETED|Overall Study||11
11096935|NCT01210144|12280651|FG000|NOT COMPLETED|Overall Study||3
11211503|NCT01902303|12402857|FG001|NOT COMPLETED|Overall Study||24
11211504|NCT01902459|12402867|FG000|STARTED|Overall Study||75
11211505|NCT01902459|12402868|FG001|STARTED|Overall Study||75
11211506|NCT01902459|12402867|FG000|COMPLETED|Overall Study||75
11211507|NCT01902459|12402868|FG001|COMPLETED|Overall Study||75
11211508|NCT01902459|12402867|FG000|NOT COMPLETED|Overall Study||0
11211509|NCT01902459|12402868|FG001|NOT COMPLETED|Overall Study||0
11211510|NCT01902628|12402874|FG000|STARTED|Overall Study||437
11211511|NCT01902628|12402874|FG000|COMPLETED|Overall Study||354
11211512|NCT01902628|12402874|FG000|NOT COMPLETED|Overall Study||83
11211513|NCT01902758|12402880|FG000|STARTED|Overall Study||14
11211514|NCT01902758|12402881|FG001|STARTED|Overall Study||14
11211515|NCT01902758|12402880|FG000|COMPLETED|Overall Study||14
11211516|NCT01902758|12402881|FG001|COMPLETED|Overall Study||14
11211517|NCT01902758|12402880|FG000|NOT COMPLETED|Overall Study||0
11211518|NCT01902758|12402881|FG001|NOT COMPLETED|Overall Study||0
11211519|NCT01902901|12402889|FG000|STARTED|Overall Study||180
11211520|NCT01902901|12402890|FG001|STARTED|Overall Study||203
11211521|NCT01902901|12402889|FG000|COMPLETED|Overall Study||180
11211522|NCT01902901|12402890|FG001|COMPLETED|Overall Study||201
11211523|NCT01902901|12402889|FG000|NOT COMPLETED|Overall Study||0
11211524|NCT01902901|12402890|FG001|NOT COMPLETED|Overall Study||2
11211525|NCT01902953|12402896|FG000|STARTED|Overall Study||16
11211526|NCT01902953|12402896|FG000|COMPLETED|Overall Study||16
11211527|NCT01902953|12402896|FG000|NOT COMPLETED|Overall Study||0
11211528|NCT01903005|12402902|FG000|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
11211529|NCT01903005|12402902|FG000|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
11211530|NCT01903005|12402902|FG000|NOT COMPLETED|Overall Study||373
11211531|NCT01903031|12402910|FG000|STARTED|Overall Study||27
11211532|NCT01903031|12402911|FG001|STARTED|Overall Study||28
11211533|NCT01903031|12402912|FG002|STARTED|Overall Study||29
11211534|NCT01903031|12402910|FG000|COMPLETED|Overall Study||25
11211535|NCT01903031|12402911|FG001|COMPLETED|Overall Study||25
11211536|NCT01903031|12402912|FG002|COMPLETED|Overall Study||24
11211537|NCT01903031|12402910|FG000|NOT COMPLETED|Overall Study||2
11211538|NCT01903031|12402911|FG001|NOT COMPLETED|Overall Study||3
11211539|NCT01903031|12402912|FG002|NOT COMPLETED|Overall Study||5
11211540|NCT01903148|12402925|FG000|STARTED|Overall Study||441
11211541|NCT01903148|12402925|FG000|COMPLETED|Overall Study||441
11211542|NCT01903148|12402925|FG000|NOT COMPLETED|Overall Study||0
11211543|NCT01903187|12402933|FG000|STARTED|Procedure||2
11211544|NCT01903187|12402934|FG001|STARTED|Procedure||2
11211545|NCT01903187|12402933|FG000|COMPLETED|Procedure||2
11211546|NCT01903187|12402934|FG001|COMPLETED|Procedure||2
11211547|NCT01903187|12402933|FG000|NOT COMPLETED|Procedure||0
11211548|NCT01903187|12402934|FG001|NOT COMPLETED|Procedure||0
11211549|NCT01903187|12402933|FG000|STARTED|1 Month||2
11211550|NCT01903187|12402934|FG001|STARTED|1 Month||2
11211551|NCT01903187|12402933|FG000|COMPLETED|1 Month||2
11211552|NCT01903187|12402934|FG001|COMPLETED|1 Month||2
11211553|NCT01903187|12402933|FG000|NOT COMPLETED|1 Month||0
11211554|NCT01903187|12402934|FG001|NOT COMPLETED|1 Month||0
11211555|NCT01903187|12402933|FG000|STARTED|3 Month||2
11211556|NCT01903187|12402934|FG001|STARTED|3 Month||0
11211557|NCT01903187|12402933|FG000|COMPLETED|3 Month||2
11211558|NCT01903187|12402934|FG001|COMPLETED|3 Month||0
11211559|NCT01903187|12402933|FG000|NOT COMPLETED|3 Month||0
11211560|NCT01903187|12402934|FG001|NOT COMPLETED|3 Month||0
11211561|NCT01903187|12402933|FG000|STARTED|6 Month||2
11211562|NCT01903187|12402934|FG001|STARTED|6 Month||0
11211563|NCT01903187|12402933|FG000|COMPLETED|6 Month||2
11211564|NCT01903187|12402934|FG001|COMPLETED|6 Month||0
11211565|NCT01903187|12402933|FG000|NOT COMPLETED|6 Month||0
11211566|NCT01903187|12402934|FG001|NOT COMPLETED|6 Month||0
11211567|NCT01903187|12402933|FG000|STARTED|12 Month||2
11211568|NCT01903187|12402934|FG001|STARTED|12 Month||0
11096936|NCT01210144|12280652|FG001|NOT COMPLETED|Overall Study||0
11096937|NCT01210170|12280659|FG000|STARTED|Overall Study||22
11211569|NCT01903187|12402933|FG000|COMPLETED|12 Month||2
11211570|NCT01903187|12402934|FG001|COMPLETED|12 Month||0
11211571|NCT01903187|12402933|FG000|NOT COMPLETED|12 Month||0
11211572|NCT01903187|12402934|FG001|NOT COMPLETED|12 Month||0
11211573|NCT01903252|12402943|FG000|STARTED|Double-Blind Induction||409
11211574|NCT01903252|12402944|FG001|STARTED|Double-Blind Induction||408
11211575|NCT01903252|12402945|FG002|STARTED|Double-Blind Induction||0
11211576|NCT01903252|12402946|FG003|STARTED|Double-Blind Induction||0
11211577|NCT01903252|12402947|FG004|STARTED|Double-Blind Induction||0
11211578|NCT01903252|12402948|FG005|STARTED|Double-Blind Induction||0
11211579|NCT01903252|12402943|FG000|COMPLETED|Double-Blind Induction||370
11211580|NCT01903252|12402944|FG001|COMPLETED|Double-Blind Induction||367
11211581|NCT01903252|12402945|FG002|COMPLETED|Double-Blind Induction||0
11211582|NCT01903252|12402946|FG003|COMPLETED|Double-Blind Induction||0
11211583|NCT01903252|12402947|FG004|COMPLETED|Double-Blind Induction||0
11211584|NCT01903252|12402948|FG005|COMPLETED|Double-Blind Induction||0
11211585|NCT01903252|12402943|FG000|NOT COMPLETED|Double-Blind Induction||39
11211586|NCT01903252|12402944|FG001|NOT COMPLETED|Double-Blind Induction||41
11211587|NCT01903252|12402945|FG002|NOT COMPLETED|Double-Blind Induction||0
11211588|NCT01903252|12402946|FG003|NOT COMPLETED|Double-Blind Induction||0
11211589|NCT01903252|12402947|FG004|NOT COMPLETED|Double-Blind Induction||0
11211590|NCT01903252|12402948|FG005|NOT COMPLETED|Double-Blind Induction||0
11211591|NCT01903252|12402943|FG000|STARTED|Extended Induction, Open-Label||0
11211592|NCT01903252|12402944|FG001|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
11211593|NCT01903252|12402945|FG002|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
11211594|NCT01903252|12402946|FG003|STARTED|Extended Induction, Open-Label||0
11211595|NCT01903252|12402947|FG004|STARTED|Extended Induction, Open-Label||0
11211596|NCT01903252|12402948|FG005|STARTED|Extended Induction, Open-Label||0
11211597|NCT01903252|12402943|FG000|COMPLETED|Extended Induction, Open-Label||0
11211598|NCT01903252|12402944|FG001|COMPLETED|Extended Induction, Open-Label||0
11211599|NCT01903252|12402945|FG002|COMPLETED|Extended Induction, Open-Label||220
11211600|NCT01903252|12402946|FG003|COMPLETED|Extended Induction, Open-Label||0
11211601|NCT01903252|12402947|FG004|COMPLETED|Extended Induction, Open-Label||0
11211602|NCT01903252|12402948|FG005|COMPLETED|Extended Induction, Open-Label||0
11211603|NCT01903252|12402943|FG000|NOT COMPLETED|Extended Induction, Open-Label||0
11211604|NCT01903252|12402944|FG001|NOT COMPLETED|Extended Induction, Open-Label||0
11211605|NCT01903252|12402945|FG002|NOT COMPLETED|Extended Induction, Open-Label||23
11211606|NCT01903252|12402946|FG003|NOT COMPLETED|Extended Induction, Open-Label||0
11211607|NCT01903252|12402947|FG004|NOT COMPLETED|Extended Induction, Open-Label||0
11211608|NCT01903252|12402948|FG005|NOT COMPLETED|Extended Induction, Open-Label||0
11211609|NCT01903252|12402943|FG000|STARTED|Maintenance, Open-Label||0
11211610|NCT01903252|12402944|FG001|STARTED|Maintenance, Open-Label||0
11211611|NCT01903252|12402945|FG002|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
11211612|NCT01903252|12402946|FG003|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
11211613|NCT01903252|12402947|FG004|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
11211614|NCT01903252|12402948|FG005|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
11211615|NCT01903252|12402943|FG000|COMPLETED|Maintenance, Open-Label||0
11211616|NCT01903252|12402944|FG001|COMPLETED|Maintenance, Open-Label||0
11211617|NCT01903252|12402945|FG002|COMPLETED|Maintenance, Open-Label||0
11211618|NCT01903252|12402946|FG003|COMPLETED|Maintenance, Open-Label||196
11211619|NCT01903252|12402947|FG004|COMPLETED|Maintenance, Open-Label||253
11211620|NCT01903252|12402948|FG005|COMPLETED|Maintenance, Open-Label||181
11211621|NCT01903252|12402943|FG000|NOT COMPLETED|Maintenance, Open-Label||0
11211622|NCT01903252|12402944|FG001|NOT COMPLETED|Maintenance, Open-Label||0
11211623|NCT01903252|12402945|FG002|NOT COMPLETED|Maintenance, Open-Label||0
11211624|NCT01903252|12402946|FG003|NOT COMPLETED|Maintenance, Open-Label||6
11211625|NCT01903252|12402947|FG004|NOT COMPLETED|Maintenance, Open-Label||21
11211626|NCT01903252|12402948|FG005|NOT COMPLETED|Maintenance, Open-Label||18
11211627|NCT01903265|12402968|FG000|STARTED|Overall Study||103
11211628|NCT01903265|12402969|FG001|STARTED|Overall Study||102
11211629|NCT01903265|12402968|FG000|COMPLETED|Overall Study||89
11211630|NCT01903265|12402969|FG001|COMPLETED|Overall Study||85
11211631|NCT01903265|12402968|FG000|NOT COMPLETED|Overall Study||14
11211632|NCT01903265|12402969|FG001|NOT COMPLETED|Overall Study||17
11211633|NCT01903356|12402975|FG000|STARTED|Overall Study||724
11211634|NCT01903356|12402975|FG000|COMPLETED|Overall Study||709
11211635|NCT01903356|12402975|FG000|NOT COMPLETED|Overall Study||15
11211636|NCT01903434|12402979|FG000|STARTED|Treatment Period 1||30
11211637|NCT01903434|12402980|FG001|STARTED|Treatment Period 1||30
11211638|NCT01903434|12402979|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
11211639|NCT01903434|12402980|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
11211640|NCT01903434|12402979|FG000|COMPLETED|Treatment Period 1||30
11211641|NCT01903434|12402980|FG001|COMPLETED|Treatment Period 1||30
11211642|NCT01903434|12402979|FG000|NOT COMPLETED|Treatment Period 1||0
11211643|NCT01903434|12402980|FG001|NOT COMPLETED|Treatment Period 1||0
11211644|NCT01903434|12402979|FG000|STARTED|Washout Period 1 (at Least 14 Days)||30
11211645|NCT01903434|12402980|FG001|STARTED|Washout Period 1 (at Least 14 Days)||30
11211646|NCT01903434|12402979|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29
11211647|NCT01903434|12402980|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28
11211648|NCT01903434|12402979|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
11211649|NCT01903434|12402980|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
11211650|NCT01903434|12402979|FG000|STARTED|Treatment Period 2||29
11211651|NCT01903434|12402980|FG001|STARTED|Treatment Period 2||28
11211652|NCT01903434|12402979|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
11211653|NCT01903434|12402980|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
11211654|NCT01903434|12402979|FG000|COMPLETED|Treatment Period 2||29
11211655|NCT01903434|12402980|FG001|COMPLETED|Treatment Period 2||28
11211656|NCT01903434|12402979|FG000|NOT COMPLETED|Treatment Period 2||0
11211657|NCT01903434|12402980|FG001|NOT COMPLETED|Treatment Period 2||0
11211658|NCT01903434|12402979|FG000|STARTED|Washout Period 1 (at Least 14 Days)||29
11211659|NCT01903434|12402980|FG001|STARTED|Washout Period 1 (at Least 14 Days)||28
11211660|NCT01903434|12402979|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29
11211661|NCT01903434|12402980|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28
11211662|NCT01903434|12402979|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
11211663|NCT01903434|12402980|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
11211664|NCT01903434|12402979|FG000|STARTED|Treatment Period 3||29
11352583|NCT03048500|12549626|FG000|NOT COMPLETED|Follow up for 3 Years||16
11352584|NCT03048747|12549630|FG000|STARTED|Overall Study||16
11352585|NCT03048747|12549630|FG000|COMPLETED|Overall Study||11
11352586|NCT03048747|12549630|FG000|NOT COMPLETED|Overall Study||5
11352587|NCT03049215|12549637|FG000|STARTED|Overall Study||1
11352588|NCT03049215|12549638|FG001|STARTED|Overall Study||0
11352589|NCT03049215|12549637|FG000|COMPLETED|Overall Study||1
11352590|NCT03049215|12549638|FG001|COMPLETED|Overall Study||0
11352591|NCT03049215|12549637|FG000|NOT COMPLETED|Overall Study||0
11352592|NCT03049215|12549638|FG001|NOT COMPLETED|Overall Study||0
11352593|NCT03049280|12549644|FG000|STARTED|Overall Study||33
11352594|NCT03049280|12549644|FG000|COMPLETED|Overall Study||32
11352595|NCT03049280|12549644|FG000|NOT COMPLETED|Overall Study||1
11352596|NCT03049488|12549656|FG000|STARTED|Overall Study||15
11352597|NCT03049488|12549657|FG001|STARTED|Overall Study||15
11352598|NCT03049488|12549658|FG002|STARTED|Overall Study||20
11352599|NCT03049488|12549659|FG003|STARTED|Overall Study||15
11352600|NCT03049488|12549660|FG004|STARTED|Overall Study||15
11352601|NCT03049488|12549661|FG005|STARTED|Overall Study||15
11096938|NCT01210170|12280659|FG000|COMPLETED|Overall Study||15
11096939|NCT01210170|12280659|FG000|NOT COMPLETED|Overall Study||7
11096940|NCT01210222|12280680|FG000|STARTED|Overall Study||35
11096941|NCT01210222|12280680|FG000|COMPLETED|Overall Study||32
11096942|NCT01210222|12280680|FG000|NOT COMPLETED|Overall Study||3
11096943|NCT01210352|12280699|FG000|STARTED|Overall Study||6
11096944|NCT01210352|12280700|FG001|STARTED|Overall Study||6
11096945|NCT01210352|12280701|FG002|STARTED|Overall Study||7
11096946|NCT01210352|12280702|FG003|STARTED|Overall Study||7
11096947|NCT01210352|12280703|FG004|STARTED|Overall Study||6
11096948|NCT01210352|12280704|FG005|STARTED|Overall Study||6
11096949|NCT01210352|12280705|FG006|STARTED|Overall Study||7
11096950|NCT01210352|12280706|FG007|STARTED|Overall Study||10
11096951|NCT01210352|12280707|FG008|STARTED|Overall Study||6
11096952|NCT01210352|12280699|FG000|COMPLETED|Overall Study||6
11096953|NCT01210352|12280700|FG001|COMPLETED|Overall Study||6
11096954|NCT01210352|12280701|FG002|COMPLETED|Overall Study||5
11096955|NCT01210352|12280702|FG003|COMPLETED|Overall Study||7
11096956|NCT01210352|12280703|FG004|COMPLETED|Overall Study||6
11096957|NCT01210352|12280704|FG005|COMPLETED|Overall Study||6
11096958|NCT01210352|12280705|FG006|COMPLETED|Overall Study||5
11096959|NCT01210352|12280706|FG007|COMPLETED|Overall Study||7
11096960|NCT01210352|12280707|FG008|COMPLETED|Overall Study||2
11096961|NCT01210352|12280699|FG000|NOT COMPLETED|Overall Study||0
11096962|NCT01210352|12280700|FG001|NOT COMPLETED|Overall Study||0
11096963|NCT01210352|12280701|FG002|NOT COMPLETED|Overall Study||2
11096964|NCT01210352|12280702|FG003|NOT COMPLETED|Overall Study||0
11096965|NCT01210352|12280703|FG004|NOT COMPLETED|Overall Study||0
11096966|NCT01210352|12280704|FG005|NOT COMPLETED|Overall Study||0
11096967|NCT01210352|12280705|FG006|NOT COMPLETED|Overall Study||2
11096968|NCT01210352|12280706|FG007|NOT COMPLETED|Overall Study||3
11096969|NCT01210352|12280707|FG008|NOT COMPLETED|Overall Study||4
11096970|NCT01210443|12280812|FG000|STARTED|Overall Study||2
11096971|NCT01210443|12280812|FG000|COMPLETED|Overall Study||0
11096972|NCT01210443|12280812|FG000|NOT COMPLETED|Overall Study||2
11096973|NCT01210495|12280820|FG000|STARTED|Overall Study||15
11096974|NCT01210495|12280821|FG001|STARTED|Overall Study||7
11096975|NCT01210495|12280822|FG002|STARTED|Overall Study||134
11096976|NCT01210495|12280823|FG003|STARTED|Overall Study||68
11096977|NCT01210495|12280820|FG000|COMPLETED|Overall Study||0
11096978|NCT01210495|12280821|FG001|COMPLETED|Overall Study||0
11096979|NCT01210495|12280822|FG002|COMPLETED|Overall Study||0
11096980|NCT01210495|12280823|FG003|COMPLETED|Overall Study||0
11096981|NCT01210495|12280820|FG000|NOT COMPLETED|Overall Study||15
11096982|NCT01210495|12280821|FG001|NOT COMPLETED|Overall Study||7
11096983|NCT01210495|12280822|FG002|NOT COMPLETED|Overall Study||134
11096984|NCT01210495|12280823|FG003|NOT COMPLETED|Overall Study||68
11096985|NCT01210560|12280835|FG000|STARTED|Intervention 1 (7 Days)||2
11096986|NCT01210560|12280836|FG001|STARTED|Intervention 1 (7 Days)||2
11096987|NCT01210560|12280837|FG002|STARTED|Intervention 1 (7 Days)||2
11096988|NCT01210560|12280838|FG003|STARTED|Intervention 1 (7 Days)||2
11096989|NCT01210560|12280839|FG004|STARTED|Intervention 1 (7 Days)||2
11096990|NCT01210560|12280840|FG005|STARTED|Intervention 1 (7 Days)||2
11096991|NCT01210560|12280841|FG006|STARTED|Intervention 1 (7 Days)||4
11211665|NCT01903434|12402980|FG001|STARTED|Treatment Period 3||28
11211666|NCT01903434|12402979|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
11211667|NCT01903434|12402980|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
11211668|NCT01903434|12402979|FG000|COMPLETED|Treatment Period 3||29
11211669|NCT01903434|12402980|FG001|COMPLETED|Treatment Period 3||28
11211670|NCT01903434|12402979|FG000|NOT COMPLETED|Treatment Period 3||0
11211671|NCT01903434|12402980|FG001|NOT COMPLETED|Treatment Period 3||0
11211672|NCT01903460|12402990|FG000|STARTED|Overall Study||6
11211673|NCT01903460|12402991|FG001|STARTED|Overall Study||8
11211674|NCT01903460|12402992|FG002|STARTED|Overall Study||3
11211675|NCT01903460|12402993|FG003|STARTED|Overall Study||3
11211676|NCT01903460|12402990|FG000|COMPLETED|Overall Study||6
11211677|NCT01903460|12402991|FG001|COMPLETED|Overall Study||8
11211678|NCT01903460|12402992|FG002|COMPLETED|Overall Study||3
11211679|NCT01903460|12402993|FG003|COMPLETED|Overall Study||2
11211680|NCT01903460|12402990|FG000|NOT COMPLETED|Overall Study||0
11211681|NCT01903460|12402991|FG001|NOT COMPLETED|Overall Study||0
11211682|NCT01903460|12402992|FG002|NOT COMPLETED|Overall Study||0
11211683|NCT01903460|12402993|FG003|NOT COMPLETED|Overall Study||1
11211684|NCT01903525|12403004|FG000|STARTED|Overall Study||20
11211685|NCT01903525|12403005|FG001|STARTED|Overall Study||20
11211686|NCT01903525|12403004|FG000|COMPLETED|Overall Study||15
11211687|NCT01903525|12403005|FG001|COMPLETED|Overall Study||10
11096992|NCT01210560|12280842|FG007|STARTED|Intervention 1 (7 Days)||4
11211688|NCT01903525|12403004|FG000|NOT COMPLETED|Overall Study||5
11211689|NCT01903525|12403005|FG001|NOT COMPLETED|Overall Study||10
11211690|NCT01903564|12403013|FG000|STARTED|Overall Study||10
11211691|NCT01903564|12403014|FG001|STARTED|Overall Study||29
11211692|NCT01903564|12403013|FG000|COMPLETED|Overall Study||10
11211693|NCT01903564|12403014|FG001|COMPLETED|Overall Study||29
11211694|NCT01903564|12403013|FG000|NOT COMPLETED|Overall Study||0
11211695|NCT01903564|12403014|FG001|NOT COMPLETED|Overall Study||0
11211696|NCT01903720|12403020|FG000|STARTED|Overall Study||71
11211697|NCT01903720|12403020|FG000|COMPLETED|Overall Study||59
11211698|NCT01903720|12403020|FG000|NOT COMPLETED|Overall Study||12
11211699|NCT01903798|12403028|FG000|STARTED|Overall Study||2
11211700|NCT01903798|12403029|FG001|STARTED|Overall Study||0
11211701|NCT01903798|12403030|FG002|STARTED|Overall Study||1
11211702|NCT01903798|12403031|FG003|STARTED|Overall Study||1
11211703|NCT01903798|12403028|FG000|COMPLETED|Overall Study||2
11211704|NCT01903798|12403029|FG001|COMPLETED|Overall Study||0
11211705|NCT01903798|12403030|FG002|COMPLETED|Overall Study||1
11211706|NCT01903798|12403031|FG003|COMPLETED|Overall Study||1
11211707|NCT01903798|12403028|FG000|NOT COMPLETED|Overall Study||0
11211708|NCT01903798|12403029|FG001|NOT COMPLETED|Overall Study||0
11211709|NCT01903798|12403030|FG002|NOT COMPLETED|Overall Study||0
11211710|NCT01903798|12403031|FG003|NOT COMPLETED|Overall Study||0
11211711|NCT01903811|12403043|FG000|STARTED|Overall Study||72
11211712|NCT01903811|12403044|FG001|STARTED|Overall Study||71
11211713|NCT01903811|12403043|FG000|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16
11211714|NCT01903811|12403044|FG001|Crossover to Arm II|Overall Study||0
11211715|NCT01903811|12403043|FG000|COMPLETED|Overall Study||64
11211716|NCT01903811|12403044|FG001|COMPLETED|Overall Study||57
11211717|NCT01903811|12403043|FG000|NOT COMPLETED|Overall Study||8
11211718|NCT01903811|12403044|FG001|NOT COMPLETED|Overall Study||14
11211719|NCT01903837|12403057|FG000|STARTED|Part A||75
11211720|NCT01903837|12403058|FG001|STARTED|Part A||80
11211721|NCT01903837|12403059|FG002|STARTED|Part A||86
11211722|NCT01903837|12403060|FG003|STARTED|Part A||68
11211723|NCT01903837|12403057|FG000|COMPLETED|Part A||56
11211724|NCT01903837|12403058|FG001|COMPLETED|Part A||52
11211725|NCT01903837|12403059|FG002|COMPLETED|Part A||58
11211726|NCT01903837|12403060|FG003|COMPLETED|Part A||55
11211727|NCT01903837|12403057|FG000|NOT COMPLETED|Part A||19
11211728|NCT01903837|12403058|FG001|NOT COMPLETED|Part A||28
11211729|NCT01903837|12403059|FG002|NOT COMPLETED|Part A||28
11211730|NCT01903837|12403060|FG003|NOT COMPLETED|Part A||13
11211731|NCT01903837|12403057|FG000|STARTED|Part B||54
11211732|NCT01903837|12403058|FG001|STARTED|Part B||52
11211733|NCT01903837|12403059|FG002|STARTED|Part B||57
11211734|NCT01903837|12403060|FG003|STARTED|Part B||55
11211735|NCT01903837|12403057|FG000|COMPLETED|Part B||45
11211736|NCT01903837|12403058|FG001|COMPLETED|Part B||46
11211737|NCT01903837|12403059|FG002|COMPLETED|Part B||52
11211738|NCT01903837|12403060|FG003|COMPLETED|Part B||44
11211739|NCT01903837|12403057|FG000|NOT COMPLETED|Part B||9
11211740|NCT01903837|12403058|FG001|NOT COMPLETED|Part B||6
11211741|NCT01903837|12403059|FG002|NOT COMPLETED|Part B||5
11211742|NCT01903837|12403060|FG003|NOT COMPLETED|Part B||11
11211743|NCT01903863|12403093|FG000|STARTED|Overall Study||15
11211744|NCT01903863|12403094|FG001|STARTED|Overall Study||16
11211745|NCT01903863|12403093|FG000|COMPLETED|Overall Study||13
11211746|NCT01903863|12403094|FG001|COMPLETED|Overall Study||16
11211747|NCT01903863|12403093|FG000|NOT COMPLETED|Overall Study||2
11211748|NCT01903863|12403094|FG001|NOT COMPLETED|Overall Study||0
11211749|NCT01903876|12403102|FG000|STARTED|Baseline to Post-Intervention Period||367
11211750|NCT01903876|12403103|FG001|STARTED|Baseline to Post-Intervention Period||376
11211751|NCT01903876|12403102|FG000|COMPLETED|Baseline to Post-Intervention Period||183
11211752|NCT01903876|12403103|FG001|COMPLETED|Baseline to Post-Intervention Period||268
11211753|NCT01903876|12403102|FG000|NOT COMPLETED|Baseline to Post-Intervention Period||184
11211754|NCT01903876|12403103|FG001|NOT COMPLETED|Baseline to Post-Intervention Period||108
11211755|NCT01903876|12403102|FG000|STARTED|Six-Month Follow-up Period||183
11211756|NCT01903876|12403103|FG001|STARTED|Six-Month Follow-up Period||268
11211757|NCT01903876|12403102|FG000|COMPLETED|Six-Month Follow-up Period||92
11211758|NCT01903876|12403103|FG001|COMPLETED|Six-Month Follow-up Period||123
11211759|NCT01903876|12403102|FG000|NOT COMPLETED|Six-Month Follow-up Period||91
11211760|NCT01903876|12403103|FG001|NOT COMPLETED|Six-Month Follow-up Period||145
11211761|NCT01903993|12403111|FG000|STARTED|Overall Study||143
11211762|NCT01903993|12403112|FG001|STARTED|Overall Study||144
11211763|NCT01903993|12403111|FG000|Received Treatment|Overall Study||135
11211764|NCT01903993|12403112|FG001|Received Treatment|Overall Study||142
11211765|NCT01903993|12403111|FG000|COMPLETED|Overall Study||0
11211766|NCT01903993|12403112|FG001|COMPLETED|Overall Study||0
11211767|NCT01903993|12403111|FG000|NOT COMPLETED|Overall Study||143
11211768|NCT01903993|12403112|FG001|NOT COMPLETED|Overall Study||144
11211769|NCT01904019|12403119|FG000|STARTED|Pre-operative||95
11211770|NCT01904019|12403119|FG000|COMPLETED|Pre-operative||95
11211771|NCT01904019|12403119|FG000|NOT COMPLETED|Pre-operative||0
11211772|NCT01904019|12403119|FG000|STARTED|1 Year Follow-up||95
11211773|NCT01904019|12403119|FG000|COMPLETED|1 Year Follow-up||86
11211774|NCT01904019|12403119|FG000|NOT COMPLETED|1 Year Follow-up||9
11211775|NCT01904019|12403119|FG000|STARTED|3 Year Follow-up||86
11211776|NCT01904019|12403119|FG000|COMPLETED|3 Year Follow-up||71
11211777|NCT01904019|12403119|FG000|NOT COMPLETED|3 Year Follow-up||15
11211778|NCT01904019|12403119|FG000|STARTED|5 Year Follow-up||71
11211779|NCT01904019|12403119|FG000|COMPLETED|5 Year Follow-up||65
11211780|NCT01904019|12403119|FG000|NOT COMPLETED|5 Year Follow-up||6
11211781|NCT01904058|12403127|FG000|STARTED|Overall Study||21
11211782|NCT01904058|12403128|FG001|STARTED|Overall Study||21
11211783|NCT01904058|12403129|FG002|STARTED|Overall Study||11
11211784|NCT01904058|12403130|FG003|STARTED|Overall Study||13
11211785|NCT01904058|12403127|FG000|COMPLETED|Overall Study||18
11211786|NCT01904058|12403128|FG001|COMPLETED|Overall Study||21
11211787|NCT01904058|12403129|FG002|COMPLETED|Overall Study||10
11211788|NCT01904058|12403130|FG003|COMPLETED|Overall Study||12
11211789|NCT01904058|12403127|FG000|NOT COMPLETED|Overall Study||3
11211790|NCT01904058|12403128|FG001|NOT COMPLETED|Overall Study||0
11211791|NCT01904058|12403129|FG002|NOT COMPLETED|Overall Study||1
11211792|NCT01904058|12403130|FG003|NOT COMPLETED|Overall Study||1
11211793|NCT01904071|12403149|FG000|STARTED|Overall Study||24
11211794|NCT01904071|12403150|FG001|STARTED|Overall Study||20
11211795|NCT01904071|12403151|FG002|STARTED|Overall Study||20
11211796|NCT01904071|12403149|FG000|COMPLETED|Overall Study||24
11211797|NCT01904071|12403150|FG001|COMPLETED|Overall Study||20
11211798|NCT01904071|12403151|FG002|COMPLETED|Overall Study||20
11211799|NCT01904071|12403149|FG000|NOT COMPLETED|Overall Study||0
11211800|NCT01904071|12403150|FG001|NOT COMPLETED|Overall Study||0
11211801|NCT01904071|12403151|FG002|NOT COMPLETED|Overall Study||0
11211802|NCT01904149|12403165|FG000|STARTED|Overall Study||152
11211803|NCT01904149|12403166|FG001|STARTED|Overall Study||151
11211804|NCT01904149|12403167|FG002|STARTED|Overall Study||150
11211805|NCT01904149|12403168|FG003|STARTED|Overall Study||51
11211806|NCT01904149|12403169|FG004|STARTED|Overall Study||51
11211807|NCT01904149|12403170|FG005|STARTED|Overall Study||51
11211808|NCT01904149|12403165|FG000|Single-dose Phase|Overall Study||152
11211809|NCT01904149|12403166|FG001|Single-dose Phase|Overall Study||151
11211810|NCT01904149|12403167|FG002|Single-dose Phase|Overall Study||150
11211811|NCT01904149|12403168|FG003|Single-dose Phase|Overall Study||51
11211812|NCT01904149|12403169|FG004|Single-dose Phase|Overall Study||51
11211813|NCT01904149|12403170|FG005|Single-dose Phase|Overall Study||51
11211814|NCT01904149|12403165|FG000|Multiple-dose Phase|Overall Study||150
11211815|NCT01904149|12403166|FG001|Multiple-dose Phase|Overall Study||146
11211816|NCT01904149|12403167|FG002|Multiple-dose Phase|Overall Study||149
11211817|NCT01904149|12403168|FG003|Multiple-dose Phase|Overall Study||48
11211818|NCT01904149|12403169|FG004|Multiple-dose Phase|Overall Study||48
11211819|NCT01904149|12403170|FG005|Multiple-dose Phase|Overall Study||49
11211820|NCT01904149|12403165|FG000|COMPLETED|Overall Study||147
11211821|NCT01904149|12403166|FG001|COMPLETED|Overall Study||140
11211822|NCT01904149|12403167|FG002|COMPLETED|Overall Study||148
11211823|NCT01904149|12403168|FG003|COMPLETED|Overall Study||47
11211824|NCT01904149|12403169|FG004|COMPLETED|Overall Study||46
11211825|NCT01904149|12403170|FG005|COMPLETED|Overall Study||48
11211826|NCT01904149|12403165|FG000|NOT COMPLETED|Overall Study||5
11211827|NCT01904149|12403166|FG001|NOT COMPLETED|Overall Study||11
11211828|NCT01904149|12403167|FG002|NOT COMPLETED|Overall Study||2
11211829|NCT01904149|12403168|FG003|NOT COMPLETED|Overall Study||4
11211830|NCT01904149|12403169|FG004|NOT COMPLETED|Overall Study||5
11211831|NCT01904149|12403170|FG005|NOT COMPLETED|Overall Study||3
11211832|NCT01904383|12403186|FG000|STARTED|Overall Study||4057
11211833|NCT01904383|12403186|FG000|Treated|Overall Study||3940
11211834|NCT01904383|12403186|FG000|COMPLETED|Overall Study||2283
11211835|NCT01904383|12403186|FG000|NOT COMPLETED|Overall Study||1774
11211836|NCT01904448|12403190|FG000|STARTED|Overall Study||5
11211837|NCT01904448|12403190|FG000|COMPLETED|Overall Study||5
11211838|NCT01904448|12403190|FG000|NOT COMPLETED|Overall Study||0
11211839|NCT01904526|12403195|FG000|STARTED|Overall Study||5
11211840|NCT01904526|12403195|FG000|COMPLETED|Overall Study||5
11211841|NCT01904526|12403195|FG000|NOT COMPLETED|Overall Study||0
11211842|NCT01904604|12403206|FG000|STARTED|Overall Study||25
11211843|NCT01904604|12403207|FG001|STARTED|Overall Study||25
11211844|NCT01904604|12403208|FG002|STARTED|Overall Study||25
11211845|NCT01904604|12403206|FG000|Completed Week 52 OFC|Overall Study||22
11211846|NCT01904604|12403207|FG001|Completed Week 52 OFC|Overall Study||21
11096993|NCT01210560|12280843|FG008|STARTED|Intervention 1 (7 Days)||5
11096994|NCT01210560|12280835|FG000|COMPLETED|Intervention 1 (7 Days)||2
11096995|NCT01210560|12280836|FG001|COMPLETED|Intervention 1 (7 Days)||2
11096996|NCT01210560|12280837|FG002|COMPLETED|Intervention 1 (7 Days)||2
11096997|NCT01210560|12280838|FG003|COMPLETED|Intervention 1 (7 Days)||2
11096998|NCT01210560|12280839|FG004|COMPLETED|Intervention 1 (7 Days)||2
11096999|NCT01210560|12280840|FG005|COMPLETED|Intervention 1 (7 Days)||2
11097000|NCT01210560|12280841|FG006|COMPLETED|Intervention 1 (7 Days)||4
11097001|NCT01210560|12280842|FG007|COMPLETED|Intervention 1 (7 Days)||4
11097002|NCT01210560|12280843|FG008|COMPLETED|Intervention 1 (7 Days)||5
11097003|NCT01210560|12280835|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0
11097004|NCT01210560|12280836|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0
11097005|NCT01210560|12280837|FG002|NOT COMPLETED|Intervention 1 (7 Days)||0
11097006|NCT01210560|12280838|FG003|NOT COMPLETED|Intervention 1 (7 Days)||0
11097007|NCT01210560|12280839|FG004|NOT COMPLETED|Intervention 1 (7 Days)||0
11097008|NCT01210560|12280840|FG005|NOT COMPLETED|Intervention 1 (7 Days)||0
11097009|NCT01210560|12280841|FG006|NOT COMPLETED|Intervention 1 (7 Days)||0
11097010|NCT01210560|12280842|FG007|NOT COMPLETED|Intervention 1 (7 Days)||0
11097011|NCT01210560|12280843|FG008|NOT COMPLETED|Intervention 1 (7 Days)||0
11097012|NCT01210560|12280835|FG000|STARTED|Intervention 2 (7 Days)||2
11097013|NCT01210560|12280836|FG001|STARTED|Intervention 2 (7 Days)||2
11097014|NCT01210560|12280837|FG002|STARTED|Intervention 2 (7 Days)||2
11097015|NCT01210560|12280838|FG003|STARTED|Intervention 2 (7 Days)||2
11097016|NCT01210560|12280839|FG004|STARTED|Intervention 2 (7 Days)||2
11097017|NCT01210560|12280840|FG005|STARTED|Intervention 2 (7 Days)||2
11097018|NCT01210560|12280841|FG006|STARTED|Intervention 2 (7 Days)||4
11097019|NCT01210560|12280842|FG007|STARTED|Intervention 2 (7 Days)||4
11097020|NCT01210560|12280843|FG008|STARTED|Intervention 2 (7 Days)||5
11097021|NCT01210560|12280835|FG000|COMPLETED|Intervention 2 (7 Days)||2
11097022|NCT01210560|12280836|FG001|COMPLETED|Intervention 2 (7 Days)||2
11097023|NCT01210560|12280837|FG002|COMPLETED|Intervention 2 (7 Days)||2
11097024|NCT01210560|12280838|FG003|COMPLETED|Intervention 2 (7 Days)||2
11097025|NCT01210560|12280839|FG004|COMPLETED|Intervention 2 (7 Days)||2
11097026|NCT01210560|12280840|FG005|COMPLETED|Intervention 2 (7 Days)||2
11097027|NCT01210560|12280841|FG006|COMPLETED|Intervention 2 (7 Days)||4
11097028|NCT01210560|12280842|FG007|COMPLETED|Intervention 2 (7 Days)||4
11097029|NCT01210560|12280843|FG008|COMPLETED|Intervention 2 (7 Days)||5
11097030|NCT01210560|12280835|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0
11097031|NCT01210560|12280836|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0
11097032|NCT01210560|12280837|FG002|NOT COMPLETED|Intervention 2 (7 Days)||0
11097033|NCT01210560|12280838|FG003|NOT COMPLETED|Intervention 2 (7 Days)||0
11097034|NCT01210560|12280839|FG004|NOT COMPLETED|Intervention 2 (7 Days)||0
11211847|NCT01904604|12403208|FG002|Completed Week 52 OFC|Overall Study||25
11097035|NCT01210560|12280840|FG005|NOT COMPLETED|Intervention 2 (7 Days)||0
11097036|NCT01210560|12280841|FG006|NOT COMPLETED|Intervention 2 (7 Days)||0
11097037|NCT01210560|12280842|FG007|NOT COMPLETED|Intervention 2 (7 Days)||0
11097038|NCT01210560|12280843|FG008|NOT COMPLETED|Intervention 2 (7 Days)||0
11097039|NCT01210560|12280835|FG000|STARTED|Intervention 3 (7 Days)||2
11097040|NCT01210560|12280836|FG001|STARTED|Intervention 3 (7 Days)||2
11097041|NCT01210560|12280837|FG002|STARTED|Intervention 3 (7 Days)||2
11097042|NCT01210560|12280838|FG003|STARTED|Intervention 3 (7 Days)||2
11097043|NCT01210560|12280839|FG004|STARTED|Intervention 3 (7 Days)||2
11097044|NCT01210560|12280840|FG005|STARTED|Intervention 3 (7 Days)||2
11211848|NCT01904604|12403206|FG000|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20
11211849|NCT01904604|12403207|FG001|Began Crossover Treatment|Overall Study||21
11097045|NCT01210560|12280841|FG006|STARTED|Intervention 3 (7 Days)||4
11211850|NCT01904604|12403208|FG002|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0
11211851|NCT01904604|12403206|FG000|Completed Week 130 OFC|Overall Study||18
11211852|NCT01904604|12403207|FG001|Completed Week 130 OFC|Overall Study||18
11211853|NCT01904604|12403208|FG002|Completed Week 130 OFC|Overall Study||23
11211854|NCT01904604|12403206|FG000|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
11211855|NCT01904604|12403207|FG001|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
11211856|NCT01904604|12403208|FG002|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23
11211857|NCT01904604|12403206|FG000|NOT COMPLETED|Overall Study||7
11211858|NCT01904604|12403207|FG001|NOT COMPLETED|Overall Study||7
11352602|NCT03049488|12549656|FG000|Received First Product Administration|Overall Study||15
11352603|NCT03049488|12549657|FG001|Received First Product Administration|Overall Study||15
11352604|NCT03049488|12549658|FG002|Received First Product Administration|Overall Study||20
11352605|NCT03049488|12549659|FG003|Received First Product Administration|Overall Study||15
11352606|NCT03049488|12549660|FG004|Received First Product Administration|Overall Study||15
11352607|NCT03049488|12549661|FG005|Received First Product Administration|Overall Study||15
11352608|NCT03049488|12549656|FG000|Received Optional Second Dose|Overall Study||10
11211859|NCT01904604|12403208|FG002|NOT COMPLETED|Overall Study||2
11211860|NCT01904721|12403226|FG000|STARTED|Overall Study||13
11211861|NCT01904721|12403227|FG001|STARTED|Overall Study||13
11211862|NCT01904721|12403228|FG002|STARTED|Overall Study||12
11211863|NCT01904721|12403229|FG003|STARTED|Overall Study||12
11211864|NCT01904721|12403230|FG004|STARTED|Overall Study||65
11211865|NCT01904721|12403231|FG005|STARTED|Overall Study||65
11211866|NCT01904721|12403232|FG006|STARTED|Overall Study||64
11211867|NCT01904721|12403226|FG000|COMPLETED|Overall Study||13
11211868|NCT01904721|12403227|FG001|COMPLETED|Overall Study||13
11211869|NCT01904721|12403228|FG002|COMPLETED|Overall Study||11
11211870|NCT01904721|12403229|FG003|COMPLETED|Overall Study||11
11211871|NCT01904721|12403230|FG004|COMPLETED|Overall Study||57
11211872|NCT01904721|12403231|FG005|COMPLETED|Overall Study||56
11211873|NCT01904721|12403232|FG006|COMPLETED|Overall Study||57
11211874|NCT01904721|12403226|FG000|NOT COMPLETED|Overall Study||0
11211875|NCT01904721|12403227|FG001|NOT COMPLETED|Overall Study||0
11211876|NCT01904721|12403228|FG002|NOT COMPLETED|Overall Study||1
11211877|NCT01904721|12403229|FG003|NOT COMPLETED|Overall Study||1
11211878|NCT01904721|12403230|FG004|NOT COMPLETED|Overall Study||8
11211879|NCT01904721|12403231|FG005|NOT COMPLETED|Overall Study||9
11211880|NCT01904721|12403232|FG006|NOT COMPLETED|Overall Study||7
11211881|NCT01904760|12403246|FG000|STARTED|Overall Study||40
11211882|NCT01904760|12403247|FG001|STARTED|Overall Study||40
11211883|NCT01904760|12403246|FG000|COMPLETED|Overall Study||39
11211884|NCT01904760|12403247|FG001|COMPLETED|Overall Study||40
11211885|NCT01904760|12403246|FG000|NOT COMPLETED|Overall Study||1
11211886|NCT01904760|12403247|FG001|NOT COMPLETED|Overall Study||0
11211887|NCT01904773|12403253|FG000|STARTED|Screen||28
11211888|NCT01904773|12403254|FG001|STARTED|Screen||0
11211889|NCT01904773|12403255|FG002|STARTED|Screen||0
11211890|NCT01904773|12403256|FG003|STARTED|Screen||0
11211891|NCT01904773|12403257|FG004|STARTED|Screen||0
11211892|NCT01904773|12403258|FG005|STARTED|Screen||0
11211893|NCT01904773|12403259|FG006|STARTED|Screen||0
11097046|NCT01210560|12280842|FG007|STARTED|Intervention 3 (7 Days)||4
11097047|NCT01210560|12280843|FG008|STARTED|Intervention 3 (7 Days)||5
11097048|NCT01210560|12280835|FG000|COMPLETED|Intervention 3 (7 Days)||2
11097049|NCT01210560|12280836|FG001|COMPLETED|Intervention 3 (7 Days)||2
11097050|NCT01210560|12280837|FG002|COMPLETED|Intervention 3 (7 Days)||2
11097051|NCT01210560|12280838|FG003|COMPLETED|Intervention 3 (7 Days)||2
11097052|NCT01210560|12280839|FG004|COMPLETED|Intervention 3 (7 Days)||2
11097053|NCT01210560|12280840|FG005|COMPLETED|Intervention 3 (7 Days)||2
11097054|NCT01210560|12280841|FG006|COMPLETED|Intervention 3 (7 Days)||4
11097055|NCT01210560|12280842|FG007|COMPLETED|Intervention 3 (7 Days)||4
11097056|NCT01210560|12280843|FG008|COMPLETED|Intervention 3 (7 Days)||5
11097057|NCT01210560|12280835|FG000|NOT COMPLETED|Intervention 3 (7 Days)||0
11097058|NCT01210560|12280836|FG001|NOT COMPLETED|Intervention 3 (7 Days)||0
11097059|NCT01210560|12280837|FG002|NOT COMPLETED|Intervention 3 (7 Days)||0
11097060|NCT01210560|12280838|FG003|NOT COMPLETED|Intervention 3 (7 Days)||0
11097061|NCT01210560|12280839|FG004|NOT COMPLETED|Intervention 3 (7 Days)||0
11097062|NCT01210560|12280840|FG005|NOT COMPLETED|Intervention 3 (7 Days)||0
11097063|NCT01210560|12280841|FG006|NOT COMPLETED|Intervention 3 (7 Days)||0
11097064|NCT01210560|12280842|FG007|NOT COMPLETED|Intervention 3 (7 Days)||0
11097065|NCT01210560|12280843|FG008|NOT COMPLETED|Intervention 3 (7 Days)||0
11097066|NCT01210651|12280858|FG000|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
11097067|NCT01210651|12280859|FG001|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
11097068|NCT01210651|12280858|FG000|Number Attending 1st Assigned Session|Overall Study||18
11097069|NCT01210651|12280859|FG001|Number Attending 1st Assigned Session|Overall Study||12
11097070|NCT01210651|12280858|FG000|COMPLETED|Overall Study||15
11097071|NCT01210651|12280859|FG001|COMPLETED|Overall Study||10
11097072|NCT01210651|12280858|FG000|NOT COMPLETED|Overall Study||5
11097073|NCT01210651|12280859|FG001|NOT COMPLETED|Overall Study||8
11097074|NCT01210664|12280869|FG000|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
11097075|NCT01210664|12280870|FG001|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
11097076|NCT01210664|12280871|FG002|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
11211894|NCT01904773|12403260|FG007|STARTED|Screen||0
11211895|NCT01904773|12403261|FG008|STARTED|Screen||0
11211896|NCT01904773|12403253|FG000|COMPLETED|Screen||24
11211897|NCT01904773|12403254|FG001|COMPLETED|Screen||0
11211898|NCT01904773|12403255|FG002|COMPLETED|Screen||0
11211899|NCT01904773|12403256|FG003|COMPLETED|Screen||0
11211900|NCT01904773|12403257|FG004|COMPLETED|Screen||0
11211901|NCT01904773|12403258|FG005|COMPLETED|Screen||0
11211902|NCT01904773|12403259|FG006|COMPLETED|Screen||0
11211903|NCT01904773|12403260|FG007|COMPLETED|Screen||0
11211904|NCT01904773|12403261|FG008|COMPLETED|Screen||0
11211905|NCT01904773|12403253|FG000|NOT COMPLETED|Screen||4
11211906|NCT01904773|12403254|FG001|NOT COMPLETED|Screen||0
11211907|NCT01904773|12403255|FG002|NOT COMPLETED|Screen||0
11211908|NCT01904773|12403256|FG003|NOT COMPLETED|Screen||0
11211909|NCT01904773|12403257|FG004|NOT COMPLETED|Screen||0
11211910|NCT01904773|12403258|FG005|NOT COMPLETED|Screen||0
11211911|NCT01904773|12403259|FG006|NOT COMPLETED|Screen||0
11211912|NCT01904773|12403260|FG007|NOT COMPLETED|Screen||0
11211913|NCT01904773|12403261|FG008|NOT COMPLETED|Screen||0
11211914|NCT01904773|12403253|FG000|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
11211915|NCT01904773|12403254|FG001|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211916|NCT01904773|12403255|FG002|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211917|NCT01904773|12403256|FG003|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211918|NCT01904773|12403257|FG004|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211919|NCT01904773|12403258|FG005|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211920|NCT01904773|12403259|FG006|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211921|NCT01904773|12403260|FG007|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211922|NCT01904773|12403261|FG008|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211923|NCT01904773|12403253|FG000|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
11211924|NCT01904773|12403254|FG001|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211925|NCT01904773|12403255|FG002|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211926|NCT01904773|12403256|FG003|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211927|NCT01904773|12403257|FG004|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211928|NCT01904773|12403258|FG005|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211929|NCT01904773|12403259|FG006|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211930|NCT01904773|12403260|FG007|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211931|NCT01904773|12403261|FG008|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211932|NCT01904773|12403253|FG000|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211933|NCT01904773|12403254|FG001|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211934|NCT01904773|12403255|FG002|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211935|NCT01904773|12403256|FG003|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211936|NCT01904773|12403257|FG004|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211937|NCT01904773|12403258|FG005|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211938|NCT01904773|12403259|FG006|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211939|NCT01904773|12403260|FG007|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211940|NCT01904773|12403261|FG008|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
11211941|NCT01904773|12403253|FG000|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
11211942|NCT01904773|12403254|FG001|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211943|NCT01904773|12403255|FG002|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211944|NCT01904773|12403256|FG003|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211945|NCT01904773|12403257|FG004|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211946|NCT01904773|12403258|FG005|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211947|NCT01904773|12403259|FG006|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211948|NCT01904773|12403260|FG007|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211949|NCT01904773|12403261|FG008|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211950|NCT01904773|12403253|FG000|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
11211951|NCT01904773|12403254|FG001|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211952|NCT01904773|12403255|FG002|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211953|NCT01904773|12403256|FG003|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211954|NCT01904773|12403257|FG004|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211955|NCT01904773|12403258|FG005|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211956|NCT01904773|12403259|FG006|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211957|NCT01904773|12403260|FG007|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211958|NCT01904773|12403261|FG008|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211959|NCT01904773|12403253|FG000|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
11211960|NCT01904773|12403254|FG001|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211961|NCT01904773|12403255|FG002|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211962|NCT01904773|12403256|FG003|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211963|NCT01904773|12403257|FG004|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211964|NCT01904773|12403258|FG005|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211965|NCT01904773|12403259|FG006|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211966|NCT01904773|12403260|FG007|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211967|NCT01904773|12403261|FG008|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211968|NCT01904773|12403253|FG000|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
11211969|NCT01904773|12403254|FG001|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211970|NCT01904773|12403255|FG002|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211971|NCT01904773|12403256|FG003|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211972|NCT01904773|12403257|FG004|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211973|NCT01904773|12403258|FG005|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211974|NCT01904773|12403259|FG006|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211975|NCT01904773|12403260|FG007|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211976|NCT01904773|12403261|FG008|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211977|NCT01904773|12403253|FG000|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
11211978|NCT01904773|12403254|FG001|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211979|NCT01904773|12403255|FG002|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11097077|NCT01210664|12280872|FG003|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
11097078|NCT01210664|12280869|FG000|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
11097079|NCT01210664|12280870|FG001|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
11097080|NCT01210664|12280871|FG002|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
11097081|NCT01210664|12280872|FG003|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
11097082|NCT01210664|12280869|FG000|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
11097083|NCT01210664|12280870|FG001|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
11211980|NCT01904773|12403256|FG003|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211981|NCT01904773|12403257|FG004|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211982|NCT01904773|12403258|FG005|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211983|NCT01904773|12403259|FG006|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211984|NCT01904773|12403260|FG007|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211985|NCT01904773|12403261|FG008|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
11211986|NCT01904773|12403253|FG000|STARTED|First Intervention||0
11211987|NCT01904773|12403254|FG001|STARTED|First Intervention||2
11211988|NCT01904773|12403255|FG002|STARTED|First Intervention||1
11211989|NCT01904773|12403256|FG003|STARTED|First Intervention||2
11211990|NCT01904773|12403257|FG004|STARTED|First Intervention||3
11211991|NCT01904773|12403258|FG005|STARTED|First Intervention||4
11211992|NCT01904773|12403259|FG006|STARTED|First Intervention||4
11211993|NCT01904773|12403260|FG007|STARTED|First Intervention||3
11211994|NCT01904773|12403261|FG008|STARTED|First Intervention||4
11211995|NCT01904773|12403253|FG000|COMPLETED|First Intervention||0
11211996|NCT01904773|12403254|FG001|COMPLETED|First Intervention||2
11211997|NCT01904773|12403255|FG002|COMPLETED|First Intervention||1
11097084|NCT01210664|12280871|FG002|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
11097085|NCT01210664|12280872|FG003|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
11097086|NCT01210664|12280869|FG000|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
11097087|NCT01210664|12280870|FG001|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
11211998|NCT01904773|12403256|FG003|COMPLETED|First Intervention||2
11211999|NCT01904773|12403257|FG004|COMPLETED|First Intervention||3
11212000|NCT01904773|12403258|FG005|COMPLETED|First Intervention||4
11212001|NCT01904773|12403259|FG006|COMPLETED|First Intervention||3
11212002|NCT01904773|12403260|FG007|COMPLETED|First Intervention||3
11212003|NCT01904773|12403261|FG008|COMPLETED|First Intervention||4
11212004|NCT01904773|12403253|FG000|NOT COMPLETED|First Intervention||0
11212005|NCT01904773|12403254|FG001|NOT COMPLETED|First Intervention||0
11212006|NCT01904773|12403255|FG002|NOT COMPLETED|First Intervention||0
11212007|NCT01904773|12403256|FG003|NOT COMPLETED|First Intervention||0
11212008|NCT01904773|12403257|FG004|NOT COMPLETED|First Intervention||0
11212009|NCT01904773|12403258|FG005|NOT COMPLETED|First Intervention||0
11212010|NCT01904773|12403259|FG006|NOT COMPLETED|First Intervention||1
11212011|NCT01904773|12403260|FG007|NOT COMPLETED|First Intervention||0
11212012|NCT01904773|12403261|FG008|NOT COMPLETED|First Intervention||0
11212013|NCT01904773|12403253|FG000|STARTED|Placebo Washout First Intervention||0
11212014|NCT01904773|12403254|FG001|STARTED|Placebo Washout First Intervention||2
11212015|NCT01904773|12403255|FG002|STARTED|Placebo Washout First Intervention||1
11212016|NCT01904773|12403256|FG003|STARTED|Placebo Washout First Intervention||2
11212017|NCT01904773|12403257|FG004|STARTED|Placebo Washout First Intervention||3
11212018|NCT01904773|12403258|FG005|STARTED|Placebo Washout First Intervention||4
11212019|NCT01904773|12403259|FG006|STARTED|Placebo Washout First Intervention||3
11212020|NCT01904773|12403260|FG007|STARTED|Placebo Washout First Intervention||3
11212021|NCT01904773|12403261|FG008|STARTED|Placebo Washout First Intervention||4
11212022|NCT01904773|12403253|FG000|COMPLETED|Placebo Washout First Intervention||0
11212023|NCT01904773|12403254|FG001|COMPLETED|Placebo Washout First Intervention||1
11212024|NCT01904773|12403255|FG002|COMPLETED|Placebo Washout First Intervention||1
11212025|NCT01904773|12403256|FG003|COMPLETED|Placebo Washout First Intervention||2
11212026|NCT01904773|12403257|FG004|COMPLETED|Placebo Washout First Intervention||3
11212027|NCT01904773|12403258|FG005|COMPLETED|Placebo Washout First Intervention||4
11212028|NCT01904773|12403259|FG006|COMPLETED|Placebo Washout First Intervention||3
11212029|NCT01904773|12403260|FG007|COMPLETED|Placebo Washout First Intervention||3
11212030|NCT01904773|12403261|FG008|COMPLETED|Placebo Washout First Intervention||4
11212031|NCT01904773|12403253|FG000|NOT COMPLETED|Placebo Washout First Intervention||0
11212032|NCT01904773|12403254|FG001|NOT COMPLETED|Placebo Washout First Intervention||1
11212033|NCT01904773|12403255|FG002|NOT COMPLETED|Placebo Washout First Intervention||0
11212034|NCT01904773|12403256|FG003|NOT COMPLETED|Placebo Washout First Intervention||0
11212035|NCT01904773|12403257|FG004|NOT COMPLETED|Placebo Washout First Intervention||0
11212036|NCT01904773|12403258|FG005|NOT COMPLETED|Placebo Washout First Intervention||0
11212037|NCT01904773|12403259|FG006|NOT COMPLETED|Placebo Washout First Intervention||0
11212038|NCT01904773|12403260|FG007|NOT COMPLETED|Placebo Washout First Intervention||0
11212039|NCT01904773|12403261|FG008|NOT COMPLETED|Placebo Washout First Intervention||0
11212040|NCT01904773|12403253|FG000|STARTED|Second Intervention||0
11212041|NCT01904773|12403254|FG001|STARTED|Second Intervention||1
11212042|NCT01904773|12403255|FG002|STARTED|Second Intervention||1
11212043|NCT01904773|12403256|FG003|STARTED|Second Intervention||2
11212044|NCT01904773|12403257|FG004|STARTED|Second Intervention||3
11212045|NCT01904773|12403258|FG005|STARTED|Second Intervention||4
11212046|NCT01904773|12403259|FG006|STARTED|Second Intervention||3
11212047|NCT01904773|12403260|FG007|STARTED|Second Intervention||3
11212048|NCT01904773|12403261|FG008|STARTED|Second Intervention||4
11212049|NCT01904773|12403253|FG000|COMPLETED|Second Intervention||0
11212050|NCT01904773|12403254|FG001|COMPLETED|Second Intervention||1
11212051|NCT01904773|12403255|FG002|COMPLETED|Second Intervention||1
11212052|NCT01904773|12403256|FG003|COMPLETED|Second Intervention||2
11212053|NCT01904773|12403257|FG004|COMPLETED|Second Intervention||3
11212054|NCT01904773|12403258|FG005|COMPLETED|Second Intervention||4
11212055|NCT01904773|12403259|FG006|COMPLETED|Second Intervention||3
11212056|NCT01904773|12403260|FG007|COMPLETED|Second Intervention||3
11212057|NCT01904773|12403261|FG008|COMPLETED|Second Intervention||4
11097088|NCT01210664|12280871|FG002|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
11097089|NCT01210664|12280872|FG003|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
11097090|NCT01210664|12280869|FG000|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
11097091|NCT01210664|12280870|FG001|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
11097092|NCT01210664|12280871|FG002|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
11097093|NCT01210664|12280872|FG003|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
11097094|NCT01210664|12280869|FG000|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
11097095|NCT01210664|12280870|FG001|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
11097096|NCT01210664|12280871|FG002|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
11097097|NCT01210664|12280872|FG003|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
11212058|NCT01904773|12403253|FG000|NOT COMPLETED|Second Intervention||0
11212059|NCT01904773|12403254|FG001|NOT COMPLETED|Second Intervention||0
11212060|NCT01904773|12403255|FG002|NOT COMPLETED|Second Intervention||0
11212061|NCT01904773|12403256|FG003|NOT COMPLETED|Second Intervention||0
11212062|NCT01904773|12403257|FG004|NOT COMPLETED|Second Intervention||0
11212063|NCT01904773|12403258|FG005|NOT COMPLETED|Second Intervention||0
11212064|NCT01904773|12403259|FG006|NOT COMPLETED|Second Intervention||0
11212065|NCT01904773|12403260|FG007|NOT COMPLETED|Second Intervention||0
11212066|NCT01904773|12403261|FG008|NOT COMPLETED|Second Intervention||0
11212067|NCT01904773|12403253|FG000|STARTED|Placebo Washout Second Intervention||0
11212068|NCT01904773|12403254|FG001|STARTED|Placebo Washout Second Intervention||1
11212069|NCT01904773|12403255|FG002|STARTED|Placebo Washout Second Intervention||1
11212070|NCT01904773|12403256|FG003|STARTED|Placebo Washout Second Intervention||2
11212071|NCT01904773|12403257|FG004|STARTED|Placebo Washout Second Intervention||3
11212072|NCT01904773|12403258|FG005|STARTED|Placebo Washout Second Intervention||4
11212073|NCT01904773|12403259|FG006|STARTED|Placebo Washout Second Intervention||3
11212074|NCT01904773|12403260|FG007|STARTED|Placebo Washout Second Intervention||3
11212075|NCT01904773|12403261|FG008|STARTED|Placebo Washout Second Intervention||4
11212076|NCT01904773|12403253|FG000|COMPLETED|Placebo Washout Second Intervention||0
11212077|NCT01904773|12403254|FG001|COMPLETED|Placebo Washout Second Intervention||1
11212078|NCT01904773|12403255|FG002|COMPLETED|Placebo Washout Second Intervention||1
11212079|NCT01904773|12403256|FG003|COMPLETED|Placebo Washout Second Intervention||2
11212080|NCT01904773|12403257|FG004|COMPLETED|Placebo Washout Second Intervention||3
11212081|NCT01904773|12403258|FG005|COMPLETED|Placebo Washout Second Intervention||4
11212082|NCT01904773|12403259|FG006|COMPLETED|Placebo Washout Second Intervention||3
11212083|NCT01904773|12403260|FG007|COMPLETED|Placebo Washout Second Intervention||3
11212084|NCT01904773|12403261|FG008|COMPLETED|Placebo Washout Second Intervention||4
11212085|NCT01904773|12403253|FG000|NOT COMPLETED|Placebo Washout Second Intervention||0
11212086|NCT01904773|12403254|FG001|NOT COMPLETED|Placebo Washout Second Intervention||0
11212087|NCT01904773|12403255|FG002|NOT COMPLETED|Placebo Washout Second Intervention||0
11212088|NCT01904773|12403256|FG003|NOT COMPLETED|Placebo Washout Second Intervention||0
11212089|NCT01904773|12403257|FG004|NOT COMPLETED|Placebo Washout Second Intervention||0
11212090|NCT01904773|12403258|FG005|NOT COMPLETED|Placebo Washout Second Intervention||0
11212091|NCT01904773|12403259|FG006|NOT COMPLETED|Placebo Washout Second Intervention||0
11212092|NCT01904773|12403260|FG007|NOT COMPLETED|Placebo Washout Second Intervention||0
11212093|NCT01904773|12403261|FG008|NOT COMPLETED|Placebo Washout Second Intervention||0
11212094|NCT01904773|12403253|FG000|STARTED|Third Intervention||0
11212095|NCT01904773|12403254|FG001|STARTED|Third Intervention||1
11212096|NCT01904773|12403255|FG002|STARTED|Third Intervention||1
11212097|NCT01904773|12403256|FG003|STARTED|Third Intervention||2
11212098|NCT01904773|12403257|FG004|STARTED|Third Intervention||3
11212099|NCT01904773|12403258|FG005|STARTED|Third Intervention||4
11212100|NCT01904773|12403259|FG006|STARTED|Third Intervention||3
11212101|NCT01904773|12403260|FG007|STARTED|Third Intervention||3
11212102|NCT01904773|12403261|FG008|STARTED|Third Intervention||4
11212103|NCT01904773|12403253|FG000|COMPLETED|Third Intervention||0
11212104|NCT01904773|12403254|FG001|COMPLETED|Third Intervention||1
11212105|NCT01904773|12403255|FG002|COMPLETED|Third Intervention||1
11212106|NCT01904773|12403256|FG003|COMPLETED|Third Intervention||2
11212107|NCT01904773|12403257|FG004|COMPLETED|Third Intervention||3
11212108|NCT01904773|12403258|FG005|COMPLETED|Third Intervention||4
11212109|NCT01904773|12403259|FG006|COMPLETED|Third Intervention||3
11212110|NCT01904773|12403260|FG007|COMPLETED|Third Intervention||3
11212111|NCT01904773|12403261|FG008|COMPLETED|Third Intervention||4
11212112|NCT01904773|12403253|FG000|NOT COMPLETED|Third Intervention||0
11212113|NCT01904773|12403254|FG001|NOT COMPLETED|Third Intervention||0
11212114|NCT01904773|12403255|FG002|NOT COMPLETED|Third Intervention||0
11212115|NCT01904773|12403256|FG003|NOT COMPLETED|Third Intervention||0
11212116|NCT01904773|12403257|FG004|NOT COMPLETED|Third Intervention||0
11212117|NCT01904773|12403258|FG005|NOT COMPLETED|Third Intervention||0
11212118|NCT01904773|12403259|FG006|NOT COMPLETED|Third Intervention||0
11212119|NCT01904773|12403260|FG007|NOT COMPLETED|Third Intervention||0
11212120|NCT01904773|12403261|FG008|NOT COMPLETED|Third Intervention||0
11212121|NCT01904773|12403253|FG000|STARTED|Placebo Washout Third Intervention||0
11212122|NCT01904773|12403254|FG001|STARTED|Placebo Washout Third Intervention||1
11212123|NCT01904773|12403255|FG002|STARTED|Placebo Washout Third Intervention||1
11212124|NCT01904773|12403256|FG003|STARTED|Placebo Washout Third Intervention||2
11212125|NCT01904773|12403257|FG004|STARTED|Placebo Washout Third Intervention||3
11212126|NCT01904773|12403258|FG005|STARTED|Placebo Washout Third Intervention||4
11212127|NCT01904773|12403259|FG006|STARTED|Placebo Washout Third Intervention||3
11212128|NCT01904773|12403260|FG007|STARTED|Placebo Washout Third Intervention||3
11212129|NCT01904773|12403261|FG008|STARTED|Placebo Washout Third Intervention||4
11212130|NCT01904773|12403253|FG000|COMPLETED|Placebo Washout Third Intervention||0
11212131|NCT01904773|12403254|FG001|COMPLETED|Placebo Washout Third Intervention||1
11212132|NCT01904773|12403255|FG002|COMPLETED|Placebo Washout Third Intervention||1
11212133|NCT01904773|12403256|FG003|COMPLETED|Placebo Washout Third Intervention||2
11212134|NCT01904773|12403257|FG004|COMPLETED|Placebo Washout Third Intervention||3
11212135|NCT01904773|12403258|FG005|COMPLETED|Placebo Washout Third Intervention||4
11212136|NCT01904773|12403259|FG006|COMPLETED|Placebo Washout Third Intervention||3
11212137|NCT01904773|12403260|FG007|COMPLETED|Placebo Washout Third Intervention||3
11212138|NCT01904773|12403261|FG008|COMPLETED|Placebo Washout Third Intervention||4
11212139|NCT01904773|12403253|FG000|NOT COMPLETED|Placebo Washout Third Intervention||0
11212140|NCT01904773|12403254|FG001|NOT COMPLETED|Placebo Washout Third Intervention||0
11212141|NCT01904773|12403255|FG002|NOT COMPLETED|Placebo Washout Third Intervention||0
11212142|NCT01904773|12403256|FG003|NOT COMPLETED|Placebo Washout Third Intervention||0
11212143|NCT01904773|12403257|FG004|NOT COMPLETED|Placebo Washout Third Intervention||0
11212144|NCT01904773|12403258|FG005|NOT COMPLETED|Placebo Washout Third Intervention||0
11212145|NCT01904773|12403259|FG006|NOT COMPLETED|Placebo Washout Third Intervention||0
11212146|NCT01904773|12403260|FG007|NOT COMPLETED|Placebo Washout Third Intervention||0
11212147|NCT01904773|12403261|FG008|NOT COMPLETED|Placebo Washout Third Intervention||0
11212148|NCT01904773|12403253|FG000|STARTED|Fourth Intervention||0
11212149|NCT01904773|12403254|FG001|STARTED|Fourth Intervention||1
11212150|NCT01904773|12403255|FG002|STARTED|Fourth Intervention||1
11212151|NCT01904773|12403256|FG003|STARTED|Fourth Intervention||2
11212152|NCT01904773|12403257|FG004|STARTED|Fourth Intervention||3
11212153|NCT01904773|12403258|FG005|STARTED|Fourth Intervention||4
11212154|NCT01904773|12403259|FG006|STARTED|Fourth Intervention||3
11212155|NCT01904773|12403260|FG007|STARTED|Fourth Intervention||3
11212156|NCT01904773|12403261|FG008|STARTED|Fourth Intervention||4
11212157|NCT01904773|12403253|FG000|COMPLETED|Fourth Intervention||0
11212158|NCT01904773|12403254|FG001|COMPLETED|Fourth Intervention||1
11212159|NCT01904773|12403255|FG002|COMPLETED|Fourth Intervention||1
11212160|NCT01904773|12403256|FG003|COMPLETED|Fourth Intervention||2
11212161|NCT01904773|12403257|FG004|COMPLETED|Fourth Intervention||3
11212162|NCT01904773|12403258|FG005|COMPLETED|Fourth Intervention||4
11212163|NCT01904773|12403259|FG006|COMPLETED|Fourth Intervention||3
11212164|NCT01904773|12403260|FG007|COMPLETED|Fourth Intervention||3
11212165|NCT01904773|12403261|FG008|COMPLETED|Fourth Intervention||4
11212166|NCT01904773|12403253|FG000|NOT COMPLETED|Fourth Intervention||0
11212167|NCT01904773|12403254|FG001|NOT COMPLETED|Fourth Intervention||0
11212168|NCT01904773|12403255|FG002|NOT COMPLETED|Fourth Intervention||0
11212169|NCT01904773|12403256|FG003|NOT COMPLETED|Fourth Intervention||0
11212170|NCT01904773|12403257|FG004|NOT COMPLETED|Fourth Intervention||0
11212171|NCT01904773|12403258|FG005|NOT COMPLETED|Fourth Intervention||0
11212172|NCT01904773|12403259|FG006|NOT COMPLETED|Fourth Intervention||0
11212173|NCT01904773|12403260|FG007|NOT COMPLETED|Fourth Intervention||0
11212174|NCT01904773|12403261|FG008|NOT COMPLETED|Fourth Intervention||0
11212175|NCT01904773|12403253|FG000|STARTED|Placebo Washout Fourth Intervention||0
11212176|NCT01904773|12403254|FG001|STARTED|Placebo Washout Fourth Intervention||1
11212177|NCT01904773|12403255|FG002|STARTED|Placebo Washout Fourth Intervention||1
11212178|NCT01904773|12403256|FG003|STARTED|Placebo Washout Fourth Intervention||2
11212179|NCT01904773|12403257|FG004|STARTED|Placebo Washout Fourth Intervention||3
11212180|NCT01904773|12403258|FG005|STARTED|Placebo Washout Fourth Intervention||4
11212181|NCT01904773|12403259|FG006|STARTED|Placebo Washout Fourth Intervention||3
11212182|NCT01904773|12403260|FG007|STARTED|Placebo Washout Fourth Intervention||3
11212183|NCT01904773|12403261|FG008|STARTED|Placebo Washout Fourth Intervention||4
11212184|NCT01904773|12403253|FG000|COMPLETED|Placebo Washout Fourth Intervention||0
11212185|NCT01904773|12403254|FG001|COMPLETED|Placebo Washout Fourth Intervention||1
11212186|NCT01904773|12403255|FG002|COMPLETED|Placebo Washout Fourth Intervention||1
11212187|NCT01904773|12403256|FG003|COMPLETED|Placebo Washout Fourth Intervention||2
11212188|NCT01904773|12403257|FG004|COMPLETED|Placebo Washout Fourth Intervention||3
11212189|NCT01904773|12403258|FG005|COMPLETED|Placebo Washout Fourth Intervention||4
11212190|NCT01904773|12403259|FG006|COMPLETED|Placebo Washout Fourth Intervention||3
11212191|NCT01904773|12403260|FG007|COMPLETED|Placebo Washout Fourth Intervention||3
11212192|NCT01904773|12403261|FG008|COMPLETED|Placebo Washout Fourth Intervention||4
11212193|NCT01904773|12403253|FG000|NOT COMPLETED|Placebo Washout Fourth Intervention||0
11212194|NCT01904773|12403254|FG001|NOT COMPLETED|Placebo Washout Fourth Intervention||0
11212195|NCT01904773|12403255|FG002|NOT COMPLETED|Placebo Washout Fourth Intervention||0
11212196|NCT01904773|12403256|FG003|NOT COMPLETED|Placebo Washout Fourth Intervention||0
11212197|NCT01904773|12403257|FG004|NOT COMPLETED|Placebo Washout Fourth Intervention||0
11212198|NCT01904773|12403258|FG005|NOT COMPLETED|Placebo Washout Fourth Intervention||0
11212199|NCT01904773|12403259|FG006|NOT COMPLETED|Placebo Washout Fourth Intervention||0
11212200|NCT01904773|12403260|FG007|NOT COMPLETED|Placebo Washout Fourth Intervention||0
11212201|NCT01904773|12403261|FG008|NOT COMPLETED|Placebo Washout Fourth Intervention||0
11212202|NCT01904773|12403253|FG000|STARTED|Fifth Intervention||0
11212203|NCT01904773|12403254|FG001|STARTED|Fifth Intervention||1
11212204|NCT01904773|12403255|FG002|STARTED|Fifth Intervention||1
11212205|NCT01904773|12403256|FG003|STARTED|Fifth Intervention||2
11212206|NCT01904773|12403257|FG004|STARTED|Fifth Intervention||3
11212207|NCT01904773|12403258|FG005|STARTED|Fifth Intervention||4
11212208|NCT01904773|12403259|FG006|STARTED|Fifth Intervention||3
11212209|NCT01904773|12403260|FG007|STARTED|Fifth Intervention||3
11212210|NCT01904773|12403261|FG008|STARTED|Fifth Intervention||4
11212211|NCT01904773|12403253|FG000|COMPLETED|Fifth Intervention||0
11212212|NCT01904773|12403254|FG001|COMPLETED|Fifth Intervention||1
11212213|NCT01904773|12403255|FG002|COMPLETED|Fifth Intervention||1
11212214|NCT01904773|12403256|FG003|COMPLETED|Fifth Intervention||2
11212215|NCT01904773|12403257|FG004|COMPLETED|Fifth Intervention||3
11212216|NCT01904773|12403258|FG005|COMPLETED|Fifth Intervention||4
11212217|NCT01904773|12403259|FG006|COMPLETED|Fifth Intervention||3
11212218|NCT01904773|12403260|FG007|COMPLETED|Fifth Intervention||2
11212219|NCT01904773|12403261|FG008|COMPLETED|Fifth Intervention||4
11212220|NCT01904773|12403253|FG000|NOT COMPLETED|Fifth Intervention||0
11212221|NCT01904773|12403254|FG001|NOT COMPLETED|Fifth Intervention||0
11212222|NCT01904773|12403255|FG002|NOT COMPLETED|Fifth Intervention||0
11212223|NCT01904773|12403256|FG003|NOT COMPLETED|Fifth Intervention||0
11212224|NCT01904773|12403257|FG004|NOT COMPLETED|Fifth Intervention||0
11212225|NCT01904773|12403258|FG005|NOT COMPLETED|Fifth Intervention||0
11212226|NCT01904773|12403259|FG006|NOT COMPLETED|Fifth Intervention||0
11212227|NCT01904773|12403260|FG007|NOT COMPLETED|Fifth Intervention||1
11212228|NCT01904773|12403261|FG008|NOT COMPLETED|Fifth Intervention||0
11212229|NCT01904773|12403253|FG000|STARTED|Placebo Washout Fifth Intervention||0
11212230|NCT01904773|12403254|FG001|STARTED|Placebo Washout Fifth Intervention||1
11212231|NCT01904773|12403255|FG002|STARTED|Placebo Washout Fifth Intervention||1
11212232|NCT01904773|12403256|FG003|STARTED|Placebo Washout Fifth Intervention||2
11212233|NCT01904773|12403257|FG004|STARTED|Placebo Washout Fifth Intervention||3
11212234|NCT01904773|12403258|FG005|STARTED|Placebo Washout Fifth Intervention||4
11212235|NCT01904773|12403259|FG006|STARTED|Placebo Washout Fifth Intervention||3
11212236|NCT01904773|12403260|FG007|STARTED|Placebo Washout Fifth Intervention||2
11212237|NCT01904773|12403261|FG008|STARTED|Placebo Washout Fifth Intervention||4
11212238|NCT01904773|12403253|FG000|COMPLETED|Placebo Washout Fifth Intervention||0
11212239|NCT01904773|12403254|FG001|COMPLETED|Placebo Washout Fifth Intervention||0
11212240|NCT01904773|12403255|FG002|COMPLETED|Placebo Washout Fifth Intervention||1
11212241|NCT01904773|12403256|FG003|COMPLETED|Placebo Washout Fifth Intervention||2
11212242|NCT01904773|12403257|FG004|COMPLETED|Placebo Washout Fifth Intervention||3
11212243|NCT01904773|12403258|FG005|COMPLETED|Placebo Washout Fifth Intervention||4
11212244|NCT01904773|12403259|FG006|COMPLETED|Placebo Washout Fifth Intervention||3
11212245|NCT01904773|12403260|FG007|COMPLETED|Placebo Washout Fifth Intervention||2
11212246|NCT01904773|12403261|FG008|COMPLETED|Placebo Washout Fifth Intervention||4
11212247|NCT01904773|12403253|FG000|NOT COMPLETED|Placebo Washout Fifth Intervention||0
11212248|NCT01904773|12403254|FG001|NOT COMPLETED|Placebo Washout Fifth Intervention||1
11212249|NCT01904773|12403255|FG002|NOT COMPLETED|Placebo Washout Fifth Intervention||0
11212250|NCT01904773|12403256|FG003|NOT COMPLETED|Placebo Washout Fifth Intervention||0
11212251|NCT01904773|12403257|FG004|NOT COMPLETED|Placebo Washout Fifth Intervention||0
11212252|NCT01904773|12403258|FG005|NOT COMPLETED|Placebo Washout Fifth Intervention||0
11212253|NCT01904773|12403259|FG006|NOT COMPLETED|Placebo Washout Fifth Intervention||0
11212254|NCT01904773|12403260|FG007|NOT COMPLETED|Placebo Washout Fifth Intervention||0
11212255|NCT01904773|12403261|FG008|NOT COMPLETED|Placebo Washout Fifth Intervention||0
11212256|NCT01904773|12403253|FG000|STARTED|Sixth Intervention||0
11212257|NCT01904773|12403254|FG001|STARTED|Sixth Intervention||0
11212258|NCT01904773|12403255|FG002|STARTED|Sixth Intervention||1
11097098|NCT01210664|12280869|FG000|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
11097099|NCT01210664|12280870|FG001|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
11097100|NCT01210664|12280871|FG002|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
11097101|NCT01210664|12280872|FG003|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
11097102|NCT01210664|12280869|FG000|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
11097103|NCT01210664|12280870|FG001|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
11097104|NCT01210664|12280871|FG002|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
11097105|NCT01210664|12280872|FG003|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
11097106|NCT01210664|12280869|FG000|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
11097107|NCT01210664|12280870|FG001|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
11097108|NCT01210664|12280871|FG002|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
11097109|NCT01210664|12280872|FG003|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
11097110|NCT01210664|12280869|FG000|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
11097111|NCT01210664|12280870|FG001|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
11097112|NCT01210664|12280871|FG002|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
11097113|NCT01210664|12280872|FG003|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
11097114|NCT01210664|12280869|FG000|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
11097115|NCT01210664|12280870|FG001|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
11097116|NCT01210664|12280871|FG002|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
11097117|NCT01210664|12280872|FG003|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
11097118|NCT01210664|12280869|FG000|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
11097119|NCT01210664|12280870|FG001|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
11097120|NCT01210664|12280871|FG002|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
11097121|NCT01210664|12280872|FG003|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
11097122|NCT01210664|12280869|FG000|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
11097123|NCT01210664|12280870|FG001|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
11097124|NCT01210664|12280871|FG002|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
11097125|NCT01210664|12280872|FG003|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
11097126|NCT01210664|12280869|FG000|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
11097127|NCT01210664|12280870|FG001|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
11097128|NCT01210664|12280871|FG002|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
11097129|NCT01210664|12280872|FG003|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
11097130|NCT01210664|12280869|FG000|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
11097131|NCT01210664|12280870|FG001|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
11097132|NCT01210664|12280871|FG002|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
11097133|NCT01210664|12280872|FG003|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
11097134|NCT01210664|12280869|FG000|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
11097135|NCT01210664|12280870|FG001|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
11212259|NCT01904773|12403256|FG003|STARTED|Sixth Intervention||2
11212260|NCT01904773|12403257|FG004|STARTED|Sixth Intervention||3
11212261|NCT01904773|12403258|FG005|STARTED|Sixth Intervention||4
11212262|NCT01904773|12403259|FG006|STARTED|Sixth Intervention||3
11212263|NCT01904773|12403260|FG007|STARTED|Sixth Intervention||2
11212264|NCT01904773|12403261|FG008|STARTED|Sixth Intervention||4
11212265|NCT01904773|12403253|FG000|COMPLETED|Sixth Intervention||0
11212266|NCT01904773|12403254|FG001|COMPLETED|Sixth Intervention||0
11212267|NCT01904773|12403255|FG002|COMPLETED|Sixth Intervention||1
11212268|NCT01904773|12403256|FG003|COMPLETED|Sixth Intervention||2
11212269|NCT01904773|12403257|FG004|COMPLETED|Sixth Intervention||3
11212270|NCT01904773|12403258|FG005|COMPLETED|Sixth Intervention||4
11212271|NCT01904773|12403259|FG006|COMPLETED|Sixth Intervention||3
11212272|NCT01904773|12403260|FG007|COMPLETED|Sixth Intervention||2
11212273|NCT01904773|12403261|FG008|COMPLETED|Sixth Intervention||4
11212274|NCT01904773|12403253|FG000|NOT COMPLETED|Sixth Intervention||0
11212275|NCT01904773|12403254|FG001|NOT COMPLETED|Sixth Intervention||0
11212276|NCT01904773|12403255|FG002|NOT COMPLETED|Sixth Intervention||0
11212277|NCT01904773|12403256|FG003|NOT COMPLETED|Sixth Intervention||0
11212278|NCT01904773|12403257|FG004|NOT COMPLETED|Sixth Intervention||0
11212279|NCT01904773|12403258|FG005|NOT COMPLETED|Sixth Intervention||0
11212280|NCT01904773|12403259|FG006|NOT COMPLETED|Sixth Intervention||0
11212281|NCT01904773|12403260|FG007|NOT COMPLETED|Sixth Intervention||0
11212282|NCT01904773|12403261|FG008|NOT COMPLETED|Sixth Intervention||0
11212283|NCT01904864|12403275|FG000|STARTED|Overall Study||40
11212284|NCT01904864|12403276|FG001|STARTED|Overall Study||40
11212285|NCT01904864|12403275|FG000|COMPLETED|Overall Study||31
11212286|NCT01904864|12403276|FG001|COMPLETED|Overall Study||28
11212287|NCT01904864|12403275|FG000|NOT COMPLETED|Overall Study||9
11212288|NCT01904864|12403276|FG001|NOT COMPLETED|Overall Study||12
11212289|NCT01905241|12403282|FG000|STARTED|Overall Study||20
11212290|NCT01905241|12403282|FG000|COMPLETED|Overall Study||20
11212291|NCT01905241|12403282|FG000|NOT COMPLETED|Overall Study||0
11212292|NCT01905254|12403286|FG000|STARTED|Overall Study||34
11212293|NCT01905254|12403286|FG000|COMPLETED|Overall Study||34
11212294|NCT01905254|12403286|FG000|NOT COMPLETED|Overall Study||0
11212295|NCT01905267|12403292|FG000|STARTED|Overall Study||17
11212296|NCT01905267|12403293|FG001|STARTED|Overall Study||16
11212297|NCT01905267|12403292|FG000|COMPLETED|Overall Study||15
11212298|NCT01905267|12403293|FG001|COMPLETED|Overall Study||14
11212299|NCT01905267|12403292|FG000|NOT COMPLETED|Overall Study||2
11212300|NCT01905267|12403293|FG001|NOT COMPLETED|Overall Study||2
11212301|NCT01905423|12403304|FG000|STARTED|Overall Study||4456
11212302|NCT01905423|12403305|FG001|STARTED|Overall Study||3297
11212303|NCT01905423|12403306|FG002|STARTED|Overall Study||4111
11212304|NCT01905423|12403307|FG003|STARTED|Overall Study||2757
11212305|NCT01905423|12403308|FG004|STARTED|Overall Study||2487
11212306|NCT01905423|12403304|FG000|Baseline|Overall Study||1443
11212307|NCT01905423|12403305|FG001|Baseline|Overall Study||722
11212308|NCT01905423|12403306|FG002|Baseline|Overall Study||1033
11212309|NCT01905423|12403307|FG003|Baseline|Overall Study||1482
11212310|NCT01905423|12403308|FG004|Baseline|Overall Study||1326
11212311|NCT01905423|12403304|FG000|Year 1 Follow-up|Overall Study||994
11212312|NCT01905423|12403305|FG001|Year 1 Follow-up|Overall Study||846
11212313|NCT01905423|12403306|FG002|Year 1 Follow-up|Overall Study||1007
11212314|NCT01905423|12403307|FG003|Year 1 Follow-up|Overall Study||1275
11212315|NCT01905423|12403308|FG004|Year 1 Follow-up|Overall Study||1161
11212316|NCT01905423|12403304|FG000|Year 2 Follow-up|Overall Study||1114
11212317|NCT01905423|12403305|FG001|Year 2 Follow-up|Overall Study||858
11212318|NCT01905423|12403306|FG002|Year 2 Follow-up|Overall Study||1043
11212319|NCT01905423|12403307|FG003|Year 2 Follow-up|Overall Study||0
11212320|NCT01905423|12403308|FG004|Year 2 Follow-up|Overall Study||0
11212321|NCT01905423|12403304|FG000|Year 3 Follow-up|Overall Study||905
11212322|NCT01905423|12403305|FG001|Year 3 Follow-up|Overall Study||871
11097136|NCT01210664|12280871|FG002|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
11097137|NCT01210664|12280872|FG003|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
11097138|NCT01210690|12280882|FG000|STARTED|Overall Study||101
11097139|NCT01210690|12280882|FG000|COMPLETED|Overall Study||75
11097140|NCT01210690|12280882|FG000|NOT COMPLETED|Overall Study||26
11097141|NCT01210716|12280887|FG000|STARTED|First TPE Procedure||20
11097142|NCT01210716|12280888|FG001|STARTED|First TPE Procedure||17
11097143|NCT01210716|12280887|FG000|COMPLETED|First TPE Procedure||18
11097144|NCT01210716|12280888|FG001|COMPLETED|First TPE Procedure||15
11097145|NCT01210716|12280887|FG000|NOT COMPLETED|First TPE Procedure||2
11097146|NCT01210716|12280888|FG001|NOT COMPLETED|First TPE Procedure||2
11097147|NCT01210716|12280887|FG000|STARTED|Second TPE Procedure||18
11097148|NCT01210716|12280888|FG001|STARTED|Second TPE Procedure||15
11097149|NCT01210716|12280887|FG000|COMPLETED|Second TPE Procedure||15
11097150|NCT01210716|12280888|FG001|COMPLETED|Second TPE Procedure||15
11212323|NCT01905423|12403306|FG002|Year 3 Follow-up|Overall Study||1028
11212324|NCT01905423|12403307|FG003|Year 3 Follow-up|Overall Study||0
11212325|NCT01905423|12403308|FG004|Year 3 Follow-up|Overall Study||0
11212326|NCT01905423|12403304|FG000|COMPLETED|Overall Study||4456
11212327|NCT01905423|12403305|FG001|COMPLETED|Overall Study||3297
11212328|NCT01905423|12403306|FG002|COMPLETED|Overall Study||4111
11212329|NCT01905423|12403307|FG003|COMPLETED|Overall Study||2757
11212330|NCT01905423|12403308|FG004|COMPLETED|Overall Study||2487
11212331|NCT01905423|12403304|FG000|NOT COMPLETED|Overall Study||0
11212332|NCT01905423|12403305|FG001|NOT COMPLETED|Overall Study||0
11212333|NCT01905423|12403306|FG002|NOT COMPLETED|Overall Study||0
11212334|NCT01905423|12403307|FG003|NOT COMPLETED|Overall Study||0
11212335|NCT01905423|12403308|FG004|NOT COMPLETED|Overall Study||0
11212336|NCT01905540|12403324|FG000|STARTED|Period 1||7
11212337|NCT01905540|12403325|FG001|STARTED|Period 1||7
11212338|NCT01905540|12403326|FG002|STARTED|Period 1||7
11212339|NCT01905540|12403327|FG003|STARTED|Period 1||7
11212340|NCT01905540|12403324|FG000|COMPLETED|Period 1||7
11212341|NCT01905540|12403325|FG001|COMPLETED|Period 1||7
11212342|NCT01905540|12403326|FG002|COMPLETED|Period 1||7
11212343|NCT01905540|12403327|FG003|COMPLETED|Period 1||7
11212344|NCT01905540|12403324|FG000|NOT COMPLETED|Period 1||0
11212345|NCT01905540|12403325|FG001|NOT COMPLETED|Period 1||0
11212346|NCT01905540|12403326|FG002|NOT COMPLETED|Period 1||0
11212347|NCT01905540|12403327|FG003|NOT COMPLETED|Period 1||0
11212348|NCT01905540|12403324|FG000|STARTED|Period 2||7
11212349|NCT01905540|12403325|FG001|STARTED|Period 2||7
11212350|NCT01905540|12403326|FG002|STARTED|Period 2||7
11212351|NCT01905540|12403327|FG003|STARTED|Period 2||7
11212352|NCT01905540|12403324|FG000|COMPLETED|Period 2||7
11212353|NCT01905540|12403325|FG001|COMPLETED|Period 2||7
11212354|NCT01905540|12403326|FG002|COMPLETED|Period 2||7
11212355|NCT01905540|12403327|FG003|COMPLETED|Period 2||7
11212356|NCT01905540|12403324|FG000|NOT COMPLETED|Period 2||0
11212357|NCT01905540|12403325|FG001|NOT COMPLETED|Period 2||0
11212358|NCT01905540|12403326|FG002|NOT COMPLETED|Period 2||0
11212359|NCT01905540|12403327|FG003|NOT COMPLETED|Period 2||0
11212360|NCT01905540|12403324|FG000|STARTED|Period 3||7
11212361|NCT01905540|12403325|FG001|STARTED|Period 3||7
11212362|NCT01905540|12403326|FG002|STARTED|Period 3||7
11212363|NCT01905540|12403327|FG003|STARTED|Period 3||7
11212364|NCT01905540|12403324|FG000|COMPLETED|Period 3||6
11212365|NCT01905540|12403325|FG001|COMPLETED|Period 3||7
11212366|NCT01905540|12403326|FG002|COMPLETED|Period 3||6
11212367|NCT01905540|12403327|FG003|COMPLETED|Period 3||6
11212368|NCT01905540|12403324|FG000|NOT COMPLETED|Period 3||1
11212369|NCT01905540|12403325|FG001|NOT COMPLETED|Period 3||0
11212370|NCT01905540|12403326|FG002|NOT COMPLETED|Period 3||1
11212371|NCT01905540|12403327|FG003|NOT COMPLETED|Period 3||1
11212372|NCT01905553|12403339|FG000|STARTED|Period 1||5
11212373|NCT01905553|12403340|FG001|STARTED|Period 1||4
11212374|NCT01905553|12403339|FG000|COMPLETED|Period 1||5
11212375|NCT01905553|12403340|FG001|COMPLETED|Period 1||4
11212376|NCT01905553|12403339|FG000|NOT COMPLETED|Period 1||0
11212377|NCT01905553|12403340|FG001|NOT COMPLETED|Period 1||0
11212378|NCT01905553|12403339|FG000|STARTED|Period 2||5
11212379|NCT01905553|12403340|FG001|STARTED|Period 2||4
11212380|NCT01905553|12403339|FG000|COMPLETED|Period 2||4
11212381|NCT01905553|12403340|FG001|COMPLETED|Period 2||4
11212382|NCT01905553|12403339|FG000|NOT COMPLETED|Period 2||1
11212383|NCT01905553|12403340|FG001|NOT COMPLETED|Period 2||0
11212384|NCT01905592|12403348|FG000|STARTED|Overall Study||71
11212385|NCT01905592|12403349|FG001|STARTED|Overall Study||135
11212386|NCT01905592|12403348|FG000|COMPLETED|Overall Study||0
11212387|NCT01905592|12403349|FG001|COMPLETED|Overall Study||0
11212388|NCT01905592|12403348|FG000|NOT COMPLETED|Overall Study||71
11212389|NCT01905592|12403349|FG001|NOT COMPLETED|Overall Study||135
11212390|NCT01905657|12403358|FG000|STARTED|Overall Study||345
11212391|NCT01905657|12403359|FG001|STARTED|Overall Study||346
11212392|NCT01905657|12403360|FG002|STARTED|Overall Study||343
11212393|NCT01905657|12403358|FG000|Treated|Overall Study||339
11212394|NCT01905657|12403359|FG001|Treated|Overall Study||343
11212395|NCT01905657|12403360|FG002|Treated|Overall Study||309
11212396|NCT01905657|12403358|FG000|Received Second Course of Pembrolizumab|Overall Study||14
11212397|NCT01905657|12403359|FG001|Received Second Course of Pembrolizumab|Overall Study||7
11212398|NCT01905657|12403360|FG002|Received Second Course of Pembrolizumab|Overall Study||0
11212399|NCT01905657|12403358|FG000|Switched Over to Pembrolizumab|Overall Study||0
11212400|NCT01905657|12403359|FG001|Switched Over to Pembrolizumab|Overall Study||0
11212401|NCT01905657|12403360|FG002|Switched Over to Pembrolizumab|Overall Study||8
11212402|NCT01905657|12403358|FG000|COMPLETED|Overall Study||142
11212403|NCT01905657|12403359|FG001|COMPLETED|Overall Study||159
11212404|NCT01905657|12403360|FG002|COMPLETED|Overall Study||143
11212405|NCT01905657|12403358|FG000|NOT COMPLETED|Overall Study||203
11212406|NCT01905657|12403359|FG001|NOT COMPLETED|Overall Study||187
11212407|NCT01905657|12403360|FG002|NOT COMPLETED|Overall Study||200
11212408|NCT01905683|12403371|FG000|STARTED|Overall Study||370
11212409|NCT01905683|12403371|FG000|COMPLETED|Overall Study||319
11212410|NCT01905683|12403371|FG000|NOT COMPLETED|Overall Study||51
11212411|NCT01905943|12403375|FG000|STARTED|Overall Study||972
11212412|NCT01905943|12403375|FG000|COMPLETED|Overall Study|All patients provide reason at final analysis|658
11212413|NCT01905943|12403375|FG000|NOT COMPLETED|Overall Study||314
11212414|NCT01905956|12403396|FG000|STARTED|Overall Study|Randomized|60
11212415|NCT01905956|12403397|FG001|STARTED|Overall Study|Randomized|59
11212416|NCT01905956|12403396|FG000|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
11212417|NCT01905956|12403397|FG001|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
11212418|NCT01905956|12403396|FG000|COMPLETED|Overall Study|Per-protocol population|54
11212419|NCT01905956|12403397|FG001|COMPLETED|Overall Study|Per-protocol population|48
11212420|NCT01905956|12403396|FG000|NOT COMPLETED|Overall Study||6
11212421|NCT01905956|12403397|FG001|NOT COMPLETED|Overall Study||11
11212422|NCT01906008|12403405|FG000|STARTED|Overall Study||59
11212423|NCT01906008|12403406|FG001|STARTED|Overall Study||61
11097151|NCT01210716|12280887|FG000|NOT COMPLETED|Second TPE Procedure||3
11097152|NCT01210716|12280888|FG001|NOT COMPLETED|Second TPE Procedure||0
11097153|NCT01210807|12280896|FG000|STARTED|Overall Study||36
11097154|NCT01210807|12280897|FG001|STARTED|Overall Study||34
11097155|NCT01210807|12280896|FG000|COMPLETED|Overall Study||33
11212424|NCT01906008|12403405|FG000|COMPLETED|Overall Study||32
11212425|NCT01906008|12403406|FG001|COMPLETED|Overall Study||34
11212426|NCT01906008|12403405|FG000|NOT COMPLETED|Overall Study||27
11212427|NCT01906008|12403406|FG001|NOT COMPLETED|Overall Study||27
11212428|NCT01906346|12403412|FG000|STARTED|Overall Study||9
11212429|NCT01906346|12403412|FG000|COMPLETED|Overall Study||8
11212430|NCT01906346|12403412|FG000|NOT COMPLETED|Overall Study||1
11212431|NCT01906372|12403418|FG000|STARTED|Overall Study||12
11212432|NCT01906372|12403418|FG000|Visit 7: Treatment Phase Completed|Overall Study||10
11212433|NCT01906372|12403418|FG000|Visit 10: Follow up Phase Completed|Overall Study||8
11212434|NCT01906372|12403418|FG000|COMPLETED|Overall Study||10
11212435|NCT01906372|12403418|FG000|NOT COMPLETED|Overall Study||2
11212436|NCT01906476|12403425|FG000|STARTED|Overall Study||157
11212437|NCT01906476|12403426|FG001|STARTED|Overall Study||155
11212438|NCT01906476|12403425|FG000|COMPLETED|Overall Study||140
11212439|NCT01906476|12403426|FG001|COMPLETED|Overall Study||139
11212440|NCT01906476|12403425|FG000|NOT COMPLETED|Overall Study||17
11212441|NCT01906476|12403426|FG001|NOT COMPLETED|Overall Study||16
11212442|NCT01906515|12403434|FG000|STARTED|Overall Study||45
11212443|NCT01906515|12403435|FG001|STARTED|Overall Study||61
11212444|NCT01906515|12403434|FG000|COMPLETED|Overall Study||45
11212445|NCT01906515|12403435|FG001|COMPLETED|Overall Study||61
11097156|NCT01210807|12280897|FG001|COMPLETED|Overall Study||31
11097157|NCT01210807|12280896|FG000|NOT COMPLETED|Overall Study||3
11097158|NCT01210807|12280897|FG001|NOT COMPLETED|Overall Study||3
11097159|NCT01210820|12280905|FG000|STARTED|Overall Study||17
11097160|NCT01210820|12280906|FG001|STARTED|Overall Study||4
11212446|NCT01906515|12403434|FG000|NOT COMPLETED|Overall Study||0
11212447|NCT01906515|12403435|FG001|NOT COMPLETED|Overall Study||0
11212448|NCT01906658|12403446|FG000|STARTED|Overall Study||11
11212449|NCT01906658|12403447|FG001|STARTED|Overall Study||11
11212450|NCT01906658|12403448|FG002|STARTED|Overall Study||10
11212451|NCT01906658|12403449|FG003|STARTED|Overall Study||11
11212452|NCT01906658|12403446|FG000|COMPLETED|Overall Study||9
11212453|NCT01906658|12403447|FG001|COMPLETED|Overall Study||10
11212454|NCT01906658|12403448|FG002|COMPLETED|Overall Study||7
11212455|NCT01906658|12403449|FG003|COMPLETED|Overall Study||11
11212456|NCT01906658|12403446|FG000|NOT COMPLETED|Overall Study||2
11212457|NCT01906658|12403447|FG001|NOT COMPLETED|Overall Study||1
11212458|NCT01906658|12403448|FG002|NOT COMPLETED|Overall Study||3
11212459|NCT01906658|12403449|FG003|NOT COMPLETED|Overall Study||0
11212460|NCT01906866|12403461|FG000|STARTED|Overall Study||60
11212461|NCT01906866|12403462|FG001|STARTED|Overall Study||65
11212462|NCT01906866|12403461|FG000|COMPLETED|Overall Study||51
11212463|NCT01906866|12403462|FG001|COMPLETED|Overall Study||44
11212464|NCT01906866|12403461|FG000|NOT COMPLETED|Overall Study||9
11212465|NCT01906866|12403462|FG001|NOT COMPLETED|Overall Study||21
11212466|NCT01907087|12403471|FG000|STARTED|Overall Study||24
11212467|NCT01907087|12403471|FG000|COMPLETED|Overall Study||23
11212468|NCT01907087|12403471|FG000|NOT COMPLETED|Overall Study||1
11212469|NCT01907100|12403479|FG000|STARTED|Overall Study||43
11212470|NCT01907100|12403480|FG001|STARTED|Overall Study||44
11212471|NCT01907100|12403481|FG002|STARTED|Overall Study||229
11212472|NCT01907100|12403482|FG003|STARTED|Overall Study||229
11212473|NCT01907100|12403479|FG000|Treated Patients|Overall Study||41
11212474|NCT01907100|12403480|FG001|Treated Patients|Overall Study||44
11212475|NCT01907100|12403481|FG002|Treated Patients|Overall Study||228
11212476|NCT01907100|12403482|FG003|Treated Patients|Overall Study||227
11212477|NCT01907100|12403479|FG000|COMPLETED|Overall Study||1
11212478|NCT01907100|12403480|FG001|COMPLETED|Overall Study||4
11212479|NCT01907100|12403481|FG002|COMPLETED|Overall Study||82
11212480|NCT01907100|12403482|FG003|COMPLETED|Overall Study||83
11212481|NCT01907100|12403479|FG000|NOT COMPLETED|Overall Study||42
11212482|NCT01907100|12403480|FG001|NOT COMPLETED|Overall Study||40
11212483|NCT01907100|12403481|FG002|NOT COMPLETED|Overall Study||147
11212484|NCT01907100|12403482|FG003|NOT COMPLETED|Overall Study||146
11212485|NCT01907113|12403495|FG000|STARTED|Overall Study||8
11212486|NCT01907113|12403496|FG001|STARTED|Overall Study||9
11212487|NCT01907113|12403497|FG002|STARTED|Overall Study||7
11212488|NCT01907113|12403498|FG003|STARTED|Overall Study||8
11212489|NCT01907113|12403499|FG004|STARTED|Overall Study||8
11212490|NCT01907113|12403495|FG000|COMPLETED|Overall Study||8
11212491|NCT01907113|12403496|FG001|COMPLETED|Overall Study||9
11212492|NCT01907113|12403497|FG002|COMPLETED|Overall Study||7
11212493|NCT01907113|12403498|FG003|COMPLETED|Overall Study||8
11212494|NCT01907113|12403499|FG004|COMPLETED|Overall Study||8
11212495|NCT01907113|12403495|FG000|NOT COMPLETED|Overall Study||0
11212496|NCT01907113|12403496|FG001|NOT COMPLETED|Overall Study||0
11212497|NCT01907113|12403497|FG002|NOT COMPLETED|Overall Study||0
11212498|NCT01907113|12403498|FG003|NOT COMPLETED|Overall Study||0
11212499|NCT01907113|12403499|FG004|NOT COMPLETED|Overall Study||0
11212500|NCT01907217|12403513|FG000|STARTED|Overall Study||69
11212501|NCT01907217|12403514|FG001|STARTED|Overall Study||69
11212502|NCT01907217|12403513|FG000|COMPLETED|Overall Study||69
11212503|NCT01907217|12403514|FG001|COMPLETED|Overall Study||67
11212504|NCT01907217|12403513|FG000|NOT COMPLETED|Overall Study||0
11212505|NCT01907217|12403514|FG001|NOT COMPLETED|Overall Study||2
11212506|NCT01907269|12403524|FG000|STARTED|6 Month Outcome Measures Post-interventi||1342
11212507|NCT01907269|12403525|FG001|STARTED|6 Month Outcome Measures Post-interventi||1342
11097161|NCT01210820|12280905|FG000|COMPLETED|Overall Study||17
11097162|NCT01210820|12280906|FG001|COMPLETED|Overall Study||4
11097163|NCT01210820|12280905|FG000|NOT COMPLETED|Overall Study||0
11097164|NCT01210820|12280906|FG001|NOT COMPLETED|Overall Study||0
11097165|NCT01211106|12280914|FG000|STARTED|Overall Study||95
11097166|NCT01211106|12280915|FG001|STARTED|Overall Study||88
11097167|NCT01211106|12280914|FG000|COMPLETED|Overall Study||82
11097168|NCT01211106|12280915|FG001|COMPLETED|Overall Study||77
11097169|NCT01211106|12280914|FG000|NOT COMPLETED|Overall Study||13
11097170|NCT01211106|12280915|FG001|NOT COMPLETED|Overall Study||11
11097171|NCT01211145|12280927|FG000|STARTED|Overall Study||296
11212508|NCT01907269|12403524|FG000|COMPLETED|6 Month Outcome Measures Post-interventi||953
11212509|NCT01907269|12403525|FG001|COMPLETED|6 Month Outcome Measures Post-interventi||1053
11097172|NCT01211145|12280928|FG001|STARTED|Overall Study||115
11212510|NCT01907269|12403524|FG000|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
11212511|NCT01907269|12403525|FG001|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
11212512|NCT01907269|12403524|FG000|STARTED|18 Month Outcome Measures Post-intervent||1178
11212513|NCT01907269|12403525|FG001|STARTED|18 Month Outcome Measures Post-intervent||1250
11212514|NCT01907269|12403524|FG000|COMPLETED|18 Month Outcome Measures Post-intervent||859
11212515|NCT01907269|12403525|FG001|COMPLETED|18 Month Outcome Measures Post-intervent||970
11212516|NCT01907269|12403524|FG000|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
11212517|NCT01907269|12403525|FG001|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
11212518|NCT01907321|12403531|FG000|STARTED|Overall Study||14
11212519|NCT01907321|12403531|FG000|COMPLETED|Overall Study||12
11212520|NCT01907321|12403531|FG000|NOT COMPLETED|Overall Study||2
11212521|NCT01907334|12403535|FG000|STARTED|Overall Study||6
11212522|NCT01907334|12403536|FG001|STARTED|Overall Study||4
11212523|NCT01907334|12403535|FG000|COMPLETED|Overall Study||6
11212524|NCT01907334|12403536|FG001|COMPLETED|Overall Study||4
11212525|NCT01907334|12403535|FG000|NOT COMPLETED|Overall Study||0
11212526|NCT01907334|12403536|FG001|NOT COMPLETED|Overall Study||0
11212527|NCT01907490|12403541|FG000|STARTED|Overall Study||38
11212528|NCT01907490|12403541|FG000|COMPLETED|Overall Study||38
11212529|NCT01907490|12403541|FG000|NOT COMPLETED|Overall Study||0
11212530|NCT01907516|12403548|FG000|STARTED|First Intervention (3 Weeks)||50
11212531|NCT01907516|12403549|FG001|STARTED|First Intervention (3 Weeks)||50
11097173|NCT01211145|12280929|FG002|STARTED|Overall Study||99
11097174|NCT01211145|12280930|FG003|STARTED|Overall Study||288
11097175|NCT01211145|12280927|FG000|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
11097176|NCT01211145|12280928|FG001|COMPLETED|Overall Study||98
11097177|NCT01211145|12280929|FG002|COMPLETED|Overall Study||86
11097178|NCT01211145|12280930|FG003|COMPLETED|Overall Study||268
11097179|NCT01211145|12280927|FG000|NOT COMPLETED|Overall Study||26
11097180|NCT01211145|12280928|FG001|NOT COMPLETED|Overall Study||17
11212532|NCT01907516|12403548|FG000|COMPLETED|First Intervention (3 Weeks)||40
11212533|NCT01907516|12403549|FG001|COMPLETED|First Intervention (3 Weeks)||34
11212534|NCT01907516|12403548|FG000|NOT COMPLETED|First Intervention (3 Weeks)||10
11212535|NCT01907516|12403549|FG001|NOT COMPLETED|First Intervention (3 Weeks)||16
11212536|NCT01907516|12403548|FG000|STARTED|Second Intervention (3 Weeks)||40
11212537|NCT01907516|12403549|FG001|STARTED|Second Intervention (3 Weeks)||34
11212538|NCT01907516|12403548|FG000|COMPLETED|Second Intervention (3 Weeks)||40
11212539|NCT01907516|12403549|FG001|COMPLETED|Second Intervention (3 Weeks)||34
11212540|NCT01907516|12403548|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
11212541|NCT01907516|12403549|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
11212542|NCT01907607|12403556|FG000|STARTED|Overall Study||29
11212543|NCT01907607|12403556|FG000|COMPLETED|Overall Study||29
11212544|NCT01907607|12403556|FG000|NOT COMPLETED|Overall Study||0
11212545|NCT01907737|12403560|FG000|STARTED|Overall Study||22
11212546|NCT01907737|12403560|FG000|COMPLETED|Overall Study||21
11212547|NCT01907737|12403560|FG000|NOT COMPLETED|Overall Study||1
11212548|NCT01907815|12403572|FG000|STARTED|Overall Study||17
11212549|NCT01907815|12403573|FG001|STARTED|Overall Study||7
11212550|NCT01907815|12403572|FG000|COMPLETED|Overall Study||16
11212551|NCT01907815|12403573|FG001|COMPLETED|Overall Study||7
11212552|NCT01907815|12403572|FG000|NOT COMPLETED|Overall Study||1
11212553|NCT01907815|12403573|FG001|NOT COMPLETED|Overall Study||0
11212554|NCT01907828|12403583|FG000|STARTED|Overall Study||39
11212555|NCT01907828|12403584|FG001|STARTED|Overall Study||22
11212556|NCT01907828|12403583|FG000|Underwent Procedure|Overall Study||39
11212557|NCT01907828|12403584|FG001|Underwent Procedure|Overall Study|2 participants terminated early|20
11212558|NCT01907828|12403583|FG000|1-month Follow-up|Overall Study|2 participants terminated early|37
11212559|NCT01907828|12403584|FG001|1-month Follow-up|Overall Study|3 participants terminated early|17
11352609|NCT03049488|12549657|FG001|Received Optional Second Dose|Overall Study||11
11352610|NCT03049488|12549658|FG002|Received Optional Second Dose|Overall Study||11
11352611|NCT03049488|12549659|FG003|Received Optional Second Dose|Overall Study||9
11352612|NCT03049488|12549660|FG004|Received Optional Second Dose|Overall Study||11
11352613|NCT03049488|12549661|FG005|Received Optional Second Dose|Overall Study||10
11352614|NCT03049488|12549656|FG000|COMPLETED|Overall Study||13
11352615|NCT03049488|12549657|FG001|COMPLETED|Overall Study||13
11352616|NCT03049488|12549658|FG002|COMPLETED|Overall Study||20
11352617|NCT03049488|12549659|FG003|COMPLETED|Overall Study||13
11352618|NCT03049488|12549660|FG004|COMPLETED|Overall Study||13
11352619|NCT03049488|12549661|FG005|COMPLETED|Overall Study||15
11352620|NCT03049488|12549656|FG000|NOT COMPLETED|Overall Study||2
11352621|NCT03049488|12549657|FG001|NOT COMPLETED|Overall Study||2
11352622|NCT03049488|12549658|FG002|NOT COMPLETED|Overall Study||0
11352623|NCT03049488|12549659|FG003|NOT COMPLETED|Overall Study||2
11352624|NCT03049488|12549660|FG004|NOT COMPLETED|Overall Study||2
11352625|NCT03049488|12549661|FG005|NOT COMPLETED|Overall Study||0
11352626|NCT03049501|12549678|FG000|STARTED|Overall Study||123
11352627|NCT03049501|12549679|FG001|STARTED|Overall Study||121
11352628|NCT03049501|12549678|FG000|6 Month Follow up|Overall Study||107
11352629|NCT03049501|12549679|FG001|6 Month Follow up|Overall Study||91
11352630|NCT03049501|12549678|FG000|12 Month Follow up|Overall Study||101
11352631|NCT03049501|12549679|FG001|12 Month Follow up|Overall Study||92
11352632|NCT03049501|12549678|FG000|COMPLETED|Overall Study||101
11352633|NCT03049501|12549679|FG001|COMPLETED|Overall Study||92
11352634|NCT03049501|12549678|FG000|NOT COMPLETED|Overall Study||22
11352635|NCT03049501|12549679|FG001|NOT COMPLETED|Overall Study||29
11352636|NCT03049748|12549687|FG000|STARTED|Overall Study||20
11352637|NCT03049748|12549688|FG001|STARTED|Overall Study||20
11352638|NCT03049748|12549687|FG000|COMPLETED|Overall Study||16
11352639|NCT03049748|12549688|FG001|COMPLETED|Overall Study||14
11352640|NCT03049748|12549687|FG000|NOT COMPLETED|Overall Study||4
11352641|NCT03049748|12549688|FG001|NOT COMPLETED|Overall Study||6
11352642|NCT03049852|12549697|FG000|STARTED|Overall Study||24
11352643|NCT03049852|12549698|FG001|STARTED|Overall Study||25
11352644|NCT03049852|12549699|FG002|STARTED|Overall Study||26
11352645|NCT03049852|12549697|FG000|COMPLETED|Overall Study||24
11352646|NCT03049852|12549698|FG001|COMPLETED|Overall Study||24
11352647|NCT03049852|12549699|FG002|COMPLETED|Overall Study||26
11352648|NCT03049852|12549697|FG000|NOT COMPLETED|Overall Study||0
11352649|NCT03049852|12549698|FG001|NOT COMPLETED|Overall Study||1
11352650|NCT03049852|12549699|FG002|NOT COMPLETED|Overall Study||0
11352651|NCT03049917|12549714|FG000|STARTED|Overall Study||90
11352652|NCT03049917|12549715|FG001|STARTED|Overall Study||89
11352653|NCT03049917|12549716|FG002|STARTED|Overall Study||93
11352654|NCT03049917|12549717|FG003|STARTED|Overall Study||92
11352655|NCT03049917|12549718|FG004|STARTED|Overall Study||88
11352656|NCT03049917|12549714|FG000|COMPLETED|Overall Study||31
11352657|NCT03049917|12549715|FG001|COMPLETED|Overall Study||31
11352658|NCT03049917|12549716|FG002|COMPLETED|Overall Study||44
11352659|NCT03049917|12549717|FG003|COMPLETED|Overall Study||51
11352660|NCT03049917|12549718|FG004|COMPLETED|Overall Study||54
11352661|NCT03049917|12549714|FG000|NOT COMPLETED|Overall Study||59
11352662|NCT03049917|12549715|FG001|NOT COMPLETED|Overall Study||58
11352663|NCT03049917|12549716|FG002|NOT COMPLETED|Overall Study||49
11352664|NCT03049917|12549717|FG003|NOT COMPLETED|Overall Study||41
11352665|NCT03049917|12549718|FG004|NOT COMPLETED|Overall Study||34
11352666|NCT03050203|12549754|FG000|STARTED|Overall Study||19
11352667|NCT03050203|12549755|FG001|STARTED|Overall Study||18
11352668|NCT03050203|12549754|FG000|COMPLETED|Overall Study||19
11352669|NCT03050203|12549755|FG001|COMPLETED|Overall Study||18
11352670|NCT03050203|12549754|FG000|NOT COMPLETED|Overall Study||0
11352671|NCT03050203|12549755|FG001|NOT COMPLETED|Overall Study||0
11352672|NCT03050216|12549761|FG000|STARTED|Overall Study||8
11212560|NCT01907828|12403583|FG000|3-month Follow-up|Overall Study|1 participant terminated early|36
11212561|NCT01907828|12403584|FG001|3-month Follow-up|Overall Study|1 participant terminated early|16
11212562|NCT01907828|12403583|FG000|6-month Follow-up|Overall Study|1 participant terminated early|35
11097181|NCT01211145|12280929|FG002|NOT COMPLETED|Overall Study||13
11097182|NCT01211145|12280930|FG003|NOT COMPLETED|Overall Study||20
11097183|NCT01211184|12280943|FG000|STARTED|Overall Study||20
11097184|NCT01211184|12280944|FG001|STARTED|Overall Study||20
11097185|NCT01211184|12280945|FG002|STARTED|Overall Study||20
11097186|NCT01211184|12280943|FG000|COMPLETED|Overall Study||20
11097187|NCT01211184|12280944|FG001|COMPLETED|Overall Study||18
11097188|NCT01211184|12280945|FG002|COMPLETED|Overall Study||19
11097189|NCT01211184|12280943|FG000|NOT COMPLETED|Overall Study||0
11097190|NCT01211184|12280944|FG001|NOT COMPLETED|Overall Study||2
11097191|NCT01211184|12280945|FG002|NOT COMPLETED|Overall Study||1
11097192|NCT01211197|12280956|FG000|STARTED|Treatment Period 1 (1 Day)||3
11097193|NCT01211197|12280957|FG001|STARTED|Treatment Period 1 (1 Day)||3
11097194|NCT01211197|12280958|FG002|STARTED|Treatment Period 1 (1 Day)||3
11097195|NCT01211197|12280959|FG003|STARTED|Treatment Period 1 (1 Day)||3
11097196|NCT01211197|12280960|FG004|STARTED|Treatment Period 1 (1 Day)||2
11097197|NCT01211197|12280961|FG005|STARTED|Treatment Period 1 (1 Day)||2
11097198|NCT01211197|12280956|FG000|COMPLETED|Treatment Period 1 (1 Day)||3
11097199|NCT01211197|12280957|FG001|COMPLETED|Treatment Period 1 (1 Day)||3
11097200|NCT01211197|12280958|FG002|COMPLETED|Treatment Period 1 (1 Day)||3
11097201|NCT01211197|12280959|FG003|COMPLETED|Treatment Period 1 (1 Day)||3
11097202|NCT01211197|12280960|FG004|COMPLETED|Treatment Period 1 (1 Day)||2
11097203|NCT01211197|12280961|FG005|COMPLETED|Treatment Period 1 (1 Day)||2
11097204|NCT01211197|12280956|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11097205|NCT01211197|12280957|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11097206|NCT01211197|12280958|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11097207|NCT01211197|12280959|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11097208|NCT01211197|12280960|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11097209|NCT01211197|12280961|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11097210|NCT01211197|12280956|FG000|STARTED|Washout Period 1 (7 Days)||3
11097211|NCT01211197|12280957|FG001|STARTED|Washout Period 1 (7 Days)||3
11097212|NCT01211197|12280958|FG002|STARTED|Washout Period 1 (7 Days)||3
11097213|NCT01211197|12280959|FG003|STARTED|Washout Period 1 (7 Days)||3
11097214|NCT01211197|12280960|FG004|STARTED|Washout Period 1 (7 Days)||2
11097215|NCT01211197|12280961|FG005|STARTED|Washout Period 1 (7 Days)||2
11097216|NCT01211197|12280956|FG000|COMPLETED|Washout Period 1 (7 Days)||3
11097217|NCT01211197|12280957|FG001|COMPLETED|Washout Period 1 (7 Days)||3
11097218|NCT01211197|12280958|FG002|COMPLETED|Washout Period 1 (7 Days)||2
11097219|NCT01211197|12280959|FG003|COMPLETED|Washout Period 1 (7 Days)||3
11097220|NCT01211197|12280960|FG004|COMPLETED|Washout Period 1 (7 Days)||2
11097221|NCT01211197|12280961|FG005|COMPLETED|Washout Period 1 (7 Days)||2
11097222|NCT01211197|12280956|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
11097223|NCT01211197|12280957|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
11097224|NCT01211197|12280958|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
11097225|NCT01211197|12280959|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
11097226|NCT01211197|12280960|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
11097227|NCT01211197|12280961|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
11097228|NCT01211197|12280956|FG000|STARTED|Treatment Period 2 (1 Day)||3
11097229|NCT01211197|12280957|FG001|STARTED|Treatment Period 2 (1 Day)||3
11097230|NCT01211197|12280958|FG002|STARTED|Treatment Period 2 (1 Day)||2
11097231|NCT01211197|12280959|FG003|STARTED|Treatment Period 2 (1 Day)||3
11097232|NCT01211197|12280960|FG004|STARTED|Treatment Period 2 (1 Day)||2
11097233|NCT01211197|12280961|FG005|STARTED|Treatment Period 2 (1 Day)||2
11097234|NCT01211197|12280956|FG000|COMPLETED|Treatment Period 2 (1 Day)||3
11097235|NCT01211197|12280957|FG001|COMPLETED|Treatment Period 2 (1 Day)||3
11097236|NCT01211197|12280958|FG002|COMPLETED|Treatment Period 2 (1 Day)||2
11097237|NCT01211197|12280959|FG003|COMPLETED|Treatment Period 2 (1 Day)||3
11097238|NCT01211197|12280960|FG004|COMPLETED|Treatment Period 2 (1 Day)||2
11097239|NCT01211197|12280961|FG005|COMPLETED|Treatment Period 2 (1 Day)||2
11097240|NCT01211197|12280956|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11097241|NCT01211197|12280957|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11097242|NCT01211197|12280958|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11097243|NCT01211197|12280959|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11212563|NCT01907828|12403584|FG001|6-month Follow-up|Overall Study||16
11212564|NCT01907828|12403583|FG000|12-month Follow-up|Overall Study|1 participant terminated early|34
11097244|NCT01211197|12280960|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11097245|NCT01211197|12280961|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11097246|NCT01211197|12280956|FG000|STARTED|Washout Period 2 (7 Days)||3
11212565|NCT01907828|12403584|FG001|12-month Follow-up|Overall Study||16
11097247|NCT01211197|12280957|FG001|STARTED|Washout Period 2 (7 Days)||3
11097248|NCT01211197|12280958|FG002|STARTED|Washout Period 2 (7 Days)||2
11097249|NCT01211197|12280959|FG003|STARTED|Washout Period 2 (7 Days)||3
11097250|NCT01211197|12280960|FG004|STARTED|Washout Period 2 (7 Days)||2
11097251|NCT01211197|12280961|FG005|STARTED|Washout Period 2 (7 Days)||2
11097252|NCT01211197|12280956|FG000|COMPLETED|Washout Period 2 (7 Days)||2
11097253|NCT01211197|12280957|FG001|COMPLETED|Washout Period 2 (7 Days)||3
11097254|NCT01211197|12280958|FG002|COMPLETED|Washout Period 2 (7 Days)||2
11097255|NCT01211197|12280959|FG003|COMPLETED|Washout Period 2 (7 Days)||3
11097256|NCT01211197|12280960|FG004|COMPLETED|Washout Period 2 (7 Days)||2
11097257|NCT01211197|12280961|FG005|COMPLETED|Washout Period 2 (7 Days)||2
11097258|NCT01211197|12280956|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1
11097259|NCT01211197|12280957|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
11097260|NCT01211197|12280958|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
11097261|NCT01211197|12280959|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
11097262|NCT01211197|12280960|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
11097263|NCT01211197|12280961|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
11097264|NCT01211197|12280956|FG000|STARTED|Treatment Period 3 (1 Day)||2
11097265|NCT01211197|12280957|FG001|STARTED|Treatment Period 3 (1 Day)||3
11097266|NCT01211197|12280958|FG002|STARTED|Treatment Period 3 (1 Day)||2
11097267|NCT01211197|12280959|FG003|STARTED|Treatment Period 3 (1 Day)||3
11097268|NCT01211197|12280960|FG004|STARTED|Treatment Period 3 (1 Day)||2
11097269|NCT01211197|12280961|FG005|STARTED|Treatment Period 3 (1 Day)||2
11097270|NCT01211197|12280956|FG000|COMPLETED|Treatment Period 3 (1 Day)||2
11097271|NCT01211197|12280957|FG001|COMPLETED|Treatment Period 3 (1 Day)||3
11097272|NCT01211197|12280958|FG002|COMPLETED|Treatment Period 3 (1 Day)||2
11097273|NCT01211197|12280959|FG003|COMPLETED|Treatment Period 3 (1 Day)||3
11097274|NCT01211197|12280960|FG004|COMPLETED|Treatment Period 3 (1 Day)||2
11097275|NCT01211197|12280961|FG005|COMPLETED|Treatment Period 3 (1 Day)||2
11097276|NCT01211197|12280956|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11097277|NCT01211197|12280957|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11097278|NCT01211197|12280958|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11097279|NCT01211197|12280959|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11097280|NCT01211197|12280960|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11097281|NCT01211197|12280961|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11097282|NCT01211262|12280971|FG000|STARTED|Overall Study||66
11097283|NCT01211262|12280972|FG001|STARTED|Overall Study||18
11097284|NCT01211262|12280971|FG000|COMPLETED|Overall Study||43
11212566|NCT01907828|12403583|FG000|24-month Follow-up|Overall Study|2 participants terminated early|32
11212567|NCT01907828|12403584|FG001|24-month Follow-up|Overall Study||16
11212568|NCT01907828|12403583|FG000|COMPLETED|Overall Study||32
11212569|NCT01907828|12403584|FG001|COMPLETED|Overall Study||16
11212570|NCT01907828|12403583|FG000|NOT COMPLETED|Overall Study||7
11212571|NCT01907828|12403584|FG001|NOT COMPLETED|Overall Study||6
11212572|NCT01907854|12403592|FG000|STARTED|Overall Study||203
11212573|NCT01907854|12403593|FG001|STARTED|Overall Study||204
11212574|NCT01907854|12403592|FG000|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
11212575|NCT01907854|12403593|FG001|Exposed|Overall Study||204
11097285|NCT01211262|12280972|FG001|COMPLETED|Overall Study||8
11097286|NCT01211262|12280971|FG000|NOT COMPLETED|Overall Study||23
11097287|NCT01211262|12280972|FG001|NOT COMPLETED|Overall Study||10
11097288|NCT01211288|12280983|FG000|STARTED|Overall Study||21
11097289|NCT01211288|12280984|FG001|STARTED|Overall Study||20
11212576|NCT01907854|12403592|FG000|COMPLETED|Overall Study||187
11212577|NCT01907854|12403593|FG001|COMPLETED|Overall Study||191
11212578|NCT01907854|12403592|FG000|NOT COMPLETED|Overall Study||16
11212579|NCT01907854|12403593|FG001|NOT COMPLETED|Overall Study||13
11212580|NCT01907906|12403601|FG000|STARTED|Overall Study||16
11212581|NCT01907906|12403602|FG001|STARTED|Overall Study||13
11097290|NCT01211288|12280983|FG000|COMPLETED|Overall Study||20
11097291|NCT01211288|12280984|FG001|COMPLETED|Overall Study||19
11212582|NCT01907906|12403601|FG000|COMPLETED|Overall Study||12
11212583|NCT01907906|12403602|FG001|COMPLETED|Overall Study||12
11212584|NCT01907906|12403601|FG000|NOT COMPLETED|Overall Study||4
11212585|NCT01907906|12403602|FG001|NOT COMPLETED|Overall Study||1
11212586|NCT01908062|12403612|FG000|STARTED|Overall Study||26
11212587|NCT01908062|12403613|FG001|STARTED|Overall Study||25
11212588|NCT01908062|12403612|FG000|COMPLETED|Overall Study||24
11212589|NCT01908062|12403613|FG001|COMPLETED|Overall Study||22
11212590|NCT01908062|12403612|FG000|NOT COMPLETED|Overall Study||2
11212591|NCT01908062|12403613|FG001|NOT COMPLETED|Overall Study||3
11212592|NCT01908101|12403622|FG000|STARTED|Overall Study||68
11212593|NCT01908101|12403622|FG000|COMPLETED|Overall Study||59
11212594|NCT01908101|12403622|FG000|NOT COMPLETED|Overall Study||9
11212595|NCT01908127|12403628|FG000|STARTED|Overall Study||23
11212596|NCT01908127|12403629|FG001|STARTED|Overall Study||23
11212597|NCT01908127|12403628|FG000|COMPLETED|Overall Study||22
11212598|NCT01908127|12403629|FG001|COMPLETED|Overall Study||23
11212599|NCT01908127|12403628|FG000|NOT COMPLETED|Overall Study||1
11212600|NCT01908127|12403629|FG001|NOT COMPLETED|Overall Study||0
11212601|NCT01908140|12403637|FG000|STARTED|Overall Study||468
11212602|NCT01908140|12403638|FG001|STARTED|Overall Study||465
11212603|NCT01908140|12403637|FG000|COMPLETED|Overall Study||402
11212604|NCT01908140|12403638|FG001|COMPLETED|Overall Study||386
11212605|NCT01908140|12403637|FG000|NOT COMPLETED|Overall Study||66
11212606|NCT01908140|12403638|FG001|NOT COMPLETED|Overall Study||79
11212607|NCT01908205|12403646|FG000|STARTED|Overall Study||30
11212608|NCT01908205|12403647|FG001|STARTED|Overall Study||30
11212609|NCT01908205|12403646|FG000|COMPLETED|Overall Study||25
11212610|NCT01908205|12403647|FG001|COMPLETED|Overall Study||29
11212611|NCT01908205|12403646|FG000|NOT COMPLETED|Overall Study||5
11212612|NCT01908205|12403647|FG001|NOT COMPLETED|Overall Study||1
11212613|NCT01908426|12403668|FG000|STARTED|Overall Study||470
11212614|NCT01908426|12403669|FG001|STARTED|Overall Study||237
11212615|NCT01908426|12403668|FG000|COMPLETED|Overall Study||73
11212616|NCT01908426|12403669|FG001|COMPLETED|Overall Study||26
11212617|NCT01908426|12403668|FG000|NOT COMPLETED|Overall Study||397
11212618|NCT01908426|12403669|FG001|NOT COMPLETED|Overall Study||211
11212619|NCT01908530|12403678|FG000|STARTED|Overall Study||8
11212620|NCT01908530|12403679|FG001|STARTED|Overall Study||8
11212621|NCT01908530|12403680|FG002|STARTED|Overall Study||10
11212622|NCT01908530|12403678|FG000|COMPLETED|Overall Study||8
11212623|NCT01908530|12403679|FG001|COMPLETED|Overall Study||8
11212624|NCT01908530|12403680|FG002|COMPLETED|Overall Study||10
11212625|NCT01908530|12403678|FG000|NOT COMPLETED|Overall Study||0
11352673|NCT03050216|12549761|FG000|COMPLETED|Overall Study||8
11352674|NCT03050216|12549761|FG000|NOT COMPLETED|Overall Study||0
11212626|NCT01908530|12403679|FG001|NOT COMPLETED|Overall Study||0
11212627|NCT01908530|12403680|FG002|NOT COMPLETED|Overall Study||0
11212628|NCT01908582|12403691|FG000|STARTED|Period 1||26
11352675|NCT03050294|12549769|FG000|STARTED|Overall Study||6
11352676|NCT03050294|12549770|FG001|STARTED|Overall Study||6
11352677|NCT03050294|12549771|FG002|STARTED|Overall Study||6
11352678|NCT03050294|12549772|FG003|STARTED|Overall Study||6
11352679|NCT03050294|12549769|FG000|COMPLETED|Overall Study||6
11352680|NCT03050294|12549770|FG001|COMPLETED|Overall Study||6
11352681|NCT03050294|12549771|FG002|COMPLETED|Overall Study||6
11352682|NCT03050294|12549772|FG003|COMPLETED|Overall Study||6
11212629|NCT01908582|12403691|FG000|Received at Least One Dose of Study Drug|Period 1||26
11212630|NCT01908582|12403691|FG000|COMPLETED|Period 1||26
11212631|NCT01908582|12403691|FG000|NOT COMPLETED|Period 1||0
11212632|NCT01908582|12403691|FG000|STARTED|Period 2||26
11212633|NCT01908582|12403691|FG000|COMPLETED|Period 2||24
11212634|NCT01908582|12403691|FG000|NOT COMPLETED|Period 2||2
11212635|NCT01908634|12403698|FG000|STARTED|Milk-based Strawberry Beverage With Meal||10
11212636|NCT01908634|12403698|FG000|COMPLETED|Milk-based Strawberry Beverage With Meal||10
11212637|NCT01908634|12403698|FG000|NOT COMPLETED|Milk-based Strawberry Beverage With Meal||0
11212638|NCT01908634|12403698|FG000|STARTED|Water-based Strawberry Beverage Wit Meal||10
11212639|NCT01908634|12403698|FG000|COMPLETED|Water-based Strawberry Beverage Wit Meal||9
11212640|NCT01908634|12403698|FG000|NOT COMPLETED|Water-based Strawberry Beverage Wit Meal||1
11212641|NCT01908634|12403698|FG000|STARTED|Milk-based Strawberry Beverage w/o Meal||9
11212642|NCT01908634|12403698|FG000|COMPLETED|Milk-based Strawberry Beverage w/o Meal||4
11212643|NCT01908634|12403698|FG000|NOT COMPLETED|Milk-based Strawberry Beverage w/o Meal||5
11212644|NCT01908634|12403698|FG000|STARTED|Water-based Strawberry Beverage w/o Meal||4
11212645|NCT01908634|12403698|FG000|COMPLETED|Water-based Strawberry Beverage w/o Meal||4
11212646|NCT01908634|12403698|FG000|NOT COMPLETED|Water-based Strawberry Beverage w/o Meal||0
11212647|NCT01908699|12403708|FG000|STARTED|Overall Study||137
11212648|NCT01908699|12403709|FG001|STARTED|Overall Study||136
11212649|NCT01908699|12403708|FG000|Received at Least 1 Dose of Study Drug|Overall Study||136
11212650|NCT01908699|12403709|FG001|Received at Least 1 Dose of Study Drug|Overall Study||135
11212651|NCT01908699|12403708|FG000|COMPLETED|Overall Study||62
11212652|NCT01908699|12403709|FG001|COMPLETED|Overall Study||58
11212653|NCT01908699|12403708|FG000|NOT COMPLETED|Overall Study||75
11212654|NCT01908699|12403709|FG001|NOT COMPLETED|Overall Study||78
11212655|NCT01908751|12403719|FG000|STARTED|Overall Study||22
11212656|NCT01908751|12403720|FG001|STARTED|Overall Study||23
11212657|NCT01908751|12403721|FG002|STARTED|Overall Study||21
11212658|NCT01908751|12403722|FG003|STARTED|Overall Study||20
11212659|NCT01908751|12403719|FG000|COMPLETED|Overall Study||17
11212660|NCT01908751|12403720|FG001|COMPLETED|Overall Study||18
11212661|NCT01908751|12403721|FG002|COMPLETED|Overall Study||16
11212662|NCT01908751|12403722|FG003|COMPLETED|Overall Study||16
11212663|NCT01908751|12403719|FG000|NOT COMPLETED|Overall Study||5
11212664|NCT01908751|12403720|FG001|NOT COMPLETED|Overall Study||5
11212665|NCT01908751|12403721|FG002|NOT COMPLETED|Overall Study||5
11212666|NCT01908751|12403722|FG003|NOT COMPLETED|Overall Study||4
11212667|NCT01908803|12403734|FG000|STARTED|Overall Study||46
11212668|NCT01908803|12403735|FG001|STARTED|Overall Study||24
11212669|NCT01908803|12403734|FG000|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
11212670|NCT01908803|12403735|FG001|Treated|Overall Study||24
11212671|NCT01908803|12403734|FG000|COMPLETED|Overall Study||42
11212672|NCT01908803|12403735|FG001|COMPLETED|Overall Study||23
11212673|NCT01908803|12403734|FG000|NOT COMPLETED|Overall Study||4
11212674|NCT01908803|12403735|FG001|NOT COMPLETED|Overall Study||1
11212675|NCT01908816|12403746|FG000|STARTED|Overall Study||93
11212676|NCT01908816|12403747|FG001|STARTED|Overall Study||84
11212677|NCT01908816|12403748|FG002|STARTED|Overall Study||58
11212678|NCT01908816|12403749|FG003|STARTED|Overall Study||35
11212679|NCT01908816|12403746|FG000|COMPLETED|Overall Study||0
11212680|NCT01908816|12403747|FG001|COMPLETED|Overall Study||0
11212681|NCT01908816|12403748|FG002|COMPLETED|Overall Study||0
11212682|NCT01908816|12403749|FG003|COMPLETED|Overall Study||0
11212683|NCT01908816|12403746|FG000|NOT COMPLETED|Overall Study||93
11212684|NCT01908816|12403747|FG001|NOT COMPLETED|Overall Study||84
11212685|NCT01908816|12403748|FG002|NOT COMPLETED|Overall Study||58
11212686|NCT01908816|12403749|FG003|NOT COMPLETED|Overall Study||35
11212687|NCT01908829|12403765|FG000|STARTED|Overall Study||727
11212688|NCT01908829|12403766|FG001|STARTED|Overall Study||728
11212689|NCT01908829|12403767|FG002|STARTED|Overall Study||719
11212690|NCT01908829|12403765|FG000|Treated With Double-blind Drug|Overall Study||725
11212691|NCT01908829|12403766|FG001|Treated With Double-blind Drug|Overall Study||728
11212692|NCT01908829|12403767|FG002|Treated With Double-blind Drug|Overall Study||719
11212693|NCT01908829|12403765|FG000|COMPLETED|Overall Study||678
11212694|NCT01908829|12403766|FG001|COMPLETED|Overall Study||679
11212695|NCT01908829|12403767|FG002|COMPLETED|Overall Study||680
11212696|NCT01908829|12403765|FG000|NOT COMPLETED|Overall Study||49
11212697|NCT01908829|12403766|FG001|NOT COMPLETED|Overall Study||49
11212698|NCT01908829|12403767|FG002|NOT COMPLETED|Overall Study||39
11212699|NCT01908842|12403777|FG000|STARTED|Induction||383
11212700|NCT01908842|12403778|FG001|STARTED|Induction||375
11212701|NCT01908842|12403777|FG000|COMPLETED|Induction||357
11212702|NCT01908842|12403778|FG001|COMPLETED|Induction||344
11212703|NCT01908842|12403777|FG000|NOT COMPLETED|Induction||26
11212704|NCT01908842|12403778|FG001|NOT COMPLETED|Induction||31
11212705|NCT01908842|12403777|FG000|STARTED|Switch to Other BNX Formulation (Day 15)||357
11212706|NCT01908842|12403778|FG001|STARTED|Switch to Other BNX Formulation (Day 15)||344
11212707|NCT01908842|12403777|FG000|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
11212708|NCT01908842|12403778|FG001|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
11212709|NCT01908842|12403777|FG000|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
11212710|NCT01908842|12403778|FG001|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
11212711|NCT01908842|12403777|FG000|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
11212712|NCT01908842|12403778|FG001|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
11212713|NCT01908842|12403777|FG000|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
11212714|NCT01908842|12403778|FG001|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
11212715|NCT01908842|12403777|FG000|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
11212716|NCT01908842|12403778|FG001|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
11212717|NCT01908907|12403786|FG000|STARTED|Overall Study||31
11212718|NCT01908907|12403787|FG001|STARTED|Overall Study||29
11212719|NCT01908907|12403786|FG000|COMPLETED|Overall Study||29
11212720|NCT01908907|12403787|FG001|COMPLETED|Overall Study||29
11212721|NCT01908907|12403786|FG000|NOT COMPLETED|Overall Study||2
11212722|NCT01908907|12403787|FG001|NOT COMPLETED|Overall Study||0
11212723|NCT01908972|12403799|FG000|STARTED|Overall Study||17
11212724|NCT01908972|12403800|FG001|STARTED|Overall Study||17
11212725|NCT01908972|12403799|FG000|COMPLETED|Overall Study||15
11212726|NCT01908972|12403800|FG001|COMPLETED|Overall Study||17
11212727|NCT01908972|12403799|FG000|NOT COMPLETED|Overall Study||2
11212728|NCT01908972|12403800|FG001|NOT COMPLETED|Overall Study||0
11212729|NCT01909011|12403808|FG000|STARTED|Overall Study||7
11212730|NCT01909011|12403809|FG001|STARTED|Overall Study||9
11212731|NCT01909011|12403808|FG000|COMPLETED|Overall Study||7
11212732|NCT01909011|12403809|FG001|COMPLETED|Overall Study||9
11212733|NCT01909011|12403808|FG000|NOT COMPLETED|Overall Study||0
11212734|NCT01909011|12403809|FG001|NOT COMPLETED|Overall Study||0
11212735|NCT01909141|12403817|FG000|STARTED|Overall Study||50
11212736|NCT01909141|12403818|FG001|STARTED|Overall Study||50
11212737|NCT01909141|12403817|FG000|COMPLETED|Overall Study||50
11212738|NCT01909141|12403818|FG001|COMPLETED|Overall Study||50
11212739|NCT01909141|12403817|FG000|NOT COMPLETED|Overall Study||0
11212740|NCT01909141|12403818|FG001|NOT COMPLETED|Overall Study||0
11212741|NCT01909154|12403826|FG000|STARTED|Overall Study||12
11212742|NCT01909154|12403826|FG000|COMPLETED|Overall Study||12
11212743|NCT01909154|12403826|FG000|NOT COMPLETED|Overall Study||0
11212744|NCT01909180|12403830|FG000|STARTED|Overall Study||49
11212745|NCT01909180|12403830|FG000|COMPLETED|Overall Study||49
11212746|NCT01909180|12403830|FG000|NOT COMPLETED|Overall Study||0
11212747|NCT01909336|12403839|FG000|STARTED|Overall Study||53
11212748|NCT01909336|12403840|FG001|STARTED|Overall Study||53
11212749|NCT01909336|12403841|FG002|STARTED|Overall Study||55
11212750|NCT01909336|12403839|FG000|COMPLETED|Overall Study||49
11212751|NCT01909336|12403840|FG001|COMPLETED|Overall Study||50
11212752|NCT01909336|12403841|FG002|COMPLETED|Overall Study||52
11212753|NCT01909336|12403839|FG000|NOT COMPLETED|Overall Study||4
11212754|NCT01909336|12403840|FG001|NOT COMPLETED|Overall Study||3
11212755|NCT01909336|12403841|FG002|NOT COMPLETED|Overall Study||3
11212756|NCT01909466|12403849|FG000|STARTED|Overall Study||68
11212757|NCT01909466|12403850|FG001|STARTED|Overall Study||73
11212758|NCT01909466|12403849|FG000|COMPLETED|Overall Study||46
11212759|NCT01909466|12403850|FG001|COMPLETED|Overall Study||50
11212760|NCT01909466|12403849|FG000|NOT COMPLETED|Overall Study||22
11212761|NCT01909466|12403850|FG001|NOT COMPLETED|Overall Study||23
11212762|NCT01909674|12403856|FG000|STARTED|Overall Study||12
11212763|NCT01909674|12403857|FG001|STARTED|Overall Study||9
11212764|NCT01909674|12403856|FG000|COMPLETED|Overall Study||7
11212765|NCT01909674|12403857|FG001|COMPLETED|Overall Study||7
11212766|NCT01909674|12403856|FG000|NOT COMPLETED|Overall Study||5
11212767|NCT01909674|12403857|FG001|NOT COMPLETED|Overall Study||2
11212768|NCT01909778|12403863|FG000|STARTED|Overall Study||2
11212769|NCT01909778|12403863|FG000|COMPLETED|Overall Study||1
11212770|NCT01909778|12403863|FG000|NOT COMPLETED|Overall Study||1
11212771|NCT01909791|12403872|FG000|STARTED|Overall Study||226
11212772|NCT01909791|12403873|FG001|STARTED|Overall Study||240
11212773|NCT01909791|12403874|FG002|STARTED|Overall Study||236
11212774|NCT01909791|12403872|FG000|COMPLETED|Overall Study||205
11212775|NCT01909791|12403873|FG001|COMPLETED|Overall Study||212
11212776|NCT01909791|12403874|FG002|COMPLETED|Overall Study||208
11212777|NCT01909791|12403872|FG000|NOT COMPLETED|Overall Study||21
11212778|NCT01909791|12403873|FG001|NOT COMPLETED|Overall Study||28
11212779|NCT01909791|12403874|FG002|NOT COMPLETED|Overall Study||28
11212780|NCT01909804|12403899|FG000|STARTED|Overall Study||26
11212781|NCT01909804|12403900|FG001|STARTED|Overall Study||28
11212782|NCT01909804|12403901|FG002|STARTED|Overall Study||27
11212783|NCT01909804|12403902|FG003|STARTED|Overall Study||26
11212784|NCT01909804|12403903|FG004|STARTED|Overall Study||26
11212785|NCT01909804|12403904|FG005|STARTED|Overall Study||25
11212786|NCT01909804|12403905|FG006|STARTED|Overall Study||27
11212787|NCT01909804|12403906|FG007|STARTED|Overall Study||26
11212788|NCT01909804|12403907|FG008|STARTED|Overall Study||27
11212789|NCT01909804|12403908|FG009|STARTED|Overall Study||29
11212790|NCT01909804|12403909|FG010|STARTED|Overall Study||27
11212791|NCT01909804|12403910|FG011|STARTED|Overall Study||29
11212792|NCT01909804|12403899|FG000|COMPLETED|Overall Study||22
11212793|NCT01909804|12403900|FG001|COMPLETED|Overall Study||27
11212794|NCT01909804|12403901|FG002|COMPLETED|Overall Study||27
11212795|NCT01909804|12403902|FG003|COMPLETED|Overall Study||26
11212796|NCT01909804|12403903|FG004|COMPLETED|Overall Study||18
11212797|NCT01909804|12403904|FG005|COMPLETED|Overall Study||21
11212798|NCT01909804|12403905|FG006|COMPLETED|Overall Study||25
11212799|NCT01909804|12403906|FG007|COMPLETED|Overall Study||25
11212800|NCT01909804|12403907|FG008|COMPLETED|Overall Study||27
11212801|NCT01909804|12403908|FG009|COMPLETED|Overall Study||28
11212802|NCT01909804|12403909|FG010|COMPLETED|Overall Study||26
11212803|NCT01909804|12403910|FG011|COMPLETED|Overall Study||26
11212804|NCT01909804|12403899|FG000|NOT COMPLETED|Overall Study||4
11212805|NCT01909804|12403900|FG001|NOT COMPLETED|Overall Study||1
11212806|NCT01909804|12403901|FG002|NOT COMPLETED|Overall Study||0
11212807|NCT01909804|12403902|FG003|NOT COMPLETED|Overall Study||0
11212808|NCT01909804|12403903|FG004|NOT COMPLETED|Overall Study||8
11212809|NCT01909804|12403904|FG005|NOT COMPLETED|Overall Study||4
11212810|NCT01909804|12403905|FG006|NOT COMPLETED|Overall Study||2
11212811|NCT01909804|12403906|FG007|NOT COMPLETED|Overall Study||1
11212812|NCT01909804|12403907|FG008|NOT COMPLETED|Overall Study||0
11212813|NCT01909804|12403908|FG009|NOT COMPLETED|Overall Study||1
11212814|NCT01909804|12403909|FG010|NOT COMPLETED|Overall Study||1
11212815|NCT01909804|12403910|FG011|NOT COMPLETED|Overall Study||3
11212816|NCT01909973|12403934|FG000|STARTED|Overall Study||8
11212817|NCT01909973|12403935|FG001|STARTED|Overall Study||7
11212818|NCT01909973|12403934|FG000|COMPLETED|Overall Study||7
11212819|NCT01909973|12403935|FG001|COMPLETED|Overall Study||7
11212820|NCT01909973|12403934|FG000|NOT COMPLETED|Overall Study||1
11212821|NCT01909973|12403935|FG001|NOT COMPLETED|Overall Study||0
11212822|NCT01910064|12403941|FG000|STARTED|Overall Study||436
11212823|NCT01910064|12403941|FG000|COMPLETED|Overall Study||391
11212824|NCT01910064|12403941|FG000|NOT COMPLETED|Overall Study||45
11352683|NCT03050294|12549769|FG000|NOT COMPLETED|Overall Study||0
11352684|NCT03050294|12549770|FG001|NOT COMPLETED|Overall Study||0
11352685|NCT03050294|12549771|FG002|NOT COMPLETED|Overall Study||0
11352686|NCT03050294|12549772|FG003|NOT COMPLETED|Overall Study||0
11352687|NCT03050307|12549784|FG000|STARTED|Overall Study||115
11352688|NCT03050307|12549785|FG001|STARTED|Overall Study||119
11352689|NCT03050307|12549784|FG000|COMPLETED|Overall Study||107
11352690|NCT03050307|12549785|FG001|COMPLETED|Overall Study||110
11352691|NCT03050307|12549784|FG000|NOT COMPLETED|Overall Study||8
11352692|NCT03050307|12549785|FG001|NOT COMPLETED|Overall Study||9
11352693|NCT03050320|12549795|FG000|STARTED|Overall Study||21
11352694|NCT03050320|12549796|FG001|STARTED|Overall Study||22
11352695|NCT03050320|12549795|FG000|COMPLETED|Overall Study||20
11352696|NCT03050320|12549796|FG001|COMPLETED|Overall Study||21
11352697|NCT03050320|12549795|FG000|NOT COMPLETED|Overall Study||1
11352698|NCT03050320|12549796|FG001|NOT COMPLETED|Overall Study||1
11352699|NCT03050359|12549804|FG000|STARTED|Overall Study||265
11352700|NCT03050359|12549805|FG001|STARTED|Overall Study||268
11352701|NCT03050359|12549804|FG000|COMPLETED|Overall Study||248
11352702|NCT03050359|12549805|FG001|COMPLETED|Overall Study||248
11352703|NCT03050359|12549804|FG000|NOT COMPLETED|Overall Study||17
11352704|NCT03050359|12549805|FG001|NOT COMPLETED|Overall Study||20
11352705|NCT03050372|12549813|FG000|STARTED|Adaptation Night (Night #1 PSG)||6
11352706|NCT03050372|12549814|FG001|STARTED|Adaptation Night (Night #1 PSG)||6
11352707|NCT03050372|12549813|FG000|COMPLETED|Adaptation Night (Night #1 PSG)|N=1 subject removed from study due to mild sleep apnea during adaptation night|5
11352708|NCT03050372|12549814|FG001|COMPLETED|Adaptation Night (Night #1 PSG)||6
11352709|NCT03050372|12549813|FG000|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1
11352710|NCT03050372|12549814|FG001|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0
11352711|NCT03050372|12549813|FG000|STARTED|First Intervention (Nights #2 and #3)||5
11352712|NCT03050372|12549814|FG001|STARTED|First Intervention (Nights #2 and #3)||6
11352713|NCT03050372|12549813|FG000|COMPLETED|First Intervention (Nights #2 and #3)||5
11352714|NCT03050372|12549814|FG001|COMPLETED|First Intervention (Nights #2 and #3)||6
11352715|NCT03050372|12549813|FG000|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
11352716|NCT03050372|12549814|FG001|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
11352717|NCT03050372|12549813|FG000|STARTED|Second Intervention (Nights #4 and #5)||5
11352718|NCT03050372|12549814|FG001|STARTED|Second Intervention (Nights #4 and #5)||6
11352719|NCT03050372|12549813|FG000|COMPLETED|Second Intervention (Nights #4 and #5)||5
11352720|NCT03050372|12549814|FG001|COMPLETED|Second Intervention (Nights #4 and #5)|N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study|5
11352721|NCT03050372|12549813|FG000|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0
11352722|NCT03050372|12549814|FG001|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1
11352723|NCT03050450|12549824|FG000|STARTED|Overall Study||6
11352724|NCT03050450|12549825|FG001|STARTED|Overall Study||0
11352725|NCT03050450|12549826|FG002|STARTED|Overall Study||0
11352726|NCT03050450|12549827|FG003|STARTED|Overall Study||0
11212825|NCT01910116|12403947|FG000|STARTED|Overall Study||110
11212826|NCT01910116|12403948|FG001|STARTED|Overall Study||110
11212827|NCT01910116|12403947|FG000|Week 4|Overall Study||106
11212828|NCT01910116|12403948|FG001|Week 4|Overall Study||102
11212829|NCT01910116|12403947|FG000|Week 8|Overall Study||98
11212830|NCT01910116|12403948|FG001|Week 8|Overall Study||99
11212831|NCT01910116|12403947|FG000|Week 12|Overall Study||97
11212832|NCT01910116|12403948|FG001|Week 12|Overall Study||96
11212833|NCT01910116|12403947|FG000|Week 16|Overall Study||96
11212834|NCT01910116|12403948|FG001|Week 16|Overall Study||94
11212835|NCT01910116|12403947|FG000|COMPLETED|Overall Study||96
11212836|NCT01910116|12403948|FG001|COMPLETED|Overall Study||94
11212837|NCT01910116|12403947|FG000|NOT COMPLETED|Overall Study||14
11212838|NCT01910116|12403948|FG001|NOT COMPLETED|Overall Study||16
11212839|NCT01910129|12403956|FG000|STARTED|Run-in Period Phase 1||0
11212840|NCT01910129|12403957|FG001|STARTED|Run-in Period Phase 1||0
11212841|NCT01910129|12403958|FG002|STARTED|Run-in Period Phase 1||13
11212842|NCT01910129|12403956|FG000|COMPLETED|Run-in Period Phase 1||0
11212843|NCT01910129|12403957|FG001|COMPLETED|Run-in Period Phase 1||0
11212844|NCT01910129|12403958|FG002|COMPLETED|Run-in Period Phase 1||13
11212845|NCT01910129|12403956|FG000|NOT COMPLETED|Run-in Period Phase 1||0
11212846|NCT01910129|12403957|FG001|NOT COMPLETED|Run-in Period Phase 1||0
11212847|NCT01910129|12403958|FG002|NOT COMPLETED|Run-in Period Phase 1||0
11212848|NCT01910129|12403956|FG000|STARTED|Randomized Phase 2||7
11212849|NCT01910129|12403957|FG001|STARTED|Randomized Phase 2||6
11212850|NCT01910129|12403958|FG002|STARTED|Randomized Phase 2||0
11212851|NCT01910129|12403956|FG000|COMPLETED|Randomized Phase 2||5
11212852|NCT01910129|12403957|FG001|COMPLETED|Randomized Phase 2||5
11212853|NCT01910129|12403958|FG002|COMPLETED|Randomized Phase 2||0
11212854|NCT01910129|12403956|FG000|NOT COMPLETED|Randomized Phase 2||2
11212855|NCT01910129|12403957|FG001|NOT COMPLETED|Randomized Phase 2||1
11212856|NCT01910129|12403958|FG002|NOT COMPLETED|Randomized Phase 2||0
11212857|NCT01910129|12403956|FG000|STARTED|Randomized Phase 3||5
11212858|NCT01910129|12403957|FG001|STARTED|Randomized Phase 3||5
11212859|NCT01910129|12403958|FG002|STARTED|Randomized Phase 3||0
11212860|NCT01910129|12403956|FG000|COMPLETED|Randomized Phase 3||5
11212861|NCT01910129|12403957|FG001|COMPLETED|Randomized Phase 3||4
11212862|NCT01910129|12403958|FG002|COMPLETED|Randomized Phase 3||0
11212863|NCT01910129|12403956|FG000|NOT COMPLETED|Randomized Phase 3||0
11212864|NCT01910129|12403957|FG001|NOT COMPLETED|Randomized Phase 3||1
11212865|NCT01910129|12403958|FG002|NOT COMPLETED|Randomized Phase 3||0
11097292|NCT01211288|12280983|FG000|NOT COMPLETED|Overall Study||1
11097293|NCT01211288|12280984|FG001|NOT COMPLETED|Overall Study||1
11097294|NCT01211340|12280994|FG000|STARTED|Overall Study||223
11097295|NCT01211340|12280995|FG001|STARTED|Overall Study||223
11097296|NCT01211340|12280994|FG000|COMPLETED|Overall Study||223
11097297|NCT01211340|12280995|FG001|COMPLETED|Overall Study||223
11097298|NCT01211340|12280994|FG000|NOT COMPLETED|Overall Study||0
11097299|NCT01211340|12280995|FG001|NOT COMPLETED|Overall Study||0
11097300|NCT01211483|12281005|FG000|STARTED|Phase 1b||7
11097301|NCT01211483|12281006|FG001|STARTED|Phase 1b||0
11097302|NCT01211483|12281007|FG002|STARTED|Phase 1b||0
11097303|NCT01211483|12281008|FG003|STARTED|Phase 1b||0
11097304|NCT01211483|12281005|FG000|COMPLETED|Phase 1b||0
11352727|NCT03050450|12549828|FG004|STARTED|Overall Study||0
11097305|NCT01211483|12281006|FG001|COMPLETED|Phase 1b||0
11097306|NCT01211483|12281007|FG002|COMPLETED|Phase 1b||0
11352728|NCT03050450|12549824|FG000|COMPLETED|Overall Study||5
11352729|NCT03050450|12549825|FG001|COMPLETED|Overall Study||0
11352730|NCT03050450|12549826|FG002|COMPLETED|Overall Study||0
11352731|NCT03050450|12549827|FG003|COMPLETED|Overall Study||0
11352732|NCT03050450|12549828|FG004|COMPLETED|Overall Study||0
11352733|NCT03050450|12549824|FG000|NOT COMPLETED|Overall Study||1
11352734|NCT03050450|12549825|FG001|NOT COMPLETED|Overall Study||0
11352735|NCT03050450|12549826|FG002|NOT COMPLETED|Overall Study||0
11352736|NCT03050450|12549827|FG003|NOT COMPLETED|Overall Study||0
11352737|NCT03050450|12549828|FG004|NOT COMPLETED|Overall Study||0
11352738|NCT03050541|12549843|FG000|STARTED|Overall Study||28
11352739|NCT03050541|12549844|FG001|STARTED|Overall Study||28
11352740|NCT03050541|12549845|FG002|STARTED|Overall Study||28
11352741|NCT03050541|12549843|FG000|COMPLETED|Overall Study||20
11352742|NCT03050541|12549844|FG001|COMPLETED|Overall Study||20
11352743|NCT03050541|12549845|FG002|COMPLETED|Overall Study||20
11352744|NCT03050541|12549843|FG000|NOT COMPLETED|Overall Study||8
11352745|NCT03050541|12549844|FG001|NOT COMPLETED|Overall Study||8
11352746|NCT03050541|12549845|FG002|NOT COMPLETED|Overall Study||8
11352747|NCT03050619|12549859|FG000|STARTED|Overall Study||129
11352748|NCT03050619|12549860|FG001|STARTED|Overall Study||3926
11352749|NCT03050619|12549861|FG002|STARTED|Overall Study||6416
11352750|NCT03050619|12549862|FG003|STARTED|Overall Study||14007
11097307|NCT01211483|12281008|FG003|COMPLETED|Phase 1b||0
11212866|NCT01910181|12403976|FG000|STARTED|Overall Study||46
11212867|NCT01910181|12403976|FG000|PK Cohort|Overall Study||20
11212868|NCT01910181|12403976|FG000|Expansion Cohort|Overall Study||26
11212869|NCT01910181|12403976|FG000|COMPLETED|Overall Study||0
11212870|NCT01910181|12403976|FG000|NOT COMPLETED|Overall Study||46
11352751|NCT03050619|12549863|FG004|STARTED|Overall Study||6079
11352752|NCT03050619|12549864|FG005|STARTED|Overall Study||1351
11352753|NCT03050619|12549859|FG000|COMPLETED|Overall Study||129
11352754|NCT03050619|12549860|FG001|COMPLETED|Overall Study||3926
11352755|NCT03050619|12549861|FG002|COMPLETED|Overall Study||6416
11352756|NCT03050619|12549862|FG003|COMPLETED|Overall Study||14007
11352757|NCT03050619|12549863|FG004|COMPLETED|Overall Study||6079
11352758|NCT03050619|12549864|FG005|COMPLETED|Overall Study||1351
11352759|NCT03050619|12549859|FG000|NOT COMPLETED|Overall Study||0
11352760|NCT03050619|12549860|FG001|NOT COMPLETED|Overall Study||0
11352761|NCT03050619|12549861|FG002|NOT COMPLETED|Overall Study||0
11352762|NCT03050619|12549862|FG003|NOT COMPLETED|Overall Study||0
11352763|NCT03050619|12549863|FG004|NOT COMPLETED|Overall Study||0
11352764|NCT03050619|12549864|FG005|NOT COMPLETED|Overall Study||0
11352765|NCT03050697|12549878|FG000|STARTED|Overall Study||12
11352766|NCT03050697|12549878|FG000|COMPLETED|Overall Study||12
11352767|NCT03050697|12549878|FG000|NOT COMPLETED|Overall Study||0
11352768|NCT03050775|12549896|FG000|STARTED|Overall Study||35
11352769|NCT03050775|12549897|FG001|STARTED|Overall Study||35
11352770|NCT03050775|12549896|FG000|COMPLETED|Overall Study||35
11352771|NCT03050775|12549897|FG001|COMPLETED|Overall Study||35
11352772|NCT03050775|12549896|FG000|NOT COMPLETED|Overall Study||0
11352773|NCT03050775|12549897|FG001|NOT COMPLETED|Overall Study||0
11352774|NCT03050801|12549909|FG000|STARTED|Experiment 1||3
11352775|NCT03050801|12549910|FG001|STARTED|Experiment 1||13
11352776|NCT03050801|12549911|FG002|STARTED|Experiment 1||8
11352777|NCT03050801|12549912|FG003|STARTED|Experiment 1||0
11352778|NCT03050801|12549913|FG004|STARTED|Experiment 1||0
11352779|NCT03050801|12549914|FG005|STARTED|Experiment 1||0
11352780|NCT03050801|12549909|FG000|COMPLETED|Experiment 1||3
11352781|NCT03050801|12549910|FG001|COMPLETED|Experiment 1||6
11352782|NCT03050801|12549911|FG002|COMPLETED|Experiment 1||6
11352783|NCT03050801|12549912|FG003|COMPLETED|Experiment 1||0
11352784|NCT03050801|12549913|FG004|COMPLETED|Experiment 1||0
11352785|NCT03050801|12549914|FG005|COMPLETED|Experiment 1||0
11352786|NCT03050801|12549909|FG000|NOT COMPLETED|Experiment 1||0
11352787|NCT03050801|12549910|FG001|NOT COMPLETED|Experiment 1||7
11352788|NCT03050801|12549911|FG002|NOT COMPLETED|Experiment 1||2
11352789|NCT03050801|12549912|FG003|NOT COMPLETED|Experiment 1||0
11352790|NCT03050801|12549913|FG004|NOT COMPLETED|Experiment 1||0
11352791|NCT03050801|12549914|FG005|NOT COMPLETED|Experiment 1||0
11352792|NCT03050801|12549909|FG000|STARTED|Experiment 2||0
11352793|NCT03050801|12549910|FG001|STARTED|Experiment 2||0
11352794|NCT03050801|12549911|FG002|STARTED|Experiment 2||0
11352795|NCT03050801|12549912|FG003|STARTED|Experiment 2||21
11352796|NCT03050801|12549913|FG004|STARTED|Experiment 2||19
11352797|NCT03050801|12549914|FG005|STARTED|Experiment 2|Experiment 2 (Prefrontal Cortex Stimulation) was terminated early due to adverse events (intolerance of stimulation) in 2 of 4 participants.|4
11352798|NCT03050801|12549909|FG000|COMPLETED|Experiment 2||0
11352799|NCT03050801|12549910|FG001|COMPLETED|Experiment 2||0
11352800|NCT03050801|12549911|FG002|COMPLETED|Experiment 2||0
11097308|NCT01211483|12281005|FG000|NOT COMPLETED|Phase 1b||7
11097309|NCT01211483|12281006|FG001|NOT COMPLETED|Phase 1b||0
11097310|NCT01211483|12281007|FG002|NOT COMPLETED|Phase 1b||0
11097311|NCT01211483|12281008|FG003|NOT COMPLETED|Phase 1b||0
11097312|NCT01211483|12281005|FG000|STARTED|Phase 2||0
11097313|NCT01211483|12281006|FG001|STARTED|Phase 2|Participants entered only at Period 2.|72
11097314|NCT01211483|12281007|FG002|STARTED|Phase 2|Participants entered only at Period 2.|72
11097315|NCT01211483|12281008|FG003|STARTED|Phase 2|Participants entered only at Period 2.|71
11097316|NCT01211483|12281005|FG000|COMPLETED|Phase 2||0
11097317|NCT01211483|12281006|FG001|COMPLETED|Phase 2||0
11097318|NCT01211483|12281007|FG002|COMPLETED|Phase 2||0
11097319|NCT01211483|12281008|FG003|COMPLETED|Phase 2||0
11097320|NCT01211483|12281005|FG000|NOT COMPLETED|Phase 2||0
11097321|NCT01211483|12281006|FG001|NOT COMPLETED|Phase 2||72
11097322|NCT01211483|12281007|FG002|NOT COMPLETED|Phase 2||72
11097323|NCT01211483|12281008|FG003|NOT COMPLETED|Phase 2||71
11097324|NCT01211522|12281025|FG000|STARTED|Overall Study||192
11097325|NCT01211522|12281026|FG001|STARTED|Overall Study||190
11097326|NCT01211522|12281027|FG002|STARTED|Overall Study||184
11097327|NCT01211522|12281025|FG000|COMPLETED|Overall Study||189
11097328|NCT01211522|12281026|FG001|COMPLETED|Overall Study||183
11097329|NCT01211522|12281027|FG002|COMPLETED|Overall Study||179
11097330|NCT01211522|12281025|FG000|NOT COMPLETED|Overall Study||3
11097331|NCT01211522|12281026|FG001|NOT COMPLETED|Overall Study||7
11097332|NCT01211522|12281027|FG002|NOT COMPLETED|Overall Study||5
11097333|NCT01211535|12281037|FG000|STARTED|Overall Study||52
11097334|NCT01211535|12281038|FG001|STARTED|Overall Study||52
11097335|NCT01211535|12281037|FG000|COMPLETED|Overall Study||52
11097336|NCT01211535|12281038|FG001|COMPLETED|Overall Study||51
11097337|NCT01211535|12281037|FG000|NOT COMPLETED|Overall Study||0
11097338|NCT01211535|12281038|FG001|NOT COMPLETED|Overall Study||1
11097339|NCT01211600|12281046|FG000|STARTED|Overall Study||370
11097340|NCT01211600|12281047|FG001|STARTED|Overall Study||376
11097341|NCT01211600|12281046|FG000|COMPLETED|Overall Study||370
11097342|NCT01211600|12281047|FG001|COMPLETED|Overall Study||376
11097343|NCT01211600|12281046|FG000|NOT COMPLETED|Overall Study||0
11097344|NCT01211600|12281047|FG001|NOT COMPLETED|Overall Study||0
11097345|NCT01211613|12281058|FG000|STARTED|Overall Study||37
11097346|NCT01211613|12281059|FG001|STARTED|Overall Study||35
11097347|NCT01211613|12281060|FG002|STARTED|Overall Study||35
11097348|NCT01211613|12281058|FG000|COMPLETED|Overall Study||34
11352801|NCT03050801|12549912|FG003|COMPLETED|Experiment 2||15
11097349|NCT01211613|12281059|FG001|COMPLETED|Overall Study||33
11097350|NCT01211613|12281060|FG002|COMPLETED|Overall Study||33
11097351|NCT01211613|12281058|FG000|NOT COMPLETED|Overall Study||3
11097352|NCT01211613|12281059|FG001|NOT COMPLETED|Overall Study||2
11097353|NCT01211613|12281060|FG002|NOT COMPLETED|Overall Study||2
11097354|NCT01211665|12281070|FG000|STARTED|Overall Study||2
11097355|NCT01211665|12281071|FG001|STARTED|Overall Study||1
11097356|NCT01211665|12281070|FG000|COMPLETED|Overall Study||0
11097357|NCT01211665|12281071|FG001|COMPLETED|Overall Study|completed treatment with study drug|1
11097358|NCT01211665|12281070|FG000|NOT COMPLETED|Overall Study||2
11097359|NCT01211665|12281071|FG001|NOT COMPLETED|Overall Study||0
11097360|NCT01211730|12281079|FG000|STARTED|Overall Study||82
11097361|NCT01211730|12281080|FG001|STARTED|Overall Study||82
11097362|NCT01211730|12281079|FG000|COMPLETED|Overall Study||82
11097363|NCT01211730|12281080|FG001|COMPLETED|Overall Study||82
11097364|NCT01211730|12281079|FG000|NOT COMPLETED|Overall Study||0
11097365|NCT01211730|12281080|FG001|NOT COMPLETED|Overall Study||0
11097366|NCT01211769|12281090|FG000|STARTED|Overall Study||20
11097367|NCT01211769|12281091|FG001|STARTED|Overall Study||20
11097368|NCT01211769|12281092|FG002|STARTED|Overall Study||20
11097369|NCT01211769|12281093|FG003|STARTED|Overall Study||20
11097370|NCT01211769|12281090|FG000|Participants/Group|Overall Study||20
11097371|NCT01211769|12281091|FG001|Participants/Group|Overall Study||20
11097372|NCT01211769|12281092|FG002|Participants/Group|Overall Study||20
11097373|NCT01211769|12281093|FG003|Participants/Group|Overall Study||20
11097374|NCT01211769|12281090|FG000|COMPLETED|Overall Study||11
11097375|NCT01211769|12281091|FG001|COMPLETED|Overall Study||10
11097376|NCT01211769|12281092|FG002|COMPLETED|Overall Study||12
11097377|NCT01211769|12281093|FG003|COMPLETED|Overall Study||9
11097378|NCT01211769|12281090|FG000|NOT COMPLETED|Overall Study||9
11097379|NCT01211769|12281091|FG001|NOT COMPLETED|Overall Study||10
11097380|NCT01211769|12281092|FG002|NOT COMPLETED|Overall Study||8
11097381|NCT01211769|12281093|FG003|NOT COMPLETED|Overall Study||11
11097382|NCT01211873|12281106|FG000|STARTED|Overall Study||245
11097383|NCT01211873|12281107|FG001|STARTED|Overall Study||119
11097384|NCT01211873|12281108|FG002|STARTED|Overall Study||38
11097385|NCT01211873|12281106|FG000|COMPLETED|Overall Study||240
11097386|NCT01211873|12281107|FG001|COMPLETED|Overall Study||117
11097387|NCT01211873|12281108|FG002|COMPLETED|Overall Study||36
11097388|NCT01211873|12281106|FG000|NOT COMPLETED|Overall Study||5
11097389|NCT01211873|12281107|FG001|NOT COMPLETED|Overall Study||2
11097390|NCT01211873|12281108|FG002|NOT COMPLETED|Overall Study||2
11097391|NCT01212094|12281120|FG000|STARTED|Year 1: Baseline Monitoring||43
11097392|NCT01212094|12281121|FG001|STARTED|Year 1: Baseline Monitoring||0
11212871|NCT01910298|12403983|FG000|STARTED|Overall Study||76
11097393|NCT01212094|12281122|FG002|STARTED|Year 1: Baseline Monitoring||0
11097394|NCT01212094|12281120|FG000|COMPLETED|Year 1: Baseline Monitoring||27
11097395|NCT01212094|12281121|FG001|COMPLETED|Year 1: Baseline Monitoring||0
11097396|NCT01212094|12281122|FG002|COMPLETED|Year 1: Baseline Monitoring||0
11097397|NCT01212094|12281120|FG000|NOT COMPLETED|Year 1: Baseline Monitoring||16
11097398|NCT01212094|12281121|FG001|NOT COMPLETED|Year 1: Baseline Monitoring||0
11097399|NCT01212094|12281122|FG002|NOT COMPLETED|Year 1: Baseline Monitoring||0
11097400|NCT01212094|12281120|FG000|STARTED|Years 2 & 3: Treatment Randomization||0
11097401|NCT01212094|12281121|FG001|STARTED|Years 2 & 3: Treatment Randomization||9
11097402|NCT01212094|12281122|FG002|STARTED|Years 2 & 3: Treatment Randomization||18
11097403|NCT01212094|12281120|FG000|COMPLETED|Years 2 & 3: Treatment Randomization||0
11212872|NCT01910298|12403984|FG001|STARTED|Overall Study||55
11212873|NCT01910298|12403983|FG000|Safety Set|Overall Study||76
11212874|NCT01910298|12403984|FG001|Safety Set|Overall Study|4 participants did not have first surgery date and were not included in Safety Set.|51
11212875|NCT01910298|12403983|FG000|COMPLETED|Overall Study||71
11212876|NCT01910298|12403984|FG001|COMPLETED|Overall Study||23
11212877|NCT01910298|12403983|FG000|NOT COMPLETED|Overall Study||5
11212878|NCT01910298|12403984|FG001|NOT COMPLETED|Overall Study||32
11212879|NCT01910311|12403990|FG000|STARTED|Period 1 (Days 1-2)||18
11212880|NCT01910311|12403990|FG000|Received Baricitinib|Period 1 (Days 1-2)||18
11212881|NCT01910311|12403990|FG000|COMPLETED|Period 1 (Days 1-2)||18
11212882|NCT01910311|12403990|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0
11212883|NCT01910311|12403990|FG000|STARTED|Period 2 (Days 3-32)||18
11212884|NCT01910311|12403990|FG000|Received Baricitinib|Period 2 (Days 3-32)||18
11212885|NCT01910311|12403990|FG000|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
11212886|NCT01910311|12403990|FG000|COMPLETED|Period 2 (Days 3-32)||18
11212887|NCT01910311|12403990|FG000|NOT COMPLETED|Period 2 (Days 3-32)||0
11212888|NCT01910519|12404000|FG000|STARTED|Overall Study||35
11212889|NCT01910519|12404001|FG001|STARTED|Overall Study||15
11212890|NCT01910519|12404000|FG000|COMPLETED|Overall Study||31
11212891|NCT01910519|12404001|FG001|COMPLETED|Overall Study||15
11212892|NCT01910519|12404000|FG000|NOT COMPLETED|Overall Study||4
11212893|NCT01910519|12404001|FG001|NOT COMPLETED|Overall Study||0
11212894|NCT01910636|12404009|FG000|STARTED|Overall Study||90
11212895|NCT01910636|12404010|FG001|STARTED|Overall Study||63
11212896|NCT01910636|12404009|FG000|COMPLETED|Overall Study||90
11212897|NCT01910636|12404010|FG001|COMPLETED|Overall Study||63
11212898|NCT01910636|12404009|FG000|NOT COMPLETED|Overall Study||0
11212899|NCT01910636|12404010|FG001|NOT COMPLETED|Overall Study||0
11212900|NCT01910688|12404016|FG000|STARTED|Overall Study||25
11212901|NCT01910688|12404016|FG000|3.5month|Overall Study||25
11212902|NCT01910688|12404016|FG000|2nd RFA Treatment|Overall Study||22
11212903|NCT01910688|12404016|FG000|7.5months|Overall Study||24
11212904|NCT01910688|12404016|FG000|3rd RFA Treatment|Overall Study||18
11212905|NCT01910688|12404016|FG000|12months|Overall Study||22
11212906|NCT01910688|12404016|FG000|COMPLETED|Overall Study||20
11212907|NCT01910688|12404016|FG000|NOT COMPLETED|Overall Study||5
11212908|NCT01910792|12404022|FG000|STARTED|Overall Study||9
11212909|NCT01910792|12404023|FG001|STARTED|Overall Study||10
11212910|NCT01910792|12404022|FG000|COMPLETED|Overall Study||9
11212911|NCT01910792|12404023|FG001|COMPLETED|Overall Study||10
11212912|NCT01910792|12404022|FG000|NOT COMPLETED|Overall Study||0
11212913|NCT01910792|12404023|FG001|NOT COMPLETED|Overall Study||0
11212914|NCT01910831|12404029|FG000|STARTED|Overall Study||20
11212915|NCT01910831|12404029|FG000|COMPLETED|Overall Study||19
11212916|NCT01910831|12404029|FG000|NOT COMPLETED|Overall Study||1
11212917|NCT01911065|12404036|FG000|STARTED|Overall Study||45
11212918|NCT01911065|12404037|FG001|STARTED|Overall Study||9
11212919|NCT01911065|12404036|FG000|COMPLETED|Overall Study||45
11212920|NCT01911065|12404037|FG001|COMPLETED|Overall Study||9
11212921|NCT01911065|12404036|FG000|NOT COMPLETED|Overall Study||0
11212922|NCT01911065|12404037|FG001|NOT COMPLETED|Overall Study||0
11212923|NCT01911169|12404045|FG000|STARTED|Overall Study||6
11212924|NCT01911169|12404046|FG001|STARTED|Overall Study||3
11212925|NCT01911169|12404045|FG000|COMPLETED|Overall Study||6
11212926|NCT01911169|12404046|FG001|COMPLETED|Overall Study||3
11212927|NCT01911169|12404045|FG000|NOT COMPLETED|Overall Study||0
11212928|NCT01911169|12404046|FG001|NOT COMPLETED|Overall Study||0
11212929|NCT01911221|12404052|FG000|STARTED|Overall Study||13
11212930|NCT01911221|12404052|FG000|COMPLETED|Overall Study||13
11212931|NCT01911221|12404052|FG000|NOT COMPLETED|Overall Study||0
11212932|NCT01911260|12404060|FG000|STARTED|Supplementation Period||50
11212933|NCT01911260|12404061|FG001|STARTED|Supplementation Period||50
11212934|NCT01911260|12404062|FG002|STARTED|Supplementation Period||49
11212935|NCT01911260|12404063|FG003|STARTED|Supplementation Period||50
11212936|NCT01911260|12404060|FG000|COMPLETED|Supplementation Period||40
11212937|NCT01911260|12404061|FG001|COMPLETED|Supplementation Period||38
11212938|NCT01911260|12404062|FG002|COMPLETED|Supplementation Period||39
11212939|NCT01911260|12404063|FG003|COMPLETED|Supplementation Period||42
11212940|NCT01911260|12404060|FG000|NOT COMPLETED|Supplementation Period||10
11212941|NCT01911260|12404061|FG001|NOT COMPLETED|Supplementation Period||12
11212942|NCT01911260|12404062|FG002|NOT COMPLETED|Supplementation Period||10
11212943|NCT01911260|12404063|FG003|NOT COMPLETED|Supplementation Period||8
11212944|NCT01911260|12404060|FG000|STARTED|Follow-up Period||40
11212945|NCT01911260|12404061|FG001|STARTED|Follow-up Period||38
11212946|NCT01911260|12404062|FG002|STARTED|Follow-up Period||39
11212947|NCT01911260|12404063|FG003|STARTED|Follow-up Period||42
11212948|NCT01911260|12404060|FG000|COMPLETED|Follow-up Period||27
11212949|NCT01911260|12404061|FG001|COMPLETED|Follow-up Period||18
11212950|NCT01911260|12404062|FG002|COMPLETED|Follow-up Period||24
11212951|NCT01911260|12404063|FG003|COMPLETED|Follow-up Period||30
11212952|NCT01911260|12404060|FG000|NOT COMPLETED|Follow-up Period||13
11352802|NCT03050801|12549913|FG004|COMPLETED|Experiment 2||15
11352803|NCT03050801|12549914|FG005|COMPLETED|Experiment 2||2
11352804|NCT03050801|12549909|FG000|NOT COMPLETED|Experiment 2||0
11212953|NCT01911260|12404061|FG001|NOT COMPLETED|Follow-up Period||20
11212954|NCT01911260|12404062|FG002|NOT COMPLETED|Follow-up Period||15
11212955|NCT01911260|12404063|FG003|NOT COMPLETED|Follow-up Period||12
11212956|NCT01911273|12404075|FG000|STARTED|Overall Study||1
11212957|NCT01911273|12404076|FG001|STARTED|Overall Study||2
11212958|NCT01911273|12404075|FG000|COMPLETED|Overall Study||0
11212959|NCT01911273|12404076|FG001|COMPLETED|Overall Study||0
11212960|NCT01911273|12404075|FG000|NOT COMPLETED|Overall Study||1
11212961|NCT01911273|12404076|FG001|NOT COMPLETED|Overall Study||2
11212962|NCT01911351|12404084|FG000|STARTED|Overall Study||39
11212963|NCT01911351|12404085|FG001|STARTED|Overall Study||43
11212964|NCT01911351|12404084|FG000|COMPLETED|Overall Study||39
11212965|NCT01911351|12404085|FG001|COMPLETED|Overall Study||43
11352805|NCT03050801|12549910|FG001|NOT COMPLETED|Experiment 2||0
11352806|NCT03050801|12549911|FG002|NOT COMPLETED|Experiment 2||0
11352807|NCT03050801|12549912|FG003|NOT COMPLETED|Experiment 2||6
11352808|NCT03050801|12549913|FG004|NOT COMPLETED|Experiment 2||4
11352809|NCT03050801|12549914|FG005|NOT COMPLETED|Experiment 2||2
11352810|NCT03050918|12549933|FG000|STARTED|Overall Study||1534
11352811|NCT03050918|12549934|FG001|STARTED|Overall Study||1520
11352812|NCT03050918|12549933|FG000|COMPLETED|Overall Study||1534
11212966|NCT01911351|12404084|FG000|NOT COMPLETED|Overall Study||0
11212967|NCT01911351|12404085|FG001|NOT COMPLETED|Overall Study||0
11212968|NCT01911390|12404095|FG000|STARTED|Overall Study||10
11212969|NCT01911390|12404096|FG001|STARTED|Overall Study||10
11212970|NCT01911390|12404097|FG002|STARTED|Overall Study||10
11212971|NCT01911390|12404098|FG003|STARTED|Overall Study||11
11212972|NCT01911390|12404095|FG000|COMPLETED|Overall Study||9
11212973|NCT01911390|12404096|FG001|COMPLETED|Overall Study||10
11212974|NCT01911390|12404097|FG002|COMPLETED|Overall Study||9
11212975|NCT01911390|12404098|FG003|COMPLETED|Overall Study||10
11212976|NCT01911390|12404095|FG000|NOT COMPLETED|Overall Study||1
11212977|NCT01911390|12404096|FG001|NOT COMPLETED|Overall Study||0
11212978|NCT01911390|12404097|FG002|NOT COMPLETED|Overall Study||1
11097404|NCT01212094|12281121|FG001|COMPLETED|Years 2 & 3: Treatment Randomization||5
11097405|NCT01212094|12281122|FG002|COMPLETED|Years 2 & 3: Treatment Randomization||7
11097406|NCT01212094|12281120|FG000|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
11097407|NCT01212094|12281121|FG001|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
11097408|NCT01212094|12281122|FG002|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
11097409|NCT01212107|12281141|FG000|STARTED|Overall Study||3
11097410|NCT01212107|12281142|FG001|STARTED|Overall Study||3
11097411|NCT01212107|12281143|FG002|STARTED|Overall Study||6
11097412|NCT01212107|12281144|FG003|STARTED|Overall Study||3
11097413|NCT01212107|12281145|FG004|STARTED|Overall Study||3
11097414|NCT01212107|12281146|FG005|STARTED|Overall Study||3
11097415|NCT01212107|12281147|FG006|STARTED|Overall Study||3
11097416|NCT01212107|12281148|FG007|STARTED|Overall Study||3
11097417|NCT01212107|12281149|FG008|STARTED|Overall Study||3
11097418|NCT01212107|12281150|FG009|STARTED|Overall Study||3
11097419|NCT01212107|12281151|FG010|STARTED|Overall Study||3
11097420|NCT01212107|12281152|FG011|STARTED|Overall Study||58
11097421|NCT01212107|12281141|FG000|COMPLETED|Overall Study||2
11097422|NCT01212107|12281142|FG001|COMPLETED|Overall Study||2
11097423|NCT01212107|12281143|FG002|COMPLETED|Overall Study||3
11097424|NCT01212107|12281144|FG003|COMPLETED|Overall Study||3
11097425|NCT01212107|12281145|FG004|COMPLETED|Overall Study||2
11097426|NCT01212107|12281146|FG005|COMPLETED|Overall Study||2
11097427|NCT01212107|12281147|FG006|COMPLETED|Overall Study||3
11097428|NCT01212107|12281148|FG007|COMPLETED|Overall Study||2
11097429|NCT01212107|12281149|FG008|COMPLETED|Overall Study||1
11097430|NCT01212107|12281150|FG009|COMPLETED|Overall Study||1
11097431|NCT01212107|12281151|FG010|COMPLETED|Overall Study||2
11097432|NCT01212107|12281152|FG011|COMPLETED|Overall Study||26
11097433|NCT01212107|12281141|FG000|NOT COMPLETED|Overall Study||1
11097434|NCT01212107|12281142|FG001|NOT COMPLETED|Overall Study||1
11097435|NCT01212107|12281143|FG002|NOT COMPLETED|Overall Study||3
11097436|NCT01212107|12281144|FG003|NOT COMPLETED|Overall Study||0
11097437|NCT01212107|12281145|FG004|NOT COMPLETED|Overall Study||1
11097438|NCT01212107|12281146|FG005|NOT COMPLETED|Overall Study||1
11097439|NCT01212107|12281147|FG006|NOT COMPLETED|Overall Study||0
11097440|NCT01212107|12281148|FG007|NOT COMPLETED|Overall Study||1
11097441|NCT01212107|12281149|FG008|NOT COMPLETED|Overall Study||2
11097442|NCT01212107|12281150|FG009|NOT COMPLETED|Overall Study||2
11097443|NCT01212107|12281151|FG010|NOT COMPLETED|Overall Study||1
11097444|NCT01212107|12281152|FG011|NOT COMPLETED|Overall Study||32
11097445|NCT01212159|12281196|FG000|STARTED|Overall Study||26
11097446|NCT01212159|12281197|FG001|STARTED|Overall Study||44
11097447|NCT01212159|12281196|FG000|COMPLETED|Overall Study||14
11097448|NCT01212159|12281197|FG001|COMPLETED|Overall Study||32
11097449|NCT01212159|12281196|FG000|NOT COMPLETED|Overall Study||12
11097450|NCT01212159|12281197|FG001|NOT COMPLETED|Overall Study||12
11097451|NCT01212172|12281203|FG000|STARTED|Overall Study||10
11097452|NCT01212172|12281204|FG001|STARTED|Overall Study||10
11212979|NCT01911390|12404098|FG003|NOT COMPLETED|Overall Study||1
11212980|NCT01911403|12404110|FG000|STARTED|Overall Study||61
11212981|NCT01911403|12404111|FG001|STARTED|Overall Study||62
11212982|NCT01911403|12404110|FG000|COMPLETED|Overall Study||52
11212983|NCT01911403|12404111|FG001|COMPLETED|Overall Study||59
11212984|NCT01911403|12404110|FG000|NOT COMPLETED|Overall Study||9
11212985|NCT01911403|12404111|FG001|NOT COMPLETED|Overall Study||3
11212986|NCT01911429|12404120|FG000|STARTED|Overall Study||108
11212987|NCT01911429|12404121|FG001|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
11212988|NCT01911429|12404122|FG002|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
11212989|NCT01911429|12404120|FG000|COMPLETED|Overall Study||96
11212990|NCT01911429|12404121|FG001|COMPLETED|Overall Study||96
11212991|NCT01911429|12404122|FG002|COMPLETED|Overall Study||93
11212992|NCT01911429|12404120|FG000|NOT COMPLETED|Overall Study||12
11212993|NCT01911429|12404121|FG001|NOT COMPLETED|Overall Study||10
11212994|NCT01911429|12404122|FG002|NOT COMPLETED|Overall Study||20
11212995|NCT01911442|12404133|FG000|STARTED|Overall Study||49
11212996|NCT01911442|12404134|FG001|STARTED|Overall Study||51
11212997|NCT01911442|12404135|FG002|STARTED|Overall Study||50
11212998|NCT01911442|12404133|FG000|COMPLETED|Overall Study||43
11212999|NCT01911442|12404134|FG001|COMPLETED|Overall Study||47
11213000|NCT01911442|12404135|FG002|COMPLETED|Overall Study||38
11213001|NCT01911442|12404133|FG000|NOT COMPLETED|Overall Study||6
11213002|NCT01911442|12404134|FG001|NOT COMPLETED|Overall Study||4
11213003|NCT01911442|12404135|FG002|NOT COMPLETED|Overall Study||12
11213004|NCT01911546|12404147|FG000|STARTED|Overall Study||20
11213005|NCT01911546|12404147|FG000|COMPLETED|Overall Study||14
11213006|NCT01911546|12404147|FG000|NOT COMPLETED|Overall Study||6
11213007|NCT01911689|12404153|FG000|STARTED|Overall Study||117
11213008|NCT01911689|12404154|FG001|STARTED|Overall Study||51
11213009|NCT01911689|12404153|FG000|COMPLETED|Overall Study||117
11213010|NCT01911689|12404154|FG001|COMPLETED|Overall Study||51
11213011|NCT01911689|12404153|FG000|NOT COMPLETED|Overall Study||0
11213012|NCT01911689|12404154|FG001|NOT COMPLETED|Overall Study||0
11213013|NCT01911780|12404169|FG000|STARTED|Double-blind Period (8 Weeks)||68
11213014|NCT01911780|12404170|FG001|STARTED|Double-blind Period (8 Weeks)||64
11213015|NCT01911780|12404169|FG000|COMPLETED|Double-blind Period (8 Weeks)||65
11213016|NCT01911780|12404170|FG001|COMPLETED|Double-blind Period (8 Weeks)||61
11213017|NCT01911780|12404169|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||3
11213018|NCT01911780|12404170|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||3
11213019|NCT01911780|12404169|FG000|STARTED|Extension Period (52 Weeks)||65
11213020|NCT01911780|12404170|FG001|STARTED|Extension Period (52 Weeks)||61
11213021|NCT01911780|12404169|FG000|COMPLETED|Extension Period (52 Weeks)||61
11213022|NCT01911780|12404170|FG001|COMPLETED|Extension Period (52 Weeks)||58
11213023|NCT01911780|12404169|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4
11213024|NCT01911780|12404170|FG001|NOT COMPLETED|Extension Period (52 Weeks)||3
11213025|NCT01911819|12404183|FG000|STARTED|Overall Study||10
11213026|NCT01911819|12404184|FG001|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
11213027|NCT01911819|12404185|FG002|STARTED|Overall Study||10
11213028|NCT01911819|12404183|FG000|COMPLETED|Overall Study||9
11213029|NCT01911819|12404184|FG001|COMPLETED|Overall Study||9
11213030|NCT01911819|12404185|FG002|COMPLETED|Overall Study||10
11213031|NCT01911819|12404183|FG000|NOT COMPLETED|Overall Study||1
11213032|NCT01911819|12404184|FG001|NOT COMPLETED|Overall Study||2
11213033|NCT01911819|12404185|FG002|NOT COMPLETED|Overall Study||0
11213034|NCT01911845|12404193|FG000|STARTED|Overall Study||38
11213035|NCT01911845|12404193|FG000|Completed Study Drug|Overall Study||37
11213036|NCT01911845|12404193|FG000|COMPLETED|Overall Study||32
11213037|NCT01911845|12404193|FG000|NOT COMPLETED|Overall Study||6
11213038|NCT01911910|12404201|FG000|STARTED|Overall Study||197
11213039|NCT01911910|12404202|FG001|STARTED|Overall Study||205
11213040|NCT01911910|12404201|FG000|COMPLETED|Overall Study||184
11213041|NCT01911910|12404202|FG001|COMPLETED|Overall Study||194
11213042|NCT01911910|12404201|FG000|NOT COMPLETED|Overall Study||13
11213043|NCT01911910|12404202|FG001|NOT COMPLETED|Overall Study||11
11213044|NCT01912222|12404211|FG000|STARTED|Part A: Pharmacokinetic Period||13
11213045|NCT01912222|12404212|FG001|STARTED|Part A: Pharmacokinetic Period||15
11213046|NCT01912222|12404213|FG002|STARTED|Part A: Pharmacokinetic Period||20
11213047|NCT01912222|12404211|FG000|COMPLETED|Part A: Pharmacokinetic Period||12
11213048|NCT01912222|12404212|FG001|COMPLETED|Part A: Pharmacokinetic Period||13
11213049|NCT01912222|12404213|FG002|COMPLETED|Part A: Pharmacokinetic Period||18
11213050|NCT01912222|12404211|FG000|NOT COMPLETED|Part A: Pharmacokinetic Period||1
11213051|NCT01912222|12404212|FG001|NOT COMPLETED|Part A: Pharmacokinetic Period||2
11213052|NCT01912222|12404213|FG002|NOT COMPLETED|Part A: Pharmacokinetic Period||2
11213053|NCT01912222|12404211|FG000|STARTED|Part B: Treatment Period||13
11213054|NCT01912222|12404212|FG001|STARTED|Part B: Treatment Period||15
11213055|NCT01912222|12404213|FG002|STARTED|Part B: Treatment Period||20
11213056|NCT01912222|12404211|FG000|COMPLETED|Part B: Treatment Period||0
11213057|NCT01912222|12404212|FG001|COMPLETED|Part B: Treatment Period||0
11213058|NCT01912222|12404213|FG002|COMPLETED|Part B: Treatment Period||0
11213059|NCT01912222|12404211|FG000|NOT COMPLETED|Part B: Treatment Period||13
11213060|NCT01912222|12404212|FG001|NOT COMPLETED|Part B: Treatment Period||15
11213061|NCT01912222|12404213|FG002|NOT COMPLETED|Part B: Treatment Period||20
11213062|NCT01912274|12404222|FG000|STARTED|Overall Study||50
11213063|NCT01912274|12404222|FG000|COMPLETED|Overall Study||50
11213064|NCT01912274|12404222|FG000|NOT COMPLETED|Overall Study||0
11213065|NCT01912287|12404229|FG000|STARTED|Overall Study||93
11213066|NCT01912287|12404230|FG001|STARTED|Overall Study||90
11213067|NCT01912287|12404231|FG002|STARTED|Overall Study||43
11213068|NCT01912287|12404229|FG000|COMPLETED|Overall Study||60
11213069|NCT01912287|12404230|FG001|COMPLETED|Overall Study||67
11213070|NCT01912287|12404231|FG002|COMPLETED|Overall Study||28
11213071|NCT01912287|12404229|FG000|NOT COMPLETED|Overall Study||33
11213072|NCT01912287|12404230|FG001|NOT COMPLETED|Overall Study||23
11213073|NCT01912287|12404231|FG002|NOT COMPLETED|Overall Study||15
11213074|NCT01912339|12404241|FG000|STARTED|Blinded (0 to 3 Months)||136
11213075|NCT01912339|12404242|FG001|STARTED|Blinded (0 to 3 Months)||61
11213076|NCT01912339|12404243|FG002|STARTED|Blinded (0 to 3 Months)||0
11213077|NCT01912339|12404241|FG000|COMPLETED|Blinded (0 to 3 Months)||134
11213078|NCT01912339|12404242|FG001|COMPLETED|Blinded (0 to 3 Months)||61
11213079|NCT01912339|12404243|FG002|COMPLETED|Blinded (0 to 3 Months)||0
11213080|NCT01912339|12404241|FG000|NOT COMPLETED|Blinded (0 to 3 Months)||2
11213081|NCT01912339|12404242|FG001|NOT COMPLETED|Blinded (0 to 3 Months)||0
11213082|NCT01912339|12404243|FG002|NOT COMPLETED|Blinded (0 to 3 Months)||0
11213083|NCT01912339|12404241|FG000|STARTED|Unblinded (3 to 6 Months/Crossover)||134
11213084|NCT01912339|12404242|FG001|STARTED|Unblinded (3 to 6 Months/Crossover)||61
11213085|NCT01912339|12404243|FG002|STARTED|Unblinded (3 to 6 Months/Crossover)||0
11213086|NCT01912339|12404241|FG000|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
11213087|NCT01912339|12404242|FG001|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
11097453|NCT01212172|12281203|FG000|COMPLETED|Overall Study||9
11097454|NCT01212172|12281204|FG001|COMPLETED|Overall Study||9
11097455|NCT01212172|12281203|FG000|NOT COMPLETED|Overall Study||1
11097456|NCT01212172|12281204|FG001|NOT COMPLETED|Overall Study||1
11097457|NCT01212185|12281214|FG000|STARTED|Overall Study||6
11097458|NCT01212185|12281215|FG001|STARTED|Overall Study||8
11097459|NCT01212185|12281214|FG000|COMPLETED|Overall Study||4
11352813|NCT03050918|12549934|FG001|COMPLETED|Overall Study||1520
11352814|NCT03050918|12549933|FG000|NOT COMPLETED|Overall Study||0
11097460|NCT01212185|12281215|FG001|COMPLETED|Overall Study||7
11097461|NCT01212185|12281214|FG000|NOT COMPLETED|Overall Study||2
11097462|NCT01212185|12281215|FG001|NOT COMPLETED|Overall Study||1
11097463|NCT01212302|12281221|FG000|STARTED|Overall Study||504
11097464|NCT01212302|12281221|FG000|COMPLETED|Overall Study||504
11097465|NCT01212302|12281221|FG000|NOT COMPLETED|Overall Study||0
11097466|NCT01212445|12281228|FG000|STARTED|Overall Study||52
11097467|NCT01212445|12281229|FG001|STARTED|Overall Study||51
11097468|NCT01212445|12281230|FG002|STARTED|Overall Study||51
11097469|NCT01212445|12281228|FG000|COMPLETED|Overall Study||52
11097470|NCT01212445|12281229|FG001|COMPLETED|Overall Study||51
11097471|NCT01212445|12281230|FG002|COMPLETED|Overall Study||51
11097472|NCT01212445|12281228|FG000|NOT COMPLETED|Overall Study||0
11097473|NCT01212445|12281229|FG001|NOT COMPLETED|Overall Study||0
11097474|NCT01212445|12281230|FG002|NOT COMPLETED|Overall Study||0
11097475|NCT01212471|12281242|FG000|STARTED|Overall Study||141
11097476|NCT01212471|12281243|FG001|STARTED|Overall Study||140
11097477|NCT01212471|12281244|FG002|STARTED|Overall Study||139
11097478|NCT01212471|12281242|FG000|COMPLETED|Overall Study||139
11097479|NCT01212471|12281243|FG001|COMPLETED|Overall Study||137
11097480|NCT01212471|12281244|FG002|COMPLETED|Overall Study||132
11097481|NCT01212471|12281242|FG000|NOT COMPLETED|Overall Study||2
11097482|NCT01212471|12281243|FG001|NOT COMPLETED|Overall Study||3
11097483|NCT01212471|12281244|FG002|NOT COMPLETED|Overall Study||7
11097484|NCT01212484|12281252|FG000|STARTED|Carbidopa Titration Period (4 Weeks)||6
11097485|NCT01212484|12281253|FG001|STARTED|Carbidopa Titration Period (4 Weeks)||6
11097486|NCT01212484|12281252|FG000|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
11097487|NCT01212484|12281253|FG001|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
11097488|NCT01212484|12281252|FG000|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
11097489|NCT01212484|12281253|FG001|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
11097490|NCT01212484|12281252|FG000|STARTED|First Intervention (4 Weeks)||5
11097491|NCT01212484|12281253|FG001|STARTED|First Intervention (4 Weeks)||6
11097492|NCT01212484|12281252|FG000|COMPLETED|First Intervention (4 Weeks)||5
11097493|NCT01212484|12281253|FG001|COMPLETED|First Intervention (4 Weeks)||4
11097494|NCT01212484|12281252|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
11097495|NCT01212484|12281253|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2
11097496|NCT01212484|12281252|FG000|STARTED|Second Intervention (4 Weeks)||5
11097497|NCT01212484|12281253|FG001|STARTED|Second Intervention (4 Weeks)||4
11097498|NCT01212484|12281252|FG000|COMPLETED|Second Intervention (4 Weeks)||5
11097499|NCT01212484|12281253|FG001|COMPLETED|Second Intervention (4 Weeks)||3
11097500|NCT01212484|12281252|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
11097501|NCT01212484|12281253|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
11097502|NCT01212588|12281261|FG000|STARTED|Overall Study||10
11097503|NCT01212588|12281262|FG001|STARTED|Overall Study||12
11097504|NCT01212588|12281261|FG000|COMPLETED|Overall Study||9
11097505|NCT01212588|12281262|FG001|COMPLETED|Overall Study||10
11213088|NCT01912339|12404243|FG002|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
11213089|NCT01912339|12404241|FG000|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
11213090|NCT01912339|12404242|FG001|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
11213091|NCT01912339|12404243|FG002|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
11213092|NCT01912339|12404241|FG000|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
11213093|NCT01912339|12404242|FG001|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
11213094|NCT01912339|12404243|FG002|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
11352815|NCT03050918|12549934|FG001|NOT COMPLETED|Overall Study||0
11352816|NCT03051100|12549942|FG000|STARTED|Overall Study||20
11352817|NCT03051100|12549943|FG001|STARTED|Overall Study||43
11352818|NCT03051100|12549942|FG000|COMPLETED|Overall Study||19
11352819|NCT03051100|12549943|FG001|COMPLETED|Overall Study||43
11352820|NCT03051100|12549942|FG000|NOT COMPLETED|Overall Study||1
11352821|NCT03051100|12549943|FG001|NOT COMPLETED|Overall Study||0
11213095|NCT01912339|12404241|FG000|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
11213096|NCT01912339|12404242|FG001|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
11213097|NCT01912339|12404243|FG002|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
11213098|NCT01912339|12404241|FG000|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
11213099|NCT01912339|12404242|FG001|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
11213100|NCT01912339|12404243|FG002|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
11213101|NCT01912352|12404249|FG000|STARTED|Overall Study||83
11213102|NCT01912352|12404249|FG000|COMPLETED|Overall Study||78
11213103|NCT01912352|12404249|FG000|NOT COMPLETED|Overall Study||5
11213104|NCT01912456|12404255|FG000|STARTED|Period 1||22
11213105|NCT01912456|12404256|FG001|STARTED|Period 1||23
11213106|NCT01912456|12404257|FG002|STARTED|Period 1||23
11213107|NCT01912456|12404258|FG003|STARTED|Period 1||22
11213108|NCT01912456|12404255|FG000|COMPLETED|Period 1||20
11213109|NCT01912456|12404256|FG001|COMPLETED|Period 1||22
11213110|NCT01912456|12404257|FG002|COMPLETED|Period 1||21
11213111|NCT01912456|12404258|FG003|COMPLETED|Period 1||19
11213112|NCT01912456|12404255|FG000|NOT COMPLETED|Period 1||2
11213113|NCT01912456|12404256|FG001|NOT COMPLETED|Period 1||1
11213114|NCT01912456|12404257|FG002|NOT COMPLETED|Period 1||2
11213115|NCT01912456|12404258|FG003|NOT COMPLETED|Period 1||3
11213116|NCT01912456|12404255|FG000|STARTED|Period 2||20
11213117|NCT01912456|12404256|FG001|STARTED|Period 2||22
11213118|NCT01912456|12404257|FG002|STARTED|Period 2||21
11213119|NCT01912456|12404258|FG003|STARTED|Period 2||19
11213120|NCT01912456|12404255|FG000|COMPLETED|Period 2||20
11213121|NCT01912456|12404256|FG001|COMPLETED|Period 2||20
11213122|NCT01912456|12404257|FG002|COMPLETED|Period 2||21
11213123|NCT01912456|12404258|FG003|COMPLETED|Period 2||18
11213124|NCT01912456|12404255|FG000|NOT COMPLETED|Period 2||0
11213125|NCT01912456|12404256|FG001|NOT COMPLETED|Period 2||2
11213126|NCT01912456|12404257|FG002|NOT COMPLETED|Period 2||0
11213127|NCT01912456|12404258|FG003|NOT COMPLETED|Period 2||1
11213128|NCT01912495|12404268|FG000|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
11213129|NCT01912495|12404268|FG000|COMPLETED|Overall Study||57
11213130|NCT01912495|12404268|FG000|NOT COMPLETED|Overall Study||0
11213131|NCT01912599|12404277|FG000|STARTED|Overall Study||20
11213132|NCT01912599|12404278|FG001|STARTED|Overall Study||16
11213133|NCT01912599|12404277|FG000|COMPLETED|Overall Study||20
11213134|NCT01912599|12404278|FG001|COMPLETED|Overall Study||15
11213135|NCT01912599|12404277|FG000|NOT COMPLETED|Overall Study||0
11213136|NCT01912599|12404278|FG001|NOT COMPLETED|Overall Study||1
11213137|NCT01912612|12404286|FG000|STARTED|Overall Study||36
11213138|NCT01912612|12404287|FG001|STARTED|Overall Study||40
11213139|NCT01912612|12404288|FG002|STARTED|Overall Study||3
11213140|NCT01912612|12404286|FG000|COMPLETED|Overall Study||31
11213141|NCT01912612|12404287|FG001|COMPLETED|Overall Study||40
11213142|NCT01912612|12404288|FG002|COMPLETED|Overall Study||0
11213143|NCT01912612|12404286|FG000|NOT COMPLETED|Overall Study||5
11213144|NCT01912612|12404287|FG001|NOT COMPLETED|Overall Study||0
11213145|NCT01912612|12404288|FG002|NOT COMPLETED|Overall Study||3
11213146|NCT01912716|12404296|FG000|STARTED|Overall Study|receipt of 1st dose of indomethacin|522
11213147|NCT01912716|12404297|FG001|STARTED|Overall Study||515
11213148|NCT01912716|12404296|FG000|Receipt of 2nd Dose|Overall Study||511
11213149|NCT01912716|12404297|FG001|Receipt of 2nd Dose|Overall Study||503
11213150|NCT01912716|12404296|FG000|5-day Follow-up|Overall Study||522
11213151|NCT01912716|12404297|FG001|5-day Follow-up|Overall Study||515
11213152|NCT01912716|12404296|FG000|3-day Follow-up|Overall Study||521
11213153|NCT01912716|12404297|FG001|3-day Follow-up|Overall Study||513
11213154|NCT01912716|12404296|FG000|COMPLETED|Overall Study||522
11213155|NCT01912716|12404297|FG001|COMPLETED|Overall Study||515
11213156|NCT01912716|12404296|FG000|NOT COMPLETED|Overall Study||0
11213157|NCT01912716|12404297|FG001|NOT COMPLETED|Overall Study||0
11213158|NCT01912729|12404307|FG000|STARTED|Overall Study||20
11213159|NCT01912729|12404308|FG001|STARTED|Overall Study||20
11213160|NCT01912729|12404307|FG000|COMPLETED|Overall Study||20
11213161|NCT01912729|12404308|FG001|COMPLETED|Overall Study||19
11213162|NCT01912729|12404307|FG000|NOT COMPLETED|Overall Study||0
11213163|NCT01912729|12404308|FG001|NOT COMPLETED|Overall Study||1
11213164|NCT01912768|12404316|FG000|STARTED|Overall Study||239
11213165|NCT01912768|12404317|FG001|STARTED|Overall Study||113
11213166|NCT01912768|12404316|FG000|COMPLETED|Overall Study||229
11213167|NCT01912768|12404317|FG001|COMPLETED|Overall Study||109
11213168|NCT01912768|12404316|FG000|NOT COMPLETED|Overall Study||10
11213169|NCT01912768|12404317|FG001|NOT COMPLETED|Overall Study||4
11213170|NCT01912781|12404326|FG000|STARTED|Overall Study||71
11213171|NCT01912781|12404327|FG001|STARTED|Overall Study||35
11097506|NCT01212588|12281261|FG000|NOT COMPLETED|Overall Study||1
11097507|NCT01212588|12281262|FG001|NOT COMPLETED|Overall Study||2
11097508|NCT01212627|12281268|FG000|STARTED|Overall Study||12
11097509|NCT01212627|12281268|FG000|COMPLETED|Overall Study||12
11097510|NCT01212627|12281268|FG000|NOT COMPLETED|Overall Study||0
11097511|NCT01212744|12281272|FG000|STARTED|Overall Study||16
11097512|NCT01212744|12281272|FG000|COMPLETED|Overall Study||15
11097513|NCT01212744|12281272|FG000|NOT COMPLETED|Overall Study||1
11097514|NCT01212757|12281281|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
11097515|NCT01212757|12281282|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
11097516|NCT01212757|12281283|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
11097517|NCT01212757|12281284|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
11097518|NCT01212757|12281285|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
11097519|NCT01212757|12281286|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
11097520|NCT01212757|12281287|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
11097521|NCT01212757|12281288|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
11097522|NCT01212757|12281289|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
11097523|NCT01212757|12281281|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
11097524|NCT01212757|12281282|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
11097525|NCT01212757|12281283|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
11097526|NCT01212757|12281284|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
11097527|NCT01212757|12281285|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
11097528|NCT01212757|12281286|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
11097529|NCT01212757|12281287|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
11097530|NCT01212757|12281288|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
11097531|NCT01212757|12281289|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
11097532|NCT01212757|12281281|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
11097533|NCT01212757|12281282|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
11097534|NCT01212757|12281283|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
11097535|NCT01212757|12281284|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097536|NCT01212757|12281285|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097537|NCT01212757|12281286|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097538|NCT01212757|12281287|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11213172|NCT01912781|12404326|FG000|COMPLETED|Overall Study||69
11213173|NCT01912781|12404327|FG001|COMPLETED|Overall Study||35
11213174|NCT01912781|12404326|FG000|NOT COMPLETED|Overall Study||2
11213175|NCT01912781|12404327|FG001|NOT COMPLETED|Overall Study||0
11213176|NCT01912807|12404336|FG000|STARTED|Overall Study|Enrolment phase: Recruiting of participants started December 11, 2013|150
11213177|NCT01912807|12404337|FG001|STARTED|Overall Study|Enrolment phase: Recruitment of participants started December 11, 2013|150
11213178|NCT01912807|12404336|FG000|Randomized|Overall Study||144
11213179|NCT01912807|12404337|FG001|Randomized|Overall Study||146
11213180|NCT01912807|12404336|FG000|COMPLETED|Overall Study|"n=108 completed study and immediate follow up~n=36 participants were lost to follow up at 24 hr"|108
11213181|NCT01912807|12404337|FG001|COMPLETED|Overall Study|"n=109 completed study and immediate follow up~n=37 participants were lost to follow up at 24 hr"|109
11213182|NCT01912807|12404336|FG000|NOT COMPLETED|Overall Study||42
11213183|NCT01912807|12404337|FG001|NOT COMPLETED|Overall Study||41
11213184|NCT01912872|12404347|FG000|STARTED|Overall Study||16
11213185|NCT01912872|12404348|FG001|STARTED|Overall Study||17
11213186|NCT01912872|12404349|FG002|STARTED|Overall Study||40
11213187|NCT01912872|12404350|FG003|STARTED|Overall Study||39
11213188|NCT01912872|12404347|FG000|Completed Study Treatment at Month 12|Overall Study||11
11213189|NCT01912872|12404348|FG001|Completed Study Treatment at Month 12|Overall Study||13
11213190|NCT01912872|12404349|FG002|Completed Study Treatment at Month 12|Overall Study||30
11213191|NCT01912872|12404350|FG003|Completed Study Treatment at Month 12|Overall Study||27
11213192|NCT01912872|12404347|FG000|Discontinued Treatment Prior to Month 12|Overall Study||5
11213193|NCT01912872|12404348|FG001|Discontinued Treatment Prior to Month 12|Overall Study||4
11213194|NCT01912872|12404349|FG002|Discontinued Treatment Prior to Month 12|Overall Study||10
11213195|NCT01912872|12404350|FG003|Discontinued Treatment Prior to Month 12|Overall Study||11
11213196|NCT01912872|12404347|FG000|COMPLETED|Overall Study||11
11213197|NCT01912872|12404348|FG001|COMPLETED|Overall Study||13
11213198|NCT01912872|12404349|FG002|COMPLETED|Overall Study||30
11213199|NCT01912872|12404350|FG003|COMPLETED|Overall Study||27
11213200|NCT01912872|12404347|FG000|NOT COMPLETED|Overall Study||5
11213201|NCT01912872|12404348|FG001|NOT COMPLETED|Overall Study||4
11213202|NCT01912872|12404349|FG002|NOT COMPLETED|Overall Study||10
11213203|NCT01912872|12404350|FG003|NOT COMPLETED|Overall Study||12
11213204|NCT01912963|12404364|FG000|STARTED|Overall Study||6
11213205|NCT01912963|12404365|FG001|STARTED|Overall Study||19
11213206|NCT01912963|12404366|FG002|STARTED|Overall Study||7
11213207|NCT01912963|12404364|FG000|COMPLETED|Overall Study||0
11213208|NCT01912963|12404365|FG001|COMPLETED|Overall Study||0
11213209|NCT01912963|12404366|FG002|COMPLETED|Overall Study||0
11213210|NCT01912963|12404364|FG000|NOT COMPLETED|Overall Study||6
11213211|NCT01912963|12404365|FG001|NOT COMPLETED|Overall Study||19
11213212|NCT01912963|12404366|FG002|NOT COMPLETED|Overall Study||7
11213213|NCT01913041|12404374|FG000|STARTED|Overall Study||869
11213214|NCT01913041|12404374|FG000|COMPLETED|Overall Study||830
11213215|NCT01913041|12404374|FG000|NOT COMPLETED|Overall Study||39
11213216|NCT01913314|12404378|FG000|STARTED|Overall Study||6
11213217|NCT01913314|12404378|FG000|Received Study Drug|Overall Study||6
11213218|NCT01913314|12404378|FG000|COMPLETED|Overall Study||6
11213219|NCT01913314|12404378|FG000|NOT COMPLETED|Overall Study||0
11213220|NCT01913340|12404384|FG000|STARTED|Overall Study|22 (92%) received all 5 doses, 1 (4%) received 4 doses, and 1 (4%) only received 1 dose.|24
11213221|NCT01913340|12404385|FG001|STARTED|Overall Study||26
11213222|NCT01913340|12404384|FG000|COMPLETED|Overall Study||21
11213223|NCT01913340|12404385|FG001|COMPLETED|Overall Study||20
11213224|NCT01913340|12404384|FG000|NOT COMPLETED|Overall Study||3
11213225|NCT01913340|12404385|FG001|NOT COMPLETED|Overall Study||6
11213226|NCT01913353|12404393|FG000|STARTED|Overall Study||221
11213227|NCT01913353|12404394|FG001|STARTED|Overall Study||219
11213228|NCT01913353|12404393|FG000|COMPLETED|Overall Study||189
11213229|NCT01913353|12404394|FG001|COMPLETED|Overall Study||204
11213230|NCT01913353|12404393|FG000|NOT COMPLETED|Overall Study||32
11213231|NCT01913353|12404394|FG001|NOT COMPLETED|Overall Study||15
11213232|NCT01913405|12404407|FG000|STARTED|Overall Study||22
11213233|NCT01913405|12404407|FG000|COMPLETED|Overall Study||20
11213234|NCT01913405|12404407|FG000|NOT COMPLETED|Overall Study||2
11213235|NCT01913470|12404426|FG000|STARTED|Overall Study||5
11213236|NCT01913470|12404427|FG001|STARTED|Overall Study||7
11213237|NCT01913470|12404426|FG000|COMPLETED|Overall Study||5
11213238|NCT01913470|12404427|FG001|COMPLETED|Overall Study||4
11213239|NCT01913470|12404426|FG000|NOT COMPLETED|Overall Study||0
11213240|NCT01913470|12404427|FG001|NOT COMPLETED|Overall Study||3
11213241|NCT01913483|12404436|FG000|STARTED|Overall Study||367
11213242|NCT01913483|12404437|FG001|STARTED|Overall Study||365
11213243|NCT01913483|12404436|FG000|Received at Least 1 Dose of Study Drug|Overall Study||335
11213244|NCT01913483|12404437|FG001|Received at Least 1 Dose of Study Drug|Overall Study||321
11213245|NCT01913483|12404436|FG000|COMPLETED|Overall Study||346
11213246|NCT01913483|12404437|FG001|COMPLETED|Overall Study||343
11213247|NCT01913483|12404436|FG000|NOT COMPLETED|Overall Study||21
11213248|NCT01913483|12404437|FG001|NOT COMPLETED|Overall Study||22
11213249|NCT01913535|12404448|FG000|STARTED|Phase 1 (Days 0-2)||2
11213250|NCT01913535|12404449|FG001|STARTED|Phase 1 (Days 0-2)||2
11213251|NCT01913535|12404450|FG002|STARTED|Phase 1 (Days 0-2)||1
11213252|NCT01913535|12404451|FG003|STARTED|Phase 1 (Days 0-2)||2
11213253|NCT01913535|12404452|FG004|STARTED|Phase 1 (Days 0-2)||1
11213254|NCT01913535|12404448|FG000|COMPLETED|Phase 1 (Days 0-2)||2
11213255|NCT01913535|12404449|FG001|COMPLETED|Phase 1 (Days 0-2)||2
11213256|NCT01913535|12404450|FG002|COMPLETED|Phase 1 (Days 0-2)||1
11213257|NCT01913535|12404451|FG003|COMPLETED|Phase 1 (Days 0-2)||2
11213258|NCT01913535|12404452|FG004|COMPLETED|Phase 1 (Days 0-2)||1
11213259|NCT01913535|12404448|FG000|NOT COMPLETED|Phase 1 (Days 0-2)||0
11213260|NCT01913535|12404449|FG001|NOT COMPLETED|Phase 1 (Days 0-2)||0
11213261|NCT01913535|12404450|FG002|NOT COMPLETED|Phase 1 (Days 0-2)||0
11213262|NCT01913535|12404451|FG003|NOT COMPLETED|Phase 1 (Days 0-2)||0
11213263|NCT01913535|12404452|FG004|NOT COMPLETED|Phase 1 (Days 0-2)||0
11213264|NCT01913535|12404448|FG000|STARTED|Phase 2 (Days 3-5)||2
11213265|NCT01913535|12404449|FG001|STARTED|Phase 2 (Days 3-5)||2
11213266|NCT01913535|12404450|FG002|STARTED|Phase 2 (Days 3-5)||1
11213267|NCT01913535|12404451|FG003|STARTED|Phase 2 (Days 3-5)||2
11213268|NCT01913535|12404452|FG004|STARTED|Phase 2 (Days 3-5)||1
11213269|NCT01913535|12404448|FG000|COMPLETED|Phase 2 (Days 3-5)||2
11213270|NCT01913535|12404449|FG001|COMPLETED|Phase 2 (Days 3-5)||2
11213271|NCT01913535|12404450|FG002|COMPLETED|Phase 2 (Days 3-5)||1
11213272|NCT01913535|12404451|FG003|COMPLETED|Phase 2 (Days 3-5)||2
11213273|NCT01913535|12404452|FG004|COMPLETED|Phase 2 (Days 3-5)||1
11213274|NCT01913535|12404448|FG000|NOT COMPLETED|Phase 2 (Days 3-5)||0
11213275|NCT01913535|12404449|FG001|NOT COMPLETED|Phase 2 (Days 3-5)||0
11213276|NCT01913535|12404450|FG002|NOT COMPLETED|Phase 2 (Days 3-5)||0
11213277|NCT01913535|12404451|FG003|NOT COMPLETED|Phase 2 (Days 3-5)||0
11213278|NCT01913535|12404452|FG004|NOT COMPLETED|Phase 2 (Days 3-5)||0
11213279|NCT01913600|12404465|FG000|STARTED|Overall Study||56
11213280|NCT01913600|12404465|FG000|COMPLETED|Overall Study||55
11213281|NCT01913600|12404465|FG000|NOT COMPLETED|Overall Study||1
11213282|NCT01913639|12404469|FG000|STARTED|Overall Study||39
11213283|NCT01913639|12404469|FG000|COMPLETED|Overall Study||36
11213284|NCT01913639|12404469|FG000|NOT COMPLETED|Overall Study||3
11213285|NCT01914003|12404475|FG000|STARTED|Overall Study||27
11213286|NCT01914003|12404476|FG001|STARTED|Overall Study||26
11213287|NCT01914003|12404475|FG000|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
11213288|NCT01914003|12404476|FG001|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
11213289|NCT01914003|12404475|FG000|NOT COMPLETED|Overall Study||8
11213290|NCT01914003|12404476|FG001|NOT COMPLETED|Overall Study||12
11213291|NCT01914159|12404482|FG000|STARTED|Overall Study||24
11213292|NCT01914159|12404482|FG000|COMPLETED|Overall Study||21
11213293|NCT01914159|12404482|FG000|NOT COMPLETED|Overall Study||3
11213294|NCT01914393|12404489|FG000|STARTED|Overall Study||271
11213295|NCT01914393|12404490|FG001|STARTED|Overall Study||125
11213296|NCT01914393|12404491|FG002|STARTED|Overall Study||306
11213297|NCT01914393|12404489|FG000|COMPLETED|Overall Study||156
11213298|NCT01914393|12404490|FG001|COMPLETED|Overall Study||54
11213299|NCT01914393|12404491|FG002|COMPLETED|Overall Study||168
11213300|NCT01914393|12404489|FG000|NOT COMPLETED|Overall Study||115
11213301|NCT01914393|12404490|FG001|NOT COMPLETED|Overall Study||71
11213302|NCT01914393|12404491|FG002|NOT COMPLETED|Overall Study||138
11213303|NCT01914510|12404503|FG000|STARTED|Overall Study||40
11213304|NCT01914510|12404503|FG000|COMPLETED|Overall Study||38
11213305|NCT01914510|12404503|FG000|NOT COMPLETED|Overall Study||2
11213306|NCT01914666|12404511|FG000|STARTED|Treatment Period||68
11213307|NCT01914666|12404512|FG001|STARTED|Treatment Period||42
11213308|NCT01914666|12404513|FG002|STARTED|Treatment Period||41
11213309|NCT01914666|12404511|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||68
11213310|NCT01914666|12404512|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||42
11213311|NCT01914666|12404513|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||41
11213312|NCT01914666|12404511|FG000|COMPLETED|Treatment Period||55
11213313|NCT01914666|12404512|FG001|COMPLETED|Treatment Period||36
11213314|NCT01914666|12404513|FG002|COMPLETED|Treatment Period||33
11213315|NCT01914666|12404511|FG000|NOT COMPLETED|Treatment Period||13
11213316|NCT01914666|12404512|FG001|NOT COMPLETED|Treatment Period||6
11213317|NCT01914666|12404513|FG002|NOT COMPLETED|Treatment Period||8
11213318|NCT01914666|12404511|FG000|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
11213319|NCT01914666|12404512|FG001|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
11213320|NCT01914666|12404513|FG002|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
11213321|NCT01914666|12404511|FG000|COMPLETED|Tapering Period||59
11213322|NCT01914666|12404512|FG001|COMPLETED|Tapering Period||39
11213323|NCT01914666|12404513|FG002|COMPLETED|Tapering Period||40
11213324|NCT01914666|12404511|FG000|NOT COMPLETED|Tapering Period||0
11213325|NCT01914666|12404512|FG001|NOT COMPLETED|Tapering Period||0
11213326|NCT01914666|12404513|FG002|NOT COMPLETED|Tapering Period||0
11213327|NCT01914679|12404519|FG000|STARTED|Overall Study||17
11213328|NCT01914679|12404519|FG000|Began 12 Week Actual RINCE Treatment|Overall Study||17
11213329|NCT01914679|12404519|FG000|COMPLETED|Overall Study||12
11213330|NCT01914679|12404519|FG000|NOT COMPLETED|Overall Study||5
11213331|NCT01914757|12404526|FG000|STARTED|Overall Study||425
11213332|NCT01914757|12404527|FG001|STARTED|Overall Study||441
11213333|NCT01914757|12404528|FG002|STARTED|Overall Study||440
11213334|NCT01914757|12404526|FG000|COMPLETED|Overall Study||389
11213335|NCT01914757|12404527|FG001|COMPLETED|Overall Study||390
11213336|NCT01914757|12404528|FG002|COMPLETED|Overall Study||402
11213337|NCT01914757|12404526|FG000|NOT COMPLETED|Overall Study||36
11213338|NCT01914757|12404527|FG001|NOT COMPLETED|Overall Study||51
11213339|NCT01914757|12404528|FG002|NOT COMPLETED|Overall Study||38
11213340|NCT01914926|12404538|FG000|STARTED|Overall Study||29
11213341|NCT01914926|12404539|FG001|STARTED|Overall Study||25
11213342|NCT01914926|12404538|FG000|COMPLETED|Overall Study||28
11213343|NCT01914926|12404539|FG001|COMPLETED|Overall Study||24
11213344|NCT01914926|12404538|FG000|NOT COMPLETED|Overall Study||1
11213345|NCT01914926|12404539|FG001|NOT COMPLETED|Overall Study||1
11213346|NCT01915095|12404552|FG000|STARTED|Overall Study||10
11213347|NCT01915095|12404553|FG001|STARTED|Overall Study||10
11213348|NCT01915095|12404554|FG002|STARTED|Overall Study||5
11213349|NCT01915095|12404555|FG003|STARTED|Overall Study||8
11213350|NCT01915095|12404556|FG004|STARTED|Overall Study||9
11213351|NCT01915095|12404552|FG000|SCI|Overall Study||5
11213352|NCT01915095|12404553|FG001|SCI|Overall Study||5
11213353|NCT01915095|12404554|FG002|SCI|Overall Study||5
11213354|NCT01915095|12404555|FG003|SCI|Overall Study||8
11213355|NCT01915095|12404556|FG004|SCI|Overall Study||9
11213356|NCT01915095|12404552|FG000|Control|Overall Study||5
11213357|NCT01915095|12404553|FG001|Control|Overall Study||5
11213358|NCT01915095|12404554|FG002|Control|Overall Study||0
11213359|NCT01915095|12404555|FG003|Control|Overall Study||0
11213360|NCT01915095|12404556|FG004|Control|Overall Study||0
11213361|NCT01915095|12404552|FG000|COMPLETED|Overall Study||10
11213362|NCT01915095|12404553|FG001|COMPLETED|Overall Study||10
11213363|NCT01915095|12404554|FG002|COMPLETED|Overall Study||5
11213364|NCT01915095|12404555|FG003|COMPLETED|Overall Study||4
11213365|NCT01915095|12404556|FG004|COMPLETED|Overall Study||3
11213366|NCT01915095|12404552|FG000|NOT COMPLETED|Overall Study||0
11213367|NCT01915095|12404553|FG001|NOT COMPLETED|Overall Study||0
11213368|NCT01915095|12404554|FG002|NOT COMPLETED|Overall Study||0
11213369|NCT01915095|12404555|FG003|NOT COMPLETED|Overall Study||4
11213370|NCT01915095|12404556|FG004|NOT COMPLETED|Overall Study||6
11213371|NCT01915108|12404581|FG000|STARTED|Overall Study||32
11213372|NCT01915108|12404582|FG001|STARTED|Overall Study||32
11213373|NCT01915108|12404583|FG002|STARTED|Overall Study||32
11213374|NCT01915108|12404584|FG003|STARTED|Overall Study||32
11213375|NCT01915108|12404581|FG000|COMPLETED|Overall Study|two patients were excluded from the study|30
11213376|NCT01915108|12404582|FG001|COMPLETED|Overall Study|three patients were excluded from the study|29
11213377|NCT01915108|12404583|FG002|COMPLETED|Overall Study|one patients were excluded from the study|31
11213378|NCT01915108|12404584|FG003|COMPLETED|Overall Study|two patients were excluded from the study|30
11213379|NCT01915108|12404581|FG000|NOT COMPLETED|Overall Study||2
11213380|NCT01915108|12404582|FG001|NOT COMPLETED|Overall Study||3
11213381|NCT01915108|12404583|FG002|NOT COMPLETED|Overall Study||1
11213382|NCT01915108|12404584|FG003|NOT COMPLETED|Overall Study||2
11213383|NCT01915173|12404598|FG000|STARTED|Overall Study||6
11213384|NCT01915173|12404599|FG001|STARTED|Overall Study||6
11213385|NCT01915173|12404600|FG002|STARTED|Overall Study||6
11213386|NCT01915173|12404601|FG003|STARTED|Overall Study||6
11213387|NCT01915173|12404598|FG000|COMPLETED|Overall Study||6
11213388|NCT01915173|12404599|FG001|COMPLETED|Overall Study||6
11213389|NCT01915173|12404600|FG002|COMPLETED|Overall Study||6
11213390|NCT01915173|12404601|FG003|COMPLETED|Overall Study||6
11213391|NCT01915173|12404598|FG000|NOT COMPLETED|Overall Study||0
11213392|NCT01915173|12404599|FG001|NOT COMPLETED|Overall Study||0
11213393|NCT01915173|12404600|FG002|NOT COMPLETED|Overall Study||0
11213394|NCT01915173|12404601|FG003|NOT COMPLETED|Overall Study||0
11213395|NCT01915303|12404611|FG000|STARTED|Core Phase||68
11213396|NCT01915303|12404611|FG000|COMPLETED|Core Phase||52
11213397|NCT01915303|12404611|FG000|NOT COMPLETED|Core Phase||16
11213398|NCT01915303|12404611|FG000|STARTED|Extension Phase||29
11213399|NCT01915303|12404611|FG000|COMPLETED|Extension Phase||12
11213400|NCT01915303|12404611|FG000|NOT COMPLETED|Extension Phase||17
11213401|NCT01915563|12404617|FG000|STARTED|Overall Study||243
11213402|NCT01915563|12404618|FG001|STARTED|Overall Study||227
11213403|NCT01915563|12404617|FG000|COMPLETED|Overall Study||243
11213404|NCT01915563|12404618|FG001|COMPLETED|Overall Study||227
11213405|NCT01915563|12404617|FG000|NOT COMPLETED|Overall Study||0
11213406|NCT01915563|12404618|FG001|NOT COMPLETED|Overall Study||0
11213407|NCT01915732|12404626|FG000|STARTED|Overall Study||500
11213408|NCT01915732|12404627|FG001|STARTED|Overall Study||516
11213409|NCT01915732|12404626|FG000|COMPLETED|Overall Study||430
11213410|NCT01915732|12404627|FG001|COMPLETED|Overall Study||445
11213411|NCT01915732|12404626|FG000|NOT COMPLETED|Overall Study||70
11213412|NCT01915732|12404627|FG001|NOT COMPLETED|Overall Study||71
11213413|NCT01915771|12404633|FG000|STARTED|Day 1||15
11213414|NCT01915771|12404633|FG000|COMPLETED|Day 1||14
11213415|NCT01915771|12404633|FG000|NOT COMPLETED|Day 1||1
11213416|NCT01915771|12404633|FG000|STARTED|Day 15||14
11213417|NCT01915771|12404633|FG000|COMPLETED|Day 15||13
11213418|NCT01915771|12404633|FG000|NOT COMPLETED|Day 15||1
11213419|NCT01915823|12404643|FG000|STARTED|Overall Study||173
11213420|NCT01915823|12404644|FG001|STARTED|Overall Study||175
11213421|NCT01915823|12404643|FG000|COMPLETED|Overall Study||171
11213422|NCT01915823|12404644|FG001|COMPLETED|Overall Study||173
11213423|NCT01915823|12404643|FG000|NOT COMPLETED|Overall Study||2
11213424|NCT01915823|12404644|FG001|NOT COMPLETED|Overall Study||2
11213425|NCT01915849|12404654|FG000|STARTED|Treatment Period 1 (4 Days)||5
11213426|NCT01915849|12404655|FG001|STARTED|Treatment Period 1 (4 Days)||3
11213427|NCT01915849|12404656|FG002|STARTED|Treatment Period 1 (4 Days)||3
11213428|NCT01915849|12404657|FG003|STARTED|Treatment Period 1 (4 Days)||3
11213429|NCT01915849|12404654|FG000|COMPLETED|Treatment Period 1 (4 Days)||3
11213430|NCT01915849|12404655|FG001|COMPLETED|Treatment Period 1 (4 Days)||3
11213431|NCT01915849|12404656|FG002|COMPLETED|Treatment Period 1 (4 Days)||3
11213432|NCT01915849|12404657|FG003|COMPLETED|Treatment Period 1 (4 Days)||3
11213433|NCT01915849|12404654|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||2
11213434|NCT01915849|12404655|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11352822|NCT03051165|12549949|FG000|STARTED|Overall Study||13
11352823|NCT03051165|12549949|FG000|Completed Some Baseline Assessments|Overall Study||1
11352824|NCT03051165|12549949|FG000|Completed Some Day 105 Assessments|Overall Study||1
11352825|NCT03051165|12549949|FG000|Began HGNS Treatment Withdrawal|Overall Study||0
11352826|NCT03051165|12549949|FG000|Completed Some Day 137 Assessments|Overall Study||0
11352827|NCT03051165|12549949|FG000|COMPLETED|Overall Study||0
11213435|NCT01915849|12404656|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11352828|NCT03051165|12549949|FG000|NOT COMPLETED|Overall Study||13
11352829|NCT03051256|12549956|FG000|STARTED|Overall Study||19
11352830|NCT03051256|12549957|FG001|STARTED|Overall Study||21
11352831|NCT03051256|12549958|FG002|STARTED|Overall Study||22
11352832|NCT03051256|12549956|FG000|COMPLETED|Overall Study||19
11352833|NCT03051256|12549957|FG001|COMPLETED|Overall Study||21
11352834|NCT03051256|12549958|FG002|COMPLETED|Overall Study||21
11352835|NCT03051256|12549956|FG000|NOT COMPLETED|Overall Study||0
11352836|NCT03051256|12549957|FG001|NOT COMPLETED|Overall Study||0
11352837|NCT03051256|12549958|FG002|NOT COMPLETED|Overall Study||1
11352838|NCT03051607|12549967|FG000|STARTED|Overall Study||66
11352839|NCT03051607|12549967|FG000|COMPLETED|Overall Study||0
11352840|NCT03051607|12549967|FG000|NOT COMPLETED|Overall Study||66
11352841|NCT03051620|12549971|FG000|STARTED|Overall Study||142
11352842|NCT03051620|12549971|FG000|COMPLETED|Overall Study||124
11352843|NCT03051620|12549971|FG000|NOT COMPLETED|Overall Study||18
11352844|NCT03051633|12549977|FG000|STARTED|Overall Study||342
11352845|NCT03051633|12549978|FG001|STARTED|Overall Study||186
11352846|NCT03051633|12549977|FG000|COMPLETED|Overall Study||249
11352847|NCT03051633|12549978|FG001|COMPLETED|Overall Study||179
11352848|NCT03051633|12549977|FG000|NOT COMPLETED|Overall Study||93
11352849|NCT03051633|12549978|FG001|NOT COMPLETED|Overall Study||7
11352850|NCT03051646|12549986|FG000|STARTED|Overall Study||6
11352851|NCT03051646|12549987|FG001|STARTED|Overall Study||6
11352852|NCT03051646|12549986|FG000|COMPLETED|Overall Study||6
11352853|NCT03051646|12549987|FG001|COMPLETED|Overall Study||6
11352854|NCT03051646|12549986|FG000|NOT COMPLETED|Overall Study||0
11352855|NCT03051646|12549987|FG001|NOT COMPLETED|Overall Study||0
11352856|NCT03051672|12549995|FG000|STARTED|Overall Study||8
11352857|NCT03051672|12549995|FG000|Began Treatment|Overall Study||8
11213436|NCT01915849|12404657|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11213437|NCT01915849|12404654|FG000|STARTED|Treatment Period 2 (4 Days)||3
11213438|NCT01915849|12404655|FG001|STARTED|Treatment Period 2 (4 Days)||3
11213439|NCT01915849|12404656|FG002|STARTED|Treatment Period 2 (4 Days)||3
11213440|NCT01915849|12404657|FG003|STARTED|Treatment Period 2 (4 Days)||3
11352858|NCT03051672|12549995|FG000|COMPLETED|Overall Study||8
11352859|NCT03051672|12549995|FG000|NOT COMPLETED|Overall Study||0
11352860|NCT03052257|12550002|FG000|STARTED|Overall Study||100
11213441|NCT01915849|12404654|FG000|COMPLETED|Treatment Period 2 (4 Days)||3
11213442|NCT01915849|12404655|FG001|COMPLETED|Treatment Period 2 (4 Days)||3
11213443|NCT01915849|12404656|FG002|COMPLETED|Treatment Period 2 (4 Days)||3
11213444|NCT01915849|12404657|FG003|COMPLETED|Treatment Period 2 (4 Days)||3
11213445|NCT01915849|12404654|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11213446|NCT01915849|12404655|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11213447|NCT01915849|12404656|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11213448|NCT01915849|12404657|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11213449|NCT01915849|12404654|FG000|STARTED|Treatment Period 3 (4 Days)||3
11213450|NCT01915849|12404655|FG001|STARTED|Treatment Period 3 (4 Days)||3
11213451|NCT01915849|12404656|FG002|STARTED|Treatment Period 3 (4 Days)||3
11213452|NCT01915849|12404657|FG003|STARTED|Treatment Period 3 (4 Days)||3
11213453|NCT01915849|12404654|FG000|COMPLETED|Treatment Period 3 (4 Days)||3
11213454|NCT01915849|12404655|FG001|COMPLETED|Treatment Period 3 (4 Days)||3
11213455|NCT01915849|12404656|FG002|COMPLETED|Treatment Period 3 (4 Days)||3
11213456|NCT01915849|12404657|FG003|COMPLETED|Treatment Period 3 (4 Days)||3
11213457|NCT01915849|12404654|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0
11213458|NCT01915849|12404655|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0
11213459|NCT01915849|12404656|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0
11213460|NCT01915849|12404657|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0
11213461|NCT01915849|12404654|FG000|STARTED|Treatment Period 4 (4 Days)||3
11213462|NCT01915849|12404655|FG001|STARTED|Treatment Period 4 (4 Days)||3
11213463|NCT01915849|12404656|FG002|STARTED|Treatment Period 4 (4 Days)||3
11213464|NCT01915849|12404657|FG003|STARTED|Treatment Period 4 (4 Days)||3
11213465|NCT01915849|12404654|FG000|COMPLETED|Treatment Period 4 (4 Days)||3
11213466|NCT01915849|12404655|FG001|COMPLETED|Treatment Period 4 (4 Days)||3
11213467|NCT01915849|12404656|FG002|COMPLETED|Treatment Period 4 (4 Days)||3
11213468|NCT01915849|12404657|FG003|COMPLETED|Treatment Period 4 (4 Days)||3
11213469|NCT01915849|12404654|FG000|NOT COMPLETED|Treatment Period 4 (4 Days)||0
11213470|NCT01915849|12404655|FG001|NOT COMPLETED|Treatment Period 4 (4 Days)||0
11213471|NCT01915849|12404656|FG002|NOT COMPLETED|Treatment Period 4 (4 Days)||0
11213472|NCT01915849|12404657|FG003|NOT COMPLETED|Treatment Period 4 (4 Days)||0
11213473|NCT01915914|12404667|FG000|STARTED|Acute Phase||123
11213474|NCT01915914|12404668|FG001|STARTED|Acute Phase||0
11213475|NCT01915914|12404669|FG002|STARTED|Acute Phase||0
11213476|NCT01915914|12404670|FG003|STARTED|Acute Phase||0
11213477|NCT01915914|12404667|FG000|Completed-Not Entered Maintenance Phase|Acute Phase||4
11213478|NCT01915914|12404668|FG001|Completed-Not Entered Maintenance Phase|Acute Phase||0
11213479|NCT01915914|12404669|FG002|Completed-Not Entered Maintenance Phase|Acute Phase||0
11352861|NCT03052257|12550003|FG001|STARTED|Overall Study||100
11352862|NCT03052257|12550002|FG000|COMPLETED|Overall Study||95
11213480|NCT01915914|12404670|FG003|Completed-Not Entered Maintenance Phase|Acute Phase||0
11213481|NCT01915914|12404667|FG000|COMPLETED|Acute Phase||111
11213482|NCT01915914|12404668|FG001|COMPLETED|Acute Phase||0
11213483|NCT01915914|12404669|FG002|COMPLETED|Acute Phase||0
11213484|NCT01915914|12404670|FG003|COMPLETED|Acute Phase||0
11213485|NCT01915914|12404667|FG000|NOT COMPLETED|Acute Phase||12
11213486|NCT01915914|12404668|FG001|NOT COMPLETED|Acute Phase||0
11213487|NCT01915914|12404669|FG002|NOT COMPLETED|Acute Phase||0
11213488|NCT01915914|12404670|FG003|NOT COMPLETED|Acute Phase||0
11213489|NCT01915914|12404667|FG000|STARTED|Maintenance Phase||0
11213490|NCT01915914|12404668|FG001|STARTED|Maintenance Phase||54
11213491|NCT01915914|12404669|FG002|STARTED|Maintenance Phase||53
11213492|NCT01915914|12404670|FG003|STARTED|Maintenance Phase||0
11213493|NCT01915914|12404667|FG000|COMPLETED|Maintenance Phase||0
11213494|NCT01915914|12404668|FG001|COMPLETED|Maintenance Phase||48
11213495|NCT01915914|12404669|FG002|COMPLETED|Maintenance Phase||51
11213496|NCT01915914|12404670|FG003|COMPLETED|Maintenance Phase||0
11213497|NCT01915914|12404667|FG000|NOT COMPLETED|Maintenance Phase||0
11213498|NCT01915914|12404668|FG001|NOT COMPLETED|Maintenance Phase||6
11213499|NCT01915914|12404669|FG002|NOT COMPLETED|Maintenance Phase||2
11213500|NCT01915914|12404670|FG003|NOT COMPLETED|Maintenance Phase||0
11213501|NCT01915914|12404667|FG000|STARTED|Follow-up Phase||0
11213502|NCT01915914|12404668|FG001|STARTED|Follow-up Phase||0
11213503|NCT01915914|12404669|FG002|STARTED|Follow-up Phase||0
11213504|NCT01915914|12404670|FG003|STARTED|Follow-up Phase||66
11213505|NCT01915914|12404667|FG000|COMPLETED|Follow-up Phase||0
11213506|NCT01915914|12404668|FG001|COMPLETED|Follow-up Phase||0
11213507|NCT01915914|12404669|FG002|COMPLETED|Follow-up Phase||0
11213508|NCT01915914|12404670|FG003|COMPLETED|Follow-up Phase||64
11213509|NCT01915914|12404667|FG000|NOT COMPLETED|Follow-up Phase||0
11213510|NCT01915914|12404668|FG001|NOT COMPLETED|Follow-up Phase||0
11213511|NCT01915914|12404669|FG002|NOT COMPLETED|Follow-up Phase||0
11213512|NCT01915914|12404670|FG003|NOT COMPLETED|Follow-up Phase||2
11213513|NCT01915940|12404690|FG000|STARTED|Pre-randomization Washout Period||169
11213514|NCT01915940|12404691|FG001|STARTED|Pre-randomization Washout Period||0
11213515|NCT01915940|12404692|FG002|STARTED|Pre-randomization Washout Period||0
11213516|NCT01915940|12404690|FG000|COMPLETED|Pre-randomization Washout Period||130
11213517|NCT01915940|12404691|FG001|COMPLETED|Pre-randomization Washout Period||0
11213518|NCT01915940|12404692|FG002|COMPLETED|Pre-randomization Washout Period||0
11213519|NCT01915940|12404690|FG000|NOT COMPLETED|Pre-randomization Washout Period||39
11213520|NCT01915940|12404691|FG001|NOT COMPLETED|Pre-randomization Washout Period||0
11213521|NCT01915940|12404692|FG002|NOT COMPLETED|Pre-randomization Washout Period||0
11213522|NCT01915940|12404690|FG000|STARTED|Treatment Period||0
11352863|NCT03052257|12550003|FG001|COMPLETED|Overall Study||97
11352864|NCT03052257|12550002|FG000|NOT COMPLETED|Overall Study||5
11352865|NCT03052257|12550003|FG001|NOT COMPLETED|Overall Study||3
11352866|NCT03052322|12550011|FG000|STARTED|Overall Study||143
11352867|NCT03052322|12550012|FG001|STARTED|Overall Study||145
11352868|NCT03052322|12550011|FG000|COMPLETED|Overall Study||122
11352869|NCT03052322|12550012|FG001|COMPLETED|Overall Study||113
11352870|NCT03052322|12550011|FG000|NOT COMPLETED|Overall Study||21
11352871|NCT03052322|12550012|FG001|NOT COMPLETED|Overall Study||32
11352872|NCT03052426|12550021|FG000|STARTED|Overall Study||6
11352873|NCT03052426|12550022|FG001|STARTED|Overall Study||6
11352874|NCT03052426|12550023|FG002|STARTED|Overall Study||6
11352875|NCT03052426|12550021|FG000|COMPLETED|Overall Study||4
11352876|NCT03052426|12550022|FG001|COMPLETED|Overall Study||5
11352877|NCT03052426|12550023|FG002|COMPLETED|Overall Study||5
11352878|NCT03052426|12550021|FG000|NOT COMPLETED|Overall Study||2
11352879|NCT03052426|12550022|FG001|NOT COMPLETED|Overall Study||1
11352880|NCT03052426|12550023|FG002|NOT COMPLETED|Overall Study||1
11352881|NCT03052517|12550039|FG000|STARTED|Overall Study||1093
11352882|NCT03052517|12550040|FG001|STARTED|Overall Study||1085
11352883|NCT03052517|12550041|FG002|STARTED|Overall Study||360
11352884|NCT03052517|12550039|FG000|Safety Set (SAF)|Overall Study|One patient received placebo. This patient was not included in QAW039 150 mg group in the SAF|1092
11352885|NCT03052517|12550040|FG001|Safety Set (SAF)|Overall Study|One patient had no treatment administered and thus was excluded from the SAF|1084
11352886|NCT03052517|12550041|FG002|Safety Set (SAF)|Overall Study|One patient in QAW039 150 mg group received placebo and was included in the placebo group in the SAF|361
11352887|NCT03052517|12550039|FG000|COMPLETED|Overall Study||76
11352888|NCT03052517|12550040|FG001|COMPLETED|Overall Study||71
11352889|NCT03052517|12550041|FG002|COMPLETED|Overall Study||32
11352890|NCT03052517|12550039|FG000|NOT COMPLETED|Overall Study||1017
11352891|NCT03052517|12550040|FG001|NOT COMPLETED|Overall Study||1014
11352892|NCT03052517|12550041|FG002|NOT COMPLETED|Overall Study||328
11352893|NCT03052530|12550049|FG000|STARTED|Overall Study||61
11352894|NCT03052530|12550049|FG000|COMPLETED|Overall Study||61
11352895|NCT03052530|12550049|FG000|NOT COMPLETED|Overall Study||0
11352896|NCT03052725|12550055|FG000|STARTED|Overall Study||194
11352897|NCT03052725|12550056|FG001|STARTED|Overall Study||197
11352898|NCT03052725|12550055|FG000|Safety Analysis Set|Overall Study||194
11352899|NCT03052725|12550056|FG001|Safety Analysis Set|Overall Study||196
11352900|NCT03052725|12550055|FG000|COMPLETED|Overall Study||46
11352901|NCT03052725|12550056|FG001|COMPLETED|Overall Study||47
11352902|NCT03052725|12550055|FG000|NOT COMPLETED|Overall Study||148
11352903|NCT03052725|12550056|FG001|NOT COMPLETED|Overall Study||150
11352904|NCT03052751|12550063|FG000|STARTED|Dosing Period 1||22
11352905|NCT03052751|12550064|FG001|STARTED|Dosing Period 1||21
11352906|NCT03052751|12550065|FG002|STARTED|Dosing Period 1||0
11352907|NCT03052751|12550066|FG003|STARTED|Dosing Period 1||0
11352908|NCT03052751|12550067|FG004|STARTED|Dosing Period 1||0
11352909|NCT03052751|12550068|FG005|STARTED|Dosing Period 1||0
11352910|NCT03052751|12550063|FG000|Completed Period 1|Dosing Period 1||22
11352911|NCT03052751|12550064|FG001|Completed Period 1|Dosing Period 1||21
11352912|NCT03052751|12550065|FG002|Completed Period 1|Dosing Period 1||0
11352913|NCT03052751|12550066|FG003|Completed Period 1|Dosing Period 1||0
11352914|NCT03052751|12550067|FG004|Completed Period 1|Dosing Period 1||0
11352915|NCT03052751|12550068|FG005|Completed Period 1|Dosing Period 1||0
11352916|NCT03052751|12550063|FG000|Completed Period 1 and Started Period 2|Dosing Period 1||22
11352917|NCT03052751|12550064|FG001|Completed Period 1 and Started Period 2|Dosing Period 1||20
11352918|NCT03052751|12550065|FG002|Completed Period 1 and Started Period 2|Dosing Period 1||0
11352919|NCT03052751|12550066|FG003|Completed Period 1 and Started Period 2|Dosing Period 1||0
11352920|NCT03052751|12550067|FG004|Completed Period 1 and Started Period 2|Dosing Period 1||0
11352921|NCT03052751|12550068|FG005|Completed Period 1 and Started Period 2|Dosing Period 1||0
11352922|NCT03052751|12550063|FG000|COMPLETED|Dosing Period 1||22
11352923|NCT03052751|12550064|FG001|COMPLETED|Dosing Period 1||20
11352924|NCT03052751|12550065|FG002|COMPLETED|Dosing Period 1||0
11352925|NCT03052751|12550066|FG003|COMPLETED|Dosing Period 1||0
11352926|NCT03052751|12550067|FG004|COMPLETED|Dosing Period 1||0
11352927|NCT03052751|12550068|FG005|COMPLETED|Dosing Period 1||0
11352928|NCT03052751|12550063|FG000|NOT COMPLETED|Dosing Period 1||0
11352929|NCT03052751|12550064|FG001|NOT COMPLETED|Dosing Period 1||1
11213523|NCT01915940|12404691|FG001|STARTED|Treatment Period||64
11213524|NCT01915940|12404692|FG002|STARTED|Treatment Period||66
11213525|NCT01915940|12404690|FG000|COMPLETED|Treatment Period||0
11213526|NCT01915940|12404691|FG001|COMPLETED|Treatment Period||53
11213527|NCT01915940|12404692|FG002|COMPLETED|Treatment Period||62
11213528|NCT01915940|12404690|FG000|NOT COMPLETED|Treatment Period||0
11213529|NCT01915940|12404691|FG001|NOT COMPLETED|Treatment Period||11
11213530|NCT01915940|12404692|FG002|NOT COMPLETED|Treatment Period||4
11213531|NCT01916109|12404698|FG000|STARTED|Overall Study||4
11213532|NCT01916109|12404698|FG000|COMPLETED|Overall Study||3
11213533|NCT01916109|12404698|FG000|NOT COMPLETED|Overall Study||1
11213534|NCT01916226|12404706|FG000|STARTED|Overall Study||170
11213535|NCT01916226|12404707|FG001|STARTED|Overall Study||170
11213536|NCT01916226|12404708|FG002|STARTED|Overall Study||171
11213537|NCT01916226|12404709|FG003|STARTED|Overall Study||171
11213538|NCT01916226|12404706|FG000|COMPLETED|Overall Study||169
11213539|NCT01916226|12404707|FG001|COMPLETED|Overall Study||169
11213540|NCT01916226|12404708|FG002|COMPLETED|Overall Study||168
11213541|NCT01916226|12404709|FG003|COMPLETED|Overall Study||167
11213542|NCT01916226|12404706|FG000|NOT COMPLETED|Overall Study||1
11213543|NCT01916226|12404707|FG001|NOT COMPLETED|Overall Study||1
11213544|NCT01916226|12404708|FG002|NOT COMPLETED|Overall Study||3
11213545|NCT01916226|12404709|FG003|NOT COMPLETED|Overall Study||4
11213546|NCT01916304|12404720|FG000|STARTED|Overall Study||101
11213547|NCT01916304|12404720|FG000|Safety Set|Overall Study||101
11213548|NCT01916304|12404720|FG000|Intent-to-Treat Set|Overall Study||84
11213549|NCT01916304|12404720|FG000|COMPLETED|Overall Study||84
11213550|NCT01916304|12404720|FG000|NOT COMPLETED|Overall Study||17
11213551|NCT01916629|12404726|FG000|STARTED|Overall Study||7
11213552|NCT01916629|12404727|FG001|STARTED|Overall Study||5
11213553|NCT01916629|12404726|FG000|COMPLETED|Overall Study||7
11213554|NCT01916629|12404727|FG001|COMPLETED|Overall Study||5
11213555|NCT01916629|12404726|FG000|NOT COMPLETED|Overall Study||0
11213556|NCT01916629|12404727|FG001|NOT COMPLETED|Overall Study||0
11213557|NCT01916655|12404736|FG000|STARTED|Overall Study||131
11213558|NCT01916655|12404737|FG001|STARTED|Overall Study||109
11213559|NCT01916655|12404738|FG002|STARTED|Overall Study||120
11213560|NCT01916655|12404736|FG000|COMPLETED|Overall Study||116
11213561|NCT01916655|12404737|FG001|COMPLETED|Overall Study||89
11213562|NCT01916655|12404738|FG002|COMPLETED|Overall Study||91
11213563|NCT01916655|12404736|FG000|NOT COMPLETED|Overall Study||15
11213564|NCT01916655|12404737|FG001|NOT COMPLETED|Overall Study||20
11213565|NCT01916655|12404738|FG002|NOT COMPLETED|Overall Study||29
11213566|NCT01916681|12404750|FG000|STARTED|Overall Study||123
11213567|NCT01916681|12404751|FG001|STARTED|Overall Study||120
11213568|NCT01916681|12404752|FG002|STARTED|Overall Study||123
11213569|NCT01916681|12404753|FG003|STARTED|Overall Study||125
11213570|NCT01916681|12404750|FG000|COMPLETED|Overall Study||123
11213571|NCT01916681|12404751|FG001|COMPLETED|Overall Study||120
11213572|NCT01916681|12404752|FG002|COMPLETED|Overall Study||123
11213573|NCT01916681|12404753|FG003|COMPLETED|Overall Study||125
11213574|NCT01916681|12404750|FG000|NOT COMPLETED|Overall Study||0
11213575|NCT01916681|12404751|FG001|NOT COMPLETED|Overall Study||0
11213576|NCT01916681|12404752|FG002|NOT COMPLETED|Overall Study||0
11213577|NCT01916681|12404753|FG003|NOT COMPLETED|Overall Study||0
11213578|NCT01916824|12404766|FG000|STARTED|Overall Study||24
11213579|NCT01916824|12404767|FG001|STARTED|Overall Study||29
11213580|NCT01916824|12404766|FG000|COMPLETED|Overall Study||17
11213581|NCT01916824|12404767|FG001|COMPLETED|Overall Study||20
11213582|NCT01916824|12404766|FG000|NOT COMPLETED|Overall Study||7
11213583|NCT01916824|12404767|FG001|NOT COMPLETED|Overall Study||9
11213584|NCT01916928|12404773|FG000|STARTED|Overall Study||50
11213585|NCT01916928|12404773|FG000|COMPLETED|Overall Study||50
11213586|NCT01916928|12404773|FG000|NOT COMPLETED|Overall Study||0
11213587|NCT01916941|12404779|FG000|STARTED|Overall Study||18
11213588|NCT01916941|12404780|FG001|STARTED|Overall Study||18
11213589|NCT01916941|12404779|FG000|COMPLETED|Overall Study||13
11213590|NCT01916941|12404780|FG001|COMPLETED|Overall Study||14
11213591|NCT01916941|12404779|FG000|NOT COMPLETED|Overall Study||5
11213592|NCT01916941|12404780|FG001|NOT COMPLETED|Overall Study||4
11213593|NCT01917006|12404793|FG000|STARTED|Randomized-treatment Period||5
11213594|NCT01917006|12404794|FG001|STARTED|Randomized-treatment Period||7
11213595|NCT01917006|12404795|FG002|STARTED|Randomized-treatment Period||8
11213596|NCT01917006|12404796|FG003|STARTED|Randomized-treatment Period||8
11213597|NCT01917006|12404797|FG004|STARTED|Randomized-treatment Period||8
11213598|NCT01917006|12404798|FG005|STARTED|Randomized-treatment Period||8
11213599|NCT01917006|12404799|FG006|STARTED|Randomized-treatment Period||15
11213600|NCT01917006|12404800|FG007|STARTED|Randomized-treatment Period||0
11213601|NCT01917006|12404793|FG000|COMPLETED|Randomized-treatment Period||3
11213602|NCT01917006|12404794|FG001|COMPLETED|Randomized-treatment Period||7
11213603|NCT01917006|12404795|FG002|COMPLETED|Randomized-treatment Period||8
11213604|NCT01917006|12404796|FG003|COMPLETED|Randomized-treatment Period||7
11213605|NCT01917006|12404797|FG004|COMPLETED|Randomized-treatment Period||8
11213606|NCT01917006|12404798|FG005|COMPLETED|Randomized-treatment Period||7
11213607|NCT01917006|12404799|FG006|COMPLETED|Randomized-treatment Period||14
11213608|NCT01917006|12404800|FG007|COMPLETED|Randomized-treatment Period||0
11213609|NCT01917006|12404793|FG000|NOT COMPLETED|Randomized-treatment Period||2
11213610|NCT01917006|12404794|FG001|NOT COMPLETED|Randomized-treatment Period||0
11213611|NCT01917006|12404795|FG002|NOT COMPLETED|Randomized-treatment Period||0
11213612|NCT01917006|12404796|FG003|NOT COMPLETED|Randomized-treatment Period||1
11213613|NCT01917006|12404797|FG004|NOT COMPLETED|Randomized-treatment Period||0
11213614|NCT01917006|12404798|FG005|NOT COMPLETED|Randomized-treatment Period||1
11213615|NCT01917006|12404799|FG006|NOT COMPLETED|Randomized-treatment Period||1
11213616|NCT01917006|12404800|FG007|NOT COMPLETED|Randomized-treatment Period||0
11213617|NCT01917006|12404793|FG000|STARTED|Open-label Period||0
11213618|NCT01917006|12404794|FG001|STARTED|Open-label Period||0
11213619|NCT01917006|12404795|FG002|STARTED|Open-label Period||0
11213620|NCT01917006|12404796|FG003|STARTED|Open-label Period||0
11213621|NCT01917006|12404797|FG004|STARTED|Open-label Period||0
11213622|NCT01917006|12404798|FG005|STARTED|Open-label Period||0
11213623|NCT01917006|12404799|FG006|STARTED|Open-label Period||0
11213624|NCT01917006|12404800|FG007|STARTED|Open-label Period||8
11213625|NCT01917006|12404793|FG000|COMPLETED|Open-label Period||0
11213626|NCT01917006|12404794|FG001|COMPLETED|Open-label Period||0
11213627|NCT01917006|12404795|FG002|COMPLETED|Open-label Period||0
11213628|NCT01917006|12404796|FG003|COMPLETED|Open-label Period||0
11213629|NCT01917006|12404797|FG004|COMPLETED|Open-label Period||0
11213630|NCT01917006|12404798|FG005|COMPLETED|Open-label Period||0
11213631|NCT01917006|12404799|FG006|COMPLETED|Open-label Period||0
11213632|NCT01917006|12404800|FG007|COMPLETED|Open-label Period||6
11213633|NCT01917006|12404793|FG000|NOT COMPLETED|Open-label Period||0
11213634|NCT01917006|12404794|FG001|NOT COMPLETED|Open-label Period||0
11213635|NCT01917006|12404795|FG002|NOT COMPLETED|Open-label Period||0
11213636|NCT01917006|12404796|FG003|NOT COMPLETED|Open-label Period||0
11213637|NCT01917006|12404797|FG004|NOT COMPLETED|Open-label Period||0
11213638|NCT01917006|12404798|FG005|NOT COMPLETED|Open-label Period||0
11213639|NCT01917006|12404799|FG006|NOT COMPLETED|Open-label Period||0
11213640|NCT01917006|12404800|FG007|NOT COMPLETED|Open-label Period||2
11213641|NCT01917084|12404817|FG000|STARTED|Overall Study||20
11213642|NCT01917084|12404817|FG000|COMPLETED|Overall Study||19
11213643|NCT01917084|12404817|FG000|NOT COMPLETED|Overall Study||1
11213644|NCT01917136|12404821|FG000|STARTED|Overall Study||21
11213645|NCT01917136|12404821|FG000|COMPLETED|Overall Study||21
11213646|NCT01917136|12404821|FG000|NOT COMPLETED|Overall Study||0
11213647|NCT01917188|12404828|FG000|STARTED|Overall Study||29
11213648|NCT01917188|12404829|FG001|STARTED|Overall Study||23
11213649|NCT01917188|12404830|FG002|STARTED|Overall Study||20
11213650|NCT01917188|12404828|FG000|COMPLETED|Overall Study||17
11213651|NCT01917188|12404829|FG001|COMPLETED|Overall Study||17
11213652|NCT01917188|12404830|FG002|COMPLETED|Overall Study||11
11213653|NCT01917188|12404828|FG000|NOT COMPLETED|Overall Study||12
11213654|NCT01917188|12404829|FG001|NOT COMPLETED|Overall Study||6
11213655|NCT01917188|12404830|FG002|NOT COMPLETED|Overall Study||9
11213656|NCT01917214|12404838|FG000|STARTED|Overall Study||212
11213657|NCT01917214|12404838|FG000|COMPLETED|Overall Study||212
11213658|NCT01917214|12404838|FG000|NOT COMPLETED|Overall Study||0
11213659|NCT01917344|12404843|FG000|STARTED|Overall Study||10
11213660|NCT01917344|12404843|FG000|COMPLETED|Overall Study||9
11213661|NCT01917344|12404843|FG000|NOT COMPLETED|Overall Study||1
11213662|NCT01917513|12404849|FG000|STARTED|Overall Study||502
11213663|NCT01917513|12404850|FG001|STARTED|Overall Study||498
11213664|NCT01917513|12404849|FG000|COMPLETED|Overall Study||407
11213665|NCT01917513|12404850|FG001|COMPLETED|Overall Study||396
11213666|NCT01917513|12404849|FG000|NOT COMPLETED|Overall Study||95
11213667|NCT01917513|12404850|FG001|NOT COMPLETED|Overall Study||102
11213668|NCT01917526|12404858|FG000|STARTED|Overall Study||250
11213669|NCT01917526|12404859|FG001|STARTED|Overall Study||250
11213670|NCT01917526|12404858|FG000|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
11213671|NCT01917526|12404859|FG001|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
11213672|NCT01917526|12404858|FG000|NOT COMPLETED|Overall Study||1
11213673|NCT01917526|12404859|FG001|NOT COMPLETED|Overall Study||1
11213674|NCT01917656|12404867|FG000|STARTED|Overall Study||172
11213675|NCT01917656|12404868|FG001|STARTED|Overall Study||171
11213676|NCT01917656|12404867|FG000|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
11213677|NCT01917656|12404868|FG001|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
11213678|NCT01917656|12404867|FG000|Exposed During Ramadan (Fasting)|Overall Study||152
11213679|NCT01917656|12404868|FG001|Exposed During Ramadan (Fasting)|Overall Study||163
11213680|NCT01917656|12404867|FG000|COMPLETED|Overall Study||146
11213681|NCT01917656|12404868|FG001|COMPLETED|Overall Study||147
11213682|NCT01917656|12404867|FG000|NOT COMPLETED|Overall Study||26
11213683|NCT01917656|12404868|FG001|NOT COMPLETED|Overall Study||24
11213684|NCT01917682|12404874|FG000|STARTED|Overall Study||754
11213685|NCT01917682|12404874|FG000|COMPLETED|Overall Study||754
11213686|NCT01917682|12404874|FG000|NOT COMPLETED|Overall Study||0
11213687|NCT01917747|12404881|FG000|STARTED|Overall Study||60
11213688|NCT01917747|12404882|FG001|STARTED|Overall Study||46
11213689|NCT01917747|12404881|FG000|COMPLETED|Overall Study||41
11213690|NCT01917747|12404882|FG001|COMPLETED|Overall Study||35
11213691|NCT01917747|12404881|FG000|NOT COMPLETED|Overall Study||19
11213692|NCT01917747|12404882|FG001|NOT COMPLETED|Overall Study||11
11213693|NCT01917773|12404892|FG000|STARTED|Overall Study||13
11213694|NCT01917773|12404892|FG000|COMPLETED|Overall Study||13
11213695|NCT01917773|12404892|FG000|NOT COMPLETED|Overall Study||0
11213696|NCT01917812|12404901|FG000|STARTED|Overall Study||16
11213697|NCT01917812|12404902|FG001|STARTED|Overall Study||16
11213698|NCT01917812|12404903|FG002|STARTED|Overall Study||16
11213699|NCT01917812|12404901|FG000|COMPLETED|Overall Study||15
11213700|NCT01917812|12404902|FG001|COMPLETED|Overall Study||16
11213701|NCT01917812|12404903|FG002|COMPLETED|Overall Study||16
11213702|NCT01917812|12404901|FG000|NOT COMPLETED|Overall Study||1
11213703|NCT01917812|12404902|FG001|NOT COMPLETED|Overall Study||0
11213704|NCT01917812|12404903|FG002|NOT COMPLETED|Overall Study||0
11213705|NCT01917968|12404913|FG000|STARTED|Overall Study||225
11213706|NCT01917968|12404914|FG001|STARTED|Overall Study||485
11213707|NCT01917968|12404913|FG000|COMPLETED|Overall Study||171
11213708|NCT01917968|12404914|FG001|COMPLETED|Overall Study||401
11213709|NCT01917968|12404913|FG000|NOT COMPLETED|Overall Study||54
11213710|NCT01917968|12404914|FG001|NOT COMPLETED|Overall Study||84
11213711|NCT01918072|12404927|FG000|STARTED|Controlled Trial Step One - Six Months||11
11097539|NCT01212757|12281288|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097540|NCT01212757|12281289|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097541|NCT01212757|12281281|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
11213712|NCT01918072|12404928|FG001|STARTED|Controlled Trial Step One - Six Months||0
11213713|NCT01918072|12404929|FG002|STARTED|Controlled Trial Step One - Six Months||0
11213714|NCT01918072|12404927|FG000|Intervention|Controlled Trial Step One - Six Months||1
11213715|NCT01918072|12404928|FG001|Intervention|Controlled Trial Step One - Six Months||0
11213716|NCT01918072|12404929|FG002|Intervention|Controlled Trial Step One - Six Months||0
11213717|NCT01918072|12404927|FG000|Control|Controlled Trial Step One - Six Months||10
11213718|NCT01918072|12404928|FG001|Control|Controlled Trial Step One - Six Months||0
11352930|NCT03052751|12550065|FG002|NOT COMPLETED|Dosing Period 1||0
11352931|NCT03052751|12550066|FG003|NOT COMPLETED|Dosing Period 1||0
11352932|NCT03052751|12550067|FG004|NOT COMPLETED|Dosing Period 1||0
11352933|NCT03052751|12550068|FG005|NOT COMPLETED|Dosing Period 1||0
11352934|NCT03052751|12550063|FG000|STARTED|Dosing Period 2||0
11352935|NCT03052751|12550064|FG001|STARTED|Dosing Period 2||0
11352936|NCT03052751|12550065|FG002|STARTED|Dosing Period 2||11
11352937|NCT03052751|12550066|FG003|STARTED|Dosing Period 2||11
11213719|NCT01918072|12404929|FG002|Control|Controlled Trial Step One - Six Months||0
11213720|NCT01918072|12404927|FG000|COMPLETED|Controlled Trial Step One - Six Months||11
11213721|NCT01918072|12404928|FG001|COMPLETED|Controlled Trial Step One - Six Months||0
11213722|NCT01918072|12404929|FG002|COMPLETED|Controlled Trial Step One - Six Months||0
11213723|NCT01918072|12404927|FG000|NOT COMPLETED|Controlled Trial Step One - Six Months||0
11213724|NCT01918072|12404928|FG001|NOT COMPLETED|Controlled Trial Step One - Six Months||0
11213725|NCT01918072|12404929|FG002|NOT COMPLETED|Controlled Trial Step One - Six Months||0
11213726|NCT01918072|12404927|FG000|STARTED|Controlled Trial Step Two - Six Months||11
11213727|NCT01918072|12404928|FG001|STARTED|Controlled Trial Step Two - Six Months||0
11213728|NCT01918072|12404929|FG002|STARTED|Controlled Trial Step Two - Six Months||0
11213729|NCT01918072|12404927|FG000|Intervention|Controlled Trial Step Two - Six Months||7
11213730|NCT01918072|12404928|FG001|Intervention|Controlled Trial Step Two - Six Months||0
11213731|NCT01918072|12404929|FG002|Intervention|Controlled Trial Step Two - Six Months||0
11213732|NCT01918072|12404927|FG000|Control|Controlled Trial Step Two - Six Months||4
11213733|NCT01918072|12404928|FG001|Control|Controlled Trial Step Two - Six Months||0
11213734|NCT01918072|12404929|FG002|Control|Controlled Trial Step Two - Six Months||0
11213735|NCT01918072|12404927|FG000|COMPLETED|Controlled Trial Step Two - Six Months||11
11352938|NCT03052751|12550067|FG004|STARTED|Dosing Period 2||10
11352939|NCT03052751|12550068|FG005|STARTED|Dosing Period 2||10
11352940|NCT03052751|12550063|FG000|COMPLETED|Dosing Period 2||0
11213736|NCT01918072|12404928|FG001|COMPLETED|Controlled Trial Step Two - Six Months||0
11213737|NCT01918072|12404929|FG002|COMPLETED|Controlled Trial Step Two - Six Months||0
11213738|NCT01918072|12404927|FG000|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
11213739|NCT01918072|12404928|FG001|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
11213740|NCT01918072|12404929|FG002|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
11213741|NCT01918072|12404927|FG000|STARTED|Controlled Trial Step Three - Six Months||11
11213742|NCT01918072|12404928|FG001|STARTED|Controlled Trial Step Three - Six Months||0
11213743|NCT01918072|12404929|FG002|STARTED|Controlled Trial Step Three - Six Months||0
11213744|NCT01918072|12404927|FG000|Intervention|Controlled Trial Step Three - Six Months||9
11213745|NCT01918072|12404928|FG001|Intervention|Controlled Trial Step Three - Six Months||0
11213746|NCT01918072|12404929|FG002|Intervention|Controlled Trial Step Three - Six Months||0
11213747|NCT01918072|12404927|FG000|Control|Controlled Trial Step Three - Six Months||2
11213748|NCT01918072|12404928|FG001|Control|Controlled Trial Step Three - Six Months||0
11213749|NCT01918072|12404929|FG002|Control|Controlled Trial Step Three - Six Months||0
11213750|NCT01918072|12404927|FG000|COMPLETED|Controlled Trial Step Three - Six Months||11
11213751|NCT01918072|12404928|FG001|COMPLETED|Controlled Trial Step Three - Six Months||0
11213752|NCT01918072|12404929|FG002|COMPLETED|Controlled Trial Step Three - Six Months||0
11213753|NCT01918072|12404927|FG000|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
11213754|NCT01918072|12404928|FG001|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
11213755|NCT01918072|12404929|FG002|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
11213756|NCT01918072|12404927|FG000|STARTED|Controlled Trial Step Four - Six Months||11
11213757|NCT01918072|12404928|FG001|STARTED|Controlled Trial Step Four - Six Months||0
11213758|NCT01918072|12404929|FG002|STARTED|Controlled Trial Step Four - Six Months||0
11213759|NCT01918072|12404927|FG000|Intervention|Controlled Trial Step Four - Six Months||11
11213760|NCT01918072|12404928|FG001|Intervention|Controlled Trial Step Four - Six Months||0
11352941|NCT03052751|12550064|FG001|COMPLETED|Dosing Period 2||0
11352942|NCT03052751|12550065|FG002|COMPLETED|Dosing Period 2||8
11352943|NCT03052751|12550066|FG003|COMPLETED|Dosing Period 2||11
11352944|NCT03052751|12550067|FG004|COMPLETED|Dosing Period 2||10
11213761|NCT01918072|12404929|FG002|Intervention|Controlled Trial Step Four - Six Months||0
11213762|NCT01918072|12404927|FG000|Control|Controlled Trial Step Four - Six Months||0
11213763|NCT01918072|12404928|FG001|Control|Controlled Trial Step Four - Six Months||0
11213764|NCT01918072|12404929|FG002|Control|Controlled Trial Step Four - Six Months||0
11213765|NCT01918072|12404927|FG000|COMPLETED|Controlled Trial Step Four - Six Months||11
11213766|NCT01918072|12404928|FG001|COMPLETED|Controlled Trial Step Four - Six Months||0
11213767|NCT01918072|12404929|FG002|COMPLETED|Controlled Trial Step Four - Six Months||0
11213768|NCT01918072|12404927|FG000|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
11213769|NCT01918072|12404928|FG001|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
11213770|NCT01918072|12404929|FG002|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
11213771|NCT01918072|12404927|FG000|STARTED|Controlled Trial Step Five - Four Months||11
11213772|NCT01918072|12404928|FG001|STARTED|Controlled Trial Step Five - Four Months||0
11213773|NCT01918072|12404929|FG002|STARTED|Controlled Trial Step Five - Four Months||0
11213774|NCT01918072|12404927|FG000|Intervention|Controlled Trial Step Five - Four Months||11
11213775|NCT01918072|12404928|FG001|Intervention|Controlled Trial Step Five - Four Months||0
11213776|NCT01918072|12404929|FG002|Intervention|Controlled Trial Step Five - Four Months||0
11213777|NCT01918072|12404927|FG000|Control|Controlled Trial Step Five - Four Months||0
11213778|NCT01918072|12404928|FG001|Control|Controlled Trial Step Five - Four Months||0
11213779|NCT01918072|12404929|FG002|Control|Controlled Trial Step Five - Four Months||0
11213780|NCT01918072|12404927|FG000|COMPLETED|Controlled Trial Step Five - Four Months||11
11213781|NCT01918072|12404928|FG001|COMPLETED|Controlled Trial Step Five - Four Months||0
11213782|NCT01918072|12404929|FG002|COMPLETED|Controlled Trial Step Five - Four Months||0
11213783|NCT01918072|12404927|FG000|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
11213784|NCT01918072|12404928|FG001|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
11213785|NCT01918072|12404929|FG002|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
11213786|NCT01918072|12404927|FG000|STARTED|E-consult Assessment Period||0
11213787|NCT01918072|12404928|FG001|STARTED|E-consult Assessment Period||42
11213788|NCT01918072|12404929|FG002|STARTED|E-consult Assessment Period||0
11213789|NCT01918072|12404927|FG000|COMPLETED|E-consult Assessment Period||0
11213790|NCT01918072|12404928|FG001|COMPLETED|E-consult Assessment Period||42
11213791|NCT01918072|12404929|FG002|COMPLETED|E-consult Assessment Period||0
11213792|NCT01918072|12404927|FG000|NOT COMPLETED|E-consult Assessment Period||0
11213793|NCT01918072|12404928|FG001|NOT COMPLETED|E-consult Assessment Period||0
11213794|NCT01918072|12404929|FG002|NOT COMPLETED|E-consult Assessment Period||0
11213795|NCT01918072|12404927|FG000|STARTED|Quality Assessment Period||0
11352945|NCT03052751|12550068|FG005|COMPLETED|Dosing Period 2||10
11213796|NCT01918072|12404928|FG001|STARTED|Quality Assessment Period||0
11213797|NCT01918072|12404929|FG002|STARTED|Quality Assessment Period||202
11213798|NCT01918072|12404927|FG000|COMPLETED|Quality Assessment Period||0
11213799|NCT01918072|12404928|FG001|COMPLETED|Quality Assessment Period||0
11213800|NCT01918072|12404929|FG002|COMPLETED|Quality Assessment Period||202
11213801|NCT01918072|12404927|FG000|NOT COMPLETED|Quality Assessment Period||0
11213802|NCT01918072|12404928|FG001|NOT COMPLETED|Quality Assessment Period||0
11213803|NCT01918072|12404929|FG002|NOT COMPLETED|Quality Assessment Period||0
11213804|NCT01918085|12404941|FG000|STARTED|Test Period 1: Strata Strip||10
11213805|NCT01918085|12404942|FG001|STARTED|Test Period 1: Strata Strip||12
11213806|NCT01918085|12404941|FG000|COMPLETED|Test Period 1: Strata Strip||10
11213807|NCT01918085|12404942|FG001|COMPLETED|Test Period 1: Strata Strip||11
11213808|NCT01918085|12404941|FG000|NOT COMPLETED|Test Period 1: Strata Strip||0
11213809|NCT01918085|12404942|FG001|NOT COMPLETED|Test Period 1: Strata Strip||1
11213810|NCT01918085|12404941|FG000|STARTED|Test Period 1: Hydrocolloid Strip||10
11213811|NCT01918085|12404942|FG001|STARTED|Test Period 1: Hydrocolloid Strip||11
11213812|NCT01918085|12404941|FG000|COMPLETED|Test Period 1: Hydrocolloid Strip||10
11213813|NCT01918085|12404942|FG001|COMPLETED|Test Period 1: Hydrocolloid Strip||11
11213814|NCT01918085|12404941|FG000|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
11213815|NCT01918085|12404942|FG001|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
11213816|NCT01918085|12404941|FG000|STARTED|Test Period 2: Strata Strip||10
11213817|NCT01918085|12404942|FG001|STARTED|Test Period 2: Strata Strip||11
11213818|NCT01918085|12404941|FG000|COMPLETED|Test Period 2: Strata Strip||10
11213819|NCT01918085|12404942|FG001|COMPLETED|Test Period 2: Strata Strip||11
11213820|NCT01918085|12404941|FG000|NOT COMPLETED|Test Period 2: Strata Strip||0
11213821|NCT01918085|12404942|FG001|NOT COMPLETED|Test Period 2: Strata Strip||0
11213822|NCT01918085|12404941|FG000|STARTED|Test Period 2: Hydrocolloid Strip||10
11213823|NCT01918085|12404942|FG001|STARTED|Test Period 2: Hydrocolloid Strip||11
11213824|NCT01918085|12404941|FG000|COMPLETED|Test Period 2: Hydrocolloid Strip||10
11213825|NCT01918085|12404942|FG001|COMPLETED|Test Period 2: Hydrocolloid Strip||11
11213826|NCT01918085|12404941|FG000|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
11213827|NCT01918085|12404942|FG001|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
11213828|NCT01918189|12404950|FG000|STARTED|Overall Study||59
11213829|NCT01918189|12404950|FG000|Completed Baseline Assessment|Overall Study||58
11213830|NCT01918189|12404950|FG000|Completed Follow-up Assessment|Overall Study||41
11213831|NCT01918189|12404950|FG000|COMPLETED|Overall Study||41
11213832|NCT01918189|12404950|FG000|NOT COMPLETED|Overall Study||18
11213833|NCT01918306|12404957|FG000|STARTED|Overall Study||6
11213834|NCT01918306|12404958|FG001|STARTED|Overall Study|No patients enrolled|0
11213835|NCT01918306|12404959|FG002|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
11213836|NCT01918306|12404960|FG003|STARTED|Overall Study||3
11213837|NCT01918306|12404957|FG000|COMPLETED|Overall Study||0
11213838|NCT01918306|12404958|FG001|COMPLETED|Overall Study||0
11213839|NCT01918306|12404959|FG002|COMPLETED|Overall Study||0
11213840|NCT01918306|12404960|FG003|COMPLETED|Overall Study||0
11213841|NCT01918306|12404957|FG000|NOT COMPLETED|Overall Study||6
11213842|NCT01918306|12404958|FG001|NOT COMPLETED|Overall Study||0
11213843|NCT01918306|12404959|FG002|NOT COMPLETED|Overall Study||2
11213844|NCT01918306|12404960|FG003|NOT COMPLETED|Overall Study||3
11213845|NCT01918332|12404984|FG000|STARTED|Overall Study||43
11213846|NCT01918332|12404985|FG001|STARTED|Overall Study||41
11213847|NCT01918332|12404986|FG002|STARTED|Overall Study||39
11213848|NCT01918332|12404987|FG003|STARTED|Overall Study||45
11213849|NCT01918332|12404984|FG000|COMPLETED|Overall Study||35
11213850|NCT01918332|12404985|FG001|COMPLETED|Overall Study||36
11213851|NCT01918332|12404986|FG002|COMPLETED|Overall Study||30
11213852|NCT01918332|12404987|FG003|COMPLETED|Overall Study||38
11213853|NCT01918332|12404984|FG000|NOT COMPLETED|Overall Study||8
11213854|NCT01918332|12404985|FG001|NOT COMPLETED|Overall Study||5
11213855|NCT01918332|12404986|FG002|NOT COMPLETED|Overall Study||9
11213856|NCT01918332|12404987|FG003|NOT COMPLETED|Overall Study||7
11213857|NCT01918371|12404999|FG000|STARTED|Overall Study||166
11213858|NCT01918371|12405000|FG001|STARTED|Overall Study||157
11213859|NCT01918371|12404999|FG000|Participants With Complete Data|Overall Study||165
11213860|NCT01918371|12405000|FG001|Participants With Complete Data|Overall Study||156
11213861|NCT01918371|12404999|FG000|COMPLETED|Overall Study||165
11213862|NCT01918371|12405000|FG001|COMPLETED|Overall Study||156
11213863|NCT01918371|12404999|FG000|NOT COMPLETED|Overall Study||1
11213864|NCT01918371|12405000|FG001|NOT COMPLETED|Overall Study||1
11352946|NCT03052751|12550063|FG000|NOT COMPLETED|Dosing Period 2||0
11352947|NCT03052751|12550064|FG001|NOT COMPLETED|Dosing Period 2||0
11352948|NCT03052751|12550065|FG002|NOT COMPLETED|Dosing Period 2||3
11352949|NCT03052751|12550066|FG003|NOT COMPLETED|Dosing Period 2||0
11352950|NCT03052751|12550067|FG004|NOT COMPLETED|Dosing Period 2||0
11352951|NCT03052751|12550068|FG005|NOT COMPLETED|Dosing Period 2||0
11352952|NCT03052751|12550063|FG000|STARTED|Observation Period||22
11352953|NCT03052751|12550064|FG001|STARTED|Observation Period||21
11352954|NCT03052751|12550065|FG002|STARTED|Observation Period||11
11352955|NCT03052751|12550066|FG003|STARTED|Observation Period||11
11213865|NCT01918761|12405006|FG000|STARTED|Overall Study||5
11213866|NCT01918761|12405006|FG000|COMPLETED|Overall Study||5
11213867|NCT01918761|12405006|FG000|NOT COMPLETED|Overall Study||0
11213868|NCT01918774|12405010|FG000|STARTED|Overall Study||57
11213869|NCT01918774|12405010|FG000|COMPLETED|Overall Study||52
11213870|NCT01918774|12405010|FG000|NOT COMPLETED|Overall Study||5
11213871|NCT01918800|12405016|FG000|STARTED|Overall Study||109
11213872|NCT01918800|12405017|FG001|STARTED|Overall Study||109
11213873|NCT01918800|12405016|FG000|COMPLETED|Overall Study||100
11213874|NCT01918800|12405017|FG001|COMPLETED|Overall Study||104
11213875|NCT01918800|12405016|FG000|NOT COMPLETED|Overall Study||9
11213876|NCT01918800|12405017|FG001|NOT COMPLETED|Overall Study||5
11213877|NCT01919112|12405026|FG000|STARTED|Primary Analysis-day 5 of Intervention||14
11213878|NCT01919112|12405027|FG001|STARTED|Primary Analysis-day 5 of Intervention||13
11213879|NCT01919112|12405028|FG002|STARTED|Primary Analysis-day 5 of Intervention||15
11213880|NCT01919112|12405026|FG000|COMPLETED|Primary Analysis-day 5 of Intervention||14
11213881|NCT01919112|12405027|FG001|COMPLETED|Primary Analysis-day 5 of Intervention||13
11213882|NCT01919112|12405028|FG002|COMPLETED|Primary Analysis-day 5 of Intervention||15
11213883|NCT01919112|12405026|FG000|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
11213884|NCT01919112|12405027|FG001|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
11213885|NCT01919112|12405028|FG002|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
11213886|NCT01919112|12405026|FG000|STARTED|Secondary Analysis-day 30||14
11213887|NCT01919112|12405027|FG001|STARTED|Secondary Analysis-day 30||13
11213888|NCT01919112|12405028|FG002|STARTED|Secondary Analysis-day 30||15
11213889|NCT01919112|12405026|FG000|COMPLETED|Secondary Analysis-day 30||12
11213890|NCT01919112|12405027|FG001|COMPLETED|Secondary Analysis-day 30||12
11213891|NCT01919112|12405028|FG002|COMPLETED|Secondary Analysis-day 30||14
11213892|NCT01919112|12405026|FG000|NOT COMPLETED|Secondary Analysis-day 30||2
11213893|NCT01919112|12405027|FG001|NOT COMPLETED|Secondary Analysis-day 30||1
11213894|NCT01919112|12405028|FG002|NOT COMPLETED|Secondary Analysis-day 30||1
11213895|NCT01919164|12405041|FG000|STARTED|Overall Study||108
11213896|NCT01919164|12405042|FG001|STARTED|Overall Study||110
11213897|NCT01919164|12405043|FG002|STARTED|Overall Study||111
11213898|NCT01919164|12405044|FG003|STARTED|Overall Study||110
11213899|NCT01919164|12405045|FG004|STARTED|Overall Study||110
11213900|NCT01919164|12405041|FG000|Safety Analysis Set|Overall Study||107
11213901|NCT01919164|12405042|FG001|Safety Analysis Set|Overall Study|1 participant assigned to Placebo arm who inadvertently received 30 mcg was included in this arm.|109
11213902|NCT01919164|12405043|FG002|Safety Analysis Set|Overall Study||111
11213903|NCT01919164|12405044|FG003|Safety Analysis Set|Overall Study|1 participant in Sprifermin2 Cycles arm who inadvertently received 100 mcg was included in this arm.|111
11213904|NCT01919164|12405045|FG004|Safety Analysis Set|Overall Study||109
11213905|NCT01919164|12405041|FG000|COMPLETED|Overall Study||65
11097542|NCT01212757|12281282|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
11097543|NCT01212757|12281283|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
11097544|NCT01212757|12281284|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097545|NCT01212757|12281285|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11213906|NCT01919164|12405042|FG001|COMPLETED|Overall Study||80
11213907|NCT01919164|12405043|FG002|COMPLETED|Overall Study||74
11213908|NCT01919164|12405044|FG003|COMPLETED|Overall Study||82
11213909|NCT01919164|12405045|FG004|COMPLETED|Overall Study||77
11213910|NCT01919164|12405041|FG000|NOT COMPLETED|Overall Study||43
11213911|NCT01919164|12405042|FG001|NOT COMPLETED|Overall Study||30
11213912|NCT01919164|12405043|FG002|NOT COMPLETED|Overall Study||37
11213913|NCT01919164|12405044|FG003|NOT COMPLETED|Overall Study||28
11213914|NCT01919164|12405045|FG004|NOT COMPLETED|Overall Study||33
11213915|NCT01919190|12405059|FG000|STARTED|Overall Study|Met eligibility criteria|33
11213916|NCT01919190|12405060|FG001|STARTED|Overall Study|Met eligibility criteria|34
11213917|NCT01919190|12405059|FG000|COMPLETED|Overall Study||30
11213918|NCT01919190|12405060|FG001|COMPLETED|Overall Study||34
11213919|NCT01919190|12405059|FG000|NOT COMPLETED|Overall Study||3
11213920|NCT01919190|12405060|FG001|NOT COMPLETED|Overall Study||0
11213921|NCT01919216|12405070|FG000|STARTED|Overall Study||28
11213922|NCT01919216|12405071|FG001|STARTED|Overall Study||21
11213923|NCT01919216|12405072|FG002|STARTED|Overall Study||5
11213924|NCT01919216|12405070|FG000|COMPLETED|Overall Study||26
11213925|NCT01919216|12405071|FG001|COMPLETED|Overall Study||20
11097546|NCT01212757|12281286|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097547|NCT01212757|12281287|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097548|NCT01212757|12281288|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097549|NCT01212757|12281289|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11213926|NCT01919216|12405072|FG002|COMPLETED|Overall Study||4
11213927|NCT01919216|12405070|FG000|NOT COMPLETED|Overall Study||2
11213928|NCT01919216|12405071|FG001|NOT COMPLETED|Overall Study||1
11213929|NCT01919216|12405072|FG002|NOT COMPLETED|Overall Study||1
11213930|NCT01919229|12405083|FG000|STARTED|Overall Study||4
11213931|NCT01919229|12405084|FG001|STARTED|Overall Study||6
11213932|NCT01919229|12405085|FG002|STARTED|Overall Study||4
11213933|NCT01919229|12405083|FG000|COMPLETED|Overall Study||4
11213934|NCT01919229|12405084|FG001|COMPLETED|Overall Study||6
11213935|NCT01919229|12405085|FG002|COMPLETED|Overall Study||3
11213936|NCT01919229|12405083|FG000|NOT COMPLETED|Overall Study||0
11213937|NCT01919229|12405084|FG001|NOT COMPLETED|Overall Study||0
11213938|NCT01919229|12405085|FG002|NOT COMPLETED|Overall Study||1
11097550|NCT01212757|12281281|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
11097551|NCT01212757|12281282|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
11097552|NCT01212757|12281283|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
11097553|NCT01212757|12281284|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11213939|NCT01919307|12405093|FG000|STARTED|Overall Study||29
11213940|NCT01919307|12405093|FG000|COMPLETED|Overall Study||20
11213941|NCT01919307|12405093|FG000|NOT COMPLETED|Overall Study||9
11213942|NCT01919398|12405100|FG000|STARTED|Overall Study||3
11213943|NCT01919398|12405101|FG001|STARTED|Overall Study||3
11213944|NCT01919398|12405102|FG002|STARTED|Overall Study||13
11213945|NCT01919398|12405100|FG000|Received at Least One Dose of Study Drug|Overall Study||3
11213946|NCT01919398|12405101|FG001|Received at Least One Dose of Study Drug|Overall Study||3
11213947|NCT01919398|12405102|FG002|Received at Least One Dose of Study Drug|Overall Study||13
11213948|NCT01919398|12405100|FG000|COMPLETED|Overall Study||3
11213949|NCT01919398|12405101|FG001|COMPLETED|Overall Study||3
11213950|NCT01919398|12405102|FG002|COMPLETED|Overall Study||9
11213951|NCT01919398|12405100|FG000|NOT COMPLETED|Overall Study||0
11213952|NCT01919398|12405101|FG001|NOT COMPLETED|Overall Study||0
11213953|NCT01919398|12405102|FG002|NOT COMPLETED|Overall Study||4
11213954|NCT01919411|12405112|FG000|STARTED|Overall Study||43
11213955|NCT01919411|12405113|FG001|STARTED|Overall Study||46
11213956|NCT01919411|12405112|FG000|COMPLETED|Overall Study||38
11097554|NCT01212757|12281285|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097555|NCT01212757|12281286|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11213957|NCT01919411|12405113|FG001|COMPLETED|Overall Study||41
11213958|NCT01919411|12405112|FG000|NOT COMPLETED|Overall Study||5
11213959|NCT01919411|12405113|FG001|NOT COMPLETED|Overall Study||5
11213960|NCT01919450|12405123|FG000|STARTED|Overall Study||20
11213961|NCT01919450|12405124|FG001|STARTED|Overall Study||20
11213962|NCT01919450|12405125|FG002|STARTED|Overall Study||20
11213963|NCT01919450|12405126|FG003|STARTED|Overall Study||20
11213964|NCT01919450|12405123|FG000|COMPLETED|Overall Study||20
11213965|NCT01919450|12405124|FG001|COMPLETED|Overall Study||20
11213966|NCT01919450|12405125|FG002|COMPLETED|Overall Study||20
11213967|NCT01919450|12405126|FG003|COMPLETED|Overall Study||19
11213968|NCT01919450|12405123|FG000|NOT COMPLETED|Overall Study||0
11097556|NCT01212757|12281287|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097557|NCT01212757|12281288|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097558|NCT01212757|12281289|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097559|NCT01212757|12281281|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
11097560|NCT01212757|12281282|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
11097561|NCT01212757|12281283|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
11097562|NCT01212757|12281284|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097563|NCT01212757|12281285|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097564|NCT01212757|12281286|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11213969|NCT01919450|12405124|FG001|NOT COMPLETED|Overall Study||0
11213970|NCT01919450|12405125|FG002|NOT COMPLETED|Overall Study||0
11213971|NCT01919450|12405126|FG003|NOT COMPLETED|Overall Study||1
11213972|NCT01919489|12405138|FG000|STARTED|Overall Study||136
11213973|NCT01919489|12405139|FG001|STARTED|Overall Study||137
11213974|NCT01919489|12405138|FG000|COMPLETED|Overall Study||80
11097565|NCT01212757|12281287|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097566|NCT01212757|12281288|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097567|NCT01212757|12281289|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097568|NCT01212757|12281281|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
11213975|NCT01919489|12405139|FG001|COMPLETED|Overall Study||93
11213976|NCT01919489|12405138|FG000|NOT COMPLETED|Overall Study||56
11213977|NCT01919489|12405139|FG001|NOT COMPLETED|Overall Study||44
11213978|NCT01919606|12405147|FG000|STARTED|Overall Study||1
11213979|NCT01919606|12405148|FG001|STARTED|Overall Study||0
11213980|NCT01919606|12405147|FG000|COMPLETED|Overall Study||1
11352956|NCT03052751|12550067|FG004|STARTED|Observation Period||10
11352957|NCT03052751|12550068|FG005|STARTED|Observation Period||10
11352958|NCT03052751|12550063|FG000|COMPLETED|Observation Period||22
11352959|NCT03052751|12550064|FG001|COMPLETED|Observation Period||21
11352960|NCT03052751|12550065|FG002|COMPLETED|Observation Period||11
11352961|NCT03052751|12550066|FG003|COMPLETED|Observation Period||11
11352962|NCT03052751|12550067|FG004|COMPLETED|Observation Period||9
11352963|NCT03052751|12550068|FG005|COMPLETED|Observation Period||10
11352964|NCT03052751|12550063|FG000|NOT COMPLETED|Observation Period||0
11352965|NCT03052751|12550064|FG001|NOT COMPLETED|Observation Period||0
11352966|NCT03052751|12550065|FG002|NOT COMPLETED|Observation Period||0
11352967|NCT03052751|12550066|FG003|NOT COMPLETED|Observation Period||0
11352968|NCT03052751|12550067|FG004|NOT COMPLETED|Observation Period||1
11352969|NCT03052751|12550068|FG005|NOT COMPLETED|Observation Period||0
11097569|NCT01212757|12281282|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
11097570|NCT01212757|12281283|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
11097571|NCT01212757|12281284|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
11097572|NCT01212757|12281285|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
11352970|NCT03052764|12550080|FG000|STARTED|Double-Blind Treatment Period||80
11352971|NCT03052764|12550081|FG001|STARTED|Double-Blind Treatment Period||40
11352972|NCT03052764|12550080|FG000|mITT|Double-Blind Treatment Period||78
11352973|NCT03052764|12550081|FG001|mITT|Double-Blind Treatment Period||39
11352974|NCT03052764|12550080|FG000|COMPLETED|Double-Blind Treatment Period||70
11352975|NCT03052764|12550081|FG001|COMPLETED|Double-Blind Treatment Period||37
11352976|NCT03052764|12550080|FG000|NOT COMPLETED|Double-Blind Treatment Period||10
11213981|NCT01919606|12405148|FG001|COMPLETED|Overall Study||0
11213982|NCT01919606|12405147|FG000|NOT COMPLETED|Overall Study||0
11213983|NCT01919606|12405148|FG001|NOT COMPLETED|Overall Study||0
11213984|NCT01919697|12405156|FG000|STARTED|Overall Study||224
11213985|NCT01919697|12405157|FG001|STARTED|Overall Study||2146
11213986|NCT01919697|12405156|FG000|COMPLETED|Overall Study||171
11213987|NCT01919697|12405157|FG001|COMPLETED|Overall Study||1761
11213988|NCT01919697|12405156|FG000|NOT COMPLETED|Overall Study||53
11213989|NCT01919697|12405157|FG001|NOT COMPLETED|Overall Study||385
11213990|NCT01919723|12405166|FG000|STARTED|Overall Study||35
11213991|NCT01919723|12405167|FG001|STARTED|Overall Study||35
11213992|NCT01919723|12405166|FG000|COMPLETED|Overall Study||33
11213993|NCT01919723|12405167|FG001|COMPLETED|Overall Study||33
11213994|NCT01919723|12405166|FG000|NOT COMPLETED|Overall Study||2
11213995|NCT01919723|12405167|FG001|NOT COMPLETED|Overall Study||2
11213996|NCT01919801|12405175|FG000|STARTED|Overall Study||61
11352977|NCT03052764|12550081|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
11352978|NCT03052764|12550080|FG000|STARTED|Open-Label Re-Treatment Period||58
11352979|NCT03052764|12550081|FG001|STARTED|Open-Label Re-Treatment Period||33
11213997|NCT01919801|12405176|FG001|STARTED|Overall Study||60
11213998|NCT01919801|12405175|FG000|COMPLETED|Overall Study||60
11213999|NCT01919801|12405176|FG001|COMPLETED|Overall Study||57
11214000|NCT01919801|12405175|FG000|NOT COMPLETED|Overall Study||1
11214001|NCT01919801|12405176|FG001|NOT COMPLETED|Overall Study||3
11214002|NCT01919814|12405182|FG000|STARTED|Overall Study||30
11214003|NCT01919814|12405183|FG001|STARTED|Overall Study||30
11214004|NCT01919814|12405182|FG000|COMPLETED|Overall Study||27
11214005|NCT01919814|12405183|FG001|COMPLETED|Overall Study||30
11214006|NCT01919814|12405182|FG000|NOT COMPLETED|Overall Study||3
11214007|NCT01919814|12405183|FG001|NOT COMPLETED|Overall Study||0
11214008|NCT01919970|12405191|FG000|STARTED|Overall Study||14
11214009|NCT01919970|12405192|FG001|STARTED|Overall Study||18
11214010|NCT01919970|12405191|FG000|COMPLETED|Overall Study||11
11214011|NCT01919970|12405192|FG001|COMPLETED|Overall Study||18
11214012|NCT01919970|12405191|FG000|NOT COMPLETED|Overall Study||3
11214013|NCT01919970|12405192|FG001|NOT COMPLETED|Overall Study||0
11214014|NCT01919996|12405198|FG000|STARTED|Overall Study||8
11214015|NCT01919996|12405198|FG000|COMPLETED|Overall Study||8
11214016|NCT01919996|12405198|FG000|NOT COMPLETED|Overall Study||0
11214017|NCT01920152|12405204|FG000|STARTED|Overall Study||19
11214018|NCT01920152|12405205|FG001|STARTED|Overall Study||15
11214019|NCT01920152|12405204|FG000|COMPLETED|Overall Study||18
11214020|NCT01920152|12405205|FG001|COMPLETED|Overall Study||13
11214021|NCT01920152|12405204|FG000|NOT COMPLETED|Overall Study||1
11214022|NCT01920152|12405205|FG001|NOT COMPLETED|Overall Study||2
11214023|NCT01920178|12405213|FG000|STARTED|Overall Study||5
11214024|NCT01920178|12405214|FG001|STARTED|Overall Study||2
11214025|NCT01920178|12405213|FG000|COMPLETED|Overall Study||3
11214026|NCT01920178|12405214|FG001|COMPLETED|Overall Study||1
11214027|NCT01920178|12405213|FG000|NOT COMPLETED|Overall Study||2
11214028|NCT01920178|12405214|FG001|NOT COMPLETED|Overall Study||1
11214029|NCT01920282|12405223|FG000|STARTED|Overall Study||15
11214030|NCT01920282|12405224|FG001|STARTED|Overall Study||15
11214031|NCT01920282|12405225|FG002|STARTED|Overall Study||15
11214032|NCT01920282|12405223|FG000|COMPLETED|Overall Study||15
11214033|NCT01920282|12405224|FG001|COMPLETED|Overall Study||15
11214034|NCT01920282|12405225|FG002|COMPLETED|Overall Study||15
11214035|NCT01920282|12405223|FG000|NOT COMPLETED|Overall Study||0
11214036|NCT01920282|12405224|FG001|NOT COMPLETED|Overall Study||0
11214037|NCT01920282|12405225|FG002|NOT COMPLETED|Overall Study||0
11214038|NCT01920477|12405235|FG000|STARTED|Overall Study||17
11214039|NCT01920477|12405236|FG001|STARTED|Overall Study||18
11214040|NCT01920477|12405235|FG000|Requiried Individualized Follow-up|Overall Study||1
11214041|NCT01920477|12405236|FG001|Requiried Individualized Follow-up|Overall Study||0
11214042|NCT01920477|12405235|FG000|COMPLETED|Overall Study||2
11214043|NCT01920477|12405236|FG001|COMPLETED|Overall Study||1
11214044|NCT01920477|12405235|FG000|NOT COMPLETED|Overall Study||15
11214045|NCT01920477|12405236|FG001|NOT COMPLETED|Overall Study||17
11214046|NCT01920555|12405247|FG000|STARTED|Overall Study||18
11214047|NCT01920555|12405248|FG001|STARTED|Overall Study||20
11352980|NCT03052764|12550080|FG000|COMPLETED|Open-Label Re-Treatment Period||58
11352981|NCT03052764|12550081|FG001|COMPLETED|Open-Label Re-Treatment Period||33
11352982|NCT03052764|12550080|FG000|NOT COMPLETED|Open-Label Re-Treatment Period||0
11352983|NCT03052764|12550081|FG001|NOT COMPLETED|Open-Label Re-Treatment Period||0
11352984|NCT03052816|12550091|FG000|STARTED|Overall Study||33
11352985|NCT03052816|12550092|FG001|STARTED|Overall Study||33
11352986|NCT03052816|12550091|FG000|COMPLETED|Overall Study||30
11214048|NCT01920555|12405249|FG002|STARTED|Overall Study||22
11214049|NCT01920555|12405250|FG003|STARTED|Overall Study||20
11214050|NCT01920555|12405251|FG004|STARTED|Overall Study||19
11214051|NCT01920555|12405247|FG000|COMPLETED|Overall Study||14
11214052|NCT01920555|12405248|FG001|COMPLETED|Overall Study||16
11214053|NCT01920555|12405249|FG002|COMPLETED|Overall Study||21
11214054|NCT01920555|12405250|FG003|COMPLETED|Overall Study||17
11214055|NCT01920555|12405251|FG004|COMPLETED|Overall Study||18
11214056|NCT01920555|12405247|FG000|NOT COMPLETED|Overall Study||4
11214057|NCT01920555|12405248|FG001|NOT COMPLETED|Overall Study||4
11214058|NCT01920555|12405249|FG002|NOT COMPLETED|Overall Study||1
11214059|NCT01920555|12405250|FG003|NOT COMPLETED|Overall Study||3
11214060|NCT01920555|12405251|FG004|NOT COMPLETED|Overall Study||1
11214061|NCT01920568|12405265|FG000|STARTED|Overall Study||326
11214062|NCT01920568|12405266|FG001|STARTED|Overall Study||159
11214063|NCT01920568|12405265|FG000|COMPLETED|Overall Study||175
11214064|NCT01920568|12405266|FG001|COMPLETED|Overall Study||75
11214065|NCT01920568|12405265|FG000|NOT COMPLETED|Overall Study||151
11214066|NCT01920568|12405266|FG001|NOT COMPLETED|Overall Study||84
11214067|NCT01920594|12405275|FG000|STARTED|Overall Study||27
11214068|NCT01920594|12405276|FG001|STARTED|Overall Study||28
11214069|NCT01920594|12405275|FG000|COMPLETED|Overall Study||20
11214070|NCT01920594|12405276|FG001|COMPLETED|Overall Study||25
11214071|NCT01920594|12405275|FG000|NOT COMPLETED|Overall Study||7
11214072|NCT01920594|12405276|FG001|NOT COMPLETED|Overall Study||3
11214073|NCT01920711|12405284|FG000|STARTED|Overall Study||2419
11214074|NCT01920711|12405285|FG001|STARTED|Overall Study||2403
11214075|NCT01920711|12405284|FG000|COMPLETED|Overall Study||2055
11214076|NCT01920711|12405285|FG001|COMPLETED|Overall Study||2030
11214077|NCT01920711|12405284|FG000|NOT COMPLETED|Overall Study||364
11214078|NCT01920711|12405285|FG001|NOT COMPLETED|Overall Study||373
11214079|NCT01920802|12405295|FG000|STARTED|Overall Study||11
11214080|NCT01920802|12405296|FG001|STARTED|Overall Study||9
11214081|NCT01920802|12405297|FG002|STARTED|Overall Study||11
11214082|NCT01920802|12405295|FG000|COMPLETED|Overall Study||7
11214083|NCT01920802|12405296|FG001|COMPLETED|Overall Study||7
11214084|NCT01920802|12405297|FG002|COMPLETED|Overall Study||10
11214085|NCT01920802|12405295|FG000|NOT COMPLETED|Overall Study||4
11214086|NCT01920802|12405296|FG001|NOT COMPLETED|Overall Study||2
11214087|NCT01920802|12405297|FG002|NOT COMPLETED|Overall Study||1
11214088|NCT01920854|12405312|FG000|STARTED|Overall Study||12
11214089|NCT01920854|12405313|FG001|STARTED|Overall Study||6
11214090|NCT01920854|12405314|FG002|STARTED|Overall Study||6
11214091|NCT01920854|12405315|FG003|STARTED|Overall Study||6
11214092|NCT01920854|12405316|FG004|STARTED|Overall Study||6
11214093|NCT01920854|12405317|FG005|STARTED|Overall Study||6
11214094|NCT01920854|12405318|FG006|STARTED|Overall Study||6
11214095|NCT01920854|12405312|FG000|COMPLETED|Overall Study||11
11214096|NCT01920854|12405313|FG001|COMPLETED|Overall Study||6
11214097|NCT01920854|12405314|FG002|COMPLETED|Overall Study||6
11214098|NCT01920854|12405315|FG003|COMPLETED|Overall Study||6
11214099|NCT01920854|12405316|FG004|COMPLETED|Overall Study||5
11214100|NCT01920854|12405317|FG005|COMPLETED|Overall Study||6
11214101|NCT01920854|12405318|FG006|COMPLETED|Overall Study||5
11214102|NCT01920854|12405312|FG000|NOT COMPLETED|Overall Study||1
11214103|NCT01920854|12405313|FG001|NOT COMPLETED|Overall Study||0
11214104|NCT01920854|12405314|FG002|NOT COMPLETED|Overall Study||0
11214105|NCT01920854|12405315|FG003|NOT COMPLETED|Overall Study||0
11214106|NCT01920854|12405316|FG004|NOT COMPLETED|Overall Study||1
11214107|NCT01920854|12405317|FG005|NOT COMPLETED|Overall Study||0
11214108|NCT01920854|12405318|FG006|NOT COMPLETED|Overall Study||1
11214109|NCT01920893|12405355|FG000|STARTED|Overall Study||30
11214110|NCT01920893|12405356|FG001|STARTED|Overall Study||30
11214111|NCT01920893|12405355|FG000|Treated (Safety Population)|Overall Study||30
11214112|NCT01920893|12405356|FG001|Treated (Safety Population)|Overall Study||30
11214113|NCT01920893|12405355|FG000|COMPLETED|Overall Study||23
11214114|NCT01920893|12405356|FG001|COMPLETED|Overall Study||28
11214115|NCT01920893|12405355|FG000|NOT COMPLETED|Overall Study||7
11214116|NCT01920893|12405356|FG001|NOT COMPLETED|Overall Study||2
11214117|NCT01920958|12405363|FG000|STARTED|Overall Study||233
11214118|NCT01920958|12405363|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
11214119|NCT01920958|12405363|FG000|NOT COMPLETED|Overall Study||5
11214120|NCT01921101|12405369|FG000|STARTED|Overall Study||40
11214121|NCT01921101|12405370|FG001|STARTED|Overall Study||38
11214122|NCT01921101|12405369|FG000|COMPLETED|Overall Study||24
11214123|NCT01921101|12405370|FG001|COMPLETED|Overall Study||32
11214124|NCT01921101|12405369|FG000|NOT COMPLETED|Overall Study||16
11214125|NCT01921101|12405370|FG001|NOT COMPLETED|Overall Study||6
11214126|NCT01921179|12405378|FG000|STARTED|5 Week Randomized GOALS vs EDU Training||24
11214127|NCT01921179|12405379|FG001|STARTED|5 Week Randomized GOALS vs EDU Training||22
11214128|NCT01921179|12405378|FG000|COMPLETED|5 Week Randomized GOALS vs EDU Training||21
11214129|NCT01921179|12405379|FG001|COMPLETED|5 Week Randomized GOALS vs EDU Training||19
11214130|NCT01921179|12405378|FG000|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
11214131|NCT01921179|12405379|FG001|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
11214132|NCT01921179|12405378|FG000|STARTED|Long Term Follow-up After GOALS Training||34
11214133|NCT01921179|12405379|FG001|STARTED|Long Term Follow-up After GOALS Training|13 out of 19 participants who completed EDU, also completed GOALS training|0
11214134|NCT01921179|12405378|FG000|COMPLETED|Long Term Follow-up After GOALS Training||32
11214135|NCT01921179|12405379|FG001|COMPLETED|Long Term Follow-up After GOALS Training||0
11214136|NCT01921179|12405378|FG000|NOT COMPLETED|Long Term Follow-up After GOALS Training||2
11214137|NCT01921179|12405379|FG001|NOT COMPLETED|Long Term Follow-up After GOALS Training||0
11214138|NCT01921205|12405388|FG000|STARTED|Overall Study||172
11214139|NCT01921205|12405389|FG001|STARTED|Overall Study||171
11214140|NCT01921205|12405388|FG000|COMPLETED|Overall Study||151
11214141|NCT01921205|12405389|FG001|COMPLETED|Overall Study||151
11214142|NCT01921205|12405388|FG000|NOT COMPLETED|Overall Study||21
11214143|NCT01921205|12405389|FG001|NOT COMPLETED|Overall Study||20
11214144|NCT01921257|12405395|FG000|STARTED|Overall Study||16
11214145|NCT01921257|12405395|FG000|Placebo run-in|Overall Study||16
11214146|NCT01921257|12405395|FG000|Active Treatment|Overall Study||13
11214147|NCT01921257|12405395|FG000|COMPLETED|Overall Study||13
11214148|NCT01921257|12405395|FG000|NOT COMPLETED|Overall Study||3
11214149|NCT01921270|12405400|FG000|STARTED|Overall Study||18
11214150|NCT01921270|12405400|FG000|COMPLETED|Overall Study||17
11214151|NCT01921270|12405400|FG000|NOT COMPLETED|Overall Study||1
11214152|NCT01921296|12405404|FG000|STARTED|Overall Study||2
11214153|NCT01921296|12405404|FG000|COMPLETED|Overall Study||2
11214154|NCT01921296|12405404|FG000|NOT COMPLETED|Overall Study||0
11214155|NCT01921322|12405410|FG000|STARTED|Overall Study||57
11214156|NCT01921322|12405411|FG001|STARTED|Overall Study||61
11214157|NCT01921322|12405410|FG000|COMPLETED|Overall Study||42
11214158|NCT01921322|12405411|FG001|COMPLETED|Overall Study||44
11214159|NCT01921322|12405410|FG000|NOT COMPLETED|Overall Study||15
11214160|NCT01921322|12405411|FG001|NOT COMPLETED|Overall Study||17
11214161|NCT01921348|12405419|FG000|STARTED|Overall Study||9
11214162|NCT01921348|12405420|FG001|STARTED|Overall Study||9
11214163|NCT01921348|12405419|FG000|COMPLETED|Overall Study||8
11214164|NCT01921348|12405420|FG001|COMPLETED|Overall Study||7
11214165|NCT01921348|12405419|FG000|NOT COMPLETED|Overall Study||1
11214166|NCT01921348|12405420|FG001|NOT COMPLETED|Overall Study||2
11214167|NCT01921387|12405426|FG000|STARTED|Overall Study||20
11214168|NCT01921387|12405426|FG000|COMPLETED|Overall Study||19
11214169|NCT01921387|12405426|FG000|NOT COMPLETED|Overall Study||1
11214170|NCT01921452|12405430|FG000|STARTED|Overall Study||283
11214171|NCT01921452|12405430|FG000|COMPLETED|Overall Study||283
11214172|NCT01921452|12405430|FG000|NOT COMPLETED|Overall Study||0
11214173|NCT01921517|12405437|FG000|STARTED|Overall Study||42
11214174|NCT01921517|12405438|FG001|STARTED|Overall Study||38
11214175|NCT01921517|12405437|FG000|COMPLETED|Overall Study||27
11214176|NCT01921517|12405438|FG001|COMPLETED|Overall Study||29
11214177|NCT01921517|12405437|FG000|NOT COMPLETED|Overall Study||15
11214178|NCT01921517|12405438|FG001|NOT COMPLETED|Overall Study||9
11214179|NCT01921634|12405444|FG000|STARTED|Overall Study||300
11214180|NCT01921634|12405444|FG000|COMPLETED|Overall Study||300
11214181|NCT01921634|12405444|FG000|NOT COMPLETED|Overall Study||0
11214182|NCT01921751|12405452|FG000|STARTED|Overall Study||4
11214183|NCT01921751|12405453|FG001|STARTED|Overall Study||4
11214184|NCT01921751|12405454|FG002|STARTED|Overall Study||5
11214185|NCT01921751|12405452|FG000|COMPLETED|Overall Study|All randomized patients are reported here.|4
11214186|NCT01921751|12405453|FG001|COMPLETED|Overall Study|All randomized patients are reported here.|4
11214187|NCT01921751|12405454|FG002|COMPLETED|Overall Study|All randomized patients are reported here.|5
11214188|NCT01921751|12405452|FG000|NOT COMPLETED|Overall Study||0
11214189|NCT01921751|12405453|FG001|NOT COMPLETED|Overall Study||0
11214190|NCT01921751|12405454|FG002|NOT COMPLETED|Overall Study||0
11214191|NCT01921829|12405465|FG000|STARTED|Overall Study||10
11214192|NCT01921829|12405466|FG001|STARTED|Overall Study||9
11214193|NCT01921829|12405465|FG000|COMPLETED|Overall Study||10
11214194|NCT01921829|12405466|FG001|COMPLETED|Overall Study||8
11214195|NCT01921829|12405465|FG000|NOT COMPLETED|Overall Study||0
11214196|NCT01921829|12405466|FG001|NOT COMPLETED|Overall Study||1
11214197|NCT01921894|12405475|FG000|STARTED|Overall Study||8
11214198|NCT01921894|12405476|FG001|STARTED|Overall Study||8
11214199|NCT01921894|12405477|FG002|STARTED|Overall Study||8
11214200|NCT01921894|12405475|FG000|COMPLETED|Overall Study||8
11214201|NCT01921894|12405476|FG001|COMPLETED|Overall Study||8
11214202|NCT01921894|12405477|FG002|COMPLETED|Overall Study||8
11214203|NCT01921894|12405475|FG000|NOT COMPLETED|Overall Study||0
11214204|NCT01921894|12405476|FG001|NOT COMPLETED|Overall Study||0
11214205|NCT01921894|12405477|FG002|NOT COMPLETED|Overall Study||0
11214206|NCT01922011|12405499|FG000|STARTED|Overall Study|Randomized participants|75
11214207|NCT01922011|12405500|FG001|STARTED|Overall Study|Randomized participants|74
11214208|NCT01922011|12405499|FG000|Treated|Overall Study|Treated Participants|73
11214209|NCT01922011|12405500|FG001|Treated|Overall Study|Treated Participants|73
11214210|NCT01922011|12405499|FG000|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
11214211|NCT01922011|12405500|FG001|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
11214212|NCT01922011|12405499|FG000|COMPLETED|Overall Study||69
11214213|NCT01922011|12405500|FG001|COMPLETED|Overall Study||69
11214214|NCT01922011|12405499|FG000|NOT COMPLETED|Overall Study||6
11214215|NCT01922011|12405500|FG001|NOT COMPLETED|Overall Study||5
11214216|NCT01922024|12405514|FG000|STARTED|Overall Study||1653
11214217|NCT01922024|12405515|FG001|STARTED|Overall Study||471
11214218|NCT01922024|12405514|FG000|COMPLETED|Overall Study||1653
11214219|NCT01922024|12405515|FG001|COMPLETED|Overall Study||471
11214220|NCT01922024|12405514|FG000|NOT COMPLETED|Overall Study||0
11214221|NCT01922024|12405515|FG001|NOT COMPLETED|Overall Study||0
11214222|NCT01922037|12405523|FG000|STARTED|Overall Study||69
11214223|NCT01922037|12405524|FG001|STARTED|Overall Study||737
11214224|NCT01922037|12405523|FG000|Treated|Overall Study||69
11214225|NCT01922037|12405524|FG001|Treated|Overall Study||732
11214226|NCT01922037|12405523|FG000|COMPLETED|Overall Study||59
11214227|NCT01922037|12405524|FG001|COMPLETED|Overall Study||563
11214228|NCT01922037|12405523|FG000|NOT COMPLETED|Overall Study||10
11214229|NCT01922037|12405524|FG001|NOT COMPLETED|Overall Study||174
11214230|NCT01922050|12405546|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||3
11214231|NCT01922050|12405547|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||3
11214232|NCT01922050|12405548|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||6
11214233|NCT01922050|12405549|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||6
11214234|NCT01922050|12405550|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||17
11214235|NCT01922050|12405551|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||18
11214236|NCT01922050|12405552|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||3
11214237|NCT01922050|12405553|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||3
11214238|NCT01922050|12405554|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||6
11214239|NCT01922050|12405555|FG009|STARTED|Part 1 Open-label, Dose-escalation Phase||12
11214240|NCT01922050|12405556|FG010|STARTED|Part 1 Open-label, Dose-escalation Phase||0
11214241|NCT01922050|12405557|FG011|STARTED|Part 1 Open-label, Dose-escalation Phase||0
11214242|NCT01922050|12405558|FG012|STARTED|Part 1 Open-label, Dose-escalation Phase||0
11214243|NCT01922050|12405559|FG013|STARTED|Part 1 Open-label, Dose-escalation Phase||0
11214244|NCT01922050|12405546|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
11214245|NCT01922050|12405547|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
11214246|NCT01922050|12405548|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
11214247|NCT01922050|12405549|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
11214248|NCT01922050|12405550|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17
11214249|NCT01922050|12405551|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18
11214250|NCT01922050|12405552|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
11214251|NCT01922050|12405553|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
11214252|NCT01922050|12405554|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
11214253|NCT01922050|12405555|FG009|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
11214254|NCT01922050|12405556|FG010|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214255|NCT01922050|12405557|FG011|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214256|NCT01922050|12405558|FG012|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214257|NCT01922050|12405559|FG013|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214258|NCT01922050|12405546|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214259|NCT01922050|12405547|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214260|NCT01922050|12405548|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214261|NCT01922050|12405549|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214262|NCT01922050|12405550|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214263|NCT01922050|12405551|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214264|NCT01922050|12405552|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214265|NCT01922050|12405553|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214266|NCT01922050|12405554|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214267|NCT01922050|12405555|FG009|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214268|NCT01922050|12405556|FG010|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214269|NCT01922050|12405557|FG011|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214270|NCT01922050|12405558|FG012|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214271|NCT01922050|12405559|FG013|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
11214272|NCT01922050|12405546|FG000|STARTED|Part 2 Double-blind Phase||0
11214273|NCT01922050|12405547|FG001|STARTED|Part 2 Double-blind Phase||0
11214274|NCT01922050|12405548|FG002|STARTED|Part 2 Double-blind Phase||0
11214275|NCT01922050|12405549|FG003|STARTED|Part 2 Double-blind Phase||0
11214276|NCT01922050|12405550|FG004|STARTED|Part 2 Double-blind Phase||0
11214277|NCT01922050|12405551|FG005|STARTED|Part 2 Double-blind Phase||0
11214278|NCT01922050|12405552|FG006|STARTED|Part 2 Double-blind Phase||0
11214279|NCT01922050|12405553|FG007|STARTED|Part 2 Double-blind Phase||0
11214280|NCT01922050|12405554|FG008|STARTED|Part 2 Double-blind Phase||0
11214281|NCT01922050|12405555|FG009|STARTED|Part 2 Double-blind Phase||0
11214282|NCT01922050|12405556|FG010|STARTED|Part 2 Double-blind Phase||62
11214283|NCT01922050|12405557|FG011|STARTED|Part 2 Double-blind Phase||60
11214284|NCT01922050|12405558|FG012|STARTED|Part 2 Double-blind Phase||62
11214285|NCT01922050|12405559|FG013|STARTED|Part 2 Double-blind Phase||59
11214286|NCT01922050|12405546|FG000|COMPLETED|Part 2 Double-blind Phase||0
11214287|NCT01922050|12405547|FG001|COMPLETED|Part 2 Double-blind Phase||0
11214288|NCT01922050|12405548|FG002|COMPLETED|Part 2 Double-blind Phase||0
11214289|NCT01922050|12405549|FG003|COMPLETED|Part 2 Double-blind Phase||0
11214290|NCT01922050|12405550|FG004|COMPLETED|Part 2 Double-blind Phase||0
11214291|NCT01922050|12405551|FG005|COMPLETED|Part 2 Double-blind Phase||0
11214292|NCT01922050|12405552|FG006|COMPLETED|Part 2 Double-blind Phase||0
11214293|NCT01922050|12405553|FG007|COMPLETED|Part 2 Double-blind Phase||0
11214294|NCT01922050|12405554|FG008|COMPLETED|Part 2 Double-blind Phase||0
11214295|NCT01922050|12405555|FG009|COMPLETED|Part 2 Double-blind Phase||0
11214296|NCT01922050|12405556|FG010|COMPLETED|Part 2 Double-blind Phase||61
11214297|NCT01922050|12405557|FG011|COMPLETED|Part 2 Double-blind Phase||58
11214298|NCT01922050|12405558|FG012|COMPLETED|Part 2 Double-blind Phase||62
11214299|NCT01922050|12405559|FG013|COMPLETED|Part 2 Double-blind Phase||56
11214300|NCT01922050|12405546|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0
11214301|NCT01922050|12405547|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0
11214302|NCT01922050|12405548|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0
11214303|NCT01922050|12405549|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0
11214304|NCT01922050|12405550|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0
11214305|NCT01922050|12405551|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0
11214306|NCT01922050|12405552|FG006|NOT COMPLETED|Part 2 Double-blind Phase||0
11214307|NCT01922050|12405553|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0
11214308|NCT01922050|12405554|FG008|NOT COMPLETED|Part 2 Double-blind Phase||0
11214309|NCT01922050|12405555|FG009|NOT COMPLETED|Part 2 Double-blind Phase||0
11214310|NCT01922050|12405556|FG010|NOT COMPLETED|Part 2 Double-blind Phase||1
11214311|NCT01922050|12405557|FG011|NOT COMPLETED|Part 2 Double-blind Phase||2
11214312|NCT01922050|12405558|FG012|NOT COMPLETED|Part 2 Double-blind Phase||0
11214313|NCT01922050|12405559|FG013|NOT COMPLETED|Part 2 Double-blind Phase||3
11214314|NCT01922089|12405591|FG000|STARTED|Overall Study||247
11214315|NCT01922089|12405592|FG001|STARTED|Overall Study||251
11214316|NCT01922089|12405591|FG000|Safety Set|Overall Study||246
11214317|NCT01922089|12405592|FG001|Safety Set|Overall Study||251
11214318|NCT01922089|12405591|FG000|COMPLETED|Overall Study||208
11214319|NCT01922089|12405592|FG001|COMPLETED|Overall Study||221
11214320|NCT01922089|12405591|FG000|NOT COMPLETED|Overall Study||39
11214321|NCT01922089|12405592|FG001|NOT COMPLETED|Overall Study||30
11214322|NCT01922102|12405601|FG000|STARTED|Overall Study||182
11214323|NCT01922102|12405602|FG001|STARTED|Overall Study||184
11214324|NCT01922102|12405603|FG002|STARTED|Overall Study||91
11214325|NCT01922102|12405601|FG000|COMPLETED|Overall Study||173
11214326|NCT01922102|12405602|FG001|COMPLETED|Overall Study||175
11214327|NCT01922102|12405603|FG002|COMPLETED|Overall Study||83
11214328|NCT01922102|12405601|FG000|NOT COMPLETED|Overall Study||9
11214329|NCT01922102|12405602|FG001|NOT COMPLETED|Overall Study||9
11214330|NCT01922102|12405603|FG002|NOT COMPLETED|Overall Study||8
11214331|NCT01922115|12405617|FG000|STARTED|Overall Study||28
11214332|NCT01922115|12405618|FG001|STARTED|Overall Study||31
11214333|NCT01922115|12405617|FG000|COMPLETED|Overall Study||21
11214334|NCT01922115|12405618|FG001|COMPLETED|Overall Study||24
11214335|NCT01922115|12405617|FG000|NOT COMPLETED|Overall Study||7
11214336|NCT01922115|12405618|FG001|NOT COMPLETED|Overall Study||7
11214337|NCT01922219|12405624|FG000|STARTED|Overall Study||37
11214338|NCT01922219|12405624|FG000|COMPLETED|Overall Study||28
11214339|NCT01922219|12405624|FG000|NOT COMPLETED|Overall Study||9
11097573|NCT01212757|12281286|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
11097574|NCT01212757|12281287|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
11097575|NCT01212757|12281288|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
11097576|NCT01212757|12281289|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
11097577|NCT01212757|12281281|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
11097578|NCT01212757|12281282|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
11097579|NCT01212757|12281283|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
11214340|NCT01922258|12405630|FG000|STARTED|Overall Study||133
11214341|NCT01922258|12405631|FG001|STARTED|Overall Study||137
11214342|NCT01922258|12405630|FG000|COMPLETED|Overall Study||117
11214343|NCT01922258|12405631|FG001|COMPLETED|Overall Study||121
11214344|NCT01922258|12405630|FG000|NOT COMPLETED|Overall Study||16
11214345|NCT01922258|12405631|FG001|NOT COMPLETED|Overall Study||16
11214346|NCT01922271|12405639|FG000|STARTED|PERIOD 1||76
11214347|NCT01922271|12405640|FG001|STARTED|PERIOD 1||76
11214348|NCT01922271|12405639|FG000|COMPLETED|PERIOD 1||76
11214349|NCT01922271|12405640|FG001|COMPLETED|PERIOD 1||76
11214350|NCT01922271|12405639|FG000|NOT COMPLETED|PERIOD 1||0
11214351|NCT01922271|12405640|FG001|NOT COMPLETED|PERIOD 1||0
11214352|NCT01922271|12405639|FG000|STARTED|WASHOUT Period||76
11214353|NCT01922271|12405640|FG001|STARTED|WASHOUT Period||76
11214354|NCT01922271|12405639|FG000|COMPLETED|WASHOUT Period||75
11214355|NCT01922271|12405640|FG001|COMPLETED|WASHOUT Period||76
11214356|NCT01922271|12405639|FG000|NOT COMPLETED|WASHOUT Period||1
11214357|NCT01922271|12405640|FG001|NOT COMPLETED|WASHOUT Period||0
11214358|NCT01922271|12405639|FG000|STARTED|PERIOD 2||75
11214359|NCT01922271|12405640|FG001|STARTED|PERIOD 2||76
11214360|NCT01922271|12405639|FG000|COMPLETED|PERIOD 2||75
11214361|NCT01922271|12405640|FG001|COMPLETED|PERIOD 2||76
11214362|NCT01922271|12405639|FG000|NOT COMPLETED|PERIOD 2||0
11214363|NCT01922271|12405640|FG001|NOT COMPLETED|PERIOD 2||0
11214364|NCT01922336|12405649|FG000|STARTED|Overall Study||53
11214365|NCT01922336|12405650|FG001|STARTED|Overall Study||53
11214366|NCT01922336|12405651|FG002|STARTED|Overall Study||53
11214367|NCT01922336|12405649|FG000|COMPLETED|Overall Study||53
11214368|NCT01922336|12405650|FG001|COMPLETED|Overall Study||53
11214369|NCT01922336|12405651|FG002|COMPLETED|Overall Study||53
11214370|NCT01922336|12405649|FG000|NOT COMPLETED|Overall Study||0
11214371|NCT01922336|12405650|FG001|NOT COMPLETED|Overall Study||0
11214372|NCT01922336|12405651|FG002|NOT COMPLETED|Overall Study||0
11214373|NCT01922349|12405663|FG000|STARTED|Single Rising Dose (SRD) Period||25
11214374|NCT01922349|12405664|FG001|STARTED|Single Rising Dose (SRD) Period||27
11214375|NCT01922349|12405665|FG002|STARTED|Single Rising Dose (SRD) Period||18
11214376|NCT01922349|12405666|FG003|STARTED|Single Rising Dose (SRD) Period||27
11214377|NCT01922349|12405663|FG000|COMPLETED|Single Rising Dose (SRD) Period||25
11214378|NCT01922349|12405664|FG001|COMPLETED|Single Rising Dose (SRD) Period||27
11214379|NCT01922349|12405665|FG002|COMPLETED|Single Rising Dose (SRD) Period||18
11214380|NCT01922349|12405666|FG003|COMPLETED|Single Rising Dose (SRD) Period||27
11214381|NCT01922349|12405663|FG000|NOT COMPLETED|Single Rising Dose (SRD) Period||0
11214382|NCT01922349|12405664|FG001|NOT COMPLETED|Single Rising Dose (SRD) Period||0
11214383|NCT01922349|12405665|FG002|NOT COMPLETED|Single Rising Dose (SRD) Period||0
11214384|NCT01922349|12405666|FG003|NOT COMPLETED|Single Rising Dose (SRD) Period||0
11214385|NCT01922349|12405663|FG000|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
11214386|NCT01922349|12405664|FG001|STARTED|Multiple Rising Dose (MRD) Period||27
11214387|NCT01922349|12405665|FG002|STARTED|Multiple Rising Dose (MRD) Period||18
11214388|NCT01922349|12405666|FG003|STARTED|Multiple Rising Dose (MRD) Period||27
11214389|NCT01922349|12405663|FG000|COMPLETED|Multiple Rising Dose (MRD) Period||24
11214390|NCT01922349|12405664|FG001|COMPLETED|Multiple Rising Dose (MRD) Period||27
11214391|NCT01922349|12405665|FG002|COMPLETED|Multiple Rising Dose (MRD) Period||18
11214392|NCT01922349|12405666|FG003|COMPLETED|Multiple Rising Dose (MRD) Period||26
11214393|NCT01922349|12405663|FG000|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
11214394|NCT01922349|12405664|FG001|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
11214395|NCT01922349|12405665|FG002|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
11214396|NCT01922349|12405666|FG003|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
11214397|NCT01922739|12405702|FG000|STARTED|Titration/Adjustment Period||182
11214398|NCT01922739|12405702|FG000|Safety Analysis Set|Titration/Adjustment Period||182
11214399|NCT01922739|12405702|FG000|COMPLETED|Titration/Adjustment Period||170
11214400|NCT01922739|12405702|FG000|NOT COMPLETED|Titration/Adjustment Period||12
11214401|NCT01922739|12405702|FG000|STARTED|Open-label Treatment Period||170
11214402|NCT01922739|12405702|FG000|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
11214403|NCT01922739|12405702|FG000|COMPLETED|Open-label Treatment Period||136
11214404|NCT01922739|12405702|FG000|NOT COMPLETED|Open-label Treatment Period||34
11214405|NCT01922934|12405720|FG000|STARTED|Eligible Patients||428
11214406|NCT01922934|12405721|FG001|STARTED|Eligible Patients||4302
11214407|NCT01922934|12405720|FG000|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
11214408|NCT01922934|12405721|FG001|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
11214409|NCT01922934|12405720|FG000|NOT COMPLETED|Eligible Patients||53
11214410|NCT01922934|12405721|FG001|NOT COMPLETED|Eligible Patients||88
11214411|NCT01922934|12405720|FG000|STARTED|Visit 0 - Patient Contacted & Consented||375
11214412|NCT01922934|12405721|FG001|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
11214413|NCT01922934|12405720|FG000|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
11214414|NCT01922934|12405721|FG001|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
11214415|NCT01922934|12405720|FG000|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
11214416|NCT01922934|12405721|FG001|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
11214417|NCT01922934|12405720|FG000|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
11214418|NCT01922934|12405721|FG001|STARTED|Visit 1- Weight Measured||4214
11214419|NCT01922934|12405720|FG000|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
11214420|NCT01922934|12405721|FG001|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
11214421|NCT01922934|12405720|FG000|NOT COMPLETED|Visit 1- Weight Measured||21
11214422|NCT01922934|12405721|FG001|NOT COMPLETED|Visit 1- Weight Measured||1284
11214423|NCT01922934|12405720|FG000|STARTED|Visit 12 / Final Visits||119
11214424|NCT01922934|12405721|FG001|STARTED|Visit 12 / Final Visits||2930
11214425|NCT01922934|12405720|FG000|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
11214426|NCT01922934|12405721|FG001|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
11214427|NCT01922934|12405720|FG000|NOT COMPLETED|Visit 12 / Final Visits||6
11214428|NCT01922934|12405721|FG001|NOT COMPLETED|Visit 12 / Final Visits||290
11214429|NCT01922986|12405731|FG000|STARTED|Overall Study||2
11214430|NCT01922986|12405732|FG001|STARTED|Overall Study||2
11214431|NCT01922986|12405731|FG000|COMPLETED|Overall Study||2
11214432|NCT01922986|12405732|FG001|COMPLETED|Overall Study||2
11214433|NCT01922986|12405731|FG000|NOT COMPLETED|Overall Study||0
11214434|NCT01922986|12405732|FG001|NOT COMPLETED|Overall Study||0
11214435|NCT01923129|12405740|FG000|STARTED|Overall Study||71
11214436|NCT01923129|12405741|FG001|STARTED|Overall Study||71
11214437|NCT01923129|12405740|FG000|COMPLETED|Overall Study||71
11214438|NCT01923129|12405741|FG001|COMPLETED|Overall Study||71
11214439|NCT01923129|12405740|FG000|NOT COMPLETED|Overall Study||0
11214440|NCT01923129|12405741|FG001|NOT COMPLETED|Overall Study||0
11214441|NCT01923181|12405756|FG000|STARTED|Overall Study||70
11214442|NCT01923181|12405757|FG001|STARTED|Overall Study||70
11214443|NCT01923181|12405758|FG002|STARTED|Overall Study||69
11214444|NCT01923181|12405759|FG003|STARTED|Overall Study||70
11214445|NCT01923181|12405760|FG004|STARTED|Overall Study||71
11214446|NCT01923181|12405761|FG005|STARTED|Overall Study||70
11214447|NCT01923181|12405762|FG006|STARTED|Overall Study||70
11214448|NCT01923181|12405763|FG007|STARTED|Overall Study||69
11214449|NCT01923181|12405764|FG008|STARTED|Overall Study||71
11214450|NCT01923181|12405756|FG000|Full Analysis Set (FAS)|Overall Study||70
11214451|NCT01923181|12405757|FG001|Full Analysis Set (FAS)|Overall Study||70
11214452|NCT01923181|12405758|FG002|Full Analysis Set (FAS)|Overall Study||69
11214453|NCT01923181|12405759|FG003|Full Analysis Set (FAS)|Overall Study||70
11214454|NCT01923181|12405760|FG004|Full Analysis Set (FAS)|Overall Study||71
11214455|NCT01923181|12405761|FG005|Full Analysis Set (FAS)|Overall Study||70
11214456|NCT01923181|12405762|FG006|Full Analysis Set (FAS)|Overall Study||70
11214457|NCT01923181|12405763|FG007|Full Analysis Set (FAS)|Overall Study||69
11214458|NCT01923181|12405764|FG008|Full Analysis Set (FAS)|Overall Study||71
11214459|NCT01923181|12405756|FG000|Safety Analysis Set (SAS)|Overall Study||70
11214460|NCT01923181|12405757|FG001|Safety Analysis Set (SAS)|Overall Study||70
11214461|NCT01923181|12405758|FG002|Safety Analysis Set (SAS)|Overall Study||69
11214462|NCT01923181|12405759|FG003|Safety Analysis Set (SAS)|Overall Study||70
11214463|NCT01923181|12405760|FG004|Safety Analysis Set (SAS)|Overall Study||71
11214464|NCT01923181|12405761|FG005|Safety Analysis Set (SAS)|Overall Study||70
11214465|NCT01923181|12405762|FG006|Safety Analysis Set (SAS)|Overall Study||70
11214466|NCT01923181|12405763|FG007|Safety Analysis Set (SAS)|Overall Study||69
11214467|NCT01923181|12405764|FG008|Safety Analysis Set (SAS)|Overall Study||71
11214468|NCT01923181|12405756|FG000|COMPLETED|Overall Study||67
11214469|NCT01923181|12405757|FG001|COMPLETED|Overall Study||64
11214470|NCT01923181|12405758|FG002|COMPLETED|Overall Study||67
11214471|NCT01923181|12405759|FG003|COMPLETED|Overall Study||65
11214472|NCT01923181|12405760|FG004|COMPLETED|Overall Study||63
11214473|NCT01923181|12405761|FG005|COMPLETED|Overall Study||66
11214474|NCT01923181|12405762|FG006|COMPLETED|Overall Study||62
11214475|NCT01923181|12405763|FG007|COMPLETED|Overall Study||61
11214476|NCT01923181|12405764|FG008|COMPLETED|Overall Study||68
11214477|NCT01923181|12405756|FG000|NOT COMPLETED|Overall Study||3
11214478|NCT01923181|12405757|FG001|NOT COMPLETED|Overall Study||6
11214479|NCT01923181|12405758|FG002|NOT COMPLETED|Overall Study||2
11214480|NCT01923181|12405759|FG003|NOT COMPLETED|Overall Study||5
11214481|NCT01923181|12405760|FG004|NOT COMPLETED|Overall Study||8
11214482|NCT01923181|12405761|FG005|NOT COMPLETED|Overall Study||4
11214483|NCT01923181|12405762|FG006|NOT COMPLETED|Overall Study||8
11214484|NCT01923181|12405763|FG007|NOT COMPLETED|Overall Study||8
11214485|NCT01923181|12405764|FG008|NOT COMPLETED|Overall Study||3
11214486|NCT01923285|12405789|FG000|STARTED|Overall Study||76
11214487|NCT01923285|12405790|FG001|STARTED|Overall Study||76
11214488|NCT01923285|12405789|FG000|Modified Intent-to-treat|Overall Study||73
11214489|NCT01923285|12405790|FG001|Modified Intent-to-treat|Overall Study||73
11214490|NCT01923285|12405789|FG000|COMPLETED|Overall Study||69
11214491|NCT01923285|12405790|FG001|COMPLETED|Overall Study||70
11214492|NCT01923285|12405789|FG000|NOT COMPLETED|Overall Study||7
11214493|NCT01923285|12405790|FG001|NOT COMPLETED|Overall Study||6
11214494|NCT01923311|12405798|FG000|STARTED|Overall Study||17
11214495|NCT01923311|12405799|FG001|STARTED|Overall Study||14
11214496|NCT01923311|12405798|FG000|COMPLETED|Overall Study||0
11214497|NCT01923311|12405799|FG001|COMPLETED|Overall Study||13
11214498|NCT01923311|12405798|FG000|NOT COMPLETED|Overall Study||17
11214499|NCT01923311|12405799|FG001|NOT COMPLETED|Overall Study||1
11214500|NCT01923363|12405806|FG000|STARTED|Overall Study||29
11214501|NCT01923363|12405806|FG000|COMPLETED|Overall Study||28
11214502|NCT01923363|12405806|FG000|NOT COMPLETED|Overall Study||1
11214503|NCT01923389|12405812|FG000|STARTED|Overall Study||2
11214504|NCT01923389|12405813|FG001|STARTED|Overall Study||2
11214505|NCT01923389|12405812|FG000|COMPLETED|Overall Study||1
11214506|NCT01923389|12405813|FG001|COMPLETED|Overall Study||2
11214507|NCT01923389|12405812|FG000|NOT COMPLETED|Overall Study||1
11214508|NCT01923389|12405813|FG001|NOT COMPLETED|Overall Study||0
11214509|NCT01923428|12405824|FG000|STARTED|Overall Study||88
11214510|NCT01923428|12405825|FG001|STARTED|Overall Study||89
11214511|NCT01923428|12405826|FG002|STARTED|Overall Study||89
11214512|NCT01923428|12405827|FG003|STARTED|Overall Study||90
11214513|NCT01923428|12405824|FG000|COMPLETED|Overall Study||69
11214514|NCT01923428|12405825|FG001|COMPLETED|Overall Study||77
11214515|NCT01923428|12405826|FG002|COMPLETED|Overall Study||78
11214516|NCT01923428|12405827|FG003|COMPLETED|Overall Study||80
11214517|NCT01923428|12405824|FG000|NOT COMPLETED|Overall Study||19
11214518|NCT01923428|12405825|FG001|NOT COMPLETED|Overall Study||12
11214519|NCT01923428|12405826|FG002|NOT COMPLETED|Overall Study||11
11214520|NCT01923428|12405827|FG003|NOT COMPLETED|Overall Study||10
11214521|NCT01923467|12405837|FG000|STARTED|Overall Study|Offered stop smoking program|767
11214522|NCT01923467|12405837|FG000|Baseline Completed, Enrolled|Overall Study||288
11214523|NCT01923467|12405837|FG000|COMPLETED|Overall Study|Completed 3-month follow up survey|226
11214524|NCT01923467|12405837|FG000|NOT COMPLETED|Overall Study||541
11214525|NCT01923740|12405843|FG000|STARTED|Overall Study||227
11214526|NCT01923740|12405844|FG001|STARTED|Overall Study||232
11214527|NCT01923740|12405843|FG000|COMPLETED|Overall Study||221
11214528|NCT01923740|12405844|FG001|COMPLETED|Overall Study||223
11214529|NCT01923740|12405843|FG000|NOT COMPLETED|Overall Study||6
11214530|NCT01923740|12405844|FG001|NOT COMPLETED|Overall Study||9
11214531|NCT01923805|12405852|FG000|STARTED|Overall Study|early termination|3
11214532|NCT01923805|12405853|FG001|STARTED|Overall Study|early termination|5
11214533|NCT01923805|12405852|FG000|COMPLETED|Overall Study||0
11214534|NCT01923805|12405853|FG001|COMPLETED|Overall Study||0
11214535|NCT01923805|12405852|FG000|NOT COMPLETED|Overall Study||3
11214536|NCT01923805|12405853|FG001|NOT COMPLETED|Overall Study||5
11214537|NCT01923896|12405861|FG000|STARTED|Overall Study||8
11214538|NCT01923896|12405862|FG001|STARTED|Overall Study||8
11214539|NCT01923896|12405861|FG000|COMPLETED|Overall Study||7
11214540|NCT01923896|12405862|FG001|COMPLETED|Overall Study||8
11214541|NCT01923896|12405861|FG000|NOT COMPLETED|Overall Study||1
11214542|NCT01923896|12405862|FG001|NOT COMPLETED|Overall Study||0
11214543|NCT01923961|12405871|FG000|STARTED|First Intervention||3
11214544|NCT01923961|12405872|FG001|STARTED|First Intervention||3
11214545|NCT01923961|12405873|FG002|STARTED|First Intervention||2
11214546|NCT01923961|12405871|FG000|COMPLETED|First Intervention||3
11214547|NCT01923961|12405872|FG001|COMPLETED|First Intervention||3
11214548|NCT01923961|12405873|FG002|COMPLETED|First Intervention||2
11214549|NCT01923961|12405871|FG000|NOT COMPLETED|First Intervention||0
11214550|NCT01923961|12405872|FG001|NOT COMPLETED|First Intervention||0
11214551|NCT01923961|12405873|FG002|NOT COMPLETED|First Intervention||0
11214552|NCT01923961|12405871|FG000|STARTED|Washout (1 Week)||3
11214553|NCT01923961|12405872|FG001|STARTED|Washout (1 Week)||3
11214554|NCT01923961|12405873|FG002|STARTED|Washout (1 Week)||2
11214555|NCT01923961|12405871|FG000|COMPLETED|Washout (1 Week)||3
11214556|NCT01923961|12405872|FG001|COMPLETED|Washout (1 Week)||3
11214557|NCT01923961|12405873|FG002|COMPLETED|Washout (1 Week)||2
11214558|NCT01923961|12405871|FG000|NOT COMPLETED|Washout (1 Week)||0
11214559|NCT01923961|12405872|FG001|NOT COMPLETED|Washout (1 Week)||0
11214560|NCT01923961|12405873|FG002|NOT COMPLETED|Washout (1 Week)||0
11214561|NCT01923961|12405871|FG000|STARTED|Second Intervention||3
11214562|NCT01923961|12405872|FG001|STARTED|Second Intervention||3
11214563|NCT01923961|12405873|FG002|STARTED|Second Intervention||2
11214564|NCT01923961|12405871|FG000|COMPLETED|Second Intervention||3
11214565|NCT01923961|12405872|FG001|COMPLETED|Second Intervention||3
11352987|NCT03052816|12550092|FG001|COMPLETED|Overall Study||33
11214566|NCT01923961|12405873|FG002|COMPLETED|Second Intervention||2
11214567|NCT01923961|12405871|FG000|NOT COMPLETED|Second Intervention||0
11352988|NCT03052816|12550091|FG000|NOT COMPLETED|Overall Study||3
11352989|NCT03052816|12550092|FG001|NOT COMPLETED|Overall Study||0
11352990|NCT03052959|12550102|FG000|STARTED|Overall Study||59
11352991|NCT03052959|12550103|FG001|STARTED|Overall Study||66
11352992|NCT03052959|12550102|FG000|COMPLETED|Overall Study||55
11352993|NCT03052959|12550103|FG001|COMPLETED|Overall Study||61
11352994|NCT03052959|12550102|FG000|NOT COMPLETED|Overall Study||4
11352995|NCT03052959|12550103|FG001|NOT COMPLETED|Overall Study||5
11352996|NCT03052972|12550112|FG000|STARTED|Overall Study||18
11352997|NCT03052972|12550113|FG001|STARTED|Overall Study||5
11352998|NCT03052972|12550112|FG000|COMPLETED|Overall Study||18
11352999|NCT03052972|12550113|FG001|COMPLETED|Overall Study||5
11353000|NCT03052972|12550112|FG000|NOT COMPLETED|Overall Study||0
11353001|NCT03052972|12550113|FG001|NOT COMPLETED|Overall Study||0
11353002|NCT03053050|12550123|FG000|STARTED|Randomized Phase||324
11353003|NCT03053050|12550124|FG001|STARTED|Randomized Phase||323
11214568|NCT01923961|12405872|FG001|NOT COMPLETED|Second Intervention||0
11214569|NCT01923961|12405873|FG002|NOT COMPLETED|Second Intervention||0
11214570|NCT01923961|12405871|FG000|STARTED|Washout (1 Week)||3
11214571|NCT01923961|12405872|FG001|STARTED|Washout (1 Week)||3
11214572|NCT01923961|12405873|FG002|STARTED|Washout (1 Week)||2
11214573|NCT01923961|12405871|FG000|COMPLETED|Washout (1 Week)||3
11214574|NCT01923961|12405872|FG001|COMPLETED|Washout (1 Week)||3
11214575|NCT01923961|12405873|FG002|COMPLETED|Washout (1 Week)||2
11214576|NCT01923961|12405871|FG000|NOT COMPLETED|Washout (1 Week)||0
11214577|NCT01923961|12405872|FG001|NOT COMPLETED|Washout (1 Week)||0
11214578|NCT01923961|12405873|FG002|NOT COMPLETED|Washout (1 Week)||0
11214579|NCT01923961|12405871|FG000|STARTED|Third Intervention||3
11214580|NCT01923961|12405872|FG001|STARTED|Third Intervention||3
11214581|NCT01923961|12405873|FG002|STARTED|Third Intervention||2
11214582|NCT01923961|12405871|FG000|COMPLETED|Third Intervention||3
11214583|NCT01923961|12405872|FG001|COMPLETED|Third Intervention||3
11214584|NCT01923961|12405873|FG002|COMPLETED|Third Intervention||2
11214585|NCT01923961|12405871|FG000|NOT COMPLETED|Third Intervention||0
11214586|NCT01923961|12405872|FG001|NOT COMPLETED|Third Intervention||0
11214587|NCT01923961|12405873|FG002|NOT COMPLETED|Third Intervention||0
11214588|NCT01924169|12405881|FG000|STARTED|Overall Study||3
11214589|NCT01924169|12405881|FG000|COMPLETED|Overall Study||3
11214590|NCT01924169|12405881|FG000|NOT COMPLETED|Overall Study||0
11214591|NCT01924182|12405887|FG000|STARTED|Overall Study||3
11214592|NCT01924182|12405888|FG001|STARTED|Overall Study||0
11214593|NCT01924182|12405887|FG000|COMPLETED|Overall Study||2
11214594|NCT01924182|12405888|FG001|COMPLETED|Overall Study||0
11214595|NCT01924182|12405887|FG000|NOT COMPLETED|Overall Study||1
11214596|NCT01924182|12405888|FG001|NOT COMPLETED|Overall Study||0
11214597|NCT01924299|12405896|FG000|STARTED|Period 1||18
11214598|NCT01924299|12405897|FG001|STARTED|Period 1||18
11214599|NCT01924299|12405896|FG000|Received Baricitinib|Period 1||18
11214600|NCT01924299|12405897|FG001|Received Baricitinib|Period 1||18
11214601|NCT01924299|12405896|FG000|COMPLETED|Period 1||18
11214602|NCT01924299|12405897|FG001|COMPLETED|Period 1||18
11214603|NCT01924299|12405896|FG000|NOT COMPLETED|Period 1||0
11214604|NCT01924299|12405897|FG001|NOT COMPLETED|Period 1||0
11214605|NCT01924299|12405896|FG000|STARTED|Period 2||18
11214606|NCT01924299|12405897|FG001|STARTED|Period 2||18
11214607|NCT01924299|12405896|FG000|Received at Least 1 Dose of Study Drug|Period 2||18
11214608|NCT01924299|12405897|FG001|Received at Least 1 Dose of Study Drug|Period 2||18
11214609|NCT01924299|12405896|FG000|Received Baricitinib|Period 2||17
11214610|NCT01924299|12405897|FG001|Received Baricitinib|Period 2||17
11214611|NCT01924299|12405896|FG000|COMPLETED|Period 2||17
11214612|NCT01924299|12405897|FG001|COMPLETED|Period 2||17
11214613|NCT01924299|12405896|FG000|NOT COMPLETED|Period 2||1
11214614|NCT01924299|12405897|FG001|NOT COMPLETED|Period 2||1
11214615|NCT01924364|12405909|FG000|STARTED|Overall Study||7
11214616|NCT01924364|12405909|FG000|COMPLETED|Overall Study||4
11214617|NCT01924364|12405909|FG000|NOT COMPLETED|Overall Study||3
11214618|NCT01924390|12405926|FG000|STARTED|Overall Study||22
11214619|NCT01924390|12405927|FG001|STARTED|Overall Study||22
11214620|NCT01924390|12405926|FG000|COMPLETED|Overall Study||21
11214621|NCT01924390|12405927|FG001|COMPLETED|Overall Study||21
11214622|NCT01924390|12405926|FG000|NOT COMPLETED|Overall Study||1
11214623|NCT01924390|12405927|FG001|NOT COMPLETED|Overall Study||1
11214624|NCT01924429|12405935|FG000|STARTED|Period 1 - First Intervention (4 Weeks)||17
11214625|NCT01924429|12405936|FG001|STARTED|Period 1 - First Intervention (4 Weeks)||13
11214626|NCT01924429|12405935|FG000|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
11214627|NCT01924429|12405936|FG001|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
11214628|NCT01924429|12405935|FG000|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
11214629|NCT01924429|12405936|FG001|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
11214630|NCT01924429|12405935|FG000|STARTED|Washout Period (2 Weeks)||17
11214631|NCT01924429|12405936|FG001|STARTED|Washout Period (2 Weeks)||13
11214632|NCT01924429|12405935|FG000|COMPLETED|Washout Period (2 Weeks)||14
11214633|NCT01924429|12405936|FG001|COMPLETED|Washout Period (2 Weeks)||11
11214634|NCT01924429|12405935|FG000|NOT COMPLETED|Washout Period (2 Weeks)||3
11214635|NCT01924429|12405936|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2
11214636|NCT01924429|12405935|FG000|STARTED|Period 2 - Second Intervention (4 Weeks)||14
11214637|NCT01924429|12405936|FG001|STARTED|Period 2 - Second Intervention (4 Weeks)||11
11214638|NCT01924429|12405935|FG000|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
11214639|NCT01924429|12405936|FG001|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
11214640|NCT01924429|12405935|FG000|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
11214641|NCT01924429|12405936|FG001|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
11214642|NCT01924442|12405946|FG000|STARTED|Overall Study||1099
11214643|NCT01924442|12405947|FG001|STARTED|Overall Study||1104
11214644|NCT01924442|12405946|FG000|COMPLETED|Overall Study||1059
11214645|NCT01924442|12405947|FG001|COMPLETED|Overall Study||967
11214646|NCT01924442|12405946|FG000|NOT COMPLETED|Overall Study||40
11214647|NCT01924442|12405947|FG001|NOT COMPLETED|Overall Study||137
11214648|NCT01924559|12405953|FG000|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
11214649|NCT01924559|12405953|FG000|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
11214650|NCT01924559|12405953|FG000|NOT COMPLETED|Overall Study||0
11214651|NCT01924689|12405973|FG000|STARTED|Overall Study||3
11214652|NCT01924689|12405974|FG001|STARTED|Overall Study||3
11214653|NCT01924689|12405975|FG002|STARTED|Overall Study||4
11214654|NCT01924689|12405976|FG003|STARTED|Overall Study||6
11214655|NCT01924689|12405977|FG004|STARTED|Overall Study||6
11214656|NCT01924689|12405978|FG005|STARTED|Overall Study||2
11214657|NCT01924689|12405973|FG000|COMPLETED|Overall Study||0
11214658|NCT01924689|12405974|FG001|COMPLETED|Overall Study||0
11214659|NCT01924689|12405975|FG002|COMPLETED|Overall Study||0
11214660|NCT01924689|12405976|FG003|COMPLETED|Overall Study||0
11214661|NCT01924689|12405977|FG004|COMPLETED|Overall Study||0
11214662|NCT01924689|12405978|FG005|COMPLETED|Overall Study||0
11214663|NCT01924689|12405973|FG000|NOT COMPLETED|Overall Study||3
11214664|NCT01924689|12405974|FG001|NOT COMPLETED|Overall Study||3
11214665|NCT01924689|12405975|FG002|NOT COMPLETED|Overall Study||4
11214666|NCT01924689|12405976|FG003|NOT COMPLETED|Overall Study||6
11214667|NCT01924689|12405977|FG004|NOT COMPLETED|Overall Study||6
11097580|NCT01212757|12281284|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
11097581|NCT01212757|12281285|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
11214668|NCT01924689|12405978|FG005|NOT COMPLETED|Overall Study||2
11214669|NCT01924754|12405999|FG000|STARTED|Overall Study||50
11214670|NCT01924754|12406000|FG001|STARTED|Overall Study||50
11214671|NCT01924754|12406001|FG002|STARTED|Overall Study||50
11214672|NCT01924754|12405999|FG000|COMPLETED|Overall Study||49
11214673|NCT01924754|12406000|FG001|COMPLETED|Overall Study||47
11214674|NCT01924754|12406001|FG002|COMPLETED|Overall Study||47
11214675|NCT01924754|12405999|FG000|NOT COMPLETED|Overall Study||1
11214676|NCT01924754|12406000|FG001|NOT COMPLETED|Overall Study||3
11214677|NCT01924754|12406001|FG002|NOT COMPLETED|Overall Study||3
11214678|NCT01924767|12406017|FG000|STARTED|Overall Study||12
11214679|NCT01924767|12406018|FG001|STARTED|Overall Study||9
11214680|NCT01924767|12406019|FG002|STARTED|Overall Study||9
11214681|NCT01924767|12406020|FG003|STARTED|Overall Study||9
11214682|NCT01924767|12406021|FG004|STARTED|Overall Study||9
11214683|NCT01924767|12406017|FG000|COMPLETED|Overall Study||11
11214684|NCT01924767|12406018|FG001|COMPLETED|Overall Study||9
11214685|NCT01924767|12406019|FG002|COMPLETED|Overall Study||8
11214686|NCT01924767|12406020|FG003|COMPLETED|Overall Study||9
11214687|NCT01924767|12406021|FG004|COMPLETED|Overall Study||9
11214688|NCT01924767|12406017|FG000|NOT COMPLETED|Overall Study||1
11214689|NCT01924767|12406018|FG001|NOT COMPLETED|Overall Study||0
11214690|NCT01924767|12406019|FG002|NOT COMPLETED|Overall Study||1
11214691|NCT01924767|12406020|FG003|NOT COMPLETED|Overall Study||0
11214692|NCT01924767|12406021|FG004|NOT COMPLETED|Overall Study||0
11214693|NCT01924806|12406040|FG000|STARTED|Overall Study||5
11214694|NCT01924806|12406041|FG001|STARTED|Overall Study||4
11214695|NCT01924806|12406040|FG000|COMPLETED|Overall Study||3
11214696|NCT01924806|12406041|FG001|COMPLETED|Overall Study||3
11214697|NCT01924806|12406040|FG000|NOT COMPLETED|Overall Study||2
11214698|NCT01924806|12406041|FG001|NOT COMPLETED|Overall Study||1
11214699|NCT01924845|12406047|FG000|STARTED|Overall Study||24
11214700|NCT01924845|12406047|FG000|COMPLETED|Overall Study||18
11214701|NCT01924845|12406047|FG000|NOT COMPLETED|Overall Study||6
11214702|NCT01924871|12406053|FG000|STARTED|Overall Study||31
11214703|NCT01924871|12406054|FG001|STARTED|Overall Study||31
11214704|NCT01924871|12406053|FG000|COMPLETED|Overall Study||25
11214705|NCT01924871|12406054|FG001|COMPLETED|Overall Study||29
11214706|NCT01924871|12406053|FG000|NOT COMPLETED|Overall Study||6
11214707|NCT01924871|12406054|FG001|NOT COMPLETED|Overall Study||2
11097582|NCT01212757|12281286|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
11097583|NCT01212757|12281287|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
11097584|NCT01212757|12281288|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
11097585|NCT01212757|12281289|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
11097586|NCT01212757|12281281|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
11097587|NCT01212757|12281282|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
11097588|NCT01212757|12281283|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
11214708|NCT01924949|12406060|FG000|STARTED|Overall Study||5
11214709|NCT01924949|12406060|FG000|COMPLETED|Overall Study||5
11097589|NCT01212757|12281284|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
11097590|NCT01212757|12281285|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
11097591|NCT01212757|12281286|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
11097592|NCT01212757|12281287|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
11097593|NCT01212757|12281288|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
11097594|NCT01212757|12281289|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
11097595|NCT01212757|12281281|FG000|STARTED|Long-Term Safety Phase (Year 2)||0
11214710|NCT01924949|12406060|FG000|NOT COMPLETED|Overall Study||0
11214711|NCT01924975|12406066|FG000|STARTED|Overall Study||51
11214712|NCT01924975|12406067|FG001|STARTED|Overall Study||51
11214713|NCT01924975|12406066|FG000|COMPLETED|Overall Study||51
11214714|NCT01924975|12406067|FG001|COMPLETED|Overall Study||51
11214715|NCT01924975|12406066|FG000|NOT COMPLETED|Overall Study||0
11214716|NCT01924975|12406067|FG001|NOT COMPLETED|Overall Study||0
11214717|NCT01924988|12406073|FG000|STARTED|Overall Study||15
11214718|NCT01924988|12406073|FG000|COMPLETED|Overall Study||15
11214719|NCT01924988|12406073|FG000|NOT COMPLETED|Overall Study||0
11214720|NCT01925014|12406082|FG000|STARTED|Overall Study||1535
11214721|NCT01925014|12406083|FG001|STARTED|Overall Study||1539
11214722|NCT01925014|12406082|FG000|COMPLETED|Overall Study||1526
11214723|NCT01925014|12406083|FG001|COMPLETED|Overall Study||1520
11214724|NCT01925014|12406082|FG000|NOT COMPLETED|Overall Study||9
11214725|NCT01925014|12406083|FG001|NOT COMPLETED|Overall Study||19
11214726|NCT01925144|12406089|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
11214727|NCT01925144|12406089|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
11214728|NCT01925144|12406089|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
11214729|NCT01925144|12406089|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
11214730|NCT01925144|12406089|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
11214731|NCT01925144|12406089|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
11214732|NCT01925144|12406089|FG000|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
11214733|NCT01925144|12406089|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
11214734|NCT01925144|12406089|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
11214735|NCT01925170|12406096|FG000|STARTED|Overall Study||1638
11214736|NCT01925170|12406096|FG000|COMPLETED|Overall Study||1585
11214737|NCT01925170|12406096|FG000|NOT COMPLETED|Overall Study||53
11214738|NCT01925183|12406104|FG000|STARTED|Overall Study||3
11214739|NCT01925183|12406105|FG001|STARTED|Overall Study||3
11214740|NCT01925183|12406104|FG000|COMPLETED|Overall Study||2
11214741|NCT01925183|12406105|FG001|COMPLETED|Overall Study||3
11214742|NCT01925183|12406104|FG000|NOT COMPLETED|Overall Study||1
11214743|NCT01925183|12406105|FG001|NOT COMPLETED|Overall Study||0
11214744|NCT01925209|12406115|FG000|STARTED|Treatment Epoch||63
11214745|NCT01925209|12406116|FG001|STARTED|Treatment Epoch||63
11214746|NCT01925209|12406117|FG002|STARTED|Treatment Epoch||63
11214747|NCT01925209|12406118|FG003|STARTED|Treatment Epoch||62
11214748|NCT01925209|12406115|FG000|Full Analysis Set|Treatment Epoch||63
11214749|NCT01925209|12406116|FG001|Full Analysis Set|Treatment Epoch||63
11214750|NCT01925209|12406117|FG002|Full Analysis Set|Treatment Epoch||63
11214751|NCT01925209|12406118|FG003|Full Analysis Set|Treatment Epoch||62
11214752|NCT01925209|12406115|FG000|COMPLETED|Treatment Epoch||54
11214753|NCT01925209|12406116|FG001|COMPLETED|Treatment Epoch||55
11214754|NCT01925209|12406117|FG002|COMPLETED|Treatment Epoch||56
11214755|NCT01925209|12406118|FG003|COMPLETED|Treatment Epoch||57
11214756|NCT01925209|12406115|FG000|NOT COMPLETED|Treatment Epoch||9
11214757|NCT01925209|12406116|FG001|NOT COMPLETED|Treatment Epoch||8
11214758|NCT01925209|12406117|FG002|NOT COMPLETED|Treatment Epoch||7
11214759|NCT01925209|12406118|FG003|NOT COMPLETED|Treatment Epoch||5
11214760|NCT01925209|12406115|FG000|STARTED|Maintenance Treatment Epoch||49
11214761|NCT01925209|12406116|FG001|STARTED|Maintenance Treatment Epoch||46
11214762|NCT01925209|12406117|FG002|STARTED|Maintenance Treatment Epoch||52
11214763|NCT01925209|12406118|FG003|STARTED|Maintenance Treatment Epoch||50
11214764|NCT01925209|12406115|FG000|COMPLETED|Maintenance Treatment Epoch||49
11214765|NCT01925209|12406116|FG001|COMPLETED|Maintenance Treatment Epoch||45
11214766|NCT01925209|12406117|FG002|COMPLETED|Maintenance Treatment Epoch||50
11214767|NCT01925209|12406118|FG003|COMPLETED|Maintenance Treatment Epoch||48
11214768|NCT01925209|12406115|FG000|NOT COMPLETED|Maintenance Treatment Epoch||0
11214769|NCT01925209|12406116|FG001|NOT COMPLETED|Maintenance Treatment Epoch||1
11214770|NCT01925209|12406117|FG002|NOT COMPLETED|Maintenance Treatment Epoch||2
11214771|NCT01925209|12406118|FG003|NOT COMPLETED|Maintenance Treatment Epoch||2
11214772|NCT01925209|12406115|FG000|STARTED|Follow-up||57
11214773|NCT01925209|12406116|FG001|STARTED|Follow-up||61
11214774|NCT01925209|12406117|FG002|STARTED|Follow-up||56
11214775|NCT01925209|12406118|FG003|STARTED|Follow-up||58
11214776|NCT01925209|12406115|FG000|COMPLETED|Follow-up||56
11214777|NCT01925209|12406116|FG001|COMPLETED|Follow-up||55
11214778|NCT01925209|12406117|FG002|COMPLETED|Follow-up||55
11214779|NCT01925209|12406118|FG003|COMPLETED|Follow-up||54
11214780|NCT01925209|12406115|FG000|NOT COMPLETED|Follow-up||1
11214781|NCT01925209|12406116|FG001|NOT COMPLETED|Follow-up||6
11214782|NCT01925209|12406117|FG002|NOT COMPLETED|Follow-up||1
11214783|NCT01925209|12406118|FG003|NOT COMPLETED|Follow-up||4
11214784|NCT01925274|12406131|FG000|STARTED|Overall Study||7
11214785|NCT01925274|12406132|FG001|STARTED|Overall Study||6
11214786|NCT01925274|12406133|FG002|STARTED|Overall Study||6
11214787|NCT01925274|12406131|FG000|COMPLETED|Overall Study||0
11214788|NCT01925274|12406132|FG001|COMPLETED|Overall Study||0
11214789|NCT01925274|12406133|FG002|COMPLETED|Overall Study||0
11214790|NCT01925274|12406131|FG000|NOT COMPLETED|Overall Study||7
11214791|NCT01925274|12406132|FG001|NOT COMPLETED|Overall Study||6
11214792|NCT01925274|12406133|FG002|NOT COMPLETED|Overall Study||6
11214793|NCT01925339|12406145|FG000|STARTED|Overall Study||20
11214794|NCT01925339|12406146|FG001|STARTED|Overall Study||20
11214795|NCT01925339|12406145|FG000|COMPLETED|Overall Study||18
11214796|NCT01925339|12406146|FG001|COMPLETED|Overall Study||20
11214797|NCT01925339|12406145|FG000|NOT COMPLETED|Overall Study||2
11214798|NCT01925339|12406146|FG001|NOT COMPLETED|Overall Study||0
11214799|NCT01925404|12406156|FG000|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|
11214800|NCT01925404|12406157|FG001|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
11214801|NCT01925404|12406158|FG002|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
11214802|NCT01925404|12406159|FG003|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
11214803|NCT01925404|12406156|FG000|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
11214804|NCT01925404|12406157|FG001|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
11214805|NCT01925404|12406158|FG002|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
11214806|NCT01925404|12406159|FG003|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
11214807|NCT01925404|12406156|FG000|NOT COMPLETED|Overall Study||
11214808|NCT01925404|12406157|FG001|NOT COMPLETED|Overall Study||
11214809|NCT01925404|12406158|FG002|NOT COMPLETED|Overall Study||
11214810|NCT01925404|12406159|FG003|NOT COMPLETED|Overall Study||
11214811|NCT01925417|12406169|FG000|STARTED|Overall Study||34
11214812|NCT01925417|12406169|FG000|COMPLETED|Overall Study||31
11214813|NCT01925417|12406169|FG000|NOT COMPLETED|Overall Study||3
11353004|NCT03053050|12550125|FG002|STARTED|Randomized Phase||161
11353005|NCT03053050|12550126|FG003|STARTED|Randomized Phase||0
11353006|NCT03053050|12550123|FG000|COMPLETED|Randomized Phase||0
11353007|NCT03053050|12550124|FG001|COMPLETED|Randomized Phase||0
11353008|NCT03053050|12550125|FG002|COMPLETED|Randomized Phase||0
11097596|NCT01212757|12281282|FG001|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
11097597|NCT01212757|12281283|FG002|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
11353009|NCT03053050|12550126|FG003|COMPLETED|Randomized Phase||0
11353010|NCT03053050|12550123|FG000|NOT COMPLETED|Randomized Phase||324
11353011|NCT03053050|12550124|FG001|NOT COMPLETED|Randomized Phase||323
11353012|NCT03053050|12550125|FG002|NOT COMPLETED|Randomized Phase||161
11353013|NCT03053050|12550126|FG003|NOT COMPLETED|Randomized Phase||0
11353014|NCT03053050|12550123|FG000|STARTED|Open-label Phase||0
11353015|NCT03053050|12550124|FG001|STARTED|Open-label Phase||0
11353016|NCT03053050|12550125|FG002|STARTED|Open-label Phase||0
11353017|NCT03053050|12550126|FG003|STARTED|Open-label Phase|Participants with hepatic clinical event or progression to cirrhosis had option to go into OL Phase.|99
11353018|NCT03053050|12550123|FG000|COMPLETED|Open-label Phase||0
11353019|NCT03053050|12550124|FG001|COMPLETED|Open-label Phase||0
11353020|NCT03053050|12550125|FG002|COMPLETED|Open-label Phase||0
11353021|NCT03053050|12550126|FG003|COMPLETED|Open-label Phase||0
11353022|NCT03053050|12550123|FG000|NOT COMPLETED|Open-label Phase||0
11353023|NCT03053050|12550124|FG001|NOT COMPLETED|Open-label Phase||0
11353024|NCT03053050|12550125|FG002|NOT COMPLETED|Open-label Phase||0
11353025|NCT03053050|12550126|FG003|NOT COMPLETED|Open-label Phase||99
11353026|NCT03053063|12550138|FG000|STARTED|Randomized Phase||355
11353027|NCT03053063|12550139|FG001|STARTED|Randomized Phase||354
11353028|NCT03053063|12550140|FG002|STARTED|Randomized Phase||174
11353029|NCT03053063|12550141|FG003|STARTED|Randomized Phase||0
11353030|NCT03053063|12550138|FG000|COMPLETED|Randomized Phase||0
11353031|NCT03053063|12550139|FG001|COMPLETED|Randomized Phase||0
11353032|NCT03053063|12550140|FG002|COMPLETED|Randomized Phase||0
11353033|NCT03053063|12550141|FG003|COMPLETED|Randomized Phase||0
11353034|NCT03053063|12550138|FG000|NOT COMPLETED|Randomized Phase||355
11353035|NCT03053063|12550139|FG001|NOT COMPLETED|Randomized Phase||354
11353036|NCT03053063|12550140|FG002|NOT COMPLETED|Randomized Phase||174
11353037|NCT03053063|12550141|FG003|NOT COMPLETED|Randomized Phase||0
11353038|NCT03053063|12550138|FG000|STARTED|Open-Label Phase||0
11353039|NCT03053063|12550139|FG001|STARTED|Open-Label Phase||0
11353040|NCT03053063|12550140|FG002|STARTED|Open-Label Phase||0
11353041|NCT03053063|12550141|FG003|STARTED|Open-Label Phase|Participants who experienced a hepatic clinical event had the option to roll over into the OL Phase.|23
11097598|NCT01212757|12281284|FG003|STARTED|Long-Term Safety Phase (Year 2)||0
11097599|NCT01212757|12281285|FG004|STARTED|Long-Term Safety Phase (Year 2)||0
11097600|NCT01212757|12281286|FG005|STARTED|Long-Term Safety Phase (Year 2)||0
11097601|NCT01212757|12281287|FG006|STARTED|Long-Term Safety Phase (Year 2)||0
11097602|NCT01212757|12281288|FG007|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
11097603|NCT01212757|12281289|FG008|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
11097604|NCT01212757|12281281|FG000|COMPLETED|Long-Term Safety Phase (Year 2)||0
11097605|NCT01212757|12281282|FG001|COMPLETED|Long-Term Safety Phase (Year 2)||107
11214814|NCT01925469|12406176|FG000|STARTED|Overall Study||15
11214815|NCT01925469|12406177|FG001|STARTED|Overall Study||15
11214816|NCT01925469|12406176|FG000|COMPLETED|Overall Study||14
11214817|NCT01925469|12406177|FG001|COMPLETED|Overall Study||15
11214818|NCT01925469|12406176|FG000|NOT COMPLETED|Overall Study||1
11214819|NCT01925469|12406177|FG001|NOT COMPLETED|Overall Study||0
11214820|NCT01925612|12406188|FG000|STARTED|Overall Study||29
11214821|NCT01925612|12406189|FG001|STARTED|Overall Study||22
11214822|NCT01925612|12406190|FG002|STARTED|Overall Study||11
11214823|NCT01925612|12406191|FG003|STARTED|Overall Study||11
11214824|NCT01925612|12406192|FG004|STARTED|Overall Study||12
11214825|NCT01925612|12406188|FG000|COMPLETED|Overall Study||25
11214826|NCT01925612|12406189|FG001|COMPLETED|Overall Study||18
11214827|NCT01925612|12406190|FG002|COMPLETED|Overall Study||10
11214828|NCT01925612|12406191|FG003|COMPLETED|Overall Study||10
11214829|NCT01925612|12406192|FG004|COMPLETED|Overall Study||10
11214830|NCT01925612|12406188|FG000|NOT COMPLETED|Overall Study||4
11214831|NCT01925612|12406189|FG001|NOT COMPLETED|Overall Study||4
11214832|NCT01925612|12406190|FG002|NOT COMPLETED|Overall Study||1
11214833|NCT01925612|12406191|FG003|NOT COMPLETED|Overall Study||1
11214834|NCT01925612|12406192|FG004|NOT COMPLETED|Overall Study||2
11214835|NCT01925677|12406204|FG000|STARTED|Overall Study||3
11214836|NCT01925677|12406204|FG000|COMPLETED|Overall Study||3
11214837|NCT01925677|12406204|FG000|NOT COMPLETED|Overall Study||0
11214838|NCT01925703|12406208|FG000|STARTED|Overall Study||13
11214839|NCT01925703|12406208|FG000|Dosing Regimen Completed|Overall Study||12
11214840|NCT01925703|12406208|FG000|Full Iron Repletion Achieved|Overall Study||11
11214841|NCT01925703|12406208|FG000|Follow-up Completed|Overall Study||9
11214842|NCT01925703|12406208|FG000|COMPLETED|Overall Study||9
11214843|NCT01925703|12406208|FG000|NOT COMPLETED|Overall Study||4
11214844|NCT01925768|12406214|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||109
11214845|NCT01925768|12406215|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||110
11214846|NCT01925768|12406214|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
11214847|NCT01925768|12406215|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
11214848|NCT01925768|12406214|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101
11214849|NCT01925768|12406215|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91
11214850|NCT01925768|12406214|FG000|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35
11214851|NCT01925768|12406215|FG001|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13
11214852|NCT01925768|12406214|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98
11214853|NCT01925768|12406215|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87
11214854|NCT01925768|12406214|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11
11214855|NCT01925768|12406215|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
11214856|NCT01925768|12406214|FG000|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95
11214857|NCT01925768|12406215|FG001|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85
11214858|NCT01925768|12406214|FG000|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75
11214859|NCT01925768|12406215|FG001|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67
11214860|NCT01925768|12406214|FG000|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20
11214861|NCT01925768|12406215|FG001|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18
11214862|NCT01925781|12406227|FG000|STARTED|Overall Study||5
11214863|NCT01925781|12406228|FG001|STARTED|Overall Study||5
11214864|NCT01925781|12406227|FG000|COMPLETED|Overall Study||3
11214865|NCT01925781|12406228|FG001|COMPLETED|Overall Study||1
11214866|NCT01925781|12406227|FG000|NOT COMPLETED|Overall Study||2
11214867|NCT01925781|12406228|FG001|NOT COMPLETED|Overall Study||4
11214868|NCT01925950|12406236|FG000|STARTED|Part 1||1
11214869|NCT01925950|12406237|FG001|STARTED|Part 1||1
11214870|NCT01925950|12406236|FG000|COMPLETED|Part 1||1
11214871|NCT01925950|12406237|FG001|COMPLETED|Part 1||1
11214872|NCT01925950|12406236|FG000|NOT COMPLETED|Part 1||0
11214873|NCT01925950|12406237|FG001|NOT COMPLETED|Part 1||0
11214874|NCT01925950|12406236|FG000|STARTED|Part 2||1
11214875|NCT01925950|12406237|FG001|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
11214876|NCT01925950|12406236|FG000|COMPLETED|Part 2||0
11214877|NCT01925950|12406237|FG001|COMPLETED|Part 2||0
11214878|NCT01925950|12406236|FG000|NOT COMPLETED|Part 2||1
11214879|NCT01925950|12406237|FG001|NOT COMPLETED|Part 2||0
11214880|NCT01925989|12406245|FG000|STARTED|Period 1||7
11214881|NCT01925989|12406246|FG001|STARTED|Period 1||8
11214882|NCT01925989|12406247|FG002|STARTED|Period 1||12
11214883|NCT01925989|12406245|FG000|Received at Least 1 Dose of Study Drug|Period 1||7
11214884|NCT01925989|12406246|FG001|Received at Least 1 Dose of Study Drug|Period 1||8
11214885|NCT01925989|12406247|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
11214886|NCT01925989|12406245|FG000|COMPLETED|Period 1||6
11214887|NCT01925989|12406246|FG001|COMPLETED|Period 1||6
11214888|NCT01925989|12406247|FG002|COMPLETED|Period 1||12
11214889|NCT01925989|12406245|FG000|NOT COMPLETED|Period 1||1
11214890|NCT01925989|12406246|FG001|NOT COMPLETED|Period 1||2
11214891|NCT01925989|12406247|FG002|NOT COMPLETED|Period 1||0
11214892|NCT01925989|12406245|FG000|STARTED|Period 2||6
11214893|NCT01925989|12406246|FG001|STARTED|Period 2||6
11214894|NCT01925989|12406247|FG002|STARTED|Period 2||12
11214895|NCT01925989|12406245|FG000|COMPLETED|Period 2||6
11214896|NCT01925989|12406246|FG001|COMPLETED|Period 2||6
11214897|NCT01925989|12406247|FG002|COMPLETED|Period 2||12
11214898|NCT01925989|12406245|FG000|NOT COMPLETED|Period 2||0
11214899|NCT01925989|12406246|FG001|NOT COMPLETED|Period 2||0
11214900|NCT01925989|12406247|FG002|NOT COMPLETED|Period 2||0
11214901|NCT01926015|12406261|FG000|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
11214902|NCT01926015|12406262|FG001|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
11214903|NCT01926015|12406261|FG000|Received >=1 Vaccination|Overall Study||94
11214904|NCT01926015|12406262|FG001|Received >=1 Vaccination|Overall Study||96
11214905|NCT01926015|12406261|FG000|COMPLETED|Overall Study||94
11214906|NCT01926015|12406262|FG001|COMPLETED|Overall Study||95
11353042|NCT03053063|12550138|FG000|COMPLETED|Open-Label Phase||0
11353043|NCT03053063|12550139|FG001|COMPLETED|Open-Label Phase||0
11353044|NCT03053063|12550140|FG002|COMPLETED|Open-Label Phase||0
11353045|NCT03053063|12550141|FG003|COMPLETED|Open-Label Phase||0
11353046|NCT03053063|12550138|FG000|NOT COMPLETED|Open-Label Phase||0
11353047|NCT03053063|12550139|FG001|NOT COMPLETED|Open-Label Phase||0
11353048|NCT03053063|12550140|FG002|NOT COMPLETED|Open-Label Phase||0
11353049|NCT03053063|12550141|FG003|NOT COMPLETED|Open-Label Phase||23
11353050|NCT03053180|12550150|FG000|STARTED|Overall Study||60
11353051|NCT03053180|12550150|FG000|COMPLETED|Overall Study||59
11353052|NCT03053180|12550150|FG000|NOT COMPLETED|Overall Study||1
11353053|NCT03053271|12550154|FG000|STARTED|Overall Study||4
11353054|NCT03053271|12550154|FG000|COMPLETED|Overall Study|All completed the open-label dose escalation, but did not meet criteria for randomization|0
11353055|NCT03053271|12550154|FG000|NOT COMPLETED|Overall Study||4
11353056|NCT03053401|12550160|FG000|STARTED|Overall Study||26
11353057|NCT03053401|12550161|FG001|STARTED|Overall Study||26
11353058|NCT03053401|12550160|FG000|COMPLETED|Overall Study||26
11353059|NCT03053401|12550161|FG001|COMPLETED|Overall Study||26
11353060|NCT03053401|12550160|FG000|NOT COMPLETED|Overall Study||0
11353061|NCT03053401|12550161|FG001|NOT COMPLETED|Overall Study||0
11353062|NCT03053427|12550170|FG000|STARTED|Overall Study||186
11353063|NCT03053427|12550171|FG001|STARTED|Overall Study||189
11353064|NCT03053427|12550170|FG000|COMPLETED|Overall Study||173
11214907|NCT01926015|12406261|FG000|NOT COMPLETED|Overall Study||2
11214908|NCT01926015|12406262|FG001|NOT COMPLETED|Overall Study||1
11214909|NCT01926028|12406271|FG000|STARTED|Overall Study||85
11214910|NCT01926028|12406272|FG001|STARTED|Overall Study||89
11214911|NCT01926028|12406273|FG002|STARTED|Overall Study||14
11214912|NCT01926028|12406271|FG000|COMPLETED|Overall Study||64
11214913|NCT01926028|12406272|FG001|COMPLETED|Overall Study||67
11214914|NCT01926028|12406273|FG002|COMPLETED|Overall Study||12
11214915|NCT01926028|12406271|FG000|NOT COMPLETED|Overall Study||21
11214916|NCT01926028|12406272|FG001|NOT COMPLETED|Overall Study||22
11214917|NCT01926028|12406273|FG002|NOT COMPLETED|Overall Study||2
11214918|NCT01926119|12406282|FG000|STARTED|Overall Study||4
11214919|NCT01926119|12406282|FG000|COMPLETED|Overall Study||3
11214920|NCT01926119|12406282|FG000|NOT COMPLETED|Overall Study||1
11214921|NCT01926444|12406290|FG000|STARTED|Overall Study||56
11214922|NCT01926444|12406291|FG001|STARTED|Overall Study||52
11214923|NCT01926444|12406292|FG002|STARTED|Overall Study||57
11214924|NCT01926444|12406293|FG003|STARTED|Overall Study||103
11214925|NCT01926444|12406290|FG000|COMPLETED|Overall Study||56
11214926|NCT01926444|12406291|FG001|COMPLETED|Overall Study||52
11214927|NCT01926444|12406292|FG002|COMPLETED|Overall Study||53
11214928|NCT01926444|12406293|FG003|COMPLETED|Overall Study||101
11214929|NCT01926444|12406290|FG000|NOT COMPLETED|Overall Study||0
11214930|NCT01926444|12406291|FG001|NOT COMPLETED|Overall Study||0
11214931|NCT01926444|12406292|FG002|NOT COMPLETED|Overall Study||4
11214932|NCT01926444|12406293|FG003|NOT COMPLETED|Overall Study||2
11097606|NCT01212757|12281283|FG002|COMPLETED|Long-Term Safety Phase (Year 2)||95
11097607|NCT01212757|12281284|FG003|COMPLETED|Long-Term Safety Phase (Year 2)||0
11097608|NCT01212757|12281285|FG004|COMPLETED|Long-Term Safety Phase (Year 2)||0
11097609|NCT01212757|12281286|FG005|COMPLETED|Long-Term Safety Phase (Year 2)||0
11097610|NCT01212757|12281287|FG006|COMPLETED|Long-Term Safety Phase (Year 2)||0
11214933|NCT01926496|12406305|FG000|STARTED|Overall Study||240
11214934|NCT01926496|12406306|FG001|STARTED|Overall Study||245
11214935|NCT01926496|12406305|FG000|COMPLETED|Overall Study||203
11214936|NCT01926496|12406306|FG001|COMPLETED|Overall Study||197
11214937|NCT01926496|12406305|FG000|NOT COMPLETED|Overall Study||37
11214938|NCT01926496|12406306|FG001|NOT COMPLETED|Overall Study||48
11214939|NCT01926509|12406320|FG000|STARTED|Overall Study||6
11214940|NCT01926509|12406321|FG001|STARTED|Overall Study||6
11214941|NCT01926509|12406322|FG002|STARTED|Overall Study||5
11214942|NCT01926509|12406323|FG003|STARTED|Overall Study||6
11214943|NCT01926509|12406320|FG000|COMPLETED|Overall Study||5
11214944|NCT01926509|12406321|FG001|COMPLETED|Overall Study||6
11214945|NCT01926509|12406322|FG002|COMPLETED|Overall Study||5
11214946|NCT01926509|12406323|FG003|COMPLETED|Overall Study||6
11214947|NCT01926509|12406320|FG000|NOT COMPLETED|Overall Study||1
11214948|NCT01926509|12406321|FG001|NOT COMPLETED|Overall Study||0
11214949|NCT01926509|12406322|FG002|NOT COMPLETED|Overall Study||0
11214950|NCT01926509|12406323|FG003|NOT COMPLETED|Overall Study||0
11214951|NCT01926626|12406333|FG000|STARTED|Overall Study||38
11214952|NCT01926626|12406333|FG000|Received Moclobemide|Overall Study||37
11214953|NCT01926626|12406333|FG000|COMPLETED|Overall Study||16
11214954|NCT01926626|12406333|FG000|NOT COMPLETED|Overall Study||22
11214955|NCT01926782|12406343|FG000|STARTED|Overall Study||157
11214956|NCT01926782|12406344|FG001|STARTED|Overall Study||78
11214957|NCT01926782|12406345|FG002|STARTED|Overall Study||312
11214958|NCT01926782|12406346|FG003|STARTED|Overall Study||73
11214959|NCT01926782|12406347|FG004|STARTED|Overall Study||37
11214960|NCT01926782|12406348|FG005|STARTED|Overall Study||146
11214961|NCT01926782|12406343|FG000|Treated|Overall Study||157
11214962|NCT01926782|12406344|FG001|Treated|Overall Study||78
11214963|NCT01926782|12406345|FG002|Treated|Overall Study||312
11214964|NCT01926782|12406346|FG003|Treated|Overall Study||72
11214965|NCT01926782|12406347|FG004|Treated|Overall Study||37
11214966|NCT01926782|12406348|FG005|Treated|Overall Study||146
11214967|NCT01926782|12406343|FG000|Completed 24 Weeks Treatment Period|Overall Study||137
11214968|NCT01926782|12406344|FG001|Completed 24 Weeks Treatment Period|Overall Study||68
11214969|NCT01926782|12406345|FG002|Completed 24 Weeks Treatment Period|Overall Study||285
11214970|NCT01926782|12406346|FG003|Completed 24 Weeks Treatment Period|Overall Study||58
11214971|NCT01926782|12406347|FG004|Completed 24 Weeks Treatment Period|Overall Study||31
11214972|NCT01926782|12406348|FG005|Completed 24 Weeks Treatment Period|Overall Study||120
11214973|NCT01926782|12406343|FG000|COMPLETED|Overall Study||129
11214974|NCT01926782|12406344|FG001|COMPLETED|Overall Study||65
11214975|NCT01926782|12406345|FG002|COMPLETED|Overall Study||272
11214976|NCT01926782|12406346|FG003|COMPLETED|Overall Study||53
11214977|NCT01926782|12406347|FG004|COMPLETED|Overall Study||29
11214978|NCT01926782|12406348|FG005|COMPLETED|Overall Study||105
11214979|NCT01926782|12406343|FG000|NOT COMPLETED|Overall Study||28
11214980|NCT01926782|12406344|FG001|NOT COMPLETED|Overall Study||13
11214981|NCT01926782|12406345|FG002|NOT COMPLETED|Overall Study||40
11214982|NCT01926782|12406346|FG003|NOT COMPLETED|Overall Study||20
11214983|NCT01926782|12406347|FG004|NOT COMPLETED|Overall Study||8
11214984|NCT01926782|12406348|FG005|NOT COMPLETED|Overall Study||41
11214985|NCT01926886|12406363|FG000|STARTED|Overall Study||102
11214986|NCT01926886|12406364|FG001|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21
11214987|NCT01926886|12406363|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101
11214988|NCT01926886|12406364|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0
11214989|NCT01926886|12406363|FG000|COMPLETED|Overall Study||70
11214990|NCT01926886|12406364|FG001|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21
11214991|NCT01926886|12406363|FG000|NOT COMPLETED|Overall Study||32
11214992|NCT01926886|12406364|FG001|NOT COMPLETED|Overall Study||0
11214993|NCT01926977|12406372|FG000|STARTED|Overall Study||47
11214994|NCT01926977|12406373|FG001|STARTED|Overall Study||53
11214995|NCT01926977|12406372|FG000|COMPLETED|Overall Study||47
11214996|NCT01926977|12406373|FG001|COMPLETED|Overall Study||53
11214997|NCT01926977|12406372|FG000|NOT COMPLETED|Overall Study||0
11214998|NCT01926977|12406373|FG001|NOT COMPLETED|Overall Study||0
11214999|NCT01927055|12406382|FG000|STARTED|Open-label||61
11215000|NCT01927055|12406383|FG001|STARTED|Open-label||0
11215001|NCT01927055|12406384|FG002|STARTED|Open-label||0
11215002|NCT01927055|12406382|FG000|COMPLETED|Open-label||45
11215003|NCT01927055|12406383|FG001|COMPLETED|Open-label||0
11215004|NCT01927055|12406384|FG002|COMPLETED|Open-label||0
11215005|NCT01927055|12406382|FG000|NOT COMPLETED|Open-label||16
11215006|NCT01927055|12406383|FG001|NOT COMPLETED|Open-label||0
11215007|NCT01927055|12406384|FG002|NOT COMPLETED|Open-label||0
11215008|NCT01927055|12406382|FG000|STARTED|Double-Blind||0
11215009|NCT01927055|12406383|FG001|STARTED|Double-Blind||22
11215010|NCT01927055|12406384|FG002|STARTED|Double-Blind||23
11215011|NCT01927055|12406382|FG000|COMPLETED|Double-Blind||0
11215012|NCT01927055|12406383|FG001|COMPLETED|Double-Blind||11
11215013|NCT01927055|12406384|FG002|COMPLETED|Double-Blind||10
11215014|NCT01927055|12406382|FG000|NOT COMPLETED|Double-Blind||0
11215015|NCT01927055|12406383|FG001|NOT COMPLETED|Double-Blind||11
11215016|NCT01927055|12406384|FG002|NOT COMPLETED|Double-Blind||13
11215017|NCT01927120|12406391|FG000|STARTED|Overall Study||20
11215018|NCT01927120|12406391|FG000|COMPLETED|Overall Study||10
11215019|NCT01927120|12406391|FG000|NOT COMPLETED|Overall Study||10
11215020|NCT01927341|12406400|FG000|STARTED|Phase 1b||10
11215021|NCT01927341|12406401|FG001|STARTED|Phase 1b||0
11215022|NCT01927341|12406402|FG002|STARTED|Phase 1b||0
11215023|NCT01927341|12406403|FG003|STARTED|Phase 1b||0
11215024|NCT01927341|12406404|FG004|STARTED|Phase 1b||0
11215025|NCT01927341|12406400|FG000|COMPLETED|Phase 1b||0
11215026|NCT01927341|12406401|FG001|COMPLETED|Phase 1b||0
11215027|NCT01927341|12406402|FG002|COMPLETED|Phase 1b||0
11215028|NCT01927341|12406403|FG003|COMPLETED|Phase 1b||0
11215029|NCT01927341|12406404|FG004|COMPLETED|Phase 1b||0
11215030|NCT01927341|12406400|FG000|NOT COMPLETED|Phase 1b||10
11215031|NCT01927341|12406401|FG001|NOT COMPLETED|Phase 1b||0
11215032|NCT01927341|12406402|FG002|NOT COMPLETED|Phase 1b||0
11215033|NCT01927341|12406403|FG003|NOT COMPLETED|Phase 1b||0
11215034|NCT01927341|12406404|FG004|NOT COMPLETED|Phase 1b||0
11215035|NCT01927341|12406400|FG000|STARTED|Phase 2||0
11215036|NCT01927341|12406401|FG001|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
11215037|NCT01927341|12406402|FG002|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|5
11215038|NCT01927341|12406403|FG003|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
11215039|NCT01927341|12406404|FG004|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|8
11215040|NCT01927341|12406400|FG000|COMPLETED|Phase 2||0
11215041|NCT01927341|12406401|FG001|COMPLETED|Phase 2||0
11215042|NCT01927341|12406402|FG002|COMPLETED|Phase 2||0
11215043|NCT01927341|12406403|FG003|COMPLETED|Phase 2||0
11215044|NCT01927341|12406404|FG004|COMPLETED|Phase 2||0
11215045|NCT01927341|12406400|FG000|NOT COMPLETED|Phase 2||0
11215046|NCT01927341|12406401|FG001|NOT COMPLETED|Phase 2||15
11215047|NCT01927341|12406402|FG002|NOT COMPLETED|Phase 2||5
11215048|NCT01927341|12406403|FG003|NOT COMPLETED|Phase 2||15
11215049|NCT01927341|12406404|FG004|NOT COMPLETED|Phase 2||8
11215050|NCT01927367|12406422|FG000|STARTED|Overall Study||597
11215051|NCT01927367|12406423|FG001|STARTED|Overall Study||548
11215052|NCT01927367|12406422|FG000|COMPLETED|Overall Study||590
11215053|NCT01927367|12406423|FG001|COMPLETED|Overall Study||543
11215054|NCT01927367|12406422|FG000|NOT COMPLETED|Overall Study||7
11215055|NCT01927367|12406423|FG001|NOT COMPLETED|Overall Study||5
11215056|NCT01927497|12406431|FG000|STARTED|Overall Study||50
11215057|NCT01927497|12406432|FG001|STARTED|Overall Study||54
11215058|NCT01927497|12406431|FG000|COMPLETED|Overall Study||48
11215059|NCT01927497|12406432|FG001|COMPLETED|Overall Study||53
11215060|NCT01927497|12406431|FG000|NOT COMPLETED|Overall Study||2
11215061|NCT01927497|12406432|FG001|NOT COMPLETED|Overall Study||1
11215062|NCT01927562|12406438|FG000|STARTED|Overall Study||57
11215063|NCT01927562|12406438|FG000|COMPLETED|Overall Study|5 at M24, 2 at M30,12 at M36 due to two protocol changes moving followups from M24 to M30 to M36|19
11215064|NCT01927562|12406438|FG000|NOT COMPLETED|Overall Study||38
11215065|NCT01927575|12406442|FG000|STARTED|Overall Study||1
11215066|NCT01927575|12406442|FG000|COMPLETED|Overall Study||1
11215067|NCT01927575|12406442|FG000|NOT COMPLETED|Overall Study||0
11215068|NCT01927627|12406450|FG000|STARTED|Overall Study||42
11215069|NCT01927627|12406450|FG000|COMPLETED|Overall Study||37
11215070|NCT01927627|12406450|FG000|NOT COMPLETED|Overall Study||5
11215071|NCT01927718|12406454|FG000|STARTED|Overall Study||10
11215072|NCT01927718|12406454|FG000|COMPLETED|Overall Study||10
11215073|NCT01927718|12406454|FG000|NOT COMPLETED|Overall Study||0
11215074|NCT01927757|12406458|FG000|STARTED|Overall Study||90
11215075|NCT01927757|12406458|FG000|Received Etanercept|Overall Study||88
11215076|NCT01927757|12406458|FG000|COMPLETED|Overall Study||67
11215077|NCT01927757|12406458|FG000|NOT COMPLETED|Overall Study||23
11215078|NCT01927861|12406468|FG000|STARTED|Pivotal Phase (104 Weeks)||25
11215079|NCT01927861|12406469|FG001|STARTED|Pivotal Phase (104 Weeks)||26
11215080|NCT01927861|12406468|FG000|COMPLETED|Pivotal Phase (104 Weeks)||25
11215081|NCT01927861|12406469|FG001|COMPLETED|Pivotal Phase (104 Weeks)||26
11215082|NCT01927861|12406468|FG000|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
11215083|NCT01927861|12406469|FG001|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
11215084|NCT01927861|12406468|FG000|STARTED|Extension Phase (104 Weeks)||25
11215085|NCT01927861|12406469|FG001|STARTED|Extension Phase (104 Weeks)||26
11215086|NCT01927861|12406468|FG000|COMPLETED|Extension Phase (104 Weeks)||25
11215087|NCT01927861|12406469|FG001|COMPLETED|Extension Phase (104 Weeks)||23
11215088|NCT01927861|12406468|FG000|NOT COMPLETED|Extension Phase (104 Weeks)||0
11215089|NCT01927861|12406469|FG001|NOT COMPLETED|Extension Phase (104 Weeks)||3
11215090|NCT01927861|12406468|FG000|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15
11215091|NCT01927861|12406469|FG001|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14
11215092|NCT01927861|12406468|FG000|COMPLETED|Extended Treatment Phase (26 Weeks)||15
11097611|NCT01212757|12281288|FG007|COMPLETED|Long-Term Safety Phase (Year 2)||48
11097612|NCT01212757|12281289|FG008|COMPLETED|Long-Term Safety Phase (Year 2)||51
11097613|NCT01212757|12281281|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
11097614|NCT01212757|12281282|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
11097615|NCT01212757|12281283|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
11097616|NCT01212757|12281284|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
11215093|NCT01927861|12406469|FG001|COMPLETED|Extended Treatment Phase (26 Weeks)||14
11215094|NCT01927861|12406468|FG000|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
11215095|NCT01927861|12406469|FG001|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
11215096|NCT01927887|12406475|FG000|STARTED|Overall Study||12
11215097|NCT01927887|12406475|FG000|COMPLETED|Overall Study||12
11215098|NCT01927887|12406475|FG000|NOT COMPLETED|Overall Study||0
11215099|NCT01928030|12406480|FG000|STARTED|Overall Study||3
11215100|NCT01928030|12406481|FG001|STARTED|Overall Study||0
11215101|NCT01928030|12406482|FG002|STARTED|Overall Study||0
11215102|NCT01928030|12406480|FG000|COMPLETED|Overall Study||3
11215103|NCT01928030|12406481|FG001|COMPLETED|Overall Study||0
11215104|NCT01928030|12406482|FG002|COMPLETED|Overall Study||0
11215105|NCT01928030|12406480|FG000|NOT COMPLETED|Overall Study||0
11097617|NCT01212757|12281285|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
11097618|NCT01212757|12281286|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
11097619|NCT01212757|12281287|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
11097620|NCT01212757|12281288|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
11097621|NCT01212757|12281289|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
11215106|NCT01928030|12406481|FG001|NOT COMPLETED|Overall Study||0
11215107|NCT01928030|12406482|FG002|NOT COMPLETED|Overall Study||0
11215108|NCT01928186|12406489|FG000|STARTED|Overall Study||28
11215109|NCT01928186|12406489|FG000|COMPLETED|Overall Study||28
11215110|NCT01928186|12406489|FG000|NOT COMPLETED|Overall Study||0
11215111|NCT01928199|12406495|FG000|STARTED|Overall Study||32
11215112|NCT01928199|12406496|FG001|STARTED|Overall Study||29
11215113|NCT01928199|12406495|FG000|COMPLETED|Overall Study||32
11215114|NCT01928199|12406496|FG001|COMPLETED|Overall Study||29
11215115|NCT01928199|12406495|FG000|NOT COMPLETED|Overall Study||0
11215116|NCT01928199|12406496|FG001|NOT COMPLETED|Overall Study||0
11215117|NCT01928225|12406504|FG000|STARTED|Overall Study||90
11215118|NCT01928225|12406505|FG001|STARTED|Overall Study||90
11215119|NCT01928225|12406504|FG000|COMPLETED|Overall Study||87
11215120|NCT01928225|12406505|FG001|COMPLETED|Overall Study||87
11215121|NCT01928225|12406504|FG000|NOT COMPLETED|Overall Study||3
11215122|NCT01928225|12406505|FG001|NOT COMPLETED|Overall Study||3
11215123|NCT01928290|12406514|FG000|STARTED|Overall Study||41
11215124|NCT01928290|12406515|FG001|STARTED|Overall Study||26
11215125|NCT01928290|12406514|FG000|COMPLETED|Overall Study||41
11215126|NCT01928290|12406515|FG001|COMPLETED|Overall Study||26
11215127|NCT01928290|12406514|FG000|NOT COMPLETED|Overall Study||0
11215128|NCT01928290|12406515|FG001|NOT COMPLETED|Overall Study||0
11215129|NCT01928329|12406523|FG000|STARTED|Overall Study||40
11215130|NCT01928329|12406524|FG001|STARTED|Overall Study||39
11215131|NCT01928329|12406523|FG000|COMPLETED|Overall Study||28
11215132|NCT01928329|12406524|FG001|COMPLETED|Overall Study||25
11215133|NCT01928329|12406523|FG000|NOT COMPLETED|Overall Study||12
11215134|NCT01928329|12406524|FG001|NOT COMPLETED|Overall Study||14
11215135|NCT01928381|12406530|FG000|STARTED|Screening for Pain Training||143
11215136|NCT01928381|12406531|FG001|STARTED|Screening for Pain Training||0
11215137|NCT01928381|12406532|FG002|STARTED|Screening for Pain Training||0
11215138|NCT01928381|12406533|FG003|STARTED|Screening for Pain Training||0
11215139|NCT01928381|12406534|FG004|STARTED|Screening for Pain Training||0
11215140|NCT01928381|12406535|FG005|STARTED|Screening for Pain Training||0
11215141|NCT01928381|12406536|FG006|STARTED|Screening for Pain Training||0
11215142|NCT01928381|12406530|FG000|COMPLETED|Screening for Pain Training||83
11215143|NCT01928381|12406531|FG001|COMPLETED|Screening for Pain Training||0
11215144|NCT01928381|12406532|FG002|COMPLETED|Screening for Pain Training||0
11215145|NCT01928381|12406533|FG003|COMPLETED|Screening for Pain Training||0
11215146|NCT01928381|12406534|FG004|COMPLETED|Screening for Pain Training||0
11215147|NCT01928381|12406535|FG005|COMPLETED|Screening for Pain Training||0
11215148|NCT01928381|12406536|FG006|COMPLETED|Screening for Pain Training||0
11215149|NCT01928381|12406530|FG000|NOT COMPLETED|Screening for Pain Training||60
11215150|NCT01928381|12406531|FG001|NOT COMPLETED|Screening for Pain Training||0
11215151|NCT01928381|12406532|FG002|NOT COMPLETED|Screening for Pain Training||0
11215152|NCT01928381|12406533|FG003|NOT COMPLETED|Screening for Pain Training||0
11215153|NCT01928381|12406534|FG004|NOT COMPLETED|Screening for Pain Training||0
11215154|NCT01928381|12406535|FG005|NOT COMPLETED|Screening for Pain Training||0
11215155|NCT01928381|12406536|FG006|NOT COMPLETED|Screening for Pain Training||0
11215156|NCT01928381|12406530|FG000|STARTED|Part 1 - Pain Training||83
11215157|NCT01928381|12406531|FG001|STARTED|Part 1 - Pain Training||0
11215158|NCT01928381|12406532|FG002|STARTED|Part 1 - Pain Training||0
11215159|NCT01928381|12406533|FG003|STARTED|Part 1 - Pain Training||0
11215160|NCT01928381|12406534|FG004|STARTED|Part 1 - Pain Training||0
11215161|NCT01928381|12406535|FG005|STARTED|Part 1 - Pain Training||0
11215162|NCT01928381|12406536|FG006|STARTED|Part 1 - Pain Training||0
11215163|NCT01928381|12406530|FG000|COMPLETED|Part 1 - Pain Training||48
11215164|NCT01928381|12406531|FG001|COMPLETED|Part 1 - Pain Training||0
11215165|NCT01928381|12406532|FG002|COMPLETED|Part 1 - Pain Training||0
11215166|NCT01928381|12406533|FG003|COMPLETED|Part 1 - Pain Training||0
11215167|NCT01928381|12406534|FG004|COMPLETED|Part 1 - Pain Training||0
11215168|NCT01928381|12406535|FG005|COMPLETED|Part 1 - Pain Training||0
11215169|NCT01928381|12406536|FG006|COMPLETED|Part 1 - Pain Training||0
11215170|NCT01928381|12406530|FG000|NOT COMPLETED|Part 1 - Pain Training||35
11215171|NCT01928381|12406531|FG001|NOT COMPLETED|Part 1 - Pain Training||0
11215172|NCT01928381|12406532|FG002|NOT COMPLETED|Part 1 - Pain Training||0
11215173|NCT01928381|12406533|FG003|NOT COMPLETED|Part 1 - Pain Training||0
11215174|NCT01928381|12406534|FG004|NOT COMPLETED|Part 1 - Pain Training||0
11215175|NCT01928381|12406535|FG005|NOT COMPLETED|Part 1 - Pain Training||0
11215176|NCT01928381|12406536|FG006|NOT COMPLETED|Part 1 - Pain Training||0
11215177|NCT01928381|12406530|FG000|STARTED|Placebo run-in & Part 2 Eligibility||48
11215178|NCT01928381|12406531|FG001|STARTED|Placebo run-in & Part 2 Eligibility||0
11215179|NCT01928381|12406532|FG002|STARTED|Placebo run-in & Part 2 Eligibility||0
11215180|NCT01928381|12406533|FG003|STARTED|Placebo run-in & Part 2 Eligibility||0
11215181|NCT01928381|12406534|FG004|STARTED|Placebo run-in & Part 2 Eligibility||0
11215182|NCT01928381|12406535|FG005|STARTED|Placebo run-in & Part 2 Eligibility||0
11215183|NCT01928381|12406536|FG006|STARTED|Placebo run-in & Part 2 Eligibility||0
11215184|NCT01928381|12406530|FG000|COMPLETED|Placebo run-in & Part 2 Eligibility||34
11215185|NCT01928381|12406531|FG001|COMPLETED|Placebo run-in & Part 2 Eligibility||0
11215186|NCT01928381|12406532|FG002|COMPLETED|Placebo run-in & Part 2 Eligibility||0
11215187|NCT01928381|12406533|FG003|COMPLETED|Placebo run-in & Part 2 Eligibility||0
11215188|NCT01928381|12406534|FG004|COMPLETED|Placebo run-in & Part 2 Eligibility||0
11215189|NCT01928381|12406535|FG005|COMPLETED|Placebo run-in & Part 2 Eligibility||0
11215190|NCT01928381|12406536|FG006|COMPLETED|Placebo run-in & Part 2 Eligibility||0
11215191|NCT01928381|12406530|FG000|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
11215192|NCT01928381|12406531|FG001|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
11215193|NCT01928381|12406532|FG002|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
11215194|NCT01928381|12406533|FG003|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
11215195|NCT01928381|12406534|FG004|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
11215196|NCT01928381|12406535|FG005|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
11215197|NCT01928381|12406536|FG006|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
11215198|NCT01928381|12406530|FG000|STARTED|Part 2 - First Intervention||0
11215199|NCT01928381|12406531|FG001|STARTED|Part 2 - First Intervention||6
11215200|NCT01928381|12406532|FG002|STARTED|Part 2 - First Intervention||6
11215201|NCT01928381|12406533|FG003|STARTED|Part 2 - First Intervention||6
11215202|NCT01928381|12406534|FG004|STARTED|Part 2 - First Intervention||4
11215203|NCT01928381|12406535|FG005|STARTED|Part 2 - First Intervention||6
11215204|NCT01928381|12406536|FG006|STARTED|Part 2 - First Intervention||6
11215205|NCT01928381|12406530|FG000|COMPLETED|Part 2 - First Intervention||0
11215206|NCT01928381|12406531|FG001|COMPLETED|Part 2 - First Intervention||6
11215207|NCT01928381|12406532|FG002|COMPLETED|Part 2 - First Intervention||4
11215208|NCT01928381|12406533|FG003|COMPLETED|Part 2 - First Intervention||5
11215209|NCT01928381|12406534|FG004|COMPLETED|Part 2 - First Intervention||4
11215210|NCT01928381|12406535|FG005|COMPLETED|Part 2 - First Intervention||5
11215211|NCT01928381|12406536|FG006|COMPLETED|Part 2 - First Intervention||5
11215212|NCT01928381|12406530|FG000|NOT COMPLETED|Part 2 - First Intervention||0
11215213|NCT01928381|12406531|FG001|NOT COMPLETED|Part 2 - First Intervention||0
11215214|NCT01928381|12406532|FG002|NOT COMPLETED|Part 2 - First Intervention||2
11215215|NCT01928381|12406533|FG003|NOT COMPLETED|Part 2 - First Intervention||1
11215216|NCT01928381|12406534|FG004|NOT COMPLETED|Part 2 - First Intervention||0
11215217|NCT01928381|12406535|FG005|NOT COMPLETED|Part 2 - First Intervention||1
11215218|NCT01928381|12406536|FG006|NOT COMPLETED|Part 2 - First Intervention||1
11215219|NCT01928381|12406530|FG000|STARTED|Washout First Intervention||0
11215220|NCT01928381|12406531|FG001|STARTED|Washout First Intervention||6
11215221|NCT01928381|12406532|FG002|STARTED|Washout First Intervention||4
11215222|NCT01928381|12406533|FG003|STARTED|Washout First Intervention||5
11215223|NCT01928381|12406534|FG004|STARTED|Washout First Intervention||4
11215224|NCT01928381|12406535|FG005|STARTED|Washout First Intervention||5
11215225|NCT01928381|12406536|FG006|STARTED|Washout First Intervention||5
11353065|NCT03053427|12550171|FG001|COMPLETED|Overall Study||173
11353066|NCT03053427|12550170|FG000|NOT COMPLETED|Overall Study||13
11353067|NCT03053427|12550171|FG001|NOT COMPLETED|Overall Study||16
11353068|NCT03053492|12550179|FG000|STARTED|Overall Study||33
11353069|NCT03053492|12550180|FG001|STARTED|Overall Study||33
11353070|NCT03053492|12550179|FG000|COMPLETED|Overall Study||25
11353071|NCT03053492|12550180|FG001|COMPLETED|Overall Study||27
11353072|NCT03053492|12550179|FG000|NOT COMPLETED|Overall Study||8
11353073|NCT03053492|12550180|FG001|NOT COMPLETED|Overall Study||6
11353074|NCT03054051|12550188|FG000|STARTED|Overall Study||30
11353075|NCT03054051|12550189|FG001|STARTED|Overall Study||30
11353076|NCT03054051|12550188|FG000|COMPLETED|Overall Study||30
11353077|NCT03054051|12550189|FG001|COMPLETED|Overall Study||30
11215226|NCT01928381|12406530|FG000|COMPLETED|Washout First Intervention||0
11215227|NCT01928381|12406531|FG001|COMPLETED|Washout First Intervention||6
11215228|NCT01928381|12406532|FG002|COMPLETED|Washout First Intervention||4
11215229|NCT01928381|12406533|FG003|COMPLETED|Washout First Intervention||5
11215230|NCT01928381|12406534|FG004|COMPLETED|Washout First Intervention||3
11215231|NCT01928381|12406535|FG005|COMPLETED|Washout First Intervention||5
11215232|NCT01928381|12406536|FG006|COMPLETED|Washout First Intervention||5
11215233|NCT01928381|12406530|FG000|NOT COMPLETED|Washout First Intervention||0
11215234|NCT01928381|12406531|FG001|NOT COMPLETED|Washout First Intervention||0
11215235|NCT01928381|12406532|FG002|NOT COMPLETED|Washout First Intervention||0
11215236|NCT01928381|12406533|FG003|NOT COMPLETED|Washout First Intervention||0
11215237|NCT01928381|12406534|FG004|NOT COMPLETED|Washout First Intervention||1
11215238|NCT01928381|12406535|FG005|NOT COMPLETED|Washout First Intervention||0
11215239|NCT01928381|12406536|FG006|NOT COMPLETED|Washout First Intervention||0
11215240|NCT01928381|12406530|FG000|STARTED|Part 2 - Second Intervention||0
11215241|NCT01928381|12406531|FG001|STARTED|Part 2 - Second Intervention||6
11215242|NCT01928381|12406532|FG002|STARTED|Part 2 - Second Intervention||4
11215243|NCT01928381|12406533|FG003|STARTED|Part 2 - Second Intervention||5
11215244|NCT01928381|12406534|FG004|STARTED|Part 2 - Second Intervention||3
11215245|NCT01928381|12406535|FG005|STARTED|Part 2 - Second Intervention||5
11215246|NCT01928381|12406536|FG006|STARTED|Part 2 - Second Intervention||5
11215247|NCT01928381|12406530|FG000|COMPLETED|Part 2 - Second Intervention||0
11215248|NCT01928381|12406531|FG001|COMPLETED|Part 2 - Second Intervention||5
11215249|NCT01928381|12406532|FG002|COMPLETED|Part 2 - Second Intervention||4
11215250|NCT01928381|12406533|FG003|COMPLETED|Part 2 - Second Intervention||4
11215251|NCT01928381|12406534|FG004|COMPLETED|Part 2 - Second Intervention||3
11215252|NCT01928381|12406535|FG005|COMPLETED|Part 2 - Second Intervention||5
11215253|NCT01928381|12406536|FG006|COMPLETED|Part 2 - Second Intervention||5
11215254|NCT01928381|12406530|FG000|NOT COMPLETED|Part 2 - Second Intervention||0
11215255|NCT01928381|12406531|FG001|NOT COMPLETED|Part 2 - Second Intervention||1
11215256|NCT01928381|12406532|FG002|NOT COMPLETED|Part 2 - Second Intervention||0
11215257|NCT01928381|12406533|FG003|NOT COMPLETED|Part 2 - Second Intervention||1
11215258|NCT01928381|12406534|FG004|NOT COMPLETED|Part 2 - Second Intervention||0
11215259|NCT01928381|12406535|FG005|NOT COMPLETED|Part 2 - Second Intervention||0
11215260|NCT01928381|12406536|FG006|NOT COMPLETED|Part 2 - Second Intervention||0
11215261|NCT01928381|12406530|FG000|STARTED|Washout Second Intervention||0
11215262|NCT01928381|12406531|FG001|STARTED|Washout Second Intervention||5
11215263|NCT01928381|12406532|FG002|STARTED|Washout Second Intervention||4
11215264|NCT01928381|12406533|FG003|STARTED|Washout Second Intervention||4
11215265|NCT01928381|12406534|FG004|STARTED|Washout Second Intervention||3
11215266|NCT01928381|12406535|FG005|STARTED|Washout Second Intervention||5
11215267|NCT01928381|12406536|FG006|STARTED|Washout Second Intervention||5
11215268|NCT01928381|12406530|FG000|COMPLETED|Washout Second Intervention||0
11215269|NCT01928381|12406531|FG001|COMPLETED|Washout Second Intervention||5
11215270|NCT01928381|12406532|FG002|COMPLETED|Washout Second Intervention||4
11215271|NCT01928381|12406533|FG003|COMPLETED|Washout Second Intervention||4
11215272|NCT01928381|12406534|FG004|COMPLETED|Washout Second Intervention||3
11215273|NCT01928381|12406535|FG005|COMPLETED|Washout Second Intervention||5
11215274|NCT01928381|12406536|FG006|COMPLETED|Washout Second Intervention||5
11215275|NCT01928381|12406530|FG000|NOT COMPLETED|Washout Second Intervention||0
11215276|NCT01928381|12406531|FG001|NOT COMPLETED|Washout Second Intervention||0
11215277|NCT01928381|12406532|FG002|NOT COMPLETED|Washout Second Intervention||0
11215278|NCT01928381|12406533|FG003|NOT COMPLETED|Washout Second Intervention||0
11215279|NCT01928381|12406534|FG004|NOT COMPLETED|Washout Second Intervention||0
11215280|NCT01928381|12406535|FG005|NOT COMPLETED|Washout Second Intervention||0
11215281|NCT01928381|12406536|FG006|NOT COMPLETED|Washout Second Intervention||0
11215282|NCT01928381|12406530|FG000|STARTED|Part 2 - Third Intervention||0
11215283|NCT01928381|12406531|FG001|STARTED|Part 2 - Third Intervention||5
11215284|NCT01928381|12406532|FG002|STARTED|Part 2 - Third Intervention||4
11215285|NCT01928381|12406533|FG003|STARTED|Part 2 - Third Intervention||4
11215286|NCT01928381|12406534|FG004|STARTED|Part 2 - Third Intervention||3
11215287|NCT01928381|12406535|FG005|STARTED|Part 2 - Third Intervention||5
11215288|NCT01928381|12406536|FG006|STARTED|Part 2 - Third Intervention||5
11215289|NCT01928381|12406530|FG000|COMPLETED|Part 2 - Third Intervention||0
11215290|NCT01928381|12406531|FG001|COMPLETED|Part 2 - Third Intervention||5
11215291|NCT01928381|12406532|FG002|COMPLETED|Part 2 - Third Intervention||4
11215292|NCT01928381|12406533|FG003|COMPLETED|Part 2 - Third Intervention||4
11215293|NCT01928381|12406534|FG004|COMPLETED|Part 2 - Third Intervention||3
11215294|NCT01928381|12406535|FG005|COMPLETED|Part 2 - Third Intervention||5
11215295|NCT01928381|12406536|FG006|COMPLETED|Part 2 - Third Intervention||5
11215296|NCT01928381|12406530|FG000|NOT COMPLETED|Part 2 - Third Intervention||0
11215297|NCT01928381|12406531|FG001|NOT COMPLETED|Part 2 - Third Intervention||0
11215298|NCT01928381|12406532|FG002|NOT COMPLETED|Part 2 - Third Intervention||0
11215299|NCT01928381|12406533|FG003|NOT COMPLETED|Part 2 - Third Intervention||0
11215300|NCT01928381|12406534|FG004|NOT COMPLETED|Part 2 - Third Intervention||0
11215301|NCT01928381|12406535|FG005|NOT COMPLETED|Part 2 - Third Intervention||0
11215302|NCT01928381|12406536|FG006|NOT COMPLETED|Part 2 - Third Intervention||0
11215303|NCT01928381|12406530|FG000|STARTED|Part 2 - Post Third Intervention||0
11215304|NCT01928381|12406531|FG001|STARTED|Part 2 - Post Third Intervention||5
11215305|NCT01928381|12406532|FG002|STARTED|Part 2 - Post Third Intervention||4
11215306|NCT01928381|12406533|FG003|STARTED|Part 2 - Post Third Intervention||4
11215307|NCT01928381|12406534|FG004|STARTED|Part 2 - Post Third Intervention||3
11215308|NCT01928381|12406535|FG005|STARTED|Part 2 - Post Third Intervention||5
11215309|NCT01928381|12406536|FG006|STARTED|Part 2 - Post Third Intervention||5
11215310|NCT01928381|12406530|FG000|COMPLETED|Part 2 - Post Third Intervention||0
11215311|NCT01928381|12406531|FG001|COMPLETED|Part 2 - Post Third Intervention||5
11215312|NCT01928381|12406532|FG002|COMPLETED|Part 2 - Post Third Intervention||3
11215313|NCT01928381|12406533|FG003|COMPLETED|Part 2 - Post Third Intervention||4
11215314|NCT01928381|12406534|FG004|COMPLETED|Part 2 - Post Third Intervention||3
11215315|NCT01928381|12406535|FG005|COMPLETED|Part 2 - Post Third Intervention||5
11215316|NCT01928381|12406536|FG006|COMPLETED|Part 2 - Post Third Intervention||5
11215317|NCT01928381|12406530|FG000|NOT COMPLETED|Part 2 - Post Third Intervention||0
11215318|NCT01928381|12406531|FG001|NOT COMPLETED|Part 2 - Post Third Intervention||0
11215319|NCT01928381|12406532|FG002|NOT COMPLETED|Part 2 - Post Third Intervention||1
11215320|NCT01928381|12406533|FG003|NOT COMPLETED|Part 2 - Post Third Intervention||0
11215321|NCT01928381|12406534|FG004|NOT COMPLETED|Part 2 - Post Third Intervention||0
11215322|NCT01928381|12406535|FG005|NOT COMPLETED|Part 2 - Post Third Intervention||0
11215323|NCT01928381|12406536|FG006|NOT COMPLETED|Part 2 - Post Third Intervention||0
11215324|NCT01928433|12406549|FG000|STARTED|Overall Study||76
11215325|NCT01928433|12406550|FG001|STARTED|Overall Study||75
11215326|NCT01928433|12406551|FG002|STARTED|Overall Study||74
11215327|NCT01928433|12406549|FG000|COMPLETED|Overall Study||56
11215328|NCT01928433|12406550|FG001|COMPLETED|Overall Study||54
11215329|NCT01928433|12406551|FG002|COMPLETED|Overall Study||46
11215330|NCT01928433|12406549|FG000|NOT COMPLETED|Overall Study||20
11215331|NCT01928433|12406550|FG001|NOT COMPLETED|Overall Study||21
11215332|NCT01928433|12406551|FG002|NOT COMPLETED|Overall Study||28
11215333|NCT01928446|12406564|FG000|STARTED|Overall Study||255
11215334|NCT01928446|12406565|FG001|STARTED|Overall Study||264
11215335|NCT01928446|12406564|FG000|COMPLETED|Overall Study|39 subjects stopped study drug but continued with followup|144
11215336|NCT01928446|12406565|FG001|COMPLETED|Overall Study|23 subjects stopped study drug but continued with followup|125
11215337|NCT01928446|12406564|FG000|NOT COMPLETED|Overall Study||111
11215338|NCT01928446|12406565|FG001|NOT COMPLETED|Overall Study||139
11215339|NCT01928472|12406577|FG000|STARTED|Overall Study||98
11215340|NCT01928472|12406578|FG001|STARTED|Overall Study||104
11215341|NCT01928472|12406579|FG002|STARTED|Overall Study||98
11215342|NCT01928472|12406580|FG003|STARTED|Overall Study||102
11215343|NCT01928472|12406577|FG000|COMPLETED|Overall Study||90
11215344|NCT01928472|12406578|FG001|COMPLETED|Overall Study||96
11215345|NCT01928472|12406579|FG002|COMPLETED|Overall Study||91
11215346|NCT01928472|12406580|FG003|COMPLETED|Overall Study||100
11215347|NCT01928472|12406577|FG000|NOT COMPLETED|Overall Study||8
11215348|NCT01928472|12406578|FG001|NOT COMPLETED|Overall Study||8
11215349|NCT01928472|12406579|FG002|NOT COMPLETED|Overall Study||7
11215350|NCT01928472|12406580|FG003|NOT COMPLETED|Overall Study||2
11215351|NCT01928485|12406593|FG000|STARTED|Overall Study||4
11215352|NCT01928485|12406594|FG001|STARTED|Overall Study||2
11215353|NCT01928485|12406593|FG000|COMPLETED|Overall Study||4
11215354|NCT01928485|12406594|FG001|COMPLETED|Overall Study||1
11215355|NCT01928485|12406593|FG000|NOT COMPLETED|Overall Study||0
11215356|NCT01928485|12406594|FG001|NOT COMPLETED|Overall Study||1
11215357|NCT01928524|12406607|FG000|STARTED|Overall Study||3
11215358|NCT01928524|12406608|FG001|STARTED|Overall Study||3
11215359|NCT01928524|12406609|FG002|STARTED|Overall Study||6
11215360|NCT01928524|12406610|FG003|STARTED|Overall Study||6
11215361|NCT01928524|12406611|FG004|STARTED|Overall Study||3
11215362|NCT01928524|12406612|FG005|STARTED|Overall Study||8
11215363|NCT01928524|12406613|FG006|STARTED|Overall Study||5
11215364|NCT01928524|12406607|FG000|COMPLETED|Overall Study||3
11215365|NCT01928524|12406608|FG001|COMPLETED|Overall Study||3
11215366|NCT01928524|12406609|FG002|COMPLETED|Overall Study||6
11215367|NCT01928524|12406610|FG003|COMPLETED|Overall Study||6
11215368|NCT01928524|12406611|FG004|COMPLETED|Overall Study||3
11215369|NCT01928524|12406612|FG005|COMPLETED|Overall Study||8
11215370|NCT01928524|12406613|FG006|COMPLETED|Overall Study||5
11215371|NCT01928524|12406607|FG000|NOT COMPLETED|Overall Study||0
11215372|NCT01928524|12406608|FG001|NOT COMPLETED|Overall Study||0
11215373|NCT01928524|12406609|FG002|NOT COMPLETED|Overall Study||0
11215374|NCT01928524|12406610|FG003|NOT COMPLETED|Overall Study||0
11215375|NCT01928524|12406611|FG004|NOT COMPLETED|Overall Study||0
11215376|NCT01928524|12406612|FG005|NOT COMPLETED|Overall Study||0
11215377|NCT01928524|12406613|FG006|NOT COMPLETED|Overall Study||0
11215378|NCT01928680|12406629|FG000|STARTED|Overall Study||33
11215379|NCT01928680|12406629|FG000|COMPLETED|Overall Study||33
11215380|NCT01928680|12406629|FG000|NOT COMPLETED|Overall Study||0
11215381|NCT01928693|12406636|FG000|STARTED|Overall Study||0
11215382|NCT01928693|12406637|FG001|STARTED|Overall Study||1
11215383|NCT01928693|12406638|FG002|STARTED|Overall Study||1
11215384|NCT01928693|12406636|FG000|COMPLETED|Overall Study||0
11215385|NCT01928693|12406637|FG001|COMPLETED|Overall Study||1
11215386|NCT01928693|12406638|FG002|COMPLETED|Overall Study||1
11215387|NCT01928693|12406636|FG000|NOT COMPLETED|Overall Study||0
11215388|NCT01928693|12406637|FG001|NOT COMPLETED|Overall Study||0
11215389|NCT01928693|12406638|FG002|NOT COMPLETED|Overall Study||0
11215390|NCT01928719|12406648|FG000|STARTED|Overall Study||122
11215391|NCT01928719|12406649|FG001|STARTED|Overall Study||123
11215392|NCT01928719|12406648|FG000|COMPLETED|Overall Study||70
11215393|NCT01928719|12406649|FG001|COMPLETED|Overall Study||104
11215394|NCT01928719|12406648|FG000|NOT COMPLETED|Overall Study||52
11215395|NCT01928719|12406649|FG001|NOT COMPLETED|Overall Study||19
11215396|NCT01928758|12406659|FG000|STARTED|Overall Study||94
11215397|NCT01928758|12406660|FG001|STARTED|Overall Study||94
11215398|NCT01928758|12406659|FG000|COMPLETED|Overall Study||69
11215399|NCT01928758|12406660|FG001|COMPLETED|Overall Study||74
11215400|NCT01928758|12406659|FG000|NOT COMPLETED|Overall Study||25
11215401|NCT01928758|12406660|FG001|NOT COMPLETED|Overall Study||20
11215402|NCT01928771|12406670|FG000|STARTED|Overall Study||400
11215403|NCT01928771|12406671|FG001|STARTED|Overall Study||398
11215404|NCT01928771|12406672|FG002|STARTED|Overall Study||407
11215405|NCT01928771|12406670|FG000|Received Treatment|Overall Study||399
11215406|NCT01928771|12406671|FG001|Received Treatment|Overall Study||398
11215407|NCT01928771|12406672|FG002|Received Treatment|Overall Study||407
11215408|NCT01928771|12406670|FG000|COMPLETED|Overall Study||354
11215409|NCT01928771|12406671|FG001|COMPLETED|Overall Study||358
11215410|NCT01928771|12406672|FG002|COMPLETED|Overall Study||367
11215411|NCT01928771|12406670|FG000|NOT COMPLETED|Overall Study||46
11215412|NCT01928771|12406671|FG001|NOT COMPLETED|Overall Study||40
11215413|NCT01928771|12406672|FG002|NOT COMPLETED|Overall Study||40
11215414|NCT01928797|12406682|FG000|STARTED|Overall Study||30
11215415|NCT01928797|12406683|FG001|STARTED|Overall Study||30
11215416|NCT01928797|12406682|FG000|COMPLETED|Overall Study||30
11215417|NCT01928797|12406683|FG001|COMPLETED|Overall Study||30
11215418|NCT01928797|12406682|FG000|NOT COMPLETED|Overall Study||0
11215419|NCT01928797|12406683|FG001|NOT COMPLETED|Overall Study||0
11215420|NCT01928849|12406693|FG000|STARTED|Overall Study||66
11215421|NCT01928849|12406694|FG001|STARTED|Overall Study||62
11215422|NCT01928849|12406693|FG000|COMPLETED|Overall Study||52
11215423|NCT01928849|12406694|FG001|COMPLETED|Overall Study||55
11215424|NCT01928849|12406693|FG000|NOT COMPLETED|Overall Study||14
11215425|NCT01928849|12406694|FG001|NOT COMPLETED|Overall Study||7
11215426|NCT01928862|12406705|FG000|STARTED|Overall Study||16
11215427|NCT01928862|12406706|FG001|STARTED|Overall Study||16
11215428|NCT01928862|12406707|FG002|STARTED|Overall Study||16
11215429|NCT01928862|12406708|FG003|STARTED|Overall Study||16
11215430|NCT01928862|12406709|FG004|STARTED|Overall Study||14
11215431|NCT01928862|12406705|FG000|COMPLETED|Overall Study||15
11215432|NCT01928862|12406706|FG001|COMPLETED|Overall Study||16
11215433|NCT01928862|12406707|FG002|COMPLETED|Overall Study||16
11215434|NCT01928862|12406708|FG003|COMPLETED|Overall Study||16
11215435|NCT01928862|12406709|FG004|COMPLETED|Overall Study||13
11215436|NCT01928862|12406705|FG000|NOT COMPLETED|Overall Study||1
11215437|NCT01928862|12406706|FG001|NOT COMPLETED|Overall Study||0
11215438|NCT01928862|12406707|FG002|NOT COMPLETED|Overall Study||0
11215439|NCT01928862|12406708|FG003|NOT COMPLETED|Overall Study||0
11215440|NCT01928862|12406709|FG004|NOT COMPLETED|Overall Study||1
11215441|NCT01928927|12406724|FG000|STARTED|Overall Study||29
11215442|NCT01928927|12406725|FG001|STARTED|Overall Study||15
11215443|NCT01928927|12406724|FG000|COMPLETED|Overall Study||27
11215444|NCT01928927|12406725|FG001|COMPLETED|Overall Study||14
11215445|NCT01928927|12406724|FG000|NOT COMPLETED|Overall Study||2
11215446|NCT01928927|12406725|FG001|NOT COMPLETED|Overall Study||1
11215447|NCT01928940|12406737|FG000|STARTED|Overall Study||6
11215448|NCT01928940|12406738|FG001|STARTED|Overall Study||6
11215449|NCT01928940|12406737|FG000|COMPLETED|Overall Study||6
11215450|NCT01928940|12406738|FG001|COMPLETED|Overall Study||5
11215451|NCT01928940|12406737|FG000|NOT COMPLETED|Overall Study||0
11215452|NCT01928940|12406738|FG001|NOT COMPLETED|Overall Study||1
11215453|NCT01929018|12406747|FG000|STARTED|Overall Study||19
11215454|NCT01929018|12406748|FG001|STARTED|Overall Study||19
11215455|NCT01929018|12406747|FG000|COMPLETED|Overall Study||18
11215456|NCT01929018|12406748|FG001|COMPLETED|Overall Study||18
11215457|NCT01929018|12406747|FG000|NOT COMPLETED|Overall Study||1
11215458|NCT01929018|12406748|FG001|NOT COMPLETED|Overall Study||1
11215459|NCT01929031|12406758|FG000|STARTED|Overall Study||213
11215460|NCT01929031|12406759|FG001|STARTED|Overall Study||209
11215461|NCT01929031|12406760|FG002|STARTED|Overall Study||35
11215462|NCT01929031|12406761|FG003|STARTED|Overall Study||35
11215463|NCT01929031|12406762|FG004|STARTED|Overall Study||34
11215464|NCT01929031|12406763|FG005|STARTED|Overall Study||36
11215465|NCT01929031|12406758|FG000|COMPLETED|Overall Study||209
11215466|NCT01929031|12406759|FG001|COMPLETED|Overall Study||207
11215467|NCT01929031|12406760|FG002|COMPLETED|Overall Study||34
11215468|NCT01929031|12406761|FG003|COMPLETED|Overall Study||35
11215469|NCT01929031|12406762|FG004|COMPLETED|Overall Study||33
11215470|NCT01929031|12406763|FG005|COMPLETED|Overall Study||35
11215471|NCT01929031|12406758|FG000|NOT COMPLETED|Overall Study||4
11215472|NCT01929031|12406759|FG001|NOT COMPLETED|Overall Study||2
11215473|NCT01929031|12406760|FG002|NOT COMPLETED|Overall Study||1
11215474|NCT01929031|12406761|FG003|NOT COMPLETED|Overall Study||0
11215475|NCT01929031|12406762|FG004|NOT COMPLETED|Overall Study||1
11215476|NCT01929031|12406763|FG005|NOT COMPLETED|Overall Study||1
11215477|NCT01929044|12406775|FG000|STARTED|Overall Study||153
11215478|NCT01929044|12406776|FG001|STARTED|Overall Study||146
11215479|NCT01929044|12406775|FG000|COMPLETED|Overall Study||142
11215480|NCT01929044|12406776|FG001|COMPLETED|Overall Study||129
11215481|NCT01929044|12406775|FG000|NOT COMPLETED|Overall Study||11
11215482|NCT01929044|12406776|FG001|NOT COMPLETED|Overall Study||17
11215483|NCT01929057|12406784|FG000|STARTED|Overall Study||31
11215484|NCT01929057|12406785|FG001|STARTED|Overall Study||3
11215485|NCT01929057|12406784|FG000|COMPLETED|Overall Study||31
11215486|NCT01929057|12406785|FG001|COMPLETED|Overall Study||3
11215487|NCT01929057|12406784|FG000|NOT COMPLETED|Overall Study||0
11215488|NCT01929057|12406785|FG001|NOT COMPLETED|Overall Study||0
11215489|NCT01929083|12406793|FG000|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
11215490|NCT01929083|12406794|FG001|STARTED|Intervention 1||9
11215491|NCT01929083|12406793|FG000|Returned for 1st Ibutilide Administratio|Intervention 1||7
11215492|NCT01929083|12406794|FG001|Returned for 1st Ibutilide Administratio|Intervention 1||9
11215493|NCT01929083|12406793|FG000|COMPLETED|Intervention 1||7
11215494|NCT01929083|12406794|FG001|COMPLETED|Intervention 1||9
11215495|NCT01929083|12406793|FG000|NOT COMPLETED|Intervention 1||3
11215496|NCT01929083|12406794|FG001|NOT COMPLETED|Intervention 1||0
11215497|NCT01929083|12406793|FG000|STARTED|Intervention 2||7
11215498|NCT01929083|12406794|FG001|STARTED|Intervention 2||9
11215499|NCT01929083|12406793|FG000|Returned for 2nd Ibutilide Administratio|Intervention 2||7
11215500|NCT01929083|12406794|FG001|Returned for 2nd Ibutilide Administratio|Intervention 2||8
11215501|NCT01929083|12406793|FG000|COMPLETED|Intervention 2||7
11215502|NCT01929083|12406794|FG001|COMPLETED|Intervention 2||8
11215503|NCT01929083|12406793|FG000|NOT COMPLETED|Intervention 2||0
11215504|NCT01929083|12406794|FG001|NOT COMPLETED|Intervention 2||1
11215505|NCT01929109|12406805|FG000|STARTED|Period 1 (All Groups)||14
11353078|NCT03054051|12550188|FG000|NOT COMPLETED|Overall Study||0
11353079|NCT03054051|12550189|FG001|NOT COMPLETED|Overall Study||0
11353080|NCT03054064|12550197|FG000|STARTED|Overall Study||48
11353081|NCT03054064|12550197|FG000|Screen Failure|Overall Study||2
11353082|NCT03054064|12550197|FG000|COMPLETED|Overall Study||42
11353083|NCT03054064|12550197|FG000|NOT COMPLETED|Overall Study||6
11353084|NCT03054077|12550203|FG000|STARTED|Overall Study||12
11353085|NCT03054077|12550204|FG001|STARTED|Overall Study||12
11353086|NCT03054077|12550203|FG000|COMPLETED|Overall Study||12
11353087|NCT03054077|12550204|FG001|COMPLETED|Overall Study||12
11353088|NCT03054077|12550203|FG000|NOT COMPLETED|Overall Study||0
11353089|NCT03054077|12550204|FG001|NOT COMPLETED|Overall Study||0
11097622|NCT01212757|12281281|FG000|STARTED|Long-Term Safety Phase (Year 3)||0
11097623|NCT01212757|12281282|FG001|STARTED|Long-Term Safety Phase (Year 3)||107
11097624|NCT01212757|12281283|FG002|STARTED|Long-Term Safety Phase (Year 3)||95
11097625|NCT01212757|12281284|FG003|STARTED|Long-Term Safety Phase (Year 3)||0
11097626|NCT01212757|12281285|FG004|STARTED|Long-Term Safety Phase (Year 3)||0
11097627|NCT01212757|12281286|FG005|STARTED|Long-Term Safety Phase (Year 3)||0
11097628|NCT01212757|12281287|FG006|STARTED|Long-Term Safety Phase (Year 3)||0
11097629|NCT01212757|12281288|FG007|STARTED|Long-Term Safety Phase (Year 3)||48
11097630|NCT01212757|12281289|FG008|STARTED|Long-Term Safety Phase (Year 3)||51
11097631|NCT01212757|12281281|FG000|COMPLETED|Long-Term Safety Phase (Year 3)||0
11097632|NCT01212757|12281282|FG001|COMPLETED|Long-Term Safety Phase (Year 3)||89
11097633|NCT01212757|12281283|FG002|COMPLETED|Long-Term Safety Phase (Year 3)||84
11097634|NCT01212757|12281284|FG003|COMPLETED|Long-Term Safety Phase (Year 3)||0
11097635|NCT01212757|12281285|FG004|COMPLETED|Long-Term Safety Phase (Year 3)||0
11097636|NCT01212757|12281286|FG005|COMPLETED|Long-Term Safety Phase (Year 3)||0
11097637|NCT01212757|12281287|FG006|COMPLETED|Long-Term Safety Phase (Year 3)||0
11097638|NCT01212757|12281288|FG007|COMPLETED|Long-Term Safety Phase (Year 3)||42
11097639|NCT01212757|12281289|FG008|COMPLETED|Long-Term Safety Phase (Year 3)||46
11097640|NCT01212757|12281281|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
11097641|NCT01212757|12281282|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
11097642|NCT01212757|12281283|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
11097643|NCT01212757|12281284|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
11097644|NCT01212757|12281285|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
11097645|NCT01212757|12281286|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
11097646|NCT01212757|12281287|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
11097647|NCT01212757|12281288|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
11097648|NCT01212757|12281289|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
11097649|NCT01212757|12281281|FG000|STARTED|Long-Term Safety Phase (Year 4)||0
11097650|NCT01212757|12281282|FG001|STARTED|Long-Term Safety Phase (Year 4)||89
11097651|NCT01212757|12281283|FG002|STARTED|Long-Term Safety Phase (Year 4)||84
11097652|NCT01212757|12281284|FG003|STARTED|Long-Term Safety Phase (Year 4)||0
11097653|NCT01212757|12281285|FG004|STARTED|Long-Term Safety Phase (Year 4)||0
11097654|NCT01212757|12281286|FG005|STARTED|Long-Term Safety Phase (Year 4)||0
11097655|NCT01212757|12281287|FG006|STARTED|Long-Term Safety Phase (Year 4)||0
11097656|NCT01212757|12281288|FG007|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
11097657|NCT01212757|12281289|FG008|STARTED|Long-Term Safety Phase (Year 4)||46
11097658|NCT01212757|12281281|FG000|COMPLETED|Long-Term Safety Phase (Year 4)||0
11097659|NCT01212757|12281282|FG001|COMPLETED|Long-Term Safety Phase (Year 4)||80
11097660|NCT01212757|12281283|FG002|COMPLETED|Long-Term Safety Phase (Year 4)||77
11097661|NCT01212757|12281284|FG003|COMPLETED|Long-Term Safety Phase (Year 4)||0
11097662|NCT01212757|12281285|FG004|COMPLETED|Long-Term Safety Phase (Year 4)||0
11097663|NCT01212757|12281286|FG005|COMPLETED|Long-Term Safety Phase (Year 4)||0
11097664|NCT01212757|12281287|FG006|COMPLETED|Long-Term Safety Phase (Year 4)||0
11097665|NCT01212757|12281288|FG007|COMPLETED|Long-Term Safety Phase (Year 4)||37
11097666|NCT01212757|12281289|FG008|COMPLETED|Long-Term Safety Phase (Year 4)||39
11097667|NCT01212757|12281281|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
11215506|NCT01929109|12406806|FG001|STARTED|Period 1 (All Groups)||8
11215507|NCT01929109|12406807|FG002|STARTED|Period 1 (All Groups)||9
11215508|NCT01929109|12406808|FG003|STARTED|Period 1 (All Groups)||8
11215509|NCT01929109|12406809|FG004|STARTED|Period 1 (All Groups)||8
11215510|NCT01929109|12406805|FG000|COMPLETED|Period 1 (All Groups)||14
11215511|NCT01929109|12406806|FG001|COMPLETED|Period 1 (All Groups)||8
11215512|NCT01929109|12406807|FG002|COMPLETED|Period 1 (All Groups)||8
11215513|NCT01929109|12406808|FG003|COMPLETED|Period 1 (All Groups)||8
11215514|NCT01929109|12406809|FG004|COMPLETED|Period 1 (All Groups)||8
11215515|NCT01929109|12406805|FG000|NOT COMPLETED|Period 1 (All Groups)||0
11215516|NCT01929109|12406806|FG001|NOT COMPLETED|Period 1 (All Groups)||0
11215517|NCT01929109|12406807|FG002|NOT COMPLETED|Period 1 (All Groups)||1
11215518|NCT01929109|12406808|FG003|NOT COMPLETED|Period 1 (All Groups)||0
11215519|NCT01929109|12406809|FG004|NOT COMPLETED|Period 1 (All Groups)||0
11215520|NCT01929109|12406805|FG000|STARTED|Period 2 (End Stage Renal Disease Only)||0
11215521|NCT01929109|12406806|FG001|STARTED|Period 2 (End Stage Renal Disease Only)||0
11215522|NCT01929109|12406807|FG002|STARTED|Period 2 (End Stage Renal Disease Only)||0
11215523|NCT01929109|12406808|FG003|STARTED|Period 2 (End Stage Renal Disease Only)||0
11215524|NCT01929109|12406809|FG004|STARTED|Period 2 (End Stage Renal Disease Only)||8
11215525|NCT01929109|12406805|FG000|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
11215526|NCT01929109|12406806|FG001|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
11215527|NCT01929109|12406807|FG002|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
11215528|NCT01929109|12406808|FG003|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
11215529|NCT01929109|12406809|FG004|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
11215530|NCT01929109|12406805|FG000|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
11215531|NCT01929109|12406806|FG001|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
11215532|NCT01929109|12406807|FG002|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
11215533|NCT01929109|12406808|FG003|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
11215534|NCT01929109|12406809|FG004|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
11215535|NCT01929135|12406826|FG000|STARTED|Overall Study||19
11215536|NCT01929135|12406827|FG001|STARTED|Overall Study||19
11215537|NCT01929135|12406826|FG000|COMPLETED|Overall Study||18
11215538|NCT01929135|12406827|FG001|COMPLETED|Overall Study||18
11215539|NCT01929135|12406826|FG000|NOT COMPLETED|Overall Study||1
11215540|NCT01929135|12406827|FG001|NOT COMPLETED|Overall Study||1
11215541|NCT01929226|12406837|FG000|STARTED|Overall Study||210
11215542|NCT01929226|12406838|FG001|STARTED|Overall Study||70
11215543|NCT01929226|12406837|FG000|COMPLETED|Overall Study||205
11215544|NCT01929226|12406838|FG001|COMPLETED|Overall Study||69
11215545|NCT01929226|12406837|FG000|NOT COMPLETED|Overall Study||5
11215546|NCT01929226|12406838|FG001|NOT COMPLETED|Overall Study||1
11215547|NCT01929291|12406845|FG000|STARTED|Overall Study||672
11215548|NCT01929291|12406845|FG000|COMPLETED|Overall Study||672
11215549|NCT01929291|12406845|FG000|NOT COMPLETED|Overall Study||0
11215550|NCT01929317|12406851|FG000|STARTED|Dose Increase Effect Verification Phase||61
11215551|NCT01929317|12406852|FG001|STARTED|Dose Increase Effect Verification Phase||20
11215552|NCT01929317|12406851|FG000|COMPLETED|Dose Increase Effect Verification Phase||52
11215553|NCT01929317|12406852|FG001|COMPLETED|Dose Increase Effect Verification Phase||19
11215554|NCT01929317|12406851|FG000|NOT COMPLETED|Dose Increase Effect Verification Phase||9
11215555|NCT01929317|12406852|FG001|NOT COMPLETED|Dose Increase Effect Verification Phase||1
11215556|NCT01929317|12406851|FG000|STARTED|Long-term Phase||44
11215557|NCT01929317|12406852|FG001|STARTED|Long-term Phase||18
11215558|NCT01929317|12406851|FG000|COMPLETED|Long-term Phase||25
11215559|NCT01929317|12406852|FG001|COMPLETED|Long-term Phase||14
11215560|NCT01929317|12406851|FG000|NOT COMPLETED|Long-term Phase||19
11215561|NCT01929317|12406852|FG001|NOT COMPLETED|Long-term Phase||4
11215562|NCT01929343|12406867|FG000|STARTED|Overall Study||12
11215563|NCT01929343|12406868|FG001|STARTED|Overall Study||9
11215564|NCT01929343|12406869|FG002|STARTED|Overall Study||12
11215565|NCT01929343|12406867|FG000|COMPLETED|Overall Study||11
11215566|NCT01929343|12406868|FG001|COMPLETED|Overall Study||7
11215567|NCT01929343|12406869|FG002|COMPLETED|Overall Study||12
11215568|NCT01929343|12406867|FG000|NOT COMPLETED|Overall Study||1
11215569|NCT01929343|12406868|FG001|NOT COMPLETED|Overall Study||2
11215570|NCT01929343|12406869|FG002|NOT COMPLETED|Overall Study||0
11215571|NCT01929395|12406880|FG000|STARTED|Overall Study||19
11215572|NCT01929395|12406881|FG001|STARTED|Overall Study||70
11215573|NCT01929395|12406882|FG002|STARTED|Overall Study||70
11215574|NCT01929395|12406880|FG000|COMPLETED|Overall Study||18
11215575|NCT01929395|12406881|FG001|COMPLETED|Overall Study||69
11215576|NCT01929395|12406882|FG002|COMPLETED|Overall Study||69
11215577|NCT01929395|12406880|FG000|NOT COMPLETED|Overall Study||1
11215578|NCT01929395|12406881|FG001|NOT COMPLETED|Overall Study||1
11215579|NCT01929395|12406882|FG002|NOT COMPLETED|Overall Study||1
11215580|NCT01929408|12406890|FG000|STARTED|Overall Study||703
11215581|NCT01929408|12406890|FG000|COMPLETED|Overall Study||695
11215582|NCT01929408|12406890|FG000|NOT COMPLETED|Overall Study||8
11215583|NCT01929460|12406896|FG000|STARTED|Overall Study||13
11215584|NCT01929460|12406897|FG001|STARTED|Overall Study||13
11215585|NCT01929460|12406896|FG000|COMPLETED|Overall Study||13
11215586|NCT01929460|12406897|FG001|COMPLETED|Overall Study||13
11215587|NCT01929460|12406896|FG000|NOT COMPLETED|Overall Study||0
11215588|NCT01929460|12406897|FG001|NOT COMPLETED|Overall Study||0
11215589|NCT01929473|12406903|FG000|STARTED|Overall Study|0 day|3830
11215590|NCT01929473|12406903|FG000|365 Day|Overall Study||3589
11215591|NCT01929473|12406903|FG000|COMPLETED|Overall Study||3243
11215592|NCT01929473|12406903|FG000|NOT COMPLETED|Overall Study||587
11215593|NCT01929642|12406907|FG000|STARTED|Overall Study||3
11215594|NCT01929642|12406907|FG000|COMPLETED|Overall Study||1
11215595|NCT01929642|12406907|FG000|NOT COMPLETED|Overall Study||2
11215596|NCT01929681|12406915|FG000|STARTED|Overall Study||28
11215597|NCT01929681|12406916|FG001|STARTED|Overall Study||25
11215598|NCT01929681|12406915|FG000|COMPLETED|Overall Study||26
11215599|NCT01929681|12406916|FG001|COMPLETED|Overall Study||24
11215600|NCT01929681|12406915|FG000|NOT COMPLETED|Overall Study||2
11215601|NCT01929681|12406916|FG001|NOT COMPLETED|Overall Study||1
11215602|NCT01929707|12406922|FG000|STARTED|Intervention Period 1||6
11215603|NCT01929707|12406923|FG001|STARTED|Intervention Period 1||8
11215604|NCT01929707|12406924|FG002|STARTED|Intervention Period 1||12
11215605|NCT01929707|12406925|FG003|STARTED|Intervention Period 1||10
11215606|NCT01929707|12406926|FG004|STARTED|Intervention Period 1||0
11215607|NCT01929707|12406927|FG005|STARTED|Intervention Period 1||0
11215608|NCT01929707|12406928|FG006|STARTED|Intervention Period 1||0
11215609|NCT01929707|12406929|FG007|STARTED|Intervention Period 1||0
11215610|NCT01929707|12406922|FG000|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
11353090|NCT03054103|12550213|FG000|STARTED|Overall Study||41
11215611|NCT01929707|12406923|FG001|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
11215612|NCT01929707|12406924|FG002|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
11215613|NCT01929707|12406925|FG003|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
11215614|NCT01929707|12406926|FG004|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
11215615|NCT01929707|12406927|FG005|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
11215616|NCT01929707|12406928|FG006|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
11215617|NCT01929707|12406929|FG007|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
11215618|NCT01929707|12406922|FG000|COMPLETED|Intervention Period 1||6
11215619|NCT01929707|12406923|FG001|COMPLETED|Intervention Period 1||8
11215620|NCT01929707|12406924|FG002|COMPLETED|Intervention Period 1||12
11215621|NCT01929707|12406925|FG003|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
11215622|NCT01929707|12406926|FG004|COMPLETED|Intervention Period 1||0
11215623|NCT01929707|12406927|FG005|COMPLETED|Intervention Period 1||0
11215624|NCT01929707|12406928|FG006|COMPLETED|Intervention Period 1||0
11215625|NCT01929707|12406929|FG007|COMPLETED|Intervention Period 1||0
11215626|NCT01929707|12406922|FG000|NOT COMPLETED|Intervention Period 1||0
11215627|NCT01929707|12406923|FG001|NOT COMPLETED|Intervention Period 1||0
11215628|NCT01929707|12406924|FG002|NOT COMPLETED|Intervention Period 1||0
11215629|NCT01929707|12406925|FG003|NOT COMPLETED|Intervention Period 1||3
11215630|NCT01929707|12406926|FG004|NOT COMPLETED|Intervention Period 1||0
11215631|NCT01929707|12406927|FG005|NOT COMPLETED|Intervention Period 1||0
11215632|NCT01929707|12406928|FG006|NOT COMPLETED|Intervention Period 1||0
11215633|NCT01929707|12406929|FG007|NOT COMPLETED|Intervention Period 1||0
11215634|NCT01929707|12406922|FG000|STARTED|Washout Period ≥7 Days||6
11215635|NCT01929707|12406923|FG001|STARTED|Washout Period ≥7 Days||8
11215636|NCT01929707|12406924|FG002|STARTED|Washout Period ≥7 Days||12
11215637|NCT01929707|12406925|FG003|STARTED|Washout Period ≥7 Days||7
11215638|NCT01929707|12406926|FG004|STARTED|Washout Period ≥7 Days||0
11215639|NCT01929707|12406927|FG005|STARTED|Washout Period ≥7 Days||0
11215640|NCT01929707|12406928|FG006|STARTED|Washout Period ≥7 Days||0
11215641|NCT01929707|12406929|FG007|STARTED|Washout Period ≥7 Days||0
11215642|NCT01929707|12406922|FG000|COMPLETED|Washout Period ≥7 Days||6
11215643|NCT01929707|12406923|FG001|COMPLETED|Washout Period ≥7 Days||8
11215644|NCT01929707|12406924|FG002|COMPLETED|Washout Period ≥7 Days||12
11215645|NCT01929707|12406925|FG003|COMPLETED|Washout Period ≥7 Days||7
11215646|NCT01929707|12406926|FG004|COMPLETED|Washout Period ≥7 Days||0
11215647|NCT01929707|12406927|FG005|COMPLETED|Washout Period ≥7 Days||0
11215648|NCT01929707|12406928|FG006|COMPLETED|Washout Period ≥7 Days||0
11215649|NCT01929707|12406929|FG007|COMPLETED|Washout Period ≥7 Days||0
11215650|NCT01929707|12406922|FG000|NOT COMPLETED|Washout Period ≥7 Days||0
11215651|NCT01929707|12406923|FG001|NOT COMPLETED|Washout Period ≥7 Days||0
11215652|NCT01929707|12406924|FG002|NOT COMPLETED|Washout Period ≥7 Days||0
11215653|NCT01929707|12406925|FG003|NOT COMPLETED|Washout Period ≥7 Days||0
11215654|NCT01929707|12406926|FG004|NOT COMPLETED|Washout Period ≥7 Days||0
11215655|NCT01929707|12406927|FG005|NOT COMPLETED|Washout Period ≥7 Days||0
11215656|NCT01929707|12406928|FG006|NOT COMPLETED|Washout Period ≥7 Days||0
11215657|NCT01929707|12406929|FG007|NOT COMPLETED|Washout Period ≥7 Days||0
11215658|NCT01929707|12406922|FG000|STARTED|Intervention Period 2|Incomplete-crossover design|0
11215659|NCT01929707|12406923|FG001|STARTED|Intervention Period 2|Incomplete-crossover design|0
11215660|NCT01929707|12406924|FG002|STARTED|Intervention Period 2|Incomplete-crossover design|0
11215661|NCT01929707|12406925|FG003|STARTED|Intervention Period 2|Incomplete-crossover design|5
11215662|NCT01929707|12406926|FG004|STARTED|Intervention Period 2|Incomplete-crossover design|6
11215663|NCT01929707|12406927|FG005|STARTED|Intervention Period 2|Incomplete-crossover design|8
11215664|NCT01929707|12406928|FG006|STARTED|Intervention Period 2|Incomplete-crossover design|12
11215665|NCT01929707|12406929|FG007|STARTED|Intervention Period 2|Incomplete-crossover design|4
11215666|NCT01929707|12406922|FG000|COMPLETED|Intervention Period 2||0
11215667|NCT01929707|12406923|FG001|COMPLETED|Intervention Period 2||0
11215668|NCT01929707|12406924|FG002|COMPLETED|Intervention Period 2||0
11215669|NCT01929707|12406925|FG003|COMPLETED|Intervention Period 2||5
11215670|NCT01929707|12406926|FG004|COMPLETED|Intervention Period 2||6
11215671|NCT01929707|12406927|FG005|COMPLETED|Intervention Period 2||6
11215672|NCT01929707|12406928|FG006|COMPLETED|Intervention Period 2||12
11215673|NCT01929707|12406929|FG007|COMPLETED|Intervention Period 2||4
11215674|NCT01929707|12406922|FG000|NOT COMPLETED|Intervention Period 2||0
11215675|NCT01929707|12406923|FG001|NOT COMPLETED|Intervention Period 2||0
11215676|NCT01929707|12406924|FG002|NOT COMPLETED|Intervention Period 2||0
11215677|NCT01929707|12406925|FG003|NOT COMPLETED|Intervention Period 2||0
11215678|NCT01929707|12406926|FG004|NOT COMPLETED|Intervention Period 2||0
11215679|NCT01929707|12406927|FG005|NOT COMPLETED|Intervention Period 2||2
11215680|NCT01929707|12406928|FG006|NOT COMPLETED|Intervention Period 2||0
11215681|NCT01929707|12406929|FG007|NOT COMPLETED|Intervention Period 2||0
11215682|NCT01929759|12406950|FG000|STARTED|Overall Study||10
11215683|NCT01929759|12406950|FG000|COMPLETED|Overall Study||10
11215684|NCT01929759|12406950|FG000|NOT COMPLETED|Overall Study||0
11215685|NCT01929863|12406954|FG000|STARTED|Period 1:Intervention Period 1 (7 Days)||7
11215686|NCT01929863|12406955|FG001|STARTED|Period 1:Intervention Period 1 (7 Days)||8
11215687|NCT01929863|12406954|FG000|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
11215688|NCT01929863|12406955|FG001|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
11215689|NCT01929863|12406954|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
11215690|NCT01929863|12406955|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
11215691|NCT01929863|12406954|FG000|STARTED|Period 2:Washout Period (13-15 Days)||6
11215692|NCT01929863|12406955|FG001|STARTED|Period 2:Washout Period (13-15 Days)||7
11215693|NCT01929863|12406954|FG000|COMPLETED|Period 2:Washout Period (13-15 Days)||6
11215694|NCT01929863|12406955|FG001|COMPLETED|Period 2:Washout Period (13-15 Days)||7
11215695|NCT01929863|12406954|FG000|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
11215696|NCT01929863|12406955|FG001|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
11215697|NCT01929863|12406954|FG000|STARTED|Period 3:Intervention Period 2 (7 Days)||6
11215698|NCT01929863|12406955|FG001|STARTED|Period 3:Intervention Period 2 (7 Days)||7
11215699|NCT01929863|12406954|FG000|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
11215700|NCT01929863|12406955|FG001|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
11215701|NCT01929863|12406954|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
11215702|NCT01929863|12406955|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
11215703|NCT01929863|12406954|FG000|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
11215704|NCT01929863|12406955|FG001|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
11215705|NCT01929863|12406954|FG000|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
11215706|NCT01929863|12406955|FG001|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
11215707|NCT01929863|12406954|FG000|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
11215708|NCT01929863|12406955|FG001|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
11215709|NCT01929876|12406966|FG000|STARTED|Period 1||16
11215710|NCT01929876|12406966|FG000|COMPLETED|Period 1||16
11215711|NCT01929876|12406966|FG000|NOT COMPLETED|Period 1||0
11215712|NCT01929876|12406966|FG000|STARTED|Period 2||16
11215713|NCT01929876|12406966|FG000|COMPLETED|Period 2||15
11215714|NCT01929876|12406966|FG000|NOT COMPLETED|Period 2||1
11215715|NCT01929889|12406970|FG000|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
11215716|NCT01929889|12406970|FG000|COMPLETED|Overall Study|3 subjects completed the study.|3
11215717|NCT01929889|12406970|FG000|NOT COMPLETED|Overall Study||5
11215718|NCT01929980|12406974|FG000|STARTED|Overall Study||4
11215719|NCT01929980|12406974|FG000|COMPLETED|Overall Study||3
11215720|NCT01929980|12406974|FG000|NOT COMPLETED|Overall Study||1
11215721|NCT01929993|12406980|FG000|STARTED|Overall Study||82
11215722|NCT01929993|12406981|FG001|STARTED|Overall Study||82
11215723|NCT01929993|12406980|FG000|COMPLETED|Overall Study||52
11215724|NCT01929993|12406981|FG001|COMPLETED|Overall Study||54
11215725|NCT01929993|12406980|FG000|NOT COMPLETED|Overall Study||30
11215726|NCT01929993|12406981|FG001|NOT COMPLETED|Overall Study||28
11215727|NCT01930045|12406987|FG000|STARTED|Part 1 - Period 1||3
11215728|NCT01930045|12406988|FG001|STARTED|Part 1 - Period 1||3
11215729|NCT01930045|12406989|FG002|STARTED|Part 1 - Period 1||3
11215730|NCT01930045|12406990|FG003|STARTED|Part 1 - Period 1||3
11215731|NCT01930045|12406991|FG004|STARTED|Part 1 - Period 1||3
11215732|NCT01930045|12406992|FG005|STARTED|Part 1 - Period 1||3
11215733|NCT01930045|12406987|FG000|COMPLETED|Part 1 - Period 1||3
11215734|NCT01930045|12406988|FG001|COMPLETED|Part 1 - Period 1||3
11215735|NCT01930045|12406989|FG002|COMPLETED|Part 1 - Period 1||3
11215736|NCT01930045|12406990|FG003|COMPLETED|Part 1 - Period 1||3
11215737|NCT01930045|12406991|FG004|COMPLETED|Part 1 - Period 1||3
11215738|NCT01930045|12406992|FG005|COMPLETED|Part 1 - Period 1||3
11215739|NCT01930045|12406987|FG000|NOT COMPLETED|Part 1 - Period 1||0
11215740|NCT01930045|12406988|FG001|NOT COMPLETED|Part 1 - Period 1||0
11097668|NCT01212757|12281282|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
11097669|NCT01212757|12281283|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
11097670|NCT01212757|12281284|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
11215741|NCT01930045|12406989|FG002|NOT COMPLETED|Part 1 - Period 1||0
11215742|NCT01930045|12406990|FG003|NOT COMPLETED|Part 1 - Period 1||0
11215743|NCT01930045|12406991|FG004|NOT COMPLETED|Part 1 - Period 1||0
11097671|NCT01212757|12281285|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
11097672|NCT01212757|12281286|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
11097673|NCT01212757|12281287|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
11097674|NCT01212757|12281288|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
11097675|NCT01212757|12281289|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
11097676|NCT01212757|12281281|FG000|STARTED|Long-Term Safety Phase (Year 5)||0
11097677|NCT01212757|12281282|FG001|STARTED|Long-Term Safety Phase (Year 5)||80
11097678|NCT01212757|12281283|FG002|STARTED|Long-Term Safety Phase (Year 5)||77
11097679|NCT01212757|12281284|FG003|STARTED|Long-Term Safety Phase (Year 5)||0
11097680|NCT01212757|12281285|FG004|STARTED|Long-Term Safety Phase (Year 5)||0
11097681|NCT01212757|12281286|FG005|STARTED|Long-Term Safety Phase (Year 5)||0
11097682|NCT01212757|12281287|FG006|STARTED|Long-Term Safety Phase (Year 5)||0
11097683|NCT01212757|12281288|FG007|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
11097684|NCT01212757|12281289|FG008|STARTED|Long-Term Safety Phase (Year 5)||39
11097685|NCT01212757|12281281|FG000|COMPLETED|Long-Term Safety Phase (Year 5)||0
11097686|NCT01212757|12281282|FG001|COMPLETED|Long-Term Safety Phase (Year 5)||72
11097687|NCT01212757|12281283|FG002|COMPLETED|Long-Term Safety Phase (Year 5)||69
11097688|NCT01212757|12281284|FG003|COMPLETED|Long-Term Safety Phase (Year 5)||0
11097689|NCT01212757|12281285|FG004|COMPLETED|Long-Term Safety Phase (Year 5)||0
11097690|NCT01212757|12281286|FG005|COMPLETED|Long-Term Safety Phase (Year 5)||0
11097691|NCT01212757|12281287|FG006|COMPLETED|Long-Term Safety Phase (Year 5)||0
11215744|NCT01930045|12406992|FG005|NOT COMPLETED|Part 1 - Period 1||0
11215745|NCT01930045|12406987|FG000|STARTED|Part 1 - Period 2||3
11215746|NCT01930045|12406988|FG001|STARTED|Part 1 - Period 2||3
11215747|NCT01930045|12406989|FG002|STARTED|Part 1 - Period 2||3
11215748|NCT01930045|12406990|FG003|STARTED|Part 1 - Period 2||3
11215749|NCT01930045|12406991|FG004|STARTED|Part 1 - Period 2||3
11215750|NCT01930045|12406992|FG005|STARTED|Part 1 - Period 2||3
11215751|NCT01930045|12406987|FG000|COMPLETED|Part 1 - Period 2||3
11215752|NCT01930045|12406988|FG001|COMPLETED|Part 1 - Period 2||3
11215753|NCT01930045|12406989|FG002|COMPLETED|Part 1 - Period 2||3
11215754|NCT01930045|12406990|FG003|COMPLETED|Part 1 - Period 2||3
11215755|NCT01930045|12406991|FG004|COMPLETED|Part 1 - Period 2||3
11215756|NCT01930045|12406992|FG005|COMPLETED|Part 1 - Period 2||3
11215757|NCT01930045|12406987|FG000|NOT COMPLETED|Part 1 - Period 2||0
11215758|NCT01930045|12406988|FG001|NOT COMPLETED|Part 1 - Period 2||0
11215759|NCT01930045|12406989|FG002|NOT COMPLETED|Part 1 - Period 2||0
11215760|NCT01930045|12406990|FG003|NOT COMPLETED|Part 1 - Period 2||0
11215761|NCT01930045|12406991|FG004|NOT COMPLETED|Part 1 - Period 2||0
11215762|NCT01930045|12406992|FG005|NOT COMPLETED|Part 1 - Period 2||0
11215763|NCT01930045|12406987|FG000|STARTED|Part 1 - Period 3||3
11215764|NCT01930045|12406988|FG001|STARTED|Part 1 - Period 3||3
11215765|NCT01930045|12406989|FG002|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
11215766|NCT01930045|12406990|FG003|STARTED|Part 1 - Period 3||3
11215767|NCT01930045|12406991|FG004|STARTED|Part 1 - Period 3||3
11215768|NCT01930045|12406992|FG005|STARTED|Part 1 - Period 3||3
11215769|NCT01930045|12406987|FG000|COMPLETED|Part 1 - Period 3||3
11215770|NCT01930045|12406988|FG001|COMPLETED|Part 1 - Period 3||3
11215771|NCT01930045|12406989|FG002|COMPLETED|Part 1 - Period 3||2
11215772|NCT01930045|12406990|FG003|COMPLETED|Part 1 - Period 3||3
11215773|NCT01930045|12406991|FG004|COMPLETED|Part 1 - Period 3||3
11215774|NCT01930045|12406992|FG005|COMPLETED|Part 1 - Period 3||3
11215775|NCT01930045|12406987|FG000|NOT COMPLETED|Part 1 - Period 3||0
11215776|NCT01930045|12406988|FG001|NOT COMPLETED|Part 1 - Period 3||0
11215777|NCT01930045|12406989|FG002|NOT COMPLETED|Part 1 - Period 3||0
11215778|NCT01930045|12406990|FG003|NOT COMPLETED|Part 1 - Period 3||0
11215779|NCT01930045|12406991|FG004|NOT COMPLETED|Part 1 - Period 3||0
11215780|NCT01930045|12406992|FG005|NOT COMPLETED|Part 1 - Period 3||0
11215781|NCT01930045|12406987|FG000|STARTED|Pause (up to 37 Days)||3
11215782|NCT01930045|12406988|FG001|STARTED|Pause (up to 37 Days)||3
11215783|NCT01930045|12406989|FG002|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
11215784|NCT01930045|12406990|FG003|STARTED|Pause (up to 37 Days)||3
11215785|NCT01930045|12406991|FG004|STARTED|Pause (up to 37 Days)||3
11215786|NCT01930045|12406992|FG005|STARTED|Pause (up to 37 Days)||3
11215787|NCT01930045|12406987|FG000|COMPLETED|Pause (up to 37 Days)||3
11215788|NCT01930045|12406988|FG001|COMPLETED|Pause (up to 37 Days)||3
11215789|NCT01930045|12406989|FG002|COMPLETED|Pause (up to 37 Days)||3
11215790|NCT01930045|12406990|FG003|COMPLETED|Pause (up to 37 Days)||3
11215791|NCT01930045|12406991|FG004|COMPLETED|Pause (up to 37 Days)||3
11215792|NCT01930045|12406992|FG005|COMPLETED|Pause (up to 37 Days)||1
11215793|NCT01930045|12406987|FG000|NOT COMPLETED|Pause (up to 37 Days)||0
11215794|NCT01930045|12406988|FG001|NOT COMPLETED|Pause (up to 37 Days)||0
11215795|NCT01930045|12406989|FG002|NOT COMPLETED|Pause (up to 37 Days)||0
11215796|NCT01930045|12406990|FG003|NOT COMPLETED|Pause (up to 37 Days)||0
11215797|NCT01930045|12406991|FG004|NOT COMPLETED|Pause (up to 37 Days)||0
11215798|NCT01930045|12406992|FG005|NOT COMPLETED|Pause (up to 37 Days)||2
11215799|NCT01930045|12406987|FG000|STARTED|Part 2 - Period 4||3
11215800|NCT01930045|12406988|FG001|STARTED|Part 2 - Period 4||3
11215801|NCT01930045|12406989|FG002|STARTED|Part 2 - Period 4||3
11215802|NCT01930045|12406990|FG003|STARTED|Part 2 - Period 4||3
11215803|NCT01930045|12406991|FG004|STARTED|Part 2 - Period 4||3
11215804|NCT01930045|12406992|FG005|STARTED|Part 2 - Period 4||1
11215805|NCT01930045|12406987|FG000|COMPLETED|Part 2 - Period 4||3
11215806|NCT01930045|12406988|FG001|COMPLETED|Part 2 - Period 4||3
11215807|NCT01930045|12406989|FG002|COMPLETED|Part 2 - Period 4||3
11215808|NCT01930045|12406990|FG003|COMPLETED|Part 2 - Period 4||3
11215809|NCT01930045|12406991|FG004|COMPLETED|Part 2 - Period 4||3
11215810|NCT01930045|12406992|FG005|COMPLETED|Part 2 - Period 4||1
11215811|NCT01930045|12406987|FG000|NOT COMPLETED|Part 2 - Period 4||0
11215812|NCT01930045|12406988|FG001|NOT COMPLETED|Part 2 - Period 4||0
11215813|NCT01930045|12406989|FG002|NOT COMPLETED|Part 2 - Period 4||0
11215814|NCT01930045|12406990|FG003|NOT COMPLETED|Part 2 - Period 4||0
11215815|NCT01930045|12406991|FG004|NOT COMPLETED|Part 2 - Period 4||0
11215816|NCT01930045|12406992|FG005|NOT COMPLETED|Part 2 - Period 4||0
11215817|NCT01930045|12406987|FG000|STARTED|Part 2 - Period 5||3
11215818|NCT01930045|12406988|FG001|STARTED|Part 2 - Period 5||3
11215819|NCT01930045|12406989|FG002|STARTED|Part 2 - Period 5||3
11215820|NCT01930045|12406990|FG003|STARTED|Part 2 - Period 5||3
11215821|NCT01930045|12406991|FG004|STARTED|Part 2 - Period 5||3
11215822|NCT01930045|12406992|FG005|STARTED|Part 2 - Period 5||1
11215823|NCT01930045|12406987|FG000|COMPLETED|Part 2 - Period 5||3
11215824|NCT01930045|12406988|FG001|COMPLETED|Part 2 - Period 5||3
11215825|NCT01930045|12406989|FG002|COMPLETED|Part 2 - Period 5||3
11215826|NCT01930045|12406990|FG003|COMPLETED|Part 2 - Period 5||3
11215827|NCT01930045|12406991|FG004|COMPLETED|Part 2 - Period 5||3
11215828|NCT01930045|12406992|FG005|COMPLETED|Part 2 - Period 5||1
11215829|NCT01930045|12406987|FG000|NOT COMPLETED|Part 2 - Period 5||0
11215830|NCT01930045|12406988|FG001|NOT COMPLETED|Part 2 - Period 5||0
11215831|NCT01930045|12406989|FG002|NOT COMPLETED|Part 2 - Period 5||0
11215832|NCT01930045|12406990|FG003|NOT COMPLETED|Part 2 - Period 5||0
11215833|NCT01930045|12406991|FG004|NOT COMPLETED|Part 2 - Period 5||0
11215834|NCT01930045|12406992|FG005|NOT COMPLETED|Part 2 - Period 5||0
11215835|NCT01930058|12407007|FG000|STARTED|Overall Study||3
11215836|NCT01930058|12407008|FG001|STARTED|Overall Study||3
11215837|NCT01930058|12407009|FG002|STARTED|Overall Study||3
11215838|NCT01930058|12407007|FG000|COMPLETED|Overall Study||3
11215839|NCT01930058|12407008|FG001|COMPLETED|Overall Study||3
11215840|NCT01930058|12407009|FG002|COMPLETED|Overall Study||3
11215841|NCT01930058|12407007|FG000|NOT COMPLETED|Overall Study||0
11215842|NCT01930058|12407008|FG001|NOT COMPLETED|Overall Study||0
11215843|NCT01930058|12407009|FG002|NOT COMPLETED|Overall Study||0
11215844|NCT01930162|12407016|FG000|STARTED|Overall Study||9
11215845|NCT01930162|12407016|FG000|COMPLETED|Overall Study||4
11215846|NCT01930162|12407016|FG000|NOT COMPLETED|Overall Study||5
11215847|NCT01930175|12407024|FG000|STARTED|Core Study||7
11215848|NCT01930175|12407025|FG001|STARTED|Core Study||2
11215849|NCT01930175|12407026|FG002|STARTED|Core Study||4
11215850|NCT01930175|12407024|FG000|Safety Analysis Set|Core Study||7
11215851|NCT01930175|12407025|FG001|Safety Analysis Set|Core Study||2
11215852|NCT01930175|12407026|FG002|Safety Analysis Set|Core Study||4
11215853|NCT01930175|12407024|FG000|Pharmacokinetics (PK) Analysis Set|Core Study||7
11215854|NCT01930175|12407025|FG001|Pharmacokinetics (PK) Analysis Set|Core Study||2
11215855|NCT01930175|12407026|FG002|Pharmacokinetics (PK) Analysis Set|Core Study|Placebo patients were excluded from the PK analyses|0
11215856|NCT01930175|12407024|FG000|COMPLETED|Core Study||7
11215857|NCT01930175|12407025|FG001|COMPLETED|Core Study||1
11215858|NCT01930175|12407026|FG002|COMPLETED|Core Study||3
11215859|NCT01930175|12407024|FG000|NOT COMPLETED|Core Study||0
11215860|NCT01930175|12407025|FG001|NOT COMPLETED|Core Study||1
11215861|NCT01930175|12407026|FG002|NOT COMPLETED|Core Study||1
11215862|NCT01930175|12407024|FG000|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
11215863|NCT01930175|12407025|FG001|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
11215864|NCT01930175|12407026|FG002|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|3
11215865|NCT01930175|12407024|FG000|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
11215866|NCT01930175|12407025|FG001|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
11215867|NCT01930175|12407026|FG002|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||3
11215868|NCT01930175|12407024|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
11215869|NCT01930175|12407025|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
11215870|NCT01930175|12407026|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
11215871|NCT01930188|12407038|FG000|STARTED|Overall Study||409
11215872|NCT01930188|12407039|FG001|STARTED|Overall Study||409
11215873|NCT01930188|12407040|FG002|STARTED|Overall Study||407
11215874|NCT01930188|12407038|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53
11215875|NCT01930188|12407039|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61
11215876|NCT01930188|12407040|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32
11215877|NCT01930188|12407038|FG000|COMPLETED|Overall Study||387
11215878|NCT01930188|12407039|FG001|COMPLETED|Overall Study||388
11215879|NCT01930188|12407040|FG002|COMPLETED|Overall Study||388
11215880|NCT01930188|12407038|FG000|NOT COMPLETED|Overall Study||22
11215881|NCT01930188|12407039|FG001|NOT COMPLETED|Overall Study||21
11215882|NCT01930188|12407040|FG002|NOT COMPLETED|Overall Study||19
11215883|NCT01930214|12407052|FG000|STARTED|Overall Study||100
11215884|NCT01930214|12407053|FG001|STARTED|Overall Study||117
11215885|NCT01930214|12407054|FG002|STARTED|Overall Study||133
11215886|NCT01930214|12407052|FG000|COMPLETED|Overall Study||80
11215887|NCT01930214|12407053|FG001|COMPLETED|Overall Study||96
11215888|NCT01930214|12407054|FG002|COMPLETED|Overall Study||108
11215889|NCT01930214|12407052|FG000|NOT COMPLETED|Overall Study||20
11215890|NCT01930214|12407053|FG001|NOT COMPLETED|Overall Study||21
11215891|NCT01930214|12407054|FG002|NOT COMPLETED|Overall Study||25
11215892|NCT01930435|12407062|FG000|STARTED|Overall Study||20
11215893|NCT01930435|12407062|FG000|COMPLETED|Overall Study||20
11215894|NCT01930435|12407062|FG000|NOT COMPLETED|Overall Study||0
11215895|NCT01930487|12407067|FG000|STARTED|First Intervention (30 Days)||21
11215896|NCT01930487|12407068|FG001|STARTED|First Intervention (30 Days)||25
11215897|NCT01930487|12407067|FG000|COMPLETED|First Intervention (30 Days)||19
11215898|NCT01930487|12407068|FG001|COMPLETED|First Intervention (30 Days)||23
11215899|NCT01930487|12407067|FG000|NOT COMPLETED|First Intervention (30 Days)||2
11215900|NCT01930487|12407068|FG001|NOT COMPLETED|First Intervention (30 Days)||2
11215901|NCT01930487|12407067|FG000|STARTED|Washout Period (3 Weeks)||19
11215902|NCT01930487|12407068|FG001|STARTED|Washout Period (3 Weeks)||23
11215903|NCT01930487|12407067|FG000|COMPLETED|Washout Period (3 Weeks)||19
11215904|NCT01930487|12407068|FG001|COMPLETED|Washout Period (3 Weeks)||23
11215905|NCT01930487|12407067|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
11215906|NCT01930487|12407068|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
11215907|NCT01930487|12407067|FG000|STARTED|Second Intervention (30 Days)||19
11215908|NCT01930487|12407068|FG001|STARTED|Second Intervention (30 Days)||23
11215909|NCT01930487|12407067|FG000|COMPLETED|Second Intervention (30 Days)||19
11215910|NCT01930487|12407068|FG001|COMPLETED|Second Intervention (30 Days)||23
11215911|NCT01930487|12407067|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
11215912|NCT01930487|12407068|FG001|NOT COMPLETED|Second Intervention (30 Days)||0
11215913|NCT01930643|12407076|FG000|STARTED|Overall Study||7
11215914|NCT01930643|12407077|FG001|STARTED|Overall Study||6
11215915|NCT01930643|12407076|FG000|COMPLETED|Overall Study||7
11215916|NCT01930643|12407077|FG001|COMPLETED|Overall Study||6
11215917|NCT01930643|12407076|FG000|NOT COMPLETED|Overall Study||0
11215918|NCT01930643|12407077|FG001|NOT COMPLETED|Overall Study||0
11215919|NCT01930747|12407086|FG000|STARTED|Overall Study||16
11215920|NCT01930747|12407087|FG001|STARTED|Overall Study||14
11215921|NCT01930747|12407088|FG002|STARTED|Overall Study||12
11215922|NCT01930747|12407086|FG000|COMPLETED|Overall Study||16
11215923|NCT01930747|12407087|FG001|COMPLETED|Overall Study||14
11215924|NCT01930747|12407088|FG002|COMPLETED|Overall Study||12
11215925|NCT01930747|12407086|FG000|NOT COMPLETED|Overall Study||0
11215926|NCT01930747|12407087|FG001|NOT COMPLETED|Overall Study||0
11215927|NCT01930747|12407088|FG002|NOT COMPLETED|Overall Study||0
11215928|NCT01930799|12407096|FG000|STARTED|Overall Study||120
11215929|NCT01930799|12407096|FG000|COMPLETED|Overall Study||112
11215930|NCT01930799|12407096|FG000|NOT COMPLETED|Overall Study||8
11215931|NCT01930890|12407104|FG000|STARTED|Overall Study||14
11215932|NCT01930890|12407105|FG001|STARTED|Overall Study||33
11215933|NCT01930890|12407106|FG002|STARTED|Overall Study||13
11215934|NCT01930890|12407107|FG003|STARTED|Overall Study||27
11215935|NCT01930890|12407104|FG000|COMPLETED|Overall Study||0
11215936|NCT01930890|12407105|FG001|COMPLETED|Overall Study||0
11215937|NCT01930890|12407106|FG002|COMPLETED|Overall Study||0
11215938|NCT01930890|12407107|FG003|COMPLETED|Overall Study||0
11215939|NCT01930890|12407104|FG000|NOT COMPLETED|Overall Study||14
11215940|NCT01930890|12407105|FG001|NOT COMPLETED|Overall Study||33
11215941|NCT01930890|12407106|FG002|NOT COMPLETED|Overall Study||13
11215942|NCT01930890|12407107|FG003|NOT COMPLETED|Overall Study||27
11215943|NCT01931059|12407119|FG000|STARTED|Day 1||6
11215944|NCT01931059|12407120|FG001|STARTED|Day 1||5
11215945|NCT01931059|12407119|FG000|COMPLETED|Day 1||6
11215946|NCT01931059|12407120|FG001|COMPLETED|Day 1||4
11215947|NCT01931059|12407119|FG000|NOT COMPLETED|Day 1||0
11215948|NCT01931059|12407120|FG001|NOT COMPLETED|Day 1||1
11215949|NCT01931059|12407119|FG000|STARTED|Day2||6
11215950|NCT01931059|12407120|FG001|STARTED|Day2||4
11215951|NCT01931059|12407119|FG000|COMPLETED|Day2||6
11215952|NCT01931059|12407120|FG001|COMPLETED|Day2||4
11215953|NCT01931059|12407119|FG000|NOT COMPLETED|Day2||0
11215954|NCT01931059|12407120|FG001|NOT COMPLETED|Day2||0
11215955|NCT01931059|12407119|FG000|STARTED|Day3||6
11215956|NCT01931059|12407120|FG001|STARTED|Day3||4
11215957|NCT01931059|12407119|FG000|COMPLETED|Day3||5
11215958|NCT01931059|12407120|FG001|COMPLETED|Day3||4
11215959|NCT01931059|12407119|FG000|NOT COMPLETED|Day3||1
11215960|NCT01931059|12407120|FG001|NOT COMPLETED|Day3||0
11215961|NCT01931150|12407134|FG000|STARTED|Overall Study||5
11215962|NCT01931150|12407135|FG001|STARTED|Overall Study||6
11215963|NCT01931150|12407134|FG000|COMPLETED|Overall Study||4
11353091|NCT03054103|12550214|FG001|STARTED|Overall Study||29
11353092|NCT03054103|12550215|FG002|STARTED|Overall Study||35
11353093|NCT03054103|12550213|FG000|COMPLETED|Overall Study||41
11353094|NCT03054103|12550214|FG001|COMPLETED|Overall Study||29
11353095|NCT03054103|12550215|FG002|COMPLETED|Overall Study||35
11353096|NCT03054103|12550213|FG000|NOT COMPLETED|Overall Study||0
11353097|NCT03054103|12550214|FG001|NOT COMPLETED|Overall Study||0
11353098|NCT03054103|12550215|FG002|NOT COMPLETED|Overall Study||0
11353099|NCT03054337|12550229|FG000|STARTED|Primary Efficacy Period (6 Weeks)||12
11353100|NCT03054337|12550230|FG001|STARTED|Primary Efficacy Period (6 Weeks)||12
11353101|NCT03054337|12550231|FG002|STARTED|Primary Efficacy Period (6 Weeks)||13
11215964|NCT01931150|12407135|FG001|COMPLETED|Overall Study||4
11215965|NCT01931150|12407134|FG000|NOT COMPLETED|Overall Study||1
11215966|NCT01931150|12407135|FG001|NOT COMPLETED|Overall Study||2
11215967|NCT01931163|12407141|FG000|STARTED|Overall Study||22
11215968|NCT01931163|12407141|FG000|COMPLETED|Overall Study||22
11215969|NCT01931163|12407141|FG000|NOT COMPLETED|Overall Study||0
11215970|NCT01931202|12407148|FG000|STARTED|Overall Study||8
11215971|NCT01931202|12407149|FG001|STARTED|Overall Study||51
11215972|NCT01931202|12407150|FG002|STARTED|Overall Study||49
11215973|NCT01931202|12407148|FG000|COMPLETED|Overall Study||8
11215974|NCT01931202|12407149|FG001|COMPLETED|Overall Study||46
11215975|NCT01931202|12407150|FG002|COMPLETED|Overall Study||45
11215976|NCT01931202|12407148|FG000|NOT COMPLETED|Overall Study||0
11353102|NCT03054337|12550232|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5
11353103|NCT03054337|12550233|FG004|STARTED|Primary Efficacy Period (6 Weeks)||4
11353104|NCT03054337|12550234|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5
11215977|NCT01931202|12407149|FG001|NOT COMPLETED|Overall Study||5
11215978|NCT01931202|12407150|FG002|NOT COMPLETED|Overall Study||4
11215979|NCT01931397|12407161|FG000|STARTED|Overall Study||30
11215980|NCT01931397|12407161|FG000|COMPLETED|Overall Study||19
11215981|NCT01931397|12407161|FG000|NOT COMPLETED|Overall Study||11
11215982|NCT01931462|12407169|FG000|STARTED|Overall Study||2
11215983|NCT01931462|12407169|FG000|COMPLETED|Overall Study||1
11215984|NCT01931462|12407169|FG000|NOT COMPLETED|Overall Study||1
11215985|NCT01931475|12407175|FG000|STARTED|Period 1: Double-Blind Treatment Phase||205
11215986|NCT01931475|12407176|FG001|STARTED|Period 1: Double-Blind Treatment Phase||202
11215987|NCT01931475|12407175|FG000|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
11353105|NCT03054337|12550229|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||12
11215988|NCT01931475|12407176|FG001|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
11353106|NCT03054337|12550230|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||12
11353107|NCT03054337|12550231|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13
11353108|NCT03054337|12550232|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||5
11353109|NCT03054337|12550233|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||4
11353110|NCT03054337|12550234|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||5
11353111|NCT03054337|12550229|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
11353112|NCT03054337|12550230|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
11353113|NCT03054337|12550231|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
11353114|NCT03054337|12550232|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
11353115|NCT03054337|12550233|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
11353116|NCT03054337|12550234|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
11353117|NCT03054337|12550229|FG000|STARTED|Dose Adjustment and Maintenance Period||12
11353118|NCT03054337|12550230|FG001|STARTED|Dose Adjustment and Maintenance Period||12
11353119|NCT03054337|12550231|FG002|STARTED|Dose Adjustment and Maintenance Period||13
11353120|NCT03054337|12550232|FG003|STARTED|Dose Adjustment and Maintenance Period||5
11353121|NCT03054337|12550233|FG004|STARTED|Dose Adjustment and Maintenance Period||4
11353122|NCT03054337|12550234|FG005|STARTED|Dose Adjustment and Maintenance Period||5
11353123|NCT03054337|12550229|FG000|COMPLETED|Dose Adjustment and Maintenance Period||11
11215989|NCT01931475|12407175|FG000|COMPLETED|Period 1: Double-Blind Treatment Phase||166
11215990|NCT01931475|12407176|FG001|COMPLETED|Period 1: Double-Blind Treatment Phase||176
11215991|NCT01931475|12407175|FG000|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
11215992|NCT01931475|12407176|FG001|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
11215993|NCT01931475|12407175|FG000|STARTED|Period 2: Extension Treatment Phase||166
11215994|NCT01931475|12407176|FG001|STARTED|Period 2: Extension Treatment Phase||176
11215995|NCT01931475|12407175|FG000|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
11215996|NCT01931475|12407176|FG001|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
11215997|NCT01931475|12407175|FG000|COMPLETED|Period 2: Extension Treatment Phase||162
11215998|NCT01931475|12407176|FG001|COMPLETED|Period 2: Extension Treatment Phase||157
11215999|NCT01931475|12407175|FG000|NOT COMPLETED|Period 2: Extension Treatment Phase||4
11216000|NCT01931475|12407176|FG001|NOT COMPLETED|Period 2: Extension Treatment Phase||19
11216001|NCT01931527|12407189|FG000|STARTED|Overall Study||16
11216002|NCT01931527|12407190|FG001|STARTED|Overall Study||15
11216003|NCT01931527|12407189|FG000|COMPLETED|Overall Study||16
11216004|NCT01931527|12407190|FG001|COMPLETED|Overall Study||15
11216005|NCT01931527|12407189|FG000|NOT COMPLETED|Overall Study||0
11216006|NCT01931527|12407190|FG001|NOT COMPLETED|Overall Study||0
11216007|NCT01931566|12407203|FG000|STARTED|Overall Study||433
11216008|NCT01931566|12407204|FG001|STARTED|Overall Study||1516
11216009|NCT01931566|12407205|FG002|STARTED|Overall Study||1545
11216010|NCT01931566|12407203|FG000|Treated|Overall Study||427
11216011|NCT01931566|12407204|FG001|Treated|Overall Study||1507
11216012|NCT01931566|12407205|FG002|Treated|Overall Study||1531
11216013|NCT01931566|12407203|FG000|COMPLETED|Overall Study||4
11216014|NCT01931566|12407204|FG001|COMPLETED|Overall Study||40
11216015|NCT01931566|12407205|FG002|COMPLETED|Overall Study||39
11216016|NCT01931566|12407203|FG000|NOT COMPLETED|Overall Study||429
11216017|NCT01931566|12407204|FG001|NOT COMPLETED|Overall Study||1476
11216018|NCT01931566|12407205|FG002|NOT COMPLETED|Overall Study||1506
11216019|NCT01931670|12407217|FG000|STARTED|Treatment Period||360
11216020|NCT01931670|12407218|FG001|STARTED|Treatment Period||226
11216021|NCT01931670|12407219|FG002|STARTED|Treatment Period||229
11216022|NCT01931670|12407217|FG000|COMPLETED|Treatment Period||270
11216023|NCT01931670|12407218|FG001|COMPLETED|Treatment Period||178
11216024|NCT01931670|12407219|FG002|COMPLETED|Treatment Period||184
11216025|NCT01931670|12407217|FG000|NOT COMPLETED|Treatment Period||90
11216026|NCT01931670|12407218|FG001|NOT COMPLETED|Treatment Period||48
11216027|NCT01931670|12407219|FG002|NOT COMPLETED|Treatment Period||45
11216028|NCT01931670|12407217|FG000|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
11216029|NCT01931670|12407218|FG001|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
11216030|NCT01931670|12407219|FG002|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
11216031|NCT01931670|12407217|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
11216032|NCT01931670|12407218|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
11216033|NCT01931670|12407219|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
11216034|NCT01931670|12407217|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
11216035|NCT01931670|12407218|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
11216036|NCT01931670|12407219|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
11216037|NCT01931670|12407217|FG000|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
11216038|NCT01931670|12407218|FG001|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
11097692|NCT01212757|12281288|FG007|COMPLETED|Long-Term Safety Phase (Year 5)||33
11097693|NCT01212757|12281289|FG008|COMPLETED|Long-Term Safety Phase (Year 5)||37
11097694|NCT01212757|12281281|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
11097695|NCT01212757|12281282|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
11097696|NCT01212757|12281283|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
11097697|NCT01212757|12281284|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
11097698|NCT01212757|12281285|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
11097699|NCT01212757|12281286|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
11097700|NCT01212757|12281287|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
11097701|NCT01212757|12281288|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
11097702|NCT01212757|12281289|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
11097703|NCT01212770|12281310|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
11097704|NCT01212770|12281311|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
11097705|NCT01212770|12281312|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
11097706|NCT01212770|12281313|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
11097707|NCT01212770|12281314|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
11097708|NCT01212770|12281315|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
11097709|NCT01212770|12281316|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
11097710|NCT01212770|12281317|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
11097711|NCT01212770|12281318|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
11216039|NCT01931670|12407219|FG002|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
11216040|NCT01931670|12407217|FG000|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
11216041|NCT01931670|12407218|FG001|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
11216042|NCT01931670|12407219|FG002|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
11216043|NCT01931735|12407231|FG000|STARTED|Randomized Phase||4
11216044|NCT01931735|12407232|FG001|STARTED|Randomized Phase||3
11216045|NCT01931735|12407233|FG002|STARTED|Randomized Phase||9
11216046|NCT01931735|12407234|FG003|STARTED|Randomized Phase||0
11216047|NCT01931735|12407231|FG000|COMPLETED|Randomized Phase||2
11216048|NCT01931735|12407232|FG001|COMPLETED|Randomized Phase||1
11216049|NCT01931735|12407233|FG002|COMPLETED|Randomized Phase||4
11216050|NCT01931735|12407234|FG003|COMPLETED|Randomized Phase||0
11216051|NCT01931735|12407231|FG000|NOT COMPLETED|Randomized Phase||2
11216052|NCT01931735|12407232|FG001|NOT COMPLETED|Randomized Phase||2
11216053|NCT01931735|12407233|FG002|NOT COMPLETED|Randomized Phase||5
11216054|NCT01931735|12407234|FG003|NOT COMPLETED|Randomized Phase||0
11216055|NCT01931735|12407231|FG000|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
11216056|NCT01931735|12407232|FG001|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
11216057|NCT01931735|12407233|FG002|STARTED|Observational Non-Randomized Phase||0
11216058|NCT01931735|12407234|FG003|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
11216059|NCT01931735|12407231|FG000|COMPLETED|Observational Non-Randomized Phase||2
11216060|NCT01931735|12407232|FG001|COMPLETED|Observational Non-Randomized Phase||1
11216061|NCT01931735|12407233|FG002|COMPLETED|Observational Non-Randomized Phase||0
11216062|NCT01931735|12407234|FG003|COMPLETED|Observational Non-Randomized Phase||9
11216063|NCT01931735|12407231|FG000|NOT COMPLETED|Observational Non-Randomized Phase||0
11216064|NCT01931735|12407232|FG001|NOT COMPLETED|Observational Non-Randomized Phase||0
11216065|NCT01931735|12407233|FG002|NOT COMPLETED|Observational Non-Randomized Phase||0
11353124|NCT03054337|12550230|FG001|COMPLETED|Dose Adjustment and Maintenance Period||10
11353125|NCT03054337|12550231|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12
11353126|NCT03054337|12550232|FG003|COMPLETED|Dose Adjustment and Maintenance Period||5
11353127|NCT03054337|12550233|FG004|COMPLETED|Dose Adjustment and Maintenance Period||4
11353128|NCT03054337|12550234|FG005|COMPLETED|Dose Adjustment and Maintenance Period||4
11216066|NCT01931735|12407234|FG003|NOT COMPLETED|Observational Non-Randomized Phase||2
11216067|NCT01931839|12407251|FG000|STARTED|Overall Study||335
11216068|NCT01931839|12407252|FG001|STARTED|Overall Study||178
11216069|NCT01931839|12407253|FG002|STARTED|Overall Study||340
11216070|NCT01931839|12407254|FG003|STARTED|Overall Study||176
11216071|NCT01931839|12407255|FG004|STARTED|Overall Study||19
11216072|NCT01931839|12407256|FG005|STARTED|Overall Study||55
11216073|NCT01931839|12407257|FG006|STARTED|Overall Study||60
11216074|NCT01931839|12407251|FG000|Full Analysis Set (As Randomized)|Overall Study||334
11216075|NCT01931839|12407252|FG001|Full Analysis Set (As Randomized)|Overall Study||179
11216076|NCT01931839|12407253|FG002|Full Analysis Set (As Randomized)|Overall Study||340
11216077|NCT01931839|12407254|FG003|Full Analysis Set (As Randomized)|Overall Study||176
11216078|NCT01931839|12407255|FG004|Full Analysis Set (As Randomized)|Overall Study||19
11353129|NCT03054337|12550229|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
11353130|NCT03054337|12550230|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||2
11353131|NCT03054337|12550231|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
11353132|NCT03054337|12550232|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
11353133|NCT03054337|12550233|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
11353134|NCT03054337|12550234|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
11216079|NCT01931839|12407256|FG005|Full Analysis Set (As Randomized)|Overall Study||55
11216080|NCT01931839|12407257|FG006|Full Analysis Set (As Randomized)|Overall Study||60
11216081|NCT01931839|12407251|FG000|Safety Analysis Set (As Dosed)|Overall Study||335
11216082|NCT01931839|12407252|FG001|Safety Analysis Set (As Dosed)|Overall Study||178
11216083|NCT01931839|12407253|FG002|Safety Analysis Set (As Dosed)|Overall Study||340
11216084|NCT01931839|12407254|FG003|Safety Analysis Set (As Dosed)|Overall Study||176
11216085|NCT01931839|12407255|FG004|Safety Analysis Set (As Dosed)|Overall Study||19
11353135|NCT03054350|12550267|FG000|STARTED|Primary Efficacy Period (6 Weeks)||15
11353136|NCT03054350|12550268|FG001|STARTED|Primary Efficacy Period (6 Weeks)||15
11353137|NCT03054350|12550269|FG002|STARTED|Primary Efficacy Period (6 Weeks)||15
11353138|NCT03054350|12550270|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5
11353139|NCT03054350|12550271|FG004|STARTED|Primary Efficacy Period (6 Weeks)||5
11353140|NCT03054350|12550272|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5
11353141|NCT03054350|12550267|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||11
11353142|NCT03054350|12550268|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||13
11353143|NCT03054350|12550269|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13
11353144|NCT03054350|12550270|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||3
11353145|NCT03054350|12550271|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||1
11353146|NCT03054350|12550272|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||2
11353147|NCT03054350|12550267|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
11353148|NCT03054350|12550268|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
11353149|NCT03054350|12550269|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
11353150|NCT03054350|12550270|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
11353151|NCT03054350|12550271|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
11353152|NCT03054350|12550272|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||3
11216086|NCT01931839|12407256|FG005|Safety Analysis Set (As Dosed)|Overall Study||55
11216087|NCT01931839|12407257|FG006|Safety Analysis Set (As Dosed)|Overall Study||60
11216088|NCT01931839|12407251|FG000|COMPLETED|Overall Study||294
11216089|NCT01931839|12407252|FG001|COMPLETED|Overall Study||152
11216090|NCT01931839|12407253|FG002|COMPLETED|Overall Study||301
11216091|NCT01931839|12407254|FG003|COMPLETED|Overall Study||162
11216092|NCT01931839|12407255|FG004|COMPLETED|Overall Study||18
11216093|NCT01931839|12407256|FG005|COMPLETED|Overall Study||50
11216094|NCT01931839|12407257|FG006|COMPLETED|Overall Study||56
11216095|NCT01931839|12407251|FG000|NOT COMPLETED|Overall Study||41
11216096|NCT01931839|12407252|FG001|NOT COMPLETED|Overall Study||26
11216097|NCT01931839|12407253|FG002|NOT COMPLETED|Overall Study||39
11216098|NCT01931839|12407254|FG003|NOT COMPLETED|Overall Study||14
11216099|NCT01931839|12407255|FG004|NOT COMPLETED|Overall Study||1
11216100|NCT01931839|12407256|FG005|NOT COMPLETED|Overall Study||5
11216101|NCT01931839|12407257|FG006|NOT COMPLETED|Overall Study||4
11353153|NCT03054350|12550267|FG000|STARTED|Dose Adjustment and Maintenance Period||11
11353154|NCT03054350|12550268|FG001|STARTED|Dose Adjustment and Maintenance Period||13
11353155|NCT03054350|12550269|FG002|STARTED|Dose Adjustment and Maintenance Period||13
11353156|NCT03054350|12550270|FG003|STARTED|Dose Adjustment and Maintenance Period||3
11353157|NCT03054350|12550271|FG004|STARTED|Dose Adjustment and Maintenance Period||1
11353158|NCT03054350|12550272|FG005|STARTED|Dose Adjustment and Maintenance Period||2
11353159|NCT03054350|12550267|FG000|COMPLETED|Dose Adjustment and Maintenance Period||10
11353160|NCT03054350|12550268|FG001|COMPLETED|Dose Adjustment and Maintenance Period||13
11353161|NCT03054350|12550269|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12
11353162|NCT03054350|12550270|FG003|COMPLETED|Dose Adjustment and Maintenance Period||2
11353163|NCT03054350|12550271|FG004|COMPLETED|Dose Adjustment and Maintenance Period||1
11216102|NCT01931865|12407277|FG000|STARTED|Overall Study||12
11216103|NCT01931865|12407277|FG000|COMPLETED|Overall Study||8
11216104|NCT01931865|12407277|FG000|NOT COMPLETED|Overall Study||4
11216105|NCT01931878|12407282|FG000|STARTED|First Intervention||10
11216106|NCT01931878|12407283|FG001|STARTED|First Intervention||14
11216107|NCT01931878|12407282|FG000|COMPLETED|First Intervention||9
11216108|NCT01931878|12407283|FG001|COMPLETED|First Intervention||14
11216109|NCT01931878|12407282|FG000|NOT COMPLETED|First Intervention||1
11216110|NCT01931878|12407283|FG001|NOT COMPLETED|First Intervention||0
11216111|NCT01931878|12407282|FG000|STARTED|Second Intervention (After 3 Months)||9
11216112|NCT01931878|12407283|FG001|STARTED|Second Intervention (After 3 Months)||14
11216113|NCT01931878|12407282|FG000|COMPLETED|Second Intervention (After 3 Months)||9
11216114|NCT01931878|12407283|FG001|COMPLETED|Second Intervention (After 3 Months)||12
11216115|NCT01931878|12407282|FG000|NOT COMPLETED|Second Intervention (After 3 Months)||0
11216116|NCT01931878|12407283|FG001|NOT COMPLETED|Second Intervention (After 3 Months)||2
11216117|NCT01931956|12407297|FG000|STARTED|Overall Study||59
11216118|NCT01931956|12407298|FG001|STARTED|Overall Study||7
11216119|NCT01931956|12407299|FG002|STARTED|Overall Study||628
11216120|NCT01931956|12407300|FG003|STARTED|Overall Study||271
11216121|NCT01931956|12407297|FG000|COMPLETED|Overall Study||8
11216122|NCT01931956|12407298|FG001|COMPLETED|Overall Study||0
11216123|NCT01931956|12407299|FG002|COMPLETED|Overall Study||141
11216124|NCT01931956|12407300|FG003|COMPLETED|Overall Study||138
11216125|NCT01931956|12407297|FG000|NOT COMPLETED|Overall Study||51
11216126|NCT01931956|12407298|FG001|NOT COMPLETED|Overall Study||7
11216127|NCT01931956|12407299|FG002|NOT COMPLETED|Overall Study||487
11216128|NCT01931956|12407300|FG003|NOT COMPLETED|Overall Study||133
11216129|NCT01931995|12407325|FG000|STARTED|First Intervention (1 Day)||23
11216130|NCT01931995|12407326|FG001|STARTED|First Intervention (1 Day)||22
11216131|NCT01931995|12407325|FG000|COMPLETED|First Intervention (1 Day)||19
11216132|NCT01931995|12407326|FG001|COMPLETED|First Intervention (1 Day)||18
11216133|NCT01931995|12407325|FG000|NOT COMPLETED|First Intervention (1 Day)||4
11216134|NCT01931995|12407326|FG001|NOT COMPLETED|First Intervention (1 Day)||4
11216135|NCT01931995|12407325|FG000|STARTED|Washout (at Least 6 Days)||19
11216136|NCT01931995|12407326|FG001|STARTED|Washout (at Least 6 Days)||18
11216137|NCT01931995|12407325|FG000|COMPLETED|Washout (at Least 6 Days)||19
11216138|NCT01931995|12407326|FG001|COMPLETED|Washout (at Least 6 Days)||18
11216139|NCT01931995|12407325|FG000|NOT COMPLETED|Washout (at Least 6 Days)||0
11216140|NCT01931995|12407326|FG001|NOT COMPLETED|Washout (at Least 6 Days)||0
11216141|NCT01931995|12407325|FG000|STARTED|Second Intervention (1 Day)||18
11216142|NCT01931995|12407326|FG001|STARTED|Second Intervention (1 Day)||19
11216143|NCT01931995|12407325|FG000|COMPLETED|Second Intervention (1 Day)||18
11216144|NCT01931995|12407326|FG001|COMPLETED|Second Intervention (1 Day)||19
11216145|NCT01931995|12407325|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11216146|NCT01931995|12407326|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11216147|NCT01932060|12407334|FG000|STARTED|Overall Study||27
11216148|NCT01932060|12407335|FG001|STARTED|Overall Study||24
11216149|NCT01932060|12407334|FG000|COMPLETED|Overall Study||27
11216150|NCT01932060|12407335|FG001|COMPLETED|Overall Study||24
11216151|NCT01932060|12407334|FG000|NOT COMPLETED|Overall Study||0
11216152|NCT01932060|12407335|FG001|NOT COMPLETED|Overall Study||0
11216153|NCT01932112|12407341|FG000|STARTED|Overall Study||378
11216154|NCT01932112|12407341|FG000|COMPLETED|Overall Study||378
11216155|NCT01932112|12407341|FG000|NOT COMPLETED|Overall Study||0
11216156|NCT01932164|12407345|FG000|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
11216157|NCT01932164|12407345|FG000|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
11216158|NCT01932164|12407345|FG000|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
11216159|NCT01932164|12407345|FG000|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
11216160|NCT01932164|12407345|FG000|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
11216161|NCT01932164|12407345|FG000|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
11216162|NCT01932164|12407345|FG000|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
11216163|NCT01932164|12407345|FG000|NOT COMPLETED|Overall Study||0
11216164|NCT01932242|12407351|FG000|STARTED|Overall Study||35
11216165|NCT01932242|12407352|FG001|STARTED|Overall Study||35
11216166|NCT01932242|12407351|FG000|COMPLETED|Overall Study||30
11216167|NCT01932242|12407352|FG001|COMPLETED|Overall Study||30
11216168|NCT01932242|12407351|FG000|NOT COMPLETED|Overall Study||5
11216169|NCT01932242|12407352|FG001|NOT COMPLETED|Overall Study||5
11216170|NCT01932294|12407358|FG000|STARTED|Overall Study||171
11216171|NCT01932294|12407358|FG000|COMPLETED|Overall Study||72
11216172|NCT01932294|12407358|FG000|NOT COMPLETED|Overall Study||99
11216173|NCT01932437|12407365|FG000|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
11216174|NCT01932437|12407366|FG001|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
11216175|NCT01932437|12407367|FG002|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
11216176|NCT01932437|12407368|FG003|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
11216177|NCT01932437|12407369|FG004|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
11216178|NCT01932437|12407370|FG005|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
11216179|NCT01932437|12407365|FG000|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
11216180|NCT01932437|12407366|FG001|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
11216181|NCT01932437|12407367|FG002|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
11216182|NCT01932437|12407368|FG003|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
11216183|NCT01932437|12407369|FG004|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
11216184|NCT01932437|12407370|FG005|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
11216185|NCT01932437|12407365|FG000|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
11216186|NCT01932437|12407366|FG001|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
11216187|NCT01932437|12407367|FG002|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
11216188|NCT01932437|12407368|FG003|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
11216189|NCT01932437|12407369|FG004|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
11216190|NCT01932437|12407370|FG005|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
11216191|NCT01932437|12407365|FG000|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
11216192|NCT01932437|12407366|FG001|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
11216193|NCT01932437|12407367|FG002|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
11216194|NCT01932437|12407368|FG003|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
11216195|NCT01932437|12407369|FG004|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
11216196|NCT01932437|12407370|FG005|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
11216197|NCT01932437|12407365|FG000|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
11216198|NCT01932437|12407366|FG001|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
11216199|NCT01932437|12407367|FG002|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
11216200|NCT01932437|12407368|FG003|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
11216201|NCT01932437|12407369|FG004|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
11216202|NCT01932437|12407370|FG005|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
11216203|NCT01932437|12407365|FG000|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
11216204|NCT01932437|12407366|FG001|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
11216205|NCT01932437|12407367|FG002|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
11216206|NCT01932437|12407368|FG003|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
11216207|NCT01932437|12407369|FG004|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
11216208|NCT01932437|12407370|FG005|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
11216209|NCT01932437|12407365|FG000|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
11216210|NCT01932437|12407366|FG001|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
11216211|NCT01932437|12407367|FG002|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
11216212|NCT01932437|12407368|FG003|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
11216213|NCT01932437|12407369|FG004|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
11216214|NCT01932437|12407370|FG005|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
11216215|NCT01932437|12407365|FG000|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
11216216|NCT01932437|12407366|FG001|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
11216217|NCT01932437|12407367|FG002|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
11216218|NCT01932437|12407368|FG003|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
11216219|NCT01932437|12407369|FG004|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
11216220|NCT01932437|12407370|FG005|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
11216221|NCT01932437|12407365|FG000|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
11216222|NCT01932437|12407366|FG001|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
11216223|NCT01932437|12407367|FG002|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
11216224|NCT01932437|12407368|FG003|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
11216225|NCT01932437|12407369|FG004|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
11216226|NCT01932437|12407370|FG005|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
11216227|NCT01932437|12407365|FG000|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
11216228|NCT01932437|12407366|FG001|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
11216229|NCT01932437|12407367|FG002|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
11216230|NCT01932437|12407368|FG003|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
11216231|NCT01932437|12407369|FG004|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
11216232|NCT01932437|12407370|FG005|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
11216233|NCT01932437|12407365|FG000|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
11216234|NCT01932437|12407366|FG001|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
11216235|NCT01932437|12407367|FG002|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
11216236|NCT01932437|12407368|FG003|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
11216237|NCT01932437|12407369|FG004|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
11216238|NCT01932437|12407370|FG005|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
11216239|NCT01932437|12407365|FG000|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
11216240|NCT01932437|12407366|FG001|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
11216241|NCT01932437|12407367|FG002|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
11216242|NCT01932437|12407368|FG003|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
11216243|NCT01932437|12407369|FG004|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
11216244|NCT01932437|12407370|FG005|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
11216245|NCT01932437|12407365|FG000|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
11216246|NCT01932437|12407366|FG001|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
11216247|NCT01932437|12407367|FG002|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
11216248|NCT01932437|12407368|FG003|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
11216249|NCT01932437|12407369|FG004|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
11216250|NCT01932437|12407370|FG005|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6
11216251|NCT01932437|12407365|FG000|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
11216252|NCT01932437|12407366|FG001|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
11216253|NCT01932437|12407367|FG002|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
11216254|NCT01932437|12407368|FG003|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
11216255|NCT01932437|12407369|FG004|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
11216256|NCT01932437|12407370|FG005|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5
11216257|NCT01932437|12407365|FG000|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
11216258|NCT01932437|12407366|FG001|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
11216259|NCT01932437|12407367|FG002|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
11216260|NCT01932437|12407368|FG003|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
11216261|NCT01932437|12407369|FG004|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
11216262|NCT01932437|12407370|FG005|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1
11216263|NCT01932606|12407393|FG000|STARTED|Overall Study||14
11216264|NCT01932606|12407394|FG001|STARTED|Overall Study||14
11216265|NCT01932606|12407393|FG000|COMPLETED|Overall Study||14
11216266|NCT01932606|12407394|FG001|COMPLETED|Overall Study||14
11216267|NCT01932606|12407393|FG000|NOT COMPLETED|Overall Study||0
11216268|NCT01932606|12407394|FG001|NOT COMPLETED|Overall Study||0
11216269|NCT01932697|12407402|FG000|STARTED|Overall Study||38
11216270|NCT01932697|12407403|FG001|STARTED|Overall Study||43
11216271|NCT01932697|12407402|FG000|COMPLETED|Overall Study||36
11216272|NCT01932697|12407403|FG001|COMPLETED|Overall Study||43
11216273|NCT01932697|12407402|FG000|NOT COMPLETED|Overall Study||2
11216274|NCT01932697|12407403|FG001|NOT COMPLETED|Overall Study||0
11216275|NCT01932762|12407415|FG000|STARTED|Overall Study||30
11216276|NCT01932762|12407416|FG001|STARTED|Overall Study||30
11216277|NCT01932762|12407417|FG002|STARTED|Overall Study||19
11216278|NCT01932762|12407418|FG003|STARTED|Overall Study||19
11216279|NCT01932762|12407415|FG000|COMPLETED|Overall Study||24
11216280|NCT01932762|12407416|FG001|COMPLETED|Overall Study||28
11216281|NCT01932762|12407417|FG002|COMPLETED|Overall Study||19
11216282|NCT01932762|12407418|FG003|COMPLETED|Overall Study||18
11216283|NCT01932762|12407415|FG000|NOT COMPLETED|Overall Study||6
11216284|NCT01932762|12407416|FG001|NOT COMPLETED|Overall Study||2
11216285|NCT01932762|12407417|FG002|NOT COMPLETED|Overall Study||0
11216286|NCT01932762|12407418|FG003|NOT COMPLETED|Overall Study||1
11216287|NCT01932788|12407430|FG000|STARTED|Overall Study||173
11216288|NCT01932788|12407431|FG001|STARTED|Overall Study||169
11216289|NCT01932788|12407430|FG000|COMPLETED|Overall Study||135
11216290|NCT01932788|12407431|FG001|COMPLETED|Overall Study||118
11216291|NCT01932788|12407430|FG000|NOT COMPLETED|Overall Study||38
11216292|NCT01932788|12407431|FG001|NOT COMPLETED|Overall Study||51
11216293|NCT01932970|12407437|FG000|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
11216294|NCT01932970|12407437|FG000|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
11216295|NCT01932970|12407437|FG000|COMPLETED|Overall Study||140
11216296|NCT01932970|12407437|FG000|NOT COMPLETED|Overall Study||18
11216297|NCT01932996|12407443|FG000|STARTED|Overall Study||172
11216298|NCT01932996|12407444|FG001|STARTED|Overall Study||180
11216299|NCT01932996|12407443|FG000|COMPLETED|Overall Study||170
11216300|NCT01932996|12407444|FG001|COMPLETED|Overall Study||180
11216301|NCT01932996|12407443|FG000|NOT COMPLETED|Overall Study||2
11216302|NCT01932996|12407444|FG001|NOT COMPLETED|Overall Study||0
11216303|NCT01933048|12407452|FG000|STARTED|Overall Study||548
11216304|NCT01933048|12407453|FG001|STARTED|Overall Study||529
11216305|NCT01933048|12407452|FG000|COMPLETED|Overall Study||523
11216306|NCT01933048|12407453|FG001|COMPLETED|Overall Study||501
11216307|NCT01933048|12407452|FG000|NOT COMPLETED|Overall Study||25
11216308|NCT01933048|12407453|FG001|NOT COMPLETED|Overall Study||28
11216309|NCT01933113|12407462|FG000|STARTED|Overall Study||3
11216310|NCT01933113|12407462|FG000|COMPLETED|Overall Study||2
11216311|NCT01933113|12407462|FG000|NOT COMPLETED|Overall Study||1
11097712|NCT01212770|12281310|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
11097713|NCT01212770|12281311|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
11097714|NCT01212770|12281312|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
11097715|NCT01212770|12281313|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
11097716|NCT01212770|12281314|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
11097717|NCT01212770|12281315|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
11097718|NCT01212770|12281316|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
11097719|NCT01212770|12281317|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
11097720|NCT01212770|12281318|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
11097721|NCT01212770|12281310|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
11097722|NCT01212770|12281311|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
11216312|NCT01933217|12407468|FG000|STARTED|Randomization (4 Weeks)||12
11216313|NCT01933217|12407469|FG001|STARTED|Randomization (4 Weeks)||14
11216314|NCT01933217|12407468|FG000|COMPLETED|Randomization (4 Weeks)||10
11216315|NCT01933217|12407469|FG001|COMPLETED|Randomization (4 Weeks)||10
11097723|NCT01212770|12281312|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
11097724|NCT01212770|12281313|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097725|NCT01212770|12281314|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097726|NCT01212770|12281315|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097727|NCT01212770|12281316|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097728|NCT01212770|12281317|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097729|NCT01212770|12281318|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097730|NCT01212770|12281310|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
11097731|NCT01212770|12281311|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
11097732|NCT01212770|12281312|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
11097733|NCT01212770|12281313|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097734|NCT01212770|12281314|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097735|NCT01212770|12281315|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097736|NCT01212770|12281316|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11216316|NCT01933217|12407468|FG000|NOT COMPLETED|Randomization (4 Weeks)||2
11216317|NCT01933217|12407469|FG001|NOT COMPLETED|Randomization (4 Weeks)||4
11216318|NCT01933217|12407468|FG000|STARTED|Crossover (4 Weeks)||10
11216319|NCT01933217|12407469|FG001|STARTED|Crossover (4 Weeks)||10
11216320|NCT01933217|12407468|FG000|COMPLETED|Crossover (4 Weeks)||10
11097737|NCT01212770|12281317|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097738|NCT01212770|12281318|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
11097739|NCT01212770|12281310|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
11216321|NCT01933217|12407469|FG001|COMPLETED|Crossover (4 Weeks)||10
11216322|NCT01933217|12407468|FG000|NOT COMPLETED|Crossover (4 Weeks)||0
11097740|NCT01212770|12281311|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
11097741|NCT01212770|12281312|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
11097742|NCT01212770|12281313|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097743|NCT01212770|12281314|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097744|NCT01212770|12281315|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097745|NCT01212770|12281316|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097746|NCT01212770|12281317|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097747|NCT01212770|12281318|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097748|NCT01212770|12281310|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
11097749|NCT01212770|12281311|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
11097750|NCT01212770|12281312|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
11097751|NCT01212770|12281313|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097752|NCT01212770|12281314|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097753|NCT01212770|12281315|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097754|NCT01212770|12281316|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097755|NCT01212770|12281317|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097756|NCT01212770|12281318|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
11097757|NCT01212770|12281310|FG000|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
11097758|NCT01212770|12281311|FG001|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
11097759|NCT01212770|12281312|FG002|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
11097760|NCT01212770|12281313|FG003|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
11097761|NCT01212770|12281314|FG004|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
11097762|NCT01212770|12281315|FG005|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
11097763|NCT01212770|12281316|FG006|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
11097764|NCT01212770|12281317|FG007|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
11097765|NCT01212770|12281318|FG008|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
11097766|NCT01212770|12281310|FG000|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
11097767|NCT01212770|12281311|FG001|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
11097768|NCT01212770|12281312|FG002|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
11097769|NCT01212770|12281313|FG003|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
11097770|NCT01212770|12281314|FG004|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
11097771|NCT01212770|12281315|FG005|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
11216323|NCT01933217|12407469|FG001|NOT COMPLETED|Crossover (4 Weeks)||0
11216324|NCT01933230|12407477|FG000|STARTED|Overall Study||2
11216325|NCT01933230|12407477|FG000|COMPLETED|Overall Study||2
11216326|NCT01933230|12407477|FG000|NOT COMPLETED|Overall Study||0
11216327|NCT01933243|12407483|FG000|STARTED|Overall Study||12
11216328|NCT01933243|12407484|FG001|STARTED|Overall Study||12
11216329|NCT01933243|12407483|FG000|COMPLETED|Overall Study||10
11216330|NCT01933243|12407484|FG001|COMPLETED|Overall Study||8
11216331|NCT01933243|12407483|FG000|NOT COMPLETED|Overall Study||2
11216332|NCT01933243|12407484|FG001|NOT COMPLETED|Overall Study||4
11216333|NCT01933334|12407492|FG000|STARTED|Overall Study||32
11216334|NCT01933334|12407493|FG001|STARTED|Overall Study||31
11216335|NCT01933334|12407492|FG000|COMPLETED|Overall Study||27
11216336|NCT01933334|12407493|FG001|COMPLETED|Overall Study||29
11216337|NCT01933334|12407492|FG000|NOT COMPLETED|Overall Study||5
11216338|NCT01933334|12407493|FG001|NOT COMPLETED|Overall Study||2
11216339|NCT01933399|12407502|FG000|STARTED|Overall Study||29
11216340|NCT01933399|12407503|FG001|STARTED|Overall Study||32
11216341|NCT01933399|12407504|FG002|STARTED|Overall Study||37
11216342|NCT01933399|12407502|FG000|COMPLETED|Overall Study||29
11216343|NCT01933399|12407503|FG001|COMPLETED|Overall Study||32
11216344|NCT01933399|12407504|FG002|COMPLETED|Overall Study||37
11216345|NCT01933399|12407502|FG000|NOT COMPLETED|Overall Study||0
11216346|NCT01933399|12407503|FG001|NOT COMPLETED|Overall Study||0
11216347|NCT01933399|12407504|FG002|NOT COMPLETED|Overall Study||0
11216348|NCT01933425|12407512|FG000|STARTED|Overall Study||7
11216349|NCT01933425|12407513|FG001|STARTED|Overall Study||7
11216350|NCT01933425|12407512|FG000|COMPLETED|Overall Study||7
11216351|NCT01933425|12407513|FG001|COMPLETED|Overall Study||7
11216352|NCT01933425|12407512|FG000|NOT COMPLETED|Overall Study||0
11216353|NCT01933425|12407513|FG001|NOT COMPLETED|Overall Study||0
11216354|NCT01933464|12407523|FG000|STARTED|Overall Study||5
11216355|NCT01933464|12407524|FG001|STARTED|Overall Study||5
11216356|NCT01933464|12407523|FG000|COMPLETED|Overall Study||5
11216357|NCT01933464|12407524|FG001|COMPLETED|Overall Study||5
11216358|NCT01933464|12407523|FG000|NOT COMPLETED|Overall Study||0
11216359|NCT01933464|12407524|FG001|NOT COMPLETED|Overall Study||0
11216360|NCT01933594|12407536|FG000|STARTED|Overall Study||12
11216361|NCT01933594|12407537|FG001|STARTED|Overall Study||12
11216362|NCT01933594|12407538|FG002|STARTED|Overall Study||12
11216363|NCT01933594|12407539|FG003|STARTED|Overall Study||7
11216364|NCT01933594|12407540|FG004|STARTED|Overall Study||13
11216365|NCT01933594|12407541|FG005|STARTED|Overall Study||3
11216366|NCT01933594|12407536|FG000|COMPLETED|Overall Study||11
11216367|NCT01933594|12407537|FG001|COMPLETED|Overall Study||12
11216368|NCT01933594|12407538|FG002|COMPLETED|Overall Study||12
11216369|NCT01933594|12407539|FG003|COMPLETED|Overall Study||7
11216370|NCT01933594|12407540|FG004|COMPLETED|Overall Study||11
11216371|NCT01933594|12407541|FG005|COMPLETED|Overall Study||3
11216372|NCT01933594|12407536|FG000|NOT COMPLETED|Overall Study||1
11216373|NCT01933594|12407537|FG001|NOT COMPLETED|Overall Study||0
11216374|NCT01933594|12407538|FG002|NOT COMPLETED|Overall Study||0
11216375|NCT01933594|12407539|FG003|NOT COMPLETED|Overall Study||0
11216376|NCT01933594|12407540|FG004|NOT COMPLETED|Overall Study||2
11216377|NCT01933594|12407541|FG005|NOT COMPLETED|Overall Study||0
11216378|NCT01933672|12407559|FG000|STARTED|Metformin Run-in Period||43
11216379|NCT01933672|12407560|FG001|STARTED|Metformin Run-in Period||0
11216380|NCT01933672|12407561|FG002|STARTED|Metformin Run-in Period||0
11216381|NCT01933672|12407562|FG003|STARTED|Metformin Run-in Period||0
11216382|NCT01933672|12407563|FG004|STARTED|Metformin Run-in Period||0
11216383|NCT01933672|12407564|FG005|STARTED|Metformin Run-in Period||0
11216384|NCT01933672|12407565|FG006|STARTED|Metformin Run-in Period||0
11216385|NCT01933672|12407559|FG000|Received Treatment|Metformin Run-in Period||43
11216386|NCT01933672|12407560|FG001|Received Treatment|Metformin Run-in Period||0
11216387|NCT01933672|12407561|FG002|Received Treatment|Metformin Run-in Period||0
11216388|NCT01933672|12407562|FG003|Received Treatment|Metformin Run-in Period||0
11216389|NCT01933672|12407563|FG004|Received Treatment|Metformin Run-in Period||0
11216390|NCT01933672|12407564|FG005|Received Treatment|Metformin Run-in Period||0
11216391|NCT01933672|12407565|FG006|Received Treatment|Metformin Run-in Period||0
11216392|NCT01933672|12407559|FG000|COMPLETED|Metformin Run-in Period||33
11216393|NCT01933672|12407560|FG001|COMPLETED|Metformin Run-in Period||0
11216394|NCT01933672|12407561|FG002|COMPLETED|Metformin Run-in Period||0
11216395|NCT01933672|12407562|FG003|COMPLETED|Metformin Run-in Period||0
11216396|NCT01933672|12407563|FG004|COMPLETED|Metformin Run-in Period||0
11216397|NCT01933672|12407564|FG005|COMPLETED|Metformin Run-in Period||0
11216398|NCT01933672|12407565|FG006|COMPLETED|Metformin Run-in Period||0
11216399|NCT01933672|12407559|FG000|NOT COMPLETED|Metformin Run-in Period||10
11216400|NCT01933672|12407560|FG001|NOT COMPLETED|Metformin Run-in Period||0
11216401|NCT01933672|12407561|FG002|NOT COMPLETED|Metformin Run-in Period||0
11097772|NCT01212770|12281316|FG006|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
11097773|NCT01212770|12281317|FG007|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
11097774|NCT01212770|12281318|FG008|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
11097775|NCT01212770|12281310|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
11097776|NCT01212770|12281311|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
11216402|NCT01933672|12407562|FG003|NOT COMPLETED|Metformin Run-in Period||0
11216403|NCT01933672|12407563|FG004|NOT COMPLETED|Metformin Run-in Period||0
11216404|NCT01933672|12407564|FG005|NOT COMPLETED|Metformin Run-in Period||0
11216405|NCT01933672|12407565|FG006|NOT COMPLETED|Metformin Run-in Period||0
11216406|NCT01933672|12407559|FG000|STARTED|First Intervention Period (12-16 Days)||0
11216407|NCT01933672|12407560|FG001|STARTED|First Intervention Period (12-16 Days)||7
11216408|NCT01933672|12407561|FG002|STARTED|First Intervention Period (12-16 Days)||3
11216409|NCT01933672|12407562|FG003|STARTED|First Intervention Period (12-16 Days)||5
11216410|NCT01933672|12407563|FG004|STARTED|First Intervention Period (12-16 Days)||7
11216411|NCT01933672|12407564|FG005|STARTED|First Intervention Period (12-16 Days)||5
11216412|NCT01933672|12407565|FG006|STARTED|First Intervention Period (12-16 Days)||6
11216413|NCT01933672|12407559|FG000|COMPLETED|First Intervention Period (12-16 Days)||0
11216414|NCT01933672|12407560|FG001|COMPLETED|First Intervention Period (12-16 Days)||7
11216415|NCT01933672|12407561|FG002|COMPLETED|First Intervention Period (12-16 Days)||2
11216416|NCT01933672|12407562|FG003|COMPLETED|First Intervention Period (12-16 Days)||5
11216417|NCT01933672|12407563|FG004|COMPLETED|First Intervention Period (12-16 Days)||6
11216418|NCT01933672|12407564|FG005|COMPLETED|First Intervention Period (12-16 Days)||4
11216419|NCT01933672|12407565|FG006|COMPLETED|First Intervention Period (12-16 Days)||6
11216420|NCT01933672|12407559|FG000|NOT COMPLETED|First Intervention Period (12-16 Days)||0
11216421|NCT01933672|12407560|FG001|NOT COMPLETED|First Intervention Period (12-16 Days)||0
11216422|NCT01933672|12407561|FG002|NOT COMPLETED|First Intervention Period (12-16 Days)||1
11216423|NCT01933672|12407562|FG003|NOT COMPLETED|First Intervention Period (12-16 Days)||0
11216424|NCT01933672|12407563|FG004|NOT COMPLETED|First Intervention Period (12-16 Days)||1
11216425|NCT01933672|12407564|FG005|NOT COMPLETED|First Intervention Period (12-16 Days)||1
11216426|NCT01933672|12407565|FG006|NOT COMPLETED|First Intervention Period (12-16 Days)||0
11216427|NCT01933672|12407559|FG000|STARTED|First Washout Period (7-14 Days)||0
11216428|NCT01933672|12407560|FG001|STARTED|First Washout Period (7-14 Days)||7
11216429|NCT01933672|12407561|FG002|STARTED|First Washout Period (7-14 Days)||2
11216430|NCT01933672|12407562|FG003|STARTED|First Washout Period (7-14 Days)||5
11216431|NCT01933672|12407563|FG004|STARTED|First Washout Period (7-14 Days)||6
11216432|NCT01933672|12407564|FG005|STARTED|First Washout Period (7-14 Days)||4
11216433|NCT01933672|12407565|FG006|STARTED|First Washout Period (7-14 Days)||6
11216434|NCT01933672|12407559|FG000|COMPLETED|First Washout Period (7-14 Days)||0
11216435|NCT01933672|12407560|FG001|COMPLETED|First Washout Period (7-14 Days)||7
11216436|NCT01933672|12407561|FG002|COMPLETED|First Washout Period (7-14 Days)||2
11216437|NCT01933672|12407562|FG003|COMPLETED|First Washout Period (7-14 Days)||5
11216438|NCT01933672|12407563|FG004|COMPLETED|First Washout Period (7-14 Days)||6
11097777|NCT01212770|12281312|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
11097778|NCT01212770|12281313|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
11097779|NCT01212770|12281314|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
11097780|NCT01212770|12281315|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
11097781|NCT01212770|12281316|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
11097782|NCT01212770|12281317|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
11097783|NCT01212770|12281318|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
11097784|NCT01212770|12281310|FG000|STARTED|Long-term Safety Phase (Year 2)||0
11097785|NCT01212770|12281311|FG001|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
11097786|NCT01212770|12281312|FG002|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
11097787|NCT01212770|12281313|FG003|STARTED|Long-term Safety Phase (Year 2)||0
11097788|NCT01212770|12281314|FG004|STARTED|Long-term Safety Phase (Year 2)||0
11097789|NCT01212770|12281315|FG005|STARTED|Long-term Safety Phase (Year 2)||0
11097790|NCT01212770|12281316|FG006|STARTED|Long-term Safety Phase (Year 2)||0
11097791|NCT01212770|12281317|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
11097792|NCT01212770|12281318|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
11216439|NCT01933672|12407564|FG005|COMPLETED|First Washout Period (7-14 Days)||4
11216440|NCT01933672|12407565|FG006|COMPLETED|First Washout Period (7-14 Days)||6
11216441|NCT01933672|12407559|FG000|NOT COMPLETED|First Washout Period (7-14 Days)||0
11216442|NCT01933672|12407560|FG001|NOT COMPLETED|First Washout Period (7-14 Days)||0
11216443|NCT01933672|12407561|FG002|NOT COMPLETED|First Washout Period (7-14 Days)||0
11216444|NCT01933672|12407562|FG003|NOT COMPLETED|First Washout Period (7-14 Days)||0
11216445|NCT01933672|12407563|FG004|NOT COMPLETED|First Washout Period (7-14 Days)||0
11216446|NCT01933672|12407564|FG005|NOT COMPLETED|First Washout Period (7-14 Days)||0
11216447|NCT01933672|12407565|FG006|NOT COMPLETED|First Washout Period (7-14 Days)||0
11216448|NCT01933672|12407559|FG000|STARTED|Second Intervention Period (12-16 Days)||0
11216449|NCT01933672|12407560|FG001|STARTED|Second Intervention Period (12-16 Days)||7
11216450|NCT01933672|12407561|FG002|STARTED|Second Intervention Period (12-16 Days)||2
11216451|NCT01933672|12407562|FG003|STARTED|Second Intervention Period (12-16 Days)||5
11216452|NCT01933672|12407563|FG004|STARTED|Second Intervention Period (12-16 Days)||6
11216453|NCT01933672|12407564|FG005|STARTED|Second Intervention Period (12-16 Days)||4
11097793|NCT01212770|12281310|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0
11097794|NCT01212770|12281311|FG001|COMPLETED|Long-term Safety Phase (Year 2)||88
11097795|NCT01212770|12281312|FG002|COMPLETED|Long-term Safety Phase (Year 2)||106
11097796|NCT01212770|12281313|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0
11097797|NCT01212770|12281314|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0
11097798|NCT01212770|12281315|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0
11097799|NCT01212770|12281316|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0
11097800|NCT01212770|12281317|FG007|COMPLETED|Long-term Safety Phase (Year 2)||42
11097801|NCT01212770|12281318|FG008|COMPLETED|Long-term Safety Phase (Year 2)||50
11097802|NCT01212770|12281310|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
11097803|NCT01212770|12281311|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
11097804|NCT01212770|12281312|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
11097805|NCT01212770|12281313|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
11097806|NCT01212770|12281314|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
11097807|NCT01212770|12281315|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
11097808|NCT01212770|12281316|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
11097809|NCT01212770|12281317|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
11216454|NCT01933672|12407565|FG006|STARTED|Second Intervention Period (12-16 Days)||6
11216455|NCT01933672|12407559|FG000|COMPLETED|Second Intervention Period (12-16 Days)||0
11216456|NCT01933672|12407560|FG001|COMPLETED|Second Intervention Period (12-16 Days)||6
11216457|NCT01933672|12407561|FG002|COMPLETED|Second Intervention Period (12-16 Days)||1
11216458|NCT01933672|12407562|FG003|COMPLETED|Second Intervention Period (12-16 Days)||5
11216459|NCT01933672|12407563|FG004|COMPLETED|Second Intervention Period (12-16 Days)||6
11216460|NCT01933672|12407564|FG005|COMPLETED|Second Intervention Period (12-16 Days)||4
11216461|NCT01933672|12407565|FG006|COMPLETED|Second Intervention Period (12-16 Days)||6
11216462|NCT01933672|12407559|FG000|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
11216463|NCT01933672|12407560|FG001|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
11216464|NCT01933672|12407561|FG002|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
11097810|NCT01212770|12281318|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
11097811|NCT01212770|12281310|FG000|STARTED|Long-term Safety Phase (Year 3)||0
11097812|NCT01212770|12281311|FG001|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
11097813|NCT01212770|12281312|FG002|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
11097814|NCT01212770|12281313|FG003|STARTED|Long-term Safety Phase (Year 3)||0
11097815|NCT01212770|12281314|FG004|STARTED|Long-term Safety Phase (Year 3)||0
11097816|NCT01212770|12281315|FG005|STARTED|Long-term Safety Phase (Year 3)||0
11097817|NCT01212770|12281316|FG006|STARTED|Long-term Safety Phase (Year 3)||0
11216465|NCT01933672|12407562|FG003|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
11216466|NCT01933672|12407563|FG004|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
11216467|NCT01933672|12407564|FG005|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
11216468|NCT01933672|12407565|FG006|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
11216469|NCT01933672|12407559|FG000|STARTED|Second Washout Period (7-14 Days)||0
11216470|NCT01933672|12407560|FG001|STARTED|Second Washout Period (7-14 Days)||6
11216471|NCT01933672|12407561|FG002|STARTED|Second Washout Period (7-14 Days)||1
11216472|NCT01933672|12407562|FG003|STARTED|Second Washout Period (7-14 Days)||5
11216473|NCT01933672|12407563|FG004|STARTED|Second Washout Period (7-14 Days)||6
11216474|NCT01933672|12407564|FG005|STARTED|Second Washout Period (7-14 Days)||4
11216475|NCT01933672|12407565|FG006|STARTED|Second Washout Period (7-14 Days)||6
11216476|NCT01933672|12407559|FG000|COMPLETED|Second Washout Period (7-14 Days)||0
11216477|NCT01933672|12407560|FG001|COMPLETED|Second Washout Period (7-14 Days)||6
11216478|NCT01933672|12407561|FG002|COMPLETED|Second Washout Period (7-14 Days)||1
11216479|NCT01933672|12407562|FG003|COMPLETED|Second Washout Period (7-14 Days)||5
11216480|NCT01933672|12407563|FG004|COMPLETED|Second Washout Period (7-14 Days)||6
11216481|NCT01933672|12407564|FG005|COMPLETED|Second Washout Period (7-14 Days)||4
11216482|NCT01933672|12407565|FG006|COMPLETED|Second Washout Period (7-14 Days)||6
11216483|NCT01933672|12407559|FG000|NOT COMPLETED|Second Washout Period (7-14 Days)||0
11216484|NCT01933672|12407560|FG001|NOT COMPLETED|Second Washout Period (7-14 Days)||0
11216485|NCT01933672|12407561|FG002|NOT COMPLETED|Second Washout Period (7-14 Days)||0
11216486|NCT01933672|12407562|FG003|NOT COMPLETED|Second Washout Period (7-14 Days)||0
11216487|NCT01933672|12407563|FG004|NOT COMPLETED|Second Washout Period (7-14 Days)||0
11216488|NCT01933672|12407564|FG005|NOT COMPLETED|Second Washout Period (7-14 Days)||0
11216489|NCT01933672|12407565|FG006|NOT COMPLETED|Second Washout Period (7-14 Days)||0
11216490|NCT01933672|12407559|FG000|STARTED|Third Intervention Period (12-16 Days)||0
11216491|NCT01933672|12407560|FG001|STARTED|Third Intervention Period (12-16 Days)||6
11216492|NCT01933672|12407561|FG002|STARTED|Third Intervention Period (12-16 Days)||1
11216493|NCT01933672|12407562|FG003|STARTED|Third Intervention Period (12-16 Days)||5
11216494|NCT01933672|12407563|FG004|STARTED|Third Intervention Period (12-16 Days)||6
11216495|NCT01933672|12407564|FG005|STARTED|Third Intervention Period (12-16 Days)||4
11216496|NCT01933672|12407565|FG006|STARTED|Third Intervention Period (12-16 Days)||6
11216497|NCT01933672|12407559|FG000|COMPLETED|Third Intervention Period (12-16 Days)||0
11216498|NCT01933672|12407560|FG001|COMPLETED|Third Intervention Period (12-16 Days)||5
11216499|NCT01933672|12407561|FG002|COMPLETED|Third Intervention Period (12-16 Days)||1
11216500|NCT01933672|12407562|FG003|COMPLETED|Third Intervention Period (12-16 Days)||4
11216501|NCT01933672|12407563|FG004|COMPLETED|Third Intervention Period (12-16 Days)||6
11216502|NCT01933672|12407564|FG005|COMPLETED|Third Intervention Period (12-16 Days)||4
11216503|NCT01933672|12407565|FG006|COMPLETED|Third Intervention Period (12-16 Days)||6
11216504|NCT01933672|12407559|FG000|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
11216505|NCT01933672|12407560|FG001|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
11216506|NCT01933672|12407561|FG002|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
11216507|NCT01933672|12407562|FG003|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
11216508|NCT01933672|12407563|FG004|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
11216509|NCT01933672|12407564|FG005|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
11216510|NCT01933672|12407565|FG006|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
11216511|NCT01933776|12407580|FG000|STARTED|Overall Study||20
11216512|NCT01933776|12407581|FG001|STARTED|Overall Study||20
11216513|NCT01933776|12407580|FG000|COMPLETED|Overall Study||20
11216514|NCT01933776|12407581|FG001|COMPLETED|Overall Study||20
11216515|NCT01933776|12407580|FG000|NOT COMPLETED|Overall Study||0
11216516|NCT01933776|12407581|FG001|NOT COMPLETED|Overall Study||0
11216517|NCT01933789|12407596|FG000|STARTED|Overall Study||65
11216518|NCT01933789|12407597|FG001|STARTED|Overall Study||67
11216519|NCT01933789|12407598|FG002|STARTED|Overall Study||2
11216520|NCT01933789|12407599|FG003|STARTED|Overall Study||2
11216521|NCT01933789|12407600|FG004|STARTED|Overall Study||249
11216522|NCT01933789|12407601|FG005|STARTED|Overall Study||288
11216523|NCT01933789|12407602|FG006|STARTED|Overall Study||58
11216524|NCT01933789|12407603|FG007|STARTED|Overall Study||61
11216525|NCT01933789|12407604|FG008|STARTED|Overall Study||25
11216526|NCT01933789|12407596|FG000|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61
11216527|NCT01933789|12407597|FG001|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65
11216528|NCT01933789|12407598|FG002|Had Target Visit|Overall Study||2
11216529|NCT01933789|12407599|FG003|Had Target Visit|Overall Study||2
11216530|NCT01933789|12407600|FG004|Had Target Visit|Overall Study||228
11216531|NCT01933789|12407601|FG005|Had Target Visit|Overall Study||266
11216532|NCT01933789|12407602|FG006|Had Target Visit|Overall Study||0
11216533|NCT01933789|12407603|FG007|Had Target Visit|Overall Study||0
11216534|NCT01933789|12407604|FG008|Had Target Visit|Overall Study||0
11216535|NCT01933789|12407596|FG000|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57
11216536|NCT01933789|12407597|FG001|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64
11216537|NCT01933789|12407598|FG002|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2
11216538|NCT01933789|12407599|FG003|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1
11216539|NCT01933789|12407600|FG004|Completed After-visit Survey|Overall Study||0
11216540|NCT01933789|12407601|FG005|Completed After-visit Survey|Overall Study||0
11216541|NCT01933789|12407602|FG006|Completed After-visit Survey|Overall Study||0
11216542|NCT01933789|12407603|FG007|Completed After-visit Survey|Overall Study||0
11216543|NCT01933789|12407604|FG008|Completed After-visit Survey|Overall Study||0
11216544|NCT01933789|12407596|FG000|Completed 2-Week Survey|Overall Study||0
11216545|NCT01933789|12407597|FG001|Completed 2-Week Survey|Overall Study||0
11216546|NCT01933789|12407598|FG002|Completed 2-Week Survey|Overall Study||0
11216547|NCT01933789|12407599|FG003|Completed 2-Week Survey|Overall Study||0
11216548|NCT01933789|12407600|FG004|Completed 2-Week Survey|Overall Study||184
11216549|NCT01933789|12407601|FG005|Completed 2-Week Survey|Overall Study||215
11216550|NCT01933789|12407602|FG006|Completed 2-Week Survey|Overall Study||0
11216551|NCT01933789|12407603|FG007|Completed 2-Week Survey|Overall Study||0
11216552|NCT01933789|12407604|FG008|Completed 2-Week Survey|Overall Study||0
11216553|NCT01933789|12407596|FG000|Completed 3-Month Survey|Overall Study||0
11216554|NCT01933789|12407597|FG001|Completed 3-Month Survey|Overall Study||0
11216555|NCT01933789|12407598|FG002|Completed 3-Month Survey|Overall Study||0
11216556|NCT01933789|12407599|FG003|Completed 3-Month Survey|Overall Study||0
11216557|NCT01933789|12407600|FG004|Completed 3-Month Survey|Overall Study||176
11216558|NCT01933789|12407601|FG005|Completed 3-Month Survey|Overall Study||211
11216559|NCT01933789|12407602|FG006|Completed 3-Month Survey|Overall Study||37
11216560|NCT01933789|12407603|FG007|Completed 3-Month Survey|Overall Study||43
11216561|NCT01933789|12407604|FG008|Completed 3-Month Survey|Overall Study||0
11216562|NCT01933789|12407596|FG000|Completed 6-Month Survey|Overall Study||0
11216563|NCT01933789|12407597|FG001|Completed 6-Month Survey|Overall Study||0
11216564|NCT01933789|12407598|FG002|Completed 6-Month Survey|Overall Study||0
11216565|NCT01933789|12407599|FG003|Completed 6-Month Survey|Overall Study||0
11216566|NCT01933789|12407600|FG004|Completed 6-Month Survey|Overall Study||160
11216567|NCT01933789|12407601|FG005|Completed 6-Month Survey|Overall Study||188
11216568|NCT01933789|12407602|FG006|Completed 6-Month Survey|Overall Study||35
11216569|NCT01933789|12407603|FG007|Completed 6-Month Survey|Overall Study||40
11216570|NCT01933789|12407604|FG008|Completed 6-Month Survey|Overall Study||0
11216571|NCT01933789|12407596|FG000|Qualitative Interviews|Overall Study||0
11216572|NCT01933789|12407597|FG001|Qualitative Interviews|Overall Study||0
11097818|NCT01212770|12281317|FG007|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
11097819|NCT01212770|12281318|FG008|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
11097820|NCT01212770|12281310|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0
11097821|NCT01212770|12281311|FG001|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
11097822|NCT01212770|12281312|FG002|COMPLETED|Long-term Safety Phase (Year 3)||94
11097823|NCT01212770|12281313|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0
11097824|NCT01212770|12281314|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0
11097825|NCT01212770|12281315|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0
11097826|NCT01212770|12281316|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0
11097827|NCT01212770|12281317|FG007|COMPLETED|Long-term Safety Phase (Year 3)||35
11097828|NCT01212770|12281318|FG008|COMPLETED|Long-term Safety Phase (Year 3)||44
11097829|NCT01212770|12281310|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
11097830|NCT01212770|12281311|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
11097831|NCT01212770|12281312|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
11097832|NCT01212770|12281313|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
11216573|NCT01933789|12407598|FG002|Qualitative Interviews|Overall Study||0
11216574|NCT01933789|12407599|FG003|Qualitative Interviews|Overall Study||0
11216575|NCT01933789|12407600|FG004|Qualitative Interviews|Overall Study||0
11216576|NCT01933789|12407601|FG005|Qualitative Interviews|Overall Study||0
11216577|NCT01933789|12407602|FG006|Qualitative Interviews|Overall Study||0
11216578|NCT01933789|12407603|FG007|Qualitative Interviews|Overall Study||0
11216579|NCT01933789|12407604|FG008|Qualitative Interviews|Overall Study||25
11097833|NCT01212770|12281314|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
11097834|NCT01212770|12281315|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
11097835|NCT01212770|12281316|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
11216580|NCT01933789|12407596|FG000|COMPLETED|Overall Study||59
11216581|NCT01933789|12407597|FG001|COMPLETED|Overall Study||66
11216582|NCT01933789|12407598|FG002|COMPLETED|Overall Study||2
11216583|NCT01933789|12407599|FG003|COMPLETED|Overall Study||1
11216584|NCT01933789|12407600|FG004|COMPLETED|Overall Study||190
11216585|NCT01933789|12407601|FG005|COMPLETED|Overall Study||221
11216586|NCT01933789|12407602|FG006|COMPLETED|Overall Study||43
11216587|NCT01933789|12407603|FG007|COMPLETED|Overall Study||47
11216588|NCT01933789|12407604|FG008|COMPLETED|Overall Study||25
11216589|NCT01933789|12407596|FG000|NOT COMPLETED|Overall Study||6
11216590|NCT01933789|12407597|FG001|NOT COMPLETED|Overall Study||1
11216591|NCT01933789|12407598|FG002|NOT COMPLETED|Overall Study||0
11216592|NCT01933789|12407599|FG003|NOT COMPLETED|Overall Study||1
11216593|NCT01933789|12407600|FG004|NOT COMPLETED|Overall Study||59
11216594|NCT01933789|12407601|FG005|NOT COMPLETED|Overall Study||67
11216595|NCT01933789|12407602|FG006|NOT COMPLETED|Overall Study||15
11216596|NCT01933789|12407603|FG007|NOT COMPLETED|Overall Study||14
11216597|NCT01933789|12407604|FG008|NOT COMPLETED|Overall Study||0
11216598|NCT01933880|12407626|FG000|STARTED|Overall Study||153
11216599|NCT01933880|12407627|FG001|STARTED|Overall Study||41
11216600|NCT01933880|12407626|FG000|COMPLETED|Overall Study||123
11216601|NCT01933880|12407627|FG001|COMPLETED|Overall Study||40
11216602|NCT01933880|12407626|FG000|NOT COMPLETED|Overall Study||30
11216603|NCT01933880|12407627|FG001|NOT COMPLETED|Overall Study||1
11216604|NCT01933919|12407640|FG000|STARTED|Double-blind Placebo-controlled Phase||19
11216605|NCT01933919|12407641|FG001|STARTED|Double-blind Placebo-controlled Phase||19
11216606|NCT01933919|12407640|FG000|Received Study Drug|Double-blind Placebo-controlled Phase||19
11216607|NCT01933919|12407641|FG001|Received Study Drug|Double-blind Placebo-controlled Phase||19
11216608|NCT01933919|12407640|FG000|COMPLETED|Double-blind Placebo-controlled Phase||19
11216609|NCT01933919|12407641|FG001|COMPLETED|Double-blind Placebo-controlled Phase||15
11216610|NCT01933919|12407640|FG000|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
11216611|NCT01933919|12407641|FG001|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
11216612|NCT01933919|12407640|FG000|STARTED|Open-label Long-term Phase||19
11216613|NCT01933919|12407641|FG001|STARTED|Open-label Long-term Phase||15
11216614|NCT01933919|12407640|FG000|COMPLETED|Open-label Long-term Phase||12
11216615|NCT01933919|12407641|FG001|COMPLETED|Open-label Long-term Phase||9
11216616|NCT01933919|12407640|FG000|NOT COMPLETED|Open-label Long-term Phase||7
11216617|NCT01933919|12407641|FG001|NOT COMPLETED|Open-label Long-term Phase||6
11216618|NCT01933984|12407661|FG000|STARTED|Overall Study||26
11216619|NCT01933984|12407662|FG001|STARTED|Overall Study||25
11216620|NCT01933984|12407661|FG000|COMPLETED|Overall Study||26
11216621|NCT01933984|12407662|FG001|COMPLETED|Overall Study||25
11216622|NCT01933984|12407661|FG000|NOT COMPLETED|Overall Study||0
11216623|NCT01933984|12407662|FG001|NOT COMPLETED|Overall Study||0
11216624|NCT01934010|12407675|FG000|STARTED|Overall Study||114
11216625|NCT01934010|12407676|FG001|STARTED|Overall Study||67
11216626|NCT01934010|12407677|FG002|STARTED|Overall Study||76
11216627|NCT01934010|12407675|FG000|COMPLETED|Overall Study||91
11216628|NCT01934010|12407676|FG001|COMPLETED|Overall Study||56
11216629|NCT01934010|12407677|FG002|COMPLETED|Overall Study||74
11216630|NCT01934010|12407675|FG000|NOT COMPLETED|Overall Study||23
11216631|NCT01934010|12407676|FG001|NOT COMPLETED|Overall Study||11
11216632|NCT01934010|12407677|FG002|NOT COMPLETED|Overall Study||2
11216633|NCT01934140|12407696|FG000|STARTED|Persistence Phase (Year 6-10)||235
11216634|NCT01934140|12407697|FG001|STARTED|Persistence Phase (Year 6-10)||76
11216635|NCT01934140|12407696|FG000|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152
11216636|NCT01934140|12407697|FG001|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51
11216637|NCT01934140|12407696|FG000|NOT COMPLETED|Persistence Phase (Year 6-10)||83
11216638|NCT01934140|12407697|FG001|NOT COMPLETED|Persistence Phase (Year 6-10)||25
11216639|NCT01934140|12407696|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164
11216640|NCT01934140|12407697|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56
11216641|NCT01934140|12407696|FG000|Vaccinated|Booster Phase (6 Months)||164
11097836|NCT01212770|12281317|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
11097837|NCT01212770|12281318|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
11097838|NCT01212770|12281310|FG000|STARTED|Long-term Safety Phase (Year 4)||0
11097839|NCT01212770|12281311|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
11097840|NCT01212770|12281312|FG002|STARTED|Long-term Safety Phase (Year 4)||94
11216642|NCT01934140|12407697|FG001|Vaccinated|Booster Phase (6 Months)||56
11216643|NCT01934140|12407696|FG000|COMPLETED|Booster Phase (6 Months)||159
11216644|NCT01934140|12407697|FG001|COMPLETED|Booster Phase (6 Months)||53
11216645|NCT01934140|12407696|FG000|NOT COMPLETED|Booster Phase (6 Months)||5
11216646|NCT01934140|12407697|FG001|NOT COMPLETED|Booster Phase (6 Months)||3
11216647|NCT01934192|12407709|FG000|STARTED|Overall Study||40
11216648|NCT01934192|12407710|FG001|STARTED|Overall Study||44
11216649|NCT01934192|12407711|FG002|STARTED|Overall Study||4
11216650|NCT01934192|12407712|FG003|STARTED|Overall Study||4
11216651|NCT01934192|12407709|FG000|COMPLETED|Overall Study||31
11216652|NCT01934192|12407710|FG001|COMPLETED|Overall Study||37
11216653|NCT01934192|12407711|FG002|COMPLETED|Overall Study||3
11216654|NCT01934192|12407712|FG003|COMPLETED|Overall Study||3
11216655|NCT01934192|12407709|FG000|NOT COMPLETED|Overall Study||9
11216656|NCT01934192|12407710|FG001|NOT COMPLETED|Overall Study||7
11216657|NCT01934192|12407711|FG002|NOT COMPLETED|Overall Study||1
11216658|NCT01934192|12407712|FG003|NOT COMPLETED|Overall Study||1
11216659|NCT01934218|12407735|FG000|STARTED|Double-blind Phase||404
11216660|NCT01934218|12407736|FG001|STARTED|Double-blind Phase||410
11216661|NCT01934218|12407735|FG000|Analyzed Participants|Double-blind Phase||402
11216662|NCT01934218|12407736|FG001|Analyzed Participants|Double-blind Phase||407
11216663|NCT01934218|12407735|FG000|COMPLETED|Double-blind Phase||356
11216664|NCT01934218|12407736|FG001|COMPLETED|Double-blind Phase||356
11216665|NCT01934218|12407735|FG000|NOT COMPLETED|Double-blind Phase||48
11216666|NCT01934218|12407736|FG001|NOT COMPLETED|Double-blind Phase||54
11216667|NCT01934218|12407735|FG000|STARTED|Open-Label Phase||316
11216668|NCT01934218|12407736|FG001|STARTED|Open-Label Phase||328
11216669|NCT01934218|12407735|FG000|COMPLETED|Open-Label Phase||290
11216670|NCT01934218|12407736|FG001|COMPLETED|Open-Label Phase||304
11216671|NCT01934218|12407735|FG000|NOT COMPLETED|Open-Label Phase||26
11216672|NCT01934218|12407736|FG001|NOT COMPLETED|Open-Label Phase||24
11216673|NCT01934231|12407742|FG000|STARTED|Overall Study||27
11216674|NCT01934231|12407742|FG000|COMPLETED|Overall Study||27
11097841|NCT01212770|12281313|FG003|STARTED|Long-term Safety Phase (Year 4)||0
11097842|NCT01212770|12281314|FG004|STARTED|Long-term Safety Phase (Year 4)||0
11097843|NCT01212770|12281315|FG005|STARTED|Long-term Safety Phase (Year 4)||0
11097844|NCT01212770|12281316|FG006|STARTED|Long-term Safety Phase (Year 4)||0
11097845|NCT01212770|12281317|FG007|STARTED|Long-term Safety Phase (Year 4)||35
11097846|NCT01212770|12281318|FG008|STARTED|Long-term Safety Phase (Year 4)||44
11097847|NCT01212770|12281310|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0
11097848|NCT01212770|12281311|FG001|COMPLETED|Long-term Safety Phase (Year 4)||71
11097849|NCT01212770|12281312|FG002|COMPLETED|Long-term Safety Phase (Year 4)||83
11097850|NCT01212770|12281313|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0
11097851|NCT01212770|12281314|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0
11097852|NCT01212770|12281315|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0
11097853|NCT01212770|12281316|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0
11097854|NCT01212770|12281317|FG007|COMPLETED|Long-term Safety Phase (Year 4)||32
11097855|NCT01212770|12281318|FG008|COMPLETED|Long-term Safety Phase (Year 4)||42
11097856|NCT01212770|12281310|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
11097857|NCT01212770|12281311|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
11097858|NCT01212770|12281312|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
11097859|NCT01212770|12281313|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
11097860|NCT01212770|12281314|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
11097861|NCT01212770|12281315|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
11097862|NCT01212770|12281316|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
11097863|NCT01212770|12281317|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
11097864|NCT01212770|12281318|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
11097865|NCT01212770|12281310|FG000|STARTED|Long-term Safety Phase (Year 5)||0
11216675|NCT01934231|12407742|FG000|NOT COMPLETED|Overall Study||0
11216676|NCT01934335|12407748|FG000|STARTED|Overall Study||7
11216677|NCT01934335|12407749|FG001|STARTED|Overall Study||5
11216678|NCT01934335|12407748|FG000|COMPLETED|Overall Study||6
11216679|NCT01934335|12407749|FG001|COMPLETED|Overall Study||4
11216680|NCT01934335|12407748|FG000|NOT COMPLETED|Overall Study||1
11216681|NCT01934335|12407749|FG001|NOT COMPLETED|Overall Study||1
11216682|NCT01934517|12407755|FG000|STARTED|Overall Study||25
11216683|NCT01934517|12407755|FG000|COMPLETED|Overall Study||25
11216684|NCT01934517|12407755|FG000|NOT COMPLETED|Overall Study||0
11216685|NCT01934556|12407766|FG000|STARTED|Overall Study||30
11216686|NCT01934556|12407767|FG001|STARTED|Overall Study||60
11216687|NCT01934556|12407768|FG002|STARTED|Overall Study||60
11216688|NCT01934556|12407766|FG000|COMPLETED|Overall Study||25
11216689|NCT01934556|12407767|FG001|COMPLETED|Overall Study||44
11216690|NCT01934556|12407768|FG002|COMPLETED|Overall Study||50
11216691|NCT01934556|12407766|FG000|NOT COMPLETED|Overall Study||5
11216692|NCT01934556|12407767|FG001|NOT COMPLETED|Overall Study||16
11216693|NCT01934556|12407768|FG002|NOT COMPLETED|Overall Study||10
11216694|NCT01934582|12407776|FG000|STARTED|Overall Study||13
11216695|NCT01934582|12407776|FG000|COMPLETED|Overall Study||13
11216696|NCT01934582|12407776|FG000|NOT COMPLETED|Overall Study||0
11216697|NCT01934790|12407782|FG000|STARTED|Treatment|Eligible for treatment|45
11216698|NCT01934790|12407782|FG000|Participants Received Study Treatment|Treatment||44
11216699|NCT01934790|12407782|FG000|COMPLETED|Treatment||29
11216700|NCT01934790|12407782|FG000|NOT COMPLETED|Treatment||16
11216701|NCT01934790|12407782|FG000|STARTED|Active Follow up||34
11216702|NCT01934790|12407782|FG000|COMPLETED|Active Follow up||10
11216703|NCT01934790|12407782|FG000|NOT COMPLETED|Active Follow up||24
11216704|NCT01934790|12407782|FG000|STARTED|Long Term Follow up||12
11216705|NCT01934790|12407782|FG000|COMPLETED|Long Term Follow up||12
11216706|NCT01934790|12407782|FG000|NOT COMPLETED|Long Term Follow up||0
11216707|NCT01934894|12407788|FG000|STARTED|Overall Study||6
11216708|NCT01934894|12407789|FG001|STARTED|Overall Study||5
11216709|NCT01934894|12407788|FG000|COMPLETED|Overall Study||0
11216710|NCT01934894|12407789|FG001|COMPLETED|Overall Study||0
11216711|NCT01934894|12407788|FG000|NOT COMPLETED|Overall Study||6
11216712|NCT01934894|12407789|FG001|NOT COMPLETED|Overall Study||5
11216713|NCT01934972|12407800|FG000|STARTED|Overall Study||13
11216714|NCT01934972|12407801|FG001|STARTED|Overall Study||11
11216715|NCT01934972|12407800|FG000|COMPLETED|Overall Study||4
11216716|NCT01934972|12407801|FG001|COMPLETED|Overall Study||5
11216717|NCT01934972|12407800|FG000|NOT COMPLETED|Overall Study||9
11216718|NCT01934972|12407801|FG001|NOT COMPLETED|Overall Study||6
11216719|NCT01935180|12407809|FG000|STARTED|Overall Study||573
11216720|NCT01935180|12407810|FG001|STARTED|Overall Study||575
11216721|NCT01935180|12407809|FG000|COMPLETED|Overall Study||552
11216722|NCT01935180|12407810|FG001|COMPLETED|Overall Study||561
11216723|NCT01935180|12407809|FG000|NOT COMPLETED|Overall Study||21
11216724|NCT01935180|12407810|FG001|NOT COMPLETED|Overall Study||14
11216725|NCT01935622|12407819|FG000|STARTED|Overall Study||3
11216726|NCT01935622|12407820|FG001|STARTED|Overall Study||3
11216727|NCT01935622|12407821|FG002|STARTED|Overall Study||4
11216728|NCT01935622|12407819|FG000|COMPLETED|Overall Study||1
11216729|NCT01935622|12407820|FG001|COMPLETED|Overall Study||1
11216730|NCT01935622|12407821|FG002|COMPLETED|Overall Study||4
11216731|NCT01935622|12407819|FG000|NOT COMPLETED|Overall Study||2
11216732|NCT01935622|12407820|FG001|NOT COMPLETED|Overall Study||2
11216733|NCT01935622|12407821|FG002|NOT COMPLETED|Overall Study||0
11216734|NCT01935700|12407831|FG000|STARTED|Overall Study||14
11216735|NCT01935700|12407832|FG001|STARTED|Overall Study||86
11216736|NCT01935700|12407831|FG000|COMPLETED|Overall Study||9
11216737|NCT01935700|12407832|FG001|COMPLETED|Overall Study||86
11216738|NCT01935700|12407831|FG000|NOT COMPLETED|Overall Study||5
11216739|NCT01935700|12407832|FG001|NOT COMPLETED|Overall Study||0
11216740|NCT01935791|12407840|FG000|STARTED|Period 1||4
11216741|NCT01935791|12407841|FG001|STARTED|Period 1||4
11216742|NCT01935791|12407842|FG002|STARTED|Period 1||3
11216743|NCT01935791|12407843|FG003|STARTED|Period 1||0
11216744|NCT01935791|12407844|FG004|STARTED|Period 1||0
11216745|NCT01935791|12407845|FG005|STARTED|Period 1||0
11216746|NCT01935791|12407846|FG006|STARTED|Period 1||0
11216747|NCT01935791|12407847|FG007|STARTED|Period 1||0
11216748|NCT01935791|12407848|FG008|STARTED|Period 1||0
11216749|NCT01935791|12407840|FG000|COMPLETED|Period 1||4
11216750|NCT01935791|12407841|FG001|COMPLETED|Period 1||4
11216751|NCT01935791|12407842|FG002|COMPLETED|Period 1||3
11216752|NCT01935791|12407843|FG003|COMPLETED|Period 1||0
11216753|NCT01935791|12407844|FG004|COMPLETED|Period 1||0
11216754|NCT01935791|12407845|FG005|COMPLETED|Period 1||0
11216755|NCT01935791|12407846|FG006|COMPLETED|Period 1||0
11216756|NCT01935791|12407847|FG007|COMPLETED|Period 1||0
11216757|NCT01935791|12407848|FG008|COMPLETED|Period 1||0
11216758|NCT01935791|12407840|FG000|NOT COMPLETED|Period 1||0
11216759|NCT01935791|12407841|FG001|NOT COMPLETED|Period 1||0
11216760|NCT01935791|12407842|FG002|NOT COMPLETED|Period 1||0
11216761|NCT01935791|12407843|FG003|NOT COMPLETED|Period 1||0
11216762|NCT01935791|12407844|FG004|NOT COMPLETED|Period 1||0
11216763|NCT01935791|12407845|FG005|NOT COMPLETED|Period 1||0
11216764|NCT01935791|12407846|FG006|NOT COMPLETED|Period 1||0
11216765|NCT01935791|12407847|FG007|NOT COMPLETED|Period 1||0
11216766|NCT01935791|12407848|FG008|NOT COMPLETED|Period 1||0
11216767|NCT01935791|12407840|FG000|STARTED|Period 2||0
11216768|NCT01935791|12407841|FG001|STARTED|Period 2||0
11216769|NCT01935791|12407842|FG002|STARTED|Period 2||0
11216770|NCT01935791|12407843|FG003|STARTED|Period 2||2
11216771|NCT01935791|12407844|FG004|STARTED|Period 2||3
11216772|NCT01935791|12407845|FG005|STARTED|Period 2||1
11216773|NCT01935791|12407846|FG006|STARTED|Period 2||1
11216774|NCT01935791|12407847|FG007|STARTED|Period 2||3
11216775|NCT01935791|12407848|FG008|STARTED|Period 2||1
11216776|NCT01935791|12407840|FG000|COMPLETED|Period 2||0
11216777|NCT01935791|12407841|FG001|COMPLETED|Period 2||0
11216778|NCT01935791|12407842|FG002|COMPLETED|Period 2||0
11216779|NCT01935791|12407843|FG003|COMPLETED|Period 2||2
11216780|NCT01935791|12407844|FG004|COMPLETED|Period 2||3
11216781|NCT01935791|12407845|FG005|COMPLETED|Period 2||1
11216782|NCT01935791|12407846|FG006|COMPLETED|Period 2||1
11216783|NCT01935791|12407847|FG007|COMPLETED|Period 2||3
11216784|NCT01935791|12407848|FG008|COMPLETED|Period 2||1
11216785|NCT01935791|12407840|FG000|NOT COMPLETED|Period 2||0
11216786|NCT01935791|12407841|FG001|NOT COMPLETED|Period 2||0
11216787|NCT01935791|12407842|FG002|NOT COMPLETED|Period 2||0
11097866|NCT01212770|12281311|FG001|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
11097867|NCT01212770|12281312|FG002|STARTED|Long-term Safety Phase (Year 5)||83
11097868|NCT01212770|12281313|FG003|STARTED|Long-term Safety Phase (Year 5)||0
11097869|NCT01212770|12281314|FG004|STARTED|Long-term Safety Phase (Year 5)||0
11097870|NCT01212770|12281315|FG005|STARTED|Long-term Safety Phase (Year 5)||0
11097871|NCT01212770|12281316|FG006|STARTED|Long-term Safety Phase (Year 5)||0
11097872|NCT01212770|12281317|FG007|STARTED|Long-term Safety Phase (Year 5)||32
11097873|NCT01212770|12281318|FG008|STARTED|Long-term Safety Phase (Year 5)||42
11097874|NCT01212770|12281310|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0
11097875|NCT01212770|12281311|FG001|COMPLETED|Long-term Safety Phase (Year 5)||68
11097876|NCT01212770|12281312|FG002|COMPLETED|Long-term Safety Phase (Year 5)||72
11216788|NCT01935791|12407843|FG003|NOT COMPLETED|Period 2||0
11216789|NCT01935791|12407844|FG004|NOT COMPLETED|Period 2||0
11216790|NCT01935791|12407845|FG005|NOT COMPLETED|Period 2||0
11216791|NCT01935791|12407846|FG006|NOT COMPLETED|Period 2||0
11216792|NCT01935791|12407847|FG007|NOT COMPLETED|Period 2||0
11216793|NCT01935791|12407848|FG008|NOT COMPLETED|Period 2||0
11216794|NCT01936181|12407864|FG000|STARTED|Randomised, Double-blind||291
11216795|NCT01936181|12407865|FG001|STARTED|Randomised, Double-blind||293
11216796|NCT01936181|12407866|FG002|STARTED|Randomised, Double-blind||0
11216797|NCT01936181|12407867|FG003|STARTED|Randomised, Double-blind||0
11216798|NCT01936181|12407864|FG000|COMPLETED|Randomised, Double-blind||227
11216799|NCT01936181|12407865|FG001|COMPLETED|Randomised, Double-blind||225
11216800|NCT01936181|12407866|FG002|COMPLETED|Randomised, Double-blind||0
11216801|NCT01936181|12407867|FG003|COMPLETED|Randomised, Double-blind||0
11216802|NCT01936181|12407864|FG000|NOT COMPLETED|Randomised, Double-blind||64
11216803|NCT01936181|12407865|FG001|NOT COMPLETED|Randomised, Double-blind||68
11216804|NCT01936181|12407866|FG002|NOT COMPLETED|Randomised, Double-blind||0
11216805|NCT01936181|12407867|FG003|NOT COMPLETED|Randomised, Double-blind||0
11216806|NCT01936181|12407864|FG000|STARTED|Transition-extension||201
11353164|NCT03054350|12550272|FG005|COMPLETED|Dose Adjustment and Maintenance Period||2
11353165|NCT03054350|12550267|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
11353166|NCT03054350|12550268|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
11353167|NCT03054350|12550269|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
11353168|NCT03054350|12550270|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
11353169|NCT03054350|12550271|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
11353170|NCT03054350|12550272|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
11353171|NCT03054428|12550306|FG000|STARTED|Overall Study||85
11353172|NCT03054428|12550307|FG001|STARTED|Overall Study||84
11353173|NCT03054428|12550308|FG002|STARTED|Overall Study||82
11353174|NCT03054428|12550306|FG000|Completed Wk 16 End of Treatment (EOT)|Overall Study||80
11353175|NCT03054428|12550307|FG001|Completed Wk 16 End of Treatment (EOT)|Overall Study||81
11353176|NCT03054428|12550308|FG002|Completed Wk 16 End of Treatment (EOT)|Overall Study||79
11353177|NCT03054428|12550306|FG000|Completed Week 28 (End of Study)|Overall Study||2
11353178|NCT03054428|12550307|FG001|Completed Week 28 (End of Study)|Overall Study||4
11353179|NCT03054428|12550308|FG002|Completed Week 28 (End of Study)|Overall Study||3
11353180|NCT03054428|12550306|FG000|COMPLETED|Overall Study||2
11353181|NCT03054428|12550307|FG001|COMPLETED|Overall Study||4
11353182|NCT03054428|12550308|FG002|COMPLETED|Overall Study||3
11353183|NCT03054428|12550306|FG000|NOT COMPLETED|Overall Study||83
11353184|NCT03054428|12550307|FG001|NOT COMPLETED|Overall Study||80
11353185|NCT03054428|12550308|FG002|NOT COMPLETED|Overall Study||79
11353186|NCT03054506|12550319|FG000|STARTED|Overall Study||20
11353187|NCT03054506|12550320|FG001|STARTED|Overall Study||11
11353188|NCT03054506|12550321|FG002|STARTED|Overall Study||9
11353189|NCT03054506|12550319|FG000|COMPLETED|Overall Study||19
11353190|NCT03054506|12550320|FG001|COMPLETED|Overall Study||11
11353191|NCT03054506|12550321|FG002|COMPLETED|Overall Study||9
11353192|NCT03054506|12550319|FG000|NOT COMPLETED|Overall Study||1
11353193|NCT03054506|12550320|FG001|NOT COMPLETED|Overall Study||0
11353194|NCT03054506|12550321|FG002|NOT COMPLETED|Overall Study||0
11097877|NCT01212770|12281313|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0
11097878|NCT01212770|12281314|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0
11097879|NCT01212770|12281315|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0
11097880|NCT01212770|12281316|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0
11097881|NCT01212770|12281317|FG007|COMPLETED|Long-term Safety Phase (Year 5)||30
11097882|NCT01212770|12281318|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41
11097883|NCT01212770|12281310|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
11097884|NCT01212770|12281311|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
11097885|NCT01212770|12281312|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
11097886|NCT01212770|12281313|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
11097887|NCT01212770|12281314|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
11216807|NCT01936181|12407865|FG001|STARTED|Transition-extension||0
11216808|NCT01936181|12407866|FG002|STARTED|Transition-extension||94
11216809|NCT01936181|12407867|FG003|STARTED|Transition-extension||101
11216810|NCT01936181|12407864|FG000|COMPLETED|Transition-extension||186
11216811|NCT01936181|12407865|FG001|COMPLETED|Transition-extension||0
11216812|NCT01936181|12407866|FG002|COMPLETED|Transition-extension||88
11216813|NCT01936181|12407867|FG003|COMPLETED|Transition-extension||96
11216814|NCT01936181|12407864|FG000|NOT COMPLETED|Transition-extension||15
11216815|NCT01936181|12407865|FG001|NOT COMPLETED|Transition-extension||0
11216816|NCT01936181|12407866|FG002|NOT COMPLETED|Transition-extension||6
11216817|NCT01936181|12407867|FG003|NOT COMPLETED|Transition-extension||5
11216818|NCT01936259|12407880|FG000|STARTED|Overall Study||130
11216819|NCT01936259|12407881|FG001|STARTED|Overall Study||131
11216820|NCT01936259|12407880|FG000|COMPLETED|Overall Study||118
11216821|NCT01936259|12407881|FG001|COMPLETED|Overall Study||111
11216822|NCT01936259|12407880|FG000|NOT COMPLETED|Overall Study||12
11216823|NCT01936259|12407881|FG001|NOT COMPLETED|Overall Study||20
11353195|NCT03054649|12550329|FG000|STARTED|Overall Study||27
11353196|NCT03054649|12550330|FG001|STARTED|Overall Study||27
11353197|NCT03054649|12550329|FG000|COMPLETED|Overall Study||27
11353198|NCT03054649|12550330|FG001|COMPLETED|Overall Study||27
11216824|NCT01936324|12407890|FG000|STARTED|Overall Study||6
11216825|NCT01936324|12407891|FG001|STARTED|Overall Study||53
11216826|NCT01936324|12407892|FG002|STARTED|Overall Study||55
11216827|NCT01936324|12407890|FG000|COMPLETED|Overall Study||6
11216828|NCT01936324|12407891|FG001|COMPLETED|Overall Study||47
11216829|NCT01936324|12407892|FG002|COMPLETED|Overall Study||50
11216830|NCT01936324|12407890|FG000|NOT COMPLETED|Overall Study||0
11216831|NCT01936324|12407891|FG001|NOT COMPLETED|Overall Study||6
11216832|NCT01936324|12407892|FG002|NOT COMPLETED|Overall Study||5
11216833|NCT01936363|12407901|FG000|STARTED|Overall Study||32
11216834|NCT01936363|12407902|FG001|STARTED|Overall Study||33
11216835|NCT01936363|12407901|FG000|COMPLETED|Overall Study||32
11216836|NCT01936363|12407902|FG001|COMPLETED|Overall Study||33
11216837|NCT01936363|12407901|FG000|NOT COMPLETED|Overall Study||0
11216838|NCT01936363|12407902|FG001|NOT COMPLETED|Overall Study||0
11216839|NCT01936389|12407910|FG000|STARTED|Overall Study||5
11216840|NCT01936389|12407911|FG001|STARTED|Overall Study||5
11216841|NCT01936389|12407910|FG000|COMPLETED|Overall Study||4
11216842|NCT01936389|12407911|FG001|COMPLETED|Overall Study||5
11216843|NCT01936389|12407910|FG000|NOT COMPLETED|Overall Study||1
11216844|NCT01936389|12407911|FG001|NOT COMPLETED|Overall Study||0
11216845|NCT01936467|12407919|FG000|STARTED|Overall Study||60
11216846|NCT01936467|12407920|FG001|STARTED|Overall Study||61
11216847|NCT01936467|12407919|FG000|COMPLETED|Overall Study||60
11216848|NCT01936467|12407920|FG001|COMPLETED|Overall Study||61
11216849|NCT01936467|12407919|FG000|NOT COMPLETED|Overall Study||0
11216850|NCT01936467|12407920|FG001|NOT COMPLETED|Overall Study||0
11216851|NCT01936519|12407932|FG000|STARTED|Overall Study||12
11216852|NCT01936519|12407933|FG001|STARTED|Overall Study||12
11216853|NCT01936519|12407932|FG000|COMPLETED|Overall Study||11
11216854|NCT01936519|12407933|FG001|COMPLETED|Overall Study||8
11216855|NCT01936519|12407932|FG000|NOT COMPLETED|Overall Study||1
11216856|NCT01936519|12407933|FG001|NOT COMPLETED|Overall Study||4
11216857|NCT01936623|12407944|FG000|STARTED|Overall Study||40
11216858|NCT01936623|12407945|FG001|STARTED|Overall Study||40
11216859|NCT01936623|12407944|FG000|COMPLETED|Overall Study||40
11216860|NCT01936623|12407945|FG001|COMPLETED|Overall Study||35
11216861|NCT01936623|12407944|FG000|NOT COMPLETED|Overall Study||0
11216862|NCT01936623|12407945|FG001|NOT COMPLETED|Overall Study||5
11216863|NCT01936649|12407951|FG000|STARTED|Overall Study||63
11216864|NCT01936649|12407951|FG000|Treated|Overall Study||51
11216865|NCT01936649|12407951|FG000|COMPLETED|Overall Study||50
11216866|NCT01936649|12407951|FG000|NOT COMPLETED|Overall Study||13
11216867|NCT01936662|12407957|FG000|STARTED|Overall Study||42
11216868|NCT01936662|12407958|FG001|STARTED|Overall Study||42
11216869|NCT01936662|12407957|FG000|COMPLETED|Overall Study||42
11216870|NCT01936662|12407958|FG001|COMPLETED|Overall Study||42
11216871|NCT01936662|12407957|FG000|NOT COMPLETED|Overall Study||0
11216872|NCT01936662|12407958|FG001|NOT COMPLETED|Overall Study||0
11216873|NCT01936844|12407968|FG000|STARTED|Overall Study||15
11216874|NCT01936844|12407969|FG001|STARTED|Overall Study||15
11216875|NCT01936844|12407968|FG000|COMPLETED|Overall Study||9
11216876|NCT01936844|12407969|FG001|COMPLETED|Overall Study||8
11216877|NCT01936844|12407968|FG000|NOT COMPLETED|Overall Study||6
11216878|NCT01936844|12407969|FG001|NOT COMPLETED|Overall Study||7
11216879|NCT01936870|12407975|FG000|STARTED|Overall Study||2492
11216880|NCT01936870|12407975|FG000|COMPLETED|Overall Study||2303
11216881|NCT01936870|12407975|FG000|NOT COMPLETED|Overall Study||189
11216882|NCT01936896|12407979|FG000|STARTED|Overall Study||10
11216883|NCT01936896|12407979|FG000|COMPLETED|Overall Study||10
11216884|NCT01936896|12407979|FG000|NOT COMPLETED|Overall Study||0
11216885|NCT01936909|12407986|FG000|STARTED|Overall Study||20
11216886|NCT01936909|12407987|FG001|STARTED|Overall Study||20
11216887|NCT01936909|12407988|FG002|STARTED|Overall Study||20
11216888|NCT01936909|12407986|FG000|COMPLETED|Overall Study||10
11216889|NCT01936909|12407987|FG001|COMPLETED|Overall Study||12
11216890|NCT01936909|12407988|FG002|COMPLETED|Overall Study||14
11216891|NCT01936909|12407986|FG000|NOT COMPLETED|Overall Study||10
11216892|NCT01936909|12407987|FG001|NOT COMPLETED|Overall Study||8
11216893|NCT01936909|12407988|FG002|NOT COMPLETED|Overall Study||6
11216894|NCT01936948|12408000|FG000|STARTED|Overall Study||227
11216895|NCT01936948|12408001|FG001|STARTED|Overall Study||231
11216896|NCT01936948|12408002|FG002|STARTED|Overall Study||237
11216897|NCT01936948|12408003|FG003|STARTED|Overall Study||233
11216898|NCT01936948|12408000|FG000|Crossover|Overall Study||31
11216899|NCT01936948|12408001|FG001|Crossover|Overall Study||27
11216900|NCT01936948|12408002|FG002|Crossover|Overall Study||22
11216901|NCT01936948|12408003|FG003|Crossover|Overall Study||25
11216902|NCT01936948|12408000|FG000|COMPLETED|Overall Study||227
11216903|NCT01936948|12408001|FG001|COMPLETED|Overall Study||228
11216904|NCT01936948|12408002|FG002|COMPLETED|Overall Study||234
11216905|NCT01936948|12408003|FG003|COMPLETED|Overall Study||230
11216906|NCT01936948|12408000|FG000|NOT COMPLETED|Overall Study||0
11216907|NCT01936948|12408001|FG001|NOT COMPLETED|Overall Study||3
11216908|NCT01936948|12408002|FG002|NOT COMPLETED|Overall Study||3
11216909|NCT01936948|12408003|FG003|NOT COMPLETED|Overall Study||3
11353199|NCT03054649|12550329|FG000|NOT COMPLETED|Overall Study||0
11353200|NCT03054649|12550330|FG001|NOT COMPLETED|Overall Study||0
11216910|NCT01937026|12408011|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
11216911|NCT01937026|12408011|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
11216912|NCT01937026|12408011|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
11216913|NCT01937026|12408011|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
11216914|NCT01937026|12408011|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
11216915|NCT01937026|12408011|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
11216916|NCT01937026|12408011|FG000|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
11216917|NCT01937026|12408011|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
11216918|NCT01937026|12408011|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
11216919|NCT01937117|12408018|FG000|STARTED|Overall Study||88
11216920|NCT01937117|12408018|FG000|COMPLETED|Overall Study||75
11216921|NCT01937117|12408018|FG000|NOT COMPLETED|Overall Study||13
11216922|NCT01937130|12408026|FG000|STARTED|Overall Study||5
11216923|NCT01937130|12408027|FG001|STARTED|Overall Study||7
11216924|NCT01937130|12408028|FG002|STARTED|Overall Study||5
11216925|NCT01937130|12408029|FG003|STARTED|Overall Study||4
11216926|NCT01937130|12408026|FG000|COMPLETED|Overall Study||0
11216927|NCT01937130|12408027|FG001|COMPLETED|Overall Study||3
11216928|NCT01937130|12408028|FG002|COMPLETED|Overall Study||2
11216929|NCT01937130|12408029|FG003|COMPLETED|Overall Study||2
11216930|NCT01937130|12408026|FG000|NOT COMPLETED|Overall Study||5
11216931|NCT01937130|12408027|FG001|NOT COMPLETED|Overall Study||4
11216932|NCT01937130|12408028|FG002|NOT COMPLETED|Overall Study||3
11216933|NCT01937130|12408029|FG003|NOT COMPLETED|Overall Study||2
11216934|NCT01937195|12408039|FG000|STARTED|Overall Study||95
11216935|NCT01937195|12408039|FG000|COMPLETED|Overall Study||95
11216936|NCT01937195|12408039|FG000|NOT COMPLETED|Overall Study||0
11216937|NCT01937260|12408045|FG000|STARTED|Overall Study||21
11216938|NCT01937260|12408046|FG001|STARTED|Overall Study||10
11216939|NCT01937260|12408045|FG000|COMPLETED|Overall Study||20
11216940|NCT01937260|12408046|FG001|COMPLETED|Overall Study||10
11097888|NCT01212770|12281315|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
11097889|NCT01212770|12281316|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
11097890|NCT01212770|12281317|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
11216941|NCT01937260|12408045|FG000|NOT COMPLETED|Overall Study||1
11216942|NCT01937260|12408046|FG001|NOT COMPLETED|Overall Study||0
11097891|NCT01212770|12281318|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
11097892|NCT01212874|12281342|FG000|STARTED|Overall Study||35
11097893|NCT01212874|12281343|FG001|STARTED|Overall Study||35
11097894|NCT01212874|12281342|FG000|Received Allocated Intervention|Overall Study||13
11097895|NCT01212874|12281343|FG001|Received Allocated Intervention|Overall Study||12
11097896|NCT01212874|12281342|FG000|COMPLETED|Overall Study||13
11097897|NCT01212874|12281343|FG001|COMPLETED|Overall Study||12
11097898|NCT01212874|12281342|FG000|NOT COMPLETED|Overall Study||22
11097899|NCT01212874|12281343|FG001|NOT COMPLETED|Overall Study||23
11097900|NCT01212900|12281351|FG000|STARTED|Overall Study||116
11097901|NCT01212900|12281352|FG001|STARTED|Overall Study||114
11097902|NCT01212900|12281351|FG000|COMPLETED|Overall Study||104
11097903|NCT01212900|12281352|FG001|COMPLETED|Overall Study||107
11097904|NCT01212900|12281351|FG000|NOT COMPLETED|Overall Study||12
11097905|NCT01212900|12281352|FG001|NOT COMPLETED|Overall Study||7
11097906|NCT01212952|12281361|FG000|STARTED|Overall Study||3
11097907|NCT01212952|12281362|FG001|STARTED|Overall Study||6
11097908|NCT01212952|12281363|FG002|STARTED|Overall Study||41
11097909|NCT01212952|12281361|FG000|COMPLETED|Overall Study||3
11097910|NCT01212952|12281362|FG001|COMPLETED|Overall Study||6
11216943|NCT01937299|12408054|FG000|STARTED|Overall Study||117
11216944|NCT01937299|12408055|FG001|STARTED|Overall Study||116
11097911|NCT01212952|12281363|FG002|COMPLETED|Overall Study||41
11097912|NCT01212952|12281361|FG000|NOT COMPLETED|Overall Study||0
11097913|NCT01212952|12281362|FG001|NOT COMPLETED|Overall Study||0
11097914|NCT01212952|12281363|FG002|NOT COMPLETED|Overall Study||0
11097915|NCT01212991|12281375|FG000|STARTED|Double-blind||872
11097916|NCT01212991|12281376|FG001|STARTED|Double-blind||845
11097917|NCT01212991|12281377|FG002|STARTED|Double-blind||0
11097918|NCT01212991|12281375|FG000|Safety Population|Double-blind||871
11097919|NCT01212991|12281376|FG001|Safety Population|Double-blind||844
11097920|NCT01212991|12281377|FG002|Safety Population|Double-blind||0
11097921|NCT01212991|12281375|FG000|COMPLETED|Double-blind||0
11097922|NCT01212991|12281376|FG001|COMPLETED|Double-blind||234
11097923|NCT01212991|12281377|FG002|COMPLETED|Double-blind||0
11097924|NCT01212991|12281375|FG000|NOT COMPLETED|Double-blind||872
11097925|NCT01212991|12281376|FG001|NOT COMPLETED|Double-blind||611
11097926|NCT01212991|12281377|FG002|NOT COMPLETED|Double-blind||0
11097927|NCT01212991|12281375|FG000|STARTED|Open-label||0
11097928|NCT01212991|12281376|FG001|STARTED|Open-label|participants were given the opportunity to receive open-label access to enzalutamide|0
11097929|NCT01212991|12281377|FG002|STARTED|Open-label|previous placebo treated participants were given the opportunity to receive enzalutamide|234
11097930|NCT01212991|12281375|FG000|COMPLETED|Open-label||0
11097931|NCT01212991|12281376|FG001|COMPLETED|Open-label||0
11216945|NCT01937299|12408054|FG000|COMPLETED|Overall Study||103
11216946|NCT01937299|12408055|FG001|COMPLETED|Overall Study||112
11216947|NCT01937299|12408054|FG000|NOT COMPLETED|Overall Study||14
11216948|NCT01937299|12408055|FG001|NOT COMPLETED|Overall Study||4
11216949|NCT01937312|12408064|FG000|STARTED|Overall Study||94
11216950|NCT01937312|12408065|FG001|STARTED|Overall Study||95
11216951|NCT01937312|12408064|FG000|Treated|Overall Study||93
11216952|NCT01937312|12408065|FG001|Treated|Overall Study||95
11097932|NCT01212991|12281377|FG002|COMPLETED|Open-label||0
11097933|NCT01212991|12281375|FG000|NOT COMPLETED|Open-label||0
11097934|NCT01212991|12281376|FG001|NOT COMPLETED|Open-label||0
11097935|NCT01212991|12281377|FG002|NOT COMPLETED|Open-label||234
11097936|NCT01213043|12281387|FG000|STARTED|Treatment Period 1||15
11097937|NCT01213043|12281388|FG001|STARTED|Treatment Period 1||15
11097938|NCT01213043|12281387|FG000|COMPLETED|Treatment Period 1||15
11097939|NCT01213043|12281388|FG001|COMPLETED|Treatment Period 1||15
11097940|NCT01213043|12281387|FG000|NOT COMPLETED|Treatment Period 1||0
11097941|NCT01213043|12281388|FG001|NOT COMPLETED|Treatment Period 1||0
11097942|NCT01213043|12281387|FG000|STARTED|Washout Period||15
11216953|NCT01937312|12408064|FG000|COMPLETED|Overall Study||83
11097943|NCT01213043|12281388|FG001|STARTED|Washout Period||15
11097944|NCT01213043|12281387|FG000|COMPLETED|Washout Period||15
11216954|NCT01937312|12408065|FG001|COMPLETED|Overall Study||92
11216955|NCT01937312|12408064|FG000|NOT COMPLETED|Overall Study||11
11216956|NCT01937312|12408065|FG001|NOT COMPLETED|Overall Study||3
11216957|NCT01937351|12408074|FG000|STARTED|Overall Study||134
11216958|NCT01937351|12408075|FG001|STARTED|Overall Study||28
11216959|NCT01937351|12408074|FG000|Treated w Study Device|Overall Study||130
11216960|NCT01937351|12408075|FG001|Treated w Study Device|Overall Study||28
11097945|NCT01213043|12281388|FG001|COMPLETED|Washout Period||15
11097946|NCT01213043|12281387|FG000|NOT COMPLETED|Washout Period||0
11097947|NCT01213043|12281388|FG001|NOT COMPLETED|Washout Period||0
11097948|NCT01213043|12281387|FG000|STARTED|Treatment Period 2||15
11097949|NCT01213043|12281388|FG001|STARTED|Treatment Period 2||15
11097950|NCT01213043|12281387|FG000|COMPLETED|Treatment Period 2||15
11097951|NCT01213043|12281388|FG001|COMPLETED|Treatment Period 2||15
11097952|NCT01213043|12281387|FG000|NOT COMPLETED|Treatment Period 2||0
11097953|NCT01213043|12281388|FG001|NOT COMPLETED|Treatment Period 2||0
11097954|NCT01213043|12281387|FG000|STARTED|Follow-up||15
11097955|NCT01213043|12281388|FG001|STARTED|Follow-up||15
11097956|NCT01213043|12281387|FG000|COMPLETED|Follow-up||15
11097957|NCT01213043|12281388|FG001|COMPLETED|Follow-up||15
11097958|NCT01213043|12281387|FG000|NOT COMPLETED|Follow-up||0
11097959|NCT01213043|12281388|FG001|NOT COMPLETED|Follow-up||0
11097960|NCT01213082|12281397|FG000|STARTED|Overall Study||12
11097961|NCT01213082|12281398|FG001|STARTED|Overall Study||11
11097962|NCT01213082|12281399|FG002|STARTED|Overall Study||11
11097963|NCT01213082|12281397|FG000|COMPLETED|Overall Study||6
11097964|NCT01213082|12281398|FG001|COMPLETED|Overall Study||4
11097965|NCT01213082|12281399|FG002|COMPLETED|Overall Study||6
11097966|NCT01213082|12281397|FG000|NOT COMPLETED|Overall Study||6
11097967|NCT01213082|12281398|FG001|NOT COMPLETED|Overall Study||7
11097968|NCT01213082|12281399|FG002|NOT COMPLETED|Overall Study||5
11097969|NCT01213173|12281409|FG000|STARTED|Overall Study|Patients who were randomized and received treatment|125
11097970|NCT01213173|12281410|FG001|STARTED|Overall Study|Patients who were randomized and received treatment|126
11097971|NCT01213173|12281409|FG000|Patients Included in Safety Population|Overall Study||139
11097972|NCT01213173|12281410|FG001|Patients Included in Safety Population|Overall Study||112
11097973|NCT01213173|12281409|FG000|Patients Included in ITT Population|Overall Study||116
11097974|NCT01213173|12281410|FG001|Patients Included in ITT Population|Overall Study||115
11097975|NCT01213173|12281409|FG000|Patients Included in PP Population|Overall Study||102
11097976|NCT01213173|12281410|FG001|Patients Included in PP Population|Overall Study||89
11097977|NCT01213173|12281409|FG000|COMPLETED|Overall Study|Patients who completed the study|113
11097978|NCT01213173|12281410|FG001|COMPLETED|Overall Study|Patients who completed the study|110
11097979|NCT01213173|12281409|FG000|NOT COMPLETED|Overall Study||12
11097980|NCT01213173|12281410|FG001|NOT COMPLETED|Overall Study||16
11097981|NCT01213199|12281416|FG000|STARTED|Overall Study||20
11097982|NCT01213199|12281416|FG000|COMPLETED|Overall Study||16
11097983|NCT01213199|12281416|FG000|NOT COMPLETED|Overall Study||4
11097984|NCT01213251|12281423|FG000|STARTED|Overall Study||40
11097985|NCT01213251|12281424|FG001|STARTED|Overall Study||41
11097986|NCT01213251|12281425|FG002|STARTED|Overall Study||45
11097987|NCT01213251|12281423|FG000|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
11097988|NCT01213251|12281424|FG001|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
11097989|NCT01213251|12281425|FG002|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
11097990|NCT01213251|12281423|FG000|NOT COMPLETED|Overall Study||6
11097991|NCT01213251|12281424|FG001|NOT COMPLETED|Overall Study||4
11097992|NCT01213251|12281425|FG002|NOT COMPLETED|Overall Study||11
11097993|NCT01213264|12281441|FG000|STARTED|Overall Study||155
11097994|NCT01213264|12281442|FG001|STARTED|Overall Study||177
11097995|NCT01213264|12281443|FG002|STARTED|Overall Study||327
11097996|NCT01213264|12281441|FG000|COMPLETED|Overall Study||153
11097997|NCT01213264|12281442|FG001|COMPLETED|Overall Study||175
11097998|NCT01213264|12281443|FG002|COMPLETED|Overall Study||321
11097999|NCT01213264|12281441|FG000|NOT COMPLETED|Overall Study||2
11098000|NCT01213264|12281442|FG001|NOT COMPLETED|Overall Study||2
11098001|NCT01213264|12281443|FG002|NOT COMPLETED|Overall Study||6
11098002|NCT01213316|12281454|FG000|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
11216961|NCT01937351|12408074|FG000|30-Day Follow-up|Overall Study||128
11216962|NCT01937351|12408075|FG001|30-Day Follow-up|Overall Study||27
11216963|NCT01937351|12408074|FG000|6-Month Follow-up|Overall Study||125
11216964|NCT01937351|12408075|FG001|6-Month Follow-up|Overall Study||26
11216965|NCT01937351|12408074|FG000|COMPLETED|Overall Study||125
11353201|NCT03054740|12550361|FG000|STARTED|Overall Study||15
11098003|NCT01213316|12281454|FG000|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
11098004|NCT01213316|12281454|FG000|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
11098005|NCT01213316|12281454|FG000|Discontinued Treatment Before 48 Weeks|Overall Study||67
11098006|NCT01213316|12281454|FG000|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
11216966|NCT01937351|12408075|FG001|COMPLETED|Overall Study||26
11098007|NCT01213316|12281454|FG000|COMPLETED|Overall Study||451
11098008|NCT01213316|12281454|FG000|NOT COMPLETED|Overall Study||0
11098009|NCT01213472|12281462|FG000|STARTED|Overall Study||33
11098010|NCT01213472|12281462|FG000|COMPLETED|Overall Study||6
11098011|NCT01213472|12281462|FG000|NOT COMPLETED|Overall Study||27
11098012|NCT01213524|12281468|FG000|STARTED|Baseline|Total number who signed informed consent.|75
11216967|NCT01937351|12408074|FG000|NOT COMPLETED|Overall Study||9
11216968|NCT01937351|12408075|FG001|NOT COMPLETED|Overall Study||2
11216969|NCT01937364|12408082|FG000|STARTED|Overall Study||9
11216970|NCT01937364|12408083|FG001|STARTED|Overall Study||8
11216971|NCT01937364|12408082|FG000|COMPLETED|Overall Study||7
11216972|NCT01937364|12408083|FG001|COMPLETED|Overall Study||7
11216973|NCT01937364|12408082|FG000|NOT COMPLETED|Overall Study||2
11216974|NCT01937364|12408083|FG001|NOT COMPLETED|Overall Study||1
11216975|NCT01937390|12408089|FG000|STARTED|Overall Study||585
11216976|NCT01937390|12408089|FG000|COMPLETED|Overall Study||550
11216977|NCT01937390|12408089|FG000|NOT COMPLETED|Overall Study||35
11216978|NCT01937520|12408095|FG000|STARTED|Overall Study||11
11216979|NCT01937520|12408096|FG001|STARTED|Overall Study||9
11216980|NCT01937520|12408095|FG000|COMPLETED|Overall Study||11
11216981|NCT01937520|12408096|FG001|COMPLETED|Overall Study||9
11216982|NCT01937520|12408095|FG000|NOT COMPLETED|Overall Study||0
11216983|NCT01937520|12408096|FG001|NOT COMPLETED|Overall Study||0
11216984|NCT01937559|12408106|FG000|STARTED|Overall Study||61
11216985|NCT01937559|12408107|FG001|STARTED|Overall Study||61
11216986|NCT01937559|12408108|FG002|STARTED|Overall Study||66
11216987|NCT01937559|12408106|FG000|COMPLETED|Overall Study||50
11216988|NCT01937559|12408107|FG001|COMPLETED|Overall Study||50
11216989|NCT01937559|12408108|FG002|COMPLETED|Overall Study||66
11216990|NCT01937559|12408106|FG000|NOT COMPLETED|Overall Study||11
11216991|NCT01937559|12408107|FG001|NOT COMPLETED|Overall Study||11
11216992|NCT01937559|12408108|FG002|NOT COMPLETED|Overall Study||0
11216993|NCT01937598|12408120|FG000|STARTED|Overall Study||8
11098013|NCT01213524|12281468|FG000|COMPLETED|Baseline|Number of participants who continued in the study past baseline|68
11098014|NCT01213524|12281468|FG000|NOT COMPLETED|Baseline||7
11098015|NCT01213524|12281468|FG000|STARTED|Session 2||68
11216994|NCT01937598|12408121|FG001|STARTED|Overall Study||8
11216995|NCT01937598|12408120|FG000|COMPLETED|Overall Study||8
11216996|NCT01937598|12408121|FG001|COMPLETED|Overall Study||8
11216997|NCT01937598|12408120|FG000|NOT COMPLETED|Overall Study||0
11216998|NCT01937598|12408121|FG001|NOT COMPLETED|Overall Study||0
11216999|NCT01937624|12408127|FG000|STARTED|Overall Study||51
11217000|NCT01937624|12408127|FG000|COMPLETED|Overall Study||51
11217001|NCT01937624|12408127|FG000|NOT COMPLETED|Overall Study||0
11217002|NCT01937715|12408136|FG000|STARTED|Overall Study||3
11217003|NCT01937715|12408137|FG001|STARTED|Overall Study||4
11217004|NCT01937715|12408138|FG002|STARTED|Overall Study||3
11217005|NCT01937715|12408139|FG003|STARTED|Overall Study||5
11217006|NCT01937715|12408140|FG004|STARTED|Overall Study||3
11217007|NCT01937715|12408136|FG000|COMPLETED|Overall Study||3
11217008|NCT01937715|12408137|FG001|COMPLETED|Overall Study||3
11217009|NCT01937715|12408138|FG002|COMPLETED|Overall Study||3
11217010|NCT01937715|12408139|FG003|COMPLETED|Overall Study||1
11217011|NCT01937715|12408140|FG004|COMPLETED|Overall Study||1
11217012|NCT01937715|12408136|FG000|NOT COMPLETED|Overall Study||0
11217013|NCT01937715|12408137|FG001|NOT COMPLETED|Overall Study||1
11217014|NCT01937715|12408138|FG002|NOT COMPLETED|Overall Study||0
11217015|NCT01937715|12408139|FG003|NOT COMPLETED|Overall Study||4
11217016|NCT01937715|12408140|FG004|NOT COMPLETED|Overall Study||2
11217017|NCT01937871|12408155|FG000|STARTED|Overall Study||361
11217018|NCT01937871|12408156|FG001|STARTED|Overall Study||363
11217019|NCT01937871|12408157|FG002|STARTED|Overall Study||185
11217020|NCT01937871|12408155|FG000|Received at Least One Dose of Study Drug|Overall Study||361
11217021|NCT01937871|12408156|FG001|Received at Least One Dose of Study Drug|Overall Study||362
11217022|NCT01937871|12408157|FG002|Received at Least One Dose of Study Drug|Overall Study||185
11098016|NCT01213524|12281468|FG000|COMPLETED|Session 2|Number who continued in the study to the next session|63
11098017|NCT01213524|12281468|FG000|NOT COMPLETED|Session 2||5
11098018|NCT01213524|12281468|FG000|STARTED|Session 3||63
11098019|NCT01213524|12281468|FG000|COMPLETED|Session 3|Number who continued in study to next session|59
11098020|NCT01213524|12281468|FG000|NOT COMPLETED|Session 3||4
11098021|NCT01213524|12281468|FG000|STARTED|Session 4||59
11098022|NCT01213524|12281468|FG000|COMPLETED|Session 4|Number who continued in the study to the next session|56
11098023|NCT01213524|12281468|FG000|NOT COMPLETED|Session 4||3
11217023|NCT01937871|12408155|FG000|COMPLETED|Overall Study||337
11217024|NCT01937871|12408156|FG001|COMPLETED|Overall Study||346
11217025|NCT01937871|12408157|FG002|COMPLETED|Overall Study||174
11217026|NCT01937871|12408155|FG000|NOT COMPLETED|Overall Study||24
11217027|NCT01937871|12408156|FG001|NOT COMPLETED|Overall Study||17
11217028|NCT01937871|12408157|FG002|NOT COMPLETED|Overall Study||11
11217029|NCT01937884|12408170|FG000|STARTED|Overall Study||7
11217030|NCT01937884|12408171|FG001|STARTED|Overall Study||11
11217031|NCT01937884|12408170|FG000|COMPLETED|Overall Study||6
11217032|NCT01937884|12408171|FG001|COMPLETED|Overall Study||11
11217033|NCT01937884|12408170|FG000|NOT COMPLETED|Overall Study||1
11217034|NCT01937884|12408171|FG001|NOT COMPLETED|Overall Study||0
11217035|NCT01937975|12408182|FG000|STARTED|Overall Study||8
11217036|NCT01937975|12408183|FG001|STARTED|Overall Study||8
11098024|NCT01213524|12281468|FG000|STARTED|Session 5||56
11098025|NCT01213524|12281468|FG000|COMPLETED|Session 5|Number who continued in the study to the next session|56
11098026|NCT01213524|12281468|FG000|NOT COMPLETED|Session 5||0
11098027|NCT01213524|12281468|FG000|STARTED|Session 6||56
11098028|NCT01213524|12281468|FG000|COMPLETED|Session 6|Number who continued in the study to the next session|56
11217037|NCT01937975|12408184|FG002|STARTED|Overall Study||8
11217038|NCT01937975|12408182|FG000|COMPLETED|Overall Study||8
11217039|NCT01937975|12408183|FG001|COMPLETED|Overall Study||8
11217040|NCT01937975|12408184|FG002|COMPLETED|Overall Study||8
11098029|NCT01213524|12281468|FG000|NOT COMPLETED|Session 6||0
11217041|NCT01937975|12408182|FG000|NOT COMPLETED|Overall Study||0
11217042|NCT01937975|12408183|FG001|NOT COMPLETED|Overall Study||0
11217043|NCT01937975|12408184|FG002|NOT COMPLETED|Overall Study||0
11217044|NCT01938040|12408198|FG000|STARTED|Overall Study||28
11217045|NCT01938040|12408199|FG001|STARTED|Overall Study||27
11217046|NCT01938040|12408198|FG000|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
11217047|NCT01938040|12408199|FG001|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
11217048|NCT01938040|12408198|FG000|Behavior Metrics|Overall Study||28
11217049|NCT01938040|12408199|FG001|Behavior Metrics|Overall Study||27
11217050|NCT01938040|12408198|FG000|COMPLETED|Overall Study||28
11217051|NCT01938040|12408199|FG001|COMPLETED|Overall Study||27
11217052|NCT01938040|12408198|FG000|NOT COMPLETED|Overall Study||0
11217053|NCT01938040|12408199|FG001|NOT COMPLETED|Overall Study||0
11217054|NCT01938066|12408213|FG000|STARTED|Overall Study||15
11217055|NCT01938066|12408214|FG001|STARTED|Overall Study||15
11217056|NCT01938066|12408213|FG000|COMPLETED|Overall Study||14
11217057|NCT01938066|12408214|FG001|COMPLETED|Overall Study||13
11217058|NCT01938066|12408213|FG000|NOT COMPLETED|Overall Study||1
11217059|NCT01938066|12408214|FG001|NOT COMPLETED|Overall Study||2
11217060|NCT01938079|12408222|FG000|STARTED|Overall Study||10
11217061|NCT01938079|12408223|FG001|STARTED|Overall Study||10
11217062|NCT01938079|12408222|FG000|COMPLETED|Overall Study||10
11217063|NCT01938079|12408223|FG001|COMPLETED|Overall Study||10
11217064|NCT01938079|12408222|FG000|NOT COMPLETED|Overall Study||0
11217065|NCT01938079|12408223|FG001|NOT COMPLETED|Overall Study||0
11217066|NCT01938170|12408229|FG000|STARTED|Overall Study||41
11217067|NCT01938170|12408229|FG000|COMPLETED|Overall Study||41
11217068|NCT01938170|12408229|FG000|NOT COMPLETED|Overall Study||0
11217069|NCT01938378|12408236|FG000|STARTED|Overall Study||41
11217070|NCT01938378|12408236|FG000|COMPLETED|Overall Study||41
11217071|NCT01938378|12408236|FG000|NOT COMPLETED|Overall Study||0
11217072|NCT01938391|12408254|FG000|STARTED|Baseline||25
11217073|NCT01938391|12408254|FG000|COMPLETED|Baseline||25
11217074|NCT01938391|12408254|FG000|NOT COMPLETED|Baseline||0
11217075|NCT01938391|12408254|FG000|STARTED|2 Week Follow up||25
11217076|NCT01938391|12408254|FG000|COMPLETED|2 Week Follow up||25
11217077|NCT01938391|12408254|FG000|NOT COMPLETED|2 Week Follow up||0
11217078|NCT01938391|12408254|FG000|STARTED|6 Month Follow up||25
11217079|NCT01938391|12408254|FG000|COMPLETED|6 Month Follow up||24
11217080|NCT01938391|12408254|FG000|NOT COMPLETED|6 Month Follow up||1
11217081|NCT01938391|12408254|FG000|STARTED|12 Month Follow up||24
11217082|NCT01938391|12408254|FG000|COMPLETED|12 Month Follow up||22
11217083|NCT01938391|12408254|FG000|NOT COMPLETED|12 Month Follow up||2
11217084|NCT01938430|12408272|FG000|STARTED|Overall Study||30
11217085|NCT01938430|12408273|FG001|STARTED|Overall Study||29
11217086|NCT01938430|12408274|FG002|STARTED|Overall Study||23
11217087|NCT01938430|12408275|FG003|STARTED|Overall Study||26
11217088|NCT01938430|12408276|FG004|STARTED|Overall Study||55
11217089|NCT01938430|12408277|FG005|STARTED|Overall Study||56
11217090|NCT01938430|12408278|FG006|STARTED|Overall Study||26
11217091|NCT01938430|12408279|FG007|STARTED|Overall Study||25
11217092|NCT01938430|12408280|FG008|STARTED|Overall Study||26
11217093|NCT01938430|12408281|FG009|STARTED|Overall Study||26
11217094|NCT01938430|12408282|FG010|STARTED|Overall Study||6
11217095|NCT01938430|12408283|FG011|STARTED|Overall Study||4
11217096|NCT01938430|12408284|FG012|STARTED|Overall Study||4
11217097|NCT01938430|12408285|FG013|STARTED|Overall Study||3
11217098|NCT01938430|12408272|FG000|COMPLETED|Overall Study||26
11217099|NCT01938430|12408273|FG001|COMPLETED|Overall Study||26
11217100|NCT01938430|12408274|FG002|COMPLETED|Overall Study||18
11217101|NCT01938430|12408275|FG003|COMPLETED|Overall Study||24
11217102|NCT01938430|12408276|FG004|COMPLETED|Overall Study||55
11217103|NCT01938430|12408277|FG005|COMPLETED|Overall Study||55
11217104|NCT01938430|12408278|FG006|COMPLETED|Overall Study||24
11098030|NCT01213524|12281468|FG000|STARTED|Session 7||56
11098031|NCT01213524|12281468|FG000|COMPLETED|Session 7||56
11098032|NCT01213524|12281468|FG000|NOT COMPLETED|Session 7||0
11098033|NCT01213576|12281483|FG000|STARTED|Overall Study||18
11098034|NCT01213576|12281484|FG001|STARTED|Overall Study||17
11098035|NCT01213576|12281485|FG002|STARTED|Overall Study||18
11098036|NCT01213576|12281486|FG003|STARTED|Overall Study||17
11098037|NCT01213576|12281483|FG000|COMPLETED|Overall Study||15
11098038|NCT01213576|12281484|FG001|COMPLETED|Overall Study||13
11098039|NCT01213576|12281485|FG002|COMPLETED|Overall Study||13
11098040|NCT01213576|12281486|FG003|COMPLETED|Overall Study||13
11098041|NCT01213576|12281483|FG000|NOT COMPLETED|Overall Study||3
11098042|NCT01213576|12281484|FG001|NOT COMPLETED|Overall Study||4
11098043|NCT01213576|12281485|FG002|NOT COMPLETED|Overall Study||5
11098044|NCT01213576|12281486|FG003|NOT COMPLETED|Overall Study||4
11098045|NCT01213589|12281499|FG000|STARTED|Overall Study||50
11098046|NCT01213589|12281500|FG001|STARTED|Overall Study||24
11098047|NCT01213589|12281501|FG002|STARTED|Overall Study||26
11098048|NCT01213589|12281499|FG000|COMPLETED|Overall Study||37
11098049|NCT01213589|12281500|FG001|COMPLETED|Overall Study||19
11098050|NCT01213589|12281501|FG002|COMPLETED|Overall Study||18
11098051|NCT01213589|12281499|FG000|NOT COMPLETED|Overall Study||13
11098052|NCT01213589|12281500|FG001|NOT COMPLETED|Overall Study||5
11098053|NCT01213589|12281501|FG002|NOT COMPLETED|Overall Study||8
11098054|NCT01213706|12281509|FG000|STARTED|Sham WBPA||45
11217105|NCT01938430|12408279|FG007|COMPLETED|Overall Study||24
11217106|NCT01938430|12408280|FG008|COMPLETED|Overall Study||22
11217107|NCT01938430|12408281|FG009|COMPLETED|Overall Study||23
11217108|NCT01938430|12408282|FG010|COMPLETED|Overall Study||3
11217109|NCT01938430|12408283|FG011|COMPLETED|Overall Study||3
11217110|NCT01938430|12408284|FG012|COMPLETED|Overall Study||4
11217111|NCT01938430|12408285|FG013|COMPLETED|Overall Study||2
11217112|NCT01938430|12408272|FG000|NOT COMPLETED|Overall Study||4
11217113|NCT01938430|12408273|FG001|NOT COMPLETED|Overall Study||3
11217114|NCT01938430|12408274|FG002|NOT COMPLETED|Overall Study||5
11217115|NCT01938430|12408275|FG003|NOT COMPLETED|Overall Study||2
11217116|NCT01938430|12408276|FG004|NOT COMPLETED|Overall Study||0
11217117|NCT01938430|12408277|FG005|NOT COMPLETED|Overall Study||1
11217118|NCT01938430|12408278|FG006|NOT COMPLETED|Overall Study||2
11217119|NCT01938430|12408279|FG007|NOT COMPLETED|Overall Study||1
11098055|NCT01213706|12281509|FG000|COMPLETED|Sham WBPA||45
11098056|NCT01213706|12281509|FG000|NOT COMPLETED|Sham WBPA||0
11098057|NCT01213706|12281509|FG000|STARTED|Washout (1 Hour)||45
11098058|NCT01213706|12281509|FG000|COMPLETED|Washout (1 Hour)||45
11098059|NCT01213706|12281509|FG000|NOT COMPLETED|Washout (1 Hour)||0
11098060|NCT01213706|12281509|FG000|STARTED|WBPA||45
11098061|NCT01213706|12281509|FG000|COMPLETED|WBPA||45
11098062|NCT01213706|12281509|FG000|NOT COMPLETED|WBPA||0
11098063|NCT01213823|12281517|FG000|STARTED|Overall Study||69
11098064|NCT01213823|12281518|FG001|STARTED|Overall Study||467
11098065|NCT01213823|12281517|FG000|COMPLETED|Overall Study||69
11098066|NCT01213823|12281518|FG001|COMPLETED|Overall Study||467
11217120|NCT01938430|12408280|FG008|NOT COMPLETED|Overall Study||4
11217121|NCT01938430|12408281|FG009|NOT COMPLETED|Overall Study||3
11217122|NCT01938430|12408282|FG010|NOT COMPLETED|Overall Study||3
11217123|NCT01938430|12408283|FG011|NOT COMPLETED|Overall Study||1
11217124|NCT01938430|12408284|FG012|NOT COMPLETED|Overall Study||0
11217125|NCT01938430|12408285|FG013|NOT COMPLETED|Overall Study||1
11217126|NCT01938573|12408340|FG000|STARTED|Overall Study||15
11217127|NCT01938573|12408341|FG001|STARTED|Overall Study||6
11217128|NCT01938573|12408340|FG000|COMPLETED|Overall Study||13
11217129|NCT01938573|12408341|FG001|COMPLETED|Overall Study||6
11217130|NCT01938573|12408340|FG000|NOT COMPLETED|Overall Study||2
11217131|NCT01938573|12408341|FG001|NOT COMPLETED|Overall Study||0
11217132|NCT01938625|12408348|FG000|STARTED|Overall Study||10
11217133|NCT01938625|12408349|FG001|STARTED|Overall Study||25
11217134|NCT01938625|12408348|FG000|COMPLETED|Overall Study||10
11217135|NCT01938625|12408349|FG001|COMPLETED|Overall Study||23
11217136|NCT01938625|12408348|FG000|NOT COMPLETED|Overall Study||0
11217137|NCT01938625|12408349|FG001|NOT COMPLETED|Overall Study||2
11217138|NCT01938664|12408357|FG000|STARTED|Overall Study||20
11217139|NCT01938664|12408358|FG001|STARTED|Overall Study||10
11217140|NCT01938664|12408357|FG000|COMPLETED|Overall Study||5
11217141|NCT01938664|12408358|FG001|COMPLETED|Overall Study||0
11217142|NCT01938664|12408357|FG000|NOT COMPLETED|Overall Study||15
11217143|NCT01938664|12408358|FG001|NOT COMPLETED|Overall Study||10
11217144|NCT01938846|12408367|FG000|STARTED|Overall Study||41
11217145|NCT01938846|12408368|FG001|STARTED|Overall Study||25
11217146|NCT01938846|12408369|FG002|STARTED|Overall Study||24
11217147|NCT01938846|12408367|FG000|COMPLETED|Overall Study||0
11217148|NCT01938846|12408368|FG001|COMPLETED|Overall Study||0
11217149|NCT01938846|12408369|FG002|COMPLETED|Overall Study||0
11217150|NCT01938846|12408367|FG000|NOT COMPLETED|Overall Study||41
11217151|NCT01938846|12408368|FG001|NOT COMPLETED|Overall Study||25
11217152|NCT01938846|12408369|FG002|NOT COMPLETED|Overall Study||24
11217153|NCT01938989|12408410|FG000|STARTED|Overall Study||77
11217154|NCT01938989|12408411|FG001|STARTED|Overall Study||77
11217155|NCT01938989|12408410|FG000|COMPLETED|Overall Study||77
11217156|NCT01938989|12408411|FG001|COMPLETED|Overall Study||77
11217157|NCT01938989|12408410|FG000|NOT COMPLETED|Overall Study||0
11217158|NCT01938989|12408411|FG001|NOT COMPLETED|Overall Study||0
11217159|NCT01939002|12408419|FG000|STARTED|Overall Study||103
11217160|NCT01939002|12408420|FG001|STARTED|Overall Study||98
11217161|NCT01939002|12408419|FG000|COMPLETED|Overall Study||84
11217162|NCT01939002|12408420|FG001|COMPLETED|Overall Study||80
11217163|NCT01939002|12408419|FG000|NOT COMPLETED|Overall Study||19
11217164|NCT01939002|12408420|FG001|NOT COMPLETED|Overall Study||18
11217165|NCT01939028|12408431|FG000|STARTED|Overall Study||58
11217166|NCT01939028|12408431|FG000|COMPLETED|Overall Study||46
11217167|NCT01939028|12408431|FG000|NOT COMPLETED|Overall Study||12
11217168|NCT01939145|12408437|FG000|STARTED|Overall Study||49
11217169|NCT01939145|12408438|FG001|STARTED|Overall Study||51
11217170|NCT01939145|12408437|FG000|COMPLETED|Overall Study||47
11217171|NCT01939145|12408438|FG001|COMPLETED|Overall Study||44
11217172|NCT01939145|12408437|FG000|NOT COMPLETED|Overall Study||2
11217173|NCT01939145|12408438|FG001|NOT COMPLETED|Overall Study||7
11217174|NCT01939158|12408448|FG000|STARTED|Overall Study||203
11098067|NCT01213823|12281517|FG000|NOT COMPLETED|Overall Study||0
11098068|NCT01213823|12281518|FG001|NOT COMPLETED|Overall Study||0
11217175|NCT01939158|12408449|FG001|STARTED|Overall Study||198
11217176|NCT01939158|12408450|FG002|STARTED|Overall Study||201
11217177|NCT01939158|12408451|FG003|STARTED|Overall Study||201
11217178|NCT01939158|12408448|FG000|Vaccinated|Overall Study||203
11217179|NCT01939158|12408449|FG001|Vaccinated|Overall Study||197
11217180|NCT01939158|12408450|FG002|Vaccinated|Overall Study||201
11217181|NCT01939158|12408451|FG003|Vaccinated|Overall Study||201
11217182|NCT01939158|12408448|FG000|COMPLETED|Overall Study||156
11217183|NCT01939158|12408449|FG001|COMPLETED|Overall Study||146
11217184|NCT01939158|12408450|FG002|COMPLETED|Overall Study||160
11217185|NCT01939158|12408451|FG003|COMPLETED|Overall Study||157
11217186|NCT01939158|12408448|FG000|NOT COMPLETED|Overall Study||47
11217187|NCT01939158|12408449|FG001|NOT COMPLETED|Overall Study||52
11217188|NCT01939158|12408450|FG002|NOT COMPLETED|Overall Study||41
11217189|NCT01939158|12408451|FG003|NOT COMPLETED|Overall Study||44
11217190|NCT01939197|12408472|FG000|STARTED|Overall Study||31
11217191|NCT01939197|12408473|FG001|STARTED|Overall Study||32
11098069|NCT01213836|12281526|FG000|STARTED|Period 1, First Intervention||34
11098070|NCT01213836|12281527|FG001|STARTED|Period 1, First Intervention||32
11098071|NCT01213836|12281526|FG000|COMPLETED|Period 1, First Intervention||31
11098072|NCT01213836|12281527|FG001|COMPLETED|Period 1, First Intervention||29
11098073|NCT01213836|12281526|FG000|NOT COMPLETED|Period 1, First Intervention||3
11098074|NCT01213836|12281527|FG001|NOT COMPLETED|Period 1, First Intervention||3
11098075|NCT01213836|12281526|FG000|STARTED|Period 2, Second Intervention||31
11098076|NCT01213836|12281527|FG001|STARTED|Period 2, Second Intervention||29
11098077|NCT01213836|12281526|FG000|COMPLETED|Period 2, Second Intervention||31
11098078|NCT01213836|12281527|FG001|COMPLETED|Period 2, Second Intervention||29
11098079|NCT01213836|12281526|FG000|NOT COMPLETED|Period 2, Second Intervention||0
11098080|NCT01213836|12281527|FG001|NOT COMPLETED|Period 2, Second Intervention||0
11217192|NCT01939197|12408474|FG002|STARTED|Overall Study||10
11217193|NCT01939197|12408475|FG003|STARTED|Overall Study||12
11098081|NCT01213940|12281538|FG000|STARTED|Overall Study||14
11098082|NCT01213940|12281539|FG001|STARTED|Overall Study||6
11098083|NCT01213940|12281538|FG000|COMPLETED|Overall Study||14
11098084|NCT01213940|12281539|FG001|COMPLETED|Overall Study||6
11098085|NCT01213940|12281538|FG000|NOT COMPLETED|Overall Study||0
11217194|NCT01939197|12408476|FG004|STARTED|Overall Study||200
11217195|NCT01939197|12408477|FG005|STARTED|Overall Study||5
11217196|NCT01939197|12408478|FG006|STARTED|Overall Study||28
11217197|NCT01939197|12408472|FG000|COMPLETED|Overall Study||30
11217198|NCT01939197|12408473|FG001|COMPLETED|Overall Study||31
11217199|NCT01939197|12408474|FG002|COMPLETED|Overall Study||10
11217200|NCT01939197|12408475|FG003|COMPLETED|Overall Study||11
11217201|NCT01939197|12408476|FG004|COMPLETED|Overall Study||196
11217202|NCT01939197|12408477|FG005|COMPLETED|Overall Study||4
11217203|NCT01939197|12408478|FG006|COMPLETED|Overall Study||26
11217204|NCT01939197|12408472|FG000|NOT COMPLETED|Overall Study||1
11217205|NCT01939197|12408473|FG001|NOT COMPLETED|Overall Study||1
11217206|NCT01939197|12408474|FG002|NOT COMPLETED|Overall Study||0
11217207|NCT01939197|12408475|FG003|NOT COMPLETED|Overall Study||1
11217208|NCT01939197|12408476|FG004|NOT COMPLETED|Overall Study||4
11217209|NCT01939197|12408477|FG005|NOT COMPLETED|Overall Study||1
11217210|NCT01939197|12408478|FG006|NOT COMPLETED|Overall Study||2
11217211|NCT01939288|12408510|FG000|STARTED|Overall Study||5
11217212|NCT01939288|12408511|FG001|STARTED|Overall Study||5
11217213|NCT01939288|12408510|FG000|COMPLETED|Overall Study||5
11217214|NCT01939288|12408511|FG001|COMPLETED|Overall Study||5
11217215|NCT01939288|12408510|FG000|NOT COMPLETED|Overall Study||0
11217216|NCT01939288|12408511|FG001|NOT COMPLETED|Overall Study||0
11217217|NCT01939301|12408518|FG000|STARTED|Overall Study||39
11217218|NCT01939301|12408519|FG001|STARTED|Overall Study||39
11217219|NCT01939301|12408518|FG000|COMPLETED|Overall Study||38
11217220|NCT01939301|12408519|FG001|COMPLETED|Overall Study||38
11217221|NCT01939301|12408518|FG000|NOT COMPLETED|Overall Study||1
11217222|NCT01939301|12408519|FG001|NOT COMPLETED|Overall Study||1
11353202|NCT03054740|12550362|FG001|STARTED|Overall Study||15
11353203|NCT03054740|12550361|FG000|COMPLETED|Overall Study||15
11353204|NCT03054740|12550362|FG001|COMPLETED|Overall Study||15
11353205|NCT03054740|12550361|FG000|NOT COMPLETED|Overall Study||0
11353206|NCT03054740|12550362|FG001|NOT COMPLETED|Overall Study||0
11353207|NCT03054805|12550371|FG000|STARTED|Overall Study||58
11353208|NCT03054805|12550372|FG001|STARTED|Overall Study||51
11353209|NCT03054805|12550373|FG002|STARTED|Overall Study||44
11353210|NCT03054805|12550371|FG000|COMPLETED|Overall Study||42
11353211|NCT03054805|12550372|FG001|COMPLETED|Overall Study||41
11353212|NCT03054805|12550373|FG002|COMPLETED|Overall Study||42
11353213|NCT03054805|12550371|FG000|NOT COMPLETED|Overall Study||16
11353214|NCT03054805|12550372|FG001|NOT COMPLETED|Overall Study||10
11353215|NCT03054805|12550373|FG002|NOT COMPLETED|Overall Study||2
11353216|NCT03054844|12550383|FG000|STARTED|Overall Study||28
11098086|NCT01213940|12281539|FG001|NOT COMPLETED|Overall Study||0
11098087|NCT01213966|12281549|FG000|STARTED|Overall Study||20
11098088|NCT01213966|12281550|FG001|STARTED|Overall Study||20
11098089|NCT01213966|12281551|FG002|STARTED|Overall Study||20
11098090|NCT01213966|12281552|FG003|STARTED|Overall Study||21
11098091|NCT01213966|12281549|FG000|COMPLETED|Overall Study||19
11098092|NCT01213966|12281550|FG001|COMPLETED|Overall Study||20
11098093|NCT01213966|12281551|FG002|COMPLETED|Overall Study||17
11098094|NCT01213966|12281552|FG003|COMPLETED|Overall Study||20
11098095|NCT01213966|12281549|FG000|NOT COMPLETED|Overall Study||1
11098096|NCT01213966|12281550|FG001|NOT COMPLETED|Overall Study||0
11353217|NCT03054844|12550384|FG001|STARTED|Overall Study||27
11353218|NCT03054844|12550383|FG000|COMPLETED|Overall Study||25
11217223|NCT01939314|12408527|FG000|STARTED|Overall Study||45
11217224|NCT01939314|12408528|FG001|STARTED|Overall Study||48
11217225|NCT01939314|12408527|FG000|15 Minute Endpoint|Overall Study||41
11217226|NCT01939314|12408528|FG001|15 Minute Endpoint|Overall Study||46
11217227|NCT01939314|12408527|FG000|24 Hour Endpoint|Overall Study||36
11217228|NCT01939314|12408528|FG001|24 Hour Endpoint|Overall Study||40
11217229|NCT01939314|12408527|FG000|COMPLETED|Overall Study||36
11217230|NCT01939314|12408528|FG001|COMPLETED|Overall Study||40
11217231|NCT01939314|12408527|FG000|NOT COMPLETED|Overall Study||9
11217232|NCT01939314|12408528|FG001|NOT COMPLETED|Overall Study||8
11217233|NCT01939353|12408536|FG000|STARTED|Placebo Run-in (1 Week)||45
11217234|NCT01939353|12408536|FG000|COMPLETED|Placebo Run-in (1 Week)||41
11217235|NCT01939353|12408536|FG000|NOT COMPLETED|Placebo Run-in (1 Week)||4
11217236|NCT01939353|12408536|FG000|STARTED|CTN SR Treatment Phase (4 Weeks)||41
11217237|NCT01939353|12408536|FG000|COMPLETED|CTN SR Treatment Phase (4 Weeks)||37
11217238|NCT01939353|12408536|FG000|NOT COMPLETED|CTN SR Treatment Phase (4 Weeks)||4
11217239|NCT01939366|12408545|FG000|STARTED|Overall Study||66
11217240|NCT01939366|12408546|FG001|STARTED|Overall Study||64
11217241|NCT01939366|12408547|FG002|STARTED|Overall Study||65
11217242|NCT01939366|12408548|FG003|STARTED|Overall Study||68
11217243|NCT01939366|12408549|FG004|STARTED|Overall Study||66
11217244|NCT01939366|12408545|FG000|Allocated Set Excl. Non-compliant Sites|Overall Study||64
11217245|NCT01939366|12408546|FG001|Allocated Set Excl. Non-compliant Sites|Overall Study||61
11217246|NCT01939366|12408547|FG002|Allocated Set Excl. Non-compliant Sites|Overall Study||63
11217247|NCT01939366|12408548|FG003|Allocated Set Excl. Non-compliant Sites|Overall Study||65
11217248|NCT01939366|12408549|FG004|Allocated Set Excl. Non-compliant Sites|Overall Study||63
11217249|NCT01939366|12408545|FG000|Safety Set|Overall Study||64
11217250|NCT01939366|12408546|FG001|Safety Set|Overall Study||61
11217251|NCT01939366|12408547|FG002|Safety Set|Overall Study||62
11217252|NCT01939366|12408548|FG003|Safety Set|Overall Study||65
11217253|NCT01939366|12408549|FG004|Safety Set|Overall Study||62
11217254|NCT01939366|12408545|FG000|Full Analysis Set|Overall Study||64
11217255|NCT01939366|12408546|FG001|Full Analysis Set|Overall Study||60
11217256|NCT01939366|12408547|FG002|Full Analysis Set|Overall Study||61
11217257|NCT01939366|12408548|FG003|Full Analysis Set|Overall Study||65
11217258|NCT01939366|12408549|FG004|Full Analysis Set|Overall Study||62
11217259|NCT01939366|12408545|FG000|Per Protocol Set|Overall Study||58
11217260|NCT01939366|12408546|FG001|Per Protocol Set|Overall Study||55
11217261|NCT01939366|12408547|FG002|Per Protocol Set|Overall Study||50
11217262|NCT01939366|12408548|FG003|Per Protocol Set|Overall Study||51
11217263|NCT01939366|12408549|FG004|Per Protocol Set|Overall Study||49
11217264|NCT01939366|12408545|FG000|COMPLETED|Overall Study||52
11098097|NCT01213966|12281551|FG002|NOT COMPLETED|Overall Study||3
11098098|NCT01213966|12281552|FG003|NOT COMPLETED|Overall Study||1
11098099|NCT01214044|12281562|FG000|STARTED|Visit 1: Screening and Consent, Washout||31
11098100|NCT01214044|12281562|FG000|COMPLETED|Visit 1: Screening and Consent, Washout||19
11098101|NCT01214044|12281562|FG000|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12
11098102|NCT01214044|12281562|FG000|STARTED|Visit 2: End Washout & Start Placebo||19
11098103|NCT01214044|12281562|FG000|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17
11098104|NCT01214044|12281562|FG000|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2
11098105|NCT01214044|12281562|FG000|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17
11098106|NCT01214044|12281562|FG000|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14
11098107|NCT01214044|12281562|FG000|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3
11098108|NCT01214044|12281562|FG000|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14
11098109|NCT01214044|12281562|FG000|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10
11098110|NCT01214044|12281562|FG000|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4
11098111|NCT01214057|12281572|FG000|STARTED|Overall Study||12
11217265|NCT01939366|12408546|FG001|COMPLETED|Overall Study||41
11098112|NCT01214057|12281573|FG001|STARTED|Overall Study||11
11098113|NCT01214057|12281572|FG000|COMPLETED|Overall Study||12
11098114|NCT01214057|12281573|FG001|COMPLETED|Overall Study||11
11098115|NCT01214057|12281572|FG000|NOT COMPLETED|Overall Study||0
11098116|NCT01214057|12281573|FG001|NOT COMPLETED|Overall Study||0
11098117|NCT01214083|12281582|FG000|STARTED|Overall Study||31
11098118|NCT01214083|12281583|FG001|STARTED|Overall Study||33
11098119|NCT01214083|12281584|FG002|STARTED|Overall Study||31
11098120|NCT01214083|12281582|FG000|COMPLETED|Overall Study||19
11098121|NCT01214083|12281583|FG001|COMPLETED|Overall Study||23
11098122|NCT01214083|12281584|FG002|COMPLETED|Overall Study||21
11098123|NCT01214083|12281582|FG000|NOT COMPLETED|Overall Study||12
11098124|NCT01214083|12281583|FG001|NOT COMPLETED|Overall Study||10
11098125|NCT01214083|12281584|FG002|NOT COMPLETED|Overall Study||10
11098126|NCT01214109|12281592|FG000|STARTED|Overall Study||24
11098127|NCT01214109|12281593|FG001|STARTED|Overall Study||24
11098128|NCT01214109|12281594|FG002|STARTED|Overall Study||24
11098129|NCT01214109|12281595|FG003|STARTED|Overall Study||24
11098130|NCT01214109|12281592|FG000|COMPLETED|Overall Study||24
11098131|NCT01214109|12281593|FG001|COMPLETED|Overall Study||24
11098132|NCT01214109|12281594|FG002|COMPLETED|Overall Study||24
11098133|NCT01214109|12281595|FG003|COMPLETED|Overall Study||24
11098134|NCT01214109|12281592|FG000|NOT COMPLETED|Overall Study||0
11098135|NCT01214109|12281593|FG001|NOT COMPLETED|Overall Study||0
11098136|NCT01214109|12281594|FG002|NOT COMPLETED|Overall Study||0
11217266|NCT01939366|12408547|FG002|COMPLETED|Overall Study||27
11217267|NCT01939366|12408548|FG003|COMPLETED|Overall Study||51
11217268|NCT01939366|12408549|FG004|COMPLETED|Overall Study||48
11217269|NCT01939366|12408545|FG000|NOT COMPLETED|Overall Study||14
11217270|NCT01939366|12408546|FG001|NOT COMPLETED|Overall Study||23
11217271|NCT01939366|12408547|FG002|NOT COMPLETED|Overall Study||38
11217272|NCT01939366|12408548|FG003|NOT COMPLETED|Overall Study||17
11217273|NCT01939366|12408549|FG004|NOT COMPLETED|Overall Study||18
11217274|NCT01939405|12408563|FG000|STARTED|Overall Study||30
11217275|NCT01939405|12408564|FG001|STARTED|Overall Study||30
11217276|NCT01939405|12408563|FG000|COMPLETED|Overall Study||27
11098137|NCT01214109|12281595|FG003|NOT COMPLETED|Overall Study||0
11098138|NCT01214161|12281610|FG000|STARTED|Overall Study||100
11098139|NCT01214161|12281611|FG001|STARTED|Overall Study||100
11098140|NCT01214161|12281610|FG000|COMPLETED|Overall Study||100
11098141|NCT01214161|12281611|FG001|COMPLETED|Overall Study||100
11098142|NCT01214161|12281610|FG000|NOT COMPLETED|Overall Study||0
11098143|NCT01214161|12281611|FG001|NOT COMPLETED|Overall Study||0
11098144|NCT01214174|12281622|FG000|STARTED|Overall Study||13
11098145|NCT01214174|12281623|FG001|STARTED|Overall Study||16
11098146|NCT01214174|12281624|FG002|STARTED|Overall Study||14
11098147|NCT01214174|12281622|FG000|COMPLETED|Overall Study||13
11098148|NCT01214174|12281623|FG001|COMPLETED|Overall Study||16
11098149|NCT01214174|12281624|FG002|COMPLETED|Overall Study||13
11098150|NCT01214174|12281622|FG000|NOT COMPLETED|Overall Study||0
11098151|NCT01214174|12281623|FG001|NOT COMPLETED|Overall Study||0
11098152|NCT01214174|12281624|FG002|NOT COMPLETED|Overall Study||1
11098153|NCT01214187|12281634|FG000|STARTED|Overall Study||29
11098154|NCT01214187|12281635|FG001|STARTED|Overall Study||29
11098155|NCT01214187|12281634|FG000|COMPLETED|Overall Study||22
11098156|NCT01214187|12281635|FG001|COMPLETED|Overall Study||23
11098157|NCT01214187|12281634|FG000|NOT COMPLETED|Overall Study||7
11098158|NCT01214187|12281635|FG001|NOT COMPLETED|Overall Study||6
11098159|NCT01214200|12281641|FG000|STARTED|Overall Study||20
11098160|NCT01214200|12281641|FG000|COMPLETED|Overall Study||9
11098161|NCT01214200|12281641|FG000|NOT COMPLETED|Overall Study||11
11098162|NCT01214239|12281649|FG000|STARTED|Overall Study|patients who were randomised and treated with placebo|99
11098163|NCT01214239|12281650|FG001|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
11098164|NCT01214239|12281649|FG000|COMPLETED|Overall Study||87
11098165|NCT01214239|12281650|FG001|COMPLETED|Overall Study||182
11098166|NCT01214239|12281649|FG000|NOT COMPLETED|Overall Study||12
11098167|NCT01214239|12281650|FG001|NOT COMPLETED|Overall Study||18
11098168|NCT01214252|12281656|FG000|STARTED|Overall Study||425
11098169|NCT01214252|12281656|FG000|COMPLETED|Overall Study||343
11098170|NCT01214252|12281656|FG000|NOT COMPLETED|Overall Study||82
11098171|NCT01214317|12281663|FG000|STARTED|Overall Study||18
11098172|NCT01214317|12281664|FG001|STARTED|Overall Study||22
11098173|NCT01214317|12281663|FG000|COMPLETED|Overall Study||18
11098174|NCT01214317|12281664|FG001|COMPLETED|Overall Study||22
11098175|NCT01214317|12281663|FG000|NOT COMPLETED|Overall Study||0
11098176|NCT01214317|12281664|FG001|NOT COMPLETED|Overall Study||0
11098177|NCT01214330|12281672|FG000|STARTED|Overall Study||150
11098178|NCT01214330|12281672|FG000|COMPLETED|Overall Study||102
11098179|NCT01214330|12281672|FG000|NOT COMPLETED|Overall Study||48
11098180|NCT01214356|12281678|FG000|STARTED|Overall Study||27
11217277|NCT01939405|12408564|FG001|COMPLETED|Overall Study||28
11217278|NCT01939405|12408563|FG000|NOT COMPLETED|Overall Study||3
11098181|NCT01214356|12281679|FG001|STARTED|Overall Study||27
11098182|NCT01214356|12281678|FG000|COMPLETED|Overall Study||10
11098183|NCT01214356|12281679|FG001|COMPLETED|Overall Study||13
11098184|NCT01214356|12281678|FG000|NOT COMPLETED|Overall Study||17
11098185|NCT01214356|12281679|FG001|NOT COMPLETED|Overall Study||14
11098186|NCT01214395|12281685|FG000|STARTED|Overall Study||5
11217279|NCT01939405|12408564|FG001|NOT COMPLETED|Overall Study||2
11217280|NCT01939496|12408573|FG000|STARTED|Overall Study||56
11217281|NCT01939496|12408574|FG001|STARTED|Overall Study||57
11217282|NCT01939496|12408575|FG002|STARTED|Overall Study||56
11217283|NCT01939496|12408573|FG000|COMPLETED|Overall Study||47
11098187|NCT01214395|12281685|FG000|COMPLETED|Overall Study||0
11098188|NCT01214395|12281685|FG000|NOT COMPLETED|Overall Study||5
11217284|NCT01939496|12408574|FG001|COMPLETED|Overall Study||54
11217285|NCT01939496|12408575|FG002|COMPLETED|Overall Study||54
11217286|NCT01939496|12408573|FG000|NOT COMPLETED|Overall Study||9
11217287|NCT01939496|12408574|FG001|NOT COMPLETED|Overall Study||3
11217288|NCT01939496|12408575|FG002|NOT COMPLETED|Overall Study||2
11217289|NCT01939548|12408586|FG000|STARTED|Overall Study||78
11217290|NCT01939548|12408587|FG001|STARTED|Overall Study||82
11217291|NCT01939548|12408588|FG002|STARTED|Overall Study||80
11098189|NCT01214421|12281694|FG000|STARTED|Overall Study||557
11098190|NCT01214421|12281695|FG001|STARTED|Overall Study||314
11098191|NCT01214421|12281696|FG002|STARTED|Overall Study||181
11217292|NCT01939548|12408586|FG000|COMPLETED|Overall Study||41
11217293|NCT01939548|12408587|FG001|COMPLETED|Overall Study||33
11217294|NCT01939548|12408588|FG002|COMPLETED|Overall Study||50
11217295|NCT01939548|12408586|FG000|NOT COMPLETED|Overall Study||37
11217296|NCT01939548|12408587|FG001|NOT COMPLETED|Overall Study||49
11217297|NCT01939548|12408588|FG002|NOT COMPLETED|Overall Study||30
11217298|NCT01939899|12408601|FG000|STARTED|Lead-in Dose Finding Phase||3
11217299|NCT01939899|12408602|FG001|STARTED|Lead-in Dose Finding Phase||7
11217300|NCT01939899|12408603|FG002|STARTED|Lead-in Dose Finding Phase||6
11217301|NCT01939899|12408604|FG003|STARTED|Lead-in Dose Finding Phase||0
11217302|NCT01939899|12408605|FG004|STARTED|Lead-in Dose Finding Phase||0
11217303|NCT01939899|12408601|FG000|COMPLETED|Lead-in Dose Finding Phase||1
11098192|NCT01214421|12281697|FG003|STARTED|Overall Study||31
11098193|NCT01214421|12281694|FG000|COMPLETED|Overall Study||507
11098194|NCT01214421|12281695|FG001|COMPLETED|Overall Study||256
11217304|NCT01939899|12408602|FG001|COMPLETED|Lead-in Dose Finding Phase||0
11217305|NCT01939899|12408603|FG002|COMPLETED|Lead-in Dose Finding Phase||1
11217306|NCT01939899|12408604|FG003|COMPLETED|Lead-in Dose Finding Phase||0
11217307|NCT01939899|12408605|FG004|COMPLETED|Lead-in Dose Finding Phase||0
11217308|NCT01939899|12408601|FG000|NOT COMPLETED|Lead-in Dose Finding Phase||2
11217309|NCT01939899|12408602|FG001|NOT COMPLETED|Lead-in Dose Finding Phase||7
11217310|NCT01939899|12408603|FG002|NOT COMPLETED|Lead-in Dose Finding Phase||5
11217311|NCT01939899|12408604|FG003|NOT COMPLETED|Lead-in Dose Finding Phase||0
11217312|NCT01939899|12408605|FG004|NOT COMPLETED|Lead-in Dose Finding Phase||0
11217313|NCT01939899|12408601|FG000|STARTED|Phase 2||0
11217314|NCT01939899|12408602|FG001|STARTED|Phase 2||0
11217315|NCT01939899|12408603|FG002|STARTED|Phase 2||0
11217316|NCT01939899|12408604|FG003|STARTED|Phase 2||12
11217317|NCT01939899|12408605|FG004|STARTED|Phase 2||1
11217318|NCT01939899|12408601|FG000|COMPLETED|Phase 2||0
11217319|NCT01939899|12408602|FG001|COMPLETED|Phase 2||0
11217320|NCT01939899|12408603|FG002|COMPLETED|Phase 2||0
11217321|NCT01939899|12408604|FG003|COMPLETED|Phase 2||1
11217322|NCT01939899|12408605|FG004|COMPLETED|Phase 2||0
11217323|NCT01939899|12408601|FG000|NOT COMPLETED|Phase 2||0
11217324|NCT01939899|12408602|FG001|NOT COMPLETED|Phase 2||0
11217325|NCT01939899|12408603|FG002|NOT COMPLETED|Phase 2||0
11217326|NCT01939899|12408604|FG003|NOT COMPLETED|Phase 2||11
11217327|NCT01939899|12408605|FG004|NOT COMPLETED|Phase 2||1
11217328|NCT01939938|12408623|FG000|STARTED|Overall Study||10
11217329|NCT01939938|12408623|FG000|COMPLETED|Overall Study||10
11217330|NCT01939938|12408623|FG000|NOT COMPLETED|Overall Study||0
11217331|NCT01939977|12408631|FG000|STARTED|Overall Study||46
11217332|NCT01939977|12408632|FG001|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
11217333|NCT01939977|12408631|FG000|COMPLETED|Overall Study||37
11217334|NCT01939977|12408632|FG001|COMPLETED|Overall Study||41
11217335|NCT01939977|12408631|FG000|NOT COMPLETED|Overall Study||9
11217336|NCT01939977|12408632|FG001|NOT COMPLETED|Overall Study||7
11217337|NCT01940120|12408638|FG000|STARTED|Overall Study||78
11217338|NCT01940120|12408638|FG000|COMPLETED|Overall Study||30
11217339|NCT01940120|12408638|FG000|NOT COMPLETED|Overall Study||48
11217340|NCT01940146|12408647|FG000|STARTED|Overall Study||56
11217341|NCT01940146|12408648|FG001|STARTED|Overall Study||55
11217342|NCT01940146|12408649|FG002|STARTED|Overall Study||56
11217343|NCT01940146|12408650|FG003|STARTED|Overall Study||55
11217344|NCT01940146|12408647|FG000|COMPLETED|Overall Study||55
11217345|NCT01940146|12408648|FG001|COMPLETED|Overall Study||55
11217346|NCT01940146|12408649|FG002|COMPLETED|Overall Study||55
11217347|NCT01940146|12408650|FG003|COMPLETED|Overall Study||53
11217348|NCT01940146|12408647|FG000|NOT COMPLETED|Overall Study||1
11217349|NCT01940146|12408648|FG001|NOT COMPLETED|Overall Study||0
11217350|NCT01940146|12408649|FG002|NOT COMPLETED|Overall Study||1
11217351|NCT01940146|12408650|FG003|NOT COMPLETED|Overall Study||2
11217352|NCT01940276|12408662|FG000|STARTED|Overall Study||50
11217353|NCT01940276|12408663|FG001|STARTED|Overall Study||50
11217354|NCT01940276|12408662|FG000|COMPLETED|Overall Study||50
11217355|NCT01940276|12408663|FG001|COMPLETED|Overall Study||50
11217356|NCT01940276|12408662|FG000|NOT COMPLETED|Overall Study||0
11217357|NCT01940276|12408663|FG001|NOT COMPLETED|Overall Study||0
11217358|NCT01940354|12408671|FG000|STARTED|Overall Study||110
11217359|NCT01940354|12408672|FG001|STARTED|Overall Study||110
11217360|NCT01940354|12408671|FG000|COMPLETED|Overall Study||106
11217361|NCT01940354|12408672|FG001|COMPLETED|Overall Study||108
11217362|NCT01940354|12408671|FG000|NOT COMPLETED|Overall Study||4
11217363|NCT01940354|12408672|FG001|NOT COMPLETED|Overall Study||2
11217364|NCT01940484|12408678|FG000|STARTED|Overall Study||98
11217365|NCT01940484|12408678|FG000|COMPLETED|Overall Study||88
11217366|NCT01940484|12408678|FG000|NOT COMPLETED|Overall Study||10
11217367|NCT01940497|12408684|FG000|STARTED|Overall Study||121
11217368|NCT01940497|12408685|FG001|STARTED|Overall Study||119
11217369|NCT01940497|12408684|FG000|Treated|Overall Study||115
11217370|NCT01940497|12408685|FG001|Treated|Overall Study||113
11217371|NCT01940497|12408684|FG000|Treated: Adjuvant|Overall Study||95
11098195|NCT01214421|12281696|FG002|COMPLETED|Overall Study||143
11098196|NCT01214421|12281697|FG003|COMPLETED|Overall Study||22
11098197|NCT01214421|12281694|FG000|NOT COMPLETED|Overall Study||50
11098198|NCT01214421|12281695|FG001|NOT COMPLETED|Overall Study||58
11098199|NCT01214421|12281696|FG002|NOT COMPLETED|Overall Study||38
11098200|NCT01214421|12281697|FG003|NOT COMPLETED|Overall Study||9
11098201|NCT01214434|12281709|FG000|STARTED|Overall Study||15
11217372|NCT01940497|12408685|FG001|Treated: Adjuvant|Overall Study||92
11217373|NCT01940497|12408684|FG000|Treated: Neoadjuvant|Overall Study||20
11217374|NCT01940497|12408685|FG001|Treated: Neoadjuvant|Overall Study||21
11217375|NCT01940497|12408684|FG000|COMPLETED|Overall Study||100
11217376|NCT01940497|12408685|FG001|COMPLETED|Overall Study||101
11353219|NCT03054844|12550384|FG001|COMPLETED|Overall Study||26
11353220|NCT03054844|12550383|FG000|NOT COMPLETED|Overall Study||3
11217377|NCT01940497|12408684|FG000|NOT COMPLETED|Overall Study||21
11217378|NCT01940497|12408685|FG001|NOT COMPLETED|Overall Study||18
11217379|NCT01940510|12408702|FG000|STARTED|Overall Study||24
11217380|NCT01940510|12408702|FG000|COMPLETED|Overall Study||24
11217381|NCT01940510|12408702|FG000|NOT COMPLETED|Overall Study||0
11217382|NCT01940523|12408711|FG000|STARTED|Overall Study||320
11217383|NCT01940523|12408712|FG001|STARTED|Overall Study||320
11217384|NCT01940523|12408711|FG000|COMPLETED|Overall Study||320
11217385|NCT01940523|12408712|FG001|COMPLETED|Overall Study||320
11217386|NCT01940523|12408711|FG000|NOT COMPLETED|Overall Study||0
11217387|NCT01940523|12408712|FG001|NOT COMPLETED|Overall Study||0
11217388|NCT01940705|12408724|FG000|STARTED|Overall Study||66
11217389|NCT01940705|12408725|FG001|STARTED|Overall Study||67
11098202|NCT01214434|12281710|FG001|STARTED|Overall Study||27
11098203|NCT01214434|12281709|FG000|COMPLETED|Overall Study||11
11098204|NCT01214434|12281710|FG001|COMPLETED|Overall Study||25
11098205|NCT01214434|12281709|FG000|NOT COMPLETED|Overall Study||4
11098206|NCT01214434|12281710|FG001|NOT COMPLETED|Overall Study||2
11098207|NCT01214603|12281719|FG000|STARTED|Overall Study||7
11098208|NCT01214603|12281720|FG001|STARTED|Overall Study||6
11098209|NCT01214603|12281721|FG002|STARTED|Overall Study||7
11098210|NCT01214603|12281719|FG000|Received at Least 1 Dose of LY2090314|Overall Study||7
11098211|NCT01214603|12281720|FG001|Received at Least 1 Dose of LY2090314|Overall Study||6
11098212|NCT01214603|12281721|FG002|Received at Least 1 Dose of LY2090314|Overall Study||7
11098213|NCT01214603|12281719|FG000|COMPLETED|Overall Study||2
11098214|NCT01214603|12281720|FG001|COMPLETED|Overall Study||5
11098215|NCT01214603|12281721|FG002|COMPLETED|Overall Study||3
11098216|NCT01214603|12281719|FG000|NOT COMPLETED|Overall Study||5
11098217|NCT01214603|12281720|FG001|NOT COMPLETED|Overall Study||1
11098218|NCT01214603|12281721|FG002|NOT COMPLETED|Overall Study||4
11098219|NCT01214616|12281734|FG000|STARTED|Overall Study||3
11098220|NCT01214616|12281735|FG001|STARTED|Overall Study||5
11098221|NCT01214616|12281736|FG002|STARTED|Overall Study||3
11098222|NCT01214616|12281737|FG003|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
11098223|NCT01214616|12281734|FG000|COMPLETED|Overall Study||0
11098224|NCT01214616|12281735|FG001|COMPLETED|Overall Study||0
11098225|NCT01214616|12281736|FG002|COMPLETED|Overall Study||0
11098226|NCT01214616|12281737|FG003|COMPLETED|Overall Study||0
11098227|NCT01214616|12281734|FG000|NOT COMPLETED|Overall Study||3
11098228|NCT01214616|12281735|FG001|NOT COMPLETED|Overall Study||5
11217390|NCT01940705|12408726|FG002|STARTED|Overall Study||69
11217391|NCT01940705|12408727|FG003|STARTED|Overall Study||67
11217392|NCT01940705|12408724|FG000|COMPLETED|Overall Study||62
11217393|NCT01940705|12408725|FG001|COMPLETED|Overall Study||59
11217394|NCT01940705|12408726|FG002|COMPLETED|Overall Study||61
11217395|NCT01940705|12408727|FG003|COMPLETED|Overall Study||63
11353221|NCT03054844|12550384|FG001|NOT COMPLETED|Overall Study||1
11353222|NCT03054857|12550392|FG000|STARTED|Overall Study||50
11353223|NCT03054857|12550393|FG001|STARTED|Overall Study||50
11353224|NCT03054857|12550392|FG000|COMPLETED|Overall Study||49
11353225|NCT03054857|12550393|FG001|COMPLETED|Overall Study||50
11353226|NCT03054857|12550392|FG000|NOT COMPLETED|Overall Study||1
11353227|NCT03054857|12550393|FG001|NOT COMPLETED|Overall Study||0
11353228|NCT03054870|12550403|FG000|STARTED|Day of Ventilation Imaging|16 of 226 enrolled subjects were withdrawn from the study prior to receiving Technegas and were not included in further study assessments.|210
11217396|NCT01940705|12408724|FG000|NOT COMPLETED|Overall Study||4
11217397|NCT01940705|12408725|FG001|NOT COMPLETED|Overall Study||8
11217398|NCT01940705|12408726|FG002|NOT COMPLETED|Overall Study||8
11217399|NCT01940705|12408727|FG003|NOT COMPLETED|Overall Study||4
11217400|NCT01940887|12408742|FG000|STARTED|Year 1||322
11217401|NCT01940887|12408743|FG001|STARTED|Year 1||320
11217402|NCT01940887|12408742|FG000|COMPLETED|Year 1||283
11217403|NCT01940887|12408743|FG001|COMPLETED|Year 1||297
11217404|NCT01940887|12408742|FG000|NOT COMPLETED|Year 1||39
11217405|NCT01940887|12408743|FG001|NOT COMPLETED|Year 1||23
11217406|NCT01940887|12408742|FG000|STARTED|Year 2||283
11217407|NCT01940887|12408743|FG001|STARTED|Year 2||297
11217408|NCT01940887|12408742|FG000|COMPLETED|Year 2||66
11217409|NCT01940887|12408743|FG001|COMPLETED|Year 2||75
11217410|NCT01940887|12408742|FG000|NOT COMPLETED|Year 2||217
11217411|NCT01940887|12408743|FG001|NOT COMPLETED|Year 2||222
11217412|NCT01940900|12408751|FG000|STARTED|Overall Study||311
11217413|NCT01940900|12408752|FG001|STARTED|Overall Study||315
11217414|NCT01940900|12408751|FG000|COMPLETED|Overall Study||282
11217415|NCT01940900|12408752|FG001|COMPLETED|Overall Study||284
11217416|NCT01940900|12408751|FG000|NOT COMPLETED|Overall Study||29
11217417|NCT01940900|12408752|FG001|NOT COMPLETED|Overall Study||31
11217418|NCT01940939|12408760|FG000|STARTED|Overall Study||35
11217419|NCT01940939|12408761|FG001|STARTED|Overall Study||35
11217420|NCT01940939|12408760|FG000|COMPLETED|Overall Study||33
11217421|NCT01940939|12408761|FG001|COMPLETED|Overall Study||27
11217422|NCT01940939|12408760|FG000|NOT COMPLETED|Overall Study||2
11217423|NCT01940939|12408761|FG001|NOT COMPLETED|Overall Study||8
11217424|NCT01941030|12408769|FG000|STARTED|Overall Study||25
11217425|NCT01941030|12408770|FG001|STARTED|Overall Study||26
11217426|NCT01941030|12408769|FG000|COMPLETED|Overall Study||12
11217427|NCT01941030|12408770|FG001|COMPLETED|Overall Study||13
11217428|NCT01941030|12408769|FG000|NOT COMPLETED|Overall Study||13
11217429|NCT01941030|12408770|FG001|NOT COMPLETED|Overall Study||13
11217430|NCT01941095|12408776|FG000|STARTED|Overall Study||97
11217431|NCT01941095|12408776|FG000|COMPLETED|Overall Study||41
11217432|NCT01941095|12408776|FG000|NOT COMPLETED|Overall Study||56
11217433|NCT01941186|12408783|FG000|STARTED|Randomization/Allocation to Study Group||31
11217434|NCT01941186|12408784|FG001|STARTED|Randomization/Allocation to Study Group||33
11217435|NCT01941186|12408783|FG000|COMPLETED|Randomization/Allocation to Study Group||31
11217436|NCT01941186|12408784|FG001|COMPLETED|Randomization/Allocation to Study Group||33
11217437|NCT01941186|12408783|FG000|NOT COMPLETED|Randomization/Allocation to Study Group||0
11217438|NCT01941186|12408784|FG001|NOT COMPLETED|Randomization/Allocation to Study Group||0
11217439|NCT01941186|12408783|FG000|STARTED|Follow-up||31
11217440|NCT01941186|12408784|FG001|STARTED|Follow-up||33
11217441|NCT01941186|12408783|FG000|COMPLETED|Follow-up||30
11217442|NCT01941186|12408784|FG001|COMPLETED|Follow-up||33
11217443|NCT01941186|12408783|FG000|NOT COMPLETED|Follow-up||1
11217444|NCT01941186|12408784|FG001|NOT COMPLETED|Follow-up||0
11217445|NCT01941472|12408803|FG000|STARTED|Overall Study||40
11217446|NCT01941472|12408803|FG000|COMPLETED|Overall Study||40
11217447|NCT01941472|12408803|FG000|NOT COMPLETED|Overall Study||0
11217448|NCT01941485|12408807|FG000|STARTED|Overall Study||59
11217449|NCT01941485|12408807|FG000|COMPLETED|Overall Study||59
11217450|NCT01941485|12408807|FG000|NOT COMPLETED|Overall Study||0
11217451|NCT01941498|12408829|FG000|STARTED|Overall Study||97
11217452|NCT01941498|12408829|FG000|COMPLETED|Overall Study||96
11217453|NCT01941498|12408829|FG000|NOT COMPLETED|Overall Study||1
11217454|NCT01941537|12408850|FG000|STARTED|Overall Study||40
11217455|NCT01941537|12408851|FG001|STARTED|Overall Study||20
11217456|NCT01941537|12408850|FG000|COMPLETED|Overall Study||36
11217457|NCT01941537|12408851|FG001|COMPLETED|Overall Study||17
11217458|NCT01941537|12408850|FG000|NOT COMPLETED|Overall Study||4
11217459|NCT01941537|12408851|FG001|NOT COMPLETED|Overall Study||3
11098229|NCT01214616|12281736|FG002|NOT COMPLETED|Overall Study||3
11098230|NCT01214616|12281737|FG003|NOT COMPLETED|Overall Study||6
11098231|NCT01214629|12281766|FG000|STARTED|Overall Study||1
11098232|NCT01214629|12281767|FG001|STARTED|Overall Study||1
11098233|NCT01214629|12281768|FG002|STARTED|Overall Study||1
11098234|NCT01214629|12281769|FG003|STARTED|Overall Study||3
11098235|NCT01214629|12281770|FG004|STARTED|Overall Study||3
11098236|NCT01214629|12281771|FG005|STARTED|Overall Study||13
11098237|NCT01214629|12281772|FG006|STARTED|Overall Study||5
11098238|NCT01214629|12281773|FG007|STARTED|Overall Study||3
11098239|NCT01214629|12281774|FG008|STARTED|Overall Study||3
11098240|NCT01214629|12281775|FG009|STARTED|Overall Study||18
11098241|NCT01214629|12281776|FG010|STARTED|Overall Study||3
11098242|NCT01214629|12281766|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
11098243|NCT01214629|12281767|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1
11098244|NCT01214629|12281768|FG002|Received at Least 1 Dose of Study Drug|Overall Study||1
11098245|NCT01214629|12281769|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
11098246|NCT01214629|12281770|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
11098247|NCT01214629|12281771|FG005|Received at Least 1 Dose of Study Drug|Overall Study||13
11098248|NCT01214629|12281772|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
11217460|NCT01941628|12408860|FG000|STARTED|Overall Study||46
11217461|NCT01941628|12408861|FG001|STARTED|Overall Study||45
11217462|NCT01941628|12408860|FG000|COMPLETED|Overall Study||45
11217463|NCT01941628|12408861|FG001|COMPLETED|Overall Study||45
11217464|NCT01941628|12408860|FG000|NOT COMPLETED|Overall Study||1
11217465|NCT01941628|12408861|FG001|NOT COMPLETED|Overall Study||0
11217466|NCT01941745|12408871|FG000|STARTED|Overall Study||22
11217467|NCT01941745|12408872|FG001|STARTED|Overall Study||22
11217468|NCT01941745|12408873|FG002|STARTED|Overall Study||21
11217469|NCT01941745|12408874|FG003|STARTED|Overall Study||23
11217470|NCT01941745|12408871|FG000|COMPLETED|Overall Study||22
11217471|NCT01941745|12408872|FG001|COMPLETED|Overall Study||22
11217472|NCT01941745|12408873|FG002|COMPLETED|Overall Study||21
11217473|NCT01941745|12408874|FG003|COMPLETED|Overall Study||23
11217474|NCT01941745|12408871|FG000|NOT COMPLETED|Overall Study||0
11217475|NCT01941745|12408872|FG001|NOT COMPLETED|Overall Study||0
11217476|NCT01941745|12408873|FG002|NOT COMPLETED|Overall Study||0
11217477|NCT01941745|12408874|FG003|NOT COMPLETED|Overall Study||0
11217478|NCT01941927|12408889|FG000|STARTED|Overall Study||10
11217479|NCT01941927|12408890|FG001|STARTED|Overall Study||10
11217480|NCT01941927|12408889|FG000|COMPLETED|Overall Study||10
11217481|NCT01941927|12408890|FG001|COMPLETED|Overall Study||10
11217482|NCT01941927|12408889|FG000|NOT COMPLETED|Overall Study||0
11217483|NCT01941927|12408890|FG001|NOT COMPLETED|Overall Study||0
11217484|NCT01941940|12408896|FG000|STARTED|Overall Study||227
11217485|NCT01941940|12408896|FG000|COMPLETED|Overall Study||194
11217486|NCT01941940|12408896|FG000|NOT COMPLETED|Overall Study||33
11217487|NCT01942148|12408900|FG000|STARTED|Overall Study||68
11217488|NCT01942148|12408900|FG000|COMPLETED|Overall Study||41
11217489|NCT01942148|12408900|FG000|NOT COMPLETED|Overall Study||27
11217490|NCT01942161|12408907|FG000|STARTED|Overall Study||35
11217491|NCT01942161|12408908|FG001|STARTED|Overall Study||30
11217492|NCT01942161|12408909|FG002|STARTED|Overall Study||41
11217493|NCT01942161|12408907|FG000|COMPLETED|Overall Study||27
11217494|NCT01942161|12408908|FG001|COMPLETED|Overall Study||24
11217495|NCT01942161|12408909|FG002|COMPLETED|Overall Study||35
11217496|NCT01942161|12408907|FG000|NOT COMPLETED|Overall Study||8
11217497|NCT01942161|12408908|FG001|NOT COMPLETED|Overall Study||6
11217498|NCT01942161|12408909|FG002|NOT COMPLETED|Overall Study||6
11217499|NCT01942486|12408917|FG000|STARTED|Overall Study||35
11217500|NCT01942486|12408917|FG000|COMPLETED|Overall Study||8
11217501|NCT01942486|12408917|FG000|NOT COMPLETED|Overall Study||27
11217502|NCT01942590|12408923|FG000|STARTED|Overall Study||8
11217503|NCT01942590|12408924|FG001|STARTED|Overall Study||5
11217504|NCT01942590|12408923|FG000|COMPLETED|Overall Study||7
11217505|NCT01942590|12408924|FG001|COMPLETED|Overall Study||4
11217506|NCT01942590|12408923|FG000|NOT COMPLETED|Overall Study||1
11217507|NCT01942590|12408924|FG001|NOT COMPLETED|Overall Study||1
11217508|NCT01942668|12408936|FG000|STARTED|Overall Study||418
11217509|NCT01942668|12408937|FG001|STARTED|Overall Study||426
11217510|NCT01942668|12408938|FG002|STARTED|Overall Study||422
11217511|NCT01942668|12408939|FG003|STARTED|Overall Study||427
11217512|NCT01942668|12408940|FG004|STARTED|Overall Study||152
11217513|NCT01942668|12408936|FG000|COMPLETED|Overall Study||284
11217514|NCT01942668|12408937|FG001|COMPLETED|Overall Study||305
11217515|NCT01942668|12408938|FG002|COMPLETED|Overall Study||312
11217516|NCT01942668|12408939|FG003|COMPLETED|Overall Study||281
11217517|NCT01942668|12408940|FG004|COMPLETED|Overall Study||93
11217518|NCT01942668|12408936|FG000|NOT COMPLETED|Overall Study||134
11217519|NCT01942668|12408937|FG001|NOT COMPLETED|Overall Study||121
11217520|NCT01942668|12408938|FG002|NOT COMPLETED|Overall Study||110
11217521|NCT01942668|12408939|FG003|NOT COMPLETED|Overall Study||146
11217522|NCT01942668|12408940|FG004|NOT COMPLETED|Overall Study||59
11217523|NCT01942707|12408959|FG000|STARTED|Overall Study||23
11217524|NCT01942707|12408960|FG001|STARTED|Overall Study||23
11217525|NCT01942707|12408959|FG000|COMPLETED|Overall Study||23
11217526|NCT01942707|12408960|FG001|COMPLETED|Overall Study||23
11217527|NCT01942707|12408959|FG000|NOT COMPLETED|Overall Study||0
11217528|NCT01942707|12408960|FG001|NOT COMPLETED|Overall Study||0
11217529|NCT01942720|12408966|FG000|STARTED|Overall Study||74
11217530|NCT01942720|12408966|FG000|COMPLETED|Overall Study||53
11217531|NCT01942720|12408966|FG000|NOT COMPLETED|Overall Study||21
11217532|NCT01942733|12408970|FG000|STARTED|Overall Study||44
11217533|NCT01942733|12408970|FG000|COMPLETED|Overall Study||41
11217534|NCT01942733|12408970|FG000|NOT COMPLETED|Overall Study||3
11217535|NCT01942785|12408974|FG000|STARTED|Overall Study||54
11217536|NCT01942785|12408974|FG000|COMPLETED|Overall Study||50
11217537|NCT01942785|12408974|FG000|NOT COMPLETED|Overall Study||4
11217538|NCT01942993|12408980|FG000|STARTED|Overall Study||3
11217539|NCT01942993|12408980|FG000|COMPLETED|Overall Study||1
11217540|NCT01942993|12408980|FG000|NOT COMPLETED|Overall Study||2
11217541|NCT01943110|12408984|FG000|STARTED|Overall Study||30
11353229|NCT03054870|12550403|FG000|COMPLETED|Day of Ventilation Imaging||205
11217542|NCT01943110|12408984|FG000|COMPLETED|Overall Study||30
11217543|NCT01943110|12408984|FG000|NOT COMPLETED|Overall Study||0
11217544|NCT01943227|12409002|FG000|STARTED|Overall Study||10
11217545|NCT01943227|12409003|FG001|STARTED|Overall Study||10
11217546|NCT01943227|12409002|FG000|COMPLETED|Overall Study||10
11217547|NCT01943227|12409003|FG001|COMPLETED|Overall Study||10
11217548|NCT01943227|12409002|FG000|NOT COMPLETED|Overall Study||0
11217549|NCT01943227|12409003|FG001|NOT COMPLETED|Overall Study||0
11217550|NCT01943292|12409012|FG000|STARTED|Overall Study||3
11217551|NCT01943292|12409013|FG001|STARTED|Overall Study||3
11217552|NCT01943292|12409014|FG002|STARTED|Overall Study||3
11217553|NCT01943292|12409012|FG000|Completed Cycle 1|Overall Study||3
11217554|NCT01943292|12409013|FG001|Completed Cycle 1|Overall Study||3
11217555|NCT01943292|12409014|FG002|Completed Cycle 1|Overall Study||3
11217556|NCT01943292|12409012|FG000|Completed Treatment|Overall Study||3
11217557|NCT01943292|12409013|FG001|Completed Treatment|Overall Study||3
11217558|NCT01943292|12409014|FG002|Completed Treatment|Overall Study||3
11217559|NCT01943292|12409012|FG000|Completed Follow-Up|Overall Study||2
11217560|NCT01943292|12409013|FG001|Completed Follow-Up|Overall Study||3
11217561|NCT01943292|12409014|FG002|Completed Follow-Up|Overall Study||3
11217562|NCT01943292|12409012|FG000|COMPLETED|Overall Study||2
11217563|NCT01943292|12409013|FG001|COMPLETED|Overall Study||3
11217564|NCT01943292|12409014|FG002|COMPLETED|Overall Study||3
11217565|NCT01943292|12409012|FG000|NOT COMPLETED|Overall Study||1
11217566|NCT01943292|12409013|FG001|NOT COMPLETED|Overall Study||0
11217567|NCT01943292|12409014|FG002|NOT COMPLETED|Overall Study||0
11217568|NCT01943344|12409022|FG000|STARTED|Overall Study||12
11217569|NCT01943344|12409022|FG000|COMPLETED|Overall Study||9
11217570|NCT01943344|12409022|FG000|NOT COMPLETED|Overall Study||3
11217571|NCT01943435|12409031|FG000|STARTED|Baseline Eligibility and Randomization||88
11217572|NCT01943435|12409032|FG001|STARTED|Baseline Eligibility and Randomization||84
11217573|NCT01943435|12409033|FG002|STARTED|Baseline Eligibility and Randomization||87
11217574|NCT01943435|12409031|FG000|COMPLETED|Baseline Eligibility and Randomization||84
11217575|NCT01943435|12409032|FG001|COMPLETED|Baseline Eligibility and Randomization||72
11217576|NCT01943435|12409033|FG002|COMPLETED|Baseline Eligibility and Randomization||84
11217577|NCT01943435|12409031|FG000|NOT COMPLETED|Baseline Eligibility and Randomization||4
11217578|NCT01943435|12409032|FG001|NOT COMPLETED|Baseline Eligibility and Randomization||12
11217579|NCT01943435|12409033|FG002|NOT COMPLETED|Baseline Eligibility and Randomization||3
11217580|NCT01943435|12409031|FG000|STARTED|Intervention Period||84
11217581|NCT01943435|12409032|FG001|STARTED|Intervention Period||72
11217582|NCT01943435|12409033|FG002|STARTED|Intervention Period||84
11217583|NCT01943435|12409031|FG000|COMPLETED|Intervention Period||81
11217584|NCT01943435|12409032|FG001|COMPLETED|Intervention Period||69
11217585|NCT01943435|12409033|FG002|COMPLETED|Intervention Period||80
11217586|NCT01943435|12409031|FG000|NOT COMPLETED|Intervention Period||3
11217587|NCT01943435|12409032|FG001|NOT COMPLETED|Intervention Period||3
11217588|NCT01943435|12409033|FG002|NOT COMPLETED|Intervention Period||4
11217589|NCT01943435|12409031|FG000|STARTED|2 Month Follow up||81
11217590|NCT01943435|12409032|FG001|STARTED|2 Month Follow up||69
11217591|NCT01943435|12409033|FG002|STARTED|2 Month Follow up||80
11217592|NCT01943435|12409031|FG000|COMPLETED|2 Month Follow up||79
11217593|NCT01943435|12409032|FG001|COMPLETED|2 Month Follow up||66
11217594|NCT01943435|12409033|FG002|COMPLETED|2 Month Follow up||80
11217595|NCT01943435|12409031|FG000|NOT COMPLETED|2 Month Follow up||2
11217596|NCT01943435|12409032|FG001|NOT COMPLETED|2 Month Follow up||3
11217597|NCT01943435|12409033|FG002|NOT COMPLETED|2 Month Follow up||0
11217598|NCT01943435|12409031|FG000|STARTED|6 Month Follow up||79
11217599|NCT01943435|12409032|FG001|STARTED|6 Month Follow up||66
11217600|NCT01943435|12409033|FG002|STARTED|6 Month Follow up||80
11217601|NCT01943435|12409031|FG000|COMPLETED|6 Month Follow up||67
11217602|NCT01943435|12409032|FG001|COMPLETED|6 Month Follow up||59
11217603|NCT01943435|12409033|FG002|COMPLETED|6 Month Follow up||65
11217604|NCT01943435|12409031|FG000|NOT COMPLETED|6 Month Follow up||12
11217605|NCT01943435|12409032|FG001|NOT COMPLETED|6 Month Follow up||7
11217606|NCT01943435|12409033|FG002|NOT COMPLETED|6 Month Follow up||15
11217607|NCT01943461|12409045|FG000|STARTED|Overall Study||5
11217608|NCT01943461|12409046|FG001|STARTED|Overall Study||6
11217609|NCT01943461|12409047|FG002|STARTED|Overall Study||6
11217610|NCT01943461|12409048|FG003|STARTED|Overall Study||40
11217611|NCT01943461|12409045|FG000|COMPLETED|Overall Study||5
11217612|NCT01943461|12409046|FG001|COMPLETED|Overall Study||6
11217613|NCT01943461|12409047|FG002|COMPLETED|Overall Study||6
11098249|NCT01214629|12281773|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
11098250|NCT01214629|12281774|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
11098251|NCT01214629|12281775|FG009|Received at Least 1 Dose of Study Drug|Overall Study||18
11098252|NCT01214629|12281776|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
11098253|NCT01214629|12281766|FG000|COMPLETED|Overall Study||0
11098254|NCT01214629|12281767|FG001|COMPLETED|Overall Study||0
11098255|NCT01214629|12281768|FG002|COMPLETED|Overall Study||1
11098256|NCT01214629|12281769|FG003|COMPLETED|Overall Study||1
11098257|NCT01214629|12281770|FG004|COMPLETED|Overall Study||1
11217614|NCT01943461|12409048|FG003|COMPLETED|Overall Study||40
11217615|NCT01943461|12409045|FG000|NOT COMPLETED|Overall Study||0
11217616|NCT01943461|12409046|FG001|NOT COMPLETED|Overall Study||0
11217617|NCT01943461|12409047|FG002|NOT COMPLETED|Overall Study||0
11098258|NCT01214629|12281771|FG005|COMPLETED|Overall Study||9
11098259|NCT01214629|12281772|FG006|COMPLETED|Overall Study||4
11217618|NCT01943461|12409048|FG003|NOT COMPLETED|Overall Study||0
11217619|NCT01943474|12409060|FG000|STARTED|Overall Study||123
11217620|NCT01943474|12409061|FG001|STARTED|Overall Study||125
11217621|NCT01943474|12409060|FG000|COMPLETED|Overall Study||123
11217622|NCT01943474|12409061|FG001|COMPLETED|Overall Study||125
11217623|NCT01943474|12409060|FG000|NOT COMPLETED|Overall Study||0
11217624|NCT01943474|12409061|FG001|NOT COMPLETED|Overall Study||0
11217625|NCT01943539|12409067|FG000|STARTED|Overall Study||44
11217626|NCT01943539|12409068|FG001|STARTED|Overall Study||40
11217627|NCT01943539|12409067|FG000|COMPLETED|Overall Study||40
11217628|NCT01943539|12409068|FG001|COMPLETED|Overall Study||40
11217629|NCT01943539|12409067|FG000|NOT COMPLETED|Overall Study||4
11217630|NCT01943539|12409068|FG001|NOT COMPLETED|Overall Study||0
11217631|NCT01943552|12409077|FG000|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
11217632|NCT01943552|12409078|FG001|STARTED|Overall Study||94
11217633|NCT01943552|12409077|FG000|COMPLETED|Overall Study||71
11217634|NCT01943552|12409078|FG001|COMPLETED|Overall Study||69
11217635|NCT01943552|12409077|FG000|NOT COMPLETED|Overall Study||25
11217636|NCT01943552|12409078|FG001|NOT COMPLETED|Overall Study||25
11217637|NCT01943565|12409087|FG000|STARTED|Overall Study||11
11217638|NCT01943565|12409088|FG001|STARTED|Overall Study||9
11217639|NCT01943565|12409089|FG002|STARTED|Overall Study||9
11217640|NCT01943565|12409087|FG000|COMPLETED|Overall Study||11
11353230|NCT03054870|12550403|FG000|NOT COMPLETED|Day of Ventilation Imaging||5
11353231|NCT03054870|12550403|FG000|STARTED|24-hour Follow-up|24-hour follow-up was omitted from Protocol Amendment 1, so 92 subjects enrolled under Amendment 1 not included.|118
11353232|NCT03054870|12550403|FG000|COMPLETED|24-hour Follow-up||118
11353233|NCT03054870|12550403|FG000|NOT COMPLETED|24-hour Follow-up||0
11353234|NCT03054870|12550403|FG000|STARTED|Blinded Read of Images|At time of study termination, 200 subjects had completed the blinded read assessments. The decision to terminate was based on the positive results of an unplanned interim analysis of these blind read data by a third party statistician.|200
11353235|NCT03054870|12550403|FG000|COMPLETED|Blinded Read of Images||200
11098260|NCT01214629|12281773|FG007|COMPLETED|Overall Study||2
11098261|NCT01214629|12281774|FG008|COMPLETED|Overall Study||2
11098262|NCT01214629|12281775|FG009|COMPLETED|Overall Study||11
11098263|NCT01214629|12281776|FG010|COMPLETED|Overall Study||1
11098264|NCT01214629|12281766|FG000|NOT COMPLETED|Overall Study||1
11098265|NCT01214629|12281767|FG001|NOT COMPLETED|Overall Study||1
11098266|NCT01214629|12281768|FG002|NOT COMPLETED|Overall Study||0
11353236|NCT03054870|12550403|FG000|NOT COMPLETED|Blinded Read of Images||0
11353237|NCT03054922|12550421|FG000|STARTED|Overall Study||20
11353238|NCT03054922|12550422|FG001|STARTED|Overall Study||19
11353239|NCT03054922|12550423|FG002|STARTED|Overall Study||20
11353240|NCT03054922|12550421|FG000|COMPLETED|Overall Study||20
11353241|NCT03054922|12550422|FG001|COMPLETED|Overall Study||19
11353242|NCT03054922|12550423|FG002|COMPLETED|Overall Study||20
11353243|NCT03054922|12550421|FG000|NOT COMPLETED|Overall Study||0
11353244|NCT03054922|12550422|FG001|NOT COMPLETED|Overall Study||0
11353245|NCT03054922|12550423|FG002|NOT COMPLETED|Overall Study||0
11098267|NCT01214629|12281769|FG003|NOT COMPLETED|Overall Study||2
11098268|NCT01214629|12281770|FG004|NOT COMPLETED|Overall Study||2
11217641|NCT01943565|12409088|FG001|COMPLETED|Overall Study||9
11217642|NCT01943565|12409089|FG002|COMPLETED|Overall Study||9
11217643|NCT01943565|12409087|FG000|NOT COMPLETED|Overall Study||0
11217644|NCT01943565|12409088|FG001|NOT COMPLETED|Overall Study||0
11217645|NCT01943565|12409089|FG002|NOT COMPLETED|Overall Study||0
11098269|NCT01214629|12281771|FG005|NOT COMPLETED|Overall Study||4
11098270|NCT01214629|12281772|FG006|NOT COMPLETED|Overall Study||1
11098271|NCT01214629|12281773|FG007|NOT COMPLETED|Overall Study||1
11098272|NCT01214629|12281774|FG008|NOT COMPLETED|Overall Study||1
11098273|NCT01214629|12281775|FG009|NOT COMPLETED|Overall Study||7
11098274|NCT01214629|12281776|FG010|NOT COMPLETED|Overall Study||2
11098275|NCT01214642|12281826|FG000|STARTED|Overall Study||3
11098276|NCT01214642|12281827|FG001|STARTED|Overall Study||3
11098277|NCT01214642|12281828|FG002|STARTED|Overall Study||6
11217646|NCT01943591|12409099|FG000|STARTED|Overall Study||104
11217647|NCT01943591|12409100|FG001|STARTED|Overall Study||106
11217648|NCT01943591|12409099|FG000|COMPLETED|Overall Study||99
11217649|NCT01943591|12409100|FG001|COMPLETED|Overall Study||95
11217650|NCT01943591|12409099|FG000|NOT COMPLETED|Overall Study||5
11217651|NCT01943591|12409100|FG001|NOT COMPLETED|Overall Study||11
11353246|NCT03055000|12550434|FG000|STARTED|Overall Study||16
11353247|NCT03055000|12550435|FG001|STARTED|Overall Study||17
11353248|NCT03055000|12550436|FG002|STARTED|Overall Study||16
11353249|NCT03055000|12550434|FG000|COMPLETED|Overall Study||16
11353250|NCT03055000|12550435|FG001|COMPLETED|Overall Study||17
11098278|NCT01214642|12281829|FG003|STARTED|Overall Study||6
11098279|NCT01214642|12281830|FG004|STARTED|Overall Study||6
11098280|NCT01214642|12281831|FG005|STARTED|Overall Study||3
11098281|NCT01214642|12281832|FG006|STARTED|Overall Study||6
11098282|NCT01214642|12281833|FG007|STARTED|Overall Study||3
11098283|NCT01214642|12281834|FG008|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
11098284|NCT01214642|12281835|FG009|STARTED|Overall Study||4
11098285|NCT01214642|12281836|FG010|STARTED|Overall Study||4
11098286|NCT01214642|12281837|FG011|STARTED|Overall Study||6
11098287|NCT01214642|12281826|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11217652|NCT01943799|12409110|FG000|STARTED|Overall Study||27
11217653|NCT01943799|12409111|FG001|STARTED|Overall Study||50
11217654|NCT01943799|12409112|FG002|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51
11217655|NCT01943799|12409113|FG003|STARTED|Overall Study||50
11217656|NCT01943799|12409110|FG000|COMPLETED|Overall Study||22
11217657|NCT01943799|12409111|FG001|COMPLETED|Overall Study||47
11217658|NCT01943799|12409112|FG002|COMPLETED|Overall Study||49
11217659|NCT01943799|12409113|FG003|COMPLETED|Overall Study||50
11217660|NCT01943799|12409110|FG000|NOT COMPLETED|Overall Study||5
11217661|NCT01943799|12409111|FG001|NOT COMPLETED|Overall Study||3
11217662|NCT01943799|12409112|FG002|NOT COMPLETED|Overall Study||2
11217663|NCT01943799|12409113|FG003|NOT COMPLETED|Overall Study||0
11353251|NCT03055000|12550436|FG002|COMPLETED|Overall Study||16
11353252|NCT03055000|12550434|FG000|NOT COMPLETED|Overall Study||0
11353253|NCT03055000|12550435|FG001|NOT COMPLETED|Overall Study||0
11353254|NCT03055000|12550436|FG002|NOT COMPLETED|Overall Study||0
11353255|NCT03055156|12550446|FG000|STARTED|Overall Study||281
11353256|NCT03055156|12550447|FG001|STARTED|Overall Study||273
11217664|NCT01943851|12409141|FG000|STARTED|Part 1 (Up to 86.9 Weeks)||1
11217665|NCT01943851|12409142|FG001|STARTED|Part 1 (Up to 86.9 Weeks)||1
11217666|NCT01943851|12409143|FG002|STARTED|Part 1 (Up to 86.9 Weeks)||1
11217667|NCT01943851|12409144|FG003|STARTED|Part 1 (Up to 86.9 Weeks)||5
11217668|NCT01943851|12409145|FG004|STARTED|Part 1 (Up to 86.9 Weeks)||1
11217669|NCT01943851|12409146|FG005|STARTED|Part 1 (Up to 86.9 Weeks)||4
11217670|NCT01943851|12409147|FG006|STARTED|Part 1 (Up to 86.9 Weeks)||8
11217671|NCT01943851|12409148|FG007|STARTED|Part 1 (Up to 86.9 Weeks)||18
11217672|NCT01943851|12409149|FG008|STARTED|Part 1 (Up to 86.9 Weeks)||3
11217673|NCT01943851|12409150|FG009|STARTED|Part 1 (Up to 86.9 Weeks)||8
11217674|NCT01943851|12409151|FG010|STARTED|Part 1 (Up to 86.9 Weeks)||1
11217675|NCT01943851|12409152|FG011|STARTED|Part 1 (Up to 86.9 Weeks)||7
11217676|NCT01943851|12409153|FG012|STARTED|Part 1 (Up to 86.9 Weeks)||7
11217677|NCT01943851|12409154|FG013|STARTED|Part 1 (Up to 86.9 Weeks)||16
11217678|NCT01943851|12409155|FG014|STARTED|Part 1 (Up to 86.9 Weeks)||6
11217679|NCT01943851|12409156|FG015|STARTED|Part 1 (Up to 86.9 Weeks)||0
11217680|NCT01943851|12409157|FG016|STARTED|Part 1 (Up to 86.9 Weeks)||0
11217681|NCT01943851|12409158|FG017|STARTED|Part 1 (Up to 86.9 Weeks)||0
11217682|NCT01943851|12409141|FG000|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
11217683|NCT01943851|12409142|FG001|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
11217684|NCT01943851|12409143|FG002|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
11217685|NCT01943851|12409144|FG003|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
11217686|NCT01943851|12409145|FG004|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217687|NCT01943851|12409146|FG005|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
11217688|NCT01943851|12409147|FG006|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
11217689|NCT01943851|12409148|FG007|COMPLETED|Part 1 (Up to 86.9 Weeks)||16
11217690|NCT01943851|12409149|FG008|COMPLETED|Part 1 (Up to 86.9 Weeks)||2
11217691|NCT01943851|12409150|FG009|COMPLETED|Part 1 (Up to 86.9 Weeks)||8
11217692|NCT01943851|12409151|FG010|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
11217693|NCT01943851|12409152|FG011|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
11217694|NCT01943851|12409153|FG012|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
11217695|NCT01943851|12409154|FG013|COMPLETED|Part 1 (Up to 86.9 Weeks)||15
11217696|NCT01943851|12409155|FG014|COMPLETED|Part 1 (Up to 86.9 Weeks)||6
11217697|NCT01943851|12409156|FG015|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217698|NCT01943851|12409157|FG016|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217699|NCT01943851|12409158|FG017|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217700|NCT01943851|12409141|FG000|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217701|NCT01943851|12409142|FG001|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217702|NCT01943851|12409143|FG002|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217703|NCT01943851|12409144|FG003|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
11217704|NCT01943851|12409145|FG004|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
11217705|NCT01943851|12409146|FG005|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217706|NCT01943851|12409147|FG006|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
11217707|NCT01943851|12409148|FG007|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||2
11217708|NCT01943851|12409149|FG008|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
11217709|NCT01943851|12409150|FG009|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217710|NCT01943851|12409151|FG010|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217711|NCT01943851|12409152|FG011|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217712|NCT01943851|12409153|FG012|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217713|NCT01943851|12409154|FG013|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
11217714|NCT01943851|12409155|FG014|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217715|NCT01943851|12409156|FG015|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217716|NCT01943851|12409157|FG016|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217717|NCT01943851|12409158|FG017|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
11217718|NCT01943851|12409141|FG000|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217719|NCT01943851|12409142|FG001|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217720|NCT01943851|12409143|FG002|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217721|NCT01943851|12409144|FG003|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217722|NCT01943851|12409145|FG004|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217723|NCT01943851|12409146|FG005|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217724|NCT01943851|12409147|FG006|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217725|NCT01943851|12409148|FG007|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217726|NCT01943851|12409149|FG008|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217727|NCT01943851|12409150|FG009|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217728|NCT01943851|12409151|FG010|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217729|NCT01943851|12409152|FG011|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217730|NCT01943851|12409153|FG012|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217731|NCT01943851|12409154|FG013|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217732|NCT01943851|12409155|FG014|STARTED|Part 2 (Up to 36.4 Weeks)||0
11217733|NCT01943851|12409156|FG015|STARTED|Part 2 (Up to 36.4 Weeks)||7
11217734|NCT01943851|12409157|FG016|STARTED|Part 2 (Up to 36.4 Weeks)||16
11217735|NCT01943851|12409158|FG017|STARTED|Part 2 (Up to 36.4 Weeks)||1
11217736|NCT01943851|12409141|FG000|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217737|NCT01943851|12409142|FG001|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217738|NCT01943851|12409143|FG002|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217739|NCT01943851|12409144|FG003|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217740|NCT01943851|12409145|FG004|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217741|NCT01943851|12409146|FG005|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217742|NCT01943851|12409147|FG006|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217743|NCT01943851|12409148|FG007|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217744|NCT01943851|12409149|FG008|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217745|NCT01943851|12409150|FG009|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217746|NCT01943851|12409151|FG010|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217747|NCT01943851|12409152|FG011|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217748|NCT01943851|12409153|FG012|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217749|NCT01943851|12409154|FG013|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217750|NCT01943851|12409155|FG014|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217751|NCT01943851|12409156|FG015|COMPLETED|Part 2 (Up to 36.4 Weeks)||1
11217752|NCT01943851|12409157|FG016|COMPLETED|Part 2 (Up to 36.4 Weeks)||13
11217753|NCT01943851|12409158|FG017|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217754|NCT01943851|12409141|FG000|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217755|NCT01943851|12409142|FG001|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217756|NCT01943851|12409143|FG002|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217757|NCT01943851|12409144|FG003|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217758|NCT01943851|12409145|FG004|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217759|NCT01943851|12409146|FG005|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217760|NCT01943851|12409147|FG006|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217761|NCT01943851|12409148|FG007|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217762|NCT01943851|12409149|FG008|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217763|NCT01943851|12409150|FG009|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217764|NCT01943851|12409151|FG010|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217765|NCT01943851|12409152|FG011|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217766|NCT01943851|12409153|FG012|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217767|NCT01943851|12409154|FG013|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217768|NCT01943851|12409155|FG014|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
11217769|NCT01943851|12409156|FG015|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||6
11217770|NCT01943851|12409157|FG016|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||3
11217771|NCT01943851|12409158|FG017|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||1
11217772|NCT01943864|12409199|FG000|STARTED|Overall Study||20
11217773|NCT01943864|12409199|FG000|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
11217774|NCT01943864|12409199|FG000|NOT COMPLETED|Overall Study||0
11217775|NCT01943916|12409203|FG000|STARTED|Overall Study||2105
11217776|NCT01943916|12409203|FG000|COMPLETED|Overall Study||1739
11217777|NCT01943916|12409203|FG000|NOT COMPLETED|Overall Study||366
11217778|NCT01944046|12409214|FG000|STARTED|Randomized to DB||146
11217779|NCT01944046|12409215|FG001|STARTED|Randomized to DB||144
11217780|NCT01944046|12409214|FG000|COMPLETED|Randomized to DB||125
11217781|NCT01944046|12409215|FG001|COMPLETED|Randomized to DB||125
11217782|NCT01944046|12409214|FG000|NOT COMPLETED|Randomized to DB||21
11217783|NCT01944046|12409215|FG001|NOT COMPLETED|Randomized to DB||19
11217784|NCT01944046|12409214|FG000|STARTED|Open Label Eligible and Consented||124
11217785|NCT01944046|12409215|FG001|STARTED|Open Label Eligible and Consented||124
11217786|NCT01944046|12409214|FG000|COMPLETED|Open Label Eligible and Consented||110
11217787|NCT01944046|12409215|FG001|COMPLETED|Open Label Eligible and Consented||116
11217788|NCT01944046|12409214|FG000|NOT COMPLETED|Open Label Eligible and Consented||14
11217789|NCT01944046|12409215|FG001|NOT COMPLETED|Open Label Eligible and Consented||8
11217790|NCT01944098|12409227|FG000|STARTED|Overall Study||10
11217791|NCT01944098|12409228|FG001|STARTED|Overall Study||10
11217792|NCT01944098|12409227|FG000|COMPLETED|Overall Study||9
11217793|NCT01944098|12409228|FG001|COMPLETED|Overall Study||10
11217794|NCT01944098|12409227|FG000|NOT COMPLETED|Overall Study||1
11217795|NCT01944098|12409228|FG001|NOT COMPLETED|Overall Study||0
11217796|NCT01944293|12409236|FG000|STARTED|Overall Study||7
11217797|NCT01944293|12409237|FG001|STARTED|Overall Study||9
11217798|NCT01944293|12409236|FG000|COMPLETED|Overall Study||7
11217799|NCT01944293|12409237|FG001|COMPLETED|Overall Study||9
11217800|NCT01944293|12409236|FG000|NOT COMPLETED|Overall Study||0
11217801|NCT01944293|12409237|FG001|NOT COMPLETED|Overall Study||0
11217802|NCT01944319|12409245|FG000|STARTED|Overall Study||40
11353257|NCT03055156|12550446|FG000|COMPLETED|Overall Study||281
11217803|NCT01944319|12409246|FG001|STARTED|Overall Study||39
11217804|NCT01944319|12409245|FG000|COMPLETED|Overall Study||40
11217805|NCT01944319|12409246|FG001|COMPLETED|Overall Study||39
11217806|NCT01944319|12409245|FG000|NOT COMPLETED|Overall Study||0
11217807|NCT01944319|12409246|FG001|NOT COMPLETED|Overall Study||0
11217808|NCT01944345|12409253|FG000|STARTED|Overall Study||69
11217809|NCT01944345|12409253|FG000|COMPLETED|Overall Study||69
11217810|NCT01944345|12409253|FG000|NOT COMPLETED|Overall Study||0
11217811|NCT01944371|12409260|FG000|STARTED|Overall Study||10
11217812|NCT01944371|12409261|FG001|STARTED|Overall Study||10
11217813|NCT01944371|12409262|FG002|STARTED|Overall Study||10
11217814|NCT01944371|12409260|FG000|COMPLETED|Overall Study||10
11217815|NCT01944371|12409261|FG001|COMPLETED|Overall Study||10
11217816|NCT01944371|12409262|FG002|COMPLETED|Overall Study||10
11217817|NCT01944371|12409260|FG000|NOT COMPLETED|Overall Study||0
11217818|NCT01944371|12409261|FG001|NOT COMPLETED|Overall Study||0
11217819|NCT01944371|12409262|FG002|NOT COMPLETED|Overall Study||0
11217820|NCT01944423|12409272|FG000|STARTED|Overall Study||27
11217821|NCT01944423|12409273|FG001|STARTED|Overall Study||26
11217822|NCT01944423|12409272|FG000|End of Treatment|Overall Study||21
11217823|NCT01944423|12409273|FG001|End of Treatment|Overall Study||20
11217824|NCT01944423|12409272|FG000|1-month Follow-up|Overall Study||22
11217825|NCT01944423|12409273|FG001|1-month Follow-up|Overall Study||19
11217826|NCT01944423|12409272|FG000|4-month Follow-up|Overall Study||19
11217827|NCT01944423|12409273|FG001|4-month Follow-up|Overall Study||16
11217828|NCT01944423|12409272|FG000|COMPLETED|Overall Study|6-month follow-up|19
11217829|NCT01944423|12409273|FG001|COMPLETED|Overall Study|6-month follow-up|17
11217830|NCT01944423|12409272|FG000|NOT COMPLETED|Overall Study||8
11217831|NCT01944423|12409273|FG001|NOT COMPLETED|Overall Study||9
11217832|NCT01944462|12409279|FG000|STARTED|PPPP Educational Program||203
11217833|NCT01944462|12409279|FG000|Baseline|PPPP Educational Program||203
11217834|NCT01944462|12409279|FG000|Post-Test|PPPP Educational Program||187
11217835|NCT01944462|12409279|FG000|3 Month Follow-Up|PPPP Educational Program||143
11217836|NCT01944462|12409279|FG000|COMPLETED|PPPP Educational Program||143
11217837|NCT01944462|12409279|FG000|NOT COMPLETED|PPPP Educational Program||60
11217838|NCT01944462|12409279|FG000|STARTED|Optional Vaccination||20
11217839|NCT01944462|12409279|FG000|COMPLETED|Optional Vaccination||20
11217840|NCT01944462|12409279|FG000|NOT COMPLETED|Optional Vaccination||0
11217841|NCT01944631|12409286|FG000|STARTED|Overall Study||100
11217842|NCT01944631|12409287|FG001|STARTED|Overall Study||100
11217843|NCT01944631|12409286|FG000|COMPLETED|Overall Study||96
11217844|NCT01944631|12409287|FG001|COMPLETED|Overall Study||98
11217845|NCT01944631|12409286|FG000|NOT COMPLETED|Overall Study||4
11217846|NCT01944631|12409287|FG001|NOT COMPLETED|Overall Study||2
11217847|NCT01944644|12409295|FG000|STARTED|Overall Study||34
11217848|NCT01944644|12409296|FG001|STARTED|Overall Study||32
11217849|NCT01944644|12409295|FG000|COMPLETED|Overall Study||34
11217850|NCT01944644|12409296|FG001|COMPLETED|Overall Study||32
11217851|NCT01944644|12409295|FG000|NOT COMPLETED|Overall Study||0
11217852|NCT01944644|12409296|FG001|NOT COMPLETED|Overall Study||0
11217853|NCT01944670|12409302|FG000|STARTED|Overall Study||26
11217854|NCT01944670|12409302|FG000|COMPLETED|Overall Study||24
11217855|NCT01944670|12409302|FG000|NOT COMPLETED|Overall Study||2
11217856|NCT01944722|12409308|FG000|STARTED|Overall Study||33858
11217857|NCT01944722|12409308|FG000|COMPLETED|Overall Study||24343
11217858|NCT01944722|12409308|FG000|NOT COMPLETED|Overall Study||9515
11217859|NCT01944774|12409320|FG000|STARTED|Overall Study||69
11217860|NCT01944774|12409321|FG001|STARTED|Overall Study||68
11217861|NCT01944774|12409322|FG002|STARTED|Overall Study||70
11217862|NCT01944774|12409320|FG000|Received Treatment|Overall Study||68
11217863|NCT01944774|12409321|FG001|Received Treatment|Overall Study||67
11217864|NCT01944774|12409322|FG002|Received Treatment|Overall Study||70
11217865|NCT01944774|12409320|FG000|COMPLETED|Overall Study||63
11217866|NCT01944774|12409321|FG001|COMPLETED|Overall Study||60
11217867|NCT01944774|12409322|FG002|COMPLETED|Overall Study||62
11217868|NCT01944774|12409320|FG000|NOT COMPLETED|Overall Study||6
11217869|NCT01944774|12409321|FG001|NOT COMPLETED|Overall Study||8
11217870|NCT01944774|12409322|FG002|NOT COMPLETED|Overall Study||8
11217871|NCT01944839|12409335|FG000|STARTED|Overall Study||309
11217872|NCT01944839|12409336|FG001|STARTED|Overall Study||310
11217873|NCT01944839|12409335|FG000|COMPLETED|Overall Study||287
11217874|NCT01944839|12409336|FG001|COMPLETED|Overall Study||282
11217875|NCT01944839|12409335|FG000|NOT COMPLETED|Overall Study||22
11217876|NCT01944839|12409336|FG001|NOT COMPLETED|Overall Study||28
11217877|NCT01944878|12409344|FG000|STARTED|Overall Study||127
11217878|NCT01944878|12409345|FG001|STARTED|Overall Study||328
11217879|NCT01944878|12409344|FG000|COMPLETED|Overall Study||127
11217880|NCT01944878|12409345|FG001|COMPLETED|Overall Study||328
11217881|NCT01944878|12409344|FG000|NOT COMPLETED|Overall Study||0
11217882|NCT01944878|12409345|FG001|NOT COMPLETED|Overall Study||0
11217883|NCT01944930|12409355|FG000|STARTED|Overall Study||12
11217884|NCT01944930|12409356|FG001|STARTED|Overall Study||11
11217885|NCT01944930|12409355|FG000|COMPLETED|Overall Study||10
11217886|NCT01944930|12409356|FG001|COMPLETED|Overall Study||10
11217887|NCT01944930|12409355|FG000|NOT COMPLETED|Overall Study||2
11217888|NCT01944930|12409356|FG001|NOT COMPLETED|Overall Study||1
11217889|NCT01944969|12409362|FG000|STARTED|Overall Study||26
11217890|NCT01944969|12409362|FG000|COMPLETED|Overall Study||0
11217891|NCT01944969|12409362|FG000|NOT COMPLETED|Overall Study||26
11217892|NCT01945034|12409371|FG000|STARTED|Overall Study||67
11217893|NCT01945034|12409372|FG001|STARTED|Overall Study||85
11217894|NCT01945034|12409373|FG002|STARTED|Overall Study||152
11217895|NCT01945034|12409371|FG000|COMPLETED|Overall Study||66
11217896|NCT01945034|12409372|FG001|COMPLETED|Overall Study||80
11217897|NCT01945034|12409373|FG002|COMPLETED|Overall Study||145
11217898|NCT01945034|12409371|FG000|NOT COMPLETED|Overall Study||1
11217899|NCT01945034|12409372|FG001|NOT COMPLETED|Overall Study||5
11217900|NCT01945034|12409373|FG002|NOT COMPLETED|Overall Study||7
11217901|NCT01945086|12409384|FG000|STARTED|Overall Study||27
11217902|NCT01945086|12409385|FG001|STARTED|Overall Study||24
11217903|NCT01945086|12409386|FG002|STARTED|Overall Study||28
11217904|NCT01945086|12409384|FG000|COMPLETED|Overall Study||26
11217905|NCT01945086|12409385|FG001|COMPLETED|Overall Study||24
11217906|NCT01945086|12409386|FG002|COMPLETED|Overall Study||26
11217907|NCT01945086|12409384|FG000|NOT COMPLETED|Overall Study||1
11217908|NCT01945086|12409385|FG001|NOT COMPLETED|Overall Study||0
11217909|NCT01945086|12409386|FG002|NOT COMPLETED|Overall Study||2
11217910|NCT01945112|12409394|FG000|STARTED|Overall Study|total number of sites where tape was applied|77
11217911|NCT01945112|12409395|FG001|STARTED|Overall Study|total number of sites where tape was applied|51
11217912|NCT01945112|12409394|FG000|COMPLETED|Overall Study||77
11217913|NCT01945112|12409395|FG001|COMPLETED|Overall Study||51
11217914|NCT01945112|12409394|FG000|NOT COMPLETED|Overall Study||0
11217915|NCT01945112|12409395|FG001|NOT COMPLETED|Overall Study||0
11217916|NCT01945138|12409402|FG000|STARTED|Overall Study||7
11217917|NCT01945138|12409403|FG001|STARTED|Overall Study||7
11217918|NCT01945138|12409402|FG000|COMPLETED|Overall Study||7
11217919|NCT01945138|12409403|FG001|COMPLETED|Overall Study||7
11217920|NCT01945138|12409402|FG000|NOT COMPLETED|Overall Study||0
11217921|NCT01945138|12409403|FG001|NOT COMPLETED|Overall Study||0
11217922|NCT01945216|12409412|FG000|STARTED|Overall Study||3317
11217923|NCT01945216|12409412|FG000|COMPLETED|Overall Study||3218
11217924|NCT01945216|12409412|FG000|NOT COMPLETED|Overall Study||99
11217925|NCT01945242|12409422|FG000|STARTED|Overall Study||1251
11217926|NCT01945242|12409423|FG001|STARTED|Overall Study||123
11217927|NCT01945242|12409422|FG000|COMPLETED|Overall Study||1248
11217928|NCT01945242|12409423|FG001|COMPLETED|Overall Study||120
11217929|NCT01945242|12409422|FG000|NOT COMPLETED|Overall Study||3
11217930|NCT01945242|12409423|FG001|NOT COMPLETED|Overall Study||3
11217931|NCT01945281|12409432|FG000|STARTED|Overall Study||34
11217932|NCT01945281|12409433|FG001|STARTED|Overall Study||17
11217933|NCT01945281|12409432|FG000|Treated|Overall Study||33
11217934|NCT01945281|12409433|FG001|Treated|Overall Study||16
11217935|NCT01945281|12409432|FG000|COMPLETED|Overall Study||28
11217936|NCT01945281|12409433|FG001|COMPLETED|Overall Study||13
11217937|NCT01945281|12409432|FG000|NOT COMPLETED|Overall Study||6
11217938|NCT01945281|12409433|FG001|NOT COMPLETED|Overall Study||4
11217939|NCT01945294|12409442|FG000|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
11217940|NCT01945294|12409443|FG001|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
11217941|NCT01945294|12409444|FG002|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
11217942|NCT01945294|12409445|FG003|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
11217943|NCT01945294|12409442|FG000|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
11217944|NCT01945294|12409443|FG001|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
11217945|NCT01945294|12409444|FG002|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
11217946|NCT01945294|12409445|FG003|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
11217947|NCT01945294|12409442|FG000|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
11217948|NCT01945294|12409443|FG001|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
11217949|NCT01945294|12409444|FG002|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
11217950|NCT01945294|12409445|FG003|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
11217951|NCT01945294|12409442|FG000|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
11217952|NCT01945294|12409443|FG001|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
11217953|NCT01945294|12409444|FG002|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
11217954|NCT01945294|12409445|FG003|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
11217955|NCT01945294|12409442|FG000|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
11217956|NCT01945294|12409443|FG001|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
11217957|NCT01945294|12409444|FG002|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
11217958|NCT01945294|12409445|FG003|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
11217959|NCT01945294|12409442|FG000|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
11217960|NCT01945294|12409443|FG001|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
11217961|NCT01945294|12409444|FG002|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
11217962|NCT01945294|12409445|FG003|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
11217963|NCT01945489|12409456|FG000|STARTED|Cycle 1||129
11217964|NCT01945489|12409457|FG001|STARTED|Cycle 1||125
11217965|NCT01945489|12409456|FG000|COMPLETED|Cycle 1||116
11217966|NCT01945489|12409457|FG001|COMPLETED|Cycle 1||121
11217967|NCT01945489|12409456|FG000|NOT COMPLETED|Cycle 1||13
11217968|NCT01945489|12409457|FG001|NOT COMPLETED|Cycle 1||4
11217969|NCT01945489|12409456|FG000|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
11217970|NCT01945489|12409457|FG001|STARTED|Cycle 2||107
11217971|NCT01945489|12409456|FG000|COMPLETED|Cycle 2||87
11217972|NCT01945489|12409457|FG001|COMPLETED|Cycle 2||106
11217973|NCT01945489|12409456|FG000|NOT COMPLETED|Cycle 2||1
11217974|NCT01945489|12409457|FG001|NOT COMPLETED|Cycle 2||1
11217975|NCT01945580|12409466|FG000|STARTED|Overall Study||228
11217976|NCT01945580|12409467|FG001|STARTED|Overall Study||485
11217977|NCT01945580|12409466|FG000|COMPLETED|Overall Study||176
11217978|NCT01945580|12409467|FG001|COMPLETED|Overall Study||401
11217979|NCT01945580|12409466|FG000|NOT COMPLETED|Overall Study||52
11217980|NCT01945580|12409467|FG001|NOT COMPLETED|Overall Study||84
11217981|NCT01945593|12409481|FG000|STARTED|Overall Study||3
11217982|NCT01945593|12409482|FG001|STARTED|Overall Study||64
11217983|NCT01945593|12409483|FG002|STARTED|Overall Study||26
11217984|NCT01945593|12409484|FG003|STARTED|Overall Study||125
11217985|NCT01945593|12409481|FG000|COMPLETED|Overall Study||3
11217986|NCT01945593|12409482|FG001|COMPLETED|Overall Study||56
11217987|NCT01945593|12409483|FG002|COMPLETED|Overall Study||23
11217988|NCT01945593|12409484|FG003|COMPLETED|Overall Study||105
11217989|NCT01945593|12409481|FG000|NOT COMPLETED|Overall Study||0
11217990|NCT01945593|12409482|FG001|NOT COMPLETED|Overall Study||8
11217991|NCT01945593|12409483|FG002|NOT COMPLETED|Overall Study||3
11217992|NCT01945593|12409484|FG003|NOT COMPLETED|Overall Study||20
11217993|NCT01945710|12409506|FG000|STARTED|Overall Study||7
11217994|NCT01945710|12409507|FG001|STARTED|Overall Study||6
11217995|NCT01945710|12409508|FG002|STARTED|Overall Study||7
11217996|NCT01945710|12409509|FG003|STARTED|Overall Study||3
11217997|NCT01945710|12409510|FG004|STARTED|Overall Study||9
11217998|NCT01945710|12409511|FG005|STARTED|Overall Study||3
11217999|NCT01945710|12409512|FG006|STARTED|Overall Study||23
11218000|NCT01945710|12409506|FG000|COMPLETED|Overall Study||0
11218001|NCT01945710|12409507|FG001|COMPLETED|Overall Study||0
11218002|NCT01945710|12409508|FG002|COMPLETED|Overall Study||0
11218003|NCT01945710|12409509|FG003|COMPLETED|Overall Study||0
11218004|NCT01945710|12409510|FG004|COMPLETED|Overall Study||0
11218005|NCT01945710|12409511|FG005|COMPLETED|Overall Study||0
11218006|NCT01945710|12409512|FG006|COMPLETED|Overall Study||0
11218007|NCT01945710|12409506|FG000|NOT COMPLETED|Overall Study||7
11218008|NCT01945710|12409507|FG001|NOT COMPLETED|Overall Study||6
11218009|NCT01945710|12409508|FG002|NOT COMPLETED|Overall Study||7
11218010|NCT01945710|12409509|FG003|NOT COMPLETED|Overall Study||3
11218011|NCT01945710|12409510|FG004|NOT COMPLETED|Overall Study||9
11218012|NCT01945710|12409511|FG005|NOT COMPLETED|Overall Study||3
11218013|NCT01945710|12409512|FG006|NOT COMPLETED|Overall Study||23
11218014|NCT01945866|12409532|FG000|STARTED|Overall Study||65
11218015|NCT01945866|12409533|FG001|STARTED|Overall Study||64
11218016|NCT01945866|12409532|FG000|COMPLETED|Overall Study||63
11218017|NCT01945866|12409533|FG001|COMPLETED|Overall Study||64
11218018|NCT01945866|12409532|FG000|NOT COMPLETED|Overall Study||2
11218019|NCT01945866|12409533|FG001|NOT COMPLETED|Overall Study||0
11218020|NCT01945944|12409542|FG000|STARTED|Overall Study||9
11218021|NCT01945944|12409543|FG001|STARTED|Overall Study||9
11218022|NCT01945944|12409542|FG000|COMPLETED|Overall Study||8
11218023|NCT01945944|12409543|FG001|COMPLETED|Overall Study||6
11218024|NCT01945944|12409542|FG000|NOT COMPLETED|Overall Study||1
11218025|NCT01945944|12409543|FG001|NOT COMPLETED|Overall Study||3
11218026|NCT01945970|12409551|FG000|STARTED|Overall Study||5
11218027|NCT01945970|12409552|FG001|STARTED|Overall Study||5
11218028|NCT01945970|12409553|FG002|STARTED|Overall Study||5
11218029|NCT01945970|12409554|FG003|STARTED|Overall Study||5
11218030|NCT01945970|12409555|FG004|STARTED|Overall Study||5
11218031|NCT01945970|12409556|FG005|STARTED|Overall Study||5
11218032|NCT01945970|12409551|FG000|COMPLETED|Overall Study||5
11218033|NCT01945970|12409552|FG001|COMPLETED|Overall Study||5
11218034|NCT01945970|12409553|FG002|COMPLETED|Overall Study||5
11218035|NCT01945970|12409554|FG003|COMPLETED|Overall Study||5
11218036|NCT01945970|12409555|FG004|COMPLETED|Overall Study||5
11218037|NCT01945970|12409556|FG005|COMPLETED|Overall Study||5
11218038|NCT01945970|12409551|FG000|NOT COMPLETED|Overall Study||0
11218039|NCT01945970|12409552|FG001|NOT COMPLETED|Overall Study||0
11218040|NCT01945970|12409553|FG002|NOT COMPLETED|Overall Study||0
11218041|NCT01945970|12409554|FG003|NOT COMPLETED|Overall Study||0
11218042|NCT01945970|12409555|FG004|NOT COMPLETED|Overall Study||0
11218043|NCT01945970|12409556|FG005|NOT COMPLETED|Overall Study||0
11218044|NCT01945996|12409568|FG000|STARTED|Overall Study||22
11218045|NCT01945996|12409569|FG001|STARTED|Overall Study||22
11218046|NCT01945996|12409568|FG000|COMPLETED|Overall Study||19
11218047|NCT01945996|12409569|FG001|COMPLETED|Overall Study||17
11218048|NCT01945996|12409568|FG000|NOT COMPLETED|Overall Study||3
11218049|NCT01945996|12409569|FG001|NOT COMPLETED|Overall Study||5
11218050|NCT01946126|12409579|FG000|STARTED|Overall Study||184
11218051|NCT01946126|12409580|FG001|STARTED|Overall Study||275
11218052|NCT01946126|12409579|FG000|COMPLETED|Overall Study||184
11218053|NCT01946126|12409580|FG001|COMPLETED|Overall Study||275
11218054|NCT01946126|12409579|FG000|NOT COMPLETED|Overall Study||0
11218055|NCT01946126|12409580|FG001|NOT COMPLETED|Overall Study||0
11218056|NCT01946152|12409590|FG000|STARTED|Overall Study||3
11218057|NCT01946152|12409591|FG001|STARTED|Overall Study||3
11218058|NCT01946152|12409592|FG002|STARTED|Overall Study||6
11098288|NCT01214642|12281827|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
11098289|NCT01214642|12281828|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11098290|NCT01214642|12281829|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
11098291|NCT01214642|12281830|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
11098292|NCT01214642|12281831|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
11098293|NCT01214642|12281832|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
11218059|NCT01946152|12409593|FG003|STARTED|Overall Study||8
11218060|NCT01946152|12409590|FG000|COMPLETED|Overall Study||2
11218061|NCT01946152|12409591|FG001|COMPLETED|Overall Study||0
11218062|NCT01946152|12409592|FG002|COMPLETED|Overall Study||0
11218063|NCT01946152|12409593|FG003|COMPLETED|Overall Study||0
11218064|NCT01946152|12409590|FG000|NOT COMPLETED|Overall Study||1
11218065|NCT01946152|12409591|FG001|NOT COMPLETED|Overall Study||3
11218066|NCT01946152|12409592|FG002|NOT COMPLETED|Overall Study||6
11218067|NCT01946152|12409593|FG003|NOT COMPLETED|Overall Study||8
11218068|NCT01946165|12409607|FG000|STARTED|Overall Study||45
11218069|NCT01946165|12409608|FG001|STARTED|Overall Study||23
11218070|NCT01946165|12409607|FG000|COMPLETED|Overall Study||43
11218071|NCT01946165|12409608|FG001|COMPLETED|Overall Study||21
11218072|NCT01946165|12409607|FG000|NOT COMPLETED|Overall Study||2
11218073|NCT01946165|12409608|FG001|NOT COMPLETED|Overall Study||2
11218074|NCT01946178|12409615|FG000|STARTED|Overall Study||73
11098294|NCT01214642|12281833|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
11098295|NCT01214642|12281834|FG008|Received at Least 1 Dose of Study Drug|Overall Study||13
11098296|NCT01214642|12281835|FG009|Received at Least 1 Dose of Study Drug|Overall Study||4
11098297|NCT01214642|12281836|FG010|Received at Least 1 Dose of Study Drug|Overall Study||4
11098298|NCT01214642|12281837|FG011|Received at Least 1 Dose of Study Drug|Overall Study||6
11098299|NCT01214642|12281826|FG000|Complete at Least 2 Cycles of Study Drug|Overall Study||3
11098300|NCT01214642|12281827|FG001|Complete at Least 2 Cycles of Study Drug|Overall Study||1
11098301|NCT01214642|12281828|FG002|Complete at Least 2 Cycles of Study Drug|Overall Study||5
11098302|NCT01214642|12281829|FG003|Complete at Least 2 Cycles of Study Drug|Overall Study||4
11098303|NCT01214642|12281830|FG004|Complete at Least 2 Cycles of Study Drug|Overall Study||6
11098304|NCT01214642|12281831|FG005|Complete at Least 2 Cycles of Study Drug|Overall Study||1
11098305|NCT01214642|12281832|FG006|Complete at Least 2 Cycles of Study Drug|Overall Study||6
11098306|NCT01214642|12281833|FG007|Complete at Least 2 Cycles of Study Drug|Overall Study||3
11098307|NCT01214642|12281834|FG008|Complete at Least 2 Cycles of Study Drug|Overall Study||12
11098308|NCT01214642|12281835|FG009|Complete at Least 2 Cycles of Study Drug|Overall Study||2
11098309|NCT01214642|12281836|FG010|Complete at Least 2 Cycles of Study Drug|Overall Study||2
11098310|NCT01214642|12281837|FG011|Complete at Least 2 Cycles of Study Drug|Overall Study||5
11098311|NCT01214642|12281826|FG000|COMPLETED|Overall Study||0
11218075|NCT01946178|12409615|FG000|COMPLETED|Overall Study||71
11218076|NCT01946178|12409615|FG000|NOT COMPLETED|Overall Study||2
11218077|NCT01946191|12409625|FG000|STARTED|Allocation||98
11218078|NCT01946191|12409626|FG001|STARTED|Allocation||96
11218079|NCT01946191|12409625|FG000|COMPLETED|Allocation||97
11218080|NCT01946191|12409626|FG001|COMPLETED|Allocation||95
11218081|NCT01946191|12409625|FG000|NOT COMPLETED|Allocation||1
11218082|NCT01946191|12409626|FG001|NOT COMPLETED|Allocation||1
11218083|NCT01946191|12409625|FG000|STARTED|Follow-Up, 24-mo Endpoint||97
11218084|NCT01946191|12409626|FG001|STARTED|Follow-Up, 24-mo Endpoint||95
11218085|NCT01946191|12409625|FG000|COMPLETED|Follow-Up, 24-mo Endpoint||80
11218086|NCT01946191|12409626|FG001|COMPLETED|Follow-Up, 24-mo Endpoint||77
11218087|NCT01946191|12409625|FG000|NOT COMPLETED|Follow-Up, 24-mo Endpoint||17
11218088|NCT01946191|12409626|FG001|NOT COMPLETED|Follow-Up, 24-mo Endpoint||18
11218089|NCT01946191|12409625|FG000|STARTED|Primary Outcome Analysis||98
11218090|NCT01946191|12409626|FG001|STARTED|Primary Outcome Analysis||95
11218091|NCT01946191|12409625|FG000|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|80
11218092|NCT01946191|12409626|FG001|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|77
11218093|NCT01946191|12409625|FG000|NOT COMPLETED|Primary Outcome Analysis||18
11218094|NCT01946191|12409626|FG001|NOT COMPLETED|Primary Outcome Analysis||18
11218095|NCT01946243|12409633|FG000|STARTED|Overall Study||96
11218096|NCT01946243|12409633|FG000|COMPLETED|Overall Study||96
11218097|NCT01946243|12409633|FG000|NOT COMPLETED|Overall Study||0
11218098|NCT01946282|12409642|FG000|STARTED|Year 1||6565
11218099|NCT01946282|12409643|FG001|STARTED|Year 1||1000
11218100|NCT01946282|12409644|FG002|STARTED|Year 1||1000
11218101|NCT01946282|12409642|FG000|COMPLETED|Year 1||2379
11218102|NCT01946282|12409643|FG001|COMPLETED|Year 1||392
11218103|NCT01946282|12409644|FG002|COMPLETED|Year 1||346
11218104|NCT01946282|12409642|FG000|NOT COMPLETED|Year 1||4186
11218105|NCT01946282|12409643|FG001|NOT COMPLETED|Year 1||608
11218106|NCT01946282|12409644|FG002|NOT COMPLETED|Year 1||654
11218107|NCT01946282|12409642|FG000|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|2051
11218108|NCT01946282|12409643|FG001|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|341
11218109|NCT01946282|12409644|FG002|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|299
11218110|NCT01946282|12409642|FG000|COMPLETED|Year 2||1248
11218111|NCT01946282|12409643|FG001|COMPLETED|Year 2||210
11218112|NCT01946282|12409644|FG002|COMPLETED|Year 2||184
11218113|NCT01946282|12409642|FG000|NOT COMPLETED|Year 2||803
11218114|NCT01946282|12409643|FG001|NOT COMPLETED|Year 2||131
11218115|NCT01946282|12409644|FG002|NOT COMPLETED|Year 2||115
11218116|NCT01946282|12409642|FG000|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|1144
11218117|NCT01946282|12409643|FG001|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|184
11218118|NCT01946282|12409644|FG002|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|170
11218119|NCT01946282|12409642|FG000|COMPLETED|Year 3||856
11218120|NCT01946282|12409643|FG001|COMPLETED|Year 3||141
11218121|NCT01946282|12409644|FG002|COMPLETED|Year 3||140
11218122|NCT01946282|12409642|FG000|NOT COMPLETED|Year 3||288
11218123|NCT01946282|12409643|FG001|NOT COMPLETED|Year 3||43
11218124|NCT01946282|12409644|FG002|NOT COMPLETED|Year 3||30
11218125|NCT01946412|12409654|FG000|STARTED|Overall Study||33
11218126|NCT01946412|12409654|FG000|COMPLETED|Overall Study||28
11218127|NCT01946412|12409654|FG000|NOT COMPLETED|Overall Study||5
11218128|NCT01946425|12409662|FG000|STARTED|Overall Study||30
11218129|NCT01946425|12409663|FG001|STARTED|Overall Study||30
11218130|NCT01946425|12409662|FG000|COMPLETED|Overall Study||28
11218131|NCT01946425|12409663|FG001|COMPLETED|Overall Study||30
11218132|NCT01946425|12409662|FG000|NOT COMPLETED|Overall Study||2
11218133|NCT01946425|12409663|FG001|NOT COMPLETED|Overall Study||0
11218134|NCT01946438|12409674|FG000|STARTED|Overall Study||52
11218135|NCT01946438|12409675|FG001|STARTED|Overall Study||52
11218136|NCT01946438|12409676|FG002|STARTED|Overall Study||52
11218137|NCT01946438|12409677|FG003|STARTED|Overall Study||52
11218138|NCT01946438|12409674|FG000|COMPLETED|Overall Study||50
11218139|NCT01946438|12409675|FG001|COMPLETED|Overall Study||52
11218140|NCT01946438|12409676|FG002|COMPLETED|Overall Study||51
11218141|NCT01946438|12409677|FG003|COMPLETED|Overall Study||51
11218142|NCT01946438|12409674|FG000|NOT COMPLETED|Overall Study||2
11218143|NCT01946438|12409675|FG001|NOT COMPLETED|Overall Study||0
11218144|NCT01946438|12409676|FG002|NOT COMPLETED|Overall Study||1
11218145|NCT01946438|12409677|FG003|NOT COMPLETED|Overall Study||1
11353258|NCT03055156|12550447|FG001|COMPLETED|Overall Study||273
11353259|NCT03055156|12550446|FG000|NOT COMPLETED|Overall Study||0
11353260|NCT03055156|12550447|FG001|NOT COMPLETED|Overall Study||0
11353261|NCT03055195|12550455|FG000|STARTED|Overall Study||16
11353262|NCT03055195|12550456|FG001|STARTED|Overall Study||18
11353263|NCT03055195|12550455|FG000|COMPLETED|Overall Study||4
11353264|NCT03055195|12550456|FG001|COMPLETED|Overall Study||4
11353265|NCT03055195|12550455|FG000|NOT COMPLETED|Overall Study||12
11353266|NCT03055195|12550456|FG001|NOT COMPLETED|Overall Study||14
11353267|NCT03055221|12550462|FG000|STARTED|Overall Study||16
11353268|NCT03055221|12550462|FG000|COMPLETED|Overall Study||0
11353269|NCT03055221|12550462|FG000|NOT COMPLETED|Overall Study||16
11353270|NCT03055260|12550468|FG000|STARTED|Overall Study||8
11353271|NCT03055260|12550469|FG001|STARTED|Overall Study||0
11353272|NCT03055260|12550468|FG000|COMPLETED|Overall Study||7
11353273|NCT03055260|12550469|FG001|COMPLETED|Overall Study||0
11353274|NCT03055260|12550468|FG000|NOT COMPLETED|Overall Study||1
11353275|NCT03055260|12550469|FG001|NOT COMPLETED|Overall Study||0
11353276|NCT03055338|12550478|FG000|STARTED|Overall Study||90
11353277|NCT03055338|12550479|FG001|STARTED|Overall Study||45
11353278|NCT03055338|12550480|FG002|STARTED|Overall Study||89
11353279|NCT03055338|12550478|FG000|COMPLETED|Overall Study||72
11353280|NCT03055338|12550479|FG001|COMPLETED|Overall Study||34
11353281|NCT03055338|12550480|FG002|COMPLETED|Overall Study||77
11353282|NCT03055338|12550478|FG000|NOT COMPLETED|Overall Study||18
11353283|NCT03055338|12550479|FG001|NOT COMPLETED|Overall Study||11
11353284|NCT03055338|12550480|FG002|NOT COMPLETED|Overall Study||12
11353285|NCT03055494|12550490|FG000|STARTED|Overall Study||54
11353286|NCT03055494|12550491|FG001|STARTED|Overall Study||28
11353287|NCT03055494|12550490|FG000|COMPLETED|Overall Study||44
11353288|NCT03055494|12550491|FG001|COMPLETED|Overall Study||27
11353289|NCT03055494|12550490|FG000|NOT COMPLETED|Overall Study||10
11353290|NCT03055494|12550491|FG001|NOT COMPLETED|Overall Study||1
11353291|NCT03055624|12550498|FG000|STARTED|Overall Study||9
11353292|NCT03055624|12550498|FG000|COMPLETED|Overall Study||0
11353293|NCT03055624|12550498|FG000|NOT COMPLETED|Overall Study||9
11353294|NCT03055650|12550502|FG000|STARTED|Overall Study||30
11353295|NCT03055650|12550502|FG000|COMPLETED|Overall Study||30
11353296|NCT03055650|12550502|FG000|NOT COMPLETED|Overall Study||0
11353297|NCT03055806|12550510|FG000|STARTED|Overall Study||48
11353298|NCT03055806|12550511|FG001|STARTED|Overall Study||48
11353299|NCT03055806|12550512|FG002|STARTED|Overall Study||71
11353300|NCT03055806|12550513|FG003|STARTED|Overall Study||72
11353301|NCT03055806|12550510|FG000|COMPLETED|Overall Study||42
11353302|NCT03055806|12550511|FG001|COMPLETED|Overall Study||41
11353303|NCT03055806|12550512|FG002|COMPLETED|Overall Study||58
11353304|NCT03055806|12550513|FG003|COMPLETED|Overall Study||57
11353305|NCT03055806|12550510|FG000|NOT COMPLETED|Overall Study||6
11353306|NCT03055806|12550511|FG001|NOT COMPLETED|Overall Study||7
11353307|NCT03055806|12550512|FG002|NOT COMPLETED|Overall Study||13
11353308|NCT03055806|12550513|FG003|NOT COMPLETED|Overall Study||15
11353309|NCT03055832|12550525|FG000|STARTED|Baseline||71
11353310|NCT03055832|12550526|FG001|STARTED|Baseline||71
11353311|NCT03055832|12550525|FG000|COMPLETED|Baseline||71
11353312|NCT03055832|12550526|FG001|COMPLETED|Baseline||71
11353313|NCT03055832|12550525|FG000|NOT COMPLETED|Baseline||0
11353314|NCT03055832|12550526|FG001|NOT COMPLETED|Baseline||0
11353315|NCT03055832|12550525|FG000|STARTED|Immediately Post-Procedure (Hour 1)||71
11353316|NCT03055832|12550526|FG001|STARTED|Immediately Post-Procedure (Hour 1)||71
11353317|NCT03055832|12550525|FG000|COMPLETED|Immediately Post-Procedure (Hour 1)||71
11218146|NCT01946802|12409693|FG000|STARTED|Overall Study||44
11218147|NCT01946802|12409693|FG000|COMPLETED|Overall Study||39
11218148|NCT01946802|12409693|FG000|NOT COMPLETED|Overall Study||5
11218149|NCT01946880|12409699|FG000|STARTED|Overall Study||50
11218150|NCT01946880|12409700|FG001|STARTED|Overall Study||52
11218151|NCT01946880|12409699|FG000|COMPLETED|Overall Study||43
11218152|NCT01946880|12409700|FG001|COMPLETED|Overall Study||49
11218153|NCT01946880|12409699|FG000|NOT COMPLETED|Overall Study||7
11218154|NCT01946880|12409700|FG001|NOT COMPLETED|Overall Study||3
11218155|NCT01947127|12409708|FG000|STARTED|Overall Study||166
11218156|NCT01947127|12409709|FG001|STARTED|Overall Study||292
11218157|NCT01947127|12409708|FG000|COMPLETED|Overall Study||143
11218158|NCT01947127|12409709|FG001|COMPLETED|Overall Study||249
11218159|NCT01947127|12409708|FG000|NOT COMPLETED|Overall Study||23
11218160|NCT01947127|12409709|FG001|NOT COMPLETED|Overall Study||43
11218161|NCT01947153|12409715|FG000|STARTED|Test Period 1||18
11218162|NCT01947153|12409716|FG001|STARTED|Test Period 1||18
11218163|NCT01947153|12409715|FG000|COMPLETED|Test Period 1||18
11218164|NCT01947153|12409716|FG001|COMPLETED|Test Period 1||18
11218165|NCT01947153|12409715|FG000|NOT COMPLETED|Test Period 1||0
11218166|NCT01947153|12409716|FG001|NOT COMPLETED|Test Period 1||0
11218167|NCT01947153|12409715|FG000|STARTED|Test Period 2||18
11218168|NCT01947153|12409716|FG001|STARTED|Test Period 2||18
11218169|NCT01947153|12409715|FG000|COMPLETED|Test Period 2||18
11218170|NCT01947153|12409716|FG001|COMPLETED|Test Period 2||18
11218171|NCT01947153|12409715|FG000|NOT COMPLETED|Test Period 2||0
11218172|NCT01947153|12409716|FG001|NOT COMPLETED|Test Period 2||0
11218173|NCT01947283|12409729|FG000|STARTED|Overall Study||89
11218174|NCT01947283|12409730|FG001|STARTED|Overall Study||68
11218175|NCT01947283|12409731|FG002|STARTED|Overall Study||83
11218176|NCT01947283|12409732|FG003|STARTED|Overall Study||72
11218177|NCT01947283|12409733|FG004|STARTED|Overall Study||95
11218178|NCT01947283|12409734|FG005|STARTED|Overall Study||34
11218179|NCT01947283|12409735|FG006|STARTED|Overall Study||40
11218180|NCT01947283|12409729|FG000|Baseline Assessment|Overall Study||89
11218181|NCT01947283|12409730|FG001|Baseline Assessment|Overall Study||68
11098312|NCT01214642|12281827|FG001|COMPLETED|Overall Study||0
11098313|NCT01214642|12281828|FG002|COMPLETED|Overall Study||0
11098314|NCT01214642|12281829|FG003|COMPLETED|Overall Study||0
11098315|NCT01214642|12281830|FG004|COMPLETED|Overall Study||0
11098316|NCT01214642|12281831|FG005|COMPLETED|Overall Study||0
11098317|NCT01214642|12281832|FG006|COMPLETED|Overall Study||0
11098318|NCT01214642|12281833|FG007|COMPLETED|Overall Study||0
11098319|NCT01214642|12281834|FG008|COMPLETED|Overall Study||0
11098320|NCT01214642|12281835|FG009|COMPLETED|Overall Study||0
11098321|NCT01214642|12281836|FG010|COMPLETED|Overall Study||0
11098322|NCT01214642|12281837|FG011|COMPLETED|Overall Study||0
11098323|NCT01214642|12281826|FG000|NOT COMPLETED|Overall Study||3
11098324|NCT01214642|12281827|FG001|NOT COMPLETED|Overall Study||3
11098325|NCT01214642|12281828|FG002|NOT COMPLETED|Overall Study||6
11098326|NCT01214642|12281829|FG003|NOT COMPLETED|Overall Study||6
11218182|NCT01947283|12409731|FG002|Baseline Assessment|Overall Study||83
11218183|NCT01947283|12409732|FG003|Baseline Assessment|Overall Study||72
11218184|NCT01947283|12409733|FG004|Baseline Assessment|Overall Study||0
11218185|NCT01947283|12409734|FG005|Baseline Assessment|Overall Study||34
11218186|NCT01947283|12409735|FG006|Baseline Assessment|Overall Study||40
11218187|NCT01947283|12409729|FG000|Follow-up Assessment|Overall Study||64
11218188|NCT01947283|12409730|FG001|Follow-up Assessment|Overall Study||51
11218189|NCT01947283|12409731|FG002|Follow-up Assessment|Overall Study||65
11098327|NCT01214642|12281830|FG004|NOT COMPLETED|Overall Study||6
11098328|NCT01214642|12281831|FG005|NOT COMPLETED|Overall Study||3
11218190|NCT01947283|12409732|FG003|Follow-up Assessment|Overall Study||59
11218191|NCT01947283|12409733|FG004|Follow-up Assessment|Overall Study||0
11218192|NCT01947283|12409734|FG005|Follow-up Assessment|Overall Study||27
11218193|NCT01947283|12409735|FG006|Follow-up Assessment|Overall Study||36
11218194|NCT01947283|12409729|FG000|Clinical Recording|Overall Study||65
11218195|NCT01947283|12409730|FG001|Clinical Recording|Overall Study||54
11218196|NCT01947283|12409731|FG002|Clinical Recording|Overall Study||68
11218197|NCT01947283|12409732|FG003|Clinical Recording|Overall Study||57
11218198|NCT01947283|12409733|FG004|Clinical Recording|Overall Study||0
11218199|NCT01947283|12409734|FG005|Clinical Recording|Overall Study||0
11218200|NCT01947283|12409735|FG006|Clinical Recording|Overall Study||0
11218201|NCT01947283|12409729|FG000|End-of-Intervention Assessment|Overall Study||74
11218202|NCT01947283|12409730|FG001|End-of-Intervention Assessment|Overall Study||53
11218203|NCT01947283|12409731|FG002|End-of-Intervention Assessment|Overall Study||73
11218204|NCT01947283|12409732|FG003|End-of-Intervention Assessment|Overall Study||66
11218205|NCT01947283|12409733|FG004|End-of-Intervention Assessment|Overall Study||0
11218206|NCT01947283|12409734|FG005|End-of-Intervention Assessment|Overall Study||32
11218207|NCT01947283|12409735|FG006|End-of-Intervention Assessment|Overall Study||33
11218208|NCT01947283|12409729|FG000|In Analysis|Overall Study||89
11218209|NCT01947283|12409730|FG001|In Analysis|Overall Study||68
11218210|NCT01947283|12409731|FG002|In Analysis|Overall Study||83
11218211|NCT01947283|12409732|FG003|In Analysis|Overall Study||72
11218212|NCT01947283|12409733|FG004|In Analysis|Overall Study||95
11218213|NCT01947283|12409734|FG005|In Analysis|Overall Study||30
11218214|NCT01947283|12409735|FG006|In Analysis|Overall Study||38
11218215|NCT01947283|12409729|FG000|Completed NRCT Baseline Assessment|Overall Study||0
11218216|NCT01947283|12409730|FG001|Completed NRCT Baseline Assessment|Overall Study||0
11218217|NCT01947283|12409731|FG002|Completed NRCT Baseline Assessment|Overall Study||0
11218218|NCT01947283|12409732|FG003|Completed NRCT Baseline Assessment|Overall Study||0
11218219|NCT01947283|12409733|FG004|Completed NRCT Baseline Assessment|Overall Study||95
11218220|NCT01947283|12409734|FG005|Completed NRCT Baseline Assessment|Overall Study||0
11218221|NCT01947283|12409735|FG006|Completed NRCT Baseline Assessment|Overall Study||0
11218222|NCT01947283|12409729|FG000|COMPLETED|Overall Study||60
11218223|NCT01947283|12409730|FG001|COMPLETED|Overall Study||45
11218224|NCT01947283|12409731|FG002|COMPLETED|Overall Study||62
11218225|NCT01947283|12409732|FG003|COMPLETED|Overall Study||55
11218226|NCT01947283|12409733|FG004|COMPLETED|Overall Study||95
11218227|NCT01947283|12409734|FG005|COMPLETED|Overall Study||27
11218228|NCT01947283|12409735|FG006|COMPLETED|Overall Study||32
11218229|NCT01947283|12409729|FG000|NOT COMPLETED|Overall Study||29
11218230|NCT01947283|12409730|FG001|NOT COMPLETED|Overall Study||23
11218231|NCT01947283|12409731|FG002|NOT COMPLETED|Overall Study||21
11218232|NCT01947283|12409732|FG003|NOT COMPLETED|Overall Study||17
11218233|NCT01947283|12409733|FG004|NOT COMPLETED|Overall Study||0
11218234|NCT01947283|12409734|FG005|NOT COMPLETED|Overall Study||7
11218235|NCT01947283|12409735|FG006|NOT COMPLETED|Overall Study||8
11218236|NCT01947335|12409754|FG000|STARTED|Overall Study||42
11218237|NCT01947335|12409755|FG001|STARTED|Overall Study||41
11218238|NCT01947335|12409754|FG000|COMPLETED|Overall Study||42
11218239|NCT01947335|12409755|FG001|COMPLETED|Overall Study||41
11218240|NCT01947335|12409754|FG000|NOT COMPLETED|Overall Study||0
11218241|NCT01947335|12409755|FG001|NOT COMPLETED|Overall Study||0
11218242|NCT01947491|12409765|FG000|STARTED|Overall Study||174
11218243|NCT01947491|12409766|FG001|STARTED|Overall Study||87
11218244|NCT01947491|12409767|FG002|STARTED|Overall Study||90
11218245|NCT01947491|12409768|FG003|STARTED|Overall Study||43
11218246|NCT01947491|12409765|FG000|COMPLETED|Overall Study||166
11218247|NCT01947491|12409766|FG001|COMPLETED|Overall Study||81
11218248|NCT01947491|12409767|FG002|COMPLETED|Overall Study||88
11218249|NCT01947491|12409768|FG003|COMPLETED|Overall Study||38
11218250|NCT01947491|12409765|FG000|NOT COMPLETED|Overall Study||8
11218251|NCT01947491|12409766|FG001|NOT COMPLETED|Overall Study||6
11218252|NCT01947491|12409767|FG002|NOT COMPLETED|Overall Study||2
11218253|NCT01947491|12409768|FG003|NOT COMPLETED|Overall Study||5
11218254|NCT01947517|12409780|FG000|STARTED|Overall Study||26
11218255|NCT01947517|12409781|FG001|STARTED|Overall Study||26
11218256|NCT01947517|12409780|FG000|COMPLETED|Overall Study||25
11218257|NCT01947517|12409781|FG001|COMPLETED|Overall Study||25
11218258|NCT01947517|12409780|FG000|NOT COMPLETED|Overall Study||1
11218259|NCT01947517|12409781|FG001|NOT COMPLETED|Overall Study||1
11218260|NCT01947582|12409787|FG000|STARTED|Overall Study||2
11218261|NCT01947582|12409787|FG000|COMPLETED|Overall Study||1
11218262|NCT01947582|12409787|FG000|NOT COMPLETED|Overall Study||1
11218263|NCT01947647|12409793|FG000|STARTED|Treatment Phase||46
11218264|NCT01947647|12409794|FG001|STARTED|Treatment Phase||47
11218265|NCT01947647|12409793|FG000|COMPLETED|Treatment Phase||29
11218266|NCT01947647|12409794|FG001|COMPLETED|Treatment Phase||21
11218267|NCT01947647|12409793|FG000|NOT COMPLETED|Treatment Phase||17
11218268|NCT01947647|12409794|FG001|NOT COMPLETED|Treatment Phase||26
11218269|NCT01947647|12409793|FG000|STARTED|6-month Followup Phase||29
11218270|NCT01947647|12409794|FG001|STARTED|6-month Followup Phase||21
11218271|NCT01947647|12409793|FG000|COMPLETED|6-month Followup Phase||20
11218272|NCT01947647|12409794|FG001|COMPLETED|6-month Followup Phase||13
11218273|NCT01947647|12409793|FG000|NOT COMPLETED|6-month Followup Phase||9
11218274|NCT01947647|12409794|FG001|NOT COMPLETED|6-month Followup Phase||8
11218275|NCT01947816|12409800|FG000|STARTED|Overall Study||1593
11218276|NCT01947816|12409800|FG000|COMPLETED|Overall Study||1523
11218277|NCT01947816|12409800|FG000|NOT COMPLETED|Overall Study||70
11218278|NCT01947855|12409807|FG000|STARTED|Overall Study||21
11218279|NCT01947855|12409808|FG001|STARTED|Overall Study||20
11218280|NCT01947855|12409809|FG002|STARTED|Overall Study||19
11218281|NCT01947855|12409807|FG000|COMPLETED|Overall Study||20
11218282|NCT01947855|12409808|FG001|COMPLETED|Overall Study||20
11218283|NCT01947855|12409809|FG002|COMPLETED|Overall Study||19
11218284|NCT01947855|12409807|FG000|NOT COMPLETED|Overall Study||1
11218285|NCT01947855|12409808|FG001|NOT COMPLETED|Overall Study||0
11218286|NCT01947855|12409809|FG002|NOT COMPLETED|Overall Study||0
11218287|NCT01947894|12409820|FG000|STARTED|Overall Study||247
11218288|NCT01947894|12409821|FG001|STARTED|Overall Study||42
11218289|NCT01947894|12409822|FG002|STARTED|Overall Study||88
11218290|NCT01947894|12409820|FG000|Treated|Overall Study||246
11218291|NCT01947894|12409821|FG001|Treated|Overall Study||41
11218292|NCT01947894|12409822|FG002|Treated|Overall Study||87
11218293|NCT01947894|12409820|FG000|COMPLETED|Overall Study||160
11218294|NCT01947894|12409821|FG001|COMPLETED|Overall Study||24
11218295|NCT01947894|12409822|FG002|COMPLETED|Overall Study||61
11218296|NCT01947894|12409820|FG000|NOT COMPLETED|Overall Study||87
11218297|NCT01947894|12409821|FG001|NOT COMPLETED|Overall Study||18
11218298|NCT01947894|12409822|FG002|NOT COMPLETED|Overall Study||27
11218299|NCT01947907|12409834|FG000|STARTED|Overall Study||12
11218300|NCT01947907|12409835|FG001|STARTED|Overall Study||14
11218301|NCT01947907|12409836|FG002|STARTED|Overall Study||14
11218302|NCT01947907|12409837|FG003|STARTED|Overall Study||13
11218303|NCT01947907|12409834|FG000|COMPLETED|Overall Study||12
11218304|NCT01947907|12409835|FG001|COMPLETED|Overall Study||14
11218305|NCT01947907|12409836|FG002|COMPLETED|Overall Study||14
11218306|NCT01947907|12409837|FG003|COMPLETED|Overall Study||13
11218307|NCT01947907|12409834|FG000|NOT COMPLETED|Overall Study||0
11218308|NCT01947907|12409835|FG001|NOT COMPLETED|Overall Study||0
11218309|NCT01947907|12409836|FG002|NOT COMPLETED|Overall Study||0
11353318|NCT03055832|12550526|FG001|COMPLETED|Immediately Post-Procedure (Hour 1)||71
11353319|NCT03055832|12550525|FG000|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
11353320|NCT03055832|12550526|FG001|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
11353321|NCT03055832|12550525|FG000|STARTED|Day 1||71
11353322|NCT03055832|12550526|FG001|STARTED|Day 1||71
11353323|NCT03055832|12550525|FG000|COMPLETED|Day 1||71
11353324|NCT03055832|12550526|FG001|COMPLETED|Day 1||71
11353325|NCT03055832|12550525|FG000|NOT COMPLETED|Day 1||0
11353326|NCT03055832|12550526|FG001|NOT COMPLETED|Day 1||0
11353327|NCT03055832|12550525|FG000|STARTED|Week 2||71
11353328|NCT03055832|12550526|FG001|STARTED|Week 2||71
11353329|NCT03055832|12550525|FG000|COMPLETED|Week 2||70
11353330|NCT03055832|12550526|FG001|COMPLETED|Week 2||71
11353331|NCT03055832|12550525|FG000|NOT COMPLETED|Week 2||1
11353332|NCT03055832|12550526|FG001|NOT COMPLETED|Week 2||0
11353333|NCT03055832|12550525|FG000|STARTED|Week 4||70
11353334|NCT03055832|12550526|FG001|STARTED|Week 4||71
11353335|NCT03055832|12550525|FG000|COMPLETED|Week 4||70
11353336|NCT03055832|12550526|FG001|COMPLETED|Week 4||71
11353337|NCT03055832|12550525|FG000|NOT COMPLETED|Week 4||0
11353338|NCT03055832|12550526|FG001|NOT COMPLETED|Week 4||0
11353339|NCT03055897|12550546|FG000|STARTED|Overall Study||15
11353340|NCT03055897|12550546|FG000|COMPLETED|Overall Study||15
11353341|NCT03055897|12550546|FG000|NOT COMPLETED|Overall Study||0
11353342|NCT03055936|12550554|FG000|STARTED|Overall Study||14
11353343|NCT03055936|12550555|FG001|STARTED|Overall Study||14
11353344|NCT03055936|12550556|FG002|STARTED|Overall Study||14
11353345|NCT03055936|12550557|FG003|STARTED|Overall Study||14
11218310|NCT01947907|12409837|FG003|NOT COMPLETED|Overall Study||0
11353346|NCT03055936|12550554|FG000|COMPLETED|Overall Study||12
11353347|NCT03055936|12550555|FG001|COMPLETED|Overall Study||13
11353348|NCT03055936|12550556|FG002|COMPLETED|Overall Study||12
11353349|NCT03055936|12550557|FG003|COMPLETED|Overall Study||13
11353350|NCT03055936|12550554|FG000|NOT COMPLETED|Overall Study||2
11353351|NCT03055936|12550555|FG001|NOT COMPLETED|Overall Study||1
11353352|NCT03055936|12550556|FG002|NOT COMPLETED|Overall Study||2
11353353|NCT03055936|12550557|FG003|NOT COMPLETED|Overall Study||1
11353354|NCT03055988|12550591|FG000|STARTED|Period 1||38
11353355|NCT03055988|12550592|FG001|STARTED|Period 1||38
11353356|NCT03055988|12550591|FG000|COMPLETED|Period 1||37
11353357|NCT03055988|12550592|FG001|COMPLETED|Period 1||33
11353358|NCT03055988|12550591|FG000|NOT COMPLETED|Period 1||1
11353359|NCT03055988|12550592|FG001|NOT COMPLETED|Period 1||5
11353360|NCT03055988|12550591|FG000|STARTED|Period 2||37
11353361|NCT03055988|12550592|FG001|STARTED|Period 2||33
11353362|NCT03055988|12550591|FG000|COMPLETED|Period 2||36
11353363|NCT03055988|12550592|FG001|COMPLETED|Period 2||31
11353364|NCT03055988|12550591|FG000|NOT COMPLETED|Period 2||1
11353365|NCT03055988|12550592|FG001|NOT COMPLETED|Period 2||2
11353366|NCT03056144|12550598|FG000|STARTED|Overall Study||1
11353367|NCT03056144|12550598|FG000|COMPLETED|Overall Study||1
11353368|NCT03056144|12550598|FG000|NOT COMPLETED|Overall Study||0
11353369|NCT03056300|12550602|FG000|STARTED|Overall Study||50
11353370|NCT03056300|12550602|FG000|COMPLETED|Overall Study||47
11353371|NCT03056300|12550602|FG000|NOT COMPLETED|Overall Study||3
11353372|NCT03056352|12550606|FG000|STARTED|Overall Study||21
11353373|NCT03056352|12550606|FG000|COMPLETED|Overall Study||20
11353374|NCT03056352|12550606|FG000|NOT COMPLETED|Overall Study||1
11353375|NCT03056456|12550610|FG000|STARTED|Period 1||6
11353376|NCT03056456|12550611|FG001|STARTED|Period 1||6
11353377|NCT03056456|12550612|FG002|STARTED|Period 1||6
11353378|NCT03056456|12550613|FG003|STARTED|Period 1||6
11353379|NCT03056456|12550610|FG000|Received One Dose of Study Drug|Period 1||6
11353380|NCT03056456|12550611|FG001|Received One Dose of Study Drug|Period 1||6
11353381|NCT03056456|12550612|FG002|Received One Dose of Study Drug|Period 1||6
11353382|NCT03056456|12550613|FG003|Received One Dose of Study Drug|Period 1||6
11353383|NCT03056456|12550610|FG000|COMPLETED|Period 1||6
11353384|NCT03056456|12550611|FG001|COMPLETED|Period 1||6
11353385|NCT03056456|12550612|FG002|COMPLETED|Period 1||6
11218311|NCT01947946|12409850|FG000|STARTED|Overall Study||3
11218312|NCT01947946|12409851|FG001|STARTED|Overall Study||5
11218313|NCT01947946|12409852|FG002|STARTED|Overall Study||5
11218314|NCT01947946|12409850|FG000|COMPLETED|Overall Study|Study Stopped|0
11218315|NCT01947946|12409851|FG001|COMPLETED|Overall Study||0
11218316|NCT01947946|12409852|FG002|COMPLETED|Overall Study||0
11218317|NCT01947946|12409850|FG000|NOT COMPLETED|Overall Study||3
11218318|NCT01947946|12409851|FG001|NOT COMPLETED|Overall Study||5
11218319|NCT01947946|12409852|FG002|NOT COMPLETED|Overall Study||5
11218320|NCT01948050|12409862|FG000|STARTED|Overall Study||16
11218321|NCT01948050|12409863|FG001|STARTED|Overall Study||8
11218322|NCT01948050|12409862|FG000|COMPLETED|Overall Study||16
11218323|NCT01948050|12409863|FG001|COMPLETED|Overall Study||7
11218324|NCT01948050|12409862|FG000|NOT COMPLETED|Overall Study||0
11218325|NCT01948050|12409863|FG001|NOT COMPLETED|Overall Study||1
11218326|NCT01948063|12409871|FG000|STARTED|Overall Study||20
11218327|NCT01948063|12409872|FG001|STARTED|Overall Study||21
11353386|NCT03056456|12550613|FG003|COMPLETED|Period 1||6
11353387|NCT03056456|12550610|FG000|NOT COMPLETED|Period 1||0
11353388|NCT03056456|12550611|FG001|NOT COMPLETED|Period 1||0
11353389|NCT03056456|12550612|FG002|NOT COMPLETED|Period 1||0
11353390|NCT03056456|12550613|FG003|NOT COMPLETED|Period 1||0
11098329|NCT01214642|12281832|FG006|NOT COMPLETED|Overall Study||6
11098330|NCT01214642|12281833|FG007|NOT COMPLETED|Overall Study||3
11098331|NCT01214642|12281834|FG008|NOT COMPLETED|Overall Study||13
11098332|NCT01214642|12281835|FG009|NOT COMPLETED|Overall Study||4
11098333|NCT01214642|12281836|FG010|NOT COMPLETED|Overall Study||4
11098334|NCT01214642|12281837|FG011|NOT COMPLETED|Overall Study||6
11098335|NCT01214655|12281883|FG000|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10
11098336|NCT01214655|12281884|FG001|STARTED|Part A||0
11098337|NCT01214655|12281885|FG002|STARTED|Part A||0
11098338|NCT01214655|12281883|FG000|Received 2 mg Study Drug|Part A||3
11098339|NCT01214655|12281884|FG001|Received 2 mg Study Drug|Part A||0
11098340|NCT01214655|12281885|FG002|Received 2 mg Study Drug|Part A||0
11098341|NCT01214655|12281883|FG000|Escalated From 2 to 4 mg/m²/Day|Part A||3
11098342|NCT01214655|12281884|FG001|Escalated From 2 to 4 mg/m²/Day|Part A||0
11098343|NCT01214655|12281885|FG002|Escalated From 2 to 4 mg/m²/Day|Part A||0
11098344|NCT01214655|12281883|FG000|Joined 4 mg Group|Part A||1
11218328|NCT01948063|12409871|FG000|COMPLETED|Overall Study||19
11218329|NCT01948063|12409872|FG001|COMPLETED|Overall Study||19
11218330|NCT01948063|12409871|FG000|NOT COMPLETED|Overall Study||1
11218331|NCT01948063|12409872|FG001|NOT COMPLETED|Overall Study||2
11218332|NCT01948076|12409880|FG000|STARTED|Overall Study||20
11218333|NCT01948076|12409881|FG001|STARTED|Overall Study||20
11218334|NCT01948076|12409880|FG000|COMPLETED|Overall Study||20
11218335|NCT01948076|12409881|FG001|COMPLETED|Overall Study||19
11218336|NCT01948076|12409880|FG000|NOT COMPLETED|Overall Study||0
11218337|NCT01948076|12409881|FG001|NOT COMPLETED|Overall Study||1
11218338|NCT01948141|12409889|FG000|STARTED|Overall Study||6
11218339|NCT01948141|12409889|FG000|COMPLETED|Overall Study||6
11218340|NCT01948141|12409889|FG000|NOT COMPLETED|Overall Study||0
11218341|NCT01948193|12409893|FG000|STARTED|Overall Study||177
11218342|NCT01948193|12409893|FG000|COMPLETED|Overall Study||168
11218343|NCT01948193|12409893|FG000|NOT COMPLETED|Overall Study||9
11218344|NCT01948258|12409898|FG000|STARTED|Overall Study||395
11218345|NCT01948258|12409898|FG000|COMPLETED|Overall Study||233
11218346|NCT01948258|12409898|FG000|NOT COMPLETED|Overall Study||162
11218347|NCT01948310|12409904|FG000|STARTED|Overall Study||19
11218348|NCT01948310|12409905|FG001|STARTED|Overall Study||18
11218349|NCT01948310|12409904|FG000|COMPLETED|Overall Study||16
11218350|NCT01948310|12409905|FG001|COMPLETED|Overall Study||13
11218351|NCT01948310|12409904|FG000|NOT COMPLETED|Overall Study||3
11218352|NCT01948310|12409905|FG001|NOT COMPLETED|Overall Study||5
11218353|NCT01948375|12409913|FG000|STARTED|Overall Study||30
11218354|NCT01948375|12409914|FG001|STARTED|Overall Study||30
11218355|NCT01948375|12409913|FG000|COMPLETED|Overall Study||30
11218356|NCT01948375|12409914|FG001|COMPLETED|Overall Study||30
11218357|NCT01948375|12409913|FG000|NOT COMPLETED|Overall Study||0
11218358|NCT01948375|12409914|FG001|NOT COMPLETED|Overall Study||0
11218359|NCT01948388|12409924|FG000|STARTED|Overall Study||10
11218360|NCT01948388|12409925|FG001|STARTED|Overall Study||10
11218361|NCT01948388|12409924|FG000|COMPLETED|Overall Study||8
11218362|NCT01948388|12409925|FG001|COMPLETED|Overall Study||9
11218363|NCT01948388|12409924|FG000|NOT COMPLETED|Overall Study||2
11218364|NCT01948388|12409925|FG001|NOT COMPLETED|Overall Study||1
11218365|NCT01948427|12409938|FG000|STARTED|Overall Study||49
11218366|NCT01948427|12409939|FG001|STARTED|Overall Study||89
11218367|NCT01948427|12409940|FG002|STARTED|Overall Study||4
11218368|NCT01948427|12409941|FG003|STARTED|Overall Study||1
11218369|NCT01948427|12409942|FG004|STARTED|Overall Study||60
11218370|NCT01948427|12409938|FG000|COMPLETED|Overall Study||42
11218371|NCT01948427|12409939|FG001|COMPLETED|Overall Study||72
11218372|NCT01948427|12409940|FG002|COMPLETED|Overall Study||4
11218373|NCT01948427|12409941|FG003|COMPLETED|Overall Study||1
11218374|NCT01948427|12409942|FG004|COMPLETED|Overall Study||46
11218375|NCT01948427|12409938|FG000|NOT COMPLETED|Overall Study||7
11218376|NCT01948427|12409939|FG001|NOT COMPLETED|Overall Study||17
11218377|NCT01948427|12409940|FG002|NOT COMPLETED|Overall Study||0
11218378|NCT01948427|12409941|FG003|NOT COMPLETED|Overall Study||0
11218379|NCT01948427|12409942|FG004|NOT COMPLETED|Overall Study||14
11218380|NCT01948518|12409959|FG000|STARTED|Overall Study||15
11218381|NCT01948518|12409959|FG000|COMPLETED|Overall Study||15
11218382|NCT01948518|12409959|FG000|NOT COMPLETED|Overall Study||0
11218383|NCT01948739|12409963|FG000|STARTED|Overall Study||18
11218384|NCT01948739|12409963|FG000|Received Intervention|Overall Study||10
11218385|NCT01948739|12409963|FG000|COMPLETED|Overall Study||10
11218386|NCT01948739|12409963|FG000|NOT COMPLETED|Overall Study||8
11218387|NCT01948791|12409967|FG000|STARTED|Overall Study||222
11218388|NCT01948791|12409967|FG000|COMPLETED|Overall Study||151
11218389|NCT01948791|12409967|FG000|NOT COMPLETED|Overall Study||71
11218390|NCT01948830|12409973|FG000|STARTED|Overall Study||323
11218391|NCT01948830|12409974|FG001|STARTED|Overall Study||327
11218392|NCT01948830|12409973|FG000|Safety Set|Overall Study||323
11218393|NCT01948830|12409974|FG001|Safety Set|Overall Study||326
11218394|NCT01948830|12409973|FG000|COMPLETED|Overall Study||290
11218395|NCT01948830|12409974|FG001|COMPLETED|Overall Study||295
11218396|NCT01948830|12409973|FG000|NOT COMPLETED|Overall Study||33
11218397|NCT01948830|12409974|FG001|NOT COMPLETED|Overall Study||32
11218398|NCT01948908|12409983|FG000|STARTED|Overall Study||33
11218399|NCT01948908|12409984|FG001|STARTED|Overall Study||33
11218400|NCT01948908|12409985|FG002|STARTED|Overall Study||33
11218401|NCT01948908|12409983|FG000|COMPLETED|Overall Study||32
11218402|NCT01948908|12409984|FG001|COMPLETED|Overall Study||33
11218403|NCT01948908|12409985|FG002|COMPLETED|Overall Study||31
11218404|NCT01948908|12409983|FG000|NOT COMPLETED|Overall Study||1
11218405|NCT01948908|12409984|FG001|NOT COMPLETED|Overall Study||0
11218406|NCT01948908|12409985|FG002|NOT COMPLETED|Overall Study||2
11218407|NCT01948947|12409995|FG000|STARTED|Overall Study||14
11218408|NCT01948947|12409996|FG001|STARTED|Overall Study||15
11218409|NCT01948947|12409995|FG000|COMPLETED|Overall Study||14
11218410|NCT01948947|12409996|FG001|COMPLETED|Overall Study||15
11218411|NCT01948947|12409995|FG000|NOT COMPLETED|Overall Study||0
11218412|NCT01948947|12409996|FG001|NOT COMPLETED|Overall Study||0
11218413|NCT01948986|12410007|FG000|STARTED|Overall Study||6
11218414|NCT01948986|12410008|FG001|STARTED|Overall Study||8
11218415|NCT01948986|12410009|FG002|STARTED|Overall Study||8
11218416|NCT01948986|12410010|FG003|STARTED|Overall Study||6
11218417|NCT01948986|12410011|FG004|STARTED|Overall Study||8
11218418|NCT01948986|12410007|FG000|COMPLETED|Overall Study||6
11218419|NCT01948986|12410008|FG001|COMPLETED|Overall Study||8
11218420|NCT01948986|12410009|FG002|COMPLETED|Overall Study||8
11218421|NCT01948986|12410010|FG003|COMPLETED|Overall Study||6
11218422|NCT01948986|12410011|FG004|COMPLETED|Overall Study||8
11218423|NCT01948986|12410007|FG000|NOT COMPLETED|Overall Study||0
11218424|NCT01948986|12410008|FG001|NOT COMPLETED|Overall Study||0
11218425|NCT01948986|12410009|FG002|NOT COMPLETED|Overall Study||0
11218426|NCT01948986|12410010|FG003|NOT COMPLETED|Overall Study||0
11218427|NCT01948986|12410011|FG004|NOT COMPLETED|Overall Study||0
11218428|NCT01949051|12410023|FG000|STARTED|Treatment Period 1 (7 Days)||13
11218429|NCT01949051|12410024|FG001|STARTED|Treatment Period 1 (7 Days)||13
11218430|NCT01949051|12410025|FG002|STARTED|Treatment Period 1 (7 Days)||13
11218431|NCT01949051|12410026|FG003|STARTED|Treatment Period 1 (7 Days)||13
11353391|NCT03056456|12550610|FG000|STARTED|Period 2||6
11353392|NCT03056456|12550611|FG001|STARTED|Period 2||6
11353393|NCT03056456|12550612|FG002|STARTED|Period 2||6
11353394|NCT03056456|12550613|FG003|STARTED|Period 2||6
11353395|NCT03056456|12550610|FG000|COMPLETED|Period 2||6
11353396|NCT03056456|12550611|FG001|COMPLETED|Period 2||6
11353397|NCT03056456|12550612|FG002|COMPLETED|Period 2||6
11353398|NCT03056456|12550613|FG003|COMPLETED|Period 2||6
11353399|NCT03056456|12550610|FG000|NOT COMPLETED|Period 2||0
11353400|NCT03056456|12550611|FG001|NOT COMPLETED|Period 2||0
11353401|NCT03056456|12550612|FG002|NOT COMPLETED|Period 2||0
11353402|NCT03056456|12550613|FG003|NOT COMPLETED|Period 2||0
11353403|NCT03056456|12550610|FG000|STARTED|Period 3||6
11353404|NCT03056456|12550611|FG001|STARTED|Period 3||6
11353405|NCT03056456|12550612|FG002|STARTED|Period 3||6
11353406|NCT03056456|12550613|FG003|STARTED|Period 3||6
11353407|NCT03056456|12550610|FG000|COMPLETED|Period 3||6
11353408|NCT03056456|12550611|FG001|COMPLETED|Period 3||6
11353409|NCT03056456|12550612|FG002|COMPLETED|Period 3||6
11353410|NCT03056456|12550613|FG003|COMPLETED|Period 3||6
11353411|NCT03056456|12550610|FG000|NOT COMPLETED|Period 3||0
11353412|NCT03056456|12550611|FG001|NOT COMPLETED|Period 3||0
11353413|NCT03056456|12550612|FG002|NOT COMPLETED|Period 3||0
11353414|NCT03056456|12550613|FG003|NOT COMPLETED|Period 3||0
11353415|NCT03056456|12550610|FG000|STARTED|Period 4||6
11353416|NCT03056456|12550611|FG001|STARTED|Period 4||6
11353417|NCT03056456|12550612|FG002|STARTED|Period 4||6
11353418|NCT03056456|12550613|FG003|STARTED|Period 4|Participant deviated from 1 week maximum between consecutive periods and did not start Period 4.|5
11353419|NCT03056456|12550610|FG000|COMPLETED|Period 4||6
11353420|NCT03056456|12550611|FG001|COMPLETED|Period 4||6
11098345|NCT01214655|12281884|FG001|Joined 4 mg Group|Part A||0
11098346|NCT01214655|12281885|FG002|Joined 4 mg Group|Part A||0
11098347|NCT01214655|12281883|FG000|Escalated From 4 mg Study Drug|Part A||0
11098348|NCT01214655|12281884|FG001|Escalated From 4 mg Study Drug|Part A||0
11098349|NCT01214655|12281885|FG002|Escalated From 4 mg Study Drug|Part A||0
11098350|NCT01214655|12281883|FG000|Joined 5 mg Study Drug|Part A||2
11098351|NCT01214655|12281884|FG001|Joined 5 mg Study Drug|Part A||0
11098352|NCT01214655|12281885|FG002|Joined 5 mg Study Drug|Part A||0
11098353|NCT01214655|12281883|FG000|Escalated From 5 mg Study Drug|Part A||1
11353421|NCT03056456|12550612|FG002|COMPLETED|Period 4||6
11353422|NCT03056456|12550613|FG003|COMPLETED|Period 4||5
11218432|NCT01949051|12410027|FG004|STARTED|Treatment Period 1 (7 Days)||13
11353423|NCT03056456|12550610|FG000|NOT COMPLETED|Period 4||0
11218433|NCT01949051|12410028|FG005|STARTED|Treatment Period 1 (7 Days)||13
11218434|NCT01949051|12410023|FG000|COMPLETED|Treatment Period 1 (7 Days)||11
11218435|NCT01949051|12410024|FG001|COMPLETED|Treatment Period 1 (7 Days)||13
11218436|NCT01949051|12410025|FG002|COMPLETED|Treatment Period 1 (7 Days)||13
11218437|NCT01949051|12410026|FG003|COMPLETED|Treatment Period 1 (7 Days)||12
11218438|NCT01949051|12410027|FG004|COMPLETED|Treatment Period 1 (7 Days)||13
11218439|NCT01949051|12410028|FG005|COMPLETED|Treatment Period 1 (7 Days)||13
11218440|NCT01949051|12410023|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||2
11218441|NCT01949051|12410024|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||0
11218442|NCT01949051|12410025|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0
11218443|NCT01949051|12410026|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||1
11218444|NCT01949051|12410027|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||0
11218445|NCT01949051|12410028|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0
11218446|NCT01949051|12410023|FG000|STARTED|Washout Period 1 (14 to 20 Days)||11
11218447|NCT01949051|12410024|FG001|STARTED|Washout Period 1 (14 to 20 Days)||13
11218448|NCT01949051|12410025|FG002|STARTED|Washout Period 1 (14 to 20 Days)||13
11218449|NCT01949051|12410026|FG003|STARTED|Washout Period 1 (14 to 20 Days)||12
11218450|NCT01949051|12410027|FG004|STARTED|Washout Period 1 (14 to 20 Days)||13
11218451|NCT01949051|12410028|FG005|STARTED|Washout Period 1 (14 to 20 Days)||13
11218452|NCT01949051|12410023|FG000|COMPLETED|Washout Period 1 (14 to 20 Days)||11
11218453|NCT01949051|12410024|FG001|COMPLETED|Washout Period 1 (14 to 20 Days)||13
11218454|NCT01949051|12410025|FG002|COMPLETED|Washout Period 1 (14 to 20 Days)||13
11218455|NCT01949051|12410026|FG003|COMPLETED|Washout Period 1 (14 to 20 Days)||12
11218456|NCT01949051|12410027|FG004|COMPLETED|Washout Period 1 (14 to 20 Days)||13
11218457|NCT01949051|12410028|FG005|COMPLETED|Washout Period 1 (14 to 20 Days)||13
11218458|NCT01949051|12410023|FG000|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
11218459|NCT01949051|12410024|FG001|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
11218460|NCT01949051|12410025|FG002|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
11218461|NCT01949051|12410026|FG003|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
11218462|NCT01949051|12410027|FG004|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
11218463|NCT01949051|12410028|FG005|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
11218464|NCT01949051|12410023|FG000|STARTED|Treatment Period 2 (7 Days)||11
11218465|NCT01949051|12410024|FG001|STARTED|Treatment Period 2 (7 Days)||13
11218466|NCT01949051|12410025|FG002|STARTED|Treatment Period 2 (7 Days)||13
11218467|NCT01949051|12410026|FG003|STARTED|Treatment Period 2 (7 Days)||12
11218468|NCT01949051|12410027|FG004|STARTED|Treatment Period 2 (7 Days)||13
11218469|NCT01949051|12410028|FG005|STARTED|Treatment Period 2 (7 Days)||13
11218470|NCT01949051|12410023|FG000|COMPLETED|Treatment Period 2 (7 Days)||11
11218471|NCT01949051|12410024|FG001|COMPLETED|Treatment Period 2 (7 Days)||12
11218472|NCT01949051|12410025|FG002|COMPLETED|Treatment Period 2 (7 Days)||12
11218473|NCT01949051|12410026|FG003|COMPLETED|Treatment Period 2 (7 Days)||12
11218474|NCT01949051|12410027|FG004|COMPLETED|Treatment Period 2 (7 Days)||13
11218475|NCT01949051|12410028|FG005|COMPLETED|Treatment Period 2 (7 Days)||12
11218476|NCT01949051|12410023|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
11218477|NCT01949051|12410024|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||1
11218478|NCT01949051|12410025|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||1
11218479|NCT01949051|12410026|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0
11218480|NCT01949051|12410027|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0
11218481|NCT01949051|12410028|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||1
11218482|NCT01949051|12410023|FG000|STARTED|Washout Period 2 (14 to 20 Days)||11
11218483|NCT01949051|12410024|FG001|STARTED|Washout Period 2 (14 to 20 Days)||12
11353424|NCT03056456|12550611|FG001|NOT COMPLETED|Period 4||0
11353425|NCT03056456|12550612|FG002|NOT COMPLETED|Period 4||0
11353426|NCT03056456|12550613|FG003|NOT COMPLETED|Period 4||0
11353427|NCT03056573|12550628|FG000|STARTED|Overall Study||45
11353428|NCT03056573|12550629|FG001|STARTED|Overall Study||19
11353429|NCT03056573|12550628|FG000|COMPLETED|Overall Study||40
11353430|NCT03056573|12550629|FG001|COMPLETED|Overall Study||14
11353431|NCT03056573|12550628|FG000|NOT COMPLETED|Overall Study||5
11353432|NCT03056573|12550629|FG001|NOT COMPLETED|Overall Study||5
11218484|NCT01949051|12410025|FG002|STARTED|Washout Period 2 (14 to 20 Days)||12
11218485|NCT01949051|12410026|FG003|STARTED|Washout Period 2 (14 to 20 Days)||12
11218486|NCT01949051|12410027|FG004|STARTED|Washout Period 2 (14 to 20 Days)||13
11218487|NCT01949051|12410028|FG005|STARTED|Washout Period 2 (14 to 20 Days)||12
11218488|NCT01949051|12410023|FG000|COMPLETED|Washout Period 2 (14 to 20 Days)||11
11218489|NCT01949051|12410024|FG001|COMPLETED|Washout Period 2 (14 to 20 Days)||12
11218490|NCT01949051|12410025|FG002|COMPLETED|Washout Period 2 (14 to 20 Days)||12
11218491|NCT01949051|12410026|FG003|COMPLETED|Washout Period 2 (14 to 20 Days)||12
11218492|NCT01949051|12410027|FG004|COMPLETED|Washout Period 2 (14 to 20 Days)||13
11218493|NCT01949051|12410028|FG005|COMPLETED|Washout Period 2 (14 to 20 Days)||12
11218494|NCT01949051|12410023|FG000|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
11218495|NCT01949051|12410024|FG001|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
11218496|NCT01949051|12410025|FG002|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
11218497|NCT01949051|12410026|FG003|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
11218498|NCT01949051|12410027|FG004|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
11218499|NCT01949051|12410028|FG005|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
11218500|NCT01949051|12410023|FG000|STARTED|Treatment Period 3 (7 Days)||11
11218501|NCT01949051|12410024|FG001|STARTED|Treatment Period 3 (7 Days)||12
11218502|NCT01949051|12410025|FG002|STARTED|Treatment Period 3 (7 Days)||12
11218503|NCT01949051|12410026|FG003|STARTED|Treatment Period 3 (7 Days)||12
11218504|NCT01949051|12410027|FG004|STARTED|Treatment Period 3 (7 Days)||13
11218505|NCT01949051|12410028|FG005|STARTED|Treatment Period 3 (7 Days)||12
11218506|NCT01949051|12410023|FG000|COMPLETED|Treatment Period 3 (7 Days)||11
11218507|NCT01949051|12410024|FG001|COMPLETED|Treatment Period 3 (7 Days)||12
11218508|NCT01949051|12410025|FG002|COMPLETED|Treatment Period 3 (7 Days)||12
11218509|NCT01949051|12410026|FG003|COMPLETED|Treatment Period 3 (7 Days)||12
11218510|NCT01949051|12410027|FG004|COMPLETED|Treatment Period 3 (7 Days)||13
11218511|NCT01949051|12410028|FG005|COMPLETED|Treatment Period 3 (7 Days)||12
11218512|NCT01949051|12410023|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
11218513|NCT01949051|12410024|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0
11218514|NCT01949051|12410025|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||0
11218515|NCT01949051|12410026|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0
11218516|NCT01949051|12410027|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0
11218517|NCT01949051|12410028|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||0
11218518|NCT01949090|12410041|FG000|STARTED|Overall Study||60
11218519|NCT01949090|12410042|FG001|STARTED|Overall Study||60
11218520|NCT01949090|12410043|FG002|STARTED|Overall Study||60
11218521|NCT01949090|12410044|FG003|STARTED|Overall Study||60
11218522|NCT01949090|12410045|FG004|STARTED|Overall Study||120
11218523|NCT01949090|12410041|FG000|COMPLETED|Overall Study||56
11218524|NCT01949090|12410042|FG001|COMPLETED|Overall Study||58
11218525|NCT01949090|12410043|FG002|COMPLETED|Overall Study||58
11218526|NCT01949090|12410044|FG003|COMPLETED|Overall Study||59
11218527|NCT01949090|12410045|FG004|COMPLETED|Overall Study||116
11218528|NCT01949090|12410041|FG000|NOT COMPLETED|Overall Study||4
11218529|NCT01949090|12410042|FG001|NOT COMPLETED|Overall Study||2
11218530|NCT01949090|12410043|FG002|NOT COMPLETED|Overall Study||2
11218531|NCT01949090|12410044|FG003|NOT COMPLETED|Overall Study||1
11218532|NCT01949090|12410045|FG004|NOT COMPLETED|Overall Study||4
11218533|NCT01949116|12410060|FG000|STARTED|Overall Study||86
11218534|NCT01949116|12410061|FG001|STARTED|Overall Study||90
11218535|NCT01949116|12410060|FG000|COMPLETED|Overall Study||78
11218536|NCT01949116|12410061|FG001|COMPLETED|Overall Study||84
11218537|NCT01949116|12410060|FG000|NOT COMPLETED|Overall Study||8
11218538|NCT01949116|12410061|FG001|NOT COMPLETED|Overall Study||6
11218539|NCT01949142|12410073|FG000|STARTED|Overall Study||179
11218540|NCT01949142|12410074|FG001|STARTED|Overall Study||87
11218541|NCT01949142|12410073|FG000|COMPLETED|Overall Study||176
11218542|NCT01949142|12410074|FG001|COMPLETED|Overall Study||86
11218543|NCT01949142|12410073|FG000|NOT COMPLETED|Overall Study||3
11218544|NCT01949142|12410074|FG001|NOT COMPLETED|Overall Study||1
11218545|NCT01949155|12410083|FG000|STARTED|Overall Study||178
11218546|NCT01949155|12410084|FG001|STARTED|Overall Study||88
11218547|NCT01949155|12410083|FG000|COMPLETED|Overall Study||176
11218548|NCT01949155|12410084|FG001|COMPLETED|Overall Study||88
11218549|NCT01949155|12410083|FG000|NOT COMPLETED|Overall Study||2
11218550|NCT01949155|12410084|FG001|NOT COMPLETED|Overall Study||0
11218551|NCT01949389|12410091|FG000|STARTED|Overall Study||51
11218552|NCT01949389|12410091|FG000|COMPLETED|Overall Study||51
11218553|NCT01949389|12410091|FG000|NOT COMPLETED|Overall Study||0
11218554|NCT01949480|12410097|FG000|STARTED|Overall Study||20
11218555|NCT01949480|12410098|FG001|STARTED|Overall Study||22
11218556|NCT01949480|12410097|FG000|COMPLETED|Overall Study||15
11218557|NCT01949480|12410098|FG001|COMPLETED|Overall Study||14
11218558|NCT01949480|12410097|FG000|NOT COMPLETED|Overall Study||5
11218559|NCT01949480|12410098|FG001|NOT COMPLETED|Overall Study||8
11218560|NCT01949532|12410106|FG000|STARTED|Overall Study||15
11218561|NCT01949532|12410107|FG001|STARTED|Overall Study||11
11218562|NCT01949532|12410106|FG000|COMPLETED|Overall Study||12
11218563|NCT01949532|12410107|FG001|COMPLETED|Overall Study||8
11218564|NCT01949532|12410106|FG000|NOT COMPLETED|Overall Study||3
11218565|NCT01949532|12410107|FG001|NOT COMPLETED|Overall Study||3
11218566|NCT01949545|12410117|FG000|STARTED|Overall Study||11
11218567|NCT01949545|12410118|FG001|STARTED|Overall Study||17
11218568|NCT01949545|12410119|FG002|STARTED|Overall Study||14
11218569|NCT01949545|12410120|FG003|STARTED|Overall Study||4
11218570|NCT01949545|12410117|FG000|COMPLETED|Overall Study||11
11218571|NCT01949545|12410118|FG001|COMPLETED|Overall Study||17
11218572|NCT01949545|12410119|FG002|COMPLETED|Overall Study||14
11218573|NCT01949545|12410120|FG003|COMPLETED|Overall Study||4
11218574|NCT01949545|12410117|FG000|NOT COMPLETED|Overall Study||0
11218575|NCT01949545|12410118|FG001|NOT COMPLETED|Overall Study||0
11218576|NCT01949545|12410119|FG002|NOT COMPLETED|Overall Study||0
11218577|NCT01949545|12410120|FG003|NOT COMPLETED|Overall Study||0
11218578|NCT01949779|12410130|FG000|STARTED|Overall Study||81
11218579|NCT01949779|12410130|FG000|COMPLETED|Overall Study||79
11218580|NCT01949779|12410130|FG000|NOT COMPLETED|Overall Study||2
11218581|NCT01949844|12410134|FG000|STARTED|Overall Study||44
11218582|NCT01949844|12410134|FG000|COMPLETED|Overall Study||44
11218583|NCT01949844|12410134|FG000|NOT COMPLETED|Overall Study||0
11218584|NCT01949870|12410138|FG000|STARTED|Overall Study||6
11218585|NCT01949870|12410138|FG000|Received Treatment|Overall Study||4
11218586|NCT01949870|12410138|FG000|COMPLETED|Overall Study||0
11218587|NCT01949870|12410138|FG000|NOT COMPLETED|Overall Study||6
11218588|NCT01950013|12410145|FG000|STARTED|Overall Study||15
11218589|NCT01950013|12410146|FG001|STARTED|Overall Study||15
11218590|NCT01950013|12410147|FG002|STARTED|Overall Study||15
11218591|NCT01950013|12410145|FG000|COMPLETED|Overall Study||15
11218592|NCT01950013|12410146|FG001|COMPLETED|Overall Study||13
11218593|NCT01950013|12410147|FG002|COMPLETED|Overall Study||15
11218594|NCT01950013|12410145|FG000|NOT COMPLETED|Overall Study||0
11218595|NCT01950013|12410146|FG001|NOT COMPLETED|Overall Study||2
11218596|NCT01950013|12410147|FG002|NOT COMPLETED|Overall Study||0
11218597|NCT01950039|12410157|FG000|STARTED|Overall Study||15
11218598|NCT01950039|12410158|FG001|STARTED|Overall Study||13
11218599|NCT01950039|12410157|FG000|Study Drug Initiated|Overall Study||14
11218600|NCT01950039|12410158|FG001|Study Drug Initiated|Overall Study||13
11218601|NCT01950039|12410157|FG000|Completed Clamp|Overall Study||13
11218602|NCT01950039|12410158|FG001|Completed Clamp|Overall Study||12
11218603|NCT01950039|12410157|FG000|Completed MRI|Overall Study||13
11218604|NCT01950039|12410158|FG001|Completed MRI|Overall Study||12
11218605|NCT01950039|12410157|FG000|Completed Endothelial Evaluation|Overall Study||14
11218606|NCT01950039|12410158|FG001|Completed Endothelial Evaluation|Overall Study||12
11218607|NCT01950039|12410157|FG000|COMPLETED|Overall Study||14
11218608|NCT01950039|12410158|FG001|COMPLETED|Overall Study||13
11218609|NCT01950039|12410157|FG000|NOT COMPLETED|Overall Study||1
11218610|NCT01950039|12410158|FG001|NOT COMPLETED|Overall Study||0
11218611|NCT01950078|12410166|FG000|STARTED|Overall Study||1025
11218612|NCT01950078|12410167|FG001|STARTED|Overall Study||508
11218613|NCT01950078|12410166|FG000|COMPLETED|Overall Study||1005
11218614|NCT01950078|12410167|FG001|COMPLETED|Overall Study||496
11218615|NCT01950078|12410166|FG000|NOT COMPLETED|Overall Study||20
11218616|NCT01950078|12410167|FG001|NOT COMPLETED|Overall Study||12
11218617|NCT01950169|12410176|FG000|STARTED|Overall Study||28
11218618|NCT01950169|12410177|FG001|STARTED|Overall Study||26
11218619|NCT01950169|12410178|FG002|STARTED|Overall Study||25
11218620|NCT01950169|12410176|FG000|COMPLETED|Overall Study||25
11218621|NCT01950169|12410177|FG001|COMPLETED|Overall Study||18
11218622|NCT01950169|12410178|FG002|COMPLETED|Overall Study||24
11218623|NCT01950169|12410176|FG000|NOT COMPLETED|Overall Study||3
11218624|NCT01950169|12410177|FG001|NOT COMPLETED|Overall Study||8
11218625|NCT01950169|12410178|FG002|NOT COMPLETED|Overall Study||1
11218626|NCT01950260|12410189|FG000|STARTED|Overall Study||30
11218627|NCT01950260|12410190|FG001|STARTED|Overall Study||31
11218628|NCT01950260|12410189|FG000|COMPLETED|Overall Study||30
11218629|NCT01950260|12410190|FG001|COMPLETED|Overall Study||31
11218630|NCT01950260|12410189|FG000|NOT COMPLETED|Overall Study||0
11218631|NCT01950260|12410190|FG001|NOT COMPLETED|Overall Study||0
11218632|NCT01950273|12410198|FG000|STARTED|Overall Study||49
11218633|NCT01950273|12410199|FG001|STARTED|Overall Study||46
11218634|NCT01950273|12410198|FG000|COMPLETED|Overall Study||45
11218635|NCT01950273|12410199|FG001|COMPLETED|Overall Study||46
11218636|NCT01950273|12410198|FG000|NOT COMPLETED|Overall Study||4
11218637|NCT01950273|12410199|FG001|NOT COMPLETED|Overall Study||0
11218638|NCT01950299|12410208|FG000|STARTED|Overall Study||33
11218639|NCT01950299|12410209|FG001|STARTED|Overall Study||31
11218640|NCT01950299|12410210|FG002|STARTED|Overall Study||35
11218641|NCT01950299|12410208|FG000|COMPLETED|Overall Study||22
11218642|NCT01950299|12410209|FG001|COMPLETED|Overall Study||27
11218643|NCT01950299|12410210|FG002|COMPLETED|Overall Study||28
11218644|NCT01950299|12410208|FG000|NOT COMPLETED|Overall Study||11
11218645|NCT01950299|12410209|FG001|NOT COMPLETED|Overall Study||4
11218646|NCT01950299|12410210|FG002|NOT COMPLETED|Overall Study||7
11218647|NCT01950364|12410220|FG000|STARTED|Overall Study||10
11218648|NCT01950364|12410221|FG001|STARTED|Overall Study||10
11218649|NCT01950364|12410220|FG000|COMPLETED|Overall Study||0
11218650|NCT01950364|12410221|FG001|COMPLETED|Overall Study||0
11218651|NCT01950364|12410220|FG000|NOT COMPLETED|Overall Study||10
11218652|NCT01950364|12410221|FG001|NOT COMPLETED|Overall Study||10
11218653|NCT01950663|12410227|FG000|STARTED|Overall Study||468
11098354|NCT01214655|12281884|FG001|Escalated From 5 mg Study Drug|Part A||0
11098355|NCT01214655|12281885|FG002|Escalated From 5 mg Study Drug|Part A||0
11098356|NCT01214655|12281883|FG000|Joined 6 mg Group|Part A||4
11098357|NCT01214655|12281884|FG001|Joined 6 mg Group|Part A||0
11098358|NCT01214655|12281885|FG002|Joined 6 mg Group|Part A||0
11098359|NCT01214655|12281883|FG000|Received 6 mg Study Drug|Part A||5
11098360|NCT01214655|12281884|FG001|Received 6 mg Study Drug|Part A||0
11098361|NCT01214655|12281885|FG002|Received 6 mg Study Drug|Part A||0
11098362|NCT01214655|12281883|FG000|COMPLETED|Part A||2
11098363|NCT01214655|12281884|FG001|COMPLETED|Part A||0
11098364|NCT01214655|12281885|FG002|COMPLETED|Part A||0
11098365|NCT01214655|12281883|FG000|NOT COMPLETED|Part A||8
11098366|NCT01214655|12281884|FG001|NOT COMPLETED|Part A||0
11098367|NCT01214655|12281885|FG002|NOT COMPLETED|Part A||0
11098368|NCT01214655|12281883|FG000|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0
11098369|NCT01214655|12281884|FG001|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15
11098370|NCT01214655|12281885|FG002|STARTED|Part B||0
11098371|NCT01214655|12281883|FG000|Received at Least 1 Dose of Study Drug|Part B||0
11098372|NCT01214655|12281884|FG001|Received at Least 1 Dose of Study Drug|Part B||15
11098373|NCT01214655|12281885|FG002|Received at Least 1 Dose of Study Drug|Part B||0
11098374|NCT01214655|12281883|FG000|Recieved 8 mg/m²/Day Study Drug|Part B||0
11098375|NCT01214655|12281884|FG001|Recieved 8 mg/m²/Day Study Drug|Part B||4
11098376|NCT01214655|12281885|FG002|Recieved 8 mg/m²/Day Study Drug|Part B||0
11098377|NCT01214655|12281883|FG000|Escalated From 8 to 10 mg/m²/Day|Part B||0
11098378|NCT01214655|12281884|FG001|Escalated From 8 to 10 mg/m²/Day|Part B||2
11098379|NCT01214655|12281885|FG002|Escalated From 8 to 10 mg/m²/Day|Part B||0
11098380|NCT01214655|12281883|FG000|Joined 10 mg/m²/Day Study D|Part B||0
11098381|NCT01214655|12281884|FG001|Joined 10 mg/m²/Day Study D|Part B||3
11098382|NCT01214655|12281885|FG002|Joined 10 mg/m²/Day Study D|Part B||0
11098383|NCT01214655|12281883|FG000|Escalated to 12 mg/m²/Day|Part B||0
11098384|NCT01214655|12281884|FG001|Escalated to 12 mg/m²/Day|Part B||2
11098385|NCT01214655|12281885|FG002|Escalated to 12 mg/m²/Day|Part B||0
11098386|NCT01214655|12281883|FG000|Joined 12 mg/m²/Day|Part B||0
11098387|NCT01214655|12281884|FG001|Joined 12 mg/m²/Day|Part B||5
11098388|NCT01214655|12281885|FG002|Joined 12 mg/m²/Day|Part B||0
11098389|NCT01214655|12281883|FG000|Escalated From 12 to 14 mg/m²/Day|Part B||0
11098390|NCT01214655|12281884|FG001|Escalated From 12 to 14 mg/m²/Day|Part B||1
11098391|NCT01214655|12281885|FG002|Escalated From 12 to 14 mg/m²/Day|Part B||0
11098392|NCT01214655|12281883|FG000|Joined 14 mg/m²/Day|Part B||0
11098393|NCT01214655|12281884|FG001|Joined 14 mg/m²/Day|Part B||3
11098394|NCT01214655|12281885|FG002|Joined 14 mg/m²/Day|Part B||0
11098395|NCT01214655|12281883|FG000|COMPLETED|Part B||0
11098396|NCT01214655|12281884|FG001|COMPLETED|Part B||2
11098397|NCT01214655|12281885|FG002|COMPLETED|Part B||0
11098398|NCT01214655|12281883|FG000|NOT COMPLETED|Part B||0
11098399|NCT01214655|12281884|FG001|NOT COMPLETED|Part B||13
11098400|NCT01214655|12281885|FG002|NOT COMPLETED|Part B||0
11098401|NCT01214655|12281883|FG000|STARTED|Part C||0
11098402|NCT01214655|12281884|FG001|STARTED|Part C||0
11098403|NCT01214655|12281885|FG002|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8
11098404|NCT01214655|12281883|FG000|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
11098405|NCT01214655|12281884|FG001|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
11098406|NCT01214655|12281885|FG002|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8
11098407|NCT01214655|12281883|FG000|COMPLETED|Part C||0
11098408|NCT01214655|12281884|FG001|COMPLETED|Part C||0
11098409|NCT01214655|12281885|FG002|COMPLETED|Part C||1
11098410|NCT01214655|12281883|FG000|NOT COMPLETED|Part C||0
11098411|NCT01214655|12281884|FG001|NOT COMPLETED|Part C||0
11098412|NCT01214655|12281885|FG002|NOT COMPLETED|Part C||7
11098413|NCT01214668|12281937|FG000|STARTED|Overall Study||4
11098414|NCT01214668|12281938|FG001|STARTED|Overall Study||3
11098415|NCT01214668|12281939|FG002|STARTED|Overall Study||6
11098416|NCT01214668|12281940|FG003|STARTED|Overall Study||6
11098417|NCT01214668|12281941|FG004|STARTED|Overall Study||6
11098418|NCT01214668|12281942|FG005|STARTED|Overall Study||6
11098419|NCT01214668|12281937|FG000|Received at Least One Dose of Study Drug|Overall Study||4
11098420|NCT01214668|12281938|FG001|Received at Least One Dose of Study Drug|Overall Study||3
11098421|NCT01214668|12281939|FG002|Received at Least One Dose of Study Drug|Overall Study||6
11098422|NCT01214668|12281940|FG003|Received at Least One Dose of Study Drug|Overall Study||6
11098423|NCT01214668|12281941|FG004|Received at Least One Dose of Study Drug|Overall Study||6
11098424|NCT01214668|12281942|FG005|Received at Least One Dose of Study Drug|Overall Study||6
11218654|NCT01950663|12410227|FG000|COMPLETED|Overall Study||467
11218655|NCT01950663|12410227|FG000|NOT COMPLETED|Overall Study||1
11218656|NCT01950741|12410231|FG000|STARTED|Overall Study||48
11218657|NCT01950741|12410231|FG000|COMPLETED|Overall Study||45
11218658|NCT01950741|12410231|FG000|NOT COMPLETED|Overall Study||3
11218659|NCT01950780|12410235|FG000|STARTED|Overall Study||12
11218660|NCT01950780|12410235|FG000|COMPLETED|Overall Study||12
11218661|NCT01950780|12410235|FG000|NOT COMPLETED|Overall Study||0
11218662|NCT01950819|12410242|FG000|STARTED|Overall Study||1022
11218663|NCT01950819|12410243|FG001|STARTED|Overall Study||1015
11218664|NCT01950819|12410242|FG000|COMPLETED|Overall Study||893
11218665|NCT01950819|12410243|FG001|COMPLETED|Overall Study||881
11218666|NCT01950819|12410242|FG000|NOT COMPLETED|Overall Study||129
11218667|NCT01950819|12410243|FG001|NOT COMPLETED|Overall Study||134
11218668|NCT01951066|12410249|FG000|STARTED|First Intervention (Baseline to Week 16)||10
11218669|NCT01951066|12410250|FG001|STARTED|First Intervention (Baseline to Week 16)||10
11218670|NCT01951066|12410249|FG000|COMPLETED|First Intervention (Baseline to Week 16)||10
11098425|NCT01214668|12281937|FG000|COMPLETED|Overall Study||0
11098426|NCT01214668|12281938|FG001|COMPLETED|Overall Study||0
11098427|NCT01214668|12281939|FG002|COMPLETED|Overall Study||0
11098428|NCT01214668|12281940|FG003|COMPLETED|Overall Study||0
11098429|NCT01214668|12281941|FG004|COMPLETED|Overall Study||0
11218671|NCT01951066|12410250|FG001|COMPLETED|First Intervention (Baseline to Week 16)||10
11218672|NCT01951066|12410249|FG000|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
11218673|NCT01951066|12410250|FG001|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
11218674|NCT01951066|12410249|FG000|STARTED|Second Intervention (Week 16 to Week 32)||10
11218675|NCT01951066|12410250|FG001|STARTED|Second Intervention (Week 16 to Week 32)||10
11218676|NCT01951066|12410249|FG000|COMPLETED|Second Intervention (Week 16 to Week 32)||10
11218677|NCT01951066|12410250|FG001|COMPLETED|Second Intervention (Week 16 to Week 32)||10
11218678|NCT01951066|12410249|FG000|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
11218679|NCT01951066|12410250|FG001|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
11218680|NCT01951092|12410255|FG000|STARTED|Overall Study||32
11218681|NCT01951092|12410255|FG000|COMPLETED|Overall Study||20
11218682|NCT01951092|12410255|FG000|NOT COMPLETED|Overall Study||12
11218683|NCT01951105|12410262|FG000|STARTED|Overall Study||11
11218684|NCT01951105|12410263|FG001|STARTED|Overall Study||31
11218685|NCT01951105|12410264|FG002|STARTED|Overall Study||30
11098430|NCT01214668|12281942|FG005|COMPLETED|Overall Study||0
11098431|NCT01214668|12281937|FG000|NOT COMPLETED|Overall Study||4
11218686|NCT01951105|12410262|FG000|Completed 12 Weeks Treatment|Overall Study||10
11218687|NCT01951105|12410263|FG001|Completed 12 Weeks Treatment|Overall Study||24
11218688|NCT01951105|12410264|FG002|Completed 12 Weeks Treatment|Overall Study||28
11098432|NCT01214668|12281938|FG001|NOT COMPLETED|Overall Study||3
11098433|NCT01214668|12281939|FG002|NOT COMPLETED|Overall Study||6
11098434|NCT01214668|12281940|FG003|NOT COMPLETED|Overall Study||6
11218689|NCT01951105|12410262|FG000|COMPLETED|Overall Study||10
11218690|NCT01951105|12410263|FG001|COMPLETED|Overall Study||21
11218691|NCT01951105|12410264|FG002|COMPLETED|Overall Study||28
11218692|NCT01951105|12410262|FG000|NOT COMPLETED|Overall Study||1
11218693|NCT01951105|12410263|FG001|NOT COMPLETED|Overall Study||10
11218694|NCT01951105|12410264|FG002|NOT COMPLETED|Overall Study||2
11218695|NCT01951118|12410278|FG000|STARTED|Overall Study||121
11218696|NCT01951118|12410278|FG000|COMPLETED|Overall Study||94
11218697|NCT01951118|12410278|FG000|NOT COMPLETED|Overall Study||27
11218698|NCT01951157|12410290|FG000|STARTED|Overall Study||22
11218699|NCT01951157|12410291|FG001|STARTED|Overall Study||22
11218700|NCT01951157|12410292|FG002|STARTED|Overall Study||25
11218701|NCT01951157|12410290|FG000|COMPLETED|Overall Study||0
11218702|NCT01951157|12410291|FG001|COMPLETED|Overall Study||0
11218703|NCT01951157|12410292|FG002|COMPLETED|Overall Study||0
11218704|NCT01951157|12410290|FG000|NOT COMPLETED|Overall Study||22
11218705|NCT01951157|12410291|FG001|NOT COMPLETED|Overall Study||22
11218706|NCT01951157|12410292|FG002|NOT COMPLETED|Overall Study||25
11218707|NCT01951170|12410301|FG000|STARTED|Overall Study||52
11218708|NCT01951170|12410301|FG000|COMPLETED|Overall Study||51
11218709|NCT01951170|12410301|FG000|NOT COMPLETED|Overall Study||1
11218710|NCT01951261|12410307|FG000|STARTED|Overall Study||58
11218711|NCT01951261|12410308|FG001|STARTED|Overall Study||58
11218712|NCT01951261|12410307|FG000|Discontinued|Overall Study|"2-readmission when was at home~1-monitor failure~1-new home hospitalitation 4-missing~1-death"|9
11218713|NCT01951261|12410308|FG001|Discontinued|Overall Study|"2-readmission when was at home~1-new home hospitalitation 3-missing"|6
11218714|NCT01951261|12410307|FG000|COMPLETED|Overall Study||49
11218715|NCT01951261|12410308|FG001|COMPLETED|Overall Study||52
11218716|NCT01951261|12410307|FG000|NOT COMPLETED|Overall Study||9
11218717|NCT01951261|12410308|FG001|NOT COMPLETED|Overall Study||6
11218718|NCT01951326|12410316|FG000|STARTED|Overall Study||166
11218719|NCT01951326|12410317|FG001|STARTED|Overall Study||165
11218720|NCT01951326|12410316|FG000|COMPLETED|Overall Study||87
11218721|NCT01951326|12410317|FG001|COMPLETED|Overall Study||87
11218722|NCT01951326|12410316|FG000|NOT COMPLETED|Overall Study||79
11218723|NCT01951326|12410317|FG001|NOT COMPLETED|Overall Study||78
11218724|NCT01951339|12410326|FG000|STARTED|Overall Study||15
11218725|NCT01951339|12410327|FG001|STARTED|Overall Study||15
11218726|NCT01951339|12410326|FG000|COMPLETED|Overall Study||13
11218727|NCT01951339|12410327|FG001|COMPLETED|Overall Study||14
11218728|NCT01951339|12410326|FG000|NOT COMPLETED|Overall Study||2
11218729|NCT01951339|12410327|FG001|NOT COMPLETED|Overall Study||1
11218730|NCT01951352|12410333|FG000|STARTED|Overall Study||10
11218731|NCT01951352|12410333|FG000|COMPLETED|Overall Study||10
11218732|NCT01951352|12410333|FG000|NOT COMPLETED|Overall Study||0
11218733|NCT01951391|12410339|FG000|STARTED|Overall Study||5
11218734|NCT01951391|12410340|FG001|STARTED|Overall Study||5
11218735|NCT01951391|12410339|FG000|COMPLETED|Overall Study||5
11218736|NCT01951391|12410340|FG001|COMPLETED|Overall Study||5
11218737|NCT01951391|12410339|FG000|NOT COMPLETED|Overall Study||0
11218738|NCT01951391|12410340|FG001|NOT COMPLETED|Overall Study||0
11218739|NCT01951573|12410348|FG000|STARTED|Period 1, First 9 Hours of Wear||17
11218740|NCT01951573|12410349|FG001|STARTED|Period 1, First 9 Hours of Wear||17
11218741|NCT01951573|12410348|FG000|COMPLETED|Period 1, First 9 Hours of Wear||17
11218742|NCT01951573|12410349|FG001|COMPLETED|Period 1, First 9 Hours of Wear||17
11218743|NCT01951573|12410348|FG000|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
11218744|NCT01951573|12410349|FG001|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
11218745|NCT01951573|12410348|FG000|STARTED|Washout Period||17
11218746|NCT01951573|12410349|FG001|STARTED|Washout Period||17
11218747|NCT01951573|12410348|FG000|COMPLETED|Washout Period||17
11218748|NCT01951573|12410349|FG001|COMPLETED|Washout Period||16
11218749|NCT01951573|12410348|FG000|NOT COMPLETED|Washout Period||0
11218750|NCT01951573|12410349|FG001|NOT COMPLETED|Washout Period||1
11218751|NCT01951573|12410348|FG000|STARTED|Period 2, Second 9 Hours of Wear||17
11218752|NCT01951573|12410349|FG001|STARTED|Period 2, Second 9 Hours of Wear||16
11218753|NCT01951573|12410348|FG000|COMPLETED|Period 2, Second 9 Hours of Wear||17
11218754|NCT01951573|12410349|FG001|COMPLETED|Period 2, Second 9 Hours of Wear||16
11218755|NCT01951573|12410348|FG000|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
11218756|NCT01951573|12410349|FG001|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
11218757|NCT01951586|12410357|FG000|STARTED|Overall Study||78
11218758|NCT01951586|12410358|FG001|STARTED|Overall Study||148
11218759|NCT01951586|12410357|FG000|Received Study Drug|Overall Study||76
11218760|NCT01951586|12410358|FG001|Received Study Drug|Overall Study||145
11218761|NCT01951586|12410357|FG000|COMPLETED|Overall Study||0
11218762|NCT01951586|12410358|FG001|COMPLETED|Overall Study||0
11218763|NCT01951586|12410357|FG000|NOT COMPLETED|Overall Study||78
11098435|NCT01214668|12281941|FG004|NOT COMPLETED|Overall Study||6
11098436|NCT01214668|12281942|FG005|NOT COMPLETED|Overall Study||6
11098437|NCT01214720|12281959|FG000|STARTED|Overall Study||306
11098438|NCT01214720|12281960|FG001|STARTED|Overall Study||301
11098439|NCT01214720|12281959|FG000|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
11098440|NCT01214720|12281960|FG001|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
11098441|NCT01214720|12281959|FG000|NOT COMPLETED|Overall Study||85
11098442|NCT01214720|12281960|FG001|NOT COMPLETED|Overall Study||68
11098443|NCT01214759|12281966|FG000|STARTED|Overall Study||103
11218764|NCT01951586|12410358|FG001|NOT COMPLETED|Overall Study||148
11218765|NCT01951625|12410370|FG000|STARTED|Treatment Period||92
11218766|NCT01951625|12410371|FG001|STARTED|Treatment Period||91
11218767|NCT01951625|12410372|FG002|STARTED|Treatment Period||91
11218768|NCT01951625|12410373|FG003|STARTED|Treatment Period||91
11218769|NCT01951625|12410374|FG004|STARTED|Treatment Period||91
11218770|NCT01951625|12410370|FG000|COMPLETED|Treatment Period||73
11218771|NCT01951625|12410371|FG001|COMPLETED|Treatment Period||70
11218772|NCT01951625|12410372|FG002|COMPLETED|Treatment Period||76
11218773|NCT01951625|12410373|FG003|COMPLETED|Treatment Period||69
11218774|NCT01951625|12410374|FG004|COMPLETED|Treatment Period||74
11218775|NCT01951625|12410370|FG000|NOT COMPLETED|Treatment Period||19
11218776|NCT01951625|12410371|FG001|NOT COMPLETED|Treatment Period||21
11218777|NCT01951625|12410372|FG002|NOT COMPLETED|Treatment Period||15
11218778|NCT01951625|12410373|FG003|NOT COMPLETED|Treatment Period||22
11218779|NCT01951625|12410374|FG004|NOT COMPLETED|Treatment Period||17
11218780|NCT01951625|12410370|FG000|STARTED|Follow Up Period||87
11218781|NCT01951625|12410371|FG001|STARTED|Follow Up Period||88
11218782|NCT01951625|12410372|FG002|STARTED|Follow Up Period||88
11218783|NCT01951625|12410373|FG003|STARTED|Follow Up Period||87
11218784|NCT01951625|12410374|FG004|STARTED|Follow Up Period||88
11218785|NCT01951625|12410370|FG000|COMPLETED|Follow Up Period||79
11218786|NCT01951625|12410371|FG001|COMPLETED|Follow Up Period||79
11218787|NCT01951625|12410372|FG002|COMPLETED|Follow Up Period||84
11218788|NCT01951625|12410373|FG003|COMPLETED|Follow Up Period||76
11218789|NCT01951625|12410374|FG004|COMPLETED|Follow Up Period||78
11218790|NCT01951625|12410370|FG000|NOT COMPLETED|Follow Up Period||8
11218791|NCT01951625|12410371|FG001|NOT COMPLETED|Follow Up Period||9
11218792|NCT01951625|12410372|FG002|NOT COMPLETED|Follow Up Period||4
11218793|NCT01951625|12410373|FG003|NOT COMPLETED|Follow Up Period||11
11218794|NCT01951625|12410374|FG004|NOT COMPLETED|Follow Up Period||10
11218795|NCT01951638|12410392|FG000|STARTED|Treatment Period||93
11218796|NCT01951638|12410393|FG001|STARTED|Treatment Period||96
11218797|NCT01951638|12410394|FG002|STARTED|Treatment Period||96
11218798|NCT01951638|12410395|FG003|STARTED|Treatment Period||96
11218799|NCT01951638|12410396|FG004|STARTED|Treatment Period||96
11218800|NCT01951638|12410392|FG000|COMPLETED|Treatment Period||80
11218801|NCT01951638|12410393|FG001|COMPLETED|Treatment Period||82
11218802|NCT01951638|12410394|FG002|COMPLETED|Treatment Period||83
11218803|NCT01951638|12410395|FG003|COMPLETED|Treatment Period||80
11218804|NCT01951638|12410396|FG004|COMPLETED|Treatment Period||86
11218805|NCT01951638|12410392|FG000|NOT COMPLETED|Treatment Period||13
11218806|NCT01951638|12410393|FG001|NOT COMPLETED|Treatment Period||14
11218807|NCT01951638|12410394|FG002|NOT COMPLETED|Treatment Period||13
11218808|NCT01951638|12410395|FG003|NOT COMPLETED|Treatment Period||16
11218809|NCT01951638|12410396|FG004|NOT COMPLETED|Treatment Period||10
11218810|NCT01951638|12410392|FG000|STARTED|Follow-up Period||89
11218811|NCT01951638|12410393|FG001|STARTED|Follow-up Period||95
11218812|NCT01951638|12410394|FG002|STARTED|Follow-up Period||95
11218813|NCT01951638|12410395|FG003|STARTED|Follow-up Period||88
11218814|NCT01951638|12410396|FG004|STARTED|Follow-up Period||94
11218815|NCT01951638|12410392|FG000|COMPLETED|Follow-up Period||87
11218816|NCT01951638|12410393|FG001|COMPLETED|Follow-up Period||86
11218817|NCT01951638|12410394|FG002|COMPLETED|Follow-up Period||90
11218818|NCT01951638|12410395|FG003|COMPLETED|Follow-up Period||80
11218819|NCT01951638|12410396|FG004|COMPLETED|Follow-up Period||89
11218820|NCT01951638|12410392|FG000|NOT COMPLETED|Follow-up Period||2
11218821|NCT01951638|12410393|FG001|NOT COMPLETED|Follow-up Period||9
11218822|NCT01951638|12410394|FG002|NOT COMPLETED|Follow-up Period||5
11218823|NCT01951638|12410395|FG003|NOT COMPLETED|Follow-up Period||8
11218824|NCT01951638|12410396|FG004|NOT COMPLETED|Follow-up Period||5
11218825|NCT01951651|12410410|FG000|STARTED|Overall Study||12
11218826|NCT01951651|12410411|FG001|STARTED|Overall Study||12
11218827|NCT01951651|12410410|FG000|COMPLETED|Overall Study||8
11218828|NCT01951651|12410411|FG001|COMPLETED|Overall Study||10
11218829|NCT01951651|12410410|FG000|NOT COMPLETED|Overall Study||4
11218830|NCT01951651|12410411|FG001|NOT COMPLETED|Overall Study||2
11218831|NCT01951703|12410419|FG000|STARTED|First Intervention||64
11218832|NCT01951703|12410420|FG001|STARTED|First Intervention||63
11218833|NCT01951703|12410419|FG000|COMPLETED|First Intervention||61
11218834|NCT01951703|12410420|FG001|COMPLETED|First Intervention||62
11218835|NCT01951703|12410419|FG000|NOT COMPLETED|First Intervention||3
11218836|NCT01951703|12410420|FG001|NOT COMPLETED|First Intervention||1
11218837|NCT01951703|12410419|FG000|STARTED|Second Intervention||61
11218838|NCT01951703|12410420|FG001|STARTED|Second Intervention||62
11218839|NCT01951703|12410419|FG000|COMPLETED|Second Intervention||61
11218840|NCT01951703|12410420|FG001|COMPLETED|Second Intervention||60
11218841|NCT01951703|12410419|FG000|NOT COMPLETED|Second Intervention||0
11218842|NCT01951703|12410420|FG001|NOT COMPLETED|Second Intervention||2
11218843|NCT01951768|12410429|FG000|STARTED|Overall Study||43
11218844|NCT01951768|12410430|FG001|STARTED|Overall Study||45
11218845|NCT01951768|12410429|FG000|COMPLETED|Overall Study|43 patients|43
11218846|NCT01951768|12410430|FG001|COMPLETED|Overall Study|45 patients|45
11218847|NCT01951768|12410429|FG000|NOT COMPLETED|Overall Study||0
11218848|NCT01951768|12410430|FG001|NOT COMPLETED|Overall Study||0
11218849|NCT01951820|12410438|FG000|STARTED|Overall Study||34
11218850|NCT01951820|12410439|FG001|STARTED|Overall Study||30
11218851|NCT01951820|12410438|FG000|COMPLETED|Overall Study||34
11218852|NCT01951820|12410439|FG001|COMPLETED|Overall Study||30
11218853|NCT01951820|12410438|FG000|NOT COMPLETED|Overall Study||0
11218854|NCT01951820|12410439|FG001|NOT COMPLETED|Overall Study||0
11218855|NCT01951950|12410447|FG000|STARTED|Overall Study||26
11218856|NCT01951950|12410448|FG001|STARTED|Overall Study||26
11218857|NCT01951950|12410447|FG000|COMPLETED|Overall Study||20
11218858|NCT01951950|12410448|FG001|COMPLETED|Overall Study||20
11218859|NCT01951950|12410447|FG000|NOT COMPLETED|Overall Study||6
11218860|NCT01951950|12410448|FG001|NOT COMPLETED|Overall Study||6
11218861|NCT01951963|12410456|FG000|STARTED|Overall Study||31
11218862|NCT01951963|12410457|FG001|STARTED|Overall Study||32
11218863|NCT01951963|12410456|FG000|COMPLETED|Overall Study||31
11218864|NCT01951963|12410457|FG001|COMPLETED|Overall Study||32
11218865|NCT01951963|12410456|FG000|NOT COMPLETED|Overall Study||0
11218866|NCT01951963|12410457|FG001|NOT COMPLETED|Overall Study||0
11218867|NCT01952015|12410467|FG000|STARTED|Induction||12
11218868|NCT01952015|12410467|FG000|COMPLETED|Induction||11
11218869|NCT01952015|12410467|FG000|NOT COMPLETED|Induction||1
11218870|NCT01952015|12410467|FG000|STARTED|Maintenance||11
11218871|NCT01952015|12410467|FG000|COMPLETED|Maintenance||9
11218872|NCT01952015|12410467|FG000|NOT COMPLETED|Maintenance||2
11218873|NCT01952015|12410467|FG000|STARTED|Treatment Period 3||9
11218874|NCT01952015|12410467|FG000|COMPLETED|Treatment Period 3||0
11218875|NCT01952015|12410467|FG000|NOT COMPLETED|Treatment Period 3||9
11218876|NCT01952041|12410485|FG000|STARTED|Overall Study||62
11218877|NCT01952041|12410486|FG001|STARTED|Overall Study||64
11218878|NCT01952041|12410485|FG000|COMPLETED|Overall Study||45
11218879|NCT01952041|12410486|FG001|COMPLETED|Overall Study||43
11218880|NCT01952041|12410485|FG000|NOT COMPLETED|Overall Study||17
11218881|NCT01952041|12410486|FG001|NOT COMPLETED|Overall Study||21
11218882|NCT01952054|12410492|FG000|STARTED|Overall Study||6
11218883|NCT01952054|12410492|FG000|COMPLETED|Overall Study||5
11218884|NCT01952054|12410492|FG000|NOT COMPLETED|Overall Study||1
11218885|NCT01952080|12410500|FG000|STARTED|Overall Study||5
11218886|NCT01952080|12410501|FG001|STARTED|Overall Study||8
11218887|NCT01952080|12410502|FG002|STARTED|Overall Study||14
11218888|NCT01952080|12410503|FG003|STARTED|Overall Study||15
11218889|NCT01952080|12410500|FG000|Treated|Overall Study||5
11218890|NCT01952080|12410501|FG001|Treated|Overall Study||8
11218891|NCT01952080|12410502|FG002|Treated|Overall Study||14
11218892|NCT01952080|12410503|FG003|Treated|Overall Study||15
11218893|NCT01952080|12410500|FG000|COMPLETED|Overall Study||5
11218894|NCT01952080|12410501|FG001|COMPLETED|Overall Study||7
11218895|NCT01952080|12410502|FG002|COMPLETED|Overall Study||14
11218896|NCT01952080|12410503|FG003|COMPLETED|Overall Study||14
11218897|NCT01952080|12410500|FG000|NOT COMPLETED|Overall Study||0
11218898|NCT01952080|12410501|FG001|NOT COMPLETED|Overall Study||1
11218899|NCT01952080|12410502|FG002|NOT COMPLETED|Overall Study||0
11218900|NCT01952080|12410503|FG003|NOT COMPLETED|Overall Study||1
11218901|NCT01952145|12410515|FG000|STARTED|Overall Study||278
11218902|NCT01952145|12410516|FG001|STARTED|Overall Study||279
11218903|NCT01952145|12410515|FG000|COMPLETED|Overall Study||250
11218904|NCT01952145|12410516|FG001|COMPLETED|Overall Study||265
11218905|NCT01952145|12410515|FG000|NOT COMPLETED|Overall Study||28
11218906|NCT01952145|12410516|FG001|NOT COMPLETED|Overall Study||14
11218907|NCT01952301|12410522|FG000|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
11218908|NCT01952301|12410522|FG000|COMPLETED|Overall Study||30
11218909|NCT01952301|12410522|FG000|NOT COMPLETED|Overall Study||0
11218910|NCT01952366|12410528|FG000|STARTED|Overall Study||169
11218911|NCT01952366|12410528|FG000|COMPLETED|Overall Study||138
11218912|NCT01952366|12410528|FG000|NOT COMPLETED|Overall Study||31
11218913|NCT01952418|12410537|FG000|STARTED|Overall Study||910
11218914|NCT01952418|12410538|FG001|STARTED|Overall Study||895
11218915|NCT01952418|12410537|FG000|COMPLETED|Overall Study||910
11218916|NCT01952418|12410538|FG001|COMPLETED|Overall Study||895
11218917|NCT01952418|12410537|FG000|NOT COMPLETED|Overall Study||0
11218918|NCT01952418|12410538|FG001|NOT COMPLETED|Overall Study||0
11218919|NCT01952444|12410546|FG000|STARTED|Overall Study||20
11218920|NCT01952444|12410547|FG001|STARTED|Overall Study||20
11218921|NCT01952444|12410546|FG000|COMPLETED|Overall Study||20
11218922|NCT01952444|12410547|FG001|COMPLETED|Overall Study||19
11218923|NCT01952444|12410546|FG000|NOT COMPLETED|Overall Study||0
11218924|NCT01952444|12410547|FG001|NOT COMPLETED|Overall Study||1
11218925|NCT01952470|12410560|FG000|STARTED|Overall Study||16
11218926|NCT01952470|12410561|FG001|STARTED|Overall Study||16
11218927|NCT01952470|12410560|FG000|ITT Analysis|Overall Study||16
11218928|NCT01952470|12410561|FG001|ITT Analysis|Overall Study||16
11218929|NCT01952470|12410560|FG000|Discontinued Intervention|Overall Study||2
11218930|NCT01952470|12410561|FG001|Discontinued Intervention|Overall Study||1
11218931|NCT01952470|12410560|FG000|Death|Overall Study||1
11218932|NCT01952470|12410561|FG001|Death|Overall Study||1
11218933|NCT01952470|12410560|FG000|Missing Baseline LCI 2% Data.|Overall Study||0
11218934|NCT01952470|12410561|FG001|Missing Baseline LCI 2% Data.|Overall Study||2
11218935|NCT01952470|12410560|FG000|Missing 1+3 Month LCI 2% Data.|Overall Study||2
11218936|NCT01952470|12410561|FG001|Missing 1+3 Month LCI 2% Data.|Overall Study||1
11218937|NCT01952470|12410560|FG000|Missing 3 Month LCI 2% Data.|Overall Study||1
11218938|NCT01952470|12410561|FG001|Missing 3 Month LCI 2% Data.|Overall Study||0
11218939|NCT01952470|12410560|FG000|COMPLETED|Overall Study||13
11218940|NCT01952470|12410561|FG001|COMPLETED|Overall Study||13
11218941|NCT01952470|12410560|FG000|NOT COMPLETED|Overall Study||3
11218942|NCT01952470|12410561|FG001|NOT COMPLETED|Overall Study||3
11218943|NCT01952600|12410570|FG000|STARTED|Overall Study||80
11218944|NCT01952600|12410571|FG001|STARTED|Overall Study||90
11218945|NCT01952600|12410572|FG002|STARTED|Overall Study||45
11218946|NCT01952600|12410570|FG000|COMPLETED|Overall Study||65
11218947|NCT01952600|12410571|FG001|COMPLETED|Overall Study||77
11218948|NCT01952600|12410572|FG002|COMPLETED|Overall Study||38
11218949|NCT01952600|12410570|FG000|NOT COMPLETED|Overall Study||15
11218950|NCT01952600|12410571|FG001|NOT COMPLETED|Overall Study||13
11218951|NCT01952600|12410572|FG002|NOT COMPLETED|Overall Study||7
11218952|NCT01952665|12410582|FG000|STARTED|Overall Study||37
11218953|NCT01952665|12410583|FG001|STARTED|Overall Study||26
11218954|NCT01952665|12410582|FG000|COMPLETED|Overall Study||31
11218955|NCT01952665|12410583|FG001|COMPLETED|Overall Study||20
11218956|NCT01952665|12410582|FG000|NOT COMPLETED|Overall Study||6
11218957|NCT01952665|12410583|FG001|NOT COMPLETED|Overall Study||6
11218958|NCT01952678|12410594|FG000|STARTED|Overall Study||102
11218959|NCT01952678|12410595|FG001|STARTED|Overall Study||102
11218960|NCT01952678|12410594|FG000|COMPLETED|Overall Study||102
11218961|NCT01952678|12410595|FG001|COMPLETED|Overall Study||102
11218962|NCT01952678|12410594|FG000|NOT COMPLETED|Overall Study||0
11218963|NCT01952678|12410595|FG001|NOT COMPLETED|Overall Study||0
11218964|NCT01952691|12410611|FG000|STARTED|Overall Study||22
11218965|NCT01952691|12410611|FG000|COMPLETED|Overall Study||20
11218966|NCT01952691|12410611|FG000|NOT COMPLETED|Overall Study||2
11218967|NCT01952834|12410615|FG000|STARTED|Overall Study||21
11218968|NCT01952834|12410615|FG000|COMPLETED|Overall Study||20
11218969|NCT01952834|12410615|FG000|NOT COMPLETED|Overall Study||1
11218970|NCT01953003|12410622|FG000|STARTED|Overall Study||56
11218971|NCT01953003|12410623|FG001|STARTED|Overall Study||56
11218972|NCT01953003|12410622|FG000|COMPLETED|Overall Study||0
11218973|NCT01953003|12410623|FG001|COMPLETED|Overall Study||1
11218974|NCT01953003|12410622|FG000|NOT COMPLETED|Overall Study||56
11218975|NCT01953003|12410623|FG001|NOT COMPLETED|Overall Study||55
11218976|NCT01953081|12410631|FG000|STARTED|Overall Study||7
11218977|NCT01953081|12410632|FG001|STARTED|Overall Study||6
11218978|NCT01953081|12410631|FG000|COMPLETED|Overall Study||5
11218979|NCT01953081|12410632|FG001|COMPLETED|Overall Study||3
11218980|NCT01953081|12410631|FG000|NOT COMPLETED|Overall Study||2
11218981|NCT01953081|12410632|FG001|NOT COMPLETED|Overall Study||3
11218982|NCT01953211|12410638|FG000|STARTED|Overall Study|completed prior to clinical trials submission|64
11218983|NCT01953211|12410638|FG000|COMPLETED|Overall Study|completed prior to clinical trials submission|64
11218984|NCT01953211|12410638|FG000|NOT COMPLETED|Overall Study||0
11218985|NCT01953224|12410646|FG000|STARTED|Overall Study||20
11218986|NCT01953224|12410647|FG001|STARTED|Overall Study||20
11218987|NCT01953224|12410646|FG000|COMPLETED|Overall Study||18
11218988|NCT01953224|12410647|FG001|COMPLETED|Overall Study||17
11218989|NCT01953224|12410646|FG000|NOT COMPLETED|Overall Study||2
11218990|NCT01953224|12410647|FG001|NOT COMPLETED|Overall Study||3
11218991|NCT01953237|12410655|FG000|STARTED|Overall Study||10
11218992|NCT01953237|12410656|FG001|STARTED|Overall Study||21
11218993|NCT01953237|12410655|FG000|COMPLETED|Overall Study||10
11218994|NCT01953237|12410656|FG001|COMPLETED|Overall Study||21
11218995|NCT01953237|12410655|FG000|NOT COMPLETED|Overall Study||0
11218996|NCT01953237|12410656|FG001|NOT COMPLETED|Overall Study||0
11218997|NCT01953328|12410670|FG000|STARTED|Overall Study||49
11218998|NCT01953328|12410671|FG001|STARTED|Overall Study||50
11218999|NCT01953328|12410672|FG002|STARTED|Overall Study||50
11219000|NCT01953328|12410673|FG003|STARTED|Overall Study||50
11219001|NCT01953328|12410674|FG004|STARTED|Overall Study||52
11219002|NCT01953328|12410675|FG005|STARTED|Overall Study||51
11219003|NCT01953328|12410676|FG006|STARTED|Overall Study||51
11219004|NCT01953328|12410677|FG007|STARTED|Overall Study||51
11219005|NCT01953328|12410670|FG000|Received Treatment|Overall Study||49
11219006|NCT01953328|12410671|FG001|Received Treatment|Overall Study||50
11219007|NCT01953328|12410672|FG002|Received Treatment|Overall Study||50
11219008|NCT01953328|12410673|FG003|Received Treatment|Overall Study||50
11219009|NCT01953328|12410674|FG004|Received Treatment|Overall Study||52
11219010|NCT01953328|12410675|FG005|Received Treatment|Overall Study||51
11219011|NCT01953328|12410676|FG006|Received Treatment|Overall Study||51
11219012|NCT01953328|12410677|FG007|Received Treatment|Overall Study||51
11219013|NCT01953328|12410670|FG000|COMPLETED|Overall Study||49
11219014|NCT01953328|12410671|FG001|COMPLETED|Overall Study||50
11219015|NCT01953328|12410672|FG002|COMPLETED|Overall Study||50
11219016|NCT01953328|12410673|FG003|COMPLETED|Overall Study||50
11219017|NCT01953328|12410674|FG004|COMPLETED|Overall Study||50
11219018|NCT01953328|12410675|FG005|COMPLETED|Overall Study||51
11219019|NCT01953328|12410676|FG006|COMPLETED|Overall Study||51
11219020|NCT01953328|12410677|FG007|COMPLETED|Overall Study||51
11219021|NCT01953328|12410670|FG000|NOT COMPLETED|Overall Study||0
11219022|NCT01953328|12410671|FG001|NOT COMPLETED|Overall Study||0
11219023|NCT01953328|12410672|FG002|NOT COMPLETED|Overall Study||0
11219024|NCT01953328|12410673|FG003|NOT COMPLETED|Overall Study||0
11219025|NCT01953328|12410674|FG004|NOT COMPLETED|Overall Study||2
11219026|NCT01953328|12410675|FG005|NOT COMPLETED|Overall Study||0
11219027|NCT01953328|12410676|FG006|NOT COMPLETED|Overall Study||0
11219028|NCT01953328|12410677|FG007|NOT COMPLETED|Overall Study||0
11219029|NCT01953354|12410697|FG000|STARTED|Overall Study||9
11219030|NCT01953354|12410698|FG001|STARTED|Overall Study||7
11219031|NCT01953354|12410697|FG000|COMPLETED|Overall Study||8
11219032|NCT01953354|12410698|FG001|COMPLETED|Overall Study||5
11219033|NCT01953354|12410697|FG000|NOT COMPLETED|Overall Study||1
11219034|NCT01953354|12410698|FG001|NOT COMPLETED|Overall Study||2
11219035|NCT01953432|12410706|FG000|STARTED|Overall Study||22
11219036|NCT01953432|12410707|FG001|STARTED|Overall Study||21
11219037|NCT01953432|12410706|FG000|COMPLETED|Overall Study||8
11219038|NCT01953432|12410707|FG001|COMPLETED|Overall Study||6
11219039|NCT01953432|12410706|FG000|NOT COMPLETED|Overall Study||14
11219040|NCT01953432|12410707|FG001|NOT COMPLETED|Overall Study||15
11353433|NCT03056690|12550637|FG000|STARTED|Overall Study||95
11353434|NCT03056690|12550638|FG001|STARTED|Overall Study||91
11353435|NCT03056690|12550637|FG000|Treated|Overall Study||94
11353436|NCT03056690|12550638|FG001|Treated|Overall Study||90
11353437|NCT03056690|12550637|FG000|COMPLETED|Overall Study||81
11353438|NCT03056690|12550638|FG001|COMPLETED|Overall Study||75
11353439|NCT03056690|12550637|FG000|NOT COMPLETED|Overall Study||14
11353440|NCT03056690|12550638|FG001|NOT COMPLETED|Overall Study||16
11353441|NCT03057132|12550644|FG000|STARTED|Overall Study||1
11353442|NCT03057132|12550644|FG000|COMPLETED|Overall Study||1
11353443|NCT03057132|12550644|FG000|NOT COMPLETED|Overall Study||0
11353444|NCT03057366|12550649|FG000|STARTED|Part A||8
11353445|NCT03057366|12550650|FG001|STARTED|Part A||0
11353446|NCT03057366|12550651|FG002|STARTED|Part A||0
11353447|NCT03057366|12550649|FG000|COMPLETED|Part A||8
11353448|NCT03057366|12550650|FG001|COMPLETED|Part A||0
11353449|NCT03057366|12550651|FG002|COMPLETED|Part A||0
11353450|NCT03057366|12550649|FG000|NOT COMPLETED|Part A||0
11219041|NCT01953575|12410716|FG000|STARTED|Overall Study||10
11219042|NCT01953575|12410717|FG001|STARTED|Overall Study||10
11219043|NCT01953575|12410718|FG002|STARTED|Overall Study||10
11219044|NCT01953575|12410716|FG000|COMPLETED|Overall Study||10
11219045|NCT01953575|12410717|FG001|COMPLETED|Overall Study||10
11219046|NCT01953575|12410718|FG002|COMPLETED|Overall Study||10
11219047|NCT01953575|12410716|FG000|NOT COMPLETED|Overall Study||0
11219048|NCT01953575|12410717|FG001|NOT COMPLETED|Overall Study||0
11219049|NCT01953575|12410718|FG002|NOT COMPLETED|Overall Study||0
11219050|NCT01953601|12410729|FG000|STARTED|Part 1 (Base Study)||485
11219051|NCT01953601|12410730|FG001|STARTED|Part 1 (Base Study)||484
11219052|NCT01953601|12410731|FG002|STARTED|Part 1 (Base Study)||485
11219053|NCT01953601|12410729|FG000|Treated|Part 1 (Base Study)||483
11219054|NCT01953601|12410730|FG001|Treated|Part 1 (Base Study)||484
11219055|NCT01953601|12410731|FG002|Treated|Part 1 (Base Study)||484
11219056|NCT01953601|12410729|FG000|COMPLETED|Part 1 (Base Study)||234
11219057|NCT01953601|12410730|FG001|COMPLETED|Part 1 (Base Study)||231
11219058|NCT01953601|12410731|FG002|COMPLETED|Part 1 (Base Study)||239
11219059|NCT01953601|12410729|FG000|NOT COMPLETED|Part 1 (Base Study)||251
11219060|NCT01953601|12410730|FG001|NOT COMPLETED|Part 1 (Base Study)||253
11219061|NCT01953601|12410731|FG002|NOT COMPLETED|Part 1 (Base Study)||246
11219062|NCT01953601|12410729|FG000|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198
11219063|NCT01953601|12410730|FG001|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191
11219064|NCT01953601|12410731|FG002|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204
11219065|NCT01953601|12410729|FG000|Treated|Part 2 (Extension Study)||197
11219066|NCT01953601|12410730|FG001|Treated|Part 2 (Extension Study)||191
11219067|NCT01953601|12410731|FG002|Treated|Part 2 (Extension Study)||204
11219068|NCT01953601|12410729|FG000|COMPLETED|Part 2 (Extension Study)||0
11219069|NCT01953601|12410730|FG001|COMPLETED|Part 2 (Extension Study)||0
11219070|NCT01953601|12410731|FG002|COMPLETED|Part 2 (Extension Study)||0
11219071|NCT01953601|12410729|FG000|NOT COMPLETED|Part 2 (Extension Study)||198
11353451|NCT03057366|12550650|FG001|NOT COMPLETED|Part A||0
11353452|NCT03057366|12550651|FG002|NOT COMPLETED|Part A||0
11353453|NCT03057366|12550649|FG000|STARTED|Part B||0
11353454|NCT03057366|12550650|FG001|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5
11353455|NCT03057366|12550651|FG002|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2
11353456|NCT03057366|12550649|FG000|COMPLETED|Part B||0
11353457|NCT03057366|12550650|FG001|COMPLETED|Part B||5
11353458|NCT03057366|12550651|FG002|COMPLETED|Part B||2
11219072|NCT01953601|12410730|FG001|NOT COMPLETED|Part 2 (Extension Study)||191
11219073|NCT01953601|12410731|FG002|NOT COMPLETED|Part 2 (Extension Study)||204
11219074|NCT01953692|12410751|FG000|STARTED|Overall Study||28
11219075|NCT01953692|12410752|FG001|STARTED|Overall Study||30
11219076|NCT01953692|12410753|FG002|STARTED|Overall Study||31
11219077|NCT01953692|12410754|FG003|STARTED|Overall Study||21
11219078|NCT01953692|12410755|FG004|STARTED|Overall Study||4
11219079|NCT01953692|12410756|FG005|STARTED|Overall Study||22
11219080|NCT01953692|12410757|FG006|STARTED|Overall Study||42
11219081|NCT01953692|12410758|FG007|STARTED|Overall Study||13
11219082|NCT01953692|12410759|FG008|STARTED|Overall Study||6
11098444|NCT01214759|12281966|FG000|28 Days nPEP Completion|Overall Study||85
11098445|NCT01214759|12281966|FG000|COMPLETED|Overall Study||55
11098446|NCT01214759|12281966|FG000|NOT COMPLETED|Overall Study||48
11098447|NCT01214811|12281970|FG000|STARTED|Overall Study||27
11098448|NCT01214811|12281970|FG000|COMPLETED|Overall Study||24
11098449|NCT01214811|12281970|FG000|NOT COMPLETED|Overall Study||3
11098450|NCT01214824|12281974|FG000|STARTED|Overall Study||32
11098451|NCT01214824|12281974|FG000|COMPLETED|Overall Study||29
11098452|NCT01214824|12281974|FG000|NOT COMPLETED|Overall Study||3
11098453|NCT01214837|12281982|FG000|STARTED|Overall Study||249
11098454|NCT01214837|12281983|FG001|STARTED|Overall Study||256
11098455|NCT01214837|12281984|FG002|STARTED|Overall Study||246
11098456|NCT01214837|12281982|FG000|COMPLETED|Overall Study||195
11098457|NCT01214837|12281983|FG001|COMPLETED|Overall Study||192
11098458|NCT01214837|12281984|FG002|COMPLETED|Overall Study||184
11098459|NCT01214837|12281982|FG000|NOT COMPLETED|Overall Study||54
11098460|NCT01214837|12281983|FG001|NOT COMPLETED|Overall Study||64
11219083|NCT01953692|12410751|FG000|COMPLETED|Overall Study||1
11219084|NCT01953692|12410752|FG001|COMPLETED|Overall Study||5
11219085|NCT01953692|12410753|FG002|COMPLETED|Overall Study||11
11219086|NCT01953692|12410754|FG003|COMPLETED|Overall Study||7
11219087|NCT01953692|12410755|FG004|COMPLETED|Overall Study||1
11219088|NCT01953692|12410756|FG005|COMPLETED|Overall Study||4
11219089|NCT01953692|12410757|FG006|COMPLETED|Overall Study||10
11219090|NCT01953692|12410758|FG007|COMPLETED|Overall Study||3
11219091|NCT01953692|12410759|FG008|COMPLETED|Overall Study||1
11219092|NCT01953692|12410751|FG000|NOT COMPLETED|Overall Study||27
11219093|NCT01953692|12410752|FG001|NOT COMPLETED|Overall Study||25
11219094|NCT01953692|12410753|FG002|NOT COMPLETED|Overall Study||20
11219095|NCT01953692|12410754|FG003|NOT COMPLETED|Overall Study||14
11219096|NCT01953692|12410755|FG004|NOT COMPLETED|Overall Study||3
11219097|NCT01953692|12410756|FG005|NOT COMPLETED|Overall Study||18
11219098|NCT01953692|12410757|FG006|NOT COMPLETED|Overall Study||32
11219099|NCT01953692|12410758|FG007|NOT COMPLETED|Overall Study||10
11219100|NCT01953692|12410759|FG008|NOT COMPLETED|Overall Study||5
11219101|NCT01953783|12410789|FG000|STARTED|Overall Study||7
11219102|NCT01953783|12410789|FG000|COMPLETED|Overall Study||5
11219103|NCT01953783|12410789|FG000|NOT COMPLETED|Overall Study||2
11219104|NCT01953874|12410795|FG000|STARTED|Overall Study||65
11219105|NCT01953874|12410796|FG001|STARTED|Overall Study||61
11219106|NCT01953874|12410795|FG000|COMPLETED|Overall Study||65
11219107|NCT01953874|12410796|FG001|COMPLETED|Overall Study||61
11219108|NCT01953874|12410795|FG000|NOT COMPLETED|Overall Study||0
11219109|NCT01953874|12410796|FG001|NOT COMPLETED|Overall Study||0
11219110|NCT01953913|12410803|FG000|STARTED|Overall Study||542
11219111|NCT01953913|12410803|FG000|Treated|Overall Study||541
11219112|NCT01953913|12410803|FG000|COMPLETED|Overall Study||0
11219113|NCT01953913|12410803|FG000|NOT COMPLETED|Overall Study||542
11219114|NCT01954017|12410810|FG000|STARTED|Overall Study||36
11219115|NCT01954017|12410811|FG001|STARTED|Overall Study||33
11219116|NCT01954017|12410812|FG002|STARTED|Overall Study||34
11219117|NCT01954017|12410810|FG000|COMPLETED|Overall Study||31
11219118|NCT01954017|12410811|FG001|COMPLETED|Overall Study||25
11219119|NCT01954017|12410812|FG002|COMPLETED|Overall Study||21
11219120|NCT01954017|12410810|FG000|NOT COMPLETED|Overall Study||5
11219121|NCT01954017|12410811|FG001|NOT COMPLETED|Overall Study||8
11219122|NCT01954017|12410812|FG002|NOT COMPLETED|Overall Study||13
11219123|NCT01954056|12410848|FG000|STARTED|Birth to 60 Days of Life||6
11219124|NCT01954056|12410849|FG001|STARTED|Birth to 60 Days of Life||6
11219125|NCT01954056|12410848|FG000|COMPLETED|Birth to 60 Days of Life||6
11219126|NCT01954056|12410849|FG001|COMPLETED|Birth to 60 Days of Life||6
11219127|NCT01954056|12410848|FG000|NOT COMPLETED|Birth to 60 Days of Life||0
11219128|NCT01954056|12410849|FG001|NOT COMPLETED|Birth to 60 Days of Life||0
11219129|NCT01954056|12410848|FG000|STARTED|Birth to 22-26 Mos. Corrected GA||6
11219130|NCT01954056|12410849|FG001|STARTED|Birth to 22-26 Mos. Corrected GA||6
11219131|NCT01954056|12410848|FG000|COMPLETED|Birth to 22-26 Mos. Corrected GA||5
11219132|NCT01954056|12410849|FG001|COMPLETED|Birth to 22-26 Mos. Corrected GA||6
11219133|NCT01954056|12410848|FG000|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1
11219134|NCT01954056|12410849|FG001|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0
11219135|NCT01954082|12410857|FG000|STARTED|Overall Study||317
11219136|NCT01954082|12410858|FG001|STARTED|Overall Study||321
11219137|NCT01954082|12410857|FG000|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
11219138|NCT01954082|12410858|FG001|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
11219139|NCT01954082|12410857|FG000|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
11219140|NCT01954082|12410858|FG001|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
11219141|NCT01954082|12410857|FG000|NOT COMPLETED|Overall Study||68
11219142|NCT01954082|12410858|FG001|NOT COMPLETED|Overall Study||57
11219143|NCT01954121|12410866|FG000|STARTED|Overall Study||220
11219144|NCT01954121|12410867|FG001|STARTED|Overall Study||216
11219145|NCT01954121|12410866|FG000|COMPLETED|Overall Study||93
11219146|NCT01954121|12410867|FG001|COMPLETED|Overall Study||125
11219147|NCT01954121|12410866|FG000|NOT COMPLETED|Overall Study||127
11219148|NCT01954121|12410867|FG001|NOT COMPLETED|Overall Study||91
11219149|NCT01954251|12410875|FG000|STARTED|Overall Study||413
11219150|NCT01954251|12410876|FG001|STARTED|Overall Study||415
11219151|NCT01954251|12410875|FG000|COMPLETED|Overall Study||400
11219152|NCT01954251|12410876|FG001|COMPLETED|Overall Study||396
11219153|NCT01954251|12410875|FG000|NOT COMPLETED|Overall Study||13
11219154|NCT01954251|12410876|FG001|NOT COMPLETED|Overall Study||19
11219155|NCT01954264|12410883|FG000|STARTED|Overall Study||2421
11219156|NCT01954264|12410883|FG000|COMPLETED|Overall Study||2421
11219157|NCT01954264|12410883|FG000|NOT COMPLETED|Overall Study||0
11219158|NCT01954342|12410904|FG000|STARTED|Overall Study||36
11219159|NCT01954342|12410905|FG001|STARTED|Overall Study||8
11219160|NCT01954342|12410906|FG002|STARTED|Overall Study||10
11219161|NCT01954342|12410907|FG003|STARTED|Overall Study||18
11219162|NCT01954342|12410904|FG000|COMPLETED|Overall Study||36
11219163|NCT01954342|12410905|FG001|COMPLETED|Overall Study||8
11219164|NCT01954342|12410906|FG002|COMPLETED|Overall Study||10
11219165|NCT01954342|12410907|FG003|COMPLETED|Overall Study||0
11219166|NCT01954342|12410904|FG000|NOT COMPLETED|Overall Study||0
11219167|NCT01954342|12410905|FG001|NOT COMPLETED|Overall Study||0
11219168|NCT01954342|12410906|FG002|NOT COMPLETED|Overall Study||0
11219169|NCT01954342|12410907|FG003|NOT COMPLETED|Overall Study||18
11219170|NCT01954394|12410919|FG000|STARTED|Overall Study|Enrolled|331
11219171|NCT01954394|12410920|FG001|STARTED|Overall Study|Enrolled|655
11219172|NCT01954394|12410919|FG000|Treated|Overall Study|Safety population|330
11219173|NCT01954394|12410920|FG001|Treated|Overall Study|Safety population|655
11219174|NCT01954394|12410919|FG000|COMPLETED|Overall Study||301
11219175|NCT01954394|12410920|FG001|COMPLETED|Overall Study||598
11219176|NCT01954394|12410919|FG000|NOT COMPLETED|Overall Study||30
11219177|NCT01954394|12410920|FG001|NOT COMPLETED|Overall Study||57
11219178|NCT01954628|12410930|FG000|STARTED|Overall Study||200
11219179|NCT01954628|12410931|FG001|STARTED|Overall Study||200
11219180|NCT01954628|12410930|FG000|Full Analysis Set (FAS)|Overall Study||200
11219181|NCT01954628|12410931|FG001|Full Analysis Set (FAS)|Overall Study||198
11219182|NCT01954628|12410930|FG000|Safety Set|Overall Study||200
11219183|NCT01954628|12410931|FG001|Safety Set|Overall Study||200
11219184|NCT01954628|12410930|FG000|Pharmacokinetic Population|Overall Study||181
11219185|NCT01954628|12410931|FG001|Pharmacokinetic Population|Overall Study||0
11219186|NCT01954628|12410930|FG000|US 6 Month Ophthalmology Safety Visit|Overall Study||37
11219187|NCT01954628|12410931|FG001|US 6 Month Ophthalmology Safety Visit|Overall Study||32
11219188|NCT01954628|12410930|FG000|COMPLETED|Overall Study||169
11219189|NCT01954628|12410931|FG001|COMPLETED|Overall Study||173
11219190|NCT01954628|12410930|FG000|NOT COMPLETED|Overall Study||31
11219191|NCT01954628|12410931|FG001|NOT COMPLETED|Overall Study||27
11098461|NCT01214837|12281984|FG002|NOT COMPLETED|Overall Study||62
11219192|NCT01954745|12410941|FG000|STARTED|Overall Study||19
11219193|NCT01954745|12410941|FG000|COMPLETED|Overall Study||0
11219194|NCT01954745|12410941|FG000|NOT COMPLETED|Overall Study||19
11219195|NCT01954771|12410948|FG000|STARTED|Overall Study||29
11219196|NCT01954771|12410949|FG001|STARTED|Overall Study||32
11219197|NCT01954771|12410950|FG002|STARTED|Overall Study||28
11219198|NCT01954771|12410948|FG000|COMPLETED|Overall Study||22
11219199|NCT01954771|12410949|FG001|COMPLETED|Overall Study||29
11219200|NCT01954771|12410950|FG002|COMPLETED|Overall Study||25
11219201|NCT01954771|12410948|FG000|NOT COMPLETED|Overall Study||7
11219202|NCT01954771|12410949|FG001|NOT COMPLETED|Overall Study||3
11219203|NCT01954771|12410950|FG002|NOT COMPLETED|Overall Study||3
11219204|NCT01954927|12410963|FG000|STARTED|Overall Study||45
11219205|NCT01954927|12410964|FG001|STARTED|Overall Study||45
11219206|NCT01954927|12410963|FG000|COMPLETED|Overall Study||42
11219207|NCT01954927|12410964|FG001|COMPLETED|Overall Study||44
11219208|NCT01954927|12410963|FG000|NOT COMPLETED|Overall Study||3
11219209|NCT01954927|12410964|FG001|NOT COMPLETED|Overall Study||1
11219210|NCT01955005|12410972|FG000|STARTED|Overall Study||30
11219211|NCT01955005|12410973|FG001|STARTED|Overall Study||30
11219212|NCT01955005|12410972|FG000|COMPLETED|Overall Study||27
11219213|NCT01955005|12410973|FG001|COMPLETED|Overall Study||25
11219214|NCT01955005|12410972|FG000|NOT COMPLETED|Overall Study||3
11219215|NCT01955005|12410973|FG001|NOT COMPLETED|Overall Study||5
11219216|NCT01955044|12410982|FG000|STARTED|Overall Study||10
11219217|NCT01955044|12410983|FG001|STARTED|Overall Study||10
11219218|NCT01955044|12410984|FG002|STARTED|Overall Study||10
11219219|NCT01955044|12410982|FG000|COMPLETED|Overall Study||9
11219220|NCT01955044|12410983|FG001|COMPLETED|Overall Study||9
11219221|NCT01955044|12410984|FG002|COMPLETED|Overall Study||10
11219222|NCT01955044|12410982|FG000|NOT COMPLETED|Overall Study||1
11219223|NCT01955044|12410983|FG001|NOT COMPLETED|Overall Study||1
11219224|NCT01955044|12410984|FG002|NOT COMPLETED|Overall Study||0
11219225|NCT01955083|12410994|FG000|STARTED|Overall Study||15
11219226|NCT01955083|12410995|FG001|STARTED|Overall Study||15
11219227|NCT01955083|12410994|FG000|COMPLETED|Overall Study||14
11219228|NCT01955083|12410995|FG001|COMPLETED|Overall Study||14
11219229|NCT01955083|12410994|FG000|NOT COMPLETED|Overall Study||1
11219230|NCT01955083|12410995|FG001|NOT COMPLETED|Overall Study||1
11219231|NCT01955122|12411027|FG000|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64
11219232|NCT01955122|12411028|FG001|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62
11353459|NCT03057366|12550649|FG000|NOT COMPLETED|Part B||0
11219233|NCT01955122|12411027|FG000|No.Patients Enrolled|Overall Study||64
11219234|NCT01955122|12411028|FG001|No.Patients Enrolled|Overall Study||62
11219235|NCT01955122|12411027|FG000|No. Patients Completed Double Procedure|Overall Study||59
11219236|NCT01955122|12411028|FG001|No. Patients Completed Double Procedure|Overall Study||57
11219237|NCT01955122|12411027|FG000|COMPLETED|Overall Study||59
11219238|NCT01955122|12411028|FG001|COMPLETED|Overall Study||57
11219239|NCT01955122|12411027|FG000|NOT COMPLETED|Overall Study||5
11219240|NCT01955122|12411028|FG001|NOT COMPLETED|Overall Study||5
11219241|NCT01955161|12411043|FG000|STARTED|Overall Study||310
11219242|NCT01955161|12411044|FG001|STARTED|Overall Study||313
11219243|NCT01955161|12411045|FG002|STARTED|Overall Study||310
11219244|NCT01955161|12411043|FG000|Treated|Overall Study||308
11219245|NCT01955161|12411044|FG001|Treated|Overall Study||313
11219246|NCT01955161|12411045|FG002|Treated|Overall Study||309
11219247|NCT01955161|12411043|FG000|COMPLETED|Overall Study||283
11219248|NCT01955161|12411044|FG001|COMPLETED|Overall Study||288
11219249|NCT01955161|12411045|FG002|COMPLETED|Overall Study||275
11219250|NCT01955161|12411043|FG000|NOT COMPLETED|Overall Study||27
11219251|NCT01955161|12411044|FG001|NOT COMPLETED|Overall Study||25
11219252|NCT01955161|12411045|FG002|NOT COMPLETED|Overall Study||35
11219253|NCT01955369|12411053|FG000|STARTED|Overall Study||200
11219254|NCT01955369|12411053|FG000|COMPLETED|Overall Study||200
11219255|NCT01955369|12411053|FG000|NOT COMPLETED|Overall Study||0
11219256|NCT01955382|12411059|FG000|STARTED|Overall Study||35
11219257|NCT01955382|12411060|FG001|STARTED|Overall Study||35
11219258|NCT01955382|12411059|FG000|COMPLETED|Overall Study||35
11219259|NCT01955382|12411060|FG001|COMPLETED|Overall Study||35
11219260|NCT01955382|12411059|FG000|NOT COMPLETED|Overall Study||0
11353460|NCT03057366|12550650|FG001|NOT COMPLETED|Part B||0
11353461|NCT03057366|12550651|FG002|NOT COMPLETED|Part B||0
11353462|NCT03057496|12550661|FG000|STARTED|Overall Study||49
11353463|NCT03057496|12550661|FG000|Started Home-use Trial|Overall Study||36
11353464|NCT03057496|12550661|FG000|COMPLETED|Overall Study||31
11353465|NCT03057496|12550661|FG000|NOT COMPLETED|Overall Study||18
11353466|NCT03057704|12550669|FG000|STARTED|Overall Study||25
11353467|NCT03057704|12550670|FG001|STARTED|Overall Study||25
11353468|NCT03057704|12550669|FG000|COMPLETED|Overall Study||25
11353469|NCT03057704|12550670|FG001|COMPLETED|Overall Study||25
11353470|NCT03057704|12550669|FG000|NOT COMPLETED|Overall Study||0
11353471|NCT03057704|12550670|FG001|NOT COMPLETED|Overall Study||0
11353472|NCT03057977|12550678|FG000|STARTED|Discontinuation From Treatment||1867
11353473|NCT03057977|12550679|FG001|STARTED|Discontinuation From Treatment||1863
11353474|NCT03057977|12550678|FG000|Treated|Discontinuation From Treatment||1863
11219261|NCT01955382|12411060|FG001|NOT COMPLETED|Overall Study||0
11219262|NCT01955434|12411067|FG000|STARTED|Overall Study||25
11219263|NCT01955434|12411067|FG000|COMPLETED|Overall Study||25
11219264|NCT01955434|12411067|FG000|NOT COMPLETED|Overall Study||0
11219265|NCT01955473|12411076|FG000|STARTED|Overall Study||3
11219266|NCT01955473|12411077|FG001|STARTED|Overall Study||6
11219267|NCT01955473|12411078|FG002|STARTED|Overall Study||6
11219268|NCT01955473|12411079|FG003|STARTED|Overall Study||6
11219269|NCT01955473|12411080|FG004|STARTED|Overall Study||30
11219270|NCT01955473|12411076|FG000|COMPLETED|Overall Study||3
11219271|NCT01955473|12411077|FG001|COMPLETED|Overall Study||6
11219272|NCT01955473|12411078|FG002|COMPLETED|Overall Study||6
11219273|NCT01955473|12411079|FG003|COMPLETED|Overall Study||6
11219274|NCT01955473|12411080|FG004|COMPLETED|Overall Study||30
11219275|NCT01955473|12411076|FG000|NOT COMPLETED|Overall Study||0
11219276|NCT01955473|12411077|FG001|NOT COMPLETED|Overall Study||0
11219277|NCT01955473|12411078|FG002|NOT COMPLETED|Overall Study||0
11219278|NCT01955473|12411079|FG003|NOT COMPLETED|Overall Study||0
11219279|NCT01955473|12411080|FG004|NOT COMPLETED|Overall Study||0
11219280|NCT01955564|12411103|FG000|STARTED|Overall Study||18
11219281|NCT01955564|12411104|FG001|STARTED|Overall Study||6
11219282|NCT01955564|12411105|FG002|STARTED|Overall Study||6
11219283|NCT01955564|12411106|FG003|STARTED|Overall Study||6
11219284|NCT01955564|12411107|FG004|STARTED|Overall Study||6
11219285|NCT01955564|12411108|FG005|STARTED|Overall Study||6
11219286|NCT01955564|12411109|FG006|STARTED|Overall Study||6
11219287|NCT01955564|12411103|FG000|COMPLETED|Overall Study||18
11219288|NCT01955564|12411104|FG001|COMPLETED|Overall Study||6
11219289|NCT01955564|12411105|FG002|COMPLETED|Overall Study||6
11353475|NCT03057977|12550679|FG001|Treated|Discontinuation From Treatment||1863
11353476|NCT03057977|12550678|FG000|COMPLETED|Discontinuation From Treatment||1352
11353477|NCT03057977|12550679|FG001|COMPLETED|Discontinuation From Treatment||1381
11353478|NCT03057977|12550678|FG000|NOT COMPLETED|Discontinuation From Treatment||515
11353479|NCT03057977|12550679|FG001|NOT COMPLETED|Discontinuation From Treatment||482
11353480|NCT03057977|12550678|FG000|STARTED|Discontinuation From Trial||1867
11353481|NCT03057977|12550679|FG001|STARTED|Discontinuation From Trial||1863
11353482|NCT03057977|12550678|FG000|Treated|Discontinuation From Trial||1863
11353483|NCT03057977|12550679|FG001|Treated|Discontinuation From Trial||1863
11353484|NCT03057977|12550678|FG000|COMPLETED|Discontinuation From Trial||1847
11353485|NCT03057977|12550679|FG001|COMPLETED|Discontinuation From Trial||1841
11353486|NCT03057977|12550678|FG000|NOT COMPLETED|Discontinuation From Trial||20
11353487|NCT03057977|12550679|FG001|NOT COMPLETED|Discontinuation From Trial||22
11353488|NCT03058679|12550687|FG000|STARTED|Baseline to Week 6|3 randomized to SCD withdrew before starting diet;2 randomized pts w/ baseline sCDAI<150 excluded.|99
11353489|NCT03058679|12550688|FG001|STARTED|Baseline to Week 6|Due to an error 1 participant was randomized with a baseline sCDAI<150. This pt was excluded.|92
11353490|NCT03058679|12550687|FG000|COMPLETED|Baseline to Week 6||81
11353491|NCT03058679|12550688|FG001|COMPLETED|Baseline to Week 6||77
11098462|NCT01214850|12281996|FG000|STARTED|Overall Study||979
11098463|NCT01214850|12281997|FG001|STARTED|Overall Study||988
11098464|NCT01214850|12281998|FG002|STARTED|Overall Study||987
11098465|NCT01214850|12281996|FG000|COMPLETED|Overall Study||796
11098466|NCT01214850|12281997|FG001|COMPLETED|Overall Study||844
11098467|NCT01214850|12281998|FG002|COMPLETED|Overall Study||826
11098468|NCT01214850|12281996|FG000|NOT COMPLETED|Overall Study||183
11098469|NCT01214850|12281997|FG001|NOT COMPLETED|Overall Study||144
11098470|NCT01214850|12281998|FG002|NOT COMPLETED|Overall Study||161
11098471|NCT01214915|12282009|FG000|STARTED|Overall Study||53
11098472|NCT01214915|12282009|FG000|COMPLETED|Overall Study||42
11098473|NCT01214915|12282009|FG000|NOT COMPLETED|Overall Study||11
11098474|NCT01214980|12282015|FG000|STARTED|Overall Study||16
11219290|NCT01955564|12411106|FG003|COMPLETED|Overall Study||6
11219291|NCT01955564|12411107|FG004|COMPLETED|Overall Study||6
11219292|NCT01955564|12411108|FG005|COMPLETED|Overall Study||6
11219293|NCT01955564|12411109|FG006|COMPLETED|Overall Study||6
11219294|NCT01955564|12411103|FG000|NOT COMPLETED|Overall Study||0
11219295|NCT01955564|12411104|FG001|NOT COMPLETED|Overall Study||0
11219296|NCT01955564|12411105|FG002|NOT COMPLETED|Overall Study||0
11219297|NCT01955564|12411106|FG003|NOT COMPLETED|Overall Study||0
11219298|NCT01955564|12411107|FG004|NOT COMPLETED|Overall Study||0
11219299|NCT01955564|12411108|FG005|NOT COMPLETED|Overall Study||0
11353492|NCT03058679|12550687|FG000|NOT COMPLETED|Baseline to Week 6||18
11353493|NCT03058679|12550688|FG001|NOT COMPLETED|Baseline to Week 6||15
11353494|NCT03058679|12550687|FG000|STARTED|Week 6 to Week 12||81
11219300|NCT01955564|12411109|FG006|NOT COMPLETED|Overall Study||0
11219301|NCT01955629|12411131|FG000|STARTED|Overall Study||4
11219302|NCT01955629|12411131|FG000|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
11219303|NCT01955629|12411131|FG000|NOT COMPLETED|Overall Study||0
11219304|NCT01955707|12411137|FG000|STARTED|Overall Study||82
11219305|NCT01955707|12411138|FG001|STARTED|Overall Study||79
11219306|NCT01955707|12411137|FG000|Withdrew Prior to Dosing|Overall Study||0
11219307|NCT01955707|12411138|FG001|Withdrew Prior to Dosing|Overall Study||1
11353495|NCT03058679|12550688|FG001|STARTED|Week 6 to Week 12||77
11353496|NCT03058679|12550687|FG000|COMPLETED|Week 6 to Week 12||61
11353497|NCT03058679|12550688|FG001|COMPLETED|Week 6 to Week 12||60
11353498|NCT03058679|12550687|FG000|NOT COMPLETED|Week 6 to Week 12||20
11353499|NCT03058679|12550688|FG001|NOT COMPLETED|Week 6 to Week 12||17
11353500|NCT03058692|12550696|FG000|STARTED|Overall Study||61
11353501|NCT03058692|12550697|FG001|STARTED|Overall Study||59
11353502|NCT03058692|12550696|FG000|COMPLETED|Overall Study||58
11353503|NCT03058692|12550697|FG001|COMPLETED|Overall Study||57
11098475|NCT01214980|12282016|FG001|STARTED|Overall Study||16
11098476|NCT01214980|12282015|FG000|COMPLETED|Overall Study||13
11098477|NCT01214980|12282016|FG001|COMPLETED|Overall Study||14
11219308|NCT01955707|12411137|FG000|Dosed|Overall Study||82
11219309|NCT01955707|12411138|FG001|Dosed|Overall Study||78
11219310|NCT01955707|12411137|FG000|Received Total Volume of Study Drug|Overall Study||82
11219311|NCT01955707|12411138|FG001|Received Total Volume of Study Drug|Overall Study||77
11219312|NCT01955707|12411137|FG000|COMPLETED|Overall Study||62
11219313|NCT01955707|12411138|FG001|COMPLETED|Overall Study||57
11219314|NCT01955707|12411137|FG000|NOT COMPLETED|Overall Study||20
11219315|NCT01955707|12411138|FG001|NOT COMPLETED|Overall Study||22
11219316|NCT01955720|12411144|FG000|STARTED|Overall Study||13
11219317|NCT01955720|12411145|FG001|STARTED|Overall Study||13
11219318|NCT01955720|12411146|FG002|STARTED|Overall Study||3
11219319|NCT01955720|12411147|FG003|STARTED|Overall Study||3
11219320|NCT01955720|12411148|FG004|STARTED|Overall Study||7
11219321|NCT01955720|12411149|FG005|STARTED|Overall Study||7
11219322|NCT01955720|12411144|FG000|Healthy Subjects Aged 45-64|Overall Study||3
11219323|NCT01955720|12411145|FG001|Healthy Subjects Aged 45-64|Overall Study||3
11219324|NCT01955720|12411146|FG002|Healthy Subjects Aged 45-64|Overall Study||3
11219325|NCT01955720|12411147|FG003|Healthy Subjects Aged 45-64|Overall Study||3
11219326|NCT01955720|12411148|FG004|Healthy Subjects Aged 45-64|Overall Study||0
11219327|NCT01955720|12411149|FG005|Healthy Subjects Aged 45-64|Overall Study||0
11219328|NCT01955720|12411144|FG000|Healthy Subjects Aged 65-80|Overall Study||4
11219329|NCT01955720|12411145|FG001|Healthy Subjects Aged 65-80|Overall Study||4
11219330|NCT01955720|12411146|FG002|Healthy Subjects Aged 65-80|Overall Study||0
11219331|NCT01955720|12411147|FG003|Healthy Subjects Aged 65-80|Overall Study||0
11219332|NCT01955720|12411148|FG004|Healthy Subjects Aged 65-80|Overall Study||4
11219333|NCT01955720|12411149|FG005|Healthy Subjects Aged 65-80|Overall Study||4
11098478|NCT01214980|12282015|FG000|NOT COMPLETED|Overall Study||3
11098479|NCT01214980|12282016|FG001|NOT COMPLETED|Overall Study||2
11098480|NCT01215032|12282022|FG000|STARTED|Overall Study||21
11098481|NCT01215032|12282022|FG000|COMPLETED|Overall Study||1
11098482|NCT01215032|12282022|FG000|NOT COMPLETED|Overall Study||20
11098483|NCT01215097|12282030|FG000|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
11098484|NCT01215097|12282031|FG001|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
11098485|NCT01215097|12282030|FG000|COMPLETED|Overall Study||88
11098486|NCT01215097|12282031|FG001|COMPLETED|Overall Study||191
11098487|NCT01215097|12282030|FG000|NOT COMPLETED|Overall Study||12
11098488|NCT01215097|12282031|FG001|NOT COMPLETED|Overall Study||14
11098489|NCT01215110|12282042|FG000|STARTED|Overall Study||15
11098490|NCT01215110|12282043|FG001|STARTED|Overall Study||15
11098491|NCT01215110|12282044|FG002|STARTED|Overall Study||15
11098492|NCT01215110|12282045|FG003|STARTED|Overall Study||15
11098493|NCT01215110|12282046|FG004|STARTED|Overall Study||8
11098494|NCT01215110|12282042|FG000|COMPLETED|Overall Study||15
11098495|NCT01215110|12282043|FG001|COMPLETED|Overall Study||15
11098496|NCT01215110|12282044|FG002|COMPLETED|Overall Study||13
11098497|NCT01215110|12282045|FG003|COMPLETED|Overall Study||14
11098498|NCT01215110|12282046|FG004|COMPLETED|Overall Study||8
11098499|NCT01215110|12282042|FG000|NOT COMPLETED|Overall Study||0
11098500|NCT01215110|12282043|FG001|NOT COMPLETED|Overall Study||0
11098501|NCT01215110|12282044|FG002|NOT COMPLETED|Overall Study||2
11098502|NCT01215110|12282045|FG003|NOT COMPLETED|Overall Study||1
11098503|NCT01215110|12282046|FG004|NOT COMPLETED|Overall Study||0
11098504|NCT01215123|12282062|FG000|STARTED|Overall Study||28
11098505|NCT01215123|12282062|FG000|COMPLETED|Overall Study||28
11098506|NCT01215123|12282062|FG000|NOT COMPLETED|Overall Study||0
11098507|NCT01215175|12282071|FG000|STARTED|Overall Study||30
11098508|NCT01215175|12282072|FG001|STARTED|Overall Study||30
11098509|NCT01215175|12282073|FG002|STARTED|Overall Study||33
11098510|NCT01215175|12282074|FG003|STARTED|Overall Study||29
11098511|NCT01215175|12282075|FG004|STARTED|Overall Study||28
11098512|NCT01215175|12282071|FG000|Treated|Overall Study||30
11098513|NCT01215175|12282072|FG001|Treated|Overall Study||30
11098514|NCT01215175|12282073|FG002|Treated|Overall Study||33
11098515|NCT01215175|12282074|FG003|Treated|Overall Study||29
11098516|NCT01215175|12282075|FG004|Treated|Overall Study||28
11098517|NCT01215175|12282071|FG000|COMPLETED|Overall Study||30
11098518|NCT01215175|12282072|FG001|COMPLETED|Overall Study||29
11098519|NCT01215175|12282073|FG002|COMPLETED|Overall Study||33
11219334|NCT01955720|12411144|FG000|Subjects With Mild Renal Impairment|Overall Study||3
11219335|NCT01955720|12411145|FG001|Subjects With Mild Renal Impairment|Overall Study||3
11219336|NCT01955720|12411146|FG002|Subjects With Mild Renal Impairment|Overall Study||0
11219337|NCT01955720|12411147|FG003|Subjects With Mild Renal Impairment|Overall Study||0
11098520|NCT01215175|12282074|FG003|COMPLETED|Overall Study||28
11098521|NCT01215175|12282075|FG004|COMPLETED|Overall Study||28
11098522|NCT01215175|12282071|FG000|NOT COMPLETED|Overall Study||0
11098523|NCT01215175|12282072|FG001|NOT COMPLETED|Overall Study||1
11098524|NCT01215175|12282073|FG002|NOT COMPLETED|Overall Study||0
11098525|NCT01215175|12282074|FG003|NOT COMPLETED|Overall Study||1
11098526|NCT01215175|12282075|FG004|NOT COMPLETED|Overall Study||0
11353504|NCT03058692|12550696|FG000|NOT COMPLETED|Overall Study||3
11353505|NCT03058692|12550697|FG001|NOT COMPLETED|Overall Study||2
11353506|NCT03058991|12550707|FG000|STARTED|Overall Study||39
11353507|NCT03058991|12550708|FG001|STARTED|Overall Study||32
11353508|NCT03058991|12550709|FG002|STARTED|Overall Study||37
11098527|NCT01215188|12282090|FG000|STARTED|Overall Study||378
11353509|NCT03058991|12550707|FG000|1-Week Follow Up|Overall Study||23
11353510|NCT03058991|12550708|FG001|1-Week Follow Up|Overall Study||27
11353511|NCT03058991|12550709|FG002|1-Week Follow Up|Overall Study||28
11353512|NCT03058991|12550707|FG000|COMPLETED|Overall Study||21
11353513|NCT03058991|12550708|FG001|COMPLETED|Overall Study||20
11353514|NCT03058991|12550709|FG002|COMPLETED|Overall Study||25
11353515|NCT03058991|12550707|FG000|NOT COMPLETED|Overall Study||18
11353516|NCT03058991|12550708|FG001|NOT COMPLETED|Overall Study||12
11353517|NCT03058991|12550709|FG002|NOT COMPLETED|Overall Study||12
11353518|NCT03059810|12550717|FG000|STARTED|Overall Study||63
11353519|NCT03059810|12550717|FG000|COMPLETED|Overall Study||63
11353520|NCT03059810|12550717|FG000|NOT COMPLETED|Overall Study||0
11353521|NCT03059901|12550723|FG000|STARTED|Overall Study||30
11353522|NCT03059901|12550724|FG001|STARTED|Overall Study||30
11353523|NCT03059901|12550723|FG000|COMPLETED|Overall Study||26
11353524|NCT03059901|12550724|FG001|COMPLETED|Overall Study||28
11353525|NCT03059901|12550723|FG000|NOT COMPLETED|Overall Study||4
11353526|NCT03059901|12550724|FG001|NOT COMPLETED|Overall Study||2
11219338|NCT01955720|12411148|FG004|Subjects With Mild Renal Impairment|Overall Study||3
11219339|NCT01955720|12411149|FG005|Subjects With Mild Renal Impairment|Overall Study||3
11219340|NCT01955720|12411144|FG000|Subjects With Moderate Renal Impairment|Overall Study||3
11219341|NCT01955720|12411145|FG001|Subjects With Moderate Renal Impairment|Overall Study||3
11353527|NCT03060447|12550732|FG000|STARTED|Overall Study||17
11353528|NCT03060447|12550733|FG001|STARTED|Overall Study||8
11353529|NCT03060447|12550732|FG000|COMPLETED|Overall Study||15
11353530|NCT03060447|12550733|FG001|COMPLETED|Overall Study||8
11353531|NCT03060447|12550732|FG000|NOT COMPLETED|Overall Study||2
11353532|NCT03060447|12550733|FG001|NOT COMPLETED|Overall Study||0
11353533|NCT03060486|12550745|FG000|STARTED|Overall Study||15
11353534|NCT03060486|12550745|FG000|COMPLETED|Overall Study||15
11353535|NCT03060486|12550745|FG000|NOT COMPLETED|Overall Study||0
11353536|NCT03060512|12550751|FG000|STARTED|Overall Study||137
11353537|NCT03060512|12550752|FG001|STARTED|Overall Study||139
11219342|NCT01955720|12411146|FG002|Subjects With Moderate Renal Impairment|Overall Study||0
11219343|NCT01955720|12411147|FG003|Subjects With Moderate Renal Impairment|Overall Study||0
11353538|NCT03060512|12550751|FG000|Treated With Movantik|Overall Study||136
11353539|NCT03060512|12550752|FG001|Treated With Movantik|Overall Study||135
11353540|NCT03060512|12550751|FG000|Treated With PEG 3350|Overall Study||130
11353541|NCT03060512|12550752|FG001|Treated With PEG 3350|Overall Study||138
11353542|NCT03060512|12550751|FG000|COMPLETED|Overall Study||130
11353543|NCT03060512|12550752|FG001|COMPLETED|Overall Study||130
11353544|NCT03060512|12550751|FG000|NOT COMPLETED|Overall Study||7
11353545|NCT03060512|12550752|FG001|NOT COMPLETED|Overall Study||9
11353546|NCT03060551|12550763|FG000|STARTED|Overall Study||20
11353547|NCT03060551|12550763|FG000|COMPLETED|Overall Study||18
11353548|NCT03060551|12550763|FG000|NOT COMPLETED|Overall Study||2
11353549|NCT03060759|12550769|FG000|STARTED|Overall Study||20
11353550|NCT03060759|12550770|FG001|STARTED|Overall Study||15
11353551|NCT03060759|12550769|FG000|COMPLETED|Overall Study||15
11353552|NCT03060759|12550770|FG001|COMPLETED|Overall Study||12
11353553|NCT03060759|12550769|FG000|NOT COMPLETED|Overall Study||5
11353554|NCT03060759|12550770|FG001|NOT COMPLETED|Overall Study||3
11353555|NCT03061097|12550778|FG000|STARTED|Overall Study||4
11353556|NCT03061097|12550779|FG001|STARTED|Overall Study||3
11353557|NCT03061097|12550778|FG000|COMPLETED|Overall Study||4
11353558|NCT03061097|12550779|FG001|COMPLETED|Overall Study||0
11353559|NCT03061097|12550778|FG000|NOT COMPLETED|Overall Study||0
11353560|NCT03061097|12550779|FG001|NOT COMPLETED|Overall Study||3
11353561|NCT03061175|12550787|FG000|STARTED|Baseline||47
11353562|NCT03061175|12550788|FG001|STARTED|Baseline||47
11353563|NCT03061175|12550787|FG000|COMPLETED|Baseline||46
11353564|NCT03061175|12550788|FG001|COMPLETED|Baseline||47
11353565|NCT03061175|12550787|FG000|NOT COMPLETED|Baseline||1
11353566|NCT03061175|12550788|FG001|NOT COMPLETED|Baseline||0
11353567|NCT03061175|12550787|FG000|STARTED|Followup 1 at 2-4 Weeks Post-surgery|1 Participant dropped out of the study before the follow-up survey was to be sent|45
11353568|NCT03061175|12550788|FG001|STARTED|Followup 1 at 2-4 Weeks Post-surgery||47
11353569|NCT03061175|12550787|FG000|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|39 participants completed the follow-up survey out of the 45 who were sent the survey|39
11353570|NCT03061175|12550788|FG001|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|44 participants completed the follow-up survey out of the 47 who were sent the survey|44
11353571|NCT03061175|12550787|FG000|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||6
11353572|NCT03061175|12550788|FG001|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||3
11353573|NCT03061175|12550787|FG000|STARTED|Followup 2 at 6 Months|Participants who skipped the first follow-up survey were still sent the second FU survey|45
11353574|NCT03061175|12550788|FG001|STARTED|Followup 2 at 6 Months|1 participant withdrew from the study in between the 1st and 2nd follow-up survey so only 46 sent|46
11353575|NCT03061175|12550787|FG000|COMPLETED|Followup 2 at 6 Months|41 participants completed the 2nd follow-up survey out of the 45 who were sent the survey|41
11353576|NCT03061175|12550788|FG001|COMPLETED|Followup 2 at 6 Months|39 participants completed the follow-up survey out of the 46 who were sent the survey|39
11353577|NCT03061175|12550787|FG000|NOT COMPLETED|Followup 2 at 6 Months||4
11353578|NCT03061175|12550788|FG001|NOT COMPLETED|Followup 2 at 6 Months||7
11353579|NCT03061188|12550798|FG000|STARTED|Completed 1st Cycle||0
11353580|NCT03061188|12550799|FG001|STARTED|Completed 1st Cycle||3
11353581|NCT03061188|12550800|FG002|STARTED|Completed 1st Cycle||6
11098528|NCT01215188|12282091|FG001|STARTED|Overall Study||386
11098529|NCT01215188|12282092|FG002|STARTED|Overall Study||378
11098530|NCT01215188|12282090|FG000|COMPLETED|Overall Study||320
11098531|NCT01215188|12282091|FG001|COMPLETED|Overall Study||327
11098532|NCT01215188|12282092|FG002|COMPLETED|Overall Study||326
11098533|NCT01215188|12282090|FG000|NOT COMPLETED|Overall Study||58
11098534|NCT01215188|12282091|FG001|NOT COMPLETED|Overall Study||59
11098535|NCT01215188|12282092|FG002|NOT COMPLETED|Overall Study||52
11098536|NCT01215227|12282106|FG000|STARTED|Overall Study||218
11098537|NCT01215227|12282107|FG001|STARTED|Overall Study||215
11098538|NCT01215227|12282108|FG002|STARTED|Overall Study||107
11098539|NCT01215227|12282109|FG003|STARTED|Overall Study||97
11098540|NCT01215227|12282110|FG004|STARTED|Overall Study||93
11353582|NCT03061188|12550801|FG003|STARTED|Completed 1st Cycle||6
11353583|NCT03061188|12550798|FG000|COMPLETED|Completed 1st Cycle||0
11353584|NCT03061188|12550799|FG001|COMPLETED|Completed 1st Cycle||3
11353585|NCT03061188|12550800|FG002|COMPLETED|Completed 1st Cycle||6
11353586|NCT03061188|12550801|FG003|COMPLETED|Completed 1st Cycle||6
11353587|NCT03061188|12550798|FG000|NOT COMPLETED|Completed 1st Cycle||0
11353588|NCT03061188|12550799|FG001|NOT COMPLETED|Completed 1st Cycle||0
11353589|NCT03061188|12550800|FG002|NOT COMPLETED|Completed 1st Cycle||0
11353590|NCT03061188|12550801|FG003|NOT COMPLETED|Completed 1st Cycle||0
11353591|NCT03061188|12550798|FG000|STARTED|Went on to Cycle 2 and Beyond||0
11353592|NCT03061188|12550799|FG001|STARTED|Went on to Cycle 2 and Beyond||3
11353593|NCT03061188|12550800|FG002|STARTED|Went on to Cycle 2 and Beyond||6
11353594|NCT03061188|12550801|FG003|STARTED|Went on to Cycle 2 and Beyond||6
11353595|NCT03061188|12550798|FG000|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||0
11353596|NCT03061188|12550799|FG001|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||3
11353597|NCT03061188|12550800|FG002|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
11353598|NCT03061188|12550801|FG003|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
11353599|NCT03061188|12550798|FG000|COMPLETED|Went on to Cycle 2 and Beyond||0
11353600|NCT03061188|12550799|FG001|COMPLETED|Went on to Cycle 2 and Beyond||3
11353601|NCT03061188|12550800|FG002|COMPLETED|Went on to Cycle 2 and Beyond||5
11353602|NCT03061188|12550801|FG003|COMPLETED|Went on to Cycle 2 and Beyond||5
11353603|NCT03061188|12550798|FG000|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
11353604|NCT03061188|12550799|FG001|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
11353605|NCT03061188|12550800|FG002|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
11353606|NCT03061188|12550801|FG003|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
11353607|NCT03061188|12550798|FG000|STARTED|On Follow-up for 3 Years||0
11353608|NCT03061188|12550799|FG001|STARTED|On Follow-up for 3 Years||3
11353609|NCT03061188|12550800|FG002|STARTED|On Follow-up for 3 Years|Patients who received at least one dose of study drug go into follow-up.|6
11353610|NCT03061188|12550801|FG003|STARTED|On Follow-up for 3 Years|Patients who receive at least one dose of study drug go into follow-up.|6
11353611|NCT03061188|12550798|FG000|COMPLETED|On Follow-up for 3 Years||0
11353612|NCT03061188|12550799|FG001|COMPLETED|On Follow-up for 3 Years||0
11353613|NCT03061188|12550800|FG002|COMPLETED|On Follow-up for 3 Years||1
11353614|NCT03061188|12550801|FG003|COMPLETED|On Follow-up for 3 Years||1
11353615|NCT03061188|12550798|FG000|NOT COMPLETED|On Follow-up for 3 Years||0
11353616|NCT03061188|12550799|FG001|NOT COMPLETED|On Follow-up for 3 Years||3
11098541|NCT01215227|12282111|FG005|STARTED|Overall Study||109
11098542|NCT01215227|12282106|FG000|Treated|Overall Study||218
11098543|NCT01215227|12282107|FG001|Treated|Overall Study||215
11098544|NCT01215227|12282108|FG002|Treated|Overall Study||106
11098545|NCT01215227|12282109|FG003|Treated|Overall Study||96
11098546|NCT01215227|12282110|FG004|Treated|Overall Study||93
11098547|NCT01215227|12282111|FG005|Treated|Overall Study||108
11098548|NCT01215227|12282106|FG000|COMPLETED|Overall Study||97
11098549|NCT01215227|12282107|FG001|COMPLETED|Overall Study||96
11098550|NCT01215227|12282108|FG002|COMPLETED|Overall Study||50
11098551|NCT01215227|12282109|FG003|COMPLETED|Overall Study||48
11098552|NCT01215227|12282110|FG004|COMPLETED|Overall Study||45
11098553|NCT01215227|12282111|FG005|COMPLETED|Overall Study||51
11098554|NCT01215227|12282106|FG000|NOT COMPLETED|Overall Study||121
11098555|NCT01215227|12282107|FG001|NOT COMPLETED|Overall Study||119
11098556|NCT01215227|12282108|FG002|NOT COMPLETED|Overall Study||57
11098557|NCT01215227|12282109|FG003|NOT COMPLETED|Overall Study||49
11098558|NCT01215227|12282110|FG004|NOT COMPLETED|Overall Study||48
11098559|NCT01215227|12282111|FG005|NOT COMPLETED|Overall Study||58
11098560|NCT01215240|12282127|FG000|STARTED|Overall Study||10
11098561|NCT01215240|12282128|FG001|STARTED|Overall Study||12
11098562|NCT01215240|12282127|FG000|COMPLETED|Overall Study||10
11098563|NCT01215240|12282128|FG001|COMPLETED|Overall Study||12
11098564|NCT01215240|12282127|FG000|NOT COMPLETED|Overall Study||0
11098565|NCT01215240|12282128|FG001|NOT COMPLETED|Overall Study||0
11098566|NCT01215253|12282136|FG000|STARTED|Overall Study||510
11098567|NCT01215253|12282137|FG001|STARTED|Overall Study||502
11098568|NCT01215253|12282136|FG000|COMPLETED|Overall Study||424
11098569|NCT01215253|12282137|FG001|COMPLETED|Overall Study||439
11098570|NCT01215253|12282136|FG000|NOT COMPLETED|Overall Study||86
11098571|NCT01215253|12282137|FG001|NOT COMPLETED|Overall Study||63
11098572|NCT01215279|12282146|FG000|STARTED|Overall Study||31
11098573|NCT01215279|12282147|FG001|STARTED|Overall Study||32
11098574|NCT01215279|12282146|FG000|COMPLETED|Overall Study||31
11098575|NCT01215279|12282147|FG001|COMPLETED|Overall Study||32
11098576|NCT01215279|12282146|FG000|NOT COMPLETED|Overall Study||0
11098577|NCT01215279|12282147|FG001|NOT COMPLETED|Overall Study||0
11098578|NCT01215292|12282158|FG000|STARTED|Overall Study||8
11098579|NCT01215292|12282159|FG001|STARTED|Overall Study||8
11219344|NCT01955720|12411148|FG004|Subjects With Moderate Renal Impairment|Overall Study||0
11219345|NCT01955720|12411149|FG005|Subjects With Moderate Renal Impairment|Overall Study||0
11219346|NCT01955720|12411144|FG000|COMPLETED|Overall Study||13
11219347|NCT01955720|12411145|FG001|COMPLETED|Overall Study||13
11098580|NCT01215292|12282160|FG002|STARTED|Overall Study||8
11098581|NCT01215292|12282161|FG003|STARTED|Overall Study||8
11098582|NCT01215292|12282162|FG004|STARTED|Overall Study||8
11098583|NCT01215292|12282158|FG000|COMPLETED|Overall Study||8
11098584|NCT01215292|12282159|FG001|COMPLETED|Overall Study||8
11098585|NCT01215292|12282160|FG002|COMPLETED|Overall Study||8
11098586|NCT01215292|12282161|FG003|COMPLETED|Overall Study||8
11098587|NCT01215292|12282162|FG004|COMPLETED|Overall Study||8
11098588|NCT01215292|12282158|FG000|NOT COMPLETED|Overall Study||0
11219348|NCT01955720|12411146|FG002|COMPLETED|Overall Study||3
11219349|NCT01955720|12411147|FG003|COMPLETED|Overall Study||3
11219350|NCT01955720|12411148|FG004|COMPLETED|Overall Study||7
11219351|NCT01955720|12411149|FG005|COMPLETED|Overall Study||7
11219352|NCT01955720|12411144|FG000|NOT COMPLETED|Overall Study||0
11219353|NCT01955720|12411145|FG001|NOT COMPLETED|Overall Study||0
11219354|NCT01955720|12411146|FG002|NOT COMPLETED|Overall Study||0
11219355|NCT01955720|12411147|FG003|NOT COMPLETED|Overall Study||0
11219356|NCT01955720|12411148|FG004|NOT COMPLETED|Overall Study||0
11219357|NCT01955720|12411149|FG005|NOT COMPLETED|Overall Study||0
11219358|NCT01955733|12411198|FG000|STARTED|Period 1||33
11219359|NCT01955733|12411199|FG001|STARTED|Period 1||29
11219360|NCT01955733|12411200|FG002|STARTED|Period 1||29
11219361|NCT01955733|12411198|FG000|COMPLETED|Period 1||32
11219362|NCT01955733|12411199|FG001|COMPLETED|Period 1||29
11219363|NCT01955733|12411200|FG002|COMPLETED|Period 1||29
11219364|NCT01955733|12411198|FG000|NOT COMPLETED|Period 1||1
11219365|NCT01955733|12411199|FG001|NOT COMPLETED|Period 1||0
11219366|NCT01955733|12411200|FG002|NOT COMPLETED|Period 1||0
11098589|NCT01215292|12282159|FG001|NOT COMPLETED|Overall Study||0
11098590|NCT01215292|12282160|FG002|NOT COMPLETED|Overall Study||0
11098591|NCT01215292|12282161|FG003|NOT COMPLETED|Overall Study||0
11098592|NCT01215292|12282162|FG004|NOT COMPLETED|Overall Study||0
11098593|NCT01215318|12282184|FG000|STARTED|Overall Study||20
11098594|NCT01215318|12282185|FG001|STARTED|Overall Study||24
11098595|NCT01215318|12282184|FG000|COMPLETED|Overall Study||20
11098596|NCT01215318|12282185|FG001|COMPLETED|Overall Study||24
11098597|NCT01215318|12282184|FG000|NOT COMPLETED|Overall Study||0
11098598|NCT01215318|12282185|FG001|NOT COMPLETED|Overall Study||0
11098599|NCT01215344|12282195|FG000|STARTED|Overall Study||33
11098600|NCT01215344|12282196|FG001|STARTED|Overall Study||3
11098601|NCT01215344|12282195|FG000|COMPLETED|Overall Study||23
11098602|NCT01215344|12282196|FG001|COMPLETED|Overall Study||3
11098603|NCT01215344|12282195|FG000|NOT COMPLETED|Overall Study||10
11098604|NCT01215344|12282196|FG001|NOT COMPLETED|Overall Study||0
11098605|NCT01215357|12282204|FG000|STARTED|Overall Study||34
11098606|NCT01215357|12282204|FG000|COMPLETED|Overall Study||22
11098607|NCT01215357|12282204|FG000|NOT COMPLETED|Overall Study||12
11098608|NCT01215422|12282212|FG000|STARTED|Overall Study||14
11098609|NCT01215422|12282213|FG001|STARTED|Overall Study||249
11098610|NCT01215422|12282214|FG002|STARTED|Overall Study||196
11219367|NCT01955733|12411198|FG000|STARTED|Period 2||32
11219368|NCT01955733|12411199|FG001|STARTED|Period 2||29
11219369|NCT01955733|12411200|FG002|STARTED|Period 2||29
11219370|NCT01955733|12411198|FG000|COMPLETED|Period 2||20
11219371|NCT01955733|12411199|FG001|COMPLETED|Period 2||10
11219372|NCT01955733|12411200|FG002|COMPLETED|Period 2||8
11219373|NCT01955733|12411198|FG000|NOT COMPLETED|Period 2||12
11219374|NCT01955733|12411199|FG001|NOT COMPLETED|Period 2||19
11219375|NCT01955733|12411200|FG002|NOT COMPLETED|Period 2||21
11219376|NCT01955837|12411210|FG000|STARTED|Overall Study||271
11219377|NCT01955837|12411211|FG001|STARTED|Overall Study||135
11219378|NCT01955837|12411210|FG000|COMPLETED|Overall Study||271
11219379|NCT01955837|12411211|FG001|COMPLETED|Overall Study||135
11219380|NCT01955837|12411210|FG000|NOT COMPLETED|Overall Study||0
11219381|NCT01955837|12411211|FG001|NOT COMPLETED|Overall Study||0
11219382|NCT01955954|12411217|FG000|STARTED|Overall Study||69
11219383|NCT01955954|12411217|FG000|Received Treatment|Overall Study||66
11219384|NCT01955954|12411217|FG000|Completed Treatment|Overall Study||53
11219385|NCT01955954|12411217|FG000|Completed Post-treatment Assessement|Overall Study||48
11219386|NCT01955954|12411217|FG000|Completed 2-month Assessment|Overall Study|Primary endpoint|46
11219387|NCT01955954|12411217|FG000|Completed 6-month Assessement|Overall Study||42
11219388|NCT01955954|12411217|FG000|COMPLETED|Overall Study|12-months|33
11219389|NCT01955954|12411217|FG000|NOT COMPLETED|Overall Study||36
11219390|NCT01956032|12411221|FG000|STARTED|Overall Study||15
11219391|NCT01956032|12411221|FG000|COMPLETED|Overall Study||15
11219392|NCT01956032|12411221|FG000|NOT COMPLETED|Overall Study||0
11219393|NCT01956071|12411225|FG000|STARTED|Overall Study||44
11219394|NCT01956071|12411225|FG000|COMPLETED|Overall Study||44
11219395|NCT01956071|12411225|FG000|NOT COMPLETED|Overall Study||0
11219396|NCT01956097|12411232|FG000|STARTED|Overall Study||30
11219397|NCT01956097|12411233|FG001|STARTED|Overall Study||30
11219398|NCT01956097|12411234|FG002|STARTED|Overall Study||15
11219399|NCT01956097|12411232|FG000|COMPLETED|Overall Study||24
11219400|NCT01956097|12411233|FG001|COMPLETED|Overall Study||28
11219401|NCT01956097|12411234|FG002|COMPLETED|Overall Study||15
11219402|NCT01956097|12411232|FG000|NOT COMPLETED|Overall Study||6
11219403|NCT01956097|12411233|FG001|NOT COMPLETED|Overall Study||2
11219404|NCT01956097|12411234|FG002|NOT COMPLETED|Overall Study||0
11219405|NCT01956123|12411244|FG000|STARTED|COS Cycle 2||252
11219406|NCT01956123|12411245|FG001|STARTED|COS Cycle 2||261
11219407|NCT01956123|12411246|FG002|STARTED|COS Cycle 2||0
11219408|NCT01956123|12411247|FG003|STARTED|COS Cycle 2||0
11219409|NCT01956123|12411244|FG000|COMPLETED|COS Cycle 2||238
11219410|NCT01956123|12411245|FG001|COMPLETED|COS Cycle 2||254
11219411|NCT01956123|12411246|FG002|COMPLETED|COS Cycle 2||0
11219412|NCT01956123|12411247|FG003|COMPLETED|COS Cycle 2||0
11219413|NCT01956123|12411244|FG000|NOT COMPLETED|COS Cycle 2||14
11219414|NCT01956123|12411245|FG001|NOT COMPLETED|COS Cycle 2||7
11219415|NCT01956123|12411246|FG002|NOT COMPLETED|COS Cycle 2||0
11219416|NCT01956123|12411247|FG003|NOT COMPLETED|COS Cycle 2||0
11219417|NCT01956123|12411244|FG000|STARTED|COS Cycle 3||0
11219418|NCT01956123|12411245|FG001|STARTED|COS Cycle 3||0
11219419|NCT01956123|12411246|FG002|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
11219420|NCT01956123|12411247|FG003|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
11219421|NCT01956123|12411244|FG000|COMPLETED|COS Cycle 3||0
11219422|NCT01956123|12411245|FG001|COMPLETED|COS Cycle 3||0
11219423|NCT01956123|12411246|FG002|COMPLETED|COS Cycle 3||89
11219424|NCT01956123|12411247|FG003|COMPLETED|COS Cycle 3||91
11219425|NCT01956123|12411244|FG000|NOT COMPLETED|COS Cycle 3||0
11219426|NCT01956123|12411245|FG001|NOT COMPLETED|COS Cycle 3||0
11219427|NCT01956123|12411246|FG002|NOT COMPLETED|COS Cycle 3||6
11219428|NCT01956123|12411247|FG003|NOT COMPLETED|COS Cycle 3||2
11219429|NCT01956240|12411260|FG000|STARTED|Overall Study||48
11219430|NCT01956240|12411261|FG001|STARTED|Overall Study||49
11219431|NCT01956240|12411260|FG000|COMPLETED|Overall Study||25
11219432|NCT01956240|12411261|FG001|COMPLETED|Overall Study||25
11219433|NCT01956240|12411260|FG000|NOT COMPLETED|Overall Study||23
11219434|NCT01956240|12411261|FG001|NOT COMPLETED|Overall Study||24
11219435|NCT01956279|12411269|FG000|STARTED|Overall Study||82
11219436|NCT01956279|12411270|FG001|STARTED|Overall Study||88
11219437|NCT01956279|12411269|FG000|COMPLETED|Overall Study||68
11219438|NCT01956279|12411270|FG001|COMPLETED|Overall Study||74
11219439|NCT01956279|12411269|FG000|NOT COMPLETED|Overall Study||14
11219440|NCT01956279|12411270|FG001|NOT COMPLETED|Overall Study||14
11219441|NCT01956435|12411276|FG000|STARTED|Overall Study||3
11219442|NCT01956435|12411277|FG001|STARTED|Overall Study||3
11219443|NCT01956435|12411276|FG000|COMPLETED|Overall Study||3
11219444|NCT01956435|12411277|FG001|COMPLETED|Overall Study||3
11219445|NCT01956435|12411276|FG000|NOT COMPLETED|Overall Study||0
11219446|NCT01956435|12411277|FG001|NOT COMPLETED|Overall Study||0
11219447|NCT01956773|12411286|FG000|STARTED|Overall Study||2520
11219448|NCT01956773|12411287|FG001|STARTED|Overall Study||100
11219449|NCT01956773|12411286|FG000|COMPLETED|Overall Study||1892
11219450|NCT01956773|12411287|FG001|COMPLETED|Overall Study||99
11219451|NCT01956773|12411286|FG000|NOT COMPLETED|Overall Study||628
11219452|NCT01956773|12411287|FG001|NOT COMPLETED|Overall Study||1
11219453|NCT01957085|12411293|FG000|STARTED|Overall Study|Per Institutional Review Board requirements, exact dates are not to be reported|366
11219454|NCT01957085|12411293|FG000|COMPLETED|Overall Study|Per Institutional Review Board, exact dates are not to be reported|366
11219455|NCT01957085|12411293|FG000|NOT COMPLETED|Overall Study||0
11219456|NCT01957111|12411300|FG000|STARTED|Overall Study||16
11219457|NCT01957111|12411301|FG001|STARTED|Overall Study||16
11219458|NCT01957111|12411300|FG000|COMPLETED|Overall Study||15
11219459|NCT01957111|12411301|FG001|COMPLETED|Overall Study||15
11219460|NCT01957111|12411300|FG000|NOT COMPLETED|Overall Study||1
11219461|NCT01957111|12411301|FG001|NOT COMPLETED|Overall Study||1
11219462|NCT01957137|12411307|FG000|STARTED|Randomized Portion||30
11219463|NCT01957137|12411307|FG000|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
11219464|NCT01957137|12411307|FG000|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
11219465|NCT01957137|12411307|FG000|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
11219466|NCT01957137|12411307|FG000|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
11219467|NCT01957137|12411307|FG000|COMPLETED|Randomized Portion||28
11219468|NCT01957137|12411307|FG000|NOT COMPLETED|Randomized Portion||2
11219469|NCT01957137|12411307|FG000|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
11219470|NCT01957137|12411307|FG000|COMPLETED|No Stimulation||28
11219471|NCT01957137|12411307|FG000|NOT COMPLETED|No Stimulation||0
11219472|NCT01957150|12411321|FG000|STARTED|Overall Study||142
11219473|NCT01957150|12411322|FG001|STARTED|Overall Study||141
11219474|NCT01957150|12411321|FG000|COMPLETED|Overall Study||87
11219475|NCT01957150|12411322|FG001|COMPLETED|Overall Study||83
11219476|NCT01957150|12411321|FG000|NOT COMPLETED|Overall Study||55
11219477|NCT01957150|12411322|FG001|NOT COMPLETED|Overall Study||58
11219478|NCT01957163|12411331|FG000|STARTED|Overall Study||206
11219479|NCT01957163|12411332|FG001|STARTED|Overall Study||206
11219480|NCT01957163|12411333|FG002|STARTED|Overall Study||207
11219481|NCT01957163|12411331|FG000|COMPLETED|Overall Study||191
11219482|NCT01957163|12411332|FG001|COMPLETED|Overall Study||195
11219483|NCT01957163|12411333|FG002|COMPLETED|Overall Study||189
11219484|NCT01957163|12411331|FG000|NOT COMPLETED|Overall Study||15
11219485|NCT01957163|12411332|FG001|NOT COMPLETED|Overall Study||11
11219486|NCT01957163|12411333|FG002|NOT COMPLETED|Overall Study||18
11219487|NCT01957202|12411341|FG000|STARTED|Treatment Period 1 (8 Days)||3
11219488|NCT01957202|12411342|FG001|STARTED|Treatment Period 1 (8 Days)||6
11219489|NCT01957202|12411343|FG002|STARTED|Treatment Period 1 (8 Days)||6
11219490|NCT01957202|12411344|FG003|STARTED|Treatment Period 1 (8 Days)||3
11219491|NCT01957202|12411345|FG004|STARTED|Treatment Period 1 (8 Days)||3
11219492|NCT01957202|12411346|FG005|STARTED|Treatment Period 1 (8 Days)||2
11219493|NCT01957202|12411347|FG006|STARTED|Treatment Period 1 (8 Days)||3
11219494|NCT01957202|12411348|FG007|STARTED|Treatment Period 1 (8 Days)||3
11219495|NCT01957202|12411349|FG008|STARTED|Treatment Period 1 (8 Days)||3
11219496|NCT01957202|12411350|FG009|STARTED|Treatment Period 1 (8 Days)||6
11219497|NCT01957202|12411351|FG010|STARTED|Treatment Period 1 (8 Days)||3
11219498|NCT01957202|12411352|FG011|STARTED|Treatment Period 1 (8 Days)||6
11219499|NCT01957202|12411353|FG012|STARTED|Treatment Period 1 (8 Days)||3
11219500|NCT01957202|12411354|FG013|STARTED|Treatment Period 1 (8 Days)||3
11219501|NCT01957202|12411355|FG014|STARTED|Treatment Period 1 (8 Days)||6
11219502|NCT01957202|12411356|FG015|STARTED|Treatment Period 1 (8 Days)||3
11219503|NCT01957202|12411357|FG016|STARTED|Treatment Period 1 (8 Days)||6
11219504|NCT01957202|12411358|FG017|STARTED|Treatment Period 1 (8 Days)||3
11219505|NCT01957202|12411341|FG000|COMPLETED|Treatment Period 1 (8 Days)||3
11219506|NCT01957202|12411342|FG001|COMPLETED|Treatment Period 1 (8 Days)||6
11219507|NCT01957202|12411343|FG002|COMPLETED|Treatment Period 1 (8 Days)||6
11219508|NCT01957202|12411344|FG003|COMPLETED|Treatment Period 1 (8 Days)||3
11219509|NCT01957202|12411345|FG004|COMPLETED|Treatment Period 1 (8 Days)||3
11219510|NCT01957202|12411346|FG005|COMPLETED|Treatment Period 1 (8 Days)||2
11219511|NCT01957202|12411347|FG006|COMPLETED|Treatment Period 1 (8 Days)||3
11219512|NCT01957202|12411348|FG007|COMPLETED|Treatment Period 1 (8 Days)||3
11219513|NCT01957202|12411349|FG008|COMPLETED|Treatment Period 1 (8 Days)||3
11219514|NCT01957202|12411350|FG009|COMPLETED|Treatment Period 1 (8 Days)||6
11219515|NCT01957202|12411351|FG010|COMPLETED|Treatment Period 1 (8 Days)||3
11219516|NCT01957202|12411352|FG011|COMPLETED|Treatment Period 1 (8 Days)||6
11219517|NCT01957202|12411353|FG012|COMPLETED|Treatment Period 1 (8 Days)||3
11219518|NCT01957202|12411354|FG013|COMPLETED|Treatment Period 1 (8 Days)||3
11219519|NCT01957202|12411355|FG014|COMPLETED|Treatment Period 1 (8 Days)||6
11219520|NCT01957202|12411356|FG015|COMPLETED|Treatment Period 1 (8 Days)||3
11219521|NCT01957202|12411357|FG016|COMPLETED|Treatment Period 1 (8 Days)||6
11219522|NCT01957202|12411358|FG017|COMPLETED|Treatment Period 1 (8 Days)||3
11219523|NCT01957202|12411341|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219524|NCT01957202|12411342|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219525|NCT01957202|12411343|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219526|NCT01957202|12411344|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219527|NCT01957202|12411345|FG004|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219528|NCT01957202|12411346|FG005|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219529|NCT01957202|12411347|FG006|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219530|NCT01957202|12411348|FG007|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219531|NCT01957202|12411349|FG008|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219532|NCT01957202|12411350|FG009|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219533|NCT01957202|12411351|FG010|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219534|NCT01957202|12411352|FG011|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219535|NCT01957202|12411353|FG012|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219536|NCT01957202|12411354|FG013|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219537|NCT01957202|12411355|FG014|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219538|NCT01957202|12411356|FG015|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219539|NCT01957202|12411357|FG016|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219540|NCT01957202|12411358|FG017|NOT COMPLETED|Treatment Period 1 (8 Days)||0
11219541|NCT01957202|12411341|FG000|STARTED|Washout Period 1 (14 to 28 Days)||3
11219542|NCT01957202|12411342|FG001|STARTED|Washout Period 1 (14 to 28 Days)||6
11219543|NCT01957202|12411343|FG002|STARTED|Washout Period 1 (14 to 28 Days)||6
11219544|NCT01957202|12411344|FG003|STARTED|Washout Period 1 (14 to 28 Days)||3
11219545|NCT01957202|12411345|FG004|STARTED|Washout Period 1 (14 to 28 Days)||3
11098611|NCT01215422|12282215|FG003|STARTED|Overall Study||201
11098612|NCT01215422|12282212|FG000|COMPLETED|Overall Study||6
11098613|NCT01215422|12282213|FG001|COMPLETED|Overall Study||249
11098614|NCT01215422|12282214|FG002|COMPLETED|Overall Study||193
11098615|NCT01215422|12282215|FG003|COMPLETED|Overall Study||193
11098616|NCT01215422|12282212|FG000|NOT COMPLETED|Overall Study||8
11098617|NCT01215422|12282213|FG001|NOT COMPLETED|Overall Study||0
11098618|NCT01215422|12282214|FG002|NOT COMPLETED|Overall Study||3
11098619|NCT01215422|12282215|FG003|NOT COMPLETED|Overall Study||8
11098620|NCT01215435|12282239|FG000|STARTED|Overall Study||122
11098621|NCT01215435|12282240|FG001|STARTED|Overall Study||123
11098622|NCT01215435|12282239|FG000|COMPLETED|Overall Study||103
11098623|NCT01215435|12282240|FG001|COMPLETED|Overall Study||107
11098624|NCT01215435|12282239|FG000|NOT COMPLETED|Overall Study||19
11098625|NCT01215435|12282240|FG001|NOT COMPLETED|Overall Study||16
11098626|NCT01215513|12282246|FG000|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
11219546|NCT01957202|12411346|FG005|STARTED|Washout Period 1 (14 to 28 Days)||2
11219547|NCT01957202|12411347|FG006|STARTED|Washout Period 1 (14 to 28 Days)||3
11219548|NCT01957202|12411348|FG007|STARTED|Washout Period 1 (14 to 28 Days)||3
11219549|NCT01957202|12411349|FG008|STARTED|Washout Period 1 (14 to 28 Days)||3
11219550|NCT01957202|12411350|FG009|STARTED|Washout Period 1 (14 to 28 Days)||6
11219551|NCT01957202|12411351|FG010|STARTED|Washout Period 1 (14 to 28 Days)||3
11219552|NCT01957202|12411352|FG011|STARTED|Washout Period 1 (14 to 28 Days)||6
11219553|NCT01957202|12411353|FG012|STARTED|Washout Period 1 (14 to 28 Days)||3
11219554|NCT01957202|12411354|FG013|STARTED|Washout Period 1 (14 to 28 Days)||3
11219555|NCT01957202|12411355|FG014|STARTED|Washout Period 1 (14 to 28 Days)||6
11219556|NCT01957202|12411356|FG015|STARTED|Washout Period 1 (14 to 28 Days)||3
11219557|NCT01957202|12411357|FG016|STARTED|Washout Period 1 (14 to 28 Days)||6
11219558|NCT01957202|12411358|FG017|STARTED|Washout Period 1 (14 to 28 Days)||3
11219559|NCT01957202|12411341|FG000|COMPLETED|Washout Period 1 (14 to 28 Days)||3
11219560|NCT01957202|12411342|FG001|COMPLETED|Washout Period 1 (14 to 28 Days)||6
11219561|NCT01957202|12411343|FG002|COMPLETED|Washout Period 1 (14 to 28 Days)||6
11098627|NCT01215513|12282246|FG000|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
11353617|NCT03061188|12550800|FG002|NOT COMPLETED|On Follow-up for 3 Years||5
11353618|NCT03061188|12550801|FG003|NOT COMPLETED|On Follow-up for 3 Years||5
11353619|NCT03061214|12550819|FG000|STARTED|Overall Study||288
11353620|NCT03061214|12550820|FG001|STARTED|Overall Study||290
11353621|NCT03061214|12550821|FG002|STARTED|Overall Study||290
11353622|NCT03061214|12550819|FG000|Exposed|Overall Study||287
11353623|NCT03061214|12550820|FG001|Exposed|Overall Study||290
11353624|NCT03061214|12550821|FG002|Exposed|Overall Study||290
11353625|NCT03061214|12550819|FG000|Full Analysis Set (FAS)|Overall Study||288
11353626|NCT03061214|12550820|FG001|Full Analysis Set (FAS)|Overall Study||290
11353627|NCT03061214|12550821|FG002|Full Analysis Set (FAS)|Overall Study||290
11219562|NCT01957202|12411344|FG003|COMPLETED|Washout Period 1 (14 to 28 Days)||3
11219563|NCT01957202|12411345|FG004|COMPLETED|Washout Period 1 (14 to 28 Days)||3
11219564|NCT01957202|12411346|FG005|COMPLETED|Washout Period 1 (14 to 28 Days)||2
11219565|NCT01957202|12411347|FG006|COMPLETED|Washout Period 1 (14 to 28 Days)||3
11098628|NCT01215513|12282246|FG000|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
11353628|NCT03061214|12550819|FG000|Safety Analysis Set (SAS)|Overall Study||287
11353629|NCT03061214|12550820|FG001|Safety Analysis Set (SAS)|Overall Study||290
11353630|NCT03061214|12550821|FG002|Safety Analysis Set (SAS)|Overall Study||290
11353631|NCT03061214|12550819|FG000|COMPLETED|Overall Study||263
11353632|NCT03061214|12550820|FG001|COMPLETED|Overall Study||262
11353633|NCT03061214|12550821|FG002|COMPLETED|Overall Study||280
11353634|NCT03061214|12550819|FG000|NOT COMPLETED|Overall Study||25
11353635|NCT03061214|12550820|FG001|NOT COMPLETED|Overall Study||28
11353636|NCT03061214|12550821|FG002|NOT COMPLETED|Overall Study||10
11353637|NCT03061331|12550831|FG000|STARTED|Treatment Period 1 (8 Weeks)||10
11353638|NCT03061331|12550832|FG001|STARTED|Treatment Period 1 (8 Weeks)||10
11353639|NCT03061331|12550831|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||10
11353640|NCT03061331|12550832|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||10
11353641|NCT03061331|12550831|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
11353642|NCT03061331|12550832|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
11353643|NCT03061331|12550831|FG000|STARTED|Washout Period (8 Weeks)||10
11353644|NCT03061331|12550832|FG001|STARTED|Washout Period (8 Weeks)||10
11353645|NCT03061331|12550831|FG000|COMPLETED|Washout Period (8 Weeks)||8
11353646|NCT03061331|12550832|FG001|COMPLETED|Washout Period (8 Weeks)||9
11353647|NCT03061331|12550831|FG000|NOT COMPLETED|Washout Period (8 Weeks)||2
11353648|NCT03061331|12550832|FG001|NOT COMPLETED|Washout Period (8 Weeks)||1
11353649|NCT03061331|12550831|FG000|STARTED|Treatment Period 2 (8 Weeks)||8
11353650|NCT03061331|12550832|FG001|STARTED|Treatment Period 2 (8 Weeks)||9
11353651|NCT03061331|12550831|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||8
11353652|NCT03061331|12550832|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||9
11353653|NCT03061331|12550831|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
11353654|NCT03061331|12550832|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
11098629|NCT01215513|12282246|FG000|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
11098630|NCT01215513|12282246|FG000|COMPLETED|Overall Study||112
11098631|NCT01215513|12282246|FG000|NOT COMPLETED|Overall Study||45
11098632|NCT01215643|12282256|FG000|STARTED|Overall Study||83
11098633|NCT01215643|12282257|FG001|STARTED|Overall Study||84
11098634|NCT01215643|12282258|FG002|STARTED|Overall Study||94
11098635|NCT01215643|12282259|FG003|STARTED|Overall Study||39
11098636|NCT01215643|12282260|FG004|STARTED|Overall Study||40
11098637|NCT01215643|12282256|FG000|COMPLETED|Overall Study||74
11098638|NCT01215643|12282257|FG001|COMPLETED|Overall Study||80
11098639|NCT01215643|12282258|FG002|COMPLETED|Overall Study||82
11098640|NCT01215643|12282259|FG003|COMPLETED|Overall Study||35
11098641|NCT01215643|12282260|FG004|COMPLETED|Overall Study||29
11098642|NCT01215643|12282256|FG000|NOT COMPLETED|Overall Study||9
11098643|NCT01215643|12282257|FG001|NOT COMPLETED|Overall Study||4
11098644|NCT01215643|12282258|FG002|NOT COMPLETED|Overall Study||12
11098645|NCT01215643|12282259|FG003|NOT COMPLETED|Overall Study||4
11098646|NCT01215643|12282260|FG004|NOT COMPLETED|Overall Study||11
11098647|NCT01215695|12282279|FG000|STARTED|Overall Study||70
11098648|NCT01215695|12282280|FG001|STARTED|Overall Study||70
11098649|NCT01215695|12282279|FG000|COMPLETED|Overall Study||70
11098650|NCT01215695|12282280|FG001|COMPLETED|Overall Study||70
11098651|NCT01215695|12282279|FG000|NOT COMPLETED|Overall Study||0
11098652|NCT01215695|12282280|FG001|NOT COMPLETED|Overall Study||0
11098653|NCT01215721|12282286|FG000|STARTED|Overall Study||40
11098654|NCT01215721|12282286|FG000|COMPLETED|Overall Study||38
11098655|NCT01215721|12282286|FG000|NOT COMPLETED|Overall Study||2
11098656|NCT01215734|12282292|FG000|STARTED|Overall Study||29
11098657|NCT01215734|12282293|FG001|STARTED|Overall Study||15
11098658|NCT01215734|12282292|FG000|COMPLETED|Overall Study||29
11098659|NCT01215734|12282293|FG001|COMPLETED|Overall Study||14
11098660|NCT01215734|12282292|FG000|NOT COMPLETED|Overall Study||0
11098661|NCT01215734|12282293|FG001|NOT COMPLETED|Overall Study||1
11098662|NCT01215786|12282302|FG000|STARTED|Overall Study||21
11098663|NCT01215786|12282303|FG001|STARTED|Overall Study||19
11098664|NCT01215786|12282304|FG002|STARTED|Overall Study||10
11098665|NCT01215786|12282302|FG000|COMPLETED|Overall Study||21
11098666|NCT01215786|12282303|FG001|COMPLETED|Overall Study||19
11098667|NCT01215786|12282304|FG002|COMPLETED|Overall Study||10
11098668|NCT01215786|12282302|FG000|NOT COMPLETED|Overall Study||0
11098669|NCT01215786|12282303|FG001|NOT COMPLETED|Overall Study||0
11098670|NCT01215786|12282304|FG002|NOT COMPLETED|Overall Study||0
11098671|NCT01215851|12282318|FG000|STARTED|Treatment Period||15
11098672|NCT01215851|12282319|FG001|STARTED|Treatment Period||15
11098673|NCT01215851|12282320|FG002|STARTED|Treatment Period||15
11098674|NCT01215851|12282321|FG003|STARTED|Treatment Period||15
11098675|NCT01215851|12282322|FG004|STARTED|Treatment Period||10
11098676|NCT01215851|12282323|FG005|STARTED|Treatment Period||15
11219566|NCT01957202|12411348|FG007|COMPLETED|Washout Period 1 (14 to 28 Days)||3
11219567|NCT01957202|12411349|FG008|COMPLETED|Washout Period 1 (14 to 28 Days)||3
11219568|NCT01957202|12411350|FG009|COMPLETED|Washout Period 1 (14 to 28 Days)||6
11219569|NCT01957202|12411351|FG010|COMPLETED|Washout Period 1 (14 to 28 Days)||3
11219570|NCT01957202|12411352|FG011|COMPLETED|Washout Period 1 (14 to 28 Days)||6
11098677|NCT01215851|12282318|FG000|COMPLETED|Treatment Period||14
11098678|NCT01215851|12282319|FG001|COMPLETED|Treatment Period||14
11098679|NCT01215851|12282320|FG002|COMPLETED|Treatment Period||14
11098680|NCT01215851|12282321|FG003|COMPLETED|Treatment Period||12
11098681|NCT01215851|12282322|FG004|COMPLETED|Treatment Period||10
11098682|NCT01215851|12282323|FG005|COMPLETED|Treatment Period||14
11098683|NCT01215851|12282318|FG000|NOT COMPLETED|Treatment Period||1
11098684|NCT01215851|12282319|FG001|NOT COMPLETED|Treatment Period||1
11098685|NCT01215851|12282320|FG002|NOT COMPLETED|Treatment Period||1
11098686|NCT01215851|12282321|FG003|NOT COMPLETED|Treatment Period||3
11098687|NCT01215851|12282322|FG004|NOT COMPLETED|Treatment Period||0
11098688|NCT01215851|12282323|FG005|NOT COMPLETED|Treatment Period||1
11098689|NCT01215851|12282318|FG000|STARTED|Follow up Period||14
11098690|NCT01215851|12282319|FG001|STARTED|Follow up Period||14
11098691|NCT01215851|12282320|FG002|STARTED|Follow up Period||14
11098692|NCT01215851|12282321|FG003|STARTED|Follow up Period||12
11098693|NCT01215851|12282322|FG004|STARTED|Follow up Period||10
11098694|NCT01215851|12282323|FG005|STARTED|Follow up Period||14
11098695|NCT01215851|12282318|FG000|COMPLETED|Follow up Period||14
11219571|NCT01957202|12411353|FG012|COMPLETED|Washout Period 1 (14 to 28 Days)||3
11219572|NCT01957202|12411354|FG013|COMPLETED|Washout Period 1 (14 to 28 Days)||3
11098696|NCT01215851|12282319|FG001|COMPLETED|Follow up Period||14
11098697|NCT01215851|12282320|FG002|COMPLETED|Follow up Period||14
11098698|NCT01215851|12282321|FG003|COMPLETED|Follow up Period||12
11098699|NCT01215851|12282322|FG004|COMPLETED|Follow up Period||10
11098700|NCT01215851|12282323|FG005|COMPLETED|Follow up Period||13
11098701|NCT01215851|12282318|FG000|NOT COMPLETED|Follow up Period||0
11098702|NCT01215851|12282319|FG001|NOT COMPLETED|Follow up Period||0
11098703|NCT01215851|12282320|FG002|NOT COMPLETED|Follow up Period||0
11098704|NCT01215851|12282321|FG003|NOT COMPLETED|Follow up Period||0
11219573|NCT01957202|12411355|FG014|COMPLETED|Washout Period 1 (14 to 28 Days)||6
11219574|NCT01957202|12411356|FG015|COMPLETED|Washout Period 1 (14 to 28 Days)||3
11219575|NCT01957202|12411357|FG016|COMPLETED|Washout Period 1 (14 to 28 Days)||6
11353655|NCT03061513|12550840|FG000|STARTED|Overall Study||6
11353656|NCT03061513|12550841|FG001|STARTED|Overall Study||5
11353657|NCT03061513|12550840|FG000|COMPLETED|Overall Study||6
11353658|NCT03061513|12550841|FG001|COMPLETED|Overall Study||4
11353659|NCT03061513|12550840|FG000|NOT COMPLETED|Overall Study||0
11353660|NCT03061513|12550841|FG001|NOT COMPLETED|Overall Study||1
11353661|NCT03061812|12550849|FG000|STARTED|Overall Study||148
11353662|NCT03061812|12550850|FG001|STARTED|Overall Study||296
11353663|NCT03061812|12550849|FG000|COMPLETED|Overall Study||148
11353664|NCT03061812|12550850|FG001|COMPLETED|Overall Study||296
11353665|NCT03061812|12550849|FG000|NOT COMPLETED|Overall Study||0
11353666|NCT03061812|12550850|FG001|NOT COMPLETED|Overall Study||0
11353667|NCT03062228|12550856|FG000|STARTED|Overall Study||162
11098705|NCT01215851|12282322|FG004|NOT COMPLETED|Follow up Period||0
11098706|NCT01215851|12282323|FG005|NOT COMPLETED|Follow up Period||1
11098707|NCT01215916|12282347|FG000|STARTED|Overall Study||1
11098708|NCT01215916|12282348|FG001|STARTED|Overall Study||5
11098709|NCT01215916|12282349|FG002|STARTED|Overall Study||3
11098710|NCT01215916|12282350|FG003|STARTED|Overall Study||6
11098711|NCT01215916|12282351|FG004|STARTED|Overall Study||6
11098712|NCT01215916|12282352|FG005|STARTED|Overall Study||4
11098713|NCT01215916|12282353|FG006|STARTED|Overall Study||9
11098714|NCT01215916|12282354|FG007|STARTED|Overall Study||3
11098715|NCT01215916|12282355|FG008|STARTED|Overall Study||2
11098716|NCT01215916|12282347|FG000|Received at Least 1 Dose of Either Drug|Overall Study||1
11098717|NCT01215916|12282348|FG001|Received at Least 1 Dose of Either Drug|Overall Study||5
11098718|NCT01215916|12282349|FG002|Received at Least 1 Dose of Either Drug|Overall Study||3
11098719|NCT01215916|12282350|FG003|Received at Least 1 Dose of Either Drug|Overall Study||6
11098720|NCT01215916|12282351|FG004|Received at Least 1 Dose of Either Drug|Overall Study||6
11098721|NCT01215916|12282352|FG005|Received at Least 1 Dose of Either Drug|Overall Study||4
11098722|NCT01215916|12282353|FG006|Received at Least 1 Dose of Either Drug|Overall Study||9
11098723|NCT01215916|12282354|FG007|Received at Least 1 Dose of Either Drug|Overall Study||3
11098724|NCT01215916|12282355|FG008|Received at Least 1 Dose of Either Drug|Overall Study||2
11098725|NCT01215916|12282347|FG000|COMPLETED|Overall Study||0
11098726|NCT01215916|12282348|FG001|COMPLETED|Overall Study||0
11098727|NCT01215916|12282349|FG002|COMPLETED|Overall Study||0
11098728|NCT01215916|12282350|FG003|COMPLETED|Overall Study||0
11098729|NCT01215916|12282351|FG004|COMPLETED|Overall Study||0
11098730|NCT01215916|12282352|FG005|COMPLETED|Overall Study||0
11098731|NCT01215916|12282353|FG006|COMPLETED|Overall Study||0
11098732|NCT01215916|12282354|FG007|COMPLETED|Overall Study||0
11098733|NCT01215916|12282355|FG008|COMPLETED|Overall Study||0
11098734|NCT01215916|12282347|FG000|NOT COMPLETED|Overall Study||1
11098735|NCT01215916|12282348|FG001|NOT COMPLETED|Overall Study||5
11098736|NCT01215916|12282349|FG002|NOT COMPLETED|Overall Study||3
11098737|NCT01215916|12282350|FG003|NOT COMPLETED|Overall Study||6
11098738|NCT01215916|12282351|FG004|NOT COMPLETED|Overall Study||6
11098739|NCT01215916|12282352|FG005|NOT COMPLETED|Overall Study||4
11098740|NCT01215916|12282353|FG006|NOT COMPLETED|Overall Study||9
11098741|NCT01215916|12282354|FG007|NOT COMPLETED|Overall Study||3
11098742|NCT01215916|12282355|FG008|NOT COMPLETED|Overall Study||2
11098743|NCT01215929|12282381|FG000|STARTED|Overall Study||18
11098744|NCT01215929|12282382|FG001|STARTED|Overall Study||17
11098745|NCT01215929|12282381|FG000|COMPLETED|Overall Study||12
11098746|NCT01215929|12282382|FG001|COMPLETED|Overall Study||12
11098747|NCT01215929|12282381|FG000|NOT COMPLETED|Overall Study||6
11098748|NCT01215929|12282382|FG001|NOT COMPLETED|Overall Study||5
11353668|NCT03062228|12550856|FG000|COMPLETED|Overall Study||162
11098749|NCT01215942|12282390|FG000|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
11098750|NCT01215942|12282391|FG001|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
11098751|NCT01215942|12282390|FG000|COMPLETED|Treatment Period||0
11219576|NCT01957202|12411358|FG017|COMPLETED|Washout Period 1 (14 to 28 Days)||3
11219577|NCT01957202|12411341|FG000|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11098752|NCT01215942|12282391|FG001|COMPLETED|Treatment Period||0
11098753|NCT01215942|12282390|FG000|NOT COMPLETED|Treatment Period||414
11098754|NCT01215942|12282391|FG001|NOT COMPLETED|Treatment Period||672
11353669|NCT03062228|12550856|FG000|NOT COMPLETED|Overall Study||0
11353670|NCT03062267|12550862|FG000|STARTED|Overall Study||12
11353671|NCT03062267|12550863|FG001|STARTED|Overall Study||37
11353672|NCT03062267|12550862|FG000|COMPLETED|Overall Study||10
11353673|NCT03062267|12550863|FG001|COMPLETED|Overall Study||32
11353674|NCT03062267|12550862|FG000|NOT COMPLETED|Overall Study||2
11353675|NCT03062267|12550863|FG001|NOT COMPLETED|Overall Study||5
11353676|NCT03062488|12550872|FG000|STARTED|Overall Study||51
11353677|NCT03062488|12550873|FG001|STARTED|Overall Study||51
11353678|NCT03062488|12550874|FG002|STARTED|Overall Study||41
11353679|NCT03062488|12550872|FG000|COMPLETED|Overall Study||51
11353680|NCT03062488|12550873|FG001|COMPLETED|Overall Study||51
11353681|NCT03062488|12550874|FG002|COMPLETED|Overall Study||41
11353682|NCT03062488|12550872|FG000|NOT COMPLETED|Overall Study||0
11353683|NCT03062488|12550873|FG001|NOT COMPLETED|Overall Study||0
11353684|NCT03062488|12550874|FG002|NOT COMPLETED|Overall Study||0
11353685|NCT03062605|12550884|FG000|STARTED|Overall Study||25
11353686|NCT03062605|12550885|FG001|STARTED|Overall Study||23
11353687|NCT03062605|12550884|FG000|COMPLETED|Overall Study||14
11353688|NCT03062605|12550885|FG001|COMPLETED|Overall Study||13
11353689|NCT03062605|12550884|FG000|NOT COMPLETED|Overall Study||11
11353690|NCT03062605|12550885|FG001|NOT COMPLETED|Overall Study||10
11353691|NCT03062891|12550893|FG000|STARTED|Overall Study||99
11353692|NCT03062891|12550894|FG001|STARTED|Overall Study||100
11353693|NCT03062891|12550893|FG000|Mid-intervention|Overall Study||68
11353694|NCT03062891|12550894|FG001|Mid-intervention|Overall Study||74
11353695|NCT03062891|12550893|FG000|End of Intervention|Overall Study||67
11353696|NCT03062891|12550894|FG001|End of Intervention|Overall Study||78
11353697|NCT03062891|12550893|FG000|Followup|Overall Study||47
11353698|NCT03062891|12550894|FG001|Followup|Overall Study||62
11353699|NCT03062891|12550893|FG000|COMPLETED|Overall Study||47
11353700|NCT03062891|12550894|FG001|COMPLETED|Overall Study||62
11353701|NCT03062891|12550893|FG000|NOT COMPLETED|Overall Study||52
11353702|NCT03062891|12550894|FG001|NOT COMPLETED|Overall Study||38
11353703|NCT03062917|12550906|FG000|STARTED|Overall Study||32
11353704|NCT03062917|12550907|FG001|STARTED|Overall Study||51
11353705|NCT03062917|12550908|FG002|STARTED|Overall Study||49
11353706|NCT03062917|12550909|FG003|STARTED|Overall Study||20
11353707|NCT03062917|12550910|FG004|STARTED|Overall Study||0
11353708|NCT03062917|12550906|FG000|COMPLETED|Overall Study||32
11353709|NCT03062917|12550907|FG001|COMPLETED|Overall Study||51
11353710|NCT03062917|12550908|FG002|COMPLETED|Overall Study||49
11353711|NCT03062917|12550909|FG003|COMPLETED|Overall Study||20
11353712|NCT03062917|12550910|FG004|COMPLETED|Overall Study||0
11353713|NCT03062917|12550906|FG000|NOT COMPLETED|Overall Study||0
11353714|NCT03062917|12550907|FG001|NOT COMPLETED|Overall Study||0
11353715|NCT03062917|12550908|FG002|NOT COMPLETED|Overall Study||0
11353716|NCT03062917|12550909|FG003|NOT COMPLETED|Overall Study||0
11353717|NCT03062917|12550910|FG004|NOT COMPLETED|Overall Study||0
11353718|NCT03063086|12550921|FG000|STARTED|Overall Study||19
11353719|NCT03063086|12550922|FG001|STARTED|Overall Study||20
11353720|NCT03063086|12550923|FG002|STARTED|Overall Study||18
11353721|NCT03063086|12550924|FG003|STARTED|Overall Study||20
11353722|NCT03063086|12550925|FG004|STARTED|Overall Study||20
11353723|NCT03063086|12550926|FG005|STARTED|Overall Study||19
11353724|NCT03063086|12550921|FG000|COMPLETED|Overall Study||16
11353725|NCT03063086|12550922|FG001|COMPLETED|Overall Study||19
11353726|NCT03063086|12550923|FG002|COMPLETED|Overall Study||17
11353727|NCT03063086|12550924|FG003|COMPLETED|Overall Study||17
11353728|NCT03063086|12550925|FG004|COMPLETED|Overall Study||20
11353729|NCT03063086|12550926|FG005|COMPLETED|Overall Study||18
11353730|NCT03063086|12550921|FG000|NOT COMPLETED|Overall Study||3
11353731|NCT03063086|12550922|FG001|NOT COMPLETED|Overall Study||1
11353732|NCT03063086|12550923|FG002|NOT COMPLETED|Overall Study||1
11353733|NCT03063086|12550924|FG003|NOT COMPLETED|Overall Study||3
11353734|NCT03063086|12550925|FG004|NOT COMPLETED|Overall Study||0
11353735|NCT03063086|12550926|FG005|NOT COMPLETED|Overall Study||1
11353736|NCT03063125|12550935|FG000|STARTED|Overall Study||25
11353737|NCT03063125|12550935|FG000|COMPLETED|Overall Study||23
11353738|NCT03063125|12550935|FG000|NOT COMPLETED|Overall Study||2
11353739|NCT03063255|12550941|FG000|STARTED|Overall Study||30
11353740|NCT03063255|12550942|FG001|STARTED|Overall Study||30
11353741|NCT03063255|12550941|FG000|COMPLETED|Overall Study||29
11353742|NCT03063255|12550942|FG001|COMPLETED|Overall Study||30
11353743|NCT03063255|12550941|FG000|NOT COMPLETED|Overall Study||1
11353744|NCT03063255|12550942|FG001|NOT COMPLETED|Overall Study||0
11353745|NCT03063294|12550950|FG000|STARTED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
11353746|NCT03063294|12550951|FG001|STARTED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
11353747|NCT03063294|12550950|FG000|COMPLETED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
11353748|NCT03063294|12550951|FG001|COMPLETED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
11353749|NCT03063294|12550950|FG000|NOT COMPLETED|Overall Study||0
11353750|NCT03063294|12550951|FG001|NOT COMPLETED|Overall Study||0
11353751|NCT03063385|12550959|FG000|STARTED|Overall Study||330
11353752|NCT03063385|12550960|FG001|STARTED|Overall Study||330
11353753|NCT03063385|12550959|FG000|3-month Follow-up|Overall Study||257
11353754|NCT03063385|12550960|FG001|3-month Follow-up|Overall Study||259
11353755|NCT03063385|12550959|FG000|6-month Follow-up|Overall Study||265
11353756|NCT03063385|12550960|FG001|6-month Follow-up|Overall Study||259
11353757|NCT03063385|12550959|FG000|12-month Follow-up|Overall Study||243
11353758|NCT03063385|12550960|FG001|12-month Follow-up|Overall Study||254
11353759|NCT03063385|12550959|FG000|COMPLETED|Overall Study||243
11353760|NCT03063385|12550960|FG001|COMPLETED|Overall Study||254
11353761|NCT03063385|12550959|FG000|NOT COMPLETED|Overall Study||87
11353762|NCT03063385|12550960|FG001|NOT COMPLETED|Overall Study||76
11353763|NCT03063437|12550968|FG000|STARTED|Overall Study||4
11353764|NCT03063437|12550969|FG001|STARTED|Overall Study||5
11353765|NCT03063437|12550968|FG000|COMPLETED|Overall Study||4
11353766|NCT03063437|12550969|FG001|COMPLETED|Overall Study||5
11353767|NCT03063437|12550968|FG000|NOT COMPLETED|Overall Study||0
11353768|NCT03063437|12550969|FG001|NOT COMPLETED|Overall Study||0
11353769|NCT03063476|12550975|FG000|STARTED|Overall Study||2
11353770|NCT03063476|12550975|FG000|COMPLETED|Overall Study||2
11353771|NCT03063476|12550975|FG000|NOT COMPLETED|Overall Study||0
11353772|NCT03064152|12550981|FG000|STARTED|Overall Study||26
11353773|NCT03064152|12550982|FG001|STARTED|Overall Study||23
11353774|NCT03064152|12550981|FG000|COMPLETED|Overall Study||26
11353775|NCT03064152|12550982|FG001|COMPLETED|Overall Study||23
11353776|NCT03064152|12550981|FG000|NOT COMPLETED|Overall Study||0
11353777|NCT03064152|12550982|FG001|NOT COMPLETED|Overall Study||0
11353778|NCT03064438|12550990|FG000|STARTED|Overall Study||27
11353779|NCT03064438|12550991|FG001|STARTED|Overall Study||13
11353780|NCT03064438|12550990|FG000|COMPLETED|Overall Study||26
11353781|NCT03064438|12550991|FG001|COMPLETED|Overall Study||12
11353782|NCT03064438|12550990|FG000|NOT COMPLETED|Overall Study||1
11353783|NCT03064438|12550991|FG001|NOT COMPLETED|Overall Study||1
11353784|NCT03064451|12550997|FG000|STARTED|Overall Study||60
11353785|NCT03064451|12550997|FG000|Safety Population|Overall Study||52
11353786|NCT03064451|12550997|FG000|COMPLETED|Overall Study||46
11353787|NCT03064451|12550997|FG000|NOT COMPLETED|Overall Study||14
11353788|NCT03064841|12551001|FG000|STARTED|Overall Study||1537
11353789|NCT03064841|12551001|FG000|COMPLETED|Overall Study||1520
11353790|NCT03064841|12551001|FG000|NOT COMPLETED|Overall Study||17
11353791|NCT03065023|12551009|FG000|STARTED|Overall Study||3
11353792|NCT03065023|12551010|FG001|STARTED|Overall Study||3
11353793|NCT03065023|12551011|FG002|STARTED|Overall Study||3
11353794|NCT03065023|12551012|FG003|STARTED|Overall Study||6
11353795|NCT03065023|12551013|FG004|STARTED|Overall Study|Group B not started for business reasons.|0
11353796|NCT03065023|12551009|FG000|COMPLETED|Overall Study||1
11353797|NCT03065023|12551010|FG001|COMPLETED|Overall Study||1
11353798|NCT03065023|12551011|FG002|COMPLETED|Overall Study||2
11353799|NCT03065023|12551012|FG003|COMPLETED|Overall Study||3
11353800|NCT03065023|12551013|FG004|COMPLETED|Overall Study||0
11353801|NCT03065023|12551009|FG000|NOT COMPLETED|Overall Study||2
11353802|NCT03065023|12551010|FG001|NOT COMPLETED|Overall Study||2
11353803|NCT03065023|12551011|FG002|NOT COMPLETED|Overall Study||1
11353804|NCT03065023|12551012|FG003|NOT COMPLETED|Overall Study||3
11353805|NCT03065023|12551013|FG004|NOT COMPLETED|Overall Study||0
11353806|NCT03065075|12551025|FG000|STARTED|Overall Study||76
11353807|NCT03065075|12551026|FG001|STARTED|Overall Study||76
11353808|NCT03065075|12551025|FG000|Intent-to-treat Analysis|Overall Study||72
11353809|NCT03065075|12551026|FG001|Intent-to-treat Analysis|Overall Study||74
11353810|NCT03065075|12551025|FG000|As-treated Analysis|Overall Study||69
11353811|NCT03065075|12551026|FG001|As-treated Analysis|Overall Study||77
11353812|NCT03065075|12551025|FG000|COMPLETED|Overall Study||76
11353813|NCT03065075|12551026|FG001|COMPLETED|Overall Study||76
11353814|NCT03065075|12551025|FG000|NOT COMPLETED|Overall Study||0
11353815|NCT03065075|12551026|FG001|NOT COMPLETED|Overall Study||0
11353816|NCT03065179|12551032|FG000|STARTED|Overall Study||25
11353817|NCT03065179|12551032|FG000|COMPLETED|Overall Study||25
11353818|NCT03065179|12551032|FG000|NOT COMPLETED|Overall Study||0
11353819|NCT03065205|12551036|FG000|STARTED|Overall Study||65
11353820|NCT03065205|12551036|FG000|COMPLETED|Overall Study||53
11353821|NCT03065205|12551036|FG000|NOT COMPLETED|Overall Study||12
11353822|NCT03065283|12551043|FG000|STARTED|Overall Study||50
11353823|NCT03065283|12551044|FG001|STARTED|Overall Study||25
11353824|NCT03065283|12551043|FG000|COMPLETED|Overall Study||50
11353825|NCT03065283|12551044|FG001|COMPLETED|Overall Study||25
11353826|NCT03065283|12551043|FG000|NOT COMPLETED|Overall Study||0
11353827|NCT03065283|12551044|FG001|NOT COMPLETED|Overall Study||0
11353828|NCT03065400|12551050|FG000|STARTED|Overall Study||10
11353829|NCT03065400|12551050|FG000|COMPLETED|Overall Study||0
11353830|NCT03065400|12551050|FG000|NOT COMPLETED|Overall Study||10
11353831|NCT03065530|12551058|FG000|STARTED|Overall Study||30
11353832|NCT03065530|12551059|FG001|STARTED|Overall Study||30
11353833|NCT03065530|12551060|FG002|STARTED|Overall Study||30
11353834|NCT03065530|12551061|FG003|STARTED|Overall Study||30
11353835|NCT03065530|12551058|FG000|COMPLETED|Overall Study||28
11353836|NCT03065530|12551059|FG001|COMPLETED|Overall Study||29
11353837|NCT03065530|12551060|FG002|COMPLETED|Overall Study||29
11353838|NCT03065530|12551061|FG003|COMPLETED|Overall Study||28
11353839|NCT03065530|12551058|FG000|NOT COMPLETED|Overall Study||2
11353840|NCT03065530|12551059|FG001|NOT COMPLETED|Overall Study||1
11353841|NCT03065530|12551060|FG002|NOT COMPLETED|Overall Study||1
11353842|NCT03065530|12551061|FG003|NOT COMPLETED|Overall Study||2
11353843|NCT03065647|12551081|FG000|STARTED|Overall Study||3
11353844|NCT03065647|12551082|FG001|STARTED|Overall Study||12
11353845|NCT03065647|12551081|FG000|COMPLETED|Overall Study||3
11353846|NCT03065647|12551082|FG001|COMPLETED|Overall Study||12
11353847|NCT03065647|12551081|FG000|NOT COMPLETED|Overall Study||0
11353848|NCT03065647|12551082|FG001|NOT COMPLETED|Overall Study||0
11353849|NCT03066102|12551088|FG000|STARTED|Overall Study||30
11353850|NCT03066102|12551088|FG000|COMPLETED|Overall Study||30
11353851|NCT03066102|12551088|FG000|NOT COMPLETED|Overall Study||0
11353852|NCT03066193|12551092|FG000|STARTED|Overall Study||17
11353853|NCT03066193|12551092|FG000|COMPLETED|Overall Study||16
11353854|NCT03066193|12551092|FG000|NOT COMPLETED|Overall Study||1
11353855|NCT03066609|12551099|FG000|STARTED|INDUCTION||136
11353856|NCT03066609|12551100|FG001|STARTED|INDUCTION||272
11353857|NCT03066609|12551101|FG002|STARTED|INDUCTION||135
11353858|NCT03066609|12551102|FG003|STARTED|INDUCTION||0
11353859|NCT03066609|12551099|FG000|COMPLETED|INDUCTION||134
11353860|NCT03066609|12551100|FG001|COMPLETED|INDUCTION||270
11353861|NCT03066609|12551101|FG002|COMPLETED|INDUCTION||133
11353862|NCT03066609|12551102|FG003|COMPLETED|INDUCTION||0
11353863|NCT03066609|12551099|FG000|NOT COMPLETED|INDUCTION||2
11353864|NCT03066609|12551100|FG001|NOT COMPLETED|INDUCTION||2
11353865|NCT03066609|12551101|FG002|NOT COMPLETED|INDUCTION||2
11353866|NCT03066609|12551102|FG003|NOT COMPLETED|INDUCTION||0
11353867|NCT03066609|12551099|FG000|STARTED|MAINTENANCE||134
11353868|NCT03066609|12551100|FG001|STARTED|MAINTENANCE||270
11353869|NCT03066609|12551101|FG002|STARTED|MAINTENANCE||4
11353870|NCT03066609|12551102|FG003|STARTED|MAINTENANCE||129
11353871|NCT03066609|12551099|FG000|COMPLETED|MAINTENANCE||127
11353872|NCT03066609|12551100|FG001|COMPLETED|MAINTENANCE||266
11353873|NCT03066609|12551101|FG002|COMPLETED|MAINTENANCE||2
11353874|NCT03066609|12551102|FG003|COMPLETED|MAINTENANCE||126
11353875|NCT03066609|12551099|FG000|NOT COMPLETED|MAINTENANCE||7
11353876|NCT03066609|12551100|FG001|NOT COMPLETED|MAINTENANCE||4
11353877|NCT03066609|12551101|FG002|NOT COMPLETED|MAINTENANCE||2
11353878|NCT03066609|12551102|FG003|NOT COMPLETED|MAINTENANCE||3
11353879|NCT03066609|12551099|FG000|STARTED|OVERALL STUDY||136
11353880|NCT03066609|12551100|FG001|STARTED|OVERALL STUDY||272
11353881|NCT03066609|12551101|FG002|STARTED|OVERALL STUDY||6
11353882|NCT03066609|12551102|FG003|STARTED|OVERALL STUDY||129
11353883|NCT03066609|12551099|FG000|COMPLETED|OVERALL STUDY||126
11353884|NCT03066609|12551100|FG001|COMPLETED|OVERALL STUDY||264
11353885|NCT03066609|12551101|FG002|COMPLETED|OVERALL STUDY||2
11353886|NCT03066609|12551102|FG003|COMPLETED|OVERALL STUDY||124
11353887|NCT03066609|12551099|FG000|NOT COMPLETED|OVERALL STUDY||10
11353888|NCT03066609|12551100|FG001|NOT COMPLETED|OVERALL STUDY||8
11353889|NCT03066609|12551101|FG002|NOT COMPLETED|OVERALL STUDY||4
11353890|NCT03066609|12551102|FG003|NOT COMPLETED|OVERALL STUDY||5
11353891|NCT03066778|12551115|FG000|STARTED|Overall Study||228
11353892|NCT03066778|12551116|FG001|STARTED|Overall Study||225
11353893|NCT03066778|12551115|FG000|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
11353894|NCT03066778|12551116|FG001|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
11353895|NCT03066778|12551115|FG000|COMPLETED|Overall Study||0
11353896|NCT03066778|12551116|FG001|COMPLETED|Overall Study||0
11353897|NCT03066778|12551115|FG000|NOT COMPLETED|Overall Study||228
11098755|NCT01215942|12282390|FG000|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
11098756|NCT01215942|12282391|FG001|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
11098757|NCT01215942|12282390|FG000|COMPLETED|Post-Treatment Follow-Up Period||283
11098758|NCT01215942|12282391|FG001|COMPLETED|Post-Treatment Follow-Up Period||445
11098759|NCT01215942|12282390|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||85
11098760|NCT01215942|12282391|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||146
11219578|NCT01957202|12411342|FG001|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219579|NCT01957202|12411343|FG002|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219580|NCT01957202|12411344|FG003|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219581|NCT01957202|12411345|FG004|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219582|NCT01957202|12411346|FG005|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219583|NCT01957202|12411347|FG006|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219584|NCT01957202|12411348|FG007|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219585|NCT01957202|12411349|FG008|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11098761|NCT01215955|12282412|FG000|STARTED|Overall Study||268
11098762|NCT01215955|12282413|FG001|STARTED|Overall Study||263
11219586|NCT01957202|12411350|FG009|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11353898|NCT03066778|12551116|FG001|NOT COMPLETED|Overall Study||225
11353899|NCT03066804|12551124|FG000|STARTED|Overall Study||1286
11353900|NCT03066804|12551125|FG001|STARTED|Overall Study||1286
11353901|NCT03066804|12551124|FG000|COMPLETED|Overall Study||1235
11353902|NCT03066804|12551125|FG001|COMPLETED|Overall Study||1236
11353903|NCT03066804|12551124|FG000|NOT COMPLETED|Overall Study||51
11353904|NCT03066804|12551125|FG001|NOT COMPLETED|Overall Study||50
11353905|NCT03066830|12551134|FG000|STARTED|Overall Study||254
11353906|NCT03066830|12551135|FG001|STARTED|Overall Study||253
11353907|NCT03066830|12551134|FG000|COMPLETED|Overall Study||221
11219587|NCT01957202|12411351|FG010|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219588|NCT01957202|12411352|FG011|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219589|NCT01957202|12411353|FG012|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219590|NCT01957202|12411354|FG013|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219591|NCT01957202|12411355|FG014|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219592|NCT01957202|12411356|FG015|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219593|NCT01957202|12411357|FG016|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219594|NCT01957202|12411358|FG017|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
11219595|NCT01957202|12411341|FG000|STARTED|Treatment Period 2 (8 Days)||3
11219596|NCT01957202|12411342|FG001|STARTED|Treatment Period 2 (8 Days)||6
11219597|NCT01957202|12411343|FG002|STARTED|Treatment Period 2 (8 Days)||6
11219598|NCT01957202|12411344|FG003|STARTED|Treatment Period 2 (8 Days)||3
11219599|NCT01957202|12411345|FG004|STARTED|Treatment Period 2 (8 Days)||3
11219600|NCT01957202|12411346|FG005|STARTED|Treatment Period 2 (8 Days)||2
11219601|NCT01957202|12411347|FG006|STARTED|Treatment Period 2 (8 Days)||3
11219602|NCT01957202|12411348|FG007|STARTED|Treatment Period 2 (8 Days)||3
11219603|NCT01957202|12411349|FG008|STARTED|Treatment Period 2 (8 Days)||3
11219604|NCT01957202|12411350|FG009|STARTED|Treatment Period 2 (8 Days)||6
11219605|NCT01957202|12411351|FG010|STARTED|Treatment Period 2 (8 Days)||3
11219606|NCT01957202|12411352|FG011|STARTED|Treatment Period 2 (8 Days)||6
11219607|NCT01957202|12411353|FG012|STARTED|Treatment Period 2 (8 Days)||3
11219608|NCT01957202|12411354|FG013|STARTED|Treatment Period 2 (8 Days)||3
11219609|NCT01957202|12411355|FG014|STARTED|Treatment Period 2 (8 Days)||6
11219610|NCT01957202|12411356|FG015|STARTED|Treatment Period 2 (8 Days)||3
11219611|NCT01957202|12411357|FG016|STARTED|Treatment Period 2 (8 Days)||6
11219612|NCT01957202|12411358|FG017|STARTED|Treatment Period 2 (8 Days)||3
11219613|NCT01957202|12411341|FG000|COMPLETED|Treatment Period 2 (8 Days)||3
11219614|NCT01957202|12411342|FG001|COMPLETED|Treatment Period 2 (8 Days)||5
11219615|NCT01957202|12411343|FG002|COMPLETED|Treatment Period 2 (8 Days)||6
11219616|NCT01957202|12411344|FG003|COMPLETED|Treatment Period 2 (8 Days)||3
11219617|NCT01957202|12411345|FG004|COMPLETED|Treatment Period 2 (8 Days)||3
11219618|NCT01957202|12411346|FG005|COMPLETED|Treatment Period 2 (8 Days)||2
11219619|NCT01957202|12411347|FG006|COMPLETED|Treatment Period 2 (8 Days)||3
11219620|NCT01957202|12411348|FG007|COMPLETED|Treatment Period 2 (8 Days)||3
11098763|NCT01215955|12282414|FG002|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
11098764|NCT01215955|12282415|FG003|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
11098765|NCT01215955|12282412|FG000|Received at Least 1 Dose of Study Drug|Overall Study||267
11098766|NCT01215955|12282413|FG001|Received at Least 1 Dose of Study Drug|Overall Study||261
11098767|NCT01215955|12282414|FG002|Received at Least 1 Dose of Study Drug|Overall Study||288
11098768|NCT01215955|12282415|FG003|Received at Least 1 Dose of Study Drug|Overall Study||290
11098769|NCT01215955|12282412|FG000|COMPLETED|Overall Study||223
11098770|NCT01215955|12282413|FG001|COMPLETED|Overall Study||210
11098771|NCT01215955|12282414|FG002|COMPLETED|Overall Study||244
11098772|NCT01215955|12282415|FG003|COMPLETED|Overall Study||241
11098773|NCT01215955|12282412|FG000|NOT COMPLETED|Overall Study||45
11098774|NCT01215955|12282413|FG001|NOT COMPLETED|Overall Study||53
11098775|NCT01215955|12282414|FG002|NOT COMPLETED|Overall Study||48
11098776|NCT01215955|12282415|FG003|NOT COMPLETED|Overall Study||53
11098777|NCT01215968|12282430|FG000|STARTED|Overall Study||13
11098778|NCT01215968|12282431|FG001|STARTED|Overall Study||25
11098779|NCT01215968|12282430|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13
11098780|NCT01215968|12282431|FG001|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
11098781|NCT01215968|12282430|FG000|COMPLETED|Overall Study||11
11098782|NCT01215968|12282431|FG001|COMPLETED|Overall Study||18
11098783|NCT01215968|12282430|FG000|NOT COMPLETED|Overall Study||2
11098784|NCT01215968|12282431|FG001|NOT COMPLETED|Overall Study||7
11098785|NCT01215981|12282442|FG000|STARTED|Overall Study||35
11098786|NCT01215981|12282443|FG001|STARTED|Overall Study||33
11098787|NCT01215981|12282442|FG000|COMPLETED|Overall Study||33
11098788|NCT01215981|12282443|FG001|COMPLETED|Overall Study||32
11098789|NCT01215981|12282442|FG000|NOT COMPLETED|Overall Study||2
11098790|NCT01215981|12282443|FG001|NOT COMPLETED|Overall Study||1
11098791|NCT01216072|12282451|FG000|STARTED|Open-Label Core Period ( 6 Months)||790
11098792|NCT01216072|12282452|FG001|STARTED|Open-Label Core Period ( 6 Months)||263
11098793|NCT01216072|12282451|FG000|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
11098794|NCT01216072|12282452|FG001|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
11098795|NCT01216072|12282451|FG000|Safety Set|Open-Label Core Period ( 6 Months)||783
11098796|NCT01216072|12282452|FG001|Safety Set|Open-Label Core Period ( 6 Months)||245
11098797|NCT01216072|12282451|FG000|COMPLETED|Open-Label Core Period ( 6 Months)||714
11098798|NCT01216072|12282452|FG001|COMPLETED|Open-Label Core Period ( 6 Months)||229
11098799|NCT01216072|12282451|FG000|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
11098800|NCT01216072|12282452|FG001|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
11098801|NCT01216072|12282451|FG000|STARTED|Open-Label Extension Period (3 Months)||0
11098802|NCT01216072|12282452|FG001|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
11098803|NCT01216072|12282451|FG000|Safety Set|Open-Label Extension Period (3 Months)||0
11098804|NCT01216072|12282452|FG001|Safety Set|Open-Label Extension Period (3 Months)||193
11098805|NCT01216072|12282451|FG000|COMPLETED|Open-Label Extension Period (3 Months)||0
11098806|NCT01216072|12282452|FG001|COMPLETED|Open-Label Extension Period (3 Months)||181
11098807|NCT01216072|12282451|FG000|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
11098808|NCT01216072|12282452|FG001|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
11098809|NCT01216163|12282464|FG000|STARTED|Overall Study||45
11098810|NCT01216163|12282465|FG001|STARTED|Overall Study||88
11098811|NCT01216163|12282466|FG002|STARTED|Overall Study||85
11098812|NCT01216163|12282464|FG000|COMPLETED|Overall Study||44
11098813|NCT01216163|12282465|FG001|COMPLETED|Overall Study||87
11098814|NCT01216163|12282466|FG002|COMPLETED|Overall Study||85
11098815|NCT01216163|12282464|FG000|NOT COMPLETED|Overall Study||1
11098816|NCT01216163|12282465|FG001|NOT COMPLETED|Overall Study||1
11098817|NCT01216163|12282466|FG002|NOT COMPLETED|Overall Study||0
11098818|NCT01216176|12282477|FG000|STARTED|Overall Study||12
11098819|NCT01216176|12282478|FG001|STARTED|Overall Study||39
11098820|NCT01216176|12282479|FG002|STARTED|Overall Study||20
11098821|NCT01216176|12282477|FG000|COMPLETED|Overall Study||12
11098822|NCT01216176|12282478|FG001|COMPLETED|Overall Study||31
11098823|NCT01216176|12282479|FG002|COMPLETED|Overall Study||19
11098824|NCT01216176|12282477|FG000|NOT COMPLETED|Overall Study||0
11098825|NCT01216176|12282478|FG001|NOT COMPLETED|Overall Study||8
11098826|NCT01216176|12282479|FG002|NOT COMPLETED|Overall Study||1
11098827|NCT01216189|12282490|FG000|STARTED|Overall Study||110
11098828|NCT01216189|12282491|FG001|STARTED|Overall Study||32
11098829|NCT01216189|12282490|FG000|COMPLETED|Overall Study||85
11098830|NCT01216189|12282491|FG001|COMPLETED|Overall Study||27
11098831|NCT01216189|12282490|FG000|NOT COMPLETED|Overall Study||25
11098832|NCT01216189|12282491|FG001|NOT COMPLETED|Overall Study||5
11098833|NCT01216202|12282499|FG000|STARTED|Overall Study||101
11098834|NCT01216202|12282500|FG001|STARTED|Overall Study||77
11098835|NCT01216202|12282499|FG000|Analysed at Baseline|Overall Study||93
11098836|NCT01216202|12282500|FG001|Analysed at Baseline|Overall Study||75
11098837|NCT01216202|12282499|FG000|Analysed After RT|Overall Study||79
11098838|NCT01216202|12282500|FG001|Analysed After RT|Overall Study||0
11098839|NCT01216202|12282499|FG000|COMPLETED|Overall Study||79
11098840|NCT01216202|12282500|FG001|COMPLETED|Overall Study||75
11098841|NCT01216202|12282499|FG000|NOT COMPLETED|Overall Study||22
11098842|NCT01216202|12282500|FG001|NOT COMPLETED|Overall Study||2
11098843|NCT01216241|12282510|FG000|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
11098844|NCT01216241|12282511|FG001|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
11098845|NCT01216241|12282510|FG000|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
11098846|NCT01216241|12282511|FG001|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
11098847|NCT01216241|12282510|FG000|NOT COMPLETED|Overall Study||0
11098848|NCT01216241|12282511|FG001|NOT COMPLETED|Overall Study||0
11098849|NCT01216319|12282517|FG000|STARTED|Overall Study||50
11098850|NCT01216319|12282517|FG000|COMPLETED|Overall Study||46
11098851|NCT01216319|12282517|FG000|NOT COMPLETED|Overall Study||4
11098852|NCT01216332|12282523|FG000|STARTED|Overall Study||34
11098853|NCT01216332|12282524|FG001|STARTED|Overall Study||16
11098854|NCT01216332|12282523|FG000|COMPLETED|Overall Study||30
11098855|NCT01216332|12282524|FG001|COMPLETED|Overall Study||16
11098856|NCT01216332|12282523|FG000|NOT COMPLETED|Overall Study||4
11098857|NCT01216332|12282524|FG001|NOT COMPLETED|Overall Study||0
11098858|NCT01216397|12282530|FG000|STARTED|Period 1||20
11098859|NCT01216397|12282531|FG001|STARTED|Period 1||20
11098860|NCT01216397|12282530|FG000|COMPLETED|Period 1||20
11098861|NCT01216397|12282531|FG001|COMPLETED|Period 1||20
11098862|NCT01216397|12282530|FG000|NOT COMPLETED|Period 1||0
11098863|NCT01216397|12282531|FG001|NOT COMPLETED|Period 1||0
11098864|NCT01216397|12282530|FG000|STARTED|Washout (35 Days)||20
11098865|NCT01216397|12282531|FG001|STARTED|Washout (35 Days)||20
11098866|NCT01216397|12282530|FG000|COMPLETED|Washout (35 Days)||20
11098867|NCT01216397|12282531|FG001|COMPLETED|Washout (35 Days)||20
11098868|NCT01216397|12282530|FG000|NOT COMPLETED|Washout (35 Days)||0
11098869|NCT01216397|12282531|FG001|NOT COMPLETED|Washout (35 Days)||0
11098870|NCT01216397|12282530|FG000|STARTED|Period 2||20
11098871|NCT01216397|12282531|FG001|STARTED|Period 2||20
11098872|NCT01216397|12282530|FG000|COMPLETED|Period 2||20
11098873|NCT01216397|12282531|FG001|COMPLETED|Period 2||20
11098874|NCT01216397|12282530|FG000|NOT COMPLETED|Period 2||0
11219621|NCT01957202|12411349|FG008|COMPLETED|Treatment Period 2 (8 Days)||3
11219622|NCT01957202|12411350|FG009|COMPLETED|Treatment Period 2 (8 Days)||6
11219623|NCT01957202|12411351|FG010|COMPLETED|Treatment Period 2 (8 Days)||3
11219624|NCT01957202|12411352|FG011|COMPLETED|Treatment Period 2 (8 Days)||6
11219625|NCT01957202|12411353|FG012|COMPLETED|Treatment Period 2 (8 Days)||3
11219626|NCT01957202|12411354|FG013|COMPLETED|Treatment Period 2 (8 Days)||3
11219627|NCT01957202|12411355|FG014|COMPLETED|Treatment Period 2 (8 Days)||6
11219628|NCT01957202|12411356|FG015|COMPLETED|Treatment Period 2 (8 Days)||3
11219629|NCT01957202|12411357|FG016|COMPLETED|Treatment Period 2 (8 Days)||5
11219630|NCT01957202|12411358|FG017|COMPLETED|Treatment Period 2 (8 Days)||3
11098875|NCT01216397|12282531|FG001|NOT COMPLETED|Period 2||0
11098876|NCT01216410|12282540|FG000|STARTED|Overall Study||103
11098877|NCT01216410|12282541|FG001|STARTED|Overall Study||100
11098878|NCT01216410|12282542|FG002|STARTED|Overall Study||103
11098879|NCT01216410|12282540|FG000|COMPLETED|Overall Study||101
11098880|NCT01216410|12282541|FG001|COMPLETED|Overall Study||99
11098881|NCT01216410|12282542|FG002|COMPLETED|Overall Study||100
11098882|NCT01216410|12282540|FG000|NOT COMPLETED|Overall Study||2
11098883|NCT01216410|12282541|FG001|NOT COMPLETED|Overall Study||1
11353908|NCT03066830|12551135|FG001|COMPLETED|Overall Study||231
11353909|NCT03066830|12551134|FG000|NOT COMPLETED|Overall Study||33
11353910|NCT03066830|12551135|FG001|NOT COMPLETED|Overall Study||22
11098884|NCT01216410|12282542|FG002|NOT COMPLETED|Overall Study||3
11098885|NCT01216735|12282552|FG000|STARTED|First Intervention (3 Weeks)||8
11353911|NCT03066947|12551142|FG000|STARTED|Overall Study||24
11353912|NCT03066947|12551142|FG000|COMPLETED|Overall Study||14
11353913|NCT03066947|12551142|FG000|NOT COMPLETED|Overall Study||10
11353914|NCT03066999|12551149|FG000|STARTED|Overall Study||2
11353915|NCT03066999|12551150|FG001|STARTED|Overall Study||3
11353916|NCT03066999|12551149|FG000|COMPLETED|Overall Study||2
11353917|NCT03066999|12551150|FG001|COMPLETED|Overall Study||1
11353918|NCT03066999|12551149|FG000|NOT COMPLETED|Overall Study||0
11353919|NCT03066999|12551150|FG001|NOT COMPLETED|Overall Study||2
11353920|NCT03067311|12551159|FG000|STARTED|Overall Study||19
11353921|NCT03067311|12551160|FG001|STARTED|Overall Study||19
11353922|NCT03067311|12551159|FG000|COMPLETED|Overall Study||17
11353923|NCT03067311|12551160|FG001|COMPLETED|Overall Study||17
11353924|NCT03067311|12551159|FG000|NOT COMPLETED|Overall Study||2
11353925|NCT03067311|12551160|FG001|NOT COMPLETED|Overall Study||2
11353926|NCT03067441|12551168|FG000|STARTED|Overall Study||492
11353927|NCT03067441|12551169|FG001|STARTED|Overall Study||970
11353928|NCT03067441|12551168|FG000|COMPLETED|Overall Study||459
11353929|NCT03067441|12551169|FG001|COMPLETED|Overall Study||913
11353930|NCT03067441|12551168|FG000|NOT COMPLETED|Overall Study||33
11353931|NCT03067441|12551169|FG001|NOT COMPLETED|Overall Study||57
11353932|NCT03067506|12551178|FG000|STARTED|Overall Study||30
11353933|NCT03067506|12551178|FG000|COMPLETED|Overall Study||30
11353934|NCT03067506|12551178|FG000|NOT COMPLETED|Overall Study||0
11098886|NCT01216735|12282553|FG001|STARTED|First Intervention (3 Weeks)||7
11098887|NCT01216735|12282552|FG000|COMPLETED|First Intervention (3 Weeks)||8
11098888|NCT01216735|12282553|FG001|COMPLETED|First Intervention (3 Weeks)||7
11098889|NCT01216735|12282552|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
11098890|NCT01216735|12282553|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
11098891|NCT01216735|12282552|FG000|STARTED|Washout (3 Weeks)||8
11098892|NCT01216735|12282553|FG001|STARTED|Washout (3 Weeks)||7
11098893|NCT01216735|12282552|FG000|COMPLETED|Washout (3 Weeks)||8
11098894|NCT01216735|12282553|FG001|COMPLETED|Washout (3 Weeks)||7
11098895|NCT01216735|12282552|FG000|NOT COMPLETED|Washout (3 Weeks)||0
11098896|NCT01216735|12282553|FG001|NOT COMPLETED|Washout (3 Weeks)||0
11098897|NCT01216735|12282552|FG000|STARTED|Second Intervention (3 Weeks)||8
11098898|NCT01216735|12282553|FG001|STARTED|Second Intervention (3 Weeks)||7
11098899|NCT01216735|12282552|FG000|COMPLETED|Second Intervention (3 Weeks)||8
11098900|NCT01216735|12282553|FG001|COMPLETED|Second Intervention (3 Weeks)||7
11098901|NCT01216735|12282552|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
11098902|NCT01216735|12282553|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
11098903|NCT01216748|12282559|FG000|STARTED|Overall Study||10
11098904|NCT01216748|12282559|FG000|Quiet Breathing|Overall Study||10
11098905|NCT01216748|12282559|FG000|Hypocapnic Hyperventilation|Overall Study||10
11098906|NCT01216748|12282559|FG000|Hypercapnic Hyperventilation|Overall Study||10
11098907|NCT01216748|12282559|FG000|Eucapnic Hyperventilation|Overall Study||10
11098908|NCT01216748|12282559|FG000|COMPLETED|Overall Study||10
11098909|NCT01216748|12282559|FG000|NOT COMPLETED|Overall Study||0
11098910|NCT01216761|12282563|FG000|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
11219631|NCT01957202|12411341|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11098911|NCT01216761|12282564|FG001|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
11098912|NCT01216761|12282565|FG002|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
11098913|NCT01216761|12282563|FG000|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
11098914|NCT01216761|12282564|FG001|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
11098915|NCT01216761|12282565|FG002|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
11098916|NCT01216761|12282563|FG000|NOT COMPLETED|Overall Study||0
11098917|NCT01216761|12282564|FG001|NOT COMPLETED|Overall Study||0
11098918|NCT01216761|12282565|FG002|NOT COMPLETED|Overall Study||0
11098919|NCT01216943|12282573|FG000|STARTED|Overall Study||126
11098920|NCT01216943|12282573|FG000|COMPLETED|Overall Study||113
11098921|NCT01216943|12282573|FG000|NOT COMPLETED|Overall Study||13
11098922|NCT01217073|12282583|FG000|STARTED|Base Period||113
11098923|NCT01217073|12282584|FG001|STARTED|Base Period||115
11098924|NCT01217073|12282585|FG002|STARTED|Base Period||114
11098925|NCT01217073|12282586|FG003|STARTED|Base Period||115
11098926|NCT01217073|12282587|FG004|STARTED|Base Period||114
11098927|NCT01217073|12282588|FG005|STARTED|Base Period||114
11098928|NCT01217073|12282589|FG006|STARTED|Base Period||0
11098929|NCT01217073|12282590|FG007|STARTED|Base Period||0
11098930|NCT01217073|12282583|FG000|COMPLETED|Base Period||106
11353935|NCT03067948|12551182|FG000|STARTED|Overall Study||32
11353936|NCT03067948|12551182|FG000|COMPLETED|Overall Study||32
11353937|NCT03067948|12551182|FG000|NOT COMPLETED|Overall Study||0
11353938|NCT03067987|12551188|FG000|STARTED|Overall Study||50
11353939|NCT03067987|12551189|FG001|STARTED|Overall Study||53
11353940|NCT03067987|12551188|FG000|COMPLETED|Overall Study||40
11353941|NCT03067987|12551189|FG001|COMPLETED|Overall Study||40
11353942|NCT03067987|12551188|FG000|NOT COMPLETED|Overall Study||10
11353943|NCT03067987|12551189|FG001|NOT COMPLETED|Overall Study||13
11353944|NCT03068091|12551195|FG000|STARTED|Overall Study||25
11353945|NCT03068091|12551195|FG000|COMPLETED|Overall Study||24
11353946|NCT03068091|12551195|FG000|NOT COMPLETED|Overall Study||1
11353947|NCT03068312|12551202|FG000|STARTED|Overall Study||19
11098931|NCT01217073|12282584|FG001|COMPLETED|Base Period||110
11098932|NCT01217073|12282585|FG002|COMPLETED|Base Period||107
11098933|NCT01217073|12282586|FG003|COMPLETED|Base Period||113
11098934|NCT01217073|12282587|FG004|COMPLETED|Base Period||99
11098935|NCT01217073|12282588|FG005|COMPLETED|Base Period||105
11098936|NCT01217073|12282589|FG006|COMPLETED|Base Period||0
11098937|NCT01217073|12282590|FG007|COMPLETED|Base Period||0
11098938|NCT01217073|12282583|FG000|NOT COMPLETED|Base Period||7
11098939|NCT01217073|12282584|FG001|NOT COMPLETED|Base Period||5
11098940|NCT01217073|12282585|FG002|NOT COMPLETED|Base Period||7
11098941|NCT01217073|12282586|FG003|NOT COMPLETED|Base Period||2
11098942|NCT01217073|12282587|FG004|NOT COMPLETED|Base Period||15
11098943|NCT01217073|12282588|FG005|NOT COMPLETED|Base Period||9
11098944|NCT01217073|12282589|FG006|NOT COMPLETED|Base Period||0
11098945|NCT01217073|12282590|FG007|NOT COMPLETED|Base Period||0
11098946|NCT01217073|12282583|FG000|STARTED|Extension Period||0
11098947|NCT01217073|12282584|FG001|STARTED|Extension Period||0
11098948|NCT01217073|12282585|FG002|STARTED|Extension Period||0
11098949|NCT01217073|12282586|FG003|STARTED|Extension Period||0
11098950|NCT01217073|12282587|FG004|STARTED|Extension Period||0
11098951|NCT01217073|12282588|FG005|STARTED|Extension Period||0
11098952|NCT01217073|12282589|FG006|STARTED|Extension Period||405
11098953|NCT01217073|12282590|FG007|STARTED|Extension Period||80
11098954|NCT01217073|12282583|FG000|COMPLETED|Extension Period||0
11098955|NCT01217073|12282584|FG001|COMPLETED|Extension Period||0
11098956|NCT01217073|12282585|FG002|COMPLETED|Extension Period||0
11098957|NCT01217073|12282586|FG003|COMPLETED|Extension Period||0
11098958|NCT01217073|12282587|FG004|COMPLETED|Extension Period||0
11098959|NCT01217073|12282588|FG005|COMPLETED|Extension Period||0
11098960|NCT01217073|12282589|FG006|COMPLETED|Extension Period||314
11098961|NCT01217073|12282590|FG007|COMPLETED|Extension Period||60
11098962|NCT01217073|12282583|FG000|NOT COMPLETED|Extension Period||0
11098963|NCT01217073|12282584|FG001|NOT COMPLETED|Extension Period||0
11098964|NCT01217073|12282585|FG002|NOT COMPLETED|Extension Period||0
11098965|NCT01217073|12282586|FG003|NOT COMPLETED|Extension Period||0
11098966|NCT01217073|12282587|FG004|NOT COMPLETED|Extension Period||0
11098967|NCT01217073|12282588|FG005|NOT COMPLETED|Extension Period||0
11098968|NCT01217073|12282589|FG006|NOT COMPLETED|Extension Period||91
11098969|NCT01217073|12282590|FG007|NOT COMPLETED|Extension Period||20
11098970|NCT01217112|12282619|FG000|STARTED|Overall Study||11
11098971|NCT01217112|12282620|FG001|STARTED|Overall Study||12
11098972|NCT01217112|12282621|FG002|STARTED|Overall Study||13
11098973|NCT01217112|12282622|FG003|STARTED|Overall Study||12
11098974|NCT01217112|12282623|FG004|STARTED|Overall Study||14
11098975|NCT01217112|12282619|FG000|COMPLETED|Overall Study||11
11098976|NCT01217112|12282620|FG001|COMPLETED|Overall Study||10
11098977|NCT01217112|12282621|FG002|COMPLETED|Overall Study||12
11098978|NCT01217112|12282622|FG003|COMPLETED|Overall Study||10
11098979|NCT01217112|12282623|FG004|COMPLETED|Overall Study||13
11098980|NCT01217112|12282619|FG000|NOT COMPLETED|Overall Study||0
11098981|NCT01217112|12282620|FG001|NOT COMPLETED|Overall Study||2
11098982|NCT01217112|12282621|FG002|NOT COMPLETED|Overall Study||1
11098983|NCT01217112|12282622|FG003|NOT COMPLETED|Overall Study||2
11098984|NCT01217112|12282623|FG004|NOT COMPLETED|Overall Study||1
11098985|NCT01217190|12282637|FG000|STARTED|First Dosing||24
11098986|NCT01217190|12282638|FG001|STARTED|First Dosing||24
11098987|NCT01217190|12282637|FG000|COMPLETED|First Dosing||24
11353948|NCT03068312|12551203|FG001|STARTED|Overall Study||19
11353949|NCT03068312|12551202|FG000|COMPLETED|Overall Study||19
11353950|NCT03068312|12551203|FG001|COMPLETED|Overall Study||19
11353951|NCT03068312|12551202|FG000|NOT COMPLETED|Overall Study||0
11353952|NCT03068312|12551203|FG001|NOT COMPLETED|Overall Study||0
11353953|NCT03068455|12551211|FG000|STARTED|Pre-treatment Period||920
11353954|NCT03068455|12551212|FG001|STARTED|Pre-treatment Period||924
11353955|NCT03068455|12551211|FG000|COMPLETED|Pre-treatment Period||916
11353956|NCT03068455|12551212|FG001|COMPLETED|Pre-treatment Period||917
11353957|NCT03068455|12551211|FG000|NOT COMPLETED|Pre-treatment Period||4
11353958|NCT03068455|12551212|FG001|NOT COMPLETED|Pre-treatment Period||7
11353959|NCT03068455|12551211|FG000|STARTED|Treatment Period||916
11353960|NCT03068455|12551212|FG001|STARTED|Treatment Period||917
11098988|NCT01217190|12282638|FG001|COMPLETED|First Dosing||24
11098989|NCT01217190|12282637|FG000|NOT COMPLETED|First Dosing||0
11098990|NCT01217190|12282638|FG001|NOT COMPLETED|First Dosing||0
11098991|NCT01217190|12282637|FG000|STARTED|Second Dosing||24
11098992|NCT01217190|12282638|FG001|STARTED|Second Dosing||24
11219632|NCT01957202|12411342|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||1
11219633|NCT01957202|12411343|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11219634|NCT01957202|12411344|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11219635|NCT01957202|12411345|FG004|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11219636|NCT01957202|12411346|FG005|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11098993|NCT01217190|12282637|FG000|COMPLETED|Second Dosing||24
11098994|NCT01217190|12282638|FG001|COMPLETED|Second Dosing|Two subjects withdrew for personal reasons (other than adverse event).|22
11098995|NCT01217190|12282637|FG000|NOT COMPLETED|Second Dosing||0
11098996|NCT01217190|12282638|FG001|NOT COMPLETED|Second Dosing||2
11098997|NCT01217229|12282647|FG000|STARTED|Overall Study||20
11098998|NCT01217229|12282647|FG000|COMPLETED|Overall Study||0
11098999|NCT01217229|12282647|FG000|NOT COMPLETED|Overall Study||20
11099000|NCT01217307|12282653|FG000|STARTED|Overall Study||191
11099001|NCT01217307|12282654|FG001|STARTED|Overall Study||189
11099002|NCT01217307|12282653|FG000|COMPLETED|Overall Study||191
11099003|NCT01217307|12282654|FG001|COMPLETED|Overall Study||188
11099004|NCT01217307|12282653|FG000|NOT COMPLETED|Overall Study||0
11099005|NCT01217307|12282654|FG001|NOT COMPLETED|Overall Study||1
11099006|NCT01217385|12282660|FG000|STARTED|Overall Study||60
11099007|NCT01217385|12282660|FG000|COMPLETED|Overall Study||34
11099008|NCT01217385|12282660|FG000|NOT COMPLETED|Overall Study||26
11099009|NCT01217411|12282672|FG000|STARTED|Overall Study||3
11099010|NCT01217411|12282673|FG001|STARTED|Overall Study||2
11099011|NCT01217411|12282672|FG000|5mg|Overall Study||3
11099012|NCT01217411|12282673|FG001|5mg|Overall Study||2
11099013|NCT01217411|12282672|FG000|10mg|Overall Study||0
11099014|NCT01217411|12282673|FG001|10mg|Overall Study||0
11099015|NCT01217411|12282672|FG000|20mg|Overall Study||0
11099016|NCT01217411|12282673|FG001|20mg|Overall Study||0
11099017|NCT01217411|12282672|FG000|COMPLETED|Overall Study||0
11099018|NCT01217411|12282673|FG001|COMPLETED|Overall Study||0
11099019|NCT01217411|12282672|FG000|NOT COMPLETED|Overall Study||3
11099020|NCT01217411|12282673|FG001|NOT COMPLETED|Overall Study||2
11099021|NCT01217437|12282683|FG000|STARTED|Overall Study||55
11099022|NCT01217437|12282684|FG001|STARTED|Overall Study||53
11099023|NCT01217437|12282683|FG000|COMPLETED|Overall Study||12
11099024|NCT01217437|12282684|FG001|COMPLETED|Overall Study||12
11099025|NCT01217437|12282683|FG000|NOT COMPLETED|Overall Study||43
11099026|NCT01217437|12282684|FG001|NOT COMPLETED|Overall Study||41
11099027|NCT01217463|12282692|FG000|STARTED|Overall Study||99
11099028|NCT01217463|12282693|FG001|STARTED|Overall Study||102
11099029|NCT01217463|12282692|FG000|COMPLETED|Overall Study||86
11099030|NCT01217463|12282693|FG001|COMPLETED|Overall Study||94
11099031|NCT01217463|12282692|FG000|NOT COMPLETED|Overall Study||13
11099032|NCT01217463|12282693|FG001|NOT COMPLETED|Overall Study||8
11099033|NCT01217476|12282703|FG000|STARTED|Overall Study||105
11099034|NCT01217476|12282704|FG001|STARTED|Overall Study||102
11099035|NCT01217476|12282703|FG000|COMPLETED|Overall Study||93
11099036|NCT01217476|12282704|FG001|COMPLETED|Overall Study||95
11099037|NCT01217476|12282703|FG000|NOT COMPLETED|Overall Study||12
11099038|NCT01217476|12282704|FG001|NOT COMPLETED|Overall Study||7
11099039|NCT01217515|12282713|FG000|STARTED|Overall Study||154
11099040|NCT01217515|12282714|FG001|STARTED|Overall Study||156
11099041|NCT01217515|12282715|FG002|STARTED|Overall Study||155
11099042|NCT01217515|12282713|FG000|COMPLETED|Overall Study||147
11099043|NCT01217515|12282714|FG001|COMPLETED|Overall Study||148
11099044|NCT01217515|12282715|FG002|COMPLETED|Overall Study||145
11099045|NCT01217515|12282713|FG000|NOT COMPLETED|Overall Study||7
11099046|NCT01217515|12282714|FG001|NOT COMPLETED|Overall Study||8
11099047|NCT01217515|12282715|FG002|NOT COMPLETED|Overall Study||10
11099048|NCT01217606|12282725|FG000|STARTED|Initial Treatment Phase||90
11099049|NCT01217606|12282726|FG001|STARTED|Initial Treatment Phase||95
11099050|NCT01217606|12282725|FG000|COMPLETED|Initial Treatment Phase||76
11099051|NCT01217606|12282726|FG001|COMPLETED|Initial Treatment Phase||83
11099052|NCT01217606|12282725|FG000|NOT COMPLETED|Initial Treatment Phase||14
11099053|NCT01217606|12282726|FG001|NOT COMPLETED|Initial Treatment Phase||12
11099054|NCT01217606|12282725|FG000|STARTED|9-Month Masked Extension||67
11099055|NCT01217606|12282726|FG001|STARTED|9-Month Masked Extension||73
11099056|NCT01217606|12282725|FG000|Not Enrolled in Masked Extension|9-Month Masked Extension||9
11099057|NCT01217606|12282726|FG001|Not Enrolled in Masked Extension|9-Month Masked Extension||10
11099058|NCT01217606|12282725|FG000|COMPLETED|9-Month Masked Extension||54
11099059|NCT01217606|12282726|FG001|COMPLETED|9-Month Masked Extension||62
11099060|NCT01217606|12282725|FG000|NOT COMPLETED|9-Month Masked Extension||13
11099061|NCT01217606|12282726|FG001|NOT COMPLETED|9-Month Masked Extension||11
11099062|NCT01217749|12282735|FG000|STARTED|Overall Study||27
11099063|NCT01217749|12282736|FG001|STARTED|Overall Study||20
11099064|NCT01217749|12282737|FG002|STARTED|Overall Study||24
11099065|NCT01217749|12282735|FG000|COMPLETED|Overall Study||24
11099066|NCT01217749|12282736|FG001|COMPLETED|Overall Study||17
11099067|NCT01217749|12282737|FG002|COMPLETED|Overall Study||22
11099068|NCT01217749|12282735|FG000|NOT COMPLETED|Overall Study||3
11099069|NCT01217749|12282736|FG001|NOT COMPLETED|Overall Study||3
11099070|NCT01217749|12282737|FG002|NOT COMPLETED|Overall Study||2
11099071|NCT01217801|12282749|FG000|STARTED|Period 1||24
11099072|NCT01217801|12282750|FG001|STARTED|Period 1||24
11099073|NCT01217801|12282749|FG000|COMPLETED|Period 1||23
11099074|NCT01217801|12282750|FG001|COMPLETED|Period 1||22
11099075|NCT01217801|12282749|FG000|NOT COMPLETED|Period 1||1
11099076|NCT01217801|12282750|FG001|NOT COMPLETED|Period 1||2
11099077|NCT01217801|12282749|FG000|STARTED|Period 2||23
11099078|NCT01217801|12282750|FG001|STARTED|Period 2||22
11099079|NCT01217801|12282749|FG000|COMPLETED|Period 2||23
11099080|NCT01217801|12282750|FG001|COMPLETED|Period 2||22
11099081|NCT01217801|12282749|FG000|NOT COMPLETED|Period 2||0
11099082|NCT01217801|12282750|FG001|NOT COMPLETED|Period 2||0
11099083|NCT01217814|12282759|FG000|STARTED|Overall Study||4
11099084|NCT01217814|12282760|FG001|STARTED|Overall Study||5
11099085|NCT01217814|12282761|FG002|STARTED|Overall Study||7
11099086|NCT01217814|12282759|FG000|COMPLETED|Overall Study||3
11099087|NCT01217814|12282760|FG001|COMPLETED|Overall Study||4
11099088|NCT01217814|12282761|FG002|COMPLETED|Overall Study||6
11099089|NCT01217814|12282759|FG000|NOT COMPLETED|Overall Study||1
11099090|NCT01217814|12282760|FG001|NOT COMPLETED|Overall Study||1
11219637|NCT01957202|12411347|FG006|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11099091|NCT01217814|12282761|FG002|NOT COMPLETED|Overall Study||1
11099092|NCT01217827|12282772|FG000|STARTED|Overall Study||46
11099093|NCT01217827|12282773|FG001|STARTED|Overall Study||43
11099094|NCT01217827|12282772|FG000|COMPLETED|Overall Study||46
11099095|NCT01217827|12282773|FG001|COMPLETED|Overall Study||43
11099096|NCT01217827|12282772|FG000|NOT COMPLETED|Overall Study||0
11099097|NCT01217827|12282773|FG001|NOT COMPLETED|Overall Study||0
11099098|NCT01217840|12282781|FG000|STARTED|Overall Study||20
11099099|NCT01217840|12282782|FG001|STARTED|Overall Study||20
11099100|NCT01217840|12282781|FG000|COMPLETED|Overall Study||14
11099101|NCT01217840|12282782|FG001|COMPLETED|Overall Study||17
11099102|NCT01217840|12282781|FG000|NOT COMPLETED|Overall Study||6
11099103|NCT01217840|12282782|FG001|NOT COMPLETED|Overall Study||3
11099104|NCT01217892|12282793|FG000|STARTED|Overall Study||100
11099105|NCT01217892|12282794|FG001|STARTED|Overall Study||100
11099106|NCT01217892|12282795|FG002|STARTED|Overall Study||99
11099107|NCT01217892|12282796|FG003|STARTED|Overall Study||101
11099108|NCT01217892|12282793|FG000|COMPLETED|Overall Study||93
11099109|NCT01217892|12282794|FG001|COMPLETED|Overall Study||94
11099110|NCT01217892|12282795|FG002|COMPLETED|Overall Study||90
11099111|NCT01217892|12282796|FG003|COMPLETED|Overall Study||93
11099112|NCT01217892|12282793|FG000|NOT COMPLETED|Overall Study||7
11099113|NCT01217892|12282794|FG001|NOT COMPLETED|Overall Study||6
11099114|NCT01217892|12282795|FG002|NOT COMPLETED|Overall Study||9
11099115|NCT01217892|12282796|FG003|NOT COMPLETED|Overall Study||8
11099116|NCT01217944|12282809|FG000|STARTED|Overall Study||106
11099117|NCT01217944|12282810|FG001|STARTED|Overall Study||116
11099118|NCT01217944|12282811|FG002|STARTED|Overall Study||55
11099119|NCT01217944|12282809|FG000|Completed 3 Months|Overall Study||105
11099120|NCT01217944|12282810|FG001|Completed 3 Months|Overall Study||116
11099121|NCT01217944|12282811|FG002|Completed 3 Months|Overall Study||55
11099122|NCT01217944|12282809|FG000|Completed 6 Months|Overall Study||103
11099123|NCT01217944|12282810|FG001|Completed 6 Months|Overall Study||116
11099124|NCT01217944|12282811|FG002|Completed 6 Months|Overall Study||55
11099125|NCT01217944|12282809|FG000|COMPLETED|Overall Study||100
11099126|NCT01217944|12282810|FG001|COMPLETED|Overall Study||112
11099127|NCT01217944|12282811|FG002|COMPLETED|Overall Study||55
11099128|NCT01217944|12282809|FG000|NOT COMPLETED|Overall Study||6
11099129|NCT01217944|12282810|FG001|NOT COMPLETED|Overall Study||4
11099130|NCT01217944|12282811|FG002|NOT COMPLETED|Overall Study||0
11099131|NCT01217957|12282826|FG000|STARTED|Phase 1||3
11099132|NCT01217957|12282827|FG001|STARTED|Phase 1||3
11099133|NCT01217957|12282828|FG002|STARTED|Phase 1||6
11099134|NCT01217957|12282829|FG003|STARTED|Phase 1||3
11099135|NCT01217957|12282830|FG004|STARTED|Phase 1||0
11099136|NCT01217957|12282826|FG000|COMPLETED|Phase 1||2
11099137|NCT01217957|12282827|FG001|COMPLETED|Phase 1||3
11099138|NCT01217957|12282828|FG002|COMPLETED|Phase 1||5
11099139|NCT01217957|12282829|FG003|COMPLETED|Phase 1||2
11099140|NCT01217957|12282830|FG004|COMPLETED|Phase 1||0
11099141|NCT01217957|12282826|FG000|NOT COMPLETED|Phase 1||1
11099142|NCT01217957|12282827|FG001|NOT COMPLETED|Phase 1||0
11099143|NCT01217957|12282828|FG002|NOT COMPLETED|Phase 1||1
10822608|NCT00162370|11988053|FG000|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
10822609|NCT00162370|11988053|FG000|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
10822610|NCT00162370|11988053|FG000|NOT COMPLETED|Completed Echocardiography Imaging||0
10822611|NCT00162370|11988053|FG000|STARTED|Efficacy Population||366
10822612|NCT00162370|11988053|FG000|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
10822613|NCT00162370|11988053|FG000|NOT COMPLETED|Efficacy Population||51
10822614|NCT00204737|11988062|FG000|STARTED|Overall Study||6
10822615|NCT00204737|11988063|FG001|STARTED|Overall Study||6
10822616|NCT00204737|11988062|FG000|COMPLETED|Overall Study||6
10822617|NCT00204737|11988063|FG001|COMPLETED|Overall Study||6
10822618|NCT00204737|11988062|FG000|NOT COMPLETED|Overall Study||0
10822619|NCT00204737|11988063|FG001|NOT COMPLETED|Overall Study||0
10822620|NCT00214500|11988069|FG000|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
10822621|NCT00214500|11988069|FG000|Safety Population|Treatment Period||9
10822622|NCT00214500|11988069|FG000|Pharmacokinetic (PK) Population|Treatment Period||9
10822623|NCT00214500|11988069|FG000|Pharmacodynamic (PD) Population|Treatment Period||9
10822624|NCT00214500|11988069|FG000|COMPLETED|Treatment Period||8
10822625|NCT00214500|11988069|FG000|NOT COMPLETED|Treatment Period||1
10822626|NCT00214500|11988069|FG000|STARTED|Extension Period||8
10822627|NCT00214500|11988069|FG000|COMPLETED|Extension Period||6
10822628|NCT00214500|11988069|FG000|NOT COMPLETED|Extension Period||2
10822629|NCT00278343|11988076|FG000|STARTED|Overall Study||74
10822630|NCT00278343|11988076|FG000|COMPLETED|Overall Study||74
10822631|NCT00278343|11988076|FG000|NOT COMPLETED|Overall Study||0
10822632|NCT00283959|11988081|FG000|STARTED|Treatment Period||4
10822633|NCT00283959|11988081|FG000|Safety Population|Treatment Period||4
10822634|NCT00283959|11988081|FG000|Pharmacodynamics (PD) Population|Treatment Period||4
10822635|NCT00283959|11988081|FG000|COMPLETED|Treatment Period||4
10822636|NCT00283959|11988081|FG000|NOT COMPLETED|Treatment Period||0
10822637|NCT00283959|11988081|FG000|STARTED|Extension Period||4
10822638|NCT00283959|11988081|FG000|COMPLETED|Extension Period||3
10822639|NCT00283959|11988081|FG000|NOT COMPLETED|Extension Period||1
10822640|NCT00290758|11988087|FG000|STARTED|Pre-Intervention rFNA Through Follow-Up||62
10822641|NCT00290758|11988088|FG001|STARTED|Pre-Intervention rFNA Through Follow-Up||64
10822642|NCT00290758|11988087|FG000|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
10822643|NCT00290758|11988088|FG001|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
10822644|NCT00290758|11988087|FG000|Randomization|Pre-Intervention rFNA Through Follow-Up||62
10822645|NCT00290758|11988088|FG001|Randomization|Pre-Intervention rFNA Through Follow-Up||62
10822646|NCT00290758|11988087|FG000|Treatment|Pre-Intervention rFNA Through Follow-Up||61
10822647|NCT00290758|11988088|FG001|Treatment|Pre-Intervention rFNA Through Follow-Up||64
10822648|NCT00290758|11988087|FG000|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
10822649|NCT00290758|11988088|FG001|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
10822650|NCT00290758|11988087|FG000|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
10822651|NCT00290758|11988088|FG001|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
10822652|NCT00290758|11988087|FG000|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
10822653|NCT00290758|11988088|FG001|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
10822654|NCT00290758|11988087|FG000|STARTED|Post Intervention rFNA||55
10822655|NCT00290758|11988088|FG001|STARTED|Post Intervention rFNA||54
10822656|NCT00290758|11988087|FG000|COMPLETED|Post Intervention rFNA||49
10822657|NCT00290758|11988088|FG001|COMPLETED|Post Intervention rFNA||49
10822658|NCT00290758|11988087|FG000|NOT COMPLETED|Post Intervention rFNA||6
10822659|NCT00290758|11988088|FG001|NOT COMPLETED|Post Intervention rFNA||5
10822660|NCT00310388|11988098|FG000|STARTED|Primary Reporting Phase||376
10822661|NCT00310388|11988099|FG001|STARTED|Primary Reporting Phase||0
10822662|NCT00310388|11988098|FG000|COMPLETED|Primary Reporting Phase||30
11219638|NCT01957202|12411348|FG007|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11219639|NCT01957202|12411349|FG008|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11219640|NCT01957202|12411350|FG009|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11219641|NCT01957202|12411351|FG010|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11219642|NCT01957202|12411352|FG011|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11219643|NCT01957202|12411353|FG012|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11219644|NCT01957202|12411354|FG013|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11219645|NCT01957202|12411355|FG014|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11219646|NCT01957202|12411356|FG015|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11219647|NCT01957202|12411357|FG016|NOT COMPLETED|Treatment Period 2 (8 Days)||1
11219648|NCT01957202|12411358|FG017|NOT COMPLETED|Treatment Period 2 (8 Days)||0
11219649|NCT01957202|12411341|FG000|STARTED|Washout Period 2 (14 to 28 Days)||3
11219650|NCT01957202|12411342|FG001|STARTED|Washout Period 2 (14 to 28 Days)||5
11219651|NCT01957202|12411343|FG002|STARTED|Washout Period 2 (14 to 28 Days)||6
11219652|NCT01957202|12411344|FG003|STARTED|Washout Period 2 (14 to 28 Days)||3
11219653|NCT01957202|12411345|FG004|STARTED|Washout Period 2 (14 to 28 Days)||3
11219654|NCT01957202|12411346|FG005|STARTED|Washout Period 2 (14 to 28 Days)||2
11219655|NCT01957202|12411347|FG006|STARTED|Washout Period 2 (14 to 28 Days)||3
11219656|NCT01957202|12411348|FG007|STARTED|Washout Period 2 (14 to 28 Days)||3
11219657|NCT01957202|12411349|FG008|STARTED|Washout Period 2 (14 to 28 Days)||3
11219658|NCT01957202|12411350|FG009|STARTED|Washout Period 2 (14 to 28 Days)||6
11219659|NCT01957202|12411351|FG010|STARTED|Washout Period 2 (14 to 28 Days)||3
11219660|NCT01957202|12411352|FG011|STARTED|Washout Period 2 (14 to 28 Days)||6
11219661|NCT01957202|12411353|FG012|STARTED|Washout Period 2 (14 to 28 Days)||3
11219662|NCT01957202|12411354|FG013|STARTED|Washout Period 2 (14 to 28 Days)||3
11219663|NCT01957202|12411355|FG014|STARTED|Washout Period 2 (14 to 28 Days)||6
11219664|NCT01957202|12411356|FG015|STARTED|Washout Period 2 (14 to 28 Days)||3
11219665|NCT01957202|12411357|FG016|STARTED|Washout Period 2 (14 to 28 Days)||5
10822663|NCT00310388|11988099|FG001|COMPLETED|Primary Reporting Phase||0
10822664|NCT00310388|11988098|FG000|NOT COMPLETED|Primary Reporting Phase||346
10822665|NCT00310388|11988099|FG001|NOT COMPLETED|Primary Reporting Phase||0
10822666|NCT00310388|11988098|FG000|STARTED|Safety Follow-up Continuation Phase||0
10822667|NCT00310388|11988099|FG001|STARTED|Safety Follow-up Continuation Phase||26
10822668|NCT00310388|11988098|FG000|COMPLETED|Safety Follow-up Continuation Phase||0
10822669|NCT00310388|11988099|FG001|COMPLETED|Safety Follow-up Continuation Phase||13
10822670|NCT00310388|11988098|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0
10822671|NCT00310388|11988099|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||13
10822672|NCT04651114|11988104|FG000|STARTED|Overall Study||38
10822673|NCT04651114|11988104|FG000|COMPLETED|Overall Study||30
10822674|NCT04651114|11988104|FG000|NOT COMPLETED|Overall Study||8
11099144|NCT01217957|12282829|FG003|NOT COMPLETED|Phase 1||1
11099145|NCT01217957|12282830|FG004|NOT COMPLETED|Phase 1||0
11099146|NCT01217957|12282826|FG000|STARTED|Phase 2||0
11099147|NCT01217957|12282827|FG001|STARTED|Phase 2||0
11099148|NCT01217957|12282828|FG002|STARTED|Phase 2||0
11099149|NCT01217957|12282829|FG003|STARTED|Phase 2||0
11099150|NCT01217957|12282830|FG004|STARTED|Phase 2||50
11099151|NCT01217957|12282826|FG000|COMPLETED|Phase 2||0
11099152|NCT01217957|12282827|FG001|COMPLETED|Phase 2||0
11099153|NCT01217957|12282828|FG002|COMPLETED|Phase 2||0
10822685|NCT04346537|11988118|FG000|STARTED|Overall Study|8 subjects did not undergo the implant procedure and did not have the INGEVITY+ lead implanted or attempted.|109
10822686|NCT04346537|11988118|FG000|Implanted/Attempted With INGEVITY+ Lead|Overall Study||101
10822687|NCT04346537|11988118|FG000|COMPLETED|Overall Study||99
10822688|NCT04346537|11988118|FG000|NOT COMPLETED|Overall Study||10
10822689|NCT04344600|11988125|FG000|STARTED|Overall Study||2
10822690|NCT04344600|11988126|FG001|STARTED|Overall Study||4
10822691|NCT04344600|11988125|FG000|COMPLETED|Overall Study||2
10822692|NCT04344600|11988126|FG001|COMPLETED|Overall Study||4
10822693|NCT04344600|11988125|FG000|NOT COMPLETED|Overall Study||0
11219666|NCT01957202|12411358|FG017|STARTED|Washout Period 2 (14 to 28 Days)||3
11219667|NCT01957202|12411341|FG000|COMPLETED|Washout Period 2 (14 to 28 Days)||3
10822694|NCT04344600|11988126|FG001|NOT COMPLETED|Overall Study||0
11099154|NCT01217957|12282829|FG003|COMPLETED|Phase 2||0
11099155|NCT01217957|12282830|FG004|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
11099156|NCT01217957|12282826|FG000|NOT COMPLETED|Phase 2||0
11099157|NCT01217957|12282827|FG001|NOT COMPLETED|Phase 2||0
11099158|NCT01217957|12282828|FG002|NOT COMPLETED|Phase 2||0
11099159|NCT01217957|12282829|FG003|NOT COMPLETED|Phase 2||0
11099160|NCT01217957|12282830|FG004|NOT COMPLETED|Phase 2||1
11099161|NCT01218009|12282853|FG000|STARTED|Overall Study||166
11099162|NCT01218009|12282854|FG001|STARTED|Overall Study||165
11099163|NCT01218009|12282853|FG000|COMPLETED|Overall Study||0
10822704|NCT03780387|11988140|FG000|STARTED|Overall Study||1
10822705|NCT03780387|11988140|FG000|COMPLETED|Overall Study||1
10822706|NCT03780387|11988140|FG000|NOT COMPLETED|Overall Study||0
10822707|NCT03768089|11988162|FG000|STARTED|Part A||8
10822708|NCT03768089|11988163|FG001|STARTED|Part A||5
10822709|NCT03768089|11988164|FG002|STARTED|Part A||6
10822710|NCT03768089|11988165|FG003|STARTED|Part A||6
10822711|NCT03768089|11988166|FG004|STARTED|Part A||6
10822712|NCT03768089|11988167|FG005|STARTED|Part A||6
10822713|NCT03768089|11988168|FG006|STARTED|Part A||8
11099164|NCT01218009|12282854|FG001|COMPLETED|Overall Study||0
11099165|NCT01218009|12282853|FG000|NOT COMPLETED|Overall Study||166
11099166|NCT01218009|12282854|FG001|NOT COMPLETED|Overall Study||165
11099167|NCT01218048|12282860|FG000|STARTED|Overall Study||40
11099168|NCT01218048|12282860|FG000|COMPLETED|Overall Study||40
11099169|NCT01218048|12282860|FG000|NOT COMPLETED|Overall Study||0
11099170|NCT01218087|12282867|FG000|STARTED|Overall Study||42
11099171|NCT01218087|12282868|FG001|STARTED|Overall Study||41
11099172|NCT01218087|12282867|FG000|COMPLETED|Overall Study||27
11099173|NCT01218087|12282868|FG001|COMPLETED|Overall Study||35
11099174|NCT01218087|12282867|FG000|NOT COMPLETED|Overall Study||15
11099175|NCT01218087|12282868|FG001|NOT COMPLETED|Overall Study||6
11099176|NCT01218100|12282878|FG000|STARTED|Overall Study||95
11099177|NCT01218100|12282879|FG001|STARTED|Overall Study||190
11099178|NCT01218100|12282880|FG002|STARTED|Overall Study||189
11099179|NCT01218100|12282881|FG003|STARTED|Overall Study||190
11099180|NCT01218100|12282878|FG000|COMPLETED|Overall Study||71
11099181|NCT01218100|12282879|FG001|COMPLETED|Overall Study||165
11099182|NCT01218100|12282880|FG002|COMPLETED|Overall Study||162
11099183|NCT01218100|12282881|FG003|COMPLETED|Overall Study||156
11099184|NCT01218100|12282878|FG000|NOT COMPLETED|Overall Study||24
11099185|NCT01218100|12282879|FG001|NOT COMPLETED|Overall Study||25
11099186|NCT01218100|12282880|FG002|NOT COMPLETED|Overall Study||27
11099187|NCT01218100|12282881|FG003|NOT COMPLETED|Overall Study||34
11099188|NCT01218113|12282894|FG000|STARTED|Overall Study||62
11099189|NCT01218113|12282895|FG001|STARTED|Overall Study||64
11099190|NCT01218113|12282896|FG002|STARTED|Overall Study||64
11099191|NCT01218113|12282894|FG000|COMPLETED|Overall Study||57
11099192|NCT01218113|12282895|FG001|COMPLETED|Overall Study||63
11099193|NCT01218113|12282896|FG002|COMPLETED|Overall Study||58
11099194|NCT01218113|12282894|FG000|NOT COMPLETED|Overall Study||5
11099195|NCT01218113|12282895|FG001|NOT COMPLETED|Overall Study||1
11099196|NCT01218113|12282896|FG002|NOT COMPLETED|Overall Study||6
11099197|NCT01218126|12282915|FG000|STARTED|Overall Study||153
11099198|NCT01218126|12282916|FG001|STARTED|Overall Study||149
11099199|NCT01218126|12282917|FG002|STARTED|Overall Study||151
11099200|NCT01218126|12282918|FG003|STARTED|Overall Study||149
11099201|NCT01218126|12282915|FG000|COMPLETED|Overall Study||129
11099202|NCT01218126|12282916|FG001|COMPLETED|Overall Study||127
11099203|NCT01218126|12282917|FG002|COMPLETED|Overall Study||127
11099204|NCT01218126|12282918|FG003|COMPLETED|Overall Study||114
11099205|NCT01218126|12282915|FG000|NOT COMPLETED|Overall Study||24
11099206|NCT01218126|12282916|FG001|NOT COMPLETED|Overall Study||22
11099207|NCT01218126|12282917|FG002|NOT COMPLETED|Overall Study||24
11099208|NCT01218126|12282918|FG003|NOT COMPLETED|Overall Study||35
11099209|NCT01218204|12282930|FG000|STARTED|Part A||6
11099210|NCT01218204|12282931|FG001|STARTED|Part A||0
10822714|NCT03768089|11988169|FG007|STARTED|Part A||0
10822715|NCT03768089|11988170|FG008|STARTED|Part A||0
10822716|NCT03768089|11988171|FG009|STARTED|Part A||0
10822717|NCT03768089|11988172|FG010|STARTED|Part A||0
10822718|NCT03768089|11988173|FG011|STARTED|Part A||0
10822719|NCT03768089|11988174|FG012|STARTED|Part A||0
10822720|NCT03768089|11988175|FG013|STARTED|Part A||0
10822721|NCT03768089|11988176|FG014|STARTED|Part A||0
10822722|NCT03768089|11988177|FG015|STARTED|Part A||0
10822723|NCT03768089|11988178|FG016|STARTED|Part A||0
10822724|NCT03768089|11988179|FG017|STARTED|Part A||0
10822725|NCT03768089|11988162|FG000|Safety Set|Part A||8
10822726|NCT03768089|11988163|FG001|Safety Set|Part A||5
11099211|NCT01218204|12282932|FG002|STARTED|Part A||0
10822727|NCT03768089|11988164|FG002|Safety Set|Part A||6
10822728|NCT03768089|11988165|FG003|Safety Set|Part A||6
10822729|NCT03768089|11988166|FG004|Safety Set|Part A||6
10822730|NCT03768089|11988167|FG005|Safety Set|Part A||6
10822731|NCT03768089|11988168|FG006|Safety Set|Part A||8
10822732|NCT03768089|11988169|FG007|Safety Set|Part A||0
10822733|NCT03768089|11988170|FG008|Safety Set|Part A||0
10822734|NCT03768089|11988171|FG009|Safety Set|Part A||0
10822735|NCT03768089|11988172|FG010|Safety Set|Part A||0
10822736|NCT03768089|11988173|FG011|Safety Set|Part A||0
10822737|NCT03768089|11988174|FG012|Safety Set|Part A||0
10822738|NCT03768089|11988175|FG013|Safety Set|Part A||0
10822739|NCT03768089|11988176|FG014|Safety Set|Part A||0
10822740|NCT03768089|11988177|FG015|Safety Set|Part A||0
11099212|NCT01218204|12282933|FG003|STARTED|Part A||0
11099213|NCT01218204|12282930|FG000|COMPLETED|Part A||6
11099214|NCT01218204|12282931|FG001|COMPLETED|Part A||0
11099215|NCT01218204|12282932|FG002|COMPLETED|Part A||0
11099216|NCT01218204|12282933|FG003|COMPLETED|Part A||0
11099217|NCT01218204|12282930|FG000|NOT COMPLETED|Part A||0
10822741|NCT03768089|11988178|FG016|Safety Set|Part A||0
10822742|NCT03768089|11988179|FG017|Safety Set|Part A||0
10822743|NCT03768089|11988162|FG000|COMPLETED|Part A||8
10822744|NCT03768089|11988163|FG001|COMPLETED|Part A||5
10822745|NCT03768089|11988164|FG002|COMPLETED|Part A||6
10822746|NCT03768089|11988165|FG003|COMPLETED|Part A||6
10822747|NCT03768089|11988166|FG004|COMPLETED|Part A||5
10822748|NCT03768089|11988167|FG005|COMPLETED|Part A||6
10822749|NCT03768089|11988168|FG006|COMPLETED|Part A||8
10822750|NCT03768089|11988169|FG007|COMPLETED|Part A||0
10822751|NCT03768089|11988170|FG008|COMPLETED|Part A||0
10822752|NCT03768089|11988171|FG009|COMPLETED|Part A||0
10822753|NCT03768089|11988172|FG010|COMPLETED|Part A||0
10822754|NCT03768089|11988173|FG011|COMPLETED|Part A||0
10822755|NCT03768089|11988174|FG012|COMPLETED|Part A||0
10822756|NCT03768089|11988175|FG013|COMPLETED|Part A||0
10822757|NCT03768089|11988176|FG014|COMPLETED|Part A||0
10822758|NCT03768089|11988177|FG015|COMPLETED|Part A||0
10822759|NCT03768089|11988178|FG016|COMPLETED|Part A||0
10822760|NCT03768089|11988179|FG017|COMPLETED|Part A||0
10822761|NCT03768089|11988162|FG000|NOT COMPLETED|Part A||0
10822762|NCT03768089|11988163|FG001|NOT COMPLETED|Part A||0
10822763|NCT03768089|11988164|FG002|NOT COMPLETED|Part A||0
10822764|NCT03768089|11988165|FG003|NOT COMPLETED|Part A||0
10822765|NCT03768089|11988166|FG004|NOT COMPLETED|Part A||1
10822766|NCT03768089|11988167|FG005|NOT COMPLETED|Part A||0
10822767|NCT03768089|11988168|FG006|NOT COMPLETED|Part A||0
10822768|NCT03768089|11988169|FG007|NOT COMPLETED|Part A||0
10822769|NCT03768089|11988170|FG008|NOT COMPLETED|Part A||0
10822770|NCT03768089|11988171|FG009|NOT COMPLETED|Part A||0
10822771|NCT03768089|11988172|FG010|NOT COMPLETED|Part A||0
10822772|NCT03768089|11988173|FG011|NOT COMPLETED|Part A||0
10822773|NCT03768089|11988174|FG012|NOT COMPLETED|Part A||0
10822774|NCT03768089|11988175|FG013|NOT COMPLETED|Part A||0
10822775|NCT03768089|11988176|FG014|NOT COMPLETED|Part A||0
10822776|NCT03768089|11988177|FG015|NOT COMPLETED|Part A||0
10822777|NCT03768089|11988178|FG016|NOT COMPLETED|Part A||0
10822778|NCT03768089|11988179|FG017|NOT COMPLETED|Part A||0
10822779|NCT03768089|11988162|FG000|STARTED|Part B||0
10822780|NCT03768089|11988163|FG001|STARTED|Part B||0
10822781|NCT03768089|11988164|FG002|STARTED|Part B||0
10822782|NCT03768089|11988165|FG003|STARTED|Part B||0
10822783|NCT03768089|11988166|FG004|STARTED|Part B||0
10822784|NCT03768089|11988167|FG005|STARTED|Part B||0
10822785|NCT03768089|11988168|FG006|STARTED|Part B||0
10822786|NCT03768089|11988169|FG007|STARTED|Part B||9
10822787|NCT03768089|11988170|FG008|STARTED|Part B||6
10822788|NCT03768089|11988171|FG009|STARTED|Part B||6
10822789|NCT03768089|11988172|FG010|STARTED|Part B|One participant who participated in A2 also participated in B3.|6
10822790|NCT03768089|11988173|FG011|STARTED|Part B||6
10822791|NCT03768089|11988174|FG012|STARTED|Part B||0
10822792|NCT03768089|11988175|FG013|STARTED|Part B||0
10822793|NCT03768089|11988176|FG014|STARTED|Part B||0
10822794|NCT03768089|11988177|FG015|STARTED|Part B||0
10822795|NCT03768089|11988178|FG016|STARTED|Part B||0
10822796|NCT03768089|11988179|FG017|STARTED|Part B||0
10822797|NCT03768089|11988162|FG000|Safety Set|Part B||0
10822798|NCT03768089|11988163|FG001|Safety Set|Part B||0
10822799|NCT03768089|11988164|FG002|Safety Set|Part B||0
10822800|NCT03768089|11988165|FG003|Safety Set|Part B||0
10822801|NCT03768089|11988166|FG004|Safety Set|Part B||0
10822802|NCT03768089|11988167|FG005|Safety Set|Part B||0
10822803|NCT03768089|11988168|FG006|Safety Set|Part B||0
10822804|NCT03768089|11988169|FG007|Safety Set|Part B||9
10822805|NCT03768089|11988170|FG008|Safety Set|Part B||6
10822806|NCT03768089|11988171|FG009|Safety Set|Part B||6
10822807|NCT03768089|11988172|FG010|Safety Set|Part B||6
10822808|NCT03768089|11988173|FG011|Safety Set|Part B||6
10822809|NCT03768089|11988174|FG012|Safety Set|Part B||0
10822810|NCT03768089|11988175|FG013|Safety Set|Part B||0
10822811|NCT03768089|11988176|FG014|Safety Set|Part B||0
10822812|NCT03768089|11988177|FG015|Safety Set|Part B||0
10822813|NCT03768089|11988178|FG016|Safety Set|Part B||0
10822814|NCT03768089|11988179|FG017|Safety Set|Part B||0
10822815|NCT03768089|11988162|FG000|COMPLETED|Part B||0
10822816|NCT03768089|11988163|FG001|COMPLETED|Part B||0
10822817|NCT03768089|11988164|FG002|COMPLETED|Part B||0
10822818|NCT03768089|11988165|FG003|COMPLETED|Part B||0
10822819|NCT03768089|11988166|FG004|COMPLETED|Part B||0
10822820|NCT03768089|11988167|FG005|COMPLETED|Part B||0
10822821|NCT03768089|11988168|FG006|COMPLETED|Part B||0
10822822|NCT03768089|11988169|FG007|COMPLETED|Part B||9
10822823|NCT03768089|11988170|FG008|COMPLETED|Part B||6
10822824|NCT03768089|11988171|FG009|COMPLETED|Part B||6
10822825|NCT03768089|11988172|FG010|COMPLETED|Part B||6
10822826|NCT03768089|11988173|FG011|COMPLETED|Part B||6
10822827|NCT03768089|11988174|FG012|COMPLETED|Part B||0
10822828|NCT03768089|11988175|FG013|COMPLETED|Part B||0
10822829|NCT03768089|11988176|FG014|COMPLETED|Part B||0
10822830|NCT03768089|11988177|FG015|COMPLETED|Part B||0
10822831|NCT03768089|11988178|FG016|COMPLETED|Part B||0
10822832|NCT03768089|11988179|FG017|COMPLETED|Part B||0
10822833|NCT03768089|11988162|FG000|NOT COMPLETED|Part B||0
10822834|NCT03768089|11988163|FG001|NOT COMPLETED|Part B||0
10822835|NCT03768089|11988164|FG002|NOT COMPLETED|Part B||0
10822836|NCT03768089|11988165|FG003|NOT COMPLETED|Part B||0
10822837|NCT03768089|11988166|FG004|NOT COMPLETED|Part B||0
10822838|NCT03768089|11988167|FG005|NOT COMPLETED|Part B||0
10822839|NCT03768089|11988168|FG006|NOT COMPLETED|Part B||0
10822840|NCT03768089|11988169|FG007|NOT COMPLETED|Part B||0
10822841|NCT03768089|11988170|FG008|NOT COMPLETED|Part B||0
10822842|NCT03768089|11988171|FG009|NOT COMPLETED|Part B||0
10822843|NCT03768089|11988172|FG010|NOT COMPLETED|Part B||0
10822844|NCT03768089|11988173|FG011|NOT COMPLETED|Part B||0
10822845|NCT03768089|11988174|FG012|NOT COMPLETED|Part B||0
10822846|NCT03768089|11988175|FG013|NOT COMPLETED|Part B||0
10822847|NCT03768089|11988176|FG014|NOT COMPLETED|Part B||0
10822848|NCT03768089|11988177|FG015|NOT COMPLETED|Part B||0
10822849|NCT03768089|11988178|FG016|NOT COMPLETED|Part B||0
10822850|NCT03768089|11988179|FG017|NOT COMPLETED|Part B||0
10822851|NCT03768089|11988162|FG000|STARTED|Part C||0
10822852|NCT03768089|11988163|FG001|STARTED|Part C||0
10822853|NCT03768089|11988164|FG002|STARTED|Part C||0
10822854|NCT03768089|11988165|FG003|STARTED|Part C||0
10822855|NCT03768089|11988166|FG004|STARTED|Part C||0
10822856|NCT03768089|11988167|FG005|STARTED|Part C||0
10822857|NCT03768089|11988168|FG006|STARTED|Part C||0
10822858|NCT03768089|11988169|FG007|STARTED|Part C||0
10822859|NCT03768089|11988170|FG008|STARTED|Part C||0
10822860|NCT03768089|11988171|FG009|STARTED|Part C||0
10822861|NCT03768089|11988172|FG010|STARTED|Part C||0
10822862|NCT03768089|11988173|FG011|STARTED|Part C||0
10822863|NCT03768089|11988174|FG012|STARTED|Part C||6
10822864|NCT03768089|11988175|FG013|STARTED|Part C||6
10822865|NCT03768089|11988176|FG014|STARTED|Part C||8
10822866|NCT03768089|11988177|FG015|STARTED|Part C||6
10822867|NCT03768089|11988178|FG016|STARTED|Part C||0
10822868|NCT03768089|11988179|FG017|STARTED|Part C||0
10822869|NCT03768089|11988162|FG000|Safety Set|Part C||0
10822870|NCT03768089|11988163|FG001|Safety Set|Part C||0
10822871|NCT03768089|11988164|FG002|Safety Set|Part C||0
10822872|NCT03768089|11988165|FG003|Safety Set|Part C||0
10822873|NCT03768089|11988166|FG004|Safety Set|Part C||0
10822874|NCT03768089|11988167|FG005|Safety Set|Part C||0
10822875|NCT03768089|11988168|FG006|Safety Set|Part C||0
10822876|NCT03768089|11988169|FG007|Safety Set|Part C||0
10822877|NCT03768089|11988170|FG008|Safety Set|Part C||0
10822878|NCT03768089|11988171|FG009|Safety Set|Part C||0
10822879|NCT03768089|11988172|FG010|Safety Set|Part C||0
10822880|NCT03768089|11988173|FG011|Safety Set|Part C||0
10822881|NCT03768089|11988174|FG012|Safety Set|Part C||6
10822882|NCT03768089|11988175|FG013|Safety Set|Part C||6
10822883|NCT03768089|11988176|FG014|Safety Set|Part C||7
10822884|NCT03768089|11988177|FG015|Safety Set|Part C||6
10822885|NCT03768089|11988178|FG016|Safety Set|Part C||0
10822886|NCT03768089|11988179|FG017|Safety Set|Part C||0
10822887|NCT03768089|11988162|FG000|COMPLETED|Part C||0
10822888|NCT03768089|11988163|FG001|COMPLETED|Part C||0
10822889|NCT03768089|11988164|FG002|COMPLETED|Part C||0
10822890|NCT03768089|11988165|FG003|COMPLETED|Part C||0
10822891|NCT03768089|11988166|FG004|COMPLETED|Part C||0
10822892|NCT03768089|11988167|FG005|COMPLETED|Part C||0
10822893|NCT03768089|11988168|FG006|COMPLETED|Part C||0
10822894|NCT03768089|11988169|FG007|COMPLETED|Part C||0
10822895|NCT03768089|11988170|FG008|COMPLETED|Part C||0
10822896|NCT03768089|11988171|FG009|COMPLETED|Part C||0
10822897|NCT03768089|11988172|FG010|COMPLETED|Part C||0
10822898|NCT03768089|11988173|FG011|COMPLETED|Part C||0
10822899|NCT03768089|11988174|FG012|COMPLETED|Part C||6
10822900|NCT03768089|11988175|FG013|COMPLETED|Part C||6
10822901|NCT03768089|11988176|FG014|COMPLETED|Part C||7
10822902|NCT03768089|11988177|FG015|COMPLETED|Part C||6
10822903|NCT03768089|11988178|FG016|COMPLETED|Part C||0
10822904|NCT03768089|11988179|FG017|COMPLETED|Part C||0
10822905|NCT03768089|11988162|FG000|NOT COMPLETED|Part C||0
10822906|NCT03768089|11988163|FG001|NOT COMPLETED|Part C||0
10822907|NCT03768089|11988164|FG002|NOT COMPLETED|Part C||0
10822908|NCT03768089|11988165|FG003|NOT COMPLETED|Part C||0
10822909|NCT03768089|11988166|FG004|NOT COMPLETED|Part C||0
10822910|NCT03768089|11988167|FG005|NOT COMPLETED|Part C||0
10822911|NCT03768089|11988168|FG006|NOT COMPLETED|Part C||0
10822912|NCT03768089|11988169|FG007|NOT COMPLETED|Part C||0
10822913|NCT03768089|11988170|FG008|NOT COMPLETED|Part C||0
10822914|NCT03768089|11988171|FG009|NOT COMPLETED|Part C||0
10822915|NCT03768089|11988172|FG010|NOT COMPLETED|Part C||0
10822916|NCT03768089|11988173|FG011|NOT COMPLETED|Part C||0
10822917|NCT03768089|11988174|FG012|NOT COMPLETED|Part C||0
10822918|NCT03768089|11988175|FG013|NOT COMPLETED|Part C||0
10822919|NCT03768089|11988176|FG014|NOT COMPLETED|Part C||1
10822920|NCT03768089|11988177|FG015|NOT COMPLETED|Part C||0
10822921|NCT03768089|11988178|FG016|NOT COMPLETED|Part C||0
10822922|NCT03768089|11988179|FG017|NOT COMPLETED|Part C||0
10822923|NCT03768089|11988162|FG000|STARTED|Part D||0
10822924|NCT03768089|11988163|FG001|STARTED|Part D||0
10822925|NCT03768089|11988164|FG002|STARTED|Part D||0
10822926|NCT03768089|11988165|FG003|STARTED|Part D||0
10822927|NCT03768089|11988166|FG004|STARTED|Part D||0
10822928|NCT03768089|11988167|FG005|STARTED|Part D||0
10822929|NCT03768089|11988168|FG006|STARTED|Part D||0
10822930|NCT03768089|11988169|FG007|STARTED|Part D||0
10822931|NCT03768089|11988170|FG008|STARTED|Part D||0
10822932|NCT03768089|11988171|FG009|STARTED|Part D||0
10822933|NCT03768089|11988172|FG010|STARTED|Part D||0
10822934|NCT03768089|11988173|FG011|STARTED|Part D||0
10822935|NCT03768089|11988174|FG012|STARTED|Part D||0
10822936|NCT03768089|11988175|FG013|STARTED|Part D||0
10822937|NCT03768089|11988176|FG014|STARTED|Part D||0
10822938|NCT03768089|11988177|FG015|STARTED|Part D||0
10822939|NCT03768089|11988178|FG016|STARTED|Part D||3
10822940|NCT03768089|11988179|FG017|STARTED|Part D||9
10822941|NCT03768089|11988162|FG000|Safety Set|Part D||0
10822942|NCT03768089|11988163|FG001|Safety Set|Part D||0
10822943|NCT03768089|11988164|FG002|Safety Set|Part D||0
10822944|NCT03768089|11988165|FG003|Safety Set|Part D||0
10822945|NCT03768089|11988166|FG004|Safety Set|Part D||0
10822946|NCT03768089|11988167|FG005|Safety Set|Part D||0
10822947|NCT03768089|11988168|FG006|Safety Set|Part D||0
10822948|NCT03768089|11988169|FG007|Safety Set|Part D||0
10822949|NCT03768089|11988170|FG008|Safety Set|Part D||0
10822950|NCT03768089|11988171|FG009|Safety Set|Part D||0
10822951|NCT03768089|11988172|FG010|Safety Set|Part D||0
10822952|NCT03768089|11988173|FG011|Safety Set|Part D||0
10822953|NCT03768089|11988174|FG012|Safety Set|Part D||0
10822954|NCT03768089|11988175|FG013|Safety Set|Part D||0
10822955|NCT03768089|11988176|FG014|Safety Set|Part D||0
10822956|NCT03768089|11988177|FG015|Safety Set|Part D||0
10822957|NCT03768089|11988178|FG016|Safety Set|Part D||3
10822958|NCT03768089|11988179|FG017|Safety Set|Part D||9
10822959|NCT03768089|11988162|FG000|COMPLETED|Part D||0
10822960|NCT03768089|11988163|FG001|COMPLETED|Part D||0
10822961|NCT03768089|11988164|FG002|COMPLETED|Part D||0
10822962|NCT03768089|11988165|FG003|COMPLETED|Part D||0
10822963|NCT03768089|11988166|FG004|COMPLETED|Part D||0
10822964|NCT03768089|11988167|FG005|COMPLETED|Part D||0
10822965|NCT03768089|11988168|FG006|COMPLETED|Part D||0
10822966|NCT03768089|11988169|FG007|COMPLETED|Part D||0
10822967|NCT03768089|11988170|FG008|COMPLETED|Part D||0
10822968|NCT03768089|11988171|FG009|COMPLETED|Part D||0
10822969|NCT03768089|11988172|FG010|COMPLETED|Part D||0
10822970|NCT03768089|11988173|FG011|COMPLETED|Part D||0
10822971|NCT03768089|11988174|FG012|COMPLETED|Part D||0
10822972|NCT03768089|11988175|FG013|COMPLETED|Part D||0
10822973|NCT03768089|11988176|FG014|COMPLETED|Part D||0
10822974|NCT03768089|11988177|FG015|COMPLETED|Part D||0
10822975|NCT03768089|11988178|FG016|COMPLETED|Part D||3
10822976|NCT03768089|11988179|FG017|COMPLETED|Part D||9
10822977|NCT03768089|11988162|FG000|NOT COMPLETED|Part D||0
10822978|NCT03768089|11988163|FG001|NOT COMPLETED|Part D||0
10822979|NCT03768089|11988164|FG002|NOT COMPLETED|Part D||0
10822980|NCT03768089|11988165|FG003|NOT COMPLETED|Part D||0
10822981|NCT03768089|11988166|FG004|NOT COMPLETED|Part D||0
10822982|NCT03768089|11988167|FG005|NOT COMPLETED|Part D||0
10822983|NCT03768089|11988168|FG006|NOT COMPLETED|Part D||0
10822984|NCT03768089|11988169|FG007|NOT COMPLETED|Part D||0
10822985|NCT03768089|11988170|FG008|NOT COMPLETED|Part D||0
10822986|NCT03768089|11988171|FG009|NOT COMPLETED|Part D||0
10822987|NCT03768089|11988172|FG010|NOT COMPLETED|Part D||0
10822988|NCT03768089|11988173|FG011|NOT COMPLETED|Part D||0
10822989|NCT03768089|11988174|FG012|NOT COMPLETED|Part D||0
10822990|NCT03768089|11988175|FG013|NOT COMPLETED|Part D||0
10822991|NCT03768089|11988176|FG014|NOT COMPLETED|Part D||0
10822992|NCT03768089|11988177|FG015|NOT COMPLETED|Part D||0
10822993|NCT03768089|11988178|FG016|NOT COMPLETED|Part D||0
10822994|NCT03768089|11988179|FG017|NOT COMPLETED|Part D||0
10822995|NCT03690544|11988234|FG000|STARTED|Overall Study||15
10822996|NCT03690544|11988234|FG000|COMPLETED|Overall Study||15
10822997|NCT03690544|11988234|FG000|NOT COMPLETED|Overall Study||0
11099218|NCT01218204|12282931|FG001|NOT COMPLETED|Part A||0
11099219|NCT01218204|12282932|FG002|NOT COMPLETED|Part A||0
11099220|NCT01218204|12282933|FG003|NOT COMPLETED|Part A||0
11099221|NCT01218204|12282930|FG000|STARTED|Part B Washout||0
11099222|NCT01218204|12282931|FG001|STARTED|Part B Washout||281
11099223|NCT01218204|12282932|FG002|STARTED|Part B Washout||0
11099224|NCT01218204|12282933|FG003|STARTED|Part B Washout||0
11099225|NCT01218204|12282930|FG000|COMPLETED|Part B Washout||0
11099226|NCT01218204|12282931|FG001|COMPLETED|Part B Washout||136
11099227|NCT01218204|12282932|FG002|COMPLETED|Part B Washout||0
11099228|NCT01218204|12282933|FG003|COMPLETED|Part B Washout||0
11099229|NCT01218204|12282930|FG000|NOT COMPLETED|Part B Washout||0
11099230|NCT01218204|12282931|FG001|NOT COMPLETED|Part B Washout||145
11099231|NCT01218204|12282932|FG002|NOT COMPLETED|Part B Washout||0
11099232|NCT01218204|12282933|FG003|NOT COMPLETED|Part B Washout||0
11099233|NCT01218204|12282930|FG000|STARTED|Part B Run-in||0
11099234|NCT01218204|12282931|FG001|STARTED|Part B Run-in||0
11099235|NCT01218204|12282932|FG002|STARTED|Part B Run-in||89
11099236|NCT01218204|12282933|FG003|STARTED|Part B Run-in||0
11099237|NCT01218204|12282930|FG000|COMPLETED|Part B Run-in||0
11099238|NCT01218204|12282931|FG001|COMPLETED|Part B Run-in||0
10823019|NCT03446573|11988255|FG000|STARTED|Overall Study||369
10823020|NCT03446573|11988256|FG001|STARTED|Overall Study||372
10823021|NCT03446573|11988255|FG000|COMPLETED|Overall Study||0
10823022|NCT03446573|11988256|FG001|COMPLETED|Overall Study||0
10823023|NCT03446573|11988255|FG000|NOT COMPLETED|Overall Study||369
10823024|NCT03446573|11988256|FG001|NOT COMPLETED|Overall Study||372
10823025|NCT03409666|11988267|FG000|STARTED|Overall Study||25
10823026|NCT03409666|11988268|FG001|STARTED|Overall Study||25
10823027|NCT03409666|11988267|FG000|COMPLETED|Overall Study||25
10823028|NCT03409666|11988268|FG001|COMPLETED|Overall Study||21
10823029|NCT03409666|11988267|FG000|NOT COMPLETED|Overall Study||0
10823030|NCT03409666|11988268|FG001|NOT COMPLETED|Overall Study||4
11099239|NCT01218204|12282932|FG002|COMPLETED|Part B Run-in||83
11099240|NCT01218204|12282933|FG003|COMPLETED|Part B Run-in||0
11099241|NCT01218204|12282930|FG000|NOT COMPLETED|Part B Run-in||0
11099242|NCT01218204|12282931|FG001|NOT COMPLETED|Part B Run-in||0
11099243|NCT01218204|12282932|FG002|NOT COMPLETED|Part B Run-in||6
11099244|NCT01218204|12282933|FG003|NOT COMPLETED|Part B Run-in||0
11099245|NCT01218204|12282930|FG000|STARTED|Part B Pooled Treatment Arm||0
11099246|NCT01218204|12282931|FG001|STARTED|Part B Pooled Treatment Arm||0
11099247|NCT01218204|12282932|FG002|STARTED|Part B Pooled Treatment Arm||0
11099248|NCT01218204|12282933|FG003|STARTED|Part B Pooled Treatment Arm||130
11099249|NCT01218204|12282930|FG000|COMPLETED|Part B Pooled Treatment Arm||0
11099250|NCT01218204|12282931|FG001|COMPLETED|Part B Pooled Treatment Arm||0
11099251|NCT01218204|12282932|FG002|COMPLETED|Part B Pooled Treatment Arm||0
11099252|NCT01218204|12282933|FG003|COMPLETED|Part B Pooled Treatment Arm||127
11099253|NCT01218204|12282930|FG000|NOT COMPLETED|Part B Pooled Treatment Arm||0
10823043|NCT03325426|11988293|FG000|STARTED|Overall Study||21
10823044|NCT03325426|11988294|FG001|STARTED|Overall Study||42
10823045|NCT03325426|11988293|FG000|COMPLETED|Overall Study||11
10823046|NCT03325426|11988294|FG001|COMPLETED|Overall Study||18
10823047|NCT03325426|11988293|FG000|NOT COMPLETED|Overall Study||10
10823048|NCT03325426|11988294|FG001|NOT COMPLETED|Overall Study||24
10823049|NCT03195088|11988306|FG000|STARTED|Overall Study||4
10823050|NCT03195088|11988307|FG001|STARTED|Overall Study||6
10823051|NCT03195088|11988308|FG002|STARTED|Overall Study||6
10823052|NCT03195088|11988306|FG000|COMPLETED|Overall Study||4
10823053|NCT03195088|11988307|FG001|COMPLETED|Overall Study||6
10823054|NCT03195088|11988308|FG002|COMPLETED|Overall Study||6
10823055|NCT03195088|11988306|FG000|NOT COMPLETED|Overall Study||0
10823056|NCT03195088|11988307|FG001|NOT COMPLETED|Overall Study||0
11099254|NCT01218204|12282931|FG001|NOT COMPLETED|Part B Pooled Treatment Arm||0
11099255|NCT01218204|12282932|FG002|NOT COMPLETED|Part B Pooled Treatment Arm||0
11099256|NCT01218204|12282933|FG003|NOT COMPLETED|Part B Pooled Treatment Arm||3
11099257|NCT01218243|12282982|FG000|STARTED|Overall Study||50
11099258|NCT01218243|12282983|FG001|STARTED|Overall Study||50
11099259|NCT01218243|12282982|FG000|Treatment Completed|Overall Study||45
11099260|NCT01218243|12282983|FG001|Treatment Completed|Overall Study||42
11219668|NCT01957202|12411342|FG001|COMPLETED|Washout Period 2 (14 to 28 Days)||5
11219669|NCT01957202|12411343|FG002|COMPLETED|Washout Period 2 (14 to 28 Days)||6
11219670|NCT01957202|12411344|FG003|COMPLETED|Washout Period 2 (14 to 28 Days)||3
11219671|NCT01957202|12411345|FG004|COMPLETED|Washout Period 2 (14 to 28 Days)||3
11219672|NCT01957202|12411346|FG005|COMPLETED|Washout Period 2 (14 to 28 Days)||2
11219673|NCT01957202|12411347|FG006|COMPLETED|Washout Period 2 (14 to 28 Days)||3
11219674|NCT01957202|12411348|FG007|COMPLETED|Washout Period 2 (14 to 28 Days)||3
11219675|NCT01957202|12411349|FG008|COMPLETED|Washout Period 2 (14 to 28 Days)||3
11353961|NCT03068455|12551211|FG000|COMPLETED|Treatment Period||364
10823057|NCT03195088|11988308|FG002|NOT COMPLETED|Overall Study||0
11099261|NCT01218243|12282982|FG000|COMPLETED|Overall Study||41
11099262|NCT01218243|12282983|FG001|COMPLETED|Overall Study||36
11099263|NCT01218243|12282982|FG000|NOT COMPLETED|Overall Study||9
11099264|NCT01218243|12282983|FG001|NOT COMPLETED|Overall Study||14
11099265|NCT01218308|12282991|FG000|STARTED|Overall Study||2584
11099266|NCT01218308|12282992|FG001|STARTED|Overall Study||2584
10823064|NCT03126019|11988341|FG000|STARTED|Overall Study||23
10823065|NCT03126019|11988342|FG001|STARTED|Overall Study||103
10823066|NCT03126019|11988341|FG000|COMPLETED|Overall Study||0
10823067|NCT03126019|11988342|FG001|COMPLETED|Overall Study||0
10823068|NCT03126019|11988341|FG000|NOT COMPLETED|Overall Study||23
10823069|NCT03126019|11988342|FG001|NOT COMPLETED|Overall Study||103
10823070|NCT03114059|11988349|FG000|STARTED|Overall Study||230
10823071|NCT03114059|11988349|FG000|COMPLETED|Overall Study||230
10823072|NCT03114059|11988349|FG000|NOT COMPLETED|Overall Study||0
11099267|NCT01218308|12282991|FG000|COMPLETED|Overall Study||2481
11099268|NCT01218308|12282992|FG001|COMPLETED|Overall Study||2464
11099269|NCT01218308|12282991|FG000|NOT COMPLETED|Overall Study||103
11099270|NCT01218308|12282992|FG001|NOT COMPLETED|Overall Study||120
11099271|NCT01218399|12283000|FG000|STARTED|Overall Study||5
11099272|NCT01218399|12283001|FG001|STARTED|Overall Study||5
11099273|NCT01218399|12283000|FG000|COMPLETED|Overall Study||5
11099274|NCT01218399|12283001|FG001|COMPLETED|Overall Study||5
11099275|NCT01218399|12283000|FG000|NOT COMPLETED|Overall Study||0
11099276|NCT01218399|12283001|FG001|NOT COMPLETED|Overall Study||0
10823083|NCT03089606|11988362|FG000|STARTED|Overall Study||27
10823084|NCT03089606|11988362|FG000|COMPLETED|Overall Study||26
10823085|NCT03089606|11988362|FG000|NOT COMPLETED|Overall Study||1
10823086|NCT03082391|11988374|FG000|STARTED|Overall Study||173
10823087|NCT03082391|11988375|FG001|STARTED|Overall Study||177
10823088|NCT03082391|11988374|FG000|COMPLETED|Overall Study||173
10823089|NCT03082391|11988375|FG001|COMPLETED|Overall Study||177
10823090|NCT03082391|11988374|FG000|NOT COMPLETED|Overall Study||0
10823091|NCT03082391|11988375|FG001|NOT COMPLETED|Overall Study||0
10823092|NCT03049111|11988381|FG000|STARTED|Overall Study||14
11099277|NCT01218438|12283007|FG000|STARTED|Epoch 1||77
10823093|NCT03049111|11988381|FG000|COMPLETED|Overall Study||14
11099278|NCT01218438|12283007|FG000|COMPLETED|Epoch 1||74
11099279|NCT01218438|12283007|FG000|NOT COMPLETED|Epoch 1||3
11099280|NCT01218438|12283007|FG000|STARTED|Epoch 2||45
10823094|NCT03049111|11988381|FG000|NOT COMPLETED|Overall Study||0
10823095|NCT02955602|11988388|FG000|STARTED|Overall Study||11
10823096|NCT02955602|11988389|FG001|STARTED|Overall Study||53
10823097|NCT02955602|11988390|FG002|STARTED|Overall Study||55
10823098|NCT02955602|11988388|FG000|COMPLETED|Overall Study||10
10823099|NCT02955602|11988389|FG001|COMPLETED|Overall Study||46
10823100|NCT02955602|11988390|FG002|COMPLETED|Overall Study||49
10823101|NCT02955602|11988388|FG000|NOT COMPLETED|Overall Study||1
10823102|NCT02955602|11988389|FG001|NOT COMPLETED|Overall Study||7
10823103|NCT02955602|11988390|FG002|NOT COMPLETED|Overall Study||6
11099281|NCT01218438|12283007|FG000|COMPLETED|Epoch 2||45
11099282|NCT01218438|12283007|FG000|NOT COMPLETED|Epoch 2||0
11099283|NCT01218438|12283007|FG000|STARTED|Epoch 3||74
10823107|NCT02850016|11988405|FG000|STARTED|Overall Study||11
10823108|NCT02850016|11988406|FG001|STARTED|Overall Study||9
10823109|NCT02850016|11988405|FG000|COMPLETED|Overall Study||10
10823110|NCT02850016|11988406|FG001|COMPLETED|Overall Study||7
10823111|NCT02850016|11988405|FG000|NOT COMPLETED|Overall Study||1
10823112|NCT02850016|11988406|FG001|NOT COMPLETED|Overall Study||2
11099284|NCT01218438|12283007|FG000|COMPLETED|Epoch 3||70
10823113|NCT02846545|11988414|FG000|STARTED|Active Treatment Period: Week 0-52||28
10823114|NCT02846545|11988415|FG001|STARTED|Active Treatment Period: Week 0-52||56
10823115|NCT02846545|11988414|FG000|COMPLETED|Active Treatment Period: Week 0-52||25
10823116|NCT02846545|11988415|FG001|COMPLETED|Active Treatment Period: Week 0-52||50
10823117|NCT02846545|11988414|FG000|NOT COMPLETED|Active Treatment Period: Week 0-52||3
10823118|NCT02846545|11988415|FG001|NOT COMPLETED|Active Treatment Period: Week 0-52||6
10823119|NCT02846545|11988414|FG000|STARTED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||25
10823120|NCT02846545|11988415|FG001|STARTED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|1 participant from the golimumab treatment group terminated study participation on the day of the Week 52 visit.|49
10823121|NCT02846545|11988414|FG000|Participants Who Entered OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||0
10823122|NCT02846545|11988415|FG001|Participants Who Entered OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||5
10823123|NCT02846545|11988414|FG000|Participants Who Completed OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||0
10823124|NCT02846545|11988415|FG001|Participants Who Completed OLE Period|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||1
10823125|NCT02846545|11988414|FG000|COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||23
10823126|NCT02846545|11988415|FG001|COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||47
10823127|NCT02846545|11988414|FG000|NOT COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||2
10823128|NCT02846545|11988415|FG001|NOT COMPLETED|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60||2
10823129|NCT02841644|11988427|FG000|STARTED|Overall Study||60
10823130|NCT02841644|11988428|FG001|STARTED|Overall Study||120
10823131|NCT02841644|11988427|FG000|COMPLETED|Overall Study||60
10823132|NCT02841644|11988428|FG001|COMPLETED|Overall Study||120
10823133|NCT02841644|11988427|FG000|NOT COMPLETED|Overall Study||0
10823134|NCT02841644|11988428|FG001|NOT COMPLETED|Overall Study||0
10823135|NCT02838979|11988436|FG000|STARTED|Overall Study||6
10823136|NCT02838979|11988437|FG001|STARTED|Overall Study||5
10823137|NCT02838979|11988436|FG000|COMPLETED|Overall Study||6
10823138|NCT02838979|11988437|FG001|COMPLETED|Overall Study||5
10823139|NCT02838979|11988436|FG000|NOT COMPLETED|Overall Study||0
10823140|NCT02838979|11988437|FG001|NOT COMPLETED|Overall Study||0
11099285|NCT01218438|12283007|FG000|NOT COMPLETED|Epoch 3||4
11099286|NCT01218438|12283007|FG000|STARTED|Epoch 4||70
11099287|NCT01218438|12283007|FG000|COMPLETED|Epoch 4||67
11099288|NCT01218438|12283007|FG000|NOT COMPLETED|Epoch 4||3
11099289|NCT01218477|12283085|FG000|STARTED|Overall Study|Participants who received treatment|3
11099290|NCT01218477|12283086|FG001|STARTED|Overall Study|Participants who received treatment|8
10823147|NCT02808585|11988457|FG000|STARTED|Overall Study||3
10823148|NCT02808585|11988458|FG001|STARTED|Overall Study||6
10823149|NCT02808585|11988459|FG002|STARTED|Overall Study||7
10823150|NCT02808585|11988460|FG003|STARTED|Overall Study||6
10823151|NCT02808585|11988461|FG004|STARTED|Overall Study||7
10823152|NCT02808585|11988457|FG000|COMPLETED|Overall Study||3
10823153|NCT02808585|11988458|FG001|COMPLETED|Overall Study||6
10823154|NCT02808585|11988459|FG002|COMPLETED|Overall Study||6
10823155|NCT02808585|11988460|FG003|COMPLETED|Overall Study||4
10823156|NCT02808585|11988461|FG004|COMPLETED|Overall Study||7
10823157|NCT02808585|11988457|FG000|NOT COMPLETED|Overall Study||0
10823158|NCT02808585|11988458|FG001|NOT COMPLETED|Overall Study||0
10823159|NCT02808585|11988459|FG002|NOT COMPLETED|Overall Study||1
10823160|NCT02808585|11988460|FG003|NOT COMPLETED|Overall Study||2
10823161|NCT02808585|11988461|FG004|NOT COMPLETED|Overall Study||0
11099291|NCT01218477|12283087|FG002|STARTED|Overall Study|Participants who received treatment|14
11099292|NCT01218477|12283088|FG003|STARTED|Overall Study|Participants who received treatment|2
11099293|NCT01218477|12283085|FG000|COMPLETED|Overall Study|Still receiving study drug|0
11099294|NCT01218477|12283086|FG001|COMPLETED|Overall Study|Still receiving study drug|0
10823168|NCT02728726|11988486|FG000|STARTED|Overall Study||127
10823169|NCT02728726|11988487|FG001|STARTED|Overall Study||133
10823170|NCT02728726|11988486|FG000|COMPLETED|Overall Study||127
10823171|NCT02728726|11988487|FG001|COMPLETED|Overall Study||133
10823172|NCT02728726|11988486|FG000|NOT COMPLETED|Overall Study||0
10823173|NCT02728726|11988487|FG001|NOT COMPLETED|Overall Study||0
10823174|NCT02544750|11988495|FG000|STARTED|Overall Study||124
10823175|NCT02544750|11988496|FG001|STARTED|Overall Study||75
10823176|NCT02544750|11988495|FG000|COMPLETED|Overall Study||22
10823177|NCT02544750|11988496|FG001|COMPLETED|Overall Study||12
10823178|NCT02544750|11988495|FG000|NOT COMPLETED|Overall Study||102
10823179|NCT02544750|11988496|FG001|NOT COMPLETED|Overall Study||63
10823180|NCT02448771|11988502|FG000|STARTED|Overall Study||36
10823181|NCT02448771|11988502|FG000|COMPLETED|Overall Study||0
10823182|NCT02448771|11988502|FG000|NOT COMPLETED|Overall Study||36
10823183|NCT02337829|11988511|FG000|STARTED|Overall Study||18
10823184|NCT02337829|11988512|FG001|STARTED|Overall Study||14
10823185|NCT02337829|11988513|FG002|STARTED|Overall Study||6
10823186|NCT02337829|11988514|FG003|STARTED|Overall Study||10
10823187|NCT02337829|11988511|FG000|COMPLETED|Overall Study||0
10823188|NCT02337829|11988512|FG001|COMPLETED|Overall Study||0
10823189|NCT02337829|11988513|FG002|COMPLETED|Overall Study||0
10823190|NCT02337829|11988514|FG003|COMPLETED|Overall Study||0
10823191|NCT02337829|11988511|FG000|NOT COMPLETED|Overall Study||18
10823192|NCT02337829|11988512|FG001|NOT COMPLETED|Overall Study||14
10823193|NCT02337829|11988513|FG002|NOT COMPLETED|Overall Study||6
10823194|NCT02337829|11988514|FG003|NOT COMPLETED|Overall Study||10
10823195|NCT02062944|11988526|FG000|STARTED|Overall Study||21
10823196|NCT02062944|11988526|FG000|COMPLETED|Overall Study||15
10823197|NCT02062944|11988526|FG000|NOT COMPLETED|Overall Study||6
10823198|NCT02053792|11988533|FG000|STARTED|Overall Study||83
10823199|NCT02053792|11988534|FG001|STARTED|Overall Study||14
10823200|NCT02053792|11988533|FG000|COMPLETED|Overall Study||77
10823201|NCT02053792|11988534|FG001|COMPLETED|Overall Study||10
10823202|NCT02053792|11988533|FG000|NOT COMPLETED|Overall Study||6
10823203|NCT02053792|11988534|FG001|NOT COMPLETED|Overall Study||4
10823204|NCT01972217|11988544|FG000|STARTED|Part A: Open-label Safety Run-in Period||3
10823205|NCT01972217|11988545|FG001|STARTED|Part A: Open-label Safety Run-in Period||13
10823206|NCT01972217|11988546|FG002|STARTED|Part A: Open-label Safety Run-in Period||0
10823207|NCT01972217|11988547|FG003|STARTED|Part A: Open-label Safety Run-in Period||0
10823208|NCT01972217|11988544|FG000|COMPLETED|Part A: Open-label Safety Run-in Period||2
10823209|NCT01972217|11988545|FG001|COMPLETED|Part A: Open-label Safety Run-in Period||1
10823210|NCT01972217|11988546|FG002|COMPLETED|Part A: Open-label Safety Run-in Period||0
10823211|NCT01972217|11988547|FG003|COMPLETED|Part A: Open-label Safety Run-in Period||0
10823212|NCT01972217|11988544|FG000|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
10823213|NCT01972217|11988545|FG001|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
10823214|NCT01972217|11988546|FG002|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
10823215|NCT01972217|11988547|FG003|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
10823216|NCT01972217|11988544|FG000|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
10823217|NCT01972217|11988545|FG001|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
10823218|NCT01972217|11988546|FG002|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
10823219|NCT01972217|11988547|FG003|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
10823220|NCT01972217|11988544|FG000|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
10823221|NCT01972217|11988545|FG001|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
10823222|NCT01972217|11988546|FG002|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
10823223|NCT01972217|11988547|FG003|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
10823224|NCT01972217|11988544|FG000|Received Abiraterone|Part B Double-blind, Randomised Period||0
10823225|NCT01972217|11988545|FG001|Received Abiraterone|Part B Double-blind, Randomised Period||0
10823226|NCT01972217|11988546|FG002|Received Abiraterone|Part B Double-blind, Randomised Period||71
10823227|NCT01972217|11988547|FG003|Received Abiraterone|Part B Double-blind, Randomised Period||71
10823228|NCT01972217|11988544|FG000|COMPLETED|Part B Double-blind, Randomised Period||0
10823229|NCT01972217|11988545|FG001|COMPLETED|Part B Double-blind, Randomised Period||0
10823230|NCT01972217|11988546|FG002|COMPLETED|Part B Double-blind, Randomised Period||25
10823231|NCT01972217|11988547|FG003|COMPLETED|Part B Double-blind, Randomised Period||24
10823232|NCT01972217|11988544|FG000|NOT COMPLETED|Part B Double-blind, Randomised Period||0
10823233|NCT01972217|11988545|FG001|NOT COMPLETED|Part B Double-blind, Randomised Period||0
10823234|NCT01972217|11988546|FG002|NOT COMPLETED|Part B Double-blind, Randomised Period||46
10823235|NCT01972217|11988547|FG003|NOT COMPLETED|Part B Double-blind, Randomised Period||47
11099295|NCT01218477|12283087|FG002|COMPLETED|Overall Study|Still receiving study drug|0
11099296|NCT01218477|12283088|FG003|COMPLETED|Overall Study|Still receiving study drug|0
11099297|NCT01218477|12283085|FG000|NOT COMPLETED|Overall Study||3
11099298|NCT01218477|12283086|FG001|NOT COMPLETED|Overall Study||8
11099299|NCT01218477|12283087|FG002|NOT COMPLETED|Overall Study||14
11099300|NCT01218477|12283088|FG003|NOT COMPLETED|Overall Study||2
11099301|NCT01218516|12283104|FG000|STARTED|Combination Therapy (up to 4.5 Months)||67
11099302|NCT01218516|12283105|FG001|STARTED|Combination Therapy (up to 4.5 Months)||63
11099303|NCT01218516|12283106|FG002|STARTED|Combination Therapy (up to 4.5 Months)||0
11099304|NCT01218516|12283107|FG003|STARTED|Combination Therapy (up to 4.5 Months)||0
10823248|NCT01785459|11988572|FG000|STARTED|Overall Study||11
10823249|NCT01785459|11988573|FG001|STARTED|Overall Study||12
10823250|NCT01785459|11988572|FG000|COMPLETED|Overall Study||11
10823251|NCT01785459|11988573|FG001|COMPLETED|Overall Study||12
10823252|NCT01785459|11988572|FG000|NOT COMPLETED|Overall Study||0
10823253|NCT01785459|11988573|FG001|NOT COMPLETED|Overall Study||0
10823254|NCT01691833|11988582|FG000|STARTED|Overall Study||50
10823255|NCT01691833|11988583|FG001|STARTED|Overall Study||50
10823256|NCT01691833|11988584|FG002|STARTED|Overall Study||13
10823257|NCT01691833|11988582|FG000|COMPLETED|Overall Study||49
10823258|NCT01691833|11988583|FG001|COMPLETED|Overall Study||49
10823259|NCT01691833|11988584|FG002|COMPLETED|Overall Study||13
10823260|NCT01691833|11988582|FG000|NOT COMPLETED|Overall Study||1
10823261|NCT01691833|11988583|FG001|NOT COMPLETED|Overall Study||1
10823262|NCT01691833|11988584|FG002|NOT COMPLETED|Overall Study||0
10823263|NCT01640301|11988594|FG000|STARTED|Overall Study||13
10823264|NCT01640301|11988595|FG001|STARTED|Overall Study||15
10823265|NCT01640301|11988594|FG000|COMPLETED|Overall Study||13
10823266|NCT01640301|11988595|FG001|COMPLETED|Overall Study||7
10823267|NCT01640301|11988594|FG000|NOT COMPLETED|Overall Study||0
10823268|NCT01640301|11988595|FG001|NOT COMPLETED|Overall Study||8
10823269|NCT01589302|11988603|FG000|STARTED|Overall Study||154
10823270|NCT01589302|11988603|FG000|Del17p Patients|Overall Study||76
10823271|NCT01589302|11988603|FG000|Non-Del17p Patients|Overall Study||76
10823272|NCT01589302|11988603|FG000|COMPLETED|Overall Study||152
10823273|NCT01589302|11988603|FG000|NOT COMPLETED|Overall Study||2
10823274|NCT00554515|11988608|FG000|STARTED|Overall Study||123
10823275|NCT00554515|11988608|FG000|Treated|Overall Study||120
10823276|NCT00554515|11988608|FG000|COMPLETED|Overall Study||5
10823277|NCT00554515|11988608|FG000|NOT COMPLETED|Overall Study||118
10823278|NCT00107198|11988633|FG000|STARTED|Overall Study||188
10823279|NCT00107198|11988633|FG000|COMPLETED|Overall Study||136
10823280|NCT00107198|11988633|FG000|NOT COMPLETED|Overall Study||52
10823281|NCT00345358|11988641|FG000|STARTED|Primary Vaccination Phase||150
10823282|NCT00345358|11988642|FG001|STARTED|Primary Vaccination Phase||150
10823283|NCT00345358|11988643|FG002|STARTED|Primary Vaccination Phase||150
10823284|NCT00345358|11988644|FG003|STARTED|Primary Vaccination Phase||150
10823285|NCT00345358|11988641|FG000|COMPLETED|Primary Vaccination Phase||145
10823286|NCT00345358|11988642|FG001|COMPLETED|Primary Vaccination Phase||146
10823287|NCT00345358|11988643|FG002|COMPLETED|Primary Vaccination Phase||142
10823288|NCT00345358|11988644|FG003|COMPLETED|Primary Vaccination Phase||148
10823289|NCT00345358|11988641|FG000|NOT COMPLETED|Primary Vaccination Phase||5
10823290|NCT00345358|11988642|FG001|NOT COMPLETED|Primary Vaccination Phase||4
10823291|NCT00345358|11988643|FG002|NOT COMPLETED|Primary Vaccination Phase||8
10823292|NCT00345358|11988644|FG003|NOT COMPLETED|Primary Vaccination Phase||2
10823293|NCT00345358|11988641|FG000|STARTED|Booster Vaccination Phase||145
10823294|NCT00345358|11988642|FG001|STARTED|Booster Vaccination Phase||145
10823295|NCT00345358|11988643|FG002|STARTED|Booster Vaccination Phase||0
10823296|NCT00345358|11988644|FG003|STARTED|Booster Vaccination Phase||0
10823297|NCT00345358|11988641|FG000|COMPLETED|Booster Vaccination Phase||141
10823298|NCT00345358|11988642|FG001|COMPLETED|Booster Vaccination Phase||145
10823299|NCT00345358|11988643|FG002|COMPLETED|Booster Vaccination Phase||0
10823300|NCT00345358|11988644|FG003|COMPLETED|Booster Vaccination Phase||0
10823301|NCT00345358|11988641|FG000|NOT COMPLETED|Booster Vaccination Phase||4
10823302|NCT00345358|11988642|FG001|NOT COMPLETED|Booster Vaccination Phase||0
10823303|NCT00345358|11988643|FG002|NOT COMPLETED|Booster Vaccination Phase||0
10823304|NCT00345358|11988644|FG003|NOT COMPLETED|Booster Vaccination Phase||0
10823305|NCT00345800|11988654|FG000|STARTED|Overall Study||25
10823306|NCT00345800|11988654|FG000|COMPLETED|Overall Study||25
10823307|NCT00345800|11988654|FG000|NOT COMPLETED|Overall Study||0
10823308|NCT00372229|11988660|FG000|STARTED|Study Phase||148
10823309|NCT00372229|11988661|FG001|STARTED|Study Phase||151
10823310|NCT00372229|11988660|FG000|COMPLETED|Study Phase||117
10823311|NCT00372229|11988661|FG001|COMPLETED|Study Phase||122
10823312|NCT00372229|11988660|FG000|NOT COMPLETED|Study Phase||31
10823313|NCT00372229|11988661|FG001|NOT COMPLETED|Study Phase||29
10823314|NCT00372229|11988660|FG000|STARTED|Follow-Up Phase||117
10823315|NCT00372229|11988661|FG001|STARTED|Follow-Up Phase||122
10823316|NCT00372229|11988660|FG000|COMPLETED|Follow-Up Phase||71
10823317|NCT00372229|11988661|FG001|COMPLETED|Follow-Up Phase||70
10823318|NCT00372229|11988660|FG000|NOT COMPLETED|Follow-Up Phase||46
10823319|NCT00372229|11988661|FG001|NOT COMPLETED|Follow-Up Phase||52
11099305|NCT01218516|12283104|FG000|COMPLETED|Combination Therapy (up to 4.5 Months)||38
11099306|NCT01218516|12283105|FG001|COMPLETED|Combination Therapy (up to 4.5 Months)||28
11099307|NCT01218516|12283106|FG002|COMPLETED|Combination Therapy (up to 4.5 Months)||0
11099308|NCT01218516|12283107|FG003|COMPLETED|Combination Therapy (up to 4.5 Months)||0
11099309|NCT01218516|12283104|FG000|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||29
11099310|NCT01218516|12283105|FG001|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||35
11099311|NCT01218516|12283106|FG002|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
10823329|NCT00413699|11988678|FG000|STARTED|Initial Period||1123
10823330|NCT00413699|11988679|FG001|STARTED|Initial Period||3358
10823331|NCT00413699|11988680|FG002|STARTED|Initial Period||0
10823332|NCT00413699|11988678|FG000|COMPLETED|Initial Period||484
10823333|NCT00413699|11988679|FG001|COMPLETED|Initial Period||1653
10823334|NCT00413699|11988680|FG002|COMPLETED|Initial Period||0
10823335|NCT00413699|11988678|FG000|NOT COMPLETED|Initial Period||639
10823336|NCT00413699|11988679|FG001|NOT COMPLETED|Initial Period||1705
10823337|NCT00413699|11988680|FG002|NOT COMPLETED|Initial Period||0
10823338|NCT00413699|11988678|FG000|STARTED|Extension Period||0
10823339|NCT00413699|11988679|FG001|STARTED|Extension Period||0
10823340|NCT00413699|11988680|FG002|STARTED|Extension Period||48
10823341|NCT00413699|11988678|FG000|COMPLETED|Extension Period||0
10823342|NCT00413699|11988679|FG001|COMPLETED|Extension Period||0
10823343|NCT00413699|11988680|FG002|COMPLETED|Extension Period||43
10823344|NCT00413699|11988678|FG000|NOT COMPLETED|Extension Period||0
10823345|NCT00413699|11988679|FG001|NOT COMPLETED|Extension Period||0
10823346|NCT00413699|11988680|FG002|NOT COMPLETED|Extension Period||5
10823347|NCT00435227|11988708|FG000|STARTED|Overall Study||5
10823348|NCT00435227|11988709|FG001|STARTED|Overall Study||7
10823349|NCT00435227|11988708|FG000|COMPLETED|Overall Study||5
10823350|NCT00435227|11988709|FG001|COMPLETED|Overall Study||7
10823351|NCT00435227|11988708|FG000|NOT COMPLETED|Overall Study||0
10823352|NCT00435227|11988709|FG001|NOT COMPLETED|Overall Study||0
10823407|NCT00442546|11988742|FG000|STARTED|Overall Study||103
10823408|NCT00442546|11988743|FG001|STARTED|Overall Study||100
10823409|NCT00442546|11988744|FG002|STARTED|Overall Study||104
10823410|NCT00442546|11988742|FG000|Received Treatment|Overall Study||98
10823411|NCT00442546|11988743|FG001|Received Treatment|Overall Study||96
10823412|NCT00442546|11988744|FG002|Received Treatment|Overall Study||98
10823413|NCT00442546|11988742|FG000|COMPLETED|Overall Study||77
10823414|NCT00442546|11988743|FG001|COMPLETED|Overall Study||63
10823415|NCT00442546|11988744|FG002|COMPLETED|Overall Study||71
10823416|NCT00442546|11988742|FG000|NOT COMPLETED|Overall Study||26
10823417|NCT00442546|11988743|FG001|NOT COMPLETED|Overall Study||37
10823418|NCT00442546|11988744|FG002|NOT COMPLETED|Overall Study||33
10823419|NCT04715932|11988756|FG000|STARTED|Overall Study||107
10823420|NCT04715932|11988757|FG001|STARTED|Overall Study||109
10823421|NCT04715932|11988756|FG000|COMPLETED|Overall Study||106
10823422|NCT04715932|11988757|FG001|COMPLETED|Overall Study||109
10823423|NCT04715932|11988756|FG000|NOT COMPLETED|Overall Study||1
10823353|NCT00436826|11988718|FG000|STARTED|Double Blind Period (DBP)||124
10823354|NCT00436826|11988719|FG001|STARTED|Double Blind Period (DBP)||48
10823355|NCT00436826|11988720|FG002|STARTED|Double Blind Period (DBP)||0
10823356|NCT00436826|11988721|FG003|STARTED|Double Blind Period (DBP)||0
10823357|NCT00436826|11988722|FG004|STARTED|Double Blind Period (DBP)||0
10823358|NCT00436826|11988723|FG005|STARTED|Double Blind Period (DBP)||0
10823359|NCT00436826|11988718|FG000|COMPLETED|Double Blind Period (DBP)||111
10823360|NCT00436826|11988719|FG001|COMPLETED|Double Blind Period (DBP)||37
10823361|NCT00436826|11988720|FG002|COMPLETED|Double Blind Period (DBP)||0
10823362|NCT00436826|11988721|FG003|COMPLETED|Double Blind Period (DBP)||0
10823363|NCT00436826|11988722|FG004|COMPLETED|Double Blind Period (DBP)||0
10823364|NCT00436826|11988723|FG005|COMPLETED|Double Blind Period (DBP)||0
10823365|NCT00436826|11988718|FG000|NOT COMPLETED|Double Blind Period (DBP)||13
10823366|NCT00436826|11988719|FG001|NOT COMPLETED|Double Blind Period (DBP)||11
10823367|NCT00436826|11988720|FG002|NOT COMPLETED|Double Blind Period (DBP)||0
10823368|NCT00436826|11988721|FG003|NOT COMPLETED|Double Blind Period (DBP)||0
10823369|NCT00436826|11988722|FG004|NOT COMPLETED|Double Blind Period (DBP)||0
10823370|NCT00436826|11988723|FG005|NOT COMPLETED|Double Blind Period (DBP)||0
10823371|NCT00436826|11988718|FG000|STARTED|Ext. Period (With Cladribine Treatment)||0
10823372|NCT00436826|11988719|FG001|STARTED|Ext. Period (With Cladribine Treatment)||0
10823373|NCT00436826|11988720|FG002|STARTED|Ext. Period (With Cladribine Treatment)||47
10823374|NCT00436826|11988721|FG003|STARTED|Ext. Period (With Cladribine Treatment)||28
10823375|NCT00436826|11988722|FG004|STARTED|Ext. Period (With Cladribine Treatment)||0
10823376|NCT00436826|11988723|FG005|STARTED|Ext. Period (With Cladribine Treatment)||0
10823377|NCT00436826|11988718|FG000|COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823378|NCT00436826|11988719|FG001|COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823379|NCT00436826|11988720|FG002|COMPLETED|Ext. Period (With Cladribine Treatment)||1
10823380|NCT00436826|11988721|FG003|COMPLETED|Ext. Period (With Cladribine Treatment)||2
10823381|NCT00436826|11988722|FG004|COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823382|NCT00436826|11988723|FG005|COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823383|NCT00436826|11988718|FG000|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823384|NCT00436826|11988719|FG001|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823385|NCT00436826|11988720|FG002|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||46
10823386|NCT00436826|11988721|FG003|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||26
10823387|NCT00436826|11988722|FG004|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823388|NCT00436826|11988723|FG005|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
10823389|NCT00436826|11988718|FG000|STARTED|Ext. Period (No Cladribine Treatment)||0
10823390|NCT00436826|11988719|FG001|STARTED|Ext. Period (No Cladribine Treatment)||0
10823391|NCT00436826|11988720|FG002|STARTED|Ext. Period (No Cladribine Treatment)||0
10823392|NCT00436826|11988721|FG003|STARTED|Ext. Period (No Cladribine Treatment)||0
10823393|NCT00436826|11988722|FG004|STARTED|Ext. Period (No Cladribine Treatment)||52
10823394|NCT00436826|11988723|FG005|STARTED|Ext. Period (No Cladribine Treatment)||7
10823395|NCT00436826|11988718|FG000|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823396|NCT00436826|11988719|FG001|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823397|NCT00436826|11988720|FG002|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823398|NCT00436826|11988721|FG003|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823399|NCT00436826|11988722|FG004|COMPLETED|Ext. Period (No Cladribine Treatment)||1
10823400|NCT00436826|11988723|FG005|COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823401|NCT00436826|11988718|FG000|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823402|NCT00436826|11988719|FG001|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823403|NCT00436826|11988720|FG002|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823404|NCT00436826|11988721|FG003|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
10823405|NCT00436826|11988722|FG004|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
10823406|NCT00436826|11988723|FG005|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
10823424|NCT04715932|11988757|FG001|NOT COMPLETED|Overall Study||0
10823425|NCT04666441|11988771|FG000|STARTED|Overall Study||82
10823426|NCT04666441|11988772|FG001|STARTED|Overall Study||165
10823427|NCT04666441|11988773|FG002|STARTED|Overall Study||162
10823428|NCT04666441|11988774|FG003|STARTED|Overall Study||165
10823429|NCT04666441|11988775|FG004|STARTED|Overall Study||166
10823430|NCT04666441|11988776|FG005|STARTED|Overall Study||82
10823431|NCT04666441|11988777|FG006|STARTED|Overall Study||163
10823432|NCT04666441|11988778|FG007|STARTED|Overall Study||164
10823433|NCT04666441|11988771|FG000|COMPLETED|Overall Study||80
10823434|NCT04666441|11988772|FG001|COMPLETED|Overall Study||160
10823435|NCT04666441|11988773|FG002|COMPLETED|Overall Study||158
10823436|NCT04666441|11988774|FG003|COMPLETED|Overall Study||161
10823437|NCT04666441|11988775|FG004|COMPLETED|Overall Study||166
10823438|NCT04666441|11988776|FG005|COMPLETED|Overall Study||79
10823439|NCT04666441|11988777|FG006|COMPLETED|Overall Study||158
10823440|NCT04666441|11988778|FG007|COMPLETED|Overall Study||160
10823441|NCT04666441|11988771|FG000|NOT COMPLETED|Overall Study||2
10823442|NCT04666441|11988772|FG001|NOT COMPLETED|Overall Study||5
10823443|NCT04666441|11988773|FG002|NOT COMPLETED|Overall Study||4
10823444|NCT04666441|11988774|FG003|NOT COMPLETED|Overall Study||4
10823445|NCT04666441|11988775|FG004|NOT COMPLETED|Overall Study||0
10823446|NCT04666441|11988776|FG005|NOT COMPLETED|Overall Study||3
10823447|NCT04666441|11988777|FG006|NOT COMPLETED|Overall Study||5
10823448|NCT04666441|11988778|FG007|NOT COMPLETED|Overall Study||4
10823449|NCT04593641|11988809|FG000|STARTED|Overall Study||5
10823450|NCT04593641|11988810|FG001|STARTED|Overall Study||5
10823451|NCT04593641|11988811|FG002|STARTED|Overall Study||5
10823452|NCT04593641|11988812|FG003|STARTED|Overall Study||3
10823453|NCT04593641|11988809|FG000|COMPLETED|Overall Study||4
10823454|NCT04593641|11988810|FG001|COMPLETED|Overall Study||5
10823455|NCT04593641|11988811|FG002|COMPLETED|Overall Study||5
10823456|NCT04593641|11988812|FG003|COMPLETED|Overall Study||3
10823457|NCT04593641|11988809|FG000|NOT COMPLETED|Overall Study||1
10823458|NCT04593641|11988810|FG001|NOT COMPLETED|Overall Study||0
10823459|NCT04593641|11988811|FG002|NOT COMPLETED|Overall Study||0
10823460|NCT04593641|11988812|FG003|NOT COMPLETED|Overall Study||0
10823461|NCT04381052|11988824|FG000|STARTED|Overall Study||1
10823462|NCT04381052|11988824|FG000|COMPLETED|Overall Study||1
10823463|NCT04381052|11988824|FG000|NOT COMPLETED|Overall Study||0
10823464|NCT04259346|11988832|FG000|STARTED|Overall Study||126
10823465|NCT04259346|11988833|FG001|STARTED|Overall Study||119
10823466|NCT04259346|11988832|FG000|Received at Least One Dose of Study Drug|Overall Study||126
10823467|NCT04259346|11988833|FG001|Received at Least One Dose of Study Drug|Overall Study||119
10823468|NCT04259346|11988832|FG000|COMPLETED|Overall Study||122
10823469|NCT04259346|11988833|FG001|COMPLETED|Overall Study||115
10823470|NCT04259346|11988832|FG000|NOT COMPLETED|Overall Study||4
10823471|NCT04259346|11988833|FG001|NOT COMPLETED|Overall Study||4
10823472|NCT03959423|11988841|FG000|STARTED|Overall Study||160
10823473|NCT03959423|11988842|FG001|STARTED|Overall Study||128
10823474|NCT03959423|11988841|FG000|COMPLETED|Overall Study||151
10823475|NCT03959423|11988842|FG001|COMPLETED|Overall Study||124
10823476|NCT03959423|11988841|FG000|NOT COMPLETED|Overall Study||9
10823477|NCT03959423|11988842|FG001|NOT COMPLETED|Overall Study||4
10823478|NCT03713320|11988850|FG000|STARTED|Randomized Period||19
10823479|NCT03713320|11988851|FG001|STARTED|Randomized Period||18
10823480|NCT03713320|11988852|FG002|STARTED|Randomized Period||0
10823481|NCT03713320|11988850|FG000|COMPLETED|Randomized Period||4
10823482|NCT03713320|11988851|FG001|COMPLETED|Randomized Period||8
10823483|NCT03713320|11988852|FG002|COMPLETED|Randomized Period||0
10823484|NCT03713320|11988850|FG000|NOT COMPLETED|Randomized Period||15
10823485|NCT03713320|11988851|FG001|NOT COMPLETED|Randomized Period||10
10823486|NCT03713320|11988852|FG002|NOT COMPLETED|Randomized Period||0
10823487|NCT03713320|11988850|FG000|STARTED|Cobomarsen Crossover Period||0
10823488|NCT03713320|11988851|FG001|STARTED|Cobomarsen Crossover Period||0
10823489|NCT03713320|11988852|FG002|STARTED|Cobomarsen Crossover Period||7
10823490|NCT03713320|11988850|FG000|COMPLETED|Cobomarsen Crossover Period||0
10823491|NCT03713320|11988851|FG001|COMPLETED|Cobomarsen Crossover Period||0
10823492|NCT03713320|11988852|FG002|COMPLETED|Cobomarsen Crossover Period||0
10823493|NCT03713320|11988850|FG000|NOT COMPLETED|Cobomarsen Crossover Period||0
10823494|NCT03713320|11988851|FG001|NOT COMPLETED|Cobomarsen Crossover Period||0
10823495|NCT03713320|11988852|FG002|NOT COMPLETED|Cobomarsen Crossover Period||7
11099312|NCT01218516|12283107|FG003|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
11099313|NCT01218516|12283104|FG000|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
11099314|NCT01218516|12283105|FG001|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
11099315|NCT01218516|12283106|FG002|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|38
11099316|NCT01218516|12283107|FG003|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|28
10823504|NCT03409731|11988868|FG000|STARTED|Overall Study||135
10823505|NCT03409731|11988868|FG000|COMPLETED|Overall Study||132
10823506|NCT03409731|11988868|FG000|NOT COMPLETED|Overall Study||3
10823507|NCT03283566|11988874|FG000|STARTED|Overall Study||4
10823508|NCT03283566|11988875|FG001|STARTED|Overall Study||5
10823509|NCT03283566|11988874|FG000|COMPLETED|Overall Study||3
10823510|NCT03283566|11988875|FG001|COMPLETED|Overall Study||3
10823511|NCT03283566|11988874|FG000|NOT COMPLETED|Overall Study||1
10823512|NCT03283566|11988875|FG001|NOT COMPLETED|Overall Study||2
10823513|NCT03077412|11988884|FG000|STARTED|Overall Study||17
10823514|NCT03077412|11988885|FG001|STARTED|Overall Study||25
10823515|NCT03077412|11988886|FG002|STARTED|Overall Study||15
10823516|NCT03077412|11988884|FG000|COMPLETED|Overall Study||14
10823517|NCT03077412|11988885|FG001|COMPLETED|Overall Study||12
10823518|NCT03077412|11988886|FG002|COMPLETED|Overall Study||6
10823519|NCT03077412|11988884|FG000|NOT COMPLETED|Overall Study||3
10823520|NCT03077412|11988885|FG001|NOT COMPLETED|Overall Study||13
10823521|NCT03077412|11988886|FG002|NOT COMPLETED|Overall Study||9
10823522|NCT03026504|11988894|FG000|STARTED|Overall Study||15
10823523|NCT03026504|11988894|FG000|COMPLETED|Overall Study||14
10823524|NCT03026504|11988894|FG000|NOT COMPLETED|Overall Study||1
10823525|NCT02971956|11988898|FG000|STARTED|Overall Study||49
10823526|NCT02971956|11988898|FG000|COMPLETED|Overall Study||49
10823527|NCT02971956|11988898|FG000|NOT COMPLETED|Overall Study||0
10823528|NCT02915367|11988904|FG000|STARTED|Overall Study||173
10823529|NCT02915367|11988905|FG001|STARTED|Overall Study||175
10823530|NCT02915367|11988904|FG000|COMPLETED|Overall Study||136
10823531|NCT02915367|11988905|FG001|COMPLETED|Overall Study||144
10823532|NCT02915367|11988904|FG000|NOT COMPLETED|Overall Study||37
10823533|NCT02915367|11988905|FG001|NOT COMPLETED|Overall Study||31
10823534|NCT02665143|11988911|FG000|STARTED|Phase 1||6
10823535|NCT02665143|11988911|FG000|COMPLETED|Phase 1||6
10823536|NCT02665143|11988911|FG000|NOT COMPLETED|Phase 1||0
10823537|NCT02665143|11988911|FG000|STARTED|Phase 2|19 Participants were enrolled in Phase 2.|19
10823538|NCT02665143|11988911|FG000|Completed 0 Cycles|Phase 2||1
10823539|NCT02665143|11988911|FG000|Completed 1 Cycle|Phase 2||12
10823540|NCT02665143|11988911|FG000|Completed 2 Cycles|Phase 2||3
10823541|NCT02665143|11988911|FG000|Completed 3 Cycles|Phase 2||3
10823542|NCT02665143|11988911|FG000|COMPLETED|Phase 2||19
10823543|NCT02665143|11988911|FG000|NOT COMPLETED|Phase 2||0
10823544|NCT02550470|11988919|FG000|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10823545|NCT02550470|11988920|FG001|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10823546|NCT02550470|11988921|FG002|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10823547|NCT02550470|11988919|FG000|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10823548|NCT02550470|11988920|FG001|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10823549|NCT02550470|11988921|FG002|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
10823550|NCT02550470|11988919|FG000|NOT COMPLETED|Overall Study||
10823551|NCT02550470|11988920|FG001|NOT COMPLETED|Overall Study||
10823552|NCT02550470|11988921|FG002|NOT COMPLETED|Overall Study||
10823553|NCT02384850|11988931|FG000|STARTED|Overall Study||4
10823554|NCT02384850|11988932|FG001|STARTED|Overall Study||6
10823555|NCT02384850|11988931|FG000|COMPLETED|Overall Study||2
10823556|NCT02384850|11988932|FG001|COMPLETED|Overall Study||4
10823557|NCT02384850|11988931|FG000|NOT COMPLETED|Overall Study||2
10823558|NCT02384850|11988932|FG001|NOT COMPLETED|Overall Study||2
11099317|NCT01218516|12283104|FG000|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
11099318|NCT01218516|12283105|FG001|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
11099319|NCT01218516|12283106|FG002|Safety Analysis Set|Monotherapy (up to 23.5 Months)||35
11099320|NCT01218516|12283107|FG003|Safety Analysis Set|Monotherapy (up to 23.5 Months)|Three participants were randomized to placebo but actually received Farletuzumab.|31
11099321|NCT01218516|12283104|FG000|COMPLETED|Monotherapy (up to 23.5 Months)||0
11099322|NCT01218516|12283105|FG001|COMPLETED|Monotherapy (up to 23.5 Months)||0
11099323|NCT01218516|12283106|FG002|COMPLETED|Monotherapy (up to 23.5 Months)||38
11099324|NCT01218516|12283107|FG003|COMPLETED|Monotherapy (up to 23.5 Months)||28
11099325|NCT01218516|12283104|FG000|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
11099326|NCT01218516|12283105|FG001|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
11099327|NCT01218516|12283106|FG002|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
11099328|NCT01218516|12283107|FG003|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
11099329|NCT01218542|12283117|FG000|STARTED|Overall Study||22
11099330|NCT01218542|12283117|FG000|COMPLETED|Overall Study||13
11099331|NCT01218542|12283117|FG000|NOT COMPLETED|Overall Study||9
11099332|NCT01218594|12283122|FG000|STARTED|Overall Study||48
11099333|NCT01218594|12283122|FG000|COMPLETED|Overall Study||36
11099334|NCT01218594|12283122|FG000|NOT COMPLETED|Overall Study||12
11099335|NCT01218646|12283130|FG000|STARTED|Overall Study||225
11099336|NCT01218646|12283131|FG001|STARTED|Overall Study||225
11099337|NCT01218646|12283132|FG002|STARTED|Overall Study||225
11219676|NCT01957202|12411350|FG009|COMPLETED|Washout Period 2 (14 to 28 Days)||6
11219677|NCT01957202|12411351|FG010|COMPLETED|Washout Period 2 (14 to 28 Days)||3
11219678|NCT01957202|12411352|FG011|COMPLETED|Washout Period 2 (14 to 28 Days)||6
11219679|NCT01957202|12411353|FG012|COMPLETED|Washout Period 2 (14 to 28 Days)||3
11219680|NCT01957202|12411354|FG013|COMPLETED|Washout Period 2 (14 to 28 Days)||3
11219681|NCT01957202|12411355|FG014|COMPLETED|Washout Period 2 (14 to 28 Days)||6
11219682|NCT01957202|12411356|FG015|COMPLETED|Washout Period 2 (14 to 28 Days)||3
11219683|NCT01957202|12411357|FG016|COMPLETED|Washout Period 2 (14 to 28 Days)||5
11219684|NCT01957202|12411358|FG017|COMPLETED|Washout Period 2 (14 to 28 Days)||3
11219685|NCT01957202|12411341|FG000|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11219686|NCT01957202|12411342|FG001|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11219687|NCT01957202|12411343|FG002|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11219688|NCT01957202|12411344|FG003|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11219689|NCT01957202|12411345|FG004|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11099338|NCT01218646|12283133|FG003|STARTED|Overall Study||64
11099339|NCT01218646|12283130|FG000|COMPLETED|Overall Study||224
11099340|NCT01218646|12283131|FG001|COMPLETED|Overall Study||225
11099341|NCT01218646|12283132|FG002|COMPLETED|Overall Study||223
11099342|NCT01218646|12283133|FG003|COMPLETED|Overall Study||63
11099343|NCT01218646|12283130|FG000|NOT COMPLETED|Overall Study||1
10823601|NCT00971867|11988991|FG000|STARTED|Overall Study||11
10823602|NCT00971867|11988991|FG000|COMPLETED|Overall Study||0
10823603|NCT00971867|11988991|FG000|NOT COMPLETED|Overall Study||11
10823604|NCT00853307|11988997|FG000|STARTED|Overall Study||6
10823605|NCT00853307|11988998|FG001|STARTED|Overall Study||25
10823606|NCT00853307|11988997|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
10823607|NCT00853307|11988998|FG001|COMPLETED|Overall Study||20
10823608|NCT00853307|11988997|FG000|NOT COMPLETED|Overall Study||2
10823609|NCT00853307|11988998|FG001|NOT COMPLETED|Overall Study||5
10823610|NCT00583804|11989004|FG000|STARTED|Overall Study||10
10823611|NCT00583804|11989004|FG000|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
10823612|NCT00583804|11989004|FG000|NOT COMPLETED|Overall Study||0
11099344|NCT01218646|12283131|FG001|NOT COMPLETED|Overall Study||0
11099345|NCT01218646|12283132|FG002|NOT COMPLETED|Overall Study||2
11099346|NCT01218646|12283133|FG003|NOT COMPLETED|Overall Study||1
11099347|NCT01218659|12283145|FG000|STARTED|18-Month Randomized Period||36
11099348|NCT01218659|12283146|FG001|STARTED|18-Month Randomized Period||24
11099349|NCT01218659|12283147|FG002|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
11099350|NCT01218659|12283145|FG000|Safety Population|18-Month Randomized Period||36
11099351|NCT01218659|12283146|FG001|Safety Population|18-Month Randomized Period||21
11099352|NCT01218659|12283147|FG002|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
11099353|NCT01218659|12283145|FG000|COMPLETED|18-Month Randomized Period||34
11099354|NCT01218659|12283146|FG001|COMPLETED|18-Month Randomized Period||18
11099355|NCT01218659|12283147|FG002|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
11099356|NCT01218659|12283145|FG000|NOT COMPLETED|18-Month Randomized Period||2
11099357|NCT01218659|12283146|FG001|NOT COMPLETED|18-Month Randomized Period||6
11099358|NCT01218659|12283147|FG002|NOT COMPLETED|18-Month Randomized Period||0
11099359|NCT01218659|12283145|FG000|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
11099360|NCT01218659|12283146|FG001|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
11099361|NCT01218659|12283147|FG002|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
11099362|NCT01218659|12283145|FG000|Safety Population|12-Month OLE||0
11099363|NCT01218659|12283146|FG001|Safety Population|12-Month OLE||0
11099364|NCT01218659|12283147|FG002|Safety Population|12-Month OLE||51
11099365|NCT01218659|12283145|FG000|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
11099366|NCT01218659|12283146|FG001|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
11099367|NCT01218659|12283147|FG002|Modified Intent-to-Treat (mITT)|12-Month OLE||46
11099368|NCT01218659|12283145|FG000|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
11099369|NCT01218659|12283146|FG001|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
11099370|NCT01218659|12283147|FG002|COMPLETED|12-Month OLE||42
11099371|NCT01218659|12283145|FG000|NOT COMPLETED|12-Month OLE||0
11099372|NCT01218659|12283146|FG001|NOT COMPLETED|12-Month OLE||0
10823613|NCT00545129|11989012|FG000|STARTED|Overall Study||29
10823614|NCT00545129|11989013|FG001|STARTED|Overall Study||30
10823615|NCT00545129|11989012|FG000|COMPLETED|Overall Study||12
10823616|NCT00545129|11989013|FG001|COMPLETED|Overall Study||6
10823617|NCT00545129|11989012|FG000|NOT COMPLETED|Overall Study||17
10823618|NCT00545129|11989013|FG001|NOT COMPLETED|Overall Study||24
10823625|NCT00554606|11989031|FG000|STARTED|Overall Study||115
10823626|NCT00554606|11989031|FG000|COMPLETED|Overall Study||30
10823627|NCT00554606|11989031|FG000|NOT COMPLETED|Overall Study||85
10823634|NCT00565461|11989050|FG000|STARTED|Overall Study||40
10823635|NCT00565461|11989051|FG001|STARTED|Overall Study||40
10823636|NCT00565461|11989052|FG002|STARTED|Overall Study||40
10823637|NCT00565461|11989053|FG003|STARTED|Overall Study||40
10823638|NCT00565461|11989050|FG000|COMPLETED|Overall Study||40
10823639|NCT00565461|11989051|FG001|COMPLETED|Overall Study||39
10823640|NCT00565461|11989052|FG002|COMPLETED|Overall Study||39
10823641|NCT00565461|11989053|FG003|COMPLETED|Overall Study||37
10823642|NCT00565461|11989050|FG000|NOT COMPLETED|Overall Study||0
10823643|NCT00565461|11989051|FG001|NOT COMPLETED|Overall Study||1
10823644|NCT00565461|11989052|FG002|NOT COMPLETED|Overall Study||1
10823645|NCT00565461|11989053|FG003|NOT COMPLETED|Overall Study||3
10823649|NCT00586924|11989079|FG000|STARTED|Overall Study||3
10823619|NCT00548093|11989021|FG000|STARTED|Overall Study||50
10823620|NCT00548093|11989022|FG001|STARTED|Overall Study||16
10823621|NCT00548093|11989021|FG000|COMPLETED|Overall Study||0
10823622|NCT00548093|11989022|FG001|COMPLETED|Overall Study||0
10823623|NCT00548093|11989021|FG000|NOT COMPLETED|Overall Study||50
10823624|NCT00548093|11989022|FG001|NOT COMPLETED|Overall Study||16
10823628|NCT00555009|11989039|FG000|STARTED|Overall Study||4
10823629|NCT00555009|11989040|FG001|STARTED|Overall Study||6
10823630|NCT00555009|11989039|FG000|COMPLETED|Overall Study||2
10823631|NCT00555009|11989040|FG001|COMPLETED|Overall Study||0
10823632|NCT00555009|11989039|FG000|NOT COMPLETED|Overall Study||2
10823633|NCT00555009|11989040|FG001|NOT COMPLETED|Overall Study||6
10823646|NCT00566995|11989069|FG000|STARTED|Overall Study||37
10823647|NCT00566995|11989069|FG000|COMPLETED|Overall Study||30
10823648|NCT00566995|11989069|FG000|NOT COMPLETED|Overall Study||7
10823650|NCT00586924|11989080|FG001|STARTED|Overall Study||3
10823651|NCT00586924|11989081|FG002|STARTED|Overall Study||3
10823652|NCT00586924|11989082|FG003|STARTED|Overall Study||3
10823653|NCT00586924|11989083|FG004|STARTED|Overall Study||4
10823654|NCT00586924|11989084|FG005|STARTED|Overall Study||33
10823655|NCT00586924|11989079|FG000|COMPLETED|Overall Study||0
10823656|NCT00586924|11989080|FG001|COMPLETED|Overall Study||0
10823657|NCT00586924|11989081|FG002|COMPLETED|Overall Study||0
10823658|NCT00586924|11989082|FG003|COMPLETED|Overall Study||0
10823659|NCT00586924|11989083|FG004|COMPLETED|Overall Study||0
10823660|NCT00586924|11989084|FG005|COMPLETED|Overall Study||0
10823661|NCT00586924|11989079|FG000|NOT COMPLETED|Overall Study||3
10823662|NCT00586924|11989080|FG001|NOT COMPLETED|Overall Study||3
10823663|NCT00586924|11989081|FG002|NOT COMPLETED|Overall Study||3
10823664|NCT00586924|11989082|FG003|NOT COMPLETED|Overall Study||3
10823665|NCT00586924|11989083|FG004|NOT COMPLETED|Overall Study||4
10823666|NCT00586924|11989084|FG005|NOT COMPLETED|Overall Study||33
11099373|NCT01218659|12283147|FG002|NOT COMPLETED|12-Month OLE||10
11099374|NCT01218672|12283156|FG000|STARTED|Overall Study||139
11099375|NCT01218672|12283157|FG001|STARTED|Overall Study||142
11099376|NCT01218672|12283156|FG000|Treated|Overall Study||136
11099377|NCT01218672|12283157|FG001|Treated|Overall Study||133
11099378|NCT01218672|12283156|FG000|COMPLETED|Overall Study||128
11099379|NCT01218672|12283157|FG001|COMPLETED|Overall Study||121
11099380|NCT01218672|12283156|FG000|NOT COMPLETED|Overall Study||11
10823667|NCT00588861|11989100|FG000|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
10823668|NCT00588861|11989101|FG001|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
10823669|NCT00588861|11989100|FG000|COMPLETED|Pre-Operative||107
10823670|NCT00588861|11989101|FG001|COMPLETED|Pre-Operative||114
10823671|NCT00588861|11989100|FG000|NOT COMPLETED|Pre-Operative||95
10823672|NCT00588861|11989101|FG001|NOT COMPLETED|Pre-Operative||86
10823673|NCT00588861|11989100|FG000|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
10823674|NCT00588861|11989101|FG001|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
10823675|NCT00588861|11989100|FG000|COMPLETED|6 Months||9
10823676|NCT00588861|11989101|FG001|COMPLETED|6 Months||41
10823677|NCT00588861|11989100|FG000|NOT COMPLETED|6 Months||98
10823678|NCT00588861|11989101|FG001|NOT COMPLETED|6 Months||73
10823679|NCT00588861|11989100|FG000|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
10823680|NCT00588861|11989101|FG001|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
10823681|NCT00588861|11989100|FG000|COMPLETED|1 Year||18
10823682|NCT00588861|11989101|FG001|COMPLETED|1 Year||32
10823683|NCT00588861|11989100|FG000|NOT COMPLETED|1 Year||89
10823684|NCT00588861|11989101|FG001|NOT COMPLETED|1 Year||82
10823685|NCT00588861|11989100|FG000|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
10823686|NCT00588861|11989101|FG001|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
10823687|NCT00588861|11989100|FG000|COMPLETED|2 Years||15
10823688|NCT00588861|11989101|FG001|COMPLETED|2 Years||27
10823689|NCT00588861|11989100|FG000|NOT COMPLETED|2 Years||92
10823690|NCT00588861|11989101|FG001|NOT COMPLETED|2 Years||87
10823691|NCT00588861|11989100|FG000|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
10823692|NCT00588861|11989101|FG001|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
10823693|NCT00588861|11989100|FG000|COMPLETED|4 Years||16
10823694|NCT00588861|11989101|FG001|COMPLETED|4 Years||11
10823695|NCT00588861|11989100|FG000|NOT COMPLETED|4 Years||91
10823696|NCT00588861|11989101|FG001|NOT COMPLETED|4 Years||103
10823697|NCT00588861|11989100|FG000|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
10823698|NCT00588861|11989101|FG001|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
10823699|NCT00588861|11989100|FG000|COMPLETED|6 Years||3
10823700|NCT00588861|11989101|FG001|COMPLETED|6 Years||5
10823701|NCT00588861|11989100|FG000|NOT COMPLETED|6 Years||104
10823702|NCT00588861|11989101|FG001|NOT COMPLETED|6 Years||109
10823703|NCT00588861|11989100|FG000|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
10823704|NCT00588861|11989101|FG001|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
10823705|NCT00588861|11989100|FG000|COMPLETED|8 Years||2
10823706|NCT00588861|11989101|FG001|COMPLETED|8 Years||0
10823707|NCT00588861|11989100|FG000|NOT COMPLETED|8 Years||105
10823708|NCT00588861|11989101|FG001|NOT COMPLETED|8 Years||114
10823709|NCT00588861|11989100|FG000|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
11099381|NCT01218672|12283157|FG001|NOT COMPLETED|Overall Study||21
11099382|NCT01218802|12283167|FG000|STARTED|Overall Study||72
11099383|NCT01218802|12283168|FG001|STARTED|Overall Study||75
11099384|NCT01218802|12283167|FG000|COMPLETED|Overall Study||62
11099385|NCT01218802|12283168|FG001|COMPLETED|Overall Study||57
11099386|NCT01218802|12283167|FG000|NOT COMPLETED|Overall Study||10
11099387|NCT01218802|12283168|FG001|NOT COMPLETED|Overall Study||18
11099388|NCT01218867|12283185|FG000|STARTED|Overall Study||1
11099389|NCT01218867|12283186|FG001|STARTED|Overall Study||1
11099390|NCT01218867|12283187|FG002|STARTED|Overall Study||3
11099391|NCT01218867|12283188|FG003|STARTED|Overall Study||1
11099392|NCT01218867|12283189|FG004|STARTED|Overall Study||1
11099393|NCT01218867|12283190|FG005|STARTED|Overall Study||1
11099394|NCT01218867|12283191|FG006|STARTED|Overall Study||4
11099395|NCT01218867|12283192|FG007|STARTED|Overall Study||3
11099396|NCT01218867|12283193|FG008|STARTED|Overall Study||3
11099397|NCT01218867|12283194|FG009|STARTED|Overall Study||4
11099398|NCT01218867|12283195|FG010|STARTED|Overall Study||2
11099399|NCT01218867|12283185|FG000|COMPLETED|Overall Study||1
11099400|NCT01218867|12283186|FG001|COMPLETED|Overall Study||1
11099401|NCT01218867|12283187|FG002|COMPLETED|Overall Study||3
11099402|NCT01218867|12283188|FG003|COMPLETED|Overall Study||1
11099403|NCT01218867|12283189|FG004|COMPLETED|Overall Study||1
11099404|NCT01218867|12283190|FG005|COMPLETED|Overall Study||1
11219690|NCT01957202|12411346|FG005|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11099405|NCT01218867|12283191|FG006|COMPLETED|Overall Study||3
11099406|NCT01218867|12283192|FG007|COMPLETED|Overall Study||3
11099407|NCT01218867|12283193|FG008|COMPLETED|Overall Study||3
11099408|NCT01218867|12283194|FG009|COMPLETED|Overall Study||4
11099409|NCT01218867|12283195|FG010|COMPLETED|Overall Study||2
11099410|NCT01218867|12283185|FG000|NOT COMPLETED|Overall Study||0
11099411|NCT01218867|12283186|FG001|NOT COMPLETED|Overall Study||0
11099412|NCT01218867|12283187|FG002|NOT COMPLETED|Overall Study||0
11099413|NCT01218867|12283188|FG003|NOT COMPLETED|Overall Study||0
11099414|NCT01218867|12283189|FG004|NOT COMPLETED|Overall Study||0
11099415|NCT01218867|12283190|FG005|NOT COMPLETED|Overall Study||0
11099416|NCT01218867|12283191|FG006|NOT COMPLETED|Overall Study||1
11099417|NCT01218867|12283192|FG007|NOT COMPLETED|Overall Study||0
11219691|NCT01957202|12411347|FG006|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
10823710|NCT00588861|11989101|FG001|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
10823711|NCT00588861|11989100|FG000|COMPLETED|10 Years||0
10823712|NCT00588861|11989101|FG001|COMPLETED|10 Years||0
10823713|NCT00588861|11989100|FG000|NOT COMPLETED|10 Years||107
10823714|NCT00588861|11989101|FG001|NOT COMPLETED|10 Years||114
11353962|NCT03068455|12551212|FG001|COMPLETED|Treatment Period||561
11353963|NCT03068455|12551211|FG000|NOT COMPLETED|Treatment Period||552
11353964|NCT03068455|12551212|FG001|NOT COMPLETED|Treatment Period||356
11353965|NCT03068468|12551220|FG000|STARTED|Placebo-Controlled Period||166
11353966|NCT03068468|12551221|FG001|STARTED|Placebo-Controlled Period||324
11353967|NCT03068468|12551222|FG002|STARTED|Placebo-Controlled Period||0
11353968|NCT03068468|12551223|FG003|STARTED|Placebo-Controlled Period||0
11353969|NCT03068468|12551220|FG000|Treated|Placebo-Controlled Period||165
11353970|NCT03068468|12551221|FG001|Treated|Placebo-Controlled Period||321
11353971|NCT03068468|12551222|FG002|Treated|Placebo-Controlled Period||0
11099418|NCT01218867|12283193|FG008|NOT COMPLETED|Overall Study||0
11099419|NCT01218867|12283194|FG009|NOT COMPLETED|Overall Study||0
11099420|NCT01218867|12283195|FG010|NOT COMPLETED|Overall Study||0
11099421|NCT01218958|12283233|FG000|STARTED|Overall Study||210
11099422|NCT01218958|12283234|FG001|STARTED|Overall Study||205
11099423|NCT01218958|12283235|FG002|STARTED|Overall Study||209
11099424|NCT01218958|12283233|FG000|COMPLETED|Overall Study||126
11099425|NCT01218958|12283234|FG001|COMPLETED|Overall Study||124
11099426|NCT01218958|12283235|FG002|COMPLETED|Overall Study||128
11099427|NCT01218958|12283233|FG000|NOT COMPLETED|Overall Study||84
11099428|NCT01218958|12283234|FG001|NOT COMPLETED|Overall Study||81
11099429|NCT01218958|12283235|FG002|NOT COMPLETED|Overall Study||81
11099430|NCT01218971|12283245|FG000|STARTED|Overall Study||175
11099431|NCT01218971|12283246|FG001|STARTED|Overall Study||157
11099432|NCT01218971|12283245|FG000|COMPLETED|Overall Study||71
11099433|NCT01218971|12283246|FG001|COMPLETED|Overall Study||77
11099434|NCT01218971|12283245|FG000|NOT COMPLETED|Overall Study||104
11099435|NCT01218971|12283246|FG001|NOT COMPLETED|Overall Study||80
11099436|NCT01218984|12283259|FG000|STARTED|Overall Study||9
11099437|NCT01218984|12283260|FG001|STARTED|Overall Study||8
11099438|NCT01218984|12283261|FG002|STARTED|Overall Study||10
11099439|NCT01218984|12283259|FG000|COMPLETED|Overall Study||8
11099440|NCT01218984|12283260|FG001|COMPLETED|Overall Study||6
11099441|NCT01218984|12283261|FG002|COMPLETED|Overall Study||7
11099442|NCT01218984|12283259|FG000|NOT COMPLETED|Overall Study||1
11099443|NCT01218984|12283260|FG001|NOT COMPLETED|Overall Study||2
11099444|NCT01218984|12283261|FG002|NOT COMPLETED|Overall Study||3
11099445|NCT01218997|12283271|FG000|STARTED|Overall Study||371
11099446|NCT01218997|12283272|FG001|STARTED|Overall Study||65
11099447|NCT01218997|12283271|FG000|COMPLETED|Overall Study||126
11099448|NCT01218997|12283272|FG001|COMPLETED|Overall Study||24
11099449|NCT01218997|12283271|FG000|NOT COMPLETED|Overall Study||245
11099450|NCT01218997|12283272|FG001|NOT COMPLETED|Overall Study||41
11099451|NCT01219738|12283278|FG000|STARTED|Overall Study||20
11099452|NCT01219738|12283278|FG000|Budesonide 360|Overall Study||20
11099453|NCT01219738|12283278|FG000|Budesonide 720|Overall Study||20
11099454|NCT01219738|12283278|FG000|Budesonide 1440|Overall Study||20
11099455|NCT01219738|12283278|FG000|Budesonide 720- 4 Times|Overall Study||20
11099456|NCT01219738|12283278|FG000|COMPLETED|Overall Study||20
11099457|NCT01219738|12283278|FG000|NOT COMPLETED|Overall Study||0
11099458|NCT01219777|12283291|FG000|STARTED|Overall Study||9
11099459|NCT01219777|12283291|FG000|COMPLETED|Overall Study||9
11099460|NCT01219777|12283291|FG000|NOT COMPLETED|Overall Study||0
11099461|NCT01219855|12283301|FG000|STARTED|Overall Study||17
11099462|NCT01219855|12283302|FG001|STARTED|Overall Study||17
11219692|NCT01957202|12411348|FG007|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11219693|NCT01957202|12411349|FG008|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11219694|NCT01957202|12411350|FG009|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11219695|NCT01957202|12411351|FG010|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11219696|NCT01957202|12411352|FG011|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11219697|NCT01957202|12411353|FG012|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11219698|NCT01957202|12411354|FG013|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11219699|NCT01957202|12411355|FG014|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11219700|NCT01957202|12411356|FG015|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11099463|NCT01219855|12283303|FG002|STARTED|Overall Study||17
11099464|NCT01219855|12283304|FG003|STARTED|Overall Study||13
11099465|NCT01219855|12283305|FG004|STARTED|Overall Study||14
11099466|NCT01219855|12283301|FG000|COMPLETED|Overall Study||16
11099467|NCT01219855|12283302|FG001|COMPLETED|Overall Study||12
11099468|NCT01219855|12283303|FG002|COMPLETED|Overall Study||16
10823765|NCT03288142|11989129|FG000|STARTED|Overall Study||166
10823766|NCT03288142|11989130|FG001|STARTED|Overall Study||167
10823767|NCT03288142|11989129|FG000|COMPLETED|Overall Study||144
10823768|NCT03288142|11989130|FG001|COMPLETED|Overall Study||152
10823769|NCT03288142|11989129|FG000|NOT COMPLETED|Overall Study||22
10823770|NCT03288142|11989130|FG001|NOT COMPLETED|Overall Study||15
10823771|NCT03112603|11989140|FG000|STARTED|End of Randomization Period||165
10823772|NCT03112603|11989141|FG001|STARTED|End of Randomization Period||164
10823773|NCT03112603|11989142|FG002|STARTED|End of Randomization Period||0
10823774|NCT03112603|11989140|FG000|COMPLETED|End of Randomization Period||0
10823775|NCT03112603|11989141|FG001|COMPLETED|End of Randomization Period||0
10823776|NCT03112603|11989142|FG002|COMPLETED|End of Randomization Period||0
10823777|NCT03112603|11989140|FG000|NOT COMPLETED|End of Randomization Period||165
10823778|NCT03112603|11989141|FG001|NOT COMPLETED|End of Randomization Period||164
10823779|NCT03112603|11989142|FG002|NOT COMPLETED|End of Randomization Period||0
10823780|NCT03112603|11989140|FG000|STARTED|End of Cross Over Period||0
10823781|NCT03112603|11989141|FG001|STARTED|End of Cross Over Period||0
10823782|NCT03112603|11989142|FG002|STARTED|End of Cross Over Period||61
10823783|NCT03112603|11989140|FG000|COMPLETED|End of Cross Over Period||0
10823784|NCT03112603|11989141|FG001|COMPLETED|End of Cross Over Period||0
10823785|NCT03112603|11989142|FG002|COMPLETED|End of Cross Over Period||0
10823786|NCT03112603|11989140|FG000|NOT COMPLETED|End of Cross Over Period||0
10823787|NCT03112603|11989141|FG001|NOT COMPLETED|End of Cross Over Period||0
10823788|NCT03112603|11989142|FG002|NOT COMPLETED|End of Cross Over Period||61
11099469|NCT01219855|12283304|FG003|COMPLETED|Overall Study||12
11099470|NCT01219855|12283305|FG004|COMPLETED|Overall Study||13
11099471|NCT01219855|12283301|FG000|NOT COMPLETED|Overall Study||1
11099472|NCT01219855|12283302|FG001|NOT COMPLETED|Overall Study||5
11099473|NCT01219855|12283303|FG002|NOT COMPLETED|Overall Study||1
11099474|NCT01219855|12283304|FG003|NOT COMPLETED|Overall Study||1
10823795|NCT02767570|11989159|FG000|STARTED|Overall Study||34
10823796|NCT02767570|11989160|FG001|STARTED|Overall Study||34
10823797|NCT02767570|11989159|FG000|Per Protocol Week 6|Overall Study||31
10823798|NCT02767570|11989160|FG001|Per Protocol Week 6|Overall Study||33
10823799|NCT02767570|11989159|FG000|COMPLETED|Overall Study||25
10823800|NCT02767570|11989160|FG001|COMPLETED|Overall Study||24
10823801|NCT02767570|11989159|FG000|NOT COMPLETED|Overall Study||9
10823802|NCT02767570|11989160|FG001|NOT COMPLETED|Overall Study||10
10823803|NCT02702180|11989169|FG000|STARTED|Double-blind Treatment Period||46
10823804|NCT02702180|11989170|FG001|STARTED|Double-blind Treatment Period||45
10823805|NCT02702180|11989171|FG002|STARTED|Double-blind Treatment Period||47
10823806|NCT02702180|11989169|FG000|COMPLETED|Double-blind Treatment Period||45
10823807|NCT02702180|11989170|FG001|COMPLETED|Double-blind Treatment Period||44
10823808|NCT02702180|11989171|FG002|COMPLETED|Double-blind Treatment Period||43
10823809|NCT02702180|11989169|FG000|NOT COMPLETED|Double-blind Treatment Period||1
10823810|NCT02702180|11989170|FG001|NOT COMPLETED|Double-blind Treatment Period||1
10823811|NCT02702180|11989171|FG002|NOT COMPLETED|Double-blind Treatment Period||4
10823812|NCT02702180|11989169|FG000|STARTED|Open-label Treatment Period||45
10823813|NCT02702180|11989170|FG001|STARTED|Open-label Treatment Period||43
10823814|NCT02702180|11989171|FG002|STARTED|Open-label Treatment Period||43
10823815|NCT02702180|11989169|FG000|COMPLETED|Open-label Treatment Period||45
10823816|NCT02702180|11989170|FG001|COMPLETED|Open-label Treatment Period||42
10823817|NCT02702180|11989171|FG002|COMPLETED|Open-label Treatment Period||41
10823818|NCT02702180|11989169|FG000|NOT COMPLETED|Open-label Treatment Period||0
10823819|NCT02702180|11989170|FG001|NOT COMPLETED|Open-label Treatment Period||1
10823820|NCT02702180|11989171|FG002|NOT COMPLETED|Open-label Treatment Period||2
10823821|NCT02545049|11989182|FG000|STARTED|Overall Study||3723
10823822|NCT02545049|11989183|FG001|STARTED|Overall Study||3714
10823823|NCT02545049|11989182|FG000|Treated|Overall Study||3683
10823824|NCT02545049|11989183|FG001|Treated|Overall Study||3658
10823825|NCT02545049|11989182|FG000|Included in FAS|Overall Study||3686
10823826|NCT02545049|11989183|FG001|Included in FAS|Overall Study||3666
10823827|NCT02545049|11989182|FG000|COMPLETED|Overall Study||3681
10823828|NCT02545049|11989183|FG001|COMPLETED|Overall Study||3653
10823829|NCT02545049|11989182|FG000|NOT COMPLETED|Overall Study||42
10823830|NCT02545049|11989183|FG001|NOT COMPLETED|Overall Study||61
10823831|NCT02448381|11989191|FG000|STARTED|Overall Study||118
10823832|NCT02448381|11989192|FG001|STARTED|Overall Study||51
10823833|NCT02448381|11989191|FG000|Randomized, Not Treated|Overall Study||2
10823834|NCT02448381|11989192|FG001|Randomized, Not Treated|Overall Study||1
10823835|NCT02448381|11989191|FG000|Cycle 1|Overall Study||116
10823836|NCT02448381|11989192|FG001|Cycle 1|Overall Study||50
10823837|NCT02448381|11989191|FG000|Cycle 2|Overall Study||110
10823838|NCT02448381|11989192|FG001|Cycle 2|Overall Study||45
10823839|NCT02448381|11989191|FG000|Cycle 3|Overall Study||78
10823840|NCT02448381|11989192|FG001|Cycle 3|Overall Study||32
10823841|NCT02448381|11989191|FG000|Follow-up Period|Overall Study||98
10823842|NCT02448381|11989192|FG001|Follow-up Period|Overall Study||39
10823843|NCT02448381|11989191|FG000|COMPLETED|Overall Study||83
10823844|NCT02448381|11989192|FG001|COMPLETED|Overall Study||32
10823845|NCT02448381|11989191|FG000|NOT COMPLETED|Overall Study||35
10823846|NCT02448381|11989192|FG001|NOT COMPLETED|Overall Study||19
10823859|NCT01849874|11989215|FG000|STARTED|Overall Study||201
10823860|NCT01849874|11989216|FG001|STARTED|Overall Study||102
10823861|NCT01849874|11989215|FG000|Treated|Overall Study||200
10823862|NCT01849874|11989216|FG001|Treated|Overall Study||94
10823863|NCT01849874|11989215|FG000|COMPLETED|Overall Study||0
10823864|NCT01849874|11989216|FG001|COMPLETED|Overall Study||0
10823865|NCT01849874|11989215|FG000|NOT COMPLETED|Overall Study||201
10823866|NCT01849874|11989216|FG001|NOT COMPLETED|Overall Study||102
10823867|NCT01724866|11989226|FG000|STARTED|Overall Study||39
10823868|NCT01724866|11989227|FG001|STARTED|Overall Study||37
10823869|NCT01724866|11989228|FG002|STARTED|Overall Study||36
10823870|NCT01724866|11989229|FG003|STARTED|Overall Study||36
10823871|NCT01724866|11989226|FG000|Evaluable Population|Overall Study||39
10823872|NCT01724866|11989227|FG001|Evaluable Population|Overall Study||36
10823873|NCT01724866|11989228|FG002|Evaluable Population|Overall Study||36
10823874|NCT01724866|11989229|FG003|Evaluable Population|Overall Study||36
10823875|NCT01724866|11989226|FG000|COMPLETED|Overall Study||38
10823876|NCT01724866|11989227|FG001|COMPLETED|Overall Study||32
10823877|NCT01724866|11989228|FG002|COMPLETED|Overall Study||33
10823878|NCT01724866|11989229|FG003|COMPLETED|Overall Study||35
10823879|NCT01724866|11989226|FG000|NOT COMPLETED|Overall Study||1
10823880|NCT01724866|11989227|FG001|NOT COMPLETED|Overall Study||5
10823881|NCT01724866|11989228|FG002|NOT COMPLETED|Overall Study||3
10823882|NCT01724866|11989229|FG003|NOT COMPLETED|Overall Study||1
10823883|NCT01670877|11989243|FG000|STARTED|Part I and Part 2||16
10823884|NCT01670877|11989244|FG001|STARTED|Part I and Part 2||5
10823885|NCT01670877|11989245|FG002|STARTED|Part I and Part 2||11
10823886|NCT01670877|11989246|FG003|STARTED|Part I and Part 2||24
10823887|NCT01670877|11989247|FG004|STARTED|Part I and Part 2||0
10823888|NCT01670877|11989248|FG005|STARTED|Part I and Part 2||0
10823889|NCT01670877|11989243|FG000|COMPLETED|Part I and Part 2||16
10823890|NCT01670877|11989244|FG001|COMPLETED|Part I and Part 2||4
10823891|NCT01670877|11989245|FG002|COMPLETED|Part I and Part 2||10
10823892|NCT01670877|11989246|FG003|COMPLETED|Part I and Part 2||21
10823893|NCT01670877|11989247|FG004|COMPLETED|Part I and Part 2||0
10823894|NCT01670877|11989248|FG005|COMPLETED|Part I and Part 2||0
10823895|NCT01670877|11989243|FG000|NOT COMPLETED|Part I and Part 2||0
10823896|NCT01670877|11989244|FG001|NOT COMPLETED|Part I and Part 2||1
10823897|NCT01670877|11989245|FG002|NOT COMPLETED|Part I and Part 2||1
10823898|NCT01670877|11989246|FG003|NOT COMPLETED|Part I and Part 2||3
10823899|NCT01670877|11989247|FG004|NOT COMPLETED|Part I and Part 2||0
10823900|NCT01670877|11989248|FG005|NOT COMPLETED|Part I and Part 2||0
10823901|NCT01670877|11989243|FG000|STARTED|Crossover||0
11099475|NCT01219855|12283305|FG004|NOT COMPLETED|Overall Study||1
10823902|NCT01670877|11989244|FG001|STARTED|Crossover||0
10823903|NCT01670877|11989245|FG002|STARTED|Crossover||0
10823904|NCT01670877|11989246|FG003|STARTED|Crossover||0
10823905|NCT01670877|11989247|FG004|STARTED|Crossover||3
10823906|NCT01670877|11989248|FG005|STARTED|Crossover||5
10823907|NCT01670877|11989243|FG000|COMPLETED|Crossover||0
10823908|NCT01670877|11989244|FG001|COMPLETED|Crossover||0
10823909|NCT01670877|11989245|FG002|COMPLETED|Crossover||0
10823910|NCT01670877|11989246|FG003|COMPLETED|Crossover||0
10823911|NCT01670877|11989247|FG004|COMPLETED|Crossover||3
10823912|NCT01670877|11989248|FG005|COMPLETED|Crossover||5
10823913|NCT01670877|11989243|FG000|NOT COMPLETED|Crossover||0
10823914|NCT01670877|11989244|FG001|NOT COMPLETED|Crossover||0
10823915|NCT01670877|11989245|FG002|NOT COMPLETED|Crossover||0
10823916|NCT01670877|11989246|FG003|NOT COMPLETED|Crossover||0
10823917|NCT01670877|11989247|FG004|NOT COMPLETED|Crossover||0
10823918|NCT01670877|11989248|FG005|NOT COMPLETED|Crossover||0
11099476|NCT01219881|12283318|FG000|STARTED|Overall Study||38
11099477|NCT01219881|12283319|FG001|STARTED|Overall Study||37
11099478|NCT01219881|12283318|FG000|COMPLETED|Overall Study||34
11099479|NCT01219881|12283319|FG001|COMPLETED|Overall Study||32
11099480|NCT01219881|12283318|FG000|NOT COMPLETED|Overall Study||4
11099481|NCT01219881|12283319|FG001|NOT COMPLETED|Overall Study||5
10823925|NCT00667628|11989273|FG000|STARTED|Overall Study||25
10823926|NCT00667628|11989274|FG001|STARTED|Overall Study||27
10823927|NCT00667628|11989273|FG000|COMPLETED|Overall Study||0
10823928|NCT00667628|11989274|FG001|COMPLETED|Overall Study||0
10823929|NCT00667628|11989273|FG000|NOT COMPLETED|Overall Study||25
10823930|NCT00667628|11989274|FG001|NOT COMPLETED|Overall Study||27
11099482|NCT01219933|12283325|FG000|STARTED|Overall Study||68
11099483|NCT01219933|12283325|FG000|COMPLETED|Overall Study||30
11099484|NCT01219933|12283325|FG000|NOT COMPLETED|Overall Study||38
11099485|NCT01219959|12283332|FG000|STARTED|Overall Study||127
11099486|NCT01219959|12283333|FG001|STARTED|Overall Study||124
10823931|NCT04286529|11989284|FG000|STARTED|Overall Study||4
10823932|NCT04286529|11989285|FG001|STARTED|Overall Study||4
10823933|NCT04286529|11989286|FG002|STARTED|Overall Study||5
10823934|NCT04286529|11989287|FG003|STARTED|Overall Study||4
10823935|NCT04286529|11989284|FG000|COMPLETED|Overall Study||3
10823936|NCT04286529|11989285|FG001|COMPLETED|Overall Study||1
10823937|NCT04286529|11989286|FG002|COMPLETED|Overall Study||3
10823938|NCT04286529|11989287|FG003|COMPLETED|Overall Study||1
10823939|NCT04286529|11989284|FG000|NOT COMPLETED|Overall Study||1
10823940|NCT04286529|11989285|FG001|NOT COMPLETED|Overall Study||3
10823941|NCT04286529|11989286|FG002|NOT COMPLETED|Overall Study||2
10823942|NCT04286529|11989287|FG003|NOT COMPLETED|Overall Study||3
10823943|NCT03581786|11989299|FG000|STARTED|Overall Study||143
11099487|NCT01219959|12283332|FG000|COMPLETED|Overall Study||120
11099488|NCT01219959|12283333|FG001|COMPLETED|Overall Study||101
11099489|NCT01219959|12283332|FG000|NOT COMPLETED|Overall Study||7
10823944|NCT03581786|11989300|FG001|STARTED|Overall Study||146
10823945|NCT03581786|11989299|FG000|COMPLETED|Overall Study||0
10823946|NCT03581786|11989300|FG001|COMPLETED|Overall Study||0
10823947|NCT03581786|11989299|FG000|NOT COMPLETED|Overall Study||143
10823948|NCT03581786|11989300|FG001|NOT COMPLETED|Overall Study||146
10823949|NCT03573518|11989310|FG000|STARTED|Overall Study||92
10823950|NCT03573518|11989311|FG001|STARTED|Overall Study||92
10823951|NCT03573518|11989312|FG002|STARTED|Overall Study||92
10823952|NCT03573518|11989313|FG003|STARTED|Overall Study||92
10823953|NCT03573518|11989310|FG000|COMPLETED|Overall Study||69
10823954|NCT03573518|11989311|FG001|COMPLETED|Overall Study||77
10823955|NCT03573518|11989312|FG002|COMPLETED|Overall Study||70
10823956|NCT03573518|11989313|FG003|COMPLETED|Overall Study||81
10823957|NCT03573518|11989310|FG000|NOT COMPLETED|Overall Study||23
10823958|NCT03573518|11989311|FG001|NOT COMPLETED|Overall Study||15
10823959|NCT03573518|11989312|FG002|NOT COMPLETED|Overall Study||22
10823960|NCT03573518|11989313|FG003|NOT COMPLETED|Overall Study||11
10823961|NCT03486314|11989323|FG000|STARTED|Part A||20
10823962|NCT03486314|11989324|FG001|STARTED|Part A||0
10823963|NCT03486314|11989325|FG002|STARTED|Part A||0
10823964|NCT03486314|11989323|FG000|COMPLETED|Part A||17
10823965|NCT03486314|11989324|FG001|COMPLETED|Part A||0
10823966|NCT03486314|11989325|FG002|COMPLETED|Part A||0
10823967|NCT03486314|11989323|FG000|NOT COMPLETED|Part A||3
10823968|NCT03486314|11989324|FG001|NOT COMPLETED|Part A||0
10823969|NCT03486314|11989325|FG002|NOT COMPLETED|Part A||0
10823970|NCT03486314|11989323|FG000|STARTED|Part B||0
10823971|NCT03486314|11989324|FG001|STARTED|Part B|These are the participants who completed Part A, met eligibility criteria, and provided consent for Part B.|9
10823972|NCT03486314|11989325|FG002|STARTED|Part B|These are the participants who completed Part A, met eligibility criteria, and provided consent for Part B.|8
10823973|NCT03486314|11989323|FG000|COMPLETED|Part B||0
10823974|NCT03486314|11989324|FG001|COMPLETED|Part B||9
10823975|NCT03486314|11989325|FG002|COMPLETED|Part B||8
10823976|NCT03486314|11989323|FG000|NOT COMPLETED|Part B||0
10823977|NCT03486314|11989324|FG001|NOT COMPLETED|Part B||0
10823978|NCT03486314|11989325|FG002|NOT COMPLETED|Part B||0
10823979|NCT02988713|11989333|FG000|STARTED|Overall Study||35
10823980|NCT02988713|11989333|FG000|COMPLETED|Overall Study||32
10823981|NCT02988713|11989333|FG000|NOT COMPLETED|Overall Study||3
10823982|NCT02794883|11989340|FG000|STARTED|Pre-Surgical Treatment||12
10823983|NCT02794883|11989341|FG001|STARTED|Pre-Surgical Treatment||12
10823984|NCT02794883|11989342|FG002|STARTED|Pre-Surgical Treatment||12
10823985|NCT02794883|11989340|FG000|Registered for Study|Pre-Surgical Treatment||12
10823986|NCT02794883|11989341|FG001|Registered for Study|Pre-Surgical Treatment||12
10823987|NCT02794883|11989342|FG002|Registered for Study|Pre-Surgical Treatment||12
10823988|NCT02794883|11989340|FG000|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||12
10823989|NCT02794883|11989341|FG001|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||11
10823990|NCT02794883|11989342|FG002|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||11
10823991|NCT02794883|11989340|FG000|COMPLETED|Pre-Surgical Treatment||12
10823992|NCT02794883|11989341|FG001|COMPLETED|Pre-Surgical Treatment||11
10823993|NCT02794883|11989342|FG002|COMPLETED|Pre-Surgical Treatment||11
10823994|NCT02794883|11989340|FG000|NOT COMPLETED|Pre-Surgical Treatment||0
10823995|NCT02794883|11989341|FG001|NOT COMPLETED|Pre-Surgical Treatment||1
10823996|NCT02794883|11989342|FG002|NOT COMPLETED|Pre-Surgical Treatment||1
10823997|NCT02794883|11989340|FG000|STARTED|Post-Surgery Treatment (Adjuvant)||12
10823998|NCT02794883|11989341|FG001|STARTED|Post-Surgery Treatment (Adjuvant)||11
10823999|NCT02794883|11989342|FG002|STARTED|Post-Surgery Treatment (Adjuvant)||11
10824000|NCT02794883|11989340|FG000|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||11
10824001|NCT02794883|11989341|FG001|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||8
10824002|NCT02794883|11989342|FG002|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||11
10824003|NCT02794883|11989340|FG000|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||7
10824004|NCT02794883|11989341|FG001|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||8
10824005|NCT02794883|11989342|FG002|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||11
10824006|NCT02794883|11989340|FG000|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||3
10824007|NCT02794883|11989341|FG001|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||7
10824008|NCT02794883|11989342|FG002|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||4
10824009|NCT02794883|11989340|FG000|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||2
10824010|NCT02794883|11989341|FG001|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||5
10824011|NCT02794883|11989342|FG002|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||2
10824012|NCT02794883|11989340|FG000|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||2
10824013|NCT02794883|11989341|FG001|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||3
10824014|NCT02794883|11989342|FG002|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||2
10824015|NCT02794883|11989340|FG000|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||0
10824016|NCT02794883|11989341|FG001|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||3
10824017|NCT02794883|11989342|FG002|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||2
10824018|NCT02794883|11989340|FG000|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||0
10824019|NCT02794883|11989341|FG001|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||3
10824020|NCT02794883|11989342|FG002|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||1
10824021|NCT02794883|11989340|FG000|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||0
10824022|NCT02794883|11989341|FG001|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||3
10824023|NCT02794883|11989342|FG002|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||1
10824024|NCT02794883|11989340|FG000|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||0
10824025|NCT02794883|11989341|FG001|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||3
10824026|NCT02794883|11989342|FG002|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||1
10824027|NCT02794883|11989340|FG000|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||0
10824028|NCT02794883|11989341|FG001|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||2
10824029|NCT02794883|11989342|FG002|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||1
10824030|NCT02794883|11989340|FG000|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||0
10824031|NCT02794883|11989341|FG001|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||2
10824032|NCT02794883|11989342|FG002|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||1
10824033|NCT02794883|11989340|FG000|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||0
10824034|NCT02794883|11989341|FG001|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||1
10824035|NCT02794883|11989342|FG002|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||1
10824036|NCT02794883|11989340|FG000|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||0
10824037|NCT02794883|11989341|FG001|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||1
10824038|NCT02794883|11989342|FG002|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||1
10824039|NCT02794883|11989340|FG000|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||0
10824040|NCT02794883|11989341|FG001|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||1
10824041|NCT02794883|11989342|FG002|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||1
10824042|NCT02794883|11989340|FG000|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||0
10824043|NCT02794883|11989341|FG001|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||0
10824044|NCT02794883|11989342|FG002|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||1
10824045|NCT02794883|11989340|FG000|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||0
10824046|NCT02794883|11989341|FG001|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||0
10824047|NCT02794883|11989342|FG002|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||1
10824048|NCT02794883|11989340|FG000|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
10824049|NCT02794883|11989341|FG001|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
10824050|NCT02794883|11989342|FG002|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
10824051|NCT02794883|11989340|FG000|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
10824052|NCT02794883|11989341|FG001|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
10824053|NCT02794883|11989342|FG002|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
10824054|NCT02794883|11989340|FG000|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||12
10824055|NCT02794883|11989341|FG001|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||11
10824056|NCT02794883|11989342|FG002|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||11
10824057|NCT02794883|11989340|FG000|STARTED|Follow-up Period (up to 2 Years)||12
10824058|NCT02794883|11989341|FG001|STARTED|Follow-up Period (up to 2 Years)||11
10824059|NCT02794883|11989342|FG002|STARTED|Follow-up Period (up to 2 Years)||11
10824060|NCT02794883|11989340|FG000|COMPLETED|Follow-up Period (up to 2 Years)||0
10824061|NCT02794883|11989341|FG001|COMPLETED|Follow-up Period (up to 2 Years)||1
10824062|NCT02794883|11989342|FG002|COMPLETED|Follow-up Period (up to 2 Years)||1
10824063|NCT02794883|11989340|FG000|NOT COMPLETED|Follow-up Period (up to 2 Years)||12
10824064|NCT02794883|11989341|FG001|NOT COMPLETED|Follow-up Period (up to 2 Years)||10
10824065|NCT02794883|11989342|FG002|NOT COMPLETED|Follow-up Period (up to 2 Years)||10
10824066|NCT02677987|11989352|FG000|STARTED|Overall Study||23
10824067|NCT02677987|11989353|FG001|STARTED|Overall Study||24
10824068|NCT02677987|11989352|FG000|COMPLETED|Overall Study||19
10824069|NCT02677987|11989353|FG001|COMPLETED|Overall Study||24
10824070|NCT02677987|11989352|FG000|NOT COMPLETED|Overall Study||4
10824071|NCT02677987|11989353|FG001|NOT COMPLETED|Overall Study||0
11099490|NCT01219959|12283333|FG001|NOT COMPLETED|Overall Study||23
11099491|NCT01219985|12283339|FG000|STARTED|Overall Study||50
11099492|NCT01219985|12283339|FG000|COMPLETED|Overall Study||30
11099493|NCT01219985|12283339|FG000|NOT COMPLETED|Overall Study||20
11099494|NCT01220024|12283347|FG000|STARTED|Overall Study||25
11099495|NCT01220024|12283348|FG001|STARTED|Overall Study||25
10824078|NCT01928394|11989396|FG000|STARTED|Treatment Period||18
10824079|NCT01928394|11989397|FG001|STARTED|Treatment Period||3
10824080|NCT01928394|11989398|FG002|STARTED|Treatment Period||18
10824081|NCT01928394|11989399|FG003|STARTED|Treatment Period||59
10824082|NCT01928394|11989400|FG004|STARTED|Treatment Period||3
10824083|NCT01928394|11989401|FG005|STARTED|Treatment Period||49
10824084|NCT01928394|11989402|FG006|STARTED|Treatment Period||52
10824085|NCT01928394|11989403|FG007|STARTED|Treatment Period||18
10824086|NCT01928394|11989404|FG008|STARTED|Treatment Period||3
10824087|NCT01928394|11989405|FG009|STARTED|Treatment Period||18
10824088|NCT01928394|11989406|FG010|STARTED|Treatment Period||30
10824089|NCT01928394|11989407|FG011|STARTED|Treatment Period||98
10824090|NCT01928394|11989408|FG012|STARTED|Treatment Period||61
10824091|NCT01928394|11989409|FG013|STARTED|Treatment Period||147
10824092|NCT01928394|11989410|FG014|STARTED|Treatment Period||96
10824093|NCT01928394|11989411|FG015|STARTED|Treatment Period||3
10824094|NCT01928394|11989412|FG016|STARTED|Treatment Period||55
10824095|NCT01928394|11989413|FG017|STARTED|Treatment Period||78
10824096|NCT01928394|11989414|FG018|STARTED|Treatment Period||92
10824097|NCT01928394|11989415|FG019|STARTED|Treatment Period||104
10824098|NCT01928394|11989416|FG020|STARTED|Treatment Period||41
10824099|NCT01928394|11989417|FG021|STARTED|Treatment Period||43
10824100|NCT01928394|11989418|FG022|STARTED|Treatment Period||42
10824101|NCT01928394|11989396|FG000|Transition|Treatment Period||3
10824102|NCT01928394|11989397|FG001|Transition|Treatment Period||0
10824103|NCT01928394|11989398|FG002|Transition|Treatment Period||0
10824104|NCT01928394|11989399|FG003|Transition|Treatment Period||9
10824105|NCT01928394|11989400|FG004|Transition|Treatment Period||0
10824106|NCT01928394|11989401|FG005|Transition|Treatment Period||0
10824107|NCT01928394|11989402|FG006|Transition|Treatment Period||0
10824108|NCT01928394|11989403|FG007|Transition|Treatment Period||2
10824109|NCT01928394|11989404|FG008|Transition|Treatment Period||0
10824110|NCT01928394|11989405|FG009|Transition|Treatment Period||0
10824111|NCT01928394|11989406|FG010|Transition|Treatment Period||0
10824112|NCT01928394|11989407|FG011|Transition|Treatment Period||17
10824113|NCT01928394|11989408|FG012|Transition|Treatment Period||0
10824114|NCT01928394|11989409|FG013|Transition|Treatment Period||2
10824115|NCT01928394|11989410|FG014|Transition|Treatment Period||0
10824116|NCT01928394|11989411|FG015|Transition|Treatment Period||0
10824117|NCT01928394|11989412|FG016|Transition|Treatment Period||0
10824118|NCT01928394|11989413|FG017|Transition|Treatment Period||20
10824119|NCT01928394|11989414|FG018|Transition|Treatment Period||0
10824120|NCT01928394|11989415|FG019|Transition|Treatment Period||0
10824121|NCT01928394|11989416|FG020|Transition|Treatment Period||0
10824122|NCT01928394|11989417|FG021|Transition|Treatment Period||0
10824123|NCT01928394|11989418|FG022|Transition|Treatment Period||0
10824124|NCT01928394|11989396|FG000|Transition- Continued|Treatment Period||0
10824125|NCT01928394|11989397|FG001|Transition- Continued|Treatment Period||0
10824126|NCT01928394|11989398|FG002|Transition- Continued|Treatment Period||3
10824127|NCT01928394|11989399|FG003|Transition- Continued|Treatment Period||0
10824128|NCT01928394|11989400|FG004|Transition- Continued|Treatment Period||0
10824129|NCT01928394|11989401|FG005|Transition- Continued|Treatment Period||3
10824130|NCT01928394|11989402|FG006|Transition- Continued|Treatment Period||6
10824131|NCT01928394|11989403|FG007|Transition- Continued|Treatment Period||0
10824132|NCT01928394|11989404|FG008|Transition- Continued|Treatment Period||1
10824133|NCT01928394|11989405|FG009|Transition- Continued|Treatment Period||1
10824134|NCT01928394|11989406|FG010|Transition- Continued|Treatment Period||0
10824135|NCT01928394|11989407|FG011|Transition- Continued|Treatment Period||0
10824136|NCT01928394|11989408|FG012|Transition- Continued|Treatment Period||17
10824137|NCT01928394|11989409|FG013|Transition- Continued|Treatment Period||0
10824138|NCT01928394|11989410|FG014|Transition- Continued|Treatment Period||2
10824139|NCT01928394|11989411|FG015|Transition- Continued|Treatment Period||0
10824140|NCT01928394|11989412|FG016|Transition- Continued|Treatment Period||0
10824141|NCT01928394|11989413|FG017|Transition- Continued|Treatment Period||0
10824142|NCT01928394|11989414|FG018|Transition- Continued|Treatment Period||1
10824143|NCT01928394|11989415|FG019|Transition- Continued|Treatment Period||19
10824144|NCT01928394|11989416|FG020|Transition- Continued|Treatment Period||0
10824145|NCT01928394|11989417|FG021|Transition- Continued|Treatment Period||0
10824146|NCT01928394|11989418|FG022|Transition- Continued|Treatment Period||0
10824147|NCT01928394|11989396|FG000|COMPLETED|Treatment Period||0
10824148|NCT01928394|11989397|FG001|COMPLETED|Treatment Period||0
10824149|NCT01928394|11989398|FG002|COMPLETED|Treatment Period||0
10824150|NCT01928394|11989399|FG003|COMPLETED|Treatment Period||3
10824151|NCT01928394|11989400|FG004|COMPLETED|Treatment Period||0
10824152|NCT01928394|11989401|FG005|COMPLETED|Treatment Period||6
10824153|NCT01928394|11989402|FG006|COMPLETED|Treatment Period||3
10824154|NCT01928394|11989403|FG007|COMPLETED|Treatment Period||0
10824155|NCT01928394|11989404|FG008|COMPLETED|Treatment Period||0
10824156|NCT01928394|11989405|FG009|COMPLETED|Treatment Period||0
10824157|NCT01928394|11989406|FG010|COMPLETED|Treatment Period||0
10824158|NCT01928394|11989407|FG011|COMPLETED|Treatment Period||5
10824159|NCT01928394|11989408|FG012|COMPLETED|Treatment Period||6
10824160|NCT01928394|11989409|FG013|COMPLETED|Treatment Period||8
10824161|NCT01928394|11989410|FG014|COMPLETED|Treatment Period||8
10824162|NCT01928394|11989411|FG015|COMPLETED|Treatment Period||1
10824163|NCT01928394|11989412|FG016|COMPLETED|Treatment Period||5
10824164|NCT01928394|11989413|FG017|COMPLETED|Treatment Period||7
10824165|NCT01928394|11989414|FG018|COMPLETED|Treatment Period||22
10824166|NCT01928394|11989415|FG019|COMPLETED|Treatment Period||8
10824167|NCT01928394|11989416|FG020|COMPLETED|Treatment Period||1
10824168|NCT01928394|11989417|FG021|COMPLETED|Treatment Period||1
10824169|NCT01928394|11989418|FG022|COMPLETED|Treatment Period||3
10824170|NCT01928394|11989396|FG000|NOT COMPLETED|Treatment Period||18
10824171|NCT01928394|11989397|FG001|NOT COMPLETED|Treatment Period||3
10824172|NCT01928394|11989398|FG002|NOT COMPLETED|Treatment Period||18
10824173|NCT01928394|11989399|FG003|NOT COMPLETED|Treatment Period||56
10824174|NCT01928394|11989400|FG004|NOT COMPLETED|Treatment Period||3
10824175|NCT01928394|11989401|FG005|NOT COMPLETED|Treatment Period||43
10824176|NCT01928394|11989402|FG006|NOT COMPLETED|Treatment Period||49
10824177|NCT01928394|11989403|FG007|NOT COMPLETED|Treatment Period||18
10824178|NCT01928394|11989404|FG008|NOT COMPLETED|Treatment Period||3
10824179|NCT01928394|11989405|FG009|NOT COMPLETED|Treatment Period||18
10824180|NCT01928394|11989406|FG010|NOT COMPLETED|Treatment Period||30
10824181|NCT01928394|11989407|FG011|NOT COMPLETED|Treatment Period||93
10824182|NCT01928394|11989408|FG012|NOT COMPLETED|Treatment Period||55
10824183|NCT01928394|11989409|FG013|NOT COMPLETED|Treatment Period||139
10824184|NCT01928394|11989410|FG014|NOT COMPLETED|Treatment Period||88
10824185|NCT01928394|11989411|FG015|NOT COMPLETED|Treatment Period||2
10824186|NCT01928394|11989412|FG016|NOT COMPLETED|Treatment Period||50
10824187|NCT01928394|11989413|FG017|NOT COMPLETED|Treatment Period||71
10824188|NCT01928394|11989414|FG018|NOT COMPLETED|Treatment Period||70
10824189|NCT01928394|11989415|FG019|NOT COMPLETED|Treatment Period||96
10824190|NCT01928394|11989416|FG020|NOT COMPLETED|Treatment Period||40
10824191|NCT01928394|11989417|FG021|NOT COMPLETED|Treatment Period||42
10824192|NCT01928394|11989418|FG022|NOT COMPLETED|Treatment Period||39
10824193|NCT01928394|11989396|FG000|STARTED|Follow-up Period||15
10824194|NCT01928394|11989397|FG001|STARTED|Follow-up Period||3
10824195|NCT01928394|11989398|FG002|STARTED|Follow-up Period||18
10824196|NCT01928394|11989399|FG003|STARTED|Follow-up Period||50
10824197|NCT01928394|11989400|FG004|STARTED|Follow-up Period||3
10824198|NCT01928394|11989401|FG005|STARTED|Follow-up Period||49
10824199|NCT01928394|11989402|FG006|STARTED|Follow-up Period||52
10824200|NCT01928394|11989403|FG007|STARTED|Follow-up Period||16
10824201|NCT01928394|11989404|FG008|STARTED|Follow-up Period||3
10824202|NCT01928394|11989405|FG009|STARTED|Follow-up Period||18
10824203|NCT01928394|11989406|FG010|STARTED|Follow-up Period||30
10824204|NCT01928394|11989407|FG011|STARTED|Follow-up Period||81
10824205|NCT01928394|11989408|FG012|STARTED|Follow-up Period||61
10824206|NCT01928394|11989409|FG013|STARTED|Follow-up Period||145
10824207|NCT01928394|11989410|FG014|STARTED|Follow-up Period||96
10824208|NCT01928394|11989411|FG015|STARTED|Follow-up Period||3
10824209|NCT01928394|11989412|FG016|STARTED|Follow-up Period||55
10824210|NCT01928394|11989413|FG017|STARTED|Follow-up Period||58
10824211|NCT01928394|11989414|FG018|STARTED|Follow-up Period||92
10824212|NCT01928394|11989415|FG019|STARTED|Follow-up Period||104
10824213|NCT01928394|11989416|FG020|STARTED|Follow-up Period||41
10824214|NCT01928394|11989417|FG021|STARTED|Follow-up Period||43
10824215|NCT01928394|11989418|FG022|STARTED|Follow-up Period||42
10824216|NCT01928394|11989396|FG000|COMPLETED|Follow-up Period||12
10824217|NCT01928394|11989397|FG001|COMPLETED|Follow-up Period||3
10824218|NCT01928394|11989398|FG002|COMPLETED|Follow-up Period||15
10824219|NCT01928394|11989399|FG003|COMPLETED|Follow-up Period||40
10824220|NCT01928394|11989400|FG004|COMPLETED|Follow-up Period||3
10824221|NCT01928394|11989401|FG005|COMPLETED|Follow-up Period||41
10824222|NCT01928394|11989402|FG006|COMPLETED|Follow-up Period||40
10824223|NCT01928394|11989403|FG007|COMPLETED|Follow-up Period||10
10824224|NCT01928394|11989404|FG008|COMPLETED|Follow-up Period||2
10824225|NCT01928394|11989405|FG009|COMPLETED|Follow-up Period||16
10824226|NCT01928394|11989406|FG010|COMPLETED|Follow-up Period||19
10824227|NCT01928394|11989407|FG011|COMPLETED|Follow-up Period||59
10824228|NCT01928394|11989408|FG012|COMPLETED|Follow-up Period||47
10824229|NCT01928394|11989409|FG013|COMPLETED|Follow-up Period||107
10824230|NCT01928394|11989410|FG014|COMPLETED|Follow-up Period||66
10824231|NCT01928394|11989411|FG015|COMPLETED|Follow-up Period||3
10824232|NCT01928394|11989412|FG016|COMPLETED|Follow-up Period||41
10824233|NCT01928394|11989413|FG017|COMPLETED|Follow-up Period||50
10824234|NCT01928394|11989414|FG018|COMPLETED|Follow-up Period||76
10824235|NCT01928394|11989415|FG019|COMPLETED|Follow-up Period||83
10824236|NCT01928394|11989416|FG020|COMPLETED|Follow-up Period||32
10824237|NCT01928394|11989417|FG021|COMPLETED|Follow-up Period||34
10824238|NCT01928394|11989418|FG022|COMPLETED|Follow-up Period||36
10824239|NCT01928394|11989396|FG000|NOT COMPLETED|Follow-up Period||3
10824240|NCT01928394|11989397|FG001|NOT COMPLETED|Follow-up Period||0
10824241|NCT01928394|11989398|FG002|NOT COMPLETED|Follow-up Period||3
10824242|NCT01928394|11989399|FG003|NOT COMPLETED|Follow-up Period||10
10824243|NCT01928394|11989400|FG004|NOT COMPLETED|Follow-up Period||0
10824244|NCT01928394|11989401|FG005|NOT COMPLETED|Follow-up Period||8
10824245|NCT01928394|11989402|FG006|NOT COMPLETED|Follow-up Period||12
10824246|NCT01928394|11989403|FG007|NOT COMPLETED|Follow-up Period||6
10824247|NCT01928394|11989404|FG008|NOT COMPLETED|Follow-up Period||1
10824248|NCT01928394|11989405|FG009|NOT COMPLETED|Follow-up Period||2
10824249|NCT01928394|11989406|FG010|NOT COMPLETED|Follow-up Period||11
10824250|NCT01928394|11989407|FG011|NOT COMPLETED|Follow-up Period||22
10824251|NCT01928394|11989408|FG012|NOT COMPLETED|Follow-up Period||14
10824252|NCT01928394|11989409|FG013|NOT COMPLETED|Follow-up Period||38
10824253|NCT01928394|11989410|FG014|NOT COMPLETED|Follow-up Period||30
10824254|NCT01928394|11989411|FG015|NOT COMPLETED|Follow-up Period||0
10824255|NCT01928394|11989412|FG016|NOT COMPLETED|Follow-up Period||14
10824256|NCT01928394|11989413|FG017|NOT COMPLETED|Follow-up Period||8
10824257|NCT01928394|11989414|FG018|NOT COMPLETED|Follow-up Period||16
10824258|NCT01928394|11989415|FG019|NOT COMPLETED|Follow-up Period||21
10824259|NCT01928394|11989416|FG020|NOT COMPLETED|Follow-up Period||9
10824260|NCT01928394|11989417|FG021|NOT COMPLETED|Follow-up Period||9
10824261|NCT01928394|11989418|FG022|NOT COMPLETED|Follow-up Period||6
10824262|NCT01657500|11989468|FG000|STARTED|Overall Study||32
10824263|NCT01657500|11989469|FG001|STARTED|Overall Study||32
10824264|NCT01657500|11989468|FG000|COMPLETED|Overall Study||27
10824265|NCT01657500|11989469|FG001|COMPLETED|Overall Study||27
10824266|NCT01657500|11989468|FG000|NOT COMPLETED|Overall Study||5
10824267|NCT01657500|11989469|FG001|NOT COMPLETED|Overall Study||5
11219701|NCT01957202|12411357|FG016|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11219702|NCT01957202|12411358|FG017|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
11219703|NCT01957202|12411341|FG000|STARTED|Treatment Period 3 (8 Days)||3
11219704|NCT01957202|12411342|FG001|STARTED|Treatment Period 3 (8 Days)||5
11219705|NCT01957202|12411343|FG002|STARTED|Treatment Period 3 (8 Days)||6
10824268|NCT04810221|11989475|FG000|STARTED|Overall Study||16
10824269|NCT04810221|11989475|FG000|COMPLETED|Overall Study|"Included in the 13 subjects which completed the study, it is necessary to consider the case 0, a pilot test for the verification of study procedures. Data from this subject were not used in the statistical evaluation, which therefore included data from 12 eligible subjects that completed the study."|13
10824270|NCT04810221|11989475|FG000|NOT COMPLETED|Overall Study||3
10824271|NCT04575038|11989481|FG000|STARTED|Overall Study||56
10824272|NCT04575038|11989482|FG001|STARTED|Overall Study||59
10824273|NCT04575038|11989481|FG000|COMPLETED|Overall Study||55
10824274|NCT04575038|11989482|FG001|COMPLETED|Overall Study||58
10824275|NCT04575038|11989481|FG000|NOT COMPLETED|Overall Study||1
10824276|NCT04575038|11989482|FG001|NOT COMPLETED|Overall Study||1
10824277|NCT04545567|11989490|FG000|STARTED|Overall Study||10
10824278|NCT04545567|11989491|FG001|STARTED|Overall Study||11
10824279|NCT04545567|11989490|FG000|COMPLETED|Overall Study||9
10824280|NCT04545567|11989491|FG001|COMPLETED|Overall Study||9
10824281|NCT04545567|11989490|FG000|NOT COMPLETED|Overall Study||1
10824282|NCT04545567|11989491|FG001|NOT COMPLETED|Overall Study||2
10824283|NCT04425538|11989497|FG000|STARTED|Overall Study||17
10824284|NCT04425538|11989497|FG000|COMPLETED|Overall Study||17
10824285|NCT04425538|11989497|FG000|NOT COMPLETED|Overall Study||0
10824286|NCT04397757|11989503|FG000|STARTED|Overall Study||41
10824287|NCT04397757|11989504|FG001|STARTED|Overall Study||39
10824288|NCT04397757|11989503|FG000|Treated|Overall Study||39
10824289|NCT04397757|11989504|FG001|Treated|Overall Study||39
10824290|NCT04397757|11989503|FG000|COMPLETED|Overall Study||32
10824291|NCT04397757|11989504|FG001|COMPLETED|Overall Study||25
10824292|NCT04397757|11989503|FG000|NOT COMPLETED|Overall Study||9
10824293|NCT04397757|11989504|FG001|NOT COMPLETED|Overall Study||14
10824294|NCT04388683|11989517|FG000|STARTED|Overall Study||6
10824295|NCT04388683|11989518|FG001|STARTED|Overall Study||3
10824296|NCT04388683|11989517|FG000|COMPLETED|Overall Study||5
10824297|NCT04388683|11989518|FG001|COMPLETED|Overall Study||3
10824298|NCT04388683|11989517|FG000|NOT COMPLETED|Overall Study||1
10824299|NCT04388683|11989518|FG001|NOT COMPLETED|Overall Study||0
10824300|NCT04329832|11989526|FG000|STARTED|Overall Study||42
10824301|NCT04329832|11989527|FG001|STARTED|Overall Study||43
11099496|NCT01220024|12283347|FG000|COMPLETED|Overall Study||24
11099497|NCT01220024|12283348|FG001|COMPLETED|Overall Study||24
11099498|NCT01220024|12283347|FG000|NOT COMPLETED|Overall Study||1
11099499|NCT01220024|12283348|FG001|NOT COMPLETED|Overall Study||1
11099500|NCT01220128|12283361|FG000|STARTED|Overall Study||15
11099501|NCT01220128|12283362|FG001|STARTED|Overall Study||7
11099502|NCT01220128|12283363|FG002|STARTED|Overall Study||9
11099503|NCT01220128|12283364|FG003|STARTED|Overall Study||6
11099504|NCT01220128|12283365|FG004|STARTED|Overall Study||11
11099505|NCT01220128|12283366|FG005|STARTED|Overall Study||4
11099506|NCT01220128|12283367|FG006|STARTED|Overall Study||8
11099507|NCT01220128|12283361|FG000|COMPLETED|Overall Study||11
11099508|NCT01220128|12283362|FG001|COMPLETED|Overall Study||6
11353972|NCT03068468|12551223|FG003|Treated|Placebo-Controlled Period||0
11353973|NCT03068468|12551220|FG000|COMPLETED|Placebo-Controlled Period||144
11353974|NCT03068468|12551221|FG001|COMPLETED|Placebo-Controlled Period||279
11353975|NCT03068468|12551222|FG002|COMPLETED|Placebo-Controlled Period||0
10824302|NCT04329832|11989526|FG000|COMPLETED|Overall Study||42
11099509|NCT01220128|12283363|FG002|COMPLETED|Overall Study||6
11099510|NCT01220128|12283364|FG003|COMPLETED|Overall Study||6
11099511|NCT01220128|12283365|FG004|COMPLETED|Overall Study||11
11099512|NCT01220128|12283366|FG005|COMPLETED|Overall Study||4
11099513|NCT01220128|12283367|FG006|COMPLETED|Overall Study||3
11099514|NCT01220128|12283361|FG000|NOT COMPLETED|Overall Study||4
11099515|NCT01220128|12283362|FG001|NOT COMPLETED|Overall Study||1
11099516|NCT01220128|12283363|FG002|NOT COMPLETED|Overall Study||3
11099517|NCT01220128|12283364|FG003|NOT COMPLETED|Overall Study||0
11099518|NCT01220128|12283365|FG004|NOT COMPLETED|Overall Study||0
11099519|NCT01220128|12283366|FG005|NOT COMPLETED|Overall Study||0
11099520|NCT01220128|12283367|FG006|NOT COMPLETED|Overall Study||5
11099521|NCT01220167|12283387|FG000|STARTED|Period 1||6
11099522|NCT01220167|12283388|FG001|STARTED|Period 1||6
11099523|NCT01220167|12283389|FG002|STARTED|Period 1||6
11099524|NCT01220167|12283387|FG000|COMPLETED|Period 1||6
11099525|NCT01220167|12283388|FG001|COMPLETED|Period 1||6
11099526|NCT01220167|12283389|FG002|COMPLETED|Period 1||6
11099527|NCT01220167|12283387|FG000|NOT COMPLETED|Period 1||0
11099528|NCT01220167|12283388|FG001|NOT COMPLETED|Period 1||0
11099529|NCT01220167|12283389|FG002|NOT COMPLETED|Period 1||0
11099530|NCT01220167|12283387|FG000|STARTED|Period 2||6
11099531|NCT01220167|12283388|FG001|STARTED|Period 2||6
11099532|NCT01220167|12283389|FG002|STARTED|Period 2||6
11099533|NCT01220167|12283387|FG000|COMPLETED|Period 2||6
11099534|NCT01220167|12283388|FG001|COMPLETED|Period 2||6
11099535|NCT01220167|12283389|FG002|COMPLETED|Period 2||6
11099536|NCT01220167|12283387|FG000|NOT COMPLETED|Period 2||0
10824303|NCT04329832|11989527|FG001|COMPLETED|Overall Study||43
10824304|NCT04329832|11989526|FG000|NOT COMPLETED|Overall Study||0
10824305|NCT04329832|11989527|FG001|NOT COMPLETED|Overall Study||0
10824306|NCT04112303|11989541|FG000|STARTED|Overall Study||37
10824307|NCT04112303|11989541|FG000|COMPLETED|Overall Study||36
10824308|NCT04112303|11989541|FG000|NOT COMPLETED|Overall Study||1
10824309|NCT03896477|11989548|FG000|STARTED|Overall Study||220
10824310|NCT03896477|11989549|FG001|STARTED|Overall Study||220
10824311|NCT03896477|11989550|FG002|STARTED|Overall Study||220
10824312|NCT03896477|11989548|FG000|Received First Vaccination|Overall Study||220
10824313|NCT03896477|11989549|FG001|Received First Vaccination|Overall Study||220
10824314|NCT03896477|11989550|FG002|Received First Vaccination|Overall Study||220
10824315|NCT03896477|11989548|FG000|Received Second Vaccination|Overall Study||217
10824316|NCT03896477|11989549|FG001|Received Second Vaccination|Overall Study||213
10824317|NCT03896477|11989550|FG002|Received Second Vaccination|Overall Study||213
10824318|NCT03896477|11989548|FG000|Received Booster Vaccination|Overall Study||208
10824319|NCT03896477|11989549|FG001|Received Booster Vaccination|Overall Study||206
11099537|NCT01220167|12283388|FG001|NOT COMPLETED|Period 2||0
11099538|NCT01220167|12283389|FG002|NOT COMPLETED|Period 2||0
11099539|NCT01220167|12283387|FG000|STARTED|Period 3||6
11099540|NCT01220167|12283388|FG001|STARTED|Period 3||6
10824320|NCT03896477|11989550|FG002|Received Booster Vaccination|Overall Study||206
10824321|NCT03896477|11989548|FG000|COMPLETED|Overall Study||203
10824322|NCT03896477|11989549|FG001|COMPLETED|Overall Study||200
10824323|NCT03896477|11989550|FG002|COMPLETED|Overall Study||200
10824324|NCT03896477|11989548|FG000|NOT COMPLETED|Overall Study||17
10824325|NCT03896477|11989549|FG001|NOT COMPLETED|Overall Study||20
10824326|NCT03896477|11989550|FG002|NOT COMPLETED|Overall Study||20
10824327|NCT03760185|11989561|FG000|STARTED|Overall Study||13
10824328|NCT03760185|11989562|FG001|STARTED|Overall Study||13
10824329|NCT03760185|11989561|FG000|COMPLETED|Overall Study||12
10824330|NCT03760185|11989562|FG001|COMPLETED|Overall Study||12
10824331|NCT03760185|11989561|FG000|NOT COMPLETED|Overall Study||1
10824332|NCT03760185|11989562|FG001|NOT COMPLETED|Overall Study||1
10824333|NCT03732534|11989570|FG000|STARTED|Overall Study||6
10824334|NCT03732534|11989570|FG000|COMPLETED|Overall Study||0
10824335|NCT03732534|11989570|FG000|NOT COMPLETED|Overall Study||6
11099541|NCT01220167|12283389|FG002|STARTED|Period 3||6
11099542|NCT01220167|12283387|FG000|COMPLETED|Period 3||6
11099543|NCT01220167|12283388|FG001|COMPLETED|Period 3||5
11099544|NCT01220167|12283389|FG002|COMPLETED|Period 3||6
11099545|NCT01220167|12283387|FG000|NOT COMPLETED|Period 3||0
11099546|NCT01220167|12283388|FG001|NOT COMPLETED|Period 3||1
11099547|NCT01220167|12283389|FG002|NOT COMPLETED|Period 3||0
11219706|NCT01957202|12411344|FG003|STARTED|Treatment Period 3 (8 Days)||3
11219707|NCT01957202|12411345|FG004|STARTED|Treatment Period 3 (8 Days)||3
11219708|NCT01957202|12411346|FG005|STARTED|Treatment Period 3 (8 Days)||2
11219709|NCT01957202|12411347|FG006|STARTED|Treatment Period 3 (8 Days)||3
11219710|NCT01957202|12411348|FG007|STARTED|Treatment Period 3 (8 Days)||3
11219711|NCT01957202|12411349|FG008|STARTED|Treatment Period 3 (8 Days)||3
11219712|NCT01957202|12411350|FG009|STARTED|Treatment Period 3 (8 Days)||6
11219713|NCT01957202|12411351|FG010|STARTED|Treatment Period 3 (8 Days)||3
11219714|NCT01957202|12411352|FG011|STARTED|Treatment Period 3 (8 Days)||6
11219715|NCT01957202|12411353|FG012|STARTED|Treatment Period 3 (8 Days)||3
11219716|NCT01957202|12411354|FG013|STARTED|Treatment Period 3 (8 Days)||3
11219717|NCT01957202|12411355|FG014|STARTED|Treatment Period 3 (8 Days)||6
11219718|NCT01957202|12411356|FG015|STARTED|Treatment Period 3 (8 Days)||3
11219719|NCT01957202|12411357|FG016|STARTED|Treatment Period 3 (8 Days)||5
11219720|NCT01957202|12411358|FG017|STARTED|Treatment Period 3 (8 Days)||3
11219721|NCT01957202|12411341|FG000|COMPLETED|Treatment Period 3 (8 Days)||3
11219722|NCT01957202|12411342|FG001|COMPLETED|Treatment Period 3 (8 Days)||5
11219723|NCT01957202|12411343|FG002|COMPLETED|Treatment Period 3 (8 Days)||6
11219724|NCT01957202|12411344|FG003|COMPLETED|Treatment Period 3 (8 Days)||3
11219725|NCT01957202|12411345|FG004|COMPLETED|Treatment Period 3 (8 Days)||3
11219726|NCT01957202|12411346|FG005|COMPLETED|Treatment Period 3 (8 Days)||2
11219727|NCT01957202|12411347|FG006|COMPLETED|Treatment Period 3 (8 Days)||3
11219728|NCT01957202|12411348|FG007|COMPLETED|Treatment Period 3 (8 Days)||3
11219729|NCT01957202|12411349|FG008|COMPLETED|Treatment Period 3 (8 Days)||3
11219730|NCT01957202|12411350|FG009|COMPLETED|Treatment Period 3 (8 Days)||6
11219731|NCT01957202|12411351|FG010|COMPLETED|Treatment Period 3 (8 Days)||3
11219732|NCT01957202|12411352|FG011|COMPLETED|Treatment Period 3 (8 Days)||6
11219733|NCT01957202|12411353|FG012|COMPLETED|Treatment Period 3 (8 Days)||3
11219734|NCT01957202|12411354|FG013|COMPLETED|Treatment Period 3 (8 Days)||3
11219735|NCT01957202|12411355|FG014|COMPLETED|Treatment Period 3 (8 Days)||6
11219736|NCT01957202|12411356|FG015|COMPLETED|Treatment Period 3 (8 Days)||3
11219737|NCT01957202|12411357|FG016|COMPLETED|Treatment Period 3 (8 Days)||4
11219738|NCT01957202|12411358|FG017|COMPLETED|Treatment Period 3 (8 Days)||3
11219739|NCT01957202|12411341|FG000|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219740|NCT01957202|12411342|FG001|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219741|NCT01957202|12411343|FG002|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219742|NCT01957202|12411344|FG003|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219743|NCT01957202|12411345|FG004|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219744|NCT01957202|12411346|FG005|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219745|NCT01957202|12411347|FG006|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219746|NCT01957202|12411348|FG007|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219747|NCT01957202|12411349|FG008|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219748|NCT01957202|12411350|FG009|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219749|NCT01957202|12411351|FG010|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219750|NCT01957202|12411352|FG011|NOT COMPLETED|Treatment Period 3 (8 Days)||0
10824336|NCT03692910|11989574|FG000|STARTED|Overall Study||35
10824337|NCT03692910|11989575|FG001|STARTED|Overall Study||0
10824338|NCT03692910|11989576|FG002|STARTED|Overall Study||0
10824339|NCT03692910|11989574|FG000|COMPLETED|Overall Study||29
10824340|NCT03692910|11989575|FG001|COMPLETED|Overall Study||0
10824341|NCT03692910|11989576|FG002|COMPLETED|Overall Study||0
10824342|NCT03692910|11989574|FG000|NOT COMPLETED|Overall Study||6
10824343|NCT03692910|11989575|FG001|NOT COMPLETED|Overall Study||0
10824344|NCT03692910|11989576|FG002|NOT COMPLETED|Overall Study||0
10824345|NCT03673956|11989586|FG000|STARTED|Overall Study||12
10824346|NCT03673956|11989587|FG001|STARTED|Overall Study||1
10824347|NCT03673956|11989588|FG002|STARTED|Overall Study||5
10824348|NCT03673956|11989589|FG003|STARTED|Overall Study||1
10824349|NCT03673956|11989586|FG000|COMPLETED|Overall Study||10
10824350|NCT03673956|11989587|FG001|COMPLETED|Overall Study||1
10824351|NCT03673956|11989588|FG002|COMPLETED|Overall Study||5
10824352|NCT03673956|11989589|FG003|COMPLETED|Overall Study||1
10824353|NCT03673956|11989586|FG000|NOT COMPLETED|Overall Study||2
10824354|NCT03673956|11989587|FG001|NOT COMPLETED|Overall Study||0
10824355|NCT03673956|11989588|FG002|NOT COMPLETED|Overall Study||0
10824356|NCT03673956|11989589|FG003|NOT COMPLETED|Overall Study||0
10824357|NCT03649347|11989603|FG000|STARTED|Overall Study||13
10824358|NCT03649347|11989604|FG001|STARTED|Overall Study||12
10824359|NCT03649347|11989605|FG002|STARTED|Overall Study||0
10824360|NCT03649347|11989606|FG003|STARTED|Overall Study||0
10824361|NCT03649347|11989603|FG000|COMPLETED|Overall Study||13
10824362|NCT03649347|11989604|FG001|COMPLETED|Overall Study||12
10824363|NCT03649347|11989605|FG002|COMPLETED|Overall Study||0
10824364|NCT03649347|11989606|FG003|COMPLETED|Overall Study||0
10824365|NCT03649347|11989603|FG000|NOT COMPLETED|Overall Study||0
10824366|NCT03649347|11989604|FG001|NOT COMPLETED|Overall Study||0
10824367|NCT03649347|11989605|FG002|NOT COMPLETED|Overall Study||0
10824368|NCT03649347|11989606|FG003|NOT COMPLETED|Overall Study||0
10824369|NCT03641326|11989616|FG000|STARTED|Overall Study||2
10824370|NCT03641326|11989617|FG001|STARTED|Overall Study||3
10824371|NCT03641326|11989616|FG000|COMPLETED|Overall Study||2
10824372|NCT03641326|11989617|FG001|COMPLETED|Overall Study||3
10824373|NCT03641326|11989616|FG000|NOT COMPLETED|Overall Study||0
10824374|NCT03641326|11989617|FG001|NOT COMPLETED|Overall Study||0
10824375|NCT03618420|11989628|FG000|STARTED|Overall Study||50
10824376|NCT03618420|11989628|FG000|COMPLETED|Overall Study||50
10824377|NCT03618420|11989628|FG000|NOT COMPLETED|Overall Study||0
10824378|NCT03411031|11989634|FG000|STARTED|Overall Study||9
10824379|NCT03411031|11989635|FG001|STARTED|Overall Study||9
10824380|NCT03411031|11989634|FG000|COMPLETED|Overall Study||9
10824381|NCT03411031|11989635|FG001|COMPLETED|Overall Study||9
10824382|NCT03411031|11989634|FG000|NOT COMPLETED|Overall Study||0
10824383|NCT03411031|11989635|FG001|NOT COMPLETED|Overall Study||0
10824384|NCT03365752|11989644|FG000|STARTED|Overall Study||13
10824385|NCT03365752|11989645|FG001|STARTED|Overall Study||13
10824386|NCT03365752|11989646|FG002|STARTED|Overall Study||13
10824387|NCT03365752|11989644|FG000|COMPLETED|Overall Study||13
10824388|NCT03365752|11989645|FG001|COMPLETED|Overall Study||13
10824389|NCT03365752|11989646|FG002|COMPLETED|Overall Study||13
10824390|NCT03365752|11989644|FG000|NOT COMPLETED|Overall Study||0
10824391|NCT03365752|11989645|FG001|NOT COMPLETED|Overall Study||0
10824392|NCT03365752|11989646|FG002|NOT COMPLETED|Overall Study||0
11099548|NCT01220180|12283398|FG000|STARTED|Overall Study||4175
11099549|NCT01220180|12283398|FG000|Treated|Overall Study||4174
11099550|NCT01220180|12283398|FG000|COMPLETED|Overall Study||3968
11099551|NCT01220180|12283398|FG000|NOT COMPLETED|Overall Study||207
10824397|NCT03205163|11989660|FG000|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7
10824398|NCT03205163|11989661|FG001|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9
10824399|NCT03205163|11989660|FG000|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7
10824400|NCT03205163|11989661|FG001|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9
10824401|NCT03205163|11989660|FG000|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6
10824402|NCT03205163|11989661|FG001|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9
10824403|NCT03205163|11989660|FG000|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1
10824404|NCT03205163|11989661|FG001|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0
10824405|NCT03205163|11989660|FG000|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6
10824406|NCT03205163|11989661|FG001|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9
10824407|NCT03205163|11989660|FG000|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6
10824408|NCT03205163|11989661|FG001|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9
10824409|NCT03205163|11989660|FG000|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6
10824410|NCT03205163|11989661|FG001|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9
10824411|NCT03205163|11989660|FG000|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
10824412|NCT03205163|11989661|FG001|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
10824413|NCT03178045|11989678|FG000|STARTED|Overall Study||1396
10824414|NCT03178045|11989679|FG001|STARTED|Overall Study||1397
10824415|NCT03178045|11989678|FG000|COMPLETED|Overall Study||1310
10824416|NCT03178045|11989679|FG001|COMPLETED|Overall Study||1314
10824417|NCT03178045|11989678|FG000|NOT COMPLETED|Overall Study||86
10824418|NCT03178045|11989679|FG001|NOT COMPLETED|Overall Study||83
10824419|NCT03145766|11989691|FG000|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
10824420|NCT03145766|11989692|FG001|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
10824421|NCT03145766|11989693|FG002|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
10824422|NCT03145766|11989694|FG003|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
10824423|NCT03145766|11989695|FG004|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
10824424|NCT03145766|11989691|FG000|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
10824425|NCT03145766|11989692|FG001|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
10824426|NCT03145766|11989693|FG002|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
10824427|NCT03145766|11989694|FG003|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of this arm received Imovax Rabies, and counted in Group 5 for safety analysis.|39
10824428|NCT03145766|11989695|FG004|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 4 received Imovax Rabies, and counted in Group 5 for safety analysis.|41
10824429|NCT03145766|11989691|FG000|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety analysis.|77
10824430|NCT03145766|11989692|FG001|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 1 received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety.|81
10824431|NCT03145766|11989693|FG002|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||80
10824432|NCT03145766|11989694|FG003|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
10824433|NCT03145766|11989695|FG004|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
10824434|NCT03145766|11989691|FG000|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||78
11099552|NCT01220297|12283404|FG000|STARTED|Overall Study||3
10824435|NCT03145766|11989692|FG001|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||79
10824436|NCT03145766|11989693|FG002|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||80
10824437|NCT03145766|11989694|FG003|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||39
10824438|NCT03145766|11989695|FG004|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||38
10824439|NCT03145766|11989691|FG000|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||78
10824440|NCT03145766|11989692|FG001|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||79
10824441|NCT03145766|11989693|FG002|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||80
10824442|NCT03145766|11989694|FG003|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
10824443|NCT03145766|11989695|FG004|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
10824444|NCT03145766|11989691|FG000|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||75
10824445|NCT03145766|11989692|FG001|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||78
10824446|NCT03145766|11989693|FG002|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||79
10824447|NCT03145766|11989694|FG003|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||34
10824448|NCT03145766|11989695|FG004|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||37
10824449|NCT03145766|11989691|FG000|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||74
10824450|NCT03145766|11989692|FG001|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||77
10824451|NCT03145766|11989693|FG002|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||78
10824452|NCT03145766|11989694|FG003|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||33
10824453|NCT03145766|11989695|FG004|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||37
10824454|NCT03145766|11989691|FG000|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||6
10824455|NCT03145766|11989692|FG001|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
10824456|NCT03145766|11989693|FG002|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||2
10824457|NCT03145766|11989694|FG003|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||7
10824458|NCT03145766|11989695|FG004|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
10824459|NCT03145766|11989691|FG000|STARTED|Follow-up Phase (Day 56 Till Month 7)||74
10824460|NCT03145766|11989692|FG001|STARTED|Follow-up Phase (Day 56 Till Month 7)||77
10824461|NCT03145766|11989693|FG002|STARTED|Follow-up Phase (Day 56 Till Month 7)||78
10824462|NCT03145766|11989694|FG003|STARTED|Follow-up Phase (Day 56 Till Month 7)||33
10824463|NCT03145766|11989695|FG004|STARTED|Follow-up Phase (Day 56 Till Month 7)||37
10824464|NCT03145766|11989691|FG000|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||67
10824465|NCT03145766|11989692|FG001|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||75
10824466|NCT03145766|11989693|FG002|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||73
10824467|NCT03145766|11989694|FG003|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||30
10824468|NCT03145766|11989695|FG004|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||34
10824469|NCT03145766|11989691|FG000|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||7
10824470|NCT03145766|11989692|FG001|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||2
10824471|NCT03145766|11989693|FG002|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||5
10824472|NCT03145766|11989694|FG003|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
10824473|NCT03145766|11989695|FG004|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
10824474|NCT03106987|11989712|FG000|STARTED|Overall Study||74
10824475|NCT03106987|11989713|FG001|STARTED|Overall Study||38
10824476|NCT03106987|11989714|FG002|STARTED|Overall Study||72
10824477|NCT03106987|11989715|FG003|STARTED|Overall Study||36
10824478|NCT03106987|11989712|FG000|COMPLETED|Overall Study||30
10824479|NCT03106987|11989713|FG001|COMPLETED|Overall Study||15
10824480|NCT03106987|11989714|FG002|COMPLETED|Overall Study||54
10824481|NCT03106987|11989715|FG003|COMPLETED|Overall Study||25
10824482|NCT03106987|11989712|FG000|NOT COMPLETED|Overall Study||44
10824483|NCT03106987|11989713|FG001|NOT COMPLETED|Overall Study||23
10824484|NCT03106987|11989714|FG002|NOT COMPLETED|Overall Study||18
10824485|NCT03106987|11989715|FG003|NOT COMPLETED|Overall Study||11
10824486|NCT03103087|11989728|FG000|STARTED|Overall Study||126
10824487|NCT03103087|11989729|FG001|STARTED|Overall Study||127
10824488|NCT03103087|11989730|FG002|STARTED|Overall Study||129
10824489|NCT03103087|11989728|FG000|COMPLETED|Overall Study||102
10824490|NCT03103087|11989729|FG001|COMPLETED|Overall Study||98
10824491|NCT03103087|11989730|FG002|COMPLETED|Overall Study||102
10824492|NCT03103087|11989728|FG000|NOT COMPLETED|Overall Study||24
10824493|NCT03103087|11989729|FG001|NOT COMPLETED|Overall Study||29
10824494|NCT03103087|11989730|FG002|NOT COMPLETED|Overall Study||27
10824495|NCT03049735|11989743|FG000|STARTED|Overall Study||128
10824496|NCT03049735|11989744|FG001|STARTED|Overall Study||132
10824497|NCT03049735|11989745|FG002|STARTED|Overall Study||128
10824498|NCT03049735|11989743|FG000|Received at Least 1 Dose of Study Drug|Overall Study||128
10824499|NCT03049735|11989744|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132
10824500|NCT03049735|11989745|FG002|Received at Least 1 Dose of Study Drug|Overall Study||127
10824501|NCT03049735|11989743|FG000|COMPLETED|Overall Study||100
10824502|NCT03049735|11989744|FG001|COMPLETED|Overall Study||103
10824503|NCT03049735|11989745|FG002|COMPLETED|Overall Study||105
10824504|NCT03049735|11989743|FG000|NOT COMPLETED|Overall Study||28
10824505|NCT03049735|11989744|FG001|NOT COMPLETED|Overall Study||29
10824506|NCT03049735|11989745|FG002|NOT COMPLETED|Overall Study||23
10824507|NCT03021551|11989753|FG000|STARTED|Overall Study||80
10824508|NCT03021551|11989753|FG000|COMPLETED|Overall Study||77
10824509|NCT03021551|11989753|FG000|NOT COMPLETED|Overall Study||3
10824510|NCT02990338|11989759|FG000|STARTED|Overall Study||153
10824511|NCT02990338|11989760|FG001|STARTED|Overall Study||154
10824512|NCT02990338|11989759|FG000|Treated|Overall Study||149
10824513|NCT02990338|11989760|FG001|Treated|Overall Study||152
10824514|NCT02990338|11989759|FG000|Ongoing|Overall Study||35
10824515|NCT02990338|11989760|FG001|Ongoing|Overall Study||65
10824516|NCT02990338|11989759|FG000|COMPLETED|Overall Study||35
10824517|NCT02990338|11989760|FG001|COMPLETED|Overall Study||65
10824518|NCT02990338|11989759|FG000|NOT COMPLETED|Overall Study||118
10824519|NCT02990338|11989760|FG001|NOT COMPLETED|Overall Study||89
10824520|NCT02972996|11989769|FG000|STARTED|Overall Study||27
10824521|NCT02972996|11989770|FG001|STARTED|Overall Study||28
10824522|NCT02972996|11989769|FG000|COMPLETED|Overall Study||26
10824523|NCT02972996|11989770|FG001|COMPLETED|Overall Study||26
10824524|NCT02972996|11989769|FG000|NOT COMPLETED|Overall Study||1
10824525|NCT02972996|11989770|FG001|NOT COMPLETED|Overall Study||2
10824526|NCT02932332|11989780|FG000|STARTED|Overall Study||5
10824527|NCT02932332|11989781|FG001|STARTED|Overall Study||4
10824528|NCT02932332|11989782|FG002|STARTED|Overall Study||5
10824529|NCT02932332|11989783|FG003|STARTED|Overall Study||5
10824530|NCT02932332|11989780|FG000|Intervention 1|Overall Study||4
10824531|NCT02932332|11989781|FG001|Intervention 1|Overall Study||4
10824532|NCT02932332|11989782|FG002|Intervention 1|Overall Study||5
10824533|NCT02932332|11989783|FG003|Intervention 1|Overall Study||4
10824534|NCT02932332|11989780|FG000|Intervention 2|Overall Study||4
10824535|NCT02932332|11989781|FG001|Intervention 2|Overall Study||3
10824536|NCT02932332|11989782|FG002|Intervention 2|Overall Study||4
10824537|NCT02932332|11989783|FG003|Intervention 2|Overall Study||4
10824538|NCT02932332|11989780|FG000|Intervention 3|Overall Study||3
10824539|NCT02932332|11989781|FG001|Intervention 3|Overall Study||2
10824540|NCT02932332|11989782|FG002|Intervention 3|Overall Study||4
10824541|NCT02932332|11989783|FG003|Intervention 3|Overall Study||3
10824542|NCT02932332|11989780|FG000|Intervention 4|Overall Study||3
10824543|NCT02932332|11989781|FG001|Intervention 4|Overall Study||1
10824544|NCT02932332|11989782|FG002|Intervention 4|Overall Study||4
10824545|NCT02932332|11989783|FG003|Intervention 4|Overall Study||3
10824546|NCT02932332|11989780|FG000|COMPLETED|Overall Study||3
10824547|NCT02932332|11989781|FG001|COMPLETED|Overall Study||1
10824548|NCT02932332|11989782|FG002|COMPLETED|Overall Study||4
10824549|NCT02932332|11989783|FG003|COMPLETED|Overall Study||3
10824550|NCT02932332|11989780|FG000|NOT COMPLETED|Overall Study||2
10824551|NCT02932332|11989781|FG001|NOT COMPLETED|Overall Study||3
10824552|NCT02932332|11989782|FG002|NOT COMPLETED|Overall Study||1
10824553|NCT02932332|11989783|FG003|NOT COMPLETED|Overall Study||2
10824554|NCT02845440|11989798|FG000|STARTED|Overall Study||333
10824555|NCT02845440|11989799|FG001|STARTED|Overall Study||336
10824556|NCT02845440|11989800|FG002|STARTED|Overall Study||341
10824557|NCT02845440|11989801|FG003|STARTED|Overall Study||78
10824558|NCT02845440|11989802|FG004|STARTED|Overall Study||77
10824559|NCT02845440|11989798|FG000|COMPLETED|Overall Study||201
10824560|NCT02845440|11989799|FG001|COMPLETED|Overall Study||203
10824561|NCT02845440|11989800|FG002|COMPLETED|Overall Study||204
10824562|NCT02845440|11989801|FG003|COMPLETED|Overall Study||49
10824563|NCT02845440|11989802|FG004|COMPLETED|Overall Study||39
10824564|NCT02845440|11989798|FG000|NOT COMPLETED|Overall Study||132
10824565|NCT02845440|11989799|FG001|NOT COMPLETED|Overall Study||133
10824566|NCT02845440|11989800|FG002|NOT COMPLETED|Overall Study||137
10824567|NCT02845440|11989801|FG003|NOT COMPLETED|Overall Study||29
10824568|NCT02845440|11989802|FG004|NOT COMPLETED|Overall Study||38
10824569|NCT02786394|11989819|FG000|STARTED|Overall Study||11
10824570|NCT02786394|11989819|FG000|COMPLETED|Overall Study||10
10824571|NCT02786394|11989819|FG000|NOT COMPLETED|Overall Study||1
10824572|NCT02588248|11989826|FG000|STARTED|Overall Study||42
10824573|NCT02588248|11989827|FG001|STARTED|Overall Study||40
10824574|NCT02588248|11989826|FG000|COMPLETED|Overall Study||38
10824575|NCT02588248|11989827|FG001|COMPLETED|Overall Study||37
10824576|NCT02588248|11989826|FG000|NOT COMPLETED|Overall Study||4
10824577|NCT02588248|11989827|FG001|NOT COMPLETED|Overall Study||3
10824578|NCT02535065|11989838|FG000|STARTED|Overall Study||62
10824579|NCT02535065|11989838|FG000|1-Month Follow-up|Overall Study||62
10824580|NCT02535065|11989838|FG000|12-Month Follow-up|Overall Study||61
10824581|NCT02535065|11989838|FG000|COMPLETED|Overall Study||42
10824582|NCT02535065|11989838|FG000|NOT COMPLETED|Overall Study||20
10824583|NCT02510885|11989842|FG000|STARTED|Overall Study||39
10824584|NCT02510885|11989842|FG000|COMPLETED|Overall Study||39
10824585|NCT02510885|11989842|FG000|NOT COMPLETED|Overall Study||0
10824586|NCT02451358|11989850|FG000|STARTED|Overall Study||100
10824587|NCT02451358|11989851|FG001|STARTED|Overall Study||100
10824588|NCT02451358|11989852|FG002|STARTED|Overall Study||100
10824589|NCT02451358|11989853|FG003|STARTED|Overall Study||100
10824590|NCT02451358|11989850|FG000|Vaccinated at Day 0|Overall Study||100
10824591|NCT02451358|11989851|FG001|Vaccinated at Day 0|Overall Study||100
10824592|NCT02451358|11989852|FG002|Vaccinated at Day 0|Overall Study||100
10824593|NCT02451358|11989853|FG003|Vaccinated at Day 0|Overall Study||100
10824594|NCT02451358|11989850|FG000|Vaccinated at Day 28|Overall Study||99
10824595|NCT02451358|11989851|FG001|Vaccinated at Day 28|Overall Study||98
10824596|NCT02451358|11989852|FG002|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
10824597|NCT02451358|11989853|FG003|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
10824598|NCT02451358|11989850|FG000|COMPLETED|Overall Study||99
10824599|NCT02451358|11989851|FG001|COMPLETED|Overall Study||98
10824600|NCT02451358|11989852|FG002|COMPLETED|Overall Study||99
10824601|NCT02451358|11989853|FG003|COMPLETED|Overall Study||100
10824602|NCT02451358|11989850|FG000|NOT COMPLETED|Overall Study||1
10824603|NCT02451358|11989851|FG001|NOT COMPLETED|Overall Study||2
10824604|NCT02451358|11989852|FG002|NOT COMPLETED|Overall Study||1
10824605|NCT02451358|11989853|FG003|NOT COMPLETED|Overall Study||0
10824606|NCT02268175|11989865|FG000|STARTED|Overall Study||50
10824607|NCT02268175|11989866|FG001|STARTED|Overall Study||25
10824608|NCT02268175|11989865|FG000|COMPLETED|Overall Study||50
10824609|NCT02268175|11989866|FG001|COMPLETED|Overall Study||25
10824610|NCT02268175|11989865|FG000|NOT COMPLETED|Overall Study||0
10824611|NCT02268175|11989866|FG001|NOT COMPLETED|Overall Study||0
10824612|NCT02178709|11989872|FG000|STARTED|Overall Study||48
10824613|NCT02178709|11989872|FG000|COMPLETED|Overall Study||32
10824614|NCT02178709|11989872|FG000|NOT COMPLETED|Overall Study||16
10824615|NCT02163681|11989876|FG000|STARTED|Overall Study||45
10824616|NCT02163681|11989876|FG000|COMPLETED|Overall Study||44
10824617|NCT02163681|11989876|FG000|NOT COMPLETED|Overall Study||1
10824618|NCT01980017|11989882|FG000|STARTED|Overall Study||114
10824619|NCT01980017|11989883|FG001|STARTED|Overall Study||199
10824620|NCT01980017|11989882|FG000|COMPLETED|Overall Study||84
10824621|NCT01980017|11989883|FG001|COMPLETED|Overall Study||177
10824622|NCT01980017|11989882|FG000|NOT COMPLETED|Overall Study||30
10824623|NCT01980017|11989883|FG001|NOT COMPLETED|Overall Study||22
10824624|NCT01890759|11989894|FG000|STARTED|Overall Study||100
10824625|NCT01890759|11989895|FG001|STARTED|Overall Study||200
10824626|NCT01890759|11989894|FG000|COMPLETED|Overall Study||98
10824627|NCT01890759|11989895|FG001|COMPLETED|Overall Study||188
10824628|NCT01890759|11989894|FG000|NOT COMPLETED|Overall Study||2
10824629|NCT01890759|11989895|FG001|NOT COMPLETED|Overall Study||12
10824630|NCT01855867|11989901|FG000|STARTED|Overall Study||100
10824631|NCT01855867|11989901|FG000|COMPLETED|Overall Study||100
10824632|NCT01855867|11989901|FG000|NOT COMPLETED|Overall Study||0
10824633|NCT01721746|11989908|FG000|STARTED|Pre-Treatment||272
10824634|NCT01721746|11989909|FG001|STARTED|Pre-Treatment||133
10824635|NCT01721746|11989908|FG000|COMPLETED|Pre-Treatment||268
10824636|NCT01721746|11989909|FG001|COMPLETED|Pre-Treatment||102
10824637|NCT01721746|11989908|FG000|NOT COMPLETED|Pre-Treatment||4
10824638|NCT01721746|11989909|FG001|NOT COMPLETED|Pre-Treatment||31
10824639|NCT01721746|11989908|FG000|STARTED|Treatment||268
10824640|NCT01721746|11989909|FG001|STARTED|Treatment||102
10824641|NCT01721746|11989908|FG000|COMPLETED|Treatment||0
10824642|NCT01721746|11989909|FG001|COMPLETED|Treatment||0
10824643|NCT01721746|11989908|FG000|NOT COMPLETED|Treatment||268
10824644|NCT01721746|11989909|FG001|NOT COMPLETED|Treatment||102
10824645|NCT01587040|11989920|FG000|STARTED|Overall Study||17
10824646|NCT01587040|11989921|FG001|STARTED|Overall Study||3
10824647|NCT01587040|11989922|FG002|STARTED|Overall Study||37
10824648|NCT01587040|11989923|FG003|STARTED|Overall Study||4
10824649|NCT01587040|11989920|FG000|COMPLETED|Overall Study||0
10824650|NCT01587040|11989921|FG001|COMPLETED|Overall Study||0
10824651|NCT01587040|11989922|FG002|COMPLETED|Overall Study||0
10824652|NCT01587040|11989923|FG003|COMPLETED|Overall Study||0
10824653|NCT01587040|11989920|FG000|NOT COMPLETED|Overall Study||17
10824654|NCT01587040|11989921|FG001|NOT COMPLETED|Overall Study||3
10824655|NCT01587040|11989922|FG002|NOT COMPLETED|Overall Study||37
10824656|NCT01587040|11989923|FG003|NOT COMPLETED|Overall Study||4
10824657|NCT01293682|11989933|FG000|STARTED|Overall Study||12
10824658|NCT01293682|11989933|FG000|COMPLETED|Overall Study||12
10824659|NCT01293682|11989933|FG000|NOT COMPLETED|Overall Study||0
10824660|NCT01254409|11989941|FG000|STARTED|Overall Study||6
10824661|NCT01254409|11989942|FG001|STARTED|Overall Study||6
10824662|NCT01254409|11989943|FG002|STARTED|Overall Study||5
10824663|NCT01254409|11989944|FG003|STARTED|Overall Study||4
10824664|NCT01254409|11989941|FG000|COMPLETED|Overall Study||6
10824665|NCT01254409|11989942|FG001|COMPLETED|Overall Study||5
10824666|NCT01254409|11989943|FG002|COMPLETED|Overall Study||5
10824667|NCT01254409|11989944|FG003|COMPLETED|Overall Study||4
10824668|NCT01254409|11989941|FG000|NOT COMPLETED|Overall Study||0
10824669|NCT01254409|11989942|FG001|NOT COMPLETED|Overall Study||1
10824670|NCT01254409|11989943|FG002|NOT COMPLETED|Overall Study||0
10824671|NCT01254409|11989944|FG003|NOT COMPLETED|Overall Study||0
10824672|NCT01253161|11989957|FG000|STARTED|Overall Study||29
10824673|NCT01253161|11989957|FG000|COMPLETED|Overall Study||28
10824674|NCT01253161|11989957|FG000|NOT COMPLETED|Overall Study||1
10824675|NCT00867321|11989964|FG000|STARTED|Overall Study||4
10824676|NCT00867321|11989965|FG001|STARTED|Overall Study||3
10824677|NCT00867321|11989966|FG002|STARTED|Overall Study||3
10824678|NCT00867321|11989967|FG003|STARTED|Overall Study||6
10824679|NCT00867321|11989968|FG004|STARTED|Overall Study||5
10824680|NCT00867321|11989969|FG005|STARTED|Overall Study||3
10824681|NCT00867321|11989964|FG000|COMPLETED|Overall Study||4
10824682|NCT00867321|11989965|FG001|COMPLETED|Overall Study||2
10824683|NCT00867321|11989966|FG002|COMPLETED|Overall Study||3
10824684|NCT00867321|11989967|FG003|COMPLETED|Overall Study||6
10824685|NCT00867321|11989968|FG004|COMPLETED|Overall Study||5
10824686|NCT00867321|11989969|FG005|COMPLETED|Overall Study||3
10824687|NCT00867321|11989964|FG000|NOT COMPLETED|Overall Study||0
10824688|NCT00867321|11989965|FG001|NOT COMPLETED|Overall Study||1
10824689|NCT00867321|11989966|FG002|NOT COMPLETED|Overall Study||0
10824690|NCT00867321|11989967|FG003|NOT COMPLETED|Overall Study||0
10824691|NCT00867321|11989968|FG004|NOT COMPLETED|Overall Study||0
10824692|NCT00867321|11989969|FG005|NOT COMPLETED|Overall Study||0
10824693|NCT00728962|11989984|FG000|STARTED|Implant Placement Surgery||75
10824694|NCT00728962|11989984|FG000|COMPLETED|Implant Placement Surgery||65
10824695|NCT00728962|11989984|FG000|NOT COMPLETED|Implant Placement Surgery||10
10824696|NCT00728962|11989984|FG000|STARTED|Permanent Prosthesis Placement||65
10824697|NCT00728962|11989984|FG000|COMPLETED|Permanent Prosthesis Placement||62
10824698|NCT00728962|11989984|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3
10824699|NCT00728962|11989984|FG000|STARTED|One Year Post Placement Follow-up||62
10824700|NCT00728962|11989984|FG000|COMPLETED|One Year Post Placement Follow-up||62
10824701|NCT00728962|11989984|FG000|NOT COMPLETED|One Year Post Placement Follow-up||0
10824702|NCT00728962|11989984|FG000|STARTED|Two Year Post Placement Follow-up||62
10824703|NCT00728962|11989984|FG000|COMPLETED|Two Year Post Placement Follow-up||59
10824704|NCT00728962|11989984|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||3
10824705|NCT00728754|11989990|FG000|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
10824706|NCT00728754|11989991|FG001|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
10824707|NCT00728754|11989990|FG000|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
10824708|NCT00728754|11989991|FG001|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
10824709|NCT00728754|11989990|FG000|NOT COMPLETED|Implant Placement Surgery||0
10824710|NCT00728754|11989991|FG001|NOT COMPLETED|Implant Placement Surgery||0
10824711|NCT00728754|11989990|FG000|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
10824712|NCT00728754|11989991|FG001|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
10824713|NCT00728754|11989990|FG000|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
10824714|NCT00728754|11989991|FG001|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
10824715|NCT00728754|11989990|FG000|NOT COMPLETED|Permanent Prosthesis Placement||4
10824716|NCT00728754|11989991|FG001|NOT COMPLETED|Permanent Prosthesis Placement||4
10824717|NCT00728754|11989990|FG000|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
10824718|NCT00728754|11989991|FG001|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
10824719|NCT00728754|11989990|FG000|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
10824720|NCT00728754|11989991|FG001|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
10824721|NCT00728754|11989990|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1
10824722|NCT00728754|11989991|FG001|NOT COMPLETED|One Year Post Placement Follow-up||0
10824723|NCT00728754|11989990|FG000|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
10824724|NCT00728754|11989991|FG001|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
10824725|NCT00728754|11989990|FG000|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
10824726|NCT00728754|11989991|FG001|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
10824727|NCT00728754|11989990|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
10824728|NCT00728754|11989991|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0
10824729|NCT00723944|11989999|FG000|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
10824730|NCT00723944|11990000|FG001|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
10824731|NCT00723944|11989999|FG000|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
10824732|NCT00723944|11990000|FG001|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
11099553|NCT01220297|12283404|FG000|COMPLETED|Overall Study||0
11099554|NCT01220297|12283404|FG000|NOT COMPLETED|Overall Study||3
11099555|NCT01220401|12283410|FG000|STARTED|Overall Study||21
11099556|NCT01220401|12283410|FG000|COMPLETED|Overall Study||18
11099557|NCT01220401|12283410|FG000|NOT COMPLETED|Overall Study||3
10824733|NCT00723944|11989999|FG000|NOT COMPLETED|Implant Placement Surgery||0
10824734|NCT00723944|11990000|FG001|NOT COMPLETED|Implant Placement Surgery||0
10824735|NCT00723944|11989999|FG000|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
10824736|NCT00723944|11990000|FG001|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
10824737|NCT00723944|11989999|FG000|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
10824738|NCT00723944|11990000|FG001|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
10824739|NCT00723944|11989999|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3
10824740|NCT00723944|11990000|FG001|NOT COMPLETED|Permanent Prosthesis Placement||9
10824741|NCT00723944|11989999|FG000|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
10824742|NCT00723944|11990000|FG001|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
10824743|NCT00723944|11989999|FG000|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
10824744|NCT00723944|11990000|FG001|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
10824745|NCT00723944|11989999|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1
10824746|NCT00723944|11990000|FG001|NOT COMPLETED|One Year Post Placement Follow-up||4
10824747|NCT00723944|11989999|FG000|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
10824748|NCT00723944|11990000|FG001|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
10824749|NCT00723944|11989999|FG000|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
10824750|NCT00723944|11990000|FG001|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
10824751|NCT00723944|11989999|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
10824752|NCT00723944|11990000|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0
10824753|NCT00467142|11990006|FG000|STARTED|Overall Study||62
10824754|NCT00467142|11990006|FG000|COMPLETED|Overall Study||59
10824755|NCT00467142|11990006|FG000|NOT COMPLETED|Overall Study||3
11099558|NCT01220414|12283416|FG000|STARTED|Overall Study||15
11099559|NCT01220414|12283417|FG001|STARTED|Overall Study||14
11099560|NCT01220414|12283418|FG002|STARTED|Overall Study||14
11099561|NCT01220414|12283419|FG003|STARTED|Overall Study||15
11099562|NCT01220414|12283416|FG000|COMPLETED|Overall Study||14
11099563|NCT01220414|12283417|FG001|COMPLETED|Overall Study||14
11099564|NCT01220414|12283418|FG002|COMPLETED|Overall Study||14
11099565|NCT01220414|12283419|FG003|COMPLETED|Overall Study||14
11099566|NCT01220414|12283416|FG000|NOT COMPLETED|Overall Study||1
11099567|NCT01220414|12283417|FG001|NOT COMPLETED|Overall Study||0
11099568|NCT01220414|12283418|FG002|NOT COMPLETED|Overall Study||0
11099569|NCT01220414|12283419|FG003|NOT COMPLETED|Overall Study||1
11099570|NCT01220466|12283429|FG000|STARTED|Overall Study|19 eyes|11
11099571|NCT01220466|12283430|FG001|STARTED|Overall Study|108 eyes|56
11099572|NCT01220466|12283431|FG002|STARTED|Overall Study|16 eyes|10
11099573|NCT01220466|12283429|FG000|COMPLETED|Overall Study|19 eyes|11
11099574|NCT01220466|12283430|FG001|COMPLETED|Overall Study|108 eyes|56
11099575|NCT01220466|12283431|FG002|COMPLETED|Overall Study|16 eyes|10
11099576|NCT01220466|12283429|FG000|NOT COMPLETED|Overall Study||0
11099577|NCT01220466|12283430|FG001|NOT COMPLETED|Overall Study||0
11099578|NCT01220466|12283431|FG002|NOT COMPLETED|Overall Study||0
11099579|NCT01220557|12283441|FG000|STARTED|Overall Study||81
11099580|NCT01220557|12283442|FG001|STARTED|Overall Study||79
11099581|NCT01220557|12283441|FG000|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
11099582|NCT01220557|12283442|FG001|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
11099583|NCT01220557|12283441|FG000|NOT COMPLETED|Overall Study||6
11219751|NCT01957202|12411353|FG012|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219752|NCT01957202|12411354|FG013|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219753|NCT01957202|12411355|FG014|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219754|NCT01957202|12411356|FG015|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219755|NCT01957202|12411357|FG016|NOT COMPLETED|Treatment Period 3 (8 Days)||1
11219756|NCT01957202|12411358|FG017|NOT COMPLETED|Treatment Period 3 (8 Days)||0
11219757|NCT01957215|12411370|FG000|STARTED|Overall Study||135
11219758|NCT01957215|12411371|FG001|STARTED|Overall Study||135
11219759|NCT01957215|12411370|FG000|COMPLETED|Overall Study||122
11219760|NCT01957215|12411371|FG001|COMPLETED|Overall Study||123
11219761|NCT01957215|12411370|FG000|NOT COMPLETED|Overall Study||13
11219762|NCT01957215|12411371|FG001|NOT COMPLETED|Overall Study||12
11099584|NCT01220557|12283442|FG001|NOT COMPLETED|Overall Study||5
11099585|NCT01220609|12283448|FG000|STARTED|Overall Study||26
11219763|NCT01957384|12411381|FG000|STARTED|Test Period 1 (14 Days)||4
11219764|NCT01957384|12411382|FG001|STARTED|Test Period 1 (14 Days)||4
10824756|NCT04878172|11990014|FG000|STARTED|Overall Study||2
10824757|NCT04878172|11990015|FG001|STARTED|Overall Study||2
10824758|NCT04878172|11990016|FG002|STARTED|Overall Study||2
10824759|NCT04878172|11990017|FG003|STARTED|Overall Study||3
10824760|NCT04878172|11990014|FG000|COMPLETED|Overall Study||2
10824761|NCT04878172|11990015|FG001|COMPLETED|Overall Study||2
10824762|NCT04878172|11990016|FG002|COMPLETED|Overall Study||2
10824763|NCT04878172|11990017|FG003|COMPLETED|Overall Study||3
10824764|NCT04878172|11990014|FG000|NOT COMPLETED|Overall Study||0
10824765|NCT04878172|11990015|FG001|NOT COMPLETED|Overall Study||0
10824766|NCT04878172|11990016|FG002|NOT COMPLETED|Overall Study||0
10824767|NCT04878172|11990017|FG003|NOT COMPLETED|Overall Study||0
10824768|NCT04671017|11990030|FG000|STARTED|Overall Study||51
10824769|NCT04671017|11990031|FG001|STARTED|Overall Study||51
10824770|NCT04671017|11990032|FG002|STARTED|Overall Study||51
10824771|NCT04671017|11990030|FG000|COMPLETED|Overall Study||51
10824772|NCT04671017|11990031|FG001|COMPLETED|Overall Study||51
10824773|NCT04671017|11990032|FG002|COMPLETED|Overall Study||51
10824774|NCT04671017|11990030|FG000|NOT COMPLETED|Overall Study||0
10824775|NCT04671017|11990031|FG001|NOT COMPLETED|Overall Study||0
10824776|NCT04671017|11990032|FG002|NOT COMPLETED|Overall Study||0
10824777|NCT04557371|11990043|FG000|STARTED|Overall Study||50
10824778|NCT04557371|11990044|FG001|STARTED|Overall Study||49
10824779|NCT04557371|11990045|FG002|STARTED|Overall Study||51
10824780|NCT04557371|11990043|FG000|COMPLETED|Overall Study||49
10824781|NCT04557371|11990044|FG001|COMPLETED|Overall Study||47
10824782|NCT04557371|11990045|FG002|COMPLETED|Overall Study||51
10824783|NCT04557371|11990043|FG000|NOT COMPLETED|Overall Study||1
10824784|NCT04557371|11990044|FG001|NOT COMPLETED|Overall Study||2
10824785|NCT04557371|11990045|FG002|NOT COMPLETED|Overall Study||0
10824786|NCT04540952|11990055|FG000|STARTED|Overall Study||34
10824787|NCT04540952|11990056|FG001|STARTED|Overall Study||34
10824788|NCT04540952|11990055|FG000|COMPLETED|Overall Study||34
10824789|NCT04540952|11990056|FG001|COMPLETED|Overall Study||34
10824790|NCT04540952|11990055|FG000|NOT COMPLETED|Overall Study||0
10824791|NCT04540952|11990056|FG001|NOT COMPLETED|Overall Study||0
10824792|NCT04369742|11990066|FG000|STARTED|Overall Study||67
10824793|NCT04369742|11990067|FG001|STARTED|Overall Study||61
11099586|NCT01220609|12283448|FG000|COMPLETED|Overall Study|Eligible and treated patients|23
11099587|NCT01220609|12283448|FG000|NOT COMPLETED|Overall Study||3
10824794|NCT04369742|11990066|FG000|COMPLETED|Overall Study||53
10824795|NCT04369742|11990067|FG001|COMPLETED|Overall Study||50
10824796|NCT04369742|11990066|FG000|NOT COMPLETED|Overall Study||14
10824797|NCT04369742|11990067|FG001|NOT COMPLETED|Overall Study||11
10824798|NCT04115644|11990076|FG000|STARTED|Overall Study||26
10824799|NCT04115644|11990077|FG001|STARTED|Overall Study||30
10824800|NCT04115644|11990078|FG002|STARTED|Overall Study||26
10824801|NCT04115644|11990076|FG000|COMPLETED|Overall Study||26
10824802|NCT04115644|11990077|FG001|COMPLETED|Overall Study||30
10824803|NCT04115644|11990078|FG002|COMPLETED|Overall Study||25
10824804|NCT04115644|11990076|FG000|NOT COMPLETED|Overall Study||0
10824805|NCT04115644|11990077|FG001|NOT COMPLETED|Overall Study||0
10824806|NCT04115644|11990078|FG002|NOT COMPLETED|Overall Study||1
11099588|NCT01220687|12283460|FG000|STARTED|Overall Study||16
11099589|NCT01220687|12283461|FG001|STARTED|Overall Study||15
11099590|NCT01220687|12283460|FG000|COMPLETED|Overall Study||14
11099591|NCT01220687|12283461|FG001|COMPLETED|Overall Study||14
11099592|NCT01220687|12283460|FG000|NOT COMPLETED|Overall Study||2
11099593|NCT01220687|12283461|FG001|NOT COMPLETED|Overall Study||1
10824813|NCT03969589|11990097|FG000|STARTED|Overall Study||20
10824814|NCT03969589|11990098|FG001|STARTED|Overall Study||20
10824815|NCT03969589|11990097|FG000|COMPLETED|Overall Study||17
10824816|NCT03969589|11990098|FG001|COMPLETED|Overall Study||17
10824817|NCT03969589|11990097|FG000|NOT COMPLETED|Overall Study||3
10824818|NCT03969589|11990098|FG001|NOT COMPLETED|Overall Study||3
11099594|NCT01220726|12283469|FG000|STARTED|Overall Study||15
11099595|NCT01220726|12283470|FG001|STARTED|Overall Study||15
11099596|NCT01220726|12283469|FG000|COMPLETED|Overall Study||15
11099597|NCT01220726|12283470|FG001|COMPLETED|Overall Study||13
11099598|NCT01220726|12283469|FG000|NOT COMPLETED|Overall Study||0
11099599|NCT01220726|12283470|FG001|NOT COMPLETED|Overall Study||2
10824825|NCT03812588|11990117|FG000|STARTED|Overall Study||5
10824826|NCT03812588|11990118|FG001|STARTED|Overall Study||7
10824827|NCT03812588|11990119|FG002|STARTED|Overall Study||5
10824828|NCT03812588|11990120|FG003|STARTED|Overall Study||8
10824829|NCT03812588|11990117|FG000|COMPLETED|Overall Study||3
10824830|NCT03812588|11990118|FG001|COMPLETED|Overall Study||5
10824831|NCT03812588|11990119|FG002|COMPLETED|Overall Study||3
10824832|NCT03812588|11990120|FG003|COMPLETED|Overall Study||8
10824833|NCT03812588|11990117|FG000|NOT COMPLETED|Overall Study||2
10824834|NCT03812588|11990118|FG001|NOT COMPLETED|Overall Study||2
10824835|NCT03812588|11990119|FG002|NOT COMPLETED|Overall Study||2
10824836|NCT03812588|11990120|FG003|NOT COMPLETED|Overall Study||0
10824837|NCT03690674|11990130|FG000|STARTED|Overall Study||35
10824838|NCT03690674|11990131|FG001|STARTED|Overall Study||35
10824839|NCT03690674|11990130|FG000|COMPLETED|Overall Study||32
10824840|NCT03690674|11990131|FG001|COMPLETED|Overall Study||32
10824841|NCT03690674|11990130|FG000|NOT COMPLETED|Overall Study||3
10824842|NCT03690674|11990131|FG001|NOT COMPLETED|Overall Study||3
10824843|NCT03655691|11990141|FG000|STARTED|Overall Study||26
10824844|NCT03655691|11990142|FG001|STARTED|Overall Study||26
10824845|NCT03655691|11990143|FG002|STARTED|Overall Study||27
10824846|NCT03655691|11990141|FG000|COMPLETED|Overall Study||24
10824847|NCT03655691|11990142|FG001|COMPLETED|Overall Study||23
10824848|NCT03655691|11990143|FG002|COMPLETED|Overall Study||24
10824849|NCT03655691|11990141|FG000|NOT COMPLETED|Overall Study||2
10824850|NCT03655691|11990142|FG001|NOT COMPLETED|Overall Study||3
10824851|NCT03655691|11990143|FG002|NOT COMPLETED|Overall Study||3
11099600|NCT01220739|12283478|FG000|STARTED|Overall Study||7
11099601|NCT01220739|12283479|FG001|STARTED|Overall Study||5
11099602|NCT01220739|12283478|FG000|COMPLETED|Overall Study||7
11099603|NCT01220739|12283479|FG001|COMPLETED|Overall Study||5
11099604|NCT01220739|12283478|FG000|NOT COMPLETED|Overall Study||0
11099605|NCT01220739|12283479|FG001|NOT COMPLETED|Overall Study||0
11099606|NCT01220856|12283487|FG000|STARTED|Overall Study||6
11099607|NCT01220856|12283488|FG001|STARTED|Overall Study||3
11099608|NCT01220856|12283487|FG000|COMPLETED|Overall Study||2
11099609|NCT01220856|12283488|FG001|COMPLETED|Overall Study||0
11099610|NCT01220856|12283487|FG000|NOT COMPLETED|Overall Study||4
11099611|NCT01220856|12283488|FG001|NOT COMPLETED|Overall Study||3
11099612|NCT01220869|12283497|FG000|STARTED|Overall Study||110
11099613|NCT01220869|12283497|FG000|COMPLETED|Overall Study||104
11099614|NCT01220869|12283497|FG000|NOT COMPLETED|Overall Study||6
11099615|NCT01220973|12283501|FG000|STARTED|Overall Study||27
11099616|NCT01220973|12283501|FG000|COMPLETED|Overall Study||23
11099617|NCT01220973|12283501|FG000|NOT COMPLETED|Overall Study||4
11099618|NCT01220999|12283510|FG000|STARTED|Overall Study||2
11099619|NCT01220999|12283511|FG001|STARTED|Overall Study||4
11099620|NCT01220999|12283512|FG002|STARTED|Overall Study||5
11099621|NCT01220999|12283513|FG003|STARTED|Overall Study||3
11099622|NCT01220999|12283514|FG004|STARTED|Overall Study||5
11099623|NCT01220999|12283510|FG000|COMPLETED|Overall Study||2
11099624|NCT01220999|12283511|FG001|COMPLETED|Overall Study||4
11099625|NCT01220999|12283512|FG002|COMPLETED|Overall Study||4
11099626|NCT01220999|12283513|FG003|COMPLETED|Overall Study||3
11099627|NCT01220999|12283514|FG004|COMPLETED|Overall Study||5
11099628|NCT01220999|12283510|FG000|NOT COMPLETED|Overall Study||0
11099629|NCT01220999|12283511|FG001|NOT COMPLETED|Overall Study||0
11099630|NCT01220999|12283512|FG002|NOT COMPLETED|Overall Study||1
11099631|NCT01220999|12283513|FG003|NOT COMPLETED|Overall Study||0
10824852|NCT03608670|11990151|FG000|STARTED|Overall Study||26
10824853|NCT03608670|11990151|FG000|Implant Attempted|Overall Study||21
10824854|NCT03608670|11990151|FG000|Successfully Implanted|Overall Study||17
10824855|NCT03608670|11990151|FG000|2-week Follow-up|Overall Study||17
10824856|NCT03608670|11990151|FG000|4-6 Weeks Follow-up|Overall Study||17
10824857|NCT03608670|11990151|FG000|COMPLETED|Overall Study||16
10824858|NCT03608670|11990151|FG000|NOT COMPLETED|Overall Study||10
10824859|NCT03364686|11990155|FG000|STARTED|Overall Study||6
10824860|NCT03364686|11990155|FG000|COMPLETED|Overall Study||4
10824861|NCT03364686|11990155|FG000|NOT COMPLETED|Overall Study||2
11099632|NCT01220999|12283514|FG004|NOT COMPLETED|Overall Study||0
11099633|NCT01221090|12283530|FG000|STARTED|Overall Study||101
11099634|NCT01221090|12283531|FG001|STARTED|Overall Study||81
11099635|NCT01221090|12283532|FG002|STARTED|Overall Study||99
11099636|NCT01221090|12283533|FG003|STARTED|Overall Study||95
11099637|NCT01221090|12283530|FG000|COMPLETED|Overall Study||86
10824862|NCT03345771|11990161|FG000|STARTED|Overall Study||115
10824863|NCT03345771|11990162|FG001|STARTED|Overall Study||115
10824864|NCT03345771|11990161|FG000|COMPLETED|Overall Study||115
10824865|NCT03345771|11990162|FG001|COMPLETED|Overall Study||115
10824866|NCT03345771|11990161|FG000|NOT COMPLETED|Overall Study||0
10824867|NCT03345771|11990162|FG001|NOT COMPLETED|Overall Study||0
10824868|NCT03326856|11990173|FG000|STARTED|Overall Study||13
10824869|NCT03326856|11990174|FG001|STARTED|Overall Study||9
10824870|NCT03326856|11990175|FG002|STARTED|Overall Study||9
10824871|NCT03326856|11990176|FG003|STARTED|Overall Study||9
10824872|NCT03326856|11990177|FG004|STARTED|Overall Study||8
10824873|NCT03326856|11990173|FG000|COMPLETED|Overall Study||12
10824874|NCT03326856|11990174|FG001|COMPLETED|Overall Study||8
10824875|NCT03326856|11990175|FG002|COMPLETED|Overall Study||9
10824876|NCT03326856|11990176|FG003|COMPLETED|Overall Study||9
10824877|NCT03326856|11990177|FG004|COMPLETED|Overall Study||8
10824878|NCT03326856|11990173|FG000|NOT COMPLETED|Overall Study||1
10824879|NCT03326856|11990174|FG001|NOT COMPLETED|Overall Study||1
10824880|NCT03326856|11990175|FG002|NOT COMPLETED|Overall Study||0
10824881|NCT03326856|11990176|FG003|NOT COMPLETED|Overall Study||0
10824882|NCT03326856|11990177|FG004|NOT COMPLETED|Overall Study||0
11099638|NCT01221090|12283531|FG001|COMPLETED|Overall Study||47
11099639|NCT01221090|12283532|FG002|COMPLETED|Overall Study||57
11099640|NCT01221090|12283533|FG003|COMPLETED|Overall Study||73
11099641|NCT01221090|12283530|FG000|NOT COMPLETED|Overall Study||15
11099642|NCT01221090|12283531|FG001|NOT COMPLETED|Overall Study||34
11099643|NCT01221090|12283532|FG002|NOT COMPLETED|Overall Study||42
11099644|NCT01221090|12283533|FG003|NOT COMPLETED|Overall Study||22
11099645|NCT01221181|12283543|FG000|STARTED|Overall Study||6
11099646|NCT01221181|12283543|FG000|COMPLETED|Overall Study||5
10824892|NCT03240692|11990202|FG000|STARTED|Overall Study||23
10824893|NCT03240692|11990202|FG000|COMPLETED|Overall Study||21
10824894|NCT03240692|11990202|FG000|NOT COMPLETED|Overall Study||2
10824895|NCT03227029|11990209|FG000|STARTED|Overall Study||26
10824896|NCT03227029|11990210|FG001|STARTED|Overall Study||26
10824897|NCT03227029|11990211|FG002|STARTED|Overall Study||13
10824898|NCT03227029|11990209|FG000|Received Inoculation|Overall Study||26
10824899|NCT03227029|11990210|FG001|Received Inoculation|Overall Study||25
10824900|NCT03227029|11990211|FG002|Received Inoculation|Overall Study||12
10824901|NCT03227029|11990209|FG000|COMPLETED|Overall Study||22
10824902|NCT03227029|11990210|FG001|COMPLETED|Overall Study||22
10824903|NCT03227029|11990211|FG002|COMPLETED|Overall Study||9
10824904|NCT03227029|11990209|FG000|NOT COMPLETED|Overall Study||4
10824905|NCT03227029|11990210|FG001|NOT COMPLETED|Overall Study||4
10824906|NCT03227029|11990211|FG002|NOT COMPLETED|Overall Study||4
10824907|NCT03207776|11990221|FG000|STARTED|Overall Study||2479
10824908|NCT03207776|11990222|FG001|STARTED|Overall Study||2353
10824909|NCT03207776|11990221|FG000|COMPLETED|Overall Study||2479
10824910|NCT03207776|11990222|FG001|COMPLETED|Overall Study||2353
10824911|NCT03207776|11990221|FG000|NOT COMPLETED|Overall Study||0
10824912|NCT03207776|11990222|FG001|NOT COMPLETED|Overall Study||0
10824913|NCT03204643|11990230|FG000|STARTED|Overall Study||323
10824914|NCT03204643|11990231|FG001|STARTED|Overall Study||314
10824915|NCT03204643|11990230|FG000|COMPLETED|Overall Study||323
10824916|NCT03204643|11990231|FG001|COMPLETED|Overall Study||314
10824917|NCT03204643|11990230|FG000|NOT COMPLETED|Overall Study||0
10824918|NCT03204643|11990231|FG001|NOT COMPLETED|Overall Study||0
10824919|NCT03182829|11990239|FG000|STARTED|Overall Study||467
10824920|NCT03182829|11990240|FG001|STARTED|Overall Study||444
10824921|NCT03182829|11990239|FG000|COMPLETED|Overall Study||451
10824922|NCT03182829|11990240|FG001|COMPLETED|Overall Study||429
10824923|NCT03182829|11990239|FG000|NOT COMPLETED|Overall Study||16
10824924|NCT03182829|11990240|FG001|NOT COMPLETED|Overall Study||15
10824925|NCT03181789|11990250|FG000|STARTED|Overall Study||25
10824926|NCT03181789|11990251|FG001|STARTED|Overall Study||25
10824927|NCT03181789|11990252|FG002|STARTED|Overall Study||3
10824928|NCT03181789|11990253|FG003|STARTED|Overall Study||3
10824929|NCT03181789|11990250|FG000|Safety Population|Overall Study||25
10824930|NCT03181789|11990251|FG001|Safety Population|Overall Study||25
10824931|NCT03181789|11990252|FG002|Safety Population|Overall Study||3
10824932|NCT03181789|11990253|FG003|Safety Population|Overall Study||3
10824933|NCT03181789|11990250|FG000|COMPLETED|Overall Study||18
10824934|NCT03181789|11990251|FG001|COMPLETED|Overall Study||22
10824935|NCT03181789|11990252|FG002|COMPLETED|Overall Study||2
10824936|NCT03181789|11990253|FG003|COMPLETED|Overall Study||3
10824937|NCT03181789|11990250|FG000|NOT COMPLETED|Overall Study||7
10824938|NCT03181789|11990251|FG001|NOT COMPLETED|Overall Study||3
10824939|NCT03181789|11990252|FG002|NOT COMPLETED|Overall Study||1
10824940|NCT03181789|11990253|FG003|NOT COMPLETED|Overall Study||0
10824941|NCT03164356|11990268|FG000|STARTED|Overall Study||19
10824942|NCT03164356|11990269|FG001|STARTED|Overall Study||15
10824943|NCT03164356|11990270|FG002|STARTED|Overall Study||17
10824944|NCT03164356|11990271|FG003|STARTED|Overall Study||17
10824945|NCT03164356|11990268|FG000|COMPLETED|Overall Study||14
10824946|NCT03164356|11990269|FG001|COMPLETED|Overall Study||10
10824947|NCT03164356|11990270|FG002|COMPLETED|Overall Study||11
10824948|NCT03164356|11990271|FG003|COMPLETED|Overall Study||15
10824949|NCT03164356|11990268|FG000|NOT COMPLETED|Overall Study||5
10824950|NCT03164356|11990269|FG001|NOT COMPLETED|Overall Study||5
10824951|NCT03164356|11990270|FG002|NOT COMPLETED|Overall Study||6
10824952|NCT03164356|11990271|FG003|NOT COMPLETED|Overall Study||2
10824953|NCT02975700|11990291|FG000|STARTED|Overall Study||6
11099647|NCT01221181|12283543|FG000|NOT COMPLETED|Overall Study||1
10824954|NCT02975700|11990291|FG000|COMPLETED|Overall Study||0
10824955|NCT02975700|11990291|FG000|NOT COMPLETED|Overall Study||6
10824956|NCT02941549|11990298|FG000|STARTED|Overall Study||31
10824957|NCT02941549|11990299|FG001|STARTED|Overall Study||32
10824958|NCT02941549|11990300|FG002|STARTED|Overall Study||33
10824959|NCT02941549|11990298|FG000|COMPLETED|Overall Study||28
10824960|NCT02941549|11990299|FG001|COMPLETED|Overall Study||31
10824961|NCT02941549|11990300|FG002|COMPLETED|Overall Study||31
10824962|NCT02941549|11990298|FG000|NOT COMPLETED|Overall Study||3
10824963|NCT02941549|11990299|FG001|NOT COMPLETED|Overall Study||1
10824964|NCT02941549|11990300|FG002|NOT COMPLETED|Overall Study||2
10824965|NCT02937766|11990313|FG000|STARTED|Overall Study||30
10824966|NCT02937766|11990314|FG001|STARTED|Overall Study||30
10824967|NCT02937766|11990313|FG000|COMPLETED|Overall Study||23
10824968|NCT02937766|11990314|FG001|COMPLETED|Overall Study||30
10824969|NCT02937766|11990313|FG000|NOT COMPLETED|Overall Study||7
10824970|NCT02937766|11990314|FG001|NOT COMPLETED|Overall Study||0
10824971|NCT02927938|11990324|FG000|STARTED|Overall Study||1
10824972|NCT02927938|11990325|FG001|STARTED|Overall Study||6
10824973|NCT02927938|11990326|FG002|STARTED|Overall Study||4
10824974|NCT02927938|11990327|FG003|STARTED|Overall Study||7
10824975|NCT02927938|11990324|FG000|COMPLETED|Overall Study||0
10824976|NCT02927938|11990325|FG001|COMPLETED|Overall Study||0
10824977|NCT02927938|11990326|FG002|COMPLETED|Overall Study||0
10824978|NCT02927938|11990327|FG003|COMPLETED|Overall Study||0
10824979|NCT02927938|11990324|FG000|NOT COMPLETED|Overall Study||1
10824980|NCT02927938|11990325|FG001|NOT COMPLETED|Overall Study||6
11099648|NCT01221194|12283549|FG000|STARTED|Overall Study||195
11099649|NCT01221194|12283550|FG001|STARTED|Overall Study||186
11099650|NCT01221194|12283549|FG000|COMPLETED|Overall Study||195
11099651|NCT01221194|12283550|FG001|COMPLETED|Overall Study||186
11099652|NCT01221194|12283549|FG000|NOT COMPLETED|Overall Study||0
11099653|NCT01221194|12283550|FG001|NOT COMPLETED|Overall Study||0
11099654|NCT01221207|12283559|FG000|STARTED|Overall Study||75
11099655|NCT01221207|12283560|FG001|STARTED|Overall Study||75
11099656|NCT01221207|12283561|FG002|STARTED|Overall Study||75
11099657|NCT01221207|12283559|FG000|COMPLETED|Overall Study||43
11099658|NCT01221207|12283560|FG001|COMPLETED|Overall Study||66
11099659|NCT01221207|12283561|FG002|COMPLETED|Overall Study||54
11099660|NCT01221207|12283559|FG000|NOT COMPLETED|Overall Study||32
11099661|NCT01221207|12283560|FG001|NOT COMPLETED|Overall Study||9
11099662|NCT01221207|12283561|FG002|NOT COMPLETED|Overall Study||21
11099663|NCT01221233|12283571|FG000|STARTED|Overall Study||18
11099664|NCT01221233|12283572|FG001|STARTED|Overall Study||20
11099665|NCT01221233|12283571|FG000|COMPLETED|Overall Study||15
11099666|NCT01221233|12283572|FG001|COMPLETED|Overall Study||19
11099667|NCT01221233|12283571|FG000|NOT COMPLETED|Overall Study||3
11099668|NCT01221233|12283572|FG001|NOT COMPLETED|Overall Study||1
11099669|NCT01221272|12283578|FG000|STARTED|Period 1||41
11099670|NCT01221272|12283579|FG001|STARTED|Period 1||40
11099671|NCT01221272|12283578|FG000|COMPLETED|Period 1||39
11099672|NCT01221272|12283579|FG001|COMPLETED|Period 1||38
11099673|NCT01221272|12283578|FG000|NOT COMPLETED|Period 1||2
11099674|NCT01221272|12283579|FG001|NOT COMPLETED|Period 1||2
11099675|NCT01221272|12283578|FG000|STARTED|Period 2||39
11099676|NCT01221272|12283579|FG001|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
11099677|NCT01221272|12283578|FG000|COMPLETED|Period 2||39
11099678|NCT01221272|12283579|FG001|COMPLETED|Period 2||37
11099679|NCT01221272|12283578|FG000|NOT COMPLETED|Period 2||0
11099680|NCT01221272|12283579|FG001|NOT COMPLETED|Period 2||2
11099681|NCT01221285|12283588|FG000|STARTED|Overall Study||11
11099682|NCT01221285|12283588|FG000|COMPLETED|Overall Study||10
11099683|NCT01221285|12283588|FG000|NOT COMPLETED|Overall Study||1
11099684|NCT01221298|12283592|FG000|STARTED|Overall Study||11
11099685|NCT01221298|12283592|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|11
11099686|NCT01221298|12283592|FG000|NOT COMPLETED|Overall Study||0
11099687|NCT01221311|12283598|FG000|STARTED|Overall Study||57
11099688|NCT01221311|12283599|FG001|STARTED|Overall Study||55
11099689|NCT01221311|12283598|FG000|COMPLETED|Overall Study||57
10824981|NCT02927938|11990326|FG002|NOT COMPLETED|Overall Study||4
10824982|NCT02927938|11990327|FG003|NOT COMPLETED|Overall Study||7
10824983|NCT02913131|11990337|FG000|STARTED|Overall Study||18
10824984|NCT02913131|11990338|FG001|STARTED|Overall Study|Two of the five participants enrolled in Part B were previously enrolled in Part A.|5
10824985|NCT02913131|11990337|FG000|COMPLETED|Overall Study||18
11099690|NCT01221311|12283599|FG001|COMPLETED|Overall Study||55
11099691|NCT01221311|12283598|FG000|NOT COMPLETED|Overall Study||0
11099692|NCT01221311|12283599|FG001|NOT COMPLETED|Overall Study||0
11099693|NCT01221350|12283607|FG000|STARTED|Overall Study||28
11099694|NCT01221350|12283608|FG001|STARTED|Overall Study||27
11099695|NCT01221350|12283607|FG000|Received Intervention|Overall Study||28
11099696|NCT01221350|12283608|FG001|Received Intervention|Overall Study||27
11099697|NCT01221350|12283607|FG000|Analysis Population|Overall Study||23
11099698|NCT01221350|12283608|FG001|Analysis Population|Overall Study||24
11099699|NCT01221350|12283607|FG000|COMPLETED|Overall Study||23
10824986|NCT02913131|11990338|FG001|COMPLETED|Overall Study||5
10824987|NCT02913131|11990337|FG000|NOT COMPLETED|Overall Study||0
10824988|NCT02913131|11990338|FG001|NOT COMPLETED|Overall Study||0
10824989|NCT02883400|11990347|FG000|STARTED|Overall Study||22
10824990|NCT02883400|11990348|FG001|STARTED|Overall Study||8
10824991|NCT02883400|11990347|FG000|COMPLETED|Overall Study||22
10824992|NCT02883400|11990348|FG001|COMPLETED|Overall Study||8
10824993|NCT02883400|11990347|FG000|NOT COMPLETED|Overall Study||0
10824994|NCT02883400|11990348|FG001|NOT COMPLETED|Overall Study||0
10824995|NCT02855060|11990356|FG000|STARTED|Overall Study||22
10824996|NCT02855060|11990357|FG001|STARTED|Overall Study||28
10824997|NCT02855060|11990356|FG000|COMPLETED|Overall Study||20
10824998|NCT02855060|11990357|FG001|COMPLETED|Overall Study||23
10824999|NCT02855060|11990356|FG000|NOT COMPLETED|Overall Study||2
10825000|NCT02855060|11990357|FG001|NOT COMPLETED|Overall Study||5
10825001|NCT02823574|11990367|FG000|STARTED|Pre-Treatment Period||159
10825002|NCT02823574|11990368|FG001|STARTED|Pre-Treatment Period||82
10825003|NCT02823574|11990369|FG002|STARTED|Pre-Treatment Period||123
10825004|NCT02823574|11990370|FG003|STARTED|Pre-Treatment Period||61
10825005|NCT02823574|11990367|FG000|COMPLETED|Pre-Treatment Period||158
10825006|NCT02823574|11990368|FG001|COMPLETED|Pre-Treatment Period||82
10825007|NCT02823574|11990369|FG002|COMPLETED|Pre-Treatment Period||122
10825008|NCT02823574|11990370|FG003|COMPLETED|Pre-Treatment Period||61
10825009|NCT02823574|11990367|FG000|NOT COMPLETED|Pre-Treatment Period||1
10825010|NCT02823574|11990368|FG001|NOT COMPLETED|Pre-Treatment Period||0
10825011|NCT02823574|11990369|FG002|NOT COMPLETED|Pre-Treatment Period||1
10825012|NCT02823574|11990370|FG003|NOT COMPLETED|Pre-Treatment Period||0
10825013|NCT02823574|11990367|FG000|STARTED|Treatment Period||158
10825014|NCT02823574|11990368|FG001|STARTED|Treatment Period||82
10825015|NCT02823574|11990369|FG002|STARTED|Treatment Period||122
10825016|NCT02823574|11990370|FG003|STARTED|Treatment Period||61
10825017|NCT02823574|11990367|FG000|COMPLETED|Treatment Period||19
10825018|NCT02823574|11990368|FG001|COMPLETED|Treatment Period||16
10825019|NCT02823574|11990369|FG002|COMPLETED|Treatment Period||14
10825020|NCT02823574|11990370|FG003|COMPLETED|Treatment Period||10
10825021|NCT02823574|11990367|FG000|NOT COMPLETED|Treatment Period||139
10825022|NCT02823574|11990368|FG001|NOT COMPLETED|Treatment Period||66
10825023|NCT02823574|11990369|FG002|NOT COMPLETED|Treatment Period||108
10825024|NCT02823574|11990370|FG003|NOT COMPLETED|Treatment Period||51
10825025|NCT02771990|11990385|FG000|STARTED|Overall Study||11
10825026|NCT02771990|11990386|FG001|STARTED|Overall Study||10
10825027|NCT02771990|11990385|FG000|COMPLETED|Overall Study||11
10825028|NCT02771990|11990386|FG001|COMPLETED|Overall Study||10
10825029|NCT02771990|11990385|FG000|NOT COMPLETED|Overall Study||0
10825030|NCT02771990|11990386|FG001|NOT COMPLETED|Overall Study||0
10825031|NCT02743819|11990392|FG000|STARTED|Overall Study||70
10825032|NCT02743819|11990392|FG000|COMPLETED|Overall Study||62
10825033|NCT02743819|11990392|FG000|NOT COMPLETED|Overall Study||8
10825034|NCT02729753|11990398|FG000|STARTED|Overall Study|First patient enrolled April 2016|3
10825035|NCT02729753|11990399|FG001|STARTED|Overall Study|First patient enrolled April 2016|7
10825036|NCT02729753|11990398|FG000|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
10825037|NCT02729753|11990399|FG001|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
10825038|NCT02729753|11990398|FG000|NOT COMPLETED|Overall Study||0
10825039|NCT02729753|11990399|FG001|NOT COMPLETED|Overall Study||1
10825040|NCT02704130|11990410|FG000|STARTED|Overall Study||5
10825041|NCT02704130|11990411|FG001|STARTED|Overall Study||3
10825042|NCT02704130|11990410|FG000|COMPLETED|Overall Study||0
10825043|NCT02704130|11990411|FG001|COMPLETED|Overall Study||0
10825044|NCT02704130|11990410|FG000|NOT COMPLETED|Overall Study||5
10825045|NCT02704130|11990411|FG001|NOT COMPLETED|Overall Study||3
10825046|NCT02701192|11990417|FG000|STARTED|Overall Study||100
10825047|NCT02701192|11990417|FG000|COMPLETED|Overall Study||94
10825048|NCT02701192|11990417|FG000|NOT COMPLETED|Overall Study||6
10825049|NCT02685709|11990425|FG000|STARTED|Run-in Phase||146
10825050|NCT02685709|11990426|FG001|STARTED|Run-in Phase||0
10825051|NCT02685709|11990427|FG002|STARTED|Run-in Phase||0
10825052|NCT02685709|11990428|FG003|STARTED|Run-in Phase||0
10825053|NCT02685709|11990425|FG000|COMPLETED|Run-in Phase|30 patients early terminated the Run-in phase and 24 patient were not randomized to RCT|116
10825054|NCT02685709|11990426|FG001|COMPLETED|Run-in Phase||0
10825055|NCT02685709|11990427|FG002|COMPLETED|Run-in Phase||0
10825056|NCT02685709|11990428|FG003|COMPLETED|Run-in Phase||0
10825057|NCT02685709|11990425|FG000|NOT COMPLETED|Run-in Phase||30
10825058|NCT02685709|11990426|FG001|NOT COMPLETED|Run-in Phase||0
10825059|NCT02685709|11990427|FG002|NOT COMPLETED|Run-in Phase||0
10825060|NCT02685709|11990428|FG003|NOT COMPLETED|Run-in Phase||0
10825061|NCT02685709|11990425|FG000|STARTED|RCT Phase|116 patients completed the Run-in phase, out of which 92 were randomized to the RCT phase, and 24 were not randomized to the RCT phase. Out of these 24, 11 patients eneterd the combination phase.|0
10825062|NCT02685709|11990426|FG001|STARTED|RCT Phase||55
10825063|NCT02685709|11990427|FG002|STARTED|RCT Phase||37
10825064|NCT02685709|11990428|FG003|STARTED|RCT Phase||0
10825065|NCT02685709|11990425|FG000|COMPLETED|RCT Phase||0
10825066|NCT02685709|11990426|FG001|COMPLETED|RCT Phase||54
10825067|NCT02685709|11990427|FG002|COMPLETED|RCT Phase||35
10825068|NCT02685709|11990428|FG003|COMPLETED|RCT Phase||0
10825069|NCT02685709|11990425|FG000|NOT COMPLETED|RCT Phase||0
10825070|NCT02685709|11990426|FG001|NOT COMPLETED|RCT Phase||1
10825071|NCT02685709|11990427|FG002|NOT COMPLETED|RCT Phase||2
10825072|NCT02685709|11990428|FG003|NOT COMPLETED|RCT Phase||0
10825073|NCT02685709|11990425|FG000|STARTED|Combination Phase||0
10825074|NCT02685709|11990426|FG001|STARTED|Combination Phase||0
10825075|NCT02685709|11990427|FG002|STARTED|Combination Phase||0
10825076|NCT02685709|11990428|FG003|STARTED|Combination Phase|14 patients entered the combination phase (3 patients early discontinued the Run-in phase, and 11 patients completed Run-in and were not eligible to RCT phase).|14
10825077|NCT02685709|11990425|FG000|COMPLETED|Combination Phase||0
10825078|NCT02685709|11990426|FG001|COMPLETED|Combination Phase||0
10825079|NCT02685709|11990427|FG002|COMPLETED|Combination Phase||0
10825080|NCT02685709|11990428|FG003|COMPLETED|Combination Phase||8
10825081|NCT02685709|11990425|FG000|NOT COMPLETED|Combination Phase||0
10825082|NCT02685709|11990426|FG001|NOT COMPLETED|Combination Phase||0
10825083|NCT02685709|11990427|FG002|NOT COMPLETED|Combination Phase||0
10825084|NCT02685709|11990428|FG003|NOT COMPLETED|Combination Phase||6
10825085|NCT02684851|11990440|FG000|STARTED|Overall Study||42
10825086|NCT02684851|11990441|FG001|STARTED|Overall Study||45
10825087|NCT02684851|11990440|FG000|COMPLETED|Overall Study||42
10825088|NCT02684851|11990441|FG001|COMPLETED|Overall Study||45
10825089|NCT02684851|11990440|FG000|NOT COMPLETED|Overall Study||0
10825090|NCT02684851|11990441|FG001|NOT COMPLETED|Overall Study||0
10825091|NCT02653482|11990451|FG000|STARTED|Overall Study||131
10825092|NCT02653482|11990452|FG001|STARTED|Overall Study||132
10825093|NCT02653482|11990451|FG000|COMPLETED|Overall Study||130
10825094|NCT02653482|11990452|FG001|COMPLETED|Overall Study||131
10825095|NCT02653482|11990451|FG000|NOT COMPLETED|Overall Study||1
10825096|NCT02653482|11990452|FG001|NOT COMPLETED|Overall Study||1
10825097|NCT02632409|11990460|FG000|STARTED|Randomized||356
10825098|NCT02632409|11990461|FG001|STARTED|Randomized||353
10825099|NCT02632409|11990460|FG000|COMPLETED|Randomized||348
10825100|NCT02632409|11990461|FG001|COMPLETED|Randomized||351
10825101|NCT02632409|11990460|FG000|NOT COMPLETED|Randomized||8
10825102|NCT02632409|11990461|FG001|NOT COMPLETED|Randomized||2
10825103|NCT02632409|11990460|FG000|STARTED|Treatment Period||348
10825104|NCT02632409|11990461|FG001|STARTED|Treatment Period||351
10825105|NCT02632409|11990460|FG000|COMPLETED|Treatment Period||132
10825106|NCT02632409|11990461|FG001|COMPLETED|Treatment Period||143
10825107|NCT02632409|11990460|FG000|NOT COMPLETED|Treatment Period||216
10825108|NCT02632409|11990461|FG001|NOT COMPLETED|Treatment Period||208
10825109|NCT02612194|11990470|FG000|STARTED|Overall Study||6
10825110|NCT02612194|11990471|FG001|STARTED|Overall Study||0
10825111|NCT02612194|11990472|FG002|STARTED|Overall Study||2
10825112|NCT02612194|11990470|FG000|COMPLETED|Overall Study||0
10825113|NCT02612194|11990471|FG001|COMPLETED|Overall Study||0
10825114|NCT02612194|11990472|FG002|COMPLETED|Overall Study||0
10825115|NCT02612194|11990470|FG000|NOT COMPLETED|Overall Study||6
10825116|NCT02612194|11990471|FG001|NOT COMPLETED|Overall Study||0
10825117|NCT02612194|11990472|FG002|NOT COMPLETED|Overall Study||2
10825118|NCT02586207|11990479|FG000|STARTED|Overall Study||59
10825119|NCT02586207|11990479|FG000|COMPLETED|Overall Study||57
10825120|NCT02586207|11990479|FG000|NOT COMPLETED|Overall Study||2
10825121|NCT02542397|11990483|FG000|STARTED|Overall Study|75 subjects were enrolled to the study (i.e., submitted buccal swab).|75
10825122|NCT02542397|11990483|FG000|COMPLETED|Overall Study|54 enrolled subjects provided pain scores at baseline and final assessments within 30 +/- 7 days.|59
10825123|NCT02542397|11990483|FG000|NOT COMPLETED|Overall Study||16
10825124|NCT02519777|11990491|FG000|STARTED|Overall Study||63
10825125|NCT02519777|11990492|FG001|STARTED|Overall Study||67
10825126|NCT02519777|11990493|FG002|STARTED|Overall Study||61
10825127|NCT02519777|11990491|FG000|COMPLETED|Overall Study||57
10825128|NCT02519777|11990492|FG001|COMPLETED|Overall Study||59
10825129|NCT02519777|11990493|FG002|COMPLETED|Overall Study||57
10825130|NCT02519777|11990491|FG000|NOT COMPLETED|Overall Study||6
10825131|NCT02519777|11990492|FG001|NOT COMPLETED|Overall Study||8
10825132|NCT02519777|11990493|FG002|NOT COMPLETED|Overall Study||4
10825136|NCT02395666|11990507|FG000|STARTED|Overall Study||101
10825137|NCT02395666|11990508|FG001|STARTED|Overall Study||39
10825138|NCT02395666|11990507|FG000|COMPLETED|Overall Study||95
10825139|NCT02395666|11990508|FG001|COMPLETED|Overall Study||38
10825140|NCT02395666|11990507|FG000|NOT COMPLETED|Overall Study||6
10825141|NCT02395666|11990508|FG001|NOT COMPLETED|Overall Study||1
10825142|NCT02357810|11990518|FG000|STARTED|Registered and Started Treatment||178
10825143|NCT02357810|11990518|FG000|Signed Consent|Registered and Started Treatment||178
10825144|NCT02357810|11990518|FG000|Registered to Study|Registered and Started Treatment||152
10825145|NCT02357810|11990518|FG000|Initiated Treatment on Study|Registered and Started Treatment||151
10825146|NCT02357810|11990518|FG000|COMPLETED|Registered and Started Treatment||151
10825147|NCT02357810|11990518|FG000|NOT COMPLETED|Registered and Started Treatment||27
10825148|NCT02357810|11990518|FG000|STARTED|Reached 12 Weeks Response||151
10825149|NCT02357810|11990518|FG000|Completed 4 Weeks/1 Cycle|Reached 12 Weeks Response||151
10825150|NCT02357810|11990518|FG000|Reached 6 Week Response|Reached 12 Weeks Response||129
10825151|NCT02357810|11990518|FG000|Reached 12 Weeks/3 Cycles|Reached 12 Weeks Response||95
10825152|NCT02357810|11990518|FG000|COMPLETED|Reached 12 Weeks Response||95
10825153|NCT02357810|11990518|FG000|NOT COMPLETED|Reached 12 Weeks Response||56
10825154|NCT02357810|11990518|FG000|STARTED|12 Week Response and Further Treatment||95
10825155|NCT02357810|11990518|FG000|Assessed for 12 Week Response|12 Week Response and Further Treatment||95
10825156|NCT02357810|11990518|FG000|Went on to be Treated After Response|12 Week Response and Further Treatment||73
10825157|NCT02357810|11990518|FG000|COMPLETED|12 Week Response and Further Treatment||73
10825158|NCT02357810|11990518|FG000|NOT COMPLETED|12 Week Response and Further Treatment||22
10825159|NCT02357810|11990518|FG000|STARTED|Follow-up at Treatment Discontinuation|All patients that receive at least one dose of study treatment go into follow up phase of the study.|151
10825160|NCT02357810|11990518|FG000|COMPLETED|Follow-up at Treatment Discontinuation||144
10825161|NCT02357810|11990518|FG000|NOT COMPLETED|Follow-up at Treatment Discontinuation||7
10825162|NCT02343549|11990522|FG000|STARTED|Overall Study||13
10825163|NCT02343549|11990522|FG000|COMPLETED|Overall Study||0
10825164|NCT02343549|11990522|FG000|NOT COMPLETED|Overall Study||13
10825165|NCT02339233|11990526|FG000|STARTED|Overall Study||8
10825166|NCT02339233|11990526|FG000|COMPLETED|Overall Study||8
10825167|NCT02339233|11990526|FG000|NOT COMPLETED|Overall Study||0
11099700|NCT01221350|12283608|FG001|COMPLETED|Overall Study||24
11099701|NCT01221350|12283607|FG000|NOT COMPLETED|Overall Study||5
11099702|NCT01221350|12283608|FG001|NOT COMPLETED|Overall Study||3
10825171|NCT02315066|11990548|FG000|STARTED|Overall Study||2
10825172|NCT02315066|11990549|FG001|STARTED|Overall Study||10
10825173|NCT02315066|11990550|FG002|STARTED|Overall Study||11
10825174|NCT02315066|11990551|FG003|STARTED|Overall Study||12
10825175|NCT02315066|11990552|FG004|STARTED|Overall Study||13
10825176|NCT02315066|11990553|FG005|STARTED|Overall Study||4
10825177|NCT02315066|11990554|FG006|STARTED|Overall Study||16
10825178|NCT02315066|11990555|FG007|STARTED|Overall Study||19
10825179|NCT02315066|11990556|FG008|STARTED|Overall Study||11
10825180|NCT02315066|11990557|FG009|STARTED|Overall Study||12
10825181|NCT02315066|11990558|FG010|STARTED|Overall Study||12
10825182|NCT02315066|11990559|FG011|STARTED|Overall Study||11
10825183|NCT02315066|11990560|FG012|STARTED|Overall Study||11
10825184|NCT02315066|11990561|FG013|STARTED|Overall Study||30
10825185|NCT02315066|11990548|FG000|COMPLETED|Overall Study||0
10825186|NCT02315066|11990549|FG001|COMPLETED|Overall Study||0
10825187|NCT02315066|11990550|FG002|COMPLETED|Overall Study||2
10825188|NCT02315066|11990551|FG003|COMPLETED|Overall Study||1
10825189|NCT02315066|11990552|FG004|COMPLETED|Overall Study||2
10825190|NCT02315066|11990553|FG005|COMPLETED|Overall Study||1
10825191|NCT02315066|11990554|FG006|COMPLETED|Overall Study||3
10825192|NCT02315066|11990555|FG007|COMPLETED|Overall Study||5
10825193|NCT02315066|11990556|FG008|COMPLETED|Overall Study||0
10825194|NCT02315066|11990557|FG009|COMPLETED|Overall Study||1
10825195|NCT02315066|11990558|FG010|COMPLETED|Overall Study||0
10825196|NCT02315066|11990559|FG011|COMPLETED|Overall Study||0
10825197|NCT02315066|11990560|FG012|COMPLETED|Overall Study||1
10825198|NCT02315066|11990561|FG013|COMPLETED|Overall Study||0
10825199|NCT02315066|11990548|FG000|NOT COMPLETED|Overall Study||2
10825200|NCT02315066|11990549|FG001|NOT COMPLETED|Overall Study||10
10825201|NCT02315066|11990550|FG002|NOT COMPLETED|Overall Study||9
10825202|NCT02315066|11990551|FG003|NOT COMPLETED|Overall Study||11
10825203|NCT02315066|11990552|FG004|NOT COMPLETED|Overall Study||11
10825204|NCT02315066|11990553|FG005|NOT COMPLETED|Overall Study||3
10825205|NCT02315066|11990554|FG006|NOT COMPLETED|Overall Study||13
10825206|NCT02315066|11990555|FG007|NOT COMPLETED|Overall Study||14
10825207|NCT02315066|11990556|FG008|NOT COMPLETED|Overall Study||11
10825208|NCT02315066|11990557|FG009|NOT COMPLETED|Overall Study||11
10825209|NCT02315066|11990558|FG010|NOT COMPLETED|Overall Study||12
10825210|NCT02315066|11990559|FG011|NOT COMPLETED|Overall Study||11
10825211|NCT02315066|11990560|FG012|NOT COMPLETED|Overall Study||10
10825212|NCT02315066|11990561|FG013|NOT COMPLETED|Overall Study||30
10825213|NCT02265367|11990593|FG000|STARTED|Overall Study||28
10825214|NCT02265367|11990594|FG001|STARTED|Overall Study||28
10825215|NCT02265367|11990593|FG000|Completed First 3-week Period|Overall Study||24
10825216|NCT02265367|11990594|FG001|Completed First 3-week Period|Overall Study||26
10825217|NCT02265367|11990593|FG000|COMPLETED|Overall Study||18
10825218|NCT02265367|11990594|FG001|COMPLETED|Overall Study||22
10825219|NCT02265367|11990593|FG000|NOT COMPLETED|Overall Study||10
10825220|NCT02265367|11990594|FG001|NOT COMPLETED|Overall Study||6
10825221|NCT02256631|11990607|FG000|STARTED|Overall Study||13
10825222|NCT02256631|11990608|FG001|STARTED|Overall Study||14
10825223|NCT02256631|11990609|FG002|STARTED|Overall Study||13
10825224|NCT02256631|11990610|FG003|STARTED|Overall Study||10
10825225|NCT02256631|11990611|FG004|STARTED|Overall Study||11
10825226|NCT02256631|11990612|FG005|STARTED|Overall Study||11
10825227|NCT02256631|11990613|FG006|STARTED|Overall Study||11
10825228|NCT02256631|11990607|FG000|COMPLETED|Overall Study||12
10825229|NCT02256631|11990608|FG001|COMPLETED|Overall Study||11
10825230|NCT02256631|11990609|FG002|COMPLETED|Overall Study||13
10825231|NCT02256631|11990610|FG003|COMPLETED|Overall Study||6
10825232|NCT02256631|11990611|FG004|COMPLETED|Overall Study||10
10825233|NCT02256631|11990612|FG005|COMPLETED|Overall Study||9
10825234|NCT02256631|11990613|FG006|COMPLETED|Overall Study||7
10825235|NCT02256631|11990607|FG000|NOT COMPLETED|Overall Study||1
10825236|NCT02256631|11990608|FG001|NOT COMPLETED|Overall Study||3
10825237|NCT02256631|11990609|FG002|NOT COMPLETED|Overall Study||0
10825238|NCT02256631|11990610|FG003|NOT COMPLETED|Overall Study||4
10825239|NCT02256631|11990611|FG004|NOT COMPLETED|Overall Study||1
10825240|NCT02256631|11990612|FG005|NOT COMPLETED|Overall Study||2
10825241|NCT02256631|11990613|FG006|NOT COMPLETED|Overall Study||4
11099703|NCT01221363|12283618|FG000|STARTED|Overall Study||93
11099704|NCT01221363|12283619|FG001|STARTED|Overall Study||73
11099705|NCT01221363|12283618|FG000|COMPLETED|Overall Study||81
11099706|NCT01221363|12283619|FG001|COMPLETED|Overall Study||68
11099707|NCT01221363|12283618|FG000|NOT COMPLETED|Overall Study||12
11099708|NCT01221363|12283619|FG001|NOT COMPLETED|Overall Study||5
10825248|NCT02129348|11990641|FG000|STARTED|Overall Study||38
10825249|NCT02129348|11990642|FG001|STARTED|Overall Study||39
11099709|NCT01221441|12283627|FG000|STARTED|Overall Study||67
10825250|NCT02129348|11990641|FG000|COMPLETED|Overall Study||29
10825251|NCT02129348|11990642|FG001|COMPLETED|Overall Study||29
10825252|NCT02129348|11990641|FG000|NOT COMPLETED|Overall Study||9
10825253|NCT02129348|11990642|FG001|NOT COMPLETED|Overall Study||10
10825254|NCT02080260|11990648|FG000|STARTED|Overall Study||20
10825255|NCT02080260|11990648|FG000|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1
10825256|NCT02080260|11990648|FG000|NOT COMPLETED|Overall Study||19
10825257|NCT02051933|11990654|FG000|STARTED|Overall Study||5
10825258|NCT02051933|11990655|FG001|STARTED|Overall Study||5
10825259|NCT02051933|11990654|FG000|COMPLETED|Overall Study||5
10825260|NCT02051933|11990655|FG001|COMPLETED|Overall Study||4
10825261|NCT02051933|11990654|FG000|NOT COMPLETED|Overall Study||0
10825262|NCT02051933|11990655|FG001|NOT COMPLETED|Overall Study||1
10825263|NCT02047929|11990669|FG000|STARTED|Overall Study||1503
10825264|NCT02047929|11990670|FG001|STARTED|Overall Study||2523
10825265|NCT02047929|11990671|FG002|STARTED|Overall Study||2248
10825266|NCT02047929|11990669|FG000|Practice Rollout|Overall Study||1503
10825267|NCT02047929|11990670|FG001|Practice Rollout|Overall Study||2523
10825268|NCT02047929|11990671|FG002|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0
10825269|NCT02047929|11990669|FG000|Practice Refresher|Overall Study||1503
10825270|NCT02047929|11990670|FG001|Practice Refresher|Overall Study||2523
10825271|NCT02047929|11990671|FG002|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0
10825272|NCT02047929|11990669|FG000|Surveys Collected|Overall Study||1503
10825273|NCT02047929|11990670|FG001|Surveys Collected|Overall Study||2523
10825274|NCT02047929|11990671|FG002|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0
10825275|NCT02047929|11990669|FG000|COMPLETED|Overall Study||1503
10825276|NCT02047929|11990670|FG001|COMPLETED|Overall Study||2523
10825277|NCT02047929|11990671|FG002|COMPLETED|Overall Study||2248
10825278|NCT02047929|11990669|FG000|NOT COMPLETED|Overall Study||0
10825279|NCT02047929|11990670|FG001|NOT COMPLETED|Overall Study||0
10825280|NCT02047929|11990671|FG002|NOT COMPLETED|Overall Study||0
10825281|NCT01999569|11990682|FG000|STARTED|Control Cycle|First cycle no meds|10
10825282|NCT01999569|11990682|FG000|COMPLETED|Control Cycle||10
10825283|NCT01999569|11990682|FG000|NOT COMPLETED|Control Cycle||0
10825284|NCT01999569|11990682|FG000|STARTED|Letrozole Treatment Cycle||10
10825285|NCT01999569|11990682|FG000|COMPLETED|Letrozole Treatment Cycle||10
10825286|NCT01999569|11990682|FG000|NOT COMPLETED|Letrozole Treatment Cycle||0
10825287|NCT01969812|11990691|FG000|STARTED|Overall Study||12
10825288|NCT01969812|11990692|FG001|STARTED|Overall Study||10
10825289|NCT01969812|11990691|FG000|COMPLETED|Overall Study||12
10825290|NCT01969812|11990692|FG001|COMPLETED|Overall Study||10
10825291|NCT01969812|11990691|FG000|NOT COMPLETED|Overall Study||0
10825292|NCT01969812|11990692|FG001|NOT COMPLETED|Overall Study||0
10825293|NCT01959464|11990700|FG000|STARTED|Overall Study||10
10825294|NCT01959464|11990701|FG001|STARTED|Overall Study||10
10825295|NCT01959464|11990700|FG000|COMPLETED|Overall Study||9
10825296|NCT01959464|11990701|FG001|COMPLETED|Overall Study||10
10825297|NCT01959464|11990700|FG000|NOT COMPLETED|Overall Study||1
10825298|NCT01959464|11990701|FG001|NOT COMPLETED|Overall Study||0
10825299|NCT01921166|11990709|FG000|STARTED|Overall Study||8
10825300|NCT01921166|11990710|FG001|STARTED|Overall Study||15
10825301|NCT01921166|11990709|FG000|COMPLETED|Overall Study||8
10825302|NCT01921166|11990710|FG001|COMPLETED|Overall Study||15
10825303|NCT01921166|11990709|FG000|NOT COMPLETED|Overall Study||0
10825304|NCT01921166|11990710|FG001|NOT COMPLETED|Overall Study||0
10825305|NCT01886963|11990718|FG000|STARTED|Overall Study||57
10825306|NCT01886963|11990719|FG001|STARTED|Overall Study||58
10825307|NCT01886963|11990718|FG000|2 Week Follow Up|Overall Study||55
10825308|NCT01886963|11990719|FG001|2 Week Follow Up|Overall Study||55
10825309|NCT01886963|11990718|FG000|4 Week Follow Up|Overall Study||50
10825310|NCT01886963|11990719|FG001|4 Week Follow Up|Overall Study||51
10825311|NCT01886963|11990718|FG000|12 Week Follow Up|Overall Study||46
10825312|NCT01886963|11990719|FG001|12 Week Follow Up|Overall Study||49
10825313|NCT01886963|11990718|FG000|COMPLETED|Overall Study||46
10825314|NCT01886963|11990719|FG001|COMPLETED|Overall Study||49
10825315|NCT01886963|11990718|FG000|NOT COMPLETED|Overall Study||11
10825316|NCT01886963|11990719|FG001|NOT COMPLETED|Overall Study||9
11099710|NCT01221441|12283628|FG001|STARTED|Overall Study||35
11099711|NCT01221441|12283627|FG000|COMPLETED|Overall Study||45
11099712|NCT01221441|12283628|FG001|COMPLETED|Overall Study||23
11099713|NCT01221441|12283627|FG000|NOT COMPLETED|Overall Study||22
11099714|NCT01221441|12283628|FG001|NOT COMPLETED|Overall Study||12
11099715|NCT01221597|12283636|FG000|STARTED|Overall Study||277
11099716|NCT01221597|12283637|FG001|STARTED|Overall Study||140
11099717|NCT01221597|12283636|FG000|COMPLETED|Overall Study||241
11099718|NCT01221597|12283637|FG001|COMPLETED|Overall Study||124
11099719|NCT01221597|12283636|FG000|NOT COMPLETED|Overall Study||36
11099720|NCT01221597|12283637|FG001|NOT COMPLETED|Overall Study||16
11099721|NCT01221623|12283646|FG000|STARTED|Overall Study||274
10825329|NCT01774253|11990734|FG000|STARTED|Overall Study||9
10825330|NCT01774253|11990734|FG000|COMPLETED|Overall Study||0
10825331|NCT01774253|11990734|FG000|NOT COMPLETED|Overall Study||9
10825332|NCT01666145|11990738|FG000|STARTED|Overall Study||14
10825333|NCT01666145|11990738|FG000|COMPLETED|Overall Study||14
10825334|NCT01666145|11990738|FG000|NOT COMPLETED|Overall Study||0
10825335|NCT01505608|11990744|FG000|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
10825336|NCT01505608|11990745|FG001|STARTED|Phase I||8
10825337|NCT01505608|11990744|FG000|COMPLETED|Phase I||0
10825338|NCT01505608|11990745|FG001|COMPLETED|Phase I||2
10825339|NCT01505608|11990744|FG000|NOT COMPLETED|Phase I||0
10825340|NCT01505608|11990745|FG001|NOT COMPLETED|Phase I||6
10825341|NCT01505608|11990744|FG000|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
10825342|NCT01505608|11990745|FG001|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
10825343|NCT01505608|11990744|FG000|COMPLETED|Phase II||0
11099722|NCT01221623|12283647|FG001|STARTED|Overall Study||141
11099723|NCT01221623|12283646|FG000|COMPLETED|Overall Study||236
10825344|NCT01505608|11990745|FG001|COMPLETED|Phase II||2
10825345|NCT01505608|11990744|FG000|NOT COMPLETED|Phase II||2
10825346|NCT01505608|11990745|FG001|NOT COMPLETED|Phase II||2
10825347|NCT01483820|11990754|FG000|STARTED|Overall Study||8
10825348|NCT01483820|11990754|FG000|COMPLETED|Overall Study||0
10825349|NCT01483820|11990754|FG000|NOT COMPLETED|Overall Study||8
10825350|NCT01355679|11990758|FG000|STARTED|Overall Study||16
10825351|NCT01355679|11990758|FG000|COMPLETED|Overall Study||14
10825352|NCT01355679|11990758|FG000|NOT COMPLETED|Overall Study||2
10825353|NCT01227616|11990765|FG000|STARTED|Overall Study||196
10825354|NCT01227616|11990766|FG001|STARTED|Overall Study||97
10825355|NCT01227616|11990765|FG000|COMPLETED|Overall Study||142
10825356|NCT01227616|11990766|FG001|COMPLETED|Overall Study||74
10825357|NCT01227616|11990765|FG000|NOT COMPLETED|Overall Study||54
10825358|NCT01227616|11990766|FG001|NOT COMPLETED|Overall Study||23
10825359|NCT01192698|11990774|FG000|STARTED|Overall Study||10
10825360|NCT01192698|11990775|FG001|STARTED|Overall Study||5
10825361|NCT01192698|11990774|FG000|COMPLETED|Overall Study||10
10825362|NCT01192698|11990775|FG001|COMPLETED|Overall Study||5
10825363|NCT01192698|11990774|FG000|NOT COMPLETED|Overall Study||0
10825364|NCT01192698|11990775|FG001|NOT COMPLETED|Overall Study||0
10825365|NCT01166386|11990783|FG000|STARTED|Overall Study||82
10825366|NCT01166386|11990784|FG001|STARTED|Overall Study||83
10825367|NCT01166386|11990783|FG000|COMPLETED|Overall Study||79
10825368|NCT01166386|11990784|FG001|COMPLETED|Overall Study||78
10825369|NCT01166386|11990783|FG000|NOT COMPLETED|Overall Study||3
10825370|NCT01166386|11990784|FG001|NOT COMPLETED|Overall Study||5
10825371|NCT01114217|11990792|FG000|STARTED|Overall Study||337
11219765|NCT01957384|12411383|FG002|STARTED|Test Period 1 (14 Days)||4
11219766|NCT01957384|12411384|FG003|STARTED|Test Period 1 (14 Days)||4
11219767|NCT01957384|12411385|FG004|STARTED|Test Period 1 (14 Days)||3
11219768|NCT01957384|12411386|FG005|STARTED|Test Period 1 (14 Days)||3
11219769|NCT01957384|12411381|FG000|COMPLETED|Test Period 1 (14 Days)||4
11219770|NCT01957384|12411382|FG001|COMPLETED|Test Period 1 (14 Days)||4
11219771|NCT01957384|12411383|FG002|COMPLETED|Test Period 1 (14 Days)||4
11219772|NCT01957384|12411384|FG003|COMPLETED|Test Period 1 (14 Days)||4
11219773|NCT01957384|12411385|FG004|COMPLETED|Test Period 1 (14 Days)||3
11219774|NCT01957384|12411386|FG005|COMPLETED|Test Period 1 (14 Days)||3
11219775|NCT01957384|12411381|FG000|NOT COMPLETED|Test Period 1 (14 Days)||0
11219776|NCT01957384|12411382|FG001|NOT COMPLETED|Test Period 1 (14 Days)||0
11219777|NCT01957384|12411383|FG002|NOT COMPLETED|Test Period 1 (14 Days)||0
11219778|NCT01957384|12411384|FG003|NOT COMPLETED|Test Period 1 (14 Days)||0
11219779|NCT01957384|12411385|FG004|NOT COMPLETED|Test Period 1 (14 Days)||0
11219780|NCT01957384|12411386|FG005|NOT COMPLETED|Test Period 1 (14 Days)||0
11219781|NCT01957384|12411381|FG000|STARTED|Test Period 2 (14 Days)||4
11219782|NCT01957384|12411382|FG001|STARTED|Test Period 2 (14 Days)||4
11219783|NCT01957384|12411383|FG002|STARTED|Test Period 2 (14 Days)||4
11219784|NCT01957384|12411384|FG003|STARTED|Test Period 2 (14 Days)||4
11219785|NCT01957384|12411385|FG004|STARTED|Test Period 2 (14 Days)||3
10825372|NCT01114217|11990793|FG001|STARTED|Overall Study||297
10825373|NCT01114217|11990792|FG000|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
10825374|NCT01114217|11990793|FG001|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
10825375|NCT01114217|11990792|FG000|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
10825376|NCT01114217|11990793|FG001|COMPLETED|Overall Study||199
10825377|NCT01114217|11990792|FG000|NOT COMPLETED|Overall Study||75
10825378|NCT01114217|11990793|FG001|NOT COMPLETED|Overall Study||98
10825379|NCT01114204|11990799|FG000|STARTED|Overall Study||406
10825380|NCT01114204|11990800|FG001|STARTED|Overall Study||199
10825381|NCT01114204|11990799|FG000|Received at Least 1 Dose of Study Drug|Overall Study||406
10825382|NCT01114204|11990800|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199
10825383|NCT01114204|11990799|FG000|COMPLETED|Overall Study||385
10825384|NCT01114204|11990800|FG001|COMPLETED|Overall Study||191
10825385|NCT01114204|11990799|FG000|NOT COMPLETED|Overall Study||21
10825386|NCT01114204|11990800|FG001|NOT COMPLETED|Overall Study||8
10825387|NCT01114139|11990808|FG000|STARTED|Overall Study||609
10825388|NCT01114139|11990809|FG001|STARTED|Overall Study||203
10825389|NCT01114139|11990808|FG000|Received at Least 1 Dose of Study Drug|Overall Study||608
10825390|NCT01114139|11990809|FG001|Received at Least 1 Dose of Study Drug|Overall Study||200
10825391|NCT01114139|11990808|FG000|COMPLETED|Overall Study||569
10825392|NCT01114139|11990809|FG001|COMPLETED|Overall Study||187
10825393|NCT01114139|11990808|FG000|NOT COMPLETED|Overall Study||40
10825394|NCT01114139|11990809|FG001|NOT COMPLETED|Overall Study||16
10825395|NCT01059071|11990815|FG000|STARTED|Overall Study||4
10825396|NCT01059071|11990816|FG001|STARTED|Overall Study||5
10825397|NCT01059071|11990817|FG002|STARTED|Overall Study||3
10825398|NCT01059071|11990818|FG003|STARTED|Overall Study||9
10825399|NCT01059071|11990815|FG000|COMPLETED|Overall Study||2
10825400|NCT01059071|11990816|FG001|COMPLETED|Overall Study||1
10825401|NCT01059071|11990817|FG002|COMPLETED|Overall Study||1
10825402|NCT01059071|11990818|FG003|COMPLETED|Overall Study||3
10825403|NCT01059071|11990815|FG000|NOT COMPLETED|Overall Study||2
10825404|NCT01059071|11990816|FG001|NOT COMPLETED|Overall Study||4
10825405|NCT01059071|11990817|FG002|NOT COMPLETED|Overall Study||2
10825406|NCT01059071|11990818|FG003|NOT COMPLETED|Overall Study||6
10825407|NCT01027702|11990826|FG000|STARTED|Overall Study||4
10825408|NCT01027702|11990827|FG001|STARTED|Overall Study||4
11219786|NCT01957384|12411386|FG005|STARTED|Test Period 2 (14 Days)||3
11219787|NCT01957384|12411381|FG000|COMPLETED|Test Period 2 (14 Days)||4
11219788|NCT01957384|12411382|FG001|COMPLETED|Test Period 2 (14 Days)||4
11219789|NCT01957384|12411383|FG002|COMPLETED|Test Period 2 (14 Days)||4
11219790|NCT01957384|12411384|FG003|COMPLETED|Test Period 2 (14 Days)||4
11219791|NCT01957384|12411385|FG004|COMPLETED|Test Period 2 (14 Days)||3
10825409|NCT01027702|11990828|FG002|STARTED|Overall Study||3
10825410|NCT01027702|11990829|FG003|STARTED|Overall Study||14
10825411|NCT01027702|11990830|FG004|STARTED|Overall Study||10
10825412|NCT01027702|11990831|FG005|STARTED|Overall Study||1
10825413|NCT01027702|11990832|FG006|STARTED|Overall Study||2
10825414|NCT01027702|11990826|FG000|COMPLETED|Overall Study||3
10825415|NCT01027702|11990827|FG001|COMPLETED|Overall Study||2
10825416|NCT01027702|11990828|FG002|COMPLETED|Overall Study||2
10825417|NCT01027702|11990829|FG003|COMPLETED|Overall Study||10
10825418|NCT01027702|11990830|FG004|COMPLETED|Overall Study||9
10825419|NCT01027702|11990831|FG005|COMPLETED|Overall Study||1
10825420|NCT01027702|11990832|FG006|COMPLETED|Overall Study||1
10825421|NCT01027702|11990826|FG000|NOT COMPLETED|Overall Study||1
10825422|NCT01027702|11990827|FG001|NOT COMPLETED|Overall Study||2
10825423|NCT01027702|11990828|FG002|NOT COMPLETED|Overall Study||1
10825424|NCT01027702|11990829|FG003|NOT COMPLETED|Overall Study||4
10825425|NCT01027702|11990830|FG004|NOT COMPLETED|Overall Study||1
10825426|NCT01027702|11990831|FG005|NOT COMPLETED|Overall Study||0
10825427|NCT01027702|11990832|FG006|NOT COMPLETED|Overall Study||1
10825428|NCT00991887|11990845|FG000|STARTED|Overall Study||26
10825429|NCT00991887|11990846|FG001|STARTED|Overall Study||22
10825430|NCT00991887|11990845|FG000|COMPLETED|Overall Study||24
10825431|NCT00991887|11990846|FG001|COMPLETED|Overall Study||21
10825432|NCT00991887|11990845|FG000|NOT COMPLETED|Overall Study||2
10825433|NCT00991887|11990846|FG001|NOT COMPLETED|Overall Study||1
10825434|NCT00968864|11990852|FG000|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
10825435|NCT00968864|11990852|FG000|COMPLETED|Overall Study||52
10825436|NCT00968864|11990852|FG000|NOT COMPLETED|Overall Study||1
10825437|NCT00934700|11990863|FG000|STARTED|Overall Study||46
10825438|NCT00934700|11990864|FG001|STARTED|Overall Study||46
10825439|NCT00934700|11990863|FG000|COMPLETED|Overall Study||33
10825440|NCT00934700|11990864|FG001|COMPLETED|Overall Study||34
10825441|NCT00934700|11990863|FG000|NOT COMPLETED|Overall Study||13
10825442|NCT00934700|11990864|FG001|NOT COMPLETED|Overall Study||12
10825443|NCT00867568|11990871|FG000|STARTED|Overall Study||18
10825444|NCT00867568|11990871|FG000|COMPLETED|Overall Study||3
10825445|NCT00867568|11990871|FG000|NOT COMPLETED|Overall Study||15
10825455|NCT00782288|11990891|FG000|STARTED|Overall Study||8
10825456|NCT00782288|11990892|FG001|STARTED|Overall Study||8
10825457|NCT00782288|11990893|FG002|STARTED|Overall Study||8
10825458|NCT00782288|11990891|FG000|COMPLETED|Overall Study||8
10825459|NCT00782288|11990892|FG001|COMPLETED|Overall Study||8
10825460|NCT00782288|11990893|FG002|COMPLETED|Overall Study||8
10825461|NCT00782288|11990891|FG000|NOT COMPLETED|Overall Study||0
10825462|NCT00782288|11990892|FG001|NOT COMPLETED|Overall Study||0
10825463|NCT00782288|11990893|FG002|NOT COMPLETED|Overall Study||0
10825464|NCT00643864|11990903|FG000|STARTED|Pre-test Assessment||3
10825465|NCT00643864|11990903|FG000|COMPLETED|Pre-test Assessment||3
10825466|NCT00643864|11990903|FG000|NOT COMPLETED|Pre-test Assessment||0
10825467|NCT00643864|11990903|FG000|STARTED|Post-test Assessment||3
10825468|NCT00643864|11990903|FG000|COMPLETED|Post-test Assessment||3
10825469|NCT00643864|11990903|FG000|NOT COMPLETED|Post-test Assessment||0
10825470|NCT00628446|11990908|FG000|STARTED|Overall Study||45
10825471|NCT00628446|11990908|FG000|COMPLETED|Overall Study||38
10825472|NCT00628446|11990908|FG000|NOT COMPLETED|Overall Study||7
10825473|NCT00621751|11990915|FG000|STARTED|Overall Study||35
10825474|NCT00621751|11990916|FG001|STARTED|Overall Study||35
10825475|NCT00621751|11990915|FG000|COMPLETED|Overall Study||35
10825476|NCT00621751|11990916|FG001|COMPLETED|Overall Study||34
10825477|NCT00621751|11990915|FG000|NOT COMPLETED|Overall Study||0
10825478|NCT00621751|11990916|FG001|NOT COMPLETED|Overall Study||1
10825479|NCT00605215|11990925|FG000|STARTED|Overall Study||450
10825480|NCT00605215|11990926|FG001|STARTED|Overall Study||434
10825481|NCT00605215|11990927|FG002|STARTED|Overall Study||447
10825482|NCT00605215|11990925|FG000|Received at Least 1 Dose of Study Drug|Overall Study||449
10825483|NCT00605215|11990926|FG001|Received at Least 1 Dose of Study Drug|Overall Study||433
10825484|NCT00605215|11990927|FG002|Received at Least 1 Dose of Study Drug|Overall Study||442
10825485|NCT00605215|11990925|FG000|COMPLETED|Overall Study||359
10825486|NCT00605215|11990926|FG001|COMPLETED|Overall Study||353
10825487|NCT00605215|11990927|FG002|COMPLETED|Overall Study||378
10825488|NCT00605215|11990925|FG000|NOT COMPLETED|Overall Study||91
10825489|NCT00605215|11990926|FG001|NOT COMPLETED|Overall Study||81
10825490|NCT00605215|11990927|FG002|NOT COMPLETED|Overall Study||69
10825491|NCT00605150|11990935|FG000|STARTED|Overall Study|11 started|11
10825492|NCT00605150|11990935|FG000|COMPLETED|Overall Study||10
10825493|NCT00605150|11990935|FG000|NOT COMPLETED|Overall Study||1
10825494|NCT00552513|11990941|FG000|STARTED|Overall Study||1593
10825495|NCT00552513|11990942|FG001|STARTED|Overall Study||1438
10825496|NCT00552513|11990941|FG000|COMPLETED|Overall Study||1588
10825497|NCT00552513|11990942|FG001|COMPLETED|Overall Study||1437
10825498|NCT00552513|11990941|FG000|NOT COMPLETED|Overall Study||5
10825499|NCT00552513|11990942|FG001|NOT COMPLETED|Overall Study||1
10825500|NCT00368836|11990952|FG000|STARTED|Phase II||350
10825501|NCT00368836|11990952|FG000|COMPLETED|Phase II||329
10825502|NCT00368836|11990952|FG000|NOT COMPLETED|Phase II||21
10825503|NCT00368836|11990952|FG000|STARTED|Phase I Pre-op/Post-op|The phases consisted of unique subjects. Those enrolled in Phase I did not carry over to Phase II.|125
10825504|NCT00368836|11990952|FG000|COMPLETED|Phase I Pre-op/Post-op||104
10825505|NCT00368836|11990952|FG000|NOT COMPLETED|Phase I Pre-op/Post-op||21
10825506|NCT00290511|11990959|FG000|STARTED|Overall Study||49
10825507|NCT00290511|11990959|FG000|No Treatment Per Protocol|Overall Study||2
10825508|NCT00290511|11990959|FG000|Toxicity Assessment|Overall Study||47
10825509|NCT00290511|11990959|FG000|Response Assessment|Overall Study||45
10825510|NCT00290511|11990959|FG000|COMPLETED|Overall Study||45
10825511|NCT00290511|11990959|FG000|NOT COMPLETED|Overall Study||4
10825515|NCT00641537|11990972|FG000|STARTED|96-week Period||98
10825516|NCT00641537|11990973|FG001|STARTED|96-week Period||92
10825517|NCT00641537|11990974|FG002|STARTED|96-week Period||186
10825518|NCT00641537|11990975|FG003|STARTED|96-week Period||186
10825519|NCT00641537|11990976|FG004|STARTED|96-week Period||244
10825520|NCT00641537|11990977|FG005|STARTED|96-week Period||22
10825521|NCT00641537|11990978|FG006|STARTED|96-week Period||17
10825522|NCT00641537|11990979|FG007|STARTED|96-week Period||22
10825523|NCT00641537|11990972|FG000|COMPLETED|96-week Period||89
10825524|NCT00641537|11990973|FG001|COMPLETED|96-week Period||82
10825525|NCT00641537|11990974|FG002|COMPLETED|96-week Period||166
10825526|NCT00641537|11990975|FG003|COMPLETED|96-week Period||174
10825527|NCT00641537|11990976|FG004|COMPLETED|96-week Period||227
10825528|NCT00641537|11990977|FG005|COMPLETED|96-week Period||15
10825529|NCT00641537|11990978|FG006|COMPLETED|96-week Period||12
10825530|NCT00641537|11990979|FG007|COMPLETED|96-week Period||16
10825531|NCT00641537|11990972|FG000|NOT COMPLETED|96-week Period||9
10825532|NCT00641537|11990973|FG001|NOT COMPLETED|96-week Period||10
10825533|NCT00641537|11990974|FG002|NOT COMPLETED|96-week Period||20
10825534|NCT00641537|11990975|FG003|NOT COMPLETED|96-week Period||12
10825535|NCT00641537|11990976|FG004|NOT COMPLETED|96-week Period||17
10825536|NCT00641537|11990977|FG005|NOT COMPLETED|96-week Period||7
10825537|NCT00641537|11990978|FG006|NOT COMPLETED|96-week Period||5
10825538|NCT00641537|11990979|FG007|NOT COMPLETED|96-week Period||6
10825539|NCT00641537|11990972|FG000|STARTED|24-Week Supplemental Follow-up Period||75
10825540|NCT00641537|11990973|FG001|STARTED|24-Week Supplemental Follow-up Period||69
10825541|NCT00641537|11990974|FG002|STARTED|24-Week Supplemental Follow-up Period||143
10825542|NCT00641537|11990975|FG003|STARTED|24-Week Supplemental Follow-up Period||151
10825543|NCT00641537|11990976|FG004|STARTED|24-Week Supplemental Follow-up Period||198
10825544|NCT00641537|11990977|FG005|STARTED|24-Week Supplemental Follow-up Period||15
10825545|NCT00641537|11990978|FG006|STARTED|24-Week Supplemental Follow-up Period||9
10825546|NCT00641537|11990979|FG007|STARTED|24-Week Supplemental Follow-up Period||11
10825547|NCT00641537|11990972|FG000|COMPLETED|24-Week Supplemental Follow-up Period||75
10825548|NCT00641537|11990973|FG001|COMPLETED|24-Week Supplemental Follow-up Period||66
10825549|NCT00641537|11990974|FG002|COMPLETED|24-Week Supplemental Follow-up Period||140
10825550|NCT00641537|11990975|FG003|COMPLETED|24-Week Supplemental Follow-up Period||147
10825551|NCT00641537|11990976|FG004|COMPLETED|24-Week Supplemental Follow-up Period||193
10825552|NCT00641537|11990977|FG005|COMPLETED|24-Week Supplemental Follow-up Period||14
10825553|NCT00641537|11990978|FG006|COMPLETED|24-Week Supplemental Follow-up Period||8
10825554|NCT00641537|11990979|FG007|COMPLETED|24-Week Supplemental Follow-up Period||10
10825555|NCT00641537|11990972|FG000|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
10825556|NCT00641537|11990973|FG001|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
10825557|NCT00641537|11990974|FG002|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
10825558|NCT00641537|11990975|FG003|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
10825559|NCT00641537|11990976|FG004|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
10825560|NCT00641537|11990977|FG005|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
10825561|NCT00641537|11990978|FG006|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
10825562|NCT00641537|11990979|FG007|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
10825563|NCT00655824|11990997|FG000|STARTED|Overall Study||92
10825564|NCT00655824|11990997|FG000|COMPLETED|Overall Study||8
10825565|NCT00655824|11990997|FG000|NOT COMPLETED|Overall Study||84
10825566|NCT00663052|11991003|FG000|STARTED|Overall Study||136
10825567|NCT00663052|11991004|FG001|STARTED|Overall Study||137
10825568|NCT00663052|11991003|FG000|COMPLETED|Overall Study||124
10825569|NCT00663052|11991004|FG001|COMPLETED|Overall Study||127
10825570|NCT00663052|11991003|FG000|NOT COMPLETED|Overall Study||12
10825571|NCT00663052|11991004|FG001|NOT COMPLETED|Overall Study||10
10825572|NCT00686374|11991010|FG000|STARTED|Overall Study||100
10825573|NCT00686374|11991010|FG000|COMPLETED|Overall Study||39
10825574|NCT00686374|11991010|FG000|NOT COMPLETED|Overall Study||61
10825575|NCT00698828|11991017|FG000|STARTED|Overall Study||76
10825576|NCT00698828|11991018|FG001|STARTED|Overall Study||75
10825577|NCT00698828|11991019|FG002|STARTED|Overall Study||76
10825578|NCT00698828|11991017|FG000|COMPLETED|Overall Study||67
10825579|NCT00698828|11991018|FG001|COMPLETED|Overall Study||60
10825580|NCT00698828|11991019|FG002|COMPLETED|Overall Study||65
10825581|NCT00698828|11991017|FG000|NOT COMPLETED|Overall Study||9
10825582|NCT00698828|11991018|FG001|NOT COMPLETED|Overall Study||15
10825583|NCT00698828|11991019|FG002|NOT COMPLETED|Overall Study||11
10825584|NCT00712933|11991027|FG000|STARTED|Overall Study||735
10825585|NCT00712933|11991027|FG000|COMPLETED|Overall Study||368
10825586|NCT00712933|11991027|FG000|NOT COMPLETED|Overall Study||367
10825596|NCT00725985|11991051|FG000|STARTED|ITP- Treatment Disposition||205
10825597|NCT00725985|11991052|FG001|STARTED|ITP- Treatment Disposition||206
10825598|NCT00725985|11991053|FG002|STARTED|ITP- Treatment Disposition||206
10825599|NCT00725985|11991054|FG003|STARTED|ITP- Treatment Disposition||0
10825600|NCT00725985|11991055|FG004|STARTED|ITP- Treatment Disposition||0
10825601|NCT00725985|11991056|FG005|STARTED|ITP- Treatment Disposition||0
10825602|NCT00725985|11991057|FG006|STARTED|ITP- Treatment Disposition||0
10825603|NCT00725985|11991058|FG007|STARTED|ITP- Treatment Disposition||0
10825604|NCT00725985|11991059|FG008|STARTED|ITP- Treatment Disposition||0
10825605|NCT00725985|11991060|FG009|STARTED|ITP- Treatment Disposition||0
10825606|NCT00725985|11991061|FG010|STARTED|ITP- Treatment Disposition||0
10825607|NCT00725985|11991062|FG011|STARTED|ITP- Treatment Disposition||0
10825608|NCT00725985|11991051|FG000|Treated|ITP- Treatment Disposition||204
10825587|NCT00715273|11991038|FG000|STARTED|Overall Study||71
10825588|NCT00715273|11991039|FG001|STARTED|Overall Study||73
10825589|NCT00715273|11991040|FG002|STARTED|Overall Study||73
10825590|NCT00715273|11991038|FG000|COMPLETED|Overall Study||63
10825591|NCT00715273|11991039|FG001|COMPLETED|Overall Study||65
10825592|NCT00715273|11991040|FG002|COMPLETED|Overall Study||68
10825593|NCT00715273|11991038|FG000|NOT COMPLETED|Overall Study||8
10825594|NCT00715273|11991039|FG001|NOT COMPLETED|Overall Study||8
10825595|NCT00715273|11991040|FG002|NOT COMPLETED|Overall Study||5
10825609|NCT00725985|11991052|FG001|Treated|ITP- Treatment Disposition||206
10825610|NCT00725985|11991053|FG002|Treated|ITP- Treatment Disposition||206
10825611|NCT00725985|11991054|FG003|Treated|ITP- Treatment Disposition||0
10825612|NCT00725985|11991055|FG004|Treated|ITP- Treatment Disposition||0
10825613|NCT00725985|11991056|FG005|Treated|ITP- Treatment Disposition||0
10825614|NCT00725985|11991057|FG006|Treated|ITP- Treatment Disposition||0
10825615|NCT00725985|11991058|FG007|Treated|ITP- Treatment Disposition||0
10825616|NCT00725985|11991059|FG008|Treated|ITP- Treatment Disposition||0
10825617|NCT00725985|11991060|FG009|Treated|ITP- Treatment Disposition||0
10825618|NCT00725985|11991061|FG010|Treated|ITP- Treatment Disposition||0
10825619|NCT00725985|11991062|FG011|Treated|ITP- Treatment Disposition||0
10825620|NCT00725985|11991051|FG000|COMPLETED|ITP- Treatment Disposition||104
10825621|NCT00725985|11991052|FG001|COMPLETED|ITP- Treatment Disposition||131
10825622|NCT00725985|11991053|FG002|COMPLETED|ITP- Treatment Disposition||104
10825623|NCT00725985|11991054|FG003|COMPLETED|ITP- Treatment Disposition||0
10825624|NCT00725985|11991055|FG004|COMPLETED|ITP- Treatment Disposition||0
10825625|NCT00725985|11991056|FG005|COMPLETED|ITP- Treatment Disposition||0
10825626|NCT00725985|11991057|FG006|COMPLETED|ITP- Treatment Disposition||0
10825627|NCT00725985|11991058|FG007|COMPLETED|ITP- Treatment Disposition||0
10825628|NCT00725985|11991059|FG008|COMPLETED|ITP- Treatment Disposition||0
10825629|NCT00725985|11991060|FG009|COMPLETED|ITP- Treatment Disposition||0
10825630|NCT00725985|11991061|FG010|COMPLETED|ITP- Treatment Disposition||0
10825631|NCT00725985|11991062|FG011|COMPLETED|ITP- Treatment Disposition||0
10825632|NCT00725985|11991051|FG000|NOT COMPLETED|ITP- Treatment Disposition||101
10825633|NCT00725985|11991052|FG001|NOT COMPLETED|ITP- Treatment Disposition||75
10825634|NCT00725985|11991053|FG002|NOT COMPLETED|ITP- Treatment Disposition||102
10825635|NCT00725985|11991054|FG003|NOT COMPLETED|ITP- Treatment Disposition||0
10825636|NCT00725985|11991055|FG004|NOT COMPLETED|ITP- Treatment Disposition||0
10825637|NCT00725985|11991056|FG005|NOT COMPLETED|ITP- Treatment Disposition||0
10825638|NCT00725985|11991057|FG006|NOT COMPLETED|ITP- Treatment Disposition||0
10825639|NCT00725985|11991058|FG007|NOT COMPLETED|ITP- Treatment Disposition||0
10825640|NCT00725985|11991059|FG008|NOT COMPLETED|ITP- Treatment Disposition||0
10825641|NCT00725985|11991060|FG009|NOT COMPLETED|ITP- Treatment Disposition||0
10825642|NCT00725985|11991061|FG010|NOT COMPLETED|ITP- Treatment Disposition||0
10825643|NCT00725985|11991062|FG011|NOT COMPLETED|ITP- Treatment Disposition||0
10825644|NCT00725985|11991051|FG000|STARTED|OLMP (Up to 96 Weeks)||0
10825645|NCT00725985|11991052|FG001|STARTED|OLMP (Up to 96 Weeks)||0
10825646|NCT00725985|11991053|FG002|STARTED|OLMP (Up to 96 Weeks)||0
10825647|NCT00725985|11991054|FG003|STARTED|OLMP (Up to 96 Weeks)||24
10825648|NCT00725985|11991055|FG004|STARTED|OLMP (Up to 96 Weeks)||25
10825649|NCT00725985|11991056|FG005|STARTED|OLMP (Up to 96 Weeks)||60
10825650|NCT00725985|11991057|FG006|STARTED|OLMP (Up to 96 Weeks)||0
10825651|NCT00725985|11991058|FG007|STARTED|OLMP (Up to 96 Weeks)||0
10825652|NCT00725985|11991059|FG008|STARTED|OLMP (Up to 96 Weeks)||0
10825653|NCT00725985|11991060|FG009|STARTED|OLMP (Up to 96 Weeks)||0
10825654|NCT00725985|11991061|FG010|STARTED|OLMP (Up to 96 Weeks)||0
10825655|NCT00725985|11991062|FG011|STARTED|OLMP (Up to 96 Weeks)||0
10825656|NCT00725985|11991051|FG000|COMPLETED|OLMP (Up to 96 Weeks)||0
10825657|NCT00725985|11991052|FG001|COMPLETED|OLMP (Up to 96 Weeks)||0
10825658|NCT00725985|11991053|FG002|COMPLETED|OLMP (Up to 96 Weeks)||0
10825659|NCT00725985|11991054|FG003|COMPLETED|OLMP (Up to 96 Weeks)||6
10825660|NCT00725985|11991055|FG004|COMPLETED|OLMP (Up to 96 Weeks)||2
10825661|NCT00725985|11991056|FG005|COMPLETED|OLMP (Up to 96 Weeks)||7
10825662|NCT00725985|11991057|FG006|COMPLETED|OLMP (Up to 96 Weeks)||0
10825663|NCT00725985|11991058|FG007|COMPLETED|OLMP (Up to 96 Weeks)||0
10825664|NCT00725985|11991059|FG008|COMPLETED|OLMP (Up to 96 Weeks)||0
10825665|NCT00725985|11991060|FG009|COMPLETED|OLMP (Up to 96 Weeks)||0
10825666|NCT00725985|11991061|FG010|COMPLETED|OLMP (Up to 96 Weeks)||0
10825667|NCT00725985|11991062|FG011|COMPLETED|OLMP (Up to 96 Weeks)||0
10825668|NCT00725985|11991051|FG000|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825669|NCT00725985|11991052|FG001|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825670|NCT00725985|11991053|FG002|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825671|NCT00725985|11991054|FG003|NOT COMPLETED|OLMP (Up to 96 Weeks)||18
10825672|NCT00725985|11991055|FG004|NOT COMPLETED|OLMP (Up to 96 Weeks)||23
10825673|NCT00725985|11991056|FG005|NOT COMPLETED|OLMP (Up to 96 Weeks)||53
10825674|NCT00725985|11991057|FG006|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825675|NCT00725985|11991058|FG007|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825676|NCT00725985|11991059|FG008|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825677|NCT00725985|11991060|FG009|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825678|NCT00725985|11991061|FG010|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825679|NCT00725985|11991062|FG011|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
10825680|NCT00725985|11991051|FG000|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825681|NCT00725985|11991052|FG001|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825682|NCT00725985|11991053|FG002|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825683|NCT00725985|11991054|FG003|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825684|NCT00725985|11991055|FG004|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825685|NCT00725985|11991056|FG005|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825686|NCT00725985|11991057|FG006|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
10825687|NCT00725985|11991058|FG007|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
10825688|NCT00725985|11991059|FG008|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||17
10825689|NCT00725985|11991060|FG009|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825690|NCT00725985|11991061|FG010|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825691|NCT00725985|11991062|FG011|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825692|NCT00725985|11991051|FG000|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825693|NCT00725985|11991052|FG001|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825694|NCT00725985|11991053|FG002|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825695|NCT00725985|11991054|FG003|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825696|NCT00725985|11991055|FG004|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825697|NCT00725985|11991056|FG005|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825698|NCT00725985|11991057|FG006|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825699|NCT00725985|11991058|FG007|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825700|NCT00725985|11991059|FG008|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825701|NCT00725985|11991060|FG009|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825702|NCT00725985|11991061|FG010|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825703|NCT00725985|11991062|FG011|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825704|NCT00725985|11991051|FG000|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825705|NCT00725985|11991052|FG001|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825706|NCT00725985|11991053|FG002|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825707|NCT00725985|11991054|FG003|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825708|NCT00725985|11991055|FG004|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825709|NCT00725985|11991056|FG005|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825710|NCT00725985|11991057|FG006|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
10825711|NCT00725985|11991058|FG007|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
10825712|NCT00725985|11991059|FG008|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||17
10825713|NCT00725985|11991060|FG009|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825714|NCT00725985|11991061|FG010|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825715|NCT00725985|11991062|FG011|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
10825716|NCT00725985|11991051|FG000|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825717|NCT00725985|11991052|FG001|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825718|NCT00725985|11991053|FG002|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825719|NCT00725985|11991054|FG003|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825720|NCT00725985|11991055|FG004|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825721|NCT00725985|11991056|FG005|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825722|NCT00725985|11991057|FG006|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825723|NCT00725985|11991058|FG007|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825724|NCT00725985|11991059|FG008|STARTED|LTFU (No Cladribine) (48 Weeks)||0
10825725|NCT00725985|11991060|FG009|STARTED|LTFU (No Cladribine) (48 Weeks)||34
10825726|NCT00725985|11991061|FG010|STARTED|LTFU (No Cladribine) (48 Weeks)||36
10825727|NCT00725985|11991062|FG011|STARTED|LTFU (No Cladribine) (48 Weeks)||14
10825728|NCT00725985|11991051|FG000|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825729|NCT00725985|11991052|FG001|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825730|NCT00725985|11991053|FG002|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825731|NCT00725985|11991054|FG003|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825732|NCT00725985|11991055|FG004|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825733|NCT00725985|11991056|FG005|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825734|NCT00725985|11991057|FG006|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825735|NCT00725985|11991058|FG007|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825736|NCT00725985|11991059|FG008|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825737|NCT00725985|11991060|FG009|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825738|NCT00725985|11991061|FG010|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825739|NCT00725985|11991062|FG011|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825740|NCT00725985|11991051|FG000|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825741|NCT00725985|11991052|FG001|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825742|NCT00725985|11991053|FG002|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825743|NCT00725985|11991054|FG003|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825744|NCT00725985|11991055|FG004|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825745|NCT00725985|11991056|FG005|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825746|NCT00725985|11991057|FG006|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825747|NCT00725985|11991058|FG007|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825748|NCT00725985|11991059|FG008|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
10825749|NCT00725985|11991060|FG009|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||34
10825750|NCT00725985|11991061|FG010|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||36
10825751|NCT00725985|11991062|FG011|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||14
11219792|NCT01957384|12411386|FG005|COMPLETED|Test Period 2 (14 Days)||3
11219793|NCT01957384|12411381|FG000|NOT COMPLETED|Test Period 2 (14 Days)||0
11219794|NCT01957384|12411382|FG001|NOT COMPLETED|Test Period 2 (14 Days)||0
11219795|NCT01957384|12411383|FG002|NOT COMPLETED|Test Period 2 (14 Days)||0
11219796|NCT01957384|12411384|FG003|NOT COMPLETED|Test Period 2 (14 Days)||0
11219797|NCT01957384|12411385|FG004|NOT COMPLETED|Test Period 2 (14 Days)||0
11219798|NCT01957384|12411386|FG005|NOT COMPLETED|Test Period 2 (14 Days)||0
11219799|NCT01957384|12411381|FG000|STARTED|Test Period 3 (14 Days)||4
11219800|NCT01957384|12411382|FG001|STARTED|Test Period 3 (14 Days)||4
11219801|NCT01957384|12411383|FG002|STARTED|Test Period 3 (14 Days)||4
10825752|NCT04860258|11991095|FG000|STARTED|Overall Study||1
10825753|NCT04860258|11991096|FG001|STARTED|Overall Study||1
10825754|NCT04860258|11991097|FG002|STARTED|Overall Study||52
10825755|NCT04860258|11991098|FG003|STARTED|Overall Study||33
10825756|NCT04860258|11991099|FG004|STARTED|Overall Study||33
10825757|NCT04860258|11991100|FG005|STARTED|Overall Study||7
10825758|NCT04860258|11991101|FG006|STARTED|Overall Study||2
10825759|NCT04860258|11991095|FG000|COMPLETED|Overall Study||1
10825760|NCT04860258|11991096|FG001|COMPLETED|Overall Study||1
10825761|NCT04860258|11991097|FG002|COMPLETED|Overall Study||48
10825762|NCT04860258|11991098|FG003|COMPLETED|Overall Study||32
10825763|NCT04860258|11991099|FG004|COMPLETED|Overall Study||29
10825764|NCT04860258|11991100|FG005|COMPLETED|Overall Study||6
10825765|NCT04860258|11991101|FG006|COMPLETED|Overall Study||2
10825766|NCT04860258|11991095|FG000|NOT COMPLETED|Overall Study||0
10825767|NCT04860258|11991096|FG001|NOT COMPLETED|Overall Study||0
10825768|NCT04860258|11991097|FG002|NOT COMPLETED|Overall Study||4
10825769|NCT04860258|11991098|FG003|NOT COMPLETED|Overall Study||1
10825770|NCT04860258|11991099|FG004|NOT COMPLETED|Overall Study||4
10825771|NCT04860258|11991100|FG005|NOT COMPLETED|Overall Study||1
10825772|NCT04860258|11991101|FG006|NOT COMPLETED|Overall Study||0
10825788|NCT04318210|11991121|FG000|STARTED|Overall Study||229
10825789|NCT04318210|11991121|FG000|COMPLETED|Overall Study||153
10825790|NCT04318210|11991121|FG000|NOT COMPLETED|Overall Study||76
10825791|NCT04237207|11991127|FG000|STARTED|Overall Study|Due to differences in speed of enrollment between the two cohorts and the delay in enrollment due to the Coronavirus (COVID-19) pandemic, enrollment for the electric only cohort was capped at 10 subjects, which exceeds the minimum sample size of 8 subjects per cohort.|10
10825792|NCT04237207|11991128|FG001|STARTED|Overall Study||12
10825793|NCT04237207|11991127|FG000|COMPLETED|Overall Study||10
10825794|NCT04237207|11991128|FG001|COMPLETED|Overall Study||12
10825795|NCT04237207|11991127|FG000|NOT COMPLETED|Overall Study||0
10825796|NCT04237207|11991128|FG001|NOT COMPLETED|Overall Study||0
10825797|NCT03787303|11991134|FG000|STARTED|Overall Study||7
10825798|NCT03787303|11991134|FG000|COMPLETED|Overall Study||5
10825799|NCT03787303|11991134|FG000|NOT COMPLETED|Overall Study||2
10825800|NCT03702283|11991138|FG000|STARTED|Overall Study|Recruitment and observation began on March 31, 2019|205
10825801|NCT03702283|11991138|FG000|COMPLETED|Overall Study|Recruitment and observation ended on March 31, 2021|205
10825802|NCT03702283|11991138|FG000|NOT COMPLETED|Overall Study||0
10825803|NCT03673098|11991144|FG000|STARTED|Overall Study||23
10825804|NCT03673098|11991145|FG001|STARTED|Overall Study||21
10825805|NCT03673098|11991144|FG000|COMPLETED|Overall Study||13
10825806|NCT03673098|11991145|FG001|COMPLETED|Overall Study||17
10825807|NCT03673098|11991144|FG000|NOT COMPLETED|Overall Study||10
10825808|NCT03673098|11991145|FG001|NOT COMPLETED|Overall Study||4
10825809|NCT03520569|11991158|FG000|STARTED|Overall Study||15
10825810|NCT03520569|11991158|FG000|Octreotide-Euglycemia|Overall Study||13
10825811|NCT03520569|11991158|FG000|Octreotide-Euglycemia-Insulin Clamp|Overall Study||14
10825812|NCT03520569|11991158|FG000|Octreotide-Hyperglycemia|Overall Study||10
10825813|NCT03520569|11991158|FG000|Octreotide-Hyperglycemia-Insulin Clamp|Overall Study||12
10825814|NCT03520569|11991158|FG000|COMPLETED|Overall Study||14
10825815|NCT03520569|11991158|FG000|NOT COMPLETED|Overall Study||1
10825816|NCT03499899|11991171|FG000|STARTED|Overall Study||20
10825817|NCT03499899|11991172|FG001|STARTED|Overall Study||34
10825818|NCT03499899|11991173|FG002|STARTED|Overall Study||34
10825819|NCT03499899|11991171|FG000|COMPLETED|Overall Study||0
11219802|NCT01957384|12411384|FG003|STARTED|Test Period 3 (14 Days)||4
10825820|NCT03499899|11991172|FG001|COMPLETED|Overall Study||0
10825821|NCT03499899|11991173|FG002|COMPLETED|Overall Study||0
10825822|NCT03499899|11991171|FG000|NOT COMPLETED|Overall Study||20
10825823|NCT03499899|11991172|FG001|NOT COMPLETED|Overall Study||34
10825824|NCT03499899|11991173|FG002|NOT COMPLETED|Overall Study||34
11099724|NCT01221623|12283647|FG001|COMPLETED|Overall Study||127
11099725|NCT01221623|12283646|FG000|NOT COMPLETED|Overall Study||38
11099726|NCT01221623|12283647|FG001|NOT COMPLETED|Overall Study||14
11099727|NCT01221727|12283655|FG000|STARTED|Overall Study|Number of subjects randomized into the study|21
11099728|NCT01221727|12283656|FG001|STARTED|Overall Study|Number of subjects randomized into the study|9
10825831|NCT03419741|11991192|FG000|STARTED|Overall Study||5
10825832|NCT03419741|11991193|FG001|STARTED|Overall Study||6
10825833|NCT03419741|11991192|FG000|Treated|Overall Study||4
10825834|NCT03419741|11991193|FG001|Treated|Overall Study||4
10825835|NCT03419741|11991192|FG000|COMPLETED|Overall Study||3
10825836|NCT03419741|11991193|FG001|COMPLETED|Overall Study||4
10825837|NCT03419741|11991192|FG000|NOT COMPLETED|Overall Study||2
10825838|NCT03419741|11991193|FG001|NOT COMPLETED|Overall Study||2
10825839|NCT03401918|11991201|FG000|STARTED|Overall Study||25
10825840|NCT03401918|11991202|FG001|STARTED|Overall Study||16
10825841|NCT03401918|11991201|FG000|COMPLETED|Overall Study||25
10825842|NCT03401918|11991202|FG001|COMPLETED|Overall Study||16
10825843|NCT03401918|11991201|FG000|NOT COMPLETED|Overall Study||0
10825844|NCT03401918|11991202|FG001|NOT COMPLETED|Overall Study||0
11099729|NCT01221727|12283655|FG000|Treated|Overall Study|Number of subjects received investigational product|19
11099730|NCT01221727|12283656|FG001|Treated|Overall Study|Number of subjects received investigational product|8
11099731|NCT01221727|12283655|FG000|COMPLETED|Overall Study||18
11099732|NCT01221727|12283656|FG001|COMPLETED|Overall Study||8
11099733|NCT01221727|12283655|FG000|NOT COMPLETED|Overall Study||3
11099734|NCT01221727|12283656|FG001|NOT COMPLETED|Overall Study||1
11099735|NCT01221753|12283668|FG000|STARTED|Overall Study||7
11099736|NCT01221753|12283668|FG000|COMPLETED|Overall Study||6
11099737|NCT01221753|12283668|FG000|NOT COMPLETED|Overall Study||1
11099738|NCT01221857|12283672|FG000|STARTED|Overall Study||12
11099739|NCT01221857|12283672|FG000|COMPLETED|Overall Study||12
11099740|NCT01221857|12283672|FG000|NOT COMPLETED|Overall Study||0
11099741|NCT01221948|12283680|FG000|STARTED|Overall Study||53
11099742|NCT01221948|12283680|FG000|COMPLETED|Overall Study||39
11099743|NCT01221948|12283680|FG000|NOT COMPLETED|Overall Study||14
11099744|NCT01222078|12283684|FG000|STARTED|Overall Study||1
11099745|NCT01222078|12283684|FG000|COMPLETED|Overall Study||0
11099746|NCT01222078|12283684|FG000|NOT COMPLETED|Overall Study||1
11099747|NCT01222091|12283689|FG000|STARTED|Overall Study||5
11099748|NCT01222091|12283690|FG001|STARTED|Overall Study||5
11099749|NCT01222091|12283689|FG000|COMPLETED|Overall Study||5
11099750|NCT01222091|12283690|FG001|COMPLETED|Overall Study||5
11099751|NCT01222091|12283689|FG000|NOT COMPLETED|Overall Study||0
11099752|NCT01222091|12283690|FG001|NOT COMPLETED|Overall Study||0
11219803|NCT01957384|12411385|FG004|STARTED|Test Period 3 (14 Days)||3
11219804|NCT01957384|12411386|FG005|STARTED|Test Period 3 (14 Days)||3
11099753|NCT01222104|12283696|FG000|STARTED|Overall Study||634
11099754|NCT01222104|12283696|FG000|Angio-Seal Deployment Attempted|Overall Study||534
11099755|NCT01222104|12283696|FG000|Successful Deployment|Overall Study||529
11099756|NCT01222104|12283696|FG000|Successful Deployment and Hemostasis|Overall Study||524
11099757|NCT01222104|12283696|FG000|Completed 30-day Visit-Angio-Seal|Overall Study||497
11099758|NCT01222104|12283696|FG000|Completed 30-day Visit-No Angio-Seal|Overall Study||90
11099759|NCT01222104|12283696|FG000|COMPLETED|Overall Study||587
11099760|NCT01222104|12283696|FG000|NOT COMPLETED|Overall Study||47
11099761|NCT01222117|12283717|FG000|STARTED|Overall Study||20
11099762|NCT01222117|12283718|FG001|STARTED|Overall Study||20
11099763|NCT01222117|12283719|FG002|STARTED|Overall Study||22
11099764|NCT01222117|12283720|FG003|STARTED|Overall Study||20
11099765|NCT01222117|12283721|FG004|STARTED|Overall Study||9
11219805|NCT01957384|12411381|FG000|COMPLETED|Test Period 3 (14 Days)||4
10825845|NCT02704156|11991210|FG000|STARTED|Overall Study||85
10825846|NCT02704156|11991211|FG001|STARTED|Overall Study||85
10825847|NCT02704156|11991210|FG000|COMPLETED|Overall Study||85
10825848|NCT02704156|11991211|FG001|COMPLETED|Overall Study||85
10825849|NCT02704156|11991210|FG000|NOT COMPLETED|Overall Study||0
10825850|NCT02704156|11991211|FG001|NOT COMPLETED|Overall Study||0
10825851|NCT02688530|11991221|FG000|STARTED|Overall Study||35
10825852|NCT02688530|11991222|FG001|STARTED|Overall Study||35
10825853|NCT02688530|11991223|FG002|STARTED|Overall Study||35
10825854|NCT02688530|11991224|FG003|STARTED|Overall Study||35
10825855|NCT02688530|11991221|FG000|COMPLETED|Overall Study||35
10825856|NCT02688530|11991222|FG001|COMPLETED|Overall Study||34
10825857|NCT02688530|11991223|FG002|COMPLETED|Overall Study||33
10825858|NCT02688530|11991224|FG003|COMPLETED|Overall Study||35
10825859|NCT02688530|11991221|FG000|NOT COMPLETED|Overall Study||0
10825860|NCT02688530|11991222|FG001|NOT COMPLETED|Overall Study||1
10825861|NCT02688530|11991223|FG002|NOT COMPLETED|Overall Study||2
10825862|NCT02688530|11991224|FG003|NOT COMPLETED|Overall Study||0
10825869|NCT02383966|11991250|FG000|STARTED|Overall Study||164
10825870|NCT02383966|11991251|FG001|STARTED|Overall Study||79
10825871|NCT02383966|11991250|FG000|COMPLETED|Overall Study||138
10825872|NCT02383966|11991251|FG001|COMPLETED|Overall Study||72
10825873|NCT02383966|11991250|FG000|NOT COMPLETED|Overall Study||26
10825874|NCT02383966|11991251|FG001|NOT COMPLETED|Overall Study||7
10825875|NCT02073565|11991259|FG000|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
10825876|NCT02073565|11991260|FG001|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
10825877|NCT02073565|11991259|FG000|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
10825878|NCT02073565|11991260|FG001|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
10825879|NCT02073565|11991259|FG000|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
10825880|NCT02073565|11991260|FG001|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
10825881|NCT02073565|11991259|FG000|STARTED|Cohort A||16
10825882|NCT02073565|11991260|FG001|STARTED|Cohort A||14
10825883|NCT02073565|11991259|FG000|COMPLETED|Cohort A||15
10825884|NCT02073565|11991260|FG001|COMPLETED|Cohort A||14
10825885|NCT02073565|11991259|FG000|NOT COMPLETED|Cohort A||1
10825886|NCT02073565|11991260|FG001|NOT COMPLETED|Cohort A||0
10825887|NCT02073565|11991259|FG000|STARTED|Cohort B||54
10825888|NCT02073565|11991260|FG001|STARTED|Cohort B||56
10825889|NCT02073565|11991259|FG000|COMPLETED|Cohort B||53
10825890|NCT02073565|11991260|FG001|COMPLETED|Cohort B||54
10825891|NCT02073565|11991259|FG000|NOT COMPLETED|Cohort B||1
10825892|NCT02073565|11991260|FG001|NOT COMPLETED|Cohort B||2
10825893|NCT02073565|11991259|FG000|STARTED|Cohort C||217
10825894|NCT02073565|11991260|FG001|STARTED|Cohort C||215
10825895|NCT02073565|11991259|FG000|COMPLETED|Cohort C||217
10825896|NCT02073565|11991260|FG001|COMPLETED|Cohort C||211
11099766|NCT01222117|12283722|FG005|STARTED|Overall Study||10
11099767|NCT01222117|12283723|FG006|STARTED|Overall Study||13
11099768|NCT01222117|12283724|FG007|STARTED|Overall Study||12
11099769|NCT01222117|12283725|FG008|STARTED|Overall Study||23
11099770|NCT01222117|12283726|FG009|STARTED|Overall Study||19
10825897|NCT02073565|11991259|FG000|NOT COMPLETED|Cohort C||0
10825898|NCT02073565|11991260|FG001|NOT COMPLETED|Cohort C||4
10825899|NCT02060487|11991269|FG000|STARTED|Overall Study||129
10825900|NCT02060487|11991270|FG001|STARTED|Overall Study||128
10825901|NCT02060487|11991271|FG002|STARTED|Overall Study||128
10825902|NCT02060487|11991269|FG000|COMPLETED|Overall Study||0
10825903|NCT02060487|11991270|FG001|COMPLETED|Overall Study||0
10825904|NCT02060487|11991271|FG002|COMPLETED|Overall Study||0
10825905|NCT02060487|11991269|FG000|NOT COMPLETED|Overall Study||129
10825906|NCT02060487|11991270|FG001|NOT COMPLETED|Overall Study||128
10825907|NCT02060487|11991271|FG002|NOT COMPLETED|Overall Study||128
10825908|NCT00732212|11991283|FG000|STARTED|Overall Study||112
10825909|NCT00732212|11991284|FG001|STARTED|Overall Study||123
10825910|NCT00732212|11991283|FG000|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
10825911|NCT00732212|11991284|FG001|Temporarily Suspended|Overall Study||50
10825912|NCT00732212|11991283|FG000|COMPLETED|Overall Study||112
10825913|NCT00732212|11991284|FG001|COMPLETED|Overall Study||123
10825914|NCT00732212|11991283|FG000|NOT COMPLETED|Overall Study||0
10825915|NCT00732212|11991284|FG001|NOT COMPLETED|Overall Study||0
10825916|NCT00331773|11991316|FG000|STARTED|Overall Study||558
10825917|NCT00331773|11991317|FG001|STARTED|Overall Study||557
10825918|NCT00331773|11991316|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
10825919|NCT00331773|11991317|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
10825920|NCT00331773|11991316|FG000|NOT COMPLETED|Overall Study||16
10825921|NCT00331773|11991317|FG001|NOT COMPLETED|Overall Study||7
10825922|NCT00321698|11991329|FG000|STARTED|Phase I, Rad Only & Dose 1-3||3
10825923|NCT00321698|11991330|FG001|STARTED|Phase I, Rad Only & Dose 1-3||3
10825924|NCT00321698|11991331|FG002|STARTED|Phase I, Rad Only & Dose 1-3||3
10825925|NCT00321698|11991332|FG003|STARTED|Phase I, Rad Only & Dose 1-3||3
10825926|NCT00321698|11991333|FG004|STARTED|Phase I, Rad Only & Dose 1-3||0
10825927|NCT00321698|11991329|FG000|COMPLETED|Phase I, Rad Only & Dose 1-3||3
10825928|NCT00321698|11991330|FG001|COMPLETED|Phase I, Rad Only & Dose 1-3||3
10825929|NCT00321698|11991331|FG002|COMPLETED|Phase I, Rad Only & Dose 1-3||3
10825930|NCT00321698|11991332|FG003|COMPLETED|Phase I, Rad Only & Dose 1-3||3
10825931|NCT00321698|11991333|FG004|COMPLETED|Phase I, Rad Only & Dose 1-3||0
10825932|NCT00321698|11991329|FG000|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10825933|NCT00321698|11991330|FG001|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10825934|NCT00321698|11991331|FG002|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10825935|NCT00321698|11991332|FG003|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10825936|NCT00321698|11991333|FG004|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
10825937|NCT00321698|11991329|FG000|STARTED|Phase II, MTD Dose||0
10825938|NCT00321698|11991330|FG001|STARTED|Phase II, MTD Dose||0
10825939|NCT00321698|11991331|FG002|STARTED|Phase II, MTD Dose||0
10825940|NCT00321698|11991332|FG003|STARTED|Phase II, MTD Dose||0
10825941|NCT00321698|11991333|FG004|STARTED|Phase II, MTD Dose|+1 screen failure|13
10825942|NCT00321698|11991329|FG000|COMPLETED|Phase II, MTD Dose||0
10825943|NCT00321698|11991330|FG001|COMPLETED|Phase II, MTD Dose||0
10825944|NCT00321698|11991331|FG002|COMPLETED|Phase II, MTD Dose||0
10825945|NCT00321698|11991332|FG003|COMPLETED|Phase II, MTD Dose||0
10825946|NCT00321698|11991333|FG004|COMPLETED|Phase II, MTD Dose||13
10825947|NCT00321698|11991329|FG000|NOT COMPLETED|Phase II, MTD Dose||0
10825948|NCT00321698|11991330|FG001|NOT COMPLETED|Phase II, MTD Dose||0
10825949|NCT00321698|11991331|FG002|NOT COMPLETED|Phase II, MTD Dose||0
10825950|NCT00321698|11991332|FG003|NOT COMPLETED|Phase II, MTD Dose||0
10825951|NCT00321698|11991333|FG004|NOT COMPLETED|Phase II, MTD Dose||0
10825952|NCT05343156|11991347|FG000|STARTED|Overall Study||99
10825953|NCT05343156|11991348|FG001|STARTED|Overall Study||45
10825954|NCT05343156|11991347|FG000|COMPLETED|Overall Study||91
10825955|NCT05343156|11991348|FG001|COMPLETED|Overall Study||42
10825956|NCT05343156|11991347|FG000|NOT COMPLETED|Overall Study||8
10825957|NCT05343156|11991348|FG001|NOT COMPLETED|Overall Study||3
10825958|NCT04913636|11991356|FG000|STARTED|Overall Study||18
10825959|NCT04913636|11991357|FG001|STARTED|Overall Study||20
10825960|NCT04913636|11991356|FG000|COMPLETED|Overall Study||18
10825961|NCT04913636|11991357|FG001|COMPLETED|Overall Study||20
10825962|NCT04913636|11991356|FG000|NOT COMPLETED|Overall Study||0
10825963|NCT04913636|11991357|FG001|NOT COMPLETED|Overall Study||0
10825964|NCT04882995|11991365|FG000|STARTED|Overall Study||41
10825965|NCT04882995|11991366|FG001|STARTED|Overall Study||43
10825966|NCT04882995|11991365|FG000|COMPLETED|Overall Study||35
10825967|NCT04882995|11991366|FG001|COMPLETED|Overall Study||36
10825968|NCT04882995|11991365|FG000|NOT COMPLETED|Overall Study||6
10825969|NCT04882995|11991366|FG001|NOT COMPLETED|Overall Study||7
10825970|NCT04707573|11991374|FG000|STARTED|Overall Study||10
10825971|NCT04707573|11991375|FG001|STARTED|Overall Study||12
10825972|NCT04707573|11991374|FG000|COMPLETED|Overall Study||10
10825973|NCT04707573|11991375|FG001|COMPLETED|Overall Study||12
10825974|NCT04707573|11991374|FG000|NOT COMPLETED|Overall Study||0
10825975|NCT04707573|11991375|FG001|NOT COMPLETED|Overall Study||0
10825976|NCT04640168|11991383|FG000|STARTED|Overall Study||516
10825977|NCT04640168|11991384|FG001|STARTED|Overall Study||494
10825978|NCT04640168|11991383|FG000|Treated|Overall Study||503
10825979|NCT04640168|11991384|FG001|Treated|Overall Study||482
10825980|NCT04640168|11991383|FG000|ITT and Modified ITT Population|Overall Study||516
10825981|NCT04640168|11991384|FG001|ITT and Modified ITT Population|Overall Study||494
10825982|NCT04640168|11991383|FG000|As Treated Population|Overall Study||503
10825983|NCT04640168|11991384|FG001|As Treated Population|Overall Study||482
10825984|NCT04640168|11991383|FG000|COMPLETED|Overall Study||495
10825985|NCT04640168|11991384|FG001|COMPLETED|Overall Study||475
10825986|NCT04640168|11991383|FG000|NOT COMPLETED|Overall Study||21
10825987|NCT04640168|11991384|FG001|NOT COMPLETED|Overall Study||19
10825988|NCT04465630|11991390|FG000|STARTED|Overall Study||78
10825989|NCT04465630|11991390|FG000|COMPLETED|Overall Study||0
10825990|NCT04465630|11991390|FG000|NOT COMPLETED|Overall Study||78
10825991|NCT04459598|11991397|FG000|STARTED|Overall Study||16
10825992|NCT04459598|11991398|FG001|STARTED|Overall Study||16
10825993|NCT04459598|11991397|FG000|COMPLETED|Overall Study||15
10825994|NCT04459598|11991398|FG001|COMPLETED|Overall Study||15
10825995|NCT04459598|11991397|FG000|NOT COMPLETED|Overall Study||1
10825996|NCT04459598|11991398|FG001|NOT COMPLETED|Overall Study||1
10826015|NCT04387136|11991422|FG000|STARTED|Overall Study||26
10826016|NCT04387136|11991423|FG001|STARTED|Overall Study||27
10826017|NCT04387136|11991422|FG000|COMPLETED|Overall Study||25
10826018|NCT04387136|11991423|FG001|COMPLETED|Overall Study||25
10826019|NCT04387136|11991422|FG000|NOT COMPLETED|Overall Study||1
10826020|NCT04387136|11991423|FG001|NOT COMPLETED|Overall Study||2
10826021|NCT04351269|11991432|FG000|STARTED|Overall Study||237
10826022|NCT04351269|11991433|FG001|STARTED|Overall Study||260
10826023|NCT04351269|11991434|FG002|STARTED|Overall Study||100
10826024|NCT04351269|11991432|FG000|COMPLETED|Overall Study||165
10826025|NCT04351269|11991433|FG001|COMPLETED|Overall Study||219
10826026|NCT04351269|11991434|FG002|COMPLETED|Overall Study||71
10826027|NCT04351269|11991432|FG000|NOT COMPLETED|Overall Study||72
10826028|NCT04351269|11991433|FG001|NOT COMPLETED|Overall Study||41
10826029|NCT04351269|11991434|FG002|NOT COMPLETED|Overall Study||29
10826030|NCT04292301|11991445|FG000|STARTED|Overall Study||92
10826031|NCT04292301|11991445|FG000|COMPLETED|Overall Study||89
10826032|NCT04292301|11991445|FG000|NOT COMPLETED|Overall Study||3
10826033|NCT04285229|11991451|FG000|STARTED|Overall Study||73
10826034|NCT04285229|11991452|FG001|STARTED|Overall Study||74
10826035|NCT04285229|11991451|FG000|Received at Least One Dose of Study Drug|Overall Study||73
10826036|NCT04285229|11991452|FG001|Received at Least One Dose of Study Drug|Overall Study||74
10826037|NCT04285229|11991451|FG000|COMPLETED|Overall Study||70
10826038|NCT04285229|11991452|FG001|COMPLETED|Overall Study||72
10826039|NCT04285229|11991451|FG000|NOT COMPLETED|Overall Study||3
10826040|NCT04285229|11991452|FG001|NOT COMPLETED|Overall Study||2
10826041|NCT04148521|11991463|FG000|STARTED|Overall Study||534
10826042|NCT04148521|11991464|FG001|STARTED|Overall Study||555
10826043|NCT04148521|11991463|FG000|COMPLETED|Overall Study||534
10826044|NCT04148521|11991464|FG001|COMPLETED|Overall Study||555
10826045|NCT04148521|11991463|FG000|NOT COMPLETED|Overall Study||0
10826046|NCT04148521|11991464|FG001|NOT COMPLETED|Overall Study||0
10826047|NCT03897348|11991474|FG000|STARTED|ADP Session 1||1
10826048|NCT03897348|11991475|FG001|STARTED|ADP Session 1||1
10826049|NCT03897348|11991476|FG002|STARTED|ADP Session 1||1
10826050|NCT03897348|11991477|FG003|STARTED|ADP Session 1||1
10826051|NCT03897348|11991474|FG000|COMPLETED|ADP Session 1||1
10826052|NCT03897348|11991475|FG001|COMPLETED|ADP Session 1||1
10826053|NCT03897348|11991476|FG002|COMPLETED|ADP Session 1||1
10826054|NCT03897348|11991477|FG003|COMPLETED|ADP Session 1||1
10826055|NCT03897348|11991474|FG000|NOT COMPLETED|ADP Session 1||0
10826056|NCT03897348|11991475|FG001|NOT COMPLETED|ADP Session 1||0
10826057|NCT03897348|11991476|FG002|NOT COMPLETED|ADP Session 1||0
10826058|NCT03897348|11991477|FG003|NOT COMPLETED|ADP Session 1||0
10826059|NCT03897348|11991474|FG000|STARTED|ADP Session 2||1
10826060|NCT03897348|11991475|FG001|STARTED|ADP Session 2||1
10826061|NCT03897348|11991476|FG002|STARTED|ADP Session 2||1
10826062|NCT03897348|11991477|FG003|STARTED|ADP Session 2||1
10826063|NCT03897348|11991474|FG000|COMPLETED|ADP Session 2||1
10826064|NCT03897348|11991475|FG001|COMPLETED|ADP Session 2||1
10826065|NCT03897348|11991476|FG002|COMPLETED|ADP Session 2||1
10826066|NCT03897348|11991477|FG003|COMPLETED|ADP Session 2||1
10826067|NCT03897348|11991474|FG000|NOT COMPLETED|ADP Session 2||0
10826068|NCT03897348|11991475|FG001|NOT COMPLETED|ADP Session 2||0
10826069|NCT03897348|11991476|FG002|NOT COMPLETED|ADP Session 2||0
10826070|NCT03897348|11991477|FG003|NOT COMPLETED|ADP Session 2||0
10826071|NCT03897348|11991474|FG000|STARTED|ADP Session 3||1
10826072|NCT03897348|11991475|FG001|STARTED|ADP Session 3||1
10826073|NCT03897348|11991476|FG002|STARTED|ADP Session 3||0
10826074|NCT03897348|11991477|FG003|STARTED|ADP Session 3||1
10826075|NCT03897348|11991474|FG000|COMPLETED|ADP Session 3||1
10826076|NCT03897348|11991475|FG001|COMPLETED|ADP Session 3||1
10826077|NCT03897348|11991476|FG002|COMPLETED|ADP Session 3||0
10826078|NCT03897348|11991477|FG003|COMPLETED|ADP Session 3||1
10826079|NCT03897348|11991474|FG000|NOT COMPLETED|ADP Session 3||0
10826080|NCT03897348|11991475|FG001|NOT COMPLETED|ADP Session 3||0
10826081|NCT03897348|11991476|FG002|NOT COMPLETED|ADP Session 3||0
10826082|NCT03897348|11991477|FG003|NOT COMPLETED|ADP Session 3||0
11099771|NCT01222117|12283727|FG010|STARTED|Overall Study||6
11099772|NCT01222117|12283717|FG000|COMPLETED|Overall Study||17
11099773|NCT01222117|12283718|FG001|COMPLETED|Overall Study||19
11099774|NCT01222117|12283719|FG002|COMPLETED|Overall Study||22
11099775|NCT01222117|12283720|FG003|COMPLETED|Overall Study||19
11099776|NCT01222117|12283721|FG004|COMPLETED|Overall Study||8
11099777|NCT01222117|12283722|FG005|COMPLETED|Overall Study||9
11099778|NCT01222117|12283723|FG006|COMPLETED|Overall Study||13
11099779|NCT01222117|12283724|FG007|COMPLETED|Overall Study||12
10826092|NCT03668808|11991502|FG000|STARTED|First Intervention||13
10826093|NCT03668808|11991503|FG001|STARTED|First Intervention||12
10826094|NCT03668808|11991502|FG000|COMPLETED|First Intervention||11
10826095|NCT03668808|11991503|FG001|COMPLETED|First Intervention||10
10826096|NCT03668808|11991502|FG000|NOT COMPLETED|First Intervention||2
10826097|NCT03668808|11991503|FG001|NOT COMPLETED|First Intervention||2
10826098|NCT03668808|11991502|FG000|STARTED|Washout Period||11
10826099|NCT03668808|11991503|FG001|STARTED|Washout Period||10
10826100|NCT03668808|11991502|FG000|COMPLETED|Washout Period||11
10826101|NCT03668808|11991503|FG001|COMPLETED|Washout Period||10
10826102|NCT03668808|11991502|FG000|NOT COMPLETED|Washout Period||0
10826103|NCT03668808|11991503|FG001|NOT COMPLETED|Washout Period||0
10826104|NCT03668808|11991502|FG000|STARTED|Second Intervention||11
10826105|NCT03668808|11991503|FG001|STARTED|Second Intervention||10
10826106|NCT03668808|11991502|FG000|COMPLETED|Second Intervention||11
10826107|NCT03668808|11991503|FG001|COMPLETED|Second Intervention||10
10826108|NCT03668808|11991502|FG000|NOT COMPLETED|Second Intervention||0
10826109|NCT03668808|11991503|FG001|NOT COMPLETED|Second Intervention||0
10826110|NCT03658642|11991513|FG000|STARTED|Patients||2787
10826111|NCT03658642|11991514|FG001|STARTED|Patients||2260
10826112|NCT03658642|11991513|FG000|COMPLETED|Patients||2787
10826113|NCT03658642|11991514|FG001|COMPLETED|Patients||2260
10826114|NCT03658642|11991513|FG000|NOT COMPLETED|Patients||0
10826115|NCT03658642|11991514|FG001|NOT COMPLETED|Patients||0
10826116|NCT03658642|11991513|FG000|STARTED|Physicians|A total of 599 physicians were also included in the study.|340
10826117|NCT03658642|11991514|FG001|STARTED|Physicians|A total of 599 physicians were also included in the study.|259
10826118|NCT03658642|11991513|FG000|COMPLETED|Physicians||340
10826119|NCT03658642|11991514|FG001|COMPLETED|Physicians||259
10826120|NCT03658642|11991513|FG000|NOT COMPLETED|Physicians||0
10826121|NCT03658642|11991514|FG001|NOT COMPLETED|Physicians||0
10826122|NCT03656874|11991522|FG000|STARTED|Overall Study||13
10826123|NCT03656874|11991523|FG001|STARTED|Overall Study||43
10826124|NCT03656874|11991522|FG000|COMPLETED|Overall Study||10
10826125|NCT03656874|11991523|FG001|COMPLETED|Overall Study||26
10826126|NCT03656874|11991522|FG000|NOT COMPLETED|Overall Study||3
10826127|NCT03656874|11991523|FG001|NOT COMPLETED|Overall Study||17
10826128|NCT03584009|11991531|FG000|STARTED|Overall Study||51
10826129|NCT03584009|11991532|FG001|STARTED|Overall Study||52
10826130|NCT03584009|11991531|FG000|COMPLETED|Overall Study||0
10826131|NCT03584009|11991532|FG001|COMPLETED|Overall Study||0
10826132|NCT03584009|11991531|FG000|NOT COMPLETED|Overall Study||51
10826133|NCT03584009|11991532|FG001|NOT COMPLETED|Overall Study||52
10826134|NCT03583359|11991543|FG000|STARTED|Overall Study||123
10826135|NCT03583359|11991544|FG001|STARTED|Overall Study||57
10826136|NCT03583359|11991543|FG000|Treated Participants|Overall Study||122
10826137|NCT03583359|11991544|FG001|Treated Participants|Overall Study||53
10826138|NCT03583359|11991543|FG000|COMPLETED|Overall Study||94
10826139|NCT03583359|11991544|FG001|COMPLETED|Overall Study||45
10826140|NCT03583359|11991543|FG000|NOT COMPLETED|Overall Study||29
10826141|NCT03583359|11991544|FG001|NOT COMPLETED|Overall Study||12
11099780|NCT01222117|12283725|FG008|COMPLETED|Overall Study||20
11099781|NCT01222117|12283726|FG009|COMPLETED|Overall Study||17
11099782|NCT01222117|12283727|FG010|COMPLETED|Overall Study||6
11099783|NCT01222117|12283717|FG000|NOT COMPLETED|Overall Study||3
11099784|NCT01222117|12283718|FG001|NOT COMPLETED|Overall Study||1
11099785|NCT01222117|12283719|FG002|NOT COMPLETED|Overall Study||0
11099786|NCT01222117|12283720|FG003|NOT COMPLETED|Overall Study||1
11099787|NCT01222117|12283721|FG004|NOT COMPLETED|Overall Study||1
11099788|NCT01222117|12283722|FG005|NOT COMPLETED|Overall Study||1
11099789|NCT01222117|12283723|FG006|NOT COMPLETED|Overall Study||0
11099790|NCT01222117|12283724|FG007|NOT COMPLETED|Overall Study||0
11099791|NCT01222117|12283725|FG008|NOT COMPLETED|Overall Study||3
11099792|NCT01222117|12283726|FG009|NOT COMPLETED|Overall Study||2
11099793|NCT01222117|12283727|FG010|NOT COMPLETED|Overall Study||0
11099794|NCT01222195|12283751|FG000|STARTED|Overall Study||1
11099795|NCT01222195|12283751|FG000|COMPLETED|Overall Study||1
11099796|NCT01222195|12283751|FG000|NOT COMPLETED|Overall Study||0
11099797|NCT01222234|12283758|FG000|STARTED|Overall Study||15
10826160|NCT03557307|11991578|FG000|STARTED|To End of OCS Reduction Phase||598
10826161|NCT03557307|11991578|FG000|COMPLETED|To End of OCS Reduction Phase||563
10826162|NCT03557307|11991578|FG000|NOT COMPLETED|To End of OCS Reduction Phase||35
10826163|NCT03557307|11991578|FG000|STARTED|Maintenance Phase||563
10826164|NCT03557307|11991578|FG000|COMPLETED|Maintenance Phase||536
10826165|NCT03557307|11991578|FG000|NOT COMPLETED|Maintenance Phase||27
10826166|NCT03492463|11991586|FG000|STARTED|Overall Study||37
10826167|NCT03492463|11991587|FG001|STARTED|Overall Study||33
10826168|NCT03492463|11991588|FG002|STARTED|Overall Study||11
10826169|NCT03492463|11991589|FG003|STARTED|Overall Study||13
10826170|NCT03492463|11991586|FG000|COMPLETED|Overall Study||26
10826171|NCT03492463|11991587|FG001|COMPLETED|Overall Study||19
10826172|NCT03492463|11991588|FG002|COMPLETED|Overall Study||7
10826173|NCT03492463|11991589|FG003|COMPLETED|Overall Study||10
10826174|NCT03492463|11991586|FG000|NOT COMPLETED|Overall Study||11
10826175|NCT03492463|11991587|FG001|NOT COMPLETED|Overall Study||14
10826176|NCT03492463|11991588|FG002|NOT COMPLETED|Overall Study||4
10826177|NCT03492463|11991589|FG003|NOT COMPLETED|Overall Study||3
10826178|NCT03417687|11991601|FG000|STARTED|Overall Study|4 subjects were randomized to the 129Xe before 133Xe group but discontinued prior to receiving the first treatment.|18
10826179|NCT03417687|11991602|FG001|STARTED|Overall Study||20
11219806|NCT01957384|12411382|FG001|COMPLETED|Test Period 3 (14 Days)||4
11219807|NCT01957384|12411383|FG002|COMPLETED|Test Period 3 (14 Days)||4
11219808|NCT01957384|12411384|FG003|COMPLETED|Test Period 3 (14 Days)||4
11219809|NCT01957384|12411385|FG004|COMPLETED|Test Period 3 (14 Days)||3
11219810|NCT01957384|12411386|FG005|COMPLETED|Test Period 3 (14 Days)||3
11219811|NCT01957384|12411381|FG000|NOT COMPLETED|Test Period 3 (14 Days)||0
10826180|NCT03417687|11991601|FG000|Received 129Xe|Overall Study||14
10826181|NCT03417687|11991602|FG001|Received 129Xe|Overall Study||20
10826182|NCT03417687|11991601|FG000|Received 133Xe|Overall Study||13
10826183|NCT03417687|11991602|FG001|Received 133Xe|Overall Study||20
10826184|NCT03417687|11991601|FG000|COMPLETED|Overall Study||14
10826185|NCT03417687|11991602|FG001|COMPLETED|Overall Study||20
10826186|NCT03417687|11991601|FG000|NOT COMPLETED|Overall Study||4
10826187|NCT03417687|11991602|FG001|NOT COMPLETED|Overall Study||0
10826194|NCT03379675|11991625|FG000|STARTED|Overall Study||24
10826195|NCT03379675|11991626|FG001|STARTED|Overall Study||24
10826196|NCT03379675|11991627|FG002|STARTED|Overall Study||24
10826197|NCT03379675|11991625|FG000|COMPLETED|Overall Study||20
10826198|NCT03379675|11991626|FG001|COMPLETED|Overall Study||22
10826199|NCT03379675|11991627|FG002|COMPLETED|Overall Study||22
11219812|NCT01957384|12411382|FG001|NOT COMPLETED|Test Period 3 (14 Days)||0
10826200|NCT03379675|11991625|FG000|NOT COMPLETED|Overall Study||4
10826201|NCT03379675|11991626|FG001|NOT COMPLETED|Overall Study||2
10826202|NCT03379675|11991627|FG002|NOT COMPLETED|Overall Study||2
11219813|NCT01957384|12411383|FG002|NOT COMPLETED|Test Period 3 (14 Days)||0
10826221|NCT03336619|11991648|FG000|STARTED|Overall Study||515
10826222|NCT03336619|11991649|FG001|STARTED|Overall Study||515
10826223|NCT03336619|11991648|FG000|Positive for Influenza by RT-PCR at Baseline (Intent-to-treat Infected [ITTI] Population)|Overall Study||314
10826224|NCT03336619|11991649|FG001|Positive for Influenza by RT-PCR at Baseline (Intent-to-treat Infected [ITTI] Population)|Overall Study||306
10826225|NCT03336619|11991648|FG000|COMPLETED|Overall Study||301
10826226|NCT03336619|11991649|FG001|COMPLETED|Overall Study||290
10826227|NCT03336619|11991648|FG000|NOT COMPLETED|Overall Study||214
10826228|NCT03336619|11991649|FG001|NOT COMPLETED|Overall Study||225
10826229|NCT03274687|11991660|FG000|STARTED|Overall Study||152
10826230|NCT03274687|11991661|FG001|STARTED|Overall Study||144
10826231|NCT03274687|11991660|FG000|Eligible|Overall Study||151
10826232|NCT03274687|11991661|FG001|Eligible|Overall Study||143
10826233|NCT03274687|11991660|FG000|Eligible With Adverse Event Data|Overall Study||148
10826234|NCT03274687|11991661|FG001|Eligible With Adverse Event Data|Overall Study||141
10826235|NCT03274687|11991660|FG000|COMPLETED|Overall Study||151
10826236|NCT03274687|11991661|FG001|COMPLETED|Overall Study||143
10826237|NCT03274687|11991660|FG000|NOT COMPLETED|Overall Study||1
10826238|NCT03274687|11991661|FG001|NOT COMPLETED|Overall Study||1
10826239|NCT03245450|11991674|FG000|STARTED|Overall Study||3
10826240|NCT03245450|11991675|FG001|STARTED|Overall Study||4
10826241|NCT03245450|11991676|FG002|STARTED|Overall Study||3
10826242|NCT03245450|11991677|FG003|STARTED|Overall Study||3
10826243|NCT03245450|11991678|FG004|STARTED|Overall Study||9
10826244|NCT03245450|11991679|FG005|STARTED|Overall Study||9
10826245|NCT03245450|11991680|FG006|STARTED|Overall Study||9
10826246|NCT03245450|11991674|FG000|COMPLETED|Overall Study||0
10826247|NCT03245450|11991675|FG001|COMPLETED|Overall Study||0
10826248|NCT03245450|11991676|FG002|COMPLETED|Overall Study||0
10826249|NCT03245450|11991677|FG003|COMPLETED|Overall Study||0
10826250|NCT03245450|11991678|FG004|COMPLETED|Overall Study||0
10826251|NCT03245450|11991679|FG005|COMPLETED|Overall Study||0
10826252|NCT03245450|11991680|FG006|COMPLETED|Overall Study||0
10826253|NCT03245450|11991674|FG000|NOT COMPLETED|Overall Study||3
10826254|NCT03245450|11991675|FG001|NOT COMPLETED|Overall Study||4
10826255|NCT03245450|11991676|FG002|NOT COMPLETED|Overall Study||3
10826256|NCT03245450|11991677|FG003|NOT COMPLETED|Overall Study||3
10826257|NCT03245450|11991678|FG004|NOT COMPLETED|Overall Study||9
10826258|NCT03245450|11991679|FG005|NOT COMPLETED|Overall Study||9
10826259|NCT03245450|11991680|FG006|NOT COMPLETED|Overall Study||9
10826260|NCT03086369|11991707|FG000|STARTED|Overall Study||3
10826261|NCT03086369|11991708|FG001|STARTED|Overall Study||7
10826262|NCT03086369|11991709|FG002|STARTED|Overall Study||12
10826263|NCT03086369|11991710|FG003|STARTED|Overall Study||82
10826264|NCT03086369|11991711|FG004|STARTED|Overall Study||80
10826265|NCT03086369|11991707|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10826266|NCT03086369|11991708|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
10826267|NCT03086369|11991709|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
10826268|NCT03086369|11991710|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81
10826269|NCT03086369|11991711|FG004|Received at Least 1 Dose of Study Drug|Overall Study||78
10826270|NCT03086369|11991707|FG000|COMPLETED|Overall Study||2
10826271|NCT03086369|11991708|FG001|COMPLETED|Overall Study||7
10826272|NCT03086369|11991709|FG002|COMPLETED|Overall Study||12
10826273|NCT03086369|11991710|FG003|COMPLETED|Overall Study||73
10826274|NCT03086369|11991711|FG004|COMPLETED|Overall Study||73
10826275|NCT03086369|11991707|FG000|NOT COMPLETED|Overall Study||1
10826276|NCT03086369|11991708|FG001|NOT COMPLETED|Overall Study||0
10826277|NCT03086369|11991709|FG002|NOT COMPLETED|Overall Study||0
10826278|NCT03086369|11991710|FG003|NOT COMPLETED|Overall Study||9
10826279|NCT03086369|11991711|FG004|NOT COMPLETED|Overall Study||7
10826280|NCT03083808|11991725|FG000|STARTED|Overall Study||35
10826281|NCT03083808|11991725|FG000|COMPLETED|Overall Study||35
10826282|NCT03083808|11991725|FG000|NOT COMPLETED|Overall Study||0
11099798|NCT01222234|12283759|FG001|STARTED|Overall Study||17
11099799|NCT01222234|12283760|FG002|STARTED|Overall Study||24
11099800|NCT01222234|12283758|FG000|COMPLETED|Overall Study||15
10826286|NCT02927847|11991735|FG000|STARTED|Overall Study||16
10826287|NCT02927847|11991736|FG001|STARTED|Overall Study||19
10826288|NCT02927847|11991735|FG000|COMPLETED|Overall Study||10
10826289|NCT02927847|11991736|FG001|COMPLETED|Overall Study||16
10826290|NCT02927847|11991735|FG000|NOT COMPLETED|Overall Study||6
10826291|NCT02927847|11991736|FG001|NOT COMPLETED|Overall Study||3
10826292|NCT02903355|11991744|FG000|STARTED|Overall Study||186
10826293|NCT02903355|11991745|FG001|STARTED|Overall Study||165
10826294|NCT02903355|11991744|FG000|COMPLETED|Overall Study||142
10826295|NCT02903355|11991745|FG001|COMPLETED|Overall Study||124
10826296|NCT02903355|11991744|FG000|NOT COMPLETED|Overall Study||44
10826297|NCT02903355|11991745|FG001|NOT COMPLETED|Overall Study||41
10826298|NCT02892149|11991753|FG000|STARTED|Overall Study||1777
10826299|NCT02892149|11991754|FG001|STARTED|Overall Study||1777
10826300|NCT02892149|11991753|FG000|COMPLETED|Overall Study||1425
10826301|NCT02892149|11991754|FG001|COMPLETED|Overall Study||1421
10826302|NCT02892149|11991753|FG000|NOT COMPLETED|Overall Study||352
10826303|NCT02892149|11991754|FG001|NOT COMPLETED|Overall Study||356
11099801|NCT01222234|12283759|FG001|COMPLETED|Overall Study||15
11099802|NCT01222234|12283760|FG002|COMPLETED|Overall Study||22
11099803|NCT01222234|12283758|FG000|NOT COMPLETED|Overall Study||0
11099804|NCT01222234|12283759|FG001|NOT COMPLETED|Overall Study||2
11099805|NCT01222234|12283760|FG002|NOT COMPLETED|Overall Study||2
11099806|NCT01222260|12283769|FG000|STARTED|Overall Study||31
11099807|NCT01222260|12283769|FG000|COMPLETED|Overall Study||29
11099808|NCT01222260|12283769|FG000|NOT COMPLETED|Overall Study||2
11099809|NCT01222273|12283773|FG000|STARTED|Overall Study||7
11099810|NCT01222273|12283773|FG000|COMPLETED|Overall Study||7
11099811|NCT01222273|12283773|FG000|NOT COMPLETED|Overall Study||0
11099812|NCT01222286|12283779|FG000|STARTED|Overall Study||16
11099813|NCT01222286|12283780|FG001|STARTED|Overall Study||14
11099814|NCT01222286|12283779|FG000|COMPLETED|Overall Study||16
11099815|NCT01222286|12283780|FG001|COMPLETED|Overall Study||14
11099816|NCT01222286|12283779|FG000|NOT COMPLETED|Overall Study||0
11099817|NCT01222286|12283780|FG001|NOT COMPLETED|Overall Study||0
11219814|NCT01957384|12411384|FG003|NOT COMPLETED|Test Period 3 (14 Days)||0
10826322|NCT02870920|11991779|FG000|STARTED|Overall Study||61
10826323|NCT02870920|11991780|FG001|STARTED|Overall Study||119
10826324|NCT02870920|11991779|FG000|COMPLETED|Overall Study||61
10826325|NCT02870920|11991780|FG001|COMPLETED|Overall Study||119
10826326|NCT02870920|11991779|FG000|NOT COMPLETED|Overall Study||0
10826327|NCT02870920|11991780|FG001|NOT COMPLETED|Overall Study||0
10826328|NCT02720523|11991790|FG000|STARTED|Period 1: Placebo-controlled Period||49
10826329|NCT02720523|11991791|FG001|STARTED|Period 1: Placebo-controlled Period||49
10826330|NCT02720523|11991792|FG002|STARTED|Period 1: Placebo-controlled Period||49
10826331|NCT02720523|11991793|FG003|STARTED|Period 1: Placebo-controlled Period||50
10826332|NCT02720523|11991794|FG004|STARTED|Period 1: Placebo-controlled Period||0
10826333|NCT02720523|11991795|FG005|STARTED|Period 1: Placebo-controlled Period||0
10826334|NCT02720523|11991796|FG006|STARTED|Period 1: Placebo-controlled Period||0
10826335|NCT02720523|11991790|FG000|COMPLETED|Period 1: Placebo-controlled Period||47
10826336|NCT02720523|11991791|FG001|COMPLETED|Period 1: Placebo-controlled Period||49
10826337|NCT02720523|11991792|FG002|COMPLETED|Period 1: Placebo-controlled Period||47
10826338|NCT02720523|11991793|FG003|COMPLETED|Period 1: Placebo-controlled Period||44
10826339|NCT02720523|11991794|FG004|COMPLETED|Period 1: Placebo-controlled Period||0
10826340|NCT02720523|11991795|FG005|COMPLETED|Period 1: Placebo-controlled Period||0
10826341|NCT02720523|11991796|FG006|COMPLETED|Period 1: Placebo-controlled Period||0
10826342|NCT02720523|11991790|FG000|NOT COMPLETED|Period 1: Placebo-controlled Period||2
10826343|NCT02720523|11991791|FG001|NOT COMPLETED|Period 1: Placebo-controlled Period||0
10826344|NCT02720523|11991792|FG002|NOT COMPLETED|Period 1: Placebo-controlled Period||2
10826345|NCT02720523|11991793|FG003|NOT COMPLETED|Period 1: Placebo-controlled Period||6
10826346|NCT02720523|11991794|FG004|NOT COMPLETED|Period 1: Placebo-controlled Period||0
10826347|NCT02720523|11991795|FG005|NOT COMPLETED|Period 1: Placebo-controlled Period||0
10826348|NCT02720523|11991796|FG006|NOT COMPLETED|Period 1: Placebo-controlled Period||0
10826349|NCT02720523|11991790|FG000|STARTED|Period 2: Long-term Extension Period||0
10826350|NCT02720523|11991791|FG001|STARTED|Period 2: Long-term Extension Period||0
10826351|NCT02720523|11991792|FG002|STARTED|Period 2: Long-term Extension Period||0
10826352|NCT02720523|11991793|FG003|STARTED|Period 2: Long-term Extension Period||0
10826353|NCT02720523|11991794|FG004|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65
10826354|NCT02720523|11991795|FG005|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62
10826355|NCT02720523|11991796|FG006|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60
10826356|NCT02720523|11991790|FG000|COMPLETED|Period 2: Long-term Extension Period||0
10826357|NCT02720523|11991791|FG001|COMPLETED|Period 2: Long-term Extension Period||0
10826358|NCT02720523|11991792|FG002|COMPLETED|Period 2: Long-term Extension Period||0
10826359|NCT02720523|11991793|FG003|COMPLETED|Period 2: Long-term Extension Period||0
10826360|NCT02720523|11991794|FG004|COMPLETED|Period 2: Long-term Extension Period||0
10826361|NCT02720523|11991795|FG005|COMPLETED|Period 2: Long-term Extension Period||0
10826362|NCT02720523|11991796|FG006|COMPLETED|Period 2: Long-term Extension Period||0
10826363|NCT02720523|11991790|FG000|NOT COMPLETED|Period 2: Long-term Extension Period||0
10826364|NCT02720523|11991791|FG001|NOT COMPLETED|Period 2: Long-term Extension Period||0
10826365|NCT02720523|11991792|FG002|NOT COMPLETED|Period 2: Long-term Extension Period||0
10826366|NCT02720523|11991793|FG003|NOT COMPLETED|Period 2: Long-term Extension Period||0
10826367|NCT02720523|11991794|FG004|NOT COMPLETED|Period 2: Long-term Extension Period||65
10826368|NCT02720523|11991795|FG005|NOT COMPLETED|Period 2: Long-term Extension Period||62
10826369|NCT02720523|11991796|FG006|NOT COMPLETED|Period 2: Long-term Extension Period||60
10826370|NCT02625324|11991809|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
10826371|NCT02625324|11991809|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86
10826372|NCT02625324|11991809|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
10826373|NCT02625324|11991809|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
10826374|NCT02625324|11991809|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
10826375|NCT02625324|11991809|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
10826376|NCT02625324|11991809|FG000|STARTED|6-Month Follow-up Subject Accountability|Note that 6-month follow up is not mandatory for OUS subjects|99
10826377|NCT02625324|11991809|FG000|COMPLETED|6-Month Follow-up Subject Accountability||91
10826378|NCT02625324|11991809|FG000|NOT COMPLETED|6-Month Follow-up Subject Accountability||8
10826379|NCT02625324|11991809|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91
10826380|NCT02625324|11991809|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87
10826381|NCT02625324|11991809|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
10826382|NCT02625324|11991809|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87
10826383|NCT02625324|11991809|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||53
10826384|NCT02625324|11991809|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||34
10826385|NCT02625324|11991809|FG000|STARTED|36-Month Follow-up Secondary Endpoint||53
10826386|NCT02625324|11991809|FG000|COMPLETED|36-Month Follow-up Secondary Endpoint||49
10826387|NCT02625324|11991809|FG000|NOT COMPLETED|36-Month Follow-up Secondary Endpoint||4
11099818|NCT01222299|12283790|FG000|STARTED|Overall Study||21
11099819|NCT01222299|12283791|FG001|STARTED|Overall Study||23
11099820|NCT01222299|12283792|FG002|STARTED|Overall Study||22
11099821|NCT01222299|12283793|FG003|STARTED|Overall Study||23
11099822|NCT01222299|12283790|FG000|COMPLETED|Overall Study||21
11099823|NCT01222299|12283791|FG001|COMPLETED|Overall Study||21
11353976|NCT03068468|12551223|FG003|COMPLETED|Placebo-Controlled Period||0
10826409|NCT02468778|11991853|FG000|STARTED|Overall Study||18
10826410|NCT02468778|11991854|FG001|STARTED|Overall Study||26
10826411|NCT02468778|11991855|FG002|STARTED|Overall Study||10
10826412|NCT02468778|11991853|FG000|COMPLETED|Overall Study||15
10826413|NCT02468778|11991854|FG001|COMPLETED|Overall Study||22
10826414|NCT02468778|11991855|FG002|COMPLETED|Overall Study||7
10826415|NCT02468778|11991853|FG000|NOT COMPLETED|Overall Study||3
10826416|NCT02468778|11991854|FG001|NOT COMPLETED|Overall Study||4
10826417|NCT02468778|11991855|FG002|NOT COMPLETED|Overall Study||3
10826418|NCT02435849|11991863|FG000|STARTED|Overall Study||97
10826419|NCT02435849|11991863|FG000|Enrolled and Infused|Overall Study||79
10826420|NCT02435849|11991863|FG000|Enrolled But Not Infused|Overall Study||18
10826421|NCT02435849|11991863|FG000|Discontinued Study Follow-up|Overall Study||34
10826422|NCT02435849|11991863|FG000|COMPLETED|Overall Study||0
10826423|NCT02435849|11991863|FG000|NOT COMPLETED|Overall Study||97
11099824|NCT01222299|12283792|FG002|COMPLETED|Overall Study||20
11099825|NCT01222299|12283793|FG003|COMPLETED|Overall Study||18
11099826|NCT01222299|12283790|FG000|NOT COMPLETED|Overall Study||0
11099827|NCT01222299|12283791|FG001|NOT COMPLETED|Overall Study||2
11099828|NCT01222299|12283792|FG002|NOT COMPLETED|Overall Study||2
11099829|NCT01222299|12283793|FG003|NOT COMPLETED|Overall Study||5
11099830|NCT01222390|12283803|FG000|STARTED|Overall Study||12
11099831|NCT01222390|12283803|FG000|COMPLETED|Overall Study||12
11099832|NCT01222390|12283803|FG000|NOT COMPLETED|Overall Study||0
11099833|NCT01222403|12283809|FG000|STARTED|Overall Study||386
11099834|NCT01222403|12283810|FG001|STARTED|Overall Study||381
11099835|NCT01222403|12283809|FG000|COMPLETED|Overall Study||386
11099836|NCT01222403|12283810|FG001|COMPLETED|Overall Study||379
11099837|NCT01222403|12283809|FG000|NOT COMPLETED|Overall Study||0
11099838|NCT01222403|12283810|FG001|NOT COMPLETED|Overall Study||2
11099839|NCT01222416|12283818|FG000|STARTED|Overall Study||50
11099840|NCT01222416|12283819|FG001|STARTED|Overall Study||0
11099841|NCT01222416|12283818|FG000|COMPLETED|Overall Study||30
11099842|NCT01222416|12283819|FG001|COMPLETED|Overall Study||0
11099843|NCT01222416|12283818|FG000|NOT COMPLETED|Overall Study||20
11099844|NCT01222416|12283819|FG001|NOT COMPLETED|Overall Study||0
11099845|NCT01222494|12283828|FG000|STARTED|Overall Study||7
11099846|NCT01222494|12283829|FG001|STARTED|Overall Study||19
11099847|NCT01222494|12283830|FG002|STARTED|Overall Study||21
11099848|NCT01222494|12283828|FG000|COMPLETED|Overall Study||6
11099849|NCT01222494|12283829|FG001|COMPLETED|Overall Study||15
11099850|NCT01222494|12283830|FG002|COMPLETED|Overall Study||17
11099851|NCT01222494|12283828|FG000|NOT COMPLETED|Overall Study||1
11099852|NCT01222494|12283829|FG001|NOT COMPLETED|Overall Study||4
11099853|NCT01222494|12283830|FG002|NOT COMPLETED|Overall Study||4
11099854|NCT01222507|12283838|FG000|STARTED|Overall Study||62
11099855|NCT01222507|12283838|FG000|COMPLETED|Overall Study||60
11099856|NCT01222507|12283838|FG000|NOT COMPLETED|Overall Study||2
11099857|NCT01222520|12283844|FG000|STARTED|Open-label run-in Period||0
11099858|NCT01222520|12283845|FG001|STARTED|Open-label run-in Period||197
11099859|NCT01222520|12283844|FG000|COMPLETED|Open-label run-in Period||0
11099860|NCT01222520|12283845|FG001|COMPLETED|Open-label run-in Period||174
11099861|NCT01222520|12283844|FG000|NOT COMPLETED|Open-label run-in Period||0
11099862|NCT01222520|12283845|FG001|NOT COMPLETED|Open-label run-in Period||23
11099863|NCT01222520|12283844|FG000|STARTED|Double-blind Period||87
11099864|NCT01222520|12283845|FG001|STARTED|Double-blind Period||87
11099865|NCT01222520|12283844|FG000|COMPLETED|Double-blind Period||86
11099866|NCT01222520|12283845|FG001|COMPLETED|Double-blind Period||85
11099867|NCT01222520|12283844|FG000|NOT COMPLETED|Double-blind Period||1
11099868|NCT01222520|12283845|FG001|NOT COMPLETED|Double-blind Period||2
10826473|NCT02311478|11991926|FG000|STARTED|Overall Study||79
10826474|NCT02311478|11991926|FG000|IUD Insertion|Overall Study||78
10826475|NCT02311478|11991926|FG000|COMPLETED|Overall Study||72
10826476|NCT02311478|11991926|FG000|NOT COMPLETED|Overall Study||7
10826477|NCT02292238|11991933|FG000|STARTED|Overall Study||34
10826478|NCT02292238|11991934|FG001|STARTED|Overall Study||37
10826479|NCT02292238|11991933|FG000|COMPLETED|Overall Study||30
10826480|NCT02292238|11991934|FG001|COMPLETED|Overall Study||33
10826481|NCT02292238|11991933|FG000|NOT COMPLETED|Overall Study||4
10826482|NCT02292238|11991934|FG001|NOT COMPLETED|Overall Study||4
10826483|NCT02287818|11991943|FG000|STARTED|Overall Study||60
10826484|NCT02287818|11991944|FG001|STARTED|Overall Study||67
10826485|NCT02287818|11991943|FG000|COMPLETED|Overall Study||53
10826486|NCT02287818|11991944|FG001|COMPLETED|Overall Study||54
10826487|NCT02287818|11991943|FG000|NOT COMPLETED|Overall Study||7
10826488|NCT02287818|11991944|FG001|NOT COMPLETED|Overall Study||13
10826489|NCT02277119|11991953|FG000|STARTED|Overall Study||58
10826490|NCT02277119|11991954|FG001|STARTED|Overall Study||24
10826491|NCT02277119|11991955|FG002|STARTED|Overall Study||27
10826492|NCT02277119|11991953|FG000|COMPLETED|Overall Study||55
10826493|NCT02277119|11991954|FG001|COMPLETED|Overall Study||20
10826494|NCT02277119|11991955|FG002|COMPLETED|Overall Study||19
10826495|NCT02277119|11991953|FG000|NOT COMPLETED|Overall Study||3
10826496|NCT02277119|11991954|FG001|NOT COMPLETED|Overall Study||4
10826497|NCT02277119|11991955|FG002|NOT COMPLETED|Overall Study||8
11099869|NCT01222533|12283851|FG000|STARTED|Overall Study|Entered and treated.|154
11099870|NCT01222533|12283851|FG000|Received Placebo|Overall Study||147
11099871|NCT01222533|12283851|FG000|Received Tio R1.25|Overall Study||147
10826501|NCT02255097|11991967|FG000|STARTED|Overall Study||172
10826502|NCT02255097|11991967|FG000|Treated|Overall Study||171
10826503|NCT02255097|11991967|FG000|Received Second Course of Pembrolizumab|Overall Study||3
10826504|NCT02255097|11991967|FG000|COMPLETED|Overall Study||0
10826505|NCT02255097|11991967|FG000|NOT COMPLETED|Overall Study||172
10826506|NCT02218164|11991972|FG000|STARTED|Overall Study||8
10826507|NCT02218164|11991972|FG000|COMPLETED|Overall Study||8
10826508|NCT02218164|11991972|FG000|NOT COMPLETED|Overall Study||0
10826509|NCT02200614|11991978|FG000|STARTED|Double Blind Treatment||955
10826510|NCT02200614|11991979|FG001|STARTED|Double Blind Treatment||554
10826511|NCT02200614|11991978|FG000|COMPLETED|Double Blind Treatment||591
10826512|NCT02200614|11991979|FG001|COMPLETED|Double Blind Treatment||170
10826513|NCT02200614|11991978|FG000|NOT COMPLETED|Double Blind Treatment||364
10826514|NCT02200614|11991979|FG001|NOT COMPLETED|Double Blind Treatment||384
10826515|NCT02200614|11991978|FG000|STARTED|Open Label|Not all participants from treatment period entered follow-up|591
10826516|NCT02200614|11991979|FG001|STARTED|Open Label|Not all participants from treatment period entered follow-up|170
10826517|NCT02200614|11991978|FG000|COMPLETED|Open Label||295
10826518|NCT02200614|11991979|FG001|COMPLETED|Open Label||114
10826519|NCT02200614|11991978|FG000|NOT COMPLETED|Open Label||296
10826520|NCT02200614|11991979|FG001|NOT COMPLETED|Open Label||56
11099872|NCT01222533|12283851|FG000|Received Tio R2.5|Overall Study||145
11099873|NCT01222533|12283851|FG000|Received Tio R5|Overall Study||150
11099874|NCT01222533|12283851|FG000|Received Tio HH18|Overall Study||146
10826524|NCT02083081|11991993|FG000|STARTED|Overall Study||188
10826525|NCT02083081|11991994|FG001|STARTED|Overall Study||164
10826526|NCT02083081|11991993|FG000|COMPLETED|Overall Study||157
10826527|NCT02083081|11991994|FG001|COMPLETED|Overall Study||155
10826528|NCT02083081|11991993|FG000|NOT COMPLETED|Overall Study||31
10826529|NCT02083081|11991994|FG001|NOT COMPLETED|Overall Study||9
10826530|NCT02069899|11992003|FG000|STARTED|Overall Study||37
10826531|NCT02069899|11992004|FG001|STARTED|Overall Study||14
10826532|NCT02069899|11992005|FG002|STARTED|Overall Study||7
10826533|NCT02069899|11992003|FG000|Treated in Current Study|Overall Study||22
10826534|NCT02069899|11992004|FG001|Treated in Current Study|Overall Study||0
10826535|NCT02069899|11992005|FG002|Treated in Current Study|Overall Study||5
10826536|NCT02069899|11992003|FG000|COMPLETED|Overall Study||24
10826537|NCT02069899|11992004|FG001|COMPLETED|Overall Study||13
10826538|NCT02069899|11992005|FG002|COMPLETED|Overall Study||4
10826539|NCT02069899|11992003|FG000|NOT COMPLETED|Overall Study||13
10826540|NCT02069899|11992004|FG001|NOT COMPLETED|Overall Study||1
10826541|NCT02069899|11992005|FG002|NOT COMPLETED|Overall Study||3
11099875|NCT01222533|12283851|FG000|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
11099876|NCT01222533|12283851|FG000|NOT COMPLETED|Overall Study||14
10826545|NCT02018861|11992028|FG000|STARTED|Parsaclisib Monotherapy: 21-day Cycles||1
10826546|NCT02018861|11992029|FG001|STARTED|Parsaclisib Monotherapy: 21-day Cycles||3
10826547|NCT02018861|11992030|FG002|STARTED|Parsaclisib Monotherapy: 21-day Cycles||3
10826548|NCT02018861|11992031|FG003|STARTED|Parsaclisib Monotherapy: 21-day Cycles||34
10826549|NCT02018861|11992032|FG004|STARTED|Parsaclisib Monotherapy: 21-day Cycles||27
10826550|NCT02018861|11992033|FG005|STARTED|Parsaclisib Monotherapy: 21-day Cycles||4
10826551|NCT02018861|11992034|FG006|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0
10826552|NCT02018861|11992035|FG007|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0
10826553|NCT02018861|11992036|FG008|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0
10826554|NCT02018861|11992037|FG009|STARTED|Parsaclisib Monotherapy: 21-day Cycles||0
10826555|NCT02018861|11992028|FG000|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826556|NCT02018861|11992029|FG001|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826557|NCT02018861|11992030|FG002|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826558|NCT02018861|11992031|FG003|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||4
10826559|NCT02018861|11992032|FG004|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826560|NCT02018861|11992033|FG005|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826561|NCT02018861|11992034|FG006|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826562|NCT02018861|11992035|FG007|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826563|NCT02018861|11992036|FG008|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826564|NCT02018861|11992037|FG009|COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826565|NCT02018861|11992028|FG000|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||1
10826566|NCT02018861|11992029|FG001|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||3
10826567|NCT02018861|11992030|FG002|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||3
10826568|NCT02018861|11992031|FG003|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||30
10826569|NCT02018861|11992032|FG004|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||27
10826570|NCT02018861|11992033|FG005|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||4
10826571|NCT02018861|11992034|FG006|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826572|NCT02018861|11992035|FG007|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826573|NCT02018861|11992036|FG008|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826574|NCT02018861|11992037|FG009|NOT COMPLETED|Parsaclisib Monotherapy: 21-day Cycles||0
10826575|NCT02018861|11992028|FG000|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826576|NCT02018861|11992029|FG001|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826577|NCT02018861|11992030|FG002|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826578|NCT02018861|11992031|FG003|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826579|NCT02018861|11992032|FG004|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826580|NCT02018861|11992033|FG005|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826581|NCT02018861|11992034|FG006|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||8
10826582|NCT02018861|11992035|FG007|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||3
10826583|NCT02018861|11992036|FG008|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826584|NCT02018861|11992037|FG009|STARTED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826585|NCT02018861|11992028|FG000|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826586|NCT02018861|11992029|FG001|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826587|NCT02018861|11992030|FG002|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826588|NCT02018861|11992031|FG003|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826589|NCT02018861|11992032|FG004|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826590|NCT02018861|11992033|FG005|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826591|NCT02018861|11992034|FG006|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826592|NCT02018861|11992035|FG007|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826593|NCT02018861|11992036|FG008|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826594|NCT02018861|11992037|FG009|COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826595|NCT02018861|11992028|FG000|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826596|NCT02018861|11992029|FG001|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826597|NCT02018861|11992030|FG002|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826598|NCT02018861|11992031|FG003|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826599|NCT02018861|11992032|FG004|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826600|NCT02018861|11992033|FG005|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826601|NCT02018861|11992034|FG006|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||8
10826602|NCT02018861|11992035|FG007|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||3
10826603|NCT02018861|11992036|FG008|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826604|NCT02018861|11992037|FG009|NOT COMPLETED|Parsaclisib + Itacitinib; 21-day Cycles||0
10826605|NCT02018861|11992028|FG000|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826606|NCT02018861|11992029|FG001|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826607|NCT02018861|11992030|FG002|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826608|NCT02018861|11992031|FG003|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826609|NCT02018861|11992032|FG004|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826610|NCT02018861|11992033|FG005|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826611|NCT02018861|11992034|FG006|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826612|NCT02018861|11992035|FG007|STARTED|Parsaclisib + R-ICE; 21-day Cycles||0
10826613|NCT02018861|11992036|FG008|STARTED|Parsaclisib + R-ICE; 21-day Cycles||4
10826614|NCT02018861|11992037|FG009|STARTED|Parsaclisib + R-ICE; 21-day Cycles||1
10826615|NCT02018861|11992028|FG000|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826616|NCT02018861|11992029|FG001|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826617|NCT02018861|11992030|FG002|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826618|NCT02018861|11992031|FG003|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
11099877|NCT01222572|12283863|FG000|STARTED|Overall Study||1
11099878|NCT01222572|12283864|FG001|STARTED|Overall Study||0
11099879|NCT01222572|12283865|FG002|STARTED|Overall Study||0
11099880|NCT01222572|12283863|FG000|COMPLETED|Overall Study||1
11099881|NCT01222572|12283864|FG001|COMPLETED|Overall Study||0
11099882|NCT01222572|12283865|FG002|COMPLETED|Overall Study||0
11099883|NCT01222572|12283863|FG000|NOT COMPLETED|Overall Study||0
11099884|NCT01222572|12283864|FG001|NOT COMPLETED|Overall Study||0
11099885|NCT01222572|12283865|FG002|NOT COMPLETED|Overall Study||0
11099886|NCT01222585|12283869|FG000|STARTED|Overall Study||24
11099887|NCT01222585|12283869|FG000|COMPLETED|Overall Study||24
11099888|NCT01222585|12283869|FG000|NOT COMPLETED|Overall Study||0
11099889|NCT01222689|12283873|FG000|STARTED|Overall Study||46
11099890|NCT01222689|12283873|FG000|COMPLETED|Overall Study||46
11099891|NCT01222689|12283873|FG000|NOT COMPLETED|Overall Study||0
11099892|NCT01222715|12283879|FG000|STARTED|Overall Study||44
11099893|NCT01222715|12283880|FG001|STARTED|Overall Study||43
11099894|NCT01222715|12283879|FG000|COMPLETED|Overall Study||8
11099895|NCT01222715|12283880|FG001|COMPLETED|Overall Study||16
11099896|NCT01222715|12283879|FG000|NOT COMPLETED|Overall Study||36
11099897|NCT01222715|12283880|FG001|NOT COMPLETED|Overall Study||27
11099898|NCT01222767|12283886|FG000|STARTED|Overall Study||17
11099899|NCT01222767|12283886|FG000|Received Treatment|Overall Study||16
11099900|NCT01222767|12283886|FG000|COMPLETED|Overall Study||0
11219815|NCT01957384|12411385|FG004|NOT COMPLETED|Test Period 3 (14 Days)||0
10826619|NCT02018861|11992032|FG004|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826620|NCT02018861|11992033|FG005|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826621|NCT02018861|11992034|FG006|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826622|NCT02018861|11992035|FG007|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826623|NCT02018861|11992036|FG008|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||1
10826624|NCT02018861|11992037|FG009|COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||1
10826625|NCT02018861|11992028|FG000|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826626|NCT02018861|11992029|FG001|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826627|NCT02018861|11992030|FG002|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826628|NCT02018861|11992031|FG003|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
11099901|NCT01222767|12283886|FG000|NOT COMPLETED|Overall Study||17
10826629|NCT02018861|11992032|FG004|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826630|NCT02018861|11992033|FG005|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826631|NCT02018861|11992034|FG006|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826632|NCT02018861|11992035|FG007|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
10826633|NCT02018861|11992036|FG008|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||3
10826634|NCT02018861|11992037|FG009|NOT COMPLETED|Parsaclisib + R-ICE; 21-day Cycles||0
11099902|NCT01222832|12283892|FG000|STARTED|Overall Study||113
11099903|NCT01222832|12283893|FG001|STARTED|Overall Study||113
11099904|NCT01222832|12283892|FG000|COMPLETED|Overall Study||113
11099905|NCT01222832|12283893|FG001|COMPLETED|Overall Study||112
11099906|NCT01222832|12283892|FG000|NOT COMPLETED|Overall Study||0
11099907|NCT01222832|12283893|FG001|NOT COMPLETED|Overall Study||1
10826641|NCT01721759|11992075|FG000|STARTED|Treatment Period||117
10826642|NCT01721759|11992075|FG000|COMPLETED|Treatment Period||0
10826643|NCT01721759|11992075|FG000|NOT COMPLETED|Treatment Period||117
10826644|NCT01721759|11992075|FG000|STARTED|End of Study Period||117
10826645|NCT01721759|11992075|FG000|COMPLETED|End of Study Period||0
10826646|NCT01721759|11992075|FG000|NOT COMPLETED|End of Study Period||117
11099908|NCT01222884|12283901|FG000|STARTED|Overall Study||234
11099909|NCT01222884|12283902|FG001|STARTED|Overall Study||117
11099910|NCT01222884|12283901|FG000|COMPLETED|Overall Study||210
11099911|NCT01222884|12283902|FG001|COMPLETED|Overall Study||113
11099912|NCT01222884|12283901|FG000|NOT COMPLETED|Overall Study||24
11099913|NCT01222884|12283902|FG001|NOT COMPLETED|Overall Study||4
11099914|NCT01223027|12283910|FG000|STARTED|Overall Study||284
11099915|NCT01223027|12283911|FG001|STARTED|Overall Study||286
11099916|NCT01223027|12283910|FG000|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
11099917|NCT01223027|12283911|FG001|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
11099918|NCT01223027|12283910|FG000|NOT COMPLETED|Overall Study||274
11099919|NCT01223027|12283911|FG001|NOT COMPLETED|Overall Study||277
11099920|NCT01223183|12283919|FG000|STARTED|Imaging Day 1||10
11099921|NCT01223183|12283920|FG001|STARTED|Imaging Day 1||10
11099922|NCT01223183|12283919|FG000|COMPLETED|Imaging Day 1||10
11099923|NCT01223183|12283920|FG001|COMPLETED|Imaging Day 1||9
11099924|NCT01223183|12283919|FG000|NOT COMPLETED|Imaging Day 1||0
11099925|NCT01223183|12283920|FG001|NOT COMPLETED|Imaging Day 1||1
10826686|NCT01544335|11992144|FG000|STARTED|Overall Study||191
10826687|NCT01544335|11992144|FG000|COMPLETED|Overall Study||138
10826688|NCT01544335|11992144|FG000|NOT COMPLETED|Overall Study||53
11099926|NCT01223183|12283919|FG000|STARTED|Washout Period (5-24 Days)||10
11099927|NCT01223183|12283920|FG001|STARTED|Washout Period (5-24 Days)||9
11099928|NCT01223183|12283919|FG000|COMPLETED|Washout Period (5-24 Days)||8
11099929|NCT01223183|12283920|FG001|COMPLETED|Washout Period (5-24 Days)||9
10826704|NCT01451515|11992177|FG000|STARTED|Overall Study||12
10826705|NCT01451515|11992178|FG001|STARTED|Overall Study||7
10826706|NCT01451515|11992179|FG002|STARTED|Overall Study||4
10826707|NCT01451515|11992177|FG000|COMPLETED|Overall Study||11
10826708|NCT01451515|11992178|FG001|COMPLETED|Overall Study||4
10826709|NCT01451515|11992179|FG002|COMPLETED|Overall Study||3
10826710|NCT01451515|11992177|FG000|NOT COMPLETED|Overall Study||1
10826711|NCT01451515|11992178|FG001|NOT COMPLETED|Overall Study||3
10826712|NCT01451515|11992179|FG002|NOT COMPLETED|Overall Study||1
10826719|NCT01413399|11992201|FG000|STARTED|Overall Study||208
10826720|NCT01413399|11992202|FG001|STARTED|Overall Study||334
10826721|NCT01413399|11992201|FG000|COMPLETED|Overall Study||208
10826722|NCT01413399|11992202|FG001|COMPLETED|Overall Study||334
10826723|NCT01413399|11992201|FG000|NOT COMPLETED|Overall Study||0
10826724|NCT01413399|11992202|FG001|NOT COMPLETED|Overall Study||0
10826935|NCT01302834|11992273|FG000|STARTED|Overall Study||424
10826936|NCT01302834|11992274|FG001|STARTED|Overall Study||425
10826937|NCT01302834|11992273|FG000|Eligible|Overall Study||406
10826938|NCT01302834|11992274|FG001|Eligible|Overall Study||399
10826939|NCT01302834|11992273|FG000|Started Treatment|Overall Study||398
10826940|NCT01302834|11992274|FG001|Started Treatment|Overall Study||394
10826941|NCT01302834|11992273|FG000|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369
10826942|NCT01302834|11992274|FG001|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363
10826943|NCT01302834|11992273|FG000|AE Assessed 3 Months PT|Overall Study||359
10826944|NCT01302834|11992274|FG001|AE Assessed 3 Months PT|Overall Study||367
10826945|NCT01302834|11992273|FG000|AE Assessed 6 Months PT|Overall Study||361
10826946|NCT01302834|11992274|FG001|AE Assessed 6 Months PT|Overall Study||352
10826947|NCT01302834|11992273|FG000|AE Assessment 1 Year PT|Overall Study||360
10826948|NCT01302834|11992274|FG001|AE Assessment 1 Year PT|Overall Study||351
10826949|NCT01302834|11992273|FG000|AE Assessed 2 Years PT|Overall Study||311
10826950|NCT01302834|11992274|FG001|AE Assessed 2 Years PT|Overall Study||303
10826951|NCT01302834|11992273|FG000|AE Assessed 5 Years PT|Overall Study||92
10826952|NCT01302834|11992274|FG001|AE Assessed 5 Years PT|Overall Study||86
10826953|NCT01302834|11992273|FG000|Dental Health Assessed 1 Year PT|Overall Study||267
10826954|NCT01302834|11992274|FG001|Dental Health Assessed 1 Year PT|Overall Study||267
10826955|NCT01302834|11992273|FG000|Dental Health Assessed 2 Years PT|Overall Study||208
10826956|NCT01302834|11992274|FG001|Dental Health Assessed 2 Years PT|Overall Study||201
10826957|NCT01302834|11992273|FG000|Dental Health Assessed 5 Years PT|Overall Study||44
10826958|NCT01302834|11992274|FG001|Dental Health Assessed 5 Years PT|Overall Study||43
10826959|NCT01302834|11992273|FG000|Feeding Tube Assessed|Overall Study||368
10826960|NCT01302834|11992274|FG001|Feeding Tube Assessed|Overall Study||356
10826961|NCT01302834|11992273|FG000|Progressed|Overall Study||76
10826962|NCT01302834|11992274|FG001|Progressed|Overall Study||122
10826963|NCT01302834|11992273|FG000|COMPLETED|Overall Study||406
10826964|NCT01302834|11992274|FG001|COMPLETED|Overall Study||399
10826965|NCT01302834|11992273|FG000|NOT COMPLETED|Overall Study||18
10826966|NCT01302834|11992274|FG001|NOT COMPLETED|Overall Study||26
10826973|NCT01275313|11992291|FG000|STARTED|Overall Study||127
10826974|NCT01275313|11992292|FG001|STARTED|Overall Study||131
10826975|NCT01275313|11992291|FG000|COMPLETED|Overall Study||102
10826976|NCT01275313|11992292|FG001|COMPLETED|Overall Study||79
10826977|NCT01275313|11992291|FG000|NOT COMPLETED|Overall Study||25
10826978|NCT01275313|11992292|FG001|NOT COMPLETED|Overall Study||52
10826991|NCT01177540|11992313|FG000|STARTED|Overall Study||11
10826992|NCT01177540|11992314|FG001|STARTED|Overall Study||14
10826993|NCT01177540|11992313|FG000|COMPLETED|Overall Study||10
10826994|NCT01177540|11992314|FG001|COMPLETED|Overall Study||14
10826995|NCT01177540|11992313|FG000|NOT COMPLETED|Overall Study||1
10826996|NCT01177540|11992314|FG001|NOT COMPLETED|Overall Study||0
11099930|NCT01223183|12283919|FG000|NOT COMPLETED|Washout Period (5-24 Days)||2
11099931|NCT01223183|12283920|FG001|NOT COMPLETED|Washout Period (5-24 Days)||0
11099932|NCT01223183|12283919|FG000|STARTED|Imaging Day 2||8
11099933|NCT01223183|12283920|FG001|STARTED|Imaging Day 2||9
11099934|NCT01223183|12283919|FG000|COMPLETED|Imaging Day 2||8
11099935|NCT01223183|12283920|FG001|COMPLETED|Imaging Day 2||9
11099936|NCT01223183|12283919|FG000|NOT COMPLETED|Imaging Day 2||0
11099937|NCT01223183|12283920|FG001|NOT COMPLETED|Imaging Day 2||0
11099938|NCT01223196|12283929|FG000|STARTED|Overall Study||13
11099939|NCT01223196|12283930|FG001|STARTED|Overall Study||11
11099940|NCT01223196|12283929|FG000|COMPLETED|Overall Study||9
11099941|NCT01223196|12283930|FG001|COMPLETED|Overall Study||11
11099942|NCT01223196|12283929|FG000|NOT COMPLETED|Overall Study||4
11099943|NCT01223196|12283930|FG001|NOT COMPLETED|Overall Study||0
11099944|NCT01223235|12283938|FG000|STARTED|Overall Study||22
11099945|NCT01223235|12283938|FG000|COMPLETED|Overall Study||21
11099946|NCT01223235|12283938|FG000|NOT COMPLETED|Overall Study||1
11099947|NCT01223352|12283944|FG000|STARTED|Overall Study||31
11099948|NCT01223352|12283945|FG001|STARTED|Overall Study||33
11099949|NCT01223352|12283944|FG000|COMPLETED|Overall Study||31
11099950|NCT01223352|12283945|FG001|COMPLETED|Overall Study||33
11099951|NCT01223352|12283944|FG000|NOT COMPLETED|Overall Study||0
11099952|NCT01223352|12283945|FG001|NOT COMPLETED|Overall Study||0
11099953|NCT01223365|12283957|FG000|STARTED|Open-label Titration Period||330
11099954|NCT01223365|12283957|FG000|Safety Analysis Set|Open-label Titration Period||329
11099955|NCT01223365|12283957|FG000|Achieved Stable Pain Relief|Open-label Titration Period||294
11099956|NCT01223365|12283957|FG000|COMPLETED|Open-label Titration Period||291
11099957|NCT01223365|12283957|FG000|NOT COMPLETED|Open-label Titration Period||39
11099958|NCT01223365|12283957|FG000|STARTED|Open-label Treatment Period||291
10827029|NCT00792259|11992372|FG000|STARTED|Overall Study||15
10827030|NCT00792259|11992373|FG001|STARTED|Overall Study||20
10827031|NCT00792259|11992374|FG002|STARTED|Overall Study||13
10827032|NCT00792259|11992372|FG000|COMPLETED|Overall Study||14
10827033|NCT00792259|11992373|FG001|COMPLETED|Overall Study||20
10827034|NCT00792259|11992374|FG002|COMPLETED|Overall Study||13
10827035|NCT00792259|11992372|FG000|NOT COMPLETED|Overall Study||1
10827036|NCT00792259|11992373|FG001|NOT COMPLETED|Overall Study||0
10827037|NCT00792259|11992374|FG002|NOT COMPLETED|Overall Study||0
10827038|NCT00662792|11992382|FG000|STARTED|Period 1||34
10827039|NCT00662792|11992383|FG001|STARTED|Period 1||38
10827040|NCT00662792|11992384|FG002|STARTED|Period 1||36
10827041|NCT00662792|11992385|FG003|STARTED|Period 1||39
10827042|NCT00662792|11992382|FG000|Treated|Period 1||34
10827043|NCT00662792|11992383|FG001|Treated|Period 1||37
10827044|NCT00662792|11992384|FG002|Treated|Period 1||36
10827045|NCT00662792|11992385|FG003|Treated|Period 1||39
10827046|NCT00662792|11992382|FG000|COMPLETED|Period 1||32
10827047|NCT00662792|11992383|FG001|COMPLETED|Period 1||31
10827048|NCT00662792|11992384|FG002|COMPLETED|Period 1||32
10827049|NCT00662792|11992385|FG003|COMPLETED|Period 1||39
10827050|NCT00662792|11992382|FG000|NOT COMPLETED|Period 1||2
10827051|NCT00662792|11992383|FG001|NOT COMPLETED|Period 1||7
10827052|NCT00662792|11992384|FG002|NOT COMPLETED|Period 1||4
11099959|NCT01223365|12283957|FG000|COMPLETED|Open-label Treatment Period||189
10827053|NCT00662792|11992385|FG003|NOT COMPLETED|Period 1||0
10827054|NCT00662792|11992382|FG000|STARTED|Period 2||32
10827055|NCT00662792|11992383|FG001|STARTED|Period 2||31
10827056|NCT00662792|11992384|FG002|STARTED|Period 2||32
10827057|NCT00662792|11992385|FG003|STARTED|Period 2||39
10827058|NCT00662792|11992382|FG000|Treated|Period 2||32
10827059|NCT00662792|11992383|FG001|Treated|Period 2||31
10827060|NCT00662792|11992384|FG002|Treated|Period 2||32
10827061|NCT00662792|11992385|FG003|Treated|Period 2||39
10827062|NCT00662792|11992382|FG000|COMPLETED|Period 2||31
10827063|NCT00662792|11992383|FG001|COMPLETED|Period 2||31
10827064|NCT00662792|11992384|FG002|COMPLETED|Period 2||32
10827065|NCT00662792|11992385|FG003|COMPLETED|Period 2||36
10827066|NCT00662792|11992382|FG000|NOT COMPLETED|Period 2||1
10827067|NCT00662792|11992383|FG001|NOT COMPLETED|Period 2||0
10827068|NCT00662792|11992384|FG002|NOT COMPLETED|Period 2||0
10827069|NCT00662792|11992385|FG003|NOT COMPLETED|Period 2||3
10827070|NCT00662792|11992382|FG000|STARTED|Period 3||31
10827071|NCT00662792|11992383|FG001|STARTED|Period 3||31
10827072|NCT00662792|11992384|FG002|STARTED|Period 3||32
10827073|NCT00662792|11992385|FG003|STARTED|Period 3||36
10827074|NCT00662792|11992382|FG000|Treated|Period 3||31
10827075|NCT00662792|11992383|FG001|Treated|Period 3||31
10827076|NCT00662792|11992384|FG002|Treated|Period 3||32
10827077|NCT00662792|11992385|FG003|Treated|Period 3||36
10827078|NCT00662792|11992382|FG000|COMPLETED|Period 3||30
10827079|NCT00662792|11992383|FG001|COMPLETED|Period 3||31
10827080|NCT00662792|11992384|FG002|COMPLETED|Period 3||30
10827081|NCT00662792|11992385|FG003|COMPLETED|Period 3||35
10827082|NCT00662792|11992382|FG000|NOT COMPLETED|Period 3||1
10827083|NCT00662792|11992383|FG001|NOT COMPLETED|Period 3||0
10827084|NCT00662792|11992384|FG002|NOT COMPLETED|Period 3||2
11219816|NCT01957384|12411386|FG005|NOT COMPLETED|Test Period 3 (14 Days)||0
10827085|NCT00662792|11992385|FG003|NOT COMPLETED|Period 3||1
10827086|NCT00662792|11992382|FG000|STARTED|Period 4||30
10827087|NCT00662792|11992383|FG001|STARTED|Period 4||31
10827088|NCT00662792|11992384|FG002|STARTED|Period 4||30
10827089|NCT00662792|11992385|FG003|STARTED|Period 4||35
10827090|NCT00662792|11992382|FG000|Treated|Period 4||30
10827091|NCT00662792|11992383|FG001|Treated|Period 4||31
10827092|NCT00662792|11992384|FG002|Treated|Period 4||30
10827093|NCT00662792|11992385|FG003|Treated|Period 4||35
10827094|NCT00662792|11992382|FG000|COMPLETED|Period 4||29
10827095|NCT00662792|11992383|FG001|COMPLETED|Period 4||30
10827096|NCT00662792|11992384|FG002|COMPLETED|Period 4||30
10827097|NCT00662792|11992385|FG003|COMPLETED|Period 4||34
10827098|NCT00662792|11992382|FG000|NOT COMPLETED|Period 4||1
10827099|NCT00662792|11992383|FG001|NOT COMPLETED|Period 4||1
10827100|NCT00662792|11992384|FG002|NOT COMPLETED|Period 4||0
10827101|NCT00662792|11992385|FG003|NOT COMPLETED|Period 4||1
11099960|NCT01223365|12283957|FG000|NOT COMPLETED|Open-label Treatment Period||102
11099961|NCT01223378|12283971|FG000|STARTED|Overall Study||82
11099962|NCT01223378|12283972|FG001|STARTED|Overall Study||85
10827129|NCT00567580|11992427|FG000|STARTED|Overall Study||592
10827130|NCT00567580|11992428|FG001|STARTED|Overall Study||602
10827131|NCT00567580|11992429|FG002|STARTED|Overall Study||598
10827132|NCT00567580|11992427|FG000|Eligible|Overall Study||564
10827133|NCT00567580|11992428|FG001|Eligible|Overall Study||578
10827134|NCT00567580|11992429|FG002|Eligible|Overall Study||574
10827135|NCT00567580|11992427|FG000|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||547
10827136|NCT00567580|11992428|FG001|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
10827137|NCT00567580|11992429|FG002|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
10827138|NCT00567580|11992427|FG000|COMPLETED|Overall Study||564
10827139|NCT00567580|11992428|FG001|COMPLETED|Overall Study||578
10827140|NCT00567580|11992429|FG002|COMPLETED|Overall Study||574
10827141|NCT00567580|11992427|FG000|NOT COMPLETED|Overall Study||28
10827142|NCT00567580|11992428|FG001|NOT COMPLETED|Overall Study||24
10827143|NCT00567580|11992429|FG002|NOT COMPLETED|Overall Study||24
10827144|NCT00528021|11992444|FG000|STARTED|Overall Study||59
10827145|NCT00528021|11992445|FG001|STARTED|Overall Study||59
10827146|NCT00528021|11992446|FG002|STARTED|Overall Study||56
10827147|NCT00528021|11992447|FG003|STARTED|Overall Study||56
10827148|NCT00528021|11992444|FG000|COMPLETED|Overall Study||42
10827149|NCT00528021|11992445|FG001|COMPLETED|Overall Study||46
10827150|NCT00528021|11992446|FG002|COMPLETED|Overall Study||49
10827151|NCT00528021|11992447|FG003|COMPLETED|Overall Study||47
10827152|NCT00528021|11992444|FG000|NOT COMPLETED|Overall Study||17
10827153|NCT00528021|11992445|FG001|NOT COMPLETED|Overall Study||13
10827154|NCT00528021|11992446|FG002|NOT COMPLETED|Overall Study||7
10827155|NCT00528021|11992447|FG003|NOT COMPLETED|Overall Study||9
10827156|NCT00485693|11992459|FG000|STARTED|Overall Study||34
10827157|NCT00485693|11992460|FG001|STARTED|Overall Study||104
10827158|NCT00485693|11992459|FG000|COMPLETED|Overall Study||34
10827159|NCT00485693|11992460|FG001|COMPLETED|Overall Study||104
10827160|NCT00485693|11992459|FG000|NOT COMPLETED|Overall Study||0
10827161|NCT00485693|11992460|FG001|NOT COMPLETED|Overall Study||0
11099963|NCT01223378|12283973|FG002|STARTED|Overall Study||83
11099964|NCT01223378|12283974|FG003|STARTED|Overall Study||81
11099965|NCT01223378|12283975|FG004|STARTED|Overall Study||82
11099966|NCT01223378|12283971|FG000|COMPLETED|Overall Study||76
11099967|NCT01223378|12283972|FG001|COMPLETED|Overall Study||81
11099968|NCT01223378|12283973|FG002|COMPLETED|Overall Study||80
11099969|NCT01223378|12283974|FG003|COMPLETED|Overall Study||80
11099970|NCT01223378|12283975|FG004|COMPLETED|Overall Study||79
11099971|NCT01223378|12283971|FG000|NOT COMPLETED|Overall Study||6
11099972|NCT01223378|12283972|FG001|NOT COMPLETED|Overall Study||4
11099973|NCT01223378|12283973|FG002|NOT COMPLETED|Overall Study||3
11099974|NCT01223378|12283974|FG003|NOT COMPLETED|Overall Study||1
11099975|NCT01223378|12283975|FG004|NOT COMPLETED|Overall Study||3
11099976|NCT01223404|12283987|FG000|STARTED|First Intervention (1 Day)||4
11099977|NCT01223404|12283988|FG001|STARTED|First Intervention (1 Day)||3
11219817|NCT01957397|12411394|FG000|STARTED|Baseline Own Product||13
11099978|NCT01223404|12283989|FG002|STARTED|First Intervention (1 Day)||4
11099979|NCT01223404|12283990|FG003|STARTED|First Intervention (1 Day)||5
11099980|NCT01223404|12283991|FG004|STARTED|First Intervention (1 Day)||2
11099981|NCT01223404|12283992|FG005|STARTED|First Intervention (1 Day)||3
11099982|NCT01223404|12283987|FG000|COMPLETED|First Intervention (1 Day)||4
11099983|NCT01223404|12283988|FG001|COMPLETED|First Intervention (1 Day)||3
11099984|NCT01223404|12283989|FG002|COMPLETED|First Intervention (1 Day)||4
11219818|NCT01957397|12411395|FG001|STARTED|Baseline Own Product||13
11219819|NCT01957397|12411394|FG000|COMPLETED|Baseline Own Product||13
11219820|NCT01957397|12411395|FG001|COMPLETED|Baseline Own Product||13
11219821|NCT01957397|12411394|FG000|NOT COMPLETED|Baseline Own Product||0
11219822|NCT01957397|12411395|FG001|NOT COMPLETED|Baseline Own Product||0
11219823|NCT01957397|12411394|FG000|STARTED|Test Period 1||13
10827195|NCT00799266|11992533|FG000|STARTED|Overall Study||18
10827196|NCT00799266|11992534|FG001|STARTED|Overall Study||16
10827197|NCT00799266|11992533|FG000|Modified Intention-to-treat (MITT)|Overall Study||17
10827198|NCT00799266|11992534|FG001|Modified Intention-to-treat (MITT)|Overall Study||16
10827199|NCT00799266|11992533|FG000|Safety Set|Overall Study||18
10827200|NCT00799266|11992534|FG001|Safety Set|Overall Study||16
10827201|NCT00799266|11992533|FG000|COMPLETED|Overall Study||15
10827202|NCT00799266|11992534|FG001|COMPLETED|Overall Study||15
10827203|NCT00799266|11992533|FG000|NOT COMPLETED|Overall Study||3
10827204|NCT00799266|11992534|FG001|NOT COMPLETED|Overall Study||1
10827205|NCT00810446|11992540|FG000|STARTED|Overall Study||72
10827206|NCT00810446|11992540|FG000|COMPLETED|Overall Study||72
10827207|NCT00810446|11992540|FG000|NOT COMPLETED|Overall Study||0
10827208|NCT00844480|11992546|FG000|STARTED|Overall Study||8
10827209|NCT00844480|11992547|FG001|STARTED|Overall Study||9
10827210|NCT00844480|11992546|FG000|COMPLETED|Overall Study||6
10827211|NCT00844480|11992547|FG001|COMPLETED|Overall Study||6
10827212|NCT00844480|11992546|FG000|NOT COMPLETED|Overall Study||2
10827213|NCT00844480|11992547|FG001|NOT COMPLETED|Overall Study||3
10827214|NCT00864474|11992553|FG000|STARTED|Overall Study||68
10827215|NCT00864474|11992553|FG000|COMPLETED|Overall Study||68
10827216|NCT00864474|11992553|FG000|NOT COMPLETED|Overall Study||0
10827217|NCT00873366|11992557|FG000|STARTED|Overall Study||77
10827218|NCT00873366|11992557|FG000|COMPLETED|Overall Study||71
10827219|NCT00873366|11992557|FG000|NOT COMPLETED|Overall Study||6
10827220|NCT00923247|11992563|FG000|STARTED|Overall Study||21
10827221|NCT00923247|11992564|FG001|STARTED|Overall Study||1
10827222|NCT00923247|11992563|FG000|COMPLETED|Overall Study||21
10827223|NCT00923247|11992564|FG001|COMPLETED|Overall Study||1
10827224|NCT00923247|11992563|FG000|NOT COMPLETED|Overall Study||0
10827225|NCT00923247|11992564|FG001|NOT COMPLETED|Overall Study||0
10827226|NCT00928226|11992580|FG000|STARTED|Overall Study||20
10827227|NCT00928226|11992581|FG001|STARTED|Overall Study||12
10827228|NCT00928226|11992582|FG002|STARTED|Overall Study||12
10827229|NCT00928226|11992583|FG003|STARTED|Overall Study||12
10827230|NCT00928226|11992580|FG000|Strata A: Small Tumor, Resected|Overall Study||6
10827231|NCT00928226|11992581|FG001|Strata A: Small Tumor, Resected|Overall Study||6
10827232|NCT00928226|11992582|FG002|Strata A: Small Tumor, Resected|Overall Study||6
10827233|NCT00928226|11992583|FG003|Strata A: Small Tumor, Resected|Overall Study||6
10827234|NCT00928226|11992580|FG000|Strata B: Small Tumor, Not Resected|Overall Study||5
10827235|NCT00928226|11992581|FG001|Strata B: Small Tumor, Not Resected|Overall Study||0
10827236|NCT00928226|11992582|FG002|Strata B: Small Tumor, Not Resected|Overall Study||0
10827237|NCT00928226|11992583|FG003|Strata B: Small Tumor, Not Resected|Overall Study||0
10827238|NCT00928226|11992580|FG000|Strata C: Large Tumor, Resected|Overall Study||8
10827239|NCT00928226|11992581|FG001|Strata C: Large Tumor, Resected|Overall Study||6
10827240|NCT00928226|11992582|FG002|Strata C: Large Tumor, Resected|Overall Study||6
10827241|NCT00928226|11992583|FG003|Strata C: Large Tumor, Resected|Overall Study||6
10827242|NCT00928226|11992580|FG000|Strata D: Large Tumor, Not Resected|Overall Study||1
10827243|NCT00928226|11992581|FG001|Strata D: Large Tumor, Not Resected|Overall Study||0
10827244|NCT00928226|11992582|FG002|Strata D: Large Tumor, Not Resected|Overall Study||0
10827245|NCT00928226|11992583|FG003|Strata D: Large Tumor, Not Resected|Overall Study||0
10827246|NCT00928226|11992580|FG000|COMPLETED|Overall Study||20
10827247|NCT00928226|11992581|FG001|COMPLETED|Overall Study||12
10827248|NCT00928226|11992582|FG002|COMPLETED|Overall Study||12
10827249|NCT00928226|11992583|FG003|COMPLETED|Overall Study||12
10827250|NCT00928226|11992580|FG000|NOT COMPLETED|Overall Study||0
10827251|NCT00928226|11992581|FG001|NOT COMPLETED|Overall Study||0
10827252|NCT00928226|11992582|FG002|NOT COMPLETED|Overall Study||0
10827253|NCT00928226|11992583|FG003|NOT COMPLETED|Overall Study||0
10827257|NCT00940498|11992605|FG000|STARTED|Overall Study||4
10827258|NCT00940498|11992606|FG001|STARTED|Overall Study||4
10827259|NCT00940498|11992607|FG002|STARTED|Overall Study||4
10827260|NCT00940498|11992608|FG003|STARTED|Overall Study||4
10827261|NCT00940498|11992609|FG004|STARTED|Overall Study||43
10827262|NCT00940498|11992610|FG005|STARTED|Overall Study||7
10827263|NCT00940498|11992611|FG006|STARTED|Overall Study||8
10827264|NCT00940498|11992612|FG007|STARTED|Overall Study||4
10827265|NCT00940498|11992605|FG000|COMPLETED|Overall Study||1
10827266|NCT00940498|11992606|FG001|COMPLETED|Overall Study||3
10827267|NCT00940498|11992607|FG002|COMPLETED|Overall Study||1
10827268|NCT00940498|11992608|FG003|COMPLETED|Overall Study||2
10827269|NCT00940498|11992609|FG004|COMPLETED|Overall Study||34
10827270|NCT00940498|11992610|FG005|COMPLETED|Overall Study||6
10827271|NCT00940498|11992611|FG006|COMPLETED|Overall Study||7
10827272|NCT00940498|11992612|FG007|COMPLETED|Overall Study||3
10827273|NCT00940498|11992605|FG000|NOT COMPLETED|Overall Study||3
10827274|NCT00940498|11992606|FG001|NOT COMPLETED|Overall Study||1
10827275|NCT00940498|11992607|FG002|NOT COMPLETED|Overall Study||3
10827276|NCT00940498|11992608|FG003|NOT COMPLETED|Overall Study||2
10827277|NCT00940498|11992609|FG004|NOT COMPLETED|Overall Study||9
10827278|NCT00940498|11992610|FG005|NOT COMPLETED|Overall Study||1
11099985|NCT01223404|12283990|FG003|COMPLETED|First Intervention (1 Day)||4
10827279|NCT00940498|11992611|FG006|NOT COMPLETED|Overall Study||1
10827280|NCT00940498|11992612|FG007|NOT COMPLETED|Overall Study||1
10827281|NCT04720547|11992638|FG000|STARTED|Overall Study||6
10827282|NCT04720547|11992639|FG001|STARTED|Overall Study||8
10827283|NCT04720547|11992638|FG000|COMPLETED|Overall Study||6
10827284|NCT04720547|11992639|FG001|COMPLETED|Overall Study||5
10827285|NCT04720547|11992638|FG000|NOT COMPLETED|Overall Study||0
10827254|NCT00930722|11992593|FG000|STARTED|Overall Study||329
10827255|NCT00930722|11992593|FG000|COMPLETED|Overall Study||302
10827256|NCT00930722|11992593|FG000|NOT COMPLETED|Overall Study||27
10827286|NCT04720547|11992639|FG001|NOT COMPLETED|Overall Study||3
10827287|NCT04553913|11992645|FG000|STARTED|Overall Study||15
10827288|NCT04553913|11992645|FG000|COMPLETED|Overall Study||9
10827289|NCT04553913|11992645|FG000|NOT COMPLETED|Overall Study||6
10827290|NCT04079452|11992650|FG000|STARTED|Overall Study||15
10827291|NCT04079452|11992650|FG000|COMPLETED|Overall Study||15
10827292|NCT04079452|11992650|FG000|NOT COMPLETED|Overall Study||0
10827293|NCT04009824|11992660|FG000|STARTED|Overall Study||10
10827294|NCT04009824|11992661|FG001|STARTED|Overall Study||10
10827295|NCT04009824|11992662|FG002|STARTED|Overall Study||11
10827296|NCT04009824|11992663|FG003|STARTED|Overall Study||10
10827297|NCT04009824|11992664|FG004|STARTED|Overall Study||10
10827298|NCT04009824|11992660|FG000|COMPLETED|Overall Study||8
10827299|NCT04009824|11992661|FG001|COMPLETED|Overall Study||7
10827300|NCT04009824|11992662|FG002|COMPLETED|Overall Study||6
10827301|NCT04009824|11992663|FG003|COMPLETED|Overall Study||8
10827302|NCT04009824|11992664|FG004|COMPLETED|Overall Study||7
10827303|NCT04009824|11992660|FG000|NOT COMPLETED|Overall Study||2
10827304|NCT04009824|11992661|FG001|NOT COMPLETED|Overall Study||3
10827305|NCT04009824|11992662|FG002|NOT COMPLETED|Overall Study||5
10827306|NCT04009824|11992663|FG003|NOT COMPLETED|Overall Study||2
10827307|NCT04009824|11992664|FG004|NOT COMPLETED|Overall Study||3
10827308|NCT03867383|11992678|FG000|STARTED|Overall Study||20
10827309|NCT03867383|11992679|FG001|STARTED|Overall Study||20
10827310|NCT03867383|11992678|FG000|COMPLETED|Overall Study||20
11099986|NCT01223404|12283991|FG004|COMPLETED|First Intervention (1 Day)||2
11099987|NCT01223404|12283992|FG005|COMPLETED|First Intervention (1 Day)||3
11099988|NCT01223404|12283987|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11099989|NCT01223404|12283988|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11099990|NCT01223404|12283989|FG002|NOT COMPLETED|First Intervention (1 Day)||0
11099991|NCT01223404|12283990|FG003|NOT COMPLETED|First Intervention (1 Day)||1
11099992|NCT01223404|12283991|FG004|NOT COMPLETED|First Intervention (1 Day)||0
11099993|NCT01223404|12283992|FG005|NOT COMPLETED|First Intervention (1 Day)||0
11099994|NCT01223404|12283987|FG000|STARTED|Second Intervention (1 Day)||4
11099995|NCT01223404|12283988|FG001|STARTED|Second Intervention (1 Day)||3
11099996|NCT01223404|12283989|FG002|STARTED|Second Intervention (1 Day)||4
11099997|NCT01223404|12283990|FG003|STARTED|Second Intervention (1 Day)||4
11099998|NCT01223404|12283991|FG004|STARTED|Second Intervention (1 Day)||2
11099999|NCT01223404|12283992|FG005|STARTED|Second Intervention (1 Day)||3
11100000|NCT01223404|12283987|FG000|COMPLETED|Second Intervention (1 Day)||3
11100001|NCT01223404|12283988|FG001|COMPLETED|Second Intervention (1 Day)||3
11100002|NCT01223404|12283989|FG002|COMPLETED|Second Intervention (1 Day)||4
11100003|NCT01223404|12283990|FG003|COMPLETED|Second Intervention (1 Day)||4
11100004|NCT01223404|12283991|FG004|COMPLETED|Second Intervention (1 Day)||2
11100005|NCT01223404|12283992|FG005|COMPLETED|Second Intervention (1 Day)||3
11100006|NCT01223404|12283987|FG000|NOT COMPLETED|Second Intervention (1 Day)||1
11100007|NCT01223404|12283988|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11100008|NCT01223404|12283989|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11100009|NCT01223404|12283990|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
11100010|NCT01223404|12283991|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
11100011|NCT01223404|12283992|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
11100012|NCT01223404|12283987|FG000|STARTED|Third Intervention (1 Day)||3
11100013|NCT01223404|12283988|FG001|STARTED|Third Intervention (1 Day)||3
11100014|NCT01223404|12283989|FG002|STARTED|Third Intervention (1 Day)||4
11100015|NCT01223404|12283990|FG003|STARTED|Third Intervention (1 Day)||4
11100016|NCT01223404|12283991|FG004|STARTED|Third Intervention (1 Day)||2
11100017|NCT01223404|12283992|FG005|STARTED|Third Intervention (1 Day)||3
11100018|NCT01223404|12283987|FG000|COMPLETED|Third Intervention (1 Day)||3
11100019|NCT01223404|12283988|FG001|COMPLETED|Third Intervention (1 Day)||3
11100020|NCT01223404|12283989|FG002|COMPLETED|Third Intervention (1 Day)||4
11100021|NCT01223404|12283990|FG003|COMPLETED|Third Intervention (1 Day)||3
11100022|NCT01223404|12283991|FG004|COMPLETED|Third Intervention (1 Day)||2
11100023|NCT01223404|12283992|FG005|COMPLETED|Third Intervention (1 Day)||3
11100024|NCT01223404|12283987|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11100025|NCT01223404|12283988|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11100026|NCT01223404|12283989|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
11100027|NCT01223404|12283990|FG003|NOT COMPLETED|Third Intervention (1 Day)||1
11100028|NCT01223404|12283991|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
11100029|NCT01223404|12283992|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
11100030|NCT01223469|12284010|FG000|STARTED|Overall Study||34
11100031|NCT01223469|12284011|FG001|STARTED|Overall Study||43
11100032|NCT01223469|12284010|FG000|COMPLETED|Overall Study||34
11100033|NCT01223469|12284011|FG001|COMPLETED|Overall Study||43
11100034|NCT01223469|12284010|FG000|NOT COMPLETED|Overall Study||0
11100035|NCT01223469|12284011|FG001|NOT COMPLETED|Overall Study||0
11100036|NCT01223703|12284019|FG000|STARTED|Overall Study||67
11100037|NCT01223703|12284020|FG001|STARTED|Overall Study||66
11100038|NCT01223703|12284019|FG000|COMPLETED|Overall Study||67
10827311|NCT03867383|11992679|FG001|COMPLETED|Overall Study||20
10827312|NCT03867383|11992678|FG000|NOT COMPLETED|Overall Study||0
10827313|NCT03867383|11992679|FG001|NOT COMPLETED|Overall Study||0
10827314|NCT03449758|11992686|FG000|STARTED|Overall Study||84
10827315|NCT03449758|11992686|FG000|COMPLETED|Overall Study||65
10827316|NCT03449758|11992686|FG000|NOT COMPLETED|Overall Study||19
10827317|NCT03222973|11992693|FG000|STARTED|Part 1 (Week 0 to Week 72)||131
10827318|NCT03222973|11992694|FG001|STARTED|Part 1 (Week 0 to Week 72)||132
10827319|NCT03222973|11992695|FG002|STARTED|Part 1 (Week 0 to Week 72)||0
10827320|NCT03222973|11992696|FG003|STARTED|Part 1 (Week 0 to Week 72)||0
10827321|NCT03222973|11992693|FG000|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||131
10827322|NCT03222973|11992694|FG001|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||132
10827323|NCT03222973|11992695|FG002|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||0
10827324|NCT03222973|11992696|FG003|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||0
10827325|NCT03222973|11992693|FG000|Safety Population|Part 1 (Week 0 to Week 72)||131
10827326|NCT03222973|11992694|FG001|Safety Population|Part 1 (Week 0 to Week 72)||132
10827327|NCT03222973|11992695|FG002|Safety Population|Part 1 (Week 0 to Week 72)||0
10827328|NCT03222973|11992696|FG003|Safety Population|Part 1 (Week 0 to Week 72)||0
10827329|NCT03222973|11992693|FG000|COMPLETED|Part 1 (Week 0 to Week 72)||107
10827330|NCT03222973|11992694|FG001|COMPLETED|Part 1 (Week 0 to Week 72)||118
10827331|NCT03222973|11992695|FG002|COMPLETED|Part 1 (Week 0 to Week 72)||0
10827332|NCT03222973|11992696|FG003|COMPLETED|Part 1 (Week 0 to Week 72)||0
10827333|NCT03222973|11992693|FG000|NOT COMPLETED|Part 1 (Week 0 to Week 72)||24
10827334|NCT03222973|11992694|FG001|NOT COMPLETED|Part 1 (Week 0 to Week 72)||14
10827335|NCT03222973|11992695|FG002|NOT COMPLETED|Part 1 (Week 0 to Week 72)||0
10827336|NCT03222973|11992696|FG003|NOT COMPLETED|Part 1 (Week 0 to Week 72)||0
10827337|NCT03222973|11992693|FG000|STARTED|Part 2 (Week 73 to Week 168)||0
10827338|NCT03222973|11992694|FG001|STARTED|Part 2 (Week 73 to Week 168)||0
10827339|NCT03222973|11992695|FG002|STARTED|Part 2 (Week 73 to Week 168)|6 participants who completed Part 1 did not enter Part 2.|101
10827340|NCT03222973|11992696|FG003|STARTED|Part 2 (Week 73 to Week 168)|5 participants who completed Part 1 did not enter Part 2.|113
10827341|NCT03222973|11992693|FG000|ITT Population|Part 2 (Week 73 to Week 168)||0
10827342|NCT03222973|11992694|FG001|ITT Population|Part 2 (Week 73 to Week 168)||0
10827343|NCT03222973|11992695|FG002|ITT Population|Part 2 (Week 73 to Week 168)||100
10827344|NCT03222973|11992696|FG003|ITT Population|Part 2 (Week 73 to Week 168)||113
10827345|NCT03222973|11992693|FG000|Safety Population|Part 2 (Week 73 to Week 168)||0
10827346|NCT03222973|11992694|FG001|Safety Population|Part 2 (Week 73 to Week 168)||0
10827347|NCT03222973|11992695|FG002|Safety Population|Part 2 (Week 73 to Week 168)||100
10827348|NCT03222973|11992696|FG003|Safety Population|Part 2 (Week 73 to Week 168)||113
10827349|NCT03222973|11992693|FG000|COMPLETED|Part 2 (Week 73 to Week 168)||0
10827350|NCT03222973|11992694|FG001|COMPLETED|Part 2 (Week 73 to Week 168)||0
10827351|NCT03222973|11992695|FG002|COMPLETED|Part 2 (Week 73 to Week 168)||0
10827352|NCT03222973|11992696|FG003|COMPLETED|Part 2 (Week 73 to Week 168)||0
10827353|NCT03222973|11992693|FG000|NOT COMPLETED|Part 2 (Week 73 to Week 168)||0
10827354|NCT03222973|11992694|FG001|NOT COMPLETED|Part 2 (Week 73 to Week 168)||0
10827355|NCT03222973|11992695|FG002|NOT COMPLETED|Part 2 (Week 73 to Week 168)||101
10827356|NCT03222973|11992696|FG003|NOT COMPLETED|Part 2 (Week 73 to Week 168)||113
10827357|NCT03187262|11992706|FG000|STARTED|Induction||13
10827358|NCT03187262|11992706|FG000|COMPLETED|Induction||7
10827359|NCT03187262|11992706|FG000|NOT COMPLETED|Induction||6
10827360|NCT03187262|11992706|FG000|STARTED|Consolidation||7
10827361|NCT03187262|11992706|FG000|COMPLETED|Consolidation||2
10827362|NCT03187262|11992706|FG000|NOT COMPLETED|Consolidation||5
10827363|NCT03187262|11992706|FG000|STARTED|Maintenance||2
10827364|NCT03187262|11992706|FG000|COMPLETED|Maintenance||2
10827365|NCT03187262|11992706|FG000|NOT COMPLETED|Maintenance||0
10827366|NCT03137693|11992710|FG000|STARTED|Overall Study||20
10827367|NCT03137693|11992710|FG000|COMPLETED|Overall Study||20
10827368|NCT03137693|11992710|FG000|NOT COMPLETED|Overall Study||0
10827369|NCT02987959|11992714|FG000|STARTED|Overall Study||6
10827370|NCT02987959|11992714|FG000|COMPLETED|Overall Study||0
10827371|NCT02987959|11992714|FG000|NOT COMPLETED|Overall Study||6
10827372|NCT02985541|11992718|FG000|STARTED|Overall Study||364
11100039|NCT01223703|12284020|FG001|COMPLETED|Overall Study||66
11100040|NCT01223703|12284019|FG000|NOT COMPLETED|Overall Study||0
11100041|NCT01223703|12284020|FG001|NOT COMPLETED|Overall Study||0
11100042|NCT01223937|12284028|FG000|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
10827373|NCT02985541|11992718|FG000|Valid for FAS|Overall Study||362
10827374|NCT02985541|11992718|FG000|Continued Into Year 7 of Mirena Use|Overall Study||305
10827375|NCT02985541|11992718|FG000|Continued Into Year 8 of Mirena Use|Overall Study||243
10827376|NCT02985541|11992718|FG000|COMPLETED|Overall Study||223
10827377|NCT02985541|11992718|FG000|NOT COMPLETED|Overall Study||141
10827378|NCT02960893|11992724|FG000|STARTED|Randomization Phase (8-week)||71
10827379|NCT02960893|11992725|FG001|STARTED|Randomization Phase (8-week)||70
10827380|NCT02960893|11992724|FG000|COMPLETED|Randomization Phase (8-week)||64
10827381|NCT02960893|11992725|FG001|COMPLETED|Randomization Phase (8-week)||68
10827382|NCT02960893|11992724|FG000|NOT COMPLETED|Randomization Phase (8-week)||7
10827383|NCT02960893|11992725|FG001|NOT COMPLETED|Randomization Phase (8-week)||2
10827384|NCT02960893|11992724|FG000|STARTED|Extension Phase (48-week)||64
10827385|NCT02960893|11992725|FG001|STARTED|Extension Phase (48-week)|One participant in placebo arm who completed Randomization Phase did not continue to Extension Phase|67
10827386|NCT02960893|11992724|FG000|COMPLETED|Extension Phase (48-week)||50
10827387|NCT02960893|11992725|FG001|COMPLETED|Extension Phase (48-week)||54
10827388|NCT02960893|11992724|FG000|NOT COMPLETED|Extension Phase (48-week)||14
10827389|NCT02960893|11992725|FG001|NOT COMPLETED|Extension Phase (48-week)||13
10827390|NCT02940522|11992740|FG000|STARTED|Overall Study||59
10827391|NCT02940522|11992741|FG001|STARTED|Overall Study||61
10827392|NCT02940522|11992740|FG000|COMPLETED|Overall Study||57
10827393|NCT02940522|11992741|FG001|COMPLETED|Overall Study||59
10827394|NCT02940522|11992740|FG000|NOT COMPLETED|Overall Study||2
10827395|NCT02940522|11992741|FG001|NOT COMPLETED|Overall Study||2
10827396|NCT02711137|11992762|FG000|STARTED|Overall Study||4
10827397|NCT02711137|11992763|FG001|STARTED|Overall Study||5
10827398|NCT02711137|11992764|FG002|STARTED|Overall Study||8
10827399|NCT02711137|11992765|FG003|STARTED|Overall Study||7
10827400|NCT02711137|11992766|FG004|STARTED|Overall Study||5
10827401|NCT02711137|11992767|FG005|STARTED|Overall Study||1
10827402|NCT02711137|11992768|FG006|STARTED|Overall Study||86
10827403|NCT02711137|11992769|FG007|STARTED|Overall Study||5
10827404|NCT02711137|11992770|FG008|STARTED|Overall Study||1
10827405|NCT02711137|11992771|FG009|STARTED|Overall Study||2
10827406|NCT02711137|11992772|FG010|STARTED|Overall Study||4
10827407|NCT02711137|11992773|FG011|STARTED|Overall Study||3
10827408|NCT02711137|11992774|FG012|STARTED|Overall Study||1
10827409|NCT02711137|11992775|FG013|STARTED|Overall Study||2
10827410|NCT02711137|11992776|FG014|STARTED|Overall Study||3
10827411|NCT02711137|11992762|FG000|COMPLETED|Overall Study||0
10827412|NCT02711137|11992763|FG001|COMPLETED|Overall Study||0
10827413|NCT02711137|11992764|FG002|COMPLETED|Overall Study||0
10827414|NCT02711137|11992765|FG003|COMPLETED|Overall Study||0
10827415|NCT02711137|11992766|FG004|COMPLETED|Overall Study||0
11100043|NCT01223937|12284029|FG001|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
11100044|NCT01223937|12284028|FG000|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
11100045|NCT01223937|12284029|FG001|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
11100046|NCT01223937|12284028|FG000|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
11219824|NCT01957397|12411395|FG001|STARTED|Test Period 1||13
11219825|NCT01957397|12411394|FG000|COMPLETED|Test Period 1||11
11219826|NCT01957397|12411395|FG001|COMPLETED|Test Period 1||12
11219827|NCT01957397|12411394|FG000|NOT COMPLETED|Test Period 1||2
11219828|NCT01957397|12411395|FG001|NOT COMPLETED|Test Period 1||1
11219829|NCT01957397|12411394|FG000|STARTED|Test Period 2||11
11219830|NCT01957397|12411395|FG001|STARTED|Test Period 2||12
11219831|NCT01957397|12411394|FG000|COMPLETED|Test Period 2||11
11219832|NCT01957397|12411395|FG001|COMPLETED|Test Period 2||11
11219833|NCT01957397|12411394|FG000|NOT COMPLETED|Test Period 2||0
11219834|NCT01957397|12411395|FG001|NOT COMPLETED|Test Period 2||1
11219835|NCT01957397|12411394|FG000|STARTED|Test Period 3||11
11219836|NCT01957397|12411395|FG001|STARTED|Test Period 3||11
11219837|NCT01957397|12411394|FG000|COMPLETED|Test Period 3||9
11219838|NCT01957397|12411395|FG001|COMPLETED|Test Period 3||9
11219839|NCT01957397|12411394|FG000|NOT COMPLETED|Test Period 3||2
11219840|NCT01957397|12411395|FG001|NOT COMPLETED|Test Period 3||2
11219841|NCT01957410|12411405|FG000|STARTED|Open Label||13
11219842|NCT01957410|12411405|FG000|COMPLETED|Open Label||13
11219843|NCT01957410|12411405|FG000|NOT COMPLETED|Open Label||0
11219844|NCT01957410|12411405|FG000|STARTED|Optional Open Label||13
11219845|NCT01957410|12411405|FG000|COMPLETED|Optional Open Label||13
11219846|NCT01957410|12411405|FG000|NOT COMPLETED|Optional Open Label||0
11219847|NCT01957462|12411409|FG000|STARTED|Test Period 1||16
11219848|NCT01957462|12411410|FG001|STARTED|Test Period 1||15
11219849|NCT01957462|12411409|FG000|COMPLETED|Test Period 1||14
11219850|NCT01957462|12411410|FG001|COMPLETED|Test Period 1||15
11219851|NCT01957462|12411409|FG000|NOT COMPLETED|Test Period 1||2
11353977|NCT03068468|12551220|FG000|NOT COMPLETED|Placebo-Controlled Period||22
11353978|NCT03068468|12551221|FG001|NOT COMPLETED|Placebo-Controlled Period||45
11353979|NCT03068468|12551222|FG002|NOT COMPLETED|Placebo-Controlled Period||0
11353980|NCT03068468|12551223|FG003|NOT COMPLETED|Placebo-Controlled Period||0
11353981|NCT03068468|12551220|FG000|STARTED|Open-Label Extension Period||0
11353982|NCT03068468|12551221|FG001|STARTED|Open-Label Extension Period||0
11353983|NCT03068468|12551222|FG002|STARTED|Open-Label Extension Period|4 participants did not enter OLE period.|140
11353984|NCT03068468|12551223|FG003|STARTED|Open-Label Extension Period|3 participants did not enter OLE period.|276
11353985|NCT03068468|12551220|FG000|COMPLETED|Open-Label Extension Period||0
11353986|NCT03068468|12551221|FG001|COMPLETED|Open-Label Extension Period||0
11353987|NCT03068468|12551222|FG002|COMPLETED|Open-Label Extension Period||0
11353988|NCT03068468|12551223|FG003|COMPLETED|Open-Label Extension Period||0
11353989|NCT03068468|12551220|FG000|NOT COMPLETED|Open-Label Extension Period||0
11353990|NCT03068468|12551221|FG001|NOT COMPLETED|Open-Label Extension Period||0
11353991|NCT03068468|12551222|FG002|NOT COMPLETED|Open-Label Extension Period||140
11353992|NCT03068468|12551223|FG003|NOT COMPLETED|Open-Label Extension Period||276
10827416|NCT02711137|11992767|FG005|COMPLETED|Overall Study||0
11219852|NCT01957462|12411410|FG001|NOT COMPLETED|Test Period 1||0
11219853|NCT01957462|12411409|FG000|STARTED|Test Period 2||14
10827417|NCT02711137|11992768|FG006|COMPLETED|Overall Study||0
10827418|NCT02711137|11992769|FG007|COMPLETED|Overall Study||0
11219854|NCT01957462|12411410|FG001|STARTED|Test Period 2||15
11219855|NCT01957462|12411409|FG000|COMPLETED|Test Period 2||14
11219856|NCT01957462|12411410|FG001|COMPLETED|Test Period 2||15
11219857|NCT01957462|12411409|FG000|NOT COMPLETED|Test Period 2||0
10827419|NCT02711137|11992770|FG008|COMPLETED|Overall Study||0
10827420|NCT02711137|11992771|FG009|COMPLETED|Overall Study||0
10827421|NCT02711137|11992772|FG010|COMPLETED|Overall Study||0
10827422|NCT02711137|11992773|FG011|COMPLETED|Overall Study||0
10827423|NCT02711137|11992774|FG012|COMPLETED|Overall Study||0
10827424|NCT02711137|11992775|FG013|COMPLETED|Overall Study||0
10827425|NCT02711137|11992776|FG014|COMPLETED|Overall Study||0
10827426|NCT02711137|11992762|FG000|NOT COMPLETED|Overall Study||4
10827427|NCT02711137|11992763|FG001|NOT COMPLETED|Overall Study||5
10827428|NCT02711137|11992764|FG002|NOT COMPLETED|Overall Study||8
10827429|NCT02711137|11992765|FG003|NOT COMPLETED|Overall Study||7
10827430|NCT02711137|11992766|FG004|NOT COMPLETED|Overall Study||5
10827431|NCT02711137|11992767|FG005|NOT COMPLETED|Overall Study||1
10827432|NCT02711137|11992768|FG006|NOT COMPLETED|Overall Study||86
10827433|NCT02711137|11992769|FG007|NOT COMPLETED|Overall Study||5
10827434|NCT02711137|11992770|FG008|NOT COMPLETED|Overall Study||1
10827435|NCT02711137|11992771|FG009|NOT COMPLETED|Overall Study||2
10827436|NCT02711137|11992772|FG010|NOT COMPLETED|Overall Study||4
10827437|NCT02711137|11992773|FG011|NOT COMPLETED|Overall Study||3
10827438|NCT02711137|11992774|FG012|NOT COMPLETED|Overall Study||1
10827439|NCT02711137|11992775|FG013|NOT COMPLETED|Overall Study||2
10827440|NCT02711137|11992776|FG014|NOT COMPLETED|Overall Study||3
11100047|NCT01223937|12284029|FG001|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
11100048|NCT01223937|12284028|FG000|COMPLETED|Overall Study||114
11100049|NCT01223937|12284029|FG001|COMPLETED|Overall Study||119
11100050|NCT01223937|12284028|FG000|NOT COMPLETED|Overall Study||17
11100051|NCT01223937|12284029|FG001|NOT COMPLETED|Overall Study||18
11100052|NCT01224015|12284038|FG000|STARTED|Overall Study||361
11100053|NCT01224015|12284039|FG001|STARTED|Overall Study||227
11100054|NCT01224015|12284040|FG002|STARTED|Overall Study||96
11100055|NCT01224015|12284038|FG000|COMPLETED|Overall Study||347
11100056|NCT01224015|12284039|FG001|COMPLETED|Overall Study||211
11100057|NCT01224015|12284040|FG002|COMPLETED|Overall Study||83
11100058|NCT01224015|12284038|FG000|NOT COMPLETED|Overall Study||14
11100059|NCT01224015|12284039|FG001|NOT COMPLETED|Overall Study||16
11100060|NCT01224015|12284040|FG002|NOT COMPLETED|Overall Study||13
11100061|NCT01224145|12284048|FG000|STARTED|Overall Study||10
11100062|NCT01224145|12284048|FG000|COMPLETED|Overall Study||10
11100063|NCT01224145|12284048|FG000|NOT COMPLETED|Overall Study||0
11100064|NCT01224158|12284055|FG000|STARTED|Overall Study||76
11100065|NCT01224158|12284056|FG001|STARTED|Overall Study||77
11100066|NCT01224158|12284055|FG000|COMPLETED|Overall Study||75
11100067|NCT01224158|12284056|FG001|COMPLETED|Overall Study||77
11100068|NCT01224158|12284055|FG000|NOT COMPLETED|Overall Study||1
11100069|NCT01224158|12284056|FG001|NOT COMPLETED|Overall Study||0
11100070|NCT01224171|12284064|FG000|STARTED|Overall Study||207
11100071|NCT01224171|12284065|FG001|STARTED|Overall Study||209
11100072|NCT01224171|12284064|FG000|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
11100073|NCT01224171|12284065|FG001|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
11100074|NCT01224171|12284064|FG000|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
11100075|NCT01224171|12284065|FG001|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
11100076|NCT01224171|12284064|FG000|NOT COMPLETED|Overall Study||15
11100077|NCT01224171|12284065|FG001|NOT COMPLETED|Overall Study||13
11100078|NCT01224210|12284071|FG000|STARTED|Overall Study||30
11100079|NCT01224210|12284071|FG000|COMPLETED|Overall Study||23
11100080|NCT01224210|12284071|FG000|NOT COMPLETED|Overall Study||7
11100081|NCT01224236|12284078|FG000|STARTED|Overall Study||76
11100082|NCT01224236|12284079|FG001|STARTED|Overall Study||74
11100083|NCT01224236|12284078|FG000|COMPLETED|Overall Study||75
11100084|NCT01224236|12284079|FG001|COMPLETED|Overall Study||73
11100085|NCT01224236|12284078|FG000|NOT COMPLETED|Overall Study||1
11100086|NCT01224236|12284079|FG001|NOT COMPLETED|Overall Study||1
11100087|NCT01224431|12284087|FG000|STARTED|Overall Study||30
11219858|NCT01957462|12411410|FG001|NOT COMPLETED|Test Period 2||0
11219859|NCT01957475|12411416|FG000|STARTED|Test Period 1||10
11219860|NCT01957475|12411417|FG001|STARTED|Test Period 1||10
11219861|NCT01957475|12411416|FG000|COMPLETED|Test Period 1||8
11219862|NCT01957475|12411417|FG001|COMPLETED|Test Period 1||9
11219863|NCT01957475|12411416|FG000|NOT COMPLETED|Test Period 1||2
11219864|NCT01957475|12411417|FG001|NOT COMPLETED|Test Period 1||1
11100088|NCT01224431|12284088|FG001|STARTED|Overall Study||30
11100089|NCT01224431|12284087|FG000|COMPLETED|Overall Study||30
11100090|NCT01224431|12284088|FG001|COMPLETED|Overall Study||25
11100091|NCT01224431|12284087|FG000|NOT COMPLETED|Overall Study||0
11100092|NCT01224431|12284088|FG001|NOT COMPLETED|Overall Study||5
11100093|NCT01224444|12284096|FG000|STARTED|Overall Study||269
11100094|NCT01224444|12284096|FG000|COMPLETED|Overall Study||269
11100095|NCT01224444|12284096|FG000|NOT COMPLETED|Overall Study||0
11100096|NCT01224626|12284100|FG000|STARTED|Overall Study||42
11100097|NCT01224626|12284100|FG000|COMPLETED|Overall Study||41
11100098|NCT01224626|12284100|FG000|NOT COMPLETED|Overall Study||1
11100099|NCT01224639|12284112|FG000|STARTED|Overall Study||19
11100100|NCT01224639|12284113|FG001|STARTED|Overall Study||5
11100101|NCT01224639|12284114|FG002|STARTED|Overall Study||21
11100102|NCT01224639|12284115|FG003|STARTED|Overall Study||3
11100103|NCT01224639|12284116|FG004|STARTED|Overall Study||21
11100104|NCT01224639|12284117|FG005|STARTED|Overall Study||4
11100105|NCT01224639|12284118|FG006|STARTED|Overall Study||18
11100106|NCT01224639|12284119|FG007|STARTED|Overall Study||5
11100107|NCT01224639|12284112|FG000|COMPLETED|Overall Study||19
11100108|NCT01224639|12284113|FG001|COMPLETED|Overall Study||5
11100109|NCT01224639|12284114|FG002|COMPLETED|Overall Study||21
11100110|NCT01224639|12284115|FG003|COMPLETED|Overall Study||3
11100111|NCT01224639|12284116|FG004|COMPLETED|Overall Study||19
11100112|NCT01224639|12284117|FG005|COMPLETED|Overall Study||4
11100113|NCT01224639|12284118|FG006|COMPLETED|Overall Study||17
11100114|NCT01224639|12284119|FG007|COMPLETED|Overall Study||3
11100115|NCT01224639|12284112|FG000|NOT COMPLETED|Overall Study||0
11100116|NCT01224639|12284113|FG001|NOT COMPLETED|Overall Study||0
11100117|NCT01224639|12284114|FG002|NOT COMPLETED|Overall Study||0
11100118|NCT01224639|12284115|FG003|NOT COMPLETED|Overall Study||0
11100119|NCT01224639|12284116|FG004|NOT COMPLETED|Overall Study||2
11100120|NCT01224639|12284117|FG005|NOT COMPLETED|Overall Study||0
11100121|NCT01224639|12284118|FG006|NOT COMPLETED|Overall Study||1
11100122|NCT01224639|12284119|FG007|NOT COMPLETED|Overall Study||2
11100123|NCT01224678|12284139|FG000|STARTED|Overall Study||150
11100124|NCT01224678|12284140|FG001|STARTED|Overall Study||150
11100125|NCT01224678|12284139|FG000|COMPLETED|Overall Study||150
11100126|NCT01224678|12284140|FG001|COMPLETED|Overall Study||150
11100127|NCT01224678|12284139|FG000|NOT COMPLETED|Overall Study||0
11100128|NCT01224678|12284140|FG001|NOT COMPLETED|Overall Study||0
11100129|NCT01224782|12284146|FG000|STARTED|Overall Study||994
11100130|NCT01224782|12284146|FG000|COMPLETED|Overall Study||730
11100131|NCT01224782|12284146|FG000|NOT COMPLETED|Overall Study||264
11100132|NCT01224821|12284150|FG000|STARTED|Dosimetric and Therapeutic Treatment||47
11100133|NCT01224821|12284150|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
11100134|NCT01224821|12284150|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
11100135|NCT01224821|12284150|FG000|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
11100136|NCT01224821|12284150|FG000|COMPLETED|Long-Term Follow-Up||0
11100137|NCT01224821|12284150|FG000|NOT COMPLETED|Long-Term Follow-Up||11
11100138|NCT01224925|12284156|FG000|STARTED|Overall Study||37
11100139|NCT01224925|12284157|FG001|STARTED|Overall Study||33
11100140|NCT01224925|12284156|FG000|COMPLETED|Overall Study||34
11100141|NCT01224925|12284157|FG001|COMPLETED|Overall Study||31
11100142|NCT01224925|12284156|FG000|NOT COMPLETED|Overall Study||3
11100143|NCT01224925|12284157|FG001|NOT COMPLETED|Overall Study||2
11100144|NCT01225029|12284167|FG000|STARTED|Overall Study||32
11100145|NCT01225029|12284168|FG001|STARTED|Overall Study||32
11100146|NCT01225029|12284167|FG000|COMPLETED|Overall Study||32
11100147|NCT01225029|12284168|FG001|COMPLETED|Overall Study||32
11100148|NCT01225029|12284167|FG000|NOT COMPLETED|Overall Study||0
11100149|NCT01225029|12284168|FG001|NOT COMPLETED|Overall Study||0
11100150|NCT01225055|12284177|FG000|STARTED|Overall Study||20
11100151|NCT01225055|12284178|FG001|STARTED|Overall Study||20
11100152|NCT01225055|12284179|FG002|STARTED|Overall Study||21
11100153|NCT01225055|12284177|FG000|COMPLETED|Overall Study||20
11100154|NCT01225055|12284178|FG001|COMPLETED|Overall Study||18
11100155|NCT01225055|12284179|FG002|COMPLETED|Overall Study||18
11100156|NCT01225055|12284177|FG000|NOT COMPLETED|Overall Study||0
11100157|NCT01225055|12284178|FG001|NOT COMPLETED|Overall Study||2
11100158|NCT01225055|12284179|FG002|NOT COMPLETED|Overall Study||3
11100159|NCT01225068|12284189|FG000|STARTED|Overall Study||20
11100160|NCT01225068|12284190|FG001|STARTED|Overall Study||20
11100161|NCT01225068|12284189|FG000|COMPLETED|Overall Study||16
11100162|NCT01225068|12284190|FG001|COMPLETED|Overall Study||19
11100163|NCT01225068|12284189|FG000|NOT COMPLETED|Overall Study||4
11100164|NCT01225068|12284190|FG001|NOT COMPLETED|Overall Study||1
11100165|NCT01225146|12284198|FG000|STARTED|Overall Study||6
11100166|NCT01225146|12284199|FG001|STARTED|Overall Study||2
11100167|NCT01225146|12284198|FG000|COMPLETED|Overall Study||6
11100168|NCT01225146|12284199|FG001|COMPLETED|Overall Study||0
11100169|NCT01225146|12284198|FG000|NOT COMPLETED|Overall Study||0
11100170|NCT01225146|12284199|FG001|NOT COMPLETED|Overall Study||2
11100171|NCT01225159|12284209|FG000|STARTED|Overall Study||100
11100172|NCT01225159|12284210|FG001|STARTED|Overall Study||100
11100173|NCT01225159|12284209|FG000|COMPLETED|Overall Study||99
11100174|NCT01225159|12284210|FG001|COMPLETED|Overall Study||100
11100175|NCT01225159|12284209|FG000|NOT COMPLETED|Overall Study||1
11100176|NCT01225159|12284210|FG001|NOT COMPLETED|Overall Study||0
11100177|NCT01225172|12284218|FG000|STARTED|Overall Study||52
11100178|NCT01225172|12284219|FG001|STARTED|Overall Study||7
11100179|NCT01225172|12284218|FG000|COMPLETED|Overall Study||46
11100180|NCT01225172|12284219|FG001|COMPLETED|Overall Study||6
11100181|NCT01225172|12284218|FG000|NOT COMPLETED|Overall Study||6
11100182|NCT01225172|12284219|FG001|NOT COMPLETED|Overall Study||1
11100183|NCT01225211|12284235|FG000|STARTED|Overall Study||21
11100184|NCT01225211|12284236|FG001|STARTED|Overall Study||20
11100185|NCT01225211|12284237|FG002|STARTED|Overall Study||21
11100186|NCT01225211|12284238|FG003|STARTED|Overall Study||27
11100187|NCT01225211|12284239|FG004|STARTED|Overall Study||23
10827557|NCT02575976|11992861|FG000|STARTED|Overall Study||37
10827558|NCT02575976|11992862|FG001|STARTED|Overall Study||39
10827559|NCT02575976|11992863|FG002|STARTED|Overall Study||39
10827560|NCT02575976|11992861|FG000|COMPLETED|Overall Study||32
10827561|NCT02575976|11992862|FG001|COMPLETED|Overall Study||31
10827562|NCT02575976|11992863|FG002|COMPLETED|Overall Study||30
10827563|NCT02575976|11992861|FG000|NOT COMPLETED|Overall Study||5
10827564|NCT02575976|11992862|FG001|NOT COMPLETED|Overall Study||8
10827565|NCT02575976|11992863|FG002|NOT COMPLETED|Overall Study||9
10827566|NCT02545868|11992874|FG000|STARTED|Immunization Study Period (ISP)||33
10827567|NCT02545868|11992875|FG001|STARTED|Immunization Study Period (ISP)||35
10827568|NCT02545868|11992876|FG002|STARTED|Immunization Study Period (ISP)||34
10827569|NCT02545868|11992874|FG000|COMPLETED|Immunization Study Period (ISP)||33
11100188|NCT01225211|12284240|FG005|STARTED|Overall Study||21
10827570|NCT02545868|11992875|FG001|COMPLETED|Immunization Study Period (ISP)||35
10827571|NCT02545868|11992876|FG002|COMPLETED|Immunization Study Period (ISP)||34
10827572|NCT02545868|11992874|FG000|NOT COMPLETED|Immunization Study Period (ISP)||0
10827573|NCT02545868|11992875|FG001|NOT COMPLETED|Immunization Study Period (ISP)||0
10827574|NCT02545868|11992876|FG002|NOT COMPLETED|Immunization Study Period (ISP)||0
10827575|NCT02545868|11992874|FG000|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
10827576|NCT02545868|11992875|FG001|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
10827577|NCT02545868|11992876|FG002|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
10827578|NCT02545868|11992874|FG000|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
10827579|NCT02545868|11992875|FG001|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
10827580|NCT02545868|11992876|FG002|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
10827581|NCT02545868|11992874|FG000|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
10827582|NCT02545868|11992875|FG001|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
10827583|NCT02545868|11992876|FG002|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
10827584|NCT02470091|11992891|FG000|STARTED|Overall Study||16
10827585|NCT02470091|11992892|FG001|STARTED|Overall Study||40
10827586|NCT02470091|11992891|FG000|Follow-up Report|Overall Study||1
10827587|NCT02470091|11992892|FG001|Follow-up Report|Overall Study||10
10827588|NCT02470091|11992891|FG000|COMPLETED|Overall Study||15
10827589|NCT02470091|11992892|FG001|COMPLETED|Overall Study||38
10827590|NCT02470091|11992891|FG000|NOT COMPLETED|Overall Study||1
10827591|NCT02470091|11992892|FG001|NOT COMPLETED|Overall Study||2
10827592|NCT02440425|11992900|FG000|STARTED|Overall Study||42
10827593|NCT02440425|11992900|FG000|COMPLETED|Overall Study||37
10827594|NCT02440425|11992900|FG000|NOT COMPLETED|Overall Study||5
10827595|NCT02343120|11992909|FG000|STARTED|Part 1: Dose Escalation||3
10827596|NCT02343120|11992910|FG001|STARTED|Part 1: Dose Escalation||4
10827597|NCT02343120|11992911|FG002|STARTED|Part 1: Dose Escalation||5
10827598|NCT02343120|11992912|FG003|STARTED|Part 1: Dose Escalation||4
10827599|NCT02343120|11992913|FG004|STARTED|Part 1: Dose Escalation||1
10827600|NCT02343120|11992909|FG000|COMPLETED|Part 1: Dose Escalation||0
10827601|NCT02343120|11992910|FG001|COMPLETED|Part 1: Dose Escalation||0
10827602|NCT02343120|11992911|FG002|COMPLETED|Part 1: Dose Escalation||0
10827603|NCT02343120|11992912|FG003|COMPLETED|Part 1: Dose Escalation||0
10827604|NCT02343120|11992913|FG004|COMPLETED|Part 1: Dose Escalation||0
10827605|NCT02343120|11992909|FG000|NOT COMPLETED|Part 1: Dose Escalation||3
10827606|NCT02343120|11992910|FG001|NOT COMPLETED|Part 1: Dose Escalation||4
10827607|NCT02343120|11992911|FG002|NOT COMPLETED|Part 1: Dose Escalation||5
10827608|NCT02343120|11992912|FG003|NOT COMPLETED|Part 1: Dose Escalation||4
10827609|NCT02343120|11992913|FG004|NOT COMPLETED|Part 1: Dose Escalation||1
10827610|NCT02343120|11992909|FG000|STARTED|Part 2: Expansion||0
10827611|NCT02343120|11992910|FG001|STARTED|Part 2: Expansion||0
10827612|NCT02343120|11992911|FG002|STARTED|Part 2: Expansion||0
10827613|NCT02343120|11992912|FG003|STARTED|Part 2: Expansion||274
10827614|NCT02343120|11992913|FG004|STARTED|Part 2: Expansion||94
10827615|NCT02343120|11992909|FG000|COMPLETED|Part 2: Expansion||0
10827616|NCT02343120|11992910|FG001|COMPLETED|Part 2: Expansion||0
10827617|NCT02343120|11992911|FG002|COMPLETED|Part 2: Expansion||0
10827618|NCT02343120|11992912|FG003|COMPLETED|Part 2: Expansion||0
10827619|NCT02343120|11992913|FG004|COMPLETED|Part 2: Expansion||0
10827620|NCT02343120|11992909|FG000|NOT COMPLETED|Part 2: Expansion||0
10827621|NCT02343120|11992910|FG001|NOT COMPLETED|Part 2: Expansion||0
10827622|NCT02343120|11992911|FG002|NOT COMPLETED|Part 2: Expansion||0
10827623|NCT02343120|11992912|FG003|NOT COMPLETED|Part 2: Expansion||274
10827624|NCT02343120|11992913|FG004|NOT COMPLETED|Part 2: Expansion||94
11100189|NCT01225211|12284241|FG006|STARTED|Overall Study||42
11100190|NCT01225211|12284242|FG007|STARTED|Overall Study||11
11100191|NCT01225211|12284243|FG008|STARTED|Overall Study||63
11100192|NCT01225211|12284244|FG009|STARTED|Overall Study||62
11100193|NCT01225211|12284235|FG000|COMPLETED|Overall Study||21
11100194|NCT01225211|12284236|FG001|COMPLETED|Overall Study||20
11100195|NCT01225211|12284237|FG002|COMPLETED|Overall Study||20
11100196|NCT01225211|12284238|FG003|COMPLETED|Overall Study||27
11100197|NCT01225211|12284239|FG004|COMPLETED|Overall Study||23
11100198|NCT01225211|12284240|FG005|COMPLETED|Overall Study||21
11100199|NCT01225211|12284241|FG006|COMPLETED|Overall Study||41
11100200|NCT01225211|12284242|FG007|COMPLETED|Overall Study||11
11100201|NCT01225211|12284243|FG008|COMPLETED|Overall Study||62
11100202|NCT01225211|12284244|FG009|COMPLETED|Overall Study||57
11100203|NCT01225211|12284235|FG000|NOT COMPLETED|Overall Study||0
11100204|NCT01225211|12284236|FG001|NOT COMPLETED|Overall Study||0
11100205|NCT01225211|12284237|FG002|NOT COMPLETED|Overall Study||1
11100206|NCT01225211|12284238|FG003|NOT COMPLETED|Overall Study||0
11100207|NCT01225211|12284239|FG004|NOT COMPLETED|Overall Study||0
11100208|NCT01225211|12284240|FG005|NOT COMPLETED|Overall Study||0
11100209|NCT01225211|12284241|FG006|NOT COMPLETED|Overall Study||1
11100210|NCT01225211|12284242|FG007|NOT COMPLETED|Overall Study||0
11100211|NCT01225211|12284243|FG008|NOT COMPLETED|Overall Study||1
11100212|NCT01225211|12284244|FG009|NOT COMPLETED|Overall Study||5
11100213|NCT01225250|12284303|FG000|STARTED|Overall Study||15
11100214|NCT01225250|12284304|FG001|STARTED|Overall Study||15
11100215|NCT01225250|12284303|FG000|COMPLETED|Overall Study||10
11100216|NCT01225250|12284304|FG001|COMPLETED|Overall Study||10
11100217|NCT01225250|12284303|FG000|NOT COMPLETED|Overall Study||5
11100218|NCT01225250|12284304|FG001|NOT COMPLETED|Overall Study||5
11100219|NCT01225263|12284312|FG000|STARTED|Weeks 1 to 12||28
11100220|NCT01225263|12284313|FG001|STARTED|Weeks 1 to 12||29
11100221|NCT01225263|12284312|FG000|COMPLETED|Weeks 1 to 12||28
11100222|NCT01225263|12284313|FG001|COMPLETED|Weeks 1 to 12||29
11100223|NCT01225263|12284312|FG000|NOT COMPLETED|Weeks 1 to 12||0
11100224|NCT01225263|12284313|FG001|NOT COMPLETED|Weeks 1 to 12||0
11100225|NCT01225263|12284312|FG000|STARTED|Weeks 13 to 24||28
11353993|NCT03068611|12551233|FG000|STARTED|Overall Study||61
11353994|NCT03068611|12551234|FG001|STARTED|Overall Study||58
11353995|NCT03068611|12551233|FG000|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30
11353996|NCT03068611|12551234|FG001|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33
11353997|NCT03068611|12551233|FG000|NOT COMPLETED|Overall Study||31
11353998|NCT03068611|12551234|FG001|NOT COMPLETED|Overall Study||25
11353999|NCT03068754|12551242|FG000|STARTED|Randomized Treatment Period (RTP)||95
11354000|NCT03068754|12551243|FG001|STARTED|Randomized Treatment Period (RTP)||48
11354001|NCT03068754|12551244|FG002|STARTED|Randomized Treatment Period (RTP)|OLE Arms were not included during the RTP|0
11354002|NCT03068754|12551245|FG003|STARTED|Randomized Treatment Period (RTP)||0
11354003|NCT03068754|12551242|FG000|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||95
11354004|NCT03068754|12551243|FG001|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||48
11354005|NCT03068754|12551244|FG002|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
11354006|NCT03068754|12551245|FG003|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
11354007|NCT03068754|12551242|FG000|Safety Population|Randomized Treatment Period (RTP)||95
11354008|NCT03068754|12551243|FG001|Safety Population|Randomized Treatment Period (RTP)||47
11354009|NCT03068754|12551244|FG002|Safety Population|Randomized Treatment Period (RTP)||0
11354010|NCT03068754|12551245|FG003|Safety Population|Randomized Treatment Period (RTP)||0
11354011|NCT03068754|12551242|FG000|Modified ITT (mITT)|Randomized Treatment Period (RTP)||93
11354012|NCT03068754|12551243|FG001|Modified ITT (mITT)|Randomized Treatment Period (RTP)||46
11354013|NCT03068754|12551244|FG002|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
11354014|NCT03068754|12551245|FG003|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
11354015|NCT03068754|12551242|FG000|Completed Taper|Randomized Treatment Period (RTP)||58
11354016|NCT03068754|12551243|FG001|Completed Taper|Randomized Treatment Period (RTP)||28
11354017|NCT03068754|12551244|FG002|Completed Taper|Randomized Treatment Period (RTP)||0
11354018|NCT03068754|12551245|FG003|Completed Taper|Randomized Treatment Period (RTP)||0
11354019|NCT03068754|12551242|FG000|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||28
11354020|NCT03068754|12551243|FG001|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||9
11354021|NCT03068754|12551244|FG002|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
11354022|NCT03068754|12551245|FG003|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
11354023|NCT03068754|12551242|FG000|Completed RTP|Randomized Treatment Period (RTP)||27
11354024|NCT03068754|12551243|FG001|Completed RTP|Randomized Treatment Period (RTP)||9
11354025|NCT03068754|12551244|FG002|Completed RTP|Randomized Treatment Period (RTP)||0
11354026|NCT03068754|12551245|FG003|Completed RTP|Randomized Treatment Period (RTP)||0
11354027|NCT03068754|12551242|FG000|Enrolled in OLE Period|Randomized Treatment Period (RTP)||25
11354028|NCT03068754|12551243|FG001|Enrolled in OLE Period|Randomized Treatment Period (RTP)||8
11354029|NCT03068754|12551244|FG002|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
11100226|NCT01225263|12284313|FG001|STARTED|Weeks 13 to 24||29
11100227|NCT01225263|12284312|FG000|COMPLETED|Weeks 13 to 24||24
11100228|NCT01225263|12284313|FG001|COMPLETED|Weeks 13 to 24||28
11100229|NCT01225263|12284312|FG000|NOT COMPLETED|Weeks 13 to 24||4
11100230|NCT01225263|12284313|FG001|NOT COMPLETED|Weeks 13 to 24||1
11100231|NCT01225289|12284322|FG000|STARTED|Overall Study||18
11100232|NCT01225289|12284323|FG001|STARTED|Overall Study||18
11100233|NCT01225289|12284322|FG000|COMPLETED|Overall Study||18
11100234|NCT01225289|12284323|FG001|COMPLETED|Overall Study||17
11100235|NCT01225289|12284322|FG000|NOT COMPLETED|Overall Study||0
11100236|NCT01225289|12284323|FG001|NOT COMPLETED|Overall Study||1
11100237|NCT01225354|12284329|FG000|STARTED|Overall Study||20
11100238|NCT01225354|12284329|FG000|COMPLETED|Overall Study||19
11100239|NCT01225354|12284329|FG000|NOT COMPLETED|Overall Study||1
11100240|NCT01225549|12284334|FG000|STARTED|Period 1 - First Treatment Period||1
11100241|NCT01225549|12284335|FG001|STARTED|Period 1 - First Treatment Period||4
11100242|NCT01225549|12284336|FG002|STARTED|Period 1 - First Treatment Period||3
11100243|NCT01225549|12284337|FG003|STARTED|Period 1 - First Treatment Period||1
11100244|NCT01225549|12284338|FG004|STARTED|Period 1 - First Treatment Period||1
11100245|NCT01225549|12284339|FG005|STARTED|Period 1 - First Treatment Period||1
11100246|NCT01225549|12284340|FG006|STARTED|Period 1 - First Treatment Period||3
11100247|NCT01225549|12284341|FG007|STARTED|Period 1 - First Treatment Period||1
11100248|NCT01225549|12284342|FG008|STARTED|Period 1 - First Treatment Period||4
11100249|NCT01225549|12284343|FG009|STARTED|Period 1 - First Treatment Period||1
11100250|NCT01225549|12284334|FG000|COMPLETED|Period 1 - First Treatment Period||1
11100251|NCT01225549|12284335|FG001|COMPLETED|Period 1 - First Treatment Period||4
11100252|NCT01225549|12284336|FG002|COMPLETED|Period 1 - First Treatment Period||3
11100253|NCT01225549|12284337|FG003|COMPLETED|Period 1 - First Treatment Period||1
11100254|NCT01225549|12284338|FG004|COMPLETED|Period 1 - First Treatment Period||1
11100255|NCT01225549|12284339|FG005|COMPLETED|Period 1 - First Treatment Period||1
11100256|NCT01225549|12284340|FG006|COMPLETED|Period 1 - First Treatment Period||3
11100257|NCT01225549|12284341|FG007|COMPLETED|Period 1 - First Treatment Period||1
11100258|NCT01225549|12284342|FG008|COMPLETED|Period 1 - First Treatment Period||4
11100259|NCT01225549|12284343|FG009|COMPLETED|Period 1 - First Treatment Period||1
11100260|NCT01225549|12284334|FG000|NOT COMPLETED|Period 1 - First Treatment Period||0
11100261|NCT01225549|12284335|FG001|NOT COMPLETED|Period 1 - First Treatment Period||0
11100262|NCT01225549|12284336|FG002|NOT COMPLETED|Period 1 - First Treatment Period||0
11100263|NCT01225549|12284337|FG003|NOT COMPLETED|Period 1 - First Treatment Period||0
11100264|NCT01225549|12284338|FG004|NOT COMPLETED|Period 1 - First Treatment Period||0
11100265|NCT01225549|12284339|FG005|NOT COMPLETED|Period 1 - First Treatment Period||0
11100266|NCT01225549|12284340|FG006|NOT COMPLETED|Period 1 - First Treatment Period||0
11100267|NCT01225549|12284341|FG007|NOT COMPLETED|Period 1 - First Treatment Period||0
11100268|NCT01225549|12284342|FG008|NOT COMPLETED|Period 1 - First Treatment Period||0
11100269|NCT01225549|12284343|FG009|NOT COMPLETED|Period 1 - First Treatment Period||0
11100270|NCT01225549|12284334|FG000|STARTED|Period 2 - Washout||1
11100271|NCT01225549|12284335|FG001|STARTED|Period 2 - Washout||4
11100272|NCT01225549|12284336|FG002|STARTED|Period 2 - Washout||3
11100273|NCT01225549|12284337|FG003|STARTED|Period 2 - Washout||1
11100274|NCT01225549|12284338|FG004|STARTED|Period 2 - Washout||1
11100275|NCT01225549|12284339|FG005|STARTED|Period 2 - Washout||1
11100276|NCT01225549|12284340|FG006|STARTED|Period 2 - Washout||3
11100277|NCT01225549|12284341|FG007|STARTED|Period 2 - Washout||1
11100278|NCT01225549|12284342|FG008|STARTED|Period 2 - Washout||4
11100279|NCT01225549|12284343|FG009|STARTED|Period 2 - Washout||1
11100280|NCT01225549|12284334|FG000|COMPLETED|Period 2 - Washout||1
11100281|NCT01225549|12284335|FG001|COMPLETED|Period 2 - Washout||4
11100282|NCT01225549|12284336|FG002|COMPLETED|Period 2 - Washout||3
11100283|NCT01225549|12284337|FG003|COMPLETED|Period 2 - Washout||1
11100284|NCT01225549|12284338|FG004|COMPLETED|Period 2 - Washout||1
11100285|NCT01225549|12284339|FG005|COMPLETED|Period 2 - Washout||1
11100286|NCT01225549|12284340|FG006|COMPLETED|Period 2 - Washout||3
11100287|NCT01225549|12284341|FG007|COMPLETED|Period 2 - Washout||1
11100288|NCT01225549|12284342|FG008|COMPLETED|Period 2 - Washout||4
11100289|NCT01225549|12284343|FG009|COMPLETED|Period 2 - Washout||1
11100290|NCT01225549|12284334|FG000|NOT COMPLETED|Period 2 - Washout||0
11100291|NCT01225549|12284335|FG001|NOT COMPLETED|Period 2 - Washout||0
11100292|NCT01225549|12284336|FG002|NOT COMPLETED|Period 2 - Washout||0
11100293|NCT01225549|12284337|FG003|NOT COMPLETED|Period 2 - Washout||0
11100294|NCT01225549|12284338|FG004|NOT COMPLETED|Period 2 - Washout||0
11100295|NCT01225549|12284339|FG005|NOT COMPLETED|Period 2 - Washout||0
11100296|NCT01225549|12284340|FG006|NOT COMPLETED|Period 2 - Washout||0
11100297|NCT01225549|12284341|FG007|NOT COMPLETED|Period 2 - Washout||0
11100298|NCT01225549|12284342|FG008|NOT COMPLETED|Period 2 - Washout||0
11100299|NCT01225549|12284343|FG009|NOT COMPLETED|Period 2 - Washout||0
11100300|NCT01225549|12284334|FG000|STARTED|Period 3 - Second Treatment Period||1
11100301|NCT01225549|12284335|FG001|STARTED|Period 3 - Second Treatment Period||4
11100302|NCT01225549|12284336|FG002|STARTED|Period 3 - Second Treatment Period||3
11100303|NCT01225549|12284337|FG003|STARTED|Period 3 - Second Treatment Period||1
10827724|NCT01634048|11992986|FG000|STARTED|Overall Study||21
10827725|NCT01634048|11992987|FG001|STARTED|Overall Study||18
10827726|NCT01634048|11992986|FG000|COMPLETED|Overall Study||15
10827727|NCT01634048|11992987|FG001|COMPLETED|Overall Study||15
10827728|NCT01634048|11992986|FG000|NOT COMPLETED|Overall Study||6
10827729|NCT01634048|11992987|FG001|NOT COMPLETED|Overall Study||3
10827730|NCT01539863|11992995|FG000|STARTED|Overall Study||166
10827731|NCT01539863|11992996|FG001|STARTED|Overall Study||162
10827732|NCT01539863|11992995|FG000|COMPLETED|Overall Study||161
10827733|NCT01539863|11992996|FG001|COMPLETED|Overall Study||158
10827734|NCT01539863|11992995|FG000|NOT COMPLETED|Overall Study||5
10827735|NCT01539863|11992996|FG001|NOT COMPLETED|Overall Study||4
10827736|NCT01505062|11993005|FG000|STARTED|Overall Study||3
10827737|NCT01505062|11993006|FG001|STARTED|Overall Study||3
10827738|NCT01505062|11993007|FG002|STARTED|Overall Study||3
10827739|NCT01505062|11993005|FG000|COMPLETED|Overall Study||3
10827740|NCT01505062|11993006|FG001|COMPLETED|Overall Study||3
10827741|NCT01505062|11993007|FG002|COMPLETED|Overall Study||3
10827742|NCT01505062|11993005|FG000|NOT COMPLETED|Overall Study||0
10827743|NCT01505062|11993006|FG001|NOT COMPLETED|Overall Study||0
10827744|NCT01505062|11993007|FG002|NOT COMPLETED|Overall Study||0
10827745|NCT01439165|11993017|FG000|STARTED|Overall Study||1002
10827746|NCT01439165|11993018|FG001|STARTED|Overall Study||328
10827747|NCT01439165|11993017|FG000|COMPLETED|Overall Study||981
10827748|NCT01439165|11993018|FG001|COMPLETED|Overall Study||326
10827749|NCT01439165|11993017|FG000|NOT COMPLETED|Overall Study||21
10827750|NCT01439165|11993018|FG001|NOT COMPLETED|Overall Study||2
10827751|NCT01264679|11993024|FG000|STARTED|Overall Study||8
10827752|NCT01264679|11993024|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
10827753|NCT01264679|11993024|FG000|COMPLETED|Overall Study||3
10827754|NCT01264679|11993024|FG000|NOT COMPLETED|Overall Study||5
10827755|NCT01155388|11993031|FG000|STARTED|Overall Study||8
10827756|NCT01155388|11993032|FG001|STARTED|Overall Study||6
10827757|NCT01155388|11993031|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10827758|NCT01155388|11993032|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10827759|NCT01155388|11993031|FG000|COMPLETED|Overall Study||7
10827760|NCT01155388|11993032|FG001|COMPLETED|Overall Study||6
10827761|NCT01155388|11993031|FG000|NOT COMPLETED|Overall Study||1
10827762|NCT01155388|11993032|FG001|NOT COMPLETED|Overall Study||0
10827763|NCT01137435|11993039|FG000|STARTED|Overall Study||687
10827764|NCT01137435|11993039|FG000|COMPLETED|Overall Study||659
10827765|NCT01137435|11993039|FG000|NOT COMPLETED|Overall Study||28
10827766|NCT01095003|11993045|FG000|STARTED|Overall Study||384
10827767|NCT01095003|11993046|FG001|STARTED|Overall Study||386
10827768|NCT01095003|11993045|FG000|COMPLETED|Overall Study||0
10827769|NCT01095003|11993046|FG001|COMPLETED|Overall Study||0
10827770|NCT01095003|11993045|FG000|NOT COMPLETED|Overall Study||384
10827771|NCT01095003|11993046|FG001|NOT COMPLETED|Overall Study||386
10827772|NCT01064817|11993056|FG000|STARTED|All Study Treatment Days 1-9||62
10827773|NCT01064817|11993057|FG001|STARTED|All Study Treatment Days 1-9||62
10827774|NCT01064817|11993056|FG000|COMPLETED|All Study Treatment Days 1-9||62
10827775|NCT01064817|11993057|FG001|COMPLETED|All Study Treatment Days 1-9||62
10827776|NCT01064817|11993056|FG000|NOT COMPLETED|All Study Treatment Days 1-9||0
10827777|NCT01064817|11993057|FG001|NOT COMPLETED|All Study Treatment Days 1-9||0
10827778|NCT01064817|11993056|FG000|STARTED|Study Completion||62
10827779|NCT01064817|11993057|FG001|STARTED|Study Completion||62
10827780|NCT01064817|11993056|FG000|COMPLETED|Study Completion||60
10827781|NCT01064817|11993057|FG001|COMPLETED|Study Completion||62
10827782|NCT01064817|11993056|FG000|NOT COMPLETED|Study Completion||2
10827783|NCT01064817|11993057|FG001|NOT COMPLETED|Study Completion||0
10827784|NCT01026220|11993063|FG000|STARTED|Induction||166
10827785|NCT01026220|11993064|FG001|STARTED|Induction||0
10827786|NCT01026220|11993065|FG002|STARTED|Induction||0
10827787|NCT01026220|11993063|FG000|COMPLETED|Induction||141
10827788|NCT01026220|11993064|FG001|COMPLETED|Induction||0
10827789|NCT01026220|11993065|FG002|COMPLETED|Induction||0
10827790|NCT01026220|11993063|FG000|NOT COMPLETED|Induction||25
10827791|NCT01026220|11993064|FG001|NOT COMPLETED|Induction||0
10827792|NCT01026220|11993065|FG002|NOT COMPLETED|Induction||0
10827793|NCT01026220|11993063|FG000|STARTED|Consolidation Maintenance||0
10827794|NCT01026220|11993064|FG001|STARTED|Consolidation Maintenance||81
10827795|NCT01026220|11993065|FG002|STARTED|Consolidation Maintenance||80
10827796|NCT01026220|11993063|FG000|COMPLETED|Consolidation Maintenance||0
10827797|NCT01026220|11993064|FG001|COMPLETED|Consolidation Maintenance||75
10827798|NCT01026220|11993065|FG002|COMPLETED|Consolidation Maintenance||66
10827799|NCT01026220|11993063|FG000|NOT COMPLETED|Consolidation Maintenance||0
10827800|NCT01026220|11993064|FG001|NOT COMPLETED|Consolidation Maintenance||6
10827801|NCT01026220|11993065|FG002|NOT COMPLETED|Consolidation Maintenance||14
10827802|NCT00961714|11993080|FG000|STARTED|Overall Study||15
10827803|NCT00961714|11993080|FG000|COMPLETED|Overall Study||13
10827804|NCT00961714|11993080|FG000|NOT COMPLETED|Overall Study||2
10827805|NCT00567567|11993087|FG000|STARTED|Overall Study||210
10827806|NCT00567567|11993088|FG001|STARTED|Overall Study||176
10827807|NCT00567567|11993089|FG002|STARTED|Overall Study||279
10827808|NCT00567567|11993087|FG000|COMPLETED|Overall Study||58
10827809|NCT00567567|11993088|FG001|COMPLETED|Overall Study||42
10827810|NCT00567567|11993089|FG002|COMPLETED|Overall Study||1
10827811|NCT00567567|11993087|FG000|NOT COMPLETED|Overall Study||152
10827812|NCT00567567|11993088|FG001|NOT COMPLETED|Overall Study||134
10827813|NCT00567567|11993089|FG002|NOT COMPLETED|Overall Study||278
10827814|NCT00450450|11993101|FG000|STARTED|Overall Study||13
10827815|NCT00450450|11993102|FG001|STARTED|Overall Study||14
10827816|NCT00450450|11993101|FG000|COMPLETED|Overall Study||8
10827817|NCT00450450|11993102|FG001|COMPLETED|Overall Study||11
10827818|NCT00450450|11993101|FG000|NOT COMPLETED|Overall Study||5
10827819|NCT00450450|11993102|FG001|NOT COMPLETED|Overall Study||3
10827820|NCT00346164|11993112|FG000|STARTED|Overall Study||222
10827821|NCT00346164|11993113|FG001|STARTED|Overall Study||21
10827822|NCT00346164|11993114|FG002|STARTED|Overall Study||122
10827823|NCT00346164|11993115|FG003|STARTED|Overall Study||223
10827824|NCT00346164|11993112|FG000|COMPLETED|Overall Study||205
10827825|NCT00346164|11993113|FG001|COMPLETED|Overall Study||14
10827826|NCT00346164|11993114|FG002|COMPLETED|Overall Study||96
10827827|NCT00346164|11993115|FG003|COMPLETED|Overall Study||117
10827828|NCT00346164|11993112|FG000|NOT COMPLETED|Overall Study||17
10827829|NCT00346164|11993113|FG001|NOT COMPLETED|Overall Study||7
10827830|NCT00346164|11993114|FG002|NOT COMPLETED|Overall Study||26
10827831|NCT00346164|11993115|FG003|NOT COMPLETED|Overall Study||106
11100304|NCT01225549|12284338|FG004|STARTED|Period 3 - Second Treatment Period||1
11100305|NCT01225549|12284339|FG005|STARTED|Period 3 - Second Treatment Period||1
11100306|NCT01225549|12284340|FG006|STARTED|Period 3 - Second Treatment Period||3
11100307|NCT01225549|12284341|FG007|STARTED|Period 3 - Second Treatment Period||1
11100308|NCT01225549|12284342|FG008|STARTED|Period 3 - Second Treatment Period||4
11100309|NCT01225549|12284343|FG009|STARTED|Period 3 - Second Treatment Period||1
11100310|NCT01225549|12284334|FG000|COMPLETED|Period 3 - Second Treatment Period||1
11100311|NCT01225549|12284335|FG001|COMPLETED|Period 3 - Second Treatment Period||4
11100312|NCT01225549|12284336|FG002|COMPLETED|Period 3 - Second Treatment Period||3
11100313|NCT01225549|12284337|FG003|COMPLETED|Period 3 - Second Treatment Period||1
11100314|NCT01225549|12284338|FG004|COMPLETED|Period 3 - Second Treatment Period||1
11100315|NCT01225549|12284339|FG005|COMPLETED|Period 3 - Second Treatment Period||1
11100316|NCT01225549|12284340|FG006|COMPLETED|Period 3 - Second Treatment Period||3
11100317|NCT01225549|12284341|FG007|COMPLETED|Period 3 - Second Treatment Period||1
11100318|NCT01225549|12284342|FG008|COMPLETED|Period 3 - Second Treatment Period||4
11100319|NCT01225549|12284343|FG009|COMPLETED|Period 3 - Second Treatment Period||1
11100320|NCT01225549|12284334|FG000|NOT COMPLETED|Period 3 - Second Treatment Period||0
11100321|NCT01225549|12284335|FG001|NOT COMPLETED|Period 3 - Second Treatment Period||0
11100322|NCT01225549|12284336|FG002|NOT COMPLETED|Period 3 - Second Treatment Period||0
11100323|NCT01225549|12284337|FG003|NOT COMPLETED|Period 3 - Second Treatment Period||0
11100324|NCT01225549|12284338|FG004|NOT COMPLETED|Period 3 - Second Treatment Period||0
10827853|NCT04360187|11993176|FG000|STARTED|Double-Blind Treatment||131
10827854|NCT04360187|11993177|FG001|STARTED|Double-Blind Treatment||260
10827855|NCT04360187|11993176|FG000|COMPLETED|Double-Blind Treatment||108
10827856|NCT04360187|11993177|FG001|COMPLETED|Double-Blind Treatment||245
10827857|NCT04360187|11993176|FG000|NOT COMPLETED|Double-Blind Treatment||23
10827858|NCT04360187|11993177|FG001|NOT COMPLETED|Double-Blind Treatment||15
10827859|NCT04360187|11993176|FG000|STARTED|Follow-Up||114
10827860|NCT04360187|11993177|FG001|STARTED|Follow-Up||232
10827861|NCT04360187|11993176|FG000|COMPLETED|Follow-Up||113
10827862|NCT04360187|11993177|FG001|COMPLETED|Follow-Up||232
10827863|NCT04360187|11993176|FG000|NOT COMPLETED|Follow-Up||1
10827864|NCT04360187|11993177|FG001|NOT COMPLETED|Follow-Up||0
11100325|NCT01225549|12284339|FG005|NOT COMPLETED|Period 3 - Second Treatment Period||0
11100326|NCT01225549|12284340|FG006|NOT COMPLETED|Period 3 - Second Treatment Period||0
11100327|NCT01225549|12284341|FG007|NOT COMPLETED|Period 3 - Second Treatment Period||0
11100328|NCT01225549|12284342|FG008|NOT COMPLETED|Period 3 - Second Treatment Period||0
11100329|NCT01225549|12284343|FG009|NOT COMPLETED|Period 3 - Second Treatment Period||0
11100330|NCT01225549|12284334|FG000|STARTED|Period 4 - Washout||1
11100331|NCT01225549|12284335|FG001|STARTED|Period 4 - Washout||4
11100332|NCT01225549|12284336|FG002|STARTED|Period 4 - Washout||3
11100333|NCT01225549|12284337|FG003|STARTED|Period 4 - Washout||1
10827879|NCT03978091|11993201|FG000|STARTED|Overall Study||8
10827880|NCT03978091|11993202|FG001|STARTED|Overall Study||8
10827881|NCT03978091|11993203|FG002|STARTED|Overall Study||8
10827882|NCT03978091|11993204|FG003|STARTED|Overall Study||8
10827883|NCT03978091|11993205|FG004|STARTED|Overall Study||8
10827884|NCT03978091|11993206|FG005|STARTED|Overall Study||8
10827885|NCT03978091|11993201|FG000|COMPLETED|Overall Study||8
10827886|NCT03978091|11993202|FG001|COMPLETED|Overall Study||8
10827887|NCT03978091|11993203|FG002|COMPLETED|Overall Study||7
10827888|NCT03978091|11993204|FG003|COMPLETED|Overall Study||7
10827889|NCT03978091|11993205|FG004|COMPLETED|Overall Study||7
10827890|NCT03978091|11993206|FG005|COMPLETED|Overall Study||8
10827891|NCT03978091|11993201|FG000|NOT COMPLETED|Overall Study||0
10827892|NCT03978091|11993202|FG001|NOT COMPLETED|Overall Study||0
10827893|NCT03978091|11993203|FG002|NOT COMPLETED|Overall Study||1
10827894|NCT03978091|11993204|FG003|NOT COMPLETED|Overall Study||1
10827895|NCT03978091|11993205|FG004|NOT COMPLETED|Overall Study||1
10827896|NCT03978091|11993206|FG005|NOT COMPLETED|Overall Study||0
10827897|NCT03903640|11993220|FG000|STARTED|Overall Study||2
10827898|NCT03903640|11993220|FG000|COMPLETED|Overall Study||2
10827899|NCT03903640|11993220|FG000|NOT COMPLETED|Overall Study||0
10827900|NCT03853291|11993230|FG000|STARTED|Overall Study||18
10827901|NCT03853291|11993231|FG001|STARTED|Overall Study||16
10827902|NCT03853291|11993232|FG002|STARTED|Overall Study||18
10827903|NCT03853291|11993233|FG003|STARTED|Overall Study||16
10827904|NCT03853291|11993234|FG004|STARTED|Overall Study||6
10827905|NCT03853291|11993235|FG005|STARTED|Overall Study||11
10827906|NCT03853291|11993230|FG000|COMPLETED|Overall Study||16
10827907|NCT03853291|11993231|FG001|COMPLETED|Overall Study||13
10827908|NCT03853291|11993232|FG002|COMPLETED|Overall Study||18
10827909|NCT03853291|11993233|FG003|COMPLETED|Overall Study||16
10827910|NCT03853291|11993234|FG004|COMPLETED|Overall Study||6
10827911|NCT03853291|11993235|FG005|COMPLETED|Overall Study||11
10827912|NCT03853291|11993230|FG000|NOT COMPLETED|Overall Study||2
10827913|NCT03853291|11993231|FG001|NOT COMPLETED|Overall Study||3
10827914|NCT03853291|11993232|FG002|NOT COMPLETED|Overall Study||0
10827915|NCT03853291|11993233|FG003|NOT COMPLETED|Overall Study||0
10827916|NCT03853291|11993234|FG004|NOT COMPLETED|Overall Study||0
10827917|NCT03853291|11993235|FG005|NOT COMPLETED|Overall Study||0
11100334|NCT01225549|12284338|FG004|STARTED|Period 4 - Washout||1
11100335|NCT01225549|12284339|FG005|STARTED|Period 4 - Washout||1
11100336|NCT01225549|12284340|FG006|STARTED|Period 4 - Washout||3
11100337|NCT01225549|12284341|FG007|STARTED|Period 4 - Washout||1
11100338|NCT01225549|12284342|FG008|STARTED|Period 4 - Washout||4
11100339|NCT01225549|12284343|FG009|STARTED|Period 4 - Washout||1
10827924|NCT03638011|11993257|FG000|STARTED|Overall Study||38
10827925|NCT03638011|11993258|FG001|STARTED|Overall Study||33
10827926|NCT03638011|11993257|FG000|COMPLETED|Overall Study||38
10827927|NCT03638011|11993258|FG001|COMPLETED|Overall Study||33
10827928|NCT03638011|11993257|FG000|NOT COMPLETED|Overall Study||0
10827929|NCT03638011|11993258|FG001|NOT COMPLETED|Overall Study||0
10827930|NCT03457129|11993266|FG000|STARTED|Overall Study||10
10827931|NCT03457129|11993267|FG001|STARTED|Overall Study||10
10827932|NCT03457129|11993266|FG000|COMPLETED|Overall Study||7
10827933|NCT03457129|11993267|FG001|COMPLETED|Overall Study||8
10827934|NCT03457129|11993266|FG000|NOT COMPLETED|Overall Study||3
10827935|NCT03457129|11993267|FG001|NOT COMPLETED|Overall Study||2
11100340|NCT01225549|12284334|FG000|COMPLETED|Period 4 - Washout||1
11100341|NCT01225549|12284335|FG001|COMPLETED|Period 4 - Washout||3
11100342|NCT01225549|12284336|FG002|COMPLETED|Period 4 - Washout||3
11100343|NCT01225549|12284337|FG003|COMPLETED|Period 4 - Washout||1
11100344|NCT01225549|12284338|FG004|COMPLETED|Period 4 - Washout||1
11100345|NCT01225549|12284339|FG005|COMPLETED|Period 4 - Washout||1
11100346|NCT01225549|12284340|FG006|COMPLETED|Period 4 - Washout||3
11100347|NCT01225549|12284341|FG007|COMPLETED|Period 4 - Washout||1
11100348|NCT01225549|12284342|FG008|COMPLETED|Period 4 - Washout||4
11100349|NCT01225549|12284343|FG009|COMPLETED|Period 4 - Washout||1
11100350|NCT01225549|12284334|FG000|NOT COMPLETED|Period 4 - Washout||0
11100351|NCT01225549|12284335|FG001|NOT COMPLETED|Period 4 - Washout||1
11100352|NCT01225549|12284336|FG002|NOT COMPLETED|Period 4 - Washout||0
11100353|NCT01225549|12284337|FG003|NOT COMPLETED|Period 4 - Washout||0
11100354|NCT01225549|12284338|FG004|NOT COMPLETED|Period 4 - Washout||0
11100355|NCT01225549|12284339|FG005|NOT COMPLETED|Period 4 - Washout||0
11100356|NCT01225549|12284340|FG006|NOT COMPLETED|Period 4 - Washout||0
11100357|NCT01225549|12284341|FG007|NOT COMPLETED|Period 4 - Washout||0
11100358|NCT01225549|12284342|FG008|NOT COMPLETED|Period 4 - Washout||0
11100359|NCT01225549|12284343|FG009|NOT COMPLETED|Period 4 - Washout||0
11100360|NCT01225549|12284334|FG000|STARTED|Period 5 - Third Treatment Period||1
10827957|NCT03274804|11993295|FG000|STARTED|Overall Study||20
10827958|NCT03274804|11993295|FG000|COMPLETED|Overall Study||20
10827959|NCT03274804|11993295|FG000|NOT COMPLETED|Overall Study||0
11100361|NCT01225549|12284335|FG001|STARTED|Period 5 - Third Treatment Period||3
11100362|NCT01225549|12284336|FG002|STARTED|Period 5 - Third Treatment Period||3
11100363|NCT01225549|12284337|FG003|STARTED|Period 5 - Third Treatment Period||1
11100364|NCT01225549|12284338|FG004|STARTED|Period 5 - Third Treatment Period||1
11100365|NCT01225549|12284339|FG005|STARTED|Period 5 - Third Treatment Period||1
11100366|NCT01225549|12284340|FG006|STARTED|Period 5 - Third Treatment Period||3
10827966|NCT03190460|11993312|FG000|STARTED|Overall Study||40
10827967|NCT03190460|11993313|FG001|STARTED|Overall Study||20
10827968|NCT03190460|11993312|FG000|COMPLETED|Overall Study||3
10827969|NCT03190460|11993313|FG001|COMPLETED|Overall Study||2
10827970|NCT03190460|11993312|FG000|NOT COMPLETED|Overall Study||37
10827971|NCT03190460|11993313|FG001|NOT COMPLETED|Overall Study||18
11100367|NCT01225549|12284341|FG007|STARTED|Period 5 - Third Treatment Period||1
11100368|NCT01225549|12284342|FG008|STARTED|Period 5 - Third Treatment Period||4
11100369|NCT01225549|12284343|FG009|STARTED|Period 5 - Third Treatment Period||1
11100370|NCT01225549|12284334|FG000|COMPLETED|Period 5 - Third Treatment Period||1
11100371|NCT01225549|12284335|FG001|COMPLETED|Period 5 - Third Treatment Period||3
11100372|NCT01225549|12284336|FG002|COMPLETED|Period 5 - Third Treatment Period||3
11100373|NCT01225549|12284337|FG003|COMPLETED|Period 5 - Third Treatment Period||1
11100374|NCT01225549|12284338|FG004|COMPLETED|Period 5 - Third Treatment Period||1
11100375|NCT01225549|12284339|FG005|COMPLETED|Period 5 - Third Treatment Period||1
10827984|NCT03120949|11993336|FG000|STARTED|Overall Study|One subject was randomized in error and did not receive any dose of study drug.|1058
10827985|NCT03120949|11993337|FG001|STARTED|Overall Study||1047
10827986|NCT03120949|11993336|FG000|mITT|Overall Study||1057
10827987|NCT03120949|11993337|FG001|mITT|Overall Study||1047
10827988|NCT03120949|11993336|FG000|Safety Population|Overall Study||1043
10827989|NCT03120949|11993337|FG001|Safety Population|Overall Study||1061
10827990|NCT03120949|11993336|FG000|COMPLETED|Overall Study||830
10827991|NCT03120949|11993337|FG001|COMPLETED|Overall Study||844
10827992|NCT03120949|11993336|FG000|NOT COMPLETED|Overall Study||228
10827993|NCT03120949|11993337|FG001|NOT COMPLETED|Overall Study||203
10827994|NCT03119766|11993349|FG000|STARTED|Overall Study||151
10827995|NCT03119766|11993350|FG001|STARTED|Overall Study||158
10827996|NCT03119766|11993349|FG000|COMPLETED|Overall Study||151
10827997|NCT03119766|11993350|FG001|COMPLETED|Overall Study||158
10827998|NCT03119766|11993349|FG000|NOT COMPLETED|Overall Study||0
10827999|NCT03119766|11993350|FG001|NOT COMPLETED|Overall Study||0
10828000|NCT03077698|11993358|FG000|STARTED|Progestin Monotherapy||16
10828001|NCT03077698|11993359|FG001|STARTED|Progestin Monotherapy||0
10828002|NCT03077698|11993358|FG000|COMPLETED|Progestin Monotherapy||6
10828003|NCT03077698|11993359|FG001|COMPLETED|Progestin Monotherapy||0
10828004|NCT03077698|11993358|FG000|NOT COMPLETED|Progestin Monotherapy||10
10828005|NCT03077698|11993359|FG001|NOT COMPLETED|Progestin Monotherapy||0
10828006|NCT03077698|11993358|FG000|STARTED|Sodium Cridanimod & Progestin Therapy|Subjects with disease progression after progestin monotherapy will roll over into treatment period 2, and receive combination treatment (Sodium Cridanimod and progestin) until documented disease progression.|6
10828007|NCT03077698|11993359|FG001|STARTED|Sodium Cridanimod & Progestin Therapy|Subjects determined to have PrR negative status from a tumor tissue sample at Screening will enroll directly into Treatment Period 2 and receive combination treatment (Sodium Cridanimod and progestin) until documented disease progression.|9
10828008|NCT03077698|11993358|FG000|COMPLETED|Sodium Cridanimod & Progestin Therapy||0
10828009|NCT03077698|11993359|FG001|COMPLETED|Sodium Cridanimod & Progestin Therapy||0
10828010|NCT03077698|11993358|FG000|NOT COMPLETED|Sodium Cridanimod & Progestin Therapy||6
10828011|NCT03077698|11993359|FG001|NOT COMPLETED|Sodium Cridanimod & Progestin Therapy||9
10828012|NCT03077698|11993358|FG000|STARTED|Safety Follow Up||6
10828013|NCT03077698|11993359|FG001|STARTED|Safety Follow Up||9
10828014|NCT03077698|11993358|FG000|COMPLETED|Safety Follow Up||3
10828015|NCT03077698|11993359|FG001|COMPLETED|Safety Follow Up||8
10828016|NCT03077698|11993358|FG000|NOT COMPLETED|Safety Follow Up||3
10828017|NCT03077698|11993359|FG001|NOT COMPLETED|Safety Follow Up||1
10828018|NCT02911935|11993366|FG000|STARTED|Overall Study||101
10828019|NCT02911935|11993367|FG001|STARTED|Overall Study||99
10828020|NCT02911935|11993366|FG000|COMPLETED|Overall Study||96
10828021|NCT02911935|11993367|FG001|COMPLETED|Overall Study||92
10828022|NCT02911935|11993366|FG000|NOT COMPLETED|Overall Study||5
10828023|NCT02911935|11993367|FG001|NOT COMPLETED|Overall Study||7
10828024|NCT02874742|11993376|FG000|STARTED|Overall Study||103
10828025|NCT02874742|11993377|FG001|STARTED|Overall Study||104
10828026|NCT02874742|11993378|FG002|STARTED|Overall Study||16
10828027|NCT02874742|11993376|FG000|Safety|Overall Study||102
10828028|NCT02874742|11993377|FG001|Safety|Overall Study||99
10828029|NCT02874742|11993378|FG002|Safety|Overall Study||16
10828030|NCT02874742|11993376|FG000|COMPLETED|Overall Study||0
10828031|NCT02874742|11993377|FG001|COMPLETED|Overall Study||0
10828032|NCT02874742|11993378|FG002|COMPLETED|Overall Study||0
10828033|NCT02874742|11993376|FG000|NOT COMPLETED|Overall Study||103
10828034|NCT02874742|11993377|FG001|NOT COMPLETED|Overall Study||104
10828035|NCT02874742|11993378|FG002|NOT COMPLETED|Overall Study||16
10828036|NCT02644525|11993390|FG000|STARTED|Group 1||2
10828037|NCT02644525|11993391|FG001|STARTED|Group 1||5
10828038|NCT02644525|11993392|FG002|STARTED|Group 1||0
10828039|NCT02644525|11993393|FG003|STARTED|Group 1||0
10828040|NCT02644525|11993390|FG000|COMPLETED|Group 1||2
10828041|NCT02644525|11993391|FG001|COMPLETED|Group 1||5
11100376|NCT01225549|12284340|FG006|COMPLETED|Period 5 - Third Treatment Period||3
11100377|NCT01225549|12284341|FG007|COMPLETED|Period 5 - Third Treatment Period||1
11100378|NCT01225549|12284342|FG008|COMPLETED|Period 5 - Third Treatment Period||4
11100379|NCT01225549|12284343|FG009|COMPLETED|Period 5 - Third Treatment Period||1
11100380|NCT01225549|12284334|FG000|NOT COMPLETED|Period 5 - Third Treatment Period||0
11100381|NCT01225549|12284335|FG001|NOT COMPLETED|Period 5 - Third Treatment Period||0
11100382|NCT01225549|12284336|FG002|NOT COMPLETED|Period 5 - Third Treatment Period||0
11100383|NCT01225549|12284337|FG003|NOT COMPLETED|Period 5 - Third Treatment Period||0
11100384|NCT01225549|12284338|FG004|NOT COMPLETED|Period 5 - Third Treatment Period||0
11100385|NCT01225549|12284339|FG005|NOT COMPLETED|Period 5 - Third Treatment Period||0
11100386|NCT01225549|12284340|FG006|NOT COMPLETED|Period 5 - Third Treatment Period||0
11100387|NCT01225549|12284341|FG007|NOT COMPLETED|Period 5 - Third Treatment Period||0
11100388|NCT01225549|12284342|FG008|NOT COMPLETED|Period 5 - Third Treatment Period||0
11100389|NCT01225549|12284343|FG009|NOT COMPLETED|Period 5 - Third Treatment Period||0
11100390|NCT01225549|12284334|FG000|STARTED|Period 6 - Washout||1
11100391|NCT01225549|12284335|FG001|STARTED|Period 6 - Washout||3
11100392|NCT01225549|12284336|FG002|STARTED|Period 6 - Washout||3
11100393|NCT01225549|12284337|FG003|STARTED|Period 6 - Washout||1
11100394|NCT01225549|12284338|FG004|STARTED|Period 6 - Washout||1
11100395|NCT01225549|12284339|FG005|STARTED|Period 6 - Washout||1
11100396|NCT01225549|12284340|FG006|STARTED|Period 6 - Washout||3
11100397|NCT01225549|12284341|FG007|STARTED|Period 6 - Washout||1
11100398|NCT01225549|12284342|FG008|STARTED|Period 6 - Washout||4
11100399|NCT01225549|12284343|FG009|STARTED|Period 6 - Washout||1
11100400|NCT01225549|12284334|FG000|COMPLETED|Period 6 - Washout||1
11100401|NCT01225549|12284335|FG001|COMPLETED|Period 6 - Washout||3
11100402|NCT01225549|12284336|FG002|COMPLETED|Period 6 - Washout||3
11100403|NCT01225549|12284337|FG003|COMPLETED|Period 6 - Washout||0
11100404|NCT01225549|12284338|FG004|COMPLETED|Period 6 - Washout||1
11100405|NCT01225549|12284339|FG005|COMPLETED|Period 6 - Washout||1
11100406|NCT01225549|12284340|FG006|COMPLETED|Period 6 - Washout||3
11100407|NCT01225549|12284341|FG007|COMPLETED|Period 6 - Washout||1
11219865|NCT01957475|12411416|FG000|STARTED|Test Period 2||9
11219866|NCT01957475|12411417|FG001|STARTED|Test Period 2||8
10828042|NCT02644525|11993392|FG002|COMPLETED|Group 1||0
10828043|NCT02644525|11993393|FG003|COMPLETED|Group 1||0
11100408|NCT01225549|12284342|FG008|COMPLETED|Period 6 - Washout||4
10828044|NCT02644525|11993390|FG000|NOT COMPLETED|Group 1||0
10828045|NCT02644525|11993391|FG001|NOT COMPLETED|Group 1||0
10828046|NCT02644525|11993392|FG002|NOT COMPLETED|Group 1||0
10828047|NCT02644525|11993393|FG003|NOT COMPLETED|Group 1||0
10828048|NCT02644525|11993390|FG000|STARTED|Group 2||2
10828049|NCT02644525|11993391|FG001|STARTED|Group 2||0
10828050|NCT02644525|11993392|FG002|STARTED|Group 2||5
11100409|NCT01225549|12284343|FG009|COMPLETED|Period 6 - Washout||1
11100410|NCT01225549|12284334|FG000|NOT COMPLETED|Period 6 - Washout||0
11100411|NCT01225549|12284335|FG001|NOT COMPLETED|Period 6 - Washout||0
11100412|NCT01225549|12284336|FG002|NOT COMPLETED|Period 6 - Washout||0
11100413|NCT01225549|12284337|FG003|NOT COMPLETED|Period 6 - Washout||1
11100414|NCT01225549|12284338|FG004|NOT COMPLETED|Period 6 - Washout||0
11100415|NCT01225549|12284339|FG005|NOT COMPLETED|Period 6 - Washout||0
11100416|NCT01225549|12284340|FG006|NOT COMPLETED|Period 6 - Washout||0
11100417|NCT01225549|12284341|FG007|NOT COMPLETED|Period 6 - Washout||0
11100418|NCT01225549|12284342|FG008|NOT COMPLETED|Period 6 - Washout||0
10828051|NCT02644525|11993393|FG003|STARTED|Group 2||0
10828052|NCT02644525|11993390|FG000|COMPLETED|Group 2||2
10828053|NCT02644525|11993391|FG001|COMPLETED|Group 2||0
10828054|NCT02644525|11993392|FG002|COMPLETED|Group 2||5
10828055|NCT02644525|11993393|FG003|COMPLETED|Group 2||0
10828056|NCT02644525|11993390|FG000|NOT COMPLETED|Group 2||0
10828057|NCT02644525|11993391|FG001|NOT COMPLETED|Group 2||0
10828058|NCT02644525|11993392|FG002|NOT COMPLETED|Group 2||0
10828059|NCT02644525|11993393|FG003|NOT COMPLETED|Group 2||0
10828060|NCT02644525|11993390|FG000|STARTED|Group 3||1
10828061|NCT02644525|11993391|FG001|STARTED|Group 3||0
10828062|NCT02644525|11993392|FG002|STARTED|Group 3||0
10828063|NCT02644525|11993393|FG003|STARTED|Group 3||5
10828064|NCT02644525|11993390|FG000|COMPLETED|Group 3||1
10828065|NCT02644525|11993391|FG001|COMPLETED|Group 3||0
10828066|NCT02644525|11993392|FG002|COMPLETED|Group 3||0
10828067|NCT02644525|11993393|FG003|COMPLETED|Group 3||5
10828068|NCT02644525|11993390|FG000|NOT COMPLETED|Group 3||0
10828069|NCT02644525|11993391|FG001|NOT COMPLETED|Group 3||0
10828070|NCT02644525|11993392|FG002|NOT COMPLETED|Group 3||0
10828071|NCT02644525|11993393|FG003|NOT COMPLETED|Group 3||0
11100419|NCT01225549|12284343|FG009|NOT COMPLETED|Period 6 - Washout||0
11100420|NCT01225549|12284334|FG000|STARTED|Period 7 - Fourth Treatment Period||1
11100421|NCT01225549|12284335|FG001|STARTED|Period 7 - Fourth Treatment Period||3
11100422|NCT01225549|12284336|FG002|STARTED|Period 7 - Fourth Treatment Period||3
11100423|NCT01225549|12284337|FG003|STARTED|Period 7 - Fourth Treatment Period||0
11100424|NCT01225549|12284338|FG004|STARTED|Period 7 - Fourth Treatment Period||1
10828078|NCT02557672|11993414|FG000|STARTED|Overall Study||53
10828079|NCT02557672|11993415|FG001|STARTED|Overall Study||53
10828080|NCT02557672|11993414|FG000|COMPLETED|Overall Study||49
10828081|NCT02557672|11993415|FG001|COMPLETED|Overall Study||51
10828082|NCT02557672|11993414|FG000|NOT COMPLETED|Overall Study||4
10828083|NCT02557672|11993415|FG001|NOT COMPLETED|Overall Study||2
10828084|NCT02509312|11993423|FG000|STARTED|Overall Study||35
10828085|NCT02509312|11993424|FG001|STARTED|Overall Study||35
10828086|NCT02509312|11993423|FG000|Intraoperative Checkpoint|Overall Study||28
10828087|NCT02509312|11993424|FG001|Intraoperative Checkpoint|Overall Study||30
10828088|NCT02509312|11993423|FG000|COMPLETED|Overall Study||28
10828089|NCT02509312|11993424|FG001|COMPLETED|Overall Study||30
10828090|NCT02509312|11993423|FG000|NOT COMPLETED|Overall Study||7
10828091|NCT02509312|11993424|FG001|NOT COMPLETED|Overall Study||5
11100425|NCT01225549|12284339|FG005|STARTED|Period 7 - Fourth Treatment Period||1
11100426|NCT01225549|12284340|FG006|STARTED|Period 7 - Fourth Treatment Period||3
11100427|NCT01225549|12284341|FG007|STARTED|Period 7 - Fourth Treatment Period||1
11100428|NCT01225549|12284342|FG008|STARTED|Period 7 - Fourth Treatment Period||4
11100429|NCT01225549|12284343|FG009|STARTED|Period 7 - Fourth Treatment Period||1
11100430|NCT01225549|12284334|FG000|COMPLETED|Period 7 - Fourth Treatment Period||1
11100431|NCT01225549|12284335|FG001|COMPLETED|Period 7 - Fourth Treatment Period||3
11100432|NCT01225549|12284336|FG002|COMPLETED|Period 7 - Fourth Treatment Period||3
11100433|NCT01225549|12284337|FG003|COMPLETED|Period 7 - Fourth Treatment Period||0
11219867|NCT01957475|12411416|FG000|COMPLETED|Test Period 2||8
11219868|NCT01957475|12411417|FG001|COMPLETED|Test Period 2||8
11219869|NCT01957475|12411416|FG000|NOT COMPLETED|Test Period 2||1
11219870|NCT01957475|12411417|FG001|NOT COMPLETED|Test Period 2||0
11219871|NCT01957488|12411423|FG000|STARTED|Test Period 1 (2 Weeks)||30
11219872|NCT01957488|12411424|FG001|STARTED|Test Period 1 (2 Weeks)||31
10828092|NCT02379247|11993436|FG000|STARTED|Overall Study||3
10828093|NCT02379247|11993437|FG001|STARTED|Overall Study||3
10828094|NCT02379247|11993438|FG002|STARTED|Overall Study||7
10828095|NCT02379247|11993439|FG003|STARTED|Overall Study||30
10828096|NCT02379247|11993436|FG000|COMPLETED|Overall Study||3
10828097|NCT02379247|11993437|FG001|COMPLETED|Overall Study||3
10828098|NCT02379247|11993438|FG002|COMPLETED|Overall Study||7
10828099|NCT02379247|11993439|FG003|COMPLETED|Overall Study||30
10828100|NCT02379247|11993436|FG000|NOT COMPLETED|Overall Study||0
10828101|NCT02379247|11993437|FG001|NOT COMPLETED|Overall Study||0
10828102|NCT02379247|11993438|FG002|NOT COMPLETED|Overall Study||0
10828103|NCT02379247|11993439|FG003|NOT COMPLETED|Overall Study||0
10828104|NCT02360280|11993454|FG000|STARTED|Overall Study||28
10828105|NCT02360280|11993455|FG001|STARTED|Overall Study||30
10828106|NCT02360280|11993454|FG000|COMPLETED|Overall Study||25
10828107|NCT02360280|11993455|FG001|COMPLETED|Overall Study||29
10828108|NCT02360280|11993454|FG000|NOT COMPLETED|Overall Study||3
10828109|NCT02360280|11993455|FG001|NOT COMPLETED|Overall Study||1
10828110|NCT02163395|11993461|FG000|STARTED|Overall Study||44
10828111|NCT02163395|11993461|FG000|COMPLETED|Overall Study||39
10828112|NCT02163395|11993461|FG000|NOT COMPLETED|Overall Study||5
10828113|NCT02097134|11993465|FG000|STARTED|Overall Study||14
10828114|NCT02097134|11993465|FG000|COMPLETED|Overall Study||5
10828115|NCT02097134|11993465|FG000|NOT COMPLETED|Overall Study||9
10828116|NCT02096588|11993472|FG000|STARTED|Overall Study||15
10828117|NCT02096588|11993473|FG001|STARTED|Overall Study||16
10828118|NCT02096588|11993472|FG000|COMPLETED|Overall Study||13
10828119|NCT02096588|11993473|FG001|COMPLETED|Overall Study||15
10828120|NCT02096588|11993472|FG000|NOT COMPLETED|Overall Study||2
10828121|NCT02096588|11993473|FG001|NOT COMPLETED|Overall Study||1
10828122|NCT02053350|11993479|FG000|STARTED|Overall Study||7
10828123|NCT02053350|11993479|FG000|COMPLETED|Overall Study||2
10828124|NCT02053350|11993479|FG000|NOT COMPLETED|Overall Study||5
11100434|NCT01225549|12284338|FG004|COMPLETED|Period 7 - Fourth Treatment Period||1
11100435|NCT01225549|12284339|FG005|COMPLETED|Period 7 - Fourth Treatment Period||1
11100436|NCT01225549|12284340|FG006|COMPLETED|Period 7 - Fourth Treatment Period||3
11100437|NCT01225549|12284341|FG007|COMPLETED|Period 7 - Fourth Treatment Period||1
11100438|NCT01225549|12284342|FG008|COMPLETED|Period 7 - Fourth Treatment Period||4
11100439|NCT01225549|12284343|FG009|COMPLETED|Period 7 - Fourth Treatment Period||1
10828133|NCT01965704|11993499|FG000|STARTED|Overall Study||48
10828134|NCT01965704|11993500|FG001|STARTED|Overall Study||48
10828135|NCT01965704|11993501|FG002|STARTED|Overall Study||50
10828136|NCT01965704|11993502|FG003|STARTED|Overall Study||50
10828137|NCT01965704|11993499|FG000|Received Intervention|Overall Study||45
10828138|NCT01965704|11993500|FG001|Received Intervention|Overall Study||45
10828139|NCT01965704|11993501|FG002|Received Intervention|Overall Study||47
10828140|NCT01965704|11993502|FG003|Received Intervention|Overall Study||47
10828141|NCT01965704|11993499|FG000|Analyzable Population|Overall Study||45
10828142|NCT01965704|11993500|FG001|Analyzable Population|Overall Study||45
10828143|NCT01965704|11993501|FG002|Analyzable Population|Overall Study||41
10828144|NCT01965704|11993502|FG003|Analyzable Population|Overall Study||41
10828145|NCT01965704|11993499|FG000|COMPLETED|Overall Study||45
10828146|NCT01965704|11993500|FG001|COMPLETED|Overall Study||45
10828147|NCT01965704|11993501|FG002|COMPLETED|Overall Study||45
10828148|NCT01965704|11993502|FG003|COMPLETED|Overall Study||45
10828149|NCT01965704|11993499|FG000|NOT COMPLETED|Overall Study||3
10828150|NCT01965704|11993500|FG001|NOT COMPLETED|Overall Study||3
10828151|NCT01965704|11993501|FG002|NOT COMPLETED|Overall Study||5
10828152|NCT01965704|11993502|FG003|NOT COMPLETED|Overall Study||5
10828153|NCT01913795|11993514|FG000|STARTED|Overall Study||4
10828154|NCT01913795|11993515|FG001|STARTED|Overall Study||10
10828155|NCT01913795|11993516|FG002|STARTED|Overall Study||9
10828156|NCT01913795|11993517|FG003|STARTED|Overall Study||6
10828157|NCT01913795|11993514|FG000|COMPLETED|Overall Study||4
10828158|NCT01913795|11993515|FG001|COMPLETED|Overall Study||7
10828159|NCT01913795|11993516|FG002|COMPLETED|Overall Study||9
10828160|NCT01913795|11993517|FG003|COMPLETED|Overall Study||5
10828161|NCT01913795|11993514|FG000|NOT COMPLETED|Overall Study||0
10828162|NCT01913795|11993515|FG001|NOT COMPLETED|Overall Study||3
10828163|NCT01913795|11993516|FG002|NOT COMPLETED|Overall Study||0
10828164|NCT01913795|11993517|FG003|NOT COMPLETED|Overall Study||1
10828174|NCT01664182|11993548|FG000|STARTED|Overall Study||19
10828175|NCT01664182|11993549|FG001|STARTED|Overall Study||22
10828176|NCT01664182|11993548|FG000|COMPLETED|Overall Study||17
10828177|NCT01664182|11993549|FG001|COMPLETED|Overall Study||18
10828178|NCT01664182|11993548|FG000|NOT COMPLETED|Overall Study||2
10828179|NCT01664182|11993549|FG001|NOT COMPLETED|Overall Study||4
10828180|NCT01661881|11993555|FG000|STARTED|Overall Study||23
10828181|NCT01661881|11993555|FG000|COMPLETED|Overall Study||22
10828182|NCT01661881|11993555|FG000|NOT COMPLETED|Overall Study||1
10828183|NCT01646814|11993561|FG000|STARTED|Overall Study||121
10828184|NCT01646814|11993562|FG001|STARTED|Overall Study||126
10828185|NCT01646814|11993561|FG000|COMPLETED|Overall Study||110
10828186|NCT01646814|11993562|FG001|COMPLETED|Overall Study||120
10828187|NCT01646814|11993561|FG000|NOT COMPLETED|Overall Study||11
10828188|NCT01646814|11993562|FG001|NOT COMPLETED|Overall Study||6
10828189|NCT01621568|11993570|FG000|STARTED|Treatment Week 1-4||41
10828190|NCT01621568|11993571|FG001|STARTED|Treatment Week 1-4||15
10828191|NCT01621568|11993570|FG000|COMPLETED|Treatment Week 1-4||41
10828192|NCT01621568|11993571|FG001|COMPLETED|Treatment Week 1-4||15
10828193|NCT01621568|11993570|FG000|NOT COMPLETED|Treatment Week 1-4||0
10828194|NCT01621568|11993571|FG001|NOT COMPLETED|Treatment Week 1-4||0
10828195|NCT01621568|11993570|FG000|STARTED|Week 5-6 No Treatment||41
10828196|NCT01621568|11993571|FG001|STARTED|Week 5-6 No Treatment||15
10828197|NCT01621568|11993570|FG000|COMPLETED|Week 5-6 No Treatment||39
10828198|NCT01621568|11993571|FG001|COMPLETED|Week 5-6 No Treatment||15
10828199|NCT01621568|11993570|FG000|NOT COMPLETED|Week 5-6 No Treatment||2
10828200|NCT01621568|11993571|FG001|NOT COMPLETED|Week 5-6 No Treatment||0
10828201|NCT01416636|11993582|FG000|STARTED|Overall Study||53
10828202|NCT01416636|11993583|FG001|STARTED|Overall Study||52
10828203|NCT01416636|11993582|FG000|COMPLETED|Overall Study||45
10828204|NCT01416636|11993583|FG001|COMPLETED|Overall Study||46
10828205|NCT01416636|11993582|FG000|NOT COMPLETED|Overall Study||8
10828206|NCT01416636|11993583|FG001|NOT COMPLETED|Overall Study||6
10828207|NCT01070069|11993594|FG000|STARTED|Overall Study||50
10828208|NCT01070069|11993595|FG001|STARTED|Overall Study||50
10828209|NCT01070069|11993596|FG002|STARTED|Overall Study||51
10828210|NCT01070069|11993597|FG003|STARTED|Overall Study||19
10828211|NCT01070069|11993598|FG004|STARTED|Overall Study||22
10828212|NCT01070069|11993594|FG000|COMPLETED|Overall Study||44
10828213|NCT01070069|11993595|FG001|COMPLETED|Overall Study||48
10828214|NCT01070069|11993596|FG002|COMPLETED|Overall Study||45
10828215|NCT01070069|11993597|FG003|COMPLETED|Overall Study||19
10828216|NCT01070069|11993598|FG004|COMPLETED|Overall Study||18
10828217|NCT01070069|11993594|FG000|NOT COMPLETED|Overall Study||6
10828218|NCT01070069|11993595|FG001|NOT COMPLETED|Overall Study||2
10828219|NCT01070069|11993596|FG002|NOT COMPLETED|Overall Study||6
10828220|NCT01070069|11993597|FG003|NOT COMPLETED|Overall Study||0
10828221|NCT01070069|11993598|FG004|NOT COMPLETED|Overall Study||4
10828222|NCT00775684|11993616|FG000|STARTED|Overall Study||17
10828223|NCT00775684|11993617|FG001|STARTED|Overall Study||13
10828224|NCT00775684|11993618|FG002|STARTED|Overall Study||17
10828225|NCT00775684|11993616|FG000|COMPLETED|Overall Study||14
10828226|NCT00775684|11993617|FG001|COMPLETED|Overall Study||12
10828227|NCT00775684|11993618|FG002|COMPLETED|Overall Study||14
10828228|NCT00775684|11993616|FG000|NOT COMPLETED|Overall Study||3
10828229|NCT00775684|11993617|FG001|NOT COMPLETED|Overall Study||1
10828230|NCT00775684|11993618|FG002|NOT COMPLETED|Overall Study||3
10828231|NCT00501046|11993637|FG000|STARTED|Overall Study||508
10828232|NCT00501046|11993638|FG001|STARTED|Overall Study||507
10828233|NCT00501046|11993637|FG000|COMPLETED|Overall Study||238
10828234|NCT00501046|11993638|FG001|COMPLETED|Overall Study||213
10828235|NCT00501046|11993637|FG000|NOT COMPLETED|Overall Study||270
10828236|NCT00501046|11993638|FG001|NOT COMPLETED|Overall Study||294
10828237|NCT00500682|11993646|FG000|STARTED|Overall Study||510
10828238|NCT00500682|11993647|FG001|STARTED|Overall Study||510
10828239|NCT00500682|11993646|FG000|COMPLETED|Overall Study||204
10828240|NCT00500682|11993647|FG001|COMPLETED|Overall Study||223
10828241|NCT00500682|11993646|FG000|NOT COMPLETED|Overall Study||306
10828242|NCT00500682|11993647|FG001|NOT COMPLETED|Overall Study||287
10828249|NCT00001277|11993667|FG000|STARTED|Overall Study||634
10828250|NCT00001277|11993668|FG001|STARTED|Overall Study||900
10828251|NCT00001277|11993669|FG002|STARTED|Overall Study||19
10828252|NCT00001277|11993667|FG000|COMPLETED|Overall Study||634
10828253|NCT00001277|11993668|FG001|COMPLETED|Overall Study||900
10828254|NCT00001277|11993669|FG002|COMPLETED|Overall Study||16
10828255|NCT00001277|11993667|FG000|NOT COMPLETED|Overall Study||0
10828256|NCT00001277|11993668|FG001|NOT COMPLETED|Overall Study||0
10828257|NCT00001277|11993669|FG002|NOT COMPLETED|Overall Study||3
10828258|NCT01009294|11993678|FG000|STARTED|Overall Study||6
10828259|NCT01009294|11993678|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
10828260|NCT01009294|11993678|FG000|COMPLETED|Overall Study||0
11100440|NCT01225549|12284334|FG000|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
11100441|NCT01225549|12284335|FG001|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
11100442|NCT01225549|12284336|FG002|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
11100443|NCT01225549|12284337|FG003|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
11100444|NCT01225549|12284338|FG004|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
11100445|NCT01225549|12284339|FG005|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
11100446|NCT01225549|12284340|FG006|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
11100447|NCT01225549|12284341|FG007|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
11100448|NCT01225549|12284342|FG008|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
11100449|NCT01225549|12284343|FG009|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
11100450|NCT01225562|12284356|FG000|STARTED|Overall Study||7050
11100451|NCT01225562|12284357|FG001|STARTED|Overall Study||7045
11100452|NCT01225562|12284358|FG002|STARTED|Overall Study||7067
11100453|NCT01225562|12284356|FG000|COMPLETED|Overall Study||6995
11100454|NCT01225562|12284357|FG001|COMPLETED|Overall Study||6989
11100455|NCT01225562|12284358|FG002|COMPLETED|Overall Study||7014
11100456|NCT01225562|12284356|FG000|NOT COMPLETED|Overall Study||55
11100457|NCT01225562|12284357|FG001|NOT COMPLETED|Overall Study||56
11100458|NCT01225562|12284358|FG002|NOT COMPLETED|Overall Study||53
11100459|NCT01225731|12284371|FG000|STARTED|Part 1||42
11100460|NCT01225731|12284372|FG001|STARTED|Part 1||92
11100461|NCT01225731|12284373|FG002|STARTED|Part 1||89
11100462|NCT01225731|12284374|FG003|STARTED|Part 1||86
11100463|NCT01225731|12284375|FG004|STARTED|Part 1||46
11100464|NCT01225731|12284376|FG005|STARTED|Part 1||0
11100465|NCT01225731|12284377|FG006|STARTED|Part 1||0
11100466|NCT01225731|12284378|FG007|STARTED|Part 1||0
11100467|NCT01225731|12284379|FG008|STARTED|Part 1||0
11100468|NCT01225731|12284380|FG009|STARTED|Part 1||0
11100469|NCT01225731|12284381|FG010|STARTED|Part 1||0
10828261|NCT01009294|11993678|FG000|NOT COMPLETED|Overall Study||6
11100470|NCT01225731|12284382|FG011|STARTED|Part 1||0
11100471|NCT01225731|12284383|FG012|STARTED|Part 1||0
11100472|NCT01225731|12284371|FG000|COMPLETED|Part 1||40
11100473|NCT01225731|12284372|FG001|COMPLETED|Part 1||87
11100474|NCT01225731|12284373|FG002|COMPLETED|Part 1||88
10828293|NCT01072175|11993715|FG012|COMPLETED|Part A (Drug-Drug Interaction)||0
11100475|NCT01225731|12284374|FG003|COMPLETED|Part 1||84
11100476|NCT01225731|12284375|FG004|COMPLETED|Part 1||40
11100477|NCT01225731|12284376|FG005|COMPLETED|Part 1||0
11100478|NCT01225731|12284377|FG006|COMPLETED|Part 1||0
11100479|NCT01225731|12284378|FG007|COMPLETED|Part 1||0
11100480|NCT01225731|12284379|FG008|COMPLETED|Part 1||0
11100481|NCT01225731|12284380|FG009|COMPLETED|Part 1||0
11100482|NCT01225731|12284381|FG010|COMPLETED|Part 1||0
11100483|NCT01225731|12284382|FG011|COMPLETED|Part 1||0
11100484|NCT01225731|12284383|FG012|COMPLETED|Part 1||0
11100485|NCT01225731|12284371|FG000|NOT COMPLETED|Part 1||2
11100486|NCT01225731|12284372|FG001|NOT COMPLETED|Part 1||5
11100487|NCT01225731|12284373|FG002|NOT COMPLETED|Part 1||1
11100488|NCT01225731|12284374|FG003|NOT COMPLETED|Part 1||2
11100489|NCT01225731|12284375|FG004|NOT COMPLETED|Part 1||6
11100490|NCT01225731|12284376|FG005|NOT COMPLETED|Part 1||0
11100491|NCT01225731|12284377|FG006|NOT COMPLETED|Part 1||0
11100492|NCT01225731|12284378|FG007|NOT COMPLETED|Part 1||0
11100493|NCT01225731|12284379|FG008|NOT COMPLETED|Part 1||0
11100494|NCT01225731|12284380|FG009|NOT COMPLETED|Part 1||0
11100495|NCT01225731|12284381|FG010|NOT COMPLETED|Part 1||0
11100496|NCT01225731|12284382|FG011|NOT COMPLETED|Part 1||0
11100497|NCT01225731|12284383|FG012|NOT COMPLETED|Part 1||0
11100498|NCT01225731|12284371|FG000|STARTED|Part 2|Participants could progress into Part 2|0
11100499|NCT01225731|12284372|FG001|STARTED|Part 2|Participants could progress into Part 2|0
11100500|NCT01225731|12284373|FG002|STARTED|Part 2|Participants could progress into Part 2|0
11100501|NCT01225731|12284374|FG003|STARTED|Part 2|Participants could progress into Part 2|0
11100502|NCT01225731|12284375|FG004|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
11100503|NCT01225731|12284376|FG005|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
11100504|NCT01225731|12284377|FG006|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
11100505|NCT01225731|12284378|FG007|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
11100506|NCT01225731|12284379|FG008|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
11100507|NCT01225731|12284380|FG009|STARTED|Part 2||0
11100508|NCT01225731|12284381|FG010|STARTED|Part 2||0
11100509|NCT01225731|12284382|FG011|STARTED|Part 2||0
11100510|NCT01225731|12284383|FG012|STARTED|Part 2||0
11100511|NCT01225731|12284371|FG000|COMPLETED|Part 2||0
11100512|NCT01225731|12284372|FG001|COMPLETED|Part 2||0
11100513|NCT01225731|12284373|FG002|COMPLETED|Part 2||0
11100514|NCT01225731|12284374|FG003|COMPLETED|Part 2||0
11100515|NCT01225731|12284375|FG004|COMPLETED|Part 2||0
11100516|NCT01225731|12284376|FG005|COMPLETED|Part 2||10
11100517|NCT01225731|12284377|FG006|COMPLETED|Part 2||86
11100518|NCT01225731|12284378|FG007|COMPLETED|Part 2||128
11100519|NCT01225731|12284379|FG008|COMPLETED|Part 2||68
11100520|NCT01225731|12284380|FG009|COMPLETED|Part 2||0
11100521|NCT01225731|12284381|FG010|COMPLETED|Part 2||0
11100522|NCT01225731|12284382|FG011|COMPLETED|Part 2||0
11100523|NCT01225731|12284383|FG012|COMPLETED|Part 2||0
11100524|NCT01225731|12284371|FG000|NOT COMPLETED|Part 2||0
11100525|NCT01225731|12284372|FG001|NOT COMPLETED|Part 2||0
10828262|NCT01053637|11993684|FG000|STARTED|Overall Study||43
10828263|NCT01053637|11993685|FG001|STARTED|Overall Study||42
10828264|NCT01053637|11993684|FG000|COMPLETED|Overall Study|2 with incomplete pain scores|43
10828265|NCT01053637|11993685|FG001|COMPLETED|Overall Study|4 incomplete pain scores 4 proceeded to procedural sedation|42
10828266|NCT01053637|11993684|FG000|NOT COMPLETED|Overall Study||0
10828267|NCT01053637|11993685|FG001|NOT COMPLETED|Overall Study||0
11100526|NCT01225731|12284373|FG002|NOT COMPLETED|Part 2||0
11100527|NCT01225731|12284374|FG003|NOT COMPLETED|Part 2||0
11100528|NCT01225731|12284375|FG004|NOT COMPLETED|Part 2||0
11100529|NCT01225731|12284376|FG005|NOT COMPLETED|Part 2||3
11100530|NCT01225731|12284377|FG006|NOT COMPLETED|Part 2||8
11100531|NCT01225731|12284378|FG007|NOT COMPLETED|Part 2||25
11100532|NCT01225731|12284379|FG008|NOT COMPLETED|Part 2||11
10828268|NCT01072175|11993703|FG000|STARTED|Part A (Drug-Drug Interaction)||8
10828269|NCT01072175|11993704|FG001|STARTED|Part A (Drug-Drug Interaction)||0
10828270|NCT01072175|11993705|FG002|STARTED|Part A (Drug-Drug Interaction)||0
10828271|NCT01072175|11993706|FG003|STARTED|Part A (Drug-Drug Interaction)||0
10828272|NCT01072175|11993707|FG004|STARTED|Part A (Drug-Drug Interaction)||0
10828273|NCT01072175|11993708|FG005|STARTED|Part A (Drug-Drug Interaction)||0
10828274|NCT01072175|11993709|FG006|STARTED|Part A (Drug-Drug Interaction)||0
10828275|NCT01072175|11993710|FG007|STARTED|Part A (Drug-Drug Interaction)||0
10828276|NCT01072175|11993711|FG008|STARTED|Part A (Drug-Drug Interaction)||0
10828277|NCT01072175|11993712|FG009|STARTED|Part A (Drug-Drug Interaction)||0
10828278|NCT01072175|11993713|FG010|STARTED|Part A (Drug-Drug Interaction)||0
10828279|NCT01072175|11993714|FG011|STARTED|Part A (Drug-Drug Interaction)||0
10828280|NCT01072175|11993715|FG012|STARTED|Part A (Drug-Drug Interaction)||0
10828281|NCT01072175|11993703|FG000|COMPLETED|Part A (Drug-Drug Interaction)||0
10828282|NCT01072175|11993704|FG001|COMPLETED|Part A (Drug-Drug Interaction)||0
10828283|NCT01072175|11993705|FG002|COMPLETED|Part A (Drug-Drug Interaction)||0
10828284|NCT01072175|11993706|FG003|COMPLETED|Part A (Drug-Drug Interaction)||0
10828285|NCT01072175|11993707|FG004|COMPLETED|Part A (Drug-Drug Interaction)||0
10828286|NCT01072175|11993708|FG005|COMPLETED|Part A (Drug-Drug Interaction)||0
10828287|NCT01072175|11993709|FG006|COMPLETED|Part A (Drug-Drug Interaction)||0
10828288|NCT01072175|11993710|FG007|COMPLETED|Part A (Drug-Drug Interaction)||0
10828289|NCT01072175|11993711|FG008|COMPLETED|Part A (Drug-Drug Interaction)||0
10828290|NCT01072175|11993712|FG009|COMPLETED|Part A (Drug-Drug Interaction)||0
10828291|NCT01072175|11993713|FG010|COMPLETED|Part A (Drug-Drug Interaction)||0
10828292|NCT01072175|11993714|FG011|COMPLETED|Part A (Drug-Drug Interaction)||0
10828294|NCT01072175|11993703|FG000|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
10828295|NCT01072175|11993704|FG001|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828296|NCT01072175|11993705|FG002|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828297|NCT01072175|11993706|FG003|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828298|NCT01072175|11993707|FG004|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828299|NCT01072175|11993708|FG005|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828300|NCT01072175|11993709|FG006|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828301|NCT01072175|11993710|FG007|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828302|NCT01072175|11993711|FG008|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828303|NCT01072175|11993712|FG009|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828304|NCT01072175|11993713|FG010|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828305|NCT01072175|11993714|FG011|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828306|NCT01072175|11993715|FG012|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
10828307|NCT01072175|11993703|FG000|STARTED|Part B (Dose Escalation and Expansion)||0
10828308|NCT01072175|11993704|FG001|STARTED|Part B (Dose Escalation and Expansion)||6
10828309|NCT01072175|11993705|FG002|STARTED|Part B (Dose Escalation and Expansion)||23
10828310|NCT01072175|11993706|FG003|STARTED|Part B (Dose Escalation and Expansion)||27
10828311|NCT01072175|11993707|FG004|STARTED|Part B (Dose Escalation and Expansion)||94
10828312|NCT01072175|11993708|FG005|STARTED|Part B (Dose Escalation and Expansion)||0
10828313|NCT01072175|11993709|FG006|STARTED|Part B (Dose Escalation and Expansion)||0
10828314|NCT01072175|11993710|FG007|STARTED|Part B (Dose Escalation and Expansion)||0
10828315|NCT01072175|11993711|FG008|STARTED|Part B (Dose Escalation and Expansion)||0
10828316|NCT01072175|11993712|FG009|STARTED|Part B (Dose Escalation and Expansion)||0
10828317|NCT01072175|11993713|FG010|STARTED|Part B (Dose Escalation and Expansion)||0
10828318|NCT01072175|11993714|FG011|STARTED|Part B (Dose Escalation and Expansion)||0
10828319|NCT01072175|11993715|FG012|STARTED|Part B (Dose Escalation and Expansion)||0
10828320|NCT01072175|11993703|FG000|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828321|NCT01072175|11993704|FG001|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828322|NCT01072175|11993705|FG002|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828323|NCT01072175|11993706|FG003|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828324|NCT01072175|11993707|FG004|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828325|NCT01072175|11993708|FG005|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828326|NCT01072175|11993709|FG006|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828327|NCT01072175|11993710|FG007|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828328|NCT01072175|11993711|FG008|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828329|NCT01072175|11993712|FG009|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828330|NCT01072175|11993713|FG010|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828331|NCT01072175|11993714|FG011|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828332|NCT01072175|11993715|FG012|COMPLETED|Part B (Dose Escalation and Expansion)||0
10828333|NCT01072175|11993703|FG000|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828334|NCT01072175|11993704|FG001|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
10828335|NCT01072175|11993705|FG002|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
10828336|NCT01072175|11993706|FG003|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
10828337|NCT01072175|11993707|FG004|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94
10828338|NCT01072175|11993708|FG005|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828339|NCT01072175|11993709|FG006|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828340|NCT01072175|11993710|FG007|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828341|NCT01072175|11993711|FG008|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828342|NCT01072175|11993712|FG009|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828343|NCT01072175|11993713|FG010|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828344|NCT01072175|11993714|FG011|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828345|NCT01072175|11993715|FG012|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
10828346|NCT01072175|11993703|FG000|STARTED|Part C (Phase II: Randomized Phase)||0
10828347|NCT01072175|11993704|FG001|STARTED|Part C (Phase II: Randomized Phase)||0
10828348|NCT01072175|11993705|FG002|STARTED|Part C (Phase II: Randomized Phase)||0
10828349|NCT01072175|11993706|FG003|STARTED|Part C (Phase II: Randomized Phase)||0
10828350|NCT01072175|11993707|FG004|STARTED|Part C (Phase II: Randomized Phase)||0
10828351|NCT01072175|11993708|FG005|STARTED|Part C (Phase II: Randomized Phase)||54
10828352|NCT01072175|11993709|FG006|STARTED|Part C (Phase II: Randomized Phase)||54
10828353|NCT01072175|11993710|FG007|STARTED|Part C (Phase II: Randomized Phase)||54
10828354|NCT01072175|11993711|FG008|STARTED|Part C (Phase II: Randomized Phase)||0
10828355|NCT01072175|11993712|FG009|STARTED|Part C (Phase II: Randomized Phase)||0
10828356|NCT01072175|11993713|FG010|STARTED|Part C (Phase II: Randomized Phase)||0
10828357|NCT01072175|11993714|FG011|STARTED|Part C (Phase II: Randomized Phase)||0
10828358|NCT01072175|11993715|FG012|STARTED|Part C (Phase II: Randomized Phase)||0
10828359|NCT01072175|11993703|FG000|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828360|NCT01072175|11993704|FG001|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828361|NCT01072175|11993705|FG002|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828362|NCT01072175|11993706|FG003|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828363|NCT01072175|11993707|FG004|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828364|NCT01072175|11993708|FG005|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828365|NCT01072175|11993709|FG006|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828366|NCT01072175|11993710|FG007|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828367|NCT01072175|11993711|FG008|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828368|NCT01072175|11993712|FG009|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828369|NCT01072175|11993713|FG010|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828370|NCT01072175|11993714|FG011|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828371|NCT01072175|11993715|FG012|COMPLETED|Part C (Phase II: Randomized Phase)||0
10828372|NCT01072175|11993703|FG000|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828373|NCT01072175|11993704|FG001|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828374|NCT01072175|11993705|FG002|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828375|NCT01072175|11993706|FG003|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828376|NCT01072175|11993707|FG004|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828377|NCT01072175|11993708|FG005|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
10828378|NCT01072175|11993709|FG006|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
10828379|NCT01072175|11993710|FG007|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
10828380|NCT01072175|11993711|FG008|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828381|NCT01072175|11993712|FG009|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828382|NCT01072175|11993713|FG010|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828383|NCT01072175|11993714|FG011|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828384|NCT01072175|11993715|FG012|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
10828385|NCT01072175|11993703|FG000|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828386|NCT01072175|11993704|FG001|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828387|NCT01072175|11993705|FG002|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828388|NCT01072175|11993706|FG003|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828389|NCT01072175|11993707|FG004|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828390|NCT01072175|11993708|FG005|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828391|NCT01072175|11993709|FG006|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828392|NCT01072175|11993710|FG007|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828393|NCT01072175|11993711|FG008|STARTED|Part C (Phase II: Crossover Phase [CP])||45
10828394|NCT01072175|11993712|FG009|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828395|NCT01072175|11993713|FG010|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828396|NCT01072175|11993714|FG011|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828397|NCT01072175|11993715|FG012|STARTED|Part C (Phase II: Crossover Phase [CP])||0
10828398|NCT01072175|11993703|FG000|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828399|NCT01072175|11993704|FG001|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828400|NCT01072175|11993705|FG002|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828401|NCT01072175|11993706|FG003|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828402|NCT01072175|11993707|FG004|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828403|NCT01072175|11993708|FG005|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828404|NCT01072175|11993709|FG006|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828405|NCT01072175|11993710|FG007|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828406|NCT01072175|11993711|FG008|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828407|NCT01072175|11993712|FG009|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828408|NCT01072175|11993713|FG010|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828409|NCT01072175|11993714|FG011|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828410|NCT01072175|11993715|FG012|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828411|NCT01072175|11993703|FG000|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828412|NCT01072175|11993704|FG001|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828413|NCT01072175|11993705|FG002|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828414|NCT01072175|11993706|FG003|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828415|NCT01072175|11993707|FG004|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828416|NCT01072175|11993708|FG005|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828417|NCT01072175|11993709|FG006|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828418|NCT01072175|11993710|FG007|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828419|NCT01072175|11993711|FG008|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45
10828420|NCT01072175|11993712|FG009|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828421|NCT01072175|11993713|FG010|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828422|NCT01072175|11993714|FG011|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828423|NCT01072175|11993715|FG012|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
10828424|NCT01072175|11993703|FG000|STARTED|Part D (HPMC Capsules)||0
10828425|NCT01072175|11993704|FG001|STARTED|Part D (HPMC Capsules)||0
10828426|NCT01072175|11993705|FG002|STARTED|Part D (HPMC Capsules)||0
10828427|NCT01072175|11993706|FG003|STARTED|Part D (HPMC Capsules)||0
10828428|NCT01072175|11993707|FG004|STARTED|Part D (HPMC Capsules)||0
10828429|NCT01072175|11993708|FG005|STARTED|Part D (HPMC Capsules)||0
10828430|NCT01072175|11993709|FG006|STARTED|Part D (HPMC Capsules)||0
10828431|NCT01072175|11993710|FG007|STARTED|Part D (HPMC Capsules)||0
10828432|NCT01072175|11993711|FG008|STARTED|Part D (HPMC Capsules)||0
10828433|NCT01072175|11993712|FG009|STARTED|Part D (HPMC Capsules)||12
10828434|NCT01072175|11993713|FG010|STARTED|Part D (HPMC Capsules)||16
10828435|NCT01072175|11993714|FG011|STARTED|Part D (HPMC Capsules)||43
10828436|NCT01072175|11993715|FG012|STARTED|Part D (HPMC Capsules)||39
10828437|NCT01072175|11993703|FG000|COMPLETED|Part D (HPMC Capsules)||0
10828438|NCT01072175|11993704|FG001|COMPLETED|Part D (HPMC Capsules)||0
10828439|NCT01072175|11993705|FG002|COMPLETED|Part D (HPMC Capsules)||0
10828440|NCT01072175|11993706|FG003|COMPLETED|Part D (HPMC Capsules)||0
10828441|NCT01072175|11993707|FG004|COMPLETED|Part D (HPMC Capsules)||0
10828442|NCT01072175|11993708|FG005|COMPLETED|Part D (HPMC Capsules)||0
10828443|NCT01072175|11993709|FG006|COMPLETED|Part D (HPMC Capsules)||0
10828444|NCT01072175|11993710|FG007|COMPLETED|Part D (HPMC Capsules)||0
10828445|NCT01072175|11993711|FG008|COMPLETED|Part D (HPMC Capsules)||0
10828446|NCT01072175|11993712|FG009|COMPLETED|Part D (HPMC Capsules)||0
10828447|NCT01072175|11993713|FG010|COMPLETED|Part D (HPMC Capsules)||0
10828448|NCT01072175|11993714|FG011|COMPLETED|Part D (HPMC Capsules)||0
10828449|NCT01072175|11993715|FG012|COMPLETED|Part D (HPMC Capsules)||0
10828450|NCT01072175|11993703|FG000|NOT COMPLETED|Part D (HPMC Capsules)||0
10828451|NCT01072175|11993704|FG001|NOT COMPLETED|Part D (HPMC Capsules)||0
10828452|NCT01072175|11993705|FG002|NOT COMPLETED|Part D (HPMC Capsules)||0
10828453|NCT01072175|11993706|FG003|NOT COMPLETED|Part D (HPMC Capsules)||0
10828454|NCT01072175|11993707|FG004|NOT COMPLETED|Part D (HPMC Capsules)||0
10828455|NCT01072175|11993708|FG005|NOT COMPLETED|Part D (HPMC Capsules)||0
10828456|NCT01072175|11993709|FG006|NOT COMPLETED|Part D (HPMC Capsules)||0
10828457|NCT01072175|11993710|FG007|NOT COMPLETED|Part D (HPMC Capsules)||0
10828458|NCT01072175|11993711|FG008|NOT COMPLETED|Part D (HPMC Capsules)||0
10828459|NCT01072175|11993712|FG009|NOT COMPLETED|Part D (HPMC Capsules)||12
10828460|NCT01072175|11993713|FG010|NOT COMPLETED|Part D (HPMC Capsules)||16
10828461|NCT01072175|11993714|FG011|NOT COMPLETED|Part D (HPMC Capsules)||43
10828462|NCT01072175|11993715|FG012|NOT COMPLETED|Part D (HPMC Capsules)||39
10828463|NCT01087203|11993749|FG000|STARTED|Overall Study||35
10828464|NCT01087203|11993750|FG001|STARTED|Overall Study||38
10828465|NCT01087203|11993749|FG000|COMPLETED|Overall Study||3
10828466|NCT01087203|11993750|FG001|COMPLETED|Overall Study||3
10828467|NCT01087203|11993749|FG000|NOT COMPLETED|Overall Study||32
10828468|NCT01087203|11993750|FG001|NOT COMPLETED|Overall Study||35
10828472|NCT01108055|11993761|FG000|STARTED|Overall Study||43
10828473|NCT01108055|11993761|FG000|Eligible and Started Treatment|Overall Study||32
10828474|NCT01108055|11993761|FG000|COMPLETED|Overall Study||28
10828475|NCT01108055|11993761|FG000|NOT COMPLETED|Overall Study||15
10828479|NCT01136967|11993771|FG000|STARTED|Overall Study||93
10828480|NCT01136967|11993772|FG001|STARTED|Overall Study||89
10828481|NCT01136967|11993771|FG000|Disease Progression|Overall Study||55
10828482|NCT01136967|11993772|FG001|Disease Progression|Overall Study||56
10828483|NCT01136967|11993771|FG000|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
10828484|NCT01136967|11993772|FG001|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
10828485|NCT01136967|11993771|FG000|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
10828486|NCT01136967|11993772|FG001|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
10828487|NCT01136967|11993771|FG000|NOT COMPLETED|Overall Study||24
10828488|NCT01136967|11993772|FG001|NOT COMPLETED|Overall Study||27
10828489|NCT01136980|11993780|FG000|STARTED|Overall Study||42
10828490|NCT01136980|11993781|FG001|STARTED|Overall Study||87
10828491|NCT01136980|11993780|FG000|COMPLETED|Overall Study||28
10828492|NCT01136980|11993781|FG001|COMPLETED|Overall Study||76
10828493|NCT01136980|11993780|FG000|NOT COMPLETED|Overall Study||14
10828494|NCT01136980|11993781|FG001|NOT COMPLETED|Overall Study||11
10828521|NCT01174563|11993807|FG000|STARTED|Overall Study||60
10828522|NCT01174563|11993807|FG000|Efficacy Set|Overall Study||59
10828523|NCT01174563|11993807|FG000|Safety Set|Overall Study||59
10828524|NCT01174563|11993807|FG000|COMPLETED|Overall Study||0
10828525|NCT01174563|11993807|FG000|NOT COMPLETED|Overall Study||60
10828526|NCT01190202|11993815|FG000|STARTED|Overall Study||6404
10828527|NCT01190202|11993816|FG001|STARTED|Overall Study||6414
10828528|NCT01190202|11993817|FG002|STARTED|Overall Study||6400
10828529|NCT01190202|11993818|FG003|STARTED|Overall Study||2400
10828530|NCT01190202|11993815|FG000|COMPLETED|Overall Study||6404
10828531|NCT01190202|11993816|FG001|COMPLETED|Overall Study||6414
10828532|NCT01190202|11993817|FG002|COMPLETED|Overall Study||6400
10828533|NCT01190202|11993818|FG003|COMPLETED|Overall Study||2400
10828534|NCT01190202|11993815|FG000|NOT COMPLETED|Overall Study||0
10828535|NCT01190202|11993816|FG001|NOT COMPLETED|Overall Study||0
10828536|NCT01190202|11993817|FG002|NOT COMPLETED|Overall Study||0
10828537|NCT01190202|11993818|FG003|NOT COMPLETED|Overall Study||0
10828538|NCT01200862|11993863|FG000|STARTED|Part 1||14
10828539|NCT01200862|11993864|FG001|STARTED|Part 1||0
10828540|NCT01200862|11993865|FG002|STARTED|Part 1||0
10828541|NCT01200862|11993863|FG000|COMPLETED|Part 1||13
10828542|NCT01200862|11993864|FG001|COMPLETED|Part 1||0
10828543|NCT01200862|11993865|FG002|COMPLETED|Part 1||0
10828544|NCT01200862|11993863|FG000|NOT COMPLETED|Part 1||1
10828545|NCT01200862|11993864|FG001|NOT COMPLETED|Part 1||0
10828546|NCT01200862|11993865|FG002|NOT COMPLETED|Part 1||0
10828547|NCT01200862|11993863|FG000|STARTED|Part 2||0
10828548|NCT01200862|11993864|FG001|STARTED|Part 2||7
10828549|NCT01200862|11993865|FG002|STARTED|Part 2||8
10828550|NCT01200862|11993863|FG000|COMPLETED|Part 2||0
10828551|NCT01200862|11993864|FG001|COMPLETED|Part 2||6
10828552|NCT01200862|11993865|FG002|COMPLETED|Part 2||8
10828553|NCT01200862|11993863|FG000|NOT COMPLETED|Part 2||0
10828554|NCT01200862|11993864|FG001|NOT COMPLETED|Part 2||1
10828555|NCT01200862|11993865|FG002|NOT COMPLETED|Part 2||0
10828556|NCT01225341|11993876|FG000|STARTED|Overall Study||0
10828557|NCT01225341|11993877|FG001|STARTED|Overall Study||0
10828558|NCT01225341|11993876|FG000|COMPLETED|Overall Study||0
10828559|NCT01225341|11993877|FG001|COMPLETED|Overall Study||0
10828560|NCT01225341|11993876|FG000|NOT COMPLETED|Overall Study||0
10828561|NCT01225341|11993877|FG001|NOT COMPLETED|Overall Study||0
10828562|NCT01235962|11993887|FG000|STARTED|Overall Study||198
10828563|NCT01235962|11993888|FG001|STARTED|Overall Study||205
10828564|NCT01235962|11993889|FG002|STARTED|Overall Study||571
10828565|NCT01235962|11993890|FG003|STARTED|Overall Study||564
10828566|NCT01235962|11993887|FG000|Prem. Withdrawn = Did Not Complete Study|Overall Study||46
10828567|NCT01235962|11993888|FG001|Prem. Withdrawn = Did Not Complete Study|Overall Study||35
10828568|NCT01235962|11993889|FG002|Prem. Withdrawn = Did Not Complete Study|Overall Study||118
10828569|NCT01235962|11993890|FG003|Prem. Withdrawn = Did Not Complete Study|Overall Study||86
10828570|NCT01235962|11993887|FG000|All Deaths|Overall Study||43
10828571|NCT01235962|11993888|FG001|All Deaths|Overall Study||46
10828572|NCT01235962|11993889|FG002|All Deaths|Overall Study||102
10828573|NCT01235962|11993890|FG003|All Deaths|Overall Study||104
10828574|NCT01235962|11993887|FG000|COMPLETED|Overall Study||152
10828575|NCT01235962|11993888|FG001|COMPLETED|Overall Study||170
10828576|NCT01235962|11993889|FG002|COMPLETED|Overall Study||453
10828577|NCT01235962|11993890|FG003|COMPLETED|Overall Study||478
10828578|NCT01235962|11993887|FG000|NOT COMPLETED|Overall Study||46
10828579|NCT01235962|11993888|FG001|NOT COMPLETED|Overall Study||35
10828580|NCT01235962|11993889|FG002|NOT COMPLETED|Overall Study||118
10828581|NCT01235962|11993890|FG003|NOT COMPLETED|Overall Study||86
10828582|NCT01239368|11993918|FG000|STARTED|Overall Study||2
10828583|NCT01239368|11993919|FG001|STARTED|Overall Study||1
10828584|NCT01239368|11993920|FG002|STARTED|Overall Study||1
10828469|NCT01088815|11993757|FG000|STARTED|Overall Study||72
10828470|NCT01088815|11993757|FG000|COMPLETED|Overall Study||72
10828471|NCT01088815|11993757|FG000|NOT COMPLETED|Overall Study||0
10828476|NCT01111019|11993765|FG000|STARTED|Overall Study||19
10828477|NCT01111019|11993765|FG000|COMPLETED|Overall Study||16
10828478|NCT01111019|11993765|FG000|NOT COMPLETED|Overall Study||3
10828495|NCT01137955|11993789|FG000|STARTED|Overall Study||25
10828496|NCT01137955|11993790|FG001|STARTED|Overall Study||25
10828497|NCT01137955|11993789|FG000|COMPLETED|Overall Study||20
10828498|NCT01137955|11993790|FG001|COMPLETED|Overall Study||21
10828499|NCT01137955|11993789|FG000|NOT COMPLETED|Overall Study||5
10828500|NCT01137955|11993790|FG001|NOT COMPLETED|Overall Study||4
10828585|NCT01239368|11993921|FG003|STARTED|Overall Study||2
10828586|NCT01239368|11993922|FG004|STARTED|Overall Study||7
10828587|NCT01239368|11993923|FG005|STARTED|Overall Study||5
10828588|NCT01239368|11993924|FG006|STARTED|Overall Study||7
10828589|NCT01239368|11993925|FG007|STARTED|Overall Study||0
10828590|NCT01239368|11993926|FG008|STARTED|Overall Study||1
10828591|NCT01239368|11993927|FG009|STARTED|Overall Study||5
10828592|NCT01239368|11993918|FG000|COMPLETED|Overall Study||0
10828593|NCT01239368|11993919|FG001|COMPLETED|Overall Study||0
10828594|NCT01239368|11993920|FG002|COMPLETED|Overall Study||0
10828595|NCT01239368|11993921|FG003|COMPLETED|Overall Study||1
10828596|NCT01239368|11993922|FG004|COMPLETED|Overall Study||2
10828597|NCT01239368|11993923|FG005|COMPLETED|Overall Study||1
10828598|NCT01239368|11993924|FG006|COMPLETED|Overall Study||1
10828599|NCT01239368|11993925|FG007|COMPLETED|Overall Study||0
10828600|NCT01239368|11993926|FG008|COMPLETED|Overall Study||1
10828601|NCT01239368|11993927|FG009|COMPLETED|Overall Study||1
10828602|NCT01239368|11993918|FG000|NOT COMPLETED|Overall Study||2
10828603|NCT01239368|11993919|FG001|NOT COMPLETED|Overall Study||1
10828604|NCT01239368|11993920|FG002|NOT COMPLETED|Overall Study||1
10828605|NCT01239368|11993921|FG003|NOT COMPLETED|Overall Study||1
10828606|NCT01239368|11993922|FG004|NOT COMPLETED|Overall Study||5
10828607|NCT01239368|11993923|FG005|NOT COMPLETED|Overall Study||4
10828608|NCT01239368|11993924|FG006|NOT COMPLETED|Overall Study||6
10828609|NCT01239368|11993925|FG007|NOT COMPLETED|Overall Study||0
10828610|NCT01239368|11993926|FG008|NOT COMPLETED|Overall Study||0
10828611|NCT01239368|11993927|FG009|NOT COMPLETED|Overall Study||4
11100533|NCT01225731|12284380|FG009|NOT COMPLETED|Part 2||0
11100534|NCT01225731|12284381|FG010|NOT COMPLETED|Part 2||0
11100535|NCT01225731|12284382|FG011|NOT COMPLETED|Part 2||0
11100536|NCT01225731|12284383|FG012|NOT COMPLETED|Part 2||0
11100537|NCT01225731|12284371|FG000|STARTED|Part 3||0
11100538|NCT01225731|12284372|FG001|STARTED|Part 3||0
11100539|NCT01225731|12284373|FG002|STARTED|Part 3||0
11100540|NCT01225731|12284374|FG003|STARTED|Part 3||0
11100541|NCT01225731|12284375|FG004|STARTED|Part 3||0
11100542|NCT01225731|12284376|FG005|STARTED|Part 3|Participants could enter the follow-up period|0
11100543|NCT01225731|12284377|FG006|STARTED|Part 3|Participants could enter the follow-up period|0
11100544|NCT01225731|12284378|FG007|STARTED|Part 3|Participants could enter the follow-up period|0
11100545|NCT01225731|12284379|FG008|STARTED|Part 3|Participants could enter the follow-up period|0
11100546|NCT01225731|12284380|FG009|STARTED|Part 3|Not all participants entered follow-up|10
11100547|NCT01225731|12284381|FG010|STARTED|Part 3|Not all participants entered follow-up|86
11100548|NCT01225731|12284382|FG011|STARTED|Part 3|Not all participants entered follow-up|126
11100549|NCT01225731|12284383|FG012|STARTED|Part 3|Not all participants entered follow-up|67
11100550|NCT01225731|12284371|FG000|COMPLETED|Part 3||0
11100551|NCT01225731|12284372|FG001|COMPLETED|Part 3||0
11100552|NCT01225731|12284373|FG002|COMPLETED|Part 3||0
11100553|NCT01225731|12284374|FG003|COMPLETED|Part 3||0
11100554|NCT01225731|12284375|FG004|COMPLETED|Part 3||0
11100555|NCT01225731|12284376|FG005|COMPLETED|Part 3||0
11100556|NCT01225731|12284377|FG006|COMPLETED|Part 3||0
11100557|NCT01225731|12284378|FG007|COMPLETED|Part 3||0
11100558|NCT01225731|12284379|FG008|COMPLETED|Part 3||0
11100559|NCT01225731|12284380|FG009|COMPLETED|Part 3||10
11100560|NCT01225731|12284381|FG010|COMPLETED|Part 3||80
11100561|NCT01225731|12284382|FG011|COMPLETED|Part 3||116
11100562|NCT01225731|12284383|FG012|COMPLETED|Part 3||60
11100563|NCT01225731|12284371|FG000|NOT COMPLETED|Part 3||0
11100564|NCT01225731|12284372|FG001|NOT COMPLETED|Part 3||0
11100565|NCT01225731|12284373|FG002|NOT COMPLETED|Part 3||0
11100566|NCT01225731|12284374|FG003|NOT COMPLETED|Part 3||0
11100567|NCT01225731|12284375|FG004|NOT COMPLETED|Part 3||0
11100568|NCT01225731|12284376|FG005|NOT COMPLETED|Part 3||0
11100569|NCT01225731|12284377|FG006|NOT COMPLETED|Part 3||0
10828501|NCT01140451|11993799|FG000|STARTED|Overall Study||95
10828502|NCT01140451|11993800|FG001|STARTED|Overall Study||96
10828503|NCT01140451|11993799|FG000|Completed 24 Weeks|Overall Study||89
10828504|NCT01140451|11993800|FG001|Completed 24 Weeks|Overall Study||86
10828505|NCT01140451|11993799|FG000|Completed 48 Weeks|Overall Study||78
10828506|NCT01140451|11993800|FG001|Completed 48 Weeks|Overall Study||70
10828507|NCT01140451|11993799|FG000|Completed 72 Weeks|Overall Study||63
10828508|NCT01140451|11993800|FG001|Completed 72 Weeks|Overall Study||62
10828509|NCT01140451|11993799|FG000|Completed 96 Weeks|Overall Study||57
10828510|NCT01140451|11993800|FG001|Completed 96 Weeks|Overall Study||54
10828511|NCT01140451|11993799|FG000|As-Treated Population|Overall Study||95
10828512|NCT01140451|11993800|FG001|As-Treated Population|Overall Study||96
10828513|NCT01140451|11993799|FG000|96-Week Completer Population|Overall Study||78
10828514|NCT01140451|11993800|FG001|96-Week Completer Population|Overall Study||70
10828515|NCT01140451|11993799|FG000|144-Week Completer Population|Overall Study||57
10828516|NCT01140451|11993800|FG001|144-Week Completer Population|Overall Study||54
10828517|NCT01140451|11993799|FG000|COMPLETED|Overall Study||57
10828518|NCT01140451|11993800|FG001|COMPLETED|Overall Study||54
10828519|NCT01140451|11993799|FG000|NOT COMPLETED|Overall Study||38
10828520|NCT01140451|11993800|FG001|NOT COMPLETED|Overall Study||42
10828612|NCT01247701|11993960|FG000|STARTED|Overall Study||16
10828613|NCT01247701|11993960|FG000|COMPLETED|Overall Study||6
10828614|NCT01247701|11993960|FG000|NOT COMPLETED|Overall Study||10
10828615|NCT01266031|11993967|FG000|STARTED|Overall Study||6
10828616|NCT01266031|11993968|FG001|STARTED|Overall Study||41
10828617|NCT01266031|11993969|FG002|STARTED|Overall Study||49
10828618|NCT01266031|11993967|FG000|COMPLETED|Overall Study||6
10828619|NCT01266031|11993968|FG001|COMPLETED|Overall Study||38
10828620|NCT01266031|11993969|FG002|COMPLETED|Overall Study||47
10828621|NCT01266031|11993967|FG000|NOT COMPLETED|Overall Study||0
10828622|NCT01266031|11993968|FG001|NOT COMPLETED|Overall Study||3
10828623|NCT01266031|11993969|FG002|NOT COMPLETED|Overall Study||2
10828624|NCT01287741|11993990|FG000|STARTED|Overall Study||712
10828625|NCT01287741|11993991|FG001|STARTED|Overall Study||706
10828626|NCT01287741|11993990|FG000|COMPLETED|Overall Study||86
10828627|NCT01287741|11993991|FG001|COMPLETED|Overall Study||91
10828628|NCT01287741|11993990|FG000|NOT COMPLETED|Overall Study||626
10828629|NCT01287741|11993991|FG001|NOT COMPLETED|Overall Study||615
10828630|NCT01304316|11993998|FG000|STARTED|Overall Study||12
10828631|NCT01304316|11993998|FG000|COMPLETED|Overall Study||12
10828632|NCT01304316|11993998|FG000|NOT COMPLETED|Overall Study||0
10828633|NCT01313689|11994008|FG000|STARTED|24-Week Randomization 1||79
10828634|NCT01313689|11994009|FG001|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
10828635|NCT01313689|11994010|FG002|STARTED|24-Week Randomization 1||0
10828636|NCT01313689|11994011|FG003|STARTED|24-Week Randomization 1||0
10828637|NCT01313689|11994012|FG004|STARTED|24-Week Randomization 1||0
10828638|NCT01313689|11994008|FG000|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
10828639|NCT01313689|11994009|FG001|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
10828640|NCT01313689|11994010|FG002|COMPLETED|24-Week Randomization 1||0
10828641|NCT01313689|11994011|FG003|COMPLETED|24-Week Randomization 1||0
10828642|NCT01313689|11994012|FG004|COMPLETED|24-Week Randomization 1||0
10828643|NCT01313689|11994008|FG000|NOT COMPLETED|24-Week Randomization 1||19
10828644|NCT01313689|11994009|FG001|NOT COMPLETED|24-Week Randomization 1||10
10828645|NCT01313689|11994010|FG002|NOT COMPLETED|24-Week Randomization 1||0
10828646|NCT01313689|11994011|FG003|NOT COMPLETED|24-Week Randomization 1||0
10828647|NCT01313689|11994012|FG004|NOT COMPLETED|24-Week Randomization 1||0
10828648|NCT01313689|11994008|FG000|STARTED|24-Week Randomization 2||0
10828649|NCT01313689|11994009|FG001|STARTED|24-Week Randomization 2||0
10828650|NCT01313689|11994010|FG002|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
10828651|NCT01313689|11994011|FG003|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
10828652|NCT01313689|11994012|FG004|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
10828653|NCT01313689|11994008|FG000|COMPLETED|24-Week Randomization 2||0
10828654|NCT01313689|11994009|FG001|COMPLETED|24-Week Randomization 2||0
10828655|NCT01313689|11994010|FG002|COMPLETED|24-Week Randomization 2||21
10828656|NCT01313689|11994011|FG003|COMPLETED|24-Week Randomization 2||12
10828657|NCT01313689|11994012|FG004|COMPLETED|24-Week Randomization 2||27
10828658|NCT01313689|11994008|FG000|NOT COMPLETED|24-Week Randomization 2||0
10828659|NCT01313689|11994009|FG001|NOT COMPLETED|24-Week Randomization 2||0
10828660|NCT01313689|11994010|FG002|NOT COMPLETED|24-Week Randomization 2||3
10828661|NCT01313689|11994011|FG003|NOT COMPLETED|24-Week Randomization 2||1
10828662|NCT01313689|11994012|FG004|NOT COMPLETED|24-Week Randomization 2||15
10828663|NCT01315353|11994034|FG000|STARTED|Overall Study||145
10828664|NCT01315353|11994035|FG001|STARTED|Overall Study||143
10828665|NCT01315353|11994036|FG002|STARTED|Overall Study||179
10828666|NCT01315353|11994034|FG000|COMPLETED|Overall Study||116
10828667|NCT01315353|11994035|FG001|COMPLETED|Overall Study||120
11100570|NCT01225731|12284378|FG007|NOT COMPLETED|Part 3||0
11100571|NCT01225731|12284379|FG008|NOT COMPLETED|Part 3||0
11100572|NCT01225731|12284380|FG009|NOT COMPLETED|Part 3||0
11100573|NCT01225731|12284381|FG010|NOT COMPLETED|Part 3||6
11100574|NCT01225731|12284382|FG011|NOT COMPLETED|Part 3||10
11100575|NCT01225731|12284383|FG012|NOT COMPLETED|Part 3||7
11100576|NCT01225822|12284417|FG000|STARTED|Overall Study||389
11100577|NCT01225822|12284418|FG001|STARTED|Overall Study||390
11100578|NCT01225822|12284419|FG002|STARTED|Overall Study||393
11100579|NCT01225822|12284420|FG003|STARTED|Overall Study||385
11100580|NCT01225822|12284421|FG004|STARTED|Overall Study||392
11100581|NCT01225822|12284417|FG000|COMPLETED|Overall Study||351
11100582|NCT01225822|12284418|FG001|COMPLETED|Overall Study||334
11100583|NCT01225822|12284419|FG002|COMPLETED|Overall Study||355
11100584|NCT01225822|12284420|FG003|COMPLETED|Overall Study||333
11100585|NCT01225822|12284421|FG004|COMPLETED|Overall Study||361
11100586|NCT01225822|12284417|FG000|NOT COMPLETED|Overall Study||38
11100587|NCT01225822|12284418|FG001|NOT COMPLETED|Overall Study||56
11100588|NCT01225822|12284419|FG002|NOT COMPLETED|Overall Study||38
11100589|NCT01225822|12284420|FG003|NOT COMPLETED|Overall Study||52
11100590|NCT01225822|12284421|FG004|NOT COMPLETED|Overall Study||31
11100591|NCT01225835|12284438|FG000|STARTED|Overall Study||62
11100592|NCT01225835|12284439|FG001|STARTED|Overall Study||62
11100593|NCT01225835|12284438|FG000|Per Protocol Population|Overall Study||48
11100594|NCT01225835|12284439|FG001|Per Protocol Population|Overall Study||58
11100595|NCT01225835|12284438|FG000|COMPLETED|Overall Study|hCG criterion met|55
11100596|NCT01225835|12284439|FG001|COMPLETED|Overall Study|hCG criterion met|59
11100597|NCT01225835|12284438|FG000|NOT COMPLETED|Overall Study||7
11100598|NCT01225835|12284439|FG001|NOT COMPLETED|Overall Study||3
11100599|NCT01225887|12284451|FG000|STARTED|Overall Study||37
11100600|NCT01225887|12284451|FG000|COMPLETED|Overall Study||32
11100601|NCT01225887|12284451|FG000|NOT COMPLETED|Overall Study||5
11100602|NCT01225926|12284457|FG000|STARTED|Overall Study||12
11100603|NCT01225926|12284458|FG001|STARTED|Overall Study||12
11100604|NCT01225926|12284457|FG000|COMPLETED|Overall Study||12
11100605|NCT01225926|12284458|FG001|COMPLETED|Overall Study||12
11100606|NCT01225926|12284457|FG000|NOT COMPLETED|Overall Study||0
11100607|NCT01225926|12284458|FG001|NOT COMPLETED|Overall Study||0
11100608|NCT01225952|12284467|FG000|STARTED|Overall Study||31
11100609|NCT01225952|12284468|FG001|STARTED|Overall Study||31
11100610|NCT01225952|12284469|FG002|STARTED|Overall Study||31
11100611|NCT01225952|12284467|FG000|COMPLETED|Overall Study||25
11100612|NCT01225952|12284468|FG001|COMPLETED|Overall Study||27
11100613|NCT01225952|12284469|FG002|COMPLETED|Overall Study||25
11100614|NCT01225952|12284467|FG000|NOT COMPLETED|Overall Study||6
11100615|NCT01225952|12284468|FG001|NOT COMPLETED|Overall Study||4
11100616|NCT01225952|12284469|FG002|NOT COMPLETED|Overall Study||6
11219873|NCT01957488|12411425|FG002|STARTED|Test Period 1 (2 Weeks)||30
11219874|NCT01957488|12411426|FG003|STARTED|Test Period 1 (2 Weeks)||32
11219875|NCT01957488|12411427|FG004|STARTED|Test Period 1 (2 Weeks)||30
11219876|NCT01957488|12411428|FG005|STARTED|Test Period 1 (2 Weeks)||30
11219877|NCT01957488|12411423|FG000|COMPLETED|Test Period 1 (2 Weeks)||27
11219878|NCT01957488|12411424|FG001|COMPLETED|Test Period 1 (2 Weeks)||28
11219879|NCT01957488|12411425|FG002|COMPLETED|Test Period 1 (2 Weeks)||26
11219880|NCT01957488|12411426|FG003|COMPLETED|Test Period 1 (2 Weeks)||29
11219881|NCT01957488|12411427|FG004|COMPLETED|Test Period 1 (2 Weeks)||27
11219882|NCT01957488|12411428|FG005|COMPLETED|Test Period 1 (2 Weeks)||24
11219883|NCT01957488|12411423|FG000|NOT COMPLETED|Test Period 1 (2 Weeks)||3
11219884|NCT01957488|12411424|FG001|NOT COMPLETED|Test Period 1 (2 Weeks)||3
11219885|NCT01957488|12411425|FG002|NOT COMPLETED|Test Period 1 (2 Weeks)||4
11219886|NCT01957488|12411426|FG003|NOT COMPLETED|Test Period 1 (2 Weeks)||3
11219887|NCT01957488|12411427|FG004|NOT COMPLETED|Test Period 1 (2 Weeks)||3
11219888|NCT01957488|12411428|FG005|NOT COMPLETED|Test Period 1 (2 Weeks)||6
11219889|NCT01957488|12411423|FG000|STARTED|Test Period 2 (2 Weeks)||27
11219890|NCT01957488|12411424|FG001|STARTED|Test Period 2 (2 Weeks)||28
11219891|NCT01957488|12411425|FG002|STARTED|Test Period 2 (2 Weeks)||26
11219892|NCT01957488|12411426|FG003|STARTED|Test Period 2 (2 Weeks)||29
10828668|NCT01315353|11994036|FG002|COMPLETED|Overall Study||166
10828669|NCT01315353|11994034|FG000|NOT COMPLETED|Overall Study||29
10828670|NCT01315353|11994035|FG001|NOT COMPLETED|Overall Study||23
10828671|NCT01315353|11994036|FG002|NOT COMPLETED|Overall Study||13
10828672|NCT01318993|11994044|FG000|STARTED|Overall Study||398
10828673|NCT01318993|11994044|FG000|COMPLETED|Overall Study||0
10828674|NCT01318993|11994044|FG000|NOT COMPLETED|Overall Study||398
10828675|NCT04764630|11994048|FG000|STARTED|Overall Study||3
10828676|NCT04764630|11994049|FG001|STARTED|Overall Study||4
10828677|NCT04764630|11994050|FG002|STARTED|Overall Study||3
10828678|NCT04764630|11994051|FG003|STARTED|Overall Study||4
10828679|NCT04764630|11994052|FG004|STARTED|Overall Study||3
11219893|NCT01957488|12411427|FG004|STARTED|Test Period 2 (2 Weeks)||27
11219894|NCT01957488|12411428|FG005|STARTED|Test Period 2 (2 Weeks)||24
11219895|NCT01957488|12411423|FG000|COMPLETED|Test Period 2 (2 Weeks)||24
11219896|NCT01957488|12411424|FG001|COMPLETED|Test Period 2 (2 Weeks)||27
11219897|NCT01957488|12411425|FG002|COMPLETED|Test Period 2 (2 Weeks)||25
11219898|NCT01957488|12411426|FG003|COMPLETED|Test Period 2 (2 Weeks)||28
11219899|NCT01957488|12411427|FG004|COMPLETED|Test Period 2 (2 Weeks)||25
11219900|NCT01957488|12411428|FG005|COMPLETED|Test Period 2 (2 Weeks)||23
11219901|NCT01957488|12411423|FG000|NOT COMPLETED|Test Period 2 (2 Weeks)||3
11219902|NCT01957488|12411424|FG001|NOT COMPLETED|Test Period 2 (2 Weeks)||1
11219903|NCT01957488|12411425|FG002|NOT COMPLETED|Test Period 2 (2 Weeks)||1
11219904|NCT01957488|12411426|FG003|NOT COMPLETED|Test Period 2 (2 Weeks)||1
11219905|NCT01957488|12411427|FG004|NOT COMPLETED|Test Period 2 (2 Weeks)||2
11219906|NCT01957488|12411428|FG005|NOT COMPLETED|Test Period 2 (2 Weeks)||1
11219907|NCT01957488|12411423|FG000|STARTED|Test Period 3 (2 Weeks)||24
11219908|NCT01957488|12411424|FG001|STARTED|Test Period 3 (2 Weeks)||27
10828680|NCT04764630|11994053|FG005|STARTED|Overall Study||4
10828681|NCT04764630|11994048|FG000|COMPLETED|Overall Study||3
10828682|NCT04764630|11994049|FG001|COMPLETED|Overall Study||3
10828683|NCT04764630|11994050|FG002|COMPLETED|Overall Study||3
10828684|NCT04764630|11994051|FG003|COMPLETED|Overall Study||3
10828685|NCT04764630|11994052|FG004|COMPLETED|Overall Study||3
10828686|NCT04764630|11994053|FG005|COMPLETED|Overall Study||3
10828687|NCT04764630|11994048|FG000|NOT COMPLETED|Overall Study||0
10828688|NCT04764630|11994049|FG001|NOT COMPLETED|Overall Study||1
10828689|NCT04764630|11994050|FG002|NOT COMPLETED|Overall Study||0
10828690|NCT04764630|11994051|FG003|NOT COMPLETED|Overall Study||1
10828691|NCT04764630|11994052|FG004|NOT COMPLETED|Overall Study||0
10828692|NCT04764630|11994053|FG005|NOT COMPLETED|Overall Study||1
10828693|NCT04480710|11994066|FG000|STARTED|Overall Study||6
10828694|NCT04480710|11994067|FG001|STARTED|Overall Study||15
10828695|NCT04480710|11994068|FG002|STARTED|Overall Study||9
10828696|NCT04480710|11994069|FG003|STARTED|Overall Study||17
10828697|NCT04480710|11994066|FG000|COMPLETED|Overall Study||6
10828698|NCT04480710|11994067|FG001|COMPLETED|Overall Study||12
10828699|NCT04480710|11994068|FG002|COMPLETED|Overall Study||8
10828700|NCT04480710|11994069|FG003|COMPLETED|Overall Study||17
10828701|NCT04480710|11994066|FG000|NOT COMPLETED|Overall Study||0
10828702|NCT04480710|11994067|FG001|NOT COMPLETED|Overall Study||3
10828703|NCT04480710|11994068|FG002|NOT COMPLETED|Overall Study||1
10828704|NCT04480710|11994069|FG003|NOT COMPLETED|Overall Study||0
11100617|NCT01225991|12284477|FG000|STARTED|Overall Study||18
11100618|NCT01225991|12284477|FG000|COMPLETED|Overall Study||12
11100619|NCT01225991|12284477|FG000|NOT COMPLETED|Overall Study||6
10828708|NCT04225676|11994089|FG000|STARTED|Overall Study||5
10828709|NCT04225676|11994089|FG000|Full Analysis, Safety and Enrolled Sets|Overall Study||5
10828710|NCT04225676|11994089|FG000|COMPLETED|Overall Study||0
10828711|NCT04225676|11994089|FG000|NOT COMPLETED|Overall Study||5
10828712|NCT04045132|11994097|FG000|STARTED|Overall Study||37
10828713|NCT04045132|11994098|FG001|STARTED|Overall Study||38
10828714|NCT04045132|11994097|FG000|COMPLETED|Overall Study||34
10828715|NCT04045132|11994098|FG001|COMPLETED|Overall Study||32
10828716|NCT04045132|11994097|FG000|NOT COMPLETED|Overall Study||3
10828717|NCT04045132|11994098|FG001|NOT COMPLETED|Overall Study||6
10828718|NCT03985813|11994108|FG000|STARTED|Overall Study||27
10828719|NCT03985813|11994109|FG001|STARTED|Overall Study||26
10828720|NCT03985813|11994108|FG000|COMPLETED|Overall Study||27
10828721|NCT03985813|11994109|FG001|COMPLETED|Overall Study||26
10828722|NCT03985813|11994108|FG000|NOT COMPLETED|Overall Study||0
10828723|NCT03985813|11994109|FG001|NOT COMPLETED|Overall Study||0
10828724|NCT03891524|11994123|FG000|STARTED|Overall Study||34
10828725|NCT03891524|11994124|FG001|STARTED|Overall Study||150
10828726|NCT03891524|11994125|FG002|STARTED|Overall Study||153
10828727|NCT03891524|11994126|FG003|STARTED|Overall Study||150
10828728|NCT03891524|11994127|FG004|STARTED|Overall Study||149
10828729|NCT03891524|11994128|FG005|STARTED|Overall Study||152
10828730|NCT03891524|11994129|FG006|STARTED|Overall Study||153
10828731|NCT03891524|11994130|FG007|STARTED|Overall Study||301
10828732|NCT03891524|11994123|FG000|Safety Analysis Set|Overall Study||33
10828733|NCT03891524|11994124|FG001|Safety Analysis Set|Overall Study||150
10828734|NCT03891524|11994125|FG002|Safety Analysis Set|Overall Study||148
10828735|NCT03891524|11994126|FG003|Safety Analysis Set|Overall Study||148
10828736|NCT03891524|11994127|FG004|Safety Analysis Set|Overall Study||147
10828737|NCT03891524|11994128|FG005|Safety Analysis Set|Overall Study||149
10828738|NCT03891524|11994129|FG006|Safety Analysis Set|Overall Study||148
10828739|NCT03891524|11994130|FG007|Safety Analysis Set|Overall Study||296
10828740|NCT03891524|11994123|FG000|COMPLETED|Overall Study||34
10828741|NCT03891524|11994124|FG001|COMPLETED|Overall Study||149
10828742|NCT03891524|11994125|FG002|COMPLETED|Overall Study||151
10828743|NCT03891524|11994126|FG003|COMPLETED|Overall Study||149
10828744|NCT03891524|11994127|FG004|COMPLETED|Overall Study||147
10828745|NCT03891524|11994128|FG005|COMPLETED|Overall Study||150
10828746|NCT03891524|11994129|FG006|COMPLETED|Overall Study||151
10828747|NCT03891524|11994130|FG007|COMPLETED|Overall Study||299
10828748|NCT03891524|11994123|FG000|NOT COMPLETED|Overall Study||0
10828749|NCT03891524|11994124|FG001|NOT COMPLETED|Overall Study||1
10828750|NCT03891524|11994125|FG002|NOT COMPLETED|Overall Study||2
10828751|NCT03891524|11994126|FG003|NOT COMPLETED|Overall Study||1
10828752|NCT03891524|11994127|FG004|NOT COMPLETED|Overall Study||2
10828753|NCT03891524|11994128|FG005|NOT COMPLETED|Overall Study||2
10828754|NCT03891524|11994129|FG006|NOT COMPLETED|Overall Study||2
10828755|NCT03891524|11994130|FG007|NOT COMPLETED|Overall Study||2
10828756|NCT03796208|11994167|FG000|STARTED|Overall Study||40
10828757|NCT03796208|11994168|FG001|STARTED|Overall Study||38
10828758|NCT03796208|11994167|FG000|COMPLETED|Overall Study||16
10828759|NCT03796208|11994168|FG001|COMPLETED|Overall Study||16
10828760|NCT03796208|11994167|FG000|NOT COMPLETED|Overall Study||24
10828761|NCT03796208|11994168|FG001|NOT COMPLETED|Overall Study||22
10828762|NCT03672344|11994176|FG000|STARTED|Overall Study||25
10828763|NCT03672344|11994177|FG001|STARTED|Overall Study||29
10828764|NCT03672344|11994176|FG000|COMPLETED|Overall Study||25
10828765|NCT03672344|11994177|FG001|COMPLETED|Overall Study||29
10828766|NCT03672344|11994176|FG000|NOT COMPLETED|Overall Study||0
10828767|NCT03672344|11994177|FG001|NOT COMPLETED|Overall Study||0
10828768|NCT03611010|11994187|FG000|STARTED|Period 1: Lead-In||14
10828769|NCT03611010|11994188|FG001|STARTED|Period 1: Lead-In||14
10828770|NCT03611010|11994189|FG002|STARTED|Period 1: Lead-In||2
10828771|NCT03611010|11994190|FG003|STARTED|Period 1: Lead-In||10
10828772|NCT03611010|11994187|FG000|COMPLETED|Period 1: Lead-In||14
10828773|NCT03611010|11994188|FG001|COMPLETED|Period 1: Lead-In||14
10828774|NCT03611010|11994189|FG002|COMPLETED|Period 1: Lead-In||2
10828775|NCT03611010|11994190|FG003|COMPLETED|Period 1: Lead-In||10
10828776|NCT03611010|11994187|FG000|NOT COMPLETED|Period 1: Lead-In||0
10828777|NCT03611010|11994188|FG001|NOT COMPLETED|Period 1: Lead-In||0
10828778|NCT03611010|11994189|FG002|NOT COMPLETED|Period 1: Lead-In||0
10828779|NCT03611010|11994190|FG003|NOT COMPLETED|Period 1: Lead-In||0
10828780|NCT03611010|11994187|FG000|STARTED|Period 2: 15 Day Treatment||14
10828781|NCT03611010|11994188|FG001|STARTED|Period 2: 15 Day Treatment||14
10828782|NCT03611010|11994189|FG002|STARTED|Period 2: 15 Day Treatment||2
10828783|NCT03611010|11994190|FG003|STARTED|Period 2: 15 Day Treatment||10
10828784|NCT03611010|11994187|FG000|COMPLETED|Period 2: 15 Day Treatment||13
10828785|NCT03611010|11994188|FG001|COMPLETED|Period 2: 15 Day Treatment||14
10828786|NCT03611010|11994189|FG002|COMPLETED|Period 2: 15 Day Treatment||2
10828787|NCT03611010|11994190|FG003|COMPLETED|Period 2: 15 Day Treatment||10
10828788|NCT03611010|11994187|FG000|NOT COMPLETED|Period 2: 15 Day Treatment||1
10828789|NCT03611010|11994188|FG001|NOT COMPLETED|Period 2: 15 Day Treatment||0
10828790|NCT03611010|11994189|FG002|NOT COMPLETED|Period 2: 15 Day Treatment||0
10828791|NCT03611010|11994190|FG003|NOT COMPLETED|Period 2: 15 Day Treatment||0
10828792|NCT03542877|11994203|FG000|STARTED|Overall Study||44
10828793|NCT03542877|11994203|FG000|COMPLETED|Overall Study||23
10828794|NCT03542877|11994203|FG000|NOT COMPLETED|Overall Study||21
10828795|NCT03476798|11994211|FG000|STARTED|Overall Study||33
10828796|NCT03476798|11994211|FG000|COMPLETED|Overall Study||28
10828797|NCT03476798|11994211|FG000|NOT COMPLETED|Overall Study||5
11100620|NCT01226043|12284483|FG000|STARTED|4-week Crossover Phase - Period 1||202
11100621|NCT01226043|12284484|FG001|STARTED|4-week Crossover Phase - Period 1||203
11100622|NCT01226043|12284485|FG002|STARTED|4-week Crossover Phase - Period 1||0
11100623|NCT01226043|12284486|FG003|STARTED|4-week Crossover Phase - Period 1||0
11100624|NCT01226043|12284483|FG000|TREATED|4-week Crossover Phase - Period 1||202
11100625|NCT01226043|12284484|FG001|TREATED|4-week Crossover Phase - Period 1||200
11100626|NCT01226043|12284485|FG002|TREATED|4-week Crossover Phase - Period 1||0
11100627|NCT01226043|12284486|FG003|TREATED|4-week Crossover Phase - Period 1||0
11100628|NCT01226043|12284483|FG000|COMPLETED|4-week Crossover Phase - Period 1||199
11100629|NCT01226043|12284484|FG001|COMPLETED|4-week Crossover Phase - Period 1||194
11100630|NCT01226043|12284485|FG002|COMPLETED|4-week Crossover Phase - Period 1||0
11100631|NCT01226043|12284486|FG003|COMPLETED|4-week Crossover Phase - Period 1||0
10828810|NCT03355664|11994239|FG000|STARTED|Overall Study||154
10828811|NCT03355664|11994240|FG001|STARTED|Overall Study||156
10828812|NCT03355664|11994239|FG000|COMPLETED|Overall Study||139
10828813|NCT03355664|11994240|FG001|COMPLETED|Overall Study||144
10828814|NCT03355664|11994239|FG000|NOT COMPLETED|Overall Study||15
10828815|NCT03355664|11994240|FG001|NOT COMPLETED|Overall Study||12
11100632|NCT01226043|12284483|FG000|NOT COMPLETED|4-week Crossover Phase - Period 1||3
11100633|NCT01226043|12284484|FG001|NOT COMPLETED|4-week Crossover Phase - Period 1||9
11100634|NCT01226043|12284485|FG002|NOT COMPLETED|4-week Crossover Phase - Period 1||0
10828819|NCT03290131|11994254|FG000|STARTED|Overall Study||179
10828820|NCT03290131|11994255|FG001|STARTED|Overall Study||179
10828821|NCT03290131|11994256|FG002|STARTED|Overall Study||178
10828822|NCT03290131|11994254|FG000|COMPLETED|Overall Study||137
10828823|NCT03290131|11994255|FG001|COMPLETED|Overall Study||107
10828824|NCT03290131|11994256|FG002|COMPLETED|Overall Study||159
10828825|NCT03290131|11994254|FG000|NOT COMPLETED|Overall Study||42
10828826|NCT03290131|11994255|FG001|NOT COMPLETED|Overall Study||72
10828827|NCT03290131|11994256|FG002|NOT COMPLETED|Overall Study||19
11100635|NCT01226043|12284486|FG003|NOT COMPLETED|4-week Crossover Phase - Period 1||0
11100636|NCT01226043|12284483|FG000|STARTED|4-week Crossover Phase - Period 2||199
11100637|NCT01226043|12284484|FG001|STARTED|4-week Crossover Phase - Period 2||194
11100638|NCT01226043|12284485|FG002|STARTED|4-week Crossover Phase - Period 2||0
11100639|NCT01226043|12284486|FG003|STARTED|4-week Crossover Phase - Period 2||0
11100640|NCT01226043|12284483|FG000|TREATED|4-week Crossover Phase - Period 2||199
11100641|NCT01226043|12284484|FG001|TREATED|4-week Crossover Phase - Period 2||194
11100642|NCT01226043|12284485|FG002|TREATED|4-week Crossover Phase - Period 2||0
10828836|NCT03251326|11994274|FG000|STARTED|Overall Study||1
10828837|NCT03251326|11994275|FG001|STARTED|Overall Study||1
10828838|NCT03251326|11994276|FG002|STARTED|Overall Study||1
10828839|NCT03251326|11994277|FG003|STARTED|Overall Study||1
10828840|NCT03251326|11994274|FG000|COMPLETED|Overall Study||1
10828841|NCT03251326|11994275|FG001|COMPLETED|Overall Study||1
10828842|NCT03251326|11994276|FG002|COMPLETED|Overall Study||0
10828843|NCT03251326|11994277|FG003|COMPLETED|Overall Study||0
10828844|NCT03251326|11994274|FG000|NOT COMPLETED|Overall Study||0
10828845|NCT03251326|11994275|FG001|NOT COMPLETED|Overall Study||0
10828846|NCT03251326|11994276|FG002|NOT COMPLETED|Overall Study||1
10828847|NCT03251326|11994277|FG003|NOT COMPLETED|Overall Study||1
11100643|NCT01226043|12284486|FG003|TREATED|4-week Crossover Phase - Period 2||0
11100644|NCT01226043|12284483|FG000|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
11100645|NCT01226043|12284484|FG001|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
11100646|NCT01226043|12284485|FG002|COMPLETED|4-week Crossover Phase - Period 2||0
11100647|NCT01226043|12284486|FG003|COMPLETED|4-week Crossover Phase - Period 2||0
11100648|NCT01226043|12284483|FG000|NOT COMPLETED|4-week Crossover Phase - Period 2||4
11100649|NCT01226043|12284484|FG001|NOT COMPLETED|4-week Crossover Phase - Period 2||6
11100650|NCT01226043|12284485|FG002|NOT COMPLETED|4-week Crossover Phase - Period 2||0
11100651|NCT01226043|12284486|FG003|NOT COMPLETED|4-week Crossover Phase - Period 2||0
11100652|NCT01226043|12284483|FG000|STARTED|6-week Re-randomization Phase||0
11100653|NCT01226043|12284484|FG001|STARTED|6-week Re-randomization Phase||0
11219909|NCT01957488|12411425|FG002|STARTED|Test Period 3 (2 Weeks)||25
11219910|NCT01957488|12411426|FG003|STARTED|Test Period 3 (2 Weeks)||28
11219911|NCT01957488|12411427|FG004|STARTED|Test Period 3 (2 Weeks)||25
11219912|NCT01957488|12411428|FG005|STARTED|Test Period 3 (2 Weeks)||23
11219913|NCT01957488|12411423|FG000|COMPLETED|Test Period 3 (2 Weeks)||23
11219914|NCT01957488|12411424|FG001|COMPLETED|Test Period 3 (2 Weeks)||26
11219915|NCT01957488|12411425|FG002|COMPLETED|Test Period 3 (2 Weeks)||25
11219916|NCT01957488|12411426|FG003|COMPLETED|Test Period 3 (2 Weeks)||28
11219917|NCT01957488|12411427|FG004|COMPLETED|Test Period 3 (2 Weeks)||25
11219918|NCT01957488|12411428|FG005|COMPLETED|Test Period 3 (2 Weeks)||23
11219919|NCT01957488|12411423|FG000|NOT COMPLETED|Test Period 3 (2 Weeks)||1
11219920|NCT01957488|12411424|FG001|NOT COMPLETED|Test Period 3 (2 Weeks)||1
11219921|NCT01957488|12411425|FG002|NOT COMPLETED|Test Period 3 (2 Weeks)||0
11219922|NCT01957488|12411426|FG003|NOT COMPLETED|Test Period 3 (2 Weeks)||0
11219923|NCT01957488|12411427|FG004|NOT COMPLETED|Test Period 3 (2 Weeks)||0
11219924|NCT01957488|12411428|FG005|NOT COMPLETED|Test Period 3 (2 Weeks)||0
11219925|NCT01957553|12411436|FG000|STARTED|Test Period 1 (21 +- 1 Days)||61
11219926|NCT01957553|12411437|FG001|STARTED|Test Period 1 (21 +- 1 Days)||66
11219927|NCT01957553|12411436|FG000|COMPLETED|Test Period 1 (21 +- 1 Days)||54
11219928|NCT01957553|12411437|FG001|COMPLETED|Test Period 1 (21 +- 1 Days)||63
11219929|NCT01957553|12411436|FG000|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
11219930|NCT01957553|12411437|FG001|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
11219931|NCT01957553|12411436|FG000|STARTED|Test Period 2 (21 +- 1 Days)||54
11219932|NCT01957553|12411437|FG001|STARTED|Test Period 2 (21 +- 1 Days)||63
11219933|NCT01957553|12411436|FG000|COMPLETED|Test Period 2 (21 +- 1 Days)||51
11219934|NCT01957553|12411437|FG001|COMPLETED|Test Period 2 (21 +- 1 Days)||56
11219935|NCT01957553|12411436|FG000|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
11219936|NCT01957553|12411437|FG001|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
11219937|NCT01957579|12411447|FG000|STARTED|Overall Study||3
11219938|NCT01957579|12411448|FG001|STARTED|Overall Study||7
11219939|NCT01957579|12411449|FG002|STARTED|Overall Study||4
11219940|NCT01957579|12411450|FG003|STARTED|Overall Study||6
11219941|NCT01957579|12411447|FG000|COMPLETED|Overall Study||3
11219942|NCT01957579|12411448|FG001|COMPLETED|Overall Study||6
11219943|NCT01957579|12411449|FG002|COMPLETED|Overall Study||2
11219944|NCT01957579|12411450|FG003|COMPLETED|Overall Study||6
11219945|NCT01957579|12411447|FG000|NOT COMPLETED|Overall Study||0
11219946|NCT01957579|12411448|FG001|NOT COMPLETED|Overall Study||1
11219947|NCT01957579|12411449|FG002|NOT COMPLETED|Overall Study||2
11219948|NCT01957579|12411450|FG003|NOT COMPLETED|Overall Study||0
11219949|NCT01957644|12411482|FG000|STARTED|Overall Study||6
11219950|NCT01957644|12411483|FG001|STARTED|Overall Study||6
11219951|NCT01957644|12411484|FG002|STARTED|Overall Study||1
11219952|NCT01957644|12411485|FG003|STARTED|Overall Study||2
11219953|NCT01957644|12411486|FG004|STARTED|Overall Study||1
11219954|NCT01957644|12411482|FG000|COMPLETED|Overall Study||0
11219955|NCT01957644|12411483|FG001|COMPLETED|Overall Study||0
11219956|NCT01957644|12411484|FG002|COMPLETED|Overall Study||0
11219957|NCT01957644|12411485|FG003|COMPLETED|Overall Study||0
11219958|NCT01957644|12411486|FG004|COMPLETED|Overall Study||0
11219959|NCT01957644|12411482|FG000|NOT COMPLETED|Overall Study||6
11219960|NCT01957644|12411483|FG001|NOT COMPLETED|Overall Study||6
11219961|NCT01957644|12411484|FG002|NOT COMPLETED|Overall Study||1
11219962|NCT01957644|12411485|FG003|NOT COMPLETED|Overall Study||2
11219963|NCT01957644|12411486|FG004|NOT COMPLETED|Overall Study||1
11219964|NCT01957657|12411500|FG000|STARTED|Overall Study||4
11219965|NCT01957657|12411500|FG000|COMPLETED|Overall Study||4
11219966|NCT01957657|12411500|FG000|NOT COMPLETED|Overall Study||0
11219967|NCT01957709|12411504|FG000|STARTED|Overall Study||8
11219968|NCT01957709|12411504|FG000|COMPLETED|Overall Study||7
11219969|NCT01957709|12411504|FG000|NOT COMPLETED|Overall Study||1
11219970|NCT01957761|12411508|FG000|STARTED|Overall Study||189
11219971|NCT01957761|12411508|FG000|COMPLETED|Overall Study||189
11219972|NCT01957761|12411508|FG000|NOT COMPLETED|Overall Study||0
11219973|NCT01957787|12411512|FG000|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131
11219974|NCT01957787|12411512|FG000|Intent-to-Treat (ITT) Population|Overall Study||130
11219975|NCT01957787|12411512|FG000|Modified ITT (mITT) Population|Overall Study||128
11219976|NCT01957787|12411512|FG000|COMPLETED|Overall Study||95
11100654|NCT01226043|12284485|FG002|STARTED|6-week Re-randomization Phase||166
11219977|NCT01957787|12411512|FG000|NOT COMPLETED|Overall Study||36
10828860|NCT03119064|11994301|FG000|STARTED|Overall Study||9
11100655|NCT01226043|12284486|FG003|STARTED|6-week Re-randomization Phase||167
11100656|NCT01226043|12284483|FG000|TREATED|6-week Re-randomization Phase||0
10828861|NCT03119064|11994302|FG001|STARTED|Overall Study||3
10828862|NCT03119064|11994303|FG002|STARTED|Overall Study||0
10828863|NCT03119064|11994301|FG000|COMPLETED|Overall Study||9
10828864|NCT03119064|11994302|FG001|COMPLETED|Overall Study||3
10828865|NCT03119064|11994303|FG002|COMPLETED|Overall Study||0
10828866|NCT03119064|11994301|FG000|NOT COMPLETED|Overall Study||0
10828867|NCT03119064|11994302|FG001|NOT COMPLETED|Overall Study||0
11100657|NCT01226043|12284484|FG001|TREATED|6-week Re-randomization Phase||0
11100658|NCT01226043|12284485|FG002|TREATED|6-week Re-randomization Phase||165
11100659|NCT01226043|12284486|FG003|TREATED|6-week Re-randomization Phase||165
11100660|NCT01226043|12284483|FG000|COMPLETED|6-week Re-randomization Phase||0
10828868|NCT03119064|11994303|FG002|NOT COMPLETED|Overall Study||0
10828869|NCT03117049|11994312|FG000|STARTED|Overall Study||275
10828870|NCT03117049|11994313|FG001|STARTED|Overall Study||275
10828871|NCT03117049|11994312|FG000|COMPLETED|Overall Study||74
10828872|NCT03117049|11994313|FG001|COMPLETED|Overall Study||44
10828873|NCT03117049|11994312|FG000|NOT COMPLETED|Overall Study||201
10828874|NCT03117049|11994313|FG001|NOT COMPLETED|Overall Study||231
10828875|NCT02842086|11994321|FG000|STARTED|Overall Study||2700
10828876|NCT02842086|11994322|FG001|STARTED|Overall Study||2699
10828877|NCT02842086|11994321|FG000|COMPLETED|Overall Study||2156
10828878|NCT02842086|11994322|FG001|COMPLETED|Overall Study||2206
10828879|NCT02842086|11994321|FG000|NOT COMPLETED|Overall Study||544
10828880|NCT02842086|11994322|FG001|NOT COMPLETED|Overall Study||493
10828881|NCT02663622|11994332|FG000|STARTED|Overall Study||6
10828882|NCT02663622|11994333|FG001|STARTED|Overall Study||6
10828883|NCT02663622|11994334|FG002|STARTED|Overall Study||6
10828884|NCT02663622|11994335|FG003|STARTED|Overall Study||26
10828885|NCT02663622|11994332|FG000|COMPLETED|Overall Study||3
10828886|NCT02663622|11994333|FG001|COMPLETED|Overall Study||5
10828887|NCT02663622|11994334|FG002|COMPLETED|Overall Study||5
10828888|NCT02663622|11994335|FG003|COMPLETED|Overall Study||17
10828889|NCT02663622|11994332|FG000|NOT COMPLETED|Overall Study||3
10828890|NCT02663622|11994333|FG001|NOT COMPLETED|Overall Study||1
10828891|NCT02663622|11994334|FG002|NOT COMPLETED|Overall Study||1
10828892|NCT02663622|11994335|FG003|NOT COMPLETED|Overall Study||9
10828893|NCT02655016|11994348|FG000|STARTED|Overall Study||246
10828894|NCT02655016|11994349|FG001|STARTED|Overall Study||487
10828895|NCT02655016|11994348|FG000|Received Study Treatment|Overall Study|2 participants never received treatment due to screen failure after randomization.|244
10828896|NCT02655016|11994349|FG001|Received Study Treatment|Overall Study|3 participants never received treatment (2 failed screening & 1 withdrew consent before first dose).|484
10828897|NCT02655016|11994348|FG000|Ongoing With Treatment in the Study|Overall Study||69
11100661|NCT01226043|12284484|FG001|COMPLETED|6-week Re-randomization Phase||0
11100662|NCT01226043|12284485|FG002|COMPLETED|6-week Re-randomization Phase||159
11100663|NCT01226043|12284486|FG003|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
11100664|NCT01226043|12284483|FG000|NOT COMPLETED|6-week Re-randomization Phase||0
11100665|NCT01226043|12284484|FG001|NOT COMPLETED|6-week Re-randomization Phase||0
11100666|NCT01226043|12284485|FG002|NOT COMPLETED|6-week Re-randomization Phase||7
11100667|NCT01226043|12284486|FG003|NOT COMPLETED|6-week Re-randomization Phase||11
11100668|NCT01226043|12284483|FG000|STARTED|30-week Observational Phase||0
11100669|NCT01226043|12284484|FG001|STARTED|30-week Observational Phase||0
11100670|NCT01226043|12284485|FG002|STARTED|30-week Observational Phase||159
11100671|NCT01226043|12284486|FG003|STARTED|30-week Observational Phase||153
11100672|NCT01226043|12284483|FG000|TREATED|30-week Observational Phase||0
11100673|NCT01226043|12284484|FG001|TREATED|30-week Observational Phase||0
11100674|NCT01226043|12284485|FG002|TREATED|30-week Observational Phase||159
11100675|NCT01226043|12284486|FG003|TREATED|30-week Observational Phase||153
11100676|NCT01226043|12284483|FG000|COMPLETED|30-week Observational Phase||0
11100677|NCT01226043|12284484|FG001|COMPLETED|30-week Observational Phase||0
11100678|NCT01226043|12284485|FG002|COMPLETED|30-week Observational Phase||153
11100679|NCT01226043|12284486|FG003|COMPLETED|30-week Observational Phase||140
11100680|NCT01226043|12284483|FG000|NOT COMPLETED|30-week Observational Phase||0
11100681|NCT01226043|12284484|FG001|NOT COMPLETED|30-week Observational Phase||0
11100682|NCT01226043|12284485|FG002|NOT COMPLETED|30-week Observational Phase||6
11100683|NCT01226043|12284486|FG003|NOT COMPLETED|30-week Observational Phase||13
11100684|NCT01226095|12284516|FG000|STARTED|Overall Study||519
11100685|NCT01226095|12284516|FG000|COMPLETED|Overall Study||518
11100686|NCT01226095|12284516|FG000|NOT COMPLETED|Overall Study||1
11100687|NCT01226121|12284530|FG000|STARTED|Overall Study||13
11100688|NCT01226121|12284531|FG001|STARTED|Overall Study||11
11100689|NCT01226121|12284532|FG002|STARTED|Overall Study||13
11100690|NCT01226121|12284530|FG000|30 Day Evaluation|Overall Study||12
11100691|NCT01226121|12284531|FG001|30 Day Evaluation|Overall Study||11
11100692|NCT01226121|12284532|FG002|30 Day Evaluation|Overall Study||13
11100693|NCT01226121|12284530|FG000|COMPLETED|Overall Study||11
11100694|NCT01226121|12284531|FG001|COMPLETED|Overall Study||11
11100695|NCT01226121|12284532|FG002|COMPLETED|Overall Study||12
11100696|NCT01226121|12284530|FG000|NOT COMPLETED|Overall Study||2
11100697|NCT01226121|12284531|FG001|NOT COMPLETED|Overall Study||0
11100698|NCT01226121|12284532|FG002|NOT COMPLETED|Overall Study||1
10828898|NCT02655016|11994349|FG001|Ongoing With Treatment in the Study|Overall Study||177
10828899|NCT02655016|11994348|FG000|COMPLETED|Overall Study|69 participants are ongoing in the study.|191
10828900|NCT02655016|11994349|FG001|COMPLETED|Overall Study|177 participants are ongoing in the study.|397
10828901|NCT02655016|11994348|FG000|NOT COMPLETED|Overall Study||55
10828902|NCT02655016|11994349|FG001|NOT COMPLETED|Overall Study||90
10828903|NCT02636439|11994358|FG000|STARTED|Overall Study||44
10828904|NCT02636439|11994359|FG001|STARTED|Overall Study||44
10828905|NCT02636439|11994358|FG000|COMPLETED|Overall Study||38
10828906|NCT02636439|11994359|FG001|COMPLETED|Overall Study||41
10828907|NCT02636439|11994358|FG000|NOT COMPLETED|Overall Study||6
10828908|NCT02636439|11994359|FG001|NOT COMPLETED|Overall Study||3
10828909|NCT02567825|11994367|FG000|STARTED|Overall Study||129
10828910|NCT02567825|11994368|FG001|STARTED|Overall Study||121
10828911|NCT02567825|11994367|FG000|COMPLETED|Overall Study||108
10828912|NCT02567825|11994368|FG001|COMPLETED|Overall Study||100
10828913|NCT02567825|11994367|FG000|NOT COMPLETED|Overall Study||21
10828914|NCT02567825|11994368|FG001|NOT COMPLETED|Overall Study||21
11100699|NCT01226420|12284540|FG000|STARTED|Overall Study||6
11100700|NCT01226420|12284540|FG000|COMPLETED|Overall Study||6
11100701|NCT01226420|12284540|FG000|NOT COMPLETED|Overall Study||0
10828918|NCT02536755|11994383|FG000|STARTED|Overall Study||31
10828919|NCT02536755|11994383|FG000|COMPLETED|Overall Study||27
10828920|NCT02536755|11994383|FG000|NOT COMPLETED|Overall Study||4
10828921|NCT02516241|11994393|FG000|STARTED|Overall Study||342
10828922|NCT02516241|11994394|FG001|STARTED|Overall Study||346
10828923|NCT02516241|11994395|FG002|STARTED|Overall Study||344
10828924|NCT02516241|11994393|FG000|Received Treatment|Overall Study||340
10828925|NCT02516241|11994394|FG001|Received Treatment|Overall Study||345
10828926|NCT02516241|11994395|FG002|Received Treatment|Overall Study||313
10828927|NCT02516241|11994393|FG000|COMPLETED|Overall Study||0
10828928|NCT02516241|11994394|FG001|COMPLETED|Overall Study||0
10828929|NCT02516241|11994395|FG002|COMPLETED|Overall Study||0
10828930|NCT02516241|11994393|FG000|NOT COMPLETED|Overall Study||342
10828931|NCT02516241|11994394|FG001|NOT COMPLETED|Overall Study||346
10828932|NCT02516241|11994395|FG002|NOT COMPLETED|Overall Study||344
10828933|NCT02442349|11994408|FG000|STARTED|Overall Study||171
10828934|NCT02442349|11994408|FG000|COMPLETED|Overall Study||0
10828935|NCT02442349|11994408|FG000|NOT COMPLETED|Overall Study||171
10828936|NCT02362035|11994412|FG000|STARTED|Overall Study||161
10828937|NCT02362035|11994412|FG000|COMPLETED|Overall Study||0
10828938|NCT02362035|11994412|FG000|NOT COMPLETED|Overall Study||161
10828939|NCT02359019|11994416|FG000|STARTED|Overall Study||45
10828940|NCT02359019|11994416|FG000|COMPLETED|Overall Study||45
10828941|NCT02359019|11994416|FG000|NOT COMPLETED|Overall Study||0
10828942|NCT02328014|11994424|FG000|STARTED|Overall Study||6
10828943|NCT02328014|11994425|FG001|STARTED|Overall Study||6
10828944|NCT02328014|11994426|FG002|STARTED|Overall Study||6
10828945|NCT02328014|11994427|FG003|STARTED|Overall Study||22
10828946|NCT02328014|11994424|FG000|COMPLETED|Overall Study||0
10828947|NCT02328014|11994425|FG001|COMPLETED|Overall Study||0
10828948|NCT02328014|11994426|FG002|COMPLETED|Overall Study||0
10828949|NCT02328014|11994427|FG003|COMPLETED|Overall Study||0
10828950|NCT02328014|11994424|FG000|NOT COMPLETED|Overall Study||6
10828951|NCT02328014|11994425|FG001|NOT COMPLETED|Overall Study||6
10828952|NCT02328014|11994426|FG002|NOT COMPLETED|Overall Study||6
10828953|NCT02328014|11994427|FG003|NOT COMPLETED|Overall Study||22
11100702|NCT01226459|12284546|FG000|STARTED|Overall Study||201
11100703|NCT01226459|12284547|FG001|STARTED|Overall Study||203
11100704|NCT01226459|12284546|FG000|COMPLETED|Overall Study||180
11100705|NCT01226459|12284547|FG001|COMPLETED|Overall Study||171
11100706|NCT01226459|12284546|FG000|NOT COMPLETED|Overall Study||21
11100707|NCT01226459|12284547|FG001|NOT COMPLETED|Overall Study||32
11100708|NCT01226472|12284553|FG000|STARTED|Overall Study||1
11100709|NCT01226472|12284553|FG000|COMPLETED|Overall Study||0
11100710|NCT01226472|12284553|FG000|NOT COMPLETED|Overall Study||1
11100711|NCT01226485|12284564|FG000|STARTED|Overall Study||3
11100712|NCT01226485|12284565|FG001|STARTED|Overall Study||6
11100713|NCT01226485|12284566|FG002|STARTED|Overall Study||3
11100714|NCT01226485|12284567|FG003|STARTED|Overall Study||6
11100715|NCT01226485|12284568|FG004|STARTED|Overall Study||7
11100716|NCT01226485|12284569|FG005|STARTED|Overall Study||19
11100717|NCT01226485|12284570|FG006|STARTED|Overall Study||40
11100718|NCT01226485|12284564|FG000|Received at Least One Dose of Drug|Overall Study||3
11100719|NCT01226485|12284565|FG001|Received at Least One Dose of Drug|Overall Study||6
11100720|NCT01226485|12284566|FG002|Received at Least One Dose of Drug|Overall Study||3
11100721|NCT01226485|12284567|FG003|Received at Least One Dose of Drug|Overall Study||6
11100722|NCT01226485|12284568|FG004|Received at Least One Dose of Drug|Overall Study||7
11100723|NCT01226485|12284569|FG005|Received at Least One Dose of Drug|Overall Study||19
11100724|NCT01226485|12284570|FG006|Received at Least One Dose of Drug|Overall Study||40
11100725|NCT01226485|12284564|FG000|COMPLETED|Overall Study||3
11100726|NCT01226485|12284565|FG001|COMPLETED|Overall Study||6
11100727|NCT01226485|12284566|FG002|COMPLETED|Overall Study||3
11100728|NCT01226485|12284567|FG003|COMPLETED|Overall Study||6
11100729|NCT01226485|12284568|FG004|COMPLETED|Overall Study||7
11100730|NCT01226485|12284569|FG005|COMPLETED|Overall Study||19
11100731|NCT01226485|12284570|FG006|COMPLETED|Overall Study||40
11100732|NCT01226485|12284564|FG000|NOT COMPLETED|Overall Study||0
11100733|NCT01226485|12284565|FG001|NOT COMPLETED|Overall Study||0
11100734|NCT01226485|12284566|FG002|NOT COMPLETED|Overall Study||0
11100735|NCT01226485|12284567|FG003|NOT COMPLETED|Overall Study||0
11100736|NCT01226485|12284568|FG004|NOT COMPLETED|Overall Study||0
10828966|NCT02207569|11994450|FG000|STARTED|Implant|241 Attempted Implant|241
10828967|NCT02207569|11994450|FG000|COMPLETED|Implant|237 Implanted|241
10828968|NCT02207569|11994450|FG000|NOT COMPLETED|Implant||0
10828969|NCT02207569|11994450|FG000|STARTED|1-Month|241 Attempted Implant|241
10828970|NCT02207569|11994450|FG000|COMPLETED|1-Month||232
10828971|NCT02207569|11994450|FG000|NOT COMPLETED|1-Month||9
10828972|NCT02207569|11994450|FG000|STARTED|6-Month||232
10828973|NCT02207569|11994450|FG000|COMPLETED|6-Month||222
10828974|NCT02207569|11994450|FG000|NOT COMPLETED|6-Month||10
10828975|NCT02207569|11994450|FG000|STARTED|12-Month||213
10828976|NCT02207569|11994450|FG000|COMPLETED|12-Month||197
10828977|NCT02207569|11994450|FG000|NOT COMPLETED|12-Month||16
10828978|NCT02207569|11994450|FG000|STARTED|24-Month||197
10828979|NCT02207569|11994450|FG000|COMPLETED|24-Month||171
10828980|NCT02207569|11994450|FG000|NOT COMPLETED|24-Month||26
10828981|NCT02207569|11994450|FG000|STARTED|36-Month||171
10828982|NCT02207569|11994450|FG000|COMPLETED|36-Month||144
10828983|NCT02207569|11994450|FG000|NOT COMPLETED|36-Month||27
10828984|NCT02207569|11994450|FG000|STARTED|48-Month||144
11100737|NCT01226485|12284569|FG005|NOT COMPLETED|Overall Study||0
11100738|NCT01226485|12284570|FG006|NOT COMPLETED|Overall Study||0
11100739|NCT01226511|12284596|FG000|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
11100740|NCT01226511|12284597|FG001|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
11100741|NCT01226511|12284596|FG000|COMPLETED|Acute Treatment Period||108
11100742|NCT01226511|12284597|FG001|COMPLETED|Acute Treatment Period||110
11100743|NCT01226511|12284596|FG000|NOT COMPLETED|Acute Treatment Period||32
11100744|NCT01226511|12284597|FG001|NOT COMPLETED|Acute Treatment Period||31
11100745|NCT01226511|12284596|FG000|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
11100746|NCT01226511|12284597|FG001|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
11100747|NCT01226511|12284596|FG000|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
11100748|NCT01226511|12284597|FG001|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
11100749|NCT01226511|12284596|FG000|NOT COMPLETED|Extension Treatment Period||27
11100750|NCT01226511|12284597|FG001|NOT COMPLETED|Extension Treatment Period||27
11100751|NCT01226511|12284596|FG000|STARTED|Taper Period||51
11100752|NCT01226511|12284597|FG001|STARTED|Taper Period||57
11100753|NCT01226511|12284596|FG000|COMPLETED|Taper Period||46
11100754|NCT01226511|12284597|FG001|COMPLETED|Taper Period||54
11100755|NCT01226511|12284596|FG000|NOT COMPLETED|Taper Period||5
11100756|NCT01226511|12284597|FG001|NOT COMPLETED|Taper Period||3
11100757|NCT01226706|12284611|FG000|STARTED|Overall Study||10
11100758|NCT01226706|12284612|FG001|STARTED|Overall Study||11
11100759|NCT01226706|12284611|FG000|COMPLETED|Overall Study||10
11100760|NCT01226706|12284612|FG001|COMPLETED|Overall Study||11
11100761|NCT01226706|12284611|FG000|NOT COMPLETED|Overall Study||0
11100762|NCT01226706|12284612|FG001|NOT COMPLETED|Overall Study||0
11100763|NCT01226719|12284620|FG000|STARTED|Overall Study||15
11100764|NCT01226719|12284620|FG000|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
11100765|NCT01226719|12284620|FG000|NOT COMPLETED|Overall Study||13
11100766|NCT01226745|12284630|FG000|STARTED|Overall Study||80
11100767|NCT01226745|12284631|FG001|STARTED|Overall Study||87
11100768|NCT01226745|12284632|FG002|STARTED|Overall Study||89
11100769|NCT01226745|12284633|FG003|STARTED|Overall Study||29
11100770|NCT01226745|12284634|FG004|STARTED|Overall Study||26
11100771|NCT01226745|12284635|FG005|STARTED|Overall Study||29
11100772|NCT01226745|12284630|FG000|COMPLETED|Overall Study||63
11100773|NCT01226745|12284631|FG001|COMPLETED|Overall Study||71
11100774|NCT01226745|12284632|FG002|COMPLETED|Overall Study||69
11100775|NCT01226745|12284633|FG003|COMPLETED|Overall Study||24
11100776|NCT01226745|12284634|FG004|COMPLETED|Overall Study||22
11100777|NCT01226745|12284635|FG005|COMPLETED|Overall Study||24
11100778|NCT01226745|12284630|FG000|NOT COMPLETED|Overall Study||17
11100779|NCT01226745|12284631|FG001|NOT COMPLETED|Overall Study||16
11100780|NCT01226745|12284632|FG002|NOT COMPLETED|Overall Study||20
11100781|NCT01226745|12284633|FG003|NOT COMPLETED|Overall Study||5
11100782|NCT01226745|12284634|FG004|NOT COMPLETED|Overall Study||4
11100783|NCT01226745|12284635|FG005|NOT COMPLETED|Overall Study||5
11100784|NCT01226914|12284652|FG000|STARTED|Overall Study||28
11100785|NCT01226914|12284653|FG001|STARTED|Overall Study||27
11100786|NCT01226914|12284652|FG000|COMPLETED|Overall Study||28
11100787|NCT01226914|12284653|FG001|COMPLETED|Overall Study||27
11100788|NCT01226914|12284652|FG000|NOT COMPLETED|Overall Study||0
11100789|NCT01226914|12284653|FG001|NOT COMPLETED|Overall Study||0
11100790|NCT01226979|12284659|FG000|STARTED|Overall Study||16
10828985|NCT02207569|11994450|FG000|COMPLETED|48-Month||113
10828986|NCT02207569|11994450|FG000|NOT COMPLETED|48-Month||31
10828987|NCT02207569|11994450|FG000|STARTED|60-Month||113
10828988|NCT02207569|11994450|FG000|COMPLETED|60-Month||109
10828989|NCT02207569|11994450|FG000|NOT COMPLETED|60-Month||4
10828990|NCT02201108|11994456|FG000|STARTED|Double-blind Period (up to Week 96)||57
10828991|NCT02201108|11994457|FG001|STARTED|Double-blind Period (up to Week 96)||109
10828992|NCT02201108|11994456|FG000|COMPLETED|Double-blind Period (up to Week 96)||53
10828993|NCT02201108|11994457|FG001|COMPLETED|Double-blind Period (up to Week 96)||102
10828994|NCT02201108|11994456|FG000|NOT COMPLETED|Double-blind Period (up to Week 96)||4
10828995|NCT02201108|11994457|FG001|NOT COMPLETED|Double-blind Period (up to Week 96)||7
10828996|NCT02201108|11994456|FG000|STARTED|Open Label Period (up to Week 192)||52
10828997|NCT02201108|11994457|FG001|STARTED|Open Label Period (up to Week 192)||100
10828998|NCT02201108|11994456|FG000|COMPLETED|Open Label Period (up to Week 192)||31
10828999|NCT02201108|11994457|FG001|COMPLETED|Open Label Period (up to Week 192)||73
10829000|NCT02201108|11994456|FG000|NOT COMPLETED|Open Label Period (up to Week 192)||21
10829001|NCT02201108|11994457|FG001|NOT COMPLETED|Open Label Period (up to Week 192)||27
11100791|NCT01226979|12284659|FG000|COMPLETED|Overall Study||16
11100792|NCT01226979|12284659|FG000|NOT COMPLETED|Overall Study||0
11100793|NCT01227005|12284666|FG000|STARTED|Overall Study||55
11100794|NCT01227005|12284667|FG001|STARTED|Overall Study||52
11100795|NCT01227005|12284666|FG000|COMPLETED|Overall Study||50
11100796|NCT01227005|12284667|FG001|COMPLETED|Overall Study||51
11100797|NCT01227005|12284666|FG000|NOT COMPLETED|Overall Study||5
11100798|NCT01227005|12284667|FG001|NOT COMPLETED|Overall Study||1
11100799|NCT01227018|12284673|FG000|STARTED|Overall Study||15
11100800|NCT01227018|12284673|FG000|COMPLETED|Overall Study||0
11100801|NCT01227018|12284673|FG000|NOT COMPLETED|Overall Study||15
11100802|NCT01227044|12284679|FG000|STARTED|Overall Study||25
10829010|NCT02150967|11994487|FG000|STARTED|Overall Study||108
10829011|NCT02150967|11994488|FG001|STARTED|Overall Study||14
10829012|NCT02150967|11994487|FG000|Treatment Ongoing (Cohort 1 Only)|Overall Study||1
10829013|NCT02150967|11994488|FG001|Treatment Ongoing (Cohort 1 Only)|Overall Study||0
10829014|NCT02150967|11994487|FG000|Treatment Ended (Cohort 1 Only)|Overall Study||107
10829015|NCT02150967|11994488|FG001|Treatment Ended (Cohort 1 Only)|Overall Study||14
10829016|NCT02150967|11994487|FG000|COMPLETED|Overall Study|Cohort 1 (FGFR2 fusions): Primary efficacy outcome measures were prespecified only for this cohort.|108
10829017|NCT02150967|11994488|FG001|COMPLETED|Overall Study|Cohort 1 (Other FGFR Alterations): not the primary efficacy analysis population, thus efficacy results for this cohort are not reported.|14
10829018|NCT02150967|11994487|FG000|NOT COMPLETED|Overall Study||0
10829019|NCT02150967|11994488|FG001|NOT COMPLETED|Overall Study||0
11100803|NCT01227044|12284680|FG001|STARTED|Overall Study||26
11100804|NCT01227044|12284679|FG000|COMPLETED|Overall Study||19
11100805|NCT01227044|12284680|FG001|COMPLETED|Overall Study||17
11100806|NCT01227044|12284679|FG000|NOT COMPLETED|Overall Study||6
11100807|NCT01227044|12284680|FG001|NOT COMPLETED|Overall Study||9
11100808|NCT01227057|12284688|FG000|STARTED|Overall Study||31
11100809|NCT01227057|12284689|FG001|STARTED|Overall Study||27
11100810|NCT01227057|12284688|FG000|COMPLETED|Overall Study||25
11100811|NCT01227057|12284689|FG001|COMPLETED|Overall Study||19
11100812|NCT01227057|12284688|FG000|NOT COMPLETED|Overall Study||6
11100813|NCT01227057|12284689|FG001|NOT COMPLETED|Overall Study||8
11100814|NCT01227252|12284700|FG000|STARTED|Overall Study||12
11100815|NCT01227252|12284701|FG001|STARTED|Overall Study||10
11100816|NCT01227252|12284702|FG002|STARTED|Overall Study||10
11100817|NCT01227252|12284703|FG003|STARTED|Overall Study||10
11100818|NCT01227252|12284700|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
11100819|NCT01227252|12284701|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
11100820|NCT01227252|12284702|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10
11100821|NCT01227252|12284703|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
11100822|NCT01227252|12284700|FG000|COMPLETED|Overall Study||12
11100823|NCT01227252|12284701|FG001|COMPLETED|Overall Study||7
11100824|NCT01227252|12284702|FG002|COMPLETED|Overall Study||10
11100825|NCT01227252|12284703|FG003|COMPLETED|Overall Study||10
11100826|NCT01227252|12284700|FG000|NOT COMPLETED|Overall Study||0
11100827|NCT01227252|12284701|FG001|NOT COMPLETED|Overall Study||3
11100828|NCT01227252|12284702|FG002|NOT COMPLETED|Overall Study||0
11100829|NCT01227252|12284703|FG003|NOT COMPLETED|Overall Study||0
11100830|NCT01227265|12284719|FG000|STARTED|Overall Study||158
11100831|NCT01227265|12284720|FG001|STARTED|Overall Study||159
11100832|NCT01227265|12284721|FG002|STARTED|Overall Study||159
11100833|NCT01227265|12284719|FG000|Treated|Overall Study||157
11100834|NCT01227265|12284720|FG001|Treated|Overall Study||157
11100835|NCT01227265|12284721|FG002|Treated|Overall Study||159
11100836|NCT01227265|12284719|FG000|COMPLETED|Overall Study||139
11100837|NCT01227265|12284720|FG001|COMPLETED|Overall Study||139
11100838|NCT01227265|12284721|FG002|COMPLETED|Overall Study||145
10829056|NCT01759459|11994548|FG000|STARTED|Overall Study||50
10829057|NCT01759459|11994549|FG001|STARTED|Overall Study||50
10829058|NCT01759459|11994550|FG002|STARTED|Overall Study||50
10829059|NCT01759459|11994548|FG000|COMPLETED|Overall Study||50
10829060|NCT01759459|11994549|FG001|COMPLETED|Overall Study||50
10829061|NCT01759459|11994550|FG002|COMPLETED|Overall Study||50
10829062|NCT01759459|11994548|FG000|NOT COMPLETED|Overall Study||0
10829063|NCT01759459|11994549|FG001|NOT COMPLETED|Overall Study||0
10829064|NCT01759459|11994550|FG002|NOT COMPLETED|Overall Study||0
11100839|NCT01227265|12284719|FG000|NOT COMPLETED|Overall Study||19
11100840|NCT01227265|12284720|FG001|NOT COMPLETED|Overall Study||20
11100841|NCT01227265|12284721|FG002|NOT COMPLETED|Overall Study||14
11100842|NCT01227278|12284731|FG000|STARTED|Overall Study||50
11100843|NCT01227278|12284732|FG001|STARTED|Overall Study||51
11100844|NCT01227278|12284731|FG000|COMPLETED|Overall Study||45
11100845|NCT01227278|12284732|FG001|COMPLETED|Overall Study||43
11100846|NCT01227278|12284731|FG000|NOT COMPLETED|Overall Study||5
11100847|NCT01227278|12284732|FG001|NOT COMPLETED|Overall Study||8
11100848|NCT01227382|12284738|FG000|STARTED|Overall Study||26
11100849|NCT01227382|12284738|FG000|COMPLETED|Overall Study||26
11100850|NCT01227382|12284738|FG000|NOT COMPLETED|Overall Study||0
11100851|NCT01227395|12284746|FG000|STARTED|Overall Study||391
11100852|NCT01227395|12284747|FG001|STARTED|Overall Study||85
10829080|NCT01116648|11994597|FG000|STARTED|Phase 1 Dose Level 0||3
10829081|NCT01116648|11994598|FG001|STARTED|Phase 1 Dose Level 0||0
10829082|NCT01116648|11994599|FG002|STARTED|Phase 1 Dose Level 0||0
10829083|NCT01116648|11994600|FG003|STARTED|Phase 1 Dose Level 0||0
10829084|NCT01116648|11994601|FG004|STARTED|Phase 1 Dose Level 0||0
10829085|NCT01116648|11994602|FG005|STARTED|Phase 1 Dose Level 0||0
10829086|NCT01116648|11994603|FG006|STARTED|Phase 1 Dose Level 0||0
10829087|NCT01116648|11994604|FG007|STARTED|Phase 1 Dose Level 0||0
10829088|NCT01116648|11994605|FG008|STARTED|Phase 1 Dose Level 0||0
10829089|NCT01116648|11994606|FG009|STARTED|Phase 1 Dose Level 0||0
10829090|NCT01116648|11994607|FG010|STARTED|Phase 1 Dose Level 0||0
10829091|NCT01116648|11994608|FG011|STARTED|Phase 1 Dose Level 0||0
10829092|NCT01116648|11994609|FG012|STARTED|Phase 1 Dose Level 0||0
10829093|NCT01116648|11994610|FG013|STARTED|Phase 1 Dose Level 0||0
10829094|NCT01116648|11994611|FG014|STARTED|Phase 1 Dose Level 0||0
10829095|NCT01116648|11994597|FG000|COMPLETED|Phase 1 Dose Level 0||3
10829096|NCT01116648|11994598|FG001|COMPLETED|Phase 1 Dose Level 0||0
10829097|NCT01116648|11994599|FG002|COMPLETED|Phase 1 Dose Level 0||0
10829098|NCT01116648|11994600|FG003|COMPLETED|Phase 1 Dose Level 0||0
10829099|NCT01116648|11994601|FG004|COMPLETED|Phase 1 Dose Level 0||0
10829100|NCT01116648|11994602|FG005|COMPLETED|Phase 1 Dose Level 0||0
10829101|NCT01116648|11994603|FG006|COMPLETED|Phase 1 Dose Level 0||0
10829102|NCT01116648|11994604|FG007|COMPLETED|Phase 1 Dose Level 0||0
10829103|NCT01116648|11994605|FG008|COMPLETED|Phase 1 Dose Level 0||0
10829104|NCT01116648|11994606|FG009|COMPLETED|Phase 1 Dose Level 0||0
10829105|NCT01116648|11994607|FG010|COMPLETED|Phase 1 Dose Level 0||0
10829106|NCT01116648|11994608|FG011|COMPLETED|Phase 1 Dose Level 0||0
10829107|NCT01116648|11994609|FG012|COMPLETED|Phase 1 Dose Level 0||0
10829108|NCT01116648|11994610|FG013|COMPLETED|Phase 1 Dose Level 0||0
10829109|NCT01116648|11994611|FG014|COMPLETED|Phase 1 Dose Level 0||0
10829110|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1 Dose Level 0||0
10829111|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1 Dose Level 0||0
10829112|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1 Dose Level 0||0
10829113|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1 Dose Level 0||0
10829114|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1 Dose Level 0||0
10829115|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1 Dose Level 0||0
10829116|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1 Dose Level 0||0
10829117|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1 Dose Level 0||0
10829118|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1 Dose Level 0||0
10829119|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1 Dose Level 0||0
10829120|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1 Dose Level 0||0
10829121|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1 Dose Level 0||0
10829122|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1 Dose Level 0||0
10829123|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1 Dose Level 0||0
10829124|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1 Dose Level 0||0
10829125|NCT01116648|11994597|FG000|STARTED|Phase 1 Dose Level 1||0
10829126|NCT01116648|11994598|FG001|STARTED|Phase 1 Dose Level 1||3
10829127|NCT01116648|11994599|FG002|STARTED|Phase 1 Dose Level 1||0
10829128|NCT01116648|11994600|FG003|STARTED|Phase 1 Dose Level 1||0
10829129|NCT01116648|11994601|FG004|STARTED|Phase 1 Dose Level 1||0
10829130|NCT01116648|11994602|FG005|STARTED|Phase 1 Dose Level 1||0
10829131|NCT01116648|11994603|FG006|STARTED|Phase 1 Dose Level 1||0
10829132|NCT01116648|11994604|FG007|STARTED|Phase 1 Dose Level 1||0
10829133|NCT01116648|11994605|FG008|STARTED|Phase 1 Dose Level 1||0
10829134|NCT01116648|11994606|FG009|STARTED|Phase 1 Dose Level 1||0
10829135|NCT01116648|11994607|FG010|STARTED|Phase 1 Dose Level 1||0
10829136|NCT01116648|11994608|FG011|STARTED|Phase 1 Dose Level 1||0
10829137|NCT01116648|11994609|FG012|STARTED|Phase 1 Dose Level 1||0
10829138|NCT01116648|11994610|FG013|STARTED|Phase 1 Dose Level 1||0
10829139|NCT01116648|11994611|FG014|STARTED|Phase 1 Dose Level 1||0
10829140|NCT01116648|11994597|FG000|COMPLETED|Phase 1 Dose Level 1||0
10829141|NCT01116648|11994598|FG001|COMPLETED|Phase 1 Dose Level 1||3
10829142|NCT01116648|11994599|FG002|COMPLETED|Phase 1 Dose Level 1||0
10829143|NCT01116648|11994600|FG003|COMPLETED|Phase 1 Dose Level 1||0
10829144|NCT01116648|11994601|FG004|COMPLETED|Phase 1 Dose Level 1||0
10829145|NCT01116648|11994602|FG005|COMPLETED|Phase 1 Dose Level 1||0
10829146|NCT01116648|11994603|FG006|COMPLETED|Phase 1 Dose Level 1||0
10829147|NCT01116648|11994604|FG007|COMPLETED|Phase 1 Dose Level 1||0
10829148|NCT01116648|11994605|FG008|COMPLETED|Phase 1 Dose Level 1||0
10829149|NCT01116648|11994606|FG009|COMPLETED|Phase 1 Dose Level 1||0
10829150|NCT01116648|11994607|FG010|COMPLETED|Phase 1 Dose Level 1||0
10829151|NCT01116648|11994608|FG011|COMPLETED|Phase 1 Dose Level 1||0
10829152|NCT01116648|11994609|FG012|COMPLETED|Phase 1 Dose Level 1||0
10829153|NCT01116648|11994610|FG013|COMPLETED|Phase 1 Dose Level 1||0
10829154|NCT01116648|11994611|FG014|COMPLETED|Phase 1 Dose Level 1||0
10829155|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1 Dose Level 1||0
10829156|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1 Dose Level 1||0
10829157|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1 Dose Level 1||0
10829158|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1 Dose Level 1||0
10829159|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1 Dose Level 1||0
10829160|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1 Dose Level 1||0
10829161|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1 Dose Level 1||0
10829162|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1 Dose Level 1||0
10829163|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1 Dose Level 1||0
10829164|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1 Dose Level 1||0
10829165|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1 Dose Level 1||0
10829166|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1 Dose Level 1||0
10829167|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1 Dose Level 1||0
10829168|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1 Dose Level 1||0
10829169|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1 Dose Level 1||0
10829170|NCT01116648|11994597|FG000|STARTED|Phase 1 Dose Level 2||0
10829171|NCT01116648|11994598|FG001|STARTED|Phase 1 Dose Level 2||0
10829172|NCT01116648|11994599|FG002|STARTED|Phase 1 Dose Level 2||7
10829173|NCT01116648|11994600|FG003|STARTED|Phase 1 Dose Level 2||0
10829174|NCT01116648|11994601|FG004|STARTED|Phase 1 Dose Level 2||0
10829175|NCT01116648|11994602|FG005|STARTED|Phase 1 Dose Level 2||0
10829176|NCT01116648|11994603|FG006|STARTED|Phase 1 Dose Level 2||0
10829177|NCT01116648|11994604|FG007|STARTED|Phase 1 Dose Level 2||0
10829178|NCT01116648|11994605|FG008|STARTED|Phase 1 Dose Level 2||0
10829179|NCT01116648|11994606|FG009|STARTED|Phase 1 Dose Level 2||0
10829180|NCT01116648|11994607|FG010|STARTED|Phase 1 Dose Level 2||0
10829181|NCT01116648|11994608|FG011|STARTED|Phase 1 Dose Level 2||0
10829182|NCT01116648|11994609|FG012|STARTED|Phase 1 Dose Level 2||0
10829183|NCT01116648|11994610|FG013|STARTED|Phase 1 Dose Level 2||0
10829184|NCT01116648|11994611|FG014|STARTED|Phase 1 Dose Level 2||0
10829185|NCT01116648|11994597|FG000|COMPLETED|Phase 1 Dose Level 2||0
10829186|NCT01116648|11994598|FG001|COMPLETED|Phase 1 Dose Level 2||0
10829187|NCT01116648|11994599|FG002|COMPLETED|Phase 1 Dose Level 2||7
10829188|NCT01116648|11994600|FG003|COMPLETED|Phase 1 Dose Level 2||0
10829189|NCT01116648|11994601|FG004|COMPLETED|Phase 1 Dose Level 2||0
10829190|NCT01116648|11994602|FG005|COMPLETED|Phase 1 Dose Level 2||0
10829191|NCT01116648|11994603|FG006|COMPLETED|Phase 1 Dose Level 2||0
10829192|NCT01116648|11994604|FG007|COMPLETED|Phase 1 Dose Level 2||0
10829193|NCT01116648|11994605|FG008|COMPLETED|Phase 1 Dose Level 2||0
10829194|NCT01116648|11994606|FG009|COMPLETED|Phase 1 Dose Level 2||0
10829195|NCT01116648|11994607|FG010|COMPLETED|Phase 1 Dose Level 2||0
10829196|NCT01116648|11994608|FG011|COMPLETED|Phase 1 Dose Level 2||0
10829197|NCT01116648|11994609|FG012|COMPLETED|Phase 1 Dose Level 2||0
10829198|NCT01116648|11994610|FG013|COMPLETED|Phase 1 Dose Level 2||0
10829199|NCT01116648|11994611|FG014|COMPLETED|Phase 1 Dose Level 2||0
10829200|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1 Dose Level 2||0
10829201|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1 Dose Level 2||0
10829202|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1 Dose Level 2||0
10829203|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1 Dose Level 2||0
10829204|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1 Dose Level 2||0
10829205|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1 Dose Level 2||0
10829206|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1 Dose Level 2||0
10829207|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1 Dose Level 2||0
10829208|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1 Dose Level 2||0
10829209|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1 Dose Level 2||0
10829210|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1 Dose Level 2||0
10829211|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1 Dose Level 2||0
10829212|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1 Dose Level 2||0
10829213|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1 Dose Level 2||0
10829214|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1 Dose Level 2||0
10829215|NCT01116648|11994597|FG000|STARTED|Phase 1 Dose Level 3||0
10829216|NCT01116648|11994598|FG001|STARTED|Phase 1 Dose Level 3||0
10829217|NCT01116648|11994599|FG002|STARTED|Phase 1 Dose Level 3||0
10829218|NCT01116648|11994600|FG003|STARTED|Phase 1 Dose Level 3||6
10829219|NCT01116648|11994601|FG004|STARTED|Phase 1 Dose Level 3||0
10829220|NCT01116648|11994602|FG005|STARTED|Phase 1 Dose Level 3||0
10829221|NCT01116648|11994603|FG006|STARTED|Phase 1 Dose Level 3||0
10829222|NCT01116648|11994604|FG007|STARTED|Phase 1 Dose Level 3||0
10829223|NCT01116648|11994605|FG008|STARTED|Phase 1 Dose Level 3||0
10829224|NCT01116648|11994606|FG009|STARTED|Phase 1 Dose Level 3||0
10829225|NCT01116648|11994607|FG010|STARTED|Phase 1 Dose Level 3||0
10829226|NCT01116648|11994608|FG011|STARTED|Phase 1 Dose Level 3||0
10829227|NCT01116648|11994609|FG012|STARTED|Phase 1 Dose Level 3||0
10829228|NCT01116648|11994610|FG013|STARTED|Phase 1 Dose Level 3||0
10829229|NCT01116648|11994611|FG014|STARTED|Phase 1 Dose Level 3||0
10829230|NCT01116648|11994597|FG000|COMPLETED|Phase 1 Dose Level 3||0
10829231|NCT01116648|11994598|FG001|COMPLETED|Phase 1 Dose Level 3||0
10829232|NCT01116648|11994599|FG002|COMPLETED|Phase 1 Dose Level 3||0
10829233|NCT01116648|11994600|FG003|COMPLETED|Phase 1 Dose Level 3||4
10829234|NCT01116648|11994601|FG004|COMPLETED|Phase 1 Dose Level 3||0
10829235|NCT01116648|11994602|FG005|COMPLETED|Phase 1 Dose Level 3||0
10829236|NCT01116648|11994603|FG006|COMPLETED|Phase 1 Dose Level 3||0
10829237|NCT01116648|11994604|FG007|COMPLETED|Phase 1 Dose Level 3||0
10829238|NCT01116648|11994605|FG008|COMPLETED|Phase 1 Dose Level 3||0
10829239|NCT01116648|11994606|FG009|COMPLETED|Phase 1 Dose Level 3||0
10829240|NCT01116648|11994607|FG010|COMPLETED|Phase 1 Dose Level 3||0
10829241|NCT01116648|11994608|FG011|COMPLETED|Phase 1 Dose Level 3||0
10829242|NCT01116648|11994609|FG012|COMPLETED|Phase 1 Dose Level 3||0
10829243|NCT01116648|11994610|FG013|COMPLETED|Phase 1 Dose Level 3||0
10829244|NCT01116648|11994611|FG014|COMPLETED|Phase 1 Dose Level 3||0
10829245|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1 Dose Level 3||0
10829246|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1 Dose Level 3||0
10829247|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1 Dose Level 3||0
10829248|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1 Dose Level 3||2
10829249|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1 Dose Level 3||0
10829250|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1 Dose Level 3||0
10829251|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1 Dose Level 3||0
10829252|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1 Dose Level 3||0
10829253|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1 Dose Level 3||0
10829254|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1 Dose Level 3||0
10829255|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1 Dose Level 3||0
10829256|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1 Dose Level 3||0
10829257|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1 Dose Level 3||0
10829258|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1 Dose Level 3||0
10829259|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1 Dose Level 3||0
10829260|NCT01116648|11994597|FG000|STARTED|Expansion at Maximum Tolerated Dose||0
10829261|NCT01116648|11994598|FG001|STARTED|Expansion at Maximum Tolerated Dose||0
10829262|NCT01116648|11994599|FG002|STARTED|Expansion at Maximum Tolerated Dose||0
10829263|NCT01116648|11994600|FG003|STARTED|Expansion at Maximum Tolerated Dose||0
10829264|NCT01116648|11994601|FG004|STARTED|Expansion at Maximum Tolerated Dose||9
10829265|NCT01116648|11994602|FG005|STARTED|Expansion at Maximum Tolerated Dose||0
10829266|NCT01116648|11994603|FG006|STARTED|Expansion at Maximum Tolerated Dose||0
10829267|NCT01116648|11994604|FG007|STARTED|Expansion at Maximum Tolerated Dose||0
10829268|NCT01116648|11994605|FG008|STARTED|Expansion at Maximum Tolerated Dose||0
10829269|NCT01116648|11994606|FG009|STARTED|Expansion at Maximum Tolerated Dose||0
10829270|NCT01116648|11994607|FG010|STARTED|Expansion at Maximum Tolerated Dose||0
10829271|NCT01116648|11994608|FG011|STARTED|Expansion at Maximum Tolerated Dose||0
10829272|NCT01116648|11994609|FG012|STARTED|Expansion at Maximum Tolerated Dose||0
10829273|NCT01116648|11994610|FG013|STARTED|Expansion at Maximum Tolerated Dose||0
10829274|NCT01116648|11994611|FG014|STARTED|Expansion at Maximum Tolerated Dose||0
10829275|NCT01116648|11994597|FG000|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829276|NCT01116648|11994598|FG001|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829277|NCT01116648|11994599|FG002|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829278|NCT01116648|11994600|FG003|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829279|NCT01116648|11994601|FG004|COMPLETED|Expansion at Maximum Tolerated Dose||9
10829280|NCT01116648|11994602|FG005|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829281|NCT01116648|11994603|FG006|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829282|NCT01116648|11994604|FG007|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829283|NCT01116648|11994605|FG008|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829284|NCT01116648|11994606|FG009|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829285|NCT01116648|11994607|FG010|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829286|NCT01116648|11994608|FG011|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829287|NCT01116648|11994609|FG012|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829288|NCT01116648|11994610|FG013|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829289|NCT01116648|11994611|FG014|COMPLETED|Expansion at Maximum Tolerated Dose||0
10829290|NCT01116648|11994597|FG000|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829291|NCT01116648|11994598|FG001|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829292|NCT01116648|11994599|FG002|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829293|NCT01116648|11994600|FG003|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829294|NCT01116648|11994601|FG004|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829295|NCT01116648|11994602|FG005|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829296|NCT01116648|11994603|FG006|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829297|NCT01116648|11994604|FG007|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829298|NCT01116648|11994605|FG008|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829299|NCT01116648|11994606|FG009|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829300|NCT01116648|11994607|FG010|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829301|NCT01116648|11994608|FG011|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829302|NCT01116648|11994609|FG012|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829303|NCT01116648|11994610|FG013|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829304|NCT01116648|11994611|FG014|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
10829305|NCT01116648|11994597|FG000|STARTED|Phase 2||0
10829306|NCT01116648|11994598|FG001|STARTED|Phase 2||0
10829307|NCT01116648|11994599|FG002|STARTED|Phase 2||0
10829308|NCT01116648|11994600|FG003|STARTED|Phase 2||0
10829309|NCT01116648|11994601|FG004|STARTED|Phase 2||0
10829310|NCT01116648|11994602|FG005|STARTED|Phase 2||46
10829311|NCT01116648|11994603|FG006|STARTED|Phase 2||44
10829312|NCT01116648|11994604|FG007|STARTED|Phase 2||0
10829313|NCT01116648|11994605|FG008|STARTED|Phase 2||0
10829314|NCT01116648|11994606|FG009|STARTED|Phase 2||0
10829315|NCT01116648|11994607|FG010|STARTED|Phase 2||0
10829316|NCT01116648|11994608|FG011|STARTED|Phase 2||0
10829317|NCT01116648|11994609|FG012|STARTED|Phase 2||0
10829318|NCT01116648|11994610|FG013|STARTED|Phase 2||0
10829319|NCT01116648|11994611|FG014|STARTED|Phase 2||0
10829320|NCT01116648|11994597|FG000|COMPLETED|Phase 2||0
10829321|NCT01116648|11994598|FG001|COMPLETED|Phase 2||0
10829322|NCT01116648|11994599|FG002|COMPLETED|Phase 2||0
10829323|NCT01116648|11994600|FG003|COMPLETED|Phase 2||0
10829324|NCT01116648|11994601|FG004|COMPLETED|Phase 2||0
10829325|NCT01116648|11994602|FG005|COMPLETED|Phase 2||46
10829326|NCT01116648|11994603|FG006|COMPLETED|Phase 2||44
10829327|NCT01116648|11994604|FG007|COMPLETED|Phase 2||0
10829328|NCT01116648|11994605|FG008|COMPLETED|Phase 2||0
10829329|NCT01116648|11994606|FG009|COMPLETED|Phase 2||0
10829330|NCT01116648|11994607|FG010|COMPLETED|Phase 2||0
10829331|NCT01116648|11994608|FG011|COMPLETED|Phase 2||0
10829332|NCT01116648|11994609|FG012|COMPLETED|Phase 2||0
10829333|NCT01116648|11994610|FG013|COMPLETED|Phase 2||0
10829334|NCT01116648|11994611|FG014|COMPLETED|Phase 2||0
10829335|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 2||0
10829336|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 2||0
10829337|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 2||0
10829338|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 2||0
10829339|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 2||0
10829340|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 2||0
10829341|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 2||0
10829342|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 2||0
10829343|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 2||0
10829344|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 2||0
10829345|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 2||0
10829346|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 2||0
10829347|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 2||0
10829348|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 2||0
10829349|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 2||0
10829350|NCT01116648|11994597|FG000|STARTED|Phase 1-T Dose Level 0-TA||0
10829351|NCT01116648|11994598|FG001|STARTED|Phase 1-T Dose Level 0-TA||0
10829352|NCT01116648|11994599|FG002|STARTED|Phase 1-T Dose Level 0-TA||0
10829353|NCT01116648|11994600|FG003|STARTED|Phase 1-T Dose Level 0-TA||0
10829354|NCT01116648|11994601|FG004|STARTED|Phase 1-T Dose Level 0-TA||0
10829355|NCT01116648|11994602|FG005|STARTED|Phase 1-T Dose Level 0-TA||0
10829356|NCT01116648|11994603|FG006|STARTED|Phase 1-T Dose Level 0-TA||0
10829357|NCT01116648|11994604|FG007|STARTED|Phase 1-T Dose Level 0-TA||3
10829358|NCT01116648|11994605|FG008|STARTED|Phase 1-T Dose Level 0-TA||0
10829359|NCT01116648|11994606|FG009|STARTED|Phase 1-T Dose Level 0-TA||0
10829360|NCT01116648|11994607|FG010|STARTED|Phase 1-T Dose Level 0-TA||0
10829361|NCT01116648|11994608|FG011|STARTED|Phase 1-T Dose Level 0-TA||0
10829362|NCT01116648|11994609|FG012|STARTED|Phase 1-T Dose Level 0-TA||0
10829363|NCT01116648|11994610|FG013|STARTED|Phase 1-T Dose Level 0-TA||0
10829364|NCT01116648|11994611|FG014|STARTED|Phase 1-T Dose Level 0-TA||0
10829365|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829366|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829367|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829368|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829369|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829370|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829371|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829372|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T Dose Level 0-TA||3
10829373|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829374|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829375|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829376|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829377|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829378|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829379|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T Dose Level 0-TA||0
10829380|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829381|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829382|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829383|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829384|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829385|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829386|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829387|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829388|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829389|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829390|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829391|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829392|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829393|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829394|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
10829395|NCT01116648|11994597|FG000|STARTED|Phase 1-T Dose Level 1-TA||0
10829396|NCT01116648|11994598|FG001|STARTED|Phase 1-T Dose Level 1-TA||0
10829397|NCT01116648|11994599|FG002|STARTED|Phase 1-T Dose Level 1-TA||0
10829398|NCT01116648|11994600|FG003|STARTED|Phase 1-T Dose Level 1-TA||0
10829399|NCT01116648|11994601|FG004|STARTED|Phase 1-T Dose Level 1-TA||0
10829400|NCT01116648|11994602|FG005|STARTED|Phase 1-T Dose Level 1-TA||0
10829401|NCT01116648|11994603|FG006|STARTED|Phase 1-T Dose Level 1-TA||0
10829402|NCT01116648|11994604|FG007|STARTED|Phase 1-T Dose Level 1-TA||0
10829403|NCT01116648|11994605|FG008|STARTED|Phase 1-T Dose Level 1-TA||6
10829404|NCT01116648|11994606|FG009|STARTED|Phase 1-T Dose Level 1-TA||0
11100853|NCT01227395|12284746|FG000|COMPLETED|Overall Study||391
10829405|NCT01116648|11994607|FG010|STARTED|Phase 1-T Dose Level 1-TA||0
10829406|NCT01116648|11994608|FG011|STARTED|Phase 1-T Dose Level 1-TA||0
10829407|NCT01116648|11994609|FG012|STARTED|Phase 1-T Dose Level 1-TA||0
10829408|NCT01116648|11994610|FG013|STARTED|Phase 1-T Dose Level 1-TA||0
10829409|NCT01116648|11994611|FG014|STARTED|Phase 1-T Dose Level 1-TA||0
10829410|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829411|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829412|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829413|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829414|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T Dose Level 1-TA||0
11100854|NCT01227395|12284747|FG001|COMPLETED|Overall Study||84
10829415|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829416|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829417|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829418|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T Dose Level 1-TA||6
10829419|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829420|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829421|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829422|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829423|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829424|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T Dose Level 1-TA||0
10829425|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829426|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829427|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829428|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829429|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829430|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829431|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829432|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829433|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829434|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829435|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829436|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
11100855|NCT01227395|12284746|FG000|NOT COMPLETED|Overall Study||0
10829437|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829438|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829439|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
10829440|NCT01116648|11994597|FG000|STARTED|Phase 1-T Dose Level 2-TA||0
10829441|NCT01116648|11994598|FG001|STARTED|Phase 1-T Dose Level 2-TA||0
10829442|NCT01116648|11994599|FG002|STARTED|Phase 1-T Dose Level 2-TA||0
10829443|NCT01116648|11994600|FG003|STARTED|Phase 1-T Dose Level 2-TA||0
10829444|NCT01116648|11994601|FG004|STARTED|Phase 1-T Dose Level 2-TA||0
10829445|NCT01116648|11994602|FG005|STARTED|Phase 1-T Dose Level 2-TA||0
10829446|NCT01116648|11994603|FG006|STARTED|Phase 1-T Dose Level 2-TA||0
10829447|NCT01116648|11994604|FG007|STARTED|Phase 1-T Dose Level 2-TA||0
10829448|NCT01116648|11994605|FG008|STARTED|Phase 1-T Dose Level 2-TA||0
10829449|NCT01116648|11994606|FG009|STARTED|Phase 1-T Dose Level 2-TA||3
10829450|NCT01116648|11994607|FG010|STARTED|Phase 1-T Dose Level 2-TA||0
10829451|NCT01116648|11994608|FG011|STARTED|Phase 1-T Dose Level 2-TA||0
10829452|NCT01116648|11994609|FG012|STARTED|Phase 1-T Dose Level 2-TA||0
10829453|NCT01116648|11994610|FG013|STARTED|Phase 1-T Dose Level 2-TA||0
10829454|NCT01116648|11994611|FG014|STARTED|Phase 1-T Dose Level 2-TA||0
10829455|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829456|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829457|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829458|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829459|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829460|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829461|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829462|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829463|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829464|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T Dose Level 2-TA||3
10829465|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829466|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829467|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829468|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829469|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T Dose Level 2-TA||0
10829470|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829471|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829472|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829473|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829474|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829475|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829476|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829477|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829478|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829479|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829480|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829481|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829482|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829483|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829484|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
10829485|NCT01116648|11994597|FG000|STARTED|Phase 1-T Dose Level 0-TB||0
10829486|NCT01116648|11994598|FG001|STARTED|Phase 1-T Dose Level 0-TB||0
10829487|NCT01116648|11994599|FG002|STARTED|Phase 1-T Dose Level 0-TB||0
10829488|NCT01116648|11994600|FG003|STARTED|Phase 1-T Dose Level 0-TB||0
10829489|NCT01116648|11994601|FG004|STARTED|Phase 1-T Dose Level 0-TB||0
10829490|NCT01116648|11994602|FG005|STARTED|Phase 1-T Dose Level 0-TB||0
10829491|NCT01116648|11994603|FG006|STARTED|Phase 1-T Dose Level 0-TB||0
10829492|NCT01116648|11994604|FG007|STARTED|Phase 1-T Dose Level 0-TB||0
10829493|NCT01116648|11994605|FG008|STARTED|Phase 1-T Dose Level 0-TB||0
10829494|NCT01116648|11994606|FG009|STARTED|Phase 1-T Dose Level 0-TB||0
10829495|NCT01116648|11994607|FG010|STARTED|Phase 1-T Dose Level 0-TB||3
10829496|NCT01116648|11994608|FG011|STARTED|Phase 1-T Dose Level 0-TB||0
10829497|NCT01116648|11994609|FG012|STARTED|Phase 1-T Dose Level 0-TB||0
10829498|NCT01116648|11994610|FG013|STARTED|Phase 1-T Dose Level 0-TB||0
10829499|NCT01116648|11994611|FG014|STARTED|Phase 1-T Dose Level 0-TB||0
10829500|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829501|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829502|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829503|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829504|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829505|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829506|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829507|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829508|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829509|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829510|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T Dose Level 0-TB||3
10829511|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829512|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829513|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829514|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T Dose Level 0-TB||0
10829515|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829516|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829517|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829518|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829519|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829520|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829521|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829522|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829523|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829524|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829525|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829526|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829527|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829528|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829529|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
10829530|NCT01116648|11994597|FG000|STARTED|Phase 1-T Dose Level 1-TB||0
10829531|NCT01116648|11994598|FG001|STARTED|Phase 1-T Dose Level 1-TB||0
10829532|NCT01116648|11994599|FG002|STARTED|Phase 1-T Dose Level 1-TB||0
10829533|NCT01116648|11994600|FG003|STARTED|Phase 1-T Dose Level 1-TB||0
10829534|NCT01116648|11994601|FG004|STARTED|Phase 1-T Dose Level 1-TB||0
10829535|NCT01116648|11994602|FG005|STARTED|Phase 1-T Dose Level 1-TB||0
10829536|NCT01116648|11994603|FG006|STARTED|Phase 1-T Dose Level 1-TB||0
10829537|NCT01116648|11994604|FG007|STARTED|Phase 1-T Dose Level 1-TB||0
10829538|NCT01116648|11994605|FG008|STARTED|Phase 1-T Dose Level 1-TB||0
10829539|NCT01116648|11994606|FG009|STARTED|Phase 1-T Dose Level 1-TB||0
10829540|NCT01116648|11994607|FG010|STARTED|Phase 1-T Dose Level 1-TB||0
10829541|NCT01116648|11994608|FG011|STARTED|Phase 1-T Dose Level 1-TB||3
10829542|NCT01116648|11994609|FG012|STARTED|Phase 1-T Dose Level 1-TB||0
10829543|NCT01116648|11994610|FG013|STARTED|Phase 1-T Dose Level 1-TB||0
10829544|NCT01116648|11994611|FG014|STARTED|Phase 1-T Dose Level 1-TB||0
10829545|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829546|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829547|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829548|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829549|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829550|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829551|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829552|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829553|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829554|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829555|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829556|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T Dose Level 1-TB||3
10829557|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829558|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829559|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T Dose Level 1-TB||0
10829560|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829561|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829562|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829563|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829564|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829565|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829566|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829567|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829568|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829569|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829570|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829571|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829572|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829573|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829574|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
10829575|NCT01116648|11994597|FG000|STARTED|Phase 1-T Dose Level 2-TB||0
10829576|NCT01116648|11994598|FG001|STARTED|Phase 1-T Dose Level 2-TB||0
10829577|NCT01116648|11994599|FG002|STARTED|Phase 1-T Dose Level 2-TB||0
10829578|NCT01116648|11994600|FG003|STARTED|Phase 1-T Dose Level 2-TB||0
10829579|NCT01116648|11994601|FG004|STARTED|Phase 1-T Dose Level 2-TB||0
10829580|NCT01116648|11994602|FG005|STARTED|Phase 1-T Dose Level 2-TB||0
10829581|NCT01116648|11994603|FG006|STARTED|Phase 1-T Dose Level 2-TB||0
10829582|NCT01116648|11994604|FG007|STARTED|Phase 1-T Dose Level 2-TB||0
10829583|NCT01116648|11994605|FG008|STARTED|Phase 1-T Dose Level 2-TB||0
10829584|NCT01116648|11994606|FG009|STARTED|Phase 1-T Dose Level 2-TB||0
10829585|NCT01116648|11994607|FG010|STARTED|Phase 1-T Dose Level 2-TB||0
10829586|NCT01116648|11994608|FG011|STARTED|Phase 1-T Dose Level 2-TB||0
10829587|NCT01116648|11994609|FG012|STARTED|Phase 1-T Dose Level 2-TB||6
10829588|NCT01116648|11994610|FG013|STARTED|Phase 1-T Dose Level 2-TB||0
10829589|NCT01116648|11994611|FG014|STARTED|Phase 1-T Dose Level 2-TB||0
10829590|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829591|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829592|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829593|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829594|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829595|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829596|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829597|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829598|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829599|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829600|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829601|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829602|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T Dose Level 2-TB||6
10829603|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829604|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T Dose Level 2-TB||0
10829605|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829606|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829607|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829608|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829609|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829610|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829611|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829612|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829613|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829614|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829615|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829616|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829617|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829618|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829619|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
10829620|NCT01116648|11994597|FG000|STARTED|Phase 1-T PKOlap Expansion||0
10829621|NCT01116648|11994598|FG001|STARTED|Phase 1-T PKOlap Expansion||0
11100856|NCT01227395|12284747|FG001|NOT COMPLETED|Overall Study||1
11100857|NCT01227421|12284775|FG000|STARTED|Overall Study||201
11100858|NCT01227421|12284776|FG001|STARTED|Overall Study||212
11100859|NCT01227421|12284777|FG002|STARTED|Overall Study||211
11100860|NCT01227421|12284775|FG000|COMPLETED|Overall Study||190
11100861|NCT01227421|12284776|FG001|COMPLETED|Overall Study||194
11100862|NCT01227421|12284777|FG002|COMPLETED|Overall Study||201
11100863|NCT01227421|12284775|FG000|NOT COMPLETED|Overall Study||11
11100864|NCT01227421|12284776|FG001|NOT COMPLETED|Overall Study||18
11100865|NCT01227421|12284777|FG002|NOT COMPLETED|Overall Study||10
11100866|NCT01227434|12284787|FG000|STARTED|Overall Study||6
11100867|NCT01227434|12284788|FG001|STARTED|Overall Study||16
11100868|NCT01227434|12284787|FG000|COMPLETED|Overall Study||6
11100869|NCT01227434|12284788|FG001|COMPLETED|Overall Study||16
11100870|NCT01227434|12284787|FG000|NOT COMPLETED|Overall Study||0
11100871|NCT01227434|12284788|FG001|NOT COMPLETED|Overall Study||0
11100872|NCT01227512|12284797|FG000|STARTED|Overall Study||66
11100873|NCT01227512|12284798|FG001|STARTED|Overall Study||58
11100874|NCT01227512|12284797|FG000|COMPLETED|Overall Study||53
11100875|NCT01227512|12284798|FG001|COMPLETED|Overall Study||48
11100876|NCT01227512|12284797|FG000|NOT COMPLETED|Overall Study||13
11100877|NCT01227512|12284798|FG001|NOT COMPLETED|Overall Study||10
11100878|NCT01227551|12284806|FG000|STARTED|Overall Study||57
11100879|NCT01227551|12284806|FG000|COMPLETED|Overall Study||23
11100880|NCT01227551|12284806|FG000|NOT COMPLETED|Overall Study||34
11100881|NCT01227564|12284813|FG000|STARTED|Overall Study||22
11100882|NCT01227564|12284814|FG001|STARTED|Overall Study||20
11100883|NCT01227564|12284815|FG002|STARTED|Overall Study||21
11100884|NCT01227564|12284813|FG000|Treated|Overall Study||22
11100885|NCT01227564|12284814|FG001|Treated|Overall Study||20
11100886|NCT01227564|12284815|FG002|Treated|Overall Study||21
11100887|NCT01227564|12284813|FG000|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
11100888|NCT01227564|12284814|FG001|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
11100889|NCT01227564|12284815|FG002|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
11100890|NCT01227564|12284813|FG000|COMPLETED|Overall Study|Completed study|18
11100891|NCT01227564|12284814|FG001|COMPLETED|Overall Study|Completed study|18
10829622|NCT01116648|11994599|FG002|STARTED|Phase 1-T PKOlap Expansion||0
10829623|NCT01116648|11994600|FG003|STARTED|Phase 1-T PKOlap Expansion||0
10829624|NCT01116648|11994601|FG004|STARTED|Phase 1-T PKOlap Expansion||0
10829625|NCT01116648|11994602|FG005|STARTED|Phase 1-T PKOlap Expansion||0
10829626|NCT01116648|11994603|FG006|STARTED|Phase 1-T PKOlap Expansion||0
10829627|NCT01116648|11994604|FG007|STARTED|Phase 1-T PKOlap Expansion||0
10829628|NCT01116648|11994605|FG008|STARTED|Phase 1-T PKOlap Expansion||0
10829629|NCT01116648|11994606|FG009|STARTED|Phase 1-T PKOlap Expansion||0
10829630|NCT01116648|11994607|FG010|STARTED|Phase 1-T PKOlap Expansion||0
10829631|NCT01116648|11994608|FG011|STARTED|Phase 1-T PKOlap Expansion||0
10829632|NCT01116648|11994609|FG012|STARTED|Phase 1-T PKOlap Expansion||0
10829633|NCT01116648|11994610|FG013|STARTED|Phase 1-T PKOlap Expansion||6
10829634|NCT01116648|11994611|FG014|STARTED|Phase 1-T PKOlap Expansion||0
10829635|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T PKOlap Expansion||0
10829636|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T PKOlap Expansion||0
10829637|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T PKOlap Expansion||0
10829638|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T PKOlap Expansion||0
10829639|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T PKOlap Expansion||0
10829640|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T PKOlap Expansion||0
10829641|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T PKOlap Expansion||0
10829642|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T PKOlap Expansion||0
10829643|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T PKOlap Expansion||0
10829644|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T PKOlap Expansion||0
10829645|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T PKOlap Expansion||0
10829646|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T PKOlap Expansion||0
10829647|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T PKOlap Expansion||0
11100892|NCT01227564|12284815|FG002|COMPLETED|Overall Study|Completed study|15
11100893|NCT01227564|12284813|FG000|NOT COMPLETED|Overall Study||4
11100894|NCT01227564|12284814|FG001|NOT COMPLETED|Overall Study||2
11100895|NCT01227564|12284815|FG002|NOT COMPLETED|Overall Study||6
10829648|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T PKOlap Expansion||6
10829649|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T PKOlap Expansion||0
10829650|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829651|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829652|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829653|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829654|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829655|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829656|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829657|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829658|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829659|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829660|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829661|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829662|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
11100896|NCT01227577|12284825|FG000|STARTED|Overall Study||128
11100897|NCT01227577|12284825|FG000|COMPLETED|Overall Study||93
11100898|NCT01227577|12284825|FG000|NOT COMPLETED|Overall Study||35
11100899|NCT01227629|12284839|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
11100900|NCT01227629|12284840|FG001|STARTED|Overall Study||20
11100901|NCT01227629|12284841|FG002|STARTED|Overall Study||27
11100902|NCT01227629|12284842|FG003|STARTED|Overall Study||99
11100903|NCT01227629|12284843|FG004|STARTED|Overall Study||34
11100904|NCT01227629|12284844|FG005|STARTED|Overall Study||33
11100905|NCT01227629|12284845|FG006|STARTED|Overall Study||98
11100906|NCT01227629|12284846|FG007|STARTED|Overall Study||33
11100907|NCT01227629|12284847|FG008|STARTED|Overall Study||30
11100908|NCT01227629|12284848|FG009|STARTED|Overall Study||70
11100909|NCT01227629|12284839|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
11100910|NCT01227629|12284840|FG001|COMPLETED|Overall Study||18
11100911|NCT01227629|12284841|FG002|COMPLETED|Overall Study||26
11100912|NCT01227629|12284842|FG003|COMPLETED|Overall Study||91
11100913|NCT01227629|12284843|FG004|COMPLETED|Overall Study||32
11100914|NCT01227629|12284844|FG005|COMPLETED|Overall Study||32
11100915|NCT01227629|12284845|FG006|COMPLETED|Overall Study||90
11100916|NCT01227629|12284846|FG007|COMPLETED|Overall Study||27
11100917|NCT01227629|12284847|FG008|COMPLETED|Overall Study||24
11100918|NCT01227629|12284848|FG009|COMPLETED|Overall Study||68
11100919|NCT01227629|12284839|FG000|NOT COMPLETED|Overall Study||2
11100920|NCT01227629|12284840|FG001|NOT COMPLETED|Overall Study||2
11100921|NCT01227629|12284841|FG002|NOT COMPLETED|Overall Study||1
11100922|NCT01227629|12284842|FG003|NOT COMPLETED|Overall Study||8
11100923|NCT01227629|12284843|FG004|NOT COMPLETED|Overall Study||2
11100924|NCT01227629|12284844|FG005|NOT COMPLETED|Overall Study||1
11100925|NCT01227629|12284845|FG006|NOT COMPLETED|Overall Study||8
11100926|NCT01227629|12284846|FG007|NOT COMPLETED|Overall Study||6
11100927|NCT01227629|12284847|FG008|NOT COMPLETED|Overall Study||6
10829663|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829664|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
10829665|NCT01116648|11994597|FG000|STARTED|Phase 1-T PKCed Expansion||0
10829666|NCT01116648|11994598|FG001|STARTED|Phase 1-T PKCed Expansion||0
10829667|NCT01116648|11994599|FG002|STARTED|Phase 1-T PKCed Expansion||0
10829668|NCT01116648|11994600|FG003|STARTED|Phase 1-T PKCed Expansion||0
10829669|NCT01116648|11994601|FG004|STARTED|Phase 1-T PKCed Expansion||0
10829670|NCT01116648|11994602|FG005|STARTED|Phase 1-T PKCed Expansion||0
10829671|NCT01116648|11994603|FG006|STARTED|Phase 1-T PKCed Expansion||0
10829672|NCT01116648|11994604|FG007|STARTED|Phase 1-T PKCed Expansion||0
10829673|NCT01116648|11994605|FG008|STARTED|Phase 1-T PKCed Expansion||0
10829674|NCT01116648|11994606|FG009|STARTED|Phase 1-T PKCed Expansion||0
10829675|NCT01116648|11994607|FG010|STARTED|Phase 1-T PKCed Expansion||0
10829676|NCT01116648|11994608|FG011|STARTED|Phase 1-T PKCed Expansion||0
10829677|NCT01116648|11994609|FG012|STARTED|Phase 1-T PKCed Expansion||0
10829678|NCT01116648|11994610|FG013|STARTED|Phase 1-T PKCed Expansion||0
10829679|NCT01116648|11994611|FG014|STARTED|Phase 1-T PKCed Expansion||7
10829680|NCT01116648|11994597|FG000|COMPLETED|Phase 1-T PKCed Expansion||0
10829681|NCT01116648|11994598|FG001|COMPLETED|Phase 1-T PKCed Expansion||0
10829682|NCT01116648|11994599|FG002|COMPLETED|Phase 1-T PKCed Expansion||0
10829683|NCT01116648|11994600|FG003|COMPLETED|Phase 1-T PKCed Expansion||0
10829684|NCT01116648|11994601|FG004|COMPLETED|Phase 1-T PKCed Expansion||0
10829685|NCT01116648|11994602|FG005|COMPLETED|Phase 1-T PKCed Expansion||0
10829686|NCT01116648|11994603|FG006|COMPLETED|Phase 1-T PKCed Expansion||0
10829687|NCT01116648|11994604|FG007|COMPLETED|Phase 1-T PKCed Expansion||0
10829688|NCT01116648|11994605|FG008|COMPLETED|Phase 1-T PKCed Expansion||0
10829689|NCT01116648|11994606|FG009|COMPLETED|Phase 1-T PKCed Expansion||0
10829690|NCT01116648|11994607|FG010|COMPLETED|Phase 1-T PKCed Expansion||0
10829691|NCT01116648|11994608|FG011|COMPLETED|Phase 1-T PKCed Expansion||0
10829692|NCT01116648|11994609|FG012|COMPLETED|Phase 1-T PKCed Expansion||0
10829693|NCT01116648|11994610|FG013|COMPLETED|Phase 1-T PKCed Expansion||0
10829694|NCT01116648|11994611|FG014|COMPLETED|Phase 1-T PKCed Expansion||7
10829695|NCT01116648|11994597|FG000|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829696|NCT01116648|11994598|FG001|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829697|NCT01116648|11994599|FG002|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829698|NCT01116648|11994600|FG003|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829699|NCT01116648|11994601|FG004|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829700|NCT01116648|11994602|FG005|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829701|NCT01116648|11994603|FG006|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829702|NCT01116648|11994604|FG007|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829703|NCT01116648|11994605|FG008|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829704|NCT01116648|11994606|FG009|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829705|NCT01116648|11994607|FG010|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829706|NCT01116648|11994608|FG011|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829707|NCT01116648|11994609|FG012|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829708|NCT01116648|11994610|FG013|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829709|NCT01116648|11994611|FG014|NOT COMPLETED|Phase 1-T PKCed Expansion||0
10829710|NCT01078662|11994641|FG000|STARTED|Overall Study||62
10829711|NCT01078662|11994642|FG001|STARTED|Overall Study||193
10829712|NCT01078662|11994643|FG002|STARTED|Overall Study||23
10829713|NCT01078662|11994644|FG003|STARTED|Overall Study||8
10829714|NCT01078662|11994645|FG004|STARTED|Overall Study||12
10829715|NCT01078662|11994641|FG000|COMPLETED|Overall Study||4
10829716|NCT01078662|11994642|FG001|COMPLETED|Overall Study||25
10829717|NCT01078662|11994643|FG002|COMPLETED|Overall Study||2
10829718|NCT01078662|11994644|FG003|COMPLETED|Overall Study||1
10829719|NCT01078662|11994645|FG004|COMPLETED|Overall Study||1
10829720|NCT01078662|11994641|FG000|NOT COMPLETED|Overall Study||58
10829721|NCT01078662|11994642|FG001|NOT COMPLETED|Overall Study||168
10829722|NCT01078662|11994643|FG002|NOT COMPLETED|Overall Study||21
10829723|NCT01078662|11994644|FG003|NOT COMPLETED|Overall Study||7
10829724|NCT01078662|11994645|FG004|NOT COMPLETED|Overall Study||11
10829725|NCT00680901|11994656|FG000|STARTED|Overall Study||272
10829726|NCT00680901|11994657|FG001|STARTED|Overall Study||273
10829727|NCT00680901|11994656|FG000|Ongoing: On Study Treatment|Overall Study||16
10829728|NCT00680901|11994657|FG001|Ongoing: On Study Treatment|Overall Study||13
10829729|NCT00680901|11994656|FG000|Ongoing: In Follow Up|Overall Study||45
10829730|NCT00680901|11994657|FG001|Ongoing: In Follow Up|Overall Study||41
10829731|NCT00680901|11994656|FG000|COMPLETED|Overall Study||199
10829732|NCT00680901|11994657|FG001|COMPLETED|Overall Study||197
10829733|NCT00680901|11994656|FG000|NOT COMPLETED|Overall Study||73
10829734|NCT00680901|11994657|FG001|NOT COMPLETED|Overall Study||76
11100928|NCT01227629|12284848|FG009|NOT COMPLETED|Overall Study||2
11100929|NCT01227655|12284897|FG000|STARTED|Overall Study||129
11100930|NCT01227655|12284898|FG001|STARTED|Overall Study||154
11100931|NCT01227655|12284899|FG002|STARTED|Overall Study||144
11100932|NCT01227655|12284897|FG000|Safety Set|Overall Study||125
11100933|NCT01227655|12284898|FG001|Safety Set|Overall Study||150
11100934|NCT01227655|12284899|FG002|Safety Set|Overall Study||136
11100935|NCT01227655|12284897|FG000|Full Analysis Set|Overall Study||125
11100936|NCT01227655|12284898|FG001|Full Analysis Set|Overall Study||147
11100937|NCT01227655|12284899|FG002|Full Analysis Set|Overall Study||135
11100938|NCT01227655|12284897|FG000|COMPLETED|Overall Study||118
11100939|NCT01227655|12284898|FG001|COMPLETED|Overall Study||128
11100940|NCT01227655|12284899|FG002|COMPLETED|Overall Study||130
11100941|NCT01227655|12284897|FG000|NOT COMPLETED|Overall Study||11
11100942|NCT01227655|12284898|FG001|NOT COMPLETED|Overall Study||26
11100943|NCT01227655|12284899|FG002|NOT COMPLETED|Overall Study||14
11100944|NCT01227668|12284909|FG000|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
11100945|NCT01227668|12284910|FG001|STARTED|Phase 1 (Stabilization Phase)||0
11100946|NCT01227668|12284909|FG000|Received Treatment|Phase 1 (Stabilization Phase)||155
11100947|NCT01227668|12284910|FG001|Received Treatment|Phase 1 (Stabilization Phase)||0
11100948|NCT01227668|12284909|FG000|COMPLETED|Phase 1 (Stabilization Phase)||85
11100949|NCT01227668|12284910|FG001|COMPLETED|Phase 1 (Stabilization Phase)||0
11100950|NCT01227668|12284909|FG000|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
11100951|NCT01227668|12284910|FG001|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
11100952|NCT01227668|12284909|FG000|STARTED|Phase 2 (Randomization Phase)|Randomized|41
11100953|NCT01227668|12284910|FG001|STARTED|Phase 2 (Randomization Phase)|Randomized|44
11100954|NCT01227668|12284909|FG000|Received Treatment|Phase 2 (Randomization Phase)||39
11100955|NCT01227668|12284910|FG001|Received Treatment|Phase 2 (Randomization Phase)||43
11100956|NCT01227668|12284909|FG000|COMPLETED|Phase 2 (Randomization Phase)||22
11100957|NCT01227668|12284910|FG001|COMPLETED|Phase 2 (Randomization Phase)||19
11100958|NCT01227668|12284909|FG000|NOT COMPLETED|Phase 2 (Randomization Phase)||19
11100959|NCT01227668|12284910|FG001|NOT COMPLETED|Phase 2 (Randomization Phase)||25
11100960|NCT01227681|12284923|FG000|STARTED|Overall Study||4
11100961|NCT01227681|12284924|FG001|STARTED|Overall Study||0
11100962|NCT01227681|12284925|FG002|STARTED|Overall Study||0
11100963|NCT01227681|12284923|FG000|COMPLETED|Overall Study||4
11100964|NCT01227681|12284924|FG001|COMPLETED|Overall Study||0
11100965|NCT01227681|12284925|FG002|COMPLETED|Overall Study||0
11100966|NCT01227681|12284923|FG000|NOT COMPLETED|Overall Study||0
11100967|NCT01227681|12284924|FG001|NOT COMPLETED|Overall Study||0
11100968|NCT01227681|12284925|FG002|NOT COMPLETED|Overall Study||0
11100969|NCT01227707|12284929|FG000|STARTED|Overall Study||43
11100970|NCT01227707|12284929|FG000|COMPLETED|Overall Study||19
11100971|NCT01227707|12284929|FG000|NOT COMPLETED|Overall Study||24
11100972|NCT01227785|12284933|FG000|STARTED|Overall Study||120
11100973|NCT01227785|12284933|FG000|COMPLETED|Overall Study||108
11100974|NCT01227785|12284933|FG000|NOT COMPLETED|Overall Study||12
11100975|NCT01227824|12284946|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||411
11100976|NCT01227824|12284947|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||411
11100977|NCT01227824|12284948|FG002|STARTED|Double-blind Phase: 96 Weeks Duration||0
11100978|NCT01227824|12284946|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
11100979|NCT01227824|12284947|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
10829787|NCT01335685|11994691|FG000|STARTED|Overall Study||7
10829788|NCT01335685|11994692|FG001|STARTED|Overall Study||4
10829789|NCT01335685|11994693|FG002|STARTED|Overall Study||3
10829790|NCT01335685|11994694|FG003|STARTED|Overall Study||26
10829791|NCT01335685|11994695|FG004|STARTED|Overall Study||5
10829792|NCT01335685|11994696|FG005|STARTED|Overall Study||6
10829793|NCT01335685|11994697|FG006|STARTED|Overall Study||4
10829794|NCT01335685|11994698|FG007|STARTED|Overall Study||6
10829795|NCT01335685|11994691|FG000|COMPLETED|Overall Study||4
10829796|NCT01335685|11994692|FG001|COMPLETED|Overall Study||3
10829797|NCT01335685|11994693|FG002|COMPLETED|Overall Study||1
10829798|NCT01335685|11994694|FG003|COMPLETED|Overall Study||15
10829799|NCT01335685|11994695|FG004|COMPLETED|Overall Study||5
10829800|NCT01335685|11994696|FG005|COMPLETED|Overall Study||1
10829801|NCT01335685|11994697|FG006|COMPLETED|Overall Study||2
10829802|NCT01335685|11994698|FG007|COMPLETED|Overall Study||3
10829803|NCT01335685|11994691|FG000|NOT COMPLETED|Overall Study||3
10829804|NCT01335685|11994692|FG001|NOT COMPLETED|Overall Study||1
10829805|NCT01335685|11994693|FG002|NOT COMPLETED|Overall Study||2
10829806|NCT01335685|11994694|FG003|NOT COMPLETED|Overall Study||11
10829807|NCT01335685|11994695|FG004|NOT COMPLETED|Overall Study||0
10829808|NCT01335685|11994696|FG005|NOT COMPLETED|Overall Study||5
10829809|NCT01335685|11994697|FG006|NOT COMPLETED|Overall Study||2
10829810|NCT01335685|11994698|FG007|NOT COMPLETED|Overall Study||3
10829811|NCT01336621|11994721|FG000|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
10829812|NCT01336621|11994721|FG000|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
10829813|NCT01336621|11994721|FG000|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
10829814|NCT01336621|11994721|FG000|STARTED|SFUCP (up to 2.6 Years)||9
10829815|NCT01336621|11994721|FG000|COMPLETED|SFUCP (up to 2.6 Years)||0
10829816|NCT01336621|11994721|FG000|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
10829817|NCT04391036|11994730|FG000|STARTED|Overall Study||15
10829818|NCT04391036|11994731|FG001|STARTED|Overall Study||15
10829819|NCT04391036|11994730|FG000|COMPLETED|Overall Study||15
10829820|NCT04391036|11994731|FG001|COMPLETED|Overall Study||15
10829821|NCT04391036|11994730|FG000|NOT COMPLETED|Overall Study||0
10829822|NCT04391036|11994731|FG001|NOT COMPLETED|Overall Study||0
10829823|NCT04170296|11994741|FG000|STARTED|Overall Study||81
10829824|NCT04170296|11994742|FG001|STARTED|Overall Study||72
10829825|NCT04170296|11994741|FG000|COMPLETED|Overall Study||73
10829826|NCT04170296|11994742|FG001|COMPLETED|Overall Study||68
10829827|NCT04170296|11994741|FG000|NOT COMPLETED|Overall Study||8
10829828|NCT04170296|11994742|FG001|NOT COMPLETED|Overall Study||4
10829829|NCT04039217|11994754|FG000|STARTED|Overall Study||20
10829830|NCT04039217|11994754|FG000|Started Study Arm A.1|Overall Study||4
10829831|NCT04039217|11994754|FG000|Completed Study Arm A.1|Overall Study||4
10829832|NCT04039217|11994754|FG000|Started Study Arm A.2|Overall Study||4
10829833|NCT04039217|11994754|FG000|Completed Study Arm A.2|Overall Study||4
10829834|NCT04039217|11994754|FG000|Started Study Arm A.3|Overall Study||4
10829835|NCT04039217|11994754|FG000|Completed Study Arm A.3|Overall Study||4
10829836|NCT04039217|11994754|FG000|Started Study Arm B.1|Overall Study||4
10829837|NCT04039217|11994754|FG000|Completed Study Arm B.1|Overall Study||4
10829838|NCT04039217|11994754|FG000|Started Study Arm B.2|Overall Study||4
10829839|NCT04039217|11994754|FG000|Completed Study Arm B.2|Overall Study||4
10829840|NCT04039217|11994754|FG000|Started Study Arm C.1|Overall Study||5
10829841|NCT04039217|11994754|FG000|Completed Study Arm C.1|Overall Study||4
10829842|NCT04039217|11994754|FG000|Started Study Arm C.2|Overall Study||0
10829843|NCT04039217|11994754|FG000|Completed Study Arm C.2|Overall Study||0
10829844|NCT04039217|11994754|FG000|COMPLETED|Overall Study||19
10829845|NCT04039217|11994754|FG000|NOT COMPLETED|Overall Study||1
10829846|NCT03998046|11994764|FG000|STARTED|Overall Study||38
10829847|NCT03998046|11994765|FG001|STARTED|Overall Study||42
10829848|NCT03998046|11994764|FG000|COMPLETED|Overall Study||38
10829849|NCT03998046|11994765|FG001|COMPLETED|Overall Study||42
10829850|NCT03998046|11994764|FG000|NOT COMPLETED|Overall Study||0
10829851|NCT03998046|11994765|FG001|NOT COMPLETED|Overall Study||0
10829852|NCT03160521|11994775|FG000|STARTED|Overall Study|From 145 randomized patients in the 75 mg dose arm, one of them withdrew consent before receiving the study treatment. Due to, only 144 patients received allocated intervention.|144
10829853|NCT03160521|11994776|FG001|STARTED|Overall Study||146
10829854|NCT03160521|11994777|FG002|STARTED|Overall Study||147
10829855|NCT03160521|11994775|FG000|COMPLETED|Overall Study||107
10829856|NCT03160521|11994776|FG001|COMPLETED|Overall Study||95
10829857|NCT03160521|11994777|FG002|COMPLETED|Overall Study||88
10829858|NCT03160521|11994775|FG000|NOT COMPLETED|Overall Study||37
10829859|NCT03160521|11994776|FG001|NOT COMPLETED|Overall Study||51
10829860|NCT03160521|11994777|FG002|NOT COMPLETED|Overall Study||59
10829861|NCT03143816|11994793|FG000|STARTED|Overall Study||26
10829862|NCT03143816|11994794|FG001|STARTED|Overall Study||34
10829863|NCT03143816|11994793|FG000|COMPLETED|Overall Study||22
10829864|NCT03143816|11994794|FG001|COMPLETED|Overall Study||34
10829865|NCT03143816|11994793|FG000|NOT COMPLETED|Overall Study||4
10829866|NCT03143816|11994794|FG001|NOT COMPLETED|Overall Study||0
10829867|NCT03078192|11994808|FG000|STARTED|Overall Study||30
10829868|NCT03078192|11994809|FG001|STARTED|Overall Study||32
10829869|NCT03078192|11994808|FG000|COMPLETED|Overall Study||28
10829870|NCT03078192|11994809|FG001|COMPLETED|Overall Study||28
10829871|NCT03078192|11994808|FG000|NOT COMPLETED|Overall Study||2
10829872|NCT03078192|11994809|FG001|NOT COMPLETED|Overall Study||4
10829873|NCT02959944|11994817|FG000|STARTED|Overall Study||95
10829874|NCT02959944|11994818|FG001|STARTED|Overall Study||98
10829875|NCT02959944|11994817|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94
10829876|NCT02959944|11994818|FG001|Received at Least 1 Dose of Study Drug|Overall Study||96
10829877|NCT02959944|11994817|FG000|COMPLETED|Overall Study||95
10829878|NCT02959944|11994818|FG001|COMPLETED|Overall Study||98
11100980|NCT01227824|12284948|FG002|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
11100981|NCT01227824|12284946|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
11100982|NCT01227824|12284947|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
11100983|NCT01227824|12284948|FG002|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
11100984|NCT01227824|12284946|FG000|STARTED|Open-label Phase: Median of 1267 Days||0
11100985|NCT01227824|12284947|FG001|STARTED|Open-label Phase: Median of 1267 Days||0
11100986|NCT01227824|12284948|FG002|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
11100987|NCT01227824|12284946|FG000|COMPLETED|Open-label Phase: Median of 1267 Days||0
11100988|NCT01227824|12284947|FG001|COMPLETED|Open-label Phase: Median of 1267 Days||0
11100989|NCT01227824|12284948|FG002|COMPLETED|Open-label Phase: Median of 1267 Days||294
11100990|NCT01227824|12284946|FG000|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
11100991|NCT01227824|12284947|FG001|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
11100992|NCT01227824|12284948|FG002|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
11100993|NCT01227889|12284957|FG000|STARTED|Randomized Phase (RP)||187
11100994|NCT01227889|12284958|FG001|STARTED|Randomized Phase (RP)||63
11100995|NCT01227889|12284957|FG000|COMPLETED|Randomized Phase (RP)||0
11100996|NCT01227889|12284958|FG001|COMPLETED|Randomized Phase (RP)||0
11100997|NCT01227889|12284957|FG000|NOT COMPLETED|Randomized Phase (RP)||187
11100998|NCT01227889|12284958|FG001|NOT COMPLETED|Randomized Phase (RP)||63
11100999|NCT01227889|12284957|FG000|STARTED|Crossover Phase||0
11101000|NCT01227889|12284958|FG001|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
11101001|NCT01227889|12284957|FG000|COMPLETED|Crossover Phase||0
11101002|NCT01227889|12284958|FG001|COMPLETED|Crossover Phase||0
11101003|NCT01227889|12284957|FG000|NOT COMPLETED|Crossover Phase||0
11101004|NCT01227889|12284958|FG001|NOT COMPLETED|Crossover Phase||37
11101005|NCT01227902|12284976|FG000|STARTED|Overall Study||56
11101006|NCT01227902|12284977|FG001|STARTED|Overall Study||51
11101007|NCT01227902|12284978|FG002|STARTED|Overall Study||44
11101008|NCT01227902|12284979|FG003|STARTED|Overall Study||52
11101009|NCT01227902|12284976|FG000|COMPLETED|Overall Study||38
11101010|NCT01227902|12284977|FG001|COMPLETED|Overall Study||38
11101011|NCT01227902|12284978|FG002|COMPLETED|Overall Study||25
11101012|NCT01227902|12284979|FG003|COMPLETED|Overall Study||42
11101013|NCT01227902|12284976|FG000|NOT COMPLETED|Overall Study||18
11101014|NCT01227902|12284977|FG001|NOT COMPLETED|Overall Study||13
11101015|NCT01227902|12284978|FG002|NOT COMPLETED|Overall Study||19
11101016|NCT01227902|12284979|FG003|NOT COMPLETED|Overall Study||10
11101017|NCT01227928|12284992|FG000|STARTED|Overall Study||72
11101018|NCT01227928|12284993|FG001|STARTED|Overall Study||73
11101019|NCT01227928|12284992|FG000|COMPLETED|Overall Study||50
11101020|NCT01227928|12284993|FG001|COMPLETED|Overall Study||56
11101021|NCT01227928|12284992|FG000|NOT COMPLETED|Overall Study||22
11101022|NCT01227928|12284993|FG001|NOT COMPLETED|Overall Study||17
11101023|NCT01227954|12284999|FG000|STARTED|Overall Study||113
11101024|NCT01227954|12284999|FG000|COMPLETED|Overall Study|Eligible subjects available for analysis|100
11101025|NCT01227954|12284999|FG000|NOT COMPLETED|Overall Study||13
11101026|NCT01227967|12285005|FG000|STARTED|Overall Study||314
11101027|NCT01227967|12285006|FG001|STARTED|Overall Study||316
11101028|NCT01227967|12285005|FG000|COMPLETED|Overall Study||298
11101029|NCT01227967|12285006|FG001|COMPLETED|Overall Study||303
10829879|NCT02959944|11994817|FG000|NOT COMPLETED|Overall Study||0
10829880|NCT02959944|11994818|FG001|NOT COMPLETED|Overall Study||0
10829881|NCT02903823|11994824|FG000|STARTED|Overall Study|First subject enrollment|27
10829882|NCT02903823|11994824|FG000|COMPLETED|Overall Study||20
10829883|NCT02903823|11994824|FG000|NOT COMPLETED|Overall Study||7
10829884|NCT02666183|11994832|FG000|STARTED|Overall Study||137
10829885|NCT02666183|11994833|FG001|STARTED|Overall Study||141
10829886|NCT02666183|11994834|FG002|STARTED|Overall Study||119
10829887|NCT02666183|11994832|FG000|COMPLETED|Overall Study||103
10829888|NCT02666183|11994833|FG001|COMPLETED|Overall Study||106
11101030|NCT01227967|12285005|FG000|NOT COMPLETED|Overall Study||16
11101031|NCT01227967|12285006|FG001|NOT COMPLETED|Overall Study||13
11101032|NCT01227980|12285014|FG000|STARTED|Overall Study||40
11101033|NCT01227980|12285015|FG001|STARTED|Overall Study||30
11101034|NCT01227980|12285014|FG000|Scripts Challenge Sessions|Overall Study||26
11101035|NCT01227980|12285015|FG001|Scripts Challenge Sessions|Overall Study||25
11101036|NCT01227980|12285014|FG000|Measure Drug Level Concentration|Overall Study||10
11101037|NCT01227980|12285015|FG001|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
11101038|NCT01227980|12285014|FG000|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
11101039|NCT01227980|12285015|FG001|COMPLETED|Overall Study||25
11101040|NCT01227980|12285014|FG000|NOT COMPLETED|Overall Study||2
11101041|NCT01227980|12285015|FG001|NOT COMPLETED|Overall Study||5
11101042|NCT01227993|12285021|FG000|STARTED|Overall Study||3
11101043|NCT01227993|12285021|FG000|COMPLETED|Overall Study||3
11101044|NCT01227993|12285021|FG000|NOT COMPLETED|Overall Study||0
11101045|NCT01228019|12285025|FG000|STARTED|Overall Study||1166
11101046|NCT01228019|12285025|FG000|COMPLETED|Overall Study||862
11101047|NCT01228019|12285025|FG000|NOT COMPLETED|Overall Study||304
10829889|NCT02666183|11994834|FG002|COMPLETED|Overall Study||93
10829890|NCT02666183|11994832|FG000|NOT COMPLETED|Overall Study||34
10829891|NCT02666183|11994833|FG001|NOT COMPLETED|Overall Study||35
10829892|NCT02666183|11994834|FG002|NOT COMPLETED|Overall Study||26
10829893|NCT01547117|11994846|FG000|STARTED|Overall Study||12
10829894|NCT01547117|11994847|FG001|STARTED|Overall Study||5
10829895|NCT01547117|11994848|FG002|STARTED|Overall Study||10
10829896|NCT01547117|11994849|FG003|STARTED|Overall Study||11
10829897|NCT01547117|11994846|FG000|Phase 1 Baseline Labs|Overall Study||12
10829898|NCT01547117|11994847|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4
10829899|NCT01547117|11994848|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8
10829900|NCT01547117|11994849|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7
10829901|NCT01547117|11994846|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12
10829902|NCT01547117|11994847|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4
10829903|NCT01547117|11994848|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8
10829904|NCT01547117|11994849|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7
10829905|NCT01547117|11994846|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12
10829906|NCT01547117|11994847|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4
10829907|NCT01547117|11994848|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8
10829908|NCT01547117|11994849|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7
10829909|NCT01547117|11994846|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11
10829910|NCT01547117|11994847|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators..|2
10829911|NCT01547117|11994848|FG002|Phase 1-finish|Overall Study||8
10829912|NCT01547117|11994849|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6
10829913|NCT01547117|11994846|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11
10829914|NCT01547117|11994847|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2
10829915|NCT01547117|11994848|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8
10829916|NCT01547117|11994849|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6
10829917|NCT01547117|11994846|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11
10829918|NCT01547117|11994847|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2
10829919|NCT01547117|11994848|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8
10829920|NCT01547117|11994849|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6
10829921|NCT01547117|11994846|FG000|Phase 2-finish|Overall Study||11
10829922|NCT01547117|11994847|FG001|Phase 2-finish|Overall Study||2
10829923|NCT01547117|11994848|FG002|Phase 2-finish|Overall Study||8
10829924|NCT01547117|11994849|FG003|Phase 2-finish|Overall Study||6
10829925|NCT01547117|11994846|FG000|COMPLETED|Overall Study||11
10829926|NCT01547117|11994847|FG001|COMPLETED|Overall Study||2
10829927|NCT01547117|11994848|FG002|COMPLETED|Overall Study||8
10829928|NCT01547117|11994849|FG003|COMPLETED|Overall Study||6
10829929|NCT01547117|11994846|FG000|NOT COMPLETED|Overall Study||1
10829930|NCT01547117|11994847|FG001|NOT COMPLETED|Overall Study||3
10829931|NCT01547117|11994848|FG002|NOT COMPLETED|Overall Study||2
10829932|NCT01547117|11994849|FG003|NOT COMPLETED|Overall Study||5
10829933|NCT01431508|11994875|FG000|STARTED|Overall Study||15
10829934|NCT01431508|11994875|FG000|COMPLETED|Overall Study||13
10829935|NCT01431508|11994875|FG000|NOT COMPLETED|Overall Study||2
10829936|NCT00871351|11994882|FG000|STARTED|Overall Study||47
10829937|NCT00871351|11994883|FG001|STARTED|Overall Study||46
10829938|NCT00871351|11994884|FG002|STARTED|Overall Study||32
10829939|NCT00871351|11994882|FG000|COMPLETED|Overall Study||43
10829940|NCT00871351|11994883|FG001|COMPLETED|Overall Study||45
10829941|NCT00871351|11994884|FG002|COMPLETED|Overall Study||32
10829942|NCT00871351|11994882|FG000|NOT COMPLETED|Overall Study||4
10829943|NCT00871351|11994883|FG001|NOT COMPLETED|Overall Study||1
10829944|NCT00871351|11994884|FG002|NOT COMPLETED|Overall Study||0
10829945|NCT00832455|11994892|FG000|STARTED|Overall Study|445 - number of patients that signed the informed consent form (Safety population)|445
10829946|NCT00832455|11994892|FG000|Baseline|Overall Study|420 -patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
10829947|NCT00832455|11994892|FG000|Week 4|Overall Study||411
10829948|NCT00832455|11994892|FG000|Week 8 (Optional)|Overall Study||247
10829949|NCT00832455|11994892|FG000|Week 12|Overall Study||373
10829950|NCT00832455|11994892|FG000|COMPLETED|Overall Study||373
10829951|NCT00832455|11994892|FG000|NOT COMPLETED|Overall Study||72
10829952|NCT00812006|11994908|FG000|STARTED|Overall Study||36
10829953|NCT00812006|11994909|FG001|STARTED|Overall Study||36
10829954|NCT00812006|11994910|FG002|STARTED|Overall Study||36
10829955|NCT00812006|11994908|FG000|COMPLETED|Overall Study||30
10829956|NCT00812006|11994909|FG001|COMPLETED|Overall Study||33
10829957|NCT00812006|11994910|FG002|COMPLETED|Overall Study||30
10829958|NCT00812006|11994908|FG000|NOT COMPLETED|Overall Study||6
10829959|NCT00812006|11994909|FG001|NOT COMPLETED|Overall Study||3
10829960|NCT00812006|11994910|FG002|NOT COMPLETED|Overall Study||6
10829961|NCT00739050|11994916|FG000|STARTED|Overall Study||4
10829962|NCT00739050|11994917|FG001|STARTED|Overall Study||0
10829963|NCT00739050|11994916|FG000|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
10829964|NCT00739050|11994917|FG001|COMPLETED|Overall Study||0
10829965|NCT00739050|11994916|FG000|NOT COMPLETED|Overall Study||1
10829966|NCT00739050|11994917|FG001|NOT COMPLETED|Overall Study||0
10829967|NCT00687531|11994923|FG000|STARTED|Overall Study|Completed screening procedures|385
10829968|NCT00687531|11994923|FG000|RECEIVED TREATMENT|Overall Study||281
10829969|NCT00687531|11994923|FG000|COMPLETED|Overall Study||250
10829970|NCT00687531|11994923|FG000|NOT COMPLETED|Overall Study||135
10829971|NCT00654628|11994927|FG000|STARTED|6-week Active Treatment Period||173
10829972|NCT00654628|11994927|FG000|COMPLETED|6-week Active Treatment Period||152
10829973|NCT00654628|11994927|FG000|NOT COMPLETED|6-week Active Treatment Period||21
10829974|NCT00654628|11994927|FG000|STARTED|6 -Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
10829975|NCT00654628|11994927|FG000|COMPLETED|6 -Week Extension Period (Single Site)||55
10829976|NCT00654628|11994927|FG000|NOT COMPLETED|6 -Week Extension Period (Single Site)||5
10829977|NCT00604812|11994934|FG000|STARTED|Overall Study||9
10829978|NCT00604812|11994935|FG001|STARTED|Overall Study||3
10829979|NCT00604812|11994936|FG002|STARTED|Overall Study||10
10829980|NCT00604812|11994937|FG003|STARTED|Overall Study||3
10829981|NCT00604812|11994938|FG004|STARTED|Overall Study||5
10829982|NCT00604812|11994939|FG005|STARTED|Overall Study||1
10829983|NCT00604812|11994934|FG000|COMPLETED|Overall Study||9
10829984|NCT00604812|11994935|FG001|COMPLETED|Overall Study||3
10829985|NCT00604812|11994936|FG002|COMPLETED|Overall Study||10
10829986|NCT00604812|11994937|FG003|COMPLETED|Overall Study||3
10829987|NCT00604812|11994938|FG004|COMPLETED|Overall Study||5
10829988|NCT00604812|11994939|FG005|COMPLETED|Overall Study||1
10829989|NCT00604812|11994934|FG000|NOT COMPLETED|Overall Study||0
10829990|NCT00604812|11994935|FG001|NOT COMPLETED|Overall Study||0
10829991|NCT00604812|11994936|FG002|NOT COMPLETED|Overall Study||0
10829992|NCT00604812|11994937|FG003|NOT COMPLETED|Overall Study||0
10829993|NCT00604812|11994938|FG004|NOT COMPLETED|Overall Study||0
10829994|NCT00604812|11994939|FG005|NOT COMPLETED|Overall Study||0
10829995|NCT00536380|11994953|FG000|STARTED|Overall Study||106
10829996|NCT00536380|11994954|FG001|STARTED|Overall Study||104
10829997|NCT00536380|11994955|FG002|STARTED|Overall Study||104
10829998|NCT00536380|11994953|FG000|COMPLETED|Overall Study||94
10829999|NCT00536380|11994954|FG001|COMPLETED|Overall Study||95
10830000|NCT00536380|11994955|FG002|COMPLETED|Overall Study||94
10830001|NCT00536380|11994953|FG000|NOT COMPLETED|Overall Study||12
10830002|NCT00536380|11994954|FG001|NOT COMPLETED|Overall Study||9
10830003|NCT00536380|11994955|FG002|NOT COMPLETED|Overall Study||10
10830004|NCT00521599|11994966|FG000|STARTED|Overall Study||268
10830005|NCT00521599|11994967|FG001|STARTED|Overall Study||268
10830006|NCT00521599|11994968|FG002|STARTED|Overall Study||136
10830007|NCT00521599|11994966|FG000|COMPLETED|Overall Study||243
10830008|NCT00521599|11994967|FG001|COMPLETED|Overall Study||239
10830009|NCT00521599|11994968|FG002|COMPLETED|Overall Study||100
10830010|NCT00521599|11994966|FG000|NOT COMPLETED|Overall Study||25
10830011|NCT00521599|11994967|FG001|NOT COMPLETED|Overall Study||29
10830012|NCT00521599|11994968|FG002|NOT COMPLETED|Overall Study||36
10830013|NCT00496834|11994979|FG000|STARTED|Overall Study||101
10830014|NCT00496834|11994980|FG001|STARTED|Overall Study||100
10830015|NCT00496834|11994979|FG000|COMPLETED|Overall Study||83
10830016|NCT00496834|11994980|FG001|COMPLETED|Overall Study||87
10830017|NCT00496834|11994979|FG000|NOT COMPLETED|Overall Study||18
10830018|NCT00496834|11994980|FG001|NOT COMPLETED|Overall Study||13
10830019|NCT00442897|11994990|FG000|STARTED|Base Study (12 Week Follow-up)||118
10830020|NCT00442897|11994991|FG001|STARTED|Base Study (12 Week Follow-up)||111
10830021|NCT00442897|11994990|FG000|COMPLETED|Base Study (12 Week Follow-up)||101
10830022|NCT00442897|11994991|FG001|COMPLETED|Base Study (12 Week Follow-up)||99
10830023|NCT00442897|11994990|FG000|NOT COMPLETED|Base Study (12 Week Follow-up)||17
10830024|NCT00442897|11994991|FG001|NOT COMPLETED|Base Study (12 Week Follow-up)||12
10830025|NCT00442897|11994990|FG000|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
10830026|NCT00442897|11994991|FG001|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
10830027|NCT00442897|11994990|FG000|COMPLETED|24 Weeks Follow-up (3 Centers)||29
10830028|NCT00442897|11994991|FG001|COMPLETED|24 Weeks Follow-up (3 Centers)||28
10830029|NCT00442897|11994990|FG000|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
10830030|NCT00442897|11994991|FG001|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
10830031|NCT00423579|11994999|FG000|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
10830032|NCT00423579|11995000|FG001|STARTED|Overall Study||60
10830033|NCT00423579|11994999|FG000|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
10830034|NCT00423579|11995000|FG001|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
10830035|NCT00423579|11994999|FG000|NOT COMPLETED|Overall Study||4
10830036|NCT00423579|11995000|FG001|NOT COMPLETED|Overall Study||4
10830037|NCT00394355|11995010|FG000|STARTED|Overall Study||140
10830038|NCT00394355|11995011|FG001|STARTED|Overall Study||137
10830039|NCT00394355|11995012|FG002|STARTED|Overall Study||147
10830040|NCT00394355|11995013|FG003|STARTED|Overall Study||142
10830041|NCT00394355|11995010|FG000|COMPLETED|Overall Study||105
10830042|NCT00394355|11995011|FG001|COMPLETED|Overall Study||103
10830043|NCT00394355|11995012|FG002|COMPLETED|Overall Study||109
10830044|NCT00394355|11995013|FG003|COMPLETED|Overall Study||111
10830045|NCT00394355|11995010|FG000|NOT COMPLETED|Overall Study||35
10830046|NCT00394355|11995011|FG001|NOT COMPLETED|Overall Study||34
10830047|NCT00394355|11995012|FG002|NOT COMPLETED|Overall Study||38
10830048|NCT00394355|11995013|FG003|NOT COMPLETED|Overall Study||31
10830049|NCT00359216|11995025|FG000|STARTED|Overall Study||20
10830050|NCT00359216|11995026|FG001|STARTED|Overall Study||10
10830051|NCT00359216|11995025|FG000|COMPLETED|Overall Study||20
10830052|NCT00359216|11995026|FG001|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
10830053|NCT00359216|11995025|FG000|NOT COMPLETED|Overall Study||0
10830054|NCT00359216|11995026|FG001|NOT COMPLETED|Overall Study||1
10830055|NCT00166504|11995034|FG000|STARTED|Overall Study||108
10830056|NCT00166504|11995035|FG001|STARTED|Overall Study||95
10830057|NCT00166504|11995034|FG000|COMPLETED|Overall Study||103
10830058|NCT00166504|11995035|FG001|COMPLETED|Overall Study||91
10830059|NCT00166504|11995034|FG000|NOT COMPLETED|Overall Study||5
10830060|NCT00166504|11995035|FG001|NOT COMPLETED|Overall Study||4
10830061|NCT01345240|11995046|FG000|STARTED|Overall Study||142
10830062|NCT01345240|11995047|FG001|STARTED|Overall Study||142
10830063|NCT01345240|11995048|FG002|STARTED|Overall Study||141
10830064|NCT01345240|11995049|FG003|STARTED|Overall Study||141
10830065|NCT01345240|11995050|FG004|STARTED|Overall Study||139
10830066|NCT01345240|11995046|FG000|COMPLETED|Overall Study||131
10830067|NCT01345240|11995047|FG001|COMPLETED|Overall Study||128
10830068|NCT01345240|11995048|FG002|COMPLETED|Overall Study||123
10830069|NCT01345240|11995049|FG003|COMPLETED|Overall Study||132
10830070|NCT01345240|11995050|FG004|COMPLETED|Overall Study||129
10830071|NCT01345240|11995046|FG000|NOT COMPLETED|Overall Study||11
10830072|NCT01345240|11995047|FG001|NOT COMPLETED|Overall Study||14
10830073|NCT01345240|11995048|FG002|NOT COMPLETED|Overall Study||18
10830074|NCT01345240|11995049|FG003|NOT COMPLETED|Overall Study||9
10830075|NCT01345240|11995050|FG004|NOT COMPLETED|Overall Study||10
10830076|NCT01371305|11995077|FG000|STARTED|Overall Study||6
10830077|NCT01371305|11995078|FG001|STARTED|Overall Study||6
10830078|NCT01371305|11995079|FG002|STARTED|Overall Study||6
10830079|NCT01371305|11995080|FG003|STARTED|Overall Study||7
10830080|NCT01371305|11995081|FG004|STARTED|Overall Study||6
10830081|NCT01371305|11995082|FG005|STARTED|Overall Study||10
10830082|NCT01371305|11995077|FG000|COMPLETED|Overall Study||6
10830083|NCT01371305|11995078|FG001|COMPLETED|Overall Study||6
10830084|NCT01371305|11995079|FG002|COMPLETED|Overall Study||6
10830085|NCT01371305|11995080|FG003|COMPLETED|Overall Study||5
10830086|NCT01371305|11995081|FG004|COMPLETED|Overall Study||2
10830087|NCT01371305|11995082|FG005|COMPLETED|Overall Study||8
10830088|NCT01371305|11995077|FG000|NOT COMPLETED|Overall Study||0
10830089|NCT01371305|11995078|FG001|NOT COMPLETED|Overall Study||0
10830090|NCT01371305|11995079|FG002|NOT COMPLETED|Overall Study||0
10830091|NCT01371305|11995080|FG003|NOT COMPLETED|Overall Study||2
10830092|NCT01371305|11995081|FG004|NOT COMPLETED|Overall Study||4
10830093|NCT01371305|11995082|FG005|NOT COMPLETED|Overall Study||2
10830094|NCT01376323|11995102|FG000|STARTED|Overall Study||20
10830095|NCT01376323|11995103|FG001|STARTED|Overall Study||18
10830096|NCT01376323|11995104|FG002|STARTED|Overall Study||19
10830097|NCT01376323|11995105|FG003|STARTED|Overall Study||19
10830098|NCT01376323|11995106|FG004|STARTED|Overall Study||18
10830099|NCT01376323|11995102|FG000|COMPLETED|Overall Study||18
10830100|NCT01376323|11995103|FG001|COMPLETED|Overall Study||17
10830101|NCT01376323|11995104|FG002|COMPLETED|Overall Study||16
10830102|NCT01376323|11995105|FG003|COMPLETED|Overall Study||14
10830103|NCT01376323|11995106|FG004|COMPLETED|Overall Study||17
10830104|NCT01376323|11995102|FG000|NOT COMPLETED|Overall Study||2
10830105|NCT01376323|11995103|FG001|NOT COMPLETED|Overall Study||1
10830106|NCT01376323|11995104|FG002|NOT COMPLETED|Overall Study||3
10830107|NCT01376323|11995105|FG003|NOT COMPLETED|Overall Study||5
10830108|NCT01376323|11995106|FG004|NOT COMPLETED|Overall Study||1
10830109|NCT01386658|11995130|FG000|STARTED|Initial Icatibant Exposure||11
10830110|NCT01386658|11995131|FG001|STARTED|Initial Icatibant Exposure||21
10830111|NCT01386658|11995130|FG000|COMPLETED|Initial Icatibant Exposure||11
10830112|NCT01386658|11995131|FG001|COMPLETED|Initial Icatibant Exposure||9
10830113|NCT01386658|11995130|FG000|NOT COMPLETED|Initial Icatibant Exposure||0
10830114|NCT01386658|11995131|FG001|NOT COMPLETED|Initial Icatibant Exposure||12
10830115|NCT01386658|11995130|FG000|STARTED|Icatibant Exposure 2||0
10830116|NCT01386658|11995131|FG001|STARTED|Icatibant Exposure 2||9
10830117|NCT01386658|11995130|FG000|COMPLETED|Icatibant Exposure 2||0
10830118|NCT01386658|11995131|FG001|COMPLETED|Icatibant Exposure 2||9
10830119|NCT01386658|11995130|FG000|NOT COMPLETED|Icatibant Exposure 2||0
10830120|NCT01386658|11995131|FG001|NOT COMPLETED|Icatibant Exposure 2||0
10830121|NCT01386658|11995130|FG000|STARTED|Icatibant Exposure 3||0
10830122|NCT01386658|11995131|FG001|STARTED|Icatibant Exposure 3||9
10830123|NCT01386658|11995130|FG000|COMPLETED|Icatibant Exposure 3||0
10830124|NCT01386658|11995131|FG001|COMPLETED|Icatibant Exposure 3||9
10830125|NCT01386658|11995130|FG000|NOT COMPLETED|Icatibant Exposure 3||0
10830126|NCT01386658|11995131|FG001|NOT COMPLETED|Icatibant Exposure 3||0
10830127|NCT01386684|11995141|FG000|STARTED|Overall Study||552
10830128|NCT01386684|11995141|FG000|COMPLETED|Overall Study||259
10830129|NCT01386684|11995141|FG000|NOT COMPLETED|Overall Study||293
10830130|NCT01386879|11995148|FG000|STARTED|Overall Study||17
10830131|NCT01386879|11995149|FG001|STARTED|Overall Study||17
10830132|NCT01386879|11995150|FG002|STARTED|Overall Study||16
10830133|NCT01386879|11995148|FG000|COMPLETED|Overall Study||17
10830134|NCT01386879|11995149|FG001|COMPLETED|Overall Study||17
10830135|NCT01386879|11995150|FG002|COMPLETED|Overall Study||16
10830136|NCT01386879|11995148|FG000|NOT COMPLETED|Overall Study||0
10830137|NCT01386879|11995149|FG001|NOT COMPLETED|Overall Study||0
10830138|NCT01386879|11995150|FG002|NOT COMPLETED|Overall Study||0
10830139|NCT04980014|11995158|FG000|STARTED|Overall Study||730
10830140|NCT04980014|11995158|FG000|Safety Analysis Set|Overall Study||655
10830141|NCT04980014|11995158|FG000|Effectiveness Analysis Set|Overall Study||482
10830142|NCT04980014|11995158|FG000|COMPLETED|Overall Study||655
10830143|NCT04980014|11995158|FG000|NOT COMPLETED|Overall Study||75
10830144|NCT04503603|11995164|FG000|STARTED|Overall Study||9
10830145|NCT04503603|11995165|FG001|STARTED|Overall Study||3
10830146|NCT04503603|11995164|FG000|COMPLETED|Overall Study||9
10830147|NCT04503603|11995165|FG001|COMPLETED|Overall Study||3
10830148|NCT04503603|11995164|FG000|NOT COMPLETED|Overall Study||0
10830149|NCT04503603|11995165|FG001|NOT COMPLETED|Overall Study||0
10830150|NCT04454918|11995171|FG000|STARTED|Treatment Period 1 (Day 1)||6
10830151|NCT04454918|11995171|FG000|COMPLETED|Treatment Period 1 (Day 1)||6
10830152|NCT04454918|11995171|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10830153|NCT04454918|11995171|FG000|STARTED|Washout Period (Day 2 to 8)||6
10830154|NCT04454918|11995171|FG000|COMPLETED|Washout Period (Day 2 to 8)||6
10830155|NCT04454918|11995171|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0
10830156|NCT04454918|11995171|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6
10830157|NCT04454918|11995171|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6
10830158|NCT04454918|11995171|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0
11101048|NCT01228071|12285029|FG000|STARTED|Overall Study||34
11101049|NCT01228071|12285029|FG000|COMPLETED|Overall Study||32
11101050|NCT01228071|12285029|FG000|NOT COMPLETED|Overall Study||2
11101051|NCT01228084|12285033|FG000|STARTED|Overall Study||20
11101052|NCT01228084|12285033|FG000|COMPLETED|Overall Study||16
11101053|NCT01228084|12285033|FG000|NOT COMPLETED|Overall Study||4
11101054|NCT01228149|12285039|FG000|STARTED|Overall Study||32
11101055|NCT01228149|12285040|FG001|STARTED|Overall Study||30
11101056|NCT01228149|12285039|FG000|COMPLETED|Overall Study||27
11101057|NCT01228149|12285040|FG001|COMPLETED|Overall Study||26
11101058|NCT01228149|12285039|FG000|NOT COMPLETED|Overall Study||5
11101059|NCT01228149|12285040|FG001|NOT COMPLETED|Overall Study||4
11101060|NCT01228175|12285051|FG000|STARTED|Overall Study||119
11101061|NCT01228175|12285052|FG001|STARTED|Overall Study||99
11101062|NCT01228175|12285051|FG000|COMPLETED|Overall Study||53
11101063|NCT01228175|12285052|FG001|COMPLETED|Overall Study||46
11101064|NCT01228175|12285051|FG000|NOT COMPLETED|Overall Study||66
11101065|NCT01228175|12285052|FG001|NOT COMPLETED|Overall Study||53
11101066|NCT01228318|12285060|FG000|STARTED|Overall Study||34
11101067|NCT01228318|12285061|FG001|STARTED|Overall Study||29
11101068|NCT01228318|12285060|FG000|COMPLETED|Overall Study||30
11101069|NCT01228318|12285061|FG001|COMPLETED|Overall Study||22
11101070|NCT01228318|12285060|FG000|NOT COMPLETED|Overall Study||4
11101071|NCT01228318|12285061|FG001|NOT COMPLETED|Overall Study||7
11101072|NCT01228435|12285069|FG000|STARTED|Overall Study||1
11101073|NCT01228435|12285070|FG001|STARTED|Overall Study||2
11101074|NCT01228435|12285069|FG000|COMPLETED|Overall Study||1
11101075|NCT01228435|12285070|FG001|COMPLETED|Overall Study||2
11101076|NCT01228435|12285069|FG000|NOT COMPLETED|Overall Study||0
11101077|NCT01228435|12285070|FG001|NOT COMPLETED|Overall Study||0
11101078|NCT01228591|12285076|FG000|STARTED|Baseline||18
11101079|NCT01228591|12285077|FG001|STARTED|Baseline||18
11101080|NCT01228591|12285076|FG000|COMPLETED|Baseline||17
11101081|NCT01228591|12285077|FG001|COMPLETED|Baseline||16
11101082|NCT01228591|12285076|FG000|NOT COMPLETED|Baseline||1
11101083|NCT01228591|12285077|FG001|NOT COMPLETED|Baseline||2
11101084|NCT01228591|12285076|FG000|STARTED|1-Week Follow-Up||17
11101085|NCT01228591|12285077|FG001|STARTED|1-Week Follow-Up||16
11101086|NCT01228591|12285076|FG000|COMPLETED|1-Week Follow-Up||17
11101087|NCT01228591|12285077|FG001|COMPLETED|1-Week Follow-Up||16
11101088|NCT01228591|12285076|FG000|NOT COMPLETED|1-Week Follow-Up||0
11101089|NCT01228591|12285077|FG001|NOT COMPLETED|1-Week Follow-Up||0
11101090|NCT01228591|12285076|FG000|STARTED|Final Visit||17
11101091|NCT01228591|12285077|FG001|STARTED|Final Visit||16
11101092|NCT01228591|12285076|FG000|COMPLETED|Final Visit||17
11101093|NCT01228591|12285077|FG001|COMPLETED|Final Visit||16
11101094|NCT01228591|12285076|FG000|NOT COMPLETED|Final Visit||0
11101095|NCT01228591|12285077|FG001|NOT COMPLETED|Final Visit||0
11101096|NCT01228734|12285089|FG000|STARTED|Overall Study||193
11101097|NCT01228734|12285090|FG001|STARTED|Overall Study||204
11101098|NCT01228734|12285089|FG000|Modified Intent-to-treat Population|Overall Study||193
11101099|NCT01228734|12285090|FG001|Modified Intent-to-treat Population|Overall Study||200
11101100|NCT01228734|12285089|FG000|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
11101101|NCT01228734|12285090|FG001|Modified Safety Population|Overall Study||199
11101102|NCT01228734|12285089|FG000|COMPLETED|Overall Study||193
11101103|NCT01228734|12285090|FG001|COMPLETED|Overall Study||200
11101104|NCT01228734|12285089|FG000|NOT COMPLETED|Overall Study||0
11101105|NCT01228734|12285090|FG001|NOT COMPLETED|Overall Study||4
11101106|NCT01228747|12285098|FG000|STARTED|Overall Study||125
11101107|NCT01228747|12285099|FG001|STARTED|Overall Study||126
11101108|NCT01228747|12285098|FG000|COMPLETED|Overall Study||60
11101109|NCT01228747|12285099|FG001|COMPLETED|Overall Study||81
11101110|NCT01228747|12285098|FG000|NOT COMPLETED|Overall Study||65
11101111|NCT01228747|12285099|FG001|NOT COMPLETED|Overall Study||45
11101112|NCT01228903|12285107|FG000|STARTED|Overall Study||41
11101113|NCT01228903|12285108|FG001|STARTED|Overall Study||39
11101114|NCT01228903|12285107|FG000|COMPLETED|Overall Study||36
11101115|NCT01228903|12285108|FG001|COMPLETED|Overall Study||34
11101116|NCT01228903|12285107|FG000|NOT COMPLETED|Overall Study||5
11101117|NCT01228903|12285108|FG001|NOT COMPLETED|Overall Study||5
11101118|NCT01228929|12285117|FG000|STARTED|Nominal Condition||6
11101119|NCT01228929|12285118|FG001|STARTED|Nominal Condition||6
11101120|NCT01228929|12285119|FG002|STARTED|Nominal Condition||6
11101121|NCT01228929|12285117|FG000|COMPLETED|Nominal Condition||6
11101122|NCT01228929|12285118|FG001|COMPLETED|Nominal Condition||6
11101123|NCT01228929|12285119|FG002|COMPLETED|Nominal Condition||6
11101124|NCT01228929|12285117|FG000|NOT COMPLETED|Nominal Condition||0
11101125|NCT01228929|12285118|FG001|NOT COMPLETED|Nominal Condition||0
11101126|NCT01228929|12285119|FG002|NOT COMPLETED|Nominal Condition||0
11101127|NCT01228929|12285117|FG000|STARTED|Low Humidity Condition||6
11101128|NCT01228929|12285118|FG001|STARTED|Low Humidity Condition||6
11101129|NCT01228929|12285119|FG002|STARTED|Low Humidity Condition||6
11101130|NCT01228929|12285117|FG000|COMPLETED|Low Humidity Condition||6
11101131|NCT01228929|12285118|FG001|COMPLETED|Low Humidity Condition||6
11101132|NCT01228929|12285119|FG002|COMPLETED|Low Humidity Condition||6
11101133|NCT01228929|12285117|FG000|NOT COMPLETED|Low Humidity Condition||0
11101134|NCT01228929|12285118|FG001|NOT COMPLETED|Low Humidity Condition||0
11101135|NCT01228929|12285119|FG002|NOT COMPLETED|Low Humidity Condition||0
11101136|NCT01228929|12285117|FG000|STARTED|High Temperature Condition||6
11101137|NCT01228929|12285118|FG001|STARTED|High Temperature Condition||6
10830219|NCT03735849|11995234|FG000|STARTED|Overall Study||11
10830220|NCT03735849|11995235|FG001|STARTED|Overall Study||13
10830221|NCT03735849|11995236|FG002|STARTED|Overall Study||4
10830222|NCT03735849|11995234|FG000|Safety Population|Overall Study||11
10830223|NCT03735849|11995235|FG001|Safety Population|Overall Study||13
10830224|NCT03735849|11995236|FG002|Safety Population|Overall Study||4
10830225|NCT03735849|11995234|FG000|COMPLETED|Overall Study||9
10830226|NCT03735849|11995235|FG001|COMPLETED|Overall Study||13
10830227|NCT03735849|11995236|FG002|COMPLETED|Overall Study||0
10830228|NCT03735849|11995234|FG000|NOT COMPLETED|Overall Study||2
10830229|NCT03735849|11995235|FG001|NOT COMPLETED|Overall Study||0
10830230|NCT03735849|11995236|FG002|NOT COMPLETED|Overall Study||4
11101138|NCT01228929|12285119|FG002|STARTED|High Temperature Condition||6
11101139|NCT01228929|12285117|FG000|COMPLETED|High Temperature Condition||6
11101140|NCT01228929|12285118|FG001|COMPLETED|High Temperature Condition||6
11101141|NCT01228929|12285119|FG002|COMPLETED|High Temperature Condition||6
11101142|NCT01228929|12285117|FG000|NOT COMPLETED|High Temperature Condition||0
11101143|NCT01228929|12285118|FG001|NOT COMPLETED|High Temperature Condition||0
11101144|NCT01228929|12285119|FG002|NOT COMPLETED|High Temperature Condition||0
11101145|NCT01228968|12285127|FG000|STARTED|Overall Study||9
11101146|NCT01228968|12285127|FG000|COMPLETED|Overall Study||9
11101147|NCT01228968|12285127|FG000|NOT COMPLETED|Overall Study||0
11101148|NCT01229111|12285131|FG000|STARTED|Overall Study||14
11101149|NCT01229111|12285131|FG000|COMPLETED|Overall Study||13
11101150|NCT01229111|12285131|FG000|NOT COMPLETED|Overall Study||1
11101151|NCT01229150|12285139|FG000|STARTED|Overall Study||30
11101152|NCT01229150|12285140|FG001|STARTED|Overall Study||11
11101153|NCT01229150|12285141|FG002|STARTED|Overall Study||19
11101154|NCT01229150|12285142|FG003|STARTED|Overall Study||19
11101155|NCT01229150|12285139|FG000|COMPLETED|Overall Study||28
11101156|NCT01229150|12285140|FG001|COMPLETED|Overall Study||9
11101157|NCT01229150|12285141|FG002|COMPLETED|Overall Study||19
11101158|NCT01229150|12285142|FG003|COMPLETED|Overall Study||19
11101159|NCT01229150|12285139|FG000|NOT COMPLETED|Overall Study||2
11101160|NCT01229150|12285140|FG001|NOT COMPLETED|Overall Study||2
11101161|NCT01229150|12285141|FG002|NOT COMPLETED|Overall Study||0
11101162|NCT01229150|12285142|FG003|NOT COMPLETED|Overall Study||0
11101163|NCT01229176|12285164|FG000|STARTED|Overall Study||40
11101164|NCT01229176|12285165|FG001|STARTED|Overall Study||40
11101165|NCT01229176|12285166|FG002|STARTED|Overall Study||20
11101166|NCT01229176|12285167|FG003|STARTED|Overall Study||20
11101167|NCT01229176|12285168|FG004|STARTED|Overall Study||20
11101168|NCT01229176|12285169|FG005|STARTED|Overall Study||20
11101169|NCT01229176|12285170|FG006|STARTED|Overall Study||20
11101170|NCT01229176|12285171|FG007|STARTED|Overall Study||20
11101171|NCT01229176|12285164|FG000|COMPLETED|Overall Study||40
11101172|NCT01229176|12285165|FG001|COMPLETED|Overall Study||37
11101173|NCT01229176|12285166|FG002|COMPLETED|Overall Study||20
11101174|NCT01229176|12285167|FG003|COMPLETED|Overall Study||19
11101175|NCT01229176|12285168|FG004|COMPLETED|Overall Study||18
11101176|NCT01229176|12285169|FG005|COMPLETED|Overall Study||18
11101177|NCT01229176|12285170|FG006|COMPLETED|Overall Study||20
11101178|NCT01229176|12285171|FG007|COMPLETED|Overall Study||17
11101179|NCT01229176|12285164|FG000|NOT COMPLETED|Overall Study||0
11101180|NCT01229176|12285165|FG001|NOT COMPLETED|Overall Study||3
11101181|NCT01229176|12285166|FG002|NOT COMPLETED|Overall Study||0
10830237|NCT03552393|11995252|FG000|STARTED|Core Period||40
10830238|NCT03552393|11995252|FG000|COMPLETED|Core Period||38
10830239|NCT03552393|11995252|FG000|NOT COMPLETED|Core Period||2
11101182|NCT01229176|12285167|FG003|NOT COMPLETED|Overall Study||1
11101183|NCT01229176|12285168|FG004|NOT COMPLETED|Overall Study||2
11101184|NCT01229176|12285169|FG005|NOT COMPLETED|Overall Study||2
11101185|NCT01229176|12285170|FG006|NOT COMPLETED|Overall Study||0
11101186|NCT01229176|12285171|FG007|NOT COMPLETED|Overall Study||3
11101187|NCT01229228|12285194|FG000|STARTED|Overall Study||51
11101188|NCT01229228|12285195|FG001|STARTED|Overall Study||51
11101189|NCT01229228|12285196|FG002|STARTED|Overall Study||50
11101190|NCT01229228|12285197|FG003|STARTED|Overall Study||51
11101191|NCT01229228|12285198|FG004|STARTED|Overall Study||51
11101192|NCT01229228|12285194|FG000|COMPLETED|Overall Study||50
11101193|NCT01229228|12285195|FG001|COMPLETED|Overall Study||51
11101194|NCT01229228|12285196|FG002|COMPLETED|Overall Study||49
11101195|NCT01229228|12285197|FG003|COMPLETED|Overall Study||51
11101196|NCT01229228|12285198|FG004|COMPLETED|Overall Study||50
10830240|NCT03552393|11995252|FG000|STARTED|Safety Extension Period||25
10830241|NCT03552393|11995252|FG000|COMPLETED|Safety Extension Period||21
10830242|NCT03552393|11995252|FG000|NOT COMPLETED|Safety Extension Period||4
10830270|NCT03333382|11995281|FG000|STARTED|Overall Study||1
10830271|NCT03333382|11995282|FG001|STARTED|Overall Study||0
10830272|NCT03333382|11995281|FG000|COMPLETED|Overall Study||0
10830273|NCT03333382|11995282|FG001|COMPLETED|Overall Study||0
10830274|NCT03333382|11995281|FG000|NOT COMPLETED|Overall Study||1
10830275|NCT03333382|11995282|FG001|NOT COMPLETED|Overall Study||0
10830276|NCT03245827|11995292|FG000|STARTED|Overall Study||1
10830277|NCT03245827|11995293|FG001|STARTED|Overall Study||0
10830278|NCT03245827|11995294|FG002|STARTED|Overall Study||3
10830279|NCT03245827|11995295|FG003|STARTED|Overall Study||5
10830280|NCT03245827|11995292|FG000|COMPLETED|Overall Study||1
10830281|NCT03245827|11995293|FG001|COMPLETED|Overall Study||0
10830282|NCT03245827|11995294|FG002|COMPLETED|Overall Study||3
10830283|NCT03245827|11995295|FG003|COMPLETED|Overall Study||5
10830284|NCT03245827|11995292|FG000|NOT COMPLETED|Overall Study||0
10830285|NCT03245827|11995293|FG001|NOT COMPLETED|Overall Study||0
10830286|NCT03245827|11995294|FG002|NOT COMPLETED|Overall Study||0
10830287|NCT03245827|11995295|FG003|NOT COMPLETED|Overall Study||0
10830288|NCT03129321|11995306|FG000|STARTED|Overall Study||351
10830289|NCT03129321|11995307|FG001|STARTED|Overall Study||350
10830290|NCT03129321|11995308|FG002|STARTED|Overall Study||175
10830291|NCT03129321|11995306|FG000|COMPLETED|Overall Study||253
10830292|NCT03129321|11995307|FG001|COMPLETED|Overall Study||241
10830293|NCT03129321|11995308|FG002|COMPLETED|Overall Study||120
10830294|NCT03129321|11995306|FG000|NOT COMPLETED|Overall Study||98
10830295|NCT03129321|11995307|FG001|NOT COMPLETED|Overall Study||109
10830296|NCT03129321|11995308|FG002|NOT COMPLETED|Overall Study||55
10830297|NCT03107611|11995321|FG000|STARTED|Overall Study||217
10830298|NCT03107611|11995322|FG001|STARTED|Overall Study||216
10830299|NCT03107611|11995323|FG002|STARTED|Overall Study||221
10830300|NCT03107611|11995321|FG000|Dosed|Overall Study||215
10830301|NCT03107611|11995322|FG001|Dosed|Overall Study||214
10830302|NCT03107611|11995323|FG002|Dosed|Overall Study||220
10830303|NCT03107611|11995321|FG000|COMPLETED|Overall Study||210
10830304|NCT03107611|11995322|FG001|COMPLETED|Overall Study||212
10830305|NCT03107611|11995323|FG002|COMPLETED|Overall Study||212
10830306|NCT03107611|11995321|FG000|NOT COMPLETED|Overall Study||7
10830307|NCT03107611|11995322|FG001|NOT COMPLETED|Overall Study||4
10830308|NCT03107611|11995323|FG002|NOT COMPLETED|Overall Study||9
10830309|NCT02720016|11995334|FG000|STARTED|Overall Study||92
10830310|NCT02720016|11995335|FG001|STARTED|Overall Study||92
10830311|NCT02720016|11995336|FG002|STARTED|Overall Study||90
10830312|NCT02720016|11995334|FG000|Y1|Overall Study||26
10830313|NCT02720016|11995335|FG001|Y1|Overall Study||26
10830314|NCT02720016|11995336|FG002|Y1|Overall Study||28
10830315|NCT02720016|11995334|FG000|Y2|Overall Study||34
10830316|NCT02720016|11995335|FG001|Y2|Overall Study||32
10830317|NCT02720016|11995336|FG002|Y2|Overall Study||34
10830318|NCT02720016|11995334|FG000|Y3|Overall Study||28
10830319|NCT02720016|11995335|FG001|Y3|Overall Study||30
10830320|NCT02720016|11995336|FG002|Y3|Overall Study||24
10830321|NCT02720016|11995334|FG000|Y4|Overall Study||4
10830322|NCT02720016|11995335|FG001|Y4|Overall Study||4
10830323|NCT02720016|11995336|FG002|Y4|Overall Study||4
10830324|NCT02720016|11995334|FG000|Veteran Total|Overall Study||46
10830325|NCT02720016|11995335|FG001|Veteran Total|Overall Study||46
10830326|NCT02720016|11995336|FG002|Veteran Total|Overall Study||45
10830327|NCT02720016|11995334|FG000|Intimate Partner Total|Overall Study||46
10830328|NCT02720016|11995335|FG001|Intimate Partner Total|Overall Study||46
10830329|NCT02720016|11995336|FG002|Intimate Partner Total|Overall Study||45
10830330|NCT02720016|11995334|FG000|COMPLETED|Overall Study||72
10830331|NCT02720016|11995335|FG001|COMPLETED|Overall Study||72
10830332|NCT02720016|11995336|FG002|COMPLETED|Overall Study||70
10830333|NCT02720016|11995334|FG000|NOT COMPLETED|Overall Study||20
10830334|NCT02720016|11995335|FG001|NOT COMPLETED|Overall Study||20
10830335|NCT02720016|11995336|FG002|NOT COMPLETED|Overall Study||20
10830336|NCT02607956|11995347|FG000|STARTED|Double-Blinded Phase||327
10830337|NCT02607956|11995348|FG001|STARTED|Double-Blinded Phase||330
10830338|NCT02607956|11995349|FG002|STARTED|Double-Blinded Phase||0
10830339|NCT02607956|11995350|FG003|STARTED|Double-Blinded Phase||0
10830340|NCT02607956|11995347|FG000|COMPLETED|Double-Blinded Phase||266
10830341|NCT02607956|11995348|FG001|COMPLETED|Double-Blinded Phase||277
10830342|NCT02607956|11995349|FG002|COMPLETED|Double-Blinded Phase||0
10830343|NCT02607956|11995350|FG003|COMPLETED|Double-Blinded Phase||0
10830344|NCT02607956|11995347|FG000|NOT COMPLETED|Double-Blinded Phase||61
10830345|NCT02607956|11995348|FG001|NOT COMPLETED|Double-Blinded Phase||53
10830346|NCT02607956|11995349|FG002|NOT COMPLETED|Double-Blinded Phase||0
10830347|NCT02607956|11995350|FG003|NOT COMPLETED|Double-Blinded Phase||0
10830348|NCT02607956|11995347|FG000|STARTED|Open-Label Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
10830349|NCT02607956|11995348|FG001|STARTED|Open-Label Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
10830350|NCT02607956|11995349|FG002|STARTED|Open-Label Extension Phase|66 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase.|254
10830351|NCT02607956|11995350|FG003|STARTED|Open-Label Extension Phase|60 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase.|265
10830352|NCT02607956|11995347|FG000|COMPLETED|Open-Label Extension Phase||0
10830353|NCT02607956|11995348|FG001|COMPLETED|Open-Label Extension Phase||0
10830354|NCT02607956|11995349|FG002|COMPLETED|Open-Label Extension Phase||225
10830355|NCT02607956|11995350|FG003|COMPLETED|Open-Label Extension Phase||235
10830356|NCT02607956|11995347|FG000|NOT COMPLETED|Open-Label Extension Phase||0
10830357|NCT02607956|11995348|FG001|NOT COMPLETED|Open-Label Extension Phase||0
10830358|NCT02607956|11995349|FG002|NOT COMPLETED|Open-Label Extension Phase||29
10830359|NCT02607956|11995350|FG003|NOT COMPLETED|Open-Label Extension Phase||30
10830360|NCT02564523|11995380|FG000|STARTED|Overall Study||225
10830361|NCT02564523|11995381|FG001|STARTED|Overall Study||43
10830362|NCT02564523|11995382|FG002|STARTED|Overall Study||224
10830363|NCT02564523|11995383|FG003|STARTED|Overall Study||44
10830364|NCT02564523|11995384|FG004|STARTED|Overall Study||110
10830365|NCT02564523|11995385|FG005|STARTED|Overall Study||22
10830366|NCT02564523|11995386|FG006|STARTED|Overall Study||59
10830367|NCT02564523|11995387|FG007|STARTED|Overall Study||12
10830368|NCT02564523|11995388|FG008|STARTED|Overall Study||59
10830369|NCT02564523|11995389|FG009|STARTED|Overall Study||12
10830370|NCT02564523|11995390|FG010|STARTED|Overall Study||55
10830371|NCT02564523|11995391|FG011|STARTED|Overall Study||11
10830372|NCT02564523|11995392|FG012|STARTED|Overall Study||55
10830373|NCT02564523|11995393|FG013|STARTED|Overall Study||10
10830374|NCT02564523|11995394|FG014|STARTED|Overall Study||54
10830375|NCT02564523|11995395|FG015|STARTED|Overall Study||12
10830376|NCT02564523|11995396|FG016|STARTED|Overall Study||54
10830377|NCT02564523|11995397|FG017|STARTED|Overall Study||12
10830378|NCT02564523|11995380|FG000|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||34
10830379|NCT02564523|11995381|FG001|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||8
10830380|NCT02564523|11995382|FG002|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||39
10830381|NCT02564523|11995383|FG003|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||9
10830382|NCT02564523|11995384|FG004|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830383|NCT02564523|11995385|FG005|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830384|NCT02564523|11995386|FG006|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830385|NCT02564523|11995387|FG007|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830386|NCT02564523|11995388|FG008|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830387|NCT02564523|11995389|FG009|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830388|NCT02564523|11995390|FG010|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830389|NCT02564523|11995391|FG011|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830390|NCT02564523|11995392|FG012|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830391|NCT02564523|11995393|FG013|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830392|NCT02564523|11995394|FG014|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830393|NCT02564523|11995395|FG015|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830394|NCT02564523|11995396|FG016|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830395|NCT02564523|11995397|FG017|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
10830396|NCT02564523|11995380|FG000|COMPLETED|Overall Study||215
10830397|NCT02564523|11995381|FG001|COMPLETED|Overall Study||40
10830398|NCT02564523|11995382|FG002|COMPLETED|Overall Study||214
10830399|NCT02564523|11995383|FG003|COMPLETED|Overall Study||43
10830400|NCT02564523|11995384|FG004|COMPLETED|Overall Study||106
10830401|NCT02564523|11995385|FG005|COMPLETED|Overall Study||22
10830402|NCT02564523|11995386|FG006|COMPLETED|Overall Study||56
10830403|NCT02564523|11995387|FG007|COMPLETED|Overall Study||12
10830404|NCT02564523|11995388|FG008|COMPLETED|Overall Study||59
10830405|NCT02564523|11995389|FG009|COMPLETED|Overall Study||12
10830406|NCT02564523|11995390|FG010|COMPLETED|Overall Study||52
10830407|NCT02564523|11995391|FG011|COMPLETED|Overall Study||10
10830408|NCT02564523|11995392|FG012|COMPLETED|Overall Study||53
11101197|NCT01229228|12285194|FG000|NOT COMPLETED|Overall Study||1
11101198|NCT01229228|12285195|FG001|NOT COMPLETED|Overall Study||0
11101199|NCT01229228|12285196|FG002|NOT COMPLETED|Overall Study||1
11101200|NCT01229228|12285197|FG003|NOT COMPLETED|Overall Study||0
11101201|NCT01229228|12285198|FG004|NOT COMPLETED|Overall Study||1
11101202|NCT01229254|12285213|FG000|STARTED|Overall Study||42
11101203|NCT01229254|12285214|FG001|STARTED|Overall Study||74
11101204|NCT01229254|12285215|FG002|STARTED|Overall Study||73
11101205|NCT01229254|12285213|FG000|COMPLETED|Overall Study||27
11101206|NCT01229254|12285214|FG001|COMPLETED|Overall Study||58
11101207|NCT01229254|12285215|FG002|COMPLETED|Overall Study||61
11101208|NCT01229254|12285213|FG000|NOT COMPLETED|Overall Study||15
11101209|NCT01229254|12285214|FG001|NOT COMPLETED|Overall Study||16
11101210|NCT01229254|12285215|FG002|NOT COMPLETED|Overall Study||12
11101211|NCT01229267|12285229|FG000|STARTED|Overall Study||189
11101212|NCT01229267|12285230|FG001|STARTED|Overall Study||184
11101213|NCT01229267|12285231|FG002|STARTED|Overall Study||187
11101214|NCT01229267|12285232|FG003|STARTED|Overall Study||106
11101215|NCT01229267|12285233|FG004|STARTED|Overall Study||564
11101216|NCT01229267|12285229|FG000|Received Vaccination 1|Overall Study||188
11101217|NCT01229267|12285230|FG001|Received Vaccination 1|Overall Study||180
11101218|NCT01229267|12285231|FG002|Received Vaccination 1|Overall Study||186
11101219|NCT01229267|12285232|FG003|Received Vaccination 1|Overall Study||104
11219978|NCT01957865|12411519|FG000|STARTED|Overall Study||21
11219979|NCT01957865|12411520|FG001|STARTED|Overall Study||20
11219980|NCT01957865|12411521|FG002|STARTED|Overall Study||22
11219981|NCT01957865|12411519|FG000|COMPLETED|Overall Study||21
11219982|NCT01957865|12411520|FG001|COMPLETED|Overall Study||18
11219983|NCT01957865|12411521|FG002|COMPLETED|Overall Study||19
11219984|NCT01957865|12411519|FG000|NOT COMPLETED|Overall Study||0
11219985|NCT01957865|12411520|FG001|NOT COMPLETED|Overall Study||2
11219986|NCT01957865|12411521|FG002|NOT COMPLETED|Overall Study||3
11219987|NCT01957930|12411533|FG000|STARTED|Overall Study||35
11219988|NCT01957930|12411534|FG001|STARTED|Overall Study||37
11219989|NCT01957930|12411535|FG002|STARTED|Overall Study||19
11219990|NCT01957930|12411533|FG000|COMPLETED|Overall Study||35
11219991|NCT01957930|12411534|FG001|COMPLETED|Overall Study||37
11219992|NCT01957930|12411535|FG002|COMPLETED|Overall Study||19
11219993|NCT01957930|12411533|FG000|NOT COMPLETED|Overall Study||0
11219994|NCT01957930|12411534|FG001|NOT COMPLETED|Overall Study||0
11219995|NCT01957930|12411535|FG002|NOT COMPLETED|Overall Study||0
11219996|NCT01958008|12411546|FG000|STARTED|Overall Study||21
11219997|NCT01958008|12411547|FG001|STARTED|Overall Study||21
11219998|NCT01958008|12411548|FG002|STARTED|Overall Study||21
11219999|NCT01958008|12411549|FG003|STARTED|Overall Study||21
11220000|NCT01958008|12411546|FG000|COMPLETED|Overall Study||20
11220001|NCT01958008|12411547|FG001|COMPLETED|Overall Study||21
11220002|NCT01958008|12411548|FG002|COMPLETED|Overall Study||20
11220003|NCT01958008|12411549|FG003|COMPLETED|Overall Study||21
11220004|NCT01958008|12411546|FG000|NOT COMPLETED|Overall Study||1
11220005|NCT01958008|12411547|FG001|NOT COMPLETED|Overall Study||0
11220006|NCT01958008|12411548|FG002|NOT COMPLETED|Overall Study||1
11220007|NCT01958008|12411549|FG003|NOT COMPLETED|Overall Study||0
11220008|NCT01958060|12411568|FG000|STARTED|Overall Study||10
11220009|NCT01958060|12411569|FG001|STARTED|Overall Study||6
11220010|NCT01958060|12411570|FG002|STARTED|Overall Study||6
11220011|NCT01958060|12411571|FG003|STARTED|Overall Study||5
11220012|NCT01958060|12411572|FG004|STARTED|Overall Study||7
11220013|NCT01958060|12411573|FG005|STARTED|Overall Study||1
10830409|NCT02564523|11995393|FG013|COMPLETED|Overall Study||10
11101220|NCT01229267|12285233|FG004|Received Vaccination 1|Overall Study||556
11101221|NCT01229267|12285229|FG000|Received Vaccination 2|Overall Study||171
11101222|NCT01229267|12285230|FG001|Received Vaccination 2|Overall Study||163
10830410|NCT02564523|11995394|FG014|COMPLETED|Overall Study||54
10830411|NCT02564523|11995395|FG015|COMPLETED|Overall Study||12
11101223|NCT01229267|12285231|FG002|Received Vaccination 2|Overall Study||168
11101224|NCT01229267|12285232|FG003|Received Vaccination 2|Overall Study||94
11220014|NCT01958060|12411568|FG000|COMPLETED|Overall Study||8
11220015|NCT01958060|12411569|FG001|COMPLETED|Overall Study||6
10830412|NCT02564523|11995396|FG016|COMPLETED|Overall Study||54
10830413|NCT02564523|11995397|FG017|COMPLETED|Overall Study||11
10830414|NCT02564523|11995380|FG000|NOT COMPLETED|Overall Study||10
10830415|NCT02564523|11995381|FG001|NOT COMPLETED|Overall Study||3
10830416|NCT02564523|11995382|FG002|NOT COMPLETED|Overall Study||10
10830417|NCT02564523|11995383|FG003|NOT COMPLETED|Overall Study||1
10830418|NCT02564523|11995384|FG004|NOT COMPLETED|Overall Study||4
10830419|NCT02564523|11995385|FG005|NOT COMPLETED|Overall Study||0
10830420|NCT02564523|11995386|FG006|NOT COMPLETED|Overall Study||3
10830421|NCT02564523|11995387|FG007|NOT COMPLETED|Overall Study||0
10830422|NCT02564523|11995388|FG008|NOT COMPLETED|Overall Study||0
10830423|NCT02564523|11995389|FG009|NOT COMPLETED|Overall Study||0
10830424|NCT02564523|11995390|FG010|NOT COMPLETED|Overall Study||3
10830425|NCT02564523|11995391|FG011|NOT COMPLETED|Overall Study||1
10830426|NCT02564523|11995392|FG012|NOT COMPLETED|Overall Study||2
10830427|NCT02564523|11995393|FG013|NOT COMPLETED|Overall Study||0
10830428|NCT02564523|11995394|FG014|NOT COMPLETED|Overall Study||0
10830429|NCT02564523|11995395|FG015|NOT COMPLETED|Overall Study||0
10830430|NCT02564523|11995396|FG016|NOT COMPLETED|Overall Study||0
10830431|NCT02564523|11995397|FG017|NOT COMPLETED|Overall Study||1
10830432|NCT02094716|11995454|FG000|STARTED|Overall Study||43
10830433|NCT02094716|11995455|FG001|STARTED|Overall Study||43
10830434|NCT02094716|11995456|FG002|STARTED|Overall Study||44
10830435|NCT02094716|11995454|FG000|Received Second Dose at Day 14|Overall Study||15
10830436|NCT02094716|11995455|FG001|Received Second Dose at Day 14|Overall Study||10
10830437|NCT02094716|11995456|FG002|Received Second Dose at Day 14|Overall Study||17
10830438|NCT02094716|11995454|FG000|COMPLETED|Overall Study||41
10830439|NCT02094716|11995455|FG001|COMPLETED|Overall Study||36
10830440|NCT02094716|11995456|FG002|COMPLETED|Overall Study||40
10830441|NCT02094716|11995454|FG000|NOT COMPLETED|Overall Study||2
10830442|NCT02094716|11995455|FG001|NOT COMPLETED|Overall Study||7
10830443|NCT02094716|11995456|FG002|NOT COMPLETED|Overall Study||4
11101225|NCT01229267|12285233|FG004|Received Vaccination 2|Overall Study||511
11101226|NCT01229267|12285229|FG000|Received Vaccination 3|Overall Study||163
11101227|NCT01229267|12285230|FG001|Received Vaccination 3|Overall Study||155
11101228|NCT01229267|12285231|FG002|Received Vaccination 3|Overall Study||160
11101229|NCT01229267|12285232|FG003|Received Vaccination 3|Overall Study||89
11101230|NCT01229267|12285233|FG004|Received Vaccination 3|Overall Study||491
11101231|NCT01229267|12285229|FG000|Received Vaccination 4|Overall Study||155
11101232|NCT01229267|12285230|FG001|Received Vaccination 4|Overall Study||149
11101233|NCT01229267|12285231|FG002|Received Vaccination 4|Overall Study||149
11220016|NCT01958060|12411570|FG002|COMPLETED|Overall Study||6
11220017|NCT01958060|12411571|FG003|COMPLETED|Overall Study||5
11220018|NCT01958060|12411572|FG004|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
11354030|NCT03068754|12551245|FG003|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
11101234|NCT01229267|12285232|FG003|Received Vaccination 4|Overall Study||87
11101235|NCT01229267|12285233|FG004|Received Vaccination 4|Overall Study||477
11101236|NCT01229267|12285229|FG000|COMPLETED|Overall Study||108
11101237|NCT01229267|12285230|FG001|COMPLETED|Overall Study||102
11101238|NCT01229267|12285231|FG002|COMPLETED|Overall Study||101
11101239|NCT01229267|12285232|FG003|COMPLETED|Overall Study||71
11101240|NCT01229267|12285233|FG004|COMPLETED|Overall Study||344
11101241|NCT01229267|12285229|FG000|NOT COMPLETED|Overall Study||81
11101242|NCT01229267|12285230|FG001|NOT COMPLETED|Overall Study||82
11101243|NCT01229267|12285231|FG002|NOT COMPLETED|Overall Study||86
11101244|NCT01229267|12285232|FG003|NOT COMPLETED|Overall Study||35
11101245|NCT01229267|12285233|FG004|NOT COMPLETED|Overall Study||220
11101246|NCT01229371|12285244|FG000|STARTED|Overall Study||109
10830469|NCT01868139|11995497|FG000|STARTED|Overall Study||1
10830470|NCT01868139|11995497|FG000|COMPLETED|Overall Study||0
10830471|NCT01868139|11995497|FG000|NOT COMPLETED|Overall Study||1
10830472|NCT01798004|11995502|FG000|STARTED|Overall Study||150
10830473|NCT01798004|11995502|FG000|COMPLETED|Overall Study||63
10830474|NCT01798004|11995502|FG000|NOT COMPLETED|Overall Study||87
10830475|NCT01620658|11995509|FG000|STARTED|Overall Study||59
10830476|NCT01620658|11995510|FG001|STARTED|Overall Study||74
10830477|NCT01620658|11995511|FG002|STARTED|Overall Study||64
10830478|NCT01620658|11995509|FG000|COMPLETED|Overall Study||35
10830479|NCT01620658|11995510|FG001|COMPLETED|Overall Study||45
10830480|NCT01620658|11995511|FG002|COMPLETED|Overall Study||44
10830481|NCT01620658|11995509|FG000|NOT COMPLETED|Overall Study||24
10830482|NCT01620658|11995510|FG001|NOT COMPLETED|Overall Study||29
10830483|NCT01620658|11995511|FG002|NOT COMPLETED|Overall Study||20
10830484|NCT01447628|11995529|FG000|STARTED|Week 0 to Week 12 (1st Intervention)||19
10830485|NCT01447628|11995530|FG001|STARTED|Week 0 to Week 12 (1st Intervention)||20
10830486|NCT01447628|11995531|FG002|STARTED|Week 0 to Week 12 (1st Intervention)|Randomisation error meant the arms were not balanced- refer to protocol description for full details|12
10830487|NCT01447628|11995532|FG003|STARTED|Week 0 to Week 12 (1st Intervention)|Randomisation error meant the arms were not balanced- refer to protocol description for full details|5
10830488|NCT01447628|11995529|FG000|COMPLETED|Week 0 to Week 12 (1st Intervention)||19
10830489|NCT01447628|11995530|FG001|COMPLETED|Week 0 to Week 12 (1st Intervention)||20
10830490|NCT01447628|11995531|FG002|COMPLETED|Week 0 to Week 12 (1st Intervention)||12
10830491|NCT01447628|11995532|FG003|COMPLETED|Week 0 to Week 12 (1st Intervention)||4
10830492|NCT01447628|11995529|FG000|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
10830493|NCT01447628|11995530|FG001|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
10830494|NCT01447628|11995531|FG002|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
10830495|NCT01447628|11995532|FG003|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||1
10830496|NCT01447628|11995529|FG000|STARTED|Week 12 to Week 24 (2nd Intervention)||19
10830497|NCT01447628|11995530|FG001|STARTED|Week 12 to Week 24 (2nd Intervention)||20
10830498|NCT01447628|11995531|FG002|STARTED|Week 12 to Week 24 (2nd Intervention)||12
10830499|NCT01447628|11995532|FG003|STARTED|Week 12 to Week 24 (2nd Intervention)||4
10830500|NCT01447628|11995529|FG000|COMPLETED|Week 12 to Week 24 (2nd Intervention)||19
10830501|NCT01447628|11995530|FG001|COMPLETED|Week 12 to Week 24 (2nd Intervention)||20
10830502|NCT01447628|11995531|FG002|COMPLETED|Week 12 to Week 24 (2nd Intervention)||12
10830503|NCT01447628|11995532|FG003|COMPLETED|Week 12 to Week 24 (2nd Intervention)||4
10830504|NCT01447628|11995529|FG000|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
10830505|NCT01447628|11995530|FG001|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
10830506|NCT01447628|11995531|FG002|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
10830507|NCT01447628|11995532|FG003|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
10830508|NCT01175356|11995552|FG000|STARTED|Overall Study||99
10830509|NCT01175356|11995552|FG000|COMPLETED|Overall Study||18
10830510|NCT01175356|11995552|FG000|NOT COMPLETED|Overall Study||81
10830511|NCT00515853|11995558|FG000|STARTED|Overall Study||61
10830512|NCT00515853|11995559|FG001|STARTED|Overall Study||60
10830513|NCT00515853|11995558|FG000|COMPLETED|Overall Study||46
10830514|NCT00515853|11995559|FG001|COMPLETED|Overall Study||43
10830515|NCT00515853|11995558|FG000|NOT COMPLETED|Overall Study||15
10830516|NCT00515853|11995559|FG001|NOT COMPLETED|Overall Study||17
10830517|NCT00003458|11995565|FG000|STARTED|Overall Study||34
10830518|NCT00003458|11995565|FG000|COMPLETED|Overall Study||30
10830519|NCT00003458|11995565|FG000|NOT COMPLETED|Overall Study||4
11354031|NCT03068754|12551242|FG000|COMPLETED|Randomized Treatment Period (RTP)||28
10830520|NCT04871815|11995570|FG000|STARTED|Baseline Day 1-7||22
10830521|NCT04871815|11995570|FG000|COMPLETED|Baseline Day 1-7||22
10830522|NCT04871815|11995570|FG000|NOT COMPLETED|Baseline Day 1-7||0
10830523|NCT04871815|11995570|FG000|STARTED|N115 Treatment Day 8-14||22
10830524|NCT04871815|11995570|FG000|COMPLETED|N115 Treatment Day 8-14||22
10830525|NCT04871815|11995570|FG000|NOT COMPLETED|N115 Treatment Day 8-14||0
10830526|NCT04772560|11995582|FG000|STARTED|Overall Study||11
10830527|NCT04772560|11995583|FG001|STARTED|Overall Study||12
10830528|NCT04772560|11995582|FG000|COMPLETED|Overall Study||11
10830529|NCT04772560|11995583|FG001|COMPLETED|Overall Study||12
10830530|NCT04772560|11995582|FG000|NOT COMPLETED|Overall Study||0
10830531|NCT04772560|11995583|FG001|NOT COMPLETED|Overall Study||0
10830532|NCT04613739|11995590|FG000|STARTED|Overall Study||19
10830533|NCT04613739|11995591|FG001|STARTED|Overall Study||37
10830534|NCT04613739|11995590|FG000|COMPLETED|Overall Study||12
10830535|NCT04613739|11995591|FG001|COMPLETED|Overall Study||25
10830536|NCT04613739|11995590|FG000|NOT COMPLETED|Overall Study||7
10830537|NCT04613739|11995591|FG001|NOT COMPLETED|Overall Study||12
10830538|NCT04573972|11995599|FG000|STARTED|Overall Study||88
10830539|NCT04573972|11995600|FG001|STARTED|Overall Study||84
10830540|NCT04573972|11995599|FG000|COMPLETED|Overall Study||56
10830541|NCT04573972|11995600|FG001|COMPLETED|Overall Study||70
10830542|NCT04573972|11995599|FG000|NOT COMPLETED|Overall Study||32
10830543|NCT04573972|11995600|FG001|NOT COMPLETED|Overall Study||14
10830544|NCT04432272|11995608|FG000|STARTED|Overall Study||43
10830545|NCT04432272|11995609|FG001|STARTED|Overall Study||28
10830546|NCT04432272|11995608|FG000|COMPLETED|Overall Study||43
10830547|NCT04432272|11995609|FG001|COMPLETED|Overall Study||28
10830548|NCT04432272|11995608|FG000|NOT COMPLETED|Overall Study||0
10830549|NCT04432272|11995609|FG001|NOT COMPLETED|Overall Study||0
10830550|NCT04407806|11995618|FG000|STARTED|Overall Study||3
10830551|NCT04407806|11995619|FG001|STARTED|Overall Study||3
10830552|NCT04407806|11995618|FG000|COMPLETED|Overall Study||2
10830553|NCT04407806|11995619|FG001|COMPLETED|Overall Study||1
10830554|NCT04407806|11995618|FG000|NOT COMPLETED|Overall Study||1
10830555|NCT04407806|11995619|FG001|NOT COMPLETED|Overall Study||2
10830569|NCT04186663|11995646|FG000|STARTED|Overall Study||59
10830570|NCT04186663|11995646|FG000|COMPLETED|Overall Study||55
10830571|NCT04186663|11995646|FG000|NOT COMPLETED|Overall Study||4
10830572|NCT04158219|11995650|FG000|STARTED|Overall Study||8
10830573|NCT04158219|11995650|FG000|COMPLETED|Overall Study||7
10830574|NCT04158219|11995650|FG000|NOT COMPLETED|Overall Study||1
10830575|NCT04131959|11995654|FG000|STARTED|Overall Study||5
10830576|NCT04131959|11995654|FG000|COMPLETED|Overall Study||5
10830577|NCT04131959|11995654|FG000|NOT COMPLETED|Overall Study||0
10830578|NCT04084990|11995661|FG000|STARTED|Overall Study||2
10830579|NCT04084990|11995662|FG001|STARTED|Overall Study||1
10830580|NCT04084990|11995661|FG000|COMPLETED|Overall Study||2
10830581|NCT04084990|11995662|FG001|COMPLETED|Overall Study||1
10830582|NCT04084990|11995661|FG000|NOT COMPLETED|Overall Study||0
10830583|NCT04084990|11995662|FG001|NOT COMPLETED|Overall Study||0
10830584|NCT04056299|11995670|FG000|STARTED|Overall Study||9
10830585|NCT04056299|11995671|FG001|STARTED|Overall Study||6
10830586|NCT04056299|11995670|FG000|COMPLETED|Overall Study||6
10830587|NCT04056299|11995671|FG001|COMPLETED|Overall Study||3
10830588|NCT04056299|11995670|FG000|NOT COMPLETED|Overall Study||3
10830589|NCT04056299|11995671|FG001|NOT COMPLETED|Overall Study||3
10830590|NCT04020718|11995679|FG000|STARTED|Pre-assessment and Adaptation||16
10830591|NCT04020718|11995680|FG001|STARTED|Pre-assessment and Adaptation||19
10830592|NCT04020718|11995681|FG002|STARTED|Pre-assessment and Adaptation||0
10830593|NCT04020718|11995682|FG003|STARTED|Pre-assessment and Adaptation||0
10830594|NCT04020718|11995683|FG004|STARTED|Pre-assessment and Adaptation||0
10830595|NCT04020718|11995684|FG005|STARTED|Pre-assessment and Adaptation||0
10830596|NCT04020718|11995685|FG006|STARTED|Pre-assessment and Adaptation||0
10830597|NCT04020718|11995686|FG007|STARTED|Pre-assessment and Adaptation||0
10830598|NCT04020718|11995679|FG000|COMPLETED|Pre-assessment and Adaptation||16
10830599|NCT04020718|11995680|FG001|COMPLETED|Pre-assessment and Adaptation||15
10830600|NCT04020718|11995681|FG002|COMPLETED|Pre-assessment and Adaptation||0
10830601|NCT04020718|11995682|FG003|COMPLETED|Pre-assessment and Adaptation||0
10830602|NCT04020718|11995683|FG004|COMPLETED|Pre-assessment and Adaptation||0
11101247|NCT01229371|12285245|FG001|STARTED|Overall Study||111
11101248|NCT01229371|12285246|FG002|STARTED|Overall Study||110
11101249|NCT01229371|12285247|FG003|STARTED|Overall Study||110
11101250|NCT01229371|12285244|FG000|COMPLETED|Overall Study||109
11101251|NCT01229371|12285245|FG001|COMPLETED|Overall Study||110
10830603|NCT04020718|11995684|FG005|COMPLETED|Pre-assessment and Adaptation||0
10830604|NCT04020718|11995685|FG006|COMPLETED|Pre-assessment and Adaptation||0
10830605|NCT04020718|11995686|FG007|COMPLETED|Pre-assessment and Adaptation||0
10830606|NCT04020718|11995679|FG000|NOT COMPLETED|Pre-assessment and Adaptation||0
10830607|NCT04020718|11995680|FG001|NOT COMPLETED|Pre-assessment and Adaptation||4
10830608|NCT04020718|11995681|FG002|NOT COMPLETED|Pre-assessment and Adaptation||0
10830609|NCT04020718|11995682|FG003|NOT COMPLETED|Pre-assessment and Adaptation||0
10830610|NCT04020718|11995683|FG004|NOT COMPLETED|Pre-assessment and Adaptation||0
10830611|NCT04020718|11995684|FG005|NOT COMPLETED|Pre-assessment and Adaptation||0
10830612|NCT04020718|11995685|FG006|NOT COMPLETED|Pre-assessment and Adaptation||0
10830613|NCT04020718|11995686|FG007|NOT COMPLETED|Pre-assessment and Adaptation||0
10830614|NCT04020718|11995679|FG000|STARTED|Post-assessment and Adaptation||0
10830556|NCT04324021|11995628|FG000|STARTED|Overall Study||5
10830557|NCT04324021|11995629|FG001|STARTED|Overall Study||5
10830558|NCT04324021|11995630|FG002|STARTED|Overall Study||6
10830559|NCT04324021|11995628|FG000|COMPLETED|Overall Study||3
10830560|NCT04324021|11995629|FG001|COMPLETED|Overall Study||4
10830561|NCT04324021|11995630|FG002|COMPLETED|Overall Study||5
10830562|NCT04324021|11995628|FG000|NOT COMPLETED|Overall Study||2
10830563|NCT04324021|11995629|FG001|NOT COMPLETED|Overall Study||1
10830564|NCT04324021|11995630|FG002|NOT COMPLETED|Overall Study||1
10830565|NCT04209621|11995641|FG000|STARTED|Overall Study||3
10830566|NCT04209621|11995641|FG000|Dose Level 1|Overall Study||3
10830567|NCT04209621|11995641|FG000|COMPLETED|Overall Study||0
10830568|NCT04209621|11995641|FG000|NOT COMPLETED|Overall Study||3
10830615|NCT04020718|11995680|FG001|STARTED|Post-assessment and Adaptation||0
10830616|NCT04020718|11995681|FG002|STARTED|Post-assessment and Adaptation||8
10830617|NCT04020718|11995682|FG003|STARTED|Post-assessment and Adaptation||6
10830618|NCT04020718|11995683|FG004|STARTED|Post-assessment and Adaptation||8
10830619|NCT04020718|11995684|FG005|STARTED|Post-assessment and Adaptation||7
10830620|NCT04020718|11995685|FG006|STARTED|Post-assessment and Adaptation||2
10830621|NCT04020718|11995686|FG007|STARTED|Post-assessment and Adaptation||0
10830622|NCT04020718|11995679|FG000|COMPLETED|Post-assessment and Adaptation||0
10830623|NCT04020718|11995680|FG001|COMPLETED|Post-assessment and Adaptation||0
10830624|NCT04020718|11995681|FG002|COMPLETED|Post-assessment and Adaptation||8
10830625|NCT04020718|11995682|FG003|COMPLETED|Post-assessment and Adaptation||5
10830626|NCT04020718|11995683|FG004|COMPLETED|Post-assessment and Adaptation||8
10830627|NCT04020718|11995684|FG005|COMPLETED|Post-assessment and Adaptation||7
10830628|NCT04020718|11995685|FG006|COMPLETED|Post-assessment and Adaptation||2
10830629|NCT04020718|11995686|FG007|COMPLETED|Post-assessment and Adaptation||0
11101252|NCT01229371|12285246|FG002|COMPLETED|Overall Study||110
11101253|NCT01229371|12285247|FG003|COMPLETED|Overall Study||110
11101254|NCT01229371|12285244|FG000|NOT COMPLETED|Overall Study||0
11101255|NCT01229371|12285245|FG001|NOT COMPLETED|Overall Study||1
11101256|NCT01229371|12285246|FG002|NOT COMPLETED|Overall Study||0
11101257|NCT01229371|12285247|FG003|NOT COMPLETED|Overall Study||0
11101258|NCT01229397|12285259|FG000|STARTED|Overall Study||103
11101259|NCT01229397|12285260|FG001|STARTED|Overall Study||102
11101260|NCT01229397|12285259|FG000|COMPLETED|Overall Study||92
11101261|NCT01229397|12285260|FG001|COMPLETED|Overall Study||93
11101262|NCT01229397|12285259|FG000|NOT COMPLETED|Overall Study||11
11101263|NCT01229397|12285260|FG001|NOT COMPLETED|Overall Study||9
11101264|NCT01229410|12285272|FG000|STARTED|Overall Study||12
11101265|NCT01229410|12285273|FG001|STARTED|Overall Study||12
11101266|NCT01229410|12285272|FG000|COMPLETED|Overall Study||7
11101267|NCT01229410|12285273|FG001|COMPLETED|Overall Study||9
11101268|NCT01229410|12285272|FG000|NOT COMPLETED|Overall Study||5
11101269|NCT01229410|12285273|FG001|NOT COMPLETED|Overall Study||3
11101270|NCT01229423|12285279|FG000|STARTED|Overall Study||62
11101271|NCT01229423|12285279|FG000|COMPLETED|Overall Study||47
11101272|NCT01229423|12285279|FG000|NOT COMPLETED|Overall Study||15
11101273|NCT01229436|12285283|FG000|STARTED|Overall Study||254
11101274|NCT01229436|12285283|FG000|COMPLETED|Overall Study||249
11101275|NCT01229436|12285283|FG000|NOT COMPLETED|Overall Study||5
11101276|NCT01229449|12285292|FG000|STARTED|Overall Study||173
11101277|NCT01229449|12285293|FG001|STARTED|Overall Study||168
11101278|NCT01229449|12285294|FG002|STARTED|Overall Study||169
11101279|NCT01229449|12285295|FG003|STARTED|Overall Study||113
11101280|NCT01229449|12285296|FG004|STARTED|Overall Study||55
11101281|NCT01229449|12285292|FG000|COMPLETED|Overall Study||172
11101282|NCT01229449|12285293|FG001|COMPLETED|Overall Study||164
11101283|NCT01229449|12285294|FG002|COMPLETED|Overall Study||167
11101284|NCT01229449|12285295|FG003|COMPLETED|Overall Study||112
11101285|NCT01229449|12285296|FG004|COMPLETED|Overall Study||54
11101286|NCT01229449|12285292|FG000|NOT COMPLETED|Overall Study||1
11101287|NCT01229449|12285293|FG001|NOT COMPLETED|Overall Study||4
11101288|NCT01229449|12285294|FG002|NOT COMPLETED|Overall Study||2
11101289|NCT01229449|12285295|FG003|NOT COMPLETED|Overall Study||1
11101290|NCT01229449|12285296|FG004|NOT COMPLETED|Overall Study||1
11220019|NCT01958060|12411573|FG005|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
11220020|NCT01958060|12411568|FG000|NOT COMPLETED|Overall Study||2
11220021|NCT01958060|12411569|FG001|NOT COMPLETED|Overall Study||0
11220022|NCT01958060|12411570|FG002|NOT COMPLETED|Overall Study||0
11220023|NCT01958060|12411571|FG003|NOT COMPLETED|Overall Study||0
11220024|NCT01958060|12411572|FG004|NOT COMPLETED|Overall Study||1
11220025|NCT01958060|12411573|FG005|NOT COMPLETED|Overall Study||0
11220026|NCT01958073|12411594|FG000|STARTED|Randomized Period||9
11220027|NCT01958073|12411595|FG001|STARTED|Randomized Period||9
11101291|NCT01229462|12285310|FG000|STARTED|Overall Study||120
11101292|NCT01229462|12285311|FG001|STARTED|Overall Study||118
11101293|NCT01229462|12285310|FG000|COMPLETED|Overall Study||115
11101294|NCT01229462|12285311|FG001|COMPLETED|Overall Study||109
11101295|NCT01229462|12285310|FG000|NOT COMPLETED|Overall Study||5
11101296|NCT01229462|12285311|FG001|NOT COMPLETED|Overall Study||9
11101297|NCT01229527|12285320|FG000|STARTED|Overall Study||30
11101298|NCT01229527|12285321|FG001|STARTED|Overall Study||30
11220028|NCT01958073|12411596|FG002|STARTED|Randomized Period||17
11101299|NCT01229527|12285322|FG002|STARTED|Overall Study||30
10830630|NCT04020718|11995679|FG000|NOT COMPLETED|Post-assessment and Adaptation||0
10830631|NCT04020718|11995680|FG001|NOT COMPLETED|Post-assessment and Adaptation||0
10830632|NCT04020718|11995681|FG002|NOT COMPLETED|Post-assessment and Adaptation||0
10830633|NCT04020718|11995682|FG003|NOT COMPLETED|Post-assessment and Adaptation||1
10830634|NCT04020718|11995683|FG004|NOT COMPLETED|Post-assessment and Adaptation||0
10830635|NCT04020718|11995684|FG005|NOT COMPLETED|Post-assessment and Adaptation||0
10830636|NCT04020718|11995685|FG006|NOT COMPLETED|Post-assessment and Adaptation||0
10830637|NCT04020718|11995686|FG007|NOT COMPLETED|Post-assessment and Adaptation||0
10830638|NCT03970109|11995707|FG000|STARTED|Overall Study||15
10830639|NCT03970109|11995708|FG001|STARTED|Overall Study||13
10830640|NCT03970109|11995709|FG002|STARTED|Overall Study||15
10830641|NCT03970109|11995707|FG000|COMPLETED|Overall Study||14
10830642|NCT03970109|11995708|FG001|COMPLETED|Overall Study||10
10830643|NCT03970109|11995709|FG002|COMPLETED|Overall Study||15
10830644|NCT03970109|11995707|FG000|NOT COMPLETED|Overall Study||1
10830645|NCT03970109|11995708|FG001|NOT COMPLETED|Overall Study||3
10830646|NCT03970109|11995709|FG002|NOT COMPLETED|Overall Study||0
11101300|NCT01229527|12285320|FG000|COMPLETED|Overall Study||30
11101301|NCT01229527|12285321|FG001|COMPLETED|Overall Study||30
11101302|NCT01229527|12285322|FG002|COMPLETED|Overall Study||30
11101303|NCT01229527|12285320|FG000|NOT COMPLETED|Overall Study||0
11101304|NCT01229527|12285321|FG001|NOT COMPLETED|Overall Study||0
11101305|NCT01229527|12285322|FG002|NOT COMPLETED|Overall Study||0
11101306|NCT01229722|12285332|FG000|STARTED|Overall Study||36
11101307|NCT01229722|12285333|FG001|STARTED|Overall Study||34
11101308|NCT01229722|12285332|FG000|COMPLETED|Overall Study||36
11101309|NCT01229722|12285333|FG001|COMPLETED|Overall Study||30
11101310|NCT01229722|12285332|FG000|NOT COMPLETED|Overall Study||0
11101311|NCT01229722|12285333|FG001|NOT COMPLETED|Overall Study||4
11101312|NCT01229735|12285345|FG000|STARTED|Overall Study||177
11101313|NCT01229735|12285346|FG001|STARTED|Overall Study||166
11101314|NCT01229735|12285345|FG000|COMPLETED|Overall Study||111
11101315|NCT01229735|12285346|FG001|COMPLETED|Overall Study||100
11101316|NCT01229735|12285345|FG000|NOT COMPLETED|Overall Study||66
11101317|NCT01229735|12285346|FG001|NOT COMPLETED|Overall Study||66
11101318|NCT01229891|12285357|FG000|STARTED|Overall Study||30
11101319|NCT01229891|12285358|FG001|STARTED|Overall Study||30
11101320|NCT01229891|12285359|FG002|STARTED|Overall Study||30
11101321|NCT01229891|12285357|FG000|COMPLETED|Overall Study||30
10830647|NCT03954743|11995719|FG000|STARTED|Overall Study||677
10830648|NCT03954743|11995720|FG001|STARTED|Overall Study||674
10830649|NCT03954743|11995719|FG000|COMPLETED|Overall Study||653
10830650|NCT03954743|11995720|FG001|COMPLETED|Overall Study||657
10830651|NCT03954743|11995719|FG000|NOT COMPLETED|Overall Study||24
10830652|NCT03954743|11995720|FG001|NOT COMPLETED|Overall Study||17
10830653|NCT03880565|11995728|FG000|STARTED|Overall Study||15
10830654|NCT03880565|11995729|FG001|STARTED|Overall Study||15
10830655|NCT03880565|11995728|FG000|COMPLETED|Overall Study||14
10830656|NCT03880565|11995729|FG001|COMPLETED|Overall Study||15
10830657|NCT03880565|11995728|FG000|NOT COMPLETED|Overall Study||1
10830658|NCT03880565|11995729|FG001|NOT COMPLETED|Overall Study||0
10830659|NCT03833661|11995735|FG000|STARTED|Overall Study||159
10830660|NCT03833661|11995735|FG000|COMPLETED|Overall Study||150
10830661|NCT03833661|11995735|FG000|NOT COMPLETED|Overall Study||9
10830662|NCT03809663|11995743|FG000|STARTED|Overall Study||63
10830663|NCT03809663|11995744|FG001|STARTED|Overall Study||62
10830664|NCT03809663|11995745|FG002|STARTED|Overall Study||63
10830665|NCT03809663|11995746|FG003|STARTED|Overall Study||63
10830666|NCT03809663|11995747|FG004|STARTED|Overall Study||0
10830667|NCT03809663|11995748|FG005|STARTED|Overall Study||0
10830668|NCT03809663|11995743|FG000|Participants Who Received Investigational Product|Overall Study||63
10830669|NCT03809663|11995744|FG001|Participants Who Received Investigational Product|Overall Study||61
10830670|NCT03809663|11995745|FG002|Participants Who Received Investigational Product|Overall Study||63
10830671|NCT03809663|11995746|FG003|Participants Who Received Investigational Product|Overall Study||63
10830672|NCT03809663|11995747|FG004|Participants Who Received Investigational Product|Overall Study||0
10830673|NCT03809663|11995748|FG005|Participants Who Received Investigational Product|Overall Study||0
10830674|NCT03809663|11995743|FG000|EASI 50 Non-responder at Week 16|Overall Study||40
10830675|NCT03809663|11995744|FG001|EASI 50 Non-responder at Week 16|Overall Study||26
10830676|NCT03809663|11995745|FG002|EASI 50 Non-responder at Week 16|Overall Study||30
10830677|NCT03809663|11995746|FG003|EASI 50 Non-responder at Week 16|Overall Study||38
10830678|NCT03809663|11995747|FG004|EASI 50 Non-responder at Week 16|Overall Study||0
10830679|NCT03809663|11995748|FG005|EASI 50 Non-responder at Week 16|Overall Study||0
10830680|NCT03809663|11995743|FG000|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||39
10830681|NCT03809663|11995744|FG001|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||24
10830682|NCT03809663|11995745|FG002|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||30
10830683|NCT03809663|11995746|FG003|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||38
10830684|NCT03809663|11995747|FG004|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||0
10830685|NCT03809663|11995748|FG005|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||0
10830686|NCT03809663|11995743|FG000|COMPLETED|Overall Study||12
10830687|NCT03809663|11995744|FG001|COMPLETED|Overall Study||18
10830688|NCT03809663|11995745|FG002|COMPLETED|Overall Study||15
10830689|NCT03809663|11995746|FG003|COMPLETED|Overall Study||16
10830690|NCT03809663|11995747|FG004|COMPLETED|Overall Study||0
10830691|NCT03809663|11995748|FG005|COMPLETED|Overall Study||0
10830692|NCT03809663|11995743|FG000|NOT COMPLETED|Overall Study||51
10830693|NCT03809663|11995744|FG001|NOT COMPLETED|Overall Study||44
10830694|NCT03809663|11995745|FG002|NOT COMPLETED|Overall Study||48
10830695|NCT03809663|11995746|FG003|NOT COMPLETED|Overall Study||47
11220029|NCT01958073|12411597|FG003|STARTED|Randomized Period||0
11220030|NCT01958073|12411598|FG004|STARTED|Randomized Period||0
11220031|NCT01958073|12411594|FG000|COMPLETED|Randomized Period||7
11220032|NCT01958073|12411595|FG001|COMPLETED|Randomized Period||8
10830696|NCT03809663|11995747|FG004|NOT COMPLETED|Overall Study||0
10830697|NCT03809663|11995748|FG005|NOT COMPLETED|Overall Study||0
10830698|NCT03782792|11995775|FG000|STARTED|Overall Study||18
10830699|NCT03782792|11995776|FG001|STARTED|Overall Study||35
10830700|NCT03782792|11995775|FG000|Received Open Label Treatment With Spesolimab at Wk1/D8|Overall Study||15
10830701|NCT03782792|11995776|FG001|Received Open Label Treatment With Spesolimab at Wk1/D8|Overall Study||12
10830702|NCT03782792|11995775|FG000|Received Rescue Treatment With Spesolimab After Wk1|Overall Study||2
10830703|NCT03782792|11995776|FG001|Received Rescue Treatment With Spesolimab After Wk1|Overall Study||4
10830704|NCT03782792|11995775|FG000|COMPLETED|Overall Study||17
10830705|NCT03782792|11995776|FG001|COMPLETED|Overall Study||32
10830706|NCT03782792|11995775|FG000|NOT COMPLETED|Overall Study||1
10830707|NCT03782792|11995776|FG001|NOT COMPLETED|Overall Study||3
10830708|NCT03750461|11995786|FG000|STARTED|Overall Study||20
10830709|NCT03750461|11995787|FG001|STARTED|Overall Study||92
10830710|NCT03750461|11995786|FG000|Primary Endpoint|Overall Study||20
10830765|NCT03600142|11995847|FG001|COMPLETED|Overall Study||758
10830711|NCT03750461|11995787|FG001|Primary Endpoint|Overall Study|Considered study completion for the Historical Controls.|92
10830712|NCT03750461|11995786|FG000|Secondary Endpoint|Overall Study||19
10830713|NCT03750461|11995787|FG001|Secondary Endpoint|Overall Study|Not applicable for the historical controls.|0
10830714|NCT03750461|11995786|FG000|COMPLETED|Overall Study||19
10830715|NCT03750461|11995787|FG001|COMPLETED|Overall Study|Not applicable for the historical controls; no follow-up data was collected.|0
10830716|NCT03750461|11995786|FG000|NOT COMPLETED|Overall Study||1
10830717|NCT03750461|11995787|FG001|NOT COMPLETED|Overall Study||92
10830718|NCT03733119|11995795|FG000|STARTED|Overall Study||2
10830719|NCT03733119|11995796|FG001|STARTED|Overall Study||2
10830720|NCT03733119|11995795|FG000|Treated|Overall Study||2
10830721|NCT03733119|11995796|FG001|Treated|Overall Study||1
10830722|NCT03733119|11995795|FG000|Stopped Treatment After 1 Dose|Overall Study||1
10830723|NCT03733119|11995796|FG001|Stopped Treatment After 1 Dose|Overall Study||0
10830724|NCT03733119|11995795|FG000|Stopped Treatment After 3 Cycles|Overall Study||1
10830725|NCT03733119|11995796|FG001|Stopped Treatment After 3 Cycles|Overall Study||1
10830726|NCT03733119|11995795|FG000|COMPLETED|Overall Study||0
10830727|NCT03733119|11995796|FG001|COMPLETED|Overall Study||0
10830728|NCT03733119|11995795|FG000|NOT COMPLETED|Overall Study||2
10830729|NCT03733119|11995796|FG001|NOT COMPLETED|Overall Study||2
10830730|NCT03661996|11995807|FG000|STARTED|Overall Study||162
10830731|NCT03661996|11995808|FG001|STARTED|Overall Study||180
10830732|NCT03661996|11995809|FG002|STARTED|Overall Study||176
10830733|NCT03661996|11995810|FG003|STARTED|Overall Study||163
10830734|NCT03661996|11995811|FG004|STARTED|Overall Study||173
10830735|NCT03661996|11995807|FG000|Treated|Overall Study||162
10830736|NCT03661996|11995808|FG001|Treated|Overall Study||179
10830737|NCT03661996|11995809|FG002|Treated|Overall Study||175
10830738|NCT03661996|11995810|FG003|Treated|Overall Study||160
10830739|NCT03661996|11995811|FG004|Treated|Overall Study||172
10830740|NCT03661996|11995807|FG000|COMPLETED|Overall Study||150
10830741|NCT03661996|11995808|FG001|COMPLETED|Overall Study||172
10830742|NCT03661996|11995809|FG002|COMPLETED|Overall Study||170
10830743|NCT03661996|11995810|FG003|COMPLETED|Overall Study||150
10830744|NCT03661996|11995811|FG004|COMPLETED|Overall Study||159
10830745|NCT03661996|11995807|FG000|NOT COMPLETED|Overall Study||12
10830746|NCT03661996|11995808|FG001|NOT COMPLETED|Overall Study||8
10830747|NCT03661996|11995809|FG002|NOT COMPLETED|Overall Study||6
10830748|NCT03661996|11995810|FG003|NOT COMPLETED|Overall Study||13
10830749|NCT03661996|11995811|FG004|NOT COMPLETED|Overall Study||14
10830750|NCT03633461|11995828|FG000|STARTED|Overall Study||34
10830751|NCT03633461|11995829|FG001|STARTED|Overall Study||19
10830752|NCT03633461|11995828|FG000|COMPLETED|Overall Study||34
10830753|NCT03633461|11995829|FG001|COMPLETED|Overall Study||18
10830754|NCT03633461|11995828|FG000|NOT COMPLETED|Overall Study||0
10830755|NCT03633461|11995829|FG001|NOT COMPLETED|Overall Study||1
10830756|NCT03622658|11995837|FG000|STARTED|Overall Study||6
10830757|NCT03622658|11995838|FG001|STARTED|Overall Study||36
10830758|NCT03622658|11995837|FG000|COMPLETED|Overall Study||3
10830759|NCT03622658|11995838|FG001|COMPLETED|Overall Study||32
10830760|NCT03622658|11995837|FG000|NOT COMPLETED|Overall Study||3
10830761|NCT03622658|11995838|FG001|NOT COMPLETED|Overall Study||4
11101322|NCT01229891|12285358|FG001|COMPLETED|Overall Study||30
11101323|NCT01229891|12285359|FG002|COMPLETED|Overall Study||30
11101324|NCT01229891|12285357|FG000|NOT COMPLETED|Overall Study||0
11101325|NCT01229891|12285358|FG001|NOT COMPLETED|Overall Study||0
11101326|NCT01229891|12285359|FG002|NOT COMPLETED|Overall Study||0
11101327|NCT01230021|12285367|FG000|STARTED|Overall Study||6
11101328|NCT01230021|12285367|FG000|COMPLETED|Overall Study||6
11101329|NCT01230021|12285367|FG000|NOT COMPLETED|Overall Study||0
11101330|NCT01230060|12285371|FG000|STARTED|Overall Study||122
11101331|NCT01230060|12285371|FG000|COMPLETED|Overall Study||121
11101332|NCT01230060|12285371|FG000|NOT COMPLETED|Overall Study||1
11101333|NCT01230125|12285377|FG000|STARTED|Overall Study||207
11101334|NCT01230125|12285378|FG001|STARTED|Overall Study||104
11101335|NCT01230125|12285377|FG000|COMPLETED|Overall Study||134
11101336|NCT01230125|12285378|FG001|COMPLETED|Overall Study||54
11101337|NCT01230125|12285377|FG000|NOT COMPLETED|Overall Study||73
11101338|NCT01230125|12285378|FG001|NOT COMPLETED|Overall Study||50
11101339|NCT01230177|12285384|FG000|STARTED|Overall Study||3
11101340|NCT01230177|12285384|FG000|COMPLETED|Overall Study||3
11101341|NCT01230177|12285384|FG000|NOT COMPLETED|Overall Study||0
11101342|NCT01230424|12285390|FG000|STARTED|Overall Study||70
11101343|NCT01230424|12285391|FG001|STARTED|Overall Study||70
11101344|NCT01230424|12285390|FG000|COMPLETED|Overall Study||70
11101345|NCT01230424|12285391|FG001|COMPLETED|Overall Study||70
11101346|NCT01230424|12285390|FG000|NOT COMPLETED|Overall Study||0
11101347|NCT01230424|12285391|FG001|NOT COMPLETED|Overall Study||0
11101348|NCT01230502|12285403|FG000|STARTED|Overall Study||9
11101349|NCT01230502|12285404|FG001|STARTED|Overall Study||0
11101350|NCT01230502|12285405|FG002|STARTED|Overall Study||0
11101351|NCT01230502|12285403|FG000|COMPLETED|Overall Study||9
11101352|NCT01230502|12285404|FG001|COMPLETED|Overall Study||0
11101353|NCT01230502|12285405|FG002|COMPLETED|Overall Study||0
11101354|NCT01230502|12285403|FG000|NOT COMPLETED|Overall Study||0
10830762|NCT03600142|11995846|FG000|STARTED|Overall Study||777
10830763|NCT03600142|11995847|FG001|STARTED|Overall Study||762
11101355|NCT01230502|12285404|FG001|NOT COMPLETED|Overall Study||0
10830764|NCT03600142|11995846|FG000|COMPLETED|Overall Study||773
11101356|NCT01230502|12285405|FG002|NOT COMPLETED|Overall Study||0
11101357|NCT01230554|12285416|FG000|STARTED|Overall Study||212
11101358|NCT01230554|12285416|FG000|COMPLETED|Overall Study||209
10830766|NCT03600142|11995846|FG000|NOT COMPLETED|Overall Study||4
10830767|NCT03600142|11995847|FG001|NOT COMPLETED|Overall Study||4
10830768|NCT03517722|11995857|FG000|STARTED|Double Blind Period: Week 0-52||208
10830769|NCT03517722|11995858|FG001|STARTED|Double Blind Period: Week 0-52||308
10830770|NCT03517722|11995857|FG000|Treated|Double Blind Period: Week 0-52||208
10830771|NCT03517722|11995858|FG001|Treated|Double Blind Period: Week 0-52||307
10830772|NCT03517722|11995857|FG000|COMPLETED|Double Blind Period: Week 0-52||105
10830773|NCT03517722|11995858|FG001|COMPLETED|Double Blind Period: Week 0-52||153
10830774|NCT03517722|11995857|FG000|NOT COMPLETED|Double Blind Period: Week 0-52||103
10830775|NCT03517722|11995858|FG001|NOT COMPLETED|Double Blind Period: Week 0-52||155
10830776|NCT03517722|11995857|FG000|STARTED|Open-label Extension Period: Week 52-113||88
10830777|NCT03517722|11995858|FG001|STARTED|Open-label Extension Period: Week 52-113||137
10830778|NCT03517722|11995857|FG000|COMPLETED|Open-label Extension Period: Week 52-113||0
10830779|NCT03517722|11995858|FG001|COMPLETED|Open-label Extension Period: Week 52-113||0
10830780|NCT03517722|11995857|FG000|NOT COMPLETED|Open-label Extension Period: Week 52-113||88
10830781|NCT03517722|11995858|FG001|NOT COMPLETED|Open-label Extension Period: Week 52-113||137
10830782|NCT03499314|11995867|FG000|STARTED|Overall Study||33
10830783|NCT03499314|11995868|FG001|STARTED|Overall Study||32
10830784|NCT03499314|11995867|FG000|COMPLETED|Overall Study||31
10830785|NCT03499314|11995868|FG001|COMPLETED|Overall Study||29
10830786|NCT03499314|11995867|FG000|NOT COMPLETED|Overall Study||2
10830787|NCT03499314|11995868|FG001|NOT COMPLETED|Overall Study||3
10830788|NCT03439124|11995876|FG000|STARTED|Overall Study||94
10830789|NCT03439124|11995877|FG001|STARTED|Overall Study||44
10830790|NCT03439124|11995876|FG000|COMPLETED|Overall Study||90
10830791|NCT03439124|11995877|FG001|COMPLETED|Overall Study||44
10830792|NCT03439124|11995876|FG000|NOT COMPLETED|Overall Study||4
10830793|NCT03439124|11995877|FG001|NOT COMPLETED|Overall Study||0
10830794|NCT03369431|11995885|FG000|STARTED|Overall Study||35
10830795|NCT03369431|11995886|FG001|STARTED|Overall Study||34
10830796|NCT03369431|11995885|FG000|Taste Test (1 Week)|Overall Study||35
10830797|NCT03369431|11995886|FG001|Taste Test (1 Week)|Overall Study||34
10830798|NCT03369431|11995885|FG000|Part 1 Treatment (12 Weeks)|Overall Study||34
10830799|NCT03369431|11995886|FG001|Part 1 Treatment (12 Weeks)|Overall Study||34
10830800|NCT03369431|11995885|FG000|Washout (4 Weeks)|Overall Study||34
10830801|NCT03369431|11995886|FG001|Washout (4 Weeks)|Overall Study||32
10830802|NCT03369431|11995885|FG000|Part 2 Treatment (12 Weeks)|Overall Study||34
10830803|NCT03369431|11995886|FG001|Part 2 Treatment (12 Weeks)|Overall Study||32
10830804|NCT03369431|11995885|FG000|COMPLETED|Overall Study||31
10830805|NCT03369431|11995886|FG001|COMPLETED|Overall Study||27
10830806|NCT03369431|11995885|FG000|NOT COMPLETED|Overall Study||4
10830807|NCT03369431|11995886|FG001|NOT COMPLETED|Overall Study||7
11101359|NCT01230554|12285416|FG000|NOT COMPLETED|Overall Study||3
11101360|NCT01230593|12285423|FG000|STARTED|Overall Study||50
11101361|NCT01230593|12285424|FG001|STARTED|Overall Study||50
11101362|NCT01230593|12285425|FG002|STARTED|Overall Study||50
11101363|NCT01230593|12285423|FG000|COMPLETED|Overall Study||35
11101364|NCT01230593|12285424|FG001|COMPLETED|Overall Study||32
11101365|NCT01230593|12285425|FG002|COMPLETED|Overall Study||38
11101366|NCT01230593|12285423|FG000|NOT COMPLETED|Overall Study||15
11101367|NCT01230593|12285424|FG001|NOT COMPLETED|Overall Study||18
11101368|NCT01230593|12285425|FG002|NOT COMPLETED|Overall Study||12
11101369|NCT01230710|12285433|FG000|STARTED|Overall Study||51
11101370|NCT01230710|12285433|FG000|COMPLETED|Overall Study||2
11101371|NCT01230710|12285433|FG000|NOT COMPLETED|Overall Study||49
11101372|NCT01230749|12285441|FG000|STARTED|Overall Study||22
11101373|NCT01230749|12285442|FG001|STARTED|Overall Study||22
11101374|NCT01230749|12285443|FG002|STARTED|Overall Study||23
11101375|NCT01230749|12285444|FG003|STARTED|Overall Study||22
11101376|NCT01230749|12285441|FG000|COMPLETED|Overall Study||22
11101377|NCT01230749|12285442|FG001|COMPLETED|Overall Study||20
11101378|NCT01230749|12285443|FG002|COMPLETED|Overall Study||21
11101379|NCT01230749|12285444|FG003|COMPLETED|Overall Study||20
11101380|NCT01230749|12285441|FG000|NOT COMPLETED|Overall Study||0
11101381|NCT01230749|12285442|FG001|NOT COMPLETED|Overall Study||2
11101382|NCT01230749|12285443|FG002|NOT COMPLETED|Overall Study||2
11101383|NCT01230749|12285444|FG003|NOT COMPLETED|Overall Study||2
11101384|NCT01230801|12285460|FG000|STARTED|Overall Study||3
11101385|NCT01230801|12285461|FG001|STARTED|Overall Study||3
11101386|NCT01230801|12285462|FG002|STARTED|Overall Study||16
10830826|NCT03336866|11995909|FG000|STARTED|Overall Study||20
10830827|NCT03336866|11995910|FG001|STARTED|Overall Study||18
10830828|NCT03336866|11995911|FG002|STARTED|Overall Study||18
10830829|NCT03336866|11995909|FG000|COMPLETED|Overall Study||17
10830830|NCT03336866|11995910|FG001|COMPLETED|Overall Study||17
10830831|NCT03336866|11995911|FG002|COMPLETED|Overall Study||14
10830832|NCT03336866|11995909|FG000|NOT COMPLETED|Overall Study||3
10830833|NCT03336866|11995910|FG001|NOT COMPLETED|Overall Study||1
10830834|NCT03336866|11995911|FG002|NOT COMPLETED|Overall Study||4
10830835|NCT03332173|11995924|FG000|STARTED|Overall Study||44
10830836|NCT03332173|11995924|FG000|COMPLETED|Overall Study||0
10830837|NCT03332173|11995924|FG000|NOT COMPLETED|Overall Study||44
10830838|NCT03322293|11995931|FG000|STARTED|Overall Study||8
10830839|NCT03322293|11995932|FG001|STARTED|Overall Study||8
10830840|NCT03322293|11995933|FG002|STARTED|Overall Study||8
10830841|NCT03322293|11995931|FG000|COMPLETED|Overall Study||8
10830842|NCT03322293|11995932|FG001|COMPLETED|Overall Study||8
10830843|NCT03322293|11995933|FG002|COMPLETED|Overall Study||7
10830844|NCT03322293|11995931|FG000|NOT COMPLETED|Overall Study||0
10830845|NCT03322293|11995932|FG001|NOT COMPLETED|Overall Study||0
10830846|NCT03322293|11995933|FG002|NOT COMPLETED|Overall Study||1
10830847|NCT03315039|11995943|FG000|STARTED|Overall Study||4
10830848|NCT03315039|11995944|FG001|STARTED|Overall Study||3
10830849|NCT03315039|11995943|FG000|COMPLETED|Overall Study||4
10830850|NCT03315039|11995944|FG001|COMPLETED|Overall Study||3
10830851|NCT03315039|11995943|FG000|NOT COMPLETED|Overall Study||0
10830852|NCT03315039|11995944|FG001|NOT COMPLETED|Overall Study||0
10830853|NCT03254394|11995955|FG000|STARTED|Overall Study||12
10830854|NCT03254394|11995956|FG001|STARTED|Overall Study||14
10830855|NCT03254394|11995955|FG000|COMPLETED|Overall Study||12
10830856|NCT03254394|11995956|FG001|COMPLETED|Overall Study||12
10830857|NCT03254394|11995955|FG000|NOT COMPLETED|Overall Study||0
10830858|NCT03254394|11995956|FG001|NOT COMPLETED|Overall Study||2
10830859|NCT03253809|11995962|FG000|STARTED|Overall Study||14
10830860|NCT03253809|11995962|FG000|COMPLETED|Overall Study||0
10830861|NCT03253809|11995962|FG000|NOT COMPLETED|Overall Study||14
11101387|NCT01230801|12285460|FG000|COMPLETED|Overall Study||3
11101388|NCT01230801|12285461|FG001|COMPLETED|Overall Study||3
11101389|NCT01230801|12285462|FG002|COMPLETED|Overall Study||15
11101390|NCT01230801|12285460|FG000|NOT COMPLETED|Overall Study||0
11101391|NCT01230801|12285461|FG001|NOT COMPLETED|Overall Study||0
11101392|NCT01230801|12285462|FG002|NOT COMPLETED|Overall Study||1
11101393|NCT01230814|12285475|FG000|STARTED|Overall Study||118
11101394|NCT01230814|12285476|FG001|STARTED|Overall Study||116
11101395|NCT01230814|12285475|FG000|COMPLETED|Overall Study||105
11101396|NCT01230814|12285476|FG001|COMPLETED|Overall Study||112
11101397|NCT01230814|12285475|FG000|NOT COMPLETED|Overall Study||13
11101398|NCT01230814|12285476|FG001|NOT COMPLETED|Overall Study||4
11101399|NCT01230827|12285486|FG000|STARTED|Overall Study||19
11101400|NCT01230827|12285487|FG001|STARTED|Overall Study||11
11101401|NCT01230827|12285488|FG002|STARTED|Overall Study||65
11101402|NCT01230827|12285489|FG003|STARTED|Overall Study||78
11101403|NCT01230827|12285486|FG000|COMPLETED|Overall Study||0
11101404|NCT01230827|12285487|FG001|COMPLETED|Overall Study||0
11101405|NCT01230827|12285488|FG002|COMPLETED|Overall Study||0
11101406|NCT01230827|12285489|FG003|COMPLETED|Overall Study||0
11101407|NCT01230827|12285486|FG000|NOT COMPLETED|Overall Study||19
11101408|NCT01230827|12285487|FG001|NOT COMPLETED|Overall Study||11
11101409|NCT01230827|12285488|FG002|NOT COMPLETED|Overall Study||65
11101410|NCT01230827|12285489|FG003|NOT COMPLETED|Overall Study||78
11101411|NCT01230892|12285499|FG000|STARTED|Overall Study||15
11101412|NCT01230892|12285500|FG001|STARTED|Overall Study||14
11101413|NCT01230892|12285499|FG000|COMPLETED|Overall Study||12
11101414|NCT01230892|12285500|FG001|COMPLETED|Overall Study||13
11101415|NCT01230892|12285499|FG000|NOT COMPLETED|Overall Study||3
11101416|NCT01230892|12285500|FG001|NOT COMPLETED|Overall Study||1
10830862|NCT03180294|11995969|FG000|STARTED|Overall Study||79
10830863|NCT03180294|11995970|FG001|STARTED|Overall Study||74
10830864|NCT03180294|11995971|FG002|STARTED|Overall Study||77
10830865|NCT03180294|11995969|FG000|Eligible Population|Overall Study||79
10830866|NCT03180294|11995970|FG001|Eligible Population|Overall Study||74
10830867|NCT03180294|11995971|FG002|Eligible Population|Overall Study||77
10830868|NCT03180294|11995969|FG000|Adverse Event Population|Overall Study||77
10830869|NCT03180294|11995970|FG001|Adverse Event Population|Overall Study||73
10830870|NCT03180294|11995971|FG002|Adverse Event Population|Overall Study||76
10830871|NCT03180294|11995969|FG000|COMPLETED|Overall Study||79
11101417|NCT01230931|12285508|FG000|STARTED|Overall Study||10
11101418|NCT01230931|12285509|FG001|STARTED|Overall Study||10
11101419|NCT01230931|12285508|FG000|COMPLETED|Overall Study||10
11101420|NCT01230931|12285509|FG001|COMPLETED|Overall Study||10
11101421|NCT01230931|12285508|FG000|NOT COMPLETED|Overall Study||0
11101422|NCT01230931|12285509|FG001|NOT COMPLETED|Overall Study||0
10830872|NCT03180294|11995970|FG001|COMPLETED|Overall Study||74
10830873|NCT03180294|11995971|FG002|COMPLETED|Overall Study||77
10830874|NCT03180294|11995969|FG000|NOT COMPLETED|Overall Study||0
10830875|NCT03180294|11995970|FG001|NOT COMPLETED|Overall Study||0
10830876|NCT03180294|11995971|FG002|NOT COMPLETED|Overall Study||0
10830877|NCT03151408|11995982|FG000|STARTED|Overall Study|Screened patients|203
10830878|NCT03151408|11995983|FG001|STARTED|Overall Study|Screened patients|203
10830879|NCT03151408|11995982|FG000|Treated|Overall Study||201
10830880|NCT03151408|11995983|FG001|Treated|Overall Study||201
10830881|NCT03151408|11995982|FG000|COMPLETED|Overall Study||0
10830882|NCT03151408|11995983|FG001|COMPLETED|Overall Study||0
10830883|NCT03151408|11995982|FG000|NOT COMPLETED|Overall Study||203
10830884|NCT03151408|11995983|FG001|NOT COMPLETED|Overall Study||203
10830885|NCT03137173|11995991|FG000|STARTED|Overall Study||335
10830886|NCT03137173|11995992|FG001|STARTED|Overall Study||344
10830887|NCT03137173|11995991|FG000|COMPLETED|Overall Study||309
10830888|NCT03137173|11995992|FG001|COMPLETED|Overall Study||308
10830889|NCT03137173|11995991|FG000|NOT COMPLETED|Overall Study||26
10830890|NCT03137173|11995992|FG001|NOT COMPLETED|Overall Study||36
10830891|NCT03111030|11996001|FG000|STARTED|Overall Study||14
10830892|NCT03111030|11996002|FG001|STARTED|Overall Study||14
10830893|NCT03111030|11996001|FG000|COMPLETED|Overall Study||14
10830894|NCT03111030|11996002|FG001|COMPLETED|Overall Study||14
10830895|NCT03111030|11996001|FG000|NOT COMPLETED|Overall Study||0
10830896|NCT03111030|11996002|FG001|NOT COMPLETED|Overall Study||0
10830897|NCT03081052|11996012|FG000|STARTED|Overall Study||98
10830898|NCT03081052|11996013|FG001|STARTED|Overall Study||103
10830899|NCT03081052|11996014|FG002|STARTED|Overall Study||111
10830900|NCT03081052|11996015|FG003|STARTED|Overall Study||120
10830901|NCT03081052|11996012|FG000|COMPLETED|Overall Study||98
10830902|NCT03081052|11996013|FG001|COMPLETED|Overall Study||103
10830903|NCT03081052|11996014|FG002|COMPLETED|Overall Study||111
10830904|NCT03081052|11996015|FG003|COMPLETED|Overall Study||120
10830905|NCT03081052|11996012|FG000|NOT COMPLETED|Overall Study||0
10830906|NCT03081052|11996013|FG001|NOT COMPLETED|Overall Study||0
10830907|NCT03081052|11996014|FG002|NOT COMPLETED|Overall Study||0
10830908|NCT03081052|11996015|FG003|NOT COMPLETED|Overall Study||0
10830909|NCT03028740|11996031|FG000|STARTED|Overall Study||593
10830910|NCT03028740|11996032|FG001|STARTED|Overall Study||1185
10830911|NCT03028740|11996031|FG000|Full Study Cohort: Received Study Drug|Overall Study||589
10830912|NCT03028740|11996032|FG001|Full Study Cohort: Received Study Drug|Overall Study||1180
10830913|NCT03028740|11996031|FG000|Participated in Part 1|Overall Study||432
10830914|NCT03028740|11996032|FG001|Participated in Part 1|Overall Study||861
10830915|NCT03028740|11996031|FG000|Part 1: Received Study Drug|Overall Study||429
10830916|NCT03028740|11996032|FG001|Part 1: Received Study Drug|Overall Study||859
10830917|NCT03028740|11996031|FG000|COMPLETED|Overall Study||0
10830918|NCT03028740|11996032|FG001|COMPLETED|Overall Study||0
10830919|NCT03028740|11996031|FG000|NOT COMPLETED|Overall Study||593
10830920|NCT03028740|11996032|FG001|NOT COMPLETED|Overall Study||1185
10830921|NCT03015142|11996041|FG000|STARTED|Overall Study||21
10830922|NCT03015142|11996041|FG000|COMPLETED|Overall Study||20
10830923|NCT03015142|11996041|FG000|NOT COMPLETED|Overall Study||1
10830924|NCT03012672|11996049|FG000|STARTED|Overall Study||20
10830925|NCT03012672|11996050|FG001|STARTED|Overall Study||30
10830926|NCT03012672|11996049|FG000|COMPLETED|Overall Study||20
10830927|NCT03012672|11996050|FG001|COMPLETED|Overall Study||30
10830928|NCT03012672|11996049|FG000|NOT COMPLETED|Overall Study||0
10830929|NCT03012672|11996050|FG001|NOT COMPLETED|Overall Study||0
10830930|NCT03011775|11996057|FG000|STARTED|Overall Study||20
10830931|NCT03011775|11996058|FG001|STARTED|Overall Study||23
10830932|NCT03011775|11996057|FG000|COMPLETED|Overall Study||20
10830933|NCT03011775|11996058|FG001|COMPLETED|Overall Study||23
10830934|NCT03011775|11996057|FG000|NOT COMPLETED|Overall Study||0
10830935|NCT03011775|11996058|FG001|NOT COMPLETED|Overall Study||0
10830936|NCT03007485|11996070|FG000|STARTED|Overall Study||98
10830937|NCT03007485|11996071|FG001|STARTED|Overall Study||111
10830938|NCT03007485|11996070|FG000|COMPLETED|Overall Study||28
10830939|NCT03007485|11996071|FG001|COMPLETED|Overall Study||57
10830940|NCT03007485|11996070|FG000|NOT COMPLETED|Overall Study||70
10830941|NCT03007485|11996071|FG001|NOT COMPLETED|Overall Study||54
10830942|NCT02998476|11996084|FG000|STARTED|Overall Study||55
10830943|NCT02998476|11996085|FG001|STARTED|Overall Study||5
10830944|NCT02998476|11996084|FG000|COMPLETED|Overall Study||0
10830945|NCT02998476|11996085|FG001|COMPLETED|Overall Study||0
10830946|NCT02998476|11996084|FG000|NOT COMPLETED|Overall Study||55
10830947|NCT02998476|11996085|FG001|NOT COMPLETED|Overall Study||5
11101423|NCT01231230|12285516|FG000|STARTED|Overall Study||14
11101424|NCT01231230|12285516|FG000|Fluticasone|Overall Study||14
11101425|NCT01231230|12285516|FG000|Salmeterol|Overall Study||14
11101426|NCT01231230|12285516|FG000|Fluticasone/Salmeterol|Overall Study||14
11101427|NCT01231230|12285516|FG000|Placebo|Overall Study||14
11101428|NCT01231230|12285516|FG000|COMPLETED|Overall Study||14
11101429|NCT01231230|12285516|FG000|NOT COMPLETED|Overall Study||0
11101430|NCT01231321|12285526|FG000|STARTED|Overall Study||100
11101431|NCT01231321|12285526|FG000|COMPLETED|Overall Study||95
11101432|NCT01231321|12285526|FG000|NOT COMPLETED|Overall Study||5
11101433|NCT01231334|12285538|FG000|STARTED|Overall Study||145
11101434|NCT01231334|12285539|FG001|STARTED|Overall Study||141
11101435|NCT01231334|12285538|FG000|COMPLETED|Overall Study||126
11101436|NCT01231334|12285539|FG001|COMPLETED|Overall Study||120
11101437|NCT01231334|12285538|FG000|NOT COMPLETED|Overall Study||19
11101438|NCT01231334|12285539|FG001|NOT COMPLETED|Overall Study||21
11101439|NCT01231373|12285549|FG000|STARTED|Overall Study||59
11101440|NCT01231373|12285550|FG001|STARTED|Overall Study||58
11101441|NCT01231373|12285551|FG002|STARTED|Overall Study||60
11101442|NCT01231373|12285552|FG003|STARTED|Overall Study||58
11101443|NCT01231373|12285549|FG000|Patients Receiving Blinded Treatment|Overall Study||57
11101444|NCT01231373|12285550|FG001|Patients Receiving Blinded Treatment|Overall Study||57
11101445|NCT01231373|12285551|FG002|Patients Receiving Blinded Treatment|Overall Study||60
11101446|NCT01231373|12285552|FG003|Patients Receiving Blinded Treatment|Overall Study||58
11101447|NCT01231373|12285549|FG000|COMPLETED|Overall Study||56
11101448|NCT01231373|12285550|FG001|COMPLETED|Overall Study||57
11101449|NCT01231373|12285551|FG002|COMPLETED|Overall Study||60
11101450|NCT01231373|12285552|FG003|COMPLETED|Overall Study||57
11101451|NCT01231373|12285549|FG000|NOT COMPLETED|Overall Study||3
11101452|NCT01231373|12285550|FG001|NOT COMPLETED|Overall Study||1
11101453|NCT01231373|12285551|FG002|NOT COMPLETED|Overall Study||0
11101454|NCT01231373|12285552|FG003|NOT COMPLETED|Overall Study||1
11101455|NCT01231399|12285564|FG000|STARTED|Overall Study||6
11101456|NCT01231399|12285564|FG000|COMPLETED|Overall Study||6
11101457|NCT01231399|12285564|FG000|NOT COMPLETED|Overall Study||0
11101458|NCT01231412|12285572|FG000|STARTED|Overall Study||77
11101459|NCT01231412|12285573|FG001|STARTED|Overall Study||91
11101460|NCT01231412|12285574|FG002|STARTED|Overall Study||6
11101461|NCT01231412|12285572|FG000|COMPLETED|Overall Study||77
11101462|NCT01231412|12285573|FG001|COMPLETED|Overall Study||90
11101463|NCT01231412|12285574|FG002|COMPLETED|Overall Study||6
11101464|NCT01231412|12285572|FG000|NOT COMPLETED|Overall Study||0
11101465|NCT01231412|12285573|FG001|NOT COMPLETED|Overall Study||1
11101466|NCT01231412|12285574|FG002|NOT COMPLETED|Overall Study||0
11101467|NCT01231464|12285584|FG000|STARTED|Overall Study||182
11101468|NCT01231464|12285585|FG001|STARTED|Overall Study||183
11101469|NCT01231464|12285584|FG000|COMPLETED|Overall Study||177
11101470|NCT01231464|12285585|FG001|COMPLETED|Overall Study||176
11101471|NCT01231464|12285584|FG000|NOT COMPLETED|Overall Study||5
11101472|NCT01231464|12285585|FG001|NOT COMPLETED|Overall Study||7
11101473|NCT01231503|12285601|FG000|STARTED|Overall Study||60
11101474|NCT01231503|12285602|FG001|STARTED|Overall Study||59
11101475|NCT01231503|12285603|FG002|STARTED|Overall Study||60
11101476|NCT01231503|12285604|FG003|STARTED|Overall Study||60
11101477|NCT01231503|12285605|FG004|STARTED|Overall Study||60
11101478|NCT01231503|12285606|FG005|STARTED|Overall Study||60
11101479|NCT01231503|12285607|FG006|STARTED|Overall Study||60
11101480|NCT01231503|12285608|FG007|STARTED|Overall Study||60
11101481|NCT01231503|12285601|FG000|COMPLETED|Overall Study||46
11101482|NCT01231503|12285602|FG001|COMPLETED|Overall Study||46
11101483|NCT01231503|12285603|FG002|COMPLETED|Overall Study||48
11101484|NCT01231503|12285604|FG003|COMPLETED|Overall Study||52
11101485|NCT01231503|12285605|FG004|COMPLETED|Overall Study||50
11101486|NCT01231503|12285606|FG005|COMPLETED|Overall Study||44
11101487|NCT01231503|12285607|FG006|COMPLETED|Overall Study||53
11101488|NCT01231503|12285608|FG007|COMPLETED|Overall Study||52
11101489|NCT01231503|12285601|FG000|NOT COMPLETED|Overall Study||14
11101490|NCT01231503|12285602|FG001|NOT COMPLETED|Overall Study||13
11220033|NCT01958073|12411596|FG002|COMPLETED|Randomized Period||11
11220034|NCT01958073|12411597|FG003|COMPLETED|Randomized Period||0
11101491|NCT01231503|12285603|FG002|NOT COMPLETED|Overall Study||12
11101492|NCT01231503|12285604|FG003|NOT COMPLETED|Overall Study||8
11101493|NCT01231503|12285605|FG004|NOT COMPLETED|Overall Study||10
11101494|NCT01231503|12285606|FG005|NOT COMPLETED|Overall Study||16
11101495|NCT01231503|12285607|FG006|NOT COMPLETED|Overall Study||7
11101496|NCT01231503|12285608|FG007|NOT COMPLETED|Overall Study||8
11101497|NCT01231555|12285639|FG000|STARTED|Overall Study||8
11101498|NCT01231555|12285640|FG001|STARTED|Overall Study||7
11101499|NCT01231555|12285641|FG002|STARTED|Overall Study||8
11101500|NCT01231555|12285639|FG000|COMPLETED|Overall Study||0
11101501|NCT01231555|12285640|FG001|COMPLETED|Overall Study||0
11101502|NCT01231555|12285641|FG002|COMPLETED|Overall Study||0
11101503|NCT01231555|12285639|FG000|NOT COMPLETED|Overall Study||8
11101504|NCT01231555|12285640|FG001|NOT COMPLETED|Overall Study||7
11101505|NCT01231555|12285641|FG002|NOT COMPLETED|Overall Study||8
11101506|NCT01231581|12285651|FG000|STARTED|Overall Study||80
11101507|NCT01231581|12285652|FG001|STARTED|Overall Study||80
11101508|NCT01231581|12285651|FG000|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
11101509|NCT01231581|12285652|FG001|Ongoing|Overall Study||0
10830948|NCT02960997|11996094|FG000|STARTED|First Intervention, 12 Weeks||4
11101510|NCT01231581|12285651|FG000|COMPLETED|Overall Study||0
11220035|NCT01958073|12411598|FG004|COMPLETED|Randomized Period||0
11220036|NCT01958073|12411594|FG000|NOT COMPLETED|Randomized Period||2
11220037|NCT01958073|12411595|FG001|NOT COMPLETED|Randomized Period||1
11220038|NCT01958073|12411596|FG002|NOT COMPLETED|Randomized Period||6
11220039|NCT01958073|12411597|FG003|NOT COMPLETED|Randomized Period||0
11220040|NCT01958073|12411598|FG004|NOT COMPLETED|Randomized Period||0
11220041|NCT01958073|12411594|FG000|STARTED|Open Label Period||0
11220042|NCT01958073|12411595|FG001|STARTED|Open Label Period||0
11220043|NCT01958073|12411596|FG002|STARTED|Open Label Period||0
11220044|NCT01958073|12411597|FG003|STARTED|Open Label Period||5
11220045|NCT01958073|12411598|FG004|STARTED|Open Label Period||17
11220046|NCT01958073|12411594|FG000|COMPLETED|Open Label Period||0
11220047|NCT01958073|12411595|FG001|COMPLETED|Open Label Period||0
11220048|NCT01958073|12411596|FG002|COMPLETED|Open Label Period||0
11220049|NCT01958073|12411597|FG003|COMPLETED|Open Label Period||5
11220050|NCT01958073|12411598|FG004|COMPLETED|Open Label Period||17
11220051|NCT01958073|12411594|FG000|NOT COMPLETED|Open Label Period||0
11220052|NCT01958073|12411595|FG001|NOT COMPLETED|Open Label Period||0
11220053|NCT01958073|12411596|FG002|NOT COMPLETED|Open Label Period||0
11220054|NCT01958073|12411597|FG003|NOT COMPLETED|Open Label Period||0
11220055|NCT01958073|12411598|FG004|NOT COMPLETED|Open Label Period||0
11220056|NCT01958112|12411614|FG000|STARTED|Overall Study||14
11220057|NCT01958112|12411614|FG000|COMPLETED|Overall Study||14
11220058|NCT01958112|12411614|FG000|NOT COMPLETED|Overall Study||0
11220059|NCT01958125|12411620|FG000|STARTED|Overall Study||50
11220060|NCT01958125|12411621|FG001|STARTED|Overall Study||52
11220061|NCT01958125|12411620|FG000|COMPLETED|Overall Study||48
11220062|NCT01958125|12411621|FG001|COMPLETED|Overall Study||44
11220063|NCT01958125|12411620|FG000|NOT COMPLETED|Overall Study||2
11220064|NCT01958125|12411621|FG001|NOT COMPLETED|Overall Study||8
11220065|NCT01958164|12411629|FG000|STARTED|Overall Study|Randomised and treated|6
11220066|NCT01958164|12411630|FG001|STARTED|Overall Study|Randomised and treated|10
11220067|NCT01958164|12411629|FG000|COMPLETED|Overall Study||4
11220068|NCT01958164|12411630|FG001|COMPLETED|Overall Study||5
11220069|NCT01958164|12411629|FG000|NOT COMPLETED|Overall Study||2
11220070|NCT01958164|12411630|FG001|NOT COMPLETED|Overall Study||5
11220071|NCT01958281|12411639|FG000|STARTED|Overall Study||10
11220072|NCT01958281|12411640|FG001|STARTED|Overall Study||10
11220073|NCT01958281|12411641|FG002|STARTED|Overall Study||18
11220074|NCT01958281|12411639|FG000|COMPLETED|Overall Study||4
11220075|NCT01958281|12411640|FG001|COMPLETED|Overall Study||6
11220076|NCT01958281|12411641|FG002|COMPLETED|Overall Study||18
11220077|NCT01958281|12411639|FG000|NOT COMPLETED|Overall Study||6
10830949|NCT02960997|11996095|FG001|STARTED|First Intervention, 12 Weeks||4
10830950|NCT02960997|11996094|FG000|COMPLETED|First Intervention, 12 Weeks||4
10830951|NCT02960997|11996095|FG001|COMPLETED|First Intervention, 12 Weeks||4
10830952|NCT02960997|11996094|FG000|NOT COMPLETED|First Intervention, 12 Weeks||0
10830953|NCT02960997|11996095|FG001|NOT COMPLETED|First Intervention, 12 Weeks||0
10830954|NCT02960997|11996094|FG000|STARTED|Washout Period, 4 Weeks||4
10830955|NCT02960997|11996095|FG001|STARTED|Washout Period, 4 Weeks||4
10830956|NCT02960997|11996094|FG000|COMPLETED|Washout Period, 4 Weeks||4
10830957|NCT02960997|11996095|FG001|COMPLETED|Washout Period, 4 Weeks||4
10830958|NCT02960997|11996094|FG000|NOT COMPLETED|Washout Period, 4 Weeks||0
10830959|NCT02960997|11996095|FG001|NOT COMPLETED|Washout Period, 4 Weeks||0
10830960|NCT02960997|11996094|FG000|STARTED|Second Treatment, 12 Weeks||4
10830961|NCT02960997|11996095|FG001|STARTED|Second Treatment, 12 Weeks||4
10830962|NCT02960997|11996094|FG000|COMPLETED|Second Treatment, 12 Weeks||4
10830963|NCT02960997|11996095|FG001|COMPLETED|Second Treatment, 12 Weeks||4
11101511|NCT01231581|12285652|FG001|COMPLETED|Overall Study||0
11101512|NCT01231581|12285651|FG000|NOT COMPLETED|Overall Study||80
11101513|NCT01231581|12285652|FG001|NOT COMPLETED|Overall Study||80
11101514|NCT01231607|12285663|FG000|STARTED|Overall Study||185
11101515|NCT01231607|12285664|FG001|STARTED|Overall Study||188
11101516|NCT01231607|12285665|FG002|STARTED|Overall Study||184
11101517|NCT01231607|12285666|FG003|STARTED|Overall Study||179
11101518|NCT01231607|12285667|FG004|STARTED|Overall Study||181
11101519|NCT01231607|12285663|FG000|COMPLETED|Overall Study||156
11101520|NCT01231607|12285664|FG001|COMPLETED|Overall Study||154
11101521|NCT01231607|12285665|FG002|COMPLETED|Overall Study||153
11101522|NCT01231607|12285666|FG003|COMPLETED|Overall Study||141
11101523|NCT01231607|12285667|FG004|COMPLETED|Overall Study||157
11101524|NCT01231607|12285663|FG000|NOT COMPLETED|Overall Study||29
11101525|NCT01231607|12285664|FG001|NOT COMPLETED|Overall Study||34
11101526|NCT01231607|12285665|FG002|NOT COMPLETED|Overall Study||31
11220078|NCT01958281|12411640|FG001|NOT COMPLETED|Overall Study||4
11220079|NCT01958281|12411641|FG002|NOT COMPLETED|Overall Study||0
11220080|NCT01958294|12411650|FG000|STARTED|Overall Study||12
11101527|NCT01231607|12285666|FG003|NOT COMPLETED|Overall Study||38
11101528|NCT01231607|12285667|FG004|NOT COMPLETED|Overall Study||24
11101529|NCT01231620|12285685|FG000|STARTED|Overall Study||201
11101530|NCT01231620|12285686|FG001|STARTED|Overall Study||209
11101531|NCT01231620|12285687|FG002|STARTED|Overall Study||205
11101532|NCT01231620|12285685|FG000|COMPLETED|Overall Study||175
11101533|NCT01231620|12285686|FG001|COMPLETED|Overall Study||178
11220081|NCT01958294|12411650|FG000|COMPLETED|Overall Study||10
11220082|NCT01958294|12411650|FG000|NOT COMPLETED|Overall Study||2
10830964|NCT02960997|11996094|FG000|NOT COMPLETED|Second Treatment, 12 Weeks||0
10830965|NCT02960997|11996095|FG001|NOT COMPLETED|Second Treatment, 12 Weeks||0
10830966|NCT02960997|11996094|FG000|STARTED|Follow-up Period, 4 Weeks||4
10830967|NCT02960997|11996095|FG001|STARTED|Follow-up Period, 4 Weeks||4
10830968|NCT02960997|11996094|FG000|COMPLETED|Follow-up Period, 4 Weeks||4
10830969|NCT02960997|11996095|FG001|COMPLETED|Follow-up Period, 4 Weeks||4
10830970|NCT02960997|11996094|FG000|NOT COMPLETED|Follow-up Period, 4 Weeks||0
10830971|NCT02960997|11996095|FG001|NOT COMPLETED|Follow-up Period, 4 Weeks||0
11101534|NCT01231620|12285687|FG002|COMPLETED|Overall Study||166
11101535|NCT01231620|12285685|FG000|NOT COMPLETED|Overall Study||26
11101536|NCT01231620|12285686|FG001|NOT COMPLETED|Overall Study||31
11101537|NCT01231620|12285687|FG002|NOT COMPLETED|Overall Study||39
11220083|NCT01958320|12411656|FG000|STARTED|Overall Study||104
11220084|NCT01958320|12411657|FG001|STARTED|Overall Study||98
11220085|NCT01958320|12411656|FG000|COMPLETED|Overall Study||104
11220086|NCT01958320|12411657|FG001|COMPLETED|Overall Study||98
10830980|NCT02924064|11996107|FG000|STARTED|Overall Study||123
10830981|NCT02924064|11996108|FG001|STARTED|Overall Study||124
10830982|NCT02924064|11996107|FG000|FAS|Overall Study||122
10830983|NCT02924064|11996108|FG001|FAS|Overall Study||124
10830984|NCT02924064|11996107|FG000|COMPLETED|Overall Study||99
10830985|NCT02924064|11996108|FG001|COMPLETED|Overall Study||81
10830986|NCT02924064|11996107|FG000|NOT COMPLETED|Overall Study||24
10830987|NCT02924064|11996108|FG001|NOT COMPLETED|Overall Study||43
10830988|NCT02916706|11996116|FG000|STARTED|Overall Study||127
10830989|NCT02916706|11996117|FG001|STARTED|Overall Study||127
10830990|NCT02916706|11996116|FG000|FAS|Overall Study||125
10830991|NCT02916706|11996117|FG001|FAS|Overall Study||126
10830992|NCT02916706|11996116|FG000|COMPLETED|Overall Study||112
10830993|NCT02916706|11996117|FG001|COMPLETED|Overall Study||96
10830994|NCT02916706|11996116|FG000|NOT COMPLETED|Overall Study||15
10830995|NCT02916706|11996117|FG001|NOT COMPLETED|Overall Study||31
10830996|NCT02889900|11996123|FG000|STARTED|Overall Study||62
10830997|NCT02889900|11996123|FG000|Received Treatment|Overall Study||60
10830998|NCT02889900|11996123|FG000|COMPLETED|Overall Study|Patients ongoing in study at primary analysis data cut off (DCO)|5
10830999|NCT02889900|11996123|FG000|NOT COMPLETED|Overall Study||57
10831000|NCT02866695|11996127|FG000|STARTED|Overall Study||20
10831001|NCT02866695|11996127|FG000|COMPLETED|Overall Study||18
10831002|NCT02866695|11996127|FG000|NOT COMPLETED|Overall Study||2
10831003|NCT02834793|11996133|FG000|STARTED|Core Study (Up to 18 Weeks)||36
10831004|NCT02834793|11996134|FG001|STARTED|Core Study (Up to 18 Weeks)||34
10831005|NCT02834793|11996135|FG002|STARTED|Core Study (Up to 18 Weeks)||0
10831006|NCT02834793|11996136|FG003|STARTED|Core Study (Up to 18 Weeks)||0
10831007|NCT02834793|11996133|FG000|COMPLETED|Core Study (Up to 18 Weeks)||32
10831008|NCT02834793|11996134|FG001|COMPLETED|Core Study (Up to 18 Weeks)||29
10831009|NCT02834793|11996135|FG002|COMPLETED|Core Study (Up to 18 Weeks)||0
10831010|NCT02834793|11996136|FG003|COMPLETED|Core Study (Up to 18 Weeks)||0
10831011|NCT02834793|11996133|FG000|NOT COMPLETED|Core Study (Up to 18 Weeks)||4
10831012|NCT02834793|11996134|FG001|NOT COMPLETED|Core Study (Up to 18 Weeks)||5
10831013|NCT02834793|11996135|FG002|NOT COMPLETED|Core Study (Up to 18 Weeks)||0
10831014|NCT02834793|11996136|FG003|NOT COMPLETED|Core Study (Up to 18 Weeks)||0
10831015|NCT02834793|11996133|FG000|STARTED|Extension Phase A (up to 52 Weeks)||0
10831016|NCT02834793|11996134|FG001|STARTED|Extension Phase A (up to 52 Weeks)||0
10831017|NCT02834793|11996135|FG002|STARTED|Extension Phase A (up to 52 Weeks)|Only eligible participants who completed Core Study entered into Extension Phase A.|58
10831018|NCT02834793|11996136|FG003|STARTED|Extension Phase A (up to 52 Weeks)||0
10831019|NCT02834793|11996133|FG000|COMPLETED|Extension Phase A (up to 52 Weeks)||0
10831020|NCT02834793|11996134|FG001|COMPLETED|Extension Phase A (up to 52 Weeks)||0
10831021|NCT02834793|11996135|FG002|COMPLETED|Extension Phase A (up to 52 Weeks)||32
10831022|NCT02834793|11996136|FG003|COMPLETED|Extension Phase A (up to 52 Weeks)||0
10831023|NCT02834793|11996133|FG000|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
10831024|NCT02834793|11996134|FG001|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
10831025|NCT02834793|11996135|FG002|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||26
10831026|NCT02834793|11996136|FG003|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
10831027|NCT02834793|11996133|FG000|STARTED|Extension Phase B (up to 188 Weeks)||0
10831028|NCT02834793|11996134|FG001|STARTED|Extension Phase B (up to 188 Weeks)||0
10831029|NCT02834793|11996135|FG002|STARTED|Extension Phase B (up to 188 Weeks)||0
10831030|NCT02834793|11996136|FG003|STARTED|Extension Phase B (up to 188 Weeks)|Only eligible participants who completed Extension Phase A entered into Extension Phase B.|13
11220087|NCT01958320|12411656|FG000|NOT COMPLETED|Overall Study||0
11220088|NCT01958320|12411657|FG001|NOT COMPLETED|Overall Study||0
11220089|NCT01958346|12411667|FG000|STARTED|Overall Study||39
11220090|NCT01958346|12411668|FG001|STARTED|Overall Study||39
11220091|NCT01958346|12411667|FG000|COMPLETED|Overall Study||39
11220092|NCT01958346|12411668|FG001|COMPLETED|Overall Study||39
11220093|NCT01958346|12411667|FG000|NOT COMPLETED|Overall Study||0
11220094|NCT01958346|12411668|FG001|NOT COMPLETED|Overall Study||0
11220095|NCT01958437|12411676|FG000|STARTED|Overall Study||11
11220096|NCT01958437|12411677|FG001|STARTED|Overall Study||11
11220097|NCT01958437|12411678|FG002|STARTED|Overall Study||11
10831031|NCT02834793|11996133|FG000|COMPLETED|Extension Phase B (up to 188 Weeks)||0
10831032|NCT02834793|11996134|FG001|COMPLETED|Extension Phase B (up to 188 Weeks)||0
11101538|NCT01231633|12285697|FG000|STARTED|Overall Study||14
11101539|NCT01231633|12285698|FG001|STARTED|Overall Study||13
11101540|NCT01231633|12285697|FG000|COMPLETED|Overall Study||14
10831033|NCT02834793|11996135|FG002|COMPLETED|Extension Phase B (up to 188 Weeks)||0
10831034|NCT02834793|11996136|FG003|COMPLETED|Extension Phase B (up to 188 Weeks)||1
10831035|NCT02834793|11996133|FG000|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
10831036|NCT02834793|11996134|FG001|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
10831037|NCT02834793|11996135|FG002|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
10831038|NCT02834793|11996136|FG003|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||12
10831039|NCT02810457|11996146|FG000|STARTED|Overall Study|362 patients received study treatment|364
10831040|NCT02810457|11996147|FG001|STARTED|Overall Study|366 patients received study treatment|367
10831041|NCT02810457|11996146|FG000|COMPLETED|Overall Study||37
10831042|NCT02810457|11996147|FG001|COMPLETED|Overall Study||38
10831043|NCT02810457|11996146|FG000|NOT COMPLETED|Overall Study||327
10831044|NCT02810457|11996147|FG001|NOT COMPLETED|Overall Study||329
10831045|NCT02797964|11996159|FG000|STARTED|Overall Study||32
10831046|NCT02797964|11996160|FG001|STARTED|Overall Study||37
10831047|NCT02797964|11996161|FG002|STARTED|Overall Study||10
10831048|NCT02797964|11996162|FG003|STARTED|Overall Study||16
10831049|NCT02797964|11996163|FG004|STARTED|Overall Study||4
10831050|NCT02797964|11996164|FG005|STARTED|Overall Study||8
10831051|NCT02797964|11996159|FG000|COMPLETED|Overall Study||32
10831052|NCT02797964|11996160|FG001|COMPLETED|Overall Study||37
10831053|NCT02797964|11996161|FG002|COMPLETED|Overall Study||10
10831054|NCT02797964|11996162|FG003|COMPLETED|Overall Study||16
10831055|NCT02797964|11996163|FG004|COMPLETED|Overall Study||4
10831056|NCT02797964|11996164|FG005|COMPLETED|Overall Study||8
10831057|NCT02797964|11996159|FG000|NOT COMPLETED|Overall Study||0
10831058|NCT02797964|11996160|FG001|NOT COMPLETED|Overall Study||0
10831059|NCT02797964|11996161|FG002|NOT COMPLETED|Overall Study||0
10831060|NCT02797964|11996162|FG003|NOT COMPLETED|Overall Study||0
10831061|NCT02797964|11996163|FG004|NOT COMPLETED|Overall Study||0
10831062|NCT02797964|11996164|FG005|NOT COMPLETED|Overall Study||0
10831063|NCT02746809|11996177|FG000|STARTED|Baseline- 30 Days||60
10831064|NCT02746809|11996177|FG000|COMPLETED|Baseline- 30 Days||59
10831065|NCT02746809|11996177|FG000|NOT COMPLETED|Baseline- 30 Days||1
10831066|NCT02746809|11996177|FG000|STARTED|Baseline-6 Months||59
10831067|NCT02746809|11996177|FG000|COMPLETED|Baseline-6 Months||54
10831068|NCT02746809|11996177|FG000|NOT COMPLETED|Baseline-6 Months||5
10831069|NCT02745535|11996183|FG000|STARTED|Overall Study||77
10831070|NCT02745535|11996183|FG000|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70
10831071|NCT02745535|11996183|FG000|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71
10831072|NCT02745535|11996183|FG000|NOT COMPLETED|Overall Study||6
10831073|NCT02738853|11996187|FG000|STARTED|Baseline -30 Days||60
10831074|NCT02738853|11996187|FG000|COMPLETED|Baseline -30 Days||59
10831075|NCT02738853|11996187|FG000|NOT COMPLETED|Baseline -30 Days||1
10831076|NCT02738853|11996187|FG000|STARTED|30 Days- 6 Months||59
10831077|NCT02738853|11996187|FG000|COMPLETED|30 Days- 6 Months||57
10831078|NCT02738853|11996187|FG000|NOT COMPLETED|30 Days- 6 Months||2
10831079|NCT02729701|11996191|FG000|STARTED|Overall Study||28
10831080|NCT02729701|11996191|FG000|COMPLETED|Overall Study||28
10831081|NCT02729701|11996191|FG000|NOT COMPLETED|Overall Study||0
10831082|NCT02684253|11996197|FG000|STARTED|Overall Study||32
10831083|NCT02684253|11996198|FG001|STARTED|Overall Study||33
10831084|NCT02684253|11996197|FG000|COMPLETED|Overall Study||32
10831085|NCT02684253|11996198|FG001|COMPLETED|Overall Study||33
10831086|NCT02684253|11996197|FG000|NOT COMPLETED|Overall Study||0
10831087|NCT02684253|11996198|FG001|NOT COMPLETED|Overall Study||0
10831088|NCT02681406|11996208|FG000|STARTED|Overall Study||65
10831089|NCT02681406|11996209|FG001|STARTED|Overall Study||59
10831090|NCT02681406|11996210|FG002|STARTED|Overall Study||68
10831091|NCT02681406|11996211|FG003|STARTED|Overall Study||70
10831092|NCT02681406|11996208|FG000|COMPLETED|Overall Study||49
10831093|NCT02681406|11996209|FG001|COMPLETED|Overall Study||35
10831094|NCT02681406|11996210|FG002|COMPLETED|Overall Study||42
10831095|NCT02681406|11996211|FG003|COMPLETED|Overall Study||58
10831096|NCT02681406|11996208|FG000|NOT COMPLETED|Overall Study||16
10831097|NCT02681406|11996209|FG001|NOT COMPLETED|Overall Study||24
10831098|NCT02681406|11996210|FG002|NOT COMPLETED|Overall Study||26
10831099|NCT02681406|11996211|FG003|NOT COMPLETED|Overall Study||12
10831100|NCT02625090|11996221|FG000|STARTED|Overall Study||42
10831101|NCT02625090|11996221|FG000|COMPLETED|Overall Study||0
10831102|NCT02625090|11996221|FG000|NOT COMPLETED|Overall Study||42
10831103|NCT02539225|11996228|FG000|STARTED|Part A||97
10831104|NCT02539225|11996229|FG001|STARTED|Part A||94
10831105|NCT02539225|11996228|FG000|Received Any Quantity of Study Drug|Part A||96
10831106|NCT02539225|11996229|FG001|Received Any Quantity of Study Drug|Part A||93
10831107|NCT02539225|11996228|FG000|COMPLETED|Part A||77
10831108|NCT02539225|11996229|FG001|COMPLETED|Part A||78
10831109|NCT02539225|11996228|FG000|NOT COMPLETED|Part A||20
10831110|NCT02539225|11996229|FG001|NOT COMPLETED|Part A||16
10831111|NCT02539225|11996228|FG000|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|63
10831200|NCT02284568|11996385|FG001|STARTED|Overall Study|Intent to treat (ITT) population|139
10831112|NCT02539225|11996229|FG001|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|66
10831113|NCT02539225|11996228|FG000|COMPLETED|Pre Treatment for Part B||58
10831114|NCT02539225|11996229|FG001|COMPLETED|Pre Treatment for Part B||64
10831115|NCT02539225|11996228|FG000|NOT COMPLETED|Pre Treatment for Part B||5
10831116|NCT02539225|11996229|FG001|NOT COMPLETED|Pre Treatment for Part B||2
10831117|NCT02539225|11996228|FG000|STARTED|Part B||58
10831118|NCT02539225|11996229|FG001|STARTED|Part B||64
10831119|NCT02539225|11996228|FG000|COMPLETED|Part B||54
10831120|NCT02539225|11996229|FG001|COMPLETED|Part B||48
10831121|NCT02539225|11996228|FG000|NOT COMPLETED|Part B||4
10831122|NCT02539225|11996229|FG001|NOT COMPLETED|Part B||16
10831123|NCT02528500|11996240|FG000|STARTED|Overall Study||10
10831124|NCT02528500|11996240|FG000|COMPLETED|Overall Study||10
10831125|NCT02528500|11996240|FG000|NOT COMPLETED|Overall Study||0
10831126|NCT02527681|11996244|FG000|STARTED|Overall Study||15
10831127|NCT02527681|11996244|FG000|COMPLETED|Overall Study||15
10831128|NCT02527681|11996244|FG000|NOT COMPLETED|Overall Study||0
10831129|NCT02526017|11996257|FG000|STARTED|Overall Study||3
10831130|NCT02526017|11996258|FG001|STARTED|Overall Study||10
10831131|NCT02526017|11996259|FG002|STARTED|Overall Study||11
10831132|NCT02526017|11996260|FG003|STARTED|Overall Study||4
10831133|NCT02526017|11996261|FG004|STARTED|Overall Study||4
10831134|NCT02526017|11996262|FG005|STARTED|Overall Study||3
10831135|NCT02526017|11996263|FG006|STARTED|Overall Study||6
10831136|NCT02526017|11996264|FG007|STARTED|Overall Study||10
10831137|NCT02526017|11996265|FG008|STARTED|Overall Study||262
10831138|NCT02526017|11996257|FG000|Received Study Treatment|Overall Study||3
10831139|NCT02526017|11996258|FG001|Received Study Treatment|Overall Study||10
10831140|NCT02526017|11996259|FG002|Received Study Treatment|Overall Study||11
10831141|NCT02526017|11996260|FG003|Received Study Treatment|Overall Study||4
10831142|NCT02526017|11996261|FG004|Received Study Treatment|Overall Study||3
10831143|NCT02526017|11996262|FG005|Received Study Treatment|Overall Study||3
10831144|NCT02526017|11996263|FG006|Received Study Treatment|Overall Study||6
10831145|NCT02526017|11996264|FG007|Received Study Treatment|Overall Study||10
10831146|NCT02526017|11996265|FG008|Received Study Treatment|Overall Study||262
10831147|NCT02526017|11996257|FG000|COMPLETED|Overall Study||3
10831148|NCT02526017|11996258|FG001|COMPLETED|Overall Study||10
10831149|NCT02526017|11996259|FG002|COMPLETED|Overall Study||11
10831150|NCT02526017|11996260|FG003|COMPLETED|Overall Study||4
10831151|NCT02526017|11996261|FG004|COMPLETED|Overall Study||3
10831152|NCT02526017|11996262|FG005|COMPLETED|Overall Study||3
10831153|NCT02526017|11996263|FG006|COMPLETED|Overall Study||6
10831154|NCT02526017|11996264|FG007|COMPLETED|Overall Study||10
10831155|NCT02526017|11996265|FG008|COMPLETED|Overall Study||262
10831156|NCT02526017|11996257|FG000|NOT COMPLETED|Overall Study||0
10831157|NCT02526017|11996258|FG001|NOT COMPLETED|Overall Study||0
10831158|NCT02526017|11996259|FG002|NOT COMPLETED|Overall Study||0
10831159|NCT02526017|11996260|FG003|NOT COMPLETED|Overall Study||0
10831160|NCT02526017|11996261|FG004|NOT COMPLETED|Overall Study||1
10831161|NCT02526017|11996262|FG005|NOT COMPLETED|Overall Study||0
10831162|NCT02526017|11996263|FG006|NOT COMPLETED|Overall Study||0
10831163|NCT02526017|11996264|FG007|NOT COMPLETED|Overall Study||0
10831164|NCT02526017|11996265|FG008|NOT COMPLETED|Overall Study||0
10831165|NCT02482233|11996327|FG000|STARTED|Overall Study||10
10831166|NCT02482233|11996328|FG001|STARTED|Overall Study||20
10831167|NCT02482233|11996327|FG000|COMPLETED|Overall Study||9
10831168|NCT02482233|11996328|FG001|COMPLETED|Overall Study||19
10831169|NCT02482233|11996327|FG000|NOT COMPLETED|Overall Study||1
10831170|NCT02482233|11996328|FG001|NOT COMPLETED|Overall Study||1
10831171|NCT02417415|11996336|FG000|STARTED|Overall Study||13
10831172|NCT02417415|11996337|FG001|STARTED|Overall Study||9
10831173|NCT02417415|11996336|FG000|COMPLETED|Overall Study||13
10831174|NCT02417415|11996337|FG001|COMPLETED|Overall Study||9
10831175|NCT02417415|11996336|FG000|NOT COMPLETED|Overall Study||0
10831176|NCT02417415|11996337|FG001|NOT COMPLETED|Overall Study||0
10831177|NCT02400736|11996345|FG000|STARTED|Overall Study||58
10831178|NCT02400736|11996346|FG001|STARTED|Overall Study||61
10831179|NCT02400736|11996345|FG000|COMPLETED|Overall Study||47
10831180|NCT02400736|11996346|FG001|COMPLETED|Overall Study||53
10831181|NCT02400736|11996345|FG000|NOT COMPLETED|Overall Study||11
10831182|NCT02400736|11996346|FG001|NOT COMPLETED|Overall Study||8
10831183|NCT02369653|11996358|FG000|STARTED|Overall Study||256
10831184|NCT02369653|11996359|FG001|STARTED|Overall Study||256
10831185|NCT02369653|11996358|FG000|Adverse Event Analysis Population|Overall Study|Out of the 256 participants randomized to Apixaban only 250 participants received an apixaban dose.|250
10831186|NCT02369653|11996359|FG001|Adverse Event Analysis Population|Overall Study|The 6 subjects who were randomized to apixaban but received no dose were analyzed in Standard of Care.|262
10831187|NCT02369653|11996358|FG000|COMPLETED|Overall Study||242
10831188|NCT02369653|11996359|FG001|COMPLETED|Overall Study||249
10831189|NCT02369653|11996358|FG000|NOT COMPLETED|Overall Study||14
10831190|NCT02369653|11996359|FG001|NOT COMPLETED|Overall Study||7
11101541|NCT01231633|12285698|FG001|COMPLETED|Overall Study||13
11101542|NCT01231633|12285697|FG000|NOT COMPLETED|Overall Study||0
11101543|NCT01231633|12285698|FG001|NOT COMPLETED|Overall Study||0
11101544|NCT01231646|12285708|FG000|STARTED|Overall Study||28
10831195|NCT02326974|11996373|FG000|STARTED|Overall Study||164
10831196|NCT02326974|11996373|FG000|Treated|Overall Study||163
10831197|NCT02326974|11996373|FG000|COMPLETED|Overall Study||157
10831198|NCT02326974|11996373|FG000|NOT COMPLETED|Overall Study||7
10831199|NCT02284568|11996384|FG000|STARTED|Overall Study|Intent to treat (ITT) population|140
10831201|NCT02284568|11996386|FG002|STARTED|Overall Study|Intent to treat (ITT) population|95
10831202|NCT02284568|11996384|FG000|Safety Population|Overall Study||140
10831203|NCT02284568|11996385|FG001|Safety Population|Overall Study||138
10831204|NCT02284568|11996386|FG002|Safety Population|Overall Study||95
10831205|NCT02284568|11996384|FG000|Completed Week 48 MRI - on Treatment|Overall Study||113
10831206|NCT02284568|11996385|FG001|Completed Week 48 MRI - on Treatment|Overall Study||107
10831207|NCT02284568|11996386|FG002|Completed Week 48 MRI - on Treatment|Overall Study||0
10831208|NCT02284568|11996384|FG000|COMPLETED|Overall Study||109
10831209|NCT02284568|11996385|FG001|COMPLETED|Overall Study||93
10831210|NCT02284568|11996386|FG002|COMPLETED|Overall Study||0
10831211|NCT02284568|11996384|FG000|NOT COMPLETED|Overall Study||31
10831212|NCT02284568|11996385|FG001|NOT COMPLETED|Overall Study||46
10831213|NCT02284568|11996386|FG002|NOT COMPLETED|Overall Study||95
10831214|NCT02228525|11996394|FG000|STARTED|Overall Study||25
10831215|NCT02228525|11996394|FG000|COMPLETED|Overall Study||25
10831216|NCT02228525|11996394|FG000|NOT COMPLETED|Overall Study||0
10831217|NCT02227238|11996400|FG000|STARTED|Overall Study||312
10831218|NCT02227238|11996401|FG001|STARTED|Overall Study||312
10831219|NCT02227238|11996400|FG000|COMPLETED|Overall Study||275
10831220|NCT02227238|11996401|FG001|COMPLETED|Overall Study||245
10831221|NCT02227238|11996400|FG000|NOT COMPLETED|Overall Study||37
10831222|NCT02227238|11996401|FG001|NOT COMPLETED|Overall Study||67
10831223|NCT02195986|11996410|FG000|STARTED|Overall Study||146
10831224|NCT02195986|11996411|FG001|STARTED|Overall Study||147
10831225|NCT02195986|11996412|FG002|STARTED|Overall Study||73
10831226|NCT02195986|11996410|FG000|COMPLETED|Overall Study||143
10831227|NCT02195986|11996411|FG001|COMPLETED|Overall Study||142
10831228|NCT02195986|11996412|FG002|COMPLETED|Overall Study||71
10831229|NCT02195986|11996410|FG000|NOT COMPLETED|Overall Study||3
10831230|NCT02195986|11996411|FG001|NOT COMPLETED|Overall Study||5
10831231|NCT02195986|11996412|FG002|NOT COMPLETED|Overall Study||2
10831232|NCT02128958|11996422|FG000|STARTED|Overall Study||50
10831233|NCT02128958|11996423|FG001|STARTED|Overall Study||28
10831234|NCT02128958|11996422|FG000|COMPLETED|Overall Study||29
10831235|NCT02128958|11996423|FG001|COMPLETED|Overall Study||18
10831236|NCT02128958|11996422|FG000|NOT COMPLETED|Overall Study||21
10831237|NCT02128958|11996423|FG001|NOT COMPLETED|Overall Study||10
10831238|NCT02086448|11996433|FG000|STARTED|Overall Study||25
10831239|NCT02086448|11996434|FG001|STARTED|Overall Study||26
10831240|NCT02086448|11996435|FG002|STARTED|Overall Study||20
10831241|NCT02086448|11996436|FG003|STARTED|Overall Study||18
10831242|NCT02086448|11996433|FG000|COMPLETED|Overall Study||24
10831243|NCT02086448|11996434|FG001|COMPLETED|Overall Study||26
10831244|NCT02086448|11996435|FG002|COMPLETED|Overall Study||20
10831245|NCT02086448|11996436|FG003|COMPLETED|Overall Study||16
10831246|NCT02086448|11996433|FG000|NOT COMPLETED|Overall Study||1
10831247|NCT02086448|11996434|FG001|NOT COMPLETED|Overall Study||0
10831248|NCT02086448|11996435|FG002|NOT COMPLETED|Overall Study||0
10831249|NCT02086448|11996436|FG003|NOT COMPLETED|Overall Study||2
10831250|NCT01982630|11996454|FG000|STARTED|Overall Study||10
10831251|NCT01982630|11996455|FG001|STARTED|Overall Study||8
10831252|NCT01982630|11996456|FG002|STARTED|Overall Study||13
10831253|NCT01982630|11996457|FG003|STARTED|Overall Study||9
10831254|NCT01982630|11996458|FG004|STARTED|Overall Study||19
10831255|NCT01982630|11996459|FG005|STARTED|Overall Study||14
10831256|NCT01982630|11996460|FG006|STARTED|Overall Study||6
10831257|NCT01982630|11996461|FG007|STARTED|Overall Study||8
10831258|NCT01982630|11996454|FG000|Treated|Overall Study||9
10831259|NCT01982630|11996455|FG001|Treated|Overall Study||8
10831260|NCT01982630|11996456|FG002|Treated|Overall Study||11
10831261|NCT01982630|11996457|FG003|Treated|Overall Study||9
10831262|NCT01982630|11996458|FG004|Treated|Overall Study||18
10831263|NCT01982630|11996459|FG005|Treated|Overall Study||14
10831264|NCT01982630|11996460|FG006|Treated|Overall Study||6
10831265|NCT01982630|11996461|FG007|Treated|Overall Study||8
10831266|NCT01982630|11996454|FG000|COMPLETED|Overall Study||7
10831267|NCT01982630|11996455|FG001|COMPLETED|Overall Study||8
10831268|NCT01982630|11996456|FG002|COMPLETED|Overall Study||8
10831269|NCT01982630|11996457|FG003|COMPLETED|Overall Study||8
10831270|NCT01982630|11996458|FG004|COMPLETED|Overall Study||16
10831271|NCT01982630|11996459|FG005|COMPLETED|Overall Study||11
10831272|NCT01982630|11996460|FG006|COMPLETED|Overall Study||5
10831273|NCT01982630|11996461|FG007|COMPLETED|Overall Study||8
10831274|NCT01982630|11996454|FG000|NOT COMPLETED|Overall Study||3
10831275|NCT01982630|11996455|FG001|NOT COMPLETED|Overall Study||0
10831276|NCT01982630|11996456|FG002|NOT COMPLETED|Overall Study||5
10831277|NCT01982630|11996457|FG003|NOT COMPLETED|Overall Study||1
10831278|NCT01982630|11996458|FG004|NOT COMPLETED|Overall Study||3
10831279|NCT01982630|11996459|FG005|NOT COMPLETED|Overall Study||3
10831280|NCT01982630|11996460|FG006|NOT COMPLETED|Overall Study||1
10831281|NCT01982630|11996461|FG007|NOT COMPLETED|Overall Study||0
10831282|NCT01982448|11996516|FG000|STARTED|Preoperative Chemotherapy||75
10831283|NCT01982448|11996517|FG001|STARTED|Preoperative Chemotherapy||72
10831284|NCT01982448|11996516|FG000|Eligible & Treated|Preoperative Chemotherapy||72
10831285|NCT01982448|11996517|FG001|Eligible & Treated|Preoperative Chemotherapy||70
10831286|NCT01982448|11996516|FG000|Evaluable for Safety|Preoperative Chemotherapy||72
11220098|NCT01958437|12411679|FG003|STARTED|Overall Study||11
10831287|NCT01982448|11996517|FG001|Evaluable for Safety|Preoperative Chemotherapy||68
10831288|NCT01982448|11996516|FG000|COMPLETED|Preoperative Chemotherapy||72
10831289|NCT01982448|11996517|FG001|COMPLETED|Preoperative Chemotherapy||67
10831290|NCT01982448|11996516|FG000|NOT COMPLETED|Preoperative Chemotherapy||3
10831291|NCT01982448|11996517|FG001|NOT COMPLETED|Preoperative Chemotherapy||5
10831292|NCT01982448|11996516|FG000|STARTED|Definitive Breast Surgery||72
10831293|NCT01982448|11996517|FG001|STARTED|Definitive Breast Surgery||67
10831294|NCT01982448|11996516|FG000|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||56
10831295|NCT01982448|11996517|FG001|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||48
10831296|NCT01982448|11996516|FG000|COMPLETED|Definitive Breast Surgery||72
10831297|NCT01982448|11996517|FG001|COMPLETED|Definitive Breast Surgery||67
10831298|NCT01982448|11996516|FG000|NOT COMPLETED|Definitive Breast Surgery||0
10831299|NCT01982448|11996517|FG001|NOT COMPLETED|Definitive Breast Surgery||0
10831300|NCT01879228|11996529|FG000|STARTED|Overall Study||13
10831301|NCT01879228|11996530|FG001|STARTED|Overall Study||13
10831302|NCT01879228|11996529|FG000|COMPLETED|Overall Study||12
10831303|NCT01879228|11996530|FG001|COMPLETED|Overall Study||12
10831304|NCT01879228|11996529|FG000|NOT COMPLETED|Overall Study||1
10831305|NCT01879228|11996530|FG001|NOT COMPLETED|Overall Study||1
11101545|NCT01231646|12285709|FG001|STARTED|Overall Study||10
11101546|NCT01231646|12285708|FG000|COMPLETED|Overall Study||28
11101547|NCT01231646|12285709|FG001|COMPLETED|Overall Study||10
11101548|NCT01231646|12285708|FG000|NOT COMPLETED|Overall Study||0
11101549|NCT01231646|12285709|FG001|NOT COMPLETED|Overall Study||0
11101550|NCT01231659|12285715|FG000|STARTED|Overall Study||72
11101551|NCT01231659|12285715|FG000|Per Protocol (PP) Set|Overall Study||72
11101552|NCT01231659|12285715|FG000|Safety Set|Overall Study||72
11101553|NCT01231659|12285715|FG000|COMPLETED|Overall Study||0
11101554|NCT01231659|12285715|FG000|NOT COMPLETED|Overall Study||72
11101555|NCT01231841|12285719|FG000|STARTED|Overall Study||20
11101556|NCT01231841|12285719|FG000|COMPLETED|Overall Study||20
10831318|NCT01752920|11996549|FG000|STARTED|Overall Study||29
10831319|NCT01752920|11996550|FG001|STARTED|Overall Study||13
10831320|NCT01752920|11996551|FG002|STARTED|Overall Study||19
10831321|NCT01752920|11996552|FG003|STARTED|Overall Study||58
10831322|NCT01752920|11996549|FG000|COMPLETED|Overall Study||0
10831323|NCT01752920|11996550|FG001|COMPLETED|Overall Study||0
10831324|NCT01752920|11996551|FG002|COMPLETED|Overall Study||0
10831325|NCT01752920|11996552|FG003|COMPLETED|Overall Study||0
10831326|NCT01752920|11996549|FG000|NOT COMPLETED|Overall Study||29
10831327|NCT01752920|11996550|FG001|NOT COMPLETED|Overall Study||13
10831328|NCT01752920|11996551|FG002|NOT COMPLETED|Overall Study||19
10831329|NCT01752920|11996552|FG003|NOT COMPLETED|Overall Study||58
10831336|NCT01740297|11996584|FG000|STARTED|Overall Study||19
10831337|NCT01740297|11996585|FG001|STARTED|Overall Study||100
10831338|NCT01740297|11996586|FG002|STARTED|Overall Study||98
10831339|NCT01740297|11996584|FG000|Received Talimogene Laherparepvec|Overall Study||19
10831340|NCT01740297|11996585|FG001|Received Talimogene Laherparepvec|Overall Study||0
10831341|NCT01740297|11996586|FG002|Received Talimogene Laherparepvec|Overall Study||95
10831342|NCT01740297|11996584|FG000|Received Ipilimumab|Overall Study||18
10831343|NCT01740297|11996585|FG001|Received Ipilimumab|Overall Study||95
10831344|NCT01740297|11996586|FG002|Received Ipilimumab|Overall Study||92
10831345|NCT01740297|11996584|FG000|COMPLETED|Overall Study||6
10831346|NCT01740297|11996585|FG001|COMPLETED|Overall Study||36
10831347|NCT01740297|11996586|FG002|COMPLETED|Overall Study||37
10831348|NCT01740297|11996584|FG000|NOT COMPLETED|Overall Study||13
10831349|NCT01740297|11996585|FG001|NOT COMPLETED|Overall Study||64
10831350|NCT01740297|11996586|FG002|NOT COMPLETED|Overall Study||61
10831351|NCT01729754|11996600|FG000|STARTED|Part 1||20
10831352|NCT01729754|11996601|FG001|STARTED|Part 1||184
10831353|NCT01729754|11996602|FG002|STARTED|Part 1||110
10831354|NCT01729754|11996603|FG003|STARTED|Part 1||18
10831355|NCT01729754|11996604|FG004|STARTED|Part 1||21
10831356|NCT01729754|11996605|FG005|STARTED|Part 1||268
10831357|NCT01729754|11996606|FG006|STARTED|Part 1||14
10831358|NCT01729754|11996607|FG007|STARTED|Part 1||72
10831359|NCT01729754|11996608|FG008|STARTED|Part 1||70
10831360|NCT01729754|11996609|FG009|STARTED|Part 1||313
10831361|NCT01729754|11996600|FG000|COMPLETED|Part 1||6
10831362|NCT01729754|11996601|FG001|COMPLETED|Part 1||184
10831363|NCT01729754|11996602|FG002|COMPLETED|Part 1||110
10831364|NCT01729754|11996603|FG003|COMPLETED|Part 1||6
10831365|NCT01729754|11996604|FG004|COMPLETED|Part 1||21
10831366|NCT01729754|11996605|FG005|COMPLETED|Part 1||268
10831367|NCT01729754|11996606|FG006|COMPLETED|Part 1||0
10831368|NCT01729754|11996607|FG007|COMPLETED|Part 1||72
10831369|NCT01729754|11996608|FG008|COMPLETED|Part 1||70
10831370|NCT01729754|11996609|FG009|COMPLETED|Part 1||289
10831371|NCT01729754|11996600|FG000|NOT COMPLETED|Part 1||14
10831372|NCT01729754|11996601|FG001|NOT COMPLETED|Part 1||0
10831373|NCT01729754|11996602|FG002|NOT COMPLETED|Part 1||0
10831374|NCT01729754|11996603|FG003|NOT COMPLETED|Part 1||12
10831375|NCT01729754|11996604|FG004|NOT COMPLETED|Part 1||0
10831376|NCT01729754|11996605|FG005|NOT COMPLETED|Part 1||0
10831377|NCT01729754|11996606|FG006|NOT COMPLETED|Part 1||14
10831378|NCT01729754|11996607|FG007|NOT COMPLETED|Part 1||0
10831379|NCT01729754|11996608|FG008|NOT COMPLETED|Part 1||0
10831380|NCT01729754|11996609|FG009|NOT COMPLETED|Part 1||24
10831381|NCT01729754|11996600|FG000|STARTED|Part 2||6
10831382|NCT01729754|11996601|FG001|STARTED|Part 2||184
10831383|NCT01729754|11996602|FG002|STARTED|Part 2||110
10831384|NCT01729754|11996603|FG003|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
10831385|NCT01729754|11996604|FG004|STARTED|Part 2||21
10831386|NCT01729754|11996605|FG005|STARTED|Part 2||268
10831387|NCT01729754|11996606|FG006|STARTED|Part 2||0
11101557|NCT01231841|12285719|FG000|NOT COMPLETED|Overall Study||0
11101558|NCT01231984|12285725|FG000|STARTED|Study Period 1||69
10831388|NCT01729754|11996607|FG007|STARTED|Part 2||72
10831389|NCT01729754|11996608|FG008|STARTED|Part 2||70
10831390|NCT01729754|11996609|FG009|STARTED|Part 2||289
10831391|NCT01729754|11996600|FG000|COMPLETED|Part 2||0
10831392|NCT01729754|11996601|FG001|COMPLETED|Part 2||184
10831393|NCT01729754|11996602|FG002|COMPLETED|Part 2||110
10831394|NCT01729754|11996603|FG003|COMPLETED|Part 2||0
10831395|NCT01729754|11996604|FG004|COMPLETED|Part 2||21
10831396|NCT01729754|11996605|FG005|COMPLETED|Part 2||268
10831397|NCT01729754|11996606|FG006|COMPLETED|Part 2||0
10831398|NCT01729754|11996607|FG007|COMPLETED|Part 2||69
10831399|NCT01729754|11996608|FG008|COMPLETED|Part 2||66
10831400|NCT01729754|11996609|FG009|COMPLETED|Part 2||277
10831401|NCT01729754|11996600|FG000|NOT COMPLETED|Part 2||6
10831402|NCT01729754|11996601|FG001|NOT COMPLETED|Part 2||0
10831403|NCT01729754|11996602|FG002|NOT COMPLETED|Part 2||0
10831404|NCT01729754|11996603|FG003|NOT COMPLETED|Part 2||5
10831405|NCT01729754|11996604|FG004|NOT COMPLETED|Part 2||0
10831406|NCT01729754|11996605|FG005|NOT COMPLETED|Part 2||0
10831407|NCT01729754|11996606|FG006|NOT COMPLETED|Part 2||0
10831408|NCT01729754|11996607|FG007|NOT COMPLETED|Part 2||3
10831409|NCT01729754|11996608|FG008|NOT COMPLETED|Part 2||4
10831410|NCT01729754|11996609|FG009|NOT COMPLETED|Part 2||12
10831411|NCT01729754|11996600|FG000|STARTED|Part 3||0
10831412|NCT01729754|11996601|FG001|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
10831413|NCT01729754|11996602|FG002|STARTED|Part 3||110
10831414|NCT01729754|11996603|FG003|STARTED|Part 3||0
10831415|NCT01729754|11996604|FG004|STARTED|Part 3||21
10831416|NCT01729754|11996605|FG005|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
10831417|NCT01729754|11996606|FG006|STARTED|Part 3||0
10831418|NCT01729754|11996607|FG007|STARTED|Part 3||69
10831419|NCT01729754|11996608|FG008|STARTED|Part 3||66
10831420|NCT01729754|11996609|FG009|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
10831421|NCT01729754|11996600|FG000|COMPLETED|Part 3||0
10831422|NCT01729754|11996601|FG001|COMPLETED|Part 3||165
10831423|NCT01729754|11996602|FG002|COMPLETED|Part 3||105
10831424|NCT01729754|11996603|FG003|COMPLETED|Part 3||0
10831425|NCT01729754|11996604|FG004|COMPLETED|Part 3||17
10831426|NCT01729754|11996605|FG005|COMPLETED|Part 3||224
10831427|NCT01729754|11996606|FG006|COMPLETED|Part 3||0
10831428|NCT01729754|11996607|FG007|COMPLETED|Part 3||66
10831429|NCT01729754|11996608|FG008|COMPLETED|Part 3||65
10831430|NCT01729754|11996609|FG009|COMPLETED|Part 3||114
10831431|NCT01729754|11996600|FG000|NOT COMPLETED|Part 3||0
10831432|NCT01729754|11996601|FG001|NOT COMPLETED|Part 3||5
10831433|NCT01729754|11996602|FG002|NOT COMPLETED|Part 3||5
10831434|NCT01729754|11996603|FG003|NOT COMPLETED|Part 3||0
10831435|NCT01729754|11996604|FG004|NOT COMPLETED|Part 3||4
10831436|NCT01729754|11996605|FG005|NOT COMPLETED|Part 3||13
10831437|NCT01729754|11996606|FG006|NOT COMPLETED|Part 3||0
10831438|NCT01729754|11996607|FG007|NOT COMPLETED|Part 3||3
10831439|NCT01729754|11996608|FG008|NOT COMPLETED|Part 3||1
10831440|NCT01729754|11996609|FG009|NOT COMPLETED|Part 3||7
10831441|NCT01684826|11996639|FG000|STARTED|Overall Study||49
10831442|NCT01684826|11996639|FG000|Collected Dose and Image Information|Overall Study||39
10831443|NCT01684826|11996639|FG000|COMPLETED|Overall Study||39
10831444|NCT01684826|11996639|FG000|NOT COMPLETED|Overall Study||10
10831445|NCT01672242|11996643|FG000|STARTED|Period 1||4
10831446|NCT01672242|11996644|FG001|STARTED|Period 1||2
10831447|NCT01672242|11996643|FG000|COMPLETED|Period 1||4
10831448|NCT01672242|11996644|FG001|COMPLETED|Period 1||2
10831449|NCT01672242|11996643|FG000|NOT COMPLETED|Period 1||0
10831450|NCT01672242|11996644|FG001|NOT COMPLETED|Period 1||0
10831451|NCT01672242|11996643|FG000|STARTED|Period 2||4
10831452|NCT01672242|11996644|FG001|STARTED|Period 2||2
10831453|NCT01672242|11996643|FG000|COMPLETED|Period 2||4
10831454|NCT01672242|11996644|FG001|COMPLETED|Period 2||2
10831455|NCT01672242|11996643|FG000|NOT COMPLETED|Period 2||0
10831456|NCT01672242|11996644|FG001|NOT COMPLETED|Period 2||0
11101559|NCT01231984|12285726|FG001|STARTED|Study Period 1||70
11101560|NCT01231984|12285727|FG002|STARTED|Study Period 1||66
11101561|NCT01231984|12285728|FG003|STARTED|Study Period 1||69
11101562|NCT01231984|12285725|FG000|COMPLETED|Study Period 1||57
11101563|NCT01231984|12285726|FG001|COMPLETED|Study Period 1||63
11101564|NCT01231984|12285727|FG002|COMPLETED|Study Period 1||59
11101565|NCT01231984|12285728|FG003|COMPLETED|Study Period 1||60
11101566|NCT01231984|12285725|FG000|NOT COMPLETED|Study Period 1||12
11101567|NCT01231984|12285726|FG001|NOT COMPLETED|Study Period 1||7
11101568|NCT01231984|12285727|FG002|NOT COMPLETED|Study Period 1||7
11101569|NCT01231984|12285728|FG003|NOT COMPLETED|Study Period 1||9
11101570|NCT01231984|12285725|FG000|STARTED|Study Period 2||57
10831469|NCT01599741|11996659|FG000|STARTED|Overall Study||51
10831470|NCT01599741|11996659|FG000|Collected Dose and Image Information|Overall Study||48
10831471|NCT01599741|11996659|FG000|COMPLETED|Overall Study||48
10831472|NCT01599741|11996659|FG000|NOT COMPLETED|Overall Study||3
10831473|NCT01593852|11996665|FG000|STARTED|Overall Study||68
10831474|NCT01593852|11996666|FG001|STARTED|Overall Study||68
10831475|NCT01593852|11996665|FG000|COMPLETED|Overall Study||68
10831476|NCT01593852|11996666|FG001|COMPLETED|Overall Study||68
10831477|NCT01593852|11996665|FG000|NOT COMPLETED|Overall Study||0
10831478|NCT01593852|11996666|FG001|NOT COMPLETED|Overall Study||0
10831479|NCT01564537|11996674|FG000|STARTED|Overall Study||360
10831480|NCT01564537|11996675|FG001|STARTED|Overall Study||362
10831481|NCT01564537|11996674|FG000|Safety Population: Received Study Drug|Overall Study||360
10831482|NCT01564537|11996675|FG001|Safety Population: Received Study Drug|Overall Study||360
11101571|NCT01231984|12285726|FG001|STARTED|Study Period 2||63
10831483|NCT01564537|11996674|FG000|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
10831484|NCT01564537|11996675|FG001|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
10831485|NCT01564537|11996674|FG000|NOT COMPLETED|Overall Study||6
10831486|NCT01564537|11996675|FG001|NOT COMPLETED|Overall Study||6
10831487|NCT01515306|11996684|FG000|STARTED|Overall Study||24
10831488|NCT01515306|11996685|FG001|STARTED|Overall Study||16
10831489|NCT01515306|11996684|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24
10831490|NCT01515306|11996685|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10831491|NCT01515306|11996684|FG000|Cycle 1|Overall Study||24
10831492|NCT01515306|11996685|FG001|Cycle 1|Overall Study||16
10831493|NCT01515306|11996684|FG000|Cycle 2|Overall Study||21
10831494|NCT01515306|11996685|FG001|Cycle 2|Overall Study||15
10831495|NCT01515306|11996684|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
10831496|NCT01515306|11996685|FG001|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
10831497|NCT01515306|11996684|FG000|COMPLETED|Overall Study||0
10831498|NCT01515306|11996685|FG001|COMPLETED|Overall Study||2
10831499|NCT01515306|11996684|FG000|NOT COMPLETED|Overall Study||24
10831500|NCT01515306|11996685|FG001|NOT COMPLETED|Overall Study||14
10831501|NCT01423851|11996706|FG000|STARTED|Whole Study||3
10831502|NCT01423851|11996707|FG001|STARTED|Whole Study||3
10831503|NCT01423851|11996708|FG002|STARTED|Whole Study||3
10831504|NCT01423851|11996709|FG003|STARTED|Whole Study||6
10831505|NCT01423851|11996710|FG004|STARTED|Whole Study||3
10831506|NCT01423851|11996711|FG005|STARTED|Whole Study||3
10831507|NCT01423851|11996712|FG006|STARTED|Whole Study||3
10831508|NCT01423851|11996713|FG007|STARTED|Whole Study||8
10831509|NCT01423851|11996714|FG008|STARTED|Whole Study||8
10831510|NCT01423851|11996715|FG009|STARTED|Whole Study||8
10831511|NCT01423851|11996716|FG010|STARTED|Whole Study||29
10831512|NCT01423851|11996706|FG000|COMPLETED|Whole Study||0
10831513|NCT01423851|11996707|FG001|COMPLETED|Whole Study||0
10831514|NCT01423851|11996708|FG002|COMPLETED|Whole Study||0
10831515|NCT01423851|11996709|FG003|COMPLETED|Whole Study||0
10831516|NCT01423851|11996710|FG004|COMPLETED|Whole Study||0
10831517|NCT01423851|11996711|FG005|COMPLETED|Whole Study||0
10831518|NCT01423851|11996712|FG006|COMPLETED|Whole Study||0
10831519|NCT01423851|11996713|FG007|COMPLETED|Whole Study||0
10831520|NCT01423851|11996714|FG008|COMPLETED|Whole Study||0
10831521|NCT01423851|11996715|FG009|COMPLETED|Whole Study||0
10831522|NCT01423851|11996716|FG010|COMPLETED|Whole Study||0
10831523|NCT01423851|11996706|FG000|NOT COMPLETED|Whole Study||3
10831524|NCT01423851|11996707|FG001|NOT COMPLETED|Whole Study||3
10831525|NCT01423851|11996708|FG002|NOT COMPLETED|Whole Study||3
10831526|NCT01423851|11996709|FG003|NOT COMPLETED|Whole Study||6
10831527|NCT01423851|11996710|FG004|NOT COMPLETED|Whole Study||3
10831528|NCT01423851|11996711|FG005|NOT COMPLETED|Whole Study||3
10831529|NCT01423851|11996712|FG006|NOT COMPLETED|Whole Study||3
10831530|NCT01423851|11996713|FG007|NOT COMPLETED|Whole Study||8
10831531|NCT01423851|11996714|FG008|NOT COMPLETED|Whole Study||8
10831532|NCT01423851|11996715|FG009|NOT COMPLETED|Whole Study||8
10831533|NCT01423851|11996716|FG010|NOT COMPLETED|Whole Study||29
10831534|NCT01423851|11996706|FG000|STARTED|Dose Finding Period - Escalation||0
10831535|NCT01423851|11996707|FG001|STARTED|Dose Finding Period - Escalation||1
10831536|NCT01423851|11996708|FG002|STARTED|Dose Finding Period - Escalation||4
10831537|NCT01423851|11996709|FG003|STARTED|Dose Finding Period - Escalation||4
10831538|NCT01423851|11996710|FG004|STARTED|Dose Finding Period - Escalation||0
10831539|NCT01423851|11996711|FG005|STARTED|Dose Finding Period - Escalation||0
10831540|NCT01423851|11996712|FG006|STARTED|Dose Finding Period - Escalation||2
10831541|NCT01423851|11996713|FG007|STARTED|Dose Finding Period - Escalation||0
10831542|NCT01423851|11996714|FG008|STARTED|Dose Finding Period - Escalation||1
10831543|NCT01423851|11996715|FG009|STARTED|Dose Finding Period - Escalation||0
10831544|NCT01423851|11996716|FG010|STARTED|Dose Finding Period - Escalation||0
10831545|NCT01423851|11996706|FG000|COMPLETED|Dose Finding Period - Escalation||0
11101572|NCT01231984|12285727|FG002|STARTED|Study Period 2||59
11101573|NCT01231984|12285728|FG003|STARTED|Study Period 2||60
11101574|NCT01231984|12285725|FG000|COMPLETED|Study Period 2||54
11101575|NCT01231984|12285726|FG001|COMPLETED|Study Period 2||61
11101576|NCT01231984|12285727|FG002|COMPLETED|Study Period 2||59
11101577|NCT01231984|12285728|FG003|COMPLETED|Study Period 2||56
11101578|NCT01231984|12285725|FG000|NOT COMPLETED|Study Period 2||3
10831546|NCT01423851|11996707|FG001|COMPLETED|Dose Finding Period - Escalation||0
10831547|NCT01423851|11996708|FG002|COMPLETED|Dose Finding Period - Escalation||0
10831548|NCT01423851|11996709|FG003|COMPLETED|Dose Finding Period - Escalation||0
10831549|NCT01423851|11996710|FG004|COMPLETED|Dose Finding Period - Escalation||0
10831550|NCT01423851|11996711|FG005|COMPLETED|Dose Finding Period - Escalation||0
10831551|NCT01423851|11996712|FG006|COMPLETED|Dose Finding Period - Escalation||0
10831552|NCT01423851|11996713|FG007|COMPLETED|Dose Finding Period - Escalation||0
10831553|NCT01423851|11996714|FG008|COMPLETED|Dose Finding Period - Escalation||0
10831554|NCT01423851|11996715|FG009|COMPLETED|Dose Finding Period - Escalation||0
10831555|NCT01423851|11996716|FG010|COMPLETED|Dose Finding Period - Escalation||0
10831556|NCT01423851|11996706|FG000|NOT COMPLETED|Dose Finding Period - Escalation||0
10831557|NCT01423851|11996707|FG001|NOT COMPLETED|Dose Finding Period - Escalation||1
11101579|NCT01231984|12285726|FG001|NOT COMPLETED|Study Period 2||2
11101580|NCT01231984|12285727|FG002|NOT COMPLETED|Study Period 2||0
10831635|NCT01317875|11996789|FG001|COMPLETED|Overall Study||1
10831558|NCT01423851|11996708|FG002|NOT COMPLETED|Dose Finding Period - Escalation||4
10831559|NCT01423851|11996709|FG003|NOT COMPLETED|Dose Finding Period - Escalation||4
10831560|NCT01423851|11996710|FG004|NOT COMPLETED|Dose Finding Period - Escalation||0
10831561|NCT01423851|11996711|FG005|NOT COMPLETED|Dose Finding Period - Escalation||0
10831562|NCT01423851|11996712|FG006|NOT COMPLETED|Dose Finding Period - Escalation||2
10831563|NCT01423851|11996713|FG007|NOT COMPLETED|Dose Finding Period - Escalation||0
10831564|NCT01423851|11996714|FG008|NOT COMPLETED|Dose Finding Period - Escalation||1
10831565|NCT01423851|11996715|FG009|NOT COMPLETED|Dose Finding Period - Escalation||0
10831566|NCT01423851|11996716|FG010|NOT COMPLETED|Dose Finding Period - Escalation||0
10831567|NCT01423851|11996706|FG000|STARTED|Dose Finding Period - Reduction||0
10831568|NCT01423851|11996707|FG001|STARTED|Dose Finding Period - Reduction||0
10831569|NCT01423851|11996708|FG002|STARTED|Dose Finding Period - Reduction||3
10831570|NCT01423851|11996709|FG003|STARTED|Dose Finding Period - Reduction||5
10831571|NCT01423851|11996710|FG004|STARTED|Dose Finding Period - Reduction||1
10831572|NCT01423851|11996711|FG005|STARTED|Dose Finding Period - Reduction||2
10831573|NCT01423851|11996712|FG006|STARTED|Dose Finding Period - Reduction||8
10831574|NCT01423851|11996713|FG007|STARTED|Dose Finding Period - Reduction||0
10831575|NCT01423851|11996714|FG008|STARTED|Dose Finding Period - Reduction||3
10831576|NCT01423851|11996715|FG009|STARTED|Dose Finding Period - Reduction||0
10831577|NCT01423851|11996716|FG010|STARTED|Dose Finding Period - Reduction||0
10831578|NCT01423851|11996706|FG000|COMPLETED|Dose Finding Period - Reduction||0
10831579|NCT01423851|11996707|FG001|COMPLETED|Dose Finding Period - Reduction||0
10831580|NCT01423851|11996708|FG002|COMPLETED|Dose Finding Period - Reduction||0
10831581|NCT01423851|11996709|FG003|COMPLETED|Dose Finding Period - Reduction||0
10831582|NCT01423851|11996710|FG004|COMPLETED|Dose Finding Period - Reduction||0
10831583|NCT01423851|11996711|FG005|COMPLETED|Dose Finding Period - Reduction||0
10831584|NCT01423851|11996712|FG006|COMPLETED|Dose Finding Period - Reduction||0
10831585|NCT01423851|11996713|FG007|COMPLETED|Dose Finding Period - Reduction||0
10831586|NCT01423851|11996714|FG008|COMPLETED|Dose Finding Period - Reduction||0
10831587|NCT01423851|11996715|FG009|COMPLETED|Dose Finding Period - Reduction||0
10831588|NCT01423851|11996716|FG010|COMPLETED|Dose Finding Period - Reduction||0
10831589|NCT01423851|11996706|FG000|NOT COMPLETED|Dose Finding Period - Reduction||0
10831590|NCT01423851|11996707|FG001|NOT COMPLETED|Dose Finding Period - Reduction||0
10831591|NCT01423851|11996708|FG002|NOT COMPLETED|Dose Finding Period - Reduction||3
10831592|NCT01423851|11996709|FG003|NOT COMPLETED|Dose Finding Period - Reduction||5
10831593|NCT01423851|11996710|FG004|NOT COMPLETED|Dose Finding Period - Reduction||1
10831594|NCT01423851|11996711|FG005|NOT COMPLETED|Dose Finding Period - Reduction||2
10831595|NCT01423851|11996712|FG006|NOT COMPLETED|Dose Finding Period - Reduction||8
10831596|NCT01423851|11996713|FG007|NOT COMPLETED|Dose Finding Period - Reduction||0
10831597|NCT01423851|11996714|FG008|NOT COMPLETED|Dose Finding Period - Reduction||3
10831598|NCT01423851|11996715|FG009|NOT COMPLETED|Dose Finding Period - Reduction||0
10831599|NCT01423851|11996716|FG010|NOT COMPLETED|Dose Finding Period - Reduction||0
11101581|NCT01231984|12285728|FG003|NOT COMPLETED|Study Period 2||4
11101582|NCT01232127|12285746|FG000|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
11101583|NCT01232127|12285747|FG001|STARTED|Period 1: Days 1-10||0
11101584|NCT01232127|12285748|FG002|STARTED|Period 1: Days 1-10||0
11101585|NCT01232127|12285746|FG000|COMPLETED|Period 1: Days 1-10||24
11101586|NCT01232127|12285747|FG001|COMPLETED|Period 1: Days 1-10||0
11101587|NCT01232127|12285748|FG002|COMPLETED|Period 1: Days 1-10||0
11101588|NCT01232127|12285746|FG000|NOT COMPLETED|Period 1: Days 1-10||1
11101589|NCT01232127|12285747|FG001|NOT COMPLETED|Period 1: Days 1-10||0
11101590|NCT01232127|12285748|FG002|NOT COMPLETED|Period 1: Days 1-10||0
11101591|NCT01232127|12285746|FG000|STARTED|Period 2: Days 11-17||0
11101592|NCT01232127|12285747|FG001|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
10831612|NCT01360593|11996759|FG000|STARTED|Overall Study||35
10831613|NCT01360593|11996759|FG000|COMPLETED|Overall Study||35
10831614|NCT01360593|11996759|FG000|NOT COMPLETED|Overall Study||0
10831615|NCT01354977|11996765|FG000|STARTED|Overall Study||12
10831616|NCT01354977|11996766|FG001|STARTED|Overall Study||8
10831617|NCT01354977|11996765|FG000|COMPLETED|Overall Study||12
10831618|NCT01354977|11996766|FG001|COMPLETED|Overall Study||8
10831619|NCT01354977|11996765|FG000|NOT COMPLETED|Overall Study||0
10831620|NCT01354977|11996766|FG001|NOT COMPLETED|Overall Study||0
10831621|NCT01334606|11996772|FG000|STARTED|Overall Study||21
10831622|NCT01334606|11996772|FG000|COMPLETED|Overall Study||3
10831623|NCT01334606|11996772|FG000|NOT COMPLETED|Overall Study||18
10831624|NCT01317875|11996788|FG000|STARTED|Overall Study||5
10831625|NCT01317875|11996789|FG001|STARTED|Overall Study||3
10831626|NCT01317875|11996790|FG002|STARTED|Overall Study||20
10831627|NCT01317875|11996791|FG003|STARTED|Overall Study||4
10831628|NCT01317875|11996792|FG004|STARTED|Overall Study||12
10831629|NCT01317875|11996793|FG005|STARTED|Overall Study||3
10831630|NCT01317875|11996794|FG006|STARTED|Overall Study||4
10831631|NCT01317875|11996795|FG007|STARTED|Overall Study||18
10831632|NCT01317875|11996796|FG008|STARTED|Overall Study|No participants enrolled in Stratum 2 : Cohort 4|0
10831633|NCT01317875|11996797|FG009|STARTED|Overall Study|No participants enrolled in Stratum 2 : Cohort 5|0
10831634|NCT01317875|11996788|FG000|COMPLETED|Overall Study||2
11101593|NCT01232127|12285748|FG002|STARTED|Period 2: Days 11-17||0
11101594|NCT01232127|12285746|FG000|COMPLETED|Period 2: Days 11-17||0
11101595|NCT01232127|12285747|FG001|COMPLETED|Period 2: Days 11-17||24
11101596|NCT01232127|12285748|FG002|COMPLETED|Period 2: Days 11-17||0
11101597|NCT01232127|12285746|FG000|NOT COMPLETED|Period 2: Days 11-17||0
11101598|NCT01232127|12285747|FG001|NOT COMPLETED|Period 2: Days 11-17||0
10831636|NCT01317875|11996790|FG002|COMPLETED|Overall Study||11
10831637|NCT01317875|11996791|FG003|COMPLETED|Overall Study||2
10831638|NCT01317875|11996792|FG004|COMPLETED|Overall Study||3
10831639|NCT01317875|11996793|FG005|COMPLETED|Overall Study||1
10831640|NCT01317875|11996794|FG006|COMPLETED|Overall Study||2
10831641|NCT01317875|11996795|FG007|COMPLETED|Overall Study||3
10831642|NCT01317875|11996796|FG008|COMPLETED|Overall Study||0
10831643|NCT01317875|11996797|FG009|COMPLETED|Overall Study||0
10831644|NCT01317875|11996788|FG000|NOT COMPLETED|Overall Study||3
10831645|NCT01317875|11996789|FG001|NOT COMPLETED|Overall Study||2
10831646|NCT01317875|11996790|FG002|NOT COMPLETED|Overall Study||9
10831647|NCT01317875|11996791|FG003|NOT COMPLETED|Overall Study||2
10831648|NCT01317875|11996792|FG004|NOT COMPLETED|Overall Study||9
10831649|NCT01317875|11996793|FG005|NOT COMPLETED|Overall Study||2
10831650|NCT01317875|11996794|FG006|NOT COMPLETED|Overall Study||2
10831651|NCT01317875|11996795|FG007|NOT COMPLETED|Overall Study||15
10831652|NCT01317875|11996796|FG008|NOT COMPLETED|Overall Study||0
10831653|NCT01317875|11996797|FG009|NOT COMPLETED|Overall Study||0
10831654|NCT01226732|11996833|FG000|STARTED|Overall Study||3
10831655|NCT01226732|11996834|FG001|STARTED|Overall Study||3
11101599|NCT01232127|12285748|FG002|NOT COMPLETED|Period 2: Days 11-17||0
11101600|NCT01232127|12285746|FG000|STARTED|Period 3: Days 18-24||0
11101601|NCT01232127|12285747|FG001|STARTED|Period 3: Days 18-24||0
11101602|NCT01232127|12285748|FG002|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
11101603|NCT01232127|12285746|FG000|COMPLETED|Period 3: Days 18-24||0
11101604|NCT01232127|12285747|FG001|COMPLETED|Period 3: Days 18-24||0
10831656|NCT01226732|11996835|FG002|STARTED|Overall Study||3
10831657|NCT01226732|11996836|FG003|STARTED|Overall Study||5
10831658|NCT01226732|11996837|FG004|STARTED|Overall Study||3
10831659|NCT01226732|11996838|FG005|STARTED|Overall Study||6
10831660|NCT01226732|11996833|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10831661|NCT01226732|11996834|FG001|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10831662|NCT01226732|11996835|FG002|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10831663|NCT01226732|11996836|FG003|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10831664|NCT01226732|11996837|FG004|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10831665|NCT01226732|11996838|FG005|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
10831666|NCT01226732|11996833|FG000|NOT COMPLETED|Overall Study||3
10831667|NCT01226732|11996834|FG001|NOT COMPLETED|Overall Study||3
10831668|NCT01226732|11996835|FG002|NOT COMPLETED|Overall Study||3
10831669|NCT01226732|11996836|FG003|NOT COMPLETED|Overall Study||5
10831670|NCT01226732|11996837|FG004|NOT COMPLETED|Overall Study||3
10831671|NCT01226732|11996838|FG005|NOT COMPLETED|Overall Study||6
10831672|NCT01216683|11996862|FG000|STARTED|Induction||65
10831673|NCT01216683|11996863|FG001|STARTED|Induction||99
10831674|NCT01216683|11996864|FG002|STARTED|Induction||125
10831675|NCT01216683|11996862|FG000|Received Treatment and Assessed for Toxicities|Induction||65
10831676|NCT01216683|11996863|FG001|Received Treatment and Assessed for Toxicities|Induction||93
10831677|NCT01216683|11996864|FG002|Received Treatment and Assessed for Toxicities|Induction||122
10831678|NCT01216683|11996862|FG000|Eligible and Treated|Induction||59
10831679|NCT01216683|11996863|FG001|Eligible and Treated|Induction||85
10831680|NCT01216683|11996864|FG002|Eligible and Treated|Induction||114
10831681|NCT01216683|11996862|FG000|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||48
10831682|NCT01216683|11996863|FG001|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||85
10831683|NCT01216683|11996864|FG002|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||89
10831684|NCT01216683|11996862|FG000|COMPLETED|Induction||61
10831685|NCT01216683|11996863|FG001|COMPLETED|Induction||80
10831686|NCT01216683|11996864|FG002|COMPLETED|Induction||104
10831687|NCT01216683|11996862|FG000|NOT COMPLETED|Induction||4
10831688|NCT01216683|11996863|FG001|NOT COMPLETED|Induction||19
10831689|NCT01216683|11996864|FG002|NOT COMPLETED|Induction||21
10831690|NCT01216683|11996862|FG000|STARTED|Continuation||59
10831691|NCT01216683|11996863|FG001|STARTED|Continuation||71
10831692|NCT01216683|11996864|FG002|STARTED|Continuation||94
10831693|NCT01216683|11996862|FG000|Received Continuation Treatment|Continuation||59
10831694|NCT01216683|11996863|FG001|Received Continuation Treatment|Continuation||70
10831695|NCT01216683|11996864|FG002|Received Continuation Treatment|Continuation||89
10831696|NCT01216683|11996862|FG000|COMPLETED|Continuation||44
10831697|NCT01216683|11996863|FG001|COMPLETED|Continuation||56
10831698|NCT01216683|11996864|FG002|COMPLETED|Continuation||51
10831699|NCT01216683|11996862|FG000|NOT COMPLETED|Continuation||15
10831700|NCT01216683|11996863|FG001|NOT COMPLETED|Continuation||15
10831701|NCT01216683|11996864|FG002|NOT COMPLETED|Continuation||43
10831702|NCT01085097|11996888|FG000|STARTED|Overall Study||15
10831703|NCT01085097|11996889|FG001|STARTED|Overall Study||16
10831704|NCT01085097|11996890|FG002|STARTED|Overall Study||15
10831705|NCT01085097|11996888|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10831706|NCT01085097|11996889|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10831707|NCT01085097|11996890|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
10831708|NCT01085097|11996888|FG000|COMPLETED|Overall Study||13
11101605|NCT01232127|12285748|FG002|COMPLETED|Period 3: Days 18-24||24
11101606|NCT01232127|12285746|FG000|NOT COMPLETED|Period 3: Days 18-24||0
11101607|NCT01232127|12285747|FG001|NOT COMPLETED|Period 3: Days 18-24||0
11101608|NCT01232127|12285748|FG002|NOT COMPLETED|Period 3: Days 18-24||0
11101609|NCT01232205|12285762|FG000|STARTED|Overall Study||52
11101610|NCT01232205|12285763|FG001|STARTED|Overall Study||58
10831709|NCT01085097|11996889|FG001|COMPLETED|Overall Study||16
10831710|NCT01085097|11996890|FG002|COMPLETED|Overall Study||13
10831711|NCT01085097|11996888|FG000|NOT COMPLETED|Overall Study||2
10831712|NCT01085097|11996889|FG001|NOT COMPLETED|Overall Study||0
10831713|NCT01085097|11996890|FG002|NOT COMPLETED|Overall Study||2
10831714|NCT00920621|11996902|FG000|STARTED|Overall Study||440
10831715|NCT00920621|11996903|FG001|STARTED|Overall Study||436
10831716|NCT00920621|11996904|FG002|STARTED|Overall Study||440
10831717|NCT00920621|11996905|FG003|STARTED|Overall Study||436
10831718|NCT00920621|11996902|FG000|COMPLETED|Overall Study||386
10831719|NCT00920621|11996903|FG001|COMPLETED|Overall Study||391
10831720|NCT00920621|11996904|FG002|COMPLETED|Overall Study||405
10831721|NCT00920621|11996905|FG003|COMPLETED|Overall Study||401
10831722|NCT00920621|11996902|FG000|NOT COMPLETED|Overall Study||54
10831723|NCT00920621|11996903|FG001|NOT COMPLETED|Overall Study||45
10831724|NCT00920621|11996904|FG002|NOT COMPLETED|Overall Study||35
10831725|NCT00920621|11996905|FG003|NOT COMPLETED|Overall Study||35
10831726|NCT00828308|11996916|FG000|STARTED|Overall Study||16
10831727|NCT00828308|11996916|FG000|COMPLETED|Overall Study||16
10831728|NCT00828308|11996916|FG000|NOT COMPLETED|Overall Study||0
10831729|NCT00600015|11996922|FG000|STARTED|Overall Study||111
10831730|NCT00600015|11996923|FG001|STARTED|Overall Study||55
10831731|NCT00600015|11996922|FG000|COMPLETED|Overall Study|Completed >=2 cycles|51
10831732|NCT00600015|11996923|FG001|COMPLETED|Overall Study|Completed >=2 cycles|20
10831733|NCT00600015|11996922|FG000|NOT COMPLETED|Overall Study||60
10831734|NCT00600015|11996923|FG001|NOT COMPLETED|Overall Study||35
10831735|NCT00500071|11996930|FG000|STARTED|Screening and Washout Phase||318
10831736|NCT00500071|11996930|FG000|COMPLETED|Screening and Washout Phase||317
10831737|NCT00500071|11996930|FG000|NOT COMPLETED|Screening and Washout Phase||1
10831738|NCT00500071|11996930|FG000|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
10831739|NCT00500071|11996930|FG000|COMPLETED|Dose-optimization and Maintenance Phase||295
10831740|NCT00500071|11996930|FG000|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
10831741|NCT00500071|11996930|FG000|STARTED|30-day Safety Follow-up||295
10831742|NCT00500071|11996930|FG000|COMPLETED|30-day Safety Follow-up||278
10831743|NCT00500071|11996930|FG000|NOT COMPLETED|30-day Safety Follow-up||17
10831744|NCT00447122|11996938|FG000|STARTED|Overall Study||3
10831745|NCT00447122|11996939|FG001|STARTED|Overall Study||11
10831746|NCT00447122|11996940|FG002|STARTED|Overall Study||6
10831747|NCT00447122|11996941|FG003|STARTED|Overall Study||5
10831748|NCT00447122|11996938|FG000|COMPLETED|Overall Study||3
10831749|NCT00447122|11996939|FG001|COMPLETED|Overall Study||10
10831750|NCT00447122|11996940|FG002|COMPLETED|Overall Study||6
10831751|NCT00447122|11996941|FG003|COMPLETED|Overall Study||5
10831752|NCT00447122|11996938|FG000|NOT COMPLETED|Overall Study||0
10831753|NCT00447122|11996939|FG001|NOT COMPLETED|Overall Study||1
10831754|NCT00447122|11996940|FG002|NOT COMPLETED|Overall Study||0
10831755|NCT00447122|11996941|FG003|NOT COMPLETED|Overall Study||0
10831756|NCT00382252|11996951|FG000|STARTED|Overall Study||89
10831757|NCT00382252|11996951|FG000|COMPLETED|Overall Study||76
10831758|NCT00382252|11996951|FG000|NOT COMPLETED|Overall Study||13
11101611|NCT01232205|12285762|FG000|COMPLETED|Overall Study||49
11101612|NCT01232205|12285763|FG001|COMPLETED|Overall Study||55
11101613|NCT01232205|12285762|FG000|NOT COMPLETED|Overall Study||3
11101614|NCT01232205|12285763|FG001|NOT COMPLETED|Overall Study||3
11101615|NCT01232296|12285771|FG000|STARTED|Overall Study||82
11101616|NCT01232296|12285772|FG001|STARTED|Overall Study||83
11101617|NCT01232296|12285771|FG000|Full Analysis Set|Overall Study||82
11101618|NCT01232296|12285772|FG001|Full Analysis Set|Overall Study||83
11101619|NCT01232296|12285771|FG000|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
11101620|NCT01232296|12285772|FG001|Safety Set|Overall Study||83
11101621|NCT01232296|12285771|FG000|COMPLETED|Overall Study||0
11101622|NCT01232296|12285772|FG001|COMPLETED|Overall Study||0
11101623|NCT01232296|12285771|FG000|NOT COMPLETED|Overall Study||82
11101624|NCT01232296|12285772|FG001|NOT COMPLETED|Overall Study||83
11101625|NCT01232452|12285780|FG000|STARTED|Overall Study||87
11101626|NCT01232452|12285781|FG001|STARTED|Overall Study||85
11101627|NCT01232452|12285780|FG000|Received at Least One Dose of Study Drug|Overall Study||85
11101628|NCT01232452|12285781|FG001|Received at Least One Dose of Study Drug|Overall Study||81
11101629|NCT01232452|12285780|FG000|COMPLETED|Overall Study||48
11101630|NCT01232452|12285781|FG001|COMPLETED|Overall Study||46
11101631|NCT01232452|12285780|FG000|NOT COMPLETED|Overall Study||39
11101632|NCT01232452|12285781|FG001|NOT COMPLETED|Overall Study||39
11101633|NCT01232465|12285789|FG000|STARTED|Overall Study||337
10831791|NCT00309985|11996983|FG000|STARTED|Overall Study||397
10831792|NCT00309985|11996984|FG001|STARTED|Overall Study||393
10831793|NCT00309985|11996983|FG000|Toxicity Analysis|Overall Study||390
10831794|NCT00309985|11996984|FG001|Toxicity Analysis|Overall Study||392
10831795|NCT00309985|11996983|FG000|Both Baseline and 3-month FACT-P Evals|Overall Study||334
10831796|NCT00309985|11996984|FG001|Both Baseline and 3-month FACT-P Evals|Overall Study||299
10831797|NCT00309985|11996983|FG000|COMPLETED|Overall Study||335
10831798|NCT00309985|11996984|FG001|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
10831799|NCT00309985|11996983|FG000|NOT COMPLETED|Overall Study||62
10831800|NCT00309985|11996984|FG001|NOT COMPLETED|Overall Study||1
10831801|NCT00290251|11996993|FG000|STARTED|Baseline (Month 1)||14
10831802|NCT00290251|11996994|FG001|STARTED|Baseline (Month 1)||14
10831803|NCT00290251|11996995|FG002|STARTED|Baseline (Month 1)||14
10831804|NCT00290251|11996996|FG003|STARTED|Baseline (Month 1)||0
11220099|NCT01958437|12411676|FG000|COMPLETED|Overall Study||11
11220100|NCT01958437|12411677|FG001|COMPLETED|Overall Study||11
10831805|NCT00290251|11996997|FG004|STARTED|Baseline (Month 1)||0
10831806|NCT00290251|11996998|FG005|STARTED|Baseline (Month 1)||0
10831807|NCT00290251|11996993|FG000|COMPLETED|Baseline (Month 1)||14
10831808|NCT00290251|11996994|FG001|COMPLETED|Baseline (Month 1)||14
10831809|NCT00290251|11996995|FG002|COMPLETED|Baseline (Month 1)||14
10831810|NCT00290251|11996996|FG003|COMPLETED|Baseline (Month 1)||0
10831811|NCT00290251|11996997|FG004|COMPLETED|Baseline (Month 1)||0
10831812|NCT00290251|11996998|FG005|COMPLETED|Baseline (Month 1)||0
10831813|NCT00290251|11996993|FG000|NOT COMPLETED|Baseline (Month 1)||0
10831814|NCT00290251|11996994|FG001|NOT COMPLETED|Baseline (Month 1)||0
10831815|NCT00290251|11996995|FG002|NOT COMPLETED|Baseline (Month 1)||0
10831816|NCT00290251|11996996|FG003|NOT COMPLETED|Baseline (Month 1)||0
10831817|NCT00290251|11996997|FG004|NOT COMPLETED|Baseline (Month 1)||0
10831818|NCT00290251|11996998|FG005|NOT COMPLETED|Baseline (Month 1)||0
10831819|NCT00290251|11996993|FG000|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
11220101|NCT01958437|12411678|FG002|COMPLETED|Overall Study||10
11220102|NCT01958437|12411679|FG003|COMPLETED|Overall Study||10
11220103|NCT01958437|12411676|FG000|NOT COMPLETED|Overall Study||0
11220104|NCT01958437|12411677|FG001|NOT COMPLETED|Overall Study||0
11101634|NCT01232465|12285790|FG001|STARTED|Overall Study||402
11101635|NCT01232465|12285789|FG000|COMPLETED|Overall Study||337
11101636|NCT01232465|12285790|FG001|COMPLETED|Overall Study||402
11101637|NCT01232465|12285789|FG000|NOT COMPLETED|Overall Study||0
11101638|NCT01232465|12285790|FG001|NOT COMPLETED|Overall Study||0
11101639|NCT01232491|12285798|FG000|STARTED|Overall Study||306
11101640|NCT01232491|12285799|FG001|STARTED|Overall Study||305
11101641|NCT01232491|12285798|FG000|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
11101642|NCT01232491|12285799|FG001|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
11101643|NCT01232491|12285798|FG000|COMPLETED|Overall Study||246
11101644|NCT01232491|12285799|FG001|COMPLETED|Overall Study||242
11101645|NCT01232491|12285798|FG000|NOT COMPLETED|Overall Study||60
11101646|NCT01232491|12285799|FG001|NOT COMPLETED|Overall Study||63
11101647|NCT01232504|12285808|FG000|STARTED|Overall Study||68
11101648|NCT01232504|12285809|FG001|STARTED|Overall Study||69
11101649|NCT01232504|12285810|FG002|STARTED|Overall Study||69
11101650|NCT01232504|12285808|FG000|COMPLETED|Overall Study||59
11101651|NCT01232504|12285809|FG001|COMPLETED|Overall Study||67
11101652|NCT01232504|12285810|FG002|COMPLETED|Overall Study||61
11101653|NCT01232504|12285808|FG000|NOT COMPLETED|Overall Study||9
11101654|NCT01232504|12285809|FG001|NOT COMPLETED|Overall Study||2
11101655|NCT01232504|12285810|FG002|NOT COMPLETED|Overall Study||8
11101656|NCT01232556|12285828|FG000|STARTED|Overall Study||166
11101657|NCT01232556|12285829|FG001|STARTED|Overall Study||172
11101658|NCT01232556|12285828|FG000|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
11101659|NCT01232556|12285829|FG001|Treated|Overall Study||167
11101660|NCT01232556|12285828|FG000|COMPLETED|Overall Study||7
11101661|NCT01232556|12285829|FG001|COMPLETED|Overall Study||1
11101662|NCT01232556|12285828|FG000|NOT COMPLETED|Overall Study||159
11101663|NCT01232556|12285829|FG001|NOT COMPLETED|Overall Study||171
11101664|NCT01232569|12285837|FG000|STARTED|Double-blind Treatment Period||438
11101665|NCT01232569|12285838|FG001|STARTED|Double-blind Treatment Period||218
11101666|NCT01232569|12285839|FG002|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
11101667|NCT01232569|12285840|FG003|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
11101668|NCT01232569|12285837|FG000|COMPLETED|Double-blind Treatment Period||410
11101669|NCT01232569|12285838|FG001|COMPLETED|Double-blind Treatment Period||209
11101670|NCT01232569|12285839|FG002|COMPLETED|Double-blind Treatment Period||0
11101671|NCT01232569|12285840|FG003|COMPLETED|Double-blind Treatment Period||0
11101672|NCT01232569|12285837|FG000|NOT COMPLETED|Double-blind Treatment Period||28
11101673|NCT01232569|12285838|FG001|NOT COMPLETED|Double-blind Treatment Period||9
11101674|NCT01232569|12285839|FG002|NOT COMPLETED|Double-blind Treatment Period||0
11101675|NCT01232569|12285840|FG003|NOT COMPLETED|Double-blind Treatment Period||0
11101676|NCT01232569|12285837|FG000|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
11101677|NCT01232569|12285838|FG001|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
11101678|NCT01232569|12285839|FG002|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
11101679|NCT01232569|12285840|FG003|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
11101680|NCT01232569|12285837|FG000|COMPLETED|Open-label Extension Period||0
11101681|NCT01232569|12285838|FG001|COMPLETED|Open-label Extension Period||0
11101682|NCT01232569|12285839|FG002|COMPLETED|Open-label Extension Period||203
11101683|NCT01232569|12285840|FG003|COMPLETED|Open-label Extension Period||200
11101684|NCT01232569|12285837|FG000|NOT COMPLETED|Open-label Extension Period||0
11101685|NCT01232569|12285838|FG001|NOT COMPLETED|Open-label Extension Period||0
11220105|NCT01958437|12411678|FG002|NOT COMPLETED|Overall Study||1
11220106|NCT01958437|12411679|FG003|NOT COMPLETED|Overall Study||1
10831820|NCT00290251|11996994|FG001|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
11101686|NCT01232569|12285839|FG002|NOT COMPLETED|Open-label Extension Period||27
11101687|NCT01232569|12285840|FG003|NOT COMPLETED|Open-label Extension Period||27
11101688|NCT01232738|12285849|FG000|STARTED|Overall Study||36
11101689|NCT01232738|12285849|FG000|COMPLETED|Overall Study||23
11101690|NCT01232738|12285849|FG000|NOT COMPLETED|Overall Study||13
11101691|NCT01232790|12285857|FG000|STARTED|Randomization||14
11101692|NCT01232790|12285858|FG001|STARTED|Randomization||14
11101693|NCT01232790|12285857|FG000|COMPLETED|Randomization||12
11101694|NCT01232790|12285858|FG001|COMPLETED|Randomization||12
11101695|NCT01232790|12285857|FG000|NOT COMPLETED|Randomization||2
11101696|NCT01232790|12285858|FG001|NOT COMPLETED|Randomization||2
11101697|NCT01232790|12285857|FG000|STARTED|Initial Assessment||12
11101698|NCT01232790|12285858|FG001|STARTED|Initial Assessment||12
10831821|NCT00290251|11996995|FG002|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
10831822|NCT00290251|11996996|FG003|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
10831823|NCT00290251|11996997|FG004|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
10831824|NCT00290251|11996998|FG005|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
10831825|NCT00290251|11996993|FG000|COMPLETED|Treatment 1 (Months 2-4)||0
10831826|NCT00290251|11996994|FG001|COMPLETED|Treatment 1 (Months 2-4)||0
10831827|NCT00290251|11996995|FG002|COMPLETED|Treatment 1 (Months 2-4)||0
10831828|NCT00290251|11996996|FG003|COMPLETED|Treatment 1 (Months 2-4)||13
10831829|NCT00290251|11996997|FG004|COMPLETED|Treatment 1 (Months 2-4)||13
10831830|NCT00290251|11996998|FG005|COMPLETED|Treatment 1 (Months 2-4)||12
10831831|NCT00290251|11996993|FG000|NOT COMPLETED|Treatment 1 (Months 2-4)||0
10831832|NCT00290251|11996994|FG001|NOT COMPLETED|Treatment 1 (Months 2-4)||0
10831833|NCT00290251|11996995|FG002|NOT COMPLETED|Treatment 1 (Months 2-4)||0
10831834|NCT00290251|11996996|FG003|NOT COMPLETED|Treatment 1 (Months 2-4)||1
10831835|NCT00290251|11996997|FG004|NOT COMPLETED|Treatment 1 (Months 2-4)||1
10831836|NCT00290251|11996998|FG005|NOT COMPLETED|Treatment 1 (Months 2-4)||2
10831837|NCT00066963|11997014|FG000|STARTED|Overall Study||126
10831838|NCT00066963|11997015|FG001|STARTED|Overall Study||124
10831839|NCT00066963|11997016|FG002|STARTED|Overall Study||126
10831840|NCT00066963|11997014|FG000|COMPLETED|Overall Study|any follow-up|100
10831841|NCT00066963|11997015|FG001|COMPLETED|Overall Study||93
10831842|NCT00066963|11997016|FG002|COMPLETED|Overall Study||87
10831843|NCT00066963|11997014|FG000|NOT COMPLETED|Overall Study||26
10831844|NCT00066963|11997015|FG001|NOT COMPLETED|Overall Study||31
10831845|NCT00066963|11997016|FG002|NOT COMPLETED|Overall Study||39
11101699|NCT01232790|12285857|FG000|COMPLETED|Initial Assessment||12
11101700|NCT01232790|12285858|FG001|COMPLETED|Initial Assessment||11
11101701|NCT01232790|12285857|FG000|NOT COMPLETED|Initial Assessment||0
11101702|NCT01232790|12285858|FG001|NOT COMPLETED|Initial Assessment||1
11101703|NCT01232790|12285857|FG000|STARTED|First Crossover||12
11101704|NCT01232790|12285858|FG001|STARTED|First Crossover||11
11101705|NCT01232790|12285857|FG000|COMPLETED|First Crossover||11
11101706|NCT01232790|12285858|FG001|COMPLETED|First Crossover||11
11101707|NCT01232790|12285857|FG000|NOT COMPLETED|First Crossover||1
11101708|NCT01232790|12285858|FG001|NOT COMPLETED|First Crossover||0
11101709|NCT01232790|12285857|FG000|STARTED|Second Crossover||11
11101710|NCT01232790|12285858|FG001|STARTED|Second Crossover||11
11101711|NCT01232790|12285857|FG000|COMPLETED|Second Crossover||10
11101712|NCT01232790|12285858|FG001|COMPLETED|Second Crossover||9
11101713|NCT01232790|12285857|FG000|NOT COMPLETED|Second Crossover||1
11101714|NCT01232790|12285858|FG001|NOT COMPLETED|Second Crossover||2
11101715|NCT01232829|12285874|FG000|STARTED|Overall Study||18
11101716|NCT01232829|12285874|FG000|COMPLETED|Overall Study||18
11101717|NCT01232829|12285874|FG000|NOT COMPLETED|Overall Study||0
11101718|NCT01232868|12285880|FG000|STARTED|Overall Study||22
11101719|NCT01232868|12285881|FG001|STARTED|Overall Study||44
11101720|NCT01232868|12285880|FG000|COMPLETED|Overall Study||20
11101721|NCT01232868|12285881|FG001|COMPLETED|Overall Study||40
11101722|NCT01232868|12285880|FG000|NOT COMPLETED|Overall Study||2
11101723|NCT01232868|12285881|FG001|NOT COMPLETED|Overall Study||4
11101724|NCT01232894|12285889|FG000|STARTED|Overall Study||60
11101725|NCT01232894|12285890|FG001|STARTED|Overall Study||30
11101726|NCT01232894|12285889|FG000|Received Study Drug|Overall Study||59
11220107|NCT01958476|12411698|FG000|STARTED|Overall Study||59
11101727|NCT01232894|12285890|FG001|Received Study Drug|Overall Study||28
11101728|NCT01232894|12285889|FG000|COMPLETED|Overall Study||48
11101729|NCT01232894|12285890|FG001|COMPLETED|Overall Study||22
11101730|NCT01232894|12285889|FG000|NOT COMPLETED|Overall Study||12
11101731|NCT01232894|12285890|FG001|NOT COMPLETED|Overall Study||8
11101732|NCT01232920|12285898|FG000|STARTED|Overall Study||41
11101733|NCT01232920|12285899|FG001|STARTED|Overall Study||39
11101734|NCT01232920|12285898|FG000|COMPLETED|Overall Study||35
11101735|NCT01232920|12285899|FG001|COMPLETED|Overall Study||32
11101736|NCT01232920|12285898|FG000|NOT COMPLETED|Overall Study||6
11101737|NCT01232920|12285899|FG001|NOT COMPLETED|Overall Study||7
10831846|NCT01403948|11997034|FG000|STARTED|Overall Study||1
10831847|NCT01403948|11997035|FG001|STARTED|Overall Study||4
10831848|NCT01403948|11997036|FG002|STARTED|Overall Study||3
10831849|NCT01403948|11997037|FG003|STARTED|Overall Study||4
10831850|NCT01403948|11997038|FG004|STARTED|Overall Study||6
10831851|NCT01403948|11997039|FG005|STARTED|Overall Study||7
10831852|NCT01403948|11997040|FG006|STARTED|Overall Study||6
11101738|NCT01232946|12285908|FG000|STARTED|Overall Study||9
11101739|NCT01232946|12285909|FG001|STARTED|Overall Study||10
10831853|NCT01403948|11997041|FG007|STARTED|Overall Study||4
10831854|NCT01403948|11997042|FG008|STARTED|Overall Study||6
10831855|NCT01403948|11997043|FG009|STARTED|Overall Study||7
10831856|NCT01403948|11997034|FG000|COMPLETED|Overall Study||0
10831857|NCT01403948|11997035|FG001|COMPLETED|Overall Study||0
10831858|NCT01403948|11997036|FG002|COMPLETED|Overall Study||0
10831859|NCT01403948|11997037|FG003|COMPLETED|Overall Study||0
10831860|NCT01403948|11997038|FG004|COMPLETED|Overall Study||0
10831861|NCT01403948|11997039|FG005|COMPLETED|Overall Study||0
10831862|NCT01403948|11997040|FG006|COMPLETED|Overall Study||0
10831863|NCT01403948|11997041|FG007|COMPLETED|Overall Study||0
10831864|NCT01403948|11997042|FG008|COMPLETED|Overall Study||0
10831865|NCT01403948|11997043|FG009|COMPLETED|Overall Study||0
10831866|NCT01403948|11997034|FG000|NOT COMPLETED|Overall Study||1
10831867|NCT01403948|11997035|FG001|NOT COMPLETED|Overall Study||4
10831868|NCT01403948|11997036|FG002|NOT COMPLETED|Overall Study||3
10831869|NCT01403948|11997037|FG003|NOT COMPLETED|Overall Study||4
10831870|NCT01403948|11997038|FG004|NOT COMPLETED|Overall Study||6
10831871|NCT01403948|11997039|FG005|NOT COMPLETED|Overall Study||7
10831872|NCT01403948|11997040|FG006|NOT COMPLETED|Overall Study||6
10831873|NCT01403948|11997041|FG007|NOT COMPLETED|Overall Study||4
10831874|NCT01403948|11997042|FG008|NOT COMPLETED|Overall Study||6
10831875|NCT01403948|11997043|FG009|NOT COMPLETED|Overall Study||7
10831882|NCT01425008|11997098|FG000|STARTED|Dose Escalation Phase||4
10831883|NCT01425008|11997099|FG001|STARTED|Dose Escalation Phase||3
10831884|NCT01425008|11997100|FG002|STARTED|Dose Escalation Phase||3
10831885|NCT01425008|11997101|FG003|STARTED|Dose Escalation Phase||3
10831886|NCT01425008|11997102|FG004|STARTED|Dose Escalation Phase||7
10831887|NCT01425008|11997103|FG005|STARTED|Dose Escalation Phase||7
10831888|NCT01425008|11997104|FG006|STARTED|Dose Escalation Phase||3
10831889|NCT01425008|11997105|FG007|STARTED|Dose Escalation Phase||3
10831890|NCT01425008|11997106|FG008|STARTED|Dose Escalation Phase||13
10831891|NCT01425008|11997107|FG009|STARTED|Dose Escalation Phase||4
10831892|NCT01425008|11997108|FG010|STARTED|Dose Escalation Phase||0
10831893|NCT01425008|11997109|FG011|STARTED|Dose Escalation Phase||0
10831894|NCT01425008|11997110|FG012|STARTED|Dose Escalation Phase||0
10831895|NCT01425008|11997111|FG013|STARTED|Dose Escalation Phase||0
10831896|NCT01425008|11997112|FG014|STARTED|Dose Escalation Phase||0
10831897|NCT01425008|11997113|FG015|STARTED|Dose Escalation Phase||0
10831898|NCT01425008|11997114|FG016|STARTED|Dose Escalation Phase||0
10831899|NCT01425008|11997115|FG017|STARTED|Dose Escalation Phase||0
10831900|NCT01425008|11997116|FG018|STARTED|Dose Escalation Phase||0
10831901|NCT01425008|11997098|FG000|COMPLETED|Dose Escalation Phase||0
10831902|NCT01425008|11997099|FG001|COMPLETED|Dose Escalation Phase||0
10831903|NCT01425008|11997100|FG002|COMPLETED|Dose Escalation Phase||0
10831904|NCT01425008|11997101|FG003|COMPLETED|Dose Escalation Phase||0
10831905|NCT01425008|11997102|FG004|COMPLETED|Dose Escalation Phase||0
11101740|NCT01232946|12285910|FG002|STARTED|Overall Study||11
11101741|NCT01232946|12285908|FG000|COMPLETED|Overall Study||9
11101742|NCT01232946|12285909|FG001|COMPLETED|Overall Study|1 participant died unrelated to study|9
11101743|NCT01232946|12285910|FG002|COMPLETED|Overall Study|2 withdrew after baseline measurements|9
11101744|NCT01232946|12285908|FG000|NOT COMPLETED|Overall Study||0
11101745|NCT01232946|12285909|FG001|NOT COMPLETED|Overall Study||1
11101746|NCT01232946|12285910|FG002|NOT COMPLETED|Overall Study||2
11101747|NCT01233050|12285920|FG000|STARTED|Overall Study||400
11101748|NCT01233050|12285921|FG001|STARTED|Overall Study||402
11101749|NCT01233050|12285920|FG000|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
11101750|NCT01233050|12285921|FG001|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
11101751|NCT01233050|12285920|FG000|NOT COMPLETED|Overall Study||8
11101752|NCT01233050|12285921|FG001|NOT COMPLETED|Overall Study||6
11101753|NCT01233076|12285927|FG000|STARTED|Period 1, One Week||30
11101754|NCT01233076|12285928|FG001|STARTED|Period 1, One Week||30
11101755|NCT01233076|12285927|FG000|COMPLETED|Period 1, One Week||30
11101756|NCT01233076|12285928|FG001|COMPLETED|Period 1, One Week||30
11101757|NCT01233076|12285927|FG000|NOT COMPLETED|Period 1, One Week||0
11101758|NCT01233076|12285928|FG001|NOT COMPLETED|Period 1, One Week||0
11101759|NCT01233076|12285927|FG000|STARTED|Period 2, One Week||30
11101760|NCT01233076|12285928|FG001|STARTED|Period 2, One Week||30
11101761|NCT01233076|12285927|FG000|COMPLETED|Period 2, One Week||29
11101762|NCT01233076|12285928|FG001|COMPLETED|Period 2, One Week||30
11101763|NCT01233076|12285927|FG000|NOT COMPLETED|Period 2, One Week||1
11101764|NCT01233076|12285928|FG001|NOT COMPLETED|Period 2, One Week||0
11101765|NCT01233232|12285937|FG000|STARTED|Overall Study||29
11101766|NCT01233232|12285938|FG001|STARTED|Overall Study||30
11101767|NCT01233232|12285939|FG002|STARTED|Overall Study||28
11101768|NCT01233232|12285937|FG000|COMPLETED|Overall Study||28
10831906|NCT01425008|11997103|FG005|COMPLETED|Dose Escalation Phase||0
10831907|NCT01425008|11997104|FG006|COMPLETED|Dose Escalation Phase||0
10831908|NCT01425008|11997105|FG007|COMPLETED|Dose Escalation Phase||0
10831909|NCT01425008|11997106|FG008|COMPLETED|Dose Escalation Phase||0
10831910|NCT01425008|11997107|FG009|COMPLETED|Dose Escalation Phase||0
10831911|NCT01425008|11997108|FG010|COMPLETED|Dose Escalation Phase||0
10831912|NCT01425008|11997109|FG011|COMPLETED|Dose Escalation Phase||0
10831913|NCT01425008|11997110|FG012|COMPLETED|Dose Escalation Phase||0
11101769|NCT01233232|12285938|FG001|COMPLETED|Overall Study||30
11101770|NCT01233232|12285939|FG002|COMPLETED|Overall Study||28
11101771|NCT01233232|12285937|FG000|NOT COMPLETED|Overall Study||1
10831916|NCT01425008|11997113|FG015|COMPLETED|Dose Escalation Phase||0
11101772|NCT01233232|12285938|FG001|NOT COMPLETED|Overall Study||0
11101773|NCT01233232|12285939|FG002|NOT COMPLETED|Overall Study||0
11101774|NCT01233258|12285952|FG000|STARTED|First Intervention (6 Months)||11
11101775|NCT01233258|12285953|FG001|STARTED|First Intervention (6 Months)||10
11101776|NCT01233258|12285954|FG002|STARTED|First Intervention (6 Months)||14
11101777|NCT01233258|12285955|FG003|STARTED|First Intervention (6 Months)||16
11101778|NCT01233258|12285956|FG004|STARTED|First Intervention (6 Months)||16
11101779|NCT01233258|12285957|FG005|STARTED|First Intervention (6 Months)||16
11101780|NCT01233258|12285952|FG000|Participants Received Treatment|First Intervention (6 Months)||11
11101781|NCT01233258|12285953|FG001|Participants Received Treatment|First Intervention (6 Months)||10
11101782|NCT01233258|12285954|FG002|Participants Received Treatment|First Intervention (6 Months)||13
11101783|NCT01233258|12285955|FG003|Participants Received Treatment|First Intervention (6 Months)||15
11101784|NCT01233258|12285956|FG004|Participants Received Treatment|First Intervention (6 Months)||16
11101785|NCT01233258|12285957|FG005|Participants Received Treatment|First Intervention (6 Months)||15
11101786|NCT01233258|12285952|FG000|COMPLETED|First Intervention (6 Months)||10
11101787|NCT01233258|12285953|FG001|COMPLETED|First Intervention (6 Months)||10
11101788|NCT01233258|12285954|FG002|COMPLETED|First Intervention (6 Months)||13
11101789|NCT01233258|12285955|FG003|COMPLETED|First Intervention (6 Months)||15
11101790|NCT01233258|12285956|FG004|COMPLETED|First Intervention (6 Months)||16
11101791|NCT01233258|12285957|FG005|COMPLETED|First Intervention (6 Months)||15
11101792|NCT01233258|12285952|FG000|NOT COMPLETED|First Intervention (6 Months)||1
11101793|NCT01233258|12285953|FG001|NOT COMPLETED|First Intervention (6 Months)||0
11101794|NCT01233258|12285954|FG002|NOT COMPLETED|First Intervention (6 Months)||1
11101795|NCT01233258|12285955|FG003|NOT COMPLETED|First Intervention (6 Months)||1
11101796|NCT01233258|12285956|FG004|NOT COMPLETED|First Intervention (6 Months)||0
11101797|NCT01233258|12285957|FG005|NOT COMPLETED|First Intervention (6 Months)||1
11101798|NCT01233258|12285952|FG000|STARTED|Washout (2-3 Days)||10
11220108|NCT01958476|12411699|FG001|STARTED|Overall Study||58
11220109|NCT01958476|12411698|FG000|COMPLETED|Overall Study||58
11220110|NCT01958476|12411699|FG001|COMPLETED|Overall Study||58
11220111|NCT01958476|12411698|FG000|NOT COMPLETED|Overall Study||1
11101799|NCT01233258|12285953|FG001|STARTED|Washout (2-3 Days)||10
11101800|NCT01233258|12285954|FG002|STARTED|Washout (2-3 Days)||13
11101801|NCT01233258|12285955|FG003|STARTED|Washout (2-3 Days)||15
11101802|NCT01233258|12285956|FG004|STARTED|Washout (2-3 Days)||16
11101803|NCT01233258|12285957|FG005|STARTED|Washout (2-3 Days)||15
11101804|NCT01233258|12285952|FG000|COMPLETED|Washout (2-3 Days)||10
11101805|NCT01233258|12285953|FG001|COMPLETED|Washout (2-3 Days)||10
11101806|NCT01233258|12285954|FG002|COMPLETED|Washout (2-3 Days)||13
11101807|NCT01233258|12285955|FG003|COMPLETED|Washout (2-3 Days)||15
11101808|NCT01233258|12285956|FG004|COMPLETED|Washout (2-3 Days)||16
11101809|NCT01233258|12285957|FG005|COMPLETED|Washout (2-3 Days)||15
11101810|NCT01233258|12285952|FG000|NOT COMPLETED|Washout (2-3 Days)||0
11101811|NCT01233258|12285953|FG001|NOT COMPLETED|Washout (2-3 Days)||0
11101812|NCT01233258|12285954|FG002|NOT COMPLETED|Washout (2-3 Days)||0
11101813|NCT01233258|12285955|FG003|NOT COMPLETED|Washout (2-3 Days)||0
11101814|NCT01233258|12285956|FG004|NOT COMPLETED|Washout (2-3 Days)||0
11101815|NCT01233258|12285957|FG005|NOT COMPLETED|Washout (2-3 Days)||0
11101816|NCT01233258|12285952|FG000|STARTED|Second Intervention (6 Months)||10
11101817|NCT01233258|12285953|FG001|STARTED|Second Intervention (6 Months)||10
11101818|NCT01233258|12285954|FG002|STARTED|Second Intervention (6 Months)||13
11101819|NCT01233258|12285955|FG003|STARTED|Second Intervention (6 Months)||15
11101820|NCT01233258|12285956|FG004|STARTED|Second Intervention (6 Months)||16
11101821|NCT01233258|12285957|FG005|STARTED|Second Intervention (6 Months)||15
11101822|NCT01233258|12285952|FG000|COMPLETED|Second Intervention (6 Months)||10
11101823|NCT01233258|12285953|FG001|COMPLETED|Second Intervention (6 Months)||10
11101824|NCT01233258|12285954|FG002|COMPLETED|Second Intervention (6 Months)||13
11101825|NCT01233258|12285955|FG003|COMPLETED|Second Intervention (6 Months)||15
11101826|NCT01233258|12285956|FG004|COMPLETED|Second Intervention (6 Months)||16
11101827|NCT01233258|12285957|FG005|COMPLETED|Second Intervention (6 Months)||15
11101828|NCT01233258|12285952|FG000|NOT COMPLETED|Second Intervention (6 Months)||0
11101829|NCT01233258|12285953|FG001|NOT COMPLETED|Second Intervention (6 Months)||0
11101830|NCT01233258|12285954|FG002|NOT COMPLETED|Second Intervention (6 Months)||0
11101831|NCT01233258|12285955|FG003|NOT COMPLETED|Second Intervention (6 Months)||0
11101832|NCT01233258|12285956|FG004|NOT COMPLETED|Second Intervention (6 Months)||0
11101833|NCT01233258|12285957|FG005|NOT COMPLETED|Second Intervention (6 Months)||0
11101834|NCT01233284|12285972|FG000|STARTED|Period 1 (4 Weeks)||37
11101835|NCT01233284|12285973|FG001|STARTED|Period 1 (4 Weeks)||38
11101836|NCT01233284|12285974|FG002|STARTED|Period 1 (4 Weeks)||38
11101837|NCT01233284|12285975|FG003|STARTED|Period 1 (4 Weeks)||35
11101838|NCT01233284|12285976|FG004|STARTED|Period 1 (4 Weeks)||1
11101839|NCT01233284|12285972|FG000|COMPLETED|Period 1 (4 Weeks)||36
11101840|NCT01233284|12285973|FG001|COMPLETED|Period 1 (4 Weeks)||37
11220112|NCT01958476|12411699|FG001|NOT COMPLETED|Overall Study||0
10831876|NCT01404312|11997071|FG000|STARTED|Overall Study||1496
10831877|NCT01404312|11997072|FG001|STARTED|Overall Study||1504
10831878|NCT01404312|11997071|FG000|COMPLETED|Overall Study||1198
10831879|NCT01404312|11997072|FG001|COMPLETED|Overall Study||1193
10831880|NCT01404312|11997071|FG000|NOT COMPLETED|Overall Study||298
10831881|NCT01404312|11997072|FG001|NOT COMPLETED|Overall Study||311
10831914|NCT01425008|11997111|FG013|COMPLETED|Dose Escalation Phase||0
10831915|NCT01425008|11997112|FG014|COMPLETED|Dose Escalation Phase||0
11101841|NCT01233284|12285974|FG002|COMPLETED|Period 1 (4 Weeks)||37
10831917|NCT01425008|11997114|FG016|COMPLETED|Dose Escalation Phase||0
10831918|NCT01425008|11997115|FG017|COMPLETED|Dose Escalation Phase||0
10831919|NCT01425008|11997116|FG018|COMPLETED|Dose Escalation Phase||0
10831920|NCT01425008|11997098|FG000|NOT COMPLETED|Dose Escalation Phase||4
10831921|NCT01425008|11997099|FG001|NOT COMPLETED|Dose Escalation Phase||3
10831922|NCT01425008|11997100|FG002|NOT COMPLETED|Dose Escalation Phase||3
10831923|NCT01425008|11997101|FG003|NOT COMPLETED|Dose Escalation Phase||3
10831924|NCT01425008|11997102|FG004|NOT COMPLETED|Dose Escalation Phase||7
10831925|NCT01425008|11997103|FG005|NOT COMPLETED|Dose Escalation Phase||7
10831926|NCT01425008|11997104|FG006|NOT COMPLETED|Dose Escalation Phase||3
10831927|NCT01425008|11997105|FG007|NOT COMPLETED|Dose Escalation Phase||3
10831928|NCT01425008|11997106|FG008|NOT COMPLETED|Dose Escalation Phase||13
10831929|NCT01425008|11997107|FG009|NOT COMPLETED|Dose Escalation Phase||4
10831930|NCT01425008|11997108|FG010|NOT COMPLETED|Dose Escalation Phase||0
10831931|NCT01425008|11997109|FG011|NOT COMPLETED|Dose Escalation Phase||0
10831932|NCT01425008|11997110|FG012|NOT COMPLETED|Dose Escalation Phase||0
10831933|NCT01425008|11997111|FG013|NOT COMPLETED|Dose Escalation Phase||0
10831934|NCT01425008|11997112|FG014|NOT COMPLETED|Dose Escalation Phase||0
10831935|NCT01425008|11997113|FG015|NOT COMPLETED|Dose Escalation Phase||0
10831936|NCT01425008|11997114|FG016|NOT COMPLETED|Dose Escalation Phase||0
10831937|NCT01425008|11997115|FG017|NOT COMPLETED|Dose Escalation Phase||0
10831938|NCT01425008|11997116|FG018|NOT COMPLETED|Dose Escalation Phase||0
10831939|NCT01425008|11997098|FG000|STARTED|Dose Expansion Phase||0
10831940|NCT01425008|11997099|FG001|STARTED|Dose Expansion Phase||0
10831941|NCT01425008|11997100|FG002|STARTED|Dose Expansion Phase||0
10831942|NCT01425008|11997101|FG003|STARTED|Dose Expansion Phase||0
10831943|NCT01425008|11997102|FG004|STARTED|Dose Expansion Phase||0
10831944|NCT01425008|11997103|FG005|STARTED|Dose Expansion Phase||0
10831945|NCT01425008|11997104|FG006|STARTED|Dose Expansion Phase||0
10831946|NCT01425008|11997105|FG007|STARTED|Dose Expansion Phase||0
10831947|NCT01425008|11997106|FG008|STARTED|Dose Expansion Phase||0
10831948|NCT01425008|11997107|FG009|STARTED|Dose Expansion Phase||0
10831949|NCT01425008|11997108|FG010|STARTED|Dose Expansion Phase||16
10831950|NCT01425008|11997109|FG011|STARTED|Dose Expansion Phase||8
10831951|NCT01425008|11997110|FG012|STARTED|Dose Expansion Phase||16
10831952|NCT01425008|11997111|FG013|STARTED|Dose Expansion Phase||1
10831953|NCT01425008|11997112|FG014|STARTED|Dose Expansion Phase||6
10831954|NCT01425008|11997113|FG015|STARTED|Dose Expansion Phase||11
10831955|NCT01425008|11997114|FG016|STARTED|Dose Expansion Phase||20
10831956|NCT01425008|11997115|FG017|STARTED|Dose Expansion Phase||2
10831957|NCT01425008|11997116|FG018|STARTED|Dose Expansion Phase||19
10831958|NCT01425008|11997098|FG000|COMPLETED|Dose Expansion Phase||0
10831959|NCT01425008|11997099|FG001|COMPLETED|Dose Expansion Phase||0
10831960|NCT01425008|11997100|FG002|COMPLETED|Dose Expansion Phase||0
10831961|NCT01425008|11997101|FG003|COMPLETED|Dose Expansion Phase||0
10831962|NCT01425008|11997102|FG004|COMPLETED|Dose Expansion Phase||0
10831963|NCT01425008|11997103|FG005|COMPLETED|Dose Expansion Phase||0
10831964|NCT01425008|11997104|FG006|COMPLETED|Dose Expansion Phase||0
10831965|NCT01425008|11997105|FG007|COMPLETED|Dose Expansion Phase||0
10831966|NCT01425008|11997106|FG008|COMPLETED|Dose Expansion Phase||0
10831967|NCT01425008|11997107|FG009|COMPLETED|Dose Expansion Phase||0
10831968|NCT01425008|11997108|FG010|COMPLETED|Dose Expansion Phase||1
10831969|NCT01425008|11997109|FG011|COMPLETED|Dose Expansion Phase||0
10831970|NCT01425008|11997110|FG012|COMPLETED|Dose Expansion Phase||0
10831971|NCT01425008|11997111|FG013|COMPLETED|Dose Expansion Phase||0
10831972|NCT01425008|11997112|FG014|COMPLETED|Dose Expansion Phase||0
10831973|NCT01425008|11997113|FG015|COMPLETED|Dose Expansion Phase||0
10831974|NCT01425008|11997114|FG016|COMPLETED|Dose Expansion Phase||0
10831975|NCT01425008|11997115|FG017|COMPLETED|Dose Expansion Phase||0
10831976|NCT01425008|11997116|FG018|COMPLETED|Dose Expansion Phase||0
10831977|NCT01425008|11997098|FG000|NOT COMPLETED|Dose Expansion Phase||0
10831978|NCT01425008|11997099|FG001|NOT COMPLETED|Dose Expansion Phase||0
10831979|NCT01425008|11997100|FG002|NOT COMPLETED|Dose Expansion Phase||0
10831980|NCT01425008|11997101|FG003|NOT COMPLETED|Dose Expansion Phase||0
10831981|NCT01425008|11997102|FG004|NOT COMPLETED|Dose Expansion Phase||0
10831982|NCT01425008|11997103|FG005|NOT COMPLETED|Dose Expansion Phase||0
10831983|NCT01425008|11997104|FG006|NOT COMPLETED|Dose Expansion Phase||0
10831984|NCT01425008|11997105|FG007|NOT COMPLETED|Dose Expansion Phase||0
10831985|NCT01425008|11997106|FG008|NOT COMPLETED|Dose Expansion Phase||0
10831986|NCT01425008|11997107|FG009|NOT COMPLETED|Dose Expansion Phase||0
10831987|NCT01425008|11997108|FG010|NOT COMPLETED|Dose Expansion Phase||15
10831988|NCT01425008|11997109|FG011|NOT COMPLETED|Dose Expansion Phase||8
10831989|NCT01425008|11997110|FG012|NOT COMPLETED|Dose Expansion Phase||16
10831990|NCT01425008|11997111|FG013|NOT COMPLETED|Dose Expansion Phase||1
10831991|NCT01425008|11997112|FG014|NOT COMPLETED|Dose Expansion Phase||6
10831992|NCT01425008|11997113|FG015|NOT COMPLETED|Dose Expansion Phase||11
10831993|NCT01425008|11997114|FG016|NOT COMPLETED|Dose Expansion Phase||20
10831994|NCT01425008|11997115|FG017|NOT COMPLETED|Dose Expansion Phase||2
10831995|NCT01425008|11997116|FG018|NOT COMPLETED|Dose Expansion Phase||19
11101842|NCT01233284|12285975|FG003|COMPLETED|Period 1 (4 Weeks)||35
11101843|NCT01233284|12285976|FG004|COMPLETED|Period 1 (4 Weeks)||1
11101844|NCT01233284|12285972|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1
11101845|NCT01233284|12285973|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
11101846|NCT01233284|12285974|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1
10831996|NCT04425902|11997169|FG000|STARTED|Treatment Period 1 (Days 1 to 10)||20
10831997|NCT04425902|11997169|FG000|COMPLETED|Treatment Period 1 (Days 1 to 10)||20
10831998|NCT04425902|11997169|FG000|NOT COMPLETED|Treatment Period 1 (Days 1 to 10)||0
10831999|NCT04425902|11997169|FG000|STARTED|Treatment Period 2 (Days 11 to 20)||20
10832000|NCT04425902|11997169|FG000|COMPLETED|Treatment Period 2 (Days 11 to 20)||19
10832001|NCT04425902|11997169|FG000|NOT COMPLETED|Treatment Period 2 (Days 11 to 20)||1
10832002|NCT04425902|11997169|FG000|STARTED|Treatment Period 3 (Days 21 to 26)||19
10832003|NCT04425902|11997169|FG000|COMPLETED|Treatment Period 3 (Days 21 to 26)||19
10832004|NCT04425902|11997169|FG000|NOT COMPLETED|Treatment Period 3 (Days 21 to 26)||0
10832005|NCT04072146|11997182|FG000|STARTED|Overall Study||11
10832006|NCT04072146|11997183|FG001|STARTED|Overall Study||11
10832007|NCT04072146|11997182|FG000|COMPLETED|Overall Study||11
10832008|NCT04072146|11997183|FG001|COMPLETED|Overall Study||10
10832009|NCT04072146|11997182|FG000|NOT COMPLETED|Overall Study||0
10832010|NCT04072146|11997183|FG001|NOT COMPLETED|Overall Study||1
10832011|NCT03861481|11997197|FG000|STARTED|Overall Study||17
10832012|NCT03861481|11997198|FG001|STARTED|Overall Study||17
10832013|NCT03861481|11997197|FG000|COMPLETED|Overall Study||11
10832014|NCT03861481|11997198|FG001|COMPLETED|Overall Study||10
10832015|NCT03861481|11997197|FG000|NOT COMPLETED|Overall Study||6
10832016|NCT03861481|11997198|FG001|NOT COMPLETED|Overall Study||7
10832017|NCT03708198|11997204|FG000|STARTED|Overall Study||15
10832018|NCT03708198|11997204|FG000|COMPLETED|Overall Study||15
10832019|NCT03708198|11997204|FG000|NOT COMPLETED|Overall Study||0
11101847|NCT01233284|12285975|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
11101848|NCT01233284|12285976|FG004|NOT COMPLETED|Period 1 (4 Weeks)||0
11101849|NCT01233284|12285972|FG000|STARTED|Period 2 (4 Weeks)||36
11101850|NCT01233284|12285973|FG001|STARTED|Period 2 (4 Weeks)||37
11101851|NCT01233284|12285974|FG002|STARTED|Period 2 (4 Weeks)||37
11101852|NCT01233284|12285975|FG003|STARTED|Period 2 (4 Weeks)||35
10832026|NCT03648476|11997214|FG000|STARTED|Overall Study||10
10832027|NCT03648476|11997215|FG001|STARTED|Overall Study||14
10832028|NCT03648476|11997214|FG000|COMPLETED|Overall Study||8
10832029|NCT03648476|11997215|FG001|COMPLETED|Overall Study||13
10832030|NCT03648476|11997214|FG000|NOT COMPLETED|Overall Study||2
10832031|NCT03648476|11997215|FG001|NOT COMPLETED|Overall Study||1
10832032|NCT03375203|11997227|FG000|STARTED|Overall Study||75
10832033|NCT03375203|11997228|FG001|STARTED|Overall Study||72
10832034|NCT03375203|11997229|FG002|STARTED|Overall Study||74
10832035|NCT03375203|11997230|FG003|STARTED|Overall Study||71
10832036|NCT03375203|11997231|FG004|STARTED|Overall Study||73
10832037|NCT03375203|11997227|FG000|COMPLETED|Overall Study||69
10832038|NCT03375203|11997228|FG001|COMPLETED|Overall Study||68
10832039|NCT03375203|11997229|FG002|COMPLETED|Overall Study||72
10832040|NCT03375203|11997230|FG003|COMPLETED|Overall Study||69
10832041|NCT03375203|11997231|FG004|COMPLETED|Overall Study||69
10832042|NCT03375203|11997227|FG000|NOT COMPLETED|Overall Study||6
10832043|NCT03375203|11997228|FG001|NOT COMPLETED|Overall Study||4
10832044|NCT03375203|11997229|FG002|NOT COMPLETED|Overall Study||2
10832045|NCT03375203|11997230|FG003|NOT COMPLETED|Overall Study||2
10832046|NCT03375203|11997231|FG004|NOT COMPLETED|Overall Study||4
10832047|NCT02926833|11997248|FG000|STARTED|Overall Study||3
10832048|NCT02926833|11997249|FG001|STARTED|Overall Study||4
10832049|NCT02926833|11997250|FG002|STARTED|Overall Study||7
10832050|NCT02926833|11997251|FG003|STARTED|Overall Study||23
10832051|NCT02926833|11997248|FG000|COMPLETED|Overall Study||0
10832052|NCT02926833|11997249|FG001|COMPLETED|Overall Study||0
10832053|NCT02926833|11997250|FG002|COMPLETED|Overall Study||0
10832054|NCT02926833|11997251|FG003|COMPLETED|Overall Study||0
10832055|NCT02926833|11997248|FG000|NOT COMPLETED|Overall Study||3
10832056|NCT02926833|11997249|FG001|NOT COMPLETED|Overall Study||4
10832057|NCT02926833|11997250|FG002|NOT COMPLETED|Overall Study||7
10832058|NCT02926833|11997251|FG003|NOT COMPLETED|Overall Study||23
11101853|NCT01233284|12285976|FG004|STARTED|Period 2 (4 Weeks)||1
11101854|NCT01233284|12285972|FG000|COMPLETED|Period 2 (4 Weeks)||36
11101855|NCT01233284|12285973|FG001|COMPLETED|Period 2 (4 Weeks)||37
11101856|NCT01233284|12285974|FG002|COMPLETED|Period 2 (4 Weeks)||36
11101857|NCT01233284|12285975|FG003|COMPLETED|Period 2 (4 Weeks)||35
11101858|NCT01233284|12285976|FG004|COMPLETED|Period 2 (4 Weeks)||1
11101859|NCT01233284|12285972|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
11101860|NCT01233284|12285973|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
11101861|NCT01233284|12285974|FG002|NOT COMPLETED|Period 2 (4 Weeks)||1
11101862|NCT01233284|12285975|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
11101863|NCT01233284|12285976|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0
11101864|NCT01233284|12285972|FG000|STARTED|Period 3 (4 Weeks)||36
10832071|NCT02547662|11997271|FG000|STARTED|Overall Study||17
10832072|NCT02547662|11997271|FG000|COMPLETED|Overall Study||17
10832073|NCT02547662|11997271|FG000|NOT COMPLETED|Overall Study||0
10832074|NCT02348216|11997282|FG000|STARTED|Overall Study||8
10832075|NCT02348216|11997283|FG001|STARTED|Overall Study||81
10832076|NCT02348216|11997284|FG002|STARTED|Overall Study||30
10832077|NCT02348216|11997285|FG003|STARTED|Overall Study||42
10832078|NCT02348216|11997286|FG004|STARTED|Overall Study||46
10832079|NCT02348216|11997287|FG005|STARTED|Overall Study||58
10832080|NCT02348216|11997288|FG006|STARTED|Overall Study||42
10832081|NCT02348216|11997282|FG000|COMPLETED|Overall Study||0
10832082|NCT02348216|11997283|FG001|COMPLETED|Overall Study||0
10832083|NCT02348216|11997284|FG002|COMPLETED|Overall Study||0
10832084|NCT02348216|11997285|FG003|COMPLETED|Overall Study||0
10832085|NCT02348216|11997286|FG004|COMPLETED|Overall Study||0
10832086|NCT02348216|11997287|FG005|COMPLETED|Overall Study||0
10832087|NCT02348216|11997288|FG006|COMPLETED|Overall Study||0
10832088|NCT02348216|11997282|FG000|NOT COMPLETED|Overall Study||8
10832089|NCT02348216|11997283|FG001|NOT COMPLETED|Overall Study||81
10832090|NCT02348216|11997284|FG002|NOT COMPLETED|Overall Study||30
10832091|NCT02348216|11997285|FG003|NOT COMPLETED|Overall Study||42
10832092|NCT02348216|11997286|FG004|NOT COMPLETED|Overall Study||46
10832093|NCT02348216|11997287|FG005|NOT COMPLETED|Overall Study||58
10832094|NCT02348216|11997288|FG006|NOT COMPLETED|Overall Study||42
10832095|NCT02275559|11997328|FG000|STARTED|Overall Study||115
10832096|NCT02275559|11997329|FG001|STARTED|Overall Study||118
10832097|NCT02275559|11997328|FG000|COMPLETED|Overall Study||115
10832098|NCT02275559|11997329|FG001|COMPLETED|Overall Study||118
10832099|NCT02275559|11997328|FG000|NOT COMPLETED|Overall Study||0
10832100|NCT02275559|11997329|FG001|NOT COMPLETED|Overall Study||0
11101865|NCT01233284|12285973|FG001|STARTED|Period 3 (4 Weeks)||37
11101866|NCT01233284|12285974|FG002|STARTED|Period 3 (4 Weeks)||36
11101867|NCT01233284|12285975|FG003|STARTED|Period 3 (4 Weeks)||35
11101868|NCT01233284|12285976|FG004|STARTED|Period 3 (4 Weeks)||1
11101869|NCT01233284|12285972|FG000|COMPLETED|Period 3 (4 Weeks)||36
11101870|NCT01233284|12285973|FG001|COMPLETED|Period 3 (4 Weeks)||37
11101871|NCT01233284|12285974|FG002|COMPLETED|Period 3 (4 Weeks)||35
11101872|NCT01233284|12285975|FG003|COMPLETED|Period 3 (4 Weeks)||34
11101873|NCT01233284|12285976|FG004|COMPLETED|Period 3 (4 Weeks)||1
11101874|NCT01233284|12285972|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
11101875|NCT01233284|12285973|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
11101876|NCT01233284|12285974|FG002|NOT COMPLETED|Period 3 (4 Weeks)||1
11101877|NCT01233284|12285975|FG003|NOT COMPLETED|Period 3 (4 Weeks)||1
11101878|NCT01233284|12285976|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0
11101879|NCT01233284|12285972|FG000|STARTED|Period 4 (4 Weeks)||36
11101880|NCT01233284|12285973|FG001|STARTED|Period 4 (4 Weeks)||37
11101881|NCT01233284|12285974|FG002|STARTED|Period 4 (4 Weeks)||35
11101882|NCT01233284|12285975|FG003|STARTED|Period 4 (4 Weeks)||34
11101883|NCT01233284|12285976|FG004|STARTED|Period 4 (4 Weeks)||1
11101884|NCT01233284|12285972|FG000|COMPLETED|Period 4 (4 Weeks)||36
11101885|NCT01233284|12285973|FG001|COMPLETED|Period 4 (4 Weeks)||36
11101886|NCT01233284|12285974|FG002|COMPLETED|Period 4 (4 Weeks)||35
11101887|NCT01233284|12285975|FG003|COMPLETED|Period 4 (4 Weeks)||33
11101888|NCT01233284|12285976|FG004|COMPLETED|Period 4 (4 Weeks)||1
11101889|NCT01233284|12285972|FG000|NOT COMPLETED|Period 4 (4 Weeks)||0
11101890|NCT01233284|12285973|FG001|NOT COMPLETED|Period 4 (4 Weeks)||1
11101891|NCT01233284|12285974|FG002|NOT COMPLETED|Period 4 (4 Weeks)||0
11101892|NCT01233284|12285975|FG003|NOT COMPLETED|Period 4 (4 Weeks)||1
11101893|NCT01233284|12285976|FG004|NOT COMPLETED|Period 4 (4 Weeks)||0
11101894|NCT01233518|12285986|FG000|STARTED|Overall Study||285
11101895|NCT01233518|12285986|FG000|COMPLETED|Overall Study||252
11101896|NCT01233518|12285986|FG000|NOT COMPLETED|Overall Study||33
11101897|NCT01233609|12285993|FG000|STARTED|Overall Study||46
11101898|NCT01233609|12285994|FG001|STARTED|Overall Study||44
11101899|NCT01233609|12285993|FG000|COMPLETED|Overall Study||37
11101900|NCT01233609|12285994|FG001|COMPLETED|Overall Study||42
11101901|NCT01233609|12285993|FG000|NOT COMPLETED|Overall Study||9
11101902|NCT01233609|12285994|FG001|NOT COMPLETED|Overall Study||2
11101903|NCT01233687|12286008|FG000|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
11101904|NCT01233687|12286008|FG000|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
11101905|NCT01233687|12286008|FG000|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
11101906|NCT01233687|12286008|FG000|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
11101907|NCT01233687|12286008|FG000|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
11101908|NCT01233687|12286008|FG000|COMPLETED|Phase II AMG 102 + Erlotinib||45
11101909|NCT01233687|12286008|FG000|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
11101910|NCT01233726|12286015|FG000|STARTED|Overall Study||53
11101911|NCT01233726|12286016|FG001|STARTED|Overall Study||53
11101912|NCT01233726|12286017|FG002|STARTED|Overall Study||53
11101913|NCT01233726|12286015|FG000|COMPLETED|Overall Study||52
11101914|NCT01233726|12286016|FG001|COMPLETED|Overall Study||53
11220113|NCT01958489|12411705|FG000|STARTED|Period 1||24
11220114|NCT01958489|12411706|FG001|STARTED|Period 1||0
11220115|NCT01958489|12411705|FG000|Received at Least 1 Dose of Study Drug|Period 1||24
11220116|NCT01958489|12411706|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
11220117|NCT01958489|12411705|FG000|COMPLETED|Period 1||24
11220118|NCT01958489|12411706|FG001|COMPLETED|Period 1||0
11220119|NCT01958489|12411705|FG000|NOT COMPLETED|Period 1||0
11220120|NCT01958489|12411706|FG001|NOT COMPLETED|Period 1||0
11220121|NCT01958489|12411705|FG000|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
11220122|NCT01958489|12411706|FG001|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
11220123|NCT01958489|12411705|FG000|Received at Least 1 Dose of Study Drug|Period 2||0
11220124|NCT01958489|12411706|FG001|Received at Least 1 Dose of Study Drug|Period 2||24
11101915|NCT01233726|12286017|FG002|COMPLETED|Overall Study||52
11101916|NCT01233726|12286015|FG000|NOT COMPLETED|Overall Study||1
11101917|NCT01233726|12286016|FG001|NOT COMPLETED|Overall Study||0
11101918|NCT01233726|12286017|FG002|NOT COMPLETED|Overall Study||1
11101919|NCT01233817|12286028|FG000|STARTED|Overall Study||12
11101920|NCT01233817|12286028|FG000|COMPLETED|Overall Study||9
11101921|NCT01233817|12286028|FG000|NOT COMPLETED|Overall Study||3
11101922|NCT01233869|12286036|FG000|STARTED|Initial Treatment Period (24 Months)||58
11101923|NCT01233869|12286037|FG001|STARTED|Initial Treatment Period (24 Months)||31
11101924|NCT01233869|12286038|FG002|STARTED|Initial Treatment Period (24 Months)||24
11101925|NCT01233869|12286039|FG003|STARTED|Initial Treatment Period (24 Months)||56
11101926|NCT01233869|12286036|FG000|COMPLETED|Initial Treatment Period (24 Months)||34
11101927|NCT01233869|12286037|FG001|COMPLETED|Initial Treatment Period (24 Months)||3
11101928|NCT01233869|12286038|FG002|COMPLETED|Initial Treatment Period (24 Months)||22
11101929|NCT01233869|12286039|FG003|COMPLETED|Initial Treatment Period (24 Months)||34
11101930|NCT01233869|12286036|FG000|NOT COMPLETED|Initial Treatment Period (24 Months)||24
11101931|NCT01233869|12286037|FG001|NOT COMPLETED|Initial Treatment Period (24 Months)||28
11101932|NCT01233869|12286038|FG002|NOT COMPLETED|Initial Treatment Period (24 Months)||2
11101933|NCT01233869|12286039|FG003|NOT COMPLETED|Initial Treatment Period (24 Months)||22
11101934|NCT01233869|12286036|FG000|STARTED|Washout Period 30 Days||34
11101935|NCT01233869|12286037|FG001|STARTED|Washout Period 30 Days||3
11101936|NCT01233869|12286038|FG002|STARTED|Washout Period 30 Days||22
11101937|NCT01233869|12286039|FG003|STARTED|Washout Period 30 Days||34
11101938|NCT01233869|12286036|FG000|COMPLETED|Washout Period 30 Days||34
11101939|NCT01233869|12286037|FG001|COMPLETED|Washout Period 30 Days||3
11101940|NCT01233869|12286038|FG002|COMPLETED|Washout Period 30 Days||22
11101941|NCT01233869|12286039|FG003|COMPLETED|Washout Period 30 Days||34
11101942|NCT01233869|12286036|FG000|NOT COMPLETED|Washout Period 30 Days||0
11101943|NCT01233869|12286037|FG001|NOT COMPLETED|Washout Period 30 Days||0
11101944|NCT01233869|12286038|FG002|NOT COMPLETED|Washout Period 30 Days||0
11101945|NCT01233869|12286039|FG003|NOT COMPLETED|Washout Period 30 Days||0
11101946|NCT01233869|12286036|FG000|STARTED|Extended Treatment Period (46 Months)||34
11101947|NCT01233869|12286037|FG001|STARTED|Extended Treatment Period (46 Months)||3
11101948|NCT01233869|12286038|FG002|STARTED|Extended Treatment Period (46 Months)||22
11101949|NCT01233869|12286039|FG003|STARTED|Extended Treatment Period (46 Months)||34
11101950|NCT01233869|12286036|FG000|COMPLETED|Extended Treatment Period (46 Months)||20
11101951|NCT01233869|12286037|FG001|COMPLETED|Extended Treatment Period (46 Months)||0
11101952|NCT01233869|12286038|FG002|COMPLETED|Extended Treatment Period (46 Months)||17
11101953|NCT01233869|12286039|FG003|COMPLETED|Extended Treatment Period (46 Months)||18
11101954|NCT01233869|12286036|FG000|NOT COMPLETED|Extended Treatment Period (46 Months)||14
11101955|NCT01233869|12286037|FG001|NOT COMPLETED|Extended Treatment Period (46 Months)||3
11101956|NCT01233869|12286038|FG002|NOT COMPLETED|Extended Treatment Period (46 Months)||5
11101957|NCT01233869|12286039|FG003|NOT COMPLETED|Extended Treatment Period (46 Months)||16
11101958|NCT01233921|12286051|FG000|STARTED|Overall Study||3
11101959|NCT01233921|12286052|FG001|STARTED|Overall Study||3
11101960|NCT01233921|12286051|FG000|COMPLETED|Overall Study||3
11101961|NCT01233921|12286052|FG001|COMPLETED|Overall Study||3
11101962|NCT01233921|12286051|FG000|NOT COMPLETED|Overall Study||0
11101963|NCT01233921|12286052|FG001|NOT COMPLETED|Overall Study||0
11101964|NCT01233999|12286058|FG000|STARTED|Overall Study||10
11101965|NCT01233999|12286058|FG000|COMPLETED|Overall Study||8
11101966|NCT01233999|12286058|FG000|NOT COMPLETED|Overall Study||2
10832173|NCT01231906|11997356|FG000|STARTED|Overall Study||319
10832174|NCT01231906|11997357|FG001|STARTED|Overall Study||323
10832175|NCT01231906|11997356|FG000|Received Therapy|Overall Study||308
10832176|NCT01231906|11997357|FG001|Received Therapy|Overall Study||318
10832177|NCT01231906|11997356|FG000|COMPLETED|Overall Study||198
10832178|NCT01231906|11997357|FG001|COMPLETED|Overall Study||222
10832179|NCT01231906|11997356|FG000|NOT COMPLETED|Overall Study||121
10832180|NCT01231906|11997357|FG001|NOT COMPLETED|Overall Study||101
11101967|NCT01234207|12286062|FG000|STARTED|First Intervention||47
11101968|NCT01234207|12286063|FG001|STARTED|First Intervention||48
11101969|NCT01234207|12286062|FG000|COMPLETED|First Intervention||47
10832181|NCT01470326|11997363|FG000|STARTED|Overall Study||3187
10832182|NCT01470326|11997363|FG000|COMPLETED|Overall Study||3034
10832183|NCT01470326|11997363|FG000|NOT COMPLETED|Overall Study||153
10832184|NCT01480180|11997369|FG000|STARTED|Main Phase||174
10832185|NCT01480180|11997370|FG001|STARTED|Main Phase||12
10832186|NCT01480180|11997371|FG002|STARTED|Main Phase|Not applicable for this phase|0
10832187|NCT01480180|11997372|FG003|STARTED|Main Phase|Not applicable for this phase|0
10832188|NCT01480180|11997373|FG004|STARTED|Main Phase|Not applicable for this phase|0
10832189|NCT01480180|11997374|FG005|STARTED|Main Phase|Not applicable for this phase|0
10832190|NCT01480180|11997369|FG000|Max. Participants After Switching|Main Phase||175
10832191|NCT01480180|11997370|FG001|Max. Participants After Switching|Main Phase||11
10832192|NCT01480180|11997371|FG002|Max. Participants After Switching|Main Phase||0
10832193|NCT01480180|11997372|FG003|Max. Participants After Switching|Main Phase||0
10832194|NCT01480180|11997373|FG004|Max. Participants After Switching|Main Phase||0
10832195|NCT01480180|11997374|FG005|Max. Participants After Switching|Main Phase||0
10832196|NCT01480180|11997369|FG000|COMPLETED|Main Phase||155
10832197|NCT01480180|11997370|FG001|COMPLETED|Main Phase||11
10832198|NCT01480180|11997371|FG002|COMPLETED|Main Phase|Not applicable for this phase|0
10832199|NCT01480180|11997372|FG003|COMPLETED|Main Phase|Not applicable for this phase|0
10832200|NCT01480180|11997373|FG004|COMPLETED|Main Phase|Not applicable for this phase|0
10832201|NCT01480180|11997374|FG005|COMPLETED|Main Phase|Not applicable for this phase|0
10832202|NCT01480180|11997369|FG000|NOT COMPLETED|Main Phase||19
10832203|NCT01480180|11997370|FG001|NOT COMPLETED|Main Phase||1
10832204|NCT01480180|11997371|FG002|NOT COMPLETED|Main Phase||0
10832205|NCT01480180|11997372|FG003|NOT COMPLETED|Main Phase||0
10832206|NCT01480180|11997373|FG004|NOT COMPLETED|Main Phase||0
10832207|NCT01480180|11997374|FG005|NOT COMPLETED|Main Phase||0
10832208|NCT01480180|11997369|FG000|STARTED|Extension Phase, Part 1||0
10832209|NCT01480180|11997370|FG001|STARTED|Extension Phase, Part 1||0
10832210|NCT01480180|11997371|FG002|STARTED|Extension Phase, Part 1||105
10832211|NCT01480180|11997372|FG003|STARTED|Extension Phase, Part 1||38
10832212|NCT01480180|11997373|FG004|STARTED|Extension Phase, Part 1||7
10832213|NCT01480180|11997374|FG005|STARTED|Extension Phase, Part 1||0
10832214|NCT01480180|11997369|FG000|COMPLETED|Extension Phase, Part 1||0
10832215|NCT01480180|11997370|FG001|COMPLETED|Extension Phase, Part 1||0
10832216|NCT01480180|11997371|FG002|COMPLETED|Extension Phase, Part 1||95
10832217|NCT01480180|11997372|FG003|COMPLETED|Extension Phase, Part 1||28
10832218|NCT01480180|11997373|FG004|COMPLETED|Extension Phase, Part 1||7
10832219|NCT01480180|11997374|FG005|COMPLETED|Extension Phase, Part 1||0
10832220|NCT01480180|11997369|FG000|NOT COMPLETED|Extension Phase, Part 1||0
10832221|NCT01480180|11997370|FG001|NOT COMPLETED|Extension Phase, Part 1||0
10832222|NCT01480180|11997371|FG002|NOT COMPLETED|Extension Phase, Part 1||10
10832223|NCT01480180|11997372|FG003|NOT COMPLETED|Extension Phase, Part 1||10
10832224|NCT01480180|11997373|FG004|NOT COMPLETED|Extension Phase, Part 1||0
10832225|NCT01480180|11997374|FG005|NOT COMPLETED|Extension Phase, Part 1||0
10832226|NCT01480180|11997369|FG000|STARTED|Extension Phase, Part 2||0
10832227|NCT01480180|11997370|FG001|STARTED|Extension Phase, Part 2||0
10832228|NCT01480180|11997371|FG002|STARTED|Extension Phase, Part 2||94
10832229|NCT01480180|11997372|FG003|STARTED|Extension Phase, Part 2||40
10832230|NCT01480180|11997373|FG004|STARTED|Extension Phase, Part 2||5
10832231|NCT01480180|11997374|FG005|STARTED|Extension Phase, Part 2||0
10832232|NCT01480180|11997369|FG000|COMPLETED|Extension Phase, Part 2||0
10832233|NCT01480180|11997370|FG001|COMPLETED|Extension Phase, Part 2||0
10832234|NCT01480180|11997371|FG002|COMPLETED|Extension Phase, Part 2||77
10832235|NCT01480180|11997372|FG003|COMPLETED|Extension Phase, Part 2||33
10832236|NCT01480180|11997373|FG004|COMPLETED|Extension Phase, Part 2||3
10832237|NCT01480180|11997374|FG005|COMPLETED|Extension Phase, Part 2||0
10832238|NCT01480180|11997369|FG000|NOT COMPLETED|Extension Phase, Part 2||0
10832239|NCT01480180|11997370|FG001|NOT COMPLETED|Extension Phase, Part 2||0
10832240|NCT01480180|11997371|FG002|NOT COMPLETED|Extension Phase, Part 2||17
10832241|NCT01480180|11997372|FG003|NOT COMPLETED|Extension Phase, Part 2||7
10832242|NCT01480180|11997373|FG004|NOT COMPLETED|Extension Phase, Part 2||2
10832243|NCT01480180|11997374|FG005|NOT COMPLETED|Extension Phase, Part 2||0
10832244|NCT01504438|11997397|FG000|STARTED|Overall Study||48
10832245|NCT01504438|11997398|FG001|STARTED|Overall Study||50
10832246|NCT01504438|11997397|FG000|COMPLETED|Overall Study||22
10832247|NCT01504438|11997398|FG001|COMPLETED|Overall Study||25
10832248|NCT01504438|11997397|FG000|NOT COMPLETED|Overall Study||26
10832249|NCT01504438|11997398|FG001|NOT COMPLETED|Overall Study||25
10832250|NCT01545050|11997410|FG000|STARTED|Overall Study||18
10832251|NCT01545050|11997411|FG001|STARTED|Overall Study||9
10832252|NCT01545050|11997412|FG002|STARTED|Overall Study||9
10832253|NCT01545050|11997413|FG003|STARTED|Overall Study||18
10832254|NCT01545050|11997414|FG004|STARTED|Overall Study||18
10832255|NCT01545050|11997410|FG000|COMPLETED|Overall Study||11
10832256|NCT01545050|11997411|FG001|COMPLETED|Overall Study||4
10832257|NCT01545050|11997412|FG002|COMPLETED|Overall Study||4
10832258|NCT01545050|11997413|FG003|COMPLETED|Overall Study||6
10832259|NCT01545050|11997414|FG004|COMPLETED|Overall Study||9
10832260|NCT01545050|11997410|FG000|NOT COMPLETED|Overall Study||7
10832261|NCT01545050|11997411|FG001|NOT COMPLETED|Overall Study||5
10832262|NCT01545050|11997412|FG002|NOT COMPLETED|Overall Study||5
10832263|NCT01545050|11997413|FG003|NOT COMPLETED|Overall Study||12
10832264|NCT01545050|11997414|FG004|NOT COMPLETED|Overall Study||9
10832265|NCT01550302|11997432|FG000|STARTED|Overall Study||5
10832266|NCT01550302|11997433|FG001|STARTED|Overall Study||5
10832267|NCT01550302|11997432|FG000|COMPLETED|Overall Study||5
10832268|NCT01550302|11997433|FG001|COMPLETED|Overall Study||5
10832269|NCT01550302|11997432|FG000|NOT COMPLETED|Overall Study||0
10832270|NCT01550302|11997433|FG001|NOT COMPLETED|Overall Study||0
11101970|NCT01234207|12286063|FG001|COMPLETED|First Intervention||48
11101971|NCT01234207|12286062|FG000|NOT COMPLETED|First Intervention||0
11101972|NCT01234207|12286063|FG001|NOT COMPLETED|First Intervention||0
11101973|NCT01234207|12286062|FG000|STARTED|1-Week Washout Period||47
11101974|NCT01234207|12286063|FG001|STARTED|1-Week Washout Period||48
11101975|NCT01234207|12286062|FG000|COMPLETED|1-Week Washout Period||47
11101976|NCT01234207|12286063|FG001|COMPLETED|1-Week Washout Period||48
11101977|NCT01234207|12286062|FG000|NOT COMPLETED|1-Week Washout Period||0
11101978|NCT01234207|12286063|FG001|NOT COMPLETED|1-Week Washout Period||0
11101979|NCT01234207|12286062|FG000|STARTED|Second Intervention||47
11101980|NCT01234207|12286063|FG001|STARTED|Second Intervention||48
11101981|NCT01234207|12286062|FG000|COMPLETED|Second Intervention||47
11101982|NCT01234207|12286063|FG001|COMPLETED|Second Intervention||48
11101983|NCT01234207|12286062|FG000|NOT COMPLETED|Second Intervention||0
11101984|NCT01234207|12286063|FG001|NOT COMPLETED|Second Intervention||0
11101985|NCT01234337|12286073|FG000|STARTED|Overall Study||266
11101986|NCT01234337|12286074|FG001|STARTED|Overall Study||271
11101987|NCT01234337|12286073|FG000|Participants Received Treatment|Overall Study||260
11101988|NCT01234337|12286074|FG001|Participants Received Treatment|Overall Study||267
11101989|NCT01234337|12286073|FG000|COMPLETED|Overall Study||0
11101990|NCT01234337|12286074|FG001|COMPLETED|Overall Study||0
11101991|NCT01234337|12286073|FG000|NOT COMPLETED|Overall Study||266
11101992|NCT01234337|12286074|FG001|NOT COMPLETED|Overall Study||271
11101993|NCT01234350|12286082|FG000|STARTED|Overall Study||1000
11101994|NCT01234350|12286083|FG001|STARTED|Overall Study||493
11101995|NCT01234350|12286082|FG000|COMPLETED|Overall Study||313
11101996|NCT01234350|12286083|FG001|COMPLETED|Overall Study||226
11101997|NCT01234350|12286082|FG000|NOT COMPLETED|Overall Study||687
11101998|NCT01234350|12286083|FG001|NOT COMPLETED|Overall Study||267
11101999|NCT01234402|12286094|FG000|STARTED|Overall Study||52
11102000|NCT01234402|12286095|FG001|STARTED|Overall Study||51
11102001|NCT01234402|12286096|FG002|STARTED|Overall Study||50
11102002|NCT01234402|12286094|FG000|Received at Least One Dose of Study Drug|Overall Study||52
11102003|NCT01234402|12286095|FG001|Received at Least One Dose of Study Drug|Overall Study||49
11102004|NCT01234402|12286096|FG002|Received at Least One Dose of Study Drug|Overall Study||49
11102005|NCT01234402|12286094|FG000|Capecitabine Crossover to Ramucirumab|Overall Study||0
11102006|NCT01234402|12286095|FG001|Capecitabine Crossover to Ramucirumab|Overall Study||0
11102007|NCT01234402|12286096|FG002|Capecitabine Crossover to Ramucirumab|Overall Study||29
11102008|NCT01234402|12286094|FG000|Capecitabine Crossover to Icrucumab|Overall Study||0
11102009|NCT01234402|12286095|FG001|Capecitabine Crossover to Icrucumab|Overall Study||0
11102010|NCT01234402|12286096|FG002|Capecitabine Crossover to Icrucumab|Overall Study||1
11102011|NCT01234402|12286094|FG000|COMPLETED|Overall Study||51
11102012|NCT01234402|12286095|FG001|COMPLETED|Overall Study||45
11102013|NCT01234402|12286096|FG002|COMPLETED|Overall Study||42
11102014|NCT01234402|12286094|FG000|NOT COMPLETED|Overall Study||1
11102015|NCT01234402|12286095|FG001|NOT COMPLETED|Overall Study||6
11102016|NCT01234402|12286096|FG002|NOT COMPLETED|Overall Study||8
11102017|NCT01234467|12286106|FG000|STARTED|Overall Study||23
11102018|NCT01234467|12286106|FG000|COMPLETED|Overall Study||11
11102019|NCT01234467|12286106|FG000|NOT COMPLETED|Overall Study||12
11102020|NCT01234480|12286110|FG000|STARTED|Overall Study||5859
11102021|NCT01234480|12286110|FG000|COMPLETED|Overall Study||5416
11102022|NCT01234480|12286110|FG000|NOT COMPLETED|Overall Study||443
11102023|NCT01234649|12286119|FG000|STARTED|Overall Study||78
11102024|NCT01234649|12286120|FG001|STARTED|Overall Study||75
11102025|NCT01234649|12286119|FG000|COMPLETED|Overall Study||35
11102026|NCT01234649|12286120|FG001|COMPLETED|Overall Study||37
11102027|NCT01234649|12286119|FG000|NOT COMPLETED|Overall Study||43
11102028|NCT01234649|12286120|FG001|NOT COMPLETED|Overall Study||38
11102029|NCT01234675|12286126|FG000|STARTED|First Intervention (6 Weeks)||10
11102030|NCT01234675|12286127|FG001|STARTED|First Intervention (6 Weeks)||9
11102031|NCT01234675|12286126|FG000|COMPLETED|First Intervention (6 Weeks)||9
11102032|NCT01234675|12286127|FG001|COMPLETED|First Intervention (6 Weeks)||8
11102033|NCT01234675|12286126|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
11220125|NCT01958489|12411705|FG000|COMPLETED|Period 2||0
11220126|NCT01958489|12411706|FG001|COMPLETED|Period 2||23
11220127|NCT01958489|12411705|FG000|NOT COMPLETED|Period 2||0
11220128|NCT01958489|12411706|FG001|NOT COMPLETED|Period 2||1
11220129|NCT01958606|12411719|FG000|STARTED|Overall Study||13
10832271|NCT01555021|11997441|FG000|STARTED|Overall Study||2
10832272|NCT01555021|11997442|FG001|STARTED|Overall Study||2
10832273|NCT01555021|11997441|FG000|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
10832274|NCT01555021|11997442|FG001|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
10832275|NCT01555021|11997441|FG000|NOT COMPLETED|Overall Study||1
10832276|NCT01555021|11997442|FG001|NOT COMPLETED|Overall Study||2
10832277|NCT01561430|11997458|FG000|STARTED|Overall Study||9
10832278|NCT01561430|11997459|FG001|STARTED|Overall Study||23
10832279|NCT01561430|11997460|FG002|STARTED|Overall Study||18
10832280|NCT01561430|11997461|FG003|STARTED|Overall Study||20
10832281|NCT01561430|11997458|FG000|Received at Least One Dose of Study Drug|Overall Study||9
10832282|NCT01561430|11997459|FG001|Received at Least One Dose of Study Drug|Overall Study||23
10832283|NCT01561430|11997460|FG002|Received at Least One Dose of Study Drug|Overall Study||18
10832284|NCT01561430|11997461|FG003|Received at Least One Dose of Study Drug|Overall Study||20
10832285|NCT01561430|11997458|FG000|COMPLETED|Overall Study||8
10832286|NCT01561430|11997459|FG001|COMPLETED|Overall Study||8
10832287|NCT01561430|11997460|FG002|COMPLETED|Overall Study||1
10832288|NCT01561430|11997461|FG003|COMPLETED|Overall Study||7
11220130|NCT01958606|12411720|FG001|STARTED|Overall Study||5
11220131|NCT01958606|12411719|FG000|COMPLETED|Overall Study||11
11220132|NCT01958606|12411720|FG001|COMPLETED|Overall Study||5
11220133|NCT01958606|12411719|FG000|NOT COMPLETED|Overall Study||2
11220134|NCT01958606|12411720|FG001|NOT COMPLETED|Overall Study||0
11220135|NCT01958619|12411730|FG000|STARTED|Overall Study||15
11220136|NCT01958619|12411731|FG001|STARTED|Overall Study||14
10832289|NCT01561430|11997458|FG000|NOT COMPLETED|Overall Study||1
10832290|NCT01561430|11997459|FG001|NOT COMPLETED|Overall Study||15
10832291|NCT01561430|11997460|FG002|NOT COMPLETED|Overall Study||17
10832292|NCT01561430|11997461|FG003|NOT COMPLETED|Overall Study||13
10832293|NCT01580813|11997472|FG000|STARTED|Overall Study||4
10832294|NCT01580813|11997473|FG001|STARTED|Overall Study||3
10832295|NCT01580813|11997472|FG000|Completed First Intervention|Overall Study||4
10832296|NCT01580813|11997473|FG001|Completed First Intervention|Overall Study||3
10832297|NCT01580813|11997472|FG000|Completed 1 Week Washout|Overall Study||4
10832298|NCT01580813|11997473|FG001|Completed 1 Week Washout|Overall Study||3
10832299|NCT01580813|11997472|FG000|Started Second Intervention|Overall Study||4
10832300|NCT01580813|11997473|FG001|Started Second Intervention|Overall Study||3
10832301|NCT01580813|11997472|FG000|COMPLETED|Overall Study||4
10832302|NCT01580813|11997473|FG001|COMPLETED|Overall Study||3
10832303|NCT01580813|11997472|FG000|NOT COMPLETED|Overall Study||0
10832304|NCT01580813|11997473|FG001|NOT COMPLETED|Overall Study||0
10832305|NCT01595009|11997481|FG000|STARTED|Core||126
10832306|NCT01595009|11997482|FG001|STARTED|Core||120
10832307|NCT01595009|11997483|FG002|STARTED|Core||0
10832308|NCT01595009|11997484|FG003|STARTED|Core||0
10832309|NCT01595009|11997481|FG000|COMPLETED|Core||0
10832310|NCT01595009|11997482|FG001|COMPLETED|Core||0
10832311|NCT01595009|11997483|FG002|COMPLETED|Core||0
10832312|NCT01595009|11997484|FG003|COMPLETED|Core||0
10832313|NCT01595009|11997481|FG000|NOT COMPLETED|Core||126
10832314|NCT01595009|11997482|FG001|NOT COMPLETED|Core||120
10832315|NCT01595009|11997483|FG002|NOT COMPLETED|Core||0
10832316|NCT01595009|11997484|FG003|NOT COMPLETED|Core||0
10832317|NCT01595009|11997481|FG000|STARTED|Extension||0
10832318|NCT01595009|11997482|FG001|STARTED|Extension||0
10832319|NCT01595009|11997483|FG002|STARTED|Extension||4
10832320|NCT01595009|11997484|FG003|STARTED|Extension||11
10832321|NCT01595009|11997481|FG000|COMPLETED|Extension||0
10832322|NCT01595009|11997482|FG001|COMPLETED|Extension||0
10832323|NCT01595009|11997483|FG002|COMPLETED|Extension||0
10832324|NCT01595009|11997484|FG003|COMPLETED|Extension||0
10832325|NCT01595009|11997481|FG000|NOT COMPLETED|Extension||0
10832326|NCT01595009|11997482|FG001|NOT COMPLETED|Extension||0
10832327|NCT01595009|11997483|FG002|NOT COMPLETED|Extension||4
10832328|NCT01595009|11997484|FG003|NOT COMPLETED|Extension||11
10832329|NCT01613807|11997501|FG000|STARTED|Overall Study||20
10832330|NCT01613807|11997502|FG001|STARTED|Overall Study||20
10832331|NCT01613807|11997501|FG000|COMPLETED|Overall Study||20
10832332|NCT01613807|11997502|FG001|COMPLETED|Overall Study||20
10832333|NCT01613807|11997501|FG000|NOT COMPLETED|Overall Study||0
10832334|NCT01613807|11997502|FG001|NOT COMPLETED|Overall Study||0
10832335|NCT01620944|11997512|FG000|STARTED|Overall Study||2
10832336|NCT01620944|11997513|FG001|STARTED|Overall Study||1
10832337|NCT01620944|11997512|FG000|COMPLETED|Overall Study||0
10832338|NCT01620944|11997513|FG001|COMPLETED|Overall Study||0
10832339|NCT01620944|11997512|FG000|NOT COMPLETED|Overall Study||2
10832340|NCT01620944|11997513|FG001|NOT COMPLETED|Overall Study||1
10832341|NCT01627561|11997521|FG000|STARTED|Overall Study||74
10832342|NCT01627561|11997522|FG001|STARTED|Overall Study||74
10832343|NCT01627561|11997521|FG000|COMPLETED|Overall Study||73
10832344|NCT01627561|11997522|FG001|COMPLETED|Overall Study||71
10832345|NCT01627561|11997521|FG000|NOT COMPLETED|Overall Study||1
10832346|NCT01627561|11997522|FG001|NOT COMPLETED|Overall Study||3
10832359|NCT01652534|11997547|FG000|STARTED|Overall Study||2
10832360|NCT01652534|11997548|FG001|STARTED|Overall Study||1
10832361|NCT01652534|11997547|FG000|COMPLETED|Overall Study||1
10832347|NCT01629511|11997532|FG000|STARTED|Overall Study||4
10832348|NCT01629511|11997533|FG001|STARTED|Overall Study||0
10832349|NCT01629511|11997534|FG002|STARTED|Overall Study||8
10832350|NCT01629511|11997535|FG003|STARTED|Overall Study||3
10832351|NCT01629511|11997532|FG000|COMPLETED|Overall Study||4
10832352|NCT01629511|11997533|FG001|COMPLETED|Overall Study||0
10832353|NCT01629511|11997534|FG002|COMPLETED|Overall Study||8
10832354|NCT01629511|11997535|FG003|COMPLETED|Overall Study||3
10832355|NCT01629511|11997532|FG000|NOT COMPLETED|Overall Study||0
10832356|NCT01629511|11997533|FG001|NOT COMPLETED|Overall Study||0
10832357|NCT01629511|11997534|FG002|NOT COMPLETED|Overall Study||0
10832358|NCT01629511|11997535|FG003|NOT COMPLETED|Overall Study||0
10832362|NCT01652534|11997548|FG001|COMPLETED|Overall Study||1
10832363|NCT01652534|11997547|FG000|NOT COMPLETED|Overall Study||1
10832364|NCT01652534|11997548|FG001|NOT COMPLETED|Overall Study||0
10832365|NCT01670565|11997556|FG000|STARTED|Overall Study||10
10832366|NCT01670565|11997557|FG001|STARTED|Overall Study||10
10832367|NCT01670565|11997556|FG000|COMPLETED|Overall Study||9
10832368|NCT01670565|11997557|FG001|COMPLETED|Overall Study||9
10832369|NCT01670565|11997556|FG000|NOT COMPLETED|Overall Study||1
10832370|NCT01670565|11997557|FG001|NOT COMPLETED|Overall Study||1
10832371|NCT04871425|11997567|FG000|STARTED|Overall Study||57
10832372|NCT04871425|11997568|FG001|STARTED|Overall Study||53
10832373|NCT04871425|11997567|FG000|COMPLETED|Overall Study||42
10832374|NCT04871425|11997568|FG001|COMPLETED|Overall Study||45
10832375|NCT04871425|11997567|FG000|NOT COMPLETED|Overall Study||15
10832376|NCT04871425|11997568|FG001|NOT COMPLETED|Overall Study||8
10832377|NCT04799405|11997574|FG000|STARTED|Phase 1 - Acute Stimulation, Daily tDCS||5
10832378|NCT04799405|11997574|FG000|COMPLETED|Phase 1 - Acute Stimulation, Daily tDCS||3
10832379|NCT04799405|11997574|FG000|NOT COMPLETED|Phase 1 - Acute Stimulation, Daily tDCS||2
10832380|NCT04799405|11997574|FG000|STARTED|Phase 2 - Tapered Stimulation Schedule||3
10832381|NCT04799405|11997574|FG000|COMPLETED|Phase 2 - Tapered Stimulation Schedule||3
10832382|NCT04799405|11997574|FG000|NOT COMPLETED|Phase 2 - Tapered Stimulation Schedule||0
10832383|NCT04799405|11997574|FG000|STARTED|Phase 3 - Follow up Phase||3
10832384|NCT04799405|11997574|FG000|COMPLETED|Phase 3 - Follow up Phase||3
10832385|NCT04799405|11997574|FG000|NOT COMPLETED|Phase 3 - Follow up Phase||0
10832386|NCT04748458|11997578|FG000|STARTED|Overall Study||85
10832387|NCT04748458|11997578|FG000|COMPLETED|Overall Study||85
10832388|NCT04748458|11997578|FG000|NOT COMPLETED|Overall Study||0
10832389|NCT04529499|11997584|FG000|STARTED|Overall Study||175
10832390|NCT04529499|11997585|FG001|STARTED|Overall Study||178
10832391|NCT04529499|11997584|FG000|Discharged From Hospital Before Day 28|Overall Study||136
10832392|NCT04529499|11997585|FG001|Discharged From Hospital Before Day 28|Overall Study||136
10832393|NCT04529499|11997584|FG000|Completed 10-day Treatment Course of IMP|Overall Study||150
10832394|NCT04529499|11997585|FG001|Completed 10-day Treatment Course of IMP|Overall Study||147
10832395|NCT04529499|11997584|FG000|Completed Day 14 Telephonic Visit|Overall Study||107
10832396|NCT04529499|11997585|FG001|Completed Day 14 Telephonic Visit|Overall Study||102
10832397|NCT04529499|11997584|FG000|Completed Day 21 Telephonic Visit|Overall Study||119
10832398|NCT04529499|11997585|FG001|Completed Day 21 Telephonic Visit|Overall Study||120
10832399|NCT04529499|11997584|FG000|Completed Day 28 Telephonic Visit|Overall Study||134
10832400|NCT04529499|11997585|FG001|Completed Day 28 Telephonic Visit|Overall Study||131
10832401|NCT04529499|11997584|FG000|Completed Days 14, 21 and 28 Telephonic Visits in Stage I|Overall Study||98
10832402|NCT04529499|11997585|FG001|Completed Days 14, 21 and 28 Telephonic Visits in Stage I|Overall Study||94
10832403|NCT04529499|11997584|FG000|Continue to be in Hospital as of Day 28|Overall Study||6
10832404|NCT04529499|11997585|FG001|Continue to be in Hospital as of Day 28|Overall Study||4
10832405|NCT04529499|11997584|FG000|Completed Day 42 Telephonic Visit|Overall Study||136
10832406|NCT04529499|11997585|FG001|Completed Day 42 Telephonic Visit|Overall Study||135
10832407|NCT04529499|11997584|FG000|Completed Day 60 Telephonic Visit|Overall Study||129
10832408|NCT04529499|11997585|FG001|Completed Day 60 Telephonic Visit|Overall Study||132
10832409|NCT04529499|11997584|FG000|Completed Days 42 and 60 Telephonic Visits in Stage II|Overall Study||126
10832410|NCT04529499|11997585|FG001|Completed Days 42 and 60 Telephonic Visits in Stage II|Overall Study||130
10832411|NCT04529499|11997584|FG000|Continued to be in Hospital When Study Was Terminated|Overall Study||11
10832412|NCT04529499|11997585|FG001|Continued to be in Hospital When Study Was Terminated|Overall Study||17
10832413|NCT04529499|11997584|FG000|COMPLETED|Overall Study||139
10832414|NCT04529499|11997585|FG001|COMPLETED|Overall Study||138
10832415|NCT04529499|11997584|FG000|NOT COMPLETED|Overall Study||36
10832416|NCT04529499|11997585|FG001|NOT COMPLETED|Overall Study||40
10832417|NCT04501094|11997593|FG000|STARTED|Overall Study||1
10832418|NCT04501094|11997594|FG001|STARTED|Overall Study||1
10832419|NCT04501094|11997593|FG000|COMPLETED|Overall Study||0
10832420|NCT04501094|11997594|FG001|COMPLETED|Overall Study||1
10832421|NCT04501094|11997593|FG000|NOT COMPLETED|Overall Study||1
10832422|NCT04501094|11997594|FG001|NOT COMPLETED|Overall Study||0
10832423|NCT04414618|11997602|FG000|STARTED|Overall Study||23
10832424|NCT04414618|11997603|FG001|STARTED|Overall Study||19
10832425|NCT04414618|11997602|FG000|COMPLETED|Overall Study||15
10832426|NCT04414618|11997603|FG001|COMPLETED|Overall Study||12
10832427|NCT04414618|11997602|FG000|NOT COMPLETED|Overall Study||8
10832428|NCT04414618|11997603|FG001|NOT COMPLETED|Overall Study||7
10832429|NCT04412057|11997612|FG000|STARTED|Overall Study||41
10832430|NCT04412057|11997613|FG001|STARTED|Overall Study||42
10832431|NCT04412057|11997612|FG000|Randomized Analysis Set|Overall Study||41
10832432|NCT04412057|11997613|FG001|Randomized Analysis Set|Overall Study||42
10832433|NCT04412057|11997612|FG000|Safety Analysis Set|Overall Study||40
10832434|NCT04412057|11997613|FG001|Safety Analysis Set|Overall Study||42
10832435|NCT04412057|11997612|FG000|Full Analysis Set|Overall Study||40
10832436|NCT04412057|11997613|FG001|Full Analysis Set|Overall Study||42
10832437|NCT04412057|11997612|FG000|Primary Analysis Set|Overall Study||31
10832438|NCT04412057|11997613|FG001|Primary Analysis Set|Overall Study||31
10832439|NCT04412057|11997612|FG000|COMPLETED|Overall Study||37
10832440|NCT04412057|11997613|FG001|COMPLETED|Overall Study||35
10832441|NCT04412057|11997612|FG000|NOT COMPLETED|Overall Study||4
10832442|NCT04412057|11997613|FG001|NOT COMPLETED|Overall Study||7
10832443|NCT04402060|11997622|FG000|STARTED|Overall Study||6
10832444|NCT04402060|11997623|FG001|STARTED|Overall Study||34
10832445|NCT04402060|11997624|FG002|STARTED|Overall Study||32
10832446|NCT04402060|11997622|FG000|Received Treatment|Overall Study||6
10832447|NCT04402060|11997623|FG001|Received Treatment|Overall Study||33
10832448|NCT04402060|11997624|FG002|Received Treatment|Overall Study||32
10832449|NCT04402060|11997622|FG000|COMPLETED|Overall Study||5
10832450|NCT04402060|11997623|FG001|COMPLETED|Overall Study||18
10832451|NCT04402060|11997624|FG002|COMPLETED|Overall Study||21
10832452|NCT04402060|11997622|FG000|NOT COMPLETED|Overall Study||1
10832453|NCT04402060|11997623|FG001|NOT COMPLETED|Overall Study||16
10832454|NCT04402060|11997624|FG002|NOT COMPLETED|Overall Study||11
10832455|NCT04396626|11997637|FG000|STARTED|Overall Study||975
10832456|NCT04396626|11997637|FG000|COMPLETED|Overall Study||0
10832457|NCT04396626|11997637|FG000|NOT COMPLETED|Overall Study||975
10832458|NCT04391179|11997643|FG000|STARTED|Overall Study||49
10832459|NCT04391179|11997644|FG001|STARTED|Overall Study||50
10832460|NCT04391179|11997643|FG000|COMPLETED|Overall Study||34
10832461|NCT04391179|11997644|FG001|COMPLETED|Overall Study||34
10832462|NCT04391179|11997643|FG000|NOT COMPLETED|Overall Study||15
11102034|NCT01234675|12286127|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1
11102035|NCT01234675|12286126|FG000|STARTED|Second Intervention (6 Weeks)||9
11102036|NCT01234675|12286127|FG001|STARTED|Second Intervention (6 Weeks)||8
11102037|NCT01234675|12286126|FG000|COMPLETED|Second Intervention (6 Weeks)||7
11102038|NCT01234675|12286127|FG001|COMPLETED|Second Intervention (6 Weeks)||8
11102039|NCT01234675|12286126|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||2
11102040|NCT01234675|12286127|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
11102041|NCT01234714|12286133|FG000|STARTED|Overall Study||84
11102042|NCT01234714|12286133|FG000|COMPLETED|Overall Study||84
11102043|NCT01234714|12286133|FG000|NOT COMPLETED|Overall Study||0
11102044|NCT01234766|12286140|FG000|STARTED|Overall Study||39
11102045|NCT01234766|12286140|FG000|COMPLETED|Overall Study||35
11102046|NCT01234766|12286140|FG000|NOT COMPLETED|Overall Study||4
11102047|NCT01234831|12286146|FG000|STARTED|Overall Study||261
11102048|NCT01234831|12286147|FG001|STARTED|Overall Study||202
11102049|NCT01234831|12286146|FG000|COMPLETED|Overall Study||259
11102050|NCT01234831|12286147|FG001|COMPLETED|Overall Study||198
11102051|NCT01234831|12286146|FG000|NOT COMPLETED|Overall Study||2
11102052|NCT01234831|12286147|FG001|NOT COMPLETED|Overall Study||4
11102053|NCT01234870|12286154|FG000|STARTED|Overall Study||40
11102054|NCT01234870|12286154|FG000|COMPLETED|Overall Study||40
11102055|NCT01234870|12286154|FG000|NOT COMPLETED|Overall Study||0
11102056|NCT01234883|12286161|FG000|STARTED|Overall Study||51
11102057|NCT01234883|12286162|FG001|STARTED|Overall Study||49
11102058|NCT01234883|12286161|FG000|COMPLETED|Overall Study||41
11102059|NCT01234883|12286162|FG001|COMPLETED|Overall Study||36
11102060|NCT01234883|12286161|FG000|NOT COMPLETED|Overall Study||10
11102061|NCT01234883|12286162|FG001|NOT COMPLETED|Overall Study||13
11102062|NCT01234922|12286172|FG000|STARTED|Overall Study||1
11102063|NCT01234922|12286173|FG001|STARTED|Overall Study||1
11102064|NCT01234922|12286174|FG002|STARTED|Overall Study||2
11102065|NCT01234922|12286175|FG003|STARTED|Overall Study||2
11102066|NCT01234922|12286172|FG000|COMPLETED|Overall Study||1
11102067|NCT01234922|12286173|FG001|COMPLETED|Overall Study||1
11102068|NCT01234922|12286174|FG002|COMPLETED|Overall Study||2
11102069|NCT01234922|12286175|FG003|COMPLETED|Overall Study||2
11102070|NCT01234922|12286172|FG000|NOT COMPLETED|Overall Study||0
11102071|NCT01234922|12286173|FG001|NOT COMPLETED|Overall Study||0
11102072|NCT01234922|12286174|FG002|NOT COMPLETED|Overall Study||0
11102073|NCT01234922|12286175|FG003|NOT COMPLETED|Overall Study||0
11102074|NCT01235195|12286185|FG000|STARTED|First Intervention||15
11102075|NCT01235195|12286186|FG001|STARTED|First Intervention||15
11102076|NCT01235195|12286185|FG000|COMPLETED|First Intervention||15
11102077|NCT01235195|12286186|FG001|COMPLETED|First Intervention||15
11102078|NCT01235195|12286185|FG000|NOT COMPLETED|First Intervention||0
11102079|NCT01235195|12286186|FG001|NOT COMPLETED|First Intervention||0
11102080|NCT01235195|12286185|FG000|STARTED|Washout Period of At Least 8 Days||15
11102081|NCT01235195|12286186|FG001|STARTED|Washout Period of At Least 8 Days||15
11102082|NCT01235195|12286185|FG000|COMPLETED|Washout Period of At Least 8 Days||15
11102083|NCT01235195|12286186|FG001|COMPLETED|Washout Period of At Least 8 Days||15
11102084|NCT01235195|12286185|FG000|NOT COMPLETED|Washout Period of At Least 8 Days||0
11102085|NCT01235195|12286186|FG001|NOT COMPLETED|Washout Period of At Least 8 Days||0
11102086|NCT01235195|12286185|FG000|STARTED|Second Intervention||15
11102087|NCT01235195|12286186|FG001|STARTED|Second Intervention||15
11102088|NCT01235195|12286185|FG000|COMPLETED|Second Intervention||15
11102089|NCT01235195|12286186|FG001|COMPLETED|Second Intervention||15
11102090|NCT01235195|12286185|FG000|NOT COMPLETED|Second Intervention||0
11102091|NCT01235195|12286186|FG001|NOT COMPLETED|Second Intervention||0
11102092|NCT01235338|12286194|FG000|STARTED|Overall Study||42
11102093|NCT01235338|12286195|FG001|STARTED|Overall Study||38
11102094|NCT01235338|12286194|FG000|COMPLETED|Overall Study||31
11102095|NCT01235338|12286195|FG001|COMPLETED|Overall Study||33
11102096|NCT01235338|12286194|FG000|NOT COMPLETED|Overall Study||11
11102097|NCT01235338|12286195|FG001|NOT COMPLETED|Overall Study||5
11102098|NCT01235351|12286205|FG000|STARTED|Initial Treatment With 75 mg and 150 mg||247
11102099|NCT01235351|12286206|FG001|STARTED|Initial Treatment With 75 mg and 150 mg||86
11102100|NCT01235351|12286205|FG000|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237
11102101|NCT01235351|12286206|FG001|COMPLETED|Initial Treatment With 75 mg and 150 mg||82
10832463|NCT04391179|11997644|FG001|NOT COMPLETED|Overall Study||16
11102102|NCT01235351|12286205|FG000|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10
11102103|NCT01235351|12286206|FG001|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4
11102104|NCT01235351|12286205|FG000|STARTED|Treatment With Different Dose Sequences||233
10832464|NCT04386096|11997652|FG000|STARTED|Overall Study||20
10832465|NCT04386096|11997653|FG001|STARTED|Overall Study||20
10832466|NCT04386096|11997652|FG000|COMPLETED|Overall Study||20
10832467|NCT04386096|11997653|FG001|COMPLETED|Overall Study||20
10832468|NCT04386096|11997652|FG000|NOT COMPLETED|Overall Study||0
10832469|NCT04386096|11997653|FG001|NOT COMPLETED|Overall Study||0
10832470|NCT04376684|11997663|FG000|STARTED|Part 1 (Up to Day 60)||403
10832471|NCT04376684|11997664|FG001|STARTED|Part 1 (Up to Day 60)||403
11102105|NCT01235351|12286206|FG001|STARTED|Treatment With Different Dose Sequences||82
11102106|NCT01235351|12286205|FG000|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116
11102107|NCT01235351|12286206|FG001|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0
11102108|NCT01235351|12286205|FG000|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117
11102109|NCT01235351|12286206|FG001|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0
11102110|NCT01235351|12286205|FG000|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0
11102111|NCT01235351|12286206|FG001|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41
11102112|NCT01235351|12286205|FG000|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0
11102113|NCT01235351|12286206|FG001|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41
11102114|NCT01235351|12286205|FG000|COMPLETED|Treatment With Different Dose Sequences||233
11102115|NCT01235351|12286206|FG001|COMPLETED|Treatment With Different Dose Sequences||82
11102116|NCT01235351|12286205|FG000|NOT COMPLETED|Treatment With Different Dose Sequences||0
11102117|NCT01235351|12286206|FG001|NOT COMPLETED|Treatment With Different Dose Sequences||0
11102118|NCT01235377|12286218|FG000|STARTED|Overall Study||11
11102119|NCT01235377|12286219|FG001|STARTED|Overall Study||9
11102120|NCT01235377|12286218|FG000|COMPLETED|Overall Study||10
11102121|NCT01235377|12286219|FG001|COMPLETED|Overall Study||8
11102122|NCT01235377|12286218|FG000|NOT COMPLETED|Overall Study||1
11102123|NCT01235377|12286219|FG001|NOT COMPLETED|Overall Study||1
11102124|NCT01235403|12286225|FG000|STARTED|Overall Study||100
11102125|NCT01235403|12286225|FG000|COMPLETED|Overall Study||74
11102126|NCT01235403|12286225|FG000|NOT COMPLETED|Overall Study||26
11102127|NCT01235442|12286231|FG000|STARTED|Overall Study||297
11102128|NCT01235442|12286232|FG001|STARTED|Overall Study||295
11102129|NCT01235442|12286231|FG000|COMPLETED|Overall Study||253
11102130|NCT01235442|12286232|FG001|COMPLETED|Overall Study||251
11102131|NCT01235442|12286231|FG000|NOT COMPLETED|Overall Study||44
11102132|NCT01235442|12286232|FG001|NOT COMPLETED|Overall Study||44
11102133|NCT01235507|12286238|FG000|STARTED|Overall Study||71
11102134|NCT01235507|12286238|FG000|COMPLETED|Overall Study||69
11102135|NCT01235507|12286238|FG000|NOT COMPLETED|Overall Study||2
11102136|NCT01235546|12286244|FG000|STARTED|Overall Study||994
11102137|NCT01235546|12286245|FG001|STARTED|Overall Study||1019
11102138|NCT01235546|12286244|FG000|COMPLETED|Overall Study||992
11102139|NCT01235546|12286245|FG001|COMPLETED|Overall Study||1018
11102140|NCT01235546|12286244|FG000|NOT COMPLETED|Overall Study||2
11102141|NCT01235546|12286245|FG001|NOT COMPLETED|Overall Study||1
11102142|NCT01235598|12286262|FG000|STARTED|Overall Study||13
11102143|NCT01235598|12286263|FG001|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
11102144|NCT01235598|12286262|FG000|COMPLETED|Overall Study||12
11102145|NCT01235598|12286263|FG001|COMPLETED|Overall Study||24
11102146|NCT01235598|12286262|FG000|NOT COMPLETED|Overall Study||1
11102147|NCT01235598|12286263|FG001|NOT COMPLETED|Overall Study||4
11102148|NCT01235689|12286272|FG000|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
11102149|NCT01235689|12286273|FG001|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
11102150|NCT01235689|12286272|FG000|Early Randomized (Baseline to Week 9)|Overall Study||63
11102151|NCT01235689|12286273|FG001|Early Randomized (Baseline to Week 9)|Overall Study||69
11102152|NCT01235689|12286272|FG000|Randomized at Week 9|Overall Study||59
11102153|NCT01235689|12286273|FG001|Randomized at Week 9|Overall Study||53
11102154|NCT01235689|12286272|FG000|COMPLETED|Overall Study||93
11102155|NCT01235689|12286273|FG001|COMPLETED|Overall Study||90
11102156|NCT01235689|12286272|FG000|NOT COMPLETED|Overall Study||29
11102157|NCT01235689|12286273|FG001|NOT COMPLETED|Overall Study||32
11102158|NCT01235715|12286281|FG000|STARTED|Overall Study||98
11102159|NCT01235715|12286282|FG001|STARTED|Overall Study||102
11102160|NCT01235715|12286281|FG000|COMPLETED|Overall Study||98
11102161|NCT01235715|12286282|FG001|COMPLETED|Overall Study||100
11102162|NCT01235715|12286281|FG000|NOT COMPLETED|Overall Study||0
11102163|NCT01235715|12286282|FG001|NOT COMPLETED|Overall Study||2
11102164|NCT01235728|12286289|FG000|STARTED|Overall Study||3
10832472|NCT04376684|11997665|FG002|STARTED|Part 1 (Up to Day 60)||0
10832473|NCT04376684|11997666|FG003|STARTED|Part 1 (Up to Day 60)||0
10832474|NCT04376684|11997663|FG000|COMPLETED|Part 1 (Up to Day 60)||388
10832475|NCT04376684|11997664|FG001|COMPLETED|Part 1 (Up to Day 60)||379
11102165|NCT01235728|12286290|FG001|STARTED|Overall Study||3
11102166|NCT01235728|12286291|FG002|STARTED|Overall Study||3
11102167|NCT01235728|12286292|FG003|STARTED|Overall Study||3
11102168|NCT01235728|12286293|FG004|STARTED|Overall Study||3
11102169|NCT01235728|12286294|FG005|STARTED|Overall Study||3
11102170|NCT01235728|12286295|FG006|STARTED|Overall Study||3
11102171|NCT01235728|12286296|FG007|STARTED|Overall Study||3
11102172|NCT01235728|12286289|FG000|COMPLETED|Overall Study||3
11102173|NCT01235728|12286290|FG001|COMPLETED|Overall Study||3
11102174|NCT01235728|12286291|FG002|COMPLETED|Overall Study||3
11102175|NCT01235728|12286292|FG003|COMPLETED|Overall Study||2
10832476|NCT04376684|11997665|FG002|COMPLETED|Part 1 (Up to Day 60)||0
10832477|NCT04376684|11997666|FG003|COMPLETED|Part 1 (Up to Day 60)||0
10832478|NCT04376684|11997663|FG000|NOT COMPLETED|Part 1 (Up to Day 60)||15
10832479|NCT04376684|11997664|FG001|NOT COMPLETED|Part 1 (Up to Day 60)||24
10832480|NCT04376684|11997665|FG002|NOT COMPLETED|Part 1 (Up to Day 60)||0
10832481|NCT04376684|11997666|FG003|NOT COMPLETED|Part 1 (Up to Day 60)||0
10832482|NCT04376684|11997663|FG000|STARTED|Part 2 (Up to Day 60)||0
10832483|NCT04376684|11997664|FG001|STARTED|Part 2 (Up to Day 60)||0
10832484|NCT04376684|11997665|FG002|STARTED|Part 2 (Up to Day 60)||175
10832485|NCT04376684|11997666|FG003|STARTED|Part 2 (Up to Day 60)||175
10832486|NCT04376684|11997663|FG000|COMPLETED|Part 2 (Up to Day 60)||0
10832487|NCT04376684|11997664|FG001|COMPLETED|Part 2 (Up to Day 60)||0
10832488|NCT04376684|11997665|FG002|COMPLETED|Part 2 (Up to Day 60)||170
10832489|NCT04376684|11997666|FG003|COMPLETED|Part 2 (Up to Day 60)||171
10832490|NCT04376684|11997663|FG000|NOT COMPLETED|Part 2 (Up to Day 60)||0
10832491|NCT04376684|11997664|FG001|NOT COMPLETED|Part 2 (Up to Day 60)||0
10832492|NCT04376684|11997665|FG002|NOT COMPLETED|Part 2 (Up to Day 60)||5
10832493|NCT04376684|11997666|FG003|NOT COMPLETED|Part 2 (Up to Day 60)||4
10832494|NCT04353284|11997678|FG000|STARTED|Overall Study||35
10832495|NCT04353284|11997679|FG001|STARTED|Overall Study||35
10832496|NCT04353284|11997678|FG000|COMPLETED|Overall Study||33
10832497|NCT04353284|11997679|FG001|COMPLETED|Overall Study||34
10832498|NCT04353284|11997678|FG000|NOT COMPLETED|Overall Study||2
10832499|NCT04353284|11997679|FG001|NOT COMPLETED|Overall Study||1
10832500|NCT04294147|11997687|FG000|STARTED|Overall Study||32
10832501|NCT04294147|11997688|FG001|STARTED|Overall Study||33
10832502|NCT04294147|11997687|FG000|Received at Least One Dose of Study Drug|Overall Study||32
10832503|NCT04294147|11997688|FG001|Received at Least One Dose of Study Drug|Overall Study||33
10832504|NCT04294147|11997687|FG000|COMPLETED|Overall Study||30
10832505|NCT04294147|11997688|FG001|COMPLETED|Overall Study||33
10832506|NCT04294147|11997687|FG000|NOT COMPLETED|Overall Study||2
10832507|NCT04294147|11997688|FG001|NOT COMPLETED|Overall Study||0
10832508|NCT04269707|11997694|FG000|STARTED|Overall Study||7
10832509|NCT04269707|11997694|FG000|COMPLETED|Overall Study||7
10832510|NCT04269707|11997694|FG000|NOT COMPLETED|Overall Study||0
10832511|NCT04231825|11997700|FG000|STARTED|Overall Study||23
10832512|NCT04231825|11997701|FG001|STARTED|Overall Study||24
10832513|NCT04231825|11997700|FG000|COMPLETED|Overall Study||20
10832514|NCT04231825|11997701|FG001|COMPLETED|Overall Study||20
10832515|NCT04231825|11997700|FG000|NOT COMPLETED|Overall Study||3
10832516|NCT04231825|11997701|FG001|NOT COMPLETED|Overall Study||4
10832517|NCT04196686|11997707|FG000|STARTED|First Treatment (4 Minutes)||78
10832518|NCT04196686|11997708|FG001|STARTED|First Treatment (4 Minutes)||78
10832519|NCT04196686|11997707|FG000|COMPLETED|First Treatment (4 Minutes)||78
10832520|NCT04196686|11997708|FG001|COMPLETED|First Treatment (4 Minutes)||75
10832521|NCT04196686|11997707|FG000|NOT COMPLETED|First Treatment (4 Minutes)||0
10832522|NCT04196686|11997708|FG001|NOT COMPLETED|First Treatment (4 Minutes)||3
10832523|NCT04196686|11997707|FG000|STARTED|Second Treatment (4 Minutes)||78
10832524|NCT04196686|11997708|FG001|STARTED|Second Treatment (4 Minutes)||75
10832525|NCT04196686|11997707|FG000|COMPLETED|Second Treatment (4 Minutes)||78
10832526|NCT04196686|11997708|FG001|COMPLETED|Second Treatment (4 Minutes)||75
10832527|NCT04196686|11997707|FG000|NOT COMPLETED|Second Treatment (4 Minutes)||0
10832528|NCT04196686|11997708|FG001|NOT COMPLETED|Second Treatment (4 Minutes)||0
10832529|NCT04178772|11997714|FG000|STARTED|Overall Study||27
10832530|NCT04178772|11997714|FG000|COMPLETED|Overall Study||19
10832531|NCT04178772|11997714|FG000|NOT COMPLETED|Overall Study||8
10832532|NCT04148651|11997718|FG000|STARTED|Overall Study||12
10832533|NCT04148651|11997718|FG000|COMPLETED|Overall Study|2 subjects did not complete the final follow-up due to COVID-19 pandemic|10
10832534|NCT04148651|11997718|FG000|NOT COMPLETED|Overall Study||2
11102176|NCT01235728|12286293|FG004|COMPLETED|Overall Study||3
11102177|NCT01235728|12286294|FG005|COMPLETED|Overall Study||3
11102178|NCT01235728|12286295|FG006|COMPLETED|Overall Study||3
11102179|NCT01235728|12286296|FG007|COMPLETED|Overall Study||3
11102180|NCT01235728|12286289|FG000|NOT COMPLETED|Overall Study||0
11102181|NCT01235728|12286290|FG001|NOT COMPLETED|Overall Study||0
10832535|NCT04113304|11997723|FG000|STARTED|Overall Study||6
10832536|NCT04113304|11997723|FG000|COMPLETED|Overall Study||6
10832537|NCT04113304|11997723|FG000|NOT COMPLETED|Overall Study||0
10832538|NCT03929588|11997727|FG000|STARTED|Overall Study||230
10832539|NCT03929588|11997727|FG000|COMPLETED|Overall Study||143
10832540|NCT03929588|11997727|FG000|NOT COMPLETED|Overall Study||87
11102182|NCT01235728|12286291|FG002|NOT COMPLETED|Overall Study||0
11102183|NCT01235728|12286292|FG003|NOT COMPLETED|Overall Study||1
11102184|NCT01235728|12286293|FG004|NOT COMPLETED|Overall Study||0
11102185|NCT01235728|12286294|FG005|NOT COMPLETED|Overall Study||0
11102186|NCT01235728|12286295|FG006|NOT COMPLETED|Overall Study||0
11102187|NCT01235728|12286296|FG007|NOT COMPLETED|Overall Study||0
11102188|NCT01235741|12286307|FG000|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
11102189|NCT01235741|12286308|FG001|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
11102190|NCT01235741|12286309|FG002|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
11102191|NCT01235741|12286307|FG000|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
11102192|NCT01235741|12286308|FG001|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
11102193|NCT01235741|12286309|FG002|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
11102194|NCT01235741|12286307|FG000|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
11102195|NCT01235741|12286308|FG001|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
11102196|NCT01235741|12286309|FG002|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
11102197|NCT01235741|12286307|FG000|STARTED|Randomized to Treatment||0
11102198|NCT01235741|12286308|FG001|STARTED|Randomized to Treatment||36
11102199|NCT01235741|12286309|FG002|STARTED|Randomized to Treatment||36
11102200|NCT01235741|12286307|FG000|COMPLETED|Randomized to Treatment||0
11102201|NCT01235741|12286308|FG001|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
11102202|NCT01235741|12286309|FG002|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
11102203|NCT01235741|12286307|FG000|NOT COMPLETED|Randomized to Treatment||0
11102204|NCT01235741|12286308|FG001|NOT COMPLETED|Randomized to Treatment||36
11102205|NCT01235741|12286309|FG002|NOT COMPLETED|Randomized to Treatment||36
11102206|NCT01235741|12286307|FG000|STARTED|Follow-Up Post Treatment up to Month 6||0
11102207|NCT01235741|12286308|FG001|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
11220137|NCT01958619|12411732|FG002|STARTED|Overall Study||14
11220138|NCT01958619|12411733|FG003|STARTED|Overall Study||12
11102208|NCT01235741|12286309|FG002|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
11102209|NCT01235741|12286307|FG000|COMPLETED|Follow-Up Post Treatment up to Month 6||0
11102210|NCT01235741|12286308|FG001|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
11102211|NCT01235741|12286309|FG002|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
11102212|NCT01235741|12286307|FG000|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
11102213|NCT01235741|12286308|FG001|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
11102214|NCT01235741|12286309|FG002|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
11102215|NCT01235793|12286321|FG000|STARTED|Overall Study||11
11102216|NCT01235793|12286321|FG000|COMPLETED|Overall Study||5
11102217|NCT01235793|12286321|FG000|NOT COMPLETED|Overall Study||6
11102218|NCT01235897|12286326|FG000|STARTED|Overall Study||16
11102219|NCT01235897|12286326|FG000|COMPLETED|Overall Study||16
11102220|NCT01235897|12286326|FG000|NOT COMPLETED|Overall Study||0
11102221|NCT01235910|12286331|FG000|STARTED|Overall Study||1
11102222|NCT01235910|12286331|FG000|COMPLETED|Overall Study||1
11102223|NCT01235910|12286331|FG000|NOT COMPLETED|Overall Study||0
11102224|NCT01235949|12286353|FG000|STARTED|Primary Phase||198
11102225|NCT01235949|12286354|FG001|STARTED|Primary Phase||198
11102226|NCT01235949|12286355|FG002|STARTED|Primary Phase||199
11102227|NCT01235949|12286356|FG003|STARTED|Primary Phase||71
11102228|NCT01235949|12286357|FG004|STARTED|Primary Phase||72
11102229|NCT01235949|12286358|FG005|STARTED|Primary Phase||74
11102230|NCT01235949|12286359|FG006|STARTED|Primary Phase||0
11102231|NCT01235949|12286360|FG007|STARTED|Primary Phase||0
11102232|NCT01235949|12286361|FG008|STARTED|Primary Phase||0
11102233|NCT01235949|12286362|FG009|STARTED|Primary Phase||0
11102234|NCT01235949|12286363|FG010|STARTED|Primary Phase||0
11102235|NCT01235949|12286364|FG011|STARTED|Primary Phase||0
11102236|NCT01235949|12286365|FG012|STARTED|Primary Phase||0
11102237|NCT01235949|12286366|FG013|STARTED|Primary Phase||0
11102238|NCT01235949|12286367|FG014|STARTED|Primary Phase||0
11102239|NCT01235949|12286368|FG015|STARTED|Primary Phase||0
11102240|NCT01235949|12286369|FG016|STARTED|Primary Phase||0
11102241|NCT01235949|12286370|FG017|STARTED|Primary Phase||0
11102242|NCT01235949|12286353|FG000|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194
11102243|NCT01235949|12286354|FG001|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195
11102244|NCT01235949|12286355|FG002|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196
10832541|NCT03893448|11997733|FG000|STARTED|Overall Study||860
10832542|NCT03893448|11997734|FG001|STARTED|Overall Study||860
10832543|NCT03893448|11997733|FG000|Treated|Overall Study||858
10832544|NCT03893448|11997734|FG001|Treated|Overall Study||856
10832545|NCT03893448|11997733|FG000|COMPLETED|Overall Study||758
10832546|NCT03893448|11997734|FG001|COMPLETED|Overall Study||734
10832547|NCT03893448|11997733|FG000|NOT COMPLETED|Overall Study||102
10832548|NCT03893448|11997734|FG001|NOT COMPLETED|Overall Study||126
10832549|NCT03870880|11997747|FG000|STARTED|Overall Study||27
10832550|NCT03870880|11997748|FG001|STARTED|Overall Study||58
10832551|NCT03870880|11997749|FG002|STARTED|Overall Study||31
10832552|NCT03870880|11997750|FG003|STARTED|Overall Study||28
10832553|NCT03870880|11997751|FG004|STARTED|Overall Study||61
10832554|NCT03870880|11997752|FG005|STARTED|Overall Study||10
10832555|NCT03870880|11997747|FG000|COMPLETED|Overall Study||21
10832556|NCT03870880|11997748|FG001|COMPLETED|Overall Study||43
10832557|NCT03870880|11997749|FG002|COMPLETED|Overall Study||26
10832558|NCT03870880|11997750|FG003|COMPLETED|Overall Study||20
10832559|NCT03870880|11997751|FG004|COMPLETED|Overall Study||44
10832560|NCT03870880|11997752|FG005|COMPLETED|Overall Study||7
10832561|NCT03870880|11997747|FG000|NOT COMPLETED|Overall Study||6
10832562|NCT03870880|11997748|FG001|NOT COMPLETED|Overall Study||15
11102245|NCT01235949|12286356|FG003|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69
11102246|NCT01235949|12286357|FG004|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71
11102247|NCT01235949|12286358|FG005|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67
11102248|NCT01235949|12286359|FG006|COMPLETED|Primary Phase||0
11102249|NCT01235949|12286360|FG007|COMPLETED|Primary Phase||0
11102250|NCT01235949|12286361|FG008|COMPLETED|Primary Phase||0
11102251|NCT01235949|12286362|FG009|COMPLETED|Primary Phase||0
11102252|NCT01235949|12286363|FG010|COMPLETED|Primary Phase||0
11102253|NCT01235949|12286364|FG011|COMPLETED|Primary Phase||0
11102254|NCT01235949|12286365|FG012|COMPLETED|Primary Phase||0
11102255|NCT01235949|12286366|FG013|COMPLETED|Primary Phase||0
11102256|NCT01235949|12286367|FG014|COMPLETED|Primary Phase||0
11102257|NCT01235949|12286368|FG015|COMPLETED|Primary Phase||0
11102258|NCT01235949|12286369|FG016|COMPLETED|Primary Phase||0
11102259|NCT01235949|12286370|FG017|COMPLETED|Primary Phase||0
11102260|NCT01235949|12286353|FG000|NOT COMPLETED|Primary Phase||4
11102261|NCT01235949|12286354|FG001|NOT COMPLETED|Primary Phase||3
11102262|NCT01235949|12286355|FG002|NOT COMPLETED|Primary Phase||3
11102263|NCT01235949|12286356|FG003|NOT COMPLETED|Primary Phase||2
11102264|NCT01235949|12286357|FG004|NOT COMPLETED|Primary Phase||1
11102265|NCT01235949|12286358|FG005|NOT COMPLETED|Primary Phase||7
11102266|NCT01235949|12286359|FG006|NOT COMPLETED|Primary Phase||0
11102267|NCT01235949|12286360|FG007|NOT COMPLETED|Primary Phase||0
11102268|NCT01235949|12286361|FG008|NOT COMPLETED|Primary Phase||0
11102269|NCT01235949|12286362|FG009|NOT COMPLETED|Primary Phase||0
11102270|NCT01235949|12286363|FG010|NOT COMPLETED|Primary Phase||0
11102271|NCT01235949|12286364|FG011|NOT COMPLETED|Primary Phase||0
11102272|NCT01235949|12286365|FG012|NOT COMPLETED|Primary Phase||0
11102273|NCT01235949|12286366|FG013|NOT COMPLETED|Primary Phase||0
11102274|NCT01235949|12286367|FG014|NOT COMPLETED|Primary Phase||0
11102275|NCT01235949|12286368|FG015|NOT COMPLETED|Primary Phase||0
11102276|NCT01235949|12286369|FG016|NOT COMPLETED|Primary Phase||0
11102277|NCT01235949|12286370|FG017|NOT COMPLETED|Primary Phase||0
11102278|NCT01235949|12286353|FG000|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0
11102279|NCT01235949|12286354|FG001|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0
11102280|NCT01235949|12286355|FG002|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0
11102281|NCT01235949|12286356|FG003|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0
11220139|NCT01958619|12411730|FG000|COMPLETED|Overall Study||13
10832563|NCT03870880|11997749|FG002|NOT COMPLETED|Overall Study||5
10832564|NCT03870880|11997750|FG003|NOT COMPLETED|Overall Study||8
10832565|NCT03870880|11997751|FG004|NOT COMPLETED|Overall Study||17
10832566|NCT03870880|11997752|FG005|NOT COMPLETED|Overall Study||3
10832567|NCT03831347|11997771|FG000|STARTED|Overall Study||11
10832568|NCT03831347|11997771|FG000|COMPLETED|Overall Study||9
10832569|NCT03831347|11997771|FG000|NOT COMPLETED|Overall Study||2
11102282|NCT01235949|12286357|FG004|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0
11102283|NCT01235949|12286358|FG005|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0
11102284|NCT01235949|12286359|FG006|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64
11102285|NCT01235949|12286360|FG007|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60
11102286|NCT01235949|12286361|FG008|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63
11102287|NCT01235949|12286362|FG009|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
11102288|NCT01235949|12286363|FG010|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
11220140|NCT01958619|12411731|FG001|COMPLETED|Overall Study||14
11220141|NCT01958619|12411732|FG002|COMPLETED|Overall Study||13
10832612|NCT03811574|11997845|FG000|STARTED|Overall Study||101
10832613|NCT03811574|11997846|FG001|STARTED|Overall Study||199
10832614|NCT03811574|11997847|FG002|STARTED|Overall Study||101
10832615|NCT03811574|11997845|FG000|Full Analysis Set (FAS)|Overall Study||101
10832616|NCT03811574|11997846|FG001|Full Analysis Set (FAS)|Overall Study||199
10832617|NCT03811574|11997847|FG002|Full Analysis Set (FAS)|Overall Study||101
10832618|NCT03811574|11997845|FG000|Safety Analysis Set (SAS)|Overall Study||100
10832619|NCT03811574|11997846|FG001|Safety Analysis Set (SAS)|Overall Study||199
10832620|NCT03811574|11997847|FG002|Safety Analysis Set (SAS)|Overall Study||101
10832621|NCT03811574|11997845|FG000|Treated|Overall Study||100
10832622|NCT03811574|11997846|FG001|Treated|Overall Study||199
10832623|NCT03811574|11997847|FG002|Treated|Overall Study||101
10832624|NCT03811574|11997845|FG000|COMPLETED|Overall Study||99
10832625|NCT03811574|11997846|FG001|COMPLETED|Overall Study||195
10832626|NCT03811574|11997847|FG002|COMPLETED|Overall Study||101
10832627|NCT03811574|11997845|FG000|NOT COMPLETED|Overall Study||2
10832628|NCT03811574|11997846|FG001|NOT COMPLETED|Overall Study||4
10832629|NCT03811574|11997847|FG002|NOT COMPLETED|Overall Study||0
10832630|NCT03800420|11997857|FG000|STARTED|Overall Study||12
10832631|NCT03800420|11997858|FG001|STARTED|Overall Study||4
10832632|NCT03800420|11997857|FG000|COMPLETED|Overall Study||10
10832633|NCT03800420|11997858|FG001|COMPLETED|Overall Study||3
10832634|NCT03800420|11997857|FG000|NOT COMPLETED|Overall Study||2
10832635|NCT03800420|11997858|FG001|NOT COMPLETED|Overall Study||1
10832636|NCT03759184|11997868|FG000|STARTED|Overall Study||1
10832637|NCT03759184|11997868|FG000|COMPLETED|Overall Study||1
10832638|NCT03759184|11997868|FG000|NOT COMPLETED|Overall Study||0
10832639|NCT03747640|11997874|FG000|STARTED|Overall Study||15
10832640|NCT03747640|11997875|FG001|STARTED|Overall Study||15
10832641|NCT03747640|11997874|FG000|COMPLETED|Overall Study||15
10832642|NCT03747640|11997875|FG001|COMPLETED|Overall Study||15
10832643|NCT03747640|11997874|FG000|NOT COMPLETED|Overall Study||0
10832644|NCT03747640|11997875|FG001|NOT COMPLETED|Overall Study||0
10832645|NCT03727750|11997883|FG000|STARTED|Overall Study||51
10832646|NCT03727750|11997883|FG000|Safety Set|Overall Study||50
10832647|NCT03727750|11997883|FG000|COMPLETED|Overall Study||2
10832648|NCT03727750|11997883|FG000|NOT COMPLETED|Overall Study||49
10832649|NCT03715829|11997893|FG000|STARTED|Dose Ranging Period||65
10832650|NCT03715829|11997894|FG001|STARTED|Dose Ranging Period||67
10832651|NCT03715829|11997895|FG002|STARTED|Dose Ranging Period||67
10832652|NCT03715829|11997896|FG003|STARTED|Dose Ranging Period||50
10832653|NCT03715829|11997897|FG004|STARTED|Dose Ranging Period||49
10832654|NCT03715829|11997898|FG005|STARTED|Dose Ranging Period||66
10832655|NCT03715829|11997899|FG006|STARTED|Dose Ranging Period||0
10832656|NCT03715829|11997900|FG007|STARTED|Dose Ranging Period||0
10832657|NCT03715829|11997901|FG008|STARTED|Dose Ranging Period||0
10832658|NCT03715829|11997902|FG009|STARTED|Dose Ranging Period||0
10832659|NCT03715829|11997903|FG010|STARTED|Dose Ranging Period||0
10832660|NCT03715829|11997893|FG000|COMPLETED|Dose Ranging Period||53
10832661|NCT03715829|11997894|FG001|COMPLETED|Dose Ranging Period||58
10832662|NCT03715829|11997895|FG002|COMPLETED|Dose Ranging Period||54
10832663|NCT03715829|11997896|FG003|COMPLETED|Dose Ranging Period||36
10832664|NCT03715829|11997897|FG004|COMPLETED|Dose Ranging Period||42
10832665|NCT03715829|11997898|FG005|COMPLETED|Dose Ranging Period||55
10832666|NCT03715829|11997899|FG006|COMPLETED|Dose Ranging Period||0
10832667|NCT03715829|11997900|FG007|COMPLETED|Dose Ranging Period||0
10832668|NCT03715829|11997901|FG008|COMPLETED|Dose Ranging Period||0
10832669|NCT03715829|11997902|FG009|COMPLETED|Dose Ranging Period||0
10832670|NCT03715829|11997903|FG010|COMPLETED|Dose Ranging Period||0
10832671|NCT03715829|11997893|FG000|NOT COMPLETED|Dose Ranging Period||12
10832672|NCT03715829|11997894|FG001|NOT COMPLETED|Dose Ranging Period||9
10832673|NCT03715829|11997895|FG002|NOT COMPLETED|Dose Ranging Period||13
10832674|NCT03715829|11997896|FG003|NOT COMPLETED|Dose Ranging Period||14
10832675|NCT03715829|11997897|FG004|NOT COMPLETED|Dose Ranging Period||7
10832676|NCT03715829|11997898|FG005|NOT COMPLETED|Dose Ranging Period||11
10832677|NCT03715829|11997899|FG006|NOT COMPLETED|Dose Ranging Period||0
10832678|NCT03715829|11997900|FG007|NOT COMPLETED|Dose Ranging Period||0
10832679|NCT03715829|11997901|FG008|NOT COMPLETED|Dose Ranging Period||0
10832680|NCT03715829|11997902|FG009|NOT COMPLETED|Dose Ranging Period||0
10832681|NCT03715829|11997903|FG010|NOT COMPLETED|Dose Ranging Period||0
10832682|NCT03715829|11997893|FG000|STARTED|Extension Period||0
10832683|NCT03715829|11997894|FG001|STARTED|Extension Period||0
10832684|NCT03715829|11997895|FG002|STARTED|Extension Period||0
10832685|NCT03715829|11997896|FG003|STARTED|Extension Period||0
10832686|NCT03715829|11997897|FG004|STARTED|Extension Period||0
10832687|NCT03715829|11997898|FG005|STARTED|Extension Period||0
10832688|NCT03715829|11997899|FG006|STARTED|Extension Period||55
10832689|NCT03715829|11997900|FG007|STARTED|Extension Period||43
10832690|NCT03715829|11997901|FG008|STARTED|Extension Period||187
10832691|NCT03715829|11997902|FG009|STARTED|Extension Period||6
10832692|NCT03715829|11997903|FG010|STARTED|Extension Period||2
10832693|NCT03715829|11997893|FG000|COMPLETED|Extension Period||0
10832694|NCT03715829|11997894|FG001|COMPLETED|Extension Period||0
10832695|NCT03715829|11997895|FG002|COMPLETED|Extension Period||0
10832696|NCT03715829|11997896|FG003|COMPLETED|Extension Period||0
10832697|NCT03715829|11997897|FG004|COMPLETED|Extension Period||0
10832698|NCT03715829|11997898|FG005|COMPLETED|Extension Period||0
10832699|NCT03715829|11997899|FG006|COMPLETED|Extension Period||47
10832700|NCT03715829|11997900|FG007|COMPLETED|Extension Period||27
10832701|NCT03715829|11997901|FG008|COMPLETED|Extension Period||158
10832702|NCT03715829|11997902|FG009|COMPLETED|Extension Period||3
10832703|NCT03715829|11997903|FG010|COMPLETED|Extension Period||2
10832704|NCT03715829|11997893|FG000|NOT COMPLETED|Extension Period||0
10832705|NCT03715829|11997894|FG001|NOT COMPLETED|Extension Period||0
10832706|NCT03715829|11997895|FG002|NOT COMPLETED|Extension Period||0
10832707|NCT03715829|11997896|FG003|NOT COMPLETED|Extension Period||0
10832708|NCT03715829|11997897|FG004|NOT COMPLETED|Extension Period||0
10832709|NCT03715829|11997898|FG005|NOT COMPLETED|Extension Period||0
10832710|NCT03715829|11997899|FG006|NOT COMPLETED|Extension Period||8
10832711|NCT03715829|11997900|FG007|NOT COMPLETED|Extension Period||16
10832712|NCT03715829|11997901|FG008|NOT COMPLETED|Extension Period||29
10832713|NCT03715829|11997902|FG009|NOT COMPLETED|Extension Period||3
10832714|NCT03715829|11997903|FG010|NOT COMPLETED|Extension Period||0
10832715|NCT03693430|11997931|FG000|STARTED|Overall Study||152
10832716|NCT03693430|11997932|FG001|STARTED|Overall Study||152
10832717|NCT03693430|11997931|FG000|Full Analysis Set (FAS)|Overall Study||152
10832718|NCT03693430|11997932|FG001|Full Analysis Set (FAS)|Overall Study||152
10832719|NCT03693430|11997931|FG000|Safety Analysis Set (SAS)|Overall Study||152
10832720|NCT03693430|11997932|FG001|Safety Analysis Set (SAS)|Overall Study||152
10832721|NCT03693430|11997931|FG000|COMPLETED|Overall Study||148
10832722|NCT03693430|11997932|FG001|COMPLETED|Overall Study||134
10832723|NCT03693430|11997931|FG000|NOT COMPLETED|Overall Study||4
10832724|NCT03693430|11997932|FG001|NOT COMPLETED|Overall Study||18
10832725|NCT03677934|11997940|FG000|STARTED|Overall Study||248
10832726|NCT03677934|11997941|FG001|STARTED|Overall Study||167
10832727|NCT03677934|11997940|FG000|COMPLETED|Overall Study||0
10832728|NCT03677934|11997941|FG001|COMPLETED|Overall Study||0
10832729|NCT03677934|11997940|FG000|NOT COMPLETED|Overall Study||248
10832730|NCT03677934|11997941|FG001|NOT COMPLETED|Overall Study||167
10832731|NCT03660839|11997951|FG000|STARTED|Overall Study||35
10832732|NCT03660839|11997952|FG001|STARTED|Overall Study||36
10832733|NCT03660839|11997953|FG002|STARTED|Overall Study||36
10832734|NCT03660839|11997954|FG003|STARTED|Overall Study||33
10832735|NCT03660839|11997951|FG000|COMPLETED|Overall Study||35
10832736|NCT03660839|11997952|FG001|COMPLETED|Overall Study||36
10832737|NCT03660839|11997953|FG002|COMPLETED|Overall Study||36
10832738|NCT03660839|11997954|FG003|COMPLETED|Overall Study||33
10832739|NCT03660839|11997951|FG000|NOT COMPLETED|Overall Study||0
10832740|NCT03660839|11997952|FG001|NOT COMPLETED|Overall Study||0
10832741|NCT03660839|11997953|FG002|NOT COMPLETED|Overall Study||0
10832742|NCT03660839|11997954|FG003|NOT COMPLETED|Overall Study||0
10832743|NCT03660241|11997970|FG000|STARTED|Overall Study||8
10832744|NCT03660241|11997971|FG001|STARTED|Overall Study||7
10832745|NCT03660241|11997972|FG002|STARTED|Overall Study||8
10832746|NCT03660241|11997970|FG000|COMPLETED|Overall Study||8
10832747|NCT03660241|11997971|FG001|COMPLETED|Overall Study||7
10832748|NCT03660241|11997972|FG002|COMPLETED|Overall Study||8
10832749|NCT03660241|11997970|FG000|NOT COMPLETED|Overall Study||0
10832750|NCT03660241|11997971|FG001|NOT COMPLETED|Overall Study||0
10832751|NCT03660241|11997972|FG002|NOT COMPLETED|Overall Study||0
10832752|NCT03575104|11997983|FG000|STARTED|Overall Study||307
10832753|NCT03575104|11997984|FG001|STARTED|Overall Study||309
10832754|NCT03575104|11997985|FG002|STARTED|Overall Study||308
10832755|NCT03575104|11997983|FG000|COMPLETED|Overall Study||283
10832756|NCT03575104|11997984|FG001|COMPLETED|Overall Study||280
10832757|NCT03575104|11997985|FG002|COMPLETED|Overall Study||286
11102289|NCT01235949|12286364|FG011|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
11102290|NCT01235949|12286365|FG012|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63
11220142|NCT01958619|12411733|FG003|COMPLETED|Overall Study||12
10832758|NCT03575104|11997983|FG000|NOT COMPLETED|Overall Study||24
10832759|NCT03575104|11997984|FG001|NOT COMPLETED|Overall Study||29
10832760|NCT03575104|11997985|FG002|NOT COMPLETED|Overall Study||22
10832761|NCT03569475|11997996|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||164
10832762|NCT03569475|11997997|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||169
10832763|NCT03569475|11997998|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||168
10832764|NCT03569475|11997996|FG000|Safety Population|Double-blind Treatment Period (8 Weeks)||160
10832765|NCT03569475|11997997|FG001|Safety Population|Double-blind Treatment Period (8 Weeks)||166
10832766|NCT03569475|11997998|FG002|Safety Population|Double-blind Treatment Period (8 Weeks)||166
10832767|NCT03569475|11997996|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||146
10832768|NCT03569475|11997997|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||146
10832769|NCT03569475|11997998|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||144
10832770|NCT03569475|11997996|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||18
10832771|NCT03569475|11997997|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||23
10832772|NCT03569475|11997998|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||24
10832773|NCT03569475|11997996|FG000|STARTED|Double-blind Down-taper Period (1 Week)||140
10832774|NCT03569475|11997997|FG001|STARTED|Double-blind Down-taper Period (1 Week)||141
10832775|NCT03569475|11997998|FG002|STARTED|Double-blind Down-taper Period (1 Week)||140
10832776|NCT03569475|11997996|FG000|COMPLETED|Double-blind Down-taper Period (1 Week)||140
10832777|NCT03569475|11997997|FG001|COMPLETED|Double-blind Down-taper Period (1 Week)||139
10832778|NCT03569475|11997998|FG002|COMPLETED|Double-blind Down-taper Period (1 Week)||138
10832779|NCT03569475|11997996|FG000|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||0
10832780|NCT03569475|11997997|FG001|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||2
10832781|NCT03569475|11997998|FG002|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||2
10832782|NCT03554798|11998018|FG000|STARTED|Overall Study||50
10832783|NCT03554798|11998019|FG001|STARTED|Overall Study||50
10832784|NCT03554798|11998020|FG002|STARTED|Overall Study||51
10832785|NCT03554798|11998021|FG003|STARTED|Overall Study||156
10832786|NCT03554798|11998022|FG004|STARTED|Overall Study||144
10832787|NCT03554798|11998023|FG005|STARTED|Overall Study||138
10832788|NCT03554798|11998024|FG006|STARTED|Overall Study||150
10832789|NCT03554798|11998025|FG007|STARTED|Overall Study||135
10832790|NCT03554798|11998026|FG008|STARTED|Overall Study||151
10832791|NCT03554798|11998018|FG000|COMPLETED|Overall Study||45
10832792|NCT03554798|11998019|FG001|COMPLETED|Overall Study||47
10832793|NCT03554798|11998020|FG002|COMPLETED|Overall Study||48
10832794|NCT03554798|11998021|FG003|COMPLETED|Overall Study||154
10832795|NCT03554798|11998022|FG004|COMPLETED|Overall Study||141
10832796|NCT03554798|11998023|FG005|COMPLETED|Overall Study||137
10832797|NCT03554798|11998024|FG006|COMPLETED|Overall Study||149
10832798|NCT03554798|11998025|FG007|COMPLETED|Overall Study||133
10832799|NCT03554798|11998026|FG008|COMPLETED|Overall Study||149
10832800|NCT03554798|11998018|FG000|NOT COMPLETED|Overall Study||5
10832801|NCT03554798|11998019|FG001|NOT COMPLETED|Overall Study||3
10832802|NCT03554798|11998020|FG002|NOT COMPLETED|Overall Study||3
10832803|NCT03554798|11998021|FG003|NOT COMPLETED|Overall Study||2
10832804|NCT03554798|11998022|FG004|NOT COMPLETED|Overall Study||3
10832805|NCT03554798|11998023|FG005|NOT COMPLETED|Overall Study||1
10832806|NCT03554798|11998024|FG006|NOT COMPLETED|Overall Study||1
10832807|NCT03554798|11998025|FG007|NOT COMPLETED|Overall Study||2
10832808|NCT03554798|11998026|FG008|NOT COMPLETED|Overall Study||2
10832809|NCT03545191|11998052|FG000|STARTED|Overall Study||310
10832810|NCT03545191|11998053|FG001|STARTED|Overall Study||310
10832811|NCT03545191|11998054|FG002|STARTED|Overall Study||310
10832812|NCT03545191|11998052|FG000|COMPLETED|Overall Study||288
10832813|NCT03545191|11998053|FG001|COMPLETED|Overall Study||285
10832814|NCT03545191|11998054|FG002|COMPLETED|Overall Study||280
10832815|NCT03545191|11998052|FG000|NOT COMPLETED|Overall Study||22
10832816|NCT03545191|11998053|FG001|NOT COMPLETED|Overall Study||25
10832817|NCT03545191|11998054|FG002|NOT COMPLETED|Overall Study||30
10832818|NCT03500549|11998064|FG000|STARTED|Run-in Period (Day -28 to ≤Day 1)||41
10832819|NCT03500549|11998065|FG001|STARTED|Run-in Period (Day -28 to ≤Day 1)||39
10832820|NCT03500549|11998064|FG000|COMPLETED|Run-in Period (Day -28 to ≤Day 1)||41
10832821|NCT03500549|11998065|FG001|COMPLETED|Run-in Period (Day -28 to ≤Day 1)||39
10832822|NCT03500549|11998064|FG000|NOT COMPLETED|Run-in Period (Day -28 to ≤Day 1)||0
10832823|NCT03500549|11998065|FG001|NOT COMPLETED|Run-in Period (Day -28 to ≤Day 1)||0
10832824|NCT03500549|11998064|FG000|STARTED|RCP (Day 1 - Week 16)||41
10832825|NCT03500549|11998065|FG001|STARTED|RCP (Day 1 - Week 16)||39
10832826|NCT03500549|11998064|FG000|COMPLETED|RCP (Day 1 - Week 16)||38
10832827|NCT03500549|11998065|FG001|COMPLETED|RCP (Day 1 - Week 16)||39
10832828|NCT03500549|11998064|FG000|NOT COMPLETED|RCP (Day 1 - Week 16)||3
10832829|NCT03500549|11998065|FG001|NOT COMPLETED|RCP (Day 1 - Week 16)||0
10832830|NCT03500549|11998064|FG000|STARTED|Open-label Period (Week 17 to Week 48)||38
10832831|NCT03500549|11998065|FG001|STARTED|Open-label Period (Week 17 to Week 48)||39
10832832|NCT03500549|11998064|FG000|COMPLETED|Open-label Period (Week 17 to Week 48)||35
10832833|NCT03500549|11998065|FG001|COMPLETED|Open-label Period (Week 17 to Week 48)||32
10832834|NCT03500549|11998064|FG000|NOT COMPLETED|Open-label Period (Week 17 to Week 48)||3
10832835|NCT03500549|11998065|FG001|NOT COMPLETED|Open-label Period (Week 17 to Week 48)||7
10832836|NCT03456700|11998076|FG000|STARTED|Overall Study||22
10832837|NCT03456700|11998076|FG000|COMPLETED|Overall Study||21
10832838|NCT03456700|11998076|FG000|NOT COMPLETED|Overall Study||1
10832839|NCT03435185|11998082|FG000|STARTED|Overall Study||44
10832840|NCT03435185|11998083|FG001|STARTED|Overall Study||43
10832841|NCT03435185|11998082|FG000|COMPLETED|Overall Study||43
10832842|NCT03435185|11998083|FG001|COMPLETED|Overall Study||28
10832843|NCT03435185|11998082|FG000|NOT COMPLETED|Overall Study||1
10832844|NCT03435185|11998083|FG001|NOT COMPLETED|Overall Study||15
10832845|NCT03427411|11998091|FG000|STARTED|Overall Study||30
10832846|NCT03427411|11998092|FG001|STARTED|Overall Study||27
10832847|NCT03427411|11998091|FG000|COMPLETED|Overall Study||30
10832848|NCT03427411|11998092|FG001|COMPLETED|Overall Study||26
10832849|NCT03427411|11998091|FG000|NOT COMPLETED|Overall Study||0
10832850|NCT03427411|11998092|FG001|NOT COMPLETED|Overall Study||1
10832851|NCT03387150|11998105|FG000|STARTED|Overall Study||19
10832852|NCT03387150|11998106|FG001|STARTED|Overall Study||19
10832853|NCT03387150|11998107|FG002|STARTED|Overall Study||21
10832854|NCT03387150|11998108|FG003|STARTED|Overall Study||21
10832855|NCT03387150|11998109|FG004|STARTED|Overall Study||20
10832856|NCT03387150|11998110|FG005|STARTED|Overall Study||21
10832857|NCT03387150|11998111|FG006|STARTED|Overall Study||3
10832858|NCT03387150|11998105|FG000|Safety Population|Overall Study||19
10832859|NCT03387150|11998106|FG001|Safety Population|Overall Study||19
10832860|NCT03387150|11998107|FG002|Safety Population|Overall Study||21
10832861|NCT03387150|11998108|FG003|Safety Population|Overall Study||21
10832862|NCT03387150|11998109|FG004|Safety Population|Overall Study||20
10832863|NCT03387150|11998110|FG005|Safety Population|Overall Study||21
10832864|NCT03387150|11998111|FG006|Safety Population|Overall Study||3
10832865|NCT03387150|11998105|FG000|COMPLETED|Overall Study||13
10832866|NCT03387150|11998106|FG001|COMPLETED|Overall Study||16
10832867|NCT03387150|11998107|FG002|COMPLETED|Overall Study||16
10832868|NCT03387150|11998108|FG003|COMPLETED|Overall Study||14
10832869|NCT03387150|11998109|FG004|COMPLETED|Overall Study||14
10832870|NCT03387150|11998110|FG005|COMPLETED|Overall Study||14
10832871|NCT03387150|11998111|FG006|COMPLETED|Overall Study||3
11102291|NCT01235949|12286366|FG013|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65
11102292|NCT01235949|12286367|FG014|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62
11102293|NCT01235949|12286368|FG015|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67
11102294|NCT01235949|12286369|FG016|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68
11102295|NCT01235949|12286370|FG017|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67
11102296|NCT01235949|12286353|FG000|COMPLETED|Booster Phase||0
11102297|NCT01235949|12286354|FG001|COMPLETED|Booster Phase||0
11102298|NCT01235949|12286355|FG002|COMPLETED|Booster Phase||0
11102299|NCT01235949|12286356|FG003|COMPLETED|Booster Phase||0
11102300|NCT01235949|12286357|FG004|COMPLETED|Booster Phase||0
11102301|NCT01235949|12286358|FG005|COMPLETED|Booster Phase||0
11220143|NCT01958619|12411730|FG000|NOT COMPLETED|Overall Study||2
11220144|NCT01958619|12411731|FG001|NOT COMPLETED|Overall Study||0
11220145|NCT01958619|12411732|FG002|NOT COMPLETED|Overall Study||1
11220146|NCT01958619|12411733|FG003|NOT COMPLETED|Overall Study||0
11220147|NCT01958645|12411746|FG000|STARTED|Overall Study||4
11220148|NCT01958645|12411747|FG001|STARTED|Overall Study||4
11220149|NCT01958645|12411748|FG002|STARTED|Overall Study||4
11102302|NCT01235949|12286359|FG006|COMPLETED|Booster Phase||64
11102303|NCT01235949|12286360|FG007|COMPLETED|Booster Phase||59
11102304|NCT01235949|12286361|FG008|COMPLETED|Booster Phase||61
11102305|NCT01235949|12286362|FG009|COMPLETED|Booster Phase||62
11102306|NCT01235949|12286363|FG010|COMPLETED|Booster Phase||61
11102307|NCT01235949|12286364|FG011|COMPLETED|Booster Phase||60
11102308|NCT01235949|12286365|FG012|COMPLETED|Booster Phase||60
11102309|NCT01235949|12286366|FG013|COMPLETED|Booster Phase||65
11102310|NCT01235949|12286367|FG014|COMPLETED|Booster Phase||60
11102311|NCT01235949|12286368|FG015|COMPLETED|Booster Phase||66
11102312|NCT01235949|12286369|FG016|COMPLETED|Booster Phase||68
11220150|NCT01958645|12411746|FG000|COMPLETED|Overall Study||4
11220151|NCT01958645|12411747|FG001|COMPLETED|Overall Study||4
11220152|NCT01958645|12411748|FG002|COMPLETED|Overall Study||4
11102313|NCT01235949|12286370|FG017|COMPLETED|Booster Phase||65
11102314|NCT01235949|12286353|FG000|NOT COMPLETED|Booster Phase||0
11102315|NCT01235949|12286354|FG001|NOT COMPLETED|Booster Phase||0
11220153|NCT01958645|12411746|FG000|NOT COMPLETED|Overall Study||0
11220154|NCT01958645|12411747|FG001|NOT COMPLETED|Overall Study||0
11220155|NCT01958645|12411748|FG002|NOT COMPLETED|Overall Study||0
11220156|NCT01958671|12411761|FG000|STARTED|Overall Study||156
10832872|NCT03387150|11998105|FG000|NOT COMPLETED|Overall Study||6
10832873|NCT03387150|11998106|FG001|NOT COMPLETED|Overall Study||3
10832874|NCT03387150|11998107|FG002|NOT COMPLETED|Overall Study||5
10832875|NCT03387150|11998108|FG003|NOT COMPLETED|Overall Study||7
10832876|NCT03387150|11998109|FG004|NOT COMPLETED|Overall Study||6
10832877|NCT03387150|11998110|FG005|NOT COMPLETED|Overall Study||7
10832878|NCT03387150|11998111|FG006|NOT COMPLETED|Overall Study||0
11220157|NCT01958671|12411762|FG001|STARTED|Overall Study||152
11220158|NCT01958671|12411763|FG002|STARTED|Overall Study||153
11220159|NCT01958671|12411761|FG000|COMPLETED|Overall Study||137
11220160|NCT01958671|12411762|FG001|COMPLETED|Overall Study||128
11220161|NCT01958671|12411763|FG002|COMPLETED|Overall Study||121
11220162|NCT01958671|12411761|FG000|NOT COMPLETED|Overall Study||19
11354032|NCT03068754|12551243|FG001|COMPLETED|Randomized Treatment Period (RTP)||9
11354033|NCT03068754|12551244|FG002|COMPLETED|Randomized Treatment Period (RTP)||0
11354034|NCT03068754|12551245|FG003|COMPLETED|Randomized Treatment Period (RTP)||0
11354035|NCT03068754|12551242|FG000|NOT COMPLETED|Randomized Treatment Period (RTP)||67
11354036|NCT03068754|12551243|FG001|NOT COMPLETED|Randomized Treatment Period (RTP)||39
11354037|NCT03068754|12551244|FG002|NOT COMPLETED|Randomized Treatment Period (RTP)||0
11354038|NCT03068754|12551245|FG003|NOT COMPLETED|Randomized Treatment Period (RTP)||0
11354039|NCT03068754|12551242|FG000|STARTED|Open Label Extension Period (OLE)|RTP arms were not included during the OLE period|0
11354040|NCT03068754|12551243|FG001|STARTED|Open Label Extension Period (OLE)||0
11354041|NCT03068754|12551244|FG002|STARTED|Open Label Extension Period (OLE)||25
11354042|NCT03068754|12551245|FG003|STARTED|Open Label Extension Period (OLE)||8
11354043|NCT03068754|12551242|FG000|Completed Taper|Open Label Extension Period (OLE)||0
11354044|NCT03068754|12551243|FG001|Completed Taper|Open Label Extension Period (OLE)||0
11354045|NCT03068754|12551244|FG002|Completed Taper|Open Label Extension Period (OLE)||19
11354046|NCT03068754|12551245|FG003|Completed Taper|Open Label Extension Period (OLE)||7
11354047|NCT03068754|12551242|FG000|Completed OLE Period|Open Label Extension Period (OLE)||0
11354048|NCT03068754|12551243|FG001|Completed OLE Period|Open Label Extension Period (OLE)||0
11354049|NCT03068754|12551244|FG002|Completed OLE Period|Open Label Extension Period (OLE)||3
11354050|NCT03068754|12551245|FG003|Completed OLE Period|Open Label Extension Period (OLE)||2
11354051|NCT03068754|12551242|FG000|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
11354052|NCT03068754|12551243|FG001|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
11354053|NCT03068754|12551244|FG002|Completed Treatment in OLE|Open Label Extension Period (OLE)||4
11354054|NCT03068754|12551245|FG003|Completed Treatment in OLE|Open Label Extension Period (OLE)||2
11354055|NCT03068754|12551242|FG000|COMPLETED|Open Label Extension Period (OLE)||0
11354056|NCT03068754|12551243|FG001|COMPLETED|Open Label Extension Period (OLE)||0
11354057|NCT03068754|12551244|FG002|COMPLETED|Open Label Extension Period (OLE)||4
11354058|NCT03068754|12551245|FG003|COMPLETED|Open Label Extension Period (OLE)||2
11354059|NCT03068754|12551242|FG000|NOT COMPLETED|Open Label Extension Period (OLE)||0
11354060|NCT03068754|12551243|FG001|NOT COMPLETED|Open Label Extension Period (OLE)||0
11354061|NCT03068754|12551244|FG002|NOT COMPLETED|Open Label Extension Period (OLE)||21
11354062|NCT03068754|12551245|FG003|NOT COMPLETED|Open Label Extension Period (OLE)||6
11354063|NCT03068767|12551257|FG000|STARTED|Overall Study|from August 2017 to September 2018|75
11354064|NCT03068767|12551258|FG001|STARTED|Overall Study|from August 2017 to September 2018|74
11354065|NCT03068767|12551257|FG000|COMPLETED|Overall Study|December 2018|65
11354066|NCT03068767|12551258|FG001|COMPLETED|Overall Study|December 2018|71
11354067|NCT03068767|12551257|FG000|NOT COMPLETED|Overall Study||10
11354068|NCT03068767|12551258|FG001|NOT COMPLETED|Overall Study||3
11354069|NCT03068897|12551268|FG000|STARTED|Overall Study||80
11354070|NCT03068897|12551269|FG001|STARTED|Overall Study||80
11354071|NCT03068897|12551270|FG002|STARTED|Overall Study||80
11354072|NCT03068897|12551271|FG003|STARTED|Overall Study||80
11354073|NCT03068897|12551268|FG000|COMPLETED|Overall Study||76
11354074|NCT03068897|12551269|FG001|COMPLETED|Overall Study||76
11354075|NCT03068897|12551270|FG002|COMPLETED|Overall Study||79
11354076|NCT03068897|12551271|FG003|COMPLETED|Overall Study||74
11354077|NCT03068897|12551268|FG000|NOT COMPLETED|Overall Study||4
11354078|NCT03068897|12551269|FG001|NOT COMPLETED|Overall Study||4
11354079|NCT03068897|12551270|FG002|NOT COMPLETED|Overall Study||1
11354080|NCT03068897|12551271|FG003|NOT COMPLETED|Overall Study||6
11354081|NCT03068949|12551285|FG000|STARTED|Overall Study||113
11354082|NCT03068949|12551286|FG001|STARTED|Overall Study||102
11354083|NCT03068949|12551287|FG002|STARTED|Overall Study||122
11354084|NCT03068949|12551288|FG003|STARTED|Overall Study||76
11354085|NCT03068949|12551285|FG000|COMPLETED|Overall Study||105
11354086|NCT03068949|12551286|FG001|COMPLETED|Overall Study||90
11354087|NCT03068949|12551287|FG002|COMPLETED|Overall Study||113
11354088|NCT03068949|12551288|FG003|COMPLETED|Overall Study||63
11354089|NCT03068949|12551285|FG000|NOT COMPLETED|Overall Study||8
11354090|NCT03068949|12551286|FG001|NOT COMPLETED|Overall Study||12
11354091|NCT03068949|12551287|FG002|NOT COMPLETED|Overall Study||9
11354092|NCT03068949|12551288|FG003|NOT COMPLETED|Overall Study||13
11354093|NCT03069313|12551298|FG000|STARTED|Overall Study||41
11354094|NCT03069313|12551298|FG000|COMPLETED|Overall Study||36
11354095|NCT03069313|12551298|FG000|NOT COMPLETED|Overall Study||5
11354096|NCT03069365|12551302|FG000|STARTED|Overall Study||101
11354097|NCT03069365|12551302|FG000|COMPLETED|Overall Study||100
11354098|NCT03069365|12551302|FG000|NOT COMPLETED|Overall Study||1
11354099|NCT03069482|12551308|FG000|STARTED|Overall Study||34
11354100|NCT03069482|12551309|FG001|STARTED|Overall Study||29
11354101|NCT03069482|12551308|FG000|COMPLETED|Overall Study||33
11354102|NCT03069482|12551309|FG001|COMPLETED|Overall Study||28
11220163|NCT01958671|12411762|FG001|NOT COMPLETED|Overall Study||24
11220164|NCT01958671|12411763|FG002|NOT COMPLETED|Overall Study||32
11220165|NCT01958788|12411775|FG000|STARTED|Overall Study||7
11220166|NCT01958788|12411775|FG000|COMPLETED|Overall Study||7
11220167|NCT01958788|12411775|FG000|NOT COMPLETED|Overall Study||0
11220168|NCT01958827|12411779|FG000|STARTED|Overall Study||28
11220169|NCT01958827|12411779|FG000|COMPLETED|Overall Study||18
11220170|NCT01958827|12411779|FG000|NOT COMPLETED|Overall Study||10
11220171|NCT01958918|12411785|FG000|STARTED|Overall Study||356
11354103|NCT03069482|12551308|FG000|NOT COMPLETED|Overall Study||1
11220172|NCT01958918|12411786|FG001|STARTED|Overall Study||356
11220173|NCT01958918|12411785|FG000|Full Analysis Set|Overall Study||353
11220174|NCT01958918|12411786|FG001|Full Analysis Set|Overall Study||354
11220175|NCT01958918|12411785|FG000|COMPLETED|Overall Study||313
11220176|NCT01958918|12411786|FG001|COMPLETED|Overall Study||314
11220177|NCT01958918|12411785|FG000|NOT COMPLETED|Overall Study||43
11220178|NCT01958918|12411786|FG001|NOT COMPLETED|Overall Study||42
11220179|NCT01959035|12411792|FG000|STARTED|Overall Study||88
11220180|NCT01959035|12411792|FG000|COMPLETED|Overall Study||77
11220181|NCT01959035|12411792|FG000|NOT COMPLETED|Overall Study||11
11220182|NCT01959048|12411796|FG000|STARTED|Overall Study||3
11220183|NCT01959048|12411796|FG000|COMPLETED|Overall Study||3
11220184|NCT01959048|12411796|FG000|NOT COMPLETED|Overall Study||0
11220185|NCT01959113|12411800|FG000|STARTED|Overall Study||5
11220186|NCT01959113|12411800|FG000|COMPLETED|Overall Study||5
11220187|NCT01959113|12411800|FG000|NOT COMPLETED|Overall Study||0
11220188|NCT01959165|12411810|FG000|STARTED|Overall Study||13
11220189|NCT01959165|12411811|FG001|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11
11220190|NCT01959165|12411812|FG002|STARTED|Overall Study||12
11220191|NCT01959165|12411813|FG003|STARTED|Overall Study||9
11220192|NCT01959165|12411810|FG000|COMPLETED|Overall Study||12
11220193|NCT01959165|12411811|FG001|COMPLETED|Overall Study||10
11102316|NCT01235949|12286355|FG002|NOT COMPLETED|Booster Phase||0
11102317|NCT01235949|12286356|FG003|NOT COMPLETED|Booster Phase||0
11102318|NCT01235949|12286357|FG004|NOT COMPLETED|Booster Phase||0
11102319|NCT01235949|12286358|FG005|NOT COMPLETED|Booster Phase||0
11102320|NCT01235949|12286359|FG006|NOT COMPLETED|Booster Phase||0
11102321|NCT01235949|12286360|FG007|NOT COMPLETED|Booster Phase||1
11102322|NCT01235949|12286361|FG008|NOT COMPLETED|Booster Phase||2
11102323|NCT01235949|12286362|FG009|NOT COMPLETED|Booster Phase||1
11102324|NCT01235949|12286363|FG010|NOT COMPLETED|Booster Phase||2
11102325|NCT01235949|12286364|FG011|NOT COMPLETED|Booster Phase||3
11102326|NCT01235949|12286365|FG012|NOT COMPLETED|Booster Phase||3
11102327|NCT01235949|12286366|FG013|NOT COMPLETED|Booster Phase||0
11102328|NCT01235949|12286367|FG014|NOT COMPLETED|Booster Phase||2
11102329|NCT01235949|12286368|FG015|NOT COMPLETED|Booster Phase||1
11102330|NCT01235949|12286369|FG016|NOT COMPLETED|Booster Phase||0
11102331|NCT01235949|12286370|FG017|NOT COMPLETED|Booster Phase||2
11102332|NCT01235975|12286410|FG000|STARTED|Overall Study||274
11102333|NCT01235975|12286411|FG001|STARTED|Overall Study||95
11102334|NCT01235975|12286410|FG000|COMPLETED|Overall Study||257
11102335|NCT01235975|12286411|FG001|COMPLETED|Overall Study||88
11102336|NCT01235975|12286410|FG000|NOT COMPLETED|Overall Study||17
11102337|NCT01235975|12286411|FG001|NOT COMPLETED|Overall Study||7
11102338|NCT01236001|12286419|FG000|STARTED|Overall Study||105
11102339|NCT01236001|12286420|FG001|STARTED|Overall Study||87
11102340|NCT01236001|12286419|FG000|COMPLETED|Overall Study||87
11102341|NCT01236001|12286420|FG001|COMPLETED|Overall Study||65
11102342|NCT01236001|12286419|FG000|NOT COMPLETED|Overall Study||18
11102343|NCT01236001|12286420|FG001|NOT COMPLETED|Overall Study||22
11102344|NCT01236053|12286449|FG000|STARTED|Overall Study||179138
11102345|NCT01236053|12286450|FG001|STARTED|Overall Study||1710950
11102346|NCT01236053|12286451|FG002|STARTED|Overall Study||1877
11102347|NCT01236053|12286452|FG003|STARTED|Overall Study||17853
11102348|NCT01236053|12286453|FG004|STARTED|Overall Study||212
11102349|NCT01236053|12286454|FG005|STARTED|Overall Study||2067
11102350|NCT01236053|12286455|FG006|STARTED|Overall Study||10855
11102351|NCT01236053|12286456|FG007|STARTED|Overall Study||102836
11102352|NCT01236053|12286457|FG008|STARTED|Overall Study||300
11102353|NCT01236053|12286458|FG009|STARTED|Overall Study||2935
11102354|NCT01236053|12286459|FG010|STARTED|Overall Study||19564
11102355|NCT01236053|12286460|FG011|STARTED|Overall Study||188924
11102356|NCT01236053|12286461|FG012|STARTED|Overall Study||148
11102357|NCT01236053|12286462|FG013|STARTED|Overall Study||1396
11102358|NCT01236053|12286463|FG014|STARTED|Overall Study||4600
11102359|NCT01236053|12286464|FG015|STARTED|Overall Study||43559
11102360|NCT01236053|12286465|FG016|STARTED|Overall Study||38
11102361|NCT01236053|12286466|FG017|STARTED|Overall Study||380
11102362|NCT01236053|12286467|FG018|STARTED|Overall Study||2155
11102363|NCT01236053|12286468|FG019|STARTED|Overall Study||20382
11102364|NCT01236053|12286469|FG020|STARTED|Overall Study||1272
11102365|NCT01236053|12286470|FG021|STARTED|Overall Study||12167
11102366|NCT01236053|12286449|FG000|COMPLETED|Overall Study||179138
11102367|NCT01236053|12286450|FG001|COMPLETED|Overall Study||1710950
11102368|NCT01236053|12286451|FG002|COMPLETED|Overall Study||1877
11102369|NCT01236053|12286452|FG003|COMPLETED|Overall Study||17853
11220194|NCT01959165|12411812|FG002|COMPLETED|Overall Study||12
11220195|NCT01959165|12411813|FG003|COMPLETED|Overall Study||7
11102370|NCT01236053|12286453|FG004|COMPLETED|Overall Study||212
11102371|NCT01236053|12286454|FG005|COMPLETED|Overall Study||2067
11102372|NCT01236053|12286455|FG006|COMPLETED|Overall Study||10855
11102373|NCT01236053|12286456|FG007|COMPLETED|Overall Study||102836
11102374|NCT01236053|12286457|FG008|COMPLETED|Overall Study||300
11102375|NCT01236053|12286458|FG009|COMPLETED|Overall Study||2935
11102376|NCT01236053|12286459|FG010|COMPLETED|Overall Study||19564
11102377|NCT01236053|12286460|FG011|COMPLETED|Overall Study||188924
11102378|NCT01236053|12286461|FG012|COMPLETED|Overall Study||148
11102379|NCT01236053|12286462|FG013|COMPLETED|Overall Study||1396
11102380|NCT01236053|12286463|FG014|COMPLETED|Overall Study||4600
11102381|NCT01236053|12286464|FG015|COMPLETED|Overall Study||43559
11220196|NCT01959165|12411810|FG000|NOT COMPLETED|Overall Study||1
11220197|NCT01959165|12411811|FG001|NOT COMPLETED|Overall Study||1
11220198|NCT01959165|12411812|FG002|NOT COMPLETED|Overall Study||0
11102382|NCT01236053|12286465|FG016|COMPLETED|Overall Study||38
11102383|NCT01236053|12286466|FG017|COMPLETED|Overall Study||380
11102384|NCT01236053|12286467|FG018|COMPLETED|Overall Study||2155
11102385|NCT01236053|12286468|FG019|COMPLETED|Overall Study||20382
11102386|NCT01236053|12286469|FG020|COMPLETED|Overall Study||1272
11102387|NCT01236053|12286470|FG021|COMPLETED|Overall Study||12167
11102388|NCT01236053|12286449|FG000|NOT COMPLETED|Overall Study||0
11102389|NCT01236053|12286450|FG001|NOT COMPLETED|Overall Study||0
11102390|NCT01236053|12286451|FG002|NOT COMPLETED|Overall Study||0
11102391|NCT01236053|12286452|FG003|NOT COMPLETED|Overall Study||0
11102392|NCT01236053|12286453|FG004|NOT COMPLETED|Overall Study||0
11102393|NCT01236053|12286454|FG005|NOT COMPLETED|Overall Study||0
11102394|NCT01236053|12286455|FG006|NOT COMPLETED|Overall Study||0
11102395|NCT01236053|12286456|FG007|NOT COMPLETED|Overall Study||0
11102396|NCT01236053|12286457|FG008|NOT COMPLETED|Overall Study||0
11102397|NCT01236053|12286458|FG009|NOT COMPLETED|Overall Study||0
10832915|NCT03366792|11998153|FG000|STARTED|Overall Study||46
10832916|NCT03366792|11998153|FG000|COMPLETED|Overall Study||31
10832917|NCT03366792|11998153|FG000|NOT COMPLETED|Overall Study||15
10832918|NCT03366337|11998161|FG000|STARTED|Overall Study||31
10832919|NCT03366337|11998162|FG001|STARTED|Overall Study||26
10832920|NCT03366337|11998163|FG002|STARTED|Overall Study||28
10832921|NCT03366337|11998164|FG003|STARTED|Overall Study||18
10832922|NCT03366337|11998161|FG000|COMPLETED|Overall Study||28
10832923|NCT03366337|11998162|FG001|COMPLETED|Overall Study||26
10832924|NCT03366337|11998163|FG002|COMPLETED|Overall Study||26
11102398|NCT01236053|12286459|FG010|NOT COMPLETED|Overall Study||0
11102399|NCT01236053|12286460|FG011|NOT COMPLETED|Overall Study||0
11102400|NCT01236053|12286461|FG012|NOT COMPLETED|Overall Study||0
11102401|NCT01236053|12286462|FG013|NOT COMPLETED|Overall Study||0
11102402|NCT01236053|12286463|FG014|NOT COMPLETED|Overall Study||0
11102403|NCT01236053|12286464|FG015|NOT COMPLETED|Overall Study||0
11102404|NCT01236053|12286465|FG016|NOT COMPLETED|Overall Study||0
11102405|NCT01236053|12286466|FG017|NOT COMPLETED|Overall Study||0
11102406|NCT01236053|12286467|FG018|NOT COMPLETED|Overall Study||0
11102407|NCT01236053|12286468|FG019|NOT COMPLETED|Overall Study||0
11102408|NCT01236053|12286469|FG020|NOT COMPLETED|Overall Study||0
11102409|NCT01236053|12286470|FG021|NOT COMPLETED|Overall Study||0
11102410|NCT01236105|12286519|FG000|STARTED|Overall Study||21
11102411|NCT01236105|12286519|FG000|COMPLETED|Overall Study||21
11102412|NCT01236105|12286519|FG000|NOT COMPLETED|Overall Study||0
11102413|NCT01236118|12286530|FG000|STARTED|Overall Study||6
11102414|NCT01236118|12286531|FG001|STARTED|Overall Study||5
11102415|NCT01236118|12286532|FG002|STARTED|Overall Study||17
11102416|NCT01236118|12286530|FG000|COMPLETED|Overall Study||4
11102417|NCT01236118|12286531|FG001|COMPLETED|Overall Study||4
11102418|NCT01236118|12286532|FG002|COMPLETED|Overall Study||14
11102419|NCT01236118|12286530|FG000|NOT COMPLETED|Overall Study||2
11220199|NCT01959165|12411813|FG003|NOT COMPLETED|Overall Study||2
11220200|NCT01959178|12411823|FG000|STARTED|Overall Study||73
11220201|NCT01959178|12411824|FG001|STARTED|Overall Study||73
10832925|NCT03366337|11998164|FG003|COMPLETED|Overall Study||17
10832926|NCT03366337|11998161|FG000|NOT COMPLETED|Overall Study||3
11220202|NCT01959178|12411823|FG000|COMPLETED|Overall Study||71
11220203|NCT01959178|12411824|FG001|COMPLETED|Overall Study||71
11220204|NCT01959178|12411823|FG000|NOT COMPLETED|Overall Study||2
11220205|NCT01959178|12411824|FG001|NOT COMPLETED|Overall Study||2
11220206|NCT01959230|12411832|FG000|STARTED|Overall Study||40
11220207|NCT01959230|12411833|FG001|STARTED|Overall Study||20
11220208|NCT01959230|12411832|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
11220209|NCT01959230|12411833|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
11220210|NCT01959230|12411832|FG000|COMPLETED|Overall Study||36
11220211|NCT01959230|12411833|FG001|COMPLETED|Overall Study||19
11220212|NCT01959230|12411832|FG000|NOT COMPLETED|Overall Study||4
11220213|NCT01959230|12411833|FG001|NOT COMPLETED|Overall Study||1
11220214|NCT01959243|12411841|FG000|STARTED|Overall Study||337
11220215|NCT01959243|12411842|FG001|STARTED|Overall Study||170
11220216|NCT01959243|12411841|FG000|Received at Least 1 Dose of Study Drug|Overall Study||337
11220217|NCT01959243|12411842|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170
11220218|NCT01959243|12411841|FG000|COMPLETED|Overall Study||324
11220219|NCT01959243|12411842|FG001|COMPLETED|Overall Study||166
11220220|NCT01959243|12411841|FG000|NOT COMPLETED|Overall Study||13
11220221|NCT01959243|12411842|FG001|NOT COMPLETED|Overall Study||4
11220222|NCT01959334|12411850|FG000|STARTED|First Dose||26
11220223|NCT01959334|12411851|FG001|STARTED|First Dose||49
11220224|NCT01959334|12411850|FG000|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26
11220225|NCT01959334|12411851|FG001|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49
11102420|NCT01236118|12286531|FG001|NOT COMPLETED|Overall Study||1
11102421|NCT01236118|12286532|FG002|NOT COMPLETED|Overall Study||3
11102422|NCT01236170|12286540|FG000|STARTED|Overall Study||497
11102423|NCT01236170|12286540|FG000|COMPLETED|Overall Study||482
11102424|NCT01236170|12286540|FG000|NOT COMPLETED|Overall Study||15
11220226|NCT01959334|12411850|FG000|NOT COMPLETED|First Dose||0
11220227|NCT01959334|12411851|FG001|NOT COMPLETED|First Dose||0
11220228|NCT01959334|12411850|FG000|STARTED|Second Dose||26
11220229|NCT01959334|12411851|FG001|STARTED|Second Dose||49
11220230|NCT01959334|12411850|FG000|COMPLETED|Second Dose||25
11220231|NCT01959334|12411851|FG001|COMPLETED|Second Dose||49
11220232|NCT01959334|12411850|FG000|NOT COMPLETED|Second Dose||1
11220233|NCT01959334|12411851|FG001|NOT COMPLETED|Second Dose||0
11220234|NCT01959334|12411850|FG000|STARTED|Third Dose||25
11220235|NCT01959334|12411851|FG001|STARTED|Third Dose||49
11220236|NCT01959334|12411850|FG000|COMPLETED|Third Dose||25
11220237|NCT01959334|12411851|FG001|COMPLETED|Third Dose||48
11220238|NCT01959334|12411850|FG000|NOT COMPLETED|Third Dose||0
11220239|NCT01959334|12411851|FG001|NOT COMPLETED|Third Dose||1
11220240|NCT01959347|12411859|FG000|STARTED|Overall Study||238
11220241|NCT01959347|12411860|FG001|STARTED|Overall Study||242
11220242|NCT01959347|12411859|FG000|COMPLETED|Overall Study||229
10832927|NCT03366337|11998162|FG001|NOT COMPLETED|Overall Study||0
10832928|NCT03366337|11998163|FG002|NOT COMPLETED|Overall Study||2
10832929|NCT03366337|11998164|FG003|NOT COMPLETED|Overall Study||1
11102425|NCT01236196|12286546|FG000|STARTED|Overall Study||18
11102426|NCT01236196|12286547|FG001|STARTED|Overall Study||21
10832930|NCT03342053|11998176|FG000|STARTED|Overall Study||23
10832931|NCT03342053|11998177|FG001|STARTED|Overall Study||23
10832932|NCT03342053|11998176|FG000|COMPLETED|Overall Study||21
10832933|NCT03342053|11998177|FG001|COMPLETED|Overall Study||22
10832934|NCT03342053|11998176|FG000|NOT COMPLETED|Overall Study||2
10832935|NCT03342053|11998177|FG001|NOT COMPLETED|Overall Study||1
10832936|NCT03283241|11998185|FG000|STARTED|Overall Study||32
10832937|NCT03283241|11998186|FG001|STARTED|Overall Study||30
10832938|NCT03283241|11998185|FG000|Completed 12 Weeks|Overall Study|Completed 12 weeks|29
10832939|NCT03283241|11998186|FG001|Completed 12 Weeks|Overall Study|Completed 12 weeks|29
10832940|NCT03283241|11998185|FG000|COMPLETED|Overall Study|Completed 24 month|28
10832941|NCT03283241|11998186|FG001|COMPLETED|Overall Study|Completed 24 month|27
10832942|NCT03283241|11998185|FG000|NOT COMPLETED|Overall Study||4
10832943|NCT03283241|11998186|FG001|NOT COMPLETED|Overall Study||3
10832944|NCT03242772|11998194|FG000|STARTED|Overall Study||9
10832945|NCT03242772|11998195|FG001|STARTED|Overall Study||9
10832946|NCT03242772|11998194|FG000|COMPLETED|Overall Study||6
10832947|NCT03242772|11998195|FG001|COMPLETED|Overall Study||8
10832948|NCT03242772|11998194|FG000|NOT COMPLETED|Overall Study||3
10832949|NCT03242772|11998195|FG001|NOT COMPLETED|Overall Study||1
10832950|NCT03236311|11998203|FG000|STARTED|Overall Study||5
10832951|NCT03236311|11998204|FG001|STARTED|Overall Study||5
10832952|NCT03236311|11998203|FG000|COMPLETED|Overall Study||5
10832953|NCT03236311|11998204|FG001|COMPLETED|Overall Study||2
10832954|NCT03236311|11998203|FG000|NOT COMPLETED|Overall Study||0
10832955|NCT03236311|11998204|FG001|NOT COMPLETED|Overall Study||3
10832956|NCT03192046|11998212|FG000|STARTED|Overall Study||5
10832957|NCT03192046|11998213|FG001|STARTED|Overall Study||4
10832958|NCT03192046|11998212|FG000|COMPLETED|Overall Study||4
10832959|NCT03192046|11998213|FG001|COMPLETED|Overall Study||3
10832960|NCT03192046|11998212|FG000|NOT COMPLETED|Overall Study||1
10832961|NCT03192046|11998213|FG001|NOT COMPLETED|Overall Study||1
10832962|NCT03190369|11998221|FG000|STARTED|Overall Study||220
10832963|NCT03190369|11998222|FG001|STARTED|Overall Study||220
10832964|NCT03190369|11998221|FG000|Treated|Overall Study||220
10832965|NCT03190369|11998222|FG001|Treated|Overall Study||218
10832966|NCT03190369|11998221|FG000|COMPLETED|Overall Study||219
10832967|NCT03190369|11998222|FG001|COMPLETED|Overall Study||212
10832968|NCT03190369|11998221|FG000|NOT COMPLETED|Overall Study||1
10832969|NCT03190369|11998222|FG001|NOT COMPLETED|Overall Study||8
10832970|NCT04657198|11998231|FG000|STARTED|Overall Study||40
10832971|NCT04657198|11998232|FG001|STARTED|Overall Study||39
10832972|NCT04657198|11998233|FG002|STARTED|Overall Study||43
10832973|NCT04657198|11998231|FG000|COMPLETED|Overall Study||39
10832974|NCT04657198|11998232|FG001|COMPLETED|Overall Study||39
10832975|NCT04657198|11998233|FG002|COMPLETED|Overall Study||43
10832976|NCT04657198|11998231|FG000|NOT COMPLETED|Overall Study||1
10832977|NCT04657198|11998232|FG001|NOT COMPLETED|Overall Study||0
10832978|NCT04657198|11998233|FG002|NOT COMPLETED|Overall Study||0
10832979|NCT04590586|11998247|FG000|STARTED|Overall Study||28
10832980|NCT04590586|11998248|FG001|STARTED|Overall Study||1
10832981|NCT04590586|11998249|FG002|STARTED|Overall Study||194
10832982|NCT04590586|11998250|FG003|STARTED|Overall Study||184
10832983|NCT04590586|11998251|FG004|STARTED|Overall Study||100
10832984|NCT04590586|11998252|FG005|STARTED|Overall Study||8
10832985|NCT04590586|11998247|FG000|Received Study Drug|Overall Study||27
10832986|NCT04590586|11998248|FG001|Received Study Drug|Overall Study||1
10832987|NCT04590586|11998249|FG002|Received Study Drug|Overall Study||189
10832988|NCT04590586|11998250|FG003|Received Study Drug|Overall Study||182
10832989|NCT04590586|11998251|FG004|Received Study Drug|Overall Study||95
10832990|NCT04590586|11998252|FG005|Received Study Drug|Overall Study||7
10832991|NCT04590586|11998247|FG000|Full Analysis Set|Overall Study||28
10832992|NCT04590586|11998248|FG001|Full Analysis Set|Overall Study|Includes participants randomized to this arm (1) and 32 participants from Apremilast Placebo + SOC group and 1 participant from Zilucoplan Placebo + SOC group.|34
10832993|NCT04590586|11998249|FG002|Full Analysis Set|Overall Study||194
10832994|NCT04590586|11998250|FG003|Full Analysis Set|Overall Study|Includes participants randomized to this arm (184) and 1 participant from Lanadelumab Placebo + SOC group and 5 participants from Zilucoplan Placebo + SOC group.|190
10832995|NCT04590586|11998251|FG004|Full Analysis Set|Overall Study||100
10832996|NCT04590586|11998252|FG005|Full Analysis Set|Overall Study|Includes participants randomized to this arm (8) and 1 participant from Lanadelumab Placebo + SOC group and 66 participants from the Apremilast Placebo + SOC group.|75
10832997|NCT04590586|11998247|FG000|COMPLETED|Overall Study||15
11220243|NCT01959347|12411860|FG001|COMPLETED|Overall Study||235
11220244|NCT01959347|12411859|FG000|NOT COMPLETED|Overall Study||9
11220245|NCT01959347|12411860|FG001|NOT COMPLETED|Overall Study||7
11220246|NCT01959412|12411866|FG000|STARTED|Overall Study||15
10832998|NCT04590586|11998248|FG001|COMPLETED|Overall Study||0
10832999|NCT04590586|11998249|FG002|COMPLETED|Overall Study||139
10833000|NCT04590586|11998250|FG003|COMPLETED|Overall Study||138
10833001|NCT04590586|11998251|FG004|COMPLETED|Overall Study||70
10833002|NCT04590586|11998252|FG005|COMPLETED|Overall Study||4
10833003|NCT04590586|11998247|FG000|NOT COMPLETED|Overall Study||13
10833004|NCT04590586|11998248|FG001|NOT COMPLETED|Overall Study||1
10833005|NCT04590586|11998249|FG002|NOT COMPLETED|Overall Study||55
10833006|NCT04590586|11998250|FG003|NOT COMPLETED|Overall Study||46
10833007|NCT04590586|11998251|FG004|NOT COMPLETED|Overall Study||30
10833008|NCT04590586|11998252|FG005|NOT COMPLETED|Overall Study||4
10833009|NCT04312009|11998278|FG000|STARTED|Overall Study||104
10833010|NCT04312009|11998279|FG001|STARTED|Overall Study||101
10833011|NCT04312009|11998278|FG000|COMPLETED|Overall Study||102
10833012|NCT04312009|11998279|FG001|COMPLETED|Overall Study||100
10833013|NCT04312009|11998278|FG000|NOT COMPLETED|Overall Study||2
10833014|NCT04312009|11998279|FG001|NOT COMPLETED|Overall Study||1
10833015|NCT04191382|11998288|FG000|STARTED|Overall Study||34
10833016|NCT04191382|11998289|FG001|STARTED|Overall Study||36
10833017|NCT04191382|11998290|FG002|STARTED|Overall Study||35
10833018|NCT04191382|11998288|FG000|Treated|Overall Study||33
10833019|NCT04191382|11998289|FG001|Treated|Overall Study||36
10833020|NCT04191382|11998290|FG002|Treated|Overall Study||35
10833021|NCT04191382|11998288|FG000|COMPLETED|Overall Study||33
10833022|NCT04191382|11998289|FG001|COMPLETED|Overall Study||36
10833023|NCT04191382|11998290|FG002|COMPLETED|Overall Study||35
11102427|NCT01236196|12286546|FG000|COMPLETED|Overall Study||17
11102428|NCT01236196|12286547|FG001|COMPLETED|Overall Study||13
11102429|NCT01236196|12286546|FG000|NOT COMPLETED|Overall Study||1
11102430|NCT01236196|12286547|FG001|NOT COMPLETED|Overall Study||8
11102431|NCT01236300|12286553|FG000|STARTED|Overall Study||66
11102432|NCT01236300|12286553|FG000|COMPLETED|Overall Study||66
11102433|NCT01236300|12286553|FG000|NOT COMPLETED|Overall Study||0
11102434|NCT01236326|12286560|FG000|STARTED|Overall Study||50
11102435|NCT01236326|12286561|FG001|STARTED|Overall Study||55
11102436|NCT01236326|12286560|FG000|COMPLETED|Overall Study||49
11102437|NCT01236326|12286561|FG001|COMPLETED|Overall Study||51
11102438|NCT01236326|12286560|FG000|NOT COMPLETED|Overall Study||1
10833024|NCT04191382|11998288|FG000|NOT COMPLETED|Overall Study||1
10833025|NCT04191382|11998289|FG001|NOT COMPLETED|Overall Study||0
10833026|NCT04191382|11998290|FG002|NOT COMPLETED|Overall Study||0
10833027|NCT03964337|11998300|FG000|STARTED|Overall Study||3
10833028|NCT03964337|11998301|FG001|STARTED|Overall Study||0
10833029|NCT03964337|11998300|FG000|COMPLETED|Overall Study||3
10833030|NCT03964337|11998301|FG001|COMPLETED|Overall Study||0
10833031|NCT03964337|11998300|FG000|NOT COMPLETED|Overall Study||0
10833032|NCT03964337|11998301|FG001|NOT COMPLETED|Overall Study||0
10833033|NCT03937466|11998307|FG000|STARTED|Overall Study||38
10833034|NCT03937466|11998307|FG000|COMPLETED|Overall Study||15
10833035|NCT03937466|11998307|FG000|NOT COMPLETED|Overall Study||23
10833036|NCT03850483|11998320|FG000|STARTED|Treatment for Stage 1||37
10833037|NCT03850483|11998321|FG001|STARTED|Treatment for Stage 1||37
10833038|NCT03850483|11998322|FG002|STARTED|Treatment for Stage 1||37
11102439|NCT01236326|12286561|FG001|NOT COMPLETED|Overall Study||4
11102440|NCT01236339|12286569|FG000|STARTED|Overall Study||13
11102441|NCT01236339|12286570|FG001|STARTED|Overall Study||13
11102442|NCT01236339|12286569|FG000|LVP Crossover to TIPS|Overall Study||0
11102443|NCT01236339|12286570|FG001|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
10833039|NCT03850483|11998323|FG003|STARTED|Treatment for Stage 1||36
10833040|NCT03850483|11998324|FG004|STARTED|Treatment for Stage 1||37
10833041|NCT03850483|11998325|FG005|STARTED|Treatment for Stage 1||38
10833042|NCT03850483|11998326|FG006|STARTED|Treatment for Stage 1||36
10833043|NCT03850483|11998327|FG007|STARTED|Treatment for Stage 1||36
10833044|NCT03850483|11998328|FG008|STARTED|Treatment for Stage 1||0
10833045|NCT03850483|11998329|FG009|STARTED|Treatment for Stage 1||0
10833046|NCT03850483|11998320|FG000|Treated|Treatment for Stage 1||37
10833047|NCT03850483|11998321|FG001|Treated|Treatment for Stage 1||37
10833048|NCT03850483|11998322|FG002|Treated|Treatment for Stage 1||37
10833049|NCT03850483|11998323|FG003|Treated|Treatment for Stage 1||36
10833050|NCT03850483|11998324|FG004|Treated|Treatment for Stage 1||37
10833051|NCT03850483|11998325|FG005|Treated|Treatment for Stage 1||37
10833052|NCT03850483|11998326|FG006|Treated|Treatment for Stage 1||36
10833053|NCT03850483|11998327|FG007|Treated|Treatment for Stage 1||36
10833054|NCT03850483|11998328|FG008|Treated|Treatment for Stage 1||0
10833055|NCT03850483|11998329|FG009|Treated|Treatment for Stage 1||0
10833056|NCT03850483|11998320|FG000|COMPLETED|Treatment for Stage 1||29
10833057|NCT03850483|11998321|FG001|COMPLETED|Treatment for Stage 1||29
10833058|NCT03850483|11998322|FG002|COMPLETED|Treatment for Stage 1||26
10833059|NCT03850483|11998323|FG003|COMPLETED|Treatment for Stage 1||30
10833060|NCT03850483|11998324|FG004|COMPLETED|Treatment for Stage 1||28
10833061|NCT03850483|11998325|FG005|COMPLETED|Treatment for Stage 1||27
10833062|NCT03850483|11998326|FG006|COMPLETED|Treatment for Stage 1||25
10833063|NCT03850483|11998327|FG007|COMPLETED|Treatment for Stage 1||30
11102444|NCT01236339|12286569|FG000|COMPLETED|Overall Study||2
11102445|NCT01236339|12286570|FG001|COMPLETED|Overall Study||0
11102446|NCT01236339|12286569|FG000|NOT COMPLETED|Overall Study||11
11102447|NCT01236339|12286570|FG001|NOT COMPLETED|Overall Study||13
11102448|NCT01236352|12286588|FG000|STARTED|Overall Study||4
11102449|NCT01236352|12286589|FG001|STARTED|Overall Study||4
11102450|NCT01236352|12286590|FG002|STARTED|Overall Study||4
11102451|NCT01236352|12286591|FG003|STARTED|Overall Study||4
11102452|NCT01236352|12286592|FG004|STARTED|Overall Study||4
11102453|NCT01236352|12286593|FG005|STARTED|Overall Study||4
11102454|NCT01236352|12286594|FG006|STARTED|Overall Study||8
11102455|NCT01236352|12286595|FG007|STARTED|Overall Study||7
11102456|NCT01236352|12286596|FG008|STARTED|Overall Study||3
11102457|NCT01236352|12286597|FG009|STARTED|Overall Study||22
11102458|NCT01236352|12286598|FG010|STARTED|Overall Study||20
11102459|NCT01236352|12286588|FG000|COMPLETED|Overall Study||0
11102460|NCT01236352|12286589|FG001|COMPLETED|Overall Study||0
11102461|NCT01236352|12286590|FG002|COMPLETED|Overall Study||0
11102462|NCT01236352|12286591|FG003|COMPLETED|Overall Study||1
11102463|NCT01236352|12286592|FG004|COMPLETED|Overall Study||0
11102464|NCT01236352|12286593|FG005|COMPLETED|Overall Study||0
11102465|NCT01236352|12286594|FG006|COMPLETED|Overall Study||0
11102466|NCT01236352|12286595|FG007|COMPLETED|Overall Study||0
11102467|NCT01236352|12286596|FG008|COMPLETED|Overall Study||0
11102468|NCT01236352|12286597|FG009|COMPLETED|Overall Study||0
11102469|NCT01236352|12286598|FG010|COMPLETED|Overall Study||0
11102470|NCT01236352|12286588|FG000|NOT COMPLETED|Overall Study||4
11102471|NCT01236352|12286589|FG001|NOT COMPLETED|Overall Study||4
11102472|NCT01236352|12286590|FG002|NOT COMPLETED|Overall Study||4
11102473|NCT01236352|12286591|FG003|NOT COMPLETED|Overall Study||3
11102474|NCT01236352|12286592|FG004|NOT COMPLETED|Overall Study||4
11102475|NCT01236352|12286593|FG005|NOT COMPLETED|Overall Study||4
11102476|NCT01236352|12286594|FG006|NOT COMPLETED|Overall Study||8
11102477|NCT01236352|12286595|FG007|NOT COMPLETED|Overall Study||7
11102478|NCT01236352|12286596|FG008|NOT COMPLETED|Overall Study||3
11102479|NCT01236352|12286597|FG009|NOT COMPLETED|Overall Study||22
11102480|NCT01236352|12286598|FG010|NOT COMPLETED|Overall Study||20
11102481|NCT01236365|12286624|FG000|STARTED|Overall Study||21
11102482|NCT01236365|12286625|FG001|STARTED|Overall Study||21
10833064|NCT03850483|11998328|FG008|COMPLETED|Treatment for Stage 1||0
10833065|NCT03850483|11998329|FG009|COMPLETED|Treatment for Stage 1||0
10833066|NCT03850483|11998320|FG000|NOT COMPLETED|Treatment for Stage 1||8
10833067|NCT03850483|11998321|FG001|NOT COMPLETED|Treatment for Stage 1||8
10833068|NCT03850483|11998322|FG002|NOT COMPLETED|Treatment for Stage 1||11
10833069|NCT03850483|11998323|FG003|NOT COMPLETED|Treatment for Stage 1||6
10833070|NCT03850483|11998324|FG004|NOT COMPLETED|Treatment for Stage 1||9
10833071|NCT03850483|11998325|FG005|NOT COMPLETED|Treatment for Stage 1||11
10833072|NCT03850483|11998326|FG006|NOT COMPLETED|Treatment for Stage 1||11
10833073|NCT03850483|11998327|FG007|NOT COMPLETED|Treatment for Stage 1||6
10833074|NCT03850483|11998328|FG008|NOT COMPLETED|Treatment for Stage 1||0
10833075|NCT03850483|11998329|FG009|NOT COMPLETED|Treatment for Stage 1||0
11102483|NCT01236365|12286624|FG000|COMPLETED|Overall Study||19
11102484|NCT01236365|12286625|FG001|COMPLETED|Overall Study||19
11102485|NCT01236365|12286624|FG000|NOT COMPLETED|Overall Study||2
11102486|NCT01236365|12286625|FG001|NOT COMPLETED|Overall Study||2
11102487|NCT01236378|12286643|FG000|STARTED|Overall Study||24
11102488|NCT01236378|12286643|FG000|COMPLETED|Overall Study||24
11102489|NCT01236378|12286643|FG000|NOT COMPLETED|Overall Study||0
11102490|NCT01236391|12286647|FG000|STARTED|Overall Study|Participants who received study treatment|111
11102491|NCT01236391|12286647|FG000|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
11102492|NCT01236391|12286647|FG000|NOT COMPLETED|Overall Study||16
10833076|NCT03850483|11998320|FG000|STARTED|Follow-up for Stage 1||37
10833077|NCT03850483|11998321|FG001|STARTED|Follow-up for Stage 1||37
10833078|NCT03850483|11998322|FG002|STARTED|Follow-up for Stage 1||37
10833079|NCT03850483|11998323|FG003|STARTED|Follow-up for Stage 1||36
10833080|NCT03850483|11998324|FG004|STARTED|Follow-up for Stage 1||37
10833081|NCT03850483|11998325|FG005|STARTED|Follow-up for Stage 1||37
10833082|NCT03850483|11998326|FG006|STARTED|Follow-up for Stage 1||36
10833083|NCT03850483|11998327|FG007|STARTED|Follow-up for Stage 1||36
10833084|NCT03850483|11998328|FG008|STARTED|Follow-up for Stage 1||0
10833085|NCT03850483|11998329|FG009|STARTED|Follow-up for Stage 1||0
10833086|NCT03850483|11998320|FG000|COMPLETED|Follow-up for Stage 1||37
10833087|NCT03850483|11998321|FG001|COMPLETED|Follow-up for Stage 1||34
10833088|NCT03850483|11998322|FG002|COMPLETED|Follow-up for Stage 1||35
10833089|NCT03850483|11998323|FG003|COMPLETED|Follow-up for Stage 1||34
10833090|NCT03850483|11998324|FG004|COMPLETED|Follow-up for Stage 1||34
10833091|NCT03850483|11998325|FG005|COMPLETED|Follow-up for Stage 1||33
10833092|NCT03850483|11998326|FG006|COMPLETED|Follow-up for Stage 1||34
10833093|NCT03850483|11998327|FG007|COMPLETED|Follow-up for Stage 1||33
10833094|NCT03850483|11998328|FG008|COMPLETED|Follow-up for Stage 1||0
10833095|NCT03850483|11998329|FG009|COMPLETED|Follow-up for Stage 1||0
10833096|NCT03850483|11998320|FG000|NOT COMPLETED|Follow-up for Stage 1||0
10833097|NCT03850483|11998321|FG001|NOT COMPLETED|Follow-up for Stage 1||3
10833098|NCT03850483|11998322|FG002|NOT COMPLETED|Follow-up for Stage 1||2
10833099|NCT03850483|11998323|FG003|NOT COMPLETED|Follow-up for Stage 1||2
10833100|NCT03850483|11998324|FG004|NOT COMPLETED|Follow-up for Stage 1||3
10833101|NCT03850483|11998325|FG005|NOT COMPLETED|Follow-up for Stage 1||4
10833102|NCT03850483|11998326|FG006|NOT COMPLETED|Follow-up for Stage 1||2
10833103|NCT03850483|11998327|FG007|NOT COMPLETED|Follow-up for Stage 1||3
10833104|NCT03850483|11998328|FG008|NOT COMPLETED|Follow-up for Stage 1||0
10833105|NCT03850483|11998329|FG009|NOT COMPLETED|Follow-up for Stage 1||0
10833106|NCT03850483|11998320|FG000|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833107|NCT03850483|11998321|FG001|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833108|NCT03850483|11998322|FG002|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833109|NCT03850483|11998323|FG003|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833110|NCT03850483|11998324|FG004|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833111|NCT03850483|11998325|FG005|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833112|NCT03850483|11998326|FG006|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833113|NCT03850483|11998327|FG007|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|0
10833114|NCT03850483|11998328|FG008|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|12
10833115|NCT03850483|11998329|FG009|STARTED|Treatment for Stage 2|Stage 1 enrolment was different from Stage 2.|38
10833116|NCT03850483|11998320|FG000|COMPLETED|Treatment for Stage 2||0
10833117|NCT03850483|11998321|FG001|COMPLETED|Treatment for Stage 2||0
10833118|NCT03850483|11998322|FG002|COMPLETED|Treatment for Stage 2||0
10833119|NCT03850483|11998323|FG003|COMPLETED|Treatment for Stage 2||0
10833120|NCT03850483|11998324|FG004|COMPLETED|Treatment for Stage 2||0
10833121|NCT03850483|11998325|FG005|COMPLETED|Treatment for Stage 2||0
10833122|NCT03850483|11998326|FG006|COMPLETED|Treatment for Stage 2||0
10833123|NCT03850483|11998327|FG007|COMPLETED|Treatment for Stage 2||0
10833124|NCT03850483|11998328|FG008|COMPLETED|Treatment for Stage 2||7
10833125|NCT03850483|11998329|FG009|COMPLETED|Treatment for Stage 2||27
10833126|NCT03850483|11998320|FG000|NOT COMPLETED|Treatment for Stage 2||0
10833127|NCT03850483|11998321|FG001|NOT COMPLETED|Treatment for Stage 2||0
10833128|NCT03850483|11998322|FG002|NOT COMPLETED|Treatment for Stage 2||0
10833129|NCT03850483|11998323|FG003|NOT COMPLETED|Treatment for Stage 2||0
10833130|NCT03850483|11998324|FG004|NOT COMPLETED|Treatment for Stage 2||0
10833131|NCT03850483|11998325|FG005|NOT COMPLETED|Treatment for Stage 2||0
10833132|NCT03850483|11998326|FG006|NOT COMPLETED|Treatment for Stage 2||0
10833133|NCT03850483|11998327|FG007|NOT COMPLETED|Treatment for Stage 2||0
10833134|NCT03850483|11998328|FG008|NOT COMPLETED|Treatment for Stage 2||5
10833135|NCT03850483|11998329|FG009|NOT COMPLETED|Treatment for Stage 2||11
10833136|NCT03850483|11998320|FG000|STARTED|Follow-up For Stage 2||0
10833137|NCT03850483|11998321|FG001|STARTED|Follow-up For Stage 2||0
10833138|NCT03850483|11998322|FG002|STARTED|Follow-up For Stage 2||0
10833139|NCT03850483|11998323|FG003|STARTED|Follow-up For Stage 2||0
10833140|NCT03850483|11998324|FG004|STARTED|Follow-up For Stage 2||0
10833141|NCT03850483|11998325|FG005|STARTED|Follow-up For Stage 2||0
10833142|NCT03850483|11998326|FG006|STARTED|Follow-up For Stage 2||0
10833143|NCT03850483|11998327|FG007|STARTED|Follow-up For Stage 2||0
10833144|NCT03850483|11998328|FG008|STARTED|Follow-up For Stage 2||12
10833145|NCT03850483|11998329|FG009|STARTED|Follow-up For Stage 2||38
10833146|NCT03850483|11998320|FG000|COMPLETED|Follow-up For Stage 2||0
10833147|NCT03850483|11998321|FG001|COMPLETED|Follow-up For Stage 2||0
10833148|NCT03850483|11998322|FG002|COMPLETED|Follow-up For Stage 2||0
10833149|NCT03850483|11998323|FG003|COMPLETED|Follow-up For Stage 2||0
10833150|NCT03850483|11998324|FG004|COMPLETED|Follow-up For Stage 2||0
10833151|NCT03850483|11998325|FG005|COMPLETED|Follow-up For Stage 2||0
10833152|NCT03850483|11998326|FG006|COMPLETED|Follow-up For Stage 2||0
10833153|NCT03850483|11998327|FG007|COMPLETED|Follow-up For Stage 2||0
10833154|NCT03850483|11998328|FG008|COMPLETED|Follow-up For Stage 2||12
10833155|NCT03850483|11998329|FG009|COMPLETED|Follow-up For Stage 2||36
10833156|NCT03850483|11998320|FG000|NOT COMPLETED|Follow-up For Stage 2||0
10833157|NCT03850483|11998321|FG001|NOT COMPLETED|Follow-up For Stage 2||0
10833158|NCT03850483|11998322|FG002|NOT COMPLETED|Follow-up For Stage 2||0
10833159|NCT03850483|11998323|FG003|NOT COMPLETED|Follow-up For Stage 2||0
10833160|NCT03850483|11998324|FG004|NOT COMPLETED|Follow-up For Stage 2||0
10833161|NCT03850483|11998325|FG005|NOT COMPLETED|Follow-up For Stage 2||0
10833162|NCT03850483|11998326|FG006|NOT COMPLETED|Follow-up For Stage 2||0
10833163|NCT03850483|11998327|FG007|NOT COMPLETED|Follow-up For Stage 2||0
10833164|NCT03850483|11998328|FG008|NOT COMPLETED|Follow-up For Stage 2||0
10833165|NCT03850483|11998329|FG009|NOT COMPLETED|Follow-up For Stage 2||2
11102493|NCT01236534|12286656|FG000|STARTED|Overall Study||11
11102494|NCT01236534|12286657|FG001|STARTED|Overall Study||10
11102495|NCT01236534|12286656|FG000|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
11102496|NCT01236534|12286657|FG001|COMPLETED|Overall Study||10
11102497|NCT01236534|12286656|FG000|NOT COMPLETED|Overall Study||3
11102498|NCT01236534|12286657|FG001|NOT COMPLETED|Overall Study||0
11102499|NCT01236573|12286674|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
11102500|NCT01236573|12286675|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
11102501|NCT01236573|12286676|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
11102502|NCT01236573|12286677|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
10833176|NCT03804684|11998361|FG000|STARTED|Overall Study||28
10833177|NCT03804684|11998362|FG001|STARTED|Overall Study||44
10833178|NCT03804684|11998361|FG000|COMPLETED|Overall Study||25
10833179|NCT03804684|11998362|FG001|COMPLETED|Overall Study||26
10833180|NCT03804684|11998361|FG000|NOT COMPLETED|Overall Study||3
10833181|NCT03804684|11998362|FG001|NOT COMPLETED|Overall Study||18
11102503|NCT01236573|12286678|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102504|NCT01236573|12286679|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102505|NCT01236573|12286680|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102506|NCT01236573|12286681|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102507|NCT01236573|12286682|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102508|NCT01236573|12286683|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
10833190|NCT03537014|11998381|FG000|STARTED|Overall Study||46
10833191|NCT03537014|11998382|FG001|STARTED|Overall Study||45
10833192|NCT03537014|11998381|FG000|Withdrew Consent Before Dosing|Overall Study||0
10833193|NCT03537014|11998382|FG001|Withdrew Consent Before Dosing|Overall Study||1
10833194|NCT03537014|11998381|FG000|Completed First Experimental Session|Overall Study||46
10833195|NCT03537014|11998382|FG001|Completed First Experimental Session|Overall Study||44
10833196|NCT03537014|11998381|FG000|Completed Second Experimental Session|Overall Study||43
10833197|NCT03537014|11998382|FG001|Completed Second Experimental Session|Overall Study||41
10833198|NCT03537014|11998381|FG000|COMPLETED|Overall Study||42
10833199|NCT03537014|11998382|FG001|COMPLETED|Overall Study||40
10833200|NCT03537014|11998381|FG000|NOT COMPLETED|Overall Study||4
10833201|NCT03537014|11998382|FG001|NOT COMPLETED|Overall Study||5
10833202|NCT03529799|11998390|FG000|STARTED|Overall Study||14
10833203|NCT03529799|11998391|FG001|STARTED|Overall Study||26
10833204|NCT03529799|11998390|FG000|COMPLETED|Overall Study||14
10833205|NCT03529799|11998391|FG001|COMPLETED|Overall Study||26
10833206|NCT03529799|11998390|FG000|NOT COMPLETED|Overall Study||0
10833207|NCT03529799|11998391|FG001|NOT COMPLETED|Overall Study||0
10833208|NCT03485287|11998397|FG000|STARTED|Overall Study||4
10833209|NCT03485287|11998397|FG000|COMPLETED|Overall Study||3
10833210|NCT03485287|11998397|FG000|NOT COMPLETED|Overall Study||1
10833211|NCT03473925|11998403|FG000|STARTED|Overall Study||52
10833212|NCT03473925|11998404|FG001|STARTED|Overall Study||55
10833213|NCT03473925|11998403|FG000|Treated|Overall Study||51
10833214|NCT03473925|11998404|FG001|Treated|Overall Study||54
10833215|NCT03473925|11998403|FG000|COMPLETED|Overall Study||0
10833216|NCT03473925|11998404|FG001|COMPLETED|Overall Study||0
10833217|NCT03473925|11998403|FG000|NOT COMPLETED|Overall Study||52
10833218|NCT03473925|11998404|FG001|NOT COMPLETED|Overall Study||55
11102509|NCT01236573|12286684|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102510|NCT01236573|12286674|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
11102511|NCT01236573|12286675|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
11102512|NCT01236573|12286676|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
11102513|NCT01236573|12286677|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
11102514|NCT01236573|12286678|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102515|NCT01236573|12286679|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102516|NCT01236573|12286680|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102517|NCT01236573|12286681|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102518|NCT01236573|12286682|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102519|NCT01236573|12286683|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102520|NCT01236573|12286684|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102521|NCT01236573|12286674|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102522|NCT01236573|12286675|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102523|NCT01236573|12286676|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102524|NCT01236573|12286677|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102525|NCT01236573|12286678|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102526|NCT01236573|12286679|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102527|NCT01236573|12286680|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102528|NCT01236573|12286681|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102529|NCT01236573|12286682|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102530|NCT01236573|12286683|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
11102531|NCT01236573|12286684|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
10833241|NCT03230097|11998432|FG000|STARTED|Overall Study||24
11102532|NCT01236573|12286674|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102533|NCT01236573|12286675|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
10833242|NCT03230097|11998433|FG001|STARTED|Overall Study||26
10833243|NCT03230097|11998432|FG000|COMPLETED|Overall Study||9
10833244|NCT03230097|11998433|FG001|COMPLETED|Overall Study||10
10833245|NCT03230097|11998432|FG000|NOT COMPLETED|Overall Study||15
11102534|NCT01236573|12286676|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
10833246|NCT03230097|11998433|FG001|NOT COMPLETED|Overall Study||16
10833247|NCT03226067|11998442|FG000|STARTED|Overall Study||36
10833248|NCT03226067|11998443|FG001|STARTED|Overall Study||38
10833249|NCT03226067|11998444|FG002|STARTED|Overall Study||37
10833250|NCT03226067|11998442|FG000|COMPLETED|Overall Study||36
10833251|NCT03226067|11998443|FG001|COMPLETED|Overall Study||38
10833252|NCT03226067|11998444|FG002|COMPLETED|Overall Study||37
10833253|NCT03226067|11998442|FG000|NOT COMPLETED|Overall Study||0
10833254|NCT03226067|11998443|FG001|NOT COMPLETED|Overall Study||0
10833255|NCT03226067|11998444|FG002|NOT COMPLETED|Overall Study||0
10833256|NCT03029780|11998454|FG000|STARTED|Overall Study||52
10833257|NCT03029780|11998455|FG001|STARTED|Overall Study||52
10833258|NCT03029780|11998454|FG000|COMPLETED|Overall Study||1
10833259|NCT03029780|11998455|FG001|COMPLETED|Overall Study||1
10833260|NCT03029780|11998454|FG000|NOT COMPLETED|Overall Study||51
10833261|NCT03029780|11998455|FG001|NOT COMPLETED|Overall Study||51
11102535|NCT01236573|12286677|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102536|NCT01236573|12286678|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
11102537|NCT01236573|12286679|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
10833265|NCT02968940|11998469|FG000|STARTED|Overall Study||6
10833266|NCT02968940|11998469|FG000|COMPLETED|Overall Study||6
10833267|NCT02968940|11998469|FG000|NOT COMPLETED|Overall Study||0
11102538|NCT01236573|12286680|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
11102539|NCT01236573|12286681|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
11102540|NCT01236573|12286682|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
11102541|NCT01236573|12286683|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
11102542|NCT01236573|12286684|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102543|NCT01236573|12286674|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102544|NCT01236573|12286675|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102545|NCT01236573|12286676|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102546|NCT01236573|12286677|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102547|NCT01236573|12286678|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
11102548|NCT01236573|12286679|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
11102549|NCT01236573|12286680|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
11102550|NCT01236573|12286681|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
10833292|NCT02803593|11998503|FG000|STARTED|Overall Study||95
10833293|NCT02803593|11998504|FG001|STARTED|Overall Study||104
10833294|NCT02803593|11998503|FG000|Completed Month 1 Assessment|Overall Study||83
10833295|NCT02803593|11998504|FG001|Completed Month 1 Assessment|Overall Study||76
10833296|NCT02803593|11998503|FG000|COMPLETED|Overall Study||78
10833297|NCT02803593|11998504|FG001|COMPLETED|Overall Study||69
10833298|NCT02803593|11998503|FG000|NOT COMPLETED|Overall Study||17
10833299|NCT02803593|11998504|FG001|NOT COMPLETED|Overall Study||35
10833300|NCT02663908|11998512|FG000|STARTED|Overall Study||276
10833301|NCT02663908|11998513|FG001|STARTED|Overall Study||269
10833302|NCT02663908|11998512|FG000|Full Analysis Set (FAS)|Overall Study||275
10833303|NCT02663908|11998513|FG001|Full Analysis Set (FAS)|Overall Study||269
10833304|NCT02663908|11998512|FG000|COMPLETED|Overall Study||244
10833305|NCT02663908|11998513|FG001|COMPLETED|Overall Study||245
10833306|NCT02663908|11998512|FG000|NOT COMPLETED|Overall Study||32
10833307|NCT02663908|11998513|FG001|NOT COMPLETED|Overall Study||24
10833308|NCT02650284|11998521|FG000|STARTED|Overall Study||8
10833309|NCT02650284|11998522|FG001|STARTED|Overall Study||9
10833310|NCT02650284|11998521|FG000|COMPLETED|Overall Study||5
10833311|NCT02650284|11998522|FG001|COMPLETED|Overall Study||5
10833312|NCT02650284|11998521|FG000|NOT COMPLETED|Overall Study||3
10833313|NCT02650284|11998522|FG001|NOT COMPLETED|Overall Study||4
11102551|NCT01236573|12286682|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
11102552|NCT01236573|12286683|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
10833317|NCT02535338|11998534|FG000|STARTED|Overall Study||3
10833318|NCT02535338|11998535|FG001|STARTED|Overall Study||8
10833319|NCT02535338|11998534|FG000|COMPLETED|Overall Study||3
10833320|NCT02535338|11998535|FG001|COMPLETED|Overall Study||8
10833321|NCT02535338|11998534|FG000|NOT COMPLETED|Overall Study||0
10833322|NCT02535338|11998535|FG001|NOT COMPLETED|Overall Study||0
10833323|NCT02500797|11998555|FG000|STARTED|Overall Study||43
10833324|NCT02500797|11998556|FG001|STARTED|Overall Study||42
10833325|NCT02500797|11998557|FG002|STARTED|Overall Study||15
10833326|NCT02500797|11998558|FG003|STARTED|Overall Study||14
10833327|NCT02500797|11998559|FG004|STARTED|Overall Study||14
10833328|NCT02500797|11998560|FG005|STARTED|Overall Study||15
10833329|NCT02500797|11998561|FG006|STARTED|Overall Study||10
10833330|NCT02500797|11998562|FG007|STARTED|Overall Study||11
10833331|NCT02500797|11998555|FG000|Arm I Crossover|Overall Study||4
10833332|NCT02500797|11998556|FG001|Arm I Crossover|Overall Study||0
10833333|NCT02500797|11998557|FG002|Arm I Crossover|Overall Study||6
10833334|NCT02500797|11998558|FG003|Arm I Crossover|Overall Study||0
10833335|NCT02500797|11998559|FG004|Arm I Crossover|Overall Study||1
10833336|NCT02500797|11998560|FG005|Arm I Crossover|Overall Study||0
10833337|NCT02500797|11998561|FG006|Arm I Crossover|Overall Study||2
10833338|NCT02500797|11998562|FG007|Arm I Crossover|Overall Study||0
10833339|NCT02500797|11998555|FG000|COMPLETED|Overall Study||42
10833340|NCT02500797|11998556|FG001|COMPLETED|Overall Study||42
10833341|NCT02500797|11998557|FG002|COMPLETED|Overall Study||15
10833342|NCT02500797|11998558|FG003|COMPLETED|Overall Study||14
10833343|NCT02500797|11998559|FG004|COMPLETED|Overall Study||13
10833344|NCT02500797|11998560|FG005|COMPLETED|Overall Study||14
10833345|NCT02500797|11998561|FG006|COMPLETED|Overall Study||10
10833346|NCT02500797|11998562|FG007|COMPLETED|Overall Study||11
10833347|NCT02500797|11998555|FG000|NOT COMPLETED|Overall Study||1
10833348|NCT02500797|11998556|FG001|NOT COMPLETED|Overall Study||0
10833349|NCT02500797|11998557|FG002|NOT COMPLETED|Overall Study||0
10833350|NCT02500797|11998558|FG003|NOT COMPLETED|Overall Study||0
10833351|NCT02500797|11998559|FG004|NOT COMPLETED|Overall Study||1
10833352|NCT02500797|11998560|FG005|NOT COMPLETED|Overall Study||1
10833353|NCT02500797|11998561|FG006|NOT COMPLETED|Overall Study||0
10833354|NCT02500797|11998562|FG007|NOT COMPLETED|Overall Study||0
10833355|NCT02447133|11998587|FG000|STARTED|Overall Study||12
10833356|NCT02447133|11998587|FG000|COMPLETED|Overall Study||12
10833357|NCT02447133|11998587|FG000|NOT COMPLETED|Overall Study||0
10833456|NCT02017717|11998674|FG008|COMPLETED|Before Treatment Period||28
11102553|NCT01236573|12286684|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102554|NCT01236573|12286674|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102555|NCT01236573|12286675|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102556|NCT01236573|12286676|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102557|NCT01236573|12286677|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102558|NCT01236573|12286678|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102559|NCT01236573|12286679|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102560|NCT01236573|12286680|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
11102561|NCT01236573|12286681|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102562|NCT01236573|12286682|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
11102563|NCT01236573|12286683|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
10833370|NCT02426658|11998610|FG000|STARTED|Overall Study||16
10833371|NCT02426658|11998610|FG000|COMPLETED|Overall Study||13
10833372|NCT02426658|11998610|FG000|NOT COMPLETED|Overall Study||3
10833385|NCT02277106|11998631|FG000|STARTED|Stage 1: Treatment Period 1||13
10833386|NCT02277106|11998632|FG001|STARTED|Stage 1: Treatment Period 1||12
10833387|NCT02277106|11998633|FG002|STARTED|Stage 1: Treatment Period 1||0
10833388|NCT02277106|11998631|FG000|COMPLETED|Stage 1: Treatment Period 1||13
10833389|NCT02277106|11998632|FG001|COMPLETED|Stage 1: Treatment Period 1||12
10833390|NCT02277106|11998633|FG002|COMPLETED|Stage 1: Treatment Period 1||0
10833391|NCT02277106|11998631|FG000|NOT COMPLETED|Stage 1: Treatment Period 1||0
10833392|NCT02277106|11998632|FG001|NOT COMPLETED|Stage 1: Treatment Period 1||0
10833393|NCT02277106|11998633|FG002|NOT COMPLETED|Stage 1: Treatment Period 1||0
10833394|NCT02277106|11998631|FG000|STARTED|Washout||13
10833395|NCT02277106|11998632|FG001|STARTED|Washout||12
10833396|NCT02277106|11998633|FG002|STARTED|Washout||0
10833397|NCT02277106|11998631|FG000|COMPLETED|Washout||13
10833398|NCT02277106|11998632|FG001|COMPLETED|Washout||12
10833399|NCT02277106|11998633|FG002|COMPLETED|Washout||0
10833400|NCT02277106|11998631|FG000|NOT COMPLETED|Washout||0
10833401|NCT02277106|11998632|FG001|NOT COMPLETED|Washout||0
10833402|NCT02277106|11998633|FG002|NOT COMPLETED|Washout||0
10833403|NCT02277106|11998631|FG000|STARTED|Stage 1: Treatment Period 2||13
10833404|NCT02277106|11998632|FG001|STARTED|Stage 1: Treatment Period 2||12
10833405|NCT02277106|11998633|FG002|STARTED|Stage 1: Treatment Period 2||0
10833406|NCT02277106|11998631|FG000|COMPLETED|Stage 1: Treatment Period 2||13
10833407|NCT02277106|11998632|FG001|COMPLETED|Stage 1: Treatment Period 2||12
10833408|NCT02277106|11998633|FG002|COMPLETED|Stage 1: Treatment Period 2||0
10833409|NCT02277106|11998631|FG000|NOT COMPLETED|Stage 1: Treatment Period 2||0
10833410|NCT02277106|11998632|FG001|NOT COMPLETED|Stage 1: Treatment Period 2||0
10833411|NCT02277106|11998633|FG002|NOT COMPLETED|Stage 1: Treatment Period 2||0
10833412|NCT02277106|11998631|FG000|STARTED|Stage 2||0
10833413|NCT02277106|11998632|FG001|STARTED|Stage 2||0
10833414|NCT02277106|11998633|FG002|STARTED|Stage 2|Out of 25, 17 participants entered Stage 2 after Screening at Stage 2.|17
10833415|NCT02277106|11998631|FG000|COMPLETED|Stage 2||0
10833416|NCT02277106|11998632|FG001|COMPLETED|Stage 2||0
10833417|NCT02277106|11998633|FG002|COMPLETED|Stage 2||16
10833418|NCT02277106|11998631|FG000|NOT COMPLETED|Stage 2||0
10833419|NCT02277106|11998632|FG001|NOT COMPLETED|Stage 2||0
10833420|NCT02277106|11998633|FG002|NOT COMPLETED|Stage 2||1
10833421|NCT02175030|11998646|FG000|STARTED|Overall Study||356
10833422|NCT02175030|11998647|FG001|STARTED|Overall Study||355
10833423|NCT02175030|11998646|FG000|COMPLETED|Overall Study||321
10833424|NCT02175030|11998647|FG001|COMPLETED|Overall Study||317
10833425|NCT02175030|11998646|FG000|NOT COMPLETED|Overall Study||35
10833426|NCT02175030|11998647|FG001|NOT COMPLETED|Overall Study||38
10833430|NCT02017717|11998666|FG000|STARTED|Before Treatment Period||10
10833431|NCT02017717|11998667|FG001|STARTED|Before Treatment Period||10
10833432|NCT02017717|11998668|FG002|STARTED|Before Treatment Period||20
10833433|NCT02017717|11998669|FG003|STARTED|Before Treatment Period||184
10833434|NCT02017717|11998670|FG004|STARTED|Before Treatment Period||185
10833435|NCT02017717|11998671|FG005|STARTED|Before Treatment Period||31
10833436|NCT02017717|11998672|FG006|STARTED|Before Treatment Period||30
10833437|NCT02017717|11998673|FG007|STARTED|Before Treatment Period||29
10833438|NCT02017717|11998674|FG008|STARTED|Before Treatment Period||30
10833439|NCT02017717|11998666|FG000|Randomized|Before Treatment Period||10
10833440|NCT02017717|11998667|FG001|Randomized|Before Treatment Period||10
10833441|NCT02017717|11998668|FG002|Randomized|Before Treatment Period||0
10833442|NCT02017717|11998669|FG003|Randomized|Before Treatment Period||184
10833443|NCT02017717|11998670|FG004|Randomized|Before Treatment Period||185
10833444|NCT02017717|11998671|FG005|Randomized|Before Treatment Period||0
10833445|NCT02017717|11998672|FG006|Randomized|Before Treatment Period||0
10833446|NCT02017717|11998673|FG007|Randomized|Before Treatment Period||29
10833447|NCT02017717|11998674|FG008|Randomized|Before Treatment Period||30
10833448|NCT02017717|11998666|FG000|COMPLETED|Before Treatment Period||10
10833449|NCT02017717|11998667|FG001|COMPLETED|Before Treatment Period||10
10833450|NCT02017717|11998668|FG002|COMPLETED|Before Treatment Period||20
10833451|NCT02017717|11998669|FG003|COMPLETED|Before Treatment Period||182
10833452|NCT02017717|11998670|FG004|COMPLETED|Before Treatment Period||165
10833453|NCT02017717|11998671|FG005|COMPLETED|Before Treatment Period||31
10833454|NCT02017717|11998672|FG006|COMPLETED|Before Treatment Period||30
10833455|NCT02017717|11998673|FG007|COMPLETED|Before Treatment Period||28
11102564|NCT01236573|12286684|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
11102565|NCT01236573|12286674|FG000|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102566|NCT01236573|12286675|FG001|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
10833457|NCT02017717|11998666|FG000|NOT COMPLETED|Before Treatment Period||0
10833458|NCT02017717|11998667|FG001|NOT COMPLETED|Before Treatment Period||0
10833459|NCT02017717|11998668|FG002|NOT COMPLETED|Before Treatment Period||0
10833460|NCT02017717|11998669|FG003|NOT COMPLETED|Before Treatment Period||2
10833461|NCT02017717|11998670|FG004|NOT COMPLETED|Before Treatment Period||20
10833462|NCT02017717|11998671|FG005|NOT COMPLETED|Before Treatment Period||0
10833463|NCT02017717|11998672|FG006|NOT COMPLETED|Before Treatment Period||0
10833464|NCT02017717|11998673|FG007|NOT COMPLETED|Before Treatment Period||1
10833465|NCT02017717|11998674|FG008|NOT COMPLETED|Before Treatment Period||2
10833466|NCT02017717|11998666|FG000|STARTED|Treatment Period||10
10833467|NCT02017717|11998667|FG001|STARTED|Treatment Period||10
10833468|NCT02017717|11998668|FG002|STARTED|Treatment Period||20
10833469|NCT02017717|11998669|FG003|STARTED|Treatment Period||182
10833470|NCT02017717|11998670|FG004|STARTED|Treatment Period||165
10833471|NCT02017717|11998671|FG005|STARTED|Treatment Period||31
10833472|NCT02017717|11998672|FG006|STARTED|Treatment Period||30
10833473|NCT02017717|11998673|FG007|STARTED|Treatment Period||28
10833474|NCT02017717|11998674|FG008|STARTED|Treatment Period||28
10833475|NCT02017717|11998666|FG000|COMPLETED|Treatment Period||0
10833476|NCT02017717|11998667|FG001|COMPLETED|Treatment Period||1
10833477|NCT02017717|11998668|FG002|COMPLETED|Treatment Period||0
10833478|NCT02017717|11998669|FG003|COMPLETED|Treatment Period||1
10833479|NCT02017717|11998670|FG004|COMPLETED|Treatment Period||1
10833480|NCT02017717|11998671|FG005|COMPLETED|Treatment Period||2
10833481|NCT02017717|11998672|FG006|COMPLETED|Treatment Period||0
10833482|NCT02017717|11998673|FG007|COMPLETED|Treatment Period||0
10833483|NCT02017717|11998674|FG008|COMPLETED|Treatment Period||0
10833484|NCT02017717|11998666|FG000|NOT COMPLETED|Treatment Period||10
10833485|NCT02017717|11998667|FG001|NOT COMPLETED|Treatment Period||9
10833486|NCT02017717|11998668|FG002|NOT COMPLETED|Treatment Period||20
10833487|NCT02017717|11998669|FG003|NOT COMPLETED|Treatment Period||181
10833488|NCT02017717|11998670|FG004|NOT COMPLETED|Treatment Period||164
10833489|NCT02017717|11998671|FG005|NOT COMPLETED|Treatment Period||29
10833490|NCT02017717|11998672|FG006|NOT COMPLETED|Treatment Period||30
10833491|NCT02017717|11998673|FG007|NOT COMPLETED|Treatment Period||28
10833492|NCT02017717|11998674|FG008|NOT COMPLETED|Treatment Period||28
11102567|NCT01236573|12286676|FG002|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102568|NCT01236573|12286677|FG003|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102569|NCT01236573|12286678|FG004|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102570|NCT01236573|12286679|FG005|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102571|NCT01236573|12286680|FG006|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102572|NCT01236573|12286681|FG007|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102573|NCT01236573|12286682|FG008|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102574|NCT01236573|12286683|FG009|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102575|NCT01236573|12286684|FG010|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
11102576|NCT01236573|12286674|FG000|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102577|NCT01236573|12286675|FG001|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102578|NCT01236573|12286676|FG002|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102579|NCT01236573|12286677|FG003|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102580|NCT01236573|12286678|FG004|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102581|NCT01236573|12286679|FG005|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102582|NCT01236573|12286680|FG006|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102583|NCT01236573|12286681|FG007|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102584|NCT01236573|12286682|FG008|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102585|NCT01236573|12286683|FG009|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102586|NCT01236573|12286684|FG010|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
11102587|NCT01236573|12286674|FG000|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102588|NCT01236573|12286675|FG001|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102589|NCT01236573|12286676|FG002|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102590|NCT01236573|12286677|FG003|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102591|NCT01236573|12286678|FG004|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102592|NCT01236573|12286679|FG005|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102593|NCT01236573|12286680|FG006|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102594|NCT01236573|12286681|FG007|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102595|NCT01236573|12286682|FG008|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102596|NCT01236573|12286683|FG009|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
11102597|NCT01236573|12286684|FG010|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
11102598|NCT01236742|12286712|FG000|STARTED|Overall Study||18
11102599|NCT01236742|12286713|FG001|STARTED|Overall Study||19
11102600|NCT01236742|12286714|FG002|STARTED|Overall Study||16
11102601|NCT01236742|12286712|FG000|COMPLETED|Overall Study||15
11102602|NCT01236742|12286713|FG001|COMPLETED|Overall Study||16
11102603|NCT01236742|12286714|FG002|COMPLETED|Overall Study||13
11102604|NCT01236742|12286712|FG000|NOT COMPLETED|Overall Study||3
11102605|NCT01236742|12286713|FG001|NOT COMPLETED|Overall Study||3
11102606|NCT01236742|12286714|FG002|NOT COMPLETED|Overall Study||3
11102607|NCT01236755|12286722|FG000|STARTED|Spectacles Wearing Phase||91
11102608|NCT01236755|12286722|FG000|COMPLETED|Spectacles Wearing Phase||74
11102609|NCT01236755|12286722|FG000|NOT COMPLETED|Spectacles Wearing Phase||17
11102610|NCT01236755|12286722|FG000|STARTED|Orthokeratology Wearing Phase||74
11102611|NCT01236755|12286722|FG000|COMPLETED|Orthokeratology Wearing Phase||66
11102612|NCT01236755|12286722|FG000|NOT COMPLETED|Orthokeratology Wearing Phase||8
11102613|NCT01236768|12286729|FG000|STARTED|Overall Study||201
11102614|NCT01236768|12286730|FG001|STARTED|Overall Study||206
11102615|NCT01236768|12286729|FG000|COMPLETED|Overall Study||112
11102616|NCT01236768|12286730|FG001|COMPLETED|Overall Study||145
11102617|NCT01236768|12286729|FG000|NOT COMPLETED|Overall Study||89
11102618|NCT01236768|12286730|FG001|NOT COMPLETED|Overall Study||61
11102619|NCT01237041|12286742|FG000|STARTED|Overall Study||2
11102620|NCT01237041|12286743|FG001|STARTED|Overall Study||3
11102621|NCT01237041|12286744|FG002|STARTED|Overall Study||2
11102622|NCT01237041|12286745|FG003|STARTED|Overall Study||5
11102623|NCT01237041|12286746|FG004|STARTED|Overall Study||5
11102624|NCT01237041|12286742|FG000|COMPLETED|Overall Study||2
11102625|NCT01237041|12286743|FG001|COMPLETED|Overall Study||3
11102626|NCT01237041|12286744|FG002|COMPLETED|Overall Study||2
11102627|NCT01237041|12286745|FG003|COMPLETED|Overall Study||5
11102628|NCT01237041|12286746|FG004|COMPLETED|Overall Study||5
11102629|NCT01237041|12286742|FG000|NOT COMPLETED|Overall Study||0
11102630|NCT01237041|12286743|FG001|NOT COMPLETED|Overall Study||0
11102631|NCT01237041|12286744|FG002|NOT COMPLETED|Overall Study||0
11102632|NCT01237041|12286745|FG003|NOT COMPLETED|Overall Study||0
11102633|NCT01237041|12286746|FG004|NOT COMPLETED|Overall Study||0
11102634|NCT01237054|12286756|FG000|STARTED|Overall Study||31
11102635|NCT01237054|12286756|FG000|COMPLETED|Overall Study||30
11102636|NCT01237054|12286756|FG000|NOT COMPLETED|Overall Study||1
11102637|NCT01237080|12286765|FG000|STARTED|Overall Study||50
11102638|NCT01237080|12286766|FG001|STARTED|Overall Study||50
11102639|NCT01237080|12286765|FG000|COMPLETED|Overall Study||50
11102640|NCT01237080|12286766|FG001|COMPLETED|Overall Study||50
11102641|NCT01237080|12286765|FG000|NOT COMPLETED|Overall Study||0
11102642|NCT01237080|12286766|FG001|NOT COMPLETED|Overall Study||0
11102643|NCT01237197|12286774|FG000|STARTED|Randomization Period||13
11102644|NCT01237197|12286775|FG001|STARTED|Randomization Period||13
11102645|NCT01237197|12286774|FG000|COMPLETED|Randomization Period||12
11102646|NCT01237197|12286775|FG001|COMPLETED|Randomization Period||10
11102647|NCT01237197|12286774|FG000|NOT COMPLETED|Randomization Period||1
11102648|NCT01237197|12286775|FG001|NOT COMPLETED|Randomization Period||3
11102649|NCT01237197|12286774|FG000|STARTED|Open Label Period||12
11220247|NCT01959412|12411867|FG001|STARTED|Overall Study||15
11220248|NCT01959412|12411868|FG002|STARTED|Overall Study||15
11220249|NCT01959412|12411869|FG003|STARTED|Overall Study||15
11220250|NCT01959412|12411870|FG004|STARTED|Overall Study||16
11220251|NCT01959412|12411871|FG005|STARTED|Overall Study||15
11220252|NCT01959412|12411866|FG000|COMPLETED|Overall Study||14
11220253|NCT01959412|12411867|FG001|COMPLETED|Overall Study||14
11220254|NCT01959412|12411868|FG002|COMPLETED|Overall Study||15
11220255|NCT01959412|12411869|FG003|COMPLETED|Overall Study||13
11102650|NCT01237197|12286775|FG001|STARTED|Open Label Period||10
11102651|NCT01237197|12286774|FG000|COMPLETED|Open Label Period||12
11102652|NCT01237197|12286775|FG001|COMPLETED|Open Label Period||10
11102653|NCT01237197|12286774|FG000|NOT COMPLETED|Open Label Period||0
11102654|NCT01237197|12286775|FG001|NOT COMPLETED|Open Label Period||0
11102655|NCT01237223|12286787|FG000|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
11102656|NCT01237223|12286788|FG001|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
11102657|NCT01237223|12286789|FG002|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
11102658|NCT01237223|12286790|FG003|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
11102659|NCT01237223|12286791|FG004|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
11102660|NCT01237223|12286792|FG005|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
11102661|NCT01237223|12286787|FG000|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
11102662|NCT01237223|12286788|FG001|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
11102663|NCT01237223|12286789|FG002|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
11102664|NCT01237223|12286790|FG003|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
11102665|NCT01237223|12286791|FG004|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
11102666|NCT01237223|12286792|FG005|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
11102667|NCT01237223|12286787|FG000|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
11102668|NCT01237223|12286788|FG001|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
11102669|NCT01237223|12286789|FG002|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
11102670|NCT01237223|12286790|FG003|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
11102671|NCT01237223|12286791|FG004|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
11102672|NCT01237223|12286792|FG005|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
11102673|NCT01237223|12286787|FG000|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
11102674|NCT01237223|12286788|FG001|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
10833527|NCT01746173|11998739|FG000|STARTED|Overall Study||5
10833528|NCT01746173|11998739|FG000|COMPLETED|Overall Study||3
10833529|NCT01746173|11998739|FG000|NOT COMPLETED|Overall Study||2
10833530|NCT01734512|11998743|FG000|STARTED|Overall Study||65
10833531|NCT01734512|11998743|FG000|COMPLETED|Overall Study||65
10833532|NCT01734512|11998743|FG000|NOT COMPLETED|Overall Study||0
11102675|NCT01237223|12286789|FG002|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
11102676|NCT01237223|12286790|FG003|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
11102677|NCT01237223|12286791|FG004|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
11102678|NCT01237223|12286792|FG005|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
11102679|NCT01237223|12286787|FG000|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
11220256|NCT01959412|12411870|FG004|COMPLETED|Overall Study||13
11220257|NCT01959412|12411871|FG005|COMPLETED|Overall Study||15
11220258|NCT01959412|12411866|FG000|NOT COMPLETED|Overall Study||1
11102680|NCT01237223|12286788|FG001|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
11102681|NCT01237223|12286789|FG002|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
11102682|NCT01237223|12286790|FG003|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
11102683|NCT01237223|12286791|FG004|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
11102684|NCT01237223|12286792|FG005|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
11102685|NCT01237223|12286787|FG000|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
11102686|NCT01237223|12286788|FG001|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
11102687|NCT01237223|12286789|FG002|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
11102688|NCT01237223|12286790|FG003|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
11102689|NCT01237223|12286791|FG004|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
11102690|NCT01237223|12286792|FG005|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
11102691|NCT01237301|12286810|FG000|STARTED|Overall Study||65
11102692|NCT01237301|12286811|FG001|STARTED|Overall Study||59
11102693|NCT01237301|12286810|FG000|COMPLETED|Overall Study||60
11102694|NCT01237301|12286811|FG001|COMPLETED|Overall Study||55
11102695|NCT01237301|12286810|FG000|NOT COMPLETED|Overall Study||5
11102696|NCT01237301|12286811|FG001|NOT COMPLETED|Overall Study||4
11102697|NCT01237327|12286821|FG000|STARTED|Overall Study||43
11102698|NCT01237327|12286822|FG001|STARTED|Overall Study||41
11102699|NCT01237327|12286821|FG000|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
11102700|NCT01237327|12286822|FG001|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
11102701|NCT01237327|12286821|FG000|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
11102702|NCT01237327|12286822|FG001|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
11102703|NCT01237327|12286821|FG000|Continued Treatment in Extension Study|Overall Study||21
11102704|NCT01237327|12286822|FG001|Continued Treatment in Extension Study|Overall Study||17
11102705|NCT01237327|12286821|FG000|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
11102706|NCT01237327|12286822|FG001|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
11102707|NCT01237327|12286821|FG000|NOT COMPLETED|Overall Study||42
11102708|NCT01237327|12286822|FG001|NOT COMPLETED|Overall Study||40
11102709|NCT01237340|12286828|FG000|STARTED|Overall Study||59
10833576|NCT01555541|11998778|FG000|STARTED|Salvage Response Assessment||19
10833577|NCT01555541|11998778|FG000|COMPLETED|Salvage Response Assessment||19
10833578|NCT01555541|11998778|FG000|NOT COMPLETED|Salvage Response Assessment||0
10833579|NCT01555541|11998778|FG000|STARTED|OVA Treatment||19
10833580|NCT01555541|11998778|FG000|COMPLETED|OVA Treatment||19
10833581|NCT01555541|11998778|FG000|NOT COMPLETED|OVA Treatment||0
10833582|NCT01555541|11998778|FG000|STARTED|Autologous Stem Cell Transplantation|7 patients did not move forward due to non-response/progression on last line of therapy prior to Autologous Stem Cell Transplantation (ASCT)|12
10833583|NCT01555541|11998778|FG000|COMPLETED|Autologous Stem Cell Transplantation||12
10833584|NCT01555541|11998778|FG000|NOT COMPLETED|Autologous Stem Cell Transplantation||0
10833585|NCT01398852|11998782|FG000|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
10833586|NCT01398852|11998782|FG000|COMPLETED|Overall Study||0
10833587|NCT01398852|11998782|FG000|NOT COMPLETED|Overall Study||372
10833588|NCT01398839|11998788|FG000|STARTED|Overall Study||35
10833589|NCT01398839|11998789|FG001|STARTED|Overall Study||37
10833590|NCT01398839|11998788|FG000|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
10833591|NCT01398839|11998789|FG001|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
10833592|NCT01398839|11998788|FG000|NOT COMPLETED|Overall Study||0
10833593|NCT01398839|11998789|FG001|NOT COMPLETED|Overall Study||0
10833594|NCT01349959|11998795|FG000|STARTED|Overall Study||40
10833595|NCT01349959|11998795|FG000|COMPLETED|Overall Study||33
10833596|NCT01349959|11998795|FG000|NOT COMPLETED|Overall Study||7
11102710|NCT01237340|12286828|FG000|COMPLETED|Overall Study||19
11102711|NCT01237340|12286828|FG000|NOT COMPLETED|Overall Study||40
11102712|NCT01237353|12286835|FG000|STARTED|Overall Study||6
11102713|NCT01237353|12286835|FG000|COMPLETED|Overall Study||6
11102714|NCT01237353|12286835|FG000|NOT COMPLETED|Overall Study||0
11102715|NCT01237587|12286841|FG000|STARTED|Double Blind Treatment (Acute Phase)||91
11102716|NCT01237587|12286842|FG001|STARTED|Double Blind Treatment (Acute Phase)||93
11102717|NCT01237587|12286841|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
11102718|NCT01237587|12286842|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
11102719|NCT01237587|12286841|FG000|COMPLETED|Double Blind Treatment (Acute Phase)||74
11102720|NCT01237587|12286842|FG001|COMPLETED|Double Blind Treatment (Acute Phase)||75
11102721|NCT01237587|12286841|FG000|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
11102722|NCT01237587|12286842|FG001|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
11102723|NCT01237587|12286841|FG000|STARTED|Open Label Treatment (Extension Phase)||74
11102724|NCT01237587|12286842|FG001|STARTED|Open Label Treatment (Extension Phase)||75
11102725|NCT01237587|12286841|FG000|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
11102726|NCT01237587|12286842|FG001|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
11102727|NCT01237587|12286841|FG000|COMPLETED|Open Label Treatment (Extension Phase)||56
11102728|NCT01237587|12286842|FG001|COMPLETED|Open Label Treatment (Extension Phase)||50
11102729|NCT01237587|12286841|FG000|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
11102730|NCT01237587|12286842|FG001|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
11102731|NCT01237587|12286841|FG000|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
11102732|NCT01237587|12286842|FG001|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
11102733|NCT01237587|12286841|FG000|COMPLETED|Taper Phase||31
11102734|NCT01237587|12286842|FG001|COMPLETED|Taper Phase||34
11102735|NCT01237587|12286841|FG000|NOT COMPLETED|Taper Phase||5
11102736|NCT01237587|12286842|FG001|NOT COMPLETED|Taper Phase||10
11102737|NCT01237678|12286858|FG000|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
11102738|NCT01237678|12286859|FG001|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
11102739|NCT01237678|12286860|FG002|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
11102740|NCT01237678|12286858|FG000|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
11102741|NCT01237678|12286859|FG001|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
11102742|NCT01237678|12286860|FG002|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
11102743|NCT01237678|12286858|FG000|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
11102744|NCT01237678|12286859|FG001|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
11102745|NCT01237678|12286860|FG002|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
11102746|NCT01237678|12286858|FG000|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
11102747|NCT01237678|12286859|FG001|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
11102748|NCT01237678|12286860|FG002|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
11102749|NCT01237678|12286858|FG000|STARTED|Phase II||0
11102750|NCT01237678|12286859|FG001|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
11102751|NCT01237678|12286860|FG002|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
11102752|NCT01237678|12286858|FG000|Received Intervention|Phase II||0
11102753|NCT01237678|12286859|FG001|Received Intervention|Phase II||94
11102754|NCT01237678|12286860|FG002|Received Intervention|Phase II||47
11102755|NCT01237678|12286858|FG000|COMPLETED|Phase II||0
11102756|NCT01237678|12286859|FG001|COMPLETED|Phase II||0
11102757|NCT01237678|12286860|FG002|COMPLETED|Phase II||0
11102758|NCT01237678|12286858|FG000|NOT COMPLETED|Phase II||0
11102759|NCT01237678|12286859|FG001|NOT COMPLETED|Phase II||98
11102760|NCT01237678|12286860|FG002|NOT COMPLETED|Phase II||50
11102761|NCT01237821|12286877|FG000|STARTED|Overall Study||32
11102762|NCT01237821|12286878|FG001|STARTED|Overall Study||34
11102763|NCT01237821|12286877|FG000|COMPLETED|Overall Study||26
11102764|NCT01237821|12286878|FG001|COMPLETED|Overall Study||34
11102765|NCT01237821|12286877|FG000|NOT COMPLETED|Overall Study||6
11102766|NCT01237821|12286878|FG001|NOT COMPLETED|Overall Study||0
11102767|NCT01237899|12286895|FG000|STARTED|First Dosing Period||1
11102768|NCT01237899|12286896|FG001|STARTED|First Dosing Period||3
11102769|NCT01237899|12286897|FG002|STARTED|First Dosing Period||4
11102770|NCT01237899|12286898|FG003|STARTED|First Dosing Period||3
11102771|NCT01237899|12286899|FG004|STARTED|First Dosing Period||2
11102772|NCT01237899|12286900|FG005|STARTED|First Dosing Period||4
11102773|NCT01237899|12286901|FG006|STARTED|First Dosing Period||1
11102774|NCT01237899|12286902|FG007|STARTED|First Dosing Period||3
11102775|NCT01237899|12286903|FG008|STARTED|First Dosing Period||4
11102776|NCT01237899|12286904|FG009|STARTED|First Dosing Period||3
11102777|NCT01237899|12286905|FG010|STARTED|First Dosing Period||4
11102778|NCT01237899|12286895|FG000|COMPLETED|First Dosing Period||1
11102779|NCT01237899|12286896|FG001|COMPLETED|First Dosing Period||3
11102780|NCT01237899|12286897|FG002|COMPLETED|First Dosing Period||4
11354104|NCT03069482|12551309|FG001|NOT COMPLETED|Overall Study||1
11354105|NCT03069677|12551320|FG000|STARTED|Overall Study||80
11354106|NCT03069677|12551321|FG001|STARTED|Overall Study||80
11354107|NCT03069677|12551320|FG000|COMPLETED|Overall Study||77
11354108|NCT03069677|12551321|FG001|COMPLETED|Overall Study||77
11354109|NCT03069677|12551320|FG000|NOT COMPLETED|Overall Study||3
11354110|NCT03069677|12551321|FG001|NOT COMPLETED|Overall Study||3
11354111|NCT03069716|12551329|FG000|STARTED|Run-in Period (2 Weeks)||49
11354112|NCT03069716|12551330|FG001|STARTED|Run-in Period (2 Weeks)||0
11354113|NCT03069716|12551331|FG002|STARTED|Run-in Period (2 Weeks)||0
11354114|NCT03069716|12551329|FG000|COMPLETED|Run-in Period (2 Weeks)||42
11102781|NCT01237899|12286898|FG003|COMPLETED|First Dosing Period||3
11102782|NCT01237899|12286899|FG004|COMPLETED|First Dosing Period||2
11102783|NCT01237899|12286900|FG005|COMPLETED|First Dosing Period||4
11102784|NCT01237899|12286901|FG006|COMPLETED|First Dosing Period||1
11102785|NCT01237899|12286902|FG007|COMPLETED|First Dosing Period||3
11102786|NCT01237899|12286903|FG008|COMPLETED|First Dosing Period||4
11102787|NCT01237899|12286904|FG009|COMPLETED|First Dosing Period||3
11102788|NCT01237899|12286905|FG010|COMPLETED|First Dosing Period||4
11102789|NCT01237899|12286895|FG000|NOT COMPLETED|First Dosing Period||0
11102790|NCT01237899|12286896|FG001|NOT COMPLETED|First Dosing Period||0
11102791|NCT01237899|12286897|FG002|NOT COMPLETED|First Dosing Period||0
11102792|NCT01237899|12286898|FG003|NOT COMPLETED|First Dosing Period||0
11102793|NCT01237899|12286899|FG004|NOT COMPLETED|First Dosing Period||0
11102794|NCT01237899|12286900|FG005|NOT COMPLETED|First Dosing Period||0
11102795|NCT01237899|12286901|FG006|NOT COMPLETED|First Dosing Period||0
11102796|NCT01237899|12286902|FG007|NOT COMPLETED|First Dosing Period||0
11102797|NCT01237899|12286903|FG008|NOT COMPLETED|First Dosing Period||0
11102798|NCT01237899|12286904|FG009|NOT COMPLETED|First Dosing Period||0
11354115|NCT03069716|12551330|FG001|COMPLETED|Run-in Period (2 Weeks)||0
11102799|NCT01237899|12286905|FG010|NOT COMPLETED|First Dosing Period||0
11354116|NCT03069716|12551331|FG002|COMPLETED|Run-in Period (2 Weeks)||0
11354117|NCT03069716|12551329|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||7
11102800|NCT01237899|12286895|FG000|STARTED|Washout Period of at Least 7 Days||1
11102801|NCT01237899|12286896|FG001|STARTED|Washout Period of at Least 7 Days||3
11102802|NCT01237899|12286897|FG002|STARTED|Washout Period of at Least 7 Days||4
11102803|NCT01237899|12286898|FG003|STARTED|Washout Period of at Least 7 Days||3
11102804|NCT01237899|12286899|FG004|STARTED|Washout Period of at Least 7 Days||2
11102805|NCT01237899|12286900|FG005|STARTED|Washout Period of at Least 7 Days||4
11102806|NCT01237899|12286901|FG006|STARTED|Washout Period of at Least 7 Days||1
11102807|NCT01237899|12286902|FG007|STARTED|Washout Period of at Least 7 Days||3
11102808|NCT01237899|12286903|FG008|STARTED|Washout Period of at Least 7 Days||4
11102809|NCT01237899|12286904|FG009|STARTED|Washout Period of at Least 7 Days||3
11102810|NCT01237899|12286905|FG010|STARTED|Washout Period of at Least 7 Days||4
11102811|NCT01237899|12286895|FG000|COMPLETED|Washout Period of at Least 7 Days||1
11102812|NCT01237899|12286896|FG001|COMPLETED|Washout Period of at Least 7 Days||3
11102813|NCT01237899|12286897|FG002|COMPLETED|Washout Period of at Least 7 Days||3
10833761|NCT00700882|11998960|FG000|STARTED|Overall Study||81
10833762|NCT00700882|11998960|FG000|Received Protocol Therapy|Overall Study||75
10833763|NCT00700882|11998960|FG000|Eligible and Treated Patients|Overall Study||73
10833764|NCT00700882|11998960|FG000|Eligible, Treated and KIT+ Patients|Overall Study||22
10833765|NCT00700882|11998960|FG000|COMPLETED|Overall Study||22
10833766|NCT00700882|11998960|FG000|NOT COMPLETED|Overall Study||59
11102814|NCT01237899|12286898|FG003|COMPLETED|Washout Period of at Least 7 Days||3
11102815|NCT01237899|12286899|FG004|COMPLETED|Washout Period of at Least 7 Days||2
11102816|NCT01237899|12286900|FG005|COMPLETED|Washout Period of at Least 7 Days||4
11102817|NCT01237899|12286901|FG006|COMPLETED|Washout Period of at Least 7 Days||1
11102818|NCT01237899|12286902|FG007|COMPLETED|Washout Period of at Least 7 Days||3
11102819|NCT01237899|12286903|FG008|COMPLETED|Washout Period of at Least 7 Days||4
11102820|NCT01237899|12286904|FG009|COMPLETED|Washout Period of at Least 7 Days||3
11102821|NCT01237899|12286905|FG010|COMPLETED|Washout Period of at Least 7 Days||4
11102822|NCT01237899|12286895|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0
11102823|NCT01237899|12286896|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
11102824|NCT01237899|12286897|FG002|NOT COMPLETED|Washout Period of at Least 7 Days||1
11102825|NCT01237899|12286898|FG003|NOT COMPLETED|Washout Period of at Least 7 Days||0
11102826|NCT01237899|12286899|FG004|NOT COMPLETED|Washout Period of at Least 7 Days||0
11102827|NCT01237899|12286900|FG005|NOT COMPLETED|Washout Period of at Least 7 Days||0
11102828|NCT01237899|12286901|FG006|NOT COMPLETED|Washout Period of at Least 7 Days||0
11102829|NCT01237899|12286902|FG007|NOT COMPLETED|Washout Period of at Least 7 Days||0
11102830|NCT01237899|12286903|FG008|NOT COMPLETED|Washout Period of at Least 7 Days||0
11102831|NCT01237899|12286904|FG009|NOT COMPLETED|Washout Period of at Least 7 Days||0
11102832|NCT01237899|12286905|FG010|NOT COMPLETED|Washout Period of at Least 7 Days||0
11102833|NCT01237899|12286895|FG000|STARTED|Second Dosing Period||1
11102834|NCT01237899|12286896|FG001|STARTED|Second Dosing Period||3
11102835|NCT01237899|12286897|FG002|STARTED|Second Dosing Period||3
11102836|NCT01237899|12286898|FG003|STARTED|Second Dosing Period||3
11102837|NCT01237899|12286899|FG004|STARTED|Second Dosing Period||2
11102838|NCT01237899|12286900|FG005|STARTED|Second Dosing Period||4
11102839|NCT01237899|12286901|FG006|STARTED|Second Dosing Period||1
10833793|NCT00644228|11998979|FG000|STARTED|Randomization & Eligibility||261
10833794|NCT00644228|11998980|FG001|STARTED|Randomization & Eligibility||264
10833795|NCT00644228|11998979|FG000|Eligible and Analyzable|Randomization & Eligibility||229
10833796|NCT00644228|11998980|FG001|Eligible and Analyzable|Randomization & Eligibility||242
10833797|NCT00644228|11998979|FG000|COMPLETED|Randomization & Eligibility||229
10833798|NCT00644228|11998980|FG001|COMPLETED|Randomization & Eligibility||242
10833799|NCT00644228|11998979|FG000|NOT COMPLETED|Randomization & Eligibility||32
10833800|NCT00644228|11998980|FG001|NOT COMPLETED|Randomization & Eligibility||22
10833801|NCT00644228|11998979|FG000|STARTED|Induction Therapy||229
10833802|NCT00644228|11998980|FG001|STARTED|Induction Therapy||242
10833803|NCT00644228|11998979|FG000|COMPLETED|Induction Therapy||146
10833804|NCT00644228|11998980|FG001|COMPLETED|Induction Therapy||137
10833805|NCT00644228|11998979|FG000|NOT COMPLETED|Induction Therapy||83
10833806|NCT00644228|11998980|FG001|NOT COMPLETED|Induction Therapy||105
10833807|NCT00644228|11998979|FG000|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
10833808|NCT00644228|11998980|FG001|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
10833809|NCT00644228|11998979|FG000|COMPLETED|Maintenance||0
10833810|NCT00644228|11998980|FG001|COMPLETED|Maintenance||0
10833811|NCT00644228|11998979|FG000|NOT COMPLETED|Maintenance||143
10833812|NCT00644228|11998980|FG001|NOT COMPLETED|Maintenance||135
11102840|NCT01237899|12286902|FG007|STARTED|Second Dosing Period||3
11102841|NCT01237899|12286903|FG008|STARTED|Second Dosing Period||4
11102842|NCT01237899|12286904|FG009|STARTED|Second Dosing Period||3
11102843|NCT01237899|12286905|FG010|STARTED|Second Dosing Period||4
11102844|NCT01237899|12286895|FG000|COMPLETED|Second Dosing Period||1
11102845|NCT01237899|12286896|FG001|COMPLETED|Second Dosing Period||3
11102846|NCT01237899|12286897|FG002|COMPLETED|Second Dosing Period||3
11102847|NCT01237899|12286898|FG003|COMPLETED|Second Dosing Period||3
11102848|NCT01237899|12286899|FG004|COMPLETED|Second Dosing Period||2
11102849|NCT01237899|12286900|FG005|COMPLETED|Second Dosing Period||4
11102850|NCT01237899|12286901|FG006|COMPLETED|Second Dosing Period||1
11102851|NCT01237899|12286902|FG007|COMPLETED|Second Dosing Period||3
11102852|NCT01237899|12286903|FG008|COMPLETED|Second Dosing Period||4
11102853|NCT01237899|12286904|FG009|COMPLETED|Second Dosing Period||3
11102854|NCT01237899|12286905|FG010|COMPLETED|Second Dosing Period||4
11102855|NCT01237899|12286895|FG000|NOT COMPLETED|Second Dosing Period||0
11102856|NCT01237899|12286896|FG001|NOT COMPLETED|Second Dosing Period||0
11102857|NCT01237899|12286897|FG002|NOT COMPLETED|Second Dosing Period||0
11102858|NCT01237899|12286898|FG003|NOT COMPLETED|Second Dosing Period||0
11102859|NCT01237899|12286899|FG004|NOT COMPLETED|Second Dosing Period||0
11102860|NCT01237899|12286900|FG005|NOT COMPLETED|Second Dosing Period||0
11102861|NCT01237899|12286901|FG006|NOT COMPLETED|Second Dosing Period||0
11102862|NCT01237899|12286902|FG007|NOT COMPLETED|Second Dosing Period||0
11102863|NCT01237899|12286903|FG008|NOT COMPLETED|Second Dosing Period||0
11102864|NCT01237899|12286904|FG009|NOT COMPLETED|Second Dosing Period||0
11102865|NCT01237899|12286905|FG010|NOT COMPLETED|Second Dosing Period||0
11102866|NCT01237951|12286923|FG000|STARTED|Overall Study||75
11102867|NCT01237951|12286923|FG000|COMPLETED|Overall Study||74
11102868|NCT01237951|12286923|FG000|NOT COMPLETED|Overall Study||1
11102869|NCT01238120|12286931|FG000|STARTED|Overall Study||25
11102870|NCT01238120|12286932|FG001|STARTED|Overall Study||23
11102871|NCT01238120|12286933|FG002|STARTED|Overall Study||25
11102872|NCT01238120|12286934|FG003|STARTED|Overall Study||24
11102873|NCT01238120|12286931|FG000|Received Intervention and Completed Baseline Assessments|Overall Study||21
11102874|NCT01238120|12286932|FG001|Received Intervention and Completed Baseline Assessments|Overall Study||22
11102875|NCT01238120|12286933|FG002|Received Intervention and Completed Baseline Assessments|Overall Study||22
11102876|NCT01238120|12286934|FG003|Received Intervention and Completed Baseline Assessments|Overall Study||21
11102877|NCT01238120|12286931|FG000|COMPLETED|Overall Study||17
11102878|NCT01238120|12286932|FG001|COMPLETED|Overall Study||22
11102879|NCT01238120|12286933|FG002|COMPLETED|Overall Study||21
11102880|NCT01238120|12286934|FG003|COMPLETED|Overall Study||18
11102881|NCT01238120|12286931|FG000|NOT COMPLETED|Overall Study||8
11102882|NCT01238120|12286932|FG001|NOT COMPLETED|Overall Study||1
11102883|NCT01238120|12286933|FG002|NOT COMPLETED|Overall Study||4
11102884|NCT01238120|12286934|FG003|NOT COMPLETED|Overall Study||6
11102885|NCT01238172|12286946|FG000|STARTED|Overall Study||237
11102886|NCT01238172|12286947|FG001|STARTED|Overall Study||241
11102887|NCT01238172|12286946|FG000|COMPLETED|Overall Study||226
11102888|NCT01238172|12286947|FG001|COMPLETED|Overall Study||217
11102889|NCT01238172|12286946|FG000|NOT COMPLETED|Overall Study||11
11102890|NCT01238172|12286947|FG001|NOT COMPLETED|Overall Study||24
11220259|NCT01959412|12411867|FG001|NOT COMPLETED|Overall Study||1
11220260|NCT01959412|12411868|FG002|NOT COMPLETED|Overall Study||0
11220261|NCT01959412|12411869|FG003|NOT COMPLETED|Overall Study||2
11220262|NCT01959412|12411870|FG004|NOT COMPLETED|Overall Study||3
11220263|NCT01959412|12411871|FG005|NOT COMPLETED|Overall Study||0
11220264|NCT01959425|12411887|FG000|STARTED|Overall Study||32
11220265|NCT01959425|12411888|FG001|STARTED|Overall Study||31
11220266|NCT01959425|12411887|FG000|COMPLETED|Overall Study||20
11220267|NCT01959425|12411888|FG001|COMPLETED|Overall Study||23
11220268|NCT01959425|12411887|FG000|NOT COMPLETED|Overall Study||12
11220269|NCT01959425|12411888|FG001|NOT COMPLETED|Overall Study||8
11220270|NCT01959490|12411897|FG000|STARTED|Overall Study||5
11220271|NCT01959490|12411898|FG001|STARTED|Overall Study||6
11220272|NCT01959490|12411899|FG002|STARTED|Overall Study||5
11220273|NCT01959490|12411897|FG000|COMPLETED|Overall Study||5
11220274|NCT01959490|12411898|FG001|COMPLETED|Overall Study||6
11220275|NCT01959490|12411899|FG002|COMPLETED|Overall Study||5
11220276|NCT01959490|12411897|FG000|NOT COMPLETED|Overall Study||0
11220277|NCT01959490|12411898|FG001|NOT COMPLETED|Overall Study||0
11220278|NCT01959490|12411899|FG002|NOT COMPLETED|Overall Study||0
11220279|NCT01959503|12411909|FG000|STARTED|Overall Study||107
11220280|NCT01959503|12411910|FG001|STARTED|Overall Study||51
11220281|NCT01959503|12411909|FG000|COMPLETED|Overall Study||104
11220282|NCT01959503|12411910|FG001|COMPLETED|Overall Study||49
11220283|NCT01959503|12411909|FG000|NOT COMPLETED|Overall Study||3
11220284|NCT01959503|12411910|FG001|NOT COMPLETED|Overall Study||2
11220285|NCT01959516|12411916|FG000|STARTED|Epoch 1||63
11220286|NCT01959516|12411917|FG001|STARTED|Epoch 1||63
11220287|NCT01959516|12411916|FG000|Safety Population|Epoch 1||62
11220288|NCT01959516|12411917|FG001|Safety Population|Epoch 1||62
11220289|NCT01959516|12411916|FG000|ITT Population|Epoch 1||62
11220290|NCT01959516|12411917|FG001|ITT Population|Epoch 1||62
11220291|NCT01959516|12411916|FG000|COMPLETED|Epoch 1||53
11220292|NCT01959516|12411917|FG001|COMPLETED|Epoch 1||58
11220293|NCT01959516|12411916|FG000|NOT COMPLETED|Epoch 1||10
11220294|NCT01959516|12411917|FG001|NOT COMPLETED|Epoch 1||5
11220295|NCT01959516|12411916|FG000|STARTED|Epoch 2||63
11220296|NCT01959516|12411917|FG001|STARTED|Epoch 2||63
11220297|NCT01959516|12411916|FG000|COMPLETED|Epoch 2||61
11220298|NCT01959516|12411917|FG001|COMPLETED|Epoch 2||62
11220299|NCT01959516|12411916|FG000|NOT COMPLETED|Epoch 2||2
11220300|NCT01959516|12411917|FG001|NOT COMPLETED|Epoch 2||1
11220301|NCT01959529|12411925|FG000|STARTED|Overall Study||3818
11220302|NCT01959529|12411926|FG001|STARTED|Overall Study||3819
11220303|NCT01959529|12411925|FG000|Exposed|Overall Study||3809
11220304|NCT01959529|12411926|FG001|Exposed|Overall Study||3806
11220305|NCT01959529|12411925|FG000|COMPLETED|Overall Study||3742
11220306|NCT01959529|12411926|FG001|COMPLETED|Overall Study||3747
11220307|NCT01959529|12411925|FG000|NOT COMPLETED|Overall Study||76
11220308|NCT01959529|12411926|FG001|NOT COMPLETED|Overall Study||72
11220309|NCT01959542|12411932|FG000|STARTED|Overall Study||15
11220310|NCT01959542|12411932|FG000|Evaluable at Visit 1|Overall Study||12
11220311|NCT01959542|12411932|FG000|Evaluable at Visit 2|Overall Study||12
11220312|NCT01959542|12411932|FG000|COMPLETED|Overall Study||12
11220313|NCT01959542|12411932|FG000|NOT COMPLETED|Overall Study||3
11102891|NCT01238341|12286953|FG000|STARTED|Overall Study||7
11102892|NCT01238341|12286953|FG000|COMPLETED|Overall Study||7
11102893|NCT01238341|12286953|FG000|NOT COMPLETED|Overall Study||0
11102894|NCT01238471|12286959|FG000|STARTED|Overall Study||10
11102895|NCT01238471|12286960|FG001|STARTED|Overall Study||10
11102896|NCT01238471|12286959|FG000|COMPLETED|Overall Study||10
11102897|NCT01238471|12286960|FG001|COMPLETED|Overall Study||10
11102898|NCT01238471|12286959|FG000|NOT COMPLETED|Overall Study||0
11102899|NCT01238471|12286960|FG001|NOT COMPLETED|Overall Study||0
11102900|NCT01238536|12286968|FG000|STARTED|Overall Study||200
11102901|NCT01238536|12286969|FG001|STARTED|Overall Study||200
11102902|NCT01238536|12286968|FG000|COMPLETED|Overall Study||153
11102903|NCT01238536|12286969|FG001|COMPLETED|Overall Study||150
11102904|NCT01238536|12286968|FG000|NOT COMPLETED|Overall Study||47
11102905|NCT01238536|12286969|FG001|NOT COMPLETED|Overall Study||50
11102906|NCT01238549|12286977|FG000|STARTED|Overall Study||284
11102907|NCT01238549|12286977|FG000|COMPLETED|Overall Study||248
11102908|NCT01238549|12286977|FG000|NOT COMPLETED|Overall Study||36
11102909|NCT01238575|12286983|FG000|STARTED|Overall Study||30
11102910|NCT01238575|12286984|FG001|STARTED|Overall Study||32
11102911|NCT01238575|12286983|FG000|COMPLETED|Overall Study||26
11102912|NCT01238575|12286984|FG001|COMPLETED|Overall Study||28
11102913|NCT01238575|12286983|FG000|NOT COMPLETED|Overall Study||4
11102914|NCT01238575|12286984|FG001|NOT COMPLETED|Overall Study||4
11102915|NCT01238588|12286990|FG000|STARTED|Overall Study||12
11102916|NCT01238588|12286990|FG000|COMPLETED|Overall Study||9
11102917|NCT01238588|12286990|FG000|NOT COMPLETED|Overall Study||3
11102918|NCT01238640|12286994|FG000|STARTED|Overall Study||84
11102919|NCT01238640|12286994|FG000|COMPLETED|Overall Study||84
11102920|NCT01238640|12286994|FG000|NOT COMPLETED|Overall Study||0
11102921|NCT01238822|12287002|FG000|STARTED|Overall Study||96
11102922|NCT01238822|12287002|FG000|Received Placebo|Overall Study||93
11102923|NCT01238822|12287002|FG000|Received Low Dosage|Overall Study||93
11102924|NCT01238822|12287002|FG000|Received Medium Dosage|Overall Study||93
11102925|NCT01238822|12287002|FG000|Received High Dosage|Overall Study||93
11102926|NCT01238822|12287002|FG000|COMPLETED|Overall Study||93
11102927|NCT01238822|12287002|FG000|NOT COMPLETED|Overall Study||3
11102928|NCT01238835|12287012|FG000|STARTED|Overall Study||218
11102929|NCT01238835|12287012|FG000|COMPLETED|Overall Study||82
11102930|NCT01238835|12287012|FG000|NOT COMPLETED|Overall Study||136
11102931|NCT01238848|12287018|FG000|STARTED|Overall Study||50
11102932|NCT01238848|12287019|FG001|STARTED|Overall Study||50
11102933|NCT01238848|12287018|FG000|COMPLETED|Overall Study||37
11102934|NCT01238848|12287019|FG001|COMPLETED|Overall Study||45
11102935|NCT01238848|12287018|FG000|NOT COMPLETED|Overall Study||13
11102936|NCT01238848|12287019|FG001|NOT COMPLETED|Overall Study||5
11102937|NCT01238861|12287031|FG000|STARTED|Overall Study||80
11102938|NCT01238861|12287032|FG001|STARTED|Overall Study||81
11102939|NCT01238861|12287033|FG002|STARTED|Overall Study||81
11102940|NCT01238861|12287034|FG003|STARTED|Overall Study||82
11102941|NCT01238861|12287035|FG004|STARTED|Overall Study||142
11102942|NCT01238861|12287036|FG005|STARTED|Overall Study||140
11102943|NCT01238861|12287031|FG000|COMPLETED|Overall Study||69
11102944|NCT01238861|12287032|FG001|COMPLETED|Overall Study||73
11102945|NCT01238861|12287033|FG002|COMPLETED|Overall Study||70
11102946|NCT01238861|12287034|FG003|COMPLETED|Overall Study||69
11102947|NCT01238861|12287035|FG004|COMPLETED|Overall Study||129
11102948|NCT01238861|12287036|FG005|COMPLETED|Overall Study||125
11102949|NCT01238861|12287031|FG000|NOT COMPLETED|Overall Study||11
11102950|NCT01238861|12287032|FG001|NOT COMPLETED|Overall Study||8
11102951|NCT01238861|12287033|FG002|NOT COMPLETED|Overall Study||11
11102952|NCT01238861|12287034|FG003|NOT COMPLETED|Overall Study||13
11102953|NCT01238861|12287035|FG004|NOT COMPLETED|Overall Study||13
11102954|NCT01238861|12287036|FG005|NOT COMPLETED|Overall Study||15
10833933|NCT00378482|11999024|FG000|STARTED|Overall Study||37
10833934|NCT00378482|11999024|FG000|COMPLETED|Overall Study||6
10833935|NCT00378482|11999024|FG000|NOT COMPLETED|Overall Study||31
10833936|NCT00316888|11999030|FG000|STARTED|Overall Study||28
10833937|NCT00316888|11999031|FG001|STARTED|Overall Study||35
10833938|NCT00316888|11999030|FG000|Eligible|Overall Study||28
11102955|NCT01238900|12287057|FG000|STARTED|6 Months Post Stent Placement||23
11102956|NCT01238900|12287057|FG000|COMPLETED|6 Months Post Stent Placement||23
11102957|NCT01238900|12287057|FG000|NOT COMPLETED|6 Months Post Stent Placement||0
11102958|NCT01238900|12287057|FG000|STARTED|<12 Months Post Stent Removal||23
11102959|NCT01238900|12287057|FG000|COMPLETED|<12 Months Post Stent Removal||18
11102960|NCT01238900|12287057|FG000|NOT COMPLETED|<12 Months Post Stent Removal||5
11102961|NCT01238991|12287072|FG000|STARTED|Overall Study||7
11102962|NCT01238991|12287073|FG001|STARTED|Overall Study||3
11102963|NCT01238991|12287074|FG002|STARTED|Overall Study||11
11102964|NCT01238991|12287075|FG003|STARTED|Overall Study||6
11102965|NCT01238991|12287076|FG004|STARTED|Overall Study||5
11102966|NCT01238991|12287077|FG005|STARTED|Overall Study||2
11102967|NCT01238991|12287078|FG006|STARTED|Overall Study||8
11102968|NCT01238991|12287079|FG007|STARTED|Overall Study||5
11102969|NCT01238991|12287080|FG008|STARTED|Overall Study||4
11102970|NCT01238991|12287081|FG009|STARTED|Overall Study||2
11102971|NCT01238991|12287072|FG000|Received Treatment|Overall Study||7
11102972|NCT01238991|12287073|FG001|Received Treatment|Overall Study||3
11102973|NCT01238991|12287074|FG002|Received Treatment|Overall Study||11
11102974|NCT01238991|12287075|FG003|Received Treatment|Overall Study||6
11102975|NCT01238991|12287076|FG004|Received Treatment|Overall Study||5
11102976|NCT01238991|12287077|FG005|Received Treatment|Overall Study||2
10833939|NCT00316888|11999031|FG001|Eligible|Overall Study||35
10833940|NCT00316888|11999030|FG000|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
10833941|NCT00316888|11999031|FG001|Treated|Overall Study||34
10833942|NCT00316888|11999030|FG000|Started Induction Chemotherapy|Overall Study||28
10833943|NCT00316888|11999031|FG001|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
10833944|NCT00316888|11999030|FG000|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
10833945|NCT00316888|11999031|FG001|Started Chemo+Radiation+Cetuximab|Overall Study||34
10833946|NCT00316888|11999030|FG000|COMPLETED|Overall Study||22
10833947|NCT00316888|11999031|FG001|COMPLETED|Overall Study||27
10833948|NCT00316888|11999030|FG000|NOT COMPLETED|Overall Study||6
10833949|NCT00316888|11999031|FG001|NOT COMPLETED|Overall Study||8
10833950|NCT00095784|11999037|FG000|STARTED|Overall Study||21
10833951|NCT00095784|11999037|FG000|COMPLETED|Overall Study||21
10833952|NCT00095784|11999037|FG000|NOT COMPLETED|Overall Study||0
11102977|NCT01238991|12287078|FG006|Received Treatment|Overall Study||8
11102978|NCT01238991|12287079|FG007|Received Treatment|Overall Study||5
11102979|NCT01238991|12287080|FG008|Received Treatment|Overall Study||4
11102980|NCT01238991|12287081|FG009|Received Treatment|Overall Study||2
11102981|NCT01238991|12287072|FG000|COMPLETED|Overall Study||5
11102982|NCT01238991|12287073|FG001|COMPLETED|Overall Study||3
11102983|NCT01238991|12287074|FG002|COMPLETED|Overall Study||5
11102984|NCT01238991|12287075|FG003|COMPLETED|Overall Study||4
11102985|NCT01238991|12287076|FG004|COMPLETED|Overall Study||3
11102986|NCT01238991|12287077|FG005|COMPLETED|Overall Study||2
11102987|NCT01238991|12287078|FG006|COMPLETED|Overall Study||0
11102988|NCT01238991|12287079|FG007|COMPLETED|Overall Study||0
11102989|NCT01238991|12287080|FG008|COMPLETED|Overall Study||0
11102990|NCT01238991|12287081|FG009|COMPLETED|Overall Study||0
11102991|NCT01238991|12287072|FG000|NOT COMPLETED|Overall Study||2
11102992|NCT01238991|12287073|FG001|NOT COMPLETED|Overall Study||0
11102993|NCT01238991|12287074|FG002|NOT COMPLETED|Overall Study||6
11102994|NCT01238991|12287075|FG003|NOT COMPLETED|Overall Study||2
11102995|NCT01238991|12287076|FG004|NOT COMPLETED|Overall Study||2
11102996|NCT01238991|12287077|FG005|NOT COMPLETED|Overall Study||0
10833973|NCT03178487|11999069|FG000|STARTED|Overall Study||94
10833974|NCT03178487|11999070|FG001|STARTED|Overall Study||93
10833975|NCT03178487|11999069|FG000|Received Treatment|Overall Study||94
10833976|NCT03178487|11999070|FG001|Received Treatment|Overall Study||93
10833977|NCT03178487|11999069|FG000|COMPLETED|Overall Study||90
10833978|NCT03178487|11999070|FG001|COMPLETED|Overall Study||89
10833979|NCT03178487|11999069|FG000|NOT COMPLETED|Overall Study||4
10833980|NCT03178487|11999070|FG001|NOT COMPLETED|Overall Study||4
10833981|NCT03155932|11999076|FG000|STARTED|Overall Study||2
10833982|NCT03155932|11999076|FG000|Participants Escalated to 2 mg Dose of APD334 at Week 12 to Week 24|Overall Study||2
10833983|NCT03155932|11999076|FG000|COMPLETED|Overall Study||2
10833984|NCT03155932|11999076|FG000|NOT COMPLETED|Overall Study||0
10833985|NCT03096834|11999083|FG000|STARTED|Double-Blind Treatment Epoch||121
10833986|NCT03096834|11999084|FG001|STARTED|Double-Blind Treatment Epoch||125
10833987|NCT03096834|11999085|FG002|STARTED|Double-Blind Treatment Epoch||0
10833988|NCT03096834|11999086|FG003|STARTED|Double-Blind Treatment Epoch||0
10833989|NCT03096834|11999083|FG000|COMPLETED|Double-Blind Treatment Epoch||118
10833990|NCT03096834|11999084|FG001|COMPLETED|Double-Blind Treatment Epoch||122
10833991|NCT03096834|11999085|FG002|COMPLETED|Double-Blind Treatment Epoch||0
10833992|NCT03096834|11999086|FG003|COMPLETED|Double-Blind Treatment Epoch||0
10833993|NCT03096834|11999083|FG000|NOT COMPLETED|Double-Blind Treatment Epoch||3
10833994|NCT03096834|11999084|FG001|NOT COMPLETED|Double-Blind Treatment Epoch||3
10833995|NCT03096834|11999085|FG002|NOT COMPLETED|Double-Blind Treatment Epoch||0
10833996|NCT03096834|11999086|FG003|NOT COMPLETED|Double-Blind Treatment Epoch||0
10833997|NCT03096834|11999083|FG000|STARTED|Open-Label Treatment Epoch||0
10833998|NCT03096834|11999084|FG001|STARTED|Open-Label Treatment Epoch||0
10833999|NCT03096834|11999085|FG002|STARTED|Open-Label Treatment Epoch||118
10834000|NCT03096834|11999086|FG003|STARTED|Open-Label Treatment Epoch||122
10834001|NCT03096834|11999083|FG000|COMPLETED|Open-Label Treatment Epoch||0
10834002|NCT03096834|11999084|FG001|COMPLETED|Open-Label Treatment Epoch||0
10834003|NCT03096834|11999085|FG002|COMPLETED|Open-Label Treatment Epoch||86
10834004|NCT03096834|11999086|FG003|COMPLETED|Open-Label Treatment Epoch||83
10834005|NCT03096834|11999083|FG000|NOT COMPLETED|Open-Label Treatment Epoch||0
10834006|NCT03096834|11999084|FG001|NOT COMPLETED|Open-Label Treatment Epoch||0
10834007|NCT03096834|11999085|FG002|NOT COMPLETED|Open-Label Treatment Epoch||32
10834008|NCT03096834|11999086|FG003|NOT COMPLETED|Open-Label Treatment Epoch||39
10834009|NCT03096834|11999083|FG000|STARTED|Safety Follow-Up Epoch||0
10834010|NCT03096834|11999084|FG001|STARTED|Safety Follow-Up Epoch||0
10834011|NCT03096834|11999085|FG002|STARTED|Safety Follow-Up Epoch||66
10834012|NCT03096834|11999086|FG003|STARTED|Safety Follow-Up Epoch||61
10834013|NCT03096834|11999083|FG000|COMPLETED|Safety Follow-Up Epoch||0
10834014|NCT03096834|11999084|FG001|COMPLETED|Safety Follow-Up Epoch||0
10834015|NCT03096834|11999085|FG002|COMPLETED|Safety Follow-Up Epoch||65
10834016|NCT03096834|11999086|FG003|COMPLETED|Safety Follow-Up Epoch||59
10834017|NCT03096834|11999083|FG000|NOT COMPLETED|Safety Follow-Up Epoch||0
10834018|NCT03096834|11999084|FG001|NOT COMPLETED|Safety Follow-Up Epoch||0
10834019|NCT03096834|11999085|FG002|NOT COMPLETED|Safety Follow-Up Epoch||1
10834020|NCT03096834|11999086|FG003|NOT COMPLETED|Safety Follow-Up Epoch||2
10834021|NCT03096834|11999083|FG000|STARTED|Post-Trial Access Epoch||0
10834022|NCT03096834|11999084|FG001|STARTED|Post-Trial Access Epoch||0
10834023|NCT03096834|11999085|FG002|STARTED|Post-Trial Access Epoch||21
10834024|NCT03096834|11999086|FG003|STARTED|Post-Trial Access Epoch||15
10834025|NCT03096834|11999083|FG000|COMPLETED|Post-Trial Access Epoch||0
10834026|NCT03096834|11999084|FG001|COMPLETED|Post-Trial Access Epoch||0
10834027|NCT03096834|11999085|FG002|COMPLETED|Post-Trial Access Epoch||21
10834028|NCT03096834|11999086|FG003|COMPLETED|Post-Trial Access Epoch||15
10834029|NCT03096834|11999083|FG000|NOT COMPLETED|Post-Trial Access Epoch||0
10834030|NCT03096834|11999084|FG001|NOT COMPLETED|Post-Trial Access Epoch||0
10834031|NCT03096834|11999085|FG002|NOT COMPLETED|Post-Trial Access Epoch||0
10834032|NCT03096834|11999086|FG003|NOT COMPLETED|Post-Trial Access Epoch||0
10834033|NCT03089853|11999097|FG000|STARTED|Overall Study||4
10834034|NCT03089853|11999098|FG001|STARTED|Overall Study||3
10834035|NCT03089853|11999097|FG000|COMPLETED|Overall Study||2
10834036|NCT03089853|11999098|FG001|COMPLETED|Overall Study||2
10834037|NCT03089853|11999097|FG000|NOT COMPLETED|Overall Study||2
10834038|NCT03089853|11999098|FG001|NOT COMPLETED|Overall Study||1
10834039|NCT03070392|11999106|FG000|STARTED|Overall Study||252
10834040|NCT03070392|11999107|FG001|STARTED|Overall Study||7
10834041|NCT03070392|11999108|FG002|STARTED|Overall Study||16
10834042|NCT03070392|11999109|FG003|STARTED|Overall Study||103
10834043|NCT03070392|11999106|FG000|COMPLETED|Overall Study||0
10834044|NCT03070392|11999107|FG001|COMPLETED|Overall Study||0
10834045|NCT03070392|11999108|FG002|COMPLETED|Overall Study||10
10834046|NCT03070392|11999109|FG003|COMPLETED|Overall Study||0
10834047|NCT03070392|11999106|FG000|NOT COMPLETED|Overall Study||252
10834048|NCT03070392|11999107|FG001|NOT COMPLETED|Overall Study||7
10834049|NCT03070392|11999108|FG002|NOT COMPLETED|Overall Study||6
10834050|NCT03070392|11999109|FG003|NOT COMPLETED|Overall Study||103
10834051|NCT03048578|11999117|FG000|STARTED|Overall Study||89
10834052|NCT03048578|11999118|FG001|STARTED|Overall Study||43
10834053|NCT03048578|11999117|FG000|COMPLETED|Overall Study||58
10834054|NCT03048578|11999118|FG001|COMPLETED|Overall Study||23
10834055|NCT03048578|11999117|FG000|NOT COMPLETED|Overall Study||31
10834056|NCT03048578|11999118|FG001|NOT COMPLETED|Overall Study||20
10834057|NCT03015194|11999124|FG000|STARTED|Overall Study||30
10834058|NCT03015194|11999124|FG000|COMPLETED|Overall Study||18
10834059|NCT03015194|11999124|FG000|NOT COMPLETED|Overall Study||12
10834060|NCT03012815|11999131|FG000|STARTED|Overall Study||46
10834061|NCT03012815|11999132|FG001|STARTED|Overall Study||42
10834062|NCT03012815|11999131|FG000|COMPLETED|Overall Study||41
10834063|NCT03012815|11999132|FG001|COMPLETED|Overall Study||40
10834064|NCT03012815|11999131|FG000|NOT COMPLETED|Overall Study||5
10834065|NCT03012815|11999132|FG001|NOT COMPLETED|Overall Study||2
10834066|NCT03001011|11999141|FG000|STARTED|Overall Study||101
10834067|NCT03001011|11999142|FG001|STARTED|Overall Study||101
10834068|NCT03001011|11999141|FG000|COMPLETED|Overall Study||74
10834069|NCT03001011|11999142|FG001|COMPLETED|Overall Study||80
10834070|NCT03001011|11999141|FG000|NOT COMPLETED|Overall Study||27
10834071|NCT03001011|11999142|FG001|NOT COMPLETED|Overall Study||21
10834072|NCT02999633|11999149|FG000|STARTED|Overall Study||14
10834073|NCT02999633|11999149|FG000|COMPLETED|Overall Study||0
10834074|NCT02999633|11999149|FG000|NOT COMPLETED|Overall Study||14
10834075|NCT02993757|11999155|FG000|STARTED|Overall Study||266
10834076|NCT02993757|11999156|FG001|STARTED|Overall Study||262
10834077|NCT02993757|11999155|FG000|Safety Analysis Set (SafAS)|Overall Study||263
10834078|NCT02993757|11999156|FG001|Safety Analysis Set (SafAS)|Overall Study||260
10834079|NCT02993757|11999155|FG000|COMPLETED|Overall Study||102
10834080|NCT02993757|11999156|FG001|COMPLETED|Overall Study||84
10834081|NCT02993757|11999155|FG000|NOT COMPLETED|Overall Study||164
10834082|NCT02993757|11999156|FG001|NOT COMPLETED|Overall Study||178
10834083|NCT02992418|11999164|FG000|STARTED|Overall Study||346
10834084|NCT02992418|11999165|FG001|STARTED|Overall Study||342
10834085|NCT02992418|11999164|FG000|Safety Analysis Set (SafAS)|Overall Study||338
10834086|NCT02992418|11999165|FG001|Safety Analysis Set (SafAS)|Overall Study||342
10834087|NCT02992418|11999164|FG000|COMPLETED|Overall Study||0
10834088|NCT02992418|11999165|FG001|COMPLETED|Overall Study||0
10834089|NCT02992418|11999164|FG000|NOT COMPLETED|Overall Study||346
10834090|NCT02992418|11999165|FG001|NOT COMPLETED|Overall Study||342
10834091|NCT02979535|11999173|FG000|STARTED|Overall Study||239
10834092|NCT02979535|11999174|FG001|STARTED|Overall Study||241
10834093|NCT02979535|11999173|FG000|Safety Analysis Set|Overall Study||237
10834094|NCT02979535|11999174|FG001|Safety Analysis Set|Overall Study||241
10834095|NCT02979535|11999173|FG000|COMPLETED|Overall Study||144
10834096|NCT02979535|11999174|FG001|COMPLETED|Overall Study||140
10834097|NCT02979535|11999173|FG000|NOT COMPLETED|Overall Study||95
10834098|NCT02979535|11999174|FG001|NOT COMPLETED|Overall Study||101
10834099|NCT02978716|11999183|FG000|STARTED|Overall Study||34
10834100|NCT02978716|11999184|FG001|STARTED|Overall Study||33
10834101|NCT02978716|11999185|FG002|STARTED|Overall Study||35
10834102|NCT02978716|11999183|FG000|ITT Population|Overall Study||34
10834103|NCT02978716|11999184|FG001|ITT Population|Overall Study||33
10834104|NCT02978716|11999185|FG002|ITT Population|Overall Study||35
10834105|NCT02978716|11999183|FG000|Safety Analysis Set|Overall Study||30
10834106|NCT02978716|11999184|FG001|Safety Analysis Set|Overall Study||33
10834107|NCT02978716|11999185|FG002|Safety Analysis Set|Overall Study||35
10834108|NCT02978716|11999183|FG000|Treated|Overall Study||30
10834109|NCT02978716|11999184|FG001|Treated|Overall Study||33
10834110|NCT02978716|11999185|FG002|Treated|Overall Study||35
10834111|NCT02978716|11999183|FG000|COMPLETED|Overall Study||0
10834112|NCT02978716|11999184|FG001|COMPLETED|Overall Study||0
10834113|NCT02978716|11999185|FG002|COMPLETED|Overall Study||0
10834114|NCT02978716|11999183|FG000|NOT COMPLETED|Overall Study||34
10834115|NCT02978716|11999184|FG001|NOT COMPLETED|Overall Study||33
10834116|NCT02978716|11999185|FG002|NOT COMPLETED|Overall Study||35
10834117|NCT02973321|11999200|FG000|STARTED|Overall Study||33
10834118|NCT02973321|11999201|FG001|STARTED|Overall Study||66
11102997|NCT01238991|12287078|FG006|NOT COMPLETED|Overall Study||8
11102998|NCT01238991|12287079|FG007|NOT COMPLETED|Overall Study||5
11102999|NCT01238991|12287080|FG008|NOT COMPLETED|Overall Study||4
11103000|NCT01238991|12287081|FG009|NOT COMPLETED|Overall Study||2
11103001|NCT01239043|12287108|FG000|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
11103002|NCT01239043|12287109|FG001|STARTED|Overall Study||103
11103003|NCT01239043|12287108|FG000|COMPLETED|Overall Study||34
11103004|NCT01239043|12287109|FG001|COMPLETED|Overall Study||102
11103005|NCT01239043|12287108|FG000|NOT COMPLETED|Overall Study||2
11103006|NCT01239043|12287109|FG001|NOT COMPLETED|Overall Study||1
11103007|NCT01239056|12287115|FG000|STARTED|Overall Study||20
11103008|NCT01239056|12287115|FG000|COMPLETED|Overall Study||20
11103009|NCT01239056|12287115|FG000|NOT COMPLETED|Overall Study||0
11103010|NCT01239121|12287123|FG000|STARTED|Overall Study||188
11103011|NCT01239121|12287124|FG001|STARTED|Overall Study||199
11103012|NCT01239121|12287125|FG002|STARTED|Overall Study||15
11103013|NCT01239121|12287123|FG000|COMPLETED|Overall Study||186
11103014|NCT01239121|12287124|FG001|COMPLETED|Overall Study||195
11103015|NCT01239121|12287125|FG002|COMPLETED|Overall Study||15
11103016|NCT01239121|12287123|FG000|NOT COMPLETED|Overall Study||2
11103017|NCT01239121|12287124|FG001|NOT COMPLETED|Overall Study||4
11103018|NCT01239121|12287125|FG002|NOT COMPLETED|Overall Study||0
11103019|NCT01239160|12287135|FG000|STARTED|Overall Study||114
11103020|NCT01239160|12287136|FG001|STARTED|Overall Study||114
11103021|NCT01239160|12287137|FG002|STARTED|Overall Study||10
11103022|NCT01239160|12287135|FG000|COMPLETED|Overall Study||89
11103023|NCT01239160|12287136|FG001|COMPLETED|Overall Study||95
11103024|NCT01239160|12287137|FG002|COMPLETED|Overall Study||0
11103025|NCT01239160|12287135|FG000|NOT COMPLETED|Overall Study||25
11103026|NCT01239160|12287136|FG001|NOT COMPLETED|Overall Study||19
11103027|NCT01239160|12287137|FG002|NOT COMPLETED|Overall Study||10
11103028|NCT01239212|12287143|FG000|STARTED|Overall Study||7
10834119|NCT02973321|11999202|FG002|STARTED|Overall Study||66
10834120|NCT02973321|11999203|FG003|STARTED|Overall Study||64
10834121|NCT02973321|11999204|FG004|STARTED|Overall Study||67
10834122|NCT02973321|11999200|FG000|COMPLETED|Overall Study||32
10834123|NCT02973321|11999201|FG001|COMPLETED|Overall Study||51
11103029|NCT01239212|12287143|FG000|COMPLETED|Overall Study||7
10834124|NCT02973321|11999202|FG002|COMPLETED|Overall Study||52
10834125|NCT02973321|11999203|FG003|COMPLETED|Overall Study||48
10834126|NCT02973321|11999204|FG004|COMPLETED|Overall Study||62
10834127|NCT02973321|11999200|FG000|NOT COMPLETED|Overall Study||1
10834128|NCT02973321|11999201|FG001|NOT COMPLETED|Overall Study||15
10834129|NCT02973321|11999202|FG002|NOT COMPLETED|Overall Study||14
10834130|NCT02973321|11999203|FG003|NOT COMPLETED|Overall Study||16
10834131|NCT02973321|11999204|FG004|NOT COMPLETED|Overall Study||5
10834132|NCT02943785|11999219|FG000|STARTED|Overall Study||713
10834133|NCT02943785|11999220|FG001|STARTED|Overall Study||713
10834134|NCT02943785|11999219|FG000|COMPLETED|Overall Study||431
10834135|NCT02943785|11999220|FG001|COMPLETED|Overall Study||350
10834136|NCT02943785|11999219|FG000|NOT COMPLETED|Overall Study||282
10834137|NCT02943785|11999220|FG001|NOT COMPLETED|Overall Study||363
10834138|NCT02923674|11999229|FG000|STARTED|Overall Study||60
10834139|NCT02923674|11999230|FG001|STARTED|Overall Study||60
10834140|NCT02923674|11999231|FG002|STARTED|Overall Study||63
10834141|NCT02923674|11999229|FG000|COMPLETED|Overall Study||32
10834142|NCT02923674|11999230|FG001|COMPLETED|Overall Study||32
10834143|NCT02923674|11999231|FG002|COMPLETED|Overall Study||38
10834144|NCT02923674|11999229|FG000|NOT COMPLETED|Overall Study||28
10834145|NCT02923674|11999230|FG001|NOT COMPLETED|Overall Study||28
10834146|NCT02923674|11999231|FG002|NOT COMPLETED|Overall Study||25
10834147|NCT02921971|11999241|FG000|STARTED|Overall Study||49
10834148|NCT02921971|11999242|FG001|STARTED|Overall Study||48
10834149|NCT02921971|11999241|FG000|COMPLETED|Overall Study||43
10834150|NCT02921971|11999242|FG001|COMPLETED|Overall Study||44
10834151|NCT02921971|11999241|FG000|NOT COMPLETED|Overall Study||6
10834152|NCT02921971|11999242|FG001|NOT COMPLETED|Overall Study||4
10834153|NCT02886286|11999250|FG000|STARTED|Overall Study||8
10834154|NCT02886286|11999251|FG001|STARTED|Overall Study||9
10834155|NCT02886286|11999250|FG000|COMPLETED|Overall Study||8
10834156|NCT02886286|11999251|FG001|COMPLETED|Overall Study||8
10834157|NCT02886286|11999250|FG000|NOT COMPLETED|Overall Study||0
10834158|NCT02886286|11999251|FG001|NOT COMPLETED|Overall Study||1
10834159|NCT02865187|11999259|FG000|STARTED|Overall Study||33
10834160|NCT02865187|11999260|FG001|STARTED|Overall Study||14
10834161|NCT02865187|11999259|FG000|Visit 2 - at 3 Months|Overall Study||23
10834162|NCT02865187|11999260|FG001|Visit 2 - at 3 Months|Overall Study||7
10834163|NCT02865187|11999259|FG000|COMPLETED|Overall Study||20
10834164|NCT02865187|11999260|FG001|COMPLETED|Overall Study||7
10834165|NCT02865187|11999259|FG000|NOT COMPLETED|Overall Study||13
10834166|NCT02865187|11999260|FG001|NOT COMPLETED|Overall Study||7
11103030|NCT01239212|12287143|FG000|NOT COMPLETED|Overall Study||0
11103031|NCT01239316|12287147|FG000|STARTED|Overall Study||12
11103032|NCT01239316|12287147|FG000|COMPLETED|Overall Study||0
11103033|NCT01239316|12287147|FG000|NOT COMPLETED|Overall Study||12
11103034|NCT01239342|12287153|FG000|STARTED|Overall Study||29
11103035|NCT01239342|12287154|FG001|STARTED|Overall Study||14
11103036|NCT01239342|12287153|FG000|COMPLETED|Overall Study||26
11103037|NCT01239342|12287154|FG001|COMPLETED|Overall Study||8
11103038|NCT01239342|12287153|FG000|NOT COMPLETED|Overall Study||3
11103039|NCT01239342|12287154|FG001|NOT COMPLETED|Overall Study||6
11103040|NCT01239355|12287160|FG000|STARTED|Overall Study||15
11103041|NCT01239355|12287160|FG000|COMPLETED|Overall Study||15
11103042|NCT01239355|12287160|FG000|NOT COMPLETED|Overall Study||0
10834176|NCT02824198|11999281|FG000|STARTED|Overall Study||89
10834177|NCT02824198|11999282|FG001|STARTED|Overall Study||29
10834178|NCT02824198|11999281|FG000|COMPLETED|Overall Study||74
10834179|NCT02824198|11999282|FG001|COMPLETED|Overall Study||26
10834180|NCT02824198|11999281|FG000|NOT COMPLETED|Overall Study||15
10834181|NCT02824198|11999282|FG001|NOT COMPLETED|Overall Study||3
10834182|NCT02821754|11999293|FG000|STARTED|Overall Study||36
10834183|NCT02821754|11999294|FG001|STARTED|Overall Study||16
10834184|NCT02821754|11999295|FG002|STARTED|Overall Study|No results data were collected for these participants.|2
10834185|NCT02821754|11999293|FG000|COMPLETED|Overall Study||20
10834186|NCT02821754|11999294|FG001|COMPLETED|Overall Study||4
10834187|NCT02821754|11999295|FG002|COMPLETED|Overall Study||0
10834188|NCT02821754|11999293|FG000|NOT COMPLETED|Overall Study||16
10834189|NCT02821754|11999294|FG001|NOT COMPLETED|Overall Study||12
10834190|NCT02821754|11999295|FG002|NOT COMPLETED|Overall Study||2
10834191|NCT02787551|11999303|FG000|STARTED|Core Period: 26 Weeks||257
10834192|NCT02787551|11999304|FG001|STARTED|Core Period: 26 Weeks||257
10834193|NCT02787551|11999303|FG000|Treated|Core Period: 26 Weeks||255
10834194|NCT02787551|11999304|FG001|Treated|Core Period: 26 Weeks||256
10834195|NCT02787551|11999303|FG000|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230
10834196|NCT02787551|11999304|FG001|COMPLETED|Core Period: 26 Weeks||246
10834197|NCT02787551|11999303|FG000|NOT COMPLETED|Core Period: 26 Weeks||27
10834198|NCT02787551|11999304|FG001|NOT COMPLETED|Core Period: 26 Weeks||11
10834199|NCT02787551|11999303|FG000|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206
10834200|NCT02787551|11999304|FG001|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0
10834201|NCT02787551|11999303|FG000|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197
10834202|NCT02787551|11999304|FG001|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
10834203|NCT02787551|11999303|FG000|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9
10834204|NCT02787551|11999304|FG001|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
10834205|NCT02747121|11999315|FG000|STARTED|Overall Study||3594
10834206|NCT02747121|11999316|FG001|STARTED|Overall Study||3813
10834207|NCT02747121|11999315|FG000|COMPLETED|Overall Study||3594
10834208|NCT02747121|11999316|FG001|COMPLETED|Overall Study||3813
10834209|NCT02747121|11999315|FG000|NOT COMPLETED|Overall Study||0
10834210|NCT02747121|11999316|FG001|NOT COMPLETED|Overall Study||0
10834211|NCT02735044|11999324|FG000|STARTED|Overall Study||233
10834212|NCT02735044|11999325|FG001|STARTED|Overall Study||230
10834213|NCT02735044|11999324|FG000|Treated|Overall Study||233
10834214|NCT02735044|11999325|FG001|Treated|Overall Study||228
10834215|NCT02735044|11999324|FG000|COMPLETED|Overall Study||217
10834216|NCT02735044|11999325|FG001|COMPLETED|Overall Study||207
10834217|NCT02735044|11999324|FG000|NOT COMPLETED|Overall Study||16
10834218|NCT02735044|11999325|FG001|NOT COMPLETED|Overall Study||23
10834219|NCT02720744|11999333|FG000|STARTED|Overall Study||107
10834220|NCT02720744|11999334|FG001|STARTED|Overall Study||105
10834221|NCT02720744|11999333|FG000|COMPLETED|Overall Study||69
10834222|NCT02720744|11999334|FG001|COMPLETED|Overall Study||79
10834223|NCT02720744|11999333|FG000|NOT COMPLETED|Overall Study||38
10834224|NCT02720744|11999334|FG001|NOT COMPLETED|Overall Study||26
10834225|NCT02713867|11999342|FG000|STARTED|Randomization||180
10834226|NCT02713867|11999343|FG001|STARTED|Randomization||183
10834227|NCT02713867|11999342|FG000|COMPLETED|Randomization||178
10834228|NCT02713867|11999343|FG001|COMPLETED|Randomization||180
10834229|NCT02713867|11999342|FG000|NOT COMPLETED|Randomization||2
10834230|NCT02713867|11999343|FG001|NOT COMPLETED|Randomization||3
10834231|NCT02713867|11999342|FG000|STARTED|Treatment Period||178
10834232|NCT02713867|11999343|FG001|STARTED|Treatment Period||180
10834233|NCT02713867|11999342|FG000|COMPLETED|Treatment Period||31
10834234|NCT02713867|11999343|FG001|COMPLETED|Treatment Period||30
10834235|NCT02713867|11999342|FG000|NOT COMPLETED|Treatment Period||147
10834236|NCT02713867|11999343|FG001|NOT COMPLETED|Treatment Period||150
10834237|NCT02704403|11999351|FG000|STARTED|Overall Study||1437
10834238|NCT02704403|11999352|FG001|STARTED|Overall Study||720
10834239|NCT02704403|11999351|FG000|Full Intent-to-Treat Population|Overall Study||1437
10834240|NCT02704403|11999352|FG001|Full Intent-to-Treat Population|Overall Study||720
10834241|NCT02704403|11999351|FG000|Full Safety Population|Overall Study||1433
10834242|NCT02704403|11999352|FG001|Full Safety Population|Overall Study||717
10834243|NCT02704403|11999351|FG000|COMPLETED|Overall Study||0
10834244|NCT02704403|11999352|FG001|COMPLETED|Overall Study||0
10834245|NCT02704403|11999351|FG000|NOT COMPLETED|Overall Study||1437
10834246|NCT02704403|11999352|FG001|NOT COMPLETED|Overall Study||720
10834247|NCT02694185|11999360|FG000|STARTED|Overall Study||476
10834248|NCT02694185|11999361|FG001|STARTED|Overall Study||4793
10834249|NCT02694185|11999360|FG000|COMPLETED|Overall Study||431
10834250|NCT02694185|11999361|FG001|COMPLETED|Overall Study||4793
10834251|NCT02694185|11999360|FG000|NOT COMPLETED|Overall Study||45
10834252|NCT02694185|11999361|FG001|NOT COMPLETED|Overall Study||0
10834253|NCT02692651|11999369|FG000|STARTED|Study Treatment||70
10834254|NCT02692651|11999370|FG001|STARTED|Study Treatment||74
10834255|NCT02692651|11999369|FG000|COMPLETED|Study Treatment||54
10834256|NCT02692651|11999370|FG001|COMPLETED|Study Treatment||64
10834257|NCT02692651|11999369|FG000|NOT COMPLETED|Study Treatment||16
10834258|NCT02692651|11999370|FG001|NOT COMPLETED|Study Treatment||10
10834259|NCT02692651|11999369|FG000|STARTED|Post Study Treatment Follow-up||54
10834260|NCT02692651|11999370|FG001|STARTED|Post Study Treatment Follow-up||64
10834261|NCT02692651|11999369|FG000|COMPLETED|Post Study Treatment Follow-up||50
10834262|NCT02692651|11999370|FG001|COMPLETED|Post Study Treatment Follow-up||60
10834263|NCT02692651|11999369|FG000|NOT COMPLETED|Post Study Treatment Follow-up||4
10834264|NCT02692651|11999370|FG001|NOT COMPLETED|Post Study Treatment Follow-up||4
10834265|NCT02674061|11999378|FG000|STARTED|Overall Study||285
10834266|NCT02674061|11999379|FG001|STARTED|Overall Study||91
10834267|NCT02674061|11999378|FG000|COMPLETED|Overall Study||0
10834268|NCT02674061|11999379|FG001|COMPLETED|Overall Study||0
10834269|NCT02674061|11999378|FG000|NOT COMPLETED|Overall Study||285
10834270|NCT02674061|11999379|FG001|NOT COMPLETED|Overall Study||91
10834271|NCT02656706|11999387|FG000|STARTED|Overall Study||22
10834272|NCT02656706|11999387|FG000|COMPLETED|Overall Study||21
10834273|NCT02656706|11999387|FG000|NOT COMPLETED|Overall Study||1
10834274|NCT02654314|11999393|FG000|STARTED|Overall Study||136
10834275|NCT02654314|11999394|FG001|STARTED|Overall Study||141
10834276|NCT02654314|11999393|FG000|COMPLETED|Overall Study||136
10834277|NCT02654314|11999394|FG001|COMPLETED|Overall Study||141
10834278|NCT02654314|11999393|FG000|NOT COMPLETED|Overall Study||0
10834279|NCT02654314|11999394|FG001|NOT COMPLETED|Overall Study||0
10834280|NCT02628444|11999403|FG000|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||350
10834281|NCT02628444|11999404|FG001|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||348
10834282|NCT02628444|11999405|FG002|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||352
10834283|NCT02628444|11999406|FG003|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834284|NCT02628444|11999407|FG004|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834285|NCT02628444|11999408|FG005|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834286|NCT02628444|11999409|FG006|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834287|NCT02628444|11999410|FG007|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834288|NCT02628444|11999411|FG008|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834289|NCT02628444|11999403|FG000|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
10834290|NCT02628444|11999404|FG001|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
10834291|NCT02628444|11999405|FG002|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||352
10834292|NCT02628444|11999406|FG003|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834293|NCT02628444|11999407|FG004|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834294|NCT02628444|11999408|FG005|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834295|NCT02628444|11999409|FG006|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834296|NCT02628444|11999410|FG007|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834297|NCT02628444|11999411|FG008|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834298|NCT02628444|11999403|FG000|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||333
10834299|NCT02628444|11999404|FG001|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||328
10834300|NCT02628444|11999405|FG002|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||332
10834301|NCT02628444|11999406|FG003|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834302|NCT02628444|11999407|FG004|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834303|NCT02628444|11999408|FG005|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834304|NCT02628444|11999409|FG006|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834305|NCT02628444|11999410|FG007|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834306|NCT02628444|11999411|FG008|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834307|NCT02628444|11999403|FG000|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||314
10834308|NCT02628444|11999404|FG001|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||309
10834309|NCT02628444|11999405|FG002|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||310
10834310|NCT02628444|11999406|FG003|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834311|NCT02628444|11999407|FG004|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834312|NCT02628444|11999408|FG005|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834313|NCT02628444|11999409|FG006|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834314|NCT02628444|11999410|FG007|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834315|NCT02628444|11999411|FG008|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834316|NCT02628444|11999403|FG000|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||36
10834317|NCT02628444|11999404|FG001|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||39
10834318|NCT02628444|11999405|FG002|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||42
10834319|NCT02628444|11999406|FG003|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834320|NCT02628444|11999407|FG004|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834321|NCT02628444|11999408|FG005|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834322|NCT02628444|11999409|FG006|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834323|NCT02628444|11999410|FG007|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834324|NCT02628444|11999411|FG008|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
10834325|NCT02628444|11999403|FG000|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834326|NCT02628444|11999404|FG001|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834327|NCT02628444|11999405|FG002|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834328|NCT02628444|11999406|FG003|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||145
10834329|NCT02628444|11999407|FG004|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
10834330|NCT02628444|11999408|FG005|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||157
10834331|NCT02628444|11999409|FG006|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||149
10834332|NCT02628444|11999410|FG007|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
10834333|NCT02628444|11999411|FG008|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||151
10834334|NCT02628444|11999403|FG000|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834335|NCT02628444|11999404|FG001|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834336|NCT02628444|11999405|FG002|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834337|NCT02628444|11999406|FG003|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||55
10834338|NCT02628444|11999407|FG004|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||59
10834339|NCT02628444|11999408|FG005|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||62
10834340|NCT02628444|11999409|FG006|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
10834341|NCT02628444|11999410|FG007|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||56
10834342|NCT02628444|11999411|FG008|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
10834343|NCT02628444|11999403|FG000|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834344|NCT02628444|11999404|FG001|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834345|NCT02628444|11999405|FG002|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834346|NCT02628444|11999406|FG003|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||55
10834347|NCT02628444|11999407|FG004|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||59
10834348|NCT02628444|11999408|FG005|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||62
10834349|NCT02628444|11999409|FG006|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||53
10834350|NCT02628444|11999410|FG007|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||54
10834351|NCT02628444|11999411|FG008|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||52
10834352|NCT02628444|11999403|FG000|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834353|NCT02628444|11999404|FG001|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834354|NCT02628444|11999405|FG002|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
10834355|NCT02628444|11999406|FG003|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||90
10834356|NCT02628444|11999407|FG004|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||93
10834357|NCT02628444|11999408|FG005|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||95
10834358|NCT02628444|11999409|FG006|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||96
10834359|NCT02628444|11999410|FG007|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||98
10834360|NCT02628444|11999411|FG008|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||99
10834361|NCT02623998|11999438|FG000|STARTED|Overall Study||50
10834362|NCT02623998|11999439|FG001|STARTED|Overall Study||52
10834363|NCT02623998|11999438|FG000|COMPLETED|Overall Study||48
10834364|NCT02623998|11999439|FG001|COMPLETED|Overall Study||51
10834365|NCT02623998|11999438|FG000|NOT COMPLETED|Overall Study||2
10834366|NCT02623998|11999439|FG001|NOT COMPLETED|Overall Study||1
10834367|NCT02623725|11999447|FG000|STARTED|Overall Study||187
10834368|NCT02623725|11999448|FG001|STARTED|Overall Study||64
10834369|NCT02623725|11999447|FG000|COMPLETED|Overall Study||171
10834370|NCT02623725|11999448|FG001|COMPLETED|Overall Study||58
10834371|NCT02623725|11999447|FG000|NOT COMPLETED|Overall Study||16
10834372|NCT02623725|11999448|FG001|NOT COMPLETED|Overall Study||6
10834373|NCT02608684|11999456|FG000|STARTED|Overall Study||21
10834374|NCT02608684|11999456|FG000|COMPLETED|Overall Study||18
10834375|NCT02608684|11999456|FG000|NOT COMPLETED|Overall Study||3
10834376|NCT02603887|11999460|FG000|STARTED|Stage 1||12
10834377|NCT02603887|11999460|FG000|Cycle 1|Stage 1||12
10834378|NCT02603887|11999460|FG000|Cycle 8|Stage 1||7
10834379|NCT02603887|11999460|FG000|COMPLETED|Stage 1||7
10834380|NCT02603887|11999460|FG000|NOT COMPLETED|Stage 1||5
10834381|NCT02603887|11999460|FG000|STARTED|Stage 2||1
10834382|NCT02603887|11999460|FG000|Cycle 1|Stage 2||1
10834383|NCT02603887|11999460|FG000|Cycle 8|Stage 2||0
10834384|NCT02603887|11999460|FG000|COMPLETED|Stage 2||0
10834385|NCT02603887|11999460|FG000|NOT COMPLETED|Stage 2||1
10834386|NCT02587520|11999482|FG000|STARTED|Overall Study||80
10834387|NCT02587520|11999483|FG001|STARTED|Overall Study||71
10834388|NCT02587520|11999484|FG002|STARTED|Overall Study||78
10834389|NCT02587520|11999485|FG003|STARTED|Overall Study||79
10834390|NCT02587520|11999486|FG004|STARTED|Overall Study||75
10834391|NCT02587520|11999487|FG005|STARTED|Overall Study||75
10834392|NCT02587520|11999488|FG006|STARTED|Overall Study||76
10834393|NCT02587520|11999489|FG007|STARTED|Overall Study||73
10834394|NCT02587520|11999490|FG008|STARTED|Overall Study||76
10834395|NCT02587520|11999491|FG009|STARTED|Overall Study||76
10834396|NCT02587520|11999492|FG010|STARTED|Overall Study||76
10834397|NCT02587520|11999493|FG011|STARTED|Overall Study||73
10834398|NCT02587520|11999494|FG012|STARTED|Overall Study||77
10834399|NCT02587520|11999495|FG013|STARTED|Overall Study||74
10834400|NCT02587520|11999496|FG014|STARTED|Overall Study||78
10834401|NCT02587520|11999497|FG015|STARTED|Overall Study||72
10834402|NCT02587520|11999498|FG016|STARTED|Overall Study||76
10834403|NCT02587520|11999499|FG017|STARTED|Overall Study||78
10834404|NCT02587520|11999482|FG000|Safety Analysis Set (SafAS)|Overall Study||79
10834405|NCT02587520|11999483|FG001|Safety Analysis Set (SafAS)|Overall Study||71
10834406|NCT02587520|11999484|FG002|Safety Analysis Set (SafAS)|Overall Study||77
10834407|NCT02587520|11999485|FG003|Safety Analysis Set (SafAS)|Overall Study||77
10834408|NCT02587520|11999486|FG004|Safety Analysis Set (SafAS)|Overall Study||75
10834409|NCT02587520|11999487|FG005|Safety Analysis Set (SafAS)|Overall Study||75
10834410|NCT02587520|11999488|FG006|Safety Analysis Set (SafAS)|Overall Study||76
10834411|NCT02587520|11999489|FG007|Safety Analysis Set (SafAS)|Overall Study||73
10834412|NCT02587520|11999490|FG008|Safety Analysis Set (SafAS)|Overall Study||76
10834413|NCT02587520|11999491|FG009|Safety Analysis Set (SafAS)|Overall Study||76
10834414|NCT02587520|11999492|FG010|Safety Analysis Set (SafAS)|Overall Study||76
10834415|NCT02587520|11999493|FG011|Safety Analysis Set (SafAS)|Overall Study||72
10834416|NCT02587520|11999494|FG012|Safety Analysis Set (SafAS)|Overall Study||77
10834417|NCT02587520|11999495|FG013|Safety Analysis Set (SafAS)|Overall Study||73
10834418|NCT02587520|11999496|FG014|Safety Analysis Set (SafAS)|Overall Study||78
10834419|NCT02587520|11999497|FG015|Safety Analysis Set (SafAS)|Overall Study||72
10834420|NCT02587520|11999498|FG016|Safety Analysis Set (SafAS)|Overall Study||76
10834421|NCT02587520|11999499|FG017|Safety Analysis Set (SafAS)|Overall Study||78
10834422|NCT02587520|11999482|FG000|COMPLETED|Overall Study||78
10834423|NCT02587520|11999483|FG001|COMPLETED|Overall Study||69
10834424|NCT02587520|11999484|FG002|COMPLETED|Overall Study||77
10834425|NCT02587520|11999485|FG003|COMPLETED|Overall Study||74
10834426|NCT02587520|11999486|FG004|COMPLETED|Overall Study||75
10834427|NCT02587520|11999487|FG005|COMPLETED|Overall Study||72
10834428|NCT02587520|11999488|FG006|COMPLETED|Overall Study||73
10834429|NCT02587520|11999489|FG007|COMPLETED|Overall Study||71
10834430|NCT02587520|11999490|FG008|COMPLETED|Overall Study||73
10834431|NCT02587520|11999491|FG009|COMPLETED|Overall Study||71
10834432|NCT02587520|11999492|FG010|COMPLETED|Overall Study||73
10834433|NCT02587520|11999493|FG011|COMPLETED|Overall Study||69
10834434|NCT02587520|11999494|FG012|COMPLETED|Overall Study||77
10834435|NCT02587520|11999495|FG013|COMPLETED|Overall Study||73
10834436|NCT02587520|11999496|FG014|COMPLETED|Overall Study||78
10834437|NCT02587520|11999497|FG015|COMPLETED|Overall Study||72
10834438|NCT02587520|11999498|FG016|COMPLETED|Overall Study||76
10834439|NCT02587520|11999499|FG017|COMPLETED|Overall Study||78
10834440|NCT02587520|11999482|FG000|NOT COMPLETED|Overall Study||2
10834441|NCT02587520|11999483|FG001|NOT COMPLETED|Overall Study||2
10834442|NCT02587520|11999484|FG002|NOT COMPLETED|Overall Study||1
10834443|NCT02587520|11999485|FG003|NOT COMPLETED|Overall Study||5
10834444|NCT02587520|11999486|FG004|NOT COMPLETED|Overall Study||0
10834445|NCT02587520|11999487|FG005|NOT COMPLETED|Overall Study||3
10834446|NCT02587520|11999488|FG006|NOT COMPLETED|Overall Study||3
10834447|NCT02587520|11999489|FG007|NOT COMPLETED|Overall Study||2
10834448|NCT02587520|11999490|FG008|NOT COMPLETED|Overall Study||3
10834449|NCT02587520|11999491|FG009|NOT COMPLETED|Overall Study||5
10834450|NCT02587520|11999492|FG010|NOT COMPLETED|Overall Study||3
10834451|NCT02587520|11999493|FG011|NOT COMPLETED|Overall Study||4
10834452|NCT02587520|11999494|FG012|NOT COMPLETED|Overall Study||0
10834453|NCT02587520|11999495|FG013|NOT COMPLETED|Overall Study||1
10834454|NCT02587520|11999496|FG014|NOT COMPLETED|Overall Study||0
10834455|NCT02587520|11999497|FG015|NOT COMPLETED|Overall Study||0
10834456|NCT02587520|11999498|FG016|NOT COMPLETED|Overall Study||0
10834457|NCT02587520|11999499|FG017|NOT COMPLETED|Overall Study||0
10834458|NCT02584829|11999539|FG000|STARTED|Overall Study||1
10834459|NCT02584829|11999540|FG001|STARTED|Overall Study||7
10834460|NCT02584829|11999539|FG000|COMPLETED|Overall Study||0
10834461|NCT02584829|11999540|FG001|COMPLETED|Overall Study||3
10834462|NCT02584829|11999539|FG000|NOT COMPLETED|Overall Study||1
10834463|NCT02584829|11999540|FG001|NOT COMPLETED|Overall Study||4
10834464|NCT02570308|11999553|FG000|STARTED|Overall Study||3
10834465|NCT02570308|11999554|FG001|STARTED|Overall Study||6
10834466|NCT02570308|11999555|FG002|STARTED|Overall Study||4
10834467|NCT02570308|11999556|FG003|STARTED|Overall Study||6
10834468|NCT02570308|11999557|FG004|STARTED|Overall Study||127
10834469|NCT02570308|11999553|FG000|COMPLETED|Overall Study||2
10834470|NCT02570308|11999554|FG001|COMPLETED|Overall Study||1
10834471|NCT02570308|11999555|FG002|COMPLETED|Overall Study||0
10834472|NCT02570308|11999556|FG003|COMPLETED|Overall Study||2
10834473|NCT02570308|11999557|FG004|COMPLETED|Overall Study||53
10834474|NCT02570308|11999553|FG000|NOT COMPLETED|Overall Study||1
10834475|NCT02570308|11999554|FG001|NOT COMPLETED|Overall Study||5
10834476|NCT02570308|11999555|FG002|NOT COMPLETED|Overall Study||4
10834477|NCT02570308|11999556|FG003|NOT COMPLETED|Overall Study||4
10834478|NCT02570308|11999557|FG004|NOT COMPLETED|Overall Study||74
10834479|NCT02514083|11999575|FG000|STARTED|Overall Study||29
10834480|NCT02514083|11999575|FG000|COMPLETED|Overall Study||28
10834481|NCT02514083|11999575|FG000|NOT COMPLETED|Overall Study||1
10834482|NCT02497612|11999583|FG000|STARTED|Overall Study||93
10834483|NCT02497612|11999584|FG001|STARTED|Overall Study||94
10834484|NCT02497612|11999585|FG002|STARTED|Overall Study||97
10834485|NCT02497612|11999586|FG003|STARTED|Overall Study||93
10834486|NCT02497612|11999583|FG000|Treated|Overall Study||92
10834487|NCT02497612|11999584|FG001|Treated|Overall Study||94
10834488|NCT02497612|11999585|FG002|Treated|Overall Study||96
10834489|NCT02497612|11999586|FG003|Treated|Overall Study||91
10834490|NCT02497612|11999583|FG000|Cohort 1: >14 Years to <70 Years|Overall Study||14
10834491|NCT02497612|11999584|FG001|Cohort 1: >14 Years to <70 Years|Overall Study||15
10834492|NCT02497612|11999585|FG002|Cohort 1: >14 Years to <70 Years|Overall Study||18
10834493|NCT02497612|11999586|FG003|Cohort 1: >14 Years to <70 Years|Overall Study||16
10834494|NCT02497612|11999583|FG000|Cohort 2: >5 Years to <=14 Years|Overall Study||6
10834495|NCT02497612|11999584|FG001|Cohort 2: >5 Years to <=14 Years|Overall Study||5
10834496|NCT02497612|11999585|FG002|Cohort 2: >5 Years to <=14 Years|Overall Study||6
10834497|NCT02497612|11999586|FG003|Cohort 2: >5 Years to <=14 Years|Overall Study||5
10834498|NCT02497612|11999583|FG000|Cohort 3: >2 Years to <=5 Years|Overall Study||66
10834499|NCT02497612|11999584|FG001|Cohort 3: >2 Years to <=5 Years|Overall Study||66
11103043|NCT01239381|12287164|FG000|STARTED|Overall Study||92
11103044|NCT01239381|12287164|FG000|COMPLETED|Overall Study||90
11103045|NCT01239381|12287164|FG000|NOT COMPLETED|Overall Study||2
11103046|NCT01239394|12287169|FG000|STARTED|Overall Study||42
11103047|NCT01239394|12287169|FG000|COMPLETED|Overall Study||41
11103048|NCT01239394|12287169|FG000|NOT COMPLETED|Overall Study||1
11103049|NCT01239472|12287175|FG000|STARTED|Overall Study||15
11103050|NCT01239472|12287176|FG001|STARTED|Overall Study||15
11103051|NCT01239472|12287175|FG000|COMPLETED|Overall Study||10
11103052|NCT01239472|12287176|FG001|COMPLETED|Overall Study||12
11103053|NCT01239472|12287175|FG000|NOT COMPLETED|Overall Study||5
11103054|NCT01239472|12287176|FG001|NOT COMPLETED|Overall Study||3
11103055|NCT01239511|12287188|FG000|STARTED|Overall Study||47
11103056|NCT01239511|12287189|FG001|STARTED|Overall Study||45
11103057|NCT01239511|12287190|FG002|STARTED|Overall Study||47
11103058|NCT01239511|12287191|FG003|STARTED|Overall Study||47
11103059|NCT01239511|12287188|FG000|COMPLETED|Overall Study||46
11103060|NCT01239511|12287189|FG001|COMPLETED|Overall Study||40
11103061|NCT01239511|12287190|FG002|COMPLETED|Overall Study||43
11103062|NCT01239511|12287191|FG003|COMPLETED|Overall Study||38
11103063|NCT01239511|12287188|FG000|NOT COMPLETED|Overall Study||1
11103064|NCT01239511|12287189|FG001|NOT COMPLETED|Overall Study||5
11103065|NCT01239511|12287190|FG002|NOT COMPLETED|Overall Study||4
11103066|NCT01239511|12287191|FG003|NOT COMPLETED|Overall Study||9
11103067|NCT01239732|12287201|FG000|STARTED|Overall Study||1021
11103068|NCT01239732|12287201|FG000|COMPLETED|Overall Study||0
11103069|NCT01239732|12287201|FG000|NOT COMPLETED|Overall Study||1021
11103070|NCT01239745|12287205|FG000|STARTED|Overall Study||46
11103071|NCT01239745|12287205|FG000|COMPLETED|Overall Study||0
11103072|NCT01239745|12287205|FG000|NOT COMPLETED|Overall Study||46
11103073|NCT01239992|12287209|FG000|STARTED|Overall Study||12
11103074|NCT01239992|12287209|FG000|COMPLETED|Overall Study||10
11103075|NCT01239992|12287209|FG000|NOT COMPLETED|Overall Study||2
11103076|NCT01240122|12287213|FG000|STARTED|Overall Study||29
11103077|NCT01240122|12287213|FG000|COMPLETED|Overall Study||29
11103078|NCT01240122|12287213|FG000|NOT COMPLETED|Overall Study||0
11103079|NCT01240135|12287224|FG000|STARTED|Period One, 14 Days of Wear||44
11103080|NCT01240135|12287225|FG001|STARTED|Period One, 14 Days of Wear||45
11103081|NCT01240135|12287224|FG000|COMPLETED|Period One, 14 Days of Wear||44
11103082|NCT01240135|12287225|FG001|COMPLETED|Period One, 14 Days of Wear||45
11103083|NCT01240135|12287224|FG000|NOT COMPLETED|Period One, 14 Days of Wear||0
11103084|NCT01240135|12287225|FG001|NOT COMPLETED|Period One, 14 Days of Wear||0
11103085|NCT01240135|12287224|FG000|STARTED|Period Two, 14 Days of Wear||44
11103086|NCT01240135|12287225|FG001|STARTED|Period Two, 14 Days of Wear||45
11103087|NCT01240135|12287224|FG000|COMPLETED|Period Two, 14 Days of Wear||43
11103088|NCT01240135|12287225|FG001|COMPLETED|Period Two, 14 Days of Wear||43
11103089|NCT01240135|12287224|FG000|NOT COMPLETED|Period Two, 14 Days of Wear||1
11103090|NCT01240135|12287225|FG001|NOT COMPLETED|Period Two, 14 Days of Wear||2
11103091|NCT01240200|12287233|FG000|STARTED|12-week Crossover Phase - Period 1||25
11103092|NCT01240200|12287234|FG001|STARTED|12-week Crossover Phase - Period 1||24
11103093|NCT01240200|12287233|FG000|COMPLETED|12-week Crossover Phase - Period 1||23
11103094|NCT01240200|12287234|FG001|COMPLETED|12-week Crossover Phase - Period 1||23
11103095|NCT01240200|12287233|FG000|NOT COMPLETED|12-week Crossover Phase - Period 1||2
11103096|NCT01240200|12287234|FG001|NOT COMPLETED|12-week Crossover Phase - Period 1||1
11103097|NCT01240200|12287233|FG000|STARTED|12-week Crossover Phase - Period 2||23
11103098|NCT01240200|12287234|FG001|STARTED|12-week Crossover Phase - Period 2||23
11103099|NCT01240200|12287233|FG000|COMPLETED|12-week Crossover Phase - Period 2||23
11103100|NCT01240200|12287234|FG001|COMPLETED|12-week Crossover Phase - Period 2||23
11103101|NCT01240200|12287233|FG000|NOT COMPLETED|12-week Crossover Phase - Period 2||0
11103102|NCT01240200|12287234|FG001|NOT COMPLETED|12-week Crossover Phase - Period 2||0
10834500|NCT02497612|11999585|FG002|Cohort 3: >2 Years to <=5 Years|Overall Study||67
10834501|NCT02497612|11999586|FG003|Cohort 3: >2 Years to <=5 Years|Overall Study||65
11103103|NCT01240330|12287243|FG000|STARTED|Overall Study||33
11103104|NCT01240330|12287243|FG000|COMPLETED|Overall Study||33
10834502|NCT02497612|11999583|FG000|Cohort 4: >6 Months to <=2 Years|Overall Study||7
10834503|NCT02497612|11999584|FG001|Cohort 4: >6 Months to <=2 Years|Overall Study||8
10834504|NCT02497612|11999585|FG002|Cohort 4: >6 Months to <=2 Years|Overall Study||6
10834505|NCT02497612|11999586|FG003|Cohort 4: >6 Months to <=2 Years|Overall Study||7
10834506|NCT02497612|11999583|FG000|COMPLETED|Overall Study||27
10834507|NCT02497612|11999584|FG001|COMPLETED|Overall Study||37
10834508|NCT02497612|11999585|FG002|COMPLETED|Overall Study||48
10834509|NCT02497612|11999586|FG003|COMPLETED|Overall Study||46
10834510|NCT02497612|11999583|FG000|NOT COMPLETED|Overall Study||66
10834511|NCT02497612|11999584|FG001|NOT COMPLETED|Overall Study||57
10834512|NCT02497612|11999585|FG002|NOT COMPLETED|Overall Study||49
10834513|NCT02497612|11999586|FG003|NOT COMPLETED|Overall Study||47
10834514|NCT02460458|11999596|FG000|STARTED|Retrospective Phase||265
10834515|NCT02460458|11999596|FG000|COMPLETED|Retrospective Phase||265
10834516|NCT02460458|11999596|FG000|NOT COMPLETED|Retrospective Phase||0
10834517|NCT02460458|11999596|FG000|STARTED|Confirmatory Phase||265
10834518|NCT02460458|11999596|FG000|COMPLETED|Confirmatory Phase||177
10834519|NCT02460458|11999596|FG000|NOT COMPLETED|Confirmatory Phase||88
10834520|NCT02460458|11999596|FG000|STARTED|First Prospective Phase||177
11220314|NCT01959581|12411937|FG000|STARTED|Overall Study||30
10834521|NCT02460458|11999596|FG000|COMPLETED|First Prospective Phase||161
10834522|NCT02460458|11999596|FG000|NOT COMPLETED|First Prospective Phase||16
11103105|NCT01240330|12287243|FG000|NOT COMPLETED|Overall Study||0
11103106|NCT01240356|12287249|FG000|STARTED|Overall Study||18
11103107|NCT01240356|12287250|FG001|STARTED|Overall Study||20
11220315|NCT01959581|12411937|FG000|COMPLETED|Overall Study||25
10834523|NCT02460458|11999596|FG000|STARTED|Confirmation of Clinical Phase Data||161
10834524|NCT02460458|11999596|FG000|COMPLETED|Confirmation of Clinical Phase Data||152
10834525|NCT02460458|11999596|FG000|NOT COMPLETED|Confirmation of Clinical Phase Data||9
10834526|NCT02460458|11999596|FG000|STARTED|Second Prospective Phase||152
10834527|NCT02460458|11999596|FG000|COMPLETED|Second Prospective Phase|Information not available yet, anticipated date is december 2022|0
10834528|NCT02460458|11999596|FG000|NOT COMPLETED|Second Prospective Phase||152
10834529|NCT02457559|11999611|FG000|STARTED|Overall Study||2
10834530|NCT02457559|11999612|FG001|STARTED|Overall Study||3
10834531|NCT02457559|11999613|FG002|STARTED|Overall Study||7
10834532|NCT02457559|11999614|FG003|STARTED|Overall Study||2
10834533|NCT02457559|11999615|FG004|STARTED|Overall Study||1
10834534|NCT02457559|11999616|FG005|STARTED|Overall Study||2
10834535|NCT02457559|11999617|FG006|STARTED|Overall Study||2
10834536|NCT02457559|11999618|FG007|STARTED|Overall Study||1
10834537|NCT02457559|11999619|FG008|STARTED|Overall Study||3
10834538|NCT02457559|11999620|FG009|STARTED|Overall Study||4
10834539|NCT02457559|11999621|FG010|STARTED|Overall Study||2
10834540|NCT02457559|11999611|FG000|COMPLETED|Overall Study||0
10834541|NCT02457559|11999612|FG001|COMPLETED|Overall Study||0
10834542|NCT02457559|11999613|FG002|COMPLETED|Overall Study||0
10834543|NCT02457559|11999614|FG003|COMPLETED|Overall Study||2
10834544|NCT02457559|11999615|FG004|COMPLETED|Overall Study||0
10834545|NCT02457559|11999616|FG005|COMPLETED|Overall Study||0
10834546|NCT02457559|11999617|FG006|COMPLETED|Overall Study||0
10834547|NCT02457559|11999618|FG007|COMPLETED|Overall Study||1
10834548|NCT02457559|11999619|FG008|COMPLETED|Overall Study||0
10834549|NCT02457559|11999620|FG009|COMPLETED|Overall Study||0
10834550|NCT02457559|11999621|FG010|COMPLETED|Overall Study||0
10834551|NCT02457559|11999611|FG000|NOT COMPLETED|Overall Study||2
10834552|NCT02457559|11999612|FG001|NOT COMPLETED|Overall Study||3
10834553|NCT02457559|11999613|FG002|NOT COMPLETED|Overall Study||7
10834554|NCT02457559|11999614|FG003|NOT COMPLETED|Overall Study||0
10834555|NCT02457559|11999615|FG004|NOT COMPLETED|Overall Study||1
10834556|NCT02457559|11999616|FG005|NOT COMPLETED|Overall Study||2
10834557|NCT02457559|11999617|FG006|NOT COMPLETED|Overall Study||2
10834558|NCT02457559|11999618|FG007|NOT COMPLETED|Overall Study||0
10834559|NCT02457559|11999619|FG008|NOT COMPLETED|Overall Study||3
10834560|NCT02457559|11999620|FG009|NOT COMPLETED|Overall Study||4
10834561|NCT02457559|11999621|FG010|NOT COMPLETED|Overall Study||2
10834562|NCT02417974|11999661|FG000|STARTED|Overall Study||15
10834563|NCT02417974|11999662|FG001|STARTED|Overall Study||9
10834564|NCT02417974|11999661|FG000|COMPLETED|Overall Study||15
10834565|NCT02417974|11999662|FG001|COMPLETED|Overall Study||9
10834566|NCT02417974|11999661|FG000|NOT COMPLETED|Overall Study||0
10834567|NCT02417974|11999662|FG001|NOT COMPLETED|Overall Study||0
10834568|NCT02381652|11999671|FG000|STARTED|Overall Study|Cingal injection in 13-01 study; receiving a 2nd Cingal injection in 13-02|94
10834569|NCT02381652|11999672|FG001|STARTED|Overall Study|Monovisc injection in 13-01 study; receiving a Cingal injection in 13-02|98
10834570|NCT02381652|11999673|FG002|STARTED|Overall Study|Saline injection in 13-01 study; receiving a Cingal injection in 13-02|50
10834571|NCT02381652|11999671|FG000|COMPLETED|Overall Study||94
10834572|NCT02381652|11999672|FG001|COMPLETED|Overall Study||98
10834573|NCT02381652|11999673|FG002|COMPLETED|Overall Study||49
10834574|NCT02381652|11999671|FG000|NOT COMPLETED|Overall Study||0
10834575|NCT02381652|11999672|FG001|NOT COMPLETED|Overall Study||0
10834576|NCT02381652|11999673|FG002|NOT COMPLETED|Overall Study||1
10834577|NCT02367794|11999682|FG000|STARTED|Overall Study||340
10834578|NCT02367794|11999683|FG001|STARTED|Overall Study||343
10834579|NCT02367794|11999684|FG002|STARTED|Overall Study||338
10834580|NCT02367794|11999682|FG000|COMPLETED|Overall Study||0
10834581|NCT02367794|11999683|FG001|COMPLETED|Overall Study||0
10834582|NCT02367794|11999684|FG002|COMPLETED|Overall Study||0
10834583|NCT02367794|11999682|FG000|NOT COMPLETED|Overall Study||340
10834584|NCT02367794|11999683|FG001|NOT COMPLETED|Overall Study||343
10834585|NCT02367794|11999684|FG002|NOT COMPLETED|Overall Study||338
10834586|NCT02363998|11999697|FG000|STARTED|Overall Study||286
10834587|NCT02363998|11999697|FG000|COMPLETED|Overall Study|A subject was defined as completed if at least one dose was taken on Day 7.|168
10834588|NCT02363998|11999697|FG000|NOT COMPLETED|Overall Study||118
10834589|NCT02353832|11999717|FG000|STARTED|Overall Study||44
10834590|NCT02353832|11999717|FG000|COMPLETED|Overall Study||42
10834591|NCT02353832|11999717|FG000|NOT COMPLETED|Overall Study||2
10834592|NCT02353728|11999721|FG000|STARTED|Overall Study||16
10834593|NCT02353728|11999721|FG000|COMPLETED|Overall Study||15
10834594|NCT02353728|11999721|FG000|NOT COMPLETED|Overall Study||1
10834595|NCT02345070|11999728|FG000|STARTED|Overall Study||110
10834596|NCT02345070|11999729|FG001|STARTED|Overall Study||109
10834597|NCT02345070|11999730|FG002|STARTED|Overall Study||108
10834598|NCT02345070|11999728|FG000|Treated|Overall Study||109
10834599|NCT02345070|11999729|FG001|Treated|Overall Study||108
10834600|NCT02345070|11999730|FG002|Treated|Overall Study||108
10834601|NCT02345070|11999728|FG000|COMPLETED|Overall Study||90
10834602|NCT02345070|11999729|FG001|COMPLETED|Overall Study||98
10834603|NCT02345070|11999730|FG002|COMPLETED|Overall Study||85
10834604|NCT02345070|11999728|FG000|NOT COMPLETED|Overall Study||20
10834605|NCT02345070|11999729|FG001|NOT COMPLETED|Overall Study||11
10834606|NCT02345070|11999730|FG002|NOT COMPLETED|Overall Study||23
10834607|NCT02325466|11999738|FG000|STARTED|Period 1 Timeframe - Baseline to Week 4||23
10834608|NCT02325466|11999739|FG001|STARTED|Period 1 Timeframe - Baseline to Week 4||23
10834609|NCT02325466|11999740|FG002|STARTED|Period 1 Timeframe - Baseline to Week 4||24
10834610|NCT02325466|11999738|FG000|COMPLETED|Period 1 Timeframe - Baseline to Week 4||22
10834611|NCT02325466|11999739|FG001|COMPLETED|Period 1 Timeframe - Baseline to Week 4||21
10834612|NCT02325466|11999740|FG002|COMPLETED|Period 1 Timeframe - Baseline to Week 4||21
10834613|NCT02325466|11999738|FG000|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||1
10834614|NCT02325466|11999739|FG001|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||2
10834615|NCT02325466|11999740|FG002|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||3
10834616|NCT02325466|11999738|FG000|STARTED|Period 2 - Timeframe Week 4 to Week 10||22
10834617|NCT02325466|11999739|FG001|STARTED|Period 2 - Timeframe Week 4 to Week 10||21
10834618|NCT02325466|11999740|FG002|STARTED|Period 2 - Timeframe Week 4 to Week 10||21
10834619|NCT02325466|11999738|FG000|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||19
10834620|NCT02325466|11999739|FG001|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||20
10834621|NCT02325466|11999740|FG002|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||21
10834622|NCT02325466|11999738|FG000|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||3
10834623|NCT02325466|11999739|FG001|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||1
10834624|NCT02325466|11999740|FG002|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||0
10834625|NCT02325466|11999738|FG000|STARTED|3rd Crossover - Week 10 to Week 16||19
10834626|NCT02325466|11999739|FG001|STARTED|3rd Crossover - Week 10 to Week 16||20
10834627|NCT02325466|11999740|FG002|STARTED|3rd Crossover - Week 10 to Week 16||21
10834628|NCT02325466|11999738|FG000|COMPLETED|3rd Crossover - Week 10 to Week 16||18
10834629|NCT02325466|11999739|FG001|COMPLETED|3rd Crossover - Week 10 to Week 16||18
10834630|NCT02325466|11999740|FG002|COMPLETED|3rd Crossover - Week 10 to Week 16||21
10834631|NCT02325466|11999738|FG000|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||1
10834632|NCT02325466|11999739|FG001|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||2
10834633|NCT02325466|11999740|FG002|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||0
10834634|NCT02322710|11999751|FG000|STARTED|Overall Study||105
10834635|NCT02322710|11999752|FG001|STARTED|Overall Study||99
10834636|NCT02322710|11999751|FG000|Safety Population|Overall Study||105
10834637|NCT02322710|11999752|FG001|Safety Population|Overall Study||99
10834638|NCT02322710|11999751|FG000|Full Analysis Population|Overall Study||105
10834639|NCT02322710|11999752|FG001|Full Analysis Population|Overall Study||98
10834640|NCT02322710|11999751|FG000|COMPLETED|Overall Study||85
10834641|NCT02322710|11999752|FG001|COMPLETED|Overall Study||73
10834642|NCT02322710|11999751|FG000|NOT COMPLETED|Overall Study||20
10834643|NCT02322710|11999752|FG001|NOT COMPLETED|Overall Study||26
10834644|NCT02303548|11999760|FG000|STARTED|Overall Study||25
10834645|NCT02303548|11999761|FG001|STARTED|Overall Study||25
10834646|NCT02303548|11999760|FG000|COMPLETED|Overall Study||25
10834647|NCT02303548|11999761|FG001|COMPLETED|Overall Study||25
10834648|NCT02303548|11999760|FG000|NOT COMPLETED|Overall Study||0
10834649|NCT02303548|11999761|FG001|NOT COMPLETED|Overall Study||0
10834650|NCT02292654|11999770|FG000|STARTED|Overall Study||4
10834651|NCT02292654|11999771|FG001|STARTED|Overall Study||9
10834652|NCT02292654|11999772|FG002|STARTED|Overall Study||7
10834653|NCT02292654|11999770|FG000|COMPLETED|Overall Study||4
10834654|NCT02292654|11999771|FG001|COMPLETED|Overall Study||9
10834655|NCT02292654|11999772|FG002|COMPLETED|Overall Study||7
10834656|NCT02292654|11999770|FG000|NOT COMPLETED|Overall Study||0
10834657|NCT02292654|11999771|FG001|NOT COMPLETED|Overall Study||0
10834658|NCT02292654|11999772|FG002|NOT COMPLETED|Overall Study||0
10834659|NCT02251548|11999786|FG000|STARTED|Overall Study||85
10834660|NCT02251548|11999786|FG000|COMPLETED|Overall Study||0
10834661|NCT02251548|11999786|FG000|NOT COMPLETED|Overall Study||85
10834662|NCT02239354|11999793|FG000|STARTED|Overall Study||19
10834663|NCT02239354|11999794|FG001|STARTED|Overall Study||0
10834664|NCT02239354|11999793|FG000|COMPLETED|Overall Study||9
10834665|NCT02239354|11999794|FG001|COMPLETED|Overall Study||0
10834666|NCT02239354|11999793|FG000|NOT COMPLETED|Overall Study||10
10834667|NCT02239354|11999794|FG001|NOT COMPLETED|Overall Study||0
10834668|NCT02234310|11999800|FG000|STARTED|Overall Study||33
10834669|NCT02234310|11999800|FG000|Episodic Treatment Regimen|Overall Study|Participants were treated in more than one regimen and counted in all categories wherever applicable|22
10834670|NCT02234310|11999800|FG000|Prophylactic Treatment Regimen|Overall Study|17 participants among the 22 who started in episodic regimen, switched to the prophylactic regimen.|28
10834671|NCT02234310|11999800|FG000|COMPLETED|Overall Study||27
10834672|NCT02234310|11999800|FG000|NOT COMPLETED|Overall Study||6
10834673|NCT02212015|11999804|FG000|STARTED|Overall Study||26
10834674|NCT02212015|11999804|FG000|COMPLETED|Overall Study||25
10834675|NCT02212015|11999804|FG000|NOT COMPLETED|Overall Study||1
10834685|NCT02139436|11999827|FG000|STARTED|Overall Study||41
10834686|NCT02139436|11999828|FG001|STARTED|Overall Study||14
10834687|NCT02139436|11999829|FG002|STARTED|Overall Study||13
10834688|NCT02139436|11999827|FG000|COMPLETED|Overall Study||41
10834689|NCT02139436|11999828|FG001|COMPLETED|Overall Study||14
10834690|NCT02139436|11999829|FG002|COMPLETED|Overall Study||13
10834691|NCT02139436|11999827|FG000|NOT COMPLETED|Overall Study||0
10834692|NCT02139436|11999828|FG001|NOT COMPLETED|Overall Study||0
10834693|NCT02139436|11999829|FG002|NOT COMPLETED|Overall Study||0
10834694|NCT02120079|11999845|FG000|STARTED|Baseline||17
10834695|NCT02120079|11999846|FG001|STARTED|Baseline||20
10834696|NCT02120079|11999845|FG000|COMPLETED|Baseline||17
10834697|NCT02120079|11999846|FG001|COMPLETED|Baseline||20
10834698|NCT02120079|11999845|FG000|NOT COMPLETED|Baseline||0
10834699|NCT02120079|11999846|FG001|NOT COMPLETED|Baseline||0
10834700|NCT02120079|11999845|FG000|STARTED|2 Weeks||17
10834701|NCT02120079|11999846|FG001|STARTED|2 Weeks||20
10834702|NCT02120079|11999845|FG000|COMPLETED|2 Weeks||17
10834703|NCT02120079|11999846|FG001|COMPLETED|2 Weeks||20
10834704|NCT02120079|11999845|FG000|NOT COMPLETED|2 Weeks||0
10834705|NCT02120079|11999846|FG001|NOT COMPLETED|2 Weeks||0
10834706|NCT02120079|11999845|FG000|STARTED|6 Weeks||17
10834707|NCT02120079|11999846|FG001|STARTED|6 Weeks||20
10834708|NCT02120079|11999845|FG000|COMPLETED|6 Weeks||17
10834709|NCT02120079|11999846|FG001|COMPLETED|6 Weeks||20
10834710|NCT02120079|11999845|FG000|NOT COMPLETED|6 Weeks||0
10834711|NCT02120079|11999846|FG001|NOT COMPLETED|6 Weeks||0
10834712|NCT02106195|11999853|FG000|STARTED|Overall Study||8
10834713|NCT02106195|11999853|FG000|COMPLETED|Overall Study|Includes all 3 periods of study: Screening, Treatment, Post-treatment|5
10834714|NCT02106195|11999853|FG000|NOT COMPLETED|Overall Study||3
10834715|NCT02104180|11999865|FG000|STARTED|Overall Study||31
10834716|NCT02104180|11999866|FG001|STARTED|Overall Study||31
10834717|NCT02104180|11999865|FG000|COMPLETED|Overall Study||30
10834718|NCT02104180|11999866|FG001|COMPLETED|Overall Study||31
10834719|NCT02104180|11999865|FG000|NOT COMPLETED|Overall Study||1
10834720|NCT02104180|11999866|FG001|NOT COMPLETED|Overall Study||0
10834721|NCT02050919|11999872|FG000|STARTED|Overall Study||20
10834722|NCT02050919|11999872|FG000|COMPLETED|Overall Study||20
10834723|NCT02050919|11999872|FG000|NOT COMPLETED|Overall Study||0
10834724|NCT02040857|11999876|FG000|STARTED|Overall Study||162
10834725|NCT02040857|11999876|FG000|Treatment Discontinuation Evaluable|Overall Study|Evaluable population excludes participants who discontinue early for reasons unrelated to treatment.|152
10834726|NCT02040857|11999876|FG000|COMPLETED|Overall Study||102
10834727|NCT02040857|11999876|FG000|NOT COMPLETED|Overall Study||60
10834728|NCT01997463|11999885|FG000|STARTED|Overall Study||192
10834729|NCT01997463|11999886|FG001|STARTED|Overall Study||250
10834730|NCT01997463|11999885|FG000|COMPLETED|Overall Study||107
10834731|NCT01997463|11999886|FG001|COMPLETED|Overall Study||147
10834732|NCT01997463|11999885|FG000|NOT COMPLETED|Overall Study||85
10834733|NCT01997463|11999886|FG001|NOT COMPLETED|Overall Study||103
10834734|NCT01943825|11999896|FG000|STARTED|Overall Study||25
10834735|NCT01943825|11999897|FG001|STARTED|Overall Study||15
10834736|NCT01943825|11999898|FG002|STARTED|Overall Study||25
10834737|NCT01943825|11999899|FG003|STARTED|Overall Study||25
10834738|NCT01943825|11999896|FG000|COMPLETED|Overall Study||15
10834739|NCT01943825|11999897|FG001|COMPLETED|Overall Study||11
10834740|NCT01943825|11999898|FG002|COMPLETED|Overall Study||10
10834741|NCT01943825|11999899|FG003|COMPLETED|Overall Study||14
10834742|NCT01943825|11999896|FG000|NOT COMPLETED|Overall Study||10
10834743|NCT01943825|11999897|FG001|NOT COMPLETED|Overall Study||4
10834744|NCT01943825|11999898|FG002|NOT COMPLETED|Overall Study||15
10834745|NCT01943825|11999899|FG003|NOT COMPLETED|Overall Study||11
11103108|NCT01240356|12287249|FG000|COMPLETED|Overall Study||15
11103109|NCT01240356|12287250|FG001|COMPLETED|Overall Study||20
11103110|NCT01240356|12287249|FG000|NOT COMPLETED|Overall Study||3
11103111|NCT01240356|12287250|FG001|NOT COMPLETED|Overall Study||0
11103112|NCT01240382|12287261|FG000|STARTED|Overall Study||144
11103113|NCT01240382|12287262|FG001|STARTED|Overall Study||143
11103114|NCT01240382|12287261|FG000|COMPLETED|Overall Study||142
11103115|NCT01240382|12287262|FG001|COMPLETED|Overall Study||139
11103116|NCT01240382|12287261|FG000|NOT COMPLETED|Overall Study||2
11103117|NCT01240382|12287262|FG001|NOT COMPLETED|Overall Study||4
11103118|NCT01240551|12287270|FG000|STARTED|Overall Study||30
11103119|NCT01240551|12287271|FG001|STARTED|Overall Study||30
10834770|NCT01863186|11999943|FG000|STARTED|Double-blind Phase|Original number of 230. One participant was randomly assigned into the study, but not dosed.|229
10834771|NCT01863186|11999944|FG001|STARTED|Double-blind Phase||222
10834772|NCT01863186|11999945|FG002|STARTED|Double-blind Phase||151
10834773|NCT01863186|11999946|FG003|STARTED|Double-blind Phase||0
10834774|NCT01863186|11999943|FG000|COMPLETED|Double-blind Phase||95
10834775|NCT01863186|11999944|FG001|COMPLETED|Double-blind Phase||88
10834776|NCT01863186|11999945|FG002|COMPLETED|Double-blind Phase||42
10834777|NCT01863186|11999946|FG003|COMPLETED|Double-blind Phase||0
10834778|NCT01863186|11999943|FG000|NOT COMPLETED|Double-blind Phase||134
10834779|NCT01863186|11999944|FG001|NOT COMPLETED|Double-blind Phase||134
10834780|NCT01863186|11999945|FG002|NOT COMPLETED|Double-blind Phase||109
10834781|NCT01863186|11999946|FG003|NOT COMPLETED|Double-blind Phase||0
10834782|NCT01863186|11999943|FG000|STARTED|Open-label Phase||0
10834783|NCT01863186|11999944|FG001|STARTED|Open-label Phase||0
10834784|NCT01863186|11999945|FG002|STARTED|Open-label Phase|No placebo group in the Open-label Phase.|0
11103120|NCT01240551|12287270|FG000|COMPLETED|Overall Study||26
11103121|NCT01240551|12287271|FG001|COMPLETED|Overall Study||27
11103122|NCT01240551|12287270|FG000|NOT COMPLETED|Overall Study||4
11103123|NCT01240551|12287271|FG001|NOT COMPLETED|Overall Study||3
11103124|NCT01240590|12287282|FG000|STARTED|Phase I||0
11103125|NCT01240590|12287283|FG001|STARTED|Phase I||6
11103126|NCT01240590|12287284|FG002|STARTED|Phase I||3
11103127|NCT01240590|12287285|FG003|STARTED|Phase I||0
11103128|NCT01240590|12287286|FG004|STARTED|Phase I||0
11103129|NCT01240590|12287282|FG000|COMPLETED|Phase I||0
11103130|NCT01240590|12287283|FG001|COMPLETED|Phase I||6
11103131|NCT01240590|12287284|FG002|COMPLETED|Phase I||0
11103132|NCT01240590|12287285|FG003|COMPLETED|Phase I||0
11103133|NCT01240590|12287286|FG004|COMPLETED|Phase I||0
11103134|NCT01240590|12287282|FG000|NOT COMPLETED|Phase I||0
11103135|NCT01240590|12287283|FG001|NOT COMPLETED|Phase I||0
11103136|NCT01240590|12287284|FG002|NOT COMPLETED|Phase I||3
11103137|NCT01240590|12287285|FG003|NOT COMPLETED|Phase I||0
11103138|NCT01240590|12287286|FG004|NOT COMPLETED|Phase I||0
11103139|NCT01240590|12287282|FG000|STARTED|Phase II||0
11103140|NCT01240590|12287283|FG001|STARTED|Phase II||0
11103141|NCT01240590|12287284|FG002|STARTED|Phase II||0
11103142|NCT01240590|12287285|FG003|STARTED|Phase II||17
11103143|NCT01240590|12287286|FG004|STARTED|Phase II||1
11103144|NCT01240590|12287282|FG000|COMPLETED|Phase II||0
11103145|NCT01240590|12287283|FG001|COMPLETED|Phase II||0
11103146|NCT01240590|12287284|FG002|COMPLETED|Phase II||0
11103147|NCT01240590|12287285|FG003|COMPLETED|Phase II||15
11103148|NCT01240590|12287286|FG004|COMPLETED|Phase II||0
11103149|NCT01240590|12287282|FG000|NOT COMPLETED|Phase II||0
11103150|NCT01240590|12287283|FG001|NOT COMPLETED|Phase II||0
11103151|NCT01240590|12287284|FG002|NOT COMPLETED|Phase II||0
11103152|NCT01240590|12287285|FG003|NOT COMPLETED|Phase II||2
11103153|NCT01240590|12287286|FG004|NOT COMPLETED|Phase II||1
11103154|NCT01240746|12287315|FG000|STARTED|Overall Study||736
11103155|NCT01240746|12287316|FG001|STARTED|Overall Study||725
11103156|NCT01240746|12287317|FG002|STARTED|Overall Study||2902
11103157|NCT01240746|12287315|FG000|COMPLETED|Overall Study||677
11103158|NCT01240746|12287316|FG001|COMPLETED|Overall Study||677
11103159|NCT01240746|12287317|FG002|COMPLETED|Overall Study||2659
11103160|NCT01240746|12287315|FG000|NOT COMPLETED|Overall Study||59
11103161|NCT01240746|12287316|FG001|NOT COMPLETED|Overall Study||48
11103162|NCT01240746|12287317|FG002|NOT COMPLETED|Overall Study||243
11103163|NCT01240785|12287327|FG000|STARTED|Overall Study||111
11103164|NCT01240785|12287328|FG001|STARTED|Overall Study||110
11103165|NCT01240785|12287327|FG000|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
11103166|NCT01240785|12287328|FG001|COMPLETED|Overall Study||107
11103167|NCT01240785|12287327|FG000|NOT COMPLETED|Overall Study||1
11103168|NCT01240785|12287328|FG001|NOT COMPLETED|Overall Study||3
10834785|NCT01863186|11999946|FG003|STARTED|Open-label Phase|36 from 2.4 mg group, 28 from 3.2mg group, and 19 from Placebo continued to the Open-label phase.|83
10834786|NCT01863186|11999943|FG000|COMPLETED|Open-label Phase||0
10834787|NCT01863186|11999944|FG001|COMPLETED|Open-label Phase||0
10834788|NCT01863186|11999945|FG002|COMPLETED|Open-label Phase||0
10834789|NCT01863186|11999946|FG003|COMPLETED|Open-label Phase||70
11103169|NCT01240811|12287337|FG000|STARTED|Overall Study||8
11103170|NCT01240811|12287338|FG001|STARTED|Overall Study||17
11103171|NCT01240811|12287339|FG002|STARTED|Overall Study||17
11103172|NCT01240811|12287337|FG000|COMPLETED|Overall Study||8
11103173|NCT01240811|12287338|FG001|COMPLETED|Overall Study||16
11103174|NCT01240811|12287339|FG002|COMPLETED|Overall Study||16
11103175|NCT01240811|12287337|FG000|NOT COMPLETED|Overall Study||0
11103176|NCT01240811|12287338|FG001|NOT COMPLETED|Overall Study||1
11103177|NCT01240811|12287339|FG002|NOT COMPLETED|Overall Study||1
10834790|NCT01863186|11999943|FG000|NOT COMPLETED|Open-label Phase||0
10834791|NCT01863186|11999944|FG001|NOT COMPLETED|Open-label Phase||0
10834792|NCT01863186|11999945|FG002|NOT COMPLETED|Open-label Phase||0
10834793|NCT01863186|11999946|FG003|NOT COMPLETED|Open-label Phase||13
10834794|NCT01853748|11999957|FG000|STARTED|Allocation||384
10834795|NCT01853748|11999958|FG001|STARTED|Allocation||128
10834796|NCT01853748|11999957|FG000|COMPLETED|Allocation||383
10834797|NCT01853748|11999958|FG001|COMPLETED|Allocation||114
10834798|NCT01853748|11999957|FG000|NOT COMPLETED|Allocation||1
10834799|NCT01853748|11999958|FG001|NOT COMPLETED|Allocation||14
10834800|NCT01853748|11999957|FG000|STARTED|Follow-Up||383
10834801|NCT01853748|11999958|FG001|STARTED|Follow-Up||114
10834802|NCT01853748|11999957|FG000|COMPLETED|Follow-Up||293
10834803|NCT01853748|11999958|FG001|COMPLETED|Follow-Up||97
10834804|NCT01853748|11999957|FG000|NOT COMPLETED|Follow-Up||90
10834805|NCT01853748|11999958|FG001|NOT COMPLETED|Follow-Up||17
10834806|NCT01817751|11999973|FG000|STARTED|Overall Study||47
10834807|NCT01817751|11999973|FG000|COMPLETED|Overall Study||46
10834808|NCT01817751|11999973|FG000|NOT COMPLETED|Overall Study||1
10834809|NCT01722331|11999980|FG000|STARTED|Part 1||308
10834810|NCT01722331|11999981|FG001|STARTED|Part 1||249
10834811|NCT01722331|11999982|FG002|STARTED|Part 1||41
10834812|NCT01722331|11999983|FG003|STARTED|Part 1||19
10834813|NCT01722331|11999984|FG004|STARTED|Part 1||9
10834814|NCT01722331|11999985|FG005|STARTED|Part 1||72
10834815|NCT01722331|11999986|FG006|STARTED|Part 1||74
10834816|NCT01722331|11999980|FG000|COMPLETED|Part 1||298
10834817|NCT01722331|11999981|FG001|COMPLETED|Part 1||249
10834818|NCT01722331|11999982|FG002|COMPLETED|Part 1||32
10834819|NCT01722331|11999983|FG003|COMPLETED|Part 1||19
10834820|NCT01722331|11999984|FG004|COMPLETED|Part 1||0
10834821|NCT01722331|11999985|FG005|COMPLETED|Part 1||72
10834822|NCT01722331|11999986|FG006|COMPLETED|Part 1||74
10834823|NCT01722331|11999980|FG000|NOT COMPLETED|Part 1||10
10834824|NCT01722331|11999981|FG001|NOT COMPLETED|Part 1||0
10834825|NCT01722331|11999982|FG002|NOT COMPLETED|Part 1||9
10834826|NCT01722331|11999983|FG003|NOT COMPLETED|Part 1||0
10834827|NCT01722331|11999984|FG004|NOT COMPLETED|Part 1||9
10834828|NCT01722331|11999985|FG005|NOT COMPLETED|Part 1||0
11103178|NCT01240863|12287351|FG000|STARTED|Open-label Titration Period||391
10834829|NCT01722331|11999986|FG006|NOT COMPLETED|Part 1||0
10834830|NCT01722331|11999980|FG000|STARTED|Part 2||298
10834831|NCT01722331|11999981|FG001|STARTED|Part 2||249
10834832|NCT01722331|11999982|FG002|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
10834833|NCT01722331|11999983|FG003|STARTED|Part 2||19
10834834|NCT01722331|11999984|FG004|STARTED|Part 2||0
10834835|NCT01722331|11999985|FG005|STARTED|Part 2||72
10834836|NCT01722331|11999986|FG006|STARTED|Part 2||74
10834837|NCT01722331|11999980|FG000|COMPLETED|Part 2||279
10834838|NCT01722331|11999981|FG001|COMPLETED|Part 2||249
10834839|NCT01722331|11999982|FG002|COMPLETED|Part 2||0
10834840|NCT01722331|11999983|FG003|COMPLETED|Part 2||19
10834841|NCT01722331|11999984|FG004|COMPLETED|Part 2||0
10834842|NCT01722331|11999985|FG005|COMPLETED|Part 2||62
10834843|NCT01722331|11999986|FG006|COMPLETED|Part 2||67
10834844|NCT01722331|11999980|FG000|NOT COMPLETED|Part 2||19
10834845|NCT01722331|11999981|FG001|NOT COMPLETED|Part 2||0
10834846|NCT01722331|11999982|FG002|NOT COMPLETED|Part 2||31
10834847|NCT01722331|11999983|FG003|NOT COMPLETED|Part 2||0
10834848|NCT01722331|11999984|FG004|NOT COMPLETED|Part 2||0
10834849|NCT01722331|11999985|FG005|NOT COMPLETED|Part 2||10
10834850|NCT01722331|11999986|FG006|NOT COMPLETED|Part 2||7
10834851|NCT01722331|11999980|FG000|STARTED|Part 3||279
10834852|NCT01722331|11999981|FG001|STARTED|Part 3||249
10834853|NCT01722331|11999982|FG002|STARTED|Part 3||0
10834854|NCT01722331|11999983|FG003|STARTED|Part 3||19
10834855|NCT01722331|11999984|FG004|STARTED|Part 3||0
10834856|NCT01722331|11999985|FG005|STARTED|Part 3||62
10834857|NCT01722331|11999986|FG006|STARTED|Part 3||67
10834858|NCT01722331|11999980|FG000|COMPLETED|Part 3||264
10834859|NCT01722331|11999981|FG001|COMPLETED|Part 3||232
10834860|NCT01722331|11999982|FG002|COMPLETED|Part 3||0
10834861|NCT01722331|11999983|FG003|COMPLETED|Part 3||18
10834862|NCT01722331|11999984|FG004|COMPLETED|Part 3||0
10834863|NCT01722331|11999985|FG005|COMPLETED|Part 3||59
10834864|NCT01722331|11999986|FG006|COMPLETED|Part 3||65
10834865|NCT01722331|11999980|FG000|NOT COMPLETED|Part 3||15
10834866|NCT01722331|11999981|FG001|NOT COMPLETED|Part 3||17
10834867|NCT01722331|11999982|FG002|NOT COMPLETED|Part 3||0
10834868|NCT01722331|11999983|FG003|NOT COMPLETED|Part 3||1
10834869|NCT01722331|11999984|FG004|NOT COMPLETED|Part 3||0
10834870|NCT01722331|11999985|FG005|NOT COMPLETED|Part 3||3
10834871|NCT01722331|11999986|FG006|NOT COMPLETED|Part 3||2
10834872|NCT01716117|12000000|FG000|STARTED|Overall Study||180
10834873|NCT01716117|12000001|FG001|STARTED|Overall Study||33
10834874|NCT01716117|12000000|FG000|Discharge|Overall Study||177
10834875|NCT01716117|12000001|FG001|Discharge|Overall Study||33
10834876|NCT01716117|12000000|FG000|1-Month Visit|Overall Study||176
10834877|NCT01716117|12000001|FG001|1-Month Visit|Overall Study||33
10834878|NCT01716117|12000000|FG000|6-Month Visit|Overall Study||174
10834879|NCT01716117|12000001|FG001|6-Month Visit|Overall Study||32
10834880|NCT01716117|12000000|FG000|COMPLETED|Overall Study||173
10834881|NCT01716117|12000001|FG001|COMPLETED|Overall Study||31
10834882|NCT01716117|12000000|FG000|NOT COMPLETED|Overall Study||7
10834883|NCT01716117|12000001|FG001|NOT COMPLETED|Overall Study||2
10834884|NCT01698905|12000015|FG000|STARTED|Overall Study||163
10834885|NCT01698905|12000015|FG000|Still on Study Phase|Overall Study||0
10834886|NCT01698905|12000015|FG000|TFR Phase|Overall Study||126
10834887|NCT01698905|12000015|FG000|NTRI Phase|Overall Study||51
10834888|NCT01698905|12000015|FG000|NTCT Phase|Overall Study||26
10834889|NCT01698905|12000015|FG000|TFR-2 Phase|Overall Study||2
10834890|NCT01698905|12000015|FG000|NTRI-2 Phase|Overall Study||1
10834891|NCT01698905|12000015|FG000|NTCT-P Phase Phase|Overall Study||6
10834892|NCT01698905|12000015|FG000|COMPLETED|Overall Study||152
10834893|NCT01698905|12000015|FG000|NOT COMPLETED|Overall Study||11
10834894|NCT01676350|12000028|FG000|STARTED|Overall Study||11
10834895|NCT01676350|12000029|FG001|STARTED|Overall Study||11
10834896|NCT01676350|12000028|FG000|COMPLETED|Overall Study||11
10834897|NCT01676350|12000029|FG001|COMPLETED|Overall Study||11
10834898|NCT01676350|12000028|FG000|NOT COMPLETED|Overall Study||0
10834899|NCT01676350|12000029|FG001|NOT COMPLETED|Overall Study||0
10834900|NCT01630590|12000036|FG000|STARTED|Overall Study||62
10834901|NCT01630590|12000036|FG000|COMPLETED|Overall Study||5
10834902|NCT01630590|12000036|FG000|NOT COMPLETED|Overall Study||57
10834903|NCT01619085|12000040|FG000|STARTED|Overall Study||752
10834904|NCT01619085|12000040|FG000|Treated|Overall Study||751
10834905|NCT01619085|12000040|FG000|COMPLETED|Overall Study||227
10834906|NCT01619085|12000040|FG000|NOT COMPLETED|Overall Study||525
10834907|NCT01499095|12000053|FG000|STARTED|Overall Study||404
10834908|NCT01499095|12000054|FG001|STARTED|Overall Study||407
10834909|NCT01499095|12000053|FG000|Treated|Overall Study||403
10834910|NCT01499095|12000054|FG001|Treated|Overall Study||406
10834911|NCT01499095|12000053|FG000|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
10834912|NCT01499095|12000054|FG001|Participated in Substudy|Overall Study||0
10834913|NCT01499095|12000053|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
10834914|NCT01499095|12000054|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
10834915|NCT01499095|12000053|FG000|COMPLETED|Overall Study||315
10834916|NCT01499095|12000054|FG001|COMPLETED|Overall Study||314
10834917|NCT01499095|12000053|FG000|NOT COMPLETED|Overall Study||89
10834918|NCT01499095|12000054|FG001|NOT COMPLETED|Overall Study||93
10834919|NCT01499082|12000065|FG000|STARTED|Overall Study||404
10834920|NCT01499082|12000066|FG001|STARTED|Overall Study||403
10834921|NCT01499082|12000065|FG000|Treated|Overall Study||404
10834922|NCT01499082|12000066|FG001|Treated|Overall Study||402
10834923|NCT01499082|12000065|FG000|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
10834924|NCT01499082|12000066|FG001|Participated in Substudy|Overall Study||0
10834925|NCT01499082|12000065|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
10834926|NCT01499082|12000066|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
10834927|NCT01499082|12000065|FG000|COMPLETED|Overall Study||359
10834928|NCT01499082|12000066|FG001|COMPLETED|Overall Study||355
10834929|NCT01499082|12000065|FG000|NOT COMPLETED|Overall Study||45
10834930|NCT01499082|12000066|FG001|NOT COMPLETED|Overall Study||48
11103179|NCT01240863|12287352|FG001|STARTED|Open-label Titration Period||0
11103180|NCT01240863|12287353|FG002|STARTED|Open-label Titration Period||0
11103181|NCT01240863|12287351|FG000|Safety Analysis Set|Open-label Titration Period||389
10834934|NCT01488890|12000082|FG000|STARTED|Overall Study||120
10834935|NCT01488890|12000083|FG001|STARTED|Overall Study||120
10834936|NCT01488890|12000084|FG002|STARTED|Overall Study||120
10834937|NCT01488890|12000085|FG003|STARTED|Overall Study||30
10834938|NCT01488890|12000082|FG000|Treated|Overall Study||120
10834939|NCT01488890|12000083|FG001|Treated|Overall Study||120
10834940|NCT01488890|12000084|FG002|Treated|Overall Study||119
10834941|NCT01488890|12000085|FG003|Treated|Overall Study||30
10834942|NCT01488890|12000082|FG000|COMPLETED|Overall Study||88
10834943|NCT01488890|12000083|FG001|COMPLETED|Overall Study||100
10834944|NCT01488890|12000084|FG002|COMPLETED|Overall Study||85
10834945|NCT01488890|12000085|FG003|COMPLETED|Overall Study||25
10834946|NCT01488890|12000082|FG000|NOT COMPLETED|Overall Study||32
10834947|NCT01488890|12000083|FG001|NOT COMPLETED|Overall Study||20
10834948|NCT01488890|12000084|FG002|NOT COMPLETED|Overall Study||35
10834949|NCT01488890|12000085|FG003|NOT COMPLETED|Overall Study||5
10834950|NCT01436396|12000101|FG000|STARTED|Overall Study||396
10834951|NCT01436396|12000102|FG001|STARTED|Overall Study||396
10834952|NCT01436396|12000101|FG000|Vaccinated|Overall Study||394
10834953|NCT01436396|12000102|FG001|Vaccinated|Overall Study||393
10834954|NCT01436396|12000101|FG000|COMPLETED|Overall Study||364
10834955|NCT01436396|12000102|FG001|COMPLETED|Overall Study||354
10834956|NCT01436396|12000101|FG000|NOT COMPLETED|Overall Study||32
10834957|NCT01436396|12000102|FG001|NOT COMPLETED|Overall Study||42
10834958|NCT01411241|12000110|FG000|STARTED|Overall Study||309
10834959|NCT01411241|12000111|FG001|STARTED|Overall Study||315
10834960|NCT01411241|12000110|FG000|COMPLETED|Overall Study||298
10834961|NCT01411241|12000111|FG001|COMPLETED|Overall Study||293
10834962|NCT01411241|12000110|FG000|NOT COMPLETED|Overall Study||11
10834963|NCT01411241|12000111|FG001|NOT COMPLETED|Overall Study||22
11103182|NCT01240863|12287352|FG001|Safety Analysis Set|Open-label Titration Period||0
10834964|NCT01374516|12000119|FG000|STARTED|Vaccination Phase (Up to 25 Months)||13920
10834965|NCT01374516|12000120|FG001|STARTED|Vaccination Phase (Up to 25 Months)||6949
10834966|NCT01374516|12000119|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||13281
10834967|NCT01374516|12000120|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||6640
10834968|NCT01374516|12000119|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639
10834969|NCT01374516|12000120|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309
10834970|NCT01374516|12000119|FG000|STARTED|Surveillance Expansion Period||13281
10834971|NCT01374516|12000120|FG001|STARTED|Surveillance Expansion Period||6640
10834972|NCT01374516|12000119|FG000|COMPLETED|Surveillance Expansion Period||10932
10834973|NCT01374516|12000120|FG001|COMPLETED|Surveillance Expansion Period||5387
10834974|NCT01374516|12000119|FG000|NOT COMPLETED|Surveillance Expansion Period||2349
10834975|NCT01374516|12000120|FG001|NOT COMPLETED|Surveillance Expansion Period||1253
10834976|NCT01373281|12000135|FG000|STARTED|Vaccination Phase (Up to 25 Months)||6851
10834977|NCT01373281|12000136|FG001|STARTED|Vaccination Phase (Up to 25 Months)||3424
10834978|NCT01373281|12000135|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
10834979|NCT01373281|12000136|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
10834980|NCT01373281|12000135|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
10834981|NCT01373281|12000136|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
10834982|NCT01373281|12000135|FG000|STARTED|Surveillance Expansion Period||6797
10834983|NCT01373281|12000136|FG001|STARTED|Surveillance Expansion Period||3397
10834984|NCT01373281|12000135|FG000|COMPLETED|Surveillance Expansion Period||6595
10834985|NCT01373281|12000136|FG001|COMPLETED|Surveillance Expansion Period||3279
10834986|NCT01373281|12000135|FG000|NOT COMPLETED|Surveillance Expansion Period||202
10834987|NCT01373281|12000136|FG001|NOT COMPLETED|Surveillance Expansion Period||118
10834988|NCT01302847|12000157|FG000|STARTED|Overall Study||23
10834989|NCT01302847|12000158|FG001|STARTED|Overall Study||23
10834990|NCT01302847|12000159|FG002|STARTED|Overall Study||17
10834991|NCT01302847|12000160|FG003|STARTED|Overall Study||15
10834992|NCT01302847|12000161|FG004|STARTED|Overall Study||7
10834993|NCT01302847|12000162|FG005|STARTED|Overall Study||36
10834994|NCT01302847|12000163|FG006|STARTED|Overall Study||35
10834995|NCT01302847|12000164|FG007|STARTED|Overall Study||25
10834996|NCT01302847|12000157|FG000|COMPLETED|Overall Study||10
10834997|NCT01302847|12000158|FG001|COMPLETED|Overall Study||16
11103183|NCT01240863|12287353|FG002|Safety Analysis Set|Open-label Titration Period||0
11103184|NCT01240863|12287351|FG000|COMPLETED|Open-label Titration Period||294
11103185|NCT01240863|12287352|FG001|COMPLETED|Open-label Titration Period||0
11103186|NCT01240863|12287353|FG002|COMPLETED|Open-label Titration Period||0
11103187|NCT01240863|12287351|FG000|NOT COMPLETED|Open-label Titration Period||97
11103188|NCT01240863|12287352|FG001|NOT COMPLETED|Open-label Titration Period||0
11103189|NCT01240863|12287353|FG002|NOT COMPLETED|Open-label Titration Period||0
11103190|NCT01240863|12287351|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0
11103191|NCT01240863|12287352|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||148
11103192|NCT01240863|12287353|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||146
11103193|NCT01240863|12287351|FG000|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
11103194|NCT01240863|12287352|FG001|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
11103195|NCT01240863|12287353|FG002|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
11103196|NCT01240863|12287351|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
11103197|NCT01240863|12287352|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
11103198|NCT01240863|12287353|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
11103199|NCT01240863|12287351|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
11103200|NCT01240863|12287352|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
11103201|NCT01240863|12287353|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
11103202|NCT01240915|12287373|FG000|STARTED|Overall Study||2
11103203|NCT01240915|12287374|FG001|STARTED|Overall Study||3
11103204|NCT01240915|12287375|FG002|STARTED|Overall Study||2
11103205|NCT01240915|12287376|FG003|STARTED|Overall Study||4
11103206|NCT01240915|12287377|FG004|STARTED|Overall Study||6
11103207|NCT01240915|12287378|FG005|STARTED|Overall Study||23
11103208|NCT01240915|12287379|FG006|STARTED|Overall Study||25
11103209|NCT01240915|12287380|FG007|STARTED|Overall Study||19
11103210|NCT01240915|12287381|FG008|STARTED|Overall Study||21
11103211|NCT01240915|12287373|FG000|COMPLETED|Overall Study||0
11103212|NCT01240915|12287374|FG001|COMPLETED|Overall Study||2
11103213|NCT01240915|12287375|FG002|COMPLETED|Overall Study||2
11103214|NCT01240915|12287376|FG003|COMPLETED|Overall Study||1
11103215|NCT01240915|12287377|FG004|COMPLETED|Overall Study||2
11103216|NCT01240915|12287378|FG005|COMPLETED|Overall Study||13
11103217|NCT01240915|12287379|FG006|COMPLETED|Overall Study||17
11220316|NCT01959581|12411937|FG000|NOT COMPLETED|Overall Study||5
11220317|NCT01959607|12411943|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
11220318|NCT01959607|12411944|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
11220319|NCT01959607|12411945|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
11220320|NCT01959607|12411946|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
11220321|NCT01959607|12411943|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
11220322|NCT01959607|12411944|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
11220323|NCT01959607|12411945|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
11220324|NCT01959607|12411946|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
10834998|NCT01302847|12000159|FG002|COMPLETED|Overall Study||15
10834999|NCT01302847|12000160|FG003|COMPLETED|Overall Study||14
11103218|NCT01240915|12287380|FG007|COMPLETED|Overall Study||15
11220325|NCT01959607|12411943|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
11220326|NCT01959607|12411944|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10835000|NCT01302847|12000161|FG004|COMPLETED|Overall Study||5
11103219|NCT01240915|12287381|FG008|COMPLETED|Overall Study||13
11220327|NCT01959607|12411945|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10835001|NCT01302847|12000162|FG005|COMPLETED|Overall Study||6
10835002|NCT01302847|12000163|FG006|COMPLETED|Overall Study||9
10835003|NCT01302847|12000164|FG007|COMPLETED|Overall Study||3
10835004|NCT01302847|12000157|FG000|NOT COMPLETED|Overall Study||13
10835005|NCT01302847|12000158|FG001|NOT COMPLETED|Overall Study||7
10835006|NCT01302847|12000159|FG002|NOT COMPLETED|Overall Study||2
10835007|NCT01302847|12000160|FG003|NOT COMPLETED|Overall Study||1
10835008|NCT01302847|12000161|FG004|NOT COMPLETED|Overall Study||2
10835009|NCT01302847|12000162|FG005|NOT COMPLETED|Overall Study||30
10835010|NCT01302847|12000163|FG006|NOT COMPLETED|Overall Study||26
10835011|NCT01302847|12000164|FG007|NOT COMPLETED|Overall Study||22
10835012|NCT01287611|12000193|FG000|STARTED|Overall Study||84
10835013|NCT01287611|12000194|FG001|STARTED|Overall Study||84
10835014|NCT01287611|12000193|FG000|The Number of Patients Who Underwent C/S|Overall Study||84
10835015|NCT01287611|12000194|FG001|The Number of Patients Who Underwent C/S|Overall Study||84
10835016|NCT01287611|12000193|FG000|COMPLETED|Overall Study||51
10835017|NCT01287611|12000194|FG001|COMPLETED|Overall Study||65
10835018|NCT01287611|12000193|FG000|NOT COMPLETED|Overall Study||33
10835019|NCT01287611|12000194|FG001|NOT COMPLETED|Overall Study||19
10835020|NCT01254422|12000204|FG000|STARTED|Overall Study||199
10835021|NCT01254422|12000205|FG001|STARTED|Overall Study||51
10835022|NCT01254422|12000204|FG000|COMPLETED|Overall Study||196
10835023|NCT01254422|12000205|FG001|COMPLETED|Overall Study||50
10835024|NCT01254422|12000204|FG000|NOT COMPLETED|Overall Study||3
10835025|NCT01254422|12000205|FG001|NOT COMPLETED|Overall Study||1
10835026|NCT01187433|12000213|FG000|STARTED|Overall Study||100
10835027|NCT01187433|12000214|FG001|STARTED|Overall Study||50
10835028|NCT01187433|12000213|FG000|COMPLETED|Overall Study||89
10835029|NCT01187433|12000214|FG001|COMPLETED|Overall Study||46
10835030|NCT01187433|12000213|FG000|NOT COMPLETED|Overall Study||11
10835031|NCT01187433|12000214|FG001|NOT COMPLETED|Overall Study||4
10835032|NCT01150045|12000224|FG000|STARTED|Overall Study||615
10835033|NCT01150045|12000225|FG001|STARTED|Overall Study||647
10835034|NCT01150045|12000226|FG002|STARTED|Overall Study||646
10835035|NCT01150045|12000227|FG003|STARTED|Overall Study||618
10835036|NCT01150045|12000224|FG000|COMPLETED|Overall Study||615
10835037|NCT01150045|12000225|FG001|COMPLETED|Overall Study||646
10835038|NCT01150045|12000226|FG002|COMPLETED|Overall Study||646
10835039|NCT01150045|12000227|FG003|COMPLETED|Overall Study||617
10835040|NCT01150045|12000224|FG000|NOT COMPLETED|Overall Study||0
10835041|NCT01150045|12000225|FG001|NOT COMPLETED|Overall Study||1
11103220|NCT01240915|12287373|FG000|NOT COMPLETED|Overall Study||2
11103221|NCT01240915|12287374|FG001|NOT COMPLETED|Overall Study||1
11103222|NCT01240915|12287375|FG002|NOT COMPLETED|Overall Study||0
11103223|NCT01240915|12287376|FG003|NOT COMPLETED|Overall Study||3
11103224|NCT01240915|12287377|FG004|NOT COMPLETED|Overall Study||4
11103225|NCT01240915|12287378|FG005|NOT COMPLETED|Overall Study||10
11103226|NCT01240915|12287379|FG006|NOT COMPLETED|Overall Study||8
11103227|NCT01240915|12287380|FG007|NOT COMPLETED|Overall Study||4
11103228|NCT01240915|12287381|FG008|NOT COMPLETED|Overall Study||8
11103229|NCT01241240|12287405|FG000|STARTED|Overall Study||94
11103230|NCT01241240|12287406|FG001|STARTED|Overall Study||98
11103231|NCT01241240|12287405|FG000|COMPLETED|Overall Study||86
11103232|NCT01241240|12287406|FG001|COMPLETED|Overall Study||89
11103233|NCT01241240|12287405|FG000|NOT COMPLETED|Overall Study||8
11103234|NCT01241240|12287406|FG001|NOT COMPLETED|Overall Study||9
11103235|NCT01241292|12287414|FG000|STARTED|Overall Study||3
11103236|NCT01241292|12287415|FG001|STARTED|Overall Study||3
11103237|NCT01241292|12287414|FG000|Entered Treatment Period|Overall Study||3
11103238|NCT01241292|12287415|FG001|Entered Treatment Period|Overall Study||3
11103239|NCT01241292|12287414|FG000|COMPLETED|Overall Study|completed=treatment on-going|0
11103240|NCT01241292|12287415|FG001|COMPLETED|Overall Study|completed=treatment on-going|0
11103241|NCT01241292|12287414|FG000|NOT COMPLETED|Overall Study||3
11103242|NCT01241292|12287415|FG001|NOT COMPLETED|Overall Study||3
11103243|NCT01241318|12287427|FG000|STARTED|Overall Study|Women enrolled|19629
11103244|NCT01241318|12287428|FG001|STARTED|Overall Study|Women enrolled|20050
11103245|NCT01241318|12287427|FG000|Liveborn Infant|Overall Study|Infants|18510
11103246|NCT01241318|12287428|FG001|Liveborn Infant|Overall Study|Infants|19346
11103247|NCT01241318|12287427|FG000|COMPLETED|Overall Study|Infants|18450
11103248|NCT01241318|12287428|FG001|COMPLETED|Overall Study|Infants|19308
11103249|NCT01241318|12287427|FG000|NOT COMPLETED|Overall Study||1179
11103250|NCT01241318|12287428|FG001|NOT COMPLETED|Overall Study||742
11103251|NCT01241344|12287441|FG000|STARTED|Overall Study||14
11103252|NCT01241344|12287442|FG001|STARTED|Overall Study||16
11103253|NCT01241344|12287443|FG002|STARTED|Overall Study||18
11103254|NCT01241344|12287444|FG003|STARTED|Overall Study||4
11103255|NCT01241344|12287441|FG000|Randomized to Open-label|Overall Study||3
11103256|NCT01241344|12287442|FG001|Randomized to Open-label|Overall Study||4
11103257|NCT01241344|12287443|FG002|Randomized to Open-label|Overall Study||5
11103258|NCT01241344|12287444|FG003|Randomized to Open-label|Overall Study||0
11103259|NCT01241344|12287441|FG000|COMPLETED|Overall Study||9
11103260|NCT01241344|12287442|FG001|COMPLETED|Overall Study||7
11103261|NCT01241344|12287443|FG002|COMPLETED|Overall Study||9
11103262|NCT01241344|12287444|FG003|COMPLETED|Overall Study||2
11220328|NCT01959607|12411946|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10835042|NCT01150045|12000226|FG002|NOT COMPLETED|Overall Study||0
10835043|NCT01150045|12000227|FG003|NOT COMPLETED|Overall Study||1
10835044|NCT01098032|12000237|FG000|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
10835045|NCT01098032|12000238|FG001|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
10835046|NCT01098032|12000237|FG000|COMPLETED|Overall Study||146
10835047|NCT01098032|12000238|FG001|COMPLETED|Overall Study||146
10835048|NCT01098032|12000237|FG000|NOT COMPLETED|Overall Study||1
10835049|NCT01098032|12000238|FG001|NOT COMPLETED|Overall Study||1
10835050|NCT01034306|12000246|FG000|STARTED|Overall Study||42
10835051|NCT01034306|12000247|FG001|STARTED|Overall Study||37
10835052|NCT01034306|12000246|FG000|COMPLETED|Overall Study||37
10835053|NCT01034306|12000247|FG001|COMPLETED|Overall Study||34
10835054|NCT01034306|12000246|FG000|NOT COMPLETED|Overall Study||5
10835055|NCT01034306|12000247|FG001|NOT COMPLETED|Overall Study||3
11103263|NCT01241344|12287441|FG000|NOT COMPLETED|Overall Study||5
10835059|NCT00993447|12000259|FG000|STARTED|Overall Study||401
10835060|NCT00993447|12000260|FG001|STARTED|Overall Study||199
10835061|NCT00993447|12000259|FG000|COMPLETED|Overall Study||364
10835062|NCT00993447|12000260|FG001|COMPLETED|Overall Study||180
10835063|NCT00993447|12000259|FG000|NOT COMPLETED|Overall Study||37
10835064|NCT00993447|12000260|FG001|NOT COMPLETED|Overall Study||19
10835065|NCT00945009|12000269|FG000|STARTED|Overall Study||201
10835066|NCT00945009|12000270|FG001|STARTED|Overall Study||39
10835067|NCT00945009|12000271|FG002|STARTED|Overall Study||9
10835068|NCT00945009|12000269|FG000|COMPLETED|Overall Study||156
10835069|NCT00945009|12000270|FG001|COMPLETED|Overall Study||32
10835070|NCT00945009|12000271|FG002|COMPLETED|Overall Study||6
10835071|NCT00945009|12000269|FG000|NOT COMPLETED|Overall Study||45
10835072|NCT00945009|12000270|FG001|NOT COMPLETED|Overall Study||7
10835073|NCT00945009|12000271|FG002|NOT COMPLETED|Overall Study||3
10835074|NCT00942877|12000281|FG000|STARTED|Overall Study||46
10835075|NCT00942877|12000282|FG001|STARTED|Overall Study||7
10835076|NCT00942877|12000281|FG000|COMPLETED|Overall Study||1
10835077|NCT00942877|12000282|FG001|COMPLETED|Overall Study||3
10835078|NCT00942877|12000281|FG000|NOT COMPLETED|Overall Study||45
10835079|NCT00942877|12000282|FG001|NOT COMPLETED|Overall Study||4
10835080|NCT00896389|12000289|FG000|STARTED|Salt Loading||124
10835081|NCT00896389|12000289|FG000|COMPLETED|Salt Loading||124
10835082|NCT00896389|12000289|FG000|NOT COMPLETED|Salt Loading||0
10835083|NCT00896389|12000289|FG000|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
10835084|NCT00896389|12000289|FG000|COMPLETED|HCTZ Low Dose||28
10835085|NCT00896389|12000289|FG000|NOT COMPLETED|HCTZ Low Dose||0
10835086|NCT00896389|12000289|FG000|STARTED|HCTZ High Dose||25
10835087|NCT00896389|12000289|FG000|COMPLETED|HCTZ High Dose||25
10835088|NCT00896389|12000289|FG000|NOT COMPLETED|HCTZ High Dose||0
10835089|NCT00880893|12000297|FG000|STARTED|Overall Study||898
10835090|NCT00880893|12000298|FG001|STARTED|Overall Study||300
10835091|NCT00880893|12000297|FG000|COMPLETED|Overall Study||791
10835092|NCT00880893|12000298|FG001|COMPLETED|Overall Study||255
10835093|NCT00880893|12000297|FG000|NOT COMPLETED|Overall Study||107
10835094|NCT00880893|12000298|FG001|NOT COMPLETED|Overall Study||45
10835095|NCT00866918|12000306|FG000|STARTED|Overall Study||69
10835096|NCT00866918|12000307|FG001|STARTED|Overall Study||39
10835097|NCT00866918|12000306|FG000|COMPLETED|Overall Study||53
10835098|NCT00866918|12000307|FG001|COMPLETED|Overall Study||27
10835099|NCT00866918|12000306|FG000|NOT COMPLETED|Overall Study||16
10835100|NCT00866918|12000307|FG001|NOT COMPLETED|Overall Study||12
10835101|NCT00587301|12000313|FG000|STARTED|Overall Study||119
10835102|NCT00587301|12000313|FG000|COMPLETED|Overall Study||74
10835103|NCT00587301|12000313|FG000|NOT COMPLETED|Overall Study||45
10835104|NCT00579527|12000317|FG000|STARTED|Overall Study||14
10835105|NCT00579527|12000317|FG000|COMPLETED|Overall Study||10
10835106|NCT00579527|12000317|FG000|NOT COMPLETED|Overall Study||4
10835107|NCT00576836|12000322|FG000|STARTED|Overall Study||0
10835108|NCT00576836|12000323|FG001|STARTED|Overall Study||7
10835109|NCT00576836|12000322|FG000|COMPLETED|Overall Study||0
10835110|NCT00576836|12000323|FG001|COMPLETED|Overall Study||5
10835111|NCT00576836|12000322|FG000|NOT COMPLETED|Overall Study||0
10835112|NCT00576836|12000323|FG001|NOT COMPLETED|Overall Study||2
10835113|NCT00576407|12000327|FG000|STARTED|Overall Study||26
10835114|NCT00576407|12000327|FG000|COMPLETED|Overall Study||18
10835115|NCT00576407|12000327|FG000|NOT COMPLETED|Overall Study||8
11103264|NCT01241344|12287442|FG001|NOT COMPLETED|Overall Study||9
11103265|NCT01241344|12287443|FG002|NOT COMPLETED|Overall Study||9
11103266|NCT01241344|12287444|FG003|NOT COMPLETED|Overall Study||2
11103267|NCT01241435|12287457|FG000|STARTED|Overall Study||12
11103268|NCT01241435|12287458|FG001|STARTED|Overall Study||8
11103269|NCT01241435|12287459|FG002|STARTED|Overall Study||8
11103270|NCT01241435|12287460|FG003|STARTED|Overall Study||8
11103271|NCT01241435|12287457|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
11103272|NCT01241435|12287458|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
11103273|NCT01241435|12287459|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
11103274|NCT01241435|12287460|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8
11103275|NCT01241435|12287457|FG000|COMPLETED|Overall Study||12
11103276|NCT01241435|12287458|FG001|COMPLETED|Overall Study||8
11103277|NCT01241435|12287459|FG002|COMPLETED|Overall Study||8
11103278|NCT01241435|12287460|FG003|COMPLETED|Overall Study||8
11103279|NCT01241435|12287457|FG000|NOT COMPLETED|Overall Study||0
11103280|NCT01241435|12287458|FG001|NOT COMPLETED|Overall Study||0
11103281|NCT01241435|12287459|FG002|NOT COMPLETED|Overall Study||0
11103282|NCT01241435|12287460|FG003|NOT COMPLETED|Overall Study||0
11103283|NCT01241448|12287474|FG000|STARTED|Overall Study||66
11103284|NCT01241448|12287475|FG001|STARTED|Overall Study||65
11103285|NCT01241448|12287476|FG002|STARTED|Overall Study||66
11103286|NCT01241448|12287477|FG003|STARTED|Overall Study||66
11103287|NCT01241448|12287474|FG000|Intent-to-Treat Population (ITT)|Overall Study||63
11103288|NCT01241448|12287475|FG001|Intent-to-Treat Population (ITT)|Overall Study||63
11103289|NCT01241448|12287476|FG002|Intent-to-Treat Population (ITT)|Overall Study||64
11103290|NCT01241448|12287477|FG003|Intent-to-Treat Population (ITT)|Overall Study||64
11103291|NCT01241448|12287474|FG000|ITT With ≥1 Post-Baseline Measure|Overall Study||61
11103292|NCT01241448|12287475|FG001|ITT With ≥1 Post-Baseline Measure|Overall Study||61
11103293|NCT01241448|12287476|FG002|ITT With ≥1 Post-Baseline Measure|Overall Study||64
11103294|NCT01241448|12287477|FG003|ITT With ≥1 Post-Baseline Measure|Overall Study||62
11103295|NCT01241448|12287474|FG000|COMPLETED|Overall Study||29
11103296|NCT01241448|12287475|FG001|COMPLETED|Overall Study||36
11103297|NCT01241448|12287476|FG002|COMPLETED|Overall Study||43
11103298|NCT01241448|12287477|FG003|COMPLETED|Overall Study||43
11103299|NCT01241448|12287474|FG000|NOT COMPLETED|Overall Study||37
11103300|NCT01241448|12287475|FG001|NOT COMPLETED|Overall Study||29
11103301|NCT01241448|12287476|FG002|NOT COMPLETED|Overall Study||23
11103302|NCT01241448|12287477|FG003|NOT COMPLETED|Overall Study||23
11103303|NCT01241461|12287490|FG000|STARTED|Overall Study||3
11103304|NCT01241461|12287491|FG001|STARTED|Overall Study||6
11103305|NCT01241461|12287490|FG000|COMPLETED|Overall Study||0
11103306|NCT01241461|12287491|FG001|COMPLETED|Overall Study||0
11103307|NCT01241461|12287490|FG000|NOT COMPLETED|Overall Study||3
11103308|NCT01241461|12287491|FG001|NOT COMPLETED|Overall Study||6
11103309|NCT01241513|12287503|FG000|STARTED|Overall Study||10
11103310|NCT01241513|12287504|FG001|STARTED|Overall Study||9
11103311|NCT01241513|12287503|FG000|COMPLETED|Overall Study|Study has been completed|10
11103312|NCT01241513|12287504|FG001|COMPLETED|Overall Study||9
11103313|NCT01241513|12287503|FG000|NOT COMPLETED|Overall Study||0
11103314|NCT01241513|12287504|FG001|NOT COMPLETED|Overall Study||0
11103315|NCT01241539|12287509|FG000|STARTED|Period 1||7
11103316|NCT01241539|12287509|FG000|COMPLETED|Period 1||7
11103317|NCT01241539|12287509|FG000|NOT COMPLETED|Period 1||0
11103318|NCT01241539|12287509|FG000|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
11103319|NCT01241539|12287509|FG000|COMPLETED|Period 2||7
11103320|NCT01241539|12287509|FG000|NOT COMPLETED|Period 2||0
11220329|NCT01959607|12411943|FG000|STARTED|First Intervention (Day 1)||22
11103321|NCT01241552|12287519|FG000|STARTED|Overall Study||242
11103322|NCT01241552|12287520|FG001|STARTED|Overall Study||403
11103323|NCT01241552|12287521|FG002|STARTED|Overall Study||403
11103324|NCT01241552|12287522|FG003|STARTED|Overall Study||404
11103325|NCT01241552|12287519|FG000|Treated|Overall Study||235
11103326|NCT01241552|12287520|FG001|Treated|Overall Study||392
11103327|NCT01241552|12287521|FG002|Treated|Overall Study||388
11103328|NCT01241552|12287522|FG003|Treated|Overall Study||397
10835152|NCT00547339|12000366|FG000|STARTED|Overall Study||15
10835153|NCT00547339|12000367|FG001|STARTED|Overall Study||15
10835154|NCT00547339|12000368|FG002|STARTED|Overall Study||15
10835155|NCT00547339|12000369|FG003|STARTED|Overall Study||47
11103329|NCT01241552|12287519|FG000|COMPLETED|Overall Study||201
10835156|NCT00547339|12000366|FG000|COMPLETED|Overall Study||15
10835157|NCT00547339|12000367|FG001|COMPLETED|Overall Study||15
10835158|NCT00547339|12000368|FG002|COMPLETED|Overall Study||14
10835159|NCT00547339|12000369|FG003|COMPLETED|Overall Study||47
10835160|NCT00547339|12000366|FG000|NOT COMPLETED|Overall Study||0
10835161|NCT00547339|12000367|FG001|NOT COMPLETED|Overall Study||0
10835162|NCT00547339|12000368|FG002|NOT COMPLETED|Overall Study||1
11220330|NCT01959607|12411944|FG001|STARTED|First Intervention (Day 1)||22
11220331|NCT01959607|12411945|FG002|STARTED|First Intervention (Day 1)||9
11220332|NCT01959607|12411946|FG003|STARTED|First Intervention (Day 1)||9
11220333|NCT01959607|12411943|FG000|COMPLETED|First Intervention (Day 1)||21
10835163|NCT00547339|12000369|FG003|NOT COMPLETED|Overall Study||0
10835164|NCT00531232|12000391|FG000|STARTED|Overall Study||4
10835165|NCT00531232|12000392|FG001|STARTED|Overall Study||9
10835166|NCT00531232|12000393|FG002|STARTED|Overall Study||25
10835167|NCT00531232|12000391|FG000|Treated|Overall Study||4
10835168|NCT00531232|12000392|FG001|Treated|Overall Study||8
10835169|NCT00531232|12000393|FG002|Treated|Overall Study||24
10835170|NCT00531232|12000391|FG000|COMPLETED|Overall Study||0
10835171|NCT00531232|12000392|FG001|COMPLETED|Overall Study||0
10835172|NCT00531232|12000393|FG002|COMPLETED|Overall Study||0
10835173|NCT00531232|12000391|FG000|NOT COMPLETED|Overall Study||4
10835174|NCT00531232|12000392|FG001|NOT COMPLETED|Overall Study||9
10835175|NCT00531232|12000393|FG002|NOT COMPLETED|Overall Study||25
10835176|NCT00379340|12000409|FG000|STARTED|Overall Study||120
10835177|NCT00379340|12000410|FG001|STARTED|Overall Study||135
10835178|NCT00379340|12000411|FG002|STARTED|Overall Study||52
10835179|NCT00379340|12000412|FG003|STARTED|Overall Study||50
10835180|NCT00379340|12000413|FG004|STARTED|Overall Study||23
10835181|NCT00379340|12000409|FG000|COMPLETED|Overall Study||107
10835182|NCT00379340|12000410|FG001|COMPLETED|Overall Study||132
10835183|NCT00379340|12000411|FG002|COMPLETED|Overall Study||50
10835184|NCT00379340|12000412|FG003|COMPLETED|Overall Study||37
10835185|NCT00379340|12000413|FG004|COMPLETED|Overall Study||9
10835186|NCT00379340|12000409|FG000|NOT COMPLETED|Overall Study||13
10835187|NCT00379340|12000410|FG001|NOT COMPLETED|Overall Study||3
10835188|NCT00379340|12000411|FG002|NOT COMPLETED|Overall Study||2
10835189|NCT00379340|12000412|FG003|NOT COMPLETED|Overall Study||13
10835190|NCT00379340|12000413|FG004|NOT COMPLETED|Overall Study||14
10835191|NCT00304070|12000429|FG000|STARTED|Overall Study||24
10835192|NCT00304070|12000430|FG001|STARTED|Overall Study||15
10835193|NCT00304070|12000431|FG002|STARTED|Overall Study||39
10835194|NCT00304070|12000429|FG000|COMPLETED|Overall Study||21
10835195|NCT00304070|12000430|FG001|COMPLETED|Overall Study||8
10835196|NCT00304070|12000431|FG002|COMPLETED|Overall Study||27
10835197|NCT00304070|12000429|FG000|NOT COMPLETED|Overall Study||3
10835198|NCT00304070|12000430|FG001|NOT COMPLETED|Overall Study||7
10835199|NCT00304070|12000431|FG002|NOT COMPLETED|Overall Study||12
10835200|NCT00001322|12000443|FG000|STARTED|Phase 1 - Lupron Only||92
10835201|NCT00001322|12000444|FG001|STARTED|Phase 1 - Lupron Only||0
10835202|NCT00001322|12000445|FG002|STARTED|Phase 1 - Lupron Only||0
10835203|NCT00001322|12000443|FG000|COMPLETED|Phase 1 - Lupron Only||92
10835204|NCT00001322|12000444|FG001|COMPLETED|Phase 1 - Lupron Only||0
10835205|NCT00001322|12000445|FG002|COMPLETED|Phase 1 - Lupron Only||0
10835206|NCT00001322|12000443|FG000|NOT COMPLETED|Phase 1 - Lupron Only||0
10835207|NCT00001322|12000444|FG001|NOT COMPLETED|Phase 1 - Lupron Only||0
10835208|NCT00001322|12000445|FG002|NOT COMPLETED|Phase 1 - Lupron Only||0
10835209|NCT00001322|12000443|FG000|STARTED|Phase 2, Period 1 - Crossover Phase||0
10835210|NCT00001322|12000444|FG001|STARTED|Phase 2, Period 1 - Crossover Phase||42
10835211|NCT00001322|12000445|FG002|STARTED|Phase 2, Period 1 - Crossover Phase||40
10835212|NCT00001322|12000443|FG000|COMPLETED|Phase 2, Period 1 - Crossover Phase||0
10835213|NCT00001322|12000444|FG001|COMPLETED|Phase 2, Period 1 - Crossover Phase||42
10835214|NCT00001322|12000445|FG002|COMPLETED|Phase 2, Period 1 - Crossover Phase||40
10835215|NCT00001322|12000443|FG000|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
10835216|NCT00001322|12000444|FG001|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
10835217|NCT00001322|12000445|FG002|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
10835218|NCT00001322|12000443|FG000|STARTED|Phase 2, Period 2 - Crossover Phase||0
10835219|NCT00001322|12000444|FG001|STARTED|Phase 2, Period 2 - Crossover Phase||42
10835220|NCT00001322|12000445|FG002|STARTED|Phase 2, Period 2 - Crossover Phase||40
10835221|NCT00001322|12000443|FG000|COMPLETED|Phase 2, Period 2 - Crossover Phase||0
10835222|NCT00001322|12000444|FG001|COMPLETED|Phase 2, Period 2 - Crossover Phase||42
10835223|NCT00001322|12000445|FG002|COMPLETED|Phase 2, Period 2 - Crossover Phase||40
10835224|NCT00001322|12000443|FG000|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
11103330|NCT01241552|12287520|FG001|COMPLETED|Overall Study||340
11103331|NCT01241552|12287521|FG002|COMPLETED|Overall Study||343
11220334|NCT01959607|12411944|FG001|COMPLETED|First Intervention (Day 1)||21
10835225|NCT00001322|12000444|FG001|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
10835226|NCT00001322|12000445|FG002|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
11220335|NCT01959607|12411945|FG002|COMPLETED|First Intervention (Day 1)||9
10835227|NCT01701583|12000455|FG000|STARTED|Overall Study||7
10835228|NCT01701583|12000456|FG001|STARTED|Overall Study||3
10835229|NCT01701583|12000455|FG000|COMPLETED|Overall Study||5
10835230|NCT01701583|12000456|FG001|COMPLETED|Overall Study||3
10835231|NCT01701583|12000455|FG000|NOT COMPLETED|Overall Study||2
10835232|NCT01701583|12000456|FG001|NOT COMPLETED|Overall Study||0
10835233|NCT01714817|12000465|FG000|STARTED|Year 1 Period||203
10835234|NCT01714817|12000466|FG001|STARTED|Year 1 Period||203
10835235|NCT01714817|12000465|FG000|Treated|Year 1 Period||202
10835236|NCT01714817|12000466|FG001|Treated|Year 1 Period||203
10835237|NCT01714817|12000465|FG000|COMPLETED|Year 1 Period|Completed = continued study through Year 1|155
10835238|NCT01714817|12000466|FG001|COMPLETED|Year 1 Period|Completed = continued study through Year 1|161
10835239|NCT01714817|12000465|FG000|NOT COMPLETED|Year 1 Period||48
10835240|NCT01714817|12000466|FG001|NOT COMPLETED|Year 1 Period||42
10835241|NCT01714817|12000465|FG000|STARTED|Year 2 Period|Started = Completed Year 1|155
10835242|NCT01714817|12000466|FG001|STARTED|Year 2 Period|Started = Completed Year 1|161
10835243|NCT01714817|12000465|FG000|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|129
10835244|NCT01714817|12000466|FG001|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|123
10835245|NCT01714817|12000465|FG000|NOT COMPLETED|Year 2 Period||26
10835246|NCT01714817|12000466|FG001|NOT COMPLETED|Year 2 Period||38
10835247|NCT01714817|12000465|FG000|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|129
10835248|NCT01714817|12000466|FG001|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|123
10835249|NCT01714817|12000465|FG000|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|62
10835250|NCT01714817|12000466|FG001|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|53
10835251|NCT01714817|12000465|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||67
10835252|NCT01714817|12000466|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||70
10835253|NCT01755689|12000479|FG000|STARTED|Overall Study||259
10835254|NCT01755689|12000480|FG001|STARTED|Overall Study||259
10835255|NCT01755689|12000481|FG002|STARTED|Overall Study||261
10835256|NCT01755689|12000482|FG003|STARTED|Overall Study||260
10835257|NCT01755689|12000483|FG004|STARTED|Overall Study||261
10835258|NCT01755689|12000479|FG000|COMPLETED|Overall Study||256
10835259|NCT01755689|12000480|FG001|COMPLETED|Overall Study||254
10835260|NCT01755689|12000481|FG002|COMPLETED|Overall Study||255
10835261|NCT01755689|12000482|FG003|COMPLETED|Overall Study||254
10835262|NCT01755689|12000483|FG004|COMPLETED|Overall Study||255
10835263|NCT01755689|12000479|FG000|NOT COMPLETED|Overall Study||3
10835264|NCT01755689|12000480|FG001|NOT COMPLETED|Overall Study||5
10835265|NCT01755689|12000481|FG002|NOT COMPLETED|Overall Study||6
10835266|NCT01755689|12000482|FG003|NOT COMPLETED|Overall Study||6
10835267|NCT01755689|12000483|FG004|NOT COMPLETED|Overall Study||6
10835268|NCT01762761|12000505|FG000|STARTED|Overall Study||51
10835269|NCT01762761|12000506|FG001|STARTED|Overall Study||104
10835270|NCT01762761|12000505|FG000|COMPLETED|Overall Study||12
10835271|NCT01762761|12000506|FG001|COMPLETED|Overall Study||39
10835272|NCT01762761|12000505|FG000|NOT COMPLETED|Overall Study||39
10835273|NCT01762761|12000506|FG001|NOT COMPLETED|Overall Study||65
10835290|NCT01774370|12000530|FG000|STARTED|Overall Study||3182
10835291|NCT01774370|12000530|FG000|COMPLETED|Overall Study||3053
10835292|NCT01774370|12000530|FG000|NOT COMPLETED|Overall Study||129
10835299|NCT01787552|12000557|FG000|STARTED|Overall Study||8
10835300|NCT01787552|12000558|FG001|STARTED|Overall Study||10
10835301|NCT01787552|12000559|FG002|STARTED|Overall Study||5
10835302|NCT01787552|12000560|FG003|STARTED|Overall Study||27
10835303|NCT01787552|12000557|FG000|COMPLETED|Overall Study||0
10835304|NCT01787552|12000558|FG001|COMPLETED|Overall Study||1
10835305|NCT01787552|12000559|FG002|COMPLETED|Overall Study||0
10835306|NCT01787552|12000560|FG003|COMPLETED|Overall Study||0
10835307|NCT01787552|12000557|FG000|NOT COMPLETED|Overall Study||8
10835308|NCT01787552|12000558|FG001|NOT COMPLETED|Overall Study||9
10835309|NCT01787552|12000559|FG002|NOT COMPLETED|Overall Study||5
10835310|NCT01787552|12000560|FG003|NOT COMPLETED|Overall Study||27
10835311|NCT01807117|12000575|FG000|STARTED|Overall Study||15
10835312|NCT01807117|12000575|FG000|COMPLETED|Overall Study||12
10835313|NCT01807117|12000575|FG000|NOT COMPLETED|Overall Study||3
10835320|NCT01814826|12000603|FG000|STARTED|Overall Study|6 participants were enrolled into the dose escalation phase and 26 in the MTD expansion phase.|32
10835321|NCT01814826|12000604|FG001|STARTED|Overall Study|29 participants were enrolled into the MTD expansion phase.|29
10835322|NCT01814826|12000605|FG002|STARTED|Overall Study|3 participants were enrolled into the dose escalation phase.|3
10835323|NCT01814826|12000603|FG000|COMPLETED|Overall Study||0
10835324|NCT01814826|12000604|FG001|COMPLETED|Overall Study||0
10835325|NCT01814826|12000605|FG002|COMPLETED|Overall Study||0
10835326|NCT01814826|12000603|FG000|NOT COMPLETED|Overall Study||32
10835327|NCT01814826|12000604|FG001|NOT COMPLETED|Overall Study||29
10835328|NCT01814826|12000605|FG002|NOT COMPLETED|Overall Study||3
10835329|NCT01829711|12000614|FG000|STARTED|Overall Study||80
10835330|NCT01829711|12000614|FG000|COMPLETED|Overall Study||37
10835331|NCT01829711|12000614|FG000|NOT COMPLETED|Overall Study||43
10835332|NCT01846273|12000621|FG000|STARTED|Overall Study||168
10835333|NCT01846273|12000622|FG001|STARTED|Overall Study||113
10835334|NCT01846273|12000623|FG002|STARTED|Overall Study||41
10835335|NCT01846273|12000621|FG000|Safety Analysis Set|Overall Study||172
10835336|NCT01846273|12000622|FG001|Safety Analysis Set|Overall Study||135
10835337|NCT01846273|12000623|FG002|Safety Analysis Set|Overall Study||14
10835338|NCT01846273|12000621|FG000|COMPLETED|Overall Study||146
10835339|NCT01846273|12000622|FG001|COMPLETED|Overall Study||87
10835274|NCT01763788|12000517|FG000|STARTED|Overall Study||3
10835275|NCT01763788|12000518|FG001|STARTED|Overall Study||6
10835276|NCT01763788|12000519|FG002|STARTED|Overall Study||91
10835277|NCT01763788|12000520|FG003|STARTED|Overall Study||92
10835278|NCT01763788|12000517|FG000|Received at Least 1dose of Study Drug|Overall Study||3
10835279|NCT01763788|12000518|FG001|Received at Least 1dose of Study Drug|Overall Study||6
10835280|NCT01763788|12000519|FG002|Received at Least 1dose of Study Drug|Overall Study||90
10835281|NCT01763788|12000520|FG003|Received at Least 1dose of Study Drug|Overall Study||91
10835282|NCT01763788|12000517|FG000|COMPLETED|Overall Study||3
10835283|NCT01763788|12000518|FG001|COMPLETED|Overall Study||6
10835284|NCT01763788|12000519|FG002|COMPLETED|Overall Study||90
10835285|NCT01763788|12000520|FG003|COMPLETED|Overall Study||92
10835286|NCT01763788|12000517|FG000|NOT COMPLETED|Overall Study||0
10835287|NCT01763788|12000518|FG001|NOT COMPLETED|Overall Study||0
10835288|NCT01763788|12000519|FG002|NOT COMPLETED|Overall Study||1
10835289|NCT01763788|12000520|FG003|NOT COMPLETED|Overall Study||0
10835293|NCT01777295|12000536|FG000|STARTED|Overall Study||40
10835294|NCT01777295|12000537|FG001|STARTED|Overall Study||41
10835295|NCT01777295|12000536|FG000|COMPLETED|Overall Study||36
10835296|NCT01777295|12000537|FG001|COMPLETED|Overall Study||38
10835297|NCT01777295|12000536|FG000|NOT COMPLETED|Overall Study||4
10835298|NCT01777295|12000537|FG001|NOT COMPLETED|Overall Study||3
10835314|NCT01808261|12000583|FG000|STARTED|Overall Study||68
10835315|NCT01808261|12000584|FG001|STARTED|Overall Study||65
10835316|NCT01808261|12000583|FG000|COMPLETED|Overall Study||32
10835317|NCT01808261|12000584|FG001|COMPLETED|Overall Study||32
10835318|NCT01808261|12000583|FG000|NOT COMPLETED|Overall Study||36
10835319|NCT01808261|12000584|FG001|NOT COMPLETED|Overall Study||33
10835340|NCT01846273|12000623|FG002|COMPLETED|Overall Study||41
10835341|NCT01846273|12000621|FG000|NOT COMPLETED|Overall Study||22
10835342|NCT01846273|12000622|FG001|NOT COMPLETED|Overall Study||26
10835343|NCT01846273|12000623|FG002|NOT COMPLETED|Overall Study||0
11103332|NCT01241552|12287522|FG003|COMPLETED|Overall Study||340
11103333|NCT01241552|12287519|FG000|NOT COMPLETED|Overall Study||41
11103334|NCT01241552|12287520|FG001|NOT COMPLETED|Overall Study||63
11103335|NCT01241552|12287521|FG002|NOT COMPLETED|Overall Study||60
11103336|NCT01241552|12287522|FG003|NOT COMPLETED|Overall Study||64
11103337|NCT01241565|12287532|FG000|STARTED|Overall Study||50
11103338|NCT01241565|12287532|FG000|COMPLETED|Overall Study||50
11103339|NCT01241565|12287532|FG000|NOT COMPLETED|Overall Study||0
11103340|NCT01241591|12287541|FG000|STARTED|Overall Study||329
11103341|NCT01241591|12287542|FG001|STARTED|Overall Study||330
11103342|NCT01241591|12287543|FG002|STARTED|Overall Study||335
11103343|NCT01241591|12287544|FG003|STARTED|Overall Study||107
11103344|NCT01241591|12287541|FG000|COMPLETED|Overall Study||306
11103345|NCT01241591|12287542|FG001|COMPLETED|Overall Study||306
11103346|NCT01241591|12287543|FG002|COMPLETED|Overall Study||313
11103347|NCT01241591|12287544|FG003|COMPLETED|Overall Study||95
11103348|NCT01241591|12287541|FG000|NOT COMPLETED|Overall Study||23
11103349|NCT01241591|12287542|FG001|NOT COMPLETED|Overall Study||24
11103350|NCT01241591|12287543|FG002|NOT COMPLETED|Overall Study||22
11103351|NCT01241591|12287544|FG003|NOT COMPLETED|Overall Study||12
11103352|NCT01241604|12287554|FG000|STARTED|Screening Period||11
11103353|NCT01241604|12287555|FG001|STARTED|Screening Period||0
11103354|NCT01241604|12287556|FG002|STARTED|Screening Period||0
10835344|NCT01875185|12000633|FG000|STARTED|Overall Study||52
10835345|NCT01875185|12000634|FG001|STARTED|Overall Study||48
10835346|NCT01875185|12000633|FG000|COMPLETED|Overall Study||0
10835347|NCT01875185|12000634|FG001|COMPLETED|Overall Study||0
10835348|NCT01875185|12000633|FG000|NOT COMPLETED|Overall Study||52
10835349|NCT01875185|12000634|FG001|NOT COMPLETED|Overall Study||48
10835350|NCT01887743|12000647|FG000|STARTED|Overall Study||20
10835351|NCT01887743|12000648|FG001|STARTED|Overall Study||19
10835352|NCT01887743|12000649|FG002|STARTED|Overall Study||32
10835353|NCT01887743|12000647|FG000|COMPLETED|Overall Study||19
10835354|NCT01887743|12000648|FG001|COMPLETED|Overall Study||17
10835355|NCT01887743|12000649|FG002|COMPLETED|Overall Study||29
10835356|NCT01887743|12000647|FG000|NOT COMPLETED|Overall Study||1
10835357|NCT01887743|12000648|FG001|NOT COMPLETED|Overall Study||2
10835358|NCT01887743|12000649|FG002|NOT COMPLETED|Overall Study||3
10835359|NCT01891643|12000660|FG000|STARTED|Overall Study||13
10835360|NCT01891643|12000661|FG001|STARTED|Overall Study||10
10835361|NCT01891643|12000660|FG000|COMPLETED|Overall Study||3
10835362|NCT01891643|12000661|FG001|COMPLETED|Overall Study||0
10835363|NCT01891643|12000660|FG000|NOT COMPLETED|Overall Study||10
10835364|NCT01891643|12000661|FG001|NOT COMPLETED|Overall Study||10
11103355|NCT01241604|12287554|FG000|COMPLETED|Screening Period||8
11103356|NCT01241604|12287555|FG001|COMPLETED|Screening Period||0
11103357|NCT01241604|12287556|FG002|COMPLETED|Screening Period||0
10835394|NCT01917318|12000712|FG000|STARTED|First Treatment||0
10835395|NCT01917318|12000713|FG001|STARTED|First Treatment||1
10835396|NCT01917318|12000712|FG000|COMPLETED|First Treatment||0
10835397|NCT01917318|12000713|FG001|COMPLETED|First Treatment||0
11103358|NCT01241604|12287554|FG000|NOT COMPLETED|Screening Period||3
11103359|NCT01241604|12287555|FG001|NOT COMPLETED|Screening Period||0
11103360|NCT01241604|12287556|FG002|NOT COMPLETED|Screening Period||0
11103361|NCT01241604|12287554|FG000|STARTED|Study Period||0
11103362|NCT01241604|12287555|FG001|STARTED|Study Period||5
11103363|NCT01241604|12287556|FG002|STARTED|Study Period||3
10835398|NCT01917318|12000712|FG000|NOT COMPLETED|First Treatment||0
10835399|NCT01917318|12000713|FG001|NOT COMPLETED|First Treatment||1
10835400|NCT01917318|12000712|FG000|STARTED|Second Treatment||0
10835401|NCT01917318|12000713|FG001|STARTED|Second Treatment||0
10835402|NCT01917318|12000712|FG000|COMPLETED|Second Treatment||0
10835403|NCT01917318|12000713|FG001|COMPLETED|Second Treatment||0
10835404|NCT01917318|12000712|FG000|NOT COMPLETED|Second Treatment||0
10835405|NCT01917318|12000713|FG001|NOT COMPLETED|Second Treatment||0
10835406|NCT01921218|12000721|FG000|STARTED|Overall Study||6
11103364|NCT01241604|12287554|FG000|COMPLETED|Study Period||0
11103365|NCT01241604|12287555|FG001|COMPLETED|Study Period||5
11103366|NCT01241604|12287556|FG002|COMPLETED|Study Period||3
11103367|NCT01241604|12287554|FG000|NOT COMPLETED|Study Period||0
11103368|NCT01241604|12287555|FG001|NOT COMPLETED|Study Period||0
11103369|NCT01241604|12287556|FG002|NOT COMPLETED|Study Period||0
11103370|NCT01241760|12287565|FG000|STARTED|Overall Study||371
11103371|NCT01241760|12287566|FG001|STARTED|Overall Study||369
11103372|NCT01241760|12287565|FG000|COMPLETED|Overall Study||337
11103373|NCT01241760|12287566|FG001|COMPLETED|Overall Study||329
11103374|NCT01241760|12287565|FG000|NOT COMPLETED|Overall Study||34
11103375|NCT01241760|12287566|FG001|NOT COMPLETED|Overall Study||40
11103376|NCT01241903|12287575|FG000|STARTED|Overall Study||27
11103377|NCT01241903|12287576|FG001|STARTED|Overall Study||27
11103378|NCT01241903|12287575|FG000|COMPLETED|Overall Study||26
11103379|NCT01241903|12287576|FG001|COMPLETED|Overall Study||27
11103380|NCT01241903|12287575|FG000|NOT COMPLETED|Overall Study||1
11103381|NCT01241903|12287576|FG001|NOT COMPLETED|Overall Study||0
11103382|NCT01241916|12287584|FG000|STARTED|Overall Study||35
11103383|NCT01241916|12287585|FG001|STARTED|Overall Study||31
11103384|NCT01241916|12287584|FG000|COMPLETED|Overall Study||28
11103385|NCT01241916|12287585|FG001|COMPLETED|Overall Study||21
11103386|NCT01241916|12287584|FG000|NOT COMPLETED|Overall Study||7
11103387|NCT01241916|12287585|FG001|NOT COMPLETED|Overall Study||10
11103388|NCT01242085|12287594|FG000|STARTED|Overall Study||30
11103389|NCT01242085|12287595|FG001|STARTED|Overall Study||33
11103390|NCT01242085|12287596|FG002|STARTED|Overall Study||1
11103391|NCT01242085|12287594|FG000|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
11103392|NCT01242085|12287595|FG001|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
11103393|NCT01242085|12287596|FG002|COMPLETED|Overall Study||1
11103394|NCT01242085|12287594|FG000|NOT COMPLETED|Overall Study||8
11103395|NCT01242085|12287595|FG001|NOT COMPLETED|Overall Study||7
11103396|NCT01242085|12287596|FG002|NOT COMPLETED|Overall Study||0
11103397|NCT01242111|12287602|FG000|STARTED|Overall Study||20
11103398|NCT01242111|12287602|FG000|COMPLETED|Overall Study||17
11103399|NCT01242111|12287602|FG000|NOT COMPLETED|Overall Study||3
11103400|NCT01242176|12287606|FG000|STARTED|First Intervention||12
10835407|NCT01921218|12000722|FG001|STARTED|Overall Study||7
11103401|NCT01242176|12287607|FG001|STARTED|First Intervention||12
11103402|NCT01242176|12287606|FG000|COMPLETED|First Intervention||12
11103403|NCT01242176|12287607|FG001|COMPLETED|First Intervention||12
11103404|NCT01242176|12287606|FG000|NOT COMPLETED|First Intervention||0
11103405|NCT01242176|12287607|FG001|NOT COMPLETED|First Intervention||0
11103406|NCT01242176|12287606|FG000|STARTED|Washout Period of 7 Days||12
11220336|NCT01959607|12411946|FG003|COMPLETED|First Intervention (Day 1)||9
11220337|NCT01959607|12411943|FG000|NOT COMPLETED|First Intervention (Day 1)||1
10835408|NCT01921218|12000721|FG000|COMPLETED|Overall Study||3
10835409|NCT01921218|12000722|FG001|COMPLETED|Overall Study||3
11103407|NCT01242176|12287607|FG001|STARTED|Washout Period of 7 Days||12
10835410|NCT01921218|12000721|FG000|NOT COMPLETED|Overall Study||3
10835411|NCT01921218|12000722|FG001|NOT COMPLETED|Overall Study||4
10835457|NCT01931098|12000763|FG000|STARTED|Overall Study||9
10835458|NCT01931098|12000764|FG001|STARTED|Overall Study||26
10835368|NCT01901432|12000677|FG000|STARTED|Overall Study||3
10835369|NCT01901432|12000678|FG001|STARTED|Overall Study||3
10835370|NCT01901432|12000679|FG002|STARTED|Overall Study||3
10835371|NCT01901432|12000680|FG003|STARTED|Overall Study||3
10835372|NCT01901432|12000681|FG004|STARTED|Overall Study||36
10835373|NCT01901432|12000677|FG000|Received Study Drug|Overall Study||3
10835374|NCT01901432|12000678|FG001|Received Study Drug|Overall Study||3
10835375|NCT01901432|12000679|FG002|Received Study Drug|Overall Study||3
10835376|NCT01901432|12000680|FG003|Received Study Drug|Overall Study||3
10835377|NCT01901432|12000681|FG004|Received Study Drug|Overall Study||35
10835378|NCT01901432|12000677|FG000|COMPLETED|Overall Study||3
10835379|NCT01901432|12000678|FG001|COMPLETED|Overall Study||2
10835380|NCT01901432|12000679|FG002|COMPLETED|Overall Study||1
10835381|NCT01901432|12000680|FG003|COMPLETED|Overall Study||3
10835382|NCT01901432|12000681|FG004|COMPLETED|Overall Study||27
10835383|NCT01901432|12000677|FG000|NOT COMPLETED|Overall Study||0
10835384|NCT01901432|12000678|FG001|NOT COMPLETED|Overall Study||1
10835385|NCT01901432|12000679|FG002|NOT COMPLETED|Overall Study||2
10835386|NCT01901432|12000680|FG003|NOT COMPLETED|Overall Study||0
10835387|NCT01901432|12000681|FG004|NOT COMPLETED|Overall Study||9
10835412|NCT01923168|12000731|FG000|STARTED|Overall Study||131
10835413|NCT01923168|12000732|FG001|STARTED|Overall Study||83
10835414|NCT01923168|12000733|FG002|STARTED|Overall Study||126
10835415|NCT01923168|12000731|FG000|COMPLETED|Overall Study||94
10835416|NCT01923168|12000732|FG001|COMPLETED|Overall Study||44
10835417|NCT01923168|12000733|FG002|COMPLETED|Overall Study||109
10835418|NCT01923168|12000731|FG000|NOT COMPLETED|Overall Study||37
10835419|NCT01923168|12000732|FG001|NOT COMPLETED|Overall Study||39
10835420|NCT01923168|12000733|FG002|NOT COMPLETED|Overall Study||17
10835421|NCT01923480|12000744|FG000|STARTED|Period 1 (Hours 1-7)||1
10835422|NCT01923480|12000745|FG001|STARTED|Period 1 (Hours 1-7)||2
10835423|NCT01923480|12000746|FG002|STARTED|Period 1 (Hours 1-7)||2
10835424|NCT01923480|12000747|FG003|STARTED|Period 1 (Hours 1-7)||2
10835425|NCT01923480|12000748|FG004|STARTED|Period 1 (Hours 1-7)||2
10835426|NCT01923480|12000749|FG005|STARTED|Period 1 (Hours 1-7)||2
10835427|NCT01923480|12000744|FG000|COMPLETED|Period 1 (Hours 1-7)||1
10835428|NCT01923480|12000745|FG001|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
10835429|NCT01923480|12000746|FG002|COMPLETED|Period 1 (Hours 1-7)||2
10835430|NCT01923480|12000747|FG003|COMPLETED|Period 1 (Hours 1-7)||2
10835431|NCT01923480|12000748|FG004|COMPLETED|Period 1 (Hours 1-7)||2
10835432|NCT01923480|12000749|FG005|COMPLETED|Period 1 (Hours 1-7)||2
10835433|NCT01923480|12000744|FG000|NOT COMPLETED|Period 1 (Hours 1-7)||0
10835434|NCT01923480|12000745|FG001|NOT COMPLETED|Period 1 (Hours 1-7)||0
10835435|NCT01923480|12000746|FG002|NOT COMPLETED|Period 1 (Hours 1-7)||0
10835436|NCT01923480|12000747|FG003|NOT COMPLETED|Period 1 (Hours 1-7)||0
10835437|NCT01923480|12000748|FG004|NOT COMPLETED|Period 1 (Hours 1-7)||0
10835438|NCT01923480|12000749|FG005|NOT COMPLETED|Period 1 (Hours 1-7)||0
10835439|NCT01923480|12000744|FG000|STARTED|Period 2 (Hours 1-7)||1
10835440|NCT01923480|12000745|FG001|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
10835441|NCT01923480|12000746|FG002|STARTED|Period 2 (Hours 1-7)||2
10835442|NCT01923480|12000747|FG003|STARTED|Period 2 (Hours 1-7)||2
10835443|NCT01923480|12000748|FG004|STARTED|Period 2 (Hours 1-7)||2
10835444|NCT01923480|12000749|FG005|STARTED|Period 2 (Hours 1-7)||2
10835445|NCT01923480|12000744|FG000|COMPLETED|Period 2 (Hours 1-7)||1
10835446|NCT01923480|12000745|FG001|COMPLETED|Period 2 (Hours 1-7)||1
10835447|NCT01923480|12000746|FG002|COMPLETED|Period 2 (Hours 1-7)||2
10835448|NCT01923480|12000747|FG003|COMPLETED|Period 2 (Hours 1-7)||2
10835449|NCT01923480|12000748|FG004|COMPLETED|Period 2 (Hours 1-7)||2
10835450|NCT01923480|12000749|FG005|COMPLETED|Period 2 (Hours 1-7)||2
10835451|NCT01923480|12000744|FG000|NOT COMPLETED|Period 2 (Hours 1-7)||0
10835452|NCT01923480|12000745|FG001|NOT COMPLETED|Period 2 (Hours 1-7)||0
10835453|NCT01923480|12000746|FG002|NOT COMPLETED|Period 2 (Hours 1-7)||0
10835454|NCT01923480|12000747|FG003|NOT COMPLETED|Period 2 (Hours 1-7)||0
10835455|NCT01923480|12000748|FG004|NOT COMPLETED|Period 2 (Hours 1-7)||0
10835456|NCT01923480|12000749|FG005|NOT COMPLETED|Period 2 (Hours 1-7)||0
10835459|NCT01931098|12000763|FG000|COMPLETED|Overall Study||9
10835460|NCT01931098|12000764|FG001|COMPLETED|Overall Study||22
11103408|NCT01242176|12287606|FG000|COMPLETED|Washout Period of 7 Days||11
10835461|NCT01931098|12000763|FG000|NOT COMPLETED|Overall Study||0
10835462|NCT01931098|12000764|FG001|NOT COMPLETED|Overall Study||4
10835388|NCT01904279|12000702|FG000|STARTED|Overall Study||27
10835389|NCT01904279|12000703|FG001|STARTED|Overall Study||25
10835390|NCT01904279|12000702|FG000|COMPLETED|Overall Study||24
10835391|NCT01904279|12000703|FG001|COMPLETED|Overall Study||22
10835392|NCT01904279|12000702|FG000|NOT COMPLETED|Overall Study||3
10835393|NCT01904279|12000703|FG001|NOT COMPLETED|Overall Study||3
10835463|NCT01945021|12000772|FG000|STARTED|Overall Study||127
10835464|NCT01945021|12000772|FG000|Safety Population|Overall Study|Received at least 1 dose of study medication.|127
10835465|NCT01945021|12000772|FG000|Response Evaluable Population|Overall Study|Received at least 1 dose of study drug and an adequate baseline tumor assessment.|127
10835466|NCT01945021|12000772|FG000|Patient Reported Outcome Evaluable|Overall Study|Received at least 1 dose of study drug, completed baseline with at least 1 post-baseline assessment.|123
10835467|NCT01945021|12000772|FG000|COMPLETED|Overall Study||44
10835468|NCT01945021|12000772|FG000|NOT COMPLETED|Overall Study||83
10835469|NCT04747808|12000776|FG000|STARTED|Overall Study||5
10835470|NCT04747808|12000776|FG000|COMPLETED|Overall Study||5
10835471|NCT04747808|12000776|FG000|NOT COMPLETED|Overall Study||0
10835472|NCT04411953|12000782|FG000|STARTED|Treatment Period 1 (8 Days)||16
10835473|NCT04411953|12000783|FG001|STARTED|Treatment Period 1 (8 Days)||16
10835474|NCT04411953|12000782|FG000|COMPLETED|Treatment Period 1 (8 Days)||16
10835475|NCT04411953|12000783|FG001|COMPLETED|Treatment Period 1 (8 Days)||16
10835476|NCT04411953|12000782|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10835477|NCT04411953|12000783|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10835478|NCT04411953|12000782|FG000|STARTED|Washout Period (14 Days)||16
10835479|NCT04411953|12000783|FG001|STARTED|Washout Period (14 Days)||16
10835480|NCT04411953|12000782|FG000|COMPLETED|Washout Period (14 Days)||16
10835481|NCT04411953|12000783|FG001|COMPLETED|Washout Period (14 Days)||15
10835482|NCT04411953|12000782|FG000|NOT COMPLETED|Washout Period (14 Days)||0
10835483|NCT04411953|12000783|FG001|NOT COMPLETED|Washout Period (14 Days)||1
10835484|NCT04411953|12000782|FG000|STARTED|Treatment Period 2 (8 Days)||16
10835485|NCT04411953|12000783|FG001|STARTED|Treatment Period 2 (8 Days)||15
10835486|NCT04411953|12000782|FG000|COMPLETED|Treatment Period 2 (8 Days)||16
10835487|NCT04411953|12000783|FG001|COMPLETED|Treatment Period 2 (8 Days)||15
10835488|NCT04411953|12000782|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10835489|NCT04411953|12000783|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10835490|NCT04411940|12000791|FG000|STARTED|Treatment Period 1 (8 Days)||16
10835491|NCT04411940|12000792|FG001|STARTED|Treatment Period 1 (8 Days)||16
10835492|NCT04411940|12000791|FG000|COMPLETED|Treatment Period 1 (8 Days)||16
10835493|NCT04411940|12000792|FG001|COMPLETED|Treatment Period 1 (8 Days)||16
10835494|NCT04411940|12000791|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10835495|NCT04411940|12000792|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10835496|NCT04411940|12000791|FG000|STARTED|Washout Period (14 Days)||16
10835497|NCT04411940|12000792|FG001|STARTED|Washout Period (14 Days)||16
10835498|NCT04411940|12000791|FG000|COMPLETED|Washout Period (14 Days)||16
10835499|NCT04411940|12000792|FG001|COMPLETED|Washout Period (14 Days)||16
10835500|NCT04411940|12000791|FG000|NOT COMPLETED|Washout Period (14 Days)||0
10835501|NCT04411940|12000792|FG001|NOT COMPLETED|Washout Period (14 Days)||0
10835502|NCT04411940|12000791|FG000|STARTED|Treatment Period 2 (8 Days)||16
10835503|NCT04411940|12000792|FG001|STARTED|Treatment Period 2 (8 Days)||16
10835504|NCT04411940|12000791|FG000|COMPLETED|Treatment Period 2 (8 Days)||16
10835505|NCT04411940|12000792|FG001|COMPLETED|Treatment Period 2 (8 Days)||16
10835506|NCT04411940|12000791|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10835507|NCT04411940|12000792|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10835508|NCT04068792|12000800|FG000|STARTED|Overall Study||11
10835509|NCT04068792|12000801|FG001|STARTED|Overall Study||11
10835510|NCT04068792|12000800|FG000|COMPLETED|Overall Study||11
10835511|NCT04068792|12000801|FG001|COMPLETED|Overall Study||11
10835512|NCT04068792|12000800|FG000|NOT COMPLETED|Overall Study||0
10835513|NCT04068792|12000801|FG001|NOT COMPLETED|Overall Study||0
10835514|NCT03960541|12000809|FG000|STARTED|Overall Study||4
10835515|NCT03960541|12000810|FG001|STARTED|Overall Study||4
10835516|NCT03960541|12000809|FG000|COMPLETED|Overall Study||4
10835517|NCT03960541|12000810|FG001|COMPLETED|Overall Study||4
10835518|NCT03960541|12000809|FG000|NOT COMPLETED|Overall Study||0
10835519|NCT03960541|12000810|FG001|NOT COMPLETED|Overall Study||0
10835520|NCT03951077|12000822|FG000|STARTED|Overall Study||27
10835521|NCT03951077|12000823|FG001|STARTED|Overall Study||18
10835522|NCT03951077|12000824|FG002|STARTED|Overall Study||18
10835523|NCT03951077|12000825|FG003|STARTED|Overall Study||18
10835524|NCT03951077|12000826|FG004|STARTED|Overall Study||19
10835525|NCT03951077|12000827|FG005|STARTED|Overall Study||18
10835526|NCT03951077|12000822|FG000|Randomized and Treated|Overall Study||26
10835527|NCT03951077|12000823|FG001|Randomized and Treated|Overall Study||18
10835528|NCT03951077|12000824|FG002|Randomized and Treated|Overall Study||17
10835529|NCT03951077|12000825|FG003|Randomized and Treated|Overall Study||17
10835530|NCT03951077|12000826|FG004|Randomized and Treated|Overall Study||18
10835531|NCT03951077|12000827|FG005|Randomized and Treated|Overall Study||18
10835532|NCT03951077|12000822|FG000|COMPLETED|Overall Study||9
10835533|NCT03951077|12000823|FG001|COMPLETED|Overall Study||4
10835534|NCT03951077|12000824|FG002|COMPLETED|Overall Study||5
10835535|NCT03951077|12000825|FG003|COMPLETED|Overall Study||6
10835536|NCT03951077|12000826|FG004|COMPLETED|Overall Study||3
10835537|NCT03951077|12000827|FG005|COMPLETED|Overall Study||7
10835538|NCT03951077|12000822|FG000|NOT COMPLETED|Overall Study||18
10835539|NCT03951077|12000823|FG001|NOT COMPLETED|Overall Study||14
10835540|NCT03951077|12000824|FG002|NOT COMPLETED|Overall Study||13
10835541|NCT03951077|12000825|FG003|NOT COMPLETED|Overall Study||12
10835542|NCT03951077|12000826|FG004|NOT COMPLETED|Overall Study||16
10835543|NCT03951077|12000827|FG005|NOT COMPLETED|Overall Study||11
10835544|NCT03873246|12000844|FG000|STARTED|Overall Study||41
10835545|NCT03873246|12000845|FG001|STARTED|Overall Study||41
10835546|NCT03873246|12000846|FG002|STARTED|Overall Study||41
10835547|NCT03873246|12000844|FG000|COMPLETED|Overall Study||36
10835548|NCT03873246|12000845|FG001|COMPLETED|Overall Study||29
10835549|NCT03873246|12000846|FG002|COMPLETED|Overall Study||32
10835550|NCT03873246|12000844|FG000|NOT COMPLETED|Overall Study||5
10835551|NCT03873246|12000845|FG001|NOT COMPLETED|Overall Study||12
10835552|NCT03873246|12000846|FG002|NOT COMPLETED|Overall Study||9
10835553|NCT03807349|12000855|FG000|STARTED|Overall Study||12
10835554|NCT03807349|12000855|FG000|COMPLETED|Overall Study||3
10835555|NCT03807349|12000855|FG000|NOT COMPLETED|Overall Study||9
10835556|NCT03769649|12000859|FG000|STARTED|Overall Study||15
10835557|NCT03769649|12000859|FG000|COMPLETED|Overall Study||11
10835558|NCT03769649|12000859|FG000|NOT COMPLETED|Overall Study||4
10835559|NCT03714880|12000865|FG000|STARTED|Overall Study||20
10835560|NCT03714880|12000866|FG001|STARTED|Overall Study||24
10835561|NCT03714880|12000865|FG000|COMPLETED|Overall Study||19
10835562|NCT03714880|12000866|FG001|COMPLETED|Overall Study||22
10835563|NCT03714880|12000865|FG000|NOT COMPLETED|Overall Study||1
10835564|NCT03714880|12000866|FG001|NOT COMPLETED|Overall Study||2
10835565|NCT03645941|12000876|FG000|STARTED|Overall Study||30
10835566|NCT03645941|12000877|FG001|STARTED|Overall Study||31
10835567|NCT03645941|12000876|FG000|COMPLETED|Overall Study||16
10835568|NCT03645941|12000877|FG001|COMPLETED|Overall Study||19
10835569|NCT03645941|12000876|FG000|NOT COMPLETED|Overall Study||14
10835570|NCT03645941|12000877|FG001|NOT COMPLETED|Overall Study||12
10835571|NCT03598088|12000883|FG000|STARTED|Screening/Baseline PCT Visits 1-4||38
10835572|NCT03598088|12000883|FG000|COMPLETED|Screening/Baseline PCT Visits 1-4||38
10835573|NCT03598088|12000883|FG000|NOT COMPLETED|Screening/Baseline PCT Visits 1-4||0
10835574|NCT03598088|12000883|FG000|STARTED|Caya PCT Cycle, Visit 5 & 6||38
10835575|NCT03598088|12000883|FG000|COMPLETED|Caya PCT Cycle, Visit 5 & 6||35
10835576|NCT03598088|12000883|FG000|NOT COMPLETED|Caya PCT Cycle, Visit 5 & 6||3
10835577|NCT03598088|12000883|FG000|STARTED|OVP Safety Cycle Visits 7-11||33
10835578|NCT03598088|12000883|FG000|Used the OVP Device During the Study|OVP Safety Cycle Visits 7-11|Any subject that used the OVP device at least one time during the study.|33
10835579|NCT03598088|12000883|FG000|COMPLETED|OVP Safety Cycle Visits 7-11||28
10835580|NCT03598088|12000883|FG000|NOT COMPLETED|OVP Safety Cycle Visits 7-11||5
10835581|NCT03598088|12000883|FG000|STARTED|OVP PCT Cycle A Visits 12-16||28
10835582|NCT03598088|12000883|FG000|Completed 1 OVP PCT Cycle|OVP PCT Cycle A Visits 12-16|Subjects Completed One PCT Visit|26
10835583|NCT03598088|12000883|FG000|COMPLETED|OVP PCT Cycle A Visits 12-16||24
10835584|NCT03598088|12000883|FG000|NOT COMPLETED|OVP PCT Cycle A Visits 12-16||4
10835585|NCT03598088|12000883|FG000|STARTED|OVP PCT Cycle B Visits 17-21||24
10835586|NCT03598088|12000883|FG000|COMPLETED|OVP PCT Cycle B Visits 17-21||23
10835587|NCT03598088|12000883|FG000|NOT COMPLETED|OVP PCT Cycle B Visits 17-21||1
10835588|NCT03408444|12000924|FG000|STARTED|Overall Study||50
10835589|NCT03408444|12000925|FG001|STARTED|Overall Study||48
10835590|NCT03408444|12000926|FG002|STARTED|Overall Study||50
10835591|NCT03408444|12000927|FG003|STARTED|Overall Study||51
10835592|NCT03408444|12000924|FG000|COMPLETED|Overall Study||49
10835593|NCT03408444|12000925|FG001|COMPLETED|Overall Study||45
10835594|NCT03408444|12000926|FG002|COMPLETED|Overall Study||44
10835595|NCT03408444|12000927|FG003|COMPLETED|Overall Study||47
10835596|NCT03408444|12000924|FG000|NOT COMPLETED|Overall Study||1
10835597|NCT03408444|12000925|FG001|NOT COMPLETED|Overall Study||3
10835598|NCT03408444|12000926|FG002|NOT COMPLETED|Overall Study||6
10835599|NCT03408444|12000927|FG003|NOT COMPLETED|Overall Study||4
11103409|NCT01242176|12287607|FG001|COMPLETED|Washout Period of 7 Days||10
11103410|NCT01242176|12287606|FG000|NOT COMPLETED|Washout Period of 7 Days||1
11103411|NCT01242176|12287607|FG001|NOT COMPLETED|Washout Period of 7 Days||2
11103412|NCT01242176|12287606|FG000|STARTED|Second Intervention||11
11103413|NCT01242176|12287607|FG001|STARTED|Second Intervention||10
11103414|NCT01242176|12287606|FG000|COMPLETED|Second Intervention||11
10835615|NCT02862548|12000961|FG000|STARTED|Randomized Phase (Up to Week 48)||26
10835616|NCT02862548|12000962|FG001|STARTED|Randomized Phase (Up to Week 48)||25
10835617|NCT02862548|12000961|FG000|COMPLETED|Randomized Phase (Up to Week 48)||26
10835618|NCT02862548|12000962|FG001|COMPLETED|Randomized Phase (Up to Week 48)||24
10835619|NCT02862548|12000961|FG000|NOT COMPLETED|Randomized Phase (Up to Week 48)||0
10835620|NCT02862548|12000962|FG001|NOT COMPLETED|Randomized Phase (Up to Week 48)||1
10835621|NCT02862548|12000961|FG000|STARTED|OLE Phase (Week 49 to Week 192)||26
10835622|NCT02862548|12000962|FG001|STARTED|OLE Phase (Week 49 to Week 192)||24
10835623|NCT02862548|12000961|FG000|COMPLETED|OLE Phase (Week 49 to Week 192)||23
10835624|NCT02862548|12000962|FG001|COMPLETED|OLE Phase (Week 49 to Week 192)||23
10835625|NCT02862548|12000961|FG000|NOT COMPLETED|OLE Phase (Week 49 to Week 192)||3
10835626|NCT02862548|12000962|FG001|NOT COMPLETED|OLE Phase (Week 49 to Week 192)||1
10835627|NCT02377089|12000972|FG000|STARTED|Overall Study||31
10835628|NCT02377089|12000973|FG001|STARTED|Overall Study||29
10835629|NCT02377089|12000972|FG000|COMPLETED|Overall Study||22
10835630|NCT02377089|12000973|FG001|COMPLETED|Overall Study||24
10835631|NCT02377089|12000972|FG000|NOT COMPLETED|Overall Study||9
10835632|NCT02377089|12000973|FG001|NOT COMPLETED|Overall Study||5
10835633|NCT02335099|12000981|FG000|STARTED|Treatment||22
10835634|NCT02335099|12000982|FG001|STARTED|Treatment||22
10835635|NCT02335099|12000981|FG000|COMPLETED|Treatment||17
10835636|NCT02335099|12000982|FG001|COMPLETED|Treatment||17
10835637|NCT02335099|12000981|FG000|NOT COMPLETED|Treatment||5
10835638|NCT02335099|12000982|FG001|NOT COMPLETED|Treatment||5
10835639|NCT02335099|12000981|FG000|STARTED|Follow-up||17
10835640|NCT02335099|12000982|FG001|STARTED|Follow-up||17
10835641|NCT02335099|12000981|FG000|COMPLETED|Follow-up||17
10835642|NCT02335099|12000982|FG001|COMPLETED|Follow-up||16
10835643|NCT02335099|12000981|FG000|NOT COMPLETED|Follow-up||0
10835644|NCT02335099|12000982|FG001|NOT COMPLETED|Follow-up||1
10835645|NCT02330562|12000999|FG000|STARTED|Overall Study||6
10835646|NCT02330562|12001000|FG001|STARTED|Overall Study||3
10835647|NCT02330562|12001001|FG002|STARTED|Overall Study||27
10835648|NCT02330562|12001002|FG003|STARTED|Overall Study||30
10835649|NCT02330562|12001003|FG004|STARTED|Overall Study||31
10835650|NCT02330562|12001004|FG005|STARTED|Overall Study||10
10835651|NCT02330562|12001005|FG006|STARTED|Overall Study||1
10835652|NCT02330562|12001006|FG007|STARTED|Overall Study||1
10835653|NCT02330562|12001007|FG008|STARTED|Overall Study||1
10835654|NCT02330562|12001008|FG009|STARTED|Overall Study||5
10835655|NCT02330562|12001009|FG010|STARTED|Overall Study||6
10835656|NCT02330562|12000999|FG000|COMPLETED|Overall Study||0
10835657|NCT02330562|12001000|FG001|COMPLETED|Overall Study||0
10835658|NCT02330562|12001001|FG002|COMPLETED|Overall Study||0
10835659|NCT02330562|12001002|FG003|COMPLETED|Overall Study||0
10835660|NCT02330562|12001003|FG004|COMPLETED|Overall Study||0
10835661|NCT02330562|12001004|FG005|COMPLETED|Overall Study||0
10835662|NCT02330562|12001005|FG006|COMPLETED|Overall Study||0
10835663|NCT02330562|12001006|FG007|COMPLETED|Overall Study||0
10835664|NCT02330562|12001007|FG008|COMPLETED|Overall Study||0
10835665|NCT02330562|12001008|FG009|COMPLETED|Overall Study||0
10835666|NCT02330562|12001009|FG010|COMPLETED|Overall Study||0
10835667|NCT02330562|12000999|FG000|NOT COMPLETED|Overall Study||6
10835668|NCT02330562|12001000|FG001|NOT COMPLETED|Overall Study||3
10835669|NCT02330562|12001001|FG002|NOT COMPLETED|Overall Study||27
10835670|NCT02330562|12001002|FG003|NOT COMPLETED|Overall Study||30
10835671|NCT02330562|12001003|FG004|NOT COMPLETED|Overall Study||31
10835672|NCT02330562|12001004|FG005|NOT COMPLETED|Overall Study||10
10835673|NCT02330562|12001005|FG006|NOT COMPLETED|Overall Study||1
10835674|NCT02330562|12001006|FG007|NOT COMPLETED|Overall Study||1
10835675|NCT02330562|12001007|FG008|NOT COMPLETED|Overall Study||1
10835676|NCT02330562|12001008|FG009|NOT COMPLETED|Overall Study||5
10835677|NCT02330562|12001009|FG010|NOT COMPLETED|Overall Study||6
10835678|NCT02053363|12001056|FG000|STARTED|Overall Study||25
10835679|NCT02053363|12001057|FG001|STARTED|Overall Study||27
10835680|NCT02053363|12001056|FG000|COMPLETED|Overall Study||25
10835681|NCT02053363|12001057|FG001|COMPLETED|Overall Study||27
10835682|NCT02053363|12001056|FG000|NOT COMPLETED|Overall Study||0
10835683|NCT02053363|12001057|FG001|NOT COMPLETED|Overall Study||0
10835684|NCT02035137|12001066|FG000|STARTED|Overall Study||38
10835685|NCT02035137|12001067|FG001|STARTED|Overall Study||37
10835686|NCT02035137|12001068|FG002|STARTED|Overall Study||39
10835687|NCT02035137|12001066|FG000|COMPLETED|Overall Study||36
10835688|NCT02035137|12001067|FG001|COMPLETED|Overall Study||35
10835689|NCT02035137|12001068|FG002|COMPLETED|Overall Study||34
10835690|NCT02035137|12001066|FG000|NOT COMPLETED|Overall Study||2
10835691|NCT02035137|12001067|FG001|NOT COMPLETED|Overall Study||2
10835692|NCT02035137|12001068|FG002|NOT COMPLETED|Overall Study||5
10835693|NCT01975571|12001079|FG000|STARTED|Overall Study||15
10835694|NCT01975571|12001080|FG001|STARTED|Overall Study||5
10835695|NCT01975571|12001081|FG002|STARTED|Overall Study||0
10835696|NCT01975571|12001079|FG000|COMPLETED|Overall Study||14
10835697|NCT01975571|12001080|FG001|COMPLETED|Overall Study||3
10835698|NCT01975571|12001081|FG002|COMPLETED|Overall Study||0
10835699|NCT01975571|12001079|FG000|NOT COMPLETED|Overall Study||1
10835700|NCT01975571|12001080|FG001|NOT COMPLETED|Overall Study||2
10835701|NCT01975571|12001081|FG002|NOT COMPLETED|Overall Study||0
10835702|NCT01589523|12001089|FG000|STARTED|Overall Study||5
10835703|NCT01589523|12001089|FG000|COMPLETED|Overall Study||4
10835704|NCT01589523|12001089|FG000|NOT COMPLETED|Overall Study||1
10835705|NCT01157091|12001095|FG000|STARTED|Overall Study||28
10835706|NCT01157091|12001095|FG000|COMPLETED|Overall Study||28
10835707|NCT01157091|12001095|FG000|NOT COMPLETED|Overall Study||0
10835708|NCT01100775|12001099|FG000|STARTED|Overall Study||6
10835709|NCT01100775|12001100|FG001|STARTED|Overall Study||6
10835710|NCT01100775|12001099|FG000|COMPLETED|Overall Study||6
10835711|NCT01100775|12001100|FG001|COMPLETED|Overall Study||6
10835712|NCT01100775|12001099|FG000|NOT COMPLETED|Overall Study||0
10835713|NCT01100775|12001100|FG001|NOT COMPLETED|Overall Study||0
10835714|NCT00777036|12001109|FG000|STARTED|On Treatment||29
10835715|NCT00777036|12001110|FG001|STARTED|On Treatment||17
10835716|NCT00777036|12001111|FG002|STARTED|On Treatment||84
10835717|NCT00777036|12001109|FG000|COMPLETED|On Treatment|Completed = Still on treatment|14
10835718|NCT00777036|12001110|FG001|COMPLETED|On Treatment|Completed = Still on treatment|1
10835719|NCT00777036|12001111|FG002|COMPLETED|On Treatment|Completed = Still on treatment|61
10835720|NCT00777036|12001109|FG000|NOT COMPLETED|On Treatment||15
10835721|NCT00777036|12001110|FG001|NOT COMPLETED|On Treatment||16
10835722|NCT00777036|12001111|FG002|NOT COMPLETED|On Treatment||23
10835723|NCT00777036|12001109|FG000|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
10835724|NCT00777036|12001110|FG001|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
10835725|NCT00777036|12001111|FG002|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
10835726|NCT00777036|12001109|FG000|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
10835727|NCT00777036|12001110|FG001|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
10835728|NCT00777036|12001111|FG002|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
10835729|NCT00777036|12001109|FG000|NOT COMPLETED|Follow-Up||5
10835730|NCT00777036|12001110|FG001|NOT COMPLETED|Follow-Up||8
10835731|NCT00777036|12001111|FG002|NOT COMPLETED|Follow-Up||4
10835732|NCT00504712|12001128|FG000|STARTED|Overall Study||11
10835733|NCT00504712|12001129|FG001|STARTED|Overall Study||13
10835734|NCT00504712|12001128|FG000|COMPLETED|Overall Study||11
10835735|NCT00504712|12001129|FG001|COMPLETED|Overall Study||13
10835736|NCT00504712|12001128|FG000|NOT COMPLETED|Overall Study||0
10835737|NCT00504712|12001129|FG001|NOT COMPLETED|Overall Study||0
10835738|NCT05097157|12001135|FG000|STARTED|Overall Study||79
10835739|NCT05097157|12001135|FG000|COMPLETED|Overall Study||56
10835740|NCT05097157|12001135|FG000|NOT COMPLETED|Overall Study||23
10835741|NCT04331795|12001141|FG000|STARTED|Overall Study||12
10835742|NCT04331795|12001142|FG001|STARTED|Overall Study||20
10835743|NCT04331795|12001141|FG000|COMPLETED|Overall Study||12
10835744|NCT04331795|12001142|FG001|COMPLETED|Overall Study||20
10835745|NCT04331795|12001141|FG000|NOT COMPLETED|Overall Study||0
10835746|NCT04331795|12001142|FG001|NOT COMPLETED|Overall Study||0
10835784|NCT03395704|12001195|FG000|STARTED|Overall Study||34
10835785|NCT03395704|12001196|FG001|STARTED|Overall Study||36
10835786|NCT03395704|12001195|FG000|Safety Population|Overall Study||34
10835787|NCT03395704|12001196|FG001|Safety Population|Overall Study||35
10835788|NCT03395704|12001195|FG000|Analysis Population|Overall Study||21
10835789|NCT03395704|12001196|FG001|Analysis Population|Overall Study||28
10835790|NCT03395704|12001195|FG000|COMPLETED|Overall Study||30
10835791|NCT03395704|12001196|FG001|COMPLETED|Overall Study||33
10835792|NCT03395704|12001195|FG000|NOT COMPLETED|Overall Study||4
10835793|NCT03395704|12001196|FG001|NOT COMPLETED|Overall Study||3
10835794|NCT03335813|12001202|FG000|STARTED|Overall Study||7
10835795|NCT03335813|12001202|FG000|COMPLETED|Overall Study||6
10835796|NCT03335813|12001202|FG000|NOT COMPLETED|Overall Study||1
10835797|NCT03246503|12001206|FG000|STARTED|Overall Study||203
10835798|NCT03246503|12001206|FG000|COMPLETED|Overall Study||150
10835799|NCT03246503|12001206|FG000|NOT COMPLETED|Overall Study||53
10835800|NCT03039595|12001210|FG000|STARTED|Overall Study||150
10835801|NCT03039595|12001210|FG000|COMPLETED|Overall Study||143
10835802|NCT03039595|12001210|FG000|NOT COMPLETED|Overall Study||7
10835803|NCT02864368|12001219|FG000|STARTED|Overall Study||4
10835804|NCT02864368|12001220|FG001|STARTED|Overall Study||1
10835805|NCT02864368|12001221|FG002|STARTED|Overall Study||6
10835806|NCT02864368|12001222|FG003|STARTED|Overall Study||8
10835807|NCT02864368|12001223|FG004|STARTED|Overall Study||8
10835808|NCT02864368|12001219|FG000|COMPLETED|Overall Study||4
10835809|NCT02864368|12001220|FG001|COMPLETED|Overall Study||1
10835810|NCT02864368|12001221|FG002|COMPLETED|Overall Study||6
10835811|NCT02864368|12001222|FG003|COMPLETED|Overall Study||8
10835812|NCT02864368|12001223|FG004|COMPLETED|Overall Study||8
10835813|NCT02864368|12001219|FG000|NOT COMPLETED|Overall Study||0
10835814|NCT02864368|12001220|FG001|NOT COMPLETED|Overall Study||0
10835815|NCT02864368|12001221|FG002|NOT COMPLETED|Overall Study||0
10835816|NCT02864368|12001222|FG003|NOT COMPLETED|Overall Study||0
10835817|NCT02864368|12001223|FG004|NOT COMPLETED|Overall Study||0
10835818|NCT02856698|12001242|FG000|STARTED|Overall Study||55
10835819|NCT02856698|12001243|FG001|STARTED|Overall Study||56
10835820|NCT02856698|12001242|FG000|COMPLETED|Overall Study||48
10835821|NCT02856698|12001243|FG001|COMPLETED|Overall Study||46
10835822|NCT02856698|12001242|FG000|NOT COMPLETED|Overall Study||7
10835823|NCT02856698|12001243|FG001|NOT COMPLETED|Overall Study||10
10835824|NCT02625610|12001251|FG000|STARTED|Overall Study||250
10835825|NCT02625610|12001252|FG001|STARTED|Overall Study||249
10835826|NCT02625610|12001251|FG000|Safety-Maintenance Analysis Set|Overall Study||238
10835827|NCT02625610|12001252|FG001|Safety-Maintenance Analysis Set|Overall Study||243
10835828|NCT02625610|12001251|FG000|COMPLETED|Overall Study||250
10835829|NCT02625610|12001252|FG001|COMPLETED|Overall Study||249
10835830|NCT02625610|12001251|FG000|NOT COMPLETED|Overall Study||0
10835831|NCT02625610|12001252|FG001|NOT COMPLETED|Overall Study||0
10835832|NCT02514447|12001267|FG000|STARTED|Overall Study||29
10835833|NCT02514447|12001268|FG001|STARTED|Overall Study||30
10835834|NCT02514447|12001269|FG002|STARTED|Overall Study||32
10835835|NCT02514447|12001270|FG003|STARTED|Overall Study||2
10835836|NCT02514447|12001271|FG004|STARTED|Overall Study||3
10835837|NCT02514447|12001272|FG005|STARTED|Overall Study||4
10835838|NCT02514447|12001273|FG006|STARTED|Overall Study||8
10835839|NCT02514447|12001274|FG007|STARTED|Overall Study||7
10835840|NCT02514447|12001275|FG008|STARTED|Overall Study||8
10835841|NCT02514447|12001267|FG000|COMPLETED|Overall Study||0
10835842|NCT02514447|12001268|FG001|COMPLETED|Overall Study||0
10835843|NCT02514447|12001269|FG002|COMPLETED|Overall Study||0
10835844|NCT02514447|12001270|FG003|COMPLETED|Overall Study||0
10835845|NCT02514447|12001271|FG004|COMPLETED|Overall Study||0
10835846|NCT02514447|12001272|FG005|COMPLETED|Overall Study||0
10835847|NCT02514447|12001273|FG006|COMPLETED|Overall Study||0
10835848|NCT02514447|12001274|FG007|COMPLETED|Overall Study||0
10835849|NCT02514447|12001275|FG008|COMPLETED|Overall Study||0
10835850|NCT02514447|12001267|FG000|NOT COMPLETED|Overall Study||29
10835851|NCT02514447|12001268|FG001|NOT COMPLETED|Overall Study||30
10835852|NCT02514447|12001269|FG002|NOT COMPLETED|Overall Study||32
10835853|NCT02514447|12001270|FG003|NOT COMPLETED|Overall Study||2
10835854|NCT02514447|12001271|FG004|NOT COMPLETED|Overall Study||3
10835855|NCT02514447|12001272|FG005|NOT COMPLETED|Overall Study||4
10835856|NCT02514447|12001273|FG006|NOT COMPLETED|Overall Study||8
10835857|NCT02514447|12001274|FG007|NOT COMPLETED|Overall Study||7
10835858|NCT02514447|12001275|FG008|NOT COMPLETED|Overall Study||8
10835859|NCT02031978|12001315|FG000|STARTED|Overall Study||4367
10835860|NCT02031978|12001315|FG000|COMPLETED|Overall Study||4367
10835861|NCT02031978|12001315|FG000|NOT COMPLETED|Overall Study||0
10835862|NCT01785563|12001319|FG000|STARTED|Overall Study||40
10835863|NCT01785563|12001319|FG000|COMPLETED|Overall Study||27
10835864|NCT01785563|12001319|FG000|NOT COMPLETED|Overall Study||13
10835865|NCT01732120|12001325|FG000|STARTED|Overall Study||40
10835866|NCT01732120|12001326|FG001|STARTED|Overall Study||40
10835867|NCT01732120|12001325|FG000|COMPLETED|Overall Study||40
10835747|NCT04175730|12001150|FG000|STARTED|Overall Study||27
10835748|NCT04175730|12001151|FG001|STARTED|Overall Study||21
10835749|NCT04175730|12001150|FG000|COMPLETED|Overall Study||27
10835750|NCT04175730|12001151|FG001|COMPLETED|Overall Study||21
10835751|NCT04175730|12001150|FG000|NOT COMPLETED|Overall Study||0
10835752|NCT04175730|12001151|FG001|NOT COMPLETED|Overall Study||0
11103415|NCT01242176|12287607|FG001|COMPLETED|Second Intervention||10
11103416|NCT01242176|12287606|FG000|NOT COMPLETED|Second Intervention||0
11103417|NCT01242176|12287607|FG001|NOT COMPLETED|Second Intervention||0
11103418|NCT01242241|12287615|FG000|STARTED|Overall Study||40
11103419|NCT01242241|12287616|FG001|STARTED|Overall Study||40
11103420|NCT01242241|12287615|FG000|COMPLETED|Overall Study||40
10835759|NCT03703102|12001172|FG000|STARTED|Overall Study||54
10835760|NCT03703102|12001173|FG001|STARTED|Overall Study||53
10835761|NCT03703102|12001174|FG002|STARTED|Overall Study||55
10835762|NCT03703102|12001175|FG003|STARTED|Overall Study||54
10835763|NCT03703102|12001176|FG004|STARTED|Overall Study||57
10835764|NCT03703102|12001172|FG000|Completed Treatment Period A|Overall Study||42
10835765|NCT03703102|12001173|FG001|Completed Treatment Period A|Overall Study||41
10835766|NCT03703102|12001174|FG002|Completed Treatment Period A|Overall Study||42
10835767|NCT03703102|12001175|FG003|Completed Treatment Period A|Overall Study||46
10835768|NCT03703102|12001176|FG004|Completed Treatment Period A|Overall Study||34
10835769|NCT03703102|12001172|FG000|Completed Treatment Period B|Overall Study||33
10835770|NCT03703102|12001173|FG001|Completed Treatment Period B|Overall Study||39
10835771|NCT03703102|12001174|FG002|Completed Treatment Period B|Overall Study||37
10835772|NCT03703102|12001175|FG003|Completed Treatment Period B|Overall Study||38
10835773|NCT03703102|12001176|FG004|Completed Treatment Period B|Overall Study||26
10835774|NCT03703102|12001172|FG000|COMPLETED|Overall Study||32
10835775|NCT03703102|12001173|FG001|COMPLETED|Overall Study||38
10835776|NCT03703102|12001174|FG002|COMPLETED|Overall Study||33
10835777|NCT03703102|12001175|FG003|COMPLETED|Overall Study||37
11103421|NCT01242241|12287616|FG001|COMPLETED|Overall Study||40
11103422|NCT01242241|12287615|FG000|NOT COMPLETED|Overall Study||0
11103423|NCT01242241|12287616|FG001|NOT COMPLETED|Overall Study||0
11103424|NCT01242371|12287624|FG000|STARTED|Overall Study||33
11103425|NCT01242371|12287625|FG001|STARTED|Overall Study||32
11103426|NCT01242371|12287624|FG000|COMPLETED|Overall Study||31
11103427|NCT01242371|12287625|FG001|COMPLETED|Overall Study||27
11103428|NCT01242371|12287624|FG000|NOT COMPLETED|Overall Study||2
11103429|NCT01242371|12287625|FG001|NOT COMPLETED|Overall Study||5
11103430|NCT01242514|12287634|FG000|STARTED|Overall Study|Patients who received treatment|1343
11103431|NCT01242514|12287635|FG001|STARTED|Overall Study|Patients who received treatment|357
11103432|NCT01242514|12287636|FG002|STARTED|Overall Study|Patients who received treatment|212
11103433|NCT01242514|12287634|FG000|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
11103434|NCT01242514|12287635|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0
11103435|NCT01242514|12287636|FG002|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
11103436|NCT01242514|12287634|FG000|COMPLETED|Overall Study|Due to project closure.|0
11103437|NCT01242514|12287635|FG001|COMPLETED|Overall Study|Due to project closure.|0
11103438|NCT01242514|12287636|FG002|COMPLETED|Overall Study|Due to project closure.|0
11103439|NCT01242514|12287634|FG000|NOT COMPLETED|Overall Study||1343
11103440|NCT01242514|12287635|FG001|NOT COMPLETED|Overall Study||357
11103441|NCT01242514|12287636|FG002|NOT COMPLETED|Overall Study||212
11103442|NCT01242527|12287648|FG000|STARTED|Overall Study||99
11103443|NCT01242527|12287649|FG001|STARTED|Overall Study||100
11103444|NCT01242527|12287650|FG002|STARTED|Overall Study||101
11103445|NCT01242527|12287651|FG003|STARTED|Overall Study||99
11103446|NCT01242527|12287648|FG000|COMPLETED|Overall Study||94
11103447|NCT01242527|12287649|FG001|COMPLETED|Overall Study||93
11103448|NCT01242527|12287650|FG002|COMPLETED|Overall Study||87
11103449|NCT01242527|12287651|FG003|COMPLETED|Overall Study||90
11103450|NCT01242527|12287648|FG000|NOT COMPLETED|Overall Study||5
11103451|NCT01242527|12287649|FG001|NOT COMPLETED|Overall Study||7
10835778|NCT03703102|12001176|FG004|COMPLETED|Overall Study||24
10835779|NCT03703102|12001172|FG000|NOT COMPLETED|Overall Study||22
10835780|NCT03703102|12001173|FG001|NOT COMPLETED|Overall Study||15
10835781|NCT03703102|12001174|FG002|NOT COMPLETED|Overall Study||22
10835782|NCT03703102|12001175|FG003|NOT COMPLETED|Overall Study||17
10835783|NCT03703102|12001176|FG004|NOT COMPLETED|Overall Study||33
10835868|NCT01732120|12001326|FG001|COMPLETED|Overall Study||40
10835869|NCT01732120|12001325|FG000|NOT COMPLETED|Overall Study||0
10835870|NCT01732120|12001326|FG001|NOT COMPLETED|Overall Study||0
10835871|NCT01434290|12001334|FG000|STARTED|Overall Study||127
11103452|NCT01242527|12287650|FG002|NOT COMPLETED|Overall Study||14
11103453|NCT01242527|12287651|FG003|NOT COMPLETED|Overall Study||9
11103454|NCT01242644|12287664|FG000|STARTED|Overall Study||16
11103455|NCT01242644|12287665|FG001|STARTED|Overall Study||17
11103456|NCT01242644|12287666|FG002|STARTED|Overall Study||15
11103457|NCT01242644|12287664|FG000|COMPLETED|Overall Study||16
11103458|NCT01242644|12287665|FG001|COMPLETED|Overall Study||17
11103459|NCT01242644|12287666|FG002|COMPLETED|Overall Study||15
11103460|NCT01242644|12287664|FG000|NOT COMPLETED|Overall Study||0
11103461|NCT01242644|12287665|FG001|NOT COMPLETED|Overall Study||0
10835872|NCT01434290|12001335|FG001|STARTED|Overall Study||128
10835873|NCT01434290|12001334|FG000|COMPLETED|Overall Study|Eligible subjects included in analysis|119
10835874|NCT01434290|12001335|FG001|COMPLETED|Overall Study|Eligible subjects included in analysis|121
10835875|NCT01434290|12001334|FG000|NOT COMPLETED|Overall Study||8
10835876|NCT01434290|12001335|FG001|NOT COMPLETED|Overall Study||7
10835877|NCT01062399|12001347|FG000|STARTED|Overall Study||8
10835878|NCT01062399|12001348|FG001|STARTED|Overall Study||10
10835879|NCT01062399|12001349|FG002|STARTED|Overall Study||8
10835880|NCT01062399|12001350|FG003|STARTED|Overall Study||89
10835881|NCT01062399|12001351|FG004|STARTED|Overall Study||92
10835882|NCT01062399|12001347|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
10835883|NCT01062399|12001348|FG001|COMPLETED|Overall Study||9
10835884|NCT01062399|12001349|FG002|COMPLETED|Overall Study||8
10835885|NCT01062399|12001350|FG003|COMPLETED|Overall Study||83
11103462|NCT01242644|12287666|FG002|NOT COMPLETED|Overall Study||0
11103463|NCT01242748|12287676|FG000|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
11103464|NCT01242748|12287677|FG001|STARTED|Overall Study||94
11103465|NCT01242748|12287676|FG000|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
11103466|NCT01242748|12287677|FG001|CS35/CS35A Safety Analysis Set|Overall Study||283
11103467|NCT01242748|12287676|FG000|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
11103468|NCT01242748|12287677|FG001|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
11103469|NCT01242748|12287676|FG000|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
11103470|NCT01242748|12287677|FG001|COMPLETED|Overall Study||80
10835886|NCT01062399|12001351|FG004|COMPLETED|Overall Study||88
10835887|NCT01062399|12001347|FG000|NOT COMPLETED|Overall Study||0
11103471|NCT01242748|12287676|FG000|NOT COMPLETED|Overall Study||38
11103472|NCT01242748|12287677|FG001|NOT COMPLETED|Overall Study||14
11103473|NCT01242813|12287683|FG000|STARTED|Overall Study||20
11103474|NCT01242813|12287683|FG000|COMPLETED|Overall Study||18
11103475|NCT01242813|12287683|FG000|NOT COMPLETED|Overall Study||2
11103476|NCT01243112|12287687|FG000|STARTED|Overall Study||25
11103477|NCT01243112|12287687|FG000|COMPLETED|Overall Study||25
11103478|NCT01243112|12287687|FG000|NOT COMPLETED|Overall Study||0
11103479|NCT01243151|12287696|FG000|STARTED|Overall Study||12
11103480|NCT01243151|12287697|FG001|STARTED|Overall Study||14
11220338|NCT01959607|12411944|FG001|NOT COMPLETED|First Intervention (Day 1)||1
11220339|NCT01959607|12411945|FG002|NOT COMPLETED|First Intervention (Day 1)||0
11220340|NCT01959607|12411946|FG003|NOT COMPLETED|First Intervention (Day 1)||0
11220341|NCT01959607|12411943|FG000|STARTED|Washout Period of 1 Day (Day 2)||21
11220342|NCT01959607|12411944|FG001|STARTED|Washout Period of 1 Day (Day 2)||21
11220343|NCT01959607|12411945|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
11220344|NCT01959607|12411946|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
11220345|NCT01959607|12411943|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21
11220346|NCT01959607|12411944|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21
11220347|NCT01959607|12411945|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
11220348|NCT01959607|12411946|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
11220349|NCT01959607|12411943|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11354118|NCT03069716|12551330|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0
11103481|NCT01243151|12287698|FG002|STARTED|Overall Study||14
11103482|NCT01243151|12287699|FG003|STARTED|Overall Study||14
11103483|NCT01243151|12287700|FG004|STARTED|Overall Study||14
11103484|NCT01243151|12287696|FG000|Treated|Overall Study||12
11220350|NCT01959607|12411944|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11220351|NCT01959607|12411945|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10835888|NCT01062399|12001348|FG001|NOT COMPLETED|Overall Study||1
10835889|NCT01062399|12001349|FG002|NOT COMPLETED|Overall Study||0
10835890|NCT01062399|12001350|FG003|NOT COMPLETED|Overall Study||6
10835891|NCT01062399|12001351|FG004|NOT COMPLETED|Overall Study||4
10835892|NCT00750269|12001368|FG000|STARTED|Overall Study||8
10835893|NCT00750269|12001369|FG001|STARTED|Overall Study||8
10835894|NCT00750269|12001370|FG002|STARTED|Overall Study||18
10835895|NCT00750269|12001371|FG003|STARTED|Overall Study||43
11103485|NCT01243151|12287697|FG001|Treated|Overall Study||14
11103486|NCT01243151|12287698|FG002|Treated|Overall Study||14
11103487|NCT01243151|12287699|FG003|Treated|Overall Study||13
11103488|NCT01243151|12287700|FG004|Treated|Overall Study||14
11103489|NCT01243151|12287696|FG000|COMPLETED|Overall Study||12
11103490|NCT01243151|12287697|FG001|COMPLETED|Overall Study||13
11103491|NCT01243151|12287698|FG002|COMPLETED|Overall Study||13
11103492|NCT01243151|12287699|FG003|COMPLETED|Overall Study||12
11103493|NCT01243151|12287700|FG004|COMPLETED|Overall Study||14
11103494|NCT01243151|12287696|FG000|NOT COMPLETED|Overall Study||0
11103495|NCT01243151|12287697|FG001|NOT COMPLETED|Overall Study||1
11220352|NCT01959607|12411946|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11220353|NCT01959607|12411943|FG000|STARTED|Second Intervention (Day 3)||21
11220354|NCT01959607|12411944|FG001|STARTED|Second Intervention (Day 3)||21
11220355|NCT01959607|12411945|FG002|STARTED|Second Intervention (Day 3)||9
11220356|NCT01959607|12411946|FG003|STARTED|Second Intervention (Day 3)||9
11220357|NCT01959607|12411943|FG000|COMPLETED|Second Intervention (Day 3)||21
11220358|NCT01959607|12411944|FG001|COMPLETED|Second Intervention (Day 3)||21
11220359|NCT01959607|12411945|FG002|COMPLETED|Second Intervention (Day 3)||9
11220360|NCT01959607|12411946|FG003|COMPLETED|Second Intervention (Day 3)||9
11220361|NCT01959607|12411943|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
11354119|NCT03069716|12551331|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0
11354120|NCT03069716|12551329|FG000|STARTED|Randomized Treatment||0
11354121|NCT03069716|12551330|FG001|STARTED|Randomized Treatment||20
11354122|NCT03069716|12551331|FG002|STARTED|Randomized Treatment||22
11103496|NCT01243151|12287698|FG002|NOT COMPLETED|Overall Study||1
11103497|NCT01243151|12287699|FG003|NOT COMPLETED|Overall Study||2
11103498|NCT01243151|12287700|FG004|NOT COMPLETED|Overall Study||0
11354123|NCT03069716|12551329|FG000|COMPLETED|Randomized Treatment||0
11354124|NCT03069716|12551330|FG001|COMPLETED|Randomized Treatment||18
11354125|NCT03069716|12551331|FG002|COMPLETED|Randomized Treatment||22
11354126|NCT03069716|12551329|FG000|NOT COMPLETED|Randomized Treatment||0
11354127|NCT03069716|12551330|FG001|NOT COMPLETED|Randomized Treatment||2
11220362|NCT01959607|12411944|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
11220363|NCT01959607|12411945|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
11220364|NCT01959607|12411946|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
11220365|NCT01959672|12411955|FG000|STARTED|Overall Study||11
11220366|NCT01959672|12411955|FG000|COMPLETED|Overall Study||10
11220367|NCT01959672|12411955|FG000|NOT COMPLETED|Overall Study||1
11220368|NCT01959685|12411962|FG000|STARTED|Overall Study||9
11220369|NCT01959685|12411962|FG000|COMPLETED|Overall Study||9
11220370|NCT01959685|12411962|FG000|NOT COMPLETED|Overall Study||0
11220371|NCT01959841|12411969|FG000|STARTED|Overall Study||252
11220372|NCT01959841|12411970|FG001|STARTED|Overall Study||250
11220373|NCT01959841|12411971|FG002|STARTED|Overall Study||249
11220374|NCT01959841|12411969|FG000|Full Analysis Set Included|Overall Study||247
11220375|NCT01959841|12411970|FG001|Full Analysis Set Included|Overall Study||243
11220376|NCT01959841|12411971|FG002|Full Analysis Set Included|Overall Study||245
11220377|NCT01959841|12411969|FG000|Full Analysis Set Excluded|Overall Study||5
11220378|NCT01959841|12411970|FG001|Full Analysis Set Excluded|Overall Study||7
11220379|NCT01959841|12411971|FG002|Full Analysis Set Excluded|Overall Study||4
11220380|NCT01959841|12411969|FG000|Reason FAS Excluding 1|Overall Study||5
11220381|NCT01959841|12411970|FG001|Reason FAS Excluding 1|Overall Study||5
11220382|NCT01959841|12411971|FG002|Reason FAS Excluding 1|Overall Study||4
11220383|NCT01959841|12411969|FG000|Reason FAS Excluding 2|Overall Study||0
11220384|NCT01959841|12411970|FG001|Reason FAS Excluding 2|Overall Study||1
11220385|NCT01959841|12411971|FG002|Reason FAS Excluding 2|Overall Study||0
11220386|NCT01959841|12411969|FG000|Reason FAS Excluding 3|Overall Study||0
11220387|NCT01959841|12411970|FG001|Reason FAS Excluding 3|Overall Study||1
11220388|NCT01959841|12411971|FG002|Reason FAS Excluding 3|Overall Study||0
11220389|NCT01959841|12411969|FG000|COMPLETED|Overall Study||209
11220390|NCT01959841|12411970|FG001|COMPLETED|Overall Study||193
11220391|NCT01959841|12411971|FG002|COMPLETED|Overall Study||206
11220392|NCT01959841|12411969|FG000|NOT COMPLETED|Overall Study||43
11220393|NCT01959841|12411970|FG001|NOT COMPLETED|Overall Study||57
11220394|NCT01959841|12411971|FG002|NOT COMPLETED|Overall Study||43
11220395|NCT01959880|12411983|FG000|STARTED|Overall Study||1132
11220396|NCT01959880|12411984|FG001|STARTED|Overall Study||369
11220397|NCT01959880|12411985|FG002|STARTED|Overall Study||209
11220398|NCT01959880|12411986|FG003|STARTED|Overall Study||181
11220399|NCT01959880|12411983|FG000|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
10835896|NCT00750269|12001372|FG004|STARTED|Overall Study||43
11103499|NCT01243177|12287718|FG000|STARTED|Overall Study||444
11103500|NCT01243177|12287719|FG001|STARTED|Overall Study||442
11220400|NCT01959880|12411984|FG001|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
11220401|NCT01959880|12411985|FG002|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
11354128|NCT03069716|12551331|FG002|NOT COMPLETED|Randomized Treatment||0
10835897|NCT00750269|12001368|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
10835898|NCT00750269|12001369|FG001|COMPLETED|Overall Study||7
10835899|NCT00750269|12001370|FG002|COMPLETED|Overall Study||14
10835900|NCT00750269|12001371|FG003|COMPLETED|Overall Study||38
10835901|NCT00750269|12001372|FG004|COMPLETED|Overall Study||33
10835902|NCT00750269|12001368|FG000|NOT COMPLETED|Overall Study||0
10835903|NCT00750269|12001369|FG001|NOT COMPLETED|Overall Study||1
10835904|NCT00750269|12001370|FG002|NOT COMPLETED|Overall Study||4
10835905|NCT00750269|12001371|FG003|NOT COMPLETED|Overall Study||5
10835906|NCT00750269|12001372|FG004|NOT COMPLETED|Overall Study||10
10835907|NCT00712322|12001394|FG000|STARTED|Overall Study||12
10835908|NCT00712322|12001395|FG001|STARTED|Overall Study||14
10835909|NCT00712322|12001396|FG002|STARTED|Overall Study||9
10835910|NCT00712322|12001394|FG000|COMPLETED|Overall Study||12
10835911|NCT00712322|12001395|FG001|COMPLETED|Overall Study||13
10835912|NCT00712322|12001396|FG002|COMPLETED|Overall Study||9
10835913|NCT00712322|12001394|FG000|NOT COMPLETED|Overall Study||0
10835914|NCT00712322|12001395|FG001|NOT COMPLETED|Overall Study||1
10835915|NCT00712322|12001396|FG002|NOT COMPLETED|Overall Study||0
10835916|NCT00323856|12001404|FG000|STARTED|Overall Study||50
10835917|NCT00323856|12001404|FG000|COMPLETED|Overall Study||45
10835918|NCT00323856|12001404|FG000|NOT COMPLETED|Overall Study||5
10835919|NCT00103038|12001408|FG000|STARTED|Overall Study||155
10835920|NCT00103038|12001408|FG000|COMPLETED|Overall Study||142
10835921|NCT00103038|12001408|FG000|NOT COMPLETED|Overall Study||13
10835922|NCT05086835|12001415|FG000|STARTED|Overall Study||10
10835923|NCT05086835|12001415|FG000|COMPLETED|Overall Study||10
10835924|NCT05086835|12001415|FG000|NOT COMPLETED|Overall Study||0
10835925|NCT04524663|12001424|FG000|STARTED|Overall Study||25
10835926|NCT04524663|12001425|FG001|STARTED|Overall Study||24
10835927|NCT04524663|12001424|FG000|COMPLETED|Overall Study||25
10835928|NCT04524663|12001425|FG001|COMPLETED|Overall Study||22
10835929|NCT04524663|12001424|FG000|NOT COMPLETED|Overall Study||0
10835930|NCT04524663|12001425|FG001|NOT COMPLETED|Overall Study||2
11103501|NCT01243177|12287718|FG000|COMPLETED|Overall Study||266
11103502|NCT01243177|12287719|FG001|COMPLETED|Overall Study||264
11103503|NCT01243177|12287718|FG000|NOT COMPLETED|Overall Study||178
11103504|NCT01243177|12287719|FG001|NOT COMPLETED|Overall Study||178
11103505|NCT01243242|12287727|FG000|STARTED|Overall Study||60
11103506|NCT01243242|12287728|FG001|STARTED|Overall Study||60
11103507|NCT01243242|12287727|FG000|COMPLETED|Overall Study||57
11103508|NCT01243242|12287728|FG001|COMPLETED|Overall Study||56
11103509|NCT01243242|12287727|FG000|NOT COMPLETED|Overall Study||3
11103510|NCT01243242|12287728|FG001|NOT COMPLETED|Overall Study||4
11103511|NCT01243268|12287734|FG000|STARTED|Overall Study||674
11103512|NCT01243268|12287734|FG000|COMPLETED|Overall Study||610
11103513|NCT01243268|12287734|FG000|NOT COMPLETED|Overall Study||64
11103514|NCT01243294|12287738|FG000|STARTED|First Intervention (10 Days +/- 2 Days)||28
11103515|NCT01243294|12287739|FG001|STARTED|First Intervention (10 Days +/- 2 Days)||26
11103516|NCT01243294|12287738|FG000|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
11103517|NCT01243294|12287739|FG001|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
11103518|NCT01243294|12287738|FG000|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
11103519|NCT01243294|12287739|FG001|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
11103520|NCT01243294|12287738|FG000|STARTED|Second Intervention (10 Days +/- 2 Days)||28
10835972|NCT03738423|12001481|FG000|STARTED|Overall Study||25
10835973|NCT03738423|12001482|FG001|STARTED|Overall Study||26
10835974|NCT03738423|12001483|FG002|STARTED|Overall Study||27
10835975|NCT03738423|12001484|FG003|STARTED|Overall Study||25
10835976|NCT03738423|12001485|FG004|STARTED|Overall Study||26
10835977|NCT03738423|12001481|FG000|Treated|Overall Study||25
10835978|NCT03738423|12001482|FG001|Treated|Overall Study||26
10835979|NCT03738423|12001483|FG002|Treated|Overall Study||26
10835980|NCT03738423|12001484|FG003|Treated|Overall Study||24
10835981|NCT03738423|12001485|FG004|Treated|Overall Study||26
10835982|NCT03738423|12001481|FG000|COMPLETED|Overall Study||11
10835983|NCT03738423|12001482|FG001|COMPLETED|Overall Study||13
10835984|NCT03738423|12001483|FG002|COMPLETED|Overall Study||14
10835985|NCT03738423|12001484|FG003|COMPLETED|Overall Study||10
10835986|NCT03738423|12001485|FG004|COMPLETED|Overall Study||11
10835987|NCT03738423|12001481|FG000|NOT COMPLETED|Overall Study||14
10835988|NCT03738423|12001482|FG001|NOT COMPLETED|Overall Study||13
10835989|NCT03738423|12001483|FG002|NOT COMPLETED|Overall Study||13
10835990|NCT03738423|12001484|FG003|NOT COMPLETED|Overall Study||15
10835991|NCT03738423|12001485|FG004|NOT COMPLETED|Overall Study||15
10835992|NCT03600818|12001499|FG000|STARTED|Overall Study||58
10835993|NCT03600818|12001500|FG001|STARTED|Overall Study||60
10835994|NCT03600818|12001499|FG000|Safety Population|Overall Study||58
10835995|NCT03600818|12001500|FG001|Safety Population|Overall Study||59
10835996|NCT03600818|12001499|FG000|COMPLETED|Overall Study||36
10835997|NCT03600818|12001500|FG001|COMPLETED|Overall Study||42
11220402|NCT01959880|12411986|FG003|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
11220403|NCT01959880|12411983|FG000|NOT COMPLETED|Overall Study||1132
11220404|NCT01959880|12411984|FG001|NOT COMPLETED|Overall Study||369
11220405|NCT01959880|12411985|FG002|NOT COMPLETED|Overall Study||208
11220406|NCT01959880|12411986|FG003|NOT COMPLETED|Overall Study||181
11220407|NCT01959919|12411996|FG000|STARTED|Overall Study||86
11220408|NCT01959919|12411996|FG000|COMPLETED|Overall Study||84
11220409|NCT01959919|12411996|FG000|NOT COMPLETED|Overall Study||2
11220410|NCT01959932|12412003|FG000|STARTED|Overall Study||80
11220411|NCT01959932|12412004|FG001|STARTED|Overall Study||41
11220412|NCT01959932|12412005|FG002|STARTED|Overall Study||39
11220413|NCT01959932|12412003|FG000|COMPLETED|Overall Study||79
11220414|NCT01959932|12412004|FG001|COMPLETED|Overall Study||41
11220415|NCT01959932|12412005|FG002|COMPLETED|Overall Study||39
11220416|NCT01959932|12412003|FG000|NOT COMPLETED|Overall Study||1
11220417|NCT01959932|12412004|FG001|NOT COMPLETED|Overall Study||0
11220418|NCT01959932|12412005|FG002|NOT COMPLETED|Overall Study||0
11220419|NCT01959945|12412018|FG000|STARTED|Overall Study||80
11220420|NCT01959945|12412019|FG001|STARTED|Overall Study||78
11220421|NCT01959945|12412020|FG002|STARTED|Overall Study||28
11220422|NCT01959945|12412021|FG003|STARTED|Overall Study||31
11220423|NCT01959945|12412018|FG000|COMPLETED|Overall Study||76
11220424|NCT01959945|12412019|FG001|COMPLETED|Overall Study||75
11220425|NCT01959945|12412020|FG002|COMPLETED|Overall Study||9
11220426|NCT01959945|12412021|FG003|COMPLETED|Overall Study||15
11220427|NCT01959945|12412018|FG000|NOT COMPLETED|Overall Study||4
11220428|NCT01959945|12412019|FG001|NOT COMPLETED|Overall Study||3
11220429|NCT01959945|12412020|FG002|NOT COMPLETED|Overall Study||19
10835998|NCT03600818|12001499|FG000|NOT COMPLETED|Overall Study||22
10835999|NCT03600818|12001500|FG001|NOT COMPLETED|Overall Study||18
10836000|NCT03578276|12001509|FG000|STARTED|Overall Study||35
10836001|NCT03578276|12001510|FG001|STARTED|Overall Study||35
10836002|NCT03578276|12001509|FG000|COMPLETED|Overall Study||33
10836003|NCT03578276|12001510|FG001|COMPLETED|Overall Study||33
10836004|NCT03578276|12001509|FG000|NOT COMPLETED|Overall Study||2
10836005|NCT03578276|12001510|FG001|NOT COMPLETED|Overall Study||2
10836006|NCT03257696|12001518|FG000|STARTED|Overall Study||123
10836007|NCT03257696|12001519|FG001|STARTED|Overall Study||29
10836008|NCT03257696|12001518|FG000|COMPLETED|Overall Study||123
10836009|NCT03257696|12001519|FG001|COMPLETED|Overall Study||29
10836010|NCT03257696|12001518|FG000|NOT COMPLETED|Overall Study||0
10836011|NCT03257696|12001519|FG001|NOT COMPLETED|Overall Study||0
10836012|NCT03035409|12001525|FG000|STARTED|Overall Study||45
10835931|NCT04435795|12001433|FG000|STARTED|Overall Study||108
10835932|NCT04435795|12001434|FG001|STARTED|Overall Study||107
10835933|NCT04435795|12001433|FG000|COMPLETED|Overall Study||105
10835934|NCT04435795|12001434|FG001|COMPLETED|Overall Study||98
10835935|NCT04435795|12001433|FG000|NOT COMPLETED|Overall Study||3
10835936|NCT04435795|12001434|FG001|NOT COMPLETED|Overall Study||9
10835937|NCT04350593|12001442|FG000|STARTED|Overall Study||625
10835938|NCT04350593|12001443|FG001|STARTED|Overall Study||625
10835939|NCT04350593|12001442|FG000|COMPLETED|Overall Study||617
10835940|NCT04350593|12001443|FG001|COMPLETED|Overall Study||620
10835941|NCT04350593|12001442|FG000|NOT COMPLETED|Overall Study||8
10835942|NCT04350593|12001443|FG001|NOT COMPLETED|Overall Study||5
10835943|NCT04208243|12001449|FG000|STARTED|Overall Study||83
10835944|NCT04208243|12001449|FG000|COMPLETED|Overall Study||83
10835945|NCT04208243|12001449|FG000|NOT COMPLETED|Overall Study||0
11103521|NCT01243294|12287739|FG001|STARTED|Second Intervention (10 Days +/- 2 Days)||26
11103522|NCT01243294|12287738|FG000|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
11103523|NCT01243294|12287739|FG001|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
11103524|NCT01243294|12287738|FG000|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
11103525|NCT01243294|12287739|FG001|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
11103526|NCT01243320|12287745|FG000|STARTED|10ppm Oral Silver (3 Days)||36
11103527|NCT01243320|12287745|FG000|COMPLETED|10ppm Oral Silver (3 Days)||36
11103528|NCT01243320|12287745|FG000|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
11103529|NCT01243320|12287745|FG000|STARTED|10ppm Oral Silver (7 Days)||36
11103530|NCT01243320|12287745|FG000|COMPLETED|10ppm Oral Silver (7 Days)||36
11103531|NCT01243320|12287745|FG000|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
11103532|NCT01243320|12287745|FG000|STARTED|10ppm Oral Silver (14 Days)||36
11103533|NCT01243320|12287745|FG000|COMPLETED|10ppm Oral Silver (14 Days)||36
11103534|NCT01243320|12287745|FG000|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
10836013|NCT03035409|12001525|FG000|Day 15|Overall Study||28
10836014|NCT03035409|12001525|FG000|Day 29|Overall Study||28
10836015|NCT03035409|12001525|FG000|Day 43|Overall Study||28
10836016|NCT03035409|12001525|FG000|COMPLETED|Overall Study||28
10836017|NCT03035409|12001525|FG000|NOT COMPLETED|Overall Study||17
10836018|NCT02971761|12001529|FG000|STARTED|Overall Study||18
10836019|NCT02971761|12001529|FG000|COMPLETED|Overall Study||16
10836020|NCT02971761|12001529|FG000|NOT COMPLETED|Overall Study||2
10836021|NCT02900560|12001537|FG000|STARTED|Overall Study||9
10836022|NCT02900560|12001538|FG001|STARTED|Overall Study||10
10836023|NCT02900560|12001539|FG002|STARTED|Overall Study||7
10836024|NCT02900560|12001540|FG003|STARTED|Overall Study||8
10836025|NCT02900560|12001537|FG000|COMPLETED|Overall Study||7
10836026|NCT02900560|12001538|FG001|COMPLETED|Overall Study||10
10836027|NCT02900560|12001539|FG002|COMPLETED|Overall Study||7
10836028|NCT02900560|12001540|FG003|COMPLETED|Overall Study||8
10836029|NCT02900560|12001537|FG000|NOT COMPLETED|Overall Study||2
10836030|NCT02900560|12001538|FG001|NOT COMPLETED|Overall Study||0
10836031|NCT02900560|12001539|FG002|NOT COMPLETED|Overall Study||0
10836032|NCT02900560|12001540|FG003|NOT COMPLETED|Overall Study||0
11103535|NCT01243320|12287745|FG000|STARTED|Washout (3 Days)||36
11103536|NCT01243320|12287745|FG000|COMPLETED|Washout (3 Days)||36
11103537|NCT01243320|12287745|FG000|NOT COMPLETED|Washout (3 Days)||0
11103538|NCT01243320|12287745|FG000|STARTED|32ppm Oral Silver (14 Days)||24
11103539|NCT01243320|12287745|FG000|COMPLETED|32ppm Oral Silver (14 Days)||24
11103540|NCT01243320|12287745|FG000|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
11103541|NCT01243333|12287751|FG000|STARTED|Overall Study||26
11103542|NCT01243333|12287751|FG000|COMPLETED|Overall Study||18
11103543|NCT01243333|12287751|FG000|NOT COMPLETED|Overall Study||8
11103544|NCT01243411|12287755|FG000|STARTED|Overall Study||347
11103545|NCT01243411|12287755|FG000|COMPLETED|Overall Study||306
11103546|NCT01243411|12287755|FG000|NOT COMPLETED|Overall Study||41
11103547|NCT01243424|12287761|FG000|STARTED|Discontinuation From Study (Treated Set)||3028
11103548|NCT01243424|12287762|FG001|STARTED|Discontinuation From Study (Treated Set)||3014
11103549|NCT01243424|12287761|FG000|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123
11103550|NCT01243424|12287762|FG001|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146
11103551|NCT01243424|12287761|FG000|Treated|Discontinuation From Study (Treated Set)||3023
11103552|NCT01243424|12287762|FG001|Treated|Discontinuation From Study (Treated Set)||3010
11103553|NCT01243424|12287761|FG000|COMPLETED|Discontinuation From Study (Treated Set)||2899
11103554|NCT01243424|12287762|FG001|COMPLETED|Discontinuation From Study (Treated Set)||2895
11103555|NCT01243424|12287761|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||129
11103556|NCT01243424|12287762|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||119
10836055|NCT01968213|12001570|FG000|STARTED|Overall Study||375
10836056|NCT01968213|12001571|FG001|STARTED|Overall Study||189
10836057|NCT01968213|12001570|FG000|COMPLETED|Overall Study||285
10836058|NCT01968213|12001571|FG001|COMPLETED|Overall Study||180
10836059|NCT01968213|12001570|FG000|NOT COMPLETED|Overall Study||90
10836060|NCT01968213|12001571|FG001|NOT COMPLETED|Overall Study||9
11103557|NCT01243424|12287761|FG000|STARTED|Discontinuation From Treatment||3028
11103558|NCT01243424|12287762|FG001|STARTED|Discontinuation From Treatment||3014
11103559|NCT01243424|12287761|FG000|Treated|Discontinuation From Treatment||3023
10836069|NCT01656486|12001589|FG000|STARTED|Overall Study||1
10836070|NCT01656486|12001589|FG000|COMPLETED|Overall Study||1
10836071|NCT01656486|12001589|FG000|NOT COMPLETED|Overall Study||0
10836072|NCT01627574|12001595|FG000|STARTED|Overall Study||142
10836073|NCT01627574|12001596|FG001|STARTED|Overall Study||130
10836074|NCT01627574|12001595|FG000|COMPLETED|Overall Study||121
10836075|NCT01627574|12001596|FG001|COMPLETED|Overall Study||112
10836076|NCT01627574|12001595|FG000|NOT COMPLETED|Overall Study||21
10836077|NCT01627574|12001596|FG001|NOT COMPLETED|Overall Study||18
10836078|NCT01498458|12001602|FG000|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
10836079|NCT01498458|12001602|FG000|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
10836080|NCT01498458|12001602|FG000|NOT COMPLETED|Overall Study||7
10836081|NCT01427712|12001611|FG000|STARTED|Overall Study||24
10836082|NCT01427712|12001611|FG000|Collected CRFs|Overall Study||21
10836083|NCT01427712|12001611|FG000|Safety Analysis Set|Overall Study||21
10836084|NCT01427712|12001611|FG000|COMPLETED|Overall Study||17
10836085|NCT01427712|12001611|FG000|NOT COMPLETED|Overall Study||7
10836086|NCT01369147|12001618|FG000|STARTED|Overall Study||3
10836087|NCT01369147|12001619|FG001|STARTED|Overall Study||5
10836088|NCT01369147|12001620|FG002|STARTED|Overall Study||4
10836089|NCT01369147|12001618|FG000|COMPLETED|Overall Study||3
10836090|NCT01369147|12001619|FG001|COMPLETED|Overall Study||4
10836091|NCT01369147|12001620|FG002|COMPLETED|Overall Study||4
10836092|NCT01369147|12001618|FG000|NOT COMPLETED|Overall Study||0
10836093|NCT01369147|12001619|FG001|NOT COMPLETED|Overall Study||1
10836094|NCT01369147|12001620|FG002|NOT COMPLETED|Overall Study||0
10836095|NCT01097746|12001628|FG000|STARTED|Overall Study||33
10836096|NCT01097746|12001628|FG000|COMPLETED|Overall Study||28
10836097|NCT01097746|12001628|FG000|NOT COMPLETED|Overall Study||5
10836098|NCT01079780|12001635|FG000|STARTED|Overall Study||70
10836099|NCT01079780|12001636|FG001|STARTED|Overall Study||16
10836100|NCT01079780|12001637|FG002|STARTED|Overall Study||50
10836101|NCT01079780|12001635|FG000|Started Protocol Therapy|Overall Study||69
10836102|NCT01079780|12001636|FG001|Started Protocol Therapy|Overall Study||16
10836103|NCT01079780|12001637|FG002|Started Protocol Therapy|Overall Study||48
10836104|NCT01079780|12001635|FG000|Treated Patients With Toxicity Data Available|Overall Study||68
10836105|NCT01079780|12001636|FG001|Treated Patients With Toxicity Data Available|Overall Study||16
10836106|NCT01079780|12001637|FG002|Treated Patients With Toxicity Data Available|Overall Study||48
11354129|NCT03069989|12551340|FG000|STARTED|Dosing Period 1 (Up to 2 Days)||3
10836107|NCT01079780|12001635|FG000|Eligible and Treated|Overall Study||62
10836108|NCT01079780|12001636|FG001|Eligible and Treated|Overall Study||16
10836109|NCT01079780|12001637|FG002|Eligible and Treated|Overall Study||45
10836110|NCT01079780|12001635|FG000|Analyzable Patients for Efficacy Analysis|Overall Study||44
10836111|NCT01079780|12001636|FG001|Analyzable Patients for Efficacy Analysis|Overall Study||0
10836112|NCT01079780|12001637|FG002|Analyzable Patients for Efficacy Analysis|Overall Study||45
10836113|NCT01079780|12001635|FG000|COMPLETED|Overall Study||0
10836114|NCT01079780|12001636|FG001|COMPLETED|Overall Study||0
10836115|NCT01079780|12001637|FG002|COMPLETED|Overall Study||0
10836116|NCT01079780|12001635|FG000|NOT COMPLETED|Overall Study||70
10836117|NCT01079780|12001636|FG001|NOT COMPLETED|Overall Study||16
10836118|NCT01079780|12001637|FG002|NOT COMPLETED|Overall Study||50
10836119|NCT00075946|12001649|FG000|STARTED|Overall Study||148
10836120|NCT00075946|12001650|FG001|STARTED|Overall Study||151
10836121|NCT00075946|12001651|FG002|STARTED|Overall Study||28
10836122|NCT00075946|12001652|FG003|STARTED|Overall Study||30
10836123|NCT00075946|12001653|FG004|STARTED|Overall Study||188
10836124|NCT00075946|12001649|FG000|Treated and With Toxicity Data Available|Overall Study||142
10836125|NCT00075946|12001650|FG001|Treated and With Toxicity Data Available|Overall Study||148
10836126|NCT00075946|12001651|FG002|Treated and With Toxicity Data Available|Overall Study||27
10836127|NCT00075946|12001652|FG003|Treated and With Toxicity Data Available|Overall Study||29
10836128|NCT00075946|12001653|FG004|Treated and With Toxicity Data Available|Overall Study||154
10836129|NCT00075946|12001649|FG000|Included in Primary Analysis|Overall Study||143
10836130|NCT00075946|12001650|FG001|Included in Primary Analysis|Overall Study||146
10836131|NCT00075946|12001651|FG002|Included in Primary Analysis|Overall Study||23
10836132|NCT00075946|12001652|FG003|Included in Primary Analysis|Overall Study||29
10836133|NCT00075946|12001653|FG004|Included in Primary Analysis|Overall Study||0
10836134|NCT00075946|12001649|FG000|COMPLETED|Overall Study||0
10836135|NCT00075946|12001650|FG001|COMPLETED|Overall Study||0
10836136|NCT00075946|12001651|FG002|COMPLETED|Overall Study||0
10836137|NCT00075946|12001652|FG003|COMPLETED|Overall Study||0
10836138|NCT00075946|12001653|FG004|COMPLETED|Overall Study||0
10836139|NCT00075946|12001649|FG000|NOT COMPLETED|Overall Study||148
10836140|NCT00075946|12001650|FG001|NOT COMPLETED|Overall Study||151
10836141|NCT00075946|12001651|FG002|NOT COMPLETED|Overall Study||28
10836142|NCT00075946|12001652|FG003|NOT COMPLETED|Overall Study||30
10836143|NCT00075946|12001653|FG004|NOT COMPLETED|Overall Study||188
10836144|NCT00003641|12001666|FG000|STARTED|Overall Study||569
10836145|NCT00003641|12001667|FG001|STARTED|Overall Study||581
10836146|NCT00003641|12001666|FG000|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
10836147|NCT00003641|12001667|FG001|Treated|Overall Study||569
10836148|NCT00003641|12001666|FG000|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
10836149|NCT00003641|12001667|FG001|Toxicity Assessed|Overall Study||568
10836150|NCT00003641|12001666|FG000|COMPLETED|Overall Study||0
10836151|NCT00003641|12001667|FG001|COMPLETED|Overall Study||407
10836152|NCT00003641|12001666|FG000|NOT COMPLETED|Overall Study||569
10836153|NCT00003641|12001667|FG001|NOT COMPLETED|Overall Study||174
10836154|NCT01956669|12001680|FG000|STARTED|Overall Study||12
10836155|NCT01956669|12001681|FG001|STARTED|Overall Study||11
10836156|NCT01956669|12001682|FG002|STARTED|Overall Study||10
10836157|NCT01956669|12001683|FG003|STARTED|Overall Study||10
10836158|NCT01956669|12001684|FG004|STARTED|Overall Study||4
10836159|NCT01956669|12001685|FG005|STARTED|Overall Study||4
10836160|NCT01956669|12001686|FG006|STARTED|Overall Study||6
10836161|NCT01956669|12001680|FG000|PK Set|Overall Study||11
10836162|NCT01956669|12001681|FG001|PK Set|Overall Study||11
10836163|NCT01956669|12001682|FG002|PK Set|Overall Study||10
10836164|NCT01956669|12001683|FG003|PK Set|Overall Study||10
10836165|NCT01956669|12001684|FG004|PK Set|Overall Study||4
10836166|NCT01956669|12001685|FG005|PK Set|Overall Study||4
10836167|NCT01956669|12001686|FG006|PK Set|Overall Study||6
10836168|NCT01956669|12001680|FG000|PKES Set|Overall Study||4
10836169|NCT01956669|12001681|FG001|PKES Set|Overall Study||0
10836170|NCT01956669|12001682|FG002|PKES Set|Overall Study||3
10836171|NCT01956669|12001683|FG003|PKES Set|Overall Study||0
10836172|NCT01956669|12001684|FG004|PKES Set|Overall Study||1
11103560|NCT01243424|12287762|FG001|Treated|Discontinuation From Treatment||3010
11103561|NCT01243424|12287761|FG000|COMPLETED|Discontinuation From Treatment||1896
11103562|NCT01243424|12287762|FG001|COMPLETED|Discontinuation From Treatment||1832
11103563|NCT01243424|12287761|FG000|NOT COMPLETED|Discontinuation From Treatment||1132
11103564|NCT01243424|12287762|FG001|NOT COMPLETED|Discontinuation From Treatment||1182
11103565|NCT01243450|12287772|FG000|STARTED|Overall Study||401
11103566|NCT01243450|12287773|FG001|STARTED|Overall Study||135
11103567|NCT01243450|12287774|FG002|STARTED|Overall Study||404
11103568|NCT01243450|12287772|FG000|COMPLETED|Overall Study||318
11103569|NCT01243450|12287773|FG001|COMPLETED|Overall Study||110
11103570|NCT01243450|12287774|FG002|COMPLETED|Overall Study||337
11103571|NCT01243450|12287772|FG000|NOT COMPLETED|Overall Study||83
11103572|NCT01243450|12287773|FG001|NOT COMPLETED|Overall Study||25
11103573|NCT01243450|12287774|FG002|NOT COMPLETED|Overall Study||67
11103574|NCT01243567|12287784|FG000|STARTED|Overall Study||43
11103575|NCT01243567|12287785|FG001|STARTED|Overall Study||38
11103576|NCT01243567|12287784|FG000|COMPLETED|Overall Study||42
11103577|NCT01243567|12287785|FG001|COMPLETED|Overall Study||38
11103578|NCT01243567|12287784|FG000|NOT COMPLETED|Overall Study||1
11103579|NCT01243567|12287785|FG001|NOT COMPLETED|Overall Study||0
11103580|NCT01243580|12287793|FG000|STARTED|Overall Study||18
11103581|NCT01243580|12287794|FG001|STARTED|Overall Study||18
11103582|NCT01243580|12287793|FG000|COMPLETED|Overall Study||18
11103583|NCT01243580|12287794|FG001|COMPLETED|Overall Study||16
11103584|NCT01243580|12287793|FG000|NOT COMPLETED|Overall Study||0
11103585|NCT01243580|12287794|FG001|NOT COMPLETED|Overall Study||2
11103586|NCT01243593|12287804|FG000|STARTED|Overall Study||16
11103587|NCT01243593|12287805|FG001|STARTED|Overall Study||16
11103588|NCT01243593|12287804|FG000|COMPLETED|Overall Study||16
11103589|NCT01243593|12287805|FG001|COMPLETED|Overall Study||16
11103590|NCT01243593|12287804|FG000|NOT COMPLETED|Overall Study||0
11103591|NCT01243593|12287805|FG001|NOT COMPLETED|Overall Study||0
11103592|NCT01243619|12287811|FG000|STARTED|Overall Study||5
11103593|NCT01243619|12287811|FG000|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
11103594|NCT01243619|12287811|FG000|NOT COMPLETED|Overall Study||0
11103595|NCT01243671|12287815|FG000|STARTED|Overall Study||20
11103596|NCT01243671|12287815|FG000|Completed 24 Weeks of Treatment|Overall Study||18
11103597|NCT01243671|12287815|FG000|Completed 52 Weeks of Treatment|Overall Study||17
11103598|NCT01243671|12287815|FG000|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
11103599|NCT01243671|12287815|FG000|NOT COMPLETED|Overall Study||5
11103600|NCT01243762|12287826|FG000|STARTED|Part 1 (Dose Escalation/MTD)||4
11103601|NCT01243762|12287827|FG001|STARTED|Part 1 (Dose Escalation/MTD)||13
11103602|NCT01243762|12287828|FG002|STARTED|Part 1 (Dose Escalation/MTD)||3
11103603|NCT01243762|12287829|FG003|STARTED|Part 1 (Dose Escalation/MTD)||8
11103604|NCT01243762|12287830|FG004|STARTED|Part 1 (Dose Escalation/MTD)||10
11103605|NCT01243762|12287831|FG005|STARTED|Part 1 (Dose Escalation/MTD)||3
11103606|NCT01243762|12287832|FG006|STARTED|Part 1 (Dose Escalation/MTD)||0
11103607|NCT01243762|12287826|FG000|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
11103608|NCT01243762|12287827|FG001|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
11103609|NCT01243762|12287828|FG002|COMPLETED|Part 1 (Dose Escalation/MTD)||0
11103610|NCT01243762|12287829|FG003|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
11103611|NCT01243762|12287830|FG004|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
11103612|NCT01243762|12287831|FG005|COMPLETED|Part 1 (Dose Escalation/MTD)||0
11103613|NCT01243762|12287832|FG006|COMPLETED|Part 1 (Dose Escalation/MTD)||0
11103614|NCT01243762|12287826|FG000|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
11103615|NCT01243762|12287827|FG001|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
11103616|NCT01243762|12287828|FG002|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
11103617|NCT01243762|12287829|FG003|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
11103618|NCT01243762|12287830|FG004|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
11103619|NCT01243762|12287831|FG005|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
11103620|NCT01243762|12287832|FG006|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
11103621|NCT01243762|12287826|FG000|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
11103622|NCT01243762|12287827|FG001|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
10836173|NCT01956669|12001685|FG005|PKES Set|Overall Study||1
10836174|NCT01956669|12001686|FG006|PKES Set|Overall Study||5
10836175|NCT01956669|12001680|FG000|Biomarker Set|Overall Study||12
10836176|NCT01956669|12001681|FG001|Biomarker Set|Overall Study||11
10836177|NCT01956669|12001682|FG002|Biomarker Set|Overall Study||9
10836178|NCT01956669|12001683|FG003|Biomarker Set|Overall Study||9
10836179|NCT01956669|12001684|FG004|Biomarker Set|Overall Study||3
10836180|NCT01956669|12001685|FG005|Biomarker Set|Overall Study||4
10836181|NCT01956669|12001686|FG006|Biomarker Set|Overall Study||3
10836182|NCT01956669|12001680|FG000|Per Protocol Set (PP Set)|Overall Study||9
10836183|NCT01956669|12001681|FG001|Per Protocol Set (PP Set)|Overall Study||10
10836184|NCT01956669|12001682|FG002|Per Protocol Set (PP Set)|Overall Study||6
10836185|NCT01956669|12001683|FG003|Per Protocol Set (PP Set)|Overall Study||9
10836186|NCT01956669|12001684|FG004|Per Protocol Set (PP Set)|Overall Study||4
10836187|NCT01956669|12001685|FG005|Per Protocol Set (PP Set)|Overall Study||4
10836188|NCT01956669|12001686|FG006|Per Protocol Set (PP Set)|Overall Study||5
10836189|NCT01956669|12001680|FG000|COMPLETED|Overall Study||0
10836190|NCT01956669|12001681|FG001|COMPLETED|Overall Study||0
10836191|NCT01956669|12001682|FG002|COMPLETED|Overall Study||0
10836192|NCT01956669|12001683|FG003|COMPLETED|Overall Study||0
10836193|NCT01956669|12001684|FG004|COMPLETED|Overall Study||0
11220430|NCT01959945|12412021|FG003|NOT COMPLETED|Overall Study||16
11220431|NCT01960075|12412036|FG000|STARTED|Overall Study||149
11220432|NCT01960075|12412037|FG001|STARTED|Overall Study||149
11220433|NCT01960075|12412038|FG002|STARTED|Overall Study||180
11220434|NCT01960075|12412036|FG000|COMPLETED|Overall Study||141
11220435|NCT01960075|12412037|FG001|COMPLETED|Overall Study||146
11220436|NCT01960075|12412038|FG002|COMPLETED|Overall Study||173
11220437|NCT01960075|12412036|FG000|NOT COMPLETED|Overall Study||8
11220438|NCT01960075|12412037|FG001|NOT COMPLETED|Overall Study||3
11220439|NCT01960075|12412038|FG002|NOT COMPLETED|Overall Study||7
11220440|NCT01960114|12412048|FG000|STARTED|Overall Study||134
11220441|NCT01960114|12412049|FG001|STARTED|Overall Study||269
11220442|NCT01960114|12412048|FG000|COMPLETED|Overall Study||133
11220443|NCT01960114|12412049|FG001|COMPLETED|Overall Study||268
11220444|NCT01960114|12412048|FG000|NOT COMPLETED|Overall Study||1
11220445|NCT01960114|12412049|FG001|NOT COMPLETED|Overall Study||1
11220446|NCT01960140|12412055|FG000|STARTED|Period 1 (Days 1-2)||40
11220447|NCT01960140|12412055|FG000|Received Simvastatin|Period 1 (Days 1-2)||40
11220448|NCT01960140|12412055|FG000|COMPLETED|Period 1 (Days 1-2)||40
11220449|NCT01960140|12412055|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0
11220450|NCT01960140|12412055|FG000|STARTED|Period 2 (Days 3-18)||40
11220451|NCT01960140|12412055|FG000|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
11220452|NCT01960140|12412055|FG000|Received Simvastatin|Period 2 (Days 3-18)||38
11220453|NCT01960140|12412055|FG000|COMPLETED|Period 2 (Days 3-18)||38
11220454|NCT01960140|12412055|FG000|NOT COMPLETED|Period 2 (Days 3-18)||2
11220455|NCT01960257|12412063|FG000|STARTED|Stage 1 (1-3 Weeks)||77
11220456|NCT01960257|12412064|FG001|STARTED|Stage 1 (1-3 Weeks)||0
11220457|NCT01960257|12412065|FG002|STARTED|Stage 1 (1-3 Weeks)||0
11220458|NCT01960257|12412063|FG000|COMPLETED|Stage 1 (1-3 Weeks)||61
11220459|NCT01960257|12412064|FG001|COMPLETED|Stage 1 (1-3 Weeks)||0
11220460|NCT01960257|12412065|FG002|COMPLETED|Stage 1 (1-3 Weeks)||0
11220461|NCT01960257|12412063|FG000|NOT COMPLETED|Stage 1 (1-3 Weeks)||16
11220462|NCT01960257|12412064|FG001|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
11220463|NCT01960257|12412065|FG002|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
11220464|NCT01960257|12412063|FG000|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
11220465|NCT01960257|12412064|FG001|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
11220466|NCT01960257|12412065|FG002|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
11220467|NCT01960257|12412063|FG000|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
11220468|NCT01960257|12412064|FG001|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
11220469|NCT01960257|12412065|FG002|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
11220470|NCT01960257|12412063|FG000|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
11220471|NCT01960257|12412064|FG001|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
11220472|NCT01960257|12412065|FG002|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
11220473|NCT01960296|12412077|FG000|STARTED|Overall Study||23
11220474|NCT01960296|12412078|FG001|STARTED|Overall Study||25
11220475|NCT01960296|12412077|FG000|COMPLETED|Overall Study||21
11220476|NCT01960296|12412078|FG001|COMPLETED|Overall Study||22
11220477|NCT01960296|12412077|FG000|NOT COMPLETED|Overall Study||2
11220478|NCT01960296|12412078|FG001|NOT COMPLETED|Overall Study||3
11220479|NCT01960348|12412086|FG000|STARTED|Overall Study||148
11220480|NCT01960348|12412087|FG001|STARTED|Overall Study||77
11220481|NCT01960348|12412086|FG000|COMPLETED|Overall Study||138
11220482|NCT01960348|12412087|FG001|COMPLETED|Overall Study||55
11220483|NCT01960348|12412086|FG000|NOT COMPLETED|Overall Study||10
11220484|NCT01960348|12412087|FG001|NOT COMPLETED|Overall Study||22
11220485|NCT01960387|12412093|FG000|STARTED|Overall Study||2
11220486|NCT01960387|12412093|FG000|COMPLETED|Overall Study||2
11220487|NCT01960387|12412093|FG000|NOT COMPLETED|Overall Study||0
11220488|NCT01960400|12412099|FG000|STARTED|Overall Study||11
11220489|NCT01960400|12412100|FG001|STARTED|Overall Study||11
11220490|NCT01960400|12412099|FG000|COMPLETED|Overall Study||11
11220491|NCT01960400|12412100|FG001|COMPLETED|Overall Study||11
11220492|NCT01960400|12412099|FG000|NOT COMPLETED|Overall Study||0
11220493|NCT01960400|12412100|FG001|NOT COMPLETED|Overall Study||0
10836194|NCT01956669|12001685|FG005|COMPLETED|Overall Study||0
10836195|NCT01956669|12001686|FG006|COMPLETED|Overall Study||0
10836196|NCT01956669|12001680|FG000|NOT COMPLETED|Overall Study||12
10836197|NCT01956669|12001681|FG001|NOT COMPLETED|Overall Study||11
10836198|NCT01956669|12001682|FG002|NOT COMPLETED|Overall Study||10
10836199|NCT01956669|12001683|FG003|NOT COMPLETED|Overall Study||10
10836200|NCT01956669|12001684|FG004|NOT COMPLETED|Overall Study||4
10836201|NCT01956669|12001685|FG005|NOT COMPLETED|Overall Study||4
10836202|NCT01956669|12001686|FG006|NOT COMPLETED|Overall Study||6
10836203|NCT01967823|12001711|FG000|STARTED|Overall Study||11
10836204|NCT01967823|12001711|FG000|COMPLETED|Overall Study||10
10836205|NCT01967823|12001711|FG000|NOT COMPLETED|Overall Study||1
10836206|NCT01989676|12001721|FG000|STARTED|Overall Study||352
10836207|NCT01989676|12001722|FG001|STARTED|Overall Study||355
10836208|NCT01989676|12001721|FG000|Treated|Overall Study||349
10836209|NCT01989676|12001722|FG001|Treated|Overall Study||353
10836210|NCT01989676|12001721|FG000|COMPLETED|Overall Study||234
10836211|NCT01989676|12001722|FG001|COMPLETED|Overall Study||217
10836212|NCT01989676|12001721|FG000|NOT COMPLETED|Overall Study||118
10836213|NCT01989676|12001722|FG001|NOT COMPLETED|Overall Study||138
11220494|NCT01960413|12412108|FG000|STARTED|Overall Study||24
10836214|NCT01992653|12001737|FG000|STARTED|Overall Study||3
10836215|NCT01992653|12001738|FG001|STARTED|Overall Study||3
10836216|NCT01992653|12001739|FG002|STARTED|Overall Study||6
10836217|NCT01992653|12001740|FG003|STARTED|Overall Study||1
10836218|NCT01992653|12001741|FG004|STARTED|Overall Study||6
10836219|NCT01992653|12001742|FG005|STARTED|Overall Study||6
10836220|NCT01992653|12001743|FG006|STARTED|Overall Study||40
10836221|NCT01992653|12001744|FG007|STARTED|Overall Study||17
10836222|NCT01992653|12001737|FG000|COMPLETED|Overall Study||3
10836223|NCT01992653|12001738|FG001|COMPLETED|Overall Study||3
10836224|NCT01992653|12001739|FG002|COMPLETED|Overall Study||5
10836225|NCT01992653|12001740|FG003|COMPLETED|Overall Study||1
10836226|NCT01992653|12001741|FG004|COMPLETED|Overall Study||5
10836227|NCT01992653|12001742|FG005|COMPLETED|Overall Study||6
10836228|NCT01992653|12001743|FG006|COMPLETED|Overall Study||32
10836229|NCT01992653|12001744|FG007|COMPLETED|Overall Study||13
10836230|NCT01992653|12001737|FG000|NOT COMPLETED|Overall Study||0
10836231|NCT01992653|12001738|FG001|NOT COMPLETED|Overall Study||0
10836232|NCT01992653|12001739|FG002|NOT COMPLETED|Overall Study||1
10836233|NCT01992653|12001740|FG003|NOT COMPLETED|Overall Study||0
10836234|NCT01992653|12001741|FG004|NOT COMPLETED|Overall Study||1
10836235|NCT01992653|12001742|FG005|NOT COMPLETED|Overall Study||0
10836236|NCT01992653|12001743|FG006|NOT COMPLETED|Overall Study||8
10836237|NCT01992653|12001744|FG007|NOT COMPLETED|Overall Study||4
10836238|NCT02001974|12001765|FG000|STARTED|Run-in Period||4
10836239|NCT02001974|12001766|FG001|STARTED|Run-in Period||3
10836240|NCT02001974|12001767|FG002|STARTED|Run-in Period||26
10836241|NCT02001974|12001765|FG000|COMPLETED|Run-in Period||4
10836242|NCT02001974|12001766|FG001|COMPLETED|Run-in Period||3
10836243|NCT02001974|12001767|FG002|COMPLETED|Run-in Period||26
10836244|NCT02001974|12001765|FG000|NOT COMPLETED|Run-in Period||0
10836245|NCT02001974|12001766|FG001|NOT COMPLETED|Run-in Period||0
10836246|NCT02001974|12001767|FG002|NOT COMPLETED|Run-in Period||0
10836247|NCT02001974|12001765|FG000|STARTED|Reparixin + Paclitaxel (28-day Cycles)||4
10836248|NCT02001974|12001766|FG001|STARTED|Reparixin + Paclitaxel (28-day Cycles)||3
10836249|NCT02001974|12001767|FG002|STARTED|Reparixin + Paclitaxel (28-day Cycles)||26
10836250|NCT02001974|12001765|FG000|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
10836251|NCT02001974|12001766|FG001|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
10836252|NCT02001974|12001767|FG002|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
10836253|NCT02001974|12001765|FG000|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||4
10836254|NCT02001974|12001766|FG001|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||3
10836255|NCT02001974|12001767|FG002|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||26
10836256|NCT02014558|12001788|FG000|STARTED|Overall Study||5
10836257|NCT02014558|12001789|FG001|STARTED|Overall Study||3
10836258|NCT02014558|12001790|FG002|STARTED|Overall Study||3
10836259|NCT02014558|12001791|FG003|STARTED|Overall Study||3
10836260|NCT02014558|12001792|FG004|STARTED|Overall Study||4
10836261|NCT02014558|12001793|FG005|STARTED|Overall Study||3
10836262|NCT02014558|12001794|FG006|STARTED|Overall Study||4
10836263|NCT02014558|12001795|FG007|STARTED|Overall Study||11
10836264|NCT02014558|12001796|FG008|STARTED|Overall Study||15
10836265|NCT02014558|12001797|FG009|STARTED|Overall Study||21
10836266|NCT02014558|12001798|FG010|STARTED|Overall Study||69
10836267|NCT02014558|12001799|FG011|STARTED|Overall Study||102
10836268|NCT02014558|12001800|FG012|STARTED|Overall Study||17
10836269|NCT02014558|12001788|FG000|Treated|Overall Study||5
10836270|NCT02014558|12001789|FG001|Treated|Overall Study||3
10836271|NCT02014558|12001790|FG002|Treated|Overall Study||3
10836272|NCT02014558|12001791|FG003|Treated|Overall Study||3
10836273|NCT02014558|12001792|FG004|Treated|Overall Study||3
10836274|NCT02014558|12001793|FG005|Treated|Overall Study||3
10836275|NCT02014558|12001794|FG006|Treated|Overall Study||3
10836276|NCT02014558|12001795|FG007|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12
10836277|NCT02014558|12001796|FG008|Treated|Overall Study||13
10836278|NCT02014558|12001797|FG009|Treated|Overall Study||21
10836279|NCT02014558|12001798|FG010|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66
10836280|NCT02014558|12001799|FG011|Treated|Overall Study||100
10836281|NCT02014558|12001800|FG012|Treated|Overall Study||17
10836282|NCT02014558|12001788|FG000|COMPLETED|Overall Study||0
10836283|NCT02014558|12001789|FG001|COMPLETED|Overall Study||0
10836284|NCT02014558|12001790|FG002|COMPLETED|Overall Study||0
10836285|NCT02014558|12001791|FG003|COMPLETED|Overall Study||0
10836286|NCT02014558|12001792|FG004|COMPLETED|Overall Study||0
10836287|NCT02014558|12001793|FG005|COMPLETED|Overall Study||0
10836288|NCT02014558|12001794|FG006|COMPLETED|Overall Study||0
10836289|NCT02014558|12001795|FG007|COMPLETED|Overall Study||0
10836290|NCT02014558|12001796|FG008|COMPLETED|Overall Study||0
10836291|NCT02014558|12001797|FG009|COMPLETED|Overall Study||0
10836292|NCT02014558|12001798|FG010|COMPLETED|Overall Study||0
10836293|NCT02014558|12001799|FG011|COMPLETED|Overall Study||0
10836294|NCT02014558|12001800|FG012|COMPLETED|Overall Study||0
10836295|NCT02014558|12001788|FG000|NOT COMPLETED|Overall Study||5
10836296|NCT02014558|12001789|FG001|NOT COMPLETED|Overall Study||3
10836297|NCT02014558|12001790|FG002|NOT COMPLETED|Overall Study||3
10836298|NCT02014558|12001791|FG003|NOT COMPLETED|Overall Study||3
10836299|NCT02014558|12001792|FG004|NOT COMPLETED|Overall Study||4
10836300|NCT02014558|12001793|FG005|NOT COMPLETED|Overall Study||3
10836301|NCT02014558|12001794|FG006|NOT COMPLETED|Overall Study||4
10836302|NCT02014558|12001795|FG007|NOT COMPLETED|Overall Study||11
10836303|NCT02014558|12001796|FG008|NOT COMPLETED|Overall Study||15
10836304|NCT02014558|12001797|FG009|NOT COMPLETED|Overall Study||21
10836305|NCT02014558|12001798|FG010|NOT COMPLETED|Overall Study||69
10836306|NCT02014558|12001799|FG011|NOT COMPLETED|Overall Study||102
10836307|NCT02014558|12001800|FG012|NOT COMPLETED|Overall Study||17
11103623|NCT01243762|12287828|FG002|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
11103624|NCT01243762|12287829|FG003|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
11103625|NCT01243762|12287830|FG004|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
11103626|NCT01243762|12287831|FG005|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
11103627|NCT01243762|12287832|FG006|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
11103628|NCT01243762|12287826|FG000|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
11103629|NCT01243762|12287827|FG001|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
11103630|NCT01243762|12287828|FG002|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
11103631|NCT01243762|12287829|FG003|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
10836308|NCT02015455|12001844|FG000|STARTED|Step 0 - Oct 2013 to Mar 2014||48233
10836309|NCT02015455|12001845|FG001|STARTED|Step 0 - Oct 2013 to Mar 2014||0
10836310|NCT02015455|12001844|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||135
10836311|NCT02015455|12001845|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||0
10836312|NCT02015455|12001844|FG000|COMPLETED|Step 0 - Oct 2013 to Mar 2014||48233
10836313|NCT02015455|12001845|FG001|COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
10836314|NCT02015455|12001844|FG000|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
10836315|NCT02015455|12001845|FG001|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
10836316|NCT02015455|12001844|FG000|STARTED|Step 1 - Apr 2014 to Sep 2014||24074
10836317|NCT02015455|12001845|FG001|STARTED|Step 1 - Apr 2014 to Sep 2014||6455
10836318|NCT02015455|12001844|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||390
10836319|NCT02015455|12001845|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||2208
10836320|NCT02015455|12001844|FG000|COMPLETED|Step 1 - Apr 2014 to Sep 2014||24074
10836321|NCT02015455|12001845|FG001|COMPLETED|Step 1 - Apr 2014 to Sep 2014||6455
10836322|NCT02015455|12001844|FG000|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0
10836323|NCT02015455|12001845|FG001|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0
10836324|NCT02015455|12001844|FG000|STARTED|Step 2 - Oct 2014 to Mar 2015||23139
10836325|NCT02015455|12001845|FG001|STARTED|Step 2 - Oct 2014 to Mar 2015||16285
10836326|NCT02015455|12001844|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||98
10836327|NCT02015455|12001845|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||1511
10836328|NCT02015455|12001844|FG000|COMPLETED|Step 2 - Oct 2014 to Mar 2015||23139
10836329|NCT02015455|12001845|FG001|COMPLETED|Step 2 - Oct 2014 to Mar 2015||16285
10836330|NCT02015455|12001844|FG000|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0
10836331|NCT02015455|12001845|FG001|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0
10836332|NCT02015455|12001844|FG000|STARTED|Step 3 - Apr 2015 to Sep 2015||14135
10836333|NCT02015455|12001845|FG001|STARTED|Step 3 - Apr 2015 to Sep 2015||27661
10836334|NCT02015455|12001844|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||72
10836335|NCT02015455|12001845|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||4915
10836336|NCT02015455|12001844|FG000|COMPLETED|Step 3 - Apr 2015 to Sep 2015||14135
10836337|NCT02015455|12001845|FG001|COMPLETED|Step 3 - Apr 2015 to Sep 2015||27661
10836338|NCT02015455|12001844|FG000|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0
10836339|NCT02015455|12001845|FG001|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0
10836340|NCT02015455|12001844|FG000|STARTED|Step 4 - Oct 2015 to Mar 2016||7874
10836341|NCT02015455|12001845|FG001|STARTED|Step 4 - Oct 2015 to Mar 2016||31316
10836342|NCT02015455|12001844|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||76
10836343|NCT02015455|12001845|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||3742
10836344|NCT02015455|12001844|FG000|COMPLETED|Step 4 - Oct 2015 to Mar 2016||7874
10836345|NCT02015455|12001845|FG001|COMPLETED|Step 4 - Oct 2015 to Mar 2016||31316
10836346|NCT02015455|12001844|FG000|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0
10836347|NCT02015455|12001845|FG001|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0
10836348|NCT02015455|12001844|FG000|STARTED|Step 5 - Apr 2016 to Sep 2016||0
10836349|NCT02015455|12001845|FG001|STARTED|Step 5 - Apr 2016 to Sep 2016||39714
10836350|NCT02015455|12001844|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||0
10836351|NCT02015455|12001845|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||3512
10836352|NCT02015455|12001844|FG000|COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
10836353|NCT02015455|12001845|FG001|COMPLETED|Step 5 - Apr 2016 to Sep 2016||39714
10836354|NCT02015455|12001844|FG000|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
10836355|NCT02015455|12001845|FG001|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
10836356|NCT02024555|12001855|FG000|STARTED|Overall Study||49
10836357|NCT02024555|12001856|FG001|STARTED|Overall Study||48
10836358|NCT02024555|12001855|FG000|COMPLETED|Overall Study||43
10836359|NCT02024555|12001856|FG001|COMPLETED|Overall Study||46
10836360|NCT02024555|12001855|FG000|NOT COMPLETED|Overall Study||6
10836361|NCT02024555|12001856|FG001|NOT COMPLETED|Overall Study||2
10836362|NCT02034123|12001880|FG000|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
10836363|NCT02034123|12001881|FG001|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
10836364|NCT02034123|12001882|FG002|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
10836365|NCT02034123|12001883|FG003|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
10836366|NCT02034123|12001884|FG004|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7
10836367|NCT02034123|12001885|FG005|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
10836368|NCT02034123|12001886|FG006|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
10836369|NCT02034123|12001887|FG007|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
10836370|NCT02034123|12001888|FG008|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
10836371|NCT02034123|12001889|FG009|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836372|NCT02034123|12001890|FG010|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836373|NCT02034123|12001891|FG011|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836374|NCT02034123|12001892|FG012|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836375|NCT02034123|12001893|FG013|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836376|NCT02034123|12001894|FG014|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836377|NCT02034123|12001895|FG015|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836378|NCT02034123|12001896|FG016|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836379|NCT02034123|12001897|FG017|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
10836380|NCT02034123|12001880|FG000|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
10836381|NCT02034123|12001881|FG001|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
10836382|NCT02034123|12001882|FG002|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
10836383|NCT02034123|12001883|FG003|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
10836384|NCT02034123|12001884|FG004|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
10836385|NCT02034123|12001885|FG005|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3
10836386|NCT02034123|12001886|FG006|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
10836387|NCT02034123|12001887|FG007|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4
10836388|NCT02034123|12001888|FG008|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836389|NCT02034123|12001889|FG009|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836390|NCT02034123|12001890|FG010|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836391|NCT02034123|12001891|FG011|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836392|NCT02034123|12001892|FG012|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836393|NCT02034123|12001893|FG013|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836394|NCT02034123|12001894|FG014|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836395|NCT02034123|12001895|FG015|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836396|NCT02034123|12001896|FG016|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836397|NCT02034123|12001897|FG017|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836398|NCT02034123|12001880|FG000|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836399|NCT02034123|12001881|FG001|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836400|NCT02034123|12001882|FG002|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836401|NCT02034123|12001883|FG003|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
10836402|NCT02034123|12001884|FG004|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
10836403|NCT02034123|12001885|FG005|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836404|NCT02034123|12001886|FG006|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836405|NCT02034123|12001887|FG007|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
10836406|NCT02034123|12001888|FG008|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
10836407|NCT02034123|12001889|FG009|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836408|NCT02034123|12001890|FG010|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836409|NCT02034123|12001891|FG011|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836410|NCT02034123|12001892|FG012|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836411|NCT02034123|12001893|FG013|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836412|NCT02034123|12001894|FG014|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836413|NCT02034123|12001895|FG015|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836414|NCT02034123|12001896|FG016|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836415|NCT02034123|12001897|FG017|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
10836416|NCT02034123|12001880|FG000|STARTED|Part2(Up to 2 Years)||0
10836417|NCT02034123|12001881|FG001|STARTED|Part2(Up to 2 Years)||0
10836418|NCT02034123|12001882|FG002|STARTED|Part2(Up to 2 Years)||0
10836419|NCT02034123|12001883|FG003|STARTED|Part2(Up to 2 Years)||0
10836420|NCT02034123|12001884|FG004|STARTED|Part2(Up to 2 Years)||0
10836421|NCT02034123|12001885|FG005|STARTED|Part2(Up to 2 Years)||0
10836422|NCT02034123|12001886|FG006|STARTED|Part2(Up to 2 Years)||0
10836423|NCT02034123|12001887|FG007|STARTED|Part2(Up to 2 Years)||0
10836424|NCT02034123|12001888|FG008|STARTED|Part2(Up to 2 Years)||0
10836425|NCT02034123|12001889|FG009|STARTED|Part2(Up to 2 Years)||0
10836426|NCT02034123|12001890|FG010|STARTED|Part2(Up to 2 Years)||0
10836427|NCT02034123|12001891|FG011|STARTED|Part2(Up to 2 Years)||0
10836428|NCT02034123|12001892|FG012|STARTED|Part2(Up to 2 Years)||0
10836429|NCT02034123|12001893|FG013|STARTED|Part2(Up to 2 Years)||0
10836430|NCT02034123|12001894|FG014|STARTED|Part2(Up to 2 Years)||0
10836431|NCT02034123|12001895|FG015|STARTED|Part2(Up to 2 Years)||0
10836432|NCT02034123|12001896|FG016|STARTED|Part2(Up to 2 Years)||0
10836433|NCT02034123|12001897|FG017|STARTED|Part2(Up to 2 Years)||0
10836434|NCT02034123|12001880|FG000|COMPLETED|Part2(Up to 2 Years)||0
10836435|NCT02034123|12001881|FG001|COMPLETED|Part2(Up to 2 Years)||0
10836436|NCT02034123|12001882|FG002|COMPLETED|Part2(Up to 2 Years)||0
10836437|NCT02034123|12001883|FG003|COMPLETED|Part2(Up to 2 Years)||0
10836438|NCT02034123|12001884|FG004|COMPLETED|Part2(Up to 2 Years)||0
10836439|NCT02034123|12001885|FG005|COMPLETED|Part2(Up to 2 Years)||0
10836440|NCT02034123|12001886|FG006|COMPLETED|Part2(Up to 2 Years)||0
10836441|NCT02034123|12001887|FG007|COMPLETED|Part2(Up to 2 Years)||0
10836442|NCT02034123|12001888|FG008|COMPLETED|Part2(Up to 2 Years)||0
10836443|NCT02034123|12001889|FG009|COMPLETED|Part2(Up to 2 Years)||0
10836444|NCT02034123|12001890|FG010|COMPLETED|Part2(Up to 2 Years)||0
10836445|NCT02034123|12001891|FG011|COMPLETED|Part2(Up to 2 Years)||0
10836446|NCT02034123|12001892|FG012|COMPLETED|Part2(Up to 2 Years)||0
10836447|NCT02034123|12001893|FG013|COMPLETED|Part2(Up to 2 Years)||0
10836448|NCT02034123|12001894|FG014|COMPLETED|Part2(Up to 2 Years)||0
10836449|NCT02034123|12001895|FG015|COMPLETED|Part2(Up to 2 Years)||0
10836450|NCT02034123|12001896|FG016|COMPLETED|Part2(Up to 2 Years)||0
10836451|NCT02034123|12001897|FG017|COMPLETED|Part2(Up to 2 Years)||0
10836452|NCT02034123|12001880|FG000|NOT COMPLETED|Part2(Up to 2 Years)||0
10836453|NCT02034123|12001881|FG001|NOT COMPLETED|Part2(Up to 2 Years)||0
10836454|NCT02034123|12001882|FG002|NOT COMPLETED|Part2(Up to 2 Years)||0
11103632|NCT01243762|12287830|FG004|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
10836455|NCT02034123|12001883|FG003|NOT COMPLETED|Part2(Up to 2 Years)||0
10836456|NCT02034123|12001884|FG004|NOT COMPLETED|Part2(Up to 2 Years)||0
10836457|NCT02034123|12001885|FG005|NOT COMPLETED|Part2(Up to 2 Years)||0
10836458|NCT02034123|12001886|FG006|NOT COMPLETED|Part2(Up to 2 Years)||0
10836459|NCT02034123|12001887|FG007|NOT COMPLETED|Part2(Up to 2 Years)||0
10836460|NCT02034123|12001888|FG008|NOT COMPLETED|Part2(Up to 2 Years)||0
10836461|NCT02034123|12001889|FG009|NOT COMPLETED|Part2(Up to 2 Years)||0
10836462|NCT02034123|12001890|FG010|NOT COMPLETED|Part2(Up to 2 Years)||0
10836463|NCT02034123|12001891|FG011|NOT COMPLETED|Part2(Up to 2 Years)||0
10836464|NCT02034123|12001892|FG012|NOT COMPLETED|Part2(Up to 2 Years)||0
10836465|NCT02034123|12001893|FG013|NOT COMPLETED|Part2(Up to 2 Years)||0
10836466|NCT02034123|12001894|FG014|NOT COMPLETED|Part2(Up to 2 Years)||0
10836467|NCT02034123|12001895|FG015|NOT COMPLETED|Part2(Up to 2 Years)||0
10836468|NCT02034123|12001896|FG016|NOT COMPLETED|Part2(Up to 2 Years)||0
10836469|NCT02034123|12001897|FG017|NOT COMPLETED|Part2(Up to 2 Years)||0
11103633|NCT01243762|12287831|FG005|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
11103634|NCT01243762|12287832|FG006|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
11103635|NCT01243762|12287826|FG000|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
11103636|NCT01243762|12287827|FG001|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
11103637|NCT01243762|12287828|FG002|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
11220495|NCT01960413|12412109|FG001|STARTED|Overall Study||22
11220496|NCT01960413|12412108|FG000|COMPLETED|Overall Study||20
11220497|NCT01960413|12412109|FG001|COMPLETED|Overall Study||21
11220498|NCT01960413|12412108|FG000|NOT COMPLETED|Overall Study||4
11220499|NCT01960413|12412109|FG001|NOT COMPLETED|Overall Study||1
11220500|NCT01960465|12412117|FG000|STARTED|Overall Study||138
11220501|NCT01960465|12412118|FG001|STARTED|Overall Study||82
11220502|NCT01960465|12412117|FG000|COMPLETED|Overall Study||118
11220503|NCT01960465|12412118|FG001|COMPLETED|Overall Study||73
11220504|NCT01960465|12412117|FG000|NOT COMPLETED|Overall Study||20
11220505|NCT01960465|12412118|FG001|NOT COMPLETED|Overall Study||9
11220506|NCT01960725|12412126|FG000|STARTED|Overall Study||33
11220507|NCT01960725|12412127|FG001|STARTED|Overall Study||33
11220508|NCT01960725|12412126|FG000|Received First Vaccine|Overall Study||33
11220509|NCT01960725|12412127|FG001|Received First Vaccine|Overall Study||33
11220510|NCT01960725|12412126|FG000|Recieved Second Vaccine|Overall Study||33
11220511|NCT01960725|12412127|FG001|Recieved Second Vaccine|Overall Study||33
11220512|NCT01960725|12412126|FG000|Received Third Vaccine|Overall Study||32
11220513|NCT01960725|12412127|FG001|Received Third Vaccine|Overall Study||32
11220514|NCT01960725|12412126|FG000|COMPLETED|Overall Study||27
11220515|NCT01960725|12412127|FG001|COMPLETED|Overall Study||28
11220516|NCT01960725|12412126|FG000|NOT COMPLETED|Overall Study||6
11220517|NCT01960725|12412127|FG001|NOT COMPLETED|Overall Study||5
11220518|NCT01960790|12412133|FG000|STARTED|Overall Study||473
11220519|NCT01960790|12412133|FG000|COMPLETED|Overall Study||462
11220520|NCT01960790|12412133|FG000|NOT COMPLETED|Overall Study||11
11220521|NCT01960816|12412137|FG000|STARTED|Overall Study||33
11220522|NCT01960816|12412137|FG000|COMPLETED|Overall Study||32
11220523|NCT01960816|12412137|FG000|NOT COMPLETED|Overall Study||1
11220524|NCT01960842|12412141|FG000|STARTED|Overall Study||31
11220525|NCT01960842|12412141|FG000|COMPLETED|Overall Study||28
11220526|NCT01960842|12412141|FG000|NOT COMPLETED|Overall Study||3
11220527|NCT01960855|12412150|FG000|STARTED|Overall Study||56
11103638|NCT01243762|12287829|FG003|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
11103639|NCT01243762|12287830|FG004|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
11103640|NCT01243762|12287831|FG005|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
11103641|NCT01243762|12287832|FG006|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
11103642|NCT01243775|12287851|FG000|STARTED|Overall Study||33
11103643|NCT01243775|12287851|FG000|COMPLETED|Overall Study||31
11103644|NCT01243775|12287851|FG000|NOT COMPLETED|Overall Study||2
11220528|NCT01960855|12412151|FG001|STARTED|Overall Study||55
11220529|NCT01960855|12412152|FG002|STARTED|Overall Study||55
11220530|NCT01960855|12412153|FG003|STARTED|Overall Study||55
11220531|NCT01960855|12412154|FG004|STARTED|Overall Study||55
11220532|NCT01960855|12412150|FG000|COMPLETED|Overall Study||45
11220533|NCT01960855|12412151|FG001|COMPLETED|Overall Study||51
11220534|NCT01960855|12412152|FG002|COMPLETED|Overall Study||46
10836470|NCT02040584|12001942|FG000|STARTED|Overall Study||105
10836471|NCT02040584|12001943|FG001|STARTED|Overall Study||106
10836472|NCT02040584|12001942|FG000|COMPLETED|Overall Study||70
11220535|NCT01960855|12412153|FG003|COMPLETED|Overall Study||51
11220536|NCT01960855|12412154|FG004|COMPLETED|Overall Study||50
11220537|NCT01960855|12412150|FG000|NOT COMPLETED|Overall Study||11
11220538|NCT01960855|12412151|FG001|NOT COMPLETED|Overall Study||4
11220539|NCT01960855|12412152|FG002|NOT COMPLETED|Overall Study||9
11220540|NCT01960855|12412153|FG003|NOT COMPLETED|Overall Study||4
11220541|NCT01960855|12412154|FG004|NOT COMPLETED|Overall Study||5
11220542|NCT01960907|12412168|FG000|STARTED|Overall Study||158
11220543|NCT01960907|12412169|FG001|STARTED|Overall Study||154
11220544|NCT01960907|12412168|FG000|COMPLETED|Overall Study||122
11220545|NCT01960907|12412169|FG001|COMPLETED|Overall Study||109
11220546|NCT01960907|12412168|FG000|NOT COMPLETED|Overall Study||36
11220547|NCT01960907|12412169|FG001|NOT COMPLETED|Overall Study||45
11220548|NCT01960998|12412180|FG000|STARTED|Overall Study||101
11220549|NCT01960998|12412181|FG001|STARTED|Overall Study||96
11220550|NCT01960998|12412180|FG000|COMPLETED|Overall Study||90
11220551|NCT01960998|12412181|FG001|COMPLETED|Overall Study||85
11220552|NCT01960998|12412180|FG000|NOT COMPLETED|Overall Study||11
11220553|NCT01960998|12412181|FG001|NOT COMPLETED|Overall Study||11
11220554|NCT01961089|12412189|FG000|STARTED|Overall Study||40
11220555|NCT01961089|12412189|FG000|COMPLETED|Overall Study||40
11220556|NCT01961089|12412189|FG000|NOT COMPLETED|Overall Study||0
11220557|NCT01961115|12412196|FG000|STARTED|Overall Study||2
11220558|NCT01961115|12412197|FG001|STARTED|Overall Study||0
11220559|NCT01961115|12412198|FG002|STARTED|Overall Study||9
11220560|NCT01961115|12412196|FG000|COMPLETED|Overall Study||0
11220561|NCT01961115|12412197|FG001|COMPLETED|Overall Study||0
11220562|NCT01961115|12412198|FG002|COMPLETED|Overall Study||5
11220563|NCT01961115|12412196|FG000|NOT COMPLETED|Overall Study||2
11220564|NCT01961115|12412197|FG001|NOT COMPLETED|Overall Study||0
11220565|NCT01961115|12412198|FG002|NOT COMPLETED|Overall Study||4
11220566|NCT01961167|12412206|FG000|STARTED|Overall Study||27
11220567|NCT01961167|12412206|FG000|COMPLETED|Overall Study||27
11220568|NCT01961167|12412206|FG000|NOT COMPLETED|Overall Study||0
11220569|NCT01961271|12412210|FG000|STARTED|Overall Study||114
11220570|NCT01961271|12412210|FG000|COMPLETED|Overall Study||64
11220571|NCT01961271|12412210|FG000|NOT COMPLETED|Overall Study||50
11220572|NCT01961297|12412216|FG000|STARTED|Overall Study||30
11220573|NCT01961297|12412217|FG001|STARTED|Overall Study||23
11220574|NCT01961297|12412216|FG000|COMPLETED|Overall Study||28
11220575|NCT01961297|12412217|FG001|COMPLETED|Overall Study||22
11220576|NCT01961297|12412216|FG000|NOT COMPLETED|Overall Study||2
11220577|NCT01961297|12412217|FG001|NOT COMPLETED|Overall Study||1
11220578|NCT01961323|12412223|FG000|STARTED|Overall Study||70
11220579|NCT01961323|12412223|FG000|COMPLETED|Overall Study||21
11220580|NCT01961323|12412223|FG000|NOT COMPLETED|Overall Study||49
11220581|NCT01961349|12412230|FG000|STARTED|Overall Study||54
11220582|NCT01961349|12412231|FG001|STARTED|Overall Study||107
11220583|NCT01961349|12412232|FG002|STARTED|Overall Study||111
11220584|NCT01961349|12412230|FG000|COMPLETED|Overall Study||51
11220585|NCT01961349|12412231|FG001|COMPLETED|Overall Study||101
11220586|NCT01961349|12412232|FG002|COMPLETED|Overall Study||109
11220587|NCT01961349|12412230|FG000|NOT COMPLETED|Overall Study||3
11220588|NCT01961349|12412231|FG001|NOT COMPLETED|Overall Study||6
11220589|NCT01961349|12412232|FG002|NOT COMPLETED|Overall Study||2
11220590|NCT01961362|12412240|FG000|STARTED|Overall Study||19
11220591|NCT01961362|12412240|FG000|COMPLETED|Overall Study||19
11220592|NCT01961362|12412240|FG000|NOT COMPLETED|Overall Study||0
11220593|NCT01961544|12412244|FG000|STARTED|Overall Study||101
11220594|NCT01961544|12412244|FG000|COMPLETED|Overall Study||88
11220595|NCT01961544|12412244|FG000|NOT COMPLETED|Overall Study||13
11220596|NCT01961609|12412250|FG000|STARTED|Initiation||119
11220597|NCT01961609|12412251|FG001|STARTED|Initiation||116
11220598|NCT01961609|12412252|FG002|STARTED|Initiation||0
11220599|NCT01961609|12412253|FG003|STARTED|Initiation||0
11220600|NCT01961609|12412250|FG000|Safety Set|Initiation||118
11220601|NCT01961609|12412251|FG001|Safety Set|Initiation||115
11220602|NCT01961609|12412252|FG002|Safety Set|Initiation||0
11220603|NCT01961609|12412253|FG003|Safety Set|Initiation||0
11220604|NCT01961609|12412250|FG000|Full Analysis Set|Initiation||118
11220605|NCT01961609|12412251|FG001|Full Analysis Set|Initiation||115
11220606|NCT01961609|12412252|FG002|Full Analysis Set|Initiation||0
10836473|NCT02040584|12001943|FG001|COMPLETED|Overall Study||74
10836474|NCT02040584|12001942|FG000|NOT COMPLETED|Overall Study||35
10836475|NCT02040584|12001943|FG001|NOT COMPLETED|Overall Study||32
10836476|NCT02045797|12001962|FG000|STARTED|Overall Study||58
10836477|NCT02045797|12001963|FG001|STARTED|Overall Study||39
10836478|NCT02045797|12001964|FG002|STARTED|Overall Study||25
10836479|NCT02045797|12001962|FG000|COMPLETED|Overall Study||51
10836480|NCT02045797|12001963|FG001|COMPLETED|Overall Study||32
10836481|NCT02045797|12001964|FG002|COMPLETED|Overall Study||24
10836482|NCT02045797|12001962|FG000|NOT COMPLETED|Overall Study||7
10836483|NCT02045797|12001963|FG001|NOT COMPLETED|Overall Study||7
10836484|NCT02045797|12001964|FG002|NOT COMPLETED|Overall Study||1
11354130|NCT03069989|12551341|FG001|STARTED|Dosing Period 1 (Up to 2 Days)||5
11354131|NCT03069989|12551340|FG000|COMPLETED|Dosing Period 1 (Up to 2 Days)||3
11220607|NCT01961609|12412253|FG003|Full Analysis Set|Initiation||0
11220608|NCT01961609|12412250|FG000|COMPLETED|Initiation||107
11220609|NCT01961609|12412251|FG001|COMPLETED|Initiation||103
11220610|NCT01961609|12412252|FG002|COMPLETED|Initiation||0
11220611|NCT01961609|12412253|FG003|COMPLETED|Initiation||0
11220612|NCT01961609|12412250|FG000|NOT COMPLETED|Initiation||12
11220613|NCT01961609|12412251|FG001|NOT COMPLETED|Initiation||13
11220614|NCT01961609|12412252|FG002|NOT COMPLETED|Initiation||0
11220615|NCT01961609|12412253|FG003|NOT COMPLETED|Initiation||0
11220616|NCT01961609|12412250|FG000|STARTED|Maintenance 1 (Weeks 17 - 48)||107
11220617|NCT01961609|12412251|FG001|STARTED|Maintenance 1 (Weeks 17 - 48)||66
11220618|NCT01961609|12412252|FG002|STARTED|Maintenance 1 (Weeks 17 - 48)||37
11354132|NCT03069989|12551341|FG001|COMPLETED|Dosing Period 1 (Up to 2 Days)||5
10836485|NCT02049710|12001974|FG000|STARTED|Overall Study||653
10836486|NCT02049710|12001975|FG001|STARTED|Overall Study||664
10836487|NCT02049710|12001974|FG000|COMPLETED|Overall Study||334
10836488|NCT02049710|12001975|FG001|COMPLETED|Overall Study||340
10836489|NCT02049710|12001974|FG000|NOT COMPLETED|Overall Study||319
10836490|NCT02049710|12001975|FG001|NOT COMPLETED|Overall Study||324
10836491|NCT02055547|12001981|FG000|STARTED|Overall Study||2
10836492|NCT02055547|12001982|FG001|STARTED|Overall Study||2
10836493|NCT02055547|12001983|FG002|STARTED|Overall Study||5
10836494|NCT02055547|12001984|FG003|STARTED|Overall Study||2
10836495|NCT02055547|12001985|FG004|STARTED|Overall Study||2
10836496|NCT02055547|12001986|FG005|STARTED|Overall Study||2
10836497|NCT02055547|12001987|FG006|STARTED|Overall Study||2
10836498|NCT02055547|12001988|FG007|STARTED|Overall Study||6
10836499|NCT02055547|12001989|FG008|STARTED|Overall Study||6
10836500|NCT02055547|12001990|FG009|STARTED|Overall Study||6
10836501|NCT02055547|12001991|FG010|STARTED|Overall Study||6
10836502|NCT02055547|12001992|FG011|STARTED|Overall Study||6
10836503|NCT02055547|12001993|FG012|STARTED|Overall Study||2
10836504|NCT02055547|12001994|FG013|STARTED|Overall Study||2
10836505|NCT02055547|12001995|FG014|STARTED|Overall Study||2
10836506|NCT02055547|12001996|FG015|STARTED|Overall Study||2
10836507|NCT02055547|12001997|FG016|STARTED|Overall Study||2
10836508|NCT02055547|12001998|FG017|STARTED|Overall Study||2
10836509|NCT02055547|12001999|FG018|STARTED|Overall Study||2
10836510|NCT02055547|12001981|FG000|COMPLETED|Overall Study||2
10836511|NCT02055547|12001982|FG001|COMPLETED|Overall Study||1
10836512|NCT02055547|12001983|FG002|COMPLETED|Overall Study||2
10836513|NCT02055547|12001984|FG003|COMPLETED|Overall Study||2
10836514|NCT02055547|12001985|FG004|COMPLETED|Overall Study||1
10836515|NCT02055547|12001986|FG005|COMPLETED|Overall Study||1
10836516|NCT02055547|12001987|FG006|COMPLETED|Overall Study||0
10836517|NCT02055547|12001988|FG007|COMPLETED|Overall Study||6
10836518|NCT02055547|12001989|FG008|COMPLETED|Overall Study||4
10836519|NCT02055547|12001990|FG009|COMPLETED|Overall Study||5
10836520|NCT02055547|12001991|FG010|COMPLETED|Overall Study||5
10836521|NCT02055547|12001992|FG011|COMPLETED|Overall Study||6
10836522|NCT02055547|12001993|FG012|COMPLETED|Overall Study||2
10836523|NCT02055547|12001994|FG013|COMPLETED|Overall Study||1
10836524|NCT02055547|12001995|FG014|COMPLETED|Overall Study||2
10836525|NCT02055547|12001996|FG015|COMPLETED|Overall Study||1
10836526|NCT02055547|12001997|FG016|COMPLETED|Overall Study||2
10836527|NCT02055547|12001998|FG017|COMPLETED|Overall Study||2
10836528|NCT02055547|12001999|FG018|COMPLETED|Overall Study||2
10836529|NCT02055547|12001981|FG000|NOT COMPLETED|Overall Study||0
10836530|NCT02055547|12001982|FG001|NOT COMPLETED|Overall Study||1
10836531|NCT02055547|12001983|FG002|NOT COMPLETED|Overall Study||3
10836532|NCT02055547|12001984|FG003|NOT COMPLETED|Overall Study||0
10836533|NCT02055547|12001985|FG004|NOT COMPLETED|Overall Study||1
10836534|NCT02055547|12001986|FG005|NOT COMPLETED|Overall Study||1
10836535|NCT02055547|12001987|FG006|NOT COMPLETED|Overall Study||2
10836536|NCT02055547|12001988|FG007|NOT COMPLETED|Overall Study||0
10836537|NCT02055547|12001989|FG008|NOT COMPLETED|Overall Study||2
10836538|NCT02055547|12001990|FG009|NOT COMPLETED|Overall Study||1
10836539|NCT02055547|12001991|FG010|NOT COMPLETED|Overall Study||1
10836540|NCT02055547|12001992|FG011|NOT COMPLETED|Overall Study||0
10836541|NCT02055547|12001993|FG012|NOT COMPLETED|Overall Study||0
10836542|NCT02055547|12001994|FG013|NOT COMPLETED|Overall Study||1
10836543|NCT02055547|12001995|FG014|NOT COMPLETED|Overall Study||0
10836544|NCT02055547|12001996|FG015|NOT COMPLETED|Overall Study||1
10836545|NCT02055547|12001997|FG016|NOT COMPLETED|Overall Study||0
11103645|NCT01243944|12287857|FG000|STARTED|Overall Study||110
11103646|NCT01243944|12287858|FG001|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112
11103647|NCT01243944|12287857|FG000|Treated|Overall Study||110
11103648|NCT01243944|12287858|FG001|Treated|Overall Study||111
11103649|NCT01243944|12287857|FG000|Followed for Survival|Overall Study||22
11103650|NCT01243944|12287858|FG001|Followed for Survival|Overall Study||21
11103651|NCT01243944|12287857|FG000|COMPLETED|Overall Study||65
11103652|NCT01243944|12287858|FG001|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61
11103653|NCT01243944|12287857|FG000|NOT COMPLETED|Overall Study||45
11103654|NCT01243944|12287858|FG001|NOT COMPLETED|Overall Study||51
11103655|NCT01243957|12287865|FG000|STARTED|Overall Study||20
11103656|NCT01243957|12287865|FG000|COMPLETED|Overall Study||20
11103657|NCT01243957|12287865|FG000|NOT COMPLETED|Overall Study||0
11103658|NCT01244035|12287871|FG000|STARTED|Part 1: Period 1||5
11103659|NCT01244035|12287872|FG001|STARTED|Part 1: Period 1||5
11103660|NCT01244035|12287873|FG002|STARTED|Part 1: Period 1||6
11103661|NCT01244035|12287874|FG003|STARTED|Part 1: Period 1||5
10836546|NCT02055547|12001998|FG017|NOT COMPLETED|Overall Study||0
10836547|NCT02055547|12001999|FG018|NOT COMPLETED|Overall Study||0
10836548|NCT02064387|12002045|FG000|STARTED|Part 1 Max 23.5 Months Followup Duration||1
10836549|NCT02064387|12002046|FG001|STARTED|Part 1 Max 23.5 Months Followup Duration||1
10836550|NCT02064387|12002047|FG002|STARTED|Part 1 Max 23.5 Months Followup Duration||4
10836551|NCT02064387|12002048|FG003|STARTED|Part 1 Max 23.5 Months Followup Duration||4
10836552|NCT02064387|12002049|FG004|STARTED|Part 1 Max 23.5 Months Followup Duration||4
10836553|NCT02064387|12002050|FG005|STARTED|Part 1 Max 23.5 Months Followup Duration||3
10836554|NCT02064387|12002051|FG006|STARTED|Part 1 Max 23.5 Months Followup Duration||4
10836555|NCT02064387|12002052|FG007|STARTED|Part 1 Max 23.5 Months Followup Duration||8
10836556|NCT02064387|12002053|FG008|STARTED|Part 1 Max 23.5 Months Followup Duration||3
10836557|NCT02064387|12002054|FG009|STARTED|Part 1 Max 23.5 Months Followup Duration||6
10836558|NCT02064387|12002055|FG010|STARTED|Part 1 Max 23.5 Months Followup Duration||0
10836559|NCT02064387|12002056|FG011|STARTED|Part 1 Max 23.5 Months Followup Duration||0
10836560|NCT02064387|12002045|FG000|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
10836561|NCT02064387|12002046|FG001|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
10836562|NCT02064387|12002047|FG002|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
10836563|NCT02064387|12002048|FG003|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
10836564|NCT02064387|12002049|FG004|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
10836565|NCT02064387|12002050|FG005|COMPLETED|Part 1 Max 23.5 Months Followup Duration||3
10836566|NCT02064387|12002051|FG006|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
10836567|NCT02064387|12002052|FG007|COMPLETED|Part 1 Max 23.5 Months Followup Duration||6
10836568|NCT02064387|12002053|FG008|COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
10836569|NCT02064387|12002054|FG009|COMPLETED|Part 1 Max 23.5 Months Followup Duration||5
10836570|NCT02064387|12002055|FG010|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836571|NCT02064387|12002056|FG011|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836572|NCT02064387|12002045|FG000|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836573|NCT02064387|12002046|FG001|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836574|NCT02064387|12002047|FG002|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836575|NCT02064387|12002048|FG003|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836576|NCT02064387|12002049|FG004|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836577|NCT02064387|12002050|FG005|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836578|NCT02064387|12002051|FG006|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836579|NCT02064387|12002052|FG007|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
10836580|NCT02064387|12002053|FG008|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
10836581|NCT02064387|12002054|FG009|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
10836582|NCT02064387|12002055|FG010|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836583|NCT02064387|12002056|FG011|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
10836584|NCT02064387|12002045|FG000|STARTED|Part 2 Max 35 Months Followup Duration||0
10836585|NCT02064387|12002046|FG001|STARTED|Part 2 Max 35 Months Followup Duration||0
10836586|NCT02064387|12002047|FG002|STARTED|Part 2 Max 35 Months Followup Duration||0
10836587|NCT02064387|12002048|FG003|STARTED|Part 2 Max 35 Months Followup Duration||0
10836588|NCT02064387|12002049|FG004|STARTED|Part 2 Max 35 Months Followup Duration||0
10836589|NCT02064387|12002050|FG005|STARTED|Part 2 Max 35 Months Followup Duration||0
10836590|NCT02064387|12002051|FG006|STARTED|Part 2 Max 35 Months Followup Duration||0
10836591|NCT02064387|12002052|FG007|STARTED|Part 2 Max 35 Months Followup Duration||0
10836592|NCT02064387|12002053|FG008|STARTED|Part 2 Max 35 Months Followup Duration||0
10836593|NCT02064387|12002054|FG009|STARTED|Part 2 Max 35 Months Followup Duration||0
10836594|NCT02064387|12002055|FG010|STARTED|Part 2 Max 35 Months Followup Duration||35
10836595|NCT02064387|12002056|FG011|STARTED|Part 2 Max 35 Months Followup Duration||6
10836596|NCT02064387|12002045|FG000|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836597|NCT02064387|12002046|FG001|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836598|NCT02064387|12002047|FG002|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836599|NCT02064387|12002048|FG003|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836600|NCT02064387|12002049|FG004|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836601|NCT02064387|12002050|FG005|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836602|NCT02064387|12002051|FG006|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836603|NCT02064387|12002052|FG007|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836604|NCT02064387|12002053|FG008|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836605|NCT02064387|12002054|FG009|COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836606|NCT02064387|12002055|FG010|COMPLETED|Part 2 Max 35 Months Followup Duration||29
10836607|NCT02064387|12002056|FG011|COMPLETED|Part 2 Max 35 Months Followup Duration||3
10836608|NCT02064387|12002045|FG000|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836609|NCT02064387|12002046|FG001|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836610|NCT02064387|12002047|FG002|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836611|NCT02064387|12002048|FG003|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836612|NCT02064387|12002049|FG004|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836613|NCT02064387|12002050|FG005|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836614|NCT02064387|12002051|FG006|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836615|NCT02064387|12002052|FG007|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836616|NCT02064387|12002053|FG008|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836617|NCT02064387|12002054|FG009|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
10836618|NCT02064387|12002055|FG010|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||6
10836619|NCT02064387|12002056|FG011|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||3
10836620|NCT02076178|12002097|FG000|STARTED|Oral Phase||21
10836621|NCT02076178|12002098|FG001|STARTED|Oral Phase||106
10836622|NCT02076178|12002097|FG000|COMPLETED|Oral Phase||21
10836623|NCT02076178|12002098|FG001|COMPLETED|Oral Phase||94
10836624|NCT02076178|12002097|FG000|NOT COMPLETED|Oral Phase||0
10836625|NCT02076178|12002098|FG001|NOT COMPLETED|Oral Phase||12
10836626|NCT02076178|12002097|FG000|STARTED|Injection Phase||21
10836627|NCT02076178|12002098|FG001|STARTED|Injection Phase||94
10836628|NCT02076178|12002097|FG000|COMPLETED|Injection Phase||20
10836629|NCT02076178|12002098|FG001|COMPLETED|Injection Phase||87
10836630|NCT02076178|12002097|FG000|NOT COMPLETED|Injection Phase||1
10836631|NCT02076178|12002098|FG001|NOT COMPLETED|Injection Phase||7
10836632|NCT02079766|12002108|FG000|STARTED|Overall Study||30
10836633|NCT02079766|12002109|FG001|STARTED|Overall Study||11
10836634|NCT02079766|12002108|FG000|COMPLETED|Overall Study||28
10836635|NCT02079766|12002109|FG001|COMPLETED|Overall Study||11
10836636|NCT02079766|12002108|FG000|NOT COMPLETED|Overall Study||2
10836637|NCT02079766|12002109|FG001|NOT COMPLETED|Overall Study||0
10836662|NCT02087189|12002142|FG000|STARTED|Overall Study||30
10836663|NCT02087189|12002142|FG000|COMPLETED|Overall Study||28
10836664|NCT02087189|12002142|FG000|NOT COMPLETED|Overall Study||2
10836665|NCT02096055|12002150|FG000|STARTED|Overall Study||13
10836666|NCT02096055|12002151|FG001|STARTED|Overall Study||9
10836667|NCT02096055|12002152|FG002|STARTED|Overall Study||13
10836668|NCT02096055|12002153|FG003|STARTED|Overall Study||9
10836669|NCT02096055|12002150|FG000|COMPLETED|Overall Study||13
10836670|NCT02096055|12002151|FG001|COMPLETED|Overall Study||9
10836671|NCT02096055|12002152|FG002|COMPLETED|Overall Study||13
10836672|NCT02096055|12002153|FG003|COMPLETED|Overall Study||9
10836673|NCT02096055|12002150|FG000|NOT COMPLETED|Overall Study||0
10836674|NCT02096055|12002151|FG001|NOT COMPLETED|Overall Study||0
10836675|NCT02096055|12002152|FG002|NOT COMPLETED|Overall Study||0
10836676|NCT02096055|12002153|FG003|NOT COMPLETED|Overall Study||0
10836677|NCT02112916|12002167|FG000|STARTED|Overall Study||312
10836678|NCT02112916|12002168|FG001|STARTED|Overall Study||315
10836679|NCT02112916|12002169|FG002|STARTED|Overall Study||111
10836680|NCT02112916|12002170|FG003|STARTED|Overall Study||109
10836681|NCT02112916|12002167|FG000|COMPLETED|Overall Study||108
10836682|NCT02112916|12002168|FG001|COMPLETED|Overall Study||123
10836683|NCT02112916|12002169|FG002|COMPLETED|Overall Study||52
10836684|NCT02112916|12002170|FG003|COMPLETED|Overall Study||62
10836685|NCT02112916|12002167|FG000|NOT COMPLETED|Overall Study||204
10836686|NCT02112916|12002168|FG001|NOT COMPLETED|Overall Study||192
10836687|NCT02112916|12002169|FG002|NOT COMPLETED|Overall Study||59
10836688|NCT02112916|12002170|FG003|NOT COMPLETED|Overall Study||47
10836697|NCT02134717|12002194|FG000|STARTED|Overall Study||3
10836698|NCT02134717|12002194|FG000|COMPLETED|Overall Study||3
10836699|NCT02134717|12002194|FG000|NOT COMPLETED|Overall Study||0
10836700|NCT02135029|12002201|FG000|STARTED|Overall Study||73
10836701|NCT02135029|12002202|FG001|STARTED|Overall Study||74
10836702|NCT02135029|12002203|FG002|STARTED|Overall Study||37
10836703|NCT02135029|12002201|FG000|Treated|Overall Study||73
10836704|NCT02135029|12002202|FG001|Treated|Overall Study||74
10836705|NCT02135029|12002203|FG002|Treated|Overall Study||36
11220619|NCT01961609|12412253|FG003|STARTED|Maintenance 1 (Weeks 17 - 48)||0
11220620|NCT01961609|12412250|FG000|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107
11220621|NCT01961609|12412251|FG001|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66
11220622|NCT01961609|12412252|FG002|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37
11220623|NCT01961609|12412253|FG003|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0
11220624|NCT01961609|12412250|FG000|Safety Set|Maintenance 1 (Weeks 17 - 48)||107
11220625|NCT01961609|12412251|FG001|Safety Set|Maintenance 1 (Weeks 17 - 48)||66
11220626|NCT01961609|12412252|FG002|Safety Set|Maintenance 1 (Weeks 17 - 48)||37
11220627|NCT01961609|12412253|FG003|Safety Set|Maintenance 1 (Weeks 17 - 48)||0
11220628|NCT01961609|12412250|FG000|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84
11220629|NCT01961609|12412251|FG001|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55
11220630|NCT01961609|12412252|FG002|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18
11220631|NCT01961609|12412253|FG003|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
11220632|NCT01961609|12412250|FG000|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23
11220633|NCT01961609|12412251|FG001|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11
11220634|NCT01961609|12412252|FG002|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19
11220635|NCT01961609|12412253|FG003|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
11220636|NCT01961609|12412250|FG000|STARTED|Maintanence 2 (Weeks 49 - 72)||83
11220637|NCT01961609|12412251|FG001|STARTED|Maintanence 2 (Weeks 49 - 72)||31
11220638|NCT01961609|12412252|FG002|STARTED|Maintanence 2 (Weeks 49 - 72)||16
11220639|NCT01961609|12412253|FG003|STARTED|Maintanence 2 (Weeks 49 - 72)||24
11220640|NCT01961609|12412250|FG000|Safety Set|Maintanence 2 (Weeks 49 - 72)||83
11220641|NCT01961609|12412251|FG001|Safety Set|Maintanence 2 (Weeks 49 - 72)||31
11220642|NCT01961609|12412252|FG002|Safety Set|Maintanence 2 (Weeks 49 - 72)||16
11220643|NCT01961609|12412253|FG003|Safety Set|Maintanence 2 (Weeks 49 - 72)||24
11220644|NCT01961609|12412250|FG000|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83
11220645|NCT01961609|12412251|FG001|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31
11220646|NCT01961609|12412252|FG002|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16
11220647|NCT01961609|12412253|FG003|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24
11220648|NCT01961609|12412250|FG000|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71
11220649|NCT01961609|12412251|FG001|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25
11220650|NCT01961609|12412252|FG002|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
11220651|NCT01961609|12412253|FG003|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17
11220652|NCT01961609|12412250|FG000|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
11220653|NCT01961609|12412251|FG001|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6
11220654|NCT01961609|12412252|FG002|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4
11220655|NCT01961609|12412253|FG003|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7
10836706|NCT02135029|12002201|FG000|COMPLETED|Overall Study||69
10836707|NCT02135029|12002202|FG001|COMPLETED|Overall Study||69
11220656|NCT01961687|12412270|FG000|STARTED|Overall Study||121
11220657|NCT01961687|12412270|FG000|COMPLETED|Overall Study||60
11220658|NCT01961687|12412270|FG000|NOT COMPLETED|Overall Study||61
11220659|NCT01961882|12412276|FG000|STARTED|Overall Study||69
11220660|NCT01961882|12412277|FG001|STARTED|Overall Study||65
11220661|NCT01961882|12412276|FG000|COMPLETED|Overall Study||19
11220662|NCT01961882|12412277|FG001|COMPLETED|Overall Study||23
11220663|NCT01961882|12412276|FG000|NOT COMPLETED|Overall Study||50
10836638|NCT02081391|12002119|FG000|STARTED|12-hour Treatment||108
10836639|NCT02081391|12002120|FG001|STARTED|12-hour Treatment||52
10836640|NCT02081391|12002121|FG002|STARTED|12-hour Treatment||11
10836641|NCT02081391|12002122|FG003|STARTED|12-hour Treatment||4
10836642|NCT02081391|12002119|FG000|COMPLETED|12-hour Treatment||90
10836643|NCT02081391|12002120|FG001|COMPLETED|12-hour Treatment||46
10836644|NCT02081391|12002121|FG002|COMPLETED|12-hour Treatment||10
10836645|NCT02081391|12002122|FG003|COMPLETED|12-hour Treatment||4
10836646|NCT02081391|12002119|FG000|NOT COMPLETED|12-hour Treatment||18
10836647|NCT02081391|12002120|FG001|NOT COMPLETED|12-hour Treatment||6
10836648|NCT02081391|12002121|FG002|NOT COMPLETED|12-hour Treatment||1
10836649|NCT02081391|12002122|FG003|NOT COMPLETED|12-hour Treatment||0
10836650|NCT02081391|12002119|FG000|STARTED|24-hour Treatment and Trial Completion||90
10836651|NCT02081391|12002120|FG001|STARTED|24-hour Treatment and Trial Completion||46
10836652|NCT02081391|12002121|FG002|STARTED|24-hour Treatment and Trial Completion||10
10836653|NCT02081391|12002122|FG003|STARTED|24-hour Treatment and Trial Completion||4
10836654|NCT02081391|12002119|FG000|COMPLETED|24-hour Treatment and Trial Completion||63
10836655|NCT02081391|12002120|FG001|COMPLETED|24-hour Treatment and Trial Completion||28
10836656|NCT02081391|12002121|FG002|COMPLETED|24-hour Treatment and Trial Completion||9
10836657|NCT02081391|12002122|FG003|COMPLETED|24-hour Treatment and Trial Completion||4
10836658|NCT02081391|12002119|FG000|NOT COMPLETED|24-hour Treatment and Trial Completion||27
10836659|NCT02081391|12002120|FG001|NOT COMPLETED|24-hour Treatment and Trial Completion||18
10836660|NCT02081391|12002121|FG002|NOT COMPLETED|24-hour Treatment and Trial Completion||1
10836661|NCT02081391|12002122|FG003|NOT COMPLETED|24-hour Treatment and Trial Completion||0
10836689|NCT02114697|12002187|FG000|STARTED|Overall Study||5
10836690|NCT02114697|12002188|FG001|STARTED|Overall Study||4
10836691|NCT02114697|12002187|FG000|Completed Month 18 Visit|Overall Study||0
10836692|NCT02114697|12002188|FG001|Completed Month 18 Visit|Overall Study||1
10836693|NCT02114697|12002187|FG000|COMPLETED|Overall Study||0
10836694|NCT02114697|12002188|FG001|COMPLETED|Overall Study||0
10836695|NCT02114697|12002187|FG000|NOT COMPLETED|Overall Study||5
10836696|NCT02114697|12002188|FG001|NOT COMPLETED|Overall Study||4
10836708|NCT02135029|12002203|FG002|COMPLETED|Overall Study||34
10836709|NCT02135029|12002201|FG000|NOT COMPLETED|Overall Study||4
10836710|NCT02135029|12002202|FG001|NOT COMPLETED|Overall Study||5
10836711|NCT02135029|12002203|FG002|NOT COMPLETED|Overall Study||3
11220664|NCT01961882|12412277|FG001|NOT COMPLETED|Overall Study||42
11220665|NCT01961921|12412283|FG000|STARTED|Overall Study||27
11220666|NCT01961921|12412283|FG000|COMPLETED|Overall Study||25
10836712|NCT02137239|12002214|FG000|STARTED|Overall Study||26
10836713|NCT02137239|12002215|FG001|STARTED|Overall Study||32
10836714|NCT02137239|12002214|FG000|COMPLETED|Overall Study||23
10836715|NCT02137239|12002215|FG001|COMPLETED|Overall Study||26
10836716|NCT02137239|12002214|FG000|NOT COMPLETED|Overall Study||3
11103662|NCT01244035|12287875|FG004|STARTED|Part 1: Period 1||5
11103663|NCT01244035|12287876|FG005|STARTED|Part 1: Period 1||5
11103664|NCT01244035|12287871|FG000|COMPLETED|Part 1: Period 1||4
11103665|NCT01244035|12287872|FG001|COMPLETED|Part 1: Period 1||3
11103666|NCT01244035|12287873|FG002|COMPLETED|Part 1: Period 1||4
11103667|NCT01244035|12287874|FG003|COMPLETED|Part 1: Period 1||5
11103668|NCT01244035|12287875|FG004|COMPLETED|Part 1: Period 1||4
11103669|NCT01244035|12287876|FG005|COMPLETED|Part 1: Period 1||3
11103670|NCT01244035|12287871|FG000|NOT COMPLETED|Part 1: Period 1||1
11103671|NCT01244035|12287872|FG001|NOT COMPLETED|Part 1: Period 1||2
11103672|NCT01244035|12287873|FG002|NOT COMPLETED|Part 1: Period 1||2
11103673|NCT01244035|12287874|FG003|NOT COMPLETED|Part 1: Period 1||0
11103674|NCT01244035|12287875|FG004|NOT COMPLETED|Part 1: Period 1||1
11103675|NCT01244035|12287876|FG005|NOT COMPLETED|Part 1: Period 1||2
11103676|NCT01244035|12287871|FG000|STARTED|Part 1: Period 2||4
11103677|NCT01244035|12287872|FG001|STARTED|Part 1: Period 2||3
11103678|NCT01244035|12287873|FG002|STARTED|Part 1: Period 2||4
11103679|NCT01244035|12287874|FG003|STARTED|Part 1: Period 2||5
11103680|NCT01244035|12287875|FG004|STARTED|Part 1: Period 2||4
11103681|NCT01244035|12287876|FG005|STARTED|Part 1: Period 2||3
11103682|NCT01244035|12287871|FG000|COMPLETED|Part 1: Period 2||4
11103683|NCT01244035|12287872|FG001|COMPLETED|Part 1: Period 2||3
11103684|NCT01244035|12287873|FG002|COMPLETED|Part 1: Period 2||3
11103685|NCT01244035|12287874|FG003|COMPLETED|Part 1: Period 2||5
11103686|NCT01244035|12287875|FG004|COMPLETED|Part 1: Period 2||4
11103687|NCT01244035|12287876|FG005|COMPLETED|Part 1: Period 2||3
11103688|NCT01244035|12287871|FG000|NOT COMPLETED|Part 1: Period 2||0
11103689|NCT01244035|12287872|FG001|NOT COMPLETED|Part 1: Period 2||0
11103690|NCT01244035|12287873|FG002|NOT COMPLETED|Part 1: Period 2||1
11103691|NCT01244035|12287874|FG003|NOT COMPLETED|Part 1: Period 2||0
11103692|NCT01244035|12287875|FG004|NOT COMPLETED|Part 1: Period 2||0
11103693|NCT01244035|12287876|FG005|NOT COMPLETED|Part 1: Period 2||0
11103694|NCT01244035|12287871|FG000|STARTED|Part 1: Period 3||4
11103695|NCT01244035|12287872|FG001|STARTED|Part 1: Period 3||3
11103696|NCT01244035|12287873|FG002|STARTED|Part 1: Period 3||3
11103697|NCT01244035|12287874|FG003|STARTED|Part 1: Period 3||5
11103698|NCT01244035|12287875|FG004|STARTED|Part 1: Period 3||4
11103699|NCT01244035|12287876|FG005|STARTED|Part 1: Period 3||3
11103700|NCT01244035|12287871|FG000|COMPLETED|Part 1: Period 3||4
11103701|NCT01244035|12287872|FG001|COMPLETED|Part 1: Period 3||2
11103702|NCT01244035|12287873|FG002|COMPLETED|Part 1: Period 3||3
11103703|NCT01244035|12287874|FG003|COMPLETED|Part 1: Period 3||5
11103704|NCT01244035|12287875|FG004|COMPLETED|Part 1: Period 3||3
11103705|NCT01244035|12287876|FG005|COMPLETED|Part 1: Period 3||2
11103706|NCT01244035|12287871|FG000|NOT COMPLETED|Part 1: Period 3||0
11103707|NCT01244035|12287872|FG001|NOT COMPLETED|Part 1: Period 3||1
11103708|NCT01244035|12287873|FG002|NOT COMPLETED|Part 1: Period 3||0
11103709|NCT01244035|12287874|FG003|NOT COMPLETED|Part 1: Period 3||0
11103710|NCT01244035|12287875|FG004|NOT COMPLETED|Part 1: Period 3||1
11103711|NCT01244035|12287876|FG005|NOT COMPLETED|Part 1: Period 3||1
11103712|NCT01244061|12287898|FG000|STARTED|Overall Study||251
11103713|NCT01244061|12287899|FG001|STARTED|Overall Study||247
11103714|NCT01244061|12287898|FG000|COMPLETED|Overall Study||169
11103715|NCT01244061|12287899|FG001|COMPLETED|Overall Study||144
11103716|NCT01244061|12287898|FG000|NOT COMPLETED|Overall Study||82
11103717|NCT01244061|12287899|FG001|NOT COMPLETED|Overall Study||103
11103718|NCT01244126|12287908|FG000|STARTED|Overall Study||59
11103719|NCT01244126|12287909|FG001|STARTED|Overall Study||55
11103720|NCT01244126|12287910|FG002|STARTED|Overall Study||57
11103721|NCT01244126|12287908|FG000|COMPLETED|Overall Study||56
11103722|NCT01244126|12287909|FG001|COMPLETED|Overall Study||52
11103723|NCT01244126|12287910|FG002|COMPLETED|Overall Study||48
11103724|NCT01244126|12287908|FG000|NOT COMPLETED|Overall Study||3
11103725|NCT01244126|12287909|FG001|NOT COMPLETED|Overall Study||3
11103726|NCT01244126|12287910|FG002|NOT COMPLETED|Overall Study||9
11103727|NCT01244191|12287920|FG000|STARTED|Overall Study||526
11103728|NCT01244191|12287921|FG001|STARTED|Overall Study||522
11103729|NCT01244191|12287920|FG000|Did Not Receive Treatment|Overall Study||6
11103730|NCT01244191|12287921|FG001|Did Not Receive Treatment|Overall Study||5
11103731|NCT01244191|12287920|FG000|COMPLETED|Overall Study||46
11103732|NCT01244191|12287921|FG001|COMPLETED|Overall Study||24
11103733|NCT01244191|12287920|FG000|NOT COMPLETED|Overall Study||480
11103734|NCT01244191|12287921|FG001|NOT COMPLETED|Overall Study||498
11103735|NCT01244243|12287927|FG000|STARTED|Overall Study||41
11103736|NCT01244243|12287927|FG000|COMPLETED|Overall Study||41
11103737|NCT01244243|12287927|FG000|NOT COMPLETED|Overall Study||0
11103738|NCT01244412|12287931|FG000|STARTED|Overall Study||1
11103739|NCT01244412|12287931|FG000|COMPLETED|Overall Study||1
11220667|NCT01961921|12412283|FG000|NOT COMPLETED|Overall Study||2
10836717|NCT02137239|12002215|FG001|NOT COMPLETED|Overall Study||6
11220668|NCT01962025|12412289|FG000|STARTED|Overall Study||8
11220669|NCT01962025|12412290|FG001|STARTED|Overall Study||6
11220670|NCT01962025|12412289|FG000|COMPLETED|Overall Study||8
10836718|NCT02148133|12002221|FG000|STARTED|Overall Study||21
10836719|NCT02148133|12002221|FG000|Safety Set (SS)|Overall Study||21
10836720|NCT02148133|12002221|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||21
10836721|NCT02148133|12002221|FG000|COMPLETED|Overall Study||16
10836722|NCT02148133|12002221|FG000|NOT COMPLETED|Overall Study||5
10836723|NCT02151383|12002228|FG000|STARTED|Overall Study||8
10836724|NCT02151383|12002229|FG001|STARTED|Overall Study||3
10836725|NCT02151383|12002230|FG002|STARTED|Overall Study||1
10836726|NCT02151383|12002228|FG000|Low-dose|Overall Study||2
10836727|NCT02151383|12002229|FG001|Low-dose|Overall Study||3
10836728|NCT02151383|12002230|FG002|Low-dose|Overall Study||1
10836729|NCT02151383|12002228|FG000|High-dose|Overall Study||6
10836730|NCT02151383|12002229|FG001|High-dose|Overall Study||0
10836731|NCT02151383|12002230|FG002|High-dose|Overall Study||0
10836732|NCT02151383|12002228|FG000|COMPLETED|Overall Study||8
10836733|NCT02151383|12002229|FG001|COMPLETED|Overall Study||3
10836734|NCT02151383|12002230|FG002|COMPLETED|Overall Study||1
10836735|NCT02151383|12002228|FG000|NOT COMPLETED|Overall Study||0
10836736|NCT02151383|12002229|FG001|NOT COMPLETED|Overall Study||0
10836737|NCT02151383|12002230|FG002|NOT COMPLETED|Overall Study||0
10836738|NCT02165215|12002241|FG000|STARTED|Induction Phase||359
10836739|NCT02165215|12002242|FG001|STARTED|Induction Phase||0
10836740|NCT02165215|12002243|FG002|STARTED|Induction Phase||0
10836741|NCT02165215|12002241|FG000|Dosed|Induction Phase||358
10836742|NCT02165215|12002242|FG001|Dosed|Induction Phase||0
10836743|NCT02165215|12002243|FG002|Dosed|Induction Phase||0
10836744|NCT02165215|12002241|FG000|COMPLETED|Induction Phase||336
10836745|NCT02165215|12002242|FG001|COMPLETED|Induction Phase||0
10836746|NCT02165215|12002243|FG002|COMPLETED|Induction Phase||0
10836747|NCT02165215|12002241|FG000|NOT COMPLETED|Induction Phase||23
10836748|NCT02165215|12002242|FG001|NOT COMPLETED|Induction Phase||0
10836749|NCT02165215|12002243|FG002|NOT COMPLETED|Induction Phase||0
10836750|NCT02165215|12002241|FG000|STARTED|Maintenance Phase||0
10836751|NCT02165215|12002242|FG001|STARTED|Maintenance Phase||108
10836752|NCT02165215|12002243|FG002|STARTED|Maintenance Phase||106
10836753|NCT02165215|12002241|FG000|Dosed|Maintenance Phase||0
10836754|NCT02165215|12002242|FG001|Dosed|Maintenance Phase||108
10836755|NCT02165215|12002243|FG002|Dosed|Maintenance Phase||102
10836756|NCT02165215|12002241|FG000|COMPLETED|Maintenance Phase||0
10836757|NCT02165215|12002242|FG001|COMPLETED|Maintenance Phase||96
10836758|NCT02165215|12002243|FG002|COMPLETED|Maintenance Phase||101
10836759|NCT02165215|12002241|FG000|NOT COMPLETED|Maintenance Phase||0
10836760|NCT02165215|12002242|FG001|NOT COMPLETED|Maintenance Phase||12
10836761|NCT02165215|12002243|FG002|NOT COMPLETED|Maintenance Phase||5
10836762|NCT02180217|12002257|FG000|STARTED|Overall Study||36
10836763|NCT02180217|12002258|FG001|STARTED|Overall Study||35
10836764|NCT02180217|12002259|FG002|STARTED|Overall Study||66
10836765|NCT02180217|12002257|FG000|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
10836766|NCT02180217|12002258|FG001|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
10836767|NCT02180217|12002259|FG002|Discontinued at/Prior to Week 12 (W12)|Overall Study||7
10836768|NCT02180217|12002257|FG000|Discont. at/Prior to W26 But After W12|Overall Study||0
10836769|NCT02180217|12002258|FG001|Discont. at/Prior to W26 But After W12|Overall Study||0
10836770|NCT02180217|12002259|FG002|Discont. at/Prior to W26 But After W12|Overall Study||12
10836771|NCT02180217|12002257|FG000|Discontinued Prior to W48 But After W26|Overall Study||0
10836772|NCT02180217|12002258|FG001|Discontinued Prior to W48 But After W26|Overall Study||2
10836773|NCT02180217|12002259|FG002|Discontinued Prior to W48 But After W26|Overall Study||3
10836774|NCT02180217|12002257|FG000|Completed Week 48 (Core Phase)|Overall Study||36
10836775|NCT02180217|12002258|FG001|Completed Week 48 (Core Phase)|Overall Study||33
10836776|NCT02180217|12002259|FG002|Completed Week 48 (Core Phase)|Overall Study||44
10836777|NCT02180217|12002257|FG000|Completed W48, Did Not Enter Ext. Phase|Overall Study||1
10836778|NCT02180217|12002258|FG001|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
11103740|NCT01244412|12287931|FG000|NOT COMPLETED|Overall Study||0
11103741|NCT01244425|12287937|FG000|STARTED|Overall Study||35
10836779|NCT02180217|12002259|FG002|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
10836780|NCT02180217|12002257|FG000|Completed W48, Entered Ext. Phase|Overall Study||35
10836781|NCT02180217|12002258|FG001|Completed W48, Entered Ext. Phase|Overall Study||30
10836782|NCT02180217|12002259|FG002|Completed W48, Entered Ext. Phase|Overall Study||41
10836783|NCT02180217|12002257|FG000|Discontinued Extension Phase|Overall Study||12
10836784|NCT02180217|12002258|FG001|Discontinued Extension Phase|Overall Study||6
10836785|NCT02180217|12002259|FG002|Discontinued Extension Phase|Overall Study||16
10836786|NCT02180217|12002257|FG000|Completed Ext. Phase|Overall Study||23
10836787|NCT02180217|12002258|FG001|Completed Ext. Phase|Overall Study||24
10836788|NCT02180217|12002259|FG002|Completed Ext. Phase|Overall Study||25
10836789|NCT02180217|12002257|FG000|COMPLETED|Overall Study||24
10836790|NCT02180217|12002258|FG001|COMPLETED|Overall Study||27
10836791|NCT02180217|12002259|FG002|COMPLETED|Overall Study||28
10836792|NCT02180217|12002257|FG000|NOT COMPLETED|Overall Study||12
10836793|NCT02180217|12002258|FG001|NOT COMPLETED|Overall Study||8
10836794|NCT02180217|12002259|FG002|NOT COMPLETED|Overall Study||38
10836795|NCT02186457|12002276|FG000|STARTED|Overall Study||95
10836796|NCT02186457|12002277|FG001|STARTED|Overall Study||95
10836797|NCT02186457|12002276|FG000|COMPLETED|Overall Study||95
10836798|NCT02186457|12002277|FG001|COMPLETED|Overall Study||95
10836799|NCT02186457|12002276|FG000|NOT COMPLETED|Overall Study||0
10836800|NCT02186457|12002277|FG001|NOT COMPLETED|Overall Study||0
10836801|NCT02193867|12002283|FG000|STARTED|Overall Study||10
10836802|NCT02193867|12002283|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||10
10836803|NCT02193867|12002283|FG000|Completed 18 Months Of Treatment|Overall Study||8
10836804|NCT02193867|12002283|FG000|COMPLETED|Overall Study||6
10836805|NCT02193867|12002283|FG000|NOT COMPLETED|Overall Study||4
10836806|NCT02215096|12002290|FG000|STARTED|Run-In Period (Up to Week 2)||37
10836807|NCT02215096|12002291|FG001|STARTED|Run-In Period (Up to Week 2)||0
10836808|NCT02215096|12002292|FG002|STARTED|Run-In Period (Up to Week 2)||0
10836809|NCT02215096|12002293|FG003|STARTED|Run-In Period (Up to Week 2)||0
10836810|NCT02215096|12002294|FG004|STARTED|Run-In Period (Up to Week 2)||0
10836811|NCT02215096|12002290|FG000|COMPLETED|Run-In Period (Up to Week 2)||36
10836812|NCT02215096|12002291|FG001|COMPLETED|Run-In Period (Up to Week 2)||0
10836813|NCT02215096|12002292|FG002|COMPLETED|Run-In Period (Up to Week 2)||0
10836814|NCT02215096|12002293|FG003|COMPLETED|Run-In Period (Up to Week 2)||0
10836815|NCT02215096|12002294|FG004|COMPLETED|Run-In Period (Up to Week 2)||0
10836816|NCT02215096|12002290|FG000|NOT COMPLETED|Run-In Period (Up to Week 2)||1
10836817|NCT02215096|12002291|FG001|NOT COMPLETED|Run-In Period (Up to Week 2)||0
10836818|NCT02215096|12002292|FG002|NOT COMPLETED|Run-In Period (Up to Week 2)||0
10836819|NCT02215096|12002293|FG003|NOT COMPLETED|Run-In Period (Up to Week 2)||0
10836820|NCT02215096|12002294|FG004|NOT COMPLETED|Run-In Period (Up to Week 2)||0
10836821|NCT02215096|12002290|FG000|STARTED|Combination TP (Up to Maximum 654 Days)||0
10836822|NCT02215096|12002291|FG001|STARTED|Combination TP (Up to Maximum 654 Days)||11
10836823|NCT02215096|12002292|FG002|STARTED|Combination TP (Up to Maximum 654 Days)||11
11220671|NCT01962025|12412290|FG001|COMPLETED|Overall Study||6
11220672|NCT01962025|12412289|FG000|NOT COMPLETED|Overall Study||0
11220673|NCT01962025|12412290|FG001|NOT COMPLETED|Overall Study||0
11220674|NCT01962103|12412307|FG000|STARTED|Phase 1||16
11220675|NCT01962103|12412308|FG001|STARTED|Phase 1||8
11220676|NCT01962103|12412309|FG002|STARTED|Phase 1||14
11220677|NCT01962103|12412310|FG003|STARTED|Phase 1||11
11220678|NCT01962103|12412311|FG004|STARTED|Phase 1||8
11220679|NCT01962103|12412312|FG005|STARTED|Phase 1||7
11220680|NCT01962103|12412313|FG006|STARTED|Phase 1||0
11220681|NCT01962103|12412314|FG007|STARTED|Phase 1||0
11220682|NCT01962103|12412315|FG008|STARTED|Phase 1||0
11220683|NCT01962103|12412307|FG000|COMPLETED|Phase 1||0
11220684|NCT01962103|12412308|FG001|COMPLETED|Phase 1||0
11220685|NCT01962103|12412309|FG002|COMPLETED|Phase 1||0
11220686|NCT01962103|12412310|FG003|COMPLETED|Phase 1||0
11220687|NCT01962103|12412311|FG004|COMPLETED|Phase 1||0
11220688|NCT01962103|12412312|FG005|COMPLETED|Phase 1||0
11220689|NCT01962103|12412313|FG006|COMPLETED|Phase 1||0
11220690|NCT01962103|12412314|FG007|COMPLETED|Phase 1||0
11220691|NCT01962103|12412315|FG008|COMPLETED|Phase 1||0
11220692|NCT01962103|12412307|FG000|NOT COMPLETED|Phase 1||16
11220693|NCT01962103|12412308|FG001|NOT COMPLETED|Phase 1||8
11220694|NCT01962103|12412309|FG002|NOT COMPLETED|Phase 1||14
11220695|NCT01962103|12412310|FG003|NOT COMPLETED|Phase 1||11
11220696|NCT01962103|12412311|FG004|NOT COMPLETED|Phase 1||8
11220697|NCT01962103|12412312|FG005|NOT COMPLETED|Phase 1||7
11220698|NCT01962103|12412313|FG006|NOT COMPLETED|Phase 1||0
11220699|NCT01962103|12412314|FG007|NOT COMPLETED|Phase 1||0
11220700|NCT01962103|12412315|FG008|NOT COMPLETED|Phase 1||0
11220701|NCT01962103|12412307|FG000|STARTED|Phase 2||0
11220702|NCT01962103|12412308|FG001|STARTED|Phase 2||0
11220703|NCT01962103|12412309|FG002|STARTED|Phase 2||0
11220704|NCT01962103|12412310|FG003|STARTED|Phase 2||0
11220705|NCT01962103|12412311|FG004|STARTED|Phase 2||0
11220706|NCT01962103|12412312|FG005|STARTED|Phase 2||0
11220707|NCT01962103|12412313|FG006|STARTED|Phase 2||14
11220708|NCT01962103|12412314|FG007|STARTED|Phase 2||14
11220709|NCT01962103|12412315|FG008|STARTED|Phase 2||14
11220710|NCT01962103|12412307|FG000|COMPLETED|Phase 2||0
11220711|NCT01962103|12412308|FG001|COMPLETED|Phase 2||0
11220712|NCT01962103|12412309|FG002|COMPLETED|Phase 2||0
11220713|NCT01962103|12412310|FG003|COMPLETED|Phase 2||0
11220714|NCT01962103|12412311|FG004|COMPLETED|Phase 2||0
11220715|NCT01962103|12412312|FG005|COMPLETED|Phase 2||0
11220716|NCT01962103|12412313|FG006|COMPLETED|Phase 2|completed treatment|0
11220717|NCT01962103|12412314|FG007|COMPLETED|Phase 2|completed treatment|0
11220718|NCT01962103|12412315|FG008|COMPLETED|Phase 2|completed treatment|0
11220719|NCT01962103|12412307|FG000|NOT COMPLETED|Phase 2||0
11220720|NCT01962103|12412308|FG001|NOT COMPLETED|Phase 2||0
11220721|NCT01962103|12412309|FG002|NOT COMPLETED|Phase 2||0
11220722|NCT01962103|12412310|FG003|NOT COMPLETED|Phase 2||0
11220723|NCT01962103|12412311|FG004|NOT COMPLETED|Phase 2||0
11220724|NCT01962103|12412312|FG005|NOT COMPLETED|Phase 2||0
11220725|NCT01962103|12412313|FG006|NOT COMPLETED|Phase 2||14
11220726|NCT01962103|12412314|FG007|NOT COMPLETED|Phase 2||14
11220727|NCT01962103|12412315|FG008|NOT COMPLETED|Phase 2||14
11220728|NCT01962207|12412339|FG000|STARTED|Persistence Phase (5 Years)||76
11220729|NCT01962207|12412340|FG001|STARTED|Persistence Phase (5 Years)||23
11220730|NCT01962207|12412341|FG002|STARTED|Persistence Phase (5 Years)||115
11220731|NCT01962207|12412342|FG003|STARTED|Persistence Phase (5 Years)||29
11220732|NCT01962207|12412339|FG000|COMPLETED|Persistence Phase (5 Years)||47
11220733|NCT01962207|12412340|FG001|COMPLETED|Persistence Phase (5 Years)||10
11220734|NCT01962207|12412341|FG002|COMPLETED|Persistence Phase (5 Years)||71
11220735|NCT01962207|12412342|FG003|COMPLETED|Persistence Phase (5 Years)||17
11220736|NCT01962207|12412339|FG000|NOT COMPLETED|Persistence Phase (5 Years)||29
11220737|NCT01962207|12412340|FG001|NOT COMPLETED|Persistence Phase (5 Years)||13
10836824|NCT02215096|12002293|FG003|STARTED|Combination TP (Up to Maximum 654 Days)||12
10836825|NCT02215096|12002294|FG004|STARTED|Combination TP (Up to Maximum 654 Days)||2
10836826|NCT02215096|12002290|FG000|COMPLETED|Combination TP (Up to Maximum 654 Days)||0
10836827|NCT02215096|12002291|FG001|COMPLETED|Combination TP (Up to Maximum 654 Days)||9
10836828|NCT02215096|12002292|FG002|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
11220738|NCT01962207|12412341|FG002|NOT COMPLETED|Persistence Phase (5 Years)||44
11220739|NCT01962207|12412342|FG003|NOT COMPLETED|Persistence Phase (5 Years)||12
11220740|NCT01962207|12412339|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67
11220741|NCT01962207|12412340|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16
11354133|NCT03069989|12551340|FG000|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
10836829|NCT02215096|12002293|FG003|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
10836830|NCT02215096|12002294|FG004|COMPLETED|Combination TP (Up to Maximum 654 Days)||1
10836831|NCT02215096|12002290|FG000|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||0
10836832|NCT02215096|12002291|FG001|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
10836833|NCT02215096|12002292|FG002|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
10836834|NCT02215096|12002293|FG003|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
10836835|NCT02215096|12002294|FG004|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
10836836|NCT02218697|12002312|FG000|STARTED|Overall Study||179
10836837|NCT02218697|12002313|FG001|STARTED|Overall Study||177
10836838|NCT02218697|12002312|FG000|COMPLETED|Overall Study||177
10836839|NCT02218697|12002313|FG001|COMPLETED|Overall Study||171
10836840|NCT02218697|12002312|FG000|NOT COMPLETED|Overall Study||2
10836841|NCT02218697|12002313|FG001|NOT COMPLETED|Overall Study||6
10836842|NCT02221037|12002323|FG000|STARTED|Overall Study||5
10836843|NCT02221037|12002324|FG001|STARTED|Overall Study||11
10836844|NCT02221037|12002325|FG002|STARTED|Overall Study||8
10836845|NCT02221037|12002326|FG003|STARTED|Overall Study||9
10836846|NCT02221037|12002323|FG000|COMPLETED|Overall Study||5
10836847|NCT02221037|12002324|FG001|COMPLETED|Overall Study||11
10836848|NCT02221037|12002325|FG002|COMPLETED|Overall Study||7
10836849|NCT02221037|12002326|FG003|COMPLETED|Overall Study||9
10836850|NCT02221037|12002323|FG000|NOT COMPLETED|Overall Study||0
10836851|NCT02221037|12002324|FG001|NOT COMPLETED|Overall Study||0
10836852|NCT02221037|12002325|FG002|NOT COMPLETED|Overall Study||1
10836853|NCT02221037|12002326|FG003|NOT COMPLETED|Overall Study||0
10836854|NCT02224456|12002340|FG000|STARTED|Overall Study||197
10836855|NCT02224456|12002340|FG000|COMPLETED|Overall Study||161
10836856|NCT02224456|12002340|FG000|NOT COMPLETED|Overall Study||36
10836857|NCT02231762|12002344|FG000|STARTED|Combination Phase||57
10836858|NCT02231762|12002345|FG001|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
10836859|NCT02231762|12002346|FG002|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
10836860|NCT02231762|12002347|FG003|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
10836861|NCT02231762|12002344|FG000|COMPLETED|Combination Phase||37
10836862|NCT02231762|12002345|FG001|COMPLETED|Combination Phase||0
10836863|NCT02231762|12002346|FG002|COMPLETED|Combination Phase||0
10836864|NCT02231762|12002347|FG003|COMPLETED|Combination Phase||0
10836865|NCT02231762|12002344|FG000|NOT COMPLETED|Combination Phase||20
11103742|NCT01244425|12287938|FG001|STARTED|Overall Study||35
11103743|NCT01244425|12287937|FG000|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
11103744|NCT01244425|12287938|FG001|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
11103745|NCT01244425|12287937|FG000|NOT COMPLETED|Overall Study||3
11103746|NCT01244425|12287938|FG001|NOT COMPLETED|Overall Study||3
11103747|NCT01244451|12287952|FG000|STARTED|Overall Study||49
11103748|NCT01244451|12287952|FG000|COMPLETED|Overall Study||36
11103749|NCT01244451|12287952|FG000|NOT COMPLETED|Overall Study||13
11103750|NCT01244477|12287959|FG000|STARTED|Overall Study||38
11103751|NCT01244477|12287960|FG001|STARTED|Overall Study||23
11103752|NCT01244477|12287959|FG000|COMPLETED|Overall Study||18
11103753|NCT01244477|12287960|FG001|COMPLETED|Overall Study||20
11103754|NCT01244477|12287959|FG000|NOT COMPLETED|Overall Study||20
11103755|NCT01244477|12287960|FG001|NOT COMPLETED|Overall Study||3
11103756|NCT01244490|12287971|FG000|STARTED|Overall Study||111
11103757|NCT01244490|12287972|FG001|STARTED|Overall Study||115
11103758|NCT01244490|12287973|FG002|STARTED|Overall Study||112
11103759|NCT01244490|12287971|FG000|COMPLETED|Overall Study||92
11103760|NCT01244490|12287972|FG001|COMPLETED|Overall Study||91
11103761|NCT01244490|12287973|FG002|COMPLETED|Overall Study||89
11103762|NCT01244490|12287971|FG000|NOT COMPLETED|Overall Study||19
11103763|NCT01244490|12287972|FG001|NOT COMPLETED|Overall Study||24
11103764|NCT01244490|12287973|FG002|NOT COMPLETED|Overall Study||23
11103765|NCT01244503|12287981|FG000|STARTED|Overall Study||61
11103766|NCT01244503|12287981|FG000|COMPLETED|Overall Study||61
11103767|NCT01244503|12287981|FG000|NOT COMPLETED|Overall Study||0
11103768|NCT01244516|12287988|FG000|STARTED|Period 1 (Baseline to 1-week Visit)||170
11103769|NCT01244516|12287989|FG001|STARTED|Period 1 (Baseline to 1-week Visit)||177
11103770|NCT01244516|12287990|FG002|STARTED|Period 1 (Baseline to 1-week Visit)||173
11103771|NCT01244516|12287988|FG000|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
11103772|NCT01244516|12287989|FG001|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
11103773|NCT01244516|12287990|FG002|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
11103774|NCT01244516|12287988|FG000|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
11103775|NCT01244516|12287989|FG001|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
11103776|NCT01244516|12287990|FG002|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
11103777|NCT01244516|12287988|FG000|STARTED|Period 2 (1-week to 2-week Visit)||166
11103778|NCT01244516|12287989|FG001|STARTED|Period 2 (1-week to 2-week Visit)||171
11103779|NCT01244516|12287990|FG002|STARTED|Period 2 (1-week to 2-week Visit)||170
11103780|NCT01244516|12287988|FG000|COMPLETED|Period 2 (1-week to 2-week Visit)||163
11103781|NCT01244516|12287989|FG001|COMPLETED|Period 2 (1-week to 2-week Visit)||170
11103782|NCT01244516|12287990|FG002|COMPLETED|Period 2 (1-week to 2-week Visit)||168
11103783|NCT01244516|12287988|FG000|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
11103784|NCT01244516|12287989|FG001|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
11103785|NCT01244516|12287990|FG002|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
11103786|NCT01244529|12287999|FG000|STARTED|Overall Study||41
11103787|NCT01244529|12287999|FG000|COMPLETED|Overall Study||41
11103788|NCT01244529|12287999|FG000|NOT COMPLETED|Overall Study||0
11220742|NCT01962207|12412341|FG002|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77
11220743|NCT01962207|12412342|FG003|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21
11220744|NCT01962207|12412339|FG000|COMPLETED|Booster Phase (6 Months)||67
10836866|NCT02231762|12002345|FG001|NOT COMPLETED|Combination Phase||0
10836867|NCT02231762|12002346|FG002|NOT COMPLETED|Combination Phase||0
10836868|NCT02231762|12002347|FG003|NOT COMPLETED|Combination Phase||0
10836869|NCT02231762|12002344|FG000|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0
10836870|NCT02231762|12002345|FG001|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11
10836871|NCT02231762|12002346|FG002|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14
10836872|NCT02231762|12002347|FG003|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12
10836873|NCT02231762|12002344|FG000|COMPLETED|Maintenance Phase||0
10836874|NCT02231762|12002345|FG001|COMPLETED|Maintenance Phase||8
10836875|NCT02231762|12002346|FG002|COMPLETED|Maintenance Phase||9
10836876|NCT02231762|12002347|FG003|COMPLETED|Maintenance Phase||7
10836877|NCT02231762|12002344|FG000|NOT COMPLETED|Maintenance Phase||0
10836878|NCT02231762|12002345|FG001|NOT COMPLETED|Maintenance Phase||3
10836879|NCT02231762|12002346|FG002|NOT COMPLETED|Maintenance Phase||5
10836880|NCT02231762|12002347|FG003|NOT COMPLETED|Maintenance Phase||5
10836881|NCT02234843|12002371|FG000|STARTED|Overall Study||184
10836882|NCT02234843|12002372|FG001|STARTED|Overall Study||67
10836883|NCT02234843|12002373|FG002|STARTED|Overall Study||47
10836884|NCT02234843|12002374|FG003|STARTED|Overall Study||21
10836885|NCT02234843|12002375|FG004|STARTED|Overall Study||16
10836886|NCT02234843|12002376|FG005|STARTED|Overall Study||92
10836887|NCT02234843|12002377|FG006|STARTED|Overall Study||34
10836888|NCT02234843|12002378|FG007|STARTED|Overall Study||22
10836889|NCT02234843|12002379|FG008|STARTED|Overall Study||9
10836890|NCT02234843|12002380|FG009|STARTED|Overall Study||8
10836891|NCT02234843|12002371|FG000|COMPLETED|Overall Study||162
10836892|NCT02234843|12002372|FG001|COMPLETED|Overall Study||61
10836893|NCT02234843|12002373|FG002|COMPLETED|Overall Study||44
10836894|NCT02234843|12002374|FG003|COMPLETED|Overall Study||16
10836895|NCT02234843|12002375|FG004|COMPLETED|Overall Study||14
10836896|NCT02234843|12002376|FG005|COMPLETED|Overall Study||79
10836897|NCT02234843|12002377|FG006|COMPLETED|Overall Study||32
10836898|NCT02234843|12002378|FG007|COMPLETED|Overall Study||20
10836899|NCT02234843|12002379|FG008|COMPLETED|Overall Study||8
10836900|NCT02234843|12002380|FG009|COMPLETED|Overall Study||8
10836901|NCT02234843|12002371|FG000|NOT COMPLETED|Overall Study||22
10836902|NCT02234843|12002372|FG001|NOT COMPLETED|Overall Study||6
10836903|NCT02234843|12002373|FG002|NOT COMPLETED|Overall Study||3
10836904|NCT02234843|12002374|FG003|NOT COMPLETED|Overall Study||5
10836905|NCT02234843|12002375|FG004|NOT COMPLETED|Overall Study||2
10836906|NCT02234843|12002376|FG005|NOT COMPLETED|Overall Study||13
10836907|NCT02234843|12002377|FG006|NOT COMPLETED|Overall Study||2
10836908|NCT02234843|12002378|FG007|NOT COMPLETED|Overall Study||2
10836909|NCT02234843|12002379|FG008|NOT COMPLETED|Overall Study||1
10836910|NCT02234843|12002380|FG009|NOT COMPLETED|Overall Study||0
10836911|NCT02243306|12002415|FG000|STARTED|Overall Study||1
10836912|NCT02243306|12002416|FG001|STARTED|Overall Study||7
10836913|NCT02243306|12002415|FG000|COMPLETED|Overall Study||1
10836914|NCT02243306|12002416|FG001|COMPLETED|Overall Study||4
10836915|NCT02243306|12002415|FG000|NOT COMPLETED|Overall Study||0
10836916|NCT02243306|12002416|FG001|NOT COMPLETED|Overall Study||3
11103789|NCT01244633|12288015|FG000|STARTED|Overall Study||18
11103790|NCT01244633|12288015|FG000|COMPLETED|Overall Study||15
11103791|NCT01244633|12288015|FG000|NOT COMPLETED|Overall Study||3
11103792|NCT01244711|12288019|FG000|STARTED|Overall Study||1
11220745|NCT01962207|12412340|FG001|COMPLETED|Booster Phase (6 Months)||16
11220746|NCT01962207|12412341|FG002|COMPLETED|Booster Phase (6 Months)||77
11220747|NCT01962207|12412342|FG003|COMPLETED|Booster Phase (6 Months)||21
11220748|NCT01962207|12412339|FG000|NOT COMPLETED|Booster Phase (6 Months)||0
11220749|NCT01962207|12412340|FG001|NOT COMPLETED|Booster Phase (6 Months)||0
11220750|NCT01962207|12412341|FG002|NOT COMPLETED|Booster Phase (6 Months)||0
11220751|NCT01962207|12412342|FG003|NOT COMPLETED|Booster Phase (6 Months)||0
11103793|NCT01244711|12288019|FG000|COMPLETED|Overall Study||1
11103794|NCT01244711|12288019|FG000|NOT COMPLETED|Overall Study||0
11103795|NCT01244724|12288023|FG000|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
11220752|NCT01962298|12412361|FG000|STARTED|Overall Study||15
11220753|NCT01962298|12412362|FG001|STARTED|Overall Study||15
11220754|NCT01962298|12412363|FG002|STARTED|Overall Study||15
11220755|NCT01962298|12412364|FG003|STARTED|Overall Study||15
11220756|NCT01962298|12412365|FG004|STARTED|Overall Study||15
11220757|NCT01962298|12412361|FG000|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
11220758|NCT01962298|12412362|FG001|Received Intervention|Overall Study||15
11220759|NCT01962298|12412363|FG002|Received Intervention|Overall Study||15
11220760|NCT01962298|12412364|FG003|Received Intervention|Overall Study||15
11220761|NCT01962298|12412365|FG004|Received Intervention|Overall Study||15
11220762|NCT01962298|12412361|FG000|COMPLETED|Overall Study||12
11220763|NCT01962298|12412362|FG001|COMPLETED|Overall Study||11
11220764|NCT01962298|12412363|FG002|COMPLETED|Overall Study||10
11220765|NCT01962298|12412364|FG003|COMPLETED|Overall Study||13
11220766|NCT01962298|12412365|FG004|COMPLETED|Overall Study||9
11220767|NCT01962298|12412361|FG000|NOT COMPLETED|Overall Study||3
11220768|NCT01962298|12412362|FG001|NOT COMPLETED|Overall Study||4
11220769|NCT01962298|12412363|FG002|NOT COMPLETED|Overall Study||5
11220770|NCT01962298|12412364|FG003|NOT COMPLETED|Overall Study||2
11220771|NCT01962298|12412365|FG004|NOT COMPLETED|Overall Study||6
11220772|NCT01962428|12412379|FG000|STARTED|Overall Study||139
11220773|NCT01962428|12412380|FG001|STARTED|Overall Study||139
11220774|NCT01962428|12412379|FG000|COMPLETED|Overall Study||129
11220775|NCT01962428|12412380|FG001|COMPLETED|Overall Study||133
11220776|NCT01962428|12412379|FG000|NOT COMPLETED|Overall Study||10
11220777|NCT01962428|12412380|FG001|NOT COMPLETED|Overall Study||6
11220778|NCT01962441|12412389|FG000|STARTED|Randomized Period||200
11220779|NCT01962441|12412390|FG001|STARTED|Randomized Period||201
11220780|NCT01962441|12412391|FG002|STARTED|Randomized Period||200
11220781|NCT01962441|12412389|FG000|COMPLETED|Randomized Period||190
11220782|NCT01962441|12412390|FG001|COMPLETED|Randomized Period||190
11220783|NCT01962441|12412391|FG002|COMPLETED|Randomized Period||189
11220784|NCT01962441|12412389|FG000|NOT COMPLETED|Randomized Period||10
11220785|NCT01962441|12412390|FG001|NOT COMPLETED|Randomized Period||11
11220786|NCT01962441|12412391|FG002|NOT COMPLETED|Randomized Period||11
11220787|NCT01962441|12412389|FG000|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
11220788|NCT01962441|12412390|FG001|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
11220789|NCT01962441|12412391|FG002|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
11220790|NCT01962441|12412389|FG000|COMPLETED|Retreatment Substudy||18
11220791|NCT01962441|12412390|FG001|COMPLETED|Retreatment Substudy||10
11220792|NCT01962441|12412391|FG002|COMPLETED|Retreatment Substudy||0
11220793|NCT01962441|12412389|FG000|NOT COMPLETED|Retreatment Substudy||2
11220794|NCT01962441|12412390|FG001|NOT COMPLETED|Retreatment Substudy||0
11220795|NCT01962441|12412391|FG002|NOT COMPLETED|Retreatment Substudy||0
11220796|NCT01962493|12412402|FG000|STARTED|Overall Study||78
11220797|NCT01962493|12412403|FG001|STARTED|Overall Study||82
11220798|NCT01962493|12412402|FG000|COMPLETED|Overall Study||73
11220799|NCT01962493|12412403|FG001|COMPLETED|Overall Study||77
11354134|NCT03069989|12551341|FG001|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
11354135|NCT03069989|12551340|FG000|STARTED|Wash Out Period (Up to 28 Days))||3
11354136|NCT03069989|12551341|FG001|STARTED|Wash Out Period (Up to 28 Days))||5
11354137|NCT03069989|12551340|FG000|COMPLETED|Wash Out Period (Up to 28 Days))||3
11354138|NCT03069989|12551341|FG001|COMPLETED|Wash Out Period (Up to 28 Days))||5
11103796|NCT01244724|12288023|FG000|Week 2 Visit|Overall Study||15
11103797|NCT01244724|12288023|FG000|COMPLETED|Overall Study||9
11103798|NCT01244724|12288023|FG000|NOT COMPLETED|Overall Study||8
11103799|NCT01244893|12288027|FG000|STARTED|Baseline||22
11103800|NCT01244893|12288028|FG001|STARTED|Baseline||22
11103801|NCT01244893|12288027|FG000|COMPLETED|Baseline||22
11103802|NCT01244893|12288028|FG001|COMPLETED|Baseline||21
11103803|NCT01244893|12288027|FG000|NOT COMPLETED|Baseline||0
11103804|NCT01244893|12288028|FG001|NOT COMPLETED|Baseline||1
11220800|NCT01962493|12412402|FG000|NOT COMPLETED|Overall Study||5
11103805|NCT01244893|12288027|FG000|STARTED|1-Week Follow Up||22
11103806|NCT01244893|12288028|FG001|STARTED|1-Week Follow Up||21
10836925|NCT04093843|12002432|FG000|STARTED|Overall Study||6
10836926|NCT04093843|12002432|FG000|COMPLETED|Overall Study||6
10836927|NCT04093843|12002432|FG000|NOT COMPLETED|Overall Study||0
10836928|NCT03926611|12002443|FG000|STARTED|Overall Study||44
10836929|NCT03926611|12002444|FG001|STARTED|Overall Study||44
10836930|NCT03926611|12002445|FG002|STARTED|Overall Study||47
10836931|NCT03926611|12002446|FG003|STARTED|Overall Study||44
10836932|NCT03926611|12002447|FG004|STARTED|Overall Study||44
10836933|NCT03926611|12002448|FG005|STARTED|Overall Study||45
10836934|NCT03926611|12002449|FG006|STARTED|Overall Study||43
10836935|NCT03926611|12002443|FG000|Randomized Set (RAN)|Overall Study||44
10836936|NCT03926611|12002444|FG001|Randomized Set (RAN)|Overall Study||44
10836937|NCT03926611|12002445|FG002|Randomized Set (RAN)|Overall Study||47
10836938|NCT03926611|12002446|FG003|Randomized Set (RAN)|Overall Study||44
10836939|NCT03926611|12002447|FG004|Randomized Set (RAN)|Overall Study||44
10836940|NCT03926611|12002448|FG005|Randomized Set (RAN)|Overall Study||45
10836941|NCT03926611|12002449|FG006|Randomized Set (RAN)|Overall Study||43
10836942|NCT03926611|12002443|FG000|Full Analysis Set (FAS)|Overall Study||44
10836943|NCT03926611|12002444|FG001|Full Analysis Set (FAS)|Overall Study||44
10836944|NCT03926611|12002445|FG002|Full Analysis Set (FAS)|Overall Study||47
10836945|NCT03926611|12002446|FG003|Full Analysis Set (FAS)|Overall Study||44
10836946|NCT03926611|12002447|FG004|Full Analysis Set (FAS)|Overall Study||43
10836947|NCT03926611|12002448|FG005|Full Analysis Set (FAS)|Overall Study||45
10836948|NCT03926611|12002449|FG006|Full Analysis Set (FAS)|Overall Study||42
10836949|NCT03926611|12002443|FG000|Safety Set (SAF)|Overall Study||44
10836950|NCT03926611|12002444|FG001|Safety Set (SAF)|Overall Study||44
10836951|NCT03926611|12002445|FG002|Safety Set (SAF)|Overall Study||47
10836952|NCT03926611|12002446|FG003|Safety Set (SAF)|Overall Study||44
10836953|NCT03926611|12002447|FG004|Safety Set (SAF)|Overall Study||43
10836954|NCT03926611|12002448|FG005|Safety Set (SAF)|Overall Study||45
10836955|NCT03926611|12002449|FG006|Safety Set (SAF)|Overall Study||42
10836956|NCT03926611|12002443|FG000|COMPLETED|Overall Study||41
10836957|NCT03926611|12002444|FG001|COMPLETED|Overall Study||41
10836958|NCT03926611|12002445|FG002|COMPLETED|Overall Study||45
10836959|NCT03926611|12002446|FG003|COMPLETED|Overall Study||40
10836960|NCT03926611|12002447|FG004|COMPLETED|Overall Study||40
10836961|NCT03926611|12002448|FG005|COMPLETED|Overall Study||36
10836962|NCT03926611|12002449|FG006|COMPLETED|Overall Study||38
10836963|NCT03926611|12002443|FG000|NOT COMPLETED|Overall Study||3
10836964|NCT03926611|12002444|FG001|NOT COMPLETED|Overall Study||3
10836965|NCT03926611|12002445|FG002|NOT COMPLETED|Overall Study||2
10836966|NCT03926611|12002446|FG003|NOT COMPLETED|Overall Study||4
10836967|NCT03926611|12002447|FG004|NOT COMPLETED|Overall Study||4
10836968|NCT03926611|12002448|FG005|NOT COMPLETED|Overall Study||9
10836969|NCT03926611|12002449|FG006|NOT COMPLETED|Overall Study||5
10836970|NCT03838484|12002473|FG000|STARTED|Overall Study||5
10836971|NCT03838484|12002474|FG001|STARTED|Overall Study||5
10836972|NCT03838484|12002475|FG002|STARTED|Overall Study||4
10836973|NCT03838484|12002476|FG003|STARTED|Overall Study||4
10836974|NCT03838484|12002473|FG000|COMPLETED|Overall Study||5
10836975|NCT03838484|12002474|FG001|COMPLETED|Overall Study||4
10836976|NCT03838484|12002475|FG002|COMPLETED|Overall Study||4
10836977|NCT03838484|12002476|FG003|COMPLETED|Overall Study||4
10836978|NCT03838484|12002473|FG000|NOT COMPLETED|Overall Study||0
10836979|NCT03838484|12002474|FG001|NOT COMPLETED|Overall Study||1
10836980|NCT03838484|12002475|FG002|NOT COMPLETED|Overall Study||0
10836981|NCT03838484|12002476|FG003|NOT COMPLETED|Overall Study||0
10836982|NCT03814720|12002497|FG000|STARTED|Overall Study||5
10836983|NCT03814720|12002498|FG001|STARTED|Overall Study||12
10836984|NCT03814720|12002499|FG002|STARTED|Overall Study||12
10836985|NCT03814720|12002500|FG003|STARTED|Overall Study||12
10836986|NCT03814720|12002501|FG004|STARTED|Overall Study||11
10836987|NCT03814720|12002497|FG000|Received First Product Administration|Overall Study||5
10836988|NCT03814720|12002498|FG001|Received First Product Administration|Overall Study||12
10836989|NCT03814720|12002499|FG002|Received First Product Administration|Overall Study||12
10836990|NCT03814720|12002500|FG003|Received First Product Administration|Overall Study||12
10836991|NCT03814720|12002501|FG004|Received First Product Administration|Overall Study||11
10836992|NCT03814720|12002497|FG000|Received All Product Administrations|Overall Study||5
10836993|NCT03814720|12002498|FG001|Received All Product Administrations|Overall Study||12
10836994|NCT03814720|12002499|FG002|Received All Product Administrations|Overall Study|One participant did not receive the second dose due to moving out of area and 4 participants did not receive the second dose due to the COVID-19 pandemic|7
10836995|NCT03814720|12002500|FG003|Received All Product Administrations|Overall Study|Three (3) participants did not receive the second dose due to the COVID-19 pandemic|9
10836996|NCT03814720|12002501|FG004|Received All Product Administrations|Overall Study|Four (4) participants did not receive the second dose due to the COVID-19 pandemic|7
10836997|NCT03814720|12002497|FG000|COMPLETED|Overall Study||5
10836998|NCT03814720|12002498|FG001|COMPLETED|Overall Study||11
10836999|NCT03814720|12002499|FG002|COMPLETED|Overall Study||12
10837000|NCT03814720|12002500|FG003|COMPLETED|Overall Study||12
10837001|NCT03814720|12002501|FG004|COMPLETED|Overall Study||11
10837002|NCT03814720|12002497|FG000|NOT COMPLETED|Overall Study||0
10837003|NCT03814720|12002498|FG001|NOT COMPLETED|Overall Study||1
10837004|NCT03814720|12002499|FG002|NOT COMPLETED|Overall Study||0
11103807|NCT01244893|12288027|FG000|COMPLETED|1-Week Follow Up||21
11103808|NCT01244893|12288028|FG001|COMPLETED|1-Week Follow Up||21
10837005|NCT03814720|12002500|FG003|NOT COMPLETED|Overall Study||0
10837006|NCT03814720|12002501|FG004|NOT COMPLETED|Overall Study||0
10837007|NCT03635424|12002515|FG000|STARTED|Overall Study||150
10837008|NCT03635424|12002515|FG000|COMPLETED|Overall Study||147
10837009|NCT03635424|12002515|FG000|NOT COMPLETED|Overall Study||3
10837010|NCT03529110|12002521|FG000|STARTED|Overall Study||261
10837011|NCT03529110|12002522|FG001|STARTED|Overall Study||263
10837012|NCT03529110|12002521|FG000|COMPLETED|Overall Study||136
10837013|NCT03529110|12002522|FG001|COMPLETED|Overall Study||49
10837014|NCT03529110|12002521|FG000|NOT COMPLETED|Overall Study||125
10837015|NCT03529110|12002522|FG001|NOT COMPLETED|Overall Study||214
10837016|NCT03517540|12002532|FG000|STARTED|Overall Study||50
10837017|NCT03517540|12002533|FG001|STARTED|Overall Study||48
10837018|NCT03517540|12002534|FG002|STARTED|Overall Study||47
10837019|NCT03517540|12002535|FG003|STARTED|Overall Study||48
10837020|NCT03517540|12002532|FG000|COMPLETED|Overall Study||36
10837021|NCT03517540|12002533|FG001|COMPLETED|Overall Study||41
10837022|NCT03517540|12002534|FG002|COMPLETED|Overall Study||38
10837023|NCT03517540|12002535|FG003|COMPLETED|Overall Study||43
10837024|NCT03517540|12002532|FG000|NOT COMPLETED|Overall Study||14
10837025|NCT03517540|12002533|FG001|NOT COMPLETED|Overall Study||7
10837026|NCT03517540|12002534|FG002|NOT COMPLETED|Overall Study||9
10837027|NCT03517540|12002535|FG003|NOT COMPLETED|Overall Study||5
10837028|NCT03443635|12002547|FG000|STARTED|Overall Study||2616
10837029|NCT03443635|12002548|FG001|STARTED|Overall Study||4576
10837030|NCT03443635|12002547|FG000|COMPLETED|Overall Study||2127
10837031|NCT03443635|12002548|FG001|COMPLETED|Overall Study||3720
10837032|NCT03443635|12002547|FG000|NOT COMPLETED|Overall Study||489
10837033|NCT03443635|12002548|FG001|NOT COMPLETED|Overall Study||856
10837034|NCT03437278|12002557|FG000|STARTED|Overall Study||24
10837035|NCT03437278|12002558|FG001|STARTED|Overall Study||13
10837036|NCT03437278|12002559|FG002|STARTED|Overall Study||12
10837037|NCT03437278|12002557|FG000|COMPLETED|Overall Study||22
10837038|NCT03437278|12002558|FG001|COMPLETED|Overall Study||13
10837039|NCT03437278|12002559|FG002|COMPLETED|Overall Study||10
10837040|NCT03437278|12002557|FG000|NOT COMPLETED|Overall Study||2
10837041|NCT03437278|12002558|FG001|NOT COMPLETED|Overall Study||0
10837042|NCT03437278|12002559|FG002|NOT COMPLETED|Overall Study||2
10837043|NCT03350815|12002569|FG000|STARTED|Period 1||322
10837044|NCT03350815|12002570|FG001|STARTED|Period 1||0
10837045|NCT03350815|12002571|FG002|STARTED|Period 1||0
10837046|NCT03350815|12002572|FG003|STARTED|Period 1||0
10837047|NCT03350815|12002569|FG000|Non-responders|Period 1||50
10837048|NCT03350815|12002570|FG001|Non-responders|Period 1||0
10837049|NCT03350815|12002571|FG002|Non-responders|Period 1||0
10837050|NCT03350815|12002572|FG003|Non-responders|Period 1||0
10837051|NCT03350815|12002569|FG000|Inadequate Responders|Period 1||207
10837052|NCT03350815|12002570|FG001|Inadequate Responders|Period 1||0
10837053|NCT03350815|12002571|FG002|Inadequate Responders|Period 1||0
10837054|NCT03350815|12002572|FG003|Inadequate Responders|Period 1||0
10837055|NCT03350815|12002569|FG000|Responders|Period 1||22
10837056|NCT03350815|12002570|FG001|Responders|Period 1||0
10837057|NCT03350815|12002571|FG002|Responders|Period 1||0
10837058|NCT03350815|12002572|FG003|Responders|Period 1||0
10837059|NCT03350815|12002569|FG000|COMPLETED|Period 1||279
10837060|NCT03350815|12002570|FG001|COMPLETED|Period 1||0
10837061|NCT03350815|12002571|FG002|COMPLETED|Period 1||0
10837062|NCT03350815|12002572|FG003|COMPLETED|Period 1||0
10837063|NCT03350815|12002569|FG000|NOT COMPLETED|Period 1||43
10837064|NCT03350815|12002570|FG001|NOT COMPLETED|Period 1||0
10837065|NCT03350815|12002571|FG002|NOT COMPLETED|Period 1||0
10837066|NCT03350815|12002572|FG003|NOT COMPLETED|Period 1||0
10837067|NCT03350815|12002569|FG000|STARTED|Period 2||0
10837068|NCT03350815|12002570|FG001|STARTED|Period 2||102
10837069|NCT03350815|12002571|FG002|STARTED|Period 2||105
10837070|NCT03350815|12002572|FG003|STARTED|Period 2||22
10837071|NCT03350815|12002569|FG000|COMPLETED|Period 2||0
10837072|NCT03350815|12002570|FG001|COMPLETED|Period 2||86
10837073|NCT03350815|12002571|FG002|COMPLETED|Period 2||88
10837074|NCT03350815|12002572|FG003|COMPLETED|Period 2||22
10837075|NCT03350815|12002569|FG000|NOT COMPLETED|Period 2||0
10837076|NCT03350815|12002570|FG001|NOT COMPLETED|Period 2||16
10837077|NCT03350815|12002571|FG002|NOT COMPLETED|Period 2||17
10837078|NCT03350815|12002572|FG003|NOT COMPLETED|Period 2||0
10837079|NCT03249714|12002585|FG000|STARTED|Double-blind Treatment (Core Part)||43
10837080|NCT03249714|12002586|FG001|STARTED|Double-blind Treatment (Core Part)||21
10837081|NCT03249714|12002585|FG000|COMPLETED|Double-blind Treatment (Core Part)||40
10837082|NCT03249714|12002586|FG001|COMPLETED|Double-blind Treatment (Core Part)||19
10837083|NCT03249714|12002585|FG000|NOT COMPLETED|Double-blind Treatment (Core Part)||3
10837084|NCT03249714|12002586|FG001|NOT COMPLETED|Double-blind Treatment (Core Part)||2
10837085|NCT03249714|12002585|FG000|STARTED|Open-label Treatment (Extension Part)||40
10837086|NCT03249714|12002586|FG001|STARTED|Open-label Treatment (Extension Part)||19
10837087|NCT03249714|12002585|FG000|COMPLETED|Open-label Treatment (Extension Part)||38
10837088|NCT03249714|12002586|FG001|COMPLETED|Open-label Treatment (Extension Part)||19
10837089|NCT03249714|12002585|FG000|NOT COMPLETED|Open-label Treatment (Extension Part)||2
10837090|NCT03249714|12002586|FG001|NOT COMPLETED|Open-label Treatment (Extension Part)||0
10837091|NCT03170882|12002610|FG000|STARTED|Overall Study||49
10837092|NCT03170882|12002611|FG001|STARTED|Overall Study||73
10837093|NCT03170882|12002610|FG000|Treated: Safety Population|Overall Study||47
10837094|NCT03170882|12002611|FG001|Treated: Safety Population|Overall Study||72
10837095|NCT03170882|12002610|FG000|ITT PRO Population|Overall Study||45
10837096|NCT03170882|12002611|FG001|ITT PRO Population|Overall Study||70
10837097|NCT03170882|12002610|FG000|COMPLETED|Overall Study||20
10837098|NCT03170882|12002611|FG001|COMPLETED|Overall Study||22
10837099|NCT03170882|12002610|FG000|NOT COMPLETED|Overall Study||29
10837100|NCT03170882|12002611|FG001|NOT COMPLETED|Overall Study||51
10837101|NCT03074318|12002621|FG000|STARTED|Overall Study||6
10837102|NCT03074318|12002622|FG001|STARTED|Overall Study||7
10837103|NCT03074318|12002623|FG002|STARTED|Overall Study||6
10837104|NCT03074318|12002624|FG003|STARTED|Overall Study||16
10837105|NCT03074318|12002621|FG000|COMPLETED|Overall Study||2
10837106|NCT03074318|12002622|FG001|COMPLETED|Overall Study||2
10837107|NCT03074318|12002623|FG002|COMPLETED|Overall Study||0
10837108|NCT03074318|12002624|FG003|COMPLETED|Overall Study||0
10837109|NCT03074318|12002621|FG000|NOT COMPLETED|Overall Study||4
10837110|NCT03074318|12002622|FG001|NOT COMPLETED|Overall Study||5
10837111|NCT03074318|12002623|FG002|NOT COMPLETED|Overall Study||6
10837112|NCT03074318|12002624|FG003|NOT COMPLETED|Overall Study||16
10837113|NCT03010319|12002645|FG000|STARTED|Overall Study||110
10837114|NCT03010319|12002646|FG001|STARTED|Overall Study||116
10837115|NCT03010319|12002645|FG000|COMPLETED|Overall Study||84
10837116|NCT03010319|12002646|FG001|COMPLETED|Overall Study||87
10837117|NCT03010319|12002645|FG000|NOT COMPLETED|Overall Study||26
10837118|NCT03010319|12002646|FG001|NOT COMPLETED|Overall Study||29
10837119|NCT02915016|12002660|FG000|STARTED|Overall Study||30
10837120|NCT02915016|12002661|FG001|STARTED|Overall Study||50
10837121|NCT02915016|12002662|FG002|STARTED|Overall Study||50
10837122|NCT02915016|12002663|FG003|STARTED|Overall Study||30
10837123|NCT02915016|12002664|FG004|STARTED|Overall Study||50
10837124|NCT02915016|12002665|FG005|STARTED|Overall Study||50
10837125|NCT02915016|12002666|FG006|STARTED|Overall Study||50
10837126|NCT02915016|12002667|FG007|STARTED|Overall Study||24
10837127|NCT02915016|12002660|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||23
10837128|NCT02915016|12002661|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||49
10837129|NCT02915016|12002662|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||46
10837130|NCT02915016|12002663|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||26
10837131|NCT02915016|12002664|FG004|Month 6.5 Immunogenicity Timepoint|Overall Study||43
10837132|NCT02915016|12002665|FG005|Month 6.5 Immunogenicity Timepoint|Overall Study||42
10837133|NCT02915016|12002666|FG006|Month 6.5 Immunogenicity Timepoint|Overall Study||42
10837134|NCT02915016|12002667|FG007|Month 6.5 Immunogenicity Timepoint|Overall Study||21
10837135|NCT02915016|12002660|FG000|COMPLETED|Overall Study||23
10837136|NCT02915016|12002661|FG001|COMPLETED|Overall Study||47
10837137|NCT02915016|12002662|FG002|COMPLETED|Overall Study||42
10837138|NCT02915016|12002663|FG003|COMPLETED|Overall Study||26
10837139|NCT02915016|12002664|FG004|COMPLETED|Overall Study||43
10837140|NCT02915016|12002665|FG005|COMPLETED|Overall Study||44
10837141|NCT02915016|12002666|FG006|COMPLETED|Overall Study||38
10837142|NCT02915016|12002667|FG007|COMPLETED|Overall Study||20
10837143|NCT02915016|12002660|FG000|NOT COMPLETED|Overall Study||7
10837144|NCT02915016|12002661|FG001|NOT COMPLETED|Overall Study||3
10837145|NCT02915016|12002662|FG002|NOT COMPLETED|Overall Study||8
10837146|NCT02915016|12002663|FG003|NOT COMPLETED|Overall Study||4
10837147|NCT02915016|12002664|FG004|NOT COMPLETED|Overall Study||7
10837148|NCT02915016|12002665|FG005|NOT COMPLETED|Overall Study||6
10837149|NCT02915016|12002666|FG006|NOT COMPLETED|Overall Study||12
10837150|NCT02915016|12002667|FG007|NOT COMPLETED|Overall Study||4
10837151|NCT02871401|12002687|FG000|STARTED|Overall Study||20
10837152|NCT02871401|12002688|FG001|STARTED|Overall Study||11
10837153|NCT02871401|12002687|FG000|COMPLETED|Overall Study||19
10837154|NCT02871401|12002688|FG001|COMPLETED|Overall Study||11
10837155|NCT02871401|12002687|FG000|NOT COMPLETED|Overall Study||1
10837156|NCT02871401|12002688|FG001|NOT COMPLETED|Overall Study||0
10837157|NCT02811913|12002694|FG000|STARTED|Overall Study||20
10837158|NCT02811913|12002694|FG000|COMPLETED|Overall Study||16
10837159|NCT02811913|12002694|FG000|NOT COMPLETED|Overall Study||4
10837160|NCT02701283|12002706|FG000|STARTED|Overall Study||737
10837161|NCT02701283|12002707|FG001|STARTED|Overall Study||741
10837162|NCT02701283|12002708|FG002|STARTED|Overall Study||745
10837163|NCT02701283|12002706|FG000|As Treated (Attempted Implant)|Overall Study||730
10837164|NCT02701283|12002707|FG001|As Treated (Attempted Implant)|Overall Study||684
10837165|NCT02701283|12002708|FG002|As Treated (Attempted Implant)|Overall Study||745
10837166|NCT02701283|12002706|FG000|Implanted|Overall Study||727
10837167|NCT02701283|12002707|FG001|Implanted|Overall Study||686
10837168|NCT02701283|12002708|FG002|Implanted|Overall Study||745
10837169|NCT02701283|12002706|FG000|COMPLETED|Overall Study||668
10837170|NCT02701283|12002707|FG001|COMPLETED|Overall Study||579
10837171|NCT02701283|12002708|FG002|COMPLETED|Overall Study||724
10837172|NCT02701283|12002706|FG000|NOT COMPLETED|Overall Study||69
10837173|NCT02701283|12002707|FG001|NOT COMPLETED|Overall Study||162
10837174|NCT02701283|12002708|FG002|NOT COMPLETED|Overall Study||21
10837175|NCT02696031|12002722|FG000|STARTED|Up to Week 24||185
10837176|NCT02696031|12002723|FG001|STARTED|Up to Week 24||184
10837177|NCT02696031|12002724|FG002|STARTED|Up to Week 24||186
10837178|NCT02696031|12002725|FG003|STARTED|Up to Week 24||0
10837179|NCT02696031|12002726|FG004|STARTED|Up to Week 24||0
10837180|NCT02696031|12002727|FG005|STARTED|Up to Week 24||0
10837181|NCT02696031|12002722|FG000|COMPLETED|Up to Week 24||175
10837182|NCT02696031|12002723|FG001|COMPLETED|Up to Week 24||177
10837183|NCT02696031|12002724|FG002|COMPLETED|Up to Week 24||175
10837184|NCT02696031|12002725|FG003|COMPLETED|Up to Week 24||0
10837185|NCT02696031|12002726|FG004|COMPLETED|Up to Week 24||0
10837186|NCT02696031|12002727|FG005|COMPLETED|Up to Week 24||0
10837187|NCT02696031|12002722|FG000|NOT COMPLETED|Up to Week 24||10
10837188|NCT02696031|12002723|FG001|NOT COMPLETED|Up to Week 24||7
10837189|NCT02696031|12002724|FG002|NOT COMPLETED|Up to Week 24||11
10837190|NCT02696031|12002725|FG003|NOT COMPLETED|Up to Week 24||0
10837191|NCT02696031|12002726|FG004|NOT COMPLETED|Up to Week 24||0
10837192|NCT02696031|12002727|FG005|NOT COMPLETED|Up to Week 24||0
10837193|NCT02696031|12002722|FG000|STARTED|Up to Week 52||185
10837194|NCT02696031|12002723|FG001|STARTED|Up to Week 52||184
10837195|NCT02696031|12002724|FG002|STARTED|Up to Week 52||186
10837196|NCT02696031|12002725|FG003|STARTED|Up to Week 52||0
10837197|NCT02696031|12002726|FG004|STARTED|Up to Week 52||0
10837198|NCT02696031|12002727|FG005|STARTED|Up to Week 52||0
10837199|NCT02696031|12002722|FG000|COMPLETED|Up to Week 52||156
10837200|NCT02696031|12002723|FG001|COMPLETED|Up to Week 52||165
10837201|NCT02696031|12002724|FG002|COMPLETED|Up to Week 52||160
10837202|NCT02696031|12002725|FG003|COMPLETED|Up to Week 52||0
10837203|NCT02696031|12002726|FG004|COMPLETED|Up to Week 52||0
10837204|NCT02696031|12002727|FG005|COMPLETED|Up to Week 52||0
10837205|NCT02696031|12002722|FG000|NOT COMPLETED|Up to Week 52||29
10837206|NCT02696031|12002723|FG001|NOT COMPLETED|Up to Week 52||19
10837207|NCT02696031|12002724|FG002|NOT COMPLETED|Up to Week 52||26
10837208|NCT02696031|12002725|FG003|NOT COMPLETED|Up to Week 52||0
10837209|NCT02696031|12002726|FG004|NOT COMPLETED|Up to Week 52||0
10837210|NCT02696031|12002727|FG005|NOT COMPLETED|Up to Week 52||0
10837211|NCT02696031|12002722|FG000|STARTED|Up to Week 104||185
10837212|NCT02696031|12002723|FG001|STARTED|Up to Week 104||184
10837213|NCT02696031|12002724|FG002|STARTED|Up to Week 104||186
10837214|NCT02696031|12002725|FG003|STARTED|Up to Week 104||0
10837215|NCT02696031|12002726|FG004|STARTED|Up to Week 104||0
10837216|NCT02696031|12002727|FG005|STARTED|Up to Week 104||0
10837217|NCT02696031|12002722|FG000|COMPLETED|Up to Week 104||146
10837218|NCT02696031|12002723|FG001|COMPLETED|Up to Week 104||143
10837219|NCT02696031|12002724|FG002|COMPLETED|Up to Week 104||149
11103809|NCT01244893|12288027|FG000|NOT COMPLETED|1-Week Follow Up||1
11103810|NCT01244893|12288028|FG001|NOT COMPLETED|1-Week Follow Up||0
11103811|NCT01244893|12288027|FG000|STARTED|Final Visit||21
11103812|NCT01244893|12288028|FG001|STARTED|Final Visit||21
11103813|NCT01244893|12288027|FG000|COMPLETED|Final Visit||21
11103814|NCT01244893|12288028|FG001|COMPLETED|Final Visit||21
11103815|NCT01244893|12288027|FG000|NOT COMPLETED|Final Visit||0
11103816|NCT01244893|12288028|FG001|NOT COMPLETED|Final Visit||0
11103817|NCT01244906|12288039|FG000|STARTED|Overall Study||26
11103818|NCT01244906|12288039|FG000|COMPLETED|Overall Study||18
11103819|NCT01244906|12288039|FG000|NOT COMPLETED|Overall Study||8
11103820|NCT01244984|12288046|FG000|STARTED|Overall Study||60
11103821|NCT01244984|12288047|FG001|STARTED|Overall Study||93
11103822|NCT01244984|12288048|FG002|STARTED|Overall Study||90
11103823|NCT01244984|12288046|FG000|COMPLETED|Overall Study||55
11103824|NCT01244984|12288047|FG001|COMPLETED|Overall Study||79
11103825|NCT01244984|12288048|FG002|COMPLETED|Overall Study||86
11103826|NCT01244984|12288046|FG000|NOT COMPLETED|Overall Study||5
11103827|NCT01244984|12288047|FG001|NOT COMPLETED|Overall Study||14
11103828|NCT01244984|12288048|FG002|NOT COMPLETED|Overall Study||4
11103829|NCT01245049|12288059|FG000|STARTED|Overall Study||255
11103830|NCT01245049|12288060|FG001|STARTED|Overall Study||130
11103831|NCT01245049|12288059|FG000|COMPLETED|Overall Study||254
11103832|NCT01245049|12288060|FG001|COMPLETED|Overall Study||126
11103833|NCT01245049|12288059|FG000|NOT COMPLETED|Overall Study||1
11103834|NCT01245049|12288060|FG001|NOT COMPLETED|Overall Study||4
11103835|NCT01245062|12288068|FG000|STARTED|Randomization and Crossover Phase||214
11103836|NCT01245062|12288069|FG001|STARTED|Randomization and Crossover Phase||108
11103837|NCT01245062|12288070|FG002|STARTED|Randomization and Crossover Phase||0
11103838|NCT01245062|12288068|FG000|COMPLETED|Randomization and Crossover Phase||173
11103839|NCT01245062|12288069|FG001|COMPLETED|Randomization and Crossover Phase||77
11103840|NCT01245062|12288070|FG002|COMPLETED|Randomization and Crossover Phase||0
11103841|NCT01245062|12288068|FG000|NOT COMPLETED|Randomization and Crossover Phase||41
11103842|NCT01245062|12288069|FG001|NOT COMPLETED|Randomization and Crossover Phase||31
11103843|NCT01245062|12288070|FG002|NOT COMPLETED|Randomization and Crossover Phase||0
11103844|NCT01245062|12288068|FG000|STARTED|Cross-over Phase||0
11103845|NCT01245062|12288069|FG001|STARTED|Cross-over Phase||0
11103846|NCT01245062|12288070|FG002|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
11103847|NCT01245062|12288068|FG000|COMPLETED|Cross-over Phase||0
11103848|NCT01245062|12288069|FG001|COMPLETED|Cross-over Phase||0
11103849|NCT01245062|12288070|FG002|COMPLETED|Cross-over Phase||53
11103850|NCT01245062|12288068|FG000|NOT COMPLETED|Cross-over Phase||0
11103851|NCT01245062|12288069|FG001|NOT COMPLETED|Cross-over Phase||0
11103852|NCT01245062|12288070|FG002|NOT COMPLETED|Cross-over Phase||17
11220801|NCT01962493|12412403|FG001|NOT COMPLETED|Overall Study||5
10837220|NCT02696031|12002725|FG003|COMPLETED|Up to Week 104||0
10837221|NCT02696031|12002726|FG004|COMPLETED|Up to Week 104||0
10837222|NCT02696031|12002727|FG005|COMPLETED|Up to Week 104||0
10837223|NCT02696031|12002722|FG000|NOT COMPLETED|Up to Week 104||39
10837224|NCT02696031|12002723|FG001|NOT COMPLETED|Up to Week 104||41
10837225|NCT02696031|12002724|FG002|NOT COMPLETED|Up to Week 104||37
10837226|NCT02696031|12002725|FG003|NOT COMPLETED|Up to Week 104||0
10837227|NCT02696031|12002726|FG004|NOT COMPLETED|Up to Week 104||0
11103853|NCT01245101|12288080|FG000|STARTED|Period 1 (Treatment)||15
11103854|NCT01245101|12288081|FG001|STARTED|Period 1 (Treatment)||0
11103855|NCT01245101|12288080|FG000|COMPLETED|Period 1 (Treatment)||13
10837228|NCT02696031|12002727|FG005|NOT COMPLETED|Up to Week 104||0
10837229|NCT02696031|12002722|FG000|STARTED|Extension Phase From wk 104 to wk 208||0
10837230|NCT02696031|12002723|FG001|STARTED|Extension Phase From wk 104 to wk 208||0
10837231|NCT02696031|12002724|FG002|STARTED|Extension Phase From wk 104 to wk 208||0
10837232|NCT02696031|12002725|FG003|STARTED|Extension Phase From wk 104 to wk 208||147
10837233|NCT02696031|12002726|FG004|STARTED|Extension Phase From wk 104 to wk 208||147
10837234|NCT02696031|12002727|FG005|STARTED|Extension Phase From wk 104 to wk 208||78
10837235|NCT02696031|12002722|FG000|COMPLETED|Extension Phase From wk 104 to wk 208||0
10837236|NCT02696031|12002723|FG001|COMPLETED|Extension Phase From wk 104 to wk 208||0
10837237|NCT02696031|12002724|FG002|COMPLETED|Extension Phase From wk 104 to wk 208||0
10837238|NCT02696031|12002725|FG003|COMPLETED|Extension Phase From wk 104 to wk 208||137
10837239|NCT02696031|12002726|FG004|COMPLETED|Extension Phase From wk 104 to wk 208||132
10837240|NCT02696031|12002727|FG005|COMPLETED|Extension Phase From wk 104 to wk 208||72
10837241|NCT02696031|12002722|FG000|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
10837242|NCT02696031|12002723|FG001|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
10837243|NCT02696031|12002724|FG002|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
10837244|NCT02696031|12002725|FG003|NOT COMPLETED|Extension Phase From wk 104 to wk 208||10
10837245|NCT02696031|12002726|FG004|NOT COMPLETED|Extension Phase From wk 104 to wk 208||15
10837246|NCT02696031|12002727|FG005|NOT COMPLETED|Extension Phase From wk 104 to wk 208||6
11220802|NCT01962558|12412411|FG000|STARTED|Overall Study||16
11220803|NCT01962558|12412412|FG001|STARTED|Overall Study||14
11220804|NCT01962558|12412411|FG000|Acute Study|Overall Study||16
11220805|NCT01962558|12412412|FG001|Acute Study|Overall Study||14
11220806|NCT01962558|12412411|FG000|12-Weeks|Overall Study||16
11220807|NCT01962558|12412412|FG001|12-Weeks|Overall Study||14
11220808|NCT01962558|12412411|FG000|COMPLETED|Overall Study||16
11220809|NCT01962558|12412412|FG001|COMPLETED|Overall Study||14
11220810|NCT01962558|12412411|FG000|NOT COMPLETED|Overall Study||0
11220811|NCT01962558|12412412|FG001|NOT COMPLETED|Overall Study||0
11220812|NCT01962688|12412420|FG000|STARTED|Overall Study||19
11220813|NCT01962688|12412421|FG001|STARTED|Overall Study||18
11220814|NCT01962688|12412420|FG000|COMPLETED|Overall Study||19
11220815|NCT01962688|12412421|FG001|COMPLETED|Overall Study||18
11220816|NCT01962688|12412420|FG000|NOT COMPLETED|Overall Study||0
11220817|NCT01962688|12412421|FG001|NOT COMPLETED|Overall Study||0
11220818|NCT01962714|12412429|FG000|STARTED|Overall Study||91
11220819|NCT01962714|12412430|FG001|STARTED|Overall Study||93
11220820|NCT01962714|12412429|FG000|Immediate Post-treatment Assessment|Overall Study||63
11220821|NCT01962714|12412430|FG001|Immediate Post-treatment Assessment|Overall Study||57
11220822|NCT01962714|12412429|FG000|3-month Follow-up|Overall Study||58
11220823|NCT01962714|12412430|FG001|3-month Follow-up|Overall Study||56
11220824|NCT01962714|12412429|FG000|COMPLETED|Overall Study||61
11220825|NCT01962714|12412430|FG001|COMPLETED|Overall Study||60
11220826|NCT01962714|12412429|FG000|NOT COMPLETED|Overall Study||30
11220827|NCT01962714|12412430|FG001|NOT COMPLETED|Overall Study||33
11220828|NCT01962870|12412438|FG000|STARTED|Overall Study||13
11220829|NCT01962870|12412439|FG001|STARTED|Overall Study||17
11220830|NCT01962870|12412438|FG000|COMPLETED|Overall Study||13
11220831|NCT01962870|12412439|FG001|COMPLETED|Overall Study||17
11220832|NCT01962870|12412438|FG000|NOT COMPLETED|Overall Study||0
11220833|NCT01962870|12412439|FG001|NOT COMPLETED|Overall Study||0
11220834|NCT01962896|12412445|FG000|STARTED|Overall Study||4
11220835|NCT01962896|12412445|FG000|COMPLETED|Overall Study||0
11220836|NCT01962896|12412445|FG000|NOT COMPLETED|Overall Study||4
11220837|NCT01962922|12412452|FG000|STARTED|PK Portion Day 7||27
10837247|NCT02689453|12002739|FG000|STARTED|Overall Study||3
10837248|NCT02689453|12002740|FG001|STARTED|Overall Study||4
10837249|NCT02689453|12002741|FG002|STARTED|Overall Study||4
10837250|NCT02689453|12002739|FG000|COMPLETED|Overall Study||3
10837251|NCT02689453|12002740|FG001|COMPLETED|Overall Study||3
10837252|NCT02689453|12002741|FG002|COMPLETED|Overall Study||3
10837253|NCT02689453|12002739|FG000|NOT COMPLETED|Overall Study||0
10837254|NCT02689453|12002740|FG001|NOT COMPLETED|Overall Study||1
10837255|NCT02689453|12002741|FG002|NOT COMPLETED|Overall Study||1
10837256|NCT02476851|12002753|FG000|STARTED|Overall Study||31
10837257|NCT02476851|12002754|FG001|STARTED|Overall Study||31
10837258|NCT02476851|12002753|FG000|COMPLETED|Overall Study||30
10837259|NCT02476851|12002754|FG001|COMPLETED|Overall Study||30
10837260|NCT02476851|12002753|FG000|NOT COMPLETED|Overall Study||1
10837261|NCT02476851|12002754|FG001|NOT COMPLETED|Overall Study||1
11103856|NCT01245101|12288081|FG001|COMPLETED|Period 1 (Treatment)||0
11103857|NCT01245101|12288080|FG000|NOT COMPLETED|Period 1 (Treatment)||2
11103858|NCT01245101|12288081|FG001|NOT COMPLETED|Period 1 (Treatment)||0
11103859|NCT01245101|12288080|FG000|STARTED|Period 2 (Washout)||13
11103860|NCT01245101|12288081|FG001|STARTED|Period 2 (Washout)||0
11103861|NCT01245101|12288080|FG000|COMPLETED|Period 2 (Washout)||12
10837268|NCT02310919|12002771|FG000|STARTED|Overall Study||54
10837269|NCT02310919|12002772|FG001|STARTED|Overall Study||51
11103862|NCT01245101|12288081|FG001|COMPLETED|Period 2 (Washout)||0
11103863|NCT01245101|12288080|FG000|NOT COMPLETED|Period 2 (Washout)||1
11103864|NCT01245101|12288081|FG001|NOT COMPLETED|Period 2 (Washout)||0
11103865|NCT01245101|12288080|FG000|STARTED|Period 3 (Treatment)||12
11103866|NCT01245101|12288081|FG001|STARTED|Period 3 (Treatment)||0
11103867|NCT01245101|12288080|FG000|COMPLETED|Period 3 (Treatment)||11
11103868|NCT01245101|12288081|FG001|COMPLETED|Period 3 (Treatment)||0
11103869|NCT01245101|12288080|FG000|NOT COMPLETED|Period 3 (Treatment)||1
11103870|NCT01245101|12288081|FG001|NOT COMPLETED|Period 3 (Treatment)||0
11103871|NCT01245140|12288089|FG000|STARTED|Overall Study||9
11103872|NCT01245140|12288090|FG001|STARTED|Overall Study||24
11103873|NCT01245140|12288089|FG000|COMPLETED|Overall Study||6
11220838|NCT01962922|12412453|FG001|STARTED|PK Portion Day 7||23
11220839|NCT01962922|12412452|FG000|COMPLETED|PK Portion Day 7||23
11220840|NCT01962922|12412453|FG001|COMPLETED|PK Portion Day 7||23
11220841|NCT01962922|12412452|FG000|NOT COMPLETED|PK Portion Day 7||4
11220842|NCT01962922|12412453|FG001|NOT COMPLETED|PK Portion Day 7||0
11220843|NCT01962922|12412452|FG000|STARTED|PK Portion Day 14||23
11220844|NCT01962922|12412453|FG001|STARTED|PK Portion Day 14||23
11220845|NCT01962922|12412452|FG000|COMPLETED|PK Portion Day 14||23
11220846|NCT01962922|12412453|FG001|COMPLETED|PK Portion Day 14||23
11220847|NCT01962922|12412452|FG000|NOT COMPLETED|PK Portion Day 14||0
11220848|NCT01962922|12412453|FG001|NOT COMPLETED|PK Portion Day 14||0
11220849|NCT01962922|12412452|FG000|STARTED|PK Portion Day 21||23
11220850|NCT01962922|12412453|FG001|STARTED|PK Portion Day 21||23
11220851|NCT01962922|12412452|FG000|COMPLETED|PK Portion Day 21||23
11220852|NCT01962922|12412453|FG001|COMPLETED|PK Portion Day 21||23
11220853|NCT01962922|12412452|FG000|NOT COMPLETED|PK Portion Day 21||0
11220854|NCT01962922|12412453|FG001|NOT COMPLETED|PK Portion Day 21||0
11220855|NCT01962922|12412452|FG000|STARTED|Extendion Portion (up to Month 6)||23
11220856|NCT01962922|12412453|FG001|STARTED|Extendion Portion (up to Month 6)||23
11220857|NCT01962922|12412452|FG000|COMPLETED|Extendion Portion (up to Month 6)||18
11220858|NCT01962922|12412453|FG001|COMPLETED|Extendion Portion (up to Month 6)||20
11220859|NCT01962922|12412452|FG000|NOT COMPLETED|Extendion Portion (up to Month 6)||5
11220860|NCT01962922|12412453|FG001|NOT COMPLETED|Extendion Portion (up to Month 6)||3
11220861|NCT01962961|12412462|FG000|STARTED|Overall Study||9
11220862|NCT01962961|12412463|FG001|STARTED|Overall Study||8
11220863|NCT01962961|12412464|FG002|STARTED|Overall Study||7
11220864|NCT01962961|12412462|FG000|COMPLETED|Overall Study||9
11220865|NCT01962961|12412463|FG001|COMPLETED|Overall Study||7
11220866|NCT01962961|12412464|FG002|COMPLETED|Overall Study||6
11220867|NCT01962961|12412462|FG000|NOT COMPLETED|Overall Study||0
11220868|NCT01962961|12412463|FG001|NOT COMPLETED|Overall Study||1
11220869|NCT01962961|12412464|FG002|NOT COMPLETED|Overall Study||1
11220870|NCT01962987|12412475|FG000|STARTED|Overall Study||190
11220871|NCT01962987|12412476|FG001|STARTED|Overall Study||191
11220872|NCT01962987|12412477|FG002|STARTED|Overall Study||95
11220873|NCT01962987|12412475|FG000|COMPLETED|Overall Study||160
11220874|NCT01962987|12412476|FG001|COMPLETED|Overall Study||163
11220875|NCT01962987|12412477|FG002|COMPLETED|Overall Study||83
11220876|NCT01962987|12412475|FG000|NOT COMPLETED|Overall Study||30
11220877|NCT01962987|12412476|FG001|NOT COMPLETED|Overall Study||28
11220878|NCT01962987|12412477|FG002|NOT COMPLETED|Overall Study||12
11220879|NCT01963078|12412489|FG000|STARTED|Overall Study||9
11220880|NCT01963078|12412490|FG001|STARTED|Overall Study||10
11220881|NCT01963078|12412491|FG002|STARTED|Overall Study||10
11220882|NCT01963078|12412492|FG003|STARTED|Overall Study||9
11220883|NCT01963078|12412489|FG000|COMPLETED|Overall Study||8
11220884|NCT01963078|12412490|FG001|COMPLETED|Overall Study||9
11220885|NCT01963078|12412491|FG002|COMPLETED|Overall Study||9
11220886|NCT01963078|12412492|FG003|COMPLETED|Overall Study||7
11220887|NCT01963078|12412489|FG000|NOT COMPLETED|Overall Study||1
11220888|NCT01963078|12412490|FG001|NOT COMPLETED|Overall Study||1
11220889|NCT01963078|12412491|FG002|NOT COMPLETED|Overall Study||1
11220890|NCT01963078|12412492|FG003|NOT COMPLETED|Overall Study||2
11220891|NCT01963091|12412504|FG000|STARTED|Overall Study||17
10837270|NCT02310919|12002771|FG000|COMPLETED|Overall Study|Four participants receiving the study trigger deviated from protocol. One patient was randomized before her E2 resulted >5,000 pg/ml. Another elected to convert to intrauterine insemination while another underwent oocyte cryopreservation as their male partner was unable to produce a fresh sperm sample for fertilization. The 4th patient inadvertently spilled a portion of the trigger prior to injection. Since her post-trigger hCG was <18 IU/L, she was unblinded and re-triggered with 10,000 IU hCG.|54
10837271|NCT02310919|12002772|FG001|COMPLETED|Overall Study|Two participants that received the standard trigger requested exclusionary embryo co-culture to be added post-trigger.|51
10837272|NCT02310919|12002771|FG000|NOT COMPLETED|Overall Study||0
10837273|NCT02310919|12002772|FG001|NOT COMPLETED|Overall Study||0
10837274|NCT02208024|12002779|FG000|STARTED|Overall Study||18
10837275|NCT02208024|12002779|FG000|COMPLETED|Overall Study||17
10837276|NCT02208024|12002779|FG000|NOT COMPLETED|Overall Study||1
10837277|NCT01866111|12002787|FG000|STARTED|Double-blind Period of Study YKP3089C017||108
10837278|NCT01866111|12002788|FG001|STARTED|Double-blind Period of Study YKP3089C017||108
10837279|NCT01866111|12002789|FG002|STARTED|Double-blind Period of Study YKP3089C017||110
10837280|NCT01866111|12002790|FG003|STARTED|Double-blind Period of Study YKP3089C017||111
10837281|NCT01866111|12002787|FG000|COMPLETED|Double-blind Period of Study YKP3089C017||94
10837282|NCT01866111|12002788|FG001|COMPLETED|Double-blind Period of Study YKP3089C017||95
10837283|NCT01866111|12002789|FG002|COMPLETED|Double-blind Period of Study YKP3089C017||90
10837284|NCT01866111|12002790|FG003|COMPLETED|Double-blind Period of Study YKP3089C017||81
10837285|NCT01866111|12002787|FG000|NOT COMPLETED|Double-blind Period of Study YKP3089C017||14
10837286|NCT01866111|12002788|FG001|NOT COMPLETED|Double-blind Period of Study YKP3089C017||13
10837287|NCT01866111|12002789|FG002|NOT COMPLETED|Double-blind Period of Study YKP3089C017||20
10837288|NCT01866111|12002790|FG003|NOT COMPLETED|Double-blind Period of Study YKP3089C017||30
10837289|NCT01866111|12002787|FG000|STARTED|Open-label Extension Study YKP3089C017|Not all patients from double-blind rolled over to open-label|91
10837290|NCT01866111|12002788|FG001|STARTED|Open-label Extension Study YKP3089C017||95
10837291|NCT01866111|12002789|FG002|STARTED|Open-label Extension Study YKP3089C017||90
10837292|NCT01866111|12002790|FG003|STARTED|Open-label Extension Study YKP3089C017|Not all patients from double-blind rolled over to open-label|80
11220892|NCT01963091|12412505|FG001|STARTED|Overall Study||16
11220893|NCT01963091|12412504|FG000|COMPLETED|Overall Study||17
11220894|NCT01963091|12412505|FG001|COMPLETED|Overall Study||16
11220895|NCT01963091|12412504|FG000|NOT COMPLETED|Overall Study||0
11220896|NCT01963091|12412505|FG001|NOT COMPLETED|Overall Study||0
11220897|NCT01963117|12412511|FG000|STARTED|Overall Study||11
11220898|NCT01963117|12412511|FG000|COMPLETED|Overall Study||10
11220899|NCT01963117|12412511|FG000|NOT COMPLETED|Overall Study||1
11220900|NCT01963143|12412518|FG000|STARTED|Overall Study||14
11220901|NCT01963143|12412519|FG001|STARTED|Overall Study||19
11220902|NCT01963143|12412520|FG002|STARTED|Overall Study||15
11220903|NCT01963143|12412518|FG000|COMPLETED|Overall Study||14
11220904|NCT01963143|12412519|FG001|COMPLETED|Overall Study||18
11220905|NCT01963143|12412520|FG002|COMPLETED|Overall Study||14
11220906|NCT01963143|12412518|FG000|NOT COMPLETED|Overall Study||0
11220907|NCT01963143|12412519|FG001|NOT COMPLETED|Overall Study||1
11220908|NCT01963143|12412520|FG002|NOT COMPLETED|Overall Study||1
11220909|NCT01963169|12412529|FG000|STARTED|Overall Study||301
11220910|NCT01963169|12412530|FG001|STARTED|Overall Study||302
11220911|NCT01963169|12412531|FG002|STARTED|Overall Study||263
11220912|NCT01963169|12412529|FG000|COMPLETED|Overall Study||242
11220913|NCT01963169|12412530|FG001|COMPLETED|Overall Study||220
11220914|NCT01963169|12412531|FG002|COMPLETED|Overall Study||237
11220915|NCT01963169|12412529|FG000|NOT COMPLETED|Overall Study||59
11220916|NCT01963169|12412530|FG001|NOT COMPLETED|Overall Study||82
11220917|NCT01963169|12412531|FG002|NOT COMPLETED|Overall Study||26
11220918|NCT01963234|12412542|FG000|STARTED|Overall Study||268
11220919|NCT01963234|12412543|FG001|STARTED|Overall Study||171
11220920|NCT01963234|12412542|FG000|COMPLETED|Overall Study||207
11220921|NCT01963234|12412543|FG001|COMPLETED|Overall Study||171
11220922|NCT01963234|12412542|FG000|NOT COMPLETED|Overall Study||61
11220923|NCT01963234|12412543|FG001|NOT COMPLETED|Overall Study||0
11220924|NCT01963260|12412565|FG000|STARTED|Overall Study||6
11220925|NCT01963260|12412566|FG001|STARTED|Overall Study||6
11220926|NCT01963260|12412567|FG002|STARTED|Overall Study||6
11220927|NCT01963260|12412568|FG003|STARTED|Overall Study||6
11220928|NCT01963260|12412569|FG004|STARTED|Overall Study||6
11220929|NCT01963260|12412570|FG005|STARTED|Overall Study||10
11220930|NCT01963260|12412571|FG006|STARTED|Overall Study||3
11220931|NCT01963260|12412572|FG007|STARTED|Overall Study||2
11220932|NCT01963260|12412573|FG008|STARTED|Overall Study||1
11220933|NCT01963260|12412574|FG009|STARTED|Overall Study||4
11220934|NCT01963260|12412565|FG000|Treated|Overall Study||6
11220935|NCT01963260|12412566|FG001|Treated|Overall Study||6
11220936|NCT01963260|12412567|FG002|Treated|Overall Study||6
11220937|NCT01963260|12412568|FG003|Treated|Overall Study||6
11220938|NCT01963260|12412569|FG004|Treated|Overall Study||6
11220939|NCT01963260|12412570|FG005|Treated|Overall Study||10
11220940|NCT01963260|12412571|FG006|Treated|Overall Study||3
11220941|NCT01963260|12412572|FG007|Treated|Overall Study||2
11220942|NCT01963260|12412573|FG008|Treated|Overall Study||1
11220943|NCT01963260|12412574|FG009|Treated|Overall Study||4
11220944|NCT01963260|12412565|FG000|COMPLETED|Overall Study||4
11220945|NCT01963260|12412566|FG001|COMPLETED|Overall Study||6
11220946|NCT01963260|12412567|FG002|COMPLETED|Overall Study||6
11220947|NCT01963260|12412568|FG003|COMPLETED|Overall Study||5
10837293|NCT01866111|12002787|FG000|COMPLETED|Open-label Extension Study YKP3089C017||26
10837294|NCT01866111|12002788|FG001|COMPLETED|Open-label Extension Study YKP3089C017||28
10837295|NCT01866111|12002789|FG002|COMPLETED|Open-label Extension Study YKP3089C017||27
10837296|NCT01866111|12002790|FG003|COMPLETED|Open-label Extension Study YKP3089C017||28
10837297|NCT01866111|12002787|FG000|NOT COMPLETED|Open-label Extension Study YKP3089C017||65
10837298|NCT01866111|12002788|FG001|NOT COMPLETED|Open-label Extension Study YKP3089C017||67
10837299|NCT01866111|12002789|FG002|NOT COMPLETED|Open-label Extension Study YKP3089C017||63
10837300|NCT01866111|12002790|FG003|NOT COMPLETED|Open-label Extension Study YKP3089C017||52
10837301|NCT01767129|12002800|FG000|STARTED|Treatment Period 1 (14 Days)||7
10837302|NCT01767129|12002801|FG001|STARTED|Treatment Period 1 (14 Days)||7
10837303|NCT01767129|12002800|FG000|COMPLETED|Treatment Period 1 (14 Days)||6
10837304|NCT01767129|12002801|FG001|COMPLETED|Treatment Period 1 (14 Days)||7
10837305|NCT01767129|12002800|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||1
10837306|NCT01767129|12002801|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10837307|NCT01767129|12002800|FG000|STARTED|Treatment Period 2 (14 Days)||6
10837308|NCT01767129|12002801|FG001|STARTED|Treatment Period 2 (14 Days)||7
10837309|NCT01767129|12002800|FG000|COMPLETED|Treatment Period 2 (14 Days)||6
10837310|NCT01767129|12002801|FG001|COMPLETED|Treatment Period 2 (14 Days)||7
10837311|NCT01767129|12002800|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10837312|NCT01767129|12002801|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11220948|NCT01963260|12412569|FG004|COMPLETED|Overall Study||4
11220949|NCT01963260|12412570|FG005|COMPLETED|Overall Study||10
11220950|NCT01963260|12412571|FG006|COMPLETED|Overall Study||3
11220951|NCT01963260|12412572|FG007|COMPLETED|Overall Study||2
11220952|NCT01963260|12412573|FG008|COMPLETED|Overall Study||1
11220953|NCT01963260|12412574|FG009|COMPLETED|Overall Study||4
11220954|NCT01963260|12412565|FG000|NOT COMPLETED|Overall Study||2
11220955|NCT01963260|12412566|FG001|NOT COMPLETED|Overall Study||0
11220956|NCT01963260|12412567|FG002|NOT COMPLETED|Overall Study||0
11220957|NCT01963260|12412568|FG003|NOT COMPLETED|Overall Study||1
11220958|NCT01963260|12412569|FG004|NOT COMPLETED|Overall Study||2
11220959|NCT01963260|12412570|FG005|NOT COMPLETED|Overall Study||0
11220960|NCT01963260|12412571|FG006|NOT COMPLETED|Overall Study||0
11220961|NCT01963260|12412572|FG007|NOT COMPLETED|Overall Study||0
11220962|NCT01963260|12412573|FG008|NOT COMPLETED|Overall Study||0
11220963|NCT01963260|12412574|FG009|NOT COMPLETED|Overall Study||0
11220964|NCT01963403|12412605|FG000|STARTED|Overall Study||13
11220965|NCT01963403|12412606|FG001|STARTED|Overall Study||13
11220966|NCT01963403|12412605|FG000|COMPLETED|Overall Study|Follow-up over three months|11
11220967|NCT01963403|12412606|FG001|COMPLETED|Overall Study|Follow-up over three months|9
11220968|NCT01963403|12412605|FG000|NOT COMPLETED|Overall Study||2
11220969|NCT01963403|12412606|FG001|NOT COMPLETED|Overall Study||4
11220970|NCT01963481|12412614|FG000|STARTED|Overall Study||23
11220971|NCT01963481|12412614|FG000|COMPLETED|Overall Study||23
11220972|NCT01963481|12412614|FG000|NOT COMPLETED|Overall Study||0
11220973|NCT01963611|12412623|FG000|STARTED|Overall Study||51
11220974|NCT01963611|12412624|FG001|STARTED|Overall Study||49
11220975|NCT01963611|12412625|FG002|STARTED|Overall Study||52
11220976|NCT01963611|12412626|FG003|STARTED|Overall Study||52
11220977|NCT01963611|12412627|FG004|STARTED|Overall Study||51
11220978|NCT01963611|12412623|FG000|Safety Analysis Set|Overall Study||51
11220979|NCT01963611|12412624|FG001|Safety Analysis Set|Overall Study||49
11220980|NCT01963611|12412625|FG002|Safety Analysis Set|Overall Study||52
11220981|NCT01963611|12412626|FG003|Safety Analysis Set|Overall Study||52
11220982|NCT01963611|12412627|FG004|Safety Analysis Set|Overall Study||50
11220983|NCT01963611|12412623|FG000|COMPLETED|Overall Study||0
11220984|NCT01963611|12412624|FG001|COMPLETED|Overall Study||0
11220985|NCT01963611|12412625|FG002|COMPLETED|Overall Study||0
11220986|NCT01963611|12412626|FG003|COMPLETED|Overall Study||0
11220987|NCT01963611|12412627|FG004|COMPLETED|Overall Study||0
11220988|NCT01963611|12412623|FG000|NOT COMPLETED|Overall Study||51
11220989|NCT01963611|12412624|FG001|NOT COMPLETED|Overall Study||49
11220990|NCT01963611|12412625|FG002|NOT COMPLETED|Overall Study||52
11220991|NCT01963611|12412626|FG003|NOT COMPLETED|Overall Study||52
11220992|NCT01963611|12412627|FG004|NOT COMPLETED|Overall Study||51
11220993|NCT01963676|12412642|FG000|STARTED|Overall Study||14
10837332|NCT01586910|12002832|FG000|STARTED|Overall Study||879
10837333|NCT01586910|12002833|FG001|STARTED|Overall Study||867
10837334|NCT01586910|12002832|FG000|COMPLETED|Overall Study||864
10837335|NCT01586910|12002833|FG001|COMPLETED|Overall Study||796
10837336|NCT01586910|12002832|FG000|NOT COMPLETED|Overall Study||15
10837337|NCT01586910|12002833|FG001|NOT COMPLETED|Overall Study||71
11103874|NCT01245140|12288090|FG001|COMPLETED|Overall Study||14
11103875|NCT01245140|12288089|FG000|NOT COMPLETED|Overall Study||3
11103876|NCT01245140|12288090|FG001|NOT COMPLETED|Overall Study||10
11103877|NCT01245270|12288098|FG000|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
11103878|NCT01245270|12288099|FG001|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
11103879|NCT01245270|12288098|FG000|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
10837392|NCT00559936|12002893|FG000|STARTED|Overall Study||24
10837393|NCT00559936|12002893|FG000|COMPLETED|Overall Study||20
10837394|NCT00559936|12002893|FG000|NOT COMPLETED|Overall Study||4
10837395|NCT00504582|12002900|FG000|STARTED|Overall Study||47
10837396|NCT00504582|12002901|FG001|STARTED|Overall Study||45
10837397|NCT00504582|12002902|FG002|STARTED|Overall Study||20
10837398|NCT00504582|12002900|FG000|COMPLETED|Overall Study||46
10837399|NCT00504582|12002901|FG001|COMPLETED|Overall Study||45
10837400|NCT00504582|12002902|FG002|COMPLETED|Overall Study||20
10837401|NCT00504582|12002900|FG000|NOT COMPLETED|Overall Study||1
10837402|NCT00504582|12002901|FG001|NOT COMPLETED|Overall Study||0
10837403|NCT00504582|12002902|FG002|NOT COMPLETED|Overall Study||0
10837404|NCT02255487|12002912|FG000|STARTED|Overall Study||309
10837405|NCT02255487|12002913|FG001|STARTED|Overall Study||308
10837406|NCT02255487|12002912|FG000|Modified Intent to Treat (mITT)|Overall Study|"Within the ITT population, subjects with unknown age entries (modified ITT or mITT) were considered non-evaluable and excluded from the analysis. The mITT population was defined as patients 18 years of age or older."|293
10837407|NCT02255487|12002913|FG001|Modified Intent to Treat (mITT)|Overall Study|"Within the ITT population, subjects with unknown age entries (modified ITT or mITT) were considered non-evaluable and excluded from the analysis. The mITT population was defined as patients 18 years of age or older."|291
10837408|NCT02255487|12002912|FG000|COMPLETED|Overall Study||218
10837409|NCT02255487|12002913|FG001|COMPLETED|Overall Study||230
10837410|NCT02255487|12002912|FG000|NOT COMPLETED|Overall Study||91
10837411|NCT02255487|12002913|FG001|NOT COMPLETED|Overall Study||78
10837444|NCT02290431|12002968|FG000|STARTED|Overall Study||31
10837445|NCT02290431|12002968|FG000|Subjects. Discont. Prematurely|Overall Study||27
10837446|NCT02290431|12002968|FG000|Subjects Completed Study Per Protocol|Overall Study||8
10837447|NCT02290431|12002968|FG000|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31
10837448|NCT02290431|12002968|FG000|Subjects Entered Survival f/u Phase|Overall Study||24
10837449|NCT02290431|12002968|FG000|Entered Treatment Phase 2|Overall Study||17
10837450|NCT02290431|12002968|FG000|COMPLETED|Overall Study||4
11103880|NCT01245270|12288099|FG001|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
11103881|NCT01245270|12288098|FG000|NOT COMPLETED|Overall Study||0
11103882|NCT01245270|12288099|FG001|NOT COMPLETED|Overall Study||0
11103883|NCT01245283|12288110|FG000|STARTED|Overall Study||32
11103884|NCT01245283|12288111|FG001|STARTED|Overall Study||28
11103885|NCT01245283|12288112|FG002|STARTED|Overall Study||30
11103886|NCT01245283|12288110|FG000|COMPLETED|Overall Study||18
11103887|NCT01245283|12288111|FG001|COMPLETED|Overall Study||17
11103888|NCT01245283|12288112|FG002|COMPLETED|Overall Study||19
11103889|NCT01245283|12288110|FG000|NOT COMPLETED|Overall Study||14
11103890|NCT01245283|12288111|FG001|NOT COMPLETED|Overall Study||11
10837451|NCT02290431|12002968|FG000|NOT COMPLETED|Overall Study||27
10837452|NCT02314923|12002982|FG000|STARTED|Overall Study||64
10837453|NCT02314923|12002983|FG001|STARTED|Overall Study||64
10837454|NCT02314923|12002984|FG002|STARTED|Overall Study||64
10837455|NCT02314923|12002985|FG003|STARTED|Overall Study||64
10837456|NCT02314923|12002986|FG004|STARTED|Overall Study||74
10837457|NCT02314923|12002987|FG005|STARTED|Overall Study||20
10837458|NCT02314923|12002988|FG006|STARTED|Overall Study||48
10837459|NCT02314923|12002989|FG007|STARTED|Overall Study||47
10837460|NCT02314923|12002990|FG008|STARTED|Overall Study||48
10837461|NCT02314923|12002991|FG009|STARTED|Overall Study||20
10837462|NCT02314923|12002982|FG000|Treated|Overall Study||64
10837463|NCT02314923|12002983|FG001|Treated|Overall Study||64
10837464|NCT02314923|12002984|FG002|Treated|Overall Study||64
10837465|NCT02314923|12002985|FG003|Treated|Overall Study||64
10837466|NCT02314923|12002986|FG004|Treated|Overall Study||74
10837467|NCT02314923|12002987|FG005|Treated|Overall Study||20
10837468|NCT02314923|12002988|FG006|Treated|Overall Study|One participant did not receive vaccination due to missing blood sample at randomization.|47
10837469|NCT02314923|12002989|FG007|Treated|Overall Study||47
10837470|NCT02314923|12002990|FG008|Treated|Overall Study||48
10837471|NCT02314923|12002991|FG009|Treated|Overall Study||20
10837472|NCT02314923|12002982|FG000|COMPLETED|Overall Study||61
10837473|NCT02314923|12002983|FG001|COMPLETED|Overall Study||60
10837474|NCT02314923|12002984|FG002|COMPLETED|Overall Study||62
10837475|NCT02314923|12002985|FG003|COMPLETED|Overall Study||63
10837476|NCT02314923|12002986|FG004|COMPLETED|Overall Study||73
10837477|NCT02314923|12002987|FG005|COMPLETED|Overall Study||19
10837478|NCT02314923|12002988|FG006|COMPLETED|Overall Study||43
10837479|NCT02314923|12002989|FG007|COMPLETED|Overall Study||42
10837480|NCT02314923|12002990|FG008|COMPLETED|Overall Study||46
10837481|NCT02314923|12002991|FG009|COMPLETED|Overall Study||20
10837482|NCT02314923|12002982|FG000|NOT COMPLETED|Overall Study||3
10837483|NCT02314923|12002983|FG001|NOT COMPLETED|Overall Study||4
10837484|NCT02314923|12002984|FG002|NOT COMPLETED|Overall Study||2
10837485|NCT02314923|12002985|FG003|NOT COMPLETED|Overall Study||1
10837486|NCT02314923|12002986|FG004|NOT COMPLETED|Overall Study||1
10837487|NCT02314923|12002987|FG005|NOT COMPLETED|Overall Study||1
10837488|NCT02314923|12002988|FG006|NOT COMPLETED|Overall Study||5
10837489|NCT02314923|12002989|FG007|NOT COMPLETED|Overall Study||5
10837490|NCT02314923|12002990|FG008|NOT COMPLETED|Overall Study||2
10837491|NCT02314923|12002991|FG009|NOT COMPLETED|Overall Study||0
10837492|NCT04821362|12003017|FG000|STARTED|Overall Study||90
10837493|NCT04821362|12003018|FG001|STARTED|Overall Study||90
10837494|NCT04821362|12003019|FG002|STARTED|Overall Study||90
10837495|NCT04821362|12003017|FG000|COMPLETED|Overall Study||90
10837496|NCT04821362|12003018|FG001|COMPLETED|Overall Study||90
10837497|NCT04821362|12003019|FG002|COMPLETED|Overall Study||90
10837498|NCT04821362|12003017|FG000|NOT COMPLETED|Overall Study||0
10837499|NCT04821362|12003018|FG001|NOT COMPLETED|Overall Study||0
10837500|NCT04821362|12003019|FG002|NOT COMPLETED|Overall Study||0
10837501|NCT04524507|12003032|FG000|STARTED|Overall Study||15
10837502|NCT04524507|12003033|FG001|STARTED|Overall Study||41
10837503|NCT04524507|12003032|FG000|Received Intervention|Overall Study||14
10837504|NCT04524507|12003033|FG001|Received Intervention|Overall Study||41
10837505|NCT04524507|12003032|FG000|Hospital Discharge|Overall Study||13
10837506|NCT04524507|12003033|FG001|Hospital Discharge|Overall Study||27
10837507|NCT04524507|12003032|FG000|COMPLETED|Overall Study||9
10837508|NCT04524507|12003033|FG001|COMPLETED|Overall Study||18
10837509|NCT04524507|12003032|FG000|NOT COMPLETED|Overall Study||6
10837510|NCT04524507|12003033|FG001|NOT COMPLETED|Overall Study||23
10837511|NCT04382924|12003042|FG000|STARTED|Overall Study||52
10837512|NCT04382924|12003043|FG001|STARTED|Overall Study||56
10837513|NCT04382924|12003044|FG002|STARTED|Overall Study||60
10837514|NCT04382924|12003042|FG000|COMPLETED|Overall Study||44
10837515|NCT04382924|12003043|FG001|COMPLETED|Overall Study||46
10837516|NCT04382924|12003044|FG002|COMPLETED|Overall Study||48
10837517|NCT04382924|12003042|FG000|NOT COMPLETED|Overall Study||8
10837518|NCT04382924|12003043|FG001|NOT COMPLETED|Overall Study||10
10837519|NCT04382924|12003044|FG002|NOT COMPLETED|Overall Study||12
10837520|NCT04166214|12003054|FG000|STARTED|Overall Study||12
10837412|NCT02257918|12002923|FG000|STARTED|Overall Study||72
10837413|NCT02257918|12002924|FG001|STARTED|Overall Study||67
10837414|NCT02257918|12002925|FG002|STARTED|Overall Study||41
10837415|NCT02257918|12002923|FG000|Test of Cure Visit|Overall Study||72
10837416|NCT02257918|12002924|FG001|Test of Cure Visit|Overall Study||67
10837417|NCT02257918|12002925|FG002|Test of Cure Visit|Overall Study||40
10837418|NCT02257918|12002923|FG000|COMPLETED|Overall Study||68
10837419|NCT02257918|12002924|FG001|COMPLETED|Overall Study||66
10837420|NCT02257918|12002925|FG002|COMPLETED|Overall Study||39
10837421|NCT02257918|12002923|FG000|NOT COMPLETED|Overall Study||4
10837422|NCT02257918|12002924|FG001|NOT COMPLETED|Overall Study||1
10837423|NCT02257918|12002925|FG002|NOT COMPLETED|Overall Study||2
10837521|NCT04166214|12003055|FG001|STARTED|Overall Study||39
10837522|NCT04166214|12003054|FG000|COMPLETED|Overall Study||12
10837523|NCT04166214|12003055|FG001|COMPLETED|Overall Study||39
10837524|NCT04166214|12003054|FG000|NOT COMPLETED|Overall Study||0
10837525|NCT04166214|12003055|FG001|NOT COMPLETED|Overall Study||0
10837526|NCT03947788|12003063|FG000|STARTED|Overall Study||69
10837527|NCT03947788|12003064|FG001|STARTED|Overall Study||74
10837528|NCT03947788|12003063|FG000|COMPLETED|Overall Study||69
10837529|NCT03947788|12003064|FG001|COMPLETED|Overall Study||74
10837530|NCT03947788|12003063|FG000|NOT COMPLETED|Overall Study||0
10837531|NCT03947788|12003064|FG001|NOT COMPLETED|Overall Study||0
10837532|NCT03842436|12003075|FG000|STARTED|Overall Study||16
10837533|NCT03842436|12003075|FG000|COMPLETED|Overall Study||15
10837534|NCT03842436|12003075|FG000|NOT COMPLETED|Overall Study||1
10837535|NCT03646162|12003082|FG000|STARTED|Overall Study||31
10837536|NCT03646162|12003083|FG001|STARTED|Overall Study||31
10837537|NCT03646162|12003084|FG002|STARTED|Overall Study||31
10837538|NCT03646162|12003082|FG000|COMPLETED|Overall Study||26
10837539|NCT03646162|12003083|FG001|COMPLETED|Overall Study||27
10837540|NCT03646162|12003084|FG002|COMPLETED|Overall Study||30
10837541|NCT03646162|12003082|FG000|NOT COMPLETED|Overall Study||5
10837542|NCT03646162|12003083|FG001|NOT COMPLETED|Overall Study||4
10837543|NCT03646162|12003084|FG002|NOT COMPLETED|Overall Study||1
10837544|NCT03462030|12003096|FG000|STARTED|Overall Study||15
10837545|NCT03462030|12003097|FG001|STARTED|Overall Study||15
10837546|NCT03462030|12003096|FG000|End of Build-up|Overall Study||14
10837547|NCT03462030|12003097|FG001|End of Build-up|Overall Study||14
10837548|NCT03462030|12003096|FG000|Month 12 Food Challenge|Overall Study||14
10837549|NCT03462030|12003097|FG001|Month 12 Food Challenge|Overall Study||14
10837550|NCT03462030|12003096|FG000|COMPLETED|Overall Study||14
10837551|NCT03462030|12003097|FG001|COMPLETED|Overall Study||14
10837552|NCT03462030|12003096|FG000|NOT COMPLETED|Overall Study||1
10837553|NCT03462030|12003097|FG001|NOT COMPLETED|Overall Study||1
10837554|NCT03446768|12003105|FG000|STARTED|Overall Study||141
10837555|NCT03446768|12003106|FG001|STARTED|Overall Study||153
10837556|NCT03446768|12003105|FG000|COMPLETED|Overall Study||141
10837557|NCT03446768|12003106|FG001|COMPLETED|Overall Study||152
10837558|NCT03446768|12003105|FG000|NOT COMPLETED|Overall Study||0
10837559|NCT03446768|12003106|FG001|NOT COMPLETED|Overall Study||1
10837560|NCT03348514|12003120|FG000|STARTED|Overall Study||1
10837561|NCT03348514|12003121|FG001|STARTED|Overall Study||1
10837562|NCT03348514|12003122|FG002|STARTED|Overall Study||1
10837563|NCT03348514|12003123|FG003|STARTED|Overall Study||1
10837564|NCT03348514|12003124|FG004|STARTED|Overall Study||3
10837565|NCT03348514|12003125|FG005|STARTED|Overall Study||4
10837566|NCT03348514|12003126|FG006|STARTED|Overall Study||6
10837567|NCT03348514|12003127|FG007|STARTED|Overall Study||2
10837568|NCT03348514|12003120|FG000|COMPLETED|Overall Study||1
10837569|NCT03348514|12003121|FG001|COMPLETED|Overall Study||1
10837570|NCT03348514|12003122|FG002|COMPLETED|Overall Study||1
10837571|NCT03348514|12003123|FG003|COMPLETED|Overall Study||1
10837572|NCT03348514|12003124|FG004|COMPLETED|Overall Study||3
10837573|NCT03348514|12003125|FG005|COMPLETED|Overall Study||4
10837574|NCT03348514|12003126|FG006|COMPLETED|Overall Study||6
10837575|NCT03348514|12003127|FG007|COMPLETED|Overall Study||2
10837576|NCT03348514|12003120|FG000|NOT COMPLETED|Overall Study||0
10837577|NCT03348514|12003121|FG001|NOT COMPLETED|Overall Study||0
10837578|NCT03348514|12003122|FG002|NOT COMPLETED|Overall Study||0
10837579|NCT03348514|12003123|FG003|NOT COMPLETED|Overall Study||0
10837580|NCT03348514|12003124|FG004|NOT COMPLETED|Overall Study||0
10837581|NCT03348514|12003125|FG005|NOT COMPLETED|Overall Study||0
10837582|NCT03348514|12003126|FG006|NOT COMPLETED|Overall Study||0
10837583|NCT03348514|12003127|FG007|NOT COMPLETED|Overall Study||0
10837584|NCT03253393|12003151|FG000|STARTED|First Intervention||12
10837585|NCT03253393|12003152|FG001|STARTED|First Intervention||13
10837586|NCT03253393|12003153|FG002|STARTED|First Intervention||0
10837587|NCT03253393|12003151|FG000|COMPLETED|First Intervention||12
10837588|NCT03253393|12003152|FG001|COMPLETED|First Intervention||13
10837589|NCT03253393|12003153|FG002|COMPLETED|First Intervention||0
10837590|NCT03253393|12003151|FG000|NOT COMPLETED|First Intervention||0
10837591|NCT03253393|12003152|FG001|NOT COMPLETED|First Intervention||0
10837592|NCT03253393|12003153|FG002|NOT COMPLETED|First Intervention||0
10837593|NCT03253393|12003151|FG000|STARTED|Washout (Minimum 48 Hours)||12
10837594|NCT03253393|12003152|FG001|STARTED|Washout (Minimum 48 Hours)||13
10837595|NCT03253393|12003153|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
10837596|NCT03253393|12003151|FG000|COMPLETED|Washout (Minimum 48 Hours)||12
10837597|NCT03253393|12003152|FG001|COMPLETED|Washout (Minimum 48 Hours)||13
10837598|NCT03253393|12003153|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
10837424|NCT02258542|12002937|FG000|STARTED|Overall Study||953
10837425|NCT02258542|12002938|FG001|STARTED|Overall Study||973
10837426|NCT02258542|12002939|FG002|STARTED|Overall Study||100
10837427|NCT02258542|12002940|FG003|STARTED|Overall Study||97
10837428|NCT02258542|12002937|FG000|Treated|Overall Study||953
10837429|NCT02258542|12002938|FG001|Treated|Overall Study||971
10837430|NCT02258542|12002939|FG002|Treated|Overall Study||100
10837431|NCT02258542|12002940|FG003|Treated|Overall Study||97
10837432|NCT02258542|12002937|FG000|Adolescents Only|Overall Study||25
10837433|NCT02258542|12002938|FG001|Adolescents Only|Overall Study||61
10837434|NCT02258542|12002939|FG002|Adolescents Only|Overall Study||0
10837435|NCT02258542|12002940|FG003|Adolescents Only|Overall Study||0
10837436|NCT02258542|12002937|FG000|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911
10837437|NCT02258542|12002938|FG001|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924
10837438|NCT02258542|12002939|FG002|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92
10837439|NCT02258542|12002940|FG003|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92
10837440|NCT02258542|12002937|FG000|NOT COMPLETED|Overall Study||42
10837441|NCT02258542|12002938|FG001|NOT COMPLETED|Overall Study||49
10837442|NCT02258542|12002939|FG002|NOT COMPLETED|Overall Study||8
10837443|NCT02258542|12002940|FG003|NOT COMPLETED|Overall Study||5
10837599|NCT03253393|12003151|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||0
10837600|NCT03253393|12003152|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||0
10837601|NCT03253393|12003153|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0
10837602|NCT03253393|12003151|FG000|STARTED|Second Intervention||12
10837603|NCT03253393|12003152|FG001|STARTED|Second Intervention||13
11220994|NCT01963676|12412643|FG001|STARTED|Overall Study||13
11220995|NCT01963676|12412642|FG000|COMPLETED|Overall Study||13
11220996|NCT01963676|12412643|FG001|COMPLETED|Overall Study||13
11220997|NCT01963676|12412642|FG000|NOT COMPLETED|Overall Study||1
11220998|NCT01963676|12412643|FG001|NOT COMPLETED|Overall Study||0
11220999|NCT01963767|12412651|FG000|STARTED|Overall Study||58
11221000|NCT01963767|12412652|FG001|STARTED|Overall Study||55
11221001|NCT01963767|12412651|FG000|COMPLETED|Overall Study||52
11221002|NCT01963767|12412652|FG001|COMPLETED|Overall Study||53
11221003|NCT01963767|12412651|FG000|NOT COMPLETED|Overall Study||6
11221004|NCT01963767|12412652|FG001|NOT COMPLETED|Overall Study||2
11221005|NCT01963793|12412658|FG000|STARTED|Overall Study||20
11221006|NCT01963793|12412658|FG000|COMPLETED|Overall Study||20
11221007|NCT01963793|12412658|FG000|NOT COMPLETED|Overall Study||0
11221008|NCT01963845|12412675|FG000|STARTED|Overall Study||25
11221009|NCT01963845|12412676|FG001|STARTED|Overall Study||25
11221010|NCT01963845|12412675|FG000|COMPLETED|Overall Study||25
11221011|NCT01963845|12412676|FG001|COMPLETED|Overall Study||25
11221012|NCT01963845|12412675|FG000|NOT COMPLETED|Overall Study||0
11221013|NCT01963845|12412676|FG001|NOT COMPLETED|Overall Study||0
11221014|NCT01963923|12412684|FG000|STARTED|3 Weeks Post-surgery||20
11221015|NCT01963923|12412685|FG001|STARTED|3 Weeks Post-surgery||20
11221016|NCT01963923|12412684|FG000|COMPLETED|3 Weeks Post-surgery||12
11221017|NCT01963923|12412685|FG001|COMPLETED|3 Weeks Post-surgery||10
10837604|NCT03253393|12003153|FG002|STARTED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0
10837605|NCT03253393|12003151|FG000|COMPLETED|Second Intervention||12
10837606|NCT03253393|12003152|FG001|COMPLETED|Second Intervention||13
10837607|NCT03253393|12003153|FG002|COMPLETED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0
11221018|NCT01963923|12412684|FG000|NOT COMPLETED|3 Weeks Post-surgery||8
11221019|NCT01963923|12412685|FG001|NOT COMPLETED|3 Weeks Post-surgery||10
11221020|NCT01963923|12412684|FG000|STARTED|3 Months Post-surgery||12
11221021|NCT01963923|12412685|FG001|STARTED|3 Months Post-surgery||10
11221022|NCT01963923|12412684|FG000|COMPLETED|3 Months Post-surgery||10
11221023|NCT01963923|12412685|FG001|COMPLETED|3 Months Post-surgery||9
11221024|NCT01963923|12412684|FG000|NOT COMPLETED|3 Months Post-surgery||2
11221025|NCT01963923|12412685|FG001|NOT COMPLETED|3 Months Post-surgery||1
11221026|NCT01964092|12412700|FG000|STARTED|Overall Study||229
11221027|NCT01964092|12412701|FG001|STARTED|Overall Study||181
11221028|NCT01964092|12412700|FG000|COMPLETED|Overall Study||227
11221029|NCT01964092|12412701|FG001|COMPLETED|Overall Study||181
11221030|NCT01964092|12412700|FG000|NOT COMPLETED|Overall Study||2
11221031|NCT01964092|12412701|FG001|NOT COMPLETED|Overall Study||0
11221032|NCT01964105|12412710|FG000|STARTED|Overall Study||15
11221033|NCT01964105|12412711|FG001|STARTED|Overall Study||75
11221034|NCT01964105|12412712|FG002|STARTED|Overall Study||10
11221035|NCT01964105|12412710|FG000|COMPLETED|Overall Study||13
11221036|NCT01964105|12412711|FG001|COMPLETED|Overall Study||62
10837608|NCT03253393|12003151|FG000|NOT COMPLETED|Second Intervention||0
10837609|NCT03253393|12003152|FG001|NOT COMPLETED|Second Intervention||0
10837610|NCT03253393|12003153|FG002|NOT COMPLETED|Second Intervention||0
11221037|NCT01964105|12412712|FG002|COMPLETED|Overall Study||10
11221038|NCT01964105|12412710|FG000|NOT COMPLETED|Overall Study||2
11221039|NCT01964105|12412711|FG001|NOT COMPLETED|Overall Study||13
11221040|NCT01964105|12412712|FG002|NOT COMPLETED|Overall Study||0
11221041|NCT01964222|12412722|FG000|STARTED|Overall Study||101
11221042|NCT01964222|12412723|FG001|STARTED|Overall Study||100
11221043|NCT01964222|12412722|FG000|COMPLETED|Overall Study||86
11221044|NCT01964222|12412723|FG001|COMPLETED|Overall Study||89
11221045|NCT01964222|12412722|FG000|NOT COMPLETED|Overall Study||15
11221046|NCT01964222|12412723|FG001|NOT COMPLETED|Overall Study||11
11221047|NCT01964300|12412731|FG000|STARTED|Overall Study||7
10837611|NCT03253393|12003151|FG000|STARTED|Washout (Minimum 48 Hours)||12
10837612|NCT03253393|12003152|FG001|STARTED|Washout (Minimum 48 Hours)||13
10837613|NCT03253393|12003153|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
10837614|NCT03253393|12003151|FG000|COMPLETED|Washout (Minimum 48 Hours)||6
10837615|NCT03253393|12003152|FG001|COMPLETED|Washout (Minimum 48 Hours)||6
10837616|NCT03253393|12003153|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
10837617|NCT03253393|12003151|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||6
10837618|NCT03253393|12003152|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||7
10837619|NCT03253393|12003153|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0
10837620|NCT03253393|12003151|FG000|STARTED|Third Intervention||6
10837621|NCT03253393|12003152|FG001|STARTED|Third Intervention||6
10837622|NCT03253393|12003153|FG002|STARTED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13
10837623|NCT03253393|12003151|FG000|COMPLETED|Third Intervention||6
10837624|NCT03253393|12003152|FG001|COMPLETED|Third Intervention||6
10837625|NCT03253393|12003153|FG002|COMPLETED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13
10837626|NCT03253393|12003151|FG000|NOT COMPLETED|Third Intervention||0
10837627|NCT03253393|12003152|FG001|NOT COMPLETED|Third Intervention||0
11221048|NCT01964300|12412732|FG001|STARTED|Overall Study||12
11221049|NCT01964300|12412731|FG000|COMPLETED|Overall Study||1
10837628|NCT03253393|12003153|FG002|NOT COMPLETED|Third Intervention||0
10837629|NCT03188822|12003167|FG000|STARTED|Overall Study||9
10837630|NCT03188822|12003167|FG000|COMPLETED|Overall Study||2
10837631|NCT03188822|12003167|FG000|NOT COMPLETED|Overall Study||7
10837632|NCT03128671|12003173|FG000|STARTED|Enrollment||89
10837633|NCT03128671|12003174|FG001|STARTED|Enrollment||89
10837634|NCT03128671|12003173|FG000|COMPLETED|Enrollment||89
10837635|NCT03128671|12003174|FG001|COMPLETED|Enrollment||89
10837636|NCT03128671|12003173|FG000|NOT COMPLETED|Enrollment||0
10837637|NCT03128671|12003174|FG001|NOT COMPLETED|Enrollment||0
10837638|NCT03128671|12003173|FG000|STARTED|Allocation||89
10837639|NCT03128671|12003174|FG001|STARTED|Allocation||89
10837640|NCT03128671|12003173|FG000|COMPLETED|Allocation||80
10837641|NCT03128671|12003174|FG001|COMPLETED|Allocation||89
10837642|NCT03128671|12003173|FG000|NOT COMPLETED|Allocation||9
10837643|NCT03128671|12003174|FG001|NOT COMPLETED|Allocation||0
10837644|NCT03128671|12003173|FG000|STARTED|Intervention||80
10837645|NCT03128671|12003174|FG001|STARTED|Intervention||89
10837646|NCT03128671|12003173|FG000|COMPLETED|Intervention||44
10837647|NCT03128671|12003174|FG001|COMPLETED|Intervention||55
10837648|NCT03128671|12003173|FG000|NOT COMPLETED|Intervention||36
10837649|NCT03128671|12003174|FG001|NOT COMPLETED|Intervention||34
10837650|NCT03111732|12003180|FG000|STARTED|Overall Study||11
10837651|NCT03111732|12003180|FG000|COMPLETED|Overall Study||6
10837652|NCT03111732|12003180|FG000|NOT COMPLETED|Overall Study||5
10837653|NCT03065244|12003191|FG000|STARTED|Overall Study||50
10837654|NCT03065244|12003192|FG001|STARTED|Overall Study||55
10837655|NCT03065244|12003191|FG000|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||22
10837656|NCT03065244|12003192|FG001|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||9
10837657|NCT03065244|12003191|FG000|COMPLETED|Overall Study||47
10837658|NCT03065244|12003192|FG001|COMPLETED|Overall Study||51
10837659|NCT03065244|12003191|FG000|NOT COMPLETED|Overall Study||3
10837660|NCT03065244|12003192|FG001|NOT COMPLETED|Overall Study||4
10837661|NCT02879305|12003200|FG000|STARTED|Overall Study||1487
10837662|NCT02879305|12003201|FG001|STARTED|Overall Study||1477
10837663|NCT02879305|12003200|FG000|COMPLETED|Overall Study||1370
10837664|NCT02879305|12003201|FG001|COMPLETED|Overall Study||1366
10837665|NCT02879305|12003200|FG000|NOT COMPLETED|Overall Study||117
10837666|NCT02879305|12003201|FG001|NOT COMPLETED|Overall Study||111
10837667|NCT02816736|12003209|FG000|STARTED|Overall Study||179
10837668|NCT02816736|12003210|FG001|STARTED|Overall Study||186
10837669|NCT02816736|12003209|FG000|COMPLETED|Overall Study||164
10837670|NCT02816736|12003210|FG001|COMPLETED|Overall Study||166
10837671|NCT02816736|12003209|FG000|NOT COMPLETED|Overall Study||15
10837672|NCT02816736|12003210|FG001|NOT COMPLETED|Overall Study||20
10837673|NCT02787850|12003218|FG000|STARTED|Overall Study||10
10837674|NCT02787850|12003219|FG001|STARTED|Overall Study||10
10837675|NCT02787850|12003218|FG000|COMPLETED|Overall Study||10
10837676|NCT02787850|12003219|FG001|COMPLETED|Overall Study||9
10837677|NCT02787850|12003218|FG000|NOT COMPLETED|Overall Study||0
10837678|NCT02787850|12003219|FG001|NOT COMPLETED|Overall Study||1
11103891|NCT01245283|12288112|FG002|NOT COMPLETED|Overall Study||11
11103892|NCT01245374|12288123|FG000|STARTED|Overall Study||103
11103893|NCT01245374|12288123|FG000|COMPLETED|Overall Study||99
10837682|NCT02676284|12003238|FG000|STARTED|Overall Study||36
10837683|NCT02676284|12003238|FG000|COMPLETED|Overall Study||35
10837684|NCT02676284|12003238|FG000|NOT COMPLETED|Overall Study||1
10837685|NCT02431702|12003242|FG000|STARTED|Part 1: 2-Month Oral Run-in Phase||273
10837686|NCT02431702|12003243|FG001|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10837687|NCT02431702|12003244|FG002|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10837688|NCT02431702|12003245|FG003|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10837689|NCT02431702|12003246|FG004|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10837690|NCT02431702|12003247|FG005|STARTED|Part 1: 2-Month Oral Run-in Phase||0
10837691|NCT02431702|12003248|FG006|STARTED|Part 1: 2-Month Oral Run-in Phase||64
10837692|NCT02431702|12003242|FG000|COMPLETED|Part 1: 2-Month Oral Run-in Phase||239
10837693|NCT02431702|12003243|FG001|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837694|NCT02431702|12003244|FG002|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837695|NCT02431702|12003245|FG003|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837696|NCT02431702|12003246|FG004|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837697|NCT02431702|12003247|FG005|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837698|NCT02431702|12003248|FG006|COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
10837699|NCT02431702|12003242|FG000|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||34
10837700|NCT02431702|12003243|FG001|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837701|NCT02431702|12003244|FG002|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837702|NCT02431702|12003245|FG003|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837703|NCT02431702|12003246|FG004|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837704|NCT02431702|12003247|FG005|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
10837705|NCT02431702|12003248|FG006|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
10837706|NCT02431702|12003242|FG000|STARTED|Part 2: 9Month Disease Progression Phase||0
11221050|NCT01964300|12412732|FG001|COMPLETED|Overall Study||1
11221051|NCT01964300|12412731|FG000|NOT COMPLETED|Overall Study||6
11221052|NCT01964300|12412732|FG001|NOT COMPLETED|Overall Study||11
11221053|NCT01964326|12412738|FG000|STARTED|Overall Study||1311
11221054|NCT01964326|12412738|FG000|COMPLETED|Overall Study||1014
11221055|NCT01964326|12412738|FG000|NOT COMPLETED|Overall Study||297
11221056|NCT01964352|12412746|FG000|STARTED|Overall Study||204
11221057|NCT01964352|12412747|FG001|STARTED|Overall Study||203
11221058|NCT01964352|12412748|FG002|STARTED|Overall Study||202
11221059|NCT01964352|12412749|FG003|STARTED|Overall Study||203
11221060|NCT01964352|12412746|FG000|COMPLETED|Overall Study||178
11221061|NCT01964352|12412747|FG001|COMPLETED|Overall Study||192
11221062|NCT01964352|12412748|FG002|COMPLETED|Overall Study||196
11221063|NCT01964352|12412749|FG003|COMPLETED|Overall Study||195
11221064|NCT01964352|12412746|FG000|NOT COMPLETED|Overall Study||26
11221065|NCT01964352|12412747|FG001|NOT COMPLETED|Overall Study||11
11221066|NCT01964352|12412748|FG002|NOT COMPLETED|Overall Study||6
11221067|NCT01964352|12412749|FG003|NOT COMPLETED|Overall Study||8
11221068|NCT01964378|12412761|FG000|STARTED|Overall Study||66
11221069|NCT01964378|12412762|FG001|STARTED|Overall Study||66
11221070|NCT01964378|12412761|FG000|Participants Treated (Safety Set)|Overall Study||65
11221071|NCT01964378|12412762|FG001|Participants Treated (Safety Set)|Overall Study|"4 Participants died during treatment, hereof 2 with withdrawal... as primary reason for discont."|61
11221072|NCT01964378|12412761|FG000|COMPLETED|Overall Study||41
11221073|NCT01964378|12412762|FG001|COMPLETED|Overall Study||45
11221074|NCT01964378|12412761|FG000|NOT COMPLETED|Overall Study||25
11221075|NCT01964378|12412762|FG001|NOT COMPLETED|Overall Study||21
11221076|NCT01964521|12412768|FG000|STARTED|Overall Study||24
11221077|NCT01964521|12412768|FG000|COMPLETED|Overall Study||20
11221078|NCT01964521|12412768|FG000|NOT COMPLETED|Overall Study||4
11221079|NCT01964547|12412775|FG000|STARTED|Overall Study||62
11221080|NCT01964547|12412776|FG001|STARTED|Overall Study||59
11221081|NCT01964547|12412775|FG000|COMPLETED|Overall Study||50
11221082|NCT01964547|12412776|FG001|COMPLETED|Overall Study||48
11221083|NCT01964547|12412775|FG000|NOT COMPLETED|Overall Study||12
11221084|NCT01964547|12412776|FG001|NOT COMPLETED|Overall Study||11
11221085|NCT01964716|12412784|FG000|STARTED|Overall Study||250
11221086|NCT01964716|12412785|FG001|STARTED|Overall Study||250
11221087|NCT01964716|12412784|FG000|Vaccinated Dose 1|Overall Study||250
11221088|NCT01964716|12412785|FG001|Vaccinated Dose 1|Overall Study||250
11221089|NCT01964716|12412784|FG000|Vaccinated Dose 2|Overall Study||249
11221090|NCT01964716|12412785|FG001|Vaccinated Dose 2|Overall Study||248
11221091|NCT01964716|12412784|FG000|Vaccinated Dose 3|Overall Study||247
11221092|NCT01964716|12412785|FG001|Vaccinated Dose 3|Overall Study||244
11221093|NCT01964716|12412784|FG000|COMPLETED|Overall Study||245
11221094|NCT01964716|12412785|FG001|COMPLETED|Overall Study||244
11221095|NCT01964716|12412784|FG000|NOT COMPLETED|Overall Study||5
11221096|NCT01964716|12412785|FG001|NOT COMPLETED|Overall Study||6
11221097|NCT01964755|12412799|FG000|STARTED|Overall Study||6
11221098|NCT01964755|12412799|FG000|Cycle 2|Overall Study||5
11221099|NCT01964755|12412799|FG000|Cycle 3|Overall Study||4
11221100|NCT01964755|12412799|FG000|Cycle 4|Overall Study||4
11221101|NCT01964755|12412799|FG000|Cycle 5|Overall Study||4
11221102|NCT01964755|12412799|FG000|COMPLETED|Overall Study||4
11221103|NCT01964755|12412799|FG000|NOT COMPLETED|Overall Study||2
11221104|NCT01964898|12412805|FG000|STARTED|Overall Study||31
11221105|NCT01964898|12412806|FG001|STARTED|Overall Study||33
11221106|NCT01964898|12412805|FG000|12 Week Assessment|Overall Study||25
11221107|NCT01964898|12412806|FG001|12 Week Assessment|Overall Study||30
11221108|NCT01964898|12412805|FG000|COMPLETED|Overall Study||24
11221109|NCT01964898|12412806|FG001|COMPLETED|Overall Study||26
11221110|NCT01964898|12412805|FG000|NOT COMPLETED|Overall Study||7
11221111|NCT01964898|12412806|FG001|NOT COMPLETED|Overall Study||7
11221112|NCT01964924|12412812|FG000|STARTED|Trametinib Monotherapy||37
11221113|NCT01964924|12412813|FG001|STARTED|Trametinib Monotherapy||0
11221114|NCT01964924|12412812|FG000|COMPLETED|Trametinib Monotherapy||18
11221115|NCT01964924|12412813|FG001|COMPLETED|Trametinib Monotherapy||0
11221116|NCT01964924|12412812|FG000|NOT COMPLETED|Trametinib Monotherapy||19
10837707|NCT02431702|12003243|FG001|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|78
10837708|NCT02431702|12003244|FG002|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|157
10837709|NCT02431702|12003245|FG003|STARTED|Part 2: 9Month Disease Progression Phase||0
10837710|NCT02431702|12003246|FG004|STARTED|Part 2: 9Month Disease Progression Phase||0
10837711|NCT02431702|12003247|FG005|STARTED|Part 2: 9Month Disease Progression Phase||0
10837712|NCT02431702|12003248|FG006|STARTED|Part 2: 9Month Disease Progression Phase||0
10837713|NCT02431702|12003242|FG000|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837714|NCT02431702|12003243|FG001|COMPLETED|Part 2: 9Month Disease Progression Phase||52
10837715|NCT02431702|12003244|FG002|COMPLETED|Part 2: 9Month Disease Progression Phase||128
10837716|NCT02431702|12003245|FG003|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837717|NCT02431702|12003246|FG004|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837718|NCT02431702|12003247|FG005|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837719|NCT02431702|12003248|FG006|COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837720|NCT02431702|12003242|FG000|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837721|NCT02431702|12003243|FG001|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||26
10837722|NCT02431702|12003244|FG002|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||29
10837723|NCT02431702|12003245|FG003|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837724|NCT02431702|12003246|FG004|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
11221117|NCT01964924|12412813|FG001|NOT COMPLETED|Trametinib Monotherapy||0
11221118|NCT01964924|12412812|FG000|STARTED|Trametinib + GSK2141||0
11221119|NCT01964924|12412813|FG001|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19
11221120|NCT01964924|12412812|FG000|COMPLETED|Trametinib + GSK2141||0
11221121|NCT01964924|12412813|FG001|COMPLETED|Trametinib + GSK2141||19
11221122|NCT01964924|12412812|FG000|NOT COMPLETED|Trametinib + GSK2141||0
10837725|NCT02431702|12003247|FG005|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837726|NCT02431702|12003248|FG006|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
10837727|NCT02431702|12003242|FG000|STARTED|Part 3: 9 Month of Additional Treatment||0
10837728|NCT02431702|12003243|FG001|STARTED|Part 3: 9 Month of Additional Treatment||0
10837729|NCT02431702|12003244|FG002|STARTED|Part 3: 9 Month of Additional Treatment||0
10837730|NCT02431702|12003245|FG003|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to continue treatment in this group.|49
10837731|NCT02431702|12003246|FG004|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|57
10837732|NCT02431702|12003247|FG005|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|63
10837733|NCT02431702|12003248|FG006|STARTED|Part 3: 9 Month of Additional Treatment||0
10837734|NCT02431702|12003242|FG000|COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837735|NCT02431702|12003243|FG001|COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837736|NCT02431702|12003244|FG002|COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837737|NCT02431702|12003245|FG003|COMPLETED|Part 3: 9 Month of Additional Treatment||40
10837738|NCT02431702|12003246|FG004|COMPLETED|Part 3: 9 Month of Additional Treatment||47
10837739|NCT02431702|12003247|FG005|COMPLETED|Part 3: 9 Month of Additional Treatment||46
10837740|NCT02431702|12003248|FG006|COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837741|NCT02431702|12003242|FG000|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837742|NCT02431702|12003243|FG001|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837743|NCT02431702|12003244|FG002|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837744|NCT02431702|12003245|FG003|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||9
10837745|NCT02431702|12003246|FG004|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||10
10837746|NCT02431702|12003247|FG005|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||17
10837747|NCT02431702|12003248|FG006|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
10837748|NCT02368002|12003268|FG000|STARTED|Stage 1 Intervention (Up to 20 Weeks)||233
10837749|NCT02368002|12003269|FG001|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
10837750|NCT02368002|12003270|FG002|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
10837751|NCT02368002|12003271|FG003|STARTED|Stage 1 Intervention (Up to 20 Weeks)||235
10837752|NCT02368002|12003272|FG004|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
10837753|NCT02368002|12003273|FG005|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
10837754|NCT02368002|12003268|FG000|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||228
10837755|NCT02368002|12003269|FG001|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837756|NCT02368002|12003270|FG002|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837757|NCT02368002|12003271|FG003|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||214
10837758|NCT02368002|12003272|FG004|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837759|NCT02368002|12003273|FG005|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837760|NCT02368002|12003268|FG000|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||5
10837761|NCT02368002|12003269|FG001|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837762|NCT02368002|12003270|FG002|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837763|NCT02368002|12003271|FG003|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||21
10837764|NCT02368002|12003272|FG004|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837765|NCT02368002|12003273|FG005|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
10837766|NCT02368002|12003268|FG000|STARTED|Stage 2 Intervention (Up to 17 Weeks)||88
10837767|NCT02368002|12003269|FG001|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70
10837768|NCT02368002|12003270|FG002|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70
10837769|NCT02368002|12003271|FG003|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
10837770|NCT02368002|12003272|FG004|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
10837771|NCT02368002|12003273|FG005|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
10837772|NCT02368002|12003268|FG000|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||86
10837773|NCT02368002|12003269|FG001|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||60
10837774|NCT02368002|12003270|FG002|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||64
11221123|NCT01964924|12412813|FG001|NOT COMPLETED|Trametinib + GSK2141||0
11221124|NCT01964950|12412824|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
11221125|NCT01964950|12412824|FG000|COMPLETED|Overall Study||1076
10837775|NCT02368002|12003271|FG003|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10837776|NCT02368002|12003272|FG004|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10837777|NCT02368002|12003273|FG005|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10837778|NCT02368002|12003268|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||2
10837779|NCT02368002|12003269|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||10
10837780|NCT02368002|12003270|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||6
10837781|NCT02368002|12003271|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10837782|NCT02368002|12003272|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10837783|NCT02368002|12003273|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
10837784|NCT02368002|12003268|FG000|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
10837785|NCT02368002|12003269|FG001|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
10837786|NCT02368002|12003270|FG002|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
10837787|NCT02368002|12003271|FG003|STARTED|Stage 2 Intervention (Up to 13 Weeks)||95
10837788|NCT02368002|12003272|FG004|STARTED|Stage 2 Intervention (Up to 13 Weeks)||57
10837789|NCT02368002|12003273|FG005|STARTED|Stage 2 Intervention (Up to 13 Weeks)||62
10837790|NCT02368002|12003268|FG000|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10837791|NCT02368002|12003269|FG001|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10837792|NCT02368002|12003270|FG002|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10837793|NCT02368002|12003271|FG003|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||94
10837794|NCT02368002|12003272|FG004|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||53
10837795|NCT02368002|12003273|FG005|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||59
10837796|NCT02368002|12003268|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10837797|NCT02368002|12003269|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10837798|NCT02368002|12003270|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
10837799|NCT02368002|12003271|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||1
10837800|NCT02368002|12003272|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||4
10837801|NCT02368002|12003273|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||3
11103894|NCT01245374|12288123|FG000|NOT COMPLETED|Overall Study||4
11103895|NCT01245387|12288128|FG000|STARTED|Overall Study||1001
11103896|NCT01245387|12288128|FG000|COMPLETED|Overall Study||188
11103897|NCT01245387|12288128|FG000|NOT COMPLETED|Overall Study||813
11103898|NCT01245413|12288132|FG000|STARTED|Sensura First,||16
11103899|NCT01245413|12288133|FG001|STARTED|Sensura First,||16
11103900|NCT01245413|12288132|FG000|COMPLETED|Sensura First,||16
11103901|NCT01245413|12288133|FG001|COMPLETED|Sensura First,||16
11103902|NCT01245413|12288132|FG000|NOT COMPLETED|Sensura First,||0
11103903|NCT01245413|12288133|FG001|NOT COMPLETED|Sensura First,||0
11103904|NCT01245413|12288132|FG000|STARTED|Athena First,||16
11103905|NCT01245413|12288133|FG001|STARTED|Athena First,||16
11103906|NCT01245413|12288132|FG000|COMPLETED|Athena First,||16
10837802|NCT02200770|12003285|FG000|STARTED|Randomized-controlled Period (RCP)||56
10837803|NCT02200770|12003286|FG001|STARTED|Randomized-controlled Period (RCP)||175
10837804|NCT02200770|12003285|FG000|Treated|Randomized-controlled Period (RCP)||56
10837805|NCT02200770|12003286|FG001|Treated|Randomized-controlled Period (RCP)||174
10837806|NCT02200770|12003285|FG000|COMPLETED|Randomized-controlled Period (RCP)||54
10837807|NCT02200770|12003286|FG001|COMPLETED|Randomized-controlled Period (RCP)||169
10837808|NCT02200770|12003285|FG000|NOT COMPLETED|Randomized-controlled Period (RCP)||2
10837809|NCT02200770|12003286|FG001|NOT COMPLETED|Randomized-controlled Period (RCP)||6
10837810|NCT02200770|12003285|FG000|STARTED|Open-label Period (OLP)|3 participants completed RCP but did not roll over to OLP.|51
10837811|NCT02200770|12003286|FG001|STARTED|Open-label Period (OLP)|4 participants completed RCP but did not roll over to OLP.|165
10837812|NCT02200770|12003285|FG000|COMPLETED|Open-label Period (OLP)||43
10837813|NCT02200770|12003286|FG001|COMPLETED|Open-label Period (OLP)||131
10837814|NCT02200770|12003285|FG000|NOT COMPLETED|Open-label Period (OLP)||8
10837815|NCT02200770|12003286|FG001|NOT COMPLETED|Open-label Period (OLP)||34
10837816|NCT02136069|12003296|FG000|STARTED|Overall Study||199
10837817|NCT02136069|12003297|FG001|STARTED|Overall Study||198
10837818|NCT02136069|12003296|FG000|COMPLETED|Overall Study||165
10837819|NCT02136069|12003297|FG001|COMPLETED|Overall Study||170
10837820|NCT02136069|12003296|FG000|NOT COMPLETED|Overall Study||34
10837821|NCT02136069|12003297|FG001|NOT COMPLETED|Overall Study||28
10837822|NCT02086552|12003303|FG000|STARTED|Overall Study||28
10837823|NCT02086552|12003303|FG000|COMPLETED|Overall Study||27
10837824|NCT02086552|12003303|FG000|NOT COMPLETED|Overall Study||1
10837825|NCT01517659|12003307|FG000|STARTED|Overall Study||45
10837826|NCT01517659|12003307|FG000|COMPLETED|Overall Study||45
10837827|NCT01517659|12003307|FG000|NOT COMPLETED|Overall Study||0
10837828|NCT01209767|12003312|FG000|STARTED|Overall Study||22
10837829|NCT01209767|12003312|FG000|COMPLETED|Overall Study||18
10837830|NCT01209767|12003312|FG000|NOT COMPLETED|Overall Study||4
10837831|NCT01186848|12003320|FG000|STARTED|Overall Study||30
10837832|NCT01186848|12003320|FG000|COMPLETED|Overall Study||22
10837833|NCT01186848|12003320|FG000|NOT COMPLETED|Overall Study||8
10837834|NCT01040624|12003328|FG000|STARTED|Overall Study||58
10837835|NCT01040624|12003329|FG001|STARTED|Overall Study||19
10837836|NCT01040624|12003328|FG000|COMPLETED|Overall Study||58
10837837|NCT01040624|12003329|FG001|COMPLETED|Overall Study||19
10837838|NCT01040624|12003328|FG000|NOT COMPLETED|Overall Study||0
10837839|NCT01040624|12003329|FG001|NOT COMPLETED|Overall Study||0
10837840|NCT01024608|12003337|FG000|STARTED|Overall Study||169
10837841|NCT01024608|12003338|FG001|STARTED|Overall Study||171
11103907|NCT01245413|12288133|FG001|COMPLETED|Athena First,||16
11103908|NCT01245413|12288132|FG000|NOT COMPLETED|Athena First,||0
10837842|NCT01024608|12003337|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
10837843|NCT01024608|12003338|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
10837844|NCT01024608|12003337|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
10837845|NCT01024608|12003338|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
10837846|NCT01024608|12003337|FG000|COMPLETED|Overall Study||165
10837847|NCT01024608|12003338|FG001|COMPLETED|Overall Study||167
10837848|NCT01024608|12003337|FG000|NOT COMPLETED|Overall Study||4
10837849|NCT01024608|12003338|FG001|NOT COMPLETED|Overall Study||4
10837850|NCT00988247|12003346|FG000|STARTED|Overall Study||418
10837851|NCT00988247|12003347|FG001|STARTED|Overall Study||111
10837852|NCT00988247|12003346|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
10837853|NCT00988247|12003347|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
10837854|NCT00988247|12003346|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
10837855|NCT00988247|12003347|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
10837856|NCT00988247|12003346|FG000|COMPLETED|Overall Study||335
10837857|NCT00988247|12003347|FG001|COMPLETED|Overall Study||85
10837858|NCT00988247|12003346|FG000|NOT COMPLETED|Overall Study||83
10837859|NCT00988247|12003347|FG001|NOT COMPLETED|Overall Study||26
10837860|NCT00838981|12003357|FG000|STARTED|Week 1 Days 1-3||26
10837861|NCT00838981|12003358|FG001|STARTED|Week 1 Days 1-3||19
10837862|NCT00838981|12003359|FG002|STARTED|Week 1 Days 1-3||27
10837863|NCT00838981|12003360|FG003|STARTED|Week 1 Days 1-3||19
10837864|NCT00838981|12003357|FG000|COMPLETED|Week 1 Days 1-3||26
10837865|NCT00838981|12003358|FG001|COMPLETED|Week 1 Days 1-3||19
10837866|NCT00838981|12003359|FG002|COMPLETED|Week 1 Days 1-3||27
10837867|NCT00838981|12003360|FG003|COMPLETED|Week 1 Days 1-3||19
10837868|NCT00838981|12003357|FG000|NOT COMPLETED|Week 1 Days 1-3||0
10837869|NCT00838981|12003358|FG001|NOT COMPLETED|Week 1 Days 1-3||0
10837870|NCT00838981|12003359|FG002|NOT COMPLETED|Week 1 Days 1-3||0
10837871|NCT00838981|12003360|FG003|NOT COMPLETED|Week 1 Days 1-3||0
10837872|NCT00838981|12003357|FG000|STARTED|Day 4 to Week 11||26
10837873|NCT00838981|12003358|FG001|STARTED|Day 4 to Week 11||19
10837874|NCT00838981|12003359|FG002|STARTED|Day 4 to Week 11||27
10837875|NCT00838981|12003360|FG003|STARTED|Day 4 to Week 11||19
10837876|NCT00838981|12003357|FG000|Completed Main Treatment on 400mg|Day 4 to Week 11||22
10837877|NCT00838981|12003358|FG001|Completed Main Treatment on 400mg|Day 4 to Week 11||13
10837878|NCT00838981|12003359|FG002|Completed Main Treatment on 400mg|Day 4 to Week 11||17
10837879|NCT00838981|12003360|FG003|Completed Main Treatment on 400mg|Day 4 to Week 11||14
10837880|NCT00838981|12003357|FG000|COMPLETED|Day 4 to Week 11||19
10837881|NCT00838981|12003358|FG001|COMPLETED|Day 4 to Week 11||11
10837882|NCT00838981|12003359|FG002|COMPLETED|Day 4 to Week 11||16
10837883|NCT00838981|12003360|FG003|COMPLETED|Day 4 to Week 11||12
10837884|NCT00838981|12003357|FG000|NOT COMPLETED|Day 4 to Week 11||7
10837885|NCT00838981|12003358|FG001|NOT COMPLETED|Day 4 to Week 11||8
10837886|NCT00838981|12003359|FG002|NOT COMPLETED|Day 4 to Week 11||11
10837887|NCT00838981|12003360|FG003|NOT COMPLETED|Day 4 to Week 11||7
10837888|NCT00730639|12003379|FG000|STARTED|Overall Study||17
10837889|NCT00730639|12003380|FG001|STARTED|Overall Study||18
10837890|NCT00730639|12003381|FG002|STARTED|Overall Study||86
10837891|NCT00730639|12003382|FG003|STARTED|Overall Study||54
10837892|NCT00730639|12003383|FG004|STARTED|Overall Study||131
10837893|NCT00730639|12003379|FG000|COMPLETED|Overall Study||0
10837894|NCT00730639|12003380|FG001|COMPLETED|Overall Study||0
10837895|NCT00730639|12003381|FG002|COMPLETED|Overall Study||0
10837896|NCT00730639|12003382|FG003|COMPLETED|Overall Study||0
10837897|NCT00730639|12003383|FG004|COMPLETED|Overall Study||0
10837898|NCT00730639|12003379|FG000|NOT COMPLETED|Overall Study||17
10837899|NCT00730639|12003380|FG001|NOT COMPLETED|Overall Study||18
10837900|NCT00730639|12003381|FG002|NOT COMPLETED|Overall Study||86
10837901|NCT00730639|12003382|FG003|NOT COMPLETED|Overall Study||54
10837902|NCT00730639|12003383|FG004|NOT COMPLETED|Overall Study||131
10837903|NCT00363038|12003406|FG000|STARTED|Overall Study||16
10837904|NCT00363038|12003406|FG000|COMPLETED|Overall Study||16
10837905|NCT00363038|12003406|FG000|NOT COMPLETED|Overall Study||0
10837906|NCT04834362|12003412|FG000|STARTED|Overall Study||53
10837907|NCT04834362|12003413|FG001|STARTED|Overall Study||52
10837908|NCT04834362|12003412|FG000|COMPLETED|Overall Study||52
10837909|NCT04834362|12003413|FG001|COMPLETED|Overall Study||50
10837910|NCT04834362|12003412|FG000|NOT COMPLETED|Overall Study||1
10837911|NCT04834362|12003413|FG001|NOT COMPLETED|Overall Study||2
10837912|NCT04681482|12003423|FG000|STARTED|Overall Study||35051
10837913|NCT04681482|12003424|FG001|STARTED|Overall Study||38756
10837914|NCT04681482|12003425|FG002|STARTED|Overall Study||12148
10837915|NCT04681482|12003426|FG003|STARTED|Overall Study||21428
10837916|NCT04681482|12003423|FG000|COMPLETED|Overall Study||35051
10837917|NCT04681482|12003424|FG001|COMPLETED|Overall Study||38756
10837918|NCT04681482|12003425|FG002|COMPLETED|Overall Study||12148
10837919|NCT04681482|12003426|FG003|COMPLETED|Overall Study||21428
10837920|NCT04681482|12003423|FG000|NOT COMPLETED|Overall Study||0
10837921|NCT04681482|12003424|FG001|NOT COMPLETED|Overall Study||0
10837922|NCT04681482|12003425|FG002|NOT COMPLETED|Overall Study||0
10837923|NCT04681482|12003426|FG003|NOT COMPLETED|Overall Study||0
10837924|NCT04611789|12003439|FG000|STARTED|Overall Study||4
10837925|NCT04611789|12003440|FG001|STARTED|Overall Study||7
10837926|NCT04611789|12003441|FG002|STARTED|Overall Study||7
10837927|NCT04611789|12003439|FG000|COMPLETED|Overall Study||3
10837928|NCT04611789|12003440|FG001|COMPLETED|Overall Study||7
10837929|NCT04611789|12003441|FG002|COMPLETED|Overall Study||7
10837930|NCT04611789|12003439|FG000|NOT COMPLETED|Overall Study||1
10837931|NCT04611789|12003440|FG001|NOT COMPLETED|Overall Study||0
10837932|NCT04611789|12003441|FG002|NOT COMPLETED|Overall Study||0
10837933|NCT04537910|12003452|FG000|STARTED|Overall Study||6
10837934|NCT04537910|12003453|FG001|STARTED|Overall Study||5
10837935|NCT04537910|12003454|FG002|STARTED|Overall Study||7
10837936|NCT04537910|12003455|FG003|STARTED|Overall Study||7
10837937|NCT04537910|12003452|FG000|Received at Least One Dose of Study Drug|Overall Study||6
10837938|NCT04537910|12003453|FG001|Received at Least One Dose of Study Drug|Overall Study||5
10837939|NCT04537910|12003454|FG002|Received at Least One Dose of Study Drug|Overall Study||7
10837940|NCT04537910|12003455|FG003|Received at Least One Dose of Study Drug|Overall Study||7
10837941|NCT04537910|12003452|FG000|COMPLETED|Overall Study||6
10837942|NCT04537910|12003453|FG001|COMPLETED|Overall Study||5
10837943|NCT04537910|12003454|FG002|COMPLETED|Overall Study||7
10837944|NCT04537910|12003455|FG003|COMPLETED|Overall Study||7
10837945|NCT04537910|12003452|FG000|NOT COMPLETED|Overall Study||0
10837946|NCT04537910|12003453|FG001|NOT COMPLETED|Overall Study||0
10837947|NCT04537910|12003454|FG002|NOT COMPLETED|Overall Study||0
10837948|NCT04537910|12003455|FG003|NOT COMPLETED|Overall Study||0
10837949|NCT04441931|12003468|FG000|STARTED|Overall Study||6
10837950|NCT04441931|12003469|FG001|STARTED|Overall Study||7
10837951|NCT04441931|12003470|FG002|STARTED|Overall Study||7
10837952|NCT04441931|12003471|FG003|STARTED|Overall Study||6
10837953|NCT04441931|12003468|FG000|Received at Least One Dose of Study Drug|Overall Study||6
11103909|NCT01245413|12288133|FG001|NOT COMPLETED|Athena First,||0
11103910|NCT01245439|12288139|FG000|STARTED|Overall Study||65
11103911|NCT01245439|12288139|FG000|COMPLETED|Overall Study||65
11103912|NCT01245439|12288139|FG000|NOT COMPLETED|Overall Study||0
11103913|NCT01245595|12288147|FG000|STARTED|Overall Study||72
11103914|NCT01245595|12288148|FG001|STARTED|Overall Study||72
11103915|NCT01245595|12288147|FG000|Completed Full Course of Study Drug|Overall Study||57
11103916|NCT01245595|12288148|FG001|Completed Full Course of Study Drug|Overall Study||61
11103917|NCT01245595|12288147|FG000|COMPLETED|Overall Study||72
11221126|NCT01964950|12412824|FG000|NOT COMPLETED|Overall Study||25
11221127|NCT01964963|12412831|FG000|STARTED|Overall Study||19192
11221128|NCT01964963|12412831|FG000|COMPLETED|Overall Study||18249
11221129|NCT01964963|12412831|FG000|NOT COMPLETED|Overall Study||943
11221130|NCT01964976|12412837|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
11221131|NCT01964976|12412837|FG000|COMPLETED|Overall Study||1065
11221132|NCT01964976|12412837|FG000|NOT COMPLETED|Overall Study||31
11221133|NCT01965002|12412844|FG000|STARTED|Overall Study||5
11221134|NCT01965002|12412844|FG000|COMPLETED|Overall Study||5
11221135|NCT01965002|12412844|FG000|NOT COMPLETED|Overall Study||0
11221136|NCT01965067|12412852|FG000|STARTED|Overall Study||30
11221137|NCT01965067|12412853|FG001|STARTED|Overall Study||30
11221138|NCT01965067|12412852|FG000|COMPLETED|Overall Study||30
11221139|NCT01965067|12412853|FG001|COMPLETED|Overall Study||30
11221140|NCT01965067|12412852|FG000|NOT COMPLETED|Overall Study||0
11221141|NCT01965067|12412853|FG001|NOT COMPLETED|Overall Study||0
11221142|NCT01965158|12412861|FG000|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
11221143|NCT01965158|12412862|FG001|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
11221144|NCT01965158|12412861|FG000|Received Treatment|Overall Study||272
11221145|NCT01965158|12412862|FG001|Received Treatment|Overall Study||273
11221146|NCT01965158|12412861|FG000|COMPLETED|Overall Study||233
11221147|NCT01965158|12412862|FG001|COMPLETED|Overall Study||238
11221148|NCT01965158|12412861|FG000|NOT COMPLETED|Overall Study||41
11221149|NCT01965158|12412862|FG001|NOT COMPLETED|Overall Study||35
11221150|NCT01965262|12412868|FG000|STARTED|First Intervention (7 Days)||15
10837954|NCT04441931|12003469|FG001|Received at Least One Dose of Study Drug|Overall Study||7
10837955|NCT04441931|12003470|FG002|Received at Least One Dose of Study Drug|Overall Study||7
10837956|NCT04441931|12003471|FG003|Received at Least One Dose of Study Drug|Overall Study||6
10837957|NCT04441931|12003468|FG000|COMPLETED|Overall Study||6
10837958|NCT04441931|12003469|FG001|COMPLETED|Overall Study||7
10837959|NCT04441931|12003470|FG002|COMPLETED|Overall Study||7
10837960|NCT04441931|12003471|FG003|COMPLETED|Overall Study||6
10837961|NCT04441931|12003468|FG000|NOT COMPLETED|Overall Study||0
10837962|NCT04441931|12003469|FG001|NOT COMPLETED|Overall Study||0
10837963|NCT04441931|12003470|FG002|NOT COMPLETED|Overall Study||0
10837964|NCT04441931|12003471|FG003|NOT COMPLETED|Overall Study||0
10837965|NCT04355728|12003486|FG000|STARTED|Overall Study||12
10837966|NCT04355728|12003487|FG001|STARTED|Overall Study||12
10837967|NCT04355728|12003486|FG000|COMPLETED|Overall Study||12
10837968|NCT04355728|12003487|FG001|COMPLETED|Overall Study||12
10837969|NCT04355728|12003486|FG000|NOT COMPLETED|Overall Study||0
10837970|NCT04355728|12003487|FG001|NOT COMPLETED|Overall Study||0
10837971|NCT04344535|12003495|FG000|STARTED|Overall Study||59
10837972|NCT04344535|12003496|FG001|STARTED|Overall Study||15
10837973|NCT04344535|12003495|FG000|COMPLETED|Overall Study||59
10837974|NCT04344535|12003496|FG001|COMPLETED|Overall Study||15
10837975|NCT04344535|12003495|FG000|NOT COMPLETED|Overall Study||0
10837976|NCT04344535|12003496|FG001|NOT COMPLETED|Overall Study||0
11103918|NCT01245595|12288148|FG001|COMPLETED|Overall Study||72
11103919|NCT01245595|12288147|FG000|NOT COMPLETED|Overall Study||0
10837977|NCT04254809|12003504|FG000|STARTED|Overall Study||48
10837978|NCT04254809|12003505|FG001|STARTED|Overall Study||48
10837979|NCT04254809|12003504|FG000|COMPLETED|Overall Study||43
10837980|NCT04254809|12003505|FG001|COMPLETED|Overall Study||38
10837981|NCT04254809|12003504|FG000|NOT COMPLETED|Overall Study||5
10837982|NCT04254809|12003505|FG001|NOT COMPLETED|Overall Study||10
10837983|NCT04230122|12003513|FG000|STARTED|Overall Study||3
10837984|NCT04230122|12003514|FG001|STARTED|Overall Study||1
10837985|NCT04230122|12003513|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10837986|NCT04230122|12003514|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1
10837987|NCT04230122|12003513|FG000|COMPLETED|Overall Study||2
10837988|NCT04230122|12003514|FG001|COMPLETED|Overall Study||1
10837989|NCT04230122|12003513|FG000|NOT COMPLETED|Overall Study||1
10837990|NCT04230122|12003514|FG001|NOT COMPLETED|Overall Study||0
10837991|NCT04110366|12003522|FG000|STARTED|Overall Study||40
10837992|NCT04110366|12003523|FG001|STARTED|Overall Study||8
10837993|NCT04110366|12003522|FG000|COMPLETED|Overall Study||40
10837994|NCT04110366|12003523|FG001|COMPLETED|Overall Study||8
10837995|NCT04110366|12003522|FG000|NOT COMPLETED|Overall Study||0
10837996|NCT04110366|12003523|FG001|NOT COMPLETED|Overall Study||0
10837997|NCT04086693|12003532|FG000|STARTED|Overall Study||175
11221151|NCT01965262|12412869|FG001|STARTED|First Intervention (7 Days)||15
11221152|NCT01965262|12412868|FG000|COMPLETED|First Intervention (7 Days)||15
11221153|NCT01965262|12412869|FG001|COMPLETED|First Intervention (7 Days)||15
11221154|NCT01965262|12412868|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11221155|NCT01965262|12412869|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11221156|NCT01965262|12412868|FG000|STARTED|Second Intervention (7 Days)||15
11221157|NCT01965262|12412869|FG001|STARTED|Second Intervention (7 Days)||15
11221158|NCT01965262|12412868|FG000|COMPLETED|Second Intervention (7 Days)||14
11221159|NCT01965262|12412869|FG001|COMPLETED|Second Intervention (7 Days)||5
11221160|NCT01965262|12412868|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
11221161|NCT01965262|12412869|FG001|NOT COMPLETED|Second Intervention (7 Days)||10
11221162|NCT01965288|12412877|FG000|STARTED|Overall Study||30
11221163|NCT01965288|12412878|FG001|STARTED|Overall Study||30
11221164|NCT01965288|12412877|FG000|COMPLETED|Overall Study||30
11221165|NCT01965288|12412878|FG001|COMPLETED|Overall Study||30
11221166|NCT01965288|12412877|FG000|NOT COMPLETED|Overall Study||0
11221167|NCT01965288|12412878|FG001|NOT COMPLETED|Overall Study||0
11221168|NCT01965327|12412896|FG000|STARTED|Overall Study||12
11221169|NCT01965327|12412896|FG000|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
11221170|NCT01965327|12412896|FG000|NOT COMPLETED|Overall Study||2
11221171|NCT01965366|12412902|FG000|STARTED|Overall Study||13
11221172|NCT01965366|12412903|FG001|STARTED|Overall Study||14
11221173|NCT01965366|12412902|FG000|COMPLETED|Overall Study||3
11221174|NCT01965366|12412903|FG001|COMPLETED|Overall Study||9
11221175|NCT01965366|12412902|FG000|NOT COMPLETED|Overall Study||10
11221176|NCT01965366|12412903|FG001|NOT COMPLETED|Overall Study||5
11221177|NCT01965431|12412909|FG000|STARTED|Overall Study|Started are actually Treated subjects|8
11221178|NCT01965431|12412910|FG001|STARTED|Overall Study||8
11221179|NCT01965431|12412911|FG002|STARTED|Overall Study||8
11221180|NCT01965431|12412912|FG003|STARTED|Overall Study||8
11221181|NCT01965431|12412913|FG004|STARTED|Overall Study||8
11221182|NCT01965431|12412914|FG005|STARTED|Overall Study||8
11221183|NCT01965431|12412909|FG000|COMPLETED|Overall Study||2
11221184|NCT01965431|12412910|FG001|COMPLETED|Overall Study||2
11221185|NCT01965431|12412911|FG002|COMPLETED|Overall Study||2
11221186|NCT01965431|12412912|FG003|COMPLETED|Overall Study||2
11221187|NCT01965431|12412913|FG004|COMPLETED|Overall Study||2
11221188|NCT01965431|12412914|FG005|COMPLETED|Overall Study||2
11221189|NCT01965431|12412909|FG000|NOT COMPLETED|Overall Study||6
11221190|NCT01965431|12412910|FG001|NOT COMPLETED|Overall Study||6
11221191|NCT01965431|12412911|FG002|NOT COMPLETED|Overall Study||6
11221192|NCT01965431|12412912|FG003|NOT COMPLETED|Overall Study||6
11221193|NCT01965431|12412913|FG004|NOT COMPLETED|Overall Study||6
10837998|NCT04086693|12003533|FG001|STARTED|Overall Study||175
11221194|NCT01965431|12412914|FG005|NOT COMPLETED|Overall Study||6
11221195|NCT01965535|12412926|FG000|STARTED|Overall Study||78
11221196|NCT01965535|12412927|FG001|STARTED|Overall Study||77
10837999|NCT04086693|12003532|FG000|COMPLETED|Overall Study||174
10838000|NCT04086693|12003533|FG001|COMPLETED|Overall Study||171
10838001|NCT04086693|12003532|FG000|NOT COMPLETED|Overall Study||1
10838002|NCT04086693|12003533|FG001|NOT COMPLETED|Overall Study||4
10838003|NCT04033068|12003543|FG000|STARTED|Overall Study||14
10838004|NCT04033068|12003544|FG001|STARTED|Overall Study||14
10838005|NCT04033068|12003545|FG002|STARTED|Overall Study||12
10838006|NCT04033068|12003546|FG003|STARTED|Overall Study||8
10838007|NCT04033068|12003543|FG000|First Dose|Overall Study||14
10838008|NCT04033068|12003544|FG001|First Dose|Overall Study||14
10838009|NCT04033068|12003545|FG002|First Dose|Overall Study||12
10838010|NCT04033068|12003546|FG003|First Dose|Overall Study||8
10838011|NCT04033068|12003543|FG000|Second Dose|Overall Study||14
10838012|NCT04033068|12003544|FG001|Second Dose|Overall Study||14
10838013|NCT04033068|12003545|FG002|Second Dose|Overall Study||11
10838014|NCT04033068|12003546|FG003|Second Dose|Overall Study||7
10838015|NCT04033068|12003543|FG000|COMPLETED|Overall Study||14
10838016|NCT04033068|12003544|FG001|COMPLETED|Overall Study||13
10838017|NCT04033068|12003545|FG002|COMPLETED|Overall Study||11
10838018|NCT04033068|12003546|FG003|COMPLETED|Overall Study||7
10838019|NCT04033068|12003543|FG000|NOT COMPLETED|Overall Study||0
11221197|NCT01965535|12412926|FG000|COMPLETED|Overall Study||76
10838020|NCT04033068|12003544|FG001|NOT COMPLETED|Overall Study||1
10838021|NCT04033068|12003545|FG002|NOT COMPLETED|Overall Study||1
10838022|NCT04033068|12003546|FG003|NOT COMPLETED|Overall Study||1
11103920|NCT01245595|12288148|FG001|NOT COMPLETED|Overall Study||0
10838023|NCT03561597|12003556|FG000|STARTED|Overall Study|Recruited|40
10838024|NCT03561597|12003556|FG000|3 Month Follow up|Overall Study|Attended 3 month follow up|21
10838025|NCT03561597|12003556|FG000|COMPLETED|Overall Study|Attend month 6 follow up|20
10838026|NCT03561597|12003556|FG000|NOT COMPLETED|Overall Study||20
10838027|NCT03350984|12003562|FG000|STARTED|Overall Study||39
10838028|NCT03350984|12003563|FG001|STARTED|Overall Study||36
10838029|NCT03350984|12003562|FG000|COMPLETED|Overall Study||31
10838030|NCT03350984|12003563|FG001|COMPLETED|Overall Study||28
10838031|NCT03350984|12003562|FG000|NOT COMPLETED|Overall Study||8
10838032|NCT03350984|12003563|FG001|NOT COMPLETED|Overall Study||8
10838033|NCT03277261|12003571|FG000|STARTED|Overall Study||274
10838034|NCT03277261|12003572|FG001|STARTED|Overall Study||275
10838035|NCT03277261|12003571|FG000|COMPLETED|Overall Study||240
10838036|NCT03277261|12003572|FG001|COMPLETED|Overall Study||252
10838037|NCT03277261|12003571|FG000|NOT COMPLETED|Overall Study||34
10838038|NCT03277261|12003572|FG001|NOT COMPLETED|Overall Study||23
10838039|NCT03277248|12003581|FG000|STARTED|Overall Study||272
10838040|NCT03277248|12003582|FG001|STARTED|Overall Study||273
10838041|NCT03277248|12003581|FG000|COMPLETED|Overall Study||254
10838042|NCT03277248|12003582|FG001|COMPLETED|Overall Study||239
10838043|NCT03277248|12003581|FG000|NOT COMPLETED|Overall Study||18
10838044|NCT03277248|12003582|FG001|NOT COMPLETED|Overall Study||34
10838045|NCT03179462|12003591|FG000|STARTED|Overall Study||9
10838046|NCT03179462|12003592|FG001|STARTED|Overall Study||10
10838047|NCT03179462|12003593|FG002|STARTED|Overall Study||8
10838048|NCT03179462|12003591|FG000|COMPLETED|Overall Study||8
11221198|NCT01965535|12412927|FG001|COMPLETED|Overall Study||76
11221199|NCT01965535|12412926|FG000|NOT COMPLETED|Overall Study||2
11221200|NCT01965535|12412927|FG001|NOT COMPLETED|Overall Study||1
11221201|NCT01965561|12412933|FG000|STARTED|Overall Study||10
11221202|NCT01965561|12412933|FG000|COMPLETED|Overall Study||10
11221203|NCT01965561|12412933|FG000|NOT COMPLETED|Overall Study||0
11221204|NCT01965600|12412940|FG000|STARTED|First Intervention||6
11221205|NCT01965600|12412941|FG001|STARTED|First Intervention||8
11221206|NCT01965600|12412942|FG002|STARTED|First Intervention||5
11221207|NCT01965600|12412943|FG003|STARTED|First Intervention||4
11221208|NCT01965600|12412940|FG000|Received at Least One Dose of Drug|First Intervention||6
11221209|NCT01965600|12412941|FG001|Received at Least One Dose of Drug|First Intervention||8
11221210|NCT01965600|12412942|FG002|Received at Least One Dose of Drug|First Intervention||5
11221211|NCT01965600|12412943|FG003|Received at Least One Dose of Drug|First Intervention||4
11221212|NCT01965600|12412940|FG000|COMPLETED|First Intervention||6
11221213|NCT01965600|12412941|FG001|COMPLETED|First Intervention||8
11221214|NCT01965600|12412942|FG002|COMPLETED|First Intervention||5
11221215|NCT01965600|12412943|FG003|COMPLETED|First Intervention||4
11221216|NCT01965600|12412940|FG000|NOT COMPLETED|First Intervention||0
11221217|NCT01965600|12412941|FG001|NOT COMPLETED|First Intervention||0
11221218|NCT01965600|12412942|FG002|NOT COMPLETED|First Intervention||0
11221219|NCT01965600|12412943|FG003|NOT COMPLETED|First Intervention||0
11221220|NCT01965600|12412940|FG000|STARTED|Washout Period of Approximately 15 Days||6
11221221|NCT01965600|12412941|FG001|STARTED|Washout Period of Approximately 15 Days||8
11221222|NCT01965600|12412942|FG002|STARTED|Washout Period of Approximately 15 Days||5
11221223|NCT01965600|12412943|FG003|STARTED|Washout Period of Approximately 15 Days||4
11221224|NCT01965600|12412940|FG000|COMPLETED|Washout Period of Approximately 15 Days||4
11221225|NCT01965600|12412941|FG001|COMPLETED|Washout Period of Approximately 15 Days||4
11221226|NCT01965600|12412942|FG002|COMPLETED|Washout Period of Approximately 15 Days||3
11221227|NCT01965600|12412943|FG003|COMPLETED|Washout Period of Approximately 15 Days||2
11221228|NCT01965600|12412940|FG000|NOT COMPLETED|Washout Period of Approximately 15 Days||2
11221229|NCT01965600|12412941|FG001|NOT COMPLETED|Washout Period of Approximately 15 Days||4
11221230|NCT01965600|12412942|FG002|NOT COMPLETED|Washout Period of Approximately 15 Days||2
11221231|NCT01965600|12412943|FG003|NOT COMPLETED|Washout Period of Approximately 15 Days||2
11221232|NCT01965600|12412940|FG000|STARTED|Second Intervention||4
11221233|NCT01965600|12412941|FG001|STARTED|Second Intervention||4
11221234|NCT01965600|12412942|FG002|STARTED|Second Intervention||3
11221235|NCT01965600|12412943|FG003|STARTED|Second Intervention||2
11221236|NCT01965600|12412940|FG000|COMPLETED|Second Intervention||4
11354139|NCT03069989|12551340|FG000|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
11354140|NCT03069989|12551341|FG001|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
11354141|NCT03069989|12551340|FG000|STARTED|Dosing Period 2 (Up to 16 Days)||3
11354142|NCT03069989|12551341|FG001|STARTED|Dosing Period 2 (Up to 16 Days)||5
10838049|NCT03179462|12003592|FG001|COMPLETED|Overall Study||8
10838050|NCT03179462|12003593|FG002|COMPLETED|Overall Study||8
10838051|NCT03179462|12003591|FG000|NOT COMPLETED|Overall Study||1
11103921|NCT01245647|12288156|FG000|STARTED|Overall Study||7
11103922|NCT01245647|12288157|FG001|STARTED|Overall Study||12
11103923|NCT01245647|12288156|FG000|COMPLETED|Overall Study||7
11103924|NCT01245647|12288157|FG001|COMPLETED|Overall Study||8
11103925|NCT01245647|12288156|FG000|NOT COMPLETED|Overall Study||0
11103926|NCT01245647|12288157|FG001|NOT COMPLETED|Overall Study||4
11103927|NCT01245673|12288163|FG000|STARTED|Enrollment||28
11103928|NCT01245673|12288163|FG000|COMPLETED|Enrollment|One subject failed to meet screening criteria for the trial.|27
11103929|NCT01245673|12288163|FG000|NOT COMPLETED|Enrollment||1
10838052|NCT03179462|12003592|FG001|NOT COMPLETED|Overall Study||2
11221237|NCT01965600|12412941|FG001|COMPLETED|Second Intervention||4
11221238|NCT01965600|12412942|FG002|COMPLETED|Second Intervention||1
10838053|NCT03179462|12003593|FG002|NOT COMPLETED|Overall Study||0
10838054|NCT03099707|12003603|FG000|STARTED|Overall Study||43
10838055|NCT03099707|12003604|FG001|STARTED|Overall Study||41
10838056|NCT03099707|12003603|FG000|COMPLETED|Overall Study||43
10838057|NCT03099707|12003604|FG001|COMPLETED|Overall Study||37
10838058|NCT03099707|12003603|FG000|NOT COMPLETED|Overall Study||0
10838059|NCT03099707|12003604|FG001|NOT COMPLETED|Overall Study||4
10838060|NCT03064763|12003610|FG000|STARTED|Overall Study||18
10838061|NCT03064763|12003610|FG000|Received Treatment|Overall Study||18
10838062|NCT03064763|12003610|FG000|COMPLETED|Overall Study||0
10838063|NCT03064763|12003610|FG000|NOT COMPLETED|Overall Study||18
10838064|NCT03036267|12003614|FG000|STARTED|Overall Study||46
10838065|NCT03036267|12003614|FG000|COMPLETED|Overall Study||46
10838066|NCT03036267|12003614|FG000|NOT COMPLETED|Overall Study||0
10838067|NCT02941146|12003618|FG000|STARTED|Overall Study||15
10838068|NCT02941146|12003618|FG000|COMPLETED|Overall Study||15
10838069|NCT02941146|12003618|FG000|NOT COMPLETED|Overall Study||0
10838070|NCT02922985|12003624|FG000|STARTED|Overall Study||60
10838071|NCT02922985|12003625|FG001|STARTED|Overall Study||60
10838072|NCT02922985|12003624|FG000|COMPLETED|Overall Study||60
10838073|NCT02922985|12003625|FG001|COMPLETED|Overall Study||60
10838074|NCT02922985|12003624|FG000|NOT COMPLETED|Overall Study||0
10838075|NCT02922985|12003625|FG001|NOT COMPLETED|Overall Study||0
10838076|NCT02906033|12003635|FG000|STARTED|Baseline||231
10838077|NCT02906033|12003636|FG001|STARTED|Baseline||222
10838078|NCT02906033|12003635|FG000|15 D at Baseline|Baseline||211
10838079|NCT02906033|12003636|FG001|15 D at Baseline|Baseline||189
10838080|NCT02906033|12003635|FG000|STATE at Baseline|Baseline||199
10838081|NCT02906033|12003636|FG001|STATE at Baseline|Baseline||190
10838082|NCT02906033|12003635|FG000|TRAIT at Baseline|Baseline||194
10838083|NCT02906033|12003636|FG001|TRAIT at Baseline|Baseline||189
10838084|NCT02906033|12003635|FG000|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety|194
10838085|NCT02906033|12003636|FG001|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety.|189
10838086|NCT02906033|12003635|FG000|NOT COMPLETED|Baseline||37
10838087|NCT02906033|12003636|FG001|NOT COMPLETED|Baseline||33
10838088|NCT02906033|12003635|FG000|STARTED|Follow-up||194
10838089|NCT02906033|12003636|FG001|STARTED|Follow-up||189
10838090|NCT02906033|12003635|FG000|15 D at Follow-up|Follow-up||151
10838091|NCT02906033|12003636|FG001|15 D at Follow-up|Follow-up||135
10838092|NCT02906033|12003635|FG000|STATE at Follow-up|Follow-up||154
10838093|NCT02906033|12003636|FG001|STATE at Follow-up|Follow-up||135
10838094|NCT02906033|12003635|FG000|TRAIT at Follow-up|Follow-up||148
10838095|NCT02906033|12003636|FG001|TRAIT at Follow-up|Follow-up||127
10838096|NCT02906033|12003635|FG000|COMPLETED|Follow-up|Analyzed for 15 D and STATE anxiety and TRAIT anxiety at follow-up|148
10838097|NCT02906033|12003636|FG001|COMPLETED|Follow-up|Analyzed at follow-up 15 D and STATE anxiety and TRAIT anxiety.|127
10838098|NCT02906033|12003635|FG000|NOT COMPLETED|Follow-up||46
10838099|NCT02906033|12003636|FG001|NOT COMPLETED|Follow-up||62
10838100|NCT02837783|12003644|FG000|STARTED|Overall Study||9
10838101|NCT02837783|12003645|FG001|STARTED|Overall Study||11
10838102|NCT02837783|12003644|FG000|Received >= 1 Dose of Study Drug|Overall Study||9
10838103|NCT02837783|12003645|FG001|Received >= 1 Dose of Study Drug|Overall Study||10
10838104|NCT02837783|12003644|FG000|COMPLETED|Overall Study||7
10838105|NCT02837783|12003645|FG001|COMPLETED|Overall Study||9
10838106|NCT02837783|12003644|FG000|NOT COMPLETED|Overall Study||2
10838107|NCT02837783|12003645|FG001|NOT COMPLETED|Overall Study||2
10838108|NCT02786537|12003657|FG000|STARTED|As Randomized||56
10838109|NCT02786537|12003658|FG001|STARTED|As Randomized||644
10838110|NCT02786537|12003659|FG002|STARTED|As Randomized||15
10838111|NCT02786537|12003660|FG003|STARTED|As Randomized||413
10838112|NCT02786537|12003661|FG004|STARTED|As Randomized||99
10838113|NCT02786537|12003662|FG005|STARTED|As Randomized||48
10838114|NCT02786537|12003657|FG000|COMPLETED|As Randomized||50
11221239|NCT01965600|12412943|FG003|COMPLETED|Second Intervention||0
11221240|NCT01965600|12412940|FG000|NOT COMPLETED|Second Intervention||0
11221241|NCT01965600|12412941|FG001|NOT COMPLETED|Second Intervention||0
11221242|NCT01965600|12412942|FG002|NOT COMPLETED|Second Intervention||2
11221243|NCT01965600|12412943|FG003|NOT COMPLETED|Second Intervention||2
11221244|NCT01965652|12412953|FG000|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
11221245|NCT01965652|12412954|FG001|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
11221246|NCT01965652|12412953|FG000|Received Treatment|Overall Study||622
11221247|NCT01965652|12412954|FG001|Received Treatment|Overall Study||623
11221248|NCT01965652|12412953|FG000|COMPLETED|Overall Study||413
11221249|NCT01965652|12412954|FG001|COMPLETED|Overall Study||413
11221250|NCT01965652|12412953|FG000|NOT COMPLETED|Overall Study||210
11221251|NCT01965652|12412954|FG001|NOT COMPLETED|Overall Study||210
11221252|NCT01965665|12412960|FG000|STARTED|Overall Study||20
11221253|NCT01965665|12412960|FG000|COMPLETED|Overall Study||19
11221254|NCT01965665|12412960|FG000|NOT COMPLETED|Overall Study||1
11221255|NCT01965756|12412966|FG000|STARTED|Overall Study||10
10838115|NCT02786537|12003658|FG001|COMPLETED|As Randomized||582
10838116|NCT02786537|12003659|FG002|COMPLETED|As Randomized||15
10838117|NCT02786537|12003660|FG003|COMPLETED|As Randomized||378
10838118|NCT02786537|12003661|FG004|COMPLETED|As Randomized||87
10838119|NCT02786537|12003662|FG005|COMPLETED|As Randomized||41
10838120|NCT02786537|12003657|FG000|NOT COMPLETED|As Randomized||6
10838121|NCT02786537|12003658|FG001|NOT COMPLETED|As Randomized||62
10838122|NCT02786537|12003659|FG002|NOT COMPLETED|As Randomized||0
11221256|NCT01965756|12412967|FG001|STARTED|Overall Study||10
11221257|NCT01965756|12412966|FG000|COMPLETED|Overall Study||10
11221258|NCT01965756|12412967|FG001|COMPLETED|Overall Study||10
10838123|NCT02786537|12003660|FG003|NOT COMPLETED|As Randomized||35
10838124|NCT02786537|12003661|FG004|NOT COMPLETED|As Randomized||12
10838125|NCT02786537|12003662|FG005|NOT COMPLETED|As Randomized||7
10838126|NCT02786537|12003657|FG000|STARTED|As Treated||56
10838127|NCT02786537|12003658|FG001|STARTED|As Treated||664
10838128|NCT02786537|12003659|FG002|STARTED|As Treated||15
10838129|NCT02786537|12003660|FG003|STARTED|As Treated||394
10838130|NCT02786537|12003661|FG004|STARTED|As Treated||99
10838131|NCT02786537|12003662|FG005|STARTED|As Treated||47
10838132|NCT02786537|12003657|FG000|COMPLETED|As Treated||50
10838133|NCT02786537|12003658|FG001|COMPLETED|As Treated||602
10838134|NCT02786537|12003659|FG002|COMPLETED|As Treated||15
10838135|NCT02786537|12003660|FG003|COMPLETED|As Treated||359
10838136|NCT02786537|12003661|FG004|COMPLETED|As Treated||87
10838137|NCT02786537|12003662|FG005|COMPLETED|As Treated||40
10838138|NCT02786537|12003657|FG000|NOT COMPLETED|As Treated||6
10838139|NCT02786537|12003658|FG001|NOT COMPLETED|As Treated||62
10838140|NCT02786537|12003659|FG002|NOT COMPLETED|As Treated||0
10838141|NCT02786537|12003660|FG003|NOT COMPLETED|As Treated||35
10838142|NCT02786537|12003661|FG004|NOT COMPLETED|As Treated||12
10838143|NCT02786537|12003662|FG005|NOT COMPLETED|As Treated||7
10838144|NCT02740231|12003772|FG000|STARTED|Overall Study||41
10838145|NCT02740231|12003773|FG001|STARTED|Overall Study||41
10838146|NCT02740231|12003774|FG002|STARTED|Overall Study||41
10838147|NCT02740231|12003775|FG003|STARTED|Overall Study||41
10838148|NCT02740231|12003772|FG000|COMPLETED|Overall Study||39
10838149|NCT02740231|12003773|FG001|COMPLETED|Overall Study||35
10838150|NCT02740231|12003774|FG002|COMPLETED|Overall Study||40
10838151|NCT02740231|12003775|FG003|COMPLETED|Overall Study||33
10838152|NCT02740231|12003772|FG000|NOT COMPLETED|Overall Study||2
10838153|NCT02740231|12003773|FG001|NOT COMPLETED|Overall Study||6
10838154|NCT02740231|12003774|FG002|NOT COMPLETED|Overall Study||1
10838155|NCT02740231|12003775|FG003|NOT COMPLETED|Overall Study||8
10838156|NCT02710084|12003787|FG000|STARTED|First Phase - 12 Weeks||10
10838157|NCT02710084|12003788|FG001|STARTED|First Phase - 12 Weeks||8
10838158|NCT02710084|12003787|FG000|COMPLETED|First Phase - 12 Weeks||7
10838159|NCT02710084|12003788|FG001|COMPLETED|First Phase - 12 Weeks||7
10838160|NCT02710084|12003787|FG000|NOT COMPLETED|First Phase - 12 Weeks||3
10838161|NCT02710084|12003788|FG001|NOT COMPLETED|First Phase - 12 Weeks||1
10838162|NCT02710084|12003787|FG000|STARTED|Open Label Phase: Week 12 to 24||7
10838163|NCT02710084|12003788|FG001|STARTED|Open Label Phase: Week 12 to 24||7
10838164|NCT02710084|12003787|FG000|COMPLETED|Open Label Phase: Week 12 to 24||7
10838165|NCT02710084|12003788|FG001|COMPLETED|Open Label Phase: Week 12 to 24||7
10838166|NCT02710084|12003787|FG000|NOT COMPLETED|Open Label Phase: Week 12 to 24||0
10838167|NCT02710084|12003788|FG001|NOT COMPLETED|Open Label Phase: Week 12 to 24||0
10838168|NCT02660034|12003809|FG000|STARTED|Overall Study||12
10838169|NCT02660034|12003810|FG001|STARTED|Overall Study||12
10838170|NCT02660034|12003811|FG002|STARTED|Overall Study||6
10838171|NCT02660034|12003812|FG003|STARTED|Overall Study||13
10838172|NCT02660034|12003813|FG004|STARTED|Overall Study||6
10838173|NCT02660034|12003814|FG005|STARTED|Overall Study||23
10838174|NCT02660034|12003815|FG006|STARTED|Overall Study||23
10838175|NCT02660034|12003816|FG007|STARTED|Overall Study||19
10838176|NCT02660034|12003817|FG008|STARTED|Overall Study||20
10838177|NCT02660034|12003818|FG009|STARTED|Overall Study||23
10838178|NCT02660034|12003819|FG010|STARTED|Overall Study||20
10838179|NCT02660034|12003820|FG011|STARTED|Overall Study||21
10838180|NCT02660034|12003821|FG012|STARTED|Overall Study||21
10838181|NCT02660034|12003822|FG013|STARTED|Overall Study||10
10838182|NCT02660034|12003809|FG000|Received At Least 1 Dose of Study Drug(s)|Overall Study||12
10838183|NCT02660034|12003810|FG001|Received At Least 1 Dose of Study Drug(s)|Overall Study||12
10838184|NCT02660034|12003811|FG002|Received At Least 1 Dose of Study Drug(s)|Overall Study||6
10838185|NCT02660034|12003812|FG003|Received At Least 1 Dose of Study Drug(s)|Overall Study||13
10838186|NCT02660034|12003813|FG004|Received At Least 1 Dose of Study Drug(s)|Overall Study||6
10838187|NCT02660034|12003814|FG005|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
10838188|NCT02660034|12003815|FG006|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
10838189|NCT02660034|12003816|FG007|Received At Least 1 Dose of Study Drug(s)|Overall Study||19
10838190|NCT02660034|12003817|FG008|Received At Least 1 Dose of Study Drug(s)|Overall Study||20
10838191|NCT02660034|12003818|FG009|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
10838192|NCT02660034|12003819|FG010|Received At Least 1 Dose of Study Drug(s)|Overall Study||20
10838193|NCT02660034|12003820|FG011|Received At Least 1 Dose of Study Drug(s)|Overall Study||21
10838194|NCT02660034|12003821|FG012|Received At Least 1 Dose of Study Drug(s)|Overall Study||21
10838195|NCT02660034|12003822|FG013|Received At Least 1 Dose of Study Drug(s)|Overall Study||10
10838196|NCT02660034|12003809|FG000|COMPLETED|Overall Study||0
11221259|NCT01965756|12412966|FG000|NOT COMPLETED|Overall Study||0
10838197|NCT02660034|12003810|FG001|COMPLETED|Overall Study||0
10838198|NCT02660034|12003811|FG002|COMPLETED|Overall Study||0
10838199|NCT02660034|12003812|FG003|COMPLETED|Overall Study||0
10838200|NCT02660034|12003813|FG004|COMPLETED|Overall Study||0
10838201|NCT02660034|12003814|FG005|COMPLETED|Overall Study||0
10838202|NCT02660034|12003815|FG006|COMPLETED|Overall Study||0
10838203|NCT02660034|12003816|FG007|COMPLETED|Overall Study||0
10838204|NCT02660034|12003817|FG008|COMPLETED|Overall Study||0
10838205|NCT02660034|12003818|FG009|COMPLETED|Overall Study||0
10838206|NCT02660034|12003819|FG010|COMPLETED|Overall Study||0
10838207|NCT02660034|12003820|FG011|COMPLETED|Overall Study||0
10838208|NCT02660034|12003821|FG012|COMPLETED|Overall Study||0
11221260|NCT01965756|12412967|FG001|NOT COMPLETED|Overall Study||0
10838209|NCT02660034|12003822|FG013|COMPLETED|Overall Study||0
10838210|NCT02660034|12003809|FG000|NOT COMPLETED|Overall Study||12
10838211|NCT02660034|12003810|FG001|NOT COMPLETED|Overall Study||12
10838212|NCT02660034|12003811|FG002|NOT COMPLETED|Overall Study||6
10838213|NCT02660034|12003812|FG003|NOT COMPLETED|Overall Study||13
10838214|NCT02660034|12003813|FG004|NOT COMPLETED|Overall Study||6
10838215|NCT02660034|12003814|FG005|NOT COMPLETED|Overall Study||23
10838216|NCT02660034|12003815|FG006|NOT COMPLETED|Overall Study||23
10838217|NCT02660034|12003816|FG007|NOT COMPLETED|Overall Study||19
10838218|NCT02660034|12003817|FG008|NOT COMPLETED|Overall Study||20
10838219|NCT02660034|12003818|FG009|NOT COMPLETED|Overall Study||23
10838220|NCT02660034|12003819|FG010|NOT COMPLETED|Overall Study||20
10838221|NCT02660034|12003820|FG011|NOT COMPLETED|Overall Study||21
10838222|NCT02660034|12003821|FG012|NOT COMPLETED|Overall Study||21
10838223|NCT02660034|12003822|FG013|NOT COMPLETED|Overall Study||10
10838224|NCT02640625|12003856|FG000|STARTED|Overall Study||20
10838225|NCT02640625|12003856|FG000|COMPLETED|Overall Study||19
10838226|NCT02640625|12003856|FG000|NOT COMPLETED|Overall Study||1
10838227|NCT02561962|12003870|FG000|STARTED|Overall Study||3
10838228|NCT02561962|12003871|FG001|STARTED|Overall Study||3
10838229|NCT02561962|12003872|FG002|STARTED|Overall Study||3
10838230|NCT02561962|12003873|FG003|STARTED|Overall Study||3
10838231|NCT02561962|12003874|FG004|STARTED|Overall Study||6
10838232|NCT02561962|12003875|FG005|STARTED|Overall Study||6
10838233|NCT02561962|12003876|FG006|STARTED|Overall Study||5
10838234|NCT02561962|12003877|FG007|STARTED|Overall Study||11
10838235|NCT02561962|12003878|FG008|STARTED|Overall Study||2
10838236|NCT02561962|12003870|FG000|Received Treatment|Overall Study||3
10838237|NCT02561962|12003871|FG001|Received Treatment|Overall Study||3
11221261|NCT01965834|12412977|FG000|STARTED|Overall Study||6
11221262|NCT01965834|12412977|FG000|COMPLETED|Overall Study||2
11221263|NCT01965834|12412977|FG000|NOT COMPLETED|Overall Study||4
11354143|NCT03069989|12551340|FG000|COMPLETED|Dosing Period 2 (Up to 16 Days)||2
11354144|NCT03069989|12551341|FG001|COMPLETED|Dosing Period 2 (Up to 16 Days)||5
11354145|NCT03069989|12551340|FG000|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1
11354146|NCT03069989|12551341|FG001|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0
11354147|NCT03070171|12551350|FG000|STARTED|Treatment Period 1 + Washout||80
11354148|NCT03070171|12551351|FG001|STARTED|Treatment Period 1 + Washout||80
11354149|NCT03070171|12551350|FG000|COMPLETED|Treatment Period 1 + Washout||80
11354150|NCT03070171|12551351|FG001|COMPLETED|Treatment Period 1 + Washout||80
11354151|NCT03070171|12551350|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0
11354152|NCT03070171|12551351|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0
11354153|NCT03070171|12551350|FG000|STARTED|Treatment Period 2 + Washout||80
11354154|NCT03070171|12551351|FG001|STARTED|Treatment Period 2 + Washout||80
11354155|NCT03070171|12551350|FG000|COMPLETED|Treatment Period 2 + Washout||80
11354156|NCT03070171|12551351|FG001|COMPLETED|Treatment Period 2 + Washout||79
11354157|NCT03070171|12551350|FG000|NOT COMPLETED|Treatment Period 2 + Washout||0
11354158|NCT03070171|12551351|FG001|NOT COMPLETED|Treatment Period 2 + Washout||1
11354159|NCT03070171|12551350|FG000|STARTED|Treatment Period 3 + Washout||80
11354160|NCT03070171|12551351|FG001|STARTED|Treatment Period 3 + Washout||79
11354161|NCT03070171|12551350|FG000|COMPLETED|Treatment Period 3 + Washout||80
11354162|NCT03070171|12551351|FG001|COMPLETED|Treatment Period 3 + Washout||79
11354163|NCT03070171|12551350|FG000|NOT COMPLETED|Treatment Period 3 + Washout||0
11354164|NCT03070171|12551351|FG001|NOT COMPLETED|Treatment Period 3 + Washout||0
11354165|NCT03070171|12551350|FG000|STARTED|Treatment Period 4 + Washout||80
11354166|NCT03070171|12551351|FG001|STARTED|Treatment Period 4 + Washout||79
11354167|NCT03070171|12551350|FG000|COMPLETED|Treatment Period 4 + Washout||80
11354168|NCT03070171|12551351|FG001|COMPLETED|Treatment Period 4 + Washout||78
11354169|NCT03070171|12551350|FG000|NOT COMPLETED|Treatment Period 4 + Washout||0
11354170|NCT03070171|12551351|FG001|NOT COMPLETED|Treatment Period 4 + Washout||1
11354171|NCT03070431|12551357|FG000|STARTED|Overall Study||44
11354172|NCT03070431|12551357|FG000|COMPLETED|Overall Study||40
11354173|NCT03070431|12551357|FG000|NOT COMPLETED|Overall Study||4
11354174|NCT03070470|12551372|FG000|STARTED|Overall Study||10
11354175|NCT03070470|12551373|FG001|STARTED|Overall Study||10
11354176|NCT03070470|12551374|FG002|STARTED|Overall Study||10
11354177|NCT03070470|12551375|FG003|STARTED|Overall Study||10
10838238|NCT02561962|12003872|FG002|Received Treatment|Overall Study||3
10838239|NCT02561962|12003873|FG003|Received Treatment|Overall Study||3
10838240|NCT02561962|12003874|FG004|Received Treatment|Overall Study||6
10838241|NCT02561962|12003875|FG005|Received Treatment|Overall Study||6
10838242|NCT02561962|12003876|FG006|Received Treatment|Overall Study||5
10838243|NCT02561962|12003877|FG007|Received Treatment|Overall Study||9
10838244|NCT02561962|12003878|FG008|Received Treatment|Overall Study||2
10838245|NCT02561962|12003870|FG000|COMPLETED|Overall Study||1
10838246|NCT02561962|12003871|FG001|COMPLETED|Overall Study||3
10838247|NCT02561962|12003872|FG002|COMPLETED|Overall Study||3
10838248|NCT02561962|12003873|FG003|COMPLETED|Overall Study||2
10838249|NCT02561962|12003874|FG004|COMPLETED|Overall Study||4
11354178|NCT03070470|12551376|FG004|STARTED|Overall Study||10
11354179|NCT03070470|12551377|FG005|STARTED|Overall Study||10
11354180|NCT03070470|12551372|FG000|COMPLETED|Overall Study||10
11354181|NCT03070470|12551373|FG001|COMPLETED|Overall Study||9
11221264|NCT01965860|12412984|FG000|STARTED|Overall Study||11
11221265|NCT01965860|12412985|FG001|STARTED|Overall Study||10
11221266|NCT01965860|12412986|FG002|STARTED|Overall Study||11
11221267|NCT01965860|12412984|FG000|COMPLETED|Overall Study||9
10838250|NCT02561962|12003875|FG005|COMPLETED|Overall Study||2
10838251|NCT02561962|12003876|FG006|COMPLETED|Overall Study||3
10838252|NCT02561962|12003877|FG007|COMPLETED|Overall Study||3
10838253|NCT02561962|12003878|FG008|COMPLETED|Overall Study||1
10838254|NCT02561962|12003870|FG000|NOT COMPLETED|Overall Study||2
10838255|NCT02561962|12003871|FG001|NOT COMPLETED|Overall Study||0
10838256|NCT02561962|12003872|FG002|NOT COMPLETED|Overall Study||0
10838257|NCT02561962|12003873|FG003|NOT COMPLETED|Overall Study||1
10838258|NCT02561962|12003874|FG004|NOT COMPLETED|Overall Study||2
10838259|NCT02561962|12003875|FG005|NOT COMPLETED|Overall Study||4
10838260|NCT02561962|12003876|FG006|NOT COMPLETED|Overall Study||2
10838261|NCT02561962|12003877|FG007|NOT COMPLETED|Overall Study||8
10838262|NCT02561962|12003878|FG008|NOT COMPLETED|Overall Study||1
10838263|NCT02500589|12003900|FG000|STARTED|Overall Study||175
10838264|NCT02500589|12003901|FG001|STARTED|Overall Study||175
10838265|NCT02500589|12003900|FG000|COMPLETED|Overall Study||147
10838266|NCT02500589|12003901|FG001|COMPLETED|Overall Study||143
10838267|NCT02500589|12003900|FG000|NOT COMPLETED|Overall Study||28
10838268|NCT02500589|12003901|FG001|NOT COMPLETED|Overall Study||32
10838269|NCT02474329|12003911|FG000|STARTED|Overall Study|Participants (People with Parkinson's Disease) who signed a consent form.|304
10838270|NCT02474329|12003911|FG000|COMPLETED|Overall Study|Participants (People with Parkinson's Disease) who contributed data for 13 weeks.|291
10838271|NCT02474329|12003911|FG000|NOT COMPLETED|Overall Study||13
10838272|NCT01976273|12003918|FG000|STARTED|Overall Study||10
10838273|NCT01976273|12003919|FG001|STARTED|Overall Study||10
10838274|NCT01976273|12003918|FG000|COMPLETED|Overall Study||9
10838275|NCT01976273|12003919|FG001|COMPLETED|Overall Study||9
10838276|NCT01976273|12003918|FG000|NOT COMPLETED|Overall Study||1
10838277|NCT01976273|12003919|FG001|NOT COMPLETED|Overall Study||1
10838278|NCT01722929|12003925|FG000|STARTED|Overall Study||4
10838279|NCT01722929|12003925|FG000|COMPLETED|Overall Study||4
10838280|NCT01722929|12003925|FG000|NOT COMPLETED|Overall Study||0
10838281|NCT01500733|12003932|FG000|STARTED|Overall Study||35
10838282|NCT01500733|12003933|FG001|STARTED|Overall Study||51
10838283|NCT01500733|12003932|FG000|COMPLETED|Overall Study||33
10838284|NCT01500733|12003933|FG001|COMPLETED|Overall Study||48
10838285|NCT01500733|12003932|FG000|NOT COMPLETED|Overall Study||2
10838286|NCT01500733|12003933|FG001|NOT COMPLETED|Overall Study||3
10838287|NCT01388491|12003941|FG000|STARTED|Overall Study|number randomized|150
10838288|NCT01388491|12003942|FG001|STARTED|Overall Study||143
10838289|NCT01388491|12003941|FG000|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
10838290|NCT01388491|12003942|FG001|Safety Population|Overall Study||142
10838291|NCT01388491|12003941|FG000|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
10838292|NCT01388491|12003942|FG001|Intent-to-Treat (ITT) Population|Overall Study||136
10838293|NCT01388491|12003941|FG000|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
10838294|NCT01388491|12003942|FG001|Per Protocol (PP) Population|Overall Study||121
10838295|NCT01388491|12003941|FG000|COMPLETED|Overall Study||116
10838296|NCT01388491|12003942|FG001|COMPLETED|Overall Study||114
10838297|NCT01388491|12003941|FG000|NOT COMPLETED|Overall Study||34
10838298|NCT01388491|12003942|FG001|NOT COMPLETED|Overall Study||29
10838299|NCT01373151|12003955|FG000|STARTED|Period 1||61
10838300|NCT01373151|12003956|FG001|STARTED|Period 1||59
10838301|NCT01373151|12003957|FG002|STARTED|Period 1||60
10838302|NCT01373151|12003958|FG003|STARTED|Period 1||60
10838303|NCT01373151|12003959|FG004|STARTED|Period 1||59
10838304|NCT01373151|12003960|FG005|STARTED|Period 1||60
10838305|NCT01373151|12003961|FG006|STARTED|Period 1||59
10838306|NCT01373151|12003955|FG000|COMPLETED|Period 1||56
10838307|NCT01373151|12003956|FG001|COMPLETED|Period 1||59
11221268|NCT01965860|12412985|FG001|COMPLETED|Overall Study||10
11221269|NCT01965860|12412986|FG002|COMPLETED|Overall Study||10
11221270|NCT01965860|12412984|FG000|NOT COMPLETED|Overall Study||2
11221271|NCT01965860|12412985|FG001|NOT COMPLETED|Overall Study||0
11221272|NCT01965860|12412986|FG002|NOT COMPLETED|Overall Study||1
11221273|NCT01965899|12412994|FG000|STARTED|Overall Study||151
11221274|NCT01965899|12412994|FG000|COMPLETED|Overall Study||145
11221275|NCT01965899|12412994|FG000|NOT COMPLETED|Overall Study||6
11221276|NCT01965938|12413001|FG000|STARTED|Overall Study||21
11221277|NCT01965938|12413002|FG001|STARTED|Overall Study||20
11221278|NCT01965938|12413001|FG000|COMPLETED|Overall Study||20
11221279|NCT01965938|12413002|FG001|COMPLETED|Overall Study||20
11221280|NCT01965938|12413001|FG000|NOT COMPLETED|Overall Study||1
11221281|NCT01965938|12413002|FG001|NOT COMPLETED|Overall Study||0
11221282|NCT01966003|12413012|FG000|STARTED|Overall Study||328
11221283|NCT01966003|12413013|FG001|STARTED|Overall Study||314
11221284|NCT01966003|12413012|FG000|Received Study Drug|Overall Study||324
11221285|NCT01966003|12413013|FG001|Received Study Drug|Overall Study||309
10838308|NCT01373151|12003957|FG002|COMPLETED|Period 1||56
10838309|NCT01373151|12003958|FG003|COMPLETED|Period 1||59
10838310|NCT01373151|12003959|FG004|COMPLETED|Period 1||54
11221286|NCT01966003|12413012|FG000|COMPLETED|Overall Study||58
11221287|NCT01966003|12413013|FG001|COMPLETED|Overall Study||44
11221288|NCT01966003|12413012|FG000|NOT COMPLETED|Overall Study||270
11221289|NCT01966003|12413013|FG001|NOT COMPLETED|Overall Study||270
11221290|NCT01966042|12413019|FG000|STARTED|Overall Study||13
11221291|NCT01966042|12413019|FG000|COMPLETED|Overall Study||11
11221292|NCT01966042|12413019|FG000|NOT COMPLETED|Overall Study||2
10838311|NCT01373151|12003960|FG005|COMPLETED|Period 1||56
10838312|NCT01373151|12003961|FG006|COMPLETED|Period 1||59
10838313|NCT01373151|12003955|FG000|NOT COMPLETED|Period 1||5
10838314|NCT01373151|12003956|FG001|NOT COMPLETED|Period 1||0
10838315|NCT01373151|12003957|FG002|NOT COMPLETED|Period 1||4
10838316|NCT01373151|12003958|FG003|NOT COMPLETED|Period 1||1
10838317|NCT01373151|12003959|FG004|NOT COMPLETED|Period 1||5
10838318|NCT01373151|12003960|FG005|NOT COMPLETED|Period 1||4
10838319|NCT01373151|12003961|FG006|NOT COMPLETED|Period 1||0
10838320|NCT01373151|12003955|FG000|STARTED|Period 2||56
10838321|NCT01373151|12003956|FG001|STARTED|Period 2||58
10838322|NCT01373151|12003957|FG002|STARTED|Period 2||56
10838323|NCT01373151|12003958|FG003|STARTED|Period 2||59
10838324|NCT01373151|12003959|FG004|STARTED|Period 2||54
10838325|NCT01373151|12003960|FG005|STARTED|Period 2||55
10838326|NCT01373151|12003961|FG006|STARTED|Period 2||59
10838327|NCT01373151|12003955|FG000|COMPLETED|Period 2||47
10838328|NCT01373151|12003956|FG001|COMPLETED|Period 2||57
10838329|NCT01373151|12003957|FG002|COMPLETED|Period 2||52
10838330|NCT01373151|12003958|FG003|COMPLETED|Period 2||54
10838331|NCT01373151|12003959|FG004|COMPLETED|Period 2||52
10838332|NCT01373151|12003960|FG005|COMPLETED|Period 2||55
10838333|NCT01373151|12003961|FG006|COMPLETED|Period 2||54
10838334|NCT01373151|12003955|FG000|NOT COMPLETED|Period 2||9
10838335|NCT01373151|12003956|FG001|NOT COMPLETED|Period 2||1
10838336|NCT01373151|12003957|FG002|NOT COMPLETED|Period 2||4
10838337|NCT01373151|12003958|FG003|NOT COMPLETED|Period 2||5
10838338|NCT01373151|12003959|FG004|NOT COMPLETED|Period 2||2
10838339|NCT01373151|12003960|FG005|NOT COMPLETED|Period 2||0
10838340|NCT01373151|12003961|FG006|NOT COMPLETED|Period 2||5
10838341|NCT01328587|12003977|FG000|STARTED|Overall Study||34
10838342|NCT01328587|12003977|FG000|COMPLETED|Overall Study||34
10838343|NCT01328587|12003977|FG000|NOT COMPLETED|Overall Study||0
10838344|NCT01285947|12003983|FG000|STARTED|Overall Study||10
10838345|NCT01285947|12003984|FG001|STARTED|Overall Study||10
10838346|NCT01285947|12003983|FG000|COMPLETED|Overall Study||10
10838347|NCT01285947|12003984|FG001|COMPLETED|Overall Study||10
10838348|NCT01285947|12003983|FG000|NOT COMPLETED|Overall Study||0
10838349|NCT01285947|12003984|FG001|NOT COMPLETED|Overall Study||0
10838350|NCT01281644|12003990|FG000|STARTED|Overall Study||23
10838351|NCT01281644|12003990|FG000|COMPLETED|Overall Study||18
10838352|NCT01281644|12003990|FG000|NOT COMPLETED|Overall Study||5
10838353|NCT01274611|12003996|FG000|STARTED|Overall Study||20
10838354|NCT01274611|12003996|FG000|COMPLETED|Overall Study||20
10838355|NCT01274611|12003996|FG000|NOT COMPLETED|Overall Study||0
10838356|NCT00960297|12004002|FG000|STARTED|Overall Study||4
10838357|NCT00960297|12004002|FG000|COMPLETED|Overall Study||1
10838358|NCT00960297|12004002|FG000|NOT COMPLETED|Overall Study||3
10838359|NCT00910650|12004006|FG000|STARTED|Overall Study||14
10838360|NCT00910650|12004006|FG000|COMPLETED|Overall Study||12
10838361|NCT00910650|12004006|FG000|NOT COMPLETED|Overall Study||2
10838362|NCT00793169|12004010|FG000|STARTED|Overall Study||19
10838363|NCT00793169|12004010|FG000|COMPLETED|Overall Study||19
10838364|NCT00793169|12004010|FG000|NOT COMPLETED|Overall Study||0
10838365|NCT00703326|12004016|FG000|STARTED|Overall Study||759
10838366|NCT00703326|12004017|FG001|STARTED|Overall Study||385
10838367|NCT00703326|12004016|FG000|Received at Least 1 Dose of Study Drug|Overall Study||752
10838368|NCT00703326|12004017|FG001|Received at Least 1 Dose of Study Drug|Overall Study||382
10838369|NCT00703326|12004016|FG000|COMPLETED|Overall Study||657
10838370|NCT00703326|12004017|FG001|COMPLETED|Overall Study||347
10838371|NCT00703326|12004016|FG000|NOT COMPLETED|Overall Study||102
10838372|NCT00703326|12004017|FG001|NOT COMPLETED|Overall Study||38
10838373|NCT00602667|12004027|FG000|STARTED|Overall Study||57
10838374|NCT00602667|12004028|FG001|STARTED|Overall Study||156
10838375|NCT00602667|12004029|FG002|STARTED|Overall Study||77
10838376|NCT00602667|12004027|FG000|COMPLETED|Overall Study||38
10838377|NCT00602667|12004028|FG001|COMPLETED|Overall Study||75
10838378|NCT00602667|12004029|FG002|COMPLETED|Overall Study||14
10838379|NCT00602667|12004027|FG000|NOT COMPLETED|Overall Study||19
10838380|NCT00602667|12004028|FG001|NOT COMPLETED|Overall Study||81
10838381|NCT00602667|12004029|FG002|NOT COMPLETED|Overall Study||63
10838382|NCT00535990|12004064|FG000|STARTED|Overall Study||250
10838383|NCT00535990|12004064|FG000|COMPLETED|Overall Study||250
10838384|NCT00535990|12004064|FG000|NOT COMPLETED|Overall Study||0
10838385|NCT00472186|12004070|FG000|STARTED|Overall Study||2
10838386|NCT00472186|12004071|FG001|STARTED|Overall Study||0
10838387|NCT00472186|12004070|FG000|COMPLETED|Overall Study||1
10838388|NCT00472186|12004071|FG001|COMPLETED|Overall Study||0
10838389|NCT00472186|12004070|FG000|NOT COMPLETED|Overall Study||1
10838390|NCT00472186|12004071|FG001|NOT COMPLETED|Overall Study||0
11221293|NCT01966068|12413025|FG000|STARTED|Overall Study||294
11221294|NCT01966068|12413025|FG000|Used the MyAsthma Portal at Least Once|Overall Study||237
10838391|NCT03996876|12004081|FG000|STARTED|Overall Study||14
10838392|NCT03996876|12004082|FG001|STARTED|Overall Study||14
10838393|NCT03996876|12004081|FG000|COMPLETED|Overall Study||12
10838394|NCT03996876|12004082|FG001|COMPLETED|Overall Study||10
10838395|NCT03996876|12004081|FG000|NOT COMPLETED|Overall Study||2
10838396|NCT03996876|12004082|FG001|NOT COMPLETED|Overall Study||4
10838471|NCT02740972|12004202|FG002|STARTED|20-week Open Label Treatment Period||0
10838472|NCT02740972|12004203|FG003|STARTED|20-week Open Label Treatment Period||8
10838473|NCT02740972|12004204|FG004|STARTED|20-week Open Label Treatment Period||8
10838474|NCT02740972|12004200|FG000|COMPLETED|20-week Open Label Treatment Period||0
10838475|NCT02740972|12004201|FG001|COMPLETED|20-week Open Label Treatment Period||0
10838476|NCT02740972|12004202|FG002|COMPLETED|20-week Open Label Treatment Period||0
10838477|NCT02740972|12004203|FG003|COMPLETED|20-week Open Label Treatment Period||8
10838478|NCT02740972|12004204|FG004|COMPLETED|20-week Open Label Treatment Period||8
10838479|NCT02740972|12004200|FG000|NOT COMPLETED|20-week Open Label Treatment Period||0
10838480|NCT02740972|12004201|FG001|NOT COMPLETED|20-week Open Label Treatment Period||0
10838481|NCT02740972|12004202|FG002|NOT COMPLETED|20-week Open Label Treatment Period||0
10838482|NCT02740972|12004203|FG003|NOT COMPLETED|20-week Open Label Treatment Period||0
10838483|NCT02740972|12004204|FG004|NOT COMPLETED|20-week Open Label Treatment Period||0
10838484|NCT02662985|12004223|FG000|STARTED|Treatment Period 1||83
10838485|NCT02662985|12004224|FG001|STARTED|Treatment Period 1||83
10838486|NCT02662985|12004223|FG000|COMPLETED|Treatment Period 1||82
10838487|NCT02662985|12004224|FG001|COMPLETED|Treatment Period 1||79
10838488|NCT02662985|12004223|FG000|NOT COMPLETED|Treatment Period 1||1
10838489|NCT02662985|12004224|FG001|NOT COMPLETED|Treatment Period 1||4
10838490|NCT02662985|12004223|FG000|STARTED|Treatment Period 2||82
10838491|NCT02662985|12004224|FG001|STARTED|Treatment Period 2||79
10838492|NCT02662985|12004223|FG000|COMPLETED|Treatment Period 2||81
10838493|NCT02662985|12004224|FG001|COMPLETED|Treatment Period 2||78
10838494|NCT02662985|12004223|FG000|NOT COMPLETED|Treatment Period 2||1
10838495|NCT02662985|12004224|FG001|NOT COMPLETED|Treatment Period 2||1
10838496|NCT02662985|12004223|FG000|STARTED|Treatment Period 3 (Extension Period)||81
10838497|NCT02662985|12004224|FG001|STARTED|Treatment Period 3 (Extension Period)||78
10838498|NCT02662985|12004223|FG000|COMPLETED|Treatment Period 3 (Extension Period)||75
10838499|NCT02662985|12004224|FG001|COMPLETED|Treatment Period 3 (Extension Period)||69
10838500|NCT02662985|12004223|FG000|NOT COMPLETED|Treatment Period 3 (Extension Period)||6
10838501|NCT02662985|12004224|FG001|NOT COMPLETED|Treatment Period 3 (Extension Period)||9
10838502|NCT02606461|12004234|FG000|STARTED|Overall Study||27
10838503|NCT02606461|12004235|FG001|STARTED|Overall Study||30
10838504|NCT02606461|12004236|FG002|STARTED|Overall Study||188
10838505|NCT02606461|12004237|FG003|STARTED|Overall Study||97
10838506|NCT02606461|12004234|FG000|Treated|Overall Study||27
10838507|NCT02606461|12004235|FG001|Treated|Overall Study||30
10838508|NCT02606461|12004236|FG002|Treated|Overall Study||187
10838509|NCT02606461|12004237|FG003|Treated|Overall Study||97
10838510|NCT02606461|12004234|FG000|Open Label|Overall Study||0
10838511|NCT02606461|12004235|FG001|Open Label|Overall Study|Participants in the placebo group who had PD during the Phase 2 double-blinded treatment, switched to open-label selinexor.|24
10838512|NCT02606461|12004236|FG002|Open Label|Overall Study||0
10838513|NCT02606461|12004237|FG003|Open Label|Overall Study|Participants in the placebo group who had PD during the Phase 3 double-blinded treatment, switched to open-label selinexor.|57
10838514|NCT02606461|12004234|FG000|COMPLETED|Overall Study||0
10838515|NCT02606461|12004235|FG001|COMPLETED|Overall Study||0
10838516|NCT02606461|12004236|FG002|COMPLETED|Overall Study||0
10838517|NCT02606461|12004237|FG003|COMPLETED|Overall Study||0
10838518|NCT02606461|12004234|FG000|NOT COMPLETED|Overall Study||27
10838519|NCT02606461|12004235|FG001|NOT COMPLETED|Overall Study||30
10838520|NCT02606461|12004236|FG002|NOT COMPLETED|Overall Study||188
10838521|NCT02606461|12004237|FG003|NOT COMPLETED|Overall Study||97
10838522|NCT02536339|12004250|FG000|STARTED|Overall Study||40
10838523|NCT02536339|12004250|FG000|Received at Least One Dose of Study Drug|Overall Study||39
10838524|NCT02536339|12004250|FG000|Efficacy-Evaluable Population|Overall Study|2 participants did not have post-baseline assessments and were not evaluable for efficacy.|37
10838525|NCT02536339|12004250|FG000|COMPLETED|Overall Study||12
10838526|NCT02536339|12004250|FG000|NOT COMPLETED|Overall Study||28
10838527|NCT02323295|12004256|FG000|STARTED|Overall Study||2
10838528|NCT02323295|12004257|FG001|STARTED|Overall Study||10
10838529|NCT02323295|12004256|FG000|COMPLETED|Overall Study||2
10838530|NCT02323295|12004257|FG001|COMPLETED|Overall Study||7
10838531|NCT02323295|12004256|FG000|NOT COMPLETED|Overall Study||0
10838532|NCT02323295|12004257|FG001|NOT COMPLETED|Overall Study||3
11221295|NCT01966068|12413025|FG000|Use the MyAsthma Portal More Than Once|Overall Study||156
11221296|NCT01966068|12413025|FG000|COMPLETED|Overall Study||156
11221297|NCT01966068|12413025|FG000|NOT COMPLETED|Overall Study||138
11221298|NCT01966107|12413032|FG000|STARTED|Overall Study||1812
11221299|NCT01966107|12413033|FG001|STARTED|Overall Study||1818
10838533|NCT02050308|12004265|FG000|STARTED|Overall Study||127
10838534|NCT02050308|12004266|FG001|STARTED|Overall Study||124
10838535|NCT02050308|12004265|FG000|COMPLETED|Overall Study||28
10838536|NCT02050308|12004266|FG001|COMPLETED|Overall Study||22
10838537|NCT02050308|12004265|FG000|NOT COMPLETED|Overall Study||99
11221300|NCT01966107|12413032|FG000|Full Analysis Set|Overall Study||1791
10838538|NCT02050308|12004266|FG001|NOT COMPLETED|Overall Study||102
10838539|NCT02036970|12004287|FG000|STARTED|Part 1: Day 1 Through Week 16||6
10838540|NCT02036970|12004288|FG001|STARTED|Part 1: Day 1 Through Week 16||12
11221301|NCT01966107|12413033|FG001|Full Analysis Set|Overall Study||1798
10838397|NCT03589976|12004091|FG000|STARTED|Overall Study||35
10838398|NCT03589976|12004092|FG001|STARTED|Overall Study||12
10838399|NCT03589976|12004091|FG000|COMPLETED|Overall Study||16
10838400|NCT03589976|12004092|FG001|COMPLETED|Overall Study||6
10838401|NCT03589976|12004091|FG000|NOT COMPLETED|Overall Study||19
10838402|NCT03589976|12004092|FG001|NOT COMPLETED|Overall Study||6
10838403|NCT03490227|12004098|FG000|STARTED|Overall Study||10
10838404|NCT03490227|12004098|FG000|COMPLETED|Overall Study||10
10838405|NCT03490227|12004098|FG000|NOT COMPLETED|Overall Study||0
10838406|NCT03401190|12004107|FG000|STARTED|Overall Study||8
10838407|NCT03401190|12004108|FG001|STARTED|Overall Study||6
10838408|NCT03401190|12004109|FG002|STARTED|Overall Study||7
10838409|NCT03401190|12004107|FG000|COMPLETED|Overall Study||8
10838410|NCT03401190|12004108|FG001|COMPLETED|Overall Study||4
10838411|NCT03401190|12004109|FG002|COMPLETED|Overall Study||7
10838412|NCT03401190|12004107|FG000|NOT COMPLETED|Overall Study||0
10838413|NCT03401190|12004108|FG001|NOT COMPLETED|Overall Study||2
10838414|NCT03401190|12004109|FG002|NOT COMPLETED|Overall Study||0
11103930|NCT01245673|12288163|FG000|STARTED|Pre Transplant Vaccinations||27
11103931|NCT01245673|12288163|FG000|Pre Transplant Vaccinations 1-3|Pre Transplant Vaccinations||27
11103932|NCT01245673|12288163|FG000|COMPLETED|Pre Transplant Vaccinations||27
11103933|NCT01245673|12288163|FG000|NOT COMPLETED|Pre Transplant Vaccinations||0
11103934|NCT01245673|12288163|FG000|STARTED|Activated/Costimulated Autologous T Cell||27
11103935|NCT01245673|12288163|FG000|COMPLETED|Activated/Costimulated Autologous T Cell||27
10838421|NCT03212963|12004130|FG000|STARTED|Overall Study||16
10838422|NCT03212963|12004130|FG000|COMPLETED|Overall Study||16
10838423|NCT03212963|12004130|FG000|NOT COMPLETED|Overall Study||0
10838424|NCT03135262|12004139|FG000|STARTED|Overall Study||9
10838425|NCT03135262|12004140|FG001|STARTED|Overall Study||6
10838426|NCT03135262|12004141|FG002|STARTED|Overall Study||7
10838427|NCT03135262|12004142|FG003|STARTED|Overall Study||6
10838428|NCT03135262|12004143|FG004|STARTED|Overall Study||1
10838429|NCT03135262|12004139|FG000|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
10838430|NCT03135262|12004140|FG001|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
10838431|NCT03135262|12004141|FG002|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
10838432|NCT03135262|12004142|FG003|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
10838433|NCT03135262|12004143|FG004|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
10838434|NCT03135262|12004139|FG000|NOT COMPLETED|Overall Study||9
10838435|NCT03135262|12004140|FG001|NOT COMPLETED|Overall Study||6
10838436|NCT03135262|12004141|FG002|NOT COMPLETED|Overall Study||7
10838437|NCT03135262|12004142|FG003|NOT COMPLETED|Overall Study||6
10838438|NCT03135262|12004143|FG004|NOT COMPLETED|Overall Study||1
10838439|NCT03104075|12004175|FG000|STARTED|Overall Study||20
10838440|NCT03104075|12004176|FG001|STARTED|Overall Study||20
10838441|NCT03104075|12004175|FG000|COMPLETED|Overall Study||19
10838442|NCT03104075|12004176|FG001|COMPLETED|Overall Study||20
10838443|NCT03104075|12004175|FG000|NOT COMPLETED|Overall Study||1
10838444|NCT03104075|12004176|FG001|NOT COMPLETED|Overall Study||0
10838445|NCT03038087|12004183|FG000|STARTED|Overall Study||10
10838446|NCT03038087|12004183|FG000|COMPLETED|Overall Study||9
10838447|NCT03038087|12004183|FG000|NOT COMPLETED|Overall Study||1
10838448|NCT02880540|12004191|FG000|STARTED|Overall Study||13
10838449|NCT02880540|12004192|FG001|STARTED|Overall Study||13
10838450|NCT02880540|12004191|FG000|COMPLETED|Overall Study||13
10838451|NCT02880540|12004192|FG001|COMPLETED|Overall Study||13
10838452|NCT02880540|12004191|FG000|NOT COMPLETED|Overall Study||0
10838453|NCT02880540|12004192|FG001|NOT COMPLETED|Overall Study||0
10838454|NCT02740972|12004200|FG000|STARTED|4-week Double-blinded Placebo-controlled||5
10838455|NCT02740972|12004201|FG001|STARTED|4-week Double-blinded Placebo-controlled||6
10838456|NCT02740972|12004202|FG002|STARTED|4-week Double-blinded Placebo-controlled||5
10838457|NCT02740972|12004203|FG003|STARTED|4-week Double-blinded Placebo-controlled||0
10838458|NCT02740972|12004204|FG004|STARTED|4-week Double-blinded Placebo-controlled||0
10838459|NCT02740972|12004200|FG000|COMPLETED|4-week Double-blinded Placebo-controlled||5
10838460|NCT02740972|12004201|FG001|COMPLETED|4-week Double-blinded Placebo-controlled||6
10838461|NCT02740972|12004202|FG002|COMPLETED|4-week Double-blinded Placebo-controlled||5
10838462|NCT02740972|12004203|FG003|COMPLETED|4-week Double-blinded Placebo-controlled||0
10838463|NCT02740972|12004204|FG004|COMPLETED|4-week Double-blinded Placebo-controlled||0
10838464|NCT02740972|12004200|FG000|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
10838465|NCT02740972|12004201|FG001|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
10838466|NCT02740972|12004202|FG002|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
11221302|NCT01966107|12413032|FG000|COMPLETED|Overall Study||1010
11221303|NCT01966107|12413033|FG001|COMPLETED|Overall Study||937
11221304|NCT01966107|12413032|FG000|NOT COMPLETED|Overall Study||802
11221305|NCT01966107|12413033|FG001|NOT COMPLETED|Overall Study||881
10838467|NCT02740972|12004203|FG003|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
10838468|NCT02740972|12004204|FG004|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
10838469|NCT02740972|12004200|FG000|STARTED|20-week Open Label Treatment Period||0
10838470|NCT02740972|12004201|FG001|STARTED|20-week Open Label Treatment Period||0
11221306|NCT01966120|12413041|FG000|STARTED|Overall Study||55
10838541|NCT02036970|12004289|FG002|STARTED|Part 1: Day 1 Through Week 16||11
10838542|NCT02036970|12004290|FG003|STARTED|Part 1: Day 1 Through Week 16||12
10838543|NCT02036970|12004291|FG004|STARTED|Part 1: Day 1 Through Week 16||2
10838544|NCT02036970|12004292|FG005|STARTED|Part 1: Day 1 Through Week 16||4
10838545|NCT02036970|12004293|FG006|STARTED|Part 1: Day 1 Through Week 16||3
10838546|NCT02036970|12004294|FG007|STARTED|Part 1: Day 1 Through Week 16||4
10838547|NCT02036970|12004295|FG008|STARTED|Part 1: Day 1 Through Week 16||74
10838548|NCT02036970|12004296|FG009|STARTED|Part 1: Day 1 Through Week 16||38
10838549|NCT02036970|12004287|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
10838550|NCT02036970|12004288|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
10838551|NCT02036970|12004289|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||11
10838552|NCT02036970|12004290|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
10838553|NCT02036970|12004291|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
10838554|NCT02036970|12004292|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
10838555|NCT02036970|12004293|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||3
10838556|NCT02036970|12004294|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
10838557|NCT02036970|12004295|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
10838558|NCT02036970|12004296|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
10838559|NCT02036970|12004287|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10838560|NCT02036970|12004288|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
10838561|NCT02036970|12004289|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10838562|NCT02036970|12004290|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
10838563|NCT02036970|12004291|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10838564|NCT02036970|12004292|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
10838565|NCT02036970|12004293|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10838566|NCT02036970|12004294|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
10838567|NCT02036970|12004295|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10838568|NCT02036970|12004296|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
10838569|NCT02036970|12004287|FG000|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838570|NCT02036970|12004288|FG001|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838571|NCT02036970|12004289|FG002|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838572|NCT02036970|12004290|FG003|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838573|NCT02036970|12004291|FG004|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838574|NCT02036970|12004292|FG005|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838575|NCT02036970|12004293|FG006|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838576|NCT02036970|12004294|FG007|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
10838577|NCT02036970|12004295|FG008|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||14
10838578|NCT02036970|12004296|FG009|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||8
10838579|NCT02036970|12004287|FG000|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10838580|NCT02036970|12004288|FG001|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10838581|NCT02036970|12004289|FG002|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10838582|NCT02036970|12004290|FG003|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
11221307|NCT01966120|12413042|FG001|STARTED|Overall Study||32
11221308|NCT01966120|12413041|FG000|COMPLETED|Overall Study||54
11221309|NCT01966120|12413042|FG001|COMPLETED|Overall Study||26
11221310|NCT01966120|12413041|FG000|NOT COMPLETED|Overall Study||1
11221311|NCT01966120|12413042|FG001|NOT COMPLETED|Overall Study||6
11221312|NCT01966159|12413050|FG000|STARTED|Overall Study||205
11221313|NCT01966159|12413051|FG001|STARTED|Overall Study||207
11221314|NCT01966159|12413050|FG000|COMPLETED|Overall Study||205
11221315|NCT01966159|12413051|FG001|COMPLETED|Overall Study||207
11221316|NCT01966159|12413050|FG000|NOT COMPLETED|Overall Study||0
11221317|NCT01966159|12413051|FG001|NOT COMPLETED|Overall Study||0
11221318|NCT01966354|12413060|FG000|STARTED|Overall Study||75
11221319|NCT01966354|12413061|FG001|STARTED|Overall Study||73
11221320|NCT01966354|12413062|FG002|STARTED|Overall Study||72
11221321|NCT01966354|12413060|FG000|COMPLETED|Overall Study||75
11221322|NCT01966354|12413061|FG001|COMPLETED|Overall Study||73
11221323|NCT01966354|12413062|FG002|COMPLETED|Overall Study||72
11221324|NCT01966354|12413060|FG000|NOT COMPLETED|Overall Study||0
11221325|NCT01966354|12413061|FG001|NOT COMPLETED|Overall Study||0
11221326|NCT01966354|12413062|FG002|NOT COMPLETED|Overall Study||0
11221327|NCT01966380|12413070|FG000|STARTED|Overall Study||3
11221328|NCT01966380|12413071|FG001|STARTED|Overall Study||3
11221329|NCT01966380|12413070|FG000|COMPLETED|Overall Study||3
11221330|NCT01966380|12413071|FG001|COMPLETED|Overall Study||2
10838583|NCT02036970|12004291|FG004|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10838584|NCT02036970|12004292|FG005|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
11221331|NCT01966380|12413070|FG000|NOT COMPLETED|Overall Study||0
11221332|NCT01966380|12413071|FG001|NOT COMPLETED|Overall Study||1
11221333|NCT01966419|12413079|FG000|STARTED|Overall Study||115
11221334|NCT01966419|12413080|FG001|STARTED|Overall Study||116
11221335|NCT01966419|12413079|FG000|Intent to Treat Population (ITT)T)115|Overall Study||115
11354182|NCT03070470|12551374|FG002|COMPLETED|Overall Study||10
10838585|NCT02036970|12004293|FG006|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
11221336|NCT01966419|12413080|FG001|Intent to Treat Population (ITT)T)115|Overall Study||116
10838586|NCT02036970|12004294|FG007|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
10838587|NCT02036970|12004295|FG008|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||16
10838588|NCT02036970|12004296|FG009|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||9
10838589|NCT02036970|12004287|FG000|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838590|NCT02036970|12004288|FG001|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838591|NCT02036970|12004289|FG002|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838592|NCT02036970|12004290|FG003|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838593|NCT02036970|12004291|FG004|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838594|NCT02036970|12004292|FG005|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838595|NCT02036970|12004293|FG006|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838596|NCT02036970|12004294|FG007|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
10838597|NCT02036970|12004295|FG008|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||17
10838598|NCT02036970|12004296|FG009|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||8
11221337|NCT01966419|12413079|FG000|Safety Analysis Set (SAS)|Overall Study||112
11221338|NCT01966419|12413080|FG001|Safety Analysis Set (SAS)|Overall Study||114
11221339|NCT01966419|12413079|FG000|COMPLETED|Overall Study||74
11221340|NCT01966419|12413080|FG001|COMPLETED|Overall Study||80
11221341|NCT01966419|12413079|FG000|NOT COMPLETED|Overall Study||41
11221342|NCT01966419|12413080|FG001|NOT COMPLETED|Overall Study||36
11221343|NCT01966432|12413089|FG000|STARTED|Overall Study||10
11221344|NCT01966432|12413090|FG001|STARTED|Overall Study||34
11221345|NCT01966432|12413091|FG002|STARTED|Overall Study||54
11221346|NCT01966432|12413089|FG000|COMPLETED|Overall Study||5
11221347|NCT01966432|12413090|FG001|COMPLETED|Overall Study||21
11221348|NCT01966432|12413091|FG002|COMPLETED|Overall Study||28
11221349|NCT01966432|12413089|FG000|NOT COMPLETED|Overall Study||5
11221350|NCT01966432|12413090|FG001|NOT COMPLETED|Overall Study||13
11221351|NCT01966432|12413091|FG002|NOT COMPLETED|Overall Study||26
11221352|NCT01966445|12413107|FG000|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1
11221353|NCT01966445|12413108|FG001|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3
11221354|NCT01966445|12413109|FG002|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2
11221355|NCT01966445|12413110|FG003|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
11221356|NCT01966445|12413111|FG004|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4
11221357|NCT01966445|12413112|FG005|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
11221358|NCT01966445|12413113|FG006|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0
11221359|NCT01966445|12413107|FG000|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
11221360|NCT01966445|12413108|FG001|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
11221361|NCT01966445|12413109|FG002|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
11221362|NCT01966445|12413110|FG003|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
11221363|NCT01966445|12413111|FG004|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
11221364|NCT01966445|12413112|FG005|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4
11221365|NCT01966445|12413113|FG006|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
11221366|NCT01966445|12413107|FG000|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
11221367|NCT01966445|12413108|FG001|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
11221368|NCT01966445|12413109|FG002|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
11221369|NCT01966445|12413110|FG003|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
11221370|NCT01966445|12413111|FG004|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
11221371|NCT01966445|12413112|FG005|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
11221372|NCT01966445|12413113|FG006|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
11221373|NCT01966445|12413107|FG000|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
11221374|NCT01966445|12413108|FG001|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
11221375|NCT01966445|12413109|FG002|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
11221376|NCT01966445|12413110|FG003|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
11221377|NCT01966445|12413111|FG004|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
11221378|NCT01966445|12413112|FG005|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
11221379|NCT01966445|12413113|FG006|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9
11221380|NCT01966445|12413107|FG000|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
11221381|NCT01966445|12413108|FG001|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
11221382|NCT01966445|12413109|FG002|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
11221383|NCT01966445|12413110|FG003|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
11221384|NCT01966445|12413111|FG004|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
11221385|NCT01966445|12413112|FG005|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
11221386|NCT01966445|12413113|FG006|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4
11221387|NCT01966445|12413107|FG000|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
11221388|NCT01966445|12413108|FG001|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
11221389|NCT01966445|12413109|FG002|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
11221390|NCT01966445|12413110|FG003|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
11221391|NCT01966445|12413111|FG004|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
11221392|NCT01966445|12413112|FG005|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
11221393|NCT01966445|12413113|FG006|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5
11221394|NCT01966458|12413131|FG000|STARTED|Overall Study||308
11221395|NCT01966458|12413132|FG001|STARTED|Overall Study||157
11221396|NCT01966458|12413131|FG000|COMPLETED|Overall Study||304
11221397|NCT01966458|12413132|FG001|COMPLETED|Overall Study||155
11221398|NCT01966458|12413131|FG000|NOT COMPLETED|Overall Study||4
11221399|NCT01966458|12413132|FG001|NOT COMPLETED|Overall Study||2
11221400|NCT01966718|12413138|FG000|STARTED|Overall Study||8
10838599|NCT02036970|12004287|FG000|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838600|NCT02036970|12004288|FG001|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838601|NCT02036970|12004289|FG002|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838602|NCT02036970|12004290|FG003|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838603|NCT02036970|12004291|FG004|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838604|NCT02036970|12004292|FG005|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838605|NCT02036970|12004293|FG006|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838606|NCT02036970|12004294|FG007|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
10838607|NCT02036970|12004295|FG008|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||6
10838608|NCT02036970|12004296|FG009|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||2
10838609|NCT02036970|12004287|FG000|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838610|NCT02036970|12004288|FG001|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838611|NCT02036970|12004289|FG002|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838612|NCT02036970|12004290|FG003|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838613|NCT02036970|12004291|FG004|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838614|NCT02036970|12004292|FG005|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838615|NCT02036970|12004293|FG006|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838616|NCT02036970|12004294|FG007|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
10838617|NCT02036970|12004295|FG008|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||4
10838618|NCT02036970|12004296|FG009|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||1
10838619|NCT02036970|12004287|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10838620|NCT02036970|12004288|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10838621|NCT02036970|12004289|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
11221401|NCT01966718|12413138|FG000|COMPLETED|Overall Study||8
11221402|NCT01966718|12413138|FG000|NOT COMPLETED|Overall Study||0
11221403|NCT01966770|12413144|FG000|STARTED|Overall Study||20
11221404|NCT01966770|12413144|FG000|COMPLETED|Overall Study||20
11221405|NCT01966770|12413144|FG000|NOT COMPLETED|Overall Study||0
11221406|NCT01966796|12413182|FG000|STARTED|Overall Study||15
11221407|NCT01966796|12413183|FG001|STARTED|Overall Study||51
11221408|NCT01966796|12413184|FG002|STARTED|Overall Study||195
11221409|NCT01966796|12413185|FG003|STARTED|Overall Study||269
11221410|NCT01966796|12413182|FG000|COMPLETED|Overall Study||15
11221411|NCT01966796|12413183|FG001|COMPLETED|Overall Study||51
11221412|NCT01966796|12413184|FG002|COMPLETED|Overall Study||195
11221413|NCT01966796|12413185|FG003|COMPLETED|Overall Study||269
11221414|NCT01966796|12413182|FG000|NOT COMPLETED|Overall Study||0
11221415|NCT01966796|12413183|FG001|NOT COMPLETED|Overall Study||0
11221416|NCT01966796|12413184|FG002|NOT COMPLETED|Overall Study||0
11221417|NCT01966796|12413185|FG003|NOT COMPLETED|Overall Study||0
11221418|NCT01966809|12413199|FG000|STARTED|Overall Study||1
11221419|NCT01966809|12413199|FG000|COMPLETED|Overall Study||1
11221420|NCT01966809|12413199|FG000|NOT COMPLETED|Overall Study||0
11221421|NCT01966900|12413205|FG000|STARTED|Overall Study||8
11221422|NCT01966900|12413206|FG001|STARTED|Overall Study||6
11221423|NCT01966900|12413205|FG000|COMPLETED|Overall Study||6
11221424|NCT01966900|12413206|FG001|COMPLETED|Overall Study||6
11221425|NCT01966900|12413205|FG000|NOT COMPLETED|Overall Study||2
11221426|NCT01966900|12413206|FG001|NOT COMPLETED|Overall Study||0
11221427|NCT01966926|12413214|FG000|STARTED|Overall Study||15
11221428|NCT01966926|12413215|FG001|STARTED|Overall Study||15
11221429|NCT01966926|12413214|FG000|COMPLETED|Overall Study||15
11221430|NCT01966926|12413215|FG001|COMPLETED|Overall Study||15
11221431|NCT01966926|12413214|FG000|NOT COMPLETED|Overall Study||0
11221432|NCT01966926|12413215|FG001|NOT COMPLETED|Overall Study||0
11221433|NCT01966978|12413223|FG000|STARTED|Overall Study||61
11221434|NCT01966978|12413224|FG001|STARTED|Overall Study||59
11221435|NCT01966978|12413223|FG000|COMPLETED|Overall Study||44
11221436|NCT01966978|12413224|FG001|COMPLETED|Overall Study||46
11221437|NCT01966978|12413223|FG000|NOT COMPLETED|Overall Study||17
11221438|NCT01966978|12413224|FG001|NOT COMPLETED|Overall Study||13
11221439|NCT01967069|12413232|FG000|STARTED|Overall Study||182
11221440|NCT01967069|12413233|FG001|STARTED|Overall Study||95
11221441|NCT01967069|12413232|FG000|COMPLETED|Overall Study||174
11221442|NCT01967069|12413233|FG001|COMPLETED|Overall Study||87
11221443|NCT01967069|12413232|FG000|NOT COMPLETED|Overall Study||8
11221444|NCT01967069|12413233|FG001|NOT COMPLETED|Overall Study||8
11221445|NCT01967121|12413242|FG000|STARTED|Overall Study||25
11221446|NCT01967121|12413243|FG001|STARTED|Overall Study||25
11221447|NCT01967121|12413244|FG002|STARTED|Overall Study||25
11221448|NCT01967121|12413242|FG000|COMPLETED|Overall Study||25
11221449|NCT01967121|12413243|FG001|COMPLETED|Overall Study||25
11221450|NCT01967121|12413244|FG002|COMPLETED|Overall Study||25
11221451|NCT01967121|12413242|FG000|NOT COMPLETED|Overall Study||0
11221452|NCT01967121|12413243|FG001|NOT COMPLETED|Overall Study||0
11221453|NCT01967121|12413244|FG002|NOT COMPLETED|Overall Study||0
11221454|NCT01967134|12413255|FG000|STARTED|Overall Study||8
11221455|NCT01967134|12413256|FG001|STARTED|Overall Study||8
11221456|NCT01967134|12413257|FG002|STARTED|Overall Study||9
11221457|NCT01967134|12413255|FG000|COMPLETED|Overall Study||8
11221458|NCT01967134|12413256|FG001|COMPLETED|Overall Study||7
11221459|NCT01967134|12413257|FG002|COMPLETED|Overall Study||9
11221460|NCT01967134|12413255|FG000|NOT COMPLETED|Overall Study||0
11221461|NCT01967134|12413256|FG001|NOT COMPLETED|Overall Study||1
10838622|NCT02036970|12004290|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10838623|NCT02036970|12004291|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10838624|NCT02036970|12004292|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10838625|NCT02036970|12004293|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10838626|NCT02036970|12004294|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
10838627|NCT02036970|12004295|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||17
10838628|NCT02036970|12004296|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||1
10838629|NCT02036970|12004287|FG000|COMPLETED|Part 1: Day 1 Through Week 16||5
10838630|NCT02036970|12004288|FG001|COMPLETED|Part 1: Day 1 Through Week 16||12
10838631|NCT02036970|12004289|FG002|COMPLETED|Part 1: Day 1 Through Week 16||7
10838632|NCT02036970|12004290|FG003|COMPLETED|Part 1: Day 1 Through Week 16||9
10838633|NCT02036970|12004291|FG004|COMPLETED|Part 1: Day 1 Through Week 16||1
10838634|NCT02036970|12004292|FG005|COMPLETED|Part 1: Day 1 Through Week 16||3
10838635|NCT02036970|12004293|FG006|COMPLETED|Part 1: Day 1 Through Week 16||3
10838636|NCT02036970|12004294|FG007|COMPLETED|Part 1: Day 1 Through Week 16||3
10838637|NCT02036970|12004295|FG008|COMPLETED|Part 1: Day 1 Through Week 16||66
10838638|NCT02036970|12004296|FG009|COMPLETED|Part 1: Day 1 Through Week 16||33
10838639|NCT02036970|12004287|FG000|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
10838640|NCT02036970|12004288|FG001|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
10838641|NCT02036970|12004289|FG002|NOT COMPLETED|Part 1: Day 1 Through Week 16||4
10838642|NCT02036970|12004290|FG003|NOT COMPLETED|Part 1: Day 1 Through Week 16||3
10838643|NCT02036970|12004291|FG004|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
10838644|NCT02036970|12004292|FG005|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
10838645|NCT02036970|12004293|FG006|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
10838646|NCT02036970|12004294|FG007|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
10838647|NCT02036970|12004295|FG008|NOT COMPLETED|Part 1: Day 1 Through Week 16||8
10838648|NCT02036970|12004296|FG009|NOT COMPLETED|Part 1: Day 1 Through Week 16||5
10838649|NCT02036970|12004287|FG000|STARTED|Part 2: Week 16 Onwards||5
10838650|NCT02036970|12004288|FG001|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|11
10838651|NCT02036970|12004289|FG002|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|6
10838652|NCT02036970|12004290|FG003|STARTED|Part 2: Week 16 Onwards||9
10838653|NCT02036970|12004291|FG004|STARTED|Part 2: Week 16 Onwards||1
10838654|NCT02036970|12004292|FG005|STARTED|Part 2: Week 16 Onwards||3
10838655|NCT02036970|12004293|FG006|STARTED|Part 2: Week 16 Onwards||3
10838656|NCT02036970|12004294|FG007|STARTED|Part 2: Week 16 Onwards||3
10838657|NCT02036970|12004295|FG008|STARTED|Part 2: Week 16 Onwards|Three patients who completed Part 1 elected not to continue to Part 2.|63
10838658|NCT02036970|12004296|FG009|STARTED|Part 2: Week 16 Onwards||33
10838659|NCT02036970|12004287|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
10838660|NCT02036970|12004288|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
10838661|NCT02036970|12004289|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||6
10838662|NCT02036970|12004290|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
10838663|NCT02036970|12004291|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
11103936|NCT01245673|12288163|FG000|NOT COMPLETED|Activated/Costimulated Autologous T Cell||0
11103937|NCT01245673|12288163|FG000|STARTED|MAGE-A3, Hiltonol®, PVC After T Cells||27
11103938|NCT01245673|12288163|FG000|COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||26
11103939|NCT01245673|12288163|FG000|NOT COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||1
11103940|NCT01245673|12288163|FG000|STARTED|Start Lenalidomide||26
11103941|NCT01245673|12288163|FG000|COMPLETED|Start Lenalidomide||26
10838664|NCT02036970|12004292|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
10838665|NCT02036970|12004293|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||3
10838666|NCT02036970|12004294|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||2
10838667|NCT02036970|12004295|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
10838668|NCT02036970|12004296|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
11103942|NCT01245673|12288163|FG000|NOT COMPLETED|Start Lenalidomide||0
11103943|NCT01245673|12288163|FG000|STARTED|Maintenance: MAGE-A3, PVC After T Cells||26
11103944|NCT01245673|12288163|FG000|COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||26
11103945|NCT01245673|12288163|FG000|NOT COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||0
11103946|NCT01245699|12288169|FG000|STARTED|Overall Study||61
11103947|NCT01245699|12288170|FG001|STARTED|Overall Study||54
11103948|NCT01245699|12288169|FG000|COMPLETED|Overall Study||52
11103949|NCT01245699|12288170|FG001|COMPLETED|Overall Study||49
11103950|NCT01245699|12288169|FG000|NOT COMPLETED|Overall Study||9
11103951|NCT01245699|12288170|FG001|NOT COMPLETED|Overall Study||5
11103952|NCT01245738|12288177|FG000|STARTED|Overall Study||514
11103953|NCT01245738|12288177|FG000|COMPLETED|Overall Study||474
11103954|NCT01245738|12288177|FG000|NOT COMPLETED|Overall Study||40
11103955|NCT01245751|12288185|FG000|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
11103956|NCT01245751|12288186|FG001|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
11103957|NCT01245751|12288187|FG002|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
11103958|NCT01245751|12288188|FG003|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
11103959|NCT01245751|12288185|FG000|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
11221462|NCT01967134|12413257|FG002|NOT COMPLETED|Overall Study||0
11103960|NCT01245751|12288186|FG001|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
11221463|NCT01967147|12413267|FG000|STARTED|Overall Study||112
10838669|NCT02036970|12004287|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10838670|NCT02036970|12004288|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||6
10838671|NCT02036970|12004289|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10838672|NCT02036970|12004290|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||4
10838673|NCT02036970|12004291|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10838674|NCT02036970|12004292|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||2
10838675|NCT02036970|12004293|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10838676|NCT02036970|12004294|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||1
10838677|NCT02036970|12004295|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10838678|NCT02036970|12004296|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
10838679|NCT02036970|12004287|FG000|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838680|NCT02036970|12004288|FG001|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838681|NCT02036970|12004289|FG002|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838682|NCT02036970|12004290|FG003|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838683|NCT02036970|12004291|FG004|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838684|NCT02036970|12004292|FG005|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838685|NCT02036970|12004293|FG006|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838686|NCT02036970|12004294|FG007|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
10838687|NCT02036970|12004295|FG008|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||12
10838688|NCT02036970|12004296|FG009|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||8
10838689|NCT02036970|12004287|FG000|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838690|NCT02036970|12004288|FG001|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838691|NCT02036970|12004289|FG002|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838692|NCT02036970|12004290|FG003|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838693|NCT02036970|12004291|FG004|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838694|NCT02036970|12004292|FG005|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838695|NCT02036970|12004293|FG006|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838696|NCT02036970|12004294|FG007|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
10838697|NCT02036970|12004295|FG008|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||12
10838698|NCT02036970|12004296|FG009|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||7
10838699|NCT02036970|12004287|FG000|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838700|NCT02036970|12004288|FG001|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838701|NCT02036970|12004289|FG002|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838702|NCT02036970|12004290|FG003|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838703|NCT02036970|12004291|FG004|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838704|NCT02036970|12004292|FG005|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838705|NCT02036970|12004293|FG006|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838706|NCT02036970|12004294|FG007|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
10838707|NCT02036970|12004295|FG008|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||16
10838708|NCT02036970|12004296|FG009|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||7
10838709|NCT02036970|12004287|FG000|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838710|NCT02036970|12004288|FG001|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838711|NCT02036970|12004289|FG002|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838712|NCT02036970|12004290|FG003|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838713|NCT02036970|12004291|FG004|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838714|NCT02036970|12004292|FG005|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838715|NCT02036970|12004293|FG006|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838716|NCT02036970|12004294|FG007|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
10838717|NCT02036970|12004295|FG008|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||5
10838718|NCT02036970|12004296|FG009|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||2
10838719|NCT02036970|12004287|FG000|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838720|NCT02036970|12004288|FG001|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838721|NCT02036970|12004289|FG002|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838722|NCT02036970|12004290|FG003|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838723|NCT02036970|12004291|FG004|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838724|NCT02036970|12004292|FG005|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838725|NCT02036970|12004293|FG006|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838726|NCT02036970|12004294|FG007|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
10838727|NCT02036970|12004295|FG008|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||3
10838728|NCT02036970|12004296|FG009|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||1
10838729|NCT02036970|12004287|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838730|NCT02036970|12004288|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838731|NCT02036970|12004289|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838732|NCT02036970|12004290|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838733|NCT02036970|12004291|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838734|NCT02036970|12004292|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838735|NCT02036970|12004293|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838736|NCT02036970|12004294|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
10838737|NCT02036970|12004295|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||15
10838738|NCT02036970|12004296|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||8
10838739|NCT02036970|12004287|FG000|COMPLETED|Part 2: Week 16 Onwards||5
10838740|NCT02036970|12004288|FG001|COMPLETED|Part 2: Week 16 Onwards||6
10838741|NCT02036970|12004289|FG002|COMPLETED|Part 2: Week 16 Onwards||3
10838742|NCT02036970|12004290|FG003|COMPLETED|Part 2: Week 16 Onwards||7
10838743|NCT02036970|12004291|FG004|COMPLETED|Part 2: Week 16 Onwards||0
10838744|NCT02036970|12004292|FG005|COMPLETED|Part 2: Week 16 Onwards||3
10838745|NCT02036970|12004293|FG006|COMPLETED|Part 2: Week 16 Onwards||2
10838746|NCT02036970|12004294|FG007|COMPLETED|Part 2: Week 16 Onwards||2
10838747|NCT02036970|12004295|FG008|COMPLETED|Part 2: Week 16 Onwards||54
10838748|NCT02036970|12004296|FG009|COMPLETED|Part 2: Week 16 Onwards||28
10838749|NCT02036970|12004287|FG000|NOT COMPLETED|Part 2: Week 16 Onwards||0
10838750|NCT02036970|12004288|FG001|NOT COMPLETED|Part 2: Week 16 Onwards||5
10838751|NCT02036970|12004289|FG002|NOT COMPLETED|Part 2: Week 16 Onwards||3
10838752|NCT02036970|12004290|FG003|NOT COMPLETED|Part 2: Week 16 Onwards||2
10838753|NCT02036970|12004291|FG004|NOT COMPLETED|Part 2: Week 16 Onwards||1
10838754|NCT02036970|12004292|FG005|NOT COMPLETED|Part 2: Week 16 Onwards||0
10838755|NCT02036970|12004293|FG006|NOT COMPLETED|Part 2: Week 16 Onwards||1
10838756|NCT02036970|12004294|FG007|NOT COMPLETED|Part 2: Week 16 Onwards||1
10838757|NCT02036970|12004295|FG008|NOT COMPLETED|Part 2: Week 16 Onwards||9
10838758|NCT02036970|12004296|FG009|NOT COMPLETED|Part 2: Week 16 Onwards||5
10838759|NCT01941719|12004330|FG000|STARTED|Overall Study||48
10838760|NCT01941719|12004331|FG001|STARTED|Overall Study||51
10838761|NCT01941719|12004330|FG000|Month 1|Overall Study||43
10838762|NCT01941719|12004331|FG001|Month 1|Overall Study||48
10838763|NCT01941719|12004330|FG000|Month 3|Overall Study||38
10838764|NCT01941719|12004331|FG001|Month 3|Overall Study||44
10838765|NCT01941719|12004330|FG000|Month 6|Overall Study||34
10838766|NCT01941719|12004331|FG001|Month 6|Overall Study||42
10838767|NCT01941719|12004330|FG000|Month 9|Overall Study||29
10838768|NCT01941719|12004331|FG001|Month 9|Overall Study||37
10838769|NCT01941719|12004330|FG000|Month 12|Overall Study||28
10838770|NCT01941719|12004331|FG001|Month 12|Overall Study||32
10838771|NCT01941719|12004330|FG000|COMPLETED|Overall Study||28
10838772|NCT01941719|12004331|FG001|COMPLETED|Overall Study||32
10838773|NCT01941719|12004330|FG000|NOT COMPLETED|Overall Study||20
10838774|NCT01941719|12004331|FG001|NOT COMPLETED|Overall Study||19
10838775|NCT01578967|12004338|FG000|STARTED|Overall Study||41
10838776|NCT01578967|12004338|FG000|COMPLETED|Overall Study||41
10838777|NCT01578967|12004338|FG000|NOT COMPLETED|Overall Study||0
10838778|NCT01186003|12004347|FG000|STARTED|Overall Study||14
10838779|NCT01186003|12004348|FG001|STARTED|Overall Study||16
10838780|NCT01186003|12004347|FG000|COMPLETED|Overall Study||14
10838781|NCT01186003|12004348|FG001|COMPLETED|Overall Study||16
10838782|NCT01186003|12004347|FG000|NOT COMPLETED|Overall Study||0
10838783|NCT01186003|12004348|FG001|NOT COMPLETED|Overall Study||0
10838784|NCT00943618|12004357|FG000|STARTED|Overall Study||163
10838785|NCT00943618|12004358|FG001|STARTED|Overall Study||166
10838786|NCT00943618|12004359|FG002|STARTED|Overall Study||56
10838787|NCT00943618|12004357|FG000|COMPLETED|Overall Study||108
10838788|NCT00943618|12004358|FG001|COMPLETED|Overall Study||89
10838789|NCT00943618|12004359|FG002|COMPLETED|Overall Study||25
10838790|NCT00943618|12004357|FG000|NOT COMPLETED|Overall Study||55
10838791|NCT00943618|12004358|FG001|NOT COMPLETED|Overall Study||77
10838792|NCT00943618|12004359|FG002|NOT COMPLETED|Overall Study||31
11354183|NCT03070470|12551375|FG003|COMPLETED|Overall Study||10
11354184|NCT03070470|12551376|FG004|COMPLETED|Overall Study||10
11354185|NCT03070470|12551377|FG005|COMPLETED|Overall Study||8
11354186|NCT03070470|12551372|FG000|NOT COMPLETED|Overall Study||0
11354187|NCT03070470|12551373|FG001|NOT COMPLETED|Overall Study||1
10838793|NCT03938272|12004369|FG000|STARTED|Overall Study||11
10838794|NCT03938272|12004370|FG001|STARTED|Overall Study||11
10838795|NCT03938272|12004369|FG000|COMPLETED|Overall Study||0
10838796|NCT03938272|12004370|FG001|COMPLETED|Overall Study||1
10838797|NCT03938272|12004369|FG000|NOT COMPLETED|Overall Study||11
10838798|NCT03938272|12004370|FG001|NOT COMPLETED|Overall Study||10
10838799|NCT03641339|12004382|FG000|STARTED|Overall Study||16
10838800|NCT03641339|12004383|FG001|STARTED|Overall Study||17
10838801|NCT03641339|12004384|FG002|STARTED|Overall Study||15
10838802|NCT03641339|12004385|FG003|STARTED|Overall Study||16
10838803|NCT03641339|12004386|FG004|STARTED|Overall Study||15
10838804|NCT03641339|12004387|FG005|STARTED|Overall Study||16
10838805|NCT03641339|12004382|FG000|COMPLETED|Overall Study||15
10838806|NCT03641339|12004383|FG001|COMPLETED|Overall Study||15
10838807|NCT03641339|12004384|FG002|COMPLETED|Overall Study||15
10838808|NCT03641339|12004385|FG003|COMPLETED|Overall Study||14
10838809|NCT03641339|12004386|FG004|COMPLETED|Overall Study||15
10838810|NCT03641339|12004387|FG005|COMPLETED|Overall Study||15
10838811|NCT03641339|12004382|FG000|NOT COMPLETED|Overall Study||1
10838812|NCT03641339|12004383|FG001|NOT COMPLETED|Overall Study||2
10838813|NCT03641339|12004384|FG002|NOT COMPLETED|Overall Study||0
10838814|NCT03641339|12004385|FG003|NOT COMPLETED|Overall Study||2
10838815|NCT03641339|12004386|FG004|NOT COMPLETED|Overall Study||0
10838816|NCT03641339|12004387|FG005|NOT COMPLETED|Overall Study||1
10838817|NCT03625466|12004403|FG000|STARTED|Overall Study||16
10838818|NCT03625466|12004404|FG001|STARTED|Overall Study||35
10838819|NCT03625466|12004403|FG000|COMPLETED|Overall Study||16
10838820|NCT03625466|12004404|FG001|COMPLETED|Overall Study||33
10838821|NCT03625466|12004403|FG000|NOT COMPLETED|Overall Study||0
10838822|NCT03625466|12004404|FG001|NOT COMPLETED|Overall Study||2
10838823|NCT03317795|12004412|FG000|STARTED|Overall Study||9
10838824|NCT03317795|12004413|FG001|STARTED|Overall Study||9
10838825|NCT03317795|12004412|FG000|COMPLETED|Overall Study||7
10838826|NCT03317795|12004413|FG001|COMPLETED|Overall Study||2
10838827|NCT03317795|12004412|FG000|NOT COMPLETED|Overall Study||2
10838828|NCT03317795|12004413|FG001|NOT COMPLETED|Overall Study||7
10838829|NCT03287245|12004423|FG000|STARTED|Overall Study||15
11354188|NCT03070470|12551374|FG002|NOT COMPLETED|Overall Study||0
10838830|NCT03287245|12004424|FG001|STARTED|Overall Study||5
10838831|NCT03287245|12004425|FG002|STARTED|Overall Study||6
10838832|NCT03287245|12004426|FG003|STARTED|Overall Study||1
10838833|NCT03287245|12004423|FG000|COMPLETED|Overall Study||0
10838834|NCT03287245|12004424|FG001|COMPLETED|Overall Study||0
10838835|NCT03287245|12004425|FG002|COMPLETED|Overall Study||0
10838836|NCT03287245|12004426|FG003|COMPLETED|Overall Study||0
10838837|NCT03287245|12004423|FG000|NOT COMPLETED|Overall Study||15
10838838|NCT03287245|12004424|FG001|NOT COMPLETED|Overall Study||5
10838839|NCT03287245|12004425|FG002|NOT COMPLETED|Overall Study||6
10838840|NCT03287245|12004426|FG003|NOT COMPLETED|Overall Study||1
10838841|NCT03165916|12004458|FG000|STARTED|Overall Study||58
10838842|NCT03165916|12004459|FG001|STARTED|Overall Study||57
10838843|NCT03165916|12004458|FG000|Reconstruction Interventions|Overall Study||59
10838844|NCT03165916|12004459|FG001|Reconstruction Interventions|Overall Study||57
10838845|NCT03165916|12004458|FG000|COMPLETED|Overall Study||58
10838846|NCT03165916|12004459|FG001|COMPLETED|Overall Study||57
10838847|NCT03165916|12004458|FG000|NOT COMPLETED|Overall Study||0
10838848|NCT03165916|12004459|FG001|NOT COMPLETED|Overall Study||0
10838849|NCT03092219|12004467|FG000|STARTED|Overall Study||150
10838850|NCT03092219|12004468|FG001|STARTED|Overall Study||52
10838851|NCT03092219|12004467|FG000|Baseline / ITT Population|Overall Study||150
10838852|NCT03092219|12004468|FG001|Baseline / ITT Population|Overall Study|Subject randomized to No Treatment group but received treatment at Visit 1.|51
10838853|NCT03092219|12004467|FG000|Primary Analysis Endpoint|Overall Study||150
10838854|NCT03092219|12004468|FG001|Primary Analysis Endpoint|Overall Study||51
10838855|NCT03092219|12004467|FG000|Pooled SAFT Population|Overall Study||150
10838856|NCT03092219|12004468|FG001|Pooled SAFT Population|Overall Study|2 subjects did not receive treatment at Visit 1b.|50
10838857|NCT03092219|12004467|FG000|COMPLETED|Overall Study||143
10838858|NCT03092219|12004468|FG001|COMPLETED|Overall Study||48
10838859|NCT03092219|12004467|FG000|NOT COMPLETED|Overall Study||7
10838860|NCT03092219|12004468|FG001|NOT COMPLETED|Overall Study||4
10838861|NCT03033069|12004481|FG000|STARTED|Overall Study||82
10838862|NCT03033069|12004482|FG001|STARTED|Overall Study||75
10838863|NCT03033069|12004483|FG002|STARTED|Overall Study||81
10838864|NCT03033069|12004484|FG003|STARTED|Overall Study||83
10838865|NCT03033069|12004481|FG000|Safety Sample|Overall Study||80
10838866|NCT03033069|12004482|FG001|Safety Sample|Overall Study||75
10838867|NCT03033069|12004483|FG002|Safety Sample|Overall Study||79
11221464|NCT01967147|12413268|FG001|STARTED|Overall Study||102
10838868|NCT03033069|12004484|FG003|Safety Sample|Overall Study||82
10838869|NCT03033069|12004481|FG000|Intent to Treat (ITT) Sample|Overall Study||79
10838870|NCT03033069|12004482|FG001|Intent to Treat (ITT) Sample|Overall Study||72
10838871|NCT03033069|12004483|FG002|Intent to Treat (ITT) Sample|Overall Study||77
10838872|NCT03033069|12004484|FG003|Intent to Treat (ITT) Sample|Overall Study||80
10838873|NCT03033069|12004481|FG000|COMPLETED|Overall Study||58
11221465|NCT01967147|12413267|FG000|COMPLETED|Overall Study||99
10838874|NCT03033069|12004482|FG001|COMPLETED|Overall Study||50
10838875|NCT03033069|12004483|FG002|COMPLETED|Overall Study||59
10838876|NCT03033069|12004484|FG003|COMPLETED|Overall Study||64
10838877|NCT03033069|12004481|FG000|NOT COMPLETED|Overall Study||24
10838878|NCT03033069|12004482|FG001|NOT COMPLETED|Overall Study||25
10838879|NCT03033069|12004483|FG002|NOT COMPLETED|Overall Study||22
10838880|NCT03033069|12004484|FG003|NOT COMPLETED|Overall Study||19
10838881|NCT02956434|12004498|FG000|STARTED|Overall Study||10
10838882|NCT02956434|12004499|FG001|STARTED|Overall Study||10
10838883|NCT02956434|12004500|FG002|STARTED|Overall Study||10
10838884|NCT02956434|12004501|FG003|STARTED|Overall Study||10
10838885|NCT02956434|12004498|FG000|COMPLETED|Overall Study||10
10838886|NCT02956434|12004499|FG001|COMPLETED|Overall Study||10
10838887|NCT02956434|12004500|FG002|COMPLETED|Overall Study||10
10838888|NCT02956434|12004501|FG003|COMPLETED|Overall Study||10
10838889|NCT02956434|12004498|FG000|NOT COMPLETED|Overall Study||0
10838890|NCT02956434|12004499|FG001|NOT COMPLETED|Overall Study||0
10838891|NCT02956434|12004500|FG002|NOT COMPLETED|Overall Study||0
10838892|NCT02956434|12004501|FG003|NOT COMPLETED|Overall Study||0
10838893|NCT02609503|12004509|FG000|STARTED|Overall Study||29
10838894|NCT02609503|12004509|FG000|COMPLETED|Overall Study||25
10838895|NCT02609503|12004509|FG000|NOT COMPLETED|Overall Study||4
10838896|NCT02587598|12004527|FG000|STARTED|Overall Study||4
10838897|NCT02587598|12004528|FG001|STARTED|Overall Study||11
10838898|NCT02587598|12004529|FG002|STARTED|Overall Study||4
10838899|NCT02587598|12004530|FG003|STARTED|Overall Study||21
10838900|NCT02587598|12004531|FG004|STARTED|Overall Study||12
10838901|NCT02587598|12004532|FG005|STARTED|Overall Study||6
10838902|NCT02587598|12004533|FG006|STARTED|Overall Study||6
10838903|NCT02587598|12004534|FG007|STARTED|Overall Study||7
10838904|NCT02587598|12004535|FG008|STARTED|Overall Study||9
10838905|NCT02587598|12004536|FG009|STARTED|Overall Study||3
10838906|NCT02587598|12004537|FG010|STARTED|Overall Study||14
10838907|NCT02587598|12004527|FG000|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838908|NCT02587598|12004528|FG001|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838909|NCT02587598|12004529|FG002|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838910|NCT02587598|12004530|FG003|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838911|NCT02587598|12004531|FG004|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838912|NCT02587598|12004532|FG005|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838913|NCT02587598|12004533|FG006|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838914|NCT02587598|12004534|FG007|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838915|NCT02587598|12004535|FG008|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838916|NCT02587598|12004536|FG009|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838917|NCT02587598|12004537|FG010|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
10838918|NCT02587598|12004527|FG000|NOT COMPLETED|Overall Study||4
10838919|NCT02587598|12004528|FG001|NOT COMPLETED|Overall Study||11
10838920|NCT02587598|12004529|FG002|NOT COMPLETED|Overall Study||4
10838921|NCT02587598|12004530|FG003|NOT COMPLETED|Overall Study||21
10838922|NCT02587598|12004531|FG004|NOT COMPLETED|Overall Study||12
10838923|NCT02587598|12004532|FG005|NOT COMPLETED|Overall Study||6
10838924|NCT02587598|12004533|FG006|NOT COMPLETED|Overall Study||6
10838925|NCT02587598|12004534|FG007|NOT COMPLETED|Overall Study||7
10838926|NCT02587598|12004535|FG008|NOT COMPLETED|Overall Study||9
10838927|NCT02587598|12004536|FG009|NOT COMPLETED|Overall Study||3
10838928|NCT02587598|12004537|FG010|NOT COMPLETED|Overall Study||14
10838929|NCT02485574|12004573|FG000|STARTED|Overall Study||69
10838930|NCT02485574|12004573|FG000|COMPLETED|Overall Study||65
10838931|NCT02485574|12004573|FG000|NOT COMPLETED|Overall Study||4
10838941|NCT01899261|12004599|FG000|STARTED|Overall Study||20
10838942|NCT01899261|12004599|FG000|COMPLETED|Overall Study||20
10838943|NCT01899261|12004599|FG000|NOT COMPLETED|Overall Study||0
10838944|NCT01595503|12004603|FG000|STARTED|Overall Study||5
10838945|NCT01595503|12004603|FG000|COMPLETED|Overall Study||5
10838946|NCT01595503|12004603|FG000|NOT COMPLETED|Overall Study||0
10838947|NCT01460160|12004607|FG000|STARTED|Treatment Phase||106
10838948|NCT01460160|12004607|FG000|COMPLETED|Treatment Phase||78
10838949|NCT01460160|12004607|FG000|NOT COMPLETED|Treatment Phase||28
10838950|NCT01460160|12004607|FG000|STARTED|Follow-up Phase|Some of the participants who did not completed the Treatment Phase were still moved to the Follow-up Phase|100
10838951|NCT01460160|12004607|FG000|COMPLETED|Follow-up Phase||0
11221466|NCT01967147|12413268|FG001|COMPLETED|Overall Study||82
11221467|NCT01967147|12413267|FG000|NOT COMPLETED|Overall Study||13
11221468|NCT01967147|12413268|FG001|NOT COMPLETED|Overall Study||20
11221469|NCT01967173|12413283|FG000|STARTED|Overall Study||69
11221470|NCT01967173|12413284|FG001|STARTED|Overall Study||69
11221471|NCT01967173|12413285|FG002|STARTED|Overall Study||71
11221472|NCT01967173|12413286|FG003|STARTED|Overall Study||71
11221473|NCT01967173|12413287|FG004|STARTED|Overall Study||73
11221474|NCT01967173|12413288|FG005|STARTED|Overall Study||72
11221475|NCT01967173|12413289|FG006|STARTED|Overall Study||75
11221476|NCT01967173|12413290|FG007|STARTED|Overall Study||74
11221477|NCT01967173|12413283|FG000|Completed 1st Period|Overall Study||58
11221478|NCT01967173|12413284|FG001|Completed 1st Period|Overall Study||60
11221479|NCT01967173|12413285|FG002|Completed 1st Period|Overall Study||67
11221480|NCT01967173|12413286|FG003|Completed 1st Period|Overall Study||65
11221481|NCT01967173|12413287|FG004|Completed 1st Period|Overall Study||64
11221482|NCT01967173|12413288|FG005|Completed 1st Period|Overall Study||62
11221483|NCT01967173|12413289|FG006|Completed 1st Period|Overall Study||67
11221484|NCT01967173|12413290|FG007|Completed 1st Period|Overall Study||69
11221485|NCT01967173|12413283|FG000|Completed 2nd Period|Overall Study||52
11221486|NCT01967173|12413284|FG001|Completed 2nd Period|Overall Study||58
11221487|NCT01967173|12413285|FG002|Completed 2nd Period|Overall Study||63
11221488|NCT01967173|12413286|FG003|Completed 2nd Period|Overall Study||62
11221489|NCT01967173|12413287|FG004|Completed 2nd Period|Overall Study||63
11221490|NCT01967173|12413288|FG005|Completed 2nd Period|Overall Study||57
11221491|NCT01967173|12413289|FG006|Completed 2nd Period|Overall Study||63
11221492|NCT01967173|12413290|FG007|Completed 2nd Period|Overall Study||61
11221493|NCT01967173|12413283|FG000|Completed 3rd Period|Overall Study||48
11221494|NCT01967173|12413284|FG001|Completed 3rd Period|Overall Study||54
11221495|NCT01967173|12413285|FG002|Completed 3rd Period|Overall Study||60
11221496|NCT01967173|12413286|FG003|Completed 3rd Period|Overall Study||61
11221497|NCT01967173|12413287|FG004|Completed 3rd Period|Overall Study||59
11221498|NCT01967173|12413288|FG005|Completed 3rd Period|Overall Study||56
11221499|NCT01967173|12413289|FG006|Completed 3rd Period|Overall Study||59
11221500|NCT01967173|12413290|FG007|Completed 3rd Period|Overall Study||56
11221501|NCT01967173|12413283|FG000|Completed 4th Period|Overall Study||45
11221502|NCT01967173|12413284|FG001|Completed 4th Period|Overall Study||52
11221503|NCT01967173|12413285|FG002|Completed 4th Period|Overall Study||55
11221504|NCT01967173|12413286|FG003|Completed 4th Period|Overall Study||57
11221505|NCT01967173|12413287|FG004|Completed 4th Period|Overall Study||56
11221506|NCT01967173|12413288|FG005|Completed 4th Period|Overall Study||49
11221507|NCT01967173|12413289|FG006|Completed 4th Period|Overall Study||57
11221508|NCT01967173|12413290|FG007|Completed 4th Period|Overall Study||50
11221509|NCT01967173|12413283|FG000|COMPLETED|Overall Study||45
11221510|NCT01967173|12413284|FG001|COMPLETED|Overall Study||52
11221511|NCT01967173|12413285|FG002|COMPLETED|Overall Study||55
11221512|NCT01967173|12413286|FG003|COMPLETED|Overall Study||57
11221513|NCT01967173|12413287|FG004|COMPLETED|Overall Study||56
11221514|NCT01967173|12413288|FG005|COMPLETED|Overall Study||49
11221515|NCT01967173|12413289|FG006|COMPLETED|Overall Study||57
11221516|NCT01967173|12413290|FG007|COMPLETED|Overall Study||50
11221517|NCT01967173|12413283|FG000|NOT COMPLETED|Overall Study||24
11221518|NCT01967173|12413284|FG001|NOT COMPLETED|Overall Study||17
11221519|NCT01967173|12413285|FG002|NOT COMPLETED|Overall Study||16
11221520|NCT01967173|12413286|FG003|NOT COMPLETED|Overall Study||14
11221521|NCT01967173|12413287|FG004|NOT COMPLETED|Overall Study||17
11221522|NCT01967173|12413288|FG005|NOT COMPLETED|Overall Study||23
11221523|NCT01967173|12413289|FG006|NOT COMPLETED|Overall Study||18
11221524|NCT01967173|12413290|FG007|NOT COMPLETED|Overall Study||24
11221525|NCT01967225|12413306|FG000|STARTED|Overall Study||84
11221526|NCT01967225|12413307|FG001|STARTED|Overall Study||41
10838952|NCT01460160|12004607|FG000|NOT COMPLETED|Follow-up Phase||100
11221527|NCT01967225|12413306|FG000|Participants Received Treatment|Overall Study||83
11221528|NCT01967225|12413307|FG001|Participants Received Treatment|Overall Study||41
11221529|NCT01967225|12413306|FG000|COMPLETED|Overall Study||72
11221530|NCT01967225|12413307|FG001|COMPLETED|Overall Study||38
11221531|NCT01967225|12413306|FG000|NOT COMPLETED|Overall Study||12
11221532|NCT01967225|12413307|FG001|NOT COMPLETED|Overall Study||3
11221533|NCT01967277|12413317|FG000|STARTED|Overall Study||22
11221534|NCT01967277|12413318|FG001|STARTED|Overall Study||22
11221535|NCT01967277|12413317|FG000|COMPLETED|Overall Study||21
11221536|NCT01967277|12413318|FG001|COMPLETED|Overall Study||19
11221537|NCT01967277|12413317|FG000|NOT COMPLETED|Overall Study||1
11221538|NCT01967277|12413318|FG001|NOT COMPLETED|Overall Study||3
11221539|NCT01967342|12413327|FG000|STARTED|Overall Study||98
10838953|NCT01170702|12004615|FG000|STARTED|Overall Study||34
10838954|NCT01170702|12004616|FG001|STARTED|Overall Study||32
10838955|NCT01170702|12004617|FG002|STARTED|Overall Study||25
10838956|NCT01170702|12004618|FG003|STARTED|Overall Study||29
10838957|NCT01170702|12004615|FG000|COMPLETED|Overall Study||33
10838958|NCT01170702|12004616|FG001|COMPLETED|Overall Study||30
10838959|NCT01170702|12004617|FG002|COMPLETED|Overall Study||25
10838960|NCT01170702|12004618|FG003|COMPLETED|Overall Study||27
10838961|NCT01170702|12004615|FG000|NOT COMPLETED|Overall Study||1
10838962|NCT01170702|12004616|FG001|NOT COMPLETED|Overall Study||2
10838963|NCT01170702|12004617|FG002|NOT COMPLETED|Overall Study||0
10838964|NCT01170702|12004618|FG003|NOT COMPLETED|Overall Study||2
10838965|NCT01018563|12004628|FG000|STARTED|Overall Study||2
10838966|NCT01018563|12004629|FG001|STARTED|Overall Study||1
10838967|NCT01018563|12004628|FG000|COMPLETED|Overall Study||0
10838968|NCT01018563|12004629|FG001|COMPLETED|Overall Study||0
10838969|NCT01018563|12004628|FG000|NOT COMPLETED|Overall Study||2
10838970|NCT01018563|12004629|FG001|NOT COMPLETED|Overall Study||1
10838971|NCT00805961|12004639|FG000|STARTED|Modality Therapy||68
10838972|NCT00805961|12004639|FG000|COMPLETED|Modality Therapy||64
10838973|NCT00805961|12004639|FG000|NOT COMPLETED|Modality Therapy||4
10838974|NCT00805961|12004639|FG000|STARTED|Treatment-Free Interval||64
10838975|NCT00805961|12004639|FG000|COMPLETED|Treatment-Free Interval||57
10838976|NCT00805961|12004639|FG000|NOT COMPLETED|Treatment-Free Interval||7
10838977|NCT00805961|12004639|FG000|STARTED|Maintenance Treatment||57
10838978|NCT00805961|12004639|FG000|COMPLETED|Maintenance Treatment||23
10838979|NCT00805961|12004639|FG000|NOT COMPLETED|Maintenance Treatment||34
10838980|NCT04056182|12004643|FG000|STARTED|Overall Study||20
10838981|NCT04056182|12004643|FG000|COMPLETED|Overall Study||3
10838982|NCT04056182|12004643|FG000|NOT COMPLETED|Overall Study||17
10838983|NCT03954106|12004649|FG000|STARTED|Part 1: Safety Lead In Phase||4
10838984|NCT03954106|12004650|FG001|STARTED|Part 1: Safety Lead In Phase||0
10838985|NCT03954106|12004649|FG000|COMPLETED|Part 1: Safety Lead In Phase||4
10838986|NCT03954106|12004650|FG001|COMPLETED|Part 1: Safety Lead In Phase||0
10838987|NCT03954106|12004649|FG000|NOT COMPLETED|Part 1: Safety Lead In Phase||0
10838988|NCT03954106|12004650|FG001|NOT COMPLETED|Part 1: Safety Lead In Phase||0
10838989|NCT03954106|12004649|FG000|STARTED|Phase 2: Treatment at RP2D||0
10838990|NCT03954106|12004650|FG001|STARTED|Phase 2: Treatment at RP2D||21
10838991|NCT03954106|12004649|FG000|COMPLETED|Phase 2: Treatment at RP2D||0
10838992|NCT03954106|12004650|FG001|COMPLETED|Phase 2: Treatment at RP2D||21
10838993|NCT03954106|12004649|FG000|NOT COMPLETED|Phase 2: Treatment at RP2D||0
10838994|NCT03954106|12004650|FG001|NOT COMPLETED|Phase 2: Treatment at RP2D||0
10838995|NCT03921424|12004660|FG000|STARTED|Overall Study||203
10838996|NCT03921424|12004661|FG001|STARTED|Overall Study||204
10838997|NCT03921424|12004660|FG000|Vaccination 1 - (Day 1)|Overall Study||203
10838998|NCT03921424|12004661|FG001|Vaccination 1 - (Day 1)|Overall Study||204
10838999|NCT03921424|12004660|FG000|Vaccination 2 - (Week 8)|Overall Study||203
10839000|NCT03921424|12004661|FG001|Vaccination 2 - (Week 8)|Overall Study|Two participants did not receive Vaccination 2.|202
10839001|NCT03921424|12004660|FG000|COMPLETED|Overall Study||203
10839002|NCT03921424|12004661|FG001|COMPLETED|Overall Study||201
10839003|NCT03921424|12004660|FG000|NOT COMPLETED|Overall Study||0
10839004|NCT03921424|12004661|FG001|NOT COMPLETED|Overall Study||3
10839005|NCT03598777|12004674|FG000|STARTED|Overall Study||13
10839006|NCT03598777|12004675|FG001|STARTED|Overall Study||8
10839007|NCT03598777|12004676|FG002|STARTED|Overall Study||8
10839008|NCT03598777|12004677|FG003|STARTED|Overall Study||14
10839009|NCT03598777|12004678|FG004|STARTED|Overall Study||17
10839010|NCT03598777|12004674|FG000|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||13
10839011|NCT03598777|12004675|FG001|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8
10839012|NCT03598777|12004676|FG002|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8
10839013|NCT03598777|12004677|FG003|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||14
10839014|NCT03598777|12004678|FG004|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||17
10839015|NCT03598777|12004674|FG000|Retreated in Cycle 2 OL Treatment Period|Overall Study||13
11221540|NCT01967342|12413328|FG001|STARTED|Overall Study||95
11221541|NCT01967342|12413329|FG002|STARTED|Overall Study||97
10839016|NCT03598777|12004675|FG001|Retreated in Cycle 2 OL Treatment Period|Overall Study||7
10839017|NCT03598777|12004676|FG002|Retreated in Cycle 2 OL Treatment Period|Overall Study||8
10839018|NCT03598777|12004677|FG003|Retreated in Cycle 2 OL Treatment Period|Overall Study||13
10839019|NCT03598777|12004678|FG004|Retreated in Cycle 2 OL Treatment Period|Overall Study||11
10839020|NCT03598777|12004674|FG000|Retreated in Cycle 3 OL Treatment Period|Overall Study||8
10839021|NCT03598777|12004675|FG001|Retreated in Cycle 3 OL Treatment Period|Overall Study||6
10839022|NCT03598777|12004676|FG002|Retreated in Cycle 3 OL Treatment Period|Overall Study||6
10839023|NCT03598777|12004677|FG003|Retreated in Cycle 3 OL Treatment Period|Overall Study||12
10839024|NCT03598777|12004678|FG004|Retreated in Cycle 3 OL Treatment Period|Overall Study||2
10839025|NCT03598777|12004674|FG000|Retreated in Cycle 4 OL Treatment Period|Overall Study||1
10839026|NCT03598777|12004675|FG001|Retreated in Cycle 4 OL Treatment Period|Overall Study||0
10839027|NCT03598777|12004676|FG002|Retreated in Cycle 4 OL Treatment Period|Overall Study||1
10839028|NCT03598777|12004677|FG003|Retreated in Cycle 4 OL Treatment Period|Overall Study||3
10839029|NCT03598777|12004678|FG004|Retreated in Cycle 4 OL Treatment Period|Overall Study||0
10839030|NCT03598777|12004674|FG000|COMPLETED|Overall Study||7
10839031|NCT03598777|12004675|FG001|COMPLETED|Overall Study||7
10839032|NCT03598777|12004676|FG002|COMPLETED|Overall Study||8
10839033|NCT03598777|12004677|FG003|COMPLETED|Overall Study||14
10839034|NCT03598777|12004678|FG004|COMPLETED|Overall Study||2
10839035|NCT03598777|12004674|FG000|NOT COMPLETED|Overall Study||6
10839036|NCT03598777|12004675|FG001|NOT COMPLETED|Overall Study||1
10839037|NCT03598777|12004676|FG002|NOT COMPLETED|Overall Study||0
10839038|NCT03598777|12004677|FG003|NOT COMPLETED|Overall Study||0
10839039|NCT03598777|12004678|FG004|NOT COMPLETED|Overall Study||15
10839040|NCT03406078|12004695|FG000|STARTED|Overall Study||74
10839041|NCT03406078|12004696|FG001|STARTED|Overall Study||76
10839042|NCT03406078|12004695|FG000|COMPLETED|Overall Study||68
10839043|NCT03406078|12004696|FG001|COMPLETED|Overall Study||73
10839044|NCT03406078|12004695|FG000|NOT COMPLETED|Overall Study||6
10839045|NCT03406078|12004696|FG001|NOT COMPLETED|Overall Study||3
10839046|NCT03397589|12004704|FG000|STARTED|Overall Study||211
10839047|NCT03397589|12004705|FG001|STARTED|Overall Study||209
10839048|NCT03397589|12004704|FG000|COMPLETED|Overall Study||175
10839049|NCT03397589|12004705|FG001|COMPLETED|Overall Study||187
10839050|NCT03397589|12004704|FG000|NOT COMPLETED|Overall Study||36
10839051|NCT03397589|12004705|FG001|NOT COMPLETED|Overall Study||22
10839052|NCT03368066|12004711|FG000|STARTED|Overall Study||58
10839053|NCT03368066|12004712|FG001|STARTED|Overall Study||37
10839054|NCT03368066|12004711|FG000|COMPLETED|Overall Study||58
10839055|NCT03368066|12004712|FG001|COMPLETED|Overall Study||37
10839056|NCT03368066|12004711|FG000|NOT COMPLETED|Overall Study||0
10839057|NCT03368066|12004712|FG001|NOT COMPLETED|Overall Study||0
10839058|NCT03345342|12004718|FG000|STARTED|Open-Label Phase||838
10839059|NCT03345342|12004719|FG001|STARTED|Open-Label Phase||0
10839060|NCT03345342|12004720|FG002|STARTED|Open-Label Phase||0
10839061|NCT03345342|12004721|FG003|STARTED|Open-Label Phase||0
10839062|NCT03345342|12004722|FG004|STARTED|Open-Label Phase||0
10839063|NCT03345342|12004718|FG000|COMPLETED|Open-Label Phase||702
10839064|NCT03345342|12004719|FG001|COMPLETED|Open-Label Phase||0
10839065|NCT03345342|12004720|FG002|COMPLETED|Open-Label Phase||0
10839066|NCT03345342|12004721|FG003|COMPLETED|Open-Label Phase||0
10839067|NCT03345342|12004722|FG004|COMPLETED|Open-Label Phase||0
10839068|NCT03345342|12004718|FG000|NOT COMPLETED|Open-Label Phase||136
10839069|NCT03345342|12004719|FG001|NOT COMPLETED|Open-Label Phase||0
10839070|NCT03345342|12004720|FG002|NOT COMPLETED|Open-Label Phase||0
10839071|NCT03345342|12004721|FG003|NOT COMPLETED|Open-Label Phase||0
10839072|NCT03345342|12004722|FG004|NOT COMPLETED|Open-Label Phase||0
10839073|NCT03345342|12004718|FG000|STARTED|Double-Blind Phase||0
10839074|NCT03345342|12004719|FG001|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|224
10839075|NCT03345342|12004720|FG002|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|478
10839076|NCT03345342|12004721|FG003|STARTED|Double-Blind Phase||0
10839077|NCT03345342|12004722|FG004|STARTED|Double-Blind Phase||0
10839078|NCT03345342|12004718|FG000|COMPLETED|Double-Blind Phase||0
10839079|NCT03345342|12004719|FG001|COMPLETED|Double-Blind Phase||202
10839080|NCT03345342|12004720|FG002|COMPLETED|Double-Blind Phase||416
11221542|NCT01967342|12413327|FG000|5-week Follow-up|Overall Study||83
11221543|NCT01967342|12413328|FG001|5-week Follow-up|Overall Study||78
11221544|NCT01967342|12413329|FG002|5-week Follow-up|Overall Study||76
10839081|NCT03345342|12004721|FG003|COMPLETED|Double-Blind Phase||0
10839082|NCT03345342|12004722|FG004|COMPLETED|Double-Blind Phase||0
10839083|NCT03345342|12004718|FG000|NOT COMPLETED|Double-Blind Phase||0
10839084|NCT03345342|12004719|FG001|NOT COMPLETED|Double-Blind Phase||22
10839085|NCT03345342|12004720|FG002|NOT COMPLETED|Double-Blind Phase||62
10839086|NCT03345342|12004721|FG003|NOT COMPLETED|Double-Blind Phase||0
10839087|NCT03345342|12004722|FG004|NOT COMPLETED|Double-Blind Phase||0
10839088|NCT03345342|12004718|FG000|STARTED|Follow-Up Phase||0
10839089|NCT03345342|12004719|FG001|STARTED|Follow-Up Phase||0
10839090|NCT03345342|12004720|FG002|STARTED|Follow-Up Phase||0
10839091|NCT03345342|12004721|FG003|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|42
10839092|NCT03345342|12004722|FG004|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|109
10839093|NCT03345342|12004718|FG000|COMPLETED|Follow-Up Phase||0
10839094|NCT03345342|12004719|FG001|COMPLETED|Follow-Up Phase||0
10839095|NCT03345342|12004720|FG002|COMPLETED|Follow-Up Phase||0
10839096|NCT03345342|12004721|FG003|COMPLETED|Follow-Up Phase||34
10839097|NCT03345342|12004722|FG004|COMPLETED|Follow-Up Phase||78
10839098|NCT03345342|12004718|FG000|NOT COMPLETED|Follow-Up Phase||0
10839099|NCT03345342|12004719|FG001|NOT COMPLETED|Follow-Up Phase||0
10839100|NCT03345342|12004720|FG002|NOT COMPLETED|Follow-Up Phase||0
10839101|NCT03345342|12004721|FG003|NOT COMPLETED|Follow-Up Phase||8
10839102|NCT03345342|12004722|FG004|NOT COMPLETED|Follow-Up Phase||31
10839103|NCT03218995|12004734|FG000|STARTED|Overall Study||15
10839104|NCT03218995|12004734|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
10839105|NCT03218995|12004734|FG000|COMPLETED|Overall Study||15
10839106|NCT03218995|12004734|FG000|NOT COMPLETED|Overall Study||0
10839107|NCT03030222|12004742|FG000|STARTED|Overall Study||33
10839108|NCT03030222|12004743|FG001|STARTED|Overall Study||32
10839109|NCT03030222|12004742|FG000|COMPLETED|Overall Study||33
10839110|NCT03030222|12004743|FG001|COMPLETED|Overall Study||32
10839111|NCT03030222|12004742|FG000|NOT COMPLETED|Overall Study||0
10839112|NCT03030222|12004743|FG001|NOT COMPLETED|Overall Study||0
10839113|NCT02880241|12004755|FG000|STARTED|Overall Study|Study terminated|8
10839114|NCT02880241|12004756|FG001|STARTED|Overall Study|Study terminated|0
10839115|NCT02880241|12004757|FG002|STARTED|Overall Study|Study terminated|0
10839116|NCT02880241|12004758|FG003|STARTED|Overall Study|Study terminated|0
10839117|NCT02880241|12004759|FG004|STARTED|Overall Study|Study terminated|0
10839118|NCT02880241|12004760|FG005|STARTED|Overall Study|Study terminated|0
10839119|NCT02880241|12004755|FG000|COMPLETED|Overall Study|Study terminated|7
10839120|NCT02880241|12004756|FG001|COMPLETED|Overall Study|Study terminated|0
10839121|NCT02880241|12004757|FG002|COMPLETED|Overall Study|Study terminated|0
10839122|NCT02880241|12004758|FG003|COMPLETED|Overall Study|Study terminated|0
10839123|NCT02880241|12004759|FG004|COMPLETED|Overall Study|Study terminated|0
10839124|NCT02880241|12004760|FG005|COMPLETED|Overall Study|Study terminated|0
10839125|NCT02880241|12004755|FG000|NOT COMPLETED|Overall Study||1
10839126|NCT02880241|12004756|FG001|NOT COMPLETED|Overall Study||0
10839127|NCT02880241|12004757|FG002|NOT COMPLETED|Overall Study||0
10839128|NCT02880241|12004758|FG003|NOT COMPLETED|Overall Study||0
10839129|NCT02880241|12004759|FG004|NOT COMPLETED|Overall Study||0
10839130|NCT02880241|12004760|FG005|NOT COMPLETED|Overall Study||0
10839131|NCT02832687|12004778|FG000|STARTED|Overall Study||41
10839132|NCT02832687|12004779|FG001|STARTED|Overall Study||47
10839133|NCT02832687|12004778|FG000|Participants Who Were Included in the Analysis|Overall Study||31
10839134|NCT02832687|12004779|FG001|Participants Who Were Included in the Analysis|Overall Study||34
10839135|NCT02832687|12004778|FG000|COMPLETED|Overall Study||41
10839136|NCT02832687|12004779|FG001|COMPLETED|Overall Study||45
10839137|NCT02832687|12004778|FG000|NOT COMPLETED|Overall Study||0
10839138|NCT02832687|12004779|FG001|NOT COMPLETED|Overall Study||2
10839139|NCT02568449|12004785|FG000|STARTED|Overall Study||20
10839140|NCT02568449|12004785|FG000|COMPLETED|Overall Study||20
10839141|NCT02568449|12004785|FG000|NOT COMPLETED|Overall Study||0
10839142|NCT02499900|12004791|FG000|STARTED|Core Study Period||430
10839143|NCT02499900|12004792|FG001|STARTED|Core Study Period||431
10839144|NCT02499900|12004791|FG000|Safety Analysis Set|Core Study Period||427
10839145|NCT02499900|12004792|FG001|Safety Analysis Set|Core Study Period||430
10839146|NCT02499900|12004791|FG000|COMPLETED|Core Study Period||395
10839147|NCT02499900|12004792|FG001|COMPLETED|Core Study Period||399
10839148|NCT02499900|12004791|FG000|NOT COMPLETED|Core Study Period||35
10839149|NCT02499900|12004792|FG001|NOT COMPLETED|Core Study Period||32
10839150|NCT02499900|12004791|FG000|STARTED|Completed Core, Continued Into Extension||395
10839151|NCT02499900|12004792|FG001|STARTED|Completed Core, Continued Into Extension||399
10839152|NCT02499900|12004791|FG000|COMPLETED|Completed Core, Continued Into Extension||392
10839153|NCT02499900|12004792|FG001|COMPLETED|Completed Core, Continued Into Extension||397
10839154|NCT02499900|12004791|FG000|NOT COMPLETED|Completed Core, Continued Into Extension||3
10839155|NCT02499900|12004792|FG001|NOT COMPLETED|Completed Core, Continued Into Extension||2
10839156|NCT02499900|12004791|FG000|STARTED|Extension Study Period||392
10839157|NCT02499900|12004792|FG001|STARTED|Extension Study Period||397
10839158|NCT02499900|12004791|FG000|Safety Analysis Set|Extension Study Period||392
10839159|NCT02499900|12004792|FG001|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
10839160|NCT02499900|12004791|FG000|COMPLETED|Extension Study Period||380
10839161|NCT02499900|12004792|FG001|COMPLETED|Extension Study Period||377
10839162|NCT02499900|12004791|FG000|NOT COMPLETED|Extension Study Period||12
10839163|NCT02499900|12004792|FG001|NOT COMPLETED|Extension Study Period||20
10839164|NCT02481986|12004806|FG000|STARTED|Overall Study||108
10839165|NCT02481986|12004807|FG001|STARTED|Overall Study||115
10839166|NCT02481986|12004806|FG000|COMPLETED|Overall Study||103
10839167|NCT02481986|12004807|FG001|COMPLETED|Overall Study||106
10839168|NCT02481986|12004806|FG000|NOT COMPLETED|Overall Study||5
10839169|NCT02481986|12004807|FG001|NOT COMPLETED|Overall Study||9
10839170|NCT02394548|12004813|FG000|STARTED|Overall Study||26
10839171|NCT02394548|12004813|FG000|COMPLETED|Overall Study||25
10839172|NCT02394548|12004813|FG000|NOT COMPLETED|Overall Study||1
10839173|NCT02269917|12004819|FG000|STARTED|BL to EOE-Test and BL to Switch-Control||766
10839174|NCT02269917|12004820|FG001|STARTED|BL to EOE-Test and BL to Switch-Control||383
10839175|NCT02269917|12004821|FG002|STARTED|BL to EOE-Test and BL to Switch-Control||0
10839176|NCT02269917|12004819|FG000|Treated|BL to EOE-Test and BL to Switch-Control||763
10839177|NCT02269917|12004820|FG001|Treated|BL to EOE-Test and BL to Switch-Control||378
10839178|NCT02269917|12004821|FG002|Treated|BL to EOE-Test and BL to Switch-Control||0
10839179|NCT02269917|12004819|FG000|COMPLETED|BL to EOE-Test and BL to Switch-Control||649
10839180|NCT02269917|12004820|FG001|COMPLETED|BL to EOE-Test and BL to Switch-Control||352
10839181|NCT02269917|12004821|FG002|COMPLETED|BL to EOE-Test and BL to Switch-Control||0
10839182|NCT02269917|12004819|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||117
10839183|NCT02269917|12004820|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||31
10839184|NCT02269917|12004821|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||0
10839185|NCT02269917|12004819|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0
10839186|NCT02269917|12004820|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)||0
10839187|NCT02269917|12004821|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)||352
10839188|NCT02269917|12004819|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10839189|NCT02269917|12004820|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10839190|NCT02269917|12004821|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||314
10839191|NCT02269917|12004819|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10839192|NCT02269917|12004820|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10839193|NCT02269917|12004821|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||38
10839194|NCT02225366|12004832|FG000|STARTED|Overall Study||2
10839195|NCT02225366|12004833|FG001|STARTED|Overall Study||1
10839196|NCT02225366|12004832|FG000|COMPLETED|Overall Study||1
10839197|NCT02225366|12004833|FG001|COMPLETED|Overall Study||1
10839198|NCT02225366|12004832|FG000|NOT COMPLETED|Overall Study||1
10839199|NCT02225366|12004833|FG001|NOT COMPLETED|Overall Study||0
10839200|NCT01530997|12004839|FG000|STARTED|Overall Study||45
10839201|NCT01530997|12004839|FG000|COMPLETED|Overall Study||43
10839202|NCT01530997|12004839|FG000|NOT COMPLETED|Overall Study||2
10839203|NCT01109004|12004853|FG000|STARTED|Overall Study||247
10839204|NCT01109004|12004854|FG001|STARTED|Overall Study||254
10839205|NCT01109004|12004855|FG002|STARTED|Overall Study||257
10839206|NCT01109004|12004853|FG000|COMPLETED|Overall Study||247
10839207|NCT01109004|12004854|FG001|COMPLETED|Overall Study||254
10839208|NCT01109004|12004855|FG002|COMPLETED|Overall Study||257
11221545|NCT01967342|12413327|FG000|10-week Follow-up|Overall Study||78
11221546|NCT01967342|12413328|FG001|10-week Follow-up|Overall Study||83
11221547|NCT01967342|12413329|FG002|10-week Follow-up|Overall Study||80
11221548|NCT01967342|12413327|FG000|COMPLETED|Overall Study||71
11221549|NCT01967342|12413328|FG001|COMPLETED|Overall Study||70
11221550|NCT01967342|12413329|FG002|COMPLETED|Overall Study||68
11221551|NCT01967342|12413327|FG000|NOT COMPLETED|Overall Study||27
11221552|NCT01967342|12413328|FG001|NOT COMPLETED|Overall Study||25
11221553|NCT01967342|12413329|FG002|NOT COMPLETED|Overall Study||29
11221554|NCT01967433|12413339|FG000|STARTED|Overall Study||61
11221555|NCT01967433|12413340|FG001|STARTED|Overall Study||59
11221556|NCT01967433|12413339|FG000|COMPLETED|Overall Study||61
11221557|NCT01967433|12413340|FG001|COMPLETED|Overall Study||58
11221558|NCT01967433|12413339|FG000|NOT COMPLETED|Overall Study||0
11221559|NCT01967433|12413340|FG001|NOT COMPLETED|Overall Study||1
11221560|NCT01967537|12413352|FG000|STARTED|Overall Study||341
11221561|NCT01967537|12413352|FG000|COMPLETED|Overall Study||281
11221562|NCT01967537|12413352|FG000|NOT COMPLETED|Overall Study||60
11221563|NCT01967550|12413358|FG000|STARTED|Overall Study||153
11221564|NCT01967550|12413359|FG001|STARTED|Overall Study||151
11221565|NCT01967550|12413358|FG000|COMPLETED|Overall Study||148
11221566|NCT01967550|12413359|FG001|COMPLETED|Overall Study||149
11221567|NCT01967550|12413358|FG000|NOT COMPLETED|Overall Study||5
11221568|NCT01967550|12413359|FG001|NOT COMPLETED|Overall Study||2
11221569|NCT01967576|12413365|FG000|STARTED|Overall Study||14
11221570|NCT01967576|12413365|FG000|COMPLETED|Overall Study||7
11221571|NCT01967576|12413365|FG000|NOT COMPLETED|Overall Study||7
11221572|NCT01967628|12413371|FG000|STARTED|Overall Study||48
11221573|NCT01967628|12413372|FG001|STARTED|Overall Study||50
11221574|NCT01967628|12413371|FG000|COMPLETED|Overall Study||21
11221575|NCT01967628|12413372|FG001|COMPLETED|Overall Study||19
11221576|NCT01967628|12413371|FG000|NOT COMPLETED|Overall Study||27
11221577|NCT01967628|12413372|FG001|NOT COMPLETED|Overall Study||31
11221578|NCT01967641|12413378|FG000|STARTED|Randomized||51
11221579|NCT01967641|12413378|FG000|COMPLETED|Randomized|Completed week 12|43
11221580|NCT01967641|12413378|FG000|NOT COMPLETED|Randomized||8
11221581|NCT01967641|12413378|FG000|STARTED|Admission to Inpatient Phase||43
11221582|NCT01967641|12413378|FG000|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
11221583|NCT01967641|12413378|FG000|NOT COMPLETED|Admission to Inpatient Phase||12
11221584|NCT01967641|12413378|FG000|STARTED|12-week Outpatient Phase||31
11221585|NCT01967641|12413378|FG000|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
11221586|NCT01967641|12413378|FG000|NOT COMPLETED|12-week Outpatient Phase||13
11221587|NCT01967706|12413385|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
11221588|NCT01967706|12413386|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
11221589|NCT01967706|12413387|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
11221590|NCT01967706|12413388|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
11221591|NCT01967706|12413385|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
11221592|NCT01967706|12413386|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
11221593|NCT01967706|12413387|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
11221594|NCT01967706|12413388|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
11221595|NCT01967706|12413385|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
11354189|NCT03070470|12551375|FG003|NOT COMPLETED|Overall Study||0
11354190|NCT03070470|12551376|FG004|NOT COMPLETED|Overall Study||0
11354191|NCT03070470|12551377|FG005|NOT COMPLETED|Overall Study||2
11354192|NCT03070483|12551393|FG000|STARTED|Overall Study||5
11354193|NCT03070483|12551393|FG000|COMPLETED|Overall Study||3
11354194|NCT03070483|12551393|FG000|NOT COMPLETED|Overall Study||2
11354195|NCT03070548|12551398|FG000|STARTED|Overall Study||6
11354196|NCT03070548|12551398|FG000|COMPLETED|Overall Study||6
11354197|NCT03070548|12551398|FG000|NOT COMPLETED|Overall Study||0
11354198|NCT03070730|12551405|FG000|STARTED|Overall Study||0
11354199|NCT03070730|12551406|FG001|STARTED|Overall Study||0
11354200|NCT03070730|12551407|FG002|STARTED|Overall Study||0
10839209|NCT01109004|12004853|FG000|NOT COMPLETED|Overall Study||0
10839210|NCT01109004|12004854|FG001|NOT COMPLETED|Overall Study||0
10839211|NCT01109004|12004855|FG002|NOT COMPLETED|Overall Study||0
10839212|NCT01067521|12004865|FG000|STARTED|Double-Blind Placebo-Controlled Period||943
10839213|NCT01067521|12004866|FG001|STARTED|Double-Blind Placebo-Controlled Period||461
10839214|NCT01067521|12004865|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||859
10839215|NCT01067521|12004866|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||430
10839216|NCT01067521|12004865|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
10839217|NCT01067521|12004866|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
10839218|NCT01067521|12004865|FG000|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
10839219|NCT01067521|12004866|FG001|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
10839220|NCT01067521|12004865|FG000|COMPLETED|Open-Label Period||580
10839221|NCT01067521|12004866|FG001|COMPLETED|Open-Label Period||261
10839222|NCT01067521|12004865|FG000|NOT COMPLETED|Open-Label Period||254
10839223|NCT01067521|12004866|FG001|NOT COMPLETED|Open-Label Period||158
10839224|NCT01047319|12004880|FG000|STARTED|Overall Study||345
10839225|NCT01047319|12004881|FG001|STARTED|Overall Study||350
10839226|NCT01047319|12004882|FG002|STARTED|Overall Study||352
10839227|NCT01047319|12004880|FG000|COMPLETED|Overall Study||0
10839228|NCT01047319|12004881|FG001|COMPLETED|Overall Study||0
10839229|NCT01047319|12004882|FG002|COMPLETED|Overall Study||0
10839230|NCT01047319|12004880|FG000|NOT COMPLETED|Overall Study||345
10839231|NCT01047319|12004881|FG001|NOT COMPLETED|Overall Study||350
10839232|NCT01047319|12004882|FG002|NOT COMPLETED|Overall Study||352
10839233|NCT00988052|12004892|FG000|STARTED|Overall Study||423
10839234|NCT00988052|12004893|FG001|STARTED|Overall Study||416
10839235|NCT00988052|12004892|FG000|COMPLETED|Overall Study||0
10839236|NCT00988052|12004893|FG001|COMPLETED|Overall Study||0
10839237|NCT00988052|12004892|FG000|NOT COMPLETED|Overall Study||423
10839238|NCT00988052|12004893|FG001|NOT COMPLETED|Overall Study||416
10839239|NCT02021773|12004902|FG000|STARTED|Overall Study||89
10839240|NCT02021773|12004903|FG001|STARTED|Overall Study||88
10839241|NCT02021773|12004904|FG002|STARTED|Overall Study||87
11221596|NCT01967706|12413386|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
11221597|NCT01967706|12413387|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
11221598|NCT01967706|12413388|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
11221599|NCT01967706|12413385|FG000|STARTED|First Intervention (Day 1)||22
11221600|NCT01967706|12413386|FG001|STARTED|First Intervention (Day 1)||22
11221601|NCT01967706|12413387|FG002|STARTED|First Intervention (Day 1)||9
11221602|NCT01967706|12413388|FG003|STARTED|First Intervention (Day 1)||9
11221603|NCT01967706|12413385|FG000|COMPLETED|First Intervention (Day 1)||21
11221604|NCT01967706|12413386|FG001|COMPLETED|First Intervention (Day 1)||22
11221605|NCT01967706|12413387|FG002|COMPLETED|First Intervention (Day 1)||9
11221606|NCT01967706|12413388|FG003|COMPLETED|First Intervention (Day 1)||9
11221607|NCT01967706|12413385|FG000|NOT COMPLETED|First Intervention (Day 1)||1
11221608|NCT01967706|12413386|FG001|NOT COMPLETED|First Intervention (Day 1)||0
11221609|NCT01967706|12413387|FG002|NOT COMPLETED|First Intervention (Day 1)||0
11221610|NCT01967706|12413388|FG003|NOT COMPLETED|First Intervention (Day 1)||0
11221611|NCT01967706|12413385|FG000|STARTED|Washout Period of 1 Day (Day 2)||21
11221612|NCT01967706|12413386|FG001|STARTED|Washout Period of 1 Day (Day 2)||22
11221613|NCT01967706|12413387|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
11221614|NCT01967706|12413388|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
11221615|NCT01967706|12413385|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21
11221616|NCT01967706|12413386|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||22
11221617|NCT01967706|12413387|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
11221618|NCT01967706|12413388|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
11354201|NCT03070730|12551405|FG000|COMPLETED|Overall Study||0
10839242|NCT02021773|12004902|FG000|Safety Analysis Set|Overall Study||89
10839243|NCT02021773|12004903|FG001|Safety Analysis Set|Overall Study||88
10839244|NCT02021773|12004904|FG002|Safety Analysis Set|Overall Study||86
10839245|NCT02021773|12004902|FG000|Intent-to-treat (ITT)|Overall Study||89
10839246|NCT02021773|12004903|FG001|Intent-to-treat (ITT)|Overall Study||87
10839247|NCT02021773|12004904|FG002|Intent-to-treat (ITT)|Overall Study||85
10839248|NCT02021773|12004902|FG000|COMPLETED|Overall Study||77
10839249|NCT02021773|12004903|FG001|COMPLETED|Overall Study||72
10839250|NCT02021773|12004904|FG002|COMPLETED|Overall Study||76
10839251|NCT02021773|12004902|FG000|NOT COMPLETED|Overall Study||12
10839252|NCT02021773|12004903|FG001|NOT COMPLETED|Overall Study||16
10839253|NCT02021773|12004904|FG002|NOT COMPLETED|Overall Study||11
10839254|NCT04689932|12004912|FG000|STARTED|Overall Study||12
10839255|NCT04689932|12004912|FG000|COMPLETED|Overall Study||12
10839256|NCT04689932|12004912|FG000|NOT COMPLETED|Overall Study||0
10839257|NCT04635579|12004919|FG000|STARTED|Overall Study||20
10839258|NCT04635579|12004920|FG001|STARTED|Overall Study||20
10839259|NCT04635579|12004919|FG000|COMPLETED|Overall Study||20
10839260|NCT04635579|12004920|FG001|COMPLETED|Overall Study||20
10839261|NCT04635579|12004919|FG000|NOT COMPLETED|Overall Study||0
10839262|NCT04635579|12004920|FG001|NOT COMPLETED|Overall Study||0
10839263|NCT04553406|12004928|FG000|STARTED|Overall Study||1
10839264|NCT04553406|12004929|FG001|STARTED|Overall Study||1
10839265|NCT04553406|12004928|FG000|COMPLETED|Overall Study||1
10839266|NCT04553406|12004929|FG001|COMPLETED|Overall Study||0
10839267|NCT04553406|12004928|FG000|NOT COMPLETED|Overall Study||0
10839268|NCT04553406|12004929|FG001|NOT COMPLETED|Overall Study||1
10839269|NCT03792750|12004935|FG000|STARTED|Overall Study||12
10839270|NCT03792750|12004935|FG000|COMPLETED|Overall Study||9
10839271|NCT03792750|12004935|FG000|NOT COMPLETED|Overall Study||3
10839272|NCT03739593|12004943|FG000|STARTED|Overall Study||5
10839273|NCT03739593|12004944|FG001|STARTED|Overall Study||22
10839274|NCT03739593|12004945|FG002|STARTED|Overall Study||22
10839275|NCT03739593|12004943|FG000|COMPLETED|Overall Study||2
10839276|NCT03739593|12004944|FG001|COMPLETED|Overall Study||16
10839277|NCT03739593|12004945|FG002|COMPLETED|Overall Study||14
10839278|NCT03739593|12004943|FG000|NOT COMPLETED|Overall Study||3
10839279|NCT03739593|12004944|FG001|NOT COMPLETED|Overall Study||6
10839280|NCT03739593|12004945|FG002|NOT COMPLETED|Overall Study||8
10839281|NCT03739138|12004956|FG000|STARTED|Overall Study||0
10839282|NCT03739138|12004957|FG001|STARTED|Overall Study||7
10839283|NCT03739138|12004958|FG002|STARTED|Overall Study||5
10839284|NCT03739138|12004959|FG003|STARTED|Overall Study||18
10839285|NCT03739138|12004960|FG004|STARTED|Overall Study||0
10839286|NCT03739138|12004956|FG000|COMPLETED|Overall Study||0
10839287|NCT03739138|12004957|FG001|COMPLETED|Overall Study||0
10839288|NCT03739138|12004958|FG002|COMPLETED|Overall Study||0
10839289|NCT03739138|12004959|FG003|COMPLETED|Overall Study||0
10839290|NCT03739138|12004960|FG004|COMPLETED|Overall Study||0
10839291|NCT03739138|12004956|FG000|NOT COMPLETED|Overall Study||0
10839292|NCT03739138|12004957|FG001|NOT COMPLETED|Overall Study||7
10839293|NCT03739138|12004958|FG002|NOT COMPLETED|Overall Study||5
10839294|NCT03739138|12004959|FG003|NOT COMPLETED|Overall Study||18
10839295|NCT03739138|12004960|FG004|NOT COMPLETED|Overall Study||0
11103961|NCT01245751|12288187|FG002|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
11103962|NCT01245751|12288188|FG003|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
11103963|NCT01245751|12288185|FG000|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
11103964|NCT01245751|12288186|FG001|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
11103965|NCT01245751|12288187|FG002|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
11103966|NCT01245751|12288188|FG003|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
11103967|NCT01245751|12288185|FG000|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
11103968|NCT01245751|12288186|FG001|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
11103969|NCT01245751|12288187|FG002|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
11103970|NCT01245751|12288188|FG003|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
11103971|NCT01245751|12288185|FG000|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
11103972|NCT01245751|12288186|FG001|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
11354202|NCT03070730|12551406|FG001|COMPLETED|Overall Study||0
10839312|NCT03468309|12004980|FG000|STARTED|Overall Study||53
10839313|NCT03468309|12004980|FG000|COMPLETED|Overall Study||47
10839314|NCT03468309|12004980|FG000|NOT COMPLETED|Overall Study||6
10839315|NCT03347123|12004986|FG000|STARTED|Overall Study||5
10839316|NCT03347123|12004987|FG001|STARTED|Overall Study||6
10839317|NCT03347123|12004988|FG002|STARTED|Overall Study||0
10839318|NCT03347123|12004989|FG003|STARTED|Overall Study||0
10839319|NCT03347123|12004990|FG004|STARTED|Overall Study||0
10839320|NCT03347123|12004991|FG005|STARTED|Overall Study||0
10839321|NCT03347123|12004992|FG006|STARTED|Overall Study||0
10839322|NCT03347123|12004986|FG000|COMPLETED|Overall Study||0
10839323|NCT03347123|12004987|FG001|COMPLETED|Overall Study||0
10839324|NCT03347123|12004988|FG002|COMPLETED|Overall Study||0
10839325|NCT03347123|12004989|FG003|COMPLETED|Overall Study||0
10839326|NCT03347123|12004990|FG004|COMPLETED|Overall Study||0
10839327|NCT03347123|12004991|FG005|COMPLETED|Overall Study||0
10839328|NCT03347123|12004992|FG006|COMPLETED|Overall Study||0
10839329|NCT03347123|12004986|FG000|NOT COMPLETED|Overall Study||5
10839330|NCT03347123|12004987|FG001|NOT COMPLETED|Overall Study||6
10839331|NCT03347123|12004988|FG002|NOT COMPLETED|Overall Study||0
10839332|NCT03347123|12004989|FG003|NOT COMPLETED|Overall Study||0
10839333|NCT03347123|12004990|FG004|NOT COMPLETED|Overall Study||0
10839334|NCT03347123|12004991|FG005|NOT COMPLETED|Overall Study||0
10839335|NCT03347123|12004992|FG006|NOT COMPLETED|Overall Study||0
10839336|NCT03318523|12005007|FG000|STARTED|PC Period: Up to Year 1||100
10839337|NCT03318523|12005008|FG001|STARTED|PC Period: Up to Year 1||55
10839338|NCT03318523|12005009|FG002|STARTED|PC Period: Up to Year 1||102
10839339|NCT03318523|12005010|FG003|STARTED|PC Period: Up to Year 1||100
10839340|NCT03318523|12005011|FG004|STARTED|PC Period: Up to Year 1||0
10839341|NCT03318523|12005012|FG005|STARTED|PC Period: Up to Year 1||0
10839342|NCT03318523|12005013|FG006|STARTED|PC Period: Up to Year 1||0
10839343|NCT03318523|12005014|FG007|STARTED|PC Period: Up to Year 1||0
10839344|NCT03318523|12005015|FG008|STARTED|PC Period: Up to Year 1||0
10839345|NCT03318523|12005016|FG009|STARTED|PC Period: Up to Year 1||0
10839346|NCT03318523|12005007|FG000|COMPLETED|PC Period: Up to Year 1||96
10839347|NCT03318523|12005008|FG001|COMPLETED|PC Period: Up to Year 1||53
10839348|NCT03318523|12005009|FG002|COMPLETED|PC Period: Up to Year 1||100
10839349|NCT03318523|12005010|FG003|COMPLETED|PC Period: Up to Year 1||96
10839350|NCT03318523|12005011|FG004|COMPLETED|PC Period: Up to Year 1||0
10839351|NCT03318523|12005012|FG005|COMPLETED|PC Period: Up to Year 1||0
10839352|NCT03318523|12005013|FG006|COMPLETED|PC Period: Up to Year 1||0
10839353|NCT03318523|12005014|FG007|COMPLETED|PC Period: Up to Year 1||0
10839354|NCT03318523|12005015|FG008|COMPLETED|PC Period: Up to Year 1||0
10839355|NCT03318523|12005016|FG009|COMPLETED|PC Period: Up to Year 1||0
10839356|NCT03318523|12005007|FG000|NOT COMPLETED|PC Period: Up to Year 1||4
10839357|NCT03318523|12005008|FG001|NOT COMPLETED|PC Period: Up to Year 1||2
10839358|NCT03318523|12005009|FG002|NOT COMPLETED|PC Period: Up to Year 1||2
10839359|NCT03318523|12005010|FG003|NOT COMPLETED|PC Period: Up to Year 1||4
10839360|NCT03318523|12005011|FG004|NOT COMPLETED|PC Period: Up to Year 1||0
10839361|NCT03318523|12005012|FG005|NOT COMPLETED|PC Period: Up to Year 1||0
10839362|NCT03318523|12005013|FG006|NOT COMPLETED|PC Period: Up to Year 1||0
10839363|NCT03318523|12005014|FG007|NOT COMPLETED|PC Period: Up to Year 1||0
10839364|NCT03318523|12005015|FG008|NOT COMPLETED|PC Period: Up to Year 1||0
10839365|NCT03318523|12005016|FG009|NOT COMPLETED|PC Period: Up to Year 1||0
10839366|NCT03318523|12005007|FG000|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839367|NCT03318523|12005008|FG001|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839368|NCT03318523|12005009|FG002|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839369|NCT03318523|12005010|FG003|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839370|NCT03318523|12005011|FG004|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||20
10839371|NCT03318523|12005012|FG005|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||37
10839372|NCT03318523|12005013|FG006|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||39
10839373|NCT03318523|12005014|FG007|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||52
10839374|NCT03318523|12005015|FG008|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||100
10839375|NCT03318523|12005016|FG009|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||96
10839376|NCT03318523|12005007|FG000|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839377|NCT03318523|12005008|FG001|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839378|NCT03318523|12005009|FG002|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839379|NCT03318523|12005010|FG003|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839380|NCT03318523|12005011|FG004|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||20
10839381|NCT03318523|12005012|FG005|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||37
10839382|NCT03318523|12005013|FG006|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||39
10839383|NCT03318523|12005014|FG007|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||52
10839384|NCT03318523|12005015|FG008|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||100
10839385|NCT03318523|12005016|FG009|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||94
10839386|NCT03318523|12005007|FG000|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839387|NCT03318523|12005008|FG001|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839388|NCT03318523|12005009|FG002|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839389|NCT03318523|12005010|FG003|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839390|NCT03318523|12005011|FG004|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839391|NCT03318523|12005012|FG005|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839392|NCT03318523|12005013|FG006|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839393|NCT03318523|12005014|FG007|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839394|NCT03318523|12005015|FG008|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839395|NCT03318523|12005016|FG009|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839396|NCT03318523|12005007|FG000|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839397|NCT03318523|12005008|FG001|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839398|NCT03318523|12005009|FG002|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839399|NCT03318523|12005010|FG003|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
10839400|NCT03318523|12005011|FG004|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||20
10839401|NCT03318523|12005012|FG005|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||37
10839402|NCT03318523|12005013|FG006|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||39
10839403|NCT03318523|12005014|FG007|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||52
10839404|NCT03318523|12005015|FG008|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||100
10839405|NCT03318523|12005016|FG009|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||96
10839406|NCT02906020|12005050|FG000|STARTED|Part 1: Dose Escalation Period||4
10839407|NCT02906020|12005051|FG001|STARTED|Part 1: Dose Escalation Period||4
10839408|NCT02906020|12005052|FG002|STARTED|Part 1: Dose Escalation Period||5
10839409|NCT02906020|12005053|FG003|STARTED|Part 1: Dose Escalation Period||4
10839410|NCT02906020|12005054|FG004|STARTED|Part 1: Dose Escalation Period||3
10839411|NCT02906020|12005055|FG005|STARTED|Part 1: Dose Escalation Period||3
10839412|NCT02906020|12005056|FG006|STARTED|Part 1: Dose Escalation Period||3
10839413|NCT02906020|12005057|FG007|STARTED|Part 1: Dose Escalation Period||3
10839414|NCT02906020|12005058|FG008|STARTED|Part 1: Dose Escalation Period||0
10839415|NCT02906020|12005059|FG009|STARTED|Part 1: Dose Escalation Period||0
10839416|NCT02906020|12005060|FG010|STARTED|Part 1: Dose Escalation Period||0
10839417|NCT02906020|12005061|FG011|STARTED|Part 1: Dose Escalation Period||0
10839418|NCT02906020|12005062|FG012|STARTED|Part 1: Dose Escalation Period||0
10839419|NCT02906020|12005063|FG013|STARTED|Part 1: Dose Escalation Period||0
10839420|NCT02906020|12005064|FG014|STARTED|Part 1: Dose Escalation Period||0
10839421|NCT02906020|12005065|FG015|STARTED|Part 1: Dose Escalation Period||0
10839422|NCT02906020|12005050|FG000|Treated|Part 1: Dose Escalation Period||4
10839423|NCT02906020|12005051|FG001|Treated|Part 1: Dose Escalation Period||4
10839424|NCT02906020|12005052|FG002|Treated|Part 1: Dose Escalation Period||5
10839425|NCT02906020|12005053|FG003|Treated|Part 1: Dose Escalation Period||4
10839426|NCT02906020|12005054|FG004|Treated|Part 1: Dose Escalation Period||3
10839427|NCT02906020|12005055|FG005|Treated|Part 1: Dose Escalation Period||3
10839428|NCT02906020|12005056|FG006|Treated|Part 1: Dose Escalation Period||3
10839429|NCT02906020|12005057|FG007|Treated|Part 1: Dose Escalation Period||3
10839430|NCT02906020|12005058|FG008|Treated|Part 1: Dose Escalation Period||0
10839431|NCT02906020|12005059|FG009|Treated|Part 1: Dose Escalation Period||0
10839432|NCT02906020|12005060|FG010|Treated|Part 1: Dose Escalation Period||0
10839433|NCT02906020|12005061|FG011|Treated|Part 1: Dose Escalation Period||0
10839434|NCT02906020|12005062|FG012|Treated|Part 1: Dose Escalation Period||0
10839435|NCT02906020|12005063|FG013|Treated|Part 1: Dose Escalation Period||0
10839436|NCT02906020|12005064|FG014|Treated|Part 1: Dose Escalation Period||0
10839437|NCT02906020|12005065|FG015|Treated|Part 1: Dose Escalation Period||0
10839438|NCT02906020|12005050|FG000|COMPLETED|Part 1: Dose Escalation Period||4
10839439|NCT02906020|12005051|FG001|COMPLETED|Part 1: Dose Escalation Period||3
10839440|NCT02906020|12005052|FG002|COMPLETED|Part 1: Dose Escalation Period||5
10839441|NCT02906020|12005053|FG003|COMPLETED|Part 1: Dose Escalation Period||3
10839442|NCT02906020|12005054|FG004|COMPLETED|Part 1: Dose Escalation Period||3
10839443|NCT02906020|12005055|FG005|COMPLETED|Part 1: Dose Escalation Period||3
10839444|NCT02906020|12005056|FG006|COMPLETED|Part 1: Dose Escalation Period||3
10839445|NCT02906020|12005057|FG007|COMPLETED|Part 1: Dose Escalation Period||3
10839446|NCT02906020|12005058|FG008|COMPLETED|Part 1: Dose Escalation Period||0
10839447|NCT02906020|12005059|FG009|COMPLETED|Part 1: Dose Escalation Period||0
10839448|NCT02906020|12005060|FG010|COMPLETED|Part 1: Dose Escalation Period||0
10839449|NCT02906020|12005061|FG011|COMPLETED|Part 1: Dose Escalation Period||0
10839450|NCT02906020|12005062|FG012|COMPLETED|Part 1: Dose Escalation Period||0
10839451|NCT02906020|12005063|FG013|COMPLETED|Part 1: Dose Escalation Period||0
10839452|NCT02906020|12005064|FG014|COMPLETED|Part 1: Dose Escalation Period||0
10839453|NCT02906020|12005065|FG015|COMPLETED|Part 1: Dose Escalation Period||0
10839454|NCT02906020|12005050|FG000|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839455|NCT02906020|12005051|FG001|NOT COMPLETED|Part 1: Dose Escalation Period||1
10839456|NCT02906020|12005052|FG002|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839457|NCT02906020|12005053|FG003|NOT COMPLETED|Part 1: Dose Escalation Period||1
10839458|NCT02906020|12005054|FG004|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839459|NCT02906020|12005055|FG005|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839460|NCT02906020|12005056|FG006|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839461|NCT02906020|12005057|FG007|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839462|NCT02906020|12005058|FG008|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839463|NCT02906020|12005059|FG009|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839464|NCT02906020|12005060|FG010|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839465|NCT02906020|12005061|FG011|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839466|NCT02906020|12005062|FG012|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839467|NCT02906020|12005063|FG013|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839468|NCT02906020|12005064|FG014|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839469|NCT02906020|12005065|FG015|NOT COMPLETED|Part 1: Dose Escalation Period||0
10839470|NCT02906020|12005050|FG000|STARTED|Part 2: Double-blind Treatment Period||0
10839471|NCT02906020|12005051|FG001|STARTED|Part 2: Double-blind Treatment Period||0
10839472|NCT02906020|12005052|FG002|STARTED|Part 2: Double-blind Treatment Period||0
10839473|NCT02906020|12005053|FG003|STARTED|Part 2: Double-blind Treatment Period||0
10839474|NCT02906020|12005054|FG004|STARTED|Part 2: Double-blind Treatment Period||0
10839475|NCT02906020|12005055|FG005|STARTED|Part 2: Double-blind Treatment Period||0
10839476|NCT02906020|12005056|FG006|STARTED|Part 2: Double-blind Treatment Period||0
10839477|NCT02906020|12005057|FG007|STARTED|Part 2: Double-blind Treatment Period||0
10839478|NCT02906020|12005058|FG008|STARTED|Part 2: Double-blind Treatment Period||111
10839479|NCT02906020|12005059|FG009|STARTED|Part 2: Double-blind Treatment Period||110
10839480|NCT02906020|12005060|FG010|STARTED|Part 2: Double-blind Treatment Period||10
10839481|NCT02906020|12005061|FG011|STARTED|Part 2: Double-blind Treatment Period||13
10839482|NCT02906020|12005062|FG012|STARTED|Part 2: Double-blind Treatment Period||0
10839483|NCT02906020|12005063|FG013|STARTED|Part 2: Double-blind Treatment Period||0
10839484|NCT02906020|12005064|FG014|STARTED|Part 2: Double-blind Treatment Period||0
10839485|NCT02906020|12005065|FG015|STARTED|Part 2: Double-blind Treatment Period||0
10839486|NCT02906020|12005050|FG000|Treated|Part 2: Double-blind Treatment Period||0
10839487|NCT02906020|12005051|FG001|Treated|Part 2: Double-blind Treatment Period||0
10839488|NCT02906020|12005052|FG002|Treated|Part 2: Double-blind Treatment Period||0
10839489|NCT02906020|12005053|FG003|Treated|Part 2: Double-blind Treatment Period||0
10839490|NCT02906020|12005054|FG004|Treated|Part 2: Double-blind Treatment Period||0
10839491|NCT02906020|12005055|FG005|Treated|Part 2: Double-blind Treatment Period||0
10839492|NCT02906020|12005056|FG006|Treated|Part 2: Double-blind Treatment Period||0
10839493|NCT02906020|12005057|FG007|Treated|Part 2: Double-blind Treatment Period||0
10839494|NCT02906020|12005058|FG008|Treated|Part 2: Double-blind Treatment Period||111
10839495|NCT02906020|12005059|FG009|Treated|Part 2: Double-blind Treatment Period||110
10839496|NCT02906020|12005060|FG010|Treated|Part 2: Double-blind Treatment Period||10
10839497|NCT02906020|12005061|FG011|Treated|Part 2: Double-blind Treatment Period||13
10839498|NCT02906020|12005062|FG012|Treated|Part 2: Double-blind Treatment Period||0
10839499|NCT02906020|12005063|FG013|Treated|Part 2: Double-blind Treatment Period||0
10839500|NCT02906020|12005064|FG014|Treated|Part 2: Double-blind Treatment Period||0
10839501|NCT02906020|12005065|FG015|Treated|Part 2: Double-blind Treatment Period||0
10839502|NCT02906020|12005050|FG000|COMPLETED|Part 2: Double-blind Treatment Period||0
11103973|NCT01245751|12288187|FG002|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
10839503|NCT02906020|12005051|FG001|COMPLETED|Part 2: Double-blind Treatment Period||0
10839504|NCT02906020|12005052|FG002|COMPLETED|Part 2: Double-blind Treatment Period||0
10839505|NCT02906020|12005053|FG003|COMPLETED|Part 2: Double-blind Treatment Period||0
10839506|NCT02906020|12005054|FG004|COMPLETED|Part 2: Double-blind Treatment Period||0
10839507|NCT02906020|12005055|FG005|COMPLETED|Part 2: Double-blind Treatment Period||0
10839508|NCT02906020|12005056|FG006|COMPLETED|Part 2: Double-blind Treatment Period||0
10839509|NCT02906020|12005057|FG007|COMPLETED|Part 2: Double-blind Treatment Period||0
10839510|NCT02906020|12005058|FG008|COMPLETED|Part 2: Double-blind Treatment Period||99
10839511|NCT02906020|12005059|FG009|COMPLETED|Part 2: Double-blind Treatment Period||85
10839512|NCT02906020|12005060|FG010|COMPLETED|Part 2: Double-blind Treatment Period||10
10839513|NCT02906020|12005061|FG011|COMPLETED|Part 2: Double-blind Treatment Period||13
10839514|NCT02906020|12005062|FG012|COMPLETED|Part 2: Double-blind Treatment Period||0
10839515|NCT02906020|12005063|FG013|COMPLETED|Part 2: Double-blind Treatment Period||0
10839516|NCT02906020|12005064|FG014|COMPLETED|Part 2: Double-blind Treatment Period||0
10839517|NCT02906020|12005065|FG015|COMPLETED|Part 2: Double-blind Treatment Period||0
10839518|NCT02906020|12005050|FG000|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839519|NCT02906020|12005051|FG001|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839520|NCT02906020|12005052|FG002|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839521|NCT02906020|12005053|FG003|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839522|NCT02906020|12005054|FG004|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839523|NCT02906020|12005055|FG005|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839524|NCT02906020|12005056|FG006|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839525|NCT02906020|12005057|FG007|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
11103974|NCT01245751|12288188|FG003|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
11103975|NCT01245751|12288185|FG000|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
11103976|NCT01245751|12288186|FG001|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
11103977|NCT01245751|12288187|FG002|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
11103978|NCT01245751|12288188|FG003|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
11103979|NCT01245751|12288185|FG000|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
11103980|NCT01245751|12288186|FG001|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
11103981|NCT01245751|12288187|FG002|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
11103982|NCT01245751|12288188|FG003|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
11103983|NCT01245764|12288203|FG000|STARTED|Study Phase A||80
11103984|NCT01245764|12288204|FG001|STARTED|Study Phase A||30
11103985|NCT01245764|12288205|FG002|STARTED|Study Phase A||120
11103986|NCT01245764|12288206|FG003|STARTED|Study Phase A||20
11103987|NCT01245764|12288203|FG000|Completed Vaccinations in Study Phase A|Study Phase A||77
11103988|NCT01245764|12288204|FG001|Completed Vaccinations in Study Phase A|Study Phase A||28
11221619|NCT01967706|12413385|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11221620|NCT01967706|12413386|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11221621|NCT01967706|12413387|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
10839526|NCT02906020|12005058|FG008|NOT COMPLETED|Part 2: Double-blind Treatment Period||12
10839527|NCT02906020|12005059|FG009|NOT COMPLETED|Part 2: Double-blind Treatment Period||25
11221622|NCT01967706|12413388|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11221623|NCT01967706|12413385|FG000|STARTED|Second Intervention (Day 3)||21
11221624|NCT01967706|12413386|FG001|STARTED|Second Intervention (Day 3)||22
11221625|NCT01967706|12413387|FG002|STARTED|Second Intervention (Day 3)||9
11221626|NCT01967706|12413388|FG003|STARTED|Second Intervention (Day 3)||9
11221627|NCT01967706|12413385|FG000|COMPLETED|Second Intervention (Day 3)||21
11221628|NCT01967706|12413386|FG001|COMPLETED|Second Intervention (Day 3)||22
11221629|NCT01967706|12413387|FG002|COMPLETED|Second Intervention (Day 3)||9
11221630|NCT01967706|12413388|FG003|COMPLETED|Second Intervention (Day 3)||9
11221631|NCT01967706|12413385|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
11221632|NCT01967706|12413386|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
11221633|NCT01967706|12413387|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
11221634|NCT01967706|12413388|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
11221635|NCT01967719|12413399|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
11221636|NCT01967719|12413400|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
11221637|NCT01967719|12413401|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
11221638|NCT01967719|12413402|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
11221639|NCT01967719|12413399|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
11221640|NCT01967719|12413400|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
11221641|NCT01967719|12413401|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
11221642|NCT01967719|12413402|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
11221643|NCT01967719|12413399|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
10839528|NCT02906020|12005060|FG010|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839529|NCT02906020|12005061|FG011|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839530|NCT02906020|12005062|FG012|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839531|NCT02906020|12005063|FG013|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839532|NCT02906020|12005064|FG014|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839533|NCT02906020|12005065|FG015|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
10839534|NCT02906020|12005050|FG000|STARTED|Part 2: Long-term Follow-up Period||0
10839535|NCT02906020|12005051|FG001|STARTED|Part 2: Long-term Follow-up Period||0
10839536|NCT02906020|12005052|FG002|STARTED|Part 2: Long-term Follow-up Period||0
10839537|NCT02906020|12005053|FG003|STARTED|Part 2: Long-term Follow-up Period||0
10839538|NCT02906020|12005054|FG004|STARTED|Part 2: Long-term Follow-up Period||0
10839539|NCT02906020|12005055|FG005|STARTED|Part 2: Long-term Follow-up Period||0
10839540|NCT02906020|12005056|FG006|STARTED|Part 2: Long-term Follow-up Period||0
10839541|NCT02906020|12005057|FG007|STARTED|Part 2: Long-term Follow-up Period||0
10839542|NCT02906020|12005058|FG008|STARTED|Part 2: Long-term Follow-up Period||0
10839543|NCT02906020|12005059|FG009|STARTED|Part 2: Long-term Follow-up Period||0
10839544|NCT02906020|12005060|FG010|STARTED|Part 2: Long-term Follow-up Period||0
10839545|NCT02906020|12005061|FG011|STARTED|Part 2: Long-term Follow-up Period||0
10839546|NCT02906020|12005062|FG012|STARTED|Part 2: Long-term Follow-up Period||99
10839547|NCT02906020|12005063|FG013|STARTED|Part 2: Long-term Follow-up Period||85
10839548|NCT02906020|12005064|FG014|STARTED|Part 2: Long-term Follow-up Period||10
10839549|NCT02906020|12005065|FG015|STARTED|Part 2: Long-term Follow-up Period|Out of 13 completed participants in the previous part 2 DB period-arm, 2 didn't enter LTFU period.|11
10839550|NCT02906020|12005050|FG000|Treated|Part 2: Long-term Follow-up Period||0
10839551|NCT02906020|12005051|FG001|Treated|Part 2: Long-term Follow-up Period||0
10839552|NCT02906020|12005052|FG002|Treated|Part 2: Long-term Follow-up Period||0
10839553|NCT02906020|12005053|FG003|Treated|Part 2: Long-term Follow-up Period||0
10839554|NCT02906020|12005054|FG004|Treated|Part 2: Long-term Follow-up Period||0
10839555|NCT02906020|12005055|FG005|Treated|Part 2: Long-term Follow-up Period||0
10839556|NCT02906020|12005056|FG006|Treated|Part 2: Long-term Follow-up Period||0
10839557|NCT02906020|12005057|FG007|Treated|Part 2: Long-term Follow-up Period||0
11221644|NCT01967719|12413400|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
11221645|NCT01967719|12413401|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
11221646|NCT01967719|12413402|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
11221647|NCT01967719|12413399|FG000|STARTED|First Intervention (Day 1)||22
11221648|NCT01967719|12413400|FG001|STARTED|First Intervention (Day 1)||22
11221649|NCT01967719|12413401|FG002|STARTED|First Intervention (Day 1)||9
11221650|NCT01967719|12413402|FG003|STARTED|First Intervention (Day 1)||9
11221651|NCT01967719|12413399|FG000|COMPLETED|First Intervention (Day 1)||22
11221652|NCT01967719|12413400|FG001|COMPLETED|First Intervention (Day 1)||21
11221653|NCT01967719|12413401|FG002|COMPLETED|First Intervention (Day 1)||9
11221654|NCT01967719|12413402|FG003|COMPLETED|First Intervention (Day 1)||8
10839558|NCT02906020|12005058|FG008|Treated|Part 2: Long-term Follow-up Period||0
10839559|NCT02906020|12005059|FG009|Treated|Part 2: Long-term Follow-up Period||0
10839560|NCT02906020|12005060|FG010|Treated|Part 2: Long-term Follow-up Period||0
10839561|NCT02906020|12005061|FG011|Treated|Part 2: Long-term Follow-up Period||0
10839562|NCT02906020|12005062|FG012|Treated|Part 2: Long-term Follow-up Period||87
10839563|NCT02906020|12005063|FG013|Treated|Part 2: Long-term Follow-up Period||75
10839564|NCT02906020|12005064|FG014|Treated|Part 2: Long-term Follow-up Period||10
10839565|NCT02906020|12005065|FG015|Treated|Part 2: Long-term Follow-up Period||11
10839566|NCT02906020|12005050|FG000|COMPLETED|Part 2: Long-term Follow-up Period||0
10839567|NCT02906020|12005051|FG001|COMPLETED|Part 2: Long-term Follow-up Period||0
10839568|NCT02906020|12005052|FG002|COMPLETED|Part 2: Long-term Follow-up Period||0
10839569|NCT02906020|12005053|FG003|COMPLETED|Part 2: Long-term Follow-up Period||0
10839570|NCT02906020|12005054|FG004|COMPLETED|Part 2: Long-term Follow-up Period||0
10839571|NCT02906020|12005055|FG005|COMPLETED|Part 2: Long-term Follow-up Period||0
10839572|NCT02906020|12005056|FG006|COMPLETED|Part 2: Long-term Follow-up Period||0
10839573|NCT02906020|12005057|FG007|COMPLETED|Part 2: Long-term Follow-up Period||0
10839574|NCT02906020|12005058|FG008|COMPLETED|Part 2: Long-term Follow-up Period||0
10839575|NCT02906020|12005059|FG009|COMPLETED|Part 2: Long-term Follow-up Period||0
10839576|NCT02906020|12005060|FG010|COMPLETED|Part 2: Long-term Follow-up Period||0
10839577|NCT02906020|12005061|FG011|COMPLETED|Part 2: Long-term Follow-up Period||0
10839578|NCT02906020|12005062|FG012|COMPLETED|Part 2: Long-term Follow-up Period||0
10839579|NCT02906020|12005063|FG013|COMPLETED|Part 2: Long-term Follow-up Period||0
10839580|NCT02906020|12005064|FG014|COMPLETED|Part 2: Long-term Follow-up Period||0
10839581|NCT02906020|12005065|FG015|COMPLETED|Part 2: Long-term Follow-up Period||0
10839582|NCT02906020|12005050|FG000|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839583|NCT02906020|12005051|FG001|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839584|NCT02906020|12005052|FG002|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839585|NCT02906020|12005053|FG003|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839586|NCT02906020|12005054|FG004|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839587|NCT02906020|12005055|FG005|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839588|NCT02906020|12005056|FG006|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839589|NCT02906020|12005057|FG007|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839590|NCT02906020|12005058|FG008|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839591|NCT02906020|12005059|FG009|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
11221655|NCT01967719|12413399|FG000|NOT COMPLETED|First Intervention (Day 1)||0
11221656|NCT01967719|12413400|FG001|NOT COMPLETED|First Intervention (Day 1)||1
11221657|NCT01967719|12413401|FG002|NOT COMPLETED|First Intervention (Day 1)||0
10839592|NCT02906020|12005060|FG010|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839593|NCT02906020|12005061|FG011|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
10839594|NCT02906020|12005062|FG012|NOT COMPLETED|Part 2: Long-term Follow-up Period||99
10839595|NCT02906020|12005063|FG013|NOT COMPLETED|Part 2: Long-term Follow-up Period||85
10839596|NCT02906020|12005064|FG014|NOT COMPLETED|Part 2: Long-term Follow-up Period||10
10839597|NCT02906020|12005065|FG015|NOT COMPLETED|Part 2: Long-term Follow-up Period||11
11221658|NCT01967719|12413402|FG003|NOT COMPLETED|First Intervention (Day 1)||1
11221659|NCT01967719|12413399|FG000|STARTED|Washout Period of 1 Day (Day 2)||22
11221660|NCT01967719|12413400|FG001|STARTED|Washout Period of 1 Day (Day 2)||21
11221661|NCT01967719|12413401|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
11221662|NCT01967719|12413402|FG003|STARTED|Washout Period of 1 Day (Day 2)||8
11221663|NCT01967719|12413399|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22
11221664|NCT01967719|12413400|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21
11221665|NCT01967719|12413401|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
11221666|NCT01967719|12413402|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||8
11221667|NCT01967719|12413399|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11221668|NCT01967719|12413400|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11221669|NCT01967719|12413401|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11221670|NCT01967719|12413402|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11221671|NCT01967719|12413399|FG000|STARTED|Second Intervention (Day 3)||22
11221672|NCT01967719|12413400|FG001|STARTED|Second Intervention (Day 3)||21
11221673|NCT01967719|12413401|FG002|STARTED|Second Intervention (Day 3)||9
11221674|NCT01967719|12413402|FG003|STARTED|Second Intervention (Day 3)||8
11221675|NCT01967719|12413399|FG000|COMPLETED|Second Intervention (Day 3)||22
11221676|NCT01967719|12413400|FG001|COMPLETED|Second Intervention (Day 3)||20
11221677|NCT01967719|12413401|FG002|COMPLETED|Second Intervention (Day 3)||9
11221678|NCT01967719|12413402|FG003|COMPLETED|Second Intervention (Day 3)||8
11221679|NCT01967719|12413399|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
11221680|NCT01967719|12413400|FG001|NOT COMPLETED|Second Intervention (Day 3)||1
11221681|NCT01967719|12413401|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
11221682|NCT01967719|12413402|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
11221683|NCT01967732|12413414|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
11221684|NCT01967732|12413415|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
11221685|NCT01967732|12413416|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
11221686|NCT01967732|12413417|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
11221687|NCT01967732|12413414|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
11221688|NCT01967732|12413415|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||21
11221689|NCT01967732|12413416|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
11221690|NCT01967732|12413417|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
11221691|NCT01967732|12413414|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
11221692|NCT01967732|12413415|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
11221693|NCT01967732|12413416|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
11221694|NCT01967732|12413417|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
11221695|NCT01967732|12413414|FG000|STARTED|First Intervention (Day 1)||22
11221696|NCT01967732|12413415|FG001|STARTED|First Intervention (Day 1)||21
11221697|NCT01967732|12413416|FG002|STARTED|First Intervention (Day 1)||9
11221698|NCT01967732|12413417|FG003|STARTED|First Intervention (Day 1)||9
11221699|NCT01967732|12413414|FG000|COMPLETED|First Intervention (Day 1)||22
11221700|NCT01967732|12413415|FG001|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
11221701|NCT01967732|12413416|FG002|COMPLETED|First Intervention (Day 1)||9
11221702|NCT01967732|12413417|FG003|COMPLETED|First Intervention (Day 1)||9
11103989|NCT01245764|12288205|FG002|Completed Vaccinations in Study Phase A|Study Phase A||117
10839806|NCT02703480|12005136|FG000|STARTED|Overall Study||11
10839807|NCT02703480|12005137|FG001|STARTED|Overall Study||11
10839808|NCT02703480|12005136|FG000|COMPLETED|Overall Study||10
10839809|NCT02703480|12005137|FG001|COMPLETED|Overall Study||10
10839810|NCT02703480|12005136|FG000|NOT COMPLETED|Overall Study||1
10839811|NCT02703480|12005137|FG001|NOT COMPLETED|Overall Study||1
10839812|NCT02549092|12005145|FG000|STARTED|Treatment Period||44
10839813|NCT02549092|12005146|FG001|STARTED|Treatment Period||45
10839814|NCT02549092|12005145|FG000|COMPLETED|Treatment Period||41
10839815|NCT02549092|12005146|FG001|COMPLETED|Treatment Period||38
10839816|NCT02549092|12005145|FG000|NOT COMPLETED|Treatment Period||3
10839817|NCT02549092|12005146|FG001|NOT COMPLETED|Treatment Period||7
10839818|NCT02549092|12005145|FG000|STARTED|Extension/Transition Period||10
10839819|NCT02549092|12005146|FG001|STARTED|Extension/Transition Period||14
10839820|NCT02549092|12005145|FG000|COMPLETED|Extension/Transition Period||5
10839821|NCT02549092|12005146|FG001|COMPLETED|Extension/Transition Period||5
10839822|NCT02549092|12005145|FG000|NOT COMPLETED|Extension/Transition Period||5
10839823|NCT02549092|12005146|FG001|NOT COMPLETED|Extension/Transition Period||9
10839824|NCT02506465|12005157|FG000|STARTED|Overall Study||128
11103990|NCT01245764|12288206|FG003|Completed Vaccinations in Study Phase A|Study Phase A||19
11103991|NCT01245764|12288203|FG000|COMPLETED|Study Phase A||71
11103992|NCT01245764|12288204|FG001|COMPLETED|Study Phase A||25
11103993|NCT01245764|12288205|FG002|COMPLETED|Study Phase A||110
11103994|NCT01245764|12288206|FG003|COMPLETED|Study Phase A||17
11103995|NCT01245764|12288203|FG000|NOT COMPLETED|Study Phase A||9
11103996|NCT01245764|12288204|FG001|NOT COMPLETED|Study Phase A||5
11103997|NCT01245764|12288205|FG002|NOT COMPLETED|Study Phase A||10
11103998|NCT01245764|12288206|FG003|NOT COMPLETED|Study Phase A||3
10839825|NCT02506465|12005158|FG001|STARTED|Overall Study||57
10839826|NCT02506465|12005157|FG000|COMPLETED|Overall Study|78 patients reached 12 months FU visit.|78
10839827|NCT02506465|12005158|FG001|COMPLETED|Overall Study|The Sham arm was analyzed up to 3 months FU visit as primary endpoint timeframe in accordance with the FDA guideline for BPH treatments, published in 2010, the most recent guidance available at the time of the study.|57
10839828|NCT02506465|12005157|FG000|NOT COMPLETED|Overall Study||50
10839829|NCT02506465|12005158|FG001|NOT COMPLETED|Overall Study||0
10839830|NCT02323126|12005167|FG000|STARTED|Overall Study||18
10839831|NCT02323126|12005168|FG001|STARTED|Overall Study||16
10839832|NCT02323126|12005169|FG002|STARTED|Overall Study||30
10839833|NCT02323126|12005167|FG000|COMPLETED|Overall Study||0
10839834|NCT02323126|12005168|FG001|COMPLETED|Overall Study||0
10839835|NCT02323126|12005169|FG002|COMPLETED|Overall Study||0
10839836|NCT02323126|12005167|FG000|NOT COMPLETED|Overall Study||18
10839837|NCT02323126|12005168|FG001|NOT COMPLETED|Overall Study||16
10839838|NCT02323126|12005169|FG002|NOT COMPLETED|Overall Study||30
11103999|NCT01245764|12288203|FG000|STARTED|Study Phase B||0
11104000|NCT01245764|12288204|FG001|STARTED|Study Phase B||0
11104001|NCT01245764|12288205|FG002|STARTED|Study Phase B||0
11104002|NCT01245764|12288206|FG003|STARTED|Study Phase B||17
11104003|NCT01245764|12288203|FG000|Completed Vaccinations in Study Phase B|Study Phase B||0
11104004|NCT01245764|12288204|FG001|Completed Vaccinations in Study Phase B|Study Phase B||0
11104005|NCT01245764|12288205|FG002|Completed Vaccinations in Study Phase B|Study Phase B||0
11354203|NCT03070730|12551407|FG002|COMPLETED|Overall Study||0
10839847|NCT01126749|12005194|FG000|STARTED|Phase 1b||3
10839848|NCT01126749|12005195|FG001|STARTED|Phase 1b||6
10839849|NCT01126749|12005196|FG002|STARTED|Phase 1b||0
10839850|NCT01126749|12005197|FG003|STARTED|Phase 1b||0
10839851|NCT01126749|12005194|FG000|COMPLETED|Phase 1b||0
10839852|NCT01126749|12005195|FG001|COMPLETED|Phase 1b||0
10839853|NCT01126749|12005196|FG002|COMPLETED|Phase 1b||0
10839854|NCT01126749|12005197|FG003|COMPLETED|Phase 1b||0
10839855|NCT01126749|12005194|FG000|NOT COMPLETED|Phase 1b||3
10839856|NCT01126749|12005195|FG001|NOT COMPLETED|Phase 1b||6
10839857|NCT01126749|12005196|FG002|NOT COMPLETED|Phase 1b||0
10839858|NCT01126749|12005197|FG003|NOT COMPLETED|Phase 1b||0
10839859|NCT01126749|12005194|FG000|STARTED|Phase 2||0
10839860|NCT01126749|12005195|FG001|STARTED|Phase 2||0
10839861|NCT01126749|12005196|FG002|STARTED|Phase 2||42
10839862|NCT01126749|12005197|FG003|STARTED|Phase 2||41
10839863|NCT01126749|12005194|FG000|Safety Analysis Set (SAS)/Treated|Phase 2||0
10839864|NCT01126749|12005195|FG001|Safety Analysis Set (SAS)/Treated|Phase 2||0
10839865|NCT01126749|12005196|FG002|Safety Analysis Set (SAS)/Treated|Phase 2||41
10839866|NCT01126749|12005197|FG003|Safety Analysis Set (SAS)/Treated|Phase 2||39
10839867|NCT01126749|12005194|FG000|Modified-intent-to-treat (MITT)|Phase 2||0
10839868|NCT01126749|12005195|FG001|Modified-intent-to-treat (MITT)|Phase 2||0
10839869|NCT01126749|12005196|FG002|Modified-intent-to-treat (MITT)|Phase 2||40
10839870|NCT01126749|12005197|FG003|Modified-intent-to-treat (MITT)|Phase 2||39
10839871|NCT01126749|12005194|FG000|COMPLETED|Phase 2||0
10839872|NCT01126749|12005195|FG001|COMPLETED|Phase 2||0
10839873|NCT01126749|12005196|FG002|COMPLETED|Phase 2||0
10839874|NCT01126749|12005197|FG003|COMPLETED|Phase 2||0
10839875|NCT01126749|12005194|FG000|NOT COMPLETED|Phase 2||0
10839876|NCT01126749|12005195|FG001|NOT COMPLETED|Phase 2||0
10839877|NCT01126749|12005196|FG002|NOT COMPLETED|Phase 2||42
10839878|NCT01126749|12005197|FG003|NOT COMPLETED|Phase 2||41
10839879|NCT01111110|12005209|FG000|STARTED|Overall Study||3
10839880|NCT01111110|12005210|FG001|STARTED|Overall Study||4
10839881|NCT01111110|12005209|FG000|COMPLETED|Overall Study||3
10839882|NCT01111110|12005210|FG001|COMPLETED|Overall Study||4
10839883|NCT01111110|12005209|FG000|NOT COMPLETED|Overall Study||0
10839884|NCT01111110|12005210|FG001|NOT COMPLETED|Overall Study||0
10839885|NCT01059448|12005220|FG000|STARTED|Overall Study||49
10839886|NCT01059448|12005221|FG001|STARTED|Overall Study||55
10839887|NCT01059448|12005222|FG002|STARTED|Overall Study||53
10839888|NCT01059448|12005223|FG003|STARTED|Overall Study||54
10839889|NCT01059448|12005220|FG000|COMPLETED|Overall Study||0
10839890|NCT01059448|12005221|FG001|COMPLETED|Overall Study||0
10839891|NCT01059448|12005222|FG002|COMPLETED|Overall Study||0
10839892|NCT01059448|12005223|FG003|COMPLETED|Overall Study||0
10839893|NCT01059448|12005220|FG000|NOT COMPLETED|Overall Study||49
10839894|NCT01059448|12005221|FG001|NOT COMPLETED|Overall Study||55
10839895|NCT01059448|12005222|FG002|NOT COMPLETED|Overall Study||53
10839896|NCT01059448|12005223|FG003|NOT COMPLETED|Overall Study||54
10839897|NCT00821587|12005235|FG000|STARTED|Overall Study||20
10839898|NCT00821587|12005236|FG001|STARTED|Overall Study||19
10839899|NCT00821587|12005235|FG000|COMPLETED|Overall Study||20
10839900|NCT00821587|12005236|FG001|COMPLETED|Overall Study||18
10839901|NCT00821587|12005235|FG000|NOT COMPLETED|Overall Study||0
10839902|NCT00821587|12005236|FG001|NOT COMPLETED|Overall Study||1
10839903|NCT00585195|12005263|FG000|STARTED|Overall Study||3
10839904|NCT00585195|12005264|FG001|STARTED|Overall Study||4
10839905|NCT00585195|12005265|FG002|STARTED|Overall Study||9
10839906|NCT00585195|12005266|FG003|STARTED|Overall Study||7
11354204|NCT03070730|12551405|FG000|NOT COMPLETED|Overall Study||0
11354205|NCT03070730|12551406|FG001|NOT COMPLETED|Overall Study||0
11354206|NCT03070730|12551407|FG002|NOT COMPLETED|Overall Study||0
10839907|NCT00585195|12005267|FG004|STARTED|Overall Study||9
10839908|NCT00585195|12005268|FG005|STARTED|Overall Study||6
10839909|NCT00585195|12005269|FG006|STARTED|Overall Study||7
10839910|NCT00585195|12005270|FG007|STARTED|Overall Study||5
10839911|NCT00585195|12005271|FG008|STARTED|Overall Study||3
11354207|NCT03070782|12551421|FG000|STARTED|Overall Study||48
10839912|NCT00585195|12005272|FG009|STARTED|Overall Study||6
10839913|NCT00585195|12005273|FG010|STARTED|Overall Study||11
10839914|NCT00585195|12005274|FG011|STARTED|Overall Study||53
10839915|NCT00585195|12005275|FG012|STARTED|Overall Study||85
10839916|NCT00585195|12005276|FG013|STARTED|Overall Study||41
10839917|NCT00585195|12005277|FG014|STARTED|Overall Study||48
10839918|NCT00585195|12005278|FG015|STARTED|Overall Study||19
10839919|NCT00585195|12005279|FG016|STARTED|Overall Study||154
10839920|NCT00585195|12005280|FG017|STARTED|Overall Study||67
10839921|NCT00585195|12005281|FG018|STARTED|Overall Study||21
10839922|NCT00585195|12005282|FG019|STARTED|Overall Study||18
10839923|NCT00585195|12005283|FG020|STARTED|Overall Study||14
10839924|NCT00585195|12005263|FG000|Treated|Overall Study||3
10839925|NCT00585195|12005264|FG001|Treated|Overall Study||4
10839926|NCT00585195|12005265|FG002|Treated|Overall Study||8
10839927|NCT00585195|12005266|FG003|Treated|Overall Study||7
10839928|NCT00585195|12005267|FG004|Treated|Overall Study||8
10839929|NCT00585195|12005268|FG005|Treated|Overall Study||6
10839930|NCT00585195|12005269|FG006|Treated|Overall Study||6
10839931|NCT00585195|12005270|FG007|Treated|Overall Study||5
10839932|NCT00585195|12005271|FG008|Treated|Overall Study||3
10839933|NCT00585195|12005272|FG009|Treated|Overall Study||6
10839934|NCT00585195|12005273|FG010|Treated|Overall Study||9
10839935|NCT00585195|12005274|FG011|Treated|Overall Study||53
10839936|NCT00585195|12005275|FG012|Treated|Overall Study||85
10839937|NCT00585195|12005276|FG013|Treated|Overall Study||41
10839938|NCT00585195|12005277|FG014|Treated|Overall Study||48
10839939|NCT00585195|12005278|FG015|Treated|Overall Study||18
10839940|NCT00585195|12005279|FG016|Treated|Overall Study||154
10839941|NCT00585195|12005280|FG017|Treated|Overall Study||66
10839942|NCT00585195|12005281|FG018|Treated|Overall Study||18
10839943|NCT00585195|12005282|FG019|Treated|Overall Study||18
10839944|NCT00585195|12005283|FG020|Treated|Overall Study||12
10839945|NCT00585195|12005263|FG000|COMPLETED|Overall Study||0
10839946|NCT00585195|12005264|FG001|COMPLETED|Overall Study||0
10839947|NCT00585195|12005265|FG002|COMPLETED|Overall Study||0
10839948|NCT00585195|12005266|FG003|COMPLETED|Overall Study||0
10839949|NCT00585195|12005267|FG004|COMPLETED|Overall Study||0
10839950|NCT00585195|12005268|FG005|COMPLETED|Overall Study||0
10839951|NCT00585195|12005269|FG006|COMPLETED|Overall Study||0
10839952|NCT00585195|12005270|FG007|COMPLETED|Overall Study||0
10839953|NCT00585195|12005271|FG008|COMPLETED|Overall Study||0
10839954|NCT00585195|12005272|FG009|COMPLETED|Overall Study||0
10839955|NCT00585195|12005273|FG010|COMPLETED|Overall Study||0
10839956|NCT00585195|12005274|FG011|COMPLETED|Overall Study||0
10839957|NCT00585195|12005275|FG012|COMPLETED|Overall Study||0
10839958|NCT00585195|12005276|FG013|COMPLETED|Overall Study||0
10839959|NCT00585195|12005277|FG014|COMPLETED|Overall Study||0
10839960|NCT00585195|12005278|FG015|COMPLETED|Overall Study||0
10839961|NCT00585195|12005279|FG016|COMPLETED|Overall Study||0
10839962|NCT00585195|12005280|FG017|COMPLETED|Overall Study||0
10839963|NCT00585195|12005281|FG018|COMPLETED|Overall Study||0
10839964|NCT00585195|12005282|FG019|COMPLETED|Overall Study||0
10839965|NCT00585195|12005283|FG020|COMPLETED|Overall Study||0
10839966|NCT00585195|12005263|FG000|NOT COMPLETED|Overall Study||3
10839967|NCT00585195|12005264|FG001|NOT COMPLETED|Overall Study||4
10839968|NCT00585195|12005265|FG002|NOT COMPLETED|Overall Study||9
10839969|NCT00585195|12005266|FG003|NOT COMPLETED|Overall Study||7
11354208|NCT03070782|12551422|FG001|STARTED|Overall Study||48
10839970|NCT00585195|12005267|FG004|NOT COMPLETED|Overall Study||9
10839971|NCT00585195|12005268|FG005|NOT COMPLETED|Overall Study||6
10839972|NCT00585195|12005269|FG006|NOT COMPLETED|Overall Study||7
10839973|NCT00585195|12005270|FG007|NOT COMPLETED|Overall Study||5
10839974|NCT00585195|12005271|FG008|NOT COMPLETED|Overall Study||3
10839975|NCT00585195|12005272|FG009|NOT COMPLETED|Overall Study||6
10839976|NCT00585195|12005273|FG010|NOT COMPLETED|Overall Study||11
10839977|NCT00585195|12005274|FG011|NOT COMPLETED|Overall Study||53
10839978|NCT00585195|12005275|FG012|NOT COMPLETED|Overall Study||85
10839979|NCT00585195|12005276|FG013|NOT COMPLETED|Overall Study||41
10839980|NCT00585195|12005277|FG014|NOT COMPLETED|Overall Study||48
10839981|NCT00585195|12005278|FG015|NOT COMPLETED|Overall Study||19
10839982|NCT00585195|12005279|FG016|NOT COMPLETED|Overall Study||154
10839983|NCT00585195|12005280|FG017|NOT COMPLETED|Overall Study||67
10839984|NCT00585195|12005281|FG018|NOT COMPLETED|Overall Study||21
10839985|NCT00585195|12005282|FG019|NOT COMPLETED|Overall Study||18
10839986|NCT00585195|12005283|FG020|NOT COMPLETED|Overall Study||14
10839987|NCT04446429|12005368|FG000|STARTED|Overall Study||134
10839988|NCT04446429|12005369|FG001|STARTED|Overall Study||134
10839989|NCT04446429|12005368|FG000|COMPLETED|Overall Study|In placebo group, 6 patients were lost to follow-up but were included in intention-to-treat analysis.|128
10839990|NCT04446429|12005369|FG001|COMPLETED|Overall Study||134
10839991|NCT04446429|12005368|FG000|NOT COMPLETED|Overall Study||6
10839992|NCT04446429|12005369|FG001|NOT COMPLETED|Overall Study||0
10839993|NCT04372017|12005379|FG000|STARTED|Overall Study||1
10839994|NCT04372017|12005380|FG001|STARTED|Overall Study||0
10839995|NCT04372017|12005381|FG002|STARTED|Overall Study||0
10839996|NCT04372017|12005382|FG003|STARTED|Overall Study||0
10839997|NCT04372017|12005379|FG000|COMPLETED|Overall Study||1
10839998|NCT04372017|12005380|FG001|COMPLETED|Overall Study||0
10839999|NCT04372017|12005381|FG002|COMPLETED|Overall Study||0
10840000|NCT04372017|12005382|FG003|COMPLETED|Overall Study||0
10840001|NCT04372017|12005379|FG000|NOT COMPLETED|Overall Study||0
10840002|NCT04372017|12005380|FG001|NOT COMPLETED|Overall Study||0
10840003|NCT04372017|12005381|FG002|NOT COMPLETED|Overall Study||0
10840004|NCT04372017|12005382|FG003|NOT COMPLETED|Overall Study||0
10840005|NCT04194528|12005392|FG000|STARTED|Overall Study||2
10840006|NCT04194528|12005392|FG000|COMPLETED|Overall Study||1
10840007|NCT04194528|12005392|FG000|NOT COMPLETED|Overall Study||1
10840008|NCT04147650|12005400|FG000|STARTED|Overall Study||127
10840009|NCT04147650|12005401|FG001|STARTED|Overall Study||126
10840010|NCT04147650|12005402|FG002|STARTED|Overall Study||128
10840011|NCT04147650|12005403|FG003|STARTED|Overall Study||127
10840012|NCT04147650|12005400|FG000|Modified Intent to Treat (mITT)|Overall Study||120
10840013|NCT04147650|12005401|FG001|Modified Intent to Treat (mITT)|Overall Study||119
10840014|NCT04147650|12005402|FG002|Modified Intent to Treat (mITT)|Overall Study||122
10840015|NCT04147650|12005403|FG003|Modified Intent to Treat (mITT)|Overall Study||121
10840016|NCT04147650|12005400|FG000|COMPLETED|Overall Study||116
10840017|NCT04147650|12005401|FG001|COMPLETED|Overall Study||107
10840018|NCT04147650|12005402|FG002|COMPLETED|Overall Study||121
10840019|NCT04147650|12005403|FG003|COMPLETED|Overall Study||120
10840020|NCT04147650|12005400|FG000|NOT COMPLETED|Overall Study||11
10840021|NCT04147650|12005401|FG001|NOT COMPLETED|Overall Study||19
10840022|NCT04147650|12005402|FG002|NOT COMPLETED|Overall Study||7
10840023|NCT04147650|12005403|FG003|NOT COMPLETED|Overall Study||7
10840024|NCT03527238|12005415|FG000|STARTED|Overall Study||31
10840025|NCT03527238|12005416|FG001|STARTED|Overall Study||31
10840026|NCT03527238|12005415|FG000|COMPLETED|Overall Study||29
10840027|NCT03527238|12005416|FG001|COMPLETED|Overall Study||27
10840028|NCT03527238|12005415|FG000|NOT COMPLETED|Overall Study||2
10840029|NCT03527238|12005416|FG001|NOT COMPLETED|Overall Study||4
10840030|NCT03116685|12005424|FG000|STARTED|Overall Study||13
10840031|NCT03116685|12005425|FG001|STARTED|Overall Study||12
10840032|NCT03116685|12005424|FG000|COMPLETED|Overall Study||13
10840033|NCT03116685|12005425|FG001|COMPLETED|Overall Study||11
10840034|NCT03116685|12005424|FG000|NOT COMPLETED|Overall Study||0
10840035|NCT03116685|12005425|FG001|NOT COMPLETED|Overall Study||1
10840036|NCT03099304|12005436|FG000|STARTED|DB Period Day 1 to Week 24||32
10840037|NCT03099304|12005437|FG001|STARTED|DB Period Day 1 to Week 24||31
10840038|NCT03099304|12005438|FG002|STARTED|DB Period Day 1 to Week 24||31
10840039|NCT03099304|12005439|FG003|STARTED|DB Period Day 1 to Week 24||30
11221703|NCT01967732|12413414|FG000|NOT COMPLETED|First Intervention (Day 1)||0
11221704|NCT01967732|12413415|FG001|NOT COMPLETED|First Intervention (Day 1)||1
11221705|NCT01967732|12413416|FG002|NOT COMPLETED|First Intervention (Day 1)||0
11221706|NCT01967732|12413417|FG003|NOT COMPLETED|First Intervention (Day 1)||0
11221707|NCT01967732|12413414|FG000|STARTED|Washout Period of 1 Day (Day 2)||22
11221708|NCT01967732|12413415|FG001|STARTED|Washout Period of 1 Day (Day 2)||20
11221709|NCT01967732|12413416|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
11221710|NCT01967732|12413417|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
11221711|NCT01967732|12413414|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22
11221712|NCT01967732|12413415|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||20
11221713|NCT01967732|12413416|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
11221714|NCT01967732|12413417|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
11221715|NCT01967732|12413414|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11221716|NCT01967732|12413415|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11221717|NCT01967732|12413416|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11221718|NCT01967732|12413417|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
11221719|NCT01967732|12413414|FG000|STARTED|Second Intervention (Day 3)||22
11221720|NCT01967732|12413415|FG001|STARTED|Second Intervention (Day 3)||20
11221721|NCT01967732|12413416|FG002|STARTED|Second Intervention (Day 3)||9
11221722|NCT01967732|12413417|FG003|STARTED|Second Intervention (Day 3)||9
11221723|NCT01967732|12413414|FG000|COMPLETED|Second Intervention (Day 3)||22
11221724|NCT01967732|12413415|FG001|COMPLETED|Second Intervention (Day 3)||20
11221725|NCT01967732|12413416|FG002|COMPLETED|Second Intervention (Day 3)||9
11221726|NCT01967732|12413417|FG003|COMPLETED|Second Intervention (Day 3)||9
11221727|NCT01967732|12413414|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
11221728|NCT01967732|12413415|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
11221729|NCT01967732|12413416|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
11221730|NCT01967732|12413417|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
11221731|NCT01967784|12413425|FG000|STARTED|Overall Study||100
11221732|NCT01967784|12413425|FG000|COMPLETED|Overall Study||100
11221733|NCT01967784|12413425|FG000|NOT COMPLETED|Overall Study||0
11221734|NCT01967836|12413429|FG000|STARTED|Overall Study||20
11221735|NCT01967836|12413429|FG000|COMPLETED|Overall Study||11
11221736|NCT01967836|12413429|FG000|NOT COMPLETED|Overall Study||9
11221737|NCT01967862|12413434|FG000|STARTED|Overall Study||54
11221738|NCT01967862|12413434|FG000|COMPLETED|Overall Study||54
11221739|NCT01967862|12413434|FG000|NOT COMPLETED|Overall Study||0
11221740|NCT01967888|12413440|FG000|STARTED|Overall Study||52
11221741|NCT01967888|12413441|FG001|STARTED|Overall Study||52
11221742|NCT01967888|12413440|FG000|COMPLETED|Overall Study||42
11221743|NCT01967888|12413441|FG001|COMPLETED|Overall Study||45
11221744|NCT01967888|12413440|FG000|NOT COMPLETED|Overall Study||10
11221745|NCT01967888|12413441|FG001|NOT COMPLETED|Overall Study||7
11221746|NCT01967940|12413450|FG000|STARTED|Part 1||12
11221747|NCT01967940|12413451|FG001|STARTED|Part 1||28
11221748|NCT01967940|12413452|FG002|STARTED|Part 1||15
11221749|NCT01967940|12413453|FG003|STARTED|Part 1||0
11221750|NCT01967940|12413450|FG000|COMPLETED|Part 1||12
11221751|NCT01967940|12413451|FG001|COMPLETED|Part 1||28
11221752|NCT01967940|12413452|FG002|COMPLETED|Part 1||15
11221753|NCT01967940|12413453|FG003|COMPLETED|Part 1||0
11221754|NCT01967940|12413450|FG000|NOT COMPLETED|Part 1||0
11221755|NCT01967940|12413451|FG001|NOT COMPLETED|Part 1||0
11221756|NCT01967940|12413452|FG002|NOT COMPLETED|Part 1||0
11221757|NCT01967940|12413453|FG003|NOT COMPLETED|Part 1||0
11221758|NCT01967940|12413450|FG000|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
11221759|NCT01967940|12413451|FG001|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
10840040|NCT03099304|12005440|FG004|STARTED|DB Period Day 1 to Week 24||33
10840041|NCT03099304|12005436|FG000|COMPLETED|DB Period Day 1 to Week 24||27
10840042|NCT03099304|12005437|FG001|COMPLETED|DB Period Day 1 to Week 24||26
11221760|NCT01967940|12413452|FG002|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
11221761|NCT01967940|12413453|FG003|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
11221762|NCT01967940|12413450|FG000|COMPLETED|Part 2||0
11221763|NCT01967940|12413451|FG001|COMPLETED|Part 2||0
11221764|NCT01967940|12413452|FG002|COMPLETED|Part 2||0
11221765|NCT01967940|12413453|FG003|COMPLETED|Part 2||35
11221766|NCT01967940|12413450|FG000|NOT COMPLETED|Part 2||0
11221767|NCT01967940|12413451|FG001|NOT COMPLETED|Part 2||0
10840043|NCT03099304|12005438|FG002|COMPLETED|DB Period Day 1 to Week 24||30
10840044|NCT03099304|12005439|FG003|COMPLETED|DB Period Day 1 to Week 24||26
10840045|NCT03099304|12005440|FG004|COMPLETED|DB Period Day 1 to Week 24||30
10840046|NCT03099304|12005436|FG000|NOT COMPLETED|DB Period Day 1 to Week 24||5
10840047|NCT03099304|12005437|FG001|NOT COMPLETED|DB Period Day 1 to Week 24||5
10840048|NCT03099304|12005438|FG002|NOT COMPLETED|DB Period Day 1 to Week 24||1
10840049|NCT03099304|12005439|FG003|NOT COMPLETED|DB Period Day 1 to Week 24||4
10840050|NCT03099304|12005440|FG004|NOT COMPLETED|DB Period Day 1 to Week 24||3
10840051|NCT03099304|12005436|FG000|STARTED|DB Period Weeks 24 to 52|Vehicle cream was not used after Week 24. After DB 24 week period, participants who met criteria were rerandomized to 1 of the 3 higher active blinded treatment groups.|0
10840052|NCT03099304|12005437|FG001|STARTED|DB Period Weeks 24 to 52|These subjects continued on the initial .15% QD treatment.|11
10840053|NCT03099304|12005438|FG002|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 0.5% QD and those re-randomized from vehicle cream and .15% QD to 0.5% QD.|45
10840054|NCT03099304|12005439|FG003|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 1.5% QD and those re-randomized from vehicle cream and .15% QD to 1.5% QD.|44
10840055|NCT03099304|12005440|FG004|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 1.5% BID and those re-randomized from vehicle cream and .15% QD to 1.5% BID|47
10840056|NCT03099304|12005436|FG000|COMPLETED|DB Period Weeks 24 to 52||0
10840057|NCT03099304|12005437|FG001|COMPLETED|DB Period Weeks 24 to 52||10
10840058|NCT03099304|12005438|FG002|COMPLETED|DB Period Weeks 24 to 52||43
10840059|NCT03099304|12005439|FG003|COMPLETED|DB Period Weeks 24 to 52||37
10840060|NCT03099304|12005440|FG004|COMPLETED|DB Period Weeks 24 to 52||45
10840061|NCT03099304|12005436|FG000|NOT COMPLETED|DB Period Weeks 24 to 52||0
10840062|NCT03099304|12005437|FG001|NOT COMPLETED|DB Period Weeks 24 to 52||1
10840063|NCT03099304|12005438|FG002|NOT COMPLETED|DB Period Weeks 24 to 52||2
10840064|NCT03099304|12005439|FG003|NOT COMPLETED|DB Period Weeks 24 to 52||7
10840065|NCT03099304|12005440|FG004|NOT COMPLETED|DB Period Weeks 24 to 52||2
10840066|NCT03034863|12005461|FG000|STARTED|Overall Study||38
10840067|NCT03034863|12005462|FG001|STARTED|Overall Study||40
10840068|NCT03034863|12005461|FG000|Veterans|Overall Study||19
10840069|NCT03034863|12005462|FG001|Veterans|Overall Study||20
11221768|NCT01967940|12413452|FG002|NOT COMPLETED|Part 2||0
11221769|NCT01967940|12413453|FG003|NOT COMPLETED|Part 2||3
11221770|NCT01968031|12413466|FG000|STARTED|Overall Study||204
11221771|NCT01968031|12413467|FG001|STARTED|Overall Study||202
11221772|NCT01968031|12413468|FG002|STARTED|Overall Study||207
11221773|NCT01968031|12413466|FG000|Completed Week 2|Overall Study||197
11221774|NCT01968031|12413467|FG001|Completed Week 2|Overall Study||190
10840070|NCT03034863|12005461|FG000|Supporting Partners|Overall Study||19
10840071|NCT03034863|12005462|FG001|Supporting Partners|Overall Study||20
10840072|NCT03034863|12005461|FG000|COMPLETED|Overall Study||28
10840073|NCT03034863|12005462|FG001|COMPLETED|Overall Study||28
10840074|NCT03034863|12005461|FG000|NOT COMPLETED|Overall Study||10
10840075|NCT03034863|12005462|FG001|NOT COMPLETED|Overall Study||12
10840076|NCT02819050|12005475|FG000|STARTED|Overall Study||40
10840077|NCT02819050|12005476|FG001|STARTED|Overall Study||40
10840078|NCT02819050|12005475|FG000|COMPLETED|Overall Study||40
10840079|NCT02819050|12005476|FG001|COMPLETED|Overall Study||40
10840080|NCT02819050|12005475|FG000|NOT COMPLETED|Overall Study||0
10840081|NCT02819050|12005476|FG001|NOT COMPLETED|Overall Study||0
10840082|NCT02682901|12005486|FG000|STARTED|Overall Study||43
10840083|NCT02682901|12005487|FG001|STARTED|Overall Study||41
10840084|NCT02682901|12005486|FG000|Completed 4 Weeks|Overall Study||38
10840085|NCT02682901|12005487|FG001|Completed 4 Weeks|Overall Study||39
10840086|NCT02682901|12005486|FG000|Completed 12 Weeks|Overall Study||36
10840087|NCT02682901|12005487|FG001|Completed 12 Weeks|Overall Study||37
10840088|NCT02682901|12005486|FG000|COMPLETED|Overall Study||33
10840089|NCT02682901|12005487|FG001|COMPLETED|Overall Study||37
10840090|NCT02682901|12005486|FG000|NOT COMPLETED|Overall Study||10
10840091|NCT02682901|12005487|FG001|NOT COMPLETED|Overall Study||4
10840092|NCT02555657|12005495|FG000|STARTED|Overall Study||312
10840093|NCT02555657|12005496|FG001|STARTED|Overall Study||310
10840094|NCT02555657|12005495|FG000|Treated|Overall Study||309
10840095|NCT02555657|12005496|FG001|Treated|Overall Study||292
10840096|NCT02555657|12005495|FG000|COMPLETED|Overall Study||0
10840097|NCT02555657|12005496|FG001|COMPLETED|Overall Study||0
10840098|NCT02555657|12005495|FG000|NOT COMPLETED|Overall Study||312
10840099|NCT02555657|12005496|FG001|NOT COMPLETED|Overall Study||310
10840100|NCT02190721|12005506|FG000|STARTED|Overall Study||2
10840101|NCT02190721|12005507|FG001|STARTED|Overall Study||30
10840102|NCT02190721|12005508|FG002|STARTED|Overall Study||18
10840103|NCT02190721|12005506|FG000|Completed Treatment|Overall Study||2
10840104|NCT02190721|12005507|FG001|Completed Treatment|Overall Study||30
11221775|NCT01968031|12413468|FG002|Completed Week 2|Overall Study||199
11221776|NCT01968031|12413466|FG000|Completed Week 6|Overall Study||191
11221777|NCT01968031|12413467|FG001|Completed Week 6|Overall Study||183
10840105|NCT02190721|12005508|FG002|Completed Treatment|Overall Study||18
10840106|NCT02190721|12005506|FG000|Completed 30 Day Follow-up|Overall Study||2
10840107|NCT02190721|12005507|FG001|Completed 30 Day Follow-up|Overall Study||29
10840108|NCT02190721|12005508|FG002|Completed 30 Day Follow-up|Overall Study||18
10840109|NCT02190721|12005506|FG000|Completed 90 Day Follow-up|Overall Study||2
10840110|NCT02190721|12005507|FG001|Completed 90 Day Follow-up|Overall Study||29
10840111|NCT02190721|12005508|FG002|Completed 90 Day Follow-up|Overall Study||18
10840112|NCT02190721|12005506|FG000|COMPLETED|Overall Study||2
10840113|NCT02190721|12005507|FG001|COMPLETED|Overall Study||29
10840114|NCT02190721|12005508|FG002|COMPLETED|Overall Study||18
10840115|NCT02190721|12005506|FG000|NOT COMPLETED|Overall Study||0
10840116|NCT02190721|12005507|FG001|NOT COMPLETED|Overall Study||1
10840117|NCT02190721|12005508|FG002|NOT COMPLETED|Overall Study||0
10840118|NCT00908687|12005522|FG000|STARTED|Overall Study||50
10840119|NCT00908687|12005523|FG001|STARTED|Overall Study||100
10840120|NCT00908687|12005524|FG002|STARTED|Overall Study||102
10840121|NCT00908687|12005525|FG003|STARTED|Overall Study||50
10840122|NCT00908687|12005526|FG004|STARTED|Overall Study||98
10840123|NCT00908687|12005527|FG005|STARTED|Overall Study||100
10840124|NCT00908687|12005522|FG000|COMPLETED|Overall Study||49
10840125|NCT00908687|12005523|FG001|COMPLETED|Overall Study||99
10840126|NCT00908687|12005524|FG002|COMPLETED|Overall Study||99
10840127|NCT00908687|12005525|FG003|COMPLETED|Overall Study||47
10840128|NCT00908687|12005526|FG004|COMPLETED|Overall Study||94
10840129|NCT00908687|12005527|FG005|COMPLETED|Overall Study||94
10840130|NCT00908687|12005522|FG000|NOT COMPLETED|Overall Study||1
10840131|NCT00908687|12005523|FG001|NOT COMPLETED|Overall Study||1
10840132|NCT00908687|12005524|FG002|NOT COMPLETED|Overall Study||3
10840133|NCT00908687|12005525|FG003|NOT COMPLETED|Overall Study||3
10840134|NCT00908687|12005526|FG004|NOT COMPLETED|Overall Study||4
10840135|NCT00908687|12005527|FG005|NOT COMPLETED|Overall Study||6
10840136|NCT00739401|12005541|FG000|STARTED|Overall Study||44
10840137|NCT00739401|12005541|FG000|COMPLETED|Overall Study||3
10840138|NCT00739401|12005541|FG000|NOT COMPLETED|Overall Study||41
10840139|NCT00651742|12005545|FG000|STARTED|Overall Study||28
10840140|NCT00651742|12005545|FG000|Treated|Overall Study||27
10840141|NCT00651742|12005545|FG000|Efficacy Analysis Per Investigator|Overall Study||21
10840142|NCT00651742|12005545|FG000|Efficacy Analysis Per Independent Reader|Overall Study||25
10840143|NCT00651742|12005545|FG000|COMPLETED|Overall Study||0
10840144|NCT00651742|12005545|FG000|NOT COMPLETED|Overall Study||28
10840145|NCT00308516|12005551|FG000|STARTED|Overall Study||35
10840146|NCT00308516|12005552|FG001|STARTED|Overall Study||31
10840147|NCT00308516|12005551|FG000|COMPLETED|Overall Study||6
10840148|NCT00308516|12005552|FG001|COMPLETED|Overall Study||10
10840149|NCT00308516|12005551|FG000|NOT COMPLETED|Overall Study||29
10840150|NCT00308516|12005552|FG001|NOT COMPLETED|Overall Study||21
10840151|NCT04331366|12005558|FG000|STARTED|Overall Study||2
10840152|NCT04331366|12005558|FG000|COMPLETED|Overall Study||2
10840153|NCT04331366|12005558|FG000|NOT COMPLETED|Overall Study||0
10840154|NCT04930263|12005564|FG000|STARTED|Overall Study||33
10840155|NCT04930263|12005565|FG001|STARTED|Overall Study||33
10840156|NCT04930263|12005564|FG000|COMPLETED|Overall Study||30
10840157|NCT04930263|12005565|FG001|COMPLETED|Overall Study||28
10840158|NCT04930263|12005564|FG000|NOT COMPLETED|Overall Study||3
10840159|NCT04930263|12005565|FG001|NOT COMPLETED|Overall Study||5
10840160|NCT04321252|12005580|FG000|STARTED|Overall Study||6
10840161|NCT04321252|12005581|FG001|STARTED|Overall Study||6
10840162|NCT04321252|12005582|FG002|STARTED|Overall Study||6
10840163|NCT04321252|12005583|FG003|STARTED|Overall Study||6
10840164|NCT04321252|12005584|FG004|STARTED|Overall Study||6
10840165|NCT04321252|12005585|FG005|STARTED|Overall Study||9
10840166|NCT04321252|12005586|FG006|STARTED|Overall Study||6
10840167|NCT04321252|12005587|FG007|STARTED|Overall Study||6
10840168|NCT04321252|12005588|FG008|STARTED|Overall Study||6
10840169|NCT04321252|12005580|FG000|PK Analysis Set|Overall Study||6
10840170|NCT04321252|12005581|FG001|PK Analysis Set|Overall Study||6
10840171|NCT04321252|12005582|FG002|PK Analysis Set|Overall Study||6
10840172|NCT04321252|12005583|FG003|PK Analysis Set|Overall Study||6
10840173|NCT04321252|12005584|FG004|PK Analysis Set|Overall Study||6
10840174|NCT04321252|12005585|FG005|PK Analysis Set|Overall Study||0
10840175|NCT04321252|12005586|FG006|PK Analysis Set|Overall Study||6
10840176|NCT04321252|12005587|FG007|PK Analysis Set|Overall Study||6
10840177|NCT04321252|12005588|FG008|PK Analysis Set|Overall Study||0
10840178|NCT04321252|12005580|FG000|COMPLETED|Overall Study||6
10840179|NCT04321252|12005581|FG001|COMPLETED|Overall Study||6
10840180|NCT04321252|12005582|FG002|COMPLETED|Overall Study||6
10840181|NCT04321252|12005583|FG003|COMPLETED|Overall Study||6
10840182|NCT04321252|12005584|FG004|COMPLETED|Overall Study||6
10840183|NCT04321252|12005585|FG005|COMPLETED|Overall Study||8
10840184|NCT04321252|12005586|FG006|COMPLETED|Overall Study||6
10840185|NCT04321252|12005587|FG007|COMPLETED|Overall Study||6
10840186|NCT04321252|12005588|FG008|COMPLETED|Overall Study||6
10840187|NCT04321252|12005580|FG000|NOT COMPLETED|Overall Study||0
10840188|NCT04321252|12005581|FG001|NOT COMPLETED|Overall Study||0
10840189|NCT04321252|12005582|FG002|NOT COMPLETED|Overall Study||0
10840190|NCT04321252|12005583|FG003|NOT COMPLETED|Overall Study||0
10840191|NCT04321252|12005584|FG004|NOT COMPLETED|Overall Study||0
10840192|NCT04321252|12005585|FG005|NOT COMPLETED|Overall Study||1
10840193|NCT04321252|12005586|FG006|NOT COMPLETED|Overall Study||0
10840194|NCT04321252|12005587|FG007|NOT COMPLETED|Overall Study||0
10840195|NCT04321252|12005588|FG008|NOT COMPLETED|Overall Study||0
10840196|NCT04285684|12005614|FG000|STARTED|Overall Study||4
10840197|NCT04285684|12005614|FG000|COMPLETED|Overall Study||4
10840198|NCT04285684|12005614|FG000|NOT COMPLETED|Overall Study||0
10840199|NCT04176445|12005618|FG000|STARTED|Overall Study||12
10840200|NCT04176445|12005619|FG001|STARTED|Overall Study||7
10840201|NCT04176445|12005618|FG000|COMPLETED|Overall Study||12
10840202|NCT04176445|12005619|FG001|COMPLETED|Overall Study||5
10840203|NCT04176445|12005618|FG000|NOT COMPLETED|Overall Study||0
10840204|NCT04176445|12005619|FG001|NOT COMPLETED|Overall Study||2
10840205|NCT04126213|12005631|FG000|STARTED|Overall Study||70
10840206|NCT04126213|12005632|FG001|STARTED|Overall Study||75
10840207|NCT04126213|12005633|FG002|STARTED|Overall Study||68
10840208|NCT04126213|12005634|FG003|STARTED|Overall Study||67
10840209|NCT04126213|12005635|FG004|STARTED|Overall Study||73
10840210|NCT04126213|12005636|FG005|STARTED|Overall Study||66
10840211|NCT04126213|12005631|FG000|COMPLETED|Overall Study||58
10840212|NCT04126213|12005632|FG001|COMPLETED|Overall Study||70
10840213|NCT04126213|12005633|FG002|COMPLETED|Overall Study||59
10840214|NCT04126213|12005634|FG003|COMPLETED|Overall Study||54
10840215|NCT04126213|12005635|FG004|COMPLETED|Overall Study||67
10840216|NCT04126213|12005636|FG005|COMPLETED|Overall Study||55
10840217|NCT04126213|12005631|FG000|NOT COMPLETED|Overall Study||12
10840218|NCT04126213|12005632|FG001|NOT COMPLETED|Overall Study||5
10840219|NCT04126213|12005633|FG002|NOT COMPLETED|Overall Study||9
10840220|NCT04126213|12005634|FG003|NOT COMPLETED|Overall Study||13
10840221|NCT04126213|12005635|FG004|NOT COMPLETED|Overall Study||6
10840222|NCT04126213|12005636|FG005|NOT COMPLETED|Overall Study||11
10840223|NCT03916458|12005653|FG000|STARTED|Overall Study||62
10840224|NCT03916458|12005653|FG000|COMPLETED|Overall Study|Out of these 62 participants, 2 participants died. But data available before censoring date for these 2 participants were observed and included in results.|62
10840225|NCT03916458|12005653|FG000|NOT COMPLETED|Overall Study||0
10840226|NCT03672188|12005672|FG000|STARTED|Overall Study||6
10840227|NCT03672188|12005673|FG001|STARTED|Overall Study||6
10840228|NCT03672188|12005674|FG002|STARTED|Overall Study||6
10840229|NCT03672188|12005675|FG003|STARTED|Overall Study||8
10840230|NCT03672188|12005676|FG004|STARTED|Overall Study||6
10840231|NCT03672188|12005677|FG005|STARTED|Overall Study||6
10840232|NCT03672188|12005678|FG006|STARTED|Overall Study||12
10840233|NCT03672188|12005679|FG007|STARTED|Overall Study||3
10840234|NCT03672188|12005680|FG008|STARTED|Overall Study||6
10840235|NCT03672188|12005681|FG009|STARTED|Overall Study||6
10840236|NCT03672188|12005682|FG010|STARTED|Overall Study||3
10840237|NCT03672188|12005683|FG011|STARTED|Overall Study||3
10840238|NCT03672188|12005684|FG012|STARTED|Overall Study||3
10840239|NCT03672188|12005685|FG013|STARTED|Overall Study||6
10840240|NCT03672188|12005686|FG014|STARTED|Overall Study||2
10840241|NCT03672188|12005672|FG000|Dosed|Overall Study||6
10840242|NCT03672188|12005673|FG001|Dosed|Overall Study||6
10840243|NCT03672188|12005674|FG002|Dosed|Overall Study||6
10840244|NCT03672188|12005675|FG003|Dosed|Overall Study|1 subject was not dosed and therefore not included in any analyses.|7
10840245|NCT03672188|12005676|FG004|Dosed|Overall Study||6
10840246|NCT03672188|12005677|FG005|Dosed|Overall Study||6
10840247|NCT03672188|12005678|FG006|Dosed|Overall Study||12
10840248|NCT03672188|12005679|FG007|Dosed|Overall Study||3
10840249|NCT03672188|12005680|FG008|Dosed|Overall Study||6
10840250|NCT03672188|12005681|FG009|Dosed|Overall Study||6
10840251|NCT03672188|12005682|FG010|Dosed|Overall Study||3
10840252|NCT03672188|12005683|FG011|Dosed|Overall Study||3
10840253|NCT03672188|12005684|FG012|Dosed|Overall Study||3
10840254|NCT03672188|12005685|FG013|Dosed|Overall Study||6
10840255|NCT03672188|12005686|FG014|Dosed|Overall Study||2
10840256|NCT03672188|12005672|FG000|COMPLETED|Overall Study||6
10840257|NCT03672188|12005673|FG001|COMPLETED|Overall Study||6
10840258|NCT03672188|12005674|FG002|COMPLETED|Overall Study|1 Subject could not attend last follow up (Week 12 visit)|5
10840259|NCT03672188|12005675|FG003|COMPLETED|Overall Study||5
10840260|NCT03672188|12005676|FG004|COMPLETED|Overall Study||6
10840261|NCT03672188|12005677|FG005|COMPLETED|Overall Study||6
10840262|NCT03672188|12005678|FG006|COMPLETED|Overall Study||12
10840263|NCT03672188|12005679|FG007|COMPLETED|Overall Study||3
10840264|NCT03672188|12005680|FG008|COMPLETED|Overall Study||6
10840265|NCT03672188|12005681|FG009|COMPLETED|Overall Study||6
10840266|NCT03672188|12005682|FG010|COMPLETED|Overall Study||3
10840267|NCT03672188|12005683|FG011|COMPLETED|Overall Study||3
10840268|NCT03672188|12005684|FG012|COMPLETED|Overall Study|1 non-treatment related SAE of suicide during follow up period|2
10840269|NCT03672188|12005685|FG013|COMPLETED|Overall Study||6
10840270|NCT03672188|12005686|FG014|COMPLETED|Overall Study||2
10840271|NCT03672188|12005672|FG000|NOT COMPLETED|Overall Study||0
10840272|NCT03672188|12005673|FG001|NOT COMPLETED|Overall Study||0
10840273|NCT03672188|12005674|FG002|NOT COMPLETED|Overall Study||1
10840274|NCT03672188|12005675|FG003|NOT COMPLETED|Overall Study||3
10840275|NCT03672188|12005676|FG004|NOT COMPLETED|Overall Study||0
10840276|NCT03672188|12005677|FG005|NOT COMPLETED|Overall Study||0
10840277|NCT03672188|12005678|FG006|NOT COMPLETED|Overall Study||0
10840278|NCT03672188|12005679|FG007|NOT COMPLETED|Overall Study||0
10840279|NCT03672188|12005680|FG008|NOT COMPLETED|Overall Study||0
10840280|NCT03672188|12005681|FG009|NOT COMPLETED|Overall Study||0
10840281|NCT03672188|12005682|FG010|NOT COMPLETED|Overall Study||0
10840282|NCT03672188|12005683|FG011|NOT COMPLETED|Overall Study||0
10840283|NCT03672188|12005684|FG012|NOT COMPLETED|Overall Study||1
10840284|NCT03672188|12005685|FG013|NOT COMPLETED|Overall Study||0
10840285|NCT03672188|12005686|FG014|NOT COMPLETED|Overall Study||0
10840286|NCT03637959|12005752|FG000|STARTED|Overall Study||270
10840287|NCT03637959|12005752|FG000|COMPLETED|Overall Study||270
10840288|NCT03637959|12005752|FG000|NOT COMPLETED|Overall Study||0
10840289|NCT03230916|12005767|FG000|STARTED|Overall Study||7
10840290|NCT03230916|12005768|FG001|STARTED|Overall Study||6
10840291|NCT03230916|12005769|FG002|STARTED|Overall Study||6
10840292|NCT03230916|12005770|FG003|STARTED|Overall Study||4
10840293|NCT03230916|12005771|FG004|STARTED|Overall Study||4
10840294|NCT03230916|12005772|FG005|STARTED|Overall Study||6
10840295|NCT03230916|12005773|FG006|STARTED|Overall Study||3
10840296|NCT03230916|12005774|FG007|STARTED|Overall Study||2
10840297|NCT03230916|12005775|FG008|STARTED|Overall Study||2
10840298|NCT03230916|12005776|FG009|STARTED|Overall Study||3
10840299|NCT03230916|12005777|FG010|STARTED|Overall Study||4
10840300|NCT03230916|12005767|FG000|Treated|Overall Study||7
10840301|NCT03230916|12005768|FG001|Treated|Overall Study||6
10840302|NCT03230916|12005769|FG002|Treated|Overall Study||6
10840303|NCT03230916|12005770|FG003|Treated|Overall Study||4
10840304|NCT03230916|12005771|FG004|Treated|Overall Study||4
10840305|NCT03230916|12005772|FG005|Treated|Overall Study||5
10840306|NCT03230916|12005773|FG006|Treated|Overall Study||3
10840307|NCT03230916|12005774|FG007|Treated|Overall Study||2
10840308|NCT03230916|12005775|FG008|Treated|Overall Study||2
10840309|NCT03230916|12005776|FG009|Treated|Overall Study||3
10840310|NCT03230916|12005777|FG010|Treated|Overall Study||4
10840311|NCT03230916|12005767|FG000|COMPLETED|Overall Study||7
10840312|NCT03230916|12005768|FG001|COMPLETED|Overall Study||6
10840313|NCT03230916|12005769|FG002|COMPLETED|Overall Study||6
10840314|NCT03230916|12005770|FG003|COMPLETED|Overall Study||4
10840315|NCT03230916|12005771|FG004|COMPLETED|Overall Study||4
10840316|NCT03230916|12005772|FG005|COMPLETED|Overall Study||5
10840317|NCT03230916|12005773|FG006|COMPLETED|Overall Study||3
10840318|NCT03230916|12005774|FG007|COMPLETED|Overall Study||2
10840319|NCT03230916|12005775|FG008|COMPLETED|Overall Study||2
10840320|NCT03230916|12005776|FG009|COMPLETED|Overall Study||3
10840321|NCT03230916|12005777|FG010|COMPLETED|Overall Study||4
10840322|NCT03230916|12005767|FG000|NOT COMPLETED|Overall Study||0
10840323|NCT03230916|12005768|FG001|NOT COMPLETED|Overall Study||0
10840324|NCT03230916|12005769|FG002|NOT COMPLETED|Overall Study||0
10840325|NCT03230916|12005770|FG003|NOT COMPLETED|Overall Study||0
10840326|NCT03230916|12005771|FG004|NOT COMPLETED|Overall Study||0
11104006|NCT01245764|12288206|FG003|Completed Vaccinations in Study Phase B|Study Phase B||17
11104007|NCT01245764|12288203|FG000|COMPLETED|Study Phase B||0
11104008|NCT01245764|12288204|FG001|COMPLETED|Study Phase B||0
11104009|NCT01245764|12288205|FG002|COMPLETED|Study Phase B||0
11104010|NCT01245764|12288206|FG003|COMPLETED|Study Phase B||17
11104011|NCT01245764|12288203|FG000|NOT COMPLETED|Study Phase B||0
11104012|NCT01245764|12288204|FG001|NOT COMPLETED|Study Phase B||0
11104013|NCT01245764|12288205|FG002|NOT COMPLETED|Study Phase B||0
11104014|NCT01245764|12288206|FG003|NOT COMPLETED|Study Phase B||0
11104015|NCT01245972|12288227|FG000|STARTED|Overall Study||7
11104016|NCT01245972|12288228|FG001|STARTED|Overall Study||8
11104017|NCT01245972|12288229|FG002|STARTED|Overall Study||8
11104018|NCT01245972|12288227|FG000|COMPLETED|Overall Study||7
11104019|NCT01245972|12288228|FG001|COMPLETED|Overall Study||8
11104020|NCT01245972|12288229|FG002|COMPLETED|Overall Study||8
11104021|NCT01245972|12288227|FG000|NOT COMPLETED|Overall Study||0
11104022|NCT01245972|12288228|FG001|NOT COMPLETED|Overall Study||0
11104023|NCT01245972|12288229|FG002|NOT COMPLETED|Overall Study||0
11104024|NCT01246050|12288239|FG000|STARTED|Overall Study||6
11104025|NCT01246050|12288240|FG001|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
11104026|NCT01246050|12288239|FG000|COMPLETED|Overall Study||6
11104027|NCT01246050|12288240|FG001|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
10840327|NCT03230916|12005772|FG005|NOT COMPLETED|Overall Study||1
10840328|NCT03230916|12005773|FG006|NOT COMPLETED|Overall Study||0
10840329|NCT03230916|12005774|FG007|NOT COMPLETED|Overall Study||0
10840330|NCT03230916|12005775|FG008|NOT COMPLETED|Overall Study||0
10840331|NCT03230916|12005776|FG009|NOT COMPLETED|Overall Study||0
10840332|NCT03230916|12005777|FG010|NOT COMPLETED|Overall Study||0
10840333|NCT03195894|12005820|FG000|STARTED|Overall Study||59
10840334|NCT03195894|12005821|FG001|STARTED|Overall Study||56
10840335|NCT03195894|12005820|FG000|COMPLETED|Overall Study||26
10840336|NCT03195894|12005821|FG001|COMPLETED|Overall Study||28
10840337|NCT03195894|12005820|FG000|NOT COMPLETED|Overall Study||33
10840338|NCT03195894|12005821|FG001|NOT COMPLETED|Overall Study||28
10840339|NCT03032705|12005832|FG000|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51
10840340|NCT03032705|12005833|FG001|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51
10840341|NCT03032705|12005832|FG000|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45
10840342|NCT03032705|12005833|FG001|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45
10840343|NCT03032705|12005832|FG000|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|29
10840344|NCT03032705|12005833|FG001|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|28
10840345|NCT03032705|12005832|FG000|NOT COMPLETED|Overall Study||22
10840346|NCT03032705|12005833|FG001|NOT COMPLETED|Overall Study||23
11104028|NCT01246050|12288239|FG000|NOT COMPLETED|Overall Study||0
11104029|NCT01246050|12288240|FG001|NOT COMPLETED|Overall Study||0
11104030|NCT01246063|12288252|FG000|STARTED|Overall Study||3
10840347|NCT02573259|12005846|FG000|STARTED|Overall Study||2
10840348|NCT02573259|12005847|FG001|STARTED|Overall Study||8
10840349|NCT02573259|12005848|FG002|STARTED|Overall Study||8
10840350|NCT02573259|12005849|FG003|STARTED|Overall Study||7
10840351|NCT02573259|12005850|FG004|STARTED|Overall Study||15
10840352|NCT02573259|12005851|FG005|STARTED|Overall Study||68
10840353|NCT02573259|12005852|FG006|STARTED|Overall Study||39
10840354|NCT02573259|12005846|FG000|Treated|Overall Study||2
10840355|NCT02573259|12005847|FG001|Treated|Overall Study||8
10840356|NCT02573259|12005848|FG002|Treated|Overall Study||8
10840357|NCT02573259|12005849|FG003|Treated|Overall Study||7
10840358|NCT02573259|12005850|FG004|Treated|Overall Study||15
10840359|NCT02573259|12005851|FG005|Treated|Overall Study||68
10840360|NCT02573259|12005852|FG006|Treated|Overall Study||38
10840361|NCT02573259|12005846|FG000|COMPLETED|Overall Study||1
10840362|NCT02573259|12005847|FG001|COMPLETED|Overall Study||0
10840363|NCT02573259|12005848|FG002|COMPLETED|Overall Study||2
10840364|NCT02573259|12005849|FG003|COMPLETED|Overall Study||1
10840365|NCT02573259|12005850|FG004|COMPLETED|Overall Study||2
10840366|NCT02573259|12005851|FG005|COMPLETED|Overall Study||10
10840367|NCT02573259|12005852|FG006|COMPLETED|Overall Study||5
10840368|NCT02573259|12005846|FG000|NOT COMPLETED|Overall Study||1
10840369|NCT02573259|12005847|FG001|NOT COMPLETED|Overall Study||8
10840370|NCT02573259|12005848|FG002|NOT COMPLETED|Overall Study||6
10840371|NCT02573259|12005849|FG003|NOT COMPLETED|Overall Study||6
10840372|NCT02573259|12005850|FG004|NOT COMPLETED|Overall Study||13
10840373|NCT02573259|12005851|FG005|NOT COMPLETED|Overall Study||58
10840374|NCT02573259|12005852|FG006|NOT COMPLETED|Overall Study||34
10840375|NCT02318329|12005894|FG000|STARTED|Overall Study||3
10840376|NCT02318329|12005895|FG001|STARTED|Overall Study||4
10840377|NCT02318329|12005896|FG002|STARTED|Overall Study||3
10840378|NCT02318329|12005897|FG003|STARTED|Overall Study||3
10840379|NCT02318329|12005898|FG004|STARTED|Overall Study||3
10840380|NCT02318329|12005899|FG005|STARTED|Overall Study||3
10840381|NCT02318329|12005900|FG006|STARTED|Overall Study||1
10840382|NCT02318329|12005901|FG007|STARTED|Overall Study||1
10840383|NCT02318329|12005902|FG008|STARTED|Overall Study||6
10840384|NCT02318329|12005903|FG009|STARTED|Overall Study||52
10840385|NCT02318329|12005894|FG000|COMPLETED|Overall Study||0
10840386|NCT02318329|12005895|FG001|COMPLETED|Overall Study||0
10840387|NCT02318329|12005896|FG002|COMPLETED|Overall Study||0
10840388|NCT02318329|12005897|FG003|COMPLETED|Overall Study||0
10840389|NCT02318329|12005898|FG004|COMPLETED|Overall Study||0
10840390|NCT02318329|12005899|FG005|COMPLETED|Overall Study||0
10840391|NCT02318329|12005900|FG006|COMPLETED|Overall Study||0
10840392|NCT02318329|12005901|FG007|COMPLETED|Overall Study||0
10840393|NCT02318329|12005902|FG008|COMPLETED|Overall Study||0
10840394|NCT02318329|12005903|FG009|COMPLETED|Overall Study||0
10840395|NCT02318329|12005894|FG000|NOT COMPLETED|Overall Study||3
10840396|NCT02318329|12005895|FG001|NOT COMPLETED|Overall Study||4
10840397|NCT02318329|12005896|FG002|NOT COMPLETED|Overall Study||3
10840398|NCT02318329|12005897|FG003|NOT COMPLETED|Overall Study||3
10840399|NCT02318329|12005898|FG004|NOT COMPLETED|Overall Study||3
10840400|NCT02318329|12005899|FG005|NOT COMPLETED|Overall Study||3
10840401|NCT02318329|12005900|FG006|NOT COMPLETED|Overall Study||1
10840402|NCT02318329|12005901|FG007|NOT COMPLETED|Overall Study||1
10840403|NCT02318329|12005902|FG008|NOT COMPLETED|Overall Study||6
10840404|NCT02318329|12005903|FG009|NOT COMPLETED|Overall Study||52
10840405|NCT01602666|12005946|FG000|STARTED|Induction Chemotherapy||107
10840406|NCT01602666|12005947|FG001|STARTED|Induction Chemotherapy||137
10840407|NCT01602666|12005946|FG000|COMPLETED|Induction Chemotherapy||70
10840408|NCT01602666|12005947|FG001|COMPLETED|Induction Chemotherapy||113
10840409|NCT01602666|12005946|FG000|NOT COMPLETED|Induction Chemotherapy||37
10840410|NCT01602666|12005947|FG001|NOT COMPLETED|Induction Chemotherapy||24
10840411|NCT01602666|12005946|FG000|STARTED|Radiation Therapy on Protocol||70
10840412|NCT01602666|12005947|FG001|STARTED|Radiation Therapy on Protocol||113
10840413|NCT01602666|12005946|FG000|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||66
10840414|NCT01602666|12005947|FG001|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||0
10840415|NCT01602666|12005946|FG000|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||0
10840416|NCT01602666|12005947|FG001|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||74
10840417|NCT01602666|12005946|FG000|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||0
10840418|NCT01602666|12005947|FG001|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||16
10840419|NCT01602666|12005946|FG000|COMPLETED|Radiation Therapy on Protocol||60
10840420|NCT01602666|12005947|FG001|COMPLETED|Radiation Therapy on Protocol||82
10840421|NCT01602666|12005946|FG000|NOT COMPLETED|Radiation Therapy on Protocol||10
10840422|NCT01602666|12005947|FG001|NOT COMPLETED|Radiation Therapy on Protocol||31
10840423|NCT01375959|12005957|FG000|STARTED|First Intervention (6 Weeks)||17
10840424|NCT01375959|12005958|FG001|STARTED|First Intervention (6 Weeks)||21
10840425|NCT01375959|12005957|FG000|Received Invertention|First Intervention (6 Weeks)||17
10840426|NCT01375959|12005958|FG001|Received Invertention|First Intervention (6 Weeks)||21
10840427|NCT01375959|12005957|FG000|COMPLETED|First Intervention (6 Weeks)|Two participants were withdrawn due to adverse events.|15
10840428|NCT01375959|12005958|FG001|COMPLETED|First Intervention (6 Weeks)|Three participants were withdrawn due to adverse events.|18
10840429|NCT01375959|12005957|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2
10840430|NCT01375959|12005958|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3
10840431|NCT01375959|12005957|FG000|STARTED|Wash-Out (3 Weeks)||15
10840432|NCT01375959|12005958|FG001|STARTED|Wash-Out (3 Weeks)||18
10840433|NCT01375959|12005957|FG000|COMPLETED|Wash-Out (3 Weeks)||15
10840434|NCT01375959|12005958|FG001|COMPLETED|Wash-Out (3 Weeks)||18
10840435|NCT01375959|12005957|FG000|NOT COMPLETED|Wash-Out (3 Weeks)||0
10840436|NCT01375959|12005958|FG001|NOT COMPLETED|Wash-Out (3 Weeks)||0
10840437|NCT01375959|12005957|FG000|STARTED|Second Intervention (6 Weeks)||15
10840438|NCT01375959|12005958|FG001|STARTED|Second Intervention (6 Weeks)||18
10840439|NCT01375959|12005957|FG000|COMPLETED|Second Intervention (6 Weeks)||15
10840440|NCT01375959|12005958|FG001|COMPLETED|Second Intervention (6 Weeks)||15
10840441|NCT01375959|12005957|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10840442|NCT01375959|12005958|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3
10840443|NCT01224106|12005969|FG000|STARTED|Double-Blind Treatment Phase||266
10840444|NCT01224106|12005970|FG001|STARTED|Double-Blind Treatment Phase||271
10840445|NCT01224106|12005971|FG002|STARTED|Double-Blind Treatment Phase||260
10840446|NCT01224106|12005972|FG003|STARTED|Double-Blind Treatment Phase||0
10840447|NCT01224106|12005973|FG004|STARTED|Double-Blind Treatment Phase||0
10840448|NCT01224106|12005969|FG000|COMPLETED|Double-Blind Treatment Phase||187
10840449|NCT01224106|12005970|FG001|COMPLETED|Double-Blind Treatment Phase||185
10840450|NCT01224106|12005971|FG002|COMPLETED|Double-Blind Treatment Phase||180
10840451|NCT01224106|12005972|FG003|COMPLETED|Double-Blind Treatment Phase||0
10840452|NCT01224106|12005973|FG004|COMPLETED|Double-Blind Treatment Phase||0
10840453|NCT01224106|12005969|FG000|NOT COMPLETED|Double-Blind Treatment Phase||79
10840454|NCT01224106|12005970|FG001|NOT COMPLETED|Double-Blind Treatment Phase||86
10840455|NCT01224106|12005971|FG002|NOT COMPLETED|Double-Blind Treatment Phase||80
10840456|NCT01224106|12005972|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
10840457|NCT01224106|12005973|FG004|NOT COMPLETED|Double-Blind Treatment Phase||0
10840458|NCT01224106|12005969|FG000|STARTED|Open-Label Extension (OLE) Phase||0
10840459|NCT01224106|12005970|FG001|STARTED|Open-Label Extension (OLE) Phase||0
10840460|NCT01224106|12005971|FG002|STARTED|Open-Label Extension (OLE) Phase||0
10840461|NCT01224106|12005972|FG003|STARTED|Open-Label Extension (OLE) Phase||49
10840462|NCT01224106|12005973|FG004|STARTED|Open-Label Extension (OLE) Phase||105
10840463|NCT01224106|12005969|FG000|COMPLETED|Open-Label Extension (OLE) Phase||0
10840464|NCT01224106|12005970|FG001|COMPLETED|Open-Label Extension (OLE) Phase||0
10840465|NCT01224106|12005971|FG002|COMPLETED|Open-Label Extension (OLE) Phase||0
10840466|NCT01224106|12005972|FG003|COMPLETED|Open-Label Extension (OLE) Phase||33
10840467|NCT01224106|12005973|FG004|COMPLETED|Open-Label Extension (OLE) Phase||71
10840468|NCT01224106|12005969|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
10840469|NCT01224106|12005970|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
10840470|NCT01224106|12005971|FG002|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
10840471|NCT01224106|12005972|FG003|NOT COMPLETED|Open-Label Extension (OLE) Phase||16
10840472|NCT01224106|12005973|FG004|NOT COMPLETED|Open-Label Extension (OLE) Phase||34
11221778|NCT01968031|12413468|FG002|Completed Week 6|Overall Study||187
11221779|NCT01968031|12413466|FG000|Completed Week 10|Overall Study||187
11221780|NCT01968031|12413467|FG001|Completed Week 10|Overall Study||181
11221781|NCT01968031|12413468|FG002|Completed Week 10|Overall Study||181
11221782|NCT01968031|12413466|FG000|COMPLETED|Overall Study||186
11221783|NCT01968031|12413467|FG001|COMPLETED|Overall Study||182
11221784|NCT01968031|12413468|FG002|COMPLETED|Overall Study||178
11221785|NCT01968031|12413466|FG000|NOT COMPLETED|Overall Study||18
11221786|NCT01968031|12413467|FG001|NOT COMPLETED|Overall Study||20
11221787|NCT01968031|12413468|FG002|NOT COMPLETED|Overall Study||29
11221788|NCT01968057|12413476|FG000|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
11221789|NCT01968057|12413476|FG000|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
11221790|NCT01968057|12413476|FG000|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
11221791|NCT01968057|12413476|FG000|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
11221792|NCT01968057|12413476|FG000|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
11221793|NCT01968057|12413476|FG000|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
11221794|NCT01968057|12413476|FG000|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
11221795|NCT01968057|12413476|FG000|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
11221796|NCT01968070|12413500|FG000|STARTED|Period 1||4
11221797|NCT01968070|12413501|FG001|STARTED|Period 1||4
11221798|NCT01968070|12413502|FG002|STARTED|Period 1||4
11221799|NCT01968070|12413503|FG003|STARTED|Period 1||4
11221800|NCT01968070|12413504|FG004|STARTED|Period 1||4
11221801|NCT01968070|12413505|FG005|STARTED|Period 1||4
11221802|NCT01968070|12413506|FG006|STARTED|Period 1||10
11221803|NCT01968070|12413507|FG007|STARTED|Period 1||2
11221804|NCT01968070|12413508|FG008|STARTED|Period 1||2
11221805|NCT01968070|12413509|FG009|STARTED|Period 1||9
11221806|NCT01968070|12413510|FG010|STARTED|Period 1||2
11221807|NCT01968070|12413511|FG011|STARTED|Period 1||2
11221808|NCT01968070|12413512|FG012|STARTED|Period 1||9
11221809|NCT01968070|12413513|FG013|STARTED|Period 1||2
10840473|NCT00999609|12005993|FG000|STARTED|Overall Study|Before intervention|21
11221810|NCT01968070|12413514|FG014|STARTED|Period 1||2
11221811|NCT01968070|12413515|FG015|STARTED|Period 1||9
11221812|NCT01968070|12413516|FG016|STARTED|Period 1||2
11221813|NCT01968070|12413517|FG017|STARTED|Period 1||2
11221814|NCT01968070|12413500|FG000|COMPLETED|Period 1||4
11221815|NCT01968070|12413501|FG001|COMPLETED|Period 1||3
11221816|NCT01968070|12413502|FG002|COMPLETED|Period 1||4
10840474|NCT00999609|12005994|FG001|STARTED|Overall Study||10
11221817|NCT01968070|12413503|FG003|COMPLETED|Period 1||2
11221818|NCT01968070|12413504|FG004|COMPLETED|Period 1||3
11221819|NCT01968070|12413505|FG005|COMPLETED|Period 1||4
10840475|NCT00999609|12005993|FG000|COMPLETED|Overall Study|1 year post intervention|20
10840476|NCT00999609|12005994|FG001|COMPLETED|Overall Study|1 year post intervention|9
10840477|NCT00999609|12005993|FG000|NOT COMPLETED|Overall Study||1
10840478|NCT00999609|12005994|FG001|NOT COMPLETED|Overall Study||1
10840479|NCT00354835|12006002|FG000|STARTED|Overall Study||239
10840480|NCT00354835|12006003|FG001|STARTED|Overall Study||242
10840481|NCT00354835|12006002|FG000|COMPLETED|Overall Study||187
10840482|NCT00354835|12006003|FG001|COMPLETED|Overall Study||181
10840483|NCT00354835|12006002|FG000|NOT COMPLETED|Overall Study||52
10840484|NCT00354835|12006003|FG001|NOT COMPLETED|Overall Study||61
10840485|NCT04531241|12006024|FG000|STARTED|Period 1||68
10840486|NCT04531241|12006025|FG001|STARTED|Period 1||67
10840487|NCT04531241|12006024|FG000|COMPLETED|Period 1||64
10840488|NCT04531241|12006025|FG001|COMPLETED|Period 1||65
10840489|NCT04531241|12006024|FG000|NOT COMPLETED|Period 1||4
10840490|NCT04531241|12006025|FG001|NOT COMPLETED|Period 1||2
10840491|NCT04531241|12006024|FG000|STARTED|Period 2||64
10840492|NCT04531241|12006025|FG001|STARTED|Period 2||65
10840493|NCT04531241|12006024|FG000|COMPLETED|Period 2||63
10840494|NCT04531241|12006025|FG001|COMPLETED|Period 2||64
10840495|NCT04531241|12006024|FG000|NOT COMPLETED|Period 2||1
10840496|NCT04531241|12006025|FG001|NOT COMPLETED|Period 2||1
10840497|NCT04456153|12006033|FG000|STARTED|Overall Study||19
10840498|NCT04456153|12006034|FG001|STARTED|Overall Study||41
11104031|NCT01246063|12288253|FG001|STARTED|Overall Study||4
11221820|NCT01968070|12413506|FG006|COMPLETED|Period 1||8
11221821|NCT01968070|12413507|FG007|COMPLETED|Period 1||2
11221822|NCT01968070|12413508|FG008|COMPLETED|Period 1||2
11221823|NCT01968070|12413509|FG009|COMPLETED|Period 1||9
11221824|NCT01968070|12413510|FG010|COMPLETED|Period 1||2
11221825|NCT01968070|12413511|FG011|COMPLETED|Period 1||1
11221826|NCT01968070|12413512|FG012|COMPLETED|Period 1||9
11221827|NCT01968070|12413513|FG013|COMPLETED|Period 1||2
11221828|NCT01968070|12413514|FG014|COMPLETED|Period 1||2
11221829|NCT01968070|12413515|FG015|COMPLETED|Period 1||8
11221830|NCT01968070|12413516|FG016|COMPLETED|Period 1||2
11221831|NCT01968070|12413517|FG017|COMPLETED|Period 1||2
11221832|NCT01968070|12413500|FG000|NOT COMPLETED|Period 1||0
11221833|NCT01968070|12413501|FG001|NOT COMPLETED|Period 1||1
11221834|NCT01968070|12413502|FG002|NOT COMPLETED|Period 1||0
11221835|NCT01968070|12413503|FG003|NOT COMPLETED|Period 1||2
11221836|NCT01968070|12413504|FG004|NOT COMPLETED|Period 1||1
11221837|NCT01968070|12413505|FG005|NOT COMPLETED|Period 1||0
11221838|NCT01968070|12413506|FG006|NOT COMPLETED|Period 1||2
11221839|NCT01968070|12413507|FG007|NOT COMPLETED|Period 1||0
11221840|NCT01968070|12413508|FG008|NOT COMPLETED|Period 1||0
11354209|NCT03070782|12551423|FG002|STARTED|Overall Study||47
11104032|NCT01246063|12288254|FG002|STARTED|Overall Study||4
10840499|NCT04456153|12006033|FG000|COMPLETED|Overall Study||19
10840500|NCT04456153|12006034|FG001|COMPLETED|Overall Study||41
10840501|NCT04456153|12006033|FG000|NOT COMPLETED|Overall Study||0
11104033|NCT01246063|12288255|FG003|STARTED|Overall Study||5
11104034|NCT01246063|12288256|FG004|STARTED|Overall Study||7
11104035|NCT01246063|12288257|FG005|STARTED|Overall Study||17
11104036|NCT01246063|12288252|FG000|COMPLETED|Overall Study||3
11104037|NCT01246063|12288253|FG001|COMPLETED|Overall Study||4
11104038|NCT01246063|12288254|FG002|COMPLETED|Overall Study||4
11104039|NCT01246063|12288255|FG003|COMPLETED|Overall Study||5
11104040|NCT01246063|12288256|FG004|COMPLETED|Overall Study||7
11104041|NCT01246063|12288257|FG005|COMPLETED|Overall Study||17
11104042|NCT01246063|12288252|FG000|NOT COMPLETED|Overall Study||0
11104043|NCT01246063|12288253|FG001|NOT COMPLETED|Overall Study||0
11104044|NCT01246063|12288254|FG002|NOT COMPLETED|Overall Study||0
11104045|NCT01246063|12288255|FG003|NOT COMPLETED|Overall Study||0
11104046|NCT01246063|12288256|FG004|NOT COMPLETED|Overall Study||0
11104047|NCT01246063|12288257|FG005|NOT COMPLETED|Overall Study||0
11104048|NCT01246076|12288275|FG000|STARTED|Overall Study||24
11104049|NCT01246076|12288275|FG000|COMPLETED|Overall Study||24
11104050|NCT01246076|12288275|FG000|NOT COMPLETED|Overall Study||0
11104051|NCT01246206|12288279|FG000|STARTED|Overall Study||21
11104052|NCT01246206|12288279|FG000|COMPLETED|Overall Study||20
11104053|NCT01246206|12288279|FG000|NOT COMPLETED|Overall Study||1
11104054|NCT01246258|12288283|FG000|STARTED|Overall Study||5
11104055|NCT01246258|12288283|FG000|COMPLETED|Overall Study||5
11104056|NCT01246258|12288283|FG000|NOT COMPLETED|Overall Study||0
11104057|NCT01246349|12288290|FG000|STARTED|Overall Study||20
11104058|NCT01246349|12288291|FG001|STARTED|Overall Study||20
11221841|NCT01968070|12413509|FG009|NOT COMPLETED|Period 1||0
11221842|NCT01968070|12413510|FG010|NOT COMPLETED|Period 1||0
11221843|NCT01968070|12413511|FG011|NOT COMPLETED|Period 1||1
11104059|NCT01246349|12288290|FG000|COMPLETED|Overall Study||20
11104060|NCT01246349|12288291|FG001|COMPLETED|Overall Study||20
11104061|NCT01246349|12288290|FG000|NOT COMPLETED|Overall Study||0
11104062|NCT01246349|12288291|FG001|NOT COMPLETED|Overall Study||0
11104063|NCT01246401|12288299|FG000|STARTED|Overall Study||66
11104064|NCT01246401|12288300|FG001|STARTED|Overall Study||27
11104065|NCT01246401|12288299|FG000|COMPLETED|Overall Study||66
11104066|NCT01246401|12288300|FG001|COMPLETED|Overall Study||27
11104067|NCT01246401|12288299|FG000|NOT COMPLETED|Overall Study||0
11104068|NCT01246401|12288300|FG001|NOT COMPLETED|Overall Study||0
11104069|NCT01246466|12288308|FG000|STARTED|Overall Study||24
11104070|NCT01246466|12288308|FG000|COMPLETED|Overall Study||22
11104071|NCT01246466|12288308|FG000|NOT COMPLETED|Overall Study||2
11104072|NCT01246479|12288313|FG000|STARTED|Overall Study||23
11104073|NCT01246479|12288313|FG000|COMPLETED|Overall Study|primary endpoint at Month 12|18
11104074|NCT01246479|12288313|FG000|NOT COMPLETED|Overall Study||5
11104075|NCT01246583|12288321|FG000|STARTED|Overall Study||23
11104076|NCT01246583|12288322|FG001|STARTED|Overall Study||13
11104077|NCT01246583|12288323|FG002|STARTED|Overall Study||25
11104078|NCT01246583|12288324|FG003|STARTED|Overall Study||10
11104079|NCT01246583|12288321|FG000|COMPLETED|Overall Study||22
11104080|NCT01246583|12288322|FG001|COMPLETED|Overall Study||13
11104081|NCT01246583|12288323|FG002|COMPLETED|Overall Study||24
11104082|NCT01246583|12288324|FG003|COMPLETED|Overall Study||9
10840502|NCT04456153|12006034|FG001|NOT COMPLETED|Overall Study||0
10840503|NCT04351243|12006056|FG000|STARTED|Overall Study||114
10840504|NCT04351243|12006057|FG001|STARTED|Overall Study||113
10840505|NCT04351243|12006056|FG000|Completed Baseline Assessment|Overall Study||113
10840506|NCT04351243|12006057|FG001|Completed Baseline Assessment|Overall Study||112
10840507|NCT04351243|12006056|FG000|COMPLETED|Overall Study||74
10840508|NCT04351243|12006057|FG001|COMPLETED|Overall Study||75
10840509|NCT04351243|12006056|FG000|NOT COMPLETED|Overall Study||40
10840510|NCT04351243|12006057|FG001|NOT COMPLETED|Overall Study||38
10840511|NCT04312256|12006063|FG000|STARTED|Overall Study||81
10840512|NCT04312256|12006063|FG000|COMPLETED|Overall Study||81
10840513|NCT04312256|12006063|FG000|NOT COMPLETED|Overall Study||0
10840514|NCT04185220|12006070|FG000|STARTED|Dose Escalation||3
10840515|NCT04185220|12006071|FG001|STARTED|Dose Escalation||3
10840516|NCT04185220|12006070|FG000|COMPLETED|Dose Escalation||3
10840517|NCT04185220|12006071|FG001|COMPLETED|Dose Escalation||1
10840518|NCT04185220|12006070|FG000|NOT COMPLETED|Dose Escalation||0
10840519|NCT04185220|12006071|FG001|NOT COMPLETED|Dose Escalation||2
10840520|NCT04185220|12006070|FG000|STARTED|Dose Expansion||0
10840521|NCT04185220|12006071|FG001|STARTED|Dose Expansion||0
10840522|NCT04185220|12006070|FG000|COMPLETED|Dose Expansion||0
10840523|NCT04185220|12006071|FG001|COMPLETED|Dose Expansion||0
10840524|NCT04185220|12006070|FG000|NOT COMPLETED|Dose Expansion||0
10840525|NCT04185220|12006071|FG001|NOT COMPLETED|Dose Expansion||0
10840526|NCT03851107|12006078|FG000|STARTED|Overall Study||9
10840527|NCT03851107|12006078|FG000|COMPLETED|Overall Study||7
10840528|NCT03851107|12006078|FG000|NOT COMPLETED|Overall Study||2
10840529|NCT03600714|12006088|FG000|STARTED|Overall Study||26
10840530|NCT03600714|12006088|FG000|COMPLETED|Overall Study||25
10840531|NCT03600714|12006088|FG000|NOT COMPLETED|Overall Study||1
10840532|NCT03479307|12006095|FG000|STARTED|Overall Study||91
10840533|NCT03479307|12006096|FG001|STARTED|Overall Study||90
10840534|NCT03479307|12006097|FG002|STARTED|Overall Study||47
10840535|NCT03479307|12006095|FG000|COMPLETED|Overall Study||90
10840536|NCT03479307|12006096|FG001|COMPLETED|Overall Study||89
10840537|NCT03479307|12006097|FG002|COMPLETED|Overall Study||47
10840538|NCT03479307|12006095|FG000|NOT COMPLETED|Overall Study||1
10840539|NCT03479307|12006096|FG001|NOT COMPLETED|Overall Study||1
10840540|NCT03479307|12006097|FG002|NOT COMPLETED|Overall Study||0
10840541|NCT03470441|12006109|FG000|STARTED|Overall Study||29
10840542|NCT03470441|12006110|FG001|STARTED|Overall Study||31
10840543|NCT03470441|12006111|FG002|STARTED|Overall Study||31
10840544|NCT03470441|12006112|FG003|STARTED|Overall Study||29
10840545|NCT03470441|12006109|FG000|COMPLETED|Overall Study||28
10840546|NCT03470441|12006110|FG001|COMPLETED|Overall Study||26
10840547|NCT03470441|12006111|FG002|COMPLETED|Overall Study||29
10840548|NCT03470441|12006112|FG003|COMPLETED|Overall Study||25
10840549|NCT03470441|12006109|FG000|NOT COMPLETED|Overall Study||1
10840550|NCT03470441|12006110|FG001|NOT COMPLETED|Overall Study||5
10840551|NCT03470441|12006111|FG002|NOT COMPLETED|Overall Study||2
10840552|NCT03470441|12006112|FG003|NOT COMPLETED|Overall Study||4
10840553|NCT03452397|12006126|FG000|STARTED|Overall Study||41
10840554|NCT03452397|12006127|FG001|STARTED|Overall Study||41
10840555|NCT03452397|12006128|FG002|STARTED|Overall Study||41
10840556|NCT03452397|12006129|FG003|STARTED|Overall Study||42
10840557|NCT03452397|12006126|FG000|COMPLETED|Overall Study||40
10840558|NCT03452397|12006127|FG001|COMPLETED|Overall Study||41
10840559|NCT03452397|12006128|FG002|COMPLETED|Overall Study||39
10840560|NCT03452397|12006129|FG003|COMPLETED|Overall Study||41
10840561|NCT03452397|12006126|FG000|NOT COMPLETED|Overall Study||1
10840562|NCT03452397|12006127|FG001|NOT COMPLETED|Overall Study||0
10840563|NCT03452397|12006128|FG002|NOT COMPLETED|Overall Study||2
10840564|NCT03452397|12006129|FG003|NOT COMPLETED|Overall Study||1
10840565|NCT03448939|12006143|FG000|STARTED|Overall Study||243
10840566|NCT03448939|12006144|FG001|STARTED|Overall Study||118
10840567|NCT03448939|12006143|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239
10840568|NCT03448939|12006144|FG001|Received at Least 1 Dose of Study Drug|Overall Study||113
10840569|NCT03448939|12006143|FG000|COMPLETED|Overall Study||222
10840570|NCT03448939|12006144|FG001|COMPLETED|Overall Study||107
10840571|NCT03448939|12006143|FG000|NOT COMPLETED|Overall Study||21
10840572|NCT03448939|12006144|FG001|NOT COMPLETED|Overall Study||11
10840573|NCT03377803|12006152|FG000|STARTED|Overall Study||150
10840574|NCT03377803|12006153|FG001|STARTED|Overall Study||112
10840575|NCT03377803|12006152|FG000|COMPLETED|Overall Study||139
10840576|NCT03377803|12006153|FG001|COMPLETED|Overall Study||108
10840577|NCT03377803|12006152|FG000|NOT COMPLETED|Overall Study||11
10840578|NCT03377803|12006153|FG001|NOT COMPLETED|Overall Study||4
10840579|NCT03283371|12006161|FG000|STARTED|Placebo-controlled||34
10840580|NCT03283371|12006162|FG001|STARTED|Placebo-controlled||33
10840581|NCT03283371|12006163|FG002|STARTED|Placebo-controlled||0
10840582|NCT03283371|12006164|FG003|STARTED|Placebo-controlled||0
10840583|NCT03283371|12006161|FG000|Number of Participants Dosed|Placebo-controlled||34
10840584|NCT03283371|12006162|FG001|Number of Participants Dosed|Placebo-controlled||32
10840585|NCT03283371|12006163|FG002|Number of Participants Dosed|Placebo-controlled||0
10840586|NCT03283371|12006164|FG003|Number of Participants Dosed|Placebo-controlled||0
10840587|NCT03283371|12006161|FG000|COMPLETED|Placebo-controlled||31
10840588|NCT03283371|12006162|FG001|COMPLETED|Placebo-controlled||30
10840589|NCT03283371|12006163|FG002|COMPLETED|Placebo-controlled||0
10840590|NCT03283371|12006164|FG003|COMPLETED|Placebo-controlled||0
10840591|NCT03283371|12006161|FG000|NOT COMPLETED|Placebo-controlled||3
10840592|NCT03283371|12006162|FG001|NOT COMPLETED|Placebo-controlled||3
10840593|NCT03283371|12006163|FG002|NOT COMPLETED|Placebo-controlled||0
10840594|NCT03283371|12006164|FG003|NOT COMPLETED|Placebo-controlled||0
10840595|NCT03283371|12006161|FG000|STARTED|Open-label Phase||0
10840596|NCT03283371|12006162|FG001|STARTED|Open-label Phase||0
10840597|NCT03283371|12006163|FG002|STARTED|Open-label Phase||31
10840598|NCT03283371|12006164|FG003|STARTED|Open-label Phase||30
10840599|NCT03283371|12006161|FG000|COMPLETED|Open-label Phase||0
10840600|NCT03283371|12006162|FG001|COMPLETED|Open-label Phase||0
10840601|NCT03283371|12006163|FG002|COMPLETED|Open-label Phase||27
10840602|NCT03283371|12006164|FG003|COMPLETED|Open-label Phase||29
10840603|NCT03283371|12006161|FG000|NOT COMPLETED|Open-label Phase||0
10840604|NCT03283371|12006162|FG001|NOT COMPLETED|Open-label Phase||0
10840605|NCT03283371|12006163|FG002|NOT COMPLETED|Open-label Phase||4
10840606|NCT03283371|12006164|FG003|NOT COMPLETED|Open-label Phase||1
10840607|NCT03257254|12006174|FG000|STARTED|Overall Study||76
10840608|NCT03257254|12006174|FG000|COMPLETED|Overall Study||55
10840609|NCT03257254|12006174|FG000|NOT COMPLETED|Overall Study||21
10840610|NCT03084718|12006183|FG000|STARTED|Overall Study||120
10840611|NCT03084718|12006184|FG001|STARTED|Overall Study||120
10840612|NCT03084718|12006185|FG002|STARTED|Overall Study||122
10840613|NCT03084718|12006186|FG003|STARTED|Overall Study||124
10840614|NCT03084718|12006187|FG004|STARTED|Overall Study||124
10840615|NCT03084718|12006183|FG000|COMPLETED|Overall Study||109
10840616|NCT03084718|12006184|FG001|COMPLETED|Overall Study||110
10840617|NCT03084718|12006185|FG002|COMPLETED|Overall Study||110
10840618|NCT03084718|12006186|FG003|COMPLETED|Overall Study||110
10840619|NCT03084718|12006187|FG004|COMPLETED|Overall Study||120
10840620|NCT03084718|12006183|FG000|NOT COMPLETED|Overall Study||11
10840621|NCT03084718|12006184|FG001|NOT COMPLETED|Overall Study||10
10840622|NCT03084718|12006185|FG002|NOT COMPLETED|Overall Study||12
10840623|NCT03084718|12006186|FG003|NOT COMPLETED|Overall Study||14
10840624|NCT03084718|12006187|FG004|NOT COMPLETED|Overall Study||4
10840625|NCT03069417|12006204|FG000|STARTED|Overall Study||14
10840626|NCT03069417|12006205|FG001|STARTED|Overall Study||9
11221844|NCT01968070|12413512|FG012|NOT COMPLETED|Period 1||0
11221845|NCT01968070|12413513|FG013|NOT COMPLETED|Period 1||0
11221846|NCT01968070|12413514|FG014|NOT COMPLETED|Period 1||0
11221847|NCT01968070|12413515|FG015|NOT COMPLETED|Period 1||1
11221848|NCT01968070|12413516|FG016|NOT COMPLETED|Period 1||0
11221849|NCT01968070|12413517|FG017|NOT COMPLETED|Period 1||0
11221850|NCT01968070|12413500|FG000|STARTED|Period 2||4
11221851|NCT01968070|12413501|FG001|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4
11221852|NCT01968070|12413502|FG002|STARTED|Period 2||4
11221853|NCT01968070|12413503|FG003|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4
11221854|NCT01968070|12413504|FG004|STARTED|Period 2||3
11221855|NCT01968070|12413505|FG005|STARTED|Period 2||4
11221856|NCT01968070|12413506|FG006|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
11221857|NCT01968070|12413507|FG007|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
11221858|NCT01968070|12413508|FG008|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
11221859|NCT01968070|12413509|FG009|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
11221860|NCT01968070|12413510|FG010|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
11221861|NCT01968070|12413511|FG011|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
11221862|NCT01968070|12413512|FG012|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
11221863|NCT01968070|12413513|FG013|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
11221864|NCT01968070|12413514|FG014|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
11221865|NCT01968070|12413515|FG015|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
11221866|NCT01968070|12413516|FG016|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
11221867|NCT01968070|12413517|FG017|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
11221868|NCT01968070|12413500|FG000|COMPLETED|Period 2||4
11221869|NCT01968070|12413501|FG001|COMPLETED|Period 2||4
11221870|NCT01968070|12413502|FG002|COMPLETED|Period 2||4
11221871|NCT01968070|12413503|FG003|COMPLETED|Period 2||4
11221872|NCT01968070|12413504|FG004|COMPLETED|Period 2||2
11221873|NCT01968070|12413505|FG005|COMPLETED|Period 2||4
11221874|NCT01968070|12413506|FG006|COMPLETED|Period 2||0
11221875|NCT01968070|12413507|FG007|COMPLETED|Period 2||0
11221876|NCT01968070|12413508|FG008|COMPLETED|Period 2||0
11221877|NCT01968070|12413509|FG009|COMPLETED|Period 2||0
11221878|NCT01968070|12413510|FG010|COMPLETED|Period 2||0
11221879|NCT01968070|12413511|FG011|COMPLETED|Period 2||0
11221880|NCT01968070|12413512|FG012|COMPLETED|Period 2||0
11221881|NCT01968070|12413513|FG013|COMPLETED|Period 2||0
11221882|NCT01968070|12413514|FG014|COMPLETED|Period 2||0
11221883|NCT01968070|12413515|FG015|COMPLETED|Period 2||0
11221884|NCT01968070|12413516|FG016|COMPLETED|Period 2||0
11221885|NCT01968070|12413517|FG017|COMPLETED|Period 2||0
11221886|NCT01968070|12413500|FG000|NOT COMPLETED|Period 2||0
11221887|NCT01968070|12413501|FG001|NOT COMPLETED|Period 2||0
11221888|NCT01968070|12413502|FG002|NOT COMPLETED|Period 2||0
11221889|NCT01968070|12413503|FG003|NOT COMPLETED|Period 2||0
11221890|NCT01968070|12413504|FG004|NOT COMPLETED|Period 2||1
11221891|NCT01968070|12413505|FG005|NOT COMPLETED|Period 2||0
11221892|NCT01968070|12413506|FG006|NOT COMPLETED|Period 2||0
11221893|NCT01968070|12413507|FG007|NOT COMPLETED|Period 2||0
11221894|NCT01968070|12413508|FG008|NOT COMPLETED|Period 2||0
11221895|NCT01968070|12413509|FG009|NOT COMPLETED|Period 2||0
11221896|NCT01968070|12413510|FG010|NOT COMPLETED|Period 2||0
11221897|NCT01968070|12413511|FG011|NOT COMPLETED|Period 2||0
11221898|NCT01968070|12413512|FG012|NOT COMPLETED|Period 2||0
11221899|NCT01968070|12413513|FG013|NOT COMPLETED|Period 2||0
11221900|NCT01968070|12413514|FG014|NOT COMPLETED|Period 2||0
11221901|NCT01968070|12413515|FG015|NOT COMPLETED|Period 2||0
11221902|NCT01968070|12413516|FG016|NOT COMPLETED|Period 2||0
11221903|NCT01968070|12413517|FG017|NOT COMPLETED|Period 2||0
11221904|NCT01968070|12413500|FG000|STARTED|Period 3||4
11221905|NCT01968070|12413501|FG001|STARTED|Period 3||4
11221906|NCT01968070|12413502|FG002|STARTED|Period 3||4
11221907|NCT01968070|12413503|FG003|STARTED|Period 3||4
11221908|NCT01968070|12413504|FG004|STARTED|Period 3||3
11221909|NCT01968070|12413505|FG005|STARTED|Period 3||4
11221910|NCT01968070|12413506|FG006|STARTED|Period 3||0
10840627|NCT03069417|12006204|FG000|Post-Treatment Assessment|Overall Study||12
10840628|NCT03069417|12006205|FG001|Post-Treatment Assessment|Overall Study||6
11221911|NCT01968070|12413507|FG007|STARTED|Period 3||0
10840629|NCT03069417|12006204|FG000|COMPLETED|Overall Study||8
10840630|NCT03069417|12006205|FG001|COMPLETED|Overall Study||2
10840631|NCT03069417|12006204|FG000|NOT COMPLETED|Overall Study||6
10840632|NCT03069417|12006205|FG001|NOT COMPLETED|Overall Study||7
10840633|NCT03063164|12006212|FG000|STARTED|Overall Study||7
10840634|NCT03063164|12006213|FG001|STARTED|Overall Study||7
10840635|NCT03063164|12006212|FG000|COMPLETED|Overall Study||7
10840636|NCT03063164|12006213|FG001|COMPLETED|Overall Study||7
10840637|NCT03063164|12006212|FG000|NOT COMPLETED|Overall Study||0
10840638|NCT03063164|12006213|FG001|NOT COMPLETED|Overall Study||0
10840639|NCT02952365|12006220|FG000|STARTED|Overall Study||2
10840640|NCT02952365|12006220|FG000|COMPLETED|Overall Study||2
10840641|NCT02952365|12006220|FG000|NOT COMPLETED|Overall Study||0
10840642|NCT02936323|12006234|FG000|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|2
10840643|NCT02936323|12006235|FG001|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10840644|NCT02936323|12006236|FG002|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10840645|NCT02936323|12006237|FG003|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10840646|NCT02936323|12006238|FG004|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10840647|NCT02936323|12006239|FG005|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|6
10840648|NCT02936323|12006240|FG006|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
10840649|NCT02936323|12006241|FG007|STARTED|Phase 1 Dose Escalation||0
10840650|NCT02936323|12006242|FG008|STARTED|Phase 1 Dose Escalation||0
10840651|NCT02936323|12006243|FG009|STARTED|Phase 1 Dose Escalation||0
10840652|NCT02936323|12006234|FG000|COMPLETED|Phase 1 Dose Escalation||0
10840653|NCT02936323|12006235|FG001|COMPLETED|Phase 1 Dose Escalation||1
10840654|NCT02936323|12006236|FG002|COMPLETED|Phase 1 Dose Escalation||0
10840655|NCT02936323|12006237|FG003|COMPLETED|Phase 1 Dose Escalation||1
10840656|NCT02936323|12006238|FG004|COMPLETED|Phase 1 Dose Escalation||0
10840657|NCT02936323|12006239|FG005|COMPLETED|Phase 1 Dose Escalation||1
10840658|NCT02936323|12006240|FG006|COMPLETED|Phase 1 Dose Escalation||0
10840659|NCT02936323|12006241|FG007|COMPLETED|Phase 1 Dose Escalation||0
10840660|NCT02936323|12006242|FG008|COMPLETED|Phase 1 Dose Escalation||0
10840661|NCT02936323|12006243|FG009|COMPLETED|Phase 1 Dose Escalation||0
10840662|NCT02936323|12006234|FG000|NOT COMPLETED|Phase 1 Dose Escalation||2
10840663|NCT02936323|12006235|FG001|NOT COMPLETED|Phase 1 Dose Escalation||2
10840664|NCT02936323|12006236|FG002|NOT COMPLETED|Phase 1 Dose Escalation||3
10840665|NCT02936323|12006237|FG003|NOT COMPLETED|Phase 1 Dose Escalation||2
10840666|NCT02936323|12006238|FG004|NOT COMPLETED|Phase 1 Dose Escalation||3
10840667|NCT02936323|12006239|FG005|NOT COMPLETED|Phase 1 Dose Escalation||5
10840668|NCT02936323|12006240|FG006|NOT COMPLETED|Phase 1 Dose Escalation||3
10840669|NCT02936323|12006241|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0
11221912|NCT01968070|12413508|FG008|STARTED|Period 3||0
11221913|NCT01968070|12413509|FG009|STARTED|Period 3||0
11221914|NCT01968070|12413510|FG010|STARTED|Period 3||0
11221915|NCT01968070|12413511|FG011|STARTED|Period 3||0
11221916|NCT01968070|12413512|FG012|STARTED|Period 3||0
10840670|NCT02936323|12006242|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0
10840671|NCT02936323|12006243|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0
10840672|NCT02936323|12006234|FG000|STARTED|Phase 2a Dose Expansion||0
10840673|NCT02936323|12006235|FG001|STARTED|Phase 2a Dose Expansion||0
10840674|NCT02936323|12006236|FG002|STARTED|Phase 2a Dose Expansion||0
10840675|NCT02936323|12006237|FG003|STARTED|Phase 2a Dose Expansion||0
10840676|NCT02936323|12006238|FG004|STARTED|Phase 2a Dose Expansion||0
10840677|NCT02936323|12006239|FG005|STARTED|Phase 2a Dose Expansion||0
10840678|NCT02936323|12006240|FG006|STARTED|Phase 2a Dose Expansion||0
10840679|NCT02936323|12006241|FG007|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|32
10840680|NCT02936323|12006242|FG008|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|15
10840681|NCT02936323|12006243|FG009|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|19
10840682|NCT02936323|12006234|FG000|COMPLETED|Phase 2a Dose Expansion||0
10840683|NCT02936323|12006235|FG001|COMPLETED|Phase 2a Dose Expansion||0
10840684|NCT02936323|12006236|FG002|COMPLETED|Phase 2a Dose Expansion||0
10840685|NCT02936323|12006237|FG003|COMPLETED|Phase 2a Dose Expansion||0
10840686|NCT02936323|12006238|FG004|COMPLETED|Phase 2a Dose Expansion||0
10840687|NCT02936323|12006239|FG005|COMPLETED|Phase 2a Dose Expansion||0
10840688|NCT02936323|12006240|FG006|COMPLETED|Phase 2a Dose Expansion||0
10840689|NCT02936323|12006241|FG007|COMPLETED|Phase 2a Dose Expansion||15
10840690|NCT02936323|12006242|FG008|COMPLETED|Phase 2a Dose Expansion||2
10840691|NCT02936323|12006243|FG009|COMPLETED|Phase 2a Dose Expansion||5
10840692|NCT02936323|12006234|FG000|NOT COMPLETED|Phase 2a Dose Expansion||0
10840693|NCT02936323|12006235|FG001|NOT COMPLETED|Phase 2a Dose Expansion||0
10840694|NCT02936323|12006236|FG002|NOT COMPLETED|Phase 2a Dose Expansion||0
10840695|NCT02936323|12006237|FG003|NOT COMPLETED|Phase 2a Dose Expansion||0
10840696|NCT02936323|12006238|FG004|NOT COMPLETED|Phase 2a Dose Expansion||0
10840697|NCT02936323|12006239|FG005|NOT COMPLETED|Phase 2a Dose Expansion||0
10840698|NCT02936323|12006240|FG006|NOT COMPLETED|Phase 2a Dose Expansion||0
11221917|NCT01968070|12413513|FG013|STARTED|Period 3||0
11221918|NCT01968070|12413514|FG014|STARTED|Period 3||0
11221919|NCT01968070|12413515|FG015|STARTED|Period 3||0
11221920|NCT01968070|12413516|FG016|STARTED|Period 3||0
11221921|NCT01968070|12413517|FG017|STARTED|Period 3||0
11221922|NCT01968070|12413500|FG000|COMPLETED|Period 3||4
11221923|NCT01968070|12413501|FG001|COMPLETED|Period 3||4
11221924|NCT01968070|12413502|FG002|COMPLETED|Period 3||4
11221925|NCT01968070|12413503|FG003|COMPLETED|Period 3||4
11221926|NCT01968070|12413504|FG004|COMPLETED|Period 3||3
11221927|NCT01968070|12413505|FG005|COMPLETED|Period 3||4
11104083|NCT01246583|12288321|FG000|NOT COMPLETED|Overall Study||1
11221928|NCT01968070|12413506|FG006|COMPLETED|Period 3||0
11221929|NCT01968070|12413507|FG007|COMPLETED|Period 3||0
11104084|NCT01246583|12288322|FG001|NOT COMPLETED|Overall Study||0
10840699|NCT02936323|12006241|FG007|NOT COMPLETED|Phase 2a Dose Expansion||17
10840700|NCT02936323|12006242|FG008|NOT COMPLETED|Phase 2a Dose Expansion||13
10840701|NCT02936323|12006243|FG009|NOT COMPLETED|Phase 2a Dose Expansion||14
10840702|NCT02631837|12006277|FG000|STARTED|Overall Study||35
10840703|NCT02631837|12006278|FG001|STARTED|Overall Study||35
10840704|NCT02631837|12006277|FG000|COMPLETED|Overall Study||35
10840705|NCT02631837|12006278|FG001|COMPLETED|Overall Study||35
10840706|NCT02631837|12006277|FG000|NOT COMPLETED|Overall Study||0
10840707|NCT02631837|12006278|FG001|NOT COMPLETED|Overall Study||0
11104085|NCT01246583|12288323|FG002|NOT COMPLETED|Overall Study||1
11104086|NCT01246583|12288324|FG003|NOT COMPLETED|Overall Study||1
11104087|NCT01246713|12288335|FG000|STARTED|First Acetaminophen Dosing (1 Day)||6
11104088|NCT01246713|12288336|FG001|STARTED|First Acetaminophen Dosing (1 Day)||9
11104089|NCT01246713|12288335|FG000|COMPLETED|First Acetaminophen Dosing (1 Day)||6
11104090|NCT01246713|12288336|FG001|COMPLETED|First Acetaminophen Dosing (1 Day)||9
11104091|NCT01246713|12288335|FG000|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
11104092|NCT01246713|12288336|FG001|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
11104093|NCT01246713|12288335|FG000|STARTED|Washout (at Least 14 Days)||6
11104094|NCT01246713|12288336|FG001|STARTED|Washout (at Least 14 Days)||9
11104095|NCT01246713|12288335|FG000|COMPLETED|Washout (at Least 14 Days)||6
11104096|NCT01246713|12288336|FG001|COMPLETED|Washout (at Least 14 Days)||9
11104097|NCT01246713|12288335|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
11104098|NCT01246713|12288336|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
11104099|NCT01246713|12288335|FG000|STARTED|Second Acetaminophen Dosing (1 Day)||6
11104100|NCT01246713|12288336|FG001|STARTED|Second Acetaminophen Dosing (1 Day)||9
11104101|NCT01246713|12288335|FG000|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
11104102|NCT01246713|12288336|FG001|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
11104103|NCT01246713|12288335|FG000|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
11221930|NCT01968070|12413508|FG008|COMPLETED|Period 3||0
10840718|NCT02429791|12006295|FG000|STARTED|Early Switch Phase (Up to Week 52)||252
10840719|NCT02429791|12006296|FG001|STARTED|Early Switch Phase (Up to Week 52)||256
10840720|NCT02429791|12006295|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||239
10840721|NCT02429791|12006296|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||238
10840722|NCT02429791|12006295|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13
10840723|NCT02429791|12006296|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18
10840724|NCT02429791|12006295|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||239
10840725|NCT02429791|12006296|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||238
10840726|NCT02429791|12006295|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214
10840727|NCT02429791|12006296|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210
10840728|NCT02429791|12006295|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25
10840729|NCT02429791|12006296|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28
10840730|NCT02422797|12006311|FG000|STARTED|Early Switch Phase (Up to Week 52)||261
10840731|NCT02422797|12006312|FG001|STARTED|Early Switch Phase (Up to Week 52)||255
10840732|NCT02422797|12006311|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||245
10840733|NCT02422797|12006312|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||239
10840734|NCT02422797|12006311|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
10840735|NCT02422797|12006312|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
10840736|NCT02422797|12006311|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||245
10840737|NCT02422797|12006312|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||239
10840738|NCT02422797|12006311|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222
10840739|NCT02422797|12006312|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221
10840740|NCT02422797|12006311|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23
10840741|NCT02422797|12006312|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18
10840742|NCT02287493|12006330|FG000|STARTED|Overall Study||19
10840743|NCT02287493|12006331|FG001|STARTED|Overall Study||16
10840744|NCT02287493|12006330|FG000|COMPLETED|Overall Study||19
10840745|NCT02287493|12006331|FG001|COMPLETED|Overall Study||16
10840746|NCT02287493|12006330|FG000|NOT COMPLETED|Overall Study||0
10840747|NCT02287493|12006331|FG001|NOT COMPLETED|Overall Study||0
10840748|NCT02132611|12006341|FG000|STARTED|Overall Study||100
10840749|NCT02132611|12006341|FG000|COMPLETED|Overall Study||98
10840750|NCT02132611|12006341|FG000|NOT COMPLETED|Overall Study||2
10840751|NCT01147822|12006347|FG000|STARTED|Overall Study||188
10840752|NCT01147822|12006348|FG001|STARTED|Overall Study||179
10840753|NCT01147822|12006347|FG000|Not Completed/Ongoing|Overall Study||111
10840754|NCT01147822|12006348|FG001|Not Completed/Ongoing|Overall Study||102
10840755|NCT01147822|12006347|FG000|COMPLETED|Overall Study||0
10840756|NCT01147822|12006348|FG001|COMPLETED|Overall Study||0
10840757|NCT01147822|12006347|FG000|NOT COMPLETED|Overall Study||188
10840758|NCT01147822|12006348|FG001|NOT COMPLETED|Overall Study||179
10840759|NCT00328653|12006357|FG000|STARTED|Period I||40
10840760|NCT00328653|12006358|FG001|STARTED|Period I||39
10840761|NCT00328653|12006359|FG002|STARTED|Period I||39
10840762|NCT00328653|12006357|FG000|COMPLETED|Period I||36
10840763|NCT00328653|12006358|FG001|COMPLETED|Period I||39
10840764|NCT00328653|12006359|FG002|COMPLETED|Period I||36
10840765|NCT00328653|12006357|FG000|NOT COMPLETED|Period I||4
10840766|NCT00328653|12006358|FG001|NOT COMPLETED|Period I||0
10840767|NCT00328653|12006359|FG002|NOT COMPLETED|Period I||3
10840768|NCT00328653|12006357|FG000|STARTED|Period II|Following completion of the first period of the trial, all patients were to be administered NOVA22007 (i.e. CsA 0.05% or 0.1%) as four times or twice daily instillations in both eyes for an additional 3 month period.|0
10840769|NCT00328653|12006358|FG001|STARTED|Period II||58
10840770|NCT00328653|12006359|FG002|STARTED|Period II||53
10840771|NCT00328653|12006357|FG000|COMPLETED|Period II||0
10840772|NCT00328653|12006358|FG001|COMPLETED|Period II||50
10840773|NCT00328653|12006359|FG002|COMPLETED|Period II||49
10840774|NCT00328653|12006357|FG000|NOT COMPLETED|Period II||0
10840775|NCT00328653|12006358|FG001|NOT COMPLETED|Period II||8
10840776|NCT00328653|12006359|FG002|NOT COMPLETED|Period II||4
11104104|NCT01246713|12288336|FG001|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
11104105|NCT01246791|12288342|FG000|STARTED|Overall Study||12
10840777|NCT04476251|12006369|FG000|STARTED|Overall Study||1
10840778|NCT04476251|12006369|FG000|COMPLETED|Overall Study||0
10840779|NCT04476251|12006369|FG000|NOT COMPLETED|Overall Study||1
10840780|NCT03924765|12006373|FG000|STARTED|Overall Study||5
10840781|NCT03924765|12006373|FG000|COMPLETED|Overall Study||5
10840782|NCT03924765|12006373|FG000|NOT COMPLETED|Overall Study||0
10840783|NCT03915860|12006377|FG000|STARTED|Overall Study||47
10840784|NCT03915860|12006377|FG000|Treated|Overall Study||46
10840785|NCT03915860|12006377|FG000|COMPLETED|Overall Study||33
10840786|NCT03915860|12006377|FG000|NOT COMPLETED|Overall Study||14
10840787|NCT03817606|12006383|FG000|STARTED|Overall Study||2
10840788|NCT03817606|12006384|FG001|STARTED|Overall Study||2
10840789|NCT03817606|12006383|FG000|COMPLETED|Overall Study||0
10840790|NCT03817606|12006384|FG001|COMPLETED|Overall Study||0
10840791|NCT03817606|12006383|FG000|NOT COMPLETED|Overall Study||2
10840792|NCT03817606|12006384|FG001|NOT COMPLETED|Overall Study||2
10840793|NCT03795233|12006396|FG000|STARTED|Overall Study||4
10840794|NCT03795233|12006397|FG001|STARTED|Overall Study||1
10840795|NCT03795233|12006396|FG000|COMPLETED|Overall Study||0
10840796|NCT03795233|12006397|FG001|COMPLETED|Overall Study||0
10840797|NCT03795233|12006396|FG000|NOT COMPLETED|Overall Study||4
10840798|NCT03795233|12006397|FG001|NOT COMPLETED|Overall Study||1
10840799|NCT03786380|12006408|FG000|STARTED|Overall Study||35
10840800|NCT03786380|12006409|FG001|STARTED|Overall Study||22
10840801|NCT03786380|12006410|FG002|STARTED|Overall Study||54
10840802|NCT03786380|12006411|FG003|STARTED|Overall Study||63
10840803|NCT03786380|12006412|FG004|STARTED|Overall Study||28
10840804|NCT03786380|12006408|FG000|Safety Population|Overall Study||35
10840805|NCT03786380|12006409|FG001|Safety Population|Overall Study||22
10840806|NCT03786380|12006410|FG002|Safety Population|Overall Study||54
10840807|NCT03786380|12006411|FG003|Safety Population|Overall Study||62
10840808|NCT03786380|12006412|FG004|Safety Population|Overall Study||28
10840809|NCT03786380|12006408|FG000|COMPLETED|Overall Study||0
10840810|NCT03786380|12006409|FG001|COMPLETED|Overall Study||0
10840811|NCT03786380|12006410|FG002|COMPLETED|Overall Study||0
10840812|NCT03786380|12006411|FG003|COMPLETED|Overall Study||0
10840813|NCT03786380|12006412|FG004|COMPLETED|Overall Study||0
10840814|NCT03786380|12006408|FG000|NOT COMPLETED|Overall Study||35
10840815|NCT03786380|12006409|FG001|NOT COMPLETED|Overall Study||22
10840816|NCT03786380|12006410|FG002|NOT COMPLETED|Overall Study||54
10840817|NCT03786380|12006411|FG003|NOT COMPLETED|Overall Study||63
10840818|NCT03786380|12006412|FG004|NOT COMPLETED|Overall Study||28
10840819|NCT03769376|12006426|FG000|STARTED|Overall Study||20
10840820|NCT03769376|12006427|FG001|STARTED|Overall Study||18
10840821|NCT03769376|12006426|FG000|COMPLETED|Overall Study||13
10840822|NCT03769376|12006427|FG001|COMPLETED|Overall Study||11
10840823|NCT03769376|12006426|FG000|NOT COMPLETED|Overall Study||7
10840824|NCT03769376|12006427|FG001|NOT COMPLETED|Overall Study||7
10840825|NCT03645863|12006436|FG000|STARTED|Overall Study||21
10840826|NCT03645863|12006437|FG001|STARTED|Overall Study||20
10840827|NCT03645863|12006438|FG002|STARTED|Overall Study||20
10840828|NCT03645863|12006436|FG000|COMPLETED|Overall Study||20
10840829|NCT03645863|12006437|FG001|COMPLETED|Overall Study||20
10840830|NCT03645863|12006438|FG002|COMPLETED|Overall Study||20
10840831|NCT03645863|12006436|FG000|NOT COMPLETED|Overall Study||1
10840832|NCT03645863|12006437|FG001|NOT COMPLETED|Overall Study||0
10840833|NCT03645863|12006438|FG002|NOT COMPLETED|Overall Study||0
10840834|NCT03564145|12006446|FG000|STARTED|Overall Study||547
10840835|NCT03564145|12006446|FG000|Received at Least 1 Dose of Study Drug|Overall Study||535
10840836|NCT03564145|12006446|FG000|COMPLETED|Overall Study||323
10840837|NCT03564145|12006446|FG000|NOT COMPLETED|Overall Study||224
10840838|NCT03564119|12006452|FG000|STARTED|Overall Study||250
10840839|NCT03564119|12006453|FG001|STARTED|Overall Study||122
10840840|NCT03564119|12006452|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249
10840841|NCT03564119|12006453|FG001|Received at Least 1 Dose of Study Drug|Overall Study||120
10840842|NCT03564119|12006452|FG000|COMPLETED|Overall Study||235
10840843|NCT03564119|12006453|FG001|COMPLETED|Overall Study||113
10840844|NCT03564119|12006452|FG000|NOT COMPLETED|Overall Study||15
10840845|NCT03564119|12006453|FG001|NOT COMPLETED|Overall Study||9
10840846|NCT03365635|12006465|FG000|STARTED|Overall Study||3
10840847|NCT03365635|12006466|FG001|STARTED|Overall Study||0
10840848|NCT03365635|12006467|FG002|STARTED|Overall Study||1
10840849|NCT03365635|12006468|FG003|STARTED|Overall Study||0
10840850|NCT03365635|12006469|FG004|STARTED|Overall Study||0
10840851|NCT03365635|12006470|FG005|STARTED|Overall Study||0
10840852|NCT03365635|12006465|FG000|COMPLETED|Overall Study||3
10840853|NCT03365635|12006466|FG001|COMPLETED|Overall Study||0
10840854|NCT03365635|12006467|FG002|COMPLETED|Overall Study||1
10840855|NCT03365635|12006468|FG003|COMPLETED|Overall Study||0
10840856|NCT03365635|12006469|FG004|COMPLETED|Overall Study||0
10840857|NCT03365635|12006470|FG005|COMPLETED|Overall Study||0
10840858|NCT03365635|12006465|FG000|NOT COMPLETED|Overall Study||0
10840859|NCT03365635|12006466|FG001|NOT COMPLETED|Overall Study||0
10840860|NCT03365635|12006467|FG002|NOT COMPLETED|Overall Study||0
10840861|NCT03365635|12006468|FG003|NOT COMPLETED|Overall Study||0
10840862|NCT03365635|12006469|FG004|NOT COMPLETED|Overall Study||0
10840863|NCT03365635|12006470|FG005|NOT COMPLETED|Overall Study||0
10840864|NCT03287050|12006484|FG000|STARTED|Overall Study||6
10840865|NCT03287050|12006484|FG000|COMPLETED|Overall Study||6
10840866|NCT03287050|12006484|FG000|NOT COMPLETED|Overall Study||0
10840867|NCT03223350|12006490|FG000|STARTED|Overall Study||17
10840868|NCT03223350|12006491|FG001|STARTED|Overall Study||13
10840869|NCT03223350|12006490|FG000|COMPLETED|Overall Study||17
10840870|NCT03223350|12006491|FG001|COMPLETED|Overall Study||13
10840871|NCT03223350|12006490|FG000|NOT COMPLETED|Overall Study||0
10840872|NCT03223350|12006491|FG001|NOT COMPLETED|Overall Study||0
10840873|NCT03181828|12006499|FG000|STARTED|Overall Study||2
10840874|NCT03181828|12006500|FG001|STARTED|Overall Study||2
10840875|NCT03181828|12006499|FG000|COMPLETED|Overall Study||2
10840876|NCT03181828|12006500|FG001|COMPLETED|Overall Study||2
10840877|NCT03181828|12006499|FG000|NOT COMPLETED|Overall Study||0
10840878|NCT03181828|12006500|FG001|NOT COMPLETED|Overall Study||0
10840879|NCT03181529|12006508|FG000|STARTED|Overall Study||15
10840880|NCT03181529|12006509|FG001|STARTED|Overall Study||12
10840881|NCT03181529|12006508|FG000|COMPLETED|Overall Study||13
10840882|NCT03181529|12006509|FG001|COMPLETED|Overall Study||11
10840883|NCT03181529|12006508|FG000|NOT COMPLETED|Overall Study||2
10840884|NCT03181529|12006509|FG001|NOT COMPLETED|Overall Study||1
11104106|NCT01246791|12288342|FG000|COMPLETED|Overall Study||12
11104107|NCT01246791|12288342|FG000|NOT COMPLETED|Overall Study||0
11104108|NCT01246895|12288348|FG000|STARTED|Overall Study||37
11104109|NCT01246895|12288349|FG001|STARTED|Overall Study||30
10840889|NCT02779556|12006521|FG000|STARTED|Baseline||394
10840890|NCT02779556|12006522|FG001|STARTED|Baseline||362
10840891|NCT02779556|12006521|FG000|COMPLETED|Baseline||393
10840892|NCT02779556|12006522|FG001|COMPLETED|Baseline||362
10840893|NCT02779556|12006521|FG000|NOT COMPLETED|Baseline||1
10840894|NCT02779556|12006522|FG001|NOT COMPLETED|Baseline||0
10840895|NCT02779556|12006521|FG000|STARTED|3 Months||393
10840896|NCT02779556|12006522|FG001|STARTED|3 Months||362
10840897|NCT02779556|12006521|FG000|COMPLETED|3 Months||326
10840898|NCT02779556|12006522|FG001|COMPLETED|3 Months||314
10840899|NCT02779556|12006521|FG000|NOT COMPLETED|3 Months||67
10840900|NCT02779556|12006522|FG001|NOT COMPLETED|3 Months||48
10840901|NCT02779556|12006521|FG000|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (314+19=333 Enhanced Usual Care).|353
10840902|NCT02779556|12006522|FG001|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (326+27=353 Intervention).|333
10840903|NCT02779556|12006521|FG000|COMPLETED|6 Month||320
10840904|NCT02779556|12006522|FG001|COMPLETED|6 Month||294
10840905|NCT02779556|12006521|FG000|NOT COMPLETED|6 Month||33
10840906|NCT02779556|12006522|FG001|NOT COMPLETED|6 Month||39
10840907|NCT02779556|12006521|FG000|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394
10840908|NCT02779556|12006522|FG001|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362
10840909|NCT02779556|12006521|FG000|COMPLETED|6 Month HbA1c||325
10840910|NCT02779556|12006522|FG001|COMPLETED|6 Month HbA1c||312
10840911|NCT02779556|12006521|FG000|NOT COMPLETED|6 Month HbA1c||69
10840912|NCT02779556|12006522|FG001|NOT COMPLETED|6 Month HbA1c||50
10840913|NCT02779556|12006521|FG000|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394
10840914|NCT02779556|12006522|FG001|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362
10840915|NCT02779556|12006521|FG000|COMPLETED|12 Month HbA1c||256
10840916|NCT02779556|12006522|FG001|COMPLETED|12 Month HbA1c||260
10840917|NCT02779556|12006521|FG000|NOT COMPLETED|12 Month HbA1c||138
10840918|NCT02779556|12006522|FG001|NOT COMPLETED|12 Month HbA1c||102
10840919|NCT02724774|12006530|FG000|STARTED|Overall Study||127
10840920|NCT02724774|12006531|FG001|STARTED|Overall Study||125
10840921|NCT02724774|12006530|FG000|Infant 6 Months|Overall Study||122
10840922|NCT02724774|12006531|FG001|Infant 6 Months|Overall Study||122
10840923|NCT02724774|12006530|FG000|Infant 12 Months|Overall Study||120
10840924|NCT02724774|12006531|FG001|Infant 12 Months|Overall Study||123
10840925|NCT02724774|12006530|FG000|COMPLETED|Overall Study||120
10840926|NCT02724774|12006531|FG001|COMPLETED|Overall Study||123
10840927|NCT02724774|12006530|FG000|NOT COMPLETED|Overall Study||7
10840928|NCT02724774|12006531|FG001|NOT COMPLETED|Overall Study||2
10840929|NCT02675751|12006537|FG000|STARTED|Overall Study||167
10840930|NCT02675751|12006537|FG000|COMPLETED|Overall Study||151
10840931|NCT02675751|12006537|FG000|NOT COMPLETED|Overall Study||16
10840932|NCT02643381|12006543|FG000|STARTED|Overall Study||400
10840933|NCT02643381|12006544|FG001|STARTED|Overall Study||401
10840934|NCT02643381|12006543|FG000|COMPLETED|Overall Study||396
10840935|NCT02643381|12006544|FG001|COMPLETED|Overall Study||395
10840936|NCT02643381|12006543|FG000|NOT COMPLETED|Overall Study||4
10840937|NCT02643381|12006544|FG001|NOT COMPLETED|Overall Study||6
10840938|NCT02621424|12006552|FG000|STARTED|Overall Study||14
10840939|NCT02621424|12006553|FG001|STARTED|Overall Study||18
10840940|NCT02621424|12006552|FG000|COMPLETED|Overall Study||13
10840941|NCT02621424|12006553|FG001|COMPLETED|Overall Study||16
10840942|NCT02621424|12006552|FG000|NOT COMPLETED|Overall Study||1
10840943|NCT02621424|12006553|FG001|NOT COMPLETED|Overall Study||2
10840944|NCT02595372|12006559|FG000|STARTED|Overall Study||42
10840945|NCT02595372|12006559|FG000|COMPLETED|Overall Study||33
10840946|NCT02595372|12006559|FG000|NOT COMPLETED|Overall Study||9
10840947|NCT02334722|12006565|FG000|STARTED|Overall Study||40
10840948|NCT02334722|12006566|FG001|STARTED|Overall Study||41
10840949|NCT02334722|12006565|FG000|COMPLETED|Overall Study||33
10840950|NCT02334722|12006566|FG001|COMPLETED|Overall Study||34
10840951|NCT02334722|12006565|FG000|NOT COMPLETED|Overall Study||7
10840952|NCT02334722|12006566|FG001|NOT COMPLETED|Overall Study||7
10840953|NCT02259725|12006572|FG000|STARTED|Overall Study||3
10840954|NCT02259725|12006572|FG000|COMPLETED|Overall Study||3
10840955|NCT02259725|12006572|FG000|NOT COMPLETED|Overall Study||0
10840956|NCT01966731|12006576|FG000|STARTED|Overall Study||635
10840957|NCT01966731|12006576|FG000|Initiated Hydroxyurea|Overall Study||606
10840958|NCT01966731|12006576|FG000|Completed 3 Months of Treatment|Overall Study||600
10840959|NCT01966731|12006576|FG000|Completed Study|Overall Study||0
10840960|NCT01966731|12006576|FG000|COMPLETED|Overall Study||0
10840961|NCT01966731|12006576|FG000|NOT COMPLETED|Overall Study||635
10840962|NCT01952288|12006582|FG000|STARTED|Overall Study||3
10840963|NCT01952288|12006583|FG001|STARTED|Overall Study||2
10840964|NCT01952288|12006582|FG000|COMPLETED|Overall Study||3
10840965|NCT01952288|12006583|FG001|COMPLETED|Overall Study||2
10840966|NCT01952288|12006582|FG000|NOT COMPLETED|Overall Study||0
10840967|NCT01952288|12006583|FG001|NOT COMPLETED|Overall Study||0
10840968|NCT01850082|12006591|FG000|STARTED|Overall Study||576
11104110|NCT01246895|12288348|FG000|COMPLETED|Overall Study||34
11104111|NCT01246895|12288349|FG001|COMPLETED|Overall Study||26
11104112|NCT01246895|12288348|FG000|NOT COMPLETED|Overall Study||3
11104113|NCT01246895|12288349|FG001|NOT COMPLETED|Overall Study||4
11104114|NCT01246960|12288359|FG000|STARTED|Overall Study||84
11104115|NCT01246960|12288360|FG001|STARTED|Overall Study||84
11104116|NCT01246960|12288359|FG000|Received Any Quantity of Study Drug|Overall Study||82
11104117|NCT01246960|12288360|FG001|Received Any Quantity of Study Drug|Overall Study||80
11104118|NCT01246960|12288359|FG000|COMPLETED|Overall Study||78
11104119|NCT01246960|12288360|FG001|COMPLETED|Overall Study||80
11104120|NCT01246960|12288359|FG000|NOT COMPLETED|Overall Study||6
11104121|NCT01246960|12288360|FG001|NOT COMPLETED|Overall Study||4
11104122|NCT01246973|12288368|FG000|STARTED|Overall Study||344
11104123|NCT01246973|12288369|FG001|STARTED|Overall Study||342
11104124|NCT01246973|12288368|FG000|COMPLETED|Overall Study||283
11104125|NCT01246973|12288369|FG001|COMPLETED|Overall Study||295
11104126|NCT01246973|12288368|FG000|NOT COMPLETED|Overall Study||61
11104127|NCT01246973|12288369|FG001|NOT COMPLETED|Overall Study||47
11104128|NCT01246986|12288382|FG000|STARTED|Overall Study||37
11104129|NCT01246986|12288383|FG001|STARTED|Overall Study||72
11104130|NCT01246986|12288384|FG002|STARTED|Overall Study||40
11104131|NCT01246986|12288385|FG003|STARTED|Overall Study||3
11104132|NCT01246986|12288386|FG004|STARTED|Overall Study||44
11104133|NCT01246986|12288387|FG005|STARTED|Overall Study||3
11104134|NCT01246986|12288388|FG006|STARTED|Overall Study||5
11104135|NCT01246986|12288382|FG000|Received at Least 1 Dose of Study Drug|Overall Study||37
11104136|NCT01246986|12288383|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
11104137|NCT01246986|12288384|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40
11104138|NCT01246986|12288385|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
11104139|NCT01246986|12288386|FG004|Received at Least 1 Dose of Study Drug|Overall Study||44
11104140|NCT01246986|12288387|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
11104141|NCT01246986|12288388|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
10840969|NCT01850082|12006592|FG001|STARTED|Overall Study||574
10840970|NCT01850082|12006591|FG000|COMPLETED|Overall Study||576
10840971|NCT01850082|12006592|FG001|COMPLETED|Overall Study||574
10840972|NCT01850082|12006591|FG000|NOT COMPLETED|Overall Study||0
10840973|NCT01850082|12006592|FG001|NOT COMPLETED|Overall Study||0
11104142|NCT01246986|12288382|FG000|COMPLETED|Overall Study||34
11104143|NCT01246986|12288383|FG001|COMPLETED|Overall Study||67
11104144|NCT01246986|12288384|FG002|COMPLETED|Overall Study||34
11104145|NCT01246986|12288385|FG003|COMPLETED|Overall Study||3
11104146|NCT01246986|12288386|FG004|COMPLETED|Overall Study||40
11104147|NCT01246986|12288387|FG005|COMPLETED|Overall Study||2
10840980|NCT01675479|12006610|FG000|STARTED|Overall Study||69
10840981|NCT01675479|12006610|FG000|COMPLETED|Overall Study||58
10840982|NCT01675479|12006610|FG000|NOT COMPLETED|Overall Study||11
10840983|NCT00812708|12006614|FG000|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
10840984|NCT00812708|12006614|FG000|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
10840985|NCT00812708|12006614|FG000|COMPLETED|Overall Study||64
10840986|NCT00812708|12006614|FG000|NOT COMPLETED|Overall Study||8
10840987|NCT00741988|12006621|FG000|STARTED|Overall Study||42
10840988|NCT00741988|12006622|FG001|STARTED|Overall Study||40
10840989|NCT00741988|12006621|FG000|COMPLETED|Overall Study||38
10840990|NCT00741988|12006622|FG001|COMPLETED|Overall Study||36
10840991|NCT00741988|12006621|FG000|NOT COMPLETED|Overall Study||4
10840992|NCT00741988|12006622|FG001|NOT COMPLETED|Overall Study||4
10840993|NCT00563576|12006630|FG000|STARTED|Overall Study||35
10840994|NCT00563576|12006631|FG001|STARTED|Overall Study||36
11104148|NCT01246986|12288388|FG006|COMPLETED|Overall Study||5
11104149|NCT01246986|12288382|FG000|NOT COMPLETED|Overall Study||3
11104150|NCT01246986|12288383|FG001|NOT COMPLETED|Overall Study||5
11104151|NCT01246986|12288384|FG002|NOT COMPLETED|Overall Study||6
11104152|NCT01246986|12288385|FG003|NOT COMPLETED|Overall Study||0
10840995|NCT00563576|12006630|FG000|COMPLETED|Overall Study||21
10840996|NCT00563576|12006631|FG001|COMPLETED|Overall Study||22
10840997|NCT00563576|12006630|FG000|NOT COMPLETED|Overall Study||14
10840998|NCT00563576|12006631|FG001|NOT COMPLETED|Overall Study||14
10840999|NCT00515671|12006639|FG000|STARTED|Overall Study||60
10841000|NCT00515671|12006640|FG001|STARTED|Overall Study||58
10841001|NCT00515671|12006639|FG000|COMPLETED|Overall Study||43
10841002|NCT00515671|12006640|FG001|COMPLETED|Overall Study||41
10841003|NCT00515671|12006639|FG000|NOT COMPLETED|Overall Study||17
10841004|NCT00515671|12006640|FG001|NOT COMPLETED|Overall Study||17
10841005|NCT00455403|12006648|FG000|STARTED|Overall Study||59
10841006|NCT00455403|12006649|FG001|STARTED|Overall Study||57
10841007|NCT00455403|12006648|FG000|COMPLETED|Overall Study||56
10841008|NCT00455403|12006649|FG001|COMPLETED|Overall Study||51
10841009|NCT00455403|12006648|FG000|NOT COMPLETED|Overall Study||3
10841010|NCT00455403|12006649|FG001|NOT COMPLETED|Overall Study||6
10841017|NCT04328961|12006666|FG000|STARTED|Overall Study||422
10841018|NCT04328961|12006667|FG001|STARTED|Overall Study||407
10841019|NCT04328961|12006666|FG000|COMPLETED|Overall Study||336
10841020|NCT04328961|12006667|FG001|COMPLETED|Overall Study||353
10841021|NCT04328961|12006666|FG000|NOT COMPLETED|Overall Study||86
10841022|NCT04328961|12006667|FG001|NOT COMPLETED|Overall Study||54
10841080|NCT02896855|12006734|FG001|NOT COMPLETED|Overall Study||53
10841081|NCT02871778|12006747|FG000|STARTED|Part A: Treatment Period 1||43
10841082|NCT02871778|12006748|FG001|STARTED|Part A: Treatment Period 1||41
10841083|NCT02871778|12006749|FG002|STARTED|Part A: Treatment Period 1||21
10841084|NCT02871778|12006750|FG003|STARTED|Part A: Treatment Period 1||18
10841085|NCT02871778|12006751|FG004|STARTED|Part A: Treatment Period 1||0
10841086|NCT02871778|12006752|FG005|STARTED|Part A: Treatment Period 1||0
10841087|NCT02871778|12006753|FG006|STARTED|Part A: Treatment Period 1||0
10841088|NCT02871778|12006754|FG007|STARTED|Part A: Treatment Period 1||0
10841089|NCT02871778|12006747|FG000|Safety Analysis Set|Part A: Treatment Period 1|1 participant was randomized to receive HS in Period 1, but instead received VX-371 in HS in Period 1.|44
10841090|NCT02871778|12006748|FG001|Safety Analysis Set|Part A: Treatment Period 1||40
10841091|NCT02871778|12006749|FG002|Safety Analysis Set|Part A: Treatment Period 1||21
10841092|NCT02871778|12006750|FG003|Safety Analysis Set|Part A: Treatment Period 1||18
10841093|NCT02871778|12006751|FG004|Safety Analysis Set|Part A: Treatment Period 1||0
10841094|NCT02871778|12006752|FG005|Safety Analysis Set|Part A: Treatment Period 1||0
10841095|NCT02871778|12006753|FG006|Safety Analysis Set|Part A: Treatment Period 1||0
10841096|NCT02871778|12006754|FG007|Safety Analysis Set|Part A: Treatment Period 1||0
10841097|NCT02871778|12006747|FG000|COMPLETED|Part A: Treatment Period 1||40
10841098|NCT02871778|12006748|FG001|COMPLETED|Part A: Treatment Period 1||37
10841099|NCT02871778|12006749|FG002|COMPLETED|Part A: Treatment Period 1||18
10841100|NCT02871778|12006750|FG003|COMPLETED|Part A: Treatment Period 1||16
10841101|NCT02871778|12006751|FG004|COMPLETED|Part A: Treatment Period 1||0
10841102|NCT02871778|12006752|FG005|COMPLETED|Part A: Treatment Period 1||0
10841103|NCT02871778|12006753|FG006|COMPLETED|Part A: Treatment Period 1||0
10841104|NCT02871778|12006754|FG007|COMPLETED|Part A: Treatment Period 1||0
10841105|NCT02871778|12006747|FG000|NOT COMPLETED|Part A: Treatment Period 1||3
10841106|NCT02871778|12006748|FG001|NOT COMPLETED|Part A: Treatment Period 1||4
10841107|NCT02871778|12006749|FG002|NOT COMPLETED|Part A: Treatment Period 1||3
10841108|NCT02871778|12006750|FG003|NOT COMPLETED|Part A: Treatment Period 1||2
10841109|NCT02871778|12006751|FG004|NOT COMPLETED|Part A: Treatment Period 1||0
10841110|NCT02871778|12006752|FG005|NOT COMPLETED|Part A: Treatment Period 1||0
10841111|NCT02871778|12006753|FG006|NOT COMPLETED|Part A: Treatment Period 1||0
10841112|NCT02871778|12006754|FG007|NOT COMPLETED|Part A: Treatment Period 1||0
10841113|NCT02871778|12006747|FG000|STARTED|Part A: Treatment Period 2||40
10841114|NCT02871778|12006748|FG001|STARTED|Part A: Treatment Period 2||37
10841115|NCT02871778|12006749|FG002|STARTED|Part A: Treatment Period 2||18
10841116|NCT02871778|12006750|FG003|STARTED|Part A: Treatment Period 2||16
10841117|NCT02871778|12006751|FG004|STARTED|Part A: Treatment Period 2||0
10841118|NCT02871778|12006752|FG005|STARTED|Part A: Treatment Period 2||0
10841119|NCT02871778|12006753|FG006|STARTED|Part A: Treatment Period 2||0
10841120|NCT02871778|12006754|FG007|STARTED|Part A: Treatment Period 2||0
10841121|NCT02871778|12006747|FG000|Safety Analysis Set|Part A: Treatment Period 2||40
10841122|NCT02871778|12006748|FG001|Safety Analysis Set|Part A: Treatment Period 2||37
10841123|NCT02871778|12006749|FG002|Safety Analysis Set|Part A: Treatment Period 2||18
10841124|NCT02871778|12006750|FG003|Safety Analysis Set|Part A: Treatment Period 2||16
10841125|NCT02871778|12006751|FG004|Safety Analysis Set|Part A: Treatment Period 2||0
10841126|NCT02871778|12006752|FG005|Safety Analysis Set|Part A: Treatment Period 2||0
10841127|NCT02871778|12006753|FG006|Safety Analysis Set|Part A: Treatment Period 2||0
10841128|NCT02871778|12006754|FG007|Safety Analysis Set|Part A: Treatment Period 2||0
10841129|NCT02871778|12006747|FG000|COMPLETED|Part A: Treatment Period 2||37
10841130|NCT02871778|12006748|FG001|COMPLETED|Part A: Treatment Period 2||35
10841131|NCT02871778|12006749|FG002|COMPLETED|Part A: Treatment Period 2||17
10841132|NCT02871778|12006750|FG003|COMPLETED|Part A: Treatment Period 2||15
10841133|NCT02871778|12006751|FG004|COMPLETED|Part A: Treatment Period 2||0
10841134|NCT02871778|12006752|FG005|COMPLETED|Part A: Treatment Period 2||0
10841135|NCT02871778|12006753|FG006|COMPLETED|Part A: Treatment Period 2||0
10841136|NCT02871778|12006754|FG007|COMPLETED|Part A: Treatment Period 2||0
10841137|NCT02871778|12006747|FG000|NOT COMPLETED|Part A: Treatment Period 2||3
10841138|NCT02871778|12006748|FG001|NOT COMPLETED|Part A: Treatment Period 2||2
10841139|NCT02871778|12006749|FG002|NOT COMPLETED|Part A: Treatment Period 2||1
10841140|NCT02871778|12006750|FG003|NOT COMPLETED|Part A: Treatment Period 2||1
10841141|NCT02871778|12006751|FG004|NOT COMPLETED|Part A: Treatment Period 2||0
10841142|NCT02871778|12006752|FG005|NOT COMPLETED|Part A: Treatment Period 2||0
10841143|NCT02871778|12006753|FG006|NOT COMPLETED|Part A: Treatment Period 2||0
10841144|NCT02871778|12006754|FG007|NOT COMPLETED|Part A: Treatment Period 2||0
10841145|NCT02871778|12006747|FG000|STARTED|Part B: Treatment Period 3||0
10841146|NCT02871778|12006748|FG001|STARTED|Part B: Treatment Period 3||0
10841147|NCT02871778|12006749|FG002|STARTED|Part B: Treatment Period 3||0
10841148|NCT02871778|12006750|FG003|STARTED|Part B: Treatment Period 3||0
10841149|NCT02871778|12006751|FG004|STARTED|Part B: Treatment Period 3|Out of 35 participants who were on VX-371 in HS in Treatment period 2 and completed Part A, 11 participants rolled-over to Part B.|11
10841150|NCT02871778|12006752|FG005|STARTED|Part B: Treatment Period 3|Out of 37 participants who were on HS in Treatment period 2 and completed Part A, 27 participants rolled-over to Part B.|27
10841023|NCT04128319|12006673|FG000|STARTED|Overall Study||3
10841024|NCT04128319|12006673|FG000|Initiated T-Guard Treatment|Overall Study||3
10841025|NCT04128319|12006673|FG000|COMPLETED|Overall Study||0
10841026|NCT04128319|12006673|FG000|NOT COMPLETED|Overall Study||3
10841027|NCT03761810|12006679|FG000|STARTED|Overall Study||290
10841028|NCT03761810|12006680|FG001|STARTED|Overall Study||144
10841029|NCT03761810|12006679|FG000|Received at Least 1 Dose of Study Drug|Overall Study||281
10841030|NCT03761810|12006680|FG001|Received at Least 1 Dose of Study Drug|Overall Study||138
10841031|NCT03761810|12006679|FG000|COMPLETED|Overall Study||242
10841032|NCT03761810|12006680|FG001|COMPLETED|Overall Study||132
10841033|NCT03761810|12006679|FG000|NOT COMPLETED|Overall Study||48
10841034|NCT03761810|12006680|FG001|NOT COMPLETED|Overall Study||12
10841035|NCT03761784|12006688|FG000|STARTED|Overall Study||281
10841036|NCT03761784|12006689|FG001|STARTED|Overall Study||143
10841037|NCT03761784|12006688|FG000|Received at Least 1 Dose of Study Drug|Overall Study||274
10841038|NCT03761784|12006689|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139
10841039|NCT03761784|12006688|FG000|COMPLETED|Overall Study||249
10841040|NCT03761784|12006689|FG001|COMPLETED|Overall Study||131
10841041|NCT03761784|12006688|FG000|NOT COMPLETED|Overall Study||32
10841042|NCT03761784|12006689|FG001|NOT COMPLETED|Overall Study||12
10841043|NCT03361865|12006697|FG000|STARTED|Overall Study||44
10841044|NCT03361865|12006698|FG001|STARTED|Overall Study||49
10841045|NCT03361865|12006697|FG000|Intention-to-Treat (ITT)|Overall Study||44
10841046|NCT03361865|12006698|FG001|Intention-to-Treat (ITT)|Overall Study||49
10841047|NCT03361865|12006697|FG000|All Participants as Treated (APaT)|Overall Study||43
11104153|NCT01246986|12288386|FG004|NOT COMPLETED|Overall Study||4
11104154|NCT01246986|12288387|FG005|NOT COMPLETED|Overall Study||1
11104155|NCT01246986|12288388|FG006|NOT COMPLETED|Overall Study||0
11104156|NCT01246999|12288423|FG000|STARTED|Overall Study||11
11104157|NCT01246999|12288424|FG001|STARTED|Overall Study||4
11104158|NCT01246999|12288425|FG002|STARTED|Overall Study||2
11104159|NCT01246999|12288426|FG003|STARTED|Overall Study||17
11104160|NCT01246999|12288423|FG000|COMPLETED|Overall Study||11
11104161|NCT01246999|12288424|FG001|COMPLETED|Overall Study||3
11104162|NCT01246999|12288425|FG002|COMPLETED|Overall Study||2
11221931|NCT01968070|12413509|FG009|COMPLETED|Period 3||0
10841048|NCT03361865|12006698|FG001|All Participants as Treated (APaT)|Overall Study||49
10841049|NCT03361865|12006697|FG000|COMPLETED|Overall Study||25
10841050|NCT03361865|12006698|FG001|COMPLETED|Overall Study||22
10841051|NCT03361865|12006697|FG000|NOT COMPLETED|Overall Study||19
10841052|NCT03361865|12006698|FG001|NOT COMPLETED|Overall Study||27
10841053|NCT03294304|12006705|FG000|STARTED|Overall Study||43
10841054|NCT03294304|12006705|FG000|COMPLETED|Overall Study||43
10841055|NCT03294304|12006705|FG000|NOT COMPLETED|Overall Study||0
10841056|NCT03122431|12006712|FG000|STARTED|Overall Study||41
10841057|NCT03122431|12006713|FG001|STARTED|Overall Study||32
10841058|NCT03122431|12006714|FG002|STARTED|Overall Study||20
10841059|NCT03122431|12006712|FG000|COMPLETED|Overall Study||41
10841060|NCT03122431|12006713|FG001|COMPLETED|Overall Study||32
10841061|NCT03122431|12006714|FG002|COMPLETED|Overall Study||9
10841062|NCT03122431|12006712|FG000|NOT COMPLETED|Overall Study||0
10841063|NCT03122431|12006713|FG001|NOT COMPLETED|Overall Study||0
10841064|NCT03122431|12006714|FG002|NOT COMPLETED|Overall Study||11
10841065|NCT02929056|12006724|FG000|STARTED|Overall Study||1
10841066|NCT02929056|12006725|FG001|STARTED|Overall Study||1
10841067|NCT02929056|12006724|FG000|COMPLETED|Overall Study||1
10841068|NCT02929056|12006725|FG001|COMPLETED|Overall Study||0
10841069|NCT02929056|12006724|FG000|NOT COMPLETED|Overall Study||0
10841070|NCT02929056|12006725|FG001|NOT COMPLETED|Overall Study||1
10841071|NCT02896855|12006733|FG000|STARTED|Overall Study||121
10841072|NCT02896855|12006734|FG001|STARTED|Overall Study||122
10841073|NCT02896855|12006733|FG000|Received Any Study Treatment|Overall Study||120
10841074|NCT02896855|12006734|FG001|Received Any Study Treatment|Overall Study||122
10841075|NCT02896855|12006733|FG000|Crossed Over From Placebo to Receive Pertuzumab|Overall Study|From 07-March-2020, 12 participants randomized to the Placebo arm crossed over to open-label pertuzumab.|12
10841076|NCT02896855|12006734|FG001|Crossed Over From Placebo to Receive Pertuzumab|Overall Study||0
10841077|NCT02896855|12006733|FG000|COMPLETED|Overall Study||49
10841078|NCT02896855|12006734|FG001|COMPLETED|Overall Study||69
10841079|NCT02896855|12006733|FG000|NOT COMPLETED|Overall Study||72
11221932|NCT01968070|12413510|FG010|COMPLETED|Period 3||0
11221933|NCT01968070|12413511|FG011|COMPLETED|Period 3||0
11221934|NCT01968070|12413512|FG012|COMPLETED|Period 3||0
11221935|NCT01968070|12413513|FG013|COMPLETED|Period 3||0
11221936|NCT01968070|12413514|FG014|COMPLETED|Period 3||0
11104163|NCT01246999|12288426|FG003|COMPLETED|Overall Study||15
11104164|NCT01246999|12288423|FG000|NOT COMPLETED|Overall Study||0
11221937|NCT01968070|12413515|FG015|COMPLETED|Period 3||0
11104165|NCT01246999|12288424|FG001|NOT COMPLETED|Overall Study||1
11221938|NCT01968070|12413516|FG016|COMPLETED|Period 3||0
11221939|NCT01968070|12413517|FG017|COMPLETED|Period 3||0
11221940|NCT01968070|12413500|FG000|NOT COMPLETED|Period 3||0
11221941|NCT01968070|12413501|FG001|NOT COMPLETED|Period 3||0
11221942|NCT01968070|12413502|FG002|NOT COMPLETED|Period 3||0
11221943|NCT01968070|12413503|FG003|NOT COMPLETED|Period 3||0
11221944|NCT01968070|12413504|FG004|NOT COMPLETED|Period 3||0
11221945|NCT01968070|12413505|FG005|NOT COMPLETED|Period 3||0
11221946|NCT01968070|12413506|FG006|NOT COMPLETED|Period 3||0
11221947|NCT01968070|12413507|FG007|NOT COMPLETED|Period 3||0
11221948|NCT01968070|12413508|FG008|NOT COMPLETED|Period 3||0
11221949|NCT01968070|12413509|FG009|NOT COMPLETED|Period 3||0
11221950|NCT01968070|12413510|FG010|NOT COMPLETED|Period 3||0
11221951|NCT01968070|12413511|FG011|NOT COMPLETED|Period 3||0
11221952|NCT01968070|12413512|FG012|NOT COMPLETED|Period 3||0
11221953|NCT01968070|12413513|FG013|NOT COMPLETED|Period 3||0
11221954|NCT01968070|12413514|FG014|NOT COMPLETED|Period 3||0
11221955|NCT01968070|12413515|FG015|NOT COMPLETED|Period 3||0
11221956|NCT01968070|12413516|FG016|NOT COMPLETED|Period 3||0
11221957|NCT01968070|12413517|FG017|NOT COMPLETED|Period 3||0
11221958|NCT01968135|12413557|FG000|STARTED|Overall Study||16
11221959|NCT01968135|12413558|FG001|STARTED|Overall Study||16
11221960|NCT01968135|12413557|FG000|COMPLETED|Overall Study||16
11221961|NCT01968135|12413558|FG001|COMPLETED|Overall Study||16
11221962|NCT01968135|12413557|FG000|NOT COMPLETED|Overall Study||0
11221963|NCT01968135|12413558|FG001|NOT COMPLETED|Overall Study||0
11221964|NCT01968317|12413566|FG000|STARTED|Overall Study||76
11221965|NCT01968317|12413567|FG001|STARTED|Overall Study||74
11221966|NCT01968317|12413566|FG000|COMPLETED|Overall Study||76
11221967|NCT01968317|12413567|FG001|COMPLETED|Overall Study||74
11221968|NCT01968317|12413566|FG000|NOT COMPLETED|Overall Study||0
11221969|NCT01968317|12413567|FG001|NOT COMPLETED|Overall Study||0
11221970|NCT01968356|12413581|FG000|STARTED|Overall Study||101
11221971|NCT01968356|12413582|FG001|STARTED|Overall Study||93
11221972|NCT01968356|12413583|FG002|STARTED|Overall Study||96
11221973|NCT01968356|12413584|FG003|STARTED|Overall Study||32
11221974|NCT01968356|12413585|FG004|STARTED|Overall Study||97
11221975|NCT01968356|12413586|FG005|STARTED|Overall Study||99
11221976|NCT01968356|12413587|FG006|STARTED|Overall Study||97
11104166|NCT01246999|12288425|FG002|NOT COMPLETED|Overall Study||0
11221977|NCT01968356|12413588|FG007|STARTED|Overall Study||31
11221978|NCT01968356|12413581|FG000|COMPLETED|Overall Study||101
11221979|NCT01968356|12413582|FG001|COMPLETED|Overall Study||93
11221980|NCT01968356|12413583|FG002|COMPLETED|Overall Study||96
11221981|NCT01968356|12413584|FG003|COMPLETED|Overall Study||32
11221982|NCT01968356|12413585|FG004|COMPLETED|Overall Study||97
11221983|NCT01968356|12413586|FG005|COMPLETED|Overall Study||99
11221984|NCT01968356|12413587|FG006|COMPLETED|Overall Study||97
11221985|NCT01968356|12413588|FG007|COMPLETED|Overall Study||31
11221986|NCT01968356|12413581|FG000|NOT COMPLETED|Overall Study||0
11221987|NCT01968356|12413582|FG001|NOT COMPLETED|Overall Study||0
11221988|NCT01968356|12413583|FG002|NOT COMPLETED|Overall Study||0
11221989|NCT01968356|12413584|FG003|NOT COMPLETED|Overall Study||0
11221990|NCT01968356|12413585|FG004|NOT COMPLETED|Overall Study||0
11221991|NCT01968356|12413586|FG005|NOT COMPLETED|Overall Study||0
11221992|NCT01968356|12413587|FG006|NOT COMPLETED|Overall Study||0
11221993|NCT01968356|12413588|FG007|NOT COMPLETED|Overall Study||0
11221994|NCT01968382|12413617|FG000|STARTED|Overall Study||18
11221995|NCT01968382|12413618|FG001|STARTED|Overall Study||19
11221996|NCT01968382|12413619|FG002|STARTED|Overall Study||20
11221997|NCT01968382|12413617|FG000|COMPLETED|Overall Study||18
11221998|NCT01968382|12413618|FG001|COMPLETED|Overall Study||19
11221999|NCT01968382|12413619|FG002|COMPLETED|Overall Study||20
11222000|NCT01968382|12413617|FG000|NOT COMPLETED|Overall Study||0
11222001|NCT01968382|12413618|FG001|NOT COMPLETED|Overall Study||0
11222002|NCT01968382|12413619|FG002|NOT COMPLETED|Overall Study||0
11222003|NCT01968421|12413629|FG000|STARTED|Overall Study|March 1, 2015 was the date for recruiting patients|99
11222004|NCT01968421|12413630|FG001|STARTED|Overall Study|March 1, 2015 was the date for recruiting controls|97
11222005|NCT01968421|12413629|FG000|Starting Trial|Overall Study||99
11222006|NCT01968421|12413630|FG001|Starting Trial|Overall Study||97
11222007|NCT01968421|12413629|FG000|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|99
11222008|NCT01968421|12413630|FG001|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|97
11222009|NCT01968421|12413629|FG000|NOT COMPLETED|Overall Study||0
11222010|NCT01968421|12413630|FG001|NOT COMPLETED|Overall Study||0
11222011|NCT01968434|12413638|FG000|STARTED|Overall Study||78
11222012|NCT01968434|12413639|FG001|STARTED|Overall Study||72
11222013|NCT01968434|12413638|FG000|COMPLETED|Overall Study||75
11222014|NCT01968434|12413639|FG001|COMPLETED|Overall Study||66
10841151|NCT02871778|12006753|FG006|STARTED|Part B: Treatment Period 3|Out of 15 participants who were on VX-371 in Treatment period 2 and completed Part A, 7 participants rolled-over to Part B.|7
10841152|NCT02871778|12006754|FG007|STARTED|Part B: Treatment Period 3|Out of 17 participants who were on Placebo in Treatment period 2 and completed Part A, 12 participants rolled-over to Part B.|12
10841153|NCT02871778|12006747|FG000|Safety Analysis Set|Part B: Treatment Period 3||0
10841154|NCT02871778|12006748|FG001|Safety Analysis Set|Part B: Treatment Period 3||0
10841155|NCT02871778|12006749|FG002|Safety Analysis Set|Part B: Treatment Period 3||0
10841156|NCT02871778|12006750|FG003|Safety Analysis Set|Part B: Treatment Period 3||0
10841157|NCT02871778|12006751|FG004|Safety Analysis Set|Part B: Treatment Period 3||11
10841158|NCT02871778|12006752|FG005|Safety Analysis Set|Part B: Treatment Period 3||27
10841159|NCT02871778|12006753|FG006|Safety Analysis Set|Part B: Treatment Period 3||7
10841160|NCT02871778|12006754|FG007|Safety Analysis Set|Part B: Treatment Period 3||12
10841161|NCT02871778|12006747|FG000|COMPLETED|Part B: Treatment Period 3||0
10841162|NCT02871778|12006748|FG001|COMPLETED|Part B: Treatment Period 3||0
10841163|NCT02871778|12006749|FG002|COMPLETED|Part B: Treatment Period 3||0
10841164|NCT02871778|12006750|FG003|COMPLETED|Part B: Treatment Period 3||0
10841165|NCT02871778|12006751|FG004|COMPLETED|Part B: Treatment Period 3||10
10841166|NCT02871778|12006752|FG005|COMPLETED|Part B: Treatment Period 3||26
10841167|NCT02871778|12006753|FG006|COMPLETED|Part B: Treatment Period 3||6
10841168|NCT02871778|12006754|FG007|COMPLETED|Part B: Treatment Period 3||12
10841169|NCT02871778|12006747|FG000|NOT COMPLETED|Part B: Treatment Period 3||0
10841170|NCT02871778|12006748|FG001|NOT COMPLETED|Part B: Treatment Period 3||0
10841171|NCT02871778|12006749|FG002|NOT COMPLETED|Part B: Treatment Period 3||0
10841172|NCT02871778|12006750|FG003|NOT COMPLETED|Part B: Treatment Period 3||0
10841173|NCT02871778|12006751|FG004|NOT COMPLETED|Part B: Treatment Period 3||1
10841174|NCT02871778|12006752|FG005|NOT COMPLETED|Part B: Treatment Period 3||1
10841175|NCT02871778|12006753|FG006|NOT COMPLETED|Part B: Treatment Period 3||1
10841176|NCT02871778|12006754|FG007|NOT COMPLETED|Part B: Treatment Period 3||0
10841177|NCT02769000|12006778|FG000|STARTED|Overall Study||5
10841178|NCT02769000|12006779|FG001|STARTED|Overall Study||0
11222015|NCT01968434|12413638|FG000|NOT COMPLETED|Overall Study||3
11222016|NCT01968434|12413639|FG001|NOT COMPLETED|Overall Study||6
11222017|NCT01968447|12413647|FG000|STARTED|Overall Study||20
11222018|NCT01968447|12413648|FG001|STARTED|Overall Study||20
11222019|NCT01968447|12413647|FG000|COMPLETED|Overall Study||20
11222020|NCT01968447|12413648|FG001|COMPLETED|Overall Study||20
11222021|NCT01968447|12413647|FG000|NOT COMPLETED|Overall Study||0
11222022|NCT01968447|12413648|FG001|NOT COMPLETED|Overall Study||0
11222023|NCT01968551|12413657|FG000|STARTED|Open Label Phase (48 Weeks)||22
11222024|NCT01968551|12413658|FG001|STARTED|Open Label Phase (48 Weeks)||90
11222025|NCT01968551|12413659|FG002|STARTED|Open Label Phase (48 Weeks)||46
11222026|NCT01968551|12413657|FG000|COMPLETED|Open Label Phase (48 Weeks)||20
10841179|NCT02769000|12006778|FG000|COMPLETED|Overall Study||5
10841180|NCT02769000|12006779|FG001|COMPLETED|Overall Study||0
10841181|NCT02769000|12006778|FG000|NOT COMPLETED|Overall Study||0
10841182|NCT02769000|12006779|FG001|NOT COMPLETED|Overall Study||0
10841183|NCT02756208|12006787|FG000|STARTED|Overall Study||18
10841184|NCT02756208|12006788|FG001|STARTED|Overall Study||16
10841185|NCT02756208|12006789|FG002|STARTED|Overall Study||15
10841186|NCT02756208|12006790|FG003|STARTED|Overall Study||16
10841187|NCT02756208|12006787|FG000|COMPLETED|Overall Study||13
10841188|NCT02756208|12006788|FG001|COMPLETED|Overall Study||14
11222027|NCT01968551|12413658|FG001|COMPLETED|Open Label Phase (48 Weeks)||87
11222028|NCT01968551|12413659|FG002|COMPLETED|Open Label Phase (48 Weeks)||41
11222029|NCT01968551|12413657|FG000|NOT COMPLETED|Open Label Phase (48 Weeks)||2
11222030|NCT01968551|12413658|FG001|NOT COMPLETED|Open Label Phase (48 Weeks)||3
11222031|NCT01968551|12413659|FG002|NOT COMPLETED|Open Label Phase (48 Weeks)||5
11222032|NCT01968551|12413657|FG000|STARTED|Extension Phase||20
11222033|NCT01968551|12413658|FG001|STARTED|Extension Phase||87
11222034|NCT01968551|12413659|FG002|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
11222035|NCT01968551|12413657|FG000|COMPLETED|Extension Phase||19
11222036|NCT01968551|12413658|FG001|COMPLETED|Extension Phase||86
11222037|NCT01968551|12413659|FG002|COMPLETED|Extension Phase||30
11222038|NCT01968551|12413657|FG000|NOT COMPLETED|Extension Phase||1
11222039|NCT01968551|12413658|FG001|NOT COMPLETED|Extension Phase||1
11222040|NCT01968551|12413659|FG002|NOT COMPLETED|Extension Phase||4
11222041|NCT01968694|12413673|FG000|STARTED|Visit 1 (1 Day)||10
11222042|NCT01968694|12413674|FG001|STARTED|Visit 1 (1 Day)||9
11222043|NCT01968694|12413673|FG000|COMPLETED|Visit 1 (1 Day)||10
11222044|NCT01968694|12413674|FG001|COMPLETED|Visit 1 (1 Day)||9
11222045|NCT01968694|12413673|FG000|NOT COMPLETED|Visit 1 (1 Day)||0
11222046|NCT01968694|12413674|FG001|NOT COMPLETED|Visit 1 (1 Day)||0
10841189|NCT02756208|12006789|FG002|COMPLETED|Overall Study||13
10841190|NCT02756208|12006790|FG003|COMPLETED|Overall Study||12
10841191|NCT02756208|12006787|FG000|NOT COMPLETED|Overall Study||5
10841192|NCT02756208|12006788|FG001|NOT COMPLETED|Overall Study||2
10841193|NCT02756208|12006789|FG002|NOT COMPLETED|Overall Study||2
10841194|NCT02756208|12006790|FG003|NOT COMPLETED|Overall Study||4
10841195|NCT02149121|12006807|FG000|STARTED|Main Study Period||161
10841196|NCT02149121|12006808|FG001|STARTED|Main Study Period||151
10841197|NCT02149121|12006809|FG002|STARTED|Main Study Period||60
10841198|NCT02149121|12006810|FG003|STARTED|Main Study Period||0
10841199|NCT02149121|12006811|FG004|STARTED|Main Study Period||0
10841200|NCT02149121|12006812|FG005|STARTED|Main Study Period||0
10841201|NCT02149121|12006813|FG006|STARTED|Main Study Period||0
10841202|NCT02149121|12006807|FG000|COMPLETED|Main Study Period||140
10841203|NCT02149121|12006808|FG001|COMPLETED|Main Study Period||134
10841204|NCT02149121|12006809|FG002|COMPLETED|Main Study Period||56
10841205|NCT02149121|12006810|FG003|COMPLETED|Main Study Period||0
10841206|NCT02149121|12006811|FG004|COMPLETED|Main Study Period||0
10841207|NCT02149121|12006812|FG005|COMPLETED|Main Study Period||0
10841208|NCT02149121|12006813|FG006|COMPLETED|Main Study Period||0
10841209|NCT02149121|12006807|FG000|NOT COMPLETED|Main Study Period||21
10841210|NCT02149121|12006808|FG001|NOT COMPLETED|Main Study Period||17
10841211|NCT02149121|12006809|FG002|NOT COMPLETED|Main Study Period||4
10841212|NCT02149121|12006810|FG003|NOT COMPLETED|Main Study Period||0
10841213|NCT02149121|12006811|FG004|NOT COMPLETED|Main Study Period||0
10841214|NCT02149121|12006812|FG005|NOT COMPLETED|Main Study Period||0
10841215|NCT02149121|12006813|FG006|NOT COMPLETED|Main Study Period||0
10841216|NCT02149121|12006807|FG000|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
10841217|NCT02149121|12006808|FG001|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
10841218|NCT02149121|12006809|FG002|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
10841219|NCT02149121|12006810|FG003|STARTED|Extension Study Period|"Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9).~From 19 patients in CT-P10 who did not initiate the extension study period, one patient did not initiate the treatment course but had been included to extension period and was monitored up to week 48"|122
10841220|NCT02149121|12006811|FG004|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|64
10841221|NCT02149121|12006812|FG005|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|62
10841234|NCT02149121|12006811|FG004|NOT COMPLETED|Extension Study Period||0
10841222|NCT02149121|12006813|FG006|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|47
10841223|NCT02149121|12006807|FG000|COMPLETED|Extension Study Period||0
11222047|NCT01968694|12413673|FG000|STARTED|Washout (1 Month)||10
11222048|NCT01968694|12413674|FG001|STARTED|Washout (1 Month)||9
11222049|NCT01968694|12413673|FG000|COMPLETED|Washout (1 Month)||10
11222050|NCT01968694|12413674|FG001|COMPLETED|Washout (1 Month)||8
11222051|NCT01968694|12413673|FG000|NOT COMPLETED|Washout (1 Month)||0
11222052|NCT01968694|12413674|FG001|NOT COMPLETED|Washout (1 Month)||1
11222053|NCT01968694|12413673|FG000|STARTED|Visit 2 (1 Day)||10
11222054|NCT01968694|12413674|FG001|STARTED|Visit 2 (1 Day)||8
11222055|NCT01968694|12413673|FG000|COMPLETED|Visit 2 (1 Day)||10
11222056|NCT01968694|12413674|FG001|COMPLETED|Visit 2 (1 Day)||8
11222057|NCT01968694|12413673|FG000|NOT COMPLETED|Visit 2 (1 Day)||0
11222058|NCT01968694|12413674|FG001|NOT COMPLETED|Visit 2 (1 Day)||0
11222059|NCT01968707|12413690|FG000|STARTED|Overall Study||247
11222060|NCT01968707|12413691|FG001|STARTED|Overall Study||74
11222061|NCT01968707|12413692|FG002|STARTED|Overall Study||246
11222062|NCT01968707|12413693|FG003|STARTED|Overall Study||245
11222063|NCT01968707|12413694|FG004|STARTED|Overall Study||236
11222064|NCT01968707|12413695|FG005|STARTED|Overall Study||70
11222065|NCT01968707|12413696|FG006|STARTED|Overall Study||238
11222066|NCT01968707|12413697|FG007|STARTED|Overall Study||238
11222067|NCT01968707|12413690|FG000|COMPLETED|Overall Study||198
11222068|NCT01968707|12413691|FG001|COMPLETED|Overall Study||62
11222069|NCT01968707|12413692|FG002|COMPLETED|Overall Study||205
11222070|NCT01968707|12413693|FG003|COMPLETED|Overall Study||201
11222071|NCT01968707|12413694|FG004|COMPLETED|Overall Study||200
11222072|NCT01968707|12413695|FG005|COMPLETED|Overall Study||59
11222073|NCT01968707|12413696|FG006|COMPLETED|Overall Study||204
11222074|NCT01968707|12413697|FG007|COMPLETED|Overall Study||203
11222075|NCT01968707|12413690|FG000|NOT COMPLETED|Overall Study||49
11222076|NCT01968707|12413691|FG001|NOT COMPLETED|Overall Study||12
11222077|NCT01968707|12413692|FG002|NOT COMPLETED|Overall Study||41
11222078|NCT01968707|12413693|FG003|NOT COMPLETED|Overall Study||44
11222079|NCT01968707|12413694|FG004|NOT COMPLETED|Overall Study||36
11222080|NCT01968707|12413695|FG005|NOT COMPLETED|Overall Study||11
11222081|NCT01968707|12413696|FG006|NOT COMPLETED|Overall Study||34
11222082|NCT01968707|12413697|FG007|NOT COMPLETED|Overall Study||35
11222083|NCT01968811|12413730|FG000|STARTED|Overall Study||10
11222084|NCT01968811|12413730|FG000|COMPLETED|Overall Study||5
11222085|NCT01968811|12413730|FG000|NOT COMPLETED|Overall Study||5
11222086|NCT01968954|12413736|FG000|STARTED|Overall Study||354
11222087|NCT01968954|12413737|FG001|STARTED|Overall Study||357
11222088|NCT01968954|12413736|FG000|Treated|Overall Study||353
11222089|NCT01968954|12413737|FG001|Treated|Overall Study||356
11222090|NCT01968954|12413736|FG000|COMPLETED|Overall Study||314
11222091|NCT01968954|12413737|FG001|COMPLETED|Overall Study||314
11222092|NCT01968954|12413736|FG000|NOT COMPLETED|Overall Study||40
11222093|NCT01968954|12413737|FG001|NOT COMPLETED|Overall Study||43
11222094|NCT01968967|12413746|FG000|STARTED|Treatment Period||1071
11222095|NCT01968967|12413747|FG001|STARTED|Treatment Period||1068
11222096|NCT01968967|12413748|FG002|STARTED|Treatment Period||0
11222097|NCT01968967|12413749|FG003|STARTED|Treatment Period||0
11222098|NCT01968967|12413750|FG004|STARTED|Treatment Period||0
11222099|NCT01968967|12413746|FG000|Treated|Treatment Period||1065
11222100|NCT01968967|12413747|FG001|Treated|Treatment Period||1063
11222101|NCT01968967|12413748|FG002|Treated|Treatment Period||0
11222102|NCT01968967|12413749|FG003|Treated|Treatment Period||0
11222103|NCT01968967|12413750|FG004|Treated|Treatment Period||0
11222104|NCT01968967|12413746|FG000|COMPLETED|Treatment Period||925
11222105|NCT01968967|12413747|FG001|COMPLETED|Treatment Period||934
11222106|NCT01968967|12413748|FG002|COMPLETED|Treatment Period||0
11222107|NCT01968967|12413749|FG003|COMPLETED|Treatment Period||0
11222108|NCT01968967|12413750|FG004|COMPLETED|Treatment Period||0
11222109|NCT01968967|12413746|FG000|NOT COMPLETED|Treatment Period||146
11222110|NCT01968967|12413747|FG001|NOT COMPLETED|Treatment Period||134
11222111|NCT01968967|12413748|FG002|NOT COMPLETED|Treatment Period||0
11222112|NCT01968967|12413749|FG003|NOT COMPLETED|Treatment Period||0
11222113|NCT01968967|12413750|FG004|NOT COMPLETED|Treatment Period||0
11222114|NCT01968967|12413746|FG000|STARTED|Extension Period||0
10841224|NCT02149121|12006808|FG001|COMPLETED|Extension Study Period||0
10841225|NCT02149121|12006809|FG002|COMPLETED|Extension Study Period||0
10841226|NCT02149121|12006810|FG003|COMPLETED|Extension Study Period||121
10841227|NCT02149121|12006811|FG004|COMPLETED|Extension Study Period||64
10841228|NCT02149121|12006812|FG005|COMPLETED|Extension Study Period||60
10841229|NCT02149121|12006813|FG006|COMPLETED|Extension Study Period||47
10841230|NCT02149121|12006807|FG000|NOT COMPLETED|Extension Study Period||0
10841231|NCT02149121|12006808|FG001|NOT COMPLETED|Extension Study Period||0
10841232|NCT02149121|12006809|FG002|NOT COMPLETED|Extension Study Period||0
10841233|NCT02149121|12006810|FG003|NOT COMPLETED|Extension Study Period||1
11222115|NCT01968967|12413747|FG001|STARTED|Extension Period||0
11222116|NCT01968967|12413748|FG002|STARTED|Extension Period||47
11222117|NCT01968967|12413749|FG003|STARTED|Extension Period||19
11222118|NCT01968967|12413750|FG004|STARTED|Extension Period||39
11222119|NCT01968967|12413746|FG000|COMPLETED|Extension Period||0
11222120|NCT01968967|12413747|FG001|COMPLETED|Extension Period||0
11222121|NCT01968967|12413748|FG002|COMPLETED|Extension Period||45
11222122|NCT01968967|12413749|FG003|COMPLETED|Extension Period||19
11222123|NCT01968967|12413750|FG004|COMPLETED|Extension Period||34
11222124|NCT01968967|12413746|FG000|NOT COMPLETED|Extension Period||0
11222125|NCT01968967|12413747|FG001|NOT COMPLETED|Extension Period||0
10841235|NCT02149121|12006812|FG005|NOT COMPLETED|Extension Study Period||2
10841236|NCT02149121|12006813|FG006|NOT COMPLETED|Extension Study Period||0
10841237|NCT01889186|12006836|FG000|STARTED|Overall Study||107
10841238|NCT01889186|12006837|FG001|STARTED|Overall Study||51
10841239|NCT01889186|12006836|FG000|COMPLETED|Overall Study||0
10841240|NCT01889186|12006837|FG001|COMPLETED|Overall Study||0
10841241|NCT01889186|12006836|FG000|NOT COMPLETED|Overall Study||107
10841242|NCT01889186|12006837|FG001|NOT COMPLETED|Overall Study||51
10841243|NCT01850004|12006845|FG000|STARTED|Overall Study||84
10841244|NCT01850004|12006845|FG000|COMPLETED|Overall Study||76
10841245|NCT01850004|12006845|FG000|NOT COMPLETED|Overall Study||8
10841246|NCT01510184|12006852|FG000|STARTED|Overall Study||36
10841247|NCT01510184|12006853|FG001|STARTED|Overall Study||43
10841248|NCT01510184|12006852|FG000|COMPLETED|Overall Study||6
10841249|NCT01510184|12006853|FG001|COMPLETED|Overall Study||8
10841250|NCT01510184|12006852|FG000|NOT COMPLETED|Overall Study||30
10841251|NCT01510184|12006853|FG001|NOT COMPLETED|Overall Study||35
10841252|NCT01471444|12006861|FG000|STARTED|Overall Study||133
10841253|NCT01471444|12006862|FG001|STARTED|Overall Study||123
10841254|NCT01471444|12006861|FG000|COMPLETED|Overall Study||130
10841255|NCT01471444|12006862|FG001|COMPLETED|Overall Study||120
10841256|NCT01471444|12006861|FG000|NOT COMPLETED|Overall Study||3
10841257|NCT01471444|12006862|FG001|NOT COMPLETED|Overall Study||3
11222126|NCT01968967|12413748|FG002|NOT COMPLETED|Extension Period||2
11222127|NCT01968967|12413749|FG003|NOT COMPLETED|Extension Period||0
11222128|NCT01968967|12413750|FG004|NOT COMPLETED|Extension Period||5
11222129|NCT01968980|12413766|FG000|STARTED|Overall Study||185
11222130|NCT01968980|12413767|FG001|STARTED|Overall Study||185
11222131|NCT01968980|12413766|FG000|COMPLETED|Overall Study||169
11222132|NCT01968980|12413767|FG001|COMPLETED|Overall Study||171
11222133|NCT01968980|12413766|FG000|NOT COMPLETED|Overall Study||16
11222134|NCT01968980|12413767|FG001|NOT COMPLETED|Overall Study||14
11222135|NCT01969058|12413776|FG000|STARTED|Overall Study||50
11222136|NCT01969058|12413777|FG001|STARTED|Overall Study||26
11222137|NCT01969058|12413776|FG000|COMPLETED|Overall Study||47
11222138|NCT01969058|12413777|FG001|COMPLETED|Overall Study||26
11222139|NCT01969058|12413776|FG000|NOT COMPLETED|Overall Study||3
11222140|NCT01969058|12413777|FG001|NOT COMPLETED|Overall Study||0
11222141|NCT01969084|12413785|FG000|STARTED|Overall Study||19
11222142|NCT01969084|12413786|FG001|STARTED|Overall Study||22
11222143|NCT01969084|12413785|FG000|COMPLETED|Overall Study||19
11222144|NCT01969084|12413786|FG001|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
11222145|NCT01969084|12413785|FG000|NOT COMPLETED|Overall Study||0
10841258|NCT00545766|12006869|FG000|STARTED|Overall Study||41
10841259|NCT00545766|12006869|FG000|COMPLETED|Overall Study||36
10841260|NCT00545766|12006869|FG000|NOT COMPLETED|Overall Study||5
10841261|NCT04101890|12006873|FG000|STARTED|Routine Diaper Care||5
10841262|NCT04101890|12006873|FG000|COMPLETED|Routine Diaper Care||5
10841263|NCT04101890|12006873|FG000|NOT COMPLETED|Routine Diaper Care||0
10841264|NCT04101890|12006873|FG000|STARTED|Diaper Care With Theraworx||5
10841265|NCT04101890|12006873|FG000|COMPLETED|Diaper Care With Theraworx||5
10841266|NCT04101890|12006873|FG000|NOT COMPLETED|Diaper Care With Theraworx||0
10841267|NCT03993314|12006881|FG000|STARTED|Overall Study||9
10841268|NCT03993314|12006882|FG001|STARTED|Overall Study||6
10841269|NCT03993314|12006881|FG000|COMPLETED|Overall Study||9
10841270|NCT03993314|12006882|FG001|COMPLETED|Overall Study||6
10841271|NCT03993314|12006881|FG000|NOT COMPLETED|Overall Study||0
10841272|NCT03993314|12006882|FG001|NOT COMPLETED|Overall Study||0
10841273|NCT03874351|12006890|FG000|STARTED|Overall Study||11
10841274|NCT03874351|12006891|FG001|STARTED|Overall Study||11
10841275|NCT03874351|12006890|FG000|COMPLETED|Overall Study||7
10841276|NCT03874351|12006891|FG001|COMPLETED|Overall Study||9
10841277|NCT03874351|12006890|FG000|NOT COMPLETED|Overall Study||4
10841278|NCT03874351|12006891|FG001|NOT COMPLETED|Overall Study||2
10841279|NCT03856359|12006897|FG000|STARTED|Overall Study||10
11104167|NCT01246999|12288426|FG003|NOT COMPLETED|Overall Study||2
11104168|NCT01247064|12288441|FG000|STARTED|Overall Study||31
11104169|NCT01247064|12288442|FG001|STARTED|Overall Study||31
11104170|NCT01247064|12288441|FG000|COMPLETED|Overall Study||31
11104171|NCT01247064|12288442|FG001|COMPLETED|Overall Study||31
11104172|NCT01247064|12288441|FG000|NOT COMPLETED|Overall Study||0
11104173|NCT01247064|12288442|FG001|NOT COMPLETED|Overall Study||0
11104174|NCT01247090|12288451|FG000|STARTED|Overall Study||4
11104175|NCT01247090|12288452|FG001|STARTED|Overall Study||4
11104176|NCT01247090|12288453|FG002|STARTED|Overall Study||4
11104177|NCT01247090|12288451|FG000|COMPLETED|Overall Study||3
11104178|NCT01247090|12288452|FG001|COMPLETED|Overall Study||3
11104179|NCT01247090|12288453|FG002|COMPLETED|Overall Study||4
11104180|NCT01247090|12288451|FG000|NOT COMPLETED|Overall Study||1
11104181|NCT01247090|12288452|FG001|NOT COMPLETED|Overall Study||1
11104182|NCT01247090|12288453|FG002|NOT COMPLETED|Overall Study||0
11104183|NCT01247220|12288463|FG000|STARTED|Overall Study||6
11104184|NCT01247220|12288464|FG001|STARTED|Overall Study||6
11104185|NCT01247220|12288463|FG000|COMPLETED|Overall Study||6
11104186|NCT01247220|12288464|FG001|COMPLETED|Overall Study||6
11104187|NCT01247220|12288463|FG000|NOT COMPLETED|Overall Study||0
11104188|NCT01247220|12288464|FG001|NOT COMPLETED|Overall Study||0
11104189|NCT01247272|12288472|FG000|STARTED|First Intervention||13
11104190|NCT01247272|12288473|FG001|STARTED|First Intervention||13
11222146|NCT01969084|12413786|FG001|NOT COMPLETED|Overall Study||1
11222147|NCT01969162|12413796|FG000|STARTED|Overall Study||35
11222148|NCT01969162|12413796|FG000|COMPLETED|Overall Study||35
11104191|NCT01247272|12288472|FG000|COMPLETED|First Intervention||13
11104192|NCT01247272|12288473|FG001|COMPLETED|First Intervention||13
11104193|NCT01247272|12288472|FG000|NOT COMPLETED|First Intervention||0
11104194|NCT01247272|12288473|FG001|NOT COMPLETED|First Intervention||0
11104195|NCT01247272|12288472|FG000|STARTED|Washout of 28 Days||13
11104196|NCT01247272|12288473|FG001|STARTED|Washout of 28 Days||13
11104197|NCT01247272|12288472|FG000|COMPLETED|Washout of 28 Days||13
11104198|NCT01247272|12288473|FG001|COMPLETED|Washout of 28 Days||13
11104199|NCT01247272|12288472|FG000|NOT COMPLETED|Washout of 28 Days||0
11104200|NCT01247272|12288473|FG001|NOT COMPLETED|Washout of 28 Days||0
11104201|NCT01247272|12288472|FG000|STARTED|Second Intervention||13
11104202|NCT01247272|12288473|FG001|STARTED|Second Intervention||13
11104203|NCT01247272|12288472|FG000|COMPLETED|Second Intervention||13
11104204|NCT01247272|12288473|FG001|COMPLETED|Second Intervention||13
11104205|NCT01247272|12288472|FG000|NOT COMPLETED|Second Intervention||0
11104206|NCT01247272|12288473|FG001|NOT COMPLETED|Second Intervention||0
11104207|NCT01247285|12288481|FG000|STARTED|First Intervention||13
11104208|NCT01247285|12288482|FG001|STARTED|First Intervention||13
11104209|NCT01247285|12288481|FG000|COMPLETED|First Intervention||13
11104210|NCT01247285|12288482|FG001|COMPLETED|First Intervention||13
11104211|NCT01247285|12288481|FG000|NOT COMPLETED|First Intervention||0
11104212|NCT01247285|12288482|FG001|NOT COMPLETED|First Intervention||0
11104213|NCT01247285|12288481|FG000|STARTED|Washout of 28 Days||13
11104214|NCT01247285|12288482|FG001|STARTED|Washout of 28 Days||13
11104215|NCT01247285|12288481|FG000|COMPLETED|Washout of 28 Days||13
11104216|NCT01247285|12288482|FG001|COMPLETED|Washout of 28 Days||13
11104217|NCT01247285|12288481|FG000|NOT COMPLETED|Washout of 28 Days||0
11104218|NCT01247285|12288482|FG001|NOT COMPLETED|Washout of 28 Days||0
11104219|NCT01247285|12288481|FG000|STARTED|Second Intervention||13
11104220|NCT01247285|12288482|FG001|STARTED|Second Intervention||13
11104221|NCT01247285|12288481|FG000|COMPLETED|Second Intervention||13
11104222|NCT01247285|12288482|FG001|COMPLETED|Second Intervention||13
11104223|NCT01247285|12288481|FG000|NOT COMPLETED|Second Intervention||0
11104224|NCT01247285|12288482|FG001|NOT COMPLETED|Second Intervention||0
11104225|NCT01247298|12288488|FG000|STARTED|Overall Study||17
11104226|NCT01247298|12288488|FG000|COMPLETED|Overall Study||17
11104227|NCT01247298|12288488|FG000|NOT COMPLETED|Overall Study||0
11104228|NCT01247350|12288498|FG000|STARTED|Overall Study||6
11104229|NCT01247350|12288499|FG001|STARTED|Overall Study||6
11104230|NCT01247350|12288500|FG002|STARTED|Overall Study||6
11104231|NCT01247350|12288501|FG003|STARTED|Overall Study||7
11104232|NCT01247350|12288502|FG004|STARTED|Overall Study||9
11104233|NCT01247350|12288498|FG000|Received Multiple Doses of Study Drug|Overall Study||0
11104234|NCT01247350|12288499|FG001|Received Multiple Doses of Study Drug|Overall Study||0
11104235|NCT01247350|12288500|FG002|Received Multiple Doses of Study Drug|Overall Study||6
11104236|NCT01247350|12288501|FG003|Received Multiple Doses of Study Drug|Overall Study||6
11104237|NCT01247350|12288502|FG004|Received Multiple Doses of Study Drug|Overall Study||5
11104238|NCT01247350|12288498|FG000|COMPLETED|Overall Study||6
10841280|NCT03856359|12006897|FG000|COMPLETED|Overall Study||9
11104239|NCT01247350|12288499|FG001|COMPLETED|Overall Study||6
10841281|NCT03856359|12006897|FG000|NOT COMPLETED|Overall Study||1
10841282|NCT03769519|12006903|FG000|STARTED|Overall Study||14
10841283|NCT03769519|12006904|FG001|STARTED|Overall Study||15
10841284|NCT03769519|12006903|FG000|COMPLETED|Overall Study||14
10841285|NCT03769519|12006904|FG001|COMPLETED|Overall Study||14
10841286|NCT03769519|12006903|FG000|NOT COMPLETED|Overall Study||0
10841287|NCT03769519|12006904|FG001|NOT COMPLETED|Overall Study||1
10841288|NCT03745651|12006913|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||124
10841289|NCT03745651|12006914|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||248
10841290|NCT03745651|12006915|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||246
10841291|NCT03745651|12006916|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841292|NCT03745651|12006917|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841293|NCT03745651|12006918|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841294|NCT03745651|12006919|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841295|NCT03745651|12006913|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||105
10841296|NCT03745651|12006914|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||209
10841297|NCT03745651|12006915|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||224
10841298|NCT03745651|12006916|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841299|NCT03745651|12006917|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841300|NCT03745651|12006918|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841301|NCT03745651|12006919|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841302|NCT03745651|12006913|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||19
10841303|NCT03745651|12006914|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||39
10841304|NCT03745651|12006915|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||22
10841305|NCT03745651|12006916|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841306|NCT03745651|12006917|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841307|NCT03745651|12006918|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841308|NCT03745651|12006919|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841309|NCT03745651|12006913|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10841310|NCT03745651|12006914|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10841311|NCT03745651|12006915|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
11104240|NCT01247350|12288500|FG002|COMPLETED|Overall Study||5
11104241|NCT01247350|12288501|FG003|COMPLETED|Overall Study||6
10841312|NCT03745651|12006916|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||53
10841313|NCT03745651|12006917|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||52
10841314|NCT03745651|12006918|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||204
10841315|NCT03745651|12006919|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||221
10841316|NCT03745651|12006913|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841317|NCT03745651|12006914|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841318|NCT03745651|12006915|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841319|NCT03745651|12006916|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||33
10841320|NCT03745651|12006917|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||41
10841321|NCT03745651|12006918|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||151
10841322|NCT03745651|12006919|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||170
10841323|NCT03745651|12006913|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841324|NCT03745651|12006914|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841325|NCT03745651|12006915|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841326|NCT03745651|12006916|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||20
10841327|NCT03745651|12006917|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11
10841328|NCT03745651|12006918|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||53
10841329|NCT03745651|12006919|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51
10841330|NCT03745638|12006938|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||126
10841331|NCT03745638|12006939|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||252
10841332|NCT03745638|12006940|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||253
10841333|NCT03745638|12006941|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841334|NCT03745638|12006942|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841335|NCT03745638|12006943|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841336|NCT03745638|12006944|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
10841337|NCT03745638|12006938|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||95
10841338|NCT03745638|12006939|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||222
10841339|NCT03745638|12006940|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||225
10841340|NCT03745638|12006941|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841341|NCT03745638|12006942|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841342|NCT03745638|12006943|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841343|NCT03745638|12006944|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841344|NCT03745638|12006938|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||31
10841345|NCT03745638|12006939|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||30
10841346|NCT03745638|12006940|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||28
10841347|NCT03745638|12006941|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841348|NCT03745638|12006942|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841349|NCT03745638|12006943|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841350|NCT03745638|12006944|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
10841351|NCT03745638|12006938|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10841352|NCT03745638|12006939|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10841353|NCT03745638|12006940|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
10841354|NCT03745638|12006941|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||48
10841355|NCT03745638|12006942|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||47
10841356|NCT03745638|12006943|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||222
10841357|NCT03745638|12006944|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||225
10841358|NCT03745638|12006938|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841359|NCT03745638|12006939|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841360|NCT03745638|12006940|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841361|NCT03745638|12006941|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||37
10841362|NCT03745638|12006942|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||38
10841363|NCT03745638|12006943|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||176
10841364|NCT03745638|12006944|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||174
10841365|NCT03745638|12006938|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841366|NCT03745638|12006939|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841367|NCT03745638|12006940|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
10841368|NCT03745638|12006941|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11
10841369|NCT03745638|12006942|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||9
10841370|NCT03745638|12006943|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||46
10841371|NCT03745638|12006944|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51
10841372|NCT03715764|12006963|FG000|STARTED|Baseline (Randomized (n=69)||35
10841373|NCT03715764|12006964|FG001|STARTED|Baseline (Randomized (n=69)||34
10841374|NCT03715764|12006963|FG000|COMPLETED|Baseline (Randomized (n=69)||33
10841375|NCT03715764|12006964|FG001|COMPLETED|Baseline (Randomized (n=69)||31
10841376|NCT03715764|12006963|FG000|NOT COMPLETED|Baseline (Randomized (n=69)||2
10841377|NCT03715764|12006964|FG001|NOT COMPLETED|Baseline (Randomized (n=69)||3
10841378|NCT03715764|12006963|FG000|STARTED|3 Month Follow-up||33
10841379|NCT03715764|12006964|FG001|STARTED|3 Month Follow-up||31
10841380|NCT03715764|12006963|FG000|COMPLETED|3 Month Follow-up||30
10841381|NCT03715764|12006964|FG001|COMPLETED|3 Month Follow-up||28
10841382|NCT03715764|12006963|FG000|NOT COMPLETED|3 Month Follow-up||3
10841383|NCT03715764|12006964|FG001|NOT COMPLETED|3 Month Follow-up||3
10841384|NCT03715764|12006963|FG000|STARTED|6 Month Follow-up||30
10841385|NCT03715764|12006964|FG001|STARTED|6 Month Follow-up||28
10841386|NCT03715764|12006963|FG000|COMPLETED|6 Month Follow-up||27
10841387|NCT03715764|12006964|FG001|COMPLETED|6 Month Follow-up||28
10841388|NCT03715764|12006963|FG000|NOT COMPLETED|6 Month Follow-up||3
10841389|NCT03715764|12006964|FG001|NOT COMPLETED|6 Month Follow-up||0
10841390|NCT03715764|12006963|FG000|STARTED|12 Month Follow-up||27
10841391|NCT03715764|12006964|FG001|STARTED|12 Month Follow-up||28
10841392|NCT03715764|12006963|FG000|COMPLETED|12 Month Follow-up||21
10841393|NCT03715764|12006964|FG001|COMPLETED|12 Month Follow-up||23
10841394|NCT03715764|12006963|FG000|NOT COMPLETED|12 Month Follow-up||6
10841395|NCT03715764|12006964|FG001|NOT COMPLETED|12 Month Follow-up||5
10841396|NCT03663855|12006970|FG000|STARTED|Overall Study||10
10841397|NCT03663855|12006970|FG000|COMPLETED|Overall Study||10
10841398|NCT03663855|12006970|FG000|NOT COMPLETED|Overall Study||0
10841399|NCT03654729|12006977|FG000|STARTED|Overall Study||97
10841400|NCT03654729|12006978|FG001|STARTED|Overall Study||96
10841401|NCT03654729|12006979|FG002|STARTED|Overall Study||98
10841402|NCT03654729|12006977|FG000|Treated|Overall Study||96
10841403|NCT03654729|12006978|FG001|Treated|Overall Study||93
10841404|NCT03654729|12006979|FG002|Treated|Overall Study||96
10841405|NCT03654729|12006977|FG000|COMPLETED|Overall Study||66
10841406|NCT03654729|12006978|FG001|COMPLETED|Overall Study||70
10841407|NCT03654729|12006979|FG002|COMPLETED|Overall Study||69
10841408|NCT03654729|12006977|FG000|NOT COMPLETED|Overall Study||31
10841409|NCT03654729|12006978|FG001|NOT COMPLETED|Overall Study||26
10841410|NCT03654729|12006979|FG002|NOT COMPLETED|Overall Study||29
10841411|NCT03531112|12006989|FG000|STARTED|Overall Study||20
10841412|NCT03531112|12006990|FG001|STARTED|Overall Study||0
10841413|NCT03531112|12006989|FG000|Month 4|Overall Study||17
10841414|NCT03531112|12006990|FG001|Month 4|Overall Study||0
11104242|NCT01247350|12288502|FG004|COMPLETED|Overall Study||8
11104243|NCT01247350|12288498|FG000|NOT COMPLETED|Overall Study||0
11104244|NCT01247350|12288499|FG001|NOT COMPLETED|Overall Study||0
11104245|NCT01247350|12288500|FG002|NOT COMPLETED|Overall Study||1
11104246|NCT01247350|12288501|FG003|NOT COMPLETED|Overall Study||1
11104247|NCT01247350|12288502|FG004|NOT COMPLETED|Overall Study||1
11104248|NCT01247363|12288528|FG000|STARTED|Overall Study||20
11104249|NCT01247363|12288528|FG000|COMPLETED|Overall Study||20
11104250|NCT01247363|12288528|FG000|NOT COMPLETED|Overall Study||0
11104251|NCT01247428|12288543|FG000|STARTED|Overall Study||30
11104252|NCT01247428|12288543|FG000|COMPLETED|Overall Study||30
11104253|NCT01247428|12288543|FG000|NOT COMPLETED|Overall Study||0
11104254|NCT01247571|12288547|FG000|STARTED|Overall Study||22
11104255|NCT01247571|12288547|FG000|COMPLETED|Overall Study||19
11104256|NCT01247571|12288547|FG000|NOT COMPLETED|Overall Study||3
11104257|NCT01247675|12288555|FG000|STARTED|Overall Study||10
11104258|NCT01247675|12288556|FG001|STARTED|Overall Study||10
11104259|NCT01247675|12288557|FG002|STARTED|Overall Study||9
10841415|NCT03531112|12006989|FG000|Month 6 (Follow-Up)|Overall Study||13
10841416|NCT03531112|12006990|FG001|Month 6 (Follow-Up)|Overall Study||0
10841417|NCT03531112|12006989|FG000|COMPLETED|Overall Study||13
11104260|NCT01247675|12288558|FG003|STARTED|Overall Study||8
11104261|NCT01247675|12288555|FG000|COMPLETED|Overall Study||8
11104262|NCT01247675|12288556|FG001|COMPLETED|Overall Study||8
11104263|NCT01247675|12288557|FG002|COMPLETED|Overall Study||9
11104264|NCT01247675|12288558|FG003|COMPLETED|Overall Study||8
10841418|NCT03531112|12006990|FG001|COMPLETED|Overall Study||0
10841419|NCT03531112|12006989|FG000|NOT COMPLETED|Overall Study||7
10841420|NCT03531112|12006990|FG001|NOT COMPLETED|Overall Study||0
10841421|NCT03112902|12007006|FG000|STARTED|Overall Study||2
10841422|NCT03112902|12007007|FG001|STARTED|Overall Study||2
10841423|NCT03112902|12007008|FG002|STARTED|Overall Study||3
10841424|NCT03112902|12007009|FG003|STARTED|Overall Study||1
10841425|NCT03112902|12007010|FG004|STARTED|Overall Study||1
10841426|NCT03112902|12007011|FG005|STARTED|Overall Study||3
10841427|NCT03112902|12007012|FG006|STARTED|Overall Study||9
10841428|NCT03112902|12007013|FG007|STARTED|Overall Study||3
10841429|NCT03112902|12007014|FG008|STARTED|Overall Study||0
10841430|NCT03112902|12007015|FG009|STARTED|Overall Study||0
10841431|NCT03112902|12007006|FG000|COMPLETED|Overall Study||0
10841432|NCT03112902|12007007|FG001|COMPLETED|Overall Study||2
10841433|NCT03112902|12007008|FG002|COMPLETED|Overall Study||2
10841434|NCT03112902|12007009|FG003|COMPLETED|Overall Study||0
10841435|NCT03112902|12007010|FG004|COMPLETED|Overall Study||1
10841436|NCT03112902|12007011|FG005|COMPLETED|Overall Study||0
10841437|NCT03112902|12007012|FG006|COMPLETED|Overall Study||1
10841438|NCT03112902|12007013|FG007|COMPLETED|Overall Study||1
10841439|NCT03112902|12007014|FG008|COMPLETED|Overall Study||0
10841440|NCT03112902|12007015|FG009|COMPLETED|Overall Study||0
10841441|NCT03112902|12007006|FG000|NOT COMPLETED|Overall Study||2
10841442|NCT03112902|12007007|FG001|NOT COMPLETED|Overall Study||0
10841443|NCT03112902|12007008|FG002|NOT COMPLETED|Overall Study||1
10841444|NCT03112902|12007009|FG003|NOT COMPLETED|Overall Study||1
10841445|NCT03112902|12007010|FG004|NOT COMPLETED|Overall Study||0
10841446|NCT03112902|12007011|FG005|NOT COMPLETED|Overall Study||3
10841447|NCT03112902|12007012|FG006|NOT COMPLETED|Overall Study||8
10841448|NCT03112902|12007013|FG007|NOT COMPLETED|Overall Study||2
10841449|NCT03112902|12007014|FG008|NOT COMPLETED|Overall Study||0
10841450|NCT03112902|12007015|FG009|NOT COMPLETED|Overall Study||0
10841451|NCT02976038|12007031|FG000|STARTED|Overall Study||28
10841452|NCT02976038|12007031|FG000|COMPLETED|Overall Study||0
10841453|NCT02976038|12007031|FG000|NOT COMPLETED|Overall Study||28
10841454|NCT02631070|12007047|FG000|STARTED|Overall Study||153
10841455|NCT02631070|12007048|FG001|STARTED|Overall Study||76
10841456|NCT02631070|12007047|FG000|COMPLETED|Overall Study||4
10841457|NCT02631070|12007048|FG001|COMPLETED|Overall Study||12
10841458|NCT02631070|12007047|FG000|NOT COMPLETED|Overall Study||149
10841459|NCT02631070|12007048|FG001|NOT COMPLETED|Overall Study||64
10841460|NCT02281955|12007054|FG000|STARTED|Overall Study||114
10841461|NCT02281955|12007054|FG000|COMPLETED|Overall Study||113
10841462|NCT02281955|12007054|FG000|NOT COMPLETED|Overall Study||1
10841463|NCT02202434|12007062|FG000|STARTED|Overall Study||607
10841464|NCT02202434|12007063|FG001|STARTED|Overall Study||305
10841465|NCT02202434|12007064|FG002|STARTED|Overall Study||102
10841466|NCT02202434|12007065|FG003|STARTED|Overall Study||295
10841467|NCT02202434|12007062|FG000|COMPLETED|Overall Study||498
10841468|NCT02202434|12007063|FG001|COMPLETED|Overall Study||236
10841469|NCT02202434|12007064|FG002|COMPLETED|Overall Study||87
10841470|NCT02202434|12007065|FG003|COMPLETED|Overall Study||258
10841471|NCT02202434|12007062|FG000|NOT COMPLETED|Overall Study||109
10841472|NCT02202434|12007063|FG001|NOT COMPLETED|Overall Study||69
10841473|NCT02202434|12007064|FG002|NOT COMPLETED|Overall Study||15
10841474|NCT02202434|12007065|FG003|NOT COMPLETED|Overall Study||37
10841475|NCT01727011|12007075|FG000|STARTED|Overall Study||31
10841476|NCT01727011|12007075|FG000|COMPLETED|Overall Study||26
10841477|NCT01727011|12007075|FG000|NOT COMPLETED|Overall Study||5
10841478|NCT01230242|12007079|FG000|STARTED|Overall Study||4
10841479|NCT01230242|12007079|FG000|COMPLETED|Overall Study||1
10841480|NCT01230242|12007079|FG000|NOT COMPLETED|Overall Study||3
10841481|NCT00983437|12007083|FG000|STARTED|Overall Study||47
10841482|NCT00983437|12007083|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
10841483|NCT00983437|12007083|FG000|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
10841484|NCT00983437|12007083|FG000|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
10841485|NCT00983437|12007083|FG000|NOT COMPLETED|Overall Study||47
10841486|NCT00965757|12007089|FG000|STARTED|Double-blind Phase||165
10841487|NCT00965757|12007090|FG001|STARTED|Double-blind Phase||88
10841488|NCT00965757|12007091|FG002|STARTED|Double-blind Phase||0
10841489|NCT00965757|12007092|FG003|STARTED|Double-blind Phase||0
10841490|NCT00965757|12007089|FG000|COMPLETED|Double-blind Phase||148
10841491|NCT00965757|12007090|FG001|COMPLETED|Double-blind Phase||70
10841492|NCT00965757|12007091|FG002|COMPLETED|Double-blind Phase||0
10841493|NCT00965757|12007092|FG003|COMPLETED|Double-blind Phase||0
10841494|NCT00965757|12007089|FG000|NOT COMPLETED|Double-blind Phase||17
10841495|NCT00965757|12007090|FG001|NOT COMPLETED|Double-blind Phase||18
10841496|NCT00965757|12007091|FG002|NOT COMPLETED|Double-blind Phase||0
10841497|NCT00965757|12007092|FG003|NOT COMPLETED|Double-blind Phase||0
10841498|NCT00965757|12007089|FG000|STARTED|Extension Phase||0
10841499|NCT00965757|12007090|FG001|STARTED|Extension Phase||0
10841500|NCT00965757|12007091|FG002|STARTED|Extension Phase||165
10841501|NCT00965757|12007092|FG003|STARTED|Extension Phase||88
10841502|NCT00965757|12007089|FG000|COMPLETED|Extension Phase||0
10841503|NCT00965757|12007090|FG001|COMPLETED|Extension Phase||0
10841504|NCT00965757|12007091|FG002|COMPLETED|Extension Phase||132
10841505|NCT00965757|12007092|FG003|COMPLETED|Extension Phase||64
10841506|NCT00965757|12007089|FG000|NOT COMPLETED|Extension Phase||0
10841507|NCT00965757|12007090|FG001|NOT COMPLETED|Extension Phase||0
10841508|NCT00965757|12007091|FG002|NOT COMPLETED|Extension Phase||33
10841509|NCT00965757|12007092|FG003|NOT COMPLETED|Extension Phase||24
10841510|NCT00928447|12007100|FG000|STARTED|Overall Study||22
10841511|NCT00928447|12007100|FG000|Received at Least 1 Dose of rHuPH20|Overall Study||21
10841512|NCT00928447|12007100|FG000|Received at Least 1 Dose of Placebo|Overall Study||21
10841513|NCT00928447|12007100|FG000|COMPLETED|Overall Study||20
10841514|NCT00928447|12007100|FG000|NOT COMPLETED|Overall Study||2
10841515|NCT00893789|12007108|FG000|STARTED|Overall Study||29
10841516|NCT00893789|12007109|FG001|STARTED|Overall Study||30
10841517|NCT00893789|12007110|FG002|STARTED|Overall Study||29
10841518|NCT00893789|12007111|FG003|STARTED|Overall Study||29
10841519|NCT00893789|12007108|FG000|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
10841520|NCT00893789|12007109|FG001|Safety Analysis Set (SAS)|Overall Study||30
10841521|NCT00893789|12007110|FG002|Safety Analysis Set (SAS)|Overall Study||29
10841522|NCT00893789|12007111|FG003|Safety Analysis Set (SAS)|Overall Study||29
10841523|NCT00893789|12007108|FG000|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
10841524|NCT00893789|12007109|FG001|Full Analysis Set (FAS)|Overall Study||29
10841525|NCT00893789|12007110|FG002|Full Analysis Set (FAS)|Overall Study||28
10841526|NCT00893789|12007111|FG003|Full Analysis Set (FAS)|Overall Study||27
10841527|NCT00893789|12007108|FG000|COMPLETED|Overall Study||23
10841528|NCT00893789|12007109|FG001|COMPLETED|Overall Study||26
10841529|NCT00893789|12007110|FG002|COMPLETED|Overall Study||22
10841530|NCT00893789|12007111|FG003|COMPLETED|Overall Study||16
10841531|NCT00893789|12007108|FG000|NOT COMPLETED|Overall Study||6
10841532|NCT00893789|12007109|FG001|NOT COMPLETED|Overall Study||4
10841533|NCT00893789|12007110|FG002|NOT COMPLETED|Overall Study||7
10841534|NCT00893789|12007111|FG003|NOT COMPLETED|Overall Study||13
10841535|NCT04349150|12007121|FG000|STARTED|Overall Study||31
10841536|NCT04349150|12007121|FG000|COMPLETED|Overall Study||27
11222149|NCT01969162|12413796|FG000|NOT COMPLETED|Overall Study||0
11222150|NCT01969201|12413802|FG000|STARTED|Overall Study||352
11222151|NCT01969201|12413803|FG001|STARTED|Overall Study||358
11222152|NCT01969201|12413802|FG000|COMPLETED|Overall Study||307
11222153|NCT01969201|12413803|FG001|COMPLETED|Overall Study||313
11222154|NCT01969201|12413802|FG000|NOT COMPLETED|Overall Study||45
11222155|NCT01969201|12413803|FG001|NOT COMPLETED|Overall Study||45
11222156|NCT01969214|12413809|FG000|STARTED|Overall Study||101
11222157|NCT01969214|12413809|FG000|COMPLETED|Overall Study||86
10841537|NCT04349150|12007121|FG000|NOT COMPLETED|Overall Study||4
11104265|NCT01247675|12288555|FG000|NOT COMPLETED|Overall Study||2
11104266|NCT01247675|12288556|FG001|NOT COMPLETED|Overall Study||2
11104267|NCT01247675|12288557|FG002|NOT COMPLETED|Overall Study||0
10841541|NCT03901144|12007129|FG000|STARTED|Overall Study||50
10841542|NCT03901144|12007130|FG001|STARTED|Overall Study||50
10841543|NCT03901144|12007131|FG002|STARTED|Overall Study||50
10841544|NCT03901144|12007132|FG003|STARTED|Overall Study||50
11222158|NCT01969214|12413809|FG000|NOT COMPLETED|Overall Study||15
10841545|NCT03901144|12007129|FG000|COMPLETED|Overall Study||49
10841546|NCT03901144|12007130|FG001|COMPLETED|Overall Study||49
10841547|NCT03901144|12007131|FG002|COMPLETED|Overall Study||49
10841548|NCT03901144|12007132|FG003|COMPLETED|Overall Study||49
10841549|NCT03901144|12007129|FG000|NOT COMPLETED|Overall Study||1
10841550|NCT03901144|12007130|FG001|NOT COMPLETED|Overall Study||1
10841551|NCT03901144|12007131|FG002|NOT COMPLETED|Overall Study||1
10841552|NCT03901144|12007132|FG003|NOT COMPLETED|Overall Study||1
11222159|NCT01969240|12413815|FG000|STARTED|Overall Study||451
11222160|NCT01969240|12413816|FG001|STARTED|Overall Study||447
11222161|NCT01969240|12413815|FG000|COMPLETED|Overall Study||451
11222162|NCT01969240|12413816|FG001|COMPLETED|Overall Study||447
11222163|NCT01969240|12413815|FG000|NOT COMPLETED|Overall Study||0
11222164|NCT01969240|12413816|FG001|NOT COMPLETED|Overall Study||0
11222165|NCT01969435|12413824|FG000|STARTED|Overall Study||50
11222166|NCT01969435|12413824|FG000|COMPLETED|Overall Study||50
11222167|NCT01969435|12413824|FG000|NOT COMPLETED|Overall Study||0
11222168|NCT01969448|12413831|FG000|STARTED|Overall Study||55
11222169|NCT01969448|12413832|FG001|STARTED|Overall Study||24
11222170|NCT01969448|12413833|FG002|STARTED|Overall Study||0
11222171|NCT01969448|12413831|FG000|COMPLETED|Overall Study||55
11222172|NCT01969448|12413832|FG001|COMPLETED|Overall Study||24
11222173|NCT01969448|12413833|FG002|COMPLETED|Overall Study||0
11222174|NCT01969448|12413831|FG000|NOT COMPLETED|Overall Study||0
11222175|NCT01969448|12413832|FG001|NOT COMPLETED|Overall Study||0
11222176|NCT01969448|12413833|FG002|NOT COMPLETED|Overall Study||0
11222177|NCT01969500|12413843|FG000|STARTED|Overall Study||25
11222178|NCT01969500|12413844|FG001|STARTED|Overall Study||26
11222179|NCT01969500|12413843|FG000|COMPLETED|Overall Study||24
11222180|NCT01969500|12413844|FG001|COMPLETED|Overall Study||24
11222181|NCT01969500|12413843|FG000|NOT COMPLETED|Overall Study||1
11222182|NCT01969500|12413844|FG001|NOT COMPLETED|Overall Study||2
11222183|NCT01969539|12413850|FG000|STARTED|Overall Study||11
11222184|NCT01969539|12413850|FG000|COMPLETED|Overall Study||11
11222185|NCT01969539|12413850|FG000|NOT COMPLETED|Overall Study||0
11222186|NCT01969708|12413856|FG000|STARTED|Overall Study||180
11222187|NCT01969708|12413857|FG001|STARTED|Overall Study||182
11222188|NCT01969708|12413856|FG000|COMPLETED|Overall Study||175
11222189|NCT01969708|12413857|FG001|COMPLETED|Overall Study||173
11222190|NCT01969708|12413856|FG000|NOT COMPLETED|Overall Study||5
11222191|NCT01969708|12413857|FG001|NOT COMPLETED|Overall Study||9
11222192|NCT01969721|12413863|FG000|STARTED|Overall Study||58
11222193|NCT01969721|12413864|FG001|STARTED|Overall Study||69
11222194|NCT01969721|12413865|FG002|STARTED|Overall Study||50
11222195|NCT01969721|12413866|FG003|STARTED|Overall Study||52
11222196|NCT01969721|12413863|FG000|COMPLETED|Overall Study||54
11222197|NCT01969721|12413864|FG001|COMPLETED|Overall Study||57
11222198|NCT01969721|12413865|FG002|COMPLETED|Overall Study||45
11222199|NCT01969721|12413866|FG003|COMPLETED|Overall Study||46
11222200|NCT01969721|12413863|FG000|NOT COMPLETED|Overall Study||4
11222201|NCT01969721|12413864|FG001|NOT COMPLETED|Overall Study||12
11222202|NCT01969721|12413865|FG002|NOT COMPLETED|Overall Study||5
11222203|NCT01969721|12413866|FG003|NOT COMPLETED|Overall Study||6
11222204|NCT01969747|12413880|FG000|STARTED|Overall Study||19
11222205|NCT01969747|12413881|FG001|STARTED|Overall Study||19
11222206|NCT01969747|12413882|FG002|STARTED|Overall Study||19
11222207|NCT01969747|12413883|FG003|STARTED|Overall Study||18
11222208|NCT01969747|12413880|FG000|COMPLETED|Overall Study||19
11222209|NCT01969747|12413881|FG001|COMPLETED|Overall Study||19
11222210|NCT01969747|12413882|FG002|COMPLETED|Overall Study||19
11222211|NCT01969747|12413883|FG003|COMPLETED|Overall Study||18
11222212|NCT01969747|12413880|FG000|NOT COMPLETED|Overall Study||0
11222213|NCT01969747|12413881|FG001|NOT COMPLETED|Overall Study||0
11222214|NCT01969747|12413882|FG002|NOT COMPLETED|Overall Study||0
11222215|NCT01969747|12413883|FG003|NOT COMPLETED|Overall Study||0
10841553|NCT03561701|12007144|FG000|STARTED|Overall Study||220
10841554|NCT03561701|12007145|FG001|STARTED|Overall Study||110
10841555|NCT03561701|12007144|FG000|COMPLETED|Overall Study||191
10841556|NCT03561701|12007145|FG001|COMPLETED|Overall Study||91
10841557|NCT03561701|12007144|FG000|NOT COMPLETED|Overall Study||29
10841558|NCT03561701|12007145|FG001|NOT COMPLETED|Overall Study||19
10841559|NCT03525808|12007151|FG000|STARTED|Overall Study||40
11222216|NCT01969799|12413895|FG000|STARTED|Overall Study||71
11222217|NCT01969799|12413896|FG001|STARTED|Overall Study||72
11222218|NCT01969799|12413895|FG000|COMPLETED|Overall Study||54
11222219|NCT01969799|12413896|FG001|COMPLETED|Overall Study||58
11222220|NCT01969799|12413895|FG000|NOT COMPLETED|Overall Study||17
11222221|NCT01969799|12413896|FG001|NOT COMPLETED|Overall Study||14
11222222|NCT01969851|12413905|FG000|STARTED|Overall Study||10
11222223|NCT01969851|12413906|FG001|STARTED|Overall Study||24
11222224|NCT01969851|12413907|FG002|STARTED|Overall Study||21
11222225|NCT01969851|12413905|FG000|COMPLETED|Overall Study||9
10841560|NCT03525808|12007151|FG000|COMPLETED|Overall Study||34
10841561|NCT03525808|12007151|FG000|NOT COMPLETED|Overall Study||6
10841562|NCT03461211|12007157|FG000|STARTED|Overall Study||37
10841563|NCT03461211|12007158|FG001|STARTED|Overall Study||14
10841564|NCT03461211|12007157|FG000|Proptosis Non-Responders in OPTIC|Overall Study||36
10841565|NCT03461211|12007158|FG001|Proptosis Non-Responders in OPTIC|Overall Study||5
10841566|NCT03461211|12007157|FG000|Relapsed During Follow-Up Period of OPTIC|Overall Study||1
10841567|NCT03461211|12007158|FG001|Relapsed During Follow-Up Period of OPTIC|Overall Study||9
10841568|NCT03461211|12007157|FG000|COMPLETED|Overall Study||36
10841569|NCT03461211|12007158|FG001|COMPLETED|Overall Study||12
10841570|NCT03461211|12007157|FG000|NOT COMPLETED|Overall Study||1
10841571|NCT03461211|12007158|FG001|NOT COMPLETED|Overall Study||2
10841572|NCT03276780|12007168|FG000|STARTED|Overall Study||41
10841573|NCT03276780|12007169|FG001|STARTED|Overall Study||39
10841574|NCT03276780|12007168|FG000|COMPLETED|Overall Study||23
10841575|NCT03276780|12007169|FG001|COMPLETED|Overall Study||29
10841576|NCT03276780|12007168|FG000|NOT COMPLETED|Overall Study||18
10841577|NCT03276780|12007169|FG001|NOT COMPLETED|Overall Study||10
10841578|NCT03205553|12007179|FG000|STARTED|Overall Study||2
10841579|NCT03205553|12007180|FG001|STARTED|Overall Study||1
10841580|NCT03205553|12007179|FG000|COMPLETED|Overall Study||2
10841581|NCT03205553|12007180|FG001|COMPLETED|Overall Study||1
10841582|NCT03205553|12007179|FG000|NOT COMPLETED|Overall Study||0
10841583|NCT03205553|12007180|FG001|NOT COMPLETED|Overall Study||0
10841584|NCT03104205|12007186|FG000|STARTED|Overall Study||53
10841585|NCT03104205|12007186|FG000|COMPLETED|Overall Study||44
10841586|NCT03104205|12007186|FG000|NOT COMPLETED|Overall Study||9
10841587|NCT03050814|12007193|FG000|STARTED|Overall Study||10
10841588|NCT03050814|12007194|FG001|STARTED|Overall Study||16
10841589|NCT03050814|12007195|FG002|STARTED|Overall Study||4
10841590|NCT03050814|12007193|FG000|COMPLETED|Overall Study||10
10841591|NCT03050814|12007194|FG001|COMPLETED|Overall Study||16
10841592|NCT03050814|12007195|FG002|COMPLETED|Overall Study||0
10841593|NCT03050814|12007193|FG000|NOT COMPLETED|Overall Study||0
10841594|NCT03050814|12007194|FG001|NOT COMPLETED|Overall Study||0
10841595|NCT03050814|12007195|FG002|NOT COMPLETED|Overall Study||4
10841596|NCT02797262|12007203|FG000|STARTED|Overall Study||65
10841597|NCT02797262|12007204|FG001|STARTED|Overall Study||65
10841598|NCT02797262|12007203|FG000|Baseline|Overall Study||54
10841599|NCT02797262|12007204|FG001|Baseline|Overall Study||58
10841600|NCT02797262|12007203|FG000|COMPLETED|Overall Study||45
10841601|NCT02797262|12007204|FG001|COMPLETED|Overall Study||54
10841602|NCT02797262|12007203|FG000|NOT COMPLETED|Overall Study||20
10841603|NCT02797262|12007204|FG001|NOT COMPLETED|Overall Study||11
10841604|NCT02639910|12007212|FG000|STARTED|Overall Study||11
10841605|NCT02639910|12007213|FG001|STARTED|Overall Study||13
10841606|NCT02639910|12007212|FG000|COMPLETED|Overall Study||7
10841607|NCT02639910|12007213|FG001|COMPLETED|Overall Study||5
10841608|NCT02639910|12007212|FG000|NOT COMPLETED|Overall Study||4
10841609|NCT02639910|12007213|FG001|NOT COMPLETED|Overall Study||8
10841610|NCT02409368|12007222|FG000|STARTED|Overall Study||173
10841611|NCT02409368|12007223|FG001|STARTED|Overall Study||534
10841612|NCT02409368|12007224|FG002|STARTED|Overall Study||103
10841613|NCT02409368|12007222|FG000|COMPLETED|Overall Study||25
10841614|NCT02409368|12007223|FG001|COMPLETED|Overall Study||45
10841615|NCT02409368|12007224|FG002|COMPLETED|Overall Study||4
10841616|NCT02409368|12007222|FG000|NOT COMPLETED|Overall Study||148
10841617|NCT02409368|12007223|FG001|NOT COMPLETED|Overall Study||489
10841618|NCT02409368|12007224|FG002|NOT COMPLETED|Overall Study||99
10841619|NCT02322593|12007235|FG000|STARTED|Overall Study||356
10841620|NCT02322593|12007236|FG001|STARTED|Overall Study||355
10841621|NCT02322593|12007235|FG000|COMPLETED|Overall Study||356
10841622|NCT02322593|12007236|FG001|COMPLETED|Overall Study||355
10841623|NCT02322593|12007235|FG000|NOT COMPLETED|Overall Study||0
10841624|NCT02322593|12007236|FG001|NOT COMPLETED|Overall Study||0
10841625|NCT02124824|12007244|FG000|STARTED|Overall Study||15
10841626|NCT02124824|12007245|FG001|STARTED|Overall Study||15
10841627|NCT02124824|12007244|FG000|COMPLETED|Overall Study||15
10841628|NCT02124824|12007245|FG001|COMPLETED|Overall Study||15
10841629|NCT02124824|12007244|FG000|NOT COMPLETED|Overall Study||0
11222226|NCT01969851|12413906|FG001|COMPLETED|Overall Study||21
11222227|NCT01969851|12413907|FG002|COMPLETED|Overall Study||14
11222228|NCT01969851|12413905|FG000|NOT COMPLETED|Overall Study||1
11222229|NCT01969851|12413906|FG001|NOT COMPLETED|Overall Study||3
11222230|NCT01969851|12413907|FG002|NOT COMPLETED|Overall Study||7
11222231|NCT01969916|12413915|FG000|STARTED|Overall Study||150
11222232|NCT01969916|12413915|FG000|COMPLETED|Overall Study||105
11222233|NCT01969916|12413915|FG000|NOT COMPLETED|Overall Study||45
11222234|NCT01970007|12413919|FG000|STARTED|Overall Study||243
11222235|NCT01970007|12413919|FG000|COMPLETED|Overall Study||188
11222236|NCT01970007|12413919|FG000|NOT COMPLETED|Overall Study||55
11222237|NCT01970176|12413925|FG000|STARTED|Overall Study||14
11222238|NCT01970176|12413926|FG001|STARTED|Overall Study||6
11222239|NCT01970176|12413925|FG000|COMPLETED|Overall Study||14
11222240|NCT01970176|12413926|FG001|COMPLETED|Overall Study||6
10841630|NCT02124824|12007245|FG001|NOT COMPLETED|Overall Study||0
10841631|NCT01772004|12007274|FG000|STARTED|Dose Escalation Phase||4
10841632|NCT01772004|12007275|FG001|STARTED|Dose Escalation Phase||13
10841633|NCT01772004|12007276|FG002|STARTED|Dose Escalation Phase||15
10841634|NCT01772004|12007277|FG003|STARTED|Dose Escalation Phase||21
10841635|NCT01772004|12007278|FG004|STARTED|Dose Escalation Phase||8
10841636|NCT01772004|12007279|FG005|STARTED|Dose Escalation Phase||0
10841637|NCT01772004|12007280|FG006|STARTED|Dose Escalation Phase||0
10841638|NCT01772004|12007281|FG007|STARTED|Dose Escalation Phase||0
10841639|NCT01772004|12007282|FG008|STARTED|Dose Escalation Phase||0
10841640|NCT01772004|12007283|FG009|STARTED|Dose Escalation Phase||0
10841641|NCT01772004|12007284|FG010|STARTED|Dose Escalation Phase||0
10841642|NCT01772004|12007285|FG011|STARTED|Dose Escalation Phase||0
10841643|NCT01772004|12007286|FG012|STARTED|Dose Escalation Phase||0
10841644|NCT01772004|12007287|FG013|STARTED|Dose Escalation Phase||0
10841645|NCT01772004|12007288|FG014|STARTED|Dose Escalation Phase||0
10841646|NCT01772004|12007289|FG015|STARTED|Dose Escalation Phase||0
10841647|NCT01772004|12007290|FG016|STARTED|Dose Escalation Phase||0
10841648|NCT01772004|12007291|FG017|STARTED|Dose Escalation Phase||0
10841649|NCT01772004|12007292|FG018|STARTED|Dose Escalation Phase||0
10841650|NCT01772004|12007293|FG019|STARTED|Dose Escalation Phase||0
10841651|NCT01772004|12007294|FG020|STARTED|Dose Escalation Phase||0
10841652|NCT01772004|12007295|FG021|STARTED|Dose Escalation Phase||0
10841653|NCT01772004|12007296|FG022|STARTED|Dose Escalation Phase||0
10841654|NCT01772004|12007274|FG000|COMPLETED|Dose Escalation Phase||4
10841655|NCT01772004|12007275|FG001|COMPLETED|Dose Escalation Phase||13
10841656|NCT01772004|12007276|FG002|COMPLETED|Dose Escalation Phase||15
10841657|NCT01772004|12007277|FG003|COMPLETED|Dose Escalation Phase||21
10841658|NCT01772004|12007278|FG004|COMPLETED|Dose Escalation Phase||8
10841659|NCT01772004|12007279|FG005|COMPLETED|Dose Escalation Phase||0
10841660|NCT01772004|12007280|FG006|COMPLETED|Dose Escalation Phase||0
10841661|NCT01772004|12007281|FG007|COMPLETED|Dose Escalation Phase||0
10841662|NCT01772004|12007282|FG008|COMPLETED|Dose Escalation Phase||0
10841663|NCT01772004|12007283|FG009|COMPLETED|Dose Escalation Phase||0
10841664|NCT01772004|12007284|FG010|COMPLETED|Dose Escalation Phase||0
10841665|NCT01772004|12007285|FG011|COMPLETED|Dose Escalation Phase||0
10841666|NCT01772004|12007286|FG012|COMPLETED|Dose Escalation Phase||0
10841667|NCT01772004|12007287|FG013|COMPLETED|Dose Escalation Phase||0
10841668|NCT01772004|12007288|FG014|COMPLETED|Dose Escalation Phase||0
10841669|NCT01772004|12007289|FG015|COMPLETED|Dose Escalation Phase||0
10841670|NCT01772004|12007290|FG016|COMPLETED|Dose Escalation Phase||0
10841671|NCT01772004|12007291|FG017|COMPLETED|Dose Escalation Phase||0
10841672|NCT01772004|12007292|FG018|COMPLETED|Dose Escalation Phase||0
10841673|NCT01772004|12007293|FG019|COMPLETED|Dose Escalation Phase||0
10841674|NCT01772004|12007294|FG020|COMPLETED|Dose Escalation Phase||0
10841675|NCT01772004|12007295|FG021|COMPLETED|Dose Escalation Phase||0
10841676|NCT01772004|12007296|FG022|COMPLETED|Dose Escalation Phase||0
10841677|NCT01772004|12007274|FG000|NOT COMPLETED|Dose Escalation Phase||0
10841678|NCT01772004|12007275|FG001|NOT COMPLETED|Dose Escalation Phase||0
10841679|NCT01772004|12007276|FG002|NOT COMPLETED|Dose Escalation Phase||0
10841680|NCT01772004|12007277|FG003|NOT COMPLETED|Dose Escalation Phase||0
11222241|NCT01970176|12413925|FG000|NOT COMPLETED|Overall Study||0
11222242|NCT01970176|12413926|FG001|NOT COMPLETED|Overall Study||0
11222243|NCT01970241|12413934|FG000|STARTED|Overall Study||46
11222244|NCT01970241|12413935|FG001|STARTED|Overall Study||39
11222245|NCT01970241|12413934|FG000|COMPLETED|Overall Study||29
11222246|NCT01970241|12413935|FG001|COMPLETED|Overall Study||31
11222247|NCT01970241|12413934|FG000|NOT COMPLETED|Overall Study||17
11222248|NCT01970241|12413935|FG001|NOT COMPLETED|Overall Study||8
11354210|NCT03070782|12551424|FG003|STARTED|Overall Study||48
11222249|NCT01970371|12413946|FG000|STARTED|Overall Study||18
11222250|NCT01970371|12413947|FG001|STARTED|Overall Study||21
11222251|NCT01970371|12413948|FG002|STARTED|Overall Study||30
11354211|NCT03070782|12551425|FG004|STARTED|Overall Study||48
11354212|NCT03070782|12551426|FG005|STARTED|Overall Study||47
11354213|NCT03070782|12551421|FG000|COMPLETED|Overall Study||41
11354214|NCT03070782|12551422|FG001|COMPLETED|Overall Study||47
11354215|NCT03070782|12551423|FG002|COMPLETED|Overall Study||43
11354216|NCT03070782|12551424|FG003|COMPLETED|Overall Study||43
11354217|NCT03070782|12551425|FG004|COMPLETED|Overall Study||36
11354218|NCT03070782|12551426|FG005|COMPLETED|Overall Study||40
11354219|NCT03070782|12551421|FG000|NOT COMPLETED|Overall Study||7
11354220|NCT03070782|12551422|FG001|NOT COMPLETED|Overall Study||1
11354221|NCT03070782|12551423|FG002|NOT COMPLETED|Overall Study||4
11354222|NCT03070782|12551424|FG003|NOT COMPLETED|Overall Study||5
11354223|NCT03070782|12551425|FG004|NOT COMPLETED|Overall Study||12
11354224|NCT03070782|12551426|FG005|NOT COMPLETED|Overall Study||7
11354225|NCT03070964|12551440|FG000|STARTED|Overall Study||14
11354226|NCT03070964|12551440|FG000|COMPLETED|Overall Study||0
11354227|NCT03070964|12551440|FG000|NOT COMPLETED|Overall Study||14
11354228|NCT03071094|12551446|FG000|STARTED|Overall Study||7
11354229|NCT03071094|12551447|FG001|STARTED|Overall Study||5
11354230|NCT03071094|12551446|FG000|COMPLETED|Overall Study||5
11354231|NCT03071094|12551447|FG001|COMPLETED|Overall Study||4
11354232|NCT03071094|12551446|FG000|NOT COMPLETED|Overall Study||2
11104268|NCT01247675|12288558|FG003|NOT COMPLETED|Overall Study||0
11104269|NCT01247922|12288570|FG000|STARTED|Overall Study||4
11104270|NCT01247922|12288570|FG000|Treated|Overall Study||4
11104271|NCT01247922|12288570|FG000|COMPLETED|Overall Study||0
11104272|NCT01247922|12288570|FG000|NOT COMPLETED|Overall Study||4
11104273|NCT01247974|12288576|FG000|STARTED|Overall Study||217
11104274|NCT01247974|12288577|FG001|STARTED|Overall Study||222
11104275|NCT01247974|12288576|FG000|COMPLETED|Overall Study||191
11104276|NCT01247974|12288577|FG001|COMPLETED|Overall Study||203
11104277|NCT01247974|12288576|FG000|NOT COMPLETED|Overall Study||26
11104278|NCT01247974|12288577|FG001|NOT COMPLETED|Overall Study||19
11104279|NCT01248013|12288583|FG000|STARTED|Overall Study||89
11104280|NCT01248013|12288583|FG000|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
11104281|NCT01248013|12288583|FG000|COMPLETED|Overall Study||75
11104282|NCT01248013|12288583|FG000|NOT COMPLETED|Overall Study||14
11104283|NCT01248065|12288589|FG000|STARTED|Overall Study||207
11104284|NCT01248065|12288590|FG001|STARTED|Overall Study||201
11104285|NCT01248065|12288589|FG000|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
11104286|NCT01248065|12288590|FG001|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
11222252|NCT01970371|12413946|FG000|COMPLETED|Overall Study||10
11222253|NCT01970371|12413947|FG001|COMPLETED|Overall Study||8
11222254|NCT01970371|12413948|FG002|COMPLETED|Overall Study||17
11222255|NCT01970371|12413946|FG000|NOT COMPLETED|Overall Study||8
11222256|NCT01970371|12413947|FG001|NOT COMPLETED|Overall Study||13
11222257|NCT01970371|12413948|FG002|NOT COMPLETED|Overall Study||13
11222258|NCT01970397|12413960|FG000|STARTED|Overall Study||69
11222259|NCT01970397|12413961|FG001|STARTED|Overall Study||69
11222260|NCT01970397|12413960|FG000|COMPLETED|Overall Study||67
11222261|NCT01970397|12413961|FG001|COMPLETED|Overall Study||64
11222262|NCT01970397|12413960|FG000|NOT COMPLETED|Overall Study||2
11222263|NCT01970397|12413961|FG001|NOT COMPLETED|Overall Study||5
11222264|NCT01970475|12413969|FG000|STARTED|Overall Study||264
11354233|NCT03071094|12551447|FG001|NOT COMPLETED|Overall Study||1
11354234|NCT03071263|12551455|FG000|STARTED|Overall Study||147
11354235|NCT03071263|12551456|FG001|STARTED|Overall Study||148
11354236|NCT03071263|12551455|FG000|COMPLETED|Overall Study||144
11222265|NCT01970475|12413970|FG001|STARTED|Overall Study||262
11222266|NCT01970475|12413969|FG000|COMPLETED|Overall Study||243
11222267|NCT01970475|12413970|FG001|COMPLETED|Overall Study||251
11222268|NCT01970475|12413969|FG000|NOT COMPLETED|Overall Study||21
11222269|NCT01970475|12413970|FG001|NOT COMPLETED|Overall Study||11
11222270|NCT01970488|12413978|FG000|STARTED|Part 1: Through Week 16||175
11222271|NCT01970488|12413979|FG001|STARTED|Part 1: Through Week 16||175
11222272|NCT01970488|12413980|FG002|STARTED|Part 1: Through Week 16||0
11222273|NCT01970488|12413981|FG003|STARTED|Part 1: Through Week 16||0
11222274|NCT01970488|12413982|FG004|STARTED|Part 1: Through Week 16||0
11222275|NCT01970488|12413978|FG000|Received Treatment|Part 1: Through Week 16||174
11222276|NCT01970488|12413979|FG001|Received Treatment|Part 1: Through Week 16||173
11222277|NCT01970488|12413980|FG002|Received Treatment|Part 1: Through Week 16||0
11222278|NCT01970488|12413981|FG003|Received Treatment|Part 1: Through Week 16||0
11222279|NCT01970488|12413982|FG004|Received Treatment|Part 1: Through Week 16||0
11222280|NCT01970488|12413978|FG000|COMPLETED|Part 1: Through Week 16||164
11222281|NCT01970488|12413979|FG001|COMPLETED|Part 1: Through Week 16||162
11222282|NCT01970488|12413980|FG002|COMPLETED|Part 1: Through Week 16||0
11222283|NCT01970488|12413981|FG003|COMPLETED|Part 1: Through Week 16||0
11222284|NCT01970488|12413982|FG004|COMPLETED|Part 1: Through Week 16||0
11222285|NCT01970488|12413978|FG000|NOT COMPLETED|Part 1: Through Week 16||11
11222286|NCT01970488|12413979|FG001|NOT COMPLETED|Part 1: Through Week 16||13
11222287|NCT01970488|12413980|FG002|NOT COMPLETED|Part 1: Through Week 16||0
11222288|NCT01970488|12413981|FG003|NOT COMPLETED|Part 1: Through Week 16||0
11222289|NCT01970488|12413982|FG004|NOT COMPLETED|Part 1: Through Week 16||0
11222290|NCT01970488|12413978|FG000|STARTED|Part 2: Post Week 16||0
11222291|NCT01970488|12413979|FG001|STARTED|Part 2: Post Week 16||0
11222292|NCT01970488|12413980|FG002|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
11222293|NCT01970488|12413981|FG003|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
11222294|NCT01970488|12413982|FG004|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
11222295|NCT01970488|12413978|FG000|COMPLETED|Part 2: Post Week 16||0
11222296|NCT01970488|12413979|FG001|COMPLETED|Part 2: Post Week 16||0
11222297|NCT01970488|12413980|FG002|COMPLETED|Part 2: Post Week 16||135
11222298|NCT01970488|12413981|FG003|COMPLETED|Part 2: Post Week 16||71
11222299|NCT01970488|12413982|FG004|COMPLETED|Part 2: Post Week 16||69
11222300|NCT01970488|12413978|FG000|NOT COMPLETED|Part 2: Post Week 16||0
11222301|NCT01970488|12413979|FG001|NOT COMPLETED|Part 2: Post Week 16||0
11222302|NCT01970488|12413980|FG002|NOT COMPLETED|Part 2: Post Week 16||17
11222303|NCT01970488|12413981|FG003|NOT COMPLETED|Part 2: Post Week 16||8
11222304|NCT01970488|12413982|FG004|NOT COMPLETED|Part 2: Post Week 16||8
11222305|NCT01970527|12413999|FG000|STARTED|Pre-treatment/Baseline||9
11222306|NCT01970527|12414000|FG001|STARTED|Pre-treatment/Baseline||14
11222307|NCT01970527|12413999|FG000|COMPLETED|Pre-treatment/Baseline||8
11222308|NCT01970527|12414000|FG001|COMPLETED|Pre-treatment/Baseline||14
11222309|NCT01970527|12413999|FG000|NOT COMPLETED|Pre-treatment/Baseline||1
11222310|NCT01970527|12414000|FG001|NOT COMPLETED|Pre-treatment/Baseline||0
11222311|NCT01970527|12413999|FG000|STARTED|Treatment||8
11222312|NCT01970527|12414000|FG001|STARTED|Treatment||14
11222313|NCT01970527|12413999|FG000|COMPLETED|Treatment||8
11222314|NCT01970527|12414000|FG001|COMPLETED|Treatment||11
11222315|NCT01970527|12413999|FG000|NOT COMPLETED|Treatment||0
11222316|NCT01970527|12414000|FG001|NOT COMPLETED|Treatment||3
11222317|NCT01970527|12413999|FG000|STARTED|Follow-up Clinic Visit||8
11222318|NCT01970527|12414000|FG001|STARTED|Follow-up Clinic Visit||11
11222319|NCT01970527|12413999|FG000|COMPLETED|Follow-up Clinic Visit||7
11222320|NCT01970527|12414000|FG001|COMPLETED|Follow-up Clinic Visit||8
11222321|NCT01970527|12413999|FG000|NOT COMPLETED|Follow-up Clinic Visit||1
11222322|NCT01970527|12414000|FG001|NOT COMPLETED|Follow-up Clinic Visit||3
11222323|NCT01970540|12414012|FG000|STARTED|Overall Study||73
11222324|NCT01970540|12414013|FG001|STARTED|Overall Study||28
11222325|NCT01970540|12414014|FG002|STARTED|Overall Study||19
11222326|NCT01970540|12414012|FG000|COMPLETED|Overall Study||0
11222327|NCT01970540|12414013|FG001|COMPLETED|Overall Study||0
11222328|NCT01970540|12414014|FG002|COMPLETED|Overall Study||0
11222329|NCT01970540|12414012|FG000|NOT COMPLETED|Overall Study||73
11222330|NCT01970540|12414013|FG001|NOT COMPLETED|Overall Study||28
11222331|NCT01970540|12414014|FG002|NOT COMPLETED|Overall Study||19
11222332|NCT01970592|12414033|FG000|STARTED|Overall Study|Completed all training sessions|56
11222333|NCT01970592|12414033|FG000|COMPLETED|Overall Study||50
11222334|NCT01970592|12414033|FG000|NOT COMPLETED|Overall Study||6
11222335|NCT01970787|12414037|FG000|STARTED|Overall Study||22
11222336|NCT01970787|12414037|FG000|COMPLETED|Overall Study||21
11222337|NCT01970787|12414037|FG000|NOT COMPLETED|Overall Study||1
11222338|NCT01970878|12414045|FG000|STARTED|Overall Study||290
11222339|NCT01970878|12414046|FG001|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
11222340|NCT01970878|12414047|FG002|STARTED|Overall Study||213
11222341|NCT01970878|12414048|FG003|STARTED|Overall Study||171
11222342|NCT01970878|12414045|FG000|COMPLETED|Overall Study||253
11222343|NCT01970878|12414046|FG001|COMPLETED|Overall Study||191
11222344|NCT01970878|12414047|FG002|COMPLETED|Overall Study||187
11222345|NCT01970878|12414048|FG003|COMPLETED|Overall Study||147
11222346|NCT01970878|12414045|FG000|NOT COMPLETED|Overall Study||37
11222347|NCT01970878|12414046|FG001|NOT COMPLETED|Overall Study||27
11222348|NCT01970878|12414047|FG002|NOT COMPLETED|Overall Study||26
11222349|NCT01970878|12414048|FG003|NOT COMPLETED|Overall Study||24
11222350|NCT01970943|12414058|FG000|STARTED|Overall Study||11
11222351|NCT01970943|12414059|FG001|STARTED|Overall Study||12
11222352|NCT01970943|12414058|FG000|COMPLETED|Overall Study||8
11222353|NCT01970943|12414059|FG001|COMPLETED|Overall Study||11
11222354|NCT01970943|12414058|FG000|NOT COMPLETED|Overall Study||3
11222355|NCT01970943|12414059|FG001|NOT COMPLETED|Overall Study||1
11222356|NCT01970982|12414068|FG000|STARTED|Overall Study||80
11222357|NCT01970982|12414069|FG001|STARTED|Overall Study||40
11222358|NCT01970982|12414070|FG002|STARTED|Overall Study||40
11222359|NCT01970982|12414068|FG000|COMPLETED|Overall Study||80
11222360|NCT01970982|12414069|FG001|COMPLETED|Overall Study||40
11222361|NCT01970982|12414070|FG002|COMPLETED|Overall Study||38
11222362|NCT01970982|12414068|FG000|NOT COMPLETED|Overall Study||0
11222363|NCT01970982|12414069|FG001|NOT COMPLETED|Overall Study||0
11222364|NCT01970982|12414070|FG002|NOT COMPLETED|Overall Study||2
11222365|NCT01970995|12414082|FG000|STARTED|Confinement Period (Population at Day 5)||78
11222366|NCT01970995|12414083|FG001|STARTED|Confinement Period (Population at Day 5)||42
11222367|NCT01970995|12414084|FG002|STARTED|Confinement Period (Population at Day 5)||40
11222368|NCT01970995|12414082|FG000|COMPLETED|Confinement Period (Population at Day 5)||77
11222369|NCT01970995|12414083|FG001|COMPLETED|Confinement Period (Population at Day 5)||41
11222370|NCT01970995|12414084|FG002|COMPLETED|Confinement Period (Population at Day 5)||39
11222371|NCT01970995|12414082|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||1
11222372|NCT01970995|12414083|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1
11222373|NCT01970995|12414084|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||1
11222374|NCT01970995|12414082|FG000|STARTED|End of Study (Population at Day 90)||77
11222375|NCT01970995|12414083|FG001|STARTED|End of Study (Population at Day 90)||41
11222376|NCT01970995|12414084|FG002|STARTED|End of Study (Population at Day 90)||39
11222377|NCT01970995|12414082|FG000|COMPLETED|End of Study (Population at Day 90)||76
11222378|NCT01970995|12414083|FG001|COMPLETED|End of Study (Population at Day 90)||41
11222379|NCT01970995|12414084|FG002|COMPLETED|End of Study (Population at Day 90)||38
11222380|NCT01970995|12414082|FG000|NOT COMPLETED|End of Study (Population at Day 90)||1
11222381|NCT01970995|12414083|FG001|NOT COMPLETED|End of Study (Population at Day 90)||0
11222382|NCT01970995|12414084|FG002|NOT COMPLETED|End of Study (Population at Day 90)||1
11222383|NCT01971086|12414092|FG000|STARTED|Overall Study||300
11222384|NCT01971086|12414092|FG000|COMPLETED|Overall Study||300
11222385|NCT01971086|12414092|FG000|NOT COMPLETED|Overall Study||0
11222386|NCT01971203|12414099|FG000|STARTED|Overall Study||26
11222387|NCT01971203|12414100|FG001|STARTED|Overall Study||29
11222388|NCT01971203|12414099|FG000|COMPLETED|Overall Study||17
11222389|NCT01971203|12414100|FG001|COMPLETED|Overall Study||21
11222390|NCT01971203|12414099|FG000|NOT COMPLETED|Overall Study||9
11222391|NCT01971203|12414100|FG001|NOT COMPLETED|Overall Study||8
11222392|NCT01971255|12414108|FG000|STARTED|Overall Study||32
11222393|NCT01971255|12414109|FG001|STARTED|Overall Study||42
11222394|NCT01971255|12414108|FG000|COMPLETED|Overall Study||31
11222395|NCT01971255|12414109|FG001|COMPLETED|Overall Study||40
11222396|NCT01971255|12414108|FG000|NOT COMPLETED|Overall Study||1
11222397|NCT01971255|12414109|FG001|NOT COMPLETED|Overall Study||2
11222398|NCT01971346|12414115|FG000|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50
11222399|NCT01971346|12414115|FG000|COMPLETED|Overall Study||42
11222400|NCT01971346|12414115|FG000|NOT COMPLETED|Overall Study||8
11222401|NCT01971385|12414130|FG000|STARTED|Overall Study||17
11222402|NCT01971385|12414131|FG001|STARTED|Overall Study||18
11222403|NCT01971385|12414132|FG002|STARTED|Overall Study||19
11222404|NCT01971385|12414130|FG000|COMPLETED|Overall Study||14
11222405|NCT01971385|12414131|FG001|COMPLETED|Overall Study||13
11222406|NCT01971385|12414132|FG002|COMPLETED|Overall Study||15
11222407|NCT01971385|12414130|FG000|NOT COMPLETED|Overall Study||3
11222408|NCT01971385|12414131|FG001|NOT COMPLETED|Overall Study||5
11222409|NCT01971385|12414132|FG002|NOT COMPLETED|Overall Study||4
11222410|NCT01971463|12414139|FG000|STARTED|Overall Study||81
11222411|NCT01971463|12414139|FG000|COMPLETED|Overall Study||81
11222412|NCT01971463|12414139|FG000|NOT COMPLETED|Overall Study||0
11222413|NCT01971476|12414146|FG000|STARTED|Cohort 1: 2 to <12 Years||3
11222414|NCT01971476|12414147|FG001|STARTED|Cohort 1: 2 to <12 Years||3
11222415|NCT01971476|12414148|FG002|STARTED|Cohort 1: 2 to <12 Years||6
11222416|NCT01971476|12414146|FG000|COMPLETED|Cohort 1: 2 to <12 Years||0
11222417|NCT01971476|12414147|FG001|COMPLETED|Cohort 1: 2 to <12 Years||0
11222418|NCT01971476|12414148|FG002|COMPLETED|Cohort 1: 2 to <12 Years||0
11222419|NCT01971476|12414146|FG000|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
11222420|NCT01971476|12414147|FG001|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
11222421|NCT01971476|12414148|FG002|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
11222422|NCT01971476|12414146|FG000|STARTED|Cohort 2: 12 to <18 Years||6
11222423|NCT01971476|12414147|FG001|STARTED|Cohort 2: 12 to <18 Years||4
11222424|NCT01971476|12414148|FG002|STARTED|Cohort 2: 12 to <18 Years||0
11222425|NCT01971476|12414146|FG000|COMPLETED|Cohort 2: 12 to <18 Years||0
11222426|NCT01971476|12414147|FG001|COMPLETED|Cohort 2: 12 to <18 Years||0
11222427|NCT01971476|12414148|FG002|COMPLETED|Cohort 2: 12 to <18 Years||0
11222428|NCT01971476|12414146|FG000|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
11222429|NCT01971476|12414147|FG001|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
11222430|NCT01971476|12414148|FG002|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
11222431|NCT01971554|12414169|FG000|STARTED|Overall Study||9
11222432|NCT01971554|12414170|FG001|STARTED|Overall Study||18
11222433|NCT01971554|12414171|FG002|STARTED|Overall Study||18
11222434|NCT01971554|12414172|FG003|STARTED|Overall Study||18
11222435|NCT01971554|12414169|FG000|COMPLETED|Overall Study||8
11222436|NCT01971554|12414170|FG001|COMPLETED|Overall Study||18
11222437|NCT01971554|12414171|FG002|COMPLETED|Overall Study||18
11222438|NCT01971554|12414172|FG003|COMPLETED|Overall Study||18
11222439|NCT01971554|12414169|FG000|NOT COMPLETED|Overall Study||1
11222440|NCT01971554|12414170|FG001|NOT COMPLETED|Overall Study||0
11222441|NCT01971554|12414171|FG002|NOT COMPLETED|Overall Study||0
11222442|NCT01971554|12414172|FG003|NOT COMPLETED|Overall Study||0
11354237|NCT03071263|12551456|FG001|COMPLETED|Overall Study||141
10841681|NCT01772004|12007278|FG004|NOT COMPLETED|Dose Escalation Phase||0
10841682|NCT01772004|12007279|FG005|NOT COMPLETED|Dose Escalation Phase||0
10841683|NCT01772004|12007280|FG006|NOT COMPLETED|Dose Escalation Phase||0
10841684|NCT01772004|12007281|FG007|NOT COMPLETED|Dose Escalation Phase||0
10841685|NCT01772004|12007282|FG008|NOT COMPLETED|Dose Escalation Phase||0
10841686|NCT01772004|12007283|FG009|NOT COMPLETED|Dose Escalation Phase||0
10841687|NCT01772004|12007284|FG010|NOT COMPLETED|Dose Escalation Phase||0
10841688|NCT01772004|12007285|FG011|NOT COMPLETED|Dose Escalation Phase||0
10841689|NCT01772004|12007286|FG012|NOT COMPLETED|Dose Escalation Phase||0
10841690|NCT01772004|12007287|FG013|NOT COMPLETED|Dose Escalation Phase||0
10841691|NCT01772004|12007288|FG014|NOT COMPLETED|Dose Escalation Phase||0
10841692|NCT01772004|12007289|FG015|NOT COMPLETED|Dose Escalation Phase||0
11354238|NCT03071263|12551455|FG000|NOT COMPLETED|Overall Study||3
11354239|NCT03071263|12551456|FG001|NOT COMPLETED|Overall Study||7
11354240|NCT03071276|12551462|FG000|STARTED|Overall Study||37
11354241|NCT03071276|12551462|FG000|COMPLETED|Overall Study||22
11354242|NCT03071276|12551462|FG000|NOT COMPLETED|Overall Study||15
11354243|NCT03071744|12551466|FG000|STARTED|Overall Study||6
11354244|NCT03071744|12551466|FG000|COMPLETED|Overall Study||4
11354245|NCT03071744|12551466|FG000|NOT COMPLETED|Overall Study||2
11354246|NCT03071887|12551470|FG000|STARTED|Overall Study||13
11354247|NCT03071887|12551470|FG000|COMPLETED|Overall Study||7
11354248|NCT03071887|12551470|FG000|NOT COMPLETED|Overall Study||6
11354249|NCT03072160|12551476|FG000|STARTED|Overall Study||13
11354250|NCT03072160|12551477|FG001|STARTED|Overall Study||4
11354251|NCT03072160|12551476|FG000|COMPLETED|Overall Study||2
11354252|NCT03072160|12551477|FG001|COMPLETED|Overall Study||0
11354253|NCT03072160|12551476|FG000|NOT COMPLETED|Overall Study||11
11354254|NCT03072160|12551477|FG001|NOT COMPLETED|Overall Study||4
11354255|NCT03072186|12551515|FG000|STARTED|Overall Study||23
11354256|NCT03072186|12551515|FG000|COMPLETED|Overall Study||17
11354257|NCT03072186|12551515|FG000|NOT COMPLETED|Overall Study||6
11354258|NCT03072550|12551519|FG000|STARTED|Overall Study||26
11354259|NCT03072550|12551519|FG000|COMPLETED|Overall Study||24
11354260|NCT03072550|12551519|FG000|NOT COMPLETED|Overall Study||2
11354261|NCT03072602|12551525|FG000|STARTED|Overall Study||39
11354262|NCT03072602|12551526|FG001|STARTED|Overall Study||42
11354263|NCT03072602|12551525|FG000|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47
11354264|NCT03072602|12551526|FG001|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47
11354265|NCT03072602|12551525|FG000|Ineligible Participants|Overall Study||8
11354266|NCT03072602|12551526|FG001|Ineligible Participants|Overall Study||5
11354267|NCT03072602|12551525|FG000|Participant Received Standardized Meals|Overall Study||39
10841693|NCT01772004|12007290|FG016|NOT COMPLETED|Dose Escalation Phase||0
10841694|NCT01772004|12007291|FG017|NOT COMPLETED|Dose Escalation Phase||0
10841695|NCT01772004|12007292|FG018|NOT COMPLETED|Dose Escalation Phase||0
10841696|NCT01772004|12007293|FG019|NOT COMPLETED|Dose Escalation Phase||0
10841697|NCT01772004|12007294|FG020|NOT COMPLETED|Dose Escalation Phase||0
10841698|NCT01772004|12007295|FG021|NOT COMPLETED|Dose Escalation Phase||0
10841699|NCT01772004|12007296|FG022|NOT COMPLETED|Dose Escalation Phase||0
10841700|NCT01772004|12007274|FG000|STARTED|Dose Expansion Phase||0
10841701|NCT01772004|12007275|FG001|STARTED|Dose Expansion Phase||0
10841702|NCT01772004|12007276|FG002|STARTED|Dose Expansion Phase||0
10841703|NCT01772004|12007277|FG003|STARTED|Dose Expansion Phase||0
10841704|NCT01772004|12007278|FG004|STARTED|Dose Expansion Phase||0
10841705|NCT01772004|12007279|FG005|STARTED|Dose Expansion Phase||184
10841706|NCT01772004|12007280|FG006|STARTED|Dose Expansion Phase||156
10841707|NCT01772004|12007281|FG007|STARTED|Dose Expansion Phase||168
10841708|NCT01772004|12007282|FG008|STARTED|Dose Expansion Phase||60
10841709|NCT01772004|12007283|FG009|STARTED|Dose Expansion Phase||90
10841710|NCT01772004|12007284|FG010|STARTED|Dose Expansion Phase||21
10841711|NCT01772004|12007285|FG011|STARTED|Dose Expansion Phase||18
10841712|NCT01772004|12007286|FG012|STARTED|Dose Expansion Phase||50
10841713|NCT01772004|12007287|FG013|STARTED|Dose Expansion Phase||51
10841714|NCT01772004|12007288|FG014|STARTED|Dose Expansion Phase||53
10841715|NCT01772004|12007289|FG015|STARTED|Dose Expansion Phase||44
10841716|NCT01772004|12007290|FG016|STARTED|Dose Expansion Phase||125
10841717|NCT01772004|12007291|FG017|STARTED|Dose Expansion Phase||62
10841718|NCT01772004|12007292|FG018|STARTED|Dose Expansion Phase||20
10841719|NCT01772004|12007293|FG019|STARTED|Dose Expansion Phase||103
10841720|NCT01772004|12007294|FG020|STARTED|Dose Expansion Phase||205
10841721|NCT01772004|12007295|FG021|STARTED|Dose Expansion Phase||132
10841722|NCT01772004|12007296|FG022|STARTED|Dose Expansion Phase||153
10841723|NCT01772004|12007274|FG000|COMPLETED|Dose Expansion Phase||0
10841724|NCT01772004|12007275|FG001|COMPLETED|Dose Expansion Phase||0
10841725|NCT01772004|12007276|FG002|COMPLETED|Dose Expansion Phase||0
11222443|NCT01971567|12414184|FG000|STARTED|Overall Study||56
11222444|NCT01971567|12414185|FG001|STARTED|Overall Study||51
11222445|NCT01971567|12414184|FG000|COMPLETED|Overall Study||52
11222446|NCT01971567|12414185|FG001|COMPLETED|Overall Study||49
11222447|NCT01971567|12414184|FG000|NOT COMPLETED|Overall Study||4
11222448|NCT01971567|12414185|FG001|NOT COMPLETED|Overall Study||2
11222449|NCT01971580|12414193|FG000|STARTED|Overall Study||14
11222450|NCT01971580|12414194|FG001|STARTED|Overall Study||14
11222451|NCT01971580|12414193|FG000|COMPLETED|Overall Study||10
11222452|NCT01971580|12414194|FG001|COMPLETED|Overall Study||9
11222453|NCT01971580|12414193|FG000|NOT COMPLETED|Overall Study||4
11222454|NCT01971580|12414194|FG001|NOT COMPLETED|Overall Study||5
11222455|NCT01971593|12414202|FG000|STARTED|Overall Study||14
11222456|NCT01971593|12414203|FG001|STARTED|Overall Study||12
11222457|NCT01971593|12414202|FG000|COMPLETED|Overall Study||9
11222458|NCT01971593|12414203|FG001|COMPLETED|Overall Study||8
11222459|NCT01971593|12414202|FG000|NOT COMPLETED|Overall Study||5
11222460|NCT01971593|12414203|FG001|NOT COMPLETED|Overall Study||4
11222461|NCT01971645|12414210|FG000|STARTED|Overall Study||25
11222462|NCT01971645|12414211|FG001|STARTED|Overall Study||27
11222463|NCT01971645|12414212|FG002|STARTED|Overall Study||25
11222464|NCT01971645|12414210|FG000|COMPLETED|Overall Study||23
11222465|NCT01971645|12414211|FG001|COMPLETED|Overall Study||27
11222466|NCT01971645|12414212|FG002|COMPLETED|Overall Study||23
11222467|NCT01971645|12414210|FG000|NOT COMPLETED|Overall Study||2
11222468|NCT01971645|12414211|FG001|NOT COMPLETED|Overall Study||0
11222469|NCT01971645|12414212|FG002|NOT COMPLETED|Overall Study||2
11222470|NCT01971723|12414222|FG000|STARTED|Overall Study||16
11222471|NCT01971723|12414223|FG001|STARTED|Overall Study||16
11222472|NCT01971723|12414222|FG000|COMPLETED|Overall Study||14
11222473|NCT01971723|12414223|FG001|COMPLETED|Overall Study||13
11222474|NCT01971723|12414222|FG000|NOT COMPLETED|Overall Study||2
11222475|NCT01971723|12414223|FG001|NOT COMPLETED|Overall Study||3
11222476|NCT01972061|12414232|FG000|STARTED|Overall Study||1
11222477|NCT01972061|12414233|FG001|STARTED|Overall Study||23
11222478|NCT01972061|12414234|FG002|STARTED|Overall Study||20
11222479|NCT01972061|12414232|FG000|COMPLETED|Overall Study||1
11222480|NCT01972061|12414233|FG001|COMPLETED|Overall Study||23
11222481|NCT01972061|12414234|FG002|COMPLETED|Overall Study||20
11222482|NCT01972061|12414232|FG000|NOT COMPLETED|Overall Study||0
11222483|NCT01972061|12414233|FG001|NOT COMPLETED|Overall Study||0
11222484|NCT01972061|12414234|FG002|NOT COMPLETED|Overall Study||0
11222485|NCT01972074|12414245|FG000|STARTED|Overall Study||22
11222486|NCT01972074|12414246|FG001|STARTED|Overall Study||21
11222487|NCT01972074|12414247|FG002|STARTED|Overall Study||18
11222488|NCT01972074|12414245|FG000|COMPLETED|Overall Study||16
11222489|NCT01972074|12414246|FG001|COMPLETED|Overall Study||17
11222490|NCT01972074|12414247|FG002|COMPLETED|Overall Study||15
11222491|NCT01972074|12414245|FG000|NOT COMPLETED|Overall Study||6
11222492|NCT01972074|12414246|FG001|NOT COMPLETED|Overall Study||4
11222493|NCT01972074|12414247|FG002|NOT COMPLETED|Overall Study||3
11222494|NCT01972152|12414254|FG000|STARTED|First Treatment Visit||5
10841726|NCT01772004|12007277|FG003|COMPLETED|Dose Expansion Phase||0
10841727|NCT01772004|12007278|FG004|COMPLETED|Dose Expansion Phase||0
10841728|NCT01772004|12007279|FG005|COMPLETED|Dose Expansion Phase||184
10841729|NCT01772004|12007280|FG006|COMPLETED|Dose Expansion Phase||156
10841730|NCT01772004|12007281|FG007|COMPLETED|Dose Expansion Phase||168
10841731|NCT01772004|12007282|FG008|COMPLETED|Dose Expansion Phase||60
10841732|NCT01772004|12007283|FG009|COMPLETED|Dose Expansion Phase||90
10841733|NCT01772004|12007284|FG010|COMPLETED|Dose Expansion Phase||21
10841734|NCT01772004|12007285|FG011|COMPLETED|Dose Expansion Phase||18
10841735|NCT01772004|12007286|FG012|COMPLETED|Dose Expansion Phase||50
10841736|NCT01772004|12007287|FG013|COMPLETED|Dose Expansion Phase||51
10841737|NCT01772004|12007288|FG014|COMPLETED|Dose Expansion Phase||53
10841738|NCT01772004|12007289|FG015|COMPLETED|Dose Expansion Phase||44
10841739|NCT01772004|12007290|FG016|COMPLETED|Dose Expansion Phase||125
10841740|NCT01772004|12007291|FG017|COMPLETED|Dose Expansion Phase||62
11222495|NCT01972152|12414255|FG001|STARTED|First Treatment Visit||5
10841741|NCT01772004|12007292|FG018|COMPLETED|Dose Expansion Phase||20
10841742|NCT01772004|12007293|FG019|COMPLETED|Dose Expansion Phase||103
10841743|NCT01772004|12007294|FG020|COMPLETED|Dose Expansion Phase||205
10841744|NCT01772004|12007295|FG021|COMPLETED|Dose Expansion Phase||132
10841745|NCT01772004|12007296|FG022|COMPLETED|Dose Expansion Phase||153
10841746|NCT01772004|12007274|FG000|NOT COMPLETED|Dose Expansion Phase||0
10841747|NCT01772004|12007275|FG001|NOT COMPLETED|Dose Expansion Phase||0
10841748|NCT01772004|12007276|FG002|NOT COMPLETED|Dose Expansion Phase||0
10841749|NCT01772004|12007277|FG003|NOT COMPLETED|Dose Expansion Phase||0
10841750|NCT01772004|12007278|FG004|NOT COMPLETED|Dose Expansion Phase||0
10841751|NCT01772004|12007279|FG005|NOT COMPLETED|Dose Expansion Phase||0
10841752|NCT01772004|12007280|FG006|NOT COMPLETED|Dose Expansion Phase||0
10841753|NCT01772004|12007281|FG007|NOT COMPLETED|Dose Expansion Phase||0
10841754|NCT01772004|12007282|FG008|NOT COMPLETED|Dose Expansion Phase||0
10841755|NCT01772004|12007283|FG009|NOT COMPLETED|Dose Expansion Phase||0
10841756|NCT01772004|12007284|FG010|NOT COMPLETED|Dose Expansion Phase||0
10841757|NCT01772004|12007285|FG011|NOT COMPLETED|Dose Expansion Phase||0
10841758|NCT01772004|12007286|FG012|NOT COMPLETED|Dose Expansion Phase||0
10841759|NCT01772004|12007287|FG013|NOT COMPLETED|Dose Expansion Phase||0
10841760|NCT01772004|12007288|FG014|NOT COMPLETED|Dose Expansion Phase||0
10841761|NCT01772004|12007289|FG015|NOT COMPLETED|Dose Expansion Phase||0
10841762|NCT01772004|12007290|FG016|NOT COMPLETED|Dose Expansion Phase||0
10841763|NCT01772004|12007291|FG017|NOT COMPLETED|Dose Expansion Phase||0
10841764|NCT01772004|12007292|FG018|NOT COMPLETED|Dose Expansion Phase||0
10841765|NCT01772004|12007293|FG019|NOT COMPLETED|Dose Expansion Phase||0
10841766|NCT01772004|12007294|FG020|NOT COMPLETED|Dose Expansion Phase||0
10841767|NCT01772004|12007295|FG021|NOT COMPLETED|Dose Expansion Phase||0
10841768|NCT01772004|12007296|FG022|NOT COMPLETED|Dose Expansion Phase||0
10841769|NCT01322971|12007393|FG000|STARTED|Overall Study||1
10841770|NCT01322971|12007394|FG001|STARTED|Overall Study||1
10841771|NCT01322971|12007393|FG000|COMPLETED|Overall Study||0
10841772|NCT01322971|12007394|FG001|COMPLETED|Overall Study||0
10841773|NCT01322971|12007393|FG000|NOT COMPLETED|Overall Study||1
10841774|NCT01322971|12007394|FG001|NOT COMPLETED|Overall Study||1
10841775|NCT01285102|12007400|FG000|STARTED|Overall Study||4
10841776|NCT01285102|12007400|FG000|COMPLETED|Overall Study||0
10841777|NCT01285102|12007400|FG000|NOT COMPLETED|Overall Study||4
10841778|NCT00952692|12007404|FG000|STARTED|Overall Study||12
10841779|NCT00952692|12007404|FG000|COMPLETED|Overall Study||12
10841780|NCT00952692|12007404|FG000|NOT COMPLETED|Overall Study||0
10841781|NCT00804713|12007408|FG000|STARTED|Overall Study||1978
10841782|NCT00804713|12007408|FG000|COMPLETED|Overall Study||1978
10841783|NCT00804713|12007408|FG000|NOT COMPLETED|Overall Study||0
10841784|NCT00677560|12007419|FG000|STARTED|Overall Study||20
10841785|NCT00677560|12007420|FG001|STARTED|Overall Study||23
10841786|NCT00677560|12007421|FG002|STARTED|Overall Study||29
10841787|NCT00677560|12007422|FG003|STARTED|Overall Study||20
10841788|NCT00677560|12007423|FG004|STARTED|Overall Study||34
10841789|NCT00677560|12007419|FG000|COMPLETED|Overall Study||5
10841790|NCT00677560|12007420|FG001|COMPLETED|Overall Study||13
10841791|NCT00677560|12007421|FG002|COMPLETED|Overall Study||6
10841792|NCT00677560|12007422|FG003|COMPLETED|Overall Study||3
10841793|NCT00677560|12007423|FG004|COMPLETED|Overall Study||21
10841794|NCT00677560|12007419|FG000|NOT COMPLETED|Overall Study||15
10841795|NCT00677560|12007420|FG001|NOT COMPLETED|Overall Study||10
10841796|NCT00677560|12007421|FG002|NOT COMPLETED|Overall Study||23
10841797|NCT00677560|12007422|FG003|NOT COMPLETED|Overall Study||17
10841798|NCT00677560|12007423|FG004|NOT COMPLETED|Overall Study||13
10841799|NCT00389649|12007448|FG000|STARTED|Overall Study||2
10841800|NCT00389649|12007449|FG001|STARTED|Overall Study||2
10841801|NCT00389649|12007450|FG002|STARTED|Overall Study||3
10841802|NCT00389649|12007451|FG003|STARTED|Overall Study||2
10841803|NCT00389649|12007452|FG004|STARTED|Overall Study||2
10841804|NCT00389649|12007453|FG005|STARTED|Overall Study||2
10841805|NCT00389649|12007448|FG000|COMPLETED|Overall Study||2
10841806|NCT00389649|12007449|FG001|COMPLETED|Overall Study||2
10841807|NCT00389649|12007450|FG002|COMPLETED|Overall Study||3
10841808|NCT00389649|12007451|FG003|COMPLETED|Overall Study||2
10841809|NCT00389649|12007452|FG004|COMPLETED|Overall Study||2
10841810|NCT00389649|12007453|FG005|COMPLETED|Overall Study||2
10841811|NCT00389649|12007448|FG000|NOT COMPLETED|Overall Study||0
10841812|NCT00389649|12007449|FG001|NOT COMPLETED|Overall Study||0
10841813|NCT00389649|12007450|FG002|NOT COMPLETED|Overall Study||0
10841814|NCT00389649|12007451|FG003|NOT COMPLETED|Overall Study||0
10841815|NCT00389649|12007452|FG004|NOT COMPLETED|Overall Study||0
10841816|NCT00389649|12007453|FG005|NOT COMPLETED|Overall Study||0
10841817|NCT04644328|12007463|FG000|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to high-intensity treatment. A total of 3,545 ZCTAs (of which 2,702 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
10841818|NCT04644328|12007464|FG001|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to low-intensity treatment. A total of 3,453 ZCTAs (of which 2,549 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
10841899|NCT03181542|12007573|FG001|STARTED|Overall Study||80
10841819|NCT04644328|12007463|FG000|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
10841820|NCT04644328|12007464|FG001|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
10841821|NCT04644328|12007463|FG000|NOT COMPLETED|Thanksgiving Period||
10841822|NCT04644328|12007464|FG001|NOT COMPLETED|Thanksgiving Period||
10841823|NCT04644328|12007463|FG000|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 386 counties were assigned to high-intensity treatment. A total of 5,077 ZCTAs (of which 3,818 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
10841824|NCT04644328|12007464|FG001|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 381 counties were assigned to low-intensity treatment. A total of 5,102 ZCTAs (of which 3,833 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
10841825|NCT04644328|12007463|FG000|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
10841826|NCT04644328|12007464|FG001|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
10841827|NCT04644328|12007463|FG000|NOT COMPLETED|Christmas Period||
10841828|NCT04644328|12007464|FG001|NOT COMPLETED|Christmas Period||
10841829|NCT04246554|12007474|FG000|STARTED|Overall Study||26
10841830|NCT04246554|12007475|FG001|STARTED|Overall Study||23
11222496|NCT01972152|12414256|FG002|STARTED|First Treatment Visit||5
11222497|NCT01972152|12414257|FG003|STARTED|First Treatment Visit||5
11222498|NCT01972152|12414258|FG004|STARTED|First Treatment Visit||5
11222499|NCT01972152|12414259|FG005|STARTED|First Treatment Visit||5
11222500|NCT01972152|12414254|FG000|COMPLETED|First Treatment Visit||5
11222501|NCT01972152|12414255|FG001|COMPLETED|First Treatment Visit||4
11222502|NCT01972152|12414256|FG002|COMPLETED|First Treatment Visit||5
11222503|NCT01972152|12414257|FG003|COMPLETED|First Treatment Visit||5
11222504|NCT01972152|12414258|FG004|COMPLETED|First Treatment Visit||5
11222505|NCT01972152|12414259|FG005|COMPLETED|First Treatment Visit||5
11222506|NCT01972152|12414254|FG000|NOT COMPLETED|First Treatment Visit||0
11222507|NCT01972152|12414255|FG001|NOT COMPLETED|First Treatment Visit||1
11222508|NCT01972152|12414256|FG002|NOT COMPLETED|First Treatment Visit||0
11222509|NCT01972152|12414257|FG003|NOT COMPLETED|First Treatment Visit||0
11222510|NCT01972152|12414258|FG004|NOT COMPLETED|First Treatment Visit||0
11222511|NCT01972152|12414259|FG005|NOT COMPLETED|First Treatment Visit||0
11222512|NCT01972152|12414254|FG000|STARTED|Second Treatment Visit||5
11222513|NCT01972152|12414255|FG001|STARTED|Second Treatment Visit||4
11222514|NCT01972152|12414256|FG002|STARTED|Second Treatment Visit||5
11222515|NCT01972152|12414257|FG003|STARTED|Second Treatment Visit||5
11222516|NCT01972152|12414258|FG004|STARTED|Second Treatment Visit||5
11222517|NCT01972152|12414259|FG005|STARTED|Second Treatment Visit||5
11222518|NCT01972152|12414254|FG000|COMPLETED|Second Treatment Visit||5
11222519|NCT01972152|12414255|FG001|COMPLETED|Second Treatment Visit||3
11222520|NCT01972152|12414256|FG002|COMPLETED|Second Treatment Visit||5
11222521|NCT01972152|12414257|FG003|COMPLETED|Second Treatment Visit||5
11222522|NCT01972152|12414258|FG004|COMPLETED|Second Treatment Visit||5
11222523|NCT01972152|12414259|FG005|COMPLETED|Second Treatment Visit||5
11222524|NCT01972152|12414254|FG000|NOT COMPLETED|Second Treatment Visit||0
11222525|NCT01972152|12414255|FG001|NOT COMPLETED|Second Treatment Visit||1
11222526|NCT01972152|12414256|FG002|NOT COMPLETED|Second Treatment Visit||0
11222527|NCT01972152|12414257|FG003|NOT COMPLETED|Second Treatment Visit||0
11222528|NCT01972152|12414258|FG004|NOT COMPLETED|Second Treatment Visit||0
11222529|NCT01972152|12414259|FG005|NOT COMPLETED|Second Treatment Visit||0
11222530|NCT01972152|12414254|FG000|STARTED|Third Treatment Visit||5
11222531|NCT01972152|12414255|FG001|STARTED|Third Treatment Visit||3
11222532|NCT01972152|12414256|FG002|STARTED|Third Treatment Visit||5
11222533|NCT01972152|12414257|FG003|STARTED|Third Treatment Visit||5
11222534|NCT01972152|12414258|FG004|STARTED|Third Treatment Visit||5
11222535|NCT01972152|12414259|FG005|STARTED|Third Treatment Visit||5
11222536|NCT01972152|12414254|FG000|COMPLETED|Third Treatment Visit||5
11222537|NCT01972152|12414255|FG001|COMPLETED|Third Treatment Visit||3
11222538|NCT01972152|12414256|FG002|COMPLETED|Third Treatment Visit||5
11222539|NCT01972152|12414257|FG003|COMPLETED|Third Treatment Visit||5
11222540|NCT01972152|12414258|FG004|COMPLETED|Third Treatment Visit||5
11222541|NCT01972152|12414259|FG005|COMPLETED|Third Treatment Visit||5
11222542|NCT01972152|12414254|FG000|NOT COMPLETED|Third Treatment Visit||0
11222543|NCT01972152|12414255|FG001|NOT COMPLETED|Third Treatment Visit||0
11222544|NCT01972152|12414256|FG002|NOT COMPLETED|Third Treatment Visit||0
11222545|NCT01972152|12414257|FG003|NOT COMPLETED|Third Treatment Visit||0
11222546|NCT01972152|12414258|FG004|NOT COMPLETED|Third Treatment Visit||0
11222547|NCT01972152|12414259|FG005|NOT COMPLETED|Third Treatment Visit||0
11222548|NCT01972204|12414272|FG000|STARTED|Overall Study||62
11222549|NCT01972204|12414273|FG001|STARTED|Overall Study||63
11222550|NCT01972204|12414272|FG000|COMPLETED|Overall Study||58
11222551|NCT01972204|12414273|FG001|COMPLETED|Overall Study||59
11222552|NCT01972204|12414272|FG000|NOT COMPLETED|Overall Study||4
11222553|NCT01972204|12414273|FG001|NOT COMPLETED|Overall Study||4
11222554|NCT01972282|12414279|FG000|STARTED|Overall Study||1020
10841900|NCT03181542|12007572|FG000|COMPLETED|Overall Study||79
11222555|NCT01972282|12414279|FG000|COMPLETED|Overall Study||1005
11222556|NCT01972282|12414279|FG000|NOT COMPLETED|Overall Study||15
11222557|NCT01972438|12414285|FG000|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
11222558|NCT01972438|12414286|FG001|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
11222559|NCT01972438|12414285|FG000|COMPLETED|Baseline-Month 3 Crossover Period||6
11222560|NCT01972438|12414286|FG001|COMPLETED|Baseline-Month 3 Crossover Period||6
11222561|NCT01972438|12414285|FG000|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
11222562|NCT01972438|12414286|FG001|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
11222563|NCT01972438|12414285|FG000|STARTED|Months 3-6 Crossover Period||6
11222564|NCT01972438|12414286|FG001|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
11222565|NCT01972438|12414285|FG000|COMPLETED|Months 3-6 Crossover Period||6
11222566|NCT01972438|12414286|FG001|COMPLETED|Months 3-6 Crossover Period||6
11222567|NCT01972438|12414285|FG000|NOT COMPLETED|Months 3-6 Crossover Period||0
11222568|NCT01972438|12414286|FG001|NOT COMPLETED|Months 3-6 Crossover Period||1
11222569|NCT01972438|12414285|FG000|STARTED|Months 6-12 Study Period||6
11222570|NCT01972438|12414286|FG001|STARTED|Months 6-12 Study Period||6
11222571|NCT01972438|12414285|FG000|COMPLETED|Months 6-12 Study Period||3
11222572|NCT01972438|12414286|FG001|COMPLETED|Months 6-12 Study Period||4
11222573|NCT01972438|12414285|FG000|NOT COMPLETED|Months 6-12 Study Period||3
10841831|NCT04246554|12007474|FG000|COMPLETED|Overall Study||26
10841832|NCT04246554|12007475|FG001|COMPLETED|Overall Study||22
10841833|NCT04246554|12007474|FG000|NOT COMPLETED|Overall Study||0
10841834|NCT04246554|12007475|FG001|NOT COMPLETED|Overall Study||1
10841835|NCT03877926|12007485|FG000|STARTED|Overall Study||1103
10841836|NCT03877926|12007486|FG001|STARTED|Overall Study||1103
10841837|NCT03877926|12007487|FG002|STARTED|Overall Study||1098
10841838|NCT03877926|12007488|FG003|STARTED|Overall Study||558
10841839|NCT03877926|12007485|FG000|Received at Least One Study Vaccination|Overall Study||1100
10841840|NCT03877926|12007486|FG001|Received at Least One Study Vaccination|Overall Study||1102
10841841|NCT03877926|12007487|FG002|Received at Least One Study Vaccination|Overall Study||1097
10841842|NCT03877926|12007488|FG003|Received at Least One Study Vaccination|Overall Study||558
10841843|NCT03877926|12007485|FG000|Did Not Receive Any Study Vaccination|Overall Study||3
10841844|NCT03877926|12007486|FG001|Did Not Receive Any Study Vaccination|Overall Study||1
10841845|NCT03877926|12007487|FG002|Did Not Receive Any Study Vaccination|Overall Study||1
10841846|NCT03877926|12007488|FG003|Did Not Receive Any Study Vaccination|Overall Study||0
10841847|NCT03877926|12007485|FG000|COMPLETED|Overall Study||1032
10841848|NCT03877926|12007486|FG001|COMPLETED|Overall Study||1026
10841849|NCT03877926|12007487|FG002|COMPLETED|Overall Study||1035
10841850|NCT03877926|12007488|FG003|COMPLETED|Overall Study||537
10841851|NCT03877926|12007485|FG000|NOT COMPLETED|Overall Study||71
10841852|NCT03877926|12007486|FG001|NOT COMPLETED|Overall Study||77
10841853|NCT03877926|12007487|FG002|NOT COMPLETED|Overall Study||63
10841854|NCT03877926|12007488|FG003|NOT COMPLETED|Overall Study||21
10841855|NCT03862807|12007511|FG000|STARTED|Overall Study||24
10841856|NCT03862807|12007511|FG000|Treated|Overall Study||23
10841857|NCT03862807|12007511|FG000|Completed Treatment|Overall Study||22
10841858|NCT03862807|12007511|FG000|COMPLETED|Overall Study||23
10841859|NCT03862807|12007511|FG000|NOT COMPLETED|Overall Study||1
10841860|NCT03857867|12007515|FG000|STARTED|Overall Study||7
10841861|NCT03857867|12007515|FG000|COMPLETED|Overall Study||6
10841862|NCT03857867|12007515|FG000|NOT COMPLETED|Overall Study||1
10841863|NCT03691571|12007522|FG000|STARTED|Overall Study||31
10841864|NCT03691571|12007523|FG001|STARTED|Overall Study||24
10841865|NCT03691571|12007522|FG000|COMPLETED|Overall Study||22
10841866|NCT03691571|12007523|FG001|COMPLETED|Overall Study||22
10841867|NCT03691571|12007522|FG000|NOT COMPLETED|Overall Study||9
10841868|NCT03691571|12007523|FG001|NOT COMPLETED|Overall Study||2
10841869|NCT03436199|12007533|FG000|STARTED|Overall Study||187
10841870|NCT03436199|12007534|FG001|STARTED|Overall Study||185
10841871|NCT03436199|12007535|FG002|STARTED|Overall Study||186
10841872|NCT03436199|12007533|FG000|COMPLETED|Overall Study||165
10841873|NCT03436199|12007534|FG001|COMPLETED|Overall Study||132
10841874|NCT03436199|12007535|FG002|COMPLETED|Overall Study||174
10841875|NCT03436199|12007533|FG000|NOT COMPLETED|Overall Study||22
10841876|NCT03436199|12007534|FG001|NOT COMPLETED|Overall Study||53
10841877|NCT03436199|12007535|FG002|NOT COMPLETED|Overall Study||12
10841878|NCT03353233|12007545|FG000|STARTED|Overall Study||25
10841879|NCT03353233|12007546|FG001|STARTED|Overall Study||25
10841880|NCT03353233|12007545|FG000|COMPLETED|Overall Study||25
10841881|NCT03353233|12007546|FG001|COMPLETED|Overall Study||25
10841882|NCT03353233|12007545|FG000|NOT COMPLETED|Overall Study||0
10841883|NCT03353233|12007546|FG001|NOT COMPLETED|Overall Study||0
11104287|NCT01248065|12288589|FG000|NOT COMPLETED|Overall Study||26
11104288|NCT01248065|12288590|FG001|NOT COMPLETED|Overall Study||22
11104289|NCT01248104|12288598|FG000|STARTED|Overall Study||50
11104290|NCT01248104|12288599|FG001|STARTED|Overall Study||50
11104291|NCT01248104|12288598|FG000|COMPLETED|Overall Study||40
10841890|NCT03217136|12007563|FG000|STARTED|Overall Study||71
10841891|NCT03217136|12007564|FG001|STARTED|Overall Study||23
10841892|NCT03217136|12007563|FG000|Treated|Overall Study||70
10841893|NCT03217136|12007564|FG001|Treated|Overall Study||21
10841894|NCT03217136|12007563|FG000|COMPLETED|Overall Study||67
10841895|NCT03217136|12007564|FG001|COMPLETED|Overall Study||20
10841896|NCT03217136|12007563|FG000|NOT COMPLETED|Overall Study||4
10841897|NCT03217136|12007564|FG001|NOT COMPLETED|Overall Study||3
10841898|NCT03181542|12007572|FG000|STARTED|Overall Study||80
10841901|NCT03181542|12007573|FG001|COMPLETED|Overall Study||80
10841902|NCT03181542|12007572|FG000|NOT COMPLETED|Overall Study||1
10841903|NCT03181542|12007573|FG001|NOT COMPLETED|Overall Study||0
10841904|NCT04458467|12007581|FG000|STARTED|Overall Study||35
10841905|NCT04458467|12007582|FG001|STARTED|Overall Study||35
10841906|NCT04458467|12007581|FG000|COMPLETED|Overall Study||35
10841907|NCT04458467|12007582|FG001|COMPLETED|Overall Study||35
10841908|NCT04458467|12007581|FG000|NOT COMPLETED|Overall Study||0
10841909|NCT04458467|12007582|FG001|NOT COMPLETED|Overall Study||0
10841910|NCT04411082|12007594|FG000|STARTED|Overall Study||29
10841911|NCT04411082|12007595|FG001|STARTED|Overall Study||25
10841912|NCT04411082|12007596|FG002|STARTED|Overall Study||20
10841913|NCT04411082|12007597|FG003|STARTED|Overall Study||24
10841914|NCT04411082|12007598|FG004|STARTED|Overall Study||12
10841915|NCT04411082|12007599|FG005|STARTED|Overall Study||12
10841916|NCT04411082|12007594|FG000|COMPLETED|Overall Study||18
10841917|NCT04411082|12007595|FG001|COMPLETED|Overall Study||16
10841918|NCT04411082|12007596|FG002|COMPLETED|Overall Study||16
10841919|NCT04411082|12007597|FG003|COMPLETED|Overall Study||10
10841920|NCT04411082|12007598|FG004|COMPLETED|Overall Study||8
11222574|NCT01972438|12414286|FG001|NOT COMPLETED|Months 6-12 Study Period||2
11222575|NCT01972438|12414285|FG000|STARTED|Post Month 12 Study Period||3
11222576|NCT01972438|12414286|FG001|STARTED|Post Month 12 Study Period||4
11222577|NCT01972438|12414285|FG000|COMPLETED|Post Month 12 Study Period||0
11222578|NCT01972438|12414286|FG001|COMPLETED|Post Month 12 Study Period||0
11222579|NCT01972438|12414285|FG000|NOT COMPLETED|Post Month 12 Study Period||3
11222580|NCT01972438|12414286|FG001|NOT COMPLETED|Post Month 12 Study Period||4
11222581|NCT01972464|12414296|FG000|STARTED|Treatment Period (Week 1 Through Week 8)||19
11222582|NCT01972464|12414297|FG001|STARTED|Treatment Period (Week 1 Through Week 8)||22
11222583|NCT01972464|12414296|FG000|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
11222584|NCT01972464|12414297|FG001|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
11222585|NCT01972464|12414296|FG000|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
11222586|NCT01972464|12414297|FG001|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
11222587|NCT01972464|12414296|FG000|STARTED|3-Month Follow-Up (Week 20)||16
11222588|NCT01972464|12414297|FG001|STARTED|3-Month Follow-Up (Week 20)||18
11222589|NCT01972464|12414296|FG000|COMPLETED|3-Month Follow-Up (Week 20)||15
11222590|NCT01972464|12414297|FG001|COMPLETED|3-Month Follow-Up (Week 20)||17
11222591|NCT01972464|12414296|FG000|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
11222592|NCT01972464|12414297|FG001|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
11222593|NCT01972516|12414306|FG000|STARTED|Overall Study||3
11222594|NCT01972516|12414307|FG001|STARTED|Overall Study||1
11222595|NCT01972516|12414306|FG000|COMPLETED|Overall Study||3
11222596|NCT01972516|12414307|FG001|COMPLETED|Overall Study||1
11222597|NCT01972516|12414306|FG000|NOT COMPLETED|Overall Study||0
11222598|NCT01972516|12414307|FG001|NOT COMPLETED|Overall Study||0
11222599|NCT01972529|12414317|FG000|STARTED|Overall Study||48
11222600|NCT01972529|12414318|FG001|STARTED|Overall Study||90
11222601|NCT01972529|12414319|FG002|STARTED|Overall Study||34
11222602|NCT01972529|12414320|FG003|STARTED|Overall Study||59
11222603|NCT01972529|12414317|FG000|COMPLETED|Overall Study||46
11222604|NCT01972529|12414318|FG001|COMPLETED|Overall Study||85
11222605|NCT01972529|12414319|FG002|COMPLETED|Overall Study||32
11222606|NCT01972529|12414320|FG003|COMPLETED|Overall Study||55
11222607|NCT01972529|12414317|FG000|NOT COMPLETED|Overall Study||2
11222608|NCT01972529|12414318|FG001|NOT COMPLETED|Overall Study||5
10841921|NCT04411082|12007599|FG005|COMPLETED|Overall Study||6
10841922|NCT04411082|12007594|FG000|NOT COMPLETED|Overall Study||11
10841923|NCT04411082|12007595|FG001|NOT COMPLETED|Overall Study||9
10841924|NCT04411082|12007596|FG002|NOT COMPLETED|Overall Study||4
10841925|NCT04411082|12007597|FG003|NOT COMPLETED|Overall Study||14
10841926|NCT04411082|12007598|FG004|NOT COMPLETED|Overall Study||4
10841927|NCT04411082|12007599|FG005|NOT COMPLETED|Overall Study||6
10841928|NCT04100590|12007616|FG000|STARTED|Overall Study||1
10841929|NCT04100590|12007616|FG000|COMPLETED|Overall Study||1
10841930|NCT04100590|12007616|FG000|NOT COMPLETED|Overall Study||0
10841931|NCT03985293|12007628|FG000|STARTED|DOUBLE-BLIND TREATMENT||66
10841932|NCT03985293|12007629|FG001|STARTED|DOUBLE-BLIND TREATMENT||68
10841933|NCT03985293|12007630|FG002|STARTED|DOUBLE-BLIND TREATMENT||68
10841934|NCT03985293|12007631|FG003|STARTED|DOUBLE-BLIND TREATMENT||71
10841935|NCT03985293|12007632|FG004|STARTED|DOUBLE-BLIND TREATMENT||67
10841936|NCT03985293|12007633|FG005|STARTED|DOUBLE-BLIND TREATMENT||71
10841937|NCT03985293|12007628|FG000|COMPLETED|DOUBLE-BLIND TREATMENT||57
10841938|NCT03985293|12007629|FG001|COMPLETED|DOUBLE-BLIND TREATMENT||54
10841939|NCT03985293|12007630|FG002|COMPLETED|DOUBLE-BLIND TREATMENT||63
10841940|NCT03985293|12007631|FG003|COMPLETED|DOUBLE-BLIND TREATMENT||57
10841941|NCT03985293|12007632|FG004|COMPLETED|DOUBLE-BLIND TREATMENT||47
10841942|NCT03985293|12007633|FG005|COMPLETED|DOUBLE-BLIND TREATMENT||38
10841943|NCT03985293|12007628|FG000|NOT COMPLETED|DOUBLE-BLIND TREATMENT||9
10841944|NCT03985293|12007629|FG001|NOT COMPLETED|DOUBLE-BLIND TREATMENT||14
10841945|NCT03985293|12007630|FG002|NOT COMPLETED|DOUBLE-BLIND TREATMENT||5
10841946|NCT03985293|12007631|FG003|NOT COMPLETED|DOUBLE-BLIND TREATMENT||14
10841947|NCT03985293|12007632|FG004|NOT COMPLETED|DOUBLE-BLIND TREATMENT||20
10841948|NCT03985293|12007633|FG005|NOT COMPLETED|DOUBLE-BLIND TREATMENT||33
10841949|NCT03985293|12007628|FG000|STARTED|FOLLOW-UP||57
10841950|NCT03985293|12007629|FG001|STARTED|FOLLOW-UP||54
10841951|NCT03985293|12007630|FG002|STARTED|FOLLOW-UP||63
10841952|NCT03985293|12007631|FG003|STARTED|FOLLOW-UP||57
10841953|NCT03985293|12007632|FG004|STARTED|FOLLOW-UP||47
10841954|NCT03985293|12007633|FG005|STARTED|FOLLOW-UP||38
10841955|NCT03985293|12007628|FG000|COMPLETED|FOLLOW-UP||57
10841956|NCT03985293|12007629|FG001|COMPLETED|FOLLOW-UP||54
10841957|NCT03985293|12007630|FG002|COMPLETED|FOLLOW-UP||62
10841958|NCT03985293|12007631|FG003|COMPLETED|FOLLOW-UP||57
10841959|NCT03985293|12007632|FG004|COMPLETED|FOLLOW-UP||47
10841960|NCT03985293|12007633|FG005|COMPLETED|FOLLOW-UP||38
10841961|NCT03985293|12007628|FG000|NOT COMPLETED|FOLLOW-UP||0
10841962|NCT03985293|12007629|FG001|NOT COMPLETED|FOLLOW-UP||0
10841963|NCT03985293|12007630|FG002|NOT COMPLETED|FOLLOW-UP||1
10841964|NCT03985293|12007631|FG003|NOT COMPLETED|FOLLOW-UP||0
10841965|NCT03985293|12007632|FG004|NOT COMPLETED|FOLLOW-UP||0
10841966|NCT03985293|12007633|FG005|NOT COMPLETED|FOLLOW-UP||0
10841967|NCT03846427|12007647|FG000|STARTED|Overall Study||68
10841968|NCT03846427|12007647|FG000|COMPLETED|Overall Study||0
10841969|NCT03846427|12007647|FG000|NOT COMPLETED|Overall Study||68
10841978|NCT03776357|12007660|FG000|STARTED|Overall Study||9
10841979|NCT03776357|12007660|FG000|COMPLETED|Overall Study||6
10841980|NCT03776357|12007660|FG000|NOT COMPLETED|Overall Study||3
10841981|NCT03656068|12007664|FG000|STARTED|Overall Study||21
10841982|NCT03656068|12007664|FG000|COMPLETED|Overall Study||16
10841983|NCT03656068|12007664|FG000|NOT COMPLETED|Overall Study||5
10841984|NCT03595982|12007670|FG000|STARTED|Overall Study||3
10841985|NCT03595982|12007671|FG001|STARTED|Overall Study||2
10841986|NCT03595982|12007670|FG000|COMPLETED|Overall Study||3
10841987|NCT03595982|12007671|FG001|COMPLETED|Overall Study||2
10841988|NCT03595982|12007670|FG000|NOT COMPLETED|Overall Study||0
10841989|NCT03595982|12007671|FG001|NOT COMPLETED|Overall Study||0
10841990|NCT03400956|12007680|FG000|STARTED|Treatment Period 1||35
10841991|NCT03400956|12007681|FG001|STARTED|Treatment Period 1||34
10841992|NCT03400956|12007682|FG002|STARTED|Treatment Period 1||34
10841993|NCT03400956|12007680|FG000|Treated|Treatment Period 1||31
10841994|NCT03400956|12007681|FG001|Treated|Treatment Period 1||30
10841995|NCT03400956|12007682|FG002|Treated|Treatment Period 1||30
10841996|NCT03400956|12007680|FG000|FAS|Treatment Period 1||32
10841997|NCT03400956|12007681|FG001|FAS|Treatment Period 1||33
10841998|NCT03400956|12007682|FG002|FAS|Treatment Period 1||31
10841999|NCT03400956|12007680|FG000|COMPLETED|Treatment Period 1||31
10842000|NCT03400956|12007681|FG001|COMPLETED|Treatment Period 1||26
10842001|NCT03400956|12007682|FG002|COMPLETED|Treatment Period 1||25
10842002|NCT03400956|12007680|FG000|NOT COMPLETED|Treatment Period 1||4
10842003|NCT03400956|12007681|FG001|NOT COMPLETED|Treatment Period 1||8
10842004|NCT03400956|12007682|FG002|NOT COMPLETED|Treatment Period 1||9
10842005|NCT03400956|12007680|FG000|STARTED|Post-treatment Period 1||31
10842006|NCT03400956|12007681|FG001|STARTED|Post-treatment Period 1||26
10842007|NCT03400956|12007682|FG002|STARTED|Post-treatment Period 1||25
10842008|NCT03400956|12007680|FG000|COMPLETED|Post-treatment Period 1||9
10842009|NCT03400956|12007681|FG001|COMPLETED|Post-treatment Period 1||10
10842010|NCT03400956|12007682|FG002|COMPLETED|Post-treatment Period 1||9
10842011|NCT03400956|12007680|FG000|NOT COMPLETED|Post-treatment Period 1||22
10842012|NCT03400956|12007681|FG001|NOT COMPLETED|Post-treatment Period 1||16
10842013|NCT03400956|12007682|FG002|NOT COMPLETED|Post-treatment Period 1||16
10842014|NCT03400956|12007680|FG000|STARTED|Treatment Period 2||9
10842015|NCT03400956|12007681|FG001|STARTED|Treatment Period 2||10
10842016|NCT03400956|12007682|FG002|STARTED|Treatment Period 2||9
10842017|NCT03400956|12007680|FG000|COMPLETED|Treatment Period 2||5
10842018|NCT03400956|12007681|FG001|COMPLETED|Treatment Period 2||7
10842019|NCT03400956|12007682|FG002|COMPLETED|Treatment Period 2||5
10842020|NCT03400956|12007680|FG000|NOT COMPLETED|Treatment Period 2||4
10842021|NCT03400956|12007681|FG001|NOT COMPLETED|Treatment Period 2||3
10842022|NCT03400956|12007682|FG002|NOT COMPLETED|Treatment Period 2||4
10842023|NCT03400956|12007680|FG000|STARTED|Follow-up Period||6
10842024|NCT03400956|12007681|FG001|STARTED|Follow-up Period||9
10842025|NCT03400956|12007682|FG002|STARTED|Follow-up Period||7
10842026|NCT03400956|12007680|FG000|COMPLETED|Follow-up Period||6
10842027|NCT03400956|12007681|FG001|COMPLETED|Follow-up Period||9
10842028|NCT03400956|12007682|FG002|COMPLETED|Follow-up Period||5
10842029|NCT03400956|12007680|FG000|NOT COMPLETED|Follow-up Period||0
10842030|NCT03400956|12007681|FG001|NOT COMPLETED|Follow-up Period||0
10842031|NCT03400956|12007682|FG002|NOT COMPLETED|Follow-up Period||2
10842032|NCT03126539|12007695|FG000|STARTED|Overall Study||9
10842033|NCT03126539|12007696|FG001|STARTED|Overall Study||9
10842034|NCT03126539|12007697|FG002|STARTED|Overall Study||9
10842035|NCT03126539|12007698|FG003|STARTED|Overall Study|Group B was not done|0
10842036|NCT03126539|12007699|FG004|STARTED|Overall Study||0
10842037|NCT03126539|12007695|FG000|COMPLETED|Overall Study||8
10842038|NCT03126539|12007696|FG001|COMPLETED|Overall Study||8
10842039|NCT03126539|12007697|FG002|COMPLETED|Overall Study||8
10842040|NCT03126539|12007698|FG003|COMPLETED|Overall Study||0
10842041|NCT03126539|12007699|FG004|COMPLETED|Overall Study||0
10842042|NCT03126539|12007695|FG000|NOT COMPLETED|Overall Study||1
10842043|NCT03126539|12007696|FG001|NOT COMPLETED|Overall Study||1
10842044|NCT03126539|12007697|FG002|NOT COMPLETED|Overall Study||1
10842045|NCT03126539|12007698|FG003|NOT COMPLETED|Overall Study||0
10842046|NCT03126539|12007699|FG004|NOT COMPLETED|Overall Study||0
10842047|NCT03057613|12007712|FG000|STARTED|Overall Study||18
10842048|NCT03057613|12007712|FG000|COMPLETED|Overall Study||18
10842049|NCT03057613|12007712|FG000|NOT COMPLETED|Overall Study||0
11104292|NCT01248104|12288599|FG001|COMPLETED|Overall Study||42
11104293|NCT01248104|12288598|FG000|NOT COMPLETED|Overall Study||10
11104294|NCT01248104|12288599|FG001|NOT COMPLETED|Overall Study||8
11104295|NCT01248221|12288607|FG000|STARTED|Overall Study||15
11104296|NCT01248221|12288608|FG001|STARTED|Overall Study||15
11104297|NCT01248221|12288607|FG000|COMPLETED|Overall Study||15
11104298|NCT01248221|12288608|FG001|COMPLETED|Overall Study||15
11104299|NCT01248221|12288607|FG000|NOT COMPLETED|Overall Study||0
11104300|NCT01248221|12288608|FG001|NOT COMPLETED|Overall Study||0
11104301|NCT01248364|12288620|FG000|STARTED|Overall Study||32
11104302|NCT01248364|12288621|FG001|STARTED|Overall Study||34
11104303|NCT01248364|12288622|FG002|STARTED|Overall Study||13
11104304|NCT01248364|12288623|FG003|STARTED|Overall Study||12
11104305|NCT01248364|12288620|FG000|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
10842065|NCT02830594|12007738|FG000|STARTED|Overall Study||14
10842066|NCT02830594|12007738|FG000|COMPLETED|Overall Study||14
10842067|NCT02830594|12007738|FG000|NOT COMPLETED|Overall Study||0
10842068|NCT02819635|12007750|FG000|STARTED|Substudy 1 and Substudy 2, Part 1||46
10842069|NCT02819635|12007751|FG001|STARTED|Substudy 1 and Substudy 2, Part 1||47
10842070|NCT02819635|12007752|FG002|STARTED|Substudy 1 and Substudy 2, Part 1||49
10842071|NCT02819635|12007753|FG003|STARTED|Substudy 1 and Substudy 2, Part 1||117
10842072|NCT02819635|12007754|FG004|STARTED|Substudy 1 and Substudy 2, Part 1||123
10842073|NCT02819635|12007755|FG005|STARTED|Substudy 1 and Substudy 2, Part 1||155
10842074|NCT02819635|12007756|FG006|STARTED|Substudy 1 and Substudy 2, Part 1||319
10842075|NCT02819635|12007757|FG007|STARTED|Substudy 1 and Substudy 2, Part 1||446
10842076|NCT02819635|12007758|FG008|STARTED|Substudy 1 and Substudy 2, Part 1||0
10842077|NCT02819635|12007759|FG009|STARTED|Substudy 1 and Substudy 2, Part 1||0
10842078|NCT02819635|12007760|FG010|STARTED|Substudy 1 and Substudy 2, Part 1||0
10842079|NCT02819635|12007761|FG011|STARTED|Substudy 1 and Substudy 2, Part 1||0
10842080|NCT02819635|12007750|FG000|COMPLETED|Substudy 1 and Substudy 2, Part 1||41
10842081|NCT02819635|12007751|FG001|COMPLETED|Substudy 1 and Substudy 2, Part 1||45
10842082|NCT02819635|12007752|FG002|COMPLETED|Substudy 1 and Substudy 2, Part 1||45
10842083|NCT02819635|12007753|FG003|COMPLETED|Substudy 1 and Substudy 2, Part 1||105
10842084|NCT02819635|12007754|FG004|COMPLETED|Substudy 1 and Substudy 2, Part 1||113
10842085|NCT02819635|12007755|FG005|COMPLETED|Substudy 1 and Substudy 2, Part 1||135
10842086|NCT02819635|12007756|FG006|COMPLETED|Substudy 1 and Substudy 2, Part 1||306
10842087|NCT02819635|12007757|FG007|COMPLETED|Substudy 1 and Substudy 2, Part 1||446
10842088|NCT02819635|12007758|FG008|COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842089|NCT02819635|12007759|FG009|COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842090|NCT02819635|12007760|FG010|COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842091|NCT02819635|12007761|FG011|COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842092|NCT02819635|12007750|FG000|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||5
10842093|NCT02819635|12007751|FG001|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||2
10842094|NCT02819635|12007752|FG002|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||4
10842095|NCT02819635|12007753|FG003|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||12
10842096|NCT02819635|12007754|FG004|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||10
10842097|NCT02819635|12007755|FG005|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||20
10842098|NCT02819635|12007756|FG006|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||13
10842099|NCT02819635|12007757|FG007|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842100|NCT02819635|12007758|FG008|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842101|NCT02819635|12007759|FG009|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842102|NCT02819635|12007760|FG010|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842103|NCT02819635|12007761|FG011|NOT COMPLETED|Substudy 1 and Substudy 2, Part 1||0
10842104|NCT02819635|12007750|FG000|STARTED|Substudy 2, Part 2||0
10842105|NCT02819635|12007751|FG001|STARTED|Substudy 2, Part 2||0
10842106|NCT02819635|12007752|FG002|STARTED|Substudy 2, Part 2||0
10842107|NCT02819635|12007753|FG003|STARTED|Substudy 2, Part 2||0
10842108|NCT02819635|12007754|FG004|STARTED|Substudy 2, Part 2||0
10842109|NCT02819635|12007755|FG005|STARTED|Substudy 2, Part 2||85
10842110|NCT02819635|12007756|FG006|STARTED|Substudy 2, Part 2||59
10842111|NCT02819635|12007757|FG007|STARTED|Substudy 2, Part 2||0
10842112|NCT02819635|12007758|FG008|STARTED|Substudy 2, Part 2||0
10842113|NCT02819635|12007759|FG009|STARTED|Substudy 2, Part 2||0
10842114|NCT02819635|12007760|FG010|STARTED|Substudy 2, Part 2||0
10842115|NCT02819635|12007761|FG011|STARTED|Substudy 2, Part 2||0
10842116|NCT02819635|12007750|FG000|COMPLETED|Substudy 2, Part 2||0
10842117|NCT02819635|12007751|FG001|COMPLETED|Substudy 2, Part 2||0
10842118|NCT02819635|12007752|FG002|COMPLETED|Substudy 2, Part 2||0
10842119|NCT02819635|12007753|FG003|COMPLETED|Substudy 2, Part 2||0
10842120|NCT02819635|12007754|FG004|COMPLETED|Substudy 2, Part 2||0
10842121|NCT02819635|12007755|FG005|COMPLETED|Substudy 2, Part 2||74
10842122|NCT02819635|12007756|FG006|COMPLETED|Substudy 2, Part 2||47
10842123|NCT02819635|12007757|FG007|COMPLETED|Substudy 2, Part 2||0
10842124|NCT02819635|12007758|FG008|COMPLETED|Substudy 2, Part 2||0
10842125|NCT02819635|12007759|FG009|COMPLETED|Substudy 2, Part 2||0
10842126|NCT02819635|12007760|FG010|COMPLETED|Substudy 2, Part 2||0
10842127|NCT02819635|12007761|FG011|COMPLETED|Substudy 2, Part 2||0
10842128|NCT02819635|12007750|FG000|NOT COMPLETED|Substudy 2, Part 2||0
10842129|NCT02819635|12007751|FG001|NOT COMPLETED|Substudy 2, Part 2||0
10842130|NCT02819635|12007752|FG002|NOT COMPLETED|Substudy 2, Part 2||0
10842131|NCT02819635|12007753|FG003|NOT COMPLETED|Substudy 2, Part 2||0
10842132|NCT02819635|12007754|FG004|NOT COMPLETED|Substudy 2, Part 2||0
10842133|NCT02819635|12007755|FG005|NOT COMPLETED|Substudy 2, Part 2||11
10842134|NCT02819635|12007756|FG006|NOT COMPLETED|Substudy 2, Part 2||12
10842135|NCT02819635|12007757|FG007|NOT COMPLETED|Substudy 2, Part 2||0
10842136|NCT02819635|12007758|FG008|NOT COMPLETED|Substudy 2, Part 2||0
10842137|NCT02819635|12007759|FG009|NOT COMPLETED|Substudy 2, Part 2||0
10842138|NCT02819635|12007760|FG010|NOT COMPLETED|Substudy 2, Part 2||0
10842139|NCT02819635|12007761|FG011|NOT COMPLETED|Substudy 2, Part 2||0
10842140|NCT02819635|12007750|FG000|STARTED|Substudy 3||0
10842141|NCT02819635|12007751|FG001|STARTED|Substudy 3||0
10842142|NCT02819635|12007752|FG002|STARTED|Substudy 3||0
10842143|NCT02819635|12007753|FG003|STARTED|Substudy 3||0
10842144|NCT02819635|12007754|FG004|STARTED|Substudy 3||0
10842145|NCT02819635|12007755|FG005|STARTED|Substudy 3||0
10842146|NCT02819635|12007756|FG006|STARTED|Substudy 3||0
10842147|NCT02819635|12007757|FG007|STARTED|Substudy 3||0
10842148|NCT02819635|12007758|FG008|STARTED|Substudy 3||386
10842149|NCT02819635|12007759|FG009|STARTED|Substudy 3||20
10842150|NCT02819635|12007760|FG010|STARTED|Substudy 3||324
10842151|NCT02819635|12007761|FG011|STARTED|Substudy 3||316
10842152|NCT02819635|12007750|FG000|COMPLETED|Substudy 3||0
10842153|NCT02819635|12007751|FG001|COMPLETED|Substudy 3||0
10842154|NCT02819635|12007752|FG002|COMPLETED|Substudy 3||0
10842155|NCT02819635|12007753|FG003|COMPLETED|Substudy 3||0
10842156|NCT02819635|12007754|FG004|COMPLETED|Substudy 3||0
10842157|NCT02819635|12007755|FG005|COMPLETED|Substudy 3||0
10842158|NCT02819635|12007756|FG006|COMPLETED|Substudy 3||0
10842159|NCT02819635|12007757|FG007|COMPLETED|Substudy 3||0
10842160|NCT02819635|12007758|FG008|COMPLETED|Substudy 3||140
10842161|NCT02819635|12007759|FG009|COMPLETED|Substudy 3||11
10842162|NCT02819635|12007760|FG010|COMPLETED|Substudy 3||218
10842163|NCT02819635|12007761|FG011|COMPLETED|Substudy 3||248
10842164|NCT02819635|12007750|FG000|NOT COMPLETED|Substudy 3||0
10842165|NCT02819635|12007751|FG001|NOT COMPLETED|Substudy 3||0
10842166|NCT02819635|12007752|FG002|NOT COMPLETED|Substudy 3||0
10842167|NCT02819635|12007753|FG003|NOT COMPLETED|Substudy 3||0
10842168|NCT02819635|12007754|FG004|NOT COMPLETED|Substudy 3||0
10842169|NCT02819635|12007755|FG005|NOT COMPLETED|Substudy 3||0
10842170|NCT02819635|12007756|FG006|NOT COMPLETED|Substudy 3||0
10842171|NCT02819635|12007757|FG007|NOT COMPLETED|Substudy 3||0
11222609|NCT01972529|12414319|FG002|NOT COMPLETED|Overall Study||2
11222610|NCT01972529|12414320|FG003|NOT COMPLETED|Overall Study||4
11222611|NCT01972568|12414334|FG000|STARTED|Overall Study||102
11222612|NCT01972568|12414335|FG001|STARTED|Overall Study||104
11222613|NCT01972568|12414336|FG002|STARTED|Overall Study||100
11222614|NCT01972568|12414334|FG000|COMPLETED|Overall Study||86
10842172|NCT02819635|12007758|FG008|NOT COMPLETED|Substudy 3||246
10842173|NCT02819635|12007759|FG009|NOT COMPLETED|Substudy 3||9
10842174|NCT02819635|12007760|FG010|NOT COMPLETED|Substudy 3||106
10842175|NCT02819635|12007761|FG011|NOT COMPLETED|Substudy 3||68
10842176|NCT02756013|12007789|FG000|STARTED|Overall Study||3
10842177|NCT02756013|12007789|FG000|COMPLETED|Overall Study||1
10842178|NCT02756013|12007789|FG000|NOT COMPLETED|Overall Study||2
10842179|NCT02681614|12007793|FG000|STARTED|Overall Study||5
10842180|NCT02681614|12007793|FG000|COMPLETED|Overall Study||5
10842181|NCT02681614|12007793|FG000|NOT COMPLETED|Overall Study||0
10842182|NCT02667067|12007800|FG000|STARTED|Overall Study||117
10842183|NCT02667067|12007801|FG001|STARTED|Overall Study||150
10842184|NCT02667067|12007800|FG000|COMPLETED|Overall Study||96
10842185|NCT02667067|12007801|FG001|COMPLETED|Overall Study||139
10842186|NCT02667067|12007800|FG000|NOT COMPLETED|Overall Study||21
10842187|NCT02667067|12007801|FG001|NOT COMPLETED|Overall Study||11
11104306|NCT01248364|12288621|FG001|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
11104307|NCT01248364|12288622|FG002|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
11222615|NCT01972568|12414335|FG001|COMPLETED|Overall Study||92
11222616|NCT01972568|12414336|FG002|COMPLETED|Overall Study||84
11222617|NCT01972568|12414334|FG000|NOT COMPLETED|Overall Study||16
11222618|NCT01972568|12414335|FG001|NOT COMPLETED|Overall Study||12
11222619|NCT01972568|12414336|FG002|NOT COMPLETED|Overall Study||16
11222620|NCT01972659|12414346|FG000|STARTED|Overall Study||40
11222621|NCT01972659|12414347|FG001|STARTED|Overall Study||40
11354268|NCT03072602|12551526|FG001|Participant Received Standardized Meals|Overall Study||42
11354269|NCT03072602|12551525|FG000|Study Dropouts|Overall Study||4
11354270|NCT03072602|12551526|FG001|Study Dropouts|Overall Study||3
11354271|NCT03072602|12551525|FG000|Participants Returned for Glucose Challenge Protocol|Overall Study||35
11354272|NCT03072602|12551526|FG001|Participants Returned for Glucose Challenge Protocol|Overall Study||39
11354273|NCT03072602|12551525|FG000|Unable to Complete the Protocol|Overall Study||1
11354274|NCT03072602|12551526|FG001|Unable to Complete the Protocol|Overall Study||1
11354275|NCT03072602|12551525|FG000|COMPLETED|Overall Study||34
11354276|NCT03072602|12551526|FG001|COMPLETED|Overall Study||38
11354277|NCT03072602|12551525|FG000|NOT COMPLETED|Overall Study||5
11354278|NCT03072602|12551526|FG001|NOT COMPLETED|Overall Study||4
11354279|NCT03072719|12551534|FG000|STARTED|Overall Study||60
11354280|NCT03072719|12551535|FG001|STARTED|Overall Study||60
11354281|NCT03072719|12551534|FG000|COMPLETED|Overall Study||59
11354282|NCT03072719|12551535|FG001|COMPLETED|Overall Study||59
11354283|NCT03072719|12551534|FG000|NOT COMPLETED|Overall Study||1
11104308|NCT01248364|12288623|FG003|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
11104309|NCT01248364|12288620|FG000|Completed Chronic Phase:28-day Treatment|Overall Study||32
11104310|NCT01248364|12288621|FG001|Completed Chronic Phase:28-day Treatment|Overall Study||33
11104311|NCT01248364|12288622|FG002|Completed Chronic Phase:28-day Treatment|Overall Study||13
11104312|NCT01248364|12288623|FG003|Completed Chronic Phase:28-day Treatment|Overall Study||0
11104313|NCT01248364|12288620|FG000|COMPLETED|Overall Study||32
11104314|NCT01248364|12288621|FG001|COMPLETED|Overall Study||33
11104315|NCT01248364|12288622|FG002|COMPLETED|Overall Study||13
11222622|NCT01972659|12414346|FG000|COMPLETED|Overall Study||36
11222623|NCT01972659|12414347|FG001|COMPLETED|Overall Study||37
11222624|NCT01972659|12414346|FG000|NOT COMPLETED|Overall Study||4
11222625|NCT01972659|12414347|FG001|NOT COMPLETED|Overall Study||3
11222626|NCT01972724|12414356|FG000|STARTED|Double-Blind||19
11104316|NCT01248364|12288623|FG003|COMPLETED|Overall Study||12
11104317|NCT01248364|12288620|FG000|NOT COMPLETED|Overall Study||0
11104318|NCT01248364|12288621|FG001|NOT COMPLETED|Overall Study||1
11104319|NCT01248364|12288622|FG002|NOT COMPLETED|Overall Study||0
11104320|NCT01248364|12288623|FG003|NOT COMPLETED|Overall Study||0
11104321|NCT01248416|12288636|FG000|STARTED|Overall Study||25
11104322|NCT01248416|12288637|FG001|STARTED|Overall Study||25
11104323|NCT01248416|12288638|FG002|STARTED|Overall Study||26
11104324|NCT01248416|12288636|FG000|COMPLETED|Overall Study||21
11104325|NCT01248416|12288637|FG001|COMPLETED|Overall Study||25
11104326|NCT01248416|12288638|FG002|COMPLETED|Overall Study||25
11104327|NCT01248416|12288636|FG000|NOT COMPLETED|Overall Study||4
11104328|NCT01248416|12288637|FG001|NOT COMPLETED|Overall Study||0
11104329|NCT01248416|12288638|FG002|NOT COMPLETED|Overall Study||1
11104330|NCT01248455|12288648|FG000|STARTED|Overall Study||9
11104331|NCT01248455|12288648|FG000|COMPLETED|Overall Study||8
11104332|NCT01248455|12288648|FG000|NOT COMPLETED|Overall Study||1
11104333|NCT01248468|12288655|FG000|STARTED|Overall Study||299
11104334|NCT01248468|12288656|FG001|STARTED|Overall Study||304
11104335|NCT01248468|12288657|FG002|STARTED|Overall Study||149
11104336|NCT01248468|12288655|FG000|Safety Population|Overall Study||266
11104337|NCT01248468|12288656|FG001|Safety Population|Overall Study||271
11104338|NCT01248468|12288657|FG002|Safety Population|Overall Study||133
11104339|NCT01248468|12288655|FG000|ITT Population|Overall Study||256
11104340|NCT01248468|12288656|FG001|ITT Population|Overall Study||261
11104341|NCT01248468|12288657|FG002|ITT Population|Overall Study||125
11104342|NCT01248468|12288655|FG000|COMPLETED|Overall Study||284
11104343|NCT01248468|12288656|FG001|COMPLETED|Overall Study||290
11104344|NCT01248468|12288657|FG002|COMPLETED|Overall Study||145
11104345|NCT01248468|12288655|FG000|NOT COMPLETED|Overall Study||15
11104346|NCT01248468|12288656|FG001|NOT COMPLETED|Overall Study||14
11104347|NCT01248468|12288657|FG002|NOT COMPLETED|Overall Study||4
11104348|NCT01248585|12288667|FG000|STARTED|Overall Study||148
11104349|NCT01248585|12288668|FG001|STARTED|Overall Study||150
11104350|NCT01248585|12288667|FG000|COMPLETED|Overall Study||148
11104351|NCT01248585|12288668|FG001|COMPLETED|Overall Study||150
11104352|NCT01248585|12288667|FG000|NOT COMPLETED|Overall Study||0
11104353|NCT01248585|12288668|FG001|NOT COMPLETED|Overall Study||0
11104354|NCT01248715|12288676|FG000|STARTED|Overall Study||556
11104355|NCT01248715|12288677|FG001|STARTED|Overall Study||551
11104356|NCT01248715|12288676|FG000|COMPLETED|Overall Study||55
11104357|NCT01248715|12288677|FG001|COMPLETED|Overall Study||41
11104358|NCT01248715|12288676|FG000|NOT COMPLETED|Overall Study||501
11104359|NCT01248715|12288677|FG001|NOT COMPLETED|Overall Study||510
11104360|NCT01248728|12288685|FG000|STARTED|Overall Study||19
11104361|NCT01248728|12288686|FG001|STARTED|Overall Study||19
11222627|NCT01972724|12414357|FG001|STARTED|Double-Blind||18
11222628|NCT01972724|12414358|FG002|STARTED|Double-Blind||0
11222629|NCT01972724|12414356|FG000|Intent-to-treat:Received Study Drug|Double-Blind||17
11222630|NCT01972724|12414357|FG001|Intent-to-treat:Received Study Drug|Double-Blind||17
11222631|NCT01972724|12414358|FG002|Intent-to-treat:Received Study Drug|Double-Blind||0
11222632|NCT01972724|12414356|FG000|COMPLETED|Double-Blind||10
11222633|NCT01972724|12414357|FG001|COMPLETED|Double-Blind||9
11222634|NCT01972724|12414358|FG002|COMPLETED|Double-Blind||0
11222635|NCT01972724|12414356|FG000|NOT COMPLETED|Double-Blind||9
11222636|NCT01972724|12414357|FG001|NOT COMPLETED|Double-Blind||9
11222637|NCT01972724|12414358|FG002|NOT COMPLETED|Double-Blind||0
11222638|NCT01972724|12414356|FG000|STARTED|Open-Label||0
11222639|NCT01972724|12414357|FG001|STARTED|Open-Label||0
11222640|NCT01972724|12414358|FG002|STARTED|Open-Label||77
11222641|NCT01972724|12414356|FG000|COMPLETED|Open-Label||0
11222642|NCT01972724|12414357|FG001|COMPLETED|Open-Label||0
11222643|NCT01972724|12414358|FG002|COMPLETED|Open-Label||72
11222644|NCT01972724|12414356|FG000|NOT COMPLETED|Open-Label||0
11222645|NCT01972724|12414357|FG001|NOT COMPLETED|Open-Label||0
11222646|NCT01972724|12414358|FG002|NOT COMPLETED|Open-Label||5
11222647|NCT01972776|12414372|FG000|STARTED|Part 1||6
11222648|NCT01972776|12414373|FG001|STARTED|Part 1||6
11104362|NCT01248728|12288685|FG000|COMPLETED|Overall Study||15
11104363|NCT01248728|12288686|FG001|COMPLETED|Overall Study||17
11104364|NCT01248728|12288685|FG000|NOT COMPLETED|Overall Study||4
11104365|NCT01248728|12288686|FG001|NOT COMPLETED|Overall Study||2
11104366|NCT01248741|12288694|FG000|STARTED|Overall Study||20
11104367|NCT01248741|12288694|FG000|COMPLETED|Overall Study||20
11104368|NCT01248741|12288694|FG000|NOT COMPLETED|Overall Study||0
11104369|NCT01248780|12288700|FG000|STARTED|Overall Study||132
11104370|NCT01248780|12288701|FG001|STARTED|Overall Study||132
11104371|NCT01248780|12288700|FG000|COMPLETED|Overall Study||123
11104372|NCT01248780|12288701|FG001|COMPLETED|Overall Study||117
11104373|NCT01248780|12288700|FG000|NOT COMPLETED|Overall Study||9
11222649|NCT01972776|12414374|FG002|STARTED|Part 1||8
11222650|NCT01972776|12414375|FG003|STARTED|Part 1||7
11222651|NCT01972776|12414376|FG004|STARTED|Part 1||0
11222652|NCT01972776|12414377|FG005|STARTED|Part 1||0
11222653|NCT01972776|12414372|FG000|COMPLETED|Part 1||6
11222654|NCT01972776|12414373|FG001|COMPLETED|Part 1||6
11222655|NCT01972776|12414374|FG002|COMPLETED|Part 1||6
11222656|NCT01972776|12414375|FG003|COMPLETED|Part 1||6
11222657|NCT01972776|12414376|FG004|COMPLETED|Part 1||0
11104374|NCT01248780|12288701|FG001|NOT COMPLETED|Overall Study||15
11104375|NCT01248793|12288709|FG000|STARTED|Overall Study||105
11104376|NCT01248793|12288710|FG001|STARTED|Overall Study||108
11104377|NCT01248793|12288709|FG000|COMPLETED|Overall Study||101
11104378|NCT01248793|12288710|FG001|COMPLETED|Overall Study||102
11104379|NCT01248793|12288709|FG000|NOT COMPLETED|Overall Study||4
11104380|NCT01248793|12288710|FG001|NOT COMPLETED|Overall Study||6
11104381|NCT01248884|12288719|FG000|STARTED|Overall Study||240
11104382|NCT01248884|12288720|FG001|STARTED|Overall Study||242
11104383|NCT01248884|12288721|FG002|STARTED|Overall Study||239
11104384|NCT01248884|12288719|FG000|COMPLETED|Overall Study||238
11104385|NCT01248884|12288720|FG001|COMPLETED|Overall Study||239
11104386|NCT01248884|12288721|FG002|COMPLETED|Overall Study||238
11104387|NCT01248884|12288719|FG000|NOT COMPLETED|Overall Study||2
11104388|NCT01248884|12288720|FG001|NOT COMPLETED|Overall Study||3
11104389|NCT01248884|12288721|FG002|NOT COMPLETED|Overall Study||1
11104390|NCT01248936|12288731|FG000|STARTED|Overall Study||374
11104391|NCT01248936|12288731|FG000|COMPLETED|Overall Study||0
11104392|NCT01248936|12288731|FG000|NOT COMPLETED|Overall Study||374
11104393|NCT01248949|12288741|FG000|STARTED|Overall Study||42
11104394|NCT01248949|12288742|FG001|STARTED|Overall Study||16
11104395|NCT01248949|12288743|FG002|STARTED|Overall Study||38
11104396|NCT01248949|12288744|FG003|STARTED|Overall Study||13
11104397|NCT01248949|12288745|FG004|STARTED|Overall Study||7
11104398|NCT01248949|12288741|FG000|COMPLETED|Overall Study||9
11104399|NCT01248949|12288742|FG001|COMPLETED|Overall Study||3
11222658|NCT01972776|12414377|FG005|COMPLETED|Part 1||0
11222659|NCT01972776|12414372|FG000|NOT COMPLETED|Part 1||0
11222660|NCT01972776|12414373|FG001|NOT COMPLETED|Part 1||0
11222661|NCT01972776|12414374|FG002|NOT COMPLETED|Part 1||2
11222662|NCT01972776|12414375|FG003|NOT COMPLETED|Part 1||1
11222663|NCT01972776|12414376|FG004|NOT COMPLETED|Part 1||0
11222664|NCT01972776|12414377|FG005|NOT COMPLETED|Part 1||0
11222665|NCT01972776|12414372|FG000|STARTED|Part 2||0
11104400|NCT01248949|12288743|FG002|COMPLETED|Overall Study||1
11104401|NCT01248949|12288744|FG003|COMPLETED|Overall Study||3
11104402|NCT01248949|12288745|FG004|COMPLETED|Overall Study||3
11104403|NCT01248949|12288741|FG000|NOT COMPLETED|Overall Study||33
11104404|NCT01248949|12288742|FG001|NOT COMPLETED|Overall Study||13
11104405|NCT01248949|12288743|FG002|NOT COMPLETED|Overall Study||37
11104406|NCT01248949|12288744|FG003|NOT COMPLETED|Overall Study||10
11104407|NCT01248949|12288745|FG004|NOT COMPLETED|Overall Study||4
11104408|NCT01248962|12288759|FG000|STARTED|Overall Study||74
11104409|NCT01248962|12288760|FG001|STARTED|Overall Study||72
11104410|NCT01248962|12288759|FG000|COMPLETED|Overall Study||58
11104411|NCT01248962|12288760|FG001|COMPLETED|Overall Study||56
11104412|NCT01248962|12288759|FG000|NOT COMPLETED|Overall Study||16
11104413|NCT01248962|12288760|FG001|NOT COMPLETED|Overall Study||16
11104414|NCT01249027|12288767|FG000|STARTED|1 Year Clinical Follow up||2482
10842242|NCT02551718|12007837|FG000|STARTED|Overall Study||34
10842243|NCT02551718|12007837|FG000|COMPLETED|Overall Study||34
10842244|NCT02551718|12007837|FG000|NOT COMPLETED|Overall Study||0
10842245|NCT02419807|12007842|FG000|STARTED|Overall Study||102
10842246|NCT02419807|12007842|FG000|COMPLETED|Overall Study||92
10842247|NCT02419807|12007842|FG000|NOT COMPLETED|Overall Study||10
11104415|NCT01249027|12288767|FG000|COMPLETED|1 Year Clinical Follow up||2391
11104416|NCT01249027|12288767|FG000|NOT COMPLETED|1 Year Clinical Follow up||91
11104417|NCT01249027|12288767|FG000|STARTED|2 Years Clinical Follow up||2391
11104418|NCT01249027|12288767|FG000|COMPLETED|2 Years Clinical Follow up||2254
11104419|NCT01249027|12288767|FG000|NOT COMPLETED|2 Years Clinical Follow up||137
11104420|NCT01249027|12288767|FG000|STARTED|3 Years Clinical Follow up||2254
10842266|NCT02231749|12007872|FG000|STARTED|Overall Study||550
10842267|NCT02231749|12007873|FG001|STARTED|Overall Study||546
10842268|NCT02231749|12007872|FG000|Received Treatment|Overall Study||547
10842269|NCT02231749|12007873|FG001|Received Treatment|Overall Study||535
10842270|NCT02231749|12007872|FG000|COMPLETED|Overall Study||128
10842271|NCT02231749|12007873|FG001|COMPLETED|Overall Study||97
11104421|NCT01249027|12288767|FG000|COMPLETED|3 Years Clinical Follow up||2223
11104422|NCT01249027|12288767|FG000|NOT COMPLETED|3 Years Clinical Follow up||31
11104423|NCT01249027|12288767|FG000|STARTED|4 Years Clinical Follow up||2223
11104424|NCT01249027|12288767|FG000|COMPLETED|4 Years Clinical Follow up||2210
11104425|NCT01249027|12288767|FG000|NOT COMPLETED|4 Years Clinical Follow up||13
11104426|NCT01249027|12288767|FG000|STARTED|5 Years Clinical Follow up||2210
11104427|NCT01249027|12288767|FG000|COMPLETED|5 Years Clinical Follow up||2142
11104428|NCT01249027|12288767|FG000|NOT COMPLETED|5 Years Clinical Follow up||68
11222666|NCT01972776|12414373|FG001|STARTED|Part 2||0
11222667|NCT01972776|12414374|FG002|STARTED|Part 2||0
11222668|NCT01972776|12414375|FG003|STARTED|Part 2||0
10842272|NCT02231749|12007872|FG000|NOT COMPLETED|Overall Study||422
10842273|NCT02231749|12007873|FG001|NOT COMPLETED|Overall Study||449
10842274|NCT02227199|12007882|FG000|STARTED|Overall Study||3
10842275|NCT02227199|12007883|FG001|STARTED|Overall Study||3
10842276|NCT02227199|12007884|FG002|STARTED|Overall Study||39
10842277|NCT02227199|12007882|FG000|COMPLETED|Overall Study||3
10842278|NCT02227199|12007883|FG001|COMPLETED|Overall Study||3
10842279|NCT02227199|12007884|FG002|COMPLETED|Overall Study||35
10842280|NCT02227199|12007882|FG000|NOT COMPLETED|Overall Study||0
10842281|NCT02227199|12007883|FG001|NOT COMPLETED|Overall Study||0
10842282|NCT02227199|12007884|FG002|NOT COMPLETED|Overall Study||4
10842283|NCT02181413|12007898|FG000|STARTED|Overall Study||261
10842284|NCT02181413|12007899|FG001|STARTED|Overall Study||395
10842285|NCT02181413|12007898|FG000|Intent-to-Treat (ITT) Population|Overall Study||261
10842286|NCT02181413|12007899|FG001|Intent-to-Treat (ITT) Population|Overall Study||395
10842287|NCT02181413|12007898|FG000|Safety Population|Overall Study||259
10842288|NCT02181413|12007899|FG001|Safety Population|Overall Study||394
10842289|NCT02181413|12007898|FG000|Per Protocol (PP) Population|Overall Study||256
10842290|NCT02181413|12007899|FG001|Per Protocol (PP) Population|Overall Study||387
10842291|NCT02181413|12007898|FG000|COMPLETED|Overall Study||109
10842292|NCT02181413|12007899|FG001|COMPLETED|Overall Study||198
10842293|NCT02181413|12007898|FG000|NOT COMPLETED|Overall Study||152
10842294|NCT02181413|12007899|FG001|NOT COMPLETED|Overall Study||197
10842295|NCT02095678|12007907|FG000|STARTED|Overall Study||34
10842296|NCT02095678|12007908|FG001|STARTED|Overall Study||18
10842297|NCT02095678|12007907|FG000|COMPLETED|Overall Study||17
10842298|NCT02095678|12007908|FG001|COMPLETED|Overall Study||0
10842299|NCT02095678|12007907|FG000|NOT COMPLETED|Overall Study||17
10842300|NCT02095678|12007908|FG001|NOT COMPLETED|Overall Study||18
10842301|NCT01990209|12007919|FG000|STARTED|Overall Study|One participant was found to be ineligible after starting with study treatment and hence excluded from further analyses|27
10842302|NCT01990209|12007920|FG001|STARTED|Overall Study||44
10842303|NCT01990209|12007919|FG000|COMPLETED|Overall Study||0
10842304|NCT01990209|12007920|FG001|COMPLETED|Overall Study||0
10842305|NCT01990209|12007919|FG000|NOT COMPLETED|Overall Study||27
10842306|NCT01990209|12007920|FG001|NOT COMPLETED|Overall Study||44
11104429|NCT01249092|12288771|FG000|STARTED|Overall Study||20
11104430|NCT01249092|12288771|FG000|COMPLETED|Overall Study||18
11104431|NCT01249092|12288771|FG000|NOT COMPLETED|Overall Study||2
11104432|NCT01249118|12288777|FG000|STARTED|First Intervention Period||2
11104433|NCT01249118|12288778|FG001|STARTED|First Intervention Period||6
11104434|NCT01249118|12288779|FG002|STARTED|First Intervention Period||5
11104435|NCT01249118|12288777|FG000|COMPLETED|First Intervention Period||2
11222669|NCT01972776|12414376|FG004|STARTED|Part 2||14
11104436|NCT01249118|12288778|FG001|COMPLETED|First Intervention Period||6
11104437|NCT01249118|12288779|FG002|COMPLETED|First Intervention Period||5
11104438|NCT01249118|12288777|FG000|NOT COMPLETED|First Intervention Period||0
10842317|NCT01955109|12007937|FG000|STARTED|Overall Study||123
10842318|NCT01955109|12007938|FG001|STARTED|Overall Study||48
10842319|NCT01955109|12007937|FG000|Completed Study Until Month 12|Overall Study||103
10842320|NCT01955109|12007938|FG001|Completed Study Until Month 12|Overall Study||46
10842321|NCT01955109|12007937|FG000|COMPLETED|Overall Study||78
10842322|NCT01955109|12007938|FG001|COMPLETED|Overall Study||39
10842323|NCT01955109|12007937|FG000|NOT COMPLETED|Overall Study||45
10842324|NCT01955109|12007938|FG001|NOT COMPLETED|Overall Study||9
11104439|NCT01249118|12288778|FG001|NOT COMPLETED|First Intervention Period||0
11104440|NCT01249118|12288779|FG002|NOT COMPLETED|First Intervention Period||0
11104441|NCT01249118|12288777|FG000|STARTED|First Washout Period||2
11104442|NCT01249118|12288778|FG001|STARTED|First Washout Period||6
11104443|NCT01249118|12288779|FG002|STARTED|First Washout Period||5
11104444|NCT01249118|12288777|FG000|COMPLETED|First Washout Period||2
11104445|NCT01249118|12288778|FG001|COMPLETED|First Washout Period||5
11104446|NCT01249118|12288779|FG002|COMPLETED|First Washout Period||5
11104447|NCT01249118|12288777|FG000|NOT COMPLETED|First Washout Period||0
11104448|NCT01249118|12288778|FG001|NOT COMPLETED|First Washout Period||1
11104449|NCT01249118|12288779|FG002|NOT COMPLETED|First Washout Period||0
11104450|NCT01249118|12288777|FG000|STARTED|Second Intervention Period||2
11104451|NCT01249118|12288778|FG001|STARTED|Second Intervention Period||5
11104452|NCT01249118|12288779|FG002|STARTED|Second Intervention Period||5
11104453|NCT01249118|12288777|FG000|COMPLETED|Second Intervention Period||2
11104454|NCT01249118|12288778|FG001|COMPLETED|Second Intervention Period||5
11104455|NCT01249118|12288779|FG002|COMPLETED|Second Intervention Period||5
11104456|NCT01249118|12288777|FG000|NOT COMPLETED|Second Intervention Period||0
11104457|NCT01249118|12288778|FG001|NOT COMPLETED|Second Intervention Period||0
11104458|NCT01249118|12288779|FG002|NOT COMPLETED|Second Intervention Period||0
11104459|NCT01249118|12288777|FG000|STARTED|Second Washout Period||2
11222670|NCT01972776|12414377|FG005|STARTED|Part 2||7
11104460|NCT01249118|12288778|FG001|STARTED|Second Washout Period||5
11104461|NCT01249118|12288779|FG002|STARTED|Second Washout Period||5
11104462|NCT01249118|12288777|FG000|COMPLETED|Second Washout Period||2
11104463|NCT01249118|12288778|FG001|COMPLETED|Second Washout Period||5
11104464|NCT01249118|12288779|FG002|COMPLETED|Second Washout Period||5
11104465|NCT01249118|12288777|FG000|NOT COMPLETED|Second Washout Period||0
11104466|NCT01249118|12288778|FG001|NOT COMPLETED|Second Washout Period||0
11104467|NCT01249118|12288779|FG002|NOT COMPLETED|Second Washout Period||0
11104468|NCT01249131|12288786|FG000|STARTED|First Intervention||3
11104469|NCT01249131|12288787|FG001|STARTED|First Intervention||3
11222671|NCT01972776|12414372|FG000|COMPLETED|Part 2||0
11104470|NCT01249131|12288788|FG002|STARTED|First Intervention||4
11104471|NCT01249131|12288789|FG003|STARTED|First Intervention||3
11104472|NCT01249131|12288790|FG004|STARTED|First Intervention||3
11104473|NCT01249131|12288791|FG005|STARTED|First Intervention||4
11104474|NCT01249131|12288786|FG000|COMPLETED|First Intervention||3
11104475|NCT01249131|12288787|FG001|COMPLETED|First Intervention||3
11104476|NCT01249131|12288788|FG002|COMPLETED|First Intervention||4
11104477|NCT01249131|12288789|FG003|COMPLETED|First Intervention||3
11104478|NCT01249131|12288790|FG004|COMPLETED|First Intervention||3
11104479|NCT01249131|12288791|FG005|COMPLETED|First Intervention||4
11104480|NCT01249131|12288786|FG000|NOT COMPLETED|First Intervention||0
11104481|NCT01249131|12288787|FG001|NOT COMPLETED|First Intervention||0
11104482|NCT01249131|12288788|FG002|NOT COMPLETED|First Intervention||0
11104483|NCT01249131|12288789|FG003|NOT COMPLETED|First Intervention||0
11104484|NCT01249131|12288790|FG004|NOT COMPLETED|First Intervention||0
11104485|NCT01249131|12288791|FG005|NOT COMPLETED|First Intervention||0
11104486|NCT01249131|12288786|FG000|STARTED|Washout Period of 10 Days||3
11104487|NCT01249131|12288787|FG001|STARTED|Washout Period of 10 Days||3
11104488|NCT01249131|12288788|FG002|STARTED|Washout Period of 10 Days||4
11104489|NCT01249131|12288789|FG003|STARTED|Washout Period of 10 Days||3
11104490|NCT01249131|12288790|FG004|STARTED|Washout Period of 10 Days||3
11104491|NCT01249131|12288791|FG005|STARTED|Washout Period of 10 Days||4
11104492|NCT01249131|12288786|FG000|COMPLETED|Washout Period of 10 Days||3
11104493|NCT01249131|12288787|FG001|COMPLETED|Washout Period of 10 Days||3
11104494|NCT01249131|12288788|FG002|COMPLETED|Washout Period of 10 Days||4
11104495|NCT01249131|12288789|FG003|COMPLETED|Washout Period of 10 Days||3
11104496|NCT01249131|12288790|FG004|COMPLETED|Washout Period of 10 Days||2
11104497|NCT01249131|12288791|FG005|COMPLETED|Washout Period of 10 Days||4
11104498|NCT01249131|12288786|FG000|NOT COMPLETED|Washout Period of 10 Days||0
11104499|NCT01249131|12288787|FG001|NOT COMPLETED|Washout Period of 10 Days||0
11104500|NCT01249131|12288788|FG002|NOT COMPLETED|Washout Period of 10 Days||0
11104501|NCT01249131|12288789|FG003|NOT COMPLETED|Washout Period of 10 Days||0
11104502|NCT01249131|12288790|FG004|NOT COMPLETED|Washout Period of 10 Days||1
11104503|NCT01249131|12288791|FG005|NOT COMPLETED|Washout Period of 10 Days||0
11104504|NCT01249131|12288786|FG000|STARTED|Second Intervention||3
11104505|NCT01249131|12288787|FG001|STARTED|Second Intervention||3
11104506|NCT01249131|12288788|FG002|STARTED|Second Intervention||4
11104507|NCT01249131|12288789|FG003|STARTED|Second Intervention||3
11104508|NCT01249131|12288790|FG004|STARTED|Second Intervention||2
11104509|NCT01249131|12288791|FG005|STARTED|Second Intervention||4
11104510|NCT01249131|12288786|FG000|COMPLETED|Second Intervention||3
11104511|NCT01249131|12288787|FG001|COMPLETED|Second Intervention||3
11104512|NCT01249131|12288788|FG002|COMPLETED|Second Intervention||4
11104513|NCT01249131|12288789|FG003|COMPLETED|Second Intervention||3
11104514|NCT01249131|12288790|FG004|COMPLETED|Second Intervention||2
11104515|NCT01249131|12288791|FG005|COMPLETED|Second Intervention||4
11104516|NCT01249131|12288786|FG000|NOT COMPLETED|Second Intervention||0
11104517|NCT01249131|12288787|FG001|NOT COMPLETED|Second Intervention||0
11104518|NCT01249131|12288788|FG002|NOT COMPLETED|Second Intervention||0
11104519|NCT01249131|12288789|FG003|NOT COMPLETED|Second Intervention||0
11104520|NCT01249131|12288790|FG004|NOT COMPLETED|Second Intervention||0
11104521|NCT01249131|12288791|FG005|NOT COMPLETED|Second Intervention||0
11104522|NCT01249131|12288786|FG000|STARTED|Washout Period of 10 Days||3
11104523|NCT01249131|12288787|FG001|STARTED|Washout Period of 10 Days||3
11104524|NCT01249131|12288788|FG002|STARTED|Washout Period of 10 Days||4
11104525|NCT01249131|12288789|FG003|STARTED|Washout Period of 10 Days||3
11104526|NCT01249131|12288790|FG004|STARTED|Washout Period of 10 Days||2
11104527|NCT01249131|12288791|FG005|STARTED|Washout Period of 10 Days||4
11104528|NCT01249131|12288786|FG000|COMPLETED|Washout Period of 10 Days||3
11104529|NCT01249131|12288787|FG001|COMPLETED|Washout Period of 10 Days||3
11104530|NCT01249131|12288788|FG002|COMPLETED|Washout Period of 10 Days||4
11104531|NCT01249131|12288789|FG003|COMPLETED|Washout Period of 10 Days||3
11104532|NCT01249131|12288790|FG004|COMPLETED|Washout Period of 10 Days||2
11104533|NCT01249131|12288791|FG005|COMPLETED|Washout Period of 10 Days||4
11104534|NCT01249131|12288786|FG000|NOT COMPLETED|Washout Period of 10 Days||0
11104535|NCT01249131|12288787|FG001|NOT COMPLETED|Washout Period of 10 Days||0
11104536|NCT01249131|12288788|FG002|NOT COMPLETED|Washout Period of 10 Days||0
11104537|NCT01249131|12288789|FG003|NOT COMPLETED|Washout Period of 10 Days||0
11104538|NCT01249131|12288790|FG004|NOT COMPLETED|Washout Period of 10 Days||0
11104539|NCT01249131|12288791|FG005|NOT COMPLETED|Washout Period of 10 Days||0
11104540|NCT01249131|12288786|FG000|STARTED|Third Intervention||3
11104541|NCT01249131|12288787|FG001|STARTED|Third Intervention||3
11104542|NCT01249131|12288788|FG002|STARTED|Third Intervention||4
11104543|NCT01249131|12288789|FG003|STARTED|Third Intervention||3
11104544|NCT01249131|12288790|FG004|STARTED|Third Intervention||2
11104545|NCT01249131|12288791|FG005|STARTED|Third Intervention||4
11104546|NCT01249131|12288786|FG000|COMPLETED|Third Intervention||3
11104547|NCT01249131|12288787|FG001|COMPLETED|Third Intervention||3
11104548|NCT01249131|12288788|FG002|COMPLETED|Third Intervention||4
11104549|NCT01249131|12288789|FG003|COMPLETED|Third Intervention||3
11104550|NCT01249131|12288790|FG004|COMPLETED|Third Intervention||2
11104551|NCT01249131|12288791|FG005|COMPLETED|Third Intervention||4
11104552|NCT01249131|12288786|FG000|NOT COMPLETED|Third Intervention||0
11104553|NCT01249131|12288787|FG001|NOT COMPLETED|Third Intervention||0
11104554|NCT01249131|12288788|FG002|NOT COMPLETED|Third Intervention||0
11104555|NCT01249131|12288789|FG003|NOT COMPLETED|Third Intervention||0
11104556|NCT01249131|12288790|FG004|NOT COMPLETED|Third Intervention||0
11104557|NCT01249131|12288791|FG005|NOT COMPLETED|Third Intervention||0
11104558|NCT01249261|12288801|FG000|STARTED|Overall Study||30
11104559|NCT01249261|12288802|FG001|STARTED|Overall Study||31
11104560|NCT01249261|12288801|FG000|COMPLETED|Overall Study||29
11104561|NCT01249261|12288802|FG001|COMPLETED|Overall Study||31
11104562|NCT01249261|12288801|FG000|NOT COMPLETED|Overall Study||1
11104563|NCT01249261|12288802|FG001|NOT COMPLETED|Overall Study||0
11104564|NCT01249274|12288810|FG000|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
11104565|NCT01249274|12288811|FG001|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
11104566|NCT01249274|12288810|FG000|Completed Treatment|Overall Study||21
11104567|NCT01249274|12288811|FG001|Completed Treatment|Overall Study||19
11104568|NCT01249274|12288810|FG000|Completed Treatment & Post Trial Visit|Overall Study||20
11104569|NCT01249274|12288811|FG001|Completed Treatment & Post Trial Visit|Overall Study||17
11104570|NCT01249274|12288810|FG000|Completed Post Trial Visit But Not tx|Overall Study||1
11104571|NCT01249274|12288811|FG001|Completed Post Trial Visit But Not tx|Overall Study||2
11104572|NCT01249274|12288810|FG000|COMPLETED|Overall Study||21
11104573|NCT01249274|12288811|FG001|COMPLETED|Overall Study||19
11104574|NCT01249274|12288810|FG000|NOT COMPLETED|Overall Study||4
11104575|NCT01249274|12288811|FG001|NOT COMPLETED|Overall Study||6
11104576|NCT01249365|12288819|FG000|STARTED|Overall Study||199
11104577|NCT01249365|12288819|FG000|COMPLETED|Overall Study||198
11104578|NCT01249365|12288819|FG000|NOT COMPLETED|Overall Study||1
11104579|NCT01249625|12288825|FG000|STARTED|Overall Study||1374
11104580|NCT01249625|12288826|FG001|STARTED|Overall Study||1488
11104581|NCT01249625|12288825|FG000|COMPLETED|Overall Study||1374
11104582|NCT01249625|12288826|FG001|COMPLETED|Overall Study||1488
11104583|NCT01249625|12288825|FG000|NOT COMPLETED|Overall Study||0
11104584|NCT01249625|12288826|FG001|NOT COMPLETED|Overall Study||0
11104585|NCT01249651|12288832|FG000|STARTED|Overall Study|Enrolled|101
11104586|NCT01249651|12288832|FG000|COMPLETED|Overall Study|Completed the 8-week treatment period|94
11104587|NCT01249651|12288832|FG000|NOT COMPLETED|Overall Study||7
11104588|NCT01249664|12288838|FG000|STARTED|Overall Study||91
11104589|NCT01249664|12288839|FG001|STARTED|Overall Study||31
11104590|NCT01249664|12288838|FG000|Participants Received Treatment|Overall Study|Safety population|91
11104591|NCT01249664|12288839|FG001|Participants Received Treatment|Overall Study|Safety population|31
11104592|NCT01249664|12288838|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
11104593|NCT01249664|12288839|FG001|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
11104594|NCT01249664|12288838|FG000|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
11104595|NCT01249664|12288839|FG001|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
11104596|NCT01249664|12288838|FG000|Completed 48 Weeks Treatment|Overall Study||78
11104597|NCT01249664|12288839|FG001|Completed 48 Weeks Treatment|Overall Study||24
11104598|NCT01249664|12288838|FG000|COMPLETED|Overall Study|Completers of study visits up to week 48|85
11104599|NCT01249664|12288839|FG001|COMPLETED|Overall Study|Completers of study visits up to week 48|31
11104600|NCT01249664|12288838|FG000|NOT COMPLETED|Overall Study||6
11104601|NCT01249664|12288839|FG001|NOT COMPLETED|Overall Study||0
11104602|NCT01249833|12288849|FG000|STARTED|Overall Study||59
11104603|NCT01249833|12288850|FG001|STARTED|Overall Study||63
11104604|NCT01249833|12288849|FG000|COMPLETED|Overall Study||59
11104605|NCT01249833|12288850|FG001|COMPLETED|Overall Study||62
11104606|NCT01249833|12288849|FG000|NOT COMPLETED|Overall Study||0
11104607|NCT01249833|12288850|FG001|NOT COMPLETED|Overall Study||1
11104608|NCT01249872|12288862|FG000|STARTED|Overall Study||16
11104609|NCT01249872|12288863|FG001|STARTED|Overall Study||16
11104610|NCT01249872|12288864|FG002|STARTED|Overall Study||16
11104611|NCT01249872|12288865|FG003|STARTED|Overall Study||16
11104612|NCT01249872|12288866|FG004|STARTED|Overall Study||16
11104613|NCT01249872|12288867|FG005|STARTED|Overall Study||16
11104614|NCT01249872|12288862|FG000|COMPLETED|Overall Study||16
11104615|NCT01249872|12288863|FG001|COMPLETED|Overall Study||16
11104616|NCT01249872|12288864|FG002|COMPLETED|Overall Study||16
11104617|NCT01249872|12288865|FG003|COMPLETED|Overall Study||16
11104618|NCT01249872|12288866|FG004|COMPLETED|Overall Study||16
11104619|NCT01249872|12288867|FG005|COMPLETED|Overall Study||16
11104620|NCT01249872|12288862|FG000|NOT COMPLETED|Overall Study||0
11104621|NCT01249872|12288863|FG001|NOT COMPLETED|Overall Study||0
11104622|NCT01249872|12288864|FG002|NOT COMPLETED|Overall Study||0
11104623|NCT01249872|12288865|FG003|NOT COMPLETED|Overall Study||0
11104624|NCT01249872|12288866|FG004|NOT COMPLETED|Overall Study||0
11104625|NCT01249872|12288867|FG005|NOT COMPLETED|Overall Study||0
11104626|NCT01250002|12288891|FG000|STARTED|Overall Study||35
11104627|NCT01250002|12288892|FG001|STARTED|Overall Study||35
11104628|NCT01250002|12288891|FG000|COMPLETED|Overall Study||31
11104629|NCT01250002|12288892|FG001|COMPLETED|Overall Study||32
11104630|NCT01250002|12288891|FG000|NOT COMPLETED|Overall Study||4
11104631|NCT01250002|12288892|FG001|NOT COMPLETED|Overall Study||3
11104632|NCT01250054|12288898|FG000|STARTED|Period 1, One Week of Wear||8
11104633|NCT01250054|12288899|FG001|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
11104634|NCT01250054|12288898|FG000|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
11104635|NCT01250054|12288899|FG001|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
11104636|NCT01250054|12288898|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
11104637|NCT01250054|12288899|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
11104638|NCT01250054|12288898|FG000|STARTED|Period 2, One Week of Wear||7
11104639|NCT01250054|12288899|FG001|STARTED|Period 2, One Week of Wear||8
11104640|NCT01250054|12288898|FG000|COMPLETED|Period 2, One Week of Wear||6
11104641|NCT01250054|12288899|FG001|COMPLETED|Period 2, One Week of Wear||8
11104642|NCT01250054|12288898|FG000|NOT COMPLETED|Period 2, One Week of Wear||1
10842457|NCT01854775|12007987|FG000|STARTED|Treatment Phase (48 Weeks)||50
10842458|NCT01854775|12007988|FG001|STARTED|Treatment Phase (48 Weeks)||52
10842459|NCT01854775|12007989|FG002|STARTED|Treatment Phase (48 Weeks)||27
10842460|NCT01854775|12007987|FG000|COMPLETED|Treatment Phase (48 Weeks)||48
10842461|NCT01854775|12007988|FG001|COMPLETED|Treatment Phase (48 Weeks)||51
10842462|NCT01854775|12007989|FG002|COMPLETED|Treatment Phase (48 Weeks)||18
10842463|NCT01854775|12007987|FG000|NOT COMPLETED|Treatment Phase (48 Weeks)||2
10842464|NCT01854775|12007988|FG001|NOT COMPLETED|Treatment Phase (48 Weeks)||1
10842465|NCT01854775|12007989|FG002|NOT COMPLETED|Treatment Phase (48 Weeks)||9
10842466|NCT01854775|12007987|FG000|STARTED|Extension Phase||48
10842467|NCT01854775|12007988|FG001|STARTED|Extension Phase||50
10842468|NCT01854775|12007989|FG002|STARTED|Extension Phase||18
10842469|NCT01854775|12007987|FG000|COMPLETED|Extension Phase||9
10842470|NCT01854775|12007988|FG001|COMPLETED|Extension Phase||3
10842471|NCT01854775|12007989|FG002|COMPLETED|Extension Phase||0
10842472|NCT01854775|12007987|FG000|NOT COMPLETED|Extension Phase||39
10842473|NCT01854775|12007988|FG001|NOT COMPLETED|Extension Phase||47
10842474|NCT01854775|12007989|FG002|NOT COMPLETED|Extension Phase||18
11104643|NCT01250054|12288899|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
11104644|NCT01250119|12288905|FG000|STARTED|Diagnostic Phase||688
11104645|NCT01250119|12288906|FG001|STARTED|Diagnostic Phase||0
11104646|NCT01250119|12288905|FG000|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
11104647|NCT01250119|12288906|FG001|COMPLETED|Diagnostic Phase||0
11104648|NCT01250119|12288905|FG000|NOT COMPLETED|Diagnostic Phase||113
11104649|NCT01250119|12288906|FG001|NOT COMPLETED|Diagnostic Phase||0
11104650|NCT01250119|12288905|FG000|STARTED|Treatment Phase||0
11104651|NCT01250119|12288906|FG001|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
11104652|NCT01250119|12288905|FG000|COMPLETED|Treatment Phase||0
11104653|NCT01250119|12288906|FG001|COMPLETED|Treatment Phase||0
10842486|NCT01839331|12008015|FG000|STARTED|Overall Study||83
10842487|NCT01839331|12008016|FG001|STARTED|Overall Study||83
10842488|NCT01839331|12008017|FG002|STARTED|Overall Study||82
10842489|NCT01839331|12008018|FG003|STARTED|Overall Study||81
10842490|NCT01839331|12008015|FG000|Week 6|Overall Study||83
10842491|NCT01839331|12008016|FG001|Week 6|Overall Study||83
10842492|NCT01839331|12008017|FG002|Week 6|Overall Study||82
10842493|NCT01839331|12008018|FG003|Week 6|Overall Study||81
10842494|NCT01839331|12008015|FG000|COMPLETED|Overall Study||79
10842495|NCT01839331|12008016|FG001|COMPLETED|Overall Study||77
10842496|NCT01839331|12008017|FG002|COMPLETED|Overall Study||77
10842497|NCT01839331|12008018|FG003|COMPLETED|Overall Study||76
10842498|NCT01839331|12008015|FG000|NOT COMPLETED|Overall Study||4
10842499|NCT01839331|12008016|FG001|NOT COMPLETED|Overall Study||6
10842500|NCT01839331|12008017|FG002|NOT COMPLETED|Overall Study||5
10842501|NCT01839331|12008018|FG003|NOT COMPLETED|Overall Study||5
11104654|NCT01250119|12288905|FG000|NOT COMPLETED|Treatment Phase||0
11104655|NCT01250119|12288906|FG001|NOT COMPLETED|Treatment Phase||41
11222672|NCT01972776|12414373|FG001|COMPLETED|Part 2||0
11222673|NCT01972776|12414374|FG002|COMPLETED|Part 2||0
11222674|NCT01972776|12414375|FG003|COMPLETED|Part 2||0
11222675|NCT01972776|12414376|FG004|COMPLETED|Part 2||1
11222676|NCT01972776|12414377|FG005|COMPLETED|Part 2||0
11222677|NCT01972776|12414372|FG000|NOT COMPLETED|Part 2||0
11222678|NCT01972776|12414373|FG001|NOT COMPLETED|Part 2||0
11222679|NCT01972776|12414374|FG002|NOT COMPLETED|Part 2||0
11222680|NCT01972776|12414375|FG003|NOT COMPLETED|Part 2||0
11222681|NCT01972776|12414376|FG004|NOT COMPLETED|Part 2||13
11222682|NCT01972776|12414377|FG005|NOT COMPLETED|Part 2||7
11222683|NCT01972789|12414393|FG000|STARTED|Overall Study||174
11222684|NCT01972789|12414394|FG001|STARTED|Overall Study||175
11222685|NCT01972789|12414393|FG000|COMPLETED|Overall Study||134
10842508|NCT01709123|12008047|FG000|STARTED|Overall Study||31
10842509|NCT01709123|12008048|FG001|STARTED|Overall Study||31
10842510|NCT01709123|12008047|FG000|COMPLETED|Overall Study||22
10842511|NCT01709123|12008048|FG001|COMPLETED|Overall Study||22
10842512|NCT01709123|12008047|FG000|NOT COMPLETED|Overall Study||9
10842513|NCT01709123|12008048|FG001|NOT COMPLETED|Overall Study||9
10842514|NCT01235234|12008057|FG000|STARTED|Overall Study||77
10842515|NCT01235234|12008058|FG001|STARTED|Overall Study||78
10842516|NCT01235234|12008059|FG002|STARTED|Overall Study||81
10842517|NCT01235234|12008057|FG000|COMPLETED|Overall Study||75
10842518|NCT01235234|12008058|FG001|COMPLETED|Overall Study||76
10842519|NCT01235234|12008059|FG002|COMPLETED|Overall Study||80
10842520|NCT01235234|12008057|FG000|NOT COMPLETED|Overall Study||2
10842521|NCT01235234|12008058|FG001|NOT COMPLETED|Overall Study||2
10842522|NCT01235234|12008059|FG002|NOT COMPLETED|Overall Study||1
11222686|NCT01972789|12414394|FG001|COMPLETED|Overall Study||145
11222687|NCT01972789|12414393|FG000|NOT COMPLETED|Overall Study||40
11222688|NCT01972789|12414394|FG001|NOT COMPLETED|Overall Study||30
10842523|NCT01160211|12008070|FG000|STARTED|Overall Study||120
10842524|NCT01160211|12008071|FG001|STARTED|Overall Study||118
10842525|NCT01160211|12008072|FG002|STARTED|Overall Study||117
10842526|NCT01160211|12008070|FG000|Ongoing|Overall Study||90
10842527|NCT01160211|12008071|FG001|Ongoing|Overall Study||75
10842528|NCT01160211|12008072|FG002|Ongoing|Overall Study||79
10842529|NCT01160211|12008070|FG000|COMPLETED|Overall Study||21
10842530|NCT01160211|12008071|FG001|COMPLETED|Overall Study||31
10842531|NCT01160211|12008072|FG002|COMPLETED|Overall Study||30
10842532|NCT01160211|12008070|FG000|NOT COMPLETED|Overall Study||99
10842533|NCT01160211|12008071|FG001|NOT COMPLETED|Overall Study||87
10842534|NCT01160211|12008072|FG002|NOT COMPLETED|Overall Study||87
10842535|NCT01093573|12008084|FG000|STARTED|Overall Study||3
10842536|NCT01093573|12008085|FG001|STARTED|Overall Study||3
10842537|NCT01093573|12008086|FG002|STARTED|Overall Study||28
10842538|NCT01093573|12008084|FG000|COMPLETED|Overall Study||3
10842539|NCT01093573|12008085|FG001|COMPLETED|Overall Study||3
10842540|NCT01093573|12008086|FG002|COMPLETED|Overall Study||26
10842541|NCT01093573|12008084|FG000|NOT COMPLETED|Overall Study||0
10842542|NCT01093573|12008085|FG001|NOT COMPLETED|Overall Study||0
10842543|NCT01093573|12008086|FG002|NOT COMPLETED|Overall Study||2
10842544|NCT00828854|12008097|FG000|STARTED|Overall Study||27
10842545|NCT00828854|12008097|FG000|COMPLETED|Overall Study||0
10842546|NCT00828854|12008097|FG000|NOT COMPLETED|Overall Study||27
10842547|NCT00753545|12008103|FG000|STARTED|Overall Study|Patients randomized|136
10842548|NCT00753545|12008104|FG001|STARTED|Overall Study|Patients randomized|129
10842549|NCT00753545|12008103|FG000|COMPLETED|Overall Study|Patients completing the Study|28
10842550|NCT00753545|12008104|FG001|COMPLETED|Overall Study|Patients completing the Study|11
10842551|NCT00753545|12008103|FG000|NOT COMPLETED|Overall Study||108
10842552|NCT00753545|12008104|FG001|NOT COMPLETED|Overall Study||118
10842553|NCT00494234|12008112|FG000|STARTED|Overall Study||27
10842554|NCT00494234|12008113|FG001|STARTED|Overall Study||27
10842555|NCT00494234|12008112|FG000|COMPLETED|Overall Study||12
10842556|NCT00494234|12008113|FG001|COMPLETED|Overall Study||17
10842557|NCT00494234|12008112|FG000|NOT COMPLETED|Overall Study||15
10842558|NCT00494234|12008113|FG001|NOT COMPLETED|Overall Study||10
10842559|NCT04884191|12008126|FG000|STARTED|Overall Study||55
10842560|NCT04884191|12008127|FG001|STARTED|Overall Study||55
10842561|NCT04884191|12008128|FG002|STARTED|Overall Study||55
10842562|NCT04884191|12008126|FG000|COMPLETED|Overall Study||52
10842563|NCT04884191|12008127|FG001|COMPLETED|Overall Study||55
10842564|NCT04884191|12008128|FG002|COMPLETED|Overall Study||54
10842565|NCT04884191|12008126|FG000|NOT COMPLETED|Overall Study||3
10842566|NCT04884191|12008127|FG001|NOT COMPLETED|Overall Study||0
10842567|NCT04884191|12008128|FG002|NOT COMPLETED|Overall Study||1
10842568|NCT04881175|12008136|FG000|STARTED|Overall Study||3
10842569|NCT04881175|12008136|FG000|COMPLETED|Overall Study||3
10842570|NCT04881175|12008136|FG000|NOT COMPLETED|Overall Study||0
10842571|NCT04881149|12008140|FG000|STARTED|Overall Study||7
10842572|NCT04881149|12008140|FG000|Control Biopsy|Overall Study||7
10842573|NCT04881149|12008140|FG000|Treatment Biopsy|Overall Study||7
10842574|NCT04881149|12008140|FG000|COMPLETED|Overall Study||7
10842575|NCT04881149|12008140|FG000|NOT COMPLETED|Overall Study||0
10842576|NCT04600076|12008145|FG000|STARTED|Overall Study||22
10842577|NCT04600076|12008145|FG000|COMPLETED|Overall Study||19
10842578|NCT04600076|12008145|FG000|NOT COMPLETED|Overall Study||3
10842579|NCT04375397|12008151|FG000|STARTED|Overall Study||22
10842580|NCT04375397|12008152|FG001|STARTED|Overall Study||24
10842581|NCT04375397|12008151|FG000|COMPLETED|Overall Study||13
10842582|NCT04375397|12008152|FG001|COMPLETED|Overall Study||18
10842583|NCT04375397|12008151|FG000|NOT COMPLETED|Overall Study||9
10842584|NCT04375397|12008152|FG001|NOT COMPLETED|Overall Study||6
10842607|NCT04048343|12008188|FG000|STARTED|Overall Study||65
10842608|NCT04048343|12008188|FG000|COMPLETED|Overall Study||65
10842609|NCT04048343|12008188|FG000|NOT COMPLETED|Overall Study||0
11104656|NCT01250145|12288915|FG000|STARTED|Overall Study||41
11104657|NCT01250145|12288916|FG001|STARTED|Overall Study||210
11104658|NCT01250145|12288915|FG000|COMPLETED|Overall Study||39
11104659|NCT01250145|12288916|FG001|COMPLETED|Overall Study||205
11104660|NCT01250145|12288915|FG000|NOT COMPLETED|Overall Study||2
11104661|NCT01250145|12288916|FG001|NOT COMPLETED|Overall Study||5
11104662|NCT01250171|12288939|FG000|STARTED|Overall Study||26
11104663|NCT01250171|12288940|FG001|STARTED|Overall Study||22
11104664|NCT01250171|12288941|FG002|STARTED|Overall Study||24
10842619|NCT03915470|12008207|FG000|STARTED|Overall Study||63
10842620|NCT03915470|12008208|FG001|STARTED|Overall Study||61
10842621|NCT03915470|12008207|FG000|COMPLETED|Overall Study|63 - 6 (discontinued intervention)|57
10842622|NCT03915470|12008208|FG001|COMPLETED|Overall Study|61-2 (discontinued intervention)|59
10842623|NCT03915470|12008207|FG000|NOT COMPLETED|Overall Study||6
10842624|NCT03915470|12008208|FG001|NOT COMPLETED|Overall Study||2
10842625|NCT03892642|12008214|FG000|STARTED|Overall Study||18
10842626|NCT03892642|12008214|FG000|COMPLETED|Overall Study||18
10842627|NCT03892642|12008214|FG000|NOT COMPLETED|Overall Study||0
10842628|NCT03881553|12008221|FG000|STARTED|Overall Study||11
10842629|NCT03881553|12008222|FG001|STARTED|Overall Study||2
10842630|NCT03881553|12008223|FG002|STARTED|Overall Study||4
10842631|NCT03881553|12008221|FG000|COMPLETED|Overall Study||10
10842585|NCT04327518|12008158|FG000|STARTED|Overall Study||125
10842586|NCT04327518|12008158|FG000|COMPLETED|Overall Study||124
10842587|NCT04327518|12008158|FG000|NOT COMPLETED|Overall Study||1
10842588|NCT04273737|12008162|FG000|STARTED|Overall Study||11
10842589|NCT04273737|12008162|FG000|COMPLETED|Overall Study||11
10842590|NCT04273737|12008162|FG000|NOT COMPLETED|Overall Study||0
10842591|NCT04267276|12008166|FG000|STARTED|Overall Study||7
10842592|NCT04267276|12008166|FG000|Treated|Overall Study||7
10842593|NCT04267276|12008166|FG000|COMPLETED|Overall Study||7
10842594|NCT04267276|12008166|FG000|NOT COMPLETED|Overall Study||0
10842595|NCT04255381|12008170|FG000|STARTED|Overall Study||20
10842596|NCT04255381|12008170|FG000|COMPLETED|Overall Study||20
10842597|NCT04255381|12008170|FG000|NOT COMPLETED|Overall Study||0
10842598|NCT04075734|12008177|FG000|STARTED|Overall Study||25
10842599|NCT04075734|12008178|FG001|STARTED|Overall Study||25
10842600|NCT04075734|12008179|FG002|STARTED|Overall Study||10
10842601|NCT04075734|12008177|FG000|COMPLETED|Overall Study||21
10842602|NCT04075734|12008178|FG001|COMPLETED|Overall Study||24
10842603|NCT04075734|12008179|FG002|COMPLETED|Overall Study||10
10842604|NCT04075734|12008177|FG000|NOT COMPLETED|Overall Study||4
10842605|NCT04075734|12008178|FG001|NOT COMPLETED|Overall Study||1
10842606|NCT04075734|12008179|FG002|NOT COMPLETED|Overall Study||0
10842632|NCT03881553|12008222|FG001|COMPLETED|Overall Study||1
10842633|NCT03881553|12008223|FG002|COMPLETED|Overall Study||3
10842634|NCT03881553|12008221|FG000|NOT COMPLETED|Overall Study||1
10842635|NCT03881553|12008222|FG001|NOT COMPLETED|Overall Study||1
10842636|NCT03881553|12008223|FG002|NOT COMPLETED|Overall Study||1
10842637|NCT03874325|12008231|FG000|STARTED|Overall Study||17
10842638|NCT03874325|12008232|FG001|STARTED|Overall Study||0
10842639|NCT03874325|12008231|FG000|COMPLETED|Overall Study||17
10842640|NCT03874325|12008232|FG001|COMPLETED|Overall Study||0
10842641|NCT03874325|12008231|FG000|NOT COMPLETED|Overall Study||0
10842642|NCT03874325|12008232|FG001|NOT COMPLETED|Overall Study||0
10842643|NCT03861611|12008239|FG000|STARTED|Overall Study||66
10842644|NCT03861611|12008240|FG001|STARTED|Overall Study||66
10842645|NCT03861611|12008241|FG002|STARTED|Overall Study||66
10842646|NCT03861611|12008239|FG000|COMPLETED|Overall Study||59
10842647|NCT03861611|12008240|FG001|COMPLETED|Overall Study||61
10842648|NCT03861611|12008241|FG002|COMPLETED|Overall Study||62
10842649|NCT03861611|12008239|FG000|NOT COMPLETED|Overall Study||7
10842650|NCT03861611|12008240|FG001|NOT COMPLETED|Overall Study||5
10842651|NCT03861611|12008241|FG002|NOT COMPLETED|Overall Study||4
10842652|NCT03860311|12008254|FG000|STARTED|Overall Study||22
10842653|NCT03860311|12008255|FG001|STARTED|Overall Study||23
10842654|NCT03860311|12008254|FG000|COMPLETED|Overall Study||22
10842655|NCT03860311|12008255|FG001|COMPLETED|Overall Study||23
10842656|NCT03860311|12008254|FG000|NOT COMPLETED|Overall Study||0
10842657|NCT03860311|12008255|FG001|NOT COMPLETED|Overall Study||0
10842658|NCT03795116|12008264|FG000|STARTED|Overall Study||10
10842659|NCT03795116|12008265|FG001|STARTED|Overall Study||10
10842660|NCT03795116|12008266|FG002|STARTED|Overall Study||10
10842661|NCT03795116|12008267|FG003|STARTED|Overall Study||10
10842662|NCT03795116|12008268|FG004|STARTED|Overall Study||10
10842663|NCT03795116|12008269|FG005|STARTED|Overall Study||10
10842664|NCT03795116|12008264|FG000|COMPLETED|Overall Study||6
10842665|NCT03795116|12008265|FG001|COMPLETED|Overall Study||6
10842666|NCT03795116|12008266|FG002|COMPLETED|Overall Study||9
10842667|NCT03795116|12008267|FG003|COMPLETED|Overall Study||9
10842668|NCT03795116|12008268|FG004|COMPLETED|Overall Study||9
10842669|NCT03795116|12008269|FG005|COMPLETED|Overall Study||9
10842670|NCT03795116|12008264|FG000|NOT COMPLETED|Overall Study||4
10842671|NCT03795116|12008265|FG001|NOT COMPLETED|Overall Study||4
10842672|NCT03795116|12008266|FG002|NOT COMPLETED|Overall Study||1
10842673|NCT03795116|12008267|FG003|NOT COMPLETED|Overall Study||1
10842674|NCT03795116|12008268|FG004|NOT COMPLETED|Overall Study||1
10842675|NCT03795116|12008269|FG005|NOT COMPLETED|Overall Study||1
10842676|NCT03750292|12008290|FG000|STARTED|First Intervention (Baseline to 8 Weeks)||5
10842677|NCT03750292|12008291|FG001|STARTED|First Intervention (Baseline to 8 Weeks)||4
10842678|NCT03750292|12008290|FG000|COMPLETED|First Intervention (Baseline to 8 Weeks)||5
10842679|NCT03750292|12008291|FG001|COMPLETED|First Intervention (Baseline to 8 Weeks)||4
10842680|NCT03750292|12008290|FG000|NOT COMPLETED|First Intervention (Baseline to 8 Weeks)||0
10842681|NCT03750292|12008291|FG001|NOT COMPLETED|First Intervention (Baseline to 8 Weeks)||0
10842682|NCT03750292|12008290|FG000|STARTED|Washout (3 Weeks)||5
10842683|NCT03750292|12008291|FG001|STARTED|Washout (3 Weeks)||4
10842684|NCT03750292|12008290|FG000|COMPLETED|Washout (3 Weeks)||5
10842685|NCT03750292|12008291|FG001|COMPLETED|Washout (3 Weeks)||4
10842686|NCT03750292|12008290|FG000|NOT COMPLETED|Washout (3 Weeks)||0
10842687|NCT03750292|12008291|FG001|NOT COMPLETED|Washout (3 Weeks)||0
10842688|NCT03750292|12008290|FG000|STARTED|Second Intervention (11 to 19 Weeks)||5
10842689|NCT03750292|12008291|FG001|STARTED|Second Intervention (11 to 19 Weeks)||4
10842690|NCT03750292|12008290|FG000|COMPLETED|Second Intervention (11 to 19 Weeks)||5
10842691|NCT03750292|12008291|FG001|COMPLETED|Second Intervention (11 to 19 Weeks)||4
10842692|NCT03750292|12008290|FG000|NOT COMPLETED|Second Intervention (11 to 19 Weeks)||0
10842693|NCT03750292|12008291|FG001|NOT COMPLETED|Second Intervention (11 to 19 Weeks)||0
10842694|NCT03749252|12008300|FG000|STARTED|Overall Study||26
10842695|NCT03749252|12008301|FG001|STARTED|Overall Study||23
10842696|NCT03749252|12008302|FG002|STARTED|Overall Study||31
10842697|NCT03749252|12008300|FG000|COMPLETED|Overall Study||26
10842698|NCT03749252|12008301|FG001|COMPLETED|Overall Study||23
10842699|NCT03749252|12008302|FG002|COMPLETED|Overall Study||31
10842700|NCT03749252|12008300|FG000|NOT COMPLETED|Overall Study||0
10842701|NCT03749252|12008301|FG001|NOT COMPLETED|Overall Study||0
10842702|NCT03749252|12008302|FG002|NOT COMPLETED|Overall Study||0
10842703|NCT03718000|12008312|FG000|STARTED|Overall Study||55
10842704|NCT03718000|12008313|FG001|STARTED|Overall Study||56
10842705|NCT03718000|12008312|FG000|COMPLETED|Overall Study||53
10842706|NCT03718000|12008313|FG001|COMPLETED|Overall Study||51
10842707|NCT03718000|12008312|FG000|NOT COMPLETED|Overall Study||2
10842708|NCT03718000|12008313|FG001|NOT COMPLETED|Overall Study||5
11104665|NCT01250171|12288939|FG000|COMPLETED|Overall Study||25
11104666|NCT01250171|12288940|FG001|COMPLETED|Overall Study||22
11104667|NCT01250171|12288941|FG002|COMPLETED|Overall Study||24
11104668|NCT01250171|12288939|FG000|NOT COMPLETED|Overall Study||1
11104669|NCT01250171|12288940|FG001|NOT COMPLETED|Overall Study||0
11104670|NCT01250171|12288941|FG002|NOT COMPLETED|Overall Study||0
11104671|NCT01250184|12288952|FG000|STARTED|Overall Study||43
11104672|NCT01250184|12288953|FG001|STARTED|Overall Study||41
11104673|NCT01250184|12288954|FG002|STARTED|Overall Study||43
11104674|NCT01250184|12288952|FG000|COMPLETED|Overall Study||43
11104675|NCT01250184|12288953|FG001|COMPLETED|Overall Study||41
11104676|NCT01250184|12288954|FG002|COMPLETED|Overall Study||43
11104677|NCT01250184|12288952|FG000|NOT COMPLETED|Overall Study||0
11104678|NCT01250184|12288953|FG001|NOT COMPLETED|Overall Study||0
11104679|NCT01250184|12288954|FG002|NOT COMPLETED|Overall Study||0
11104680|NCT01250210|12288965|FG000|STARTED|Overall Study||45
11104681|NCT01250210|12288966|FG001|STARTED|Overall Study||45
11104682|NCT01250210|12288967|FG002|STARTED|Overall Study||33
11104683|NCT01250210|12288965|FG000|COMPLETED|Overall Study||41
11104684|NCT01250210|12288966|FG001|COMPLETED|Overall Study||41
11104685|NCT01250210|12288967|FG002|COMPLETED|Overall Study||25
10842730|NCT03698409|12008349|FG000|STARTED|Overall Study||39
10842731|NCT03698409|12008350|FG001|STARTED|Overall Study||29
10842732|NCT03698409|12008349|FG000|COMPLETED|Overall Study||39
10842733|NCT03698409|12008350|FG001|COMPLETED|Overall Study||29
10842734|NCT03698409|12008349|FG000|NOT COMPLETED|Overall Study||0
10842735|NCT03698409|12008350|FG001|NOT COMPLETED|Overall Study||0
10842736|NCT03654651|12008358|FG000|STARTED|First Intervention (6 Weeks)||26
10842737|NCT03654651|12008359|FG001|STARTED|First Intervention (6 Weeks)||25
10842738|NCT03654651|12008358|FG000|COMPLETED|First Intervention (6 Weeks)||25
10842739|NCT03654651|12008359|FG001|COMPLETED|First Intervention (6 Weeks)||25
10842740|NCT03654651|12008358|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
10842741|NCT03654651|12008359|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10842742|NCT03654651|12008358|FG000|STARTED|Washout Period (2-weeks)||25
10842743|NCT03654651|12008359|FG001|STARTED|Washout Period (2-weeks)||25
10842744|NCT03654651|12008358|FG000|COMPLETED|Washout Period (2-weeks)||25
10842745|NCT03654651|12008359|FG001|COMPLETED|Washout Period (2-weeks)||25
10842746|NCT03654651|12008358|FG000|NOT COMPLETED|Washout Period (2-weeks)||0
10842747|NCT03654651|12008359|FG001|NOT COMPLETED|Washout Period (2-weeks)||0
10842748|NCT03654651|12008358|FG000|STARTED|Second Intervention (6 Weeks)||25
10842749|NCT03654651|12008359|FG001|STARTED|Second Intervention (6 Weeks)||25
10842750|NCT03654651|12008358|FG000|COMPLETED|Second Intervention (6 Weeks)||25
10842751|NCT03654651|12008359|FG001|COMPLETED|Second Intervention (6 Weeks)||25
10842752|NCT03654651|12008358|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10842753|NCT03654651|12008359|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10842754|NCT03633396|12008368|FG000|STARTED|Overall Study||29
10842755|NCT03633396|12008369|FG001|STARTED|Overall Study||30
10842756|NCT03633396|12008368|FG000|COMPLETED|Overall Study||23
10842757|NCT03633396|12008369|FG001|COMPLETED|Overall Study||24
10842758|NCT03633396|12008368|FG000|NOT COMPLETED|Overall Study||6
10842759|NCT03633396|12008369|FG001|NOT COMPLETED|Overall Study||6
10842760|NCT03612856|12008378|FG000|STARTED|Pre-dose Period||8
10842761|NCT03612856|12008379|FG001|STARTED|Pre-dose Period||10
10842762|NCT03612856|12008380|FG002|STARTED|Pre-dose Period||9
10842763|NCT03612856|12008378|FG000|COMPLETED|Pre-dose Period||8
10842764|NCT03612856|12008379|FG001|COMPLETED|Pre-dose Period||8
10842765|NCT03612856|12008380|FG002|COMPLETED|Pre-dose Period||8
10842766|NCT03612856|12008378|FG000|NOT COMPLETED|Pre-dose Period||0
10842767|NCT03612856|12008379|FG001|NOT COMPLETED|Pre-dose Period||2
10842768|NCT03612856|12008380|FG002|NOT COMPLETED|Pre-dose Period||1
10842769|NCT03612856|12008378|FG000|STARTED|Post-dose Period||8
10842770|NCT03612856|12008379|FG001|STARTED|Post-dose Period||8
10842771|NCT03612856|12008380|FG002|STARTED|Post-dose Period||8
10842772|NCT03612856|12008378|FG000|COMPLETED|Post-dose Period||8
10842773|NCT03612856|12008379|FG001|COMPLETED|Post-dose Period||8
10842774|NCT03612856|12008380|FG002|COMPLETED|Post-dose Period||8
10842775|NCT03612856|12008378|FG000|NOT COMPLETED|Post-dose Period||0
10842776|NCT03612856|12008379|FG001|NOT COMPLETED|Post-dose Period||0
10842777|NCT03612856|12008380|FG002|NOT COMPLETED|Post-dose Period||0
10842778|NCT03607994|12008390|FG000|STARTED|Overall Study||10
10842779|NCT03607994|12008391|FG001|STARTED|Overall Study||12
10842780|NCT03607994|12008390|FG000|COMPLETED|Overall Study||9
10842781|NCT03607994|12008391|FG001|COMPLETED|Overall Study||11
10842782|NCT03607994|12008390|FG000|NOT COMPLETED|Overall Study||1
10842783|NCT03607994|12008391|FG001|NOT COMPLETED|Overall Study||1
11104686|NCT01250210|12288965|FG000|NOT COMPLETED|Overall Study||4
11104687|NCT01250210|12288966|FG001|NOT COMPLETED|Overall Study||4
11104688|NCT01250210|12288967|FG002|NOT COMPLETED|Overall Study||8
11104689|NCT01250379|12288977|FG000|STARTED|Overall Study||247
11222689|NCT01972841|12414406|FG000|STARTED|Overall Study||447
11222690|NCT01972841|12414407|FG001|STARTED|Overall Study||441
11222691|NCT01972841|12414408|FG002|STARTED|Overall Study||437
11222692|NCT01972841|12414409|FG003|STARTED|Overall Study||434
11222693|NCT01972841|12414410|FG004|STARTED|Overall Study||885
11222694|NCT01972841|12414411|FG005|STARTED|Overall Study||883
11222695|NCT01972841|12414406|FG000|COMPLETED|Overall Study||404
11222696|NCT01972841|12414407|FG001|COMPLETED|Overall Study||397
11222697|NCT01972841|12414408|FG002|COMPLETED|Overall Study||387
11222698|NCT01972841|12414409|FG003|COMPLETED|Overall Study||397
11104690|NCT01250379|12288978|FG001|STARTED|Overall Study||247
11222699|NCT01972841|12414410|FG004|COMPLETED|Overall Study||802
11222700|NCT01972841|12414411|FG005|COMPLETED|Overall Study||798
11222701|NCT01972841|12414406|FG000|NOT COMPLETED|Overall Study||43
11222702|NCT01972841|12414407|FG001|NOT COMPLETED|Overall Study||44
11222703|NCT01972841|12414408|FG002|NOT COMPLETED|Overall Study||50
11222704|NCT01972841|12414409|FG003|NOT COMPLETED|Overall Study||37
11222705|NCT01972841|12414410|FG004|NOT COMPLETED|Overall Study||83
11222706|NCT01972841|12414411|FG005|NOT COMPLETED|Overall Study||85
11222707|NCT01973036|12414427|FG000|STARTED|Overall Study||108
11222708|NCT01973036|12414428|FG001|STARTED|Overall Study||93
11222709|NCT01973036|12414427|FG000|Received Assigned Intervention|Overall Study||113
11222710|NCT01973036|12414428|FG001|Received Assigned Intervention|Overall Study||88
11222711|NCT01973036|12414427|FG000|COMPLETED|Overall Study||108
11222712|NCT01973036|12414428|FG001|COMPLETED|Overall Study||93
11222713|NCT01973036|12414427|FG000|NOT COMPLETED|Overall Study||0
11222714|NCT01973036|12414428|FG001|NOT COMPLETED|Overall Study||0
11222715|NCT01973205|12414437|FG000|STARTED|Overall Study||453
11222716|NCT01973205|12414438|FG001|STARTED|Overall Study||447
11222717|NCT01973205|12414437|FG000|COMPLETED|Overall Study||423
11222718|NCT01973205|12414438|FG001|COMPLETED|Overall Study||425
11222719|NCT01973205|12414437|FG000|NOT COMPLETED|Overall Study||30
11222720|NCT01973205|12414438|FG001|NOT COMPLETED|Overall Study||22
11222721|NCT01973218|12414446|FG000|STARTED|Overall Study||176
11222722|NCT01973218|12414447|FG001|STARTED|Overall Study||88
11104691|NCT01250379|12288977|FG000|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
11104692|NCT01250379|12288978|FG001|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
11104693|NCT01250379|12288977|FG000|NOT COMPLETED|Overall Study||202
11104694|NCT01250379|12288978|FG001|NOT COMPLETED|Overall Study||193
11104695|NCT01250418|12288986|FG000|STARTED|Overall Study||9
11104696|NCT01250418|12288987|FG001|STARTED|Overall Study||16
11104697|NCT01250418|12288986|FG000|COMPLETED|Overall Study||8
11104698|NCT01250418|12288987|FG001|COMPLETED|Overall Study||15
11222723|NCT01973218|12414446|FG000|COMPLETED|Overall Study||174
11104699|NCT01250418|12288986|FG000|NOT COMPLETED|Overall Study||1
11104700|NCT01250418|12288987|FG001|NOT COMPLETED|Overall Study||1
11104701|NCT01250509|12288995|FG000|STARTED|Overall Study||24
11104702|NCT01250509|12288996|FG001|STARTED|Overall Study||23
11104703|NCT01250509|12288995|FG000|COMPLETED|Overall Study||19
11104704|NCT01250509|12288996|FG001|COMPLETED|Overall Study||21
11222724|NCT01973218|12414447|FG001|COMPLETED|Overall Study||88
10842803|NCT03505671|12008425|FG000|STARTED|Overall Study||11
10842804|NCT03505671|12008426|FG001|STARTED|Overall Study||12
10842805|NCT03505671|12008425|FG000|COMPLETED|Overall Study||8
10842806|NCT03505671|12008426|FG001|COMPLETED|Overall Study||11
10842807|NCT03505671|12008425|FG000|NOT COMPLETED|Overall Study||3
10842808|NCT03505671|12008426|FG001|NOT COMPLETED|Overall Study||1
10842809|NCT03469999|12008432|FG000|STARTED|Overall Study||12
10842810|NCT03469999|12008432|FG000|COMPLETED|Overall Study||10
10842811|NCT03469999|12008432|FG000|NOT COMPLETED|Overall Study||2
10842812|NCT03463993|12008439|FG000|STARTED|Overall Study||253
10842813|NCT03463993|12008440|FG001|STARTED|Overall Study||253
10842814|NCT03463993|12008439|FG000|COMPLETED|Overall Study||224
10842815|NCT03463993|12008440|FG001|COMPLETED|Overall Study||227
10842816|NCT03463993|12008439|FG000|NOT COMPLETED|Overall Study||29
10842817|NCT03463993|12008440|FG001|NOT COMPLETED|Overall Study||26
11222725|NCT01973218|12414446|FG000|NOT COMPLETED|Overall Study||2
11222726|NCT01973218|12414447|FG001|NOT COMPLETED|Overall Study||0
11222727|NCT01973231|12414457|FG000|STARTED|Overall Study||202
11222728|NCT01973231|12414458|FG001|STARTED|Overall Study||202
11222729|NCT01973231|12414457|FG000|COMPLETED|Overall Study||191
11222730|NCT01973231|12414458|FG001|COMPLETED|Overall Study||190
11222731|NCT01973231|12414457|FG000|NOT COMPLETED|Overall Study||11
11222732|NCT01973231|12414458|FG001|NOT COMPLETED|Overall Study||12
11222733|NCT01973283|12414464|FG000|STARTED|Overall Study||100
11222734|NCT01973283|12414464|FG000|COMPLETED|Overall Study||96
11222735|NCT01973283|12414464|FG000|NOT COMPLETED|Overall Study||4
11222736|NCT01973335|12414474|FG000|STARTED|Overall Study||9
11222737|NCT01973335|12414475|FG001|STARTED|Overall Study||7
11222738|NCT01973335|12414476|FG002|STARTED|Overall Study||9
11222739|NCT01973335|12414477|FG003|STARTED|Overall Study||9
11222740|NCT01973335|12414474|FG000|COMPLETED|Overall Study||9
11222741|NCT01973335|12414475|FG001|COMPLETED|Overall Study||7
11222742|NCT01973335|12414476|FG002|COMPLETED|Overall Study||9
11222743|NCT01973335|12414477|FG003|COMPLETED|Overall Study||9
11222744|NCT01973335|12414474|FG000|NOT COMPLETED|Overall Study||0
11222745|NCT01973335|12414475|FG001|NOT COMPLETED|Overall Study||0
11222746|NCT01973335|12414476|FG002|NOT COMPLETED|Overall Study||0
11222747|NCT01973335|12414477|FG003|NOT COMPLETED|Overall Study||0
11222748|NCT01973348|12414491|FG000|STARTED|Overall Study||27
11222749|NCT01973348|12414492|FG001|STARTED|Overall Study||18
10842818|NCT03390101|12008449|FG000|STARTED|Weeks 0-12||85
10842819|NCT03390101|12008450|FG001|STARTED|Weeks 0-12||84
10842820|NCT03390101|12008451|FG002|STARTED|Weeks 0-12||44
10842821|NCT03390101|12008449|FG000|COMPLETED|Weeks 0-12||85
10842822|NCT03390101|12008450|FG001|COMPLETED|Weeks 0-12||82
10842823|NCT03390101|12008451|FG002|COMPLETED|Weeks 0-12||43
10842824|NCT03390101|12008449|FG000|NOT COMPLETED|Weeks 0-12||0
10842825|NCT03390101|12008450|FG001|NOT COMPLETED|Weeks 0-12||2
10842826|NCT03390101|12008451|FG002|NOT COMPLETED|Weeks 0-12||1
10842827|NCT03390101|12008449|FG000|STARTED|Weeks 12-54||85
10842828|NCT03390101|12008450|FG001|STARTED|Weeks 12-54||82
10842829|NCT03390101|12008451|FG002|STARTED|Weeks 12-54||43
10842830|NCT03390101|12008449|FG000|COMPLETED|Weeks 12-54||82
10842831|NCT03390101|12008450|FG001|COMPLETED|Weeks 12-54||78
10842832|NCT03390101|12008451|FG002|COMPLETED|Weeks 12-54||41
10842833|NCT03390101|12008449|FG000|NOT COMPLETED|Weeks 12-54||3
10842834|NCT03390101|12008450|FG001|NOT COMPLETED|Weeks 12-54||4
10842835|NCT03390101|12008451|FG002|NOT COMPLETED|Weeks 12-54||2
10842836|NCT03213158|12008459|FG000|STARTED|Overall Study||10
10842837|NCT03213158|12008459|FG000|COMPLETED|Overall Study||7
10842838|NCT03213158|12008459|FG000|NOT COMPLETED|Overall Study||3
10842839|NCT03179605|12008463|FG000|STARTED|Overall Study||22
10842840|NCT03179605|12008463|FG000|COMPLETED|Overall Study||21
10842841|NCT03179605|12008463|FG000|NOT COMPLETED|Overall Study||1
10842842|NCT03159195|12008469|FG000|STARTED|Overall Study||360
10842843|NCT03159195|12008470|FG001|STARTED|Overall Study||292
10842844|NCT03159195|12008469|FG000|COMPLETED|Overall Study||360
10842845|NCT03159195|12008470|FG001|COMPLETED|Overall Study||292
10842846|NCT03159195|12008469|FG000|NOT COMPLETED|Overall Study||0
10842847|NCT03159195|12008470|FG001|NOT COMPLETED|Overall Study||0
10842848|NCT03150862|12008484|FG000|STARTED|Overall Study||3
10842849|NCT03150862|12008485|FG001|STARTED|Overall Study||8
10842850|NCT03150862|12008486|FG002|STARTED|Overall Study||9
10842851|NCT03150862|12008487|FG003|STARTED|Overall Study||40
10842852|NCT03150862|12008488|FG004|STARTED|Overall Study||9
10842853|NCT03150862|12008489|FG005|STARTED|Overall Study||9
10842854|NCT03150862|12008490|FG006|STARTED|Overall Study||8
10842855|NCT03150862|12008491|FG007|STARTED|Overall Study||30
10842856|NCT03150862|12008484|FG000|COMPLETED|Overall Study||0
10842857|NCT03150862|12008485|FG001|COMPLETED|Overall Study||0
10842858|NCT03150862|12008486|FG002|COMPLETED|Overall Study||0
10842859|NCT03150862|12008487|FG003|COMPLETED|Overall Study||0
10842860|NCT03150862|12008488|FG004|COMPLETED|Overall Study||0
10842861|NCT03150862|12008489|FG005|COMPLETED|Overall Study||0
10842862|NCT03150862|12008490|FG006|COMPLETED|Overall Study||0
10842863|NCT03150862|12008491|FG007|COMPLETED|Overall Study||0
10842864|NCT03150862|12008484|FG000|NOT COMPLETED|Overall Study||3
10842865|NCT03150862|12008485|FG001|NOT COMPLETED|Overall Study||8
10842866|NCT03150862|12008486|FG002|NOT COMPLETED|Overall Study||9
10842867|NCT03150862|12008487|FG003|NOT COMPLETED|Overall Study||40
10842868|NCT03150862|12008488|FG004|NOT COMPLETED|Overall Study||9
10842869|NCT03150862|12008489|FG005|NOT COMPLETED|Overall Study||9
10842870|NCT03150862|12008490|FG006|NOT COMPLETED|Overall Study||8
10842871|NCT03150862|12008491|FG007|NOT COMPLETED|Overall Study||30
10842872|NCT03074695|12008520|FG000|STARTED|Overall Study||70
10842873|NCT03074695|12008521|FG001|STARTED|Overall Study||71
10842874|NCT03074695|12008520|FG000|COMPLETED|Overall Study||66
10842875|NCT03074695|12008521|FG001|COMPLETED|Overall Study||66
10842876|NCT03074695|12008520|FG000|NOT COMPLETED|Overall Study||4
10842877|NCT03074695|12008521|FG001|NOT COMPLETED|Overall Study||5
10842878|NCT03052608|12008529|FG000|STARTED|Treatment Phase||149
10842879|NCT03052608|12008530|FG001|STARTED|Treatment Phase||147
11222750|NCT01973348|12414493|FG002|STARTED|Overall Study||0
11222751|NCT01973348|12414494|FG003|STARTED|Overall Study||0
11222752|NCT01973348|12414491|FG000|COMPLETED|Overall Study||19
11222753|NCT01973348|12414492|FG001|COMPLETED|Overall Study||15
11222754|NCT01973348|12414493|FG002|COMPLETED|Overall Study||0
11222755|NCT01973348|12414494|FG003|COMPLETED|Overall Study||0
11222756|NCT01973348|12414491|FG000|NOT COMPLETED|Overall Study||8
11222757|NCT01973348|12414492|FG001|NOT COMPLETED|Overall Study||3
11222758|NCT01973348|12414493|FG002|NOT COMPLETED|Overall Study||0
11222759|NCT01973348|12414494|FG003|NOT COMPLETED|Overall Study||0
11222760|NCT01973387|12414506|FG000|STARTED|Overall Study||106
11222761|NCT01973387|12414507|FG001|STARTED|Overall Study||54
11222762|NCT01973387|12414506|FG000|Treated|Overall Study||104
11222763|NCT01973387|12414507|FG001|Treated|Overall Study||52
10842880|NCT03052608|12008529|FG000|COMPLETED|Treatment Phase||26
10842881|NCT03052608|12008530|FG001|COMPLETED|Treatment Phase||83
10842882|NCT03052608|12008529|FG000|NOT COMPLETED|Treatment Phase||123
10842883|NCT03052608|12008530|FG001|NOT COMPLETED|Treatment Phase||64
10842884|NCT03052608|12008529|FG000|STARTED|Long-Term Follow-up Phase||149
10842885|NCT03052608|12008530|FG001|STARTED|Long-Term Follow-up Phase||147
10842886|NCT03052608|12008529|FG000|COMPLETED|Long-Term Follow-up Phase||0
10842887|NCT03052608|12008530|FG001|COMPLETED|Long-Term Follow-up Phase||0
10842888|NCT03052608|12008529|FG000|NOT COMPLETED|Long-Term Follow-up Phase||149
10842889|NCT03052608|12008530|FG001|NOT COMPLETED|Long-Term Follow-up Phase||147
11104705|NCT01250509|12288995|FG000|NOT COMPLETED|Overall Study||5
11222764|NCT01973387|12414506|FG000|COMPLETED|Overall Study||0
11222765|NCT01973387|12414507|FG001|COMPLETED|Overall Study||36
11104706|NCT01250509|12288996|FG001|NOT COMPLETED|Overall Study||2
11104707|NCT01250717|12289004|FG000|STARTED|Overall Study||28
11222766|NCT01973387|12414506|FG000|NOT COMPLETED|Overall Study||106
11104708|NCT01250717|12289004|FG000|COMPLETED|Overall Study||28
11104709|NCT01250717|12289004|FG000|NOT COMPLETED|Overall Study||0
11104710|NCT01250730|12289011|FG000|STARTED|Overall Study||6
10842896|NCT02922725|12008551|FG000|STARTED|Overall Study||12
10842897|NCT02922725|12008552|FG001|STARTED|Overall Study||12
10842898|NCT02922725|12008553|FG002|STARTED|Overall Study||8
10842899|NCT02922725|12008551|FG000|COMPLETED|Overall Study||11
10842900|NCT02922725|12008552|FG001|COMPLETED|Overall Study||12
10842901|NCT02922725|12008553|FG002|COMPLETED|Overall Study||8
10842902|NCT02922725|12008551|FG000|NOT COMPLETED|Overall Study||1
10842903|NCT02922725|12008552|FG001|NOT COMPLETED|Overall Study||0
10842904|NCT02922725|12008553|FG002|NOT COMPLETED|Overall Study||0
10842905|NCT02886572|12008560|FG000|STARTED|Overall Study||40
10842906|NCT02886572|12008560|FG000|Survival Analysis Population|Overall Study||40
10842907|NCT02886572|12008560|FG000|Distant Brain Recurrence|Overall Study||32
10842908|NCT02886572|12008560|FG000|Local Recurrence|Overall Study||32
10842909|NCT02886572|12008560|FG000|Time to Neurologic Death|Overall Study||32
10842910|NCT02886572|12008560|FG000|SRS Related Adverse Events|Overall Study||32
10842911|NCT02886572|12008560|FG000|COMPLETED|Overall Study||32
10842912|NCT02886572|12008560|FG000|NOT COMPLETED|Overall Study||8
11354284|NCT03072719|12551535|FG001|NOT COMPLETED|Overall Study||1
11354285|NCT03072732|12551543|FG000|STARTED|Overall Study||20
11354286|NCT03072732|12551544|FG001|STARTED|Overall Study||20
11354287|NCT03072732|12551543|FG000|COMPLETED|Overall Study||20
11354288|NCT03072732|12551544|FG001|COMPLETED|Overall Study||20
11354289|NCT03072732|12551543|FG000|NOT COMPLETED|Overall Study||0
11354290|NCT03072732|12551544|FG001|NOT COMPLETED|Overall Study||0
11354291|NCT03072875|12551550|FG000|STARTED|Overall Study||26
11354292|NCT03072875|12551550|FG000|COMPLETED|Overall Study||25
11354293|NCT03072875|12551550|FG000|NOT COMPLETED|Overall Study||1
10842913|NCT02805257|12008566|FG000|STARTED|Overall Study||60
10842914|NCT02805257|12008567|FG001|STARTED|Overall Study||59
10842915|NCT02805257|12008566|FG000|COMPLETED|Overall Study||53
10842916|NCT02805257|12008567|FG001|COMPLETED|Overall Study||52
10842917|NCT02805257|12008566|FG000|NOT COMPLETED|Overall Study||7
10842918|NCT02805257|12008567|FG001|NOT COMPLETED|Overall Study||7
10842919|NCT02780609|12008577|FG000|STARTED|Overall Study||3
10842920|NCT02780609|12008578|FG001|STARTED|Overall Study||3
10842921|NCT02780609|12008579|FG002|STARTED|Overall Study||6
10842922|NCT02780609|12008580|FG003|STARTED|Overall Study||10
10842923|NCT02780609|12008577|FG000|COMPLETED|Overall Study||3
10842924|NCT02780609|12008578|FG001|COMPLETED|Overall Study||3
10842925|NCT02780609|12008579|FG002|COMPLETED|Overall Study||6
10842926|NCT02780609|12008580|FG003|COMPLETED|Overall Study||10
10842927|NCT02780609|12008577|FG000|NOT COMPLETED|Overall Study||0
10842928|NCT02780609|12008578|FG001|NOT COMPLETED|Overall Study||0
10842929|NCT02780609|12008579|FG002|NOT COMPLETED|Overall Study||0
10842930|NCT02780609|12008580|FG003|NOT COMPLETED|Overall Study||0
10842931|NCT02747433|12008594|FG000|STARTED|Overall Study||5
10842932|NCT02747433|12008595|FG001|STARTED|Overall Study||5
10842933|NCT02747433|12008594|FG000|COMPLETED|Overall Study||5
10842934|NCT02747433|12008595|FG001|COMPLETED|Overall Study||5
10842935|NCT02747433|12008594|FG000|NOT COMPLETED|Overall Study||0
10842936|NCT02747433|12008595|FG001|NOT COMPLETED|Overall Study||0
10842937|NCT02696564|12008606|FG000|STARTED|Overall Study||108
10842938|NCT02696564|12008607|FG001|STARTED|Overall Study||112
10842939|NCT02696564|12008606|FG000|COMPLETED|Overall Study||94
10842940|NCT02696564|12008607|FG001|COMPLETED|Overall Study||99
10842941|NCT02696564|12008606|FG000|NOT COMPLETED|Overall Study||14
10842942|NCT02696564|12008607|FG001|NOT COMPLETED|Overall Study||13
11104711|NCT01250730|12289012|FG001|STARTED|Overall Study||6
11104712|NCT01250730|12289013|FG002|STARTED|Overall Study||6
11104713|NCT01250730|12289011|FG000|COMPLETED|Overall Study||6
11104714|NCT01250730|12289012|FG001|COMPLETED|Overall Study||6
11104715|NCT01250730|12289013|FG002|COMPLETED|Overall Study||6
11104716|NCT01250730|12289011|FG000|NOT COMPLETED|Overall Study||0
11104717|NCT01250730|12289012|FG001|NOT COMPLETED|Overall Study||0
11104718|NCT01250730|12289013|FG002|NOT COMPLETED|Overall Study||0
11104719|NCT01250756|12289023|FG000|STARTED|Infant Series||161
10842952|NCT02640950|12008626|FG000|STARTED|Overall Study||31
10842953|NCT02640950|12008626|FG000|COMPLETED|Overall Study||29
10842954|NCT02640950|12008626|FG000|NOT COMPLETED|Overall Study||2
10842955|NCT02639065|12008630|FG000|STARTED|Study Treatment||37
10842956|NCT02639065|12008630|FG000|COMPLETED|Study Treatment||17
10842957|NCT02639065|12008630|FG000|NOT COMPLETED|Study Treatment||20
10842958|NCT02639065|12008630|FG000|STARTED|Follow up||37
10842959|NCT02639065|12008630|FG000|COMPLETED|Follow up||28
10842960|NCT02639065|12008630|FG000|NOT COMPLETED|Follow up||9
10842961|NCT02564263|12008636|FG000|STARTED|Overall Study||314
10842962|NCT02564263|12008637|FG001|STARTED|Overall Study||314
10842963|NCT02564263|12008636|FG000|Treated|Overall Study||314
10842964|NCT02564263|12008637|FG001|Treated|Overall Study||296
10842965|NCT02564263|12008636|FG000|COMPLETED|Overall Study||0
10842966|NCT02564263|12008637|FG001|COMPLETED|Overall Study||0
10842967|NCT02564263|12008636|FG000|NOT COMPLETED|Overall Study||314
10842968|NCT02564263|12008637|FG001|NOT COMPLETED|Overall Study||314
11104720|NCT01250756|12289024|FG001|STARTED|Infant Series||160
11104721|NCT01250756|12289023|FG000|Vaccinated Dose 1|Infant Series||159
11104722|NCT01250756|12289024|FG001|Vaccinated Dose 1|Infant Series||158
11104723|NCT01250756|12289023|FG000|Vaccinated Dose 2|Infant Series||147
11104724|NCT01250756|12289024|FG001|Vaccinated Dose 2|Infant Series||157
11104725|NCT01250756|12289023|FG000|Vaccinated Dose 3|Infant Series||133
11104726|NCT01250756|12289024|FG001|Vaccinated Dose 3|Infant Series||155
11104727|NCT01250756|12289023|FG000|COMPLETED|Infant Series||133
10842977|NCT02372136|12008654|FG000|STARTED|Overall Study||62
10842978|NCT02372136|12008655|FG001|STARTED|Overall Study||58
10842979|NCT02372136|12008654|FG000|COMPLETED|Overall Study||59
10842980|NCT02372136|12008655|FG001|COMPLETED|Overall Study||57
10842981|NCT02372136|12008654|FG000|NOT COMPLETED|Overall Study||3
10842982|NCT02372136|12008655|FG001|NOT COMPLETED|Overall Study||1
10842983|NCT02367456|12008666|FG000|STARTED|Overall Study||12
10842984|NCT02367456|12008667|FG001|STARTED|Overall Study||30
10842985|NCT02367456|12008668|FG002|STARTED|Overall Study||30
10842986|NCT02367456|12008666|FG000|COMPLETED|Overall Study||0
11354294|NCT03072953|12551555|FG000|STARTED|Overall Study||2
11354295|NCT03072953|12551555|FG000|COMPLETED|Overall Study||2
10842987|NCT02367456|12008667|FG001|COMPLETED|Overall Study||0
10842988|NCT02367456|12008668|FG002|COMPLETED|Overall Study||0
10842989|NCT02367456|12008666|FG000|NOT COMPLETED|Overall Study||12
10842990|NCT02367456|12008667|FG001|NOT COMPLETED|Overall Study||30
10842991|NCT02367456|12008668|FG002|NOT COMPLETED|Overall Study||30
11104728|NCT01250756|12289024|FG001|COMPLETED|Infant Series||153
11104729|NCT01250756|12289023|FG000|NOT COMPLETED|Infant Series||28
11104730|NCT01250756|12289024|FG001|NOT COMPLETED|Infant Series||7
11104731|NCT01250756|12289023|FG000|STARTED|After Infant Series||133
10842996|NCT02022033|12008685|FG000|STARTED|Overall Study||25
10842997|NCT02022033|12008685|FG000|COMPLETED|Overall Study||24
10842998|NCT02022033|12008685|FG000|NOT COMPLETED|Overall Study||1
11104732|NCT01250756|12289024|FG001|STARTED|After Infant Series||153
11104733|NCT01250756|12289023|FG000|COMPLETED|After Infant Series||122
11104734|NCT01250756|12289024|FG001|COMPLETED|After Infant Series||149
11104735|NCT01250756|12289023|FG000|NOT COMPLETED|After Infant Series||11
11104736|NCT01250756|12289024|FG001|NOT COMPLETED|After Infant Series||4
11104737|NCT01250756|12289023|FG000|STARTED|Toddler Dose||122
10843005|NCT01434602|12008703|FG000|STARTED|Phase I Dose Escalation||6
10843006|NCT01434602|12008704|FG001|STARTED|Phase I Dose Escalation||7
10843007|NCT01434602|12008705|FG002|STARTED|Phase I Dose Escalation||0
10843008|NCT01434602|12008706|FG003|STARTED|Phase I Dose Escalation||0
10843009|NCT01434602|12008707|FG004|STARTED|Phase I Dose Escalation||0
10843010|NCT01434602|12008703|FG000|COMPLETED|Phase I Dose Escalation||6
10843011|NCT01434602|12008704|FG001|COMPLETED|Phase I Dose Escalation||6
10843012|NCT01434602|12008705|FG002|COMPLETED|Phase I Dose Escalation||0
10843013|NCT01434602|12008706|FG003|COMPLETED|Phase I Dose Escalation||0
11222767|NCT01973387|12414507|FG001|NOT COMPLETED|Overall Study||18
11222768|NCT01973413|12414515|FG000|STARTED|Overall Study||12
11222769|NCT01973413|12414516|FG001|STARTED|Overall Study||20
11222770|NCT01973413|12414515|FG000|COMPLETED|Overall Study||11
11222771|NCT01973413|12414516|FG001|COMPLETED|Overall Study||20
11222772|NCT01973413|12414515|FG000|NOT COMPLETED|Overall Study||1
11222773|NCT01973413|12414516|FG001|NOT COMPLETED|Overall Study||0
11222774|NCT01973439|12414523|FG000|STARTED|Overall Study||23
11222775|NCT01973439|12414523|FG000|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
11222776|NCT01973439|12414523|FG000|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
11222777|NCT01973439|12414523|FG000|COMPLETED|Overall Study||18
11222778|NCT01973439|12414523|FG000|NOT COMPLETED|Overall Study||5
11222779|NCT01973491|12414527|FG000|STARTED|Baseline Control Period (8 Weeks)||37
11222780|NCT01973491|12414527|FG000|COMPLETED|Baseline Control Period (8 Weeks)||19
11222781|NCT01973491|12414527|FG000|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
11222782|NCT01973491|12414527|FG000|STARTED|Titration Period(4 Weeks)||19
11222783|NCT01973491|12414527|FG000|COMPLETED|Titration Period(4 Weeks)||19
11222784|NCT01973491|12414527|FG000|NOT COMPLETED|Titration Period(4 Weeks)||0
11222785|NCT01973491|12414527|FG000|STARTED|Treatment Period (16 Weeks)||19
11222786|NCT01973491|12414527|FG000|COMPLETED|Treatment Period (16 Weeks)||18
11222787|NCT01973491|12414527|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||1
11222788|NCT01973569|12414534|FG000|STARTED|Overall Study||228
11222789|NCT01973569|12414535|FG001|STARTED|Overall Study||225
11222790|NCT01973569|12414536|FG002|STARTED|Overall Study||226
11222791|NCT01973569|12414534|FG000|Received Study Drug|Overall Study||222
11222792|NCT01973569|12414535|FG001|Received Study Drug|Overall Study||222
11222793|NCT01973569|12414536|FG002|Received Study Drug|Overall Study||223
11222794|NCT01973569|12414534|FG000|Did Not Receive Study Drug|Overall Study||6
11222795|NCT01973569|12414535|FG001|Did Not Receive Study Drug|Overall Study||3
11222796|NCT01973569|12414536|FG002|Did Not Receive Study Drug|Overall Study||3
11222797|NCT01973569|12414534|FG000|Discontinued Study Treatment|Overall Study||23
11222798|NCT01973569|12414535|FG001|Discontinued Study Treatment|Overall Study||22
11222799|NCT01973569|12414536|FG002|Discontinued Study Treatment|Overall Study||15
11222800|NCT01973569|12414534|FG000|Discontinued Study|Overall Study||23
11222801|NCT01973569|12414535|FG001|Discontinued Study|Overall Study||22
11222802|NCT01973569|12414536|FG002|Discontinued Study|Overall Study||15
11222803|NCT01973569|12414534|FG000|COMPLETED|Overall Study||199
11222804|NCT01973569|12414535|FG001|COMPLETED|Overall Study||200
11222805|NCT01973569|12414536|FG002|COMPLETED|Overall Study||208
11222806|NCT01973569|12414534|FG000|NOT COMPLETED|Overall Study||29
11222807|NCT01973569|12414535|FG001|NOT COMPLETED|Overall Study||25
11222808|NCT01973569|12414536|FG002|NOT COMPLETED|Overall Study||18
11222809|NCT01973595|12414548|FG000|STARTED|Intervention Phase 1||15
11222810|NCT01973595|12414549|FG001|STARTED|Intervention Phase 1||14
11222811|NCT01973595|12414550|FG002|STARTED|Intervention Phase 1||15
11222812|NCT01973595|12414551|FG003|STARTED|Intervention Phase 1||14
11222813|NCT01973595|12414548|FG000|COMPLETED|Intervention Phase 1||15
11222814|NCT01973595|12414549|FG001|COMPLETED|Intervention Phase 1||14
11222815|NCT01973595|12414550|FG002|COMPLETED|Intervention Phase 1||15
11222816|NCT01973595|12414551|FG003|COMPLETED|Intervention Phase 1||14
11222817|NCT01973595|12414548|FG000|NOT COMPLETED|Intervention Phase 1||0
11222818|NCT01973595|12414549|FG001|NOT COMPLETED|Intervention Phase 1||0
11222819|NCT01973595|12414550|FG002|NOT COMPLETED|Intervention Phase 1||0
11222820|NCT01973595|12414551|FG003|NOT COMPLETED|Intervention Phase 1||0
11222821|NCT01973595|12414548|FG000|STARTED|Washout||15
11222822|NCT01973595|12414549|FG001|STARTED|Washout||14
11222823|NCT01973595|12414550|FG002|STARTED|Washout||15
11222824|NCT01973595|12414551|FG003|STARTED|Washout||14
11222825|NCT01973595|12414548|FG000|COMPLETED|Washout||14
11222826|NCT01973595|12414549|FG001|COMPLETED|Washout||14
11104738|NCT01250756|12289024|FG001|STARTED|Toddler Dose||149
11222827|NCT01973595|12414550|FG002|COMPLETED|Washout||14
11222828|NCT01973595|12414551|FG003|COMPLETED|Washout||14
11222829|NCT01973595|12414548|FG000|NOT COMPLETED|Washout||1
11222830|NCT01973595|12414549|FG001|NOT COMPLETED|Washout||0
11222831|NCT01973595|12414550|FG002|NOT COMPLETED|Washout||1
11222832|NCT01973595|12414551|FG003|NOT COMPLETED|Washout||0
11222833|NCT01973595|12414548|FG000|STARTED|Intervention Phase 2||14
10843014|NCT01434602|12008707|FG004|COMPLETED|Phase I Dose Escalation||0
11222834|NCT01973595|12414549|FG001|STARTED|Intervention Phase 2||14
11222835|NCT01973595|12414550|FG002|STARTED|Intervention Phase 2||14
11222836|NCT01973595|12414551|FG003|STARTED|Intervention Phase 2||14
11222837|NCT01973595|12414548|FG000|COMPLETED|Intervention Phase 2||14
11222838|NCT01973595|12414549|FG001|COMPLETED|Intervention Phase 2||14
11354296|NCT03072953|12551555|FG000|NOT COMPLETED|Overall Study||0
11354297|NCT03073005|12551563|FG000|STARTED|Overall Study||33
11354298|NCT03073005|12551564|FG001|STARTED|Overall Study||37
11354299|NCT03073005|12551565|FG002|STARTED|Overall Study||36
11354300|NCT03073005|12551566|FG003|STARTED|Overall Study||37
11354301|NCT03073005|12551563|FG000|Received Initial Training|Overall Study|29 pairs (29 patients plus their caregivers)|29
11354302|NCT03073005|12551564|FG001|Received Initial Training|Overall Study||29
11354303|NCT03073005|12551565|FG002|Received Initial Training|Overall Study|33 pairs (33 patients plus their caregivers)|33
10843015|NCT01434602|12008703|FG000|NOT COMPLETED|Phase I Dose Escalation||0
10843016|NCT01434602|12008704|FG001|NOT COMPLETED|Phase I Dose Escalation||1
10843017|NCT01434602|12008705|FG002|NOT COMPLETED|Phase I Dose Escalation||0
10843018|NCT01434602|12008706|FG003|NOT COMPLETED|Phase I Dose Escalation||0
10843019|NCT01434602|12008707|FG004|NOT COMPLETED|Phase I Dose Escalation||0
10843020|NCT01434602|12008703|FG000|STARTED|Phase II Recommended Phase 2 Dose||0
10843021|NCT01434602|12008704|FG001|STARTED|Phase II Recommended Phase 2 Dose||0
10843022|NCT01434602|12008705|FG002|STARTED|Phase II Recommended Phase 2 Dose||12
10843023|NCT01434602|12008706|FG003|STARTED|Phase II Recommended Phase 2 Dose||40
11354304|NCT03073005|12551566|FG003|Received Initial Training|Overall Study||33
11354305|NCT03073005|12551563|FG000|COMPLETED|Overall Study|25 pairs (25 patients plus their caregivers)|25
11354306|NCT03073005|12551564|FG001|COMPLETED|Overall Study||25
10843024|NCT01434602|12008707|FG004|STARTED|Phase II Recommended Phase 2 Dose||21
10843025|NCT01434602|12008703|FG000|COMPLETED|Phase II Recommended Phase 2 Dose||0
10843026|NCT01434602|12008704|FG001|COMPLETED|Phase II Recommended Phase 2 Dose||0
10843027|NCT01434602|12008705|FG002|COMPLETED|Phase II Recommended Phase 2 Dose||12
10843028|NCT01434602|12008706|FG003|COMPLETED|Phase II Recommended Phase 2 Dose||31
10843029|NCT01434602|12008707|FG004|COMPLETED|Phase II Recommended Phase 2 Dose||19
10843030|NCT01434602|12008703|FG000|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
10843031|NCT01434602|12008704|FG001|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
10843032|NCT01434602|12008705|FG002|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
10843033|NCT01434602|12008706|FG003|NOT COMPLETED|Phase II Recommended Phase 2 Dose||9
10843034|NCT01434602|12008707|FG004|NOT COMPLETED|Phase II Recommended Phase 2 Dose||2
10843035|NCT01358877|12008731|FG000|STARTED|Overall Study||2400
10843036|NCT01358877|12008732|FG001|STARTED|Overall Study||2404
10843037|NCT01358877|12008731|FG000|Did Not Receive Study Drug|Overall Study||22
10843038|NCT01358877|12008732|FG001|Did Not Receive Study Drug|Overall Study||13
10843039|NCT01358877|12008731|FG000|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
10843040|NCT01358877|12008732|FG001|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
10843041|NCT01358877|12008731|FG000|COMPLETED|Overall Study||0
10843042|NCT01358877|12008732|FG001|COMPLETED|Overall Study||0
10843043|NCT01358877|12008731|FG000|NOT COMPLETED|Overall Study||2400
10843044|NCT01358877|12008732|FG001|NOT COMPLETED|Overall Study||2404
11104739|NCT01250756|12289023|FG000|COMPLETED|Toddler Dose||122
11104740|NCT01250756|12289024|FG001|COMPLETED|Toddler Dose||148
11104741|NCT01250756|12289023|FG000|NOT COMPLETED|Toddler Dose||0
11104742|NCT01250756|12289024|FG001|NOT COMPLETED|Toddler Dose||1
11104743|NCT01250756|12289023|FG000|STARTED|After Toddler Dose||0
11104744|NCT01250756|12289024|FG001|STARTED|After Toddler Dose||148
11104745|NCT01250756|12289023|FG000|COMPLETED|After Toddler Dose||0
11104746|NCT01250756|12289024|FG001|COMPLETED|After Toddler Dose||147
11104747|NCT01250756|12289023|FG000|NOT COMPLETED|After Toddler Dose||0
11104748|NCT01250756|12289024|FG001|NOT COMPLETED|After Toddler Dose||1
11104749|NCT01250769|12289040|FG000|STARTED|Overall Study||11
11104750|NCT01250769|12289041|FG001|STARTED|Overall Study||73
11104751|NCT01250769|12289042|FG002|STARTED|Overall Study||75
11104752|NCT01250769|12289043|FG003|STARTED|Overall Study||11
11104753|NCT01250769|12289040|FG000|Day 14|Overall Study||11
11104754|NCT01250769|12289041|FG001|Day 14|Overall Study||72
11104755|NCT01250769|12289042|FG002|Day 14|Overall Study||74
11104756|NCT01250769|12289043|FG003|Day 14|Overall Study||11
11104757|NCT01250769|12289040|FG000|COMPLETED|Overall Study||11
11104758|NCT01250769|12289041|FG001|COMPLETED|Overall Study||72
11104759|NCT01250769|12289042|FG002|COMPLETED|Overall Study||73
11104760|NCT01250769|12289043|FG003|COMPLETED|Overall Study||11
11104761|NCT01250769|12289040|FG000|NOT COMPLETED|Overall Study||0
11104762|NCT01250769|12289041|FG001|NOT COMPLETED|Overall Study||1
11104763|NCT01250769|12289042|FG002|NOT COMPLETED|Overall Study||2
11104764|NCT01250769|12289043|FG003|NOT COMPLETED|Overall Study||0
11104765|NCT01250834|12289053|FG000|STARTED|Overall Study||27
11104766|NCT01250834|12289053|FG000|COMPLETED|Overall Study||27
11104767|NCT01250834|12289053|FG000|NOT COMPLETED|Overall Study||0
11354307|NCT03073005|12551565|FG002|COMPLETED|Overall Study|24 pairs (24 patients plus their caregivers)|24
10843045|NCT01239797|12008740|FG000|STARTED|Randomized Participants||321
10843046|NCT01239797|12008741|FG001|STARTED|Randomized Participants||325
10843047|NCT01239797|12008740|FG000|COMPLETED|Randomized Participants||319
11104768|NCT01250873|12289060|FG000|STARTED|Period 1: LY2216684 (Days 1-3)||20
11104769|NCT01250873|12289060|FG000|COMPLETED|Period 1: LY2216684 (Days 1-3)||18
11104770|NCT01250873|12289060|FG000|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2
11104771|NCT01250873|12289060|FG000|STARTED|Period 2: Sertraline (Day 4, 5-10)||18
11104772|NCT01250873|12289060|FG000|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18
11104773|NCT01250873|12289060|FG000|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0
11104774|NCT01250873|12289060|FG000|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18
11104775|NCT01250873|12289060|FG000|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17
11104776|NCT01250873|12289060|FG000|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1
11222839|NCT01973595|12414550|FG002|COMPLETED|Intervention Phase 2||14
11222840|NCT01973595|12414551|FG003|COMPLETED|Intervention Phase 2||14
11222841|NCT01973595|12414548|FG000|NOT COMPLETED|Intervention Phase 2||0
11222842|NCT01973595|12414549|FG001|NOT COMPLETED|Intervention Phase 2||0
11222843|NCT01973595|12414550|FG002|NOT COMPLETED|Intervention Phase 2||0
10843048|NCT01239797|12008741|FG001|COMPLETED|Randomized Participants||316
10843049|NCT01239797|12008740|FG000|NOT COMPLETED|Randomized Participants||2
10843050|NCT01239797|12008741|FG001|NOT COMPLETED|Randomized Participants||9
10843051|NCT01239797|12008740|FG000|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
10843052|NCT01239797|12008741|FG001|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
10843053|NCT01239797|12008740|FG000|COMPLETED|Treated Participants||0
10843054|NCT01239797|12008741|FG001|COMPLETED|Treated Participants||0
10843055|NCT01239797|12008740|FG000|NOT COMPLETED|Treated Participants||318
10843056|NCT01239797|12008741|FG001|NOT COMPLETED|Treated Participants||317
10843057|NCT01236521|12008749|FG000|STARTED|Overall Study||131
10843058|NCT01236521|12008750|FG001|STARTED|Overall Study||130
10843059|NCT01236521|12008749|FG000|3-month Completed|Overall Study||122
10843060|NCT01236521|12008750|FG001|3-month Completed|Overall Study||118
10843061|NCT01236521|12008749|FG000|6-month Completed|Overall Study||121
10843062|NCT01236521|12008750|FG001|6-month Completed|Overall Study||114
10843063|NCT01236521|12008749|FG000|9-month Completed|Overall Study||105
10843064|NCT01236521|12008750|FG001|9-month Completed|Overall Study||98
10843065|NCT01236521|12008749|FG000|12-moth Completed|Overall Study||108
10843066|NCT01236521|12008750|FG001|12-moth Completed|Overall Study||105
10843067|NCT01236521|12008749|FG000|COMPLETED|Overall Study||108
10843068|NCT01236521|12008750|FG001|COMPLETED|Overall Study||105
10843069|NCT01236521|12008749|FG000|NOT COMPLETED|Overall Study||23
10843070|NCT01236521|12008750|FG001|NOT COMPLETED|Overall Study||25
10843071|NCT01103349|12008759|FG000|STARTED|Overall Study||95
10843072|NCT01103349|12008760|FG001|STARTED|Overall Study||81
10843073|NCT01103349|12008761|FG002|STARTED|Overall Study||67
10843074|NCT01103349|12008759|FG000|COMPLETED|Overall Study||84
10843075|NCT01103349|12008760|FG001|COMPLETED|Overall Study||74
10843076|NCT01103349|12008761|FG002|COMPLETED|Overall Study||63
10843077|NCT01103349|12008759|FG000|NOT COMPLETED|Overall Study||11
10843078|NCT01103349|12008760|FG001|NOT COMPLETED|Overall Study||7
10843079|NCT01103349|12008761|FG002|NOT COMPLETED|Overall Study||4
10843080|NCT01092143|12008774|FG000|STARTED|Overall Study||78
10843081|NCT01092143|12008775|FG001|STARTED|Overall Study||77
10843082|NCT01092143|12008776|FG002|STARTED|Overall Study||84
10843083|NCT01092143|12008777|FG003|STARTED|Overall Study||79
10843084|NCT01092143|12008778|FG004|STARTED|Overall Study||71
10843085|NCT01092143|12008774|FG000|Treated|Overall Study||78
10843086|NCT01092143|12008775|FG001|Treated|Overall Study||77
10843087|NCT01092143|12008776|FG002|Treated|Overall Study||83
10843088|NCT01092143|12008777|FG003|Treated|Overall Study||79
10843089|NCT01092143|12008778|FG004|Treated|Overall Study||71
10843090|NCT01092143|12008774|FG000|COMPLETED|Overall Study||63
10843091|NCT01092143|12008775|FG001|COMPLETED|Overall Study||70
10843092|NCT01092143|12008776|FG002|COMPLETED|Overall Study||80
10843093|NCT01092143|12008777|FG003|COMPLETED|Overall Study||72
10843094|NCT01092143|12008778|FG004|COMPLETED|Overall Study||63
10843095|NCT01092143|12008774|FG000|NOT COMPLETED|Overall Study||15
10843096|NCT01092143|12008775|FG001|NOT COMPLETED|Overall Study||7
10843097|NCT01092143|12008776|FG002|NOT COMPLETED|Overall Study||4
10843098|NCT01092143|12008777|FG003|NOT COMPLETED|Overall Study||7
10843099|NCT01092143|12008778|FG004|NOT COMPLETED|Overall Study||8
10843100|NCT01004029|12008792|FG000|STARTED|Overall Study||578
10843101|NCT01004029|12008793|FG001|STARTED|Overall Study||1130
10843102|NCT01004029|12008792|FG000|Safety Population|Overall Study||578
10843103|NCT01004029|12008793|FG001|Safety Population|Overall Study||1128
10843104|NCT01004029|12008792|FG000|COMPLETED|Overall Study||530
10843105|NCT01004029|12008793|FG001|COMPLETED|Overall Study||1057
10843106|NCT01004029|12008792|FG000|NOT COMPLETED|Overall Study||48
10843107|NCT01004029|12008793|FG001|NOT COMPLETED|Overall Study||73
10843108|NCT00640133|12008802|FG000|STARTED|Randomization Phase (Baseline-Month 3)||15
10843109|NCT00640133|12008803|FG001|STARTED|Randomization Phase (Baseline-Month 3)||12
11222844|NCT01973595|12414551|FG003|NOT COMPLETED|Intervention Phase 2||0
11222845|NCT01973608|12414566|FG000|STARTED|Overall Study||2
11222846|NCT01973608|12414567|FG001|STARTED|Overall Study||2
11222847|NCT01973608|12414568|FG002|STARTED|Overall Study||6
11222848|NCT01973608|12414569|FG003|STARTED|Overall Study||2
11222849|NCT01973608|12414566|FG000|COMPLETED|Overall Study||2
11222850|NCT01973608|12414567|FG001|COMPLETED|Overall Study||2
11222851|NCT01973608|12414568|FG002|COMPLETED|Overall Study||6
11222852|NCT01973608|12414569|FG003|COMPLETED|Overall Study||2
11222853|NCT01973608|12414566|FG000|NOT COMPLETED|Overall Study||0
11222854|NCT01973608|12414567|FG001|NOT COMPLETED|Overall Study||0
11222855|NCT01973608|12414568|FG002|NOT COMPLETED|Overall Study||0
11222856|NCT01973608|12414569|FG003|NOT COMPLETED|Overall Study||0
10843110|NCT00640133|12008802|FG000|COMPLETED|Randomization Phase (Baseline-Month 3)||15
10843111|NCT00640133|12008803|FG001|COMPLETED|Randomization Phase (Baseline-Month 3)||12
10843112|NCT00640133|12008802|FG000|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
10843113|NCT00640133|12008803|FG001|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
10843114|NCT00640133|12008802|FG000|STARTED|Open Label Phase (Month 4-12)||27
10843115|NCT00640133|12008803|FG001|STARTED|Open Label Phase (Month 4-12)||0
10843116|NCT00640133|12008802|FG000|COMPLETED|Open Label Phase (Month 4-12)||24
10843117|NCT00640133|12008803|FG001|COMPLETED|Open Label Phase (Month 4-12)||0
10843118|NCT00640133|12008802|FG000|NOT COMPLETED|Open Label Phase (Month 4-12)||3
10843119|NCT00640133|12008803|FG001|NOT COMPLETED|Open Label Phase (Month 4-12)||0
10843120|NCT00593567|12008813|FG000|STARTED|Overall Study||48
10843121|NCT00593567|12008814|FG001|STARTED|Overall Study||22
10843122|NCT00593567|12008813|FG000|COMPLETED|Overall Study||28
10843123|NCT00593567|12008814|FG001|COMPLETED|Overall Study||12
10843124|NCT00593567|12008813|FG000|NOT COMPLETED|Overall Study||20
10843125|NCT00593567|12008814|FG001|NOT COMPLETED|Overall Study||10
10843136|NCT02983617|12008831|FG000|STARTED|Overall Study||6
10843137|NCT02983617|12008832|FG001|STARTED|Overall Study||30
10843138|NCT02983617|12008831|FG000|COMPLETED|Overall Study||6
10843139|NCT02983617|12008832|FG001|COMPLETED|Overall Study||21
10843140|NCT02983617|12008831|FG000|NOT COMPLETED|Overall Study||0
10843141|NCT02983617|12008832|FG001|NOT COMPLETED|Overall Study||9
10843142|NCT02964377|12008841|FG000|STARTED|Overall Study||5
10843143|NCT02964377|12008842|FG001|STARTED|Overall Study||5
10843144|NCT02964377|12008843|FG002|STARTED|Overall Study||5
10843145|NCT02964377|12008841|FG000|COMPLETED|Overall Study||5
10843146|NCT02964377|12008842|FG001|COMPLETED|Overall Study||5
10843147|NCT02964377|12008843|FG002|COMPLETED|Overall Study||5
10843148|NCT02964377|12008841|FG000|NOT COMPLETED|Overall Study||0
10843149|NCT02964377|12008842|FG001|NOT COMPLETED|Overall Study||0
10843150|NCT02964377|12008843|FG002|NOT COMPLETED|Overall Study||0
10843151|NCT02790034|12008854|FG000|STARTED|Overall Study||33
10843152|NCT02790034|12008855|FG001|STARTED|Overall Study||56
10843153|NCT02790034|12008856|FG002|STARTED|Overall Study||40
10843154|NCT02790034|12008854|FG000|COMPLETED|Overall Study||27
10843155|NCT02790034|12008855|FG001|COMPLETED|Overall Study||46
10843156|NCT02790034|12008856|FG002|COMPLETED|Overall Study||36
10843157|NCT02790034|12008854|FG000|NOT COMPLETED|Overall Study||6
10843158|NCT02790034|12008855|FG001|NOT COMPLETED|Overall Study||10
10843159|NCT02790034|12008856|FG002|NOT COMPLETED|Overall Study||4
10843160|NCT02649946|12008866|FG000|STARTED|Overall Study||142
10843161|NCT02649946|12008867|FG001|STARTED|Overall Study||138
10843162|NCT02649946|12008866|FG000|COMPLETED|Overall Study||130
10843163|NCT02649946|12008867|FG001|COMPLETED|Overall Study||123
10843164|NCT02649946|12008866|FG000|NOT COMPLETED|Overall Study||12
10843165|NCT02649946|12008867|FG001|NOT COMPLETED|Overall Study||15
11104777|NCT01250899|12289068|FG000|STARTED|Overall Study||40
11104778|NCT01250899|12289069|FG001|STARTED|Overall Study||82
11104779|NCT01250899|12289068|FG000|COMPLETED|Overall Study||40
11104780|NCT01250899|12289069|FG001|COMPLETED|Overall Study||82
11104781|NCT01250899|12289068|FG000|NOT COMPLETED|Overall Study||0
11104782|NCT01250899|12289069|FG001|NOT COMPLETED|Overall Study||0
11104783|NCT01250925|12289076|FG000|STARTED|Overall Study||31
11104784|NCT01250925|12289077|FG001|STARTED|Overall Study||31
11104785|NCT01250925|12289078|FG002|STARTED|Overall Study||32
11104786|NCT01250925|12289076|FG000|COMPLETED|Overall Study||26
11104787|NCT01250925|12289077|FG001|COMPLETED|Overall Study||28
11104788|NCT01250925|12289078|FG002|COMPLETED|Overall Study||30
11104789|NCT01250925|12289076|FG000|NOT COMPLETED|Overall Study||5
11104790|NCT01250925|12289077|FG001|NOT COMPLETED|Overall Study||3
11104791|NCT01250925|12289078|FG002|NOT COMPLETED|Overall Study||2
11104792|NCT01250977|12289088|FG000|STARTED|Overall Study||6
11104793|NCT01250977|12289089|FG001|STARTED|Overall Study||14
11104794|NCT01250977|12289088|FG000|COMPLETED|Overall Study||6
10843184|NCT02345850|12008892|FG000|STARTED|Overall Study||114
10843185|NCT02345850|12008893|FG001|STARTED|Overall Study||114
10843186|NCT02345850|12008894|FG002|STARTED|Overall Study||118
10843187|NCT02345850|12008892|FG000|COMPLETED|Overall Study||101
10843188|NCT02345850|12008893|FG001|COMPLETED|Overall Study||106
10843189|NCT02345850|12008894|FG002|COMPLETED|Overall Study||112
10843190|NCT02345850|12008892|FG000|NOT COMPLETED|Overall Study||13
10843191|NCT02345850|12008893|FG001|NOT COMPLETED|Overall Study||8
10843192|NCT02345850|12008894|FG002|NOT COMPLETED|Overall Study||6
10843193|NCT02343302|12008904|FG000|STARTED|Overall Study||1
10843194|NCT02343302|12008905|FG001|STARTED|Overall Study||1
10843195|NCT02343302|12008904|FG000|COMPLETED|Overall Study||0
10843196|NCT02343302|12008905|FG001|COMPLETED|Overall Study||0
11104795|NCT01250977|12289089|FG001|COMPLETED|Overall Study||12
11104796|NCT01250977|12289088|FG000|NOT COMPLETED|Overall Study||0
11104797|NCT01250977|12289089|FG001|NOT COMPLETED|Overall Study||2
11104798|NCT01250990|12289097|FG000|STARTED|Overall Study||11
11104799|NCT01250990|12289098|FG001|STARTED|Overall Study||11
11104800|NCT01250990|12289097|FG000|COMPLETED|Overall Study||7
11222857|NCT01973777|12414583|FG000|STARTED|Overall Study|January 2014|51
11222858|NCT01973777|12414583|FG000|One Year Follow-up|Overall Study||44
10843197|NCT02343302|12008904|FG000|NOT COMPLETED|Overall Study||1
10843198|NCT02343302|12008905|FG001|NOT COMPLETED|Overall Study||1
10843199|NCT02053584|12008911|FG000|STARTED|Overall Study||230
10843200|NCT02053584|12008911|FG000|COMPLETED|Overall Study|68 subjects (day one participants) were excluded from the final analysis.|230
10843201|NCT02053584|12008911|FG000|NOT COMPLETED|Overall Study||0
10843202|NCT01962792|12008922|FG000|STARTED|Overall Study||3
10843203|NCT01962792|12008923|FG001|STARTED|Overall Study||5
10843204|NCT01962792|12008924|FG002|STARTED|Overall Study||17
10843205|NCT01962792|12008925|FG003|STARTED|Overall Study||59
10843206|NCT01962792|12008922|FG000|COMPLETED|Overall Study||3
10843207|NCT01962792|12008923|FG001|COMPLETED|Overall Study||5
10843208|NCT01962792|12008924|FG002|COMPLETED|Overall Study||17
10843209|NCT01962792|12008925|FG003|COMPLETED|Overall Study||59
10843210|NCT01962792|12008922|FG000|NOT COMPLETED|Overall Study||0
10843211|NCT01962792|12008923|FG001|NOT COMPLETED|Overall Study||0
10843212|NCT01962792|12008924|FG002|NOT COMPLETED|Overall Study||0
10843213|NCT01962792|12008925|FG003|NOT COMPLETED|Overall Study||0
10843214|NCT01878500|12008936|FG000|STARTED|Overall Study||47
10843215|NCT01878500|12008936|FG000|COMPLETED|Overall Study||47
10843216|NCT01878500|12008936|FG000|NOT COMPLETED|Overall Study||0
10843217|NCT01464164|12008947|FG000|STARTED|Overall Study||3
10843218|NCT01464164|12008948|FG001|STARTED|Overall Study||4
10843219|NCT01464164|12008949|FG002|STARTED|Overall Study||4
10843220|NCT01464164|12008950|FG003|STARTED|Overall Study||2
10843221|NCT01464164|12008951|FG004|STARTED|Overall Study||3
10843222|NCT01464164|12008952|FG005|STARTED|Overall Study||0
10843223|NCT01464164|12008953|FG006|STARTED|Overall Study||3
10843224|NCT01464164|12008947|FG000|COMPLETED|Overall Study||3
10843225|NCT01464164|12008948|FG001|COMPLETED|Overall Study||3
10843226|NCT01464164|12008949|FG002|COMPLETED|Overall Study||2
10843227|NCT01464164|12008950|FG003|COMPLETED|Overall Study||2
10843228|NCT01464164|12008951|FG004|COMPLETED|Overall Study||3
10843229|NCT01464164|12008952|FG005|COMPLETED|Overall Study||0
10843230|NCT01464164|12008953|FG006|COMPLETED|Overall Study||1
10843231|NCT01464164|12008947|FG000|NOT COMPLETED|Overall Study||0
10843232|NCT01464164|12008948|FG001|NOT COMPLETED|Overall Study||1
10843233|NCT01464164|12008949|FG002|NOT COMPLETED|Overall Study||2
10843234|NCT01464164|12008950|FG003|NOT COMPLETED|Overall Study||0
10843235|NCT01464164|12008951|FG004|NOT COMPLETED|Overall Study||0
10843236|NCT01464164|12008952|FG005|NOT COMPLETED|Overall Study||0
10843237|NCT01464164|12008953|FG006|NOT COMPLETED|Overall Study||2
11104801|NCT01250990|12289098|FG001|COMPLETED|Overall Study||9
11104802|NCT01250990|12289097|FG000|NOT COMPLETED|Overall Study||4
11104803|NCT01250990|12289098|FG001|NOT COMPLETED|Overall Study||2
11104804|NCT01251042|12289106|FG000|STARTED|Overall Study||26
11104805|NCT01251042|12289107|FG001|STARTED|Overall Study||23
11104806|NCT01251042|12289106|FG000|COMPLETED|Overall Study||26
11104807|NCT01251042|12289107|FG001|COMPLETED|Overall Study||23
11104808|NCT01251042|12289106|FG000|NOT COMPLETED|Overall Study||0
11104809|NCT01251042|12289107|FG001|NOT COMPLETED|Overall Study||0
10843247|NCT01111565|12008983|FG000|STARTED|Phase B (Weeks 0 to 8)||137
10843248|NCT01111565|12008984|FG001|STARTED|Phase B (Weeks 0 to 8)||0
10843249|NCT01111565|12008985|FG002|STARTED|Phase B (Weeks 0 to 8)||0
10843250|NCT01111565|12008986|FG003|STARTED|Phase B (Weeks 0 to 8)||0
10843251|NCT01111565|12008987|FG004|STARTED|Phase B (Weeks 0 to 8)||0
10843252|NCT01111565|12008983|FG000|COMPLETED|Phase B (Weeks 0 to 8)||71
10843253|NCT01111565|12008984|FG001|COMPLETED|Phase B (Weeks 0 to 8)||0
10843254|NCT01111565|12008985|FG002|COMPLETED|Phase B (Weeks 0 to 8)||0
10843255|NCT01111565|12008986|FG003|COMPLETED|Phase B (Weeks 0 to 8)||0
10843256|NCT01111565|12008987|FG004|COMPLETED|Phase B (Weeks 0 to 8)||0
10843257|NCT01111565|12008983|FG000|NOT COMPLETED|Phase B (Weeks 0 to 8)||66
10843258|NCT01111565|12008984|FG001|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
10843259|NCT01111565|12008985|FG002|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
10843260|NCT01111565|12008986|FG003|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
10843261|NCT01111565|12008987|FG004|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
10843262|NCT01111565|12008983|FG000|STARTED|Phase B + and Phase C (Weeks 9 to 14)||0
10843263|NCT01111565|12008984|FG001|STARTED|Phase B + and Phase C (Weeks 9 to 14)||26
10843264|NCT01111565|12008985|FG002|STARTED|Phase B + and Phase C (Weeks 9 to 14)||16
10843265|NCT01111565|12008986|FG003|STARTED|Phase B + and Phase C (Weeks 9 to 14)||14
10843266|NCT01111565|12008987|FG004|STARTED|Phase B + and Phase C (Weeks 9 to 14)||15
10843267|NCT01111565|12008983|FG000|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0
10843268|NCT01111565|12008984|FG001|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||19
10843269|NCT01111565|12008985|FG002|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11
10843270|NCT01111565|12008986|FG003|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||10
10843271|NCT01111565|12008987|FG004|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11
10843272|NCT01111565|12008983|FG000|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0
10843273|NCT01111565|12008984|FG001|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||7
10843274|NCT01111565|12008985|FG002|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||5
10843275|NCT01111565|12008986|FG003|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4
10843276|NCT01111565|12008987|FG004|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4
10843277|NCT01092117|12008997|FG000|STARTED|Index Procedure to 1 Month||161
10843278|NCT01092117|12008997|FG000|COMPLETED|Index Procedure to 1 Month||160
10843279|NCT01092117|12008997|FG000|NOT COMPLETED|Index Procedure to 1 Month||1
10843280|NCT01092117|12008997|FG000|STARTED|1 Month||160
10843281|NCT01092117|12008997|FG000|COMPLETED|1 Month||157
10843282|NCT01092117|12008997|FG000|NOT COMPLETED|1 Month||3
10843283|NCT01092117|12008997|FG000|STARTED|6 Months||157
10843284|NCT01092117|12008997|FG000|COMPLETED|6 Months||152
10843285|NCT01092117|12008997|FG000|NOT COMPLETED|6 Months||5
10843286|NCT01092117|12008997|FG000|STARTED|12 Month||152
10843287|NCT01092117|12008997|FG000|COMPLETED|12 Month||138
10843288|NCT01092117|12008997|FG000|NOT COMPLETED|12 Month||14
10843289|NCT01092117|12008997|FG000|STARTED|Year 2||138
10843290|NCT01092117|12008997|FG000|COMPLETED|Year 2||128
10843291|NCT01092117|12008997|FG000|NOT COMPLETED|Year 2||10
10843292|NCT01092117|12008997|FG000|STARTED|Year 3||128
10843293|NCT01092117|12008997|FG000|COMPLETED|Year 3||109
10843294|NCT01092117|12008997|FG000|NOT COMPLETED|Year 3||19
10843295|NCT01092117|12008997|FG000|STARTED|Year 4||109
10843296|NCT01092117|12008997|FG000|COMPLETED|Year 4||93
10843297|NCT01092117|12008997|FG000|NOT COMPLETED|Year 4||16
10843298|NCT00950989|12009005|FG000|STARTED|Overall Study||63
10843299|NCT00950989|12009006|FG001|STARTED|Overall Study||63
10843300|NCT00950989|12009007|FG002|STARTED|Overall Study||63
10843301|NCT00950989|12009008|FG003|STARTED|Overall Study||63
10843302|NCT00950989|12009005|FG000|COMPLETED|Overall Study||59
10843303|NCT00950989|12009006|FG001|COMPLETED|Overall Study||60
10843304|NCT00950989|12009007|FG002|COMPLETED|Overall Study||60
10843305|NCT00950989|12009008|FG003|COMPLETED|Overall Study||63
10843306|NCT00950989|12009005|FG000|NOT COMPLETED|Overall Study||4
10843307|NCT00950989|12009006|FG001|NOT COMPLETED|Overall Study||3
10843308|NCT00950989|12009007|FG002|NOT COMPLETED|Overall Study||3
10843309|NCT00950989|12009008|FG003|NOT COMPLETED|Overall Study||0
10843310|NCT00489307|12009023|FG000|STARTED|Overall Study||67
10843311|NCT00489307|12009024|FG001|STARTED|Overall Study||65
10843312|NCT00489307|12009023|FG000|COMPLETED|Overall Study||43
10843313|NCT00489307|12009024|FG001|COMPLETED|Overall Study||41
10843314|NCT00489307|12009023|FG000|NOT COMPLETED|Overall Study||24
10843315|NCT00489307|12009024|FG001|NOT COMPLETED|Overall Study||24
10843316|NCT00072410|12009032|FG000|STARTED|Overall Study||3
10843317|NCT00072410|12009033|FG001|STARTED|Overall Study||4
10843318|NCT00072410|12009032|FG000|COMPLETED|Overall Study||3
10843319|NCT00072410|12009033|FG001|COMPLETED|Overall Study||1
10843320|NCT00072410|12009032|FG000|NOT COMPLETED|Overall Study||0
10843321|NCT00072410|12009033|FG001|NOT COMPLETED|Overall Study||3
11104810|NCT01251146|12289115|FG000|STARTED|Overall Study||86
10843322|NCT05057923|12009039|FG000|STARTED|Overall Study||6
10843323|NCT05057923|12009039|FG000|COMPLETED|Overall Study||6
10843324|NCT05057923|12009039|FG000|NOT COMPLETED|Overall Study||0
10843325|NCT04632706|12009047|FG000|STARTED|Overall Study||6
10843326|NCT04632706|12009048|FG001|STARTED|Overall Study||6
10843327|NCT04632706|12009049|FG002|STARTED|Overall Study||6
10843328|NCT04632706|12009050|FG003|STARTED|Overall Study||6
10843329|NCT04632706|12009047|FG000|COMPLETED|Overall Study||6
10843330|NCT04632706|12009048|FG001|COMPLETED|Overall Study||6
10843331|NCT04632706|12009049|FG002|COMPLETED|Overall Study||5
10843332|NCT04632706|12009050|FG003|COMPLETED|Overall Study||6
10843333|NCT04632706|12009047|FG000|NOT COMPLETED|Overall Study||0
10843334|NCT04632706|12009048|FG001|NOT COMPLETED|Overall Study||0
10843335|NCT04632706|12009049|FG002|NOT COMPLETED|Overall Study||1
10843336|NCT04632706|12009050|FG003|NOT COMPLETED|Overall Study||0
10843337|NCT04544358|12009064|FG000|STARTED|Overall Study||12
10843338|NCT04544358|12009065|FG001|STARTED|Overall Study||10
10843339|NCT04544358|12009064|FG000|COMPLETED|Overall Study||12
10843340|NCT04544358|12009065|FG001|COMPLETED|Overall Study||10
10843341|NCT04544358|12009064|FG000|NOT COMPLETED|Overall Study||0
10843342|NCT04544358|12009065|FG001|NOT COMPLETED|Overall Study||0
10843343|NCT04498247|12009080|FG000|STARTED|Overall Study||21
10843344|NCT04498247|12009081|FG001|STARTED|Overall Study||80
10843345|NCT04498247|12009082|FG002|STARTED|Overall Study||4
10843346|NCT04498247|12009083|FG003|STARTED|Overall Study||81
10843347|NCT04498247|12009084|FG004|STARTED|Overall Study||4
10843348|NCT04498247|12009085|FG005|STARTED|Overall Study||20
10843349|NCT04498247|12009086|FG006|STARTED|Overall Study||51
10843350|NCT04498247|12009087|FG007|STARTED|Overall Study||2
10843351|NCT04498247|12009080|FG000|Vaccination 1|Overall Study||20
10843352|NCT04498247|12009081|FG001|Vaccination 1|Overall Study||80
10843353|NCT04498247|12009082|FG002|Vaccination 1|Overall Study||4
10843354|NCT04498247|12009083|FG003|Vaccination 1|Overall Study||81
10843355|NCT04498247|12009084|FG004|Vaccination 1|Overall Study||4
10843356|NCT04498247|12009085|FG005|Vaccination 1|Overall Study||20
10843357|NCT04498247|12009086|FG006|Vaccination 1|Overall Study||51
10843358|NCT04498247|12009087|FG007|Vaccination 1|Overall Study||2
10843359|NCT04498247|12009080|FG000|Vaccination 2|Overall Study||0
10843360|NCT04498247|12009081|FG001|Vaccination 2|Overall Study||0
10843361|NCT04498247|12009082|FG002|Vaccination 2|Overall Study||4
10843362|NCT04498247|12009083|FG003|Vaccination 2|Overall Study||0
10843363|NCT04498247|12009084|FG004|Vaccination 2|Overall Study||4
10843364|NCT04498247|12009085|FG005|Vaccination 2|Overall Study||0
10843365|NCT04498247|12009086|FG006|Vaccination 2|Overall Study||0
10843366|NCT04498247|12009087|FG007|Vaccination 2|Overall Study||2
10843367|NCT04498247|12009080|FG000|COMPLETED|Overall Study||20
10843368|NCT04498247|12009081|FG001|COMPLETED|Overall Study||68
10843369|NCT04498247|12009082|FG002|COMPLETED|Overall Study||4
10843370|NCT04498247|12009083|FG003|COMPLETED|Overall Study||70
10843371|NCT04498247|12009084|FG004|COMPLETED|Overall Study||4
10843372|NCT04498247|12009085|FG005|COMPLETED|Overall Study||20
10843373|NCT04498247|12009086|FG006|COMPLETED|Overall Study||43
10843374|NCT04498247|12009087|FG007|COMPLETED|Overall Study||2
10843375|NCT04498247|12009080|FG000|NOT COMPLETED|Overall Study||1
10843376|NCT04498247|12009081|FG001|NOT COMPLETED|Overall Study||12
10843377|NCT04498247|12009082|FG002|NOT COMPLETED|Overall Study||0
10843378|NCT04498247|12009083|FG003|NOT COMPLETED|Overall Study||11
10843379|NCT04498247|12009084|FG004|NOT COMPLETED|Overall Study||0
10843380|NCT04498247|12009085|FG005|NOT COMPLETED|Overall Study||0
10843381|NCT04498247|12009086|FG006|NOT COMPLETED|Overall Study||8
10843382|NCT04498247|12009087|FG007|NOT COMPLETED|Overall Study||0
10843383|NCT04472650|12009104|FG000|STARTED|Period 1 (Up to 15 Days)||13
10843384|NCT04472650|12009105|FG001|STARTED|Period 1 (Up to 15 Days)||13
10843385|NCT04472650|12009104|FG000|COMPLETED|Period 1 (Up to 15 Days)||13
10843386|NCT04472650|12009105|FG001|COMPLETED|Period 1 (Up to 15 Days)||13
10843387|NCT04472650|12009104|FG000|NOT COMPLETED|Period 1 (Up to 15 Days)||0
10843388|NCT04472650|12009105|FG001|NOT COMPLETED|Period 1 (Up to 15 Days)||0
10843389|NCT04472650|12009104|FG000|STARTED|Washout Period (Minimum 14 Days)||13
10843390|NCT04472650|12009105|FG001|STARTED|Washout Period (Minimum 14 Days)||13
10843391|NCT04472650|12009104|FG000|COMPLETED|Washout Period (Minimum 14 Days)||12
10843392|NCT04472650|12009105|FG001|COMPLETED|Washout Period (Minimum 14 Days)||13
10843393|NCT04472650|12009104|FG000|NOT COMPLETED|Washout Period (Minimum 14 Days)||1
10843394|NCT04472650|12009105|FG001|NOT COMPLETED|Washout Period (Minimum 14 Days)||0
10843395|NCT04472650|12009104|FG000|STARTED|Period 2 (Up to 15 Days)||12
10843396|NCT04472650|12009105|FG001|STARTED|Period 2 (Up to 15 Days)||13
10843397|NCT04472650|12009104|FG000|COMPLETED|Period 2 (Up to 15 Days)||12
10843398|NCT04472650|12009105|FG001|COMPLETED|Period 2 (Up to 15 Days)||13
10843399|NCT04472650|12009104|FG000|NOT COMPLETED|Period 2 (Up to 15 Days)||0
10843400|NCT04472650|12009105|FG001|NOT COMPLETED|Period 2 (Up to 15 Days)||0
10843401|NCT04359797|12009115|FG000|STARTED|Overall Study||243
10843402|NCT04359797|12009116|FG001|STARTED|Overall Study||258
10843403|NCT04359797|12009115|FG000|COMPLETED|Overall Study||243
10843404|NCT04359797|12009116|FG001|COMPLETED|Overall Study||258
10843405|NCT04359797|12009115|FG000|NOT COMPLETED|Overall Study||0
10843406|NCT04359797|12009116|FG001|NOT COMPLETED|Overall Study||0
10843407|NCT04151290|12009122|FG000|STARTED|Overall Study||711
10843408|NCT04151290|12009122|FG000|COMPLETED|Overall Study||425
10843409|NCT04151290|12009122|FG000|NOT COMPLETED|Overall Study||286
10843410|NCT04038385|12009128|FG000|STARTED|Overall Study||160
10843411|NCT04038385|12009129|FG001|STARTED|Overall Study||137
10843412|NCT04038385|12009128|FG000|COMPLETED|Overall Study||143
10843413|NCT04038385|12009129|FG001|COMPLETED|Overall Study||130
10843414|NCT04038385|12009128|FG000|NOT COMPLETED|Overall Study||17
10843415|NCT04038385|12009129|FG001|NOT COMPLETED|Overall Study||7
11354308|NCT03073005|12551566|FG003|COMPLETED|Overall Study||24
11354309|NCT03073005|12551563|FG000|NOT COMPLETED|Overall Study||8
11354310|NCT03073005|12551564|FG001|NOT COMPLETED|Overall Study||12
11354311|NCT03073005|12551565|FG002|NOT COMPLETED|Overall Study||12
11354312|NCT03073005|12551566|FG003|NOT COMPLETED|Overall Study||13
11354313|NCT03073109|12551581|FG000|STARTED|Overall Study||100
11354314|NCT03073109|12551582|FG001|STARTED|Overall Study||70
10843416|NCT03923738|12009135|FG000|STARTED|Period 1||24
10843417|NCT03923738|12009135|FG000|COMPLETED|Period 1||22
10843418|NCT03923738|12009135|FG000|NOT COMPLETED|Period 1||2
10843419|NCT03923738|12009135|FG000|STARTED|Period 2||22
10843420|NCT03923738|12009135|FG000|COMPLETED|Period 2||22
10843421|NCT03923738|12009135|FG000|NOT COMPLETED|Period 2||0
10843422|NCT03887117|12009145|FG000|STARTED|Overall Study||25
10843423|NCT03887117|12009146|FG001|STARTED|Overall Study||15
10843424|NCT03887117|12009147|FG002|STARTED|Overall Study||26
10843425|NCT03887117|12009148|FG003|STARTED|Overall Study||27
10843426|NCT03887117|12009145|FG000|COMPLETED|Overall Study||25
10843427|NCT03887117|12009146|FG001|COMPLETED|Overall Study||14
10843428|NCT03887117|12009147|FG002|COMPLETED|Overall Study||25
10843429|NCT03887117|12009148|FG003|COMPLETED|Overall Study||25
10843430|NCT03887117|12009145|FG000|NOT COMPLETED|Overall Study||0
10843431|NCT03887117|12009146|FG001|NOT COMPLETED|Overall Study||1
10843432|NCT03887117|12009147|FG002|NOT COMPLETED|Overall Study||1
10843433|NCT03887117|12009148|FG003|NOT COMPLETED|Overall Study||2
10843434|NCT03858634|12009169|FG000|STARTED|Overall Study||39
10843435|NCT03858634|12009170|FG001|STARTED|Overall Study||19
10843436|NCT03858634|12009169|FG000|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||4
10843437|NCT03858634|12009170|FG001|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||2
10843438|NCT03858634|12009169|FG000|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||14
10843439|NCT03858634|12009170|FG001|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||9
10843440|NCT03858634|12009169|FG000|Participants With Lichen Planus (LP)|Overall Study||3
10843441|NCT03858634|12009170|FG001|Participants With Lichen Planus (LP)|Overall Study||0
10843442|NCT03858634|12009169|FG000|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||4
10843443|NCT03858634|12009170|FG001|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||1
10843444|NCT03858634|12009169|FG000|Participants With Plaque Psoriasis (PPs)|Overall Study||14
10843445|NCT03858634|12009170|FG001|Participants With Plaque Psoriasis (PPs)|Overall Study||7
10843446|NCT03858634|12009169|FG000|COMPLETED|Overall Study||36
10843447|NCT03858634|12009170|FG001|COMPLETED|Overall Study||17
10843448|NCT03858634|12009169|FG000|NOT COMPLETED|Overall Study||3
11222859|NCT01973777|12414583|FG000|COMPLETED|Overall Study||44
11222860|NCT01973777|12414583|FG000|NOT COMPLETED|Overall Study||7
11222861|NCT01973972|12414589|FG000|STARTED|Overall Study||127
11222862|NCT01973972|12414590|FG001|STARTED|Overall Study||136
11222863|NCT01973972|12414589|FG000|COMPLETED|Overall Study||109
11222864|NCT01973972|12414590|FG001|COMPLETED|Overall Study||117
11222865|NCT01973972|12414589|FG000|NOT COMPLETED|Overall Study||18
11222866|NCT01973972|12414590|FG001|NOT COMPLETED|Overall Study||19
11222867|NCT01973998|12414598|FG000|STARTED|Overall Study||33
11222868|NCT01973998|12414599|FG001|STARTED|Overall Study||35
11222869|NCT01973998|12414598|FG000|COMPLETED|Overall Study||31
11222870|NCT01973998|12414599|FG001|COMPLETED|Overall Study||33
11222871|NCT01973998|12414598|FG000|NOT COMPLETED|Overall Study||2
11222872|NCT01973998|12414599|FG001|NOT COMPLETED|Overall Study||2
11222873|NCT01974050|12414605|FG000|STARTED|Overall Study||166
11222874|NCT01974050|12414605|FG000|COMPLETED|Overall Study||141
11222875|NCT01974050|12414605|FG000|NOT COMPLETED|Overall Study||25
11222876|NCT01974089|12414611|FG000|STARTED|Overall Study||53
11222877|NCT01974089|12414612|FG001|STARTED|Overall Study||101
11222878|NCT01974089|12414611|FG000|COMPLETED|Overall Study||53
11222879|NCT01974089|12414612|FG001|COMPLETED|Overall Study||101
11222880|NCT01974089|12414611|FG000|NOT COMPLETED|Overall Study||0
11222881|NCT01974089|12414612|FG001|NOT COMPLETED|Overall Study||0
11222882|NCT01974102|12414622|FG000|STARTED|Overall Study||22
11222883|NCT01974102|12414623|FG001|STARTED|Overall Study||20
11222884|NCT01974102|12414622|FG000|COMPLETED|Overall Study||15
11222885|NCT01974102|12414623|FG001|COMPLETED|Overall Study||19
11222886|NCT01974102|12414622|FG000|NOT COMPLETED|Overall Study||7
11222887|NCT01974102|12414623|FG001|NOT COMPLETED|Overall Study||1
11222888|NCT01974141|12414633|FG000|STARTED|Overall Study||1044
11222889|NCT01974141|12414634|FG001|STARTED|Overall Study||1058
11222890|NCT01974141|12414633|FG000|COMPLETED|Overall Study||948
11222891|NCT01974141|12414634|FG001|COMPLETED|Overall Study||976
11222892|NCT01974141|12414633|FG000|NOT COMPLETED|Overall Study||96
11222893|NCT01974141|12414634|FG001|NOT COMPLETED|Overall Study||82
11222894|NCT01974245|12414642|FG000|STARTED|Overall Study||27
11222895|NCT01974245|12414643|FG001|STARTED|Overall Study||28
11222896|NCT01974245|12414642|FG000|COMPLETED|Overall Study||18
11222897|NCT01974245|12414643|FG001|COMPLETED|Overall Study||20
11222898|NCT01974245|12414642|FG000|NOT COMPLETED|Overall Study||9
11222899|NCT01974245|12414643|FG001|NOT COMPLETED|Overall Study||8
11222900|NCT01974323|12414651|FG000|STARTED|Overall Study||1118
11222901|NCT01974323|12414652|FG001|STARTED|Overall Study||1120
11222902|NCT01974323|12414651|FG000|COMPLETED|Overall Study||1026
11222903|NCT01974323|12414652|FG001|COMPLETED|Overall Study||1027
11222904|NCT01974323|12414651|FG000|NOT COMPLETED|Overall Study||92
10843449|NCT03858634|12009170|FG001|NOT COMPLETED|Overall Study||2
10843450|NCT03819114|12009188|FG000|STARTED|Overall Study||17
10843451|NCT03819114|12009189|FG001|STARTED|Overall Study||36
10843452|NCT03819114|12009190|FG002|STARTED|Overall Study||35
10843453|NCT03819114|12009191|FG003|STARTED|Overall Study||34
10843454|NCT03819114|12009188|FG000|Received LNG Treatment|Overall Study||17
10843455|NCT03819114|12009189|FG001|Received LNG Treatment|Overall Study||36
10843456|NCT03819114|12009190|FG002|Received LNG Treatment|Overall Study||35
10843457|NCT03819114|12009191|FG003|Received LNG Treatment|Overall Study||34
10843458|NCT03819114|12009188|FG000|COMPLETED|Overall Study||17
10843459|NCT03819114|12009189|FG001|COMPLETED|Overall Study||35
10843460|NCT03819114|12009190|FG002|COMPLETED|Overall Study||33
10843461|NCT03819114|12009191|FG003|COMPLETED|Overall Study||34
10843462|NCT03819114|12009188|FG000|NOT COMPLETED|Overall Study||0
10843463|NCT03819114|12009189|FG001|NOT COMPLETED|Overall Study||1
10843464|NCT03819114|12009190|FG002|NOT COMPLETED|Overall Study||2
10843465|NCT03819114|12009191|FG003|NOT COMPLETED|Overall Study||0
10843466|NCT03804268|12009205|FG000|STARTED|Overall Study||160
10843467|NCT03804268|12009206|FG001|STARTED|Overall Study||163
10843468|NCT03804268|12009205|FG000|COMPLETED|Overall Study||153
10843469|NCT03804268|12009206|FG001|COMPLETED|Overall Study||161
10843470|NCT03804268|12009205|FG000|NOT COMPLETED|Overall Study||7
10843471|NCT03804268|12009206|FG001|NOT COMPLETED|Overall Study||2
10843472|NCT04435808|12009215|FG000|STARTED|Overall Study||0
10843473|NCT04435808|12009216|FG001|STARTED|Overall Study||1
10843474|NCT04435808|12009215|FG000|COMPLETED|Overall Study||0
10843475|NCT04435808|12009216|FG001|COMPLETED|Overall Study|Study stopped prior to any data collection for this lone participant|0
10843476|NCT04435808|12009215|FG000|NOT COMPLETED|Overall Study||0
10843477|NCT04435808|12009216|FG001|NOT COMPLETED|Overall Study||1
10843478|NCT04409262|12009224|FG000|STARTED|Overall Study||215
10843479|NCT04409262|12009225|FG001|STARTED|Overall Study||434
10843480|NCT04409262|12009224|FG000|COMPLETED|Overall Study||140
10843481|NCT04409262|12009225|FG001|COMPLETED|Overall Study||300
10843482|NCT04409262|12009224|FG000|NOT COMPLETED|Overall Study||75
10843483|NCT04409262|12009225|FG001|NOT COMPLETED|Overall Study||134
10843484|NCT04305912|12009234|FG000|STARTED|First Intervention||26
10843485|NCT04305912|12009235|FG001|STARTED|First Intervention||25
10843486|NCT04305912|12009234|FG000|COMPLETED|First Intervention||24
10843487|NCT04305912|12009235|FG001|COMPLETED|First Intervention||24
10843488|NCT04305912|12009234|FG000|NOT COMPLETED|First Intervention||2
10843489|NCT04305912|12009235|FG001|NOT COMPLETED|First Intervention||1
10843490|NCT04305912|12009234|FG000|STARTED|Second Intervention||24
10843491|NCT04305912|12009235|FG001|STARTED|Second Intervention||24
10843492|NCT04305912|12009234|FG000|COMPLETED|Second Intervention||24
10843493|NCT04305912|12009235|FG001|COMPLETED|Second Intervention||23
10843494|NCT04305912|12009234|FG000|NOT COMPLETED|Second Intervention||0
10843495|NCT04305912|12009235|FG001|NOT COMPLETED|Second Intervention||1
10843496|NCT04030416|12009241|FG000|STARTED|Overall Study||120
10843497|NCT04030416|12009241|FG000|COMPLETED|Overall Study||119
10843498|NCT04030416|12009241|FG000|NOT COMPLETED|Overall Study||1
11222905|NCT01974323|12414652|FG001|NOT COMPLETED|Overall Study||93
11222906|NCT01974687|12414683|FG000|STARTED|Overall Study||6
11222907|NCT01974687|12414684|FG001|STARTED|Overall Study||6
10843499|NCT04028648|12009245|FG000|STARTED|Overall Study||150
10843500|NCT04028648|12009245|FG000|COMPLETED|Overall Study||150
10843501|NCT04028648|12009245|FG000|NOT COMPLETED|Overall Study||0
10843502|NCT03987919|12009254|FG000|STARTED|Overall Study||471
10843503|NCT03987919|12009255|FG001|STARTED|Overall Study||469
10843504|NCT03987919|12009256|FG002|STARTED|Overall Study||470
10843505|NCT03987919|12009257|FG003|STARTED|Overall Study||469
10843506|NCT03987919|12009254|FG000|Received at Least One Dose of Study Drug|Overall Study||470
10843507|NCT03987919|12009255|FG001|Received at Least One Dose of Study Drug|Overall Study||469
10843508|NCT03987919|12009256|FG002|Received at Least One Dose of Study Drug|Overall Study||470
10843509|NCT03987919|12009257|FG003|Received at Least One Dose of Study Drug|Overall Study||469
10843510|NCT03987919|12009254|FG000|COMPLETED|Overall Study||452
10843511|NCT03987919|12009255|FG001|COMPLETED|Overall Study||442
10843512|NCT03987919|12009256|FG002|COMPLETED|Overall Study||446
10843513|NCT03987919|12009257|FG003|COMPLETED|Overall Study||443
10843514|NCT03987919|12009254|FG000|NOT COMPLETED|Overall Study||19
10843515|NCT03987919|12009255|FG001|NOT COMPLETED|Overall Study||27
10843516|NCT03987919|12009256|FG002|NOT COMPLETED|Overall Study||24
10843517|NCT03987919|12009257|FG003|NOT COMPLETED|Overall Study||26
10843518|NCT03980145|12009274|FG000|STARTED|Overall Study||7
10843519|NCT03980145|12009275|FG001|STARTED|Overall Study||8
10843520|NCT03980145|12009274|FG000|COMPLETED|Overall Study||7
10843521|NCT03980145|12009275|FG001|COMPLETED|Overall Study||8
10843522|NCT03980145|12009274|FG000|NOT COMPLETED|Overall Study||0
10843523|NCT03980145|12009275|FG001|NOT COMPLETED|Overall Study||0
10843524|NCT03861039|12009286|FG000|STARTED|Overall Study||148
10843525|NCT03861039|12009287|FG001|STARTED|Overall Study||147
10843526|NCT03861039|12009288|FG002|STARTED|Overall Study||148
10843527|NCT03861039|12009286|FG000|Received at Least One Dose of Study Drug|Overall Study||148
10843528|NCT03861039|12009287|FG001|Received at Least One Dose of Study Drug|Overall Study||147
10843529|NCT03861039|12009288|FG002|Received at Least One Dose of Study Drug|Overall Study||148
10843530|NCT03861039|12009286|FG000|COMPLETED|Overall Study||145
10843531|NCT03861039|12009287|FG001|COMPLETED|Overall Study||139
10843532|NCT03861039|12009288|FG002|COMPLETED|Overall Study||133
10843533|NCT03861039|12009286|FG000|NOT COMPLETED|Overall Study||3
10843534|NCT03861039|12009287|FG001|NOT COMPLETED|Overall Study||8
10843535|NCT03861039|12009288|FG002|NOT COMPLETED|Overall Study||15
10843536|NCT03759587|12009298|FG000|STARTED|Overall Study||19
10843537|NCT03759587|12009298|FG000|COMPLETED|Overall Study||0
10843538|NCT03759587|12009298|FG000|NOT COMPLETED|Overall Study||19
10843539|NCT03730662|12009306|FG000|STARTED|Treatment Period (52 Weeks)||329
10843540|NCT03730662|12009307|FG001|STARTED|Treatment Period (52 Weeks)||330
10843541|NCT03730662|12009308|FG002|STARTED|Treatment Period (52 Weeks)||338
10843542|NCT03730662|12009309|FG003|STARTED|Treatment Period (52 Weeks)||1005
10843543|NCT03730662|12009306|FG000|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||329
10843544|NCT03730662|12009307|FG001|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||328
10843545|NCT03730662|12009308|FG002|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||338
10843546|NCT03730662|12009309|FG003|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||1000
10843547|NCT03730662|12009306|FG000|COMPLETED|Treatment Period (52 Weeks)||308
10843548|NCT03730662|12009307|FG001|COMPLETED|Treatment Period (52 Weeks)||319
10843549|NCT03730662|12009308|FG002|COMPLETED|Treatment Period (52 Weeks)||329
10843550|NCT03730662|12009309|FG003|COMPLETED|Treatment Period (52 Weeks)||953
10843551|NCT03730662|12009306|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||21
10843552|NCT03730662|12009307|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||11
10843553|NCT03730662|12009308|FG002|NOT COMPLETED|Treatment Period (52 Weeks)||9
10843554|NCT03730662|12009309|FG003|NOT COMPLETED|Treatment Period (52 Weeks)||52
10843555|NCT03730662|12009306|FG000|STARTED|Variable Treatment Period||308
10843556|NCT03730662|12009307|FG001|STARTED|Variable Treatment Period||319
10843557|NCT03730662|12009308|FG002|STARTED|Variable Treatment Period||329
10843558|NCT03730662|12009309|FG003|STARTED|Variable Treatment Period||953
10843559|NCT03730662|12009306|FG000|COMPLETED|Variable Treatment Period||294
10843560|NCT03730662|12009307|FG001|COMPLETED|Variable Treatment Period||312
10843561|NCT03730662|12009308|FG002|COMPLETED|Variable Treatment Period||313
10843562|NCT03730662|12009309|FG003|COMPLETED|Variable Treatment Period||882
10843563|NCT03730662|12009306|FG000|NOT COMPLETED|Variable Treatment Period||14
10843564|NCT03730662|12009307|FG001|NOT COMPLETED|Variable Treatment Period||7
10843565|NCT03730662|12009308|FG002|NOT COMPLETED|Variable Treatment Period||16
10843566|NCT03730662|12009309|FG003|NOT COMPLETED|Variable Treatment Period||71
10843567|NCT03538444|12009325|FG000|STARTED|Overall Study||4
10843568|NCT03538444|12009326|FG001|STARTED|Overall Study||3
10843569|NCT03538444|12009325|FG000|COMPLETED|Overall Study||3
11222908|NCT01974687|12414685|FG002|STARTED|Overall Study||6
11222909|NCT01974687|12414686|FG003|STARTED|Overall Study||6
11222910|NCT01974687|12414687|FG004|STARTED|Overall Study||2
11222911|NCT01974687|12414688|FG005|STARTED|Overall Study||6
11222912|NCT01974687|12414689|FG006|STARTED|Overall Study||3
11222913|NCT01974687|12414690|FG007|STARTED|Overall Study||3
11222914|NCT01974687|12414691|FG008|STARTED|Overall Study||3
11222915|NCT01974687|12414692|FG009|STARTED|Overall Study||3
11222916|NCT01974687|12414693|FG010|STARTED|Overall Study||3
11222917|NCT01974687|12414694|FG011|STARTED|Overall Study||13
11222918|NCT01974687|12414695|FG012|STARTED|Overall Study||13
11222919|NCT01974687|12414696|FG013|STARTED|Overall Study||10
11222920|NCT01974687|12414697|FG014|STARTED|Overall Study||19
11222921|NCT01974687|12414698|FG015|STARTED|Overall Study||9
11222922|NCT01974687|12414699|FG016|STARTED|Overall Study||9
11222923|NCT01974687|12414700|FG017|STARTED|Overall Study||11
11222924|NCT01974687|12414701|FG018|STARTED|Overall Study||9
11222925|NCT01974687|12414702|FG019|STARTED|Overall Study||3
11222926|NCT01974687|12414703|FG020|STARTED|Overall Study||3
11222927|NCT01974687|12414704|FG021|STARTED|Overall Study||8
11222928|NCT01974687|12414705|FG022|STARTED|Overall Study||8
11222929|NCT01974687|12414706|FG023|STARTED|Overall Study||6
11222930|NCT01974687|12414707|FG024|STARTED|Overall Study||10
11222931|NCT01974687|12414683|FG000|Treated|Overall Study||6
11222932|NCT01974687|12414684|FG001|Treated|Overall Study||6
11222933|NCT01974687|12414685|FG002|Treated|Overall Study||6
11222934|NCT01974687|12414686|FG003|Treated|Overall Study||6
11222935|NCT01974687|12414687|FG004|Treated|Overall Study||2
11222936|NCT01974687|12414688|FG005|Treated|Overall Study||6
11222937|NCT01974687|12414689|FG006|Treated|Overall Study||3
11222938|NCT01974687|12414690|FG007|Treated|Overall Study||3
11222939|NCT01974687|12414691|FG008|Treated|Overall Study||3
11222940|NCT01974687|12414692|FG009|Treated|Overall Study||3
11222941|NCT01974687|12414693|FG010|Treated|Overall Study||3
11222942|NCT01974687|12414694|FG011|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
11222943|NCT01974687|12414695|FG012|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
11222944|NCT01974687|12414696|FG013|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
11222945|NCT01974687|12414697|FG014|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
11222946|NCT01974687|12414698|FG015|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
11222947|NCT01974687|12414699|FG016|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
11222948|NCT01974687|12414700|FG017|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
11222949|NCT01974687|12414701|FG018|Treated|Overall Study||9
11222950|NCT01974687|12414702|FG019|Treated|Overall Study||3
11222951|NCT01974687|12414703|FG020|Treated|Overall Study||3
11222952|NCT01974687|12414704|FG021|Treated|Overall Study||8
11222953|NCT01974687|12414705|FG022|Treated|Overall Study||8
11222954|NCT01974687|12414706|FG023|Treated|Overall Study||6
11222955|NCT01974687|12414707|FG024|Treated|Overall Study||10
11222956|NCT01974687|12414683|FG000|COMPLETED|Overall Study||6
11222957|NCT01974687|12414684|FG001|COMPLETED|Overall Study||6
11222958|NCT01974687|12414685|FG002|COMPLETED|Overall Study||6
11222959|NCT01974687|12414686|FG003|COMPLETED|Overall Study||6
11222960|NCT01974687|12414687|FG004|COMPLETED|Overall Study||2
11222961|NCT01974687|12414688|FG005|COMPLETED|Overall Study||6
11222962|NCT01974687|12414689|FG006|COMPLETED|Overall Study||3
11222963|NCT01974687|12414690|FG007|COMPLETED|Overall Study||3
11222964|NCT01974687|12414691|FG008|COMPLETED|Overall Study||3
11222965|NCT01974687|12414692|FG009|COMPLETED|Overall Study||3
11222966|NCT01974687|12414693|FG010|COMPLETED|Overall Study||3
11222967|NCT01974687|12414694|FG011|COMPLETED|Overall Study||11
11222968|NCT01974687|12414695|FG012|COMPLETED|Overall Study||10
11222969|NCT01974687|12414696|FG013|COMPLETED|Overall Study||8
11222970|NCT01974687|12414697|FG014|COMPLETED|Overall Study||18
11222971|NCT01974687|12414698|FG015|COMPLETED|Overall Study||8
11222972|NCT01974687|12414699|FG016|COMPLETED|Overall Study||8
11222973|NCT01974687|12414700|FG017|COMPLETED|Overall Study||8
11222974|NCT01974687|12414701|FG018|COMPLETED|Overall Study||9
11222975|NCT01974687|12414702|FG019|COMPLETED|Overall Study||3
11222976|NCT01974687|12414703|FG020|COMPLETED|Overall Study||3
11222977|NCT01974687|12414704|FG021|COMPLETED|Overall Study||8
10843570|NCT03538444|12009326|FG001|COMPLETED|Overall Study||3
10843571|NCT03538444|12009325|FG000|NOT COMPLETED|Overall Study||1
10843572|NCT03538444|12009326|FG001|NOT COMPLETED|Overall Study||0
11104811|NCT01251146|12289116|FG001|STARTED|Overall Study||91
11104812|NCT01251146|12289115|FG000|COMPLETED|Overall Study||83
11222978|NCT01974687|12414705|FG022|COMPLETED|Overall Study||8
11222979|NCT01974687|12414706|FG023|COMPLETED|Overall Study||6
11222980|NCT01974687|12414707|FG024|COMPLETED|Overall Study||10
11104813|NCT01251146|12289116|FG001|COMPLETED|Overall Study||81
11104814|NCT01251146|12289115|FG000|NOT COMPLETED|Overall Study||3
11104815|NCT01251146|12289116|FG001|NOT COMPLETED|Overall Study||10
11104816|NCT01251315|12289128|FG000|STARTED|Overall Study||4
11104817|NCT01251315|12289129|FG001|STARTED|Overall Study||4
11104818|NCT01251315|12289130|FG002|STARTED|Overall Study||4
11104819|NCT01251315|12289131|FG003|STARTED|Overall Study||4
11104820|NCT01251315|12289132|FG004|STARTED|Overall Study||4
11104821|NCT01251315|12289133|FG005|STARTED|Overall Study||4
11104822|NCT01251315|12289128|FG000|COMPLETED|Overall Study||4
11104823|NCT01251315|12289129|FG001|COMPLETED|Overall Study||4
11104824|NCT01251315|12289130|FG002|COMPLETED|Overall Study||4
11104825|NCT01251315|12289131|FG003|COMPLETED|Overall Study||4
11104826|NCT01251315|12289132|FG004|COMPLETED|Overall Study||4
11104827|NCT01251315|12289133|FG005|COMPLETED|Overall Study||4
11104828|NCT01251315|12289128|FG000|NOT COMPLETED|Overall Study||0
10843591|NCT03252925|12009362|FG000|STARTED|Overall Study||80
10843592|NCT03252925|12009363|FG001|STARTED|Overall Study||80
10843593|NCT03252925|12009362|FG000|COMPLETED|Overall Study||66
10843594|NCT03252925|12009363|FG001|COMPLETED|Overall Study||74
10843595|NCT03252925|12009362|FG000|NOT COMPLETED|Overall Study||14
10843596|NCT03252925|12009363|FG001|NOT COMPLETED|Overall Study||6
10843597|NCT03185832|12009373|FG000|STARTED|Overall Study||69
10843598|NCT03185832|12009374|FG001|STARTED|Overall Study||102
10843599|NCT03185832|12009375|FG002|STARTED|Overall Study||68
10843600|NCT03185832|12009376|FG003|STARTED|Overall Study||115
10843601|NCT03185832|12009373|FG000|COMPLETED|Overall Study||60
10843602|NCT03185832|12009374|FG001|COMPLETED|Overall Study||87
11104829|NCT01251315|12289129|FG001|NOT COMPLETED|Overall Study||0
10843603|NCT03185832|12009375|FG002|COMPLETED|Overall Study||58
10843604|NCT03185832|12009376|FG003|COMPLETED|Overall Study||104
10843605|NCT03185832|12009373|FG000|NOT COMPLETED|Overall Study||9
10843606|NCT03185832|12009374|FG001|NOT COMPLETED|Overall Study||15
10843607|NCT03185832|12009375|FG002|NOT COMPLETED|Overall Study||10
10843608|NCT03185832|12009376|FG003|NOT COMPLETED|Overall Study||11
10843609|NCT02963714|12009386|FG000|STARTED|Overall Study||176
10843610|NCT02963714|12009387|FG001|STARTED|Overall Study||176
10843611|NCT02963714|12009386|FG000|COMPLETED|Overall Study||126
10843612|NCT02963714|12009387|FG001|COMPLETED|Overall Study||126
10843613|NCT02963714|12009386|FG000|NOT COMPLETED|Overall Study||50
10843614|NCT02963714|12009387|FG001|NOT COMPLETED|Overall Study||50
10843615|NCT02959918|12009407|FG000|STARTED|Overall Study||3
10843616|NCT02959918|12009408|FG001|STARTED|Overall Study||3
10843617|NCT02959918|12009409|FG002|STARTED|Overall Study||9
10843618|NCT02959918|12009410|FG003|STARTED|Overall Study||10
10843619|NCT02959918|12009411|FG004|STARTED|Overall Study||6
10843620|NCT02959918|12009412|FG005|STARTED|Overall Study||11
10843621|NCT02959918|12009413|FG006|STARTED|Overall Study||11
10843622|NCT02959918|12009414|FG007|STARTED|Overall Study||12
10843623|NCT02959918|12009415|FG008|STARTED|Overall Study||14
10843624|NCT02959918|12009416|FG009|STARTED|Overall Study||13
10843625|NCT02959918|12009417|FG010|STARTED|Overall Study||14
10843626|NCT02959918|12009418|FG011|STARTED|Overall Study||23
10843627|NCT02959918|12009419|FG012|STARTED|Overall Study||11
10843628|NCT02959918|12009420|FG013|STARTED|Overall Study||12
10843629|NCT02959918|12009407|FG000|COMPLETED|Overall Study||0
10843630|NCT02959918|12009408|FG001|COMPLETED|Overall Study||0
10843631|NCT02959918|12009409|FG002|COMPLETED|Overall Study||1
10843632|NCT02959918|12009410|FG003|COMPLETED|Overall Study||1
10843633|NCT02959918|12009411|FG004|COMPLETED|Overall Study||1
10843634|NCT02959918|12009412|FG005|COMPLETED|Overall Study||5
10843635|NCT02959918|12009413|FG006|COMPLETED|Overall Study||6
10843636|NCT02959918|12009414|FG007|COMPLETED|Overall Study||6
10843637|NCT02959918|12009415|FG008|COMPLETED|Overall Study||7
10843638|NCT02959918|12009416|FG009|COMPLETED|Overall Study||7
10843639|NCT02959918|12009417|FG010|COMPLETED|Overall Study||8
10843640|NCT02959918|12009418|FG011|COMPLETED|Overall Study||11
10843641|NCT02959918|12009419|FG012|COMPLETED|Overall Study||4
10843642|NCT02959918|12009420|FG013|COMPLETED|Overall Study||6
10843643|NCT02959918|12009407|FG000|NOT COMPLETED|Overall Study||3
10843644|NCT02959918|12009408|FG001|NOT COMPLETED|Overall Study||3
10843645|NCT02959918|12009409|FG002|NOT COMPLETED|Overall Study||8
10843646|NCT02959918|12009410|FG003|NOT COMPLETED|Overall Study||9
10843647|NCT02959918|12009411|FG004|NOT COMPLETED|Overall Study||5
10843648|NCT02959918|12009412|FG005|NOT COMPLETED|Overall Study||6
10843649|NCT02959918|12009413|FG006|NOT COMPLETED|Overall Study||5
10843650|NCT02959918|12009414|FG007|NOT COMPLETED|Overall Study||6
10843651|NCT02959918|12009415|FG008|NOT COMPLETED|Overall Study||7
10843652|NCT02959918|12009416|FG009|NOT COMPLETED|Overall Study||6
10843653|NCT02959918|12009417|FG010|NOT COMPLETED|Overall Study||6
10843654|NCT02959918|12009418|FG011|NOT COMPLETED|Overall Study||12
10843655|NCT02959918|12009419|FG012|NOT COMPLETED|Overall Study||7
10843656|NCT02959918|12009420|FG013|NOT COMPLETED|Overall Study||6
10843657|NCT02472964|12009455|FG000|STARTED|Part 1 (up to Week 24)||246
10843658|NCT02472964|12009456|FG001|STARTED|Part 1 (up to Week 24)||247
10843659|NCT02472964|12009455|FG000|COMPLETED|Part 1 (up to Week 24)||171
10843660|NCT02472964|12009456|FG001|COMPLETED|Part 1 (up to Week 24)||185
10843661|NCT02472964|12009455|FG000|NOT COMPLETED|Part 1 (up to Week 24)||75
10843662|NCT02472964|12009456|FG001|NOT COMPLETED|Part 1 (up to Week 24)||62
10843663|NCT02472964|12009455|FG000|STARTED|Part 2 (Week 24-week 48)||163
10843664|NCT02472964|12009456|FG001|STARTED|Part 2 (Week 24-week 48)||179
10843665|NCT02472964|12009455|FG000|COMPLETED|Part 2 (Week 24-week 48)||98
10843666|NCT02472964|12009456|FG001|COMPLETED|Part 2 (Week 24-week 48)||116
10843667|NCT02472964|12009455|FG000|NOT COMPLETED|Part 2 (Week 24-week 48)||65
10843668|NCT02472964|12009456|FG001|NOT COMPLETED|Part 2 (Week 24-week 48)||63
10843669|NCT02178722|12009467|FG000|STARTED|Overall Study||4
10843670|NCT02178722|12009468|FG001|STARTED|Overall Study||20
10843671|NCT02178722|12009469|FG002|STARTED|Overall Study||18
10843672|NCT02178722|12009470|FG003|STARTED|Overall Study||20
10843673|NCT02178722|12009471|FG004|STARTED|Overall Study||382
10843674|NCT02178722|12009467|FG000|COMPLETED|Overall Study||0
10843675|NCT02178722|12009468|FG001|COMPLETED|Overall Study||0
10843676|NCT02178722|12009469|FG002|COMPLETED|Overall Study||0
10843677|NCT02178722|12009470|FG003|COMPLETED|Overall Study||0
10843678|NCT02178722|12009471|FG004|COMPLETED|Overall Study||0
10843679|NCT02178722|12009467|FG000|NOT COMPLETED|Overall Study||4
10843680|NCT02178722|12009468|FG001|NOT COMPLETED|Overall Study||20
10843681|NCT02178722|12009469|FG002|NOT COMPLETED|Overall Study||18
10843682|NCT02178722|12009470|FG003|NOT COMPLETED|Overall Study||20
10843683|NCT02178722|12009471|FG004|NOT COMPLETED|Overall Study||382
10843684|NCT01258803|12009486|FG000|STARTED|Treatment Period 1 (1 Dose)||15
10843685|NCT01258803|12009487|FG001|STARTED|Treatment Period 1 (1 Dose)||16
10843686|NCT01258803|12009488|FG002|STARTED|Treatment Period 1 (1 Dose)||15
10843687|NCT01258803|12009489|FG003|STARTED|Treatment Period 1 (1 Dose)||15
10843688|NCT01258803|12009490|FG004|STARTED|Treatment Period 1 (1 Dose)||15
11222981|NCT01974687|12414683|FG000|NOT COMPLETED|Overall Study||0
11222982|NCT01974687|12414684|FG001|NOT COMPLETED|Overall Study||0
11222983|NCT01974687|12414685|FG002|NOT COMPLETED|Overall Study||0
11222984|NCT01974687|12414686|FG003|NOT COMPLETED|Overall Study||0
11222985|NCT01974687|12414687|FG004|NOT COMPLETED|Overall Study||0
11222986|NCT01974687|12414688|FG005|NOT COMPLETED|Overall Study||0
11222987|NCT01974687|12414689|FG006|NOT COMPLETED|Overall Study||0
11222988|NCT01974687|12414690|FG007|NOT COMPLETED|Overall Study||0
11222989|NCT01974687|12414691|FG008|NOT COMPLETED|Overall Study||0
11222990|NCT01974687|12414692|FG009|NOT COMPLETED|Overall Study||0
11222991|NCT01974687|12414693|FG010|NOT COMPLETED|Overall Study||0
11222992|NCT01974687|12414694|FG011|NOT COMPLETED|Overall Study||2
11222993|NCT01974687|12414695|FG012|NOT COMPLETED|Overall Study||3
11222994|NCT01974687|12414696|FG013|NOT COMPLETED|Overall Study||2
11222995|NCT01974687|12414697|FG014|NOT COMPLETED|Overall Study||1
11222996|NCT01974687|12414698|FG015|NOT COMPLETED|Overall Study||1
11222997|NCT01974687|12414699|FG016|NOT COMPLETED|Overall Study||1
11222998|NCT01974687|12414700|FG017|NOT COMPLETED|Overall Study||3
11222999|NCT01974687|12414701|FG018|NOT COMPLETED|Overall Study||0
11223000|NCT01974687|12414702|FG019|NOT COMPLETED|Overall Study||0
11223001|NCT01974687|12414703|FG020|NOT COMPLETED|Overall Study||0
11223002|NCT01974687|12414704|FG021|NOT COMPLETED|Overall Study||0
11223003|NCT01974687|12414705|FG022|NOT COMPLETED|Overall Study||0
11223004|NCT01974687|12414706|FG023|NOT COMPLETED|Overall Study||0
11223005|NCT01974687|12414707|FG024|NOT COMPLETED|Overall Study||0
11223006|NCT01974700|12414789|FG000|STARTED|Overall Study||5
11223007|NCT01974700|12414790|FG001|STARTED|Overall Study||3
11223008|NCT01974700|12414789|FG000|COMPLETED|Overall Study||5
11223009|NCT01974700|12414790|FG001|COMPLETED|Overall Study||3
11223010|NCT01974700|12414789|FG000|NOT COMPLETED|Overall Study||0
11223011|NCT01974700|12414790|FG001|NOT COMPLETED|Overall Study||0
11223012|NCT01974752|12414798|FG000|STARTED|Overall Study||97
11223013|NCT01974752|12414799|FG001|STARTED|Overall Study||32
11223014|NCT01974752|12414798|FG000|COMPLETED|Overall Study||60
11223015|NCT01974752|12414799|FG001|COMPLETED|Overall Study||17
11223016|NCT01974752|12414798|FG000|NOT COMPLETED|Overall Study||37
11223017|NCT01974752|12414799|FG001|NOT COMPLETED|Overall Study||15
11223018|NCT01974817|12414805|FG000|STARTED|Overall Study||25
11223019|NCT01974817|12414805|FG000|COMPLETED|Overall Study||17
11223020|NCT01974817|12414805|FG000|NOT COMPLETED|Overall Study||8
11223021|NCT01974895|12414811|FG000|STARTED|Overall Study||158
11223022|NCT01974895|12414812|FG001|STARTED|Overall Study||156
11223023|NCT01974895|12414811|FG000|COMPLETED|Overall Study||143
11223024|NCT01974895|12414812|FG001|COMPLETED|Overall Study||141
11223025|NCT01974895|12414811|FG000|NOT COMPLETED|Overall Study||15
11223026|NCT01974895|12414812|FG001|NOT COMPLETED|Overall Study||15
10843689|NCT01258803|12009491|FG005|STARTED|Treatment Period 1 (1 Dose)||16
10843690|NCT01258803|12009486|FG000|COMPLETED|Treatment Period 1 (1 Dose)||15
10843691|NCT01258803|12009487|FG001|COMPLETED|Treatment Period 1 (1 Dose)||16
11223027|NCT01975090|12414818|FG000|STARTED|Overall Study||129
11223028|NCT01975090|12414818|FG000|6-month Follow-up|Overall Study||117
11223029|NCT01975090|12414818|FG000|COMPLETED|Overall Study||117
11223030|NCT01975090|12414818|FG000|NOT COMPLETED|Overall Study||12
11223031|NCT01975220|12414831|FG000|STARTED|Test Period 1||12
11223032|NCT01975220|12414832|FG001|STARTED|Test Period 1||12
11223033|NCT01975220|12414833|FG002|STARTED|Test Period 1||12
11223034|NCT01975220|12414834|FG003|STARTED|Test Period 1||12
11223035|NCT01975220|12414835|FG004|STARTED|Test Period 1||12
11354315|NCT03073109|12551581|FG000|COMPLETED|Overall Study||90
10843692|NCT01258803|12009488|FG002|COMPLETED|Treatment Period 1 (1 Dose)||15
10843693|NCT01258803|12009489|FG003|COMPLETED|Treatment Period 1 (1 Dose)||15
10843694|NCT01258803|12009490|FG004|COMPLETED|Treatment Period 1 (1 Dose)||15
10843695|NCT01258803|12009491|FG005|COMPLETED|Treatment Period 1 (1 Dose)||16
10843696|NCT01258803|12009486|FG000|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
10843697|NCT01258803|12009487|FG001|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
10843698|NCT01258803|12009488|FG002|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
10843699|NCT01258803|12009489|FG003|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
10843700|NCT01258803|12009490|FG004|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
10843701|NCT01258803|12009491|FG005|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
10843702|NCT01258803|12009486|FG000|STARTED|Treatment Period 2 (1 Dose)||15
10843703|NCT01258803|12009487|FG001|STARTED|Treatment Period 2 (1 Dose)||16
10843704|NCT01258803|12009488|FG002|STARTED|Treatment Period 2 (1 Dose)||15
10843705|NCT01258803|12009489|FG003|STARTED|Treatment Period 2 (1 Dose)||15
10843706|NCT01258803|12009490|FG004|STARTED|Treatment Period 2 (1 Dose)||15
10843707|NCT01258803|12009491|FG005|STARTED|Treatment Period 2 (1 Dose)||16
10843708|NCT01258803|12009486|FG000|COMPLETED|Treatment Period 2 (1 Dose)||14
10843709|NCT01258803|12009487|FG001|COMPLETED|Treatment Period 2 (1 Dose)||14
10843710|NCT01258803|12009488|FG002|COMPLETED|Treatment Period 2 (1 Dose)||15
10843711|NCT01258803|12009489|FG003|COMPLETED|Treatment Period 2 (1 Dose)||15
10843712|NCT01258803|12009490|FG004|COMPLETED|Treatment Period 2 (1 Dose)||15
10843713|NCT01258803|12009491|FG005|COMPLETED|Treatment Period 2 (1 Dose)||15
10843714|NCT01258803|12009486|FG000|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
10843715|NCT01258803|12009487|FG001|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
10843716|NCT01258803|12009488|FG002|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
10843717|NCT01258803|12009489|FG003|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
10843718|NCT01258803|12009490|FG004|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
10843719|NCT01258803|12009491|FG005|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
10843720|NCT01258803|12009486|FG000|STARTED|Treatment Period 3 (1 Dose)||14
10843721|NCT01258803|12009487|FG001|STARTED|Treatment Period 3 (1 Dose)||14
10843722|NCT01258803|12009488|FG002|STARTED|Treatment Period 3 (1 Dose)||15
10843723|NCT01258803|12009489|FG003|STARTED|Treatment Period 3 (1 Dose)||15
11223036|NCT01975220|12414836|FG005|STARTED|Test Period 1||12
10843724|NCT01258803|12009490|FG004|STARTED|Treatment Period 3 (1 Dose)||15
10843725|NCT01258803|12009491|FG005|STARTED|Treatment Period 3 (1 Dose)||15
10843726|NCT01258803|12009486|FG000|COMPLETED|Treatment Period 3 (1 Dose)||14
10843727|NCT01258803|12009487|FG001|COMPLETED|Treatment Period 3 (1 Dose)||14
10843728|NCT01258803|12009488|FG002|COMPLETED|Treatment Period 3 (1 Dose)||14
10843729|NCT01258803|12009489|FG003|COMPLETED|Treatment Period 3 (1 Dose)||15
10843730|NCT01258803|12009490|FG004|COMPLETED|Treatment Period 3 (1 Dose)||15
10843731|NCT01258803|12009491|FG005|COMPLETED|Treatment Period 3 (1 Dose)||15
10843732|NCT01258803|12009486|FG000|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
10843733|NCT01258803|12009487|FG001|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
10843734|NCT01258803|12009488|FG002|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
10843735|NCT01258803|12009489|FG003|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
10843736|NCT01258803|12009490|FG004|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
10843737|NCT01258803|12009491|FG005|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
10843738|NCT01258803|12009486|FG000|STARTED|Treatment Period 4 (1 Dose)||14
10843739|NCT01258803|12009487|FG001|STARTED|Treatment Period 4 (1 Dose)||14
10843740|NCT01258803|12009488|FG002|STARTED|Treatment Period 4 (1 Dose)||14
10843741|NCT01258803|12009489|FG003|STARTED|Treatment Period 4 (1 Dose)||15
10843742|NCT01258803|12009490|FG004|STARTED|Treatment Period 4 (1 Dose)||15
10843743|NCT01258803|12009491|FG005|STARTED|Treatment Period 4 (1 Dose)||15
10843744|NCT01258803|12009486|FG000|COMPLETED|Treatment Period 4 (1 Dose)||14
10843745|NCT01258803|12009487|FG001|COMPLETED|Treatment Period 4 (1 Dose)||14
10843746|NCT01258803|12009488|FG002|COMPLETED|Treatment Period 4 (1 Dose)||14
10843747|NCT01258803|12009489|FG003|COMPLETED|Treatment Period 4 (1 Dose)||15
10843748|NCT01258803|12009490|FG004|COMPLETED|Treatment Period 4 (1 Dose)||15
10843749|NCT01258803|12009491|FG005|COMPLETED|Treatment Period 4 (1 Dose)||15
10843750|NCT01258803|12009486|FG000|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
10843751|NCT01258803|12009487|FG001|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
10843752|NCT01258803|12009488|FG002|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
10843753|NCT01258803|12009489|FG003|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
10843754|NCT01258803|12009490|FG004|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
10843755|NCT01258803|12009491|FG005|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
10843756|NCT01104922|12009505|FG000|STARTED|Overall Study||48
10843757|NCT01104922|12009505|FG000|COMPLETED|Overall Study||48
10843758|NCT01104922|12009505|FG000|NOT COMPLETED|Overall Study||0
10843759|NCT00862251|12009512|FG000|STARTED|Overall Study||322
10843760|NCT00862251|12009513|FG001|STARTED|Overall Study||162
10843761|NCT00862251|12009514|FG002|STARTED|Overall Study||324
10843762|NCT00862251|12009512|FG000|COMPLETED|Overall Study||303
10843763|NCT00862251|12009513|FG001|COMPLETED|Overall Study||157
10843764|NCT00862251|12009514|FG002|COMPLETED|Overall Study||315
10843765|NCT00862251|12009512|FG000|NOT COMPLETED|Overall Study||19
10843766|NCT00862251|12009513|FG001|NOT COMPLETED|Overall Study||5
10843767|NCT00862251|12009514|FG002|NOT COMPLETED|Overall Study||9
10843768|NCT00783263|12009529|FG000|STARTED|Overall Study||99
10843769|NCT00783263|12009530|FG001|STARTED|Overall Study||98
10843770|NCT00783263|12009531|FG002|STARTED|Overall Study||122
10843771|NCT00783263|12009532|FG003|STARTED|Overall Study||121
10843772|NCT00783263|12009529|FG000|COMPLETED|Overall Study||95
10843773|NCT00783263|12009530|FG001|COMPLETED|Overall Study||96
10843774|NCT00783263|12009531|FG002|COMPLETED|Overall Study||119
10843775|NCT00783263|12009532|FG003|COMPLETED|Overall Study||118
10843776|NCT00783263|12009529|FG000|NOT COMPLETED|Overall Study||4
10843777|NCT00783263|12009530|FG001|NOT COMPLETED|Overall Study||2
10843778|NCT00783263|12009531|FG002|NOT COMPLETED|Overall Study||3
10843779|NCT00783263|12009532|FG003|NOT COMPLETED|Overall Study||3
10843780|NCT00782184|12009557|FG000|STARTED|Overall Study||120
10843781|NCT00782184|12009558|FG001|STARTED|Overall Study||130
10843782|NCT00782184|12009557|FG000|COMPLETED|Overall Study||116
10843783|NCT00782184|12009558|FG001|COMPLETED|Overall Study||125
10843784|NCT00782184|12009557|FG000|NOT COMPLETED|Overall Study||4
10843785|NCT00782184|12009558|FG001|NOT COMPLETED|Overall Study||5
10843786|NCT00635882|12009571|FG000|STARTED|Overall Study||20
10843787|NCT00635882|12009572|FG001|STARTED|Overall Study||17
10843788|NCT00635882|12009573|FG002|STARTED|Overall Study||12
10843789|NCT00635882|12009574|FG003|STARTED|Overall Study||15
10843790|NCT00635882|12009575|FG004|STARTED|Overall Study||16
10843791|NCT00635882|12009576|FG005|STARTED|Overall Study||13
10843792|NCT00635882|12009571|FG000|COMPLETED|Overall Study||19
10843793|NCT00635882|12009572|FG001|COMPLETED|Overall Study||17
10843794|NCT00635882|12009573|FG002|COMPLETED|Overall Study||12
10843795|NCT00635882|12009574|FG003|COMPLETED|Overall Study||15
10843796|NCT00635882|12009575|FG004|COMPLETED|Overall Study||16
10843797|NCT00635882|12009576|FG005|COMPLETED|Overall Study||13
10843798|NCT00635882|12009571|FG000|NOT COMPLETED|Overall Study||1
10843799|NCT00635882|12009572|FG001|NOT COMPLETED|Overall Study||0
10843800|NCT00635882|12009573|FG002|NOT COMPLETED|Overall Study||0
10843801|NCT00635882|12009574|FG003|NOT COMPLETED|Overall Study||0
10843802|NCT00635882|12009575|FG004|NOT COMPLETED|Overall Study||0
11223037|NCT01975220|12414831|FG000|COMPLETED|Test Period 1||12
11223038|NCT01975220|12414832|FG001|COMPLETED|Test Period 1||11
11223039|NCT01975220|12414833|FG002|COMPLETED|Test Period 1||12
11223040|NCT01975220|12414834|FG003|COMPLETED|Test Period 1||12
11223041|NCT01975220|12414835|FG004|COMPLETED|Test Period 1||12
11223042|NCT01975220|12414836|FG005|COMPLETED|Test Period 1||12
11223043|NCT01975220|12414831|FG000|NOT COMPLETED|Test Period 1||0
11223044|NCT01975220|12414832|FG001|NOT COMPLETED|Test Period 1||1
11223045|NCT01975220|12414833|FG002|NOT COMPLETED|Test Period 1||0
11223046|NCT01975220|12414834|FG003|NOT COMPLETED|Test Period 1||0
11223047|NCT01975220|12414835|FG004|NOT COMPLETED|Test Period 1||0
11223048|NCT01975220|12414836|FG005|NOT COMPLETED|Test Period 1||0
11223049|NCT01975220|12414831|FG000|STARTED|Test Period 2||12
11223050|NCT01975220|12414832|FG001|STARTED|Test Period 2||11
11223051|NCT01975220|12414833|FG002|STARTED|Test Period 2||12
11223052|NCT01975220|12414834|FG003|STARTED|Test Period 2||12
11223053|NCT01975220|12414835|FG004|STARTED|Test Period 2||12
11223054|NCT01975220|12414836|FG005|STARTED|Test Period 2||12
11223055|NCT01975220|12414831|FG000|COMPLETED|Test Period 2||12
11223056|NCT01975220|12414832|FG001|COMPLETED|Test Period 2||11
11223057|NCT01975220|12414833|FG002|COMPLETED|Test Period 2||12
11223058|NCT01975220|12414834|FG003|COMPLETED|Test Period 2||12
11223059|NCT01975220|12414835|FG004|COMPLETED|Test Period 2||12
11223060|NCT01975220|12414836|FG005|COMPLETED|Test Period 2||12
11223061|NCT01975220|12414831|FG000|NOT COMPLETED|Test Period 2||0
11223062|NCT01975220|12414832|FG001|NOT COMPLETED|Test Period 2||0
11223063|NCT01975220|12414833|FG002|NOT COMPLETED|Test Period 2||0
11223064|NCT01975220|12414834|FG003|NOT COMPLETED|Test Period 2||0
11223065|NCT01975220|12414835|FG004|NOT COMPLETED|Test Period 2||0
11223066|NCT01975220|12414836|FG005|NOT COMPLETED|Test Period 2||0
11223067|NCT01975246|12414853|FG000|STARTED|Overall Study||149
11223068|NCT01975246|12414854|FG001|STARTED|Overall Study||160
11223069|NCT01975246|12414853|FG000|COMPLETED|Overall Study||145
11223070|NCT01975246|12414854|FG001|COMPLETED|Overall Study||158
11223071|NCT01975246|12414853|FG000|NOT COMPLETED|Overall Study||4
11223072|NCT01975246|12414854|FG001|NOT COMPLETED|Overall Study||2
11223073|NCT01975285|12414862|FG000|STARTED|Overall Study||30
11223074|NCT01975285|12414863|FG001|STARTED|Overall Study||30
11223075|NCT01975285|12414862|FG000|COMPLETED|Overall Study||28
11223076|NCT01975285|12414863|FG001|COMPLETED|Overall Study||28
11223077|NCT01975285|12414862|FG000|NOT COMPLETED|Overall Study||2
11223078|NCT01975285|12414863|FG001|NOT COMPLETED|Overall Study||2
11223079|NCT01975376|12414871|FG000|STARTED|Overall Study||8390
11223080|NCT01975376|12414872|FG001|STARTED|Overall Study||8394
11223081|NCT01975376|12414871|FG000|Treated|Overall Study||8374
11223082|NCT01975376|12414872|FG001|Treated|Overall Study||8386
11223083|NCT01975376|12414871|FG000|COMPLETED|Overall Study||8164
11223084|NCT01975376|12414872|FG001|COMPLETED|Overall Study||8177
11223085|NCT01975376|12414871|FG000|NOT COMPLETED|Overall Study||226
11223086|NCT01975376|12414872|FG001|NOT COMPLETED|Overall Study||217
11223087|NCT01975389|12414880|FG000|STARTED|Overall Study||5283
11223088|NCT01975389|12414881|FG001|STARTED|Overall Study||5281
11223089|NCT01975389|12414880|FG000|Treated|Overall Study||5279
11223090|NCT01975389|12414881|FG001|Treated|Overall Study||5276
11223091|NCT01975389|12414880|FG000|COMPLETED|Overall Study||5031
11223092|NCT01975389|12414881|FG001|COMPLETED|Overall Study||5045
11223093|NCT01975389|12414880|FG000|NOT COMPLETED|Overall Study||252
11223094|NCT01975389|12414881|FG001|NOT COMPLETED|Overall Study||236
11223095|NCT01975428|12414889|FG000|STARTED|Overall Study||85
11223096|NCT01975428|12414890|FG001|STARTED|Overall Study||97
11223097|NCT01975428|12414889|FG000|COMPLETED|Overall Study||65
10843803|NCT00635882|12009576|FG005|NOT COMPLETED|Overall Study||0
10843804|NCT00594620|12009592|FG000|STARTED|Overall Study|Study was terminated early due to low accrual. Study was blinded and no data was collected|0
10843805|NCT00594620|12009593|FG001|STARTED|Overall Study|Study was terminated early due to low accrual. Study was blinded and no data was collected|0
10843806|NCT00594620|12009592|FG000|COMPLETED|Overall Study||0
11223098|NCT01975428|12414890|FG001|COMPLETED|Overall Study||83
11223099|NCT01975428|12414889|FG000|NOT COMPLETED|Overall Study||20
10843807|NCT00594620|12009593|FG001|COMPLETED|Overall Study||0
10843808|NCT00594620|12009592|FG000|NOT COMPLETED|Overall Study||0
10843809|NCT00594620|12009593|FG001|NOT COMPLETED|Overall Study||0
10843810|NCT00535405|12009604|FG000|STARTED|Overall Study||257
10843811|NCT00535405|12009605|FG001|STARTED|Overall Study||259
10843812|NCT00535405|12009606|FG002|STARTED|Overall Study||259
10843813|NCT00535405|12009607|FG003|STARTED|Overall Study||257
10843814|NCT00535405|12009608|FG004|STARTED|Overall Study||257
10843815|NCT00535405|12009604|FG000|COMPLETED|Overall Study||240
10843816|NCT00535405|12009605|FG001|COMPLETED|Overall Study||233
10843817|NCT00535405|12009606|FG002|COMPLETED|Overall Study||241
10843818|NCT00535405|12009607|FG003|COMPLETED|Overall Study||235
10843819|NCT00535405|12009608|FG004|COMPLETED|Overall Study||241
10843820|NCT00535405|12009604|FG000|NOT COMPLETED|Overall Study||17
10843821|NCT00535405|12009605|FG001|NOT COMPLETED|Overall Study||26
10843822|NCT00535405|12009606|FG002|NOT COMPLETED|Overall Study||18
10843823|NCT00535405|12009607|FG003|NOT COMPLETED|Overall Study||22
10843824|NCT00535405|12009608|FG004|NOT COMPLETED|Overall Study||16
10843825|NCT00496730|12009622|FG000|STARTED|Overall Study||130
10843826|NCT00496730|12009623|FG001|STARTED|Overall Study||126
10843827|NCT00496730|12009622|FG000|COMPLETED|Overall Study||124
10843828|NCT00496730|12009623|FG001|COMPLETED|Overall Study||121
10843829|NCT00496730|12009622|FG000|NOT COMPLETED|Overall Study||6
10843830|NCT00496730|12009623|FG001|NOT COMPLETED|Overall Study||5
10843831|NCT00462748|12009632|FG000|STARTED|Overall Study||261
10843832|NCT00462748|12009633|FG001|STARTED|Overall Study||263
10843833|NCT00462748|12009634|FG002|STARTED|Overall Study||262
10843834|NCT00462748|12009632|FG000|COMPLETED|Overall Study||249
10843835|NCT00462748|12009633|FG001|COMPLETED|Overall Study||252
10843836|NCT00462748|12009634|FG002|COMPLETED|Overall Study||251
10843837|NCT00462748|12009632|FG000|NOT COMPLETED|Overall Study||12
10843838|NCT00462748|12009633|FG001|NOT COMPLETED|Overall Study||11
10843839|NCT00462748|12009634|FG002|NOT COMPLETED|Overall Study||11
10843840|NCT00418834|12009644|FG000|STARTED|Overall Study||526
11223100|NCT01975428|12414890|FG001|NOT COMPLETED|Overall Study||14
10843841|NCT00418834|12009645|FG001|STARTED|Overall Study||527
10843842|NCT00418834|12009644|FG000|COMPLETED|Overall Study||503
10843843|NCT00418834|12009645|FG001|COMPLETED|Overall Study||507
10843844|NCT00418834|12009644|FG000|NOT COMPLETED|Overall Study||23
10843845|NCT00418834|12009645|FG001|NOT COMPLETED|Overall Study||20
10843846|NCT00409773|12009656|FG000|STARTED|Overall Study||229
10843847|NCT00409773|12009657|FG001|STARTED|Overall Study||229
10843848|NCT00409773|12009658|FG002|STARTED|Overall Study||229
10843849|NCT00409773|12009659|FG003|STARTED|Overall Study||228
10843850|NCT00409773|12009660|FG004|STARTED|Overall Study||228
10843851|NCT00409773|12009656|FG000|COMPLETED|Overall Study||220
10843852|NCT00409773|12009657|FG001|COMPLETED|Overall Study||222
10843853|NCT00409773|12009658|FG002|COMPLETED|Overall Study||220
10843854|NCT00409773|12009659|FG003|COMPLETED|Overall Study||216
10843855|NCT00409773|12009660|FG004|COMPLETED|Overall Study||218
10843856|NCT00409773|12009656|FG000|NOT COMPLETED|Overall Study||9
10843857|NCT00409773|12009657|FG001|NOT COMPLETED|Overall Study||7
10843858|NCT00409773|12009658|FG002|NOT COMPLETED|Overall Study||9
10843859|NCT00409773|12009659|FG003|NOT COMPLETED|Overall Study||12
10843860|NCT00409773|12009660|FG004|NOT COMPLETED|Overall Study||10
10843861|NCT00276484|12009674|FG000|STARTED|Overall Study||288
10843862|NCT00276484|12009675|FG001|STARTED|Overall Study||291
10843863|NCT00276484|12009674|FG000|COMPLETED|Overall Study||279
10843864|NCT00276484|12009675|FG001|COMPLETED|Overall Study||278
10843865|NCT00276484|12009674|FG000|NOT COMPLETED|Overall Study||9
10843866|NCT00276484|12009675|FG001|NOT COMPLETED|Overall Study||13
10843867|NCT00276458|12009683|FG000|STARTED|Overall Study||98
10843868|NCT00276458|12009684|FG001|STARTED|Overall Study||98
10843869|NCT00276458|12009683|FG000|COMPLETED|Overall Study||92
10843870|NCT00276458|12009684|FG001|COMPLETED|Overall Study||91
10843871|NCT00276458|12009683|FG000|NOT COMPLETED|Overall Study||6
10843872|NCT00276458|12009684|FG001|NOT COMPLETED|Overall Study||7
10843873|NCT00271817|12009693|FG000|STARTED|Part 1||272
10843874|NCT00271817|12009694|FG001|STARTED|Part 1||272
10843875|NCT00271817|12009695|FG002|STARTED|Part 1||676
10843876|NCT00271817|12009693|FG000|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
10843877|NCT00271817|12009694|FG001|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
10843878|NCT00271817|12009695|FG002|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
10843879|NCT00271817|12009693|FG000|NOT COMPLETED|Part 1||106
10843880|NCT00271817|12009694|FG001|NOT COMPLETED|Part 1||59
10843881|NCT00271817|12009695|FG002|NOT COMPLETED|Part 1||285
10843882|NCT00271817|12009693|FG000|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
10843883|NCT00271817|12009694|FG001|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
10843884|NCT00271817|12009695|FG002|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
10843885|NCT00271817|12009693|FG000|COMPLETED|Part 2||0
10843886|NCT00271817|12009694|FG001|COMPLETED|Part 2||234
10843887|NCT00271817|12009695|FG002|COMPLETED|Part 2||401
10843888|NCT00271817|12009693|FG000|NOT COMPLETED|Part 2||0
10843889|NCT00271817|12009694|FG001|NOT COMPLETED|Part 2||32
10843890|NCT00271817|12009695|FG002|NOT COMPLETED|Part 2||84
10843891|NCT03660865|12009709|FG000|STARTED|Overall Study||105
10843892|NCT03660865|12009710|FG001|STARTED|Overall Study||105
10843893|NCT03660865|12009709|FG000|COMPLETED|Overall Study||105
10843894|NCT03660865|12009710|FG001|COMPLETED|Overall Study||105
10843895|NCT03660865|12009709|FG000|NOT COMPLETED|Overall Study||0
10843896|NCT03660865|12009710|FG001|NOT COMPLETED|Overall Study||0
10843897|NCT03493126|12009718|FG000|STARTED|Overall Study||31
10843898|NCT03493126|12009719|FG001|STARTED|Overall Study||28
10843899|NCT03493126|12009718|FG000|COMPLETED|Overall Study||28
10843900|NCT03493126|12009719|FG001|COMPLETED|Overall Study||28
10843901|NCT03493126|12009718|FG000|NOT COMPLETED|Overall Study||3
10843902|NCT03493126|12009719|FG001|NOT COMPLETED|Overall Study||0
10843903|NCT03420781|12009727|FG000|STARTED|Treatment Period (40 Weeks)||236
10843904|NCT03420781|12009728|FG001|STARTED|Treatment Period (40 Weeks)||231
10843905|NCT03420781|12009729|FG002|STARTED|Treatment Period (40 Weeks)||0
10843906|NCT03420781|12009730|FG003|STARTED|Treatment Period (40 Weeks)||0
10843907|NCT03420781|12009731|FG004|STARTED|Treatment Period (40 Weeks)||0
10843908|NCT03420781|12009727|FG000|Safety Population|Treatment Period (40 Weeks)||235
10843909|NCT03420781|12009728|FG001|Safety Population|Treatment Period (40 Weeks)||231
10843910|NCT03420781|12009729|FG002|Safety Population|Treatment Period (40 Weeks)||0
10843911|NCT03420781|12009730|FG003|Safety Population|Treatment Period (40 Weeks)||0
11104830|NCT01251315|12289130|FG002|NOT COMPLETED|Overall Study||0
11104831|NCT01251315|12289131|FG003|NOT COMPLETED|Overall Study||0
11104832|NCT01251315|12289132|FG004|NOT COMPLETED|Overall Study||0
11104833|NCT01251315|12289133|FG005|NOT COMPLETED|Overall Study||0
11104834|NCT01251354|12289151|FG000|STARTED|Overall Study||6
11104835|NCT01251354|12289151|FG000|COMPLETED|Overall Study||0
11104836|NCT01251354|12289151|FG000|NOT COMPLETED|Overall Study||6
11104837|NCT01251393|12289157|FG000|STARTED|Overall Study||56
11104838|NCT01251393|12289158|FG001|STARTED|Overall Study||55
11104839|NCT01251393|12289157|FG000|COMPLETED|Overall Study||24
11104840|NCT01251393|12289158|FG001|COMPLETED|Overall Study||11
11104841|NCT01251393|12289157|FG000|NOT COMPLETED|Overall Study||32
11104842|NCT01251393|12289158|FG001|NOT COMPLETED|Overall Study||44
11104843|NCT01251536|12289167|FG000|STARTED|Overall Study||8
11104844|NCT01251536|12289168|FG001|STARTED|Overall Study||93
11104845|NCT01251536|12289169|FG002|STARTED|Overall Study||7
11104846|NCT01251536|12289167|FG000|COMPLETED|Overall Study||8
11104847|NCT01251536|12289168|FG001|COMPLETED|Overall Study||93
11104848|NCT01251536|12289169|FG002|COMPLETED|Overall Study||7
11104849|NCT01251536|12289167|FG000|NOT COMPLETED|Overall Study||0
11104850|NCT01251536|12289168|FG001|NOT COMPLETED|Overall Study||0
11104851|NCT01251536|12289169|FG002|NOT COMPLETED|Overall Study||0
11104852|NCT01251575|12289179|FG000|STARTED|Overall Study||77
11104853|NCT01251575|12289179|FG000|COMPLETED|Overall Study||76
11104854|NCT01251575|12289179|FG000|NOT COMPLETED|Overall Study||1
11104855|NCT01251588|12289187|FG000|STARTED|Overall Study||65
11104856|NCT01251588|12289188|FG001|STARTED|Overall Study||63
11104857|NCT01251588|12289187|FG000|COMPLETED|Overall Study||65
11104858|NCT01251588|12289188|FG001|COMPLETED|Overall Study||59
11104859|NCT01251588|12289187|FG000|NOT COMPLETED|Overall Study||0
11104860|NCT01251588|12289188|FG001|NOT COMPLETED|Overall Study||4
11104861|NCT01251614|12289199|FG000|STARTED|Overall Study||37
11104862|NCT01251614|12289200|FG001|STARTED|Overall Study||39
11104863|NCT01251614|12289201|FG002|STARTED|Overall Study||38
11104864|NCT01251614|12289199|FG000|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
11104865|NCT01251614|12289200|FG001|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
11104866|NCT01251614|12289201|FG002|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
11104867|NCT01251614|12289199|FG000|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
11104868|NCT01251614|12289200|FG001|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
11104869|NCT01251614|12289201|FG002|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
11104870|NCT01251614|12289199|FG000|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
11104871|NCT01251614|12289200|FG001|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
11104872|NCT01251614|12289201|FG002|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
11104873|NCT01251614|12289199|FG000|COMPLETED|Overall Study||34
11104874|NCT01251614|12289200|FG001|COMPLETED|Overall Study||26
11104875|NCT01251614|12289201|FG002|COMPLETED|Overall Study||30
11104876|NCT01251614|12289199|FG000|NOT COMPLETED|Overall Study||3
11104877|NCT01251614|12289200|FG001|NOT COMPLETED|Overall Study||13
11104878|NCT01251614|12289201|FG002|NOT COMPLETED|Overall Study||8
11104879|NCT01251653|12289228|FG000|STARTED|Overall Study||3
11104880|NCT01251653|12289229|FG001|STARTED|Overall Study||8
11104881|NCT01251653|12289230|FG002|STARTED|Overall Study||20
11104882|NCT01251653|12289231|FG003|STARTED|Overall Study||6
11104883|NCT01251653|12289232|FG004|STARTED|Overall Study||2
11104884|NCT01251653|12289233|FG005|STARTED|Overall Study||18
11223101|NCT01975519|12414898|FG000|STARTED|Overall Study||3
11223102|NCT01975519|12414899|FG001|STARTED|Overall Study||108
11223103|NCT01975519|12414898|FG000|Phase 1b|Overall Study||3
11223104|NCT01975519|12414899|FG001|Phase 1b|Overall Study||23
11223105|NCT01975519|12414898|FG000|Phase 2a Soft Tissue Sarcoma|Overall Study||0
11223106|NCT01975519|12414899|FG001|Phase 2a Soft Tissue Sarcoma|Overall Study||63
10843912|NCT03420781|12009731|FG004|Safety Population|Treatment Period (40 Weeks)||0
10843913|NCT03420781|12009727|FG000|COMPLETED|Treatment Period (40 Weeks)||92
10843914|NCT03420781|12009728|FG001|COMPLETED|Treatment Period (40 Weeks)||105
10843915|NCT03420781|12009729|FG002|COMPLETED|Treatment Period (40 Weeks)||0
11104885|NCT01251653|12289234|FG006|STARTED|Overall Study||18
11223107|NCT01975519|12414898|FG000|Phase 2a Angiosarcoma Cohort|Overall Study||0
11223108|NCT01975519|12414899|FG001|Phase 2a Angiosarcoma Cohort|Overall Study||22
10843916|NCT03420781|12009730|FG003|COMPLETED|Treatment Period (40 Weeks)||0
10843917|NCT03420781|12009731|FG004|COMPLETED|Treatment Period (40 Weeks)||0
10843918|NCT03420781|12009727|FG000|NOT COMPLETED|Treatment Period (40 Weeks)||144
10843919|NCT03420781|12009728|FG001|NOT COMPLETED|Treatment Period (40 Weeks)||126
10843920|NCT03420781|12009729|FG002|NOT COMPLETED|Treatment Period (40 Weeks)||0
10843921|NCT03420781|12009730|FG003|NOT COMPLETED|Treatment Period (40 Weeks)||0
10843922|NCT03420781|12009731|FG004|NOT COMPLETED|Treatment Period (40 Weeks)||0
10843923|NCT03420781|12009727|FG000|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0
10843924|NCT03420781|12009728|FG001|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0
10843925|NCT03420781|12009729|FG002|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||91
10843926|NCT03420781|12009730|FG003|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||59
10843927|NCT03420781|12009731|FG004|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||43
10843928|NCT03420781|12009727|FG000|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
10843929|NCT03420781|12009728|FG001|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
10843930|NCT03420781|12009729|FG002|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||85
10843931|NCT03420781|12009730|FG003|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||54
10843932|NCT03420781|12009731|FG004|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||38
10843933|NCT03420781|12009727|FG000|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
10843934|NCT03420781|12009728|FG001|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
10843935|NCT03420781|12009729|FG002|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||6
10843936|NCT03420781|12009730|FG003|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5
10843937|NCT03420781|12009731|FG004|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5
10843938|NCT03316586|12009747|FG000|STARTED|Overall Study||18
10843939|NCT03316586|12009747|FG000|COMPLETED|Overall Study||0
10843940|NCT03316586|12009747|FG000|NOT COMPLETED|Overall Study||18
10843941|NCT03277066|12009754|FG000|STARTED|Overall Study||71
10843942|NCT03277066|12009755|FG001|STARTED|Overall Study||72
10843943|NCT03277066|12009756|FG002|STARTED|Overall Study||146
10843944|NCT03277066|12009754|FG000|COMPLETED|Overall Study||69
10843945|NCT03277066|12009755|FG001|COMPLETED|Overall Study||71
10843946|NCT03277066|12009756|FG002|COMPLETED|Overall Study||143
10843947|NCT03277066|12009754|FG000|NOT COMPLETED|Overall Study||2
10843948|NCT03277066|12009755|FG001|NOT COMPLETED|Overall Study||1
10843949|NCT03277066|12009756|FG002|NOT COMPLETED|Overall Study||3
10843950|NCT03269695|12009766|FG000|STARTED|Overall Study||10
11223109|NCT01975519|12414898|FG000|COMPLETED|Overall Study||3
11223110|NCT01975519|12414899|FG001|COMPLETED|Overall Study||108
11223111|NCT01975519|12414898|FG000|NOT COMPLETED|Overall Study||0
11223112|NCT01975519|12414899|FG001|NOT COMPLETED|Overall Study||0
11223113|NCT01975675|12414917|FG000|STARTED|Overall Study||83
11223114|NCT01975675|12414918|FG001|STARTED|Overall Study||83
11223115|NCT01975675|12414919|FG002|STARTED|Overall Study||88
11223116|NCT01975675|12414920|FG003|STARTED|Overall Study||87
11223117|NCT01975675|12414917|FG000|COMPLETED|Overall Study||83
11223118|NCT01975675|12414918|FG001|COMPLETED|Overall Study||82
11223119|NCT01975675|12414919|FG002|COMPLETED|Overall Study||88
11223120|NCT01975675|12414920|FG003|COMPLETED|Overall Study||87
11223121|NCT01975675|12414917|FG000|NOT COMPLETED|Overall Study||0
11223122|NCT01975675|12414918|FG001|NOT COMPLETED|Overall Study||1
11223123|NCT01975675|12414919|FG002|NOT COMPLETED|Overall Study||0
11223124|NCT01975675|12414920|FG003|NOT COMPLETED|Overall Study||0
11223125|NCT01975701|12414930|FG000|STARTED|Overall Study||26
11223126|NCT01975701|12414930|FG000|COMPLETED|Overall Study||1
11223127|NCT01975701|12414930|FG000|NOT COMPLETED|Overall Study||25
11223128|NCT01975831|12414943|FG000|STARTED|Overall Study||3
11223129|NCT01975831|12414944|FG001|STARTED|Overall Study||11
11223130|NCT01975831|12414945|FG002|STARTED|Overall Study||4
11223131|NCT01975831|12414946|FG003|STARTED|Overall Study||4
11223132|NCT01975831|12414947|FG004|STARTED|Overall Study||19
11223133|NCT01975831|12414948|FG005|STARTED|Overall Study||16
11223134|NCT01975831|12414949|FG006|STARTED|Overall Study||16
11223135|NCT01975831|12414950|FG007|STARTED|Overall Study||16
11223136|NCT01975831|12414951|FG008|STARTED|Overall Study||15
11223137|NCT01975831|12414943|FG000|COMPLETED|Overall Study||0
11223138|NCT01975831|12414944|FG001|COMPLETED|Overall Study||2
11223139|NCT01975831|12414945|FG002|COMPLETED|Overall Study||0
11223140|NCT01975831|12414946|FG003|COMPLETED|Overall Study||0
11223141|NCT01975831|12414947|FG004|COMPLETED|Overall Study||1
11223142|NCT01975831|12414948|FG005|COMPLETED|Overall Study||2
11223143|NCT01975831|12414949|FG006|COMPLETED|Overall Study||0
11223144|NCT01975831|12414950|FG007|COMPLETED|Overall Study||1
11223145|NCT01975831|12414951|FG008|COMPLETED|Overall Study||3
11223146|NCT01975831|12414943|FG000|NOT COMPLETED|Overall Study||3
11223147|NCT01975831|12414944|FG001|NOT COMPLETED|Overall Study||9
11223148|NCT01975831|12414945|FG002|NOT COMPLETED|Overall Study||4
11223149|NCT01975831|12414946|FG003|NOT COMPLETED|Overall Study||4
11223150|NCT01975831|12414947|FG004|NOT COMPLETED|Overall Study||18
11223151|NCT01975831|12414948|FG005|NOT COMPLETED|Overall Study||14
11223152|NCT01975831|12414949|FG006|NOT COMPLETED|Overall Study||16
11223153|NCT01975831|12414950|FG007|NOT COMPLETED|Overall Study||15
11223154|NCT01975831|12414951|FG008|NOT COMPLETED|Overall Study||12
11223155|NCT01975909|12414973|FG000|STARTED|Overall Study||10
11223156|NCT01975909|12414974|FG001|STARTED|Overall Study||10
11223157|NCT01975909|12414973|FG000|COMPLETED|Overall Study||10
11223158|NCT01975909|12414974|FG001|COMPLETED|Overall Study||10
11223159|NCT01975909|12414973|FG000|NOT COMPLETED|Overall Study||0
11223160|NCT01975909|12414974|FG001|NOT COMPLETED|Overall Study||0
11223161|NCT01975922|12414982|FG000|STARTED|Overall Study||45
11223162|NCT01975922|12414983|FG001|STARTED|Overall Study||52
11223163|NCT01975922|12414982|FG000|COMPLETED|Overall Study||45
11223164|NCT01975922|12414983|FG001|COMPLETED|Overall Study||43
11223165|NCT01975922|12414982|FG000|NOT COMPLETED|Overall Study||0
11223166|NCT01975922|12414983|FG001|NOT COMPLETED|Overall Study||9
11223167|NCT01975935|12414991|FG000|STARTED|Overall Study||21
11223168|NCT01975935|12414992|FG001|STARTED|Overall Study||21
11223169|NCT01975935|12414991|FG000|COMPLETED|Overall Study||18
10843951|NCT03269695|12009767|FG001|STARTED|Overall Study||10
10843952|NCT03269695|12009766|FG000|Treated|Overall Study||10
11223170|NCT01975935|12414992|FG001|COMPLETED|Overall Study||20
11223171|NCT01975935|12414991|FG000|NOT COMPLETED|Overall Study||3
11223172|NCT01975935|12414992|FG001|NOT COMPLETED|Overall Study||1
11223173|NCT01975948|12415002|FG000|STARTED|Overall Study||56
11223174|NCT01975948|12415003|FG001|STARTED|Overall Study||55
11223175|NCT01975948|12415004|FG002|STARTED|Overall Study||72
11223176|NCT01975948|12415005|FG003|STARTED|Overall Study||57
11223177|NCT01975948|12415002|FG000|COMPLETED|Overall Study||39
11223178|NCT01975948|12415003|FG001|COMPLETED|Overall Study||34
11223179|NCT01975948|12415004|FG002|COMPLETED|Overall Study||65
11223180|NCT01975948|12415005|FG003|COMPLETED|Overall Study||51
11223181|NCT01975948|12415002|FG000|NOT COMPLETED|Overall Study||17
11223182|NCT01975948|12415003|FG001|NOT COMPLETED|Overall Study||21
11223183|NCT01975948|12415004|FG002|NOT COMPLETED|Overall Study||7
11223184|NCT01975948|12415005|FG003|NOT COMPLETED|Overall Study||6
10843953|NCT03269695|12009767|FG001|Treated|Overall Study||10
10843954|NCT03269695|12009766|FG000|COMPLETED|Overall Study||8
10843955|NCT03269695|12009767|FG001|COMPLETED|Overall Study||7
10843956|NCT03269695|12009766|FG000|NOT COMPLETED|Overall Study||2
11223185|NCT01975974|12415015|FG000|STARTED|Overall Study||100
11223186|NCT01975974|12415015|FG000|COMPLETED|Overall Study||100
11223187|NCT01975974|12415015|FG000|NOT COMPLETED|Overall Study||0
11223188|NCT01976104|12415023|FG000|STARTED|Overall Study||43
10843957|NCT03269695|12009767|FG001|NOT COMPLETED|Overall Study||3
10843958|NCT03268811|12009776|FG000|STARTED|Overall Study||7
10843959|NCT03268811|12009777|FG001|STARTED|Overall Study||2
10843960|NCT03268811|12009776|FG000|COMPLETED|Overall Study||7
10843961|NCT03268811|12009777|FG001|COMPLETED|Overall Study||1
10843962|NCT03268811|12009776|FG000|NOT COMPLETED|Overall Study||0
10843963|NCT03268811|12009777|FG001|NOT COMPLETED|Overall Study||1
10843964|NCT03227757|12009784|FG000|STARTED|Overall Study||85
10843965|NCT03227757|12009784|FG000|COMPLETED|Overall Study||69
10843966|NCT03227757|12009784|FG000|NOT COMPLETED|Overall Study||16
10843967|NCT03222128|12009788|FG000|STARTED|Overall Study||1074
10843968|NCT03222128|12009788|FG000|Valve-Implanted|Overall Study||1069
10843969|NCT03222128|12009788|FG000|COMPLETED|Overall Study||968
10843970|NCT03222128|12009788|FG000|NOT COMPLETED|Overall Study||106
10843971|NCT03142334|12009794|FG000|STARTED|Overall Study||496
10843972|NCT03142334|12009795|FG001|STARTED|Overall Study||498
11223189|NCT01976104|12415024|FG001|STARTED|Overall Study||70
11223190|NCT01976104|12415025|FG002|STARTED|Overall Study||33
11223191|NCT01976104|12415026|FG003|STARTED|Overall Study||58
11223192|NCT01976104|12415023|FG000|COMPLETED|Overall Study||37
11223193|NCT01976104|12415024|FG001|COMPLETED|Overall Study||68
11223194|NCT01976104|12415025|FG002|COMPLETED|Overall Study||31
11223195|NCT01976104|12415026|FG003|COMPLETED|Overall Study||55
11223196|NCT01976104|12415023|FG000|NOT COMPLETED|Overall Study||6
11223197|NCT01976104|12415024|FG001|NOT COMPLETED|Overall Study||2
11223198|NCT01976104|12415025|FG002|NOT COMPLETED|Overall Study||2
11223199|NCT01976104|12415026|FG003|NOT COMPLETED|Overall Study||3
11223200|NCT01976299|12415039|FG000|STARTED|Overall Study||292
11223201|NCT01976299|12415040|FG001|STARTED|Overall Study||286
11223202|NCT01976299|12415039|FG000|Completed Procedure|Overall Study||283
11223203|NCT01976299|12415040|FG001|Completed Procedure|Overall Study||284
11223204|NCT01976299|12415039|FG000|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
11223205|NCT01976299|12415040|FG001|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
11223206|NCT01976299|12415039|FG000|NOT COMPLETED|Overall Study||23
11223207|NCT01976299|12415040|FG001|NOT COMPLETED|Overall Study||6
11223208|NCT01976312|12415048|FG000|STARTED|Overall Study||190
11223209|NCT01976312|12415049|FG001|STARTED|Overall Study||62
10843973|NCT03142334|12009794|FG000|Treated|Overall Study||488
10843974|NCT03142334|12009795|FG001|Treated|Overall Study||496
10843975|NCT03142334|12009794|FG000|Continuing Study Treatment|Overall Study||0
10843976|NCT03142334|12009795|FG001|Continuing Study Treatment|Overall Study||1
10843977|NCT03142334|12009794|FG000|Completed Study Treatment|Overall Study||298
10843978|NCT03142334|12009795|FG001|Completed Study Treatment|Overall Study||365
10843979|NCT03142334|12009794|FG000|Discontinued Study Treatment|Overall Study||190
10843980|NCT03142334|12009795|FG001|Discontinued Study Treatment|Overall Study||130
10843981|NCT03142334|12009794|FG000|COMPLETED|Overall Study||0
10843982|NCT03142334|12009795|FG001|COMPLETED|Overall Study||0
10843983|NCT03142334|12009794|FG000|NOT COMPLETED|Overall Study||496
10843984|NCT03142334|12009795|FG001|NOT COMPLETED|Overall Study||498
10843985|NCT03093701|12009804|FG000|STARTED|Overall Study||10
10843986|NCT03093701|12009805|FG001|STARTED|Overall Study||10
10843987|NCT03093701|12009806|FG002|STARTED|Overall Study||11
10843988|NCT03093701|12009807|FG003|STARTED|Overall Study||0
10843989|NCT03093701|12009804|FG000|COMPLETED|Overall Study||10
10843990|NCT03093701|12009805|FG001|COMPLETED|Overall Study||7
10843991|NCT03093701|12009806|FG002|COMPLETED|Overall Study||11
10843992|NCT03093701|12009807|FG003|COMPLETED|Overall Study||0
10843993|NCT03093701|12009804|FG000|NOT COMPLETED|Overall Study||0
10843994|NCT03093701|12009805|FG001|NOT COMPLETED|Overall Study||3
10843995|NCT03093701|12009806|FG002|NOT COMPLETED|Overall Study||0
10843996|NCT03093701|12009807|FG003|NOT COMPLETED|Overall Study||0
10843997|NCT03093246|12009817|FG000|STARTED|Overall Study||19
10843998|NCT03093246|12009818|FG001|STARTED|Overall Study||19
10843999|NCT03093246|12009817|FG000|COMPLETED|Overall Study||19
10844000|NCT03093246|12009818|FG001|COMPLETED|Overall Study||19
10844001|NCT03093246|12009817|FG000|NOT COMPLETED|Overall Study||0
10844002|NCT03093246|12009818|FG001|NOT COMPLETED|Overall Study||0
10844003|NCT02991599|12009826|FG000|STARTED|Overall Study||98
10844004|NCT02991599|12009827|FG001|STARTED|Overall Study||98
10844005|NCT02991599|12009826|FG000|COMPLETED|Overall Study||60
10844006|NCT02991599|12009827|FG001|COMPLETED|Overall Study||61
10844007|NCT02991599|12009826|FG000|NOT COMPLETED|Overall Study||38
10844008|NCT02991599|12009827|FG001|NOT COMPLETED|Overall Study||37
10844009|NCT02976129|12009835|FG000|STARTED|Overall Study||82
10844010|NCT02976129|12009836|FG001|STARTED|Overall Study||43
10844011|NCT02976129|12009835|FG000|COMPLETED|Overall Study||77
10844012|NCT02976129|12009836|FG001|COMPLETED|Overall Study||41
10844013|NCT02976129|12009835|FG000|NOT COMPLETED|Overall Study||5
10844014|NCT02976129|12009836|FG001|NOT COMPLETED|Overall Study||2
10844015|NCT02970136|12009844|FG000|STARTED|Overall Study||377
10844016|NCT02970136|12009845|FG001|STARTED|Overall Study||377
10844017|NCT02970136|12009844|FG000|COMPLETED|Overall Study||297
10844018|NCT02970136|12009845|FG001|COMPLETED|Overall Study||282
10844019|NCT02970136|12009844|FG000|NOT COMPLETED|Overall Study||80
10844020|NCT02970136|12009845|FG001|NOT COMPLETED|Overall Study||95
10844021|NCT02969928|12009853|FG000|STARTED|Overall Study||23
10844022|NCT02969928|12009854|FG001|STARTED|Overall Study||23
10844023|NCT02969928|12009853|FG000|COMPLETED|Overall Study||23
10844024|NCT02969928|12009854|FG001|COMPLETED|Overall Study||23
10844025|NCT02969928|12009853|FG000|NOT COMPLETED|Overall Study||0
10844026|NCT02969928|12009854|FG001|NOT COMPLETED|Overall Study||0
10844027|NCT02949297|12009860|FG000|STARTED|1 Month||75
10844028|NCT02949297|12009860|FG000|COMPLETED|1 Month||75
10844029|NCT02949297|12009860|FG000|NOT COMPLETED|1 Month||0
10844030|NCT02949297|12009860|FG000|STARTED|6 Months||75
10844031|NCT02949297|12009860|FG000|COMPLETED|6 Months||72
10844032|NCT02949297|12009860|FG000|NOT COMPLETED|6 Months||3
10844033|NCT02949297|12009860|FG000|STARTED|12 Months||72
10844034|NCT02949297|12009860|FG000|COMPLETED|12 Months||67
10844035|NCT02949297|12009860|FG000|NOT COMPLETED|12 Months||5
10844036|NCT02945787|12009866|FG000|STARTED|Overall Study||714
10844037|NCT02945787|12009867|FG001|STARTED|Overall Study||703
10844038|NCT02945787|12009866|FG000|COMPLETED|Overall Study||714
10844039|NCT02945787|12009867|FG001|COMPLETED|Overall Study||703
10844040|NCT02945787|12009866|FG000|NOT COMPLETED|Overall Study||0
10844041|NCT02945787|12009867|FG001|NOT COMPLETED|Overall Study||0
10844042|NCT02857426|12009875|FG000|STARTED|Overall Study||47
10844043|NCT02857426|12009876|FG001|STARTED|Overall Study||19
10844044|NCT02857426|12009875|FG000|COMPLETED|Overall Study||0
10844045|NCT02857426|12009876|FG001|COMPLETED|Overall Study||0
10844046|NCT02857426|12009875|FG000|NOT COMPLETED|Overall Study||47
10844047|NCT02857426|12009876|FG001|NOT COMPLETED|Overall Study||19
10844048|NCT02855125|12009884|FG000|STARTED|Overall Study||64
10844049|NCT02855125|12009885|FG001|STARTED|Overall Study||64
10844050|NCT02855125|12009884|FG000|Treated|Overall Study||64
10844051|NCT02855125|12009885|FG001|Treated|Overall Study||63
10844052|NCT02855125|12009884|FG000|COMPLETED|Overall Study||0
10844053|NCT02855125|12009885|FG001|COMPLETED|Overall Study||0
10844054|NCT02855125|12009884|FG000|NOT COMPLETED|Overall Study||64
10844055|NCT02855125|12009885|FG001|NOT COMPLETED|Overall Study||64
10844056|NCT02728752|12009893|FG000|STARTED|First Period||48
10844057|NCT02728752|12009894|FG001|STARTED|First Period||47
10844058|NCT02728752|12009893|FG000|COMPLETED|First Period||46
10844059|NCT02728752|12009894|FG001|COMPLETED|First Period||45
10844060|NCT02728752|12009893|FG000|NOT COMPLETED|First Period||2
10844061|NCT02728752|12009894|FG001|NOT COMPLETED|First Period||2
10844062|NCT02728752|12009893|FG000|STARTED|Extension Period||46
10844063|NCT02728752|12009894|FG001|STARTED|Extension Period||45
10844064|NCT02728752|12009893|FG000|COMPLETED|Extension Period||35
10844065|NCT02728752|12009894|FG001|COMPLETED|Extension Period||34
10844066|NCT02728752|12009893|FG000|NOT COMPLETED|Extension Period||11
10844067|NCT02728752|12009894|FG001|NOT COMPLETED|Extension Period||11
11104886|NCT01251653|12289235|FG007|STARTED|Overall Study||12
11104887|NCT01251653|12289236|FG008|STARTED|Overall Study||6
11104888|NCT01251653|12289228|FG000|COMPLETED|Overall Study||0
11104889|NCT01251653|12289229|FG001|COMPLETED|Overall Study||0
11104890|NCT01251653|12289230|FG002|COMPLETED|Overall Study||0
11104891|NCT01251653|12289231|FG003|COMPLETED|Overall Study||0
10844074|NCT02667639|12009916|FG000|STARTED|Overall Study||25
10844075|NCT02667639|12009917|FG001|STARTED|Overall Study||10
10844076|NCT02667639|12009916|FG000|COMPLETED|Overall Study||25
10844077|NCT02667639|12009917|FG001|COMPLETED|Overall Study||10
10844078|NCT02667639|12009916|FG000|NOT COMPLETED|Overall Study||0
10844079|NCT02667639|12009917|FG001|NOT COMPLETED|Overall Study||0
10844080|NCT02527798|12009931|FG000|STARTED|Overall Study||32
10844081|NCT02527798|12009932|FG001|STARTED|Overall Study||10
10844082|NCT02527798|12009933|FG002|STARTED|Overall Study||30
10844083|NCT02527798|12009934|FG003|STARTED|Overall Study||10
10844084|NCT02527798|12009935|FG004|STARTED|Overall Study||0
10844085|NCT02527798|12009936|FG005|STARTED|Overall Study||0
10844086|NCT02527798|12009931|FG000|Randomized, Not Dosed|Overall Study||31
10844087|NCT02527798|12009932|FG001|Randomized, Not Dosed|Overall Study||9
10844088|NCT02527798|12009933|FG002|Randomized, Not Dosed|Overall Study||30
10844089|NCT02527798|12009934|FG003|Randomized, Not Dosed|Overall Study||10
10844090|NCT02527798|12009935|FG004|Randomized, Not Dosed|Overall Study||0
10844091|NCT02527798|12009936|FG005|Randomized, Not Dosed|Overall Study||0
10844092|NCT02527798|12009931|FG000|Pharmacokinetic (PK) Population|Overall Study||20
10844093|NCT02527798|12009932|FG001|Pharmacokinetic (PK) Population|Overall Study||0
10844094|NCT02527798|12009933|FG002|Pharmacokinetic (PK) Population|Overall Study||19
10844095|NCT02527798|12009934|FG003|Pharmacokinetic (PK) Population|Overall Study||0
10844096|NCT02527798|12009935|FG004|Pharmacokinetic (PK) Population|Overall Study||0
10844097|NCT02527798|12009936|FG005|Pharmacokinetic (PK) Population|Overall Study||0
10844098|NCT02527798|12009931|FG000|COMPLETED|Overall Study||29
10844099|NCT02527798|12009932|FG001|COMPLETED|Overall Study||8
10844100|NCT02527798|12009933|FG002|COMPLETED|Overall Study||25
10844101|NCT02527798|12009934|FG003|COMPLETED|Overall Study||9
10844102|NCT02527798|12009935|FG004|COMPLETED|Overall Study||0
10844103|NCT02527798|12009936|FG005|COMPLETED|Overall Study||0
10844104|NCT02527798|12009931|FG000|NOT COMPLETED|Overall Study||3
10844105|NCT02527798|12009932|FG001|NOT COMPLETED|Overall Study||2
10844106|NCT02527798|12009933|FG002|NOT COMPLETED|Overall Study||5
10844107|NCT02527798|12009934|FG003|NOT COMPLETED|Overall Study||1
10844108|NCT02527798|12009935|FG004|NOT COMPLETED|Overall Study||0
10844109|NCT02527798|12009936|FG005|NOT COMPLETED|Overall Study||0
10844110|NCT02416492|12009967|FG000|STARTED|Overall Study||15
10844111|NCT02416492|12009968|FG001|STARTED|Overall Study||15
10844112|NCT02416492|12009969|FG002|STARTED|Overall Study||16
10844113|NCT02416492|12009970|FG003|STARTED|Overall Study||15
10844114|NCT02416492|12009967|FG000|COMPLETED|Overall Study||15
10844115|NCT02416492|12009968|FG001|COMPLETED|Overall Study||15
10844116|NCT02416492|12009969|FG002|COMPLETED|Overall Study||16
10844117|NCT02416492|12009970|FG003|COMPLETED|Overall Study||15
10844118|NCT02416492|12009967|FG000|NOT COMPLETED|Overall Study||0
10844119|NCT02416492|12009968|FG001|NOT COMPLETED|Overall Study||0
10844120|NCT02416492|12009969|FG002|NOT COMPLETED|Overall Study||0
10844121|NCT02416492|12009970|FG003|NOT COMPLETED|Overall Study||0
10844122|NCT02324816|12009983|FG000|STARTED|Overall Study||19
10844123|NCT02324816|12009983|FG000|COMPLETED|Overall Study||19
10844124|NCT02324816|12009983|FG000|NOT COMPLETED|Overall Study||0
10844125|NCT02279745|12009987|FG000|STARTED|Overall Study||45
10844126|NCT02279745|12009987|FG000|COMPLETED|Overall Study||25
10844127|NCT02279745|12009987|FG000|NOT COMPLETED|Overall Study||20
10844128|NCT02067975|12009993|FG000|STARTED|Overall Study||20
10844129|NCT02067975|12009994|FG001|STARTED|Overall Study||18
10844130|NCT02067975|12009995|FG002|STARTED|Overall Study||21
10844131|NCT02067975|12009996|FG003|STARTED|Overall Study||18
10844132|NCT02067975|12009997|FG004|STARTED|Overall Study||8
10844133|NCT02067975|12009998|FG005|STARTED|Overall Study||8
10844134|NCT02067975|12009993|FG000|COMPLETED|Overall Study||16
10844135|NCT02067975|12009994|FG001|COMPLETED|Overall Study||16
10844136|NCT02067975|12009995|FG002|COMPLETED|Overall Study||19
10844137|NCT02067975|12009996|FG003|COMPLETED|Overall Study||14
10844138|NCT02067975|12009997|FG004|COMPLETED|Overall Study||0
10844139|NCT02067975|12009998|FG005|COMPLETED|Overall Study||0
10844140|NCT02067975|12009993|FG000|NOT COMPLETED|Overall Study||4
10844141|NCT02067975|12009994|FG001|NOT COMPLETED|Overall Study||2
10844142|NCT02067975|12009995|FG002|NOT COMPLETED|Overall Study||2
10844143|NCT02067975|12009996|FG003|NOT COMPLETED|Overall Study||4
10844144|NCT02067975|12009997|FG004|NOT COMPLETED|Overall Study||8
10844145|NCT02067975|12009998|FG005|NOT COMPLETED|Overall Study||8
10844146|NCT02030938|12010010|FG000|STARTED|Overall Study||34
10844147|NCT02030938|12010010|FG000|COMPLETED|Overall Study||29
10844148|NCT02030938|12010010|FG000|NOT COMPLETED|Overall Study||5
10844149|NCT02006147|12010022|FG000|STARTED|Overall Study||5
10844150|NCT02006147|12010023|FG001|STARTED|Overall Study||9
10844151|NCT02006147|12010024|FG002|STARTED|Overall Study||0
10844152|NCT02006147|12010025|FG003|STARTED|Overall Study||0
10844153|NCT02006147|12010022|FG000|COMPLETED|Overall Study||3
10844154|NCT02006147|12010023|FG001|COMPLETED|Overall Study||7
10844155|NCT02006147|12010024|FG002|COMPLETED|Overall Study||0
10844156|NCT02006147|12010025|FG003|COMPLETED|Overall Study||0
10844157|NCT02006147|12010022|FG000|NOT COMPLETED|Overall Study||2
10844158|NCT02006147|12010023|FG001|NOT COMPLETED|Overall Study||2
10844159|NCT02006147|12010024|FG002|NOT COMPLETED|Overall Study||0
10844160|NCT02006147|12010025|FG003|NOT COMPLETED|Overall Study||0
10844161|NCT01925794|12010031|FG000|STARTED|30 Days||296
10844162|NCT01925794|12010031|FG000|COMPLETED|30 Days||296
10844163|NCT01925794|12010031|FG000|NOT COMPLETED|30 Days||0
10844164|NCT01925794|12010031|FG000|STARTED|180 Days||296
10844165|NCT01925794|12010031|FG000|COMPLETED|180 Days||292
10844166|NCT01925794|12010031|FG000|NOT COMPLETED|180 Days||4
10844167|NCT01925794|12010031|FG000|STARTED|270 Days||292
10844168|NCT01925794|12010031|FG000|COMPLETED|270 Days||287
10844169|NCT01925794|12010031|FG000|NOT COMPLETED|270 Days||5
10844170|NCT01907360|12010041|FG000|STARTED|Overall Study||18
10844171|NCT01907360|12010042|FG001|STARTED|Overall Study||11
10844172|NCT01907360|12010041|FG000|COMPLETED|Overall Study||18
10844173|NCT01907360|12010042|FG001|COMPLETED|Overall Study||11
10844174|NCT01907360|12010041|FG000|NOT COMPLETED|Overall Study||0
10844175|NCT01907360|12010042|FG001|NOT COMPLETED|Overall Study||0
10844176|NCT01856868|12010048|FG000|STARTED|Overall Study||7
10844177|NCT01856868|12010048|FG000|COMPLETED|Overall Study||7
10844178|NCT01856868|12010048|FG000|NOT COMPLETED|Overall Study||0
10844179|NCT01849250|12010054|FG000|STARTED|Overall Study||32
10844180|NCT01849250|12010055|FG001|STARTED|Overall Study||32
10844181|NCT01849250|12010054|FG000|COMPLETED|Overall Study||25
10844182|NCT01849250|12010055|FG001|COMPLETED|Overall Study||29
10844183|NCT01849250|12010054|FG000|NOT COMPLETED|Overall Study||7
10844184|NCT01849250|12010055|FG001|NOT COMPLETED|Overall Study||3
10844185|NCT01592643|12010062|FG000|STARTED|Overall Study||30
10844186|NCT01592643|12010062|FG000|COMPLETED|Overall Study||30
10844187|NCT01592643|12010062|FG000|NOT COMPLETED|Overall Study||0
10844188|NCT01441115|12010066|FG000|STARTED|Overall Study||2
10844189|NCT01441115|12010066|FG000|COMPLETED|Overall Study||1
10844190|NCT01441115|12010066|FG000|NOT COMPLETED|Overall Study||1
10844191|NCT01199302|12010077|FG000|STARTED|Overall Study||20
10844192|NCT01199302|12010078|FG001|STARTED|Overall Study||16
10844193|NCT01199302|12010079|FG002|STARTED|Overall Study||20
10844194|NCT01199302|12010080|FG003|STARTED|Overall Study||11
10844195|NCT01199302|12010077|FG000|COMPLETED|Overall Study||0
10844196|NCT01199302|12010078|FG001|COMPLETED|Overall Study||0
10844197|NCT01199302|12010079|FG002|COMPLETED|Overall Study||0
10844198|NCT01199302|12010080|FG003|COMPLETED|Overall Study||0
10844199|NCT01199302|12010077|FG000|NOT COMPLETED|Overall Study||20
10844200|NCT01199302|12010078|FG001|NOT COMPLETED|Overall Study||16
10844201|NCT01199302|12010079|FG002|NOT COMPLETED|Overall Study||20
10844202|NCT01199302|12010080|FG003|NOT COMPLETED|Overall Study||11
10844203|NCT01123707|12010091|FG000|STARTED|Overall Study||44
10844204|NCT01123707|12010092|FG001|STARTED|Overall Study||41
10844205|NCT01123707|12010093|FG002|STARTED|Overall Study||38
10844206|NCT01123707|12010094|FG003|STARTED|Overall Study||50
10844207|NCT01123707|12010091|FG000|Safety Sample|Overall Study||44
10844208|NCT01123707|12010092|FG001|Safety Sample|Overall Study||41
10844209|NCT01123707|12010093|FG002|Safety Sample|Overall Study||36
10844210|NCT01123707|12010094|FG003|Safety Sample|Overall Study||49
10844211|NCT01123707|12010091|FG000|COMPLETED|Overall Study||0
10844212|NCT01123707|12010092|FG001|COMPLETED|Overall Study||0
10844213|NCT01123707|12010093|FG002|COMPLETED|Overall Study||0
10844214|NCT01123707|12010094|FG003|COMPLETED|Overall Study||0
10844215|NCT01123707|12010091|FG000|NOT COMPLETED|Overall Study||44
10844216|NCT01123707|12010092|FG001|NOT COMPLETED|Overall Study||41
10844217|NCT01123707|12010093|FG002|NOT COMPLETED|Overall Study||38
10844218|NCT01123707|12010094|FG003|NOT COMPLETED|Overall Study||50
10844219|NCT00894244|12010104|FG000|STARTED|Overall Study||25
10844220|NCT00894244|12010104|FG000|COMPLETED|Overall Study||24
10844221|NCT00894244|12010104|FG000|NOT COMPLETED|Overall Study||1
10844222|NCT00462943|12010111|FG000|STARTED|Overall Study||46
10844223|NCT00462943|12010112|FG001|STARTED|Overall Study||31
10844224|NCT00462943|12010113|FG002|STARTED|Overall Study||23
10844225|NCT00462943|12010111|FG000|COMPLETED|Overall Study||1
10844226|NCT00462943|12010112|FG001|COMPLETED|Overall Study||1
10844227|NCT00462943|12010113|FG002|COMPLETED|Overall Study||0
11223210|NCT01976312|12415048|FG000|Completed 3 Months|Overall Study||186
11223211|NCT01976312|12415049|FG001|Completed 3 Months|Overall Study||60
11223212|NCT01976312|12415048|FG000|Discontinued Study Prior to 3 Months|Overall Study||4
11223213|NCT01976312|12415049|FG001|Discontinued Study Prior to 3 Months|Overall Study||2
11223214|NCT01976312|12415048|FG000|COMPLETED|Overall Study|Completed study at 12 months|173
11223215|NCT01976312|12415049|FG001|COMPLETED|Overall Study|Completed study at 12 months|53
11223216|NCT01976312|12415048|FG000|NOT COMPLETED|Overall Study||17
11223217|NCT01976312|12415049|FG001|NOT COMPLETED|Overall Study||9
11223218|NCT01976338|12415058|FG000|STARTED|Overall Study||190
11223219|NCT01976338|12415059|FG001|STARTED|Overall Study||93
11223220|NCT01976338|12415058|FG000|Completed 6 Months|Overall Study||185
11223221|NCT01976338|12415059|FG001|Completed 6 Months|Overall Study||91
11223222|NCT01976338|12415058|FG000|Discontinued Study Prior to 6 Months|Overall Study||5
11223223|NCT01976338|12415059|FG001|Discontinued Study Prior to 6 Months|Overall Study||2
11223224|NCT01976338|12415058|FG000|COMPLETED|Overall Study|12 months|177
11223225|NCT01976338|12415059|FG001|COMPLETED|Overall Study|12 months|89
11223226|NCT01976338|12415058|FG000|NOT COMPLETED|Overall Study||13
11223227|NCT01976338|12415059|FG001|NOT COMPLETED|Overall Study||4
11223228|NCT01976364|12415066|FG000|STARTED|Main Study (36 Months)||686
11223229|NCT01976364|12415067|FG001|STARTED|Main Study (36 Months)||0
11223230|NCT01976364|12415068|FG002|STARTED|Main Study (36 Months)||0
11223231|NCT01976364|12415066|FG000|COMPLETED|Main Study (36 Months)||465
11223232|NCT01976364|12415067|FG001|COMPLETED|Main Study (36 Months)||0
11223233|NCT01976364|12415068|FG002|COMPLETED|Main Study (36 Months)||0
11223234|NCT01976364|12415066|FG000|NOT COMPLETED|Main Study (36 Months)||221
11223235|NCT01976364|12415067|FG001|NOT COMPLETED|Main Study (36 Months)||0
11223236|NCT01976364|12415068|FG002|NOT COMPLETED|Main Study (36 Months)||0
11223237|NCT01976364|12415066|FG000|STARTED|Sub-study (12 Months)||0
11223238|NCT01976364|12415067|FG001|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|89
11223239|NCT01976364|12415068|FG002|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|90
11223240|NCT01976364|12415066|FG000|COMPLETED|Sub-study (12 Months)||0
11223241|NCT01976364|12415067|FG001|COMPLETED|Sub-study (12 Months)||83
11223242|NCT01976364|12415068|FG002|COMPLETED|Sub-study (12 Months)||85
11223243|NCT01976364|12415066|FG000|NOT COMPLETED|Sub-study (12 Months)||0
11223244|NCT01976364|12415067|FG001|NOT COMPLETED|Sub-study (12 Months)||6
11223245|NCT01976364|12415068|FG002|NOT COMPLETED|Sub-study (12 Months)||5
11223246|NCT01976390|12415079|FG000|STARTED|Overall Study||41
11223247|NCT01976390|12415080|FG001|STARTED|Overall Study||19
11223248|NCT01976390|12415079|FG000|COMPLETED|Overall Study||41
11223249|NCT01976390|12415080|FG001|COMPLETED|Overall Study||19
11223250|NCT01976390|12415079|FG000|NOT COMPLETED|Overall Study||0
11223251|NCT01976390|12415080|FG001|NOT COMPLETED|Overall Study||0
11223252|NCT01976416|12415088|FG000|STARTED|Overall Study||104
11223253|NCT01976416|12415089|FG001|STARTED|Overall Study||104
11223254|NCT01976416|12415088|FG000|COMPLETED|Overall Study||102
11223255|NCT01976416|12415089|FG001|COMPLETED|Overall Study||102
11223256|NCT01976416|12415088|FG000|NOT COMPLETED|Overall Study||2
11223257|NCT01976416|12415089|FG001|NOT COMPLETED|Overall Study||2
11223258|NCT01976442|12415097|FG000|STARTED|Overall Study||69
11223259|NCT01976442|12415098|FG001|STARTED|Overall Study||31
11223260|NCT01976442|12415097|FG000|COMPLETED|Overall Study||69
11223261|NCT01976442|12415098|FG001|COMPLETED|Overall Study||31
11223262|NCT01976442|12415097|FG000|NOT COMPLETED|Overall Study||0
11223263|NCT01976442|12415098|FG001|NOT COMPLETED|Overall Study||0
11223264|NCT01976507|12415104|FG000|STARTED|Overall Study||101
10844228|NCT00462943|12010111|FG000|NOT COMPLETED|Overall Study||45
10844229|NCT00462943|12010112|FG001|NOT COMPLETED|Overall Study||30
10844230|NCT00462943|12010113|FG002|NOT COMPLETED|Overall Study||23
10844231|NCT00248287|12010123|FG000|STARTED|Overall Study||75
10844232|NCT00248287|12010124|FG001|STARTED|Overall Study||79
10844233|NCT00248287|12010123|FG000|COMPLETED|Overall Study||51
10844234|NCT00248287|12010124|FG001|COMPLETED|Overall Study||60
10844235|NCT00248287|12010123|FG000|NOT COMPLETED|Overall Study||24
10844236|NCT00248287|12010124|FG001|NOT COMPLETED|Overall Study||19
10844237|NCT00182728|12010130|FG000|STARTED|Overall Study||71
10844238|NCT00182728|12010130|FG000|COMPLETED|Overall Study||71
10844239|NCT00182728|12010130|FG000|NOT COMPLETED|Overall Study||0
10844240|NCT00105560|12010134|FG000|STARTED|Overall Study||59
10844241|NCT00105560|12010134|FG000|COMPLETED|Overall Study||58
10844242|NCT00105560|12010134|FG000|NOT COMPLETED|Overall Study||1
10844243|NCT00038727|12010150|FG000|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
10844244|NCT00038727|12010151|FG001|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
10844245|NCT00038727|12010152|FG002|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
10844246|NCT00038727|12010150|FG000|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
10844247|NCT00038727|12010151|FG001|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
10844248|NCT00038727|12010152|FG002|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
10844249|NCT00038727|12010150|FG000|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
10844250|NCT00038727|12010151|FG001|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
10844251|NCT00038727|12010152|FG002|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
10844252|NCT00038727|12010150|FG000|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
10844253|NCT00038727|12010151|FG001|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
10844254|NCT00038727|12010152|FG002|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
10844255|NCT00038727|12010150|FG000|DPPOS Phase 3 Enrolled|Overall Study||916
10844256|NCT00038727|12010151|FG001|DPPOS Phase 3 Enrolled|Overall Study||927
10844257|NCT00038727|12010152|FG002|DPPOS Phase 3 Enrolled|Overall Study||936
10844258|NCT00038727|12010150|FG000|COMPLETED|Overall Study||916
10844259|NCT00038727|12010151|FG001|COMPLETED|Overall Study||927
10844260|NCT00038727|12010152|FG002|COMPLETED|Overall Study||936
10844261|NCT00038727|12010150|FG000|NOT COMPLETED|Overall Study||0
10844262|NCT00038727|12010151|FG001|NOT COMPLETED|Overall Study||0
10844263|NCT00038727|12010152|FG002|NOT COMPLETED|Overall Study||0
11223265|NCT01976507|12415104|FG000|Received Initial Dose of Dabigatran|Overall Study||100
11223266|NCT01976507|12415104|FG000|COMPLETED|Overall Study||94
11223267|NCT01976507|12415104|FG000|NOT COMPLETED|Overall Study||7
11223268|NCT01976572|12415108|FG000|STARTED|Overall Study||6
11223269|NCT01976572|12415109|FG001|STARTED|Overall Study||6
11223270|NCT01976572|12415110|FG002|STARTED|Overall Study||6
11223271|NCT01976572|12415108|FG000|COMPLETED|Overall Study||6
11223272|NCT01976572|12415109|FG001|COMPLETED|Overall Study||6
11223273|NCT01976572|12415110|FG002|COMPLETED|Overall Study||6
11223274|NCT01976572|12415108|FG000|NOT COMPLETED|Overall Study||0
11223275|NCT01976572|12415109|FG001|NOT COMPLETED|Overall Study||0
11223276|NCT01976572|12415110|FG002|NOT COMPLETED|Overall Study||0
11223277|NCT01976624|12415119|FG000|STARTED|Overall Study||756
11223278|NCT01976624|12415119|FG000|COMPLETED|Overall Study||742
11223279|NCT01976624|12415119|FG000|NOT COMPLETED|Overall Study||14
11223280|NCT01976650|12415123|FG000|STARTED|Overall Study||724
11223281|NCT01976650|12415123|FG000|COMPLETED|Overall Study||718
11223282|NCT01976650|12415123|FG000|NOT COMPLETED|Overall Study||6
11223283|NCT01976663|12415127|FG000|STARTED|Overall Study||126
11223284|NCT01976663|12415127|FG000|Received Touch-up Treatment|Overall Study||63
11223285|NCT01976663|12415127|FG000|Received Asymmetry Correction|Overall Study||45
11223286|NCT01976663|12415127|FG000|Received Repeat Treatment|Overall Study||85
10844264|NCT04569786|12010168|FG000|STARTED|Overall Study||39
10844265|NCT04569786|12010169|FG001|STARTED|Overall Study||39
10844266|NCT04569786|12010170|FG002|STARTED|Overall Study||42
10844267|NCT04569786|12010171|FG003|STARTED|Overall Study||56
10844268|NCT04569786|12010172|FG004|STARTED|Overall Study||56
10844269|NCT04569786|12010168|FG000|COMPLETED|Overall Study||38
10844270|NCT04569786|12010169|FG001|COMPLETED|Overall Study||39
10844271|NCT04569786|12010170|FG002|COMPLETED|Overall Study||38
10844272|NCT04569786|12010171|FG003|COMPLETED|Overall Study||49
10844273|NCT04569786|12010172|FG004|COMPLETED|Overall Study||55
10844274|NCT04569786|12010168|FG000|NOT COMPLETED|Overall Study||1
10844275|NCT04569786|12010169|FG001|NOT COMPLETED|Overall Study||0
10844276|NCT04569786|12010170|FG002|NOT COMPLETED|Overall Study||4
10844277|NCT04569786|12010171|FG003|NOT COMPLETED|Overall Study||7
10844278|NCT04569786|12010172|FG004|NOT COMPLETED|Overall Study||1
11223287|NCT01976663|12415127|FG000|COMPLETED|Overall Study||84
11223288|NCT01976663|12415127|FG000|NOT COMPLETED|Overall Study||42
11223289|NCT01976728|12415139|FG000|STARTED|Overall Study||10
11223290|NCT01976728|12415140|FG001|STARTED|Overall Study||9
11223291|NCT01976728|12415141|FG002|STARTED|Overall Study||10
11223292|NCT01976728|12415142|FG003|STARTED|Overall Study||10
11223293|NCT01976728|12415139|FG000|Dosed|Overall Study||10
11223294|NCT01976728|12415140|FG001|Dosed|Overall Study||9
11223295|NCT01976728|12415141|FG002|Dosed|Overall Study||10
11223296|NCT01976728|12415142|FG003|Dosed|Overall Study||10
11223297|NCT01976728|12415139|FG000|COMPLETED|Overall Study||9
11223298|NCT01976728|12415140|FG001|COMPLETED|Overall Study||9
11223299|NCT01976728|12415141|FG002|COMPLETED|Overall Study||10
11223300|NCT01976728|12415142|FG003|COMPLETED|Overall Study||10
11223301|NCT01976728|12415139|FG000|NOT COMPLETED|Overall Study||1
11223302|NCT01976728|12415140|FG001|NOT COMPLETED|Overall Study||0
11223303|NCT01976728|12415141|FG002|NOT COMPLETED|Overall Study||0
11223304|NCT01976728|12415142|FG003|NOT COMPLETED|Overall Study||0
11223305|NCT01976741|12415178|FG000|STARTED|Overall Study||4
11223306|NCT01976741|12415179|FG001|STARTED|Overall Study||4
11223307|NCT01976741|12415180|FG002|STARTED|Overall Study||4
11223308|NCT01976741|12415181|FG003|STARTED|Overall Study||3
11223309|NCT01976741|12415182|FG004|STARTED|Overall Study||4
11223310|NCT01976741|12415183|FG005|STARTED|Overall Study||4
11223311|NCT01976741|12415184|FG006|STARTED|Overall Study||23
11223312|NCT01976741|12415185|FG007|STARTED|Overall Study||74
11223313|NCT01976741|12415186|FG008|STARTED|Overall Study||8
11223314|NCT01976741|12415187|FG009|STARTED|Overall Study||40
11223315|NCT01976741|12415178|FG000|COMPLETED|Overall Study||3
11223316|NCT01976741|12415179|FG001|COMPLETED|Overall Study||4
11223317|NCT01976741|12415180|FG002|COMPLETED|Overall Study||1
11223318|NCT01976741|12415181|FG003|COMPLETED|Overall Study||2
11223319|NCT01976741|12415182|FG004|COMPLETED|Overall Study||4
11223320|NCT01976741|12415183|FG005|COMPLETED|Overall Study||4
11223321|NCT01976741|12415184|FG006|COMPLETED|Overall Study||19
11223322|NCT01976741|12415185|FG007|COMPLETED|Overall Study||62
11223323|NCT01976741|12415186|FG008|COMPLETED|Overall Study||7
11223324|NCT01976741|12415187|FG009|COMPLETED|Overall Study||36
11223325|NCT01976741|12415178|FG000|NOT COMPLETED|Overall Study||1
11223326|NCT01976741|12415179|FG001|NOT COMPLETED|Overall Study||0
11223327|NCT01976741|12415180|FG002|NOT COMPLETED|Overall Study||3
11223328|NCT01976741|12415181|FG003|NOT COMPLETED|Overall Study||1
11223329|NCT01976741|12415182|FG004|NOT COMPLETED|Overall Study||0
11223330|NCT01976741|12415183|FG005|NOT COMPLETED|Overall Study||0
11223331|NCT01976741|12415184|FG006|NOT COMPLETED|Overall Study||4
11223332|NCT01976741|12415185|FG007|NOT COMPLETED|Overall Study||12
11223333|NCT01976741|12415186|FG008|NOT COMPLETED|Overall Study||1
11223334|NCT01976741|12415187|FG009|NOT COMPLETED|Overall Study||4
11223335|NCT01976806|12415223|FG000|STARTED|Overall Study||27
11223336|NCT01976806|12415224|FG001|STARTED|Overall Study||28
11223337|NCT01976806|12415223|FG000|COMPLETED|Overall Study||24
11223338|NCT01976806|12415224|FG001|COMPLETED|Overall Study||22
11223339|NCT01976806|12415223|FG000|NOT COMPLETED|Overall Study||3
11223340|NCT01976806|12415224|FG001|NOT COMPLETED|Overall Study||6
11223341|NCT01976819|12415230|FG000|STARTED|Overall Study||16
11223342|NCT01976819|12415230|FG000|COMPLETED|Overall Study||11
11223343|NCT01976819|12415230|FG000|NOT COMPLETED|Overall Study||5
11223344|NCT01976845|12415242|FG000|STARTED|Overall Study||48
11223345|NCT01976845|12415243|FG001|STARTED|Overall Study||48
11223346|NCT01976845|12415244|FG002|STARTED|Overall Study||43
11223347|NCT01976845|12415242|FG000|COMPLETED|Overall Study||40
11223348|NCT01976845|12415243|FG001|COMPLETED|Overall Study||40
11223349|NCT01976845|12415244|FG002|COMPLETED|Overall Study||40
11223350|NCT01976845|12415242|FG000|NOT COMPLETED|Overall Study||8
11223351|NCT01976845|12415243|FG001|NOT COMPLETED|Overall Study||8
11223352|NCT01976845|12415244|FG002|NOT COMPLETED|Overall Study||3
11223353|NCT01976871|12415252|FG000|STARTED|Overall Study||21
11223354|NCT01976871|12415252|FG000|COMPLETED|Overall Study||20
11223355|NCT01976871|12415252|FG000|NOT COMPLETED|Overall Study||1
11223356|NCT01976975|12415258|FG000|STARTED|Overall Study||226
11223357|NCT01976975|12415259|FG001|STARTED|Overall Study||44
11223358|NCT01976975|12415258|FG000|COMPLETED|Overall Study||79
11223359|NCT01976975|12415259|FG001|COMPLETED|Overall Study||32
11223360|NCT01976975|12415258|FG000|NOT COMPLETED|Overall Study||147
11223361|NCT01976975|12415259|FG001|NOT COMPLETED|Overall Study||12
11223362|NCT01976988|12415267|FG000|STARTED|Overall Study||208
11223363|NCT01976988|12415268|FG001|STARTED|Overall Study||202
10844279|NCT04409041|12010184|FG000|STARTED|Overall Study||43
10844280|NCT04409041|12010184|FG000|COMPLETED|Overall Study||26
10844281|NCT04409041|12010184|FG000|NOT COMPLETED|Overall Study||17
10844282|NCT04129944|12010193|FG000|STARTED|Overall Study||46
10844283|NCT04129944|12010194|FG001|STARTED|Overall Study||45
10844284|NCT04129944|12010195|FG002|STARTED|Overall Study||46
10844285|NCT04129944|12010196|FG003|STARTED|Overall Study||46
10844286|NCT04129944|12010193|FG000|COMPLETED|Overall Study||44
10844287|NCT04129944|12010194|FG001|COMPLETED|Overall Study||45
10844288|NCT04129944|12010195|FG002|COMPLETED|Overall Study||45
10844289|NCT04129944|12010196|FG003|COMPLETED|Overall Study||43
10844290|NCT04129944|12010193|FG000|NOT COMPLETED|Overall Study||2
10844291|NCT04129944|12010194|FG001|NOT COMPLETED|Overall Study||0
10844292|NCT04129944|12010195|FG002|NOT COMPLETED|Overall Study||1
10844293|NCT04129944|12010196|FG003|NOT COMPLETED|Overall Study||3
10844294|NCT03861728|12010208|FG000|STARTED|Overall Study||6
10844295|NCT03861728|12010209|FG001|STARTED|Overall Study||5
10844296|NCT03861728|12010208|FG000|COMPLETED|Overall Study||6
10844297|NCT03861728|12010209|FG001|COMPLETED|Overall Study||5
10844298|NCT03861728|12010208|FG000|NOT COMPLETED|Overall Study||0
10844299|NCT03861728|12010209|FG001|NOT COMPLETED|Overall Study||0
10844300|NCT03857542|12010217|FG000|STARTED|Overall Study||215
10844301|NCT03857542|12010218|FG001|STARTED|Overall Study||212
10844302|NCT03857542|12010217|FG000|COMPLETED|Overall Study||209
10844303|NCT03857542|12010218|FG001|COMPLETED|Overall Study||207
10844304|NCT03857542|12010217|FG000|NOT COMPLETED|Overall Study||6
10844305|NCT03857542|12010218|FG001|NOT COMPLETED|Overall Study||5
11104892|NCT01251653|12289232|FG004|COMPLETED|Overall Study||0
11104893|NCT01251653|12289233|FG005|COMPLETED|Overall Study||0
11104894|NCT01251653|12289234|FG006|COMPLETED|Overall Study||0
11104895|NCT01251653|12289235|FG007|COMPLETED|Overall Study||0
11104896|NCT01251653|12289236|FG008|COMPLETED|Overall Study||0
11104897|NCT01251653|12289228|FG000|NOT COMPLETED|Overall Study||3
11104898|NCT01251653|12289229|FG001|NOT COMPLETED|Overall Study||8
11104899|NCT01251653|12289230|FG002|NOT COMPLETED|Overall Study||20
11104900|NCT01251653|12289231|FG003|NOT COMPLETED|Overall Study||6
11104901|NCT01251653|12289232|FG004|NOT COMPLETED|Overall Study||2
11104902|NCT01251653|12289233|FG005|NOT COMPLETED|Overall Study||18
11104903|NCT01251653|12289234|FG006|NOT COMPLETED|Overall Study||18
11104904|NCT01251653|12289235|FG007|NOT COMPLETED|Overall Study||12
11104905|NCT01251653|12289236|FG008|NOT COMPLETED|Overall Study||6
11104906|NCT01251744|12289274|FG000|STARTED|Overall Study||77
11104907|NCT01251744|12289275|FG001|STARTED|Overall Study||78
11104908|NCT01251744|12289274|FG000|COMPLETED|Overall Study||76
11223364|NCT01976988|12415267|FG000|COMPLETED|Overall Study||192
11104909|NCT01251744|12289275|FG001|COMPLETED|Overall Study||78
11104910|NCT01251744|12289274|FG000|NOT COMPLETED|Overall Study||1
11104911|NCT01251744|12289275|FG001|NOT COMPLETED|Overall Study||0
11104912|NCT01251757|12289291|FG000|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
10844315|NCT03688802|12010242|FG000|STARTED|Overall Study||12
10844316|NCT03688802|12010243|FG001|STARTED|Overall Study||6
10844317|NCT03688802|12010242|FG000|COMPLETED|Overall Study||11
10844318|NCT03688802|12010243|FG001|COMPLETED|Overall Study||6
10844319|NCT03688802|12010242|FG000|NOT COMPLETED|Overall Study||1
10844320|NCT03688802|12010243|FG001|NOT COMPLETED|Overall Study||0
10844321|NCT03656744|12010252|FG000|STARTED|Overall Study||34
10844322|NCT03656744|12010253|FG001|STARTED|Overall Study||34
10844323|NCT03656744|12010254|FG002|STARTED|Overall Study||33
10844324|NCT03656744|12010252|FG000|COMPLETED|Overall Study||29
10844325|NCT03656744|12010253|FG001|COMPLETED|Overall Study||27
10844326|NCT03656744|12010254|FG002|COMPLETED|Overall Study||32
10844327|NCT03656744|12010252|FG000|NOT COMPLETED|Overall Study||5
10844328|NCT03656744|12010253|FG001|NOT COMPLETED|Overall Study||7
10844329|NCT03656744|12010254|FG002|NOT COMPLETED|Overall Study||1
10844330|NCT03510598|12010262|FG000|STARTED|Overall Study||16
10844331|NCT03510598|12010262|FG000|COMPLETED|Overall Study||15
10844332|NCT03510598|12010262|FG000|NOT COMPLETED|Overall Study||1
10844333|NCT03487796|12010270|FG000|STARTED|Overall Study||41
10844334|NCT03487796|12010271|FG001|STARTED|Overall Study||31
10844335|NCT03487796|12010270|FG000|2 Month Follow-up|Overall Study||24
10844336|NCT03487796|12010271|FG001|2 Month Follow-up|Overall Study||26
10844337|NCT03487796|12010270|FG000|COMPLETED|Overall Study||23
10844338|NCT03487796|12010271|FG001|COMPLETED|Overall Study||25
10844339|NCT03487796|12010270|FG000|NOT COMPLETED|Overall Study||18
10844340|NCT03487796|12010271|FG001|NOT COMPLETED|Overall Study||6
10844341|NCT03446612|12010285|FG000|STARTED|Overall Study||2
10844342|NCT03446612|12010286|FG001|STARTED|Overall Study||3
10844343|NCT03446612|12010285|FG000|COMPLETED|Overall Study||2
10844344|NCT03446612|12010286|FG001|COMPLETED|Overall Study||2
10844345|NCT03446612|12010285|FG000|NOT COMPLETED|Overall Study||0
10844346|NCT03446612|12010286|FG001|NOT COMPLETED|Overall Study||1
10844347|NCT03436433|12010297|FG000|STARTED|Overall Study||1
10844348|NCT03436433|12010298|FG001|STARTED|Overall Study||2
10844349|NCT03436433|12010299|FG002|STARTED|Overall Study||1
10844350|NCT03436433|12010297|FG000|COMPLETED|Overall Study||1
10844351|NCT03436433|12010298|FG001|COMPLETED|Overall Study||2
10844352|NCT03436433|12010299|FG002|COMPLETED|Overall Study||1
10844353|NCT03436433|12010297|FG000|NOT COMPLETED|Overall Study||0
10844354|NCT03436433|12010298|FG001|NOT COMPLETED|Overall Study||0
10844355|NCT03436433|12010299|FG002|NOT COMPLETED|Overall Study||0
10844356|NCT03370120|12010307|FG000|STARTED|Overall Study||406
10844357|NCT03370120|12010307|FG000|COMPLETED|Overall Study||0
10844358|NCT03370120|12010307|FG000|NOT COMPLETED|Overall Study||406
10844359|NCT03367429|12010316|FG000|STARTED|Overall Study||0
10844360|NCT03367429|12010317|FG001|STARTED|Overall Study||1
10844361|NCT03367429|12010318|FG002|STARTED|Overall Study||2
10844362|NCT03367429|12010316|FG000|COMPLETED|Overall Study||0
10844363|NCT03367429|12010317|FG001|COMPLETED|Overall Study||1
10844364|NCT03367429|12010318|FG002|COMPLETED|Overall Study||2
10844365|NCT03367429|12010316|FG000|NOT COMPLETED|Overall Study||0
10844366|NCT03367429|12010317|FG001|NOT COMPLETED|Overall Study||0
10844367|NCT03367429|12010318|FG002|NOT COMPLETED|Overall Study||0
10844368|NCT03143829|12010330|FG000|STARTED|Overall Study||38
10844369|NCT03143829|12010331|FG001|STARTED|Overall Study||42
10844370|NCT03143829|12010330|FG000|COMPLETED|Overall Study||33
10844371|NCT03143829|12010331|FG001|COMPLETED|Overall Study||32
10844372|NCT03143829|12010330|FG000|NOT COMPLETED|Overall Study||5
10844373|NCT03143829|12010331|FG001|NOT COMPLETED|Overall Study||10
10844374|NCT03099863|12010339|FG000|STARTED|Overall Study||121
10844375|NCT03099863|12010340|FG001|STARTED|Overall Study||121
10844376|NCT03099863|12010339|FG000|COMPLETED|Overall Study||111
10844377|NCT03099863|12010340|FG001|COMPLETED|Overall Study||105
10844378|NCT03099863|12010339|FG000|NOT COMPLETED|Overall Study||10
10844379|NCT03099863|12010340|FG001|NOT COMPLETED|Overall Study||16
10844380|NCT02963610|12010346|FG000|STARTED|Overall Study||3
10844381|NCT02963610|12010346|FG000|COMPLETED|Overall Study||0
10844382|NCT02963610|12010346|FG000|NOT COMPLETED|Overall Study||3
10844383|NCT02766335|12010353|FG000|STARTED|Initial Registration||68
10844384|NCT02766335|12010354|FG001|STARTED|Initial Registration||30
10844385|NCT02766335|12010355|FG002|STARTED|Initial Registration||0
10844386|NCT02766335|12010353|FG000|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||32
10844387|NCT02766335|12010354|FG001|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||30
10844388|NCT02766335|12010355|FG002|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||0
10844389|NCT02766335|12010353|FG000|COMPLETED|Initial Registration||10
10844390|NCT02766335|12010354|FG001|COMPLETED|Initial Registration||0
10844391|NCT02766335|12010355|FG002|COMPLETED|Initial Registration||0
10844392|NCT02766335|12010353|FG000|NOT COMPLETED|Initial Registration||58
10844393|NCT02766335|12010354|FG001|NOT COMPLETED|Initial Registration||30
10844394|NCT02766335|12010355|FG002|NOT COMPLETED|Initial Registration||0
10844395|NCT02766335|12010353|FG000|STARTED|Re-registration of Arm I to MEDI4738||0
10844396|NCT02766335|12010354|FG001|STARTED|Re-registration of Arm I to MEDI4738||0
10844397|NCT02766335|12010355|FG002|STARTED|Re-registration of Arm I to MEDI4738||4
10844398|NCT02766335|12010353|FG000|COMPLETED|Re-registration of Arm I to MEDI4738||0
10844399|NCT02766335|12010354|FG001|COMPLETED|Re-registration of Arm I to MEDI4738||0
10844400|NCT02766335|12010355|FG002|COMPLETED|Re-registration of Arm I to MEDI4738||2
10844401|NCT02766335|12010353|FG000|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0
10844402|NCT02766335|12010354|FG001|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0
10844403|NCT02766335|12010355|FG002|NOT COMPLETED|Re-registration of Arm I to MEDI4738||2
10844404|NCT02606136|12010361|FG000|STARTED|Overall Study||21
10844405|NCT02606136|12010361|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
10844406|NCT02606136|12010361|FG000|COMPLETED|Overall Study||15
10844407|NCT02606136|12010361|FG000|NOT COMPLETED|Overall Study||6
11223365|NCT01976988|12415268|FG001|COMPLETED|Overall Study||184
11223366|NCT01976988|12415267|FG000|NOT COMPLETED|Overall Study||16
11223367|NCT01976988|12415268|FG001|NOT COMPLETED|Overall Study||18
11223368|NCT01977040|12415276|FG000|STARTED|Overall Study||68
11223369|NCT01977040|12415276|FG000|COMPLETED|Overall Study||66
11223370|NCT01977040|12415276|FG000|NOT COMPLETED|Overall Study||2
11223371|NCT01977092|12415286|FG000|STARTED|Overall Study||149
11223372|NCT01977092|12415287|FG001|STARTED|Overall Study||181
11223373|NCT01977092|12415286|FG000|COMPLETED|Overall Study||118
10844408|NCT02228382|12010370|FG000|STARTED|Overall Study||46
10844409|NCT02228382|12010371|FG001|STARTED|Overall Study||61
10844410|NCT02228382|12010372|FG002|STARTED|Overall Study||49
10844411|NCT02228382|12010373|FG003|STARTED|Overall Study||4
10844412|NCT02228382|12010374|FG004|STARTED|Overall Study||3
10844413|NCT02228382|12010370|FG000|COMPLETED|Overall Study||36
10844414|NCT02228382|12010371|FG001|COMPLETED|Overall Study||43
10844415|NCT02228382|12010372|FG002|COMPLETED|Overall Study||28
10844416|NCT02228382|12010373|FG003|COMPLETED|Overall Study||2
10844417|NCT02228382|12010374|FG004|COMPLETED|Overall Study||1
10844418|NCT02228382|12010370|FG000|NOT COMPLETED|Overall Study||10
10844419|NCT02228382|12010371|FG001|NOT COMPLETED|Overall Study||18
10844420|NCT02228382|12010372|FG002|NOT COMPLETED|Overall Study||21
10844421|NCT02228382|12010373|FG003|NOT COMPLETED|Overall Study||2
10844422|NCT02228382|12010374|FG004|NOT COMPLETED|Overall Study||2
10844423|NCT02090998|12010393|FG000|STARTED|Overall Study||2
10844424|NCT02090998|12010394|FG001|STARTED|Overall Study||8
10844425|NCT02090998|12010393|FG000|COMPLETED|Overall Study||2
10844426|NCT02090998|12010394|FG001|COMPLETED|Overall Study||8
10844427|NCT02090998|12010393|FG000|NOT COMPLETED|Overall Study||0
10844428|NCT02090998|12010394|FG001|NOT COMPLETED|Overall Study||0
10844429|NCT02051309|12010402|FG000|STARTED|Overall Study||58
10844430|NCT02051309|12010403|FG001|STARTED|Overall Study||63
10844431|NCT02051309|12010402|FG000|COMPLETED|Overall Study||26
10844432|NCT02051309|12010403|FG001|COMPLETED|Overall Study||35
10844433|NCT02051309|12010402|FG000|NOT COMPLETED|Overall Study||32
10844434|NCT02051309|12010403|FG001|NOT COMPLETED|Overall Study||28
10844435|NCT02001623|12010424|FG000|STARTED|Overall Study||3
10844436|NCT02001623|12010425|FG001|STARTED|Overall Study||3
10844437|NCT02001623|12010426|FG002|STARTED|Overall Study||3
10844438|NCT02001623|12010427|FG003|STARTED|Overall Study||3
10844439|NCT02001623|12010428|FG004|STARTED|Overall Study||3
10844440|NCT02001623|12010429|FG005|STARTED|Overall Study||3
10844441|NCT02001623|12010430|FG006|STARTED|Overall Study||3
10844442|NCT02001623|12010431|FG007|STARTED|Overall Study||6
10844443|NCT02001623|12010432|FG008|STARTED|Overall Study||15
10844444|NCT02001623|12010433|FG009|STARTED|Overall Study||55
10844445|NCT02001623|12010434|FG010|STARTED|Overall Study||14
10844446|NCT02001623|12010435|FG011|STARTED|Overall Study||15
10844447|NCT02001623|12010436|FG012|STARTED|Overall Study||15
10844448|NCT02001623|12010437|FG013|STARTED|Overall Study||36
10844449|NCT02001623|12010438|FG014|STARTED|Overall Study||18
10844450|NCT02001623|12010424|FG000|Completed 4 Cycles of Treatment|Overall Study||0
10844451|NCT02001623|12010425|FG001|Completed 4 Cycles of Treatment|Overall Study||1
10844452|NCT02001623|12010426|FG002|Completed 4 Cycles of Treatment|Overall Study||1
10844453|NCT02001623|12010427|FG003|Completed 4 Cycles of Treatment|Overall Study||2
10844454|NCT02001623|12010428|FG004|Completed 4 Cycles of Treatment|Overall Study||0
10844455|NCT02001623|12010429|FG005|Completed 4 Cycles of Treatment|Overall Study||2
10844456|NCT02001623|12010430|FG006|Completed 4 Cycles of Treatment|Overall Study||2
10844457|NCT02001623|12010431|FG007|Completed 4 Cycles of Treatment|Overall Study||1
10844458|NCT02001623|12010432|FG008|Completed 4 Cycles of Treatment|Overall Study||5
10844459|NCT02001623|12010433|FG009|Completed 4 Cycles of Treatment|Overall Study||31
10844460|NCT02001623|12010434|FG010|Completed 4 Cycles of Treatment|Overall Study||6
10844461|NCT02001623|12010435|FG011|Completed 4 Cycles of Treatment|Overall Study||4
10844462|NCT02001623|12010436|FG012|Completed 4 Cycles of Treatment|Overall Study||6
10844463|NCT02001623|12010437|FG013|Completed 4 Cycles of Treatment|Overall Study||22
10844464|NCT02001623|12010438|FG014|Completed 4 Cycles of Treatment|Overall Study||7
10844465|NCT02001623|12010424|FG000|Completed 12 Cycles of Treatment|Overall Study||0
10844466|NCT02001623|12010425|FG001|Completed 12 Cycles of Treatment|Overall Study||1
10844467|NCT02001623|12010426|FG002|Completed 12 Cycles of Treatment|Overall Study||0
10844468|NCT02001623|12010427|FG003|Completed 12 Cycles of Treatment|Overall Study||1
10844469|NCT02001623|12010428|FG004|Completed 12 Cycles of Treatment|Overall Study||0
10844470|NCT02001623|12010429|FG005|Completed 12 Cycles of Treatment|Overall Study||0
10844471|NCT02001623|12010430|FG006|Completed 12 Cycles of Treatment|Overall Study||0
10844472|NCT02001623|12010431|FG007|Completed 12 Cycles of Treatment|Overall Study||0
10844473|NCT02001623|12010432|FG008|Completed 12 Cycles of Treatment|Overall Study||0
10844474|NCT02001623|12010433|FG009|Completed 12 Cycles of Treatment|Overall Study||3
10844475|NCT02001623|12010434|FG010|Completed 12 Cycles of Treatment|Overall Study||0
10844476|NCT02001623|12010435|FG011|Completed 12 Cycles of Treatment|Overall Study||0
10844477|NCT02001623|12010436|FG012|Completed 12 Cycles of Treatment|Overall Study||1
10844478|NCT02001623|12010437|FG013|Completed 12 Cycles of Treatment|Overall Study||1
10844479|NCT02001623|12010438|FG014|Completed 12 Cycles of Treatment|Overall Study||0
10844480|NCT02001623|12010424|FG000|COMPLETED|Overall Study||0
10844481|NCT02001623|12010425|FG001|COMPLETED|Overall Study||0
10844482|NCT02001623|12010426|FG002|COMPLETED|Overall Study||0
10844483|NCT02001623|12010427|FG003|COMPLETED|Overall Study||1
10844484|NCT02001623|12010428|FG004|COMPLETED|Overall Study||0
10844485|NCT02001623|12010429|FG005|COMPLETED|Overall Study||0
10844486|NCT02001623|12010430|FG006|COMPLETED|Overall Study||0
10844487|NCT02001623|12010431|FG007|COMPLETED|Overall Study||0
10844488|NCT02001623|12010432|FG008|COMPLETED|Overall Study||0
10844489|NCT02001623|12010433|FG009|COMPLETED|Overall Study||2
10844490|NCT02001623|12010434|FG010|COMPLETED|Overall Study||0
10844491|NCT02001623|12010435|FG011|COMPLETED|Overall Study||0
10844492|NCT02001623|12010436|FG012|COMPLETED|Overall Study||1
10844493|NCT02001623|12010437|FG013|COMPLETED|Overall Study||1
10844494|NCT02001623|12010438|FG014|COMPLETED|Overall Study||0
10844495|NCT02001623|12010424|FG000|NOT COMPLETED|Overall Study||3
10844496|NCT02001623|12010425|FG001|NOT COMPLETED|Overall Study||3
10844497|NCT02001623|12010426|FG002|NOT COMPLETED|Overall Study||3
10844498|NCT02001623|12010427|FG003|NOT COMPLETED|Overall Study||2
10844499|NCT02001623|12010428|FG004|NOT COMPLETED|Overall Study||3
10844500|NCT02001623|12010429|FG005|NOT COMPLETED|Overall Study||3
10844501|NCT02001623|12010430|FG006|NOT COMPLETED|Overall Study||3
10844502|NCT02001623|12010431|FG007|NOT COMPLETED|Overall Study||6
10844503|NCT02001623|12010432|FG008|NOT COMPLETED|Overall Study||15
10844504|NCT02001623|12010433|FG009|NOT COMPLETED|Overall Study||53
10844505|NCT02001623|12010434|FG010|NOT COMPLETED|Overall Study||14
10844506|NCT02001623|12010435|FG011|NOT COMPLETED|Overall Study||15
10844507|NCT02001623|12010436|FG012|NOT COMPLETED|Overall Study||14
10844508|NCT02001623|12010437|FG013|NOT COMPLETED|Overall Study||35
10844509|NCT02001623|12010438|FG014|NOT COMPLETED|Overall Study||18
10844510|NCT01900002|12010487|FG000|STARTED|Overall Study||40
10844511|NCT01900002|12010487|FG000|COMPLETED|Overall Study||34
10844512|NCT01900002|12010487|FG000|NOT COMPLETED|Overall Study||6
10844513|NCT01595061|12010491|FG000|STARTED|Overall Study||57
10844514|NCT01595061|12010491|FG000|COMPLETED|Overall Study||53
10844515|NCT01595061|12010491|FG000|NOT COMPLETED|Overall Study||4
10844516|NCT04502212|12010495|FG000|STARTED|Overall Study||16
10844517|NCT04502212|12010495|FG000|COMPLETED|Overall Study||14
10844518|NCT04502212|12010495|FG000|NOT COMPLETED|Overall Study||2
10844519|NCT04442230|12010502|FG000|STARTED|Overall Study||23
10844520|NCT04442230|12010503|FG001|STARTED|Overall Study||25
10844521|NCT04442230|12010502|FG000|COMPLETED|Overall Study||23
10844522|NCT04442230|12010503|FG001|COMPLETED|Overall Study||24
10844523|NCT04442230|12010502|FG000|NOT COMPLETED|Overall Study||0
10844524|NCT04442230|12010503|FG001|NOT COMPLETED|Overall Study||1
10844525|NCT04794803|12010511|FG000|STARTED|Overall Study||37
10844526|NCT04794803|12010512|FG001|STARTED|Overall Study||19
10844527|NCT04794803|12010511|FG000|FAS Population|Overall Study||36
10844528|NCT04794803|12010512|FG001|FAS Population|Overall Study||19
10844529|NCT04794803|12010511|FG000|Safety Set|Overall Study||36
10844530|NCT04794803|12010512|FG001|Safety Set|Overall Study||19
10844531|NCT04794803|12010511|FG000|Per Protocol Set|Overall Study||17
10844532|NCT04794803|12010512|FG001|Per Protocol Set|Overall Study||11
10844533|NCT04794803|12010511|FG000|COMPLETED|Overall Study||27
10844534|NCT04794803|12010512|FG001|COMPLETED|Overall Study||11
10844535|NCT04794803|12010511|FG000|NOT COMPLETED|Overall Study||10
10844536|NCT04794803|12010512|FG001|NOT COMPLETED|Overall Study||8
10844537|NCT04706403|12010523|FG000|STARTED|Overall Study||172
10844538|NCT04706403|12010524|FG001|STARTED|Overall Study||121
10844539|NCT04706403|12010525|FG002|STARTED|Overall Study||165
10844540|NCT04706403|12010526|FG003|STARTED|Overall Study||146
10844541|NCT04706403|12010527|FG004|STARTED|Overall Study||152
10844542|NCT04706403|12010523|FG000|COMPLETED|Overall Study||172
10844543|NCT04706403|12010524|FG001|COMPLETED|Overall Study||121
10844544|NCT04706403|12010525|FG002|COMPLETED|Overall Study||164
10844545|NCT04706403|12010526|FG003|COMPLETED|Overall Study||145
10844546|NCT04706403|12010527|FG004|COMPLETED|Overall Study||150
10844547|NCT04706403|12010523|FG000|NOT COMPLETED|Overall Study||0
10844548|NCT04706403|12010524|FG001|NOT COMPLETED|Overall Study||0
10844549|NCT04706403|12010525|FG002|NOT COMPLETED|Overall Study||1
10844550|NCT04706403|12010526|FG003|NOT COMPLETED|Overall Study||1
10844551|NCT04706403|12010527|FG004|NOT COMPLETED|Overall Study||2
10844552|NCT04440449|12010541|FG000|STARTED|Overall Study||20
10844553|NCT04440449|12010542|FG001|STARTED|Overall Study||0
10844554|NCT04440449|12010541|FG000|COMPLETED|Overall Study||18
10844555|NCT04440449|12010542|FG001|COMPLETED|Overall Study||0
10844556|NCT04440449|12010541|FG000|NOT COMPLETED|Overall Study||2
10844557|NCT04440449|12010542|FG001|NOT COMPLETED|Overall Study||0
10844558|NCT04369469|12010551|FG000|STARTED|Overall Study||135
10844559|NCT04369469|12010552|FG001|STARTED|Overall Study||67
10844560|NCT04369469|12010551|FG000|Intent to Treat (ITT) Population|Overall Study||135
10844561|NCT04369469|12010552|FG001|Intent to Treat (ITT) Population|Overall Study||66
10844562|NCT04369469|12010551|FG000|Pharmacokinetic (PK)|Overall Study||127
10844563|NCT04369469|12010552|FG001|Pharmacokinetic (PK)|Overall Study||52
10844564|NCT04369469|12010551|FG000|Safety Population|Overall Study||127
10844565|NCT04369469|12010552|FG001|Safety Population|Overall Study||67
10844566|NCT04369469|12010551|FG000|COMPLETED|Overall Study||125
10844567|NCT04369469|12010552|FG001|COMPLETED|Overall Study||58
10844568|NCT04369469|12010551|FG000|NOT COMPLETED|Overall Study||10
10844569|NCT04369469|12010552|FG001|NOT COMPLETED|Overall Study||9
10844570|NCT04036799|12010558|FG000|STARTED|Overall Study||572
10844571|NCT04036799|12010558|FG000|COMPLETED|Overall Study||572
10844572|NCT04036799|12010558|FG000|NOT COMPLETED|Overall Study||0
11104913|NCT01251757|12289292|FG001|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
11104914|NCT01251757|12289293|FG002|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
11104915|NCT01251757|12289291|FG000|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
11104916|NCT01251757|12289292|FG001|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
11104917|NCT01251757|12289293|FG002|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
11104918|NCT01251757|12289291|FG000|NOT COMPLETED|Overall Study||0
11104919|NCT01251757|12289292|FG001|NOT COMPLETED|Overall Study||0
11104920|NCT01251757|12289293|FG002|NOT COMPLETED|Overall Study||0
11104921|NCT01251770|12289307|FG000|STARTED|Overall Study||42
11104922|NCT01251770|12289308|FG001|STARTED|Overall Study||36
11104923|NCT01251770|12289307|FG000|COMPLETED|Overall Study||29
11104924|NCT01251770|12289308|FG001|COMPLETED|Overall Study||29
11104925|NCT01251770|12289307|FG000|NOT COMPLETED|Overall Study||13
10844609|NCT03772574|12010582|FG000|STARTED|Overall Study||42
10844610|NCT03772574|12010583|FG001|STARTED|Overall Study||25
10844611|NCT03772574|12010584|FG002|STARTED|Overall Study||24
10844612|NCT03772574|12010582|FG000|COMPLETED|Overall Study||40
10844613|NCT03772574|12010583|FG001|COMPLETED|Overall Study||20
10844614|NCT03772574|12010584|FG002|COMPLETED|Overall Study||20
10844615|NCT03772574|12010582|FG000|NOT COMPLETED|Overall Study||2
10844616|NCT03772574|12010583|FG001|NOT COMPLETED|Overall Study||5
10844617|NCT03772574|12010584|FG002|NOT COMPLETED|Overall Study||4
10844618|NCT03594955|12010592|FG000|STARTED|Overall Study||7
10844619|NCT03594955|12010592|FG000|COMPLETED|Overall Study||0
10844620|NCT03594955|12010592|FG000|NOT COMPLETED|Overall Study||7
10844621|NCT03548220|12010600|FG000|STARTED|Overall Study||40
10844622|NCT03548220|12010601|FG001|STARTED|Overall Study||2
10844623|NCT03548220|12010602|FG002|STARTED|Overall Study||3
10844624|NCT03548220|12010603|FG003|STARTED|Overall Study||35
10844625|NCT03548220|12010600|FG000|COMPLETED|Overall Study||39
10844626|NCT03548220|12010601|FG001|COMPLETED|Overall Study||2
10844627|NCT03548220|12010602|FG002|COMPLETED|Overall Study||3
10844628|NCT03548220|12010603|FG003|COMPLETED|Overall Study||35
10844629|NCT03548220|12010600|FG000|NOT COMPLETED|Overall Study||1
10844630|NCT03548220|12010601|FG001|NOT COMPLETED|Overall Study||0
10844631|NCT03548220|12010602|FG002|NOT COMPLETED|Overall Study||0
10844632|NCT03548220|12010603|FG003|NOT COMPLETED|Overall Study||0
10844633|NCT03453684|12010623|FG000|STARTED|Overall Study||60
10844634|NCT03453684|12010623|FG000|COMPLETED|Overall Study||60
10844635|NCT03453684|12010623|FG000|NOT COMPLETED|Overall Study||0
10844636|NCT03434041|12010629|FG000|STARTED|Double Blind Treatment Phase (4 Weeks)||126
10844637|NCT03434041|12010630|FG001|STARTED|Double Blind Treatment Phase (4 Weeks)||126
10844638|NCT03434041|12010629|FG000|Full Analysis Set|Double Blind Treatment Phase (4 Weeks)||124
10844639|NCT03434041|12010630|FG001|Full Analysis Set|Double Blind Treatment Phase (4 Weeks)||126
10844640|NCT03434041|12010629|FG000|COMPLETED|Double Blind Treatment Phase (4 Weeks)||108
10844641|NCT03434041|12010630|FG001|COMPLETED|Double Blind Treatment Phase (4 Weeks)||106
10844642|NCT03434041|12010629|FG000|NOT COMPLETED|Double Blind Treatment Phase (4 Weeks)||18
10844643|NCT03434041|12010630|FG001|NOT COMPLETED|Double Blind Treatment Phase (4 Weeks)||20
10844644|NCT03434041|12010629|FG000|STARTED|Follow-up Phase (Up to 8 Weeks)||106
10844645|NCT03434041|12010630|FG001|STARTED|Follow-up Phase (Up to 8 Weeks)||103
10844646|NCT03434041|12010629|FG000|COMPLETED|Follow-up Phase (Up to 8 Weeks)||99
10844647|NCT03434041|12010630|FG001|COMPLETED|Follow-up Phase (Up to 8 Weeks)||100
10844648|NCT03434041|12010629|FG000|NOT COMPLETED|Follow-up Phase (Up to 8 Weeks)||7
10844649|NCT03434041|12010630|FG001|NOT COMPLETED|Follow-up Phase (Up to 8 Weeks)||3
10844650|NCT03420222|12010640|FG000|STARTED|Overall Study||8
10844651|NCT03420222|12010641|FG001|STARTED|Overall Study||2
10844652|NCT03420222|12010640|FG000|COMPLETED|Overall Study||3
10844653|NCT03420222|12010641|FG001|COMPLETED|Overall Study||1
10844654|NCT03420222|12010640|FG000|NOT COMPLETED|Overall Study||5
10844655|NCT03420222|12010641|FG001|NOT COMPLETED|Overall Study||1
10844656|NCT03409796|12010649|FG000|STARTED|Overall Study||9
10844657|NCT03409796|12010650|FG001|STARTED|Overall Study||7
10844658|NCT03409796|12010649|FG000|COMPLETED|Overall Study||7
10844659|NCT03409796|12010650|FG001|COMPLETED|Overall Study||6
10844660|NCT03409796|12010649|FG000|NOT COMPLETED|Overall Study||2
10844661|NCT03409796|12010650|FG001|NOT COMPLETED|Overall Study||1
10844662|NCT03215706|12010658|FG000|STARTED|Randomization||361
10844663|NCT03215706|12010659|FG001|STARTED|Randomization||358
10844664|NCT03215706|12010658|FG000|COMPLETED|Randomization||358
10844665|NCT03215706|12010659|FG001|COMPLETED|Randomization||349
10844666|NCT03215706|12010658|FG000|NOT COMPLETED|Randomization||3
10844667|NCT03215706|12010659|FG001|NOT COMPLETED|Randomization||9
10844668|NCT03215706|12010658|FG000|STARTED|Treatment Period||358
10844669|NCT03215706|12010659|FG001|STARTED|Treatment Period||349
10844670|NCT03215706|12010658|FG000|COMPLETED|Treatment Period||16
10844671|NCT03215706|12010659|FG001|COMPLETED|Treatment Period||103
10844672|NCT03215706|12010658|FG000|NOT COMPLETED|Treatment Period||342
10844673|NCT03215706|12010659|FG001|NOT COMPLETED|Treatment Period||246
10844674|NCT03189563|12010668|FG000|STARTED|Overall Study||20
10844675|NCT03189563|12010669|FG001|STARTED|Overall Study||21
10844676|NCT03189563|12010670|FG002|STARTED|Overall Study||20
10844677|NCT03189563|12010668|FG000|ITT Population|Overall Study||20
10844678|NCT03189563|12010669|FG001|ITT Population|Overall Study||21
10844679|NCT03189563|12010670|FG002|ITT Population|Overall Study||19
10844680|NCT03189563|12010668|FG000|Safety Population|Overall Study||20
10844681|NCT03189563|12010669|FG001|Safety Population|Overall Study||21
10844682|NCT03189563|12010670|FG002|Safety Population|Overall Study||19
10844683|NCT03189563|12010668|FG000|COMPLETED|Overall Study||19
10844684|NCT03189563|12010669|FG001|COMPLETED|Overall Study||20
10844685|NCT03189563|12010670|FG002|COMPLETED|Overall Study||18
10844686|NCT03189563|12010668|FG000|NOT COMPLETED|Overall Study||1
10844687|NCT03189563|12010669|FG001|NOT COMPLETED|Overall Study||1
10844688|NCT03189563|12010670|FG002|NOT COMPLETED|Overall Study||2
11104926|NCT01251770|12289308|FG001|NOT COMPLETED|Overall Study||7
11104927|NCT01251887|12289317|FG000|STARTED|Overall Study||18
11104928|NCT01251887|12289318|FG001|STARTED|Overall Study||29
11104929|NCT01251887|12289319|FG002|STARTED|Overall Study||18
11104930|NCT01251887|12289317|FG000|COMPLETED|Overall Study||17
11104931|NCT01251887|12289318|FG001|COMPLETED|Overall Study||26
11104932|NCT01251887|12289319|FG002|COMPLETED|Overall Study||16
11104933|NCT01251887|12289317|FG000|NOT COMPLETED|Overall Study||1
11104934|NCT01251887|12289318|FG001|NOT COMPLETED|Overall Study||3
11104935|NCT01251887|12289319|FG002|NOT COMPLETED|Overall Study||2
11104936|NCT01251965|12289330|FG000|STARTED|Overall Study||4
11104937|NCT01251965|12289331|FG001|STARTED|Overall Study||5
11223374|NCT01977092|12415287|FG001|COMPLETED|Overall Study||151
11223375|NCT01977092|12415286|FG000|NOT COMPLETED|Overall Study||31
11223376|NCT01977092|12415287|FG001|NOT COMPLETED|Overall Study||30
11223377|NCT01977222|12415293|FG000|STARTED|Overall Study||12
11223378|NCT01977222|12415293|FG000|COMPLETED|Overall Study||11
11223379|NCT01977222|12415293|FG000|NOT COMPLETED|Overall Study||1
11223380|NCT01977352|12415299|FG000|STARTED|Overall Study||21
11223381|NCT01977352|12415300|FG001|STARTED|Overall Study||21
11223382|NCT01977352|12415299|FG000|COMPLETED|Overall Study||20
11223383|NCT01977352|12415300|FG001|COMPLETED|Overall Study||19
11223384|NCT01977352|12415299|FG000|NOT COMPLETED|Overall Study||1
11223385|NCT01977352|12415300|FG001|NOT COMPLETED|Overall Study||2
11223386|NCT01977456|12415306|FG000|STARTED|Overall Study||27
11223387|NCT01977456|12415306|FG000|COMPLETED|Overall Study||22
11223388|NCT01977456|12415306|FG000|NOT COMPLETED|Overall Study||5
11223389|NCT01977482|12415316|FG000|STARTED|Overall Study||39
11223390|NCT01977482|12415317|FG001|STARTED|Overall Study||39
11223391|NCT01977482|12415318|FG002|STARTED|Overall Study||40
11223392|NCT01977482|12415319|FG003|STARTED|Overall Study||39
11223393|NCT01977482|12415320|FG004|STARTED|Overall Study||40
11223394|NCT01977482|12415321|FG005|STARTED|Overall Study||19
11223395|NCT01977482|12415316|FG000|COMPLETED|Overall Study||36
11223396|NCT01977482|12415317|FG001|COMPLETED|Overall Study||30
11223397|NCT01977482|12415318|FG002|COMPLETED|Overall Study||35
11223398|NCT01977482|12415319|FG003|COMPLETED|Overall Study||35
11223399|NCT01977482|12415320|FG004|COMPLETED|Overall Study||37
11223400|NCT01977482|12415321|FG005|COMPLETED|Overall Study||14
11223401|NCT01977482|12415316|FG000|NOT COMPLETED|Overall Study||3
11223402|NCT01977482|12415317|FG001|NOT COMPLETED|Overall Study||9
11223403|NCT01977482|12415318|FG002|NOT COMPLETED|Overall Study||5
11223404|NCT01977482|12415319|FG003|NOT COMPLETED|Overall Study||4
11223405|NCT01977482|12415320|FG004|NOT COMPLETED|Overall Study||3
11223406|NCT01977482|12415321|FG005|NOT COMPLETED|Overall Study||5
11223407|NCT01977547|12415342|FG000|STARTED|Overall Study||768
11223408|NCT01977547|12415343|FG001|STARTED|Overall Study||770
11223409|NCT01977547|12415342|FG000|COMPLETED|Overall Study||728
10844701|NCT03093350|12010700|FG000|STARTED|Overall Study||12
10844702|NCT03093350|12010700|FG000|Started Treatment|Overall Study||10
10844703|NCT03093350|12010700|FG000|COMPLETED|Overall Study||10
10844704|NCT03093350|12010700|FG000|NOT COMPLETED|Overall Study||2
11104938|NCT01251965|12289332|FG002|STARTED|Overall Study||18
11104939|NCT01251965|12289330|FG000|COMPLETED|Overall Study||3
11104940|NCT01251965|12289331|FG001|COMPLETED|Overall Study||3
11104941|NCT01251965|12289332|FG002|COMPLETED|Overall Study||7
11104942|NCT01251965|12289330|FG000|NOT COMPLETED|Overall Study||1
10844710|NCT02999854|12010713|FG000|STARTED|Active Study Phase (up to 18 Months)||32
10844711|NCT02999854|12010714|FG001|STARTED|Active Study Phase (up to 18 Months)||31
10844712|NCT02999854|12010713|FG000|COMPLETED|Active Study Phase (up to 18 Months)||8
10844713|NCT02999854|12010714|FG001|COMPLETED|Active Study Phase (up to 18 Months)||22
10844714|NCT02999854|12010713|FG000|NOT COMPLETED|Active Study Phase (up to 18 Months)||24
10844715|NCT02999854|12010714|FG001|NOT COMPLETED|Active Study Phase (up to 18 Months)||9
10844716|NCT02999854|12010713|FG000|STARTED|Long Term Safety FU (up to 24 Months)||8
10844717|NCT02999854|12010714|FG001|STARTED|Long Term Safety FU (up to 24 Months)||22
10844718|NCT02999854|12010713|FG000|COMPLETED|Long Term Safety FU (up to 24 Months)||5
10844719|NCT02999854|12010714|FG001|COMPLETED|Long Term Safety FU (up to 24 Months)||19
10844720|NCT02999854|12010713|FG000|NOT COMPLETED|Long Term Safety FU (up to 24 Months)||3
10844721|NCT02999854|12010714|FG001|NOT COMPLETED|Long Term Safety FU (up to 24 Months)||3
10844722|NCT02960763|12010725|FG000|STARTED|Step 1||211
10844723|NCT02960763|12010726|FG001|STARTED|Step 1||206
10844724|NCT02960763|12010727|FG002|STARTED|Step 1||202
10844725|NCT02960763|12010728|FG003|STARTED|Step 1||0
10844726|NCT02960763|12010729|FG004|STARTED|Step 1||0
10844727|NCT02960763|12010725|FG000|COMPLETED|Step 1||192
10844728|NCT02960763|12010726|FG001|COMPLETED|Step 1||188
10844729|NCT02960763|12010727|FG002|COMPLETED|Step 1||174
10844730|NCT02960763|12010728|FG003|COMPLETED|Step 1||0
10844731|NCT02960763|12010729|FG004|COMPLETED|Step 1||0
10844732|NCT02960763|12010725|FG000|NOT COMPLETED|Step 1||19
10844733|NCT02960763|12010726|FG001|NOT COMPLETED|Step 1||18
10844734|NCT02960763|12010727|FG002|NOT COMPLETED|Step 1||28
10844735|NCT02960763|12010728|FG003|NOT COMPLETED|Step 1||0
10844736|NCT02960763|12010729|FG004|NOT COMPLETED|Step 1||0
10844737|NCT02960763|12010725|FG000|STARTED|Step 2||0
10844738|NCT02960763|12010726|FG001|STARTED|Step 2||0
10844739|NCT02960763|12010727|FG002|STARTED|Step 2||0
10844740|NCT02960763|12010728|FG003|STARTED|Step 2||127
10844741|NCT02960763|12010729|FG004|STARTED|Step 2||121
10844742|NCT02960763|12010725|FG000|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||43
10844743|NCT02960763|12010726|FG001|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||44
10844744|NCT02960763|12010727|FG002|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||38
10844745|NCT02960763|12010728|FG003|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||0
10844746|NCT02960763|12010729|FG004|People Who Participated in Step 1 and Continued to Participate in Step 2|Step 2||0
10844747|NCT02960763|12010725|FG000|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0
10844748|NCT02960763|12010726|FG001|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0
10844749|NCT02960763|12010727|FG002|People Who Began Step 2 Without Having Participated in Step 1|Step 2||0
10844750|NCT02960763|12010728|FG003|People Who Began Step 2 Without Having Participated in Step 1|Step 2||63
10844751|NCT02960763|12010729|FG004|People Who Began Step 2 Without Having Participated in Step 1|Step 2||60
10844752|NCT02960763|12010725|FG000|COMPLETED|Step 2||0
10844753|NCT02960763|12010726|FG001|COMPLETED|Step 2||0
10844754|NCT02960763|12010727|FG002|COMPLETED|Step 2||0
10844755|NCT02960763|12010728|FG003|COMPLETED|Step 2||116
10844756|NCT02960763|12010729|FG004|COMPLETED|Step 2||116
10844757|NCT02960763|12010725|FG000|NOT COMPLETED|Step 2||0
10844758|NCT02960763|12010726|FG001|NOT COMPLETED|Step 2||0
10844759|NCT02960763|12010727|FG002|NOT COMPLETED|Step 2||0
10844760|NCT02960763|12010728|FG003|NOT COMPLETED|Step 2||11
10844761|NCT02960763|12010729|FG004|NOT COMPLETED|Step 2||5
10844762|NCT02839343|12010743|FG000|STARTED|Overall Study||70
10844763|NCT02839343|12010744|FG001|STARTED|Overall Study||56
10844764|NCT02839343|12010743|FG000|COMPLETED|Overall Study||65
10844765|NCT02839343|12010744|FG001|COMPLETED|Overall Study||55
10844766|NCT02839343|12010743|FG000|NOT COMPLETED|Overall Study||5
10844767|NCT02839343|12010744|FG001|NOT COMPLETED|Overall Study||1
10844768|NCT02819479|12010750|FG000|STARTED|Overall Study||10
10844769|NCT02819479|12010750|FG000|COMPLETED|Overall Study|2 subjects experienced recurrence of radiation necrosis requiring intervention at approx. month 11.|8
10844770|NCT02819479|12010750|FG000|NOT COMPLETED|Overall Study||2
10844771|NCT02601313|12010758|FG000|STARTED|Overall Study||14
10844772|NCT02601313|12010759|FG001|STARTED|Overall Study||74
11104943|NCT01251965|12289331|FG001|NOT COMPLETED|Overall Study||2
11104944|NCT01251965|12289332|FG002|NOT COMPLETED|Overall Study||11
11104945|NCT01251978|12289343|FG000|STARTED|Overall Study||5
11104946|NCT01251978|12289344|FG001|STARTED|Overall Study||3
11104947|NCT01251978|12289343|FG000|COMPLETED|Overall Study||5
11104948|NCT01251978|12289344|FG001|COMPLETED|Overall Study||3
11104949|NCT01251978|12289343|FG000|NOT COMPLETED|Overall Study||0
10844773|NCT02601313|12010760|FG002|STARTED|Overall Study||17
10844774|NCT02601313|12010758|FG000|COMPLETED|Overall Study||8
10844775|NCT02601313|12010759|FG001|COMPLETED|Overall Study||0
10844776|NCT02601313|12010760|FG002|COMPLETED|Overall Study||0
10844777|NCT02601313|12010758|FG000|NOT COMPLETED|Overall Study||6
10844778|NCT02601313|12010759|FG001|NOT COMPLETED|Overall Study||74
10844779|NCT02601313|12010760|FG002|NOT COMPLETED|Overall Study||17
11104950|NCT01251978|12289344|FG001|NOT COMPLETED|Overall Study||0
11104951|NCT01252095|12289352|FG000|STARTED|Overall Study||3
11104952|NCT01252095|12289353|FG001|STARTED|Overall Study||1
11104953|NCT01252095|12289352|FG000|COMPLETED|Overall Study||2
11104954|NCT01252095|12289353|FG001|COMPLETED|Overall Study||1
11104955|NCT01252095|12289352|FG000|NOT COMPLETED|Overall Study||1
11104956|NCT01252095|12289353|FG001|NOT COMPLETED|Overall Study||0
11104957|NCT01252134|12289359|FG000|STARTED|Period 1, 8 Hours||3
11104958|NCT01252134|12289360|FG001|STARTED|Period 1, 8 Hours||4
11104959|NCT01252134|12289361|FG002|STARTED|Period 1, 8 Hours||3
11104960|NCT01252134|12289362|FG003|STARTED|Period 1, 8 Hours||5
11104961|NCT01252134|12289363|FG004|STARTED|Period 1, 8 Hours||3
11104962|NCT01252134|12289364|FG005|STARTED|Period 1, 8 Hours||4
11104963|NCT01252134|12289359|FG000|COMPLETED|Period 1, 8 Hours||3
11104964|NCT01252134|12289360|FG001|COMPLETED|Period 1, 8 Hours||3
11104965|NCT01252134|12289361|FG002|COMPLETED|Period 1, 8 Hours||2
11104966|NCT01252134|12289362|FG003|COMPLETED|Period 1, 8 Hours||5
11104967|NCT01252134|12289363|FG004|COMPLETED|Period 1, 8 Hours||3
11104968|NCT01252134|12289364|FG005|COMPLETED|Period 1, 8 Hours||4
11104969|NCT01252134|12289359|FG000|NOT COMPLETED|Period 1, 8 Hours||0
10844800|NCT02484430|12010784|FG000|STARTED|Overall Study||16
10844801|NCT02484430|12010784|FG000|COMPLETED|Overall Study||16
10844802|NCT02484430|12010784|FG000|NOT COMPLETED|Overall Study||0
10844803|NCT02438722|12010790|FG000|STARTED|Overall Study||83
10844804|NCT02438722|12010791|FG001|STARTED|Overall Study||85
10844805|NCT02438722|12010790|FG000|Participants Evaluable for Adverse Events|Overall Study||78
10844806|NCT02438722|12010791|FG001|Participants Evaluable for Adverse Events|Overall Study||85
10844807|NCT02438722|12010790|FG000|COMPLETED|Overall Study||0
10844808|NCT02438722|12010791|FG001|COMPLETED|Overall Study||0
10844809|NCT02438722|12010790|FG000|NOT COMPLETED|Overall Study||83
10844810|NCT02438722|12010791|FG001|NOT COMPLETED|Overall Study||85
11104970|NCT01252134|12289360|FG001|NOT COMPLETED|Period 1, 8 Hours||1
11104971|NCT01252134|12289361|FG002|NOT COMPLETED|Period 1, 8 Hours||1
11104972|NCT01252134|12289362|FG003|NOT COMPLETED|Period 1, 8 Hours||0
11104973|NCT01252134|12289363|FG004|NOT COMPLETED|Period 1, 8 Hours||0
11104974|NCT01252134|12289364|FG005|NOT COMPLETED|Period 1, 8 Hours||0
11104975|NCT01252134|12289359|FG000|STARTED|Period 2, 8 Hours||3
11104976|NCT01252134|12289360|FG001|STARTED|Period 2, 8 Hours||3
11223410|NCT01977547|12415343|FG001|COMPLETED|Overall Study||733
11223411|NCT01977547|12415342|FG000|NOT COMPLETED|Overall Study||40
11223412|NCT01977547|12415343|FG001|NOT COMPLETED|Overall Study||37
11223413|NCT01977573|12415353|FG000|STARTED|Overall Study||136
11223414|NCT01977573|12415354|FG001|STARTED|Overall Study||44
11223415|NCT01977573|12415355|FG002|STARTED|Overall Study||36
11223416|NCT01977573|12415356|FG003|STARTED|Overall Study||36
11223417|NCT01977573|12415353|FG000|COMPLETED|Overall Study||116
11223418|NCT01977573|12415354|FG001|COMPLETED|Overall Study||41
11223419|NCT01977573|12415355|FG002|COMPLETED|Overall Study||32
11223420|NCT01977573|12415356|FG003|COMPLETED|Overall Study||33
11223421|NCT01977573|12415353|FG000|NOT COMPLETED|Overall Study||20
11223422|NCT01977573|12415354|FG001|NOT COMPLETED|Overall Study||3
11223423|NCT01977573|12415355|FG002|NOT COMPLETED|Overall Study||4
11223424|NCT01977573|12415356|FG003|NOT COMPLETED|Overall Study||3
11223425|NCT01977599|12415369|FG000|STARTED|Overall Study||1118
11223426|NCT01977599|12415370|FG001|STARTED|Overall Study||1122
11223427|NCT01977599|12415369|FG000|COMPLETED|Overall Study||1118
11223428|NCT01977599|12415370|FG001|COMPLETED|Overall Study||1122
11223429|NCT01977599|12415369|FG000|NOT COMPLETED|Overall Study||0
11223430|NCT01977599|12415370|FG001|NOT COMPLETED|Overall Study||0
11223431|NCT01977612|12415378|FG000|STARTED|Overall Study||85
11223432|NCT01977612|12415379|FG001|STARTED|Overall Study||80
11223433|NCT01977612|12415378|FG000|COMPLETED|Overall Study||84
11223434|NCT01977612|12415379|FG001|COMPLETED|Overall Study||79
11223435|NCT01977612|12415378|FG000|NOT COMPLETED|Overall Study||1
11223436|NCT01977612|12415379|FG001|NOT COMPLETED|Overall Study||1
11223437|NCT01977625|12415385|FG000|STARTED|First Intervention (4 Weeks)||11
11223438|NCT01977625|12415386|FG001|STARTED|First Intervention (4 Weeks)||7
11223439|NCT01977625|12415385|FG000|COMPLETED|First Intervention (4 Weeks)||8
11223440|NCT01977625|12415386|FG001|COMPLETED|First Intervention (4 Weeks)||7
11223441|NCT01977625|12415385|FG000|NOT COMPLETED|First Intervention (4 Weeks)||3
11223442|NCT01977625|12415386|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
11223443|NCT01977625|12415385|FG000|STARTED|Washout (2 Weeks)||8
11223444|NCT01977625|12415386|FG001|STARTED|Washout (2 Weeks)||7
11223445|NCT01977625|12415385|FG000|COMPLETED|Washout (2 Weeks)||8
11223446|NCT01977625|12415386|FG001|COMPLETED|Washout (2 Weeks)||7
11223447|NCT01977625|12415385|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11223448|NCT01977625|12415386|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11223449|NCT01977625|12415385|FG000|STARTED|Second Intervention (4 Weeks)||8
11104977|NCT01252134|12289361|FG002|STARTED|Period 2, 8 Hours||2
11104978|NCT01252134|12289362|FG003|STARTED|Period 2, 8 Hours||5
11104979|NCT01252134|12289363|FG004|STARTED|Period 2, 8 Hours||3
11104980|NCT01252134|12289364|FG005|STARTED|Period 2, 8 Hours||4
11104981|NCT01252134|12289359|FG000|COMPLETED|Period 2, 8 Hours||3
11223450|NCT01977625|12415386|FG001|STARTED|Second Intervention (4 Weeks)||7
11223451|NCT01977625|12415385|FG000|COMPLETED|Second Intervention (4 Weeks)||7
11223452|NCT01977625|12415386|FG001|COMPLETED|Second Intervention (4 Weeks)||7
11223453|NCT01977625|12415385|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
11223454|NCT01977625|12415386|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
11223455|NCT01977651|12415394|FG000|STARTED|4 Month Treatment Period||423
11223456|NCT01977651|12415394|FG000|COMPLETED|4 Month Treatment Period||322
11223457|NCT01977651|12415394|FG000|NOT COMPLETED|4 Month Treatment Period||101
11223458|NCT01977651|12415394|FG000|STARTED|1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the 1 year extension period|287
11223459|NCT01977651|12415394|FG000|COMPLETED|1 Year Extension Period||157
11104982|NCT01252134|12289360|FG001|COMPLETED|Period 2, 8 Hours||3
11104983|NCT01252134|12289361|FG002|COMPLETED|Period 2, 8 Hours||2
11104984|NCT01252134|12289362|FG003|COMPLETED|Period 2, 8 Hours||5
11104985|NCT01252134|12289363|FG004|COMPLETED|Period 2, 8 Hours||3
11104986|NCT01252134|12289364|FG005|COMPLETED|Period 2, 8 Hours||4
11104987|NCT01252134|12289359|FG000|NOT COMPLETED|Period 2, 8 Hours||0
11104988|NCT01252134|12289360|FG001|NOT COMPLETED|Period 2, 8 Hours||0
11104989|NCT01252134|12289361|FG002|NOT COMPLETED|Period 2, 8 Hours||0
11104990|NCT01252134|12289362|FG003|NOT COMPLETED|Period 2, 8 Hours||0
11104991|NCT01252134|12289363|FG004|NOT COMPLETED|Period 2, 8 Hours||0
11104992|NCT01252134|12289364|FG005|NOT COMPLETED|Period 2, 8 Hours||0
11104993|NCT01252134|12289359|FG000|STARTED|Period 3, 8 Hours||3
11104994|NCT01252134|12289360|FG001|STARTED|Period 3, 8 Hours||3
11104995|NCT01252134|12289361|FG002|STARTED|Period 3, 8 Hours||2
11104996|NCT01252134|12289362|FG003|STARTED|Period 3, 8 Hours||5
11104997|NCT01252134|12289363|FG004|STARTED|Period 3, 8 Hours||3
11104998|NCT01252134|12289364|FG005|STARTED|Period 3, 8 Hours||4
10844835|NCT02114814|12010816|FG000|STARTED|Overall Study||103
10844836|NCT02114814|12010817|FG001|STARTED|Overall Study||83
10844837|NCT02114814|12010816|FG000|COMPLETED|Overall Study||88
10844838|NCT02114814|12010817|FG001|COMPLETED|Overall Study||74
10844839|NCT02114814|12010816|FG000|NOT COMPLETED|Overall Study||15
10844840|NCT02114814|12010817|FG001|NOT COMPLETED|Overall Study||9
10844841|NCT02067819|12010829|FG000|STARTED|Overall Study||11
10844842|NCT02067819|12010830|FG001|STARTED|Overall Study||10
10844843|NCT02067819|12010829|FG000|COMPLETED|Overall Study||6
10844844|NCT02067819|12010830|FG001|COMPLETED|Overall Study||7
10844845|NCT02067819|12010829|FG000|NOT COMPLETED|Overall Study||5
10844846|NCT02067819|12010830|FG001|NOT COMPLETED|Overall Study||3
10844847|NCT02004691|12010838|FG000|STARTED|PAP: Up to 52 Weeks||18
10844848|NCT02004691|12010839|FG001|STARTED|PAP: Up to 52 Weeks||18
10844849|NCT02004691|12010838|FG000|COMPLETED|PAP: Up to 52 Weeks||17
10844850|NCT02004691|12010839|FG001|COMPLETED|PAP: Up to 52 Weeks||18
10844851|NCT02004691|12010838|FG000|NOT COMPLETED|PAP: Up to 52 Weeks||1
10844852|NCT02004691|12010839|FG001|NOT COMPLETED|PAP: Up to 52 Weeks||0
10844853|NCT02004691|12010838|FG000|STARTED|ETP: Ongoing From Week 52||17
10844854|NCT02004691|12010839|FG001|STARTED|ETP: Ongoing From Week 52||18
10844855|NCT02004691|12010838|FG000|COMPLETED|ETP: Ongoing From Week 52||0
10844856|NCT02004691|12010839|FG001|COMPLETED|ETP: Ongoing From Week 52||0
10844857|NCT02004691|12010838|FG000|NOT COMPLETED|ETP: Ongoing From Week 52||17
10844858|NCT02004691|12010839|FG001|NOT COMPLETED|ETP: Ongoing From Week 52||18
11104999|NCT01252134|12289359|FG000|COMPLETED|Period 3, 8 Hours||3
11105000|NCT01252134|12289360|FG001|COMPLETED|Period 3, 8 Hours||3
11105001|NCT01252134|12289361|FG002|COMPLETED|Period 3, 8 Hours||2
11105002|NCT01252134|12289362|FG003|COMPLETED|Period 3, 8 Hours||5
11105003|NCT01252134|12289363|FG004|COMPLETED|Period 3, 8 Hours||3
11105004|NCT01252134|12289364|FG005|COMPLETED|Period 3, 8 Hours||4
11105005|NCT01252134|12289359|FG000|NOT COMPLETED|Period 3, 8 Hours||0
11105006|NCT01252134|12289360|FG001|NOT COMPLETED|Period 3, 8 Hours||0
11105007|NCT01252134|12289361|FG002|NOT COMPLETED|Period 3, 8 Hours||0
11105008|NCT01252134|12289362|FG003|NOT COMPLETED|Period 3, 8 Hours||0
11105009|NCT01252134|12289363|FG004|NOT COMPLETED|Period 3, 8 Hours||0
11105010|NCT01252134|12289364|FG005|NOT COMPLETED|Period 3, 8 Hours||0
11105011|NCT01252147|12289372|FG000|STARTED|Overall Study||68
11105012|NCT01252147|12289372|FG000|COMPLETED|Overall Study||68
11105013|NCT01252147|12289372|FG000|NOT COMPLETED|Overall Study||0
11105014|NCT01252186|12289379|FG000|STARTED|Overall Study||87
11105015|NCT01252186|12289380|FG001|STARTED|Overall Study||91
11105016|NCT01252186|12289381|FG002|STARTED|Overall Study||87
10844877|NCT01668719|12010871|FG000|STARTED|Phase I||6
10844878|NCT01668719|12010872|FG001|STARTED|Phase I||0
10844879|NCT01668719|12010873|FG002|STARTED|Phase I||0
10844880|NCT01668719|12010871|FG000|COMPLETED|Phase I||0
10844881|NCT01668719|12010872|FG001|COMPLETED|Phase I||0
10844882|NCT01668719|12010873|FG002|COMPLETED|Phase I||0
10844883|NCT01668719|12010871|FG000|NOT COMPLETED|Phase I||6
10844884|NCT01668719|12010872|FG001|NOT COMPLETED|Phase I||0
10844885|NCT01668719|12010873|FG002|NOT COMPLETED|Phase I||0
10844886|NCT01668719|12010871|FG000|STARTED|Phase II||0
10844887|NCT01668719|12010872|FG001|STARTED|Phase II||52
10844888|NCT01668719|12010873|FG002|STARTED|Phase II||48
10844889|NCT01668719|12010871|FG000|COMPLETED|Phase II||0
10844890|NCT01668719|12010872|FG001|COMPLETED|Phase II||0
10844891|NCT01668719|12010873|FG002|COMPLETED|Phase II||0
10844892|NCT01668719|12010871|FG000|NOT COMPLETED|Phase II||0
10844893|NCT01668719|12010872|FG001|NOT COMPLETED|Phase II||52
10844894|NCT01668719|12010873|FG002|NOT COMPLETED|Phase II||48
11105017|NCT01252186|12289379|FG000|Received Study Drug|Overall Study||83
11105018|NCT01252186|12289380|FG001|Received Study Drug|Overall Study||89
11105019|NCT01252186|12289381|FG002|Received Study Drug|Overall Study||80
11105020|NCT01252186|12289379|FG000|COMPLETED|Overall Study||57
11105021|NCT01252186|12289380|FG001|COMPLETED|Overall Study||59
11105022|NCT01252186|12289381|FG002|COMPLETED|Overall Study||53
11105023|NCT01252186|12289379|FG000|NOT COMPLETED|Overall Study||30
11105024|NCT01252186|12289380|FG001|NOT COMPLETED|Overall Study||32
11105025|NCT01252186|12289381|FG002|NOT COMPLETED|Overall Study||34
11105026|NCT01252238|12289392|FG000|STARTED|Overall Study||8
11105027|NCT01252238|12289393|FG001|STARTED|Overall Study||8
11105028|NCT01252238|12289394|FG002|STARTED|Overall Study||8
11105029|NCT01252238|12289392|FG000|COMPLETED|Overall Study|sponsor terminated study|4
11105030|NCT01252238|12289393|FG001|COMPLETED|Overall Study|sponsor terminated study|4
11105031|NCT01252238|12289394|FG002|COMPLETED|Overall Study|sponsor terminated study|4
11105032|NCT01252238|12289392|FG000|NOT COMPLETED|Overall Study||4
11105033|NCT01252238|12289393|FG001|NOT COMPLETED|Overall Study||4
11105034|NCT01252238|12289394|FG002|NOT COMPLETED|Overall Study||4
11105035|NCT01252251|12289405|FG000|STARTED|Overall Study||14
11105036|NCT01252251|12289405|FG000|COMPLETED|Overall Study||13
11105037|NCT01252251|12289405|FG000|NOT COMPLETED|Overall Study||1
11223460|NCT01977651|12415394|FG000|NOT COMPLETED|1 Year Extension Period||130
11223461|NCT01977651|12415394|FG000|STARTED|Post 1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the post 1 year extension period|145
11223462|NCT01977651|12415394|FG000|COMPLETED|Post 1 Year Extension Period||1
11223463|NCT01977651|12415394|FG000|NOT COMPLETED|Post 1 Year Extension Period||144
11223464|NCT01977677|12415401|FG000|STARTED|Overall Study||3
11223465|NCT01977677|12415402|FG001|STARTED|Overall Study||6
11223466|NCT01977677|12415403|FG002|STARTED|Overall Study||21
11223467|NCT01977677|12415401|FG000|COMPLETED|Overall Study||3
11223468|NCT01977677|12415402|FG001|COMPLETED|Overall Study||6
11223469|NCT01977677|12415403|FG002|COMPLETED|Overall Study||20
11223470|NCT01977677|12415401|FG000|NOT COMPLETED|Overall Study||0
11223471|NCT01977677|12415402|FG001|NOT COMPLETED|Overall Study||0
11223472|NCT01977677|12415403|FG002|NOT COMPLETED|Overall Study||1
11223473|NCT01977690|12415413|FG000|STARTED|Overall Study||15
11223474|NCT01977690|12415414|FG001|STARTED|Overall Study||15
11223475|NCT01977690|12415413|FG000|COMPLETED|Overall Study||15
11223476|NCT01977690|12415414|FG001|COMPLETED|Overall Study||11
11223477|NCT01977690|12415413|FG000|NOT COMPLETED|Overall Study||0
11223478|NCT01977690|12415414|FG001|NOT COMPLETED|Overall Study||4
11354316|NCT03073109|12551582|FG001|COMPLETED|Overall Study||68
11354317|NCT03073109|12551581|FG000|NOT COMPLETED|Overall Study||10
11354318|NCT03073109|12551582|FG001|NOT COMPLETED|Overall Study||2
11354319|NCT03073148|12551604|FG000|STARTED|Overall Study||21
11354320|NCT03073148|12551605|FG001|STARTED|Overall Study||10
11354321|NCT03073148|12551606|FG002|STARTED|Overall Study||4
11354322|NCT03073148|12551604|FG000|COMPLETED|Overall Study||21
11354323|NCT03073148|12551605|FG001|COMPLETED|Overall Study||10
11354324|NCT03073148|12551606|FG002|COMPLETED|Overall Study||0
11354325|NCT03073148|12551604|FG000|NOT COMPLETED|Overall Study||0
11354326|NCT03073148|12551605|FG001|NOT COMPLETED|Overall Study||0
11354327|NCT03073148|12551606|FG002|NOT COMPLETED|Overall Study||4
11354328|NCT03073200|12551617|FG000|STARTED|Double Blind Treatment Period||56
11354329|NCT03073200|12551618|FG001|STARTED|Double Blind Treatment Period||115
11354330|NCT03073200|12551619|FG002|STARTED|Double Blind Treatment Period||30
11354331|NCT03073200|12551620|FG003|STARTED|Double Blind Treatment Period||0
11354332|NCT03073200|12551621|FG004|STARTED|Double Blind Treatment Period||0
11354333|NCT03073200|12551622|FG005|STARTED|Double Blind Treatment Period||0
11354334|NCT03073200|12551623|FG006|STARTED|Double Blind Treatment Period||0
11354335|NCT03073200|12551624|FG007|STARTED|Double Blind Treatment Period||0
11354336|NCT03073200|12551625|FG008|STARTED|Double Blind Treatment Period||0
11354337|NCT03073200|12551626|FG009|STARTED|Double Blind Treatment Period||0
11354338|NCT03073200|12551627|FG010|STARTED|Double Blind Treatment Period||0
11354339|NCT03073200|12551628|FG011|STARTED|Double Blind Treatment Period||0
11354340|NCT03073200|12551629|FG012|STARTED|Double Blind Treatment Period||0
11354341|NCT03073200|12551630|FG013|STARTED|Double Blind Treatment Period||0
11354342|NCT03073200|12551631|FG014|STARTED|Double Blind Treatment Period||0
11354343|NCT03073200|12551617|FG000|Participants in Etanercept Approved Countries|Double Blind Treatment Period||19
11354344|NCT03073200|12551618|FG001|Participants in Etanercept Approved Countries|Double Blind Treatment Period||38
11354345|NCT03073200|12551619|FG002|Participants in Etanercept Approved Countries|Double Blind Treatment Period||30
11354346|NCT03073200|12551620|FG003|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
11354347|NCT03073200|12551621|FG004|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
11354348|NCT03073200|12551622|FG005|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
11354349|NCT03073200|12551623|FG006|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
11354350|NCT03073200|12551624|FG007|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
11354351|NCT03073200|12551625|FG008|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
11354352|NCT03073200|12551626|FG009|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
11354353|NCT03073200|12551627|FG010|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
11354354|NCT03073200|12551628|FG011|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
11354355|NCT03073200|12551629|FG012|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
11354356|NCT03073200|12551630|FG013|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
11105038|NCT01252277|12289409|FG000|STARTED|Overall Study||36
11105039|NCT01252277|12289409|FG000|COMPLETED|Overall Study||34
11105040|NCT01252277|12289409|FG000|NOT COMPLETED|Overall Study||2
11223479|NCT01977781|12415422|FG000|STARTED|Overall Study||24
11223480|NCT01977781|12415423|FG001|STARTED|Overall Study||16
11223481|NCT01977781|12415422|FG000|COMPLETED|Overall Study||18
11354357|NCT03073200|12551631|FG014|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
11354358|NCT03073200|12551617|FG000|COMPLETED|Double Blind Treatment Period||54
11354359|NCT03073200|12551618|FG001|COMPLETED|Double Blind Treatment Period||114
11354360|NCT03073200|12551619|FG002|COMPLETED|Double Blind Treatment Period||30
11354361|NCT03073200|12551620|FG003|COMPLETED|Double Blind Treatment Period||0
11354362|NCT03073200|12551621|FG004|COMPLETED|Double Blind Treatment Period||0
11105041|NCT01252290|12289414|FG000|STARTED|Overall Study||35
11105042|NCT01252290|12289414|FG000|COMPLETED|Overall Study||34
11105043|NCT01252290|12289414|FG000|NOT COMPLETED|Overall Study||1
11105044|NCT01252355|12289421|FG000|STARTED|Overall Study|Randomized.|177
11105045|NCT01252355|12289422|FG001|STARTED|Overall Study|Randomized.|178
11105046|NCT01252355|12289423|FG002|STARTED|Overall Study|Randomized.|179
11105047|NCT01252355|12289421|FG000|Treated|Overall Study||175
11105048|NCT01252355|12289422|FG001|Treated|Overall Study||178
11105049|NCT01252355|12289423|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
11105050|NCT01252355|12289421|FG000|COMPLETED|Overall Study||0
11105051|NCT01252355|12289422|FG001|COMPLETED|Overall Study||0
11105052|NCT01252355|12289423|FG002|COMPLETED|Overall Study||0
11105053|NCT01252355|12289421|FG000|NOT COMPLETED|Overall Study||177
11105054|NCT01252355|12289422|FG001|NOT COMPLETED|Overall Study||178
10844930|NCT01515748|12010914|FG000|STARTED|Overall Study||264
10844931|NCT01515748|12010915|FG001|STARTED|Overall Study||266
10844932|NCT01515748|12010914|FG000|Treated|Overall Study||195
10844933|NCT01515748|12010915|FG001|Treated|Overall Study||241
10844934|NCT01515748|12010914|FG000|COMPLETED|Overall Study||144
10844935|NCT01515748|12010915|FG001|COMPLETED|Overall Study||131
10844936|NCT01515748|12010914|FG000|NOT COMPLETED|Overall Study||120
10844937|NCT01515748|12010915|FG001|NOT COMPLETED|Overall Study||135
10844938|NCT01261247|12010922|FG000|STARTED|Overall Study||41
10844939|NCT01261247|12010922|FG000|COMPLETED|Overall Study||39
10844940|NCT01261247|12010922|FG000|NOT COMPLETED|Overall Study||2
10844941|NCT01169259|12010930|FG000|STARTED|Overall Study||6463
10844942|NCT01169259|12010931|FG001|STARTED|Overall Study||6464
10844943|NCT01169259|12010932|FG002|STARTED|Overall Study||6470
10844944|NCT01169259|12010933|FG003|STARTED|Overall Study||6474
10844945|NCT01169259|12010930|FG000|COMPLETED|Overall Study||6463
10844946|NCT01169259|12010931|FG001|COMPLETED|Overall Study||6464
10844947|NCT01169259|12010932|FG002|COMPLETED|Overall Study||6470
10844948|NCT01169259|12010933|FG003|COMPLETED|Overall Study||6474
10844949|NCT01169259|12010930|FG000|NOT COMPLETED|Overall Study||0
10844950|NCT01169259|12010931|FG001|NOT COMPLETED|Overall Study||0
10844951|NCT01169259|12010932|FG002|NOT COMPLETED|Overall Study||0
10844952|NCT01169259|12010933|FG003|NOT COMPLETED|Overall Study||0
11223482|NCT01977781|12415423|FG001|COMPLETED|Overall Study||15
11223483|NCT01977781|12415422|FG000|NOT COMPLETED|Overall Study||6
11223484|NCT01977781|12415423|FG001|NOT COMPLETED|Overall Study||1
11354363|NCT03073200|12551622|FG005|COMPLETED|Double Blind Treatment Period||0
11354364|NCT03073200|12551623|FG006|COMPLETED|Double Blind Treatment Period||0
11354365|NCT03073200|12551624|FG007|COMPLETED|Double Blind Treatment Period||0
11354366|NCT03073200|12551625|FG008|COMPLETED|Double Blind Treatment Period||0
11354367|NCT03073200|12551626|FG009|COMPLETED|Double Blind Treatment Period||0
11354368|NCT03073200|12551627|FG010|COMPLETED|Double Blind Treatment Period||0
11354369|NCT03073200|12551628|FG011|COMPLETED|Double Blind Treatment Period||0
11354370|NCT03073200|12551629|FG012|COMPLETED|Double Blind Treatment Period||0
11354371|NCT03073200|12551630|FG013|COMPLETED|Double Blind Treatment Period||0
11354372|NCT03073200|12551631|FG014|COMPLETED|Double Blind Treatment Period||0
11354373|NCT03073200|12551617|FG000|NOT COMPLETED|Double Blind Treatment Period||2
11354374|NCT03073200|12551618|FG001|NOT COMPLETED|Double Blind Treatment Period||1
11354375|NCT03073200|12551619|FG002|NOT COMPLETED|Double Blind Treatment Period||0
11354376|NCT03073200|12551620|FG003|NOT COMPLETED|Double Blind Treatment Period||0
11354377|NCT03073200|12551621|FG004|NOT COMPLETED|Double Blind Treatment Period||0
11354378|NCT03073200|12551622|FG005|NOT COMPLETED|Double Blind Treatment Period||0
11354379|NCT03073200|12551623|FG006|NOT COMPLETED|Double Blind Treatment Period||0
11354380|NCT03073200|12551624|FG007|NOT COMPLETED|Double Blind Treatment Period||0
11354381|NCT03073200|12551625|FG008|NOT COMPLETED|Double Blind Treatment Period||0
11354382|NCT03073200|12551626|FG009|NOT COMPLETED|Double Blind Treatment Period||0
11354383|NCT03073200|12551627|FG010|NOT COMPLETED|Double Blind Treatment Period||0
11354384|NCT03073200|12551628|FG011|NOT COMPLETED|Double Blind Treatment Period||0
11354385|NCT03073200|12551629|FG012|NOT COMPLETED|Double Blind Treatment Period||0
11354386|NCT03073200|12551630|FG013|NOT COMPLETED|Double Blind Treatment Period||0
11354387|NCT03073200|12551631|FG014|NOT COMPLETED|Double Blind Treatment Period||0
11354388|NCT03073200|12551617|FG000|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
11354389|NCT03073200|12551618|FG001|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
11354390|NCT03073200|12551619|FG002|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
11354391|NCT03073200|12551620|FG003|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|53
11354392|NCT03073200|12551621|FG004|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|113
11223485|NCT01977794|12415431|FG000|STARTED|Overall Study||100
11223486|NCT01977794|12415432|FG001|STARTED|Overall Study||100
11223487|NCT01977794|12415431|FG000|COMPLETED|Overall Study||92
10844953|NCT00790933|12010954|FG000|STARTED|Overall Study||675
10844954|NCT00790933|12010955|FG001|STARTED|Overall Study||726
11223488|NCT01977794|12415432|FG001|COMPLETED|Overall Study||94
11223489|NCT01977794|12415431|FG000|NOT COMPLETED|Overall Study||8
11223490|NCT01977794|12415432|FG001|NOT COMPLETED|Overall Study||6
11223491|NCT01977820|12415440|FG000|STARTED|Overall Study||1
11223492|NCT01977820|12415441|FG001|STARTED|Overall Study||1
10844955|NCT00790933|12010956|FG002|STARTED|Overall Study||384
10844956|NCT00790933|12010957|FG003|STARTED|Overall Study||37
10844957|NCT00790933|12010958|FG004|STARTED|Overall Study||421
10844958|NCT00790933|12010954|FG000|COMPLETED|Overall Study||237
10844959|NCT00790933|12010955|FG001|COMPLETED|Overall Study||246
10844960|NCT00790933|12010956|FG002|COMPLETED|Overall Study||115
10844961|NCT00790933|12010957|FG003|COMPLETED|Overall Study||23
10844962|NCT00790933|12010958|FG004|COMPLETED|Overall Study||145
10844963|NCT00790933|12010954|FG000|NOT COMPLETED|Overall Study||438
10844964|NCT00790933|12010955|FG001|NOT COMPLETED|Overall Study||480
10844965|NCT00790933|12010956|FG002|NOT COMPLETED|Overall Study||269
10844966|NCT00790933|12010957|FG003|NOT COMPLETED|Overall Study||14
10844967|NCT00790933|12010958|FG004|NOT COMPLETED|Overall Study||276
10844968|NCT00624234|12010980|FG000|STARTED|Overall Study||8
10844969|NCT00624234|12010981|FG001|STARTED|Overall Study||9
10844970|NCT00624234|12010982|FG002|STARTED|Overall Study||26
10844971|NCT00624234|12010983|FG003|STARTED|Overall Study||14
10844972|NCT00624234|12010984|FG004|STARTED|Overall Study||18
10844973|NCT00624234|12010985|FG005|STARTED|Overall Study||14
10844974|NCT00624234|12010980|FG000|COMPLETED|Overall Study||8
10844975|NCT00624234|12010981|FG001|COMPLETED|Overall Study||9
10844976|NCT00624234|12010982|FG002|COMPLETED|Overall Study||26
10844977|NCT00624234|12010983|FG003|COMPLETED|Overall Study||14
10844978|NCT00624234|12010984|FG004|COMPLETED|Overall Study||18
10844979|NCT00624234|12010985|FG005|COMPLETED|Overall Study||14
10844980|NCT00624234|12010980|FG000|NOT COMPLETED|Overall Study||0
10844981|NCT00624234|12010981|FG001|NOT COMPLETED|Overall Study||0
10844982|NCT00624234|12010982|FG002|NOT COMPLETED|Overall Study||0
10844983|NCT00624234|12010983|FG003|NOT COMPLETED|Overall Study||0
10844984|NCT00624234|12010984|FG004|NOT COMPLETED|Overall Study||0
10844985|NCT00624234|12010985|FG005|NOT COMPLETED|Overall Study||0
10844986|NCT00127673|12011003|FG000|STARTED|Overall Study||48
10844987|NCT00127673|12011004|FG001|STARTED|Overall Study||61
10844988|NCT00127673|12011005|FG002|STARTED|Overall Study||55
10844989|NCT00127673|12011006|FG003|STARTED|Overall Study||36
10844990|NCT00127673|12011003|FG000|COMPLETED|Overall Study||23
10844991|NCT00127673|12011004|FG001|COMPLETED|Overall Study||44
10844992|NCT00127673|12011005|FG002|COMPLETED|Overall Study||35
10844993|NCT00127673|12011006|FG003|COMPLETED|Overall Study||25
10844994|NCT00127673|12011003|FG000|NOT COMPLETED|Overall Study||25
11223493|NCT01977820|12415440|FG000|COMPLETED|Overall Study||0
11223494|NCT01977820|12415441|FG001|COMPLETED|Overall Study||0
11223495|NCT01977820|12415440|FG000|NOT COMPLETED|Overall Study||1
11223496|NCT01977820|12415441|FG001|NOT COMPLETED|Overall Study||1
11223497|NCT01977846|12415449|FG000|STARTED|Total Study - Retrospective||251
11223498|NCT01977846|12415450|FG001|STARTED|Total Study - Retrospective||0
11223499|NCT01977846|12415449|FG000|COMPLETED|Total Study - Retrospective||251
11223500|NCT01977846|12415450|FG001|COMPLETED|Total Study - Retrospective||0
11223501|NCT01977846|12415449|FG000|NOT COMPLETED|Total Study - Retrospective||0
11223502|NCT01977846|12415450|FG001|NOT COMPLETED|Total Study - Retrospective||0
11223503|NCT01977846|12415449|FG000|STARTED|Total Study - Prospective||0
11223504|NCT01977846|12415450|FG001|STARTED|Total Study - Prospective||259
11223505|NCT01977846|12415449|FG000|COMPLETED|Total Study - Prospective||0
11223506|NCT01977846|12415450|FG001|COMPLETED|Total Study - Prospective||230
11223507|NCT01977846|12415449|FG000|NOT COMPLETED|Total Study - Prospective||0
11223508|NCT01977846|12415450|FG001|NOT COMPLETED|Total Study - Prospective||29
11223509|NCT01977898|12415459|FG000|STARTED|Overall Study||28
11223510|NCT01977898|12415460|FG001|STARTED|Overall Study||35
11223511|NCT01977898|12415459|FG000|COMPLETED|Overall Study||27
11223512|NCT01977898|12415460|FG001|COMPLETED|Overall Study||34
11223513|NCT01977898|12415459|FG000|NOT COMPLETED|Overall Study||1
11223514|NCT01977898|12415460|FG001|NOT COMPLETED|Overall Study||1
11223515|NCT01977937|12415468|FG000|STARTED|Overall Study||27
11223516|NCT01977937|12415469|FG001|STARTED|Overall Study||28
11223517|NCT01977937|12415468|FG000|COMPLETED|Overall Study||24
11223518|NCT01977937|12415469|FG001|COMPLETED|Overall Study||26
11223519|NCT01977937|12415468|FG000|NOT COMPLETED|Overall Study||3
11223520|NCT01977937|12415469|FG001|NOT COMPLETED|Overall Study||2
11223521|NCT01978093|12415477|FG000|STARTED|Overall Study||297
11223522|NCT01978093|12415478|FG001|STARTED|Overall Study||303
11223523|NCT01978093|12415477|FG000|COMPLETED|Overall Study||232
11223524|NCT01978093|12415478|FG001|COMPLETED|Overall Study||230
11223525|NCT01978093|12415477|FG000|NOT COMPLETED|Overall Study||65
11223526|NCT01978093|12415478|FG001|NOT COMPLETED|Overall Study||73
11223527|NCT01978119|12415487|FG000|STARTED|Treatment Period 1 (12 Weeks)||40
11223528|NCT01978119|12415488|FG001|STARTED|Treatment Period 1 (12 Weeks)||42
11223529|NCT01978119|12415487|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||38
10844995|NCT00127673|12011004|FG001|NOT COMPLETED|Overall Study||17
10844996|NCT00127673|12011005|FG002|NOT COMPLETED|Overall Study||20
10844997|NCT00127673|12011006|FG003|NOT COMPLETED|Overall Study||11
11223530|NCT01978119|12415488|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||42
11223531|NCT01978119|12415487|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
11354393|NCT03073200|12551622|FG005|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|28
10844998|NCT04388527|12011020|FG000|STARTED|Overall Study||32
10844999|NCT04388527|12011020|FG000|COMPLETED|Overall Study||15
10845000|NCT04388527|12011020|FG000|NOT COMPLETED|Overall Study||17
10845001|NCT04369833|12011024|FG000|STARTED|Overall Study||130
10845002|NCT04369833|12011024|FG000|COMPLETED|Overall Study||129
10845003|NCT04369833|12011024|FG000|NOT COMPLETED|Overall Study||1
10845004|NCT04280081|12011028|FG000|STARTED|Overall Study||77
10845005|NCT04280081|12011028|FG000|Enrolled: All NSCLC|Overall Study||47
10845006|NCT04280081|12011028|FG000|Enrolled: All TC|Overall Study||1
10845007|NCT04280081|12011028|FG000|Enrolled: All MTC|Overall Study||29
10845008|NCT04280081|12011028|FG000|PAS: RET Fusion Positive NSCLC|Overall Study||26
10845009|NCT04280081|12011028|FG000|PAS: RET Fusion Positive TC|Overall Study||1
10845010|NCT04280081|12011028|FG000|PAS: Advance RET-mutant MTC|Overall Study||26
10845011|NCT04280081|12011028|FG000|COMPLETED|Overall Study||65
10845012|NCT04280081|12011028|FG000|NOT COMPLETED|Overall Study||12
10845013|NCT04238429|12011043|FG000|STARTED|Overall Study||43
10845014|NCT04238429|12011044|FG001|STARTED|Overall Study||43
10845015|NCT04238429|12011043|FG000|COMPLETED|Overall Study||40
10845016|NCT04238429|12011044|FG001|COMPLETED|Overall Study||41
10845017|NCT04238429|12011043|FG000|NOT COMPLETED|Overall Study||3
10845018|NCT04238429|12011044|FG001|NOT COMPLETED|Overall Study||2
10845019|NCT04126083|12011050|FG000|STARTED|Overall Study||6
10845020|NCT04126083|12011050|FG000|COMPLETED|Overall Study||5
10845021|NCT04126083|12011050|FG000|NOT COMPLETED|Overall Study||1
11105055|NCT01252355|12289423|FG002|NOT COMPLETED|Overall Study||179
11105056|NCT01252563|12289431|FG000|STARTED|Overall Study||13775
11105057|NCT01252563|12289431|FG000|COMPLETED|Overall Study||13343
11105058|NCT01252563|12289431|FG000|NOT COMPLETED|Overall Study||432
11105059|NCT01252667|12289472|FG000|STARTED|Overall Study||3
11105060|NCT01252667|12289473|FG001|STARTED|Overall Study||3
10845028|NCT03744637|12011073|FG000|STARTED|Overall Study||2
10845029|NCT03744637|12011074|FG001|STARTED|Overall Study||2
10845030|NCT03744637|12011075|FG002|STARTED|Overall Study||2
10845031|NCT03744637|12011076|FG003|STARTED|Overall Study||1
10845032|NCT03744637|12011077|FG004|STARTED|Overall Study||1
10845033|NCT03744637|12011078|FG005|STARTED|Overall Study||1
10845034|NCT03744637|12011079|FG006|STARTED|Overall Study||8
10845035|NCT03744637|12011080|FG007|STARTED|Overall Study||4
10845036|NCT03744637|12011081|FG008|STARTED|Overall Study||3
10845037|NCT03744637|12011082|FG009|STARTED|Overall Study||1
10845038|NCT03744637|12011073|FG000|COMPLETED|Overall Study||2
10845039|NCT03744637|12011074|FG001|COMPLETED|Overall Study||2
10845040|NCT03744637|12011075|FG002|COMPLETED|Overall Study||2
10845041|NCT03744637|12011076|FG003|COMPLETED|Overall Study||1
10845042|NCT03744637|12011077|FG004|COMPLETED|Overall Study|Participant did not receive MK-5475 240 ug in Part 2 as planned.|1
10845043|NCT03744637|12011078|FG005|COMPLETED|Overall Study|Participant received 165 ug in Part 2 Periods 2 and 3, instead of planned 360 ug.|1
10845044|NCT03744637|12011079|FG006|COMPLETED|Overall Study||8
10845045|NCT03744637|12011080|FG007|COMPLETED|Overall Study|Participants received 120 ug in Part 2 Periods 2 and 3, instead of planned 360 ug.|4
10845046|NCT03744637|12011081|FG008|COMPLETED|Overall Study||3
10845047|NCT03744637|12011082|FG009|COMPLETED|Overall Study|Participant did not receive 120 ug in Part 2 Period 3 as planned.|1
10845048|NCT03744637|12011073|FG000|NOT COMPLETED|Overall Study||0
10845049|NCT03744637|12011074|FG001|NOT COMPLETED|Overall Study||0
10845050|NCT03744637|12011075|FG002|NOT COMPLETED|Overall Study||0
10845051|NCT03744637|12011076|FG003|NOT COMPLETED|Overall Study||0
10845052|NCT03744637|12011077|FG004|NOT COMPLETED|Overall Study||0
10845053|NCT03744637|12011078|FG005|NOT COMPLETED|Overall Study||0
10845054|NCT03744637|12011079|FG006|NOT COMPLETED|Overall Study||0
10845055|NCT03744637|12011080|FG007|NOT COMPLETED|Overall Study||0
10845056|NCT03744637|12011081|FG008|NOT COMPLETED|Overall Study||0
10845057|NCT03744637|12011082|FG009|NOT COMPLETED|Overall Study||0
11354394|NCT03073200|12551623|FG006|STARTED|Open-Label Maintenance Period||0
10845058|NCT03576144|12011149|FG000|STARTED|Overall Study||10
10845059|NCT03576144|12011150|FG001|STARTED|Overall Study||8
10845060|NCT03576144|12011151|FG002|STARTED|Overall Study||8
10845061|NCT03576144|12011152|FG003|STARTED|Overall Study||8
10845062|NCT03576144|12011153|FG004|STARTED|Overall Study||8
10845063|NCT03576144|12011154|FG005|STARTED|Overall Study||8
10845064|NCT03576144|12011149|FG000|COMPLETED|Overall Study||10
10845065|NCT03576144|12011150|FG001|COMPLETED|Overall Study||8
10845066|NCT03576144|12011151|FG002|COMPLETED|Overall Study||8
10845067|NCT03576144|12011152|FG003|COMPLETED|Overall Study||8
10845068|NCT03576144|12011153|FG004|COMPLETED|Overall Study||8
10845069|NCT03576144|12011154|FG005|COMPLETED|Overall Study||8
10845070|NCT03576144|12011149|FG000|NOT COMPLETED|Overall Study||0
10845071|NCT03576144|12011150|FG001|NOT COMPLETED|Overall Study||0
10845072|NCT03576144|12011151|FG002|NOT COMPLETED|Overall Study||0
10845073|NCT03576144|12011152|FG003|NOT COMPLETED|Overall Study||0
10845074|NCT03576144|12011153|FG004|NOT COMPLETED|Overall Study||0
10845075|NCT03576144|12011154|FG005|NOT COMPLETED|Overall Study||0
10845076|NCT03444038|12011173|FG000|STARTED|Overall Study||85
10845077|NCT03444038|12011173|FG000|COMPLETED|Overall Study||56
10845078|NCT03444038|12011173|FG000|NOT COMPLETED|Overall Study||29
10845079|NCT03432897|12011177|FG000|STARTED|Overall Study||1
10845080|NCT03432897|12011177|FG000|COMPLETED|Overall Study||1
10845081|NCT03432897|12011177|FG000|NOT COMPLETED|Overall Study||0
11105061|NCT01252667|12289474|FG002|STARTED|Overall Study||3
10845082|NCT03265665|12011183|FG000|STARTED|24-week Data Collection||25
10845083|NCT03265665|12011184|FG001|STARTED|24-week Data Collection||28
10845084|NCT03265665|12011183|FG000|COMPLETED|24-week Data Collection||19
10845085|NCT03265665|12011184|FG001|COMPLETED|24-week Data Collection||21
10845086|NCT03265665|12011183|FG000|NOT COMPLETED|24-week Data Collection||6
10845087|NCT03265665|12011184|FG001|NOT COMPLETED|24-week Data Collection||7
10845088|NCT03265665|12011183|FG000|STARTED|36-week Data Collection|Used the number of participants that did not withdraw from the study. If a participant did not complete the 24 week week data collection, they were still allowed to complete the 36-week data collection. Thus the number we started with for this period was the total number of participants in each group that did not withdraw from the study.|23
10845089|NCT03265665|12011184|FG001|STARTED|36-week Data Collection|Used the number of participants that did not withdraw from the study. If a participant did not complete the 24 week week data collection, they were still allowed to complete the 36-week data collection. Thus the number we started with for this period was the total number of participants in each group that did not withdraw from the study.|26
10845090|NCT03265665|12011183|FG000|COMPLETED|36-week Data Collection||17
10845091|NCT03265665|12011184|FG001|COMPLETED|36-week Data Collection||18
10845092|NCT03265665|12011183|FG000|NOT COMPLETED|36-week Data Collection||6
10845093|NCT03265665|12011184|FG001|NOT COMPLETED|36-week Data Collection||8
10845094|NCT03196180|12011192|FG000|STARTED|Overall Study||13
10845095|NCT03196180|12011192|FG000|COMPLETED|Overall Study||11
10845096|NCT03196180|12011192|FG000|NOT COMPLETED|Overall Study||2
10845097|NCT02725593|12011198|FG000|STARTED|Blinded Treatment Period||39
10845098|NCT02725593|12011199|FG001|STARTED|Blinded Treatment Period||33
10845099|NCT02725593|12011198|FG000|Received Treatment|Blinded Treatment Period||39
10845100|NCT02725593|12011199|FG001|Received Treatment|Blinded Treatment Period||33
10845101|NCT02725593|12011198|FG000|COMPLETED|Blinded Treatment Period||34
10845102|NCT02725593|12011199|FG001|COMPLETED|Blinded Treatment Period||27
10845103|NCT02725593|12011198|FG000|NOT COMPLETED|Blinded Treatment Period||5
10845104|NCT02725593|12011199|FG001|NOT COMPLETED|Blinded Treatment Period||6
10845105|NCT02725593|12011198|FG000|STARTED|Long Term Extension|1 participant who completed Period 1 did not enter the long-term extension period.|33
10845106|NCT02725593|12011199|FG001|STARTED|Long Term Extension||27
10845107|NCT02725593|12011198|FG000|COMPLETED|Long Term Extension||32
10845108|NCT02725593|12011199|FG001|COMPLETED|Long Term Extension||24
10845109|NCT02725593|12011198|FG000|NOT COMPLETED|Long Term Extension||1
10845110|NCT02725593|12011199|FG001|NOT COMPLETED|Long Term Extension||3
10845111|NCT02716675|12011208|FG000|STARTED|Overall Study||903
10845112|NCT02716675|12011209|FG001|STARTED|Overall Study||899
10845113|NCT02716675|12011210|FG002|STARTED|Overall Study||897
10845114|NCT02716675|12011208|FG000|Modified Intent-to-treat Population|Overall Study||898
10845115|NCT02716675|12011209|FG001|Modified Intent-to-treat Population|Overall Study||895
10845116|NCT02716675|12011210|FG002|Modified Intent-to-treat Population|Overall Study||894
10845117|NCT02716675|12011208|FG000|COMPLETED|Overall Study||703
10845118|NCT02716675|12011209|FG001|COMPLETED|Overall Study||702
10845119|NCT02716675|12011210|FG002|COMPLETED|Overall Study||686
10845120|NCT02716675|12011208|FG000|NOT COMPLETED|Overall Study||200
10845121|NCT02716675|12011209|FG001|NOT COMPLETED|Overall Study||197
10845122|NCT02716675|12011210|FG002|NOT COMPLETED|Overall Study||211
10845123|NCT02636946|12011225|FG000|STARTED|Cycle 1 (Day 1 to Week 15)||72
10845124|NCT02636946|12011226|FG001|STARTED|Cycle 1 (Day 1 to Week 15)||72
10845125|NCT02636946|12011225|FG000|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||72
10845126|NCT02636946|12011226|FG001|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||70
10845127|NCT02636946|12011225|FG000|COMPLETED|Cycle 1 (Day 1 to Week 15)||71
10845128|NCT02636946|12011226|FG001|COMPLETED|Cycle 1 (Day 1 to Week 15)||67
10845129|NCT02636946|12011225|FG000|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||1
10845130|NCT02636946|12011226|FG001|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||5
10845131|NCT02636946|12011225|FG000|STARTED|Cycle 2 (Week 16 to Week 31)||65
10845132|NCT02636946|12011226|FG001|STARTED|Cycle 2 (Week 16 to Week 31)||62
10845133|NCT02636946|12011225|FG000|COMPLETED|Cycle 2 (Week 16 to Week 31)||63
10845134|NCT02636946|12011226|FG001|COMPLETED|Cycle 2 (Week 16 to Week 31)||61
10845135|NCT02636946|12011225|FG000|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||2
10845136|NCT02636946|12011226|FG001|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||1
10845137|NCT02636946|12011225|FG000|STARTED|Cycle 3 (Week 32 to Week 52)||17
10845138|NCT02636946|12011226|FG001|STARTED|Cycle 3 (Week 32 to Week 52)||16
10845139|NCT02636946|12011225|FG000|COMPLETED|Cycle 3 (Week 32 to Week 52)||17
10845140|NCT02636946|12011226|FG001|COMPLETED|Cycle 3 (Week 32 to Week 52)||16
10845141|NCT02636946|12011225|FG000|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0
10845142|NCT02636946|12011226|FG001|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0
10845143|NCT02631941|12011242|FG000|STARTED|Overall Study||9
10845144|NCT02631941|12011243|FG001|STARTED|Overall Study||10
10845145|NCT02631941|12011244|FG002|STARTED|Overall Study||9
10845146|NCT02631941|12011245|FG003|STARTED|Overall Study||9
10845147|NCT02631941|12011246|FG004|STARTED|Overall Study||9
10845148|NCT02631941|12011247|FG005|STARTED|Overall Study||8
10845149|NCT02631941|12011248|FG006|STARTED|Overall Study||9
10845150|NCT02631941|12011249|FG007|STARTED|Overall Study||9
10845151|NCT02631941|12011250|FG008|STARTED|Overall Study||10
10845152|NCT02631941|12011251|FG009|STARTED|Overall Study||9
10845153|NCT02631941|12011242|FG000|A|Overall Study||9
10845154|NCT02631941|12011243|FG001|A|Overall Study||8
10845155|NCT02631941|12011244|FG002|A|Overall Study||9
10845156|NCT02631941|12011245|FG003|A|Overall Study||9
10845157|NCT02631941|12011246|FG004|A|Overall Study||9
10845158|NCT02631941|12011247|FG005|A|Overall Study||8
10845159|NCT02631941|12011248|FG006|A|Overall Study||9
10845160|NCT02631941|12011249|FG007|A|Overall Study||9
10845161|NCT02631941|12011250|FG008|A|Overall Study||9
10845162|NCT02631941|12011251|FG009|A|Overall Study||9
10845163|NCT02631941|12011242|FG000|B1|Overall Study||9
10845164|NCT02631941|12011243|FG001|B1|Overall Study||10
10845165|NCT02631941|12011244|FG002|B1|Overall Study||9
10845166|NCT02631941|12011245|FG003|B1|Overall Study||9
10845167|NCT02631941|12011246|FG004|B1|Overall Study||8
10845168|NCT02631941|12011247|FG005|B1|Overall Study||8
10845169|NCT02631941|12011248|FG006|B1|Overall Study||9
10845170|NCT02631941|12011249|FG007|B1|Overall Study||9
10845171|NCT02631941|12011250|FG008|B1|Overall Study||10
10845172|NCT02631941|12011251|FG009|B1|Overall Study||9
10845173|NCT02631941|12011242|FG000|B2|Overall Study||9
10845174|NCT02631941|12011243|FG001|B2|Overall Study||8
10845175|NCT02631941|12011244|FG002|B2|Overall Study||9
10845176|NCT02631941|12011245|FG003|B2|Overall Study||9
10845177|NCT02631941|12011246|FG004|B2|Overall Study||9
10845178|NCT02631941|12011247|FG005|B2|Overall Study||8
10845179|NCT02631941|12011248|FG006|B2|Overall Study||9
10845180|NCT02631941|12011249|FG007|B2|Overall Study||9
10845181|NCT02631941|12011250|FG008|B2|Overall Study||9
10845182|NCT02631941|12011251|FG009|B2|Overall Study||9
10845183|NCT02631941|12011242|FG000|C|Overall Study||9
10845184|NCT02631941|12011243|FG001|C|Overall Study||8
10845185|NCT02631941|12011244|FG002|C|Overall Study||9
10845186|NCT02631941|12011245|FG003|C|Overall Study||9
10845187|NCT02631941|12011246|FG004|C|Overall Study||8
10845188|NCT02631941|12011247|FG005|C|Overall Study||8
10845189|NCT02631941|12011248|FG006|C|Overall Study||9
10845190|NCT02631941|12011249|FG007|C|Overall Study||8
10845191|NCT02631941|12011250|FG008|C|Overall Study||9
10845192|NCT02631941|12011251|FG009|C|Overall Study||9
10845193|NCT02631941|12011242|FG000|D|Overall Study||9
10845194|NCT02631941|12011243|FG001|D|Overall Study||8
10845195|NCT02631941|12011244|FG002|D|Overall Study||9
10845196|NCT02631941|12011245|FG003|D|Overall Study||9
10845197|NCT02631941|12011246|FG004|D|Overall Study||8
10845198|NCT02631941|12011247|FG005|D|Overall Study||8
10845199|NCT02631941|12011248|FG006|D|Overall Study||9
10845200|NCT02631941|12011249|FG007|D|Overall Study||9
10845201|NCT02631941|12011250|FG008|D|Overall Study||9
10845202|NCT02631941|12011251|FG009|D|Overall Study||9
10845203|NCT02631941|12011242|FG000|COMPLETED|Overall Study||9
10845204|NCT02631941|12011243|FG001|COMPLETED|Overall Study||8
10845205|NCT02631941|12011244|FG002|COMPLETED|Overall Study||9
10845206|NCT02631941|12011245|FG003|COMPLETED|Overall Study||9
10845207|NCT02631941|12011246|FG004|COMPLETED|Overall Study||8
10845208|NCT02631941|12011247|FG005|COMPLETED|Overall Study||8
10845209|NCT02631941|12011248|FG006|COMPLETED|Overall Study||9
10845210|NCT02631941|12011249|FG007|COMPLETED|Overall Study||8
10845211|NCT02631941|12011250|FG008|COMPLETED|Overall Study||9
10845212|NCT02631941|12011251|FG009|COMPLETED|Overall Study||9
10845213|NCT02631941|12011242|FG000|NOT COMPLETED|Overall Study||0
10845214|NCT02631941|12011243|FG001|NOT COMPLETED|Overall Study||2
10845215|NCT02631941|12011244|FG002|NOT COMPLETED|Overall Study||0
10845216|NCT02631941|12011245|FG003|NOT COMPLETED|Overall Study||0
10845217|NCT02631941|12011246|FG004|NOT COMPLETED|Overall Study||1
10845218|NCT02631941|12011247|FG005|NOT COMPLETED|Overall Study||0
10845219|NCT02631941|12011248|FG006|NOT COMPLETED|Overall Study||0
10845220|NCT02631941|12011249|FG007|NOT COMPLETED|Overall Study||1
10845221|NCT02631941|12011250|FG008|NOT COMPLETED|Overall Study||1
10845222|NCT02631941|12011251|FG009|NOT COMPLETED|Overall Study||0
10845223|NCT02568215|12011264|FG000|STARTED|Overall Study||637
10845224|NCT02568215|12011265|FG001|STARTED|Overall Study||642
10845225|NCT02568215|12011266|FG002|STARTED|Overall Study||645
10845226|NCT02568215|12011264|FG000|Modified Intent-to-treat Population|Overall Study||637
10845227|NCT02568215|12011265|FG001|Modified Intent-to-treat Population|Overall Study||642
10845228|NCT02568215|12011266|FG002|Modified Intent-to-treat Population|Overall Study||645
10845229|NCT02568215|12011264|FG000|COMPLETED|Overall Study||558
10845230|NCT02568215|12011265|FG001|COMPLETED|Overall Study||562
10845231|NCT02568215|12011266|FG002|COMPLETED|Overall Study||555
10845232|NCT02568215|12011264|FG000|NOT COMPLETED|Overall Study||79
11223532|NCT01978119|12415488|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
10845233|NCT02568215|12011265|FG001|NOT COMPLETED|Overall Study||80
10845234|NCT02568215|12011266|FG002|NOT COMPLETED|Overall Study||90
11223533|NCT01978119|12415487|FG000|STARTED|Washout Period 1 (3 Weeks)||38
10845235|NCT02562378|12011282|FG000|STARTED|Overall Study||3
10845236|NCT02562378|12011283|FG001|STARTED|Overall Study||3
10845237|NCT02562378|12011284|FG002|STARTED|Overall Study||9
10845238|NCT02562378|12011282|FG000|COMPLETED|Overall Study||3
10845239|NCT02562378|12011283|FG001|COMPLETED|Overall Study||3
10845240|NCT02562378|12011284|FG002|COMPLETED|Overall Study||9
10845241|NCT02562378|12011282|FG000|NOT COMPLETED|Overall Study||0
10845242|NCT02562378|12011283|FG001|NOT COMPLETED|Overall Study||0
10845243|NCT02562378|12011284|FG002|NOT COMPLETED|Overall Study||0
10845244|NCT02528643|12011294|FG000|STARTED|DB (Median Duration up to 14.65 Months)||55
10845245|NCT02528643|12011295|FG001|STARTED|DB (Median Duration up to 14.65 Months)||110
10845246|NCT02528643|12011294|FG000|Treated|DB (Median Duration up to 14.65 Months)||55
10845247|NCT02528643|12011295|FG001|Treated|DB (Median Duration up to 14.65 Months)||107
10845248|NCT02528643|12011294|FG000|COMPLETED|DB (Median Duration up to 14.65 Months)||0
10845249|NCT02528643|12011295|FG001|COMPLETED|DB (Median Duration up to 14.65 Months)||0
10845250|NCT02528643|12011294|FG000|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||55
10845251|NCT02528643|12011295|FG001|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||110
10845252|NCT02528643|12011294|FG000|STARTED|OL (Median Duration up to 27.56 Months)||0
10845253|NCT02528643|12011295|FG001|STARTED|OL (Median Duration up to 27.56 Months)||1
10845254|NCT02528643|12011294|FG000|COMPLETED|OL (Median Duration up to 27.56 Months)||0
10845255|NCT02528643|12011295|FG001|COMPLETED|OL (Median Duration up to 27.56 Months)||0
10845256|NCT02528643|12011294|FG000|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||0
10845257|NCT02528643|12011295|FG001|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||1
10845258|NCT02416011|12011306|FG000|STARTED|Overall Study||575
10845259|NCT02416011|12011307|FG001|STARTED|Overall Study||1154
10845260|NCT02416011|12011308|FG002|STARTED|Overall Study||1167
10845261|NCT02416011|12011306|FG000|COMPLETED|Overall Study||561
10845262|NCT02416011|12011307|FG001|COMPLETED|Overall Study||1101
10845263|NCT02416011|12011308|FG002|COMPLETED|Overall Study||1114
10845264|NCT02416011|12011306|FG000|NOT COMPLETED|Overall Study||14
10845265|NCT02416011|12011307|FG001|NOT COMPLETED|Overall Study||53
10845266|NCT02416011|12011308|FG002|NOT COMPLETED|Overall Study||53
10845267|NCT02237508|12011339|FG000|STARTED|Overall Study||9
10845268|NCT02237508|12011340|FG001|STARTED|Overall Study||9
10845269|NCT02237508|12011341|FG002|STARTED|Overall Study||9
10845270|NCT02237508|12011342|FG003|STARTED|Overall Study||9
10845271|NCT02237508|12011343|FG004|STARTED|Overall Study||9
10845272|NCT02237508|12011344|FG005|STARTED|Overall Study||9
10845273|NCT02237508|12011345|FG006|STARTED|Overall Study||9
10845274|NCT02237508|12011346|FG007|STARTED|Overall Study||9
10845275|NCT02237508|12011347|FG008|STARTED|Overall Study||9
10845276|NCT02237508|12011348|FG009|STARTED|Overall Study||9
10845277|NCT02237508|12011339|FG000|A|Overall Study||9
10845278|NCT02237508|12011340|FG001|A|Overall Study||6
10845279|NCT02237508|12011341|FG002|A|Overall Study||8
10845280|NCT02237508|12011342|FG003|A|Overall Study||8
10845281|NCT02237508|12011343|FG004|A|Overall Study||9
10845282|NCT02237508|12011344|FG005|A|Overall Study||8
10845283|NCT02237508|12011345|FG006|A|Overall Study||8
10845284|NCT02237508|12011346|FG007|A|Overall Study||9
10845285|NCT02237508|12011347|FG008|A|Overall Study||9
10845286|NCT02237508|12011348|FG009|A|Overall Study||9
10845287|NCT02237508|12011339|FG000|B1|Overall Study||9
10845288|NCT02237508|12011340|FG001|B1|Overall Study||9
10845289|NCT02237508|12011341|FG002|B1|Overall Study||9
10845290|NCT02237508|12011342|FG003|B1|Overall Study||8
10845291|NCT02237508|12011343|FG004|B1|Overall Study||9
10845292|NCT02237508|12011344|FG005|B1|Overall Study||9
10845293|NCT02237508|12011345|FG006|B1|Overall Study||9
10845294|NCT02237508|12011346|FG007|B1|Overall Study||9
10845295|NCT02237508|12011347|FG008|B1|Overall Study||9
10845296|NCT02237508|12011348|FG009|B1|Overall Study||9
10845297|NCT02237508|12011339|FG000|B2|Overall Study||9
10845298|NCT02237508|12011340|FG001|B2|Overall Study||6
10845299|NCT02237508|12011341|FG002|B2|Overall Study||9
10845300|NCT02237508|12011342|FG003|B2|Overall Study||9
10845301|NCT02237508|12011343|FG004|B2|Overall Study||9
10845302|NCT02237508|12011344|FG005|B2|Overall Study||9
10845303|NCT02237508|12011345|FG006|B2|Overall Study||9
10845304|NCT02237508|12011346|FG007|B2|Overall Study||9
10845305|NCT02237508|12011347|FG008|B2|Overall Study||8
10845306|NCT02237508|12011348|FG009|B2|Overall Study||9
10845307|NCT02237508|12011339|FG000|C|Overall Study||9
10845308|NCT02237508|12011340|FG001|C|Overall Study||8
10845309|NCT02237508|12011341|FG002|C|Overall Study||9
10845310|NCT02237508|12011342|FG003|C|Overall Study||8
10845311|NCT02237508|12011343|FG004|C|Overall Study||9
10845312|NCT02237508|12011344|FG005|C|Overall Study||9
10845313|NCT02237508|12011345|FG006|C|Overall Study||9
10845314|NCT02237508|12011346|FG007|C|Overall Study||9
10845315|NCT02237508|12011347|FG008|C|Overall Study||9
10845316|NCT02237508|12011348|FG009|C|Overall Study||9
10845317|NCT02237508|12011339|FG000|D|Overall Study||9
10845318|NCT02237508|12011340|FG001|D|Overall Study||6
10845319|NCT02237508|12011341|FG002|D|Overall Study||9
10845320|NCT02237508|12011342|FG003|D|Overall Study||9
10845321|NCT02237508|12011343|FG004|D|Overall Study||9
10845322|NCT02237508|12011344|FG005|D|Overall Study||9
10845323|NCT02237508|12011345|FG006|D|Overall Study||9
10845324|NCT02237508|12011346|FG007|D|Overall Study||9
10845325|NCT02237508|12011347|FG008|D|Overall Study||8
10845326|NCT02237508|12011348|FG009|D|Overall Study||9
10845327|NCT02237508|12011339|FG000|COMPLETED|Overall Study||9
10845328|NCT02237508|12011340|FG001|COMPLETED|Overall Study||6
10845329|NCT02237508|12011341|FG002|COMPLETED|Overall Study||8
10845330|NCT02237508|12011342|FG003|COMPLETED|Overall Study||8
10845331|NCT02237508|12011343|FG004|COMPLETED|Overall Study||9
10845332|NCT02237508|12011344|FG005|COMPLETED|Overall Study||8
10845333|NCT02237508|12011345|FG006|COMPLETED|Overall Study||8
10845334|NCT02237508|12011346|FG007|COMPLETED|Overall Study||9
11223534|NCT01978119|12415488|FG001|STARTED|Washout Period 1 (3 Weeks)||42
11223535|NCT01978119|12415487|FG000|COMPLETED|Washout Period 1 (3 Weeks)||38
11223536|NCT01978119|12415488|FG001|COMPLETED|Washout Period 1 (3 Weeks)||42
11223537|NCT01978119|12415487|FG000|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
11223538|NCT01978119|12415488|FG001|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
11223539|NCT01978119|12415487|FG000|STARTED|Treatment Period 2 (12 Weeks)||38
11223540|NCT01978119|12415488|FG001|STARTED|Treatment Period 2 (12 Weeks)||42
11223541|NCT01978119|12415487|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||38
11223542|NCT01978119|12415488|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||40
11223543|NCT01978119|12415487|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
11223544|NCT01978119|12415488|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
11223545|NCT01978145|12415494|FG000|STARTED|Treatment Period 1||214
11223546|NCT01978145|12415495|FG001|STARTED|Treatment Period 1||212
11223547|NCT01978145|12415494|FG000|COMPLETED|Treatment Period 1||205
11223548|NCT01978145|12415495|FG001|COMPLETED|Treatment Period 1||196
11223549|NCT01978145|12415494|FG000|NOT COMPLETED|Treatment Period 1||9
11223550|NCT01978145|12415495|FG001|NOT COMPLETED|Treatment Period 1||16
11223551|NCT01978145|12415494|FG000|STARTED|Washout Period 1||205
11223552|NCT01978145|12415495|FG001|STARTED|Washout Period 1||196
11223553|NCT01978145|12415494|FG000|COMPLETED|Washout Period 1||204
11223554|NCT01978145|12415495|FG001|COMPLETED|Washout Period 1||193
11223555|NCT01978145|12415494|FG000|NOT COMPLETED|Washout Period 1||1
11223556|NCT01978145|12415495|FG001|NOT COMPLETED|Washout Period 1||3
11223557|NCT01978145|12415494|FG000|STARTED|Treatment Period 2||204
11223558|NCT01978145|12415495|FG001|STARTED|Treatment Period 2||193
11223559|NCT01978145|12415494|FG000|COMPLETED|Treatment Period 2||185
11223560|NCT01978145|12415495|FG001|COMPLETED|Treatment Period 2||179
11223561|NCT01978145|12415494|FG000|NOT COMPLETED|Treatment Period 2||19
11223562|NCT01978145|12415495|FG001|NOT COMPLETED|Treatment Period 2||14
11223563|NCT01978184|12415503|FG000|STARTED|Overall Study||43
11223564|NCT01978184|12415504|FG001|STARTED|Overall Study||61
11223565|NCT01978184|12415503|FG000|COMPLETED|Overall Study||30
11223566|NCT01978184|12415504|FG001|COMPLETED|Overall Study||41
11223567|NCT01978184|12415503|FG000|NOT COMPLETED|Overall Study||13
11223568|NCT01978184|12415504|FG001|NOT COMPLETED|Overall Study||20
11223569|NCT01978236|12415510|FG000|STARTED|Overall Study||6
11223570|NCT01978236|12415510|FG000|COMPLETED|Overall Study||4
11223571|NCT01978236|12415510|FG000|NOT COMPLETED|Overall Study||2
11223572|NCT01978262|12415514|FG000|STARTED|Overall Study||103
11223573|NCT01978262|12415514|FG000|COMPLETED|Overall Study||92
11223574|NCT01978262|12415514|FG000|NOT COMPLETED|Overall Study||11
11223575|NCT01978314|12415524|FG000|STARTED|Overall Study||8
11223576|NCT01978314|12415525|FG001|STARTED|Overall Study||8
11223577|NCT01978314|12415526|FG002|STARTED|Overall Study||8
11223578|NCT01978314|12415527|FG003|STARTED|Overall Study||1
11223579|NCT01978314|12415528|FG004|STARTED|Overall Study||8
11223580|NCT01978314|12415524|FG000|COMPLETED|Overall Study||8
11223581|NCT01978314|12415525|FG001|COMPLETED|Overall Study||8
11223582|NCT01978314|12415526|FG002|COMPLETED|Overall Study||8
11223583|NCT01978314|12415527|FG003|COMPLETED|Overall Study||1
11223584|NCT01978314|12415528|FG004|COMPLETED|Overall Study||8
11223585|NCT01978314|12415524|FG000|NOT COMPLETED|Overall Study||0
11223586|NCT01978314|12415525|FG001|NOT COMPLETED|Overall Study||0
11223587|NCT01978314|12415526|FG002|NOT COMPLETED|Overall Study||0
11223588|NCT01978314|12415527|FG003|NOT COMPLETED|Overall Study||0
11223589|NCT01978314|12415528|FG004|NOT COMPLETED|Overall Study||0
11223590|NCT01978509|12415554|FG000|STARTED|Overall Study||10
10845335|NCT02237508|12011347|FG008|COMPLETED|Overall Study||8
10845336|NCT02237508|12011348|FG009|COMPLETED|Overall Study||9
11223591|NCT01978509|12415555|FG001|STARTED|Overall Study||13
11223592|NCT01978509|12415556|FG002|STARTED|Overall Study||9
11223593|NCT01978509|12415554|FG000|COMPLETED|Overall Study||8
11223594|NCT01978509|12415555|FG001|COMPLETED|Overall Study||8
11223595|NCT01978509|12415556|FG002|COMPLETED|Overall Study||9
10845337|NCT02237508|12011339|FG000|NOT COMPLETED|Overall Study||0
10845338|NCT02237508|12011340|FG001|NOT COMPLETED|Overall Study||3
10845339|NCT02237508|12011341|FG002|NOT COMPLETED|Overall Study||1
10845340|NCT02237508|12011342|FG003|NOT COMPLETED|Overall Study||1
10845341|NCT02237508|12011343|FG004|NOT COMPLETED|Overall Study||0
10845342|NCT02237508|12011344|FG005|NOT COMPLETED|Overall Study||1
10845343|NCT02237508|12011345|FG006|NOT COMPLETED|Overall Study||1
10845344|NCT02237508|12011346|FG007|NOT COMPLETED|Overall Study||0
10845345|NCT02237508|12011347|FG008|NOT COMPLETED|Overall Study||1
10845346|NCT02237508|12011348|FG009|NOT COMPLETED|Overall Study||0
10845347|NCT01706705|12011366|FG000|STARTED|Overall Study||57
10845348|NCT01706705|12011366|FG000|COMPLETED|Overall Study||37
10845349|NCT01706705|12011366|FG000|NOT COMPLETED|Overall Study||20
10845350|NCT01609842|12011375|FG000|STARTED|Pre-Intervention Control||0
10845351|NCT01609842|12011376|FG001|STARTED|Pre-Intervention Control|Intervention sites patients prior to enrollment period who did not receive the intervention|6081
10845352|NCT01609842|12011375|FG000|COMPLETED|Pre-Intervention Control||0
10845353|NCT01609842|12011376|FG001|COMPLETED|Pre-Intervention Control||6081
10845354|NCT01609842|12011375|FG000|NOT COMPLETED|Pre-Intervention Control||0
10845355|NCT01609842|12011376|FG001|NOT COMPLETED|Pre-Intervention Control||0
10845356|NCT01609842|12011375|FG000|STARTED|Post-Intervention Control||0
11223596|NCT01978509|12415554|FG000|NOT COMPLETED|Overall Study||2
11223597|NCT01978509|12415555|FG001|NOT COMPLETED|Overall Study||5
11223598|NCT01978509|12415556|FG002|NOT COMPLETED|Overall Study||0
10845357|NCT01609842|12011376|FG001|STARTED|Post-Intervention Control|Intervention sites patients after enrollment period ended who did not receive the intervention.|2917
10845358|NCT01609842|12011375|FG000|COMPLETED|Post-Intervention Control||0
10845359|NCT01609842|12011376|FG001|COMPLETED|Post-Intervention Control||2917
10845360|NCT01609842|12011375|FG000|NOT COMPLETED|Post-Intervention Control||0
10845361|NCT01609842|12011376|FG001|NOT COMPLETED|Post-Intervention Control||0
10845362|NCT01609842|12011375|FG000|STARTED|Concurrent Intervention Control||708
10845363|NCT01609842|12011376|FG001|STARTED|Concurrent Intervention Control|Nonintervention sites patients during the period prior and post enrollment at the intervention sites|4869
10845364|NCT01609842|12011375|FG000|COMPLETED|Concurrent Intervention Control||706
10845365|NCT01609842|12011376|FG001|COMPLETED|Concurrent Intervention Control||4869
10845366|NCT01609842|12011375|FG000|NOT COMPLETED|Concurrent Intervention Control||2
10845367|NCT01609842|12011376|FG001|NOT COMPLETED|Concurrent Intervention Control||0
10845368|NCT01341600|12011389|FG000|STARTED|Clopidogrel 75 mg||6
10845369|NCT01341600|12011390|FG001|STARTED|Clopidogrel 75 mg||6
10845370|NCT01341600|12011391|FG002|STARTED|Clopidogrel 75 mg||6
10845371|NCT01341600|12011389|FG000|COMPLETED|Clopidogrel 75 mg||6
10845372|NCT01341600|12011390|FG001|COMPLETED|Clopidogrel 75 mg||6
10845373|NCT01341600|12011391|FG002|COMPLETED|Clopidogrel 75 mg||6
10845374|NCT01341600|12011389|FG000|NOT COMPLETED|Clopidogrel 75 mg||0
10845375|NCT01341600|12011390|FG001|NOT COMPLETED|Clopidogrel 75 mg||0
10845376|NCT01341600|12011391|FG002|NOT COMPLETED|Clopidogrel 75 mg||0
10845377|NCT01341600|12011389|FG000|STARTED|Clopidogrel 150 mg||6
10845378|NCT01341600|12011390|FG001|STARTED|Clopidogrel 150 mg||6
10845379|NCT01341600|12011391|FG002|STARTED|Clopidogrel 150 mg||6
10845380|NCT01341600|12011389|FG000|COMPLETED|Clopidogrel 150 mg||6
10845381|NCT01341600|12011390|FG001|COMPLETED|Clopidogrel 150 mg||6
10845382|NCT01341600|12011391|FG002|COMPLETED|Clopidogrel 150 mg||6
10845383|NCT01341600|12011389|FG000|NOT COMPLETED|Clopidogrel 150 mg||0
10845384|NCT01341600|12011390|FG001|NOT COMPLETED|Clopidogrel 150 mg||0
10845385|NCT01341600|12011391|FG002|NOT COMPLETED|Clopidogrel 150 mg||0
10845386|NCT01341600|12011389|FG000|STARTED|Clopidogrel 225 mg||6
10845387|NCT01341600|12011390|FG001|STARTED|Clopidogrel 225 mg||6
10845388|NCT01341600|12011391|FG002|STARTED|Clopidogrel 225 mg||6
10845389|NCT01341600|12011389|FG000|COMPLETED|Clopidogrel 225 mg||6
10845390|NCT01341600|12011390|FG001|COMPLETED|Clopidogrel 225 mg||6
10845391|NCT01341600|12011391|FG002|COMPLETED|Clopidogrel 225 mg||6
10845392|NCT01341600|12011389|FG000|NOT COMPLETED|Clopidogrel 225 mg||0
10845393|NCT01341600|12011390|FG001|NOT COMPLETED|Clopidogrel 225 mg||0
10845394|NCT01341600|12011391|FG002|NOT COMPLETED|Clopidogrel 225 mg||0
10845395|NCT01341600|12011389|FG000|STARTED|Clopidogrel Plus Omeprazole||5
10845396|NCT01341600|12011390|FG001|STARTED|Clopidogrel Plus Omeprazole||5
10845397|NCT01341600|12011391|FG002|STARTED|Clopidogrel Plus Omeprazole||4
10845398|NCT01341600|12011389|FG000|COMPLETED|Clopidogrel Plus Omeprazole||5
10845399|NCT01341600|12011390|FG001|COMPLETED|Clopidogrel Plus Omeprazole||5
10845400|NCT01341600|12011391|FG002|COMPLETED|Clopidogrel Plus Omeprazole||4
10845401|NCT01341600|12011389|FG000|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
10845402|NCT01341600|12011390|FG001|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
10845403|NCT01341600|12011391|FG002|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
10845404|NCT01044901|12011401|FG000|STARTED|Overall Study||38
10845405|NCT01044901|12011402|FG001|STARTED|Overall Study||13
10845406|NCT01044901|12011401|FG000|COMPLETED|Overall Study||38
10845407|NCT01044901|12011402|FG001|COMPLETED|Overall Study||13
10845408|NCT01044901|12011401|FG000|NOT COMPLETED|Overall Study||0
10845409|NCT01044901|12011402|FG001|NOT COMPLETED|Overall Study||0
10845410|NCT00003479|12011408|FG000|STARTED|Overall Study||9
10845411|NCT00003479|12011408|FG000|COMPLETED|Overall Study||6
10845412|NCT00003479|12011408|FG000|NOT COMPLETED|Overall Study||3
10845413|NCT04160195|12011414|FG000|STARTED|Overall Study||2
10845414|NCT04160195|12011415|FG001|STARTED|Overall Study||0
10845415|NCT04160195|12011414|FG000|COMPLETED|Overall Study||1
10845416|NCT04160195|12011415|FG001|COMPLETED|Overall Study||0
10845417|NCT04160195|12011414|FG000|NOT COMPLETED|Overall Study||1
10845418|NCT04160195|12011415|FG001|NOT COMPLETED|Overall Study||0
10845445|NCT04152447|12011438|FG000|STARTED|Overall Study||16
10845446|NCT04152447|12011439|FG001|STARTED|Overall Study||19
10845447|NCT04152447|12011438|FG000|COMPLETED|Overall Study||13
10845448|NCT04152447|12011439|FG001|COMPLETED|Overall Study||14
10845449|NCT04152447|12011438|FG000|NOT COMPLETED|Overall Study||3
10845450|NCT04152447|12011439|FG001|NOT COMPLETED|Overall Study||5
10845469|NCT04006847|12011456|FG000|STARTED|Overall Study||1
10845470|NCT04006847|12011456|FG000|COMPLETED|Overall Study||0
10845471|NCT04006847|12011456|FG000|NOT COMPLETED|Overall Study||1
10845472|NCT03922711|12011463|FG000|STARTED|Overall Study||7
10845473|NCT03922711|12011464|FG001|STARTED|Overall Study||8
10845474|NCT03922711|12011465|FG002|STARTED|Overall Study||8
10845475|NCT03922711|12011463|FG000|Treatment Group Based on Maximal Possible Highest Dose Received (Used for Analysis)|Overall Study||12
10845476|NCT03922711|12011464|FG001|Treatment Group Based on Maximal Possible Highest Dose Received (Used for Analysis)|Overall Study||3
10845477|NCT03922711|12011465|FG002|Treatment Group Based on Maximal Possible Highest Dose Received (Used for Analysis)|Overall Study||8
10845478|NCT03922711|12011463|FG000|COMPLETED|Overall Study||3
10845479|NCT03922711|12011464|FG001|COMPLETED|Overall Study||3
10845480|NCT03922711|12011465|FG002|COMPLETED|Overall Study||4
10845481|NCT03922711|12011463|FG000|NOT COMPLETED|Overall Study||4
10845482|NCT03922711|12011464|FG001|NOT COMPLETED|Overall Study||5
10845483|NCT03922711|12011465|FG002|NOT COMPLETED|Overall Study||4
10845484|NCT04460183|12011474|FG000|STARTED|Overall Study||14
10845485|NCT04460183|12011475|FG001|STARTED|Overall Study||5
10845486|NCT04460183|12011474|FG000|COMPLETED|Overall Study||10
10845487|NCT04460183|12011475|FG001|COMPLETED|Overall Study||4
10845488|NCT04460183|12011474|FG000|NOT COMPLETED|Overall Study||4
10845489|NCT04460183|12011475|FG001|NOT COMPLETED|Overall Study||1
11105062|NCT01252667|12289475|FG003|STARTED|Overall Study||0
11105063|NCT01252667|12289476|FG004|STARTED|Overall Study||0
11105064|NCT01252667|12289477|FG005|STARTED|Overall Study||35
11105065|NCT01252667|12289472|FG000|COMPLETED|Overall Study||3
11105066|NCT01252667|12289473|FG001|COMPLETED|Overall Study||3
11105067|NCT01252667|12289474|FG002|COMPLETED|Overall Study||3
11105068|NCT01252667|12289475|FG003|COMPLETED|Overall Study||0
11105069|NCT01252667|12289476|FG004|COMPLETED|Overall Study||0
10845498|NCT03831360|12011494|FG000|STARTED|Overall Study||15
10845499|NCT03831360|12011495|FG001|STARTED|Overall Study||15
10845500|NCT03831360|12011494|FG000|COMPLETED|Overall Study||12
10845501|NCT03831360|12011495|FG001|COMPLETED|Overall Study||14
10845502|NCT03831360|12011494|FG000|NOT COMPLETED|Overall Study||3
10845503|NCT03831360|12011495|FG001|NOT COMPLETED|Overall Study||1
10845504|NCT03829332|12011503|FG000|STARTED|Overall Study||309
10845505|NCT03829332|12011504|FG001|STARTED|Overall Study||314
10845506|NCT03829332|12011503|FG000|Treated|Overall Study||309
10845507|NCT03829332|12011504|FG001|Treated|Overall Study||312
10845508|NCT03829332|12011503|FG000|COMPLETED|Overall Study||0
10845509|NCT03829332|12011504|FG001|COMPLETED|Overall Study||0
10845510|NCT03829332|12011503|FG000|NOT COMPLETED|Overall Study||309
10845511|NCT03829332|12011504|FG001|NOT COMPLETED|Overall Study||314
11105070|NCT01252667|12289477|FG005|COMPLETED|Overall Study||34
11105071|NCT01252667|12289472|FG000|NOT COMPLETED|Overall Study||0
11105072|NCT01252667|12289473|FG001|NOT COMPLETED|Overall Study||0
11105073|NCT01252667|12289474|FG002|NOT COMPLETED|Overall Study||0
11105074|NCT01252667|12289475|FG003|NOT COMPLETED|Overall Study||0
11105075|NCT01252667|12289476|FG004|NOT COMPLETED|Overall Study||0
11105076|NCT01252667|12289477|FG005|NOT COMPLETED|Overall Study||1
11105077|NCT01252732|12289493|FG000|STARTED|Overall Study|Randomized|509
11105078|NCT01252732|12289494|FG001|STARTED|Overall Study|Randomized|510
11105079|NCT01252732|12289493|FG000|Modified Intent to Treat Population|Overall Study||503
11105080|NCT01252732|12289494|FG001|Modified Intent to Treat Population|Overall Study||502
11105081|NCT01252732|12289493|FG000|COMPLETED|Overall Study||455
11105082|NCT01252732|12289494|FG001|COMPLETED|Overall Study||446
11105083|NCT01252732|12289493|FG000|NOT COMPLETED|Overall Study||54
11105084|NCT01252732|12289494|FG001|NOT COMPLETED|Overall Study||64
11105085|NCT01252745|12289503|FG000|STARTED|Overall Study||8
11105086|NCT01252745|12289504|FG001|STARTED|Overall Study||7
11105087|NCT01252745|12289505|FG002|STARTED|Overall Study||7
11105088|NCT01252745|12289503|FG000|COMPLETED|Overall Study||8
11105089|NCT01252745|12289504|FG001|COMPLETED|Overall Study||7
11105090|NCT01252745|12289505|FG002|COMPLETED|Overall Study||7
11105091|NCT01252745|12289503|FG000|NOT COMPLETED|Overall Study||0
11105092|NCT01252745|12289504|FG001|NOT COMPLETED|Overall Study||0
11105093|NCT01252745|12289505|FG002|NOT COMPLETED|Overall Study||0
11105094|NCT01252810|12289518|FG000|STARTED|Overall Study||142
11105095|NCT01252810|12289519|FG001|STARTED|Overall Study||142
11105096|NCT01252810|12289518|FG000|COMPLETED|Overall Study||128
11105097|NCT01252810|12289519|FG001|COMPLETED|Overall Study||139
11105098|NCT01252810|12289518|FG000|NOT COMPLETED|Overall Study||14
11105099|NCT01252810|12289519|FG001|NOT COMPLETED|Overall Study||3
11105100|NCT01252940|12289527|FG000|STARTED|Main Study Phase||321
11105101|NCT01252940|12289528|FG001|STARTED|Main Study Phase||161
11105102|NCT01252940|12289527|FG000|Completed 24 Weeks|Main Study Phase||0
11105103|NCT01252940|12289528|FG001|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
11105104|NCT01252940|12289527|FG000|COMPLETED|Main Study Phase||295
10845419|NCT04159701|12011425|FG000|STARTED|Period 1: Treatment Period||39
10845420|NCT04159701|12011426|FG001|STARTED|Period 1: Treatment Period||13
10845421|NCT04159701|12011425|FG000|Received at Least One Dose of Study Drug|Period 1: Treatment Period||39
10845422|NCT04159701|12011426|FG001|Received at Least One Dose of Study Drug|Period 1: Treatment Period||13
10845423|NCT04159701|12011425|FG000|COMPLETED|Period 1: Treatment Period||31
10845424|NCT04159701|12011426|FG001|COMPLETED|Period 1: Treatment Period||12
10845425|NCT04159701|12011425|FG000|NOT COMPLETED|Period 1: Treatment Period||8
10845426|NCT04159701|12011426|FG001|NOT COMPLETED|Period 1: Treatment Period||1
10845427|NCT04159701|12011425|FG000|STARTED|Washout Period||31
10845428|NCT04159701|12011426|FG001|STARTED|Washout Period||12
10845429|NCT04159701|12011425|FG000|COMPLETED|Washout Period||18
10845430|NCT04159701|12011426|FG001|COMPLETED|Washout Period||8
10845431|NCT04159701|12011425|FG000|NOT COMPLETED|Washout Period||13
10845432|NCT04159701|12011426|FG001|NOT COMPLETED|Washout Period||4
10845433|NCT04159701|12011425|FG000|STARTED|Period 2: Treatment Period (Crossover)||18
10845434|NCT04159701|12011426|FG001|STARTED|Period 2: Treatment Period (Crossover)||8
10845435|NCT04159701|12011425|FG000|COMPLETED|Period 2: Treatment Period (Crossover)||18
10845436|NCT04159701|12011426|FG001|COMPLETED|Period 2: Treatment Period (Crossover)||5
10845437|NCT04159701|12011425|FG000|NOT COMPLETED|Period 2: Treatment Period (Crossover)||0
10845438|NCT04159701|12011426|FG001|NOT COMPLETED|Period 2: Treatment Period (Crossover)||3
10845439|NCT04159701|12011425|FG000|STARTED|Post-treatment Follow-up|All participants who received study drug could move to post-treatment follow-up.|29
10845440|NCT04159701|12011426|FG001|STARTED|Post-treatment Follow-up|All participants who received study drug could move to post-treatment follow-up.|9
10845441|NCT04159701|12011425|FG000|COMPLETED|Post-treatment Follow-up||19
10845442|NCT04159701|12011426|FG001|COMPLETED|Post-treatment Follow-up||6
10845443|NCT04159701|12011425|FG000|NOT COMPLETED|Post-treatment Follow-up||10
10845444|NCT04159701|12011426|FG001|NOT COMPLETED|Post-treatment Follow-up||3
10845451|NCT04150107|12011447|FG000|STARTED|Period 1- Placebo run-in (All Patients)||14
10845452|NCT04150107|12011448|FG001|STARTED|Period 1- Placebo run-in (All Patients)||16
10845453|NCT04150107|12011447|FG000|COMPLETED|Period 1- Placebo run-in (All Patients)||14
10845454|NCT04150107|12011448|FG001|COMPLETED|Period 1- Placebo run-in (All Patients)||16
10845455|NCT04150107|12011447|FG000|NOT COMPLETED|Period 1- Placebo run-in (All Patients)||0
10845456|NCT04150107|12011448|FG001|NOT COMPLETED|Period 1- Placebo run-in (All Patients)||0
10845457|NCT04150107|12011447|FG000|STARTED|Period 2- Either Treatment A or B||14
10845458|NCT04150107|12011448|FG001|STARTED|Period 2- Either Treatment A or B||16
10845459|NCT04150107|12011447|FG000|COMPLETED|Period 2- Either Treatment A or B||14
10845460|NCT04150107|12011448|FG001|COMPLETED|Period 2- Either Treatment A or B||16
10845461|NCT04150107|12011447|FG000|NOT COMPLETED|Period 2- Either Treatment A or B||0
10845462|NCT04150107|12011448|FG001|NOT COMPLETED|Period 2- Either Treatment A or B||0
10845463|NCT04150107|12011447|FG000|STARTED|Period 3 Crossover-Treatment B or A||14
10845464|NCT04150107|12011448|FG001|STARTED|Period 3 Crossover-Treatment B or A||16
10845465|NCT04150107|12011447|FG000|COMPLETED|Period 3 Crossover-Treatment B or A||12
10845466|NCT04150107|12011448|FG001|COMPLETED|Period 3 Crossover-Treatment B or A||15
10845467|NCT04150107|12011447|FG000|NOT COMPLETED|Period 3 Crossover-Treatment B or A||2
10845468|NCT04150107|12011448|FG001|NOT COMPLETED|Period 3 Crossover-Treatment B or A||1
11223599|NCT01978600|12415566|FG000|STARTED|Overall Study||44
11223600|NCT01978600|12415567|FG001|STARTED|Overall Study||42
11223601|NCT01978600|12415566|FG000|COMPLETED|Overall Study||44
11223602|NCT01978600|12415567|FG001|COMPLETED|Overall Study||42
11223603|NCT01978600|12415566|FG000|NOT COMPLETED|Overall Study||0
11223604|NCT01978600|12415567|FG001|NOT COMPLETED|Overall Study||0
11223605|NCT01978743|12415573|FG000|STARTED|Overall Study||10
11223606|NCT01978743|12415573|FG000|COMPLETED|Overall Study||10
11223607|NCT01978743|12415573|FG000|NOT COMPLETED|Overall Study||0
11223608|NCT01978912|12415582|FG000|STARTED|Overall Study||6
11223609|NCT01978912|12415583|FG001|STARTED|Overall Study||6
11223610|NCT01978912|12415584|FG002|STARTED|Overall Study||6
11223611|NCT01978912|12415585|FG003|STARTED|Overall Study||6
11223612|NCT01978912|12415582|FG000|COMPLETED|Overall Study||3
11223613|NCT01978912|12415583|FG001|COMPLETED|Overall Study||3
11223614|NCT01978912|12415584|FG002|COMPLETED|Overall Study||3
11223615|NCT01978912|12415585|FG003|COMPLETED|Overall Study||3
11223616|NCT01978912|12415582|FG000|NOT COMPLETED|Overall Study||3
11223617|NCT01978912|12415583|FG001|NOT COMPLETED|Overall Study||3
11223618|NCT01978912|12415584|FG002|NOT COMPLETED|Overall Study||3
11223619|NCT01978912|12415585|FG003|NOT COMPLETED|Overall Study||3
11223620|NCT01979016|12415597|FG000|STARTED|Overall Study||27
11223621|NCT01979016|12415598|FG001|STARTED|Overall Study||27
11223622|NCT01979016|12415597|FG000|COMPLETED|Overall Study||25
11105105|NCT01252940|12289528|FG001|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
11105106|NCT01252940|12289527|FG000|NOT COMPLETED|Main Study Phase||26
11105107|NCT01252940|12289528|FG001|NOT COMPLETED|Main Study Phase||12
11105108|NCT01252940|12289527|FG000|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
11105109|NCT01252940|12289528|FG001|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
11105110|NCT01252940|12289527|FG000|COMPLETED|Extension Phase||100
11105111|NCT01252940|12289528|FG001|COMPLETED|Extension Phase||46
11105112|NCT01252940|12289527|FG000|NOT COMPLETED|Extension Phase||10
11105113|NCT01252940|12289528|FG001|NOT COMPLETED|Extension Phase||3
11105114|NCT01252966|12289537|FG000|STARTED|Overall Study||108
11105115|NCT01252966|12289538|FG001|STARTED|Overall Study||105
11105116|NCT01252966|12289537|FG000|COMPLETED|Overall Study||85
11105117|NCT01252966|12289538|FG001|COMPLETED|Overall Study||92
11105118|NCT01252966|12289537|FG000|NOT COMPLETED|Overall Study||23
11105119|NCT01252966|12289538|FG001|NOT COMPLETED|Overall Study||13
11105120|NCT01253018|12289548|FG000|STARTED|Overall Study||22
11105121|NCT01253018|12289549|FG001|STARTED|Overall Study||23
11105122|NCT01253018|12289548|FG000|COMPLETED|Overall Study||18
11105123|NCT01253018|12289549|FG001|COMPLETED|Overall Study||21
11105124|NCT01253018|12289548|FG000|NOT COMPLETED|Overall Study||4
11105125|NCT01253018|12289549|FG001|NOT COMPLETED|Overall Study||2
11105126|NCT01253044|12289558|FG000|STARTED|Overall Study||80
11105127|NCT01253044|12289559|FG001|STARTED|Overall Study||80
11105128|NCT01253044|12289558|FG000|COMPLETED|Overall Study||42
11105129|NCT01253044|12289559|FG001|COMPLETED|Overall Study||51
11105130|NCT01253044|12289558|FG000|NOT COMPLETED|Overall Study||38
11105131|NCT01253044|12289559|FG001|NOT COMPLETED|Overall Study||29
11105132|NCT01253135|12289565|FG000|STARTED|Original Protocol||15
11105133|NCT01253135|12289565|FG000|COMPLETED|Original Protocol||0
11105134|NCT01253135|12289565|FG000|NOT COMPLETED|Original Protocol||15
11223623|NCT01979016|12415598|FG001|COMPLETED|Overall Study||26
11223624|NCT01979016|12415597|FG000|NOT COMPLETED|Overall Study||2
11105135|NCT01253135|12289565|FG000|STARTED|Amended Protocol||25
11105136|NCT01253135|12289565|FG000|COMPLETED|Amended Protocol||24
11105137|NCT01253135|12289565|FG000|NOT COMPLETED|Amended Protocol||1
11105138|NCT01253148|12289573|FG000|STARTED|Overall Study||25
11105139|NCT01253148|12289573|FG000|COMPLETED|Overall Study||25
11105140|NCT01253148|12289573|FG000|NOT COMPLETED|Overall Study||0
11105141|NCT01253174|12289577|FG000|STARTED|Period 1||6
11105142|NCT01253174|12289578|FG001|STARTED|Period 1||10
11223625|NCT01979016|12415598|FG001|NOT COMPLETED|Overall Study||1
11223626|NCT01979029|12415606|FG000|STARTED|Overall Study||29
11223627|NCT01979029|12415607|FG001|STARTED|Overall Study||28
11105143|NCT01253174|12289579|FG002|STARTED|Period 1||9
11105144|NCT01253174|12289580|FG003|STARTED|Period 1||7
11105145|NCT01253174|12289581|FG004|STARTED|Period 1||9
11105146|NCT01253174|12289582|FG005|STARTED|Period 1||7
11105147|NCT01253174|12289577|FG000|COMPLETED|Period 1||6
11105148|NCT01253174|12289578|FG001|COMPLETED|Period 1||9
11105149|NCT01253174|12289579|FG002|COMPLETED|Period 1||8
11105150|NCT01253174|12289580|FG003|COMPLETED|Period 1||7
11105151|NCT01253174|12289581|FG004|COMPLETED|Period 1||8
11105152|NCT01253174|12289582|FG005|COMPLETED|Period 1||7
11105153|NCT01253174|12289577|FG000|NOT COMPLETED|Period 1||0
11105154|NCT01253174|12289578|FG001|NOT COMPLETED|Period 1||1
11105155|NCT01253174|12289579|FG002|NOT COMPLETED|Period 1||1
11105156|NCT01253174|12289580|FG003|NOT COMPLETED|Period 1||0
11105157|NCT01253174|12289581|FG004|NOT COMPLETED|Period 1||1
11105158|NCT01253174|12289582|FG005|NOT COMPLETED|Period 1||0
11105159|NCT01253174|12289577|FG000|STARTED|Period 2||6
11105160|NCT01253174|12289578|FG001|STARTED|Period 2||9
11105161|NCT01253174|12289579|FG002|STARTED|Period 2||8
11105162|NCT01253174|12289580|FG003|STARTED|Period 2||7
11105163|NCT01253174|12289581|FG004|STARTED|Period 2||8
11105164|NCT01253174|12289582|FG005|STARTED|Period 2||7
11105165|NCT01253174|12289577|FG000|COMPLETED|Period 2||6
11105166|NCT01253174|12289578|FG001|COMPLETED|Period 2||9
11105167|NCT01253174|12289579|FG002|COMPLETED|Period 2||7
11105168|NCT01253174|12289580|FG003|COMPLETED|Period 2||7
11105169|NCT01253174|12289581|FG004|COMPLETED|Period 2||8
11105170|NCT01253174|12289582|FG005|COMPLETED|Period 2||7
11105171|NCT01253174|12289577|FG000|NOT COMPLETED|Period 2||0
11105172|NCT01253174|12289578|FG001|NOT COMPLETED|Period 2||0
11105173|NCT01253174|12289579|FG002|NOT COMPLETED|Period 2||1
11105174|NCT01253174|12289580|FG003|NOT COMPLETED|Period 2||0
11105175|NCT01253174|12289581|FG004|NOT COMPLETED|Period 2||0
11105176|NCT01253174|12289582|FG005|NOT COMPLETED|Period 2||0
11105177|NCT01253174|12289577|FG000|STARTED|Period 3||6
11105178|NCT01253174|12289578|FG001|STARTED|Period 3||9
11105179|NCT01253174|12289579|FG002|STARTED|Period 3||7
11105180|NCT01253174|12289580|FG003|STARTED|Period 3||7
11105181|NCT01253174|12289581|FG004|STARTED|Period 3||8
11105182|NCT01253174|12289582|FG005|STARTED|Period 3||7
11105183|NCT01253174|12289577|FG000|COMPLETED|Period 3||6
11105184|NCT01253174|12289578|FG001|COMPLETED|Period 3||8
11105185|NCT01253174|12289579|FG002|COMPLETED|Period 3||6
11105186|NCT01253174|12289580|FG003|COMPLETED|Period 3||7
11105187|NCT01253174|12289581|FG004|COMPLETED|Period 3||7
11105188|NCT01253174|12289582|FG005|COMPLETED|Period 3||7
11105189|NCT01253174|12289577|FG000|NOT COMPLETED|Period 3||0
11105190|NCT01253174|12289578|FG001|NOT COMPLETED|Period 3||1
11105191|NCT01253174|12289579|FG002|NOT COMPLETED|Period 3||1
11105192|NCT01253174|12289580|FG003|NOT COMPLETED|Period 3||0
11105193|NCT01253174|12289581|FG004|NOT COMPLETED|Period 3||1
11223628|NCT01979029|12415606|FG000|COMPLETED|Overall Study||29
11105194|NCT01253174|12289582|FG005|NOT COMPLETED|Period 3||0
11105195|NCT01253187|12289591|FG000|STARTED|Period 1||7
11223629|NCT01979029|12415607|FG001|COMPLETED|Overall Study||28
11223630|NCT01979029|12415606|FG000|NOT COMPLETED|Overall Study||0
11223631|NCT01979029|12415607|FG001|NOT COMPLETED|Overall Study||0
11223632|NCT01979133|12415613|FG000|STARTED|Overall Study||10
11223633|NCT01979133|12415613|FG000|COMPLETED|Overall Study||7
11223634|NCT01979133|12415613|FG000|NOT COMPLETED|Overall Study||3
11223635|NCT01979159|12415630|FG000|STARTED|Overall Study||4
11223636|NCT01979159|12415630|FG000|COMPLETED|Overall Study||4
11223637|NCT01979159|12415630|FG000|NOT COMPLETED|Overall Study||0
11223638|NCT01979185|12415638|FG000|STARTED|Period 1||15
11223639|NCT01979185|12415639|FG001|STARTED|Period 1||15
11223640|NCT01979185|12415638|FG000|COMPLETED|Period 1||15
11223641|NCT01979185|12415639|FG001|COMPLETED|Period 1||15
11223642|NCT01979185|12415638|FG000|NOT COMPLETED|Period 1||0
11223643|NCT01979185|12415639|FG001|NOT COMPLETED|Period 1||0
11223644|NCT01979185|12415638|FG000|STARTED|Period 2||15
11223645|NCT01979185|12415639|FG001|STARTED|Period 2||15
11223646|NCT01979185|12415638|FG000|COMPLETED|Period 2||15
11223647|NCT01979185|12415639|FG001|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
11223648|NCT01979185|12415638|FG000|NOT COMPLETED|Period 2||0
11223649|NCT01979185|12415639|FG001|NOT COMPLETED|Period 2||1
11223650|NCT01979276|12415645|FG000|STARTED|Overall Study||2
11223651|NCT01979276|12415645|FG000|COMPLETED|Overall Study||2
11223652|NCT01979276|12415645|FG000|NOT COMPLETED|Overall Study||0
11223653|NCT01979445|12415651|FG000|STARTED|Overall Study||3
11223654|NCT01979445|12415652|FG001|STARTED|Overall Study||3
11223655|NCT01979445|12415653|FG002|STARTED|Overall Study||6
11223656|NCT01979445|12415654|FG003|STARTED|Overall Study||3
11223657|NCT01979445|12415651|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11223658|NCT01979445|12415652|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
11223659|NCT01979445|12415653|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11105196|NCT01253187|12289592|FG001|STARTED|Period 1||8
11105197|NCT01253187|12289593|FG002|STARTED|Period 1||7
11105198|NCT01253187|12289594|FG003|STARTED|Period 1||7
11105199|NCT01253187|12289595|FG004|STARTED|Period 1||9
11105200|NCT01253187|12289596|FG005|STARTED|Period 1||6
11105201|NCT01253187|12289591|FG000|COMPLETED|Period 1||7
11105202|NCT01253187|12289592|FG001|COMPLETED|Period 1||8
11105203|NCT01253187|12289593|FG002|COMPLETED|Period 1||7
11105204|NCT01253187|12289594|FG003|COMPLETED|Period 1||7
11105205|NCT01253187|12289595|FG004|COMPLETED|Period 1||9
11105206|NCT01253187|12289596|FG005|COMPLETED|Period 1||6
11223660|NCT01979445|12415654|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
11223661|NCT01979445|12415651|FG000|ITT Population|Overall Study||3
11223662|NCT01979445|12415652|FG001|ITT Population|Overall Study||3
11223663|NCT01979445|12415653|FG002|ITT Population|Overall Study||6
11223664|NCT01979445|12415654|FG003|ITT Population|Overall Study||3
11223665|NCT01979445|12415651|FG000|COMPLETED|Overall Study||3
11223666|NCT01979445|12415652|FG001|COMPLETED|Overall Study||3
11223667|NCT01979445|12415653|FG002|COMPLETED|Overall Study||6
11223668|NCT01979445|12415654|FG003|COMPLETED|Overall Study||3
11223669|NCT01979445|12415651|FG000|NOT COMPLETED|Overall Study||0
11223670|NCT01979445|12415652|FG001|NOT COMPLETED|Overall Study||0
11223671|NCT01979445|12415653|FG002|NOT COMPLETED|Overall Study||0
11223672|NCT01979445|12415654|FG003|NOT COMPLETED|Overall Study||0
11223673|NCT01979523|12415674|FG000|STARTED|Overall Study||21
11223674|NCT01979523|12415675|FG001|STARTED|Overall Study||21
11223675|NCT01979523|12415674|FG000|COMPLETED|Overall Study||20
11223676|NCT01979523|12415675|FG001|COMPLETED|Overall Study||21
11223677|NCT01979523|12415674|FG000|NOT COMPLETED|Overall Study||1
11223678|NCT01979523|12415675|FG001|NOT COMPLETED|Overall Study||0
11223679|NCT01979614|12415684|FG000|STARTED|Overall Study||30
11223680|NCT01979614|12415685|FG001|STARTED|Overall Study||28
11223681|NCT01979614|12415684|FG000|Safety Analysis Set|Overall Study||30
11223682|NCT01979614|12415685|FG001|Safety Analysis Set|Overall Study||28
11223683|NCT01979614|12415684|FG000|PK Analysis Set|Overall Study||30
11223684|NCT01979614|12415685|FG001|PK Analysis Set|Overall Study||0
11223685|NCT01979614|12415684|FG000|PD Analysis Set|Overall Study||25
11354395|NCT03073200|12551624|FG007|STARTED|Open-Label Maintenance Period||0
11354396|NCT03073200|12551625|FG008|STARTED|Open-Label Maintenance Period||0
11354397|NCT03073200|12551626|FG009|STARTED|Open-Label Maintenance Period||0
11354398|NCT03073200|12551627|FG010|STARTED|Open-Label Maintenance Period||0
11354399|NCT03073200|12551628|FG011|STARTED|Open-Label Maintenance Period||0
11354400|NCT03073200|12551629|FG012|STARTED|Open-Label Maintenance Period||0
11354401|NCT03073200|12551630|FG013|STARTED|Open-Label Maintenance Period||0
11354402|NCT03073200|12551631|FG014|STARTED|Open-Label Maintenance Period||0
11354403|NCT03073200|12551617|FG000|COMPLETED|Open-Label Maintenance Period||0
11354404|NCT03073200|12551618|FG001|COMPLETED|Open-Label Maintenance Period||0
11354405|NCT03073200|12551619|FG002|COMPLETED|Open-Label Maintenance Period||0
11354406|NCT03073200|12551620|FG003|COMPLETED|Open-Label Maintenance Period||49
11354407|NCT03073200|12551621|FG004|COMPLETED|Open-Label Maintenance Period||109
11354408|NCT03073200|12551622|FG005|COMPLETED|Open-Label Maintenance Period||28
11354409|NCT03073200|12551623|FG006|COMPLETED|Open-Label Maintenance Period||0
11354410|NCT03073200|12551624|FG007|COMPLETED|Open-Label Maintenance Period||0
11354411|NCT03073200|12551625|FG008|COMPLETED|Open-Label Maintenance Period||0
11354412|NCT03073200|12551626|FG009|COMPLETED|Open-Label Maintenance Period||0
11354413|NCT03073200|12551627|FG010|COMPLETED|Open-Label Maintenance Period||0
11354414|NCT03073200|12551628|FG011|COMPLETED|Open-Label Maintenance Period||0
11354415|NCT03073200|12551629|FG012|COMPLETED|Open-Label Maintenance Period||0
11354416|NCT03073200|12551630|FG013|COMPLETED|Open-Label Maintenance Period||0
11354417|NCT03073200|12551631|FG014|COMPLETED|Open-Label Maintenance Period||0
11354418|NCT03073200|12551617|FG000|NOT COMPLETED|Open-Label Maintenance Period||0
11354419|NCT03073200|12551618|FG001|NOT COMPLETED|Open-Label Maintenance Period||0
11354420|NCT03073200|12551619|FG002|NOT COMPLETED|Open-Label Maintenance Period||0
11223686|NCT01979614|12415685|FG001|PD Analysis Set|Overall Study||26
11223687|NCT01979614|12415684|FG000|COMPLETED|Overall Study||29
10845638|NCT03543046|12011562|FG000|STARTED|Overall Study||14
10845639|NCT03543046|12011563|FG001|STARTED|Overall Study||13
10845640|NCT03543046|12011562|FG000|COMPLETED|Overall Study||11
10845641|NCT03543046|12011563|FG001|COMPLETED|Overall Study||11
10845642|NCT03543046|12011562|FG000|NOT COMPLETED|Overall Study||3
10845643|NCT03543046|12011563|FG001|NOT COMPLETED|Overall Study||2
10845644|NCT03530800|12011571|FG000|STARTED|Overall Study||25
10845645|NCT03530800|12011572|FG001|STARTED|Overall Study||25
10845646|NCT03530800|12011571|FG000|COMPLETED|Overall Study||14
10845647|NCT03530800|12011572|FG001|COMPLETED|Overall Study||16
10845648|NCT03530800|12011571|FG000|NOT COMPLETED|Overall Study||11
10845649|NCT03530800|12011572|FG001|NOT COMPLETED|Overall Study||9
11223688|NCT01979614|12415685|FG001|COMPLETED|Overall Study||27
11223689|NCT01979614|12415684|FG000|NOT COMPLETED|Overall Study||1
11223690|NCT01979614|12415685|FG001|NOT COMPLETED|Overall Study||1
10845650|NCT03270462|12011578|FG000|STARTED|Overall Study||20
10845651|NCT03270462|12011578|FG000|COMPLETED|Overall Study||20
10845652|NCT03270462|12011578|FG000|NOT COMPLETED|Overall Study||0
11105207|NCT01253187|12289591|FG000|NOT COMPLETED|Period 1||0
11105208|NCT01253187|12289592|FG001|NOT COMPLETED|Period 1||0
11105209|NCT01253187|12289593|FG002|NOT COMPLETED|Period 1||0
11105210|NCT01253187|12289594|FG003|NOT COMPLETED|Period 1||0
11105211|NCT01253187|12289595|FG004|NOT COMPLETED|Period 1||0
11105212|NCT01253187|12289596|FG005|NOT COMPLETED|Period 1||0
11105213|NCT01253187|12289591|FG000|STARTED|Period 2||7
11105214|NCT01253187|12289592|FG001|STARTED|Period 2||8
11105215|NCT01253187|12289593|FG002|STARTED|Period 2||7
10845662|NCT03090412|12011597|FG000|STARTED|Overall Study||1
10845663|NCT03090412|12011598|FG001|STARTED|Overall Study||1
10845664|NCT03090412|12011597|FG000|COMPLETED|Overall Study||1
11105216|NCT01253187|12289594|FG003|STARTED|Period 2||7
11105217|NCT01253187|12289595|FG004|STARTED|Period 2||9
11105218|NCT01253187|12289596|FG005|STARTED|Period 2||6
11105219|NCT01253187|12289591|FG000|COMPLETED|Period 2||7
11105220|NCT01253187|12289592|FG001|COMPLETED|Period 2||8
10845665|NCT03090412|12011598|FG001|COMPLETED|Overall Study||1
10845666|NCT03090412|12011597|FG000|NOT COMPLETED|Overall Study||0
10845667|NCT03090412|12011598|FG001|NOT COMPLETED|Overall Study||0
10845668|NCT03065517|12011606|FG000|STARTED|Overall Study||110
10845669|NCT03065517|12011607|FG001|STARTED|Overall Study||106
10845670|NCT03065517|12011606|FG000|COMPLETED|Overall Study||84
10845671|NCT03065517|12011607|FG001|COMPLETED|Overall Study||90
10845672|NCT03065517|12011606|FG000|NOT COMPLETED|Overall Study||26
10845673|NCT03065517|12011607|FG001|NOT COMPLETED|Overall Study||16
10845674|NCT03063203|12011613|FG000|STARTED|Overall Study||17
10845675|NCT03063203|12011613|FG000|COMPLETED|Overall Study||3
10845676|NCT03063203|12011613|FG000|NOT COMPLETED|Overall Study||14
11105221|NCT01253187|12289593|FG002|COMPLETED|Period 2||7
11105222|NCT01253187|12289594|FG003|COMPLETED|Period 2||7
11105223|NCT01253187|12289595|FG004|COMPLETED|Period 2||8
11105224|NCT01253187|12289596|FG005|COMPLETED|Period 2||6
11105225|NCT01253187|12289591|FG000|NOT COMPLETED|Period 2||0
11223691|NCT01979835|12415691|FG000|STARTED|Primary Outcome SA Measurment||1030
11223692|NCT01979835|12415691|FG000|COMPLETED|Primary Outcome SA Measurment||1012
11223693|NCT01979835|12415691|FG000|NOT COMPLETED|Primary Outcome SA Measurment||18
11223694|NCT01979835|12415691|FG000|STARTED|Follow-up||1012
11223695|NCT01979835|12415691|FG000|COMPLETED|Follow-up||980
11223696|NCT01979835|12415691|FG000|NOT COMPLETED|Follow-up||32
11223697|NCT01979952|12415697|FG000|STARTED|Overall Study||56
11223698|NCT01979952|12415698|FG001|STARTED|Overall Study||57
11223699|NCT01979952|12415697|FG000|COMPLETED|Overall Study||48
11223700|NCT01979952|12415698|FG001|COMPLETED|Overall Study||51
11223701|NCT01979952|12415697|FG000|NOT COMPLETED|Overall Study||8
11223702|NCT01979952|12415698|FG001|NOT COMPLETED|Overall Study||6
11223703|NCT01980056|12415707|FG000|STARTED|Overall Study||4
11223704|NCT01980056|12415708|FG001|STARTED|Overall Study||4
11223705|NCT01980056|12415709|FG002|STARTED|Overall Study||2
11223706|NCT01980056|12415707|FG000|COMPLETED|Overall Study||3
11223707|NCT01980056|12415708|FG001|COMPLETED|Overall Study||3
11223708|NCT01980056|12415709|FG002|COMPLETED|Overall Study||2
11223709|NCT01980056|12415707|FG000|NOT COMPLETED|Overall Study||1
11223710|NCT01980056|12415708|FG001|NOT COMPLETED|Overall Study||1
11223711|NCT01980056|12415709|FG002|NOT COMPLETED|Overall Study||0
11223712|NCT01980095|12415723|FG000|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78
11223713|NCT01980095|12415724|FG001|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
11223714|NCT01980095|12415723|FG000|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
11105226|NCT01253187|12289592|FG001|NOT COMPLETED|Period 2||0
10845683|NCT02722941|12011635|FG000|STARTED|Overall Study||15
10845684|NCT02722941|12011636|FG001|STARTED|Overall Study||15
10845685|NCT02722941|12011635|FG000|COMPLETED|Overall Study||15
10845686|NCT02722941|12011636|FG001|COMPLETED|Overall Study||15
10845687|NCT02722941|12011635|FG000|NOT COMPLETED|Overall Study||0
10845688|NCT02722941|12011636|FG001|NOT COMPLETED|Overall Study||0
10845689|NCT02655692|12011645|FG000|STARTED|Overall Study||55
10845690|NCT02655692|12011646|FG001|STARTED|Overall Study||55
10845691|NCT02655692|12011647|FG002|STARTED|Overall Study||53
10845692|NCT02655692|12011645|FG000|COMPLETED|Overall Study||36
11223715|NCT01980095|12415724|FG001|Treated|Overall Study||41
11223716|NCT01980095|12415723|FG000|COMPLETED|Overall Study||63
10845693|NCT02655692|12011646|FG001|COMPLETED|Overall Study||41
10845694|NCT02655692|12011647|FG002|COMPLETED|Overall Study||40
10845695|NCT02655692|12011645|FG000|NOT COMPLETED|Overall Study||19
10845696|NCT02655692|12011646|FG001|NOT COMPLETED|Overall Study||14
10845697|NCT02655692|12011647|FG002|NOT COMPLETED|Overall Study||13
10845698|NCT02623205|12011657|FG000|STARTED|Overall Study||42
10845699|NCT02623205|12011658|FG001|STARTED|Overall Study||43
10845700|NCT02623205|12011657|FG000|COMPLETED|Overall Study||38
10845701|NCT02623205|12011658|FG001|COMPLETED|Overall Study||40
10845702|NCT02623205|12011657|FG000|NOT COMPLETED|Overall Study||4
10845703|NCT02623205|12011658|FG001|NOT COMPLETED|Overall Study||3
10845704|NCT02348203|12011666|FG000|STARTED|Overall Study||31
11105227|NCT01253187|12289593|FG002|NOT COMPLETED|Period 2||0
11105228|NCT01253187|12289594|FG003|NOT COMPLETED|Period 2||0
11105229|NCT01253187|12289595|FG004|NOT COMPLETED|Period 2||1
11105230|NCT01253187|12289596|FG005|NOT COMPLETED|Period 2||0
11105231|NCT01253187|12289591|FG000|STARTED|Period 3||7
11105232|NCT01253187|12289592|FG001|STARTED|Period 3||8
11105233|NCT01253187|12289593|FG002|STARTED|Period 3||7
11105234|NCT01253187|12289594|FG003|STARTED|Period 3||7
11105235|NCT01253187|12289595|FG004|STARTED|Period 3||8
11105236|NCT01253187|12289596|FG005|STARTED|Period 3||6
11105237|NCT01253187|12289591|FG000|COMPLETED|Period 3||6
11105238|NCT01253187|12289592|FG001|COMPLETED|Period 3||7
11105239|NCT01253187|12289593|FG002|COMPLETED|Period 3||7
11105240|NCT01253187|12289594|FG003|COMPLETED|Period 3||7
11105241|NCT01253187|12289595|FG004|COMPLETED|Period 3||7
11105242|NCT01253187|12289596|FG005|COMPLETED|Period 3||6
11105243|NCT01253187|12289591|FG000|NOT COMPLETED|Period 3||1
11105244|NCT01253187|12289592|FG001|NOT COMPLETED|Period 3||1
11105245|NCT01253187|12289593|FG002|NOT COMPLETED|Period 3||0
11105246|NCT01253187|12289594|FG003|NOT COMPLETED|Period 3||0
11105247|NCT01253187|12289595|FG004|NOT COMPLETED|Period 3||1
11105248|NCT01253187|12289596|FG005|NOT COMPLETED|Period 3||0
11105249|NCT01253200|12289612|FG000|STARTED|Overall Study||125
11223717|NCT01980095|12415724|FG001|COMPLETED|Overall Study||30
11223718|NCT01980095|12415723|FG000|NOT COMPLETED|Overall Study||15
11223719|NCT01980095|12415724|FG001|NOT COMPLETED|Overall Study||11
11105250|NCT01253200|12289613|FG001|STARTED|Overall Study||125
11105251|NCT01253200|12289614|FG002|STARTED|Overall Study||30
11105252|NCT01253200|12289615|FG003|STARTED|Overall Study||17
11105253|NCT01253200|12289616|FG004|STARTED|Overall Study||5
11105254|NCT01253200|12289612|FG000|Procedure|Overall Study||109
11105255|NCT01253200|12289613|FG001|Procedure|Overall Study||111
11105256|NCT01253200|12289614|FG002|Procedure|Overall Study||28
11105257|NCT01253200|12289615|FG003|Procedure|Overall Study||12
11105258|NCT01253200|12289616|FG004|Procedure|Overall Study||0
11105259|NCT01253200|12289612|FG000|10 Day Follow-up|Overall Study||106
11105260|NCT01253200|12289613|FG001|10 Day Follow-up|Overall Study||111
11105261|NCT01253200|12289614|FG002|10 Day Follow-up|Overall Study||28
11105262|NCT01253200|12289615|FG003|10 Day Follow-up|Overall Study||12
11105263|NCT01253200|12289616|FG004|10 Day Follow-up|Overall Study||0
11105264|NCT01253200|12289612|FG000|3 Month Follow-up|Overall Study||104
11105265|NCT01253200|12289613|FG001|3 Month Follow-up|Overall Study||106
11105266|NCT01253200|12289614|FG002|3 Month Follow-up|Overall Study||28
11105267|NCT01253200|12289615|FG003|3 Month Follow-up|Overall Study||12
11105268|NCT01253200|12289616|FG004|3 Month Follow-up|Overall Study||0
11105269|NCT01253200|12289612|FG000|COMPLETED|Overall Study||104
11105270|NCT01253200|12289613|FG001|COMPLETED|Overall Study||106
11105271|NCT01253200|12289614|FG002|COMPLETED|Overall Study||28
11105272|NCT01253200|12289615|FG003|COMPLETED|Overall Study||12
11105273|NCT01253200|12289616|FG004|COMPLETED|Overall Study||0
11105274|NCT01253200|12289612|FG000|NOT COMPLETED|Overall Study||21
11105275|NCT01253200|12289613|FG001|NOT COMPLETED|Overall Study||19
11105276|NCT01253200|12289614|FG002|NOT COMPLETED|Overall Study||2
11105277|NCT01253200|12289615|FG003|NOT COMPLETED|Overall Study||5
11105278|NCT01253200|12289616|FG004|NOT COMPLETED|Overall Study||5
11105279|NCT01253226|12289630|FG000|STARTED|Overall Study||6
11105280|NCT01253226|12289631|FG001|STARTED|Overall Study||6
11105281|NCT01253226|12289632|FG002|STARTED|Overall Study||6
11105282|NCT01253226|12289633|FG003|STARTED|Overall Study||6
11105283|NCT01253226|12289634|FG004|STARTED|Overall Study||8
11105284|NCT01253226|12289630|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
11105285|NCT01253226|12289631|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
11105286|NCT01253226|12289632|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11105287|NCT01253226|12289633|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
11105288|NCT01253226|12289634|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
11105289|NCT01253226|12289630|FG000|COMPLETED|Overall Study||6
11105290|NCT01253226|12289631|FG001|COMPLETED|Overall Study||5
11105291|NCT01253226|12289632|FG002|COMPLETED|Overall Study||5
11105292|NCT01253226|12289633|FG003|COMPLETED|Overall Study||5
11105293|NCT01253226|12289634|FG004|COMPLETED|Overall Study||6
11105294|NCT01253226|12289630|FG000|NOT COMPLETED|Overall Study||0
11105295|NCT01253226|12289631|FG001|NOT COMPLETED|Overall Study||1
11105296|NCT01253226|12289632|FG002|NOT COMPLETED|Overall Study||1
11105297|NCT01253226|12289633|FG003|NOT COMPLETED|Overall Study||1
11105298|NCT01253226|12289634|FG004|NOT COMPLETED|Overall Study||2
11105299|NCT01253265|12289651|FG000|STARTED|Overall Study||6
11105300|NCT01253265|12289652|FG001|STARTED|Overall Study||6
11105301|NCT01253265|12289653|FG002|STARTED|Overall Study||6
11105302|NCT01253265|12289654|FG003|STARTED|Overall Study||6
11105303|NCT01253265|12289655|FG004|STARTED|Overall Study||8
11105304|NCT01253265|12289651|FG000|COMPLETED|Overall Study||5
11105305|NCT01253265|12289652|FG001|COMPLETED|Overall Study||6
11105306|NCT01253265|12289653|FG002|COMPLETED|Overall Study||6
11105307|NCT01253265|12289654|FG003|COMPLETED|Overall Study||6
11105308|NCT01253265|12289655|FG004|COMPLETED|Overall Study||7
11105309|NCT01253265|12289651|FG000|NOT COMPLETED|Overall Study||1
11105310|NCT01253265|12289652|FG001|NOT COMPLETED|Overall Study||0
11105311|NCT01253265|12289653|FG002|NOT COMPLETED|Overall Study||0
11105312|NCT01253265|12289654|FG003|NOT COMPLETED|Overall Study||0
11105313|NCT01253265|12289655|FG004|NOT COMPLETED|Overall Study||1
11105314|NCT01253291|12289672|FG000|STARTED|Overall Study||6
10845705|NCT02348203|12011667|FG001|STARTED|Overall Study||32
10845706|NCT02348203|12011666|FG000|COMPLETED|Overall Study||21
10845707|NCT02348203|12011667|FG001|COMPLETED|Overall Study||22
10845708|NCT02348203|12011666|FG000|NOT COMPLETED|Overall Study||10
10845709|NCT02348203|12011667|FG001|NOT COMPLETED|Overall Study||10
11105315|NCT01253291|12289673|FG001|STARTED|Overall Study||6
11105316|NCT01253291|12289674|FG002|STARTED|Overall Study||4
11105317|NCT01253291|12289675|FG003|STARTED|Overall Study||5
11105318|NCT01253291|12289676|FG004|STARTED|Overall Study||5
11105319|NCT01253291|12289672|FG000|Received Study Drug During BCDL|Overall Study||6
11105320|NCT01253291|12289673|FG001|Received Study Drug During BCDL|Overall Study||6
11105321|NCT01253291|12289674|FG002|Received Study Drug During BCDL|Overall Study||4
11105322|NCT01253291|12289675|FG003|Received Study Drug During BCDL|Overall Study||5
11105323|NCT01253291|12289676|FG004|Received Study Drug During BCDL|Overall Study||5
11105324|NCT01253291|12289672|FG000|COMPLETED|Overall Study||2
11105325|NCT01253291|12289673|FG001|COMPLETED|Overall Study||4
11105326|NCT01253291|12289674|FG002|COMPLETED|Overall Study||4
11105327|NCT01253291|12289675|FG003|COMPLETED|Overall Study||5
11105328|NCT01253291|12289676|FG004|COMPLETED|Overall Study||3
11105329|NCT01253291|12289672|FG000|NOT COMPLETED|Overall Study||4
11105330|NCT01253291|12289673|FG001|NOT COMPLETED|Overall Study||2
11105331|NCT01253291|12289674|FG002|NOT COMPLETED|Overall Study||0
11105332|NCT01253291|12289675|FG003|NOT COMPLETED|Overall Study||0
11105333|NCT01253291|12289676|FG004|NOT COMPLETED|Overall Study||2
11105334|NCT01253304|12289693|FG000|STARTED|Overall Study||11
11105335|NCT01253304|12289694|FG001|STARTED|Overall Study||6
11105336|NCT01253304|12289695|FG002|STARTED|Overall Study||6
11105337|NCT01253304|12289696|FG003|STARTED|Overall Study||3
11105338|NCT01253304|12289693|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
11105339|NCT01253304|12289694|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
11105340|NCT01253304|12289695|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
11105341|NCT01253304|12289696|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
11105342|NCT01253304|12289693|FG000|COMPLETED|Overall Study||11
11105343|NCT01253304|12289694|FG001|COMPLETED|Overall Study||6
11105344|NCT01253304|12289695|FG002|COMPLETED|Overall Study||6
11105345|NCT01253304|12289696|FG003|COMPLETED|Overall Study||2
11105346|NCT01253304|12289693|FG000|NOT COMPLETED|Overall Study||0
11105347|NCT01253304|12289694|FG001|NOT COMPLETED|Overall Study||0
11105348|NCT01253304|12289695|FG002|NOT COMPLETED|Overall Study||0
11105349|NCT01253304|12289696|FG003|NOT COMPLETED|Overall Study||1
11105350|NCT01253317|12289706|FG000|STARTED|Overall Study||12
11105351|NCT01253317|12289706|FG000|COMPLETED|Overall Study||10
11105352|NCT01253317|12289706|FG000|NOT COMPLETED|Overall Study||2
11105353|NCT01253343|12289716|FG000|STARTED|Overall Study||9
11105354|NCT01253343|12289717|FG001|STARTED|Overall Study||8
11105355|NCT01253343|12289716|FG000|COMPLETED|Overall Study||9
11105356|NCT01253343|12289717|FG001|COMPLETED|Overall Study||8
11105357|NCT01253343|12289716|FG000|NOT COMPLETED|Overall Study||0
11105358|NCT01253343|12289717|FG001|NOT COMPLETED|Overall Study||0
11105359|NCT01253369|12289739|FG000|STARTED|Overall Study||33
11105360|NCT01253369|12289739|FG000|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
11105361|NCT01253369|12289739|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
11105362|NCT01253369|12289739|FG000|NOT COMPLETED|Overall Study||33
11105363|NCT01253408|12289746|FG000|STARTED|Overall Study||10
11105364|NCT01253408|12289747|FG001|STARTED|Overall Study||13
11105365|NCT01253408|12289748|FG002|STARTED|Overall Study||13
11105366|NCT01253408|12289746|FG000|COMPLETED|Overall Study||10
11105367|NCT01253408|12289747|FG001|COMPLETED|Overall Study||12
11105368|NCT01253408|12289748|FG002|COMPLETED|Overall Study||13
11105369|NCT01253408|12289746|FG000|NOT COMPLETED|Overall Study||0
11105370|NCT01253408|12289747|FG001|NOT COMPLETED|Overall Study||1
11105371|NCT01253408|12289748|FG002|NOT COMPLETED|Overall Study||0
11105372|NCT01253421|12289760|FG000|STARTED|Assessment and Scheduling||159
11105373|NCT01253421|12289761|FG001|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
11105374|NCT01253421|12289762|FG002|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
11105375|NCT01253421|12289763|FG003|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
11105376|NCT01253421|12289764|FG004|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
11105377|NCT01253421|12289760|FG000|Eligible After Screening Visit|Assessment and Scheduling||85
11105378|NCT01253421|12289761|FG001|Eligible After Screening Visit|Assessment and Scheduling||0
11105379|NCT01253421|12289762|FG002|Eligible After Screening Visit|Assessment and Scheduling||0
11105380|NCT01253421|12289763|FG003|Eligible After Screening Visit|Assessment and Scheduling||0
11105381|NCT01253421|12289764|FG004|Eligible After Screening Visit|Assessment and Scheduling||0
11105382|NCT01253421|12289760|FG000|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
11105383|NCT01253421|12289761|FG001|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
11105384|NCT01253421|12289762|FG002|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
11105385|NCT01253421|12289763|FG003|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
11105386|NCT01253421|12289764|FG004|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
11105387|NCT01253421|12289760|FG000|COMPLETED|Assessment and Scheduling||60
11105388|NCT01253421|12289761|FG001|COMPLETED|Assessment and Scheduling||0
11105389|NCT01253421|12289762|FG002|COMPLETED|Assessment and Scheduling||0
11105390|NCT01253421|12289763|FG003|COMPLETED|Assessment and Scheduling||0
11105391|NCT01253421|12289764|FG004|COMPLETED|Assessment and Scheduling||0
11105392|NCT01253421|12289760|FG000|NOT COMPLETED|Assessment and Scheduling||99
11105393|NCT01253421|12289761|FG001|NOT COMPLETED|Assessment and Scheduling||0
11105394|NCT01253421|12289762|FG002|NOT COMPLETED|Assessment and Scheduling||0
11105395|NCT01253421|12289763|FG003|NOT COMPLETED|Assessment and Scheduling||0
11105396|NCT01253421|12289764|FG004|NOT COMPLETED|Assessment and Scheduling||0
11223720|NCT01980485|12415734|FG000|STARTED|Overall Study||120
11223721|NCT01980485|12415735|FG001|STARTED|Overall Study||105
10845742|NCT01560637|12011698|FG000|STARTED|Overall Study|471 subjects from the parent study (TDE-PH-310) consented to participate in TDE-PH-311. However, one subject withdrew consent prior to receiving oral treprostinil in TDE-PH-311. This subject was not included in the data summary.|470
10845743|NCT01560637|12011698|FG000|COMPLETED|Overall Study||272
10845744|NCT01560637|12011698|FG000|NOT COMPLETED|Overall Study||198
10845745|NCT00999804|12011704|FG000|STARTED|Overall Study||85
10845746|NCT00999804|12011705|FG001|STARTED|Overall Study||43
10845747|NCT00999804|12011704|FG000|COMPLETED|Overall Study||64
10845748|NCT00999804|12011705|FG001|COMPLETED|Overall Study||38
10845749|NCT00999804|12011704|FG000|NOT COMPLETED|Overall Study||21
10845750|NCT00999804|12011705|FG001|NOT COMPLETED|Overall Study||5
10845751|NCT00458003|12011713|FG000|STARTED|Overall Study||55
10845752|NCT00458003|12011714|FG001|STARTED|Overall Study||55
10845753|NCT00458003|12011713|FG000|COMPLETED|Overall Study||54
10845754|NCT00458003|12011714|FG001|COMPLETED|Overall Study||54
10845755|NCT00458003|12011713|FG000|NOT COMPLETED|Overall Study||1
10845756|NCT00458003|12011714|FG001|NOT COMPLETED|Overall Study||1
11223722|NCT01980485|12415734|FG000|COMPLETED|Overall Study||84
11223723|NCT01980485|12415735|FG001|COMPLETED|Overall Study||80
11223724|NCT01980485|12415734|FG000|NOT COMPLETED|Overall Study||36
11223725|NCT01980485|12415735|FG001|NOT COMPLETED|Overall Study||25
11223726|NCT01980524|12415743|FG000|STARTED|Study Day 1||4
11223727|NCT01980524|12415744|FG001|STARTED|Study Day 1||4
11223728|NCT01980524|12415743|FG000|COMPLETED|Study Day 1||4
11223729|NCT01980524|12415744|FG001|COMPLETED|Study Day 1||4
11223730|NCT01980524|12415743|FG000|NOT COMPLETED|Study Day 1||0
11223731|NCT01980524|12415744|FG001|NOT COMPLETED|Study Day 1||0
11223732|NCT01980524|12415743|FG000|STARTED|Washout (at Least 2 Weeks)||4
11223733|NCT01980524|12415744|FG001|STARTED|Washout (at Least 2 Weeks)||4
11223734|NCT01980524|12415743|FG000|COMPLETED|Washout (at Least 2 Weeks)||4
11223735|NCT01980524|12415744|FG001|COMPLETED|Washout (at Least 2 Weeks)||4
11223736|NCT01980524|12415743|FG000|NOT COMPLETED|Washout (at Least 2 Weeks)||0
11223737|NCT01980524|12415744|FG001|NOT COMPLETED|Washout (at Least 2 Weeks)||0
11223738|NCT01980524|12415743|FG000|STARTED|Study Day 2||4
11223739|NCT01980524|12415744|FG001|STARTED|Study Day 2||4
11223740|NCT01980524|12415743|FG000|COMPLETED|Study Day 2||4
11223741|NCT01980524|12415744|FG001|COMPLETED|Study Day 2||4
10845757|NCT03882788|12011724|FG000|STARTED|Overall Study||44
10845758|NCT03882788|12011725|FG001|STARTED|Overall Study||45
10845759|NCT03882788|12011724|FG000|COMPLETED|Overall Study||44
10845760|NCT03882788|12011725|FG001|COMPLETED|Overall Study||45
10845761|NCT03882788|12011724|FG000|NOT COMPLETED|Overall Study||0
10845762|NCT03882788|12011725|FG001|NOT COMPLETED|Overall Study||0
10845763|NCT03834974|12011733|FG000|STARTED|Overall Study||34
10845764|NCT03834974|12011734|FG001|STARTED|Overall Study||32
10845765|NCT03834974|12011733|FG000|COMPLETED|Overall Study||34
10845766|NCT03834974|12011734|FG001|COMPLETED|Overall Study||32
10845767|NCT03834974|12011733|FG000|NOT COMPLETED|Overall Study||0
10845768|NCT03834974|12011734|FG001|NOT COMPLETED|Overall Study||0
10845769|NCT03821675|12011743|FG000|STARTED|Overall Study||19
10845770|NCT03821675|12011744|FG001|STARTED|Overall Study||19
10845771|NCT03821675|12011743|FG000|COMPLETED|Overall Study||16
10845772|NCT03821675|12011744|FG001|COMPLETED|Overall Study||17
10845773|NCT03821675|12011743|FG000|NOT COMPLETED|Overall Study||3
10845774|NCT03821675|12011744|FG001|NOT COMPLETED|Overall Study||2
10845775|NCT03794544|12011756|FG000|STARTED|Overall Study||27
10845776|NCT03794544|12011757|FG001|STARTED|Overall Study||21
10845777|NCT03794544|12011758|FG002|STARTED|Overall Study||20
10845778|NCT03794544|12011759|FG003|STARTED|Overall Study||16
10845779|NCT03794544|12011756|FG000|Treated|Overall Study||26
10845780|NCT03794544|12011757|FG001|Treated|Overall Study||21
10845781|NCT03794544|12011758|FG002|Treated|Overall Study||20
10845782|NCT03794544|12011759|FG003|Treated|Overall Study||16
10845783|NCT03794544|12011756|FG000|COMPLETED|Overall Study||26
10845784|NCT03794544|12011757|FG001|COMPLETED|Overall Study||18
10845785|NCT03794544|12011758|FG002|COMPLETED|Overall Study||19
10845786|NCT03794544|12011759|FG003|COMPLETED|Overall Study||15
10845787|NCT03794544|12011756|FG000|NOT COMPLETED|Overall Study||1
10845788|NCT03794544|12011757|FG001|NOT COMPLETED|Overall Study||3
10845789|NCT03794544|12011758|FG002|NOT COMPLETED|Overall Study||1
10845790|NCT03794544|12011759|FG003|NOT COMPLETED|Overall Study||1
10845791|NCT03732807|12011776|FG000|STARTED|Treatment Period (up to Week 24)||132
10845792|NCT03732807|12011777|FG001|STARTED|Treatment Period (up to Week 24)||130
10845793|NCT03732807|12011778|FG002|STARTED|Treatment Period (up to Week 24)||130
10845794|NCT03732807|12011779|FG003|STARTED|Treatment Period (up to Week 24)||132
10845795|NCT03732807|12011780|FG004|STARTED|Treatment Period (up to Week 24)||63
10845796|NCT03732807|12011781|FG005|STARTED|Treatment Period (up to Week 24)||65
10845797|NCT03732807|12011782|FG006|STARTED|Treatment Period (up to Week 24)||66
10845798|NCT03732807|12011776|FG000|COMPLETED|Treatment Period (up to Week 24)||122
10845799|NCT03732807|12011777|FG001|COMPLETED|Treatment Period (up to Week 24)||124
10845800|NCT03732807|12011778|FG002|COMPLETED|Treatment Period (up to Week 24)||121
10845801|NCT03732807|12011779|FG003|COMPLETED|Treatment Period (up to Week 24)||117
10845802|NCT03732807|12011780|FG004|COMPLETED|Treatment Period (up to Week 24)||58
10845803|NCT03732807|12011781|FG005|COMPLETED|Treatment Period (up to Week 24)||63
11223742|NCT01980524|12415743|FG000|NOT COMPLETED|Study Day 2||0
11223743|NCT01980524|12415744|FG001|NOT COMPLETED|Study Day 2||0
11223744|NCT01980589|12415753|FG000|STARTED|Overall Study||3
11223745|NCT01980589|12415754|FG001|STARTED|Overall Study||3
11223746|NCT01980589|12415755|FG002|STARTED|Overall Study||16
11223747|NCT01980589|12415753|FG000|COMPLETED|Overall Study||3
11223748|NCT01980589|12415754|FG001|COMPLETED|Overall Study||3
11223749|NCT01980589|12415755|FG002|COMPLETED|Overall Study||16
11223750|NCT01980589|12415753|FG000|NOT COMPLETED|Overall Study||0
11223751|NCT01980589|12415754|FG001|NOT COMPLETED|Overall Study||0
11223752|NCT01980589|12415755|FG002|NOT COMPLETED|Overall Study||0
11223753|NCT01980628|12415763|FG000|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
11223754|NCT01980628|12415763|FG000|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
11223755|NCT01980628|12415763|FG000|NOT COMPLETED|Overall Study||63
11223756|NCT01980654|12415770|FG000|STARTED|Overall Study||60
11223757|NCT01980654|12415771|FG001|STARTED|Overall Study||20
11223758|NCT01980654|12415770|FG000|COMPLETED|Overall Study||60
11223759|NCT01980654|12415771|FG001|COMPLETED|Overall Study||20
11223760|NCT01980654|12415770|FG000|NOT COMPLETED|Overall Study||0
11223761|NCT01980654|12415771|FG001|NOT COMPLETED|Overall Study||0
11223762|NCT01980706|12415780|FG000|STARTED|Overall Study||40
11223763|NCT01980706|12415781|FG001|STARTED|Overall Study||43
11223764|NCT01980706|12415782|FG002|STARTED|Overall Study||37
11223765|NCT01980706|12415780|FG000|COMPLETED|Overall Study||23
11223766|NCT01980706|12415781|FG001|COMPLETED|Overall Study||26
11223767|NCT01980706|12415782|FG002|COMPLETED|Overall Study||24
11223768|NCT01980706|12415780|FG000|NOT COMPLETED|Overall Study||17
11223769|NCT01980706|12415781|FG001|NOT COMPLETED|Overall Study||17
11223770|NCT01980706|12415782|FG002|NOT COMPLETED|Overall Study||13
11223771|NCT01980771|12415792|FG000|STARTED|Overall Study||436
11223772|NCT01980771|12415793|FG001|STARTED|Overall Study||424
11223773|NCT01980771|12415792|FG000|COMPLETED|Overall Study||352
11223774|NCT01980771|12415793|FG001|COMPLETED|Overall Study||305
11223775|NCT01980771|12415792|FG000|NOT COMPLETED|Overall Study||84
11223776|NCT01980771|12415793|FG001|NOT COMPLETED|Overall Study||119
11223777|NCT01980888|12415801|FG000|STARTED|Overall Study||157
11223778|NCT01980888|12415802|FG001|STARTED|Overall Study||154
10845804|NCT03732807|12011782|FG006|COMPLETED|Treatment Period (up to Week 24)||61
10845805|NCT03732807|12011776|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||10
10845806|NCT03732807|12011777|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6
10845807|NCT03732807|12011778|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9
10845808|NCT03732807|12011779|FG003|NOT COMPLETED|Treatment Period (up to Week 24)||15
10845809|NCT03732807|12011780|FG004|NOT COMPLETED|Treatment Period (up to Week 24)||5
10845810|NCT03732807|12011781|FG005|NOT COMPLETED|Treatment Period (up to Week 24)||2
10845811|NCT03732807|12011782|FG006|NOT COMPLETED|Treatment Period (up to Week 24)||5
10845812|NCT03732807|12011776|FG000|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|113
10845813|NCT03732807|12011777|FG001|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|111
10845814|NCT03732807|12011778|FG002|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|108
10845815|NCT03732807|12011779|FG003|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|106
10845816|NCT03732807|12011780|FG004|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|49
10845817|NCT03732807|12011781|FG005|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|59
10845818|NCT03732807|12011782|FG006|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|57
10845819|NCT03732807|12011776|FG000|COMPLETED|Treatment Extension (Week 25 up to 48)||107
10845820|NCT03732807|12011777|FG001|COMPLETED|Treatment Extension (Week 25 up to 48)||100
10845821|NCT03732807|12011778|FG002|COMPLETED|Treatment Extension (Week 25 up to 48)||103
10845822|NCT03732807|12011779|FG003|COMPLETED|Treatment Extension (Week 25 up to 48)||97
10845823|NCT03732807|12011780|FG004|COMPLETED|Treatment Extension (Week 25 up to 48)||44
10845824|NCT03732807|12011781|FG005|COMPLETED|Treatment Extension (Week 25 up to 48)||56
10845825|NCT03732807|12011782|FG006|COMPLETED|Treatment Extension (Week 25 up to 48)||53
10845826|NCT03732807|12011776|FG000|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||6
10845827|NCT03732807|12011777|FG001|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||11
10845828|NCT03732807|12011778|FG002|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5
10845829|NCT03732807|12011779|FG003|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||9
10845830|NCT03732807|12011780|FG004|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5
10845831|NCT03732807|12011781|FG005|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||3
10845832|NCT03732807|12011782|FG006|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||4
11354421|NCT03073200|12551620|FG003|NOT COMPLETED|Open-Label Maintenance Period||4
11354422|NCT03073200|12551621|FG004|NOT COMPLETED|Open-Label Maintenance Period||4
11354423|NCT03073200|12551622|FG005|NOT COMPLETED|Open-Label Maintenance Period||0
11354424|NCT03073200|12551623|FG006|NOT COMPLETED|Open-Label Maintenance Period||0
11354425|NCT03073200|12551624|FG007|NOT COMPLETED|Open-Label Maintenance Period||0
11354426|NCT03073200|12551625|FG008|NOT COMPLETED|Open-Label Maintenance Period||0
11354427|NCT03073200|12551626|FG009|NOT COMPLETED|Open-Label Maintenance Period||0
11354428|NCT03073200|12551627|FG010|NOT COMPLETED|Open-Label Maintenance Period||0
10845833|NCT03731364|12011804|FG000|STARTED|Overall Study||9
10845834|NCT03731364|12011805|FG001|STARTED|Overall Study||9
10845835|NCT03731364|12011806|FG002|STARTED|Overall Study||13
10845836|NCT03731364|12011807|FG003|STARTED|Overall Study||13
10845837|NCT03731364|12011808|FG004|STARTED|Overall Study||11
10845838|NCT03731364|12011804|FG000|COMPLETED|Overall Study||9
10845839|NCT03731364|12011805|FG001|COMPLETED|Overall Study||9
10845840|NCT03731364|12011806|FG002|COMPLETED|Overall Study||12
10845841|NCT03731364|12011807|FG003|COMPLETED|Overall Study||11
10845842|NCT03731364|12011808|FG004|COMPLETED|Overall Study||10
10845843|NCT03731364|12011804|FG000|NOT COMPLETED|Overall Study||0
10845844|NCT03731364|12011805|FG001|NOT COMPLETED|Overall Study||0
10845845|NCT03731364|12011806|FG002|NOT COMPLETED|Overall Study||1
10845846|NCT03731364|12011807|FG003|NOT COMPLETED|Overall Study||2
10845847|NCT03731364|12011808|FG004|NOT COMPLETED|Overall Study||1
11105397|NCT01253421|12289760|FG000|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
11223779|NCT01980888|12415801|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
11223780|NCT01980888|12415802|FG001|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
11223781|NCT01980888|12415801|FG000|NOT COMPLETED|Overall Study||144
11223782|NCT01980888|12415802|FG001|NOT COMPLETED|Overall Study||133
11223783|NCT01980914|12415808|FG000|STARTED|Overall Study||11
11105398|NCT01253421|12289761|FG001|STARTED|Drug+Scanning Visit||15
11105399|NCT01253421|12289762|FG002|STARTED|Drug+Scanning Visit||14
11105400|NCT01253421|12289763|FG003|STARTED|Drug+Scanning Visit||16
11105401|NCT01253421|12289764|FG004|STARTED|Drug+Scanning Visit||15
11105402|NCT01253421|12289760|FG000|Received Drug Challenge|Drug+Scanning Visit||0
11105403|NCT01253421|12289761|FG001|Received Drug Challenge|Drug+Scanning Visit||15
10845848|NCT03728153|12011820|FG000|STARTED|Overall Study||34
10845849|NCT03728153|12011820|FG000|COMPLETED|Overall Study||32
10845850|NCT03728153|12011820|FG000|NOT COMPLETED|Overall Study||2
10845857|NCT03720899|12011835|FG000|STARTED|Overall Study||21
10845858|NCT03720899|12011836|FG001|STARTED|Overall Study||24
10845859|NCT03720899|12011835|FG000|COMPLETED|Overall Study||13
10845860|NCT03720899|12011836|FG001|COMPLETED|Overall Study||13
10845861|NCT03720899|12011835|FG000|NOT COMPLETED|Overall Study||8
10845862|NCT03720899|12011836|FG001|NOT COMPLETED|Overall Study||11
10845863|NCT03716869|12011844|FG000|STARTED|Overall Study||6436
10845864|NCT03716869|12011845|FG001|STARTED|Overall Study||6473
10845865|NCT03716869|12011844|FG000|COMPLETED|Overall Study||6436
10845866|NCT03716869|12011845|FG001|COMPLETED|Overall Study||6473
10845867|NCT03716869|12011844|FG000|NOT COMPLETED|Overall Study||0
10845868|NCT03716869|12011845|FG001|NOT COMPLETED|Overall Study||0
10845875|NCT04598152|12011860|FG000|STARTED|Overall Study||3
10845876|NCT04598152|12011861|FG001|STARTED|Overall Study||1
10845877|NCT04598152|12011860|FG000|COMPLETED|Overall Study||3
10845878|NCT04598152|12011861|FG001|COMPLETED|Overall Study||0
10845879|NCT04598152|12011860|FG000|NOT COMPLETED|Overall Study||0
11223784|NCT01980914|12415808|FG000|COMPLETED|Overall Study||11
11223785|NCT01980914|12415808|FG000|NOT COMPLETED|Overall Study||0
11223786|NCT01980992|12415815|FG000|STARTED|52 Weeks Blinded Study Treatment||23
11223787|NCT01980992|12415816|FG001|STARTED|52 Weeks Blinded Study Treatment||23
11223788|NCT01980992|12415815|FG000|COMPLETED|52 Weeks Blinded Study Treatment||21
11223789|NCT01980992|12415816|FG001|COMPLETED|52 Weeks Blinded Study Treatment||19
11223790|NCT01980992|12415815|FG000|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
11223791|NCT01980992|12415816|FG001|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
11223792|NCT01980992|12415815|FG000|STARTED|52 Weeks Open Label Active Wheat OIT||21
11223793|NCT01980992|12415816|FG001|STARTED|52 Weeks Open Label Active Wheat OIT||19
11223794|NCT01980992|12415815|FG000|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
11223795|NCT01980992|12415816|FG001|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
11223796|NCT01980992|12415815|FG000|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
11223797|NCT01980992|12415816|FG001|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
11223798|NCT01981057|12415831|FG000|STARTED|Overall Study||50
11223799|NCT01981057|12415832|FG001|STARTED|Overall Study||50
11223800|NCT01981057|12415831|FG000|COMPLETED|Overall Study||50
11223801|NCT01981057|12415832|FG001|COMPLETED|Overall Study||50
11223802|NCT01981057|12415831|FG000|NOT COMPLETED|Overall Study||0
11223803|NCT01981057|12415832|FG001|NOT COMPLETED|Overall Study||0
11223804|NCT01981109|12415838|FG000|STARTED|Overall Study||225
11223805|NCT01981109|12415838|FG000|COMPLETED|Overall Study||1
11223806|NCT01981109|12415838|FG000|NOT COMPLETED|Overall Study||224
11223807|NCT01981122|12415845|FG000|STARTED|Overall Study||25
11223808|NCT01981122|12415846|FG001|STARTED|Overall Study||27
11223809|NCT01981122|12415845|FG000|COMPLETED|Overall Study||11
11223810|NCT01981122|12415846|FG001|COMPLETED|Overall Study||7
11223811|NCT01981122|12415845|FG000|NOT COMPLETED|Overall Study||14
11223812|NCT01981122|12415846|FG001|NOT COMPLETED|Overall Study||20
11223813|NCT01981187|12415852|FG000|STARTED|Overall Study||12
11223814|NCT01981187|12415852|FG000|COMPLETED|Overall Study||0
11223815|NCT01981187|12415852|FG000|NOT COMPLETED|Overall Study||12
11223816|NCT01981356|12415858|FG000|STARTED|Overall Study||12
11223817|NCT01981356|12415859|FG001|STARTED|Overall Study||6
11223818|NCT01981356|12415858|FG000|COMPLETED|Overall Study||5
11223819|NCT01981356|12415859|FG001|COMPLETED|Overall Study||4
11223820|NCT01981356|12415858|FG000|NOT COMPLETED|Overall Study||7
11223821|NCT01981356|12415859|FG001|NOT COMPLETED|Overall Study||2
11223822|NCT01981473|12415869|FG000|STARTED|Overall Study||202
11223823|NCT01981473|12415870|FG001|STARTED|Overall Study||199
11105404|NCT01253421|12289762|FG002|Received Drug Challenge|Drug+Scanning Visit||14
11105405|NCT01253421|12289763|FG003|Received Drug Challenge|Drug+Scanning Visit||16
11105406|NCT01253421|12289764|FG004|Received Drug Challenge|Drug+Scanning Visit||15
11105407|NCT01253421|12289760|FG000|COMPLETED|Drug+Scanning Visit||0
11105408|NCT01253421|12289761|FG001|COMPLETED|Drug+Scanning Visit||15
11105409|NCT01253421|12289762|FG002|COMPLETED|Drug+Scanning Visit||14
11105410|NCT01253421|12289763|FG003|COMPLETED|Drug+Scanning Visit||16
11105411|NCT01253421|12289764|FG004|COMPLETED|Drug+Scanning Visit||14
11105412|NCT01253421|12289760|FG000|NOT COMPLETED|Drug+Scanning Visit||0
11105413|NCT01253421|12289761|FG001|NOT COMPLETED|Drug+Scanning Visit||0
11105414|NCT01253421|12289762|FG002|NOT COMPLETED|Drug+Scanning Visit||0
11105415|NCT01253421|12289763|FG003|NOT COMPLETED|Drug+Scanning Visit||0
11105416|NCT01253421|12289764|FG004|NOT COMPLETED|Drug+Scanning Visit||1
11105417|NCT01253447|12289774|FG000|STARTED|Overall Study||19
11105418|NCT01253447|12289774|FG000|COMPLETED|Overall Study||17
11105419|NCT01253447|12289774|FG000|NOT COMPLETED|Overall Study||2
11105420|NCT01253460|12289779|FG000|STARTED|Overall Study||18
11105421|NCT01253460|12289779|FG000|COMPLETED|Overall Study||18
11105422|NCT01253460|12289779|FG000|NOT COMPLETED|Overall Study||0
11105423|NCT01253525|12289783|FG000|STARTED|Overall Study||6
11105424|NCT01253525|12289783|FG000|Received Any Quantity of Study Drug|Overall Study||6
11105425|NCT01253525|12289783|FG000|COMPLETED|Overall Study||6
10845880|NCT04598152|12011861|FG001|NOT COMPLETED|Overall Study||1
10845881|NCT04353271|12011869|FG000|STARTED|Overall Study||1
10845882|NCT04353271|12011870|FG001|STARTED|Overall Study||2
10845883|NCT04353271|12011869|FG000|COMPLETED|Overall Study||1
10845884|NCT04353271|12011870|FG001|COMPLETED|Overall Study||1
10845851|NCT03724422|12011826|FG000|STARTED|Overall Study||1
10845852|NCT03724422|12011827|FG001|STARTED|Overall Study||2
10845853|NCT03724422|12011826|FG000|COMPLETED|Overall Study||1
10845854|NCT03724422|12011827|FG001|COMPLETED|Overall Study|Patients had interval healing then lost follow up|0
10845855|NCT03724422|12011826|FG000|NOT COMPLETED|Overall Study||0
10845856|NCT03724422|12011827|FG001|NOT COMPLETED|Overall Study||2
10845869|NCT03713957|12011853|FG000|STARTED|Overall Study||53
10845870|NCT03713957|12011854|FG001|STARTED|Overall Study||26
10845871|NCT03713957|12011853|FG000|COMPLETED|Overall Study||35
10845872|NCT03713957|12011854|FG001|COMPLETED|Overall Study||16
10845873|NCT03713957|12011853|FG000|NOT COMPLETED|Overall Study||18
10845874|NCT03713957|12011854|FG001|NOT COMPLETED|Overall Study||10
10845885|NCT04353271|12011869|FG000|NOT COMPLETED|Overall Study||0
10845886|NCT04353271|12011870|FG001|NOT COMPLETED|Overall Study||1
10845887|NCT05166824|12011880|FG000|STARTED|Overall Study||1
10845888|NCT05166824|12011881|FG001|STARTED|Overall Study||10
10845889|NCT05166824|12011882|FG002|STARTED|Overall Study||68
10845890|NCT05166824|12011883|FG003|STARTED|Overall Study||10
10845891|NCT05166824|12011880|FG000|COMPLETED|Overall Study||1
10845892|NCT05166824|12011881|FG001|COMPLETED|Overall Study||10
10845893|NCT05166824|12011882|FG002|COMPLETED|Overall Study||59
10845894|NCT05166824|12011883|FG003|COMPLETED|Overall Study||10
10845895|NCT05166824|12011880|FG000|NOT COMPLETED|Overall Study||0
10845896|NCT05166824|12011881|FG001|NOT COMPLETED|Overall Study||0
10845897|NCT05166824|12011882|FG002|NOT COMPLETED|Overall Study||9
10845898|NCT05166824|12011883|FG003|NOT COMPLETED|Overall Study||0
10845899|NCT04570670|12011895|FG000|STARTED|Overall Study||25
10845900|NCT04570670|12011896|FG001|STARTED|Overall Study||25
10845901|NCT04570670|12011895|FG000|COMPLETED|Overall Study||24
10845902|NCT04570670|12011896|FG001|COMPLETED|Overall Study||25
10845903|NCT04570670|12011895|FG000|NOT COMPLETED|Overall Study||1
10845904|NCT04570670|12011896|FG001|NOT COMPLETED|Overall Study||0
10845905|NCT04552704|12011905|FG000|STARTED|Overall Study||3
10845906|NCT04552704|12011905|FG000|COMPLETED|Overall Study||3
10845907|NCT04552704|12011905|FG000|NOT COMPLETED|Overall Study||0
10845908|NCT04546581|12011912|FG000|STARTED|Overall Study||301
10845909|NCT04546581|12011913|FG001|STARTED|Overall Study||292
10845910|NCT04546581|12011912|FG000|COMPLETED|Overall Study||288
10845911|NCT04546581|12011913|FG001|COMPLETED|Overall Study||279
10845912|NCT04546581|12011912|FG000|NOT COMPLETED|Overall Study||13
10845913|NCT04546581|12011913|FG001|NOT COMPLETED|Overall Study||13
10845914|NCT04236245|12011919|FG000|STARTED|Overall Study||25
10845915|NCT04236245|12011919|FG000|COMPLETED|Overall Study||25
10845916|NCT04236245|12011919|FG000|NOT COMPLETED|Overall Study||0
10845917|NCT04021290|12011925|FG000|STARTED|Overall Study||246
10845918|NCT04021290|12011926|FG001|STARTED|Overall Study||247
10845919|NCT04021290|12011925|FG000|COMPLETED|Overall Study||143
10845920|NCT04021290|12011926|FG001|COMPLETED|Overall Study||229
10845921|NCT04021290|12011925|FG000|NOT COMPLETED|Overall Study||103
10845922|NCT04021290|12011926|FG001|NOT COMPLETED|Overall Study||18
10845923|NCT03915626|12011932|FG000|STARTED|Overall Study||7
10845924|NCT03915626|12011932|FG000|COMPLETED|Overall Study||6
10845925|NCT03915626|12011932|FG000|NOT COMPLETED|Overall Study||1
10845926|NCT03698279|12011948|FG000|STARTED|Overall Study||124
10845927|NCT03698279|12011949|FG001|STARTED|Overall Study||122
10845928|NCT03698279|12011950|FG002|STARTED|Overall Study||159
10845929|NCT03698279|12011951|FG003|STARTED|Overall Study||234
10845930|NCT03698279|12011952|FG004|STARTED|Overall Study||13
10845931|NCT03698279|12011953|FG005|STARTED|Overall Study||13
10845932|NCT03698279|12011948|FG000|Safety Analysis Set Population (SafAS)|Overall Study||122
10845933|NCT03698279|12011949|FG001|Safety Analysis Set Population (SafAS)|Overall Study||121
10845934|NCT03698279|12011950|FG002|Safety Analysis Set Population (SafAS)|Overall Study||158
10845935|NCT03698279|12011951|FG003|Safety Analysis Set Population (SafAS)|Overall Study||234
10845936|NCT03698279|12011952|FG004|Safety Analysis Set Population (SafAS)|Overall Study||13
10845937|NCT03698279|12011953|FG005|Safety Analysis Set Population (SafAS)|Overall Study||13
10845938|NCT03698279|12011948|FG000|COMPLETED|Overall Study||119
10845939|NCT03698279|12011949|FG001|COMPLETED|Overall Study||120
10845940|NCT03698279|12011950|FG002|COMPLETED|Overall Study||152
10845941|NCT03698279|12011951|FG003|COMPLETED|Overall Study||228
10845942|NCT03698279|12011952|FG004|COMPLETED|Overall Study||13
10845943|NCT03698279|12011953|FG005|COMPLETED|Overall Study||13
10845944|NCT03698279|12011948|FG000|NOT COMPLETED|Overall Study||5
10845945|NCT03698279|12011949|FG001|NOT COMPLETED|Overall Study||2
10845946|NCT03698279|12011950|FG002|NOT COMPLETED|Overall Study||7
10845947|NCT03698279|12011951|FG003|NOT COMPLETED|Overall Study||6
10845948|NCT03698279|12011952|FG004|NOT COMPLETED|Overall Study||0
10845949|NCT03698279|12011953|FG005|NOT COMPLETED|Overall Study||0
10845950|NCT03559010|12011972|FG000|STARTED|Overall Study|The number of participants to start a period is not equal to the number who completed previous period|189
10845951|NCT03559010|12011972|FG000|Purchaser Population|Overall Study||113
10845952|NCT03559010|12011972|FG000|Use Phase Norgestrel 0.075 mg|Overall Study||109
10845953|NCT03559010|12011972|FG000|COMPLETED|Overall Study||189
10845954|NCT03559010|12011972|FG000|NOT COMPLETED|Overall Study||0
10845955|NCT03478930|12011983|FG000|STARTED|Overall Study||126
10845956|NCT03478930|12011984|FG001|STARTED|Overall Study||123
10845957|NCT03478930|12011983|FG000|COMPLETED|Overall Study||117
10845958|NCT03478930|12011984|FG001|COMPLETED|Overall Study||114
10845959|NCT03478930|12011983|FG000|NOT COMPLETED|Overall Study||9
10845960|NCT03478930|12011984|FG001|NOT COMPLETED|Overall Study||9
10845961|NCT03434353|12011995|FG000|STARTED|Overall Study||30
10845962|NCT03434353|12011996|FG001|STARTED|Overall Study||12
10845963|NCT03434353|12011997|FG002|STARTED|Overall Study||30
10845964|NCT03434353|12011998|FG003|STARTED|Overall Study||21
10845965|NCT03434353|12011999|FG004|STARTED|Overall Study||30
10845966|NCT03434353|12011995|FG000|COMPLETED|Overall Study||16
11105426|NCT01253525|12289783|FG000|NOT COMPLETED|Overall Study||0
10845967|NCT03434353|12011996|FG001|COMPLETED|Overall Study||9
10845968|NCT03434353|12011997|FG002|COMPLETED|Overall Study||16
10845969|NCT03434353|12011998|FG003|COMPLETED|Overall Study||18
10845970|NCT03434353|12011999|FG004|COMPLETED|Overall Study||12
10845971|NCT03434353|12011995|FG000|NOT COMPLETED|Overall Study||14
10845972|NCT03434353|12011996|FG001|NOT COMPLETED|Overall Study||3
10845973|NCT03434353|12011997|FG002|NOT COMPLETED|Overall Study||14
10845974|NCT03434353|12011998|FG003|NOT COMPLETED|Overall Study||3
10845975|NCT03434353|12011999|FG004|NOT COMPLETED|Overall Study||18
10845976|NCT03415022|12012013|FG000|STARTED|Overall Study||21
10845977|NCT03415022|12012014|FG001|STARTED|Overall Study||20
10845978|NCT03415022|12012013|FG000|COMPLETED|Overall Study||16
10845979|NCT03415022|12012014|FG001|COMPLETED|Overall Study||15
11223824|NCT01981473|12415871|FG002|STARTED|Overall Study||204
11223825|NCT01981473|12415869|FG000|COMPLETED|Overall Study||200
11223826|NCT01981473|12415870|FG001|COMPLETED|Overall Study||199
11223827|NCT01981473|12415871|FG002|COMPLETED|Overall Study||196
11223828|NCT01981473|12415869|FG000|NOT COMPLETED|Overall Study||2
11223829|NCT01981473|12415870|FG001|NOT COMPLETED|Overall Study||0
11223830|NCT01981473|12415871|FG002|NOT COMPLETED|Overall Study||8
11223831|NCT01981564|12415884|FG000|STARTED|Overall Study||107
11223832|NCT01981564|12415885|FG001|STARTED|Overall Study||115
11223833|NCT01981564|12415884|FG000|COMPLETED|Overall Study||98
11223834|NCT01981564|12415885|FG001|COMPLETED|Overall Study||106
11223835|NCT01981564|12415884|FG000|NOT COMPLETED|Overall Study||9
11223836|NCT01981564|12415885|FG001|NOT COMPLETED|Overall Study||9
11223837|NCT01981590|12415892|FG000|STARTED|Overall Study||15
11223838|NCT01981590|12415892|FG000|COMPLETED|Overall Study||15
11223839|NCT01981590|12415892|FG000|NOT COMPLETED|Overall Study||0
11223840|NCT01981616|12415899|FG000|STARTED|Overall Study||64
11223841|NCT01981616|12415900|FG001|STARTED|Overall Study||63
11223842|NCT01981616|12415899|FG000|COMPLETED|Overall Study||63
11223843|NCT01981616|12415900|FG001|COMPLETED|Overall Study||62
11223844|NCT01981616|12415899|FG000|NOT COMPLETED|Overall Study||1
11223845|NCT01981616|12415900|FG001|NOT COMPLETED|Overall Study||1
11223846|NCT01981759|12415908|FG000|STARTED|Overall Study||28
11223847|NCT01981759|12415909|FG001|STARTED|Overall Study||30
11223848|NCT01981759|12415908|FG000|Baseline (Week 1)|Overall Study||28
11223849|NCT01981759|12415909|FG001|Baseline (Week 1)|Overall Study||30
11223850|NCT01981759|12415908|FG000|Randomization (Week 3)|Overall Study||28
11223851|NCT01981759|12415909|FG001|Randomization (Week 3)|Overall Study||30
11223852|NCT01981759|12415908|FG000|Completed Week 12|Overall Study||22
11223853|NCT01981759|12415909|FG001|Completed Week 12|Overall Study||22
11223854|NCT01981759|12415908|FG000|COMPLETED|Overall Study||21
11223855|NCT01981759|12415909|FG001|COMPLETED|Overall Study||19
11223856|NCT01981759|12415908|FG000|NOT COMPLETED|Overall Study||7
11223857|NCT01981759|12415909|FG001|NOT COMPLETED|Overall Study||11
11223858|NCT01981772|12415917|FG000|STARTED|Overall Study||45
11223859|NCT01981772|12415918|FG001|STARTED|Overall Study||43
11223860|NCT01981772|12415917|FG000|COMPLETED|Overall Study||45
11223861|NCT01981772|12415918|FG001|COMPLETED|Overall Study||43
11223862|NCT01981772|12415917|FG000|NOT COMPLETED|Overall Study||0
11223863|NCT01981772|12415918|FG001|NOT COMPLETED|Overall Study||0
11223864|NCT01981863|12415926|FG000|STARTED|Overall Study||20
11223865|NCT01981863|12415927|FG001|STARTED|Overall Study||20
11223866|NCT01981863|12415926|FG000|COMPLETED|Overall Study||20
11223867|NCT01981863|12415927|FG001|COMPLETED|Overall Study||20
11223868|NCT01981863|12415926|FG000|NOT COMPLETED|Overall Study||0
11223869|NCT01981863|12415927|FG001|NOT COMPLETED|Overall Study||0
11223870|NCT01981954|12415933|FG000|STARTED|Titration Period||23
11223871|NCT01981954|12415933|FG000|Treated|Titration Period||23
11223872|NCT01981954|12415933|FG000|COMPLETED|Titration Period||22
11223873|NCT01981954|12415933|FG000|NOT COMPLETED|Titration Period||1
11223874|NCT01981954|12415933|FG000|STARTED|Fixed-Dose Assessment Period||22
11223875|NCT01981954|12415933|FG000|Treated|Fixed-Dose Assessment Period||22
11223876|NCT01981954|12415933|FG000|COMPLETED|Fixed-Dose Assessment Period||21
11223877|NCT01981954|12415933|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||1
11223878|NCT01981967|12415939|FG000|STARTED|Overall Study||6851
11223879|NCT01981967|12415940|FG001|STARTED|Overall Study||3149
11223880|NCT01981967|12415939|FG000|COMPLETED|Overall Study||6851
11105427|NCT01253564|12289787|FG000|STARTED|Overall Study||24
11105428|NCT01253564|12289787|FG000|COMPLETED|Overall Study||0
11105429|NCT01253564|12289787|FG000|NOT COMPLETED|Overall Study||24
11105430|NCT01253577|12289791|FG000|STARTED|Overall Study||105
11105431|NCT01253577|12289791|FG000|COMPLETED|Overall Study||102
11105432|NCT01253577|12289791|FG000|NOT COMPLETED|Overall Study||3
11105433|NCT01253642|12289797|FG000|STARTED|Overall Study||11
11105434|NCT01253642|12289797|FG000|COMPLETED|Overall Study||6
11105435|NCT01253642|12289797|FG000|NOT COMPLETED|Overall Study||5
11105436|NCT01253811|12289802|FG000|STARTED|Overall Study||6
11105437|NCT01253811|12289802|FG000|Exposed|Overall Study||6
11223881|NCT01981967|12415940|FG001|COMPLETED|Overall Study||3149
11223882|NCT01981967|12415939|FG000|NOT COMPLETED|Overall Study||0
11223883|NCT01981967|12415940|FG001|NOT COMPLETED|Overall Study||0
11354429|NCT03073200|12551628|FG011|NOT COMPLETED|Open-Label Maintenance Period||0
11354430|NCT03073200|12551629|FG012|NOT COMPLETED|Open-Label Maintenance Period||0
10845980|NCT03415022|12012013|FG000|NOT COMPLETED|Overall Study||5
11223884|NCT01982123|12415946|FG000|STARTED|Overall Study||12
11223885|NCT01982123|12415946|FG000|COMPLETED|Overall Study||12
11223886|NCT01982123|12415946|FG000|NOT COMPLETED|Overall Study||0
11223887|NCT01982240|12415953|FG000|STARTED|Overall Study||452
11223888|NCT01982240|12415954|FG001|STARTED|Overall Study||453
10845981|NCT03415022|12012014|FG001|NOT COMPLETED|Overall Study||5
10845982|NCT03283670|12012020|FG000|STARTED|Placebo Gas||24
10845983|NCT03283670|12012020|FG000|COMPLETED|Placebo Gas||22
10845984|NCT03283670|12012020|FG000|NOT COMPLETED|Placebo Gas||2
10845985|NCT03283670|12012020|FG000|STARTED|25% Nitrous Oxide||24
10845986|NCT03283670|12012020|FG000|COMPLETED|25% Nitrous Oxide||20
10845987|NCT03283670|12012020|FG000|NOT COMPLETED|25% Nitrous Oxide||4
10845988|NCT03283670|12012020|FG000|STARTED|50% Nitrous Oxide||24
10845989|NCT03283670|12012020|FG000|COMPLETED|50% Nitrous Oxide||23
10845990|NCT03283670|12012020|FG000|NOT COMPLETED|50% Nitrous Oxide||1
10845991|NCT03233217|12012033|FG000|STARTED|Overall Study||5
10845992|NCT03233217|12012034|FG001|STARTED|Overall Study||5
10845993|NCT03233217|12012035|FG002|STARTED|Overall Study||55
10845994|NCT03233217|12012036|FG003|STARTED|Overall Study||55
10845995|NCT03233217|12012037|FG004|STARTED|Overall Study||55
10845996|NCT03233217|12012033|FG000|Safety Analysis Set (SafAS)|Overall Study||5
10845997|NCT03233217|12012034|FG001|Safety Analysis Set (SafAS)|Overall Study||5
10845998|NCT03233217|12012035|FG002|Safety Analysis Set (SafAS)|Overall Study||55
10845999|NCT03233217|12012036|FG003|Safety Analysis Set (SafAS)|Overall Study||55
10846000|NCT03233217|12012037|FG004|Safety Analysis Set (SafAS)|Overall Study||55
10846001|NCT03233217|12012033|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||5
10846002|NCT03233217|12012034|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||5
10846003|NCT03233217|12012035|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||55
10846004|NCT03233217|12012036|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||55
10846005|NCT03233217|12012037|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||54
10846006|NCT03233217|12012033|FG000|COMPLETED|Overall Study||5
10846007|NCT03233217|12012034|FG001|COMPLETED|Overall Study||5
10846008|NCT03233217|12012035|FG002|COMPLETED|Overall Study||55
10846009|NCT03233217|12012036|FG003|COMPLETED|Overall Study||55
10846010|NCT03233217|12012037|FG004|COMPLETED|Overall Study||55
10846011|NCT03233217|12012033|FG000|NOT COMPLETED|Overall Study||0
10846012|NCT03233217|12012034|FG001|NOT COMPLETED|Overall Study||0
10846013|NCT03233217|12012035|FG002|NOT COMPLETED|Overall Study||0
10846014|NCT03233217|12012036|FG003|NOT COMPLETED|Overall Study||0
10846015|NCT03233217|12012037|FG004|NOT COMPLETED|Overall Study||0
10846016|NCT03219567|12012051|FG000|STARTED|Overall Study||18
10846017|NCT03219567|12012052|FG001|STARTED|Overall Study||64
10846018|NCT03219567|12012051|FG000|COMPLETED|Overall Study||18
10846019|NCT03219567|12012052|FG001|COMPLETED|Overall Study||63
10846020|NCT03219567|12012051|FG000|NOT COMPLETED|Overall Study||0
10846021|NCT03219567|12012052|FG001|NOT COMPLETED|Overall Study||1
10846022|NCT03205358|12012061|FG000|STARTED|Overall Study||94
10846023|NCT03205358|12012062|FG001|STARTED|Overall Study||94
10846024|NCT03205358|12012061|FG000|COMPLETED|Overall Study||94
10846025|NCT03205358|12012062|FG001|COMPLETED|Overall Study||94
10846026|NCT03205358|12012061|FG000|NOT COMPLETED|Overall Study||0
10846027|NCT03205358|12012062|FG001|NOT COMPLETED|Overall Study||0
10846028|NCT03153111|12012070|FG000|STARTED|Overall Study||71
10846029|NCT03153111|12012071|FG001|STARTED|Overall Study||71
10846030|NCT03153111|12012070|FG000|COMPLETED|Overall Study||60
10846031|NCT03153111|12012071|FG001|COMPLETED|Overall Study||62
10846032|NCT03153111|12012070|FG000|NOT COMPLETED|Overall Study||11
10846033|NCT03153111|12012071|FG001|NOT COMPLETED|Overall Study||9
10846034|NCT03073733|12012080|FG000|STARTED|Overall Study||29
10846035|NCT03073733|12012081|FG001|STARTED|Overall Study||27
10846036|NCT03073733|12012082|FG002|STARTED|Overall Study||27
10846037|NCT03073733|12012080|FG000|COMPLETED|Overall Study||28
10846038|NCT03073733|12012081|FG001|COMPLETED|Overall Study||26
10846039|NCT03073733|12012082|FG002|COMPLETED|Overall Study||26
10846040|NCT03073733|12012080|FG000|NOT COMPLETED|Overall Study||1
10846041|NCT03073733|12012081|FG001|NOT COMPLETED|Overall Study||1
10846042|NCT03073733|12012082|FG002|NOT COMPLETED|Overall Study||1
11105438|NCT01253811|12289802|FG000|COMPLETED|Overall Study||5
11105439|NCT01253811|12289802|FG000|NOT COMPLETED|Overall Study||1
11105440|NCT01253824|12289808|FG000|STARTED|Overall Study||7
11105441|NCT01253824|12289809|FG001|STARTED|Overall Study||7
10846047|NCT02749968|12012098|FG000|STARTED|Overall Study||50
10846048|NCT02749968|12012099|FG001|STARTED|Overall Study||50
10846049|NCT02749968|12012098|FG000|Interim Analysis|Overall Study||25
10846050|NCT02749968|12012099|FG001|Interim Analysis|Overall Study||25
10846051|NCT02749968|12012098|FG000|COMPLETED|Overall Study||50
10846052|NCT02749968|12012099|FG001|COMPLETED|Overall Study||50
11105442|NCT01253824|12289808|FG000|COMPLETED|Overall Study||7
11105443|NCT01253824|12289809|FG001|COMPLETED|Overall Study||7
11105444|NCT01253824|12289808|FG000|NOT COMPLETED|Overall Study||0
11105445|NCT01253824|12289809|FG001|NOT COMPLETED|Overall Study||0
11105446|NCT01253902|12289818|FG000|STARTED|Overall Study||56
11105447|NCT01253902|12289819|FG001|STARTED|Overall Study||53
11223889|NCT01982240|12415955|FG002|STARTED|Overall Study||441
10846053|NCT02749968|12012098|FG000|NOT COMPLETED|Overall Study||0
10846054|NCT02749968|12012099|FG001|NOT COMPLETED|Overall Study||0
10846055|NCT02738255|12012107|FG000|STARTED|Overall Study||11
10846056|NCT02738255|12012108|FG001|STARTED|Overall Study||15
10846057|NCT02738255|12012107|FG000|COMPLETED|Overall Study||11
10846058|NCT02738255|12012108|FG001|COMPLETED|Overall Study||14
11105448|NCT01253902|12289820|FG002|STARTED|Overall Study||55
10846059|NCT02738255|12012107|FG000|NOT COMPLETED|Overall Study||0
10846060|NCT02738255|12012108|FG001|NOT COMPLETED|Overall Study||1
10846061|NCT02702414|12012120|FG000|STARTED|Overall Study||105
10846062|NCT02702414|12012121|FG001|STARTED|Overall Study||51
10846063|NCT02702414|12012120|FG000|Treated|Overall Study||104
10846064|NCT02702414|12012121|FG001|Treated|Overall Study||51
10846065|NCT02702414|12012120|FG000|COMPLETED|Overall Study||0
10846066|NCT02702414|12012121|FG001|COMPLETED|Overall Study||0
10846067|NCT02702414|12012120|FG000|NOT COMPLETED|Overall Study||105
10846068|NCT02702414|12012121|FG001|NOT COMPLETED|Overall Study||51
10846069|NCT02605616|12012131|FG000|STARTED|Overall Study||46
10846070|NCT02605616|12012132|FG001|STARTED|Overall Study||47
10846071|NCT02605616|12012131|FG000|COMPLETED|Overall Study||42
10846072|NCT02605616|12012132|FG001|COMPLETED|Overall Study||43
10846073|NCT02605616|12012131|FG000|NOT COMPLETED|Overall Study||4
10846074|NCT02605616|12012132|FG001|NOT COMPLETED|Overall Study||4
10846075|NCT02573233|12012140|FG000|STARTED|Overall Study||22
10846076|NCT02573233|12012141|FG001|STARTED|Overall Study||20
10846077|NCT02573233|12012140|FG000|COMPLETED|Overall Study||22
10846078|NCT02573233|12012141|FG001|COMPLETED|Overall Study||20
10846079|NCT02573233|12012140|FG000|NOT COMPLETED|Overall Study||0
10846080|NCT02573233|12012141|FG001|NOT COMPLETED|Overall Study||0
11105449|NCT01253902|12289818|FG000|COMPLETED|Overall Study||51
11105450|NCT01253902|12289819|FG001|COMPLETED|Overall Study||51
11105451|NCT01253902|12289820|FG002|COMPLETED|Overall Study||51
11105452|NCT01253902|12289818|FG000|NOT COMPLETED|Overall Study||5
11105453|NCT01253902|12289819|FG001|NOT COMPLETED|Overall Study||2
11105454|NCT01253902|12289820|FG002|NOT COMPLETED|Overall Study||4
11105455|NCT01253980|12289830|FG000|STARTED|Overall Study||35
11105456|NCT01253980|12289831|FG001|STARTED|Overall Study||39
10846089|NCT02420795|12012161|FG000|STARTED|Overall Study||4
10846090|NCT02420795|12012162|FG001|STARTED|Overall Study||2
10846091|NCT02420795|12012163|FG002|STARTED|Overall Study||5
10846092|NCT02420795|12012161|FG000|COMPLETED|Overall Study||0
10846093|NCT02420795|12012162|FG001|COMPLETED|Overall Study||0
10846094|NCT02420795|12012163|FG002|COMPLETED|Overall Study||0
10846095|NCT02420795|12012161|FG000|NOT COMPLETED|Overall Study||4
10846096|NCT02420795|12012162|FG001|NOT COMPLETED|Overall Study||2
10846097|NCT02420795|12012163|FG002|NOT COMPLETED|Overall Study||5
10846098|NCT02240485|12012175|FG000|STARTED|3 Months Post-admission||44
10846099|NCT02240485|12012176|FG001|STARTED|3 Months Post-admission||36
10846100|NCT02240485|12012175|FG000|COMPLETED|3 Months Post-admission|Couple modality: 1 couple refused and one gambler refused but his partner continued|41
10846101|NCT02240485|12012176|FG001|COMPLETED|3 Months Post-admission||30
10846102|NCT02240485|12012175|FG000|NOT COMPLETED|3 Months Post-admission||3
10846103|NCT02240485|12012176|FG001|NOT COMPLETED|3 Months Post-admission||6
10846104|NCT02240485|12012175|FG000|STARTED|9 Months Post-admission||41
10846105|NCT02240485|12012176|FG001|STARTED|9 Months Post-admission||30
10846106|NCT02240485|12012175|FG000|COMPLETED|9 Months Post-admission||38
10846107|NCT02240485|12012176|FG001|COMPLETED|9 Months Post-admission|26 couples completed + 1 individual (partner lost)|26
10846108|NCT02240485|12012175|FG000|NOT COMPLETED|9 Months Post-admission||3
10846109|NCT02240485|12012176|FG001|NOT COMPLETED|9 Months Post-admission||4
10846110|NCT02240485|12012175|FG000|STARTED|18 Months Post-admission||38
10846111|NCT02240485|12012176|FG001|STARTED|18 Months Post-admission||26
10846112|NCT02240485|12012175|FG000|COMPLETED|18 Months Post-admission||35
10846113|NCT02240485|12012176|FG001|COMPLETED|18 Months Post-admission||21
10846114|NCT02240485|12012175|FG000|NOT COMPLETED|18 Months Post-admission||3
10846115|NCT02240485|12012176|FG001|NOT COMPLETED|18 Months Post-admission||5
10846116|NCT02227147|12012188|FG000|STARTED|Controlled Treatment Period||24
10846117|NCT02227147|12012189|FG001|STARTED|Controlled Treatment Period||24
10846118|NCT02227147|12012188|FG000|COMPLETED|Controlled Treatment Period||18
10846119|NCT02227147|12012189|FG001|COMPLETED|Controlled Treatment Period||21
10846120|NCT02227147|12012188|FG000|NOT COMPLETED|Controlled Treatment Period||6
10846121|NCT02227147|12012189|FG001|NOT COMPLETED|Controlled Treatment Period||3
10846122|NCT02227147|12012188|FG000|STARTED|Follow-up Period||18
10846123|NCT02227147|12012189|FG001|STARTED|Follow-up Period||21
10846124|NCT02227147|12012188|FG000|COMPLETED|Follow-up Period||15
10846125|NCT02227147|12012189|FG001|COMPLETED|Follow-up Period||16
10846126|NCT02227147|12012188|FG000|NOT COMPLETED|Follow-up Period||3
10846127|NCT02227147|12012189|FG001|NOT COMPLETED|Follow-up Period||5
10846128|NCT02199691|12012203|FG000|STARTED|Overall Study||505
10846129|NCT02199691|12012204|FG001|STARTED|Overall Study||507
10846130|NCT02199691|12012205|FG002|STARTED|Overall Study||403
10846131|NCT02199691|12012206|FG003|STARTED|Overall Study||300
10846132|NCT02199691|12012203|FG000|Safety Analysis Set (SafAS)|Overall Study||503
10846133|NCT02199691|12012204|FG001|Safety Analysis Set (SafAS)|Overall Study||501
10846134|NCT02199691|12012205|FG002|Safety Analysis Set (SafAS)|Overall Study||392
10846135|NCT02199691|12012206|FG003|Safety Analysis Set (SafAS)|Overall Study||296
10846136|NCT02199691|12012203|FG000|COMPLETED|Overall Study||495
10846137|NCT02199691|12012204|FG001|COMPLETED|Overall Study||500
10846138|NCT02199691|12012205|FG002|COMPLETED|Overall Study||376
11105457|NCT01253980|12289830|FG000|COMPLETED|Overall Study||35
11105458|NCT01253980|12289831|FG001|COMPLETED|Overall Study||39
10846139|NCT02199691|12012206|FG003|COMPLETED|Overall Study||270
10846140|NCT02199691|12012203|FG000|NOT COMPLETED|Overall Study||10
10846141|NCT02199691|12012204|FG001|NOT COMPLETED|Overall Study||7
10846142|NCT02199691|12012205|FG002|NOT COMPLETED|Overall Study||27
10846143|NCT02199691|12012206|FG003|NOT COMPLETED|Overall Study||30
10846144|NCT02143726|12012220|FG000|STARTED|Overall Study||18
10846145|NCT02143726|12012221|FG001|STARTED|Overall Study||17
10846146|NCT02143726|12012220|FG000|Received Everolimus After Disease Progression|Overall Study||11
10846147|NCT02143726|12012221|FG001|Received Everolimus After Disease Progression|Overall Study||0
10846148|NCT02143726|12012220|FG000|COMPLETED|Overall Study||16
10846149|NCT02143726|12012221|FG001|COMPLETED|Overall Study||17
10846150|NCT02143726|12012220|FG000|NOT COMPLETED|Overall Study||2
10846151|NCT02143726|12012221|FG001|NOT COMPLETED|Overall Study||0
10846152|NCT02046512|12012229|FG000|STARTED|Overall Study||45
10846153|NCT02046512|12012230|FG001|STARTED|Overall Study||44
10846154|NCT02046512|12012229|FG000|COMPLETED|Overall Study||44
10846155|NCT02046512|12012230|FG001|COMPLETED|Overall Study||44
10846156|NCT02046512|12012229|FG000|NOT COMPLETED|Overall Study||1
10846157|NCT02046512|12012230|FG001|NOT COMPLETED|Overall Study||0
11223890|NCT01982240|12415953|FG000|COMPLETED|Overall Study||385
11223891|NCT01982240|12415954|FG001|COMPLETED|Overall Study||384
11223892|NCT01982240|12415955|FG002|COMPLETED|Overall Study||371
11223893|NCT01982240|12415953|FG000|NOT COMPLETED|Overall Study||67
11223894|NCT01982240|12415954|FG001|NOT COMPLETED|Overall Study||69
11223895|NCT01982240|12415955|FG002|NOT COMPLETED|Overall Study||70
11223896|NCT01982292|12415969|FG000|STARTED|Overall Study|"Started indicates Randomized set"|215
11223897|NCT01982292|12415970|FG001|STARTED|Overall Study||108
11223898|NCT01982292|12415969|FG000|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
11223899|NCT01982292|12415970|FG001|Full Analaysis Set (FAS)|Overall Study||108
11223900|NCT01982292|12415969|FG000|Safety Set|Overall Study||212
11223901|NCT01982292|12415970|FG001|Safety Set|Overall Study||108
11223902|NCT01982292|12415969|FG000|COMPLETED|Overall Study||203
11223903|NCT01982292|12415970|FG001|COMPLETED|Overall Study||107
11223904|NCT01982292|12415969|FG000|NOT COMPLETED|Overall Study||12
11223905|NCT01982292|12415970|FG001|NOT COMPLETED|Overall Study||1
11223906|NCT01982331|12415978|FG000|STARTED|Received Vaccination 1||28
11223907|NCT01982331|12415979|FG001|STARTED|Received Vaccination 1||10
11223908|NCT01982331|12415978|FG000|COMPLETED|Received Vaccination 1||28
11223909|NCT01982331|12415979|FG001|COMPLETED|Received Vaccination 1||10
11223910|NCT01982331|12415978|FG000|NOT COMPLETED|Received Vaccination 1||0
11223911|NCT01982331|12415979|FG001|NOT COMPLETED|Received Vaccination 1||0
11354431|NCT03073200|12551630|FG013|NOT COMPLETED|Open-Label Maintenance Period||0
11354432|NCT03073200|12551631|FG014|NOT COMPLETED|Open-Label Maintenance Period||0
11354433|NCT03073200|12551617|FG000|STARTED|Extension Period||0
11354434|NCT03073200|12551618|FG001|STARTED|Extension Period||0
11354435|NCT03073200|12551619|FG002|STARTED|Extension Period||0
11354436|NCT03073200|12551620|FG003|STARTED|Extension Period|This period is to report Extension Period participants.|0
11354437|NCT03073200|12551621|FG004|STARTED|Extension Period|This period is to report Extension Period participants.|0
11354438|NCT03073200|12551622|FG005|STARTED|Extension Period|This period is to report Extension Period participants.|0
11354439|NCT03073200|12551623|FG006|STARTED|Extension Period|This period is to report Extension Period participants.|34
11354440|NCT03073200|12551624|FG007|STARTED|Extension Period|This period is to report Extension Period participants.|68
10846158|NCT01842035|12012236|FG000|STARTED|Overall Study||90
10846159|NCT01842035|12012236|FG000|COMPLETED|Overall Study||90
10846160|NCT01842035|12012236|FG000|NOT COMPLETED|Overall Study||0
10846161|NCT01751984|12012243|FG000|STARTED|Overall Study||37
10846162|NCT01751984|12012244|FG001|STARTED|Overall Study||19
10846163|NCT01751984|12012243|FG000|COMPLETED|Overall Study||31
10846164|NCT01751984|12012244|FG001|COMPLETED|Overall Study||15
10846165|NCT01751984|12012243|FG000|NOT COMPLETED|Overall Study||6
10846166|NCT01751984|12012244|FG001|NOT COMPLETED|Overall Study||4
10846167|NCT01732627|12012252|FG000|STARTED|Overall Study||201
10846168|NCT01732627|12012253|FG001|STARTED|Overall Study||100
10846169|NCT01732627|12012252|FG000|Safety Analysis Set (SafAS)|Overall Study||199
10846170|NCT01732627|12012253|FG001|Safety Analysis Set (SafAS)|Overall Study||100
10846171|NCT01732627|12012252|FG000|COMPLETED|Overall Study||200
10846172|NCT01732627|12012253|FG001|COMPLETED|Overall Study||100
10846173|NCT01732627|12012252|FG000|NOT COMPLETED|Overall Study||1
10846174|NCT01732627|12012253|FG001|NOT COMPLETED|Overall Study||0
10846175|NCT01702571|12012261|FG000|STARTED|Overall Study||2003
10846176|NCT01702571|12012262|FG001|STARTED|Overall Study||182
10846177|NCT01702571|12012261|FG000|COMPLETED|Overall Study|For one participant, the site incorrectly answered the question 'Did the participant complete follow-up as per protocol?' It was answered No, however the participant was in survival follow-up and the site should have answered Yes. This participant is wrongly counted in the 'discontinued from study' number.|494
10846178|NCT01702571|12012262|FG001|COMPLETED|Overall Study||65
10846179|NCT01702571|12012261|FG000|NOT COMPLETED|Overall Study||1509
10846180|NCT01702571|12012262|FG001|NOT COMPLETED|Overall Study||117
10846181|NCT01578239|12012270|FG000|STARTED|Treatment Period||117
10846182|NCT01578239|12012271|FG001|STARTED|Treatment Period||114
10846183|NCT01578239|12012270|FG000|Full Analysis Set (FAS)|Treatment Period||117
10846184|NCT01578239|12012271|FG001|Full Analysis Set (FAS)|Treatment Period||114
10846185|NCT01578239|12012270|FG000|Safety Analysis Set (SAF)|Treatment Period||111
10846186|NCT01578239|12012271|FG001|Safety Analysis Set (SAF)|Treatment Period||112
10846187|NCT01578239|12012270|FG000|FAS-Entered Long-term Follow-up|Treatment Period||101
10846188|NCT01578239|12012271|FG001|FAS-Entered Long-term Follow-up|Treatment Period||99
10846189|NCT01578239|12012270|FG000|COMPLETED|Treatment Period||50
10846190|NCT01578239|12012271|FG001|COMPLETED|Treatment Period||13
10846191|NCT01578239|12012270|FG000|NOT COMPLETED|Treatment Period||67
10846192|NCT01578239|12012271|FG001|NOT COMPLETED|Treatment Period||101
10846193|NCT01578239|12012270|FG000|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|101
10846194|NCT01578239|12012271|FG001|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|99
10846195|NCT01578239|12012270|FG000|COMPLETED|Long-term Follow-Up Period||24
10846196|NCT01578239|12012271|FG001|COMPLETED|Long-term Follow-Up Period||19
10846197|NCT01578239|12012270|FG000|NOT COMPLETED|Long-term Follow-Up Period||77
10846198|NCT01578239|12012271|FG001|NOT COMPLETED|Long-term Follow-Up Period||80
10846199|NCT01458340|12012280|FG000|STARTED|Overall Study||97
10846200|NCT01458340|12012281|FG001|STARTED|Overall Study||99
10846201|NCT01458340|12012282|FG002|STARTED|Overall Study||99
10846202|NCT01458340|12012280|FG000|Received Study Treatment|Overall Study||97
10846203|NCT01458340|12012281|FG001|Received Study Treatment|Overall Study||98
10846204|NCT01458340|12012282|FG002|Received Study Treatment|Overall Study||98
10846205|NCT01458340|12012280|FG000|COMPLETED|Overall Study||70
10846206|NCT01458340|12012281|FG001|COMPLETED|Overall Study||78
10846207|NCT01458340|12012282|FG002|COMPLETED|Overall Study||76
10846208|NCT01458340|12012280|FG000|NOT COMPLETED|Overall Study||27
10846209|NCT01458340|12012281|FG001|NOT COMPLETED|Overall Study||21
10846210|NCT01458340|12012282|FG002|NOT COMPLETED|Overall Study||23
10846211|NCT01411267|12012300|FG000|STARTED|Overall Study||0
10846212|NCT01411267|12012301|FG001|STARTED|Overall Study||3
10846213|NCT01411267|12012302|FG002|STARTED|Overall Study||2
10846214|NCT01411267|12012303|FG003|STARTED|Overall Study||5
10846215|NCT01411267|12012304|FG004|STARTED|Overall Study||2
10846216|NCT01411267|12012305|FG005|STARTED|Overall Study||12
10846217|NCT01411267|12012306|FG006|STARTED|Overall Study||0
10846218|NCT01411267|12012307|FG007|STARTED|Overall Study||0
10846219|NCT01411267|12012308|FG008|STARTED|Overall Study||0
10846220|NCT01411267|12012309|FG009|STARTED|Overall Study||0
10846221|NCT01411267|12012300|FG000|COMPLETED|Overall Study||0
10846222|NCT01411267|12012301|FG001|COMPLETED|Overall Study||3
10846223|NCT01411267|12012302|FG002|COMPLETED|Overall Study||2
10846224|NCT01411267|12012303|FG003|COMPLETED|Overall Study||4
10846225|NCT01411267|12012304|FG004|COMPLETED|Overall Study||0
10846226|NCT01411267|12012305|FG005|COMPLETED|Overall Study||10
10846227|NCT01411267|12012306|FG006|COMPLETED|Overall Study||0
10846228|NCT01411267|12012307|FG007|COMPLETED|Overall Study||0
10846229|NCT01411267|12012308|FG008|COMPLETED|Overall Study||0
10846230|NCT01411267|12012309|FG009|COMPLETED|Overall Study||0
10846231|NCT01411267|12012300|FG000|NOT COMPLETED|Overall Study||0
10846232|NCT01411267|12012301|FG001|NOT COMPLETED|Overall Study||0
10846233|NCT01411267|12012302|FG002|NOT COMPLETED|Overall Study||0
10846234|NCT01411267|12012303|FG003|NOT COMPLETED|Overall Study||1
10846235|NCT01411267|12012304|FG004|NOT COMPLETED|Overall Study||2
10846236|NCT01411267|12012305|FG005|NOT COMPLETED|Overall Study||2
10846237|NCT01411267|12012306|FG006|NOT COMPLETED|Overall Study||0
10846238|NCT01411267|12012307|FG007|NOT COMPLETED|Overall Study||0
10846239|NCT01411267|12012308|FG008|NOT COMPLETED|Overall Study||0
10846240|NCT01411267|12012309|FG009|NOT COMPLETED|Overall Study||0
10846241|NCT01336634|12012330|FG000|STARTED|Overall Study||84
10846242|NCT01336634|12012331|FG001|STARTED|Overall Study||57
10846243|NCT01336634|12012332|FG002|STARTED|Overall Study|includes 34 subjects from Cohort C and 2 subjects enrolled as protocol deviations from Cohort B.|36
10846244|NCT01336634|12012330|FG000|2nd Line Plus All Treated|Overall Study||78
10846245|NCT01336634|12012331|FG001|2nd Line Plus All Treated|Overall Study||57
10846246|NCT01336634|12012332|FG002|2nd Line Plus All Treated|Overall Study||0
10846247|NCT01336634|12012330|FG000|1st Line All Treated|Overall Study||6
10846248|NCT01336634|12012331|FG001|1st Line All Treated|Overall Study||2
10846249|NCT01336634|12012332|FG002|1st Line All Treated|Overall Study||34
10846250|NCT01336634|12012330|FG000|Crossover|Overall Study||20
10846251|NCT01336634|12012331|FG001|Crossover|Overall Study||0
10846252|NCT01336634|12012332|FG002|Crossover|Overall Study||0
10846253|NCT01336634|12012330|FG000|COMPLETED|Overall Study||70
10846254|NCT01336634|12012331|FG001|COMPLETED|Overall Study||49
10846255|NCT01336634|12012332|FG002|COMPLETED|Overall Study||27
10846256|NCT01336634|12012330|FG000|NOT COMPLETED|Overall Study||14
10846257|NCT01336634|12012331|FG001|NOT COMPLETED|Overall Study||8
10846258|NCT01336634|12012332|FG002|NOT COMPLETED|Overall Study||9
10846259|NCT01155375|12012345|FG000|STARTED|Overall Study||8
10846260|NCT01155375|12012346|FG001|STARTED|Overall Study||6
10846261|NCT01155375|12012345|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10846262|NCT01155375|12012346|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10846263|NCT01155375|12012345|FG000|COMPLETED|Overall Study||7
10846264|NCT01155375|12012346|FG001|COMPLETED|Overall Study||6
10846265|NCT01155375|12012345|FG000|NOT COMPLETED|Overall Study||1
10846266|NCT01155375|12012346|FG001|NOT COMPLETED|Overall Study||0
10846267|NCT00785798|12012353|FG000|STARTED|Overall Study||17
10846268|NCT00785798|12012353|FG000|COMPLETED|Overall Study||16
10846269|NCT00785798|12012353|FG000|NOT COMPLETED|Overall Study||1
10846270|NCT00628095|12012359|FG000|STARTED|Overall Study||53
10846271|NCT00628095|12012360|FG001|STARTED|Overall Study||47
10846272|NCT00628095|12012359|FG000|COMPLETED|Overall Study||46
11105459|NCT01253980|12289830|FG000|NOT COMPLETED|Overall Study||0
11105460|NCT01253980|12289831|FG001|NOT COMPLETED|Overall Study||0
11105461|NCT01254019|12289839|FG000|STARTED|Overall Study||61
11105462|NCT01254019|12289840|FG001|STARTED|Overall Study||125
11105463|NCT01254019|12289839|FG000|COMPLETED|Overall Study||60
11105464|NCT01254019|12289840|FG001|COMPLETED|Overall Study||121
11105465|NCT01254019|12289839|FG000|NOT COMPLETED|Overall Study||1
11105466|NCT01254019|12289840|FG001|NOT COMPLETED|Overall Study||4
11105467|NCT01254045|12289849|FG000|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
11105468|NCT01254045|12289850|FG001|STARTED|First/Baseline (1 Day at Week 1 )||2
11105469|NCT01254045|12289851|FG002|STARTED|First/Baseline (1 Day at Week 1 )||2
11105470|NCT01254045|12289852|FG003|STARTED|First/Baseline (1 Day at Week 1 )||1
11105471|NCT01254045|12289853|FG004|STARTED|First/Baseline (1 Day at Week 1 )||1
11105472|NCT01254045|12289854|FG005|STARTED|First/Baseline (1 Day at Week 1 )||1
11105473|NCT01254045|12289849|FG000|COMPLETED|First/Baseline (1 Day at Week 1 )||1
11105474|NCT01254045|12289850|FG001|COMPLETED|First/Baseline (1 Day at Week 1 )||2
11105475|NCT01254045|12289851|FG002|COMPLETED|First/Baseline (1 Day at Week 1 )||2
11105476|NCT01254045|12289852|FG003|COMPLETED|First/Baseline (1 Day at Week 1 )||1
11105477|NCT01254045|12289853|FG004|COMPLETED|First/Baseline (1 Day at Week 1 )||1
11105478|NCT01254045|12289854|FG005|COMPLETED|First/Baseline (1 Day at Week 1 )||1
11105479|NCT01254045|12289849|FG000|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
11105480|NCT01254045|12289850|FG001|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
11105481|NCT01254045|12289851|FG002|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
11105482|NCT01254045|12289852|FG003|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
11105483|NCT01254045|12289853|FG004|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
11105484|NCT01254045|12289854|FG005|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
11105485|NCT01254045|12289849|FG000|STARTED|Second/Time 2 (1 Day at Week 2)||1
11105486|NCT01254045|12289850|FG001|STARTED|Second/Time 2 (1 Day at Week 2)||2
11223912|NCT01982331|12415978|FG000|STARTED|Received Vaccination 2||28
11223913|NCT01982331|12415979|FG001|STARTED|Received Vaccination 2||10
11223914|NCT01982331|12415978|FG000|COMPLETED|Received Vaccination 2||27
11223915|NCT01982331|12415979|FG001|COMPLETED|Received Vaccination 2||7
11223916|NCT01982331|12415978|FG000|NOT COMPLETED|Received Vaccination 2||1
11223917|NCT01982331|12415979|FG001|NOT COMPLETED|Received Vaccination 2||3
11223918|NCT01982331|12415978|FG000|STARTED|Completed Study (Day 112)||27
11223919|NCT01982331|12415979|FG001|STARTED|Completed Study (Day 112)||7
10846273|NCT00628095|12012360|FG001|COMPLETED|Overall Study||40
10846274|NCT00628095|12012359|FG000|NOT COMPLETED|Overall Study||7
10846275|NCT00628095|12012360|FG001|NOT COMPLETED|Overall Study||7
10846276|NCT04246021|12012368|FG000|STARTED|Overall Study||84
10846277|NCT04246021|12012368|FG000|COMPLETED|Overall Study||84
10846278|NCT04246021|12012368|FG000|NOT COMPLETED|Overall Study||0
10846279|NCT04098497|12012382|FG000|STARTED|Overall Study||30
10846280|NCT04098497|12012382|FG000|Initial Interview|Overall Study||30
10846281|NCT04098497|12012382|FG000|Set Up Study App|Overall Study||29
10846282|NCT04098497|12012382|FG000|Logged Symptoms Into Study App at Least Once|Overall Study||26
10846283|NCT04098497|12012382|FG000|Linked Fitbit to Study Database|Overall Study||27
10846284|NCT04098497|12012382|FG000|Used Fitbit|Overall Study||24
10846285|NCT04098497|12012382|FG000|Exit Interview|Overall Study||29
10846286|NCT04098497|12012382|FG000|COMPLETED|Overall Study||30
10846287|NCT04098497|12012382|FG000|NOT COMPLETED|Overall Study||0
11223920|NCT01982331|12415978|FG000|COMPLETED|Completed Study (Day 112)||25
11354441|NCT03073200|12551625|FG008|STARTED|Extension Period|This period is to report Extension Period participants.|9
11354442|NCT03073200|12551626|FG009|STARTED|Extension Period||0
11354443|NCT03073200|12551627|FG010|STARTED|Extension Period||0
11354444|NCT03073200|12551628|FG011|STARTED|Extension Period||0
11354445|NCT03073200|12551629|FG012|STARTED|Extension Period||0
11354446|NCT03073200|12551630|FG013|STARTED|Extension Period||0
11354447|NCT03073200|12551631|FG014|STARTED|Extension Period||0
11354448|NCT03073200|12551617|FG000|COMPLETED|Extension Period||0
11354449|NCT03073200|12551618|FG001|COMPLETED|Extension Period||0
11354450|NCT03073200|12551619|FG002|COMPLETED|Extension Period||0
11354451|NCT03073200|12551620|FG003|COMPLETED|Extension Period||0
11354452|NCT03073200|12551621|FG004|COMPLETED|Extension Period||0
11354453|NCT03073200|12551622|FG005|COMPLETED|Extension Period||0
11354454|NCT03073200|12551623|FG006|COMPLETED|Extension Period||31
11354455|NCT03073200|12551624|FG007|COMPLETED|Extension Period||62
11354456|NCT03073200|12551625|FG008|COMPLETED|Extension Period||7
11354457|NCT03073200|12551626|FG009|COMPLETED|Extension Period||0
11354458|NCT03073200|12551627|FG010|COMPLETED|Extension Period||0
11354459|NCT03073200|12551628|FG011|COMPLETED|Extension Period||0
11354460|NCT03073200|12551629|FG012|COMPLETED|Extension Period||0
11354461|NCT03073200|12551630|FG013|COMPLETED|Extension Period||0
10846288|NCT03945825|12012392|FG000|STARTED|Overall Study||41
10846289|NCT03945825|12012393|FG001|STARTED|Overall Study||37
10846290|NCT03945825|12012394|FG002|STARTED|Overall Study||40
10846291|NCT03945825|12012395|FG003|STARTED|Overall Study||41
10846292|NCT03945825|12012396|FG004|STARTED|Overall Study||39
10846293|NCT03945825|12012397|FG005|STARTED|Overall Study||43
10846294|NCT03945825|12012392|FG000|COMPLETED|Overall Study||39
10846295|NCT03945825|12012393|FG001|COMPLETED|Overall Study||32
10846296|NCT03945825|12012394|FG002|COMPLETED|Overall Study||39
10846297|NCT03945825|12012395|FG003|COMPLETED|Overall Study||39
10846298|NCT03945825|12012396|FG004|COMPLETED|Overall Study||36
10846299|NCT03945825|12012397|FG005|COMPLETED|Overall Study||40
10846300|NCT03945825|12012392|FG000|NOT COMPLETED|Overall Study||2
10846301|NCT03945825|12012393|FG001|NOT COMPLETED|Overall Study||5
10846302|NCT03945825|12012394|FG002|NOT COMPLETED|Overall Study||1
10846303|NCT03945825|12012395|FG003|NOT COMPLETED|Overall Study||2
10846304|NCT03945825|12012396|FG004|NOT COMPLETED|Overall Study||3
10846305|NCT03945825|12012397|FG005|NOT COMPLETED|Overall Study||3
10846306|NCT03937141|12012420|FG000|STARTED|Overall Study||16
10846307|NCT03937141|12012420|FG000|COMPLETED|Overall Study||16
10846308|NCT03937141|12012420|FG000|NOT COMPLETED|Overall Study||0
10846309|NCT03678402|12012424|FG000|STARTED|Overall Study||521
10846310|NCT03678402|12012424|FG000|COMPLETED|Overall Study||521
10846311|NCT03678402|12012424|FG000|NOT COMPLETED|Overall Study||0
10846312|NCT03641937|12012428|FG000|STARTED|Overall Study||10
10846313|NCT03641937|12012428|FG000|COMPLETED|Overall Study||10
10846314|NCT03641937|12012428|FG000|NOT COMPLETED|Overall Study||0
10846315|NCT03572244|12012434|FG000|STARTED|Overall Study||6
10846316|NCT03572244|12012435|FG001|STARTED|Overall Study||6
10846317|NCT03572244|12012434|FG000|COMPLETED|Overall Study||6
10846318|NCT03572244|12012435|FG001|COMPLETED|Overall Study||6
10846319|NCT03572244|12012434|FG000|NOT COMPLETED|Overall Study||0
10846320|NCT03572244|12012435|FG001|NOT COMPLETED|Overall Study||0
10846321|NCT03562767|12012444|FG000|STARTED|Overall Study||10
10846322|NCT03562767|12012445|FG001|STARTED|Overall Study||10
10846323|NCT03562767|12012446|FG002|STARTED|Overall Study||0
10846324|NCT03562767|12012444|FG000|COMPLETED|Overall Study||7
10846325|NCT03562767|12012445|FG001|COMPLETED|Overall Study||7
10846326|NCT03562767|12012446|FG002|COMPLETED|Overall Study||0
10846327|NCT03562767|12012444|FG000|NOT COMPLETED|Overall Study||3
10846328|NCT03562767|12012445|FG001|NOT COMPLETED|Overall Study||3
10846329|NCT03562767|12012446|FG002|NOT COMPLETED|Overall Study||0
10846330|NCT03559699|12012458|FG000|STARTED|Overall Study||27
10846331|NCT03559699|12012458|FG000|COMPLETED|Overall Study||20
10846332|NCT03559699|12012458|FG000|NOT COMPLETED|Overall Study||7
10846333|NCT03333057|12012465|FG000|STARTED|Overall Study||111
10846334|NCT03333057|12012466|FG001|STARTED|Overall Study||114
10846335|NCT03333057|12012467|FG002|STARTED|Overall Study||111
10846336|NCT03333057|12012465|FG000|COMPLETED|Overall Study||105
10846337|NCT03333057|12012466|FG001|COMPLETED|Overall Study||110
10846338|NCT03333057|12012467|FG002|COMPLETED|Overall Study||108
10846339|NCT03333057|12012465|FG000|NOT COMPLETED|Overall Study||6
10846340|NCT03333057|12012466|FG001|NOT COMPLETED|Overall Study||4
10846341|NCT03333057|12012467|FG002|NOT COMPLETED|Overall Study||3
10846342|NCT03305016|12012475|FG000|STARTED|Overall Study||146
10846343|NCT03305016|12012475|FG000|COMPLETED|Overall Study||144
10846344|NCT03305016|12012475|FG000|NOT COMPLETED|Overall Study||2
10846345|NCT03300336|12012481|FG000|STARTED|Overall Study||7267
10846346|NCT03300336|12012482|FG001|STARTED|Overall Study||6859
10846347|NCT03300336|12012481|FG000|COMPLETED|Overall Study||7267
10846348|NCT03300336|12012482|FG001|COMPLETED|Overall Study||6859
10846349|NCT03300336|12012481|FG000|NOT COMPLETED|Overall Study||0
10846350|NCT03300336|12012482|FG001|NOT COMPLETED|Overall Study||0
10846351|NCT03291067|12012492|FG000|STARTED|Overall Study||94
10846352|NCT03291067|12012493|FG001|STARTED|Overall Study||92
10846353|NCT03291067|12012494|FG002|STARTED|Overall Study||94
10846354|NCT03291067|12012495|FG003|STARTED|Overall Study||94
10846355|NCT03291067|12012492|FG000|Treated|Overall Study||95
10846356|NCT03291067|12012493|FG001|Treated|Overall Study||90
10846357|NCT03291067|12012494|FG002|Treated|Overall Study||93
10846358|NCT03291067|12012495|FG003|Treated|Overall Study||90
11105487|NCT01254045|12289851|FG002|STARTED|Second/Time 2 (1 Day at Week 2)||2
10846359|NCT03291067|12012492|FG000|COMPLETED|Overall Study||84
10846360|NCT03291067|12012493|FG001|COMPLETED|Overall Study||78
10846361|NCT03291067|12012494|FG002|COMPLETED|Overall Study||61
10846362|NCT03291067|12012495|FG003|COMPLETED|Overall Study||77
10846363|NCT03291067|12012492|FG000|NOT COMPLETED|Overall Study||10
10846364|NCT03291067|12012493|FG001|NOT COMPLETED|Overall Study||14
10846365|NCT03291067|12012494|FG002|NOT COMPLETED|Overall Study||33
11105488|NCT01254045|12289852|FG003|STARTED|Second/Time 2 (1 Day at Week 2)||1
10846366|NCT03291067|12012495|FG003|NOT COMPLETED|Overall Study||17
10846367|NCT03271047|12012509|FG000|STARTED|Phase 1b: Dose Finding Period||10
10846368|NCT03271047|12012510|FG001|STARTED|Phase 1b: Dose Finding Period||11
10846369|NCT03271047|12012511|FG002|STARTED|Phase 1b: Dose Finding Period||0
10846370|NCT03271047|12012512|FG003|STARTED|Phase 1b: Dose Finding Period||0
10846371|NCT03271047|12012509|FG000|COMPLETED|Phase 1b: Dose Finding Period||0
10846372|NCT03271047|12012510|FG001|COMPLETED|Phase 1b: Dose Finding Period||0
10846373|NCT03271047|12012511|FG002|COMPLETED|Phase 1b: Dose Finding Period||0
10846374|NCT03271047|12012512|FG003|COMPLETED|Phase 1b: Dose Finding Period||0
10846375|NCT03271047|12012509|FG000|NOT COMPLETED|Phase 1b: Dose Finding Period||10
10846376|NCT03271047|12012510|FG001|NOT COMPLETED|Phase 1b: Dose Finding Period||11
10846377|NCT03271047|12012511|FG002|NOT COMPLETED|Phase 1b: Dose Finding Period||0
10846378|NCT03271047|12012512|FG003|NOT COMPLETED|Phase 1b: Dose Finding Period||0
10846379|NCT03271047|12012509|FG000|STARTED|Randomized Phase 2 Period||0
10846380|NCT03271047|12012510|FG001|STARTED|Randomized Phase 2 Period||0
10846381|NCT03271047|12012511|FG002|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27
10846382|NCT03271047|12012512|FG003|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27
10846383|NCT03271047|12012509|FG000|COMPLETED|Randomized Phase 2 Period||0
10846384|NCT03271047|12012510|FG001|COMPLETED|Randomized Phase 2 Period||0
10846385|NCT03271047|12012511|FG002|COMPLETED|Randomized Phase 2 Period||0
10846386|NCT03271047|12012512|FG003|COMPLETED|Randomized Phase 2 Period||0
10846387|NCT03271047|12012509|FG000|NOT COMPLETED|Randomized Phase 2 Period||0
10846388|NCT03271047|12012510|FG001|NOT COMPLETED|Randomized Phase 2 Period||0
10846389|NCT03271047|12012511|FG002|NOT COMPLETED|Randomized Phase 2 Period||27
10846390|NCT03271047|12012512|FG003|NOT COMPLETED|Randomized Phase 2 Period||27
10846391|NCT03257436|12012524|FG000|STARTED|Overall Study||584
10846392|NCT03257436|12012524|FG000|COMPLETED|Overall Study||489
10846393|NCT03257436|12012524|FG000|NOT COMPLETED|Overall Study||95
10846394|NCT03171480|12012530|FG000|STARTED|Overall Study||89
10846395|NCT03171480|12012531|FG001|STARTED|Overall Study||87
10846396|NCT03171480|12012530|FG000|COMPLETED|Overall Study||89
10846397|NCT03171480|12012531|FG001|COMPLETED|Overall Study||87
10846398|NCT03171480|12012530|FG000|NOT COMPLETED|Overall Study||0
10846399|NCT03171480|12012531|FG001|NOT COMPLETED|Overall Study||0
10846400|NCT03158285|12012541|FG000|STARTED|Placebo-controlled Period: Week 0 - 24||246
10846401|NCT03158285|12012542|FG001|STARTED|Placebo-controlled Period: Week 0 - 24||248
10846402|NCT03158285|12012543|FG002|STARTED|Placebo-controlled Period: Week 0 - 24||245
10846403|NCT03158285|12012541|FG000|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (255) = 77 (CNTO1959PSA3001[NCT03162796]) + 178 (CNTO1959PSA3002)|255
10846404|NCT03158285|12012542|FG001|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (230)= 72 (CNTO1959PSA3001) + 158 (CNTO1959PSA3002)|230
10846405|NCT03158285|12012543|FG002|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (243)= 73 (CNTO1959PSA3001) + 170 (CNTO1959PSA3002)|243
10846406|NCT03158285|12012541|FG000|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (154) = 55 (CNTO1959PSA3001) + 99 (CNTO1959PSA3002)|154
10846407|NCT03158285|12012542|FG001|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (160) = 49 (CNTO1959PSA3001) + 111 (CNTO1959PSA3002)|160
10846408|NCT03158285|12012543|FG002|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (159) = 38 (CNTO1959PSA3001) + 121 (CNTO1959PSA3002)|159
10846409|NCT03158285|12012541|FG000|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
10846410|NCT03158285|12012542|FG001|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
10846411|NCT03158285|12012543|FG002|COMPLETED|Placebo-controlled Period: Week 0 - 24||236
10846412|NCT03158285|12012541|FG000|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||6
10846413|NCT03158285|12012542|FG001|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||8
10846414|NCT03158285|12012543|FG002|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||9
10846415|NCT03158285|12012541|FG000|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|238
10846416|NCT03158285|12012542|FG001|STARTED|Active Treatment Period: Week 24 - 52||240
10846417|NCT03158285|12012543|FG002|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|234
10846418|NCT03158285|12012541|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||228
10846419|NCT03158285|12012542|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||234
10846420|NCT03158285|12012543|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||227
10846421|NCT03158285|12012541|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||10
10846422|NCT03158285|12012542|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||6
10846423|NCT03158285|12012543|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
10846424|NCT03158285|12012541|FG000|STARTED|Active Treatment Period: Week 52-100||228
10846425|NCT03158285|12012542|FG001|STARTED|Active Treatment Period: Week 52-100|2 participants did not enter the active treatment.|232
10846426|NCT03158285|12012543|FG002|STARTED|Active Treatment Period: Week 52-100||227
10846427|NCT03158285|12012541|FG000|COMPLETED|Active Treatment Period: Week 52-100||210
10846428|NCT03158285|12012542|FG001|COMPLETED|Active Treatment Period: Week 52-100||223
10846429|NCT03158285|12012543|FG002|COMPLETED|Active Treatment Period: Week 52-100||219
11223921|NCT01982331|12415979|FG001|COMPLETED|Completed Study (Day 112)||7
11223922|NCT01982331|12415978|FG000|NOT COMPLETED|Completed Study (Day 112)||2
11223923|NCT01982331|12415979|FG001|NOT COMPLETED|Completed Study (Day 112)||0
11223924|NCT01982435|12415987|FG000|STARTED|Overall Study||15
11223925|NCT01982435|12415988|FG001|STARTED|Overall Study||12
11223926|NCT01982435|12415987|FG000|COMPLETED|Overall Study||14
11223927|NCT01982435|12415988|FG001|COMPLETED|Overall Study||12
11223928|NCT01982435|12415987|FG000|NOT COMPLETED|Overall Study||1
11223929|NCT01982435|12415988|FG001|NOT COMPLETED|Overall Study||0
11223930|NCT01982539|12415994|FG000|STARTED|Overall Study||25
11223931|NCT01982539|12415994|FG000|COMPLETED|Overall Study||25
11223932|NCT01982539|12415994|FG000|NOT COMPLETED|Overall Study||0
11223933|NCT01982643|12415998|FG000|STARTED|Overall Study||49
11223934|NCT01982643|12415998|FG000|COMPLETED|Overall Study||37
10846430|NCT03158285|12012541|FG000|NOT COMPLETED|Active Treatment Period: Week 52-100||18
10846431|NCT03158285|12012542|FG001|NOT COMPLETED|Active Treatment Period: Week 52-100||9
10846432|NCT03158285|12012543|FG002|NOT COMPLETED|Active Treatment Period: Week 52-100||8
11223935|NCT01982643|12415998|FG000|NOT COMPLETED|Overall Study||12
11223936|NCT01982682|12416002|FG000|STARTED|Overall Study||41
11223937|NCT01982682|12416002|FG000|COMPLETED|Overall Study||40
11223938|NCT01982682|12416002|FG000|NOT COMPLETED|Overall Study||1
11223939|NCT01982695|12416009|FG000|STARTED|Overall Study||12
10846433|NCT04723173|12012556|FG000|STARTED|Measure of Detection Threshold (in dB)||10
10846434|NCT04723173|12012556|FG000|Feature for Soft Sounds On|Measure of Detection Threshold (in dB)||10
10846435|NCT04723173|12012556|FG000|Feature for Soft Sounds Off|Measure of Detection Threshold (in dB)||10
10846436|NCT04723173|12012556|FG000|COMPLETED|Measure of Detection Threshold (in dB)||10
10846437|NCT04723173|12012556|FG000|NOT COMPLETED|Measure of Detection Threshold (in dB)||0
10846438|NCT04723173|12012556|FG000|STARTED|Subjective Listening Effort Scaling|The test in this test period is independent (also temporally) from the previous test period. That is the reason, why the number of participants, who started this test period is lesser than the number of participants, who completed the previous period.|9
10846439|NCT04723173|12012556|FG000|DNC on|Subjective Listening Effort Scaling||9
10846440|NCT04723173|12012556|FG000|DNC Off|Subjective Listening Effort Scaling||9
10846441|NCT04723173|12012556|FG000|COMPLETED|Subjective Listening Effort Scaling||8
10846442|NCT04723173|12012556|FG000|NOT COMPLETED|Subjective Listening Effort Scaling||1
10846443|NCT04723173|12012556|FG000|STARTED|Subjective Ratings of Sound Samples|The test in this test period is independent (also temporal) from the previous test period. That is the reason, why the number of participants, who started this test period is greater than the number of participants, who completed the previous period.|9
10846444|NCT04723173|12012556|FG000|DNC on|Subjective Ratings of Sound Samples||9
10846445|NCT04723173|12012556|FG000|DNC Off|Subjective Ratings of Sound Samples||9
10846446|NCT04723173|12012556|FG000|COMPLETED|Subjective Ratings of Sound Samples|"All participants completed this study period, but just the results of 8 participants could be used.~This was because technical issues limited the reliability of the measures made for one participant.~N.B. this test was independent from the other tests in the study. Therefore the results are not influenced by other test periods. The number of people included in the analysis described here relates only to this test."|9
10846447|NCT04723173|12012556|FG000|NOT COMPLETED|Subjective Ratings of Sound Samples||0
10846448|NCT04552470|12012572|FG000|STARTED|Overall Study||9
10846449|NCT04552470|12012573|FG001|STARTED|Overall Study||10
10846450|NCT04552470|12012574|FG002|STARTED|Overall Study||9
10846451|NCT04552470|12012575|FG003|STARTED|Overall Study||9
10846452|NCT04552470|12012572|FG000|COMPLETED|Overall Study||9
10846453|NCT04552470|12012573|FG001|COMPLETED|Overall Study||10
10846454|NCT04552470|12012574|FG002|COMPLETED|Overall Study||9
10846455|NCT04552470|12012575|FG003|COMPLETED|Overall Study||9
10846456|NCT04552470|12012572|FG000|NOT COMPLETED|Overall Study||0
10846457|NCT04552470|12012573|FG001|NOT COMPLETED|Overall Study||0
10846458|NCT04552470|12012574|FG002|NOT COMPLETED|Overall Study||0
10846459|NCT04552470|12012575|FG003|NOT COMPLETED|Overall Study||0
10846460|NCT04251884|12012590|FG000|STARTED|Overall Study||23
10846461|NCT04251884|12012591|FG001|STARTED|Overall Study||26
10846462|NCT04251884|12012590|FG000|COMPLETED|Overall Study||23
10846463|NCT04251884|12012591|FG001|COMPLETED|Overall Study||26
10846464|NCT04251884|12012590|FG000|NOT COMPLETED|Overall Study||0
10846465|NCT04251884|12012591|FG001|NOT COMPLETED|Overall Study||0
10846466|NCT03683823|12012600|FG000|STARTED|Post-treatment Assessment||11
10846467|NCT03683823|12012601|FG001|STARTED|Post-treatment Assessment||10
10846468|NCT03683823|12012600|FG000|COMPLETED|Post-treatment Assessment||10
10846469|NCT03683823|12012601|FG001|COMPLETED|Post-treatment Assessment||8
10846470|NCT03683823|12012600|FG000|NOT COMPLETED|Post-treatment Assessment||1
10846471|NCT03683823|12012601|FG001|NOT COMPLETED|Post-treatment Assessment||2
10846472|NCT03683823|12012600|FG000|STARTED|1-week Follow-up||10
10846473|NCT03683823|12012601|FG001|STARTED|1-week Follow-up||8
10846474|NCT03683823|12012600|FG000|COMPLETED|1-week Follow-up||9
10846475|NCT03683823|12012601|FG001|COMPLETED|1-week Follow-up||7
10846476|NCT03683823|12012600|FG000|NOT COMPLETED|1-week Follow-up||1
10846477|NCT03683823|12012601|FG001|NOT COMPLETED|1-week Follow-up||1
10846478|NCT03546439|12012610|FG000|STARTED|Overall Study||203
10846479|NCT03546439|12012611|FG001|STARTED|Overall Study||156
10846480|NCT03546439|12012612|FG002|STARTED|Overall Study||75
10846481|NCT03546439|12012610|FG000|COMPLETED|Overall Study||203
10846482|NCT03546439|12012611|FG001|COMPLETED|Overall Study||156
10846483|NCT03546439|12012612|FG002|COMPLETED|Overall Study||75
10846484|NCT03546439|12012610|FG000|NOT COMPLETED|Overall Study||0
10846485|NCT03546439|12012611|FG001|NOT COMPLETED|Overall Study||0
10846486|NCT03546439|12012612|FG002|NOT COMPLETED|Overall Study||0
10846487|NCT03515551|12012627|FG000|STARTED|Overall Study||4
10846488|NCT03515551|12012628|FG001|STARTED|Overall Study||3
10846489|NCT03515551|12012629|FG002|STARTED|Overall Study||5
10846490|NCT03515551|12012630|FG003|STARTED|Overall Study||3
10846491|NCT03515551|12012631|FG004|STARTED|Overall Study|1 participant from the 10 mcg cohort was sequentially enrolled in the 30-100 mcg cohort and is counted as starting in both columns; reason for study discontinuation recorded as part of 30-100 mcg cohort.|5
10846492|NCT03515551|12012632|FG005|STARTED|Overall Study||4
10846493|NCT03515551|12012633|FG006|STARTED|Overall Study||5
10846494|NCT03515551|12012627|FG000|COMPLETED|Overall Study||0
10846495|NCT03515551|12012628|FG001|COMPLETED|Overall Study||0
10846496|NCT03515551|12012629|FG002|COMPLETED|Overall Study||0
10846497|NCT03515551|12012630|FG003|COMPLETED|Overall Study||0
10846498|NCT03515551|12012631|FG004|COMPLETED|Overall Study||0
10846499|NCT03515551|12012632|FG005|COMPLETED|Overall Study||0
10846500|NCT03515551|12012633|FG006|COMPLETED|Overall Study||0
10846501|NCT03515551|12012627|FG000|NOT COMPLETED|Overall Study||4
10846502|NCT03515551|12012628|FG001|NOT COMPLETED|Overall Study||3
10846503|NCT03515551|12012629|FG002|NOT COMPLETED|Overall Study||5
10846504|NCT03515551|12012630|FG003|NOT COMPLETED|Overall Study||3
10846505|NCT03515551|12012631|FG004|NOT COMPLETED|Overall Study||5
11223940|NCT01982695|12416010|FG001|STARTED|Overall Study||11
10846506|NCT03515551|12012632|FG005|NOT COMPLETED|Overall Study||4
11223941|NCT01982695|12416009|FG000|COMPLETED|Overall Study||12
10846507|NCT03515551|12012633|FG006|NOT COMPLETED|Overall Study||5
10846508|NCT03385265|12012658|FG000|STARTED|Overall Study||20
10846509|NCT03385265|12012659|FG001|STARTED|Overall Study||11
10846510|NCT03385265|12012660|FG002|STARTED|Overall Study||20
10846511|NCT03385265|12012661|FG003|STARTED|Overall Study||11
10846512|NCT03385265|12012658|FG000|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|15
10846513|NCT03385265|12012659|FG001|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|9
10846514|NCT03385265|12012660|FG002|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|15
10846515|NCT03385265|12012661|FG003|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|9
10846516|NCT03385265|12012658|FG000|NOT COMPLETED|Overall Study||5
10846517|NCT03385265|12012659|FG001|NOT COMPLETED|Overall Study||2
10846518|NCT03385265|12012660|FG002|NOT COMPLETED|Overall Study||5
10846519|NCT03385265|12012661|FG003|NOT COMPLETED|Overall Study||2
10846520|NCT03316807|12012675|FG000|STARTED|Overall Study||91
10846521|NCT03316807|12012676|FG001|STARTED|Overall Study||91
10846522|NCT03316807|12012675|FG000|COMPLETED|Overall Study||60
10846523|NCT03316807|12012676|FG001|COMPLETED|Overall Study||65
10846524|NCT03316807|12012675|FG000|NOT COMPLETED|Overall Study||31
10846525|NCT03316807|12012676|FG001|NOT COMPLETED|Overall Study||26
10846526|NCT03138538|12012688|FG000|STARTED|Overall Study||3
10846527|NCT03138538|12012689|FG001|STARTED|Overall Study||3
10846528|NCT03138538|12012690|FG002|STARTED|Overall Study||3
10846529|NCT03138538|12012691|FG003|STARTED|Overall Study||8
10846530|NCT03138538|12012692|FG004|STARTED|Overall Study||7
10846531|NCT03138538|12012693|FG005|STARTED|Overall Study||3
10846532|NCT03138538|12012688|FG000|COMPLETED|Overall Study||3
10846533|NCT03138538|12012689|FG001|COMPLETED|Overall Study||3
10846534|NCT03138538|12012690|FG002|COMPLETED|Overall Study||3
10846535|NCT03138538|12012691|FG003|COMPLETED|Overall Study||8
10846536|NCT03138538|12012692|FG004|COMPLETED|Overall Study||7
10846537|NCT03138538|12012693|FG005|COMPLETED|Overall Study||3
10846538|NCT03138538|12012688|FG000|NOT COMPLETED|Overall Study||0
10846539|NCT03138538|12012689|FG001|NOT COMPLETED|Overall Study||0
10846540|NCT03138538|12012690|FG002|NOT COMPLETED|Overall Study||0
10846541|NCT03138538|12012691|FG003|NOT COMPLETED|Overall Study||0
10846542|NCT03138538|12012692|FG004|NOT COMPLETED|Overall Study||0
10846543|NCT03138538|12012693|FG005|NOT COMPLETED|Overall Study||0
10846544|NCT02919306|12012714|FG000|STARTED|Overall Study||18
10846545|NCT02919306|12012715|FG001|STARTED|Overall Study||9
10846546|NCT02919306|12012714|FG000|COMPLETED|Overall Study||16
10846547|NCT02919306|12012715|FG001|COMPLETED|Overall Study||9
10846548|NCT02919306|12012714|FG000|NOT COMPLETED|Overall Study||2
10846549|NCT02919306|12012715|FG001|NOT COMPLETED|Overall Study||0
10846550|NCT02763189|12012723|FG000|STARTED|Overall Study||4
11223942|NCT01982695|12416010|FG001|COMPLETED|Overall Study||10
11223943|NCT01982695|12416009|FG000|NOT COMPLETED|Overall Study||0
11223944|NCT01982695|12416010|FG001|NOT COMPLETED|Overall Study||1
11223945|NCT01982773|12416018|FG000|STARTED|Overall Study||58
11223946|NCT01982773|12416019|FG001|STARTED|Overall Study||60
11223947|NCT01982773|12416018|FG000|COMPLETED|Overall Study||50
11223948|NCT01982773|12416019|FG001|COMPLETED|Overall Study||56
11223949|NCT01982773|12416018|FG000|NOT COMPLETED|Overall Study||8
11223950|NCT01982773|12416019|FG001|NOT COMPLETED|Overall Study||4
11223951|NCT01982786|12416027|FG000|STARTED|Overall Study||29
11223952|NCT01982786|12416028|FG001|STARTED|Overall Study||28
11223953|NCT01982786|12416027|FG000|COMPLETED|Overall Study||29
11223954|NCT01982786|12416028|FG001|COMPLETED|Overall Study||28
11223955|NCT01982786|12416027|FG000|NOT COMPLETED|Overall Study||0
11223956|NCT01982786|12416028|FG001|NOT COMPLETED|Overall Study||0
11223957|NCT01982812|12416036|FG000|STARTED|Overall Study||23
11223958|NCT01982812|12416037|FG001|STARTED|Overall Study||21
11223959|NCT01982812|12416036|FG000|COMPLETED|Overall Study||22
11223960|NCT01982812|12416037|FG001|COMPLETED|Overall Study||11
11223961|NCT01982812|12416036|FG000|NOT COMPLETED|Overall Study||1
11223962|NCT01982812|12416037|FG001|NOT COMPLETED|Overall Study||10
11223963|NCT01982942|12416045|FG000|STARTED|Overall Study||129
11223964|NCT01982942|12416046|FG001|STARTED|Overall Study||126
11223965|NCT01982942|12416045|FG000|COMPLETED|Overall Study||108
11223966|NCT01982942|12416046|FG001|COMPLETED|Overall Study||112
11223967|NCT01982942|12416045|FG000|NOT COMPLETED|Overall Study||21
11223968|NCT01982942|12416046|FG001|NOT COMPLETED|Overall Study||14
11223969|NCT01982968|12416054|FG000|STARTED|Overall Study||29
11223970|NCT01982968|12416055|FG001|STARTED|Overall Study||29
11223971|NCT01982968|12416054|FG000|COMPLETED|Overall Study||21
11223972|NCT01982968|12416055|FG001|COMPLETED|Overall Study||27
11223973|NCT01982968|12416054|FG000|NOT COMPLETED|Overall Study||8
11223974|NCT01982968|12416055|FG001|NOT COMPLETED|Overall Study||2
11223975|NCT01983020|12416065|FG000|STARTED|Overall Study||12
11223976|NCT01983020|12416066|FG001|STARTED|Overall Study||11
11223977|NCT01983020|12416067|FG002|STARTED|Overall Study||12
11223978|NCT01983020|12416068|FG003|STARTED|Overall Study||11
11223979|NCT01983020|12416065|FG000|COMPLETED|Overall Study||12
11223980|NCT01983020|12416066|FG001|COMPLETED|Overall Study||11
11223981|NCT01983020|12416067|FG002|COMPLETED|Overall Study||12
11223982|NCT01983020|12416068|FG003|COMPLETED|Overall Study||11
10846551|NCT02763189|12012724|FG001|STARTED|Overall Study||4
10846552|NCT02763189|12012723|FG000|COMPLETED|Overall Study||4
10846553|NCT02763189|12012724|FG001|COMPLETED|Overall Study||2
10846554|NCT02763189|12012723|FG000|NOT COMPLETED|Overall Study||0
10846555|NCT02763189|12012724|FG001|NOT COMPLETED|Overall Study||2
11223983|NCT01983020|12416065|FG000|NOT COMPLETED|Overall Study||0
11223984|NCT01983020|12416066|FG001|NOT COMPLETED|Overall Study||0
10846556|NCT02700945|12012732|FG000|STARTED|Overall Study||242
11223985|NCT01983020|12416067|FG002|NOT COMPLETED|Overall Study||0
11223986|NCT01983020|12416068|FG003|NOT COMPLETED|Overall Study||0
11223987|NCT01983111|12416080|FG000|STARTED|Overall Study||70
11223988|NCT01983111|12416081|FG001|STARTED|Overall Study||66
11223989|NCT01983111|12416080|FG000|COMPLETED|Overall Study||58
11223990|NCT01983111|12416081|FG001|COMPLETED|Overall Study||59
11223991|NCT01983111|12416080|FG000|NOT COMPLETED|Overall Study||12
11223992|NCT01983111|12416081|FG001|NOT COMPLETED|Overall Study||7
11223993|NCT01983228|12416089|FG000|STARTED|Overall Study||249
11223994|NCT01983228|12416090|FG001|STARTED|Overall Study||251
11223995|NCT01983228|12416089|FG000|COMPLETED|Overall Study||211
10846557|NCT02700945|12012733|FG001|STARTED|Overall Study||250
10846558|NCT02700945|12012732|FG000|COMPLETED|Overall Study||210
10846559|NCT02700945|12012733|FG001|COMPLETED|Overall Study||207
10846560|NCT02700945|12012732|FG000|NOT COMPLETED|Overall Study||32
10846561|NCT02700945|12012733|FG001|NOT COMPLETED|Overall Study||43
10846562|NCT02659514|12012741|FG000|STARTED|Overall Study||33
10846563|NCT02659514|12012742|FG001|STARTED|Overall Study||34
11354462|NCT03073200|12551631|FG014|COMPLETED|Extension Period||0
11354463|NCT03073200|12551617|FG000|NOT COMPLETED|Extension Period||0
11354464|NCT03073200|12551618|FG001|NOT COMPLETED|Extension Period||0
11354465|NCT03073200|12551619|FG002|NOT COMPLETED|Extension Period||0
11354466|NCT03073200|12551620|FG003|NOT COMPLETED|Extension Period||0
10846564|NCT02659514|12012741|FG000|Safety Population|Overall Study||33
10846565|NCT02659514|12012742|FG001|Safety Population|Overall Study||34
10846566|NCT02659514|12012741|FG000|Evaluable Population|Overall Study||30
10846567|NCT02659514|12012742|FG001|Evaluable Population|Overall Study||27
10846568|NCT02659514|12012741|FG000|COMPLETED|Overall Study||1
10846569|NCT02659514|12012742|FG001|COMPLETED|Overall Study||0
10846570|NCT02659514|12012741|FG000|NOT COMPLETED|Overall Study||32
10846571|NCT02659514|12012742|FG001|NOT COMPLETED|Overall Study||34
11105489|NCT01254045|12289853|FG004|STARTED|Second/Time 2 (1 Day at Week 2)||1
11105490|NCT01254045|12289854|FG005|STARTED|Second/Time 2 (1 Day at Week 2)||1
11105491|NCT01254045|12289849|FG000|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
11105492|NCT01254045|12289850|FG001|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
11105493|NCT01254045|12289851|FG002|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
11105494|NCT01254045|12289852|FG003|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
11105495|NCT01254045|12289853|FG004|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
11105496|NCT01254045|12289854|FG005|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
11105497|NCT01254045|12289849|FG000|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
11105498|NCT01254045|12289850|FG001|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
11105499|NCT01254045|12289851|FG002|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
11105500|NCT01254045|12289852|FG003|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
11105501|NCT01254045|12289853|FG004|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
11105502|NCT01254045|12289854|FG005|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
11105503|NCT01254045|12289849|FG000|STARTED|Third/Time 3 (1 Day at Week 3)||1
11105504|NCT01254045|12289850|FG001|STARTED|Third/Time 3 (1 Day at Week 3)||2
11105505|NCT01254045|12289851|FG002|STARTED|Third/Time 3 (1 Day at Week 3)||2
11105506|NCT01254045|12289852|FG003|STARTED|Third/Time 3 (1 Day at Week 3)||1
11105507|NCT01254045|12289853|FG004|STARTED|Third/Time 3 (1 Day at Week 3)||1
11105508|NCT01254045|12289854|FG005|STARTED|Third/Time 3 (1 Day at Week 3)||1
11105509|NCT01254045|12289849|FG000|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
11105510|NCT01254045|12289850|FG001|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
11105511|NCT01254045|12289851|FG002|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
11105512|NCT01254045|12289852|FG003|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
11105513|NCT01254045|12289853|FG004|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
11105514|NCT01254045|12289854|FG005|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
11105515|NCT01254045|12289849|FG000|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
11105516|NCT01254045|12289850|FG001|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
11105517|NCT01254045|12289851|FG002|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
11105518|NCT01254045|12289852|FG003|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
11105519|NCT01254045|12289853|FG004|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
11105520|NCT01254045|12289854|FG005|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
11105521|NCT01254188|12289864|FG000|STARTED|Overall Study||421
11105522|NCT01254188|12289864|FG000|COMPLETED|Overall Study||328
11105523|NCT01254188|12289864|FG000|NOT COMPLETED|Overall Study||93
11105524|NCT01254214|12289870|FG000|STARTED|Overall Study||27
11105525|NCT01254214|12289871|FG001|STARTED|Overall Study||28
11223996|NCT01983228|12416090|FG001|COMPLETED|Overall Study||189
11223997|NCT01983228|12416089|FG000|NOT COMPLETED|Overall Study||38
11223998|NCT01983228|12416090|FG001|NOT COMPLETED|Overall Study||62
11223999|NCT01983254|12416100|FG000|STARTED|Overall Study|86 patients, 39 caregivers|125
11224000|NCT01983254|12416101|FG001|STARTED|Overall Study|89 patients, 47 caregivers|136
11224001|NCT01983254|12416100|FG000|Interview 1|Overall Study|86 patients, 39 caregivers|125
11224002|NCT01983254|12416101|FG001|Interview 1|Overall Study|89 patients, 47 caregivers|136
11224003|NCT01983254|12416100|FG000|Interview 2|Overall Study|65 patients, 30 caregivers|95
11224004|NCT01983254|12416101|FG001|Interview 2|Overall Study|71 patients, 39 caregivers|110
11224005|NCT01983254|12416100|FG000|Interview 3|Overall Study|62 patients, 29 caregivers|91
11224006|NCT01983254|12416101|FG001|Interview 3|Overall Study|69 patients, 37 caregivers|106
11224007|NCT01983254|12416100|FG000|COMPLETED|Overall Study|62 patients, 29 caregivers|91
11224008|NCT01983254|12416101|FG001|COMPLETED|Overall Study|69 patients, 37 caregivers|106
11105526|NCT01254214|12289870|FG000|COMPLETED|Overall Study||24
11105527|NCT01254214|12289871|FG001|COMPLETED|Overall Study||27
11224009|NCT01983254|12416100|FG000|NOT COMPLETED|Overall Study||34
11224010|NCT01983254|12416101|FG001|NOT COMPLETED|Overall Study||30
11224011|NCT01983293|12416109|FG000|STARTED|Overall Study||161
11224012|NCT01983293|12416110|FG001|STARTED|Overall Study||81
11105528|NCT01254214|12289870|FG000|NOT COMPLETED|Overall Study||3
11224013|NCT01983293|12416109|FG000|COMPLETED|Overall Study||128
11224014|NCT01983293|12416110|FG001|COMPLETED|Overall Study||62
11224015|NCT01983293|12416109|FG000|NOT COMPLETED|Overall Study||33
11224016|NCT01983293|12416110|FG001|NOT COMPLETED|Overall Study||19
11224017|NCT01983566|12416120|FG000|STARTED|Test Period 1||4
11224018|NCT01983566|12416121|FG001|STARTED|Test Period 1||4
11224019|NCT01983566|12416122|FG002|STARTED|Test Period 1||4
11224020|NCT01983566|12416123|FG003|STARTED|Test Period 1||4
11354467|NCT03073200|12551621|FG004|NOT COMPLETED|Extension Period||0
11105529|NCT01254214|12289871|FG001|NOT COMPLETED|Overall Study||1
11105530|NCT01254227|12289877|FG000|STARTED|Overall Study||60
11105531|NCT01254227|12289877|FG000|Completion of 12 Months|Overall Study||39
11105532|NCT01254227|12289877|FG000|Completion of 24 Months|Overall Study||34
11105533|NCT01254227|12289877|FG000|COMPLETED|Overall Study||34
11105534|NCT01254227|12289877|FG000|NOT COMPLETED|Overall Study||26
11105535|NCT01254292|12289883|FG000|STARTED|Comparative Phase||282
11105536|NCT01254292|12289884|FG001|STARTED|Comparative Phase||285
11105537|NCT01254292|12289883|FG000|Participants Received Treatment|Comparative Phase|safety population|279
11105538|NCT01254292|12289884|FG001|Participants Received Treatment|Comparative Phase|safety population|281
11105539|NCT01254292|12289883|FG000|COMPLETED|Comparative Phase||227
11105540|NCT01254292|12289884|FG001|COMPLETED|Comparative Phase||204
11105541|NCT01254292|12289883|FG000|NOT COMPLETED|Comparative Phase||55
11105542|NCT01254292|12289884|FG001|NOT COMPLETED|Comparative Phase||81
11105543|NCT01254292|12289883|FG000|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
10846626|NCT01673867|12012790|FG000|STARTED|Randomization||292
10846627|NCT01673867|12012791|FG001|STARTED|Randomization||290
10846628|NCT01673867|12012790|FG000|COMPLETED|Randomization||287
10846629|NCT01673867|12012791|FG001|COMPLETED|Randomization||268
10846630|NCT01673867|12012790|FG000|NOT COMPLETED|Randomization||5
10846631|NCT01673867|12012791|FG001|NOT COMPLETED|Randomization||22
10846632|NCT01673867|12012790|FG000|STARTED|Treatment||287
10846633|NCT01673867|12012791|FG001|STARTED|Treatment||268
10846634|NCT01673867|12012790|FG000|COMPLETED|Treatment||43
10846635|NCT01673867|12012791|FG001|COMPLETED|Treatment||0
10846636|NCT01673867|12012790|FG000|NOT COMPLETED|Treatment||244
10846637|NCT01673867|12012791|FG001|NOT COMPLETED|Treatment||268
10846638|NCT01182727|12012797|FG000|STARTED|Overall Study||10
10846639|NCT01182727|12012797|FG000|COMPLETED|Overall Study||10
10846640|NCT01182727|12012797|FG000|NOT COMPLETED|Overall Study||0
10846641|NCT00335777|12012801|FG000|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
10846642|NCT00335777|12012801|FG000|COMPLETED|Enrolled and Dispensed Study Medication||35
10846643|NCT00335777|12012801|FG000|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
10846644|NCT00335777|12012801|FG000|STARTED|Treated 2 Headaches Per Protocol||35
10846645|NCT00335777|12012801|FG000|COMPLETED|Treated 2 Headaches Per Protocol||22
10846646|NCT00335777|12012801|FG000|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
10846647|NCT00159588|12012809|FG000|STARTED|5 Month Follow-up||19
10846648|NCT00159588|12012810|FG001|STARTED|5 Month Follow-up||22
10846649|NCT00159588|12012811|FG002|STARTED|5 Month Follow-up||20
10846650|NCT00159588|12012809|FG000|COMPLETED|5 Month Follow-up||17
10846651|NCT00159588|12012810|FG001|COMPLETED|5 Month Follow-up||18
10846652|NCT00159588|12012811|FG002|COMPLETED|5 Month Follow-up||18
10846653|NCT00159588|12012809|FG000|NOT COMPLETED|5 Month Follow-up||2
10846654|NCT00159588|12012810|FG001|NOT COMPLETED|5 Month Follow-up||4
10846655|NCT00159588|12012811|FG002|NOT COMPLETED|5 Month Follow-up||2
10846656|NCT00159588|12012809|FG000|STARTED|1-year Follow-up for Group 1 and 2||17
10846657|NCT00159588|12012810|FG001|STARTED|1-year Follow-up for Group 1 and 2||18
10846658|NCT00159588|12012811|FG002|STARTED|1-year Follow-up for Group 1 and 2||18
10846659|NCT00159588|12012809|FG000|COMPLETED|1-year Follow-up for Group 1 and 2||16
10846660|NCT00159588|12012810|FG001|COMPLETED|1-year Follow-up for Group 1 and 2||14
10846661|NCT00159588|12012811|FG002|COMPLETED|1-year Follow-up for Group 1 and 2||18
10846662|NCT00159588|12012809|FG000|NOT COMPLETED|1-year Follow-up for Group 1 and 2||1
10846663|NCT00159588|12012810|FG001|NOT COMPLETED|1-year Follow-up for Group 1 and 2||4
10846664|NCT00159588|12012811|FG002|NOT COMPLETED|1-year Follow-up for Group 1 and 2||0
10846665|NCT03051217|12012825|FG000|STARTED|Initial Period (Week 0 to Week 16)||26
10846666|NCT03051217|12012826|FG001|STARTED|Initial Period (Week 0 to Week 16)||48
10846667|NCT03051217|12012827|FG002|STARTED|Initial Period (Week 0 to Week 16)||53
10846668|NCT03051217|12012828|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
10846669|NCT03051217|12012829|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
10846670|NCT03051217|12012830|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
10846671|NCT03051217|12012831|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
10846672|NCT03051217|12012825|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||23
10846673|NCT03051217|12012826|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||46
10846674|NCT03051217|12012827|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||51
10846675|NCT03051217|12012828|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
10846676|NCT03051217|12012829|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
10846677|NCT03051217|12012830|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
10846678|NCT03051217|12012831|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
10846679|NCT03051217|12012825|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
10846680|NCT03051217|12012826|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
10846681|NCT03051217|12012827|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
10846682|NCT03051217|12012828|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10846683|NCT03051217|12012829|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10846684|NCT03051217|12012830|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10846685|NCT03051217|12012831|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
10846686|NCT03051217|12012825|FG000|STARTED|Maintenance Period (Week 16 to Week 52)||0
10846687|NCT03051217|12012826|FG001|STARTED|Maintenance Period (Week 16 to Week 52)||0
10846688|NCT03051217|12012827|FG002|STARTED|Maintenance Period (Week 16 to Week 52)||0
10846689|NCT03051217|12012828|FG003|STARTED|Maintenance Period (Week 16 to Week 52)||23
10846690|NCT03051217|12012829|FG004|STARTED|Maintenance Period (Week 16 to Week 52)||51
10846691|NCT03051217|12012830|FG005|STARTED|Maintenance Period (Week 16 to Week 52)||26
10846692|NCT03051217|12012831|FG006|STARTED|Maintenance Period (Week 16 to Week 52)||20
10846693|NCT03051217|12012825|FG000|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
10846694|NCT03051217|12012826|FG001|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
10846695|NCT03051217|12012827|FG002|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
10846696|NCT03051217|12012828|FG003|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21
10846697|NCT03051217|12012829|FG004|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
10846698|NCT03051217|12012830|FG005|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7
10846699|NCT03051217|12012831|FG006|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
10846700|NCT03051217|12012825|FG000|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
10846701|NCT03051217|12012826|FG001|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
10846702|NCT03051217|12012827|FG002|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
10846703|NCT03051217|12012828|FG003|COMPLETED|Maintenance Period (Week 16 to Week 52)||20
10846704|NCT03051217|12012829|FG004|COMPLETED|Maintenance Period (Week 16 to Week 52)||48
10846705|NCT03051217|12012830|FG005|COMPLETED|Maintenance Period (Week 16 to Week 52)||24
10846706|NCT03051217|12012831|FG006|COMPLETED|Maintenance Period (Week 16 to Week 52)||19
10846707|NCT03051217|12012825|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
10846708|NCT03051217|12012826|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
10846709|NCT03051217|12012827|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
10846710|NCT03051217|12012828|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
10846711|NCT03051217|12012829|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
10846712|NCT03051217|12012830|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2
10846713|NCT03051217|12012831|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1
11224021|NCT01983566|12416120|FG000|COMPLETED|Test Period 1||4
11224022|NCT01983566|12416121|FG001|COMPLETED|Test Period 1||4
11224023|NCT01983566|12416122|FG002|COMPLETED|Test Period 1||4
11224024|NCT01983566|12416123|FG003|COMPLETED|Test Period 1||4
11224025|NCT01983566|12416120|FG000|NOT COMPLETED|Test Period 1||0
11224026|NCT01983566|12416121|FG001|NOT COMPLETED|Test Period 1||0
11224027|NCT01983566|12416122|FG002|NOT COMPLETED|Test Period 1||0
11224028|NCT01983566|12416123|FG003|NOT COMPLETED|Test Period 1||0
11224029|NCT01983566|12416120|FG000|STARTED|Wash-Out 1||4
11224030|NCT01983566|12416121|FG001|STARTED|Wash-Out 1||4
11224031|NCT01983566|12416122|FG002|STARTED|Wash-Out 1||4
11224032|NCT01983566|12416123|FG003|STARTED|Wash-Out 1||4
11224033|NCT01983566|12416120|FG000|COMPLETED|Wash-Out 1||4
11224034|NCT01983566|12416121|FG001|COMPLETED|Wash-Out 1||4
11224035|NCT01983566|12416122|FG002|COMPLETED|Wash-Out 1||4
11224036|NCT01983566|12416123|FG003|COMPLETED|Wash-Out 1||4
11224037|NCT01983566|12416120|FG000|NOT COMPLETED|Wash-Out 1||0
11224038|NCT01983566|12416121|FG001|NOT COMPLETED|Wash-Out 1||0
11224039|NCT01983566|12416122|FG002|NOT COMPLETED|Wash-Out 1||0
11224040|NCT01983566|12416123|FG003|NOT COMPLETED|Wash-Out 1||0
11224041|NCT01983566|12416120|FG000|STARTED|Test Period 2||4
11224042|NCT01983566|12416121|FG001|STARTED|Test Period 2||4
11354468|NCT03073200|12551622|FG005|NOT COMPLETED|Extension Period||0
11354469|NCT03073200|12551623|FG006|NOT COMPLETED|Extension Period||3
11354470|NCT03073200|12551624|FG007|NOT COMPLETED|Extension Period||6
11354471|NCT03073200|12551625|FG008|NOT COMPLETED|Extension Period||2
11354472|NCT03073200|12551626|FG009|NOT COMPLETED|Extension Period||0
11354473|NCT03073200|12551627|FG010|NOT COMPLETED|Extension Period||0
10846720|NCT02958319|12012860|FG000|STARTED|Overall Study||145
10846721|NCT02958319|12012861|FG001|STARTED|Overall Study||133
10846722|NCT02958319|12012860|FG000|COMPLETED|Overall Study||145
10846723|NCT02958319|12012861|FG001|COMPLETED|Overall Study||133
10846724|NCT02958319|12012860|FG000|NOT COMPLETED|Overall Study||0
11354474|NCT03073200|12551628|FG011|NOT COMPLETED|Extension Period||0
11354475|NCT03073200|12551629|FG012|NOT COMPLETED|Extension Period||0
11354476|NCT03073200|12551630|FG013|NOT COMPLETED|Extension Period||0
11354477|NCT03073200|12551631|FG014|NOT COMPLETED|Extension Period||0
10846725|NCT02958319|12012861|FG001|NOT COMPLETED|Overall Study||0
10846726|NCT02929069|12012870|FG000|STARTED|Overall Study||100
11354478|NCT03073200|12551617|FG000|STARTED|Randomized Withdrawal Period||0
11354479|NCT03073200|12551618|FG001|STARTED|Randomized Withdrawal Period||0
11224043|NCT01983566|12416122|FG002|STARTED|Test Period 2||4
11224044|NCT01983566|12416123|FG003|STARTED|Test Period 2||4
10846727|NCT02929069|12012871|FG001|STARTED|Overall Study||102
10846728|NCT02929069|12012872|FG002|STARTED|Overall Study||52
10846729|NCT02929069|12012870|FG000|Completed 4 Month Follow Up|Overall Study||83
10846730|NCT02929069|12012871|FG001|Completed 4 Month Follow Up|Overall Study||76
10846731|NCT02929069|12012872|FG002|Completed 4 Month Follow Up|Overall Study||43
10846732|NCT02929069|12012870|FG000|Completed 8 Month Follow Up|Overall Study||82
10846733|NCT02929069|12012871|FG001|Completed 8 Month Follow Up|Overall Study||77
10846734|NCT02929069|12012872|FG002|Completed 8 Month Follow Up|Overall Study||36
10846735|NCT02929069|12012870|FG000|Assessed STI 12 Month|Overall Study||74
10846736|NCT02929069|12012871|FG001|Assessed STI 12 Month|Overall Study||75
10846737|NCT02929069|12012872|FG002|Assessed STI 12 Month|Overall Study||38
10846738|NCT02929069|12012870|FG000|Assessed HIV 12 Month|Overall Study||76
10846739|NCT02929069|12012871|FG001|Assessed HIV 12 Month|Overall Study||76
10846740|NCT02929069|12012872|FG002|Assessed HIV 12 Month|Overall Study||39
10846741|NCT02929069|12012870|FG000|Complete 12 Month Follow Up|Overall Study||81
10846742|NCT02929069|12012871|FG001|Complete 12 Month Follow Up|Overall Study||81
10846743|NCT02929069|12012872|FG002|Complete 12 Month Follow Up|Overall Study||42
10846744|NCT02929069|12012870|FG000|COMPLETED|Overall Study||81
10846745|NCT02929069|12012871|FG001|COMPLETED|Overall Study||81
10846746|NCT02929069|12012872|FG002|COMPLETED|Overall Study||42
10846747|NCT02929069|12012870|FG000|NOT COMPLETED|Overall Study||19
10846748|NCT02929069|12012871|FG001|NOT COMPLETED|Overall Study||21
10846749|NCT02929069|12012872|FG002|NOT COMPLETED|Overall Study||10
10846750|NCT02889809|12012884|FG000|STARTED|Overall Study||239
10846751|NCT02889809|12012885|FG001|STARTED|Overall Study||238
10846752|NCT02889809|12012884|FG000|COMPLETED|Overall Study||196
10846753|NCT02889809|12012885|FG001|COMPLETED|Overall Study||205
10846754|NCT02889809|12012884|FG000|NOT COMPLETED|Overall Study||43
10846755|NCT02889809|12012885|FG001|NOT COMPLETED|Overall Study||33
10846756|NCT02849587|12012894|FG000|STARTED|Overall Study||65
10846757|NCT02849587|12012895|FG001|STARTED|Overall Study||70
10846758|NCT02849587|12012896|FG002|STARTED|Overall Study||64
10846759|NCT02849587|12012894|FG000|COMPLETED|Overall Study||63
10846760|NCT02849587|12012895|FG001|COMPLETED|Overall Study||66
10846761|NCT02849587|12012896|FG002|COMPLETED|Overall Study||62
10846762|NCT02849587|12012894|FG000|NOT COMPLETED|Overall Study||2
10846763|NCT02849587|12012895|FG001|NOT COMPLETED|Overall Study||4
10846764|NCT02849587|12012896|FG002|NOT COMPLETED|Overall Study||2
11105544|NCT01254292|12289884|FG001|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
11105545|NCT01254292|12289883|FG000|COMPLETED|LCS12 Extension Phase||163
10846768|NCT02814708|12012919|FG000|STARTED|Overall Study||20
10846769|NCT02814708|12012920|FG001|STARTED|Overall Study||20
10846770|NCT02814708|12012921|FG002|STARTED|Overall Study||20
10846771|NCT02814708|12012922|FG003|STARTED|Overall Study||20
10846772|NCT02814708|12012923|FG004|STARTED|Overall Study||20
10846773|NCT02814708|12012924|FG005|STARTED|Overall Study||20
10846774|NCT02814708|12012925|FG006|STARTED|Overall Study||20
10846775|NCT02814708|12012919|FG000|COMPLETED|Overall Study||18
10846776|NCT02814708|12012920|FG001|COMPLETED|Overall Study||17
10846777|NCT02814708|12012921|FG002|COMPLETED|Overall Study||19
10846778|NCT02814708|12012922|FG003|COMPLETED|Overall Study||20
10846779|NCT02814708|12012923|FG004|COMPLETED|Overall Study||17
10846780|NCT02814708|12012924|FG005|COMPLETED|Overall Study||16
10846781|NCT02814708|12012925|FG006|COMPLETED|Overall Study||19
10846782|NCT02814708|12012919|FG000|NOT COMPLETED|Overall Study||2
10846783|NCT02814708|12012920|FG001|NOT COMPLETED|Overall Study||3
10846784|NCT02814708|12012921|FG002|NOT COMPLETED|Overall Study||1
10846785|NCT02814708|12012922|FG003|NOT COMPLETED|Overall Study||0
10846786|NCT02814708|12012923|FG004|NOT COMPLETED|Overall Study||3
10846787|NCT02814708|12012924|FG005|NOT COMPLETED|Overall Study||4
10846788|NCT02814708|12012925|FG006|NOT COMPLETED|Overall Study||1
10846789|NCT02781727|12012943|FG000|STARTED|Pre-dosing Period|106 subjects were randomized to the lonapegsomatropin arm, but 1 subject withdrew consent before receiving the first dose of study drug.|106
10846790|NCT02781727|12012944|FG001|STARTED|Pre-dosing Period||56
10846791|NCT02781727|12012943|FG000|COMPLETED|Pre-dosing Period||105
10846792|NCT02781727|12012944|FG001|COMPLETED|Pre-dosing Period||56
10846793|NCT02781727|12012943|FG000|NOT COMPLETED|Pre-dosing Period||1
10846794|NCT02781727|12012944|FG001|NOT COMPLETED|Pre-dosing Period||0
10846795|NCT02781727|12012943|FG000|STARTED|Treatment Period||105
10846796|NCT02781727|12012944|FG001|STARTED|Treatment Period||56
10846797|NCT02781727|12012943|FG000|COMPLETED|Treatment Period||104
10846798|NCT02781727|12012944|FG001|COMPLETED|Treatment Period||55
10846799|NCT02781727|12012943|FG000|NOT COMPLETED|Treatment Period||1
10846800|NCT02781727|12012944|FG001|NOT COMPLETED|Treatment Period||1
10846801|NCT02778204|12012954|FG000|STARTED|Overall Study||8
10846802|NCT02778204|12012955|FG001|STARTED|Overall Study||7
10846803|NCT02778204|12012956|FG002|STARTED|Overall Study||16
10846804|NCT02778204|12012957|FG003|STARTED|Overall Study||16
10846805|NCT02778204|12012954|FG000|COMPLETED|Overall Study||6
10846806|NCT02778204|12012955|FG001|COMPLETED|Overall Study||7
10846807|NCT02778204|12012956|FG002|COMPLETED|Overall Study||12
10846808|NCT02778204|12012957|FG003|COMPLETED|Overall Study||12
10846809|NCT02778204|12012954|FG000|NOT COMPLETED|Overall Study||2
10846810|NCT02778204|12012955|FG001|NOT COMPLETED|Overall Study||0
10846811|NCT02778204|12012956|FG002|NOT COMPLETED|Overall Study||4
10846812|NCT02778204|12012957|FG003|NOT COMPLETED|Overall Study||4
10846813|NCT02743364|12012971|FG000|STARTED|Overall Study||6
10846814|NCT02743364|12012972|FG001|STARTED|Overall Study||2
10846815|NCT02743364|12012971|FG000|COMPLETED|Overall Study||6
10846816|NCT02743364|12012972|FG001|COMPLETED|Overall Study||2
10846817|NCT02743364|12012971|FG000|NOT COMPLETED|Overall Study||0
10846818|NCT02743364|12012972|FG001|NOT COMPLETED|Overall Study||0
10846819|NCT02496611|12012980|FG000|STARTED|Overall Study||33
10846820|NCT02496611|12012981|FG001|STARTED|Overall Study||33
10846821|NCT02496611|12012980|FG000|COMPLETED|Overall Study||26
10846822|NCT02496611|12012981|FG001|COMPLETED|Overall Study||30
10846823|NCT02496611|12012980|FG000|NOT COMPLETED|Overall Study||7
10846824|NCT02496611|12012981|FG001|NOT COMPLETED|Overall Study||3
10846825|NCT02245308|12012990|FG000|STARTED|Overall Study||63
10846826|NCT02245308|12012991|FG001|STARTED|Overall Study||64
10846827|NCT02245308|12012990|FG000|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63
10846828|NCT02245308|12012991|FG001|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64
10846829|NCT02245308|12012990|FG000|NOT COMPLETED|Overall Study||0
10846830|NCT02245308|12012991|FG001|NOT COMPLETED|Overall Study||0
10846831|NCT02177695|12012999|FG000|STARTED|ITT Analysis||120
10846832|NCT02177695|12013000|FG001|STARTED|ITT Analysis||117
10846833|NCT02177695|12012999|FG000|COMPLETED|ITT Analysis||115
10846834|NCT02177695|12013000|FG001|COMPLETED|ITT Analysis||112
10846835|NCT02177695|12012999|FG000|NOT COMPLETED|ITT Analysis||5
10846836|NCT02177695|12013000|FG001|NOT COMPLETED|ITT Analysis||5
10846837|NCT02177695|12012999|FG000|STARTED|Primary COXEN Analysis||115
10846838|NCT02177695|12013000|FG001|STARTED|Primary COXEN Analysis||112
10846839|NCT02177695|12012999|FG000|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||33
10846840|NCT02177695|12013000|FG001|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||27
10846841|NCT02177695|12012999|FG000|COMPLETED|Primary COXEN Analysis||82
10846842|NCT02177695|12013000|FG001|COMPLETED|Primary COXEN Analysis||85
10846843|NCT02177695|12012999|FG000|NOT COMPLETED|Primary COXEN Analysis||33
10846844|NCT02177695|12013000|FG001|NOT COMPLETED|Primary COXEN Analysis||27
10846845|NCT02145403|12013012|FG000|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
10846846|NCT02145403|12013013|FG001|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846847|NCT02145403|12013014|FG002|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846848|NCT02145403|12013015|FG003|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846849|NCT02145403|12013012|FG000|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
10846850|NCT02145403|12013013|FG001|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846851|NCT02145403|12013014|FG002|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846852|NCT02145403|12013015|FG003|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846853|NCT02145403|12013012|FG000|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846854|NCT02145403|12013013|FG001|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846855|NCT02145403|12013014|FG002|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846856|NCT02145403|12013015|FG003|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
10846857|NCT02145403|12013012|FG000|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846858|NCT02145403|12013013|FG001|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
10846859|NCT02145403|12013014|FG002|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846860|NCT02145403|12013015|FG003|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846861|NCT02145403|12013012|FG000|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846862|NCT02145403|12013013|FG001|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
10846863|NCT02145403|12013014|FG002|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846864|NCT02145403|12013015|FG003|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846865|NCT02145403|12013012|FG000|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846866|NCT02145403|12013013|FG001|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846867|NCT02145403|12013014|FG002|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846868|NCT02145403|12013015|FG003|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
10846869|NCT02145403|12013012|FG000|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846870|NCT02145403|12013013|FG001|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846871|NCT02145403|12013014|FG002|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4
10846872|NCT02145403|12013015|FG003|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846873|NCT02145403|12013012|FG000|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846874|NCT02145403|12013013|FG001|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846875|NCT02145403|12013014|FG002|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3
10846876|NCT02145403|12013015|FG003|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846877|NCT02145403|12013012|FG000|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846878|NCT02145403|12013013|FG001|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846879|NCT02145403|12013014|FG002|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1
10846880|NCT02145403|12013015|FG003|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
10846881|NCT02145403|12013012|FG000|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846882|NCT02145403|12013013|FG001|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846883|NCT02145403|12013014|FG002|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846884|NCT02145403|12013015|FG003|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4
10846885|NCT02145403|12013012|FG000|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846886|NCT02145403|12013013|FG001|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846887|NCT02145403|12013014|FG002|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846888|NCT02145403|12013015|FG003|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
10846889|NCT02145403|12013012|FG000|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846890|NCT02145403|12013013|FG001|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846891|NCT02145403|12013014|FG002|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
10846892|NCT02145403|12013015|FG003|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
10846893|NCT02145403|12013012|FG000|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846894|NCT02145403|12013013|FG001|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846895|NCT02145403|12013014|FG002|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37
10846896|NCT02145403|12013015|FG003|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846897|NCT02145403|12013012|FG000|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846898|NCT02145403|12013013|FG001|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846899|NCT02145403|12013014|FG002|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36
10846900|NCT02145403|12013015|FG003|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846901|NCT02145403|12013012|FG000|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846902|NCT02145403|12013013|FG001|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846903|NCT02145403|12013014|FG002|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1
10846904|NCT02145403|12013015|FG003|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
10846905|NCT02105636|12013030|FG000|STARTED|Overall Study||236
10846906|NCT02105636|12013031|FG001|STARTED|Overall Study||111
10846907|NCT02105636|12013030|FG000|COMPLETED|Overall Study|Completed=Still on Treatment|41
10846908|NCT02105636|12013031|FG001|COMPLETED|Overall Study|Completed=Still on Treatment|3
10846909|NCT02105636|12013030|FG000|NOT COMPLETED|Overall Study||195
10846910|NCT02105636|12013031|FG001|NOT COMPLETED|Overall Study||108
10846911|NCT02038946|12013038|FG000|STARTED|Overall Study||92
10846912|NCT02038946|12013038|FG000|COMPLETED|Overall Study||80
10846913|NCT02038946|12013038|FG000|NOT COMPLETED|Overall Study||12
10846914|NCT01988571|12013044|FG000|STARTED|Overall Study||139
10846915|NCT01988571|12013045|FG001|STARTED|Overall Study||140
10846916|NCT01988571|12013044|FG000|Completed Baseline|Overall Study||136
10846917|NCT01988571|12013045|FG001|Completed Baseline|Overall Study||139
10846918|NCT01988571|12013044|FG000|Completed 6 Month Visit|Overall Study||122
10846919|NCT01988571|12013045|FG001|Completed 6 Month Visit|Overall Study||126
10846920|NCT01988571|12013044|FG000|COMPLETED|Overall Study||100
10846921|NCT01988571|12013045|FG001|COMPLETED|Overall Study||105
10846922|NCT01988571|12013044|FG000|NOT COMPLETED|Overall Study||39
10846923|NCT01988571|12013045|FG001|NOT COMPLETED|Overall Study||35
10846924|NCT01332266|12013056|FG000|STARTED|Phase 1b||4
10846925|NCT01332266|12013057|FG001|STARTED|Phase 1b||5
10846926|NCT01332266|12013058|FG002|STARTED|Phase 1b||3
10846927|NCT01332266|12013059|FG003|STARTED|Phase 1b||0
10846928|NCT01332266|12013060|FG004|STARTED|Phase 1b||0
10846929|NCT01332266|12013056|FG000|COMPLETED|Phase 1b||0
10846930|NCT01332266|12013057|FG001|COMPLETED|Phase 1b||0
10846931|NCT01332266|12013058|FG002|COMPLETED|Phase 1b||0
10846932|NCT01332266|12013059|FG003|COMPLETED|Phase 1b||0
10846933|NCT01332266|12013060|FG004|COMPLETED|Phase 1b||0
10846934|NCT01332266|12013056|FG000|NOT COMPLETED|Phase 1b||4
10846935|NCT01332266|12013057|FG001|NOT COMPLETED|Phase 1b||5
10846936|NCT01332266|12013058|FG002|NOT COMPLETED|Phase 1b||3
10846937|NCT01332266|12013059|FG003|NOT COMPLETED|Phase 1b||0
10846938|NCT01332266|12013060|FG004|NOT COMPLETED|Phase 1b||0
10846939|NCT01332266|12013056|FG000|STARTED|Phase 2||0
10846940|NCT01332266|12013057|FG001|STARTED|Phase 2||0
10846941|NCT01332266|12013058|FG002|STARTED|Phase 2||0
10846942|NCT01332266|12013059|FG003|STARTED|Phase 2||42
10846943|NCT01332266|12013060|FG004|STARTED|Phase 2||41
10846944|NCT01332266|12013056|FG000|COMPLETED|Phase 2||0
10846945|NCT01332266|12013057|FG001|COMPLETED|Phase 2||0
10846946|NCT01332266|12013058|FG002|COMPLETED|Phase 2||0
10846947|NCT01332266|12013059|FG003|COMPLETED|Phase 2||0
10846948|NCT01332266|12013060|FG004|COMPLETED|Phase 2||0
10846949|NCT01332266|12013056|FG000|NOT COMPLETED|Phase 2||0
10846950|NCT01332266|12013057|FG001|NOT COMPLETED|Phase 2||0
10846951|NCT01332266|12013058|FG002|NOT COMPLETED|Phase 2||0
10846952|NCT01332266|12013059|FG003|NOT COMPLETED|Phase 2||42
10846953|NCT01332266|12013060|FG004|NOT COMPLETED|Phase 2||41
10846954|NCT01150890|12013077|FG000|STARTED|Overall Study||32
10846955|NCT01150890|12013078|FG001|STARTED|Overall Study||32
10846956|NCT01150890|12013079|FG002|STARTED|Overall Study||33
10846957|NCT01150890|12013080|FG003|STARTED|Overall Study||33
10846958|NCT01150890|12013077|FG000|Received Study Drug|Overall Study||32
10846959|NCT01150890|12013078|FG001|Received Study Drug|Overall Study||31
10846960|NCT01150890|12013079|FG002|Received Study Drug|Overall Study||32
10846961|NCT01150890|12013080|FG003|Received Study Drug|Overall Study||33
10846962|NCT01150890|12013077|FG000|COMPLETED|Overall Study||28
10846963|NCT01150890|12013078|FG001|COMPLETED|Overall Study||19
10846964|NCT01150890|12013079|FG002|COMPLETED|Overall Study||21
10846965|NCT01150890|12013080|FG003|COMPLETED|Overall Study||16
10846966|NCT01150890|12013077|FG000|NOT COMPLETED|Overall Study||4
10846967|NCT01150890|12013078|FG001|NOT COMPLETED|Overall Study||13
10846968|NCT01150890|12013079|FG002|NOT COMPLETED|Overall Study||12
10846969|NCT01150890|12013080|FG003|NOT COMPLETED|Overall Study||17
10846970|NCT01140867|12013093|FG000|STARTED|Overall Study||121
10846971|NCT01140867|12013093|FG000|COMPLETED|Overall Study||88
10846972|NCT01140867|12013093|FG000|NOT COMPLETED|Overall Study||33
10846973|NCT01137773|12013099|FG000|STARTED|Overall Study||33
10846974|NCT01137773|12013100|FG001|STARTED|Overall Study||23
10846975|NCT01137773|12013099|FG000|COMPLETED|Overall Study||24
10846976|NCT01137773|12013100|FG001|COMPLETED|Overall Study||20
10846977|NCT01137773|12013099|FG000|NOT COMPLETED|Overall Study||9
10846978|NCT01137773|12013100|FG001|NOT COMPLETED|Overall Study||3
10846979|NCT01127256|12013110|FG000|STARTED|Overall Study||96
10846980|NCT01127256|12013111|FG001|STARTED|Overall Study||104
10846981|NCT01127256|12013110|FG000|COMPLETED|Overall Study||57
10846982|NCT01127256|12013111|FG001|COMPLETED|Overall Study||65
10846983|NCT01127256|12013110|FG000|NOT COMPLETED|Overall Study||39
10846984|NCT01127256|12013111|FG001|NOT COMPLETED|Overall Study||39
10846985|NCT01004861|12013130|FG000|STARTED|Overall Study||3
10846986|NCT01004861|12013131|FG001|STARTED|Overall Study||6
10846987|NCT01004861|12013132|FG002|STARTED|Overall Study||6
10846988|NCT01004861|12013133|FG003|STARTED|Overall Study||6
10846989|NCT01004861|12013134|FG004|STARTED|Overall Study||7
10846990|NCT01004861|12013135|FG005|STARTED|Overall Study||6
10846991|NCT01004861|12013136|FG006|STARTED|Overall Study||7
10846992|NCT01004861|12013137|FG007|STARTED|Overall Study||4
10846993|NCT01004861|12013138|FG008|STARTED|Overall Study||39
10846994|NCT01004861|12013139|FG009|STARTED|Overall Study||11
11224045|NCT01983566|12416120|FG000|COMPLETED|Test Period 2||4
11224046|NCT01983566|12416121|FG001|COMPLETED|Test Period 2||4
10846995|NCT01004861|12013140|FG010|STARTED|Overall Study||9
10846996|NCT01004861|12013141|FG011|STARTED|Overall Study||8
10846997|NCT01004861|12013142|FG012|STARTED|Overall Study||20
10846998|NCT01004861|12013130|FG000|COMPLETED|Overall Study||0
10846999|NCT01004861|12013131|FG001|COMPLETED|Overall Study||0
10847000|NCT01004861|12013132|FG002|COMPLETED|Overall Study||0
10847001|NCT01004861|12013133|FG003|COMPLETED|Overall Study||0
10847002|NCT01004861|12013134|FG004|COMPLETED|Overall Study||0
10847003|NCT01004861|12013135|FG005|COMPLETED|Overall Study||0
10847004|NCT01004861|12013136|FG006|COMPLETED|Overall Study||0
10847005|NCT01004861|12013137|FG007|COMPLETED|Overall Study||0
10847006|NCT01004861|12013138|FG008|COMPLETED|Overall Study||0
10847007|NCT01004861|12013139|FG009|COMPLETED|Overall Study||0
10847008|NCT01004861|12013140|FG010|COMPLETED|Overall Study||0
10847009|NCT01004861|12013141|FG011|COMPLETED|Overall Study||0
10847010|NCT01004861|12013142|FG012|COMPLETED|Overall Study||0
10847011|NCT01004861|12013130|FG000|NOT COMPLETED|Overall Study||3
10847012|NCT01004861|12013131|FG001|NOT COMPLETED|Overall Study||6
10847013|NCT01004861|12013132|FG002|NOT COMPLETED|Overall Study||6
10847014|NCT01004861|12013133|FG003|NOT COMPLETED|Overall Study||6
10847015|NCT01004861|12013134|FG004|NOT COMPLETED|Overall Study||7
10847016|NCT01004861|12013135|FG005|NOT COMPLETED|Overall Study||6
10847017|NCT01004861|12013136|FG006|NOT COMPLETED|Overall Study||7
10847018|NCT01004861|12013137|FG007|NOT COMPLETED|Overall Study||4
10847019|NCT01004861|12013138|FG008|NOT COMPLETED|Overall Study||39
10847020|NCT01004861|12013139|FG009|NOT COMPLETED|Overall Study||11
10847021|NCT01004861|12013140|FG010|NOT COMPLETED|Overall Study||9
10847022|NCT01004861|12013141|FG011|NOT COMPLETED|Overall Study||8
10847023|NCT01004861|12013142|FG012|NOT COMPLETED|Overall Study||20
10847024|NCT00912223|12013174|FG000|STARTED|Overall Study||65
10847025|NCT00912223|12013174|FG000|COMPLETED|Overall Study||62
10847026|NCT00912223|12013174|FG000|NOT COMPLETED|Overall Study||3
10847027|NCT00381381|12013178|FG000|STARTED|Overall Study||199
10847028|NCT00381381|12013178|FG000|COMPLETED|Overall Study||135
10847029|NCT00381381|12013178|FG000|NOT COMPLETED|Overall Study||64
10847030|NCT00038675|12013182|FG000|STARTED|Overall Study||125
10847031|NCT00038675|12013182|FG000|COMPLETED|Overall Study||125
10847032|NCT00038675|12013182|FG000|NOT COMPLETED|Overall Study||0
11105546|NCT01254292|12289884|FG001|COMPLETED|LCS12 Extension Phase||0
11105547|NCT01254292|12289883|FG000|NOT COMPLETED|LCS12 Extension Phase||37
11105548|NCT01254292|12289884|FG001|NOT COMPLETED|LCS12 Extension Phase||0
11105549|NCT01254305|12289894|FG000|STARTED|Overall Study||93
11105550|NCT01254305|12289895|FG001|STARTED|Overall Study||90
11105551|NCT01254305|12289896|FG002|STARTED|Overall Study||79
11105552|NCT01254305|12289894|FG000|Safety Population|Overall Study||89
11105553|NCT01254305|12289895|FG001|Safety Population|Overall Study||85
11105554|NCT01254305|12289896|FG002|Safety Population|Overall Study||77
11105555|NCT01254305|12289894|FG000|COMPLETED|Overall Study||71
11105556|NCT01254305|12289895|FG001|COMPLETED|Overall Study||72
11105557|NCT01254305|12289896|FG002|COMPLETED|Overall Study||62
11105558|NCT01254305|12289894|FG000|NOT COMPLETED|Overall Study||22
11105559|NCT01254305|12289895|FG001|NOT COMPLETED|Overall Study||18
11105560|NCT01254305|12289896|FG002|NOT COMPLETED|Overall Study||17
11105561|NCT01254318|12289907|FG000|STARTED|Overall Study|Alive at start of study|130
11105562|NCT01254318|12289907|FG000|COMPLETED|Overall Study|Alive at end of study|78
11105563|NCT01254318|12289907|FG000|NOT COMPLETED|Overall Study||52
11105564|NCT01254331|12289911|FG000|STARTED|Initial Phase||51
11105565|NCT01254331|12289911|FG000|COMPLETED|Initial Phase||46
11105566|NCT01254331|12289911|FG000|NOT COMPLETED|Initial Phase||5
11105567|NCT01254331|12289911|FG000|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
11105568|NCT01254331|12289911|FG000|COMPLETED|Extension Phase||41
11105569|NCT01254331|12289911|FG000|NOT COMPLETED|Extension Phase||4
11105570|NCT01254344|12289917|FG000|STARTED|Overall Study||299
11105571|NCT01254344|12289918|FG001|STARTED|Overall Study||300
11105572|NCT01254344|12289917|FG000|Treated|Overall Study||290
11105573|NCT01254344|12289918|FG001|Treated|Overall Study||297
11105574|NCT01254344|12289917|FG000|COMPLETED|Overall Study||286
11105575|NCT01254344|12289918|FG001|COMPLETED|Overall Study||281
11105576|NCT01254344|12289917|FG000|NOT COMPLETED|Overall Study||13
11105577|NCT01254344|12289918|FG001|NOT COMPLETED|Overall Study||19
11105578|NCT01254396|12289924|FG000|STARTED|First Intervention Period||6
11105579|NCT01254396|12289925|FG001|STARTED|First Intervention Period||6
11105580|NCT01254396|12289924|FG000|COMPLETED|First Intervention Period||6
11105581|NCT01254396|12289925|FG001|COMPLETED|First Intervention Period||6
11105582|NCT01254396|12289924|FG000|NOT COMPLETED|First Intervention Period||0
11105583|NCT01254396|12289925|FG001|NOT COMPLETED|First Intervention Period||0
11105584|NCT01254396|12289924|FG000|STARTED|Washout Period (at Least 1 Day)||6
11105585|NCT01254396|12289925|FG001|STARTED|Washout Period (at Least 1 Day)||6
11105586|NCT01254396|12289924|FG000|COMPLETED|Washout Period (at Least 1 Day)||6
11105587|NCT01254396|12289925|FG001|COMPLETED|Washout Period (at Least 1 Day)||6
11105588|NCT01254396|12289924|FG000|NOT COMPLETED|Washout Period (at Least 1 Day)||0
11105589|NCT01254396|12289925|FG001|NOT COMPLETED|Washout Period (at Least 1 Day)||0
11105590|NCT01254396|12289924|FG000|STARTED|Second Intervention Period||6
11105591|NCT01254396|12289925|FG001|STARTED|Second Intervention Period||6
11105592|NCT01254396|12289924|FG000|COMPLETED|Second Intervention Period||6
11105593|NCT01254396|12289925|FG001|COMPLETED|Second Intervention Period||6
10847033|NCT04389333|12013188|FG000|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and underwent non-contract MCE in Changhai hpospital and the first medical center of PLA general hospital.|20
10847034|NCT04389333|12013189|FG001|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and accept MCE in Changhai hpospital and the first medical center of PLA general hospital.|20
10847035|NCT04389333|12013188|FG000|COMPLETED|Overall Study||20
10847036|NCT04389333|12013189|FG001|COMPLETED|Overall Study||20
10847037|NCT04389333|12013188|FG000|NOT COMPLETED|Overall Study||0
11224047|NCT01983566|12416122|FG002|COMPLETED|Test Period 2||4
11224048|NCT01983566|12416123|FG003|COMPLETED|Test Period 2||4
11224049|NCT01983566|12416120|FG000|NOT COMPLETED|Test Period 2||0
11224050|NCT01983566|12416121|FG001|NOT COMPLETED|Test Period 2||0
11224051|NCT01983566|12416122|FG002|NOT COMPLETED|Test Period 2||0
11224052|NCT01983566|12416123|FG003|NOT COMPLETED|Test Period 2||0
11224053|NCT01983566|12416120|FG000|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
11224054|NCT01983566|12416121|FG001|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
11224055|NCT01983566|12416122|FG002|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
11224056|NCT01983566|12416123|FG003|STARTED|Wash-Out 2||4
11224057|NCT01983566|12416120|FG000|COMPLETED|Wash-Out 2||2
11224058|NCT01983566|12416121|FG001|COMPLETED|Wash-Out 2||3
11224059|NCT01983566|12416122|FG002|COMPLETED|Wash-Out 2||2
11224060|NCT01983566|12416123|FG003|COMPLETED|Wash-Out 2||4
11224061|NCT01983566|12416120|FG000|NOT COMPLETED|Wash-Out 2||0
11224062|NCT01983566|12416121|FG001|NOT COMPLETED|Wash-Out 2||0
11224063|NCT01983566|12416122|FG002|NOT COMPLETED|Wash-Out 2||0
11224064|NCT01983566|12416123|FG003|NOT COMPLETED|Wash-Out 2||0
11224065|NCT01983566|12416120|FG000|STARTED|Test Period 3||2
11224066|NCT01983566|12416121|FG001|STARTED|Test Period 3||3
11224067|NCT01983566|12416122|FG002|STARTED|Test Period 3||2
11224068|NCT01983566|12416123|FG003|STARTED|Test Period 3||4
11224069|NCT01983566|12416120|FG000|COMPLETED|Test Period 3||2
11224070|NCT01983566|12416121|FG001|COMPLETED|Test Period 3||3
11224071|NCT01983566|12416122|FG002|COMPLETED|Test Period 3||2
11224072|NCT01983566|12416123|FG003|COMPLETED|Test Period 3||4
11224073|NCT01983566|12416120|FG000|NOT COMPLETED|Test Period 3||0
11224074|NCT01983566|12416121|FG001|NOT COMPLETED|Test Period 3||0
11224075|NCT01983566|12416122|FG002|NOT COMPLETED|Test Period 3||0
11224076|NCT01983566|12416123|FG003|NOT COMPLETED|Test Period 3||0
11354480|NCT03073200|12551619|FG002|STARTED|Randomized Withdrawal Period||0
10847038|NCT04389333|12013189|FG001|NOT COMPLETED|Overall Study||0
10847039|NCT03712124|12013198|FG000|STARTED|Overall Study||10
10847040|NCT03712124|12013199|FG001|STARTED|Overall Study||11
10847041|NCT03712124|12013198|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10
10847042|NCT03712124|12013199|FG001|Received at Least 1 Dose of Study Drug|Overall Study||11
10847043|NCT03712124|12013198|FG000|COMPLETED|Overall Study||9
10847044|NCT03712124|12013199|FG001|COMPLETED|Overall Study||11
10847045|NCT03712124|12013198|FG000|NOT COMPLETED|Overall Study||1
10847046|NCT03712124|12013199|FG001|NOT COMPLETED|Overall Study||0
10847047|NCT03689582|12013205|FG000|STARTED|Overall Study||11
10847048|NCT03689582|12013205|FG000|COMPLETED|Overall Study||11
10847049|NCT03689582|12013205|FG000|NOT COMPLETED|Overall Study||0
10847050|NCT03535740|12013211|FG000|STARTED|Overall Study||103
10847051|NCT03535740|12013211|FG000|Participants Who Received Escalated Dose of Brigatinib 240 mg|Overall Study||13
10847052|NCT03535740|12013211|FG000|COMPLETED|Overall Study||0
10847053|NCT03535740|12013211|FG000|NOT COMPLETED|Overall Study||103
10847054|NCT02986789|12013218|FG000|STARTED|Overall Study||43
10847055|NCT02986789|12013219|FG001|STARTED|Overall Study||0
10847056|NCT02986789|12013218|FG000|COMPLETED|Overall Study||43
10847057|NCT02986789|12013219|FG001|COMPLETED|Overall Study||0
10847058|NCT02986789|12013218|FG000|NOT COMPLETED|Overall Study||0
10847059|NCT02986789|12013219|FG001|NOT COMPLETED|Overall Study||0
10847060|NCT02974907|12013227|FG000|STARTED|Overall Study||299
10847061|NCT02974907|12013228|FG001|STARTED|Overall Study||302
10847062|NCT02974907|12013227|FG000|COMPLETED|Overall Study||286
10847063|NCT02974907|12013228|FG001|COMPLETED|Overall Study||292
10847064|NCT02974907|12013227|FG000|NOT COMPLETED|Overall Study||13
10847065|NCT02974907|12013228|FG001|NOT COMPLETED|Overall Study||10
10847066|NCT02918500|12013236|FG000|STARTED|Overall Study||2
10847067|NCT02918500|12013237|FG001|STARTED|Overall Study||2
10847068|NCT02918500|12013236|FG000|COMPLETED|Overall Study||2
10847069|NCT02918500|12013237|FG001|COMPLETED|Overall Study||2
10847070|NCT02918500|12013236|FG000|NOT COMPLETED|Overall Study||0
11105594|NCT01254396|12289924|FG000|NOT COMPLETED|Second Intervention Period||0
10847071|NCT02918500|12013237|FG001|NOT COMPLETED|Overall Study||0
10847072|NCT02896257|12013248|FG000|STARTED|Providers||88
10847073|NCT02896257|12013249|FG001|STARTED|Providers||93
10847074|NCT02896257|12013248|FG000|PCPs Assigned to 1 Primary Care Team|Providers||68
10847075|NCT02896257|12013249|FG001|PCPs Assigned to 1 Primary Care Team|Providers||79
10847076|NCT02896257|12013248|FG000|PCPs Assigned to Two Primary Care Teams|Providers||18
10847077|NCT02896257|12013249|FG001|PCPs Assigned to Two Primary Care Teams|Providers||12
10847078|NCT02896257|12013248|FG000|PCPs Assigned to 3 Primary Care Teams|Providers||1
10847079|NCT02896257|12013249|FG001|PCPs Assigned to 3 Primary Care Teams|Providers||2
10847080|NCT02896257|12013248|FG000|PCPs Assigned to Four Primary Care Teams|Providers||1
10847081|NCT02896257|12013249|FG001|PCPs Assigned to Four Primary Care Teams|Providers||0
10847082|NCT02896257|12013248|FG000|COMPLETED|Providers||67
10847083|NCT02896257|12013249|FG001|COMPLETED|Providers||65
10847084|NCT02896257|12013248|FG000|NOT COMPLETED|Providers||21
10847085|NCT02896257|12013249|FG001|NOT COMPLETED|Providers||28
10847086|NCT02896257|12013248|FG000|STARTED|Patients|Eligible patient participants assigned to a usual care PCP=344|344
10847087|NCT02896257|12013249|FG001|STARTED|Patients|Eligible patient participants assigned to an intervention PCP=342|342
10847088|NCT02896257|12013248|FG000|COMPLETED|Patients|Patients with an eligible primary care appointment with a usual care PCP who were assigned an index date=281|281
10847089|NCT02896257|12013249|FG001|COMPLETED|Patients|Patients with an eligible primary care appointment with an intervention PCP who were assigned an index date=269|269
10847090|NCT02896257|12013248|FG000|NOT COMPLETED|Patients||63
10847091|NCT02896257|12013249|FG001|NOT COMPLETED|Patients||73
10847092|NCT02774265|12013258|FG000|STARTED|Overall Study||164
10847093|NCT02774265|12013259|FG001|STARTED|Overall Study||165
10847094|NCT02774265|12013258|FG000|COMPLETED|Overall Study||151
10847095|NCT02774265|12013259|FG001|COMPLETED|Overall Study||159
10847096|NCT02774265|12013258|FG000|NOT COMPLETED|Overall Study||13
10847097|NCT02774265|12013259|FG001|NOT COMPLETED|Overall Study||6
10847098|NCT02736617|12013265|FG000|STARTED|Treatment||10
10847099|NCT02736617|12013265|FG000|COMPLETED|Treatment||7
10847100|NCT02736617|12013265|FG000|NOT COMPLETED|Treatment||3
10847101|NCT02736617|12013265|FG000|STARTED|Maintenance||7
10847102|NCT02736617|12013265|FG000|COMPLETED|Maintenance||2
10847103|NCT02736617|12013265|FG000|NOT COMPLETED|Maintenance||5
10847104|NCT02652468|12013270|FG000|STARTED|Overall Study||11
10847105|NCT02652468|12013270|FG000|COMPLETED|Overall Study||11
10847106|NCT02652468|12013270|FG000|NOT COMPLETED|Overall Study||0
10847107|NCT02579265|12013276|FG000|STARTED|Overall Study||83
10847108|NCT02579265|12013277|FG001|STARTED|Overall Study||78
10847109|NCT02579265|12013276|FG000|COMPLETED|Overall Study||33
10847110|NCT02579265|12013277|FG001|COMPLETED|Overall Study||33
10847111|NCT02579265|12013276|FG000|NOT COMPLETED|Overall Study||50
10847112|NCT02579265|12013277|FG001|NOT COMPLETED|Overall Study||45
10847113|NCT02013167|12013285|FG000|STARTED|Overall Study||134
10847114|NCT02013167|12013286|FG001|STARTED|Overall Study||271
10847115|NCT02013167|12013285|FG000|Received Treatment|Overall Study||109
10847116|NCT02013167|12013286|FG001|Received Treatment|Overall Study||267
10847117|NCT02013167|12013285|FG000|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
10847118|NCT02013167|12013286|FG001|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
10847119|NCT02013167|12013285|FG000|NOT COMPLETED|Overall Study||101
10847120|NCT02013167|12013286|FG001|NOT COMPLETED|Overall Study||178
10847121|NCT02004522|12013295|FG000|STARTED|Overall Study||160
10847122|NCT02004522|12013296|FG001|STARTED|Overall Study||159
10847123|NCT02004522|12013295|FG000|Number of Subjects Treated|Overall Study||158
10847124|NCT02004522|12013296|FG001|Number of Subjects Treated|Overall Study||155
10847125|NCT02004522|12013295|FG000|COMPLETED|Overall Study|Completed defined here as still on treatment.|34
10847126|NCT02004522|12013296|FG001|COMPLETED|Overall Study|Completed defined here as still on treatment.|0
10847127|NCT02004522|12013295|FG000|NOT COMPLETED|Overall Study||126
10847128|NCT02004522|12013296|FG001|NOT COMPLETED|Overall Study||159
11105595|NCT01254396|12289925|FG001|NOT COMPLETED|Second Intervention Period||0
11105596|NCT01254552|12289931|FG000|STARTED|Screening Visit||351
11105597|NCT01254552|12289931|FG000|COMPLETED|Screening Visit||348
10847132|NCT01981850|12013313|FG000|STARTED|Main Phase Stage 1||8
10847133|NCT01981850|12013314|FG001|STARTED|Main Phase Stage 1||7
10847134|NCT01981850|12013315|FG002|STARTED|Main Phase Stage 1||6
10847135|NCT01981850|12013316|FG003|STARTED|Main Phase Stage 1||6
10847136|NCT01981850|12013317|FG004|STARTED|Main Phase Stage 1||0
10847137|NCT01981850|12013318|FG005|STARTED|Main Phase Stage 1||0
10847138|NCT01981850|12013319|FG006|STARTED|Main Phase Stage 1||0
10847139|NCT01981850|12013320|FG007|STARTED|Main Phase Stage 1||0
10847140|NCT01981850|12013321|FG008|STARTED|Main Phase Stage 1||0
10847141|NCT01981850|12013322|FG009|STARTED|Main Phase Stage 1||0
10847142|NCT01981850|12013313|FG000|COMPLETED|Main Phase Stage 1||5
10847143|NCT01981850|12013314|FG001|COMPLETED|Main Phase Stage 1||5
10847144|NCT01981850|12013315|FG002|COMPLETED|Main Phase Stage 1||4
10847145|NCT01981850|12013316|FG003|COMPLETED|Main Phase Stage 1||6
10847146|NCT01981850|12013317|FG004|COMPLETED|Main Phase Stage 1||0
10847147|NCT01981850|12013318|FG005|COMPLETED|Main Phase Stage 1||0
10847148|NCT01981850|12013319|FG006|COMPLETED|Main Phase Stage 1||0
10847149|NCT01981850|12013320|FG007|COMPLETED|Main Phase Stage 1||0
10847150|NCT01981850|12013321|FG008|COMPLETED|Main Phase Stage 1||0
10847151|NCT01981850|12013322|FG009|COMPLETED|Main Phase Stage 1||0
10847152|NCT01981850|12013313|FG000|NOT COMPLETED|Main Phase Stage 1||3
11105598|NCT01254552|12289931|FG000|NOT COMPLETED|Screening Visit||3
10847153|NCT01981850|12013314|FG001|NOT COMPLETED|Main Phase Stage 1||2
10847154|NCT01981850|12013315|FG002|NOT COMPLETED|Main Phase Stage 1||2
10847155|NCT01981850|12013316|FG003|NOT COMPLETED|Main Phase Stage 1||0
10847156|NCT01981850|12013317|FG004|NOT COMPLETED|Main Phase Stage 1||0
10847157|NCT01981850|12013318|FG005|NOT COMPLETED|Main Phase Stage 1||0
10847158|NCT01981850|12013319|FG006|NOT COMPLETED|Main Phase Stage 1||0
10847159|NCT01981850|12013320|FG007|NOT COMPLETED|Main Phase Stage 1||0
10847160|NCT01981850|12013321|FG008|NOT COMPLETED|Main Phase Stage 1||0
10847161|NCT01981850|12013322|FG009|NOT COMPLETED|Main Phase Stage 1||0
10847162|NCT01981850|12013313|FG000|STARTED|Main Phase Stage 2||0
10847163|NCT01981850|12013314|FG001|STARTED|Main Phase Stage 2||0
10847164|NCT01981850|12013315|FG002|STARTED|Main Phase Stage 2||0
10847165|NCT01981850|12013316|FG003|STARTED|Main Phase Stage 2||0
10847166|NCT01981850|12013317|FG004|STARTED|Main Phase Stage 2||33
10847167|NCT01981850|12013318|FG005|STARTED|Main Phase Stage 2||32
10847168|NCT01981850|12013319|FG006|STARTED|Main Phase Stage 2||32
10847169|NCT01981850|12013320|FG007|STARTED|Main Phase Stage 2||0
10847170|NCT01981850|12013321|FG008|STARTED|Main Phase Stage 2||0
10847171|NCT01981850|12013322|FG009|STARTED|Main Phase Stage 2||0
10847172|NCT01981850|12013313|FG000|COMPLETED|Main Phase Stage 2||0
10847173|NCT01981850|12013314|FG001|COMPLETED|Main Phase Stage 2||0
10847174|NCT01981850|12013315|FG002|COMPLETED|Main Phase Stage 2||0
10847175|NCT01981850|12013316|FG003|COMPLETED|Main Phase Stage 2||0
10847176|NCT01981850|12013317|FG004|COMPLETED|Main Phase Stage 2||20
10847177|NCT01981850|12013318|FG005|COMPLETED|Main Phase Stage 2||16
10847178|NCT01981850|12013319|FG006|COMPLETED|Main Phase Stage 2||15
10847179|NCT01981850|12013320|FG007|COMPLETED|Main Phase Stage 2||0
10847180|NCT01981850|12013321|FG008|COMPLETED|Main Phase Stage 2||0
10847181|NCT01981850|12013322|FG009|COMPLETED|Main Phase Stage 2||0
10847182|NCT01981850|12013313|FG000|NOT COMPLETED|Main Phase Stage 2||0
10847183|NCT01981850|12013314|FG001|NOT COMPLETED|Main Phase Stage 2||0
10847184|NCT01981850|12013315|FG002|NOT COMPLETED|Main Phase Stage 2||0
10847185|NCT01981850|12013316|FG003|NOT COMPLETED|Main Phase Stage 2||0
10847186|NCT01981850|12013317|FG004|NOT COMPLETED|Main Phase Stage 2||13
10847187|NCT01981850|12013318|FG005|NOT COMPLETED|Main Phase Stage 2||16
10847188|NCT01981850|12013319|FG006|NOT COMPLETED|Main Phase Stage 2||17
10847189|NCT01981850|12013320|FG007|NOT COMPLETED|Main Phase Stage 2||0
10847190|NCT01981850|12013321|FG008|NOT COMPLETED|Main Phase Stage 2||0
10847191|NCT01981850|12013322|FG009|NOT COMPLETED|Main Phase Stage 2||0
10847192|NCT01981850|12013313|FG000|STARTED|Open Label Extension (OLE)||0
10847193|NCT01981850|12013314|FG001|STARTED|Open Label Extension (OLE)||0
10847194|NCT01981850|12013315|FG002|STARTED|Open Label Extension (OLE)||0
10847195|NCT01981850|12013316|FG003|STARTED|Open Label Extension (OLE)||0
10847196|NCT01981850|12013317|FG004|STARTED|Open Label Extension (OLE)||0
10847197|NCT01981850|12013318|FG005|STARTED|Open Label Extension (OLE)||0
10847198|NCT01981850|12013319|FG006|STARTED|Open Label Extension (OLE)||0
10847199|NCT01981850|12013320|FG007|STARTED|Open Label Extension (OLE)||13
10847200|NCT01981850|12013321|FG008|STARTED|Open Label Extension (OLE)||5
10847201|NCT01981850|12013322|FG009|STARTED|Open Label Extension (OLE)||48
10847202|NCT01981850|12013313|FG000|COMPLETED|Open Label Extension (OLE)||0
10847203|NCT01981850|12013314|FG001|COMPLETED|Open Label Extension (OLE)||0
10847204|NCT01981850|12013315|FG002|COMPLETED|Open Label Extension (OLE)||0
10847205|NCT01981850|12013316|FG003|COMPLETED|Open Label Extension (OLE)||0
10847206|NCT01981850|12013317|FG004|COMPLETED|Open Label Extension (OLE)||0
10847207|NCT01981850|12013318|FG005|COMPLETED|Open Label Extension (OLE)||0
10847208|NCT01981850|12013319|FG006|COMPLETED|Open Label Extension (OLE)||0
10847209|NCT01981850|12013320|FG007|COMPLETED|Open Label Extension (OLE)||1
10847210|NCT01981850|12013321|FG008|COMPLETED|Open Label Extension (OLE)||0
10847211|NCT01981850|12013322|FG009|COMPLETED|Open Label Extension (OLE)||0
10847212|NCT01981850|12013313|FG000|NOT COMPLETED|Open Label Extension (OLE)||0
10847213|NCT01981850|12013314|FG001|NOT COMPLETED|Open Label Extension (OLE)||0
10847214|NCT01981850|12013315|FG002|NOT COMPLETED|Open Label Extension (OLE)||0
10847215|NCT01981850|12013316|FG003|NOT COMPLETED|Open Label Extension (OLE)||0
10847216|NCT01981850|12013317|FG004|NOT COMPLETED|Open Label Extension (OLE)||0
10847217|NCT01981850|12013318|FG005|NOT COMPLETED|Open Label Extension (OLE)||0
10847218|NCT01981850|12013319|FG006|NOT COMPLETED|Open Label Extension (OLE)||0
10847219|NCT01981850|12013320|FG007|NOT COMPLETED|Open Label Extension (OLE)||12
10847220|NCT01981850|12013321|FG008|NOT COMPLETED|Open Label Extension (OLE)||5
10847221|NCT01981850|12013322|FG009|NOT COMPLETED|Open Label Extension (OLE)||48
11354481|NCT03073200|12551620|FG003|STARTED|Randomized Withdrawal Period||0
11354482|NCT03073200|12551621|FG004|STARTED|Randomized Withdrawal Period||0
11354483|NCT03073200|12551622|FG005|STARTED|Randomized Withdrawal Period||0
11354484|NCT03073200|12551623|FG006|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
11354485|NCT03073200|12551624|FG007|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
11354486|NCT03073200|12551625|FG008|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
11354487|NCT03073200|12551626|FG009|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33
11354488|NCT03073200|12551627|FG010|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|34
11354489|NCT03073200|12551628|FG011|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33
11224077|NCT01983566|12416120|FG000|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
10847222|NCT01804816|12013354|FG000|STARTED|No Acupuncture (Initial 5 Weeks)||14
10847223|NCT01804816|12013354|FG000|COMPLETED|No Acupuncture (Initial 5 Weeks)||11
10847224|NCT01804816|12013354|FG000|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3
11224078|NCT01983566|12416121|FG001|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
11224079|NCT01983566|12416122|FG002|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
10847225|NCT01804816|12013354|FG000|STARTED|Acupuncture (Second 5 Weeks)||11
10847226|NCT01804816|12013354|FG000|COMPLETED|Acupuncture (Second 5 Weeks)||10
10847227|NCT01804816|12013354|FG000|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1
10847228|NCT01572207|12013363|FG000|STARTED|Overall Study||14
10847229|NCT01572207|12013364|FG001|STARTED|Overall Study||16
10847230|NCT01572207|12013363|FG000|COMPLETED|Overall Study||12
10847231|NCT01572207|12013364|FG001|COMPLETED|Overall Study||13
10847232|NCT01572207|12013363|FG000|NOT COMPLETED|Overall Study||2
10847233|NCT01572207|12013364|FG001|NOT COMPLETED|Overall Study||3
10847234|NCT01550315|12013372|FG000|STARTED|Overall Study||7
11224080|NCT01983566|12416123|FG003|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
11224081|NCT01983566|12416120|FG000|COMPLETED|Wash-Out 3||0
11224082|NCT01983566|12416121|FG001|COMPLETED|Wash-Out 3||0
11224083|NCT01983566|12416122|FG002|COMPLETED|Wash-Out 3||0
11224084|NCT01983566|12416123|FG003|COMPLETED|Wash-Out 3||0
11224085|NCT01983566|12416120|FG000|NOT COMPLETED|Wash-Out 3||0
11224086|NCT01983566|12416121|FG001|NOT COMPLETED|Wash-Out 3||0
11224087|NCT01983566|12416122|FG002|NOT COMPLETED|Wash-Out 3||0
11224088|NCT01983566|12416123|FG003|NOT COMPLETED|Wash-Out 3||0
11224089|NCT01983566|12416120|FG000|STARTED|Test Period 4||0
11224090|NCT01983566|12416121|FG001|STARTED|Test Period 4||0
11224091|NCT01983566|12416122|FG002|STARTED|Test Period 4||0
11224092|NCT01983566|12416123|FG003|STARTED|Test Period 4||0
11224093|NCT01983566|12416120|FG000|COMPLETED|Test Period 4||0
11224094|NCT01983566|12416121|FG001|COMPLETED|Test Period 4||0
11224095|NCT01983566|12416122|FG002|COMPLETED|Test Period 4||0
11224096|NCT01983566|12416123|FG003|COMPLETED|Test Period 4||0
11224097|NCT01983566|12416120|FG000|NOT COMPLETED|Test Period 4||0
11224098|NCT01983566|12416121|FG001|NOT COMPLETED|Test Period 4||0
11224099|NCT01983566|12416122|FG002|NOT COMPLETED|Test Period 4||0
11224100|NCT01983566|12416123|FG003|NOT COMPLETED|Test Period 4||0
11224101|NCT01983683|12416136|FG000|STARTED|Overall Study||298
11224102|NCT01983683|12416137|FG001|STARTED|Overall Study||311
11224103|NCT01983683|12416136|FG000|COMPLETED|Overall Study||260
11224104|NCT01983683|12416137|FG001|COMPLETED|Overall Study||260
11224105|NCT01983683|12416136|FG000|NOT COMPLETED|Overall Study||38
11224106|NCT01983683|12416137|FG001|NOT COMPLETED|Overall Study||51
11224107|NCT01983787|12416143|FG000|STARTED|Overall Study||10
11224108|NCT01983787|12416143|FG000|COMPLETED|Overall Study||10
11224109|NCT01983787|12416143|FG000|NOT COMPLETED|Overall Study||0
11224110|NCT01983826|12416168|FG000|STARTED|Overall Study||13
11224111|NCT01983826|12416169|FG001|STARTED|Overall Study||8
11224112|NCT01983826|12416168|FG000|COMPLETED|Overall Study||13
11224113|NCT01983826|12416169|FG001|COMPLETED|Overall Study||8
11224114|NCT01983826|12416168|FG000|NOT COMPLETED|Overall Study||0
11224115|NCT01983826|12416169|FG001|NOT COMPLETED|Overall Study||0
11224116|NCT01983839|12416179|FG000|STARTED|Overall Study||18
11224117|NCT01983839|12416179|FG000|COMPLETED|Overall Study||18
11224118|NCT01983839|12416179|FG000|NOT COMPLETED|Overall Study||0
11224119|NCT01983878|12416183|FG000|STARTED|Overall Study||36
11224120|NCT01983878|12416183|FG000|Received At Least One Dose of Study Drug|Overall Study||36
11224121|NCT01983878|12416183|FG000|COMPLETED|Overall Study||36
11224122|NCT01983878|12416183|FG000|NOT COMPLETED|Overall Study||0
11224123|NCT01983930|12416190|FG000|STARTED|Overall Study||41
11224124|NCT01983930|12416191|FG001|STARTED|Overall Study||38
11224125|NCT01983930|12416190|FG000|COMPLETED|Overall Study||32
11224126|NCT01983930|12416191|FG001|COMPLETED|Overall Study||29
11224127|NCT01983930|12416190|FG000|NOT COMPLETED|Overall Study||9
11224128|NCT01983930|12416191|FG001|NOT COMPLETED|Overall Study||9
11224129|NCT01983969|12416201|FG000|STARTED|Overall Study||37
11224130|NCT01983969|12416202|FG001|STARTED|Overall Study||19
11224131|NCT01983969|12416203|FG002|STARTED|Overall Study||5
11224132|NCT01983969|12416201|FG000|COMPLETED|Overall Study||37
11224133|NCT01983969|12416202|FG001|COMPLETED|Overall Study||18
11224134|NCT01983969|12416203|FG002|COMPLETED|Overall Study||5
11224135|NCT01983969|12416201|FG000|NOT COMPLETED|Overall Study||0
11224136|NCT01983969|12416202|FG001|NOT COMPLETED|Overall Study||1
11224137|NCT01983969|12416203|FG002|NOT COMPLETED|Overall Study||0
11224138|NCT01984164|12416217|FG000|STARTED|Overall Study||87
11224139|NCT01984164|12416218|FG001|STARTED|Overall Study||89
11224140|NCT01984164|12416217|FG000|COMPLETED|Overall Study||77
11224141|NCT01984164|12416218|FG001|COMPLETED|Overall Study||64
11224142|NCT01984164|12416217|FG000|NOT COMPLETED|Overall Study||10
11224143|NCT01984164|12416218|FG001|NOT COMPLETED|Overall Study||25
11224144|NCT01984229|12416226|FG000|STARTED|Period 1||6
11224145|NCT01984229|12416227|FG001|STARTED|Period 1||17
11224146|NCT01984229|12416226|FG000|COMPLETED|Period 1||6
11224147|NCT01984229|12416227|FG001|COMPLETED|Period 1||17
11224148|NCT01984229|12416226|FG000|NOT COMPLETED|Period 1||0
11224149|NCT01984229|12416227|FG001|NOT COMPLETED|Period 1||0
11224150|NCT01984229|12416226|FG000|STARTED|Period 2||6
11224151|NCT01984229|12416227|FG001|STARTED|Period 2||17
11224152|NCT01984229|12416226|FG000|COMPLETED|Period 2||6
11224153|NCT01984229|12416227|FG001|COMPLETED|Period 2||17
11224154|NCT01984229|12416226|FG000|NOT COMPLETED|Period 2||0
11224155|NCT01984229|12416227|FG001|NOT COMPLETED|Period 2||0
11224156|NCT01984229|12416226|FG000|STARTED|Period 3||6
11224157|NCT01984229|12416227|FG001|STARTED|Period 3||17
10847235|NCT01550315|12013373|FG001|STARTED|Overall Study||7
10847236|NCT01550315|12013374|FG002|STARTED|Overall Study||6
10847237|NCT01550315|12013375|FG003|STARTED|Overall Study||7
10847238|NCT01550315|12013372|FG000|COMPLETED|Overall Study||7
10847239|NCT01550315|12013373|FG001|COMPLETED|Overall Study||7
10847240|NCT01550315|12013374|FG002|COMPLETED|Overall Study||6
10847241|NCT01550315|12013375|FG003|COMPLETED|Overall Study||7
10847242|NCT01550315|12013372|FG000|NOT COMPLETED|Overall Study||0
10847243|NCT01550315|12013373|FG001|NOT COMPLETED|Overall Study||0
10847244|NCT01550315|12013374|FG002|NOT COMPLETED|Overall Study||0
10847245|NCT01550315|12013375|FG003|NOT COMPLETED|Overall Study||0
10847246|NCT01519960|12013388|FG000|STARTED|Overall Study||101
10847247|NCT01519960|12013389|FG001|STARTED|Overall Study||50
10847248|NCT01519960|12013390|FG002|STARTED|Overall Study||10
10847249|NCT01519960|12013388|FG000|Completed Week 48|Overall Study||99
10847250|NCT01519960|12013389|FG001|Completed Week 48|Overall Study||47
10847251|NCT01519960|12013390|FG002|Completed Week 48|Overall Study||10
10847252|NCT01519960|12013388|FG000|Completed Follow-Up (FU) Week 12|Overall Study||101
10847253|NCT01519960|12013389|FG001|Completed Follow-Up (FU) Week 12|Overall Study||26
10847254|NCT01519960|12013390|FG002|Completed Follow-Up (FU) Week 12|Overall Study||10
10847255|NCT01519960|12013388|FG000|Completed FU Week 24|Overall Study||101
10847256|NCT01519960|12013389|FG001|Completed FU Week 24|Overall Study||15
10847257|NCT01519960|12013390|FG002|Completed FU Week 24|Overall Study||10
10847258|NCT01519960|12013388|FG000|COMPLETED|Overall Study||0
10847259|NCT01519960|12013389|FG001|COMPLETED|Overall Study||0
10847260|NCT01519960|12013390|FG002|COMPLETED|Overall Study||0
10847261|NCT01519960|12013388|FG000|NOT COMPLETED|Overall Study||101
10847262|NCT01519960|12013389|FG001|NOT COMPLETED|Overall Study||50
10847263|NCT01519960|12013390|FG002|NOT COMPLETED|Overall Study||10
10847264|NCT00688376|12013403|FG000|STARTED|Double-Blind Phase||40
10847265|NCT00688376|12013404|FG001|STARTED|Double-Blind Phase||32
10847266|NCT00688376|12013403|FG000|Safety Population|Double-Blind Phase||40
10847267|NCT00688376|12013404|FG001|Safety Population|Double-Blind Phase||31
10847268|NCT00688376|12013403|FG000|COMPLETED|Double-Blind Phase||34
10847269|NCT00688376|12013404|FG001|COMPLETED|Double-Blind Phase||25
10847270|NCT00688376|12013403|FG000|NOT COMPLETED|Double-Blind Phase||6
10847271|NCT00688376|12013404|FG001|NOT COMPLETED|Double-Blind Phase||7
10847272|NCT00688376|12013403|FG000|STARTED|Blinded Extension Phase||34
10847273|NCT00688376|12013404|FG001|STARTED|Blinded Extension Phase||25
10847274|NCT00688376|12013403|FG000|COMPLETED|Blinded Extension Phase||29
10847275|NCT00688376|12013404|FG001|COMPLETED|Blinded Extension Phase||20
10847276|NCT00688376|12013403|FG000|NOT COMPLETED|Blinded Extension Phase||5
10847277|NCT00688376|12013404|FG001|NOT COMPLETED|Blinded Extension Phase||5
10847278|NCT00604201|12013412|FG000|STARTED|Overall Study||31
10847279|NCT00604201|12013412|FG000|COMPLETED|Overall Study||21
10847280|NCT00604201|12013412|FG000|NOT COMPLETED|Overall Study||10
10847281|NCT00492349|12013418|FG000|STARTED|Overall Study||35
10847282|NCT00492349|12013419|FG001|STARTED|Overall Study||34
10847283|NCT00492349|12013418|FG000|Week 2|Overall Study||32
10847284|NCT00492349|12013419|FG001|Week 2|Overall Study||33
10847285|NCT00492349|12013418|FG000|Week 8|Overall Study||32
10847286|NCT00492349|12013419|FG001|Week 8|Overall Study||27
10847287|NCT00492349|12013418|FG000|COMPLETED|Overall Study||32
10847288|NCT00492349|12013419|FG001|COMPLETED|Overall Study||27
10847289|NCT00492349|12013418|FG000|NOT COMPLETED|Overall Study||3
10847290|NCT00492349|12013419|FG001|NOT COMPLETED|Overall Study||7
10847291|NCT00121108|12013431|FG000|STARTED|Overall Study||710
10847292|NCT00121108|12013432|FG001|STARTED|Overall Study||1417
10847293|NCT00121108|12013431|FG000|COMPLETED|Overall Study||589
10847294|NCT00121108|12013432|FG001|COMPLETED|Overall Study||1192
10847295|NCT00121108|12013431|FG000|NOT COMPLETED|Overall Study||121
10847296|NCT00121108|12013432|FG001|NOT COMPLETED|Overall Study||225
10847297|NCT00003102|12013442|FG000|STARTED|Overall Study||3
10847298|NCT00003102|12013443|FG001|STARTED|Overall Study||9
10847299|NCT00003102|12013444|FG002|STARTED|Overall Study||3
10847300|NCT00003102|12013442|FG000|COMPLETED|Overall Study||2
10847301|NCT00003102|12013443|FG001|COMPLETED|Overall Study||6
10847302|NCT00003102|12013444|FG002|COMPLETED|Overall Study||1
10847303|NCT00003102|12013442|FG000|NOT COMPLETED|Overall Study||1
10847304|NCT00003102|12013443|FG001|NOT COMPLETED|Overall Study||3
10847305|NCT00003102|12013444|FG002|NOT COMPLETED|Overall Study||2
11105599|NCT01254552|12289931|FG000|STARTED|Delayed-enhanced MRI With Dotarem||348
11105600|NCT01254552|12289931|FG000|COMPLETED|Delayed-enhanced MRI With Dotarem||328
11105601|NCT01254552|12289931|FG000|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20
11105602|NCT01254552|12289931|FG000|STARTED|CCTA With Xenetix 350||328
11105603|NCT01254552|12289931|FG000|COMPLETED|CCTA With Xenetix 350||322
11105604|NCT01254552|12289931|FG000|NOT COMPLETED|CCTA With Xenetix 350||6
11105605|NCT01254565|12289945|FG000|STARTED|Overall Study||5
11105606|NCT01254565|12289946|FG001|STARTED|Overall Study||7
11105607|NCT01254565|12289947|FG002|STARTED|Overall Study||21
11105608|NCT01254565|12289948|FG003|STARTED|Overall Study||21
11224158|NCT01984229|12416226|FG000|COMPLETED|Period 3||6
11224159|NCT01984229|12416227|FG001|COMPLETED|Period 3||17
11105609|NCT01254565|12289949|FG004|STARTED|Overall Study||16
11105610|NCT01254565|12289950|FG005|STARTED|Overall Study||17
11105611|NCT01254565|12289945|FG000|Received Treatment|Overall Study||4
10847306|NCT04633837|12013454|FG000|STARTED|Overall Study||5
10847307|NCT04633837|12013455|FG001|STARTED|Overall Study||0
10847308|NCT04633837|12013454|FG000|COMPLETED|Overall Study||0
10847309|NCT04633837|12013455|FG001|COMPLETED|Overall Study||0
10847310|NCT04633837|12013454|FG000|NOT COMPLETED|Overall Study||5
10847311|NCT04633837|12013455|FG001|NOT COMPLETED|Overall Study||0
10847312|NCT04057937|12013463|FG000|STARTED|Placebo-controlled Phase||44
10847313|NCT04057937|12013464|FG001|STARTED|Placebo-controlled Phase||46
10847314|NCT04057937|12013463|FG000|COMPLETED|Placebo-controlled Phase||41
10847315|NCT04057937|12013464|FG001|COMPLETED|Placebo-controlled Phase||46
10847316|NCT04057937|12013463|FG000|NOT COMPLETED|Placebo-controlled Phase||3
10847317|NCT04057937|12013464|FG001|NOT COMPLETED|Placebo-controlled Phase||0
10847318|NCT04057937|12013463|FG000|STARTED|Active-treatment Phase||41
10847319|NCT04057937|12013464|FG001|STARTED|Active-treatment Phase||46
10847320|NCT04057937|12013463|FG000|COMPLETED|Active-treatment Phase||40
10847321|NCT04057937|12013464|FG001|COMPLETED|Active-treatment Phase||44
10847322|NCT04057937|12013463|FG000|NOT COMPLETED|Active-treatment Phase||1
10847323|NCT04057937|12013464|FG001|NOT COMPLETED|Active-treatment Phase||2
10847324|NCT03566732|12013471|FG000|STARTED|Overall Study|1683 eligible cases identified and screened, 914 participants enrolled.|914
10847325|NCT03566732|12013471|FG000|COMPLETED|Overall Study|914 completed questionnaires|914
10847326|NCT03566732|12013471|FG000|NOT COMPLETED|Overall Study||0
10847327|NCT03032510|12013477|FG000|STARTED|Overall Study||603
10847328|NCT03032510|12013478|FG001|STARTED|Overall Study||602
10847329|NCT03032510|12013477|FG000|COMPLETED|Overall Study||576
10847330|NCT03032510|12013478|FG001|COMPLETED|Overall Study||584
10847331|NCT03032510|12013477|FG000|NOT COMPLETED|Overall Study||27
10847332|NCT03032510|12013478|FG001|NOT COMPLETED|Overall Study||18
10847333|NCT03029000|12013488|FG000|STARTED|Overall Study||1
10847334|NCT03029000|12013488|FG000|COMPLETED|Overall Study||1
10847335|NCT03029000|12013488|FG000|NOT COMPLETED|Overall Study||0
10847336|NCT03022292|12013492|FG000|STARTED|Overall Study||26
10847337|NCT03022292|12013492|FG000|COMPLETED|Overall Study||24
10847338|NCT03022292|12013492|FG000|NOT COMPLETED|Overall Study||2
10847339|NCT02968602|12013498|FG000|STARTED|Overall Study||16
10847340|NCT02968602|12013499|FG001|STARTED|Overall Study||16
10847341|NCT02968602|12013498|FG000|COMPLETED|Overall Study||16
10847342|NCT02968602|12013499|FG001|COMPLETED|Overall Study||16
10847343|NCT02968602|12013498|FG000|NOT COMPLETED|Overall Study||0
10847344|NCT02968602|12013499|FG001|NOT COMPLETED|Overall Study||0
10847345|NCT02946047|12013509|FG000|STARTED|Overall Study||4
10847346|NCT02946047|12013510|FG001|STARTED|Overall Study||3
10847347|NCT02946047|12013511|FG002|STARTED|Overall Study||3
10847348|NCT02946047|12013512|FG003|STARTED|Overall Study||7
10847349|NCT02946047|12013509|FG000|COMPLETED|Overall Study||3
10847350|NCT02946047|12013510|FG001|COMPLETED|Overall Study||3
10847351|NCT02946047|12013511|FG002|COMPLETED|Overall Study||3
10847352|NCT02946047|12013512|FG003|COMPLETED|Overall Study||7
10847353|NCT02946047|12013509|FG000|NOT COMPLETED|Overall Study||1
10847354|NCT02946047|12013510|FG001|NOT COMPLETED|Overall Study||0
10847355|NCT02946047|12013511|FG002|NOT COMPLETED|Overall Study||0
10847356|NCT02946047|12013512|FG003|NOT COMPLETED|Overall Study||0
10847357|NCT02830165|12013522|FG000|STARTED|Overall Study||11
10847358|NCT02830165|12013522|FG000|COMPLETED|Overall Study||11
10847359|NCT02830165|12013522|FG000|NOT COMPLETED|Overall Study||0
10847360|NCT02784704|12013530|FG000|STARTED|Overall Study||250
10847361|NCT02784704|12013531|FG001|STARTED|Overall Study||250
10847362|NCT02784704|12013530|FG000|Treated|Overall Study||250
10847363|NCT02784704|12013531|FG001|Treated|Overall Study||249
10847364|NCT02784704|12013530|FG000|COMPLETED|Overall Study||237
10847365|NCT02784704|12013531|FG001|COMPLETED|Overall Study||241
10847366|NCT02784704|12013530|FG000|NOT COMPLETED|Overall Study||13
10847367|NCT02784704|12013531|FG001|NOT COMPLETED|Overall Study||9
10847368|NCT04831515|12013539|FG000|STARTED|First Intervention||24
10847369|NCT04831515|12013540|FG001|STARTED|First Intervention||24
10847370|NCT04831515|12013539|FG000|COMPLETED|First Intervention||24
10847371|NCT04831515|12013540|FG001|COMPLETED|First Intervention||23
10847372|NCT04831515|12013539|FG000|NOT COMPLETED|First Intervention||0
10847373|NCT04831515|12013540|FG001|NOT COMPLETED|First Intervention||1
10847374|NCT04831515|12013539|FG000|STARTED|Second Intervention||24
10847375|NCT04831515|12013540|FG001|STARTED|Second Intervention||23
10847376|NCT04831515|12013539|FG000|COMPLETED|Second Intervention||24
10847377|NCT04831515|12013540|FG001|COMPLETED|Second Intervention||23
10847378|NCT04831515|12013539|FG000|NOT COMPLETED|Second Intervention||0
10847379|NCT04831515|12013540|FG001|NOT COMPLETED|Second Intervention||0
10847380|NCT04634409|12013573|FG000|STARTED|Overall Study||155
10847381|NCT04634409|12013574|FG001|STARTED|Overall Study||83
10847382|NCT04634409|12013575|FG002|STARTED|Overall Study||158
10847383|NCT04634409|12013576|FG003|STARTED|Overall Study||103
10847384|NCT04634409|12013577|FG004|STARTED|Overall Study||105
10847385|NCT04634409|12013578|FG005|STARTED|Overall Study||101
10847386|NCT04634409|12013579|FG006|STARTED|Overall Study|During the study period, 20 participants from the BAM 175-mg + ETE 350-mg arm potentially received 700 mg bamlanivimab + 700 mg etesevimab instead. These 20 participants, who were randomized at 8 different sites were identified through pharmacokinetics analyses.|20
10847387|NCT04634409|12013580|FG007|STARTED|Overall Study||101
10847388|NCT04634409|12013581|FG008|STARTED|Overall Study||101
10847389|NCT04634409|12013582|FG009|STARTED|Overall Study||125
11105612|NCT01254565|12289946|FG001|Received Treatment|Overall Study||6
10847390|NCT04634409|12013583|FG010|STARTED|Overall Study||127
10847391|NCT04634409|12013584|FG011|STARTED|Overall Study||128
10847392|NCT04634409|12013585|FG012|STARTED|Overall Study||100
10847393|NCT04634409|12013586|FG013|STARTED|Overall Study||50
10847394|NCT04634409|12013587|FG014|STARTED|Overall Study||176
10847395|NCT04634409|12013588|FG015|STARTED|Overall Study||30
10847396|NCT04634409|12013589|FG016|STARTED|Overall Study||6
10847397|NCT04634409|12013590|FG017|STARTED|Overall Study||30
10847398|NCT04634409|12013591|FG018|STARTED|Overall Study||10
10847399|NCT04634409|12013592|FG019|STARTED|Overall Study||6
10847400|NCT04634409|12013593|FG020|STARTED|Overall Study||6
10847401|NCT04634409|12013594|FG021|STARTED|Overall Study||6
10847402|NCT04634409|12013595|FG022|STARTED|Overall Study||6
10847403|NCT04634409|12013596|FG023|STARTED|Overall Study||6
10847404|NCT04634409|12013597|FG024|STARTED|Overall Study||4
10847405|NCT04634409|12013598|FG025|STARTED|Overall Study||6
10847406|NCT04634409|12013599|FG026|STARTED|Overall Study||6
10847407|NCT04634409|12013573|FG000|Received at Least One Dose of Study Drug|Overall Study||155
10847408|NCT04634409|12013574|FG001|Received at Least One Dose of Study Drug|Overall Study||83
10847409|NCT04634409|12013575|FG002|Received at Least One Dose of Study Drug|Overall Study||158
10847410|NCT04634409|12013576|FG003|Received at Least One Dose of Study Drug|Overall Study||103
10847411|NCT04634409|12013577|FG004|Received at Least One Dose of Study Drug|Overall Study||105
10847412|NCT04634409|12013578|FG005|Received at Least One Dose of Study Drug|Overall Study||101
10847413|NCT04634409|12013579|FG006|Received at Least One Dose of Study Drug|Overall Study||20
10847414|NCT04634409|12013580|FG007|Received at Least One Dose of Study Drug|Overall Study||101
10847415|NCT04634409|12013581|FG008|Received at Least One Dose of Study Drug|Overall Study||101
10847416|NCT04634409|12013582|FG009|Received at Least One Dose of Study Drug|Overall Study||125
10847417|NCT04634409|12013583|FG010|Received at Least One Dose of Study Drug|Overall Study||127
10847418|NCT04634409|12013584|FG011|Received at Least One Dose of Study Drug|Overall Study||128
10847419|NCT04634409|12013585|FG012|Received at Least One Dose of Study Drug|Overall Study||100
10847420|NCT04634409|12013586|FG013|Received at Least One Dose of Study Drug|Overall Study||50
10847421|NCT04634409|12013587|FG014|Received at Least One Dose of Study Drug|Overall Study||176
10847422|NCT04634409|12013588|FG015|Received at Least One Dose of Study Drug|Overall Study||30
10847423|NCT04634409|12013589|FG016|Received at Least One Dose of Study Drug|Overall Study||6
10847424|NCT04634409|12013590|FG017|Received at Least One Dose of Study Drug|Overall Study||30
10847425|NCT04634409|12013591|FG018|Received at Least One Dose of Study Drug|Overall Study||10
10847426|NCT04634409|12013592|FG019|Received at Least One Dose of Study Drug|Overall Study||6
10847427|NCT04634409|12013593|FG020|Received at Least One Dose of Study Drug|Overall Study||6
10847428|NCT04634409|12013594|FG021|Received at Least One Dose of Study Drug|Overall Study||6
10847429|NCT04634409|12013595|FG022|Received at Least One Dose of Study Drug|Overall Study||6
10847430|NCT04634409|12013596|FG023|Received at Least One Dose of Study Drug|Overall Study||6
10847431|NCT04634409|12013597|FG024|Received at Least One Dose of Study Drug|Overall Study||4
10847432|NCT04634409|12013598|FG025|Received at Least One Dose of Study Drug|Overall Study||6
10847433|NCT04634409|12013599|FG026|Received at Least One Dose of Study Drug|Overall Study||6
10847434|NCT04634409|12013573|FG000|COMPLETED|Overall Study||148
10847435|NCT04634409|12013574|FG001|COMPLETED|Overall Study||81
10847436|NCT04634409|12013575|FG002|COMPLETED|Overall Study||150
10847437|NCT04634409|12013576|FG003|COMPLETED|Overall Study||96
10847438|NCT04634409|12013577|FG004|COMPLETED|Overall Study||102
10847439|NCT04634409|12013578|FG005|COMPLETED|Overall Study||99
10847440|NCT04634409|12013579|FG006|COMPLETED|Overall Study||19
10847441|NCT04634409|12013580|FG007|COMPLETED|Overall Study||90
10847442|NCT04634409|12013581|FG008|COMPLETED|Overall Study||91
10847443|NCT04634409|12013582|FG009|COMPLETED|Overall Study||112
10847444|NCT04634409|12013583|FG010|COMPLETED|Overall Study||114
10847445|NCT04634409|12013584|FG011|COMPLETED|Overall Study||109
11224160|NCT01984229|12416226|FG000|NOT COMPLETED|Period 3||0
11224161|NCT01984229|12416227|FG001|NOT COMPLETED|Period 3||0
11224162|NCT01984229|12416226|FG000|STARTED|Safety Follow-up Period||6
11224163|NCT01984229|12416227|FG001|STARTED|Safety Follow-up Period||17
11224164|NCT01984229|12416226|FG000|COMPLETED|Safety Follow-up Period||4
11224165|NCT01984229|12416227|FG001|COMPLETED|Safety Follow-up Period||16
11224166|NCT01984229|12416226|FG000|NOT COMPLETED|Safety Follow-up Period||2
11224167|NCT01984229|12416227|FG001|NOT COMPLETED|Safety Follow-up Period||1
11224168|NCT01984242|12416242|FG000|STARTED|Overall Study||101
11224169|NCT01984242|12416243|FG001|STARTED|Overall Study||103
11224170|NCT01984242|12416244|FG002|STARTED|Overall Study||101
11224171|NCT01984242|12416242|FG000|Treated|Overall Study||101
11224172|NCT01984242|12416243|FG001|Treated|Overall Study||103
11224173|NCT01984242|12416244|FG002|Treated|Overall Study||100
11224174|NCT01984242|12416242|FG000|COMPLETED|Overall Study||0
11224175|NCT01984242|12416243|FG001|COMPLETED|Overall Study||0
11224176|NCT01984242|12416244|FG002|COMPLETED|Overall Study||0
11224177|NCT01984242|12416242|FG000|NOT COMPLETED|Overall Study||101
10847446|NCT04634409|12013585|FG012|COMPLETED|Overall Study||92
10847447|NCT04634409|12013586|FG013|COMPLETED|Overall Study||46
10847448|NCT04634409|12013587|FG014|COMPLETED|Overall Study||164
10847449|NCT04634409|12013588|FG015|COMPLETED|Overall Study||30
10847450|NCT04634409|12013589|FG016|COMPLETED|Overall Study||6
10847451|NCT04634409|12013590|FG017|COMPLETED|Overall Study||29
10847452|NCT04634409|12013591|FG018|COMPLETED|Overall Study||10
10847453|NCT04634409|12013592|FG019|COMPLETED|Overall Study||6
10847454|NCT04634409|12013593|FG020|COMPLETED|Overall Study||6
10847455|NCT04634409|12013594|FG021|COMPLETED|Overall Study||6
10847456|NCT04634409|12013595|FG022|COMPLETED|Overall Study||6
10847457|NCT04634409|12013596|FG023|COMPLETED|Overall Study||5
10847458|NCT04634409|12013597|FG024|COMPLETED|Overall Study||4
10847459|NCT04634409|12013598|FG025|COMPLETED|Overall Study||6
10847460|NCT04634409|12013599|FG026|COMPLETED|Overall Study||6
10847461|NCT04634409|12013573|FG000|NOT COMPLETED|Overall Study||7
10847462|NCT04634409|12013574|FG001|NOT COMPLETED|Overall Study||2
10847463|NCT04634409|12013575|FG002|NOT COMPLETED|Overall Study||8
10847464|NCT04634409|12013576|FG003|NOT COMPLETED|Overall Study||7
10847465|NCT04634409|12013577|FG004|NOT COMPLETED|Overall Study||3
10847466|NCT04634409|12013578|FG005|NOT COMPLETED|Overall Study||2
10847467|NCT04634409|12013579|FG006|NOT COMPLETED|Overall Study||1
10847468|NCT04634409|12013580|FG007|NOT COMPLETED|Overall Study||11
10847469|NCT04634409|12013581|FG008|NOT COMPLETED|Overall Study||10
10847470|NCT04634409|12013582|FG009|NOT COMPLETED|Overall Study||13
10847471|NCT04634409|12013583|FG010|NOT COMPLETED|Overall Study||13
10847472|NCT04634409|12013584|FG011|NOT COMPLETED|Overall Study||19
10847473|NCT04634409|12013585|FG012|NOT COMPLETED|Overall Study||8
10847474|NCT04634409|12013586|FG013|NOT COMPLETED|Overall Study||4
10847475|NCT04634409|12013587|FG014|NOT COMPLETED|Overall Study||12
10847476|NCT04634409|12013588|FG015|NOT COMPLETED|Overall Study||0
10847477|NCT04634409|12013589|FG016|NOT COMPLETED|Overall Study||0
10847478|NCT04634409|12013590|FG017|NOT COMPLETED|Overall Study||1
10847479|NCT04634409|12013591|FG018|NOT COMPLETED|Overall Study||0
10847480|NCT04634409|12013592|FG019|NOT COMPLETED|Overall Study||0
10847481|NCT04634409|12013593|FG020|NOT COMPLETED|Overall Study||0
10847482|NCT04634409|12013594|FG021|NOT COMPLETED|Overall Study||0
10847483|NCT04634409|12013595|FG022|NOT COMPLETED|Overall Study||0
10847484|NCT04634409|12013596|FG023|NOT COMPLETED|Overall Study||1
10847485|NCT04634409|12013597|FG024|NOT COMPLETED|Overall Study||0
10847486|NCT04634409|12013598|FG025|NOT COMPLETED|Overall Study||0
10847487|NCT04634409|12013599|FG026|NOT COMPLETED|Overall Study||0
10847488|NCT04286412|12013677|FG000|STARTED|Overall Study||25
10847489|NCT04286412|12013677|FG000|COMPLETED|Overall Study||25
10847490|NCT04286412|12013677|FG000|NOT COMPLETED|Overall Study||0
10847491|NCT04278846|12013683|FG000|STARTED|Overall Study|No longer patients to study|25
10847492|NCT04278846|12013684|FG001|STARTED|Overall Study||25
10847493|NCT04278846|12013683|FG000|COMPLETED|Overall Study||25
10847494|NCT04278846|12013684|FG001|COMPLETED|Overall Study||25
10847495|NCT04278846|12013683|FG000|NOT COMPLETED|Overall Study||0
10847496|NCT04278846|12013684|FG001|NOT COMPLETED|Overall Study||0
11354490|NCT03073200|12551629|FG012|STARTED|Randomized Withdrawal Period||0
11354491|NCT03073200|12551630|FG013|STARTED|Randomized Withdrawal Period||0
11354492|NCT03073200|12551631|FG014|STARTED|Randomized Withdrawal Period||0
11354493|NCT03073200|12551617|FG000|COMPLETED|Randomized Withdrawal Period||0
11354494|NCT03073200|12551618|FG001|COMPLETED|Randomized Withdrawal Period||0
11354495|NCT03073200|12551619|FG002|COMPLETED|Randomized Withdrawal Period||0
11354496|NCT03073200|12551620|FG003|COMPLETED|Randomized Withdrawal Period||0
11354497|NCT03073200|12551621|FG004|COMPLETED|Randomized Withdrawal Period||0
11354498|NCT03073200|12551622|FG005|COMPLETED|Randomized Withdrawal Period||0
11354499|NCT03073200|12551623|FG006|COMPLETED|Randomized Withdrawal Period||0
11354500|NCT03073200|12551624|FG007|COMPLETED|Randomized Withdrawal Period||0
11354501|NCT03073200|12551625|FG008|COMPLETED|Randomized Withdrawal Period||0
11354502|NCT03073200|12551626|FG009|COMPLETED|Randomized Withdrawal Period||33
11354503|NCT03073200|12551627|FG010|COMPLETED|Randomized Withdrawal Period||32
11354504|NCT03073200|12551628|FG011|COMPLETED|Randomized Withdrawal Period||30
11354505|NCT03073200|12551629|FG012|COMPLETED|Randomized Withdrawal Period||0
11354506|NCT03073200|12551630|FG013|COMPLETED|Randomized Withdrawal Period||0
11354507|NCT03073200|12551631|FG014|COMPLETED|Randomized Withdrawal Period||0
11354508|NCT03073200|12551617|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
11354509|NCT03073200|12551618|FG001|NOT COMPLETED|Randomized Withdrawal Period||0
11354510|NCT03073200|12551619|FG002|NOT COMPLETED|Randomized Withdrawal Period||0
11354511|NCT03073200|12551620|FG003|NOT COMPLETED|Randomized Withdrawal Period||0
11354512|NCT03073200|12551621|FG004|NOT COMPLETED|Randomized Withdrawal Period||0
11354513|NCT03073200|12551622|FG005|NOT COMPLETED|Randomized Withdrawal Period||0
11354514|NCT03073200|12551623|FG006|NOT COMPLETED|Randomized Withdrawal Period||0
11354515|NCT03073200|12551624|FG007|NOT COMPLETED|Randomized Withdrawal Period||0
11354516|NCT03073200|12551625|FG008|NOT COMPLETED|Randomized Withdrawal Period||0
11354517|NCT03073200|12551626|FG009|NOT COMPLETED|Randomized Withdrawal Period||0
11354518|NCT03073200|12551627|FG010|NOT COMPLETED|Randomized Withdrawal Period||2
11354519|NCT03073200|12551628|FG011|NOT COMPLETED|Randomized Withdrawal Period||3
11354520|NCT03073200|12551629|FG012|NOT COMPLETED|Randomized Withdrawal Period||0
11354521|NCT03073200|12551630|FG013|NOT COMPLETED|Randomized Withdrawal Period||0
11354522|NCT03073200|12551631|FG014|NOT COMPLETED|Randomized Withdrawal Period||0
11354523|NCT03073200|12551617|FG000|STARTED|Post-Treatment Follow-Up Period||0
11354524|NCT03073200|12551618|FG001|STARTED|Post-Treatment Follow-Up Period||0
11354525|NCT03073200|12551619|FG002|STARTED|Post-Treatment Follow-Up Period||0
11354526|NCT03073200|12551620|FG003|STARTED|Post-Treatment Follow-Up Period||0
11354527|NCT03073200|12551621|FG004|STARTED|Post-Treatment Follow-Up Period||0
11354528|NCT03073200|12551622|FG005|STARTED|Post-Treatment Follow-Up Period||0
11354529|NCT03073200|12551623|FG006|STARTED|Post-Treatment Follow-Up Period||0
11354530|NCT03073200|12551624|FG007|STARTED|Post-Treatment Follow-Up Period||0
11354531|NCT03073200|12551625|FG008|STARTED|Post-Treatment Follow-Up Period||0
11354532|NCT03073200|12551626|FG009|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
11354533|NCT03073200|12551627|FG010|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
11354534|NCT03073200|12551628|FG011|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
11354535|NCT03073200|12551629|FG012|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|6
11354536|NCT03073200|12551630|FG013|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|166
11354537|NCT03073200|12551631|FG014|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|2
11354538|NCT03073200|12551617|FG000|COMPLETED|Post-Treatment Follow-Up Period||0
11354539|NCT03073200|12551618|FG001|COMPLETED|Post-Treatment Follow-Up Period||0
11354540|NCT03073200|12551619|FG002|COMPLETED|Post-Treatment Follow-Up Period||0
11354541|NCT03073200|12551620|FG003|COMPLETED|Post-Treatment Follow-Up Period||0
11354542|NCT03073200|12551621|FG004|COMPLETED|Post-Treatment Follow-Up Period||0
11354543|NCT03073200|12551622|FG005|COMPLETED|Post-Treatment Follow-Up Period||0
11354544|NCT03073200|12551623|FG006|COMPLETED|Post-Treatment Follow-Up Period||0
11354545|NCT03073200|12551624|FG007|COMPLETED|Post-Treatment Follow-Up Period||0
11354546|NCT03073200|12551625|FG008|COMPLETED|Post-Treatment Follow-Up Period||0
11354547|NCT03073200|12551626|FG009|COMPLETED|Post-Treatment Follow-Up Period||0
11354548|NCT03073200|12551627|FG010|COMPLETED|Post-Treatment Follow-Up Period||0
11354549|NCT03073200|12551628|FG011|COMPLETED|Post-Treatment Follow-Up Period||0
11354550|NCT03073200|12551629|FG012|COMPLETED|Post-Treatment Follow-Up Period||6
11354551|NCT03073200|12551630|FG013|COMPLETED|Post-Treatment Follow-Up Period||139
11354552|NCT03073200|12551631|FG014|COMPLETED|Post-Treatment Follow-Up Period||1
11354553|NCT03073200|12551617|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11354554|NCT03073200|12551618|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11354555|NCT03073200|12551619|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11354556|NCT03073200|12551620|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11354557|NCT03073200|12551621|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11354558|NCT03073200|12551622|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11354559|NCT03073200|12551623|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11354560|NCT03073200|12551624|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11354561|NCT03073200|12551625|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11354562|NCT03073200|12551626|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11354563|NCT03073200|12551627|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11354564|NCT03073200|12551628|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11354565|NCT03073200|12551629|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||0
11354566|NCT03073200|12551630|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||27
11354567|NCT03073200|12551631|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period||1
11354568|NCT03073213|12551656|FG000|STARTED|Single Dose Period||12
11354569|NCT03073213|12551657|FG001|STARTED|Single Dose Period||0
11354570|NCT03073213|12551658|FG002|STARTED|Single Dose Period||0
11354571|NCT03073213|12551656|FG000|COMPLETED|Single Dose Period||12
11354572|NCT03073213|12551657|FG001|COMPLETED|Single Dose Period||0
11354573|NCT03073213|12551658|FG002|COMPLETED|Single Dose Period||0
11354574|NCT03073213|12551656|FG000|NOT COMPLETED|Single Dose Period||0
11354575|NCT03073213|12551657|FG001|NOT COMPLETED|Single Dose Period||0
11354576|NCT03073213|12551658|FG002|NOT COMPLETED|Single Dose Period||0
11354577|NCT03073213|12551656|FG000|STARTED|Multiple Dose Period||0
11354578|NCT03073213|12551657|FG001|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|14
11354579|NCT03073213|12551658|FG002|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|15
11354580|NCT03073213|12551656|FG000|Participants Enrolled From Single Dose|Multiple Dose Period||0
11354581|NCT03073213|12551657|FG001|Participants Enrolled From Single Dose|Multiple Dose Period||7
11354582|NCT03073213|12551658|FG002|Participants Enrolled From Single Dose|Multiple Dose Period||2
11354583|NCT03073213|12551656|FG000|COMPLETED|Multiple Dose Period||0
11354584|NCT03073213|12551657|FG001|COMPLETED|Multiple Dose Period||14
11354585|NCT03073213|12551658|FG002|COMPLETED|Multiple Dose Period||14
11354586|NCT03073213|12551656|FG000|NOT COMPLETED|Multiple Dose Period||0
11354587|NCT03073213|12551657|FG001|NOT COMPLETED|Multiple Dose Period||0
11354588|NCT03073213|12551658|FG002|NOT COMPLETED|Multiple Dose Period||1
11354589|NCT03073486|12551669|FG000|STARTED|Overall Study||493
11354590|NCT03073486|12551670|FG001|STARTED|Overall Study||251
11354591|NCT03073486|12551669|FG000|COMPLETED|Overall Study||405
11354592|NCT03073486|12551670|FG001|COMPLETED|Overall Study||207
11354593|NCT03073486|12551669|FG000|NOT COMPLETED|Overall Study||88
11354594|NCT03073486|12551670|FG001|NOT COMPLETED|Overall Study||44
11354595|NCT03073759|12551678|FG000|STARTED|Overall Study||2
11354596|NCT03073759|12551679|FG001|STARTED|Overall Study||2
10847497|NCT03638947|12013695|FG000|STARTED|Overall Study||130
10847498|NCT03638947|12013696|FG001|STARTED|Overall Study||106
10847499|NCT03638947|12013695|FG000|COMPLETED|Overall Study||130
10847500|NCT03638947|12013696|FG001|COMPLETED|Overall Study||106
10847501|NCT03638947|12013695|FG000|NOT COMPLETED|Overall Study||0
10847502|NCT03638947|12013696|FG001|NOT COMPLETED|Overall Study||0
10847503|NCT03502681|12013704|FG000|STARTED|Overall Study||3
10847504|NCT03502681|12013705|FG001|STARTED|Overall Study||3
10847505|NCT03502681|12013704|FG000|COMPLETED|Overall Study||0
10847506|NCT03502681|12013705|FG001|COMPLETED|Overall Study||1
10847507|NCT03502681|12013704|FG000|NOT COMPLETED|Overall Study||3
10847508|NCT03502681|12013705|FG001|NOT COMPLETED|Overall Study||2
10847509|NCT03405662|12013712|FG000|STARTED|Overall Study||7
10847510|NCT03405662|12013713|FG001|STARTED|Overall Study||7
10847511|NCT03405662|12013712|FG000|COMPLETED|Overall Study||6
10847512|NCT03405662|12013713|FG001|COMPLETED|Overall Study||4
10847513|NCT03405662|12013712|FG000|NOT COMPLETED|Overall Study||1
10847514|NCT03405662|12013713|FG001|NOT COMPLETED|Overall Study||3
10847515|NCT03367715|12013719|FG000|STARTED|Overall Study||10
10847516|NCT03367715|12013719|FG000|COMPLETED|Overall Study||10
10847517|NCT03367715|12013719|FG000|NOT COMPLETED|Overall Study||0
10847518|NCT03334435|12013728|FG000|STARTED|Overall Study||91
10847519|NCT03334435|12013729|FG001|STARTED|Overall Study||45
10847520|NCT03334435|12013730|FG002|STARTED|Overall Study||519
10847521|NCT03334435|12013731|FG003|STARTED|Overall Study||743
10847522|NCT03334435|12013732|FG004|STARTED|Overall Study||247
10847523|NCT03334435|12013728|FG000|RPR|Overall Study||91
10847524|NCT03334435|12013729|FG001|RPR|Overall Study||45
10847525|NCT03334435|12013730|FG002|RPR|Overall Study||108
10847526|NCT03334435|12013731|FG003|RPR|Overall Study||134
10847527|NCT03334435|12013732|FG004|RPR|Overall Study||0
10847528|NCT03334435|12013728|FG000|NR|Overall Study||0
10847529|NCT03334435|12013729|FG001|NR|Overall Study||0
10847530|NCT03334435|12013730|FG002|NR|Overall Study||411
10847531|NCT03334435|12013731|FG003|NR|Overall Study||609
10847532|NCT03334435|12013732|FG004|NR|Overall Study||0
10847533|NCT03334435|12013728|FG000|COMPLETED|Overall Study||2
10847534|NCT03334435|12013729|FG001|COMPLETED|Overall Study||2
10847535|NCT03334435|12013730|FG002|COMPLETED|Overall Study||12
10847536|NCT03334435|12013731|FG003|COMPLETED|Overall Study||15
10847537|NCT03334435|12013732|FG004|COMPLETED|Overall Study||5
10847538|NCT03334435|12013728|FG000|NOT COMPLETED|Overall Study||89
10847539|NCT03334435|12013729|FG001|NOT COMPLETED|Overall Study||43
10847540|NCT03334435|12013730|FG002|NOT COMPLETED|Overall Study||507
10847541|NCT03334435|12013731|FG003|NOT COMPLETED|Overall Study||728
10847542|NCT03334435|12013732|FG004|NOT COMPLETED|Overall Study||242
10847543|NCT03284424|12013764|FG000|STARTED|Overall Study||105
10847544|NCT03284424|12013765|FG001|STARTED|Overall Study||54
10847545|NCT03284424|12013764|FG000|COMPLETED|Overall Study||0
10847546|NCT03284424|12013765|FG001|COMPLETED|Overall Study||0
10847547|NCT03284424|12013764|FG000|NOT COMPLETED|Overall Study||105
10847548|NCT03284424|12013765|FG001|NOT COMPLETED|Overall Study||54
11105613|NCT01254565|12289947|FG002|Received Treatment|Overall Study||21
11105614|NCT01254565|12289948|FG003|Received Treatment|Overall Study||21
11105615|NCT01254565|12289949|FG004|Received Treatment|Overall Study||13
11105616|NCT01254565|12289950|FG005|Received Treatment|Overall Study||13
11105617|NCT01254565|12289945|FG000|COMPLETED|Overall Study||4
11105618|NCT01254565|12289946|FG001|COMPLETED|Overall Study||6
11105619|NCT01254565|12289947|FG002|COMPLETED|Overall Study||21
11105620|NCT01254565|12289948|FG003|COMPLETED|Overall Study||20
11105621|NCT01254565|12289949|FG004|COMPLETED|Overall Study||12
11105622|NCT01254565|12289950|FG005|COMPLETED|Overall Study||13
11105623|NCT01254565|12289945|FG000|NOT COMPLETED|Overall Study||1
11105624|NCT01254565|12289946|FG001|NOT COMPLETED|Overall Study||1
11105625|NCT01254565|12289947|FG002|NOT COMPLETED|Overall Study||0
11105626|NCT01254565|12289948|FG003|NOT COMPLETED|Overall Study||1
11105627|NCT01254565|12289949|FG004|NOT COMPLETED|Overall Study||4
11105628|NCT01254565|12289950|FG005|NOT COMPLETED|Overall Study||4
10847565|NCT02963766|12013795|FG000|STARTED|Double-Blind Period||51
10847566|NCT02963766|12013796|FG001|STARTED|Double-Blind Period||51
10847567|NCT02963766|12013797|FG002|STARTED|Double-Blind Period||52
10847568|NCT02963766|12013795|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Period||51
10847569|NCT02963766|12013796|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Period||51
10847570|NCT02963766|12013797|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Period||52
10847571|NCT02963766|12013795|FG000|COMPLETED|Double-Blind Period||47
10847572|NCT02963766|12013796|FG001|COMPLETED|Double-Blind Period||49
10847573|NCT02963766|12013797|FG002|COMPLETED|Double-Blind Period||50
10847574|NCT02963766|12013795|FG000|NOT COMPLETED|Double-Blind Period||4
10847575|NCT02963766|12013796|FG001|NOT COMPLETED|Double-Blind Period||2
10847576|NCT02963766|12013797|FG002|NOT COMPLETED|Double-Blind Period||2
10847577|NCT02963766|12013795|FG000|STARTED|Open Label Extension (OLE)||47
10847578|NCT02963766|12013796|FG001|STARTED|Open Label Extension (OLE)||49
10847579|NCT02963766|12013797|FG002|STARTED|Open Label Extension (OLE)||50
10847580|NCT02963766|12013795|FG000|COMPLETED|Open Label Extension (OLE)||45
10847581|NCT02963766|12013796|FG001|COMPLETED|Open Label Extension (OLE)||46
10847582|NCT02963766|12013797|FG002|COMPLETED|Open Label Extension (OLE)||48
10847583|NCT02963766|12013795|FG000|NOT COMPLETED|Open Label Extension (OLE)||2
11354597|NCT03073759|12551678|FG000|COMPLETED|Overall Study||2
10847584|NCT02963766|12013796|FG001|NOT COMPLETED|Open Label Extension (OLE)||3
10847585|NCT02963766|12013797|FG002|NOT COMPLETED|Open Label Extension (OLE)||2
10847586|NCT02795182|12013819|FG000|STARTED|Overall Study||15
10847587|NCT02795182|12013820|FG001|STARTED|Overall Study||10
10847588|NCT02795182|12013821|FG002|STARTED|Overall Study||7
10847589|NCT02795182|12013822|FG003|STARTED|Overall Study||43
10847590|NCT02795182|12013819|FG000|COMPLETED|Overall Study||0
10847591|NCT02795182|12013820|FG001|COMPLETED|Overall Study||0
10847592|NCT02795182|12013821|FG002|COMPLETED|Overall Study||0
10847593|NCT02795182|12013822|FG003|COMPLETED|Overall Study||0
10847594|NCT02795182|12013819|FG000|NOT COMPLETED|Overall Study||15
10847595|NCT02795182|12013820|FG001|NOT COMPLETED|Overall Study||10
10847596|NCT02795182|12013821|FG002|NOT COMPLETED|Overall Study||7
10847597|NCT02795182|12013822|FG003|NOT COMPLETED|Overall Study||43
10847598|NCT02711878|12013841|FG000|STARTED|Overall Study||76
10847599|NCT02711878|12013842|FG001|STARTED|Overall Study||39
10847600|NCT02711878|12013841|FG000|Completed Visit T1 (13-15 Weeks Post Baseline)|Overall Study||69
10847601|NCT02711878|12013842|FG001|Completed Visit T1 (13-15 Weeks Post Baseline)|Overall Study||33
10847602|NCT02711878|12013841|FG000|Completed Visit T2 (28-30 Weeks Post Baseline)|Overall Study||68
10847603|NCT02711878|12013842|FG001|Completed Visit T2 (28-30 Weeks Post Baseline)|Overall Study||33
10847604|NCT02711878|12013841|FG000|Completed Visit T3 (56-58 Weeks Post Baseline)|Overall Study||72
10847605|NCT02711878|12013842|FG001|Completed Visit T3 (56-58 Weeks Post Baseline)|Overall Study||31
10847606|NCT02711878|12013841|FG000|COMPLETED|Overall Study||68
10847607|NCT02711878|12013842|FG001|COMPLETED|Overall Study||33
10847608|NCT02711878|12013841|FG000|NOT COMPLETED|Overall Study||8
10847609|NCT02711878|12013842|FG001|NOT COMPLETED|Overall Study||6
10847610|NCT02674464|12013857|FG000|STARTED|Overall Study|There were 15 practices in this arm. Each practice makes a cluster|927
10847611|NCT02674464|12013858|FG001|STARTED|Overall Study|There were 15 practices in the arm. Each practice makes a cluster|893
10847612|NCT02674464|12013857|FG000|6 Month Follow-up|Overall Study|10 deceased; 17 withdrew; 95 missed|771
10847613|NCT02674464|12013858|FG001|6 Month Follow-up|Overall Study|2 deceased; 8 withdrew; 111 missed|806
10847614|NCT02674464|12013857|FG000|COMPLETED|Overall Study||790
10847615|NCT02674464|12013858|FG001|COMPLETED|Overall Study||733
10847616|NCT02674464|12013857|FG000|NOT COMPLETED|Overall Study||137
10847617|NCT02674464|12013858|FG001|NOT COMPLETED|Overall Study||160
10847618|NCT02318784|12013864|FG000|STARTED|Overall Study||62
11224178|NCT01984242|12416243|FG001|NOT COMPLETED|Overall Study||103
11224179|NCT01984242|12416244|FG002|NOT COMPLETED|Overall Study||101
11224180|NCT01984294|12416263|FG000|STARTED|Overall Study||35
11224181|NCT01984294|12416264|FG001|STARTED|Overall Study||32
11224182|NCT01984294|12416265|FG002|STARTED|Overall Study||34
11224183|NCT01984294|12416263|FG000|COMPLETED|Overall Study||31
11224184|NCT01984294|12416264|FG001|COMPLETED|Overall Study||29
11224185|NCT01984294|12416265|FG002|COMPLETED|Overall Study||27
11224186|NCT01984294|12416263|FG000|NOT COMPLETED|Overall Study||4
11224187|NCT01984294|12416264|FG001|NOT COMPLETED|Overall Study||3
11224188|NCT01984294|12416265|FG002|NOT COMPLETED|Overall Study||7
11224189|NCT01984398|12416275|FG000|STARTED|Treatment Period 1||4
11224190|NCT01984398|12416276|FG001|STARTED|Treatment Period 1||4
11224191|NCT01984398|12416277|FG002|STARTED|Treatment Period 1||4
11224192|NCT01984398|12416278|FG003|STARTED|Treatment Period 1||4
11224193|NCT01984398|12416275|FG000|COMPLETED|Treatment Period 1||4
11224194|NCT01984398|12416276|FG001|COMPLETED|Treatment Period 1||4
11224195|NCT01984398|12416277|FG002|COMPLETED|Treatment Period 1||4
11224196|NCT01984398|12416278|FG003|COMPLETED|Treatment Period 1||4
11224197|NCT01984398|12416275|FG000|NOT COMPLETED|Treatment Period 1||0
11224198|NCT01984398|12416276|FG001|NOT COMPLETED|Treatment Period 1||0
11224199|NCT01984398|12416277|FG002|NOT COMPLETED|Treatment Period 1||0
11224200|NCT01984398|12416278|FG003|NOT COMPLETED|Treatment Period 1||0
11224201|NCT01984398|12416275|FG000|STARTED|Washout Period of 5 to 7 Days||4
11224202|NCT01984398|12416276|FG001|STARTED|Washout Period of 5 to 7 Days||4
11224203|NCT01984398|12416277|FG002|STARTED|Washout Period of 5 to 7 Days||4
11224204|NCT01984398|12416278|FG003|STARTED|Washout Period of 5 to 7 Days||4
11354598|NCT03073759|12551679|FG001|COMPLETED|Overall Study||2
11354599|NCT03073759|12551678|FG000|NOT COMPLETED|Overall Study||0
11354600|NCT03073759|12551679|FG001|NOT COMPLETED|Overall Study||0
11354601|NCT03073798|12551686|FG000|STARTED|Overall Study||12
11354602|NCT03073798|12551686|FG000|COMPLETED|Overall Study||10
11354603|NCT03073798|12551686|FG000|NOT COMPLETED|Overall Study||2
10847619|NCT02318784|12013864|FG000|COMPLETED|Overall Study||0
10847620|NCT02318784|12013864|FG000|NOT COMPLETED|Overall Study||62
10847621|NCT02317991|12013868|FG000|STARTED|Overall Study||65
10847622|NCT02317991|12013868|FG000|COMPLETED|Overall Study||0
11354604|NCT03073876|12551693|FG000|STARTED|Overall Study||12
11354605|NCT03073876|12551694|FG001|STARTED|Overall Study||11
11354606|NCT03073876|12551693|FG000|COMPLETED|Overall Study||12
11354607|NCT03073876|12551694|FG001|COMPLETED|Overall Study||11
10847623|NCT02317991|12013868|FG000|NOT COMPLETED|Overall Study||65
11105629|NCT01254604|12289966|FG000|STARTED|Overall Study||95
11105630|NCT01254604|12289967|FG001|STARTED|Overall Study||95
11224205|NCT01984398|12416275|FG000|COMPLETED|Washout Period of 5 to 7 Days||4
11224206|NCT01984398|12416276|FG001|COMPLETED|Washout Period of 5 to 7 Days||4
11354608|NCT03073876|12551693|FG000|NOT COMPLETED|Overall Study||0
11224207|NCT01984398|12416277|FG002|COMPLETED|Washout Period of 5 to 7 Days||4
11224208|NCT01984398|12416278|FG003|COMPLETED|Washout Period of 5 to 7 Days||4
11224209|NCT01984398|12416275|FG000|NOT COMPLETED|Washout Period of 5 to 7 Days||0
11105631|NCT01254604|12289966|FG000|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
11105632|NCT01254604|12289967|FG001|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
11105633|NCT01254604|12289966|FG000|COMPLETED|Overall Study||87
11105634|NCT01254604|12289967|FG001|COMPLETED|Overall Study||86
11105635|NCT01254604|12289966|FG000|NOT COMPLETED|Overall Study||8
11105636|NCT01254604|12289967|FG001|NOT COMPLETED|Overall Study||9
11105637|NCT01254630|12289977|FG000|STARTED|Overall Study||1348
11105638|NCT01254630|12289978|FG001|STARTED|Overall Study||1288
11105639|NCT01254630|12289979|FG002|STARTED|Overall Study||1364
11105640|NCT01254630|12289980|FG003|STARTED|Overall Study||1285
11105641|NCT01254630|12289977|FG000|Received Vaccination 1|Overall Study||1328
11105642|NCT01254630|12289978|FG001|Received Vaccination 1|Overall Study||1277
10847638|NCT02263014|12013895|FG000|STARTED|Overall Study||44
10847639|NCT02263014|12013896|FG001|STARTED|Overall Study||208
10847640|NCT02263014|12013895|FG000|COMPLETED|Overall Study||44
10847641|NCT02263014|12013896|FG001|COMPLETED|Overall Study||208
10847642|NCT02263014|12013895|FG000|NOT COMPLETED|Overall Study||0
10847643|NCT02263014|12013896|FG001|NOT COMPLETED|Overall Study||0
10847644|NCT02260193|12013907|FG000|STARTED|Overall Study||30
10847645|NCT02260193|12013908|FG001|STARTED|Overall Study||33
10847646|NCT02260193|12013909|FG002|STARTED|Overall Study||31
10847647|NCT02260193|12013907|FG000|COMPLETED|Overall Study||24
10847648|NCT02260193|12013908|FG001|COMPLETED|Overall Study||24
10847649|NCT02260193|12013909|FG002|COMPLETED|Overall Study||21
10847650|NCT02260193|12013907|FG000|NOT COMPLETED|Overall Study||6
11224210|NCT01984398|12416276|FG001|NOT COMPLETED|Washout Period of 5 to 7 Days||0
11224211|NCT01984398|12416277|FG002|NOT COMPLETED|Washout Period of 5 to 7 Days||0
11224212|NCT01984398|12416278|FG003|NOT COMPLETED|Washout Period of 5 to 7 Days||0
11224213|NCT01984398|12416275|FG000|STARTED|Treatment Period 2||4
11354609|NCT03073876|12551694|FG001|NOT COMPLETED|Overall Study||0
11105643|NCT01254630|12289979|FG002|Received Vaccination 1|Overall Study||1350
11105644|NCT01254630|12289980|FG003|Received Vaccination 1|Overall Study||1275
11105645|NCT01254630|12289977|FG000|Received Vaccination 2|Overall Study||1255
11354610|NCT03074162|12551711|FG000|STARTED|Period 1 Including Washout 1||8
11224214|NCT01984398|12416276|FG001|STARTED|Treatment Period 2||4
11224215|NCT01984398|12416277|FG002|STARTED|Treatment Period 2||4
11224216|NCT01984398|12416278|FG003|STARTED|Treatment Period 2||4
11224217|NCT01984398|12416275|FG000|COMPLETED|Treatment Period 2||4
11224218|NCT01984398|12416276|FG001|COMPLETED|Treatment Period 2||4
11224219|NCT01984398|12416277|FG002|COMPLETED|Treatment Period 2||4
11224220|NCT01984398|12416278|FG003|COMPLETED|Treatment Period 2||4
11224221|NCT01984398|12416275|FG000|NOT COMPLETED|Treatment Period 2||0
11224222|NCT01984398|12416276|FG001|NOT COMPLETED|Treatment Period 2||0
11224223|NCT01984398|12416277|FG002|NOT COMPLETED|Treatment Period 2||0
11224224|NCT01984398|12416278|FG003|NOT COMPLETED|Treatment Period 2||0
11224225|NCT01984424|12416290|FG000|STARTED|Overall Study||73
11224226|NCT01984424|12416291|FG001|STARTED|Overall Study||145
11224227|NCT01984424|12416290|FG000|COMPLETED|Overall Study||70
11224228|NCT01984424|12416291|FG001|COMPLETED|Overall Study||138
11224229|NCT01984424|12416290|FG000|NOT COMPLETED|Overall Study||3
11224230|NCT01984424|12416291|FG001|NOT COMPLETED|Overall Study||7
11224231|NCT01984515|12416297|FG000|STARTED|Overall Study||59
11224232|NCT01984515|12416297|FG000|Received CBT Session|Overall Study||40
11224233|NCT01984515|12416297|FG000|COMPLETED|Overall Study||40
11224234|NCT01984515|12416297|FG000|NOT COMPLETED|Overall Study||19
11224235|NCT01984684|12416303|FG000|STARTED|Overall Study||423
11224236|NCT01984684|12416304|FG001|STARTED|Overall Study||427
11224237|NCT01984684|12416303|FG000|COMPLETED|Overall Study||366
11224238|NCT01984684|12416304|FG001|COMPLETED|Overall Study||368
11224239|NCT01984684|12416303|FG000|NOT COMPLETED|Overall Study||57
11224240|NCT01984684|12416304|FG001|NOT COMPLETED|Overall Study||59
11224241|NCT01984697|12416315|FG000|STARTED|Overall Study||301
11224242|NCT01984697|12416316|FG001|STARTED|Overall Study||301
11224243|NCT01984697|12416317|FG002|STARTED|Overall Study||301
11224244|NCT01984697|12416318|FG003|STARTED|Overall Study||301
11224245|NCT01984697|12416319|FG004|STARTED|Overall Study||314
11224246|NCT01984697|12416315|FG000|Vaccination 1|Overall Study||301
11224247|NCT01984697|12416316|FG001|Vaccination 1|Overall Study||301
11224248|NCT01984697|12416317|FG002|Vaccination 1|Overall Study||300
11224249|NCT01984697|12416318|FG003|Vaccination 1|Overall Study||300
11224250|NCT01984697|12416319|FG004|Vaccination 1|Overall Study||314
11224251|NCT01984697|12416315|FG000|Vaccination 2|Overall Study||293
11224252|NCT01984697|12416316|FG001|Vaccination 2|Overall Study||296
11224253|NCT01984697|12416317|FG002|Vaccination 2|Overall Study||291
11224254|NCT01984697|12416318|FG003|Vaccination 2|Overall Study||298
11224255|NCT01984697|12416319|FG004|Vaccination 2|Overall Study||313
11224256|NCT01984697|12416315|FG000|Vaccination 3|Overall Study||0
11224257|NCT01984697|12416316|FG001|Vaccination 3|Overall Study||0
11224258|NCT01984697|12416317|FG002|Vaccination 3|Overall Study||0
11224259|NCT01984697|12416318|FG003|Vaccination 3|Overall Study||293
11224260|NCT01984697|12416319|FG004|Vaccination 3|Overall Study||311
11224261|NCT01984697|12416315|FG000|Month 36 Vaccination|Overall Study||270
11224262|NCT01984697|12416316|FG001|Month 36 Vaccination|Overall Study||281
11224263|NCT01984697|12416317|FG002|Month 36 Vaccination|Overall Study||280
10847651|NCT02260193|12013908|FG001|NOT COMPLETED|Overall Study||9
10847652|NCT02260193|12013909|FG002|NOT COMPLETED|Overall Study||10
11105646|NCT01254630|12289978|FG001|Received Vaccination 2|Overall Study||1217
11105647|NCT01254630|12289979|FG002|Received Vaccination 2|Overall Study||1286
11105648|NCT01254630|12289980|FG003|Received Vaccination 2|Overall Study||1226
11105649|NCT01254630|12289977|FG000|Received Vaccination 3|Overall Study||1198
11105650|NCT01254630|12289978|FG001|Received Vaccination 3|Overall Study||1178
11105651|NCT01254630|12289979|FG002|Received Vaccination 3|Overall Study||1247
11105652|NCT01254630|12289980|FG003|Received Vaccination 3|Overall Study||1194
11105653|NCT01254630|12289977|FG000|Received Vaccination 4|Overall Study||1155
11105654|NCT01254630|12289978|FG001|Received Vaccination 4|Overall Study||1145
11105655|NCT01254630|12289979|FG002|Received Vaccination 4|Overall Study||1212
11105656|NCT01254630|12289980|FG003|Received Vaccination 4|Overall Study||1160
11105657|NCT01254630|12289977|FG000|COMPLETED|Overall Study||546
11105658|NCT01254630|12289978|FG001|COMPLETED|Overall Study||0
11105659|NCT01254630|12289979|FG002|COMPLETED|Overall Study||552
11105660|NCT01254630|12289980|FG003|COMPLETED|Overall Study||0
11105661|NCT01254630|12289977|FG000|NOT COMPLETED|Overall Study||802
11105662|NCT01254630|12289978|FG001|NOT COMPLETED|Overall Study||1288
11105663|NCT01254630|12289979|FG002|NOT COMPLETED|Overall Study||812
11105664|NCT01254630|12289980|FG003|NOT COMPLETED|Overall Study||1285
11105665|NCT01254643|12289988|FG000|STARTED|Overall Study||100
11105666|NCT01254643|12289988|FG000|Vaccination 1|Overall Study||100
11105667|NCT01254643|12289988|FG000|Vaccination 2|Overall Study||99
11105668|NCT01254643|12289988|FG000|Vaccination 3|Overall Study||99
11105669|NCT01254643|12289988|FG000|COMPLETED|Overall Study||99
11105670|NCT01254643|12289988|FG000|NOT COMPLETED|Overall Study||1
11105671|NCT01254656|12289995|FG000|STARTED|Overall Study||47
11105672|NCT01254656|12289996|FG001|STARTED|Overall Study||43
11105673|NCT01254656|12289997|FG002|STARTED|Overall Study||18
11105674|NCT01254656|12289995|FG000|Treated|Overall Study||47
11105675|NCT01254656|12289996|FG001|Treated|Overall Study||43
11105676|NCT01254656|12289997|FG002|Treated|Overall Study||18
11105677|NCT01254656|12289995|FG000|COMPLETED|Overall Study||0
11105678|NCT01254656|12289996|FG001|COMPLETED|Overall Study||0
11105679|NCT01254656|12289997|FG002|COMPLETED|Overall Study||0
11224264|NCT01984697|12416318|FG003|Month 36 Vaccination|Overall Study||9
11224265|NCT01984697|12416319|FG004|Month 36 Vaccination|Overall Study||31
11224266|NCT01984697|12416315|FG000|COMPLETED|Overall Study||258
11105680|NCT01254656|12289995|FG000|NOT COMPLETED|Overall Study||47
11105681|NCT01254656|12289996|FG001|NOT COMPLETED|Overall Study||43
11105682|NCT01254656|12289997|FG002|NOT COMPLETED|Overall Study||18
11105683|NCT01254669|12290007|FG000|STARTED|Overall Study||100
11105684|NCT01254669|12290008|FG001|STARTED|Overall Study||100
11105685|NCT01254669|12290007|FG000|COMPLETED|Overall Study||97
11105686|NCT01254669|12290008|FG001|COMPLETED|Overall Study||96
11105687|NCT01254669|12290007|FG000|NOT COMPLETED|Overall Study||3
11105688|NCT01254669|12290008|FG001|NOT COMPLETED|Overall Study||4
11105689|NCT01254721|12290018|FG000|STARTED|Overall Study|Seroquel XR: 300mg|67
11105690|NCT01254721|12290019|FG001|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
11105691|NCT01254721|12290018|FG000|COMPLETED|Overall Study||52
11105692|NCT01254721|12290019|FG001|COMPLETED|Overall Study||42
11105693|NCT01254721|12290018|FG000|NOT COMPLETED|Overall Study||15
11105694|NCT01254721|12290019|FG001|NOT COMPLETED|Overall Study||22
11105695|NCT01254747|12290029|FG000|STARTED|Overall Study||40
11105696|NCT01254747|12290030|FG001|STARTED|Overall Study||29
11105697|NCT01254747|12290031|FG002|STARTED|Overall Study||30
11105698|NCT01254747|12290032|FG003|STARTED|Overall Study||30
11105699|NCT01254747|12290029|FG000|COMPLETED|Overall Study||40
11105700|NCT01254747|12290030|FG001|COMPLETED|Overall Study||23
11105701|NCT01254747|12290031|FG002|COMPLETED|Overall Study||26
11105702|NCT01254747|12290032|FG003|COMPLETED|Overall Study||28
11105703|NCT01254747|12290029|FG000|NOT COMPLETED|Overall Study||0
11105704|NCT01254747|12290030|FG001|NOT COMPLETED|Overall Study||6
11105705|NCT01254747|12290031|FG002|NOT COMPLETED|Overall Study||4
11105706|NCT01254747|12290032|FG003|NOT COMPLETED|Overall Study||2
11105707|NCT01254760|12290042|FG000|STARTED|First Period, 5 Days of Wear||34
11105708|NCT01254760|12290043|FG001|STARTED|First Period, 5 Days of Wear||38
11105709|NCT01254760|12290042|FG000|COMPLETED|First Period, 5 Days of Wear||34
11105710|NCT01254760|12290043|FG001|COMPLETED|First Period, 5 Days of Wear||38
11105711|NCT01254760|12290042|FG000|NOT COMPLETED|First Period, 5 Days of Wear||0
11105712|NCT01254760|12290043|FG001|NOT COMPLETED|First Period, 5 Days of Wear||0
11224267|NCT01984697|12416316|FG001|COMPLETED|Overall Study||270
10847719|NCT02006251|12013994|FG000|STARTED|Overall Study||12
10847720|NCT02006251|12013995|FG001|STARTED|Overall Study||12
10847721|NCT02006251|12013994|FG000|COMPLETED|Overall Study||10
10847722|NCT02006251|12013995|FG001|COMPLETED|Overall Study||11
10847723|NCT02006251|12013994|FG000|NOT COMPLETED|Overall Study||2
10847724|NCT02006251|12013995|FG001|NOT COMPLETED|Overall Study||1
10847731|NCT01832402|12014012|FG000|STARTED|Overall Study||19
10847732|NCT01832402|12014013|FG001|STARTED|Overall Study||16
10847733|NCT01832402|12014012|FG000|Received Allocated Medication|Overall Study||12
10847734|NCT01832402|12014013|FG001|Received Allocated Medication|Overall Study||12
10847735|NCT01832402|12014012|FG000|Completed Study With Correct Dose|Overall Study||10
10847736|NCT01832402|12014013|FG001|Completed Study With Correct Dose|Overall Study||9
10847737|NCT01832402|12014012|FG000|Completed Study With Incorrect Dose|Overall Study||2
10847738|NCT01832402|12014013|FG001|Completed Study With Incorrect Dose|Overall Study||3
10847739|NCT01832402|12014012|FG000|COMPLETED|Overall Study||12
10847740|NCT01832402|12014013|FG001|COMPLETED|Overall Study||12
10847741|NCT01832402|12014012|FG000|NOT COMPLETED|Overall Study||7
10847742|NCT01832402|12014013|FG001|NOT COMPLETED|Overall Study||4
10847743|NCT01468922|12014032|FG000|STARTED|Overall Study||3
10847744|NCT01468922|12014033|FG001|STARTED|Overall Study||3
10847745|NCT01468922|12014034|FG002|STARTED|Overall Study||2
10847746|NCT01468922|12014035|FG003|STARTED|Overall Study||1
10847747|NCT01468922|12014036|FG004|STARTED|Overall Study||4
10847748|NCT01468922|12014037|FG005|STARTED|Overall Study||1
10847749|NCT01468922|12014038|FG006|STARTED|Overall Study||1
10847750|NCT01468922|12014039|FG007|STARTED|Overall Study||16
10847751|NCT01468922|12014040|FG008|STARTED|Overall Study||1
10847752|NCT01468922|12014032|FG000|COMPLETED|Overall Study||1
10847753|NCT01468922|12014033|FG001|COMPLETED|Overall Study||3
10847754|NCT01468922|12014034|FG002|COMPLETED|Overall Study||2
11224268|NCT01984697|12416317|FG002|COMPLETED|Overall Study||272
11224269|NCT01984697|12416318|FG003|COMPLETED|Overall Study||280
11224270|NCT01984697|12416319|FG004|COMPLETED|Overall Study||279
11224271|NCT01984697|12416315|FG000|NOT COMPLETED|Overall Study||43
11224272|NCT01984697|12416316|FG001|NOT COMPLETED|Overall Study||31
11224273|NCT01984697|12416317|FG002|NOT COMPLETED|Overall Study||29
11224274|NCT01984697|12416318|FG003|NOT COMPLETED|Overall Study||21
11224275|NCT01984697|12416319|FG004|NOT COMPLETED|Overall Study||35
11224276|NCT01984892|12416331|FG000|STARTED|Overall Study||8
11224277|NCT01984892|12416331|FG000|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
11224278|NCT01984892|12416331|FG000|NOT COMPLETED|Overall Study||7
11224279|NCT01985126|12416337|FG000|STARTED|Overall Study||18
11224280|NCT01985126|12416338|FG001|STARTED|Overall Study||106
11224281|NCT01985126|12416337|FG000|COMPLETED|Overall Study||0
11224282|NCT01985126|12416338|FG001|COMPLETED|Overall Study||0
11224283|NCT01985126|12416337|FG000|NOT COMPLETED|Overall Study||18
11224284|NCT01985126|12416338|FG001|NOT COMPLETED|Overall Study||106
11224285|NCT01985321|12416346|FG000|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
11224286|NCT01985321|12416347|FG001|STARTED|Overall Study|This is treatment eligible subjects only|83
11224287|NCT01985321|12416346|FG000|COMPLETED|Overall Study||79
11224288|NCT01985321|12416347|FG001|COMPLETED|Overall Study||78
11224289|NCT01985321|12416346|FG000|NOT COMPLETED|Overall Study||11
11224290|NCT01985321|12416347|FG001|NOT COMPLETED|Overall Study||5
11224291|NCT01985334|12416361|FG000|STARTED|Overall Study||130
11224292|NCT01985334|12416362|FG001|STARTED|Overall Study||387
11224293|NCT01985334|12416363|FG002|STARTED|Overall Study||420
10847755|NCT01468922|12014035|FG003|COMPLETED|Overall Study||1
10847756|NCT01468922|12014036|FG004|COMPLETED|Overall Study||2
10847757|NCT01468922|12014037|FG005|COMPLETED|Overall Study||1
10847758|NCT01468922|12014038|FG006|COMPLETED|Overall Study||1
10847759|NCT01468922|12014039|FG007|COMPLETED|Overall Study||12
10847760|NCT01468922|12014040|FG008|COMPLETED|Overall Study||0
10847761|NCT01468922|12014032|FG000|NOT COMPLETED|Overall Study||2
10847762|NCT01468922|12014033|FG001|NOT COMPLETED|Overall Study||0
10847763|NCT01468922|12014034|FG002|NOT COMPLETED|Overall Study||0
10847764|NCT01468922|12014035|FG003|NOT COMPLETED|Overall Study||0
10847765|NCT01468922|12014036|FG004|NOT COMPLETED|Overall Study||2
10847766|NCT01468922|12014037|FG005|NOT COMPLETED|Overall Study||0
10847767|NCT01468922|12014038|FG006|NOT COMPLETED|Overall Study||0
10847768|NCT01468922|12014039|FG007|NOT COMPLETED|Overall Study||4
10847769|NCT01468922|12014040|FG008|NOT COMPLETED|Overall Study||1
10847770|NCT01381094|12014063|FG000|STARTED|Overall Study||18
10847771|NCT01381094|12014064|FG001|STARTED|Overall Study||18
10847772|NCT01381094|12014065|FG002|STARTED|Overall Study||17
10847773|NCT01381094|12014066|FG003|STARTED|Overall Study||19
10847774|NCT01381094|12014067|FG004|STARTED|Overall Study||19
10847775|NCT01381094|12014063|FG000|COMPLETED|Overall Study||16
10847776|NCT01381094|12014064|FG001|COMPLETED|Overall Study||15
10847777|NCT01381094|12014065|FG002|COMPLETED|Overall Study||17
10847778|NCT01381094|12014066|FG003|COMPLETED|Overall Study||18
10847779|NCT01381094|12014067|FG004|COMPLETED|Overall Study||18
10847780|NCT01381094|12014063|FG000|NOT COMPLETED|Overall Study||2
10847781|NCT01381094|12014064|FG001|NOT COMPLETED|Overall Study||3
10847782|NCT01381094|12014065|FG002|NOT COMPLETED|Overall Study||0
10847783|NCT01381094|12014066|FG003|NOT COMPLETED|Overall Study||1
10847784|NCT01381094|12014067|FG004|NOT COMPLETED|Overall Study||1
11105713|NCT01254760|12290042|FG000|STARTED|Second Period, 5 Days of Wear||34
11105714|NCT01254760|12290043|FG001|STARTED|Second Period, 5 Days of Wear||38
11105715|NCT01254760|12290042|FG000|COMPLETED|Second Period, 5 Days of Wear||34
10847788|NCT01235936|12014083|FG000|STARTED|Overall Study||10
10847789|NCT01235936|12014083|FG000|COMPLETED|Overall Study||10
10847790|NCT01235936|12014083|FG000|NOT COMPLETED|Overall Study||0
10847791|NCT01081951|12014089|FG000|STARTED|Overall Study||81
10847792|NCT01081951|12014090|FG001|STARTED|Overall Study||81
10847793|NCT01081951|12014089|FG000|Received Study Treatment|Overall Study||81
10847794|NCT01081951|12014090|FG001|Received Study Treatment|Overall Study||75
10847795|NCT01081951|12014089|FG000|Entered Maintenance Phase|Overall Study||66
10847796|NCT01081951|12014090|FG001|Entered Maintenance Phase|Overall Study||55
10847797|NCT01081951|12014089|FG000|Ongoing Study Treatment at Data Cut-off|Overall Study||11
10847798|NCT01081951|12014090|FG001|Ongoing Study Treatment at Data Cut-off|Overall Study||0
10847899|NCT03135249|12014184|FG000|STARTED|Overall Study|Nine patient entered the study|9
11105716|NCT01254760|12290043|FG001|COMPLETED|Second Period, 5 Days of Wear||38
11105717|NCT01254760|12290042|FG000|NOT COMPLETED|Second Period, 5 Days of Wear||0
11105718|NCT01254760|12290043|FG001|NOT COMPLETED|Second Period, 5 Days of Wear||0
11105719|NCT01254851|12290052|FG000|STARTED|Overall Study||69
11105720|NCT01254851|12290053|FG001|STARTED|Overall Study||77
11105721|NCT01254851|12290052|FG000|COMPLETED|Overall Study||61
11105722|NCT01254851|12290053|FG001|COMPLETED|Overall Study||68
11105723|NCT01254851|12290052|FG000|NOT COMPLETED|Overall Study||8
11105724|NCT01254851|12290053|FG001|NOT COMPLETED|Overall Study||9
11105725|NCT01254877|12290062|FG000|STARTED|Overall Study||67
11105726|NCT01254877|12290063|FG001|STARTED|Overall Study||69
11105727|NCT01254877|12290064|FG002|STARTED|Overall Study||69
11105728|NCT01254877|12290062|FG000|COMPLETED|Overall Study||57
11105729|NCT01254877|12290063|FG001|COMPLETED|Overall Study||58
11105730|NCT01254877|12290064|FG002|COMPLETED|Overall Study||64
11105731|NCT01254877|12290062|FG000|NOT COMPLETED|Overall Study||10
11105732|NCT01254877|12290063|FG001|NOT COMPLETED|Overall Study||11
11105733|NCT01254877|12290064|FG002|NOT COMPLETED|Overall Study||5
11105734|NCT01254890|12290074|FG000|STARTED|Overall Study||3
11105735|NCT01254890|12290075|FG001|STARTED|Overall Study||57
11105736|NCT01254890|12290074|FG000|COMPLETED|Overall Study||2
11105737|NCT01254890|12290075|FG001|COMPLETED|Overall Study||47
11105738|NCT01254890|12290074|FG000|NOT COMPLETED|Overall Study||1
11105739|NCT01254890|12290075|FG001|NOT COMPLETED|Overall Study||10
11105740|NCT01255137|12290080|FG000|STARTED|Overall Study||13
11105741|NCT01255137|12290080|FG000|COMPLETED|Overall Study||13
11105742|NCT01255137|12290080|FG000|NOT COMPLETED|Overall Study||0
11105743|NCT01255163|12290086|FG000|STARTED|Overall Study||13
11105744|NCT01255163|12290087|FG001|STARTED|Overall Study||14
11105745|NCT01255163|12290086|FG000|COMPLETED|Overall Study||9
11105746|NCT01255163|12290087|FG001|COMPLETED|Overall Study||9
11105747|NCT01255163|12290086|FG000|NOT COMPLETED|Overall Study||4
11105748|NCT01255163|12290087|FG001|NOT COMPLETED|Overall Study||5
11105749|NCT01255306|12290097|FG000|STARTED|Overall Study||26
11105750|NCT01255306|12290098|FG001|STARTED|Overall Study||33
11105751|NCT01255306|12290097|FG000|COMPLETED|Overall Study||25
11105752|NCT01255306|12290098|FG001|COMPLETED|Overall Study||32
11105753|NCT01255306|12290097|FG000|NOT COMPLETED|Overall Study||1
11105754|NCT01255306|12290098|FG001|NOT COMPLETED|Overall Study||1
11105755|NCT01255423|12290109|FG000|STARTED|Overall Study||104
11105756|NCT01255423|12290110|FG001|STARTED|Overall Study||102
11105757|NCT01255423|12290109|FG000|COMPLETED|Overall Study||101
11105758|NCT01255423|12290110|FG001|COMPLETED|Overall Study||99
10847799|NCT01081951|12014089|FG000|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
11224294|NCT01985334|12416364|FG003|STARTED|Overall Study||1262
11224295|NCT01985334|12416365|FG004|STARTED|Overall Study||274
11224296|NCT01985334|12416366|FG005|STARTED|Overall Study||822
11224297|NCT01985334|12416367|FG006|STARTED|Overall Study||274
11224298|NCT01985334|12416368|FG007|STARTED|Overall Study||820
11224299|NCT01985334|12416361|FG000|The Intention-to-treat (ITT) Population|Overall Study||122
11224300|NCT01985334|12416362|FG001|The Intention-to-treat (ITT) Population|Overall Study||369
11224301|NCT01985334|12416363|FG002|The Intention-to-treat (ITT) Population|Overall Study||420
11224302|NCT01985334|12416364|FG003|The Intention-to-treat (ITT) Population|Overall Study||1254
11224303|NCT01985334|12416365|FG004|The Intention-to-treat (ITT) Population|Overall Study||269
11224304|NCT01985334|12416366|FG005|The Intention-to-treat (ITT) Population|Overall Study||811
11224305|NCT01985334|12416367|FG006|The Intention-to-treat (ITT) Population|Overall Study||268
10847800|NCT01081951|12014090|FG001|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
10847801|NCT01081951|12014089|FG000|NOT COMPLETED|Overall Study||56
10847802|NCT01081951|12014090|FG001|NOT COMPLETED|Overall Study||55
10847803|NCT00852696|12014096|FG000|STARTED|Overall Study||0
10847804|NCT00852696|12014097|FG001|STARTED|Overall Study||0
10847805|NCT00852696|12014096|FG000|COMPLETED|Overall Study||0
10847806|NCT00852696|12014097|FG001|COMPLETED|Overall Study||0
10847807|NCT00852696|12014096|FG000|NOT COMPLETED|Overall Study||0
10847808|NCT00852696|12014097|FG001|NOT COMPLETED|Overall Study||0
10847839|NCT00788671|12014119|FG000|STARTED|Overall Study||57
10847840|NCT00788671|12014119|FG000|COMPLETED|Overall Study||47
10847841|NCT00788671|12014119|FG000|NOT COMPLETED|Overall Study||10
10847842|NCT00367003|12014123|FG000|STARTED|Overall Study||37
10847843|NCT00367003|12014123|FG000|COMPLETED|Overall Study||28
10847844|NCT00367003|12014123|FG000|NOT COMPLETED|Overall Study||9
10847845|NCT04253834|12014129|FG000|STARTED|Overall Study||10
10847846|NCT04253834|12014130|FG001|STARTED|Overall Study||10
10847847|NCT04253834|12014129|FG000|COMPLETED|Overall Study||10
10847848|NCT04253834|12014130|FG001|COMPLETED|Overall Study||10
10847849|NCT04253834|12014129|FG000|NOT COMPLETED|Overall Study||0
10847850|NCT04253834|12014130|FG001|NOT COMPLETED|Overall Study||0
10847851|NCT03881059|12014139|FG000|STARTED|Treatment Period - Part A||66
10847852|NCT03881059|12014140|FG001|STARTED|Treatment Period - Part A||70
10847853|NCT03881059|12014141|FG002|STARTED|Treatment Period - Part A||67
10847854|NCT03881059|12014139|FG000|COMPLETED|Treatment Period - Part A||58
10847855|NCT03881059|12014140|FG001|COMPLETED|Treatment Period - Part A||63
10847856|NCT03881059|12014141|FG002|COMPLETED|Treatment Period - Part A||59
10847857|NCT03881059|12014139|FG000|NOT COMPLETED|Treatment Period - Part A||8
10847858|NCT03881059|12014140|FG001|NOT COMPLETED|Treatment Period - Part A||7
10847859|NCT03881059|12014141|FG002|NOT COMPLETED|Treatment Period - Part A||8
10847860|NCT03881059|12014139|FG000|STARTED|Treatment Period - Part B||55
10847861|NCT03881059|12014140|FG001|STARTED|Treatment Period - Part B||60
10847862|NCT03881059|12014141|FG002|STARTED|Treatment Period - Part B||58
10847863|NCT03881059|12014139|FG000|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||0
10847864|NCT03881059|12014140|FG001|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||13
10847865|NCT03881059|12014141|FG002|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||16
10847866|NCT03881059|12014139|FG000|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||55
10847867|NCT03881059|12014140|FG001|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||47
10847868|NCT03881059|12014141|FG002|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||42
10847869|NCT03881059|12014139|FG000|COMPLETED|Treatment Period - Part B||47
10847870|NCT03881059|12014140|FG001|COMPLETED|Treatment Period - Part B||54
10847871|NCT03881059|12014141|FG002|COMPLETED|Treatment Period - Part B||47
10847872|NCT03881059|12014139|FG000|NOT COMPLETED|Treatment Period - Part B||8
10847873|NCT03881059|12014140|FG001|NOT COMPLETED|Treatment Period - Part B||6
10847874|NCT03881059|12014141|FG002|NOT COMPLETED|Treatment Period - Part B||11
10847875|NCT03878277|12014154|FG000|STARTED|Overall Study||10
10847876|NCT03878277|12014154|FG000|COMPLETED|Overall Study||10
10847877|NCT03878277|12014154|FG000|NOT COMPLETED|Overall Study||0
10847878|NCT03450629|12014160|FG000|STARTED|Overall Study||341
10847879|NCT03450629|12014161|FG001|STARTED|Overall Study||341
10847880|NCT03450629|12014160|FG000|COMPLETED|Overall Study||293
10847881|NCT03450629|12014161|FG001|COMPLETED|Overall Study||307
10847882|NCT03450629|12014160|FG000|NOT COMPLETED|Overall Study||48
10847883|NCT03450629|12014161|FG001|NOT COMPLETED|Overall Study||34
10847884|NCT03367403|12014170|FG000|STARTED|Overall Study||131
10847885|NCT03367403|12014171|FG001|STARTED|Overall Study||126
10847886|NCT03367403|12014172|FG002|STARTED|Overall Study||15
10847887|NCT03367403|12014170|FG000|Received at Least One Dose of Study Drug|Overall Study||131
10847888|NCT03367403|12014171|FG001|Received at Least One Dose of Study Drug|Overall Study||125
10847889|NCT03367403|12014172|FG002|Received at Least One Dose of Study Drug|Overall Study||15
10847890|NCT03367403|12014170|FG000|COMPLETED|Overall Study||94
10847891|NCT03367403|12014171|FG001|COMPLETED|Overall Study||93
10847892|NCT03367403|12014172|FG002|COMPLETED|Overall Study||12
10847893|NCT03367403|12014170|FG000|NOT COMPLETED|Overall Study||37
10847894|NCT03367403|12014171|FG001|NOT COMPLETED|Overall Study||33
10847895|NCT03367403|12014172|FG002|NOT COMPLETED|Overall Study||3
10847896|NCT03286426|12014180|FG000|STARTED|Overall Study||3
10847897|NCT03286426|12014180|FG000|COMPLETED|Overall Study||0
10847898|NCT03286426|12014180|FG000|NOT COMPLETED|Overall Study||3
10847900|NCT03135249|12014184|FG000|COMPLETED|Overall Study|Eight patient completed the study.|7
10847901|NCT03135249|12014184|FG000|NOT COMPLETED|Overall Study||2
10847902|NCT02818582|12014190|FG000|STARTED|Overall Study||20
10847903|NCT02818582|12014191|FG001|STARTED|Overall Study||18
10847904|NCT02818582|12014190|FG000|COMPLETED|Overall Study||20
10847905|NCT02818582|12014191|FG001|COMPLETED|Overall Study||18
10847906|NCT02818582|12014190|FG000|NOT COMPLETED|Overall Study||0
10847907|NCT02818582|12014191|FG001|NOT COMPLETED|Overall Study||0
10847908|NCT02809677|12014197|FG000|STARTED|Overall Study||205
10847909|NCT02809677|12014197|FG000|COMPLETED|Overall Study||197
10847910|NCT02809677|12014197|FG000|NOT COMPLETED|Overall Study||8
10847911|NCT02728258|12014202|FG000|STARTED|Overall Study||11
10847912|NCT02728258|12014202|FG000|COMPLETED|Overall Study||11
10847913|NCT02728258|12014202|FG000|NOT COMPLETED|Overall Study||0
10847914|NCT02554253|12014208|FG000|STARTED|Overall Study||26
10847915|NCT02554253|12014209|FG001|STARTED|Overall Study||26
10847916|NCT02554253|12014208|FG000|COMPLETED|Overall Study||25
10847917|NCT02554253|12014209|FG001|COMPLETED|Overall Study||24
10847918|NCT02554253|12014208|FG000|NOT COMPLETED|Overall Study||1
10847919|NCT02554253|12014209|FG001|NOT COMPLETED|Overall Study||2
10847920|NCT01524536|12014216|FG000|STARTED|Overall Study||23
10847921|NCT01524536|12014216|FG000|COMPLETED|Overall Study||23
10847922|NCT01524536|12014216|FG000|NOT COMPLETED|Overall Study||0
10847923|NCT01307046|12014228|FG000|STARTED|Overall Study||166
10847924|NCT01307046|12014229|FG001|STARTED|Overall Study||170
10847925|NCT01307046|12014228|FG000|COMPLETED|Overall Study||154
10847926|NCT01307046|12014229|FG001|COMPLETED|Overall Study||159
10847927|NCT01307046|12014228|FG000|NOT COMPLETED|Overall Study||12
10847928|NCT01307046|12014229|FG001|NOT COMPLETED|Overall Study||11
10847929|NCT01307033|12014237|FG000|STARTED|8-week Double-blind Period||144
10847930|NCT01307033|12014238|FG001|STARTED|8-week Double-blind Period||134
10847931|NCT01307033|12014239|FG002|STARTED|8-week Double-blind Period||0
10847932|NCT01307033|12014240|FG003|STARTED|8-week Double-blind Period||0
10847933|NCT01307033|12014237|FG000|COMPLETED|8-week Double-blind Period||131
10847934|NCT01307033|12014238|FG001|COMPLETED|8-week Double-blind Period||127
10847935|NCT01307033|12014239|FG002|COMPLETED|8-week Double-blind Period||0
10847936|NCT01307033|12014240|FG003|COMPLETED|8-week Double-blind Period||0
10847937|NCT01307033|12014237|FG000|NOT COMPLETED|8-week Double-blind Period||13
10847938|NCT01307033|12014238|FG001|NOT COMPLETED|8-week Double-blind Period||7
10847939|NCT01307033|12014239|FG002|NOT COMPLETED|8-week Double-blind Period||0
10847940|NCT01307033|12014240|FG003|NOT COMPLETED|8-week Double-blind Period||0
10847941|NCT01307033|12014237|FG000|STARTED|44-week Open-label Extension||0
10847942|NCT01307033|12014238|FG001|STARTED|44-week Open-label Extension||0
10847943|NCT01307033|12014239|FG002|STARTED|44-week Open-label Extension||131
10847944|NCT01307033|12014240|FG003|STARTED|44-week Open-label Extension||127
10847945|NCT01307033|12014237|FG000|COMPLETED|44-week Open-label Extension||0
10847946|NCT01307033|12014238|FG001|COMPLETED|44-week Open-label Extension||0
10847947|NCT01307033|12014239|FG002|COMPLETED|44-week Open-label Extension||120
10847948|NCT01307033|12014240|FG003|COMPLETED|44-week Open-label Extension||115
10847949|NCT01307033|12014237|FG000|NOT COMPLETED|44-week Open-label Extension||0
10847950|NCT01307033|12014238|FG001|NOT COMPLETED|44-week Open-label Extension||0
10847951|NCT01307033|12014239|FG002|NOT COMPLETED|44-week Open-label Extension||11
10847952|NCT01307033|12014240|FG003|NOT COMPLETED|44-week Open-label Extension||12
10847953|NCT00739674|12014254|FG000|STARTED|Overall Study||535
10847954|NCT00739674|12014255|FG001|STARTED|Overall Study||457
10847955|NCT00739674|12014254|FG000|Screening Failures|Overall Study||19
10847956|NCT00739674|12014255|FG001|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
10847957|NCT00739674|12014254|FG000|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
10847958|NCT00739674|12014255|FG001|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
10847959|NCT00739674|12014254|FG000|No Follow-up Data|Overall Study||33
10847960|NCT00739674|12014255|FG001|No Follow-up Data|Overall Study||18
10847961|NCT00739674|12014254|FG000|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
10847962|NCT00739674|12014255|FG001|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
10847963|NCT00739674|12014254|FG000|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
10847964|NCT00739674|12014255|FG001|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
10847965|NCT00739674|12014254|FG000|COMPLETED|Overall Study||354
10847966|NCT00739674|12014255|FG001|COMPLETED|Overall Study||335
10847967|NCT00739674|12014254|FG000|NOT COMPLETED|Overall Study||181
10847968|NCT00739674|12014255|FG001|NOT COMPLETED|Overall Study||122
10847969|NCT00546754|12014263|FG000|STARTED|Overall Study|Number of patients enrolled and randomized|425
10847970|NCT00546754|12014264|FG001|STARTED|Overall Study|Number of patients enrolled and randomized|383
10847971|NCT00546754|12014263|FG000|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
10847972|NCT00546754|12014264|FG001|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
10847973|NCT00546754|12014263|FG000|Week 6|Overall Study||396
10847974|NCT00546754|12014264|FG001|Week 6|Overall Study||347
10847975|NCT00546754|12014263|FG000|Week 12|Overall Study||375
11224306|NCT01985334|12416368|FG007|The Intention-to-treat (ITT) Population|Overall Study||811
11224307|NCT01985334|12416361|FG000|COMPLETED|Overall Study||107
11224308|NCT01985334|12416362|FG001|COMPLETED|Overall Study||303
11224309|NCT01985334|12416363|FG002|COMPLETED|Overall Study||367
11224310|NCT01985334|12416364|FG003|COMPLETED|Overall Study||1033
11224311|NCT01985334|12416365|FG004|COMPLETED|Overall Study||234
11224312|NCT01985334|12416366|FG005|COMPLETED|Overall Study||666
11224313|NCT01985334|12416367|FG006|COMPLETED|Overall Study||237
11224314|NCT01985334|12416368|FG007|COMPLETED|Overall Study||699
11224315|NCT01985334|12416361|FG000|NOT COMPLETED|Overall Study||23
11224316|NCT01985334|12416362|FG001|NOT COMPLETED|Overall Study||84
11224317|NCT01985334|12416363|FG002|NOT COMPLETED|Overall Study||53
11224318|NCT01985334|12416364|FG003|NOT COMPLETED|Overall Study||229
11224319|NCT01985334|12416365|FG004|NOT COMPLETED|Overall Study||40
11224320|NCT01985334|12416366|FG005|NOT COMPLETED|Overall Study||156
11224321|NCT01985334|12416367|FG006|NOT COMPLETED|Overall Study||37
11224322|NCT01985334|12416368|FG007|NOT COMPLETED|Overall Study||121
11224323|NCT01985360|12416402|FG000|STARTED|Overall Study||388
11224324|NCT01985360|12416403|FG001|STARTED|Overall Study||389
11224325|NCT01985360|12416402|FG000|COMPLETED|Overall Study||379
11224326|NCT01985360|12416403|FG001|COMPLETED|Overall Study||386
11224327|NCT01985360|12416402|FG000|NOT COMPLETED|Overall Study||9
11224328|NCT01985360|12416403|FG001|NOT COMPLETED|Overall Study||3
11224329|NCT01985425|12416411|FG000|STARTED|Overall Study||49
11224330|NCT01985425|12416412|FG001|STARTED|Overall Study||51
11224331|NCT01985425|12416411|FG000|COMPLETED|Overall Study||49
11224332|NCT01985425|12416412|FG001|COMPLETED|Overall Study||51
11224333|NCT01985425|12416411|FG000|NOT COMPLETED|Overall Study||0
11224334|NCT01985425|12416412|FG001|NOT COMPLETED|Overall Study||0
11224335|NCT01985542|12416420|FG000|STARTED|Overall Study||7
11224336|NCT01985542|12416421|FG001|STARTED|Overall Study||9
11224337|NCT01985542|12416420|FG000|COMPLETED|Overall Study||3
11224338|NCT01985542|12416421|FG001|COMPLETED|Overall Study||3
11224339|NCT01985542|12416420|FG000|NOT COMPLETED|Overall Study||4
10847976|NCT00546754|12014264|FG001|Week 12|Overall Study||334
10847977|NCT00546754|12014263|FG000|COMPLETED|Overall Study||375
10847978|NCT00546754|12014264|FG001|COMPLETED|Overall Study||334
10847979|NCT00546754|12014263|FG000|NOT COMPLETED|Overall Study||50
10847980|NCT00546754|12014264|FG001|NOT COMPLETED|Overall Study||49
10847981|NCT00479713|12014272|FG000|STARTED|Overall Study||314
10847982|NCT00479713|12014273|FG001|STARTED|Overall Study||304
10847983|NCT00479713|12014272|FG000|COMPLETED|Overall Study||301
10847984|NCT00479713|12014273|FG001|COMPLETED|Overall Study||295
10847985|NCT00479713|12014272|FG000|NOT COMPLETED|Overall Study||13
10847986|NCT00479713|12014273|FG001|NOT COMPLETED|Overall Study||9
10847987|NCT00406783|12014281|FG000|STARTED|Overall Study||276
10847988|NCT00406783|12014282|FG001|STARTED|Overall Study||271
10847989|NCT00406783|12014281|FG000|COMPLETED|Overall Study||262
10847990|NCT00406783|12014282|FG001|COMPLETED|Overall Study||256
10847991|NCT00406783|12014281|FG000|NOT COMPLETED|Overall Study||14
10847992|NCT00406783|12014282|FG001|NOT COMPLETED|Overall Study||15
10847993|NCT00405964|12014290|FG000|STARTED|Overall Study||360
10847994|NCT00405964|12014291|FG001|STARTED|Overall Study||356
10847995|NCT00405964|12014290|FG000|COMPLETED|Overall Study||301
10847996|NCT00405964|12014291|FG001|COMPLETED|Overall Study||261
10847997|NCT00405964|12014290|FG000|NOT COMPLETED|Overall Study||59
10847998|NCT00405964|12014291|FG001|NOT COMPLETED|Overall Study||95
10847999|NCT00383721|12014302|FG000|STARTED|26-Week Double-Blind Treatment Period||225
10848000|NCT00383721|12014303|FG001|STARTED|26-Week Double-Blind Treatment Period||239
10848001|NCT00383721|12014304|FG002|STARTED|26-Week Double-Blind Treatment Period||253
10848002|NCT00383721|12014305|FG003|STARTED|26-Week Double-Blind Treatment Period||243
10848003|NCT00383721|12014306|FG004|STARTED|26-Week Double-Blind Treatment Period||236
10848004|NCT00383721|12014302|FG000|COMPLETED|26-Week Double-Blind Treatment Period|"1 participant listed as ongoing since the participant status could not be formally confirmed."|190
10848005|NCT00383721|12014303|FG001|COMPLETED|26-Week Double-Blind Treatment Period||202
10848006|NCT00383721|12014304|FG002|COMPLETED|26-Week Double-Blind Treatment Period||202
10848007|NCT00383721|12014305|FG003|COMPLETED|26-Week Double-Blind Treatment Period||193
10848008|NCT00383721|12014306|FG004|COMPLETED|26-Week Double-Blind Treatment Period||169
10848009|NCT00383721|12014302|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
10848010|NCT00383721|12014303|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
10848011|NCT00383721|12014304|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
10848012|NCT00383721|12014305|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
10848013|NCT00383721|12014306|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
10848014|NCT00383721|12014302|FG000|STARTED|26-Week Treatment Safety Extension||145
10848015|NCT00383721|12014303|FG001|STARTED|26-Week Treatment Safety Extension||153
10848016|NCT00383721|12014304|FG002|STARTED|26-Week Treatment Safety Extension||149
10848017|NCT00383721|12014305|FG003|STARTED|26-Week Treatment Safety Extension||148
10848018|NCT00383721|12014306|FG004|STARTED|26-Week Treatment Safety Extension||8
10848019|NCT00383721|12014302|FG000|COMPLETED|26-Week Treatment Safety Extension||126
10848020|NCT00383721|12014303|FG001|COMPLETED|26-Week Treatment Safety Extension||136
10848021|NCT00383721|12014304|FG002|COMPLETED|26-Week Treatment Safety Extension||126
10848022|NCT00383721|12014305|FG003|COMPLETED|26-Week Treatment Safety Extension||131
10848023|NCT00383721|12014306|FG004|COMPLETED|26-Week Treatment Safety Extension||8
10848024|NCT00383721|12014302|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||19
11224340|NCT01985542|12416421|FG001|NOT COMPLETED|Overall Study||6
11224341|NCT01985581|12416430|FG000|STARTED|First Intervention||25
11224342|NCT01985581|12416431|FG001|STARTED|First Intervention||25
10848025|NCT00383721|12014303|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||17
10848026|NCT00383721|12014304|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||23
10848027|NCT00383721|12014305|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||17
10848028|NCT00383721|12014306|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||0
10848029|NCT00383552|12014322|FG000|STARTED|Overall Study||182
10848030|NCT00383552|12014323|FG001|STARTED|Overall Study||188
10848031|NCT00383552|12014324|FG002|STARTED|Overall Study||188
10848032|NCT00383552|12014325|FG003|STARTED|Overall Study||188
10848033|NCT00383552|12014322|FG000|COMPLETED|Overall Study||146
10848034|NCT00383552|12014323|FG001|COMPLETED|Overall Study||147
11105759|NCT01255423|12290109|FG000|NOT COMPLETED|Overall Study||3
11105760|NCT01255423|12290110|FG001|NOT COMPLETED|Overall Study||3
11105761|NCT01255436|12290118|FG000|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
11105762|NCT01255436|12290119|FG001|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
11105763|NCT01255436|12290118|FG000|COMPLETED|Overall Study||151
10848035|NCT00383552|12014324|FG002|COMPLETED|Overall Study||127
10848036|NCT00383552|12014325|FG003|COMPLETED|Overall Study||116
10848037|NCT00383552|12014322|FG000|NOT COMPLETED|Overall Study||36
10848038|NCT00383552|12014323|FG001|NOT COMPLETED|Overall Study||41
10848039|NCT00383552|12014324|FG002|NOT COMPLETED|Overall Study||61
10848040|NCT00383552|12014325|FG003|NOT COMPLETED|Overall Study||72
10848041|NCT00383435|12014345|FG000|STARTED|26-Week Double-Blind Treatment Period||217
10848042|NCT00383435|12014346|FG001|STARTED|26-Week Double-Blind Treatment Period||207
10848043|NCT00383435|12014347|FG002|STARTED|26-Week Double-Blind Treatment Period||210
10848044|NCT00383435|12014348|FG003|STARTED|26-Week Double-Blind Treatment Period||209
10848045|NCT00383435|12014349|FG004|STARTED|26-Week Double-Blind Treatment Period||212
10848046|NCT00383435|12014345|FG000|COMPLETED|26-Week Double-Blind Treatment Period||176
10848047|NCT00383435|12014346|FG001|COMPLETED|26-Week Double-Blind Treatment Period||169
10848048|NCT00383435|12014347|FG002|COMPLETED|26-Week Double-Blind Treatment Period||164
10848049|NCT00383435|12014348|FG003|COMPLETED|26-Week Double-Blind Treatment Period||172
10848050|NCT00383435|12014349|FG004|COMPLETED|26-Week Double-Blind Treatment Period||159
10848051|NCT00383435|12014345|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
10848052|NCT00383435|12014346|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
10848053|NCT00383435|12014347|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
10848054|NCT00383435|12014348|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
10848055|NCT00383435|12014349|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
10848056|NCT00383435|12014345|FG000|STARTED|26-Week Treatment Safety Extension||131
10848057|NCT00383435|12014346|FG001|STARTED|26-Week Treatment Safety Extension||130
10848058|NCT00383435|12014347|FG002|STARTED|26-Week Treatment Safety Extension||124
10848059|NCT00383435|12014348|FG003|STARTED|26-Week Treatment Safety Extension||131
10848060|NCT00383435|12014349|FG004|STARTED|26-Week Treatment Safety Extension||13
10848061|NCT00383435|12014345|FG000|COMPLETED|26-Week Treatment Safety Extension||117
10848062|NCT00383435|12014346|FG001|COMPLETED|26-Week Treatment Safety Extension||121
10848063|NCT00383435|12014347|FG002|COMPLETED|26-Week Treatment Safety Extension||108
10848064|NCT00383435|12014348|FG003|COMPLETED|26-Week Treatment Safety Extension||116
10848065|NCT00383435|12014349|FG004|COMPLETED|26-Week Treatment Safety Extension||10
10848066|NCT00383435|12014345|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||14
10848067|NCT00383435|12014346|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||9
10848068|NCT00383435|12014347|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||16
10848069|NCT00383435|12014348|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||15
10848070|NCT00383435|12014349|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||3
10848071|NCT00381485|12014364|FG000|STARTED|Open-Label Run-In Period||834
10848072|NCT00381485|12014365|FG001|STARTED|Open-Label Run-In Period||0
10848073|NCT00381485|12014366|FG002|STARTED|Open-Label Run-In Period||0
10848074|NCT00381485|12014367|FG003|STARTED|Open-Label Run-In Period||0
10848075|NCT00381485|12014364|FG000|COMPLETED|Open-Label Run-In Period||728
10848076|NCT00381485|12014365|FG001|COMPLETED|Open-Label Run-In Period||0
10848077|NCT00381485|12014366|FG002|COMPLETED|Open-Label Run-In Period||0
10848078|NCT00381485|12014367|FG003|COMPLETED|Open-Label Run-In Period||0
10848079|NCT00381485|12014364|FG000|NOT COMPLETED|Open-Label Run-In Period||106
10848080|NCT00381485|12014365|FG001|NOT COMPLETED|Open-Label Run-In Period||0
10848081|NCT00381485|12014366|FG002|NOT COMPLETED|Open-Label Run-In Period||0
10848082|NCT00381485|12014367|FG003|NOT COMPLETED|Open-Label Run-In Period||0
10848083|NCT00381485|12014364|FG000|STARTED|Double-Blind Treatment Period||0
10848084|NCT00381485|12014365|FG001|STARTED|Double-Blind Treatment Period||255
10848085|NCT00381485|12014366|FG002|STARTED|Double-Blind Treatment Period||233
10848086|NCT00381485|12014367|FG003|STARTED|Double-Blind Treatment Period||240
10848087|NCT00381485|12014364|FG000|COMPLETED|Double-Blind Treatment Period||0
10848088|NCT00381485|12014365|FG001|COMPLETED|Double-Blind Treatment Period||228
10848089|NCT00381485|12014366|FG002|COMPLETED|Double-Blind Treatment Period||208
10848090|NCT00381485|12014367|FG003|COMPLETED|Double-Blind Treatment Period||207
10848091|NCT00381485|12014364|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10848092|NCT00381485|12014365|FG001|NOT COMPLETED|Double-Blind Treatment Period||27
10848093|NCT00381485|12014366|FG002|NOT COMPLETED|Double-Blind Treatment Period||25
10848094|NCT00381485|12014367|FG003|NOT COMPLETED|Double-Blind Treatment Period||33
10848095|NCT00379288|12014380|FG000|STARTED|Overall Study||141
10848096|NCT00379288|12014381|FG001|STARTED|Overall Study||130
10848097|NCT00379288|12014382|FG002|STARTED|Overall Study||68
10848098|NCT00379288|12014383|FG003|STARTED|Overall Study||65
11105764|NCT01255436|12290119|FG001|COMPLETED|Overall Study||135
10848099|NCT00379288|12014380|FG000|COMPLETED|Overall Study||122
10848100|NCT00379288|12014381|FG001|COMPLETED|Overall Study||108
10848101|NCT00379288|12014382|FG002|COMPLETED|Overall Study||58
10848102|NCT00379288|12014383|FG003|COMPLETED|Overall Study||57
10848103|NCT00379288|12014380|FG000|NOT COMPLETED|Overall Study||19
10848104|NCT00379288|12014381|FG001|NOT COMPLETED|Overall Study||22
10848105|NCT00379288|12014382|FG002|NOT COMPLETED|Overall Study||10
10848106|NCT00379288|12014383|FG003|NOT COMPLETED|Overall Study||8
10848107|NCT00378378|12014396|FG000|STARTED|Overall Study||51
10848108|NCT00378378|12014397|FG001|STARTED|Overall Study||50
10848109|NCT00378378|12014398|FG002|STARTED|Overall Study||26
10848110|NCT00378378|12014396|FG000|COMPLETED|Overall Study||51
10848111|NCT00378378|12014397|FG001|COMPLETED|Overall Study||49
10848112|NCT00378378|12014398|FG002|COMPLETED|Overall Study||24
10848113|NCT00378378|12014396|FG000|NOT COMPLETED|Overall Study||0
10848114|NCT00378378|12014397|FG001|NOT COMPLETED|Overall Study||1
10848115|NCT00378378|12014398|FG002|NOT COMPLETED|Overall Study||2
10848116|NCT00089895|12014408|FG000|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
10848117|NCT00089895|12014409|FG001|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
10848118|NCT00089895|12014408|FG000|COMPLETED|Overall Study|Number of Subjects treated|4687
10848119|NCT00089895|12014409|FG001|COMPLETED|Overall Study|Number of Subjects treated|4642
10848120|NCT00089895|12014408|FG000|NOT COMPLETED|Overall Study||35
10848121|NCT00089895|12014409|FG001|NOT COMPLETED|Overall Study||42
11224343|NCT01985581|12416430|FG000|COMPLETED|First Intervention||22
10848122|NCT02577354|12014417|FG000|STARTED|Overall Study||102
10848123|NCT02577354|12014418|FG001|STARTED|Overall Study||102
10848124|NCT02577354|12014417|FG000|120 Day Primary Endpoint|Overall Study||100
10848125|NCT02577354|12014418|FG001|120 Day Primary Endpoint|Overall Study||101
10848126|NCT02577354|12014417|FG000|COMPLETED|Overall Study||87
10848127|NCT02577354|12014418|FG001|COMPLETED|Overall Study||89
10848128|NCT02577354|12014417|FG000|NOT COMPLETED|Overall Study||15
10848129|NCT02577354|12014418|FG001|NOT COMPLETED|Overall Study||13
10848130|NCT02471807|12014434|FG000|STARTED|Overall Study||34
10848131|NCT02471807|12014434|FG000|COMPLETED|Overall Study||11
10848132|NCT02471807|12014434|FG000|NOT COMPLETED|Overall Study||23
11105765|NCT01255436|12290118|FG000|NOT COMPLETED|Overall Study||182
11105766|NCT01255436|12290119|FG001|NOT COMPLETED|Overall Study||194
10848136|NCT02118610|12014444|FG000|STARTED|Overall Study||30
10848137|NCT02118610|12014445|FG001|STARTED|Overall Study||33
10848138|NCT02118610|12014444|FG000|COMPLETED|Overall Study||29
10848139|NCT02118610|12014445|FG001|COMPLETED|Overall Study||32
10848140|NCT02118610|12014444|FG000|NOT COMPLETED|Overall Study||1
10848141|NCT02118610|12014445|FG001|NOT COMPLETED|Overall Study||1
10848142|NCT01909570|12014453|FG000|STARTED|Overall Study||84
10848143|NCT01909570|12014454|FG001|STARTED|Overall Study||91
10848144|NCT01909570|12014453|FG000|COMPLETED|Overall Study||57
10848145|NCT01909570|12014454|FG001|COMPLETED|Overall Study||64
10848146|NCT01909570|12014453|FG000|NOT COMPLETED|Overall Study||27
10848147|NCT01909570|12014454|FG001|NOT COMPLETED|Overall Study||27
10848148|NCT01453946|12014460|FG000|STARTED|Overall Study||50
10848149|NCT01453946|12014460|FG000|COMPLETED|Overall Study||41
10848150|NCT01453946|12014460|FG000|NOT COMPLETED|Overall Study||9
10848151|NCT01444092|12014464|FG000|STARTED|Overall Study||108
10848152|NCT01444092|12014464|FG000|INFORMED CONSENT OBTAINED|Overall Study||108
10848153|NCT01444092|12014464|FG000|COMPLETED|Overall Study||91
10848154|NCT01444092|12014464|FG000|NOT COMPLETED|Overall Study||17
10848155|NCT01265784|12014471|FG000|STARTED|Overall Study||56
10848156|NCT01265784|12014472|FG001|STARTED|Overall Study||57
10848157|NCT01265784|12014473|FG002|STARTED|Overall Study||30
10848158|NCT01265784|12014471|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
10848159|NCT01265784|12014472|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56
10848160|NCT01265784|12014473|FG002|Received at Least 1 Dose of Study Drug|Overall Study||29
10848161|NCT01265784|12014471|FG000|COMPLETED|Overall Study||44
10848162|NCT01265784|12014472|FG001|COMPLETED|Overall Study||49
10848163|NCT01265784|12014473|FG002|COMPLETED|Overall Study||26
10848164|NCT01265784|12014471|FG000|NOT COMPLETED|Overall Study||12
10848165|NCT01265784|12014472|FG001|NOT COMPLETED|Overall Study||8
10848166|NCT01265784|12014473|FG002|NOT COMPLETED|Overall Study||4
10848167|NCT00577577|12014483|FG000|STARTED|Overall Study||34
10848168|NCT00577577|12014484|FG001|STARTED|Overall Study||35
10848169|NCT00577577|12014483|FG000|Received Treatment|Overall Study||34
10848170|NCT00577577|12014484|FG001|Received Treatment|Overall Study||35
10848171|NCT00577577|12014483|FG000|COMPLETED|Overall Study||29
10848172|NCT00577577|12014484|FG001|COMPLETED|Overall Study||30
10848173|NCT00577577|12014483|FG000|NOT COMPLETED|Overall Study||5
10848174|NCT00577577|12014484|FG001|NOT COMPLETED|Overall Study||5
10848175|NCT00392327|12014498|FG000|STARTED|Overall Study||87
10848176|NCT00392327|12014499|FG001|STARTED|Overall Study||93
10848177|NCT00392327|12014500|FG002|STARTED|Overall Study||56
10848178|NCT00392327|12014501|FG003|STARTED|Overall Study||58
10848179|NCT00392327|12014502|FG004|STARTED|Overall Study||23
10848180|NCT00392327|12014503|FG005|STARTED|Overall Study||19
10848181|NCT00392327|12014504|FG006|STARTED|Overall Study||21
10848182|NCT00392327|12014505|FG007|STARTED|Overall Study||22
10848183|NCT00392327|12014498|FG000|COMPLETED|Overall Study||72
10848184|NCT00392327|12014499|FG001|COMPLETED|Overall Study||74
10848185|NCT00392327|12014500|FG002|COMPLETED|Overall Study||36
10848186|NCT00392327|12014501|FG003|COMPLETED|Overall Study||42
10848187|NCT00392327|12014502|FG004|COMPLETED|Overall Study||20
10848188|NCT00392327|12014503|FG005|COMPLETED|Overall Study||14
10848189|NCT00392327|12014504|FG006|COMPLETED|Overall Study||12
10848190|NCT00392327|12014505|FG007|COMPLETED|Overall Study||11
10848191|NCT00392327|12014498|FG000|NOT COMPLETED|Overall Study||15
10848192|NCT00392327|12014499|FG001|NOT COMPLETED|Overall Study||19
10848193|NCT00392327|12014500|FG002|NOT COMPLETED|Overall Study||20
10848194|NCT00392327|12014501|FG003|NOT COMPLETED|Overall Study||16
10848195|NCT00392327|12014502|FG004|NOT COMPLETED|Overall Study||3
10848196|NCT00392327|12014503|FG005|NOT COMPLETED|Overall Study||5
10848197|NCT00392327|12014504|FG006|NOT COMPLETED|Overall Study||9
10848198|NCT00392327|12014505|FG007|NOT COMPLETED|Overall Study||11
10848199|NCT00085202|12014525|FG000|STARTED|Overall Study||269
10848200|NCT00085202|12014526|FG001|STARTED|Overall Study||144
10848201|NCT00085202|12014525|FG000|COMPLETED|Overall Study||251
10848202|NCT00085202|12014526|FG001|COMPLETED|Overall Study||120
10848203|NCT00085202|12014525|FG000|NOT COMPLETED|Overall Study||18
10848204|NCT00085202|12014526|FG001|NOT COMPLETED|Overall Study||24
10848205|NCT05007639|12014545|FG000|STARTED|Overall Study||274
10848206|NCT05007639|12014545|FG000|COMPLETED|Overall Study||274
10848207|NCT05007639|12014545|FG000|NOT COMPLETED|Overall Study||0
10848208|NCT04739735|12014551|FG000|STARTED|Overall Study||25
10848209|NCT04739735|12014552|FG001|STARTED|Overall Study||25
10848210|NCT04739735|12014551|FG000|COMPLETED|Overall Study||25
10848211|NCT04739735|12014552|FG001|COMPLETED|Overall Study||25
10848212|NCT04739735|12014551|FG000|NOT COMPLETED|Overall Study||0
10848213|NCT04739735|12014552|FG001|NOT COMPLETED|Overall Study||0
10848214|NCT04552535|12014560|FG000|STARTED|Overall Study||99
10848215|NCT04552535|12014561|FG001|STARTED|Overall Study||101
10848216|NCT04552535|12014560|FG000|COMPLETED|Overall Study||99
10848217|NCT04552535|12014561|FG001|COMPLETED|Overall Study||101
10848218|NCT04552535|12014560|FG000|NOT COMPLETED|Overall Study||0
10848219|NCT04552535|12014561|FG001|NOT COMPLETED|Overall Study||0
10848220|NCT04502472|12014572|FG000|STARTED|Overall Study||61
10848221|NCT04502472|12014573|FG001|STARTED|Overall Study||48
10848222|NCT04502472|12014572|FG000|COMPLETED|Overall Study||58
10848223|NCT04502472|12014573|FG001|COMPLETED|Overall Study||45
10848224|NCT04502472|12014572|FG000|NOT COMPLETED|Overall Study||3
10848225|NCT04502472|12014573|FG001|NOT COMPLETED|Overall Study||3
10848226|NCT04495166|12014582|FG000|STARTED|Overall Study||37
10848227|NCT04495166|12014583|FG001|STARTED|Overall Study||44
10848228|NCT04495166|12014582|FG000|COMPLETED|Overall Study||30
10848229|NCT04495166|12014583|FG001|COMPLETED|Overall Study||41
10848230|NCT04495166|12014582|FG000|NOT COMPLETED|Overall Study||7
10848231|NCT04495166|12014583|FG001|NOT COMPLETED|Overall Study||3
10848316|NCT04172467|12014698|FG000|STARTED|Overall Study||1086
11354611|NCT03074162|12551712|FG001|STARTED|Period 1 Including Washout 1||8
11354612|NCT03074162|12551713|FG002|STARTED|Period 1 Including Washout 1||8
11354613|NCT03074162|12551714|FG003|STARTED|Period 1 Including Washout 1||8
11354614|NCT03074162|12551715|FG004|STARTED|Period 1 Including Washout 1||8
11354615|NCT03074162|12551716|FG005|STARTED|Period 1 Including Washout 1||8
11354616|NCT03074162|12551711|FG000|COMPLETED|Period 1 Including Washout 1||8
11354617|NCT03074162|12551712|FG001|COMPLETED|Period 1 Including Washout 1||8
11354618|NCT03074162|12551713|FG002|COMPLETED|Period 1 Including Washout 1||7
11354619|NCT03074162|12551714|FG003|COMPLETED|Period 1 Including Washout 1||8
11354620|NCT03074162|12551715|FG004|COMPLETED|Period 1 Including Washout 1||8
11354621|NCT03074162|12551716|FG005|COMPLETED|Period 1 Including Washout 1||8
11354622|NCT03074162|12551711|FG000|NOT COMPLETED|Period 1 Including Washout 1||0
11354623|NCT03074162|12551712|FG001|NOT COMPLETED|Period 1 Including Washout 1||0
11354624|NCT03074162|12551713|FG002|NOT COMPLETED|Period 1 Including Washout 1||1
11354625|NCT03074162|12551714|FG003|NOT COMPLETED|Period 1 Including Washout 1||0
11354626|NCT03074162|12551715|FG004|NOT COMPLETED|Period 1 Including Washout 1||0
11354627|NCT03074162|12551716|FG005|NOT COMPLETED|Period 1 Including Washout 1||0
11354628|NCT03074162|12551711|FG000|STARTED|Period 2 Including Washout 2||8
11354629|NCT03074162|12551712|FG001|STARTED|Period 2 Including Washout 2||8
11354630|NCT03074162|12551713|FG002|STARTED|Period 2 Including Washout 2||7
11354631|NCT03074162|12551714|FG003|STARTED|Period 2 Including Washout 2||8
11354632|NCT03074162|12551715|FG004|STARTED|Period 2 Including Washout 2||8
11354633|NCT03074162|12551716|FG005|STARTED|Period 2 Including Washout 2||8
11354634|NCT03074162|12551711|FG000|COMPLETED|Period 2 Including Washout 2||8
11354635|NCT03074162|12551712|FG001|COMPLETED|Period 2 Including Washout 2||8
11354636|NCT03074162|12551713|FG002|COMPLETED|Period 2 Including Washout 2||6
11354637|NCT03074162|12551714|FG003|COMPLETED|Period 2 Including Washout 2||8
11354638|NCT03074162|12551715|FG004|COMPLETED|Period 2 Including Washout 2||8
11354639|NCT03074162|12551716|FG005|COMPLETED|Period 2 Including Washout 2||7
11354640|NCT03074162|12551711|FG000|NOT COMPLETED|Period 2 Including Washout 2||0
11354641|NCT03074162|12551712|FG001|NOT COMPLETED|Period 2 Including Washout 2||0
11354642|NCT03074162|12551713|FG002|NOT COMPLETED|Period 2 Including Washout 2||1
11354643|NCT03074162|12551714|FG003|NOT COMPLETED|Period 2 Including Washout 2||0
11354644|NCT03074162|12551715|FG004|NOT COMPLETED|Period 2 Including Washout 2||0
11354645|NCT03074162|12551716|FG005|NOT COMPLETED|Period 2 Including Washout 2||1
11354646|NCT03074162|12551711|FG000|STARTED|Period 3||8
11354647|NCT03074162|12551712|FG001|STARTED|Period 3||8
11354648|NCT03074162|12551713|FG002|STARTED|Period 3||6
11354649|NCT03074162|12551714|FG003|STARTED|Period 3||8
11354650|NCT03074162|12551715|FG004|STARTED|Period 3||8
11354651|NCT03074162|12551716|FG005|STARTED|Period 3||7
11354652|NCT03074162|12551711|FG000|COMPLETED|Period 3||7
11354653|NCT03074162|12551712|FG001|COMPLETED|Period 3||8
10848317|NCT04172467|12014698|FG000|COMPLETED|Overall Study||1086
10848318|NCT04172467|12014698|FG000|NOT COMPLETED|Overall Study||0
11105767|NCT01255449|12290125|FG000|STARTED|Overall Study||26
11105768|NCT01255449|12290125|FG000|COMPLETED|Overall Study||26
11105769|NCT01255449|12290125|FG000|NOT COMPLETED|Overall Study||0
11354654|NCT03074162|12551713|FG002|COMPLETED|Period 3||6
11354655|NCT03074162|12551714|FG003|COMPLETED|Period 3||8
11354656|NCT03074162|12551715|FG004|COMPLETED|Period 3||7
11354657|NCT03074162|12551716|FG005|COMPLETED|Period 3||7
11354658|NCT03074162|12551711|FG000|NOT COMPLETED|Period 3||1
11354659|NCT03074162|12551712|FG001|NOT COMPLETED|Period 3||0
11354660|NCT03074162|12551713|FG002|NOT COMPLETED|Period 3||0
11354661|NCT03074162|12551714|FG003|NOT COMPLETED|Period 3||0
10848322|NCT03963011|12014711|FG000|STARTED|Overall Study||8
10848323|NCT03963011|12014712|FG001|STARTED|Overall Study||6
10848324|NCT03963011|12014711|FG000|COMPLETED|Overall Study||8
10848232|NCT04461483|12014595|FG000|STARTED|Part 1 (Day 1)||6
10848233|NCT04461483|12014596|FG001|STARTED|Part 1 (Day 1)||6
10848234|NCT04461483|12014597|FG002|STARTED|Part 1 (Day 1)||6
10848235|NCT04461483|12014598|FG003|STARTED|Part 1 (Day 1)||6
10848236|NCT04461483|12014599|FG004|STARTED|Part 1 (Day 1)||0
10848237|NCT04461483|12014600|FG005|STARTED|Part 1 (Day 1)||0
10848238|NCT04461483|12014595|FG000|COMPLETED|Part 1 (Day 1)||6
10848239|NCT04461483|12014596|FG001|COMPLETED|Part 1 (Day 1)||6
10848240|NCT04461483|12014597|FG002|COMPLETED|Part 1 (Day 1)||6
10848241|NCT04461483|12014598|FG003|COMPLETED|Part 1 (Day 1)||6
10848242|NCT04461483|12014599|FG004|COMPLETED|Part 1 (Day 1)||0
10848243|NCT04461483|12014600|FG005|COMPLETED|Part 1 (Day 1)||0
10848244|NCT04461483|12014595|FG000|NOT COMPLETED|Part 1 (Day 1)||0
10848245|NCT04461483|12014596|FG001|NOT COMPLETED|Part 1 (Day 1)||0
10848246|NCT04461483|12014597|FG002|NOT COMPLETED|Part 1 (Day 1)||0
10848247|NCT04461483|12014598|FG003|NOT COMPLETED|Part 1 (Day 1)||0
10848248|NCT04461483|12014599|FG004|NOT COMPLETED|Part 1 (Day 1)||0
10848249|NCT04461483|12014600|FG005|NOT COMPLETED|Part 1 (Day 1)||0
10848250|NCT04461483|12014595|FG000|STARTED|Part 2 (Day 1 to 21)||0
10848251|NCT04461483|12014596|FG001|STARTED|Part 2 (Day 1 to 21)||0
10848252|NCT04461483|12014597|FG002|STARTED|Part 2 (Day 1 to 21)||0
10848253|NCT04461483|12014598|FG003|STARTED|Part 2 (Day 1 to 21)||0
10848254|NCT04461483|12014599|FG004|STARTED|Part 2 (Day 1 to 21)||3
10848255|NCT04461483|12014600|FG005|STARTED|Part 2 (Day 1 to 21)||6
10848256|NCT04461483|12014595|FG000|COMPLETED|Part 2 (Day 1 to 21)||0
10848257|NCT04461483|12014596|FG001|COMPLETED|Part 2 (Day 1 to 21)||0
10848258|NCT04461483|12014597|FG002|COMPLETED|Part 2 (Day 1 to 21)||0
10848259|NCT04461483|12014598|FG003|COMPLETED|Part 2 (Day 1 to 21)||0
10848260|NCT04461483|12014599|FG004|COMPLETED|Part 2 (Day 1 to 21)||3
10848261|NCT04461483|12014600|FG005|COMPLETED|Part 2 (Day 1 to 21)||6
10848262|NCT04461483|12014595|FG000|NOT COMPLETED|Part 2 (Day 1 to 21)||0
10848263|NCT04461483|12014596|FG001|NOT COMPLETED|Part 2 (Day 1 to 21)||0
10848264|NCT04461483|12014597|FG002|NOT COMPLETED|Part 2 (Day 1 to 21)||0
10848265|NCT04461483|12014598|FG003|NOT COMPLETED|Part 2 (Day 1 to 21)||0
10848266|NCT04461483|12014599|FG004|NOT COMPLETED|Part 2 (Day 1 to 21)||0
10848267|NCT04461483|12014600|FG005|NOT COMPLETED|Part 2 (Day 1 to 21)||0
10848268|NCT04386616|12014627|FG000|STARTED|Overall Study||134
10848269|NCT04386616|12014628|FG001|STARTED|Overall Study||130
10848270|NCT04386616|12014629|FG002|STARTED|Overall Study||132
10848271|NCT04386616|12014627|FG000|Received at Least One Dose of Study Drug|Overall Study|In this arm, 68 and 66 participants received MSTT1041A-matched placebo and UTTR1147A-matched placebo, respectively.|134
10848272|NCT04386616|12014628|FG001|Received at Least One Dose of Study Drug|Overall Study||130
10848273|NCT04386616|12014629|FG002|Received at Least One Dose of Study Drug|Overall Study||132
10848274|NCT04386616|12014627|FG000|Completed Both Doses of Study Drug at Day 15|Overall Study||31
10848275|NCT04386616|12014628|FG001|Completed Both Doses of Study Drug at Day 15|Overall Study||27
10848276|NCT04386616|12014629|FG002|Completed Both Doses of Study Drug at Day 15|Overall Study||25
10848277|NCT04386616|12014627|FG000|COMPLETED|Overall Study||104
10848278|NCT04386616|12014628|FG001|COMPLETED|Overall Study||95
10848279|NCT04386616|12014629|FG002|COMPLETED|Overall Study||104
10848280|NCT04386616|12014627|FG000|NOT COMPLETED|Overall Study||30
10848281|NCT04386616|12014628|FG001|NOT COMPLETED|Overall Study||35
10848282|NCT04386616|12014629|FG002|NOT COMPLETED|Overall Study||28
10848283|NCT04377711|12014648|FG000|STARTED|Overall Study||197
10848284|NCT04377711|12014649|FG001|STARTED|Overall Study||203
10848285|NCT04377711|12014648|FG000|COMPLETED|Overall Study||178
10848286|NCT04377711|12014649|FG001|COMPLETED|Overall Study||181
10848287|NCT04377711|12014648|FG000|NOT COMPLETED|Overall Study||19
10848288|NCT04377711|12014649|FG001|NOT COMPLETED|Overall Study||22
10848289|NCT04347408|12014655|FG000|STARTED|Overall Study||992
10848290|NCT04347408|12014655|FG000|COMPLETED|Overall Study||992
10848291|NCT04347408|12014655|FG000|NOT COMPLETED|Overall Study||0
10848292|NCT04296942|12014662|FG000|STARTED|Overall Study||1
10848293|NCT04296942|12014663|FG001|STARTED|Overall Study||0
10848294|NCT04296942|12014664|FG002|STARTED|Overall Study||0
10848295|NCT04296942|12014662|FG000|COMPLETED|Overall Study||0
10848296|NCT04296942|12014663|FG001|COMPLETED|Overall Study||0
10848297|NCT04296942|12014664|FG002|COMPLETED|Overall Study||0
10848298|NCT04296942|12014662|FG000|NOT COMPLETED|Overall Study||1
10848299|NCT04296942|12014663|FG001|NOT COMPLETED|Overall Study||0
10848300|NCT04296942|12014664|FG002|NOT COMPLETED|Overall Study||0
10848301|NCT04278872|12014676|FG000|STARTED|Overall Study||7
10848302|NCT04278872|12014677|FG001|STARTED|Overall Study||6
11354662|NCT03074162|12551715|FG004|NOT COMPLETED|Period 3||1
10848303|NCT04278872|12014676|FG000|COMPLETED|Overall Study||4
10848304|NCT04278872|12014677|FG001|COMPLETED|Overall Study||5
10848305|NCT04278872|12014676|FG000|NOT COMPLETED|Overall Study||3
10848306|NCT04278872|12014677|FG001|NOT COMPLETED|Overall Study||1
10848307|NCT04213807|12014686|FG000|STARTED|Overall Study||5
10848308|NCT04213807|12014687|FG001|STARTED|Overall Study||6
10848309|NCT04213807|12014688|FG002|STARTED|Overall Study||7
10848310|NCT04213807|12014686|FG000|COMPLETED|Overall Study||5
10848311|NCT04213807|12014687|FG001|COMPLETED|Overall Study||6
10848312|NCT04213807|12014688|FG002|COMPLETED|Overall Study||6
10848313|NCT04213807|12014686|FG000|NOT COMPLETED|Overall Study||0
10848314|NCT04213807|12014687|FG001|NOT COMPLETED|Overall Study||0
10848315|NCT04213807|12014688|FG002|NOT COMPLETED|Overall Study||1
10848325|NCT03963011|12014712|FG001|COMPLETED|Overall Study||6
10848326|NCT03963011|12014711|FG000|NOT COMPLETED|Overall Study||0
10848327|NCT03963011|12014712|FG001|NOT COMPLETED|Overall Study||0
10848328|NCT03894501|12014720|FG000|STARTED|Overall Study||15
10848329|NCT03894501|12014721|FG001|STARTED|Overall Study||15
10848330|NCT03894501|12014720|FG000|COMPLETED|Overall Study||15
10848331|NCT03894501|12014721|FG001|COMPLETED|Overall Study||15
10848332|NCT03894501|12014720|FG000|NOT COMPLETED|Overall Study||0
10848333|NCT03894501|12014721|FG001|NOT COMPLETED|Overall Study||0
11105770|NCT01255592|12290132|FG000|STARTED|Overall Study||26
11105771|NCT01255592|12290133|FG001|STARTED|Overall Study||26
11105772|NCT01255592|12290132|FG000|COMPLETED|Overall Study||20
10848337|NCT03735420|12014748|FG000|STARTED|Overall Study||16
10848338|NCT03735420|12014749|FG001|STARTED|Overall Study||14
10848339|NCT03735420|12014748|FG000|COMPLETED|Overall Study||16
10848340|NCT03735420|12014749|FG001|COMPLETED|Overall Study||14
10848341|NCT03735420|12014748|FG000|NOT COMPLETED|Overall Study||0
10848342|NCT03735420|12014749|FG001|NOT COMPLETED|Overall Study||0
10848343|NCT03721328|12014757|FG000|STARTED|Overall Study||15
10848344|NCT03721328|12014757|FG000|COMPLETED|Overall Study||15
10848345|NCT03721328|12014757|FG000|NOT COMPLETED|Overall Study||0
10848346|NCT03721107|12014765|FG000|STARTED|Overall Study||80
10848347|NCT03721107|12014766|FG001|STARTED|Overall Study||84
10848348|NCT03721107|12014767|FG002|STARTED|Overall Study||98
10848349|NCT03721107|12014768|FG003|STARTED|Overall Study||104
10848350|NCT03721107|12014765|FG000|Treated|Overall Study||80
10848351|NCT03721107|12014766|FG001|Treated|Overall Study||84
10848352|NCT03721107|12014767|FG002|Treated|Overall Study||97
10848353|NCT03721107|12014768|FG003|Treated|Overall Study||104
10848354|NCT03721107|12014765|FG000|COMPLETED|Overall Study||75
10848355|NCT03721107|12014766|FG001|COMPLETED|Overall Study||81
10848356|NCT03721107|12014767|FG002|COMPLETED|Overall Study||83
10848357|NCT03721107|12014768|FG003|COMPLETED|Overall Study||92
10848358|NCT03721107|12014765|FG000|NOT COMPLETED|Overall Study||5
10848359|NCT03721107|12014766|FG001|NOT COMPLETED|Overall Study||3
10848360|NCT03721107|12014767|FG002|NOT COMPLETED|Overall Study||15
10848361|NCT03721107|12014768|FG003|NOT COMPLETED|Overall Study||12
10848362|NCT03691727|12014780|FG000|STARTED|Overall Study||18
10848363|NCT03691727|12014781|FG001|STARTED|Overall Study||12
10848364|NCT03691727|12014780|FG000|COMPLETED|Overall Study||16
10848365|NCT03691727|12014781|FG001|COMPLETED|Overall Study||11
10848366|NCT03691727|12014780|FG000|NOT COMPLETED|Overall Study||2
10848367|NCT03691727|12014781|FG001|NOT COMPLETED|Overall Study||1
10848368|NCT03689920|12014789|FG000|STARTED|Overall Study||47
10848369|NCT03689920|12014790|FG001|STARTED|Overall Study||52
10848370|NCT03689920|12014789|FG000|COMPLETED|Overall Study||41
10848371|NCT03689920|12014790|FG001|COMPLETED|Overall Study||48
10848372|NCT03689920|12014789|FG000|NOT COMPLETED|Overall Study||6
10848373|NCT03689920|12014790|FG001|NOT COMPLETED|Overall Study||4
10848374|NCT03672227|12014798|FG000|STARTED|Overall Study||112
10848375|NCT03672227|12014799|FG001|STARTED|Overall Study||52
10848376|NCT03672227|12014798|FG000|Teachers Started|Overall Study||8
10848377|NCT03672227|12014799|FG001|Teachers Started|Overall Study||6
10848378|NCT03672227|12014798|FG000|Children Started|Overall Study||52
10848379|NCT03672227|12014799|FG001|Children Started|Overall Study||23
10848380|NCT03672227|12014798|FG000|Parents Started|Overall Study||52
10848381|NCT03672227|12014799|FG001|Parents Started|Overall Study||23
10848382|NCT03672227|12014798|FG000|COMPLETED|Overall Study||105
10848383|NCT03672227|12014799|FG001|COMPLETED|Overall Study||52
10848384|NCT03672227|12014798|FG000|NOT COMPLETED|Overall Study||7
10848385|NCT03672227|12014799|FG001|NOT COMPLETED|Overall Study||0
10848386|NCT03644849|12014808|FG000|STARTED|Overall Study||24
10848387|NCT03644849|12014809|FG001|STARTED|Overall Study||24
10848388|NCT03644849|12014808|FG000|COMPLETED|Overall Study||23
10848389|NCT03644849|12014809|FG001|COMPLETED|Overall Study||21
10848390|NCT03644849|12014808|FG000|NOT COMPLETED|Overall Study||1
10848391|NCT03644849|12014809|FG001|NOT COMPLETED|Overall Study||3
10848392|NCT03604159|12014817|FG000|STARTED|Overall Study||26
10848393|NCT03604159|12014818|FG001|STARTED|Overall Study||26
10848394|NCT03604159|12014817|FG000|COMPLETED|Overall Study||20
10848395|NCT03604159|12014818|FG001|COMPLETED|Overall Study||19
10848396|NCT03604159|12014817|FG000|NOT COMPLETED|Overall Study||6
10848397|NCT03604159|12014818|FG001|NOT COMPLETED|Overall Study||7
10848398|NCT03602885|12014826|FG000|STARTED|Overall Study||5
10848399|NCT03602885|12014827|FG001|STARTED|Overall Study||5
10848400|NCT03602885|12014826|FG000|COMPLETED|Overall Study||2
10848401|NCT03602885|12014827|FG001|COMPLETED|Overall Study||5
10848402|NCT03602885|12014826|FG000|NOT COMPLETED|Overall Study||3
10848403|NCT03602885|12014827|FG001|NOT COMPLETED|Overall Study||0
10848404|NCT03539601|12014837|FG000|STARTED|Overall Study||60
11105773|NCT01255592|12290133|FG001|COMPLETED|Overall Study||25
10848405|NCT03539601|12014838|FG001|STARTED|Overall Study||59
10848406|NCT03539601|12014839|FG002|STARTED|Overall Study||71
10848407|NCT03539601|12014840|FG003|STARTED|Overall Study||47
10848408|NCT03539601|12014837|FG000|Treated|Overall Study||59
10848409|NCT03539601|12014838|FG001|Treated|Overall Study||58
10848410|NCT03539601|12014839|FG002|Treated|Overall Study||71
10848411|NCT03539601|12014840|FG003|Treated|Overall Study||47
10848412|NCT03539601|12014837|FG000|COMPLETED|Overall Study||54
10848413|NCT03539601|12014838|FG001|COMPLETED|Overall Study||52
10848414|NCT03539601|12014839|FG002|COMPLETED|Overall Study||65
10848415|NCT03539601|12014840|FG003|COMPLETED|Overall Study||46
10848416|NCT03539601|12014837|FG000|NOT COMPLETED|Overall Study||6
10848417|NCT03539601|12014838|FG001|NOT COMPLETED|Overall Study||7
10848418|NCT03539601|12014839|FG002|NOT COMPLETED|Overall Study||6
10848419|NCT03539601|12014840|FG003|NOT COMPLETED|Overall Study||1
10848420|NCT03539458|12014858|FG000|STARTED|Overall Study||11
10848421|NCT03539458|12014858|FG000|COMPLETED|Overall Study||10
10848422|NCT03539458|12014858|FG000|NOT COMPLETED|Overall Study||1
10848423|NCT03532451|12014864|FG000|STARTED|Overall Study||13
10848424|NCT03532451|12014865|FG001|STARTED|Overall Study||30
10848425|NCT03532451|12014864|FG000|COMPLETED|Overall Study||12
10848426|NCT03532451|12014865|FG001|COMPLETED|Overall Study||29
10848427|NCT03532451|12014864|FG000|NOT COMPLETED|Overall Study||1
10848428|NCT03532451|12014865|FG001|NOT COMPLETED|Overall Study||1
11105774|NCT01255592|12290132|FG000|NOT COMPLETED|Overall Study||6
11105775|NCT01255592|12290133|FG001|NOT COMPLETED|Overall Study||1
11105776|NCT01255631|12290142|FG000|STARTED|Overall Study||13
11105777|NCT01255631|12290143|FG001|STARTED|Overall Study||9
11105778|NCT01255631|12290142|FG000|COMPLETED|Overall Study|study terminated due to poor enrollment|4
11105779|NCT01255631|12290143|FG001|COMPLETED|Overall Study|study terminated due to poor enrollment|3
11105780|NCT01255631|12290142|FG000|NOT COMPLETED|Overall Study||9
11105781|NCT01255631|12290143|FG001|NOT COMPLETED|Overall Study||6
10848437|NCT03494647|12014882|FG000|STARTED|Overall Study||21
10848438|NCT03494647|12014883|FG001|STARTED|Overall Study||22
10848439|NCT03494647|12014882|FG000|COMPLETED|Overall Study||16
10848440|NCT03494647|12014883|FG001|COMPLETED|Overall Study||16
10848441|NCT03494647|12014882|FG000|NOT COMPLETED|Overall Study||5
10848442|NCT03494647|12014883|FG001|NOT COMPLETED|Overall Study||6
10848443|NCT03439657|12014891|FG000|STARTED|Overall Study||449
10848444|NCT03439657|12014892|FG001|STARTED|Overall Study||463
10848445|NCT03439657|12014891|FG000|COMPLETED|Overall Study||442
10848446|NCT03439657|12014892|FG001|COMPLETED|Overall Study||459
10848447|NCT03439657|12014891|FG000|NOT COMPLETED|Overall Study||7
10848448|NCT03439657|12014892|FG001|NOT COMPLETED|Overall Study||4
10848449|NCT03377790|12014902|FG000|STARTED|Overall Study||160
10848450|NCT03377790|12014903|FG001|STARTED|Overall Study||106
10848451|NCT03377790|12014902|FG000|COMPLETED|Overall Study||150
10848452|NCT03377790|12014903|FG001|COMPLETED|Overall Study||100
10848453|NCT03377790|12014902|FG000|NOT COMPLETED|Overall Study||10
10848454|NCT03377790|12014903|FG001|NOT COMPLETED|Overall Study||6
10848455|NCT03353675|12014909|FG000|STARTED|Overall Study||44
10848456|NCT03353675|12014909|FG000|COMPLETED|Overall Study||40
10848457|NCT03353675|12014909|FG000|NOT COMPLETED|Overall Study||4
10848458|NCT03294109|12014915|FG000|STARTED|Overall Study||46
10848459|NCT03294109|12014916|FG001|STARTED|Overall Study||57
10848460|NCT03294109|12014915|FG000|Underwent Surgery|Overall Study||40
10848461|NCT03294109|12014916|FG001|Underwent Surgery|Overall Study||52
10848462|NCT03294109|12014915|FG000|COMPLETED|Overall Study||40
10848463|NCT03294109|12014916|FG001|COMPLETED|Overall Study||52
10848464|NCT03294109|12014915|FG000|NOT COMPLETED|Overall Study||6
10848465|NCT03294109|12014916|FG001|NOT COMPLETED|Overall Study||5
10848466|NCT03268005|12014925|FG000|STARTED|Overall Study||546
10848467|NCT03268005|12014926|FG001|STARTED|Overall Study||545
10848468|NCT03268005|12014925|FG000|Full Analysis Set|Overall Study||546
10848469|NCT03268005|12014926|FG001|Full Analysis Set|Overall Study||545
10848470|NCT03268005|12014925|FG000|Safety Analysis Set|Overall Study||544
10848471|NCT03268005|12014926|FG001|Safety Analysis Set|Overall Study||544
10848472|NCT03268005|12014925|FG000|COMPLETED|Overall Study||531
10848473|NCT03268005|12014926|FG001|COMPLETED|Overall Study||531
10848474|NCT03268005|12014925|FG000|NOT COMPLETED|Overall Study||15
10848475|NCT03268005|12014926|FG001|NOT COMPLETED|Overall Study||14
10848476|NCT03225170|12014935|FG000|STARTED|Overall Study||23
10848477|NCT03225170|12014936|FG001|STARTED|Overall Study||22
10848478|NCT03225170|12014937|FG002|STARTED|Overall Study||2
10848479|NCT03225170|12014935|FG000|COMPLETED|Overall Study||19
10848480|NCT03225170|12014936|FG001|COMPLETED|Overall Study||17
10848481|NCT03225170|12014937|FG002|COMPLETED|Overall Study||2
10848482|NCT03225170|12014935|FG000|NOT COMPLETED|Overall Study||4
10848483|NCT03225170|12014936|FG001|NOT COMPLETED|Overall Study||5
10848484|NCT03225170|12014937|FG002|NOT COMPLETED|Overall Study||0
10848485|NCT03220854|12014946|FG000|STARTED|Overall Study||4
10848486|NCT03220854|12014947|FG001|STARTED|Overall Study||0
10848487|NCT03220854|12014948|FG002|STARTED|Overall Study||1
10848488|NCT03220854|12014946|FG000|COMPLETED|Overall Study||4
10848489|NCT03220854|12014947|FG001|COMPLETED|Overall Study||0
10848490|NCT03220854|12014948|FG002|COMPLETED|Overall Study||1
10848491|NCT03220854|12014946|FG000|NOT COMPLETED|Overall Study||0
10848492|NCT03220854|12014947|FG001|NOT COMPLETED|Overall Study||0
10848493|NCT03220854|12014948|FG002|NOT COMPLETED|Overall Study||0
10848494|NCT03219034|12014961|FG000|STARTED|Overall Study||31
10848495|NCT03219034|12014962|FG001|STARTED|Overall Study||31
10848496|NCT03219034|12014961|FG000|COMPLETED|Overall Study||20
10848497|NCT03219034|12014962|FG001|COMPLETED|Overall Study||16
10848498|NCT03219034|12014961|FG000|NOT COMPLETED|Overall Study||11
10848499|NCT03219034|12014962|FG001|NOT COMPLETED|Overall Study||15
10848500|NCT03168438|12014972|FG000|STARTED|Overall Study||3
10848501|NCT03168438|12014973|FG001|STARTED|Overall Study||3
10848502|NCT03168438|12014972|FG000|COMPLETED|Overall Study||3
10848503|NCT03168438|12014973|FG001|COMPLETED|Overall Study||2
10848504|NCT03168438|12014972|FG000|NOT COMPLETED|Overall Study||0
10848505|NCT03168438|12014973|FG001|NOT COMPLETED|Overall Study||1
10848506|NCT03110380|12014982|FG000|STARTED|Double-Blind Treatment Phase||284
10848507|NCT03110380|12014983|FG001|STARTED|Double-Blind Treatment Phase||283
10848508|NCT03110380|12014984|FG002|STARTED|Double-Blind Treatment Phase||0
10848509|NCT03110380|12014985|FG003|STARTED|Double-Blind Treatment Phase||0
10848510|NCT03110380|12014982|FG000|Safety Analysis Set|Double-Blind Treatment Phase||284
10848511|NCT03110380|12014983|FG001|Safety Analysis Set|Double-Blind Treatment Phase||281
10848512|NCT03110380|12014984|FG002|Safety Analysis Set|Double-Blind Treatment Phase||0
10848513|NCT03110380|12014985|FG003|Safety Analysis Set|Double-Blind Treatment Phase||0
10848514|NCT03110380|12014982|FG000|COMPLETED|Double-Blind Treatment Phase||263
10848515|NCT03110380|12014983|FG001|COMPLETED|Double-Blind Treatment Phase||253
10848516|NCT03110380|12014984|FG002|COMPLETED|Double-Blind Treatment Phase||0
10848517|NCT03110380|12014985|FG003|COMPLETED|Double-Blind Treatment Phase||0
10848518|NCT03110380|12014982|FG000|NOT COMPLETED|Double-Blind Treatment Phase||21
10848519|NCT03110380|12014983|FG001|NOT COMPLETED|Double-Blind Treatment Phase||30
10848520|NCT03110380|12014984|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0
10848521|NCT03110380|12014985|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
10848522|NCT03110380|12014982|FG000|STARTED|Open-label B/F/TAF Extension Phase|Following the end of Double-Blind treatment phase, participants in a country where B/F/TAF FDC was not available were given the option to receive open-label B/F/TAF.|0
10848523|NCT03110380|12014983|FG001|STARTED|Open-label B/F/TAF Extension Phase|Following the end of Double-Blind treatment phase, participants in a country where B/F/TAF FDC was not available were given the option to receive open-label B/F/TAF.|0
10848524|NCT03110380|12014984|FG002|STARTED|Open-label B/F/TAF Extension Phase|138 participants completed the Double-Blind treatment phase, but did not continue in the Open-label B/F/TAF extension phase.|125
10848525|NCT03110380|12014985|FG003|STARTED|Open-label B/F/TAF Extension Phase|137 participants completed the Double-Blind treatment phase, but did not continue in the Open-label B/F/TAF extension phase.|116
10848526|NCT03110380|12014982|FG000|COMPLETED|Open-label B/F/TAF Extension Phase||0
10848527|NCT03110380|12014983|FG001|COMPLETED|Open-label B/F/TAF Extension Phase||0
10848528|NCT03110380|12014984|FG002|COMPLETED|Open-label B/F/TAF Extension Phase||121
10848529|NCT03110380|12014985|FG003|COMPLETED|Open-label B/F/TAF Extension Phase||113
10848530|NCT03110380|12014982|FG000|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0
10848531|NCT03110380|12014983|FG001|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0
10848532|NCT03110380|12014984|FG002|NOT COMPLETED|Open-label B/F/TAF Extension Phase||4
10848533|NCT03110380|12014985|FG003|NOT COMPLETED|Open-label B/F/TAF Extension Phase||3
10848534|NCT03109262|12014993|FG000|STARTED|Overall Study||42
10848535|NCT03109262|12014993|FG000|COMPLETED|Overall Study||42
10848536|NCT03109262|12014993|FG000|NOT COMPLETED|Overall Study||0
10848537|NCT03078478|12015001|FG000|STARTED|Titration Period (16 Weeks)||805
10848538|NCT03078478|12015002|FG001|STARTED|Titration Period (16 Weeks)||804
10848539|NCT03078478|12015001|FG000|Full Analysis Set|Titration Period (16 Weeks)||805
10848540|NCT03078478|12015002|FG001|Full Analysis Set|Titration Period (16 Weeks)||804
10848541|NCT03078478|12015001|FG000|Safety Analysis Set|Titration Period (16 Weeks)||802
10848542|NCT03078478|12015002|FG001|Safety Analysis Set|Titration Period (16 Weeks)||798
10848543|NCT03078478|12015001|FG000|COMPLETED|Titration Period (16 Weeks)||805
10848544|NCT03078478|12015002|FG001|COMPLETED|Titration Period (16 Weeks)||804
10848545|NCT03078478|12015001|FG000|NOT COMPLETED|Titration Period (16 Weeks)||0
10848546|NCT03078478|12015002|FG001|NOT COMPLETED|Titration Period (16 Weeks)||0
10848547|NCT03078478|12015001|FG000|STARTED|Maintenance Period 1 (36 Weeks)||805
10848548|NCT03078478|12015002|FG001|STARTED|Maintenance Period 1 (36 Weeks)||804
10848549|NCT03078478|12015001|FG000|COMPLETED|Maintenance Period 1 (36 Weeks)||758
10848550|NCT03078478|12015002|FG001|COMPLETED|Maintenance Period 1 (36 Weeks)||761
10848551|NCT03078478|12015001|FG000|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||47
11224344|NCT01985581|12416431|FG001|COMPLETED|First Intervention||23
11224345|NCT01985581|12416430|FG000|NOT COMPLETED|First Intervention||3
11224346|NCT01985581|12416431|FG001|NOT COMPLETED|First Intervention||2
11224347|NCT01985581|12416430|FG000|STARTED|Second Intervention||22
11224348|NCT01985581|12416431|FG001|STARTED|Second Intervention||23
11224349|NCT01985581|12416430|FG000|COMPLETED|Second Intervention||20
11224350|NCT01985581|12416431|FG001|COMPLETED|Second Intervention||19
11224351|NCT01985581|12416430|FG000|NOT COMPLETED|Second Intervention||2
11224352|NCT01985581|12416431|FG001|NOT COMPLETED|Second Intervention||4
11224353|NCT01985685|12416450|FG000|STARTED|Overall Study||27
11224354|NCT01985685|12416451|FG001|STARTED|Overall Study||29
11224355|NCT01985685|12416450|FG000|COMPLETED|Overall Study||27
11224356|NCT01985685|12416451|FG001|COMPLETED|Overall Study||29
11224357|NCT01985685|12416450|FG000|NOT COMPLETED|Overall Study||0
11224358|NCT01985685|12416451|FG001|NOT COMPLETED|Overall Study||0
11224359|NCT01985763|12416457|FG000|STARTED|Overall Study||13
11224360|NCT01985763|12416457|FG000|COMPLETED|Overall Study||13
11224361|NCT01985763|12416457|FG000|NOT COMPLETED|Overall Study||0
11224362|NCT01985932|12416462|FG000|STARTED|Overall Study||15
11224363|NCT01985932|12416462|FG000|COMPLETED|Overall Study||15
11224364|NCT01985932|12416462|FG000|NOT COMPLETED|Overall Study||0
11354663|NCT03074162|12551716|FG005|NOT COMPLETED|Period 3||0
11354664|NCT03074331|12551724|FG000|STARTED|Overall Study||130
11354665|NCT03074331|12551724|FG000|COMPLETED|Overall Study||123
11224365|NCT01985958|12416466|FG000|STARTED|Overall Study||4
11224366|NCT01985958|12416466|FG000|COMPLETED|Overall Study||3
11224367|NCT01985958|12416466|FG000|NOT COMPLETED|Overall Study||1
11224368|NCT01985971|12416470|FG000|STARTED|Overall Study||2
11224369|NCT01985971|12416470|FG000|COMPLETED|Overall Study||1
11224370|NCT01985971|12416470|FG000|NOT COMPLETED|Overall Study||1
11224371|NCT01986010|12416491|FG000|STARTED|Overall Study||13
11224372|NCT01986010|12416492|FG001|STARTED|Overall Study||14
11224373|NCT01986010|12416493|FG002|STARTED|Overall Study||14
11224374|NCT01986010|12416494|FG003|STARTED|Overall Study||10
11224375|NCT01986010|12416495|FG004|STARTED|Overall Study||11
11224376|NCT01986010|12416496|FG005|STARTED|Overall Study||19
11224377|NCT01986010|12416497|FG006|STARTED|Overall Study||10
11224378|NCT01986010|12416498|FG007|STARTED|Overall Study||4
11224379|NCT01986010|12416499|FG008|STARTED|Overall Study||12
11224380|NCT01986010|12416500|FG009|STARTED|Overall Study||10
11224381|NCT01986010|12416501|FG010|STARTED|Overall Study||10
11224382|NCT01986010|12416502|FG011|STARTED|Overall Study||11
11224383|NCT01986010|12416503|FG012|STARTED|Overall Study||10
11224384|NCT01986010|12416504|FG013|STARTED|Overall Study||11
11224385|NCT01986010|12416505|FG014|STARTED|Overall Study||16
11224386|NCT01986010|12416506|FG015|STARTED|Overall Study||11
11224387|NCT01986010|12416507|FG016|STARTED|Overall Study||4
11224388|NCT01986010|12416491|FG000|Vaccination 1|Overall Study||13
11224389|NCT01986010|12416492|FG001|Vaccination 1|Overall Study||14
11224390|NCT01986010|12416493|FG002|Vaccination 1|Overall Study||14
11224391|NCT01986010|12416494|FG003|Vaccination 1|Overall Study||10
11224392|NCT01986010|12416495|FG004|Vaccination 1|Overall Study||11
11224393|NCT01986010|12416496|FG005|Vaccination 1|Overall Study||19
11224394|NCT01986010|12416497|FG006|Vaccination 1|Overall Study||10
11224395|NCT01986010|12416498|FG007|Vaccination 1|Overall Study||4
11224396|NCT01986010|12416499|FG008|Vaccination 1|Overall Study||12
11224397|NCT01986010|12416500|FG009|Vaccination 1|Overall Study||10
11224398|NCT01986010|12416501|FG010|Vaccination 1|Overall Study||10
11224399|NCT01986010|12416502|FG011|Vaccination 1|Overall Study||11
11224400|NCT01986010|12416503|FG012|Vaccination 1|Overall Study||10
11224401|NCT01986010|12416504|FG013|Vaccination 1|Overall Study||11
11224402|NCT01986010|12416505|FG014|Vaccination 1|Overall Study||16
11224403|NCT01986010|12416506|FG015|Vaccination 1|Overall Study||11
11224404|NCT01986010|12416507|FG016|Vaccination 1|Overall Study||4
11224405|NCT01986010|12416491|FG000|Vaccination 2|Overall Study||12
11224406|NCT01986010|12416492|FG001|Vaccination 2|Overall Study||13
11224407|NCT01986010|12416493|FG002|Vaccination 2|Overall Study||12
11224408|NCT01986010|12416494|FG003|Vaccination 2|Overall Study||10
11224409|NCT01986010|12416495|FG004|Vaccination 2|Overall Study||9
11224410|NCT01986010|12416496|FG005|Vaccination 2|Overall Study||19
11224411|NCT01986010|12416497|FG006|Vaccination 2|Overall Study||10
11224412|NCT01986010|12416498|FG007|Vaccination 2|Overall Study||4
11224413|NCT01986010|12416499|FG008|Vaccination 2|Overall Study||11
11224414|NCT01986010|12416500|FG009|Vaccination 2|Overall Study||10
10848552|NCT03078478|12015002|FG001|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||43
10848553|NCT03078478|12015001|FG000|STARTED|Maintencance Period 2 (36 Weeks)||758
10848554|NCT03078478|12015002|FG001|STARTED|Maintencance Period 2 (36 Weeks)||761
10848555|NCT03078478|12015001|FG000|COMPLETED|Maintencance Period 2 (36 Weeks)||733
10848556|NCT03078478|12015002|FG001|COMPLETED|Maintencance Period 2 (36 Weeks)||734
10848557|NCT03078478|12015001|FG000|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||25
10848558|NCT03078478|12015002|FG001|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||27
10848559|NCT03040661|12015010|FG000|STARTED|Overall Study||35
10848560|NCT03040661|12015011|FG001|STARTED|Overall Study||35
10848561|NCT03040661|12015010|FG000|COMPLETED|Overall Study||35
10848562|NCT03040661|12015011|FG001|COMPLETED|Overall Study||35
10848563|NCT03040661|12015010|FG000|NOT COMPLETED|Overall Study||0
10848564|NCT03040661|12015011|FG001|NOT COMPLETED|Overall Study||0
10848565|NCT02993263|12015017|FG000|STARTED|Overall Study||323
10848566|NCT02993263|12015017|FG000|COMPLETED|Overall Study||0
10848567|NCT02993263|12015017|FG000|NOT COMPLETED|Overall Study||323
10848568|NCT02985684|12015021|FG000|STARTED|6-Month Clinical Success Evaluation||125
10848569|NCT02985684|12015021|FG000|COMPLETED|6-Month Clinical Success Evaluation||120
10848570|NCT02985684|12015021|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||5
10848571|NCT02985684|12015021|FG000|STARTED|6-Month Closure Success Evaluation||120
10848572|NCT02985684|12015021|FG000|COMPLETED|6-Month Closure Success Evaluation||112
10848573|NCT02985684|12015021|FG000|NOT COMPLETED|6-Month Closure Success Evaluation||8
10848574|NCT02964897|12015027|FG000|STARTED|Overall Study||43
10848575|NCT02964897|12015028|FG001|STARTED|Overall Study||36
10848576|NCT02964897|12015027|FG000|COMPLETED|Overall Study||43
10848577|NCT02964897|12015028|FG001|COMPLETED|Overall Study||36
10848578|NCT02964897|12015027|FG000|NOT COMPLETED|Overall Study||0
10848579|NCT02964897|12015028|FG001|NOT COMPLETED|Overall Study||0
10848580|NCT02873195|12015036|FG000|STARTED|Overall Study||87
10848581|NCT02873195|12015037|FG001|STARTED|Overall Study||46
10848582|NCT02873195|12015036|FG000|Never Began Treatment (Cancel)|Overall Study||1
10848583|NCT02873195|12015037|FG001|Never Began Treatment (Cancel)|Overall Study||0
10848584|NCT02873195|12015036|FG000|COMPLETED|Overall Study||82
10848585|NCT02873195|12015037|FG001|COMPLETED|Overall Study||46
10848586|NCT02873195|12015036|FG000|NOT COMPLETED|Overall Study||5
10848587|NCT02873195|12015037|FG001|NOT COMPLETED|Overall Study||0
10848588|NCT02809131|12015045|FG000|STARTED|Overall Study||505
10848589|NCT02809131|12015046|FG001|STARTED|Overall Study||505
11224415|NCT01986010|12416501|FG010|Vaccination 2|Overall Study||10
10848590|NCT02809131|12015045|FG000|COMPLETED|Overall Study||445
10848591|NCT02809131|12015046|FG001|COMPLETED|Overall Study||445
10848592|NCT02809131|12015045|FG000|NOT COMPLETED|Overall Study||60
10848593|NCT02809131|12015046|FG001|NOT COMPLETED|Overall Study||60
10848594|NCT02785952|12015054|FG000|STARTED|Overall Study||125
10848595|NCT02785952|12015055|FG001|STARTED|Overall Study||127
10848596|NCT02785952|12015054|FG000|COMPLETED|Overall Study||0
10848597|NCT02785952|12015055|FG001|COMPLETED|Overall Study||0
10848598|NCT02785952|12015054|FG000|NOT COMPLETED|Overall Study||125
10848599|NCT02785952|12015055|FG001|NOT COMPLETED|Overall Study||127
10848603|NCT02748616|12015067|FG000|STARTED|Overall Study||9
10848604|NCT02748616|12015067|FG000|COMPLETED|Overall Study||2
10848605|NCT02748616|12015067|FG000|NOT COMPLETED|Overall Study||7
10848606|NCT02719522|12015071|FG000|STARTED|Overall Study|In 1 consented subject, device deployment was not attempted due to significant arterial stenosis.|204
10848607|NCT02719522|12015071|FG000|COMPLETED|Overall Study||193
10848608|NCT02719522|12015071|FG000|NOT COMPLETED|Overall Study||11
11105782|NCT01255670|12290151|FG000|STARTED|Overall Study||100
11105783|NCT01255670|12290152|FG001|STARTED|Overall Study||100
11105784|NCT01255670|12290151|FG000|COMPLETED|Overall Study||74
11105785|NCT01255670|12290152|FG001|COMPLETED|Overall Study||80
11105786|NCT01255670|12290151|FG000|NOT COMPLETED|Overall Study||26
11105787|NCT01255670|12290152|FG001|NOT COMPLETED|Overall Study||20
10848618|NCT02585232|12015092|FG000|STARTED|Overall Study||40
10848619|NCT02585232|12015093|FG001|STARTED|Overall Study||42
10848620|NCT02585232|12015092|FG000|COMPLETED|Overall Study||28
10848621|NCT02585232|12015093|FG001|COMPLETED|Overall Study||26
10848622|NCT02585232|12015092|FG000|NOT COMPLETED|Overall Study||12
10848623|NCT02585232|12015093|FG001|NOT COMPLETED|Overall Study||16
11224416|NCT01986010|12416502|FG011|Vaccination 2|Overall Study||10
11224417|NCT01986010|12416503|FG012|Vaccination 2|Overall Study||10
11224418|NCT01986010|12416504|FG013|Vaccination 2|Overall Study||9
11224419|NCT01986010|12416505|FG014|Vaccination 2|Overall Study||16
11224420|NCT01986010|12416506|FG015|Vaccination 2|Overall Study||10
11224421|NCT01986010|12416507|FG016|Vaccination 2|Overall Study||4
11224422|NCT01986010|12416491|FG000|Vaccination 3|Overall Study||10
11224423|NCT01986010|12416492|FG001|Vaccination 3|Overall Study||10
11224424|NCT01986010|12416493|FG002|Vaccination 3|Overall Study||9
11224425|NCT01986010|12416494|FG003|Vaccination 3|Overall Study||10
11224426|NCT01986010|12416495|FG004|Vaccination 3|Overall Study||9
11224427|NCT01986010|12416496|FG005|Vaccination 3|Overall Study||15
11224428|NCT01986010|12416497|FG006|Vaccination 3|Overall Study||10
11224429|NCT01986010|12416498|FG007|Vaccination 3|Overall Study||4
11224430|NCT01986010|12416499|FG008|Vaccination 3|Overall Study||10
11224431|NCT01986010|12416500|FG009|Vaccination 3|Overall Study||10
11224432|NCT01986010|12416501|FG010|Vaccination 3|Overall Study||10
11224433|NCT01986010|12416502|FG011|Vaccination 3|Overall Study||8
11224434|NCT01986010|12416503|FG012|Vaccination 3|Overall Study||10
11224435|NCT01986010|12416504|FG013|Vaccination 3|Overall Study||9
11224436|NCT01986010|12416505|FG014|Vaccination 3|Overall Study||13
11224437|NCT01986010|12416506|FG015|Vaccination 3|Overall Study||10
11224438|NCT01986010|12416507|FG016|Vaccination 3|Overall Study||4
11224439|NCT01986010|12416491|FG000|COMPLETED|Overall Study||7
11224440|NCT01986010|12416492|FG001|COMPLETED|Overall Study||6
11224441|NCT01986010|12416493|FG002|COMPLETED|Overall Study||7
11224442|NCT01986010|12416494|FG003|COMPLETED|Overall Study||8
11224443|NCT01986010|12416495|FG004|COMPLETED|Overall Study||6
11224444|NCT01986010|12416496|FG005|COMPLETED|Overall Study||11
11224445|NCT01986010|12416497|FG006|COMPLETED|Overall Study||10
11224446|NCT01986010|12416498|FG007|COMPLETED|Overall Study||4
11224447|NCT01986010|12416499|FG008|COMPLETED|Overall Study||6
11224448|NCT01986010|12416500|FG009|COMPLETED|Overall Study||7
11224449|NCT01986010|12416501|FG010|COMPLETED|Overall Study||3
11224450|NCT01986010|12416502|FG011|COMPLETED|Overall Study||1
11224451|NCT01986010|12416503|FG012|COMPLETED|Overall Study||0
11224452|NCT01986010|12416504|FG013|COMPLETED|Overall Study||0
11224453|NCT01986010|12416505|FG014|COMPLETED|Overall Study||6
11224454|NCT01986010|12416506|FG015|COMPLETED|Overall Study||0
11224455|NCT01986010|12416507|FG016|COMPLETED|Overall Study||0
11224456|NCT01986010|12416491|FG000|NOT COMPLETED|Overall Study||6
11224457|NCT01986010|12416492|FG001|NOT COMPLETED|Overall Study||8
11224458|NCT01986010|12416493|FG002|NOT COMPLETED|Overall Study||7
11224459|NCT01986010|12416494|FG003|NOT COMPLETED|Overall Study||2
11224460|NCT01986010|12416495|FG004|NOT COMPLETED|Overall Study||5
11224461|NCT01986010|12416496|FG005|NOT COMPLETED|Overall Study||8
11224462|NCT01986010|12416497|FG006|NOT COMPLETED|Overall Study||0
11224463|NCT01986010|12416498|FG007|NOT COMPLETED|Overall Study||0
10848639|NCT02556606|12015125|FG000|STARTED|Overall Study||4
10848640|NCT02556606|12015126|FG001|STARTED|Overall Study||5
10848641|NCT02556606|12015127|FG002|STARTED|Overall Study||11
11224464|NCT01986010|12416499|FG008|NOT COMPLETED|Overall Study||6
11224465|NCT01986010|12416500|FG009|NOT COMPLETED|Overall Study||3
11224466|NCT01986010|12416501|FG010|NOT COMPLETED|Overall Study||7
10848642|NCT02556606|12015128|FG003|STARTED|Overall Study||13
10848643|NCT02556606|12015125|FG000|COMPLETED|Overall Study||4
10848644|NCT02556606|12015126|FG001|COMPLETED|Overall Study||5
10848645|NCT02556606|12015127|FG002|COMPLETED|Overall Study||11
10848646|NCT02556606|12015128|FG003|COMPLETED|Overall Study||13
11105788|NCT01255722|12290161|FG000|STARTED|Overall Study||155
11105789|NCT01255722|12290162|FG001|STARTED|Overall Study||160
11105790|NCT01255722|12290163|FG002|STARTED|Overall Study||153
11105791|NCT01255722|12290161|FG000|COMPLETED|Overall Study||152
10848647|NCT02556606|12015125|FG000|NOT COMPLETED|Overall Study||0
10848648|NCT02556606|12015126|FG001|NOT COMPLETED|Overall Study||0
10848649|NCT02556606|12015127|FG002|NOT COMPLETED|Overall Study||0
10848650|NCT02556606|12015128|FG003|NOT COMPLETED|Overall Study||0
10848651|NCT02545283|12015144|FG000|STARTED|Overall Study||149
10848652|NCT02545283|12015145|FG001|STARTED|Overall Study||298
10848653|NCT02545283|12015144|FG000|Received Treatment|Overall Study||149
10848654|NCT02545283|12015145|FG001|Received Treatment|Overall Study||292
10848655|NCT02545283|12015144|FG000|Safety Follow Up|Overall Study|I participant was not treated and 1 participant entered from the Idasanutlin arm|149
10848656|NCT02545283|12015145|FG001|Safety Follow Up|Overall Study|5 participants were not treated, 1 participant did not receive Idasanutlin and was moved to the Placebo arm|292
10848657|NCT02545283|12015144|FG000|COMPLETED|Overall Study||0
10848658|NCT02545283|12015145|FG001|COMPLETED|Overall Study||0
10848659|NCT02545283|12015144|FG000|NOT COMPLETED|Overall Study||149
10848660|NCT02545283|12015145|FG001|NOT COMPLETED|Overall Study||298
10848661|NCT02524171|12015155|FG000|STARTED|6-month Follow-up||172
10848662|NCT02524171|12015156|FG001|STARTED|6-month Follow-up||169
10848663|NCT02524171|12015155|FG000|COMPLETED|6-month Follow-up||119
10848664|NCT02524171|12015156|FG001|COMPLETED|6-month Follow-up||124
10848665|NCT02524171|12015155|FG000|NOT COMPLETED|6-month Follow-up||53
11224467|NCT01986010|12416502|FG011|NOT COMPLETED|Overall Study||10
11224468|NCT01986010|12416503|FG012|NOT COMPLETED|Overall Study||10
11224469|NCT01986010|12416504|FG013|NOT COMPLETED|Overall Study||11
11224470|NCT01986010|12416505|FG014|NOT COMPLETED|Overall Study||10
11224471|NCT01986010|12416506|FG015|NOT COMPLETED|Overall Study||11
11224472|NCT01986010|12416507|FG016|NOT COMPLETED|Overall Study||4
11224473|NCT01986062|12416555|FG000|STARTED|Overall Study||47
11224474|NCT01986062|12416556|FG001|STARTED|Overall Study||50
11224475|NCT01986062|12416555|FG000|COMPLETED|Overall Study||46
11224476|NCT01986062|12416556|FG001|COMPLETED|Overall Study||49
11224477|NCT01986062|12416555|FG000|NOT COMPLETED|Overall Study||1
11224478|NCT01986062|12416556|FG001|NOT COMPLETED|Overall Study||1
11224479|NCT01986140|12416564|FG000|STARTED|Overall Study||157
11224480|NCT01986140|12416565|FG001|STARTED|Overall Study||79
11224481|NCT01986140|12416564|FG000|COMPLETED|Overall Study||122
11224482|NCT01986140|12416565|FG001|COMPLETED|Overall Study||51
11224483|NCT01986140|12416564|FG000|NOT COMPLETED|Overall Study||35
11224484|NCT01986140|12416565|FG001|NOT COMPLETED|Overall Study||28
11224485|NCT01986231|12416571|FG000|STARTED|Overall Study||12
11224486|NCT01986231|12416571|FG000|COMPLETED|Overall Study||11
11224487|NCT01986231|12416571|FG000|NOT COMPLETED|Overall Study||1
11224488|NCT01986348|12416579|FG000|STARTED|Overall Study||8
11224489|NCT01986348|12416580|FG001|STARTED|Overall Study||24
11224490|NCT01986348|12416581|FG002|STARTED|Overall Study||14
11224491|NCT01986348|12416582|FG003|STARTED|Overall Study||30
11224492|NCT01986348|12416579|FG000|COMPLETED|Overall Study||0
11224493|NCT01986348|12416580|FG001|COMPLETED|Overall Study||0
11224494|NCT01986348|12416581|FG002|COMPLETED|Overall Study||0
11224495|NCT01986348|12416582|FG003|COMPLETED|Overall Study||0
11224496|NCT01986348|12416579|FG000|NOT COMPLETED|Overall Study||8
11224497|NCT01986348|12416580|FG001|NOT COMPLETED|Overall Study||24
11224498|NCT01986348|12416581|FG002|NOT COMPLETED|Overall Study||14
11224499|NCT01986348|12416582|FG003|NOT COMPLETED|Overall Study||30
11224500|NCT01986361|12416597|FG000|STARTED|Overall Study||101
11224501|NCT01986361|12416598|FG001|STARTED|Overall Study||21
11224502|NCT01986361|12416597|FG000|COMPLETED|Overall Study||101
11224503|NCT01986361|12416598|FG001|COMPLETED|Overall Study||21
11224504|NCT01986361|12416597|FG000|NOT COMPLETED|Overall Study||0
11224505|NCT01986361|12416598|FG001|NOT COMPLETED|Overall Study||0
11224506|NCT01986647|12416608|FG000|STARTED|Overall Study||152
11224507|NCT01986647|12416609|FG001|STARTED|Overall Study||146
11224508|NCT01986647|12416610|FG002|STARTED|Overall Study||49
11224509|NCT01986647|12416611|FG003|STARTED|Overall Study||77
10848666|NCT02524171|12015156|FG001|NOT COMPLETED|6-month Follow-up||45
10848667|NCT02524171|12015155|FG000|STARTED|12-month Follow-up Interview||172
10848668|NCT02524171|12015156|FG001|STARTED|12-month Follow-up Interview||169
10848669|NCT02524171|12015155|FG000|COMPLETED|12-month Follow-up Interview||127
10848670|NCT02524171|12015156|FG001|COMPLETED|12-month Follow-up Interview||128
10848671|NCT02524171|12015155|FG000|NOT COMPLETED|12-month Follow-up Interview||45
10848672|NCT02524171|12015156|FG001|NOT COMPLETED|12-month Follow-up Interview||41
10848673|NCT02489422|12015164|FG000|STARTED|Overall Study||23
10848674|NCT02489422|12015165|FG001|STARTED|Overall Study||21
10848675|NCT02489422|12015164|FG000|COMPLETED|Overall Study||23
11224510|NCT01986647|12416608|FG000|COMPLETED|Overall Study||142
11224511|NCT01986647|12416609|FG001|COMPLETED|Overall Study||139
11224512|NCT01986647|12416610|FG002|COMPLETED|Overall Study||37
11224513|NCT01986647|12416611|FG003|COMPLETED|Overall Study||66
11224514|NCT01986647|12416608|FG000|NOT COMPLETED|Overall Study||10
10848676|NCT02489422|12015165|FG001|COMPLETED|Overall Study||21
10848677|NCT02489422|12015164|FG000|NOT COMPLETED|Overall Study||0
10848678|NCT02489422|12015165|FG001|NOT COMPLETED|Overall Study||0
10848679|NCT02487251|12015176|FG000|STARTED|Overall Study||434
10848680|NCT02487251|12015177|FG001|STARTED|Overall Study||65
10848681|NCT02487251|12015178|FG002|STARTED|Overall Study||152
11224515|NCT01986647|12416609|FG001|NOT COMPLETED|Overall Study||7
11224516|NCT01986647|12416610|FG002|NOT COMPLETED|Overall Study||12
11224517|NCT01986647|12416611|FG003|NOT COMPLETED|Overall Study||11
11224518|NCT01986686|12416627|FG000|STARTED|Overall Study||81
11224519|NCT01986686|12416628|FG001|STARTED|Overall Study||26
11224520|NCT01986686|12416627|FG000|COMPLETED|Overall Study||81
11224521|NCT01986686|12416628|FG001|COMPLETED|Overall Study||26
10848682|NCT02487251|12015179|FG003|STARTED|Overall Study||159
10848683|NCT02487251|12015176|FG000|COMPLETED|Overall Study||366
10848684|NCT02487251|12015177|FG001|COMPLETED|Overall Study||55
10848685|NCT02487251|12015178|FG002|COMPLETED|Overall Study||125
10848686|NCT02487251|12015179|FG003|COMPLETED|Overall Study||134
10848687|NCT02487251|12015176|FG000|NOT COMPLETED|Overall Study||68
10848688|NCT02487251|12015177|FG001|NOT COMPLETED|Overall Study||10
10848689|NCT02487251|12015178|FG002|NOT COMPLETED|Overall Study||27
10848690|NCT02487251|12015179|FG003|NOT COMPLETED|Overall Study||25
11105792|NCT01255722|12290162|FG001|COMPLETED|Overall Study||159
11105793|NCT01255722|12290163|FG002|COMPLETED|Overall Study||152
11105794|NCT01255722|12290161|FG000|NOT COMPLETED|Overall Study||3
11105795|NCT01255722|12290162|FG001|NOT COMPLETED|Overall Study||1
11105796|NCT01255722|12290163|FG002|NOT COMPLETED|Overall Study||1
11105797|NCT01255761|12290174|FG000|STARTED|Overall Study||369
11105798|NCT01255761|12290175|FG001|STARTED|Overall Study||367
11105799|NCT01255761|12290174|FG000|COMPLETED|Overall Study||187
11105800|NCT01255761|12290175|FG001|COMPLETED|Overall Study||192
11105801|NCT01255761|12290174|FG000|NOT COMPLETED|Overall Study||182
11105802|NCT01255761|12290175|FG001|NOT COMPLETED|Overall Study||175
11105803|NCT01255787|12290185|FG000|STARTED|Overall Study||152
10848703|NCT02306122|12015211|FG000|STARTED|Initial Physician Randomization||0
10848704|NCT02306122|12015212|FG001|STARTED|Initial Physician Randomization||0
10848705|NCT02306122|12015213|FG002|STARTED|Initial Physician Randomization||0
10848706|NCT02306122|12015214|FG003|STARTED|Initial Physician Randomization||0
10848707|NCT02306122|12015215|FG004|STARTED|Initial Physician Randomization||0
10848708|NCT02306122|12015216|FG005|STARTED|Initial Physician Randomization||0
10848709|NCT02306122|12015217|FG006|STARTED|Initial Physician Randomization||0
10848710|NCT02306122|12015218|FG007|STARTED|Initial Physician Randomization||0
10848711|NCT02306122|12015219|FG008|STARTED|Initial Physician Randomization||29
10848712|NCT02306122|12015220|FG009|STARTED|Initial Physician Randomization||31
10848713|NCT02306122|12015221|FG010|STARTED|Initial Physician Randomization||31
10848714|NCT02306122|12015211|FG000|COMPLETED|Initial Physician Randomization||0
10848715|NCT02306122|12015212|FG001|COMPLETED|Initial Physician Randomization||0
10848716|NCT02306122|12015213|FG002|COMPLETED|Initial Physician Randomization||0
10848717|NCT02306122|12015214|FG003|COMPLETED|Initial Physician Randomization||0
10848718|NCT02306122|12015215|FG004|COMPLETED|Initial Physician Randomization||0
10848719|NCT02306122|12015216|FG005|COMPLETED|Initial Physician Randomization||0
10848720|NCT02306122|12015217|FG006|COMPLETED|Initial Physician Randomization||0
10848721|NCT02306122|12015218|FG007|COMPLETED|Initial Physician Randomization||0
10848722|NCT02306122|12015219|FG008|COMPLETED|Initial Physician Randomization||28
10848723|NCT02306122|12015220|FG009|COMPLETED|Initial Physician Randomization||31
10848724|NCT02306122|12015221|FG010|COMPLETED|Initial Physician Randomization||31
10848725|NCT02306122|12015211|FG000|NOT COMPLETED|Initial Physician Randomization||0
10848726|NCT02306122|12015212|FG001|NOT COMPLETED|Initial Physician Randomization||0
10848727|NCT02306122|12015213|FG002|NOT COMPLETED|Initial Physician Randomization||0
10848728|NCT02306122|12015214|FG003|NOT COMPLETED|Initial Physician Randomization||0
10848729|NCT02306122|12015215|FG004|NOT COMPLETED|Initial Physician Randomization||0
10848730|NCT02306122|12015216|FG005|NOT COMPLETED|Initial Physician Randomization||0
10848731|NCT02306122|12015217|FG006|NOT COMPLETED|Initial Physician Randomization||0
10848732|NCT02306122|12015218|FG007|NOT COMPLETED|Initial Physician Randomization||0
10848733|NCT02306122|12015219|FG008|NOT COMPLETED|Initial Physician Randomization||1
10848734|NCT02306122|12015220|FG009|NOT COMPLETED|Initial Physician Randomization||0
10848735|NCT02306122|12015221|FG010|NOT COMPLETED|Initial Physician Randomization||0
10848736|NCT02306122|12015211|FG000|STARTED|Post Nonadherence Subgroup Randomization||244
10848737|NCT02306122|12015212|FG001|STARTED|Post Nonadherence Subgroup Randomization||123
10848738|NCT02306122|12015213|FG002|STARTED|Post Nonadherence Subgroup Randomization||121
10848739|NCT02306122|12015214|FG003|STARTED|Post Nonadherence Subgroup Randomization||274
10848740|NCT02306122|12015215|FG004|STARTED|Post Nonadherence Subgroup Randomization||134
10848741|NCT02306122|12015216|FG005|STARTED|Post Nonadherence Subgroup Randomization||137
10848742|NCT02306122|12015217|FG006|STARTED|Post Nonadherence Subgroup Randomization||220
10848743|NCT02306122|12015218|FG007|STARTED|Post Nonadherence Subgroup Randomization||221
10848744|NCT02306122|12015219|FG008|STARTED|Post Nonadherence Subgroup Randomization||28
10848745|NCT02306122|12015220|FG009|STARTED|Post Nonadherence Subgroup Randomization||31
10848746|NCT02306122|12015221|FG010|STARTED|Post Nonadherence Subgroup Randomization||31
10848747|NCT02306122|12015211|FG000|COMPLETED|Post Nonadherence Subgroup Randomization||244
10848748|NCT02306122|12015212|FG001|COMPLETED|Post Nonadherence Subgroup Randomization||123
10848749|NCT02306122|12015213|FG002|COMPLETED|Post Nonadherence Subgroup Randomization||121
10848750|NCT02306122|12015214|FG003|COMPLETED|Post Nonadherence Subgroup Randomization||274
10848751|NCT02306122|12015215|FG004|COMPLETED|Post Nonadherence Subgroup Randomization||134
10848752|NCT02306122|12015216|FG005|COMPLETED|Post Nonadherence Subgroup Randomization||137
10848753|NCT02306122|12015217|FG006|COMPLETED|Post Nonadherence Subgroup Randomization||220
10848754|NCT02306122|12015218|FG007|COMPLETED|Post Nonadherence Subgroup Randomization||221
10848755|NCT02306122|12015219|FG008|COMPLETED|Post Nonadherence Subgroup Randomization||28
10848756|NCT02306122|12015220|FG009|COMPLETED|Post Nonadherence Subgroup Randomization||31
10848757|NCT02306122|12015221|FG010|COMPLETED|Post Nonadherence Subgroup Randomization||31
10848758|NCT02306122|12015211|FG000|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848759|NCT02306122|12015212|FG001|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848760|NCT02306122|12015213|FG002|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848761|NCT02306122|12015214|FG003|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848762|NCT02306122|12015215|FG004|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848763|NCT02306122|12015216|FG005|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848764|NCT02306122|12015217|FG006|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848765|NCT02306122|12015218|FG007|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848766|NCT02306122|12015219|FG008|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848767|NCT02306122|12015220|FG009|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848768|NCT02306122|12015221|FG010|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
10848769|NCT02304991|12015241|FG000|STARTED|Overall Study||25
10848770|NCT02304991|12015242|FG001|STARTED|Overall Study||25
10848771|NCT02304991|12015241|FG000|COMPLETED|Overall Study||18
10848772|NCT02304991|12015242|FG001|COMPLETED|Overall Study||15
10848773|NCT02304991|12015241|FG000|NOT COMPLETED|Overall Study||7
10848774|NCT02304991|12015242|FG001|NOT COMPLETED|Overall Study||10
10848775|NCT02223520|12015250|FG000|STARTED|Overall Study||147
10848776|NCT02223520|12015251|FG001|STARTED|Overall Study||160
10848777|NCT02223520|12015250|FG000|COMPLETED|Overall Study|101 neonates of these parents were enrolled. 12 were lost to follow-up.|147
10848778|NCT02223520|12015251|FG001|COMPLETED|Overall Study|107 neonates of these parents were enrolled. 6 were lost to follow-up.|160
10848779|NCT02223520|12015250|FG000|NOT COMPLETED|Overall Study||0
10848780|NCT02223520|12015251|FG001|NOT COMPLETED|Overall Study||0
10848781|NCT02147184|12015259|FG000|STARTED|Overall Study||127
10848782|NCT02147184|12015260|FG001|STARTED|Overall Study||137
10848783|NCT02147184|12015259|FG000|COMPLETED|Overall Study||78
10848784|NCT02147184|12015260|FG001|COMPLETED|Overall Study||110
10848785|NCT02147184|12015259|FG000|NOT COMPLETED|Overall Study||49
10848786|NCT02147184|12015260|FG001|NOT COMPLETED|Overall Study||27
10848787|NCT02122198|12015268|FG000|STARTED|Overall Study||5
10848788|NCT02122198|12015269|FG001|STARTED|Overall Study||12
10848789|NCT02122198|12015268|FG000|COMPLETED|Overall Study||3
10848790|NCT02122198|12015269|FG001|COMPLETED|Overall Study||10
10848791|NCT02122198|12015268|FG000|NOT COMPLETED|Overall Study||2
10848792|NCT02122198|12015269|FG001|NOT COMPLETED|Overall Study||2
10848793|NCT02055053|12015278|FG000|STARTED|Overall Study||35
10848794|NCT02055053|12015279|FG001|STARTED|Overall Study||35
10848795|NCT02055053|12015278|FG000|COMPLETED|Overall Study||35
10848796|NCT02055053|12015279|FG001|COMPLETED|Overall Study||35
10848797|NCT02055053|12015278|FG000|NOT COMPLETED|Overall Study||0
10848798|NCT02055053|12015279|FG001|NOT COMPLETED|Overall Study||0
10848799|NCT02000219|12015285|FG000|STARTED|14-Week Study Period||12
11224522|NCT01986686|12416627|FG000|NOT COMPLETED|Overall Study||0
11224523|NCT01986686|12416628|FG001|NOT COMPLETED|Overall Study||0
11224524|NCT01986790|12416637|FG000|STARTED|Overall Study||91
11224525|NCT01986790|12416638|FG001|STARTED|Overall Study||154
11224526|NCT01986790|12416639|FG002|STARTED|Overall Study||98
11224527|NCT01986790|12416637|FG000|COMPLETED|Overall Study||91
10848800|NCT02000219|12015285|FG000|COMPLETED|14-Week Study Period||9
10848801|NCT02000219|12015285|FG000|NOT COMPLETED|14-Week Study Period||3
10848802|NCT02000219|12015285|FG000|STARTED|Continuation Period||8
10848803|NCT02000219|12015285|FG000|COMPLETED|Continuation Period||3
10848804|NCT02000219|12015285|FG000|NOT COMPLETED|Continuation Period||5
10848805|NCT01978938|12015291|FG000|STARTED|Overall Study||455
10848806|NCT01978938|12015292|FG001|STARTED|Overall Study||453
10848807|NCT01978938|12015291|FG000|Received at Least 1 Dose of Study Drug|Overall Study||454
11224528|NCT01986790|12416638|FG001|COMPLETED|Overall Study||154
11224529|NCT01986790|12416639|FG002|COMPLETED|Overall Study||98
11224530|NCT01986790|12416637|FG000|NOT COMPLETED|Overall Study||0
11224531|NCT01986790|12416638|FG001|NOT COMPLETED|Overall Study||0
11224532|NCT01986790|12416639|FG002|NOT COMPLETED|Overall Study||0
11224533|NCT01986829|12416647|FG000|STARTED|Overall Study||9
11224534|NCT01986829|12416647|FG000|COMPLETED|Overall Study||8
11224535|NCT01986829|12416647|FG000|NOT COMPLETED|Overall Study||1
11224536|NCT01986855|12416657|FG000|STARTED|Overall Study||158
11224537|NCT01986855|12416658|FG001|STARTED|Overall Study||156
11224538|NCT01986855|12416659|FG002|STARTED|Overall Study||154
11224539|NCT01986855|12416657|FG000|Treated|Overall Study||158
11224540|NCT01986855|12416658|FG001|Treated|Overall Study||155
11224541|NCT01986855|12416659|FG002|Treated|Overall Study||154
11224542|NCT01986855|12416657|FG000|COMPLETED|Overall Study||145
11224543|NCT01986855|12416658|FG001|COMPLETED|Overall Study||142
10848808|NCT01978938|12015292|FG001|Received at Least 1 Dose of Study Drug|Overall Study||451
10848809|NCT01978938|12015291|FG000|COMPLETED|Overall Study||432
10848810|NCT01978938|12015292|FG001|COMPLETED|Overall Study||439
10848811|NCT01978938|12015291|FG000|NOT COMPLETED|Overall Study||23
10848812|NCT01978938|12015292|FG001|NOT COMPLETED|Overall Study||14
11224544|NCT01986855|12416659|FG002|COMPLETED|Overall Study||143
11224545|NCT01986855|12416657|FG000|NOT COMPLETED|Overall Study||13
11224546|NCT01986855|12416658|FG001|NOT COMPLETED|Overall Study||14
11224547|NCT01986855|12416659|FG002|NOT COMPLETED|Overall Study||11
11224548|NCT01986907|12416667|FG000|STARTED|Overall Study||936
10848813|NCT01854385|12015298|FG000|STARTED|Pre-Treatment||40
10848814|NCT01854385|12015298|FG000|COMPLETED|Pre-Treatment||17
10848815|NCT01854385|12015298|FG000|NOT COMPLETED|Pre-Treatment||23
10848816|NCT01854385|12015298|FG000|STARTED|Treatment||17
10848817|NCT01854385|12015298|FG000|COMPLETED|Treatment||16
10848818|NCT01854385|12015298|FG000|NOT COMPLETED|Treatment||1
10848819|NCT01844856|12015304|FG000|STARTED|Overall Study||270
10848820|NCT01844856|12015305|FG001|STARTED|Overall Study||271
11224549|NCT01986907|12416667|FG000|COMPLETED|Overall Study||774
11224550|NCT01986907|12416667|FG000|NOT COMPLETED|Overall Study||162
11224551|NCT01986920|12416674|FG000|STARTED|A- 101 25%||35
10848821|NCT01844856|12015304|FG000|Received at Least 1 Dose of Study Drug|Overall Study||270
10848822|NCT01844856|12015305|FG001|Received at Least 1 Dose of Study Drug|Overall Study||268
10848823|NCT01844856|12015304|FG000|COMPLETED|Overall Study||246
10848824|NCT01844856|12015305|FG001|COMPLETED|Overall Study||255
10848825|NCT01844856|12015304|FG000|NOT COMPLETED|Overall Study||24
10848826|NCT01844856|12015305|FG001|NOT COMPLETED|Overall Study||16
10848827|NCT01788306|12015313|FG000|STARTED|Overall Study||125
10848828|NCT01788306|12015314|FG001|STARTED|Overall Study||131
10848829|NCT01788306|12015313|FG000|COMPLETED|Overall Study||115
10848830|NCT01788306|12015314|FG001|COMPLETED|Overall Study||126
10848831|NCT01788306|12015313|FG000|NOT COMPLETED|Overall Study||10
10848832|NCT01788306|12015314|FG001|NOT COMPLETED|Overall Study||5
10848833|NCT01744041|12015328|FG000|STARTED|Overall Study||21
10848834|NCT01744041|12015329|FG001|STARTED|Overall Study||21
10848835|NCT01744041|12015328|FG000|COMPLETED|Overall Study||15
10848836|NCT01744041|12015329|FG001|COMPLETED|Overall Study||13
10848837|NCT01744041|12015328|FG000|NOT COMPLETED|Overall Study||6
10848838|NCT01744041|12015329|FG001|NOT COMPLETED|Overall Study||8
10848839|NCT01733147|12015337|FG000|STARTED|Overall Study||30
10848840|NCT01733147|12015338|FG001|STARTED|Overall Study||30
10848841|NCT01733147|12015337|FG000|COMPLETED|Overall Study||30
10848842|NCT01733147|12015338|FG001|COMPLETED|Overall Study||30
10848843|NCT01733147|12015337|FG000|NOT COMPLETED|Overall Study||0
10848844|NCT01733147|12015338|FG001|NOT COMPLETED|Overall Study||0
10848845|NCT01712789|12015344|FG000|STARTED|Overall Study||682
10848846|NCT01712789|12015344|FG000|Received Study Treatment|Overall Study||676
10848847|NCT01712789|12015344|FG000|COMPLETED|Overall Study||0
10848848|NCT01712789|12015344|FG000|NOT COMPLETED|Overall Study||682
10848861|NCT01543633|12015362|FG000|STARTED|Overall Study||36
10848862|NCT01543633|12015362|FG000|COMPLETED|Overall Study||17
10848863|NCT01543633|12015362|FG000|NOT COMPLETED|Overall Study||19
10848864|NCT01542736|12015366|FG000|STARTED|Overall Study||8
10848865|NCT01542736|12015366|FG000|COMPLETED|Overall Study||7
10848866|NCT01542736|12015366|FG000|NOT COMPLETED|Overall Study||1
10848867|NCT01535807|12015372|FG000|STARTED|Overall Study||22
10848868|NCT01535807|12015373|FG001|STARTED|Overall Study||22
10848869|NCT01535807|12015372|FG000|COMPLETED|Overall Study||20
10848870|NCT01535807|12015373|FG001|COMPLETED|Overall Study||20
10848871|NCT01535807|12015372|FG000|NOT COMPLETED|Overall Study||2
10848872|NCT01535807|12015373|FG001|NOT COMPLETED|Overall Study||2
10848873|NCT01147666|12015394|FG000|STARTED|Dosing Period 1: 6-Week Treatment||12
10848874|NCT01147666|12015395|FG001|STARTED|Dosing Period 1: 6-Week Treatment||12
10848875|NCT01147666|12015396|FG002|STARTED|Dosing Period 1: 6-Week Treatment||12
10848876|NCT01147666|12015397|FG003|STARTED|Dosing Period 1: 6-Week Treatment||12
10848877|NCT01147666|12015398|FG004|STARTED|Dosing Period 1: 6-Week Treatment||12
10848878|NCT01147666|12015399|FG005|STARTED|Dosing Period 1: 6-Week Treatment||12
10848879|NCT01147666|12015400|FG006|STARTED|Dosing Period 1: 6-Week Treatment||12
10848880|NCT01147666|12015401|FG007|STARTED|Dosing Period 1: 6-Week Treatment||12
10848881|NCT01147666|12015402|FG008|STARTED|Dosing Period 1: 6-Week Treatment||2
10848882|NCT01147666|12015403|FG009|STARTED|Dosing Period 1: 6-Week Treatment||10
10848883|NCT01147666|12015404|FG010|STARTED|Dosing Period 1: 6-Week Treatment||36
10848884|NCT01147666|12015405|FG011|STARTED|Dosing Period 1: 6-Week Treatment||4
10848885|NCT01147666|12015406|FG012|STARTED|Dosing Period 1: 6-Week Treatment||5
10848886|NCT01147666|12015407|FG013|STARTED|Dosing Period 1: 6-Week Treatment||4
10848887|NCT01147666|12015408|FG014|STARTED|Dosing Period 1: 6-Week Treatment||4
10848888|NCT01147666|12015394|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848889|NCT01147666|12015395|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848890|NCT01147666|12015396|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848891|NCT01147666|12015397|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848892|NCT01147666|12015398|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848893|NCT01147666|12015399|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848894|NCT01147666|12015400|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848895|NCT01147666|12015401|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
10848896|NCT01147666|12015402|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||2
10848897|NCT01147666|12015403|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||10
10848898|NCT01147666|12015404|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||36
10848899|NCT01147666|12015405|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
10848900|NCT01147666|12015406|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||5
10848901|NCT01147666|12015407|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
10848902|NCT01147666|12015408|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
10848903|NCT01147666|12015394|FG000|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9
10848904|NCT01147666|12015395|FG001|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
10848905|NCT01147666|12015396|FG002|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9
10848906|NCT01147666|12015397|FG003|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
10848907|NCT01147666|12015398|FG004|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
10848908|NCT01147666|12015399|FG005|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
10848909|NCT01147666|12015400|FG006|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
10848910|NCT01147666|12015401|FG007|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
10848911|NCT01147666|12015402|FG008|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||2
10848912|NCT01147666|12015403|FG009|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
10848913|NCT01147666|12015404|FG010|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||31
10848914|NCT01147666|12015405|FG011|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||1
10848915|NCT01147666|12015406|FG012|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3
10848916|NCT01147666|12015407|FG013|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||4
10848917|NCT01147666|12015408|FG014|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3
10848918|NCT01147666|12015394|FG000|COMPLETED|Dosing Period 1: 6-Week Treatment||10
10848919|NCT01147666|12015395|FG001|COMPLETED|Dosing Period 1: 6-Week Treatment||10
10848920|NCT01147666|12015396|FG002|COMPLETED|Dosing Period 1: 6-Week Treatment||11
10848921|NCT01147666|12015397|FG003|COMPLETED|Dosing Period 1: 6-Week Treatment||10
10848922|NCT01147666|12015398|FG004|COMPLETED|Dosing Period 1: 6-Week Treatment||7
10848923|NCT01147666|12015399|FG005|COMPLETED|Dosing Period 1: 6-Week Treatment||9
10848924|NCT01147666|12015400|FG006|COMPLETED|Dosing Period 1: 6-Week Treatment||9
10848925|NCT01147666|12015401|FG007|COMPLETED|Dosing Period 1: 6-Week Treatment||9
10848926|NCT01147666|12015402|FG008|COMPLETED|Dosing Period 1: 6-Week Treatment||2
10848927|NCT01147666|12015403|FG009|COMPLETED|Dosing Period 1: 6-Week Treatment||8
10848928|NCT01147666|12015404|FG010|COMPLETED|Dosing Period 1: 6-Week Treatment||33
10848929|NCT01147666|12015405|FG011|COMPLETED|Dosing Period 1: 6-Week Treatment||2
10848930|NCT01147666|12015406|FG012|COMPLETED|Dosing Period 1: 6-Week Treatment||1
10848931|NCT01147666|12015407|FG013|COMPLETED|Dosing Period 1: 6-Week Treatment||3
10848932|NCT01147666|12015408|FG014|COMPLETED|Dosing Period 1: 6-Week Treatment||0
10848933|NCT01147666|12015394|FG000|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
10848934|NCT01147666|12015395|FG001|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
10848935|NCT01147666|12015396|FG002|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1
10848936|NCT01147666|12015397|FG003|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
10848937|NCT01147666|12015398|FG004|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||5
10848938|NCT01147666|12015399|FG005|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
10848939|NCT01147666|12015400|FG006|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
10848940|NCT01147666|12015401|FG007|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
10848941|NCT01147666|12015402|FG008|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||0
10848942|NCT01147666|12015403|FG009|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
10848943|NCT01147666|12015404|FG010|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
10848944|NCT01147666|12015405|FG011|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
10848945|NCT01147666|12015406|FG012|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4
10848946|NCT01147666|12015407|FG013|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1
10848947|NCT01147666|12015408|FG014|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4
10848948|NCT01147666|12015394|FG000|STARTED|Dosing Period 2: 19-Week Treatment||0
10848949|NCT01147666|12015395|FG001|STARTED|Dosing Period 2: 19-Week Treatment||0
10848950|NCT01147666|12015396|FG002|STARTED|Dosing Period 2: 19-Week Treatment||0
10848951|NCT01147666|12015397|FG003|STARTED|Dosing Period 2: 19-Week Treatment||7
10848952|NCT01147666|12015398|FG004|STARTED|Dosing Period 2: 19-Week Treatment||12
10848953|NCT01147666|12015399|FG005|STARTED|Dosing Period 2: 19-Week Treatment||12
10848954|NCT01147666|12015400|FG006|STARTED|Dosing Period 2: 19-Week Treatment||12
10848955|NCT01147666|12015401|FG007|STARTED|Dosing Period 2: 19-Week Treatment||12
10848956|NCT01147666|12015402|FG008|STARTED|Dosing Period 2: 19-Week Treatment||2
10848957|NCT01147666|12015403|FG009|STARTED|Dosing Period 2: 19-Week Treatment||10
10848958|NCT01147666|12015404|FG010|STARTED|Dosing Period 2: 19-Week Treatment||23
10848959|NCT01147666|12015405|FG011|STARTED|Dosing Period 2: 19-Week Treatment||0
10848960|NCT01147666|12015406|FG012|STARTED|Dosing Period 2: 19-Week Treatment||5
10848961|NCT01147666|12015407|FG013|STARTED|Dosing Period 2: 19-Week Treatment||3
10848962|NCT01147666|12015408|FG014|STARTED|Dosing Period 2: 19-Week Treatment||3
10848963|NCT01147666|12015394|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
10848964|NCT01147666|12015395|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
10848965|NCT01147666|12015396|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
10848966|NCT01147666|12015397|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||7
10848967|NCT01147666|12015398|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
10848968|NCT01147666|12015399|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
10848969|NCT01147666|12015400|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
10848970|NCT01147666|12015401|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
10848971|NCT01147666|12015402|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||2
10848972|NCT01147666|12015403|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||10
10848973|NCT01147666|12015404|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||23
10848974|NCT01147666|12015405|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
10848975|NCT01147666|12015406|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||5
10848976|NCT01147666|12015407|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3
10848977|NCT01147666|12015408|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3
10848978|NCT01147666|12015394|FG000|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
10848979|NCT01147666|12015395|FG001|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
10848980|NCT01147666|12015396|FG002|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
10848981|NCT01147666|12015397|FG003|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||6
10848982|NCT01147666|12015398|FG004|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
10848983|NCT01147666|12015399|FG005|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
10848984|NCT01147666|12015400|FG006|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
10848985|NCT01147666|12015401|FG007|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10
10848986|NCT01147666|12015402|FG008|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2
10848987|NCT01147666|12015403|FG009|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10
10848988|NCT01147666|12015404|FG010|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||22
10848989|NCT01147666|12015405|FG011|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
10848990|NCT01147666|12015406|FG012|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3
10848991|NCT01147666|12015407|FG013|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3
10848992|NCT01147666|12015408|FG014|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2
10848993|NCT01147666|12015394|FG000|COMPLETED|Dosing Period 2: 19-Week Treatment||0
10848994|NCT01147666|12015395|FG001|COMPLETED|Dosing Period 2: 19-Week Treatment||0
10848995|NCT01147666|12015396|FG002|COMPLETED|Dosing Period 2: 19-Week Treatment||0
10848996|NCT01147666|12015397|FG003|COMPLETED|Dosing Period 2: 19-Week Treatment||5
10848997|NCT01147666|12015398|FG004|COMPLETED|Dosing Period 2: 19-Week Treatment||7
10848998|NCT01147666|12015399|FG005|COMPLETED|Dosing Period 2: 19-Week Treatment||9
10848999|NCT01147666|12015400|FG006|COMPLETED|Dosing Period 2: 19-Week Treatment||9
10849000|NCT01147666|12015401|FG007|COMPLETED|Dosing Period 2: 19-Week Treatment||9
10849001|NCT01147666|12015402|FG008|COMPLETED|Dosing Period 2: 19-Week Treatment||2
10849002|NCT01147666|12015403|FG009|COMPLETED|Dosing Period 2: 19-Week Treatment||8
10849003|NCT01147666|12015404|FG010|COMPLETED|Dosing Period 2: 19-Week Treatment||21
10849004|NCT01147666|12015405|FG011|COMPLETED|Dosing Period 2: 19-Week Treatment||0
10849005|NCT01147666|12015406|FG012|COMPLETED|Dosing Period 2: 19-Week Treatment||1
10849006|NCT01147666|12015407|FG013|COMPLETED|Dosing Period 2: 19-Week Treatment||2
10849007|NCT01147666|12015408|FG014|COMPLETED|Dosing Period 2: 19-Week Treatment||0
10849008|NCT01147666|12015394|FG000|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
10849009|NCT01147666|12015395|FG001|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
10849010|NCT01147666|12015396|FG002|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
10849011|NCT01147666|12015397|FG003|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
10849012|NCT01147666|12015398|FG004|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||5
10849013|NCT01147666|12015399|FG005|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
10849014|NCT01147666|12015400|FG006|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
10849015|NCT01147666|12015401|FG007|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
10849016|NCT01147666|12015402|FG008|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
10849017|NCT01147666|12015403|FG009|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
10849018|NCT01147666|12015404|FG010|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
10849019|NCT01147666|12015405|FG011|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
10849020|NCT01147666|12015406|FG012|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||4
10849021|NCT01147666|12015407|FG013|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||1
10849022|NCT01147666|12015408|FG014|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
10849023|NCT00982111|12015472|FG000|STARTED|Overall Study||315
10849024|NCT00982111|12015473|FG001|STARTED|Overall Study||318
10849025|NCT00982111|12015472|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304
10849026|NCT00982111|12015473|FG001|Received at Least 1 Dose of Study Drug|Overall Study||312
10849027|NCT00982111|12015472|FG000|Death Due to Any Cause|Overall Study||236
10849028|NCT00982111|12015473|FG001|Death Due to Any Cause|Overall Study||246
10849029|NCT00982111|12015472|FG000|COMPLETED|Overall Study||236
10849030|NCT00982111|12015473|FG001|COMPLETED|Overall Study||246
10849031|NCT00982111|12015472|FG000|NOT COMPLETED|Overall Study||79
10849032|NCT00982111|12015473|FG001|NOT COMPLETED|Overall Study||72
10849033|NCT00193219|12015480|FG000|STARTED|Overall Study||36
10849034|NCT00193219|12015480|FG000|COMPLETED|Overall Study||6
10849035|NCT00193219|12015480|FG000|NOT COMPLETED|Overall Study||30
10849036|NCT00116142|12015487|FG000|STARTED|Overall Study||175
10849037|NCT00116142|12015488|FG001|STARTED|Overall Study||175
10849038|NCT00116142|12015487|FG000|Treated|Overall Study||174
10849039|NCT00116142|12015488|FG001|Treated|Overall Study||171
10849040|NCT00116142|12015487|FG000|COMPLETED|Overall Study||156
10849041|NCT00116142|12015488|FG001|COMPLETED|Overall Study||155
10849042|NCT00116142|12015487|FG000|NOT COMPLETED|Overall Study||19
10849043|NCT00116142|12015488|FG001|NOT COMPLETED|Overall Study||20
10849044|NCT00070018|12015497|FG000|STARTED|Overall Study||46
10849045|NCT00070018|12015497|FG000|Eligible|Overall Study||46
10849046|NCT00070018|12015497|FG000|Eligible and Began Protocol Therapy|Overall Study||46
10849047|NCT00070018|12015497|FG000|COMPLETED|Overall Study||42
10849048|NCT00070018|12015497|FG000|NOT COMPLETED|Overall Study||4
11105804|NCT01255787|12290186|FG001|STARTED|Overall Study||144
11105805|NCT01255787|12290187|FG002|STARTED|Overall Study||150
11105806|NCT01255787|12290188|FG003|STARTED|Overall Study||154
11105807|NCT01255787|12290185|FG000|Treated|Overall Study||152
11105808|NCT01255787|12290186|FG001|Treated|Overall Study||144
11105809|NCT01255787|12290187|FG002|Treated|Overall Study||148
11105810|NCT01255787|12290188|FG003|Treated|Overall Study||150
11105811|NCT01255787|12290185|FG000|COMPLETED|Overall Study||136
11105812|NCT01255787|12290186|FG001|COMPLETED|Overall Study||127
11105813|NCT01255787|12290187|FG002|COMPLETED|Overall Study||132
11105814|NCT01255787|12290188|FG003|COMPLETED|Overall Study||132
11105815|NCT01255787|12290185|FG000|NOT COMPLETED|Overall Study||16
11105816|NCT01255787|12290186|FG001|NOT COMPLETED|Overall Study||17
11105817|NCT01255787|12290187|FG002|NOT COMPLETED|Overall Study||18
11105818|NCT01255787|12290188|FG003|NOT COMPLETED|Overall Study||22
11105819|NCT01255865|12290205|FG000|STARTED|Overall Study||1
11105820|NCT01255865|12290206|FG001|STARTED|Overall Study||10
11105821|NCT01255865|12290207|FG002|STARTED|Overall Study||10
11105822|NCT01255865|12290208|FG003|STARTED|Overall Study||30
11105823|NCT01255865|12290209|FG004|STARTED|Overall Study||20
11105824|NCT01255865|12290210|FG005|STARTED|Overall Study||20
11105825|NCT01255865|12290211|FG006|STARTED|Overall Study||20
11105826|NCT01255865|12290205|FG000|COMPLETED|Overall Study||1
11105827|NCT01255865|12290206|FG001|COMPLETED|Overall Study||10
11105828|NCT01255865|12290207|FG002|COMPLETED|Overall Study||10
11105829|NCT01255865|12290208|FG003|COMPLETED|Overall Study||30
11105830|NCT01255865|12290209|FG004|COMPLETED|Overall Study||20
11105831|NCT01255865|12290210|FG005|COMPLETED|Overall Study||20
11105832|NCT01255865|12290211|FG006|COMPLETED|Overall Study||20
11105833|NCT01255865|12290205|FG000|NOT COMPLETED|Overall Study||0
11105834|NCT01255865|12290206|FG001|NOT COMPLETED|Overall Study||0
11105835|NCT01255865|12290207|FG002|NOT COMPLETED|Overall Study||0
11105836|NCT01255865|12290208|FG003|NOT COMPLETED|Overall Study||0
11105837|NCT01255865|12290209|FG004|NOT COMPLETED|Overall Study||0
11105838|NCT01255865|12290210|FG005|NOT COMPLETED|Overall Study||0
11105839|NCT01255865|12290211|FG006|NOT COMPLETED|Overall Study||0
11105840|NCT01255904|12290229|FG000|STARTED|Overall Study||45
11105841|NCT01255904|12290230|FG001|STARTED|Overall Study||45
11105842|NCT01255904|12290229|FG000|COMPLETED|Overall Study||44
11105843|NCT01255904|12290230|FG001|COMPLETED|Overall Study||41
11105844|NCT01255904|12290229|FG000|NOT COMPLETED|Overall Study||1
11105845|NCT01255904|12290230|FG001|NOT COMPLETED|Overall Study||4
11224552|NCT01986920|12416675|FG001|STARTED|A- 101 25%||0
11224553|NCT01986920|12416676|FG002|STARTED|A- 101 25%||0
11224554|NCT01986920|12416677|FG003|STARTED|A- 101 25%||0
11224555|NCT01986920|12416674|FG000|COMPLETED|A- 101 25%||34
11224556|NCT01986920|12416675|FG001|COMPLETED|A- 101 25%||0
11224557|NCT01986920|12416676|FG002|COMPLETED|A- 101 25%||0
11224558|NCT01986920|12416677|FG003|COMPLETED|A- 101 25%||0
11224559|NCT01986920|12416674|FG000|NOT COMPLETED|A- 101 25%||1
11224560|NCT01986920|12416675|FG001|NOT COMPLETED|A- 101 25%||0
11224561|NCT01986920|12416676|FG002|NOT COMPLETED|A- 101 25%||0
11224562|NCT01986920|12416677|FG003|NOT COMPLETED|A- 101 25%||0
11224563|NCT01986920|12416674|FG000|STARTED|A-101 32.5%||0
11224564|NCT01986920|12416675|FG001|STARTED|A-101 32.5%||35
11224565|NCT01986920|12416676|FG002|STARTED|A-101 32.5%||0
11224566|NCT01986920|12416677|FG003|STARTED|A-101 32.5%||0
11224567|NCT01986920|12416674|FG000|COMPLETED|A-101 32.5%||0
11224568|NCT01986920|12416675|FG001|COMPLETED|A-101 32.5%||34
11224569|NCT01986920|12416676|FG002|COMPLETED|A-101 32.5%||0
11224570|NCT01986920|12416677|FG003|COMPLETED|A-101 32.5%||0
11224571|NCT01986920|12416674|FG000|NOT COMPLETED|A-101 32.5%||0
11224572|NCT01986920|12416675|FG001|NOT COMPLETED|A-101 32.5%||1
11224573|NCT01986920|12416676|FG002|NOT COMPLETED|A-101 32.5%||0
11224574|NCT01986920|12416677|FG003|NOT COMPLETED|A-101 32.5%||0
11224575|NCT01986920|12416674|FG000|STARTED|A-101 40%||0
10849049|NCT04631796|12015501|FG000|STARTED|Overall Study||35
10849050|NCT04631796|12015501|FG000|COMPLETED|Overall Study||35
10849051|NCT04631796|12015501|FG000|NOT COMPLETED|Overall Study||0
10849052|NCT04447287|12015510|FG000|STARTED|Period 1: Run-in Period||23
10849053|NCT04447287|12015511|FG001|STARTED|Period 1: Run-in Period||0
10849054|NCT04447287|12015512|FG002|STARTED|Period 1: Run-in Period||0
10849055|NCT04447287|12015510|FG000|COMPLETED|Period 1: Run-in Period||19
10849056|NCT04447287|12015511|FG001|COMPLETED|Period 1: Run-in Period||0
10849057|NCT04447287|12015512|FG002|COMPLETED|Period 1: Run-in Period||0
10849058|NCT04447287|12015510|FG000|NOT COMPLETED|Period 1: Run-in Period||4
10849059|NCT04447287|12015511|FG001|NOT COMPLETED|Period 1: Run-in Period||0
10849060|NCT04447287|12015512|FG002|NOT COMPLETED|Period 1: Run-in Period||0
10849061|NCT04447287|12015510|FG000|STARTED|Period 2: Investigational Period||1
10849062|NCT04447287|12015511|FG001|STARTED|Period 2: Investigational Period||12
10849063|NCT04447287|12015512|FG002|STARTED|Period 2: Investigational Period||6
10849064|NCT04447287|12015510|FG000|COMPLETED|Period 2: Investigational Period||0
10849065|NCT04447287|12015511|FG001|COMPLETED|Period 2: Investigational Period||12
10849066|NCT04447287|12015512|FG002|COMPLETED|Period 2: Investigational Period||6
10849067|NCT04447287|12015510|FG000|NOT COMPLETED|Period 2: Investigational Period||1
10849068|NCT04447287|12015511|FG001|NOT COMPLETED|Period 2: Investigational Period||0
10849069|NCT04447287|12015512|FG002|NOT COMPLETED|Period 2: Investigational Period||0
10849070|NCT04447287|12015510|FG000|STARTED|Period 3: Down-Titration Period||0
10849071|NCT04447287|12015511|FG001|STARTED|Period 3: Down-Titration Period||12
10849072|NCT04447287|12015512|FG002|STARTED|Period 3: Down-Titration Period||6
10849073|NCT04447287|12015510|FG000|COMPLETED|Period 3: Down-Titration Period||0
10849074|NCT04447287|12015511|FG001|COMPLETED|Period 3: Down-Titration Period||12
10849075|NCT04447287|12015512|FG002|COMPLETED|Period 3: Down-Titration Period||6
10849076|NCT04447287|12015510|FG000|NOT COMPLETED|Period 3: Down-Titration Period||0
10849077|NCT04447287|12015511|FG001|NOT COMPLETED|Period 3: Down-Titration Period||0
10849078|NCT04447287|12015512|FG002|NOT COMPLETED|Period 3: Down-Titration Period||0
10849079|NCT04203537|12015535|FG000|STARTED|Overall Study||6
11224576|NCT01986920|12416675|FG001|STARTED|A-101 40%||0
11224577|NCT01986920|12416676|FG002|STARTED|A-101 40%||35
11224578|NCT01986920|12416677|FG003|STARTED|A-101 40%||0
11224579|NCT01986920|12416674|FG000|COMPLETED|A-101 40%||0
10849080|NCT04203537|12015536|FG001|STARTED|Overall Study||6
10849081|NCT04203537|12015537|FG002|STARTED|Overall Study||6
10849082|NCT04203537|12015538|FG003|STARTED|Overall Study||6
10849083|NCT04203537|12015539|FG004|STARTED|Overall Study||54
10849084|NCT04203537|12015540|FG005|STARTED|Overall Study||55
10849085|NCT04203537|12015541|FG006|STARTED|Overall Study||60
10849086|NCT04203537|12015535|FG000|COMPLETED|Overall Study||6
10849087|NCT04203537|12015536|FG001|COMPLETED|Overall Study||6
10849088|NCT04203537|12015537|FG002|COMPLETED|Overall Study||6
10849089|NCT04203537|12015538|FG003|COMPLETED|Overall Study||6
10849090|NCT04203537|12015539|FG004|COMPLETED|Overall Study||54
10849091|NCT04203537|12015540|FG005|COMPLETED|Overall Study||55
10849092|NCT04203537|12015541|FG006|COMPLETED|Overall Study||60
10849093|NCT04203537|12015535|FG000|NOT COMPLETED|Overall Study||0
10849094|NCT04203537|12015536|FG001|NOT COMPLETED|Overall Study||0
10849095|NCT04203537|12015537|FG002|NOT COMPLETED|Overall Study||0
10849096|NCT04203537|12015538|FG003|NOT COMPLETED|Overall Study||0
10849097|NCT04203537|12015539|FG004|NOT COMPLETED|Overall Study||0
10849098|NCT04203537|12015540|FG005|NOT COMPLETED|Overall Study||0
10849099|NCT04203537|12015541|FG006|NOT COMPLETED|Overall Study||0
10849100|NCT04125745|12015551|FG000|STARTED|Overall Study||1
10849101|NCT04125745|12015551|FG000|COMPLETED|Overall Study||1
10849102|NCT04125745|12015551|FG000|NOT COMPLETED|Overall Study||0
10849103|NCT04074928|12015557|FG000|STARTED|Overall Study||1605
10849104|NCT04074928|12015558|FG001|STARTED|Overall Study||809
10849105|NCT04074928|12015557|FG000|Received Study Vaccine|Overall Study||1597
10849106|NCT04074928|12015558|FG001|Received Study Vaccine|Overall Study||805
10849107|NCT04074928|12015557|FG000|COMPLETED|Overall Study||1370
10849108|NCT04074928|12015558|FG001|COMPLETED|Overall Study||710
10849109|NCT04074928|12015557|FG000|NOT COMPLETED|Overall Study||235
10849110|NCT04074928|12015558|FG001|NOT COMPLETED|Overall Study||99
10849111|NCT04039503|12015568|FG000|STARTED|Overall Study||116
10849112|NCT04039503|12015569|FG001|STARTED|Overall Study||119
10849113|NCT04039503|12015570|FG002|STARTED|Overall Study||120
10849114|NCT04039503|12015571|FG003|STARTED|Overall Study||120
10849115|NCT04039503|12015568|FG000|Received at Least One Dose of Study Drug|Overall Study||116
10849116|NCT04039503|12015569|FG001|Received at Least One Dose of Study Drug|Overall Study||119
10849117|NCT04039503|12015570|FG002|Received at Least One Dose of Study Drug|Overall Study||120
11105846|NCT01256008|12290239|FG000|STARTED|Overall Study||98
11105847|NCT01256008|12290240|FG001|STARTED|Overall Study||98
11105848|NCT01256008|12290241|FG002|STARTED|Overall Study||196
10849118|NCT04039503|12015571|FG003|Received at Least One Dose of Study Drug|Overall Study||120
10849119|NCT04039503|12015568|FG000|COMPLETED|Overall Study||109
10849120|NCT04039503|12015569|FG001|COMPLETED|Overall Study||115
10849121|NCT04039503|12015570|FG002|COMPLETED|Overall Study||110
10849122|NCT04039503|12015571|FG003|COMPLETED|Overall Study||117
10849123|NCT04039503|12015568|FG000|NOT COMPLETED|Overall Study||7
10849124|NCT04039503|12015569|FG001|NOT COMPLETED|Overall Study||4
10849125|NCT04039503|12015570|FG002|NOT COMPLETED|Overall Study||10
10849126|NCT04039503|12015571|FG003|NOT COMPLETED|Overall Study||3
11224580|NCT01986920|12416675|FG001|COMPLETED|A-101 40%||0
10849127|NCT03695172|12015589|FG000|STARTED|Overall Study||5
10849128|NCT03695172|12015590|FG001|STARTED|Overall Study||4
10849129|NCT03695172|12015591|FG002|STARTED|Overall Study||3
10849130|NCT03695172|12015589|FG000|COMPLETED|Overall Study||4
10849131|NCT03695172|12015590|FG001|COMPLETED|Overall Study||3
10849132|NCT03695172|12015591|FG002|COMPLETED|Overall Study||3
10849133|NCT03695172|12015589|FG000|NOT COMPLETED|Overall Study||1
10849134|NCT03695172|12015590|FG001|NOT COMPLETED|Overall Study||1
10849135|NCT03695172|12015591|FG002|NOT COMPLETED|Overall Study||0
10849136|NCT03433040|12015602|FG000|STARTED|Overall Study||19
10849137|NCT03433040|12015603|FG001|STARTED|Overall Study||16
10849138|NCT03433040|12015604|FG002|STARTED|Overall Study||9
10849139|NCT03433040|12015602|FG000|COMPLETED|Overall Study||17
10849140|NCT03433040|12015603|FG001|COMPLETED|Overall Study||8
10849141|NCT03433040|12015604|FG002|COMPLETED|Overall Study||5
10849142|NCT03433040|12015602|FG000|NOT COMPLETED|Overall Study||2
10849143|NCT03433040|12015603|FG001|NOT COMPLETED|Overall Study||8
10849144|NCT03433040|12015604|FG002|NOT COMPLETED|Overall Study||4
11105849|NCT01256008|12290239|FG000|COMPLETED|Overall Study||90
11105850|NCT01256008|12290240|FG001|COMPLETED|Overall Study||91
11105851|NCT01256008|12290241|FG002|COMPLETED|Overall Study||175
11105852|NCT01256008|12290239|FG000|NOT COMPLETED|Overall Study||8
11105853|NCT01256008|12290240|FG001|NOT COMPLETED|Overall Study||7
11105854|NCT01256008|12290241|FG002|NOT COMPLETED|Overall Study||21
11105855|NCT01256034|12290253|FG000|STARTED|Overall Study||25
11105856|NCT01256034|12290254|FG001|STARTED|Overall Study||25
11105857|NCT01256034|12290253|FG000|COMPLETED|Overall Study||0
10849154|NCT03357952|12015645|FG000|STARTED|Overall Study||9
10849155|NCT03357952|12015646|FG001|STARTED|Overall Study||1
10849156|NCT03357952|12015645|FG000|COMPLETED|Overall Study||0
10849157|NCT03357952|12015646|FG001|COMPLETED|Overall Study||0
10849158|NCT03357952|12015645|FG000|NOT COMPLETED|Overall Study||9
10849159|NCT03357952|12015646|FG001|NOT COMPLETED|Overall Study||1
10849160|NCT03237234|12015654|FG000|STARTED|Overall Study||14
10849161|NCT03237234|12015655|FG001|STARTED|Overall Study||11
10849162|NCT03237234|12015654|FG000|COMPLETED|Overall Study||14
10849163|NCT03237234|12015655|FG001|COMPLETED|Overall Study||11
10849164|NCT03237234|12015654|FG000|NOT COMPLETED|Overall Study||0
10849165|NCT03237234|12015655|FG001|NOT COMPLETED|Overall Study||0
10849166|NCT03170869|12015661|FG000|STARTED|Overall Study||11
10849167|NCT03170869|12015661|FG000|COMPLETED|Overall Study||3
10849168|NCT03170869|12015661|FG000|NOT COMPLETED|Overall Study||8
10849169|NCT03066622|12015668|FG000|STARTED|Overall Study||61
10849170|NCT03066622|12015669|FG001|STARTED|Overall Study||61
10849171|NCT03066622|12015668|FG000|COMPLETED|Overall Study||35
10849172|NCT03066622|12015669|FG001|COMPLETED|Overall Study||35
10849173|NCT03066622|12015668|FG000|NOT COMPLETED|Overall Study||26
10849174|NCT03066622|12015669|FG001|NOT COMPLETED|Overall Study||26
10849175|NCT03052920|12015675|FG000|STARTED|Overall Study||40
10849176|NCT03052920|12015675|FG000|COMPLETED|Overall Study||39
10849177|NCT03052920|12015675|FG000|NOT COMPLETED|Overall Study||1
10849178|NCT03029104|12015682|FG000|STARTED|Overall Study||745
10849179|NCT03029104|12015683|FG001|STARTED|Overall Study||735
10849180|NCT03029104|12015684|FG002|STARTED|Overall Study||748
10849181|NCT03029104|12015682|FG000|COMPLETED|Overall Study||612
10849182|NCT03029104|12015683|FG001|COMPLETED|Overall Study||597
10849183|NCT03029104|12015684|FG002|COMPLETED|Overall Study||623
10849184|NCT03029104|12015682|FG000|NOT COMPLETED|Overall Study||133
10849185|NCT03029104|12015683|FG001|NOT COMPLETED|Overall Study||138
10849186|NCT03029104|12015684|FG002|NOT COMPLETED|Overall Study||125
11105858|NCT01256034|12290254|FG001|COMPLETED|Overall Study||0
11105859|NCT01256034|12290253|FG000|NOT COMPLETED|Overall Study||25
11105860|NCT01256034|12290254|FG001|NOT COMPLETED|Overall Study||25
11105861|NCT01256060|12290260|FG000|STARTED|Overall Study||3
11105862|NCT01256060|12290261|FG001|STARTED|Overall Study||3
11105863|NCT01256060|12290262|FG002|STARTED|Overall Study||3
10849193|NCT02722434|12015703|FG000|STARTED|Overall Study||25
10849194|NCT02722434|12015704|FG001|STARTED|Overall Study||25
10849195|NCT02722434|12015703|FG000|Started Treatment|Overall Study||24
10849196|NCT02722434|12015704|FG001|Started Treatment|Overall Study||25
10849197|NCT02722434|12015703|FG000|COMPLETED|Overall Study||24
10849198|NCT02722434|12015704|FG001|COMPLETED|Overall Study||22
10849199|NCT02722434|12015703|FG000|NOT COMPLETED|Overall Study||1
10849200|NCT02722434|12015704|FG001|NOT COMPLETED|Overall Study||3
10849201|NCT02721979|12015710|FG000|STARTED|Overall Study||23
10849202|NCT02721979|12015710|FG000|COMPLETED|Overall Study||22
10849203|NCT02721979|12015710|FG000|NOT COMPLETED|Overall Study||1
11105864|NCT01256060|12290263|FG003|STARTED|Overall Study||6
11105865|NCT01256060|12290260|FG000|COMPLETED|Overall Study||3
11105866|NCT01256060|12290261|FG001|COMPLETED|Overall Study||2
10849207|NCT02369536|12015720|FG000|STARTED|Overall Study||62
10849208|NCT02369536|12015721|FG001|STARTED|Overall Study||64
10849209|NCT02369536|12015720|FG000|COMPLETED|Overall Study||55
10849210|NCT02369536|12015721|FG001|COMPLETED|Overall Study||58
10849211|NCT02369536|12015720|FG000|NOT COMPLETED|Overall Study||7
10849212|NCT02369536|12015721|FG001|NOT COMPLETED|Overall Study||6
10849213|NCT02358681|12015731|FG000|STARTED|Overall Study||29
10849214|NCT02358681|12015732|FG001|STARTED|Overall Study||30
10849215|NCT02358681|12015731|FG000|COMPLETED|Overall Study||27
10849216|NCT02358681|12015732|FG001|COMPLETED|Overall Study||29
10849217|NCT02358681|12015731|FG000|NOT COMPLETED|Overall Study||2
10849218|NCT02358681|12015732|FG001|NOT COMPLETED|Overall Study||1
10849219|NCT02101788|12015740|FG000|STARTED|Overall Study||130
10849220|NCT02101788|12015741|FG001|STARTED|Overall Study||130
10849221|NCT02101788|12015740|FG000|Crossover From Arm A to Arm B|Overall Study||88
10849222|NCT02101788|12015741|FG001|Crossover From Arm A to Arm B|Overall Study||0
10849223|NCT02101788|12015740|FG000|COMPLETED|Overall Study||120
10849224|NCT02101788|12015741|FG001|COMPLETED|Overall Study||116
10849225|NCT02101788|12015740|FG000|NOT COMPLETED|Overall Study||10
10849226|NCT02101788|12015741|FG001|NOT COMPLETED|Overall Study||14
11105867|NCT01256060|12290262|FG002|COMPLETED|Overall Study||3
11105868|NCT01256060|12290263|FG003|COMPLETED|Overall Study||6
11105869|NCT01256060|12290260|FG000|NOT COMPLETED|Overall Study||0
11105870|NCT01256060|12290261|FG001|NOT COMPLETED|Overall Study||1
11105871|NCT01256060|12290262|FG002|NOT COMPLETED|Overall Study||0
11105872|NCT01256060|12290263|FG003|NOT COMPLETED|Overall Study||0
10849233|NCT01248247|12015767|FG000|STARTED|Overall Study||22
10849234|NCT01248247|12015768|FG001|STARTED|Overall Study||42
10849235|NCT01248247|12015769|FG002|STARTED|Overall Study||75
11224581|NCT01986920|12416676|FG002|COMPLETED|A-101 40%||34
11224582|NCT01986920|12416677|FG003|COMPLETED|A-101 40%||0
11224583|NCT01986920|12416674|FG000|NOT COMPLETED|A-101 40%||0
11224584|NCT01986920|12416675|FG001|NOT COMPLETED|A-101 40%||0
11224585|NCT01986920|12416676|FG002|NOT COMPLETED|A-101 40%||1
11224586|NCT01986920|12416677|FG003|NOT COMPLETED|A-101 40%||0
11224587|NCT01986920|12416674|FG000|STARTED|Placebo||0
11224588|NCT01986920|12416675|FG001|STARTED|Placebo||0
11224589|NCT01986920|12416676|FG002|STARTED|Placebo||0
11224590|NCT01986920|12416677|FG003|STARTED|Placebo||35
11224591|NCT01986920|12416674|FG000|COMPLETED|Placebo||0
11224592|NCT01986920|12416675|FG001|COMPLETED|Placebo||0
11105873|NCT01256164|12290271|FG000|STARTED|Overall Study||47
11224593|NCT01986920|12416676|FG002|COMPLETED|Placebo||0
11224594|NCT01986920|12416677|FG003|COMPLETED|Placebo||34
11224595|NCT01986920|12416674|FG000|NOT COMPLETED|Placebo||0
11224596|NCT01986920|12416675|FG001|NOT COMPLETED|Placebo||0
11224597|NCT01986920|12416676|FG002|NOT COMPLETED|Placebo||0
11224598|NCT01986920|12416677|FG003|NOT COMPLETED|Placebo||1
11224599|NCT01986946|12416689|FG000|STARTED|Overall Study||5
11224600|NCT01986946|12416690|FG001|STARTED|Overall Study||9
11224601|NCT01986946|12416689|FG000|COMPLETED|Overall Study||5
11224602|NCT01986946|12416690|FG001|COMPLETED|Overall Study||9
11224603|NCT01986946|12416689|FG000|NOT COMPLETED|Overall Study||0
11224604|NCT01986946|12416690|FG001|NOT COMPLETED|Overall Study||0
11224605|NCT01986985|12416696|FG000|STARTED|Overall Study||58
11224606|NCT01986985|12416696|FG000|COMPLETED|Overall Study||51
11224607|NCT01986985|12416696|FG000|NOT COMPLETED|Overall Study||7
11224608|NCT01987089|12416702|FG000|STARTED|Overall Study||31
11224609|NCT01987089|12416703|FG001|STARTED|Overall Study||32
11224610|NCT01987089|12416702|FG000|COMPLETED|Overall Study||30
11224611|NCT01987089|12416703|FG001|COMPLETED|Overall Study||28
11224612|NCT01987089|12416702|FG000|NOT COMPLETED|Overall Study||1
11224613|NCT01987089|12416703|FG001|NOT COMPLETED|Overall Study||4
11224614|NCT01987102|12416711|FG000|STARTED|2 Courses of HDMTX With SOC Rescue||8
11224615|NCT01987102|12416712|FG001|STARTED|2 Courses of HDMTX With SOC Rescue||10
10849236|NCT01248247|12015770|FG003|STARTED|Overall Study||61
10849237|NCT01248247|12015767|FG000|COMPLETED|Overall Study||0
10849238|NCT01248247|12015768|FG001|COMPLETED|Overall Study||0
10849239|NCT01248247|12015769|FG002|COMPLETED|Overall Study||0
11105874|NCT01256164|12290272|FG001|STARTED|Overall Study||23
11105875|NCT01256164|12290271|FG000|COMPLETED|Overall Study||47
10849240|NCT01248247|12015770|FG003|COMPLETED|Overall Study||0
10849241|NCT01248247|12015767|FG000|NOT COMPLETED|Overall Study||22
10849242|NCT01248247|12015768|FG001|NOT COMPLETED|Overall Study||42
10849243|NCT01248247|12015769|FG002|NOT COMPLETED|Overall Study||75
11105876|NCT01256164|12290272|FG001|COMPLETED|Overall Study||23
11105877|NCT01256164|12290271|FG000|NOT COMPLETED|Overall Study||0
11105878|NCT01256164|12290272|FG001|NOT COMPLETED|Overall Study||0
10849244|NCT01248247|12015770|FG003|NOT COMPLETED|Overall Study||61
10849245|NCT01164228|12015782|FG000|STARTED|Overall Study||47
10849246|NCT01164228|12015783|FG001|STARTED|Overall Study||40
10849247|NCT01164228|12015782|FG000|Receipt of Protocol Therapy|Overall Study||46
10849248|NCT01164228|12015783|FG001|Receipt of Protocol Therapy|Overall Study||37
10849249|NCT01164228|12015782|FG000|Treated and Eligible Patients|Overall Study||45
10849250|NCT01164228|12015783|FG001|Treated and Eligible Patients|Overall Study||37
10849251|NCT01164228|12015782|FG000|COMPLETED|Overall Study||3
10849252|NCT01164228|12015783|FG001|COMPLETED|Overall Study||2
10849253|NCT01164228|12015782|FG000|NOT COMPLETED|Overall Study||44
10849254|NCT01164228|12015783|FG001|NOT COMPLETED|Overall Study||38
10849255|NCT01012167|12015792|FG000|STARTED|Overall Study||17
10849256|NCT01012167|12015793|FG001|STARTED|Overall Study||20
10849257|NCT01012167|12015794|FG002|STARTED|Overall Study||21
10849258|NCT01012167|12015792|FG000|Withdrawn Prior to Study Drug Exposure|Overall Study||1
10849259|NCT01012167|12015793|FG001|Withdrawn Prior to Study Drug Exposure|Overall Study||0
10849260|NCT01012167|12015794|FG002|Withdrawn Prior to Study Drug Exposure|Overall Study||1
10849261|NCT01012167|12015792|FG000|Exposed to Study Drug|Overall Study||16
10849262|NCT01012167|12015793|FG001|Exposed to Study Drug|Overall Study||20
10849263|NCT01012167|12015794|FG002|Exposed to Study Drug|Overall Study||20
10849264|NCT01012167|12015792|FG000|COMPLETED|Overall Study||15
10849265|NCT01012167|12015793|FG001|COMPLETED|Overall Study||18
10849266|NCT01012167|12015794|FG002|COMPLETED|Overall Study||17
10849267|NCT01012167|12015792|FG000|NOT COMPLETED|Overall Study||2
10849268|NCT01012167|12015793|FG001|NOT COMPLETED|Overall Study||2
10849269|NCT01012167|12015794|FG002|NOT COMPLETED|Overall Study||4
10849270|NCT00924326|12015818|FG000|STARTED|Dose Administration||8
10849271|NCT00924326|12015819|FG001|STARTED|Dose Administration||2
10849272|NCT00924326|12015820|FG002|STARTED|Dose Administration||5
10849273|NCT00924326|12015821|FG003|STARTED|Dose Administration||6
10849274|NCT00924326|12015822|FG004|STARTED|Dose Administration||7
10849275|NCT00924326|12015823|FG005|STARTED|Dose Administration||10
10849276|NCT00924326|12015824|FG006|STARTED|Dose Administration||1
10849277|NCT00924326|12015825|FG007|STARTED|Dose Administration||2
10849278|NCT00924326|12015826|FG008|STARTED|Dose Administration||2
10849279|NCT00924326|12015818|FG000|COMPLETED|Dose Administration||8
10849280|NCT00924326|12015819|FG001|COMPLETED|Dose Administration||2
10849281|NCT00924326|12015820|FG002|COMPLETED|Dose Administration||5
10849282|NCT00924326|12015821|FG003|COMPLETED|Dose Administration||6
10849283|NCT00924326|12015822|FG004|COMPLETED|Dose Administration||7
10849284|NCT00924326|12015823|FG005|COMPLETED|Dose Administration||10
10849285|NCT00924326|12015824|FG006|COMPLETED|Dose Administration||1
10849286|NCT00924326|12015825|FG007|COMPLETED|Dose Administration||2
10849287|NCT00924326|12015826|FG008|COMPLETED|Dose Administration||2
10849288|NCT00924326|12015818|FG000|NOT COMPLETED|Dose Administration||0
11105879|NCT01256177|12290280|FG000|STARTED|Overall Study||148
11105880|NCT01256177|12290281|FG001|STARTED|Overall Study||148
11105881|NCT01256177|12290280|FG000|COMPLETED|Overall Study||98
11105882|NCT01256177|12290281|FG001|COMPLETED|Overall Study||111
11105883|NCT01256177|12290280|FG000|NOT COMPLETED|Overall Study||50
11105884|NCT01256177|12290281|FG001|NOT COMPLETED|Overall Study||37
11105885|NCT01256190|12290289|FG000|STARTED|Overall Study||39
11105886|NCT01256190|12290290|FG001|STARTED|Overall Study||17
11105887|NCT01256190|12290289|FG000|COMPLETED|Overall Study||37
10849289|NCT00924326|12015819|FG001|NOT COMPLETED|Dose Administration||0
10849290|NCT00924326|12015820|FG002|NOT COMPLETED|Dose Administration||0
10849291|NCT00924326|12015821|FG003|NOT COMPLETED|Dose Administration||0
10849292|NCT00924326|12015822|FG004|NOT COMPLETED|Dose Administration||0
10849293|NCT00924326|12015823|FG005|NOT COMPLETED|Dose Administration||0
10849294|NCT00924326|12015824|FG006|NOT COMPLETED|Dose Administration||0
10849295|NCT00924326|12015825|FG007|NOT COMPLETED|Dose Administration||0
10849296|NCT00924326|12015826|FG008|NOT COMPLETED|Dose Administration||0
10849297|NCT00924326|12015818|FG000|STARTED|1x10^9-1x10^10 + High Dose Retreat||3
10849298|NCT00924326|12015819|FG001|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849299|NCT00924326|12015820|FG002|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849300|NCT00924326|12015821|FG003|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849301|NCT00924326|12015822|FG004|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849302|NCT00924326|12015823|FG005|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849303|NCT00924326|12015824|FG006|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849304|NCT00924326|12015825|FG007|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849305|NCT00924326|12015826|FG008|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
10849306|NCT00924326|12015818|FG000|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3
10849307|NCT00924326|12015819|FG001|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849308|NCT00924326|12015820|FG002|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849309|NCT00924326|12015821|FG003|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849310|NCT00924326|12015822|FG004|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849311|NCT00924326|12015823|FG005|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849312|NCT00924326|12015824|FG006|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849313|NCT00924326|12015825|FG007|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849314|NCT00924326|12015826|FG008|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849315|NCT00924326|12015818|FG000|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849316|NCT00924326|12015819|FG001|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849317|NCT00924326|12015820|FG002|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849318|NCT00924326|12015821|FG003|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849319|NCT00924326|12015822|FG004|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849320|NCT00924326|12015823|FG005|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849321|NCT00924326|12015824|FG006|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849322|NCT00924326|12015825|FG007|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849323|NCT00924326|12015826|FG008|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
10849324|NCT00591318|12015850|FG000|STARTED|Overall Study||5
10849325|NCT00591318|12015851|FG001|STARTED|Overall Study||5
10849326|NCT00591318|12015850|FG000|COMPLETED|Overall Study|For our protocol, participants in both treatment arms were considered completers if they completed at least 6 weeks. At the 6 week point, if response on PANS was not sufficient (15% or greater), they were considered unlikely to respond and therefore were not given the option of the 2 additional weeks of ceftriaxone or placebo. For the analysis, we used the last observed rating between baseline to week 8 for each participant, regardless of whether the participant completed the study treatments.|1
10849327|NCT00591318|12015851|FG001|COMPLETED|Overall Study|For our protocol, participants in both treatment arms were considered completers if they completed at least 6 weeks. At the 6 week point, if response on PANS was not sufficient (15% or greater), they were considered unlikely to respond and therefore were not given the option of the 2 additional weeks of ceftriaxone or placebo. For the analysis, we used the last observed rating between baseline to week 8 for each participant regardless of whether the participant completed the study treatments..|5
10849328|NCT00591318|12015850|FG000|NOT COMPLETED|Overall Study||4
10849329|NCT00591318|12015851|FG001|NOT COMPLETED|Overall Study||0
10849330|NCT00321100|12015863|FG000|STARTED|Overall Study||12
10849331|NCT00321100|12015864|FG001|STARTED|Overall Study||11
10849332|NCT00321100|12015863|FG000|COMPLETED|Overall Study||12
10849333|NCT00321100|12015864|FG001|COMPLETED|Overall Study||11
10849334|NCT00321100|12015863|FG000|NOT COMPLETED|Overall Study||0
10849335|NCT00321100|12015864|FG001|NOT COMPLETED|Overall Study||0
10849336|NCT04534517|12015872|FG000|STARTED|Overall Study||114
10849337|NCT04534517|12015872|FG000|COMPLETED|Overall Study||110
10849338|NCT04534517|12015872|FG000|NOT COMPLETED|Overall Study||4
10849339|NCT04494646|12015878|FG000|STARTED|Overall Study||21
10849340|NCT04494646|12015879|FG001|STARTED|Overall Study||19
10849341|NCT04494646|12015878|FG000|COMPLETED|Overall Study||21
10849342|NCT04494646|12015879|FG001|COMPLETED|Overall Study||17
10849343|NCT04494646|12015878|FG000|NOT COMPLETED|Overall Study||0
10849344|NCT04494646|12015879|FG001|NOT COMPLETED|Overall Study||2
11224616|NCT01987102|12416711|FG000|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
11224617|NCT01987102|12416712|FG001|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
11224618|NCT01987102|12416711|FG000|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4
11224619|NCT01987102|12416712|FG001|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6
11224620|NCT01987102|12416711|FG000|STARTED|2 Courses of HDMTX With MOD Rescue||4
11224621|NCT01987102|12416712|FG001|STARTED|2 Courses of HDMTX With MOD Rescue||4
11224622|NCT01987102|12416711|FG000|COMPLETED|2 Courses of HDMTX With MOD Rescue||4
11224623|NCT01987102|12416712|FG001|COMPLETED|2 Courses of HDMTX With MOD Rescue||3
11224624|NCT01987102|12416711|FG000|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0
11224625|NCT01987102|12416712|FG001|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1
11224626|NCT01987219|12416725|FG000|STARTED|Overall Study||2
11224627|NCT01987219|12416726|FG001|STARTED|Overall Study||2
11224628|NCT01987219|12416727|FG002|STARTED|Overall Study||7
11224629|NCT01987219|12416728|FG003|STARTED|Overall Study||2
11224630|NCT01987219|12416729|FG004|STARTED|Overall Study||1
11224631|NCT01987219|12416730|FG005|STARTED|Overall Study||1
11224632|NCT01987219|12416725|FG000|COMPLETED|Overall Study||2
11224633|NCT01987219|12416726|FG001|COMPLETED|Overall Study||2
11224634|NCT01987219|12416727|FG002|COMPLETED|Overall Study||6
11224635|NCT01987219|12416728|FG003|COMPLETED|Overall Study||2
11224636|NCT01987219|12416729|FG004|COMPLETED|Overall Study||1
11224637|NCT01987219|12416730|FG005|COMPLETED|Overall Study||1
11224638|NCT01987219|12416725|FG000|NOT COMPLETED|Overall Study||0
11224639|NCT01987219|12416726|FG001|NOT COMPLETED|Overall Study||0
11224640|NCT01987219|12416727|FG002|NOT COMPLETED|Overall Study||1
11224641|NCT01987219|12416728|FG003|NOT COMPLETED|Overall Study||0
11224642|NCT01987219|12416729|FG004|NOT COMPLETED|Overall Study||0
11224643|NCT01987219|12416730|FG005|NOT COMPLETED|Overall Study||0
11224644|NCT01987232|12416743|FG000|STARTED|Overall Study||5
11224645|NCT01987232|12416744|FG001|STARTED|Overall Study||3
11224646|NCT01987232|12416745|FG002|STARTED|Overall Study||3
11224647|NCT01987232|12416746|FG003|STARTED|Overall Study||15
11224648|NCT01987232|12416747|FG004|STARTED|Overall Study||6
11224649|NCT01987232|12416743|FG000|COMPLETED|Overall Study||5
11224650|NCT01987232|12416744|FG001|COMPLETED|Overall Study||3
11224651|NCT01987232|12416745|FG002|COMPLETED|Overall Study||3
11224652|NCT01987232|12416746|FG003|COMPLETED|Overall Study||14
11224653|NCT01987232|12416747|FG004|COMPLETED|Overall Study||6
11224654|NCT01987232|12416743|FG000|NOT COMPLETED|Overall Study||0
11224655|NCT01987232|12416744|FG001|NOT COMPLETED|Overall Study||0
11224656|NCT01987232|12416745|FG002|NOT COMPLETED|Overall Study||0
11224657|NCT01987232|12416746|FG003|NOT COMPLETED|Overall Study||1
11224658|NCT01987232|12416747|FG004|NOT COMPLETED|Overall Study||0
11224659|NCT01987349|12416769|FG000|STARTED|Overall Study||6
11224660|NCT01987349|12416770|FG001|STARTED|Overall Study||6
11224661|NCT01987349|12416771|FG002|STARTED|Overall Study||8
11224662|NCT01987349|12416772|FG003|STARTED|Overall Study||6
11224663|NCT01987349|12416773|FG004|STARTED|Overall Study||6
11224664|NCT01987349|12416774|FG005|STARTED|Overall Study||6
11224665|NCT01987349|12416775|FG006|STARTED|Overall Study||10
11224666|NCT01987349|12416776|FG007|STARTED|Overall Study||25
11224667|NCT01987349|12416769|FG000|COMPLETED|Overall Study||6
11224668|NCT01987349|12416770|FG001|COMPLETED|Overall Study||6
11224669|NCT01987349|12416771|FG002|COMPLETED|Overall Study||8
10849345|NCT04258020|12015887|FG000|STARTED|Overall Study||4
10849346|NCT04258020|12015888|FG001|STARTED|Overall Study||0
10849347|NCT04258020|12015887|FG000|COMPLETED|Overall Study||3
10849348|NCT04258020|12015888|FG001|COMPLETED|Overall Study||0
10849349|NCT04258020|12015887|FG000|NOT COMPLETED|Overall Study||1
10849350|NCT04258020|12015888|FG001|NOT COMPLETED|Overall Study||0
10849351|NCT04234464|12015896|FG000|STARTED|Period 1 (First Treatment Intervention)||29
10849352|NCT04234464|12015897|FG001|STARTED|Period 1 (First Treatment Intervention)||31
10849353|NCT04234464|12015896|FG000|COMPLETED|Period 1 (First Treatment Intervention)||29
10849354|NCT04234464|12015897|FG001|COMPLETED|Period 1 (First Treatment Intervention)||31
10849355|NCT04234464|12015896|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
10849356|NCT04234464|12015897|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
10849357|NCT04234464|12015896|FG000|STARTED|Period 2 (Second Treatment Intervention)||29
10849358|NCT04234464|12015897|FG001|STARTED|Period 2 (Second Treatment Intervention)||31
10849359|NCT04234464|12015896|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||28
10849360|NCT04234464|12015897|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||31
10849361|NCT04234464|12015896|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1
10849362|NCT04234464|12015897|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0
10849363|NCT03852316|12015903|FG000|STARTED|Overall Study||1585
10849364|NCT03852316|12015903|FG000|COMPLETED|Overall Study||1581
10849365|NCT03852316|12015903|FG000|NOT COMPLETED|Overall Study||4
10849366|NCT03789318|12015912|FG000|STARTED|Overall Study||9
10849367|NCT03789318|12015913|FG001|STARTED|Overall Study||9
10849368|NCT03789318|12015914|FG002|STARTED|Overall Study||12
10849369|NCT03789318|12015915|FG003|STARTED|Overall Study||12
10849370|NCT03789318|12015916|FG004|STARTED|Overall Study||12
10849371|NCT03789318|12015912|FG000|COMPLETED|Overall Study||9
10849372|NCT03789318|12015913|FG001|COMPLETED|Overall Study||9
10849373|NCT03789318|12015914|FG002|COMPLETED|Overall Study||9
10849374|NCT03789318|12015915|FG003|COMPLETED|Overall Study||11
10849375|NCT03789318|12015916|FG004|COMPLETED|Overall Study||12
10849376|NCT03789318|12015912|FG000|NOT COMPLETED|Overall Study||0
10849377|NCT03789318|12015913|FG001|NOT COMPLETED|Overall Study||0
10849378|NCT03789318|12015914|FG002|NOT COMPLETED|Overall Study||3
10849379|NCT03789318|12015915|FG003|NOT COMPLETED|Overall Study||1
11224670|NCT01987349|12416772|FG003|COMPLETED|Overall Study||6
11224671|NCT01987349|12416773|FG004|COMPLETED|Overall Study||6
11224672|NCT01987349|12416774|FG005|COMPLETED|Overall Study||6
11224673|NCT01987349|12416775|FG006|COMPLETED|Overall Study||10
11224674|NCT01987349|12416776|FG007|COMPLETED|Overall Study||24
11224675|NCT01987349|12416769|FG000|NOT COMPLETED|Overall Study||0
11224676|NCT01987349|12416770|FG001|NOT COMPLETED|Overall Study||0
11224677|NCT01987349|12416771|FG002|NOT COMPLETED|Overall Study||0
11224678|NCT01987349|12416772|FG003|NOT COMPLETED|Overall Study||0
11224679|NCT01987349|12416773|FG004|NOT COMPLETED|Overall Study||0
11224680|NCT01987349|12416774|FG005|NOT COMPLETED|Overall Study||0
11224681|NCT01987349|12416775|FG006|NOT COMPLETED|Overall Study||0
11224682|NCT01987349|12416776|FG007|NOT COMPLETED|Overall Study||1
11224683|NCT01987401|12416801|FG000|STARTED|Overall Study||591
11224684|NCT01987401|12416802|FG001|STARTED|Overall Study||591
11224685|NCT01987401|12416803|FG002|STARTED|Overall Study||60
11224686|NCT01987401|12416801|FG000|COMPLETED|Overall Study||137
11224687|NCT01987401|12416802|FG001|COMPLETED|Overall Study||121
11224688|NCT01987401|12416803|FG002|COMPLETED|Overall Study||16
11224689|NCT01987401|12416801|FG000|NOT COMPLETED|Overall Study||454
11224690|NCT01987401|12416802|FG001|NOT COMPLETED|Overall Study||470
11224691|NCT01987401|12416803|FG002|NOT COMPLETED|Overall Study||44
11224692|NCT01987414|12416813|FG000|STARTED|Overall Study||10
11224693|NCT01987414|12416814|FG001|STARTED|Overall Study||8
11224694|NCT01987414|12416813|FG000|COMPLETED|Overall Study||8
11224695|NCT01987414|12416814|FG001|COMPLETED|Overall Study||6
11224696|NCT01987414|12416813|FG000|NOT COMPLETED|Overall Study||2
11224697|NCT01987414|12416814|FG001|NOT COMPLETED|Overall Study||2
11224698|NCT01987427|12416823|FG000|STARTED|Overall Study||78
11224699|NCT01987427|12416824|FG001|STARTED|Overall Study||78
11224700|NCT01987427|12416825|FG002|STARTED|Overall Study||79
11224701|NCT01987427|12416823|FG000|COMPLETED|Overall Study||64
11224702|NCT01987427|12416824|FG001|COMPLETED|Overall Study||68
11224703|NCT01987427|12416825|FG002|COMPLETED|Overall Study||59
11224704|NCT01987427|12416823|FG000|NOT COMPLETED|Overall Study||14
11224705|NCT01987427|12416824|FG001|NOT COMPLETED|Overall Study||10
11224706|NCT01987427|12416825|FG002|NOT COMPLETED|Overall Study||20
11224707|NCT01987453|12416836|FG000|STARTED|Overall Study||51
11224708|NCT01987453|12416837|FG001|STARTED|Overall Study||41
11224709|NCT01987453|12416838|FG002|STARTED|Overall Study||8
10849380|NCT03789318|12015916|FG004|NOT COMPLETED|Overall Study||0
11105888|NCT01256190|12290290|FG001|COMPLETED|Overall Study||17
11105889|NCT01256190|12290289|FG000|NOT COMPLETED|Overall Study||2
11105890|NCT01256190|12290290|FG001|NOT COMPLETED|Overall Study||0
11105891|NCT01256294|12290296|FG000|STARTED|Overall Study||36
11224710|NCT01987453|12416836|FG000|COMPLETED|Overall Study||50
11224711|NCT01987453|12416837|FG001|COMPLETED|Overall Study||29
11224712|NCT01987453|12416838|FG002|COMPLETED|Overall Study||7
11224713|NCT01987453|12416836|FG000|NOT COMPLETED|Overall Study||1
11224714|NCT01987453|12416837|FG001|NOT COMPLETED|Overall Study||12
11224715|NCT01987453|12416838|FG002|NOT COMPLETED|Overall Study||1
11224716|NCT01987479|12416850|FG000|STARTED|Overall Study||150
11224717|NCT01987479|12416850|FG000|COMPLETED|Overall Study||133
11224718|NCT01987479|12416850|FG000|NOT COMPLETED|Overall Study||17
11224719|NCT01987505|12416856|FG000|STARTED|Overall Study||140
11224720|NCT01987505|12416856|FG000|COMPLETED|Overall Study||106
11224721|NCT01987505|12416856|FG000|NOT COMPLETED|Overall Study||34
11105892|NCT01256294|12290297|FG001|STARTED|Overall Study||35
11105893|NCT01256294|12290296|FG000|COMPLETED|Overall Study||32
11105894|NCT01256294|12290297|FG001|COMPLETED|Overall Study||33
11105895|NCT01256294|12290296|FG000|NOT COMPLETED|Overall Study||4
10849389|NCT03613662|12015937|FG000|STARTED|Overall Study||19
10849390|NCT03613662|12015937|FG000|COMPLETED|Overall Study||19
10849391|NCT03613662|12015937|FG000|NOT COMPLETED|Overall Study||0
10849392|NCT03232736|12015943|FG000|STARTED|Overall Study||9
10849393|NCT03232736|12015944|FG001|STARTED|Overall Study||13
10849394|NCT03232736|12015943|FG000|COMPLETED|Overall Study||9
10849395|NCT03232736|12015944|FG001|COMPLETED|Overall Study||13
10849396|NCT03232736|12015943|FG000|NOT COMPLETED|Overall Study||0
10849397|NCT03232736|12015944|FG001|NOT COMPLETED|Overall Study||0
10849398|NCT03208530|12015954|FG000|STARTED|Overall Study||75
10849399|NCT03208530|12015954|FG000|COMPLETED|Overall Study||48
10849400|NCT03208530|12015954|FG000|NOT COMPLETED|Overall Study||27
11105896|NCT01256294|12290297|FG001|NOT COMPLETED|Overall Study||2
11105897|NCT01256385|12290305|FG000|STARTED|Overall Study||43
11105898|NCT01256385|12290306|FG001|STARTED|Overall Study||43
11105899|NCT01256385|12290305|FG000|Crossover From Arm B to Arm A|Overall Study||0
11105900|NCT01256385|12290306|FG001|Crossover From Arm B to Arm A|Overall Study||15
11105901|NCT01256385|12290305|FG000|COMPLETED|Overall Study||40
11105902|NCT01256385|12290306|FG001|COMPLETED|Overall Study||40
11224722|NCT01987557|12416865|FG000|STARTED|Overall Study||16
10849409|NCT03103321|12015971|FG000|STARTED|Overall Study||25
10849410|NCT03103321|12015972|FG001|STARTED|Overall Study||39
10849411|NCT03103321|12015973|FG002|STARTED|Overall Study||44
10849412|NCT03103321|12015974|FG003|STARTED|Overall Study||50
10849413|NCT03103321|12015971|FG000|COMPLETED|Overall Study||24
10849414|NCT03103321|12015972|FG001|COMPLETED|Overall Study||38
10849415|NCT03103321|12015973|FG002|COMPLETED|Overall Study||43
10849416|NCT03103321|12015974|FG003|COMPLETED|Overall Study||50
10849417|NCT03103321|12015971|FG000|NOT COMPLETED|Overall Study||1
10849418|NCT03103321|12015972|FG001|NOT COMPLETED|Overall Study||1
10849419|NCT03103321|12015973|FG002|NOT COMPLETED|Overall Study||1
10849420|NCT03103321|12015974|FG003|NOT COMPLETED|Overall Study||0
10849421|NCT03079869|12015986|FG000|STARTED|Overall Study||28
10849422|NCT03079869|12015987|FG001|STARTED|Overall Study||27
10849423|NCT03079869|12015986|FG000|COMPLETED|Overall Study||15
10849424|NCT03079869|12015987|FG001|COMPLETED|Overall Study||16
10849425|NCT03079869|12015986|FG000|NOT COMPLETED|Overall Study||13
10849426|NCT03079869|12015987|FG001|NOT COMPLETED|Overall Study||11
10849427|NCT03033875|12015996|FG000|STARTED|Overall Study||96
10849428|NCT03033875|12015997|FG001|STARTED|Overall Study||111
10849429|NCT03033875|12015998|FG002|STARTED|Overall Study||54
10849430|NCT03033875|12015996|FG000|Completed Month 3 Assessment|Overall Study||71
10849431|NCT03033875|12015997|FG001|Completed Month 3 Assessment|Overall Study||83
10849432|NCT03033875|12015998|FG002|Completed Month 3 Assessment|Overall Study||43
10849433|NCT03033875|12015996|FG000|Completed Month 6 Assessment|Overall Study||73
10849434|NCT03033875|12015997|FG001|Completed Month 6 Assessment|Overall Study||81
10849435|NCT03033875|12015998|FG002|Completed Month 6 Assessment|Overall Study||46
10849436|NCT03033875|12015996|FG000|COMPLETED|Overall Study||77
11224723|NCT01987557|12416866|FG001|STARTED|Overall Study||16
10849437|NCT03033875|12015997|FG001|COMPLETED|Overall Study||87
10849438|NCT03033875|12015998|FG002|COMPLETED|Overall Study||42
10849439|NCT03033875|12015996|FG000|NOT COMPLETED|Overall Study||19
10849440|NCT03033875|12015997|FG001|NOT COMPLETED|Overall Study||24
10849441|NCT03033875|12015998|FG002|NOT COMPLETED|Overall Study||12
10849442|NCT02935595|12016006|FG000|STARTED|Overall Study||5
10849443|NCT02935595|12016006|FG000|COMPLETED|Overall Study||4
10849444|NCT02935595|12016006|FG000|NOT COMPLETED|Overall Study||1
10849445|NCT02887248|12016010|FG000|STARTED|Overall Study||3
10849446|NCT02887248|12016010|FG000|COMPLETED|Overall Study||0
10849447|NCT02887248|12016010|FG000|NOT COMPLETED|Overall Study||3
10849448|NCT02849990|12016014|FG000|STARTED|Overall Study||22
10849449|NCT02849990|12016014|FG000|COMPLETED|Overall Study||20
10849450|NCT02849990|12016014|FG000|NOT COMPLETED|Overall Study||2
10849451|NCT02673151|12016018|FG000|STARTED|Overall Study||61
10849452|NCT02673151|12016018|FG000|COMPLETED|Overall Study||61
10849453|NCT02673151|12016018|FG000|NOT COMPLETED|Overall Study||0
10849454|NCT02523274|12016030|FG000|STARTED|Overall Study||20
10849455|NCT02523274|12016031|FG001|STARTED|Overall Study||20
10849456|NCT02523274|12016032|FG002|STARTED|Overall Study||20
10849457|NCT02523274|12016030|FG000|COMPLETED|Overall Study||19
10849458|NCT02523274|12016031|FG001|COMPLETED|Overall Study||18
10849459|NCT02523274|12016032|FG002|COMPLETED|Overall Study||18
10849460|NCT02523274|12016030|FG000|NOT COMPLETED|Overall Study||1
10849461|NCT02523274|12016031|FG001|NOT COMPLETED|Overall Study||2
10849462|NCT02523274|12016032|FG002|NOT COMPLETED|Overall Study||2
10849463|NCT02467270|12016047|FG000|STARTED|Overall Study||94
10849464|NCT02467270|12016048|FG001|STARTED|Overall Study||95
10849465|NCT02467270|12016049|FG002|STARTED|Overall Study||94
10849466|NCT02467270|12016047|FG000|Treated (Safety Population)|Overall Study||94
10849467|NCT02467270|12016048|FG001|Treated (Safety Population)|Overall Study||94
10849468|NCT02467270|12016049|FG002|Treated (Safety Population)|Overall Study||94
10849469|NCT02467270|12016047|FG000|COMPLETED|Overall Study||0
10849470|NCT02467270|12016048|FG001|COMPLETED|Overall Study||0
10849471|NCT02467270|12016049|FG002|COMPLETED|Overall Study||0
10849472|NCT02467270|12016047|FG000|NOT COMPLETED|Overall Study||94
10849473|NCT02467270|12016048|FG001|NOT COMPLETED|Overall Study||95
10849474|NCT02467270|12016049|FG002|NOT COMPLETED|Overall Study||94
10849475|NCT02452554|12016063|FG000|STARTED|Overall Study||17
10849476|NCT02452554|12016064|FG001|STARTED|Overall Study||17
10849477|NCT02452554|12016065|FG002|STARTED|Overall Study||12
10849478|NCT02452554|12016066|FG003|STARTED|Overall Study||1
10849479|NCT02452554|12016067|FG004|STARTED|Overall Study||5
10849480|NCT02452554|12016068|FG005|STARTED|Overall Study||10
10849481|NCT02452554|12016063|FG000|COMPLETED|Overall Study||0
10849482|NCT02452554|12016064|FG001|COMPLETED|Overall Study||0
10849483|NCT02452554|12016065|FG002|COMPLETED|Overall Study||1
10849484|NCT02452554|12016066|FG003|COMPLETED|Overall Study||0
10849485|NCT02452554|12016067|FG004|COMPLETED|Overall Study||0
10849486|NCT02452554|12016068|FG005|COMPLETED|Overall Study||1
10849487|NCT02452554|12016063|FG000|NOT COMPLETED|Overall Study||17
10849488|NCT02452554|12016064|FG001|NOT COMPLETED|Overall Study||17
10849489|NCT02452554|12016065|FG002|NOT COMPLETED|Overall Study||11
10849490|NCT02452554|12016066|FG003|NOT COMPLETED|Overall Study||1
10849491|NCT02452554|12016067|FG004|NOT COMPLETED|Overall Study||5
10849492|NCT02452554|12016068|FG005|NOT COMPLETED|Overall Study||9
10849493|NCT02318277|12016091|FG000|STARTED|Overall Study||6
10849494|NCT02318277|12016092|FG001|STARTED|Overall Study||3
10849495|NCT02318277|12016093|FG002|STARTED|Overall Study||4
10849496|NCT02318277|12016094|FG003|STARTED|Overall Study||4
10849497|NCT02318277|12016095|FG004|STARTED|Overall Study||8
10849498|NCT02318277|12016096|FG005|STARTED|Overall Study||9
10849499|NCT02318277|12016097|FG006|STARTED|Overall Study||49
10849500|NCT02318277|12016098|FG007|STARTED|Overall Study||93
10849501|NCT02318277|12016091|FG000|COMPLETED|Overall Study||0
10849502|NCT02318277|12016092|FG001|COMPLETED|Overall Study||0
10849503|NCT02318277|12016093|FG002|COMPLETED|Overall Study||0
10849504|NCT02318277|12016094|FG003|COMPLETED|Overall Study||0
10849505|NCT02318277|12016095|FG004|COMPLETED|Overall Study||0
10849506|NCT02318277|12016096|FG005|COMPLETED|Overall Study||0
10849507|NCT02318277|12016097|FG006|COMPLETED|Overall Study||0
10849508|NCT02318277|12016098|FG007|COMPLETED|Overall Study||0
10849509|NCT02318277|12016091|FG000|NOT COMPLETED|Overall Study||6
10849510|NCT02318277|12016092|FG001|NOT COMPLETED|Overall Study||3
10849511|NCT02318277|12016093|FG002|NOT COMPLETED|Overall Study||4
10849512|NCT02318277|12016094|FG003|NOT COMPLETED|Overall Study||4
10849513|NCT02318277|12016095|FG004|NOT COMPLETED|Overall Study||8
10849514|NCT02318277|12016096|FG005|NOT COMPLETED|Overall Study||9
10849515|NCT02318277|12016097|FG006|NOT COMPLETED|Overall Study||49
10849516|NCT02318277|12016098|FG007|NOT COMPLETED|Overall Study||93
10849517|NCT02296801|12016134|FG000|STARTED|Overall Study||103
10849518|NCT02296801|12016135|FG001|STARTED|Overall Study||68
10849519|NCT02296801|12016136|FG002|STARTED|Overall Study||69
10849520|NCT02296801|12016137|FG003|STARTED|Overall Study||67
10849521|NCT02296801|12016134|FG000|COMPLETED|Overall Study||83
10849522|NCT02296801|12016135|FG001|COMPLETED|Overall Study||53
10849523|NCT02296801|12016136|FG002|COMPLETED|Overall Study||50
10849524|NCT02296801|12016137|FG003|COMPLETED|Overall Study||58
10849525|NCT02296801|12016134|FG000|NOT COMPLETED|Overall Study||20
10849526|NCT02296801|12016135|FG001|NOT COMPLETED|Overall Study||15
10849527|NCT02296801|12016136|FG002|NOT COMPLETED|Overall Study||19
10849528|NCT02296801|12016137|FG003|NOT COMPLETED|Overall Study||9
10849529|NCT02143063|12016154|FG000|STARTED|Overall Study||61
10849530|NCT02143063|12016155|FG001|STARTED|Overall Study||105
10849531|NCT02143063|12016156|FG002|STARTED|Overall Study||108
10849532|NCT02143063|12016154|FG000|COMPLETED|Overall Study||45
10849533|NCT02143063|12016155|FG001|COMPLETED|Overall Study||75
10849534|NCT02143063|12016156|FG002|COMPLETED|Overall Study||78
10849535|NCT02143063|12016154|FG000|NOT COMPLETED|Overall Study||16
10849536|NCT02143063|12016155|FG001|NOT COMPLETED|Overall Study||30
10849537|NCT02143063|12016156|FG002|NOT COMPLETED|Overall Study||30
10849538|NCT02017964|12016164|FG000|STARTED|Overall Study||26
10849539|NCT02017964|12016164|FG000|COMPLETED|Overall Study||25
10849540|NCT02017964|12016164|FG000|NOT COMPLETED|Overall Study||1
10849541|NCT01968785|12016170|FG000|STARTED|Overall Study||2
10849542|NCT01968785|12016171|FG001|STARTED|Overall Study||0
10849543|NCT01968785|12016170|FG000|COMPLETED|Overall Study||1
10849544|NCT01968785|12016171|FG001|COMPLETED|Overall Study||0
10849545|NCT01968785|12016170|FG000|NOT COMPLETED|Overall Study||1
10849546|NCT01968785|12016171|FG001|NOT COMPLETED|Overall Study||0
10849547|NCT01956110|12016179|FG000|STARTED|Overall Study||665
10849548|NCT01956110|12016180|FG001|STARTED|Overall Study||661
10849549|NCT01956110|12016179|FG000|COMPLETED|Overall Study||630
10849550|NCT01956110|12016180|FG001|COMPLETED|Overall Study||639
10849551|NCT01956110|12016179|FG000|NOT COMPLETED|Overall Study||35
10849552|NCT01956110|12016180|FG001|NOT COMPLETED|Overall Study||22
10849553|NCT01648023|12016189|FG000|STARTED|Overall Study||25
10849554|NCT01648023|12016190|FG001|STARTED|Overall Study||24
10849555|NCT01648023|12016189|FG000|COMPLETED|Overall Study||24
10849556|NCT01648023|12016190|FG001|COMPLETED|Overall Study||22
10849557|NCT01648023|12016189|FG000|NOT COMPLETED|Overall Study||1
10849558|NCT01648023|12016190|FG001|NOT COMPLETED|Overall Study||2
10849559|NCT01335581|12016198|FG000|STARTED|Overall Study||9
10849560|NCT01335581|12016199|FG001|STARTED|Overall Study||9
10849561|NCT01335581|12016198|FG000|COMPLETED|Overall Study||5
10849562|NCT01335581|12016199|FG001|COMPLETED|Overall Study||3
10849563|NCT01335581|12016198|FG000|NOT COMPLETED|Overall Study||4
10849564|NCT01335581|12016199|FG001|NOT COMPLETED|Overall Study||6
10849565|NCT01209923|12016205|FG000|STARTED|Overall Study||362
10849566|NCT01209923|12016205|FG000|COMPLETED|Overall Study||362
10849567|NCT01209923|12016205|FG000|NOT COMPLETED|Overall Study||0
10849568|NCT01083433|12016213|FG000|STARTED|Overall Study||22
10849569|NCT01083433|12016214|FG001|STARTED|Overall Study||23
10849570|NCT01083433|12016215|FG002|STARTED|Overall Study||23
10849571|NCT01083433|12016213|FG000|COMPLETED|Overall Study||20
10849572|NCT01083433|12016214|FG001|COMPLETED|Overall Study||17
10849573|NCT01083433|12016215|FG002|COMPLETED|Overall Study||18
10849574|NCT01083433|12016213|FG000|NOT COMPLETED|Overall Study||2
10849575|NCT01083433|12016214|FG001|NOT COMPLETED|Overall Study||6
10849576|NCT01083433|12016215|FG002|NOT COMPLETED|Overall Study||5
10849577|NCT00787176|12016231|FG000|STARTED|Overall Study||69
10849578|NCT00787176|12016232|FG001|STARTED|Overall Study||62
10849579|NCT00787176|12016233|FG002|STARTED|Overall Study||60
10849580|NCT00787176|12016234|FG003|STARTED|Overall Study||60
10849581|NCT00787176|12016231|FG000|COMPLETED|Overall Study||62
10849582|NCT00787176|12016232|FG001|COMPLETED|Overall Study||59
10849583|NCT00787176|12016233|FG002|COMPLETED|Overall Study||54
10849584|NCT00787176|12016234|FG003|COMPLETED|Overall Study||55
10849585|NCT00787176|12016231|FG000|NOT COMPLETED|Overall Study||7
10849586|NCT00787176|12016232|FG001|NOT COMPLETED|Overall Study||3
10849587|NCT00787176|12016233|FG002|NOT COMPLETED|Overall Study||6
10849588|NCT00787176|12016234|FG003|NOT COMPLETED|Overall Study||5
10849589|NCT00352534|12016247|FG000|STARTED|Initial Staging||211
10849590|NCT00352534|12016248|FG001|STARTED|Initial Staging||597
10849591|NCT00352534|12016249|FG002|STARTED|Initial Staging||0
10849592|NCT00352534|12016250|FG003|STARTED|Initial Staging||0
11224724|NCT01987557|12416867|FG002|STARTED|Overall Study||16
11224725|NCT01987557|12416865|FG000|COMPLETED|Overall Study||13
11224726|NCT01987557|12416866|FG001|COMPLETED|Overall Study||13
11224727|NCT01987557|12416867|FG002|COMPLETED|Overall Study||13
11224728|NCT01987557|12416865|FG000|NOT COMPLETED|Overall Study||3
11224729|NCT01987557|12416866|FG001|NOT COMPLETED|Overall Study||3
11224730|NCT01987557|12416867|FG002|NOT COMPLETED|Overall Study||3
11224731|NCT01987583|12416877|FG000|STARTED|Overall Study||40
11224732|NCT01987583|12416878|FG001|STARTED|Overall Study||40
11224733|NCT01987583|12416877|FG000|COMPLETED|Overall Study||37
11224734|NCT01987583|12416878|FG001|COMPLETED|Overall Study||38
11224735|NCT01987583|12416877|FG000|NOT COMPLETED|Overall Study||3
11224736|NCT01987583|12416878|FG001|NOT COMPLETED|Overall Study||2
11224737|NCT01987596|12416886|FG000|STARTED|Overall Study||12
11224738|NCT01987596|12416887|FG001|STARTED|Overall Study||11
11224739|NCT01987596|12416886|FG000|COMPLETED|Overall Study||11
11224740|NCT01987596|12416887|FG001|COMPLETED|Overall Study||10
11224741|NCT01987596|12416886|FG000|NOT COMPLETED|Overall Study||1
11224742|NCT01987596|12416887|FG001|NOT COMPLETED|Overall Study||1
11224743|NCT01987609|12416899|FG000|STARTED|Overall Study|one arm on one patient|7
11224744|NCT01987609|12416899|FG000|Hylenex Injected in Arm|Overall Study||6
11224745|NCT01987609|12416899|FG000|Normal Saline Injected in Arm|Overall Study||6
11224746|NCT01987609|12416899|FG000|COMPLETED|Overall Study||6
11224747|NCT01987609|12416899|FG000|NOT COMPLETED|Overall Study||1
11224748|NCT01987752|12416913|FG000|STARTED|Overall Study||732
11224749|NCT01987752|12416913|FG000|COMPLETED|Overall Study||732
11224750|NCT01987752|12416913|FG000|NOT COMPLETED|Overall Study||0
11224751|NCT01987765|12416917|FG000|STARTED|Overall Study||847
11224752|NCT01987765|12416917|FG000|COMPLETED|Overall Study||745
11224753|NCT01987765|12416917|FG000|NOT COMPLETED|Overall Study||102
11224754|NCT01987817|12416923|FG000|STARTED|Overall Study||29
11224755|NCT01987817|12416924|FG001|STARTED|Overall Study||27
11224756|NCT01987817|12416923|FG000|COMPLETED|Overall Study||23
11224757|NCT01987817|12416924|FG001|COMPLETED|Overall Study||26
11224758|NCT01987817|12416923|FG000|NOT COMPLETED|Overall Study||6
11224759|NCT01987817|12416924|FG001|NOT COMPLETED|Overall Study||1
11224760|NCT01987830|12416931|FG000|STARTED|Overall Study||13
11224761|NCT01987830|12416931|FG000|COMPLETED|Overall Study||12
11224762|NCT01987830|12416931|FG000|NOT COMPLETED|Overall Study||1
11224763|NCT01987895|12416937|FG000|STARTED|Overall Study||306
10849593|NCT00352534|12016251|FG004|STARTED|Initial Staging||0
10849594|NCT00352534|12016252|FG005|STARTED|Initial Staging||0
10849595|NCT00352534|12016253|FG006|STARTED|Initial Staging||0
10849596|NCT00352534|12016247|FG000|COMPLETED|Initial Staging||203
10849597|NCT00352534|12016248|FG001|COMPLETED|Initial Staging||588
10849598|NCT00352534|12016249|FG002|COMPLETED|Initial Staging||0
10849599|NCT00352534|12016250|FG003|COMPLETED|Initial Staging||0
10849600|NCT00352534|12016251|FG004|COMPLETED|Initial Staging||0
11105903|NCT01256385|12290305|FG000|NOT COMPLETED|Overall Study||3
11105904|NCT01256385|12290306|FG001|NOT COMPLETED|Overall Study||3
11105905|NCT01256411|12290316|FG000|STARTED|Extension by Maximum Treatment||139
11105906|NCT01256411|12290317|FG001|STARTED|Extension by Maximum Treatment||89
11105907|NCT01256411|12290318|FG002|STARTED|Extension by Maximum Treatment||109
11105908|NCT01256411|12290319|FG003|STARTED|Extension by Maximum Treatment||4
11105909|NCT01256411|12290320|FG004|STARTED|Extension by Maximum Treatment||0
11105910|NCT01256411|12290321|FG005|STARTED|Extension by Maximum Treatment||0
11105911|NCT01256411|12290316|FG000|Down Titrated to 100 mg|Extension by Maximum Treatment||12
11105912|NCT01256411|12290317|FG001|Down Titrated to 100 mg|Extension by Maximum Treatment||0
11105913|NCT01256411|12290318|FG002|Down Titrated to 100 mg|Extension by Maximum Treatment||0
11105914|NCT01256411|12290319|FG003|Down Titrated to 100 mg|Extension by Maximum Treatment||0
11105915|NCT01256411|12290320|FG004|Down Titrated to 100 mg|Extension by Maximum Treatment||0
11105916|NCT01256411|12290321|FG005|Down Titrated to 100 mg|Extension by Maximum Treatment||0
11105917|NCT01256411|12290316|FG000|COMPLETED|Extension by Maximum Treatment||132
11105918|NCT01256411|12290317|FG001|COMPLETED|Extension by Maximum Treatment||79
11105919|NCT01256411|12290318|FG002|COMPLETED|Extension by Maximum Treatment||105
11105920|NCT01256411|12290319|FG003|COMPLETED|Extension by Maximum Treatment||4
11105921|NCT01256411|12290320|FG004|COMPLETED|Extension by Maximum Treatment||0
11105922|NCT01256411|12290321|FG005|COMPLETED|Extension by Maximum Treatment||0
11105923|NCT01256411|12290316|FG000|NOT COMPLETED|Extension by Maximum Treatment||7
11105924|NCT01256411|12290317|FG001|NOT COMPLETED|Extension by Maximum Treatment||10
11105925|NCT01256411|12290318|FG002|NOT COMPLETED|Extension by Maximum Treatment||4
11105926|NCT01256411|12290319|FG003|NOT COMPLETED|Extension by Maximum Treatment||0
11105927|NCT01256411|12290320|FG004|NOT COMPLETED|Extension by Maximum Treatment||0
11105928|NCT01256411|12290321|FG005|NOT COMPLETED|Extension by Maximum Treatment||0
11105929|NCT01256411|12290316|FG000|STARTED|Extension by Mono or Combination Therapy||0
11105930|NCT01256411|12290317|FG001|STARTED|Extension by Mono or Combination Therapy||0
11105931|NCT01256411|12290318|FG002|STARTED|Extension by Mono or Combination Therapy||0
11105932|NCT01256411|12290319|FG003|STARTED|Extension by Mono or Combination Therapy||0
11105933|NCT01256411|12290320|FG004|STARTED|Extension by Mono or Combination Therapy||228
11105934|NCT01256411|12290321|FG005|STARTED|Extension by Mono or Combination Therapy||113
11105935|NCT01256411|12290316|FG000|COMPLETED|Extension by Mono or Combination Therapy||0
11105936|NCT01256411|12290317|FG001|COMPLETED|Extension by Mono or Combination Therapy||0
10849651|NCT04118348|12016293|FG001|STARTED|Overall Study||3312
11105937|NCT01256411|12290318|FG002|COMPLETED|Extension by Mono or Combination Therapy||0
11224764|NCT01987895|12416938|FG001|STARTED|Overall Study||326
11105938|NCT01256411|12290319|FG003|COMPLETED|Extension by Mono or Combination Therapy||0
11105939|NCT01256411|12290320|FG004|COMPLETED|Extension by Mono or Combination Therapy||211
11105940|NCT01256411|12290321|FG005|COMPLETED|Extension by Mono or Combination Therapy||109
11105941|NCT01256411|12290316|FG000|NOT COMPLETED|Extension by Mono or Combination Therapy||0
11105942|NCT01256411|12290317|FG001|NOT COMPLETED|Extension by Mono or Combination Therapy||0
11105943|NCT01256411|12290318|FG002|NOT COMPLETED|Extension by Mono or Combination Therapy||0
11105944|NCT01256411|12290319|FG003|NOT COMPLETED|Extension by Mono or Combination Therapy||0
11105945|NCT01256411|12290320|FG004|NOT COMPLETED|Extension by Mono or Combination Therapy||17
11105946|NCT01256411|12290321|FG005|NOT COMPLETED|Extension by Mono or Combination Therapy||4
11105947|NCT01256424|12290339|FG000|STARTED|Overall Study||65
11105948|NCT01256424|12290340|FG001|STARTED|Overall Study||67
11105949|NCT01256424|12290341|FG002|STARTED|Overall Study||62
11105950|NCT01256424|12290342|FG003|STARTED|Overall Study||68
11105951|NCT01256424|12290339|FG000|COMPLETED|Overall Study||56
11105952|NCT01256424|12290340|FG001|COMPLETED|Overall Study||59
11105953|NCT01256424|12290341|FG002|COMPLETED|Overall Study||55
11105954|NCT01256424|12290342|FG003|COMPLETED|Overall Study||61
11105955|NCT01256424|12290339|FG000|NOT COMPLETED|Overall Study||9
11105956|NCT01256424|12290340|FG001|NOT COMPLETED|Overall Study||8
11105957|NCT01256424|12290341|FG002|NOT COMPLETED|Overall Study||7
11105958|NCT01256424|12290342|FG003|NOT COMPLETED|Overall Study||7
11105959|NCT01256450|12290355|FG000|STARTED|Open-label Titration||334
11105960|NCT01256450|12290356|FG001|STARTED|Open-label Titration||0
11105961|NCT01256450|12290357|FG002|STARTED|Open-label Titration||0
10849601|NCT00352534|12016252|FG005|COMPLETED|Initial Staging||0
10849602|NCT00352534|12016253|FG006|COMPLETED|Initial Staging||0
10849603|NCT00352534|12016247|FG000|NOT COMPLETED|Initial Staging||8
10849604|NCT00352534|12016248|FG001|NOT COMPLETED|Initial Staging||9
10849605|NCT00352534|12016249|FG002|NOT COMPLETED|Initial Staging||0
10849606|NCT00352534|12016250|FG003|NOT COMPLETED|Initial Staging||0
10849607|NCT00352534|12016251|FG004|NOT COMPLETED|Initial Staging||0
10849608|NCT00352534|12016252|FG005|NOT COMPLETED|Initial Staging||0
10849609|NCT00352534|12016253|FG006|NOT COMPLETED|Initial Staging||0
10849610|NCT00352534|12016247|FG000|STARTED|Final Risk Group Assignment||0
10849611|NCT00352534|12016248|FG001|STARTED|Final Risk Group Assignment||0
10849612|NCT00352534|12016249|FG002|STARTED|Final Risk Group Assignment||119
10849613|NCT00352534|12016250|FG003|STARTED|Final Risk Group Assignment||52
10849614|NCT00352534|12016251|FG004|STARTED|Final Risk Group Assignment||32
10849615|NCT00352534|12016252|FG005|STARTED|Final Risk Group Assignment||548
10849616|NCT00352534|12016253|FG006|STARTED|Final Risk Group Assignment||40
10849617|NCT00352534|12016247|FG000|COMPLETED|Final Risk Group Assignment||0
10849618|NCT00352534|12016248|FG001|COMPLETED|Final Risk Group Assignment||0
10849619|NCT00352534|12016249|FG002|COMPLETED|Final Risk Group Assignment||116
10849620|NCT00352534|12016250|FG003|COMPLETED|Final Risk Group Assignment||49
10849621|NCT00352534|12016251|FG004|COMPLETED|Final Risk Group Assignment||31
10849622|NCT00352534|12016252|FG005|COMPLETED|Final Risk Group Assignment||503
10849623|NCT00352534|12016253|FG006|COMPLETED|Final Risk Group Assignment||1
10849624|NCT00352534|12016247|FG000|NOT COMPLETED|Final Risk Group Assignment||0
10849625|NCT00352534|12016248|FG001|NOT COMPLETED|Final Risk Group Assignment||0
10849626|NCT00352534|12016249|FG002|NOT COMPLETED|Final Risk Group Assignment||3
10849627|NCT00352534|12016250|FG003|NOT COMPLETED|Final Risk Group Assignment||3
10849628|NCT00352534|12016251|FG004|NOT COMPLETED|Final Risk Group Assignment||1
10849629|NCT00352534|12016252|FG005|NOT COMPLETED|Final Risk Group Assignment||45
10849630|NCT00352534|12016253|FG006|NOT COMPLETED|Final Risk Group Assignment||39
10849631|NCT00033293|12016265|FG000|STARTED|Overall Study||26
10849632|NCT00033293|12016266|FG001|STARTED|Overall Study||27
10849633|NCT00033293|12016265|FG000|COMPLETED|Overall Study||16
10849634|NCT00033293|12016266|FG001|COMPLETED|Overall Study||9
10849635|NCT00033293|12016265|FG000|NOT COMPLETED|Overall Study||10
10849636|NCT00033293|12016266|FG001|NOT COMPLETED|Overall Study||18
10849637|NCT04497415|12016276|FG000|STARTED|Overall Study||229
10849638|NCT04497415|12016277|FG001|STARTED|Overall Study||121
10849639|NCT04497415|12016276|FG000|Post-intervention Assessment (Day 1)|Overall Study||229
10849640|NCT04497415|12016277|FG001|Post-intervention Assessment (Day 1)|Overall Study||121
10849641|NCT04497415|12016276|FG000|First Follow-up Assessment (Day 14)|Overall Study||195
10849642|NCT04497415|12016277|FG001|First Follow-up Assessment (Day 14)|Overall Study||102
10849643|NCT04497415|12016276|FG000|COMPLETED|Overall Study||186
10849644|NCT04497415|12016277|FG001|COMPLETED|Overall Study||94
10849645|NCT04497415|12016276|FG000|NOT COMPLETED|Overall Study||43
11224765|NCT01987895|12416937|FG000|COMPLETED|Overall Study||276
10849646|NCT04497415|12016277|FG001|NOT COMPLETED|Overall Study||27
10849647|NCT04231396|12016283|FG000|STARTED|Overall Study||27
10849648|NCT04231396|12016283|FG000|COMPLETED|Overall Study||27
10849649|NCT04231396|12016283|FG000|NOT COMPLETED|Overall Study||0
10849650|NCT04118348|12016292|FG000|STARTED|Overall Study||3445
11105962|NCT01256450|12290355|FG000|COMPLETED|Open-label Titration||235
11105963|NCT01256450|12290356|FG001|COMPLETED|Open-label Titration||0
11105964|NCT01256450|12290357|FG002|COMPLETED|Open-label Titration||0
11105965|NCT01256450|12290355|FG000|NOT COMPLETED|Open-label Titration||99
11105966|NCT01256450|12290356|FG001|NOT COMPLETED|Open-label Titration||0
11105967|NCT01256450|12290357|FG002|NOT COMPLETED|Open-label Titration||0
11105968|NCT01256450|12290355|FG000|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
11105969|NCT01256450|12290356|FG001|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
10849652|NCT04118348|12016294|FG002|STARTED|Overall Study||3461
10849653|NCT04118348|12016295|FG003|STARTED|Overall Study||3262
10849654|NCT04118348|12016292|FG000|COMPLETED|Overall Study||3445
10849655|NCT04118348|12016293|FG001|COMPLETED|Overall Study||3312
10849656|NCT04118348|12016294|FG002|COMPLETED|Overall Study||3461
10849657|NCT04118348|12016295|FG003|COMPLETED|Overall Study||3262
10849658|NCT04118348|12016292|FG000|NOT COMPLETED|Overall Study||0
10849659|NCT04118348|12016293|FG001|NOT COMPLETED|Overall Study||0
10849660|NCT04118348|12016294|FG002|NOT COMPLETED|Overall Study||0
10849661|NCT04118348|12016295|FG003|NOT COMPLETED|Overall Study||0
10849662|NCT04975321|12016308|FG000|STARTED|Overall Study||25
10849663|NCT04975321|12016309|FG001|STARTED|Overall Study||26
10849664|NCT04975321|12016310|FG002|STARTED|Overall Study||25
10849665|NCT04975321|12016308|FG000|COMPLETED|Overall Study||15
10849666|NCT04975321|12016309|FG001|COMPLETED|Overall Study||15
10849667|NCT04975321|12016310|FG002|COMPLETED|Overall Study||17
10849668|NCT04975321|12016308|FG000|NOT COMPLETED|Overall Study||10
10849669|NCT04975321|12016309|FG001|NOT COMPLETED|Overall Study||11
10849670|NCT04975321|12016310|FG002|NOT COMPLETED|Overall Study||8
10849671|NCT04594759|12016318|FG000|STARTED|Overall Study||22
10849672|NCT04594759|12016318|FG000|COMPLETED|Overall Study||19
10849673|NCT04594759|12016318|FG000|NOT COMPLETED|Overall Study||3
10849674|NCT04463069|12016324|FG000|STARTED|Overall Study||41
10849675|NCT04463069|12016325|FG001|STARTED|Overall Study||45
10849676|NCT04463069|12016324|FG000|COMPLETED|Overall Study||39
10849677|NCT04463069|12016325|FG001|COMPLETED|Overall Study||22
10849678|NCT04463069|12016324|FG000|NOT COMPLETED|Overall Study||2
10849679|NCT04463069|12016325|FG001|NOT COMPLETED|Overall Study||23
10849680|NCT04250337|12016333|FG000|STARTED|Overall Study||75
10849681|NCT04250337|12016334|FG001|STARTED|Overall Study||153
10849682|NCT04250337|12016333|FG000|Received at Least One Dose of Study Drug|Overall Study||75
10849683|NCT04250337|12016334|FG001|Received at Least One Dose of Study Drug|Overall Study||153
10849684|NCT04250337|12016333|FG000|COMPLETED|Overall Study||67
10849685|NCT04250337|12016334|FG001|COMPLETED|Overall Study||142
10849686|NCT04250337|12016333|FG000|NOT COMPLETED|Overall Study||8
10849687|NCT04250337|12016334|FG001|NOT COMPLETED|Overall Study||11
10849688|NCT04126733|12016341|FG000|STARTED|Treatment Period||70
10849689|NCT04126733|12016341|FG000|COMPLETED|Treatment Period||0
10849690|NCT04126733|12016341|FG000|NOT COMPLETED|Treatment Period||70
10849691|NCT04126733|12016341|FG000|STARTED|Active Follow-up Period|Participants had the option to decline participation in active follow-up.|34
10849692|NCT04126733|12016341|FG000|COMPLETED|Active Follow-up Period||14
10849693|NCT04126733|12016341|FG000|NOT COMPLETED|Active Follow-up Period||20
10849694|NCT04126733|12016341|FG000|STARTED|Long-term Follow-up Period|All participants who accepted long-term follow-up.|6
10849695|NCT04126733|12016341|FG000|COMPLETED|Long-term Follow-up Period||0
10849696|NCT04126733|12016341|FG000|NOT COMPLETED|Long-term Follow-up Period||6
10849697|NCT03909178|12016347|FG000|STARTED|Overall Study||46
10849698|NCT03909178|12016348|FG001|STARTED|Overall Study||44
10849699|NCT03909178|12016347|FG000|COMPLETED|Overall Study||42
10849700|NCT03909178|12016348|FG001|COMPLETED|Overall Study||39
10849701|NCT03909178|12016347|FG000|NOT COMPLETED|Overall Study||4
10849702|NCT03909178|12016348|FG001|NOT COMPLETED|Overall Study||5
11105970|NCT01256450|12290357|FG002|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
11105971|NCT01256450|12290355|FG000|COMPLETED|Double-blind Treatment||0
11105972|NCT01256450|12290356|FG001|COMPLETED|Double-blind Treatment||89
11105973|NCT01256450|12290357|FG002|COMPLETED|Double-blind Treatment||81
11105974|NCT01256450|12290355|FG000|NOT COMPLETED|Double-blind Treatment||0
11105975|NCT01256450|12290356|FG001|NOT COMPLETED|Double-blind Treatment||28
11105976|NCT01256450|12290357|FG002|NOT COMPLETED|Double-blind Treatment||37
11105977|NCT01256476|12290366|FG000|STARTED|Overall Study||164
11105978|NCT01256476|12290367|FG001|STARTED|Overall Study||164
11105979|NCT01256476|12290366|FG000|COMPLETED|Overall Study||158
11105980|NCT01256476|12290367|FG001|COMPLETED|Overall Study||157
11105981|NCT01256476|12290366|FG000|NOT COMPLETED|Overall Study||6
10849715|NCT03631472|12016365|FG000|STARTED|Overall Study||21
10849716|NCT03631472|12016365|FG000|COMPLETED|Overall Study||21
10849717|NCT03631472|12016365|FG000|NOT COMPLETED|Overall Study||0
10849718|NCT03575572|12016371|FG000|STARTED|Overall Study||9
10849719|NCT03575572|12016371|FG000|COMPLETED|Overall Study||5
10849720|NCT03575572|12016371|FG000|NOT COMPLETED|Overall Study||4
10849721|NCT03521687|12016384|FG000|STARTED|Overall Study||20
10849722|NCT03521687|12016384|FG000|COMPLETED|Overall Study||15
11224766|NCT01987895|12416938|FG001|COMPLETED|Overall Study||296
10849723|NCT03521687|12016384|FG000|NOT COMPLETED|Overall Study||5
11105982|NCT01256476|12290367|FG001|NOT COMPLETED|Overall Study||7
11105983|NCT01256502|12290373|FG000|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
11105984|NCT01256502|12290373|FG000|COMPLETED|Overall Study||129
11105985|NCT01256502|12290373|FG000|NOT COMPLETED|Overall Study||10
11105986|NCT01256567|12290382|FG000|STARTED|Overall Study||7
11105987|NCT01256567|12290382|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
11105988|NCT01256567|12290382|FG000|COMPLETED|Overall Study||6
11105989|NCT01256567|12290382|FG000|NOT COMPLETED|Overall Study||1
11105990|NCT01256593|12290387|FG000|STARTED|Overall Study||3827
11105991|NCT01256593|12290387|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613
11105992|NCT01256593|12290387|FG000|NOT COMPLETED|Overall Study||214
11105993|NCT01256658|12290393|FG000|STARTED|Period 1||6817
11105994|NCT01256658|12290394|FG001|STARTED|Period 1||7258
11105995|NCT01256658|12290393|FG000|COMPLETED|Period 1||5897
11105996|NCT01256658|12290394|FG001|COMPLETED|Period 1||6510
11105997|NCT01256658|12290393|FG000|NOT COMPLETED|Period 1||920
11105998|NCT01256658|12290394|FG001|NOT COMPLETED|Period 1||748
11105999|NCT01256658|12290393|FG000|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
11106000|NCT01256658|12290394|FG001|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
11106001|NCT01256658|12290393|FG000|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
11106002|NCT01256658|12290394|FG001|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
11106003|NCT01256658|12290393|FG000|Death|Period 2 - Follow up Only - No Treatment||6
11106004|NCT01256658|12290394|FG001|Death|Period 2 - Follow up Only - No Treatment||8
11106005|NCT01256658|12290393|FG000|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
11106006|NCT01256658|12290394|FG001|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
11354666|NCT03074331|12551724|FG000|NOT COMPLETED|Overall Study||7
11354667|NCT03074409|12551730|FG000|STARTED|Overall Study||41
11354668|NCT03074409|12551731|FG001|STARTED|Overall Study||42
11354669|NCT03074409|12551730|FG000|COMPLETED|Overall Study||37
10849755|NCT03256045|12016410|FG000|STARTED|Overall Study||9
10849756|NCT03256045|12016410|FG000|COMPLETED|Overall Study||9
10849757|NCT03256045|12016410|FG000|NOT COMPLETED|Overall Study||0
10849758|NCT03216499|12016414|FG000|STARTED|Overall Study||24
10849759|NCT03216499|12016414|FG000|COMPLETED|Overall Study||24
10849760|NCT03216499|12016414|FG000|NOT COMPLETED|Overall Study||0
10849761|NCT03046836|12016420|FG000|STARTED|Overall Study||100
10849762|NCT03046836|12016421|FG001|STARTED|Overall Study||100
10849763|NCT03046836|12016420|FG000|COMPLETED|Overall Study||100
10849764|NCT03046836|12016421|FG001|COMPLETED|Overall Study||100
10849765|NCT03046836|12016420|FG000|NOT COMPLETED|Overall Study||0
10849766|NCT03046836|12016421|FG001|NOT COMPLETED|Overall Study||0
10849767|NCT02966301|12016428|FG000|STARTED|Overall Study||21
10849768|NCT02966301|12016428|FG000|Full Analysis Set (FAS)|Overall Study|All patients who entered the study, completed their first cycle of ATO (11 infusions) and for whom the response at Week 6 after diagnosis of chronic GvHD has been evaluated.|20
10849769|NCT02966301|12016428|FG000|Safety Analysis (SA)|Overall Study|All patients included in the study for whom received at least one ATO infusion. One patient received 2 infusions and then exited the study due to SAE (reversible liver toxicity).|21
10849770|NCT02966301|12016428|FG000|COMPLETED|Overall Study||18
10849771|NCT02966301|12016428|FG000|NOT COMPLETED|Overall Study||3
11354670|NCT03074409|12551731|FG001|COMPLETED|Overall Study||38
11354671|NCT03074409|12551730|FG000|NOT COMPLETED|Overall Study||4
10849772|NCT02893514|12016434|FG000|STARTED|Overall Study||42
10849773|NCT02893514|12016435|FG001|STARTED|Overall Study||37
10849774|NCT02893514|12016434|FG000|COMPLETED|Overall Study||42
10849775|NCT02893514|12016435|FG001|COMPLETED|Overall Study||37
10849776|NCT02893514|12016434|FG000|NOT COMPLETED|Overall Study||0
10849777|NCT02893514|12016435|FG001|NOT COMPLETED|Overall Study||0
10849778|NCT02832167|12016441|FG000|STARTED|Treatment Period 1||239
10849779|NCT02832167|12016441|FG000|COMPLETED|Treatment Period 1||110
10849780|NCT02832167|12016441|FG000|NOT COMPLETED|Treatment Period 1||129
10849781|NCT02832167|12016441|FG000|STARTED|Transition From Period 1 to Period 2||110
10849782|NCT02832167|12016441|FG000|COMPLETED|Transition From Period 1 to Period 2||103
10849783|NCT02832167|12016441|FG000|NOT COMPLETED|Transition From Period 1 to Period 2||7
10849784|NCT02832167|12016441|FG000|STARTED|Treatment Period 2||103
10849785|NCT02832167|12016441|FG000|COMPLETED|Treatment Period 2||19
10849786|NCT02832167|12016441|FG000|NOT COMPLETED|Treatment Period 2||84
10849787|NCT02699554|12016445|FG000|STARTED|Overall Study||55
10849788|NCT02699554|12016445|FG000|COMPLETED|Overall Study||46
10849789|NCT02699554|12016445|FG000|NOT COMPLETED|Overall Study||9
10849790|NCT02659020|12016456|FG000|STARTED|Overall Study||21
10849791|NCT02659020|12016457|FG001|STARTED|Overall Study||18
10849792|NCT02659020|12016458|FG002|STARTED|Overall Study||15
10849793|NCT02659020|12016459|FG003|STARTED|Overall Study||81
10849794|NCT02659020|12016460|FG004|STARTED|Overall Study||46
10849795|NCT02659020|12016461|FG005|STARTED|Overall Study||86
10849796|NCT02659020|12016462|FG006|STARTED|Overall Study||43
10849797|NCT02659020|12016456|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
10849798|NCT02659020|12016457|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18
10849799|NCT02659020|12016458|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
10849800|NCT02659020|12016459|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81
10849801|NCT02659020|12016460|FG004|Received at Least 1 Dose of Study Drug|Overall Study||45
10849802|NCT02659020|12016461|FG005|Received at Least 1 Dose of Study Drug|Overall Study||86
10849803|NCT02659020|12016462|FG006|Received at Least 1 Dose of Study Drug|Overall Study||43
10849804|NCT02659020|12016456|FG000|COMPLETED|Overall Study||18
10849805|NCT02659020|12016457|FG001|COMPLETED|Overall Study||15
10849806|NCT02659020|12016458|FG002|COMPLETED|Overall Study||14
10849807|NCT02659020|12016459|FG003|COMPLETED|Overall Study||65
10849808|NCT02659020|12016460|FG004|COMPLETED|Overall Study||40
10849809|NCT02659020|12016461|FG005|COMPLETED|Overall Study||75
10849810|NCT02659020|12016462|FG006|COMPLETED|Overall Study||35
10849811|NCT02659020|12016456|FG000|NOT COMPLETED|Overall Study||3
10849812|NCT02659020|12016457|FG001|NOT COMPLETED|Overall Study||3
10849813|NCT02659020|12016458|FG002|NOT COMPLETED|Overall Study||1
10849814|NCT02659020|12016459|FG003|NOT COMPLETED|Overall Study||16
10849815|NCT02659020|12016460|FG004|NOT COMPLETED|Overall Study||6
10849816|NCT02659020|12016461|FG005|NOT COMPLETED|Overall Study||11
10849817|NCT02659020|12016462|FG006|NOT COMPLETED|Overall Study||8
10849818|NCT02626949|12016487|FG000|STARTED|Randomization, Pre-Enrollment||56
10849819|NCT02626949|12016488|FG001|STARTED|Randomization, Pre-Enrollment||58
10849820|NCT02626949|12016487|FG000|COMPLETED|Randomization, Pre-Enrollment||40
10849821|NCT02626949|12016488|FG001|COMPLETED|Randomization, Pre-Enrollment||44
10849822|NCT02626949|12016487|FG000|NOT COMPLETED|Randomization, Pre-Enrollment||16
10849823|NCT02626949|12016488|FG001|NOT COMPLETED|Randomization, Pre-Enrollment||14
10849824|NCT02626949|12016487|FG000|STARTED|Enrolled||40
10849825|NCT02626949|12016488|FG001|STARTED|Enrolled||44
10849826|NCT02626949|12016487|FG000|COMPLETED|Enrolled||30
10849827|NCT02626949|12016488|FG001|COMPLETED|Enrolled||36
10849828|NCT02626949|12016487|FG000|NOT COMPLETED|Enrolled||10
10849829|NCT02626949|12016488|FG001|NOT COMPLETED|Enrolled||8
10849830|NCT02625766|12016496|FG000|STARTED|Overall Study||47
10849831|NCT02625766|12016497|FG001|STARTED|Overall Study||48
10849832|NCT02625766|12016496|FG000|COMPLETED|Overall Study||47
10849833|NCT02625766|12016497|FG001|COMPLETED|Overall Study||48
10849834|NCT02625766|12016496|FG000|NOT COMPLETED|Overall Study||0
10849835|NCT02625766|12016497|FG001|NOT COMPLETED|Overall Study||0
10849836|NCT02565914|12016503|FG000|STARTED|Overall Study||1044
10849837|NCT02565914|12016503|FG000|Safety Set|Overall Study||1042
10849838|NCT02565914|12016503|FG000|COMPLETED|Overall Study||951
10849839|NCT02565914|12016503|FG000|NOT COMPLETED|Overall Study||93
10849840|NCT02385045|12016515|FG000|STARTED|Overall Study||157
10849841|NCT02385045|12016515|FG000|COMPLETED|Overall Study|4 patients could not complete endoscopy as planned|153
10849842|NCT02385045|12016515|FG000|NOT COMPLETED|Overall Study||4
10849843|NCT02373241|12016521|FG000|STARTED|Overall Study||0
10849844|NCT02373241|12016522|FG001|STARTED|Overall Study||1
10849845|NCT02373241|12016521|FG000|COMPLETED|Overall Study||0
11106007|NCT01256658|12290393|FG000|COMPLETED|Period 2 - Follow up Only - No Treatment||0
10849846|NCT02373241|12016522|FG001|COMPLETED|Overall Study||1
10849847|NCT02373241|12016521|FG000|NOT COMPLETED|Overall Study||0
10849848|NCT02373241|12016522|FG001|NOT COMPLETED|Overall Study||0
10849849|NCT01845649|12016530|FG000|STARTED|Overall Study||273
10849850|NCT01845649|12016531|FG001|STARTED|Overall Study||277
10849851|NCT01845649|12016530|FG000|Safety Population|Overall Study||271
10849852|NCT01845649|12016531|FG001|Safety Population|Overall Study||277
10849853|NCT01845649|12016530|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||233
10849854|NCT01845649|12016531|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||239
10849855|NCT01845649|12016530|FG000|COMPLETED|Overall Study||242
10849856|NCT01845649|12016531|FG001|COMPLETED|Overall Study||255
10849857|NCT01845649|12016530|FG000|NOT COMPLETED|Overall Study||31
10849858|NCT01845649|12016531|FG001|NOT COMPLETED|Overall Study||22
11106008|NCT01256658|12290394|FG001|COMPLETED|Period 2 - Follow up Only - No Treatment||0
11106009|NCT01256658|12290393|FG000|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
11106010|NCT01256658|12290394|FG001|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
11106011|NCT01256671|12290403|FG000|STARTED|Overall Study||530
10849865|NCT01816139|12016548|FG000|STARTED|Overall Study||289
10849866|NCT01816139|12016549|FG001|STARTED|Overall Study||287
10849867|NCT01816139|12016548|FG000|Safety Population|Overall Study||287
10849868|NCT01816139|12016549|FG001|Safety Population|Overall Study||286
10849869|NCT01816139|12016548|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||240
10849870|NCT01816139|12016549|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||248
10849871|NCT01816139|12016548|FG000|COMPLETED|Overall Study||261
10849872|NCT01816139|12016549|FG001|COMPLETED|Overall Study||265
10849873|NCT01816139|12016548|FG000|NOT COMPLETED|Overall Study||28
10849874|NCT01816139|12016549|FG001|NOT COMPLETED|Overall Study||22
10849875|NCT01455597|12016555|FG000|STARTED|Overall Study||101
10849876|NCT01455597|12016556|FG001|STARTED|Overall Study||56
10849877|NCT01455597|12016557|FG002|STARTED|Overall Study||100
10849878|NCT01455597|12016558|FG003|STARTED|Overall Study||52
10849879|NCT01455597|12016555|FG000|All-Participants-Treated Population|Overall Study||101
10849880|NCT01455597|12016556|FG001|All-Participants-Treated Population|Overall Study||56
10849881|NCT01455597|12016557|FG002|All-Participants-Treated Population|Overall Study||99
10849882|NCT01455597|12016558|FG003|All-Participants-Treated Population|Overall Study||52
10849883|NCT01455597|12016555|FG000|COMPLETED|Overall Study||84
10849884|NCT01455597|12016556|FG001|COMPLETED|Overall Study||48
10849885|NCT01455597|12016557|FG002|COMPLETED|Overall Study||80
10849886|NCT01455597|12016558|FG003|COMPLETED|Overall Study||42
10849887|NCT01455597|12016555|FG000|NOT COMPLETED|Overall Study||17
10849888|NCT01455597|12016556|FG001|NOT COMPLETED|Overall Study||8
10849889|NCT01455597|12016557|FG002|NOT COMPLETED|Overall Study||20
10849890|NCT01455597|12016558|FG003|NOT COMPLETED|Overall Study||10
10849891|NCT01400776|12016574|FG000|STARTED|Overall Study||238
10849892|NCT01400776|12016575|FG001|STARTED|Overall Study||124
10849893|NCT01400776|12016576|FG002|STARTED|Overall Study||237
10849894|NCT01400776|12016577|FG003|STARTED|Overall Study||123
10849895|NCT01400776|12016574|FG000|COMPLETED|Overall Study||217
10849896|NCT01400776|12016575|FG001|COMPLETED|Overall Study||119
10849897|NCT01400776|12016576|FG002|COMPLETED|Overall Study||209
10849898|NCT01400776|12016577|FG003|COMPLETED|Overall Study||114
10849899|NCT01400776|12016574|FG000|NOT COMPLETED|Overall Study||21
10849900|NCT01400776|12016575|FG001|NOT COMPLETED|Overall Study||5
10849901|NCT01400776|12016576|FG002|NOT COMPLETED|Overall Study||28
10849902|NCT01400776|12016577|FG003|NOT COMPLETED|Overall Study||9
10849903|NCT00511134|12016589|FG000|STARTED|Overall Study||1
10849904|NCT00511134|12016590|FG001|STARTED|Overall Study||3
10849905|NCT00511134|12016589|FG000|COMPLETED|Overall Study||1
10849906|NCT00511134|12016590|FG001|COMPLETED|Overall Study||1
10849907|NCT00511134|12016589|FG000|NOT COMPLETED|Overall Study||0
10849908|NCT00511134|12016590|FG001|NOT COMPLETED|Overall Study||2
10849909|NCT00349466|12016598|FG000|STARTED|Overall Study||42
10849910|NCT00349466|12016599|FG001|STARTED|Overall Study||38
10849911|NCT00349466|12016598|FG000|COMPLETED|Overall Study||33
10849912|NCT00349466|12016599|FG001|COMPLETED|Overall Study||35
10849913|NCT00349466|12016598|FG000|NOT COMPLETED|Overall Study||9
10849914|NCT00349466|12016599|FG001|NOT COMPLETED|Overall Study||3
11106012|NCT01256671|12290403|FG000|Safety Population|Overall Study||521
11106013|NCT01256671|12290403|FG000|COMPLETED|Overall Study||435
11106014|NCT01256671|12290403|FG000|NOT COMPLETED|Overall Study||95
11106015|NCT01256684|12290410|FG000|STARTED|Overall Study||81
11106016|NCT01256684|12290411|FG001|STARTED|Overall Study||87
11106017|NCT01256684|12290412|FG002|STARTED|Overall Study||87
11106018|NCT01256684|12290410|FG000|Safety Population|Overall Study||80
11106019|NCT01256684|12290411|FG001|Safety Population|Overall Study||86
11106020|NCT01256684|12290412|FG002|Safety Population|Overall Study||87
11106021|NCT01256684|12290410|FG000|ITT Population|Overall Study||77
11106022|NCT01256684|12290411|FG001|ITT Population|Overall Study||79
11106023|NCT01256684|12290412|FG002|ITT Population|Overall Study||81
11106024|NCT01256684|12290410|FG000|COMPLETED|Overall Study||72
11106025|NCT01256684|12290411|FG001|COMPLETED|Overall Study||74
11106026|NCT01256684|12290412|FG002|COMPLETED|Overall Study||76
11106027|NCT01256684|12290410|FG000|NOT COMPLETED|Overall Study||9
11106028|NCT01256684|12290411|FG001|NOT COMPLETED|Overall Study||13
11106029|NCT01256684|12290412|FG002|NOT COMPLETED|Overall Study||11
10849933|NCT03816202|12016636|FG000|STARTED|Overall Study||100
10849934|NCT03816202|12016636|FG000|COMPLETED|Overall Study||100
10849935|NCT03816202|12016636|FG000|NOT COMPLETED|Overall Study||0
10849936|NCT03725293|12016642|FG000|STARTED|Overall Study||106
10849937|NCT03725293|12016643|FG001|STARTED|Overall Study||106
10849938|NCT03725293|12016642|FG000|COMPLETED|Overall Study||94
10849939|NCT03725293|12016643|FG001|COMPLETED|Overall Study||97
10849940|NCT03725293|12016642|FG000|NOT COMPLETED|Overall Study||12
10849941|NCT03725293|12016643|FG001|NOT COMPLETED|Overall Study||9
10849942|NCT03702231|12016652|FG000|STARTED|Overall Study||59
10849943|NCT03702231|12016653|FG001|STARTED|Overall Study||29
10849944|NCT03702231|12016654|FG002|STARTED|Overall Study||28
10849945|NCT03702231|12016652|FG000|COMPLETED|Overall Study||55
10849946|NCT03702231|12016653|FG001|COMPLETED|Overall Study||25
10849947|NCT03702231|12016654|FG002|COMPLETED|Overall Study||26
10849948|NCT03702231|12016652|FG000|NOT COMPLETED|Overall Study||4
10849949|NCT03702231|12016653|FG001|NOT COMPLETED|Overall Study||4
10849950|NCT03702231|12016654|FG002|NOT COMPLETED|Overall Study||2
10849951|NCT03690284|12016664|FG000|STARTED|Overall Study||25
10849952|NCT03690284|12016665|FG001|STARTED|Overall Study||25
10849953|NCT03690284|12016664|FG000|COMPLETED|Overall Study||25
10849954|NCT03690284|12016665|FG001|COMPLETED|Overall Study||25
10849955|NCT03690284|12016664|FG000|NOT COMPLETED|Overall Study||0
10849956|NCT03690284|12016665|FG001|NOT COMPLETED|Overall Study||0
10849957|NCT03670277|12016673|FG000|STARTED|Overall Study||20
10849958|NCT03670277|12016674|FG001|STARTED|Overall Study||8
10849959|NCT03670277|12016673|FG000|COMPLETED|Overall Study||20
10849960|NCT03670277|12016674|FG001|COMPLETED|Overall Study||8
10849961|NCT03670277|12016673|FG000|NOT COMPLETED|Overall Study||0
10849962|NCT03670277|12016674|FG001|NOT COMPLETED|Overall Study||0
10849963|NCT03556358|12016685|FG000|STARTED|Overall Study||404
10849964|NCT03556358|12016686|FG001|STARTED|Overall Study||405
10849965|NCT03556358|12016685|FG000|Subjects Treated|Overall Study||401
10849966|NCT03556358|12016686|FG001|Subjects Treated|Overall Study||405
10849967|NCT03556358|12016685|FG000|Subjects Receiving TX05 or Herceptin|Overall Study||394
10849968|NCT03556358|12016686|FG001|Subjects Receiving TX05 or Herceptin|Overall Study||400
10849969|NCT03556358|12016685|FG000|COMPLETED|Overall Study||393
10849970|NCT03556358|12016686|FG001|COMPLETED|Overall Study||393
10849971|NCT03556358|12016685|FG000|NOT COMPLETED|Overall Study||11
10849972|NCT03556358|12016686|FG001|NOT COMPLETED|Overall Study||12
10849973|NCT03290781|12016699|FG000|STARTED|Overall Study||73
10849974|NCT03290781|12016700|FG001|STARTED|Overall Study||71
10849975|NCT03290781|12016701|FG002|STARTED|Overall Study||86
10849976|NCT03290781|12016702|FG003|STARTED|Overall Study||82
10849977|NCT03290781|12016703|FG004|STARTED|Overall Study||11
10849978|NCT03290781|12016704|FG005|STARTED|Overall Study||22
10849979|NCT03290781|12016705|FG006|STARTED|Overall Study||21
10849980|NCT03290781|12016699|FG000|COMPLETED|Overall Study||24
10849981|NCT03290781|12016700|FG001|COMPLETED|Overall Study||53
10849982|NCT03290781|12016701|FG002|COMPLETED|Overall Study||30
10849983|NCT03290781|12016702|FG003|COMPLETED|Overall Study||59
10849984|NCT03290781|12016703|FG004|COMPLETED|Overall Study||6
10849985|NCT03290781|12016704|FG005|COMPLETED|Overall Study||19
10849986|NCT03290781|12016705|FG006|COMPLETED|Overall Study||17
10849987|NCT03290781|12016699|FG000|NOT COMPLETED|Overall Study||49
10849988|NCT03290781|12016700|FG001|NOT COMPLETED|Overall Study||18
10849989|NCT03290781|12016701|FG002|NOT COMPLETED|Overall Study||56
10849990|NCT03290781|12016702|FG003|NOT COMPLETED|Overall Study||23
10849991|NCT03290781|12016703|FG004|NOT COMPLETED|Overall Study||5
10849992|NCT03290781|12016704|FG005|NOT COMPLETED|Overall Study||3
10849993|NCT03290781|12016705|FG006|NOT COMPLETED|Overall Study||4
10849994|NCT03263195|12016732|FG000|STARTED|Overall Study||174
10849995|NCT03263195|12016733|FG001|STARTED|Overall Study||0
10849996|NCT03263195|12016734|FG002|STARTED|Overall Study||0
10849997|NCT03263195|12016735|FG003|STARTED|Overall Study||26
10849998|NCT03263195|12016736|FG004|STARTED|Overall Study||170
10849999|NCT03263195|12016737|FG005|STARTED|Overall Study||0
10850000|NCT03263195|12016738|FG006|STARTED|Overall Study||0
10850001|NCT03263195|12016739|FG007|STARTED|Overall Study||25
10850002|NCT03263195|12016732|FG000|COMPLETED|Overall Study||168
10850003|NCT03263195|12016733|FG001|COMPLETED|Overall Study||0
10850004|NCT03263195|12016734|FG002|COMPLETED|Overall Study||0
10850005|NCT03263195|12016735|FG003|COMPLETED|Overall Study||23
10850006|NCT03263195|12016736|FG004|COMPLETED|Overall Study||155
10850007|NCT03263195|12016737|FG005|COMPLETED|Overall Study||0
10850008|NCT03263195|12016738|FG006|COMPLETED|Overall Study||0
10850009|NCT03263195|12016739|FG007|COMPLETED|Overall Study||19
10850010|NCT03263195|12016732|FG000|NOT COMPLETED|Overall Study||6
10850011|NCT03263195|12016733|FG001|NOT COMPLETED|Overall Study||0
10850012|NCT03263195|12016734|FG002|NOT COMPLETED|Overall Study||0
10850013|NCT03263195|12016735|FG003|NOT COMPLETED|Overall Study||3
10850014|NCT03263195|12016736|FG004|NOT COMPLETED|Overall Study||15
10850015|NCT03263195|12016737|FG005|NOT COMPLETED|Overall Study||0
10850016|NCT03263195|12016738|FG006|NOT COMPLETED|Overall Study||0
10850017|NCT03263195|12016739|FG007|NOT COMPLETED|Overall Study||6
10850018|NCT03228680|12016764|FG000|STARTED|Overall Study||170
10850019|NCT03228680|12016765|FG001|STARTED|Overall Study||178
10850020|NCT03228680|12016764|FG000|COMPLETED|Overall Study||147
10850021|NCT03228680|12016765|FG001|COMPLETED|Overall Study||143
10850022|NCT03228680|12016764|FG000|NOT COMPLETED|Overall Study||23
10850023|NCT03228680|12016765|FG001|NOT COMPLETED|Overall Study||35
10850024|NCT03196167|12016774|FG000|STARTED|Overall Study||45
10850025|NCT03196167|12016775|FG001|STARTED|Overall Study||45
10850026|NCT03196167|12016774|FG000|COMPLETED|Overall Study||40
10850027|NCT03196167|12016775|FG001|COMPLETED|Overall Study||43
10850028|NCT03196167|12016774|FG000|NOT COMPLETED|Overall Study||5
10850029|NCT03196167|12016775|FG001|NOT COMPLETED|Overall Study||2
10850030|NCT03077204|12016785|FG000|STARTED|Overall Study||20
10850031|NCT03077204|12016785|FG000|COMPLETED|Overall Study||20
10850032|NCT03077204|12016785|FG000|NOT COMPLETED|Overall Study||0
10850033|NCT03029611|12016790|FG000|STARTED|Overall Study|We had 11 patients sign consent with 2 patients deciding not to continue to receive treatment.|9
10850034|NCT03029611|12016790|FG000|COMPLETED|Overall Study|Please note that we did not fully enroll this study due to lack of funding. The complete date here relates to the last treatment administration.|9
10850035|NCT03029611|12016790|FG000|NOT COMPLETED|Overall Study||0
10850036|NCT02891798|12016796|FG000|STARTED|Overall Study||62
10850037|NCT02891798|12016797|FG001|STARTED|Overall Study||16
10850038|NCT02891798|12016796|FG000|COMPLETED|Overall Study||62
10850039|NCT02891798|12016797|FG001|COMPLETED|Overall Study||16
10850040|NCT02891798|12016796|FG000|NOT COMPLETED|Overall Study||0
10850041|NCT02891798|12016797|FG001|NOT COMPLETED|Overall Study||0
10850042|NCT02679781|12016805|FG000|STARTED|Overall Study||37
10850043|NCT02679781|12016806|FG001|STARTED|Overall Study||33
10850044|NCT02679781|12016805|FG000|COMPLETED|Overall Study||30
10850045|NCT02679781|12016806|FG001|COMPLETED|Overall Study||30
10850046|NCT02679781|12016805|FG000|NOT COMPLETED|Overall Study||7
10850047|NCT02679781|12016806|FG001|NOT COMPLETED|Overall Study||3
10850048|NCT02624869|12016815|FG000|STARTED|Overall Study||49
10850049|NCT02624869|12016816|FG001|STARTED|Overall Study||101
10850050|NCT02624869|12016817|FG002|STARTED|Overall Study||13
10850051|NCT02624869|12016815|FG000|Received Study Drug|Overall Study||49
10850052|NCT02624869|12016816|FG001|Received Study Drug|Overall Study||101
10850053|NCT02624869|12016817|FG002|Received Study Drug|Overall Study||12
10850054|NCT02624869|12016815|FG000|COMPLETED|Overall Study||48
10850055|NCT02624869|12016816|FG001|COMPLETED|Overall Study||98
10850056|NCT02624869|12016817|FG002|COMPLETED|Overall Study||11
11224767|NCT01987895|12416937|FG000|NOT COMPLETED|Overall Study||30
11224768|NCT01987895|12416938|FG001|NOT COMPLETED|Overall Study||30
11224769|NCT01987908|12416944|FG000|STARTED|Placebo Lead-in Period||23
11224770|NCT01987908|12416945|FG001|STARTED|Placebo Lead-in Period||0
11224771|NCT01987908|12416946|FG002|STARTED|Placebo Lead-in Period||0
11224772|NCT01987908|12416944|FG000|COMPLETED|Placebo Lead-in Period||14
11224773|NCT01987908|12416945|FG001|COMPLETED|Placebo Lead-in Period||0
11224774|NCT01987908|12416946|FG002|COMPLETED|Placebo Lead-in Period||0
11224775|NCT01987908|12416944|FG000|NOT COMPLETED|Placebo Lead-in Period||9
11224776|NCT01987908|12416945|FG001|NOT COMPLETED|Placebo Lead-in Period||0
11224777|NCT01987908|12416946|FG002|NOT COMPLETED|Placebo Lead-in Period||0
11224778|NCT01987908|12416944|FG000|STARTED|Treatment Period||0
11224779|NCT01987908|12416945|FG001|STARTED|Treatment Period||11
11224780|NCT01987908|12416946|FG002|STARTED|Treatment Period||3
11224781|NCT01987908|12416944|FG000|COMPLETED|Treatment Period||0
11224782|NCT01987908|12416945|FG001|COMPLETED|Treatment Period||10
11224783|NCT01987908|12416946|FG002|COMPLETED|Treatment Period||2
11224784|NCT01987908|12416944|FG000|NOT COMPLETED|Treatment Period||0
11224785|NCT01987908|12416945|FG001|NOT COMPLETED|Treatment Period||1
11224786|NCT01987908|12416946|FG002|NOT COMPLETED|Treatment Period||1
11224787|NCT01987908|12416944|FG000|STARTED|Post-Treatment Observation Period||0
11224788|NCT01987908|12416945|FG001|STARTED|Post-Treatment Observation Period||10
11224789|NCT01987908|12416946|FG002|STARTED|Post-Treatment Observation Period||2
11224790|NCT01987908|12416944|FG000|COMPLETED|Post-Treatment Observation Period||0
11224791|NCT01987908|12416945|FG001|COMPLETED|Post-Treatment Observation Period||7
11224792|NCT01987908|12416946|FG002|COMPLETED|Post-Treatment Observation Period||2
11224793|NCT01987908|12416944|FG000|NOT COMPLETED|Post-Treatment Observation Period||0
11224794|NCT01987908|12416945|FG001|NOT COMPLETED|Post-Treatment Observation Period||3
11224795|NCT01987908|12416946|FG002|NOT COMPLETED|Post-Treatment Observation Period||0
11224796|NCT01987960|12416972|FG000|STARTED|Period 1||417
10850057|NCT02624869|12016815|FG000|NOT COMPLETED|Overall Study||1
10850058|NCT02624869|12016816|FG001|NOT COMPLETED|Overall Study||3
10850059|NCT02624869|12016817|FG002|NOT COMPLETED|Overall Study||2
10850060|NCT02614690|12016829|FG000|STARTED|Overall Study||20
10850061|NCT02614690|12016830|FG001|STARTED|Overall Study||20
11224797|NCT01987960|12416973|FG001|STARTED|Period 1||0
11224798|NCT01987960|12416974|FG002|STARTED|Period 1||0
11224799|NCT01987960|12416975|FG003|STARTED|Period 1||0
11224800|NCT01987960|12416972|FG000|COMPLETED|Period 1||231
11224801|NCT01987960|12416973|FG001|COMPLETED|Period 1||0
11224802|NCT01987960|12416974|FG002|COMPLETED|Period 1||0
11224803|NCT01987960|12416975|FG003|COMPLETED|Period 1||0
11224804|NCT01987960|12416972|FG000|NOT COMPLETED|Period 1||186
11224805|NCT01987960|12416973|FG001|NOT COMPLETED|Period 1||0
11224806|NCT01987960|12416974|FG002|NOT COMPLETED|Period 1||0
11224807|NCT01987960|12416975|FG003|NOT COMPLETED|Period 1||0
11224808|NCT01987960|12416972|FG000|STARTED|Period 2||0
11224809|NCT01987960|12416973|FG001|STARTED|Period 2||17
11224810|NCT01987960|12416974|FG002|STARTED|Period 2||23
10850062|NCT02614690|12016831|FG002|STARTED|Overall Study||20
10850063|NCT02614690|12016829|FG000|COMPLETED|Overall Study||20
10850064|NCT02614690|12016830|FG001|COMPLETED|Overall Study||20
10850065|NCT02614690|12016831|FG002|COMPLETED|Overall Study||20
10850066|NCT02614690|12016829|FG000|NOT COMPLETED|Overall Study||0
10850067|NCT02614690|12016830|FG001|NOT COMPLETED|Overall Study||0
10850068|NCT02614690|12016831|FG002|NOT COMPLETED|Overall Study||0
10850069|NCT02516969|12016841|FG000|STARTED|Overall Study||3
10850070|NCT02516969|12016842|FG001|STARTED|Overall Study||4
10850071|NCT02516969|12016841|FG000|COMPLETED|Overall Study||3
10850072|NCT02516969|12016842|FG001|COMPLETED|Overall Study||4
10850073|NCT02516969|12016841|FG000|NOT COMPLETED|Overall Study||0
10850074|NCT02516969|12016842|FG001|NOT COMPLETED|Overall Study||0
10850075|NCT02507960|12016850|FG000|STARTED|Overall Study||17
10850076|NCT02507960|12016850|FG000|COMPLETED|Overall Study||17
10850077|NCT02507960|12016850|FG000|NOT COMPLETED|Overall Study||0
10850078|NCT02435433|12016856|FG000|STARTED|Overall Study||197
10850079|NCT02435433|12016857|FG001|STARTED|Overall Study||95
10850080|NCT02435433|12016858|FG002|STARTED|Overall Study||0
10850081|NCT02435433|12016859|FG003|STARTED|Overall Study||0
10850082|NCT02435433|12016860|FG004|STARTED|Overall Study||0
10850083|NCT02435433|12016856|FG000|Participants Who Received Study Drug|Overall Study||197
10850084|NCT02435433|12016857|FG001|Participants Who Received Study Drug|Overall Study||95
10850085|NCT02435433|12016858|FG002|Participants Who Received Study Drug|Overall Study||0
10850086|NCT02435433|12016859|FG003|Participants Who Received Study Drug|Overall Study||0
10850087|NCT02435433|12016860|FG004|Participants Who Received Study Drug|Overall Study||0
10850088|NCT02435433|12016856|FG000|COMPLETED|Overall Study||182
10850089|NCT02435433|12016857|FG001|COMPLETED|Overall Study||90
10850090|NCT02435433|12016858|FG002|COMPLETED|Overall Study||0
10850091|NCT02435433|12016859|FG003|COMPLETED|Overall Study||0
10850092|NCT02435433|12016860|FG004|COMPLETED|Overall Study||0
10850093|NCT02435433|12016856|FG000|NOT COMPLETED|Overall Study||15
10850094|NCT02435433|12016857|FG001|NOT COMPLETED|Overall Study||5
10850095|NCT02435433|12016858|FG002|NOT COMPLETED|Overall Study||0
10850096|NCT02435433|12016859|FG003|NOT COMPLETED|Overall Study||0
10850097|NCT02435433|12016860|FG004|NOT COMPLETED|Overall Study||0
11106030|NCT01256788|12290423|FG000|STARTED|Overall Study||12
11106031|NCT01256788|12290424|FG001|STARTED|Overall Study||14
11106032|NCT01256788|12290425|FG002|STARTED|Overall Study||8
11106033|NCT01256788|12290423|FG000|COMPLETED|Overall Study||7
11106034|NCT01256788|12290424|FG001|COMPLETED|Overall Study||6
11106035|NCT01256788|12290425|FG002|COMPLETED|Overall Study||5
11106036|NCT01256788|12290423|FG000|NOT COMPLETED|Overall Study||5
11106037|NCT01256788|12290424|FG001|NOT COMPLETED|Overall Study||8
11106038|NCT01256788|12290425|FG002|NOT COMPLETED|Overall Study||3
11106039|NCT01256840|12290436|FG000|STARTED|Overall Study||30
10850108|NCT02417142|12016881|FG000|STARTED|Overall Study||35
10850109|NCT02417142|12016882|FG001|STARTED|Overall Study||35
10850110|NCT02417142|12016881|FG000|COMPLETED|Overall Study||19
10850111|NCT02417142|12016882|FG001|COMPLETED|Overall Study||22
10850112|NCT02417142|12016881|FG000|NOT COMPLETED|Overall Study||16
10850113|NCT02417142|12016882|FG001|NOT COMPLETED|Overall Study||13
10850114|NCT02368886|12016892|FG000|STARTED|Overall Study||29
10850115|NCT02368886|12016893|FG001|STARTED|Overall Study||27
10850116|NCT02368886|12016894|FG002|STARTED|Overall Study||34
10850117|NCT02368886|12016895|FG003|STARTED|Overall Study||33
10850118|NCT02368886|12016892|FG000|COMPLETED|Overall Study||28
10850119|NCT02368886|12016893|FG001|COMPLETED|Overall Study||26
10850120|NCT02368886|12016894|FG002|COMPLETED|Overall Study||33
10850121|NCT02368886|12016895|FG003|COMPLETED|Overall Study||29
10850122|NCT02368886|12016892|FG000|NOT COMPLETED|Overall Study||1
10850123|NCT02368886|12016893|FG001|NOT COMPLETED|Overall Study||1
10850124|NCT02368886|12016894|FG002|NOT COMPLETED|Overall Study||1
10850125|NCT02368886|12016895|FG003|NOT COMPLETED|Overall Study||4
10850126|NCT02354703|12016907|FG000|STARTED|Overall Study||12
10850127|NCT02354703|12016908|FG001|STARTED|Overall Study||34
10850128|NCT02354703|12016909|FG002|STARTED|Overall Study||39
10850129|NCT02354703|12016910|FG003|STARTED|Overall Study||10
10850130|NCT02354703|12016907|FG000|COMPLETED|Overall Study||9
10850131|NCT02354703|12016908|FG001|COMPLETED|Overall Study||26
10850132|NCT02354703|12016909|FG002|COMPLETED|Overall Study||28
10850133|NCT02354703|12016910|FG003|COMPLETED|Overall Study||7
11106040|NCT01256840|12290437|FG001|STARTED|Overall Study||16
11224811|NCT01987960|12416975|FG003|STARTED|Period 2||0
10850134|NCT02354703|12016907|FG000|NOT COMPLETED|Overall Study||3
10850135|NCT02354703|12016908|FG001|NOT COMPLETED|Overall Study||8
10850136|NCT02354703|12016909|FG002|NOT COMPLETED|Overall Study||11
10850137|NCT02354703|12016910|FG003|NOT COMPLETED|Overall Study||3
10850138|NCT01981551|12016922|FG000|STARTED|Overall Study||17
10850139|NCT01981551|12016922|FG000|COMPLETED|Overall Study||8
10850140|NCT01981551|12016922|FG000|NOT COMPLETED|Overall Study||9
10850141|NCT00740181|12016926|FG000|STARTED|Overall Study||9
10850142|NCT00740181|12016926|FG000|COMPLETED|Overall Study||9
10850143|NCT00740181|12016926|FG000|NOT COMPLETED|Overall Study||0
10850144|NCT00468130|12016932|FG000|STARTED|Overall Study||7
10850145|NCT00468130|12016933|FG001|STARTED|Overall Study||6
10850146|NCT00468130|12016932|FG000|COMPLETED|Overall Study||5
10850147|NCT00468130|12016933|FG001|COMPLETED|Overall Study||4
10850148|NCT00468130|12016932|FG000|NOT COMPLETED|Overall Study||2
10850149|NCT00468130|12016933|FG001|NOT COMPLETED|Overall Study||2
10850150|NCT00384111|12016941|FG000|STARTED|Overall Study||26
10850151|NCT00384111|12016941|FG000|COMPLETED|Overall Study||0
10850152|NCT00384111|12016941|FG000|NOT COMPLETED|Overall Study||26
10850153|NCT04854642|12016945|FG000|STARTED|Overall Study||18
10850154|NCT04854642|12016946|FG001|STARTED|Overall Study||18
10850155|NCT04854642|12016945|FG000|Safety Set|Overall Study||18
10850156|NCT04854642|12016946|FG001|Safety Set|Overall Study||18
10850157|NCT04854642|12016945|FG000|PK Set 1|Overall Study||18
10850158|NCT04854642|12016946|FG001|PK Set 1|Overall Study||18
10850159|NCT04854642|12016945|FG000|PK Set 2|Overall Study||18
10850160|NCT04854642|12016946|FG001|PK Set 2|Overall Study||18
10850161|NCT04854642|12016945|FG000|COMPLETED|Overall Study||17
10850162|NCT04854642|12016946|FG001|COMPLETED|Overall Study||15
10850163|NCT04854642|12016945|FG000|NOT COMPLETED|Overall Study||1
10850164|NCT04854642|12016946|FG001|NOT COMPLETED|Overall Study||3
10850165|NCT04583592|12016956|FG000|STARTED|Overall Study||194
10850166|NCT04583592|12016957|FG001|STARTED|Overall Study||101
10850167|NCT04583592|12016956|FG000|COMPLETED|Overall Study||194
10850168|NCT04583592|12016957|FG001|COMPLETED|Overall Study||100
10850169|NCT04583592|12016956|FG000|NOT COMPLETED|Overall Study||0
10850170|NCT04583592|12016957|FG001|NOT COMPLETED|Overall Study||1
10850171|NCT04572399|12016963|FG000|STARTED|Overall Study||5
10850172|NCT04572399|12016963|FG000|COMPLETED|Overall Study||5
10850173|NCT04572399|12016963|FG000|NOT COMPLETED|Overall Study||0
10850230|NCT04097301|12017040|FG000|STARTED|Overall Study|Enrolled patients. Overall, 8 patients were enrolled in the study and underwent the screening phase to evaluate the compliance to the clinical inclusion / exclusion criteria as well as the CD44v6 expression by tumor cells.|8
10850231|NCT04097301|12017040|FG000|Treated Patients|Overall Study|Of the 8 enrolled patients, 2 were treated with MLM-CAR44.1 T-cell at the first dose level.|2
10850232|NCT04097301|12017040|FG000|COMPLETED|Overall Study||1
10850233|NCT04097301|12017040|FG000|NOT COMPLETED|Overall Study||7
10850234|NCT04054375|12017046|FG000|STARTED|Overall Study||20
10850235|NCT04054375|12017046|FG000|COMPLETED|Overall Study|Due to COVID-19, some participants were not able to come to our site to complete all outcome measurements. Our study team worked with individuals to make them feel safe and collect as much data as we possibly could. This is the reason why some outcome metrics have less than 20 data points. All 20 patients completed the study and took the medication for all 24 weeks.|20
10850236|NCT04054375|12017046|FG000|NOT COMPLETED|Overall Study||0
10850237|NCT03953079|12017053|FG000|STARTED|Core Study||21
10850238|NCT03953079|12017054|FG001|STARTED|Core Study||22
10850239|NCT03953079|12017055|FG002|STARTED|Core Study||13
10850240|NCT03953079|12017053|FG000|COMPLETED|Core Study||20
10850241|NCT03953079|12017054|FG001|COMPLETED|Core Study||18
10850242|NCT03953079|12017055|FG002|COMPLETED|Core Study||12
10850243|NCT03953079|12017053|FG000|NOT COMPLETED|Core Study||1
10850244|NCT03953079|12017054|FG001|NOT COMPLETED|Core Study||4
10850245|NCT03953079|12017055|FG002|NOT COMPLETED|Core Study||1
10850246|NCT03953079|12017053|FG000|STARTED|Extension Study||12
10850247|NCT03953079|12017054|FG001|STARTED|Extension Study||10
10850248|NCT03953079|12017055|FG002|STARTED|Extension Study||6
10850249|NCT03953079|12017053|FG000|COMPLETED|Extension Study||6
10850250|NCT03953079|12017054|FG001|COMPLETED|Extension Study||4
10850251|NCT03953079|12017055|FG002|COMPLETED|Extension Study||1
10850252|NCT03953079|12017053|FG000|NOT COMPLETED|Extension Study||6
10850253|NCT03953079|12017054|FG001|NOT COMPLETED|Extension Study||6
10850254|NCT03953079|12017055|FG002|NOT COMPLETED|Extension Study||5
10850255|NCT03922750|12017067|FG000|STARTED|Overall Study||50
10850256|NCT03922750|12017068|FG001|STARTED|Overall Study||54
10850257|NCT03922750|12017069|FG002|STARTED|Overall Study||50
10850258|NCT03922750|12017067|FG000|Full Analysis Set (FAS)|Overall Study||50
10850259|NCT03922750|12017068|FG001|Full Analysis Set (FAS)|Overall Study||54
10850260|NCT03922750|12017069|FG002|Full Analysis Set (FAS)|Overall Study||50
10850261|NCT03922750|12017067|FG000|Safety Analysis Set (SAS)|Overall Study||50
10850262|NCT03922750|12017068|FG001|Safety Analysis Set (SAS)|Overall Study||54
10850263|NCT03922750|12017069|FG002|Safety Analysis Set (SAS)|Overall Study||50
10850264|NCT03922750|12017067|FG000|COMPLETED|Overall Study||50
10850265|NCT03922750|12017068|FG001|COMPLETED|Overall Study||53
10850266|NCT03922750|12017069|FG002|COMPLETED|Overall Study||49
10850267|NCT03922750|12017067|FG000|NOT COMPLETED|Overall Study||0
10850268|NCT03922750|12017068|FG001|NOT COMPLETED|Overall Study||1
10850269|NCT03922750|12017069|FG002|NOT COMPLETED|Overall Study||1
10850270|NCT03910673|12017082|FG000|STARTED|Overall Study||7
10850271|NCT03910673|12017083|FG001|STARTED|Overall Study||6
10850272|NCT03910673|12017084|FG002|STARTED|Overall Study||7
10850273|NCT03910673|12017085|FG003|STARTED|Overall Study||13
10850274|NCT03910673|12017086|FG004|STARTED|Overall Study||6
10850275|NCT03910673|12017082|FG000|Enrolled and Randomized|Overall Study||6
10850174|NCT04388787|12016967|FG000|STARTED|Blinded Period||16
10850175|NCT04388787|12016967|FG000|Completed First Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15
10850176|NCT04388787|12016967|FG000|Completed Second Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15
10850177|NCT04388787|12016967|FG000|COMPLETED|Blinded Period||15
10850178|NCT04388787|12016967|FG000|NOT COMPLETED|Blinded Period||1
10850179|NCT04388787|12016967|FG000|STARTED|Unblinded Period||15
10850180|NCT04388787|12016967|FG000|COMPLETED|Unblinded Period||6
10850181|NCT04388787|12016967|FG000|NOT COMPLETED|Unblinded Period||9
10850182|NCT04380090|12016977|FG000|STARTED|Overall Study||76
10850183|NCT04380090|12016978|FG001|STARTED|Overall Study||78
10850184|NCT04380090|12016977|FG000|COMPLETED|Overall Study||60
10850185|NCT04380090|12016978|FG001|COMPLETED|Overall Study||58
10850186|NCT04380090|12016977|FG000|NOT COMPLETED|Overall Study||16
10850187|NCT04380090|12016978|FG001|NOT COMPLETED|Overall Study||20
10850188|NCT04377620|12016991|FG000|STARTED|Overall Study||77
10850189|NCT04377620|12016992|FG001|STARTED|Overall Study||87
10850190|NCT04377620|12016993|FG002|STARTED|Overall Study||47
10850191|NCT04377620|12016991|FG000|COMPLETED|Overall Study||35
10850192|NCT04377620|12016992|FG001|COMPLETED|Overall Study||37
10850193|NCT04377620|12016993|FG002|COMPLETED|Overall Study||11
10850194|NCT04377620|12016991|FG000|NOT COMPLETED|Overall Study||42
10850195|NCT04377620|12016992|FG001|NOT COMPLETED|Overall Study||50
10850196|NCT04377620|12016993|FG002|NOT COMPLETED|Overall Study||36
10850197|NCT04355169|12017006|FG000|STARTED|Overall Study||0
10850198|NCT04355169|12017007|FG001|STARTED|Overall Study||0
10850199|NCT04355169|12017008|FG002|STARTED|Overall Study||0
10850200|NCT04355169|12017009|FG003|STARTED|Overall Study||0
10850201|NCT04355169|12017006|FG000|COMPLETED|Overall Study||0
10850202|NCT04355169|12017007|FG001|COMPLETED|Overall Study||0
10850203|NCT04355169|12017008|FG002|COMPLETED|Overall Study||0
10850204|NCT04355169|12017009|FG003|COMPLETED|Overall Study||0
10850205|NCT04355169|12017006|FG000|NOT COMPLETED|Overall Study||0
10850206|NCT04355169|12017007|FG001|NOT COMPLETED|Overall Study||0
10850207|NCT04355169|12017008|FG002|NOT COMPLETED|Overall Study||0
10850208|NCT04355169|12017009|FG003|NOT COMPLETED|Overall Study||0
10850209|NCT04338971|12017019|FG000|STARTED|Overall Study||24
10850210|NCT04338971|12017019|FG000|COMPLETED|Overall Study||17
10850211|NCT04338971|12017019|FG000|NOT COMPLETED|Overall Study||7
10850212|NCT04310566|12017024|FG000|STARTED|Period 1||31
10850213|NCT04310566|12017025|FG001|STARTED|Period 1||34
10850214|NCT04310566|12017024|FG000|COMPLETED|Period 1||15
10850215|NCT04310566|12017025|FG001|COMPLETED|Period 1||14
10850216|NCT04310566|12017024|FG000|NOT COMPLETED|Period 1||16
10850217|NCT04310566|12017025|FG001|NOT COMPLETED|Period 1||20
10850218|NCT04310566|12017024|FG000|STARTED|Period 2||15
10850219|NCT04310566|12017025|FG001|STARTED|Period 2||14
10850220|NCT04310566|12017024|FG000|COMPLETED|Period 2||8
10850221|NCT04310566|12017025|FG001|COMPLETED|Period 2||9
10850222|NCT04310566|12017024|FG000|NOT COMPLETED|Period 2||7
10850223|NCT04310566|12017025|FG001|NOT COMPLETED|Period 2||5
10850224|NCT04206020|12017033|FG000|STARTED|Overall Study||306
10850225|NCT04206020|12017034|FG001|STARTED|Overall Study||304
10850226|NCT04206020|12017033|FG000|COMPLETED|Overall Study||298
10850227|NCT04206020|12017034|FG001|COMPLETED|Overall Study||297
10850228|NCT04206020|12017033|FG000|NOT COMPLETED|Overall Study||8
10850229|NCT04206020|12017034|FG001|NOT COMPLETED|Overall Study||7
10850276|NCT03910673|12017083|FG001|Enrolled and Randomized|Overall Study||6
10850277|NCT03910673|12017084|FG002|Enrolled and Randomized|Overall Study||6
10850278|NCT03910673|12017085|FG003|Enrolled and Randomized|Overall Study||6
10850279|NCT03910673|12017086|FG004|Enrolled and Randomized|Overall Study||6
10850280|NCT03910673|12017082|FG000|Enrolled as Replacement|Overall Study||1
10850281|NCT03910673|12017083|FG001|Enrolled as Replacement|Overall Study||0
10850282|NCT03910673|12017084|FG002|Enrolled as Replacement|Overall Study||1
10850283|NCT03910673|12017085|FG003|Enrolled as Replacement|Overall Study||7
10850284|NCT03910673|12017086|FG004|Enrolled as Replacement|Overall Study||0
10850285|NCT03910673|12017082|FG000|Began Infusion of Dose 1|Overall Study||7
10850286|NCT03910673|12017083|FG001|Began Infusion of Dose 1|Overall Study||6
10850287|NCT03910673|12017084|FG002|Began Infusion of Dose 1|Overall Study||7
10850288|NCT03910673|12017085|FG003|Began Infusion of Dose 1|Overall Study||13
10850289|NCT03910673|12017086|FG004|Began Infusion of Dose 1|Overall Study||6
10850290|NCT03910673|12017082|FG000|Completed Dose 1|Overall Study||7
10850291|NCT03910673|12017083|FG001|Completed Dose 1|Overall Study||6
10850292|NCT03910673|12017084|FG002|Completed Dose 1|Overall Study||7
10850293|NCT03910673|12017085|FG003|Completed Dose 1|Overall Study||13
10850294|NCT03910673|12017086|FG004|Completed Dose 1|Overall Study||6
10850295|NCT03910673|12017082|FG000|Completed Dose 2|Overall Study||7
10850296|NCT03910673|12017083|FG001|Completed Dose 2|Overall Study||6
10850297|NCT03910673|12017084|FG002|Completed Dose 2|Overall Study||7
10850298|NCT03910673|12017085|FG003|Completed Dose 2|Overall Study||13
10850299|NCT03910673|12017086|FG004|Completed Dose 2|Overall Study||6
10850300|NCT03910673|12017082|FG000|Completed Dose 3|Overall Study||6
10850301|NCT03910673|12017083|FG001|Completed Dose 3|Overall Study||6
10850302|NCT03910673|12017084|FG002|Completed Dose 3|Overall Study||7
10850303|NCT03910673|12017085|FG003|Completed Dose 3|Overall Study||12
10850304|NCT03910673|12017086|FG004|Completed Dose 3|Overall Study||6
10850305|NCT03910673|12017082|FG000|Completed All Scheduled Treatment|Overall Study||6
10850306|NCT03910673|12017083|FG001|Completed All Scheduled Treatment|Overall Study||6
10850307|NCT03910673|12017084|FG002|Completed All Scheduled Treatment|Overall Study||7
10850308|NCT03910673|12017085|FG003|Completed All Scheduled Treatment|Overall Study||12
10850309|NCT03910673|12017086|FG004|Completed All Scheduled Treatment|Overall Study||6
10850310|NCT03910673|12017082|FG000|Completed All PK Blood Draws|Overall Study||6
10850311|NCT03910673|12017083|FG001|Completed All PK Blood Draws|Overall Study||6
10850312|NCT03910673|12017084|FG002|Completed All PK Blood Draws|Overall Study||6
10850313|NCT03910673|12017085|FG003|Completed All PK Blood Draws|Overall Study||6
10850314|NCT03910673|12017086|FG004|Completed All PK Blood Draws|Overall Study||6
10850315|NCT03910673|12017082|FG000|Completed Bronchoscopy With BAL|Overall Study||6
10850316|NCT03910673|12017083|FG001|Completed Bronchoscopy With BAL|Overall Study||6
10850317|NCT03910673|12017084|FG002|Completed Bronchoscopy With BAL|Overall Study||6
10850318|NCT03910673|12017085|FG003|Completed Bronchoscopy With BAL|Overall Study||6
10850319|NCT03910673|12017086|FG004|Completed Bronchoscopy With BAL|Overall Study||6
10850320|NCT03910673|12017082|FG000|Completed All Plasma Urea Samples|Overall Study||6
10850321|NCT03910673|12017083|FG001|Completed All Plasma Urea Samples|Overall Study||6
10850322|NCT03910673|12017084|FG002|Completed All Plasma Urea Samples|Overall Study||6
10850323|NCT03910673|12017085|FG003|Completed All Plasma Urea Samples|Overall Study||6
10850324|NCT03910673|12017086|FG004|Completed All Plasma Urea Samples|Overall Study||6
10850325|NCT03910673|12017082|FG000|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
10850326|NCT03910673|12017083|FG001|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
10850327|NCT03910673|12017084|FG002|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
10850328|NCT03910673|12017085|FG003|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
10850329|NCT03910673|12017086|FG004|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
11224812|NCT01987960|12416972|FG000|COMPLETED|Period 2||0
11224813|NCT01987960|12416973|FG001|COMPLETED|Period 2||12
11224814|NCT01987960|12416974|FG002|COMPLETED|Period 2||14
11224815|NCT01987960|12416975|FG003|COMPLETED|Period 2||0
11224816|NCT01987960|12416972|FG000|NOT COMPLETED|Period 2||0
11224817|NCT01987960|12416973|FG001|NOT COMPLETED|Period 2||5
11224818|NCT01987960|12416974|FG002|NOT COMPLETED|Period 2||9
11224819|NCT01987960|12416975|FG003|NOT COMPLETED|Period 2||0
11224820|NCT01987960|12416972|FG000|STARTED|Period 3||0
11224821|NCT01987960|12416973|FG001|STARTED|Period 3||0
11224822|NCT01987960|12416974|FG002|STARTED|Period 3||0
11224823|NCT01987960|12416975|FG003|STARTED|Period 3||190
11224824|NCT01987960|12416972|FG000|COMPLETED|Period 3||0
11224825|NCT01987960|12416973|FG001|COMPLETED|Period 3||0
11224826|NCT01987960|12416974|FG002|COMPLETED|Period 3||0
11224827|NCT01987960|12416975|FG003|COMPLETED|Period 3||119
11224828|NCT01987960|12416972|FG000|NOT COMPLETED|Period 3||0
11224829|NCT01987960|12416973|FG001|NOT COMPLETED|Period 3||0
11224830|NCT01987960|12416974|FG002|NOT COMPLETED|Period 3||0
11224831|NCT01987960|12416975|FG003|NOT COMPLETED|Period 3||71
11224832|NCT01987986|12416989|FG000|STARTED|Overall Study||43
11224833|NCT01987986|12416990|FG001|STARTED|Overall Study||43
11224834|NCT01987986|12416991|FG002|STARTED|Overall Study||40
11224835|NCT01987986|12416992|FG003|STARTED|Overall Study||24
11224836|NCT01987986|12416989|FG000|COMPLETED|Overall Study||41
11224837|NCT01987986|12416990|FG001|COMPLETED|Overall Study||43
11224838|NCT01987986|12416991|FG002|COMPLETED|Overall Study||38
11224839|NCT01987986|12416992|FG003|COMPLETED|Overall Study||24
11224840|NCT01987986|12416989|FG000|NOT COMPLETED|Overall Study||2
11224841|NCT01987986|12416990|FG001|NOT COMPLETED|Overall Study||0
11224842|NCT01987986|12416991|FG002|NOT COMPLETED|Overall Study||2
11224843|NCT01987986|12416992|FG003|NOT COMPLETED|Overall Study||0
11224844|NCT01988012|12417002|FG000|STARTED|Overall Study||100
11224845|NCT01988012|12417002|FG000|COMPLETED|Overall Study||85
11224846|NCT01988012|12417002|FG000|NOT COMPLETED|Overall Study||15
11224847|NCT01988090|12417008|FG000|STARTED|Start Treament After Randomization||46
11224848|NCT01988090|12417009|FG001|STARTED|Start Treament After Randomization||47
11224849|NCT01988090|12417008|FG000|COMPLETED|Start Treament After Randomization||44
11224850|NCT01988090|12417009|FG001|COMPLETED|Start Treament After Randomization||43
11224851|NCT01988090|12417008|FG000|NOT COMPLETED|Start Treament After Randomization||2
11224852|NCT01988090|12417009|FG001|NOT COMPLETED|Start Treament After Randomization||4
11224853|NCT01988090|12417008|FG000|STARTED|Complete Study After Start||44
11224854|NCT01988090|12417009|FG001|STARTED|Complete Study After Start||43
11224855|NCT01988090|12417008|FG000|COMPLETED|Complete Study After Start||41
11224856|NCT01988090|12417009|FG001|COMPLETED|Complete Study After Start||42
10850330|NCT03910673|12017082|FG000|COMPLETED|Overall Study||7
10850331|NCT03910673|12017083|FG001|COMPLETED|Overall Study||6
10850332|NCT03910673|12017084|FG002|COMPLETED|Overall Study||7
11224857|NCT01988090|12417008|FG000|NOT COMPLETED|Complete Study After Start||3
11224858|NCT01988090|12417009|FG001|NOT COMPLETED|Complete Study After Start||1
11224859|NCT01988103|12417018|FG000|STARTED|Placebo-Controlled Phase Week 0-16||84
11224860|NCT01988103|12417019|FG001|STARTED|Placebo-Controlled Phase Week 0-16||85
11224861|NCT01988103|12417020|FG002|STARTED|Placebo-Controlled Phase Week 0-16||85
11224862|NCT01988103|12417021|FG003|STARTED|Placebo-Controlled Phase Week 0-16||0
11224863|NCT01988103|12417022|FG004|STARTED|Placebo-Controlled Phase Week 0-16||0
11224864|NCT01988103|12417018|FG000|COMPLETED|Placebo-Controlled Phase Week 0-16||72
11224865|NCT01988103|12417019|FG001|COMPLETED|Placebo-Controlled Phase Week 0-16||69
11224866|NCT01988103|12417020|FG002|COMPLETED|Placebo-Controlled Phase Week 0-16||76
10850333|NCT03910673|12017085|FG003|COMPLETED|Overall Study||11
11224867|NCT01988103|12417021|FG003|COMPLETED|Placebo-Controlled Phase Week 0-16||0
11224868|NCT01988103|12417022|FG004|COMPLETED|Placebo-Controlled Phase Week 0-16||0
10850334|NCT03910673|12017086|FG004|COMPLETED|Overall Study||6
10850335|NCT03910673|12017082|FG000|NOT COMPLETED|Overall Study||0
10850336|NCT03910673|12017083|FG001|NOT COMPLETED|Overall Study||0
10850337|NCT03910673|12017084|FG002|NOT COMPLETED|Overall Study||0
10850338|NCT03910673|12017085|FG003|NOT COMPLETED|Overall Study||2
10850339|NCT03910673|12017086|FG004|NOT COMPLETED|Overall Study||0
10850340|NCT03885999|12017090|FG000|STARTED|Overall Study||12
10850341|NCT03885999|12017090|FG000|COMPLETED|Overall Study||11
10850342|NCT03885999|12017090|FG000|NOT COMPLETED|Overall Study||1
10850343|NCT03882970|12017098|FG000|STARTED|Overall Study||359
10850344|NCT03882970|12017099|FG001|STARTED|Overall Study||361
10850345|NCT03882970|12017100|FG002|STARTED|Overall Study||359
10850346|NCT03882970|12017101|FG003|STARTED|Overall Study||365
10850347|NCT03882970|12017098|FG000|Received at Least One Dose of Study Drug|Overall Study||358
10850348|NCT03882970|12017099|FG001|Received at Least One Dose of Study Drug|Overall Study||360
10850349|NCT03882970|12017100|FG002|Received at Least One Dose of Study Drug|Overall Study||359
10850350|NCT03882970|12017101|FG003|Received at Least One Dose of Study Drug|Overall Study||360
10850351|NCT03882970|12017098|FG000|COMPLETED|Overall Study||333
10850352|NCT03882970|12017099|FG001|COMPLETED|Overall Study||321
10850353|NCT03882970|12017100|FG002|COMPLETED|Overall Study||340
10850354|NCT03882970|12017101|FG003|COMPLETED|Overall Study||331
10850355|NCT03882970|12017098|FG000|NOT COMPLETED|Overall Study||26
10850356|NCT03882970|12017099|FG001|NOT COMPLETED|Overall Study||40
10850357|NCT03882970|12017100|FG002|NOT COMPLETED|Overall Study||19
10850358|NCT03882970|12017101|FG003|NOT COMPLETED|Overall Study||34
10850359|NCT03879525|12017117|FG000|STARTED|Overall Study||15
10850360|NCT03879525|12017118|FG001|STARTED|Overall Study||15
10850361|NCT03879525|12017117|FG000|COMPLETED|Overall Study||15
10850362|NCT03879525|12017118|FG001|COMPLETED|Overall Study||15
10850363|NCT03879525|12017117|FG000|NOT COMPLETED|Overall Study||0
10850364|NCT03879525|12017118|FG001|NOT COMPLETED|Overall Study||0
10850365|NCT03867734|12017125|FG000|STARTED|Overall Study||32
10850366|NCT03867734|12017125|FG000|COMPLETED|Overall Study||30
10850367|NCT03867734|12017125|FG000|NOT COMPLETED|Overall Study||2
10850368|NCT03781778|12017135|FG000|STARTED|Overall Study||4
10850369|NCT03781778|12017136|FG001|STARTED|Overall Study||6
10850370|NCT03781778|12017135|FG000|Started Intervention|Overall Study||3
10850371|NCT03781778|12017136|FG001|Started Intervention|Overall Study||4
10850372|NCT03781778|12017135|FG000|COMPLETED|Overall Study||2
10850373|NCT03781778|12017136|FG001|COMPLETED|Overall Study||4
10850374|NCT03781778|12017135|FG000|NOT COMPLETED|Overall Study||2
10850375|NCT03781778|12017136|FG001|NOT COMPLETED|Overall Study||2
10850376|NCT03764735|12017145|FG000|STARTED|Overall Study||151
10850377|NCT03764735|12017146|FG001|STARTED|Overall Study||150
10850378|NCT03764735|12017147|FG002|STARTED|Overall Study||151
10850379|NCT03764735|12017145|FG000|COMPLETED|Overall Study||147
10850380|NCT03764735|12017146|FG001|COMPLETED|Overall Study||144
10850381|NCT03764735|12017147|FG002|COMPLETED|Overall Study||147
10850382|NCT03764735|12017145|FG000|NOT COMPLETED|Overall Study||4
10850383|NCT03764735|12017146|FG001|NOT COMPLETED|Overall Study||6
11224869|NCT01988103|12417018|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||12
11224870|NCT01988103|12417019|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||16
11224871|NCT01988103|12417020|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||9
11224872|NCT01988103|12417021|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
11224873|NCT01988103|12417022|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
11224874|NCT01988103|12417018|FG000|STARTED|Active Treatment Phase (Weeks 16-68)||0
11224875|NCT01988103|12417019|FG001|STARTED|Active Treatment Phase (Weeks 16-68)||69
11224876|NCT01988103|12417020|FG002|STARTED|Active Treatment Phase (Weeks 16-68)||76
11224877|NCT01988103|12417021|FG003|STARTED|Active Treatment Phase (Weeks 16-68)||36
11224878|NCT01988103|12417022|FG004|STARTED|Active Treatment Phase (Weeks 16-68)||35
11224879|NCT01988103|12417018|FG000|COMPLETED|Active Treatment Phase (Weeks 16-68)||0
11224880|NCT01988103|12417019|FG001|COMPLETED|Active Treatment Phase (Weeks 16-68)||56
11224881|NCT01988103|12417020|FG002|COMPLETED|Active Treatment Phase (Weeks 16-68)||65
11224882|NCT01988103|12417021|FG003|COMPLETED|Active Treatment Phase (Weeks 16-68)||33
11224883|NCT01988103|12417022|FG004|COMPLETED|Active Treatment Phase (Weeks 16-68)||30
11224884|NCT01988103|12417018|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||0
11224885|NCT01988103|12417019|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||13
11224886|NCT01988103|12417020|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||11
11224887|NCT01988103|12417021|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||3
11224888|NCT01988103|12417022|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||5
11224889|NCT01988103|12417018|FG000|STARTED|Observational Follow-up Phase||12
11224890|NCT01988103|12417019|FG001|STARTED|Observational Follow-up Phase||82
11224891|NCT01988103|12417020|FG002|STARTED|Observational Follow-up Phase||83
11224892|NCT01988103|12417021|FG003|STARTED|Observational Follow-up Phase||36
11224893|NCT01988103|12417022|FG004|STARTED|Observational Follow-up Phase||33
11224894|NCT01988103|12417018|FG000|COMPLETED|Observational Follow-up Phase||12
11224895|NCT01988103|12417019|FG001|COMPLETED|Observational Follow-up Phase||79
11224896|NCT01988103|12417020|FG002|COMPLETED|Observational Follow-up Phase||82
11224897|NCT01988103|12417021|FG003|COMPLETED|Observational Follow-up Phase||36
10850384|NCT03764735|12017147|FG002|NOT COMPLETED|Overall Study||4
10850385|NCT03730480|12017155|FG000|STARTED|Overall Study||372
10850386|NCT03730480|12017155|FG000|COMPLETED|Overall Study||371
10850387|NCT03730480|12017155|FG000|NOT COMPLETED|Overall Study||1
10850388|NCT03713073|12017160|FG000|STARTED|Overall Study||19
10850389|NCT03713073|12017160|FG000|Allogenic Amnion Chorion Membrane|Overall Study||19
11106041|NCT01256840|12290438|FG002|STARTED|Overall Study||25
11106042|NCT01256840|12290436|FG000|COMPLETED|Overall Study||30
11106043|NCT01256840|12290437|FG001|COMPLETED|Overall Study||16
11106044|NCT01256840|12290438|FG002|COMPLETED|Overall Study||25
11106045|NCT01256840|12290436|FG000|NOT COMPLETED|Overall Study||0
11106046|NCT01256840|12290437|FG001|NOT COMPLETED|Overall Study||0
11106047|NCT01256840|12290438|FG002|NOT COMPLETED|Overall Study||0
11106048|NCT01256879|12290446|FG000|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25
11106049|NCT01256879|12290446|FG000|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25
11106050|NCT01256879|12290446|FG000|CimTest-B|Overall Study|24 started this intervention and 24 completed|24
11106051|NCT01256879|12290446|FG000|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
11106052|NCT01256879|12290446|FG000|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
11106053|NCT01256879|12290446|FG000|COMPLETED|Overall Study||24
11106054|NCT01256879|12290446|FG000|NOT COMPLETED|Overall Study||1
11106055|NCT01256918|12290456|FG000|STARTED|Overall Study||200
11106056|NCT01256918|12290456|FG000|Full Thickness Nuclear Crack Achieved|Overall Study||200
11106057|NCT01256918|12290456|FG000|COMPLETED|Overall Study||200
11106058|NCT01256918|12290456|FG000|NOT COMPLETED|Overall Study||0
11106059|NCT01256944|12290469|FG000|STARTED|Overall Study||70
11106060|NCT01256944|12290470|FG001|STARTED|Overall Study||220
11106061|NCT01256944|12290469|FG000|COMPLETED|Overall Study||70
11106062|NCT01256944|12290470|FG001|COMPLETED|Overall Study||220
11106063|NCT01256944|12290469|FG000|NOT COMPLETED|Overall Study||0
11224898|NCT01988103|12417022|FG004|COMPLETED|Observational Follow-up Phase||33
11224899|NCT01988103|12417018|FG000|NOT COMPLETED|Observational Follow-up Phase||0
11224900|NCT01988103|12417019|FG001|NOT COMPLETED|Observational Follow-up Phase||3
11224901|NCT01988103|12417020|FG002|NOT COMPLETED|Observational Follow-up Phase||1
11224902|NCT01988103|12417021|FG003|NOT COMPLETED|Observational Follow-up Phase||0
11224903|NCT01988103|12417022|FG004|NOT COMPLETED|Observational Follow-up Phase||0
11224904|NCT01988129|12417039|FG000|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
11224905|NCT01988129|12417040|FG001|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
11224906|NCT01988129|12417039|FG000|Attended Education Session|Overall Study||542
11224907|NCT01988129|12417040|FG001|Attended Education Session|Overall Study||18
11224908|NCT01988129|12417039|FG000|Screened for Sleep Disorders|Overall Study||416
11224909|NCT01988129|12417040|FG001|Screened for Sleep Disorders|Overall Study||15
11224910|NCT01988129|12417039|FG000|Completed 1-year Follow-up Survey|Overall Study||100
11224911|NCT01988129|12417040|FG001|Completed 1-year Follow-up Survey|Overall Study||4
11224912|NCT01988129|12417039|FG000|COMPLETED|Overall Study||601
11224913|NCT01988129|12417040|FG001|COMPLETED|Overall Study||588
11224914|NCT01988129|12417039|FG000|NOT COMPLETED|Overall Study||0
11224915|NCT01988129|12417040|FG001|NOT COMPLETED|Overall Study||0
11224916|NCT01988246|12417051|FG000|STARTED|Overall Study||15
11224917|NCT01988246|12417052|FG001|STARTED|Overall Study||15
11224918|NCT01988246|12417051|FG000|COMPLETED|Overall Study||14
11224919|NCT01988246|12417052|FG001|COMPLETED|Overall Study||15
11224920|NCT01988246|12417051|FG000|NOT COMPLETED|Overall Study||1
11224921|NCT01988246|12417052|FG001|NOT COMPLETED|Overall Study||0
11224922|NCT01988376|12417060|FG000|STARTED|Overall Study||129
11224923|NCT01988376|12417061|FG001|STARTED|Overall Study||129
11224924|NCT01988376|12417060|FG000|COMPLETED|Overall Study||129
11224925|NCT01988376|12417061|FG001|COMPLETED|Overall Study||129
11224926|NCT01988376|12417060|FG000|NOT COMPLETED|Overall Study||0
11224927|NCT01988376|12417061|FG001|NOT COMPLETED|Overall Study||0
11224928|NCT01988402|12417069|FG000|STARTED|Overall Study||16
11224929|NCT01988402|12417070|FG001|STARTED|Overall Study||19
11224930|NCT01988402|12417069|FG000|COMPLETED|Overall Study||14
11224931|NCT01988402|12417070|FG001|COMPLETED|Overall Study||17
11224932|NCT01988402|12417069|FG000|NOT COMPLETED|Overall Study||2
11224933|NCT01988402|12417070|FG001|NOT COMPLETED|Overall Study||2
11224934|NCT01988415|12417076|FG000|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
11224935|NCT01988415|12417076|FG000|COMPLETED|Overall Study||26
11224936|NCT01988415|12417076|FG000|NOT COMPLETED|Overall Study||0
11224937|NCT01988662|12417084|FG000|STARTED|Overall Study||104
11224938|NCT01988662|12417085|FG001|STARTED|Overall Study||101
11224939|NCT01988662|12417084|FG000|COMPLETED|Overall Study||100
11224940|NCT01988662|12417085|FG001|COMPLETED|Overall Study||99
11224941|NCT01988662|12417084|FG000|NOT COMPLETED|Overall Study||4
11224942|NCT01988662|12417085|FG001|NOT COMPLETED|Overall Study||2
11224943|NCT01988779|12417094|FG000|STARTED|Overall Study||12
11224944|NCT01988779|12417095|FG001|STARTED|Overall Study||13
11224945|NCT01988779|12417094|FG000|COMPLETED|Overall Study||9
11224946|NCT01988779|12417095|FG001|COMPLETED|Overall Study||11
11224947|NCT01988779|12417094|FG000|NOT COMPLETED|Overall Study||3
11224948|NCT01988779|12417095|FG001|NOT COMPLETED|Overall Study||2
11224949|NCT01988857|12417101|FG000|STARTED|Overall Study||300
11224950|NCT01988857|12417101|FG000|COMPLETED|Overall Study||300
10850390|NCT03713073|12017160|FG000|Collagen Dressing|Overall Study||19
10850391|NCT03713073|12017160|FG000|COMPLETED|Overall Study||19
10850392|NCT03713073|12017160|FG000|NOT COMPLETED|Overall Study||0
10850393|NCT03713034|12017168|FG000|STARTED|Overall Study||150
10850394|NCT03713034|12017169|FG001|STARTED|Overall Study||146
10850395|NCT03713034|12017168|FG000|COMPLETED|Overall Study||145
10850396|NCT03713034|12017169|FG001|COMPLETED|Overall Study||142
10850397|NCT03713034|12017168|FG000|NOT COMPLETED|Overall Study||5
10850398|NCT03713034|12017169|FG001|NOT COMPLETED|Overall Study||4
10850399|NCT03654404|12017177|FG000|STARTED|Overall Study||20
10850400|NCT03654404|12017177|FG000|COMPLETED|Overall Study||12
10850401|NCT03654404|12017177|FG000|NOT COMPLETED|Overall Study||8
10850402|NCT03567057|12017184|FG000|STARTED|Overall Study||159
10850403|NCT03567057|12017185|FG001|STARTED|Overall Study||151
10850404|NCT03567057|12017186|FG002|STARTED|Overall Study||114
10850405|NCT03567057|12017184|FG000|COMPLETED|Overall Study||64
10850406|NCT03567057|12017185|FG001|COMPLETED|Overall Study||64
10850407|NCT03567057|12017186|FG002|COMPLETED|Overall Study||68
10850408|NCT03567057|12017184|FG000|NOT COMPLETED|Overall Study||95
10850409|NCT03567057|12017185|FG001|NOT COMPLETED|Overall Study||87
10850410|NCT03567057|12017186|FG002|NOT COMPLETED|Overall Study||46
10850411|NCT03548987|12017196|FG000|STARTED|Run-in Period (Week 0 to Week 20)||902
10850412|NCT03548987|12017197|FG001|STARTED|Run-in Period (Week 0 to Week 20)||0
10850413|NCT03548987|12017196|FG000|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||902
10850414|NCT03548987|12017197|FG001|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||0
10850415|NCT03548987|12017196|FG000|COMPLETED|Run-in Period (Week 0 to Week 20)||803
10850416|NCT03548987|12017197|FG001|COMPLETED|Run-in Period (Week 0 to Week 20)||0
10850417|NCT03548987|12017196|FG000|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||99
10850418|NCT03548987|12017197|FG001|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||0
10850419|NCT03548987|12017196|FG000|STARTED|Maintenance Period (Week 20 to Week 68)||535
10850420|NCT03548987|12017197|FG001|STARTED|Maintenance Period (Week 20 to Week 68)||268
10850421|NCT03548987|12017196|FG000|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||535
10850422|NCT03548987|12017197|FG001|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||268
10850423|NCT03548987|12017196|FG000|COMPLETED|Maintenance Period (Week 20 to Week 68)||504
10850424|NCT03548987|12017197|FG001|COMPLETED|Maintenance Period (Week 20 to Week 68)||237
10850425|NCT03548987|12017196|FG000|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
10850426|NCT03548987|12017197|FG001|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
10850427|NCT03548064|12017212|FG000|STARTED|Overall Study||12
10850428|NCT03548064|12017213|FG001|STARTED|Overall Study||12
10850429|NCT03548064|12017214|FG002|STARTED|Overall Study||6
10850430|NCT03548064|12017215|FG003|STARTED|Overall Study||12
10850431|NCT03548064|12017216|FG004|STARTED|Overall Study||12
10850432|NCT03548064|12017217|FG005|STARTED|Overall Study||6
10850433|NCT03548064|12017218|FG006|STARTED|Overall Study||12
10850434|NCT03548064|12017219|FG007|STARTED|Overall Study||3
10850435|NCT03548064|12017212|FG000|COMPLETED|Overall Study||12
10850436|NCT03548064|12017213|FG001|COMPLETED|Overall Study||12
10850437|NCT03548064|12017214|FG002|COMPLETED|Overall Study||6
10850438|NCT03548064|12017215|FG003|COMPLETED|Overall Study||11
10850439|NCT03548064|12017216|FG004|COMPLETED|Overall Study||0
10850440|NCT03548064|12017217|FG005|COMPLETED|Overall Study||3
10850441|NCT03548064|12017218|FG006|COMPLETED|Overall Study||12
10850442|NCT03548064|12017219|FG007|COMPLETED|Overall Study||3
10850443|NCT03548064|12017212|FG000|NOT COMPLETED|Overall Study||0
10850444|NCT03548064|12017213|FG001|NOT COMPLETED|Overall Study||0
10850445|NCT03548064|12017214|FG002|NOT COMPLETED|Overall Study||0
10850446|NCT03548064|12017215|FG003|NOT COMPLETED|Overall Study||1
10850447|NCT03548064|12017216|FG004|NOT COMPLETED|Overall Study||12
10850448|NCT03548064|12017217|FG005|NOT COMPLETED|Overall Study||3
10850449|NCT03548064|12017218|FG006|NOT COMPLETED|Overall Study||0
10850450|NCT03548064|12017219|FG007|NOT COMPLETED|Overall Study||0
10850451|NCT03446456|12017245|FG000|STARTED|Overall Study||20
10850452|NCT03446456|12017246|FG001|STARTED|Overall Study||20
10850453|NCT03446456|12017245|FG000|COMPLETED|Overall Study||16
10850454|NCT03446456|12017246|FG001|COMPLETED|Overall Study||16
10850455|NCT03446456|12017245|FG000|NOT COMPLETED|Overall Study||4
10850456|NCT03446456|12017246|FG001|NOT COMPLETED|Overall Study||4
10850457|NCT03382834|12017254|FG000|STARTED|Overall Study||21
10850458|NCT03382834|12017255|FG001|STARTED|Overall Study||10
10850459|NCT03382834|12017254|FG000|COMPLETED|Overall Study||20
10850460|NCT03382834|12017255|FG001|COMPLETED|Overall Study||9
10850461|NCT03382834|12017254|FG000|NOT COMPLETED|Overall Study||1
10850462|NCT03382834|12017255|FG001|NOT COMPLETED|Overall Study||1
10850463|NCT03371823|12017263|FG000|STARTED|Overall Study||8
10850464|NCT03371823|12017264|FG001|STARTED|Overall Study|We had trouble enrolling naive to therapy women with high blood pressure|0
10850465|NCT03371823|12017263|FG000|COMPLETED|Overall Study||7
10850466|NCT03371823|12017264|FG001|COMPLETED|Overall Study||0
10850467|NCT03371823|12017263|FG000|NOT COMPLETED|Overall Study||1
10850468|NCT03371823|12017264|FG001|NOT COMPLETED|Overall Study||0
10850469|NCT03353350|12017274|FG000|STARTED|30-week Core Treatment Period||102
10850470|NCT03353350|12017275|FG001|STARTED|30-week Core Treatment Period||100
10850471|NCT03353350|12017276|FG002|STARTED|30-week Core Treatment Period||101
10850472|NCT03353350|12017277|FG003|STARTED|30-week Core Treatment Period||103
10850473|NCT03353350|12017274|FG000|COMPLETED|30-week Core Treatment Period||80
10850474|NCT03353350|12017275|FG001|COMPLETED|30-week Core Treatment Period||81
10850475|NCT03353350|12017276|FG002|COMPLETED|30-week Core Treatment Period||77
10850476|NCT03353350|12017277|FG003|COMPLETED|30-week Core Treatment Period||81
10850477|NCT03353350|12017274|FG000|NOT COMPLETED|30-week Core Treatment Period||22
10850478|NCT03353350|12017275|FG001|NOT COMPLETED|30-week Core Treatment Period||19
10850479|NCT03353350|12017276|FG002|NOT COMPLETED|30-week Core Treatment Period||24
10850480|NCT03353350|12017277|FG003|NOT COMPLETED|30-week Core Treatment Period||22
10850481|NCT03353350|12017274|FG000|STARTED|26-week Treatment Extension Period||80
10850482|NCT03353350|12017275|FG001|STARTED|26-week Treatment Extension Period||81
10850483|NCT03353350|12017276|FG002|STARTED|26-week Treatment Extension Period||77
10850484|NCT03353350|12017277|FG003|STARTED|26-week Treatment Extension Period||81
10850485|NCT03353350|12017274|FG000|COMPLETED|26-week Treatment Extension Period||75
10850486|NCT03353350|12017275|FG001|COMPLETED|26-week Treatment Extension Period||78
10850487|NCT03353350|12017276|FG002|COMPLETED|26-week Treatment Extension Period||73
10850488|NCT03353350|12017277|FG003|COMPLETED|26-week Treatment Extension Period||67
10850489|NCT03353350|12017274|FG000|NOT COMPLETED|26-week Treatment Extension Period||5
10850490|NCT03353350|12017275|FG001|NOT COMPLETED|26-week Treatment Extension Period||3
10850491|NCT03353350|12017276|FG002|NOT COMPLETED|26-week Treatment Extension Period||4
10850492|NCT03353350|12017277|FG003|NOT COMPLETED|26-week Treatment Extension Period||14
10850493|NCT03350503|12017287|FG000|STARTED|Overall Study||121
10850494|NCT03350503|12017287|FG000|COMPLETED|Overall Study||116
10850495|NCT03350503|12017287|FG000|NOT COMPLETED|Overall Study||5
10850499|NCT03287687|12017297|FG000|STARTED|Overall Study||88
10850500|NCT03287687|12017298|FG001|STARTED|Overall Study||90
10850501|NCT03287687|12017297|FG000|Procedures|Overall Study||88
10850502|NCT03287687|12017298|FG001|Procedures|Overall Study||90
10850503|NCT03287687|12017297|FG000|COMPLETED|Overall Study||88
10850504|NCT03287687|12017298|FG001|COMPLETED|Overall Study||90
10850505|NCT03287687|12017297|FG000|NOT COMPLETED|Overall Study||0
10850506|NCT03287687|12017298|FG001|NOT COMPLETED|Overall Study||0
10850507|NCT03282565|12017307|FG000|STARTED|Overall Study||10
10850508|NCT03282565|12017308|FG001|STARTED|Overall Study||10
10850509|NCT03282565|12017309|FG002|STARTED|Overall Study||10
10850510|NCT03282565|12017307|FG000|COMPLETED|Overall Study||10
10850511|NCT03282565|12017308|FG001|COMPLETED|Overall Study||8
10850512|NCT03282565|12017309|FG002|COMPLETED|Overall Study||8
10850513|NCT03282565|12017307|FG000|NOT COMPLETED|Overall Study||0
10850514|NCT03282565|12017308|FG001|NOT COMPLETED|Overall Study||2
10850515|NCT03282565|12017309|FG002|NOT COMPLETED|Overall Study||2
10850516|NCT03276936|12017319|FG000|STARTED|Overall Study||332
10850517|NCT03276936|12017320|FG001|STARTED|Overall Study||172
10850518|NCT03276936|12017319|FG000|COMPLETED|Overall Study||276
10850519|NCT03276936|12017320|FG001|COMPLETED|Overall Study||134
10850520|NCT03276936|12017319|FG000|NOT COMPLETED|Overall Study||56
10850521|NCT03276936|12017320|FG001|NOT COMPLETED|Overall Study||38
10850522|NCT03271021|12017328|FG000|STARTED|Overall Study||738
10850523|NCT03271021|12017329|FG001|STARTED|Overall Study||750
10850524|NCT03271021|12017328|FG000|COMPLETED|Overall Study||649
10850525|NCT03271021|12017329|FG001|COMPLETED|Overall Study||644
10850526|NCT03271021|12017328|FG000|NOT COMPLETED|Overall Study||89
10850527|NCT03271021|12017329|FG001|NOT COMPLETED|Overall Study||106
10850528|NCT03255083|12017339|FG000|STARTED|Overall Study||6
10850529|NCT03255083|12017340|FG001|STARTED|Overall Study||3
10850530|NCT03255083|12017341|FG002|STARTED|Overall Study||3
10850531|NCT03255083|12017342|FG003|STARTED|Overall Study||1
10850532|NCT03255083|12017339|FG000|COMPLETED|Overall Study||0
10850533|NCT03255083|12017340|FG001|COMPLETED|Overall Study||0
10850534|NCT03255083|12017341|FG002|COMPLETED|Overall Study||0
10850535|NCT03255083|12017342|FG003|COMPLETED|Overall Study||0
10850536|NCT03255083|12017339|FG000|NOT COMPLETED|Overall Study||6
10850537|NCT03255083|12017340|FG001|NOT COMPLETED|Overall Study||3
10850538|NCT03255083|12017341|FG002|NOT COMPLETED|Overall Study||3
10850539|NCT03255083|12017342|FG003|NOT COMPLETED|Overall Study||1
10850540|NCT03227471|12017367|FG000|STARTED|Overall Study||9
10850541|NCT03227471|12017368|FG001|STARTED|Overall Study||30
10850542|NCT03227471|12017369|FG002|STARTED|Overall Study||8
10850543|NCT03227471|12017370|FG003|STARTED|Overall Study||7
10850544|NCT03227471|12017371|FG004|STARTED|Overall Study||25
10850545|NCT03227471|12017372|FG005|STARTED|Overall Study||6
10850546|NCT03227471|12017373|FG006|STARTED|Overall Study||17
10850547|NCT03227471|12017374|FG007|STARTED|Overall Study||12
10850548|NCT03227471|12017375|FG008|STARTED|Overall Study||10
10850549|NCT03227471|12017376|FG009|STARTED|Overall Study||22
10850550|NCT03227471|12017377|FG010|STARTED|Overall Study||21
10850551|NCT03227471|12017378|FG011|STARTED|Overall Study||7
10850552|NCT03227471|12017379|FG012|STARTED|Overall Study||21
10850553|NCT03227471|12017380|FG013|STARTED|Overall Study||8
10850554|NCT03227471|12017381|FG014|STARTED|Overall Study||22
10850555|NCT03227471|12017367|FG000|Safety Set|Overall Study||9
10850556|NCT03227471|12017368|FG001|Safety Set|Overall Study||30
10850557|NCT03227471|12017369|FG002|Safety Set|Overall Study||8
10850558|NCT03227471|12017370|FG003|Safety Set|Overall Study||7
10850559|NCT03227471|12017371|FG004|Safety Set|Overall Study||25
10850560|NCT03227471|12017372|FG005|Safety Set|Overall Study||6
10850561|NCT03227471|12017373|FG006|Safety Set|Overall Study||17
10850562|NCT03227471|12017374|FG007|Safety Set|Overall Study||12
10850563|NCT03227471|12017375|FG008|Safety Set|Overall Study||10
10850564|NCT03227471|12017376|FG009|Safety Set|Overall Study||22
10850565|NCT03227471|12017377|FG010|Safety Set|Overall Study||21
10850566|NCT03227471|12017378|FG011|Safety Set|Overall Study||7
10850567|NCT03227471|12017379|FG012|Safety Set|Overall Study||21
10850568|NCT03227471|12017380|FG013|Safety Set|Overall Study||8
10850569|NCT03227471|12017381|FG014|Safety Set|Overall Study||21
10850570|NCT03227471|12017367|FG000|COMPLETED|Overall Study||9
10850571|NCT03227471|12017368|FG001|COMPLETED|Overall Study||30
10850572|NCT03227471|12017369|FG002|COMPLETED|Overall Study||8
10850573|NCT03227471|12017370|FG003|COMPLETED|Overall Study||7
10850574|NCT03227471|12017371|FG004|COMPLETED|Overall Study||24
10850575|NCT03227471|12017372|FG005|COMPLETED|Overall Study||6
10850576|NCT03227471|12017373|FG006|COMPLETED|Overall Study||17
10850577|NCT03227471|12017374|FG007|COMPLETED|Overall Study||12
10850578|NCT03227471|12017375|FG008|COMPLETED|Overall Study||10
10850579|NCT03227471|12017376|FG009|COMPLETED|Overall Study||22
10850580|NCT03227471|12017377|FG010|COMPLETED|Overall Study||21
10850581|NCT03227471|12017378|FG011|COMPLETED|Overall Study||7
10850582|NCT03227471|12017379|FG012|COMPLETED|Overall Study||20
10850583|NCT03227471|12017380|FG013|COMPLETED|Overall Study||8
10850584|NCT03227471|12017381|FG014|COMPLETED|Overall Study||21
10850585|NCT03227471|12017367|FG000|NOT COMPLETED|Overall Study||0
10850586|NCT03227471|12017368|FG001|NOT COMPLETED|Overall Study||0
10850587|NCT03227471|12017369|FG002|NOT COMPLETED|Overall Study||0
10850588|NCT03227471|12017370|FG003|NOT COMPLETED|Overall Study||0
10850589|NCT03227471|12017371|FG004|NOT COMPLETED|Overall Study||1
10850590|NCT03227471|12017372|FG005|NOT COMPLETED|Overall Study||0
10850591|NCT03227471|12017373|FG006|NOT COMPLETED|Overall Study||0
10850592|NCT03227471|12017374|FG007|NOT COMPLETED|Overall Study||0
10850593|NCT03227471|12017375|FG008|NOT COMPLETED|Overall Study||0
10850594|NCT03227471|12017376|FG009|NOT COMPLETED|Overall Study||0
10850595|NCT03227471|12017377|FG010|NOT COMPLETED|Overall Study||0
10850596|NCT03227471|12017378|FG011|NOT COMPLETED|Overall Study||0
10850597|NCT03227471|12017379|FG012|NOT COMPLETED|Overall Study||1
10850598|NCT03227471|12017380|FG013|NOT COMPLETED|Overall Study||0
10850599|NCT03227471|12017381|FG014|NOT COMPLETED|Overall Study||1
11106064|NCT01256944|12290470|FG001|NOT COMPLETED|Overall Study||0
11106065|NCT01256983|12290482|FG000|STARTED|Overall Study||15
11106066|NCT01256983|12290483|FG001|STARTED|Overall Study||15
11106067|NCT01256983|12290482|FG000|COMPLETED|Overall Study||14
11106068|NCT01256983|12290483|FG001|COMPLETED|Overall Study||12
11106069|NCT01256983|12290482|FG000|NOT COMPLETED|Overall Study||1
11106070|NCT01256983|12290483|FG001|NOT COMPLETED|Overall Study||3
11106071|NCT01257087|12290491|FG000|STARTED|Overall Study||18
11106072|NCT01257087|12290492|FG001|STARTED|Overall Study||17
11106073|NCT01257087|12290491|FG000|COMPLETED|Overall Study||18
11106074|NCT01257087|12290492|FG001|COMPLETED|Overall Study||17
11106075|NCT01257087|12290491|FG000|NOT COMPLETED|Overall Study||0
10850612|NCT03194321|12017453|FG000|STARTED|Overall Study||20
10850613|NCT03194321|12017453|FG000|COMPLETED|Overall Study||17
10850614|NCT03194321|12017453|FG000|NOT COMPLETED|Overall Study||3
10850615|NCT03085095|12017459|FG000|STARTED|Overall Study||624
10850616|NCT03085095|12017460|FG001|STARTED|Overall Study||310
10850617|NCT03085095|12017459|FG000|Received at Least 1 Dose of Study Drug|Overall Study||622
10850618|NCT03085095|12017460|FG001|Received at Least 1 Dose of Study Drug|Overall Study||308
10850619|NCT03085095|12017459|FG000|COMPLETED|Overall Study||563
10850620|NCT03085095|12017460|FG001|COMPLETED|Overall Study||276
10850621|NCT03085095|12017459|FG000|NOT COMPLETED|Overall Study||61
10850622|NCT03085095|12017460|FG001|NOT COMPLETED|Overall Study||34
10850623|NCT03048422|12017472|FG000|STARTED|Overall Study||217
10850624|NCT03048422|12017473|FG001|STARTED|Overall Study||215
10850625|NCT03048422|12017474|FG002|STARTED|Overall Study||211
10850626|NCT03048422|12017472|FG000|COMPLETED|Overall Study||200
10850627|NCT03048422|12017473|FG001|COMPLETED|Overall Study||205
10850628|NCT03048422|12017474|FG002|COMPLETED|Overall Study||202
10850629|NCT03048422|12017472|FG000|NOT COMPLETED|Overall Study||17
10850630|NCT03048422|12017473|FG001|NOT COMPLETED|Overall Study||10
10850631|NCT03048422|12017474|FG002|NOT COMPLETED|Overall Study||9
10850632|NCT03032068|12017492|FG000|STARTED|Overall Study||10
10850633|NCT03032068|12017492|FG000|Preoperative Visit|Overall Study||10
10850634|NCT03032068|12017492|FG000|Postoperative Home Care Visit 1|Overall Study||10
10850635|NCT03032068|12017492|FG000|Postoperative Home Care Visit 2|Overall Study||10
10850636|NCT03032068|12017492|FG000|Postoperative Home Care Visit 3|Overall Study||10
10850637|NCT03032068|12017492|FG000|4 Weeks Postoperative Visit|Overall Study||9
10850638|NCT03032068|12017492|FG000|8 Weeks Postoperative Visit|Overall Study||9
10850639|NCT03032068|12017492|FG000|12 Weeks Postoperative Visit|Overall Study||9
10850640|NCT03032068|12017492|FG000|COMPLETED|Overall Study||9
10850641|NCT03032068|12017492|FG000|NOT COMPLETED|Overall Study||1
11106076|NCT01257087|12290492|FG001|NOT COMPLETED|Overall Study||0
11106077|NCT01257204|12290501|FG000|STARTED|Treatment Period (up to Week 24)||50
11106078|NCT01257204|12290502|FG001|STARTED|Treatment Period (up to Week 24)||50
11106079|NCT01257204|12290503|FG002|STARTED|Treatment Period (up to Week 24)||51
11106080|NCT01257204|12290501|FG000|COMPLETED|Treatment Period (up to Week 24)||45
11106081|NCT01257204|12290502|FG001|COMPLETED|Treatment Period (up to Week 24)||44
11106082|NCT01257204|12290503|FG002|COMPLETED|Treatment Period (up to Week 24)||42
11106083|NCT01257204|12290501|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||5
11106084|NCT01257204|12290502|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6
10850651|NCT02835690|12017512|FG000|STARTED|Overall Study||14
10850652|NCT02835690|12017513|FG001|STARTED|Overall Study||15
10850653|NCT02835690|12017514|FG002|STARTED|Overall Study||15
10850654|NCT02835690|12017512|FG000|Treated|Overall Study||14
10850655|NCT02835690|12017513|FG001|Treated|Overall Study||13
10850656|NCT02835690|12017514|FG002|Treated|Overall Study||15
10850657|NCT02835690|12017512|FG000|COMPLETED|Overall Study||0
10850658|NCT02835690|12017513|FG001|COMPLETED|Overall Study||0
10850659|NCT02835690|12017514|FG002|COMPLETED|Overall Study||0
10850660|NCT02835690|12017512|FG000|NOT COMPLETED|Overall Study||14
10850661|NCT02835690|12017513|FG001|NOT COMPLETED|Overall Study||15
10850662|NCT02835690|12017514|FG002|NOT COMPLETED|Overall Study||15
10850663|NCT02828982|12017522|FG000|STARTED|First Intervention (3 Weeks)||5
10850664|NCT02828982|12017523|FG001|STARTED|First Intervention (3 Weeks)||7
10850665|NCT02828982|12017522|FG000|Received Intervention|First Intervention (3 Weeks)||5
10850666|NCT02828982|12017523|FG001|Received Intervention|First Intervention (3 Weeks)||7
10850667|NCT02828982|12017522|FG000|COMPLETED|First Intervention (3 Weeks)||4
10850668|NCT02828982|12017523|FG001|COMPLETED|First Intervention (3 Weeks)||6
10850669|NCT02828982|12017522|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
10850670|NCT02828982|12017523|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
10850671|NCT02828982|12017522|FG000|STARTED|Second Intervention (3 Weeks)||4
10850672|NCT02828982|12017523|FG001|STARTED|Second Intervention (3 Weeks)||6
10850673|NCT02828982|12017522|FG000|Received Intervention|Second Intervention (3 Weeks)||4
10850674|NCT02828982|12017523|FG001|Received Intervention|Second Intervention (3 Weeks)||6
10850675|NCT02828982|12017522|FG000|COMPLETED|Second Intervention (3 Weeks)||4
10850676|NCT02828982|12017523|FG001|COMPLETED|Second Intervention (3 Weeks)||6
10850677|NCT02828982|12017522|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10850678|NCT02828982|12017523|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10850679|NCT02823457|12017531|FG000|STARTED|Overall Study||20
10850680|NCT02823457|12017531|FG000|COMPLETED|Overall Study||15
10850681|NCT02823457|12017531|FG000|NOT COMPLETED|Overall Study||5
10850682|NCT02815280|12017537|FG000|STARTED|Double-Blind Phase||333
10850683|NCT02815280|12017538|FG001|STARTED|Double-Blind Phase||162
10850684|NCT02815280|12017537|FG000|COMPLETED|Double-Blind Phase||297
10850685|NCT02815280|12017538|FG001|COMPLETED|Double-Blind Phase||137
10850686|NCT02815280|12017537|FG000|NOT COMPLETED|Double-Blind Phase||36
10850687|NCT02815280|12017538|FG001|NOT COMPLETED|Double-Blind Phase||25
10850688|NCT02815280|12017537|FG000|STARTED|Open-Label Phase||256
10850689|NCT02815280|12017538|FG001|STARTED|Open-Label Phase||117
10850690|NCT02815280|12017537|FG000|COMPLETED|Open-Label Phase||169
10850691|NCT02815280|12017538|FG001|COMPLETED|Open-Label Phase||73
10850692|NCT02815280|12017537|FG000|NOT COMPLETED|Open-Label Phase||87
10850693|NCT02815280|12017538|FG001|NOT COMPLETED|Open-Label Phase||44
10850694|NCT02815267|12017550|FG000|STARTED|Double-Blind Phase||307
10850695|NCT02815267|12017551|FG001|STARTED|Double-Blind Phase||159
10850696|NCT02815267|12017550|FG000|COMPLETED|Double-Blind Phase||274
10850697|NCT02815267|12017551|FG001|COMPLETED|Double-Blind Phase||128
10850698|NCT02815267|12017550|FG000|NOT COMPLETED|Double-Blind Phase||33
10850699|NCT02815267|12017551|FG001|NOT COMPLETED|Double-Blind Phase||31
10850700|NCT02815267|12017550|FG000|STARTED|Open-Label Phase||193
10850701|NCT02815267|12017551|FG001|STARTED|Open-Label Phase||91
10850702|NCT02815267|12017550|FG000|COMPLETED|Open-Label Phase||122
10850703|NCT02815267|12017551|FG001|COMPLETED|Open-Label Phase||50
10850704|NCT02815267|12017550|FG000|NOT COMPLETED|Open-Label Phase||71
10850705|NCT02815267|12017551|FG001|NOT COMPLETED|Open-Label Phase||41
10850706|NCT02802228|12017563|FG000|STARTED|Overall Study||20
10850707|NCT02802228|12017564|FG001|STARTED|Overall Study||10
10850708|NCT02802228|12017563|FG000|COMPLETED|Overall Study||15
10850709|NCT02802228|12017564|FG001|COMPLETED|Overall Study||10
10850710|NCT02802228|12017563|FG000|NOT COMPLETED|Overall Study||5
10850711|NCT02802228|12017564|FG001|NOT COMPLETED|Overall Study||0
11106085|NCT01257204|12290503|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9
11106086|NCT01257204|12290501|FG000|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
11106087|NCT01257204|12290502|FG001|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
11106088|NCT01257204|12290503|FG002|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
11106089|NCT01257204|12290501|FG000|COMPLETED|Follow-up Period (up to Week 48)||48
11106090|NCT01257204|12290502|FG001|COMPLETED|Follow-up Period (up to Week 48)||41
11106091|NCT01257204|12290503|FG002|COMPLETED|Follow-up Period (up to Week 48)||39
11106092|NCT01257204|12290501|FG000|NOT COMPLETED|Follow-up Period (up to Week 48)||1
11106093|NCT01257204|12290502|FG001|NOT COMPLETED|Follow-up Period (up to Week 48)||6
10850727|NCT02674516|12017595|FG000|STARTED|Overall Study||17
10850728|NCT02674516|12017596|FG001|STARTED|Overall Study||15
10850729|NCT02674516|12017595|FG000|COMPLETED|Overall Study||13
10850730|NCT02674516|12017596|FG001|COMPLETED|Overall Study||11
10850731|NCT02674516|12017595|FG000|NOT COMPLETED|Overall Study||4
10850732|NCT02674516|12017596|FG001|NOT COMPLETED|Overall Study||4
10850733|NCT02607046|12017604|FG000|STARTED|Overall Study||22
10850734|NCT02607046|12017605|FG001|STARTED|Overall Study||13
10850735|NCT02607046|12017604|FG000|COMPLETED|Overall Study||14
10850736|NCT02607046|12017605|FG001|COMPLETED|Overall Study||10
10850737|NCT02607046|12017604|FG000|NOT COMPLETED|Overall Study||8
10850738|NCT02607046|12017605|FG001|NOT COMPLETED|Overall Study||3
10850739|NCT02505425|12017615|FG000|STARTED|Overall Study||208
10850740|NCT02505425|12017616|FG001|STARTED|Overall Study||207
10850741|NCT02505425|12017617|FG002|STARTED|Overall Study||82
10850742|NCT02505425|12017618|FG003|STARTED|Overall Study||76
10850743|NCT02505425|12017615|FG000|COMPLETED|Overall Study||120
10850744|NCT02505425|12017616|FG001|COMPLETED|Overall Study||125
10850745|NCT02505425|12017617|FG002|COMPLETED|Overall Study||32
10850746|NCT02505425|12017618|FG003|COMPLETED|Overall Study||50
10850747|NCT02505425|12017615|FG000|NOT COMPLETED|Overall Study||88
10850748|NCT02505425|12017616|FG001|NOT COMPLETED|Overall Study||82
10850749|NCT02505425|12017617|FG002|NOT COMPLETED|Overall Study||50
10850750|NCT02505425|12017618|FG003|NOT COMPLETED|Overall Study||26
10850751|NCT02487979|12017628|FG000|STARTED|Overall Study||22
10850752|NCT02487979|12017628|FG000|COMPLETED|Overall Study||1
10850753|NCT02487979|12017628|FG000|NOT COMPLETED|Overall Study||21
10850754|NCT02463448|12017632|FG000|STARTED|Enrollment Through 6 Months||23
10850755|NCT02463448|12017632|FG000|COMPLETED|Enrollment Through 6 Months||20
10850756|NCT02463448|12017632|FG000|NOT COMPLETED|Enrollment Through 6 Months||3
10850757|NCT02463448|12017632|FG000|STARTED|6 Months Through 12 Months||20
10850758|NCT02463448|12017632|FG000|COMPLETED|6 Months Through 12 Months||18
10850759|NCT02463448|12017632|FG000|NOT COMPLETED|6 Months Through 12 Months||2
10850760|NCT02463448|12017632|FG000|STARTED|12 Months Through End of Study||18
10850761|NCT02463448|12017632|FG000|COMPLETED|12 Months Through End of Study||17
10850762|NCT02463448|12017632|FG000|NOT COMPLETED|12 Months Through End of Study||1
10850763|NCT02288897|12017638|FG000|STARTED|Overall Study||12
10850764|NCT02288897|12017639|FG001|STARTED|Overall Study||8
10850765|NCT02288897|12017638|FG000|COMPLETED|Overall Study||12
10850766|NCT02288897|12017639|FG001|COMPLETED|Overall Study||8
10850767|NCT02288897|12017638|FG000|NOT COMPLETED|Overall Study||0
10850768|NCT02288897|12017639|FG001|NOT COMPLETED|Overall Study||0
10850769|NCT02276547|12017645|FG000|STARTED|Overall Study||27
10850770|NCT02276547|12017645|FG000|COMPLETED|Overall Study||23
10850771|NCT02276547|12017645|FG000|NOT COMPLETED|Overall Study||4
10850772|NCT02263885|12017649|FG000|STARTED|Overall Study||20
10850773|NCT02263885|12017649|FG000|COMPLETED|Overall Study||10
10850774|NCT02263885|12017649|FG000|NOT COMPLETED|Overall Study||10
11106094|NCT01257204|12290503|FG002|NOT COMPLETED|Follow-up Period (up to Week 48)||10
11106095|NCT01257217|12290525|FG000|STARTED|Overall Study||15
11106096|NCT01257217|12290526|FG001|STARTED|Overall Study||10
10850778|NCT01995175|12017658|FG000|STARTED|Overall Study||2401
10850779|NCT01995175|12017658|FG000|COMPLETED|Overall Study||2148
10850780|NCT01995175|12017658|FG000|NOT COMPLETED|Overall Study||253
10850781|NCT01883804|12017662|FG000|STARTED|Overall Study||25
10850782|NCT01883804|12017662|FG000|COMPLETED|Overall Study||20
10850783|NCT01883804|12017662|FG000|NOT COMPLETED|Overall Study||5
10850784|NCT01804296|12017666|FG000|STARTED|Overall Study||4
10850785|NCT01804296|12017666|FG000|COMPLETED|Overall Study||4
10850786|NCT01804296|12017666|FG000|NOT COMPLETED|Overall Study||0
10850787|NCT01804270|12017672|FG000|STARTED|Overall Study||2
10850788|NCT01804270|12017673|FG001|STARTED|Overall Study||4
10850789|NCT01804270|12017672|FG000|COMPLETED|Overall Study||1
10850790|NCT01804270|12017673|FG001|COMPLETED|Overall Study||3
10850791|NCT01804270|12017672|FG000|NOT COMPLETED|Overall Study||1
10850792|NCT01804270|12017673|FG001|NOT COMPLETED|Overall Study||1
10850793|NCT01338636|12017679|FG000|STARTED|Overall Study||30
10850794|NCT01338636|12017679|FG000|COMPLETED|Overall Study||22
10850795|NCT01338636|12017679|FG000|NOT COMPLETED|Overall Study||8
10850796|NCT01208974|12017683|FG000|STARTED|NAC-Sparing Mastectomy||21
10850797|NCT01208974|12017684|FG001|STARTED|NAC-Sparing Mastectomy||0
10850798|NCT01208974|12017685|FG002|STARTED|NAC-Sparing Mastectomy||0
10850799|NCT01208974|12017686|FG003|STARTED|NAC-Sparing Mastectomy||0
10850800|NCT01208974|12017683|FG000|COMPLETED|NAC-Sparing Mastectomy||21
10850801|NCT01208974|12017684|FG001|COMPLETED|NAC-Sparing Mastectomy||0
10850802|NCT01208974|12017685|FG002|COMPLETED|NAC-Sparing Mastectomy||0
10850803|NCT01208974|12017686|FG003|COMPLETED|NAC-Sparing Mastectomy||0
10850804|NCT01208974|12017683|FG000|NOT COMPLETED|NAC-Sparing Mastectomy||0
10850805|NCT01208974|12017684|FG001|NOT COMPLETED|NAC-Sparing Mastectomy||0
10850806|NCT01208974|12017685|FG002|NOT COMPLETED|NAC-Sparing Mastectomy||0
10850807|NCT01208974|12017686|FG003|NOT COMPLETED|NAC-Sparing Mastectomy||0
10850808|NCT01208974|12017683|FG000|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||21
10850809|NCT01208974|12017684|FG001|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850810|NCT01208974|12017685|FG002|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850811|NCT01208974|12017686|FG003|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850812|NCT01208974|12017683|FG000|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||18
10850813|NCT01208974|12017684|FG001|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850814|NCT01208974|12017685|FG002|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850815|NCT01208974|12017686|FG003|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850816|NCT01208974|12017683|FG000|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||3
10850817|NCT01208974|12017684|FG001|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850818|NCT01208974|12017685|FG002|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850819|NCT01208974|12017686|FG003|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
10850820|NCT01208974|12017683|FG000|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||0
10850821|NCT01208974|12017684|FG001|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
10850822|NCT01208974|12017685|FG002|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
10850823|NCT01208974|12017686|FG003|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
10850824|NCT01208974|12017683|FG000|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
10850825|NCT01208974|12017684|FG001|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||6
10850826|NCT01208974|12017685|FG002|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
10850827|NCT01208974|12017686|FG003|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
10850828|NCT01208974|12017683|FG000|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
10850829|NCT01208974|12017684|FG001|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
10850830|NCT01208974|12017685|FG002|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6
10850831|NCT01208974|12017686|FG003|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
10850832|NCT01208974|12017683|FG000|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
10850833|NCT01208974|12017684|FG001|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
10850834|NCT01208974|12017685|FG002|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
10850835|NCT01208974|12017686|FG003|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6
10850836|NCT01208974|12017683|FG000|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
10850837|NCT01208974|12017684|FG001|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
10850838|NCT01208974|12017685|FG002|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
10850839|NCT01208974|12017686|FG003|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
10850840|NCT01208974|12017683|FG000|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
10850841|NCT01208974|12017684|FG001|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
10850842|NCT01208974|12017685|FG002|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
10850843|NCT01208974|12017686|FG003|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
10850844|NCT00938912|12017693|FG000|STARTED|Overall Study||365
11224951|NCT01988857|12417101|FG000|NOT COMPLETED|Overall Study||0
11224952|NCT01988922|12417108|FG000|STARTED|Overall Study||10
11224953|NCT01988922|12417109|FG001|STARTED|Overall Study||10
11224954|NCT01988922|12417110|FG002|STARTED|Overall Study||10
11224955|NCT01988922|12417108|FG000|COMPLETED|Overall Study||10
11224956|NCT01988922|12417109|FG001|COMPLETED|Overall Study||10
11224957|NCT01988922|12417110|FG002|COMPLETED|Overall Study||10
11224958|NCT01988922|12417108|FG000|NOT COMPLETED|Overall Study||0
11224959|NCT01988922|12417109|FG001|NOT COMPLETED|Overall Study||0
11224960|NCT01988922|12417110|FG002|NOT COMPLETED|Overall Study||0
11224961|NCT01989130|12417123|FG000|STARTED|Overall Study||43
11224962|NCT01989130|12417124|FG001|STARTED|Overall Study||27
11224963|NCT01989130|12417123|FG000|COMPLETED|Overall Study||43
11224964|NCT01989130|12417124|FG001|COMPLETED|Overall Study||27
11224965|NCT01989130|12417123|FG000|NOT COMPLETED|Overall Study||0
11224966|NCT01989130|12417124|FG001|NOT COMPLETED|Overall Study||0
11224967|NCT01989156|12417133|FG000|STARTED|Confinement Period (Population at Day 5)||80
11224968|NCT01989156|12417134|FG001|STARTED|Confinement Period (Population at Day 5)||41
11224969|NCT01989156|12417135|FG002|STARTED|Confinement Period (Population at Day 5)||39
11224970|NCT01989156|12417133|FG000|COMPLETED|Confinement Period (Population at Day 5)||80
11224971|NCT01989156|12417134|FG001|COMPLETED|Confinement Period (Population at Day 5)||40
11224972|NCT01989156|12417135|FG002|COMPLETED|Confinement Period (Population at Day 5)||34
11224973|NCT01989156|12417133|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||0
11224974|NCT01989156|12417134|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1
11224975|NCT01989156|12417135|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||5
11224976|NCT01989156|12417133|FG000|STARTED|End of Study (Population at Day 90)||80
10850845|NCT00938912|12017693|FG000|COMPLETED|Overall Study||254
10850846|NCT00938912|12017693|FG000|NOT COMPLETED|Overall Study||111
10850847|NCT00925652|12017704|FG000|STARTED|Overall Study||13
10850848|NCT00925652|12017705|FG001|STARTED|Overall Study||13
10850849|NCT00925652|12017706|FG002|STARTED|Overall Study||11
10850850|NCT00925652|12017707|FG003|STARTED|Overall Study||13
10850851|NCT00925652|12017704|FG000|Withdraw|Overall Study||6
10850852|NCT00925652|12017705|FG001|Withdraw|Overall Study||5
10850853|NCT00925652|12017706|FG002|Withdraw|Overall Study||3
10850854|NCT00925652|12017707|FG003|Withdraw|Overall Study||1
10850855|NCT00925652|12017704|FG000|Off Treatment Because of Other Complicating Disease|Overall Study||0
10850856|NCT00925652|12017705|FG001|Off Treatment Because of Other Complicating Disease|Overall Study||0
10850857|NCT00925652|12017706|FG002|Off Treatment Because of Other Complicating Disease|Overall Study||2
10850858|NCT00925652|12017707|FG003|Off Treatment Because of Other Complicating Disease|Overall Study||3
10850859|NCT00925652|12017704|FG000|Off Treatment Because of Disease Recurrence|Overall Study||1
10850860|NCT00925652|12017705|FG001|Off Treatment Because of Disease Recurrence|Overall Study||3
10850861|NCT00925652|12017706|FG002|Off Treatment Because of Disease Recurrence|Overall Study||0
10850862|NCT00925652|12017707|FG003|Off Treatment Because of Disease Recurrence|Overall Study||0
10850863|NCT00925652|12017704|FG000|Lost of Follow-up|Overall Study||0
10850864|NCT00925652|12017705|FG001|Lost of Follow-up|Overall Study||1
10850865|NCT00925652|12017706|FG002|Lost of Follow-up|Overall Study||0
10850866|NCT00925652|12017707|FG003|Lost of Follow-up|Overall Study||0
10850867|NCT00925652|12017704|FG000|Death|Overall Study||0
10850868|NCT00925652|12017705|FG001|Death|Overall Study||0
10850869|NCT00925652|12017706|FG002|Death|Overall Study||0
10850870|NCT00925652|12017707|FG003|Death|Overall Study||3
10850871|NCT00925652|12017704|FG000|COMPLETED|Overall Study||6
10850872|NCT00925652|12017705|FG001|COMPLETED|Overall Study||4
10850873|NCT00925652|12017706|FG002|COMPLETED|Overall Study||6
10850874|NCT00925652|12017707|FG003|COMPLETED|Overall Study||6
10850875|NCT00925652|12017704|FG000|NOT COMPLETED|Overall Study||7
10850876|NCT00925652|12017705|FG001|NOT COMPLETED|Overall Study||9
10850877|NCT00925652|12017706|FG002|NOT COMPLETED|Overall Study||5
10850878|NCT00925652|12017707|FG003|NOT COMPLETED|Overall Study||7
11106097|NCT01257217|12290525|FG000|COMPLETED|Overall Study||13
11106098|NCT01257217|12290526|FG001|COMPLETED|Overall Study||10
11106099|NCT01257217|12290525|FG000|NOT COMPLETED|Overall Study||2
11106100|NCT01257217|12290526|FG001|NOT COMPLETED|Overall Study||0
11106101|NCT01257230|12290539|FG000|STARTED|Overall Study||138
11106102|NCT01257230|12290540|FG001|STARTED|Overall Study||125
11106103|NCT01257230|12290541|FG002|STARTED|Overall Study||135
11106104|NCT01257230|12290539|FG000|COMPLETED|Overall Study||132
11106105|NCT01257230|12290540|FG001|COMPLETED|Overall Study||115
11106106|NCT01257230|12290541|FG002|COMPLETED|Overall Study||129
11106107|NCT01257230|12290539|FG000|NOT COMPLETED|Overall Study||6
11106108|NCT01257230|12290540|FG001|NOT COMPLETED|Overall Study||10
10850891|NCT00579826|12017744|FG000|STARTED|Overall Study||29
10850892|NCT00579826|12017745|FG001|STARTED|Overall Study||26
10850893|NCT00579826|12017744|FG000|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
10850894|NCT00579826|12017745|FG001|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
10850895|NCT00579826|12017744|FG000|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
11106109|NCT01257230|12290541|FG002|NOT COMPLETED|Overall Study||6
10850896|NCT00579826|12017745|FG001|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
10850897|NCT00579826|12017744|FG000|NOT COMPLETED|Overall Study||5
10850898|NCT00579826|12017745|FG001|NOT COMPLETED|Overall Study||3
10850899|NCT00322218|12017753|FG000|STARTED|Overall Study||34
10850900|NCT00322218|12017754|FG001|STARTED|Overall Study||34
10850901|NCT00322218|12017753|FG000|Per-Protocol Set|Overall Study||33
10850902|NCT00322218|12017754|FG001|Per-Protocol Set|Overall Study||32
10850903|NCT00322218|12017753|FG000|COMPLETED|Overall Study||31
10850904|NCT00322218|12017754|FG001|COMPLETED|Overall Study||28
10850905|NCT00322218|12017753|FG000|NOT COMPLETED|Overall Study||3
10850906|NCT00322218|12017754|FG001|NOT COMPLETED|Overall Study||6
10850907|NCT00186888|12017763|FG000|STARTED|Overall Study||23
10850908|NCT00186888|12017764|FG001|STARTED|Overall Study||27
10850909|NCT00186888|12017765|FG002|STARTED|Overall Study||55
10850910|NCT00186888|12017763|FG000|Window Therapy|Overall Study||0
10850911|NCT00186888|12017764|FG001|Window Therapy|Overall Study||27
10850912|NCT00186888|12017765|FG002|Window Therapy|Overall Study||0
10850913|NCT00186888|12017763|FG000|COMPLETED|Overall Study||19
10850914|NCT00186888|12017764|FG001|COMPLETED|Overall Study||24
10850915|NCT00186888|12017765|FG002|COMPLETED|Overall Study||55
10850916|NCT00186888|12017763|FG000|NOT COMPLETED|Overall Study||4
10850917|NCT00186888|12017764|FG001|NOT COMPLETED|Overall Study||3
10850918|NCT00186888|12017765|FG002|NOT COMPLETED|Overall Study||0
10850919|NCT04579549|12017800|FG000|STARTED|Overall Study||464
10850920|NCT04579549|12017800|FG000|Number of Individuals Trained In COVID-19 Assay|Overall Study||11
10850921|NCT04579549|12017800|FG000|COMPLETED|Overall Study||464
10850922|NCT04579549|12017800|FG000|NOT COMPLETED|Overall Study||0
10850923|NCT04622709|12017804|FG000|STARTED|Period 1 (First 6 Weeks)||39
10850924|NCT04622709|12017804|FG000|COMPLETED|Period 1 (First 6 Weeks)||36
10850925|NCT04622709|12017804|FG000|NOT COMPLETED|Period 1 (First 6 Weeks)||3
10850926|NCT04622709|12017804|FG000|STARTED|Period 2 (Subsequent 12 Weeks)||36
10850927|NCT04622709|12017804|FG000|COMPLETED|Period 2 (Subsequent 12 Weeks)||32
10850928|NCT04622709|12017804|FG000|NOT COMPLETED|Period 2 (Subsequent 12 Weeks)||4
10850929|NCT04066491|12017811|FG000|STARTED|Overall Study||12
10850930|NCT04066491|12017812|FG001|STARTED|Overall Study||149
10850931|NCT04066491|12017813|FG002|STARTED|Overall Study||148
10850932|NCT04066491|12017811|FG000|Treated|Overall Study||12
10850933|NCT04066491|12017812|FG001|Treated|Overall Study||149
10850934|NCT04066491|12017813|FG002|Treated|Overall Study||146
10850935|NCT04066491|12017811|FG000|COMPLETED|Overall Study||8
10850936|NCT04066491|12017812|FG001|COMPLETED|Overall Study||38
10850937|NCT04066491|12017813|FG002|COMPLETED|Overall Study||39
10850938|NCT04066491|12017811|FG000|NOT COMPLETED|Overall Study||4
10850939|NCT04066491|12017812|FG001|NOT COMPLETED|Overall Study||111
10850940|NCT04066491|12017813|FG002|NOT COMPLETED|Overall Study||109
10850941|NCT03259425|12017822|FG000|STARTED|Overall Study||7
10850942|NCT03259425|12017822|FG000|Surgery|Overall Study||6
10850943|NCT03259425|12017822|FG000|COMPLETED|Overall Study||6
10850944|NCT03259425|12017822|FG000|NOT COMPLETED|Overall Study||1
10850945|NCT03129100|12017831|FG000|STARTED|Lead-In Period (Period 1)||350
10850946|NCT03129100|12017832|FG001|STARTED|Lead-In Period (Period 1)||423
10850947|NCT03129100|12017833|FG002|STARTED|Lead-In Period (Period 1)||0
10850948|NCT03129100|12017834|FG003|STARTED|Lead-In Period (Period 1)||0
10850949|NCT03129100|12017835|FG004|STARTED|Lead-In Period (Period 1)||0
10850950|NCT03129100|12017836|FG005|STARTED|Lead-In Period (Period 1)||0
10850951|NCT03129100|12017837|FG006|STARTED|Lead-In Period (Period 1)||0
10850952|NCT03129100|12017838|FG007|STARTED|Lead-In Period (Period 1)||0
10850953|NCT03129100|12017839|FG008|STARTED|Lead-In Period (Period 1)||0
10850954|NCT03129100|12017840|FG009|STARTED|Lead-In Period (Period 1)||0
10850955|NCT03129100|12017841|FG010|STARTED|Lead-In Period (Period 1)||0
11224977|NCT01989156|12417134|FG001|STARTED|End of Study (Population at Day 90)||40
11224978|NCT01989156|12417135|FG002|STARTED|End of Study (Population at Day 90)||34
11224979|NCT01989156|12417133|FG000|COMPLETED|End of Study (Population at Day 90)||73
11224980|NCT01989156|12417134|FG001|COMPLETED|End of Study (Population at Day 90)||35
10850956|NCT03129100|12017842|FG011|STARTED|Lead-In Period (Period 1)||0
10850957|NCT03129100|12017843|FG012|STARTED|Lead-In Period (Period 1)||0
10850958|NCT03129100|12017844|FG013|STARTED|Lead-In Period (Period 1)||0
10850959|NCT03129100|12017845|FG014|STARTED|Lead-In Period (Period 1)||0
10850960|NCT03129100|12017846|FG015|STARTED|Lead-In Period (Period 1)||0
10850961|NCT03129100|12017847|FG016|STARTED|Lead-In Period (Period 1)||0
10850962|NCT03129100|12017848|FG017|STARTED|Lead-In Period (Period 1)||0
10850963|NCT03129100|12017849|FG018|STARTED|Lead-In Period (Period 1)||0
10850964|NCT03129100|12017850|FG019|STARTED|Lead-In Period (Period 1)||0
10850965|NCT03129100|12017851|FG020|STARTED|Lead-In Period (Period 1)||0
10850966|NCT03129100|12017852|FG021|STARTED|Lead-In Period (Period 1)||0
10850967|NCT03129100|12017853|FG022|STARTED|Lead-In Period (Period 1)||0
10850968|NCT03129100|12017854|FG023|STARTED|Lead-In Period (Period 1)||0
10850969|NCT03129100|12017855|FG024|STARTED|Lead-In Period (Period 1)||0
10850970|NCT03129100|12017856|FG025|STARTED|Lead-In Period (Period 1)||0
10850971|NCT03129100|12017831|FG000|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||348
10850972|NCT03129100|12017832|FG001|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||423
11106110|NCT01257347|12290554|FG000|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
11106111|NCT01257347|12290555|FG001|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
11106112|NCT01257347|12290556|FG002|STARTED|Overall Study||35
11106113|NCT01257347|12290557|FG003|STARTED|Overall Study||65
11106114|NCT01257347|12290554|FG000|COMPLETED|Overall Study||12
11106115|NCT01257347|12290555|FG001|COMPLETED|Overall Study||12
11106116|NCT01257347|12290556|FG002|COMPLETED|Overall Study||35
11106117|NCT01257347|12290557|FG003|COMPLETED|Overall Study||65
11106118|NCT01257347|12290554|FG000|NOT COMPLETED|Overall Study||0
11106119|NCT01257347|12290555|FG001|NOT COMPLETED|Overall Study||0
11106120|NCT01257347|12290556|FG002|NOT COMPLETED|Overall Study||0
11106121|NCT01257347|12290557|FG003|NOT COMPLETED|Overall Study||0
11106122|NCT01257425|12290572|FG000|STARTED|Overall Study||52
11106123|NCT01257425|12290573|FG001|STARTED|Overall Study||51
11106124|NCT01257425|12290572|FG000|COMPLETED|Overall Study||46
11106125|NCT01257425|12290573|FG001|COMPLETED|Overall Study||45
11106126|NCT01257425|12290572|FG000|NOT COMPLETED|Overall Study||6
11106127|NCT01257425|12290573|FG001|NOT COMPLETED|Overall Study||6
11106128|NCT01257438|12290581|FG000|STARTED|Overall Study||132
11106129|NCT01257438|12290582|FG001|STARTED|Overall Study||143
11106130|NCT01257438|12290581|FG000|COMPLETED|Overall Study||102
11106131|NCT01257438|12290582|FG001|COMPLETED|Overall Study||97
10850973|NCT03129100|12017833|FG002|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850974|NCT03129100|12017834|FG003|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850975|NCT03129100|12017835|FG004|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850976|NCT03129100|12017836|FG005|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850977|NCT03129100|12017837|FG006|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850978|NCT03129100|12017838|FG007|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850979|NCT03129100|12017839|FG008|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850980|NCT03129100|12017840|FG009|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850981|NCT03129100|12017841|FG010|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850982|NCT03129100|12017842|FG011|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850983|NCT03129100|12017843|FG012|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850984|NCT03129100|12017844|FG013|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850985|NCT03129100|12017845|FG014|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850986|NCT03129100|12017846|FG015|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850987|NCT03129100|12017847|FG016|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850988|NCT03129100|12017848|FG017|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850989|NCT03129100|12017849|FG018|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850990|NCT03129100|12017850|FG019|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850991|NCT03129100|12017851|FG020|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850992|NCT03129100|12017852|FG021|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850993|NCT03129100|12017853|FG022|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850994|NCT03129100|12017854|FG023|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850995|NCT03129100|12017855|FG024|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850996|NCT03129100|12017856|FG025|Received at Least One Dose of Study Drug|Lead-In Period (Period 1)||0
10850997|NCT03129100|12017831|FG000|COMPLETED|Lead-In Period (Period 1)||335
10850998|NCT03129100|12017832|FG001|COMPLETED|Lead-In Period (Period 1)||406
10850999|NCT03129100|12017833|FG002|COMPLETED|Lead-In Period (Period 1)||0
10851000|NCT03129100|12017834|FG003|COMPLETED|Lead-In Period (Period 1)||0
10851001|NCT03129100|12017835|FG004|COMPLETED|Lead-In Period (Period 1)||0
10851002|NCT03129100|12017836|FG005|COMPLETED|Lead-In Period (Period 1)||0
10851003|NCT03129100|12017837|FG006|COMPLETED|Lead-In Period (Period 1)||0
10851004|NCT03129100|12017838|FG007|COMPLETED|Lead-In Period (Period 1)||0
10851005|NCT03129100|12017839|FG008|COMPLETED|Lead-In Period (Period 1)||0
10851006|NCT03129100|12017840|FG009|COMPLETED|Lead-In Period (Period 1)||0
10851007|NCT03129100|12017841|FG010|COMPLETED|Lead-In Period (Period 1)||0
10851008|NCT03129100|12017842|FG011|COMPLETED|Lead-In Period (Period 1)||0
10851009|NCT03129100|12017843|FG012|COMPLETED|Lead-In Period (Period 1)||0
10851010|NCT03129100|12017844|FG013|COMPLETED|Lead-In Period (Period 1)||0
10851011|NCT03129100|12017845|FG014|COMPLETED|Lead-In Period (Period 1)||0
10851012|NCT03129100|12017846|FG015|COMPLETED|Lead-In Period (Period 1)||0
10851013|NCT03129100|12017847|FG016|COMPLETED|Lead-In Period (Period 1)||0
10851014|NCT03129100|12017848|FG017|COMPLETED|Lead-In Period (Period 1)||0
10851015|NCT03129100|12017849|FG018|COMPLETED|Lead-In Period (Period 1)||0
10851016|NCT03129100|12017850|FG019|COMPLETED|Lead-In Period (Period 1)||0
10851017|NCT03129100|12017851|FG020|COMPLETED|Lead-In Period (Period 1)||0
10851018|NCT03129100|12017852|FG021|COMPLETED|Lead-In Period (Period 1)||0
10851019|NCT03129100|12017853|FG022|COMPLETED|Lead-In Period (Period 1)||0
10851020|NCT03129100|12017854|FG023|COMPLETED|Lead-In Period (Period 1)||0
10851021|NCT03129100|12017855|FG024|COMPLETED|Lead-In Period (Period 1)||0
10851022|NCT03129100|12017856|FG025|COMPLETED|Lead-In Period (Period 1)||0
10851023|NCT03129100|12017831|FG000|NOT COMPLETED|Lead-In Period (Period 1)||15
10851024|NCT03129100|12017832|FG001|NOT COMPLETED|Lead-In Period (Period 1)||17
10851025|NCT03129100|12017833|FG002|NOT COMPLETED|Lead-In Period (Period 1)||0
10851026|NCT03129100|12017834|FG003|NOT COMPLETED|Lead-In Period (Period 1)||0
10851027|NCT03129100|12017835|FG004|NOT COMPLETED|Lead-In Period (Period 1)||0
10851028|NCT03129100|12017836|FG005|NOT COMPLETED|Lead-In Period (Period 1)||0
10851029|NCT03129100|12017837|FG006|NOT COMPLETED|Lead-In Period (Period 1)||0
11106132|NCT01257438|12290581|FG000|NOT COMPLETED|Overall Study||30
11106133|NCT01257438|12290582|FG001|NOT COMPLETED|Overall Study||46
10851030|NCT03129100|12017838|FG007|NOT COMPLETED|Lead-In Period (Period 1)||0
10851031|NCT03129100|12017839|FG008|NOT COMPLETED|Lead-In Period (Period 1)||0
11224981|NCT01989156|12417135|FG002|COMPLETED|End of Study (Population at Day 90)||31
11224982|NCT01989156|12417133|FG000|NOT COMPLETED|End of Study (Population at Day 90)||7
11224983|NCT01989156|12417134|FG001|NOT COMPLETED|End of Study (Population at Day 90)||5
11224984|NCT01989156|12417135|FG002|NOT COMPLETED|End of Study (Population at Day 90)||3
11224985|NCT01989169|12417145|FG000|STARTED|Period 1||15
11224986|NCT01989169|12417146|FG001|STARTED|Period 1||15
11224987|NCT01989169|12417145|FG000|COMPLETED|Period 1||15
11224988|NCT01989169|12417146|FG001|COMPLETED|Period 1||15
11224989|NCT01989169|12417145|FG000|NOT COMPLETED|Period 1||0
11224990|NCT01989169|12417146|FG001|NOT COMPLETED|Period 1||0
11224991|NCT01989169|12417145|FG000|STARTED|Period 2||15
11224992|NCT01989169|12417146|FG001|STARTED|Period 2||15
11224993|NCT01989169|12417145|FG000|COMPLETED|Period 2||15
11224994|NCT01989169|12417146|FG001|COMPLETED|Period 2||14
11224995|NCT01989169|12417145|FG000|NOT COMPLETED|Period 2||0
11224996|NCT01989169|12417146|FG001|NOT COMPLETED|Period 2||1
10851032|NCT03129100|12017840|FG009|NOT COMPLETED|Lead-In Period (Period 1)||0
10851033|NCT03129100|12017841|FG010|NOT COMPLETED|Lead-In Period (Period 1)||0
10851034|NCT03129100|12017842|FG011|NOT COMPLETED|Lead-In Period (Period 1)||0
10851035|NCT03129100|12017843|FG012|NOT COMPLETED|Lead-In Period (Period 1)||0
10851036|NCT03129100|12017844|FG013|NOT COMPLETED|Lead-In Period (Period 1)||0
10851037|NCT03129100|12017845|FG014|NOT COMPLETED|Lead-In Period (Period 1)||0
10851038|NCT03129100|12017846|FG015|NOT COMPLETED|Lead-In Period (Period 1)||0
10851039|NCT03129100|12017847|FG016|NOT COMPLETED|Lead-In Period (Period 1)||0
10851040|NCT03129100|12017848|FG017|NOT COMPLETED|Lead-In Period (Period 1)||0
10851041|NCT03129100|12017849|FG018|NOT COMPLETED|Lead-In Period (Period 1)||0
10851042|NCT03129100|12017850|FG019|NOT COMPLETED|Lead-In Period (Period 1)||0
10851043|NCT03129100|12017851|FG020|NOT COMPLETED|Lead-In Period (Period 1)||0
10851044|NCT03129100|12017852|FG021|NOT COMPLETED|Lead-In Period (Period 1)||0
10851045|NCT03129100|12017853|FG022|NOT COMPLETED|Lead-In Period (Period 1)||0
10851046|NCT03129100|12017854|FG023|NOT COMPLETED|Lead-In Period (Period 1)||0
10851047|NCT03129100|12017855|FG024|NOT COMPLETED|Lead-In Period (Period 1)||0
10851048|NCT03129100|12017856|FG025|NOT COMPLETED|Lead-In Period (Period 1)||0
10851049|NCT03129100|12017831|FG000|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
10851050|NCT03129100|12017832|FG001|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
10851051|NCT03129100|12017833|FG002|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|255
10851052|NCT03129100|12017834|FG003|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|318
10851053|NCT03129100|12017835|FG004|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|48
10851054|NCT03129100|12017836|FG005|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|54
10851055|NCT03129100|12017837|FG006|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|53
10851056|NCT03129100|12017838|FG007|STARTED|Period2 Extension Period (Group A and B)||0
10851057|NCT03129100|12017839|FG008|STARTED|Period2 Extension Period (Group A and B)||0
10851058|NCT03129100|12017840|FG009|STARTED|Period2 Extension Period (Group A and B)||0
10851059|NCT03129100|12017841|FG010|STARTED|Period2 Extension Period (Group A and B)||0
10851060|NCT03129100|12017842|FG011|STARTED|Period2 Extension Period (Group A and B)||0
10851061|NCT03129100|12017843|FG012|STARTED|Period2 Extension Period (Group A and B)||0
10851062|NCT03129100|12017844|FG013|STARTED|Period2 Extension Period (Group A and B)||0
10851063|NCT03129100|12017845|FG014|STARTED|Period2 Extension Period (Group A and B)||0
10851064|NCT03129100|12017846|FG015|STARTED|Period2 Extension Period (Group A and B)||0
10851065|NCT03129100|12017847|FG016|STARTED|Period2 Extension Period (Group A and B)||0
10851066|NCT03129100|12017848|FG017|STARTED|Period2 Extension Period (Group A and B)||0
10851067|NCT03129100|12017849|FG018|STARTED|Period2 Extension Period (Group A and B)||0
10851068|NCT03129100|12017850|FG019|STARTED|Period2 Extension Period (Group A and B)||0
10851069|NCT03129100|12017851|FG020|STARTED|Period2 Extension Period (Group A and B)||0
10851070|NCT03129100|12017852|FG021|STARTED|Period2 Extension Period (Group A and B)||0
10851071|NCT03129100|12017853|FG022|STARTED|Period2 Extension Period (Group A and B)||0
10851072|NCT03129100|12017854|FG023|STARTED|Period2 Extension Period (Group A and B)||0
10851073|NCT03129100|12017855|FG024|STARTED|Period2 Extension Period (Group A and B)||0
10851074|NCT03129100|12017856|FG025|STARTED|Period2 Extension Period (Group A and B)||0
10851075|NCT03129100|12017831|FG000|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851076|NCT03129100|12017832|FG001|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851077|NCT03129100|12017833|FG002|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||255
10851078|NCT03129100|12017834|FG003|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||318
10851079|NCT03129100|12017835|FG004|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||47
10851080|NCT03129100|12017836|FG005|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||54
10851081|NCT03129100|12017837|FG006|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||53
10851082|NCT03129100|12017838|FG007|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851083|NCT03129100|12017839|FG008|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851084|NCT03129100|12017840|FG009|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851372|NCT03129100|12017842|FG011|NOT COMPLETED|Period 3 (Flare)||0
11224997|NCT01989195|12417152|FG000|STARTED|Overall Study||6
11224998|NCT01989195|12417152|FG000|COMPLETED|Overall Study||6
10851085|NCT03129100|12017841|FG010|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851086|NCT03129100|12017842|FG011|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851087|NCT03129100|12017843|FG012|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851088|NCT03129100|12017844|FG013|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851089|NCT03129100|12017845|FG014|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851090|NCT03129100|12017846|FG015|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851091|NCT03129100|12017847|FG016|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851092|NCT03129100|12017848|FG017|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851093|NCT03129100|12017849|FG018|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851094|NCT03129100|12017850|FG019|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851095|NCT03129100|12017851|FG020|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851096|NCT03129100|12017852|FG021|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851097|NCT03129100|12017853|FG022|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851098|NCT03129100|12017854|FG023|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851099|NCT03129100|12017855|FG024|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851100|NCT03129100|12017856|FG025|Received at Least One Dose of Study Drug|Period2 Extension Period (Group A and B)||0
10851101|NCT03129100|12017831|FG000|COMPLETED|Period2 Extension Period (Group A and B)||0
10851102|NCT03129100|12017832|FG001|COMPLETED|Period2 Extension Period (Group A and B)||0
10851103|NCT03129100|12017833|FG002|COMPLETED|Period2 Extension Period (Group A and B)||234
10851104|NCT03129100|12017834|FG003|COMPLETED|Period2 Extension Period (Group A and B)||312
10851105|NCT03129100|12017835|FG004|COMPLETED|Period2 Extension Period (Group A and B)||42
10851106|NCT03129100|12017836|FG005|COMPLETED|Period2 Extension Period (Group A and B)||45
10851107|NCT03129100|12017837|FG006|COMPLETED|Period2 Extension Period (Group A and B)||32
10851108|NCT03129100|12017838|FG007|COMPLETED|Period2 Extension Period (Group A and B)||0
10851109|NCT03129100|12017839|FG008|COMPLETED|Period2 Extension Period (Group A and B)||0
10851110|NCT03129100|12017840|FG009|COMPLETED|Period2 Extension Period (Group A and B)||0
10851111|NCT03129100|12017841|FG010|COMPLETED|Period2 Extension Period (Group A and B)||0
10851112|NCT03129100|12017842|FG011|COMPLETED|Period2 Extension Period (Group A and B)||0
10851113|NCT03129100|12017843|FG012|COMPLETED|Period2 Extension Period (Group A and B)||0
10851114|NCT03129100|12017844|FG013|COMPLETED|Period2 Extension Period (Group A and B)||0
11224999|NCT01989195|12417152|FG000|NOT COMPLETED|Overall Study||0
11225000|NCT01989208|12417161|FG000|STARTED|200 mg (7 Days)||4
11225001|NCT01989208|12417162|FG001|STARTED|200 mg (7 Days)||12
11225002|NCT01989208|12417161|FG000|COMPLETED|200 mg (7 Days)||4
11225003|NCT01989208|12417162|FG001|COMPLETED|200 mg (7 Days)||11
11225004|NCT01989208|12417161|FG000|NOT COMPLETED|200 mg (7 Days)||0
11225005|NCT01989208|12417162|FG001|NOT COMPLETED|200 mg (7 Days)||1
11225006|NCT01989208|12417161|FG000|STARTED|400 mg (7 Days)||4
11225007|NCT01989208|12417162|FG001|STARTED|400 mg (7 Days)||11
10851115|NCT03129100|12017845|FG014|COMPLETED|Period2 Extension Period (Group A and B)||0
10851116|NCT03129100|12017846|FG015|COMPLETED|Period2 Extension Period (Group A and B)||0
10851117|NCT03129100|12017847|FG016|COMPLETED|Period2 Extension Period (Group A and B)||0
10851118|NCT03129100|12017848|FG017|COMPLETED|Period2 Extension Period (Group A and B)||0
10851119|NCT03129100|12017849|FG018|COMPLETED|Period2 Extension Period (Group A and B)||0
10851120|NCT03129100|12017850|FG019|COMPLETED|Period2 Extension Period (Group A and B)||0
10851121|NCT03129100|12017851|FG020|COMPLETED|Period2 Extension Period (Group A and B)||0
10851122|NCT03129100|12017852|FG021|COMPLETED|Period2 Extension Period (Group A and B)||0
10851123|NCT03129100|12017853|FG022|COMPLETED|Period2 Extension Period (Group A and B)||0
10851124|NCT03129100|12017854|FG023|COMPLETED|Period2 Extension Period (Group A and B)||0
10851125|NCT03129100|12017855|FG024|COMPLETED|Period2 Extension Period (Group A and B)||0
10851126|NCT03129100|12017856|FG025|COMPLETED|Period2 Extension Period (Group A and B)||0
10851127|NCT03129100|12017831|FG000|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851128|NCT03129100|12017832|FG001|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851129|NCT03129100|12017833|FG002|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
10851130|NCT03129100|12017834|FG003|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
10851131|NCT03129100|12017835|FG004|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
10851132|NCT03129100|12017836|FG005|NOT COMPLETED|Period2 Extension Period (Group A and B)||9
10851133|NCT03129100|12017837|FG006|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
10851134|NCT03129100|12017838|FG007|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851135|NCT03129100|12017839|FG008|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851136|NCT03129100|12017840|FG009|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851137|NCT03129100|12017841|FG010|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851138|NCT03129100|12017842|FG011|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851139|NCT03129100|12017843|FG012|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851140|NCT03129100|12017844|FG013|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851141|NCT03129100|12017845|FG014|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851142|NCT03129100|12017846|FG015|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
11225008|NCT01989208|12417161|FG000|COMPLETED|400 mg (7 Days)||4
11225009|NCT01989208|12417162|FG001|COMPLETED|400 mg (7 Days)||11
11225010|NCT01989208|12417161|FG000|NOT COMPLETED|400 mg (7 Days)||0
10851143|NCT03129100|12017847|FG016|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851144|NCT03129100|12017848|FG017|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851145|NCT03129100|12017849|FG018|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851146|NCT03129100|12017850|FG019|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851147|NCT03129100|12017851|FG020|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851148|NCT03129100|12017852|FG021|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851149|NCT03129100|12017853|FG022|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851150|NCT03129100|12017854|FG023|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851151|NCT03129100|12017855|FG024|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851152|NCT03129100|12017856|FG025|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
10851153|NCT03129100|12017831|FG000|STARTED|Period 2 (Retreatment Extension Period)||0
10851154|NCT03129100|12017832|FG001|STARTED|Period 2 (Retreatment Extension Period)||0
11225011|NCT01989208|12417162|FG001|NOT COMPLETED|400 mg (7 Days)||0
10851155|NCT03129100|12017833|FG002|STARTED|Period 2 (Retreatment Extension Period)||0
10851156|NCT03129100|12017834|FG003|STARTED|Period 2 (Retreatment Extension Period)||0
10851157|NCT03129100|12017835|FG004|STARTED|Period 2 (Retreatment Extension Period)||0
10851158|NCT03129100|12017836|FG005|STARTED|Period 2 (Retreatment Extension Period)||0
10851159|NCT03129100|12017837|FG006|STARTED|Period 2 (Retreatment Extension Period)||0
10851160|NCT03129100|12017838|FG007|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|6
10851161|NCT03129100|12017839|FG008|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|5
10851162|NCT03129100|12017840|FG009|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|9
10851163|NCT03129100|12017841|FG010|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|10
10851164|NCT03129100|12017842|FG011|STARTED|Period 2 (Retreatment Extension Period)||0
10851165|NCT03129100|12017843|FG012|STARTED|Period 2 (Retreatment Extension Period)||0
10851166|NCT03129100|12017844|FG013|STARTED|Period 2 (Retreatment Extension Period)||0
10851167|NCT03129100|12017845|FG014|STARTED|Period 2 (Retreatment Extension Period)||0
10851168|NCT03129100|12017846|FG015|STARTED|Period 2 (Retreatment Extension Period)||0
10851169|NCT03129100|12017847|FG016|STARTED|Period 2 (Retreatment Extension Period)||0
10851170|NCT03129100|12017848|FG017|STARTED|Period 2 (Retreatment Extension Period)||0
10851171|NCT03129100|12017849|FG018|STARTED|Period 2 (Retreatment Extension Period)||0
10851172|NCT03129100|12017850|FG019|STARTED|Period 2 (Retreatment Extension Period)||0
10851173|NCT03129100|12017851|FG020|STARTED|Period 2 (Retreatment Extension Period)||0
10851174|NCT03129100|12017852|FG021|STARTED|Period 2 (Retreatment Extension Period)||0
10851175|NCT03129100|12017853|FG022|STARTED|Period 2 (Retreatment Extension Period)||0
10851176|NCT03129100|12017854|FG023|STARTED|Period 2 (Retreatment Extension Period)||0
10851177|NCT03129100|12017855|FG024|STARTED|Period 2 (Retreatment Extension Period)||0
10851178|NCT03129100|12017856|FG025|STARTED|Period 2 (Retreatment Extension Period)||0
10851179|NCT03129100|12017831|FG000|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851180|NCT03129100|12017832|FG001|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851181|NCT03129100|12017833|FG002|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851182|NCT03129100|12017834|FG003|COMPLETED|Period 2 (Retreatment Extension Period)||0
11225012|NCT01989208|12417161|FG000|STARTED|800 mg (7 Days)||4
11225013|NCT01989208|12417162|FG001|STARTED|800 mg (7 Days)||11
11225014|NCT01989208|12417161|FG000|COMPLETED|800 mg (7 Days)||4
11225015|NCT01989208|12417162|FG001|COMPLETED|800 mg (7 Days)||11
11225016|NCT01989208|12417161|FG000|NOT COMPLETED|800 mg (7 Days)||0
11225017|NCT01989208|12417162|FG001|NOT COMPLETED|800 mg (7 Days)||0
11225018|NCT01989221|12417180|FG000|STARTED|Overall Study||14
11225019|NCT01989221|12417180|FG000|COMPLETED|Overall Study||14
11225020|NCT01989221|12417180|FG000|NOT COMPLETED|Overall Study||0
11225021|NCT01989455|12417189|FG000|STARTED|Overall Study||14
11225022|NCT01989455|12417190|FG001|STARTED|Overall Study||14
11225023|NCT01989455|12417191|FG002|STARTED|Overall Study||14
11225024|NCT01989455|12417192|FG003|STARTED|Overall Study||14
11225025|NCT01989455|12417193|FG004|STARTED|Overall Study||8
11225026|NCT01989455|12417189|FG000|COMPLETED|Overall Study||14
11225027|NCT01989455|12417190|FG001|COMPLETED|Overall Study||12
11225028|NCT01989455|12417191|FG002|COMPLETED|Overall Study||13
11225029|NCT01989455|12417192|FG003|COMPLETED|Overall Study||14
11225030|NCT01989455|12417193|FG004|COMPLETED|Overall Study||7
11225031|NCT01989455|12417189|FG000|NOT COMPLETED|Overall Study||0
11225032|NCT01989455|12417190|FG001|NOT COMPLETED|Overall Study||2
11225033|NCT01989455|12417191|FG002|NOT COMPLETED|Overall Study||1
11225034|NCT01989455|12417192|FG003|NOT COMPLETED|Overall Study||0
11225035|NCT01989455|12417193|FG004|NOT COMPLETED|Overall Study||1
11225036|NCT01989468|12417212|FG000|STARTED|Overall Study||138
10851183|NCT03129100|12017835|FG004|COMPLETED|Period 2 (Retreatment Extension Period)||0
11106134|NCT01257503|12290590|FG000|STARTED|Overall Study||133
11106135|NCT01257503|12290591|FG001|STARTED|Overall Study||130
11106136|NCT01257503|12290590|FG000|Returned Symptom Diaries|Overall Study||80
10851184|NCT03129100|12017836|FG005|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851185|NCT03129100|12017837|FG006|COMPLETED|Period 2 (Retreatment Extension Period)||0
11106137|NCT01257503|12290591|FG001|Returned Symptom Diaries|Overall Study||83
11225037|NCT01989468|12417213|FG001|STARTED|Overall Study||139
11225038|NCT01989468|12417214|FG002|STARTED|Overall Study||64
11225039|NCT01989468|12417215|FG003|STARTED|Overall Study||65
11225040|NCT01989468|12417216|FG004|STARTED|Overall Study||8
11225041|NCT01989468|12417212|FG000|COMPLETED|Overall Study||91
11225042|NCT01989468|12417213|FG001|COMPLETED|Overall Study||102
10851186|NCT03129100|12017838|FG007|COMPLETED|Period 2 (Retreatment Extension Period)||6
10851187|NCT03129100|12017839|FG008|COMPLETED|Period 2 (Retreatment Extension Period)||5
10851188|NCT03129100|12017840|FG009|COMPLETED|Period 2 (Retreatment Extension Period)||8
10851189|NCT03129100|12017841|FG010|COMPLETED|Period 2 (Retreatment Extension Period)||10
10851190|NCT03129100|12017842|FG011|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851191|NCT03129100|12017843|FG012|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851192|NCT03129100|12017844|FG013|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851193|NCT03129100|12017845|FG014|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851194|NCT03129100|12017846|FG015|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851195|NCT03129100|12017847|FG016|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851196|NCT03129100|12017848|FG017|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851197|NCT03129100|12017849|FG018|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851198|NCT03129100|12017850|FG019|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851199|NCT03129100|12017851|FG020|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851200|NCT03129100|12017852|FG021|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851201|NCT03129100|12017853|FG022|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851202|NCT03129100|12017854|FG023|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851203|NCT03129100|12017855|FG024|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851204|NCT03129100|12017856|FG025|COMPLETED|Period 2 (Retreatment Extension Period)||0
10851205|NCT03129100|12017831|FG000|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851206|NCT03129100|12017832|FG001|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851207|NCT03129100|12017833|FG002|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851208|NCT03129100|12017834|FG003|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851209|NCT03129100|12017835|FG004|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
11225043|NCT01989468|12417214|FG002|COMPLETED|Overall Study||45
11225044|NCT01989468|12417215|FG003|COMPLETED|Overall Study||49
11225045|NCT01989468|12417216|FG004|COMPLETED|Overall Study||0
11225046|NCT01989468|12417212|FG000|NOT COMPLETED|Overall Study||47
11225047|NCT01989468|12417213|FG001|NOT COMPLETED|Overall Study||37
11225048|NCT01989468|12417214|FG002|NOT COMPLETED|Overall Study||19
11225049|NCT01989468|12417215|FG003|NOT COMPLETED|Overall Study||16
11225050|NCT01989468|12417216|FG004|NOT COMPLETED|Overall Study||8
11225051|NCT01989546|12417229|FG000|STARTED|Overall Study||9
11225052|NCT01989546|12417229|FG000|COMPLETED|Overall Study||0
11225053|NCT01989546|12417229|FG000|NOT COMPLETED|Overall Study||9
11225054|NCT01989572|12417239|FG000|STARTED|Overall Study||109
11225055|NCT01989572|12417240|FG001|STARTED|Overall Study||111
10851210|NCT03129100|12017836|FG005|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851211|NCT03129100|12017837|FG006|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851212|NCT03129100|12017838|FG007|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851213|NCT03129100|12017839|FG008|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851214|NCT03129100|12017840|FG009|NOT COMPLETED|Period 2 (Retreatment Extension Period)||1
10851215|NCT03129100|12017841|FG010|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
11106138|NCT01257503|12290590|FG000|Returned Dosage Logbooks|Overall Study||75
11106139|NCT01257503|12290591|FG001|Returned Dosage Logbooks|Overall Study||80
11106140|NCT01257503|12290590|FG000|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
11106141|NCT01257503|12290591|FG001|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
11106142|NCT01257503|12290590|FG000|NOT COMPLETED|Overall Study||8
11106143|NCT01257503|12290591|FG001|NOT COMPLETED|Overall Study||11
11106144|NCT01257542|12290599|FG000|STARTED|Overall Study||55
11106145|NCT01257542|12290600|FG001|STARTED|Overall Study||52
11106146|NCT01257542|12290599|FG000|COMPLETED|Overall Study||52
11106147|NCT01257542|12290600|FG001|COMPLETED|Overall Study||45
11106148|NCT01257542|12290599|FG000|NOT COMPLETED|Overall Study||3
11106149|NCT01257542|12290600|FG001|NOT COMPLETED|Overall Study||7
11106150|NCT01257581|12290609|FG000|STARTED|Overall Study||22
11106151|NCT01257581|12290610|FG001|STARTED|Overall Study||21
11106152|NCT01257581|12290611|FG002|STARTED|Overall Study||17
11106153|NCT01257581|12290609|FG000|COMPLETED|Overall Study||17
11106154|NCT01257581|12290610|FG001|COMPLETED|Overall Study||18
11106155|NCT01257581|12290611|FG002|COMPLETED|Overall Study||11
11106156|NCT01257581|12290609|FG000|NOT COMPLETED|Overall Study||5
11106157|NCT01257581|12290610|FG001|NOT COMPLETED|Overall Study||3
11225056|NCT01989572|12417241|FG002|STARTED|Overall Study||109
10851216|NCT03129100|12017842|FG011|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851217|NCT03129100|12017843|FG012|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851218|NCT03129100|12017844|FG013|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851219|NCT03129100|12017845|FG014|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851220|NCT03129100|12017846|FG015|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851221|NCT03129100|12017847|FG016|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851222|NCT03129100|12017848|FG017|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851223|NCT03129100|12017849|FG018|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851224|NCT03129100|12017850|FG019|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851225|NCT03129100|12017851|FG020|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851373|NCT03129100|12017843|FG012|NOT COMPLETED|Period 3 (Flare)||0
11106158|NCT01257581|12290611|FG002|NOT COMPLETED|Overall Study||6
11106159|NCT01257698|12290621|FG000|STARTED|Overall Study||12
11106160|NCT01257698|12290622|FG001|STARTED|Overall Study||9
11106161|NCT01257698|12290621|FG000|COMPLETED|Overall Study||8
10851226|NCT03129100|12017852|FG021|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851227|NCT03129100|12017853|FG022|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851228|NCT03129100|12017854|FG023|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851229|NCT03129100|12017855|FG024|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851230|NCT03129100|12017856|FG025|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
10851231|NCT03129100|12017831|FG000|STARTED|Period3-Long-Term Extension Period A & B||0
10851232|NCT03129100|12017832|FG001|STARTED|Period3-Long-Term Extension Period A & B||0
10851233|NCT03129100|12017833|FG002|STARTED|Period3-Long-Term Extension Period A & B||0
10851234|NCT03129100|12017834|FG003|STARTED|Period3-Long-Term Extension Period A & B||0
10851235|NCT03129100|12017835|FG004|STARTED|Period3-Long-Term Extension Period A & B||0
10851236|NCT03129100|12017836|FG005|STARTED|Period3-Long-Term Extension Period A & B||0
10851237|NCT03129100|12017837|FG006|STARTED|Period3-Long-Term Extension Period A & B||0
10851238|NCT03129100|12017838|FG007|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0
10851239|NCT03129100|12017839|FG008|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0
10851240|NCT03129100|12017840|FG009|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0
10851241|NCT03129100|12017841|FG010|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|0
10851242|NCT03129100|12017842|FG011|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|306
10851243|NCT03129100|12017843|FG012|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|177
10851244|NCT03129100|12017844|FG013|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|45
10851245|NCT03129100|12017845|FG014|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|42
10851246|NCT03129100|12017846|FG015|STARTED|Period3-Long-Term Extension Period A & B|This period is to report Long-Term Extension Period participants|30
10851247|NCT03129100|12017847|FG016|STARTED|Period3-Long-Term Extension Period A & B||0
10851248|NCT03129100|12017848|FG017|STARTED|Period3-Long-Term Extension Period A & B||0
10851249|NCT03129100|12017849|FG018|STARTED|Period3-Long-Term Extension Period A & B||0
10851250|NCT03129100|12017850|FG019|STARTED|Period3-Long-Term Extension Period A & B||0
10851251|NCT03129100|12017851|FG020|STARTED|Period3-Long-Term Extension Period A & B||0
10851252|NCT03129100|12017852|FG021|STARTED|Period3-Long-Term Extension Period A & B||0
10851253|NCT03129100|12017853|FG022|STARTED|Period3-Long-Term Extension Period A & B||0
10851254|NCT03129100|12017854|FG023|STARTED|Period3-Long-Term Extension Period A & B||0
10851255|NCT03129100|12017855|FG024|STARTED|Period3-Long-Term Extension Period A & B||0
10851256|NCT03129100|12017856|FG025|STARTED|Period3-Long-Term Extension Period A & B||0
10851257|NCT03129100|12017831|FG000|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851258|NCT03129100|12017832|FG001|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851259|NCT03129100|12017833|FG002|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851260|NCT03129100|12017834|FG003|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851261|NCT03129100|12017835|FG004|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851262|NCT03129100|12017836|FG005|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851263|NCT03129100|12017837|FG006|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851264|NCT03129100|12017838|FG007|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851265|NCT03129100|12017839|FG008|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851266|NCT03129100|12017840|FG009|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851267|NCT03129100|12017841|FG010|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851268|NCT03129100|12017842|FG011|COMPLETED|Period3-Long-Term Extension Period A & B||287
10851269|NCT03129100|12017843|FG012|COMPLETED|Period3-Long-Term Extension Period A & B||146
10851270|NCT03129100|12017844|FG013|COMPLETED|Period3-Long-Term Extension Period A & B||40
10851271|NCT03129100|12017845|FG014|COMPLETED|Period3-Long-Term Extension Period A & B||37
10851272|NCT03129100|12017846|FG015|COMPLETED|Period3-Long-Term Extension Period A & B||21
10851273|NCT03129100|12017847|FG016|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851274|NCT03129100|12017848|FG017|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851275|NCT03129100|12017849|FG018|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851276|NCT03129100|12017850|FG019|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851277|NCT03129100|12017851|FG020|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851278|NCT03129100|12017852|FG021|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851279|NCT03129100|12017853|FG022|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851280|NCT03129100|12017854|FG023|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851281|NCT03129100|12017855|FG024|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851282|NCT03129100|12017856|FG025|COMPLETED|Period3-Long-Term Extension Period A & B||0
10851283|NCT03129100|12017831|FG000|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851284|NCT03129100|12017832|FG001|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851285|NCT03129100|12017833|FG002|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851286|NCT03129100|12017834|FG003|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851287|NCT03129100|12017835|FG004|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851288|NCT03129100|12017836|FG005|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851289|NCT03129100|12017837|FG006|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851290|NCT03129100|12017838|FG007|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851291|NCT03129100|12017839|FG008|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851292|NCT03129100|12017840|FG009|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851293|NCT03129100|12017841|FG010|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851294|NCT03129100|12017842|FG011|NOT COMPLETED|Period3-Long-Term Extension Period A & B||19
10851295|NCT03129100|12017843|FG012|NOT COMPLETED|Period3-Long-Term Extension Period A & B||31
10851296|NCT03129100|12017844|FG013|NOT COMPLETED|Period3-Long-Term Extension Period A & B||5
10851297|NCT03129100|12017845|FG014|NOT COMPLETED|Period3-Long-Term Extension Period A & B||5
10851298|NCT03129100|12017846|FG015|NOT COMPLETED|Period3-Long-Term Extension Period A & B||9
10851299|NCT03129100|12017847|FG016|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851300|NCT03129100|12017848|FG017|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851301|NCT03129100|12017849|FG018|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851302|NCT03129100|12017850|FG019|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851303|NCT03129100|12017851|FG020|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851304|NCT03129100|12017852|FG021|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851305|NCT03129100|12017853|FG022|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851306|NCT03129100|12017854|FG023|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851307|NCT03129100|12017855|FG024|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851308|NCT03129100|12017856|FG025|NOT COMPLETED|Period3-Long-Term Extension Period A & B||0
10851309|NCT03129100|12017831|FG000|STARTED|Period 3 (Flare)||0
10851310|NCT03129100|12017832|FG001|STARTED|Period 3 (Flare)||0
10851311|NCT03129100|12017833|FG002|STARTED|Period 3 (Flare)||0
10851312|NCT03129100|12017834|FG003|STARTED|Period 3 (Flare)||0
10851313|NCT03129100|12017835|FG004|STARTED|Period 3 (Flare)||0
10851314|NCT03129100|12017836|FG005|STARTED|Period 3 (Flare)||0
10851315|NCT03129100|12017837|FG006|STARTED|Period 3 (Flare)||0
10851316|NCT03129100|12017838|FG007|STARTED|Period 3 (Flare)||0
10851317|NCT03129100|12017839|FG008|STARTED|Period 3 (Flare)||0
10851318|NCT03129100|12017840|FG009|STARTED|Period 3 (Flare)||0
10851319|NCT03129100|12017841|FG010|STARTED|Period 3 (Flare)||0
10851320|NCT03129100|12017842|FG011|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
10851321|NCT03129100|12017843|FG012|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
10851322|NCT03129100|12017844|FG013|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
10851323|NCT03129100|12017845|FG014|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
10851324|NCT03129100|12017846|FG015|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|0
10851325|NCT03129100|12017847|FG016|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|6
10851326|NCT03129100|12017848|FG017|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|4
10851327|NCT03129100|12017849|FG018|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|11
10851328|NCT03129100|12017850|FG019|STARTED|Period 3 (Flare)|This period is to report participants who experienced a flare in Period 3.|15
10851329|NCT03129100|12017851|FG020|STARTED|Period 3 (Flare)||0
10851330|NCT03129100|12017852|FG021|STARTED|Period 3 (Flare)||0
10851331|NCT03129100|12017853|FG022|STARTED|Period 3 (Flare)||0
10851332|NCT03129100|12017854|FG023|STARTED|Period 3 (Flare)||0
10851333|NCT03129100|12017855|FG024|STARTED|Period 3 (Flare)||0
10851334|NCT03129100|12017856|FG025|STARTED|Period 3 (Flare)||0
10851335|NCT03129100|12017831|FG000|COMPLETED|Period 3 (Flare)||0
10851336|NCT03129100|12017832|FG001|COMPLETED|Period 3 (Flare)||0
10851337|NCT03129100|12017833|FG002|COMPLETED|Period 3 (Flare)||0
10851338|NCT03129100|12017834|FG003|COMPLETED|Period 3 (Flare)||0
10851339|NCT03129100|12017835|FG004|COMPLETED|Period 3 (Flare)||0
10851340|NCT03129100|12017836|FG005|COMPLETED|Period 3 (Flare)||0
10851341|NCT03129100|12017837|FG006|COMPLETED|Period 3 (Flare)||0
10851342|NCT03129100|12017838|FG007|COMPLETED|Period 3 (Flare)||0
10851343|NCT03129100|12017839|FG008|COMPLETED|Period 3 (Flare)||0
10851344|NCT03129100|12017840|FG009|COMPLETED|Period 3 (Flare)||0
10851345|NCT03129100|12017841|FG010|COMPLETED|Period 3 (Flare)||0
10851346|NCT03129100|12017842|FG011|COMPLETED|Period 3 (Flare)||0
10851347|NCT03129100|12017843|FG012|COMPLETED|Period 3 (Flare)||0
10851348|NCT03129100|12017844|FG013|COMPLETED|Period 3 (Flare)||0
10851349|NCT03129100|12017845|FG014|COMPLETED|Period 3 (Flare)||0
10851350|NCT03129100|12017846|FG015|COMPLETED|Period 3 (Flare)||0
10851351|NCT03129100|12017847|FG016|COMPLETED|Period 3 (Flare)||6
10851352|NCT03129100|12017848|FG017|COMPLETED|Period 3 (Flare)||2
10851353|NCT03129100|12017849|FG018|COMPLETED|Period 3 (Flare)||11
10851354|NCT03129100|12017850|FG019|COMPLETED|Period 3 (Flare)||12
10851355|NCT03129100|12017851|FG020|COMPLETED|Period 3 (Flare)||0
10851356|NCT03129100|12017852|FG021|COMPLETED|Period 3 (Flare)||0
10851357|NCT03129100|12017853|FG022|COMPLETED|Period 3 (Flare)||0
10851358|NCT03129100|12017854|FG023|COMPLETED|Period 3 (Flare)||0
10851359|NCT03129100|12017855|FG024|COMPLETED|Period 3 (Flare)||0
10851360|NCT03129100|12017856|FG025|COMPLETED|Period 3 (Flare)||0
10851361|NCT03129100|12017831|FG000|NOT COMPLETED|Period 3 (Flare)||0
10851362|NCT03129100|12017832|FG001|NOT COMPLETED|Period 3 (Flare)||0
10851363|NCT03129100|12017833|FG002|NOT COMPLETED|Period 3 (Flare)||0
10851364|NCT03129100|12017834|FG003|NOT COMPLETED|Period 3 (Flare)||0
10851365|NCT03129100|12017835|FG004|NOT COMPLETED|Period 3 (Flare)||0
10851366|NCT03129100|12017836|FG005|NOT COMPLETED|Period 3 (Flare)||0
10851367|NCT03129100|12017837|FG006|NOT COMPLETED|Period 3 (Flare)||0
10851368|NCT03129100|12017838|FG007|NOT COMPLETED|Period 3 (Flare)||0
10851369|NCT03129100|12017839|FG008|NOT COMPLETED|Period 3 (Flare)||0
10851370|NCT03129100|12017840|FG009|NOT COMPLETED|Period 3 (Flare)||0
10851371|NCT03129100|12017841|FG010|NOT COMPLETED|Period 3 (Flare)||0
10851374|NCT03129100|12017844|FG013|NOT COMPLETED|Period 3 (Flare)||0
11225057|NCT01989572|12417242|FG003|STARTED|Overall Study||107
11225058|NCT01989572|12417243|FG004|STARTED|Overall Study||190
11225059|NCT01989572|12417244|FG005|STARTED|Overall Study||189
11225060|NCT01989572|12417239|FG000|Treated|Overall Study||104
11225061|NCT01989572|12417240|FG001|Treated|Overall Study||110
11225062|NCT01989572|12417241|FG002|Treated|Overall Study||107
11225063|NCT01989572|12417242|FG003|Treated|Overall Study||104
11225064|NCT01989572|12417243|FG004|Treated|Overall Study||186
11225065|NCT01989572|12417244|FG005|Treated|Overall Study||171
11225066|NCT01989572|12417239|FG000|COMPLETED|Overall Study||54
11225067|NCT01989572|12417240|FG001|COMPLETED|Overall Study||53
11225068|NCT01989572|12417241|FG002|COMPLETED|Overall Study||47
11225069|NCT01989572|12417242|FG003|COMPLETED|Overall Study||56
11225070|NCT01989572|12417243|FG004|COMPLETED|Overall Study||92
11225071|NCT01989572|12417244|FG005|COMPLETED|Overall Study||79
11225072|NCT01989572|12417239|FG000|NOT COMPLETED|Overall Study||55
11225073|NCT01989572|12417240|FG001|NOT COMPLETED|Overall Study||58
11225074|NCT01989572|12417241|FG002|NOT COMPLETED|Overall Study||62
11225075|NCT01989572|12417242|FG003|NOT COMPLETED|Overall Study||51
11225076|NCT01989572|12417243|FG004|NOT COMPLETED|Overall Study||98
11225077|NCT01989572|12417244|FG005|NOT COMPLETED|Overall Study||110
11225078|NCT01989689|12417264|FG000|STARTED|Baseline||11
11225079|NCT01989689|12417265|FG001|STARTED|Baseline||13
11225080|NCT01989689|12417264|FG000|COMPLETED|Baseline||11
11225081|NCT01989689|12417265|FG001|COMPLETED|Baseline||13
11225082|NCT01989689|12417264|FG000|NOT COMPLETED|Baseline||0
11225083|NCT01989689|12417265|FG001|NOT COMPLETED|Baseline||0
11225084|NCT01989689|12417264|FG000|STARTED|Treatment Period 1 ( 3 Months)||11
11225085|NCT01989689|12417265|FG001|STARTED|Treatment Period 1 ( 3 Months)||13
11225086|NCT01989689|12417264|FG000|COMPLETED|Treatment Period 1 ( 3 Months)||11
11225087|NCT01989689|12417265|FG001|COMPLETED|Treatment Period 1 ( 3 Months)||10
11225088|NCT01989689|12417264|FG000|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
11225089|NCT01989689|12417265|FG001|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
11225090|NCT01989689|12417264|FG000|STARTED|Treatment Period ( 3 Months)||11
11225091|NCT01989689|12417265|FG001|STARTED|Treatment Period ( 3 Months)||10
11225092|NCT01989689|12417264|FG000|COMPLETED|Treatment Period ( 3 Months)||11
11225093|NCT01989689|12417265|FG001|COMPLETED|Treatment Period ( 3 Months)||10
11225094|NCT01989689|12417264|FG000|NOT COMPLETED|Treatment Period ( 3 Months)||0
11225095|NCT01989689|12417265|FG001|NOT COMPLETED|Treatment Period ( 3 Months)||0
11225096|NCT01989754|12417275|FG000|STARTED|Overall Study||2905
11225097|NCT01989754|12417276|FG001|STARTED|Overall Study||2907
11225098|NCT01989754|12417275|FG000|Treated|Overall Study||2903
11225099|NCT01989754|12417276|FG001|Treated|Overall Study||2904
11225100|NCT01989754|12417275|FG000|COMPLETED|Overall Study|Participants who died are included in this category.|2866
11225101|NCT01989754|12417276|FG001|COMPLETED|Overall Study|Participants who died are included in this category.|2872
11225102|NCT01989754|12417275|FG000|NOT COMPLETED|Overall Study||39
11225103|NCT01989754|12417276|FG001|NOT COMPLETED|Overall Study||35
11225104|NCT01989793|12417284|FG000|STARTED|Overall Study||18
11225105|NCT01989793|12417285|FG001|STARTED|Overall Study||19
11225106|NCT01989793|12417284|FG000|COMPLETED|Overall Study||10
11225107|NCT01989793|12417285|FG001|COMPLETED|Overall Study||15
11225108|NCT01989793|12417284|FG000|NOT COMPLETED|Overall Study||8
11225109|NCT01989793|12417285|FG001|NOT COMPLETED|Overall Study||4
11225110|NCT01989910|12417293|FG000|STARTED|Overall Study||53
11225111|NCT01989910|12417294|FG001|STARTED|Overall Study||54
11225112|NCT01989910|12417293|FG000|COMPLETED|Overall Study||51
10851375|NCT03129100|12017845|FG014|NOT COMPLETED|Period 3 (Flare)||0
11225113|NCT01989910|12417294|FG001|COMPLETED|Overall Study||54
11225114|NCT01989910|12417293|FG000|NOT COMPLETED|Overall Study||2
11225115|NCT01989910|12417294|FG001|NOT COMPLETED|Overall Study||0
11225116|NCT01989975|12417300|FG000|STARTED|Overall Study||40
11225117|NCT01989975|12417300|FG000|COMPLETED|Overall Study||40
11225118|NCT01989975|12417300|FG000|NOT COMPLETED|Overall Study||0
11225119|NCT01990261|12417304|FG000|STARTED|Overall Study||33
11225120|NCT01990261|12417304|FG000|Treated|Overall Study||29
11225121|NCT01990261|12417304|FG000|COMPLETED|Overall Study||8
11225122|NCT01990261|12417304|FG000|NOT COMPLETED|Overall Study||25
11225123|NCT01990300|12417308|FG000|STARTED|Overall Study||3281
10851376|NCT03129100|12017846|FG015|NOT COMPLETED|Period 3 (Flare)||0
10851377|NCT03129100|12017847|FG016|NOT COMPLETED|Period 3 (Flare)||0
10851378|NCT03129100|12017848|FG017|NOT COMPLETED|Period 3 (Flare)||2
10851379|NCT03129100|12017849|FG018|NOT COMPLETED|Period 3 (Flare)||0
10851380|NCT03129100|12017850|FG019|NOT COMPLETED|Period 3 (Flare)||3
10851381|NCT03129100|12017851|FG020|NOT COMPLETED|Period 3 (Flare)||0
10851382|NCT03129100|12017852|FG021|NOT COMPLETED|Period 3 (Flare)||0
10851383|NCT03129100|12017853|FG022|NOT COMPLETED|Period 3 (Flare)||0
10851384|NCT03129100|12017854|FG023|NOT COMPLETED|Period 3 (Flare)||0
10851385|NCT03129100|12017855|FG024|NOT COMPLETED|Period 3 (Flare)||0
10851386|NCT03129100|12017856|FG025|NOT COMPLETED|Period 3 (Flare)||0
10851387|NCT03129100|12017831|FG000|STARTED|Period 3 (Dose Escalation)||0
10851388|NCT03129100|12017832|FG001|STARTED|Period 3 (Dose Escalation)||0
10851389|NCT03129100|12017833|FG002|STARTED|Period 3 (Dose Escalation)||0
10851390|NCT03129100|12017834|FG003|STARTED|Period 3 (Dose Escalation)||0
10851391|NCT03129100|12017835|FG004|STARTED|Period 3 (Dose Escalation)||0
10851392|NCT03129100|12017836|FG005|STARTED|Period 3 (Dose Escalation)||0
11225124|NCT01990300|12417308|FG000|COMPLETED|Overall Study||3139
11225125|NCT01990300|12417308|FG000|NOT COMPLETED|Overall Study||142
11225126|NCT01990313|12417312|FG000|STARTED|Overall Study||15
10851393|NCT03129100|12017837|FG006|STARTED|Period 3 (Dose Escalation)||0
10851394|NCT03129100|12017838|FG007|STARTED|Period 3 (Dose Escalation)||0
10851395|NCT03129100|12017839|FG008|STARTED|Period 3 (Dose Escalation)||0
10851396|NCT03129100|12017840|FG009|STARTED|Period 3 (Dose Escalation)||0
10851397|NCT03129100|12017841|FG010|STARTED|Period 3 (Dose Escalation)||0
10851398|NCT03129100|12017842|FG011|STARTED|Period 3 (Dose Escalation)||0
10851399|NCT03129100|12017843|FG012|STARTED|Period 3 (Dose Escalation)||0
10851400|NCT03129100|12017844|FG013|STARTED|Period 3 (Dose Escalation)||0
10851401|NCT03129100|12017845|FG014|STARTED|Period 3 (Dose Escalation)||0
10851402|NCT03129100|12017846|FG015|STARTED|Period 3 (Dose Escalation)||0
10851403|NCT03129100|12017847|FG016|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0
10851404|NCT03129100|12017848|FG017|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0
10851405|NCT03129100|12017849|FG018|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0
10851406|NCT03129100|12017850|FG019|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|0
10851407|NCT03129100|12017851|FG020|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|77
10851408|NCT03129100|12017852|FG021|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|5
10851409|NCT03129100|12017853|FG022|STARTED|Period 3 (Dose Escalation)|Participants who are eligible for dose escalations.|4
10851410|NCT03129100|12017854|FG023|STARTED|Period 3 (Dose Escalation)||0
10851411|NCT03129100|12017855|FG024|STARTED|Period 3 (Dose Escalation)||0
10851412|NCT03129100|12017856|FG025|STARTED|Period 3 (Dose Escalation)||0
10851413|NCT03129100|12017831|FG000|COMPLETED|Period 3 (Dose Escalation)||0
10851414|NCT03129100|12017832|FG001|COMPLETED|Period 3 (Dose Escalation)||0
10851415|NCT03129100|12017833|FG002|COMPLETED|Period 3 (Dose Escalation)||0
10851416|NCT03129100|12017834|FG003|COMPLETED|Period 3 (Dose Escalation)||0
10851417|NCT03129100|12017835|FG004|COMPLETED|Period 3 (Dose Escalation)||0
10851418|NCT03129100|12017836|FG005|COMPLETED|Period 3 (Dose Escalation)||0
10851419|NCT03129100|12017837|FG006|COMPLETED|Period 3 (Dose Escalation)||0
10851420|NCT03129100|12017838|FG007|COMPLETED|Period 3 (Dose Escalation)||0
10851421|NCT03129100|12017839|FG008|COMPLETED|Period 3 (Dose Escalation)||0
10851422|NCT03129100|12017840|FG009|COMPLETED|Period 3 (Dose Escalation)||0
10851423|NCT03129100|12017841|FG010|COMPLETED|Period 3 (Dose Escalation)||0
10851424|NCT03129100|12017842|FG011|COMPLETED|Period 3 (Dose Escalation)||0
10851425|NCT03129100|12017843|FG012|COMPLETED|Period 3 (Dose Escalation)||0
10851426|NCT03129100|12017844|FG013|COMPLETED|Period 3 (Dose Escalation)||0
10851427|NCT03129100|12017845|FG014|COMPLETED|Period 3 (Dose Escalation)||0
10851428|NCT03129100|12017846|FG015|COMPLETED|Period 3 (Dose Escalation)||0
10851429|NCT03129100|12017847|FG016|COMPLETED|Period 3 (Dose Escalation)||0
10851430|NCT03129100|12017848|FG017|COMPLETED|Period 3 (Dose Escalation)||0
10851431|NCT03129100|12017849|FG018|COMPLETED|Period 3 (Dose Escalation)||0
10851432|NCT03129100|12017850|FG019|COMPLETED|Period 3 (Dose Escalation)||0
10851433|NCT03129100|12017851|FG020|COMPLETED|Period 3 (Dose Escalation)||73
10851434|NCT03129100|12017852|FG021|COMPLETED|Period 3 (Dose Escalation)||5
10851435|NCT03129100|12017853|FG022|COMPLETED|Period 3 (Dose Escalation)||4
10851436|NCT03129100|12017854|FG023|COMPLETED|Period 3 (Dose Escalation)||0
10851437|NCT03129100|12017855|FG024|COMPLETED|Period 3 (Dose Escalation)||0
10851438|NCT03129100|12017856|FG025|COMPLETED|Period 3 (Dose Escalation)||0
10851439|NCT03129100|12017831|FG000|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851440|NCT03129100|12017832|FG001|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851441|NCT03129100|12017833|FG002|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851442|NCT03129100|12017834|FG003|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851443|NCT03129100|12017835|FG004|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851444|NCT03129100|12017836|FG005|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851445|NCT03129100|12017837|FG006|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851446|NCT03129100|12017838|FG007|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851447|NCT03129100|12017839|FG008|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851448|NCT03129100|12017840|FG009|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851449|NCT03129100|12017841|FG010|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851450|NCT03129100|12017842|FG011|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851451|NCT03129100|12017843|FG012|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851452|NCT03129100|12017844|FG013|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851453|NCT03129100|12017845|FG014|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851454|NCT03129100|12017846|FG015|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851455|NCT03129100|12017847|FG016|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851456|NCT03129100|12017848|FG017|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851457|NCT03129100|12017849|FG018|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851458|NCT03129100|12017850|FG019|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851459|NCT03129100|12017851|FG020|NOT COMPLETED|Period 3 (Dose Escalation)||4
10851460|NCT03129100|12017852|FG021|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851461|NCT03129100|12017853|FG022|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851462|NCT03129100|12017854|FG023|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851463|NCT03129100|12017855|FG024|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851464|NCT03129100|12017856|FG025|NOT COMPLETED|Period 3 (Dose Escalation)||0
10851465|NCT03129100|12017831|FG000|STARTED|Period 4 (Post Treatment Follow-up)||0
10851466|NCT03129100|12017832|FG001|STARTED|Period 4 (Post Treatment Follow-up)||0
10851467|NCT03129100|12017833|FG002|STARTED|Period 4 (Post Treatment Follow-up)||0
10851468|NCT03129100|12017834|FG003|STARTED|Period 4 (Post Treatment Follow-up)||0
10851469|NCT03129100|12017835|FG004|STARTED|Period 4 (Post Treatment Follow-up)||0
10851470|NCT03129100|12017836|FG005|STARTED|Period 4 (Post Treatment Follow-up)||0
10851471|NCT03129100|12017837|FG006|STARTED|Period 4 (Post Treatment Follow-up)||0
10851472|NCT03129100|12017838|FG007|STARTED|Period 4 (Post Treatment Follow-up)||0
10851473|NCT03129100|12017839|FG008|STARTED|Period 4 (Post Treatment Follow-up)||0
10851474|NCT03129100|12017840|FG009|STARTED|Period 4 (Post Treatment Follow-up)||0
10851475|NCT03129100|12017841|FG010|STARTED|Period 4 (Post Treatment Follow-up)||0
10851476|NCT03129100|12017842|FG011|STARTED|Period 4 (Post Treatment Follow-up)||0
10851477|NCT03129100|12017843|FG012|STARTED|Period 4 (Post Treatment Follow-up)||0
10851478|NCT03129100|12017844|FG013|STARTED|Period 4 (Post Treatment Follow-up)||0
10851479|NCT03129100|12017845|FG014|STARTED|Period 4 (Post Treatment Follow-up)||0
10851480|NCT03129100|12017846|FG015|STARTED|Period 4 (Post Treatment Follow-up)||0
10851481|NCT03129100|12017847|FG016|STARTED|Period 4 (Post Treatment Follow-up)||0
10851482|NCT03129100|12017848|FG017|STARTED|Period 4 (Post Treatment Follow-up)||0
10851483|NCT03129100|12017849|FG018|STARTED|Period 4 (Post Treatment Follow-up)||0
10851484|NCT03129100|12017850|FG019|STARTED|Period 4 (Post Treatment Follow-up)||0
10851485|NCT03129100|12017851|FG020|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|0
10851486|NCT03129100|12017852|FG021|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|0
10851487|NCT03129100|12017853|FG022|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|0
10851488|NCT03129100|12017854|FG023|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|25
10851489|NCT03129100|12017855|FG024|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|223
10851490|NCT03129100|12017856|FG025|STARTED|Period 4 (Post Treatment Follow-up)|This period is to report Follow-Up period participants.|453
10851491|NCT03129100|12017831|FG000|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851492|NCT03129100|12017832|FG001|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851493|NCT03129100|12017833|FG002|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851494|NCT03129100|12017834|FG003|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851495|NCT03129100|12017835|FG004|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851496|NCT03129100|12017836|FG005|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851497|NCT03129100|12017837|FG006|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851498|NCT03129100|12017838|FG007|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851499|NCT03129100|12017839|FG008|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851500|NCT03129100|12017840|FG009|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851501|NCT03129100|12017841|FG010|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851502|NCT03129100|12017842|FG011|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851503|NCT03129100|12017843|FG012|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851504|NCT03129100|12017844|FG013|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851505|NCT03129100|12017845|FG014|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851506|NCT03129100|12017846|FG015|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851507|NCT03129100|12017847|FG016|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851508|NCT03129100|12017848|FG017|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851509|NCT03129100|12017849|FG018|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851510|NCT03129100|12017850|FG019|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851511|NCT03129100|12017851|FG020|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851512|NCT03129100|12017852|FG021|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851513|NCT03129100|12017853|FG022|COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851514|NCT03129100|12017854|FG023|COMPLETED|Period 4 (Post Treatment Follow-up)||22
10851515|NCT03129100|12017855|FG024|COMPLETED|Period 4 (Post Treatment Follow-up)||198
10851516|NCT03129100|12017856|FG025|COMPLETED|Period 4 (Post Treatment Follow-up)||411
10851517|NCT03129100|12017831|FG000|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851518|NCT03129100|12017832|FG001|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851519|NCT03129100|12017833|FG002|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851520|NCT03129100|12017834|FG003|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851521|NCT03129100|12017835|FG004|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851522|NCT03129100|12017836|FG005|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851523|NCT03129100|12017837|FG006|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851524|NCT03129100|12017838|FG007|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851525|NCT03129100|12017839|FG008|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851526|NCT03129100|12017840|FG009|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851527|NCT03129100|12017841|FG010|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851528|NCT03129100|12017842|FG011|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851529|NCT03129100|12017843|FG012|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851530|NCT03129100|12017844|FG013|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851531|NCT03129100|12017845|FG014|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851532|NCT03129100|12017846|FG015|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851533|NCT03129100|12017847|FG016|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851534|NCT03129100|12017848|FG017|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851535|NCT03129100|12017849|FG018|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851536|NCT03129100|12017850|FG019|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851537|NCT03129100|12017851|FG020|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851538|NCT03129100|12017852|FG021|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
11106162|NCT01257698|12290622|FG001|COMPLETED|Overall Study||9
11106163|NCT01257698|12290621|FG000|NOT COMPLETED|Overall Study||4
11106164|NCT01257698|12290622|FG001|NOT COMPLETED|Overall Study||0
11106165|NCT01257737|12290630|FG000|STARTED|Overall Study||45
11106166|NCT01257737|12290631|FG001|STARTED|Overall Study||43
11106167|NCT01257737|12290630|FG000|COMPLETED|Overall Study||43
11106168|NCT01257737|12290631|FG001|COMPLETED|Overall Study||39
11106169|NCT01257737|12290630|FG000|NOT COMPLETED|Overall Study||2
11106170|NCT01257737|12290631|FG001|NOT COMPLETED|Overall Study||4
11106171|NCT01257750|12290638|FG000|STARTED|Overall Study||20
11106172|NCT01257750|12290638|FG000|COMPLETED|Overall Study||20
11106173|NCT01257750|12290638|FG000|NOT COMPLETED|Overall Study||0
11106174|NCT01257802|12290645|FG000|STARTED|Overall Study||6
11106175|NCT01257802|12290646|FG001|STARTED|Overall Study||8
11106176|NCT01257802|12290645|FG000|6 Month / 24 Week Visit|Overall Study||5
11106177|NCT01257802|12290646|FG001|6 Month / 24 Week Visit|Overall Study||2
11106178|NCT01257802|12290645|FG000|COMPLETED|Overall Study||5
11106179|NCT01257802|12290646|FG001|COMPLETED|Overall Study||2
11106180|NCT01257802|12290645|FG000|NOT COMPLETED|Overall Study||1
11106181|NCT01257802|12290646|FG001|NOT COMPLETED|Overall Study||6
11106182|NCT01257880|12290655|FG000|STARTED|Overall Study||12
11106183|NCT01257880|12290656|FG001|STARTED|Overall Study||19
11106184|NCT01257880|12290655|FG000|COMPLETED|Overall Study||12
11106185|NCT01257880|12290656|FG001|COMPLETED|Overall Study||19
11106186|NCT01257880|12290655|FG000|NOT COMPLETED|Overall Study||0
11106187|NCT01257880|12290656|FG001|NOT COMPLETED|Overall Study||0
11106188|NCT01258049|12290664|FG000|STARTED|Overall Study||77
11106189|NCT01258049|12290665|FG001|STARTED|Overall Study||74
11106190|NCT01258049|12290664|FG000|COMPLETED|Overall Study||75
11106191|NCT01258049|12290665|FG001|COMPLETED|Overall Study||72
11106192|NCT01258049|12290664|FG000|NOT COMPLETED|Overall Study||2
11106193|NCT01258049|12290665|FG001|NOT COMPLETED|Overall Study||2
11106194|NCT01258075|12290673|FG000|STARTED|Overall Study||141
11106195|NCT01258075|12290674|FG001|STARTED|Overall Study||95
11106196|NCT01258075|12290673|FG000|COMPLETED|Overall Study||99
11106197|NCT01258075|12290674|FG001|COMPLETED|Overall Study||72
11106198|NCT01258075|12290673|FG000|NOT COMPLETED|Overall Study||42
11106199|NCT01258075|12290674|FG001|NOT COMPLETED|Overall Study||23
11106200|NCT01258101|12290684|FG000|STARTED|Overall Study||151
11106201|NCT01258101|12290685|FG001|STARTED|Overall Study||144
11106202|NCT01258101|12290686|FG002|STARTED|Overall Study||33
11106203|NCT01258101|12290687|FG003|STARTED|Overall Study||52
11106204|NCT01258101|12290684|FG000|Safety Analysis Population|Overall Study||144
11106205|NCT01258101|12290685|FG001|Safety Analysis Population|Overall Study||141
11106206|NCT01258101|12290686|FG002|Safety Analysis Population|Overall Study||30
11106207|NCT01258101|12290687|FG003|Safety Analysis Population|Overall Study||48
11106208|NCT01258101|12290684|FG000|Standard Analysis Population|Overall Study||115
11106209|NCT01258101|12290685|FG001|Standard Analysis Population|Overall Study||110
11106210|NCT01258101|12290686|FG002|Standard Analysis Population|Overall Study||21
11106211|NCT01258101|12290687|FG003|Standard Analysis Population|Overall Study||26
11106212|NCT01258101|12290684|FG000|COMPLETED|Overall Study||118
11106213|NCT01258101|12290685|FG001|COMPLETED|Overall Study||110
11106214|NCT01258101|12290686|FG002|COMPLETED|Overall Study||22
11106215|NCT01258101|12290687|FG003|COMPLETED|Overall Study||27
11106216|NCT01258101|12290684|FG000|NOT COMPLETED|Overall Study||33
11106217|NCT01258101|12290685|FG001|NOT COMPLETED|Overall Study||34
11106218|NCT01258101|12290686|FG002|NOT COMPLETED|Overall Study||11
10851539|NCT03129100|12017853|FG022|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||0
10851540|NCT03129100|12017854|FG023|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||3
10851541|NCT03129100|12017855|FG024|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||25
10851542|NCT03129100|12017856|FG025|NOT COMPLETED|Period 4 (Post Treatment Follow-up)||42
10851543|NCT02831257|12017893|FG000|STARTED|Overall Study||18
10851544|NCT02831257|12017893|FG000|COMPLETED|Overall Study||6
10851545|NCT02831257|12017893|FG000|NOT COMPLETED|Overall Study||12
11106219|NCT01258101|12290687|FG003|NOT COMPLETED|Overall Study||25
11106220|NCT01258153|12290700|FG000|STARTED|Overall Study||40
11106221|NCT01258153|12290701|FG001|STARTED|Overall Study||38
11106222|NCT01258153|12290702|FG002|STARTED|Overall Study||37
11106223|NCT01258153|12290700|FG000|COMPLETED|Overall Study||39
11106224|NCT01258153|12290701|FG001|COMPLETED|Overall Study||37
11106225|NCT01258153|12290702|FG002|COMPLETED|Overall Study||36
11106226|NCT01258153|12290700|FG000|NOT COMPLETED|Overall Study||1
11106227|NCT01258153|12290701|FG001|NOT COMPLETED|Overall Study||1
11106228|NCT01258153|12290702|FG002|NOT COMPLETED|Overall Study||1
11106229|NCT01258348|12290712|FG000|STARTED|Overall Study||1
11106230|NCT01258348|12290713|FG001|STARTED|Overall Study||5
11106231|NCT01258348|12290714|FG002|STARTED|Overall Study||3
11106232|NCT01258348|12290715|FG003|STARTED|Overall Study||6
11106233|NCT01258348|12290716|FG004|STARTED|Overall Study||6
11106234|NCT01258348|12290712|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
11106235|NCT01258348|12290713|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
11106236|NCT01258348|12290714|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
11106237|NCT01258348|12290715|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
11106238|NCT01258348|12290716|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
11106239|NCT01258348|12290712|FG000|COMPLETED|Overall Study||0
11106240|NCT01258348|12290713|FG001|COMPLETED|Overall Study||0
11106241|NCT01258348|12290714|FG002|COMPLETED|Overall Study||0
11106242|NCT01258348|12290715|FG003|COMPLETED|Overall Study||0
11106243|NCT01258348|12290716|FG004|COMPLETED|Overall Study||0
11106244|NCT01258348|12290712|FG000|NOT COMPLETED|Overall Study||1
11106245|NCT01258348|12290713|FG001|NOT COMPLETED|Overall Study||5
11106246|NCT01258348|12290714|FG002|NOT COMPLETED|Overall Study||3
11106247|NCT01258348|12290715|FG003|NOT COMPLETED|Overall Study||6
11106248|NCT01258348|12290716|FG004|NOT COMPLETED|Overall Study||6
11106249|NCT01258374|12290730|FG000|STARTED|Overall Study||15
11106250|NCT01258374|12290730|FG000|COMPLETED|Overall Study||15
11106251|NCT01258374|12290730|FG000|NOT COMPLETED|Overall Study||0
11106252|NCT01258387|12290743|FG000|STARTED|Overall Study||6
11106253|NCT01258387|12290744|FG001|STARTED|Overall Study||6
11106254|NCT01258387|12290745|FG002|STARTED|Overall Study||6
11106255|NCT01258387|12290746|FG003|STARTED|Overall Study||6
11106256|NCT01258387|12290747|FG004|STARTED|Overall Study||6
11106257|NCT01258387|12290748|FG005|STARTED|Overall Study||6
11106258|NCT01258387|12290749|FG006|STARTED|Overall Study||4
11106259|NCT01258387|12290743|FG000|Patients Randomized to GGF2|Overall Study||4
11106260|NCT01258387|12290744|FG001|Patients Randomized to GGF2|Overall Study||4
11106261|NCT01258387|12290745|FG002|Patients Randomized to GGF2|Overall Study||4
10851574|NCT02406027|12017931|FG000|STARTED|Double-blind Treatment Phase (Period 1)||35
10851575|NCT02406027|12017932|FG001|STARTED|Double-blind Treatment Phase (Period 1)||29
10851576|NCT02406027|12017933|FG002|STARTED|Double-blind Treatment Phase (Period 1)||26
10851577|NCT02406027|12017934|FG003|STARTED|Double-blind Treatment Phase (Period 1)||0
10851578|NCT02406027|12017935|FG004|STARTED|Double-blind Treatment Phase (Period 1)||0
10851579|NCT02406027|12017936|FG005|STARTED|Double-blind Treatment Phase (Period 1)||0
10851580|NCT02406027|12017937|FG006|STARTED|Double-blind Treatment Phase (Period 1)||0
10851581|NCT02406027|12017931|FG000|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
10851582|NCT02406027|12017932|FG001|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8
10851583|NCT02406027|12017933|FG002|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
10851584|NCT02406027|12017934|FG003|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
10851585|NCT02406027|12017935|FG004|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
10851586|NCT02406027|12017936|FG005|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
10851587|NCT02406027|12017937|FG006|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
10851588|NCT02406027|12017931|FG000|Prodromal|Double-blind Treatment Phase (Period 1)||29
10851589|NCT02406027|12017932|FG001|Prodromal|Double-blind Treatment Phase (Period 1)||21
10851590|NCT02406027|12017933|FG002|Prodromal|Double-blind Treatment Phase (Period 1)||20
10851591|NCT02406027|12017934|FG003|Prodromal|Double-blind Treatment Phase (Period 1)||0
10851592|NCT02406027|12017935|FG004|Prodromal|Double-blind Treatment Phase (Period 1)||0
10851593|NCT02406027|12017936|FG005|Prodromal|Double-blind Treatment Phase (Period 1)||0
10851594|NCT02406027|12017937|FG006|Prodromal|Double-blind Treatment Phase (Period 1)||0
10851595|NCT02406027|12017931|FG000|COMPLETED|Double-blind Treatment Phase (Period 1)||29
10851596|NCT02406027|12017932|FG001|COMPLETED|Double-blind Treatment Phase (Period 1)||26
10851597|NCT02406027|12017933|FG002|COMPLETED|Double-blind Treatment Phase (Period 1)||22
10851598|NCT02406027|12017934|FG003|COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851599|NCT02406027|12017935|FG004|COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851600|NCT02406027|12017936|FG005|COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851601|NCT02406027|12017937|FG006|COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851602|NCT02406027|12017931|FG000|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6
10851603|NCT02406027|12017932|FG001|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3
10851604|NCT02406027|12017933|FG002|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4
10851605|NCT02406027|12017934|FG003|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851606|NCT02406027|12017935|FG004|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851607|NCT02406027|12017936|FG005|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851608|NCT02406027|12017937|FG006|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
10851609|NCT02406027|12017931|FG000|STARTED|Open-label Phase (Period 2)||0
10851610|NCT02406027|12017932|FG001|STARTED|Open-label Phase (Period 2)||0
10851611|NCT02406027|12017933|FG002|STARTED|Open-label Phase (Period 2)||0
10851612|NCT02406027|12017934|FG003|STARTED|Open-label Phase (Period 2)||15
10851613|NCT02406027|12017935|FG004|STARTED|Open-label Phase (Period 2)||14
10851614|NCT02406027|12017936|FG005|STARTED|Open-label Phase (Period 2)||26
10851615|NCT02406027|12017937|FG006|STARTED|Open-label Phase (Period 2)||22
10851616|NCT02406027|12017931|FG000|COMPLETED|Open-label Phase (Period 2)||0
10851617|NCT02406027|12017932|FG001|COMPLETED|Open-label Phase (Period 2)||0
10851618|NCT02406027|12017933|FG002|COMPLETED|Open-label Phase (Period 2)||0
10851619|NCT02406027|12017934|FG003|COMPLETED|Open-label Phase (Period 2)||0
10851620|NCT02406027|12017935|FG004|COMPLETED|Open-label Phase (Period 2)||0
10851621|NCT02406027|12017936|FG005|COMPLETED|Open-label Phase (Period 2)||0
10851622|NCT02406027|12017937|FG006|COMPLETED|Open-label Phase (Period 2)||0
10851623|NCT02406027|12017931|FG000|NOT COMPLETED|Open-label Phase (Period 2)||0
10851624|NCT02406027|12017932|FG001|NOT COMPLETED|Open-label Phase (Period 2)||0
10851625|NCT02406027|12017933|FG002|NOT COMPLETED|Open-label Phase (Period 2)||0
10851626|NCT02406027|12017934|FG003|NOT COMPLETED|Open-label Phase (Period 2)||15
10851627|NCT02406027|12017935|FG004|NOT COMPLETED|Open-label Phase (Period 2)||14
10851628|NCT02406027|12017936|FG005|NOT COMPLETED|Open-label Phase (Period 2)||26
10851629|NCT02406027|12017937|FG006|NOT COMPLETED|Open-label Phase (Period 2)||22
10851630|NCT02374814|12017959|FG000|STARTED|Overall Study||12
10851631|NCT02374814|12017960|FG001|STARTED|Overall Study||12
10851632|NCT02374814|12017961|FG002|STARTED|Overall Study||12
10851633|NCT02374814|12017962|FG003|STARTED|Overall Study||11
10851634|NCT02374814|12017963|FG004|STARTED|Overall Study||6
10851635|NCT02374814|12017964|FG005|STARTED|Overall Study||6
11106262|NCT01258387|12290746|FG003|Patients Randomized to GGF2|Overall Study||4
11106263|NCT01258387|12290747|FG004|Patients Randomized to GGF2|Overall Study||4
11106264|NCT01258387|12290748|FG005|Patients Randomized to GGF2|Overall Study||4
11106265|NCT01258387|12290749|FG006|Patients Randomized to GGF2|Overall Study||3
11106266|NCT01258387|12290743|FG000|Patients Randomized to Placebo|Overall Study||2
11106267|NCT01258387|12290744|FG001|Patients Randomized to Placebo|Overall Study||2
11106268|NCT01258387|12290745|FG002|Patients Randomized to Placebo|Overall Study||2
11106269|NCT01258387|12290746|FG003|Patients Randomized to Placebo|Overall Study||2
11354672|NCT03074409|12551731|FG001|NOT COMPLETED|Overall Study||4
11354673|NCT03074500|12551740|FG000|STARTED|Overall Study||11
11354674|NCT03074500|12551741|FG001|STARTED|Overall Study||11
11354675|NCT03074500|12551742|FG002|STARTED|Overall Study||11
11354676|NCT03074500|12551740|FG000|COMPLETED|Overall Study||10
11106270|NCT01258387|12290747|FG004|Patients Randomized to Placebo|Overall Study||2
11106271|NCT01258387|12290748|FG005|Patients Randomized to Placebo|Overall Study||2
11106272|NCT01258387|12290749|FG006|Patients Randomized to Placebo|Overall Study||1
11106273|NCT01258387|12290743|FG000|COMPLETED|Overall Study||6
11106274|NCT01258387|12290744|FG001|COMPLETED|Overall Study||6
11106275|NCT01258387|12290745|FG002|COMPLETED|Overall Study||6
11106276|NCT01258387|12290746|FG003|COMPLETED|Overall Study||6
11106277|NCT01258387|12290747|FG004|COMPLETED|Overall Study||6
11106278|NCT01258387|12290748|FG005|COMPLETED|Overall Study||6
11106279|NCT01258387|12290749|FG006|COMPLETED|Overall Study||4
11106280|NCT01258387|12290743|FG000|NOT COMPLETED|Overall Study||0
11106281|NCT01258387|12290744|FG001|NOT COMPLETED|Overall Study||0
11106282|NCT01258387|12290745|FG002|NOT COMPLETED|Overall Study||0
11106283|NCT01258387|12290746|FG003|NOT COMPLETED|Overall Study||0
11106284|NCT01258387|12290747|FG004|NOT COMPLETED|Overall Study||0
11106285|NCT01258387|12290748|FG005|NOT COMPLETED|Overall Study||0
11106286|NCT01258387|12290749|FG006|NOT COMPLETED|Overall Study||0
11106287|NCT01258504|12290767|FG000|STARTED|Bosentan Single Dose||13
11106288|NCT01258504|12290767|FG000|COMPLETED|Bosentan Single Dose||13
11106289|NCT01258504|12290767|FG000|NOT COMPLETED|Bosentan Single Dose||0
11106290|NCT01258504|12290767|FG000|STARTED|Bosentan Steady-state||13
11106291|NCT01258504|12290767|FG000|COMPLETED|Bosentan Steady-state||13
11106292|NCT01258504|12290767|FG000|NOT COMPLETED|Bosentan Steady-state||0
11106293|NCT01258504|12290767|FG000|STARTED|Bosentan and SJW||13
11106294|NCT01258504|12290767|FG000|COMPLETED|Bosentan and SJW||13
11106295|NCT01258504|12290767|FG000|NOT COMPLETED|Bosentan and SJW||0
11106296|NCT01258582|12290778|FG000|STARTED|Overall Study||830
11106297|NCT01258582|12290779|FG001|STARTED|Overall Study||821
11106298|NCT01258582|12290778|FG000|COMPLETED|Overall Study||548
11106299|NCT01258582|12290779|FG001|COMPLETED|Overall Study||563
11106300|NCT01258582|12290778|FG000|NOT COMPLETED|Overall Study||282
11106301|NCT01258582|12290779|FG001|NOT COMPLETED|Overall Study||258
11106302|NCT01258595|12290787|FG000|STARTED|Overall Study||148
11106303|NCT01258595|12290788|FG001|STARTED|Overall Study||152
11106304|NCT01258595|12290787|FG000|COMPLETED|Overall Study||147
11106305|NCT01258595|12290788|FG001|COMPLETED|Overall Study||151
11106306|NCT01258595|12290787|FG000|NOT COMPLETED|Overall Study||1
11106307|NCT01258595|12290788|FG001|NOT COMPLETED|Overall Study||1
11106308|NCT01258608|12290796|FG000|STARTED|Overall Study||51
11106309|NCT01258608|12290797|FG001|STARTED|Overall Study||50
10851636|NCT02374814|12017959|FG000|COMPLETED|Overall Study||11
10851637|NCT02374814|12017960|FG001|COMPLETED|Overall Study||11
10851638|NCT02374814|12017961|FG002|COMPLETED|Overall Study||11
10851639|NCT02374814|12017962|FG003|COMPLETED|Overall Study||9
10851640|NCT02374814|12017963|FG004|COMPLETED|Overall Study||6
10851641|NCT02374814|12017964|FG005|COMPLETED|Overall Study||6
10851642|NCT02374814|12017959|FG000|NOT COMPLETED|Overall Study||1
10851643|NCT02374814|12017960|FG001|NOT COMPLETED|Overall Study||1
10851644|NCT02374814|12017961|FG002|NOT COMPLETED|Overall Study||1
10851645|NCT02374814|12017962|FG003|NOT COMPLETED|Overall Study||2
10851646|NCT02374814|12017963|FG004|NOT COMPLETED|Overall Study||0
10851647|NCT02374814|12017964|FG005|NOT COMPLETED|Overall Study||0
10851648|NCT02142738|12017988|FG000|STARTED|Overall Study||154
10851649|NCT02142738|12017989|FG001|STARTED|Overall Study||151
10851650|NCT02142738|12017988|FG000|Treated|Overall Study||154
10851651|NCT02142738|12017989|FG001|Treated|Overall Study||150
10851652|NCT02142738|12017988|FG000|Chemotherapy Switch to Pembrolizumab|Overall Study||0
10851653|NCT02142738|12017989|FG001|Chemotherapy Switch to Pembrolizumab|Overall Study||83
10851654|NCT02142738|12017988|FG000|Second Course Pembrolizumab|Overall Study||12
10851655|NCT02142738|12017989|FG001|Second Course Pembrolizumab|Overall Study||1
10851656|NCT02142738|12017988|FG000|COMPLETED|Overall Study||0
10851657|NCT02142738|12017989|FG001|COMPLETED|Overall Study||0
10851658|NCT02142738|12017988|FG000|NOT COMPLETED|Overall Study||154
10851659|NCT02142738|12017989|FG001|NOT COMPLETED|Overall Study||151
11106310|NCT01258608|12290796|FG000|COMPLETED|Overall Study||30
11106311|NCT01258608|12290797|FG001|COMPLETED|Overall Study||31
11106312|NCT01258608|12290796|FG000|NOT COMPLETED|Overall Study||21
11106313|NCT01258608|12290797|FG001|NOT COMPLETED|Overall Study||19
11106314|NCT01258660|12290806|FG000|STARTED|Overall Study|randomized and received at least one dose of treatment|86
11106315|NCT01258660|12290807|FG001|STARTED|Overall Study|randomized and received at least one dose of treatment|86
11106316|NCT01258660|12290806|FG000|Received Treatment|Overall Study||79
11106317|NCT01258660|12290807|FG001|Received Treatment|Overall Study||82
11106318|NCT01258660|12290806|FG000|Completed Treatment|Overall Study||79
11106319|NCT01258660|12290807|FG001|Completed Treatment|Overall Study||81
11106320|NCT01258660|12290806|FG000|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
11106321|NCT01258660|12290807|FG001|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
11106322|NCT01258660|12290806|FG000|NOT COMPLETED|Overall Study||11
11106323|NCT01258660|12290807|FG001|NOT COMPLETED|Overall Study||11
10851666|NCT02005172|12018007|FG000|STARTED|Overall Study||33
10851667|NCT02005172|12018007|FG000|ITT|Overall Study||38
10851668|NCT02005172|12018007|FG000|COMPLETED|Overall Study||33
10851669|NCT02005172|12018007|FG000|NOT COMPLETED|Overall Study||0
10851670|NCT01931709|12018012|FG000|STARTED|Overall Study||35
10851671|NCT01931709|12018012|FG000|COMPLETED|Overall Study||35
10851672|NCT01931709|12018012|FG000|NOT COMPLETED|Overall Study||0
10851673|NCT01667133|12018030|FG000|STARTED|Phase 1: Dose-escalation||1
10851674|NCT01667133|12018031|FG001|STARTED|Phase 1: Dose-escalation||1
10851675|NCT01667133|12018032|FG002|STARTED|Phase 1: Dose-escalation||4
10851676|NCT01667133|12018033|FG003|STARTED|Phase 1: Dose-escalation||3
10851677|NCT01667133|12018034|FG004|STARTED|Phase 1: Dose-escalation||1
10851678|NCT01667133|12018035|FG005|STARTED|Phase 1: Dose-escalation||1
10851679|NCT01667133|12018036|FG006|STARTED|Phase 1: Dose-escalation||1
10851680|NCT01667133|12018037|FG007|STARTED|Phase 1: Dose-escalation||0
10851681|NCT01667133|12018038|FG008|STARTED|Phase 1: Dose-escalation||0
10851682|NCT01667133|12018039|FG009|STARTED|Phase 1: Dose-escalation||0
10851683|NCT01667133|12018040|FG010|STARTED|Phase 1: Dose-escalation||0
10851684|NCT01667133|12018041|FG011|STARTED|Phase 1: Dose-escalation||0
10851685|NCT01667133|12018030|FG000|COMPLETED|Phase 1: Dose-escalation||1
10851686|NCT01667133|12018031|FG001|COMPLETED|Phase 1: Dose-escalation||0
10851687|NCT01667133|12018032|FG002|COMPLETED|Phase 1: Dose-escalation||0
10851688|NCT01667133|12018033|FG003|COMPLETED|Phase 1: Dose-escalation||2
10851689|NCT01667133|12018034|FG004|COMPLETED|Phase 1: Dose-escalation||0
10851690|NCT01667133|12018035|FG005|COMPLETED|Phase 1: Dose-escalation||0
10851691|NCT01667133|12018036|FG006|COMPLETED|Phase 1: Dose-escalation||0
10851692|NCT01667133|12018037|FG007|COMPLETED|Phase 1: Dose-escalation||0
10851693|NCT01667133|12018038|FG008|COMPLETED|Phase 1: Dose-escalation||0
10851694|NCT01667133|12018039|FG009|COMPLETED|Phase 1: Dose-escalation||0
10851695|NCT01667133|12018040|FG010|COMPLETED|Phase 1: Dose-escalation||0
10851696|NCT01667133|12018041|FG011|COMPLETED|Phase 1: Dose-escalation||0
10851697|NCT01667133|12018030|FG000|NOT COMPLETED|Phase 1: Dose-escalation||0
10851698|NCT01667133|12018031|FG001|NOT COMPLETED|Phase 1: Dose-escalation||1
10851699|NCT01667133|12018032|FG002|NOT COMPLETED|Phase 1: Dose-escalation||4
10851700|NCT01667133|12018033|FG003|NOT COMPLETED|Phase 1: Dose-escalation||1
10851701|NCT01667133|12018034|FG004|NOT COMPLETED|Phase 1: Dose-escalation||1
10851702|NCT01667133|12018035|FG005|NOT COMPLETED|Phase 1: Dose-escalation||1
10851703|NCT01667133|12018036|FG006|NOT COMPLETED|Phase 1: Dose-escalation||1
10851704|NCT01667133|12018037|FG007|NOT COMPLETED|Phase 1: Dose-escalation||0
10851705|NCT01667133|12018038|FG008|NOT COMPLETED|Phase 1: Dose-escalation||0
10851706|NCT01667133|12018039|FG009|NOT COMPLETED|Phase 1: Dose-escalation||0
10851707|NCT01667133|12018040|FG010|NOT COMPLETED|Phase 1: Dose-escalation||0
10851708|NCT01667133|12018041|FG011|NOT COMPLETED|Phase 1: Dose-escalation||0
10851709|NCT01667133|12018030|FG000|STARTED|Phase 2: Dose-expansion||0
10851710|NCT01667133|12018031|FG001|STARTED|Phase 2: Dose-expansion||0
10851711|NCT01667133|12018032|FG002|STARTED|Phase 2: Dose-expansion||0
10851712|NCT01667133|12018033|FG003|STARTED|Phase 2: Dose-expansion||0
10851713|NCT01667133|12018034|FG004|STARTED|Phase 2: Dose-expansion||0
10851714|NCT01667133|12018035|FG005|STARTED|Phase 2: Dose-expansion||0
10851715|NCT01667133|12018036|FG006|STARTED|Phase 2: Dose-expansion||0
10851716|NCT01667133|12018037|FG007|STARTED|Phase 2: Dose-expansion||2
10851717|NCT01667133|12018038|FG008|STARTED|Phase 2: Dose-expansion||1
10851718|NCT01667133|12018039|FG009|STARTED|Phase 2: Dose-expansion||11
10851719|NCT01667133|12018040|FG010|STARTED|Phase 2: Dose-expansion||3
10851720|NCT01667133|12018041|FG011|STARTED|Phase 2: Dose-expansion||6
10851721|NCT01667133|12018030|FG000|COMPLETED|Phase 2: Dose-expansion||0
10851722|NCT01667133|12018031|FG001|COMPLETED|Phase 2: Dose-expansion||0
10851723|NCT01667133|12018032|FG002|COMPLETED|Phase 2: Dose-expansion||0
10851724|NCT01667133|12018033|FG003|COMPLETED|Phase 2: Dose-expansion||0
10851725|NCT01667133|12018034|FG004|COMPLETED|Phase 2: Dose-expansion||0
10851726|NCT01667133|12018035|FG005|COMPLETED|Phase 2: Dose-expansion||0
10851727|NCT01667133|12018036|FG006|COMPLETED|Phase 2: Dose-expansion||0
10851728|NCT01667133|12018037|FG007|COMPLETED|Phase 2: Dose-expansion||0
10851729|NCT01667133|12018038|FG008|COMPLETED|Phase 2: Dose-expansion||0
10851730|NCT01667133|12018039|FG009|COMPLETED|Phase 2: Dose-expansion||5
10851731|NCT01667133|12018040|FG010|COMPLETED|Phase 2: Dose-expansion||0
10851732|NCT01667133|12018041|FG011|COMPLETED|Phase 2: Dose-expansion||0
10851733|NCT01667133|12018030|FG000|NOT COMPLETED|Phase 2: Dose-expansion||0
10851734|NCT01667133|12018031|FG001|NOT COMPLETED|Phase 2: Dose-expansion||0
10851735|NCT01667133|12018032|FG002|NOT COMPLETED|Phase 2: Dose-expansion||0
10851736|NCT01667133|12018033|FG003|NOT COMPLETED|Phase 2: Dose-expansion||0
10851737|NCT01667133|12018034|FG004|NOT COMPLETED|Phase 2: Dose-expansion||0
10851738|NCT01667133|12018035|FG005|NOT COMPLETED|Phase 2: Dose-expansion||0
10851739|NCT01667133|12018036|FG006|NOT COMPLETED|Phase 2: Dose-expansion||0
10851740|NCT01667133|12018037|FG007|NOT COMPLETED|Phase 2: Dose-expansion||2
10851741|NCT01667133|12018038|FG008|NOT COMPLETED|Phase 2: Dose-expansion||1
10851742|NCT01667133|12018039|FG009|NOT COMPLETED|Phase 2: Dose-expansion||6
10851743|NCT01667133|12018040|FG010|NOT COMPLETED|Phase 2: Dose-expansion||3
10851744|NCT01667133|12018041|FG011|NOT COMPLETED|Phase 2: Dose-expansion||6
10851745|NCT01585103|12018102|FG000|STARTED|Overall Study||86
10851746|NCT01585103|12018102|FG000|COMPLETED|Overall Study||80
10851747|NCT01585103|12018102|FG000|NOT COMPLETED|Overall Study||6
10851748|NCT01427725|12018106|FG000|STARTED|Overall Study||579
10851749|NCT01427725|12018106|FG000|Collected CRFs|Overall Study|Not collected Case Report Forms (CRFs) of 17 patients.|562
10851750|NCT01427725|12018106|FG000|Safety Analysis Set|Overall Study|Analysis of safety data. 9 patients dropped out, could not confirm existence of Adverse Events.|553
10851751|NCT01427725|12018106|FG000|COMPLETED|Overall Study|Among the patients in the safety analysis set, 175 patients discontinued the survey.|378
10851752|NCT01427725|12018106|FG000|NOT COMPLETED|Overall Study||201
10851753|NCT00921115|12018111|FG000|STARTED|Overall Study||42
10851754|NCT00921115|12018111|FG000|COMPLETED|Overall Study||42
10851755|NCT00921115|12018111|FG000|NOT COMPLETED|Overall Study||0
11225127|NCT01990313|12417312|FG000|COMPLETED|Overall Study||14
11225128|NCT01990313|12417312|FG000|NOT COMPLETED|Overall Study||1
11225129|NCT01990339|12417316|FG000|STARTED|Overall Study||14965
11225130|NCT01990339|12417316|FG000|COMPLETED|Overall Study||12653
11225131|NCT01990339|12417316|FG000|NOT COMPLETED|Overall Study||2312
11225132|NCT01990495|12417322|FG000|STARTED|Overall Study||18
11225133|NCT01990495|12417323|FG001|STARTED|Overall Study||19
11225134|NCT01990495|12417322|FG000|COMPLETED|Overall Study||13
11225135|NCT01990495|12417323|FG001|COMPLETED|Overall Study||15
11225136|NCT01990495|12417322|FG000|NOT COMPLETED|Overall Study||5
11225137|NCT01990495|12417323|FG001|NOT COMPLETED|Overall Study||4
11225138|NCT01990534|12417331|FG000|STARTED|Overall Study||60
11225139|NCT01990534|12417331|FG000|COMPLETED|Overall Study||25
11225140|NCT01990534|12417331|FG000|NOT COMPLETED|Overall Study||35
11225141|NCT01990560|12417335|FG000|STARTED|Overall Study||8
11225142|NCT01990560|12417335|FG000|COMPLETED|Overall Study||7
10851756|NCT04608344|12018117|FG000|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||14
10851757|NCT04608344|12018118|FG001|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||13
10851758|NCT04608344|12018117|FG000|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||13
10851759|NCT04608344|12018118|FG001|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||12
10851760|NCT04608344|12018117|FG000|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1
10851761|NCT04608344|12018118|FG001|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1
10851762|NCT04608344|12018117|FG000|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||13
10851763|NCT04608344|12018118|FG001|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||12
10851764|NCT04608344|12018117|FG000|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||13
10851765|NCT04608344|12018118|FG001|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||12
10851766|NCT04608344|12018117|FG000|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0
10851767|NCT04608344|12018118|FG001|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0
10851768|NCT04569253|12018132|FG000|STARTED|Overall Study||65
10851769|NCT04569253|12018132|FG000|Control Flanks|Overall Study||65
10851770|NCT04569253|12018132|FG000|Treatment Flanks|Overall Study||65
10851771|NCT04569253|12018132|FG000|COMPLETED|Overall Study||57
10851772|NCT04569253|12018132|FG000|NOT COMPLETED|Overall Study||8
10851773|NCT04350372|12018137|FG000|STARTED|Overall Study||16
10851774|NCT04350372|12018137|FG000|COMPLETED|Overall Study||15
10851775|NCT04350372|12018137|FG000|NOT COMPLETED|Overall Study||1
10851776|NCT04343989|12018144|FG000|STARTED|Overall Study||78
10851777|NCT04343989|12018145|FG001|STARTED|Overall Study||26
10851778|NCT04343989|12018146|FG002|STARTED|Overall Study||74
10851779|NCT04343989|12018144|FG000|COMPLETED|Overall Study||78
10851780|NCT04343989|12018145|FG001|COMPLETED|Overall Study||26
10851781|NCT04343989|12018146|FG002|COMPLETED|Overall Study||74
10851782|NCT04343989|12018144|FG000|NOT COMPLETED|Overall Study||0
10851783|NCT04343989|12018145|FG001|NOT COMPLETED|Overall Study||0
10851784|NCT04343989|12018146|FG002|NOT COMPLETED|Overall Study||0
11106324|NCT01258738|12290816|FG000|STARTED|Double-blind Period||111
11106325|NCT01258738|12290817|FG001|STARTED|Double-blind Period||114
11106326|NCT01258738|12290816|FG000|Treated|Double-blind Period||111
11106327|NCT01258738|12290817|FG001|Treated|Double-blind Period||113
11106328|NCT01258738|12290816|FG000|COMPLETED|Double-blind Period||102
11106329|NCT01258738|12290817|FG001|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
11106330|NCT01258738|12290816|FG000|NOT COMPLETED|Double-blind Period||9
11106331|NCT01258738|12290817|FG001|NOT COMPLETED|Double-blind Period||7
11354677|NCT03074500|12551741|FG001|COMPLETED|Overall Study||10
11354678|NCT03074500|12551742|FG002|COMPLETED|Overall Study||10
11106332|NCT01258738|12290816|FG000|STARTED|Open-label Period||102
11106333|NCT01258738|12290817|FG001|STARTED|Open-label Period||106
11106334|NCT01258738|12290816|FG000|COMPLETED|Open-label Period||85
11354679|NCT03074500|12551740|FG000|NOT COMPLETED|Overall Study||1
10851797|NCT04249310|12018179|FG000|STARTED|Overall Study||1436
10851798|NCT04249310|12018180|FG001|STARTED|Overall Study||5352
10851799|NCT04249310|12018179|FG000|PS-matched Cohort|Overall Study||1412
10851800|NCT04249310|12018180|FG001|PS-matched Cohort|Overall Study||1412
10851801|NCT04249310|12018179|FG000|hdPS-matched Cohort|Overall Study||1302
10851802|NCT04249310|12018180|FG001|hdPS-matched Cohort|Overall Study||1302
10851803|NCT04249310|12018179|FG000|COMPLETED|Overall Study||1436
10851804|NCT04249310|12018180|FG001|COMPLETED|Overall Study||5352
10851805|NCT04249310|12018179|FG000|NOT COMPLETED|Overall Study||0
10851806|NCT04249310|12018180|FG001|NOT COMPLETED|Overall Study||0
10851807|NCT04234984|12018188|FG000|STARTED|Follow-up at 6 Weeks||61
10851808|NCT04234984|12018188|FG000|COMPLETED|Follow-up at 6 Weeks||59
10851809|NCT04234984|12018188|FG000|NOT COMPLETED|Follow-up at 6 Weeks||2
10851810|NCT04234984|12018188|FG000|STARTED|Follow-up at the Second Time Point||19
10851811|NCT04234984|12018188|FG000|COMPLETED|Follow-up at the Second Time Point||17
10851812|NCT04234984|12018188|FG000|NOT COMPLETED|Follow-up at the Second Time Point||2
10851813|NCT04227197|12018196|FG000|STARTED|Randomization||117
10851814|NCT04227197|12018197|FG001|STARTED|Randomization||113
10851815|NCT04227197|12018196|FG000|COMPLETED|Randomization||115
10851816|NCT04227197|12018197|FG001|COMPLETED|Randomization||113
10851817|NCT04227197|12018196|FG000|NOT COMPLETED|Randomization||2
10851818|NCT04227197|12018197|FG001|NOT COMPLETED|Randomization||0
10851819|NCT04227197|12018196|FG000|STARTED|Primary Care Provider (PCP) Visit||115
10851820|NCT04227197|12018197|FG001|STARTED|Primary Care Provider (PCP) Visit||113
10851821|NCT04227197|12018196|FG000|COMPLETED|Primary Care Provider (PCP) Visit||113
10851822|NCT04227197|12018197|FG001|COMPLETED|Primary Care Provider (PCP) Visit||113
10851823|NCT04227197|12018196|FG000|NOT COMPLETED|Primary Care Provider (PCP) Visit||2
10851824|NCT04227197|12018197|FG001|NOT COMPLETED|Primary Care Provider (PCP) Visit||0
10851825|NCT04227197|12018196|FG000|STARTED|2-week Follow-up Survey for Caregivers||113
10851826|NCT04227197|12018197|FG001|STARTED|2-week Follow-up Survey for Caregivers||113
10851827|NCT04227197|12018196|FG000|COMPLETED|2-week Follow-up Survey for Caregivers||101
10851828|NCT04227197|12018197|FG001|COMPLETED|2-week Follow-up Survey for Caregivers||108
10851829|NCT04227197|12018196|FG000|NOT COMPLETED|2-week Follow-up Survey for Caregivers||12
10851830|NCT04227197|12018197|FG001|NOT COMPLETED|2-week Follow-up Survey for Caregivers||5
10851831|NCT04227197|12018196|FG000|STARTED|2-week Follow-up Survey for PCP's||114
10851832|NCT04227197|12018197|FG001|STARTED|2-week Follow-up Survey for PCP's||113
10851833|NCT04227197|12018196|FG000|COMPLETED|2-week Follow-up Survey for PCP's||94
10851834|NCT04227197|12018197|FG001|COMPLETED|2-week Follow-up Survey for PCP's||88
10851835|NCT04227197|12018196|FG000|NOT COMPLETED|2-week Follow-up Survey for PCP's||20
10851836|NCT04227197|12018197|FG001|NOT COMPLETED|2-week Follow-up Survey for PCP's||25
10851837|NCT04227197|12018196|FG000|STARTED|7-month Follow-up Survey for Caregivers||114
10851838|NCT04227197|12018197|FG001|STARTED|7-month Follow-up Survey for Caregivers||113
10851839|NCT04227197|12018196|FG000|COMPLETED|7-month Follow-up Survey for Caregivers||103
10851840|NCT04227197|12018197|FG001|COMPLETED|7-month Follow-up Survey for Caregivers||110
10851841|NCT04227197|12018196|FG000|NOT COMPLETED|7-month Follow-up Survey for Caregivers||11
10851842|NCT04227197|12018197|FG001|NOT COMPLETED|7-month Follow-up Survey for Caregivers||3
10851843|NCT04105725|12018208|FG000|STARTED|Primary Intervention||37
10851844|NCT04105725|12018209|FG001|STARTED|Primary Intervention||29
10851845|NCT04105725|12018208|FG000|COMPLETED|Primary Intervention||37
10851846|NCT04105725|12018209|FG001|COMPLETED|Primary Intervention||26
10851847|NCT04105725|12018208|FG000|NOT COMPLETED|Primary Intervention||0
10851848|NCT04105725|12018209|FG001|NOT COMPLETED|Primary Intervention||3
10851849|NCT04105725|12018208|FG000|STARTED|Mini-Session Week 1|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
10851850|NCT04105725|12018209|FG001|STARTED|Mini-Session Week 1|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
10851851|NCT04105725|12018208|FG000|COMPLETED|Mini-Session Week 1|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 1|36
10851852|NCT04105725|12018209|FG001|COMPLETED|Mini-Session Week 1|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 1|25
10851853|NCT04105725|12018208|FG000|NOT COMPLETED|Mini-Session Week 1||1
10851854|NCT04105725|12018209|FG001|NOT COMPLETED|Mini-Session Week 1||1
10851855|NCT04105725|12018208|FG000|STARTED|Mini-Session Week 2|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
10851856|NCT04105725|12018209|FG001|STARTED|Mini-Session Week 2|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
10851857|NCT04105725|12018208|FG000|COMPLETED|Mini-Session Week 2|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 2|34
10851858|NCT04105725|12018209|FG001|COMPLETED|Mini-Session Week 2|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 2|22
10851859|NCT04105725|12018208|FG000|NOT COMPLETED|Mini-Session Week 2||3
10851860|NCT04105725|12018209|FG001|NOT COMPLETED|Mini-Session Week 2||4
10851861|NCT04105725|12018208|FG000|STARTED|Mini-Session Week 3|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
11225143|NCT01990560|12417335|FG000|NOT COMPLETED|Overall Study||1
11225144|NCT01990573|12417342|FG000|STARTED|Overall Study||20
11225145|NCT01990573|12417343|FG001|STARTED|Overall Study||14
11225146|NCT01990573|12417344|FG002|STARTED|Overall Study||17
11225147|NCT01990573|12417342|FG000|COMPLETED|Overall Study||20
11225148|NCT01990573|12417343|FG001|COMPLETED|Overall Study||14
11225149|NCT01990573|12417344|FG002|COMPLETED|Overall Study||16
11225150|NCT01990573|12417342|FG000|NOT COMPLETED|Overall Study||0
11225151|NCT01990573|12417343|FG001|NOT COMPLETED|Overall Study||0
11225152|NCT01990573|12417344|FG002|NOT COMPLETED|Overall Study||1
11225153|NCT01990612|12417354|FG000|STARTED|Overall Study||3044
11225154|NCT01990612|12417355|FG001|STARTED|Overall Study||3062
11225155|NCT01990612|12417354|FG000|COMPLETED|Overall Study||3037
11225156|NCT01990612|12417355|FG001|COMPLETED|Overall Study||3059
11225157|NCT01990612|12417354|FG000|NOT COMPLETED|Overall Study||7
11225158|NCT01990612|12417355|FG001|NOT COMPLETED|Overall Study||3
11225159|NCT01990664|12417363|FG000|STARTED|Overall Study||102
11225160|NCT01990664|12417364|FG001|STARTED|Overall Study||90
11225161|NCT01990664|12417363|FG000|COMPLETED|Overall Study||95
11225162|NCT01990664|12417364|FG001|COMPLETED|Overall Study||79
11225163|NCT01990664|12417363|FG000|NOT COMPLETED|Overall Study||7
11225164|NCT01990664|12417364|FG001|NOT COMPLETED|Overall Study||11
11225165|NCT01990677|12417372|FG000|STARTED|Overall Study||12
11225166|NCT01990677|12417373|FG001|STARTED|Overall Study||6
11225167|NCT01990677|12417372|FG000|COMPLETED|Overall Study||10
11225168|NCT01990677|12417373|FG001|COMPLETED|Overall Study||5
11225169|NCT01990677|12417372|FG000|NOT COMPLETED|Overall Study||2
11225170|NCT01990677|12417373|FG001|NOT COMPLETED|Overall Study||1
10851862|NCT04105725|12018209|FG001|STARTED|Mini-Session Week 3|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
10851863|NCT04105725|12018208|FG000|COMPLETED|Mini-Session Week 3|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 3|34
10851864|NCT04105725|12018209|FG001|COMPLETED|Mini-Session Week 3|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 3|22
10851865|NCT04105725|12018208|FG000|NOT COMPLETED|Mini-Session Week 3||3
10851866|NCT04105725|12018209|FG001|NOT COMPLETED|Mini-Session Week 3||4
10851867|NCT04105725|12018208|FG000|STARTED|Mini-Session Week 4|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
10851868|NCT04105725|12018209|FG001|STARTED|Mini-Session Week 4|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
10851869|NCT04105725|12018208|FG000|COMPLETED|Mini-Session Week 4|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and Mini-Session Week 4|35
10851870|NCT04105725|12018209|FG001|COMPLETED|Mini-Session Week 4|Number of participants who completed both sessions of the Alcohol + Nutrition Education and Mini-Session Week 4|21
10851871|NCT04105725|12018208|FG000|NOT COMPLETED|Mini-Session Week 4||2
10851872|NCT04105725|12018209|FG001|NOT COMPLETED|Mini-Session Week 4||5
10851873|NCT04105725|12018208|FG000|STARTED|Post-Intervention Survey|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
10851874|NCT04105725|12018209|FG001|STARTED|Post-Intervention Survey|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
10851875|NCT04105725|12018208|FG000|COMPLETED|Post-Intervention Survey|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and the Post-Intervention Survey|33
10851876|NCT04105725|12018209|FG001|COMPLETED|Post-Intervention Survey|Number of participants who completed both sessions of the Alcohol + Nutrition Education and the Post-Intervention Survey|18
10851877|NCT04105725|12018208|FG000|NOT COMPLETED|Post-Intervention Survey||4
10851878|NCT04105725|12018209|FG001|NOT COMPLETED|Post-Intervention Survey||8
10851879|NCT04105725|12018208|FG000|STARTED|3-Month Follow-up Survey|Number based on number completed both sessions of the BMI+Substance-Free Activity Session.|37
10851880|NCT04105725|12018209|FG001|STARTED|3-Month Follow-up Survey|Number based on number completed both sessions of the Alcohol + Nutrition Education Session.|26
10851881|NCT04105725|12018208|FG000|COMPLETED|3-Month Follow-up Survey|Number of participants who completed both sessions of the BMI+Substance-Free Activity Session and the 3-Month Follow-up Survey|33
10851882|NCT04105725|12018209|FG001|COMPLETED|3-Month Follow-up Survey|Number of participants who completed both sessions of the Alcohol + Nutrition Education and the 3-Month Follow-up Survey|22
10851883|NCT04105725|12018208|FG000|NOT COMPLETED|3-Month Follow-up Survey||4
10851884|NCT04105725|12018209|FG001|NOT COMPLETED|3-Month Follow-up Survey||4
10851885|NCT04066023|12018218|FG000|STARTED|Overall Study||12
10851886|NCT04066023|12018219|FG001|STARTED|Overall Study||17
10851887|NCT04066023|12018220|FG002|STARTED|Overall Study||13
10851888|NCT04066023|12018218|FG000|COMPLETED|Overall Study||9
10851889|NCT04066023|12018219|FG001|COMPLETED|Overall Study||9
10851890|NCT04066023|12018220|FG002|COMPLETED|Overall Study||7
10851891|NCT04066023|12018218|FG000|NOT COMPLETED|Overall Study||3
10851892|NCT04066023|12018219|FG001|NOT COMPLETED|Overall Study||8
10851893|NCT04066023|12018220|FG002|NOT COMPLETED|Overall Study||6
10851894|NCT04011475|12018231|FG000|STARTED|Overall Study||239
10851895|NCT04011475|12018232|FG001|STARTED|Overall Study||937
10851896|NCT04011475|12018233|FG002|STARTED|Overall Study||441
10851897|NCT04011475|12018231|FG000|Propensity Score Matched Cohort|Overall Study||114
10851898|NCT04011475|12018232|FG001|Propensity Score Matched Cohort|Overall Study||114
10851899|NCT04011475|12018233|FG002|Propensity Score Matched Cohort|Overall Study||114
10851900|NCT04011475|12018231|FG000|COMPLETED|Overall Study||239
10851901|NCT04011475|12018232|FG001|COMPLETED|Overall Study||937
10851902|NCT04011475|12018233|FG002|COMPLETED|Overall Study||441
10851903|NCT04011475|12018231|FG000|NOT COMPLETED|Overall Study||0
10851904|NCT04011475|12018232|FG001|NOT COMPLETED|Overall Study||0
10851905|NCT04011475|12018233|FG002|NOT COMPLETED|Overall Study||0
10851906|NCT03882957|12018241|FG000|STARTED|Overall Study||92
10851907|NCT03882957|12018241|FG000|Participant Flow 1|Overall Study|participant flow sequence: video --> media multitask --> sustained attention|17
10851908|NCT03882957|12018241|FG000|Participant Flow 2|Overall Study|participant flow sequence: video --> sustained attention -- media multitask|16
10851909|NCT03882957|12018241|FG000|Participant Flow 3|Overall Study|participant flow sequence: media multitask --> video --> sustained attention|13
10852000|NCT03104413|12018362|FG003|STARTED|Induction Period 1||0
10851910|NCT03882957|12018241|FG000|Participant Flow 4|Overall Study|participant flow sequence: sustained attention --> video -- media multitask|15
10851911|NCT03882957|12018241|FG000|Participant Flow 5|Overall Study|participant flow sequence: sustained attention --> media multitask --> video|16
10851912|NCT03882957|12018241|FG000|Participant Flow 6|Overall Study|participant flow 6: media multitask --> sustained attention --> video|14
10851913|NCT03882957|12018241|FG000|COMPLETED|Overall Study||91
10851914|NCT03882957|12018241|FG000|NOT COMPLETED|Overall Study||1
10851915|NCT03711500|12018254|FG000|STARTED|Overall Study||12
10851916|NCT03711500|12018255|FG001|STARTED|Overall Study||12
10851917|NCT03711500|12018256|FG002|STARTED|Overall Study||12
10851918|NCT03711500|12018257|FG003|STARTED|Overall Study||9
10851919|NCT03711500|12018254|FG000|COMPLETED|Overall Study||12
10851920|NCT03711500|12018255|FG001|COMPLETED|Overall Study|One subject completed 2 of three treatment sessions, with LOCF carried forward for analysis|11
10851921|NCT03711500|12018256|FG002|COMPLETED|Overall Study||12
10851922|NCT03711500|12018257|FG003|COMPLETED|Overall Study||9
10851923|NCT03711500|12018254|FG000|NOT COMPLETED|Overall Study||0
10851924|NCT03711500|12018255|FG001|NOT COMPLETED|Overall Study||1
10851925|NCT03711500|12018256|FG002|NOT COMPLETED|Overall Study||0
10851926|NCT03711500|12018257|FG003|NOT COMPLETED|Overall Study||0
10851927|NCT03639558|12018269|FG000|STARTED|Overall Study||52
10851928|NCT03639558|12018270|FG001|STARTED|Overall Study||48
10851929|NCT03639558|12018269|FG000|COMPLETED|Overall Study||51
10851930|NCT03639558|12018270|FG001|COMPLETED|Overall Study||43
10851931|NCT03639558|12018269|FG000|NOT COMPLETED|Overall Study||1
10851932|NCT03639558|12018270|FG001|NOT COMPLETED|Overall Study||5
10851933|NCT03630770|12018278|FG000|STARTED|Overall Study||4
10851934|NCT03630770|12018279|FG001|STARTED|Overall Study||8
10851935|NCT03630770|12018278|FG000|COMPLETED|Overall Study||4
10851936|NCT03630770|12018279|FG001|COMPLETED|Overall Study||8
10851937|NCT03630770|12018278|FG000|NOT COMPLETED|Overall Study||0
10851938|NCT03630770|12018279|FG001|NOT COMPLETED|Overall Study||0
10851939|NCT03387852|12018289|FG000|STARTED|Overall Study||74
10851940|NCT03387852|12018290|FG001|STARTED|Overall Study||73
10851941|NCT03387852|12018291|FG002|STARTED|Overall Study||74
10851942|NCT03387852|12018292|FG003|STARTED|Overall Study||75
10851943|NCT03387852|12018289|FG000|Treated|Overall Study||74
10851944|NCT03387852|12018290|FG001|Treated|Overall Study||73
10851945|NCT03387852|12018291|FG002|Treated|Overall Study||74
10851946|NCT03387852|12018292|FG003|Treated|Overall Study||74
10851947|NCT03387852|12018289|FG000|COMPLETED|Overall Study||41
10851948|NCT03387852|12018290|FG001|COMPLETED|Overall Study||55
10851949|NCT03387852|12018291|FG002|COMPLETED|Overall Study||47
10851950|NCT03387852|12018292|FG003|COMPLETED|Overall Study||56
10851951|NCT03387852|12018289|FG000|NOT COMPLETED|Overall Study||33
10851952|NCT03387852|12018290|FG001|NOT COMPLETED|Overall Study||18
10851953|NCT03387852|12018291|FG002|NOT COMPLETED|Overall Study||27
10851954|NCT03387852|12018292|FG003|NOT COMPLETED|Overall Study||19
10851955|NCT03382574|12018303|FG000|STARTED|Overall Study||0
10851956|NCT03382574|12018303|FG000|COMPLETED|Overall Study||0
10851957|NCT03382574|12018303|FG000|NOT COMPLETED|Overall Study||0
10851958|NCT03364673|12018309|FG000|STARTED|Overall Study||29
10851959|NCT03364673|12018309|FG000|COMPLETED|Overall Study||24
10851960|NCT03364673|12018309|FG000|NOT COMPLETED|Overall Study||5
10851961|NCT03343704|12018315|FG000|STARTED|Overall Study||13
10851962|NCT03343704|12018316|FG001|STARTED|Overall Study||6
10851963|NCT03343704|12018315|FG000|COMPLETED|Overall Study||12
10851964|NCT03343704|12018316|FG001|COMPLETED|Overall Study||4
10851965|NCT03343704|12018315|FG000|NOT COMPLETED|Overall Study||1
10851966|NCT03343704|12018316|FG001|NOT COMPLETED|Overall Study||2
10851967|NCT03265145|12018326|FG000|STARTED|Overall Study||356
10851968|NCT03265145|12018327|FG001|STARTED|Overall Study||358
10851969|NCT03265145|12018326|FG000|COMPLETED|Overall Study||285
10851970|NCT03265145|12018327|FG001|COMPLETED|Overall Study||302
10851971|NCT03265145|12018326|FG000|NOT COMPLETED|Overall Study||71
10851972|NCT03265145|12018327|FG001|NOT COMPLETED|Overall Study||56
10851973|NCT03219164|12018336|FG000|STARTED|Overall Study||74
10851974|NCT03219164|12018337|FG001|STARTED|Overall Study||75
10851975|NCT03219164|12018336|FG000|COMPLETED|Overall Study||49
10851976|NCT03219164|12018337|FG001|COMPLETED|Overall Study||57
10851977|NCT03219164|12018336|FG000|NOT COMPLETED|Overall Study||25
10851978|NCT03219164|12018337|FG001|NOT COMPLETED|Overall Study||18
10851979|NCT03143153|12018346|FG000|STARTED|Pre-Treatment||325
10851980|NCT03143153|12018347|FG001|STARTED|Pre-Treatment||321
10851981|NCT03143153|12018348|FG002|STARTED|Pre-Treatment||324
10851982|NCT03143153|12018346|FG000|COMPLETED|Pre-Treatment||322
10851983|NCT03143153|12018347|FG001|COMPLETED|Pre-Treatment||310
10851984|NCT03143153|12018348|FG002|COMPLETED|Pre-Treatment||304
10851985|NCT03143153|12018346|FG000|NOT COMPLETED|Pre-Treatment||3
10851986|NCT03143153|12018347|FG001|NOT COMPLETED|Pre-Treatment||11
10851987|NCT03143153|12018348|FG002|NOT COMPLETED|Pre-Treatment||20
10851988|NCT03143153|12018346|FG000|STARTED|Treatment||322
10851989|NCT03143153|12018347|FG001|STARTED|Treatment||310
10851990|NCT03143153|12018348|FG002|STARTED|Treatment||304
10851991|NCT03143153|12018346|FG000|COMPLETED|Treatment||21
10851992|NCT03143153|12018347|FG001|COMPLETED|Treatment||25
10851993|NCT03143153|12018348|FG002|COMPLETED|Treatment||4
10851994|NCT03143153|12018346|FG000|NOT COMPLETED|Treatment||301
10851995|NCT03143153|12018347|FG001|NOT COMPLETED|Treatment||285
10851996|NCT03143153|12018348|FG002|NOT COMPLETED|Treatment||300
10851997|NCT03104413|12018359|FG000|STARTED|Induction Period 1||207
10851998|NCT03104413|12018360|FG001|STARTED|Induction Period 1||206
10851999|NCT03104413|12018361|FG002|STARTED|Induction Period 1||205
10852001|NCT03104413|12018363|FG004|STARTED|Induction Period 1||0
10852002|NCT03104413|12018364|FG005|STARTED|Induction Period 1||0
10852003|NCT03104413|12018365|FG006|STARTED|Induction Period 1||0
10852004|NCT03104413|12018359|FG000|COMPLETED|Induction Period 1||186
10852005|NCT03104413|12018360|FG001|COMPLETED|Induction Period 1||202
10852006|NCT03104413|12018361|FG002|COMPLETED|Induction Period 1||199
10852007|NCT03104413|12018362|FG003|COMPLETED|Induction Period 1||0
10852008|NCT03104413|12018363|FG004|COMPLETED|Induction Period 1||0
10852009|NCT03104413|12018364|FG005|COMPLETED|Induction Period 1||0
10852010|NCT03104413|12018365|FG006|COMPLETED|Induction Period 1||0
10852011|NCT03104413|12018359|FG000|NOT COMPLETED|Induction Period 1||21
10852012|NCT03104413|12018360|FG001|NOT COMPLETED|Induction Period 1||4
10852013|NCT03104413|12018361|FG002|NOT COMPLETED|Induction Period 1||6
10852014|NCT03104413|12018362|FG003|NOT COMPLETED|Induction Period 1||0
10852015|NCT03104413|12018363|FG004|NOT COMPLETED|Induction Period 1||0
10852016|NCT03104413|12018364|FG005|NOT COMPLETED|Induction Period 1||0
10852017|NCT03104413|12018365|FG006|NOT COMPLETED|Induction Period 1||0
10852018|NCT03104413|12018359|FG000|STARTED|Induction Period 2||0
10852019|NCT03104413|12018360|FG001|STARTED|Induction Period 2||0
10852020|NCT03104413|12018361|FG002|STARTED|Induction Period 2||0
10852021|NCT03104413|12018362|FG003|STARTED|Induction Period 2||41
10852022|NCT03104413|12018363|FG004|STARTED|Induction Period 2||42
10852023|NCT03104413|12018364|FG005|STARTED|Induction Period 2||42
10852024|NCT03104413|12018365|FG006|STARTED|Induction Period 2||86
10852025|NCT03104413|12018359|FG000|COMPLETED|Induction Period 2||0
10852026|NCT03104413|12018360|FG001|COMPLETED|Induction Period 2||0
10852027|NCT03104413|12018361|FG002|COMPLETED|Induction Period 2||0
10852028|NCT03104413|12018362|FG003|COMPLETED|Induction Period 2||39
10852029|NCT03104413|12018363|FG004|COMPLETED|Induction Period 2||39
10852030|NCT03104413|12018364|FG005|COMPLETED|Induction Period 2||38
10852031|NCT03104413|12018365|FG006|COMPLETED|Induction Period 2||76
10852032|NCT03104413|12018359|FG000|NOT COMPLETED|Induction Period 2||0
10852033|NCT03104413|12018360|FG001|NOT COMPLETED|Induction Period 2||0
10852034|NCT03104413|12018361|FG002|NOT COMPLETED|Induction Period 2||0
10852035|NCT03104413|12018362|FG003|NOT COMPLETED|Induction Period 2||2
10852036|NCT03104413|12018363|FG004|NOT COMPLETED|Induction Period 2||3
10852037|NCT03104413|12018364|FG005|NOT COMPLETED|Induction Period 2||4
10852038|NCT03104413|12018365|FG006|NOT COMPLETED|Induction Period 2||10
10852039|NCT02930590|12018379|FG000|STARTED|First Intervention (2 Hours)||3
10852040|NCT02930590|12018380|FG001|STARTED|First Intervention (2 Hours)||3
10852041|NCT02930590|12018381|FG002|STARTED|First Intervention (2 Hours)||3
10852042|NCT02930590|12018382|FG003|STARTED|First Intervention (2 Hours)||2
10852043|NCT02930590|12018383|FG004|STARTED|First Intervention (2 Hours)||2
10852044|NCT02930590|12018384|FG005|STARTED|First Intervention (2 Hours)||2
10852045|NCT02930590|12018379|FG000|COMPLETED|First Intervention (2 Hours)||3
10852046|NCT02930590|12018380|FG001|COMPLETED|First Intervention (2 Hours)||3
10852047|NCT02930590|12018381|FG002|COMPLETED|First Intervention (2 Hours)||3
10852048|NCT02930590|12018382|FG003|COMPLETED|First Intervention (2 Hours)||2
10852049|NCT02930590|12018383|FG004|COMPLETED|First Intervention (2 Hours)||2
10852050|NCT02930590|12018384|FG005|COMPLETED|First Intervention (2 Hours)||2
10852051|NCT02930590|12018379|FG000|NOT COMPLETED|First Intervention (2 Hours)||0
10852052|NCT02930590|12018380|FG001|NOT COMPLETED|First Intervention (2 Hours)||0
10852053|NCT02930590|12018381|FG002|NOT COMPLETED|First Intervention (2 Hours)||0
10852054|NCT02930590|12018382|FG003|NOT COMPLETED|First Intervention (2 Hours)||0
10852055|NCT02930590|12018383|FG004|NOT COMPLETED|First Intervention (2 Hours)||0
10852056|NCT02930590|12018384|FG005|NOT COMPLETED|First Intervention (2 Hours)||0
10852057|NCT02930590|12018379|FG000|STARTED|Second Intervention (2 Hours)||3
10852058|NCT02930590|12018380|FG001|STARTED|Second Intervention (2 Hours)||3
10852059|NCT02930590|12018381|FG002|STARTED|Second Intervention (2 Hours)||3
10852060|NCT02930590|12018382|FG003|STARTED|Second Intervention (2 Hours)||2
10852061|NCT02930590|12018383|FG004|STARTED|Second Intervention (2 Hours)||2
10852062|NCT02930590|12018384|FG005|STARTED|Second Intervention (2 Hours)||2
10852063|NCT02930590|12018379|FG000|COMPLETED|Second Intervention (2 Hours)||3
10852064|NCT02930590|12018380|FG001|COMPLETED|Second Intervention (2 Hours)||3
10852065|NCT02930590|12018381|FG002|COMPLETED|Second Intervention (2 Hours)||3
10852066|NCT02930590|12018382|FG003|COMPLETED|Second Intervention (2 Hours)||2
10852067|NCT02930590|12018383|FG004|COMPLETED|Second Intervention (2 Hours)||2
10852068|NCT02930590|12018384|FG005|COMPLETED|Second Intervention (2 Hours)||2
10852069|NCT02930590|12018379|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0
10852070|NCT02930590|12018380|FG001|NOT COMPLETED|Second Intervention (2 Hours)||0
10852071|NCT02930590|12018381|FG002|NOT COMPLETED|Second Intervention (2 Hours)||0
10852072|NCT02930590|12018382|FG003|NOT COMPLETED|Second Intervention (2 Hours)||0
10852073|NCT02930590|12018383|FG004|NOT COMPLETED|Second Intervention (2 Hours)||0
10852074|NCT02930590|12018384|FG005|NOT COMPLETED|Second Intervention (2 Hours)||0
10852075|NCT02930590|12018379|FG000|STARTED|Third Intervention (2 Hours)||3
10852076|NCT02930590|12018380|FG001|STARTED|Third Intervention (2 Hours)||3
10852077|NCT02930590|12018381|FG002|STARTED|Third Intervention (2 Hours)||3
10852078|NCT02930590|12018382|FG003|STARTED|Third Intervention (2 Hours)||2
10852079|NCT02930590|12018383|FG004|STARTED|Third Intervention (2 Hours)||2
10852080|NCT02930590|12018384|FG005|STARTED|Third Intervention (2 Hours)||2
10852081|NCT02930590|12018379|FG000|COMPLETED|Third Intervention (2 Hours)||3
10852082|NCT02930590|12018380|FG001|COMPLETED|Third Intervention (2 Hours)||3
10852083|NCT02930590|12018381|FG002|COMPLETED|Third Intervention (2 Hours)||3
10852084|NCT02930590|12018382|FG003|COMPLETED|Third Intervention (2 Hours)||2
10852085|NCT02930590|12018383|FG004|COMPLETED|Third Intervention (2 Hours)||2
10852086|NCT02930590|12018384|FG005|COMPLETED|Third Intervention (2 Hours)||2
10852087|NCT02930590|12018379|FG000|NOT COMPLETED|Third Intervention (2 Hours)||0
10852088|NCT02930590|12018380|FG001|NOT COMPLETED|Third Intervention (2 Hours)||0
10852089|NCT02930590|12018381|FG002|NOT COMPLETED|Third Intervention (2 Hours)||0
10852090|NCT02930590|12018382|FG003|NOT COMPLETED|Third Intervention (2 Hours)||0
10852091|NCT02930590|12018383|FG004|NOT COMPLETED|Third Intervention (2 Hours)||0
10852092|NCT02930590|12018384|FG005|NOT COMPLETED|Third Intervention (2 Hours)||0
10852093|NCT02921789|12018396|FG000|STARTED|Overall Study||34
10852094|NCT02921789|12018397|FG001|STARTED|Overall Study||29
10852095|NCT02921789|12018396|FG000|Randomized and Took Study Drug|Overall Study||34
10852096|NCT02921789|12018397|FG001|Randomized and Took Study Drug|Overall Study||29
10852097|NCT02921789|12018396|FG000|COMPLETED|Overall Study||26
10852098|NCT02921789|12018397|FG001|COMPLETED|Overall Study||25
10852099|NCT02921789|12018396|FG000|NOT COMPLETED|Overall Study||8
10852100|NCT02921789|12018397|FG001|NOT COMPLETED|Overall Study||4
10852101|NCT02898077|12018405|FG000|STARTED|Overall Study||294
10852102|NCT02898077|12018406|FG001|STARTED|Overall Study||146
10852103|NCT02898077|12018405|FG000|Received at Least 1 Dose of Study Drug|Overall Study||293
10852104|NCT02898077|12018406|FG001|Received at Least 1 Dose of Study Drug|Overall Study||145
10852105|NCT02898077|12018405|FG000|COMPLETED|Overall Study||246
10852106|NCT02898077|12018406|FG001|COMPLETED|Overall Study||123
10852107|NCT02898077|12018405|FG000|NOT COMPLETED|Overall Study||48
10852108|NCT02898077|12018406|FG001|NOT COMPLETED|Overall Study||23
10852109|NCT02702271|12018414|FG000|STARTED|Overall Study||400
10852110|NCT02702271|12018415|FG001|STARTED|Overall Study||58
10852111|NCT02702271|12018414|FG000|COMPLETED|Overall Study||337
10852112|NCT02702271|12018415|FG001|COMPLETED|Overall Study||49
10852113|NCT02702271|12018414|FG000|NOT COMPLETED|Overall Study||63
10852114|NCT02702271|12018415|FG001|NOT COMPLETED|Overall Study||9
10852115|NCT02658136|12018421|FG000|STARTED|Overall Study|Approved to start in year 2016. Goal was to reach 15 participants (1 day study).|15
10852116|NCT02658136|12018421|FG000|COMPLETED|Overall Study|Date of end of study: June 2017, N=15|15
10852117|NCT02658136|12018421|FG000|NOT COMPLETED|Overall Study||0
10852118|NCT02558634|12018426|FG000|STARTED|Blinded: First Intervention (3 Months)||4
10852119|NCT02558634|12018427|FG001|STARTED|Blinded: First Intervention (3 Months)||2
10852120|NCT02558634|12018426|FG000|COMPLETED|Blinded: First Intervention (3 Months)||4
10852121|NCT02558634|12018427|FG001|COMPLETED|Blinded: First Intervention (3 Months)||2
10852122|NCT02558634|12018426|FG000|NOT COMPLETED|Blinded: First Intervention (3 Months)||0
10852123|NCT02558634|12018427|FG001|NOT COMPLETED|Blinded: First Intervention (3 Months)||0
10852124|NCT02558634|12018426|FG000|STARTED|Blinded: Second Intervention (3 Months)||4
10852125|NCT02558634|12018427|FG001|STARTED|Blinded: Second Intervention (3 Months)||2
10852126|NCT02558634|12018426|FG000|COMPLETED|Blinded: Second Intervention (3 Months)|Assessed after 2 weeks - 1 participant requested to have their DBS 'on'|3
10852127|NCT02558634|12018427|FG001|COMPLETED|Blinded: Second Intervention (3 Months)||2
10852128|NCT02558634|12018426|FG000|NOT COMPLETED|Blinded: Second Intervention (3 Months)||1
10852129|NCT02558634|12018427|FG001|NOT COMPLETED|Blinded: Second Intervention (3 Months)||0
10852130|NCT02558634|12018426|FG000|STARTED|Unblinded: DBS on (6 Months)||4
10852131|NCT02558634|12018427|FG001|STARTED|Unblinded: DBS on (6 Months)||2
10852132|NCT02558634|12018426|FG000|COMPLETED|Unblinded: DBS on (6 Months)||4
10852133|NCT02558634|12018427|FG001|COMPLETED|Unblinded: DBS on (6 Months)||2
10852134|NCT02558634|12018426|FG000|NOT COMPLETED|Unblinded: DBS on (6 Months)||0
10852135|NCT02558634|12018427|FG001|NOT COMPLETED|Unblinded: DBS on (6 Months)||0
10852136|NCT02471339|12018439|FG000|STARTED|Overall Study||32
10852137|NCT02471339|12018440|FG001|STARTED|Overall Study||34
10852138|NCT02471339|12018439|FG000|COMPLETED|Overall Study||30
10852139|NCT02471339|12018440|FG001|COMPLETED|Overall Study||34
10852140|NCT02471339|12018439|FG000|NOT COMPLETED|Overall Study||2
10852141|NCT02471339|12018440|FG001|NOT COMPLETED|Overall Study||0
10852142|NCT02470585|12018449|FG000|STARTED|Overall Study||375
10852143|NCT02470585|12018450|FG001|STARTED|Overall Study||383
10852144|NCT02470585|12018451|FG002|STARTED|Overall Study||382
10852145|NCT02470585|12018449|FG000|Received Study Drug|Overall Study||371
10852146|NCT02470585|12018450|FG001|Received Study Drug|Overall Study||376
10852147|NCT02470585|12018451|FG002|Received Study Drug|Overall Study||377
10852148|NCT02470585|12018449|FG000|COMPLETED|Overall Study||268
10852149|NCT02470585|12018450|FG001|COMPLETED|Overall Study||266
10852150|NCT02470585|12018451|FG002|COMPLETED|Overall Study||257
10852151|NCT02470585|12018449|FG000|NOT COMPLETED|Overall Study||107
11225171|NCT01990703|12417381|FG000|STARTED|Overall Study||147
11225172|NCT01990703|12417382|FG001|STARTED|Overall Study||138
11225173|NCT01990703|12417381|FG000|COMPLETED|Overall Study||108
11225174|NCT01990703|12417382|FG001|COMPLETED|Overall Study||93
11225175|NCT01990703|12417381|FG000|NOT COMPLETED|Overall Study||39
11225176|NCT01990703|12417382|FG001|NOT COMPLETED|Overall Study||45
11225177|NCT01990742|12417390|FG000|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
11225178|NCT01990742|12417391|FG001|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
11225179|NCT01990742|12417390|FG000|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
11225180|NCT01990742|12417391|FG001|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
11225181|NCT01990742|12417390|FG000|NOT COMPLETED|Overall Study||407
11225182|NCT01990742|12417391|FG001|NOT COMPLETED|Overall Study||1353
11225183|NCT01990768|12417400|FG000|STARTED|Intervention Started||345
11225184|NCT01990768|12417401|FG001|STARTED|Intervention Started||345
11225185|NCT01990768|12417402|FG002|STARTED|Intervention Started||373
11225186|NCT01990768|12417400|FG000|COMPLETED|Intervention Started||309
11225187|NCT01990768|12417401|FG001|COMPLETED|Intervention Started||312
11225188|NCT01990768|12417402|FG002|COMPLETED|Intervention Started||346
11225189|NCT01990768|12417400|FG000|NOT COMPLETED|Intervention Started||36
11225190|NCT01990768|12417401|FG001|NOT COMPLETED|Intervention Started||33
11225191|NCT01990768|12417402|FG002|NOT COMPLETED|Intervention Started||27
11225192|NCT01990768|12417400|FG000|STARTED|Prehospital Study Drug Infusion||309
11225193|NCT01990768|12417401|FG001|STARTED|Prehospital Study Drug Infusion||312
11225194|NCT01990768|12417402|FG002|STARTED|Prehospital Study Drug Infusion||346
11225195|NCT01990768|12417400|FG000|COMPLETED|Prehospital Study Drug Infusion||290
11225196|NCT01990768|12417401|FG001|COMPLETED|Prehospital Study Drug Infusion||285
11225197|NCT01990768|12417402|FG002|COMPLETED|Prehospital Study Drug Infusion||327
11225198|NCT01990768|12417400|FG000|NOT COMPLETED|Prehospital Study Drug Infusion||19
11225199|NCT01990768|12417401|FG001|NOT COMPLETED|Prehospital Study Drug Infusion||27
11225200|NCT01990768|12417402|FG002|NOT COMPLETED|Prehospital Study Drug Infusion||19
11225201|NCT01990768|12417400|FG000|STARTED|In-Hospital Study Drug Infusion||309
11225202|NCT01990768|12417401|FG001|STARTED|In-Hospital Study Drug Infusion||312
10852152|NCT02470585|12018450|FG001|NOT COMPLETED|Overall Study||117
10852153|NCT02470585|12018451|FG002|NOT COMPLETED|Overall Study||125
10852154|NCT02426749|12018461|FG000|STARTED|Overall Study||12
10852155|NCT02426749|12018462|FG001|STARTED|Overall Study||10
10852156|NCT02426749|12018461|FG000|COMPLETED|Overall Study||9
11225203|NCT01990768|12417402|FG002|STARTED|In-Hospital Study Drug Infusion||346
11225204|NCT01990768|12417400|FG000|COMPLETED|In-Hospital Study Drug Infusion||214
11225205|NCT01990768|12417401|FG001|COMPLETED|In-Hospital Study Drug Infusion||229
11225206|NCT01990768|12417402|FG002|COMPLETED|In-Hospital Study Drug Infusion||266
11225207|NCT01990768|12417400|FG000|NOT COMPLETED|In-Hospital Study Drug Infusion||95
10852157|NCT02426749|12018462|FG001|COMPLETED|Overall Study||9
10852158|NCT02426749|12018461|FG000|NOT COMPLETED|Overall Study||3
10852159|NCT02426749|12018462|FG001|NOT COMPLETED|Overall Study||1
10852160|NCT02318264|12018472|FG000|STARTED|Overall Study||8
10852161|NCT02318264|12018473|FG001|STARTED|Overall Study||7
10852162|NCT02318264|12018472|FG000|COMPLETED|Overall Study||8
10852163|NCT02318264|12018473|FG001|COMPLETED|Overall Study||7
10852164|NCT02318264|12018472|FG000|NOT COMPLETED|Overall Study||0
10852165|NCT02318264|12018473|FG001|NOT COMPLETED|Overall Study||0
10852166|NCT02163694|12018482|FG000|STARTED|Overall Study||172
10852167|NCT02163694|12018483|FG001|STARTED|Overall Study||337
10852168|NCT02163694|12018482|FG000|COMPLETED|Overall Study||18
10852169|NCT02163694|12018483|FG001|COMPLETED|Overall Study||70
10852170|NCT02163694|12018482|FG000|NOT COMPLETED|Overall Study||154
10852171|NCT02163694|12018483|FG001|NOT COMPLETED|Overall Study||267
11106335|NCT01258738|12290817|FG001|COMPLETED|Open-label Period||85
11106336|NCT01258738|12290816|FG000|NOT COMPLETED|Open-label Period||17
11106337|NCT01258738|12290817|FG001|NOT COMPLETED|Open-label Period||21
11106338|NCT01258790|12290825|FG000|STARTED|Overall Study||6
11106339|NCT01258790|12290826|FG001|STARTED|Overall Study||6
10852172|NCT01966471|12018491|FG000|STARTED|Overall Study||918
10852173|NCT01966471|12018492|FG001|STARTED|Overall Study||928
10852174|NCT01966471|12018491|FG000|COMPLETED|Overall Study||0
11106340|NCT01258790|12290825|FG000|COMPLETED|Overall Study||6
11106341|NCT01258790|12290826|FG001|COMPLETED|Overall Study||6
11106342|NCT01258790|12290825|FG000|NOT COMPLETED|Overall Study||0
11106343|NCT01258790|12290826|FG001|NOT COMPLETED|Overall Study||0
11106344|NCT01258855|12290834|FG000|STARTED|Overall Study||55
11106345|NCT01258855|12290835|FG001|STARTED|Overall Study||29
11106346|NCT01258855|12290834|FG000|COMPLETED|Overall Study||55
11106347|NCT01258855|12290835|FG001|COMPLETED|Overall Study||29
11106348|NCT01258855|12290834|FG000|NOT COMPLETED|Overall Study||0
11106349|NCT01258855|12290835|FG001|NOT COMPLETED|Overall Study||0
11106350|NCT01258985|12290843|FG000|STARTED|Overall Study||106
11106351|NCT01258985|12290844|FG001|STARTED|Overall Study||98
11106352|NCT01258985|12290843|FG000|COMPLETED|Overall Study||106
11106353|NCT01258985|12290844|FG001|COMPLETED|Overall Study||98
11106354|NCT01258985|12290843|FG000|NOT COMPLETED|Overall Study||0
11106355|NCT01258985|12290844|FG001|NOT COMPLETED|Overall Study||0
11106356|NCT01258998|12290850|FG000|STARTED|Overall Study||60
11106357|NCT01258998|12290850|FG000|COMPLETED|Overall Study||59
11106358|NCT01258998|12290850|FG000|NOT COMPLETED|Overall Study||1
11106359|NCT01259011|12290856|FG000|STARTED|Main Study Period|101 dyads (=202 individuals)|101
11106360|NCT01259011|12290857|FG001|STARTED|Main Study Period|109 dyads (=218 individuals)|109
11106361|NCT01259011|12290856|FG000|COMPLETED|Main Study Period||101
11106362|NCT01259011|12290857|FG001|COMPLETED|Main Study Period||109
11106363|NCT01259011|12290856|FG000|NOT COMPLETED|Main Study Period||0
11106364|NCT01259011|12290857|FG001|NOT COMPLETED|Main Study Period||0
11106365|NCT01259011|12290856|FG000|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
11106366|NCT01259011|12290857|FG001|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
11106367|NCT01259011|12290856|FG000|COMPLETED|After Patient Death||17
11106368|NCT01259011|12290857|FG001|COMPLETED|After Patient Death||28
11106369|NCT01259011|12290856|FG000|NOT COMPLETED|After Patient Death||0
11106370|NCT01259011|12290857|FG001|NOT COMPLETED|After Patient Death||0
11106371|NCT01259063|12290865|FG000|STARTED|Overall Study||33
11225208|NCT01990768|12417401|FG001|NOT COMPLETED|In-Hospital Study Drug Infusion||83
11225209|NCT01990768|12417402|FG002|NOT COMPLETED|In-Hospital Study Drug Infusion||80
11225210|NCT01990768|12417400|FG000|STARTED|6-Month Follow-up||309
11225211|NCT01990768|12417401|FG001|STARTED|6-Month Follow-up||312
11225212|NCT01990768|12417402|FG002|STARTED|6-Month Follow-up||346
11225213|NCT01990768|12417400|FG000|COMPLETED|6-Month Follow-up||270
11225214|NCT01990768|12417401|FG001|COMPLETED|6-Month Follow-up||261
11225215|NCT01990768|12417402|FG002|COMPLETED|6-Month Follow-up||288
11225216|NCT01990768|12417400|FG000|NOT COMPLETED|6-Month Follow-up||39
11225217|NCT01990768|12417401|FG001|NOT COMPLETED|6-Month Follow-up||51
11225218|NCT01990768|12417402|FG002|NOT COMPLETED|6-Month Follow-up||58
11225219|NCT01990794|12417411|FG000|STARTED|Overall Study||13
11225220|NCT01990794|12417411|FG000|One Month Into Study|Overall Study||10
11225221|NCT01990794|12417411|FG000|COMPLETED|Overall Study||10
11225222|NCT01990794|12417411|FG000|NOT COMPLETED|Overall Study||3
11225223|NCT01990820|12417500|FG000|STARTED|Overall Study||13
11225224|NCT01990820|12417501|FG001|STARTED|Overall Study||12
11225225|NCT01990820|12417500|FG000|COMPLETED|Overall Study||13
11225226|NCT01990820|12417501|FG001|COMPLETED|Overall Study||12
11225227|NCT01990820|12417500|FG000|NOT COMPLETED|Overall Study||0
11225228|NCT01990820|12417501|FG001|NOT COMPLETED|Overall Study||0
11225229|NCT01990859|12417507|FG000|STARTED|Treatment (4 Doses Over 12 Weeks)||20
11225230|NCT01990859|12417507|FG000|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
11225231|NCT01990859|12417507|FG000|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
11225232|NCT01990859|12417507|FG000|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
11225233|NCT01990859|12417507|FG000|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
11225234|NCT01990859|12417507|FG000|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
11225235|NCT01990859|12417507|FG000|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
11225236|NCT01990859|12417507|FG000|COMPLETED|90 Day Follow Up for All Participants||20
11225237|NCT01990859|12417507|FG000|NOT COMPLETED|90 Day Follow Up for All Participants||0
11225238|NCT01990898|12417512|FG000|STARTED|Overall Study||26
11225239|NCT01990898|12417512|FG000|3 Months|Overall Study||22
11225240|NCT01990898|12417512|FG000|COMPLETED|Overall Study||22
11225241|NCT01990898|12417512|FG000|NOT COMPLETED|Overall Study||4
11225242|NCT01990950|12417516|FG000|STARTED|Overall Study||21
11225243|NCT01990950|12417516|FG000|COMPLETED|Overall Study||10
11225244|NCT01990950|12417516|FG000|NOT COMPLETED|Overall Study||11
11225245|NCT01991197|12417522|FG000|STARTED|Overall Study||9
11225246|NCT01991197|12417523|FG001|STARTED|Overall Study||11
11225247|NCT01991197|12417522|FG000|COMPLETED|Overall Study||6
11225248|NCT01991197|12417523|FG001|COMPLETED|Overall Study||8
11225249|NCT01991197|12417522|FG000|NOT COMPLETED|Overall Study||3
11225250|NCT01991197|12417523|FG001|NOT COMPLETED|Overall Study||3
11225251|NCT01991314|12417536|FG000|STARTED|Overall Study||45
11354680|NCT03074500|12551741|FG001|NOT COMPLETED|Overall Study||1
10852175|NCT01966471|12018492|FG001|COMPLETED|Overall Study|There is a difference in the death count displayed here and in the All-Cause Mortality section under Adverse Events. The difference relates to a participant that died and who was randomized to the AC-KP arm, but never received trastuzumab emtansine. Consequently they were assigned to the AC-THP for safety analyses. This death counts in the AC-KP arm when summary is based on the ITT population, but counts in the AC-THP arm when the summary on the safety population.|0
10852176|NCT01966471|12018491|FG000|NOT COMPLETED|Overall Study||918
10852177|NCT01966471|12018492|FG001|NOT COMPLETED|Overall Study||928
10852178|NCT01871220|12018500|FG000|STARTED|Overall Study||29
10852179|NCT01871220|12018501|FG001|STARTED|Overall Study||32
10852180|NCT01871220|12018500|FG000|COMPLETED|Overall Study||25
10852181|NCT01871220|12018501|FG001|COMPLETED|Overall Study||29
10852182|NCT01871220|12018500|FG000|NOT COMPLETED|Overall Study||4
10852183|NCT01871220|12018501|FG001|NOT COMPLETED|Overall Study||3
10852184|NCT01825187|12018509|FG000|STARTED|Overall Study||25
10852185|NCT01825187|12018510|FG001|STARTED|Overall Study||25
10852186|NCT01825187|12018511|FG002|STARTED|Overall Study||25
10852187|NCT01825187|12018509|FG000|COMPLETED|Overall Study||24
10852188|NCT01825187|12018510|FG001|COMPLETED|Overall Study||24
10852189|NCT01825187|12018511|FG002|COMPLETED|Overall Study||24
10852190|NCT01825187|12018509|FG000|NOT COMPLETED|Overall Study||1
10852191|NCT01825187|12018510|FG001|NOT COMPLETED|Overall Study||1
10852192|NCT01825187|12018511|FG002|NOT COMPLETED|Overall Study||1
10852193|NCT01465334|12018522|FG000|STARTED|Overall Study||15
10852194|NCT01465334|12018523|FG001|STARTED|Overall Study||15
10852195|NCT01465334|12018522|FG000|Complete Part A Induction|Overall Study||12
10852196|NCT01465334|12018523|FG001|Complete Part A Induction|Overall Study||15
10852197|NCT01465334|12018522|FG000|Complete Part B Induction|Overall Study||7
10852198|NCT01465334|12018523|FG001|Complete Part B Induction|Overall Study||15
10852199|NCT01465334|12018522|FG000|Eligible for Allogeneic Transplant|Overall Study||9
10852200|NCT01465334|12018523|FG001|Eligible for Allogeneic Transplant|Overall Study||9
10852201|NCT01465334|12018522|FG000|COMPLETED|Overall Study||13
10852202|NCT01465334|12018523|FG001|COMPLETED|Overall Study||9
10852203|NCT01465334|12018522|FG000|NOT COMPLETED|Overall Study||2
10852204|NCT01465334|12018523|FG001|NOT COMPLETED|Overall Study||6
10852205|NCT01307423|12018532|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
10852206|NCT01307423|12018533|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
10852207|NCT01307423|12018534|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
10852208|NCT01307423|12018535|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10852209|NCT01307423|12018536|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10852210|NCT01307423|12018537|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10852211|NCT01307423|12018538|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10852212|NCT01307423|12018539|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10852213|NCT01307423|12018540|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
10852214|NCT01307423|12018532|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
10852215|NCT01307423|12018533|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
10852216|NCT01307423|12018534|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
10852217|NCT01307423|12018535|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10852218|NCT01307423|12018536|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10852219|NCT01307423|12018537|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10852220|NCT01307423|12018538|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10852221|NCT01307423|12018539|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10852222|NCT01307423|12018540|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
10852223|NCT01307423|12018532|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
10852224|NCT01307423|12018533|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
10852225|NCT01307423|12018534|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
10852226|NCT01307423|12018535|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852227|NCT01307423|12018536|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852228|NCT01307423|12018537|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852229|NCT01307423|12018538|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852230|NCT01307423|12018539|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852231|NCT01307423|12018540|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852232|NCT01307423|12018532|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
10852233|NCT01307423|12018533|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
10852234|NCT01307423|12018534|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
10852235|NCT01307423|12018535|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852236|NCT01307423|12018536|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852237|NCT01307423|12018537|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852238|NCT01307423|12018538|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852239|NCT01307423|12018539|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852240|NCT01307423|12018540|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
10852241|NCT01307423|12018532|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
10852242|NCT01307423|12018533|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
10852243|NCT01307423|12018534|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
10852244|NCT01307423|12018535|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852245|NCT01307423|12018536|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852246|NCT01307423|12018537|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852247|NCT01307423|12018538|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852248|NCT01307423|12018539|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852249|NCT01307423|12018540|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852250|NCT01307423|12018532|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
10852251|NCT01307423|12018533|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
10852252|NCT01307423|12018534|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
10852253|NCT01307423|12018535|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852254|NCT01307423|12018536|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852255|NCT01307423|12018537|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852256|NCT01307423|12018538|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852257|NCT01307423|12018539|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852258|NCT01307423|12018540|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
10852259|NCT01307423|12018532|FG000|STARTED|Active Treatment Phase (Week 25-52)||0
10852260|NCT01307423|12018533|FG001|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
10852261|NCT01307423|12018534|FG002|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
10852262|NCT01307423|12018535|FG003|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
10852263|NCT01307423|12018536|FG004|STARTED|Active Treatment Phase (Week 25-52)||26
10852264|NCT01307423|12018537|FG005|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
10852265|NCT01307423|12018538|FG006|STARTED|Active Treatment Phase (Week 25-52)||26
10852266|NCT01307423|12018539|FG007|STARTED|Active Treatment Phase (Week 25-52)||0
10852267|NCT01307423|12018540|FG008|STARTED|Active Treatment Phase (Week 25-52)||0
10852268|NCT01307423|12018532|FG000|COMPLETED|Active Treatment Phase (Week 25-52)||0
10852269|NCT01307423|12018533|FG001|COMPLETED|Active Treatment Phase (Week 25-52)||132
10852270|NCT01307423|12018534|FG002|COMPLETED|Active Treatment Phase (Week 25-52)||141
10852271|NCT01307423|12018535|FG003|COMPLETED|Active Treatment Phase (Week 25-52)||38
10852272|NCT01307423|12018536|FG004|COMPLETED|Active Treatment Phase (Week 25-52)||23
10852273|NCT01307423|12018537|FG005|COMPLETED|Active Treatment Phase (Week 25-52)||43
10852274|NCT01307423|12018538|FG006|COMPLETED|Active Treatment Phase (Week 25-52)||25
10852275|NCT01307423|12018539|FG007|COMPLETED|Active Treatment Phase (Week 25-52)||0
10852276|NCT01307423|12018540|FG008|COMPLETED|Active Treatment Phase (Week 25-52)||0
10852277|NCT01307423|12018532|FG000|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
10852278|NCT01307423|12018533|FG001|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
10852279|NCT01307423|12018534|FG002|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
10852280|NCT01307423|12018535|FG003|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
10852281|NCT01307423|12018536|FG004|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
10852282|NCT01307423|12018537|FG005|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
10852283|NCT01307423|12018538|FG006|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
10852284|NCT01307423|12018539|FG007|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
10852285|NCT01307423|12018540|FG008|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
10852286|NCT01307423|12018532|FG000|STARTED|Long-term Safety Phase (Year 2)||0
10852287|NCT01307423|12018533|FG001|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
10852288|NCT01307423|12018534|FG002|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
10852289|NCT01307423|12018535|FG003|STARTED|Long-term Safety Phase (Year 2)||0
10852290|NCT01307423|12018536|FG004|STARTED|Long-term Safety Phase (Year 2)||0
10852291|NCT01307423|12018537|FG005|STARTED|Long-term Safety Phase (Year 2)||0
10852292|NCT01307423|12018538|FG006|STARTED|Long-term Safety Phase (Year 2)||0
10852293|NCT01307423|12018539|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
10852294|NCT01307423|12018540|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
10852295|NCT01307423|12018532|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0
10852296|NCT01307423|12018533|FG001|COMPLETED|Long-term Safety Phase (Year 2)||99
10852297|NCT01307423|12018534|FG002|COMPLETED|Long-term Safety Phase (Year 2)||109
10852298|NCT01307423|12018535|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0
10852299|NCT01307423|12018536|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0
10852300|NCT01307423|12018537|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0
10852301|NCT01307423|12018538|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0
10852302|NCT01307423|12018539|FG007|COMPLETED|Long-term Safety Phase (Year 2)||48
10852303|NCT01307423|12018540|FG008|COMPLETED|Long-term Safety Phase (Year 2)||60
10852304|NCT01307423|12018532|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10852305|NCT01307423|12018533|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
10852306|NCT01307423|12018534|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
10852307|NCT01307423|12018535|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10852308|NCT01307423|12018536|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10852309|NCT01307423|12018537|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10852310|NCT01307423|12018538|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
10852311|NCT01307423|12018539|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
10852312|NCT01307423|12018540|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
10852313|NCT01307423|12018532|FG000|STARTED|Long-term Safety Phase (Year 3)||0
10852314|NCT01307423|12018533|FG001|STARTED|Long-term Safety Phase (Year 3)||99
10852315|NCT01307423|12018534|FG002|STARTED|Long-term Safety Phase (Year 3)||109
10852316|NCT01307423|12018535|FG003|STARTED|Long-term Safety Phase (Year 3)||0
10852317|NCT01307423|12018536|FG004|STARTED|Long-term Safety Phase (Year 3)||0
10852318|NCT01307423|12018537|FG005|STARTED|Long-term Safety Phase (Year 3)||0
10852319|NCT01307423|12018538|FG006|STARTED|Long-term Safety Phase (Year 3)||0
10852320|NCT01307423|12018539|FG007|STARTED|Long-term Safety Phase (Year 3)||48
10852321|NCT01307423|12018540|FG008|STARTED|Long-term Safety Phase (Year 3)||60
10852322|NCT01307423|12018532|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0
10852323|NCT01307423|12018533|FG001|COMPLETED|Long-term Safety Phase (Year 3)||90
10852324|NCT01307423|12018534|FG002|COMPLETED|Long-term Safety Phase (Year 3)||91
10852325|NCT01307423|12018535|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0
10852326|NCT01307423|12018536|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0
11225252|NCT01991314|12417537|FG001|STARTED|Overall Study||43
11225253|NCT01991314|12417536|FG000|COMPLETED|Overall Study||34
11225254|NCT01991314|12417537|FG001|COMPLETED|Overall Study||32
11225255|NCT01991314|12417536|FG000|NOT COMPLETED|Overall Study||11
11225256|NCT01991314|12417537|FG001|NOT COMPLETED|Overall Study||11
11225257|NCT01991470|12417543|FG000|STARTED|Enlite 1 Period||161
11225258|NCT01991470|12417543|FG000|COMPLETED|Enlite 1 Period||141
11225259|NCT01991470|12417543|FG000|NOT COMPLETED|Enlite 1 Period||20
11225260|NCT01991470|12417543|FG000|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
11225261|NCT01991470|12417543|FG000|COMPLETED|Enlite 3 Period||146
11225262|NCT01991470|12417543|FG000|NOT COMPLETED|Enlite 3 Period||12
11225263|NCT01991483|12417559|FG000|STARTED|Dose Level: Placebo||7
11225264|NCT01991483|12417560|FG001|STARTED|Dose Level: Placebo||0
11225265|NCT01991483|12417561|FG002|STARTED|Dose Level: Placebo||0
11225266|NCT01991483|12417562|FG003|STARTED|Dose Level: Placebo||0
11225267|NCT01991483|12417559|FG000|Received at Least One Dose of Study Drug|Dose Level: Placebo||7
11354681|NCT03074500|12551742|FG002|NOT COMPLETED|Overall Study||1
11354682|NCT03074630|12551752|FG000|STARTED|Overall Study||12
11354683|NCT03074630|12551752|FG000|COMPLETED|Overall Study||11
11354684|NCT03074630|12551752|FG000|NOT COMPLETED|Overall Study||1
11354685|NCT03074682|12551760|FG000|STARTED|Overall Study||18
11354686|NCT03074682|12551761|FG001|STARTED|Overall Study||18
11354687|NCT03074682|12551762|FG002|STARTED|Overall Study||18
11354688|NCT03074682|12551760|FG000|COMPLETED|Overall Study||18
11354689|NCT03074682|12551761|FG001|COMPLETED|Overall Study||18
11354690|NCT03074682|12551762|FG002|COMPLETED|Overall Study||18
11354691|NCT03074682|12551760|FG000|NOT COMPLETED|Overall Study||0
11354692|NCT03074682|12551761|FG001|NOT COMPLETED|Overall Study||0
11354693|NCT03074682|12551762|FG002|NOT COMPLETED|Overall Study||0
11354694|NCT03075085|12551772|FG000|STARTED|Overall Study||352
11354695|NCT03075085|12551773|FG001|STARTED|Overall Study||344
11354696|NCT03075085|12551772|FG000|COMPLETED|Overall Study||247
11354697|NCT03075085|12551773|FG001|COMPLETED|Overall Study||232
11354698|NCT03075085|12551772|FG000|NOT COMPLETED|Overall Study||105
11354699|NCT03075085|12551773|FG001|NOT COMPLETED|Overall Study||112
11354700|NCT03075163|12551781|FG000|STARTED|Overall Study||150
11354701|NCT03075163|12551782|FG001|STARTED|Overall Study||150
11354702|NCT03075163|12551781|FG000|COMPLETED|Overall Study||12
11354703|NCT03075163|12551782|FG001|COMPLETED|Overall Study||12
11354704|NCT03075163|12551781|FG000|NOT COMPLETED|Overall Study||138
11354705|NCT03075163|12551782|FG001|NOT COMPLETED|Overall Study||138
11354706|NCT03075267|12551791|FG000|STARTED|Overall Study||32
11354707|NCT03075267|12551792|FG001|STARTED|Overall Study||32
11354708|NCT03075267|12551793|FG002|STARTED|Overall Study||32
11354709|NCT03075267|12551791|FG000|COMPLETED|Overall Study||31
11354710|NCT03075267|12551792|FG001|COMPLETED|Overall Study||32
11354711|NCT03075267|12551793|FG002|COMPLETED|Overall Study||32
11354712|NCT03075267|12551791|FG000|NOT COMPLETED|Overall Study||1
11354713|NCT03075267|12551792|FG001|NOT COMPLETED|Overall Study||0
11354714|NCT03075267|12551793|FG002|NOT COMPLETED|Overall Study||0
11354715|NCT03075410|12551810|FG000|STARTED|Part A-Period 1 (14 Days)||2
11354716|NCT03075410|12551811|FG001|STARTED|Part A-Period 1 (14 Days)||1
11354717|NCT03075410|12551812|FG002|STARTED|Part A-Period 1 (14 Days)||2
11354718|NCT03075410|12551813|FG003|STARTED|Part A-Period 1 (14 Days)||1
11354719|NCT03075410|12551814|FG004|STARTED|Part A-Period 1 (14 Days)||2
11354720|NCT03075410|12551815|FG005|STARTED|Part A-Period 1 (14 Days)||1
11354721|NCT03075410|12551816|FG006|STARTED|Part A-Period 1 (14 Days)||0
11354722|NCT03075410|12551817|FG007|STARTED|Part A-Period 1 (14 Days)||0
11354723|NCT03075410|12551818|FG008|STARTED|Part A-Period 1 (14 Days)||0
11354724|NCT03075410|12551810|FG000|COMPLETED|Part A-Period 1 (14 Days)||2
11354725|NCT03075410|12551811|FG001|COMPLETED|Part A-Period 1 (14 Days)||1
11354726|NCT03075410|12551812|FG002|COMPLETED|Part A-Period 1 (14 Days)||2
11354727|NCT03075410|12551813|FG003|COMPLETED|Part A-Period 1 (14 Days)||1
11354728|NCT03075410|12551814|FG004|COMPLETED|Part A-Period 1 (14 Days)||2
11354729|NCT03075410|12551815|FG005|COMPLETED|Part A-Period 1 (14 Days)||1
11354730|NCT03075410|12551816|FG006|COMPLETED|Part A-Period 1 (14 Days)||0
11354731|NCT03075410|12551817|FG007|COMPLETED|Part A-Period 1 (14 Days)||0
11354732|NCT03075410|12551818|FG008|COMPLETED|Part A-Period 1 (14 Days)||0
11354733|NCT03075410|12551810|FG000|NOT COMPLETED|Part A-Period 1 (14 Days)||0
11225268|NCT01991483|12417560|FG001|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
11225269|NCT01991483|12417561|FG002|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
11225270|NCT01991483|12417562|FG003|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
11225271|NCT01991483|12417559|FG000|COMPLETED|Dose Level: Placebo||7
11225272|NCT01991483|12417560|FG001|COMPLETED|Dose Level: Placebo||0
11225273|NCT01991483|12417561|FG002|COMPLETED|Dose Level: Placebo||0
10852327|NCT01307423|12018537|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0
10852328|NCT01307423|12018538|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0
10852329|NCT01307423|12018539|FG007|COMPLETED|Long-term Safety Phase (Year 3)||40
10852330|NCT01307423|12018540|FG008|COMPLETED|Long-term Safety Phase (Year 3)||49
10852331|NCT01307423|12018532|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10852332|NCT01307423|12018533|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
10852333|NCT01307423|12018534|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
10852334|NCT01307423|12018535|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10852335|NCT01307423|12018536|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10852336|NCT01307423|12018537|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10852337|NCT01307423|12018538|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
10852338|NCT01307423|12018539|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
10852339|NCT01307423|12018540|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
10852340|NCT01307423|12018532|FG000|STARTED|Long-term Safety Phase (Year 4)||0
10852341|NCT01307423|12018533|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
10852342|NCT01307423|12018534|FG002|STARTED|Long-term Safety Phase (Year 4)||91
10852343|NCT01307423|12018535|FG003|STARTED|Long-term Safety Phase (Year 4)||0
10852344|NCT01307423|12018536|FG004|STARTED|Long-term Safety Phase (Year 4)||0
10852345|NCT01307423|12018537|FG005|STARTED|Long-term Safety Phase (Year 4)||0
10852346|NCT01307423|12018538|FG006|STARTED|Long-term Safety Phase (Year 4)||0
10852347|NCT01307423|12018539|FG007|STARTED|Long-term Safety Phase (Year 4)||40
10852348|NCT01307423|12018540|FG008|STARTED|Long-term Safety Phase (Year 4)||49
10852349|NCT01307423|12018532|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0
10852350|NCT01307423|12018533|FG001|COMPLETED|Long-term Safety Phase (Year 4)||81
10852351|NCT01307423|12018534|FG002|COMPLETED|Long-term Safety Phase (Year 4)||86
10852352|NCT01307423|12018535|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0
10852353|NCT01307423|12018536|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0
10852354|NCT01307423|12018537|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0
10852355|NCT01307423|12018538|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0
10852356|NCT01307423|12018539|FG007|COMPLETED|Long-term Safety Phase (Year 4)||38
10852357|NCT01307423|12018540|FG008|COMPLETED|Long-term Safety Phase (Year 4)||44
10852358|NCT01307423|12018532|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10852359|NCT01307423|12018533|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
10852360|NCT01307423|12018534|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
10852361|NCT01307423|12018535|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10852362|NCT01307423|12018536|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10852363|NCT01307423|12018537|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10852364|NCT01307423|12018538|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
10852365|NCT01307423|12018539|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
10852366|NCT01307423|12018540|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
10852367|NCT01307423|12018532|FG000|STARTED|Long-term Safety Phase (Year 5)||0
10852368|NCT01307423|12018533|FG001|STARTED|Long-term Safety Phase (Year 5)||81
10852369|NCT01307423|12018534|FG002|STARTED|Long-term Safety Phase (Year 5)||86
10852370|NCT01307423|12018535|FG003|STARTED|Long-term Safety Phase (Year 5)||0
10852371|NCT01307423|12018536|FG004|STARTED|Long-term Safety Phase (Year 5)||0
10852372|NCT01307423|12018537|FG005|STARTED|Long-term Safety Phase (Year 5)||0
10852373|NCT01307423|12018538|FG006|STARTED|Long-term Safety Phase (Year 5)||0
10852374|NCT01307423|12018539|FG007|STARTED|Long-term Safety Phase (Year 5)||38
10852375|NCT01307423|12018540|FG008|STARTED|Long-term Safety Phase (Year 5)||44
10852376|NCT01307423|12018532|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0
10852377|NCT01307423|12018533|FG001|COMPLETED|Long-term Safety Phase (Year 5)||71
10852378|NCT01307423|12018534|FG002|COMPLETED|Long-term Safety Phase (Year 5)||80
10852379|NCT01307423|12018535|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0
10852380|NCT01307423|12018536|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0
10852381|NCT01307423|12018537|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0
10852382|NCT01307423|12018538|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0
10852383|NCT01307423|12018539|FG007|COMPLETED|Long-term Safety Phase (Year 5)||37
10852384|NCT01307423|12018540|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41
10852385|NCT01307423|12018532|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
10852386|NCT01307423|12018533|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
10852387|NCT01307423|12018534|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
10852388|NCT01307423|12018535|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
10852389|NCT01307423|12018536|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
10852390|NCT01307423|12018537|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
10852391|NCT01307423|12018538|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
11106372|NCT01259063|12290865|FG000|COMPLETED|Overall Study||33
11106373|NCT01259063|12290865|FG000|NOT COMPLETED|Overall Study||0
11106374|NCT01259089|12290869|FG000|STARTED|Reached First Response at 4 Weeks||3
11106375|NCT01259089|12290870|FG001|STARTED|Reached First Response at 4 Weeks||3
11106376|NCT01259089|12290871|FG002|STARTED|Reached First Response at 4 Weeks||3
11106377|NCT01259089|12290872|FG003|STARTED|Reached First Response at 4 Weeks||3
11106378|NCT01259089|12290873|FG004|STARTED|Reached First Response at 4 Weeks||6
11106379|NCT01259089|12290874|FG005|STARTED|Reached First Response at 4 Weeks||20
11106380|NCT01259089|12290869|FG000|Started Treatment on Study|Reached First Response at 4 Weeks||3
11106381|NCT01259089|12290870|FG001|Started Treatment on Study|Reached First Response at 4 Weeks||3
11106382|NCT01259089|12290871|FG002|Started Treatment on Study|Reached First Response at 4 Weeks||3
10852392|NCT01307423|12018539|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
10852393|NCT01307423|12018540|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
10852394|NCT01030575|12018576|FG000|STARTED|Overall Study||29
10852395|NCT01030575|12018577|FG001|STARTED|Overall Study||30
10852396|NCT01030575|12018578|FG002|STARTED|Overall Study||28
10852397|NCT01030575|12018579|FG003|STARTED|Overall Study||35
10852398|NCT01030575|12018576|FG000|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|29
10852399|NCT01030575|12018577|FG001|COMPLETED|Overall Study||30
10852400|NCT01030575|12018578|FG002|COMPLETED|Overall Study||28
10852401|NCT01030575|12018579|FG003|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|35
10852402|NCT01030575|12018576|FG000|NOT COMPLETED|Overall Study||0
10852403|NCT01030575|12018577|FG001|NOT COMPLETED|Overall Study||0
10852404|NCT01030575|12018578|FG002|NOT COMPLETED|Overall Study||0
10852405|NCT01030575|12018579|FG003|NOT COMPLETED|Overall Study||0
10852406|NCT00911183|12018592|FG000|STARTED|Overall Study||47
10852407|NCT00911183|12018593|FG001|STARTED|Overall Study||20
10852408|NCT00911183|12018592|FG000|COMPLETED|Overall Study||47
10852409|NCT00911183|12018593|FG001|COMPLETED|Overall Study||20
10852410|NCT00911183|12018592|FG000|NOT COMPLETED|Overall Study||0
10852411|NCT00911183|12018593|FG001|NOT COMPLETED|Overall Study||0
10852412|NCT00655876|12018601|FG000|STARTED|Overall Study||168
10852413|NCT00655876|12018602|FG001|STARTED|Overall Study||176
10852414|NCT00655876|12018601|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
10852415|NCT00655876|12018602|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
10852416|NCT00655876|12018601|FG000|NOT COMPLETED|Overall Study||9
10852417|NCT00655876|12018602|FG001|NOT COMPLETED|Overall Study||7
10852418|NCT00602576|12018612|FG000|STARTED|Overall Study||38
10852419|NCT00602576|12018613|FG001|STARTED|Overall Study||40
10852420|NCT00602576|12018614|FG002|STARTED|Overall Study||38
10852421|NCT00602576|12018615|FG003|STARTED|Overall Study||53
10852422|NCT00602576|12018612|FG000|COMPLETED|Overall Study||38
10852423|NCT00602576|12018613|FG001|COMPLETED|Overall Study||40
10852424|NCT00602576|12018614|FG002|COMPLETED|Overall Study||38
10852425|NCT00602576|12018615|FG003|COMPLETED|Overall Study||53
10852426|NCT00602576|12018612|FG000|NOT COMPLETED|Overall Study||0
10852427|NCT00602576|12018613|FG001|NOT COMPLETED|Overall Study||0
10852428|NCT00602576|12018614|FG002|NOT COMPLETED|Overall Study||0
11106383|NCT01259089|12290872|FG003|Started Treatment on Study|Reached First Response at 4 Weeks||3
10852429|NCT00602576|12018615|FG003|NOT COMPLETED|Overall Study||0
10852430|NCT00265941|12018627|FG000|STARTED|Overall Study||470
10852431|NCT00265941|12018628|FG001|STARTED|Overall Study||470
10852432|NCT00265941|12018627|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
10852433|NCT00265941|12018628|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
10852434|NCT00265941|12018627|FG000|NOT COMPLETED|Overall Study||23
10852435|NCT00265941|12018628|FG001|NOT COMPLETED|Overall Study||26
10852436|NCT00114140|12018642|FG000|STARTED|Overall Study||136
10852437|NCT00114140|12018642|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
10852438|NCT00114140|12018642|FG000|NOT COMPLETED|Overall Study||7
10852439|NCT00047008|12018655|FG000|STARTED|Overall Study||372
10852440|NCT00047008|12018656|FG001|STARTED|Overall Study||371
10852441|NCT00047008|12018655|FG000|COMPLETED|Overall Study||361
10852442|NCT00047008|12018656|FG001|COMPLETED|Overall Study||360
10852443|NCT00047008|12018655|FG000|NOT COMPLETED|Overall Study||11
10852444|NCT00047008|12018656|FG001|NOT COMPLETED|Overall Study||11
10852445|NCT04701138|12018662|FG000|STARTED|Overall Study||24
10852446|NCT04701138|12018662|FG000|COMPLETED|Overall Study||23
10852447|NCT04701138|12018662|FG000|NOT COMPLETED|Overall Study||1
10852448|NCT04392583|12018666|FG000|STARTED|Overall Study||40
10852449|NCT04392583|12018666|FG000|COMPLETED|Overall Study||39
10852450|NCT04392583|12018666|FG000|NOT COMPLETED|Overall Study||1
10852451|NCT04332640|12018670|FG000|STARTED|Overall Study||79
10852452|NCT04332640|12018670|FG000|COMPLETED|Overall Study||79
10852453|NCT04332640|12018670|FG000|NOT COMPLETED|Overall Study||0
10852454|NCT04326439|12018676|FG000|STARTED|Overall Study||5
10852455|NCT04326439|12018677|FG001|STARTED|Overall Study||3
10852456|NCT04326439|12018676|FG000|COMPLETED|Overall Study||3
10852457|NCT04326439|12018677|FG001|COMPLETED|Overall Study||0
10852458|NCT04326439|12018676|FG000|NOT COMPLETED|Overall Study||2
10852459|NCT04326439|12018677|FG001|NOT COMPLETED|Overall Study||3
10852460|NCT04188730|12018689|FG000|STARTED|Overall Study||4
10852461|NCT04188730|12018690|FG001|STARTED|Overall Study||4
10852462|NCT04188730|12018691|FG002|STARTED|Overall Study||4
10852463|NCT04188730|12018692|FG003|STARTED|Overall Study||4
10852464|NCT04188730|12018689|FG000|Period 1|Overall Study||4
10852465|NCT04188730|12018690|FG001|Period 1|Overall Study||4
10852466|NCT04188730|12018691|FG002|Period 1|Overall Study||4
10852467|NCT04188730|12018692|FG003|Period 1|Overall Study||4
10852468|NCT04188730|12018689|FG000|Period 2|Overall Study||3
10852469|NCT04188730|12018690|FG001|Period 2|Overall Study||4
10852470|NCT04188730|12018691|FG002|Period 2|Overall Study||4
10852471|NCT04188730|12018692|FG003|Period 2|Overall Study||4
10852472|NCT04188730|12018689|FG000|Period 3|Overall Study||3
11225274|NCT01991483|12417562|FG003|COMPLETED|Dose Level: Placebo||0
11225275|NCT01991483|12417559|FG000|NOT COMPLETED|Dose Level: Placebo||0
11225276|NCT01991483|12417560|FG001|NOT COMPLETED|Dose Level: Placebo||0
11225277|NCT01991483|12417561|FG002|NOT COMPLETED|Dose Level: Placebo||0
11225278|NCT01991483|12417562|FG003|NOT COMPLETED|Dose Level: Placebo||0
11225279|NCT01991483|12417559|FG000|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0
11354734|NCT03075410|12551811|FG001|NOT COMPLETED|Part A-Period 1 (14 Days)||0
11354735|NCT03075410|12551812|FG002|NOT COMPLETED|Part A-Period 1 (14 Days)||0
11354736|NCT03075410|12551813|FG003|NOT COMPLETED|Part A-Period 1 (14 Days)||0
11354737|NCT03075410|12551814|FG004|NOT COMPLETED|Part A-Period 1 (14 Days)||0
11354738|NCT03075410|12551815|FG005|NOT COMPLETED|Part A-Period 1 (14 Days)||0
11354739|NCT03075410|12551816|FG006|NOT COMPLETED|Part A-Period 1 (14 Days)||0
11354740|NCT03075410|12551817|FG007|NOT COMPLETED|Part A-Period 1 (14 Days)||0
11354741|NCT03075410|12551818|FG008|NOT COMPLETED|Part A-Period 1 (14 Days)||0
11354742|NCT03075410|12551810|FG000|STARTED|Part A-Washout Period 1 (14 Days)||2
11354743|NCT03075410|12551811|FG001|STARTED|Part A-Washout Period 1 (14 Days)||1
11354744|NCT03075410|12551812|FG002|STARTED|Part A-Washout Period 1 (14 Days)||2
11354745|NCT03075410|12551813|FG003|STARTED|Part A-Washout Period 1 (14 Days)||1
11354746|NCT03075410|12551814|FG004|STARTED|Part A-Washout Period 1 (14 Days)||2
11354747|NCT03075410|12551815|FG005|STARTED|Part A-Washout Period 1 (14 Days)||1
11354748|NCT03075410|12551816|FG006|STARTED|Part A-Washout Period 1 (14 Days)||0
11354749|NCT03075410|12551817|FG007|STARTED|Part A-Washout Period 1 (14 Days)||0
11354750|NCT03075410|12551818|FG008|STARTED|Part A-Washout Period 1 (14 Days)||0
11354751|NCT03075410|12551810|FG000|COMPLETED|Part A-Washout Period 1 (14 Days)||2
11354752|NCT03075410|12551811|FG001|COMPLETED|Part A-Washout Period 1 (14 Days)||1
11354753|NCT03075410|12551812|FG002|COMPLETED|Part A-Washout Period 1 (14 Days)||2
11354754|NCT03075410|12551813|FG003|COMPLETED|Part A-Washout Period 1 (14 Days)||1
11354755|NCT03075410|12551814|FG004|COMPLETED|Part A-Washout Period 1 (14 Days)||2
11354756|NCT03075410|12551815|FG005|COMPLETED|Part A-Washout Period 1 (14 Days)||1
11354757|NCT03075410|12551816|FG006|COMPLETED|Part A-Washout Period 1 (14 Days)||0
11354758|NCT03075410|12551817|FG007|COMPLETED|Part A-Washout Period 1 (14 Days)||0
11354759|NCT03075410|12551818|FG008|COMPLETED|Part A-Washout Period 1 (14 Days)||0
11354760|NCT03075410|12551810|FG000|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
11354761|NCT03075410|12551811|FG001|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
11354762|NCT03075410|12551812|FG002|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
11354763|NCT03075410|12551813|FG003|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
10852473|NCT04188730|12018690|FG001|Period 3|Overall Study||4
10852474|NCT04188730|12018691|FG002|Period 3|Overall Study||4
10852475|NCT04188730|12018692|FG003|Period 3|Overall Study||4
10852476|NCT04188730|12018689|FG000|COMPLETED|Overall Study||3
10852477|NCT04188730|12018690|FG001|COMPLETED|Overall Study||4
10852478|NCT04188730|12018691|FG002|COMPLETED|Overall Study||4
10852479|NCT04188730|12018692|FG003|COMPLETED|Overall Study||4
10852480|NCT04188730|12018689|FG000|NOT COMPLETED|Overall Study||1
10852481|NCT04188730|12018690|FG001|NOT COMPLETED|Overall Study||0
11354764|NCT03075410|12551814|FG004|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
11354765|NCT03075410|12551815|FG005|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
11354766|NCT03075410|12551816|FG006|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
11354767|NCT03075410|12551817|FG007|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
11354768|NCT03075410|12551818|FG008|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
11354769|NCT03075410|12551810|FG000|STARTED|Part A-Period 2 (14 Days)||2
10852482|NCT04188730|12018691|FG002|NOT COMPLETED|Overall Study||0
10852483|NCT04188730|12018692|FG003|NOT COMPLETED|Overall Study||0
11225280|NCT01991483|12417560|FG001|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6
10852484|NCT04003142|12018706|FG000|STARTED|Double-blind Period (12 Weeks)||168
10852485|NCT04003142|12018707|FG001|STARTED|Double-blind Period (12 Weeks)||166
10852486|NCT04003142|12018708|FG002|STARTED|Double-blind Period (12 Weeks)||167
10852487|NCT04003142|12018709|FG003|STARTED|Double-blind Period (12 Weeks)||0
10852488|NCT04003142|12018710|FG004|STARTED|Double-blind Period (12 Weeks)||0
10852489|NCT04003142|12018706|FG000|Treated|Double-blind Period (12 Weeks)||167
10852490|NCT04003142|12018707|FG001|Treated|Double-blind Period (12 Weeks)||166
11225281|NCT01991483|12417561|FG002|STARTED|Dose Level 300 mg||0
11225282|NCT01991483|12417562|FG003|STARTED|Dose Level 300 mg||0
11225283|NCT01991483|12417559|FG000|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
11225284|NCT01991483|12417560|FG001|Received at Least One Dose of Study Drug|Dose Level 300 mg||6
11225285|NCT01991483|12417561|FG002|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
11225286|NCT01991483|12417562|FG003|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
11225287|NCT01991483|12417559|FG000|COMPLETED|Dose Level 300 mg||0
11225288|NCT01991483|12417560|FG001|COMPLETED|Dose Level 300 mg||6
11225289|NCT01991483|12417561|FG002|COMPLETED|Dose Level 300 mg||0
11225290|NCT01991483|12417562|FG003|COMPLETED|Dose Level 300 mg||0
11225291|NCT01991483|12417559|FG000|NOT COMPLETED|Dose Level 300 mg||0
11225292|NCT01991483|12417560|FG001|NOT COMPLETED|Dose Level 300 mg||0
11225293|NCT01991483|12417561|FG002|NOT COMPLETED|Dose Level 300 mg||0
11225294|NCT01991483|12417562|FG003|NOT COMPLETED|Dose Level 300 mg||0
11225295|NCT01991483|12417559|FG000|STARTED|Dose Level 600 mg||0
11225296|NCT01991483|12417560|FG001|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0
11225297|NCT01991483|12417561|FG002|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11
11225298|NCT01991483|12417562|FG003|STARTED|Dose Level 600 mg||0
11225299|NCT01991483|12417559|FG000|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
11225300|NCT01991483|12417560|FG001|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
11225301|NCT01991483|12417561|FG002|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11
11225302|NCT01991483|12417562|FG003|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
11225303|NCT01991483|12417559|FG000|COMPLETED|Dose Level 600 mg||0
11225304|NCT01991483|12417560|FG001|COMPLETED|Dose Level 600 mg||0
11225305|NCT01991483|12417561|FG002|COMPLETED|Dose Level 600 mg||9
11225306|NCT01991483|12417562|FG003|COMPLETED|Dose Level 600 mg||0
11225307|NCT01991483|12417559|FG000|NOT COMPLETED|Dose Level 600 mg||0
11225308|NCT01991483|12417560|FG001|NOT COMPLETED|Dose Level 600 mg||0
11225309|NCT01991483|12417561|FG002|NOT COMPLETED|Dose Level 600 mg||2
11225310|NCT01991483|12417562|FG003|NOT COMPLETED|Dose Level 600 mg||0
11225311|NCT01991483|12417559|FG000|STARTED|Dose Level 1000 mg||0
11225312|NCT01991483|12417560|FG001|STARTED|Dose Level 1000 mg||0
11225313|NCT01991483|12417561|FG002|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0
11225314|NCT01991483|12417562|FG003|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4
11225315|NCT01991483|12417559|FG000|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
11225316|NCT01991483|12417560|FG001|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
11225317|NCT01991483|12417561|FG002|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
11225318|NCT01991483|12417562|FG003|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4
11225319|NCT01991483|12417559|FG000|COMPLETED|Dose Level 1000 mg||0
11225320|NCT01991483|12417560|FG001|COMPLETED|Dose Level 1000 mg||0
11225321|NCT01991483|12417561|FG002|COMPLETED|Dose Level 1000 mg||0
11225322|NCT01991483|12417562|FG003|COMPLETED|Dose Level 1000 mg||3
11225323|NCT01991483|12417559|FG000|NOT COMPLETED|Dose Level 1000 mg||0
11225324|NCT01991483|12417560|FG001|NOT COMPLETED|Dose Level 1000 mg||0
11225325|NCT01991483|12417561|FG002|NOT COMPLETED|Dose Level 1000 mg||0
11225326|NCT01991483|12417562|FG003|NOT COMPLETED|Dose Level 1000 mg||1
11225327|NCT01991522|12417577|FG000|STARTED|Overall Study||16
11225328|NCT01991522|12417578|FG001|STARTED|Overall Study||17
11225329|NCT01991522|12417577|FG000|COMPLETED|Overall Study||16
11225330|NCT01991522|12417578|FG001|COMPLETED|Overall Study||17
11225331|NCT01991522|12417577|FG000|NOT COMPLETED|Overall Study||0
11225332|NCT01991522|12417578|FG001|NOT COMPLETED|Overall Study||0
11225333|NCT01991548|12417584|FG000|STARTED|Overall Study||40
11225334|NCT01991548|12417584|FG000|COMPLETED|Overall Study||39
11225335|NCT01991548|12417584|FG000|NOT COMPLETED|Overall Study||1
11225336|NCT01991743|12417592|FG000|STARTED|Overall Study||60
11225337|NCT01991743|12417593|FG001|STARTED|Overall Study||60
11225338|NCT01991743|12417594|FG002|STARTED|Overall Study||60
11225339|NCT01991743|12417595|FG003|STARTED|Overall Study||60
11225340|NCT01991743|12417592|FG000|COMPLETED|Overall Study||60
11225341|NCT01991743|12417593|FG001|COMPLETED|Overall Study||60
11225342|NCT01991743|12417594|FG002|COMPLETED|Overall Study||59
11225343|NCT01991743|12417595|FG003|COMPLETED|Overall Study||60
11225344|NCT01991743|12417592|FG000|NOT COMPLETED|Overall Study||0
11225345|NCT01991743|12417593|FG001|NOT COMPLETED|Overall Study||0
11225346|NCT01991743|12417594|FG002|NOT COMPLETED|Overall Study||1
11225347|NCT01991743|12417595|FG003|NOT COMPLETED|Overall Study||0
11225348|NCT01991795|12417607|FG000|STARTED|Overall Study||9645
11225349|NCT01991795|12417608|FG001|STARTED|Overall Study||9626
11225350|NCT01991795|12417607|FG000|COMPLETED|Overall Study||9496
11225351|NCT01991795|12417608|FG001|COMPLETED|Overall Study||9503
11354770|NCT03075410|12551811|FG001|STARTED|Part A-Period 2 (14 Days)||1
11354771|NCT03075410|12551812|FG002|STARTED|Part A-Period 2 (14 Days)||2
10852491|NCT04003142|12018708|FG002|Treated|Double-blind Period (12 Weeks)||167
10852492|NCT04003142|12018709|FG003|Treated|Double-blind Period (12 Weeks)||0
10852493|NCT04003142|12018710|FG004|Treated|Double-blind Period (12 Weeks)||0
10852494|NCT04003142|12018706|FG000|COMPLETED|Double-blind Period (12 Weeks)||151
10852495|NCT04003142|12018707|FG001|COMPLETED|Double-blind Period (12 Weeks)||152
10852496|NCT04003142|12018708|FG002|COMPLETED|Double-blind Period (12 Weeks)||155
10852497|NCT04003142|12018709|FG003|COMPLETED|Double-blind Period (12 Weeks)||0
10852498|NCT04003142|12018710|FG004|COMPLETED|Double-blind Period (12 Weeks)||0
10852499|NCT04003142|12018706|FG000|NOT COMPLETED|Double-blind Period (12 Weeks)||17
10852500|NCT04003142|12018707|FG001|NOT COMPLETED|Double-blind Period (12 Weeks)||14
10852501|NCT04003142|12018708|FG002|NOT COMPLETED|Double-blind Period (12 Weeks)||12
10852502|NCT04003142|12018709|FG003|NOT COMPLETED|Double-blind Period (12 Weeks)||0
10852503|NCT04003142|12018710|FG004|NOT COMPLETED|Double-blind Period (12 Weeks)||0
10852504|NCT04003142|12018706|FG000|STARTED|Extension Period (40 Weeks)|Participants who received placebo in double-blind period were moved to fezolinetant 30/45 mg arms in extension treatment period|0
10852505|NCT04003142|12018707|FG001|STARTED|Extension Period (40 Weeks)||152
10852506|NCT04003142|12018708|FG002|STARTED|Extension Period (40 Weeks)|One participant who completed double-blind period discontinued the study before entering the extension treatment period.|154
10852507|NCT04003142|12018709|FG003|STARTED|Extension Period (40 Weeks)|Participants who received placebo in double-blind period were randomized to fezolinetant 30 mg arms|76
10852508|NCT04003142|12018710|FG004|STARTED|Extension Period (40 Weeks)|Participants who received placebo in double-blind period were randomized to fezolinetant 45 mg arms|75
10852509|NCT04003142|12018706|FG000|COMPLETED|Extension Period (40 Weeks)||0
10852510|NCT04003142|12018707|FG001|COMPLETED|Extension Period (40 Weeks)||125
10852511|NCT04003142|12018708|FG002|COMPLETED|Extension Period (40 Weeks)||132
10852512|NCT04003142|12018709|FG003|COMPLETED|Extension Period (40 Weeks)||63
10852513|NCT04003142|12018710|FG004|COMPLETED|Extension Period (40 Weeks)||63
10852514|NCT04003142|12018706|FG000|NOT COMPLETED|Extension Period (40 Weeks)||0
10852515|NCT04003142|12018707|FG001|NOT COMPLETED|Extension Period (40 Weeks)||27
10852516|NCT04003142|12018708|FG002|NOT COMPLETED|Extension Period (40 Weeks)||22
10852517|NCT04003142|12018709|FG003|NOT COMPLETED|Extension Period (40 Weeks)||13
10852518|NCT04003142|12018710|FG004|NOT COMPLETED|Extension Period (40 Weeks)||12
10852519|NCT03909607|12018731|FG000|STARTED|Overall Study||40
10852520|NCT03909607|12018732|FG001|STARTED|Overall Study||40
10852521|NCT03909607|12018733|FG002|STARTED|Overall Study||40
10852522|NCT03909607|12018731|FG000|COMPLETED|Overall Study||35
10852523|NCT03909607|12018732|FG001|COMPLETED|Overall Study||36
10852524|NCT03909607|12018733|FG002|COMPLETED|Overall Study||38
10852525|NCT03909607|12018731|FG000|NOT COMPLETED|Overall Study||5
10852526|NCT03909607|12018732|FG001|NOT COMPLETED|Overall Study||4
10852527|NCT03909607|12018733|FG002|NOT COMPLETED|Overall Study||2
10852528|NCT03430531|12018741|FG000|STARTED|Overall Study||6
10852529|NCT03430531|12018741|FG000|COMPLETED|Overall Study||6
10852530|NCT03430531|12018741|FG000|NOT COMPLETED|Overall Study||0
10852531|NCT03402841|12018745|FG000|STARTED|Overall Study||279
10852532|NCT03402841|12018745|FG000|COMPLETED|Overall Study||187
10852533|NCT03402841|12018745|FG000|NOT COMPLETED|Overall Study||92
10852534|NCT03383666|12018749|FG000|STARTED|Overall Study||21
10852535|NCT03383666|12018749|FG000|Implanted With Pulse Rider|Overall Study||18
10852536|NCT03383666|12018749|FG000|Attempted But Unsuccessful Implantation|Overall Study||3
10852537|NCT03383666|12018749|FG000|COMPLETED|Overall Study||17
10852538|NCT03383666|12018749|FG000|NOT COMPLETED|Overall Study||4
11106384|NCT01259089|12290873|FG004|Started Treatment on Study|Reached First Response at 4 Weeks||6
11106385|NCT01259089|12290874|FG005|Started Treatment on Study|Reached First Response at 4 Weeks||19
11106386|NCT01259089|12290869|FG000|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
11106387|NCT01259089|12290870|FG001|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
11106388|NCT01259089|12290871|FG002|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
11106389|NCT01259089|12290872|FG003|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
10852545|NCT03219333|12018771|FG000|STARTED|Overall Study||128
10852546|NCT03219333|12018772|FG001|STARTED|Overall Study||91
10852547|NCT03219333|12018771|FG000|Treated|Overall Study||125
10852548|NCT03219333|12018772|FG001|Treated|Overall Study||89
10852549|NCT03219333|12018771|FG000|COMPLETED|Overall Study|Cohort 1 Completed includes 4 participants on treatment and 19 participants in follow-up.|23
10852550|NCT03219333|12018772|FG001|COMPLETED|Overall Study|Cohort 2 Completed includes 16 participants on treatment and 26 participants in follow-up.|42
10852551|NCT03219333|12018771|FG000|NOT COMPLETED|Overall Study||105
10852552|NCT03219333|12018772|FG001|NOT COMPLETED|Overall Study||49
11106390|NCT01259089|12290873|FG004|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
11106391|NCT01259089|12290874|FG005|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
11106392|NCT01259089|12290869|FG000|COMPLETED|Reached First Response at 4 Weeks||3
11106393|NCT01259089|12290870|FG001|COMPLETED|Reached First Response at 4 Weeks||3
11106394|NCT01259089|12290871|FG002|COMPLETED|Reached First Response at 4 Weeks||3
11106395|NCT01259089|12290872|FG003|COMPLETED|Reached First Response at 4 Weeks||3
11106396|NCT01259089|12290873|FG004|COMPLETED|Reached First Response at 4 Weeks||6
11106397|NCT01259089|12290874|FG005|COMPLETED|Reached First Response at 4 Weeks||18
11106398|NCT01259089|12290869|FG000|NOT COMPLETED|Reached First Response at 4 Weeks||0
11106399|NCT01259089|12290870|FG001|NOT COMPLETED|Reached First Response at 4 Weeks||0
11106400|NCT01259089|12290871|FG002|NOT COMPLETED|Reached First Response at 4 Weeks||0
11106401|NCT01259089|12290872|FG003|NOT COMPLETED|Reached First Response at 4 Weeks||0
11106402|NCT01259089|12290873|FG004|NOT COMPLETED|Reached First Response at 4 Weeks||0
11106403|NCT01259089|12290874|FG005|NOT COMPLETED|Reached First Response at 4 Weeks||2
11106404|NCT01259089|12290869|FG000|STARTED|Confirmed Response at 8 Weeks||3
11106405|NCT01259089|12290870|FG001|STARTED|Confirmed Response at 8 Weeks||3
11106406|NCT01259089|12290871|FG002|STARTED|Confirmed Response at 8 Weeks||3
11106407|NCT01259089|12290872|FG003|STARTED|Confirmed Response at 8 Weeks||3
11106408|NCT01259089|12290873|FG004|STARTED|Confirmed Response at 8 Weeks||6
11106409|NCT01259089|12290874|FG005|STARTED|Confirmed Response at 8 Weeks||18
11106410|NCT01259089|12290869|FG000|COMPLETED|Confirmed Response at 8 Weeks||3
11106411|NCT01259089|12290870|FG001|COMPLETED|Confirmed Response at 8 Weeks||3
11106412|NCT01259089|12290871|FG002|COMPLETED|Confirmed Response at 8 Weeks||2
11106413|NCT01259089|12290872|FG003|COMPLETED|Confirmed Response at 8 Weeks||2
11106414|NCT01259089|12290873|FG004|COMPLETED|Confirmed Response at 8 Weeks||2
11106415|NCT01259089|12290874|FG005|COMPLETED|Confirmed Response at 8 Weeks||8
11106416|NCT01259089|12290869|FG000|NOT COMPLETED|Confirmed Response at 8 Weeks||0
11106417|NCT01259089|12290870|FG001|NOT COMPLETED|Confirmed Response at 8 Weeks||0
11106418|NCT01259089|12290871|FG002|NOT COMPLETED|Confirmed Response at 8 Weeks||1
11106419|NCT01259089|12290872|FG003|NOT COMPLETED|Confirmed Response at 8 Weeks||1
11106420|NCT01259089|12290873|FG004|NOT COMPLETED|Confirmed Response at 8 Weeks||4
11106421|NCT01259089|12290874|FG005|NOT COMPLETED|Confirmed Response at 8 Weeks||10
11106422|NCT01259089|12290869|FG000|STARTED|Continued Treatment After 8 Weeks||3
11106423|NCT01259089|12290870|FG001|STARTED|Continued Treatment After 8 Weeks||3
11106424|NCT01259089|12290871|FG002|STARTED|Continued Treatment After 8 Weeks||2
11106425|NCT01259089|12290872|FG003|STARTED|Continued Treatment After 8 Weeks||2
11106426|NCT01259089|12290873|FG004|STARTED|Continued Treatment After 8 Weeks||2
11106427|NCT01259089|12290874|FG005|STARTED|Continued Treatment After 8 Weeks||8
11106428|NCT01259089|12290869|FG000|COMPLETED|Continued Treatment After 8 Weeks||1
11106429|NCT01259089|12290870|FG001|COMPLETED|Continued Treatment After 8 Weeks||2
11106430|NCT01259089|12290871|FG002|COMPLETED|Continued Treatment After 8 Weeks||1
11106431|NCT01259089|12290872|FG003|COMPLETED|Continued Treatment After 8 Weeks||1
11106432|NCT01259089|12290873|FG004|COMPLETED|Continued Treatment After 8 Weeks||0
11106433|NCT01259089|12290874|FG005|COMPLETED|Continued Treatment After 8 Weeks||7
11106434|NCT01259089|12290869|FG000|NOT COMPLETED|Continued Treatment After 8 Weeks||2
11106435|NCT01259089|12290870|FG001|NOT COMPLETED|Continued Treatment After 8 Weeks||1
11106436|NCT01259089|12290871|FG002|NOT COMPLETED|Continued Treatment After 8 Weeks||1
11106437|NCT01259089|12290872|FG003|NOT COMPLETED|Continued Treatment After 8 Weeks||1
11106438|NCT01259089|12290873|FG004|NOT COMPLETED|Continued Treatment After 8 Weeks||2
11106439|NCT01259089|12290874|FG005|NOT COMPLETED|Continued Treatment After 8 Weeks||1
11106440|NCT01259089|12290869|FG000|STARTED|Survival Follow up for Two Years||3
11106441|NCT01259089|12290870|FG001|STARTED|Survival Follow up for Two Years||3
11106442|NCT01259089|12290871|FG002|STARTED|Survival Follow up for Two Years||3
11106443|NCT01259089|12290872|FG003|STARTED|Survival Follow up for Two Years||3
11106444|NCT01259089|12290873|FG004|STARTED|Survival Follow up for Two Years||6
11106445|NCT01259089|12290874|FG005|STARTED|Survival Follow up for Two Years||19
11106446|NCT01259089|12290869|FG000|COMPLETED|Survival Follow up for Two Years||0
11106447|NCT01259089|12290870|FG001|COMPLETED|Survival Follow up for Two Years||1
11106448|NCT01259089|12290871|FG002|COMPLETED|Survival Follow up for Two Years||1
11106449|NCT01259089|12290872|FG003|COMPLETED|Survival Follow up for Two Years||0
11106450|NCT01259089|12290873|FG004|COMPLETED|Survival Follow up for Two Years||0
11106451|NCT01259089|12290874|FG005|COMPLETED|Survival Follow up for Two Years||0
11106452|NCT01259089|12290869|FG000|NOT COMPLETED|Survival Follow up for Two Years||3
11106453|NCT01259089|12290870|FG001|NOT COMPLETED|Survival Follow up for Two Years||2
11106454|NCT01259089|12290871|FG002|NOT COMPLETED|Survival Follow up for Two Years||2
11106455|NCT01259089|12290872|FG003|NOT COMPLETED|Survival Follow up for Two Years||3
11106456|NCT01259089|12290873|FG004|NOT COMPLETED|Survival Follow up for Two Years||6
11225352|NCT01991795|12417607|FG000|NOT COMPLETED|Overall Study||149
11225353|NCT01991795|12417608|FG001|NOT COMPLETED|Overall Study||123
11225354|NCT01991808|12417614|FG000|STARTED|Overall Study||16
11225355|NCT01991808|12417614|FG000|COMPLETED|Overall Study||16
11225356|NCT01991808|12417614|FG000|NOT COMPLETED|Overall Study||0
11225357|NCT01991821|12417620|FG000|STARTED|Overall Study||169
11225358|NCT01991821|12417621|FG001|STARTED|Overall Study||178
11225359|NCT01991821|12417620|FG000|COMPLETED|Overall Study||6
11225360|NCT01991821|12417621|FG001|COMPLETED|Overall Study||11
11225361|NCT01991821|12417620|FG000|NOT COMPLETED|Overall Study||163
11225362|NCT01991821|12417621|FG001|NOT COMPLETED|Overall Study||167
11225363|NCT01991860|12417631|FG000|STARTED|Overall Study||176
11225364|NCT01991860|12417632|FG001|STARTED|Overall Study||166
11225365|NCT01991860|12417631|FG000|COMPLETED|Overall Study||172
11225366|NCT01991860|12417632|FG001|COMPLETED|Overall Study||164
11225367|NCT01991860|12417631|FG000|NOT COMPLETED|Overall Study||4
11225368|NCT01991860|12417632|FG001|NOT COMPLETED|Overall Study||2
11225369|NCT01991990|12417640|FG000|STARTED|Overall Study||6
11225370|NCT01991990|12417641|FG001|STARTED|Overall Study||12
11225371|NCT01991990|12417640|FG000|COMPLETED|Overall Study||6
11225372|NCT01991990|12417641|FG001|COMPLETED|Overall Study||12
11225373|NCT01991990|12417640|FG000|NOT COMPLETED|Overall Study||0
11225374|NCT01991990|12417641|FG001|NOT COMPLETED|Overall Study||0
11225375|NCT01992016|12417653|FG000|STARTED|Overall Study||4
11225376|NCT01992016|12417654|FG001|STARTED|Overall Study||7
11225377|NCT01992016|12417653|FG000|COMPLETED|Overall Study||4
11225378|NCT01992016|12417654|FG001|COMPLETED|Overall Study||7
11225379|NCT01992016|12417653|FG000|NOT COMPLETED|Overall Study||0
11225380|NCT01992016|12417654|FG001|NOT COMPLETED|Overall Study||0
11225381|NCT01992094|12417663|FG000|STARTED|Overall Study||1335
11225382|NCT01992094|12417664|FG001|STARTED|Overall Study||676
11225383|NCT01992094|12417665|FG002|STARTED|Overall Study||669
11225384|NCT01992094|12417663|FG000|COMPLETED|Overall Study||1285
11225385|NCT01992094|12417664|FG001|COMPLETED|Overall Study||652
11225386|NCT01992094|12417665|FG002|COMPLETED|Overall Study||648
11225387|NCT01992094|12417663|FG000|NOT COMPLETED|Overall Study||50
11225388|NCT01992094|12417664|FG001|NOT COMPLETED|Overall Study||24
11225389|NCT01992094|12417665|FG002|NOT COMPLETED|Overall Study||21
11354772|NCT03075410|12551813|FG003|STARTED|Part A-Period 2 (14 Days)||1
11354773|NCT03075410|12551814|FG004|STARTED|Part A-Period 2 (14 Days)||2
11354774|NCT03075410|12551815|FG005|STARTED|Part A-Period 2 (14 Days)||1
11354775|NCT03075410|12551816|FG006|STARTED|Part A-Period 2 (14 Days)||0
11354776|NCT03075410|12551817|FG007|STARTED|Part A-Period 2 (14 Days)||0
11354777|NCT03075410|12551818|FG008|STARTED|Part A-Period 2 (14 Days)||0
11354778|NCT03075410|12551810|FG000|COMPLETED|Part A-Period 2 (14 Days)||1
11354779|NCT03075410|12551811|FG001|COMPLETED|Part A-Period 2 (14 Days)||1
11354780|NCT03075410|12551812|FG002|COMPLETED|Part A-Period 2 (14 Days)||1
11354781|NCT03075410|12551813|FG003|COMPLETED|Part A-Period 2 (14 Days)||1
11354782|NCT03075410|12551814|FG004|COMPLETED|Part A-Period 2 (14 Days)||2
11354783|NCT03075410|12551815|FG005|COMPLETED|Part A-Period 2 (14 Days)||1
11354784|NCT03075410|12551816|FG006|COMPLETED|Part A-Period 2 (14 Days)||0
11354785|NCT03075410|12551817|FG007|COMPLETED|Part A-Period 2 (14 Days)||0
11354786|NCT03075410|12551818|FG008|COMPLETED|Part A-Period 2 (14 Days)||0
11354787|NCT03075410|12551810|FG000|NOT COMPLETED|Part A-Period 2 (14 Days)||1
11354788|NCT03075410|12551811|FG001|NOT COMPLETED|Part A-Period 2 (14 Days)||0
11354789|NCT03075410|12551812|FG002|NOT COMPLETED|Part A-Period 2 (14 Days)||1
11354790|NCT03075410|12551813|FG003|NOT COMPLETED|Part A-Period 2 (14 Days)||0
11354791|NCT03075410|12551814|FG004|NOT COMPLETED|Part A-Period 2 (14 Days)||0
11354792|NCT03075410|12551815|FG005|NOT COMPLETED|Part A-Period 2 (14 Days)||0
11354793|NCT03075410|12551816|FG006|NOT COMPLETED|Part A-Period 2 (14 Days)||0
11354794|NCT03075410|12551817|FG007|NOT COMPLETED|Part A-Period 2 (14 Days)||0
11354795|NCT03075410|12551818|FG008|NOT COMPLETED|Part A-Period 2 (14 Days)||0
11106457|NCT01259089|12290874|FG005|NOT COMPLETED|Survival Follow up for Two Years||19
11106458|NCT01259102|12290893|FG000|STARTED|Overall Study||13
11106459|NCT01259102|12290894|FG001|STARTED|Overall Study||14
11106460|NCT01259102|12290895|FG002|STARTED|Overall Study||15
11106461|NCT01259102|12290896|FG003|STARTED|Overall Study||14
10852637|NCT02881957|12018833|FG000|STARTED|Overall Study||136
10852638|NCT02881957|12018834|FG001|STARTED|Overall Study||138
10852639|NCT02881957|12018833|FG000|COMPLETED|Overall Study||133
10852640|NCT02881957|12018834|FG001|COMPLETED|Overall Study||134
10852641|NCT02881957|12018833|FG000|NOT COMPLETED|Overall Study||3
10852642|NCT02881957|12018834|FG001|NOT COMPLETED|Overall Study||4
10852643|NCT02880189|12018840|FG000|STARTED|Overall Study||21
10852644|NCT02880189|12018840|FG000|COMPLETED|Overall Study||21
10852645|NCT02880189|12018840|FG000|NOT COMPLETED|Overall Study||0
10852646|NCT02761694|12018856|FG000|STARTED|Overall Study||4
10852647|NCT02761694|12018857|FG001|STARTED|Overall Study||4
10852648|NCT02761694|12018858|FG002|STARTED|Overall Study||1
10852649|NCT02761694|12018859|FG003|STARTED|Overall Study||3
10852650|NCT02761694|12018860|FG004|STARTED|Overall Study||3
10852651|NCT02761694|12018861|FG005|STARTED|Overall Study||3
10852652|NCT02761694|12018862|FG006|STARTED|Overall Study||33
10852653|NCT02761694|12018863|FG007|STARTED|Overall Study||8
10852654|NCT02761694|12018864|FG008|STARTED|Overall Study||5
10852655|NCT02761694|12018865|FG009|STARTED|Overall Study||5
10852656|NCT02761694|12018866|FG010|STARTED|Overall Study||3
10852657|NCT02761694|12018867|FG011|STARTED|Overall Study||6
10852658|NCT02761694|12018856|FG000|Treated|Overall Study||4
10852659|NCT02761694|12018857|FG001|Treated|Overall Study||4
10852660|NCT02761694|12018858|FG002|Treated|Overall Study||1
10852661|NCT02761694|12018859|FG003|Treated|Overall Study||3
10852662|NCT02761694|12018860|FG004|Treated|Overall Study||3
10852663|NCT02761694|12018861|FG005|Treated|Overall Study||3
10852664|NCT02761694|12018862|FG006|Treated|Overall Study||32
11106462|NCT01259102|12290897|FG004|STARTED|Overall Study||14
11106463|NCT01259102|12290893|FG000|COMPLETED|Overall Study||12
11106464|NCT01259102|12290894|FG001|COMPLETED|Overall Study||14
11106465|NCT01259102|12290895|FG002|COMPLETED|Overall Study||13
11106466|NCT01259102|12290896|FG003|COMPLETED|Overall Study||12
11106467|NCT01259102|12290897|FG004|COMPLETED|Overall Study||13
11106468|NCT01259102|12290893|FG000|NOT COMPLETED|Overall Study||1
11106469|NCT01259102|12290894|FG001|NOT COMPLETED|Overall Study||0
11106470|NCT01259102|12290895|FG002|NOT COMPLETED|Overall Study||2
10852665|NCT02761694|12018863|FG007|Treated|Overall Study||8
10852666|NCT02761694|12018864|FG008|Treated|Overall Study||5
10852667|NCT02761694|12018865|FG009|Treated|Overall Study||5
10852668|NCT02761694|12018866|FG010|Treated|Overall Study||3
10852669|NCT02761694|12018867|FG011|Treated|Overall Study||6
10852670|NCT02761694|12018856|FG000|COMPLETED|Overall Study||0
10852671|NCT02761694|12018857|FG001|COMPLETED|Overall Study||0
10852672|NCT02761694|12018858|FG002|COMPLETED|Overall Study||0
10852673|NCT02761694|12018859|FG003|COMPLETED|Overall Study||0
10852674|NCT02761694|12018860|FG004|COMPLETED|Overall Study||0
10852675|NCT02761694|12018861|FG005|COMPLETED|Overall Study||0
10852676|NCT02761694|12018862|FG006|COMPLETED|Overall Study||0
10852677|NCT02761694|12018863|FG007|COMPLETED|Overall Study||0
10852678|NCT02761694|12018864|FG008|COMPLETED|Overall Study||0
10852679|NCT02761694|12018865|FG009|COMPLETED|Overall Study||0
10852680|NCT02761694|12018866|FG010|COMPLETED|Overall Study||0
10852681|NCT02761694|12018867|FG011|COMPLETED|Overall Study||0
10852682|NCT02761694|12018856|FG000|NOT COMPLETED|Overall Study||4
10852683|NCT02761694|12018857|FG001|NOT COMPLETED|Overall Study||4
10852684|NCT02761694|12018858|FG002|NOT COMPLETED|Overall Study||1
10852685|NCT02761694|12018859|FG003|NOT COMPLETED|Overall Study||3
10852686|NCT02761694|12018860|FG004|NOT COMPLETED|Overall Study||3
10852687|NCT02761694|12018861|FG005|NOT COMPLETED|Overall Study||3
10852688|NCT02761694|12018862|FG006|NOT COMPLETED|Overall Study||33
10852689|NCT02761694|12018863|FG007|NOT COMPLETED|Overall Study||8
10852690|NCT02761694|12018864|FG008|NOT COMPLETED|Overall Study||5
10852691|NCT02761694|12018865|FG009|NOT COMPLETED|Overall Study||5
10852692|NCT02761694|12018866|FG010|NOT COMPLETED|Overall Study||3
10852693|NCT02761694|12018867|FG011|NOT COMPLETED|Overall Study||6
10852694|NCT02611960|12018896|FG000|STARTED|Overall Study||117
10852695|NCT02611960|12018897|FG001|STARTED|Overall Study||116
10852696|NCT02611960|12018896|FG000|Treated|Overall Study||116
10852697|NCT02611960|12018897|FG001|Treated|Overall Study||112
10852698|NCT02611960|12018896|FG000|COMPLETED|Overall Study||0
10852699|NCT02611960|12018897|FG001|COMPLETED|Overall Study||0
10852700|NCT02611960|12018896|FG000|NOT COMPLETED|Overall Study||117
10852701|NCT02611960|12018897|FG001|NOT COMPLETED|Overall Study||116
10852702|NCT02574455|12018906|FG000|STARTED|Overall Study||267
10852703|NCT02574455|12018907|FG001|STARTED|Overall Study||262
10852704|NCT02574455|12018906|FG000|Enrolled and Treated|Overall Study||258
10852705|NCT02574455|12018907|FG001|Enrolled and Treated|Overall Study||224
10852706|NCT02574455|12018906|FG000|COMPLETED|Overall Study||0
10852707|NCT02574455|12018907|FG001|COMPLETED|Overall Study||0
10852708|NCT02574455|12018906|FG000|NOT COMPLETED|Overall Study||267
10852709|NCT02574455|12018907|FG001|NOT COMPLETED|Overall Study||262
10852710|NCT02493660|12018915|FG000|STARTED|Overall Study|ITT|93
10852711|NCT02493660|12018916|FG001|STARTED|Overall Study|ITT|91
10852712|NCT02493660|12018915|FG000|COMPLETED|Overall Study||83
10852713|NCT02493660|12018916|FG001|COMPLETED|Overall Study|Investigator requested subject be discontinued prior to any post-procedure efficacy assessments.|79
10852714|NCT02493660|12018915|FG000|NOT COMPLETED|Overall Study||10
10852715|NCT02493660|12018916|FG001|NOT COMPLETED|Overall Study||12
10852716|NCT02232087|12018924|FG000|STARTED|Overall Study||9
10852717|NCT02232087|12018925|FG001|STARTED|Overall Study||10
10852718|NCT02232087|12018926|FG002|STARTED|Overall Study||8
10852719|NCT02232087|12018927|FG003|STARTED|Overall Study||8
10852720|NCT02232087|12018928|FG004|STARTED|Overall Study||8
10852721|NCT02232087|12018929|FG005|STARTED|Overall Study||9
10852722|NCT02232087|12018924|FG000|COMPLETED|Overall Study||7
10852723|NCT02232087|12018925|FG001|COMPLETED|Overall Study||8
10852724|NCT02232087|12018926|FG002|COMPLETED|Overall Study||8
10852725|NCT02232087|12018927|FG003|COMPLETED|Overall Study||7
10852726|NCT02232087|12018928|FG004|COMPLETED|Overall Study||7
10852727|NCT02232087|12018929|FG005|COMPLETED|Overall Study||6
10852728|NCT02232087|12018924|FG000|NOT COMPLETED|Overall Study||2
10852729|NCT02232087|12018925|FG001|NOT COMPLETED|Overall Study||2
10852730|NCT02232087|12018926|FG002|NOT COMPLETED|Overall Study||0
10852731|NCT02232087|12018927|FG003|NOT COMPLETED|Overall Study||1
10852732|NCT02232087|12018928|FG004|NOT COMPLETED|Overall Study||1
10852733|NCT02232087|12018929|FG005|NOT COMPLETED|Overall Study||3
10852737|NCT01952847|12018956|FG000|STARTED|Overall Study||27
10852738|NCT01952847|12018957|FG001|STARTED|Overall Study||26
10852739|NCT01952847|12018958|FG002|STARTED|Overall Study||7
10852740|NCT01952847|12018959|FG003|STARTED|Overall Study||7
10852741|NCT01952847|12018956|FG000|COMPLETED|Overall Study||25
11106471|NCT01259102|12290896|FG003|NOT COMPLETED|Overall Study||2
11106472|NCT01259102|12290897|FG004|NOT COMPLETED|Overall Study||1
11106473|NCT01259115|12290909|FG000|STARTED|Period 1||10
11106474|NCT01259115|12290910|FG001|STARTED|Period 1||10
11106475|NCT01259115|12290909|FG000|COMPLETED|Period 1||7
11106476|NCT01259115|12290910|FG001|COMPLETED|Period 1||9
11106477|NCT01259115|12290909|FG000|NOT COMPLETED|Period 1||3
11106478|NCT01259115|12290910|FG001|NOT COMPLETED|Period 1||1
11106479|NCT01259115|12290909|FG000|STARTED|Period: Washout Period of 4 to 18 Days||7
11106480|NCT01259115|12290910|FG001|STARTED|Period: Washout Period of 4 to 18 Days||9
11106481|NCT01259115|12290909|FG000|COMPLETED|Period: Washout Period of 4 to 18 Days||7
11106482|NCT01259115|12290910|FG001|COMPLETED|Period: Washout Period of 4 to 18 Days||9
11106483|NCT01259115|12290909|FG000|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
11106484|NCT01259115|12290910|FG001|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
10852742|NCT01952847|12018957|FG001|COMPLETED|Overall Study||24
10852743|NCT01952847|12018958|FG002|COMPLETED|Overall Study||7
10852744|NCT01952847|12018959|FG003|COMPLETED|Overall Study||6
10852745|NCT01952847|12018956|FG000|NOT COMPLETED|Overall Study||2
10852746|NCT01952847|12018957|FG001|NOT COMPLETED|Overall Study||2
10852747|NCT01952847|12018958|FG002|NOT COMPLETED|Overall Study||0
10852748|NCT01952847|12018959|FG003|NOT COMPLETED|Overall Study||1
10852749|NCT01889238|12018971|FG000|STARTED|Overall Study||118
10852750|NCT01889238|12018971|FG000|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
10852751|NCT01889238|12018971|FG000|NOT COMPLETED|Overall Study||9
11106485|NCT01259115|12290909|FG000|STARTED|Period 2||7
11106486|NCT01259115|12290910|FG001|STARTED|Period 2||9
11106487|NCT01259115|12290909|FG000|COMPLETED|Period 2||6
11106488|NCT01259115|12290910|FG001|COMPLETED|Period 2||9
11106489|NCT01259115|12290909|FG000|NOT COMPLETED|Period 2||1
11106490|NCT01259115|12290910|FG001|NOT COMPLETED|Period 2||0
10852758|NCT01672892|12018986|FG000|STARTED|Overall Study||137
10852759|NCT01672892|12018987|FG001|STARTED|Overall Study||152
10852760|NCT01672892|12018986|FG000|Eligible Population|Overall Study||130
10852761|NCT01672892|12018987|FG001|Eligible Population|Overall Study||149
10852762|NCT01672892|12018986|FG000|Adverse Event Population|Overall Study||125
10852763|NCT01672892|12018987|FG001|Adverse Event Population|Overall Study||144
10852764|NCT01672892|12018986|FG000|COMPLETED|Overall Study||130
10852765|NCT01672892|12018987|FG001|COMPLETED|Overall Study||149
10852766|NCT01672892|12018986|FG000|NOT COMPLETED|Overall Study||7
10852767|NCT01672892|12018987|FG001|NOT COMPLETED|Overall Study||3
10852768|NCT01560585|12018996|FG000|STARTED|Overall Study||3
10852769|NCT01560585|12018996|FG000|Screened|Overall Study|3 subjects screend and started treatment in open label|3
10852770|NCT01560585|12018996|FG000|COMPLETED|Overall Study|Study stopped due to adverse events One subject had transient loss of consciousness - possibly related to treatment One subject declined rapidly and found to have glioblastoma- not rrelated to treatment|0
10852771|NCT01560585|12018996|FG000|NOT COMPLETED|Overall Study||3
10852772|NCT00979212|12019003|FG000|STARTED|Overall Study||24
10852773|NCT00979212|12019004|FG001|STARTED|Overall Study||47
10852774|NCT00979212|12019003|FG000|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
10852775|NCT00979212|12019004|FG001|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
10852776|NCT00979212|12019003|FG000|NOT COMPLETED|Overall Study||2
10852777|NCT00979212|12019004|FG001|NOT COMPLETED|Overall Study||8
10852778|NCT00777491|12019012|FG000|STARTED|Overall Study||35
10852779|NCT00777491|12019013|FG001|STARTED|Overall Study||35
10852780|NCT00777491|12019012|FG000|Eligible|Overall Study||33
10852781|NCT00777491|12019013|FG001|Eligible|Overall Study||33
10852782|NCT00777491|12019012|FG000|Has 3-year Efficacy Data|Overall Study||27
10852783|NCT00777491|12019013|FG001|Has 3-year Efficacy Data|Overall Study||25
10852784|NCT00777491|12019012|FG000|Started Induction Therapy|Overall Study||33
10852785|NCT00777491|12019013|FG001|Started Induction Therapy|Overall Study||33
10852786|NCT00777491|12019012|FG000|Started Consolidation Therapy|Overall Study||29
10852787|NCT00777491|12019013|FG001|Started Consolidation Therapy|Overall Study||25
10852788|NCT00777491|12019012|FG000|Started Adjuvant Therapy|Overall Study||32
10852789|NCT00777491|12019013|FG001|Started Adjuvant Therapy|Overall Study||31
10852790|NCT00777491|12019012|FG000|Has Adverse Event Data (Treatment)|Overall Study||33
10852791|NCT00777491|12019013|FG001|Has Adverse Event Data (Treatment)|Overall Study||33
10852792|NCT00777491|12019012|FG000|Has Adverse Event Data (Late)|Overall Study||32
10852793|NCT00777491|12019013|FG001|Has Adverse Event Data (Late)|Overall Study||31
10852794|NCT00777491|12019012|FG000|Has 3 Year AUASI Data|Overall Study||6
10852795|NCT00777491|12019013|FG001|Has 3 Year AUASI Data|Overall Study||6
10852796|NCT00777491|12019012|FG000|COMPLETED|Overall Study||33
10852797|NCT00777491|12019013|FG001|COMPLETED|Overall Study||33
10852798|NCT00777491|12019012|FG000|NOT COMPLETED|Overall Study||2
10852799|NCT00777491|12019013|FG001|NOT COMPLETED|Overall Study||2
10852800|NCT00759655|12019019|FG000|STARTED|Overall Study||1
10852801|NCT00759655|12019019|FG000|COMPLETED|Overall Study||0
10852802|NCT00759655|12019019|FG000|NOT COMPLETED|Overall Study||1
10852803|NCT00145795|12019025|FG000|STARTED|Overall Study||10
10852804|NCT00145795|12019026|FG001|STARTED|Overall Study||10
10852805|NCT00145795|12019025|FG000|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
10852806|NCT00145795|12019026|FG001|COMPLETED|Overall Study||10
10852807|NCT00145795|12019025|FG000|NOT COMPLETED|Overall Study||1
10852808|NCT00145795|12019026|FG001|NOT COMPLETED|Overall Study||0
10852809|NCT00005044|12019034|FG000|STARTED|Overall Study||790
10852810|NCT00005044|12019035|FG001|STARTED|Overall Study||789
10852811|NCT00005044|12019034|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
10852812|NCT00005044|12019035|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
10852813|NCT00005044|12019034|FG000|NOT COMPLETED|Overall Study||38
10852814|NCT00005044|12019035|FG001|NOT COMPLETED|Overall Study||52
10852815|NCT00002874|12019043|FG000|STARTED|Overall Study||421
10852816|NCT00002874|12019044|FG001|STARTED|Overall Study||419
10852817|NCT00002874|12019043|FG000|COMPLETED|Overall Study||376
10852818|NCT00002874|12019044|FG001|COMPLETED|Overall Study||384
10852819|NCT00002874|12019043|FG000|NOT COMPLETED|Overall Study||45
10852820|NCT00002874|12019044|FG001|NOT COMPLETED|Overall Study||35
10852821|NCT04391894|12019055|FG000|STARTED|Overall Study||111
10852822|NCT04391894|12019056|FG001|STARTED|Overall Study||112
11106491|NCT01259128|12290923|FG000|STARTED|Overall Study||15
10852823|NCT04391894|12019057|FG002|STARTED|Overall Study||112
10852824|NCT04391894|12019058|FG003|STARTED|Overall Study||109
10852825|NCT04391894|12019059|FG004|STARTED|Overall Study||114
10852826|NCT04391894|12019055|FG000|COMPLETED|Overall Study||107
10852827|NCT04391894|12019056|FG001|COMPLETED|Overall Study||111
10852828|NCT04391894|12019057|FG002|COMPLETED|Overall Study||108
10852829|NCT04391894|12019058|FG003|COMPLETED|Overall Study||107
10852830|NCT04391894|12019059|FG004|COMPLETED|Overall Study||111
10852831|NCT04391894|12019055|FG000|NOT COMPLETED|Overall Study||4
10852832|NCT04391894|12019056|FG001|NOT COMPLETED|Overall Study||1
10852833|NCT04391894|12019057|FG002|NOT COMPLETED|Overall Study||4
10852834|NCT04391894|12019058|FG003|NOT COMPLETED|Overall Study||2
10852835|NCT04391894|12019059|FG004|NOT COMPLETED|Overall Study||3
10852842|NCT03501966|12019084|FG000|STARTED|Overall Study||2
10852843|NCT03501966|12019085|FG001|STARTED|Overall Study||2
10852844|NCT03501966|12019086|FG002|STARTED|Overall Study||3
10852845|NCT03501966|12019084|FG000|COMPLETED|Overall Study||0
10852846|NCT03501966|12019085|FG001|COMPLETED|Overall Study||0
10852847|NCT03501966|12019086|FG002|COMPLETED|Overall Study||0
10852848|NCT03501966|12019084|FG000|NOT COMPLETED|Overall Study||2
10852849|NCT03501966|12019085|FG001|NOT COMPLETED|Overall Study||2
10852850|NCT03501966|12019086|FG002|NOT COMPLETED|Overall Study||3
10852851|NCT03489291|12019094|FG000|STARTED|Overall Study||3
10852852|NCT03489291|12019094|FG000|COMPLETED|Overall Study||3
10852853|NCT03489291|12019094|FG000|NOT COMPLETED|Overall Study||0
10852854|NCT03428100|12019102|FG000|STARTED|Overall Study||93
10852855|NCT03428100|12019103|FG001|STARTED|Overall Study||93
10852856|NCT03428100|12019104|FG002|STARTED|Overall Study||185
10852857|NCT03428100|12019105|FG003|STARTED|Overall Study||92
10852858|NCT03428100|12019102|FG000|Received at Least One Dose of Study Drug|Overall Study||93
10852859|NCT03428100|12019103|FG001|Received at Least One Dose of Study Drug|Overall Study||93
10852860|NCT03428100|12019104|FG002|Received at Least One Dose of Study Drug|Overall Study||184
10852861|NCT03428100|12019105|FG003|Received at Least One Dose of Study Drug|Overall Study||92
10852862|NCT03428100|12019102|FG000|COMPLETED|Overall Study||72
10852863|NCT03428100|12019103|FG001|COMPLETED|Overall Study||80
10852864|NCT03428100|12019104|FG002|COMPLETED|Overall Study||173
10852865|NCT03428100|12019105|FG003|COMPLETED|Overall Study||85
10852866|NCT03428100|12019102|FG000|NOT COMPLETED|Overall Study||21
10852867|NCT03428100|12019103|FG001|NOT COMPLETED|Overall Study||13
10852868|NCT03428100|12019104|FG002|NOT COMPLETED|Overall Study||12
10852869|NCT03428100|12019105|FG003|NOT COMPLETED|Overall Study||7
10852870|NCT03341936|12019125|FG000|STARTED|Overall Study||29
10852871|NCT03341936|12019125|FG000|Treated|Overall Study||28
10852872|NCT03341936|12019125|FG000|COMPLETED|Overall Study||18
10852873|NCT03341936|12019125|FG000|NOT COMPLETED|Overall Study||11
10852874|NCT03174353|12019129|FG000|STARTED|Overall Study||114
10852875|NCT03174353|12019129|FG000|COMPLETED|Overall Study||98
10852876|NCT03174353|12019129|FG000|NOT COMPLETED|Overall Study||16
10852877|NCT03144687|12019135|FG000|STARTED|Overall Study||13
10852878|NCT03144687|12019136|FG001|STARTED|Overall Study||10
10852879|NCT03144687|12019135|FG000|COMPLETED|Overall Study||10
10852880|NCT03144687|12019136|FG001|COMPLETED|Overall Study||3
10852881|NCT03144687|12019135|FG000|NOT COMPLETED|Overall Study||3
10852882|NCT03144687|12019136|FG001|NOT COMPLETED|Overall Study||7
10852886|NCT02880371|12019158|FG000|STARTED|Phase 1b||6
10852887|NCT02880371|12019159|FG001|STARTED|Phase 1b||7
10852888|NCT02880371|12019160|FG002|STARTED|Phase 1b||7
10852889|NCT02880371|12019161|FG003|STARTED|Phase 1b||1
10852890|NCT02880371|12019162|FG004|STARTED|Phase 1b||0
10852891|NCT02880371|12019163|FG005|STARTED|Phase 1b||0
10852892|NCT02880371|12019164|FG006|STARTED|Phase 1b||0
10852893|NCT02880371|12019165|FG007|STARTED|Phase 1b||0
10852894|NCT02880371|12019158|FG000|Treated|Phase 1b||6
10852895|NCT02880371|12019159|FG001|Treated|Phase 1b||6
10852896|NCT02880371|12019160|FG002|Treated|Phase 1b||7
10852897|NCT02880371|12019161|FG003|Treated|Phase 1b||1
10852898|NCT02880371|12019162|FG004|Treated|Phase 1b||0
10852899|NCT02880371|12019163|FG005|Treated|Phase 1b||0
10852900|NCT02880371|12019164|FG006|Treated|Phase 1b||0
10852901|NCT02880371|12019165|FG007|Treated|Phase 1b||0
10852902|NCT02880371|12019158|FG000|COMPLETED|Phase 1b||0
10852903|NCT02880371|12019159|FG001|COMPLETED|Phase 1b||0
10852904|NCT02880371|12019160|FG002|COMPLETED|Phase 1b||1
10852905|NCT02880371|12019161|FG003|COMPLETED|Phase 1b||0
10852906|NCT02880371|12019162|FG004|COMPLETED|Phase 1b||0
10852907|NCT02880371|12019163|FG005|COMPLETED|Phase 1b||0
10852908|NCT02880371|12019164|FG006|COMPLETED|Phase 1b||0
10852909|NCT02880371|12019165|FG007|COMPLETED|Phase 1b||0
10852910|NCT02880371|12019158|FG000|NOT COMPLETED|Phase 1b||6
10852911|NCT02880371|12019159|FG001|NOT COMPLETED|Phase 1b||7
10852912|NCT02880371|12019160|FG002|NOT COMPLETED|Phase 1b||6
10852913|NCT02880371|12019161|FG003|NOT COMPLETED|Phase 1b||1
10852914|NCT02880371|12019162|FG004|NOT COMPLETED|Phase 1b||0
10852915|NCT02880371|12019163|FG005|NOT COMPLETED|Phase 1b||0
10852916|NCT02880371|12019164|FG006|NOT COMPLETED|Phase 1b||0
10852917|NCT02880371|12019165|FG007|NOT COMPLETED|Phase 1b||0
10852918|NCT02880371|12019158|FG000|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0
10852919|NCT02880371|12019159|FG001|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0
10852920|NCT02880371|12019160|FG002|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0
10852921|NCT02880371|12019161|FG003|STARTED|Phase 2|Participants of Phase 1b were different from Phase 2.|0
10852922|NCT02880371|12019162|FG004|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|2
10853012|NCT02395120|12019257|FG004|Completed-Caregivers|Overall Study||164
10852923|NCT02880371|12019163|FG005|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|20
10852924|NCT02880371|12019164|FG006|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|28
10852925|NCT02880371|12019165|FG007|STARTED|Phase 2|Participants enrolled for Phase 2 were different from participants enrolled for Phase 1b.|11
10852926|NCT02880371|12019158|FG000|Treated|Phase 2||0
10852927|NCT02880371|12019159|FG001|Treated|Phase 2||0
10852928|NCT02880371|12019160|FG002|Treated|Phase 2||0
10852929|NCT02880371|12019161|FG003|Treated|Phase 2||0
10852930|NCT02880371|12019162|FG004|Treated|Phase 2||2
10852931|NCT02880371|12019163|FG005|Treated|Phase 2||19
10852932|NCT02880371|12019164|FG006|Treated|Phase 2||27
10852933|NCT02880371|12019165|FG007|Treated|Phase 2||11
10852934|NCT02880371|12019158|FG000|COMPLETED|Phase 2||0
10852935|NCT02880371|12019159|FG001|COMPLETED|Phase 2||0
10852936|NCT02880371|12019160|FG002|COMPLETED|Phase 2||0
10852937|NCT02880371|12019161|FG003|COMPLETED|Phase 2||0
10852938|NCT02880371|12019162|FG004|COMPLETED|Phase 2||0
10852939|NCT02880371|12019163|FG005|COMPLETED|Phase 2||0
10852940|NCT02880371|12019164|FG006|COMPLETED|Phase 2||0
10852941|NCT02880371|12019165|FG007|COMPLETED|Phase 2||0
10852942|NCT02880371|12019158|FG000|NOT COMPLETED|Phase 2||0
10852943|NCT02880371|12019159|FG001|NOT COMPLETED|Phase 2||0
10852944|NCT02880371|12019160|FG002|NOT COMPLETED|Phase 2||0
10852945|NCT02880371|12019161|FG003|NOT COMPLETED|Phase 2||0
10852946|NCT02880371|12019162|FG004|NOT COMPLETED|Phase 2||2
10852947|NCT02880371|12019163|FG005|NOT COMPLETED|Phase 2||20
10852948|NCT02880371|12019164|FG006|NOT COMPLETED|Phase 2||28
10852949|NCT02880371|12019165|FG007|NOT COMPLETED|Phase 2||11
11106492|NCT01259128|12290924|FG001|STARTED|Overall Study||17
11106493|NCT01259128|12290923|FG000|COMPLETED|Overall Study||15
11106494|NCT01259128|12290924|FG001|COMPLETED|Overall Study||15
11106495|NCT01259128|12290923|FG000|NOT COMPLETED|Overall Study||0
11106496|NCT01259128|12290924|FG001|NOT COMPLETED|Overall Study||2
11106497|NCT01259245|12290932|FG000|STARTED|Overall Study||98
10852956|NCT02434354|12019194|FG000|STARTED|Overall Study|Consented|33
10852957|NCT02434354|12019194|FG000|Post Consent Screening|Overall Study||30
10852958|NCT02434354|12019194|FG000|COMPLETED|Overall Study||30
10852959|NCT02434354|12019194|FG000|NOT COMPLETED|Overall Study||3
10852960|NCT02419417|12019209|FG000|STARTED|Overall Study||5
10852961|NCT02419417|12019210|FG001|STARTED|Overall Study||4
10852962|NCT02419417|12019211|FG002|STARTED|Overall Study||13
10852963|NCT02419417|12019212|FG003|STARTED|Overall Study||10
10852964|NCT02419417|12019213|FG004|STARTED|Overall Study||13
10852965|NCT02419417|12019214|FG005|STARTED|Overall Study||4
10852966|NCT02419417|12019215|FG006|STARTED|Overall Study||4
10852967|NCT02419417|12019216|FG007|STARTED|Overall Study||6
10852968|NCT02419417|12019217|FG008|STARTED|Overall Study||13
10852969|NCT02419417|12019218|FG009|STARTED|Overall Study||10
10852970|NCT02419417|12019219|FG010|STARTED|Overall Study||1
10852971|NCT02419417|12019209|FG000|COMPLETED|Overall Study||0
10852972|NCT02419417|12019210|FG001|COMPLETED|Overall Study||0
10852973|NCT02419417|12019211|FG002|COMPLETED|Overall Study||0
10852974|NCT02419417|12019212|FG003|COMPLETED|Overall Study||0
10852975|NCT02419417|12019213|FG004|COMPLETED|Overall Study||0
10852976|NCT02419417|12019214|FG005|COMPLETED|Overall Study||0
10852977|NCT02419417|12019215|FG006|COMPLETED|Overall Study||0
10852978|NCT02419417|12019216|FG007|COMPLETED|Overall Study||0
10852979|NCT02419417|12019217|FG008|COMPLETED|Overall Study||0
10852980|NCT02419417|12019218|FG009|COMPLETED|Overall Study||0
10852981|NCT02419417|12019219|FG010|COMPLETED|Overall Study||0
10852982|NCT02419417|12019209|FG000|NOT COMPLETED|Overall Study||5
10852983|NCT02419417|12019210|FG001|NOT COMPLETED|Overall Study||4
10852984|NCT02419417|12019211|FG002|NOT COMPLETED|Overall Study||13
10852985|NCT02419417|12019212|FG003|NOT COMPLETED|Overall Study||10
10852986|NCT02419417|12019213|FG004|NOT COMPLETED|Overall Study||13
10852987|NCT02419417|12019214|FG005|NOT COMPLETED|Overall Study||4
10852988|NCT02419417|12019215|FG006|NOT COMPLETED|Overall Study||4
10852989|NCT02419417|12019216|FG007|NOT COMPLETED|Overall Study||6
10852990|NCT02419417|12019217|FG008|NOT COMPLETED|Overall Study||13
10852991|NCT02419417|12019218|FG009|NOT COMPLETED|Overall Study||10
10852992|NCT02419417|12019219|FG010|NOT COMPLETED|Overall Study||1
10852993|NCT02395120|12019253|FG000|STARTED|Overall Study|Caregivers and Children|400
10852994|NCT02395120|12019254|FG001|STARTED|Overall Study|Caregivers and Children|398
10852995|NCT02395120|12019255|FG002|STARTED|Overall Study|Caregivers and Children|43
10852996|NCT02395120|12019256|FG003|STARTED|Overall Study|Caregivers and Children|63
10852997|NCT02395120|12019257|FG004|STARTED|Overall Study|Caregivers and Children|401
10852998|NCT02395120|12019253|FG000|Started-Caregivers|Overall Study||188
10852999|NCT02395120|12019254|FG001|Started-Caregivers|Overall Study||188
10853000|NCT02395120|12019255|FG002|Started-Caregivers|Overall Study||20
10853001|NCT02395120|12019256|FG003|Started-Caregivers|Overall Study||28
10853002|NCT02395120|12019257|FG004|Started-Caregivers|Overall Study||187
10853003|NCT02395120|12019253|FG000|Started-Children|Overall Study||212
10853004|NCT02395120|12019254|FG001|Started-Children|Overall Study||210
10853005|NCT02395120|12019255|FG002|Started-Children|Overall Study||23
10853006|NCT02395120|12019256|FG003|Started-Children|Overall Study||35
10853007|NCT02395120|12019257|FG004|Started-Children|Overall Study||214
10853008|NCT02395120|12019253|FG000|Completed-Caregivers|Overall Study||161
10853009|NCT02395120|12019254|FG001|Completed-Caregivers|Overall Study||159
10853010|NCT02395120|12019255|FG002|Completed-Caregivers|Overall Study||17
10853011|NCT02395120|12019256|FG003|Completed-Caregivers|Overall Study||25
11106498|NCT01259245|12290933|FG001|STARTED|Overall Study||94
10853013|NCT02395120|12019253|FG000|Completed-Children|Overall Study||182
10853014|NCT02395120|12019254|FG001|Completed-Children|Overall Study||177
10853015|NCT02395120|12019255|FG002|Completed-Children|Overall Study||20
10853016|NCT02395120|12019256|FG003|Completed-Children|Overall Study||32
10853017|NCT02395120|12019257|FG004|Completed-Children|Overall Study||186
10853018|NCT02395120|12019253|FG000|COMPLETED|Overall Study|Caregivers and Children|343
10853019|NCT02395120|12019254|FG001|COMPLETED|Overall Study|Caregivers and Children|336
11106499|NCT01259245|12290932|FG000|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
10853020|NCT02395120|12019255|FG002|COMPLETED|Overall Study|Caregivers and Children|37
10853021|NCT02395120|12019256|FG003|COMPLETED|Overall Study|Caregivers and Children|57
10853022|NCT02395120|12019257|FG004|COMPLETED|Overall Study|Caregivers and Children|350
10853023|NCT02395120|12019253|FG000|NOT COMPLETED|Overall Study||57
10853024|NCT02395120|12019254|FG001|NOT COMPLETED|Overall Study||62
10853025|NCT02395120|12019255|FG002|NOT COMPLETED|Overall Study||6
10853026|NCT02395120|12019256|FG003|NOT COMPLETED|Overall Study||6
10853027|NCT02395120|12019257|FG004|NOT COMPLETED|Overall Study||51
10853028|NCT02342275|12019271|FG000|STARTED|Overall Study||190
10853029|NCT02342275|12019272|FG001|STARTED|Overall Study||187
10853030|NCT02342275|12019271|FG000|COMPLETED|Overall Study||184
10853031|NCT02342275|12019272|FG001|COMPLETED|Overall Study||182
10853032|NCT02342275|12019271|FG000|NOT COMPLETED|Overall Study||6
10853033|NCT02342275|12019272|FG001|NOT COMPLETED|Overall Study||5
11106500|NCT01259245|12290933|FG001|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
11106501|NCT01259245|12290932|FG000|NOT COMPLETED|Overall Study||28
11106502|NCT01259245|12290933|FG001|NOT COMPLETED|Overall Study||26
11106503|NCT01259297|12290949|FG000|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
11106504|NCT01259297|12290950|FG001|STARTED|Run-in Open Label Period (4-5 Weeks)||0
11106505|NCT01259297|12290951|FG002|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
11106506|NCT01259297|12290952|FG003|STARTED|Run-in Open Label Period (4-5 Weeks)||0
11106507|NCT01259297|12290953|FG004|STARTED|Run-in Open Label Period (4-5 Weeks)||0
11106508|NCT01259297|12290954|FG005|STARTED|Run-in Open Label Period (4-5 Weeks)||0
11106509|NCT01259297|12290955|FG006|STARTED|Run-in Open Label Period (4-5 Weeks)||0
11106510|NCT01259297|12290956|FG007|STARTED|Run-in Open Label Period (4-5 Weeks)||0
11106511|NCT01259297|12290949|FG000|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
11106512|NCT01259297|12290950|FG001|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
11106513|NCT01259297|12290951|FG002|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
11106514|NCT01259297|12290952|FG003|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
11106515|NCT01259297|12290953|FG004|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
11106516|NCT01259297|12290954|FG005|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
11106517|NCT01259297|12290955|FG006|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
11106518|NCT01259297|12290956|FG007|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
11106519|NCT01259297|12290949|FG000|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
11106520|NCT01259297|12290950|FG001|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
11106521|NCT01259297|12290951|FG002|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
11106522|NCT01259297|12290952|FG003|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
11106523|NCT01259297|12290953|FG004|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
11106524|NCT01259297|12290954|FG005|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
11106525|NCT01259297|12290955|FG006|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
11106526|NCT01259297|12290956|FG007|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
11106527|NCT01259297|12290949|FG000|STARTED|Double Blind Randomized Period||244
11106528|NCT01259297|12290950|FG001|STARTED|Double Blind Randomized Period||232
11106529|NCT01259297|12290951|FG002|STARTED|Double Blind Randomized Period||189
11106530|NCT01259297|12290952|FG003|STARTED|Double Blind Randomized Period||195
11106531|NCT01259297|12290953|FG004|STARTED|Double Blind Randomized Period||251
11106532|NCT01259297|12290954|FG005|STARTED|Double Blind Randomized Period||253
11106533|NCT01259297|12290955|FG006|STARTED|Double Blind Randomized Period||196
11225390|NCT01992107|12417692|FG000|STARTED|Overall Study||1159
11225391|NCT01992107|12417693|FG001|STARTED|Overall Study||593
11225392|NCT01992107|12417694|FG002|STARTED|Overall Study||581
11225393|NCT01992107|12417692|FG000|COMPLETED|Overall Study||1091
11225394|NCT01992107|12417693|FG001|COMPLETED|Overall Study||560
11225395|NCT01992107|12417694|FG002|COMPLETED|Overall Study||545
11225396|NCT01992107|12417692|FG000|NOT COMPLETED|Overall Study||68
11225397|NCT01992107|12417693|FG001|NOT COMPLETED|Overall Study||33
11225398|NCT01992107|12417694|FG002|NOT COMPLETED|Overall Study||36
11225399|NCT01992159|12417723|FG000|STARTED|Overall Study||63
11225400|NCT01992159|12417724|FG001|STARTED|Overall Study||63
11225401|NCT01992159|12417725|FG002|STARTED|Overall Study||63
11225402|NCT01992159|12417726|FG003|STARTED|Overall Study||63
11225403|NCT01992159|12417723|FG000|Received Treatment|Overall Study||63
11225404|NCT01992159|12417724|FG001|Received Treatment|Overall Study||63
11225405|NCT01992159|12417725|FG002|Received Treatment|Overall Study||63
11225406|NCT01992159|12417726|FG003|Received Treatment|Overall Study||63
11225407|NCT01992159|12417723|FG000|Completed First 12 Months of Study|Overall Study||59
11225408|NCT01992159|12417724|FG001|Completed First 12 Months of Study|Overall Study||56
11225409|NCT01992159|12417725|FG002|Completed First 12 Months of Study|Overall Study||63
11225410|NCT01992159|12417726|FG003|Completed First 12 Months of Study|Overall Study||59
11225411|NCT01992159|12417723|FG000|COMPLETED|Overall Study||59
11225412|NCT01992159|12417724|FG001|COMPLETED|Overall Study||55
11225413|NCT01992159|12417725|FG002|COMPLETED|Overall Study||62
11225414|NCT01992159|12417726|FG003|COMPLETED|Overall Study||59
11225415|NCT01992159|12417723|FG000|NOT COMPLETED|Overall Study||4
11225416|NCT01992159|12417724|FG001|NOT COMPLETED|Overall Study||8
11225417|NCT01992159|12417725|FG002|NOT COMPLETED|Overall Study||1
11225418|NCT01992159|12417726|FG003|NOT COMPLETED|Overall Study||4
11225419|NCT01992172|12417738|FG000|STARTED|Overall Study||7
11106534|NCT01259297|12290956|FG007|STARTED|Double Blind Randomized Period||199
11106535|NCT01259297|12290949|FG000|COMPLETED|Double Blind Randomized Period||242
11106536|NCT01259297|12290950|FG001|COMPLETED|Double Blind Randomized Period||229
11106537|NCT01259297|12290951|FG002|COMPLETED|Double Blind Randomized Period||188
11354796|NCT03075410|12551810|FG000|STARTED|Part A-Washout Period 2 (14 Days)||1
11354797|NCT03075410|12551811|FG001|STARTED|Part A-Washout Period 2 (14 Days)||1
11354798|NCT03075410|12551812|FG002|STARTED|Part A-Washout Period 2 (14 Days)||1
11354799|NCT03075410|12551813|FG003|STARTED|Part A-Washout Period 2 (14 Days)||1
11106538|NCT01259297|12290952|FG003|COMPLETED|Double Blind Randomized Period||191
10853040|NCT02051608|12019292|FG000|STARTED|Part 1: Double Blind Treatment||195
10853041|NCT02051608|12019293|FG001|STARTED|Part 1: Double Blind Treatment||192
10853042|NCT02051608|12019294|FG002|STARTED|Part 1: Double Blind Treatment||0
10853043|NCT02051608|12019295|FG003|STARTED|Part 1: Double Blind Treatment||0
10853044|NCT02051608|12019292|FG000|COMPLETED|Part 1: Double Blind Treatment||134
10853045|NCT02051608|12019293|FG001|COMPLETED|Part 1: Double Blind Treatment||136
10853046|NCT02051608|12019294|FG002|COMPLETED|Part 1: Double Blind Treatment||0
10853047|NCT02051608|12019295|FG003|COMPLETED|Part 1: Double Blind Treatment||0
10853048|NCT02051608|12019292|FG000|NOT COMPLETED|Part 1: Double Blind Treatment||61
10853049|NCT02051608|12019293|FG001|NOT COMPLETED|Part 1: Double Blind Treatment||56
10853050|NCT02051608|12019294|FG002|NOT COMPLETED|Part 1: Double Blind Treatment||0
10853051|NCT02051608|12019295|FG003|NOT COMPLETED|Part 1: Double Blind Treatment||0
10853052|NCT02051608|12019292|FG000|STARTED|Part 2: Open-label Extension||0
10853053|NCT02051608|12019293|FG001|STARTED|Part 2: Open-label Extension||0
10853054|NCT02051608|12019294|FG002|STARTED|Part 2: Open-label Extension||119
10853055|NCT02051608|12019295|FG003|STARTED|Part 2: Open-label Extension||111
10853056|NCT02051608|12019292|FG000|COMPLETED|Part 2: Open-label Extension||0
10853057|NCT02051608|12019293|FG001|COMPLETED|Part 2: Open-label Extension||0
10853058|NCT02051608|12019294|FG002|COMPLETED|Part 2: Open-label Extension||49
10853059|NCT02051608|12019295|FG003|COMPLETED|Part 2: Open-label Extension||50
10853060|NCT02051608|12019292|FG000|NOT COMPLETED|Part 2: Open-label Extension||0
10853061|NCT02051608|12019293|FG001|NOT COMPLETED|Part 2: Open-label Extension||0
10853062|NCT02051608|12019294|FG002|NOT COMPLETED|Part 2: Open-label Extension||70
10853063|NCT02051608|12019295|FG003|NOT COMPLETED|Part 2: Open-label Extension||61
11106539|NCT01259297|12290953|FG004|COMPLETED|Double Blind Randomized Period||247
11106540|NCT01259297|12290954|FG005|COMPLETED|Double Blind Randomized Period||245
11106541|NCT01259297|12290955|FG006|COMPLETED|Double Blind Randomized Period||190
11106542|NCT01259297|12290956|FG007|COMPLETED|Double Blind Randomized Period||196
11106543|NCT01259297|12290949|FG000|NOT COMPLETED|Double Blind Randomized Period||2
11106544|NCT01259297|12290950|FG001|NOT COMPLETED|Double Blind Randomized Period||3
11106545|NCT01259297|12290951|FG002|NOT COMPLETED|Double Blind Randomized Period||1
11106546|NCT01259297|12290952|FG003|NOT COMPLETED|Double Blind Randomized Period||4
11106547|NCT01259297|12290953|FG004|NOT COMPLETED|Double Blind Randomized Period||4
11106548|NCT01259297|12290954|FG005|NOT COMPLETED|Double Blind Randomized Period||8
11106549|NCT01259297|12290955|FG006|NOT COMPLETED|Double Blind Randomized Period||6
11106550|NCT01259297|12290956|FG007|NOT COMPLETED|Double Blind Randomized Period||3
11106551|NCT01259375|12290973|FG000|STARTED|Overall Study||24
11106552|NCT01259375|12290973|FG000|COMPLETED|Overall Study||23
11106553|NCT01259375|12290973|FG000|NOT COMPLETED|Overall Study||1
11106554|NCT01259388|12290981|FG000|STARTED|Overall Study||11
10853083|NCT01700673|12019331|FG000|STARTED|Overall Study||1
10853084|NCT01700673|12019332|FG001|STARTED|Overall Study||23
10853085|NCT01700673|12019333|FG002|STARTED|Overall Study||1
10853086|NCT01700673|12019331|FG000|COMPLETED|Overall Study||1
10853087|NCT01700673|12019332|FG001|COMPLETED|Overall Study||17
10853088|NCT01700673|12019333|FG002|COMPLETED|Overall Study||1
10853089|NCT01700673|12019331|FG000|NOT COMPLETED|Overall Study||0
10853090|NCT01700673|12019332|FG001|NOT COMPLETED|Overall Study||6
10853091|NCT01700673|12019333|FG002|NOT COMPLETED|Overall Study||0
10853092|NCT01531374|12019345|FG000|STARTED|Overall Study||1285
10853093|NCT01531374|12019346|FG001|STARTED|Overall Study||373
10853094|NCT01531374|12019347|FG002|STARTED|Overall Study||1119
10853095|NCT01531374|12019345|FG000|COMPLETED|Overall Study||921
10853096|NCT01531374|12019346|FG001|COMPLETED|Overall Study||231
10853097|NCT01531374|12019347|FG002|COMPLETED|Overall Study||836
10853098|NCT01531374|12019345|FG000|NOT COMPLETED|Overall Study||364
10853099|NCT01531374|12019346|FG001|NOT COMPLETED|Overall Study||142
10853100|NCT01531374|12019347|FG002|NOT COMPLETED|Overall Study||283
10853101|NCT01240902|12019361|FG000|STARTED|Overall Study||500
10853102|NCT01240902|12019362|FG001|STARTED|Overall Study||156
10853103|NCT01240902|12019363|FG002|STARTED|Overall Study||395
10853104|NCT01240902|12019364|FG003|STARTED|Overall Study||402
10853105|NCT01240902|12019361|FG000|COMPLETED|Overall Study||289
10853106|NCT01240902|12019362|FG001|COMPLETED|Overall Study||77
10853107|NCT01240902|12019363|FG002|COMPLETED|Overall Study||295
10853108|NCT01240902|12019364|FG003|COMPLETED|Overall Study||237
10853109|NCT01240902|12019361|FG000|NOT COMPLETED|Overall Study||211
10853110|NCT01240902|12019362|FG001|NOT COMPLETED|Overall Study||79
10853111|NCT01240902|12019363|FG002|NOT COMPLETED|Overall Study||100
10853112|NCT01240902|12019364|FG003|NOT COMPLETED|Overall Study||165
10853113|NCT00726596|12019376|FG000|STARTED|Overall Study||36
11106555|NCT01259388|12290982|FG001|STARTED|Overall Study||12
10853114|NCT00726596|12019377|FG001|STARTED|Overall Study||28
10853115|NCT00726596|12019376|FG000|COMPLETED|Overall Study||31
10853116|NCT00726596|12019377|FG001|COMPLETED|Overall Study||24
10853117|NCT00726596|12019376|FG000|NOT COMPLETED|Overall Study||5
10853118|NCT00726596|12019377|FG001|NOT COMPLETED|Overall Study||4
10853119|NCT00489827|12019385|FG000|STARTED|Overall Study||430
10853120|NCT00489827|12019386|FG001|STARTED|Overall Study||435
10853121|NCT00489827|12019385|FG000|COMPLETED|Overall Study||428
10853122|NCT00489827|12019386|FG001|COMPLETED|Overall Study||433
10853123|NCT00489827|12019385|FG000|NOT COMPLETED|Overall Study||2
10853124|NCT00489827|12019386|FG001|NOT COMPLETED|Overall Study||2
11106556|NCT01259388|12290981|FG000|COMPLETED|Overall Study||6
11106557|NCT01259388|12290982|FG001|COMPLETED|Overall Study||11
11106558|NCT01259388|12290981|FG000|NOT COMPLETED|Overall Study||5
10853128|NCT04460690|12019398|FG000|STARTED|Overall Study||93
10853129|NCT04460690|12019398|FG000|Community Participants|Overall Study||83
10853130|NCT04460690|12019398|FG000|Investigator Participants|Overall Study||10
10853131|NCT04460690|12019398|FG000|COMPLETED|Overall Study||93
10853132|NCT04460690|12019398|FG000|NOT COMPLETED|Overall Study||0
10853133|NCT04374019|12019409|FG000|STARTED|Overall Study||1
10853134|NCT04374019|12019410|FG001|STARTED|Overall Study||1
10853135|NCT04374019|12019411|FG002|STARTED|Overall Study||6
10853136|NCT04374019|12019412|FG003|STARTED|Overall Study||5
10853137|NCT04374019|12019409|FG000|COMPLETED|Overall Study||1
10853138|NCT04374019|12019410|FG001|COMPLETED|Overall Study||1
10853139|NCT04374019|12019411|FG002|COMPLETED|Overall Study||5
10853140|NCT04374019|12019412|FG003|COMPLETED|Overall Study||5
10853141|NCT04374019|12019409|FG000|NOT COMPLETED|Overall Study||0
10853142|NCT04374019|12019410|FG001|NOT COMPLETED|Overall Study||0
10853143|NCT04374019|12019411|FG002|NOT COMPLETED|Overall Study||1
10853144|NCT04374019|12019412|FG003|NOT COMPLETED|Overall Study||0
10853145|NCT04357730|12019426|FG000|STARTED|Phase 1||17
10853146|NCT04357730|12019427|FG001|STARTED|Phase 1||19
10853147|NCT04357730|12019428|FG002|STARTED|Phase 1||0
10853148|NCT04357730|12019426|FG000|COMPLETED|Phase 1||17
10853149|NCT04357730|12019427|FG001|COMPLETED|Phase 1||19
10853150|NCT04357730|12019428|FG002|COMPLETED|Phase 1||0
10853151|NCT04357730|12019426|FG000|NOT COMPLETED|Phase 1||0
10853152|NCT04357730|12019427|FG001|NOT COMPLETED|Phase 1||0
10853153|NCT04357730|12019428|FG002|NOT COMPLETED|Phase 1||0
10853154|NCT04357730|12019426|FG000|STARTED|Phase 2||8
10853155|NCT04357730|12019427|FG001|STARTED|Phase 2||0
10853156|NCT04357730|12019428|FG002|STARTED|Phase 2||6
10853157|NCT04357730|12019426|FG000|COMPLETED|Phase 2||8
10853158|NCT04357730|12019427|FG001|COMPLETED|Phase 2||0
10853159|NCT04357730|12019428|FG002|COMPLETED|Phase 2||6
10853160|NCT04357730|12019426|FG000|NOT COMPLETED|Phase 2||0
10853161|NCT04357730|12019427|FG001|NOT COMPLETED|Phase 2||0
10853162|NCT04357730|12019428|FG002|NOT COMPLETED|Phase 2||0
10853163|NCT04311463|12019442|FG000|STARTED|Period 1 (Up to Day 3)||19
10853164|NCT04311463|12019443|FG001|STARTED|Period 1 (Up to Day 3)||19
10853165|NCT04311463|12019442|FG000|COMPLETED|Period 1 (Up to Day 3)||18
10853166|NCT04311463|12019443|FG001|COMPLETED|Period 1 (Up to Day 3)||19
10853167|NCT04311463|12019442|FG000|NOT COMPLETED|Period 1 (Up to Day 3)||1
10853168|NCT04311463|12019443|FG001|NOT COMPLETED|Period 1 (Up to Day 3)||0
11106559|NCT01259388|12290982|FG001|NOT COMPLETED|Overall Study||1
11106560|NCT01259401|12290990|FG000|STARTED|End of 4-week Intervention||21
11106561|NCT01259401|12290991|FG001|STARTED|End of 4-week Intervention||21
11106562|NCT01259401|12290990|FG000|COMPLETED|End of 4-week Intervention||21
11106563|NCT01259401|12290991|FG001|COMPLETED|End of 4-week Intervention||21
11106564|NCT01259401|12290990|FG000|NOT COMPLETED|End of 4-week Intervention||0
11106565|NCT01259401|12290991|FG001|NOT COMPLETED|End of 4-week Intervention||0
11106566|NCT01259401|12290990|FG000|STARTED|4-month Follow-up||21
11225420|NCT01992172|12417739|FG001|STARTED|Overall Study||0
11225421|NCT01992172|12417738|FG000|COMPLETED|Overall Study||7
11225422|NCT01992172|12417739|FG001|COMPLETED|Overall Study||0
11225423|NCT01992172|12417738|FG000|NOT COMPLETED|Overall Study||0
11225424|NCT01992172|12417739|FG001|NOT COMPLETED|Overall Study||0
11225425|NCT01992185|12417747|FG000|STARTED|Overall Study||7
11225426|NCT01992185|12417748|FG001|STARTED|Overall Study||8
11225427|NCT01992185|12417747|FG000|COMPLETED|Overall Study||7
11225428|NCT01992185|12417748|FG001|COMPLETED|Overall Study||8
11225429|NCT01992185|12417747|FG000|NOT COMPLETED|Overall Study||0
11225430|NCT01992185|12417748|FG001|NOT COMPLETED|Overall Study||0
11225431|NCT01992354|12417754|FG000|STARTED|Overall Study||4
11225432|NCT01992354|12417754|FG000|COMPLETED|Overall Study||4
11225433|NCT01992354|12417754|FG000|NOT COMPLETED|Overall Study||0
11225434|NCT01992380|12417762|FG000|STARTED|Overall Study||6
11106567|NCT01259401|12290991|FG001|STARTED|4-month Follow-up||21
11106568|NCT01259401|12290990|FG000|COMPLETED|4-month Follow-up||21
11106569|NCT01259401|12290991|FG001|COMPLETED|4-month Follow-up||19
11225435|NCT01992380|12417763|FG001|STARTED|Overall Study||8
11225436|NCT01992380|12417764|FG002|STARTED|Overall Study||10
10853169|NCT04311463|12019442|FG000|STARTED|Washout Period (Up to Day 7)||18
10853170|NCT04311463|12019443|FG001|STARTED|Washout Period (Up to Day 7)||19
10853171|NCT04311463|12019442|FG000|COMPLETED|Washout Period (Up to Day 7)||17
10853172|NCT04311463|12019443|FG001|COMPLETED|Washout Period (Up to Day 7)||18
10853173|NCT04311463|12019442|FG000|NOT COMPLETED|Washout Period (Up to Day 7)||1
10853174|NCT04311463|12019443|FG001|NOT COMPLETED|Washout Period (Up to Day 7)||1
10853175|NCT04311463|12019442|FG000|STARTED|Period 2 (Up to Day 3)||17
10853176|NCT04311463|12019443|FG001|STARTED|Period 2 (Up to Day 3)||18
11106570|NCT01259401|12290990|FG000|NOT COMPLETED|4-month Follow-up||0
11106571|NCT01259401|12290991|FG001|NOT COMPLETED|4-month Follow-up||2
11106572|NCT01259427|12290999|FG000|STARTED|Overall Study||124
11106573|NCT01259427|12291000|FG001|STARTED|Overall Study||124
11106574|NCT01259427|12290999|FG000|COMPLETED|Overall Study||106
11106575|NCT01259427|12291000|FG001|COMPLETED|Overall Study||110
11106576|NCT01259427|12290999|FG000|NOT COMPLETED|Overall Study||18
11106577|NCT01259427|12291000|FG001|NOT COMPLETED|Overall Study||14
10853177|NCT04311463|12019442|FG000|COMPLETED|Period 2 (Up to Day 3)||15
10853178|NCT04311463|12019443|FG001|COMPLETED|Period 2 (Up to Day 3)||17
10853179|NCT04311463|12019442|FG000|NOT COMPLETED|Period 2 (Up to Day 3)||2
10853180|NCT04311463|12019443|FG001|NOT COMPLETED|Period 2 (Up to Day 3)||1
10853181|NCT04175509|12019452|FG000|STARTED|Overall Study||19
10853182|NCT04175509|12019453|FG001|STARTED|Overall Study||21
10853183|NCT04175509|12019452|FG000|COMPLETED|Overall Study||17
10853184|NCT04175509|12019453|FG001|COMPLETED|Overall Study||19
10853185|NCT04175509|12019452|FG000|NOT COMPLETED|Overall Study||2
10853186|NCT04175509|12019453|FG001|NOT COMPLETED|Overall Study||2
10853187|NCT03930186|12019459|FG000|STARTED|Weeks 0 to 16||152
10853188|NCT03930186|12019459|FG000|Received Study Drug|Weeks 0 to 16||152
10853189|NCT03930186|12019459|FG000|COMPLETED|Weeks 0 to 16||140
10853190|NCT03930186|12019459|FG000|NOT COMPLETED|Weeks 0 to 16||12
10853191|NCT03930186|12019459|FG000|STARTED|Weeks 16 to 32||140
10853192|NCT03930186|12019459|FG000|COMPLETED|Weeks 16 to 32||136
10853193|NCT03930186|12019459|FG000|NOT COMPLETED|Weeks 16 to 32||4
10853194|NCT03740100|12019463|FG000|STARTED|Overall Study|Note: Ten patients were consented, but two died before starting therapy.|8
10853195|NCT03740100|12019463|FG000|Confirmed Partial Response|Overall Study|"Using a Simon's optimal two-stage design, we planned to enroll up to 10 evaluable patients in the first stage.~Two of eight treated patients were not evaluable for response based on toxicity.~We did not reach this milestone."|1
10853196|NCT03740100|12019463|FG000|COMPLETED|Overall Study||6
10853197|NCT03740100|12019463|FG000|NOT COMPLETED|Overall Study||2
10853198|NCT03597295|12019467|FG000|STARTED|Overall Study||94
10853199|NCT03597295|12019467|FG000|COMPLETED|Overall Study||0
10853200|NCT03597295|12019467|FG000|NOT COMPLETED|Overall Study||94
11225437|NCT01992380|12417762|FG000|COMPLETED|Overall Study||6
11225438|NCT01992380|12417763|FG001|COMPLETED|Overall Study||8
11225439|NCT01992380|12417764|FG002|COMPLETED|Overall Study||10
11225440|NCT01992380|12417762|FG000|NOT COMPLETED|Overall Study||0
11225441|NCT01992380|12417763|FG001|NOT COMPLETED|Overall Study||0
11225442|NCT01992380|12417764|FG002|NOT COMPLETED|Overall Study||0
11225443|NCT01992523|12417772|FG000|STARTED|Overall Study||41
11225444|NCT01992523|12417773|FG001|STARTED|Overall Study||41
11225445|NCT01992523|12417772|FG000|COMPLETED|Overall Study||41
11225446|NCT01992523|12417773|FG001|COMPLETED|Overall Study||41
11225447|NCT01992523|12417772|FG000|NOT COMPLETED|Overall Study||0
11225448|NCT01992523|12417773|FG001|NOT COMPLETED|Overall Study||0
11225449|NCT01992536|12417791|FG000|STARTED|Overall Study||26
11225450|NCT01992536|12417792|FG001|STARTED|Overall Study||25
11225451|NCT01992536|12417793|FG002|STARTED|Overall Study||17
11225452|NCT01992536|12417794|FG003|STARTED|Overall Study||24
11225453|NCT01992536|12417795|FG004|STARTED|Overall Study||11
11225454|NCT01992536|12417796|FG005|STARTED|Overall Study||21
11225455|NCT01992536|12417797|FG006|STARTED|Overall Study||7
11225456|NCT01992536|12417798|FG007|STARTED|Overall Study||21
11225457|NCT01992536|12417799|FG008|STARTED|Overall Study||19
11225458|NCT01992536|12417800|FG009|STARTED|Overall Study||19
11225459|NCT01992536|12417791|FG000|COMPLETED|Overall Study||22
11225460|NCT01992536|12417792|FG001|COMPLETED|Overall Study||22
11225461|NCT01992536|12417793|FG002|COMPLETED|Overall Study||16
10853201|NCT03053362|12019474|FG000|STARTED|Overall Study||100
10853202|NCT03053362|12019475|FG001|STARTED|Overall Study||58
10853203|NCT03053362|12019474|FG000|COMPLETED|Overall Study||83
10853204|NCT03053362|12019475|FG001|COMPLETED|Overall Study||50
10853205|NCT03053362|12019474|FG000|NOT COMPLETED|Overall Study||17
10853206|NCT03053362|12019475|FG001|NOT COMPLETED|Overall Study||8
10853207|NCT05059366|12019484|FG000|STARTED|Overall Study||8
10853208|NCT05059366|12019485|FG001|STARTED|Overall Study||8
10853209|NCT05059366|12019486|FG002|STARTED|Overall Study||8
10853210|NCT05059366|12019487|FG003|STARTED|Overall Study||8
10853211|NCT05059366|12019484|FG000|COMPLETED|Overall Study||8
10853212|NCT05059366|12019485|FG001|COMPLETED|Overall Study||8
10853213|NCT05059366|12019486|FG002|COMPLETED|Overall Study||8
10853214|NCT05059366|12019487|FG003|COMPLETED|Overall Study||8
10853215|NCT05059366|12019484|FG000|NOT COMPLETED|Overall Study||0
10853216|NCT05059366|12019485|FG001|NOT COMPLETED|Overall Study||0
10853217|NCT05059366|12019486|FG002|NOT COMPLETED|Overall Study||0
10853218|NCT05059366|12019487|FG003|NOT COMPLETED|Overall Study||0
10853219|NCT04808609|12019495|FG000|STARTED|Overall Study||20
10853220|NCT04808609|12019496|FG001|STARTED|Overall Study||20
11106578|NCT01259440|12291009|FG000|STARTED|Overall Study||13
11106579|NCT01259440|12291010|FG001|STARTED|Overall Study||10
11225462|NCT01992536|12417794|FG003|COMPLETED|Overall Study||22
10853221|NCT04808609|12019495|FG000|COMPLETED|Overall Study||20
10853222|NCT04808609|12019496|FG001|COMPLETED|Overall Study||17
10853223|NCT04808609|12019495|FG000|NOT COMPLETED|Overall Study||0
10853224|NCT04808609|12019496|FG001|NOT COMPLETED|Overall Study||3
10853225|NCT04577781|12019504|FG000|STARTED|Overall Study||16
10853226|NCT04577781|12019505|FG001|STARTED|Overall Study||12
10853227|NCT04577781|12019504|FG000|COMPLETED|Overall Study||13
10853228|NCT04577781|12019505|FG001|COMPLETED|Overall Study||10
10853229|NCT04577781|12019504|FG000|NOT COMPLETED|Overall Study||3
10853230|NCT04577781|12019505|FG001|NOT COMPLETED|Overall Study||2
10853231|NCT04524598|12019516|FG000|STARTED|Phase I - Feasibility||35
11225463|NCT01992536|12417795|FG004|COMPLETED|Overall Study||11
11225464|NCT01992536|12417796|FG005|COMPLETED|Overall Study||20
11225465|NCT01992536|12417797|FG006|COMPLETED|Overall Study||0
11225466|NCT01992536|12417798|FG007|COMPLETED|Overall Study||21
11225467|NCT01992536|12417799|FG008|COMPLETED|Overall Study||18
11225468|NCT01992536|12417800|FG009|COMPLETED|Overall Study||18
11225469|NCT01992536|12417791|FG000|NOT COMPLETED|Overall Study||4
11225470|NCT01992536|12417792|FG001|NOT COMPLETED|Overall Study||3
11225471|NCT01992536|12417793|FG002|NOT COMPLETED|Overall Study||1
11225472|NCT01992536|12417794|FG003|NOT COMPLETED|Overall Study||2
11225473|NCT01992536|12417795|FG004|NOT COMPLETED|Overall Study||0
11225474|NCT01992536|12417796|FG005|NOT COMPLETED|Overall Study||1
11225475|NCT01992536|12417797|FG006|NOT COMPLETED|Overall Study||7
11225476|NCT01992536|12417798|FG007|NOT COMPLETED|Overall Study||0
11225477|NCT01992536|12417799|FG008|NOT COMPLETED|Overall Study||1
11225478|NCT01992536|12417800|FG009|NOT COMPLETED|Overall Study||1
11225479|NCT01992549|12417842|FG000|STARTED|Overall Study||48
11225480|NCT01992549|12417842|FG000|SAF Population|Overall Study||48
11225481|NCT01992549|12417842|FG000|ITT Population|Overall Study||47
11225482|NCT01992549|12417842|FG000|PROPH Population|Overall Study||47
11225483|NCT01992549|12417842|FG000|BLEED Population|Overall Study||29
11225484|NCT01992549|12417842|FG000|SURG Population|Overall Study||3
11225485|NCT01992549|12417842|FG000|COMPLETED|Overall Study||44
11225486|NCT01992549|12417842|FG000|NOT COMPLETED|Overall Study||4
11225487|NCT01992757|12417852|FG000|STARTED|Overall Study||51
11225488|NCT01992757|12417852|FG000|COMPLETED|Overall Study||49
11225489|NCT01992757|12417852|FG000|NOT COMPLETED|Overall Study||2
11225490|NCT01992874|12417857|FG000|STARTED|Part A||21
11225491|NCT01992874|12417858|FG001|STARTED|Part A||17
11225492|NCT01992874|12417859|FG002|STARTED|Part A||0
11225493|NCT01992874|12417857|FG000|COMPLETED|Part A||21
11225494|NCT01992874|12417858|FG001|COMPLETED|Part A||17
11225495|NCT01992874|12417859|FG002|COMPLETED|Part A||0
11225496|NCT01992874|12417857|FG000|NOT COMPLETED|Part A||0
10853232|NCT04524598|12019517|FG001|STARTED|Phase I - Feasibility||25
10853233|NCT04524598|12019518|FG002|STARTED|Phase I - Feasibility||0
10853234|NCT04524598|12019519|FG003|STARTED|Phase I - Feasibility||0
10853235|NCT04524598|12019520|FG004|STARTED|Phase I - Feasibility||0
10853236|NCT04524598|12019516|FG000|COMPLETED|Phase I - Feasibility||31
10853237|NCT04524598|12019517|FG001|COMPLETED|Phase I - Feasibility||20
10853238|NCT04524598|12019518|FG002|COMPLETED|Phase I - Feasibility||0
10853239|NCT04524598|12019519|FG003|COMPLETED|Phase I - Feasibility||0
10853240|NCT04524598|12019520|FG004|COMPLETED|Phase I - Feasibility||0
10853241|NCT04524598|12019516|FG000|NOT COMPLETED|Phase I - Feasibility||4
10853242|NCT04524598|12019517|FG001|NOT COMPLETED|Phase I - Feasibility||5
10853243|NCT04524598|12019518|FG002|NOT COMPLETED|Phase I - Feasibility||0
10853244|NCT04524598|12019519|FG003|NOT COMPLETED|Phase I - Feasibility||0
10853245|NCT04524598|12019520|FG004|NOT COMPLETED|Phase I - Feasibility||0
10853246|NCT04524598|12019516|FG000|STARTED|Phase II - Outcomes||0
10853247|NCT04524598|12019517|FG001|STARTED|Phase II - Outcomes||0
10853248|NCT04524598|12019518|FG002|STARTED|Phase II - Outcomes||80
10853249|NCT04524598|12019519|FG003|STARTED|Phase II - Outcomes||80
10853250|NCT04524598|12019520|FG004|STARTED|Phase II - Outcomes||0
10853251|NCT04524598|12019516|FG000|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
10853252|NCT04524598|12019517|FG001|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
11225497|NCT01992874|12417858|FG001|NOT COMPLETED|Part A||0
11225498|NCT01992874|12417859|FG002|NOT COMPLETED|Part A||0
11225499|NCT01992874|12417857|FG000|STARTED|Part B||0
11225500|NCT01992874|12417858|FG001|STARTED|Part B||0
11225501|NCT01992874|12417859|FG002|STARTED|Part B||38
11225502|NCT01992874|12417857|FG000|COMPLETED|Part B||0
10853253|NCT04524598|12019518|FG002|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||63
10853254|NCT04524598|12019519|FG003|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||58
10853255|NCT04524598|12019520|FG004|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
10853256|NCT04524598|12019516|FG000|COMPLETED|Phase II - Outcomes||0
10853257|NCT04524598|12019517|FG001|COMPLETED|Phase II - Outcomes||0
10853258|NCT04524598|12019518|FG002|COMPLETED|Phase II - Outcomes||54
10853259|NCT04524598|12019519|FG003|COMPLETED|Phase II - Outcomes||67
10853260|NCT04524598|12019520|FG004|COMPLETED|Phase II - Outcomes||0
10853261|NCT04524598|12019516|FG000|NOT COMPLETED|Phase II - Outcomes||0
10853262|NCT04524598|12019517|FG001|NOT COMPLETED|Phase II - Outcomes||0
10853263|NCT04524598|12019518|FG002|NOT COMPLETED|Phase II - Outcomes||26
10853264|NCT04524598|12019519|FG003|NOT COMPLETED|Phase II - Outcomes||13
10853265|NCT04524598|12019520|FG004|NOT COMPLETED|Phase II - Outcomes||0
10853266|NCT04524598|12019516|FG000|STARTED|Phase II - Control Extension||0
10853267|NCT04524598|12019517|FG001|STARTED|Phase II - Control Extension||0
10853268|NCT04524598|12019518|FG002|STARTED|Phase II - Control Extension||0
10853269|NCT04524598|12019519|FG003|STARTED|Phase II - Control Extension||0
10853270|NCT04524598|12019520|FG004|STARTED|Phase II - Control Extension||66
10853271|NCT04524598|12019516|FG000|COMPLETED|Phase II - Control Extension||0
10853272|NCT04524598|12019517|FG001|COMPLETED|Phase II - Control Extension||0
10853273|NCT04524598|12019518|FG002|COMPLETED|Phase II - Control Extension||0
10853274|NCT04524598|12019519|FG003|COMPLETED|Phase II - Control Extension||0
10853275|NCT04524598|12019520|FG004|COMPLETED|Phase II - Control Extension||54
10853276|NCT04524598|12019516|FG000|NOT COMPLETED|Phase II - Control Extension||0
10853277|NCT04524598|12019517|FG001|NOT COMPLETED|Phase II - Control Extension||0
10853278|NCT04524598|12019518|FG002|NOT COMPLETED|Phase II - Control Extension||0
10853279|NCT04524598|12019519|FG003|NOT COMPLETED|Phase II - Control Extension||0
10853280|NCT04524598|12019520|FG004|NOT COMPLETED|Phase II - Control Extension||12
10853281|NCT04518462|12019537|FG000|STARTED|Overall Study||40
10853282|NCT04518462|12019538|FG001|STARTED|Overall Study||41
10853283|NCT04518462|12019539|FG002|STARTED|Overall Study||40
10853284|NCT04518462|12019537|FG000|COMPLETED|Overall Study||39
10853285|NCT04518462|12019538|FG001|COMPLETED|Overall Study||40
10853286|NCT04518462|12019539|FG002|COMPLETED|Overall Study||39
10853287|NCT04518462|12019537|FG000|NOT COMPLETED|Overall Study||1
10853288|NCT04518462|12019538|FG001|NOT COMPLETED|Overall Study||1
10853289|NCT04518462|12019539|FG002|NOT COMPLETED|Overall Study||1
10853290|NCT04432298|12019549|FG000|STARTED|Overall Study||11
10853291|NCT04432298|12019550|FG001|STARTED|Overall Study||11
10853292|NCT04432298|12019549|FG000|Intent-to-Treat (ITT) Population|Overall Study||11
10853293|NCT04432298|12019550|FG001|Intent-to-Treat (ITT) Population|Overall Study||11
10853294|NCT04432298|12019549|FG000|Safety Population|Overall Study||9
10853295|NCT04432298|12019550|FG001|Safety Population|Overall Study||11
10853296|NCT04432298|12019549|FG000|COMPLETED|Overall Study||5
10853297|NCT04432298|12019550|FG001|COMPLETED|Overall Study||8
10853298|NCT04432298|12019549|FG000|NOT COMPLETED|Overall Study||6
10853299|NCT04432298|12019550|FG001|NOT COMPLETED|Overall Study||3
10853300|NCT04428034|12019556|FG000|STARTED|Enrollment to Intervention Completion||45
10853301|NCT04428034|12019556|FG000|Attended at Least 2 Intervention Sessions in One Cohort|Enrollment to Intervention Completion|"Forty-five (45) participants enrolled and completed the baseline survey. Of those who completed they baseline survey, six participants of those who completed the baseline survey did not attend at least 2 sessions. Three participants started the intervention in one cohort, but completed in another (off-protocol). One participant was found to be a fraudulent case, identified through none-varying (straight line) responses to survey questions."|35
10853302|NCT04428034|12019556|FG000|COMPLETED|Enrollment to Intervention Completion||35
10853303|NCT04428034|12019556|FG000|NOT COMPLETED|Enrollment to Intervention Completion||10
10853304|NCT04428034|12019556|FG000|STARTED|4-Week Follow Up Survey||35
10853305|NCT04428034|12019556|FG000|COMPLETED|4-Week Follow Up Survey||29
10853306|NCT04428034|12019556|FG000|NOT COMPLETED|4-Week Follow Up Survey||6
10853307|NCT04428034|12019556|FG000|STARTED|8-Week Follow Up Survey||29
10853308|NCT04428034|12019556|FG000|COMPLETED|8-Week Follow Up Survey|Of those 27 who completed the 8-week follow up survey, one participant skipped the 4-week follow up survey but completed the 8-week survey.|27
10853309|NCT04428034|12019556|FG000|NOT COMPLETED|8-Week Follow Up Survey||2
10853310|NCT03895632|12019560|FG000|STARTED|Overall Study||25
10853311|NCT03895632|12019560|FG000|COMPLETED|Overall Study||25
10853312|NCT03895632|12019560|FG000|NOT COMPLETED|Overall Study||0
10853313|NCT03888885|12019566|FG000|STARTED|Overall Study||208
10853314|NCT03888885|12019567|FG001|STARTED|Overall Study||202
10853315|NCT03888885|12019566|FG000|Post-intervention|Overall Study||191
10853316|NCT03888885|12019567|FG001|Post-intervention|Overall Study||190
10853317|NCT03888885|12019566|FG000|COMPLETED|Overall Study||188
10853318|NCT03888885|12019567|FG001|COMPLETED|Overall Study||184
10853319|NCT03888885|12019566|FG000|NOT COMPLETED|Overall Study||20
10853320|NCT03888885|12019567|FG001|NOT COMPLETED|Overall Study||18
10853321|NCT03853694|12019576|FG000|STARTED|Overall Study||56
10853322|NCT03853694|12019577|FG001|STARTED|Overall Study||56
10853323|NCT03853694|12019578|FG002|STARTED|Overall Study||55
10853324|NCT03853694|12019576|FG000|COMPLETED|Overall Study||53
10853325|NCT03853694|12019577|FG001|COMPLETED|Overall Study||47
10853326|NCT03853694|12019578|FG002|COMPLETED|Overall Study||51
10853327|NCT03853694|12019576|FG000|NOT COMPLETED|Overall Study||3
10853328|NCT03853694|12019577|FG001|NOT COMPLETED|Overall Study||9
10853329|NCT03853694|12019578|FG002|NOT COMPLETED|Overall Study||4
10853330|NCT03785340|12019588|FG000|STARTED|Overall Study||126
10853331|NCT03785340|12019589|FG001|STARTED|Overall Study||126
10853332|NCT03785340|12019588|FG000|Received at Least 1 Study Treatment|Overall Study||126
10853333|NCT03785340|12019589|FG001|Received at Least 1 Study Treatment|Overall Study||126
10853334|NCT03785340|12019588|FG000|COMPLETED|Overall Study||123
10853335|NCT03785340|12019589|FG001|COMPLETED|Overall Study||126
10853336|NCT03785340|12019588|FG000|NOT COMPLETED|Overall Study||3
10853337|NCT03785340|12019589|FG001|NOT COMPLETED|Overall Study||0
10853338|NCT03760224|12019597|FG000|STARTED|Overall Study||469
10853339|NCT03760224|12019598|FG001|STARTED|Overall Study||459
10853340|NCT03760224|12019597|FG000|COMPLETED|Overall Study||469
10853341|NCT03760224|12019598|FG001|COMPLETED|Overall Study||459
10853342|NCT03760224|12019597|FG000|NOT COMPLETED|Overall Study||0
10853343|NCT03760224|12019598|FG001|NOT COMPLETED|Overall Study||0
10853344|NCT03657264|12019608|FG000|STARTED|Overall Study||12
10853345|NCT03657264|12019609|FG001|STARTED|Overall Study||12
10853346|NCT03657264|12019610|FG002|STARTED|Overall Study||12
10853347|NCT03657264|12019611|FG003|STARTED|Overall Study||12
10853348|NCT03657264|12019608|FG000|COMPLETED|Overall Study||12
10853349|NCT03657264|12019609|FG001|COMPLETED|Overall Study||12
10853350|NCT03657264|12019610|FG002|COMPLETED|Overall Study||12
10853351|NCT03657264|12019611|FG003|COMPLETED|Overall Study||12
10853352|NCT03657264|12019608|FG000|NOT COMPLETED|Overall Study||0
10853353|NCT03657264|12019609|FG001|NOT COMPLETED|Overall Study||0
10853354|NCT03657264|12019610|FG002|NOT COMPLETED|Overall Study||0
10853355|NCT03657264|12019611|FG003|NOT COMPLETED|Overall Study||0
10853356|NCT03427528|12019624|FG000|STARTED|Overall Study||30
10853357|NCT03427528|12019625|FG001|STARTED|Overall Study||30
10853358|NCT03427528|12019624|FG000|COMPLETED|Overall Study||17
10853359|NCT03427528|12019625|FG001|COMPLETED|Overall Study||23
10853360|NCT03427528|12019624|FG000|NOT COMPLETED|Overall Study||13
10853361|NCT03427528|12019625|FG001|NOT COMPLETED|Overall Study||7
10853362|NCT03373435|12019633|FG000|STARTED|Treatment Period 1 (14 Days)||8
10853363|NCT03373435|12019634|FG001|STARTED|Treatment Period 1 (14 Days)||10
10853364|NCT03373435|12019633|FG000|COMPLETED|Treatment Period 1 (14 Days)||8
10853365|NCT03373435|12019634|FG001|COMPLETED|Treatment Period 1 (14 Days)||10
10853366|NCT03373435|12019633|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10853367|NCT03373435|12019634|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
10853368|NCT03373435|12019633|FG000|STARTED|Treatment Period 2 (14 Days)||8
10853369|NCT03373435|12019634|FG001|STARTED|Treatment Period 2 (14 Days)||10
10853370|NCT03373435|12019633|FG000|COMPLETED|Treatment Period 2 (14 Days)||8
10853371|NCT03373435|12019634|FG001|COMPLETED|Treatment Period 2 (14 Days)||10
10853372|NCT03373435|12019633|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10853373|NCT03373435|12019634|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10853374|NCT03373435|12019633|FG000|STARTED|Treatment Period 3 (14 Days)||8
10853375|NCT03373435|12019634|FG001|STARTED|Treatment Period 3 (14 Days)||10
10853376|NCT03373435|12019633|FG000|COMPLETED|Treatment Period 3 (14 Days)||8
10853377|NCT03373435|12019634|FG001|COMPLETED|Treatment Period 3 (14 Days)||10
10853378|NCT03373435|12019633|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
10853379|NCT03373435|12019634|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11106580|NCT01259440|12291009|FG000|COMPLETED|Overall Study||13
11106581|NCT01259440|12291010|FG001|COMPLETED|Overall Study||10
11106582|NCT01259440|12291009|FG000|NOT COMPLETED|Overall Study||0
11106583|NCT01259440|12291010|FG001|NOT COMPLETED|Overall Study||0
11106584|NCT01259466|12291018|FG000|STARTED|Overall Study||27
11106585|NCT01259466|12291019|FG001|STARTED|Overall Study||27
10853386|NCT03248297|12019654|FG000|STARTED|Overall Study||253
10853387|NCT03248297|12019655|FG001|STARTED|Overall Study||253
10853388|NCT03248297|12019656|FG002|STARTED|Overall Study||250
10853389|NCT03248297|12019654|FG000|COMPLETED|Overall Study||253
10853390|NCT03248297|12019655|FG001|COMPLETED|Overall Study||253
10853391|NCT03248297|12019656|FG002|COMPLETED|Overall Study||250
10853392|NCT03248297|12019654|FG000|NOT COMPLETED|Overall Study||0
10853393|NCT03248297|12019655|FG001|NOT COMPLETED|Overall Study||0
10853394|NCT03248297|12019656|FG002|NOT COMPLETED|Overall Study||0
10853395|NCT03197064|12019664|FG000|STARTED|Overall Study||11
10853396|NCT03197064|12019664|FG000|COMPLETED|Overall Study||11
10853397|NCT03197064|12019664|FG000|NOT COMPLETED|Overall Study||0
10853398|NCT03173560|12019670|FG000|STARTED|Overall Study||172
10853399|NCT03173560|12019671|FG001|STARTED|Overall Study||171
10853400|NCT03173560|12019670|FG000|Treated Participants|Overall Study||172
10853401|NCT03173560|12019671|FG001|Treated Participants|Overall Study||169
10853402|NCT03173560|12019670|FG000|Safety Set|Overall Study||173
10853403|NCT03173560|12019671|FG001|Safety Set|Overall Study||168
10853404|NCT03173560|12019670|FG000|COMPLETED|Overall Study||67
10853405|NCT03173560|12019671|FG001|COMPLETED|Overall Study||54
10853406|NCT03173560|12019670|FG000|NOT COMPLETED|Overall Study||105
10853407|NCT03173560|12019671|FG001|NOT COMPLETED|Overall Study||117
10853408|NCT03113422|12019677|FG000|STARTED|Overall Study||56
10853409|NCT03113422|12019677|FG000|COMPLETED|Overall Study||56
10853410|NCT03113422|12019677|FG000|NOT COMPLETED|Overall Study||0
11106586|NCT01259466|12291018|FG000|COMPLETED|Overall Study||26
11106587|NCT01259466|12291019|FG001|COMPLETED|Overall Study||18
11106588|NCT01259466|12291018|FG000|NOT COMPLETED|Overall Study||1
11106589|NCT01259466|12291019|FG001|NOT COMPLETED|Overall Study||9
11106590|NCT01259492|12291029|FG000|STARTED|Period 1 (9 Weeks)||181
11106591|NCT01259492|12291030|FG001|STARTED|Period 1 (9 Weeks)||182
10853417|NCT02865850|12019693|FG000|STARTED|Overall Study||181
11106592|NCT01259492|12291031|FG002|STARTED|Period 1 (9 Weeks)||181
11225503|NCT01992874|12417858|FG001|COMPLETED|Part B||0
11225504|NCT01992874|12417859|FG002|COMPLETED|Part B||38
11106593|NCT01259492|12291032|FG003|STARTED|Period 1 (9 Weeks)||181
11106594|NCT01259492|12291029|FG000|Full Analysis Set|Period 1 (9 Weeks)||174
11225505|NCT01992874|12417857|FG000|NOT COMPLETED|Part B||0
11225506|NCT01992874|12417858|FG001|NOT COMPLETED|Part B||0
11225507|NCT01992874|12417859|FG002|NOT COMPLETED|Part B||0
11225508|NCT01993017|12417872|FG000|STARTED|Overall Study||499
11225509|NCT01993017|12417873|FG001|STARTED|Overall Study||501
11225510|NCT01993017|12417874|FG002|STARTED|Overall Study||500
11225511|NCT01993017|12417872|FG000|COMPLETED|Overall Study||393
11225512|NCT01993017|12417873|FG001|COMPLETED|Overall Study||411
11225513|NCT01993017|12417874|FG002|COMPLETED|Overall Study||421
11225514|NCT01993017|12417872|FG000|NOT COMPLETED|Overall Study||106
11225515|NCT01993017|12417873|FG001|NOT COMPLETED|Overall Study||90
11225516|NCT01993017|12417874|FG002|NOT COMPLETED|Overall Study||79
11225517|NCT01993030|12417885|FG000|STARTED|Overall Study||36
11225518|NCT01993030|12417886|FG001|STARTED|Overall Study||35
10853418|NCT02865850|12019694|FG001|STARTED|Overall Study||188
10853419|NCT02865850|12019693|FG000|COMPLETED|Overall Study||160
10853420|NCT02865850|12019694|FG001|COMPLETED|Overall Study||165
10853421|NCT02865850|12019693|FG000|NOT COMPLETED|Overall Study||21
10853422|NCT02865850|12019694|FG001|NOT COMPLETED|Overall Study||23
10853423|NCT02763579|12019702|FG000|STARTED|Overall Study||201
10853424|NCT02763579|12019703|FG001|STARTED|Overall Study||202
10853425|NCT02763579|12019702|FG000|COMPLETED|Overall Study||0
10853426|NCT02763579|12019703|FG001|COMPLETED|Overall Study||0
10853427|NCT02763579|12019702|FG000|NOT COMPLETED|Overall Study||201
10853428|NCT02763579|12019703|FG001|NOT COMPLETED|Overall Study||202
10853429|NCT02746471|12019709|FG000|STARTED|Overall Study||1604
10853430|NCT02746471|12019709|FG000|COMPLETED|Overall Study||442
10853431|NCT02746471|12019709|FG000|NOT COMPLETED|Overall Study||1162
11106595|NCT01259492|12291030|FG001|Full Analysis Set|Period 1 (9 Weeks)||175
11106596|NCT01259492|12291031|FG002|Full Analysis Set|Period 1 (9 Weeks)||179
11106597|NCT01259492|12291032|FG003|Full Analysis Set|Period 1 (9 Weeks)||172
11106598|NCT01259492|12291029|FG000|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
11106599|NCT01259492|12291030|FG001|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
11106600|NCT01259492|12291031|FG002|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
11106601|NCT01259492|12291032|FG003|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
11106602|NCT01259492|12291029|FG000|NOT COMPLETED|Period 1 (9 Weeks)||29
11106603|NCT01259492|12291030|FG001|NOT COMPLETED|Period 1 (9 Weeks)||41
11106604|NCT01259492|12291031|FG002|NOT COMPLETED|Period 1 (9 Weeks)||43
11106605|NCT01259492|12291032|FG003|NOT COMPLETED|Period 1 (9 Weeks)||28
11106606|NCT01259492|12291029|FG000|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
10853444|NCT02706873|12019727|FG000|STARTED|Overall Study||315
10853445|NCT02706873|12019728|FG001|STARTED|Overall Study||55
10853446|NCT02706873|12019729|FG002|STARTED|Overall Study||317
10853447|NCT02706873|12019730|FG003|STARTED|Overall Study||315
10853448|NCT02706873|12019727|FG000|Received Study Drug|Overall Study||314
10853449|NCT02706873|12019728|FG001|Received Study Drug|Overall Study||55
10853450|NCT02706873|12019729|FG002|Received Study Drug|Overall Study||317
10853451|NCT02706873|12019730|FG003|Received Study Drug|Overall Study||314
10853452|NCT02706873|12019727|FG000|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
10853453|NCT02706873|12019728|FG001|Global Analysis Population|Overall Study||0
10853454|NCT02706873|12019729|FG002|Global Analysis Population|Overall Study|Includes 27 participants in the Japan sub-study|317
10853455|NCT02706873|12019730|FG003|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
10853456|NCT02706873|12019727|FG000|Japan Sub-study|Overall Study||28
10853457|NCT02706873|12019728|FG001|Japan Sub-study|Overall Study||55
10853458|NCT02706873|12019729|FG002|Japan Sub-study|Overall Study||27
10853459|NCT02706873|12019730|FG003|Japan Sub-study|Overall Study||28
10853460|NCT02706873|12019727|FG000|COMPLETED|Overall Study||268
10853461|NCT02706873|12019728|FG001|COMPLETED|Overall Study||51
10853462|NCT02706873|12019729|FG002|COMPLETED|Overall Study||290
10853463|NCT02706873|12019730|FG003|COMPLETED|Overall Study||282
11106607|NCT01259492|12291030|FG001|STARTED|Period 2 (Week 10 to Week 14)||141
11106608|NCT01259492|12291031|FG002|STARTED|Period 2 (Week 10 to Week 14)||138
11106609|NCT01259492|12291032|FG003|STARTED|Period 2 (Week 10 to Week 14)||153
11225519|NCT01993030|12417885|FG000|COMPLETED|Overall Study||36
11225520|NCT01993030|12417886|FG001|COMPLETED|Overall Study||31
10853464|NCT02706873|12019727|FG000|NOT COMPLETED|Overall Study||47
10853465|NCT02706873|12019728|FG001|NOT COMPLETED|Overall Study||4
10853466|NCT02706873|12019729|FG002|NOT COMPLETED|Overall Study||27
10853467|NCT02706873|12019730|FG003|NOT COMPLETED|Overall Study||33
10853468|NCT02591953|12019744|FG000|STARTED|Overall Study||12
10853469|NCT02591953|12019745|FG001|STARTED|Overall Study||10
10853470|NCT02591953|12019744|FG000|COMPLETED|Overall Study||6
10853471|NCT02591953|12019745|FG001|COMPLETED|Overall Study||4
10853472|NCT02591953|12019744|FG000|NOT COMPLETED|Overall Study||6
10853473|NCT02591953|12019745|FG001|NOT COMPLETED|Overall Study||6
10853474|NCT02509494|12019759|FG000|STARTED|Overall Study||43
10853475|NCT02509494|12019760|FG001|STARTED|Overall Study||298
10853476|NCT02509494|12019761|FG002|STARTED|Overall Study||102
10853477|NCT02509494|12019762|FG003|STARTED|Overall Study||143
10853478|NCT02509494|12019763|FG004|STARTED|Overall Study||48
10853479|NCT02509494|12019764|FG005|STARTED|Overall Study||144
10853480|NCT02509494|12019765|FG006|STARTED|Overall Study||48
10853481|NCT02509494|12019766|FG007|STARTED|Overall Study||144
10853482|NCT02509494|12019767|FG008|STARTED|Overall Study||48
11225521|NCT01993030|12417885|FG000|NOT COMPLETED|Overall Study||0
11225522|NCT01993030|12417886|FG001|NOT COMPLETED|Overall Study||4
11225523|NCT01993108|12417894|FG000|STARTED|Overall Study||11
11225524|NCT01993108|12417895|FG001|STARTED|Overall Study||12
11225525|NCT01993108|12417894|FG000|COMPLETED|Overall Study||11
11225526|NCT01993108|12417895|FG001|COMPLETED|Overall Study||12
11225527|NCT01993108|12417894|FG000|NOT COMPLETED|Overall Study||0
11225528|NCT01993108|12417895|FG001|NOT COMPLETED|Overall Study||0
11225529|NCT01993186|12417915|FG000|STARTED|Double-Blind Placebo-Controlled Period||25
11225530|NCT01993186|12417916|FG001|STARTED|Double-Blind Placebo-Controlled Period||11
11225531|NCT01993186|12417915|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||23
11225532|NCT01993186|12417916|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||11
11225533|NCT01993186|12417915|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||2
10853483|NCT02509494|12019759|FG000|COMPLETED|Overall Study||28
10853484|NCT02509494|12019760|FG001|COMPLETED|Overall Study||217
10853485|NCT02509494|12019761|FG002|COMPLETED|Overall Study||64
10853486|NCT02509494|12019762|FG003|COMPLETED|Overall Study||132
10853487|NCT02509494|12019763|FG004|COMPLETED|Overall Study||43
10853488|NCT02509494|12019764|FG005|COMPLETED|Overall Study||133
10853489|NCT02509494|12019765|FG006|COMPLETED|Overall Study||45
10853490|NCT02509494|12019766|FG007|COMPLETED|Overall Study||137
10853491|NCT02509494|12019767|FG008|COMPLETED|Overall Study||46
10853492|NCT02509494|12019759|FG000|NOT COMPLETED|Overall Study||15
10853493|NCT02509494|12019760|FG001|NOT COMPLETED|Overall Study||81
10853494|NCT02509494|12019761|FG002|NOT COMPLETED|Overall Study||38
10853495|NCT02509494|12019762|FG003|NOT COMPLETED|Overall Study||11
10853496|NCT02509494|12019763|FG004|NOT COMPLETED|Overall Study||5
10853497|NCT02509494|12019764|FG005|NOT COMPLETED|Overall Study||11
10853498|NCT02509494|12019765|FG006|NOT COMPLETED|Overall Study||3
10853499|NCT02509494|12019766|FG007|NOT COMPLETED|Overall Study||7
10853500|NCT02509494|12019767|FG008|NOT COMPLETED|Overall Study||2
10853501|NCT02420990|12019803|FG000|STARTED|Baseline||53
10853502|NCT02420990|12019804|FG001|STARTED|Baseline||92
10853503|NCT02420990|12019803|FG000|COMPLETED|Baseline||53
10853504|NCT02420990|12019804|FG001|COMPLETED|Baseline||92
10853505|NCT02420990|12019803|FG000|NOT COMPLETED|Baseline||0
10853506|NCT02420990|12019804|FG001|NOT COMPLETED|Baseline||0
10853507|NCT02420990|12019803|FG000|STARTED|3-Month Follow-up||53
10853508|NCT02420990|12019804|FG001|STARTED|3-Month Follow-up||92
10853509|NCT02420990|12019803|FG000|COMPLETED|3-Month Follow-up||53
10853510|NCT02420990|12019804|FG001|COMPLETED|3-Month Follow-up||92
10853511|NCT02420990|12019803|FG000|NOT COMPLETED|3-Month Follow-up||0
10853512|NCT02420990|12019804|FG001|NOT COMPLETED|3-Month Follow-up||0
10853513|NCT02420990|12019803|FG000|STARTED|6-Month Follow-up||53
10853514|NCT02420990|12019804|FG001|STARTED|6-Month Follow-up||92
10853515|NCT02420990|12019803|FG000|COMPLETED|6-Month Follow-up||53
10853516|NCT02420990|12019804|FG001|COMPLETED|6-Month Follow-up||92
10853517|NCT02420990|12019803|FG000|NOT COMPLETED|6-Month Follow-up||0
10853518|NCT02420990|12019804|FG001|NOT COMPLETED|6-Month Follow-up||0
10853519|NCT02420990|12019803|FG000|STARTED|12-Month Follow-up||53
10853520|NCT02420990|12019804|FG001|STARTED|12-Month Follow-up||92
10853521|NCT02420990|12019803|FG000|COMPLETED|12-Month Follow-up||53
10853522|NCT02420990|12019804|FG001|COMPLETED|12-Month Follow-up||92
10853523|NCT02420990|12019803|FG000|NOT COMPLETED|12-Month Follow-up||0
10853524|NCT02420990|12019804|FG001|NOT COMPLETED|12-Month Follow-up||0
10853525|NCT02151981|12019812|FG000|STARTED|Overall Study||279
11225534|NCT01993186|12417916|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0
11225535|NCT01993186|12417915|FG000|STARTED|Open-Label Extension Period||23
10853526|NCT02151981|12019813|FG001|STARTED|Overall Study||140
10853527|NCT02151981|12019812|FG000|Received Randomised Treatment Only|Overall Study||279
10853528|NCT02151981|12019813|FG001|Received Randomised Treatment Only|Overall Study||136
10853529|NCT02151981|12019812|FG000|Did Not Receive Treatment|Overall Study||0
10853530|NCT02151981|12019813|FG001|Did Not Receive Treatment|Overall Study||4
10853531|NCT02151981|12019812|FG000|Crossed Over Osimertinib|Overall Study||0
10853532|NCT02151981|12019813|FG001|Crossed Over Osimertinib|Overall Study|Patients randomised to chemotherapy were allowed to crossover to Osimertinib after progression|99
10853533|NCT02151981|12019812|FG000|COMPLETED|Overall Study||0
10853534|NCT02151981|12019813|FG001|COMPLETED|Overall Study||0
10853535|NCT02151981|12019812|FG000|NOT COMPLETED|Overall Study||279
10853536|NCT02151981|12019813|FG001|NOT COMPLETED|Overall Study||140
10853537|NCT02087423|12019822|FG000|STARTED|Overall Study|Treated|111
10853538|NCT02087423|12019823|FG001|STARTED|Overall Study|Treated|265
10853539|NCT02087423|12019824|FG002|STARTED|Overall Study|Treated|68
10853540|NCT02087423|12019822|FG000|Completed 12 Months of Treatment|Overall Study||18
10853541|NCT02087423|12019823|FG001|Completed 12 Months of Treatment|Overall Study||60
10853542|NCT02087423|12019824|FG002|Completed 12 Months of Treatment|Overall Study||26
10853543|NCT02087423|12019822|FG000|COMPLETED|Overall Study||0
10853544|NCT02087423|12019823|FG001|COMPLETED|Overall Study||0
10853545|NCT02087423|12019824|FG002|COMPLETED|Overall Study||0
10853546|NCT02087423|12019822|FG000|NOT COMPLETED|Overall Study||111
10853547|NCT02087423|12019823|FG001|NOT COMPLETED|Overall Study||265
10853548|NCT02087423|12019824|FG002|NOT COMPLETED|Overall Study||68
11106610|NCT01259492|12291029|FG000|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
11106611|NCT01259492|12291030|FG001|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
11106612|NCT01259492|12291031|FG002|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
11106613|NCT01259492|12291032|FG003|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
11106614|NCT01259492|12291029|FG000|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
11106615|NCT01259492|12291030|FG001|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
10853557|NCT01874353|12019845|FG000|STARTED|Overall Study||196
10853558|NCT01874353|12019846|FG001|STARTED|Overall Study||99
10853559|NCT01874353|12019847|FG002|STARTED|Overall Study||22
10853560|NCT01874353|12019848|FG003|STARTED|Overall Study||10
10853561|NCT01874353|12019845|FG000|COMPLETED|Overall Study||69
10853562|NCT01874353|12019846|FG001|COMPLETED|Overall Study||26
10853563|NCT01874353|12019847|FG002|COMPLETED|Overall Study||7
10853564|NCT01874353|12019848|FG003|COMPLETED|Overall Study||3
10853565|NCT01874353|12019845|FG000|NOT COMPLETED|Overall Study||127
10853566|NCT01874353|12019846|FG001|NOT COMPLETED|Overall Study||73
10853567|NCT01874353|12019847|FG002|NOT COMPLETED|Overall Study||15
10853568|NCT01874353|12019848|FG003|NOT COMPLETED|Overall Study||7
10853569|NCT01773395|12019862|FG000|STARTED|Overall Study||64
10853570|NCT01773395|12019863|FG001|STARTED|Overall Study||59
10853571|NCT01773395|12019862|FG000|COMPLETED|Overall Study||30
10853572|NCT01773395|12019863|FG001|COMPLETED|Overall Study||27
10853573|NCT01773395|12019862|FG000|NOT COMPLETED|Overall Study||34
10853574|NCT01773395|12019863|FG001|NOT COMPLETED|Overall Study||32
11106616|NCT01259492|12291031|FG002|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
11106617|NCT01259492|12291032|FG003|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
11106618|NCT01259492|12291029|FG000|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
11106619|NCT01259492|12291030|FG001|STARTED|Period 3 (Week 15 to End of Week 40)||132
11106620|NCT01259492|12291031|FG002|STARTED|Period 3 (Week 15 to End of Week 40)||120
11106621|NCT01259492|12291032|FG003|STARTED|Period 3 (Week 15 to End of Week 40)||123
11106622|NCT01259492|12291029|FG000|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
11106623|NCT01259492|12291030|FG001|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
11106624|NCT01259492|12291031|FG002|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
11106625|NCT01259492|12291032|FG003|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
11106626|NCT01259492|12291029|FG000|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
11106627|NCT01259492|12291030|FG001|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
11225536|NCT01993186|12417916|FG001|STARTED|Open-Label Extension Period||11
11225537|NCT01993186|12417915|FG000|COMPLETED|Open-Label Extension Period||16
11225538|NCT01993186|12417916|FG001|COMPLETED|Open-Label Extension Period||5
11225539|NCT01993186|12417915|FG000|NOT COMPLETED|Open-Label Extension Period||7
11225540|NCT01993186|12417916|FG001|NOT COMPLETED|Open-Label Extension Period||6
11225541|NCT01993238|12417923|FG000|STARTED|Overall Study||11
11225542|NCT01993238|12417923|FG000|COMPLETED|Overall Study||11
11225543|NCT01993238|12417923|FG000|NOT COMPLETED|Overall Study||0
11106628|NCT01259492|12291031|FG002|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
11106629|NCT01259492|12291032|FG003|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
11106630|NCT01259492|12291029|FG000|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
11106631|NCT01259492|12291030|FG001|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
11106632|NCT01259492|12291031|FG002|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
11106633|NCT01259492|12291032|FG003|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
11106634|NCT01259596|12291043|FG000|STARTED|Overall Study||70
11106635|NCT01259596|12291044|FG001|STARTED|Overall Study||71
11106636|NCT01259596|12291043|FG000|COMPLETED|Overall Study||66
11106637|NCT01259596|12291044|FG001|COMPLETED|Overall Study||65
11106638|NCT01259596|12291043|FG000|NOT COMPLETED|Overall Study||4
11106639|NCT01259596|12291044|FG001|NOT COMPLETED|Overall Study||6
11106640|NCT01259713|12291054|FG000|STARTED|Overall Study||237
11106641|NCT01259713|12291055|FG001|STARTED|Overall Study||118
11106642|NCT01259713|12291054|FG000|COMPLETED|Overall Study||142
11106643|NCT01259713|12291055|FG001|COMPLETED|Overall Study||77
11225544|NCT01993329|12417933|FG000|STARTED|Period 1||3
11225545|NCT01993329|12417934|FG001|STARTED|Period 1||4
11106644|NCT01259713|12291054|FG000|NOT COMPLETED|Overall Study||95
11106645|NCT01259713|12291055|FG001|NOT COMPLETED|Overall Study||41
11106646|NCT01259726|12291065|FG000|STARTED|Overall Study||43
11106647|NCT01259726|12291066|FG001|STARTED|Overall Study||41
11106648|NCT01259726|12291067|FG002|STARTED|Overall Study||43
11106649|NCT01259726|12291068|FG003|STARTED|Overall Study||41
11106650|NCT01259726|12291065|FG000|Treated|Overall Study||40
11106651|NCT01259726|12291066|FG001|Treated|Overall Study||37
11106652|NCT01259726|12291067|FG002|Treated|Overall Study||41
11225546|NCT01993329|12417935|FG002|STARTED|Period 1||3
10853619|NCT00614432|12019923|FG000|STARTED|Overall Study||4
10853620|NCT00614432|12019924|FG001|STARTED|Overall Study||6
10853621|NCT00614432|12019923|FG000|COMPLETED|Overall Study||4
10853622|NCT00614432|12019924|FG001|COMPLETED|Overall Study||6
10853623|NCT00614432|12019923|FG000|NOT COMPLETED|Overall Study||0
10853624|NCT00614432|12019924|FG001|NOT COMPLETED|Overall Study||0
10853625|NCT02849626|12019932|FG000|STARTED|Core Phase (up to 23 Weeks)||149
10853626|NCT02849626|12019933|FG001|STARTED|Core Phase (up to 23 Weeks)||31
10853627|NCT02849626|12019932|FG000|COMPLETED|Core Phase (up to 23 Weeks)||122
10853628|NCT02849626|12019933|FG001|COMPLETED|Core Phase (up to 23 Weeks)||24
10853629|NCT02849626|12019932|FG000|NOT COMPLETED|Core Phase (up to 23 Weeks)||27
10853630|NCT02849626|12019933|FG001|NOT COMPLETED|Core Phase (up to 23 Weeks)||7
10853631|NCT02849626|12019932|FG000|STARTED|Extension Phase A (up to 29 Weeks)||116
10853632|NCT02849626|12019933|FG001|STARTED|Extension Phase A (up to 29 Weeks)||20
10853633|NCT02849626|12019932|FG000|COMPLETED|Extension Phase A (up to 29 Weeks)||105
10853634|NCT02849626|12019933|FG001|COMPLETED|Extension Phase A (up to 29 Weeks)||17
10853635|NCT02849626|12019932|FG000|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||11
10853636|NCT02849626|12019933|FG001|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||3
10853637|NCT02654132|12019951|FG000|STARTED|Overall Study||60
10853638|NCT02654132|12019952|FG001|STARTED|Overall Study||57
10853639|NCT02654132|12019951|FG000|COMPLETED|Overall Study||24
10853640|NCT02654132|12019952|FG001|COMPLETED|Overall Study||11
10853641|NCT02654132|12019951|FG000|NOT COMPLETED|Overall Study||36
10853642|NCT02654132|12019952|FG001|NOT COMPLETED|Overall Study||46
10853649|NCT02600923|12019968|FG000|STARTED|Overall Study||131
10853650|NCT02600923|12019968|FG000|Treated|Overall Study||130
10853651|NCT02600923|12019968|FG000|COMPLETED|Overall Study||0
10853652|NCT02600923|12019968|FG000|NOT COMPLETED|Overall Study||131
10853653|NCT02597790|12019974|FG000|STARTED|Overall Study||45
10853654|NCT02597790|12019975|FG001|STARTED|Overall Study||41
10853655|NCT02597790|12019974|FG000|COMPLETED|Overall Study||36
10853656|NCT02597790|12019975|FG001|COMPLETED|Overall Study||29
10853657|NCT02597790|12019974|FG000|NOT COMPLETED|Overall Study||9
10853658|NCT02597790|12019975|FG001|NOT COMPLETED|Overall Study||12
10853659|NCT02484664|12019986|FG000|STARTED|Overall Study||12
10853660|NCT02484664|12019986|FG000|COMPLETED|Overall Study||9
10853661|NCT02484664|12019986|FG000|NOT COMPLETED|Overall Study||3
10853662|NCT02412735|12019993|FG000|STARTED|Overall Study||143
10853663|NCT02412735|12019994|FG001|STARTED|Overall Study||129
10853664|NCT02412735|12019995|FG002|STARTED|Overall Study||132
10853665|NCT02412735|12019993|FG000|Received Treatment|Overall Study||140
10853666|NCT02412735|12019994|FG001|Received Treatment|Overall Study||128
10853667|NCT02412735|12019995|FG002|Received Treatment|Overall Study||130
10853668|NCT02412735|12019993|FG000|COMPLETED|Overall Study||97
10853669|NCT02412735|12019994|FG001|COMPLETED|Overall Study||85
10853670|NCT02412735|12019995|FG002|COMPLETED|Overall Study||86
10853671|NCT02412735|12019993|FG000|NOT COMPLETED|Overall Study||46
10853672|NCT02412735|12019994|FG001|NOT COMPLETED|Overall Study||44
10853673|NCT02412735|12019995|FG002|NOT COMPLETED|Overall Study||46
10853674|NCT02371889|12020005|FG000|STARTED|Overall Study||85
10853675|NCT02371889|12020006|FG001|STARTED|Overall Study||85
10853676|NCT02371889|12020005|FG000|COMPLETED|Overall Study||66
10853677|NCT02371889|12020006|FG001|COMPLETED|Overall Study||71
10853678|NCT02371889|12020005|FG000|NOT COMPLETED|Overall Study||19
10853679|NCT02371889|12020006|FG001|NOT COMPLETED|Overall Study||14
10853680|NCT02121158|12020018|FG000|STARTED|Overall Study||85
10853681|NCT02121158|12020019|FG001|STARTED|Overall Study||82
10853682|NCT02121158|12020018|FG000|COMPLETED|Overall Study||85
10853683|NCT02121158|12020019|FG001|COMPLETED|Overall Study||82
10853684|NCT02121158|12020018|FG000|NOT COMPLETED|Overall Study||0
10853685|NCT02121158|12020019|FG001|NOT COMPLETED|Overall Study||0
10853686|NCT02100722|12020027|FG000|STARTED|Overall Study||757
10853687|NCT02100722|12020028|FG001|STARTED|Overall Study||743
10853688|NCT02100722|12020027|FG000|Underwent Alternate Procedure|Overall Study||11
10853689|NCT02100722|12020028|FG001|Underwent Alternate Procedure|Overall Study||37
10853690|NCT02100722|12020027|FG000|COMPLETED|Overall Study||0
10853691|NCT02100722|12020028|FG001|COMPLETED|Overall Study||0
10853692|NCT02100722|12020027|FG000|NOT COMPLETED|Overall Study||757
10853693|NCT02100722|12020028|FG001|NOT COMPLETED|Overall Study||743
10853694|NCT02046096|12020037|FG000|STARTED|Overall Study||149
10853695|NCT02046096|12020038|FG001|STARTED|Overall Study||324
10853696|NCT02046096|12020037|FG000|COMPLETED|Overall Study||105
10853697|NCT02046096|12020038|FG001|COMPLETED|Overall Study||223
10853698|NCT02046096|12020037|FG000|NOT COMPLETED|Overall Study||44
10853699|NCT02046096|12020038|FG001|NOT COMPLETED|Overall Study||101
10853700|NCT01945775|12020048|FG000|STARTED|Overall Study||287
10853701|NCT01945775|12020049|FG001|STARTED|Overall Study||144
10853702|NCT01945775|12020048|FG000|Treated|Overall Study||286
10853703|NCT01945775|12020049|FG001|Treated|Overall Study||126
10853704|NCT01945775|12020048|FG000|COMPLETED|Overall Study||0
10853705|NCT01945775|12020049|FG001|COMPLETED|Overall Study||0
10853706|NCT01945775|12020048|FG000|NOT COMPLETED|Overall Study||287
10853707|NCT01945775|12020049|FG001|NOT COMPLETED|Overall Study||144
10853708|NCT01781637|12020057|FG000|STARTED|Overall Study||28
10853709|NCT01781637|12020058|FG001|STARTED|Overall Study||8
10853710|NCT01781637|12020057|FG000|COMPLETED|Overall Study||24
10853711|NCT01781637|12020058|FG001|COMPLETED|Overall Study||2
10853712|NCT01781637|12020057|FG000|NOT COMPLETED|Overall Study||4
10853713|NCT01781637|12020058|FG001|NOT COMPLETED|Overall Study||6
10853714|NCT01670539|12020064|FG000|STARTED|Overall Study||26
10853715|NCT01670539|12020065|FG001|STARTED|Overall Study||21
10853716|NCT01670539|12020064|FG000|COMPLETED|Overall Study||20
10853717|NCT01670539|12020065|FG001|COMPLETED|Overall Study||16
10853718|NCT01670539|12020064|FG000|NOT COMPLETED|Overall Study||6
10853719|NCT01670539|12020065|FG001|NOT COMPLETED|Overall Study||5
10853720|NCT00407602|12020072|FG000|STARTED|Overall Study||30
10853721|NCT00407602|12020072|FG000|COMPLETED|Overall Study||23
10853722|NCT00407602|12020072|FG000|NOT COMPLETED|Overall Study||7
10853723|NCT05143541|12020079|FG000|STARTED|Overall Study||80
10853724|NCT05143541|12020079|FG000|COMPLETED|Overall Study||80
10853725|NCT05143541|12020079|FG000|NOT COMPLETED|Overall Study||0
10853726|NCT04685213|12020085|FG000|STARTED|Overall Study||9
10853727|NCT04685213|12020086|FG001|STARTED|Overall Study||10
10853728|NCT04685213|12020085|FG000|COMPLETED|Overall Study||8
10853729|NCT04685213|12020086|FG001|COMPLETED|Overall Study||7
10853730|NCT04685213|12020085|FG000|NOT COMPLETED|Overall Study||1
10853731|NCT04685213|12020086|FG001|NOT COMPLETED|Overall Study||3
10853732|NCT04567186|12020092|FG000|STARTED|Period 1||38
10853733|NCT04567186|12020093|FG001|STARTED|Period 1||40
10853734|NCT04567186|12020092|FG000|COMPLETED|Period 1||37
10853735|NCT04567186|12020093|FG001|COMPLETED|Period 1||37
10853736|NCT04567186|12020092|FG000|NOT COMPLETED|Period 1||1
10853737|NCT04567186|12020093|FG001|NOT COMPLETED|Period 1||3
10853738|NCT04567186|12020092|FG000|STARTED|Period 2||37
10853739|NCT04567186|12020093|FG001|STARTED|Period 2||37
11106653|NCT01259726|12291068|FG003|Treated|Overall Study||39
11106654|NCT01259726|12291065|FG000|COMPLETED|Overall Study||38
11106655|NCT01259726|12291066|FG001|COMPLETED|Overall Study||37
11106656|NCT01259726|12291067|FG002|COMPLETED|Overall Study||39
11106657|NCT01259726|12291068|FG003|COMPLETED|Overall Study||36
11106658|NCT01259726|12291065|FG000|NOT COMPLETED|Overall Study||5
11106659|NCT01259726|12291066|FG001|NOT COMPLETED|Overall Study||4
11106660|NCT01259726|12291067|FG002|NOT COMPLETED|Overall Study||4
11106661|NCT01259726|12291068|FG003|NOT COMPLETED|Overall Study||5
11106662|NCT01259856|12291080|FG000|STARTED|Overall Study||82
11106663|NCT01259856|12291081|FG001|STARTED|Overall Study||86
11106664|NCT01259856|12291080|FG000|COMPLETED|Overall Study||13
11106665|NCT01259856|12291081|FG001|COMPLETED|Overall Study||12
11106666|NCT01259856|12291080|FG000|NOT COMPLETED|Overall Study||69
11106667|NCT01259856|12291081|FG001|NOT COMPLETED|Overall Study||74
11106668|NCT01259869|12291087|FG000|STARTED|Overall Study||34
11106669|NCT01259869|12291087|FG000|COMPLETED|Overall Study||33
11106670|NCT01259869|12291087|FG000|NOT COMPLETED|Overall Study||1
11106671|NCT01260142|12291097|FG000|STARTED|Treatment Period 1||6
11106672|NCT01260142|12291098|FG001|STARTED|Treatment Period 1||6
11106673|NCT01260142|12291099|FG002|STARTED|Treatment Period 1||6
11106674|NCT01260142|12291100|FG003|STARTED|Treatment Period 1||6
11106675|NCT01260142|12291101|FG004|STARTED|Treatment Period 1||6
11106676|NCT01260142|12291102|FG005|STARTED|Treatment Period 1||6
11106677|NCT01260142|12291097|FG000|COMPLETED|Treatment Period 1||5
11106678|NCT01260142|12291098|FG001|COMPLETED|Treatment Period 1||5
11106679|NCT01260142|12291099|FG002|COMPLETED|Treatment Period 1||6
11106680|NCT01260142|12291100|FG003|COMPLETED|Treatment Period 1||6
11106681|NCT01260142|12291101|FG004|COMPLETED|Treatment Period 1||4
11106682|NCT01260142|12291102|FG005|COMPLETED|Treatment Period 1||3
11106683|NCT01260142|12291097|FG000|NOT COMPLETED|Treatment Period 1||1
11106684|NCT01260142|12291098|FG001|NOT COMPLETED|Treatment Period 1||1
11106685|NCT01260142|12291099|FG002|NOT COMPLETED|Treatment Period 1||0
11106686|NCT01260142|12291100|FG003|NOT COMPLETED|Treatment Period 1||0
11106687|NCT01260142|12291101|FG004|NOT COMPLETED|Treatment Period 1||2
11225547|NCT01993329|12417936|FG003|STARTED|Period 1||3
11225548|NCT01993329|12417937|FG004|STARTED|Period 1||3
11225549|NCT01993329|12417938|FG005|STARTED|Period 1||4
11225550|NCT01993329|12417933|FG000|COMPLETED|Period 1||3
11225551|NCT01993329|12417934|FG001|COMPLETED|Period 1||4
11225552|NCT01993329|12417935|FG002|COMPLETED|Period 1||3
11225553|NCT01993329|12417936|FG003|COMPLETED|Period 1||3
11225554|NCT01993329|12417937|FG004|COMPLETED|Period 1||3
11225555|NCT01993329|12417938|FG005|COMPLETED|Period 1||4
11225556|NCT01993329|12417933|FG000|NOT COMPLETED|Period 1||0
11225557|NCT01993329|12417934|FG001|NOT COMPLETED|Period 1||0
11225558|NCT01993329|12417935|FG002|NOT COMPLETED|Period 1||0
11225559|NCT01993329|12417936|FG003|NOT COMPLETED|Period 1||0
11225560|NCT01993329|12417937|FG004|NOT COMPLETED|Period 1||0
11225561|NCT01993329|12417938|FG005|NOT COMPLETED|Period 1||0
11225562|NCT01993329|12417933|FG000|STARTED|Wash-out||3
11225563|NCT01993329|12417934|FG001|STARTED|Wash-out||4
11225564|NCT01993329|12417935|FG002|STARTED|Wash-out||3
11225565|NCT01993329|12417936|FG003|STARTED|Wash-out||3
11225566|NCT01993329|12417937|FG004|STARTED|Wash-out||3
11225567|NCT01993329|12417938|FG005|STARTED|Wash-out||4
11225568|NCT01993329|12417933|FG000|COMPLETED|Wash-out||3
10853740|NCT04567186|12020092|FG000|COMPLETED|Period 2||37
10853741|NCT04567186|12020093|FG001|COMPLETED|Period 2||34
10853742|NCT04567186|12020092|FG000|NOT COMPLETED|Period 2||0
10853743|NCT04567186|12020093|FG001|NOT COMPLETED|Period 2||3
10853744|NCT04567186|12020092|FG000|STARTED|Period 3||37
10853745|NCT04567186|12020093|FG001|STARTED|Period 3||34
10853746|NCT04567186|12020092|FG000|COMPLETED|Period 3||36
11106688|NCT01260142|12291102|FG005|NOT COMPLETED|Treatment Period 1||3
11106689|NCT01260142|12291097|FG000|STARTED|Treatment Period 2||5
10853747|NCT04567186|12020093|FG001|COMPLETED|Period 3||34
10853748|NCT04567186|12020092|FG000|NOT COMPLETED|Period 3||1
10853749|NCT04567186|12020093|FG001|NOT COMPLETED|Period 3||0
10853750|NCT04065074|12020099|FG000|STARTED|Overall Study||16
10853751|NCT04065074|12020099|FG000|COMPLETED|Overall Study||14
10853752|NCT04065074|12020099|FG000|NOT COMPLETED|Overall Study||2
10853753|NCT03980730|12020105|FG000|STARTED|Overall Study||21
10853754|NCT03980730|12020106|FG001|STARTED|Overall Study||22
10853755|NCT03980730|12020105|FG000|COMPLETED|Overall Study||19
10853756|NCT03980730|12020106|FG001|COMPLETED|Overall Study||18
10853757|NCT03980730|12020105|FG000|NOT COMPLETED|Overall Study||2
10853758|NCT03980730|12020106|FG001|NOT COMPLETED|Overall Study||4
10853759|NCT03793010|12020114|FG000|STARTED|Overall Study||35
10853760|NCT03793010|12020115|FG001|STARTED|Overall Study||35
11106690|NCT01260142|12291098|FG001|STARTED|Treatment Period 2||5
11106691|NCT01260142|12291099|FG002|STARTED|Treatment Period 2||6
11106692|NCT01260142|12291100|FG003|STARTED|Treatment Period 2||6
11106693|NCT01260142|12291101|FG004|STARTED|Treatment Period 2||4
11106694|NCT01260142|12291102|FG005|STARTED|Treatment Period 2||3
11225569|NCT01993329|12417934|FG001|COMPLETED|Wash-out||4
11225570|NCT01993329|12417935|FG002|COMPLETED|Wash-out||3
11225571|NCT01993329|12417936|FG003|COMPLETED|Wash-out||3
11225572|NCT01993329|12417937|FG004|COMPLETED|Wash-out||3
11225573|NCT01993329|12417938|FG005|COMPLETED|Wash-out||4
11225574|NCT01993329|12417933|FG000|NOT COMPLETED|Wash-out||0
11225575|NCT01993329|12417934|FG001|NOT COMPLETED|Wash-out||0
10853761|NCT03793010|12020114|FG000|Randomized But Not Dosed|Overall Study||2
10853762|NCT03793010|12020115|FG001|Randomized But Not Dosed|Overall Study||0
10853763|NCT03793010|12020114|FG000|COMPLETED|Overall Study||7
10853764|NCT03793010|12020115|FG001|COMPLETED|Overall Study||8
10853765|NCT03793010|12020114|FG000|NOT COMPLETED|Overall Study||28
10853766|NCT03793010|12020115|FG001|NOT COMPLETED|Overall Study||27
10853767|NCT03644017|12020121|FG000|STARTED|Overall Study||46
10853768|NCT03644017|12020121|FG000|COMPLETED|Overall Study||39
10853769|NCT03644017|12020121|FG000|NOT COMPLETED|Overall Study||7
10853770|NCT03592186|12020127|FG000|STARTED|Overall Study||60
10853771|NCT03592186|12020128|FG001|STARTED|Overall Study||62
10853772|NCT03592186|12020127|FG000|6-week Follow-up|Overall Study||49
10853773|NCT03592186|12020128|FG001|6-week Follow-up|Overall Study||56
10853774|NCT03592186|12020127|FG000|12-week Follow-up|Overall Study||47
10853775|NCT03592186|12020128|FG001|12-week Follow-up|Overall Study||51
10853776|NCT03592186|12020127|FG000|COMPLETED|Overall Study||43
10853777|NCT03592186|12020128|FG001|COMPLETED|Overall Study||51
10853778|NCT03592186|12020127|FG000|NOT COMPLETED|Overall Study||17
10853779|NCT03592186|12020128|FG001|NOT COMPLETED|Overall Study||11
10853780|NCT03529942|12020134|FG000|STARTED|Overall Study||129
10853781|NCT03529942|12020134|FG000|Reached Week 6 With Paired MRI|Overall Study||108
10853782|NCT03529942|12020134|FG000|COMPLETED|Overall Study||106
10853783|NCT03529942|12020134|FG000|NOT COMPLETED|Overall Study||23
10853784|NCT03349775|12020143|FG000|STARTED|Overall Study||10
10853785|NCT03349775|12020144|FG001|STARTED|Overall Study||11
10853786|NCT03349775|12020143|FG000|COMPLETED|Overall Study||8
10853787|NCT03349775|12020144|FG001|COMPLETED|Overall Study||7
10853788|NCT03349775|12020143|FG000|NOT COMPLETED|Overall Study||2
10853789|NCT03349775|12020144|FG001|NOT COMPLETED|Overall Study||4
10853790|NCT03292471|12020152|FG000|STARTED|Overall Study||8
10853791|NCT03292471|12020153|FG001|STARTED|Overall Study||8
10853792|NCT03292471|12020152|FG000|COMPLETED|Overall Study||8
10853793|NCT03292471|12020153|FG001|COMPLETED|Overall Study||8
10853794|NCT03292471|12020152|FG000|NOT COMPLETED|Overall Study||0
10853795|NCT03292471|12020153|FG001|NOT COMPLETED|Overall Study||0
10853796|NCT03256344|12020161|FG000|STARTED|Overall Study||11
10853797|NCT03256344|12020162|FG001|STARTED|Overall Study||25
10853798|NCT03256344|12020161|FG000|Received Talimogene Laherparepvec|Overall Study||8
10853799|NCT03256344|12020162|FG001|Received Talimogene Laherparepvec|Overall Study||23
10853800|NCT03256344|12020161|FG000|Received Atezolizumab|Overall Study||10
10853801|NCT03256344|12020162|FG001|Received Atezolizumab|Overall Study||24
10853802|NCT03256344|12020161|FG000|COMPLETED|Overall Study||0
10853803|NCT03256344|12020162|FG001|COMPLETED|Overall Study||0
10853804|NCT03256344|12020161|FG000|NOT COMPLETED|Overall Study||11
10853805|NCT03256344|12020162|FG001|NOT COMPLETED|Overall Study||25
10853806|NCT03207815|12020170|FG000|STARTED|Overall Study||38
10853807|NCT03207815|12020171|FG001|STARTED|Overall Study||36
10853808|NCT03207815|12020170|FG000|COMPLETED|Overall Study||30
10853809|NCT03207815|12020171|FG001|COMPLETED|Overall Study||29
10853810|NCT03207815|12020170|FG000|NOT COMPLETED|Overall Study||8
10853811|NCT03207815|12020171|FG001|NOT COMPLETED|Overall Study||7
10853812|NCT03077737|12020179|FG000|STARTED|Week 6 (10 Weeks After Enrollment)||97
10853813|NCT03077737|12020180|FG001|STARTED|Week 6 (10 Weeks After Enrollment)||93
10853814|NCT03077737|12020179|FG000|COMPLETED|Week 6 (10 Weeks After Enrollment)||89
10853815|NCT03077737|12020180|FG001|COMPLETED|Week 6 (10 Weeks After Enrollment)||79
11225576|NCT01993329|12417935|FG002|NOT COMPLETED|Wash-out||0
11225577|NCT01993329|12417936|FG003|NOT COMPLETED|Wash-out||0
11225578|NCT01993329|12417937|FG004|NOT COMPLETED|Wash-out||0
11225579|NCT01993329|12417938|FG005|NOT COMPLETED|Wash-out||0
11225580|NCT01993329|12417933|FG000|STARTED|Period 2||3
11225581|NCT01993329|12417934|FG001|STARTED|Period 2||4
11225582|NCT01993329|12417935|FG002|STARTED|Period 2||3
11225583|NCT01993329|12417936|FG003|STARTED|Period 2||3
11225584|NCT01993329|12417937|FG004|STARTED|Period 2||3
11225585|NCT01993329|12417938|FG005|STARTED|Period 2||4
11225586|NCT01993329|12417933|FG000|COMPLETED|Period 2||3
11225587|NCT01993329|12417934|FG001|COMPLETED|Period 2||4
11225588|NCT01993329|12417935|FG002|COMPLETED|Period 2||3
11225589|NCT01993329|12417936|FG003|COMPLETED|Period 2||3
11225590|NCT01993329|12417937|FG004|COMPLETED|Period 2||3
11225591|NCT01993329|12417938|FG005|COMPLETED|Period 2||3
11225592|NCT01993329|12417933|FG000|NOT COMPLETED|Period 2||0
10853816|NCT03077737|12020179|FG000|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||8
10853817|NCT03077737|12020180|FG001|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||14
10853818|NCT03077737|12020179|FG000|STARTED|Week 14 (18 Weeks After Enrollment)||97
10853819|NCT03077737|12020180|FG001|STARTED|Week 14 (18 Weeks After Enrollment)||93
10853820|NCT03077737|12020179|FG000|COMPLETED|Week 14 (18 Weeks After Enrollment)||83
10853821|NCT03077737|12020180|FG001|COMPLETED|Week 14 (18 Weeks After Enrollment)||76
10853822|NCT03077737|12020179|FG000|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||14
10853823|NCT03077737|12020180|FG001|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||17
10853824|NCT03077737|12020179|FG000|STARTED|Week 28 (32 Weeks After Enrollment)||49
10853825|NCT03077737|12020180|FG001|STARTED|Week 28 (32 Weeks After Enrollment)||47
10853826|NCT03077737|12020179|FG000|COMPLETED|Week 28 (32 Weeks After Enrollment)||39
10853827|NCT03077737|12020180|FG001|COMPLETED|Week 28 (32 Weeks After Enrollment)||40
10853828|NCT03077737|12020179|FG000|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||10
11225593|NCT01993329|12417934|FG001|NOT COMPLETED|Period 2||0
11225594|NCT01993329|12417935|FG002|NOT COMPLETED|Period 2||0
11225595|NCT01993329|12417936|FG003|NOT COMPLETED|Period 2||0
11225596|NCT01993329|12417937|FG004|NOT COMPLETED|Period 2||0
10853829|NCT03077737|12020180|FG001|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||7
10853830|NCT02991937|12020188|FG000|STARTED|Overall Study||20
10853831|NCT02991937|12020189|FG001|STARTED|Overall Study||19
10853832|NCT02991937|12020188|FG000|COMPLETED|Overall Study||20
10853833|NCT02991937|12020189|FG001|COMPLETED|Overall Study||19
10853834|NCT02991937|12020188|FG000|NOT COMPLETED|Overall Study||0
10853835|NCT02991937|12020189|FG001|NOT COMPLETED|Overall Study||0
10853836|NCT02968563|12020197|FG000|STARTED|Overall Study||5
10853837|NCT02968563|12020198|FG001|STARTED|Overall Study||30
10853838|NCT02968563|12020197|FG000|COMPLETED|Overall Study||4
11225597|NCT01993329|12417938|FG005|NOT COMPLETED|Period 2||1
11225598|NCT01993329|12417933|FG000|STARTED|Wash-out||3
11225599|NCT01993329|12417934|FG001|STARTED|Wash-out||4
11225600|NCT01993329|12417935|FG002|STARTED|Wash-out||3
11225601|NCT01993329|12417936|FG003|STARTED|Wash-out||3
11225602|NCT01993329|12417937|FG004|STARTED|Wash-out||3
11225603|NCT01993329|12417938|FG005|STARTED|Wash-out||3
11225604|NCT01993329|12417933|FG000|COMPLETED|Wash-out||3
11225605|NCT01993329|12417934|FG001|COMPLETED|Wash-out||3
11225606|NCT01993329|12417935|FG002|COMPLETED|Wash-out||3
11225607|NCT01993329|12417936|FG003|COMPLETED|Wash-out||3
11225608|NCT01993329|12417937|FG004|COMPLETED|Wash-out||3
11225609|NCT01993329|12417938|FG005|COMPLETED|Wash-out||3
11225610|NCT01993329|12417933|FG000|NOT COMPLETED|Wash-out||0
11225611|NCT01993329|12417934|FG001|NOT COMPLETED|Wash-out||1
11225612|NCT01993329|12417935|FG002|NOT COMPLETED|Wash-out||0
11225613|NCT01993329|12417936|FG003|NOT COMPLETED|Wash-out||0
11225614|NCT01993329|12417937|FG004|NOT COMPLETED|Wash-out||0
11225615|NCT01993329|12417938|FG005|NOT COMPLETED|Wash-out||0
11225616|NCT01993329|12417933|FG000|STARTED|Period 3||3
11225617|NCT01993329|12417934|FG001|STARTED|Period 3||3
11225618|NCT01993329|12417935|FG002|STARTED|Period 3||3
11225619|NCT01993329|12417936|FG003|STARTED|Period 3||3
11225620|NCT01993329|12417937|FG004|STARTED|Period 3||3
11225621|NCT01993329|12417938|FG005|STARTED|Period 3||3
11225622|NCT01993329|12417933|FG000|COMPLETED|Period 3||3
11225623|NCT01993329|12417934|FG001|COMPLETED|Period 3||3
11225624|NCT01993329|12417935|FG002|COMPLETED|Period 3||3
11225625|NCT01993329|12417936|FG003|COMPLETED|Period 3||3
11225626|NCT01993329|12417937|FG004|COMPLETED|Period 3||3
11225627|NCT01993329|12417938|FG005|COMPLETED|Period 3||3
11225628|NCT01993329|12417933|FG000|NOT COMPLETED|Period 3||0
11225629|NCT01993329|12417934|FG001|NOT COMPLETED|Period 3||0
11225630|NCT01993329|12417935|FG002|NOT COMPLETED|Period 3||0
11225631|NCT01993329|12417936|FG003|NOT COMPLETED|Period 3||0
11225632|NCT01993329|12417937|FG004|NOT COMPLETED|Period 3||0
11225633|NCT01993329|12417938|FG005|NOT COMPLETED|Period 3||0
11225634|NCT01993615|12417952|FG000|STARTED|Overall Study||40
11225635|NCT01993615|12417953|FG001|STARTED|Overall Study||40
11225636|NCT01993615|12417952|FG000|COMPLETED|Overall Study||39
11225637|NCT01993615|12417953|FG001|COMPLETED|Overall Study||40
11225638|NCT01993615|12417952|FG000|NOT COMPLETED|Overall Study||1
11225639|NCT01993615|12417953|FG001|NOT COMPLETED|Overall Study||0
11225640|NCT01993667|12417961|FG000|STARTED|Overall Study||64
11225641|NCT01993667|12417962|FG001|STARTED|Overall Study||66
11225642|NCT01993667|12417961|FG000|COMPLETED|Overall Study||43
11225643|NCT01993667|12417962|FG001|COMPLETED|Overall Study||47
11225644|NCT01993667|12417961|FG000|NOT COMPLETED|Overall Study||21
11225645|NCT01993667|12417962|FG001|NOT COMPLETED|Overall Study||19
11225646|NCT01993823|12417970|FG000|STARTED|Overall Study||95
11225647|NCT01993823|12417971|FG001|STARTED|Overall Study||95
11225648|NCT01993823|12417970|FG000|COMPLETED|Overall Study||88
11225649|NCT01993823|12417971|FG001|COMPLETED|Overall Study||79
11225650|NCT01993823|12417970|FG000|NOT COMPLETED|Overall Study||7
11225651|NCT01993823|12417971|FG001|NOT COMPLETED|Overall Study||16
11225652|NCT01993836|12417980|FG000|STARTED|Overall Study|This represents the number of enrolled patients who completed baseline cognitive testing|72
11225653|NCT01993836|12417981|FG001|STARTED|Overall Study||68
11225654|NCT01993836|12417982|FG002|STARTED|Overall Study||51
11225655|NCT01993836|12417980|FG000|COMPLETED|Overall Study||55
11225656|NCT01993836|12417981|FG001|COMPLETED|Overall Study||55
11225657|NCT01993836|12417982|FG002|COMPLETED|Overall Study||46
11225658|NCT01993836|12417980|FG000|NOT COMPLETED|Overall Study||17
11225659|NCT01993836|12417981|FG001|NOT COMPLETED|Overall Study||13
11225660|NCT01993836|12417982|FG002|NOT COMPLETED|Overall Study||5
11225661|NCT01993849|12417992|FG000|STARTED|Overall Study||12
11225662|NCT01993849|12417993|FG001|STARTED|Overall Study||11
11225663|NCT01993849|12417992|FG000|COMPLETED|Overall Study||9
11225664|NCT01993849|12417993|FG001|COMPLETED|Overall Study||9
11225665|NCT01993849|12417992|FG000|NOT COMPLETED|Overall Study||3
11225666|NCT01993849|12417993|FG001|NOT COMPLETED|Overall Study||2
11225667|NCT01993875|12418003|FG000|STARTED|Overall Study||82
11225668|NCT01993875|12418004|FG001|STARTED|Overall Study||82
11225669|NCT01993875|12418003|FG000|COMPLETED|Overall Study||75
10853839|NCT02968563|12020198|FG001|COMPLETED|Overall Study||22
10853840|NCT02968563|12020197|FG000|NOT COMPLETED|Overall Study||1
10853841|NCT02968563|12020198|FG001|NOT COMPLETED|Overall Study||8
10853842|NCT02915783|12020204|FG000|STARTED|Overall Study||31
10853843|NCT02915783|12020204|FG000|COMPLETED|Overall Study||17
10853844|NCT02915783|12020204|FG000|NOT COMPLETED|Overall Study||14
11225670|NCT01993875|12418004|FG001|COMPLETED|Overall Study||76
11225671|NCT01993875|12418003|FG000|NOT COMPLETED|Overall Study||7
11225672|NCT01993875|12418004|FG001|NOT COMPLETED|Overall Study||6
11225673|NCT01993888|12418013|FG000|STARTED|Overall Study||50
11225674|NCT01993888|12418014|FG001|STARTED|Overall Study||52
11225675|NCT01993888|12418013|FG000|COMPLETED|Overall Study||48
10853845|NCT02913482|12020211|FG000|STARTED|Overall Study||4
10853846|NCT02913482|12020212|FG001|STARTED|Overall Study||17
10853847|NCT02913482|12020213|FG002|STARTED|Overall Study||41
10853848|NCT02913482|12020211|FG000|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|3
10853849|NCT02913482|12020212|FG001|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|14
10853850|NCT02913482|12020213|FG002|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|38
10853851|NCT02913482|12020211|FG000|NOT COMPLETED|Overall Study||1
10853852|NCT02913482|12020212|FG001|NOT COMPLETED|Overall Study||3
10853853|NCT02913482|12020213|FG002|NOT COMPLETED|Overall Study||3
10853854|NCT02787044|12020225|FG000|STARTED|Overall Study||2630
10853855|NCT02787044|12020226|FG001|STARTED|Overall Study||2630
10853856|NCT02787044|12020225|FG000|COMPLETED|Overall Study||2615
10853857|NCT02787044|12020226|FG001|COMPLETED|Overall Study||2611
10853858|NCT02787044|12020225|FG000|NOT COMPLETED|Overall Study||15
10853859|NCT02787044|12020226|FG001|NOT COMPLETED|Overall Study||19
10853860|NCT02698163|12020238|FG000|STARTED|Overall Study||1
10853861|NCT02698163|12020239|FG001|STARTED|Overall Study||3
10853862|NCT02698163|12020238|FG000|COMPLETED|Overall Study||1
10853863|NCT02698163|12020239|FG001|COMPLETED|Overall Study||2
10853864|NCT02698163|12020238|FG000|NOT COMPLETED|Overall Study||0
11225676|NCT01993888|12418014|FG001|COMPLETED|Overall Study||49
11225677|NCT01993888|12418013|FG000|NOT COMPLETED|Overall Study||2
11225678|NCT01993888|12418014|FG001|NOT COMPLETED|Overall Study||3
11225679|NCT01993927|12418020|FG000|STARTED|Overall Study||742
11225680|NCT01993927|12418020|FG000|COMPLETED|Overall Study||713
11225681|NCT01993927|12418020|FG000|NOT COMPLETED|Overall Study||29
11225682|NCT01993940|12418026|FG000|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
11225683|NCT01993940|12418027|FG001|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
11225684|NCT01993940|12418026|FG000|Received Treatment|Overall Study||272
11225685|NCT01993940|12418027|FG001|Received Treatment|Overall Study||276
11225686|NCT01993940|12418026|FG000|COMPLETED|Overall Study||237
11225687|NCT01993940|12418027|FG001|COMPLETED|Overall Study||232
11225688|NCT01993940|12418026|FG000|NOT COMPLETED|Overall Study||40
11225689|NCT01993940|12418027|FG001|NOT COMPLETED|Overall Study||44
11225690|NCT01994109|12418036|FG000|STARTED|Double-blind Phase (Part A)||63
11225691|NCT01994109|12418037|FG001|STARTED|Double-blind Phase (Part A)||64
11225692|NCT01994109|12418038|FG002|STARTED|Double-blind Phase (Part A)||60
11225693|NCT01994109|12418039|FG003|STARTED|Double-blind Phase (Part A)||0
11225694|NCT01994109|12418036|FG000|COMPLETED|Double-blind Phase (Part A)||62
11225695|NCT01994109|12418037|FG001|COMPLETED|Double-blind Phase (Part A)||61
11225696|NCT01994109|12418038|FG002|COMPLETED|Double-blind Phase (Part A)||53
11225697|NCT01994109|12418039|FG003|COMPLETED|Double-blind Phase (Part A)||0
11225698|NCT01994109|12418036|FG000|NOT COMPLETED|Double-blind Phase (Part A)||1
11225699|NCT01994109|12418037|FG001|NOT COMPLETED|Double-blind Phase (Part A)||3
11225700|NCT01994109|12418038|FG002|NOT COMPLETED|Double-blind Phase (Part A)||7
11225701|NCT01994109|12418039|FG003|NOT COMPLETED|Double-blind Phase (Part A)||0
11225702|NCT01994109|12418036|FG000|STARTED|Open-label Phase (Part B)||0
11225703|NCT01994109|12418037|FG001|STARTED|Open-label Phase (Part B)||0
11225704|NCT01994109|12418038|FG002|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0
11225705|NCT01994109|12418039|FG003|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170
11225706|NCT01994109|12418036|FG000|COMPLETED|Open-label Phase (Part B)||0
11225707|NCT01994109|12418037|FG001|COMPLETED|Open-label Phase (Part B)||0
11225708|NCT01994109|12418038|FG002|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0
11225709|NCT01994109|12418039|FG003|COMPLETED|Open-label Phase (Part B)||128
11225710|NCT01994109|12418036|FG000|NOT COMPLETED|Open-label Phase (Part B)||0
11225711|NCT01994109|12418037|FG001|NOT COMPLETED|Open-label Phase (Part B)||0
11225712|NCT01994109|12418038|FG002|NOT COMPLETED|Open-label Phase (Part B)||0
11225713|NCT01994109|12418039|FG003|NOT COMPLETED|Open-label Phase (Part B)||42
11225714|NCT01994226|12418051|FG000|STARTED|Overall Study||199
11225715|NCT01994226|12418052|FG001|STARTED|Overall Study||200
11225716|NCT01994226|12418051|FG000|COMPLETED|Overall Study||180
11225717|NCT01994226|12418052|FG001|COMPLETED|Overall Study||179
11225718|NCT01994226|12418051|FG000|NOT COMPLETED|Overall Study||19
11225719|NCT01994226|12418052|FG001|NOT COMPLETED|Overall Study||21
11225720|NCT01994291|12418061|FG000|STARTED|Overall Study||99
11225721|NCT01994291|12418062|FG001|STARTED|Overall Study||43
11225722|NCT01994291|12418063|FG002|STARTED|Overall Study||56
11225723|NCT01994291|12418061|FG000|Received Treatment|Overall Study||99
11225724|NCT01994291|12418062|FG001|Received Treatment|Overall Study||43
11225725|NCT01994291|12418063|FG002|Received Treatment|Overall Study||56
10853865|NCT02698163|12020239|FG001|NOT COMPLETED|Overall Study||1
10853866|NCT02586675|12020245|FG000|STARTED|Overall Study||7
10853867|NCT02586675|12020245|FG000|COMPLETED|Overall Study||7
10853868|NCT02586675|12020245|FG000|NOT COMPLETED|Overall Study||0
11106695|NCT01260142|12291097|FG000|COMPLETED|Treatment Period 2||5
11106696|NCT01260142|12291098|FG001|COMPLETED|Treatment Period 2||5
11106697|NCT01260142|12291099|FG002|COMPLETED|Treatment Period 2||6
11106698|NCT01260142|12291100|FG003|COMPLETED|Treatment Period 2||6
11106699|NCT01260142|12291101|FG004|COMPLETED|Treatment Period 2||4
11106700|NCT01260142|12291102|FG005|COMPLETED|Treatment Period 2||3
11106701|NCT01260142|12291097|FG000|NOT COMPLETED|Treatment Period 2||0
11106702|NCT01260142|12291098|FG001|NOT COMPLETED|Treatment Period 2||0
11106703|NCT01260142|12291099|FG002|NOT COMPLETED|Treatment Period 2||0
11106704|NCT01260142|12291100|FG003|NOT COMPLETED|Treatment Period 2||0
11106705|NCT01260142|12291101|FG004|NOT COMPLETED|Treatment Period 2||0
10853875|NCT01816165|12020266|FG000|STARTED|Overall Study||5
10853876|NCT01816165|12020267|FG001|STARTED|Overall Study||4
10853877|NCT01816165|12020268|FG002|STARTED|Overall Study||5
10853878|NCT01816165|12020269|FG003|STARTED|Overall Study||4
10853879|NCT01816165|12020266|FG000|Completed Intervention 1|Overall Study||4
10853880|NCT01816165|12020267|FG001|Completed Intervention 1|Overall Study||4
10853881|NCT01816165|12020268|FG002|Completed Intervention 1|Overall Study||5
10853882|NCT01816165|12020269|FG003|Completed Intervention 1|Overall Study||4
10853883|NCT01816165|12020266|FG000|Completed ~2 Week Washout|Overall Study||4
10853884|NCT01816165|12020267|FG001|Completed ~2 Week Washout|Overall Study||4
10853885|NCT01816165|12020268|FG002|Completed ~2 Week Washout|Overall Study||5
10853886|NCT01816165|12020269|FG003|Completed ~2 Week Washout|Overall Study||4
10853887|NCT01816165|12020266|FG000|Started Second Intervention|Overall Study||4
10853888|NCT01816165|12020267|FG001|Started Second Intervention|Overall Study||4
10853889|NCT01816165|12020268|FG002|Started Second Intervention|Overall Study||5
10853890|NCT01816165|12020269|FG003|Started Second Intervention|Overall Study||4
10853891|NCT01816165|12020266|FG000|COMPLETED|Overall Study||4
10853892|NCT01816165|12020267|FG001|COMPLETED|Overall Study||4
10853893|NCT01816165|12020268|FG002|COMPLETED|Overall Study||5
10853894|NCT01816165|12020269|FG003|COMPLETED|Overall Study||4
10853895|NCT01816165|12020266|FG000|NOT COMPLETED|Overall Study||1
10853896|NCT01816165|12020267|FG001|NOT COMPLETED|Overall Study||0
10853897|NCT01816165|12020268|FG002|NOT COMPLETED|Overall Study||0
10853898|NCT01816165|12020269|FG003|NOT COMPLETED|Overall Study||0
10853899|NCT01813929|12020291|FG000|STARTED|Overall Study||5
10853900|NCT01813929|12020292|FG001|STARTED|Overall Study||12
10853901|NCT01813929|12020291|FG000|Completed Intervention 1|Overall Study||5
10853902|NCT01813929|12020292|FG001|Completed Intervention 1|Overall Study||12
10853903|NCT01813929|12020291|FG000|Completed Washout (2weeks up to 2 Months)|Overall Study||5
10853904|NCT01813929|12020292|FG001|Completed Washout (2weeks up to 2 Months)|Overall Study||11
10853905|NCT01813929|12020291|FG000|Started Intervention 2|Overall Study||5
10853906|NCT01813929|12020292|FG001|Started Intervention 2|Overall Study||11
10853907|NCT01813929|12020291|FG000|COMPLETED|Overall Study||5
10853908|NCT01813929|12020292|FG001|COMPLETED|Overall Study||11
10853909|NCT01813929|12020291|FG000|NOT COMPLETED|Overall Study||0
10853910|NCT01813929|12020292|FG001|NOT COMPLETED|Overall Study||1
10853911|NCT01502085|12020298|FG000|STARTED|Overall Study||25
10853912|NCT01502085|12020298|FG000|COMPLETED|Overall Study||25
10853913|NCT01502085|12020298|FG000|NOT COMPLETED|Overall Study||0
10853914|NCT01178814|12020302|FG000|STARTED|Overall Study||57
10853915|NCT01178814|12020302|FG000|COMPLETED|Overall Study||57
10853916|NCT01178814|12020302|FG000|NOT COMPLETED|Overall Study||0
10853917|NCT01125176|12020306|FG000|STARTED|Treatment Phase||14
10853918|NCT01125176|12020306|FG000|COMPLETED|Treatment Phase||13
10853919|NCT01125176|12020306|FG000|NOT COMPLETED|Treatment Phase||1
10853920|NCT01125176|12020306|FG000|STARTED|Post-treatment Follow-up Phase||13
10853921|NCT01125176|12020306|FG000|COMPLETED|Post-treatment Follow-up Phase||2
10853922|NCT01125176|12020306|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||11
10853923|NCT00882050|12020313|FG000|STARTED|Overall Study||32
10853924|NCT00882050|12020314|FG001|STARTED|Overall Study||33
10853925|NCT00882050|12020315|FG002|STARTED|Overall Study||39
10853926|NCT00882050|12020313|FG000|COMPLETED|Overall Study||31
10853927|NCT00882050|12020314|FG001|COMPLETED|Overall Study||33
10853928|NCT00882050|12020315|FG002|COMPLETED|Overall Study||39
10853929|NCT00882050|12020313|FG000|NOT COMPLETED|Overall Study||1
10853930|NCT00882050|12020314|FG001|NOT COMPLETED|Overall Study||0
10853931|NCT00882050|12020315|FG002|NOT COMPLETED|Overall Study||0
10853932|NCT00070564|12020329|FG000|STARTED|Overall Study||678
10853933|NCT00070564|12020330|FG001|STARTED|Overall Study||693
10853934|NCT00070564|12020331|FG002|STARTED|Overall Study||697
10853935|NCT00070564|12020332|FG003|STARTED|Overall Study||648
10853936|NCT00070564|12020333|FG004|STARTED|Overall Study||282
10853937|NCT00070564|12020334|FG005|STARTED|Overall Study||296
10853938|NCT00070564|12020329|FG000|COMPLETED|Overall Study||478
10853939|NCT00070564|12020330|FG001|COMPLETED|Overall Study||490
11106706|NCT01260142|12291102|FG005|NOT COMPLETED|Treatment Period 2||0
10853940|NCT00070564|12020331|FG002|COMPLETED|Overall Study||526
10853941|NCT00070564|12020332|FG003|COMPLETED|Overall Study||481
10853942|NCT00070564|12020333|FG004|COMPLETED|Overall Study||203
10853943|NCT00070564|12020334|FG005|COMPLETED|Overall Study||244
10853944|NCT00070564|12020329|FG000|NOT COMPLETED|Overall Study||200
10853945|NCT00070564|12020330|FG001|NOT COMPLETED|Overall Study||203
10853946|NCT00070564|12020331|FG002|NOT COMPLETED|Overall Study||171
10853947|NCT00070564|12020332|FG003|NOT COMPLETED|Overall Study||167
10853948|NCT00070564|12020333|FG004|NOT COMPLETED|Overall Study||79
10853949|NCT00070564|12020334|FG005|NOT COMPLETED|Overall Study||52
10853950|NCT05167370|12020354|FG000|STARTED|Overall Study||2
10853951|NCT05167370|12020354|FG000|COMPLETED|Overall Study||2
10853952|NCT05167370|12020354|FG000|NOT COMPLETED|Overall Study||0
10853953|NCT04500821|12020358|FG000|STARTED|Overall Study||44
10853954|NCT04500821|12020358|FG000|COMPLETED|Overall Study||44
10853955|NCT04500821|12020358|FG000|NOT COMPLETED|Overall Study||0
10853956|NCT04425720|12020365|FG000|STARTED|Overall Study||150
10853957|NCT04425720|12020366|FG001|STARTED|Overall Study||150
10853958|NCT04425720|12020365|FG000|COMPLETED|Overall Study||150
10853959|NCT04425720|12020366|FG001|COMPLETED|Overall Study||130
10853960|NCT04425720|12020365|FG000|NOT COMPLETED|Overall Study||0
10853961|NCT04425720|12020366|FG001|NOT COMPLETED|Overall Study||20
10853962|NCT04409509|12020375|FG000|STARTED|Overall Study||61
10853963|NCT04409509|12020376|FG001|STARTED|Overall Study||63
10853964|NCT04409509|12020375|FG000|COMPLETED|Overall Study||48
10853965|NCT04409509|12020376|FG001|COMPLETED|Overall Study||43
10853966|NCT04409509|12020375|FG000|NOT COMPLETED|Overall Study||13
10853967|NCT04409509|12020376|FG001|NOT COMPLETED|Overall Study||20
10853968|NCT04380519|12020386|FG000|STARTED|Overall Study||124
10853969|NCT04380519|12020387|FG001|STARTED|Overall Study||124
10853970|NCT04380519|12020388|FG002|STARTED|Overall Study||124
10853971|NCT04380519|12020386|FG000|Intent-to-Treat (ITT)|Overall Study||124
10853972|NCT04380519|12020387|FG001|Intent-to-Treat (ITT)|Overall Study||124
10853973|NCT04380519|12020388|FG002|Intent-to-Treat (ITT)|Overall Study||124
10853974|NCT04380519|12020386|FG000|Modified Intent-to-Treat (mITT)|Overall Study||115
10853975|NCT04380519|12020387|FG001|Modified Intent-to-Treat (mITT)|Overall Study||119
10853976|NCT04380519|12020388|FG002|Modified Intent-to-Treat (mITT)|Overall Study||118
10853977|NCT04380519|12020386|FG000|Safety Population|Overall Study||123
10853978|NCT04380519|12020387|FG001|Safety Population|Overall Study||124
10853979|NCT04380519|12020388|FG002|Safety Population|Overall Study||124
10853980|NCT04380519|12020386|FG000|COMPLETED|Overall Study||106
10853981|NCT04380519|12020387|FG001|COMPLETED|Overall Study||113
10853982|NCT04380519|12020388|FG002|COMPLETED|Overall Study||117
10853983|NCT04380519|12020386|FG000|NOT COMPLETED|Overall Study||18
10853984|NCT04380519|12020387|FG001|NOT COMPLETED|Overall Study||11
10853985|NCT04380519|12020388|FG002|NOT COMPLETED|Overall Study||7
10853986|NCT04362813|12020398|FG000|STARTED|Overall Study||227
10853987|NCT04362813|12020399|FG001|STARTED|Overall Study||227
10853988|NCT04362813|12020398|FG000|Safety Set|Overall Study||225
10853989|NCT04362813|12020399|FG001|Safety Set|Overall Study||223
10853990|NCT04362813|12020398|FG000|Completed Day 29|Overall Study||211
10853991|NCT04362813|12020399|FG001|Completed Day 29|Overall Study||206
10853992|NCT04362813|12020398|FG000|COMPLETED|Overall Study||209
10853993|NCT04362813|12020399|FG001|COMPLETED|Overall Study||202
10853994|NCT04362813|12020398|FG000|NOT COMPLETED|Overall Study||18
10853995|NCT04362813|12020399|FG001|NOT COMPLETED|Overall Study||25
11225726|NCT01994291|12418061|FG000|COMPLETED|Overall Study||84
11225727|NCT01994291|12418062|FG001|COMPLETED|Overall Study||36
11225728|NCT01994291|12418063|FG002|COMPLETED|Overall Study||47
11225729|NCT01994291|12418061|FG000|NOT COMPLETED|Overall Study||15
11225730|NCT01994291|12418062|FG001|NOT COMPLETED|Overall Study||7
11225731|NCT01994291|12418063|FG002|NOT COMPLETED|Overall Study||9
11225732|NCT01994395|12418074|FG000|STARTED|Overall Study||26
11225733|NCT01994395|12418075|FG001|STARTED|Overall Study||27
11225734|NCT01994395|12418074|FG000|COMPLETED|Overall Study||25
11225735|NCT01994395|12418075|FG001|COMPLETED|Overall Study||25
11225736|NCT01994395|12418074|FG000|NOT COMPLETED|Overall Study||1
10853996|NCT04231409|12020407|FG000|STARTED|Overall Study||5
10853997|NCT04231409|12020408|FG001|STARTED|Overall Study||4
10853998|NCT04231409|12020407|FG000|COMPLETED|Overall Study||0
10853999|NCT04231409|12020408|FG001|COMPLETED|Overall Study||0
10854000|NCT04231409|12020407|FG000|NOT COMPLETED|Overall Study||5
10854001|NCT04231409|12020408|FG001|NOT COMPLETED|Overall Study||4
10854002|NCT04136548|12020414|FG000|STARTED|Enrolled & Randomized||19
10854003|NCT04136548|12020415|FG001|STARTED|Enrolled & Randomized||19
10854004|NCT04136548|12020414|FG000|COMPLETED|Enrolled & Randomized||13
10854005|NCT04136548|12020415|FG001|COMPLETED|Enrolled & Randomized||15
10854006|NCT04136548|12020414|FG000|NOT COMPLETED|Enrolled & Randomized||6
10854007|NCT04136548|12020415|FG001|NOT COMPLETED|Enrolled & Randomized||4
10854008|NCT04136548|12020414|FG000|STARTED|First Visit||13
10854009|NCT04136548|12020415|FG001|STARTED|First Visit||15
10854010|NCT04136548|12020414|FG000|COMPLETED|First Visit||13
10854011|NCT04136548|12020415|FG001|COMPLETED|First Visit||15
10854012|NCT04136548|12020414|FG000|NOT COMPLETED|First Visit||0
10854013|NCT04136548|12020415|FG001|NOT COMPLETED|First Visit||0
10854014|NCT04136548|12020414|FG000|STARTED|Washout (at Least 48 Hours)||13
10854015|NCT04136548|12020415|FG001|STARTED|Washout (at Least 48 Hours)||15
10854016|NCT04136548|12020414|FG000|COMPLETED|Washout (at Least 48 Hours)||13
10854017|NCT04136548|12020415|FG001|COMPLETED|Washout (at Least 48 Hours)||15
10854018|NCT04136548|12020414|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0
10854019|NCT04136548|12020415|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0
10854020|NCT04136548|12020414|FG000|STARTED|Second Visit||13
10854021|NCT04136548|12020415|FG001|STARTED|Second Visit||15
10854022|NCT04136548|12020414|FG000|COMPLETED|Second Visit||13
10854023|NCT04136548|12020415|FG001|COMPLETED|Second Visit||15
10854024|NCT04136548|12020414|FG000|NOT COMPLETED|Second Visit||0
10854025|NCT04136548|12020415|FG001|NOT COMPLETED|Second Visit||0
10854026|NCT04126057|12020423|FG000|STARTED|Overall Study||50
10854027|NCT04126057|12020424|FG001|STARTED|Overall Study||50
10854028|NCT04126057|12020423|FG000|COMPLETED|Overall Study||47
10854029|NCT04126057|12020424|FG001|COMPLETED|Overall Study||46
10854030|NCT04126057|12020423|FG000|NOT COMPLETED|Overall Study||3
10854031|NCT04126057|12020424|FG001|NOT COMPLETED|Overall Study||4
10854032|NCT04087395|12020430|FG000|STARTED|Overall Study||30
10854033|NCT04087395|12020430|FG000|COMPLETED|Overall Study||30
10854034|NCT04087395|12020430|FG000|NOT COMPLETED|Overall Study||0
10854035|NCT04072432|12020441|FG000|STARTED|Overall Study||6
10854036|NCT04072432|12020442|FG001|STARTED|Overall Study||6
10854037|NCT04072432|12020443|FG002|STARTED|Overall Study||6
10854038|NCT04072432|12020441|FG000|COMPLETED|Overall Study||6
10854039|NCT04072432|12020442|FG001|COMPLETED|Overall Study||6
10854040|NCT04072432|12020443|FG002|COMPLETED|Overall Study||6
11225737|NCT01994395|12418075|FG001|NOT COMPLETED|Overall Study||2
11225738|NCT01994486|12418081|FG000|STARTED|Overall Study||20
10854041|NCT04072432|12020441|FG000|NOT COMPLETED|Overall Study||0
10854042|NCT04072432|12020442|FG001|NOT COMPLETED|Overall Study||0
10854043|NCT04072432|12020443|FG002|NOT COMPLETED|Overall Study||0
10854044|NCT04069585|12020451|FG000|STARTED|Overall Study||30
10854045|NCT04069585|12020451|FG000|COMPLETED|Overall Study||30
10854046|NCT04069585|12020451|FG000|NOT COMPLETED|Overall Study||0
10854047|NCT03922321|12020457|FG000|STARTED|Overall Study||7
10854048|NCT03922321|12020457|FG000|COMPLETED|Overall Study||5
10854049|NCT03922321|12020457|FG000|NOT COMPLETED|Overall Study||2
10854050|NCT03911713|12020466|FG000|STARTED|Overall Study||12
10854051|NCT03911713|12020467|FG001|STARTED|Overall Study||6
10854052|NCT03911713|12020468|FG002|STARTED|Overall Study||11
10854053|NCT03911713|12020469|FG003|STARTED|Overall Study||24
10854054|NCT03911713|12020470|FG004|STARTED|Overall Study||24
10854055|NCT03911713|12020466|FG000|Full Analysis Set|Overall Study||11
10854056|NCT03911713|12020467|FG001|Full Analysis Set|Overall Study||6
10854057|NCT03911713|12020468|FG002|Full Analysis Set|Overall Study||11
10854058|NCT03911713|12020469|FG003|Full Analysis Set|Overall Study||23
10854059|NCT03911713|12020470|FG004|Full Analysis Set|Overall Study||24
10854060|NCT03911713|12020466|FG000|COMPLETED|Overall Study||11
10854061|NCT03911713|12020467|FG001|COMPLETED|Overall Study||4
10854062|NCT03911713|12020468|FG002|COMPLETED|Overall Study||11
10854063|NCT03911713|12020469|FG003|COMPLETED|Overall Study||22
10854064|NCT03911713|12020470|FG004|COMPLETED|Overall Study||24
10854065|NCT03911713|12020466|FG000|NOT COMPLETED|Overall Study||1
10854066|NCT03911713|12020467|FG001|NOT COMPLETED|Overall Study||2
10854067|NCT03911713|12020468|FG002|NOT COMPLETED|Overall Study||0
10854068|NCT03911713|12020469|FG003|NOT COMPLETED|Overall Study||2
10854069|NCT03911713|12020470|FG004|NOT COMPLETED|Overall Study||0
10854070|NCT03879642|12020486|FG000|STARTED|Overall Study||22
10854071|NCT03879642|12020487|FG001|STARTED|Overall Study||21
10854072|NCT03879642|12020486|FG000|COMPLETED|Overall Study||19
10854073|NCT03879642|12020487|FG001|COMPLETED|Overall Study||18
10854074|NCT03879642|12020486|FG000|NOT COMPLETED|Overall Study||3
10854075|NCT03879642|12020487|FG001|NOT COMPLETED|Overall Study||3
10854076|NCT03852459|12020495|FG000|STARTED|Overall Study||126
10854077|NCT03852459|12020496|FG001|STARTED|Overall Study||125
10854078|NCT03852459|12020495|FG000|COMPLETED|Overall Study||123
10854079|NCT03852459|12020496|FG001|COMPLETED|Overall Study||122
10854080|NCT03852459|12020495|FG000|NOT COMPLETED|Overall Study||3
10854081|NCT03852459|12020496|FG001|NOT COMPLETED|Overall Study||3
10854082|NCT03740919|12020505|FG000|STARTED|Lead-in Period||751
10854083|NCT03740919|12020506|FG001|STARTED|Lead-in Period||0
10854084|NCT03740919|12020507|FG002|STARTED|Lead-in Period||0
10854085|NCT03740919|12020508|FG003|STARTED|Lead-in Period||0
10854086|NCT03740919|12020505|FG000|Received at Least One Dose of Study Drug|Lead-in Period||751
10854087|NCT03740919|12020506|FG001|Received at Least One Dose of Study Drug|Lead-in Period||0
10854088|NCT03740919|12020507|FG002|Received at Least One Dose of Study Drug|Lead-in Period||0
10854089|NCT03740919|12020508|FG003|Received at Least One Dose of Study Drug|Lead-in Period||0
10854090|NCT03740919|12020505|FG000|COMPLETED|Lead-in Period||716
10854091|NCT03740919|12020506|FG001|COMPLETED|Lead-in Period||0
10854092|NCT03740919|12020507|FG002|COMPLETED|Lead-in Period||0
10854093|NCT03740919|12020508|FG003|COMPLETED|Lead-in Period||0
10854094|NCT03740919|12020505|FG000|NOT COMPLETED|Lead-in Period||35
10854095|NCT03740919|12020506|FG001|NOT COMPLETED|Lead-in Period||0
10854096|NCT03740919|12020507|FG002|NOT COMPLETED|Lead-in Period||0
10854097|NCT03740919|12020508|FG003|NOT COMPLETED|Lead-in Period||0
10854098|NCT03740919|12020505|FG000|STARTED|Treatment Period||0
10854099|NCT03740919|12020506|FG001|STARTED|Treatment Period|Participants were randomized from Lead-in Period to Insulin Lispro (Humalog).|298
10854100|NCT03740919|12020507|FG002|STARTED|Treatment Period|Participants were randomized from Lead-in Period to LY900014.|280
10854101|NCT03740919|12020508|FG003|STARTED|Treatment Period|Participants were randomized from Lead-in Period to open-label LY900014.|138
10854102|NCT03740919|12020505|FG000|Received at Least One Dose of Study Drug|Treatment Period||0
10854103|NCT03740919|12020506|FG001|Received at Least One Dose of Study Drug|Treatment Period||298
10854104|NCT03740919|12020507|FG002|Received at Least One Dose of Study Drug|Treatment Period||280
10854105|NCT03740919|12020508|FG003|Received at Least One Dose of Study Drug|Treatment Period||138
10854106|NCT03740919|12020505|FG000|COMPLETED|Treatment Period||0
10854107|NCT03740919|12020506|FG001|COMPLETED|Treatment Period||288
10854108|NCT03740919|12020507|FG002|COMPLETED|Treatment Period||266
10854109|NCT03740919|12020508|FG003|COMPLETED|Treatment Period||135
10854110|NCT03740919|12020505|FG000|NOT COMPLETED|Treatment Period||0
10854111|NCT03740919|12020506|FG001|NOT COMPLETED|Treatment Period||10
10854112|NCT03740919|12020507|FG002|NOT COMPLETED|Treatment Period||14
10854113|NCT03740919|12020508|FG003|NOT COMPLETED|Treatment Period||3
10854114|NCT03700970|12020521|FG000|STARTED|Overall Study||30
10854115|NCT03700970|12020522|FG001|STARTED|Overall Study||30
10854116|NCT03700970|12020521|FG000|COMPLETED|Overall Study||21
10854117|NCT03700970|12020522|FG001|COMPLETED|Overall Study||19
10854118|NCT03700970|12020521|FG000|NOT COMPLETED|Overall Study||9
10854119|NCT03700970|12020522|FG001|NOT COMPLETED|Overall Study||11
10854120|NCT03652454|12020532|FG000|STARTED|Overall Study||14
10854121|NCT03652454|12020533|FG001|STARTED|Overall Study||14
10854122|NCT03652454|12020532|FG000|COMPLETED|Overall Study||14
10854123|NCT03652454|12020533|FG001|COMPLETED|Overall Study||14
10854124|NCT03652454|12020532|FG000|NOT COMPLETED|Overall Study||0
10854125|NCT03652454|12020533|FG001|NOT COMPLETED|Overall Study||0
10854126|NCT03647488|12020542|FG000|STARTED|Overall Study||18
10854127|NCT03647488|12020543|FG001|STARTED|Overall Study|Randomized part was not opened|0
10854128|NCT03647488|12020544|FG002|STARTED|Overall Study|Randomized part was not opened|0
10854129|NCT03647488|12020542|FG000|COMPLETED|Overall Study||0
10854130|NCT03647488|12020543|FG001|COMPLETED|Overall Study||0
10854131|NCT03647488|12020544|FG002|COMPLETED|Overall Study||0
10854132|NCT03647488|12020542|FG000|NOT COMPLETED|Overall Study||18
10854133|NCT03647488|12020543|FG001|NOT COMPLETED|Overall Study||0
10854134|NCT03647488|12020544|FG002|NOT COMPLETED|Overall Study||0
10854135|NCT03614923|12020553|FG000|STARTED|Overall Study||35
10854136|NCT03614923|12020554|FG001|STARTED|Overall Study||35
10854137|NCT03614923|12020555|FG002|STARTED|Overall Study||35
10854138|NCT03614923|12020553|FG000|COMPLETED|Overall Study||30
10854139|NCT03614923|12020554|FG001|COMPLETED|Overall Study||30
11225739|NCT01994486|12418081|FG000|COMPLETED|Overall Study||20
11225740|NCT01994486|12418081|FG000|NOT COMPLETED|Overall Study||0
11225741|NCT01994538|12418089|FG000|STARTED|Overall Study||136
11225742|NCT01994538|12418090|FG001|STARTED|Overall Study||136
11225743|NCT01994538|12418089|FG000|COMPLETED|Overall Study||136
11225744|NCT01994538|12418090|FG001|COMPLETED|Overall Study||136
11225745|NCT01994538|12418089|FG000|NOT COMPLETED|Overall Study||0
11225746|NCT01994538|12418090|FG001|NOT COMPLETED|Overall Study||0
11225747|NCT01994590|12418096|FG000|STARTED|Overall Study||4
11225748|NCT01994590|12418096|FG000|COMPLETED|Overall Study||2
11225749|NCT01994590|12418096|FG000|NOT COMPLETED|Overall Study||2
11225750|NCT01994629|12418102|FG000|STARTED|Overall Study||100
11225751|NCT01994629|12418103|FG001|STARTED|Overall Study||102
11225752|NCT01994629|12418102|FG000|COMPLETED|Overall Study||99
11225753|NCT01994629|12418103|FG001|COMPLETED|Overall Study||99
11225754|NCT01994629|12418102|FG000|NOT COMPLETED|Overall Study||1
11225755|NCT01994629|12418103|FG001|NOT COMPLETED|Overall Study||3
11225756|NCT01994720|12418111|FG000|STARTED|Overall Study||6589
11225757|NCT01994720|12418112|FG001|STARTED|Overall Study||6610
11225758|NCT01994720|12418111|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
11225759|NCT01994720|12418112|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
11225760|NCT01994720|12418111|FG000|NOT COMPLETED|Overall Study||46
11225761|NCT01994720|12418112|FG001|NOT COMPLETED|Overall Study||56
11225762|NCT01994746|12418118|FG000|STARTED|First Visit||39
11225763|NCT01994746|12418119|FG001|STARTED|First Visit||38
10854140|NCT03614923|12020555|FG002|COMPLETED|Overall Study||30
10854141|NCT03614923|12020553|FG000|NOT COMPLETED|Overall Study||5
10854142|NCT03614923|12020554|FG001|NOT COMPLETED|Overall Study||5
10854143|NCT03614923|12020555|FG002|NOT COMPLETED|Overall Study||5
10854144|NCT03502187|12020566|FG000|STARTED|Overall Study||43
10854145|NCT03502187|12020567|FG001|STARTED|Overall Study||43
10854146|NCT03502187|12020568|FG002|STARTED|Overall Study||42
10854147|NCT03502187|12020566|FG000|COMPLETED|Overall Study||34
10854148|NCT03502187|12020567|FG001|COMPLETED|Overall Study||36
10854149|NCT03502187|12020568|FG002|COMPLETED|Overall Study||34
10854150|NCT03502187|12020566|FG000|NOT COMPLETED|Overall Study||9
10854151|NCT03502187|12020567|FG001|NOT COMPLETED|Overall Study||7
10854152|NCT03502187|12020568|FG002|NOT COMPLETED|Overall Study||8
10854153|NCT03447262|12020576|FG000|STARTED|Overall Study||481
10854154|NCT03447262|12020576|FG000|COMPLETED|Overall Study||2
10854155|NCT03447262|12020576|FG000|NOT COMPLETED|Overall Study||479
10854156|NCT03432819|12020585|FG000|STARTED|Overall Study||38
10854157|NCT03432819|12020586|FG001|STARTED|Overall Study||38
10854158|NCT03432819|12020585|FG000|COMPLETED|Overall Study||31
10854159|NCT03432819|12020586|FG001|COMPLETED|Overall Study||33
10854160|NCT03432819|12020585|FG000|NOT COMPLETED|Overall Study||7
10854161|NCT03432819|12020586|FG001|NOT COMPLETED|Overall Study||5
10854162|NCT03323749|12020594|FG000|STARTED|Double-blind Period||109
10854163|NCT03323749|12020595|FG001|STARTED|Double-blind Period||109
10854164|NCT03323749|12020594|FG000|COMPLETED|Double-blind Period||102
10854165|NCT03323749|12020595|FG001|COMPLETED|Double-blind Period||103
10854166|NCT03323749|12020594|FG000|NOT COMPLETED|Double-blind Period||7
10854167|NCT03323749|12020595|FG001|NOT COMPLETED|Double-blind Period||6
10854168|NCT03323749|12020594|FG000|STARTED|Open-Label Period||93
10854169|NCT03323749|12020595|FG001|STARTED|Open-Label Period||103
10854170|NCT03323749|12020594|FG000|COMPLETED|Open-Label Period||0
10854171|NCT03323749|12020595|FG001|COMPLETED|Open-Label Period||0
10854172|NCT03323749|12020594|FG000|NOT COMPLETED|Open-Label Period||93
10854173|NCT03323749|12020595|FG001|NOT COMPLETED|Open-Label Period||103
10854174|NCT03322566|12020608|FG000|STARTED|Overall Study||91
10854175|NCT03322566|12020609|FG001|STARTED|Overall Study||87
10854176|NCT03322566|12020610|FG002|STARTED|Overall Study||55
10854177|NCT03322566|12020608|FG000|COMPLETED|Overall Study||46
10854178|NCT03322566|12020609|FG001|COMPLETED|Overall Study||42
10854179|NCT03322566|12020610|FG002|COMPLETED|Overall Study||22
10854180|NCT03322566|12020608|FG000|NOT COMPLETED|Overall Study||45
10854181|NCT03322566|12020609|FG001|NOT COMPLETED|Overall Study||45
10854182|NCT03322566|12020610|FG002|NOT COMPLETED|Overall Study||33
10854183|NCT03322540|12020620|FG000|STARTED|Overall Study||77
10854184|NCT03322540|12020621|FG001|STARTED|Overall Study||77
10854185|NCT03322540|12020620|FG000|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||75
10854186|NCT03322540|12020621|FG001|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||77
10854187|NCT03322540|12020620|FG000|COMPLETED|Overall Study||46
10854188|NCT03322540|12020621|FG001|COMPLETED|Overall Study||40
10854189|NCT03322540|12020620|FG000|NOT COMPLETED|Overall Study||31
10854190|NCT03322540|12020621|FG001|NOT COMPLETED|Overall Study||37
10854191|NCT03240601|12020631|FG000|STARTED|Overall Study||9
10854192|NCT03240601|12020632|FG001|STARTED|Overall Study||9
10854193|NCT03240601|12020631|FG000|COMPLETED|Overall Study||8
10854194|NCT03240601|12020632|FG001|COMPLETED|Overall Study||8
10854195|NCT03240601|12020631|FG000|NOT COMPLETED|Overall Study||1
10854196|NCT03240601|12020632|FG001|NOT COMPLETED|Overall Study||1
10854197|NCT03189719|12020640|FG000|STARTED|Overall Study||373
10854198|NCT03189719|12020641|FG001|STARTED|Overall Study||376
10854199|NCT03189719|12020640|FG000|Treated|Overall Study||370
10854200|NCT03189719|12020641|FG001|Treated|Overall Study||370
10854201|NCT03189719|12020640|FG000|COMPLETED|Overall Study||0
10854202|NCT03189719|12020641|FG001|COMPLETED|Overall Study||0
10854203|NCT03189719|12020640|FG000|NOT COMPLETED|Overall Study||373
10854204|NCT03189719|12020641|FG001|NOT COMPLETED|Overall Study||376
10854205|NCT03155997|12020649|FG000|STARTED|Overall Study||2808
10854206|NCT03155997|12020650|FG001|STARTED|Overall Study||2829
10854207|NCT03155997|12020649|FG000|Received at Least One Dose of Study Drug|Overall Study||2791
10854208|NCT03155997|12020650|FG001|Received at Least One Dose of Study Drug|Overall Study||2800
10854209|NCT03155997|12020649|FG000|COMPLETED|Overall Study||650
10854210|NCT03155997|12020650|FG001|COMPLETED|Overall Study||607
10854211|NCT03155997|12020649|FG000|NOT COMPLETED|Overall Study||2158
10854212|NCT03155997|12020650|FG001|NOT COMPLETED|Overall Study||2222
10854213|NCT03104400|12020660|FG000|STARTED|Overall Study||211
10854214|NCT03104400|12020661|FG001|STARTED|Overall Study||212
10854215|NCT03104400|12020662|FG002|STARTED|Overall Study||429
10854216|NCT03104400|12020663|FG003|STARTED|Overall Study||430
10854217|NCT03104400|12020664|FG004|STARTED|Overall Study||423
10854218|NCT03104400|12020660|FG000|Received Study Drug|Overall Study||211
10854219|NCT03104400|12020661|FG001|Received Study Drug|Overall Study||212
10854220|NCT03104400|12020662|FG002|Received Study Drug|Overall Study||429
10854221|NCT03104400|12020663|FG003|Received Study Drug|Overall Study||429
10854222|NCT03104400|12020664|FG004|Received Study Drug|Overall Study||423
10854223|NCT03104400|12020660|FG000|Completed Week 24|Overall Study||190
10854224|NCT03104400|12020661|FG001|Completed Week 24|Overall Study||193
10854225|NCT03104400|12020662|FG002|Completed Week 24|Overall Study||404
10854226|NCT03104400|12020663|FG003|Completed Week 24|Overall Study||408
10854227|NCT03104400|12020664|FG004|Completed Week 24|Overall Study||394
10854228|NCT03104400|12020660|FG000|COMPLETED|Overall Study||177
10854229|NCT03104400|12020661|FG001|COMPLETED|Overall Study||178
10854230|NCT03104400|12020662|FG002|COMPLETED|Overall Study||370
11106707|NCT01260181|12291122|FG000|STARTED|Overall Study||30
11106708|NCT01260181|12291122|FG000|COMPLETED|Overall Study||29
11106709|NCT01260181|12291122|FG000|NOT COMPLETED|Overall Study||1
11106710|NCT01260194|12291126|FG000|STARTED|Overall Study||4
11106711|NCT01260194|12291126|FG000|COMPLETED|Overall Study||3
11106712|NCT01260194|12291126|FG000|NOT COMPLETED|Overall Study||1
11106713|NCT01260272|12291132|FG000|STARTED|Overall Study||17
11106714|NCT01260272|12291133|FG001|STARTED|Overall Study||32
11106715|NCT01260272|12291132|FG000|COMPLETED|Overall Study||15
11106716|NCT01260272|12291133|FG001|COMPLETED|Overall Study||30
11106717|NCT01260272|12291132|FG000|NOT COMPLETED|Overall Study||2
11106718|NCT01260272|12291133|FG001|NOT COMPLETED|Overall Study||2
11106719|NCT01260311|12291141|FG000|STARTED|Overall Study||508
11106720|NCT01260311|12291141|FG000|COMPLETED|Overall Study||381
11106721|NCT01260311|12291141|FG000|NOT COMPLETED|Overall Study||127
11106722|NCT01260324|12291147|FG000|STARTED|Overall Study||1283
11106723|NCT01260324|12291148|FG001|STARTED|Overall Study||20000
11106724|NCT01260324|12291147|FG000|COMPLETED|Overall Study||1283
11106725|NCT01260324|12291148|FG001|COMPLETED|Overall Study||20000
11106726|NCT01260324|12291147|FG000|NOT COMPLETED|Overall Study||0
11106727|NCT01260324|12291148|FG001|NOT COMPLETED|Overall Study||0
11106728|NCT01260350|12291174|FG000|STARTED|Overall Study||10
11106729|NCT01260350|12291175|FG001|STARTED|Overall Study||9
11106730|NCT01260350|12291176|FG002|STARTED|Overall Study||10
11106731|NCT01260350|12291177|FG003|STARTED|Overall Study||11
11106732|NCT01260350|12291178|FG004|STARTED|Overall Study||10
11106733|NCT01260350|12291179|FG005|STARTED|Overall Study||10
11106734|NCT01260350|12291180|FG006|STARTED|Overall Study||10
11106735|NCT01260350|12291181|FG007|STARTED|Overall Study||25
11106736|NCT01260350|12291182|FG008|STARTED|Overall Study||25
11106737|NCT01260350|12291183|FG009|STARTED|Overall Study||25
11106738|NCT01260350|12291184|FG010|STARTED|Overall Study||10
10854231|NCT03104400|12020663|FG003|COMPLETED|Overall Study||379
10854232|NCT03104400|12020664|FG004|COMPLETED|Overall Study||366
10854233|NCT03104400|12020660|FG000|NOT COMPLETED|Overall Study||34
10854234|NCT03104400|12020661|FG001|NOT COMPLETED|Overall Study||34
10854235|NCT03104400|12020662|FG002|NOT COMPLETED|Overall Study||59
11106739|NCT01260350|12291185|FG011|STARTED|Overall Study||9
11106740|NCT01260350|12291186|FG012|STARTED|Overall Study||25
11106741|NCT01260350|12291187|FG013|STARTED|Overall Study||10
11106742|NCT01260350|12291188|FG014|STARTED|Overall Study||25
11106743|NCT01260350|12291189|FG015|STARTED|Overall Study||10
11106744|NCT01260350|12291190|FG016|STARTED|Overall Study||9
11106745|NCT01260350|12291191|FG017|STARTED|Overall Study||10
11106746|NCT01260350|12291192|FG018|STARTED|Overall Study||0
11106747|NCT01260350|12291193|FG019|STARTED|Overall Study||14
11106748|NCT01260350|12291194|FG020|STARTED|Overall Study||25
11106749|NCT01260350|12291195|FG021|STARTED|Overall Study||0
11106750|NCT01260350|12291174|FG000|COMPLETED|Overall Study||10
11106751|NCT01260350|12291175|FG001|COMPLETED|Overall Study||9
11106752|NCT01260350|12291176|FG002|COMPLETED|Overall Study||10
11106753|NCT01260350|12291177|FG003|COMPLETED|Overall Study||11
11106754|NCT01260350|12291178|FG004|COMPLETED|Overall Study||10
11106755|NCT01260350|12291179|FG005|COMPLETED|Overall Study||10
11106756|NCT01260350|12291180|FG006|COMPLETED|Overall Study||10
10854236|NCT03104400|12020663|FG003|NOT COMPLETED|Overall Study||51
10854237|NCT03104400|12020664|FG004|NOT COMPLETED|Overall Study||57
10854238|NCT03104374|12020681|FG000|STARTED|Overall Study||106
10854239|NCT03104374|12020682|FG001|STARTED|Overall Study||106
10854240|NCT03104374|12020683|FG002|STARTED|Overall Study||211
10854241|NCT03104374|12020684|FG003|STARTED|Overall Study||219
10854242|NCT03104374|12020681|FG000|Received Study Drug|Overall Study||106
10854243|NCT03104374|12020682|FG001|Received Study Drug|Overall Study||106
10854244|NCT03104374|12020683|FG002|Received Study Drug|Overall Study||211
10854245|NCT03104374|12020684|FG003|Received Study Drug|Overall Study||218
10854246|NCT03104374|12020681|FG000|Completed Week 24|Overall Study||81
10854247|NCT03104374|12020682|FG001|Completed Week 24|Overall Study||92
10854248|NCT03104374|12020683|FG002|Completed Week 24|Overall Study||192
10854249|NCT03104374|12020684|FG003|Completed Week 24|Overall Study||195
10854250|NCT03104374|12020681|FG000|COMPLETED|Overall Study||69
10854251|NCT03104374|12020682|FG001|COMPLETED|Overall Study||77
10854252|NCT03104374|12020683|FG002|COMPLETED|Overall Study||167
10854253|NCT03104374|12020684|FG003|COMPLETED|Overall Study||166
10854254|NCT03104374|12020681|FG000|NOT COMPLETED|Overall Study||37
10854255|NCT03104374|12020682|FG001|NOT COMPLETED|Overall Study||29
10854256|NCT03104374|12020683|FG002|NOT COMPLETED|Overall Study||44
10854257|NCT03104374|12020684|FG003|NOT COMPLETED|Overall Study||53
10854258|NCT03072043|12020697|FG000|STARTED|Overall Study||3
10854259|NCT03072043|12020698|FG001|STARTED|Overall Study||3
10854260|NCT03072043|12020699|FG002|STARTED|Overall Study||49
10854261|NCT03072043|12020697|FG000|COMPLETED|Overall Study||3
10854262|NCT03072043|12020698|FG001|COMPLETED|Overall Study||3
10854263|NCT03072043|12020699|FG002|COMPLETED|Overall Study||40
10854264|NCT03072043|12020697|FG000|NOT COMPLETED|Overall Study||0
10854265|NCT03072043|12020698|FG001|NOT COMPLETED|Overall Study||0
10854266|NCT03072043|12020699|FG002|NOT COMPLETED|Overall Study||9
11106757|NCT01260350|12291181|FG007|COMPLETED|Overall Study||25
11106758|NCT01260350|12291182|FG008|COMPLETED|Overall Study||24
11106759|NCT01260350|12291183|FG009|COMPLETED|Overall Study||25
10854270|NCT02946853|12020717|FG000|STARTED|Overall Study||13
10854271|NCT02946853|12020718|FG001|STARTED|Overall Study||13
10854272|NCT02946853|12020717|FG000|COMPLETED|Overall Study||12
10854273|NCT02946853|12020718|FG001|COMPLETED|Overall Study||13
10854274|NCT02946853|12020717|FG000|NOT COMPLETED|Overall Study||1
10854275|NCT02946853|12020718|FG001|NOT COMPLETED|Overall Study||0
10854276|NCT02905032|12020727|FG000|STARTED|Overall Study||467
10854277|NCT02905032|12020728|FG001|STARTED|Overall Study||475
10854278|NCT02905032|12020729|FG002|STARTED|Overall Study||244
10854279|NCT02905032|12020727|FG000|COMPLETED|Overall Study||459
10854280|NCT02905032|12020728|FG001|COMPLETED|Overall Study||463
10854281|NCT02905032|12020729|FG002|COMPLETED|Overall Study||244
10854282|NCT02905032|12020727|FG000|NOT COMPLETED|Overall Study||8
10854283|NCT02905032|12020728|FG001|NOT COMPLETED|Overall Study||12
10854284|NCT02905032|12020729|FG002|NOT COMPLETED|Overall Study||0
10854285|NCT02837029|12020739|FG000|STARTED|Screening||15
10854286|NCT02837029|12020740|FG001|STARTED|Screening||12
10854287|NCT02837029|12020741|FG002|STARTED|Screening||0
10854288|NCT02837029|12020739|FG000|COMPLETED|Screening||8
10854289|NCT02837029|12020740|FG001|COMPLETED|Screening||9
10854290|NCT02837029|12020741|FG002|COMPLETED|Screening||0
10854291|NCT02837029|12020739|FG000|NOT COMPLETED|Screening||7
10854292|NCT02837029|12020740|FG001|NOT COMPLETED|Screening||3
11106760|NCT01260350|12291184|FG010|COMPLETED|Overall Study||10
11106761|NCT01260350|12291185|FG011|COMPLETED|Overall Study||9
11106762|NCT01260350|12291186|FG012|COMPLETED|Overall Study||25
11106763|NCT01260350|12291187|FG013|COMPLETED|Overall Study||10
11106764|NCT01260350|12291188|FG014|COMPLETED|Overall Study||25
11106765|NCT01260350|12291189|FG015|COMPLETED|Overall Study||10
11106766|NCT01260350|12291190|FG016|COMPLETED|Overall Study||9
11106767|NCT01260350|12291191|FG017|COMPLETED|Overall Study||9
11106768|NCT01260350|12291192|FG018|COMPLETED|Overall Study||0
11106769|NCT01260350|12291193|FG019|COMPLETED|Overall Study||14
11106770|NCT01260350|12291194|FG020|COMPLETED|Overall Study||22
11106771|NCT01260350|12291195|FG021|COMPLETED|Overall Study||0
11106772|NCT01260350|12291174|FG000|NOT COMPLETED|Overall Study||0
11106773|NCT01260350|12291175|FG001|NOT COMPLETED|Overall Study||0
11106774|NCT01260350|12291176|FG002|NOT COMPLETED|Overall Study||0
11106775|NCT01260350|12291177|FG003|NOT COMPLETED|Overall Study||0
11106776|NCT01260350|12291178|FG004|NOT COMPLETED|Overall Study||0
11106777|NCT01260350|12291179|FG005|NOT COMPLETED|Overall Study||0
11106778|NCT01260350|12291180|FG006|NOT COMPLETED|Overall Study||0
11106779|NCT01260350|12291181|FG007|NOT COMPLETED|Overall Study||0
11225764|NCT01994746|12418118|FG000|Received At Least 1 Dose|First Visit||39
10854293|NCT02837029|12020741|FG002|NOT COMPLETED|Screening||0
10854294|NCT02837029|12020739|FG000|STARTED|Induction Treatment With Y90||8
10854295|NCT02837029|12020740|FG001|STARTED|Induction Treatment With Y90||9
10854296|NCT02837029|12020741|FG002|STARTED|Induction Treatment With Y90||0
10854297|NCT02837029|12020739|FG000|COMPLETED|Induction Treatment With Y90||8
10854298|NCT02837029|12020740|FG001|COMPLETED|Induction Treatment With Y90||9
10854299|NCT02837029|12020741|FG002|COMPLETED|Induction Treatment With Y90||0
10854300|NCT02837029|12020739|FG000|NOT COMPLETED|Induction Treatment With Y90||0
11106780|NCT01260350|12291182|FG008|NOT COMPLETED|Overall Study||1
11106781|NCT01260350|12291183|FG009|NOT COMPLETED|Overall Study||0
11106782|NCT01260350|12291184|FG010|NOT COMPLETED|Overall Study||0
11106783|NCT01260350|12291185|FG011|NOT COMPLETED|Overall Study||0
11106784|NCT01260350|12291186|FG012|NOT COMPLETED|Overall Study||0
11106785|NCT01260350|12291187|FG013|NOT COMPLETED|Overall Study||0
10854301|NCT02837029|12020740|FG001|NOT COMPLETED|Induction Treatment With Y90||0
10854302|NCT02837029|12020741|FG002|NOT COMPLETED|Induction Treatment With Y90||0
10854303|NCT02837029|12020739|FG000|STARTED|Cycle 1 (DLT Monitoring Period)||8
10854304|NCT02837029|12020740|FG001|STARTED|Cycle 1 (DLT Monitoring Period)||9
10854305|NCT02837029|12020741|FG002|STARTED|Cycle 1 (DLT Monitoring Period)||0
10854306|NCT02837029|12020739|FG000|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||6
10854307|NCT02837029|12020740|FG001|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||7
10854308|NCT02837029|12020741|FG002|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||0
10854309|NCT02837029|12020739|FG000|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
10854310|NCT02837029|12020740|FG001|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
10854311|NCT02837029|12020741|FG002|COMPLETED|Cycle 1 (DLT Monitoring Period)||0
10854312|NCT02837029|12020739|FG000|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||2
10854313|NCT02837029|12020740|FG001|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||3
10854314|NCT02837029|12020741|FG002|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||0
10854315|NCT02837029|12020739|FG000|STARTED|Cycle 2 and Beyond||6
10854316|NCT02837029|12020740|FG001|STARTED|Cycle 2 and Beyond||6
10854317|NCT02837029|12020741|FG002|STARTED|Cycle 2 and Beyond||0
10854318|NCT02837029|12020739|FG000|COMPLETED|Cycle 2 and Beyond||5
10854319|NCT02837029|12020740|FG001|COMPLETED|Cycle 2 and Beyond||6
10854320|NCT02837029|12020741|FG002|COMPLETED|Cycle 2 and Beyond||0
10854321|NCT02837029|12020739|FG000|NOT COMPLETED|Cycle 2 and Beyond||1
10854322|NCT02837029|12020740|FG001|NOT COMPLETED|Cycle 2 and Beyond||0
10854323|NCT02837029|12020741|FG002|NOT COMPLETED|Cycle 2 and Beyond||0
10854324|NCT02837029|12020739|FG000|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|6
10854325|NCT02837029|12020740|FG001|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|7
10854326|NCT02837029|12020741|FG002|STARTED|2 Year Follow-up||0
10854327|NCT02837029|12020739|FG000|COMPLETED|2 Year Follow-up||0
10854328|NCT02837029|12020740|FG001|COMPLETED|2 Year Follow-up||0
11225765|NCT01994746|12418119|FG001|Received At Least 1 Dose|First Visit||38
11225766|NCT01994746|12418118|FG000|COMPLETED|First Visit||39
11225767|NCT01994746|12418119|FG001|COMPLETED|First Visit||38
11225768|NCT01994746|12418118|FG000|NOT COMPLETED|First Visit||0
11225769|NCT01994746|12418119|FG001|NOT COMPLETED|First Visit||0
11225770|NCT01994746|12418118|FG000|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
11225771|NCT01994746|12418119|FG001|STARTED|Second Visit||38
11225772|NCT01994746|12418118|FG000|Completed Both Dosing Visits|Second Visit||38
11225773|NCT01994746|12418119|FG001|Completed Both Dosing Visits|Second Visit||38
11225774|NCT01994746|12418118|FG000|COMPLETED|Second Visit||38
11225775|NCT01994746|12418119|FG001|COMPLETED|Second Visit||38
11225776|NCT01994746|12418118|FG000|NOT COMPLETED|Second Visit||0
11225777|NCT01994746|12418119|FG001|NOT COMPLETED|Second Visit||0
11225778|NCT01994785|12418129|FG000|STARTED|Overall Study||109
11225779|NCT01994785|12418130|FG001|STARTED|Overall Study||109
11225780|NCT01994785|12418131|FG002|STARTED|Overall Study||117
11225781|NCT01994785|12418132|FG003|STARTED|Overall Study||117
11225782|NCT01994785|12418129|FG000|COMPLETED|Overall Study||101
11225783|NCT01994785|12418130|FG001|COMPLETED|Overall Study||108
11225784|NCT01994785|12418131|FG002|COMPLETED|Overall Study||117
11225785|NCT01994785|12418132|FG003|COMPLETED|Overall Study||114
11225786|NCT01994785|12418129|FG000|NOT COMPLETED|Overall Study||8
11225787|NCT01994785|12418130|FG001|NOT COMPLETED|Overall Study||1
11225788|NCT01994785|12418131|FG002|NOT COMPLETED|Overall Study||0
11225789|NCT01994785|12418132|FG003|NOT COMPLETED|Overall Study||3
11225790|NCT01994837|12418142|FG000|STARTED|Overall Study||32
11225791|NCT01994837|12418142|FG000|Treated|Overall Study||32
11225792|NCT01994837|12418142|FG000|COMPLETED|Overall Study||0
11225793|NCT01994837|12418142|FG000|NOT COMPLETED|Overall Study||32
11225794|NCT01994850|12418146|FG000|STARTED|Overall Study||32
11225795|NCT01994850|12418146|FG000|COMPLETED|Overall Study||30
11225796|NCT01994850|12418146|FG000|NOT COMPLETED|Overall Study||2
11225797|NCT01994863|12418150|FG000|STARTED|Period 1||11
11225798|NCT01994863|12418151|FG001|STARTED|Period 1||12
11225799|NCT01994863|12418150|FG000|COMPLETED|Period 1||4
11225800|NCT01994863|12418151|FG001|COMPLETED|Period 1||9
11225801|NCT01994863|12418150|FG000|NOT COMPLETED|Period 1||7
11225802|NCT01994863|12418151|FG001|NOT COMPLETED|Period 1||3
11225803|NCT01994863|12418150|FG000|STARTED|Period 2||8
11225804|NCT01994863|12418151|FG001|STARTED|Period 2||9
11225805|NCT01994863|12418150|FG000|COMPLETED|Period 2||7
11225806|NCT01994863|12418151|FG001|COMPLETED|Period 2||5
11225807|NCT01994863|12418150|FG000|NOT COMPLETED|Period 2||1
11225808|NCT01994863|12418151|FG001|NOT COMPLETED|Period 2||4
11225809|NCT01994876|12418157|FG000|STARTED|Baseline - Own Product||9
11225810|NCT01994876|12418158|FG001|STARTED|Baseline - Own Product||9
11225811|NCT01994876|12418157|FG000|COMPLETED|Baseline - Own Product||9
11225812|NCT01994876|12418158|FG001|COMPLETED|Baseline - Own Product||9
11225813|NCT01994876|12418157|FG000|NOT COMPLETED|Baseline - Own Product||0
11225814|NCT01994876|12418158|FG001|NOT COMPLETED|Baseline - Own Product||0
11225815|NCT01994876|12418157|FG000|STARTED|Test Period 1||9
11225816|NCT01994876|12418158|FG001|STARTED|Test Period 1||9
11225817|NCT01994876|12418157|FG000|COMPLETED|Test Period 1||9
11225818|NCT01994876|12418158|FG001|COMPLETED|Test Period 1||7
11225819|NCT01994876|12418157|FG000|NOT COMPLETED|Test Period 1||0
11225820|NCT01994876|12418158|FG001|NOT COMPLETED|Test Period 1||2
11225821|NCT01994876|12418157|FG000|STARTED|Test Period 2||9
11225822|NCT01994876|12418158|FG001|STARTED|Test Period 2||7
11225823|NCT01994876|12418157|FG000|COMPLETED|Test Period 2||8
11225824|NCT01994876|12418158|FG001|COMPLETED|Test Period 2||6
11225825|NCT01994876|12418157|FG000|NOT COMPLETED|Test Period 2||1
11225826|NCT01994876|12418158|FG001|NOT COMPLETED|Test Period 2||1
11225827|NCT01994889|12418169|FG000|STARTED|Overall Study||88
11225828|NCT01994889|12418170|FG001|STARTED|Overall Study||176
10854329|NCT02837029|12020741|FG002|COMPLETED|2 Year Follow-up||0
10854330|NCT02837029|12020739|FG000|NOT COMPLETED|2 Year Follow-up||6
10854331|NCT02837029|12020740|FG001|NOT COMPLETED|2 Year Follow-up||7
10854332|NCT02837029|12020741|FG002|NOT COMPLETED|2 Year Follow-up||0
10854333|NCT02740127|12020752|FG000|STARTED|Overall Study||24
10854334|NCT02740127|12020753|FG001|STARTED|Overall Study||28
10854335|NCT02740127|12020752|FG000|COMPLETED|Overall Study||24
10854336|NCT02740127|12020753|FG001|COMPLETED|Overall Study||28
10854337|NCT02740127|12020752|FG000|NOT COMPLETED|Overall Study||0
10854338|NCT02740127|12020753|FG001|NOT COMPLETED|Overall Study||0
10854339|NCT02737553|12020761|FG000|STARTED|Overall Study||49
10854340|NCT02737553|12020762|FG001|STARTED|Overall Study||48
10854341|NCT02737553|12020761|FG000|COMPLETED|Overall Study||49
10854342|NCT02737553|12020762|FG001|COMPLETED|Overall Study||48
10854343|NCT02737553|12020761|FG000|NOT COMPLETED|Overall Study||0
10854344|NCT02737553|12020762|FG001|NOT COMPLETED|Overall Study||0
10854345|NCT02737475|12020796|FG000|STARTED|Overall Study||4
10854346|NCT02737475|12020797|FG001|STARTED|Overall Study||4
10854347|NCT02737475|12020798|FG002|STARTED|Overall Study||4
10854348|NCT02737475|12020799|FG003|STARTED|Overall Study||4
10854349|NCT02737475|12020800|FG004|STARTED|Overall Study||4
10854350|NCT02737475|12020801|FG005|STARTED|Overall Study||7
10854351|NCT02737475|12020802|FG006|STARTED|Overall Study||8
10854352|NCT02737475|12020803|FG007|STARTED|Overall Study||12
10854353|NCT02737475|12020804|FG008|STARTED|Overall Study||8
10854354|NCT02737475|12020805|FG009|STARTED|Overall Study||8
10854355|NCT02737475|12020806|FG010|STARTED|Overall Study||4
10854356|NCT02737475|12020807|FG011|STARTED|Overall Study||10
10854357|NCT02737475|12020808|FG012|STARTED|Overall Study||7
10854358|NCT02737475|12020809|FG013|STARTED|Overall Study||8
10854359|NCT02737475|12020810|FG014|STARTED|Overall Study||6
10854360|NCT02737475|12020811|FG015|STARTED|Overall Study||18
10854361|NCT02737475|12020812|FG016|STARTED|Overall Study||12
10854362|NCT02737475|12020813|FG017|STARTED|Overall Study||6
10854363|NCT02737475|12020814|FG018|STARTED|Overall Study||7
10854364|NCT02737475|12020815|FG019|STARTED|Overall Study||1
10854365|NCT02737475|12020816|FG020|STARTED|Overall Study||6
10854366|NCT02737475|12020817|FG021|STARTED|Overall Study||9
10854367|NCT02737475|12020818|FG022|STARTED|Overall Study||2
10854368|NCT02737475|12020819|FG023|STARTED|Overall Study||2
10854369|NCT02737475|12020820|FG024|STARTED|Overall Study||2
10854370|NCT02737475|12020821|FG025|STARTED|Overall Study||2
10854371|NCT02737475|12020822|FG026|STARTED|Overall Study||1
10854372|NCT02737475|12020796|FG000|COMPLETED|Overall Study||3
10854373|NCT02737475|12020797|FG001|COMPLETED|Overall Study||4
10854374|NCT02737475|12020798|FG002|COMPLETED|Overall Study||4
10854375|NCT02737475|12020799|FG003|COMPLETED|Overall Study||3
10854376|NCT02737475|12020800|FG004|COMPLETED|Overall Study||3
10854377|NCT02737475|12020801|FG005|COMPLETED|Overall Study||4
10854378|NCT02737475|12020802|FG006|COMPLETED|Overall Study||8
10854379|NCT02737475|12020803|FG007|COMPLETED|Overall Study||10
10854380|NCT02737475|12020804|FG008|COMPLETED|Overall Study||7
11106786|NCT01260350|12291188|FG014|NOT COMPLETED|Overall Study||0
11106787|NCT01260350|12291189|FG015|NOT COMPLETED|Overall Study||0
11106788|NCT01260350|12291190|FG016|NOT COMPLETED|Overall Study||0
11106789|NCT01260350|12291191|FG017|NOT COMPLETED|Overall Study||1
11106790|NCT01260350|12291192|FG018|NOT COMPLETED|Overall Study||0
11106791|NCT01260350|12291193|FG019|NOT COMPLETED|Overall Study||0
11106792|NCT01260350|12291194|FG020|NOT COMPLETED|Overall Study||3
11106793|NCT01260350|12291195|FG021|NOT COMPLETED|Overall Study||0
11106794|NCT01260454|12291249|FG000|STARTED|Overall Study||6
11106795|NCT01260454|12291249|FG000|COMPLETED|Overall Study||6
11106796|NCT01260454|12291249|FG000|NOT COMPLETED|Overall Study||0
11106797|NCT01260467|12291253|FG000|STARTED|Overall Study||4
11106798|NCT01260467|12291253|FG000|COMPLETED|Overall Study||2
11106799|NCT01260467|12291253|FG000|NOT COMPLETED|Overall Study||2
11106800|NCT01260493|12291261|FG000|STARTED|Overall Study||92
11106801|NCT01260493|12291262|FG001|STARTED|Overall Study||89
11106802|NCT01260493|12291261|FG000|COMPLETED|Overall Study||76
11106803|NCT01260493|12291262|FG001|COMPLETED|Overall Study||85
11106804|NCT01260493|12291261|FG000|NOT COMPLETED|Overall Study||16
11106805|NCT01260493|12291262|FG001|NOT COMPLETED|Overall Study||4
11106806|NCT01260584|12291272|FG000|STARTED|Period 1||27
11106807|NCT01260584|12291273|FG001|STARTED|Period 1||28
11106808|NCT01260584|12291274|FG002|STARTED|Period 1||27
11106809|NCT01260584|12291275|FG003|STARTED|Period 1||28
11106810|NCT01260584|12291272|FG000|COMPLETED|Period 1||27
11106811|NCT01260584|12291273|FG001|COMPLETED|Period 1||28
11106812|NCT01260584|12291274|FG002|COMPLETED|Period 1||25
10854381|NCT02737475|12020805|FG009|COMPLETED|Overall Study||8
11106813|NCT01260584|12291275|FG003|COMPLETED|Period 1||27
11106814|NCT01260584|12291272|FG000|NOT COMPLETED|Period 1||0
11106815|NCT01260584|12291273|FG001|NOT COMPLETED|Period 1||0
11106816|NCT01260584|12291274|FG002|NOT COMPLETED|Period 1||2
11106817|NCT01260584|12291275|FG003|NOT COMPLETED|Period 1||1
11106818|NCT01260584|12291272|FG000|STARTED|Period 2||27
11106819|NCT01260584|12291273|FG001|STARTED|Period 2||28
11106820|NCT01260584|12291274|FG002|STARTED|Period 2||25
11106821|NCT01260584|12291275|FG003|STARTED|Period 2||27
11225829|NCT01994889|12418171|FG002|STARTED|Overall Study||177
10854382|NCT02737475|12020806|FG010|COMPLETED|Overall Study||3
10854383|NCT02737475|12020807|FG011|COMPLETED|Overall Study||6
10854384|NCT02737475|12020808|FG012|COMPLETED|Overall Study||5
10854385|NCT02737475|12020809|FG013|COMPLETED|Overall Study||6
10854386|NCT02737475|12020810|FG014|COMPLETED|Overall Study||5
10854387|NCT02737475|12020811|FG015|COMPLETED|Overall Study||15
10854388|NCT02737475|12020812|FG016|COMPLETED|Overall Study||10
10854389|NCT02737475|12020813|FG017|COMPLETED|Overall Study||2
10854390|NCT02737475|12020814|FG018|COMPLETED|Overall Study||5
10854391|NCT02737475|12020815|FG019|COMPLETED|Overall Study||1
10854392|NCT02737475|12020816|FG020|COMPLETED|Overall Study||4
10854393|NCT02737475|12020817|FG021|COMPLETED|Overall Study||8
10854394|NCT02737475|12020818|FG022|COMPLETED|Overall Study||2
10854395|NCT02737475|12020819|FG023|COMPLETED|Overall Study||1
10854396|NCT02737475|12020820|FG024|COMPLETED|Overall Study||1
10854397|NCT02737475|12020821|FG025|COMPLETED|Overall Study||1
10854398|NCT02737475|12020822|FG026|COMPLETED|Overall Study||0
10854399|NCT02737475|12020796|FG000|NOT COMPLETED|Overall Study||1
10854400|NCT02737475|12020797|FG001|NOT COMPLETED|Overall Study||0
10854401|NCT02737475|12020798|FG002|NOT COMPLETED|Overall Study||0
10854402|NCT02737475|12020799|FG003|NOT COMPLETED|Overall Study||1
10854403|NCT02737475|12020800|FG004|NOT COMPLETED|Overall Study||1
10854404|NCT02737475|12020801|FG005|NOT COMPLETED|Overall Study||3
10854405|NCT02737475|12020802|FG006|NOT COMPLETED|Overall Study||0
10854406|NCT02737475|12020803|FG007|NOT COMPLETED|Overall Study||2
10854407|NCT02737475|12020804|FG008|NOT COMPLETED|Overall Study||1
10854408|NCT02737475|12020805|FG009|NOT COMPLETED|Overall Study||0
10854409|NCT02737475|12020806|FG010|NOT COMPLETED|Overall Study||1
10854410|NCT02737475|12020807|FG011|NOT COMPLETED|Overall Study||4
10854411|NCT02737475|12020808|FG012|NOT COMPLETED|Overall Study||2
10854412|NCT02737475|12020809|FG013|NOT COMPLETED|Overall Study||2
10854413|NCT02737475|12020810|FG014|NOT COMPLETED|Overall Study||1
10854414|NCT02737475|12020811|FG015|NOT COMPLETED|Overall Study||3
10854415|NCT02737475|12020812|FG016|NOT COMPLETED|Overall Study||2
10854416|NCT02737475|12020813|FG017|NOT COMPLETED|Overall Study||4
10854417|NCT02737475|12020814|FG018|NOT COMPLETED|Overall Study||2
10854418|NCT02737475|12020815|FG019|NOT COMPLETED|Overall Study||0
10854419|NCT02737475|12020816|FG020|NOT COMPLETED|Overall Study||2
10854420|NCT02737475|12020817|FG021|NOT COMPLETED|Overall Study||1
10854421|NCT02737475|12020818|FG022|NOT COMPLETED|Overall Study||0
10854422|NCT02737475|12020819|FG023|NOT COMPLETED|Overall Study||1
10854423|NCT02737475|12020820|FG024|NOT COMPLETED|Overall Study||1
10854424|NCT02737475|12020821|FG025|NOT COMPLETED|Overall Study||1
10854425|NCT02737475|12020822|FG026|NOT COMPLETED|Overall Study||1
10854426|NCT02703714|12020910|FG000|STARTED|Overall Study||42
10854427|NCT02703714|12020910|FG000|COMPLETED|Overall Study||42
10854428|NCT02703714|12020910|FG000|NOT COMPLETED|Overall Study||0
10854429|NCT02642965|12020914|FG000|STARTED|Overall Study||38
10854430|NCT02642965|12020914|FG000|COMPLETED|Overall Study||25
10854431|NCT02642965|12020914|FG000|NOT COMPLETED|Overall Study||13
10854432|NCT02604433|12020920|FG000|STARTED|Overall Study||224
10854433|NCT02604433|12020921|FG001|STARTED|Overall Study||112
10854434|NCT02604433|12020920|FG000|Participants Treated|Overall Study||223
10854435|NCT02604433|12020921|FG001|Participants Treated|Overall Study||109
10854436|NCT02604433|12020920|FG000|Completed 24 Weeks of Treatment|Overall Study||211
10854437|NCT02604433|12020921|FG001|Completed 24 Weeks of Treatment|Overall Study||102
10854438|NCT02604433|12020920|FG000|Completed 48 Weeks of Treatment|Overall Study||202
10854439|NCT02604433|12020921|FG001|Completed 48 Weeks of Treatment|Overall Study||96
10854440|NCT02604433|12020920|FG000|Completed 96 Weeks of Treatment|Overall Study||155
10854441|NCT02604433|12020921|FG001|Completed 96 Weeks of Treatment|Overall Study||3
10854442|NCT02604433|12020920|FG000|Completed 144 Weeks of Treatment|Overall Study||125
10854443|NCT02604433|12020921|FG001|Completed 144 Weeks of Treatment|Overall Study||0
10854444|NCT02604433|12020920|FG000|Completed 192 Weeks of Treatment|Overall Study||6
10854445|NCT02604433|12020921|FG001|Completed 192 Weeks of Treatment|Overall Study||0
10854446|NCT02604433|12020920|FG000|COMPLETED|Overall Study||6
10854447|NCT02604433|12020921|FG001|COMPLETED|Overall Study||6
11225830|NCT01994889|12418169|FG000|COMPLETED|Overall Study||60
11225831|NCT01994889|12418170|FG001|COMPLETED|Overall Study||113
11225832|NCT01994889|12418171|FG002|COMPLETED|Overall Study||85
11225833|NCT01994889|12418169|FG000|NOT COMPLETED|Overall Study||28
11225834|NCT01994889|12418170|FG001|NOT COMPLETED|Overall Study||63
10854448|NCT02604433|12020920|FG000|NOT COMPLETED|Overall Study||218
10854449|NCT02604433|12020921|FG001|NOT COMPLETED|Overall Study||106
10854450|NCT02519738|12020930|FG000|STARTED|Overall Study||20
10854451|NCT02519738|12020931|FG001|STARTED|Overall Study||17
11106822|NCT01260584|12291272|FG000|COMPLETED|Period 2||26
11106823|NCT01260584|12291273|FG001|COMPLETED|Period 2||25
11106824|NCT01260584|12291274|FG002|COMPLETED|Period 2||20
11106825|NCT01260584|12291275|FG003|COMPLETED|Period 2||26
11106826|NCT01260584|12291272|FG000|NOT COMPLETED|Period 2||1
11106827|NCT01260584|12291273|FG001|NOT COMPLETED|Period 2||3
11106828|NCT01260584|12291274|FG002|NOT COMPLETED|Period 2||5
11106829|NCT01260584|12291275|FG003|NOT COMPLETED|Period 2||1
11106830|NCT01260649|12291287|FG000|STARTED|Overall Study||8
11106831|NCT01260649|12291288|FG001|STARTED|Overall Study||9
11106832|NCT01260649|12291287|FG000|COMPLETED|Overall Study||6
11106833|NCT01260649|12291288|FG001|COMPLETED|Overall Study||8
11106834|NCT01260649|12291287|FG000|NOT COMPLETED|Overall Study||2
11106835|NCT01260649|12291288|FG001|NOT COMPLETED|Overall Study||1
11106836|NCT01260662|12291297|FG000|STARTED|Overall Study||90
11106837|NCT01260662|12291298|FG001|STARTED|Overall Study||85
11106838|NCT01260662|12291299|FG002|STARTED|Overall Study||96
11106839|NCT01260662|12291297|FG000|COMPLETED|Overall Study||90
11106840|NCT01260662|12291298|FG001|COMPLETED|Overall Study||85
10854452|NCT02519738|12020932|FG002|STARTED|Overall Study||15
10854453|NCT02519738|12020930|FG000|COMPLETED|Overall Study||6
10854454|NCT02519738|12020931|FG001|COMPLETED|Overall Study||4
10854455|NCT02519738|12020932|FG002|COMPLETED|Overall Study||3
10854456|NCT02519738|12020930|FG000|NOT COMPLETED|Overall Study||14
10854457|NCT02519738|12020931|FG001|NOT COMPLETED|Overall Study||13
10854458|NCT02519738|12020932|FG002|NOT COMPLETED|Overall Study||12
10854459|NCT02502071|12020940|FG000|STARTED|Overall Study||45
10854460|NCT02502071|12020940|FG000|COMPLETED|Overall Study||45
10854461|NCT02502071|12020940|FG000|NOT COMPLETED|Overall Study||0
10854462|NCT02420821|12020946|FG000|STARTED|Overall Study||461
10854463|NCT02420821|12020947|FG001|STARTED|Overall Study||454
10854464|NCT02420821|12020946|FG000|COMPLETED|Overall Study||293
10854465|NCT02420821|12020947|FG001|COMPLETED|Overall Study||317
10854466|NCT02420821|12020946|FG000|NOT COMPLETED|Overall Study||168
10854467|NCT02420821|12020947|FG001|NOT COMPLETED|Overall Study||137
11106841|NCT01260662|12291299|FG002|COMPLETED|Overall Study||96
11106842|NCT01260662|12291297|FG000|NOT COMPLETED|Overall Study||0
11106843|NCT01260662|12291298|FG001|NOT COMPLETED|Overall Study||0
11106844|NCT01260662|12291299|FG002|NOT COMPLETED|Overall Study||0
11106845|NCT01260688|12291309|FG000|STARTED|Overall Study||11
11106846|NCT01260688|12291310|FG001|STARTED|Overall Study||11
11106847|NCT01260688|12291309|FG000|COMPLETED|Overall Study||11
11106848|NCT01260688|12291310|FG001|COMPLETED|Overall Study||11
10854476|NCT02410343|12020965|FG000|STARTED|Core Period (24 Weeks)||6
10854477|NCT02410343|12020966|FG001|STARTED|Core Period (24 Weeks)||8
10854478|NCT02410343|12020965|FG000|COMPLETED|Core Period (24 Weeks)||1
10854479|NCT02410343|12020966|FG001|COMPLETED|Core Period (24 Weeks)||1
10854480|NCT02410343|12020965|FG000|NOT COMPLETED|Core Period (24 Weeks)||5
10854481|NCT02410343|12020966|FG001|NOT COMPLETED|Core Period (24 Weeks)||7
10854482|NCT02410343|12020965|FG000|STARTED|Extension Period (12 Months)||1
10854483|NCT02410343|12020966|FG001|STARTED|Extension Period (12 Months)||1
10854484|NCT02410343|12020965|FG000|COMPLETED|Extension Period (12 Months)||0
10854485|NCT02410343|12020966|FG001|COMPLETED|Extension Period (12 Months)||0
10854486|NCT02410343|12020965|FG000|NOT COMPLETED|Extension Period (12 Months)||1
10854487|NCT02410343|12020966|FG001|NOT COMPLETED|Extension Period (12 Months)||1
10854488|NCT02343224|12020973|FG000|STARTED|Overall Study||9
10854489|NCT02343224|12020973|FG000|COMPLETED|Overall Study||0
10854490|NCT02343224|12020973|FG000|NOT COMPLETED|Overall Study||9
10854491|NCT02339740|12020979|FG000|STARTED|Overall Study||101
10854492|NCT02339740|12020980|FG001|STARTED|Overall Study||57
10854493|NCT02339740|12020979|FG000|COMPLETED|Overall Study||92
10854494|NCT02339740|12020980|FG001|COMPLETED|Overall Study||53
10854495|NCT02339740|12020979|FG000|NOT COMPLETED|Overall Study||9
10854496|NCT02339740|12020980|FG001|NOT COMPLETED|Overall Study||4
10854497|NCT02291445|12020988|FG000|STARTED|Overall Study||4
10854498|NCT02291445|12020989|FG001|STARTED|Overall Study||4
10854499|NCT02291445|12020988|FG000|COMPLETED|Overall Study||4
10854500|NCT02291445|12020989|FG001|COMPLETED|Overall Study||4
10854501|NCT02291445|12020988|FG000|NOT COMPLETED|Overall Study||0
10854502|NCT02291445|12020989|FG001|NOT COMPLETED|Overall Study||0
10854503|NCT02248688|12020997|FG000|STARTED|Overall Study||5
10854504|NCT02248688|12020997|FG000|COMPLETED|Overall Study||5
10854505|NCT02248688|12020997|FG000|NOT COMPLETED|Overall Study||0
10854506|NCT02045303|12021003|FG000|STARTED|Overall Study||6
10854507|NCT02045303|12021004|FG001|STARTED|Overall Study||3
10854508|NCT02045303|12021005|FG002|STARTED|Overall Study||2
10854509|NCT02045303|12021003|FG000|COMPLETED|Overall Study||4
10854510|NCT02045303|12021004|FG001|COMPLETED|Overall Study||0
10854511|NCT02045303|12021005|FG002|COMPLETED|Overall Study||2
10854512|NCT02045303|12021003|FG000|NOT COMPLETED|Overall Study||2
10854513|NCT02045303|12021004|FG001|NOT COMPLETED|Overall Study||3
10854514|NCT02045303|12021005|FG002|NOT COMPLETED|Overall Study||0
10854515|NCT02025556|12021017|FG000|STARTED|Overall Study||104
10854516|NCT02025556|12021018|FG001|STARTED|Overall Study||96
10854517|NCT02025556|12021019|FG002|STARTED|Overall Study||97
10854518|NCT02025556|12021017|FG000|Safety Analysis Set|Overall Study||104
10854519|NCT02025556|12021018|FG001|Safety Analysis Set|Overall Study||96
10854520|NCT02025556|12021019|FG002|Safety Analysis Set|Overall Study||96
10854521|NCT02025556|12021017|FG000|Intent-to-treat (ITT) Set|Overall Study||104
10854522|NCT02025556|12021018|FG001|Intent-to-treat (ITT) Set|Overall Study||95
10854523|NCT02025556|12021019|FG002|Intent-to-treat (ITT) Set|Overall Study||96
10854524|NCT02025556|12021017|FG000|COMPLETED|Overall Study||98
11106849|NCT01260688|12291309|FG000|NOT COMPLETED|Overall Study||0
10854525|NCT02025556|12021018|FG001|COMPLETED|Overall Study||83
10854526|NCT02025556|12021019|FG002|COMPLETED|Overall Study||88
10854527|NCT02025556|12021017|FG000|NOT COMPLETED|Overall Study||6
10854528|NCT02025556|12021018|FG001|NOT COMPLETED|Overall Study||13
10854529|NCT02025556|12021019|FG002|NOT COMPLETED|Overall Study||9
10854530|NCT01986933|12021032|FG000|STARTED|Placebo-controlled (Part A)||53
10854531|NCT01986933|12021033|FG001|STARTED|Placebo-controlled (Part A)||53
10854532|NCT01986933|12021034|FG002|STARTED|Placebo-controlled (Part A)||54
10854533|NCT01986933|12021035|FG003|STARTED|Placebo-controlled (Part A)||52
10854534|NCT01986933|12021036|FG004|STARTED|Placebo-controlled (Part A)||52
10854535|NCT01986933|12021032|FG000|COMPLETED|Placebo-controlled (Part A)||44
10854536|NCT01986933|12021033|FG001|COMPLETED|Placebo-controlled (Part A)||44
10854537|NCT01986933|12021034|FG002|COMPLETED|Placebo-controlled (Part A)||45
10854538|NCT01986933|12021035|FG003|COMPLETED|Placebo-controlled (Part A)||45
10854539|NCT01986933|12021036|FG004|COMPLETED|Placebo-controlled (Part A)||38
10854540|NCT01986933|12021032|FG000|NOT COMPLETED|Placebo-controlled (Part A)||9
10854541|NCT01986933|12021033|FG001|NOT COMPLETED|Placebo-controlled (Part A)||9
10854542|NCT01986933|12021034|FG002|NOT COMPLETED|Placebo-controlled (Part A)||9
10854543|NCT01986933|12021035|FG003|NOT COMPLETED|Placebo-controlled (Part A)||7
10854544|NCT01986933|12021036|FG004|NOT COMPLETED|Placebo-controlled (Part A)||14
10854545|NCT01986933|12021032|FG000|STARTED|Active-to-active (Part B)||0
10854546|NCT01986933|12021033|FG001|STARTED|Active-to-active (Part B)||41
10854547|NCT01986933|12021034|FG002|STARTED|Active-to-active (Part B)||38
10854548|NCT01986933|12021035|FG003|STARTED|Active-to-active (Part B)||39
10854549|NCT01986933|12021036|FG004|STARTED|Active-to-active (Part B)||35
10854550|NCT01986933|12021032|FG000|COMPLETED|Active-to-active (Part B)||0
10854551|NCT01986933|12021033|FG001|COMPLETED|Active-to-active (Part B)||31
10854552|NCT01986933|12021034|FG002|COMPLETED|Active-to-active (Part B)||28
10854553|NCT01986933|12021035|FG003|COMPLETED|Active-to-active (Part B)||30
10854554|NCT01986933|12021036|FG004|COMPLETED|Active-to-active (Part B)||19
10854555|NCT01986933|12021032|FG000|NOT COMPLETED|Active-to-active (Part B)||0
10854556|NCT01986933|12021033|FG001|NOT COMPLETED|Active-to-active (Part B)||10
10854557|NCT01986933|12021034|FG002|NOT COMPLETED|Active-to-active (Part B)||10
10854558|NCT01986933|12021035|FG003|NOT COMPLETED|Active-to-active (Part B)||9
10854559|NCT01986933|12021036|FG004|NOT COMPLETED|Active-to-active (Part B)||16
10854560|NCT01986933|12021032|FG000|STARTED|Placebo-to-active (Part B)||0
10854561|NCT01986933|12021033|FG001|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13
10854562|NCT01986933|12021034|FG002|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|12
10854563|NCT01986933|12021035|FG003|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13
10854564|NCT01986933|12021036|FG004|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were not re-randomized into Nemoliozumab (2.0 mg/kg) Q8W group in Part B.|0
10854565|NCT01986933|12021032|FG000|COMPLETED|Placebo-to-active (Part B)||0
10854566|NCT01986933|12021033|FG001|COMPLETED|Placebo-to-active (Part B)||8
10854567|NCT01986933|12021034|FG002|COMPLETED|Placebo-to-active (Part B)||7
10854568|NCT01986933|12021035|FG003|COMPLETED|Placebo-to-active (Part B)||8
10854569|NCT01986933|12021036|FG004|COMPLETED|Placebo-to-active (Part B)||0
10854570|NCT01986933|12021032|FG000|NOT COMPLETED|Placebo-to-active (Part B)||0
10854571|NCT01986933|12021033|FG001|NOT COMPLETED|Placebo-to-active (Part B)||5
10854572|NCT01986933|12021034|FG002|NOT COMPLETED|Placebo-to-active (Part B)||5
10854573|NCT01986933|12021035|FG003|NOT COMPLETED|Placebo-to-active (Part B)||5
10854574|NCT01986933|12021036|FG004|NOT COMPLETED|Placebo-to-active (Part B)||0
10854575|NCT01986075|12021058|FG000|STARTED|Initial CBT + CM (Pre-randomization)||0
10854576|NCT01986075|12021059|FG001|STARTED|Initial CBT + CM (Pre-randomization)||0
10854577|NCT01986075|12021060|FG002|STARTED|Initial CBT + CM (Pre-randomization)||145
10854578|NCT01986075|12021058|FG000|COMPLETED|Initial CBT + CM (Pre-randomization)||0
10854579|NCT01986075|12021059|FG001|COMPLETED|Initial CBT + CM (Pre-randomization)||0
10854580|NCT01986075|12021060|FG002|COMPLETED|Initial CBT + CM (Pre-randomization)||86
10854581|NCT01986075|12021058|FG000|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0
10854582|NCT01986075|12021059|FG001|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0
10854583|NCT01986075|12021060|FG002|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||59
10854584|NCT01986075|12021058|FG000|STARTED|Randomized Intervention||45
10854585|NCT01986075|12021059|FG001|STARTED|Randomized Intervention||41
10854586|NCT01986075|12021060|FG002|STARTED|Randomized Intervention||0
10854587|NCT01986075|12021058|FG000|COMPLETED|Randomized Intervention||30
10854588|NCT01986075|12021059|FG001|COMPLETED|Randomized Intervention||27
10854589|NCT01986075|12021060|FG002|COMPLETED|Randomized Intervention||0
10854590|NCT01986075|12021058|FG000|NOT COMPLETED|Randomized Intervention||15
10854591|NCT01986075|12021059|FG001|NOT COMPLETED|Randomized Intervention||14
10854592|NCT01986075|12021060|FG002|NOT COMPLETED|Randomized Intervention||0
10854593|NCT01841333|12021067|FG000|STARTED|Overall Study||31
10854594|NCT01841333|12021067|FG000|COMPLETED|Overall Study||31
10854595|NCT01841333|12021067|FG000|NOT COMPLETED|Overall Study||0
10854596|NCT01802788|12021073|FG000|STARTED|Overall Study||941
10854597|NCT01802788|12021074|FG001|STARTED|Overall Study||59
10854598|NCT01802788|12021073|FG000|COMPLETED|Overall Study||755
10854599|NCT01802788|12021074|FG001|COMPLETED|Overall Study||59
10854600|NCT01802788|12021073|FG000|NOT COMPLETED|Overall Study||186
10854601|NCT01802788|12021074|FG001|NOT COMPLETED|Overall Study||0
10854602|NCT01563107|12021082|FG000|STARTED|Overall Study|12 Healthy Controls were randomized to receive LS diet followed by HS diet|12
10854603|NCT01563107|12021083|FG001|STARTED|Overall Study|5 Healthy Controls were randomized to receive HS diet followed by LS diet|5
10854604|NCT01563107|12021084|FG002|STARTED|Overall Study|10 POTS patients were randomized to receive LS diet followed by HS diet|10
10854605|NCT01563107|12021085|FG003|STARTED|Overall Study|11 POTS patients were randomized to receive HS diet followed by LS diet|11
10854606|NCT01563107|12021082|FG000|Phase 1 Baseline Labs|Overall Study||12
10854607|NCT01563107|12021083|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4
10854608|NCT01563107|12021084|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8
10854609|NCT01563107|12021085|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7
10854610|NCT01563107|12021082|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12
10854611|NCT01563107|12021083|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4
10854612|NCT01563107|12021084|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8
10854613|NCT01563107|12021085|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7
10854614|NCT01563107|12021082|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12
10854615|NCT01563107|12021083|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4
10854616|NCT01563107|12021084|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8
10854617|NCT01563107|12021085|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7
10854618|NCT01563107|12021082|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11
10854619|NCT01563107|12021083|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators.|2
10854620|NCT01563107|12021084|FG002|Phase 1-finish|Overall Study||8
10854621|NCT01563107|12021085|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6
10854622|NCT01563107|12021082|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11
10854623|NCT01563107|12021083|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2
11225835|NCT01994889|12418171|FG002|NOT COMPLETED|Overall Study||92
11225836|NCT01994902|12418178|FG000|STARTED|Test Period 1||63
11225837|NCT01994902|12418179|FG001|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
11225838|NCT01994902|12418178|FG000|COMPLETED|Test Period 1||57
11225839|NCT01994902|12418179|FG001|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
11225840|NCT01994902|12418178|FG000|NOT COMPLETED|Test Period 1||6
11225841|NCT01994902|12418179|FG001|NOT COMPLETED|Test Period 1||3
11225842|NCT01994902|12418178|FG000|STARTED|Test Period 2||57
11225843|NCT01994902|12418179|FG001|STARTED|Test Period 2||61
10854624|NCT01563107|12021084|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8
10854625|NCT01563107|12021085|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6
10854626|NCT01563107|12021082|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11
10854627|NCT01563107|12021083|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2
10854628|NCT01563107|12021084|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8
10854629|NCT01563107|12021085|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6
10854630|NCT01563107|12021082|FG000|Phase 2-finish|Overall Study||11
10854631|NCT01563107|12021083|FG001|Phase 2-finish|Overall Study||2
10854632|NCT01563107|12021084|FG002|Phase 2-finish|Overall Study||8
10854633|NCT01563107|12021085|FG003|Phase 2-finish|Overall Study||6
10854634|NCT01563107|12021082|FG000|COMPLETED|Overall Study||11
10854635|NCT01563107|12021083|FG001|COMPLETED|Overall Study||2
10854636|NCT01563107|12021084|FG002|COMPLETED|Overall Study||8
10854637|NCT01563107|12021085|FG003|COMPLETED|Overall Study||6
10854638|NCT01563107|12021082|FG000|NOT COMPLETED|Overall Study||1
10854639|NCT01563107|12021083|FG001|NOT COMPLETED|Overall Study||3
10854640|NCT01563107|12021084|FG002|NOT COMPLETED|Overall Study||2
10854641|NCT01563107|12021085|FG003|NOT COMPLETED|Overall Study||5
10854642|NCT01320072|12021147|FG000|STARTED|Overall Study||16
10854643|NCT01320072|12021148|FG001|STARTED|Overall Study||13
10854644|NCT01320072|12021147|FG000|COMPLETED|Overall Study||16
10854645|NCT01320072|12021148|FG001|COMPLETED|Overall Study||13
10854646|NCT01320072|12021147|FG000|NOT COMPLETED|Overall Study||0
10854647|NCT01320072|12021148|FG001|NOT COMPLETED|Overall Study||0
11106850|NCT01260688|12291310|FG001|NOT COMPLETED|Overall Study||0
11106851|NCT01260701|12291319|FG000|STARTED|Overall Study||75
11106852|NCT01260701|12291319|FG000|Eligible|Overall Study||71
11106853|NCT01260701|12291319|FG000|Eligible and Began Protocol Therapy|Overall Study||70
11106854|NCT01260701|12291319|FG000|COMPLETED|Overall Study||0
11106855|NCT01260701|12291319|FG000|NOT COMPLETED|Overall Study||75
10854654|NCT01042522|12021166|FG000|STARTED|Overall Study||31
10854655|NCT01042522|12021167|FG001|STARTED|Overall Study||32
10854656|NCT01042522|12021166|FG000|COMPLETED|Overall Study|Completed 6 cycles of protocol regimen|23
10854760|NCT04034355|12021268|FG000|COMPLETED|Overall Study||117
11106856|NCT01260883|12291326|FG000|STARTED|Overall Study||22
11106857|NCT01260883|12291327|FG001|STARTED|Overall Study||11
11106858|NCT01260883|12291328|FG002|STARTED|Overall Study||18
11106859|NCT01260883|12291326|FG000|COMPLETED|Overall Study||22
11106860|NCT01260883|12291327|FG001|COMPLETED|Overall Study||11
11106861|NCT01260883|12291328|FG002|COMPLETED|Overall Study||18
11106862|NCT01260883|12291326|FG000|NOT COMPLETED|Overall Study||0
11106863|NCT01260883|12291327|FG001|NOT COMPLETED|Overall Study||0
11106864|NCT01260883|12291328|FG002|NOT COMPLETED|Overall Study||0
11106865|NCT01260896|12291359|FG000|STARTED|First Intervention||12
10854657|NCT01042522|12021167|FG001|COMPLETED|Overall Study|Completed 4 cycles of protocol regimen|26
10854658|NCT01042522|12021166|FG000|NOT COMPLETED|Overall Study||8
10854659|NCT01042522|12021167|FG001|NOT COMPLETED|Overall Study||6
10854660|NCT00944528|12021176|FG000|STARTED|Overall Study||9
10854661|NCT00944528|12021177|FG001|STARTED|Overall Study||10
10854662|NCT00944528|12021178|FG002|STARTED|Overall Study||16
10854663|NCT00944528|12021176|FG000|COMPLETED|Overall Study||8
10854664|NCT00944528|12021177|FG001|COMPLETED|Overall Study||8
10854665|NCT00944528|12021178|FG002|COMPLETED|Overall Study||16
10854666|NCT00944528|12021176|FG000|NOT COMPLETED|Overall Study||1
10854667|NCT00944528|12021177|FG001|NOT COMPLETED|Overall Study||2
10854668|NCT00944528|12021178|FG002|NOT COMPLETED|Overall Study||0
10854669|NCT00941915|12021187|FG000|STARTED|Overall Study||60
10854670|NCT00941915|12021187|FG000|COMPLETED|Overall Study||60
10854671|NCT00941915|12021187|FG000|NOT COMPLETED|Overall Study||0
10854672|NCT00826462|12021194|FG000|STARTED|Overall Study||59
10854673|NCT00826462|12021195|FG001|STARTED|Overall Study||58
10854674|NCT00826462|12021196|FG002|STARTED|Overall Study||60
10854675|NCT00826462|12021194|FG000|COMPLETED|Overall Study||52
10854676|NCT00826462|12021195|FG001|COMPLETED|Overall Study||53
10854677|NCT00826462|12021196|FG002|COMPLETED|Overall Study||52
10854678|NCT00826462|12021194|FG000|NOT COMPLETED|Overall Study||7
10854679|NCT00826462|12021195|FG001|NOT COMPLETED|Overall Study||5
10854680|NCT00826462|12021196|FG002|NOT COMPLETED|Overall Study||8
10854681|NCT00710970|12021206|FG000|STARTED|Overall Study||28
10854682|NCT00710970|12021206|FG000|COMPLETED|Overall Study||25
10854683|NCT00710970|12021206|FG000|NOT COMPLETED|Overall Study||3
10854684|NCT00685919|12021214|FG000|STARTED|Overall Study|8 healthy controls were randomized to receive placebo followed by carbidopa. 1 received only 50 mg doses of carbidopa and her data were excluded.|8
10854685|NCT00685919|12021215|FG001|STARTED|Overall Study|9 healthy controls were randomized to receive carbidopa followed by placebo.|9
10854686|NCT00685919|12021216|FG002|STARTED|Overall Study|8 patients with POTS were randomized to receive placebo followed by carbidopa. 1 of these received only 50 mg doses of carbidopa and her data are excluded.|8
10854687|NCT00685919|12021217|FG003|STARTED|Overall Study|3 patients with POTS were randomized to receive carbidopa followed by placebo.|3
10854688|NCT00685919|12021214|FG000|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|8
10854689|NCT00685919|12021215|FG001|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|9
10854690|NCT00685919|12021216|FG002|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|8
10854691|NCT00685919|12021217|FG003|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|3
10854692|NCT00685919|12021214|FG000|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
10854693|NCT00685919|12021215|FG001|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9
10854694|NCT00685919|12021216|FG002|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|8
10854695|NCT00685919|12021217|FG003|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3
10854696|NCT00685919|12021214|FG000|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7
10854697|NCT00685919|12021215|FG001|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|9
10854698|NCT00685919|12021216|FG002|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7
10854699|NCT00685919|12021217|FG003|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|3
10854700|NCT00685919|12021214|FG000|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7
10854701|NCT00685919|12021215|FG001|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|9
10854761|NCT04034355|12021269|FG001|COMPLETED|Overall Study||115
10854702|NCT00685919|12021216|FG002|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7
10854703|NCT00685919|12021217|FG003|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|3
10854704|NCT00685919|12021214|FG000|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
10854705|NCT00685919|12021215|FG001|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9
10854706|NCT00685919|12021216|FG002|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
10854707|NCT00685919|12021217|FG003|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3
10854708|NCT00685919|12021214|FG000|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7
10854709|NCT00685919|12021215|FG001|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|9
10854710|NCT00685919|12021216|FG002|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7
10854711|NCT00685919|12021217|FG003|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|3
10854712|NCT00685919|12021214|FG000|COMPLETED|Overall Study||7
10854713|NCT00685919|12021215|FG001|COMPLETED|Overall Study||9
10854714|NCT00685919|12021216|FG002|COMPLETED|Overall Study||7
10854715|NCT00685919|12021217|FG003|COMPLETED|Overall Study||3
10854716|NCT00685919|12021214|FG000|NOT COMPLETED|Overall Study||1
10854717|NCT00685919|12021215|FG001|NOT COMPLETED|Overall Study||0
10854718|NCT00685919|12021216|FG002|NOT COMPLETED|Overall Study||1
10854719|NCT00685919|12021217|FG003|NOT COMPLETED|Overall Study||0
10854720|NCT00344487|12021227|FG000|STARTED|Overall Study||3
10854721|NCT00344487|12021227|FG000|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
10854722|NCT00344487|12021227|FG000|NOT COMPLETED|Overall Study||1
10854723|NCT00281658|12021235|FG000|STARTED|Double-blind, Randomized Phase||222
10854724|NCT00281658|12021236|FG001|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
10854725|NCT00281658|12021237|FG002|STARTED|Double-blind, Randomized Phase||0
10854726|NCT00281658|12021235|FG000|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
10854727|NCT00281658|12021236|FG001|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
10854728|NCT00281658|12021237|FG002|COMPLETED|Double-blind, Randomized Phase||0
10854729|NCT00281658|12021235|FG000|NOT COMPLETED|Double-blind, Randomized Phase||137
10854730|NCT00281658|12021236|FG001|NOT COMPLETED|Double-blind, Randomized Phase||54
10854731|NCT00281658|12021237|FG002|NOT COMPLETED|Double-blind, Randomized Phase||0
10854732|NCT00281658|12021235|FG000|STARTED|Open-label Monotherapy Extension Phase||0
10854733|NCT00281658|12021236|FG001|STARTED|Open-label Monotherapy Extension Phase||0
10854734|NCT00281658|12021237|FG002|STARTED|Open-label Monotherapy Extension Phase||149
10854735|NCT00281658|12021235|FG000|COMPLETED|Open-label Monotherapy Extension Phase||0
10854736|NCT00281658|12021236|FG001|COMPLETED|Open-label Monotherapy Extension Phase||0
10854737|NCT00281658|12021237|FG002|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
10854738|NCT00281658|12021235|FG000|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
10854739|NCT00281658|12021236|FG001|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
10854740|NCT00281658|12021237|FG002|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
11225844|NCT01994902|12418178|FG000|COMPLETED|Test Period 2||57
11225845|NCT01994902|12418179|FG001|COMPLETED|Test Period 2||55
11106866|NCT01260896|12291360|FG001|STARTED|First Intervention||12
11225846|NCT01994902|12418178|FG000|NOT COMPLETED|Test Period 2||0
10854741|NCT04368910|12021246|FG000|STARTED|Overall Study||15
10854742|NCT04368910|12021247|FG001|STARTED|Overall Study||15
10854743|NCT04368910|12021246|FG000|COMPLETED|Overall Study||15
10854744|NCT04368910|12021247|FG001|COMPLETED|Overall Study||15
10854745|NCT04368910|12021246|FG000|NOT COMPLETED|Overall Study||0
10854746|NCT04368910|12021247|FG001|NOT COMPLETED|Overall Study||0
10854747|NCT04365985|12021256|FG000|STARTED|Overall Study||9
10854748|NCT04365985|12021257|FG001|STARTED|Overall Study||9
10854749|NCT04365985|12021258|FG002|STARTED|Overall Study||52
10854750|NCT04365985|12021256|FG000|COMPLETED|Overall Study||9
10854751|NCT04365985|12021257|FG001|COMPLETED|Overall Study||9
10854752|NCT04365985|12021258|FG002|COMPLETED|Overall Study||52
10854753|NCT04365985|12021256|FG000|NOT COMPLETED|Overall Study||0
10854754|NCT04365985|12021257|FG001|NOT COMPLETED|Overall Study||0
10854755|NCT04365985|12021258|FG002|NOT COMPLETED|Overall Study||0
11106867|NCT01260896|12291359|FG000|COMPLETED|First Intervention||10
10854756|NCT04034355|12021268|FG000|STARTED|Overall Study||151
10854757|NCT04034355|12021269|FG001|STARTED|Overall Study||150
10854758|NCT04034355|12021268|FG000|Treated|Overall Study||147
10854759|NCT04034355|12021269|FG001|Treated|Overall Study||150
11225847|NCT01994902|12418179|FG001|NOT COMPLETED|Test Period 2||6
10854762|NCT04034355|12021268|FG000|NOT COMPLETED|Overall Study||34
10854763|NCT04034355|12021269|FG001|NOT COMPLETED|Overall Study||35
10854764|NCT03781726|12021275|FG000|STARTED|Overall Study||30
10854765|NCT03781726|12021275|FG000|COMPLETED|Overall Study||28
10854766|NCT03781726|12021275|FG000|NOT COMPLETED|Overall Study||2
10854767|NCT03721276|12021281|FG000|STARTED|Overall Study||30
10854768|NCT03721276|12021282|FG001|STARTED|Overall Study||30
10854769|NCT03721276|12021281|FG000|Three-month Pre-intervention|Overall Study|Participants in this arm started therapy immediately after randomization, and therefore, did not have a three-month waiting period prior to receiving the intervention.|0
10854770|NCT03721276|12021282|FG001|Three-month Pre-intervention|Overall Study||30
10854771|NCT03721276|12021281|FG000|Immediate Pre-intervention|Overall Study||30
10854772|NCT03721276|12021282|FG001|Immediate Pre-intervention|Overall Study||29
10854773|NCT03721276|12021281|FG000|Post-intervention|Overall Study||25
10854774|NCT03721276|12021282|FG001|Post-intervention|Overall Study||26
10854775|NCT03721276|12021281|FG000|Three-month Follow-up (Post Intervention)|Overall Study||25
10854776|NCT03721276|12021282|FG001|Three-month Follow-up (Post Intervention)|Overall Study|Participants in this arm started therapy three months after randomization (waitlist) and therefore, were not assessed at the three-month follow-up time point due to completion of the study|0
10854777|NCT03721276|12021281|FG000|COMPLETED|Overall Study||25
10854778|NCT03721276|12021282|FG001|COMPLETED|Overall Study||26
10854779|NCT03721276|12021281|FG000|NOT COMPLETED|Overall Study||5
10854780|NCT03721276|12021282|FG001|NOT COMPLETED|Overall Study||4
10854781|NCT03700658|12021288|FG000|STARTED|Overall Study||27
10854782|NCT03700658|12021288|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27
10854783|NCT03700658|12021288|FG000|COMPLETED|Overall Study||27
10854784|NCT03700658|12021288|FG000|NOT COMPLETED|Overall Study||0
10854785|NCT03637491|12021305|FG000|STARTED|Overall Study||10
10854786|NCT03637491|12021306|FG001|STARTED|Overall Study||12
10854787|NCT03637491|12021307|FG002|STARTED|Overall Study||7
10854788|NCT03637491|12021308|FG003|STARTED|Overall Study||6
10854789|NCT03637491|12021305|FG000|Received Treatment|Overall Study||10
10854790|NCT03637491|12021306|FG001|Received Treatment|Overall Study||12
10854791|NCT03637491|12021307|FG002|Received Treatment|Overall Study||7
10854792|NCT03637491|12021308|FG003|Received Treatment|Overall Study||6
10854793|NCT03637491|12021305|FG000|COMPLETED|Overall Study||0
10854794|NCT03637491|12021306|FG001|COMPLETED|Overall Study||0
10854795|NCT03637491|12021307|FG002|COMPLETED|Overall Study||0
10854796|NCT03637491|12021308|FG003|COMPLETED|Overall Study||0
10854797|NCT03637491|12021305|FG000|NOT COMPLETED|Overall Study||10
10854798|NCT03637491|12021306|FG001|NOT COMPLETED|Overall Study||12
10854799|NCT03637491|12021307|FG002|NOT COMPLETED|Overall Study||7
10854800|NCT03637491|12021308|FG003|NOT COMPLETED|Overall Study||6
10854801|NCT03610334|12021332|FG000|STARTED|Period 1: 2.5mg (1 Day)||6
10854802|NCT03610334|12021333|FG001|STARTED|Period 1: 2.5mg (1 Day)||2
10854803|NCT03610334|12021334|FG002|STARTED|Period 1: 2.5mg (1 Day)||0
10854804|NCT03610334|12021335|FG003|STARTED|Period 1: 2.5mg (1 Day)||0
10854805|NCT03610334|12021336|FG004|STARTED|Period 1: 2.5mg (1 Day)||0
10854806|NCT03610334|12021337|FG005|STARTED|Period 1: 2.5mg (1 Day)||0
10854807|NCT03610334|12021338|FG006|STARTED|Period 1: 2.5mg (1 Day)||0
10854808|NCT03610334|12021339|FG007|STARTED|Period 1: 2.5mg (1 Day)||0
10854809|NCT03610334|12021340|FG008|STARTED|Period 1: 2.5mg (1 Day)||0
10854810|NCT03610334|12021341|FG009|STARTED|Period 1: 2.5mg (1 Day)||0
10854811|NCT03610334|12021342|FG010|STARTED|Period 1: 2.5mg (1 Day)||0
10854812|NCT03610334|12021343|FG011|STARTED|Period 1: 2.5mg (1 Day)||0
10854813|NCT03610334|12021344|FG012|STARTED|Period 1: 2.5mg (1 Day)||0
10854814|NCT03610334|12021345|FG013|STARTED|Period 1: 2.5mg (1 Day)||0
10854815|NCT03610334|12021346|FG014|STARTED|Period 1: 2.5mg (1 Day)||0
10854816|NCT03610334|12021347|FG015|STARTED|Period 1: 2.5mg (1 Day)||0
10854817|NCT03610334|12021348|FG016|STARTED|Period 1: 2.5mg (1 Day)||0
10854818|NCT03610334|12021349|FG017|STARTED|Period 1: 2.5mg (1 Day)||0
10854819|NCT03610334|12021332|FG000|COMPLETED|Period 1: 2.5mg (1 Day)||6
10854820|NCT03610334|12021333|FG001|COMPLETED|Period 1: 2.5mg (1 Day)||2
10854821|NCT03610334|12021334|FG002|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854822|NCT03610334|12021335|FG003|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854823|NCT03610334|12021336|FG004|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854824|NCT03610334|12021337|FG005|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854825|NCT03610334|12021338|FG006|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854826|NCT03610334|12021339|FG007|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854827|NCT03610334|12021340|FG008|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854828|NCT03610334|12021341|FG009|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854829|NCT03610334|12021342|FG010|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854830|NCT03610334|12021343|FG011|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854831|NCT03610334|12021344|FG012|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854832|NCT03610334|12021345|FG013|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854833|NCT03610334|12021346|FG014|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854834|NCT03610334|12021347|FG015|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854835|NCT03610334|12021348|FG016|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854836|NCT03610334|12021349|FG017|COMPLETED|Period 1: 2.5mg (1 Day)||0
10854837|NCT03610334|12021332|FG000|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854838|NCT03610334|12021333|FG001|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854839|NCT03610334|12021334|FG002|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
11354800|NCT03075410|12551814|FG004|STARTED|Part A-Washout Period 2 (14 Days)||2
11354801|NCT03075410|12551815|FG005|STARTED|Part A-Washout Period 2 (14 Days)||1
10854840|NCT03610334|12021335|FG003|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854841|NCT03610334|12021336|FG004|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854842|NCT03610334|12021337|FG005|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854843|NCT03610334|12021338|FG006|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854844|NCT03610334|12021339|FG007|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854845|NCT03610334|12021340|FG008|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854846|NCT03610334|12021341|FG009|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854847|NCT03610334|12021342|FG010|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854848|NCT03610334|12021343|FG011|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854849|NCT03610334|12021344|FG012|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854850|NCT03610334|12021345|FG013|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854851|NCT03610334|12021346|FG014|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854852|NCT03610334|12021347|FG015|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854853|NCT03610334|12021348|FG016|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854854|NCT03610334|12021349|FG017|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
10854855|NCT03610334|12021332|FG000|STARTED|Period 2: 5.0mg (1 Day)||6
10854856|NCT03610334|12021333|FG001|STARTED|Period 2: 5.0mg (1 Day)||2
10854857|NCT03610334|12021334|FG002|STARTED|Period 2: 5.0mg (1 Day)||6
10854858|NCT03610334|12021335|FG003|STARTED|Period 2: 5.0mg (1 Day)||2
10854859|NCT03610334|12021336|FG004|STARTED|Period 2: 5.0mg (1 Day)||0
10854860|NCT03610334|12021337|FG005|STARTED|Period 2: 5.0mg (1 Day)||0
10854861|NCT03610334|12021338|FG006|STARTED|Period 2: 5.0mg (1 Day)||0
10854862|NCT03610334|12021339|FG007|STARTED|Period 2: 5.0mg (1 Day)||0
10854863|NCT03610334|12021340|FG008|STARTED|Period 2: 5.0mg (1 Day)||0
10854864|NCT03610334|12021341|FG009|STARTED|Period 2: 5.0mg (1 Day)||0
10854865|NCT03610334|12021342|FG010|STARTED|Period 2: 5.0mg (1 Day)||0
10854866|NCT03610334|12021343|FG011|STARTED|Period 2: 5.0mg (1 Day)||0
10854867|NCT03610334|12021344|FG012|STARTED|Period 2: 5.0mg (1 Day)||0
10854868|NCT03610334|12021345|FG013|STARTED|Period 2: 5.0mg (1 Day)||0
10854869|NCT03610334|12021346|FG014|STARTED|Period 2: 5.0mg (1 Day)||0
10854870|NCT03610334|12021347|FG015|STARTED|Period 2: 5.0mg (1 Day)||0
10854871|NCT03610334|12021348|FG016|STARTED|Period 2: 5.0mg (1 Day)||0
10854872|NCT03610334|12021349|FG017|STARTED|Period 2: 5.0mg (1 Day)||0
10854873|NCT03610334|12021332|FG000|COMPLETED|Period 2: 5.0mg (1 Day)||6
10854874|NCT03610334|12021333|FG001|COMPLETED|Period 2: 5.0mg (1 Day)||2
10854875|NCT03610334|12021334|FG002|COMPLETED|Period 2: 5.0mg (1 Day)||6
10854876|NCT03610334|12021335|FG003|COMPLETED|Period 2: 5.0mg (1 Day)||2
10854877|NCT03610334|12021336|FG004|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854878|NCT03610334|12021337|FG005|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854879|NCT03610334|12021338|FG006|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854880|NCT03610334|12021339|FG007|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854881|NCT03610334|12021340|FG008|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854882|NCT03610334|12021341|FG009|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854883|NCT03610334|12021342|FG010|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854884|NCT03610334|12021343|FG011|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854885|NCT03610334|12021344|FG012|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854886|NCT03610334|12021345|FG013|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854887|NCT03610334|12021346|FG014|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854888|NCT03610334|12021347|FG015|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854889|NCT03610334|12021348|FG016|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854890|NCT03610334|12021349|FG017|COMPLETED|Period 2: 5.0mg (1 Day)||0
10854891|NCT03610334|12021332|FG000|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854892|NCT03610334|12021333|FG001|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854893|NCT03610334|12021334|FG002|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854894|NCT03610334|12021335|FG003|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854895|NCT03610334|12021336|FG004|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854896|NCT03610334|12021337|FG005|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854897|NCT03610334|12021338|FG006|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854898|NCT03610334|12021339|FG007|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854899|NCT03610334|12021340|FG008|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854900|NCT03610334|12021341|FG009|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854901|NCT03610334|12021342|FG010|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854902|NCT03610334|12021343|FG011|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854903|NCT03610334|12021344|FG012|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854904|NCT03610334|12021345|FG013|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854905|NCT03610334|12021346|FG014|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854906|NCT03610334|12021347|FG015|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854907|NCT03610334|12021348|FG016|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854908|NCT03610334|12021349|FG017|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
10854909|NCT03610334|12021332|FG000|STARTED|Period 3: 10.0mg (1 Day)||6
10854910|NCT03610334|12021333|FG001|STARTED|Period 3: 10.0mg (1 Day)||2
10854911|NCT03610334|12021334|FG002|STARTED|Period 3: 10.0mg (1 Day)||6
10854912|NCT03610334|12021335|FG003|STARTED|Period 3: 10.0mg (1 Day)||2
10854913|NCT03610334|12021336|FG004|STARTED|Period 3: 10.0mg (1 Day)||6
10854914|NCT03610334|12021337|FG005|STARTED|Period 3: 10.0mg (1 Day)||2
10854915|NCT03610334|12021338|FG006|STARTED|Period 3: 10.0mg (1 Day)||0
10854916|NCT03610334|12021339|FG007|STARTED|Period 3: 10.0mg (1 Day)||0
10854917|NCT03610334|12021340|FG008|STARTED|Period 3: 10.0mg (1 Day)||0
10854918|NCT03610334|12021341|FG009|STARTED|Period 3: 10.0mg (1 Day)||0
10854919|NCT03610334|12021342|FG010|STARTED|Period 3: 10.0mg (1 Day)||0
10854920|NCT03610334|12021343|FG011|STARTED|Period 3: 10.0mg (1 Day)||0
10854921|NCT03610334|12021344|FG012|STARTED|Period 3: 10.0mg (1 Day)||0
10854922|NCT03610334|12021345|FG013|STARTED|Period 3: 10.0mg (1 Day)||0
10854923|NCT03610334|12021346|FG014|STARTED|Period 3: 10.0mg (1 Day)||0
10854924|NCT03610334|12021347|FG015|STARTED|Period 3: 10.0mg (1 Day)||0
10854925|NCT03610334|12021348|FG016|STARTED|Period 3: 10.0mg (1 Day)||0
10854926|NCT03610334|12021349|FG017|STARTED|Period 3: 10.0mg (1 Day)||0
10854927|NCT03610334|12021332|FG000|COMPLETED|Period 3: 10.0mg (1 Day)||6
10854928|NCT03610334|12021333|FG001|COMPLETED|Period 3: 10.0mg (1 Day)||2
10854929|NCT03610334|12021334|FG002|COMPLETED|Period 3: 10.0mg (1 Day)||6
10854930|NCT03610334|12021335|FG003|COMPLETED|Period 3: 10.0mg (1 Day)||2
10854931|NCT03610334|12021336|FG004|COMPLETED|Period 3: 10.0mg (1 Day)||6
10854932|NCT03610334|12021337|FG005|COMPLETED|Period 3: 10.0mg (1 Day)||2
10854933|NCT03610334|12021338|FG006|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854934|NCT03610334|12021339|FG007|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854935|NCT03610334|12021340|FG008|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854936|NCT03610334|12021341|FG009|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854937|NCT03610334|12021342|FG010|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854938|NCT03610334|12021343|FG011|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854939|NCT03610334|12021344|FG012|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854940|NCT03610334|12021345|FG013|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854941|NCT03610334|12021346|FG014|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854942|NCT03610334|12021347|FG015|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854943|NCT03610334|12021348|FG016|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854944|NCT03610334|12021349|FG017|COMPLETED|Period 3: 10.0mg (1 Day)||0
10854945|NCT03610334|12021332|FG000|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854946|NCT03610334|12021333|FG001|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854947|NCT03610334|12021334|FG002|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854948|NCT03610334|12021335|FG003|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854949|NCT03610334|12021336|FG004|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854950|NCT03610334|12021337|FG005|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854951|NCT03610334|12021338|FG006|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854952|NCT03610334|12021339|FG007|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854953|NCT03610334|12021340|FG008|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854954|NCT03610334|12021341|FG009|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854955|NCT03610334|12021342|FG010|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854956|NCT03610334|12021343|FG011|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854957|NCT03610334|12021344|FG012|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854958|NCT03610334|12021345|FG013|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854959|NCT03610334|12021346|FG014|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854960|NCT03610334|12021347|FG015|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854961|NCT03610334|12021348|FG016|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854962|NCT03610334|12021349|FG017|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
10854963|NCT03610334|12021332|FG000|STARTED|Period 4: 20.0mg (1 Day)||6
10854964|NCT03610334|12021333|FG001|STARTED|Period 4: 20.0mg (1 Day)||2
10854965|NCT03610334|12021334|FG002|STARTED|Period 4: 20.0mg (1 Day)||6
10854966|NCT03610334|12021335|FG003|STARTED|Period 4: 20.0mg (1 Day)||2
10854967|NCT03610334|12021336|FG004|STARTED|Period 4: 20.0mg (1 Day)||6
10854968|NCT03610334|12021337|FG005|STARTED|Period 4: 20.0mg (1 Day)||2
10854969|NCT03610334|12021338|FG006|STARTED|Period 4: 20.0mg (1 Day)||6
10854970|NCT03610334|12021339|FG007|STARTED|Period 4: 20.0mg (1 Day)||2
10854971|NCT03610334|12021340|FG008|STARTED|Period 4: 20.0mg (1 Day)||0
10854972|NCT03610334|12021341|FG009|STARTED|Period 4: 20.0mg (1 Day)||0
10854973|NCT03610334|12021342|FG010|STARTED|Period 4: 20.0mg (1 Day)||0
10854974|NCT03610334|12021343|FG011|STARTED|Period 4: 20.0mg (1 Day)||0
10854975|NCT03610334|12021344|FG012|STARTED|Period 4: 20.0mg (1 Day)||0
10854976|NCT03610334|12021345|FG013|STARTED|Period 4: 20.0mg (1 Day)||0
11106868|NCT01260896|12291360|FG001|COMPLETED|First Intervention||12
11106869|NCT01260896|12291359|FG000|NOT COMPLETED|First Intervention||2
11106870|NCT01260896|12291360|FG001|NOT COMPLETED|First Intervention||0
11106871|NCT01260896|12291359|FG000|STARTED|Washout of 7 Days||10
11106872|NCT01260896|12291360|FG001|STARTED|Washout of 7 Days||12
11106873|NCT01260896|12291359|FG000|COMPLETED|Washout of 7 Days||10
11106874|NCT01260896|12291360|FG001|COMPLETED|Washout of 7 Days||12
11106875|NCT01260896|12291359|FG000|NOT COMPLETED|Washout of 7 Days||0
11106876|NCT01260896|12291360|FG001|NOT COMPLETED|Washout of 7 Days||0
11106877|NCT01260896|12291359|FG000|STARTED|Second Intervention||10
11106878|NCT01260896|12291360|FG001|STARTED|Second Intervention||12
11106879|NCT01260896|12291359|FG000|COMPLETED|Second Intervention||10
11106880|NCT01260896|12291360|FG001|COMPLETED|Second Intervention||12
11106881|NCT01260896|12291359|FG000|NOT COMPLETED|Second Intervention||0
11106882|NCT01260896|12291360|FG001|NOT COMPLETED|Second Intervention||0
11106883|NCT01260922|12291368|FG000|STARTED|First Intervention||13
11106884|NCT01260922|12291369|FG001|STARTED|First Intervention||13
11106885|NCT01260922|12291368|FG000|COMPLETED|First Intervention||13
11106886|NCT01260922|12291369|FG001|COMPLETED|First Intervention||12
11106887|NCT01260922|12291368|FG000|NOT COMPLETED|First Intervention||0
11106888|NCT01260922|12291369|FG001|NOT COMPLETED|First Intervention||1
11106889|NCT01260922|12291368|FG000|STARTED|Washout of 28 Days||13
11106890|NCT01260922|12291369|FG001|STARTED|Washout of 28 Days||12
11106891|NCT01260922|12291368|FG000|COMPLETED|Washout of 28 Days||9
11106892|NCT01260922|12291369|FG001|COMPLETED|Washout of 28 Days||10
11106893|NCT01260922|12291368|FG000|NOT COMPLETED|Washout of 28 Days||4
11106894|NCT01260922|12291369|FG001|NOT COMPLETED|Washout of 28 Days||2
10854977|NCT03610334|12021346|FG014|STARTED|Period 4: 20.0mg (1 Day)||0
10854978|NCT03610334|12021347|FG015|STARTED|Period 4: 20.0mg (1 Day)||0
10854979|NCT03610334|12021348|FG016|STARTED|Period 4: 20.0mg (1 Day)||0
10854980|NCT03610334|12021349|FG017|STARTED|Period 4: 20.0mg (1 Day)||0
10854981|NCT03610334|12021332|FG000|COMPLETED|Period 4: 20.0mg (1 Day)||6
10854982|NCT03610334|12021333|FG001|COMPLETED|Period 4: 20.0mg (1 Day)||2
10854983|NCT03610334|12021334|FG002|COMPLETED|Period 4: 20.0mg (1 Day)||6
10854984|NCT03610334|12021335|FG003|COMPLETED|Period 4: 20.0mg (1 Day)||2
10854985|NCT03610334|12021336|FG004|COMPLETED|Period 4: 20.0mg (1 Day)||6
10854986|NCT03610334|12021337|FG005|COMPLETED|Period 4: 20.0mg (1 Day)||2
10854987|NCT03610334|12021338|FG006|COMPLETED|Period 4: 20.0mg (1 Day)||6
10854988|NCT03610334|12021339|FG007|COMPLETED|Period 4: 20.0mg (1 Day)||2
10854989|NCT03610334|12021340|FG008|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854990|NCT03610334|12021341|FG009|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854991|NCT03610334|12021342|FG010|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854992|NCT03610334|12021343|FG011|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854993|NCT03610334|12021344|FG012|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854994|NCT03610334|12021345|FG013|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854995|NCT03610334|12021346|FG014|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854996|NCT03610334|12021347|FG015|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854997|NCT03610334|12021348|FG016|COMPLETED|Period 4: 20.0mg (1 Day)||0
10854998|NCT03610334|12021349|FG017|COMPLETED|Period 4: 20.0mg (1 Day)||0
11106895|NCT01260922|12291368|FG000|STARTED|Second Intervention||9
11106896|NCT01260922|12291369|FG001|STARTED|Second Intervention||10
11106897|NCT01260922|12291368|FG000|COMPLETED|Second Intervention||9
11106898|NCT01260922|12291369|FG001|COMPLETED|Second Intervention||8
10854999|NCT03610334|12021332|FG000|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
11106899|NCT01260922|12291368|FG000|NOT COMPLETED|Second Intervention||0
11106900|NCT01260922|12291369|FG001|NOT COMPLETED|Second Intervention||2
11106901|NCT01260948|12291377|FG000|STARTED|First Intervention||13
11106902|NCT01260948|12291378|FG001|STARTED|First Intervention||13
11106903|NCT01260948|12291377|FG000|COMPLETED|First Intervention||13
11106904|NCT01260948|12291378|FG001|COMPLETED|First Intervention||13
11106905|NCT01260948|12291377|FG000|NOT COMPLETED|First Intervention||0
11106906|NCT01260948|12291378|FG001|NOT COMPLETED|First Intervention||0
11106907|NCT01260948|12291377|FG000|STARTED|Washout of 28 Days||13
11106908|NCT01260948|12291378|FG001|STARTED|Washout of 28 Days||13
11106909|NCT01260948|12291377|FG000|COMPLETED|Washout of 28 Days||12
11106910|NCT01260948|12291378|FG001|COMPLETED|Washout of 28 Days||10
11106911|NCT01260948|12291377|FG000|NOT COMPLETED|Washout of 28 Days||1
11106912|NCT01260948|12291378|FG001|NOT COMPLETED|Washout of 28 Days||3
11106913|NCT01260948|12291377|FG000|STARTED|Second Intervention||12
11106914|NCT01260948|12291378|FG001|STARTED|Second Intervention||10
11225848|NCT01994954|12418187|FG000|STARTED|Overall Study||99
11225849|NCT01994954|12418188|FG001|STARTED|Overall Study||97
11225850|NCT01994954|12418187|FG000|COMPLETED|Overall Study||74
11225851|NCT01994954|12418188|FG001|COMPLETED|Overall Study||67
11225852|NCT01994954|12418187|FG000|NOT COMPLETED|Overall Study||25
11225853|NCT01994954|12418188|FG001|NOT COMPLETED|Overall Study||30
11106915|NCT01260948|12291377|FG000|COMPLETED|Second Intervention||12
11106916|NCT01260948|12291378|FG001|COMPLETED|Second Intervention||9
11106917|NCT01260948|12291377|FG000|NOT COMPLETED|Second Intervention||0
11106918|NCT01260948|12291378|FG001|NOT COMPLETED|Second Intervention||1
11106919|NCT01261000|12291384|FG000|STARTED|Overall Study||8
11106920|NCT01261000|12291384|FG000|COMPLETED|Overall Study||7
11106921|NCT01261000|12291384|FG000|NOT COMPLETED|Overall Study||1
11106922|NCT01261052|12291388|FG000|STARTED|FMPD/APD Intervention (33 Hours)||14
11106923|NCT01261052|12291388|FG000|COMPLETED|FMPD/APD Intervention (33 Hours)||14
11106924|NCT01261052|12291388|FG000|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
11225854|NCT01994993|12418205|FG000|STARTED|Overall Study||63
11225855|NCT01994993|12418206|FG001|STARTED|Overall Study||47
11225856|NCT01994993|12418207|FG002|STARTED|Overall Study||70
11225857|NCT01994993|12418208|FG003|STARTED|Overall Study||55
11225858|NCT01994993|12418209|FG004|STARTED|Overall Study||24
11225859|NCT01994993|12418205|FG000|COMPLETED|Overall Study||28
11225860|NCT01994993|12418206|FG001|COMPLETED|Overall Study||12
11225861|NCT01994993|12418207|FG002|COMPLETED|Overall Study||23
11225862|NCT01994993|12418208|FG003|COMPLETED|Overall Study||9
11225863|NCT01994993|12418209|FG004|COMPLETED|Overall Study||22
11225864|NCT01994993|12418205|FG000|NOT COMPLETED|Overall Study||35
11225865|NCT01994993|12418206|FG001|NOT COMPLETED|Overall Study||35
11225866|NCT01994993|12418207|FG002|NOT COMPLETED|Overall Study||47
11225867|NCT01994993|12418208|FG003|NOT COMPLETED|Overall Study||46
11225868|NCT01994993|12418209|FG004|NOT COMPLETED|Overall Study||2
11225869|NCT01995045|12418223|FG000|STARTED|Overall Study||29
11225870|NCT01995045|12418224|FG001|STARTED|Overall Study||28
11106925|NCT01261052|12291388|FG000|STARTED|APD Only Intervention (33 Hours)||14
11106926|NCT01261052|12291388|FG000|COMPLETED|APD Only Intervention (33 Hours)||14
11106927|NCT01261052|12291388|FG000|NOT COMPLETED|APD Only Intervention (33 Hours)||0
11106928|NCT01261338|12291395|FG000|STARTED|Overall Study|One person in the olestra group started 4 months after the trial began.|14
11106929|NCT01261338|12291396|FG001|STARTED|Overall Study||14
11106930|NCT01261338|12291395|FG000|COMPLETED|Overall Study||11
11106931|NCT01261338|12291396|FG001|COMPLETED|Overall Study||12
11106932|NCT01261338|12291395|FG000|NOT COMPLETED|Overall Study||3
11106933|NCT01261338|12291396|FG001|NOT COMPLETED|Overall Study||2
11106934|NCT01261390|12291406|FG000|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
11106935|NCT01261390|12291407|FG001|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
10855000|NCT03610334|12021333|FG001|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855001|NCT03610334|12021334|FG002|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855002|NCT03610334|12021335|FG003|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855003|NCT03610334|12021336|FG004|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855004|NCT03610334|12021337|FG005|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855005|NCT03610334|12021338|FG006|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855006|NCT03610334|12021339|FG007|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855007|NCT03610334|12021340|FG008|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855008|NCT03610334|12021341|FG009|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855009|NCT03610334|12021342|FG010|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855010|NCT03610334|12021343|FG011|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855011|NCT03610334|12021344|FG012|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855012|NCT03610334|12021345|FG013|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855013|NCT03610334|12021346|FG014|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855014|NCT03610334|12021347|FG015|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855015|NCT03610334|12021348|FG016|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855016|NCT03610334|12021349|FG017|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
10855017|NCT03610334|12021332|FG000|STARTED|Period 5: 40.0mg (1 Day)||6
10855018|NCT03610334|12021333|FG001|STARTED|Period 5: 40.0mg (1 Day)||2
10855019|NCT03610334|12021334|FG002|STARTED|Period 5: 40.0mg (1 Day)||6
10855020|NCT03610334|12021335|FG003|STARTED|Period 5: 40.0mg (1 Day)||2
11225871|NCT01995045|12418223|FG000|COMPLETED|Overall Study||29
11225872|NCT01995045|12418224|FG001|COMPLETED|Overall Study||28
11225873|NCT01995045|12418223|FG000|NOT COMPLETED|Overall Study||0
11225874|NCT01995045|12418224|FG001|NOT COMPLETED|Overall Study||0
10855021|NCT03610334|12021336|FG004|STARTED|Period 5: 40.0mg (1 Day)||6
10855022|NCT03610334|12021337|FG005|STARTED|Period 5: 40.0mg (1 Day)||2
10855023|NCT03610334|12021338|FG006|STARTED|Period 5: 40.0mg (1 Day)||6
10855024|NCT03610334|12021339|FG007|STARTED|Period 5: 40.0mg (1 Day)||2
10855025|NCT03610334|12021340|FG008|STARTED|Period 5: 40.0mg (1 Day)||6
10855026|NCT03610334|12021341|FG009|STARTED|Period 5: 40.0mg (1 Day)||2
10855027|NCT03610334|12021342|FG010|STARTED|Period 5: 40.0mg (1 Day)||0
10855028|NCT03610334|12021343|FG011|STARTED|Period 5: 40.0mg (1 Day)||0
10855029|NCT03610334|12021344|FG012|STARTED|Period 5: 40.0mg (1 Day)||0
10855030|NCT03610334|12021345|FG013|STARTED|Period 5: 40.0mg (1 Day)||0
10855031|NCT03610334|12021346|FG014|STARTED|Period 5: 40.0mg (1 Day)||0
10855032|NCT03610334|12021347|FG015|STARTED|Period 5: 40.0mg (1 Day)||0
10855033|NCT03610334|12021348|FG016|STARTED|Period 5: 40.0mg (1 Day)||0
10855034|NCT03610334|12021349|FG017|STARTED|Period 5: 40.0mg (1 Day)||0
10855035|NCT03610334|12021332|FG000|COMPLETED|Period 5: 40.0mg (1 Day)||6
10855036|NCT03610334|12021333|FG001|COMPLETED|Period 5: 40.0mg (1 Day)||2
10855037|NCT03610334|12021334|FG002|COMPLETED|Period 5: 40.0mg (1 Day)||6
10855038|NCT03610334|12021335|FG003|COMPLETED|Period 5: 40.0mg (1 Day)||2
10855039|NCT03610334|12021336|FG004|COMPLETED|Period 5: 40.0mg (1 Day)||6
10855040|NCT03610334|12021337|FG005|COMPLETED|Period 5: 40.0mg (1 Day)||2
10855041|NCT03610334|12021338|FG006|COMPLETED|Period 5: 40.0mg (1 Day)||6
10855042|NCT03610334|12021339|FG007|COMPLETED|Period 5: 40.0mg (1 Day)||2
10855043|NCT03610334|12021340|FG008|COMPLETED|Period 5: 40.0mg (1 Day)||6
10855044|NCT03610334|12021341|FG009|COMPLETED|Period 5: 40.0mg (1 Day)||2
10855045|NCT03610334|12021342|FG010|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855046|NCT03610334|12021343|FG011|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855047|NCT03610334|12021344|FG012|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855048|NCT03610334|12021345|FG013|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855049|NCT03610334|12021346|FG014|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855050|NCT03610334|12021347|FG015|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855051|NCT03610334|12021348|FG016|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855052|NCT03610334|12021349|FG017|COMPLETED|Period 5: 40.0mg (1 Day)||0
10855053|NCT03610334|12021332|FG000|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855054|NCT03610334|12021333|FG001|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855055|NCT03610334|12021334|FG002|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855056|NCT03610334|12021335|FG003|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855057|NCT03610334|12021336|FG004|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855058|NCT03610334|12021337|FG005|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855059|NCT03610334|12021338|FG006|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855060|NCT03610334|12021339|FG007|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855061|NCT03610334|12021340|FG008|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855062|NCT03610334|12021341|FG009|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855063|NCT03610334|12021342|FG010|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855064|NCT03610334|12021343|FG011|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855065|NCT03610334|12021344|FG012|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855066|NCT03610334|12021345|FG013|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855067|NCT03610334|12021346|FG014|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855068|NCT03610334|12021347|FG015|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855069|NCT03610334|12021348|FG016|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855070|NCT03610334|12021349|FG017|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
10855071|NCT03610334|12021332|FG000|STARTED|Period 6: 60.0mg (1 Day)||6
10855072|NCT03610334|12021333|FG001|STARTED|Period 6: 60.0mg (1 Day)||2
10855073|NCT03610334|12021334|FG002|STARTED|Period 6: 60.0mg (1 Day)||6
10855074|NCT03610334|12021335|FG003|STARTED|Period 6: 60.0mg (1 Day)||2
10855075|NCT03610334|12021336|FG004|STARTED|Period 6: 60.0mg (1 Day)||6
10855076|NCT03610334|12021337|FG005|STARTED|Period 6: 60.0mg (1 Day)||2
10855077|NCT03610334|12021338|FG006|STARTED|Period 6: 60.0mg (1 Day)||6
10855078|NCT03610334|12021339|FG007|STARTED|Period 6: 60.0mg (1 Day)||2
10855079|NCT03610334|12021340|FG008|STARTED|Period 6: 60.0mg (1 Day)||6
10855080|NCT03610334|12021341|FG009|STARTED|Period 6: 60.0mg (1 Day)||2
10855081|NCT03610334|12021342|FG010|STARTED|Period 6: 60.0mg (1 Day)||6
10855082|NCT03610334|12021343|FG011|STARTED|Period 6: 60.0mg (1 Day)||2
10855083|NCT03610334|12021344|FG012|STARTED|Period 6: 60.0mg (1 Day)||0
10855084|NCT03610334|12021345|FG013|STARTED|Period 6: 60.0mg (1 Day)||0
10855085|NCT03610334|12021346|FG014|STARTED|Period 6: 60.0mg (1 Day)||0
10855086|NCT03610334|12021347|FG015|STARTED|Period 6: 60.0mg (1 Day)||0
10855087|NCT03610334|12021348|FG016|STARTED|Period 6: 60.0mg (1 Day)||0
10855088|NCT03610334|12021349|FG017|STARTED|Period 6: 60.0mg (1 Day)||0
10855089|NCT03610334|12021332|FG000|COMPLETED|Period 6: 60.0mg (1 Day)||6
10855090|NCT03610334|12021333|FG001|COMPLETED|Period 6: 60.0mg (1 Day)||2
10855091|NCT03610334|12021334|FG002|COMPLETED|Period 6: 60.0mg (1 Day)||6
10855092|NCT03610334|12021335|FG003|COMPLETED|Period 6: 60.0mg (1 Day)||2
10855093|NCT03610334|12021336|FG004|COMPLETED|Period 6: 60.0mg (1 Day)||6
10855094|NCT03610334|12021337|FG005|COMPLETED|Period 6: 60.0mg (1 Day)||2
10855095|NCT03610334|12021338|FG006|COMPLETED|Period 6: 60.0mg (1 Day)||6
10855096|NCT03610334|12021339|FG007|COMPLETED|Period 6: 60.0mg (1 Day)||2
10855097|NCT03610334|12021340|FG008|COMPLETED|Period 6: 60.0mg (1 Day)||6
10855098|NCT03610334|12021341|FG009|COMPLETED|Period 6: 60.0mg (1 Day)||2
10855099|NCT03610334|12021342|FG010|COMPLETED|Period 6: 60.0mg (1 Day)||6
10855100|NCT03610334|12021343|FG011|COMPLETED|Period 6: 60.0mg (1 Day)||2
11225875|NCT01995071|12418242|FG000|STARTED|Overall Study||8
11225876|NCT01995071|12418243|FG001|STARTED|Overall Study||8
11225877|NCT01995071|12418244|FG002|STARTED|Overall Study||9
11225878|NCT01995071|12418245|FG003|STARTED|Overall Study||8
11225879|NCT01995071|12418246|FG004|STARTED|Overall Study||8
11225880|NCT01995071|12418247|FG005|STARTED|Overall Study||8
11225881|NCT01995071|12418248|FG006|STARTED|Overall Study||8
11225882|NCT01995071|12418249|FG007|STARTED|Overall Study||8
11225883|NCT01995071|12418250|FG008|STARTED|Overall Study||8
11225884|NCT01995071|12418251|FG009|STARTED|Overall Study||8
10855101|NCT03610334|12021344|FG012|COMPLETED|Period 6: 60.0mg (1 Day)||0
10855102|NCT03610334|12021345|FG013|COMPLETED|Period 6: 60.0mg (1 Day)||0
10855103|NCT03610334|12021346|FG014|COMPLETED|Period 6: 60.0mg (1 Day)||0
10855104|NCT03610334|12021347|FG015|COMPLETED|Period 6: 60.0mg (1 Day)||0
10855105|NCT03610334|12021348|FG016|COMPLETED|Period 6: 60.0mg (1 Day)||0
10855106|NCT03610334|12021349|FG017|COMPLETED|Period 6: 60.0mg (1 Day)||0
10855107|NCT03610334|12021332|FG000|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855108|NCT03610334|12021333|FG001|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855109|NCT03610334|12021334|FG002|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
11225885|NCT01995071|12418252|FG010|STARTED|Overall Study||8
11225886|NCT01995071|12418253|FG011|STARTED|Overall Study||0
11225887|NCT01995071|12418242|FG000|COMPLETED|Overall Study||7
11225888|NCT01995071|12418243|FG001|COMPLETED|Overall Study||8
11225889|NCT01995071|12418244|FG002|COMPLETED|Overall Study||8
11225890|NCT01995071|12418245|FG003|COMPLETED|Overall Study||8
11225891|NCT01995071|12418246|FG004|COMPLETED|Overall Study||7
11225892|NCT01995071|12418247|FG005|COMPLETED|Overall Study||8
11225893|NCT01995071|12418248|FG006|COMPLETED|Overall Study||7
11225894|NCT01995071|12418249|FG007|COMPLETED|Overall Study||6
11225895|NCT01995071|12418250|FG008|COMPLETED|Overall Study||7
11225896|NCT01995071|12418251|FG009|COMPLETED|Overall Study||8
11225897|NCT01995071|12418252|FG010|COMPLETED|Overall Study||7
11225898|NCT01995071|12418253|FG011|COMPLETED|Overall Study||0
11225899|NCT01995071|12418242|FG000|NOT COMPLETED|Overall Study||1
11225900|NCT01995071|12418243|FG001|NOT COMPLETED|Overall Study||0
11225901|NCT01995071|12418244|FG002|NOT COMPLETED|Overall Study||1
11225902|NCT01995071|12418245|FG003|NOT COMPLETED|Overall Study||0
11225903|NCT01995071|12418246|FG004|NOT COMPLETED|Overall Study||1
11225904|NCT01995071|12418247|FG005|NOT COMPLETED|Overall Study||0
10855110|NCT03610334|12021335|FG003|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855111|NCT03610334|12021336|FG004|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855112|NCT03610334|12021337|FG005|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855113|NCT03610334|12021338|FG006|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855114|NCT03610334|12021339|FG007|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855115|NCT03610334|12021340|FG008|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855116|NCT03610334|12021341|FG009|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855117|NCT03610334|12021342|FG010|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855118|NCT03610334|12021343|FG011|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855119|NCT03610334|12021344|FG012|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855120|NCT03610334|12021345|FG013|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855121|NCT03610334|12021346|FG014|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855122|NCT03610334|12021347|FG015|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855123|NCT03610334|12021348|FG016|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855124|NCT03610334|12021349|FG017|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
10855125|NCT03610334|12021332|FG000|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
10855126|NCT03610334|12021333|FG001|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
10855127|NCT03610334|12021334|FG002|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
10855128|NCT03610334|12021335|FG003|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
10855129|NCT03610334|12021336|FG004|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
10855130|NCT03610334|12021337|FG005|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
10855131|NCT03610334|12021338|FG006|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
10855132|NCT03610334|12021339|FG007|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
10855133|NCT03610334|12021340|FG008|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
10855134|NCT03610334|12021341|FG009|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
10855135|NCT03610334|12021342|FG010|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
10855136|NCT03610334|12021343|FG011|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
10855137|NCT03610334|12021344|FG012|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
10855138|NCT03610334|12021345|FG013|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
10855139|NCT03610334|12021346|FG014|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
10855140|NCT03610334|12021347|FG015|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
10855141|NCT03610334|12021348|FG016|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
11225905|NCT01995071|12418248|FG006|NOT COMPLETED|Overall Study||1
11225906|NCT01995071|12418249|FG007|NOT COMPLETED|Overall Study||2
11225907|NCT01995071|12418250|FG008|NOT COMPLETED|Overall Study||1
11225908|NCT01995071|12418251|FG009|NOT COMPLETED|Overall Study||0
11225909|NCT01995071|12418252|FG010|NOT COMPLETED|Overall Study||1
11225910|NCT01995071|12418253|FG011|NOT COMPLETED|Overall Study||0
11225911|NCT01995123|12418287|FG000|STARTED|Overall Study||63
11225912|NCT01995123|12418288|FG001|STARTED|Overall Study||61
11225913|NCT01995123|12418287|FG000|COMPLETED|Overall Study||45
11225914|NCT01995123|12418288|FG001|COMPLETED|Overall Study||46
11225915|NCT01995123|12418287|FG000|NOT COMPLETED|Overall Study||18
11225916|NCT01995123|12418288|FG001|NOT COMPLETED|Overall Study||15
11225917|NCT01995136|12418294|FG000|STARTED|Overall Study||32
11225918|NCT01995136|12418294|FG000|COMPLETED|Overall Study||31
11225919|NCT01995136|12418294|FG000|NOT COMPLETED|Overall Study||1
11225920|NCT01995201|12418300|FG000|STARTED|From Baseline Until Week 24||74
11225921|NCT01995201|12418301|FG001|STARTED|From Baseline Until Week 24||327
11225922|NCT01995201|12418302|FG002|STARTED|From Baseline Until Week 24||0
11225923|NCT01995201|12418303|FG003|STARTED|From Baseline Until Week 24||0
11225924|NCT01995201|12418304|FG004|STARTED|From Baseline Until Week 24||0
11225925|NCT01995201|12418305|FG005|STARTED|From Baseline Until Week 24||0
11225926|NCT01995201|12418306|FG006|STARTED|From Baseline Until Week 24||0
11225927|NCT01995201|12418300|FG000|COMPLETED|From Baseline Until Week 24||64
11225928|NCT01995201|12418301|FG001|COMPLETED|From Baseline Until Week 24||281
11225929|NCT01995201|12418302|FG002|COMPLETED|From Baseline Until Week 24||0
11225930|NCT01995201|12418303|FG003|COMPLETED|From Baseline Until Week 24||0
11225931|NCT01995201|12418304|FG004|COMPLETED|From Baseline Until Week 24||0
11225932|NCT01995201|12418305|FG005|COMPLETED|From Baseline Until Week 24||0
11225933|NCT01995201|12418306|FG006|COMPLETED|From Baseline Until Week 24||0
11225934|NCT01995201|12418300|FG000|NOT COMPLETED|From Baseline Until Week 24||10
11225935|NCT01995201|12418301|FG001|NOT COMPLETED|From Baseline Until Week 24||46
11225936|NCT01995201|12418302|FG002|NOT COMPLETED|From Baseline Until Week 24||0
10855142|NCT03610334|12021349|FG017|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
10855143|NCT03610334|12021332|FG000|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
10855144|NCT03610334|12021333|FG001|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
10855145|NCT03610334|12021334|FG002|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
10855146|NCT03610334|12021335|FG003|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
10855147|NCT03610334|12021336|FG004|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
10855148|NCT03610334|12021337|FG005|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
10855149|NCT03610334|12021338|FG006|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
10855150|NCT03610334|12021339|FG007|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
10855151|NCT03610334|12021340|FG008|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
10855152|NCT03610334|12021341|FG009|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
10855153|NCT03610334|12021342|FG010|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
10855154|NCT03610334|12021343|FG011|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
10855155|NCT03610334|12021344|FG012|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
10855156|NCT03610334|12021345|FG013|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
10855157|NCT03610334|12021346|FG014|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855158|NCT03610334|12021347|FG015|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855159|NCT03610334|12021348|FG016|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855160|NCT03610334|12021349|FG017|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855161|NCT03610334|12021332|FG000|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855162|NCT03610334|12021333|FG001|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855163|NCT03610334|12021334|FG002|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855164|NCT03610334|12021335|FG003|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855165|NCT03610334|12021336|FG004|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855166|NCT03610334|12021337|FG005|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855167|NCT03610334|12021338|FG006|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855168|NCT03610334|12021339|FG007|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855169|NCT03610334|12021340|FG008|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855170|NCT03610334|12021341|FG009|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855171|NCT03610334|12021342|FG010|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855172|NCT03610334|12021343|FG011|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855173|NCT03610334|12021344|FG012|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855174|NCT03610334|12021345|FG013|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855175|NCT03610334|12021346|FG014|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855176|NCT03610334|12021347|FG015|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855177|NCT03610334|12021348|FG016|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855178|NCT03610334|12021349|FG017|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
10855179|NCT03610334|12021332|FG000|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855180|NCT03610334|12021333|FG001|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855181|NCT03610334|12021334|FG002|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855182|NCT03610334|12021335|FG003|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855183|NCT03610334|12021336|FG004|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855184|NCT03610334|12021337|FG005|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855185|NCT03610334|12021338|FG006|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855186|NCT03610334|12021339|FG007|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855187|NCT03610334|12021340|FG008|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855188|NCT03610334|12021341|FG009|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855189|NCT03610334|12021342|FG010|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855190|NCT03610334|12021343|FG011|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855191|NCT03610334|12021344|FG012|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855192|NCT03610334|12021345|FG013|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855193|NCT03610334|12021346|FG014|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
10855194|NCT03610334|12021347|FG015|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
10855195|NCT03610334|12021348|FG016|STARTED|Period 8: 30.0mg (Day 1 to 14)||0
10855196|NCT03610334|12021349|FG017|STARTED|Period 8: 30.0mg (Day 1 to 14)||0
10855197|NCT03610334|12021332|FG000|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855198|NCT03610334|12021333|FG001|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855199|NCT03610334|12021334|FG002|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855200|NCT03610334|12021335|FG003|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855201|NCT03610334|12021336|FG004|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855202|NCT03610334|12021337|FG005|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855203|NCT03610334|12021338|FG006|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855204|NCT03610334|12021339|FG007|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855205|NCT03610334|12021340|FG008|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855206|NCT03610334|12021341|FG009|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855207|NCT03610334|12021342|FG010|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855208|NCT03610334|12021343|FG011|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855209|NCT03610334|12021344|FG012|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855210|NCT03610334|12021345|FG013|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855211|NCT03610334|12021346|FG014|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
10855212|NCT03610334|12021347|FG015|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
10855213|NCT03610334|12021348|FG016|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855214|NCT03610334|12021349|FG017|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855215|NCT03610334|12021332|FG000|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855216|NCT03610334|12021333|FG001|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855217|NCT03610334|12021334|FG002|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855218|NCT03610334|12021335|FG003|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855219|NCT03610334|12021336|FG004|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855220|NCT03610334|12021337|FG005|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855221|NCT03610334|12021338|FG006|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855222|NCT03610334|12021339|FG007|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855223|NCT03610334|12021340|FG008|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855224|NCT03610334|12021341|FG009|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855225|NCT03610334|12021342|FG010|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855226|NCT03610334|12021343|FG011|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855227|NCT03610334|12021344|FG012|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855228|NCT03610334|12021345|FG013|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855229|NCT03610334|12021346|FG014|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855230|NCT03610334|12021347|FG015|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855231|NCT03610334|12021348|FG016|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855232|NCT03610334|12021349|FG017|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
10855233|NCT03610334|12021332|FG000|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855234|NCT03610334|12021333|FG001|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855235|NCT03610334|12021334|FG002|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855236|NCT03610334|12021335|FG003|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
11106936|NCT01261390|12291408|FG002|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
11106937|NCT01261390|12291409|FG003|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
11106938|NCT01261390|12291406|FG000|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
11106939|NCT01261390|12291407|FG001|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
11106940|NCT01261390|12291408|FG002|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
11106941|NCT01261390|12291409|FG003|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
11106942|NCT01261390|12291406|FG000|12-Month Visit|Overall Study||23
11106943|NCT01261390|12291407|FG001|12-Month Visit|Overall Study||21
11225937|NCT01995201|12418303|FG003|NOT COMPLETED|From Baseline Until Week 24||0
11225938|NCT01995201|12418304|FG004|NOT COMPLETED|From Baseline Until Week 24||0
11225939|NCT01995201|12418305|FG005|NOT COMPLETED|From Baseline Until Week 24||0
11225940|NCT01995201|12418306|FG006|NOT COMPLETED|From Baseline Until Week 24||0
11225941|NCT01995201|12418300|FG000|STARTED|From Week 24 Until Week 48||0
11225942|NCT01995201|12418301|FG001|STARTED|From Week 24 Until Week 48||0
11225943|NCT01995201|12418302|FG002|STARTED|From Week 24 Until Week 48||89
11225944|NCT01995201|12418303|FG003|STARTED|From Week 24 Until Week 48||90
11225945|NCT01995201|12418304|FG004|STARTED|From Week 24 Until Week 48||95
11225946|NCT01995201|12418305|FG005|STARTED|From Week 24 Until Week 48||67
11225947|NCT01995201|12418306|FG006|STARTED|From Week 24 Until Week 48||2
10855237|NCT03610334|12021336|FG004|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855238|NCT03610334|12021337|FG005|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855239|NCT03610334|12021338|FG006|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855240|NCT03610334|12021339|FG007|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855241|NCT03610334|12021340|FG008|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855242|NCT03610334|12021341|FG009|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855243|NCT03610334|12021342|FG010|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855244|NCT03610334|12021343|FG011|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855245|NCT03610334|12021344|FG012|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855246|NCT03610334|12021345|FG013|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855247|NCT03610334|12021346|FG014|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855248|NCT03610334|12021347|FG015|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855249|NCT03610334|12021348|FG016|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
10855250|NCT03610334|12021349|FG017|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
10855251|NCT03610334|12021332|FG000|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855252|NCT03610334|12021333|FG001|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855253|NCT03610334|12021334|FG002|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855254|NCT03610334|12021335|FG003|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855255|NCT03610334|12021336|FG004|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855256|NCT03610334|12021337|FG005|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855257|NCT03610334|12021338|FG006|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855258|NCT03610334|12021339|FG007|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855259|NCT03610334|12021340|FG008|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855260|NCT03610334|12021341|FG009|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855261|NCT03610334|12021342|FG010|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855262|NCT03610334|12021343|FG011|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855263|NCT03610334|12021344|FG012|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855264|NCT03610334|12021345|FG013|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855265|NCT03610334|12021346|FG014|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855266|NCT03610334|12021347|FG015|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855267|NCT03610334|12021348|FG016|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
10855268|NCT03610334|12021349|FG017|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
10855269|NCT03610334|12021332|FG000|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855270|NCT03610334|12021333|FG001|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855271|NCT03610334|12021334|FG002|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855272|NCT03610334|12021335|FG003|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855273|NCT03610334|12021336|FG004|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855274|NCT03610334|12021337|FG005|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855275|NCT03610334|12021338|FG006|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855276|NCT03610334|12021339|FG007|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855277|NCT03610334|12021340|FG008|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855278|NCT03610334|12021341|FG009|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855279|NCT03610334|12021342|FG010|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855280|NCT03610334|12021343|FG011|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855281|NCT03610334|12021344|FG012|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855282|NCT03610334|12021345|FG013|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855283|NCT03610334|12021346|FG014|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855284|NCT03610334|12021347|FG015|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855285|NCT03610334|12021348|FG016|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855286|NCT03610334|12021349|FG017|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
10855287|NCT03334539|12021399|FG000|STARTED|Overall Study||50
10855288|NCT03334539|12021400|FG001|STARTED|Overall Study||50
10855289|NCT03334539|12021401|FG002|STARTED|Overall Study||50
10855290|NCT03334539|12021399|FG000|COMPLETED|Overall Study||46
10855291|NCT03334539|12021400|FG001|COMPLETED|Overall Study||43
10855292|NCT03334539|12021401|FG002|COMPLETED|Overall Study||49
10855293|NCT03334539|12021399|FG000|NOT COMPLETED|Overall Study||4
10855294|NCT03334539|12021400|FG001|NOT COMPLETED|Overall Study||7
10855295|NCT03334539|12021401|FG002|NOT COMPLETED|Overall Study||1
10855296|NCT03311854|12021414|FG000|STARTED|Overall Study||14
10855297|NCT03311854|12021414|FG000|COMPLETED|Overall Study||14
10855298|NCT03311854|12021414|FG000|NOT COMPLETED|Overall Study||0
10855299|NCT03269344|12021423|FG000|STARTED|Overall Study||33
10855300|NCT03269344|12021424|FG001|STARTED|Overall Study||32
10855301|NCT03269344|12021423|FG000|COMPLETED|Overall Study||29
10855302|NCT03269344|12021424|FG001|COMPLETED|Overall Study||29
10855303|NCT03269344|12021423|FG000|NOT COMPLETED|Overall Study||4
11106944|NCT01261390|12291408|FG002|12-Month Visit|Overall Study||19
11106945|NCT01261390|12291409|FG003|12-Month Visit|Overall Study||19
11225948|NCT01995201|12418300|FG000|COMPLETED|From Week 24 Until Week 48||0
11225949|NCT01995201|12418301|FG001|COMPLETED|From Week 24 Until Week 48||0
11225950|NCT01995201|12418302|FG002|COMPLETED|From Week 24 Until Week 48||84
11225951|NCT01995201|12418303|FG003|COMPLETED|From Week 24 Until Week 48||89
11225952|NCT01995201|12418304|FG004|COMPLETED|From Week 24 Until Week 48||89
11225953|NCT01995201|12418305|FG005|COMPLETED|From Week 24 Until Week 48||59
11225954|NCT01995201|12418306|FG006|COMPLETED|From Week 24 Until Week 48||0
11106946|NCT01261390|12291406|FG000|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
11106947|NCT01261390|12291407|FG001|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
11106948|NCT01261390|12291408|FG002|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
11106949|NCT01261390|12291409|FG003|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
11106950|NCT01261390|12291406|FG000|NOT COMPLETED|Overall Study||7
11106951|NCT01261390|12291407|FG001|NOT COMPLETED|Overall Study||9
10855304|NCT03269344|12021424|FG001|NOT COMPLETED|Overall Study||3
10855305|NCT03079284|12021430|FG000|STARTED|Overall Study||10
10855306|NCT03079284|12021430|FG000|COMPLETED|Overall Study||10
10855307|NCT03079284|12021430|FG000|NOT COMPLETED|Overall Study||0
10855308|NCT03076775|12021438|FG000|STARTED|Overall Study||44
10855309|NCT03076775|12021439|FG001|STARTED|Overall Study||42
10855310|NCT03076775|12021438|FG000|Neonates Born During Study|Overall Study||43
10855311|NCT03076775|12021439|FG001|Neonates Born During Study|Overall Study||42
10855312|NCT03076775|12021438|FG000|Umbilical Cord Blood Collected|Overall Study||33
10855313|NCT03076775|12021439|FG001|Umbilical Cord Blood Collected|Overall Study||38
10855314|NCT03076775|12021438|FG000|COMPLETED|Overall Study||43
10855315|NCT03076775|12021439|FG001|COMPLETED|Overall Study||42
10855316|NCT03076775|12021438|FG000|NOT COMPLETED|Overall Study||1
10855317|NCT03076775|12021439|FG001|NOT COMPLETED|Overall Study||0
11225955|NCT01995201|12418300|FG000|NOT COMPLETED|From Week 24 Until Week 48||0
11225956|NCT01995201|12418301|FG001|NOT COMPLETED|From Week 24 Until Week 48||0
11225957|NCT01995201|12418302|FG002|NOT COMPLETED|From Week 24 Until Week 48||5
11225958|NCT01995201|12418303|FG003|NOT COMPLETED|From Week 24 Until Week 48||1
11225959|NCT01995201|12418304|FG004|NOT COMPLETED|From Week 24 Until Week 48||6
11225960|NCT01995201|12418305|FG005|NOT COMPLETED|From Week 24 Until Week 48||8
11225961|NCT01995201|12418306|FG006|NOT COMPLETED|From Week 24 Until Week 48||2
11225962|NCT01995266|12418327|FG000|STARTED|Overall Study||159
11225963|NCT01995266|12418327|FG000|COMPLETED|Overall Study||150
11225964|NCT01995266|12418327|FG000|NOT COMPLETED|Overall Study||9
11225965|NCT01995357|12418331|FG000|STARTED|Period 1||4
11225966|NCT01995357|12418332|FG001|STARTED|Period 1||3
11225967|NCT01995357|12418333|FG002|STARTED|Period 1||4
11225968|NCT01995357|12418334|FG003|STARTED|Period 1||3
11225969|NCT01995357|12418335|FG004|STARTED|Period 1||4
11225970|NCT01995357|12418336|FG005|STARTED|Period 1||4
11225971|NCT01995357|12418331|FG000|COMPLETED|Period 1||4
11225972|NCT01995357|12418332|FG001|COMPLETED|Period 1||3
11225973|NCT01995357|12418333|FG002|COMPLETED|Period 1||4
11225974|NCT01995357|12418334|FG003|COMPLETED|Period 1||3
11225975|NCT01995357|12418335|FG004|COMPLETED|Period 1||4
11225976|NCT01995357|12418336|FG005|COMPLETED|Period 1||4
11225977|NCT01995357|12418331|FG000|NOT COMPLETED|Period 1||0
11225978|NCT01995357|12418332|FG001|NOT COMPLETED|Period 1||0
11225979|NCT01995357|12418333|FG002|NOT COMPLETED|Period 1||0
11225980|NCT01995357|12418334|FG003|NOT COMPLETED|Period 1||0
11106952|NCT01261390|12291408|FG002|NOT COMPLETED|Overall Study||7
11106953|NCT01261390|12291409|FG003|NOT COMPLETED|Overall Study||8
11106954|NCT01261507|12291424|FG000|STARTED|Overall Study||15
11106955|NCT01261507|12291424|FG000|COMPLETED|Overall Study||15
11225981|NCT01995357|12418335|FG004|NOT COMPLETED|Period 1||0
11225982|NCT01995357|12418336|FG005|NOT COMPLETED|Period 1||0
11225983|NCT01995357|12418331|FG000|STARTED|Period 2||4
11225984|NCT01995357|12418332|FG001|STARTED|Period 2||3
11225985|NCT01995357|12418333|FG002|STARTED|Period 2||4
11225986|NCT01995357|12418334|FG003|STARTED|Period 2||3
11225987|NCT01995357|12418335|FG004|STARTED|Period 2||4
11225988|NCT01995357|12418336|FG005|STARTED|Period 2||4
11225989|NCT01995357|12418331|FG000|COMPLETED|Period 2||4
11225990|NCT01995357|12418332|FG001|COMPLETED|Period 2||3
10855318|NCT02933944|12021449|FG000|STARTED|Overall Study||6
10855319|NCT02933944|12021449|FG000|COMPLETED|Overall Study||6
10855320|NCT02933944|12021449|FG000|NOT COMPLETED|Overall Study||0
10855321|NCT02921997|12021458|FG000|STARTED|Overall Study||10
10855322|NCT02921997|12021459|FG001|STARTED|Overall Study||10
10855323|NCT02921997|12021460|FG002|STARTED|Overall Study||10
10855324|NCT02921997|12021458|FG000|COMPLETED|Overall Study||10
10855325|NCT02921997|12021459|FG001|COMPLETED|Overall Study||10
10855326|NCT02921997|12021460|FG002|COMPLETED|Overall Study||10
10855327|NCT02921997|12021458|FG000|NOT COMPLETED|Overall Study||0
10855328|NCT02921997|12021459|FG001|NOT COMPLETED|Overall Study||0
10855329|NCT02921997|12021460|FG002|NOT COMPLETED|Overall Study||0
10855330|NCT02833935|12021472|FG000|STARTED|Overall Study||12
10855331|NCT02833935|12021473|FG001|STARTED|Overall Study||12
10855332|NCT02833935|12021472|FG000|COMPLETED|Overall Study||10
10855333|NCT02833935|12021473|FG001|COMPLETED|Overall Study||12
10855334|NCT02833935|12021472|FG000|NOT COMPLETED|Overall Study||2
10855335|NCT02833935|12021473|FG001|NOT COMPLETED|Overall Study||0
10855336|NCT02660827|12021479|FG000|STARTED|From Study to End of Continued Access||151
10855337|NCT02660827|12021479|FG000|COMPLETED|From Study to End of Continued Access||120
10855338|NCT02660827|12021479|FG000|NOT COMPLETED|From Study to End of Continued Access||31
10855339|NCT02660827|12021479|FG000|STARTED|Period 1: Study Period||151
10855340|NCT02660827|12021479|FG000|COMPLETED|Period 1: Study Period||150
10855341|NCT02660827|12021479|FG000|NOT COMPLETED|Period 1: Study Period||1
10855342|NCT02660827|12021479|FG000|STARTED|Period 2: Continued Access Period||145
10855343|NCT02660827|12021479|FG000|COMPLETED|Period 2: Continued Access Period||120
10855344|NCT02660827|12021479|FG000|NOT COMPLETED|Period 2: Continued Access Period||25
10855345|NCT02627963|12021488|FG000|STARTED|Overall Study||175
10855346|NCT02627963|12021489|FG001|STARTED|Overall Study||175
10855347|NCT02627963|12021488|FG000|COMPLETED|Overall Study||139
10855348|NCT02627963|12021489|FG001|COMPLETED|Overall Study||161
10855349|NCT02627963|12021488|FG000|NOT COMPLETED|Overall Study||36
10855350|NCT02627963|12021489|FG001|NOT COMPLETED|Overall Study||14
10855351|NCT02425644|12021497|FG000|STARTED|Overall Study||567
10855352|NCT02425644|12021498|FG001|STARTED|Overall Study||566
10855353|NCT02425644|12021497|FG000|Treated|Overall Study||565
10855354|NCT02425644|12021498|FG001|Treated|Overall Study||566
10855355|NCT02425644|12021497|FG000|COMPLETED|Overall Study||490
10855356|NCT02425644|12021498|FG001|COMPLETED|Overall Study||495
10855357|NCT02425644|12021497|FG000|NOT COMPLETED|Overall Study||77
10855358|NCT02425644|12021498|FG001|NOT COMPLETED|Overall Study||71
10855359|NCT02395614|12021504|FG000|STARTED|Overall Study||88
10855360|NCT02395614|12021504|FG000|Chlorhexidine Irrigation|Overall Study||88
10855361|NCT02395614|12021504|FG000|Triple Antibiotic Irrigation|Overall Study||88
10855362|NCT02395614|12021504|FG000|COMPLETED|Overall Study||88
10855363|NCT02395614|12021504|FG000|NOT COMPLETED|Overall Study||0
10855364|NCT02270957|12021511|FG000|STARTED|Overall Study||31
10855365|NCT02270957|12021512|FG001|STARTED|Overall Study||35
10855366|NCT02270957|12021511|FG000|COMPLETED|Overall Study||27
10855367|NCT02270957|12021512|FG001|COMPLETED|Overall Study||31
10855368|NCT02270957|12021511|FG000|NOT COMPLETED|Overall Study||4
10855369|NCT02270957|12021512|FG001|NOT COMPLETED|Overall Study||4
10855370|NCT02054104|12021521|FG000|STARTED|Overall Study||10
10855371|NCT02054104|12021522|FG001|STARTED|Overall Study||11
10855372|NCT02054104|12021521|FG000|COMPLETED|Overall Study||2
10855373|NCT02054104|12021522|FG001|COMPLETED|Overall Study||2
10855374|NCT02054104|12021521|FG000|NOT COMPLETED|Overall Study||8
10855375|NCT02054104|12021522|FG001|NOT COMPLETED|Overall Study||9
10855376|NCT01899144|12021528|FG000|STARTED|Treatment Period 1||61
10855377|NCT01899144|12021528|FG000|COMPLETED|Treatment Period 1||61
10855378|NCT01899144|12021528|FG000|NOT COMPLETED|Treatment Period 1||0
10855379|NCT01899144|12021528|FG000|STARTED|Treatment Period 2||61
10855380|NCT01899144|12021528|FG000|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
10855381|NCT01899144|12021528|FG000|NOT COMPLETED|Treatment Period 2||1
10855382|NCT01899144|12021528|FG000|STARTED|Treatment Period 3||60
10855465|NCT00603954|12021613|FG001|COMPLETED|Overall Study||45
10855466|NCT00603954|12021612|FG000|NOT COMPLETED|Overall Study||1
11225991|NCT01995357|12418333|FG002|COMPLETED|Period 2||4
10855383|NCT01899144|12021528|FG000|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
10855384|NCT01899144|12021528|FG000|NOT COMPLETED|Treatment Period 3||2
10855385|NCT01899144|12021528|FG000|STARTED|Treatment Period 4||58
10855386|NCT01899144|12021528|FG000|COMPLETED|Treatment Period 4||58
10855387|NCT01899144|12021528|FG000|NOT COMPLETED|Treatment Period 4||0
10855388|NCT01899144|12021528|FG000|STARTED|Treatment Period 5||58
10855389|NCT01899144|12021528|FG000|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
10855390|NCT01899144|12021528|FG000|NOT COMPLETED|Treatment Period 5||1
10855391|NCT01757665|12021542|FG000|STARTED|Overall Study||694
10855392|NCT01757665|12021543|FG001|STARTED|Overall Study||83
10855393|NCT01757665|12021542|FG000|Implanted With Device|Overall Study||689
10855394|NCT01757665|12021543|FG001|Implanted With Device|Overall Study||82
10855395|NCT01757665|12021542|FG000|COMPLETED|Overall Study||0
10855396|NCT01757665|12021543|FG001|COMPLETED|Overall Study||0
10855397|NCT01757665|12021542|FG000|NOT COMPLETED|Overall Study||694
10855398|NCT01757665|12021543|FG001|NOT COMPLETED|Overall Study||83
10855399|NCT01482195|12021564|FG000|STARTED|Overall Study||6
10855400|NCT01482195|12021564|FG000|One Year Results|Overall Study||6
10855401|NCT01482195|12021564|FG000|COMPLETED|Overall Study||6
10855402|NCT01482195|12021564|FG000|NOT COMPLETED|Overall Study||0
10855403|NCT01468831|12021571|FG000|STARTED|Overall Study||4
10855404|NCT01468831|12021572|FG001|STARTED|Overall Study||5
10855405|NCT01468831|12021571|FG000|Month 12 (Primary Outcome)|Overall Study||4
10855406|NCT01468831|12021572|FG001|Month 12 (Primary Outcome)|Overall Study||4
10855407|NCT01468831|12021571|FG000|COMPLETED|Overall Study||4
10855408|NCT01468831|12021572|FG001|COMPLETED|Overall Study||4
10855409|NCT01468831|12021571|FG000|NOT COMPLETED|Overall Study||0
10855410|NCT01468831|12021572|FG001|NOT COMPLETED|Overall Study||1
10855411|NCT01383109|12021578|FG000|STARTED|Overall Study||6
10855412|NCT01383109|12021578|FG000|COMPLETED|Overall Study||6
10855413|NCT01383109|12021578|FG000|NOT COMPLETED|Overall Study||0
11106956|NCT01261507|12291424|FG000|NOT COMPLETED|Overall Study||0
11225992|NCT01995357|12418334|FG003|COMPLETED|Period 2||3
11225993|NCT01995357|12418335|FG004|COMPLETED|Period 2||4
11225994|NCT01995357|12418336|FG005|COMPLETED|Period 2||4
11225995|NCT01995357|12418331|FG000|NOT COMPLETED|Period 2||0
11225996|NCT01995357|12418332|FG001|NOT COMPLETED|Period 2||0
11225997|NCT01995357|12418333|FG002|NOT COMPLETED|Period 2||0
11225998|NCT01995357|12418334|FG003|NOT COMPLETED|Period 2||0
11225999|NCT01995357|12418335|FG004|NOT COMPLETED|Period 2||0
11226000|NCT01995357|12418336|FG005|NOT COMPLETED|Period 2||0
11226001|NCT01995357|12418331|FG000|STARTED|Period 3||4
11226002|NCT01995357|12418332|FG001|STARTED|Period 3||3
11226003|NCT01995357|12418333|FG002|STARTED|Period 3||4
11226004|NCT01995357|12418334|FG003|STARTED|Period 3||3
11226005|NCT01995357|12418335|FG004|STARTED|Period 3||4
11226006|NCT01995357|12418336|FG005|STARTED|Period 3||4
11226007|NCT01995357|12418331|FG000|COMPLETED|Period 3||4
11226008|NCT01995357|12418332|FG001|COMPLETED|Period 3||3
11226009|NCT01995357|12418333|FG002|COMPLETED|Period 3||4
11226010|NCT01995357|12418334|FG003|COMPLETED|Period 3||3
11226011|NCT01995357|12418335|FG004|COMPLETED|Period 3||4
11226012|NCT01995357|12418336|FG005|COMPLETED|Period 3||4
11226013|NCT01995357|12418331|FG000|NOT COMPLETED|Period 3||0
11226014|NCT01995357|12418332|FG001|NOT COMPLETED|Period 3||0
11226015|NCT01995357|12418333|FG002|NOT COMPLETED|Period 3||0
11226016|NCT01995357|12418334|FG003|NOT COMPLETED|Period 3||0
11226017|NCT01995357|12418335|FG004|NOT COMPLETED|Period 3||0
11226018|NCT01995357|12418336|FG005|NOT COMPLETED|Period 3||0
11226019|NCT01995357|12418331|FG000|STARTED|Period 4||4
11226020|NCT01995357|12418332|FG001|STARTED|Period 4||3
11226021|NCT01995357|12418333|FG002|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
11226022|NCT01995357|12418334|FG003|STARTED|Period 4||3
11226023|NCT01995357|12418335|FG004|STARTED|Period 4||4
11226024|NCT01995357|12418336|FG005|STARTED|Period 4||4
11226025|NCT01995357|12418331|FG000|COMPLETED|Period 4||4
11226026|NCT01995357|12418332|FG001|COMPLETED|Period 4||3
11226027|NCT01995357|12418333|FG002|COMPLETED|Period 4||4
11226028|NCT01995357|12418334|FG003|COMPLETED|Period 4||3
11226029|NCT01995357|12418335|FG004|COMPLETED|Period 4||4
11226030|NCT01995357|12418336|FG005|COMPLETED|Period 4||4
11226031|NCT01995357|12418331|FG000|NOT COMPLETED|Period 4||0
11226032|NCT01995357|12418332|FG001|NOT COMPLETED|Period 4||0
11226033|NCT01995357|12418333|FG002|NOT COMPLETED|Period 4||0
11226034|NCT01995357|12418334|FG003|NOT COMPLETED|Period 4||0
11226035|NCT01995357|12418335|FG004|NOT COMPLETED|Period 4||0
11226036|NCT01995357|12418336|FG005|NOT COMPLETED|Period 4||0
11226037|NCT01995357|12418331|FG000|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
11226038|NCT01995357|12418332|FG001|STARTED|Period 5||3
10855462|NCT00603954|12021612|FG000|STARTED|Overall Study|5 patients in Screening failure between inclusion and transplantation|50
10855463|NCT00603954|12021613|FG001|STARTED|Overall Study|5 patients in Screening failure between inclusion and transplantation|47
10855464|NCT00603954|12021612|FG000|COMPLETED|Overall Study||49
11226039|NCT01995357|12418333|FG002|STARTED|Period 5||4
11226040|NCT01995357|12418334|FG003|STARTED|Period 5||3
11226041|NCT01995357|12418335|FG004|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
11226042|NCT01995357|12418336|FG005|STARTED|Period 5||4
11226043|NCT01995357|12418331|FG000|COMPLETED|Period 5||2
11226044|NCT01995357|12418332|FG001|COMPLETED|Period 5||3
11226045|NCT01995357|12418333|FG002|COMPLETED|Period 5||3
10855467|NCT00603954|12021613|FG001|NOT COMPLETED|Overall Study||2
10855468|NCT05087524|12021620|FG000|STARTED|Overall Study||65
10855469|NCT05087524|12021620|FG000|COMPLETED|Overall Study||65
10855470|NCT05087524|12021620|FG000|NOT COMPLETED|Overall Study||0
10855471|NCT04532294|12021627|FG000|STARTED|Overall Study||4
10855472|NCT04532294|12021628|FG001|STARTED|Overall Study||6
10855473|NCT04532294|12021629|FG002|STARTED|Overall Study||8
10855474|NCT04532294|12021627|FG000|COMPLETED|Overall Study||4
10855475|NCT04532294|12021628|FG001|COMPLETED|Overall Study||6
10855476|NCT04532294|12021629|FG002|COMPLETED|Overall Study||5
10855477|NCT04532294|12021627|FG000|NOT COMPLETED|Overall Study||0
10855478|NCT04532294|12021628|FG001|NOT COMPLETED|Overall Study||0
10855479|NCT04532294|12021629|FG002|NOT COMPLETED|Overall Study||3
10855480|NCT04250077|12021642|FG000|STARTED|Overall Study||15
10855481|NCT04250077|12021643|FG001|STARTED|Overall Study||15
10855482|NCT04250077|12021644|FG002|STARTED|Overall Study||15
10855483|NCT04250077|12021642|FG000|COMPLETED|Overall Study||13
10855484|NCT04250077|12021643|FG001|COMPLETED|Overall Study||11
10855485|NCT04250077|12021644|FG002|COMPLETED|Overall Study||15
10855486|NCT04250077|12021642|FG000|NOT COMPLETED|Overall Study||2
10855487|NCT04250077|12021643|FG001|NOT COMPLETED|Overall Study||4
10855488|NCT04250077|12021644|FG002|NOT COMPLETED|Overall Study||0
10855510|NCT03583931|12021688|FG000|STARTED|Overall Study||5
10855511|NCT03583931|12021689|FG001|STARTED|Overall Study||5
10855512|NCT03583931|12021688|FG000|COMPLETED|Overall Study||5
10855513|NCT03583931|12021689|FG001|COMPLETED|Overall Study||5
10855514|NCT03583931|12021688|FG000|NOT COMPLETED|Overall Study||0
10855515|NCT03583931|12021689|FG001|NOT COMPLETED|Overall Study||0
10855516|NCT03505710|12021698|FG000|STARTED|Overall Study||49
10855517|NCT03505710|12021699|FG001|STARTED|Overall Study||41
10855518|NCT03505710|12021700|FG002|STARTED|Overall Study||91
10855519|NCT03505710|12021698|FG000|COMPLETED|Overall Study||2
10855520|NCT03505710|12021699|FG001|COMPLETED|Overall Study||14
10855521|NCT03505710|12021700|FG002|COMPLETED|Overall Study||15
10855522|NCT03505710|12021698|FG000|NOT COMPLETED|Overall Study||47
10855523|NCT03505710|12021699|FG001|NOT COMPLETED|Overall Study||27
10855524|NCT03505710|12021700|FG002|NOT COMPLETED|Overall Study||76
10855525|NCT03296553|12021710|FG000|STARTED|Overall Study||20
10855526|NCT03296553|12021711|FG001|STARTED|Overall Study||20
10855527|NCT03296553|12021710|FG000|COMPLETED|Overall Study||18
10855528|NCT03296553|12021711|FG001|COMPLETED|Overall Study||19
10855529|NCT03296553|12021710|FG000|NOT COMPLETED|Overall Study||2
10855530|NCT03296553|12021711|FG001|NOT COMPLETED|Overall Study||1
10855531|NCT03049449|12021725|FG000|STARTED|Overall Study||0
10855532|NCT03049449|12021726|FG001|STARTED|Overall Study||3
10855533|NCT03049449|12021727|FG002|STARTED|Overall Study|One participant was enrolled and removed from study with no treatment and was later re-enrolled and treated.|4
10855534|NCT03049449|12021728|FG003|STARTED|Overall Study|One participant was enrolled and removed from study with no treatment and was later re-enrolled and treated.|8
10855535|NCT03049449|12021729|FG004|STARTED|Overall Study||5
10855536|NCT03049449|12021730|FG005|STARTED|Overall Study||0
10855537|NCT03049449|12021731|FG006|STARTED|Overall Study||3
10855538|NCT03049449|12021732|FG007|STARTED|Overall Study||1
10855539|NCT03049449|12021733|FG008|STARTED|Overall Study||1
10855540|NCT03049449|12021734|FG009|STARTED|Overall Study||1
10855541|NCT03049449|12021725|FG000|COMPLETED|Overall Study||0
10855542|NCT03049449|12021726|FG001|COMPLETED|Overall Study||3
10855543|NCT03049449|12021727|FG002|COMPLETED|Overall Study||3
10855544|NCT03049449|12021728|FG003|COMPLETED|Overall Study||7
10855545|NCT03049449|12021729|FG004|COMPLETED|Overall Study||5
10855546|NCT03049449|12021730|FG005|COMPLETED|Overall Study||0
10855547|NCT03049449|12021731|FG006|COMPLETED|Overall Study||3
10855548|NCT03049449|12021732|FG007|COMPLETED|Overall Study||0
10855549|NCT03049449|12021733|FG008|COMPLETED|Overall Study||0
10855550|NCT03049449|12021734|FG009|COMPLETED|Overall Study||0
10855551|NCT03049449|12021725|FG000|NOT COMPLETED|Overall Study||0
10855552|NCT03049449|12021726|FG001|NOT COMPLETED|Overall Study||0
10855553|NCT03049449|12021727|FG002|NOT COMPLETED|Overall Study||1
10855554|NCT03049449|12021728|FG003|NOT COMPLETED|Overall Study||1
10855555|NCT03049449|12021729|FG004|NOT COMPLETED|Overall Study||0
10855556|NCT03049449|12021730|FG005|NOT COMPLETED|Overall Study||0
10855557|NCT03049449|12021731|FG006|NOT COMPLETED|Overall Study||0
10855558|NCT03049449|12021732|FG007|NOT COMPLETED|Overall Study||1
10855559|NCT03049449|12021733|FG008|NOT COMPLETED|Overall Study||1
10855560|NCT03049449|12021734|FG009|NOT COMPLETED|Overall Study||1
10855561|NCT03000569|12021754|FG000|STARTED|Overall Study||15
10855562|NCT03000569|12021755|FG001|STARTED|Overall Study||14
10855489|NCT04068142|12021656|FG000|STARTED|Overall Study||17
10855490|NCT04068142|12021657|FG001|STARTED|Overall Study||20
10855491|NCT04068142|12021656|FG000|COMPLETED|Overall Study||15
10855492|NCT04068142|12021657|FG001|COMPLETED|Overall Study||16
10855493|NCT04068142|12021656|FG000|NOT COMPLETED|Overall Study||2
10855494|NCT04068142|12021657|FG001|NOT COMPLETED|Overall Study||4
10855495|NCT03961009|12021663|FG000|STARTED|Overall Study||47
10855496|NCT03961009|12021663|FG000|COMPLETED|Overall Study||47
10855497|NCT03961009|12021663|FG000|NOT COMPLETED|Overall Study||0
10855498|NCT03875495|12021667|FG000|STARTED|Overall Study||3
10855499|NCT03875495|12021667|FG000|COMPLETED|Overall Study||0
10855500|NCT03875495|12021667|FG000|NOT COMPLETED|Overall Study||3
10855501|NCT03702439|12021671|FG000|STARTED|Overall Study||408
10855502|NCT03702439|12021671|FG000|COMPLETED|Overall Study||408
10855503|NCT03702439|12021671|FG000|NOT COMPLETED|Overall Study||0
10855504|NCT03687190|12021679|FG000|STARTED|Overall Study||12
10855505|NCT03687190|12021680|FG001|STARTED|Overall Study||9
10855506|NCT03687190|12021679|FG000|COMPLETED|Overall Study||12
10855507|NCT03687190|12021680|FG001|COMPLETED|Overall Study||9
10855508|NCT03687190|12021679|FG000|NOT COMPLETED|Overall Study||0
10855509|NCT03687190|12021680|FG001|NOT COMPLETED|Overall Study||0
10855563|NCT03000569|12021754|FG000|COMPLETED|Overall Study||14
10855564|NCT03000569|12021755|FG001|COMPLETED|Overall Study||14
10855565|NCT03000569|12021754|FG000|NOT COMPLETED|Overall Study||1
10855566|NCT03000569|12021755|FG001|NOT COMPLETED|Overall Study||0
10855567|NCT03000530|12021772|FG000|STARTED|Overall Study||13
10855568|NCT03000530|12021773|FG001|STARTED|Overall Study||44
10855569|NCT03000530|12021774|FG002|STARTED|Overall Study||45
10855570|NCT03000530|12021772|FG000|COMPLETED|Overall Study||13
10855571|NCT03000530|12021773|FG001|COMPLETED|Overall Study||39
10855572|NCT03000530|12021774|FG002|COMPLETED|Overall Study||41
10855573|NCT03000530|12021772|FG000|NOT COMPLETED|Overall Study||0
10855574|NCT03000530|12021773|FG001|NOT COMPLETED|Overall Study||5
10855575|NCT03000530|12021774|FG002|NOT COMPLETED|Overall Study||4
10855576|NCT02978781|12021788|FG000|STARTED|Part A||2
10855577|NCT02978781|12021789|FG001|STARTED|Part A||14
10855578|NCT02978781|12021790|FG002|STARTED|Part A||0
10855579|NCT02978781|12021791|FG003|STARTED|Part A||0
10855580|NCT02978781|12021792|FG004|STARTED|Part A||0
10855581|NCT02978781|12021788|FG000|COMPLETED|Part A||1
10855582|NCT02978781|12021789|FG001|COMPLETED|Part A||12
10855583|NCT02978781|12021790|FG002|COMPLETED|Part A||0
10855584|NCT02978781|12021791|FG003|COMPLETED|Part A||0
10855585|NCT02978781|12021792|FG004|COMPLETED|Part A||0
10855586|NCT02978781|12021788|FG000|NOT COMPLETED|Part A||1
10855587|NCT02978781|12021789|FG001|NOT COMPLETED|Part A||2
10855588|NCT02978781|12021790|FG002|NOT COMPLETED|Part A||0
10855589|NCT02978781|12021791|FG003|NOT COMPLETED|Part A||0
10855590|NCT02978781|12021792|FG004|NOT COMPLETED|Part A||0
10855591|NCT02978781|12021788|FG000|STARTED|Part B||0
10855592|NCT02978781|12021789|FG001|STARTED|Part B||0
10855593|NCT02978781|12021790|FG002|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
10855594|NCT02978781|12021791|FG003|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
10855595|NCT02978781|12021792|FG004|STARTED|Part B||0
10855596|NCT02978781|12021788|FG000|COMPLETED|Part B||0
10855597|NCT02978781|12021789|FG001|COMPLETED|Part B||0
10855598|NCT02978781|12021790|FG002|COMPLETED|Part B||4
10855599|NCT02978781|12021791|FG003|COMPLETED|Part B||3
10855600|NCT02978781|12021792|FG004|COMPLETED|Part B||0
10855601|NCT02978781|12021788|FG000|NOT COMPLETED|Part B||0
10855602|NCT02978781|12021789|FG001|NOT COMPLETED|Part B||0
10855603|NCT02978781|12021790|FG002|NOT COMPLETED|Part B||0
10855604|NCT02978781|12021791|FG003|NOT COMPLETED|Part B||1
11226046|NCT01995357|12418334|FG003|COMPLETED|Period 5||3
11226047|NCT01995357|12418335|FG004|COMPLETED|Period 5||4
11226048|NCT01995357|12418336|FG005|COMPLETED|Period 5||4
11226049|NCT01995357|12418331|FG000|NOT COMPLETED|Period 5||2
11226050|NCT01995357|12418332|FG001|NOT COMPLETED|Period 5||0
11226051|NCT01995357|12418333|FG002|NOT COMPLETED|Period 5||1
10855605|NCT02978781|12021792|FG004|NOT COMPLETED|Part B||0
10855606|NCT02978781|12021788|FG000|STARTED|Part C||0
10855607|NCT02978781|12021789|FG001|STARTED|Part C||0
10855608|NCT02978781|12021790|FG002|STARTED|Part C||0
10855609|NCT02978781|12021791|FG003|STARTED|Part C||0
10855610|NCT02978781|12021792|FG004|STARTED|Part C||18
10855611|NCT02978781|12021788|FG000|COMPLETED|Part C||0
10855612|NCT02978781|12021789|FG001|COMPLETED|Part C||0
10855613|NCT02978781|12021790|FG002|COMPLETED|Part C||0
10855614|NCT02978781|12021791|FG003|COMPLETED|Part C||0
10855615|NCT02978781|12021792|FG004|COMPLETED|Part C||14
10855616|NCT02978781|12021788|FG000|NOT COMPLETED|Part C||0
10855617|NCT02978781|12021789|FG001|NOT COMPLETED|Part C||0
10855618|NCT02978781|12021790|FG002|NOT COMPLETED|Part C||0
10855619|NCT02978781|12021791|FG003|NOT COMPLETED|Part C||0
11226052|NCT01995357|12418334|FG003|NOT COMPLETED|Period 5||0
11226053|NCT01995357|12418335|FG004|NOT COMPLETED|Period 5||0
11226054|NCT01995357|12418336|FG005|NOT COMPLETED|Period 5||0
10855620|NCT02978781|12021792|FG004|NOT COMPLETED|Part C||4
10855621|NCT02964507|12021826|FG000|STARTED|Overall Study||33
10855622|NCT02964507|12021827|FG001|STARTED|Overall Study||12
10855623|NCT02964507|12021828|FG002|STARTED|Overall Study||42
10855624|NCT02964507|12021829|FG003|STARTED|Overall Study||7
11226055|NCT01995461|12418352|FG000|STARTED|Overall Study||26
10855625|NCT02964507|12021830|FG004|STARTED|Overall Study||18
10855626|NCT02964507|12021831|FG005|STARTED|Overall Study||11
11226056|NCT01995461|12418352|FG000|COMPLETED|Overall Study||21
11226057|NCT01995461|12418352|FG000|NOT COMPLETED|Overall Study||5
11226058|NCT01995487|12418358|FG000|STARTED|Overall Study||958
11226059|NCT01995487|12418359|FG001|STARTED|Overall Study||961
11226060|NCT01995487|12418358|FG000|COMPLETED|Overall Study||884
11226061|NCT01995487|12418359|FG001|COMPLETED|Overall Study||878
11226062|NCT01995487|12418358|FG000|NOT COMPLETED|Overall Study||74
11226063|NCT01995487|12418359|FG001|NOT COMPLETED|Overall Study||83
11226064|NCT01995513|12418365|FG000|STARTED|Open Label Treatment Period||509
11226065|NCT01995513|12418366|FG001|STARTED|Open Label Treatment Period||0
11226066|NCT01995513|12418367|FG002|STARTED|Open Label Treatment Period||0
11226067|NCT01995513|12418365|FG000|COMPLETED|Open Label Treatment Period||251
11226068|NCT01995513|12418366|FG001|COMPLETED|Open Label Treatment Period||0
11226069|NCT01995513|12418367|FG002|COMPLETED|Open Label Treatment Period||0
11226070|NCT01995513|12418365|FG000|NOT COMPLETED|Open Label Treatment Period||258
11226071|NCT01995513|12418366|FG001|NOT COMPLETED|Open Label Treatment Period||0
11226072|NCT01995513|12418367|FG002|NOT COMPLETED|Open Label Treatment Period||0
11226073|NCT01995513|12418365|FG000|STARTED|Double Blind Treatment Period||0
11226074|NCT01995513|12418366|FG001|STARTED|Double Blind Treatment Period||126
11226075|NCT01995513|12418367|FG002|STARTED|Double Blind Treatment Period||125
11226076|NCT01995513|12418365|FG000|Treated|Double Blind Treatment Period||0
11226077|NCT01995513|12418366|FG001|Treated|Double Blind Treatment Period||125
10855627|NCT02964507|12021832|FG006|STARTED|Overall Study||0
10855628|NCT02964507|12021833|FG007|STARTED|Overall Study||0
10855629|NCT02964507|12021826|FG000|COMPLETED|Overall Study||7
10855630|NCT02964507|12021827|FG001|COMPLETED|Overall Study||1
10855631|NCT02964507|12021828|FG002|COMPLETED|Overall Study||17
10855632|NCT02964507|12021829|FG003|COMPLETED|Overall Study||1
10855633|NCT02964507|12021830|FG004|COMPLETED|Overall Study||2
10855634|NCT02964507|12021831|FG005|COMPLETED|Overall Study||3
10855635|NCT02964507|12021832|FG006|COMPLETED|Overall Study||0
10855636|NCT02964507|12021833|FG007|COMPLETED|Overall Study||0
10855637|NCT02964507|12021826|FG000|NOT COMPLETED|Overall Study||26
10855638|NCT02964507|12021827|FG001|NOT COMPLETED|Overall Study||11
10855639|NCT02964507|12021828|FG002|NOT COMPLETED|Overall Study||25
10855640|NCT02964507|12021829|FG003|NOT COMPLETED|Overall Study||6
10855641|NCT02964507|12021830|FG004|NOT COMPLETED|Overall Study||16
10855642|NCT02964507|12021831|FG005|NOT COMPLETED|Overall Study||8
10855643|NCT02964507|12021832|FG006|NOT COMPLETED|Overall Study||0
10855644|NCT02964507|12021833|FG007|NOT COMPLETED|Overall Study||0
10855645|NCT02942277|12021863|FG000|STARTED|Year 1||5
10855646|NCT02942277|12021864|FG001|STARTED|Year 1||10
10855647|NCT02942277|12021865|FG002|STARTED|Year 1||5
10855648|NCT02942277|12021866|FG003|STARTED|Year 1||10
10855649|NCT02942277|12021867|FG004|STARTED|Year 1||56
10855650|NCT02942277|12021868|FG005|STARTED|Year 1||61
10855651|NCT02942277|12021869|FG006|STARTED|Year 1||5
10855652|NCT02942277|12021870|FG007|STARTED|Year 1||10
10855653|NCT02942277|12021871|FG008|STARTED|Year 1||10
10855654|NCT02942277|12021872|FG009|STARTED|Year 1||10
10855655|NCT02942277|12021873|FG010|STARTED|Year 1||119
10855656|NCT02942277|12021863|FG000|COMPLETED|Year 1||5
10855657|NCT02942277|12021864|FG001|COMPLETED|Year 1||8
10855658|NCT02942277|12021865|FG002|COMPLETED|Year 1||5
10855659|NCT02942277|12021866|FG003|COMPLETED|Year 1||9
10855660|NCT02942277|12021867|FG004|COMPLETED|Year 1||49
10855661|NCT02942277|12021868|FG005|COMPLETED|Year 1||51
10855662|NCT02942277|12021869|FG006|COMPLETED|Year 1||5
10855663|NCT02942277|12021870|FG007|COMPLETED|Year 1||9
10855664|NCT02942277|12021871|FG008|COMPLETED|Year 1||10
10855665|NCT02942277|12021872|FG009|COMPLETED|Year 1||10
10855666|NCT02942277|12021873|FG010|COMPLETED|Year 1||104
10855667|NCT02942277|12021863|FG000|NOT COMPLETED|Year 1||0
10855668|NCT02942277|12021864|FG001|NOT COMPLETED|Year 1||2
10855669|NCT02942277|12021865|FG002|NOT COMPLETED|Year 1||0
10855670|NCT02942277|12021866|FG003|NOT COMPLETED|Year 1||1
10855671|NCT02942277|12021867|FG004|NOT COMPLETED|Year 1||7
10855672|NCT02942277|12021868|FG005|NOT COMPLETED|Year 1||10
10855673|NCT02942277|12021869|FG006|NOT COMPLETED|Year 1||0
10855674|NCT02942277|12021870|FG007|NOT COMPLETED|Year 1||1
10855675|NCT02942277|12021871|FG008|NOT COMPLETED|Year 1||0
10855676|NCT02942277|12021872|FG009|NOT COMPLETED|Year 1||0
10855677|NCT02942277|12021873|FG010|NOT COMPLETED|Year 1||15
10855678|NCT02942277|12021863|FG000|STARTED|Year 2||5
10855679|NCT02942277|12021864|FG001|STARTED|Year 2||8
10855680|NCT02942277|12021865|FG002|STARTED|Year 2||5
10855681|NCT02942277|12021866|FG003|STARTED|Year 2||9
10855682|NCT02942277|12021867|FG004|STARTED|Year 2||49
10855683|NCT02942277|12021868|FG005|STARTED|Year 2||51
10855684|NCT02942277|12021869|FG006|STARTED|Year 2||5
10855685|NCT02942277|12021870|FG007|STARTED|Year 2||9
10855686|NCT02942277|12021871|FG008|STARTED|Year 2||10
10855687|NCT02942277|12021872|FG009|STARTED|Year 2||10
10855688|NCT02942277|12021873|FG010|STARTED|Year 2||104
10855689|NCT02942277|12021863|FG000|COMPLETED|Year 2||5
10855690|NCT02942277|12021864|FG001|COMPLETED|Year 2||7
10855691|NCT02942277|12021865|FG002|COMPLETED|Year 2||4
10855692|NCT02942277|12021866|FG003|COMPLETED|Year 2||8
10855693|NCT02942277|12021867|FG004|COMPLETED|Year 2||36
10855694|NCT02942277|12021868|FG005|COMPLETED|Year 2||40
10855695|NCT02942277|12021869|FG006|COMPLETED|Year 2||4
10855696|NCT02942277|12021870|FG007|COMPLETED|Year 2||8
10855697|NCT02942277|12021871|FG008|COMPLETED|Year 2||10
10855698|NCT02942277|12021872|FG009|COMPLETED|Year 2||9
10855699|NCT02942277|12021873|FG010|COMPLETED|Year 2||79
10855700|NCT02942277|12021863|FG000|NOT COMPLETED|Year 2||0
10855701|NCT02942277|12021864|FG001|NOT COMPLETED|Year 2||1
10855702|NCT02942277|12021865|FG002|NOT COMPLETED|Year 2||1
10855703|NCT02942277|12021866|FG003|NOT COMPLETED|Year 2||1
10855704|NCT02942277|12021867|FG004|NOT COMPLETED|Year 2||13
10855705|NCT02942277|12021868|FG005|NOT COMPLETED|Year 2||11
10855706|NCT02942277|12021869|FG006|NOT COMPLETED|Year 2||1
10855707|NCT02942277|12021870|FG007|NOT COMPLETED|Year 2||1
10855708|NCT02942277|12021871|FG008|NOT COMPLETED|Year 2||0
10855709|NCT02942277|12021872|FG009|NOT COMPLETED|Year 2||1
10855710|NCT02942277|12021873|FG010|NOT COMPLETED|Year 2||25
10855711|NCT02942017|12021902|FG000|STARTED|Overall Study||54
10855712|NCT02942017|12021903|FG001|STARTED|Overall Study||54
10855713|NCT02942017|12021902|FG000|Treated|Overall Study||53
10855714|NCT02942017|12021903|FG001|Treated|Overall Study||51
10855715|NCT02942017|12021902|FG000|COMPLETED|Overall Study||52
10855716|NCT02942017|12021903|FG001|COMPLETED|Overall Study||48
10855717|NCT02942017|12021902|FG000|NOT COMPLETED|Overall Study||2
10855718|NCT02942017|12021903|FG001|NOT COMPLETED|Overall Study||6
10855719|NCT02942004|12021912|FG000|STARTED|Overall Study||46
10855720|NCT02942004|12021913|FG001|STARTED|Overall Study||47
10855721|NCT02942004|12021914|FG002|STARTED|Overall Study||45
10855722|NCT02942004|12021912|FG000|Participants Who Received Study Drug|Overall Study||43
10855723|NCT02942004|12021913|FG001|Participants Who Received Study Drug|Overall Study||38
10855724|NCT02942004|12021914|FG002|Participants Who Received Study Drug|Overall Study||41
10855725|NCT02942004|12021912|FG000|COMPLETED|Overall Study||42
10855726|NCT02942004|12021913|FG001|COMPLETED|Overall Study||35
10855727|NCT02942004|12021914|FG002|COMPLETED|Overall Study||36
10855728|NCT02942004|12021912|FG000|NOT COMPLETED|Overall Study||4
10855729|NCT02942004|12021913|FG001|NOT COMPLETED|Overall Study||12
10855730|NCT02942004|12021914|FG002|NOT COMPLETED|Overall Study||9
10855731|NCT02861014|12021922|FG000|STARTED|Primary Analysis||680
10855732|NCT02861014|12021922|FG000|COMPLETED|Primary Analysis||641
10855733|NCT02861014|12021922|FG000|NOT COMPLETED|Primary Analysis||39
10855734|NCT02861014|12021922|FG000|STARTED|Safety Follow-up||64
10855735|NCT02861014|12021922|FG000|COMPLETED|Safety Follow-up||14
10855736|NCT02861014|12021922|FG000|NOT COMPLETED|Safety Follow-up||50
11106957|NCT01261559|12291433|FG000|STARTED|Overall Study||36
11106958|NCT01261559|12291434|FG001|STARTED|Overall Study||36
11106959|NCT01261559|12291433|FG000|COMPLETED|Overall Study||36
11106960|NCT01261559|12291434|FG001|COMPLETED|Overall Study||36
11106961|NCT01261559|12291433|FG000|NOT COMPLETED|Overall Study||0
11106962|NCT01261559|12291434|FG001|NOT COMPLETED|Overall Study||0
11106963|NCT01261624|12291443|FG000|STARTED|Week 0 to Week 12||10
11106964|NCT01261624|12291444|FG001|STARTED|Week 0 to Week 12||6
11106965|NCT01261624|12291443|FG000|COMPLETED|Week 0 to Week 12||9
11106966|NCT01261624|12291444|FG001|COMPLETED|Week 0 to Week 12||3
11106967|NCT01261624|12291443|FG000|NOT COMPLETED|Week 0 to Week 12||1
11106968|NCT01261624|12291444|FG001|NOT COMPLETED|Week 0 to Week 12||3
11106969|NCT01261624|12291443|FG000|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
11106970|NCT01261624|12291444|FG001|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
11106971|NCT01261624|12291443|FG000|COMPLETED|Week 13 to Week 24||1
11106972|NCT01261624|12291444|FG001|COMPLETED|Week 13 to Week 24||10
11106973|NCT01261624|12291443|FG000|NOT COMPLETED|Week 13 to Week 24||0
11106974|NCT01261624|12291444|FG001|NOT COMPLETED|Week 13 to Week 24||1
11106975|NCT01261780|12291458|FG000|STARTED|Overall Study||7
11106976|NCT01261780|12291459|FG001|STARTED|Overall Study||7
11106977|NCT01261780|12291458|FG000|COMPLETED|Overall Study||5
11106978|NCT01261780|12291459|FG001|COMPLETED|Overall Study||5
11106979|NCT01261780|12291458|FG000|NOT COMPLETED|Overall Study||2
11106980|NCT01261780|12291459|FG001|NOT COMPLETED|Overall Study||2
11106981|NCT01261793|12291468|FG000|STARTED|Overall Study||263
11106982|NCT01261793|12291469|FG001|STARTED|Overall Study||262
11106983|NCT01261793|12291470|FG002|STARTED|Overall Study||266
11106984|NCT01261793|12291468|FG000|COMPLETED|Overall Study||178
11106985|NCT01261793|12291469|FG001|COMPLETED|Overall Study||171
11106986|NCT01261793|12291470|FG002|COMPLETED|Overall Study||184
11106987|NCT01261793|12291468|FG000|NOT COMPLETED|Overall Study||85
11106988|NCT01261793|12291469|FG001|NOT COMPLETED|Overall Study||91
11106989|NCT01261793|12291470|FG002|NOT COMPLETED|Overall Study||82
11106990|NCT01261819|12291480|FG000|STARTED|Overall Study||33
11106991|NCT01261819|12291481|FG001|STARTED|Overall Study||33
11226078|NCT01995513|12418367|FG002|Treated|Double Blind Treatment Period||124
11106992|NCT01261819|12291480|FG000|COMPLETED|Overall Study||33
11106993|NCT01261819|12291481|FG001|COMPLETED|Overall Study||33
11106994|NCT01261819|12291480|FG000|NOT COMPLETED|Overall Study||0
10855747|NCT02767531|12021937|FG000|STARTED|Period 1|Orlistat therapy|1
10855748|NCT02767531|12021938|FG001|STARTED|Period 1|Off Orlistat|1
10855749|NCT02767531|12021937|FG000|COMPLETED|Period 1||1
10855750|NCT02767531|12021938|FG001|COMPLETED|Period 1||1
10855751|NCT02767531|12021937|FG000|NOT COMPLETED|Period 1||0
10855752|NCT02767531|12021938|FG001|NOT COMPLETED|Period 1||0
10855753|NCT02767531|12021937|FG000|STARTED|Period 2|Off Orlistat|1
10855754|NCT02767531|12021938|FG001|STARTED|Period 2|Orlistat Therapy|1
10855755|NCT02767531|12021937|FG000|COMPLETED|Period 2||1
10855756|NCT02767531|12021938|FG001|COMPLETED|Period 2||1
10855757|NCT02767531|12021937|FG000|NOT COMPLETED|Period 2||0
10855758|NCT02767531|12021938|FG001|NOT COMPLETED|Period 2||0
11106995|NCT01261819|12291481|FG001|NOT COMPLETED|Overall Study||0
11106996|NCT01261975|12291487|FG000|STARTED|Overall Study|36 Participants 72 eyes started|36
11106997|NCT01261975|12291487|FG000|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
10855759|NCT02767531|12021937|FG000|STARTED|Period 3|Orlistat Therapy|1
10855760|NCT02767531|12021938|FG001|STARTED|Period 3|Off Orlistat|1
10855761|NCT02767531|12021937|FG000|COMPLETED|Period 3||1
10855762|NCT02767531|12021938|FG001|COMPLETED|Period 3||1
10855763|NCT02767531|12021937|FG000|NOT COMPLETED|Period 3||0
10855764|NCT02767531|12021938|FG001|NOT COMPLETED|Period 3||0
10855765|NCT02767531|12021937|FG000|STARTED|Period 4|Off Orlistat|1
10855766|NCT02767531|12021938|FG001|STARTED|Period 4|Orlistat Therapy|1
10855767|NCT02767531|12021937|FG000|COMPLETED|Period 4||1
10855768|NCT02767531|12021938|FG001|COMPLETED|Period 4||1
10855769|NCT02767531|12021937|FG000|NOT COMPLETED|Period 4||0
10855770|NCT02767531|12021938|FG001|NOT COMPLETED|Period 4||0
10855771|NCT02726880|12021946|FG000|STARTED|Overall Study||17
10855772|NCT02726880|12021947|FG001|STARTED|Overall Study||19
10855773|NCT02726880|12021946|FG000|COMPLETED|Overall Study||14
10855774|NCT02726880|12021947|FG001|COMPLETED|Overall Study||16
10855775|NCT02726880|12021946|FG000|NOT COMPLETED|Overall Study||3
10855776|NCT02726880|12021947|FG001|NOT COMPLETED|Overall Study||3
11226079|NCT01995513|12418365|FG000|COMPLETED|Double Blind Treatment Period||0
11226080|NCT01995513|12418366|FG001|COMPLETED|Double Blind Treatment Period||0
11226081|NCT01995513|12418367|FG002|COMPLETED|Double Blind Treatment Period||0
11226082|NCT01995513|12418365|FG000|NOT COMPLETED|Double Blind Treatment Period||0
11226083|NCT01995513|12418366|FG001|NOT COMPLETED|Double Blind Treatment Period||126
11226084|NCT01995513|12418367|FG002|NOT COMPLETED|Double Blind Treatment Period||125
11226085|NCT01995526|12418377|FG000|STARTED|Overall Study||11
11226086|NCT01995526|12418377|FG000|Received One Dose of Study Drug|Overall Study||11
11226087|NCT01995526|12418377|FG000|COMPLETED|Overall Study||10
11226088|NCT01995526|12418377|FG000|NOT COMPLETED|Overall Study||1
11226089|NCT01995539|12418381|FG000|STARTED|Overall Study||181
11226090|NCT01995539|12418381|FG000|COMPLETED|Overall Study||148
11226091|NCT01995539|12418381|FG000|NOT COMPLETED|Overall Study||33
10855777|NCT02614547|12021956|FG000|STARTED|Overall Study||11
10855778|NCT02614547|12021957|FG001|STARTED|Overall Study||10
10855779|NCT02614547|12021956|FG000|COMPLETED|Overall Study||11
10855780|NCT02614547|12021957|FG001|COMPLETED|Overall Study||10
10855781|NCT02614547|12021956|FG000|NOT COMPLETED|Overall Study||0
10855782|NCT02614547|12021957|FG001|NOT COMPLETED|Overall Study||0
11106998|NCT01261975|12291487|FG000|NOT COMPLETED|Overall Study||1
11106999|NCT01262027|12291494|FG000|STARTED|Overall Study||22
11107000|NCT01262027|12291494|FG000|COMPLETED|Overall Study||17
11107001|NCT01262027|12291494|FG000|NOT COMPLETED|Overall Study||5
11107002|NCT01262092|12291500|FG000|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
11107003|NCT01262092|12291501|FG001|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
11107004|NCT01262092|12291500|FG000|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
11107005|NCT01262092|12291501|FG001|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
11107006|NCT01262092|12291500|FG000|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
10855792|NCT02583048|12021983|FG000|STARTED|Overall Study||28
10855793|NCT02583048|12021984|FG001|STARTED|Overall Study||28
10855794|NCT02583048|12021985|FG002|STARTED|Overall Study||28
10855795|NCT02583048|12021983|FG000|COMPLETED|Overall Study||28
10855796|NCT02583048|12021984|FG001|COMPLETED|Overall Study||27
10855797|NCT02583048|12021985|FG002|COMPLETED|Overall Study||27
10855798|NCT02583048|12021983|FG000|NOT COMPLETED|Overall Study||0
10855799|NCT02583048|12021984|FG001|NOT COMPLETED|Overall Study||1
10855800|NCT02583048|12021985|FG002|NOT COMPLETED|Overall Study||1
11107007|NCT01262092|12291501|FG001|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
11107008|NCT01262092|12291500|FG000|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
11107009|NCT01262092|12291501|FG001|STARTED|Buprenorphine Taper||13
11107010|NCT01262092|12291500|FG000|COMPLETED|Buprenorphine Taper||11
11107011|NCT01262092|12291501|FG001|COMPLETED|Buprenorphine Taper||12
11107012|NCT01262092|12291500|FG000|NOT COMPLETED|Buprenorphine Taper||1
11107013|NCT01262092|12291501|FG001|NOT COMPLETED|Buprenorphine Taper||1
11107014|NCT01262092|12291500|FG000|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
11107015|NCT01262092|12291501|FG001|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
11107016|NCT01262092|12291500|FG000|COMPLETED|Gabapentin Taper||9
10855813|NCT02539160|12022007|FG000|STARTED|Phase 1 Pre-crossover||24
10855814|NCT02539160|12022008|FG001|STARTED|Phase 1 Pre-crossover||24
10855815|NCT02539160|12022009|FG002|STARTED|Phase 1 Pre-crossover||22
10855816|NCT02539160|12022010|FG003|STARTED|Phase 1 Pre-crossover||22
10855817|NCT02539160|12022007|FG000|COMPLETED|Phase 1 Pre-crossover||19
10855818|NCT02539160|12022008|FG001|COMPLETED|Phase 1 Pre-crossover||20
10855819|NCT02539160|12022009|FG002|COMPLETED|Phase 1 Pre-crossover||19
10855820|NCT02539160|12022010|FG003|COMPLETED|Phase 1 Pre-crossover||19
10855821|NCT02539160|12022007|FG000|NOT COMPLETED|Phase 1 Pre-crossover||5
10855822|NCT02539160|12022008|FG001|NOT COMPLETED|Phase 1 Pre-crossover||4
10855823|NCT02539160|12022009|FG002|NOT COMPLETED|Phase 1 Pre-crossover||3
10855824|NCT02539160|12022010|FG003|NOT COMPLETED|Phase 1 Pre-crossover||3
10855825|NCT02539160|12022007|FG000|STARTED|Phase 2 Post-crossover||19
10855826|NCT02539160|12022008|FG001|STARTED|Phase 2 Post-crossover||20
10855827|NCT02539160|12022009|FG002|STARTED|Phase 2 Post-crossover||19
10855828|NCT02539160|12022010|FG003|STARTED|Phase 2 Post-crossover||19
10855829|NCT02539160|12022007|FG000|COMPLETED|Phase 2 Post-crossover||19
10855830|NCT02539160|12022008|FG001|COMPLETED|Phase 2 Post-crossover||20
10855831|NCT02539160|12022009|FG002|COMPLETED|Phase 2 Post-crossover||19
10855832|NCT02539160|12022010|FG003|COMPLETED|Phase 2 Post-crossover||19
10855833|NCT02539160|12022007|FG000|NOT COMPLETED|Phase 2 Post-crossover||0
10855834|NCT02539160|12022008|FG001|NOT COMPLETED|Phase 2 Post-crossover||0
10855835|NCT02539160|12022009|FG002|NOT COMPLETED|Phase 2 Post-crossover||0
10855836|NCT02539160|12022010|FG003|NOT COMPLETED|Phase 2 Post-crossover||0
10855837|NCT02507973|12022020|FG000|STARTED|Overall Study||8
10855838|NCT02507973|12022020|FG000|COMPLETED|Overall Study||7
10855839|NCT02507973|12022020|FG000|NOT COMPLETED|Overall Study||1
10855840|NCT02477618|12022028|FG000|STARTED|Overall Study||65
10855841|NCT02477618|12022029|FG001|STARTED|Overall Study||67
10855842|NCT02477618|12022028|FG000|Intent-to-Treat Analysis Set|Overall Study||66
10855843|NCT02477618|12022029|FG001|Intent-to-Treat Analysis Set|Overall Study||66
10855844|NCT02477618|12022028|FG000|COMPLETED|Overall Study||50
10855845|NCT02477618|12022029|FG001|COMPLETED|Overall Study||53
10855846|NCT02477618|12022028|FG000|NOT COMPLETED|Overall Study||15
10855847|NCT02477618|12022029|FG001|NOT COMPLETED|Overall Study||14
10855848|NCT02424851|12022037|FG000|STARTED|Overall Study||16
10855849|NCT02424851|12022038|FG001|STARTED|Overall Study||15
10855850|NCT02424851|12022037|FG000|COMPLETED|Overall Study||14
10855851|NCT02424851|12022038|FG001|COMPLETED|Overall Study||12
10855852|NCT02424851|12022037|FG000|NOT COMPLETED|Overall Study||2
10855853|NCT02424851|12022038|FG001|NOT COMPLETED|Overall Study||3
10855854|NCT02285504|12022044|FG000|STARTED|Overall Study||4
10855855|NCT02285504|12022044|FG000|COMPLETED|Overall Study||4
10855856|NCT02285504|12022044|FG000|NOT COMPLETED|Overall Study||0
10855857|NCT02227394|12022048|FG000|STARTED|Overall Study||10
10855858|NCT02227394|12022049|FG001|STARTED|Overall Study||10
10855859|NCT02227394|12022048|FG000|COMPLETED|Overall Study||10
10855860|NCT02227394|12022049|FG001|COMPLETED|Overall Study||10
10855861|NCT02227394|12022048|FG000|NOT COMPLETED|Overall Study||0
10855862|NCT02227394|12022049|FG001|NOT COMPLETED|Overall Study||0
10855863|NCT02073968|12022055|FG000|STARTED|Overall Study||35
10855864|NCT02073968|12022055|FG000|COMPLETED|Overall Study||35
10855865|NCT02073968|12022055|FG000|NOT COMPLETED|Overall Study||0
10855866|NCT02003924|12022061|FG000|STARTED|Double-blind Phase||933
10855867|NCT02003924|12022062|FG001|STARTED|Double-blind Phase||468
10855868|NCT02003924|12022063|FG002|STARTED|Double-blind Phase||0
10855869|NCT02003924|12022061|FG000|Treated|Double-blind Phase||930
10855870|NCT02003924|12022062|FG001|Treated|Double-blind Phase||465
10855871|NCT02003924|12022063|FG002|Treated|Double-blind Phase||0
10855872|NCT02003924|12022061|FG000|COMPLETED|Double-blind Phase||478
10855873|NCT02003924|12022062|FG001|COMPLETED|Double-blind Phase||87
10855874|NCT02003924|12022063|FG002|COMPLETED|Double-blind Phase||0
10855875|NCT02003924|12022061|FG000|NOT COMPLETED|Double-blind Phase||455
10855876|NCT02003924|12022062|FG001|NOT COMPLETED|Double-blind Phase||381
10855877|NCT02003924|12022063|FG002|NOT COMPLETED|Double-blind Phase||0
10855878|NCT02003924|12022061|FG000|STARTED|Open-label Phase||478
10855879|NCT02003924|12022062|FG001|STARTED|Open-label Phase|Participants were offered to switch from double blind placebo to open label Enzalutamide.|0
10855880|NCT02003924|12022063|FG002|STARTED|Open-label Phase|Participants previously treated with placebo, switched to receive open label Enzalutamide.|87
10855881|NCT02003924|12022061|FG000|Treated|Open-label Phase||478
10855882|NCT02003924|12022062|FG001|Treated|Open-label Phase||0
10855883|NCT02003924|12022063|FG002|Treated|Open-label Phase||87
10855884|NCT02003924|12022061|FG000|COMPLETED|Open-label Phase||378
10855885|NCT02003924|12022062|FG001|COMPLETED|Open-label Phase||0
10855886|NCT02003924|12022063|FG002|COMPLETED|Open-label Phase||70
10855887|NCT02003924|12022061|FG000|NOT COMPLETED|Open-label Phase||100
10855888|NCT02003924|12022062|FG001|NOT COMPLETED|Open-label Phase||0
10855889|NCT02003924|12022063|FG002|NOT COMPLETED|Open-label Phase||17
10855890|NCT02003924|12022061|FG000|STARTED|Long-term Follow-up Phase|Participants followed up after discontinuing study drug in either double blind or open label phase.|933
10855891|NCT02003924|12022062|FG001|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in double blind phase.|381
10855892|NCT02003924|12022063|FG002|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in open label phase.|87
10855893|NCT02003924|12022061|FG000|COMPLETED|Long-term Follow-up Phase||566
10855894|NCT02003924|12022062|FG001|COMPLETED|Long-term Follow-up Phase||144
10855895|NCT02003924|12022063|FG002|COMPLETED|Long-term Follow-up Phase||80
10855896|NCT02003924|12022061|FG000|NOT COMPLETED|Long-term Follow-up Phase||367
10855897|NCT02003924|12022062|FG001|NOT COMPLETED|Long-term Follow-up Phase||237
10855898|NCT02003924|12022063|FG002|NOT COMPLETED|Long-term Follow-up Phase||7
10855899|NCT01971970|12022072|FG000|STARTED|Baseline Until Week 6||24
10855900|NCT01971970|12022073|FG001|STARTED|Baseline Until Week 6||21
10855901|NCT01971970|12022072|FG000|Receiving Standard Therapy|Baseline Until Week 6||23
10855902|NCT01971970|12022073|FG001|Receiving Standard Therapy|Baseline Until Week 6||21
10855903|NCT01971970|12022072|FG000|Therapy Escalation|Baseline Until Week 6||1
10855904|NCT01971970|12022073|FG001|Therapy Escalation|Baseline Until Week 6||0
10855905|NCT01971970|12022072|FG000|COMPLETED|Baseline Until Week 6||23
10855906|NCT01971970|12022073|FG001|COMPLETED|Baseline Until Week 6||21
10855907|NCT01971970|12022072|FG000|NOT COMPLETED|Baseline Until Week 6||1
10855908|NCT01971970|12022073|FG001|NOT COMPLETED|Baseline Until Week 6||0
10855909|NCT01971970|12022072|FG000|STARTED|Week 6 Until Week 8||23
10855910|NCT01971970|12022073|FG001|STARTED|Week 6 Until Week 8||21
10855911|NCT01971970|12022072|FG000|Receiving Standard Therapy|Week 6 Until Week 8||23
10855912|NCT01971970|12022073|FG001|Receiving Standard Therapy|Week 6 Until Week 8||20
10855913|NCT01971970|12022072|FG000|COMPLETED|Week 6 Until Week 8||23
10855914|NCT01971970|12022073|FG001|COMPLETED|Week 6 Until Week 8||20
10855915|NCT01971970|12022072|FG000|NOT COMPLETED|Week 6 Until Week 8||0
10855916|NCT01971970|12022073|FG001|NOT COMPLETED|Week 6 Until Week 8||1
10855917|NCT01971970|12022072|FG000|STARTED|Week 8 Until Week 14||23
10855918|NCT01971970|12022073|FG001|STARTED|Week 8 Until Week 14||20
10855919|NCT01971970|12022072|FG000|Receiving Standard Therapy|Week 8 Until Week 14||16
10855920|NCT01971970|12022073|FG001|Receiving Standard Therapy|Week 8 Until Week 14||19
10855921|NCT01971970|12022072|FG000|Therapy Escalation|Week 8 Until Week 14||7
10855922|NCT01971970|12022073|FG001|Therapy Escalation|Week 8 Until Week 14||1
10855923|NCT01971970|12022072|FG000|COMPLETED|Week 8 Until Week 14||23
10855924|NCT01971970|12022073|FG001|COMPLETED|Week 8 Until Week 14||20
10855925|NCT01971970|12022072|FG000|NOT COMPLETED|Week 8 Until Week 14||0
10855926|NCT01971970|12022073|FG001|NOT COMPLETED|Week 8 Until Week 14||0
10855927|NCT01971970|12022072|FG000|STARTED|Week 14 Until Week 22||23
10855928|NCT01971970|12022073|FG001|STARTED|Week 14 Until Week 22||20
10855929|NCT01971970|12022072|FG000|Receiving Standard Therapy|Week 14 Until Week 22||12
10855930|NCT01971970|12022073|FG001|Receiving Standard Therapy|Week 14 Until Week 22||16
10855931|NCT01971970|12022072|FG000|Therapy Escalation|Week 14 Until Week 22||3
10855932|NCT01971970|12022073|FG001|Therapy Escalation|Week 14 Until Week 22||2
10855933|NCT01971970|12022072|FG000|COMPLETED|Week 14 Until Week 22||23
10855934|NCT01971970|12022073|FG001|COMPLETED|Week 14 Until Week 22||19
10855935|NCT01971970|12022072|FG000|NOT COMPLETED|Week 14 Until Week 22||0
10855936|NCT01971970|12022073|FG001|NOT COMPLETED|Week 14 Until Week 22||1
10855937|NCT01971970|12022072|FG000|STARTED|Week 22 Until Week 52||23
10855938|NCT01971970|12022073|FG001|STARTED|Week 22 Until Week 52||19
10855939|NCT01971970|12022072|FG000|Receiving Standard Therapy|Week 22 Until Week 52||5
10855940|NCT01971970|12022073|FG001|Receiving Standard Therapy|Week 22 Until Week 52||9
10855941|NCT01971970|12022072|FG000|Therapy Escalation|Week 22 Until Week 52||6
10855942|NCT01971970|12022073|FG001|Therapy Escalation|Week 22 Until Week 52||6
10855943|NCT01971970|12022072|FG000|COMPLETED|Week 22 Until Week 52||15
10855944|NCT01971970|12022073|FG001|COMPLETED|Week 22 Until Week 52||15
10855945|NCT01971970|12022072|FG000|NOT COMPLETED|Week 22 Until Week 52||8
10855946|NCT01971970|12022073|FG001|NOT COMPLETED|Week 22 Until Week 52||4
10855947|NCT01971970|12022072|FG000|STARTED|Week 52 Until Week 78||15
10855948|NCT01971970|12022073|FG001|STARTED|Week 52 Until Week 78||15
10855949|NCT01971970|12022072|FG000|COMPLETED|Week 52 Until Week 78||14
10855950|NCT01971970|12022073|FG001|COMPLETED|Week 52 Until Week 78||12
10855951|NCT01971970|12022072|FG000|NOT COMPLETED|Week 52 Until Week 78||1
10855952|NCT01971970|12022073|FG001|NOT COMPLETED|Week 52 Until Week 78||3
10855953|NCT01969409|12022086|FG000|STARTED|Overall Study||28
10855954|NCT01969409|12022087|FG001|STARTED|Overall Study||30
10855955|NCT01969409|12022086|FG000|COMPLETED|Overall Study||25
10855956|NCT01969409|12022087|FG001|COMPLETED|Overall Study||26
10855957|NCT01969409|12022086|FG000|NOT COMPLETED|Overall Study||3
10855958|NCT01969409|12022087|FG001|NOT COMPLETED|Overall Study||4
10855959|NCT01459497|12022095|FG000|STARTED|Overall Study||52
10855960|NCT01459497|12022096|FG001|STARTED|Overall Study||51
10855961|NCT01459497|12022095|FG000|COMPLETED|Overall Study||50
10855962|NCT01459497|12022096|FG001|COMPLETED|Overall Study||46
10855963|NCT01459497|12022095|FG000|NOT COMPLETED|Overall Study||2
10855964|NCT01459497|12022096|FG001|NOT COMPLETED|Overall Study||5
10855965|NCT01307787|12022104|FG000|STARTED|Overall Study||19
10855966|NCT01307787|12022105|FG001|STARTED|Overall Study||15
10855967|NCT01307787|12022104|FG000|T1= After 9 Weeks Post Intervention|Overall Study||18
10855968|NCT01307787|12022105|FG001|T1= After 9 Weeks Post Intervention|Overall Study||15
10855969|NCT01307787|12022104|FG000|T2= After 22 Weeks at Follow-up|Overall Study||17
10855970|NCT01307787|12022105|FG001|T2= After 22 Weeks at Follow-up|Overall Study||15
10855971|NCT01307787|12022104|FG000|COMPLETED|Overall Study||17
10855972|NCT01307787|12022105|FG001|COMPLETED|Overall Study||15
10855973|NCT01307787|12022104|FG000|NOT COMPLETED|Overall Study||2
10855974|NCT01307787|12022105|FG001|NOT COMPLETED|Overall Study||0
10855975|NCT01250912|12022116|FG000|STARTED|Overall Study||20
10855976|NCT01250912|12022116|FG000|COMPLETED|Overall Study||19
10855977|NCT01250912|12022116|FG000|NOT COMPLETED|Overall Study||1
10855978|NCT01218555|12022123|FG000|STARTED|Overall Study||3
10855979|NCT01218555|12022124|FG001|STARTED|Overall Study||3
10855980|NCT01218555|12022125|FG002|STARTED|Overall Study||5
10855981|NCT01218555|12022126|FG003|STARTED|Overall Study||3
10855982|NCT01218555|12022127|FG004|STARTED|Overall Study||8
10855983|NCT01218555|12022128|FG005|STARTED|Overall Study||22
10855984|NCT01218555|12022123|FG000|COMPLETED|Overall Study||3
10855985|NCT01218555|12022124|FG001|COMPLETED|Overall Study||3
10855986|NCT01218555|12022125|FG002|COMPLETED|Overall Study||5
10855987|NCT01218555|12022126|FG003|COMPLETED|Overall Study||3
10855988|NCT01218555|12022127|FG004|COMPLETED|Overall Study||8
10855989|NCT01218555|12022128|FG005|COMPLETED|Overall Study||22
10855990|NCT01218555|12022123|FG000|NOT COMPLETED|Overall Study||0
10855991|NCT01218555|12022124|FG001|NOT COMPLETED|Overall Study||0
10855992|NCT01218555|12022125|FG002|NOT COMPLETED|Overall Study||0
10855993|NCT01218555|12022126|FG003|NOT COMPLETED|Overall Study||0
10855994|NCT01218555|12022127|FG004|NOT COMPLETED|Overall Study||0
11226092|NCT01995552|12418385|FG000|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250
11226093|NCT01995552|12418385|FG000|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233
11226094|NCT01995552|12418385|FG000|NOT COMPLETED|Overall Study||17
11226095|NCT01995825|12418393|FG000|STARTED|Overall Study||18
11226096|NCT01995825|12418394|FG001|STARTED|Overall Study||17
11226097|NCT01995825|12418393|FG000|COMPLETED|Overall Study||17
11226098|NCT01995825|12418394|FG001|COMPLETED|Overall Study||17
11226099|NCT01995825|12418393|FG000|NOT COMPLETED|Overall Study||1
11226100|NCT01995825|12418394|FG001|NOT COMPLETED|Overall Study||0
11226101|NCT01995838|12418407|FG000|STARTED|Overall Study||56
11226102|NCT01995838|12418408|FG001|STARTED|Overall Study||32
11226103|NCT01995838|12418409|FG002|STARTED|Overall Study||27
11226104|NCT01995838|12418410|FG003|STARTED|Overall Study||38
11226105|NCT01995838|12418411|FG004|STARTED|Overall Study||32
11226106|NCT01995838|12418412|FG005|STARTED|Overall Study||56
11226107|NCT01995838|12418413|FG006|STARTED|Overall Study||50
11226108|NCT01995838|12418407|FG000|COMPLETED|Overall Study||51
11226109|NCT01995838|12418408|FG001|COMPLETED|Overall Study||30
11226110|NCT01995838|12418409|FG002|COMPLETED|Overall Study||27
11226111|NCT01995838|12418410|FG003|COMPLETED|Overall Study||36
11226112|NCT01995838|12418411|FG004|COMPLETED|Overall Study||30
11226113|NCT01995838|12418412|FG005|COMPLETED|Overall Study||54
11226114|NCT01995838|12418413|FG006|COMPLETED|Overall Study||45
10855995|NCT01218555|12022128|FG005|NOT COMPLETED|Overall Study||0
10855996|NCT01141712|12022132|FG000|STARTED|Overall Study||43
10855997|NCT01141712|12022132|FG000|COMPLETED|Overall Study||40
10855998|NCT01141712|12022132|FG000|NOT COMPLETED|Overall Study||3
10855999|NCT01111305|12022138|FG000|STARTED|Overall Study||4
10856000|NCT01111305|12022139|FG001|STARTED|Overall Study||4
10856001|NCT01111305|12022138|FG000|COMPLETED|Overall Study||4
11226115|NCT01995838|12418407|FG000|NOT COMPLETED|Overall Study||5
11226116|NCT01995838|12418408|FG001|NOT COMPLETED|Overall Study||2
11226117|NCT01995838|12418409|FG002|NOT COMPLETED|Overall Study||0
11226118|NCT01995838|12418410|FG003|NOT COMPLETED|Overall Study||2
11226119|NCT01995838|12418411|FG004|NOT COMPLETED|Overall Study||2
11226120|NCT01995838|12418412|FG005|NOT COMPLETED|Overall Study||2
10856002|NCT01111305|12022139|FG001|COMPLETED|Overall Study||4
11226121|NCT01995838|12418413|FG006|NOT COMPLETED|Overall Study||5
11226122|NCT01996033|12418430|FG000|STARTED|Overall Study||25
11226123|NCT01996033|12418430|FG000|COMPLETED|Overall Study||16
11226124|NCT01996033|12418430|FG000|NOT COMPLETED|Overall Study||9
11226125|NCT01996241|12418436|FG000|STARTED|Overall Study||1164
11226126|NCT01996241|12418437|FG001|STARTED|Overall Study||1111
10856003|NCT01111305|12022138|FG000|NOT COMPLETED|Overall Study||0
10856004|NCT01111305|12022139|FG001|NOT COMPLETED|Overall Study||0
10856005|NCT00659646|12022149|FG000|STARTED|Overall Study||38
10856006|NCT00659646|12022150|FG001|STARTED|Overall Study||18
10856007|NCT00659646|12022149|FG000|COMPLETED|Overall Study||23
10856008|NCT00659646|12022150|FG001|COMPLETED|Overall Study||10
10856009|NCT00659646|12022149|FG000|NOT COMPLETED|Overall Study||15
10856010|NCT00659646|12022150|FG001|NOT COMPLETED|Overall Study||8
10856011|NCT00477412|12022162|FG000|STARTED|Overall Study||4
10856012|NCT00477412|12022163|FG001|STARTED|Overall Study||3
10856013|NCT00477412|12022164|FG002|STARTED|Overall Study||5
10856014|NCT00477412|12022165|FG003|STARTED|Overall Study||95
10856015|NCT00477412|12022162|FG000|COMPLETED|Overall Study||3
10856016|NCT00477412|12022163|FG001|COMPLETED|Overall Study||3
10856017|NCT00477412|12022164|FG002|COMPLETED|Overall Study||4
10856018|NCT00477412|12022165|FG003|COMPLETED|Overall Study||87
10856019|NCT00477412|12022162|FG000|NOT COMPLETED|Overall Study||1
10856020|NCT00477412|12022163|FG001|NOT COMPLETED|Overall Study||0
10856021|NCT00477412|12022164|FG002|NOT COMPLETED|Overall Study||1
10856022|NCT00477412|12022165|FG003|NOT COMPLETED|Overall Study||8
10856023|NCT00369317|12022173|FG000|STARTED|Overall Study||205
10856024|NCT00369317|12022173|FG000|COMPLETED|Overall Study||185
10856025|NCT00369317|12022173|FG000|NOT COMPLETED|Overall Study||20
10856026|NCT00261807|12022178|FG000|STARTED|Overall Study||25
10856027|NCT00261807|12022178|FG000|COMPLETED|Overall Study||18
10856028|NCT00261807|12022178|FG000|NOT COMPLETED|Overall Study||7
11226127|NCT01996241|12418436|FG000|COMPLETED|Overall Study||912
11226128|NCT01996241|12418437|FG001|COMPLETED|Overall Study||876
11226129|NCT01996241|12418436|FG000|NOT COMPLETED|Overall Study||252
11226130|NCT01996241|12418437|FG001|NOT COMPLETED|Overall Study||235
11226131|NCT01996254|12418447|FG000|STARTED|Overall Study||5
11226132|NCT01996254|12418448|FG001|STARTED|Overall Study||14
11226133|NCT01996254|12418449|FG002|STARTED|Overall Study||14
11226134|NCT01996254|12418447|FG000|Safety Set|Overall Study||5
11226135|NCT01996254|12418448|FG001|Safety Set|Overall Study||14
11226136|NCT01996254|12418449|FG002|Safety Set|Overall Study||14
11226137|NCT01996254|12418447|FG000|Full Analysis Set|Overall Study||0
11226138|NCT01996254|12418448|FG001|Full Analysis Set|Overall Study||12
11226139|NCT01996254|12418449|FG002|Full Analysis Set|Overall Study||14
10856029|NCT04964193|12022183|FG000|STARTED|1st Intervention||12
10856030|NCT04964193|12022184|FG001|STARTED|1st Intervention||12
10856031|NCT04964193|12022183|FG000|COMPLETED|1st Intervention||12
10856032|NCT04964193|12022184|FG001|COMPLETED|1st Intervention||12
10856033|NCT04964193|12022183|FG000|NOT COMPLETED|1st Intervention||0
10856034|NCT04964193|12022184|FG001|NOT COMPLETED|1st Intervention||0
10856035|NCT04964193|12022183|FG000|STARTED|Washout = Three Weeks||12
10856036|NCT04964193|12022184|FG001|STARTED|Washout = Three Weeks||12
10856037|NCT04964193|12022183|FG000|COMPLETED|Washout = Three Weeks||12
10856038|NCT04964193|12022184|FG001|COMPLETED|Washout = Three Weeks||12
10856039|NCT04964193|12022183|FG000|NOT COMPLETED|Washout = Three Weeks||0
10856040|NCT04964193|12022184|FG001|NOT COMPLETED|Washout = Three Weeks||0
10856041|NCT04964193|12022183|FG000|STARTED|2nd Intervention||12
10856042|NCT04964193|12022184|FG001|STARTED|2nd Intervention||12
10856043|NCT04964193|12022183|FG000|COMPLETED|2nd Intervention||12
10856044|NCT04964193|12022184|FG001|COMPLETED|2nd Intervention||12
10856045|NCT04964193|12022183|FG000|NOT COMPLETED|2nd Intervention||0
10856046|NCT04964193|12022184|FG001|NOT COMPLETED|2nd Intervention||0
11107017|NCT01262092|12291501|FG001|COMPLETED|Gabapentin Taper||11
11107018|NCT01262092|12291500|FG000|NOT COMPLETED|Gabapentin Taper||1
11107019|NCT01262092|12291501|FG001|NOT COMPLETED|Gabapentin Taper||0
11107020|NCT01262105|12291509|FG000|STARTED|Overall Study||13
11107021|NCT01262105|12291510|FG001|STARTED|Overall Study||10
11107022|NCT01262105|12291509|FG000|COMPLETED|Overall Study||13
11107023|NCT01262105|12291510|FG001|COMPLETED|Overall Study||10
11107024|NCT01262105|12291509|FG000|NOT COMPLETED|Overall Study||0
11107025|NCT01262105|12291510|FG001|NOT COMPLETED|Overall Study||0
11107026|NCT01262118|12291518|FG000|STARTED|Baseline Assessment Period (3 Days)||36
11107027|NCT01262118|12291519|FG001|STARTED|Baseline Assessment Period (3 Days)||33
11107028|NCT01262118|12291518|FG000|COMPLETED|Baseline Assessment Period (3 Days)||36
11107029|NCT01262118|12291519|FG001|COMPLETED|Baseline Assessment Period (3 Days)||33
11107030|NCT01262118|12291518|FG000|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
11107031|NCT01262118|12291519|FG001|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
11107032|NCT01262118|12291518|FG000|STARTED|Treatment Period (6 Weeks)||36
11107033|NCT01262118|12291519|FG001|STARTED|Treatment Period (6 Weeks)||0
11107034|NCT01262118|12291518|FG000|COMPLETED|Treatment Period (6 Weeks)||36
11107035|NCT01262118|12291519|FG001|COMPLETED|Treatment Period (6 Weeks)||0
11107036|NCT01262118|12291518|FG000|NOT COMPLETED|Treatment Period (6 Weeks)||0
11107037|NCT01262118|12291519|FG001|NOT COMPLETED|Treatment Period (6 Weeks)||0
11107038|NCT01262131|12291528|FG000|STARTED|Overall Study||5
11107039|NCT01262131|12291529|FG001|STARTED|Overall Study||4
11107040|NCT01262131|12291530|FG002|STARTED|Overall Study||4
11107041|NCT01262131|12291528|FG000|COMPLETED|Overall Study||5
11107042|NCT01262131|12291529|FG001|COMPLETED|Overall Study||4
11107043|NCT01262131|12291530|FG002|COMPLETED|Overall Study||4
11107044|NCT01262131|12291528|FG000|NOT COMPLETED|Overall Study||0
11107045|NCT01262131|12291529|FG001|NOT COMPLETED|Overall Study||0
11107046|NCT01262131|12291530|FG002|NOT COMPLETED|Overall Study||0
11107047|NCT01262287|12291540|FG000|STARTED|Overall Study||20
11107048|NCT01262287|12291541|FG001|STARTED|Overall Study||19
11107049|NCT01262287|12291540|FG000|COMPLETED|Overall Study||18
11107050|NCT01262287|12291541|FG001|COMPLETED|Overall Study||18
11107051|NCT01262287|12291540|FG000|NOT COMPLETED|Overall Study||2
11107052|NCT01262287|12291541|FG001|NOT COMPLETED|Overall Study||1
11107053|NCT01262352|12291553|FG000|STARTED|Period 1||11
11107054|NCT01262352|12291554|FG001|STARTED|Period 1||10
11107055|NCT01262352|12291553|FG000|Dosed|Period 1||10
11107056|NCT01262352|12291554|FG001|Dosed|Period 1||10
11107057|NCT01262352|12291553|FG000|COMPLETED|Period 1||10
11107058|NCT01262352|12291554|FG001|COMPLETED|Period 1||10
11107059|NCT01262352|12291553|FG000|NOT COMPLETED|Period 1||1
11107060|NCT01262352|12291554|FG001|NOT COMPLETED|Period 1||0
11226140|NCT01996254|12418447|FG000|Long Term Analysis Set|Overall Study||0
11226141|NCT01996254|12418448|FG001|Long Term Analysis Set|Overall Study||12
11226142|NCT01996254|12418449|FG002|Long Term Analysis Set|Overall Study||14
11226143|NCT01996254|12418447|FG000|Per Protocol Set|Overall Study||0
11226144|NCT01996254|12418448|FG001|Per Protocol Set|Overall Study||10
11226145|NCT01996254|12418449|FG002|Per Protocol Set|Overall Study||13
11226146|NCT01996254|12418447|FG000|COMPLETED|Overall Study||4
11226147|NCT01996254|12418448|FG001|COMPLETED|Overall Study||9
11226148|NCT01996254|12418449|FG002|COMPLETED|Overall Study||6
11226149|NCT01996254|12418447|FG000|NOT COMPLETED|Overall Study||1
11226150|NCT01996254|12418448|FG001|NOT COMPLETED|Overall Study||5
11226151|NCT01996254|12418449|FG002|NOT COMPLETED|Overall Study||8
11226152|NCT01996319|12418461|FG000|STARTED|Overall Study||96
11226153|NCT01996319|12418462|FG001|STARTED|Overall Study||98
11226154|NCT01996319|12418461|FG000|COMPLETED|Overall Study||88
11226155|NCT01996319|12418462|FG001|COMPLETED|Overall Study||95
11226156|NCT01996319|12418461|FG000|NOT COMPLETED|Overall Study||8
11226157|NCT01996319|12418462|FG001|NOT COMPLETED|Overall Study||3
11226158|NCT01996332|12418468|FG000|STARTED|Overall Study||1805
11226159|NCT01996332|12418468|FG000|COMPLETED|Overall Study||0
11226160|NCT01996332|12418468|FG000|NOT COMPLETED|Overall Study||1805
11226161|NCT01996592|12418472|FG000|STARTED|Overall Study||575
11226162|NCT01996592|12418472|FG000|COMPLETED|Overall Study||530
11226163|NCT01996592|12418472|FG000|NOT COMPLETED|Overall Study||45
11226164|NCT01996644|12418483|FG000|STARTED|Overall Study||20
11226165|NCT01996644|12418484|FG001|STARTED|Overall Study||16
11226166|NCT01996644|12418483|FG000|COMPLETED|Overall Study||20
11226167|NCT01996644|12418484|FG001|COMPLETED|Overall Study||16
11226168|NCT01996644|12418483|FG000|NOT COMPLETED|Overall Study||0
11226169|NCT01996644|12418484|FG001|NOT COMPLETED|Overall Study||0
11226170|NCT01996657|12418496|FG000|STARTED|Overall Study||250
11226171|NCT01996657|12418497|FG001|STARTED|Overall Study||250
11226172|NCT01996657|12418498|FG002|STARTED|Overall Study||248
11226173|NCT01996657|12418496|FG000|COMPLETED|Overall Study||237
11226174|NCT01996657|12418497|FG001|COMPLETED|Overall Study||239
11226175|NCT01996657|12418498|FG002|COMPLETED|Overall Study||234
11226176|NCT01996657|12418496|FG000|NOT COMPLETED|Overall Study||13
11226177|NCT01996657|12418497|FG001|NOT COMPLETED|Overall Study||11
11226178|NCT01996657|12418498|FG002|NOT COMPLETED|Overall Study||14
11226179|NCT01996709|12418508|FG000|STARTED|Overall Study||66
11226180|NCT01996709|12418509|FG001|STARTED|Overall Study||68
11226181|NCT01996709|12418508|FG000|COMPLETED|Overall Study||61
11226182|NCT01996709|12418509|FG001|COMPLETED|Overall Study||67
11107061|NCT01262352|12291553|FG000|STARTED|Washout||10
10856091|NCT03284853|12022250|FG000|STARTED|Overall Study||218
10856092|NCT03284853|12022251|FG001|STARTED|Overall Study||212
10856093|NCT03284853|12022250|FG000|Intent-to-Treat Population|Overall Study||218
11107062|NCT01262352|12291554|FG001|STARTED|Washout||10
10856047|NCT04826731|12022192|FG000|STARTED|Overall Study||10
10856048|NCT04826731|12022193|FG001|STARTED|Overall Study||4
10856049|NCT04826731|12022192|FG000|COMPLETED|Overall Study|All patients were initially accepted as the study group per study design, with those unable to utilize respiratory exerciser (n=4) were later removed to standard care group.|10
10856050|NCT04826731|12022193|FG001|COMPLETED|Overall Study|Patients who could not use the respiratory exerciser (n=2) or refused to do so (n=2) were accepted as the control group.|4
10856051|NCT04826731|12022192|FG000|NOT COMPLETED|Overall Study||0
10856052|NCT04826731|12022193|FG001|NOT COMPLETED|Overall Study||0
10856053|NCT04620798|12022201|FG000|STARTED|Overall Study||536
10856054|NCT04620798|12022202|FG001|STARTED|Overall Study||540
10856055|NCT04620798|12022201|FG000|Completed Behavioral Survey|Overall Study||477
10856056|NCT04620798|12022202|FG001|Completed Behavioral Survey|Overall Study||508
10856057|NCT04620798|12022201|FG000|COMPLETED|Overall Study||410
10856058|NCT04620798|12022202|FG001|COMPLETED|Overall Study||402
10856059|NCT04620798|12022201|FG000|NOT COMPLETED|Overall Study||126
10856060|NCT04620798|12022202|FG001|NOT COMPLETED|Overall Study||138
10856061|NCT04507321|12022208|FG000|STARTED|Treatment Period 1 (8 Days)||5
10856062|NCT04507321|12022208|FG000|COMPLETED|Treatment Period 1 (8 Days)||5
10856063|NCT04507321|12022208|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
10856064|NCT04507321|12022208|FG000|STARTED|Treatment Period 2 (8 Days)||5
10856065|NCT04507321|12022208|FG000|COMPLETED|Treatment Period 2 (8 Days)||5
10856066|NCT04507321|12022208|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
10856067|NCT04256629|12022227|FG000|STARTED|Overall Study||4
10856068|NCT04256629|12022228|FG001|STARTED|Overall Study||4
10856069|NCT04256629|12022229|FG002|STARTED|Overall Study||4
10856070|NCT04256629|12022230|FG003|STARTED|Overall Study||4
10856071|NCT04256629|12022231|FG004|STARTED|Overall Study||4
10856072|NCT04256629|12022232|FG005|STARTED|Overall Study||4
10856073|NCT04256629|12022227|FG000|COMPLETED|Overall Study||4
10856074|NCT04256629|12022228|FG001|COMPLETED|Overall Study||3
10856075|NCT04256629|12022229|FG002|COMPLETED|Overall Study||4
10856076|NCT04256629|12022230|FG003|COMPLETED|Overall Study||4
11107063|NCT01262352|12291553|FG000|COMPLETED|Washout||9
11107064|NCT01262352|12291554|FG001|COMPLETED|Washout||8
11107065|NCT01262352|12291553|FG000|NOT COMPLETED|Washout||1
11107066|NCT01262352|12291554|FG001|NOT COMPLETED|Washout||2
11107067|NCT01262352|12291553|FG000|STARTED|Period 2||9
11107068|NCT01262352|12291554|FG001|STARTED|Period 2||8
11107069|NCT01262352|12291553|FG000|Dosed|Period 2||9
11107070|NCT01262352|12291554|FG001|Dosed|Period 2||8
11107071|NCT01262352|12291553|FG000|COMPLETED|Period 2||9
11107072|NCT01262352|12291554|FG001|COMPLETED|Period 2||8
11107073|NCT01262352|12291553|FG000|NOT COMPLETED|Period 2||0
10856077|NCT04256629|12022231|FG004|COMPLETED|Overall Study||4
10856078|NCT04256629|12022232|FG005|COMPLETED|Overall Study||3
10856079|NCT04256629|12022227|FG000|NOT COMPLETED|Overall Study||0
10856080|NCT04256629|12022228|FG001|NOT COMPLETED|Overall Study||1
10856081|NCT04256629|12022229|FG002|NOT COMPLETED|Overall Study||0
10856082|NCT04256629|12022230|FG003|NOT COMPLETED|Overall Study||0
10856083|NCT04256629|12022231|FG004|NOT COMPLETED|Overall Study||0
10856084|NCT04256629|12022232|FG005|NOT COMPLETED|Overall Study||1
10856085|NCT04174521|12022240|FG000|STARTED|Overall Study|A unit is defined as a mother-child pair; each unit was comprised of two participants: the mother and the child.|20670
10856086|NCT04174521|12022240|FG000|COMPLETED|Overall Study|This was a retrospective observational study so there really was no drop-out.|20670
10856087|NCT04174521|12022240|FG000|NOT COMPLETED|Overall Study||0
10856094|NCT03284853|12022251|FG001|Intent-to-Treat Population|Overall Study||212
10856095|NCT03284853|12022250|FG000|Per-Protocol Population|Overall Study||169
10856096|NCT03284853|12022251|FG001|Per-Protocol Population|Overall Study||170
10856097|NCT03284853|12022250|FG000|Safety Population|Overall Study||218
10856098|NCT03284853|12022251|FG001|Safety Population|Overall Study||212
10856099|NCT03284853|12022250|FG000|COMPLETED|Overall Study||163
10856100|NCT03284853|12022251|FG001|COMPLETED|Overall Study||199
10856101|NCT03284853|12022250|FG000|NOT COMPLETED|Overall Study||55
10856102|NCT03284853|12022251|FG001|NOT COMPLETED|Overall Study||13
10856103|NCT03032250|12022259|FG000|STARTED|Overall Study||17
10856104|NCT03032250|12022260|FG001|STARTED|Overall Study||18
10856105|NCT03032250|12022259|FG000|COMPLETED|Overall Study||17
10856106|NCT03032250|12022260|FG001|COMPLETED|Overall Study||18
10856107|NCT03032250|12022259|FG000|NOT COMPLETED|Overall Study||0
10856108|NCT03032250|12022260|FG001|NOT COMPLETED|Overall Study||0
10856109|NCT02942966|12022268|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|233
10856110|NCT02942966|12022268|FG000|COMPLETED|Overall Study|Completed 6-month follow-up|205
10856111|NCT02942966|12022268|FG000|NOT COMPLETED|Overall Study||28
10856112|NCT02774889|12022274|FG000|STARTED|Overall Study||23
10856113|NCT02774889|12022275|FG001|STARTED|Overall Study||22
10856114|NCT02774889|12022274|FG000|COMPLETED|Overall Study||21
10856115|NCT02774889|12022275|FG001|COMPLETED|Overall Study||21
10856116|NCT02774889|12022274|FG000|NOT COMPLETED|Overall Study||2
10856117|NCT02774889|12022275|FG001|NOT COMPLETED|Overall Study||1
10856118|NCT02721069|12022283|FG000|STARTED|Overall Study||175
10856119|NCT02721069|12022283|FG000|COMPLETED|Overall Study||117
10856120|NCT02721069|12022283|FG000|NOT COMPLETED|Overall Study||58
10856121|NCT02297438|12022295|FG000|STARTED|Overall Study||169
10856122|NCT02297438|12022296|FG001|STARTED|Overall Study||171
10856123|NCT02297438|12022295|FG000|Received Treatment|Overall Study||168
10856124|NCT02297438|12022296|FG001|Received Treatment|Overall Study||171
10856125|NCT02297438|12022295|FG000|COMPLETED|Overall Study||0
10856126|NCT02297438|12022296|FG001|COMPLETED|Overall Study||0
10856127|NCT02297438|12022295|FG000|NOT COMPLETED|Overall Study||169
10856128|NCT02297438|12022296|FG001|NOT COMPLETED|Overall Study||171
10856129|NCT02297412|12022304|FG000|STARTED|Overall Study||23
10856130|NCT02297412|12022305|FG001|STARTED|Overall Study||24
10856131|NCT02297412|12022304|FG000|COMPLETED|Overall Study||22
10856132|NCT02297412|12022305|FG001|COMPLETED|Overall Study||23
10856133|NCT02297412|12022304|FG000|NOT COMPLETED|Overall Study||1
10856134|NCT02297412|12022305|FG001|NOT COMPLETED|Overall Study||1
10856135|NCT02292758|12022313|FG000|STARTED|Overall Study||19
10856136|NCT02292758|12022314|FG001|STARTED|Overall Study||17
10856137|NCT02292758|12022313|FG000|COMPLETED|Overall Study||19
10856138|NCT02292758|12022314|FG001|COMPLETED|Overall Study||17
10856139|NCT02292758|12022313|FG000|NOT COMPLETED|Overall Study||0
10856140|NCT02292758|12022314|FG001|NOT COMPLETED|Overall Study||0
10856141|NCT02250326|12022323|FG000|STARTED|Treatment Period||81
10856142|NCT02250326|12022324|FG001|STARTED|Treatment Period||79
10856143|NCT02250326|12022325|FG002|STARTED|Treatment Period||80
10856144|NCT02250326|12022323|FG000|Treated Population|Treatment Period||79
10856145|NCT02250326|12022324|FG001|Treated Population|Treatment Period||78
10856146|NCT02250326|12022325|FG002|Treated Population|Treatment Period||79
10856147|NCT02250326|12022323|FG000|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
10856148|NCT02250326|12022324|FG001|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
10856149|NCT02250326|12022325|FG002|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
10856150|NCT02250326|12022323|FG000|NOT COMPLETED|Treatment Period||81
10856151|NCT02250326|12022324|FG001|NOT COMPLETED|Treatment Period||64
10856152|NCT02250326|12022325|FG002|NOT COMPLETED|Treatment Period||77
10856153|NCT02250326|12022323|FG000|STARTED|Follow-Up Period||67
11107074|NCT01262352|12291554|FG001|NOT COMPLETED|Period 2||0
11107075|NCT01262365|12291563|FG000|STARTED|Overall Study||266
11107076|NCT01262365|12291564|FG001|STARTED|Overall Study||262
11107077|NCT01262365|12291565|FG002|STARTED|Overall Study||265
11107078|NCT01262365|12291563|FG000|COMPLETED|Overall Study||176
11107079|NCT01262365|12291564|FG001|COMPLETED|Overall Study||181
11107080|NCT01262365|12291565|FG002|COMPLETED|Overall Study||171
11107081|NCT01262365|12291563|FG000|NOT COMPLETED|Overall Study||90
11107082|NCT01262365|12291564|FG001|NOT COMPLETED|Overall Study||81
11107083|NCT01262365|12291565|FG002|NOT COMPLETED|Overall Study||94
11107084|NCT01262456|12291576|FG000|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
11107085|NCT01262456|12291577|FG001|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
11107086|NCT01262456|12291578|FG002|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
11107087|NCT01262456|12291576|FG000|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
11107088|NCT01262456|12291577|FG001|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
11107089|NCT01262456|12291578|FG002|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
11226183|NCT01996709|12418508|FG000|NOT COMPLETED|Overall Study||5
11226184|NCT01996709|12418509|FG001|NOT COMPLETED|Overall Study||1
11226185|NCT01996748|12418521|FG000|STARTED|Overall Study||66
11226186|NCT01996748|12418522|FG001|STARTED|Overall Study||69
11226187|NCT01996748|12418521|FG000|COMPLETED|Overall Study||58
11226188|NCT01996748|12418522|FG001|COMPLETED|Overall Study||63
11226189|NCT01996748|12418521|FG000|NOT COMPLETED|Overall Study||8
11226190|NCT01996748|12418522|FG001|NOT COMPLETED|Overall Study||6
11226191|NCT01996813|12418532|FG000|STARTED|Overall Study||23
11226192|NCT01996813|12418533|FG001|STARTED|Overall Study||24
11226193|NCT01996813|12418532|FG000|COMPLETED|Overall Study||23
11226194|NCT01996813|12418533|FG001|COMPLETED|Overall Study||24
11226195|NCT01996813|12418532|FG000|NOT COMPLETED|Overall Study||0
11226196|NCT01996813|12418533|FG001|NOT COMPLETED|Overall Study||0
11226197|NCT01996826|12418541|FG000|STARTED|Overall Study||39
11226198|NCT01996826|12418542|FG001|STARTED|Overall Study||36
11226199|NCT01996826|12418541|FG000|COMPLETED|Overall Study||32
11226200|NCT01996826|12418542|FG001|COMPLETED|Overall Study||33
11226201|NCT01996826|12418541|FG000|NOT COMPLETED|Overall Study||7
11226202|NCT01996826|12418542|FG001|NOT COMPLETED|Overall Study||3
11226203|NCT01996839|12418551|FG000|STARTED|Overall Study||172
11226204|NCT01996839|12418552|FG001|STARTED|Overall Study||171
11226205|NCT01996839|12418553|FG002|STARTED|Overall Study||171
11107090|NCT01262456|12291576|FG000|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
11107091|NCT01262456|12291577|FG001|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
11107092|NCT01262456|12291578|FG002|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
11107093|NCT01262456|12291576|FG000|COMPLETED|3-Month Double-Blind Period||124
11107094|NCT01262456|12291577|FG001|COMPLETED|3-Month Double-Blind Period||100
11107095|NCT01262456|12291578|FG002|COMPLETED|3-Month Double-Blind Period||103
11107096|NCT01262456|12291576|FG000|NOT COMPLETED|3-Month Double-Blind Period||19
11107097|NCT01262456|12291577|FG001|NOT COMPLETED|3-Month Double-Blind Period||23
11107098|NCT01262456|12291578|FG002|NOT COMPLETED|3-Month Double-Blind Period||26
11107099|NCT01262456|12291576|FG000|STARTED|1-Month Open-Label Extension Period||124
11107100|NCT01262456|12291577|FG001|STARTED|1-Month Open-Label Extension Period||100
11107101|NCT01262456|12291578|FG002|STARTED|1-Month Open-Label Extension Period||103
11226206|NCT01996839|12418551|FG000|COMPLETED|Overall Study||80
11226207|NCT01996839|12418552|FG001|COMPLETED|Overall Study||133
11226208|NCT01996839|12418553|FG002|COMPLETED|Overall Study||139
11226209|NCT01996839|12418551|FG000|NOT COMPLETED|Overall Study||92
11226210|NCT01996839|12418552|FG001|NOT COMPLETED|Overall Study||38
11226211|NCT01996839|12418553|FG002|NOT COMPLETED|Overall Study||32
11226212|NCT01996904|12418563|FG000|STARTED|Overall Study||139
11226213|NCT01996904|12418564|FG001|STARTED|Overall Study||117
10856154|NCT02250326|12022324|FG001|STARTED|Follow-Up Period||43
10856155|NCT02250326|12022325|FG002|STARTED|Follow-Up Period||64
10856156|NCT02250326|12022323|FG000|COMPLETED|Follow-Up Period||18
10856157|NCT02250326|12022324|FG001|COMPLETED|Follow-Up Period||13
10856158|NCT02250326|12022325|FG002|COMPLETED|Follow-Up Period||26
10856159|NCT02250326|12022323|FG000|NOT COMPLETED|Follow-Up Period||49
10856160|NCT02250326|12022324|FG001|NOT COMPLETED|Follow-Up Period||30
10856161|NCT02250326|12022325|FG002|NOT COMPLETED|Follow-Up Period||38
10856162|NCT01856270|12022336|FG000|STARTED|Overall Study||24
10856163|NCT01856270|12022337|FG001|STARTED|Overall Study||26
10856164|NCT01856270|12022336|FG000|COMPLETED|Overall Study||13
10856165|NCT01856270|12022337|FG001|COMPLETED|Overall Study||14
10856166|NCT01856270|12022336|FG000|NOT COMPLETED|Overall Study||11
10856167|NCT01856270|12022337|FG001|NOT COMPLETED|Overall Study||12
10856168|NCT01503515|12022347|FG000|STARTED|Overall Study||145
10856169|NCT01503515|12022348|FG001|STARTED|Overall Study||147
10856170|NCT01503515|12022347|FG000|COMPLETED|Overall Study||124
10856171|NCT01503515|12022348|FG001|COMPLETED|Overall Study||112
10856172|NCT01503515|12022347|FG000|NOT COMPLETED|Overall Study||21
10856173|NCT01503515|12022348|FG001|NOT COMPLETED|Overall Study||35
10856174|NCT01491893|12022354|FG000|STARTED|Overall Study||1
10856175|NCT01491893|12022355|FG001|STARTED|Overall Study||1
10856176|NCT01491893|12022356|FG002|STARTED|Overall Study||1
10856177|NCT01491893|12022357|FG003|STARTED|Overall Study||1
10856178|NCT01491893|12022358|FG004|STARTED|Overall Study||4
10856179|NCT01491893|12022359|FG005|STARTED|Overall Study||1
10856180|NCT01491893|12022360|FG006|STARTED|Overall Study||6
10856181|NCT01491893|12022361|FG007|STARTED|Overall Study||24
10856182|NCT01491893|12022362|FG008|STARTED|Overall Study||15
10856183|NCT01491893|12022363|FG009|STARTED|Overall Study||7
10856184|NCT01491893|12022354|FG000|COMPLETED|Overall Study||1
10856185|NCT01491893|12022355|FG001|COMPLETED|Overall Study||1
10856186|NCT01491893|12022356|FG002|COMPLETED|Overall Study||1
10856187|NCT01491893|12022357|FG003|COMPLETED|Overall Study||1
10856188|NCT01491893|12022358|FG004|COMPLETED|Overall Study||4
10856189|NCT01491893|12022359|FG005|COMPLETED|Overall Study||1
10856190|NCT01491893|12022360|FG006|COMPLETED|Overall Study||6
10856191|NCT01491893|12022361|FG007|COMPLETED|Overall Study||24
10856192|NCT01491893|12022362|FG008|COMPLETED|Overall Study||15
10856193|NCT01491893|12022363|FG009|COMPLETED|Overall Study||7
10856194|NCT01491893|12022354|FG000|NOT COMPLETED|Overall Study||0
10856195|NCT01491893|12022355|FG001|NOT COMPLETED|Overall Study||0
10856196|NCT01491893|12022356|FG002|NOT COMPLETED|Overall Study||0
10856197|NCT01491893|12022357|FG003|NOT COMPLETED|Overall Study||0
10856198|NCT01491893|12022358|FG004|NOT COMPLETED|Overall Study||0
10856199|NCT01491893|12022359|FG005|NOT COMPLETED|Overall Study||0
10856200|NCT01491893|12022360|FG006|NOT COMPLETED|Overall Study||0
10856201|NCT01491893|12022361|FG007|NOT COMPLETED|Overall Study||0
10856202|NCT01491893|12022362|FG008|NOT COMPLETED|Overall Study||0
10856203|NCT01491893|12022363|FG009|NOT COMPLETED|Overall Study||0
10856204|NCT00245960|12022381|FG000|STARTED|Period 1 (Double Blind): 1-12 Weeks||379
10856205|NCT00245960|12022382|FG001|STARTED|Period 1 (Double Blind): 1-12 Weeks||373
10856206|NCT00245960|12022381|FG000|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||364
10856207|NCT00245960|12022382|FG001|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||362
10856208|NCT00245960|12022381|FG000|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||15
10856209|NCT00245960|12022382|FG001|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||11
10856210|NCT00245960|12022381|FG000|STARTED|Period 2 (Open Label): 13-24 Weeks||364
10856211|NCT00245960|12022382|FG001|STARTED|Period 2 (Open Label): 13-24 Weeks||362
10856212|NCT00245960|12022381|FG000|COMPLETED|Period 2 (Open Label): 13-24 Weeks||350
10856213|NCT00245960|12022382|FG001|COMPLETED|Period 2 (Open Label): 13-24 Weeks||344
10856214|NCT00245960|12022381|FG000|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||14
10856215|NCT00245960|12022382|FG001|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||18
10856216|NCT04565353|12022408|FG000|STARTED|Overall Study||3742
10856217|NCT04565353|12022409|FG001|STARTED|Overall Study||3737
10856218|NCT04565353|12022410|FG002|STARTED|Overall Study||3709
10856219|NCT04565353|12022411|FG003|STARTED|Overall Study||3735
10856220|NCT04565353|12022412|FG004|STARTED|Overall Study||3758
10856221|NCT04565353|12022413|FG005|STARTED|Overall Study||3769
10856222|NCT04565353|12022414|FG006|STARTED|Overall Study||3719
10856223|NCT04565353|12022415|FG007|STARTED|Overall Study||3732
10856224|NCT04565353|12022416|FG008|STARTED|Overall Study||3728
10856225|NCT04565353|12022417|FG009|STARTED|Overall Study||3777
10856226|NCT04565353|12022418|FG010|STARTED|Overall Study||3672
10856227|NCT04565353|12022419|FG011|STARTED|Overall Study||3751
10856228|NCT04565353|12022420|FG012|STARTED|Overall Study||3737
10856229|NCT04565353|12022421|FG013|STARTED|Overall Study||3714
10856230|NCT04565353|12022422|FG014|STARTED|Overall Study||3773
10856231|NCT04565353|12022423|FG015|STARTED|Overall Study||3739
10856232|NCT04565353|12022424|FG016|STARTED|Overall Study||3776
10856233|NCT04565353|12022425|FG017|STARTED|Overall Study||3744
10856234|NCT04565353|12022426|FG018|STARTED|Overall Study||3741
10856235|NCT04565353|12022427|FG019|STARTED|Overall Study||3758
10856236|NCT04565353|12022408|FG000|COMPLETED|Overall Study||3742
10856237|NCT04565353|12022409|FG001|COMPLETED|Overall Study||3688
10856238|NCT04565353|12022410|FG002|COMPLETED|Overall Study||3670
10856239|NCT04565353|12022411|FG003|COMPLETED|Overall Study||3693
10856240|NCT04565353|12022412|FG004|COMPLETED|Overall Study||3717
10856241|NCT04565353|12022413|FG005|COMPLETED|Overall Study||3716
10856242|NCT04565353|12022414|FG006|COMPLETED|Overall Study||3665
10856243|NCT04565353|12022415|FG007|COMPLETED|Overall Study||3693
10856244|NCT04565353|12022416|FG008|COMPLETED|Overall Study||3662
10856245|NCT04565353|12022417|FG009|COMPLETED|Overall Study||3734
10856246|NCT04565353|12022418|FG010|COMPLETED|Overall Study||3623
10856247|NCT04565353|12022419|FG011|COMPLETED|Overall Study||3710
10856248|NCT04565353|12022420|FG012|COMPLETED|Overall Study||3685
10856249|NCT04565353|12022421|FG013|COMPLETED|Overall Study||3664
10856250|NCT04565353|12022422|FG014|COMPLETED|Overall Study||3736
10856251|NCT04565353|12022423|FG015|COMPLETED|Overall Study||3690
10856252|NCT04565353|12022424|FG016|COMPLETED|Overall Study||3734
10856253|NCT04565353|12022425|FG017|COMPLETED|Overall Study||3696
10856254|NCT04565353|12022426|FG018|COMPLETED|Overall Study||3698
10856255|NCT04565353|12022427|FG019|COMPLETED|Overall Study||3712
10856256|NCT04565353|12022408|FG000|NOT COMPLETED|Overall Study||0
10856257|NCT04565353|12022409|FG001|NOT COMPLETED|Overall Study||49
10856258|NCT04565353|12022410|FG002|NOT COMPLETED|Overall Study||39
10856259|NCT04565353|12022411|FG003|NOT COMPLETED|Overall Study||42
10856260|NCT04565353|12022412|FG004|NOT COMPLETED|Overall Study||41
10856261|NCT04565353|12022413|FG005|NOT COMPLETED|Overall Study||53
10856262|NCT04565353|12022414|FG006|NOT COMPLETED|Overall Study||54
10856263|NCT04565353|12022415|FG007|NOT COMPLETED|Overall Study||39
10856264|NCT04565353|12022416|FG008|NOT COMPLETED|Overall Study||66
10856265|NCT04565353|12022417|FG009|NOT COMPLETED|Overall Study||43
10856266|NCT04565353|12022418|FG010|NOT COMPLETED|Overall Study||49
10856267|NCT04565353|12022419|FG011|NOT COMPLETED|Overall Study||41
10856268|NCT04565353|12022420|FG012|NOT COMPLETED|Overall Study||52
10856269|NCT04565353|12022421|FG013|NOT COMPLETED|Overall Study||50
10856270|NCT04565353|12022422|FG014|NOT COMPLETED|Overall Study||37
10856271|NCT04565353|12022423|FG015|NOT COMPLETED|Overall Study||49
10856272|NCT04565353|12022424|FG016|NOT COMPLETED|Overall Study||42
10856273|NCT04565353|12022425|FG017|NOT COMPLETED|Overall Study||48
10856274|NCT04565353|12022426|FG018|NOT COMPLETED|Overall Study||43
10856275|NCT04565353|12022427|FG019|NOT COMPLETED|Overall Study||46
10856276|NCT04015336|12022469|FG000|STARTED|Overall Study||1
10856277|NCT04015336|12022469|FG000|COMPLETED|Overall Study||0
10856278|NCT04015336|12022469|FG000|NOT COMPLETED|Overall Study||1
10856279|NCT03972813|12022491|FG000|STARTED|Overall Study||85
10856280|NCT03972813|12022492|FG001|STARTED|Overall Study||49
10856281|NCT03972813|12022493|FG002|STARTED|Overall Study||58
10856282|NCT03972813|12022494|FG003|STARTED|Overall Study||55
10856283|NCT03972813|12022495|FG004|STARTED|Overall Study||52
10856284|NCT03972813|12022496|FG005|STARTED|Overall Study||51
10856285|NCT03972813|12022497|FG006|STARTED|Overall Study||53
10856286|NCT03972813|12022498|FG007|STARTED|Overall Study||55
10856287|NCT03972813|12022499|FG008|STARTED|Overall Study||58
10856288|NCT03972813|12022500|FG009|STARTED|Overall Study||60
10856289|NCT03972813|12022501|FG010|STARTED|Overall Study||62
10856290|NCT03972813|12022502|FG011|STARTED|Overall Study||55
10856291|NCT03972813|12022503|FG012|STARTED|Overall Study||58
10856292|NCT03972813|12022504|FG013|STARTED|Overall Study||55
10856293|NCT03972813|12022505|FG014|STARTED|Overall Study||58
10856294|NCT03972813|12022506|FG015|STARTED|Overall Study||56
10856295|NCT03972813|12022507|FG016|STARTED|Overall Study||51
10856296|NCT03972813|12022508|FG017|STARTED|Overall Study||50
10856297|NCT03972813|12022491|FG000|COMPLETED|Overall Study||79
10856298|NCT03972813|12022492|FG001|COMPLETED|Overall Study||45
10856299|NCT03972813|12022493|FG002|COMPLETED|Overall Study||52
10856300|NCT03972813|12022494|FG003|COMPLETED|Overall Study||51
10856301|NCT03972813|12022495|FG004|COMPLETED|Overall Study||48
10856302|NCT03972813|12022496|FG005|COMPLETED|Overall Study||49
10856303|NCT03972813|12022497|FG006|COMPLETED|Overall Study||49
10856304|NCT03972813|12022498|FG007|COMPLETED|Overall Study||52
10856305|NCT03972813|12022499|FG008|COMPLETED|Overall Study||53
10856306|NCT03972813|12022500|FG009|COMPLETED|Overall Study||58
10856307|NCT03972813|12022501|FG010|COMPLETED|Overall Study||57
10856308|NCT03972813|12022502|FG011|COMPLETED|Overall Study||51
10856309|NCT03972813|12022503|FG012|COMPLETED|Overall Study||55
10856310|NCT03972813|12022504|FG013|COMPLETED|Overall Study||52
10856311|NCT03972813|12022505|FG014|COMPLETED|Overall Study||56
10856312|NCT03972813|12022506|FG015|COMPLETED|Overall Study||50
10856313|NCT03972813|12022507|FG016|COMPLETED|Overall Study||48
10856314|NCT03972813|12022508|FG017|COMPLETED|Overall Study||48
10856315|NCT03972813|12022491|FG000|NOT COMPLETED|Overall Study||6
10856316|NCT03972813|12022492|FG001|NOT COMPLETED|Overall Study||4
10856317|NCT03972813|12022493|FG002|NOT COMPLETED|Overall Study||6
10856318|NCT03972813|12022494|FG003|NOT COMPLETED|Overall Study||4
10856319|NCT03972813|12022495|FG004|NOT COMPLETED|Overall Study||4
10856320|NCT03972813|12022496|FG005|NOT COMPLETED|Overall Study||2
10856321|NCT03972813|12022497|FG006|NOT COMPLETED|Overall Study||4
10856322|NCT03972813|12022498|FG007|NOT COMPLETED|Overall Study||3
10856323|NCT03972813|12022499|FG008|NOT COMPLETED|Overall Study||5
10856324|NCT03972813|12022500|FG009|NOT COMPLETED|Overall Study||2
10856325|NCT03972813|12022501|FG010|NOT COMPLETED|Overall Study||5
10856326|NCT03972813|12022502|FG011|NOT COMPLETED|Overall Study||4
10856327|NCT03972813|12022503|FG012|NOT COMPLETED|Overall Study||3
10856328|NCT03972813|12022504|FG013|NOT COMPLETED|Overall Study||3
10856329|NCT03972813|12022505|FG014|NOT COMPLETED|Overall Study||2
10856330|NCT03972813|12022506|FG015|NOT COMPLETED|Overall Study||6
10856331|NCT03972813|12022507|FG016|NOT COMPLETED|Overall Study||3
10856332|NCT03972813|12022508|FG017|NOT COMPLETED|Overall Study||2
11107102|NCT01262456|12291576|FG000|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
11107103|NCT01262456|12291577|FG001|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
11107104|NCT01262456|12291578|FG002|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
11107105|NCT01262456|12291576|FG000|COMPLETED|1-Month Open-Label Extension Period||120
10856339|NCT03913091|12022560|FG000|STARTED|Overall Study||92
10856340|NCT03913091|12022561|FG001|STARTED|Overall Study||92
10856341|NCT03913091|12022560|FG000|COMPLETED|Overall Study||72
10856342|NCT03913091|12022561|FG001|COMPLETED|Overall Study||78
10856343|NCT03913091|12022560|FG000|NOT COMPLETED|Overall Study||20
10856344|NCT03913091|12022561|FG001|NOT COMPLETED|Overall Study||14
10856345|NCT03802565|12022572|FG000|STARTED|Overall Study||82
10856346|NCT03802565|12022573|FG001|STARTED|Overall Study||87
10856347|NCT03802565|12022574|FG002|STARTED|Overall Study||83
10856348|NCT03802565|12022575|FG003|STARTED|Overall Study||85
10856349|NCT03802565|12022576|FG004|STARTED|Overall Study||78
10856350|NCT03802565|12022572|FG000|COMPLETED|Overall Study||77
10856351|NCT03802565|12022573|FG001|COMPLETED|Overall Study||83
10856352|NCT03802565|12022574|FG002|COMPLETED|Overall Study||74
10856353|NCT03802565|12022575|FG003|COMPLETED|Overall Study||77
10856354|NCT03802565|12022576|FG004|COMPLETED|Overall Study||72
10856355|NCT03802565|12022572|FG000|NOT COMPLETED|Overall Study||5
10856356|NCT03802565|12022573|FG001|NOT COMPLETED|Overall Study||4
10856357|NCT03802565|12022574|FG002|NOT COMPLETED|Overall Study||9
10856358|NCT03802565|12022575|FG003|NOT COMPLETED|Overall Study||8
10856359|NCT03802565|12022576|FG004|NOT COMPLETED|Overall Study||6
10856360|NCT03769194|12022592|FG000|STARTED|Overall Study||29
10856361|NCT03769194|12022593|FG001|STARTED|Overall Study||214
10856362|NCT03769194|12022594|FG002|STARTED|Overall Study||205
10856363|NCT03769194|12022595|FG003|STARTED|Overall Study||124
10856364|NCT03769194|12022592|FG000|COMPLETED|Overall Study||25
10856365|NCT03769194|12022593|FG001|COMPLETED|Overall Study||196
10856366|NCT03769194|12022594|FG002|COMPLETED|Overall Study||197
10856367|NCT03769194|12022595|FG003|COMPLETED|Overall Study||115
10856368|NCT03769194|12022592|FG000|NOT COMPLETED|Overall Study||4
10856369|NCT03769194|12022593|FG001|NOT COMPLETED|Overall Study||18
10856370|NCT03769194|12022594|FG002|NOT COMPLETED|Overall Study||8
10856371|NCT03769194|12022595|FG003|NOT COMPLETED|Overall Study||9
10856372|NCT03738332|12022605|FG000|STARTED|Overall Study||12
10856373|NCT03738332|12022605|FG000|COMPLETED|Overall Study||11
10856374|NCT03738332|12022605|FG000|NOT COMPLETED|Overall Study||1
10856375|NCT03451786|12022610|FG000|STARTED|Overall Study||369
10856376|NCT03451786|12022610|FG000|COMPLETED|Overall Study||310
10856377|NCT03451786|12022610|FG000|NOT COMPLETED|Overall Study||59
10856378|NCT03416179|12022618|FG000|STARTED|Overall Study||201
10856379|NCT03416179|12022619|FG001|STARTED|Overall Study||203
10856380|NCT03416179|12022620|FG002|STARTED|Overall Study||163
10856381|NCT03416179|12022621|FG003|STARTED|Overall Study||162
10856382|NCT03416179|12022618|FG000|COMPLETED|Overall Study||0
10856383|NCT03416179|12022619|FG001|COMPLETED|Overall Study||0
10856384|NCT03416179|12022620|FG002|COMPLETED|Overall Study||0
10856385|NCT03416179|12022621|FG003|COMPLETED|Overall Study||0
10856386|NCT03416179|12022618|FG000|NOT COMPLETED|Overall Study||201
10856387|NCT03416179|12022619|FG001|NOT COMPLETED|Overall Study||203
10856388|NCT03416179|12022620|FG002|NOT COMPLETED|Overall Study||163
10856389|NCT03416179|12022621|FG003|NOT COMPLETED|Overall Study||162
10856390|NCT03353922|12022631|FG000|STARTED|Overall Study||6
10856391|NCT03353922|12022632|FG001|STARTED|Overall Study||6
10856392|NCT03353922|12022633|FG002|STARTED|Overall Study||6
10856393|NCT03353922|12022634|FG003|STARTED|Overall Study||6
10856394|NCT03353922|12022635|FG004|STARTED|Overall Study||5
10856395|NCT03353922|12022636|FG005|STARTED|Overall Study||6
10856396|NCT03353922|12022631|FG000|COMPLETED|Overall Study||5
10856397|NCT03353922|12022632|FG001|COMPLETED|Overall Study||5
10856398|NCT03353922|12022633|FG002|COMPLETED|Overall Study||5
10856399|NCT03353922|12022634|FG003|COMPLETED|Overall Study||5
10856400|NCT03353922|12022635|FG004|COMPLETED|Overall Study||5
10856401|NCT03353922|12022636|FG005|COMPLETED|Overall Study||6
10856402|NCT03353922|12022631|FG000|NOT COMPLETED|Overall Study||1
10856403|NCT03353922|12022632|FG001|NOT COMPLETED|Overall Study||1
10856404|NCT03353922|12022633|FG002|NOT COMPLETED|Overall Study||1
10856405|NCT03353922|12022634|FG003|NOT COMPLETED|Overall Study||1
10856406|NCT03353922|12022635|FG004|NOT COMPLETED|Overall Study||0
10856407|NCT03353922|12022636|FG005|NOT COMPLETED|Overall Study||0
10856408|NCT03322384|12022647|FG000|STARTED|Overall Study||20
10856409|NCT03322384|12022647|FG000|COMPLETED|Overall Study||14
10856410|NCT03322384|12022647|FG000|NOT COMPLETED|Overall Study||6
10856411|NCT03243071|12022653|FG000|STARTED|Overall Study||59
10856412|NCT03243071|12022654|FG001|STARTED|Overall Study||53
10856413|NCT03243071|12022653|FG000|COMPLETED|Overall Study||59
10856414|NCT03243071|12022654|FG001|COMPLETED|Overall Study||53
10856415|NCT03243071|12022653|FG000|NOT COMPLETED|Overall Study||0
10856416|NCT03243071|12022654|FG001|NOT COMPLETED|Overall Study||0
10856417|NCT03173456|12022671|FG000|STARTED|Baseline||120
10856418|NCT03173456|12022672|FG001|STARTED|Baseline||120
10856419|NCT03173456|12022673|FG002|STARTED|Baseline||120
10856420|NCT03173456|12022674|FG003|STARTED|Baseline||120
10856421|NCT03173456|12022675|FG004|STARTED|Baseline||120
10856422|NCT03173456|12022671|FG000|COMPLETED|Baseline||120
10856423|NCT03173456|12022672|FG001|COMPLETED|Baseline||119
10856424|NCT03173456|12022673|FG002|COMPLETED|Baseline||120
10856425|NCT03173456|12022674|FG003|COMPLETED|Baseline||120
10856426|NCT03173456|12022675|FG004|COMPLETED|Baseline||118
10856427|NCT03173456|12022671|FG000|NOT COMPLETED|Baseline||0
10856428|NCT03173456|12022672|FG001|NOT COMPLETED|Baseline||1
10856429|NCT03173456|12022673|FG002|NOT COMPLETED|Baseline||0
10856430|NCT03173456|12022674|FG003|NOT COMPLETED|Baseline||0
10856431|NCT03173456|12022675|FG004|NOT COMPLETED|Baseline||2
10856432|NCT03173456|12022671|FG000|STARTED|2 Hour Follow-up||120
10856433|NCT03173456|12022672|FG001|STARTED|2 Hour Follow-up||119
10856434|NCT03173456|12022673|FG002|STARTED|2 Hour Follow-up||120
10856435|NCT03173456|12022674|FG003|STARTED|2 Hour Follow-up||120
10856436|NCT03173456|12022675|FG004|STARTED|2 Hour Follow-up||118
10856437|NCT03173456|12022671|FG000|COMPLETED|2 Hour Follow-up||120
10856438|NCT03173456|12022672|FG001|COMPLETED|2 Hour Follow-up||118
10856439|NCT03173456|12022673|FG002|COMPLETED|2 Hour Follow-up||119
10856440|NCT03173456|12022674|FG003|COMPLETED|2 Hour Follow-up||119
10856441|NCT03173456|12022675|FG004|COMPLETED|2 Hour Follow-up||116
10856442|NCT03173456|12022671|FG000|NOT COMPLETED|2 Hour Follow-up||0
10856443|NCT03173456|12022672|FG001|NOT COMPLETED|2 Hour Follow-up||1
10856444|NCT03173456|12022673|FG002|NOT COMPLETED|2 Hour Follow-up||1
10856445|NCT03173456|12022674|FG003|NOT COMPLETED|2 Hour Follow-up||1
10856446|NCT03173456|12022675|FG004|NOT COMPLETED|2 Hour Follow-up||2
10856447|NCT03101566|12022689|FG000|STARTED|Overall Study||37
10856448|NCT03101566|12022690|FG001|STARTED|Overall Study||38
10856449|NCT03101566|12022689|FG000|Received at Least One Dose of Protocol Therapy|Overall Study||35
10856450|NCT03101566|12022690|FG001|Received at Least One Dose of Protocol Therapy|Overall Study||33
10856451|NCT03101566|12022689|FG000|Assessed for Primary and Secondary Progression-free Survival|Overall Study||32
10856452|NCT03101566|12022690|FG001|Assessed for Primary and Secondary Progression-free Survival|Overall Study||33
10856453|NCT03101566|12022689|FG000|COMPLETED|Overall Study||31
10856454|NCT03101566|12022690|FG001|COMPLETED|Overall Study||31
10856455|NCT03101566|12022689|FG000|NOT COMPLETED|Overall Study||6
10856456|NCT03101566|12022690|FG001|NOT COMPLETED|Overall Study||7
11107106|NCT01262456|12291577|FG001|COMPLETED|1-Month Open-Label Extension Period||97
11107107|NCT01262456|12291578|FG002|COMPLETED|1-Month Open-Label Extension Period||98
11107108|NCT01262456|12291576|FG000|NOT COMPLETED|1-Month Open-Label Extension Period||4
11107109|NCT01262456|12291577|FG001|NOT COMPLETED|1-Month Open-Label Extension Period||3
11107110|NCT01262456|12291578|FG002|NOT COMPLETED|1-Month Open-Label Extension Period||5
11107111|NCT01262547|12291594|FG000|STARTED|Overall Study||3
11107112|NCT01262547|12291594|FG000|COMPLETED|Overall Study||3
11107113|NCT01262547|12291594|FG000|NOT COMPLETED|Overall Study||0
11107114|NCT01262560|12291606|FG000|STARTED|Overall Study||53
11107115|NCT01262560|12291607|FG001|STARTED|Overall Study||54
11107116|NCT01262560|12291608|FG002|STARTED|Overall Study||56
11107117|NCT01262560|12291606|FG000|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
11107118|NCT01262560|12291607|FG001|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
11107119|NCT01262560|12291608|FG002|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
11107120|NCT01262560|12291606|FG000|NOT COMPLETED|Overall Study||0
11107121|NCT01262560|12291607|FG001|NOT COMPLETED|Overall Study||1
11107122|NCT01262560|12291608|FG002|NOT COMPLETED|Overall Study||2
11107123|NCT01262573|12291618|FG000|STARTED|Overall Study||32
11107124|NCT01262573|12291619|FG001|STARTED|Overall Study||32
11107125|NCT01262573|12291618|FG000|COMPLETED|Overall Study||32
11107126|NCT01262573|12291619|FG001|COMPLETED|Overall Study||31
11107127|NCT01262573|12291618|FG000|NOT COMPLETED|Overall Study||0
11107128|NCT01262573|12291619|FG001|NOT COMPLETED|Overall Study||1
11107129|NCT01262599|12291627|FG000|STARTED|Overall Study||16
11107130|NCT01262599|12291628|FG001|STARTED|Overall Study||16
11107131|NCT01262599|12291627|FG000|COMPLETED|Overall Study||16
11107132|NCT01262599|12291628|FG001|COMPLETED|Overall Study||16
11107133|NCT01262599|12291627|FG000|NOT COMPLETED|Overall Study||0
11107134|NCT01262599|12291628|FG001|NOT COMPLETED|Overall Study||0
11354802|NCT03075410|12551816|FG006|STARTED|Part A-Washout Period 2 (14 Days)||0
11354803|NCT03075410|12551817|FG007|STARTED|Part A-Washout Period 2 (14 Days)||0
11354804|NCT03075410|12551818|FG008|STARTED|Part A-Washout Period 2 (14 Days)||0
11354805|NCT03075410|12551810|FG000|COMPLETED|Part A-Washout Period 2 (14 Days)||1
11107135|NCT01262638|12291640|FG000|STARTED|Overall Study||45
11107136|NCT01262638|12291641|FG001|STARTED|Overall Study||44
11107137|NCT01262638|12291642|FG002|STARTED|Overall Study||44
11107138|NCT01262638|12291643|FG003|STARTED|Overall Study||44
11107139|NCT01262638|12291640|FG000|COMPLETED|Overall Study||38
11107140|NCT01262638|12291641|FG001|COMPLETED|Overall Study||38
11107141|NCT01262638|12291642|FG002|COMPLETED|Overall Study||38
11107142|NCT01262638|12291643|FG003|COMPLETED|Overall Study||37
11107143|NCT01262638|12291640|FG000|NOT COMPLETED|Overall Study||7
11107144|NCT01262638|12291641|FG001|NOT COMPLETED|Overall Study||6
11107145|NCT01262638|12291642|FG002|NOT COMPLETED|Overall Study||6
11226214|NCT01996904|12418563|FG000|COMPLETED|Overall Study||101
11226215|NCT01996904|12418564|FG001|COMPLETED|Overall Study||90
11226216|NCT01996904|12418563|FG000|NOT COMPLETED|Overall Study||38
10856500|NCT02820753|12022752|FG000|STARTED|Baseline||256
10856501|NCT02820753|12022753|FG001|STARTED|Baseline||421
10856502|NCT02820753|12022752|FG000|COMPLETED|Baseline||256
10856503|NCT02820753|12022753|FG001|COMPLETED|Baseline||421
10856504|NCT02820753|12022752|FG000|NOT COMPLETED|Baseline||0
11354806|NCT03075410|12551811|FG001|COMPLETED|Part A-Washout Period 2 (14 Days)||1
11354807|NCT03075410|12551812|FG002|COMPLETED|Part A-Washout Period 2 (14 Days)||1
11354808|NCT03075410|12551813|FG003|COMPLETED|Part A-Washout Period 2 (14 Days)||1
11354809|NCT03075410|12551814|FG004|COMPLETED|Part A-Washout Period 2 (14 Days)||2
11354810|NCT03075410|12551815|FG005|COMPLETED|Part A-Washout Period 2 (14 Days)||1
11354811|NCT03075410|12551816|FG006|COMPLETED|Part A-Washout Period 2 (14 Days)||0
11354812|NCT03075410|12551817|FG007|COMPLETED|Part A-Washout Period 2 (14 Days)||0
11354813|NCT03075410|12551818|FG008|COMPLETED|Part A-Washout Period 2 (14 Days)||0
11354814|NCT03075410|12551810|FG000|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
11354815|NCT03075410|12551811|FG001|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
11354816|NCT03075410|12551812|FG002|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
11354817|NCT03075410|12551813|FG003|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
11354818|NCT03075410|12551814|FG004|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
11354819|NCT03075410|12551815|FG005|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
11354820|NCT03075410|12551816|FG006|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
11354821|NCT03075410|12551817|FG007|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
11354822|NCT03075410|12551818|FG008|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
11354823|NCT03075410|12551810|FG000|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
11354824|NCT03075410|12551811|FG001|STARTED|Part A-Period 3 (14 Days)||1
11354825|NCT03075410|12551812|FG002|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
11354826|NCT03075410|12551813|FG003|STARTED|Part A-Period 3 (14 Days)||1
10856505|NCT02820753|12022753|FG001|NOT COMPLETED|Baseline||0
10856506|NCT02820753|12022752|FG000|STARTED|2 Month||256
10856507|NCT02820753|12022753|FG001|STARTED|2 Month||421
10856508|NCT02820753|12022752|FG000|COMPLETED|2 Month||178
10856509|NCT02820753|12022753|FG001|COMPLETED|2 Month||379
10856510|NCT02820753|12022752|FG000|NOT COMPLETED|2 Month||78
10856511|NCT02820753|12022753|FG001|NOT COMPLETED|2 Month||42
10856512|NCT02820753|12022752|FG000|STARTED|6 Month||253
10856513|NCT02820753|12022753|FG001|STARTED|6 Month||418
10856514|NCT02820753|12022752|FG000|COMPLETED|6 Month||150
10856515|NCT02820753|12022753|FG001|COMPLETED|6 Month||307
10856516|NCT02820753|12022752|FG000|NOT COMPLETED|6 Month||103
10856517|NCT02820753|12022753|FG001|NOT COMPLETED|6 Month||111
10856518|NCT02733042|12022778|FG000|STARTED|Treatment Period||3
10856519|NCT02733042|12022779|FG001|STARTED|Treatment Period||3
10856520|NCT02733042|12022780|FG002|STARTED|Treatment Period||8
11226217|NCT01996904|12418564|FG001|NOT COMPLETED|Overall Study||27
11226218|NCT01996917|12418570|FG000|STARTED|Overall Study||21
11226219|NCT01996917|12418570|FG000|COMPLETED|Overall Study||21
11226220|NCT01996917|12418570|FG000|NOT COMPLETED|Overall Study||0
11226221|NCT01996943|12418577|FG000|STARTED|Overall Study||50
11226222|NCT01996943|12418578|FG001|STARTED|Overall Study||50
11226223|NCT01996943|12418577|FG000|COMPLETED|Overall Study||50
11226224|NCT01996943|12418578|FG001|COMPLETED|Overall Study||50
11354827|NCT03075410|12551814|FG004|STARTED|Part A-Period 3 (14 Days)||2
11354828|NCT03075410|12551815|FG005|STARTED|Part A-Period 3 (14 Days)||1
11354829|NCT03075410|12551816|FG006|STARTED|Part A-Period 3 (14 Days)||0
11354830|NCT03075410|12551817|FG007|STARTED|Part A-Period 3 (14 Days)||0
11354831|NCT03075410|12551818|FG008|STARTED|Part A-Period 3 (14 Days)||0
11354832|NCT03075410|12551810|FG000|COMPLETED|Part A-Period 3 (14 Days)||1
11354833|NCT03075410|12551811|FG001|COMPLETED|Part A-Period 3 (14 Days)||1
11354834|NCT03075410|12551812|FG002|COMPLETED|Part A-Period 3 (14 Days)||2
11354835|NCT03075410|12551813|FG003|COMPLETED|Part A-Period 3 (14 Days)||1
11354836|NCT03075410|12551814|FG004|COMPLETED|Part A-Period 3 (14 Days)||2
11354837|NCT03075410|12551815|FG005|COMPLETED|Part A-Period 3 (14 Days)||1
11354838|NCT03075410|12551816|FG006|COMPLETED|Part A-Period 3 (14 Days)||0
11354839|NCT03075410|12551817|FG007|COMPLETED|Part A-Period 3 (14 Days)||0
11354840|NCT03075410|12551818|FG008|COMPLETED|Part A-Period 3 (14 Days)||0
11354841|NCT03075410|12551810|FG000|NOT COMPLETED|Part A-Period 3 (14 Days)||1
11354842|NCT03075410|12551811|FG001|NOT COMPLETED|Part A-Period 3 (14 Days)||0
11354843|NCT03075410|12551812|FG002|NOT COMPLETED|Part A-Period 3 (14 Days)||0
11354844|NCT03075410|12551813|FG003|NOT COMPLETED|Part A-Period 3 (14 Days)||0
11354845|NCT03075410|12551814|FG004|NOT COMPLETED|Part A-Period 3 (14 Days)||0
11354846|NCT03075410|12551815|FG005|NOT COMPLETED|Part A-Period 3 (14 Days)||0
11354847|NCT03075410|12551816|FG006|NOT COMPLETED|Part A-Period 3 (14 Days)||0
11354848|NCT03075410|12551817|FG007|NOT COMPLETED|Part A-Period 3 (14 Days)||0
11354849|NCT03075410|12551818|FG008|NOT COMPLETED|Part A-Period 3 (14 Days)||0
11354850|NCT03075410|12551810|FG000|STARTED|Part A-Washout Period 3 (14 Days)||1
11354851|NCT03075410|12551811|FG001|STARTED|Part A-Washout Period 3 (14 Days)||1
11354852|NCT03075410|12551812|FG002|STARTED|Part A-Washout Period 3 (14 Days)||2
11354853|NCT03075410|12551813|FG003|STARTED|Part A-Washout Period 3 (14 Days)||1
11354854|NCT03075410|12551814|FG004|STARTED|Part A-Washout Period 3 (14 Days)||2
11354855|NCT03075410|12551815|FG005|STARTED|Part A-Washout Period 3 (14 Days)||1
11354856|NCT03075410|12551816|FG006|STARTED|Part A-Washout Period 3 (14 Days)||0
11354857|NCT03075410|12551817|FG007|STARTED|Part A-Washout Period 3 (14 Days)||0
11354858|NCT03075410|12551818|FG008|STARTED|Part A-Washout Period 3 (14 Days)||0
11354859|NCT03075410|12551810|FG000|COMPLETED|Part A-Washout Period 3 (14 Days)||1
11354860|NCT03075410|12551811|FG001|COMPLETED|Part A-Washout Period 3 (14 Days)||1
11354861|NCT03075410|12551812|FG002|COMPLETED|Part A-Washout Period 3 (14 Days)||2
11354862|NCT03075410|12551813|FG003|COMPLETED|Part A-Washout Period 3 (14 Days)||1
10856521|NCT02733042|12022781|FG003|STARTED|Treatment Period||3
10856522|NCT02733042|12022782|FG004|STARTED|Treatment Period||4
10856523|NCT02733042|12022783|FG005|STARTED|Treatment Period||3
11354863|NCT03075410|12551814|FG004|COMPLETED|Part A-Washout Period 3 (14 Days)||2
11354864|NCT03075410|12551815|FG005|COMPLETED|Part A-Washout Period 3 (14 Days)||1
11354865|NCT03075410|12551816|FG006|COMPLETED|Part A-Washout Period 3 (14 Days)||0
11354866|NCT03075410|12551817|FG007|COMPLETED|Part A-Washout Period 3 (14 Days)||0
11354867|NCT03075410|12551818|FG008|COMPLETED|Part A-Washout Period 3 (14 Days)||0
11354868|NCT03075410|12551810|FG000|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
11354869|NCT03075410|12551811|FG001|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
11354870|NCT03075410|12551812|FG002|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10856524|NCT02733042|12022784|FG006|STARTED|Treatment Period||1
10856525|NCT02733042|12022785|FG007|STARTED|Treatment Period||4
11226225|NCT01996943|12418577|FG000|NOT COMPLETED|Overall Study||0
11354871|NCT03075410|12551813|FG003|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
10856526|NCT02733042|12022786|FG008|STARTED|Treatment Period||5
10856527|NCT02733042|12022787|FG009|STARTED|Treatment Period||10
10856528|NCT02733042|12022788|FG010|STARTED|Treatment Period||10
10856529|NCT02733042|12022789|FG011|STARTED|Treatment Period||10
10856530|NCT02733042|12022790|FG012|STARTED|Treatment Period||10
10856531|NCT02733042|12022791|FG013|STARTED|Treatment Period||5
10856532|NCT02733042|12022792|FG014|STARTED|Treatment Period||5
10856533|NCT02733042|12022793|FG015|STARTED|Treatment Period||10
10856534|NCT02733042|12022794|FG016|STARTED|Treatment Period||2
10856535|NCT02733042|12022795|FG017|STARTED|Treatment Period||5
10856536|NCT02733042|12022796|FG018|STARTED|Treatment Period||5
10856537|NCT02733042|12022778|FG000|COMPLETED|Treatment Period||0
10856538|NCT02733042|12022779|FG001|COMPLETED|Treatment Period||1
10856539|NCT02733042|12022780|FG002|COMPLETED|Treatment Period||1
10856540|NCT02733042|12022781|FG003|COMPLETED|Treatment Period||0
10856541|NCT02733042|12022782|FG004|COMPLETED|Treatment Period||0
10856542|NCT02733042|12022783|FG005|COMPLETED|Treatment Period||0
10856543|NCT02733042|12022784|FG006|COMPLETED|Treatment Period||0
10856544|NCT02733042|12022785|FG007|COMPLETED|Treatment Period||1
10856545|NCT02733042|12022786|FG008|COMPLETED|Treatment Period||0
10856546|NCT02733042|12022787|FG009|COMPLETED|Treatment Period||0
10856547|NCT02733042|12022788|FG010|COMPLETED|Treatment Period||0
10856548|NCT02733042|12022789|FG011|COMPLETED|Treatment Period||4
10856549|NCT02733042|12022790|FG012|COMPLETED|Treatment Period||1
10856550|NCT02733042|12022791|FG013|COMPLETED|Treatment Period||1
10856551|NCT02733042|12022792|FG014|COMPLETED|Treatment Period||0
10856552|NCT02733042|12022793|FG015|COMPLETED|Treatment Period||0
10856553|NCT02733042|12022794|FG016|COMPLETED|Treatment Period||0
10856554|NCT02733042|12022795|FG017|COMPLETED|Treatment Period||0
10856555|NCT02733042|12022796|FG018|COMPLETED|Treatment Period||0
10856556|NCT02733042|12022778|FG000|NOT COMPLETED|Treatment Period||3
10856557|NCT02733042|12022779|FG001|NOT COMPLETED|Treatment Period||2
10856558|NCT02733042|12022780|FG002|NOT COMPLETED|Treatment Period||7
10856559|NCT02733042|12022781|FG003|NOT COMPLETED|Treatment Period||3
10856560|NCT02733042|12022782|FG004|NOT COMPLETED|Treatment Period||4
10856561|NCT02733042|12022783|FG005|NOT COMPLETED|Treatment Period||3
10856562|NCT02733042|12022784|FG006|NOT COMPLETED|Treatment Period||1
10856563|NCT02733042|12022785|FG007|NOT COMPLETED|Treatment Period||3
10856564|NCT02733042|12022786|FG008|NOT COMPLETED|Treatment Period||5
10856565|NCT02733042|12022787|FG009|NOT COMPLETED|Treatment Period||10
10856566|NCT02733042|12022788|FG010|NOT COMPLETED|Treatment Period||10
10856567|NCT02733042|12022789|FG011|NOT COMPLETED|Treatment Period||6
10856568|NCT02733042|12022790|FG012|NOT COMPLETED|Treatment Period||9
10856569|NCT02733042|12022791|FG013|NOT COMPLETED|Treatment Period||4
10856570|NCT02733042|12022792|FG014|NOT COMPLETED|Treatment Period||5
10856571|NCT02733042|12022793|FG015|NOT COMPLETED|Treatment Period||10
10856572|NCT02733042|12022794|FG016|NOT COMPLETED|Treatment Period||2
10856573|NCT02733042|12022795|FG017|NOT COMPLETED|Treatment Period||5
10856574|NCT02733042|12022796|FG018|NOT COMPLETED|Treatment Period||5
10856575|NCT02733042|12022778|FG000|STARTED|Follow-up Period||3
10856576|NCT02733042|12022779|FG001|STARTED|Follow-up Period||3
10856577|NCT02733042|12022780|FG002|STARTED|Follow-up Period||6
10856578|NCT02733042|12022781|FG003|STARTED|Follow-up Period||3
10856579|NCT02733042|12022782|FG004|STARTED|Follow-up Period||1
10856580|NCT02733042|12022783|FG005|STARTED|Follow-up Period||2
10856581|NCT02733042|12022784|FG006|STARTED|Follow-up Period||0
10856582|NCT02733042|12022785|FG007|STARTED|Follow-up Period||4
10856583|NCT02733042|12022786|FG008|STARTED|Follow-up Period||4
10856584|NCT02733042|12022787|FG009|STARTED|Follow-up Period||2
10856585|NCT02733042|12022788|FG010|STARTED|Follow-up Period||5
10856586|NCT02733042|12022789|FG011|STARTED|Follow-up Period||9
10856587|NCT02733042|12022790|FG012|STARTED|Follow-up Period||9
10856588|NCT02733042|12022791|FG013|STARTED|Follow-up Period||4
10856589|NCT02733042|12022792|FG014|STARTED|Follow-up Period||1
10856590|NCT02733042|12022793|FG015|STARTED|Follow-up Period||5
10856591|NCT02733042|12022794|FG016|STARTED|Follow-up Period||0
10856592|NCT02733042|12022795|FG017|STARTED|Follow-up Period||3
10856593|NCT02733042|12022796|FG018|STARTED|Follow-up Period||2
10856594|NCT02733042|12022778|FG000|COMPLETED|Follow-up Period||0
10856595|NCT02733042|12022779|FG001|COMPLETED|Follow-up Period||0
10856596|NCT02733042|12022780|FG002|COMPLETED|Follow-up Period||0
10856597|NCT02733042|12022781|FG003|COMPLETED|Follow-up Period||0
10856598|NCT02733042|12022782|FG004|COMPLETED|Follow-up Period||0
10856599|NCT02733042|12022783|FG005|COMPLETED|Follow-up Period||0
10856600|NCT02733042|12022784|FG006|COMPLETED|Follow-up Period||0
10856601|NCT02733042|12022785|FG007|COMPLETED|Follow-up Period||0
10856602|NCT02733042|12022786|FG008|COMPLETED|Follow-up Period||0
10856603|NCT02733042|12022787|FG009|COMPLETED|Follow-up Period||0
10856604|NCT02733042|12022788|FG010|COMPLETED|Follow-up Period||0
10856605|NCT02733042|12022789|FG011|COMPLETED|Follow-up Period||0
10856606|NCT02733042|12022790|FG012|COMPLETED|Follow-up Period||0
10856607|NCT02733042|12022791|FG013|COMPLETED|Follow-up Period||0
10856608|NCT02733042|12022792|FG014|COMPLETED|Follow-up Period||0
10856609|NCT02733042|12022793|FG015|COMPLETED|Follow-up Period||0
10856610|NCT02733042|12022794|FG016|COMPLETED|Follow-up Period||0
10856611|NCT02733042|12022795|FG017|COMPLETED|Follow-up Period||1
10856612|NCT02733042|12022796|FG018|COMPLETED|Follow-up Period||0
10856613|NCT02733042|12022778|FG000|NOT COMPLETED|Follow-up Period||3
10856614|NCT02733042|12022779|FG001|NOT COMPLETED|Follow-up Period||3
10856615|NCT02733042|12022780|FG002|NOT COMPLETED|Follow-up Period||6
10856616|NCT02733042|12022781|FG003|NOT COMPLETED|Follow-up Period||3
10856617|NCT02733042|12022782|FG004|NOT COMPLETED|Follow-up Period||1
10856618|NCT02733042|12022783|FG005|NOT COMPLETED|Follow-up Period||2
10856619|NCT02733042|12022784|FG006|NOT COMPLETED|Follow-up Period||0
10856620|NCT02733042|12022785|FG007|NOT COMPLETED|Follow-up Period||4
10856621|NCT02733042|12022786|FG008|NOT COMPLETED|Follow-up Period||4
10856622|NCT02733042|12022787|FG009|NOT COMPLETED|Follow-up Period||2
10856623|NCT02733042|12022788|FG010|NOT COMPLETED|Follow-up Period||5
10856624|NCT02733042|12022789|FG011|NOT COMPLETED|Follow-up Period||9
10856625|NCT02733042|12022790|FG012|NOT COMPLETED|Follow-up Period||9
10856626|NCT02733042|12022791|FG013|NOT COMPLETED|Follow-up Period||4
10856627|NCT02733042|12022792|FG014|NOT COMPLETED|Follow-up Period||1
10856628|NCT02733042|12022793|FG015|NOT COMPLETED|Follow-up Period||5
10856629|NCT02733042|12022794|FG016|NOT COMPLETED|Follow-up Period||0
10856630|NCT02733042|12022795|FG017|NOT COMPLETED|Follow-up Period||2
10856631|NCT02733042|12022796|FG018|NOT COMPLETED|Follow-up Period||2
10856632|NCT02668874|12022846|FG000|STARTED|Overall Study||104
10856633|NCT02668874|12022847|FG001|STARTED|Overall Study||104
10856634|NCT02668874|12022846|FG000|6 Months After Placement|Overall Study||59
10856635|NCT02668874|12022847|FG001|6 Months After Placement|Overall Study||59
10856636|NCT02668874|12022846|FG000|COMPLETED|Overall Study||47
10856637|NCT02668874|12022847|FG001|COMPLETED|Overall Study||47
10856638|NCT02668874|12022846|FG000|NOT COMPLETED|Overall Study||57
10856639|NCT02668874|12022847|FG001|NOT COMPLETED|Overall Study||57
10856640|NCT02609737|12022853|FG000|STARTED|Overall Study||20
10856641|NCT02609737|12022853|FG000|COMPLETED|Overall Study||20
10856642|NCT02609737|12022853|FG000|NOT COMPLETED|Overall Study||0
10856643|NCT02574286|12022857|FG000|STARTED|Overall Study||21
10856644|NCT02574286|12022857|FG000|COMPLETED|Overall Study||16
10856645|NCT02574286|12022857|FG000|NOT COMPLETED|Overall Study||5
10856646|NCT02471144|12022865|FG000|STARTED|Induction Period (Up to Week 12)||40
10856647|NCT02471144|12022866|FG001|STARTED|Induction Period (Up to Week 12)||40
10856648|NCT02471144|12022867|FG002|STARTED|Induction Period (Up to Week 12)||41
10856649|NCT02471144|12022868|FG003|STARTED|Induction Period (Up to Week 12)||41
10856650|NCT02471144|12022869|FG004|STARTED|Induction Period (Up to Week 12)||0
10856651|NCT02471144|12022870|FG005|STARTED|Induction Period (Up to Week 12)||0
10856652|NCT02471144|12022871|FG006|STARTED|Induction Period (Up to Week 12)||0
10856653|NCT02471144|12022872|FG007|STARTED|Induction Period (Up to Week 12)||0
10856654|NCT02471144|12022873|FG008|STARTED|Induction Period (Up to Week 12)||0
10856655|NCT02471144|12022874|FG009|STARTED|Induction Period (Up to Week 12)||0
10856656|NCT02471144|12022875|FG010|STARTED|Induction Period (Up to Week 12)||0
10856657|NCT02471144|12022865|FG000|COMPLETED|Induction Period (Up to Week 12)||39
10856658|NCT02471144|12022866|FG001|COMPLETED|Induction Period (Up to Week 12)||38
10856659|NCT02471144|12022867|FG002|COMPLETED|Induction Period (Up to Week 12)||39
10856660|NCT02471144|12022868|FG003|COMPLETED|Induction Period (Up to Week 12)||40
10856661|NCT02471144|12022869|FG004|COMPLETED|Induction Period (Up to Week 12)||0
10856662|NCT02471144|12022870|FG005|COMPLETED|Induction Period (Up to Week 12)||0
10856663|NCT02471144|12022871|FG006|COMPLETED|Induction Period (Up to Week 12)||0
10856664|NCT02471144|12022872|FG007|COMPLETED|Induction Period (Up to Week 12)||0
10856665|NCT02471144|12022873|FG008|COMPLETED|Induction Period (Up to Week 12)||0
10856666|NCT02471144|12022874|FG009|COMPLETED|Induction Period (Up to Week 12)||0
10856667|NCT02471144|12022875|FG010|COMPLETED|Induction Period (Up to Week 12)||0
10856668|NCT02471144|12022865|FG000|NOT COMPLETED|Induction Period (Up to Week 12)||1
10856669|NCT02471144|12022866|FG001|NOT COMPLETED|Induction Period (Up to Week 12)||2
10856670|NCT02471144|12022867|FG002|NOT COMPLETED|Induction Period (Up to Week 12)||2
10856671|NCT02471144|12022868|FG003|NOT COMPLETED|Induction Period (Up to Week 12)||1
10856672|NCT02471144|12022869|FG004|NOT COMPLETED|Induction Period (Up to Week 12)||0
10856673|NCT02471144|12022870|FG005|NOT COMPLETED|Induction Period (Up to Week 12)||0
10856674|NCT02471144|12022871|FG006|NOT COMPLETED|Induction Period (Up to Week 12)||0
10856675|NCT02471144|12022872|FG007|NOT COMPLETED|Induction Period (Up to Week 12)||0
10856676|NCT02471144|12022873|FG008|NOT COMPLETED|Induction Period (Up to Week 12)||0
10856677|NCT02471144|12022874|FG009|NOT COMPLETED|Induction Period (Up to Week 12)||0
10856678|NCT02471144|12022875|FG010|NOT COMPLETED|Induction Period (Up to Week 12)||0
10856679|NCT02471144|12022865|FG000|STARTED|Maintenance Period (Week 12 to Week 52)||0
10856680|NCT02471144|12022866|FG001|STARTED|Maintenance Period (Week 12 to Week 52)||0
10856681|NCT02471144|12022867|FG002|STARTED|Maintenance Period (Week 12 to Week 52)||0
10856682|NCT02471144|12022868|FG003|STARTED|Maintenance Period (Week 12 to Week 52)||0
10856683|NCT02471144|12022869|FG004|STARTED|Maintenance Period (Week 12 to Week 52)||39
10856684|NCT02471144|12022870|FG005|STARTED|Maintenance Period (Week 12 to Week 52)||38
10856685|NCT02471144|12022871|FG006|STARTED|Maintenance Period (Week 12 to Week 52)||16
10856686|NCT02471144|12022872|FG007|STARTED|Maintenance Period (Week 12 to Week 52)||18
10856687|NCT02471144|12022873|FG008|STARTED|Maintenance Period (Week 12 to Week 52)||40
10856688|NCT02471144|12022874|FG009|STARTED|Maintenance Period (Week 12 to Week 52)||0
10856689|NCT02471144|12022875|FG010|STARTED|Maintenance Period (Week 12 to Week 52)||0
10856690|NCT02471144|12022865|FG000|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856691|NCT02471144|12022866|FG001|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856692|NCT02471144|12022867|FG002|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856693|NCT02471144|12022868|FG003|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856694|NCT02471144|12022869|FG004|COMPLETED|Maintenance Period (Week 12 to Week 52)||38
10856695|NCT02471144|12022870|FG005|COMPLETED|Maintenance Period (Week 12 to Week 52)||37
10856696|NCT02471144|12022871|FG006|COMPLETED|Maintenance Period (Week 12 to Week 52)||15
10856697|NCT02471144|12022872|FG007|COMPLETED|Maintenance Period (Week 12 to Week 52)||16
10856698|NCT02471144|12022873|FG008|COMPLETED|Maintenance Period (Week 12 to Week 52)||34
10856699|NCT02471144|12022874|FG009|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856700|NCT02471144|12022875|FG010|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856701|NCT02471144|12022865|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856702|NCT02471144|12022866|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856703|NCT02471144|12022867|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856704|NCT02471144|12022868|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856705|NCT02471144|12022869|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
10856706|NCT02471144|12022870|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
10856707|NCT02471144|12022871|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
10856708|NCT02471144|12022872|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||2
10856709|NCT02471144|12022873|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||6
10856710|NCT02471144|12022874|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856711|NCT02471144|12022875|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
10856712|NCT02471144|12022865|FG000|STARTED|Extension Period (Week 52 to Week 236)||0
10856713|NCT02471144|12022866|FG001|STARTED|Extension Period (Week 52 to Week 236)||0
10856714|NCT02471144|12022867|FG002|STARTED|Extension Period (Week 52 to Week 236)||0
10856715|NCT02471144|12022868|FG003|STARTED|Extension Period (Week 52 to Week 236)||0
10856716|NCT02471144|12022869|FG004|STARTED|Extension Period (Week 52 to Week 236)||0
10856717|NCT02471144|12022870|FG005|STARTED|Extension Period (Week 52 to Week 236)||0
10856718|NCT02471144|12022871|FG006|STARTED|Extension Period (Week 52 to Week 236)||0
10856719|NCT02471144|12022872|FG007|STARTED|Extension Period (Week 52 to Week 236)||0
10856720|NCT02471144|12022873|FG008|STARTED|Extension Period (Week 52 to Week 236)||0
10856721|NCT02471144|12022874|FG009|STARTED|Extension Period (Week 52 to Week 236)||53
11226226|NCT01996943|12418578|FG001|NOT COMPLETED|Overall Study||0
11226227|NCT01997125|12418584|FG000|STARTED|Overall Study||1
11226228|NCT01997125|12418584|FG000|COMPLETED|Overall Study||1
11226229|NCT01997125|12418584|FG000|NOT COMPLETED|Overall Study||0
11226230|NCT01997216|12418588|FG000|STARTED|First 9 Hours||18
11226231|NCT01997216|12418589|FG001|STARTED|First 9 Hours||21
11226232|NCT01997216|12418588|FG000|COMPLETED|First 9 Hours||18
11226233|NCT01997216|12418589|FG001|COMPLETED|First 9 Hours||21
11226234|NCT01997216|12418588|FG000|NOT COMPLETED|First 9 Hours||0
11226235|NCT01997216|12418589|FG001|NOT COMPLETED|First 9 Hours||0
11226236|NCT01997216|12418588|FG000|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
11226237|NCT01997216|12418589|FG001|STARTED|Second 9 Hours||21
11226238|NCT01997216|12418588|FG000|COMPLETED|Second 9 Hours||19
11226239|NCT01997216|12418589|FG001|COMPLETED|Second 9 Hours||21
11226240|NCT01997216|12418588|FG000|NOT COMPLETED|Second 9 Hours||0
11226241|NCT01997216|12418589|FG001|NOT COMPLETED|Second 9 Hours||0
11226242|NCT01997229|12418597|FG000|STARTED|Overall Study||62
11226243|NCT01997229|12418598|FG001|STARTED|Overall Study||63
11226244|NCT01997229|12418597|FG000|COMPLETED|Overall Study||57
11226245|NCT01997229|12418598|FG001|COMPLETED|Overall Study||61
11226246|NCT01997229|12418597|FG000|NOT COMPLETED|Overall Study||5
11226247|NCT01997229|12418598|FG001|NOT COMPLETED|Overall Study||2
11226248|NCT01997281|12418606|FG000|STARTED|Overall Study||7
11226249|NCT01997281|12418607|FG001|STARTED|Overall Study||7
11226250|NCT01997281|12418606|FG000|Withdrawal|Overall Study||1
11226251|NCT01997281|12418607|FG001|Withdrawal|Overall Study||0
11226252|NCT01997281|12418606|FG000|COMPLETED|Overall Study||6
11226253|NCT01997281|12418607|FG001|COMPLETED|Overall Study||7
11226254|NCT01997281|12418606|FG000|NOT COMPLETED|Overall Study||1
11226255|NCT01997281|12418607|FG001|NOT COMPLETED|Overall Study||0
11354872|NCT03075410|12551814|FG004|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
11354873|NCT03075410|12551815|FG005|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
11354874|NCT03075410|12551816|FG006|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
11354875|NCT03075410|12551817|FG007|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
11354876|NCT03075410|12551818|FG008|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
11354877|NCT03075410|12551810|FG000|STARTED|Part A-Period 4 (14 Days)||1
11354878|NCT03075410|12551811|FG001|STARTED|Part A-Period 4 (14 Days)||1
11354879|NCT03075410|12551812|FG002|STARTED|Part A-Period 4 (14 Days)||2
11354880|NCT03075410|12551813|FG003|STARTED|Part A-Period 4 (14 Days)||1
11354881|NCT03075410|12551814|FG004|STARTED|Part A-Period 4 (14 Days)||2
11354882|NCT03075410|12551815|FG005|STARTED|Part A-Period 4 (14 Days)||1
11354883|NCT03075410|12551816|FG006|STARTED|Part A-Period 4 (14 Days)||0
11354884|NCT03075410|12551817|FG007|STARTED|Part A-Period 4 (14 Days)||0
11354885|NCT03075410|12551818|FG008|STARTED|Part A-Period 4 (14 Days)||0
11354886|NCT03075410|12551810|FG000|COMPLETED|Part A-Period 4 (14 Days)||1
11354887|NCT03075410|12551811|FG001|COMPLETED|Part A-Period 4 (14 Days)||1
11354888|NCT03075410|12551812|FG002|COMPLETED|Part A-Period 4 (14 Days)||2
11354889|NCT03075410|12551813|FG003|COMPLETED|Part A-Period 4 (14 Days)||1
11354890|NCT03075410|12551814|FG004|COMPLETED|Part A-Period 4 (14 Days)||2
11354891|NCT03075410|12551815|FG005|COMPLETED|Part A-Period 4 (14 Days)||1
11354892|NCT03075410|12551816|FG006|COMPLETED|Part A-Period 4 (14 Days)||0
11354893|NCT03075410|12551817|FG007|COMPLETED|Part A-Period 4 (14 Days)||0
11354894|NCT03075410|12551818|FG008|COMPLETED|Part A-Period 4 (14 Days)||0
11354895|NCT03075410|12551810|FG000|NOT COMPLETED|Part A-Period 4 (14 Days)||0
11354896|NCT03075410|12551811|FG001|NOT COMPLETED|Part A-Period 4 (14 Days)||0
11354897|NCT03075410|12551812|FG002|NOT COMPLETED|Part A-Period 4 (14 Days)||0
11354898|NCT03075410|12551813|FG003|NOT COMPLETED|Part A-Period 4 (14 Days)||0
11354899|NCT03075410|12551814|FG004|NOT COMPLETED|Part A-Period 4 (14 Days)||0
11354900|NCT03075410|12551815|FG005|NOT COMPLETED|Part A-Period 4 (14 Days)||0
11354901|NCT03075410|12551816|FG006|NOT COMPLETED|Part A-Period 4 (14 Days)||0
11226256|NCT01997333|12418615|FG000|STARTED|Randomization and Treatment||109
11226257|NCT01997333|12418616|FG001|STARTED|Randomization and Treatment||218
11226258|NCT01997333|12418615|FG000|COMPLETED|Randomization and Treatment||6
10856722|NCT02471144|12022875|FG010|STARTED|Extension Period (Week 52 to Week 236)||53
10856723|NCT02471144|12022865|FG000|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856724|NCT02471144|12022866|FG001|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856725|NCT02471144|12022867|FG002|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856726|NCT02471144|12022868|FG003|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856727|NCT02471144|12022869|FG004|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856728|NCT02471144|12022870|FG005|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856729|NCT02471144|12022871|FG006|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856730|NCT02471144|12022872|FG007|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856731|NCT02471144|12022873|FG008|COMPLETED|Extension Period (Week 52 to Week 236)||0
10856732|NCT02471144|12022874|FG009|COMPLETED|Extension Period (Week 52 to Week 236)||46
10856733|NCT02471144|12022875|FG010|COMPLETED|Extension Period (Week 52 to Week 236)||49
11226259|NCT01997333|12418616|FG001|COMPLETED|Randomization and Treatment||15
11226260|NCT01997333|12418615|FG000|NOT COMPLETED|Randomization and Treatment||103
11226261|NCT01997333|12418616|FG001|NOT COMPLETED|Randomization and Treatment||203
11226262|NCT01997333|12418615|FG000|STARTED|Survival Follow up||92
11226263|NCT01997333|12418616|FG001|STARTED|Survival Follow up||213
11226264|NCT01997333|12418615|FG000|COMPLETED|Survival Follow up||76
11226265|NCT01997333|12418616|FG001|COMPLETED|Survival Follow up||199
11226266|NCT01997333|12418615|FG000|NOT COMPLETED|Survival Follow up||16
11226267|NCT01997333|12418616|FG001|NOT COMPLETED|Survival Follow up||14
11226268|NCT01997398|12418624|FG000|STARTED|Overall Study||35
11226269|NCT01997398|12418624|FG000|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
11226270|NCT01997398|12418624|FG000|NOT COMPLETED|Overall Study||1
11226271|NCT01997411|12418638|FG000|STARTED|Overall Study||6
11226272|NCT01997411|12418639|FG001|STARTED|Overall Study||6
11226273|NCT01997411|12418640|FG002|STARTED|Overall Study||6
11226274|NCT01997411|12418641|FG003|STARTED|Overall Study||6
11226275|NCT01997411|12418642|FG004|STARTED|Overall Study||6
11226276|NCT01997411|12418643|FG005|STARTED|Overall Study||6
11226277|NCT01997411|12418644|FG006|STARTED|Overall Study||6
11226278|NCT01997411|12418645|FG007|STARTED|Overall Study||6
11226279|NCT01997411|12418638|FG000|COMPLETED|Overall Study||6
11226280|NCT01997411|12418639|FG001|COMPLETED|Overall Study||6
11226281|NCT01997411|12418640|FG002|COMPLETED|Overall Study||6
11226282|NCT01997411|12418641|FG003|COMPLETED|Overall Study||6
11226283|NCT01997411|12418642|FG004|COMPLETED|Overall Study||6
11226284|NCT01997411|12418643|FG005|COMPLETED|Overall Study||5
11226285|NCT01997411|12418644|FG006|COMPLETED|Overall Study||6
11226286|NCT01997411|12418645|FG007|COMPLETED|Overall Study||6
11226287|NCT01997411|12418638|FG000|NOT COMPLETED|Overall Study||0
11226288|NCT01997411|12418639|FG001|NOT COMPLETED|Overall Study||0
11226289|NCT01997411|12418640|FG002|NOT COMPLETED|Overall Study||0
11226290|NCT01997411|12418641|FG003|NOT COMPLETED|Overall Study||0
11226291|NCT01997411|12418642|FG004|NOT COMPLETED|Overall Study||0
11226292|NCT01997411|12418643|FG005|NOT COMPLETED|Overall Study||1
11226293|NCT01997411|12418644|FG006|NOT COMPLETED|Overall Study||0
11226294|NCT01997411|12418645|FG007|NOT COMPLETED|Overall Study||0
11226295|NCT01997437|12418663|FG000|STARTED|Overall Study||6
11226296|NCT01997437|12418663|FG000|COMPLETED|Overall Study||6
11226297|NCT01997437|12418663|FG000|NOT COMPLETED|Overall Study||0
11226298|NCT01997515|12418669|FG000|STARTED|Overall Study||40
11226299|NCT01997515|12418670|FG001|STARTED|Overall Study||40
11226300|NCT01997515|12418669|FG000|COMPLETED|Overall Study||36
11226301|NCT01997515|12418670|FG001|COMPLETED|Overall Study||35
11226302|NCT01997515|12418669|FG000|NOT COMPLETED|Overall Study||4
11226303|NCT01997515|12418670|FG001|NOT COMPLETED|Overall Study||5
11226304|NCT01997723|12418676|FG000|STARTED|Overall Study||75
11226305|NCT01997723|12418676|FG000|COMPLETED|Overall Study||75
11226306|NCT01997723|12418676|FG000|NOT COMPLETED|Overall Study||0
11226307|NCT01997892|12418680|FG000|STARTED|Overall Study||1027
11226308|NCT01997892|12418680|FG000|Received Darbepoetin Alfa|Overall Study||987
11226309|NCT01997892|12418680|FG000|COMPLETED|Overall Study||959
11226310|NCT01997892|12418680|FG000|NOT COMPLETED|Overall Study||68
11226311|NCT01997905|12418689|FG000|STARTED|Overall Study||13
11226312|NCT01997905|12418689|FG000|Baseline Completed|Overall Study||11
11226313|NCT01997905|12418689|FG000|COMPLETED|Overall Study||10
11226314|NCT01997905|12418689|FG000|NOT COMPLETED|Overall Study||3
10856734|NCT02471144|12022865|FG000|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856735|NCT02471144|12022866|FG001|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856736|NCT02471144|12022867|FG002|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856737|NCT02471144|12022868|FG003|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856738|NCT02471144|12022869|FG004|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856739|NCT02471144|12022870|FG005|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856740|NCT02471144|12022871|FG006|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856741|NCT02471144|12022872|FG007|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856742|NCT02471144|12022873|FG008|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
10856743|NCT02471144|12022874|FG009|NOT COMPLETED|Extension Period (Week 52 to Week 236)||7
10856744|NCT02471144|12022875|FG010|NOT COMPLETED|Extension Period (Week 52 to Week 236)||4
10856745|NCT02440464|12022893|FG000|STARTED|Overall Study||21
10856746|NCT02440464|12022894|FG001|STARTED|Overall Study||22
10856747|NCT02440464|12022893|FG000|COMPLETED|Overall Study||18
10856748|NCT02440464|12022894|FG001|COMPLETED|Overall Study||20
10856749|NCT02440464|12022893|FG000|NOT COMPLETED|Overall Study||3
10856750|NCT02440464|12022894|FG001|NOT COMPLETED|Overall Study||2
10856751|NCT02384421|12022901|FG000|STARTED|Overall Study||22
10856752|NCT02384421|12022901|FG000|COMPLETED|Overall Study||22
10856753|NCT02384421|12022901|FG000|NOT COMPLETED|Overall Study||0
10856754|NCT02366728|12022911|FG000|STARTED|Overall Study||27
10856755|NCT02366728|12022912|FG001|STARTED|Overall Study||28
10856756|NCT02366728|12022913|FG002|STARTED|Overall Study||9
10856757|NCT02366728|12022911|FG000|Received at Least One ppp65 Vaccine|Overall Study||25
10856758|NCT02366728|12022912|FG001|Received at Least One ppp65 Vaccine|Overall Study||27
10856759|NCT02366728|12022913|FG002|Received at Least One ppp65 Vaccine|Overall Study||8
10856760|NCT02366728|12022911|FG000|COMPLETED|Overall Study||23
10856761|NCT02366728|12022912|FG001|COMPLETED|Overall Study||27
10856762|NCT02366728|12022913|FG002|COMPLETED|Overall Study||8
10856763|NCT02366728|12022911|FG000|NOT COMPLETED|Overall Study||4
10856764|NCT02366728|12022912|FG001|NOT COMPLETED|Overall Study||1
10856765|NCT02366728|12022913|FG002|NOT COMPLETED|Overall Study||1
10856766|NCT02236572|12022921|FG000|STARTED|Overall Study||17
10856767|NCT02236572|12022921|FG000|COMPLETED|Overall Study||14
10856768|NCT02236572|12022921|FG000|NOT COMPLETED|Overall Study||3
10856769|NCT02083354|12022925|FG000|STARTED|Overall Study||77
10856770|NCT02083354|12022925|FG000|COMPLETED|Overall Study||13
10856771|NCT02083354|12022925|FG000|NOT COMPLETED|Overall Study||64
10856772|NCT01775813|12022933|FG000|STARTED|Overall Study||47
10856773|NCT01775813|12022934|FG001|STARTED|Overall Study||13
10856774|NCT01775813|12022935|FG002|STARTED|Overall Study||24
11226315|NCT01998243|12418695|FG000|STARTED|Overall Study||42
11226316|NCT01998243|12418696|FG001|STARTED|Overall Study||39
10856775|NCT01775813|12022936|FG003|STARTED|Overall Study||20
10856776|NCT01775813|12022933|FG000|Study Visit 2 (Tanner 4)|Overall Study||36
10856777|NCT01775813|12022934|FG001|Study Visit 2 (Tanner 4)|Overall Study||4
10856778|NCT01775813|12022935|FG002|Study Visit 2 (Tanner 4)|Overall Study||11
10856779|NCT01775813|12022936|FG003|Study Visit 2 (Tanner 4)|Overall Study||11
10856780|NCT01775813|12022933|FG000|Study Visit 3 (Tanner 5)|Overall Study||34
10856781|NCT01775813|12022934|FG001|Study Visit 3 (Tanner 5)|Overall Study||8
10856782|NCT01775813|12022935|FG002|Study Visit 3 (Tanner 5)|Overall Study||12
10856783|NCT01775813|12022936|FG003|Study Visit 3 (Tanner 5)|Overall Study||11
10856784|NCT01775813|12022933|FG000|Study Visit 4 (Post-Puberty)|Overall Study||10
10856785|NCT01775813|12022934|FG001|Study Visit 4 (Post-Puberty)|Overall Study||0
10856786|NCT01775813|12022935|FG002|Study Visit 4 (Post-Puberty)|Overall Study||13
10856787|NCT01775813|12022936|FG003|Study Visit 4 (Post-Puberty)|Overall Study||11
10856788|NCT01775813|12022933|FG000|COMPLETED|Overall Study||34
10856789|NCT01775813|12022934|FG001|COMPLETED|Overall Study||8
10856790|NCT01775813|12022935|FG002|COMPLETED|Overall Study||12
10856791|NCT01775813|12022936|FG003|COMPLETED|Overall Study||11
11226317|NCT01998243|12418695|FG000|COMPLETED|Overall Study||34
11226318|NCT01998243|12418696|FG001|COMPLETED|Overall Study||32
11226319|NCT01998243|12418695|FG000|NOT COMPLETED|Overall Study||8
11226320|NCT01998243|12418696|FG001|NOT COMPLETED|Overall Study||7
11226321|NCT01998269|12418704|FG000|STARTED|Overall Study||193
11226322|NCT01998269|12418704|FG000|COMPLETED|Overall Study||193
11226323|NCT01998269|12418704|FG000|NOT COMPLETED|Overall Study||0
11226324|NCT01998360|12418710|FG000|STARTED|Overall Study||50
11226325|NCT01998360|12418711|FG001|STARTED|Overall Study||50
11226326|NCT01998360|12418710|FG000|COMPLETED|Overall Study||50
11226327|NCT01998360|12418711|FG001|COMPLETED|Overall Study||50
11354902|NCT03075410|12551817|FG007|NOT COMPLETED|Part A-Period 4 (14 Days)||0
10856792|NCT01775813|12022933|FG000|NOT COMPLETED|Overall Study||13
10856793|NCT01775813|12022934|FG001|NOT COMPLETED|Overall Study||5
10856794|NCT01775813|12022935|FG002|NOT COMPLETED|Overall Study||12
10856795|NCT01775813|12022936|FG003|NOT COMPLETED|Overall Study||9
10856796|NCT01694069|12022953|FG000|STARTED|Overall Study||6
10856797|NCT01694069|12022953|FG000|COMPLETED|Overall Study||6
10856798|NCT01694069|12022953|FG000|NOT COMPLETED|Overall Study||0
10856799|NCT01446016|12022959|FG000|STARTED|Overall Study||38
10856800|NCT01446016|12022959|FG000|COMPLETED|Overall Study||31
10856801|NCT01446016|12022959|FG000|NOT COMPLETED|Overall Study||7
10856802|NCT01445327|12022966|FG000|STARTED|Overall Study||3
10856803|NCT01445327|12022967|FG001|STARTED|Overall Study||1
11226328|NCT01998360|12418710|FG000|NOT COMPLETED|Overall Study||0
11226329|NCT01998360|12418711|FG001|NOT COMPLETED|Overall Study||0
11226330|NCT01998399|12418719|FG000|STARTED|Overall Study||12
11226331|NCT01998399|12418720|FG001|STARTED|Overall Study||13
10856804|NCT01445327|12022968|FG002|STARTED|Overall Study||5
10856805|NCT01445327|12022966|FG000|COMPLETED|Overall Study||3
10856806|NCT01445327|12022967|FG001|COMPLETED|Overall Study||1
10856807|NCT01445327|12022968|FG002|COMPLETED|Overall Study||5
10856808|NCT01445327|12022966|FG000|NOT COMPLETED|Overall Study||0
10856809|NCT01445327|12022967|FG001|NOT COMPLETED|Overall Study||0
10856810|NCT01445327|12022968|FG002|NOT COMPLETED|Overall Study||0
10856811|NCT01411332|12022978|FG000|STARTED|Overall Study||10
10856812|NCT01411332|12022979|FG001|STARTED|Overall Study||9
10856813|NCT01411332|12022978|FG000|COMPLETED|Overall Study||8
10856814|NCT01411332|12022979|FG001|COMPLETED|Overall Study||7
10856815|NCT01411332|12022978|FG000|NOT COMPLETED|Overall Study||2
10856816|NCT01411332|12022979|FG001|NOT COMPLETED|Overall Study||2
10856817|NCT01399918|12022985|FG000|STARTED|Overall Study||57
10856818|NCT01399918|12022985|FG000|COMPLETED|Overall Study||55
10856819|NCT01399918|12022985|FG000|NOT COMPLETED|Overall Study||2
10856820|NCT01377753|12022989|FG000|STARTED|Overall Study||15
10856821|NCT01377753|12022989|FG000|COMPLETED|Overall Study||15
10856822|NCT01377753|12022989|FG000|NOT COMPLETED|Overall Study||0
10856823|NCT01147653|12022995|FG000|STARTED|Year 1||32
10856824|NCT01147653|12022996|FG001|STARTED|Year 1||31
10856825|NCT01147653|12022995|FG000|COMPLETED|Year 1||32
10856826|NCT01147653|12022996|FG001|COMPLETED|Year 1||31
10856827|NCT01147653|12022995|FG000|NOT COMPLETED|Year 1||0
10856828|NCT01147653|12022996|FG001|NOT COMPLETED|Year 1||0
10856829|NCT01147653|12022995|FG000|STARTED|Year 2||32
10856830|NCT01147653|12022996|FG001|STARTED|Year 2||31
11226332|NCT01998399|12418719|FG000|COMPLETED|Overall Study||4
11226333|NCT01998399|12418720|FG001|COMPLETED|Overall Study||4
11226334|NCT01998399|12418719|FG000|NOT COMPLETED|Overall Study||8
11226335|NCT01998399|12418720|FG001|NOT COMPLETED|Overall Study||9
11226336|NCT01998438|12418729|FG000|STARTED|Overall Study||319
11226337|NCT01998438|12418730|FG001|STARTED|Overall Study||318
11226338|NCT01998438|12418731|FG002|STARTED|Overall Study||318
11226339|NCT01998438|12418729|FG000|COMPLETED|Overall Study||319
11226340|NCT01998438|12418730|FG001|COMPLETED|Overall Study||318
11226341|NCT01998438|12418731|FG002|COMPLETED|Overall Study||318
11226342|NCT01998438|12418729|FG000|NOT COMPLETED|Overall Study||0
11226343|NCT01998438|12418730|FG001|NOT COMPLETED|Overall Study||0
11226344|NCT01998438|12418731|FG002|NOT COMPLETED|Overall Study||0
11226345|NCT01998477|12418741|FG000|STARTED|Overall Study||282
11226346|NCT01998477|12418742|FG001|STARTED|Overall Study||148
11226347|NCT01998477|12418741|FG000|COMPLETED|Overall Study||272
11226348|NCT01998477|12418742|FG001|COMPLETED|Overall Study||143
11226349|NCT01998477|12418741|FG000|NOT COMPLETED|Overall Study||10
11226350|NCT01998477|12418742|FG001|NOT COMPLETED|Overall Study||5
11226351|NCT01998581|12418775|FG000|STARTED|Overall Study||169
11226352|NCT01998581|12418776|FG001|STARTED|Overall Study||56
11226353|NCT01998581|12418775|FG000|COMPLETED|Overall Study||123
11226354|NCT01998581|12418776|FG001|COMPLETED|Overall Study||44
11226355|NCT01998581|12418775|FG000|NOT COMPLETED|Overall Study||46
11226356|NCT01998581|12418776|FG001|NOT COMPLETED|Overall Study||12
11226357|NCT01998633|12418785|FG000|STARTED|Overall Study||47
11226358|NCT01998633|12418785|FG000|COMPLETED|Overall Study||46
11226359|NCT01998633|12418785|FG000|NOT COMPLETED|Overall Study||1
11226360|NCT01998737|12418795|FG000|STARTED|Overall Study||911
11226361|NCT01998737|12418796|FG001|STARTED|Overall Study||100
11226362|NCT01998737|12418795|FG000|COMPLETED|Overall Study||888
11226363|NCT01998737|12418796|FG001|COMPLETED|Overall Study||100
11226364|NCT01998737|12418795|FG000|NOT COMPLETED|Overall Study||23
11226365|NCT01998737|12418796|FG001|NOT COMPLETED|Overall Study||0
11226366|NCT01998880|12418804|FG000|STARTED|Overall Study||233
11226367|NCT01998880|12418805|FG001|STARTED|Overall Study||118
11226368|NCT01998880|12418804|FG000|Received Study Drug|Overall Study||230
11226369|NCT01998880|12418805|FG001|Received Study Drug|Overall Study||116
11226370|NCT01998880|12418804|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|205
11226371|NCT01998880|12418805|FG001|COMPLETED|Overall Study||78
11226372|NCT01998880|12418804|FG000|NOT COMPLETED|Overall Study||28
11226373|NCT01998880|12418805|FG001|NOT COMPLETED|Overall Study||40
11226374|NCT01998893|12418811|FG000|STARTED|Overall Study||38
11226375|NCT01998893|12418811|FG000|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
11226376|NCT01998893|12418811|FG000|2nd Treatment Cycle Started|Overall Study||5
11226377|NCT01998893|12418811|FG000|2nd Treatment Cycle Completed Until PD|Overall Study||3
11226378|NCT01998893|12418811|FG000|COMPLETED|Overall Study||21
11226379|NCT01998893|12418811|FG000|NOT COMPLETED|Overall Study||17
11226380|NCT01998906|12418818|FG000|STARTED|Overall Study||115
11226381|NCT01998906|12418819|FG001|STARTED|Overall Study||116
11226382|NCT01998906|12418820|FG002|STARTED|Overall Study||99
11226383|NCT01998906|12418818|FG000|COMPLETED|Overall Study||1
10856831|NCT01147653|12022995|FG000|COMPLETED|Year 2||30
10856832|NCT01147653|12022996|FG001|COMPLETED|Year 2||28
10856833|NCT01147653|12022995|FG000|NOT COMPLETED|Year 2||2
10856834|NCT01147653|12022996|FG001|NOT COMPLETED|Year 2||3
10856835|NCT01078454|12023016|FG000|STARTED|Overall Study||6
10856836|NCT01078454|12023017|FG001|STARTED|Overall Study||5
10856837|NCT01078454|12023016|FG000|COMPLETED|Overall Study||5
10856838|NCT01078454|12023017|FG001|COMPLETED|Overall Study||3
10856839|NCT01078454|12023016|FG000|NOT COMPLETED|Overall Study||1
10856840|NCT01078454|12023017|FG001|NOT COMPLETED|Overall Study||2
10856841|NCT00687596|12023025|FG000|STARTED|Overall Study||26
10856842|NCT00687596|12023026|FG001|STARTED|Overall Study||26
10856843|NCT00687596|12023025|FG000|COMPLETED|Overall Study||0
10856844|NCT00687596|12023026|FG001|COMPLETED|Overall Study||0
10856845|NCT00687596|12023025|FG000|NOT COMPLETED|Overall Study||26
10856846|NCT00687596|12023026|FG001|NOT COMPLETED|Overall Study||26
10856847|NCT00458536|12023032|FG000|STARTED|Overall Study||38
10856848|NCT00458536|12023032|FG000|COMPLETED|Overall Study||19
10856849|NCT00458536|12023032|FG000|NOT COMPLETED|Overall Study||19
10856850|NCT00112840|12023039|FG000|STARTED|Overall Study||8
10856851|NCT00112840|12023040|FG001|STARTED|Overall Study||6
10856852|NCT00112840|12023041|FG002|STARTED|Overall Study||46
10856853|NCT00112840|12023039|FG000|COMPLETED|Overall Study||6
10856854|NCT00112840|12023040|FG001|COMPLETED|Overall Study||6
10856855|NCT00112840|12023041|FG002|COMPLETED|Overall Study||40
10856856|NCT00112840|12023039|FG000|NOT COMPLETED|Overall Study||2
10856857|NCT00112840|12023040|FG001|NOT COMPLETED|Overall Study||0
10856858|NCT00112840|12023041|FG002|NOT COMPLETED|Overall Study||6
11107146|NCT01262638|12291643|FG003|NOT COMPLETED|Overall Study||7
10856859|NCT04957732|12023056|FG000|STARTED|Overall Study||19
10856860|NCT04957732|12023057|FG001|STARTED|Overall Study||16
10856861|NCT04957732|12023056|FG000|COMPLETED|Overall Study||18
10856862|NCT04957732|12023057|FG001|COMPLETED|Overall Study||12
10856863|NCT04957732|12023056|FG000|NOT COMPLETED|Overall Study||1
10856864|NCT04957732|12023057|FG001|NOT COMPLETED|Overall Study||4
10856865|NCT04207749|12023070|FG000|STARTED|Overall Study||78
10856866|NCT04207749|12023071|FG001|STARTED|Overall Study||156
10856867|NCT04207749|12023070|FG000|COMPLETED|Overall Study||74
10856868|NCT04207749|12023071|FG001|COMPLETED|Overall Study||149
10856869|NCT04207749|12023070|FG000|NOT COMPLETED|Overall Study||4
10856870|NCT04207749|12023071|FG001|NOT COMPLETED|Overall Study||7
10856871|NCT04167345|12023085|FG000|STARTED|Overall Study||10
10856872|NCT04167345|12023086|FG001|STARTED|Overall Study||4
10856873|NCT04167345|12023087|FG002|STARTED|Overall Study||3
10856874|NCT04167345|12023088|FG003|STARTED|Overall Study||13
10856875|NCT04167345|12023089|FG004|STARTED|Overall Study||18
10856876|NCT04167345|12023085|FG000|COMPLETED|Overall Study||9
10856877|NCT04167345|12023086|FG001|COMPLETED|Overall Study||3
10856878|NCT04167345|12023087|FG002|COMPLETED|Overall Study||3
10856879|NCT04167345|12023088|FG003|COMPLETED|Overall Study||13
11107147|NCT01262651|12291658|FG000|STARTED|Overall Study||199
11107148|NCT01262651|12291659|FG001|STARTED|Overall Study||198
11107149|NCT01262651|12291658|FG000|Received at Least 1 Dose of Study Drug|Overall Study||199
11107150|NCT01262651|12291659|FG001|Received at Least 1 Dose of Study Drug|Overall Study||198
11107151|NCT01262651|12291658|FG000|Safety Population|Overall Study||199
11107152|NCT01262651|12291659|FG001|Safety Population|Overall Study||198
11107153|NCT01262651|12291658|FG000|ITT Population|Overall Study||199
11107154|NCT01262651|12291659|FG001|ITT Population|Overall Study||198
11107155|NCT01262651|12291658|FG000|COMPLETED|Overall Study||141
11107156|NCT01262651|12291659|FG001|COMPLETED|Overall Study||150
10856880|NCT04167345|12023089|FG004|COMPLETED|Overall Study||18
10856881|NCT04167345|12023085|FG000|NOT COMPLETED|Overall Study||1
10856882|NCT04167345|12023086|FG001|NOT COMPLETED|Overall Study||1
10856883|NCT04167345|12023087|FG002|NOT COMPLETED|Overall Study||0
10856884|NCT04167345|12023088|FG003|NOT COMPLETED|Overall Study||0
10856885|NCT04167345|12023089|FG004|NOT COMPLETED|Overall Study||0
10856886|NCT04042077|12023107|FG000|STARTED|Overall Study||134
10856887|NCT04042077|12023108|FG001|STARTED|Overall Study||132
10856888|NCT04042077|12023107|FG000|Vancomycin IV|Overall Study||0
10856889|NCT04042077|12023108|FG001|Vancomycin IV|Overall Study||2
10856890|NCT04042077|12023107|FG000|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||0
10856891|NCT04042077|12023108|FG001|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||8
10856892|NCT04042077|12023107|FG000|Piperacillin/Tazobactam IV|Overall Study||0
10856893|NCT04042077|12023108|FG001|Piperacillin/Tazobactam IV|Overall Study||68
10856894|NCT04042077|12023107|FG000|Tigecycline IV|Overall Study||0
10856895|NCT04042077|12023108|FG001|Tigecycline IV|Overall Study||54
10856896|NCT04042077|12023107|FG000|COMPLETED|Overall Study||127
10856897|NCT04042077|12023108|FG001|COMPLETED|Overall Study||127
10856898|NCT04042077|12023107|FG000|NOT COMPLETED|Overall Study||7
10856899|NCT04042077|12023108|FG001|NOT COMPLETED|Overall Study||5
10856900|NCT04001803|12023120|FG000|STARTED|Overall Study||115
10856901|NCT04001803|12023120|FG000|COMPLETED|Overall Study||1
10856902|NCT04001803|12023120|FG000|NOT COMPLETED|Overall Study||114
10856903|NCT03936699|12023127|FG000|STARTED|Overall Study||83
10856904|NCT03936699|12023128|FG001|STARTED|Overall Study||78
10856905|NCT03936699|12023127|FG000|COMPLETED|Overall Study||61
10856906|NCT03936699|12023128|FG001|COMPLETED|Overall Study||55
10856907|NCT03936699|12023127|FG000|NOT COMPLETED|Overall Study||22
10856908|NCT03936699|12023128|FG001|NOT COMPLETED|Overall Study||23
10856909|NCT03925324|12023136|FG000|STARTED|Overall Study||2
10856910|NCT03925324|12023137|FG001|STARTED|Overall Study||2
10856911|NCT03925324|12023136|FG000|COMPLETED|Overall Study||1
10856912|NCT03925324|12023137|FG001|COMPLETED|Overall Study||1
10856913|NCT03925324|12023136|FG000|NOT COMPLETED|Overall Study||1
10856914|NCT03925324|12023137|FG001|NOT COMPLETED|Overall Study||1
11107157|NCT01262651|12291658|FG000|NOT COMPLETED|Overall Study||58
11107158|NCT01262651|12291659|FG001|NOT COMPLETED|Overall Study||48
11107159|NCT01262677|12291668|FG000|STARTED|Overall Study||100
11107160|NCT01262677|12291669|FG001|STARTED|Overall Study||113
11107161|NCT01262677|12291670|FG002|STARTED|Overall Study||110
11107162|NCT01262677|12291668|FG000|COMPLETED|Overall Study||91
11107163|NCT01262677|12291669|FG001|COMPLETED|Overall Study||98
11107164|NCT01262677|12291670|FG002|COMPLETED|Overall Study||98
11107165|NCT01262677|12291668|FG000|NOT COMPLETED|Overall Study||9
11107166|NCT01262677|12291669|FG001|NOT COMPLETED|Overall Study||15
10856925|NCT03814382|12023152|FG000|STARTED|Overall Study||10
10856926|NCT03814382|12023152|FG000|COMPLETED|Overall Study||10
10856927|NCT03814382|12023152|FG000|NOT COMPLETED|Overall Study||0
10856928|NCT03740009|12023156|FG000|STARTED|Overall Study||20
10856929|NCT03740009|12023156|FG000|Consented|Overall Study||20
10856930|NCT03740009|12023156|FG000|Received Intervention|Overall Study||10
10856931|NCT03740009|12023156|FG000|COMPLETED|Overall Study||10
10856932|NCT03740009|12023156|FG000|NOT COMPLETED|Overall Study||10
10856933|NCT03738397|12023162|FG000|STARTED|Overall Study||344
10856934|NCT03738397|12023163|FG001|STARTED|Overall Study||348
10856935|NCT03738397|12023162|FG000|COMPLETED|Overall Study||320
10856936|NCT03738397|12023163|FG001|COMPLETED|Overall Study||318
10856937|NCT03738397|12023162|FG000|NOT COMPLETED|Overall Study||24
10856938|NCT03738397|12023163|FG001|NOT COMPLETED|Overall Study||30
10856939|NCT03666624|12023171|FG000|STARTED|Overall Study||15
10856940|NCT03666624|12023172|FG001|STARTED|Overall Study||15
10856941|NCT03666624|12023171|FG000|COMPLETED|Overall Study||14
10856942|NCT03666624|12023172|FG001|COMPLETED|Overall Study||15
10856943|NCT03666624|12023171|FG000|NOT COMPLETED|Overall Study||1
10856944|NCT03666624|12023172|FG001|NOT COMPLETED|Overall Study||0
10856945|NCT03649217|12023178|FG000|STARTED|Overall Study||23
10856946|NCT03649217|12023178|FG000|COMPLETED|Overall Study||21
10856947|NCT03649217|12023178|FG000|NOT COMPLETED|Overall Study||2
10856948|NCT03569293|12023188|FG000|STARTED|Overall Study||241
10856949|NCT03569293|12023189|FG001|STARTED|Overall Study||239
10856950|NCT03569293|12023190|FG002|STARTED|Overall Study||243
10856951|NCT03569293|12023191|FG003|STARTED|Overall Study||61
10856952|NCT03569293|12023192|FG004|STARTED|Overall Study||64
10856953|NCT03569293|12023193|FG005|STARTED|Overall Study||64
10856954|NCT03569293|12023188|FG000|Received Study Drug|Overall Study||241
10856955|NCT03569293|12023189|FG001|Received Study Drug|Overall Study||239
10856956|NCT03569293|12023190|FG002|Received Study Drug|Overall Study||243
10856957|NCT03569293|12023191|FG003|Received Study Drug|Overall Study||61
10856958|NCT03569293|12023192|FG004|Received Study Drug|Overall Study||64
10856959|NCT03569293|12023193|FG005|Received Study Drug|Overall Study||64
10856960|NCT03569293|12023188|FG000|COMPLETED|Overall Study||204
10856961|NCT03569293|12023189|FG001|COMPLETED|Overall Study||230
10856962|NCT03569293|12023190|FG002|COMPLETED|Overall Study||229
10856963|NCT03569293|12023191|FG003|COMPLETED|Overall Study||57
10856964|NCT03569293|12023192|FG004|COMPLETED|Overall Study||64
10856965|NCT03569293|12023193|FG005|COMPLETED|Overall Study||64
10856966|NCT03569293|12023188|FG000|NOT COMPLETED|Overall Study||37
10856967|NCT03569293|12023189|FG001|NOT COMPLETED|Overall Study||9
10856968|NCT03569293|12023190|FG002|NOT COMPLETED|Overall Study||14
10856969|NCT03569293|12023191|FG003|NOT COMPLETED|Overall Study||4
10856970|NCT03569293|12023192|FG004|NOT COMPLETED|Overall Study||0
10856971|NCT03569293|12023193|FG005|NOT COMPLETED|Overall Study||0
10856972|NCT03564353|12023211|FG000|STARTED|Overall Study||10
10856973|NCT03564353|12023212|FG001|STARTED|Overall Study||10
10856974|NCT03564353|12023213|FG002|STARTED|Overall Study||10
10856975|NCT03564353|12023214|FG003|STARTED|Overall Study||10
10856976|NCT03564353|12023211|FG000|COMPLETED|Overall Study||10
10856977|NCT03564353|12023212|FG001|COMPLETED|Overall Study||10
10856978|NCT03564353|12023213|FG002|COMPLETED|Overall Study||10
10856979|NCT03564353|12023214|FG003|COMPLETED|Overall Study||10
10856980|NCT03564353|12023211|FG000|NOT COMPLETED|Overall Study||0
10856981|NCT03564353|12023212|FG001|NOT COMPLETED|Overall Study||0
10856982|NCT03564353|12023213|FG002|NOT COMPLETED|Overall Study||0
10856983|NCT03564353|12023214|FG003|NOT COMPLETED|Overall Study||0
10856984|NCT03541499|12023228|FG000|STARTED|Overall Study||15
10856985|NCT03541499|12023229|FG001|STARTED|Overall Study||15
10856986|NCT03541499|12023230|FG002|STARTED|Overall Study||5
10856987|NCT03541499|12023231|FG003|STARTED|Overall Study||15
10856988|NCT03541499|12023228|FG000|COMPLETED|Overall Study||15
10856989|NCT03541499|12023229|FG001|COMPLETED|Overall Study||15
10856990|NCT03541499|12023230|FG002|COMPLETED|Overall Study||5
10856991|NCT03541499|12023231|FG003|COMPLETED|Overall Study||15
10856992|NCT03541499|12023228|FG000|NOT COMPLETED|Overall Study||0
10856993|NCT03541499|12023229|FG001|NOT COMPLETED|Overall Study||0
10856994|NCT03541499|12023230|FG002|NOT COMPLETED|Overall Study||0
10856995|NCT03541499|12023231|FG003|NOT COMPLETED|Overall Study||0
11107167|NCT01262677|12291670|FG002|NOT COMPLETED|Overall Study||12
11107168|NCT01262755|12291678|FG000|STARTED|Overall Study||450
11107169|NCT01262755|12291678|FG000|COMPLETED|Overall Study||450
11107170|NCT01262755|12291678|FG000|NOT COMPLETED|Overall Study||0
11107171|NCT01262820|12291682|FG000|STARTED|Overall Study||15
11107172|NCT01262820|12291682|FG000|COMPLETED|Overall Study||0
11107173|NCT01262820|12291682|FG000|NOT COMPLETED|Overall Study||15
11107174|NCT01262846|12291688|FG000|STARTED|Overall Study||95
11107175|NCT01262846|12291689|FG001|STARTED|Overall Study||100
11107176|NCT01262846|12291688|FG000|COMPLETED|Overall Study||93
11107177|NCT01262846|12291689|FG001|COMPLETED|Overall Study||97
11107178|NCT01262846|12291688|FG000|NOT COMPLETED|Overall Study||2
10856996|NCT03473977|12023243|FG000|STARTED|Overall Study||13
10856997|NCT03473977|12023244|FG001|STARTED|Overall Study||13
10856998|NCT03473977|12023243|FG000|COMPLETED|Overall Study||13
10856999|NCT03473977|12023244|FG001|COMPLETED|Overall Study||13
10857000|NCT03473977|12023243|FG000|NOT COMPLETED|Overall Study||0
10857001|NCT03473977|12023244|FG001|NOT COMPLETED|Overall Study||0
10857002|NCT03373110|12023253|FG000|STARTED|Overall Study||133
10857003|NCT03373110|12023254|FG001|STARTED|Overall Study||137
10857004|NCT03373110|12023255|FG002|STARTED|Overall Study||70
10857005|NCT03373110|12023253|FG000|Provided Fitbit Data|Overall Study||123
10857006|NCT03373110|12023254|FG001|Provided Fitbit Data|Overall Study||130
10857007|NCT03373110|12023255|FG002|Provided Fitbit Data|Overall Study||63
10857008|NCT03373110|12023253|FG000|COMPLETED|Overall Study||55
10857009|NCT03373110|12023254|FG001|COMPLETED|Overall Study||58
10857010|NCT03373110|12023255|FG002|COMPLETED|Overall Study||26
10857011|NCT03373110|12023253|FG000|NOT COMPLETED|Overall Study||78
10857012|NCT03373110|12023254|FG001|NOT COMPLETED|Overall Study||79
10857013|NCT03373110|12023255|FG002|NOT COMPLETED|Overall Study||44
10857014|NCT03365102|12023266|FG000|STARTED|Overall Study||22
10857015|NCT03365102|12023267|FG001|STARTED|Overall Study||22
10857016|NCT03365102|12023268|FG002|STARTED|Overall Study||20
10857017|NCT03365102|12023266|FG000|COMPLETED|Overall Study||18
10857018|NCT03365102|12023267|FG001|COMPLETED|Overall Study||21
10857019|NCT03365102|12023268|FG002|COMPLETED|Overall Study||19
10857020|NCT03365102|12023266|FG000|NOT COMPLETED|Overall Study||4
10857021|NCT03365102|12023267|FG001|NOT COMPLETED|Overall Study||1
10857022|NCT03365102|12023268|FG002|NOT COMPLETED|Overall Study||1
10857023|NCT03318003|12023278|FG000|STARTED|Overall Study||21
10857024|NCT03318003|12023279|FG001|STARTED|Overall Study||22
10857025|NCT03318003|12023278|FG000|COMPLETED|Overall Study|completed means the presence of 3rd trimester ultrasound and delivery information.|20
10857026|NCT03318003|12023279|FG001|COMPLETED|Overall Study||20
10857027|NCT03318003|12023278|FG000|NOT COMPLETED|Overall Study||1
10857028|NCT03318003|12023279|FG001|NOT COMPLETED|Overall Study||2
10857029|NCT03309072|12023287|FG000|STARTED|Overall Study||15
10857030|NCT03309072|12023288|FG001|STARTED|Overall Study||15
10857031|NCT03309072|12023287|FG000|COMPLETED|Overall Study||15
10857032|NCT03309072|12023288|FG001|COMPLETED|Overall Study||15
10857033|NCT03309072|12023287|FG000|NOT COMPLETED|Overall Study||0
10857034|NCT03309072|12023288|FG001|NOT COMPLETED|Overall Study||0
10857035|NCT03138590|12023296|FG000|STARTED|Overall Study||10
10857036|NCT03138590|12023297|FG001|STARTED|Overall Study||10
10857037|NCT03138590|12023296|FG000|COMPLETED|Overall Study||10
10857038|NCT03138590|12023297|FG001|COMPLETED|Overall Study||10
10857039|NCT03138590|12023296|FG000|NOT COMPLETED|Overall Study||0
10857040|NCT03138590|12023297|FG001|NOT COMPLETED|Overall Study||0
10857041|NCT03132753|12023305|FG000|STARTED|Baseline - 6 Month Follow-Up||46
10857042|NCT03132753|12023306|FG001|STARTED|Baseline - 6 Month Follow-Up||54
10857043|NCT03132753|12023305|FG000|COMPLETED|Baseline - 6 Month Follow-Up||19
10857044|NCT03132753|12023306|FG001|COMPLETED|Baseline - 6 Month Follow-Up||22
10857045|NCT03132753|12023305|FG000|NOT COMPLETED|Baseline - 6 Month Follow-Up||27
10857046|NCT03132753|12023306|FG001|NOT COMPLETED|Baseline - 6 Month Follow-Up||32
10857047|NCT03132753|12023305|FG000|STARTED|6 Month Follow-Up - 12 Month Follow-Up||19
11107179|NCT01262846|12291689|FG001|NOT COMPLETED|Overall Study||3
11107180|NCT01262872|12291703|FG000|STARTED|Step 1||60
10857048|NCT03132753|12023306|FG001|STARTED|6 Month Follow-Up - 12 Month Follow-Up||22
10857049|NCT03132753|12023305|FG000|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||13
10857050|NCT03132753|12023306|FG001|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||20
10857051|NCT03132753|12023305|FG000|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||6
10857052|NCT03132753|12023306|FG001|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||2
11107181|NCT01262872|12291704|FG001|STARTED|Step 1||60
11107182|NCT01262872|12291705|FG002|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
11107183|NCT01262872|12291706|FG003|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
11107184|NCT01262872|12291707|FG004|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
11107185|NCT01262872|12291708|FG005|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
11107186|NCT01262872|12291709|FG006|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10857059|NCT03067077|12023321|FG000|STARTED|Overall Study||44
10857060|NCT03067077|12023322|FG001|STARTED|Overall Study||44
10857061|NCT03067077|12023321|FG000|Received Surgery|Overall Study||40
10857062|NCT03067077|12023322|FG001|Received Surgery|Overall Study||39
10857063|NCT03067077|12023321|FG000|COMPLETED|Overall Study||37
10857064|NCT03067077|12023322|FG001|COMPLETED|Overall Study||37
10857065|NCT03067077|12023321|FG000|NOT COMPLETED|Overall Study||7
10857066|NCT03067077|12023322|FG001|NOT COMPLETED|Overall Study||7
10857067|NCT03059446|12023328|FG000|STARTED|Overall Study||167
10857068|NCT03059446|12023328|FG000|COMPLETED|Overall Study||0
10857069|NCT03059446|12023328|FG000|NOT COMPLETED|Overall Study||167
10857070|NCT03019575|12023332|FG000|STARTED|Overall Study||17
10857071|NCT03019575|12023332|FG000|COMPLETED|Overall Study||17
10857072|NCT03019575|12023332|FG000|NOT COMPLETED|Overall Study||0
10857073|NCT03011034|12023338|FG000|STARTED|Overall Study||1
10857074|NCT03011034|12023339|FG001|STARTED|Overall Study||33
10857075|NCT03011034|12023338|FG000|COMPLETED|Overall Study||0
10857076|NCT03011034|12023339|FG001|COMPLETED|Overall Study||33
10857077|NCT03011034|12023338|FG000|NOT COMPLETED|Overall Study||1
10857078|NCT03011034|12023339|FG001|NOT COMPLETED|Overall Study||0
10857079|NCT02980666|12023347|FG000|STARTED|Overall Study||8
10857080|NCT02980666|12023348|FG001|STARTED|Overall Study||2
10857081|NCT02980666|12023347|FG000|COMPLETED|Overall Study||8
10857082|NCT02980666|12023348|FG001|COMPLETED|Overall Study||2
10857083|NCT02980666|12023347|FG000|NOT COMPLETED|Overall Study||0
10857084|NCT02980666|12023348|FG001|NOT COMPLETED|Overall Study||0
10857085|NCT02962102|12023357|FG000|STARTED|Overall Study||51
10857086|NCT02962102|12023358|FG001|STARTED|Overall Study||50
10857087|NCT02962102|12023359|FG002|STARTED|Overall Study||49
10857088|NCT02962102|12023357|FG000|COMPLETED|Overall Study||51
10857089|NCT02962102|12023358|FG001|COMPLETED|Overall Study||50
10857090|NCT02962102|12023359|FG002|COMPLETED|Overall Study||49
10857091|NCT02962102|12023357|FG000|NOT COMPLETED|Overall Study||0
10857092|NCT02962102|12023358|FG001|NOT COMPLETED|Overall Study||0
10857093|NCT02962102|12023359|FG002|NOT COMPLETED|Overall Study||0
11107187|NCT01262872|12291710|FG007|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
11107188|NCT01262872|12291703|FG000|COMPLETED|Step 1||60
11107189|NCT01262872|12291704|FG001|COMPLETED|Step 1||60
11107190|NCT01262872|12291705|FG002|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
11107191|NCT01262872|12291706|FG003|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
11107192|NCT01262872|12291707|FG004|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
10857102|NCT02749045|12023376|FG000|STARTED|Overall Study||27
10857103|NCT02749045|12023376|FG000|COMPLETED|Overall Study||27
10857104|NCT02749045|12023376|FG000|NOT COMPLETED|Overall Study||0
10857105|NCT02659605|12023382|FG000|STARTED|Overall Study||40
10857106|NCT02659605|12023383|FG001|STARTED|Overall Study||34
10857107|NCT02659605|12023382|FG000|COMPLETED|Overall Study||31
10857108|NCT02659605|12023383|FG001|COMPLETED|Overall Study||30
10857109|NCT02659605|12023382|FG000|NOT COMPLETED|Overall Study||9
10857110|NCT02659605|12023383|FG001|NOT COMPLETED|Overall Study||4
10857111|NCT02601014|12023391|FG000|STARTED|Overall Study||15
10857112|NCT02601014|12023392|FG001|STARTED|Overall Study||15
10857113|NCT02601014|12023391|FG000|COMPLETED|Overall Study||5
10857114|NCT02601014|12023392|FG001|COMPLETED|Overall Study||3
10857115|NCT02601014|12023391|FG000|NOT COMPLETED|Overall Study||10
10857116|NCT02601014|12023392|FG001|NOT COMPLETED|Overall Study||12
11107193|NCT01262872|12291708|FG005|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
11107194|NCT01262872|12291709|FG006|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
11107195|NCT01262872|12291710|FG007|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
11226384|NCT01998906|12418819|FG001|COMPLETED|Overall Study||2
11226385|NCT01998906|12418820|FG002|COMPLETED|Overall Study||1
11226386|NCT01998906|12418818|FG000|NOT COMPLETED|Overall Study||114
11226387|NCT01998906|12418819|FG001|NOT COMPLETED|Overall Study||114
11226388|NCT01998906|12418820|FG002|NOT COMPLETED|Overall Study||98
11354903|NCT03075410|12551818|FG008|NOT COMPLETED|Part A-Period 4 (14 Days)||0
11354904|NCT03075410|12551810|FG000|STARTED|Part B (up to 28 Days)||0
11354905|NCT03075410|12551811|FG001|STARTED|Part B (up to 28 Days)||0
11354906|NCT03075410|12551812|FG002|STARTED|Part B (up to 28 Days)||0
11354907|NCT03075410|12551813|FG003|STARTED|Part B (up to 28 Days)||0
11354908|NCT03075410|12551814|FG004|STARTED|Part B (up to 28 Days)||0
11354909|NCT03075410|12551815|FG005|STARTED|Part B (up to 28 Days)||0
11354910|NCT03075410|12551816|FG006|STARTED|Part B (up to 28 Days)||4
11354911|NCT03075410|12551817|FG007|STARTED|Part B (up to 28 Days)||7
11354912|NCT03075410|12551818|FG008|STARTED|Part B (up to 28 Days)||8
11354913|NCT03075410|12551810|FG000|COMPLETED|Part B (up to 28 Days)||0
11354914|NCT03075410|12551811|FG001|COMPLETED|Part B (up to 28 Days)||0
11354915|NCT03075410|12551812|FG002|COMPLETED|Part B (up to 28 Days)||0
11354916|NCT03075410|12551813|FG003|COMPLETED|Part B (up to 28 Days)||0
11354917|NCT03075410|12551814|FG004|COMPLETED|Part B (up to 28 Days)||0
11354918|NCT03075410|12551815|FG005|COMPLETED|Part B (up to 28 Days)||0
11354919|NCT03075410|12551816|FG006|COMPLETED|Part B (up to 28 Days)||4
11354920|NCT03075410|12551817|FG007|COMPLETED|Part B (up to 28 Days)||7
11354921|NCT03075410|12551818|FG008|COMPLETED|Part B (up to 28 Days)||8
11354922|NCT03075410|12551810|FG000|NOT COMPLETED|Part B (up to 28 Days)||0
11354923|NCT03075410|12551811|FG001|NOT COMPLETED|Part B (up to 28 Days)||0
11354924|NCT03075410|12551812|FG002|NOT COMPLETED|Part B (up to 28 Days)||0
11354925|NCT03075410|12551813|FG003|NOT COMPLETED|Part B (up to 28 Days)||0
11354926|NCT03075410|12551814|FG004|NOT COMPLETED|Part B (up to 28 Days)||0
11354927|NCT03075410|12551815|FG005|NOT COMPLETED|Part B (up to 28 Days)||0
11354928|NCT03075410|12551816|FG006|NOT COMPLETED|Part B (up to 28 Days)||0
11354929|NCT03075410|12551817|FG007|NOT COMPLETED|Part B (up to 28 Days)||0
11354930|NCT03075410|12551818|FG008|NOT COMPLETED|Part B (up to 28 Days)||0
11354931|NCT03075449|12551842|FG000|STARTED|Overall Study||170
11354932|NCT03075449|12551842|FG000|COMPLETED|Overall Study||170
11354933|NCT03075449|12551842|FG000|NOT COMPLETED|Overall Study||0
11354934|NCT03075501|12551848|FG000|STARTED|Overall Study||89
11354935|NCT03075501|12551849|FG001|STARTED|Overall Study||44
11354936|NCT03075501|12551848|FG000|COMPLETED|Overall Study||74
11354937|NCT03075501|12551849|FG001|COMPLETED|Overall Study||35
11354938|NCT03075501|12551848|FG000|NOT COMPLETED|Overall Study||15
11354939|NCT03075501|12551849|FG001|NOT COMPLETED|Overall Study||9
11354940|NCT03075553|12551856|FG000|STARTED|Overall Study||12
11354941|NCT03075553|12551856|FG000|COMPLETED|Overall Study||12
11354942|NCT03075553|12551856|FG000|NOT COMPLETED|Overall Study||0
11354943|NCT03075644|12551862|FG000|STARTED|Overall Study||16
11354944|NCT03075644|12551863|FG001|STARTED|Overall Study||46
11354945|NCT03075644|12551862|FG000|Full Analysis Set (FAS)|Overall Study||16
11354946|NCT03075644|12551863|FG001|Full Analysis Set (FAS)|Overall Study||46
11354947|NCT03075644|12551862|FG000|Safety Analysis Set (SAS)|Overall Study||16
11354948|NCT03075644|12551863|FG001|Safety Analysis Set (SAS)|Overall Study||46
11354949|NCT03075644|12551862|FG000|COMPLETED|Overall Study||15
11354950|NCT03075644|12551863|FG001|COMPLETED|Overall Study||45
11354951|NCT03075644|12551862|FG000|NOT COMPLETED|Overall Study||1
11354952|NCT03075644|12551863|FG001|NOT COMPLETED|Overall Study||1
11354953|NCT03075761|12551872|FG000|STARTED|Overall Study||11
11354954|NCT03075761|12551873|FG001|STARTED|Overall Study||12
11354955|NCT03075761|12551872|FG000|COMPLETED|Overall Study||10
11354956|NCT03075761|12551873|FG001|COMPLETED|Overall Study||6
11354957|NCT03075761|12551872|FG000|NOT COMPLETED|Overall Study||1
11354958|NCT03075761|12551873|FG001|NOT COMPLETED|Overall Study||6
11354959|NCT03075839|12551884|FG000|STARTED|Overall Study||33
11354960|NCT03075839|12551884|FG000|COMPLETED|Overall Study||29
11354961|NCT03075839|12551884|FG000|NOT COMPLETED|Overall Study||4
11354962|NCT03075878|12551888|FG000|STARTED|Overall Study||8
11354963|NCT03075878|12551888|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
11107196|NCT01262872|12291703|FG000|NOT COMPLETED|Step 1||0
11107197|NCT01262872|12291704|FG001|NOT COMPLETED|Step 1||0
11107198|NCT01262872|12291705|FG002|NOT COMPLETED|Step 1||0
11107199|NCT01262872|12291706|FG003|NOT COMPLETED|Step 1||0
11107200|NCT01262872|12291707|FG004|NOT COMPLETED|Step 1||0
11354964|NCT03075878|12551888|FG000|COMPLETED|Overall Study||7
11354965|NCT03075878|12551888|FG000|NOT COMPLETED|Overall Study||1
10857135|NCT02538666|12023410|FG000|STARTED|Overall Study||275
10857136|NCT02538666|12023411|FG001|STARTED|Overall Study||280
10857137|NCT02538666|12023412|FG002|STARTED|Overall Study||279
10857138|NCT02538666|12023410|FG000|COMPLETED|Overall Study||273
10857139|NCT02538666|12023411|FG001|COMPLETED|Overall Study||279
10857140|NCT02538666|12023412|FG002|COMPLETED|Overall Study||278
10857141|NCT02538666|12023410|FG000|NOT COMPLETED|Overall Study||2
10857142|NCT02538666|12023411|FG001|NOT COMPLETED|Overall Study||1
11354966|NCT03075891|12551894|FG000|STARTED|Overall Study||135
11354967|NCT03075891|12551895|FG001|STARTED|Overall Study||138
11354968|NCT03075891|12551894|FG000|COMPLETED|Overall Study||126
10857143|NCT02538666|12023412|FG002|NOT COMPLETED|Overall Study||1
10857144|NCT02527200|12023425|FG000|STARTED|Overall Study||20
10857145|NCT02527200|12023426|FG001|STARTED|Overall Study||12
10857146|NCT02527200|12023427|FG002|STARTED|Overall Study||17
10857147|NCT02527200|12023428|FG003|STARTED|Overall Study||7
10857148|NCT02527200|12023425|FG000|Safety Analysis Set (SAS)|Overall Study||20
10857149|NCT02527200|12023426|FG001|Safety Analysis Set (SAS)|Overall Study||12
10857150|NCT02527200|12023427|FG002|Safety Analysis Set (SAS)|Overall Study||17
10857151|NCT02527200|12023428|FG003|Safety Analysis Set (SAS)|Overall Study||7
10857152|NCT02527200|12023425|FG000|Full Analysis Set (FAS)|Overall Study||19
10857153|NCT02527200|12023426|FG001|Full Analysis Set (FAS)|Overall Study||12
10857154|NCT02527200|12023427|FG002|Full Analysis Set (FAS)|Overall Study||17
10857155|NCT02527200|12023428|FG003|Full Analysis Set (FAS)|Overall Study||7
10857156|NCT02527200|12023425|FG000|COMPLETED|Overall Study||17
10857157|NCT02527200|12023426|FG001|COMPLETED|Overall Study||9
10857158|NCT02527200|12023427|FG002|COMPLETED|Overall Study||15
10857159|NCT02527200|12023428|FG003|COMPLETED|Overall Study||7
10857160|NCT02527200|12023425|FG000|NOT COMPLETED|Overall Study||3
10857161|NCT02527200|12023426|FG001|NOT COMPLETED|Overall Study||3
10857162|NCT02527200|12023427|FG002|NOT COMPLETED|Overall Study||2
10857163|NCT02527200|12023428|FG003|NOT COMPLETED|Overall Study||0
10857164|NCT02511106|12023444|FG000|STARTED|Overall Study||339
10857165|NCT02511106|12023445|FG001|STARTED|Overall Study||343
10857166|NCT02511106|12023444|FG000|Received Treatment|Overall Study||337
10857167|NCT02511106|12023445|FG001|Received Treatment|Overall Study||343
10857168|NCT02511106|12023444|FG000|COMPLETED|Overall Study||8
10857169|NCT02511106|12023445|FG001|COMPLETED|Overall Study||20
10857170|NCT02511106|12023444|FG000|NOT COMPLETED|Overall Study||331
10857171|NCT02511106|12023445|FG001|NOT COMPLETED|Overall Study||323
10857172|NCT02477358|12023455|FG000|STARTED|Overall Study||18
10857173|NCT02477358|12023456|FG001|STARTED|Overall Study||18
10857174|NCT02477358|12023455|FG000|COMPLETED|Overall Study||18
10857175|NCT02477358|12023456|FG001|COMPLETED|Overall Study||18
10857176|NCT02477358|12023455|FG000|NOT COMPLETED|Overall Study||0
10857177|NCT02477358|12023456|FG001|NOT COMPLETED|Overall Study||0
10857178|NCT02432209|12023466|FG000|STARTED|Overall Study||188
10857179|NCT02432209|12023467|FG001|STARTED|Overall Study||191
10857180|NCT02432209|12023466|FG000|COMPLETED|Overall Study||157
10857181|NCT02432209|12023467|FG001|COMPLETED|Overall Study||151
10857182|NCT02432209|12023466|FG000|NOT COMPLETED|Overall Study||31
10857183|NCT02432209|12023467|FG001|NOT COMPLETED|Overall Study||40
10857184|NCT02392637|12023475|FG000|STARTED|Overall Study||32
10857185|NCT02392637|12023476|FG001|STARTED|Overall Study||28
10857186|NCT02392637|12023475|FG000|COMPLETED|Overall Study||32
10857187|NCT02392637|12023476|FG001|COMPLETED|Overall Study||28
10857188|NCT02392637|12023475|FG000|NOT COMPLETED|Overall Study||0
10857189|NCT02392637|12023476|FG001|NOT COMPLETED|Overall Study||0
10857190|NCT02224573|12023487|FG000|STARTED|Treatment Phase||315
10857191|NCT02224573|12023488|FG001|STARTED|Treatment Phase||366
10857192|NCT02224573|12023487|FG000|COMPLETED|Treatment Phase||170
10857193|NCT02224573|12023488|FG001|COMPLETED|Treatment Phase||243
10857194|NCT02224573|12023487|FG000|NOT COMPLETED|Treatment Phase||145
10857195|NCT02224573|12023488|FG001|NOT COMPLETED|Treatment Phase||123
10857196|NCT02224573|12023487|FG000|STARTED|Taper Phase|The number of participants to start the Taper Phase is not equal to the number who completed the Treatment Phase because not all participants tapered IMP.|79
10857197|NCT02224573|12023488|FG001|STARTED|Taper Phase|The number of participants to start the Taper Phase is not equal to the number who completed the Treatment Phase because not all participants tapered IMP.|71
10857198|NCT02224573|12023487|FG000|COMPLETED|Taper Phase||76
10857199|NCT02224573|12023488|FG001|COMPLETED|Taper Phase||67
10857200|NCT02224573|12023487|FG000|NOT COMPLETED|Taper Phase||3
10857201|NCT02224573|12023488|FG001|NOT COMPLETED|Taper Phase||4
10857202|NCT01991067|12023497|FG000|STARTED|Overall Study||19
10857203|NCT01991067|12023498|FG001|STARTED|Overall Study||15
10857204|NCT01991067|12023497|FG000|COMPLETED|Overall Study||13
10857205|NCT01991067|12023498|FG001|COMPLETED|Overall Study||10
10857206|NCT01991067|12023497|FG000|NOT COMPLETED|Overall Study||6
10857207|NCT01991067|12023498|FG001|NOT COMPLETED|Overall Study||5
10857208|NCT01928732|12023506|FG000|STARTED|Overall Study||455
10857209|NCT01928732|12023507|FG001|STARTED|Overall Study||461
10857210|NCT01928732|12023506|FG000|COMPLETED|Overall Study||326
10857211|NCT01928732|12023507|FG001|COMPLETED|Overall Study||334
10857212|NCT01928732|12023506|FG000|NOT COMPLETED|Overall Study||129
10857213|NCT01928732|12023507|FG001|NOT COMPLETED|Overall Study||127
10857214|NCT01925573|12023513|FG000|STARTED|Overall Study||7
10857215|NCT01925573|12023513|FG000|COMPLETED|Overall Study||0
10857216|NCT01925573|12023513|FG000|NOT COMPLETED|Overall Study||7
10857217|NCT01774721|12023519|FG000|STARTED|Overall Study||227
10857218|NCT01774721|12023520|FG001|STARTED|Overall Study||225
10857219|NCT01774721|12023519|FG000|Treated|Overall Study||227
10857220|NCT01774721|12023520|FG001|Treated|Overall Study||224
10857221|NCT01774721|12023519|FG000|COMPLETED|Overall Study||0
10857222|NCT01774721|12023520|FG001|COMPLETED|Overall Study||0
10857223|NCT01774721|12023519|FG000|NOT COMPLETED|Overall Study||227
10857224|NCT01774721|12023520|FG001|NOT COMPLETED|Overall Study||225
10857225|NCT01747447|12023530|FG000|STARTED|Overall Study||388
10857226|NCT01747447|12023531|FG001|STARTED|Overall Study||383
10857227|NCT01747447|12023530|FG000|COMPLETED|Overall Study||347
10857228|NCT01747447|12023531|FG001|COMPLETED|Overall Study||340
10857229|NCT01747447|12023530|FG000|NOT COMPLETED|Overall Study||41
10857230|NCT01747447|12023531|FG001|NOT COMPLETED|Overall Study||43
10857231|NCT01709331|12023537|FG000|STARTED|Overall Study||18
10857232|NCT01709331|12023537|FG000|COMPLETED|Overall Study||17
10857233|NCT01709331|12023537|FG000|NOT COMPLETED|Overall Study||1
10857234|NCT01656434|12023543|FG000|STARTED|Overall Study||2553
10857235|NCT01656434|12023544|FG001|STARTED|Overall Study||620
10857236|NCT01656434|12023543|FG000|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
10857237|NCT01656434|12023544|FG001|Treated|Overall Study||604
10857238|NCT01656434|12023543|FG000|COMPLETED|Overall Study||152
10857239|NCT01656434|12023544|FG001|COMPLETED|Overall Study||40
10857240|NCT01656434|12023543|FG000|NOT COMPLETED|Overall Study||2401
10857241|NCT01656434|12023544|FG001|NOT COMPLETED|Overall Study||580
10857242|NCT01518517|12023553|FG000|STARTED|Overall Study||29
10857243|NCT01518517|12023554|FG001|STARTED|Overall Study||30
10857244|NCT01518517|12023555|FG002|STARTED|Overall Study||26
10857245|NCT01518517|12023553|FG000|COMPLETED|Overall Study||1
10857246|NCT01518517|12023554|FG001|COMPLETED|Overall Study||3
10857247|NCT01518517|12023555|FG002|COMPLETED|Overall Study||0
10857248|NCT01518517|12023553|FG000|NOT COMPLETED|Overall Study||28
10857249|NCT01518517|12023554|FG001|NOT COMPLETED|Overall Study||27
10857250|NCT01518517|12023555|FG002|NOT COMPLETED|Overall Study||26
10857251|NCT01496118|12023573|FG000|STARTED|Overall Study||4
10857252|NCT01496118|12023574|FG001|STARTED|Overall Study||3
10857253|NCT01496118|12023575|FG002|STARTED|Overall Study||3
10857254|NCT01496118|12023576|FG003|STARTED|Overall Study||3
10857255|NCT01496118|12023577|FG004|STARTED|Overall Study||3
10857256|NCT01496118|12023578|FG005|STARTED|Overall Study||3
10857257|NCT01496118|12023579|FG006|STARTED|Overall Study||31
10857258|NCT01496118|12023580|FG007|STARTED|Overall Study||30
10857259|NCT01496118|12023573|FG000|COMPLETED|Overall Study||0
10857260|NCT01496118|12023574|FG001|COMPLETED|Overall Study||0
10857261|NCT01496118|12023575|FG002|COMPLETED|Overall Study||0
10857262|NCT01496118|12023576|FG003|COMPLETED|Overall Study||0
10857263|NCT01496118|12023577|FG004|COMPLETED|Overall Study||0
10857264|NCT01496118|12023578|FG005|COMPLETED|Overall Study||0
10857265|NCT01496118|12023579|FG006|COMPLETED|Overall Study||0
10857266|NCT01496118|12023580|FG007|COMPLETED|Overall Study||0
10857267|NCT01496118|12023573|FG000|NOT COMPLETED|Overall Study||4
10857268|NCT01496118|12023574|FG001|NOT COMPLETED|Overall Study||3
10857269|NCT01496118|12023575|FG002|NOT COMPLETED|Overall Study||3
10857270|NCT01496118|12023576|FG003|NOT COMPLETED|Overall Study||3
10857271|NCT01496118|12023577|FG004|NOT COMPLETED|Overall Study||3
10857272|NCT01496118|12023578|FG005|NOT COMPLETED|Overall Study||3
10857273|NCT01496118|12023579|FG006|NOT COMPLETED|Overall Study||31
10857274|NCT01496118|12023580|FG007|NOT COMPLETED|Overall Study||30
10857275|NCT01350934|12023600|FG000|STARTED|Base Study||111
10857276|NCT01350934|12023601|FG001|STARTED|Base Study||108
10857277|NCT01350934|12023600|FG000|COMPLETED|Base Study||100
10857278|NCT01350934|12023601|FG001|COMPLETED|Base Study||105
10857279|NCT01350934|12023600|FG000|NOT COMPLETED|Base Study||11
10857280|NCT01350934|12023601|FG001|NOT COMPLETED|Base Study||3
10857281|NCT01350934|12023600|FG000|STARTED|Extension Study||100
10857282|NCT01350934|12023601|FG001|STARTED|Extension Study||105
10857283|NCT01350934|12023600|FG000|COMPLETED|Extension Study||95
10857284|NCT01350934|12023601|FG001|COMPLETED|Extension Study||101
10857285|NCT01350934|12023600|FG000|NOT COMPLETED|Extension Study||5
10857286|NCT01350934|12023601|FG001|NOT COMPLETED|Extension Study||4
10857287|NCT01286207|12023610|FG000|STARTED|Overall Study||751
10857288|NCT01286207|12023611|FG001|STARTED|Overall Study||857
10857289|NCT01286207|12023612|FG002|STARTED|Overall Study||351
10857290|NCT01286207|12023610|FG000|COMPLETED|Overall Study||453
10857291|NCT01286207|12023611|FG001|COMPLETED|Overall Study||609
10857292|NCT01286207|12023612|FG002|COMPLETED|Overall Study||261
10857293|NCT01286207|12023610|FG000|NOT COMPLETED|Overall Study||298
10857294|NCT01286207|12023611|FG001|NOT COMPLETED|Overall Study||248
10857295|NCT01286207|12023612|FG002|NOT COMPLETED|Overall Study||90
11107201|NCT01262872|12291708|FG005|NOT COMPLETED|Step 1||0
11107202|NCT01262872|12291709|FG006|NOT COMPLETED|Step 1||0
11107203|NCT01262872|12291710|FG007|NOT COMPLETED|Step 1||0
10857299|NCT01227187|12023628|FG000|STARTED|Overall Study||1
10857300|NCT01227187|12023629|FG001|STARTED|Overall Study||3
10857301|NCT01227187|12023630|FG002|STARTED|Overall Study||3
10857302|NCT01227187|12023631|FG003|STARTED|Overall Study||5
10857303|NCT01227187|12023628|FG000|COMPLETED|Overall Study||1
10857304|NCT01227187|12023629|FG001|COMPLETED|Overall Study||3
10857305|NCT01227187|12023630|FG002|COMPLETED|Overall Study||3
10857306|NCT01227187|12023631|FG003|COMPLETED|Overall Study||4
10857307|NCT01227187|12023628|FG000|NOT COMPLETED|Overall Study||0
10857308|NCT01227187|12023629|FG001|NOT COMPLETED|Overall Study||0
10857309|NCT01227187|12023630|FG002|NOT COMPLETED|Overall Study||0
10857310|NCT01227187|12023631|FG003|NOT COMPLETED|Overall Study||1
10857311|NCT01146418|12023643|FG000|STARTED|Base Study P06029 (NCT01144416)||694
10857312|NCT01146418|12023644|FG001|STARTED|Base Study P06029 (NCT01144416)||696
10857313|NCT01146418|12023645|FG002|STARTED|Base Study P06029 (NCT01144416)||0
10857314|NCT01146418|12023646|FG003|STARTED|Base Study P06029 (NCT01144416)||0
10857315|NCT01146418|12023643|FG000|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
10857316|NCT01146418|12023644|FG001|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
10857317|NCT01146418|12023645|FG002|COMPLETED|Base Study P06029 (NCT01144416)||0
10857318|NCT01146418|12023646|FG003|COMPLETED|Base Study P06029 (NCT01144416)||0
10857319|NCT01146418|12023643|FG000|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
10857320|NCT01146418|12023644|FG001|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
10857321|NCT01146418|12023645|FG002|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
10857322|NCT01146418|12023646|FG003|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
10857323|NCT01146418|12023643|FG000|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
10857324|NCT01146418|12023644|FG001|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
10857325|NCT01146418|12023645|FG002|STARTED|Women/Expectant Mother Follow Up||0
10857326|NCT01146418|12023646|FG003|STARTED|Women/Expectant Mother Follow Up||0
10857327|NCT01146418|12023643|FG000|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
10857328|NCT01146418|12023644|FG001|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
10857329|NCT01146418|12023645|FG002|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
10857330|NCT01146418|12023646|FG003|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
10857331|NCT01146418|12023643|FG000|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
10857332|NCT01146418|12023644|FG001|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
10857333|NCT01146418|12023645|FG002|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
10857334|NCT01146418|12023646|FG003|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
10857335|NCT01146418|12023643|FG000|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
10857336|NCT01146418|12023644|FG001|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
10857337|NCT01146418|12023645|FG002|COMPLETED|Women/Expectant Mother Follow Up||0
10857338|NCT01146418|12023646|FG003|COMPLETED|Women/Expectant Mother Follow Up||0
10857339|NCT01146418|12023643|FG000|NOT COMPLETED|Women/Expectant Mother Follow Up||44
10857340|NCT01146418|12023644|FG001|NOT COMPLETED|Women/Expectant Mother Follow Up||40
10857341|NCT01146418|12023645|FG002|NOT COMPLETED|Women/Expectant Mother Follow Up||0
10857342|NCT01146418|12023646|FG003|NOT COMPLETED|Women/Expectant Mother Follow Up||0
10857343|NCT01146418|12023643|FG000|STARTED|Live-Born Infant Follow Up||0
10857344|NCT01146418|12023644|FG001|STARTED|Live-Born Infant Follow Up||0
10857345|NCT01146418|12023645|FG002|STARTED|Live-Born Infant Follow Up||61
10857346|NCT01146418|12023646|FG003|STARTED|Live-Born Infant Follow Up||56
10857347|NCT01146418|12023643|FG000|COMPLETED|Live-Born Infant Follow Up||0
10857348|NCT01146418|12023644|FG001|COMPLETED|Live-Born Infant Follow Up||0
10857349|NCT01146418|12023645|FG002|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
10857350|NCT01146418|12023646|FG003|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
10857351|NCT01146418|12023643|FG000|NOT COMPLETED|Live-Born Infant Follow Up||0
10857352|NCT01146418|12023644|FG001|NOT COMPLETED|Live-Born Infant Follow Up||0
10857353|NCT01146418|12023645|FG002|NOT COMPLETED|Live-Born Infant Follow Up||6
10857354|NCT01146418|12023646|FG003|NOT COMPLETED|Live-Born Infant Follow Up||5
10857355|NCT01144416|12023658|FG000|STARTED|Intervention Period||694
10857356|NCT01144416|12023659|FG001|STARTED|Intervention Period||696
10857357|NCT01144416|12023658|FG000|COMPLETED|Intervention Period||632
10857358|NCT01144416|12023659|FG001|COMPLETED|Intervention Period||647
10857359|NCT01144416|12023658|FG000|NOT COMPLETED|Intervention Period||62
10857360|NCT01144416|12023659|FG001|NOT COMPLETED|Intervention Period||49
10857361|NCT01144416|12023658|FG000|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
10857362|NCT01144416|12023659|FG001|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
10857363|NCT01144416|12023658|FG000|COMPLETED|Pregnancy Follow-up Period||146
10857364|NCT01144416|12023659|FG001|COMPLETED|Pregnancy Follow-up Period||157
10857365|NCT01144416|12023658|FG000|NOT COMPLETED|Pregnancy Follow-up Period||8
10857366|NCT01144416|12023659|FG001|NOT COMPLETED|Pregnancy Follow-up Period||10
10857367|NCT01140048|12023669|FG000|STARTED|Overall Study||343
10857368|NCT01140048|12023669|FG000|COMPLETED|Overall Study||298
10857369|NCT01140048|12023669|FG000|NOT COMPLETED|Overall Study||45
10857370|NCT01077817|12023673|FG000|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
10857371|NCT01077817|12023673|FG000|COMPLETED|Overall Study||684815
10857372|NCT01077817|12023673|FG000|NOT COMPLETED|Overall Study||0
10857373|NCT01065779|12023684|FG000|STARTED|Overall Study||880
10857374|NCT01065779|12023684|FG000|COMPLETED|Overall Study||798
10857375|NCT01065779|12023684|FG000|NOT COMPLETED|Overall Study||82
11226389|NCT01998919|12418833|FG000|STARTED|Overall Study||79
11226390|NCT01998919|12418834|FG001|STARTED|Overall Study||74
11226391|NCT01998919|12418833|FG000|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
11226392|NCT01998919|12418834|FG001|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
11107204|NCT01262872|12291703|FG000|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
11107205|NCT01262872|12291704|FG001|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
11107206|NCT01262872|12291705|FG002|STARTED|Step 2||200
11107207|NCT01262872|12291706|FG003|STARTED|Step 2||200
11107208|NCT01262872|12291707|FG004|STARTED|Step 2||200
11107209|NCT01262872|12291708|FG005|STARTED|Step 2||200
11107210|NCT01262872|12291709|FG006|STARTED|Step 2||200
10857376|NCT00974571|12023691|FG000|STARTED|Overall Study||630
10857377|NCT00974571|12023692|FG001|STARTED|Overall Study||122
10857378|NCT00974571|12023693|FG002|STARTED|Overall Study||613
10857379|NCT00974571|12023691|FG000|COMPLETED|Overall Study||562
10857380|NCT00974571|12023692|FG001|COMPLETED|Overall Study||106
11226393|NCT01998919|12418833|FG000|COMPLETED|Overall Study||37
11226394|NCT01998919|12418834|FG001|COMPLETED|Overall Study||39
11226395|NCT01998919|12418833|FG000|NOT COMPLETED|Overall Study||42
11226396|NCT01998919|12418834|FG001|NOT COMPLETED|Overall Study||35
11226397|NCT01998958|12418847|FG000|STARTED|Period 1 (Panel A and B)||33
11226398|NCT01998958|12418848|FG001|STARTED|Period 1 (Panel A and B)||11
11226399|NCT01998958|12418849|FG002|STARTED|Period 1 (Panel A and B)||11
11226400|NCT01998958|12418850|FG003|STARTED|Period 1 (Panel A and B)||12
11226401|NCT01998958|12418851|FG004|STARTED|Period 1 (Panel A and B)||21
11226402|NCT01998958|12418852|FG005|STARTED|Period 1 (Panel A and B)||11
11226403|NCT01998958|12418853|FG006|STARTED|Period 1 (Panel A and B)||9
11226404|NCT01998958|12418854|FG007|STARTED|Period 1 (Panel A and B)||0
11226405|NCT01998958|12418855|FG008|STARTED|Period 1 (Panel A and B)||0
11226406|NCT01998958|12418856|FG009|STARTED|Period 1 (Panel A and B)||0
11226407|NCT01998958|12418857|FG010|STARTED|Period 1 (Panel A and B)||0
11226408|NCT01998958|12418858|FG011|STARTED|Period 1 (Panel A and B)||0
11226409|NCT01998958|12418859|FG012|STARTED|Period 1 (Panel A and B)||0
11226410|NCT01998958|12418860|FG013|STARTED|Period 1 (Panel A and B)||0
11226411|NCT01998958|12418861|FG014|STARTED|Period 1 (Panel A and B)||0
11226412|NCT01998958|12418862|FG015|STARTED|Period 1 (Panel A and B)||0
11226413|NCT01998958|12418863|FG016|STARTED|Period 1 (Panel A and B)||0
11226414|NCT01998958|12418864|FG017|STARTED|Period 1 (Panel A and B)||0
11226415|NCT01998958|12418865|FG018|STARTED|Period 1 (Panel A and B)||0
11226416|NCT01998958|12418866|FG019|STARTED|Period 1 (Panel A and B)||0
11226417|NCT01998958|12418867|FG020|STARTED|Period 1 (Panel A and B)||0
11226418|NCT01998958|12418868|FG021|STARTED|Period 1 (Panel A and B)||0
11226419|NCT01998958|12418869|FG022|STARTED|Period 1 (Panel A and B)||0
11226420|NCT01998958|12418870|FG023|STARTED|Period 1 (Panel A and B)||0
11226421|NCT01998958|12418871|FG024|STARTED|Period 1 (Panel A and B)||0
11226422|NCT01998958|12418872|FG025|STARTED|Period 1 (Panel A and B)||0
11226423|NCT01998958|12418873|FG026|STARTED|Period 1 (Panel A and B)||0
11226424|NCT01998958|12418874|FG027|STARTED|Period 1 (Panel A and B)||0
11226425|NCT01998958|12418875|FG028|STARTED|Period 1 (Panel A and B)||0
11226426|NCT01998958|12418876|FG029|STARTED|Period 1 (Panel A and B)||0
11226427|NCT01998958|12418877|FG030|STARTED|Period 1 (Panel A and B)||0
11226428|NCT01998958|12418878|FG031|STARTED|Period 1 (Panel A and B)||0
11226429|NCT01998958|12418847|FG000|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9
11226430|NCT01998958|12418848|FG001|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226431|NCT01998958|12418849|FG002|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226432|NCT01998958|12418850|FG003|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226433|NCT01998958|12418851|FG004|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226434|NCT01998958|12418852|FG005|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226435|NCT01998958|12418853|FG006|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226436|NCT01998958|12418854|FG007|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226437|NCT01998958|12418855|FG008|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226438|NCT01998958|12418856|FG009|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226439|NCT01998958|12418857|FG010|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226440|NCT01998958|12418858|FG011|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226441|NCT01998958|12418859|FG012|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226442|NCT01998958|12418860|FG013|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226443|NCT01998958|12418861|FG014|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226444|NCT01998958|12418862|FG015|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226445|NCT01998958|12418863|FG016|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226446|NCT01998958|12418864|FG017|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226447|NCT01998958|12418865|FG018|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226448|NCT01998958|12418866|FG019|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226449|NCT01998958|12418867|FG020|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226450|NCT01998958|12418868|FG021|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226451|NCT01998958|12418869|FG022|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226452|NCT01998958|12418870|FG023|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226453|NCT01998958|12418871|FG024|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226454|NCT01998958|12418872|FG025|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226455|NCT01998958|12418873|FG026|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226456|NCT01998958|12418874|FG027|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226457|NCT01998958|12418875|FG028|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226458|NCT01998958|12418876|FG029|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226459|NCT01998958|12418877|FG030|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226460|NCT01998958|12418878|FG031|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
11226461|NCT01998958|12418847|FG000|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8
11226462|NCT01998958|12418848|FG001|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226463|NCT01998958|12418849|FG002|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226464|NCT01998958|12418850|FG003|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10857381|NCT00974571|12023693|FG002|COMPLETED|Overall Study||530
10857382|NCT00974571|12023691|FG000|NOT COMPLETED|Overall Study||68
10857383|NCT00974571|12023692|FG001|NOT COMPLETED|Overall Study||16
10857384|NCT00974571|12023693|FG002|NOT COMPLETED|Overall Study||83
10857385|NCT00972738|12023704|FG000|STARTED|Overall Study||522
10857386|NCT00972738|12023705|FG001|STARTED|Overall Study||171
10857387|NCT00972738|12023706|FG002|STARTED|Overall Study||521
10857388|NCT00972738|12023704|FG000|COMPLETED|Overall Study||501
10857389|NCT00972738|12023705|FG001|COMPLETED|Overall Study||165
10857390|NCT00972738|12023706|FG002|COMPLETED|Overall Study||492
10857391|NCT00972738|12023704|FG000|NOT COMPLETED|Overall Study||21
10857392|NCT00972738|12023705|FG001|NOT COMPLETED|Overall Study||6
10857393|NCT00972738|12023706|FG002|NOT COMPLETED|Overall Study||29
10857394|NCT00968201|12023716|FG000|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
10857395|NCT00968201|12023717|FG001|STARTED|Base Study - (Period II)||0
10857396|NCT00968201|12023718|FG002|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
10857397|NCT00968201|12023716|FG000|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
10857398|NCT00968201|12023717|FG001|COMPLETED|Base Study - (Period II)||0
10857399|NCT00968201|12023718|FG002|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
10857400|NCT00968201|12023716|FG000|NOT COMPLETED|Base Study - (Period II)||26
10857401|NCT00968201|12023717|FG001|NOT COMPLETED|Base Study - (Period II)||0
10857402|NCT00968201|12023718|FG002|NOT COMPLETED|Base Study - (Period II)||45
10857403|NCT00968201|12023716|FG000|STARTED|Extension Study - (Period III)||0
10857404|NCT00968201|12023717|FG001|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
10857405|NCT00968201|12023718|FG002|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
10857406|NCT00968201|12023716|FG000|COMPLETED|Extension Study - (Period III)||0
10857407|NCT00968201|12023717|FG001|COMPLETED|Extension Study - (Period III)||33
10857408|NCT00968201|12023718|FG002|COMPLETED|Extension Study - (Period III)||84
10857409|NCT00968201|12023716|FG000|NOT COMPLETED|Extension Study - (Period III)||0
10857410|NCT00968201|12023717|FG001|NOT COMPLETED|Extension Study - (Period III)||124
10857411|NCT00968201|12023718|FG002|NOT COMPLETED|Extension Study - (Period III)||280
10857412|NCT00968149|12023729|FG000|STARTED|Overall Study||280
10857413|NCT00968149|12023730|FG001|STARTED|Overall Study||133
10857414|NCT00968149|12023729|FG000|COMPLETED|Overall Study||269
10857415|NCT00968149|12023730|FG001|COMPLETED|Overall Study||127
10857416|NCT00968149|12023729|FG000|NOT COMPLETED|Overall Study||11
10857417|NCT00968149|12023730|FG001|NOT COMPLETED|Overall Study||6
10857418|NCT00963469|12023739|FG000|STARTED|Overall Study||451
10857419|NCT00963469|12023740|FG001|STARTED|Overall Study||448
10857420|NCT00963469|12023741|FG002|STARTED|Overall Study||180
10857421|NCT00963469|12023739|FG000|COMPLETED|Overall Study||410
10857422|NCT00963469|12023740|FG001|COMPLETED|Overall Study||420
10857423|NCT00963469|12023741|FG002|COMPLETED|Overall Study||170
10857424|NCT00963469|12023739|FG000|NOT COMPLETED|Overall Study||41
10857425|NCT00963469|12023740|FG001|NOT COMPLETED|Overall Study||28
10857426|NCT00963469|12023741|FG002|NOT COMPLETED|Overall Study||10
10857427|NCT00960141|12023752|FG000|STARTED|Overall Study||333
10857428|NCT00960141|12023753|FG001|STARTED|Overall Study||326
10857429|NCT00960141|12023754|FG002|STARTED|Overall Study||170
10857430|NCT00960141|12023752|FG000|COMPLETED|Overall Study||323
10857431|NCT00960141|12023753|FG001|COMPLETED|Overall Study||309
10857432|NCT00960141|12023754|FG002|COMPLETED|Overall Study||163
10857433|NCT00960141|12023752|FG000|NOT COMPLETED|Overall Study||10
10857434|NCT00960141|12023753|FG001|NOT COMPLETED|Overall Study||17
10857435|NCT00960141|12023754|FG002|NOT COMPLETED|Overall Study||7
10857436|NCT00943683|12023764|FG000|STARTED|Overall Study||81
10857437|NCT00943683|12023765|FG001|STARTED|Overall Study||175
10857438|NCT00943683|12023764|FG000|COMPLETED|Overall Study||74
10857439|NCT00943683|12023765|FG001|COMPLETED|Overall Study||169
10857440|NCT00943683|12023764|FG000|NOT COMPLETED|Overall Study||7
10857441|NCT00943683|12023765|FG001|NOT COMPLETED|Overall Study||6
10857442|NCT00943397|12023773|FG000|STARTED|Overall Study||32
10857443|NCT00943397|12023774|FG001|STARTED|Overall Study||158
10857444|NCT00943397|12023773|FG000|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
10857445|NCT00943397|12023774|FG001|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
10857446|NCT00943397|12023773|FG000|NOT COMPLETED|Overall Study||15
10857447|NCT00943397|12023774|FG001|NOT COMPLETED|Overall Study||72
10857448|NCT00911547|12023784|FG000|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
10857449|NCT00911547|12023785|FG001|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
10857450|NCT00911547|12023786|FG002|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
10857451|NCT00911547|12023787|FG003|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
10857452|NCT00911547|12023784|FG000|COMPLETED|Overall Study||37
10857453|NCT00911547|12023785|FG001|COMPLETED|Overall Study||159
10857454|NCT00911547|12023786|FG002|COMPLETED|Overall Study||178
10857455|NCT00911547|12023787|FG003|COMPLETED|Overall Study||177
10857456|NCT00911547|12023784|FG000|NOT COMPLETED|Overall Study||11
10857457|NCT00911547|12023785|FG001|NOT COMPLETED|Overall Study||42
10857458|NCT00911547|12023786|FG002|NOT COMPLETED|Overall Study||22
10857459|NCT00911547|12023787|FG003|NOT COMPLETED|Overall Study||16
10857460|NCT00899379|12023802|FG000|STARTED|Overall Study|Patients who were allocated study drug|95
10857461|NCT00899379|12023803|FG001|STARTED|Overall Study|Patients who were allocated study drug|95
10857462|NCT00899379|12023804|FG002|STARTED|Overall Study|Patients who were allocated study drug|95
10857463|NCT00899379|12023805|FG003|STARTED|Overall Study|Patients who were allocated study drug|94
10857464|NCT00899379|12023806|FG004|STARTED|Overall Study|Patients who were allocated study drug|94
10857465|NCT00899379|12023802|FG000|Patients Treated|Overall Study|Patients who took study drug|83
10857466|NCT00899379|12023803|FG001|Patients Treated|Overall Study|Patients who took study drug|82
10857467|NCT00899379|12023804|FG002|Patients Treated|Overall Study|Patients who took study drug|84
10857468|NCT00899379|12023805|FG003|Patients Treated|Overall Study|Patients who took study drug|77
10857469|NCT00899379|12023806|FG004|Patients Treated|Overall Study|Patients who took study drug|81
10857470|NCT00899379|12023802|FG000|Patients Not Treated|Overall Study|Patients who did not take study drug|12
10857471|NCT00899379|12023803|FG001|Patients Not Treated|Overall Study|Patients who did not take study drug|13
10857472|NCT00899379|12023804|FG002|Patients Not Treated|Overall Study|Patients who did not take study drug|11
10857473|NCT00899379|12023805|FG003|Patients Not Treated|Overall Study|Patients who did not take study drug|17
10857474|NCT00899379|12023806|FG004|Patients Not Treated|Overall Study|Patients who did not take study drug|13
10857475|NCT00899379|12023802|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
10857476|NCT00899379|12023803|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
10857477|NCT00899379|12023804|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
10857478|NCT00899379|12023805|FG003|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
10857479|NCT00899379|12023806|FG004|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
10857480|NCT00899379|12023802|FG000|NOT COMPLETED|Overall Study||34
10857481|NCT00899379|12023803|FG001|NOT COMPLETED|Overall Study||29
10857482|NCT00899379|12023804|FG002|NOT COMPLETED|Overall Study||29
10857483|NCT00899379|12023805|FG003|NOT COMPLETED|Overall Study||37
10857484|NCT00899379|12023806|FG004|NOT COMPLETED|Overall Study||31
10857485|NCT00898677|12023816|FG000|STARTED|Overall Study||180
10857486|NCT00898677|12023817|FG001|STARTED|Overall Study||455
10857487|NCT00898677|12023818|FG002|STARTED|Overall Study||455
10857488|NCT00898677|12023819|FG003|STARTED|Overall Study||178
10857489|NCT00898677|12023816|FG000|Patients Treated|Overall Study|Patients Not Treated: 16|164
10857490|NCT00898677|12023817|FG001|Patients Treated|Overall Study|Patients Not Treated: 68|387
10857491|NCT00898677|12023818|FG002|Patients Treated|Overall Study|Patients Not Treated: 67|388
10857492|NCT00898677|12023819|FG003|Patients Treated|Overall Study|Patients Not Treated: 18|160
10857493|NCT00898677|12023816|FG000|COMPLETED|Overall Study||163
10857494|NCT00898677|12023817|FG001|COMPLETED|Overall Study||386
10857495|NCT00898677|12023818|FG002|COMPLETED|Overall Study||383
10857496|NCT00898677|12023819|FG003|COMPLETED|Overall Study||159
10857497|NCT00898677|12023816|FG000|NOT COMPLETED|Overall Study||17
10857498|NCT00898677|12023817|FG001|NOT COMPLETED|Overall Study||69
10857499|NCT00898677|12023818|FG002|NOT COMPLETED|Overall Study||72
10857500|NCT00898677|12023819|FG003|NOT COMPLETED|Overall Study||19
10857501|NCT00897949|12023832|FG000|STARTED|Overall Study|Patients who were allocated study drug|554
10857502|NCT00897949|12023833|FG001|STARTED|Overall Study|Patients who were allocated study drug|549
10857503|NCT00897949|12023834|FG002|STARTED|Overall Study|Patients who were allocated study drug|370
10857504|NCT00897949|12023832|FG000|Patients Treated|Overall Study|Patients who took study drug|458
10857505|NCT00897949|12023833|FG001|Patients Treated|Overall Study|Patients who took study drug|456
10857506|NCT00897949|12023834|FG002|Patients Treated|Overall Study|Patients who took study drug|304
10857507|NCT00897949|12023832|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
10857508|NCT00897949|12023833|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
10857509|NCT00897949|12023834|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
10857510|NCT00897949|12023832|FG000|NOT COMPLETED|Overall Study||104
10857511|NCT00897949|12023833|FG001|NOT COMPLETED|Overall Study||103
11226465|NCT01998958|12418851|FG004|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226466|NCT01998958|12418852|FG005|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226467|NCT01998958|12418853|FG006|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226468|NCT01998958|12418854|FG007|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226469|NCT01998958|12418855|FG008|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226470|NCT01998958|12418856|FG009|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226471|NCT01998958|12418857|FG010|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226472|NCT01998958|12418858|FG011|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226473|NCT01998958|12418859|FG012|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226474|NCT01998958|12418860|FG013|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226475|NCT01998958|12418861|FG014|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226476|NCT01998958|12418862|FG015|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226477|NCT01998958|12418863|FG016|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226478|NCT01998958|12418864|FG017|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226479|NCT01998958|12418865|FG018|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226480|NCT01998958|12418866|FG019|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226481|NCT01998958|12418867|FG020|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226482|NCT01998958|12418868|FG021|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
10857512|NCT00897949|12023834|FG002|NOT COMPLETED|Overall Study||69
10857513|NCT00897104|12023851|FG000|STARTED|Overall Study|Participants who were allocated study drug|418
10857514|NCT00897104|12023852|FG001|STARTED|Overall Study|Participants who were allocated study drug|428
10857515|NCT00897104|12023853|FG002|STARTED|Overall Study|Participants who were allocated study drug|87
10857516|NCT00897104|12023851|FG000|Participants Treated|Overall Study|Participants who took study drug|355
10857517|NCT00897104|12023852|FG001|Participants Treated|Overall Study|Participants who took study drug|357
10857518|NCT00897104|12023853|FG002|Participants Treated|Overall Study|Participants who took study drug|80
10857519|NCT00897104|12023851|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|63
10857520|NCT00897104|12023852|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|71
10857521|NCT00897104|12023853|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|7
10857522|NCT00897104|12023851|FG000|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
10857523|NCT00897104|12023852|FG001|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
10857524|NCT00897104|12023853|FG002|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
10857525|NCT00897104|12023851|FG000|NOT COMPLETED|Overall Study||64
10857526|NCT00897104|12023852|FG001|NOT COMPLETED|Overall Study||71
10857527|NCT00897104|12023853|FG002|NOT COMPLETED|Overall Study||8
10857528|NCT00803790|12023863|FG000|STARTED|Period 1||125
10857529|NCT00803790|12023864|FG001|STARTED|Period 1||126
10857530|NCT00803790|12023865|FG002|STARTED|Period 1||32
10857531|NCT00803790|12023866|FG003|STARTED|Period 1||35
10857532|NCT00803790|12023863|FG000|COMPLETED|Period 1||116
10857533|NCT00803790|12023864|FG001|COMPLETED|Period 1||114
10857534|NCT00803790|12023865|FG002|COMPLETED|Period 1||31
10857535|NCT00803790|12023866|FG003|COMPLETED|Period 1||31
10857536|NCT00803790|12023863|FG000|NOT COMPLETED|Period 1||9
10857537|NCT00803790|12023864|FG001|NOT COMPLETED|Period 1||12
10857538|NCT00803790|12023865|FG002|NOT COMPLETED|Period 1||1
10857539|NCT00803790|12023866|FG003|NOT COMPLETED|Period 1||4
10857540|NCT00803790|12023863|FG000|STARTED|Period 2||116
10857541|NCT00803790|12023864|FG001|STARTED|Period 2||114
10857542|NCT00803790|12023865|FG002|STARTED|Period 2||31
10857543|NCT00803790|12023866|FG003|STARTED|Period 2||31
10857544|NCT00803790|12023863|FG000|COMPLETED|Period 2||114
10857545|NCT00803790|12023864|FG001|COMPLETED|Period 2||114
10857546|NCT00803790|12023865|FG002|COMPLETED|Period 2||30
10857547|NCT00803790|12023866|FG003|COMPLETED|Period 2||30
10857548|NCT00803790|12023863|FG000|NOT COMPLETED|Period 2||2
10857549|NCT00803790|12023864|FG001|NOT COMPLETED|Period 2||0
10857550|NCT00803790|12023865|FG002|NOT COMPLETED|Period 2||1
10857551|NCT00803790|12023866|FG003|NOT COMPLETED|Period 2||1
10857552|NCT00725491|12023879|FG000|STARTED|Overall Study|Intent-to-Treat Group|113
10857553|NCT00725491|12023880|FG001|STARTED|Overall Study|Intent-to-Treat Group|120
10857554|NCT00725491|12023879|FG000|COMPLETED|Overall Study||104
10857555|NCT00725491|12023880|FG001|COMPLETED|Overall Study||102
10857556|NCT00725491|12023879|FG000|NOT COMPLETED|Overall Study||9
10857557|NCT00725491|12023880|FG001|NOT COMPLETED|Overall Study||18
10857558|NCT00703014|12023888|FG000|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
10857559|NCT00703014|12023889|FG001|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
10857560|NCT00703014|12023890|FG002|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
10857561|NCT00703014|12023891|FG003|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
10857562|NCT00703014|12023888|FG000|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
10857563|NCT00703014|12023889|FG001|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
10857564|NCT00703014|12023890|FG002|Treated|Mothers Base Trial P05787 (NCT00696800)||0
11226483|NCT01998958|12418869|FG022|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226484|NCT01998958|12418870|FG023|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226485|NCT01998958|12418871|FG024|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226486|NCT01998958|12418872|FG025|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226487|NCT01998958|12418873|FG026|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226488|NCT01998958|12418874|FG027|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226489|NCT01998958|12418875|FG028|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226490|NCT01998958|12418876|FG029|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226491|NCT01998958|12418877|FG030|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226492|NCT01998958|12418878|FG031|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
11226493|NCT01998958|12418847|FG000|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5
11226494|NCT01998958|12418848|FG001|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226495|NCT01998958|12418849|FG002|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226496|NCT01998958|12418850|FG003|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226497|NCT01998958|12418851|FG004|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226498|NCT01998958|12418852|FG005|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226499|NCT01998958|12418853|FG006|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226500|NCT01998958|12418854|FG007|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226501|NCT01998958|12418855|FG008|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
10857565|NCT00703014|12023891|FG003|Treated|Mothers Base Trial P05787 (NCT00696800)||0
10857566|NCT00703014|12023888|FG000|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
10857567|NCT00703014|12023889|FG001|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
10857568|NCT00703014|12023890|FG002|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
10857569|NCT00703014|12023891|FG003|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
10857570|NCT00703014|12023888|FG000|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
10857571|NCT00703014|12023889|FG001|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
10857572|NCT00703014|12023890|FG002|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
10857573|NCT00703014|12023891|FG003|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
10857574|NCT00703014|12023888|FG000|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
10857575|NCT00703014|12023889|FG001|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
10857576|NCT00703014|12023890|FG002|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
10857577|NCT00703014|12023891|FG003|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
10857578|NCT00703014|12023888|FG000|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
10857579|NCT00703014|12023889|FG001|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
10857580|NCT00703014|12023890|FG002|STARTED|Mothers Follow Up Trial P05712||0
10857581|NCT00703014|12023891|FG003|STARTED|Mothers Follow Up Trial P05712||0
10857582|NCT00703014|12023888|FG000|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
10857583|NCT00703014|12023889|FG001|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
10857584|NCT00703014|12023890|FG002|COMPLETED|Mothers Follow Up Trial P05712||0
10857585|NCT00703014|12023891|FG003|COMPLETED|Mothers Follow Up Trial P05712||0
10857586|NCT00703014|12023888|FG000|NOT COMPLETED|Mothers Follow Up Trial P05712||33
10857587|NCT00703014|12023889|FG001|NOT COMPLETED|Mothers Follow Up Trial P05712||32
10857588|NCT00703014|12023890|FG002|NOT COMPLETED|Mothers Follow Up Trial P05712||0
10857589|NCT00703014|12023891|FG003|NOT COMPLETED|Mothers Follow Up Trial P05712||0
10857590|NCT00703014|12023888|FG000|STARTED|Fetuses/Infants Follow Up Trial P05712||0
10857591|NCT00703014|12023889|FG001|STARTED|Fetuses/Infants Follow Up Trial P05712||0
10857592|NCT00703014|12023890|FG002|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
10857593|NCT00703014|12023891|FG003|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
10857594|NCT00703014|12023888|FG000|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
10857595|NCT00703014|12023889|FG001|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
10857596|NCT00703014|12023890|FG002|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
10857597|NCT00703014|12023891|FG003|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
10857598|NCT00703014|12023888|FG000|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
10857599|NCT00703014|12023889|FG001|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
10857600|NCT00703014|12023890|FG002|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
10857601|NCT00703014|12023891|FG003|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
10857602|NCT00703014|12023888|FG000|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
10857603|NCT00703014|12023889|FG001|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
10857604|NCT00703014|12023890|FG002|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
10857605|NCT00703014|12023891|FG003|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
10857606|NCT00702845|12023903|FG000|STARTED|Overall Study||268
10857607|NCT00702845|12023904|FG001|STARTED|Overall Study|Includes one treated participant who was not randomized|129
10857608|NCT00702845|12023903|FG000|Randomized|Overall Study||268
10857609|NCT00702845|12023904|FG001|Randomized|Overall Study||128
10857610|NCT00702845|12023903|FG000|COMPLETED|Overall Study||246
10857611|NCT00702845|12023904|FG001|COMPLETED|Overall Study||121
10857612|NCT00702845|12023903|FG000|NOT COMPLETED|Overall Study||22
10857613|NCT00702845|12023904|FG001|NOT COMPLETED|Overall Study||8
10857614|NCT00702624|12023912|FG000|STARTED|Base Study P05690 (NCT00702845)||268
10857615|NCT00702624|12023913|FG001|STARTED|Base Study P05690 (NCT00702845)||128
10857616|NCT00702624|12023914|FG002|STARTED|Base Study P05690 (NCT00702845)||0
10857617|NCT00702624|12023915|FG003|STARTED|Base Study P05690 (NCT00702845)||0
10857618|NCT00702624|12023912|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
10857619|NCT00702624|12023913|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
10857620|NCT00702624|12023914|FG002|COMPLETED|Base Study P05690 (NCT00702845)||0
10857621|NCT00702624|12023915|FG003|COMPLETED|Base Study P05690 (NCT00702845)||0
10857622|NCT00702624|12023912|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
10857623|NCT00702624|12023913|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
10857624|NCT00702624|12023914|FG002|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
10857625|NCT00702624|12023915|FG003|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
10857626|NCT00702624|12023912|FG000|STARTED|Expectant Mother Follow-up||68
10857627|NCT00702624|12023913|FG001|STARTED|Expectant Mother Follow-up||45
10857628|NCT00702624|12023914|FG002|STARTED|Expectant Mother Follow-up||0
10857629|NCT00702624|12023915|FG003|STARTED|Expectant Mother Follow-up||0
10857630|NCT00702624|12023912|FG000|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
10857631|NCT00702624|12023913|FG001|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
10857632|NCT00702624|12023914|FG002|COMPLETED|Expectant Mother Follow-up||0
10857633|NCT00702624|12023915|FG003|COMPLETED|Expectant Mother Follow-up||0
11226502|NCT01998958|12418856|FG009|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226503|NCT01998958|12418857|FG010|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226504|NCT01998958|12418858|FG011|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226505|NCT01998958|12418859|FG012|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226506|NCT01998958|12418860|FG013|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226507|NCT01998958|12418861|FG014|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226508|NCT01998958|12418862|FG015|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226509|NCT01998958|12418863|FG016|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226510|NCT01998958|12418864|FG017|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226511|NCT01998958|12418865|FG018|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226512|NCT01998958|12418866|FG019|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226513|NCT01998958|12418867|FG020|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226514|NCT01998958|12418868|FG021|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226515|NCT01998958|12418869|FG022|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226516|NCT01998958|12418870|FG023|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226517|NCT01998958|12418871|FG024|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226518|NCT01998958|12418872|FG025|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226519|NCT01998958|12418873|FG026|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226520|NCT01998958|12418874|FG027|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226521|NCT01998958|12418875|FG028|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226522|NCT01998958|12418876|FG029|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226523|NCT01998958|12418877|FG030|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226524|NCT01998958|12418878|FG031|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
11226525|NCT01998958|12418847|FG000|COMPLETED|Period 1 (Panel A and B)||32
11226526|NCT01998958|12418848|FG001|COMPLETED|Period 1 (Panel A and B)||8
11226527|NCT01998958|12418849|FG002|COMPLETED|Period 1 (Panel A and B)||11
11226528|NCT01998958|12418850|FG003|COMPLETED|Period 1 (Panel A and B)||12
11226529|NCT01998958|12418851|FG004|COMPLETED|Period 1 (Panel A and B)||21
11226530|NCT01998958|12418852|FG005|COMPLETED|Period 1 (Panel A and B)||11
11226531|NCT01998958|12418853|FG006|COMPLETED|Period 1 (Panel A and B)||9
11226532|NCT01998958|12418854|FG007|COMPLETED|Period 1 (Panel A and B)||0
11226533|NCT01998958|12418855|FG008|COMPLETED|Period 1 (Panel A and B)||0
11226534|NCT01998958|12418856|FG009|COMPLETED|Period 1 (Panel A and B)||0
11226535|NCT01998958|12418857|FG010|COMPLETED|Period 1 (Panel A and B)||0
11226536|NCT01998958|12418858|FG011|COMPLETED|Period 1 (Panel A and B)||0
11226537|NCT01998958|12418859|FG012|COMPLETED|Period 1 (Panel A and B)||0
11226538|NCT01998958|12418860|FG013|COMPLETED|Period 1 (Panel A and B)||0
11226539|NCT01998958|12418861|FG014|COMPLETED|Period 1 (Panel A and B)||0
11226540|NCT01998958|12418862|FG015|COMPLETED|Period 1 (Panel A and B)||0
11226541|NCT01998958|12418863|FG016|COMPLETED|Period 1 (Panel A and B)||0
11226542|NCT01998958|12418864|FG017|COMPLETED|Period 1 (Panel A and B)||0
11226543|NCT01998958|12418865|FG018|COMPLETED|Period 1 (Panel A and B)||0
11226544|NCT01998958|12418866|FG019|COMPLETED|Period 1 (Panel A and B)||0
11226545|NCT01998958|12418867|FG020|COMPLETED|Period 1 (Panel A and B)||0
11226546|NCT01998958|12418868|FG021|COMPLETED|Period 1 (Panel A and B)||0
11226547|NCT01998958|12418869|FG022|COMPLETED|Period 1 (Panel A and B)||0
11226548|NCT01998958|12418870|FG023|COMPLETED|Period 1 (Panel A and B)||0
11226549|NCT01998958|12418871|FG024|COMPLETED|Period 1 (Panel A and B)||0
11226550|NCT01998958|12418872|FG025|COMPLETED|Period 1 (Panel A and B)||0
11226551|NCT01998958|12418873|FG026|COMPLETED|Period 1 (Panel A and B)||0
11226552|NCT01998958|12418874|FG027|COMPLETED|Period 1 (Panel A and B)||0
11226553|NCT01998958|12418875|FG028|COMPLETED|Period 1 (Panel A and B)||0
11226554|NCT01998958|12418876|FG029|COMPLETED|Period 1 (Panel A and B)||0
11226555|NCT01998958|12418877|FG030|COMPLETED|Period 1 (Panel A and B)||0
11226556|NCT01998958|12418878|FG031|COMPLETED|Period 1 (Panel A and B)||0
11226557|NCT01998958|12418847|FG000|NOT COMPLETED|Period 1 (Panel A and B)||1
11226558|NCT01998958|12418848|FG001|NOT COMPLETED|Period 1 (Panel A and B)||3
11226559|NCT01998958|12418849|FG002|NOT COMPLETED|Period 1 (Panel A and B)||0
11226560|NCT01998958|12418850|FG003|NOT COMPLETED|Period 1 (Panel A and B)||0
11226561|NCT01998958|12418851|FG004|NOT COMPLETED|Period 1 (Panel A and B)||0
11226562|NCT01998958|12418852|FG005|NOT COMPLETED|Period 1 (Panel A and B)||0
11226563|NCT01998958|12418853|FG006|NOT COMPLETED|Period 1 (Panel A and B)||0
11226564|NCT01998958|12418854|FG007|NOT COMPLETED|Period 1 (Panel A and B)||0
11226565|NCT01998958|12418855|FG008|NOT COMPLETED|Period 1 (Panel A and B)||0
11226566|NCT01998958|12418856|FG009|NOT COMPLETED|Period 1 (Panel A and B)||0
11226567|NCT01998958|12418857|FG010|NOT COMPLETED|Period 1 (Panel A and B)||0
11226568|NCT01998958|12418858|FG011|NOT COMPLETED|Period 1 (Panel A and B)||0
11226569|NCT01998958|12418859|FG012|NOT COMPLETED|Period 1 (Panel A and B)||0
11354969|NCT03075891|12551895|FG001|COMPLETED|Overall Study||125
11354970|NCT03075891|12551894|FG000|NOT COMPLETED|Overall Study||9
11354971|NCT03075891|12551895|FG001|NOT COMPLETED|Overall Study||13
10857634|NCT00702624|12023912|FG000|NOT COMPLETED|Expectant Mother Follow-up||7
10857635|NCT00702624|12023913|FG001|NOT COMPLETED|Expectant Mother Follow-up||0
10857636|NCT00702624|12023914|FG002|NOT COMPLETED|Expectant Mother Follow-up||0
10857637|NCT00702624|12023915|FG003|NOT COMPLETED|Expectant Mother Follow-up||0
10857638|NCT00702624|12023912|FG000|STARTED|Fetuses/Infant Follow-up||0
10857639|NCT00702624|12023913|FG001|STARTED|Fetuses/Infant Follow-up||0
10857640|NCT00702624|12023914|FG002|STARTED|Fetuses/Infant Follow-up||88
10857641|NCT00702624|12023915|FG003|STARTED|Fetuses/Infant Follow-up||55
10857642|NCT00702624|12023912|FG000|Live Born Infants|Fetuses/Infant Follow-up||0
10857643|NCT00702624|12023913|FG001|Live Born Infants|Fetuses/Infant Follow-up||0
10857644|NCT00702624|12023914|FG002|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
10857645|NCT00702624|12023915|FG003|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
10857646|NCT00702624|12023912|FG000|COMPLETED|Fetuses/Infant Follow-up||0
10857647|NCT00702624|12023913|FG001|COMPLETED|Fetuses/Infant Follow-up||0
10857648|NCT00702624|12023914|FG002|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
10857649|NCT00702624|12023915|FG003|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
10857650|NCT00702624|12023912|FG000|NOT COMPLETED|Fetuses/Infant Follow-up||0
10857651|NCT00702624|12023913|FG001|NOT COMPLETED|Fetuses/Infant Follow-up||0
10857652|NCT00702624|12023914|FG002|NOT COMPLETED|Fetuses/Infant Follow-up||10
10857653|NCT00702624|12023915|FG003|NOT COMPLETED|Fetuses/Infant Follow-up||0
10857654|NCT00702546|12023930|FG000|STARTED|Base Study P05690 (NCT00702845)||268
10857655|NCT00702546|12023931|FG001|STARTED|Base Study P05690 (NCT00702845)||128
10857656|NCT00702546|12023930|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
10857657|NCT00702546|12023931|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
10857658|NCT00702546|12023930|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
10857659|NCT00702546|12023931|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
10857660|NCT00702546|12023930|FG000|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
10857661|NCT00702546|12023931|FG001|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
10857662|NCT00702546|12023930|FG000|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
10857663|NCT00702546|12023931|FG001|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
10857664|NCT00702546|12023930|FG000|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
10857665|NCT00702546|12023931|FG001|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
10857666|NCT00702520|12023939|FG000|STARTED|Base Study P05788 - Assigned Treatment||25
10857667|NCT00702520|12023940|FG001|STARTED|Base Study P05788 - Assigned Treatment||25
10857668|NCT00702520|12023941|FG002|STARTED|Base Study P05788 - Assigned Treatment||0
10857669|NCT00702520|12023942|FG003|STARTED|Base Study P05788 - Assigned Treatment||0
10857670|NCT00702520|12023939|FG000|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
10857671|NCT00702520|12023940|FG001|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
10857672|NCT00702520|12023941|FG002|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
10857673|NCT00702520|12023942|FG003|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
10857674|NCT00702520|12023939|FG000|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
10857675|NCT00702520|12023940|FG001|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
10857676|NCT00702520|12023941|FG002|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
10857677|NCT00702520|12023942|FG003|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
10857678|NCT00702520|12023939|FG000|COMPLETED|Base Study P05788 - Assigned Treatment||25
10857679|NCT00702520|12023940|FG001|COMPLETED|Base Study P05788 - Assigned Treatment||24
10857680|NCT00702520|12023941|FG002|COMPLETED|Base Study P05788 - Assigned Treatment||0
10857681|NCT00702520|12023942|FG003|COMPLETED|Base Study P05788 - Assigned Treatment||0
10857682|NCT00702520|12023939|FG000|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
10857683|NCT00702520|12023940|FG001|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
10857684|NCT00702520|12023941|FG002|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
10857685|NCT00702520|12023942|FG003|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
10857686|NCT00702520|12023939|FG000|STARTED|Base Study P05788 - Embryo Transfer||25
10857687|NCT00702520|12023940|FG001|STARTED|Base Study P05788 - Embryo Transfer||24
10857688|NCT00702520|12023941|FG002|STARTED|Base Study P05788 - Embryo Transfer||0
10857689|NCT00702520|12023942|FG003|STARTED|Base Study P05788 - Embryo Transfer||0
10857690|NCT00702520|12023939|FG000|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
10857691|NCT00702520|12023940|FG001|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
10857692|NCT00702520|12023941|FG002|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
10857693|NCT00702520|12023942|FG003|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
10857694|NCT00702520|12023939|FG000|COMPLETED|Base Study P05788 - Embryo Transfer||22
10857695|NCT00702520|12023940|FG001|COMPLETED|Base Study P05788 - Embryo Transfer||18
10857696|NCT00702520|12023941|FG002|COMPLETED|Base Study P05788 - Embryo Transfer||0
10857697|NCT00702520|12023942|FG003|COMPLETED|Base Study P05788 - Embryo Transfer||0
10857698|NCT00702520|12023939|FG000|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
10857699|NCT00702520|12023940|FG001|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
10857700|NCT00702520|12023941|FG002|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
10857701|NCT00702520|12023942|FG003|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
10857702|NCT00702520|12023939|FG000|STARTED|Base Study P05788 - Follow-Up||22
10857703|NCT00702520|12023940|FG001|STARTED|Base Study P05788 - Follow-Up||18
10857704|NCT00702520|12023941|FG002|STARTED|Base Study P05788 - Follow-Up||0
10857705|NCT00702520|12023942|FG003|STARTED|Base Study P05788 - Follow-Up||0
10857706|NCT00702520|12023939|FG000|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
10857707|NCT00702520|12023940|FG001|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
10857708|NCT00702520|12023941|FG002|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
10857709|NCT00702520|12023942|FG003|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
10857710|NCT00702520|12023939|FG000|COMPLETED|Base Study P05788 - Follow-Up||7
11107211|NCT01262872|12291710|FG007|STARTED|Step 2||200
11107212|NCT01262872|12291703|FG000|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
11107213|NCT01262872|12291704|FG001|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
11107214|NCT01262872|12291705|FG002|COMPLETED|Step 2||191
11107215|NCT01262872|12291706|FG003|COMPLETED|Step 2||190
11107216|NCT01262872|12291707|FG004|COMPLETED|Step 2||195
11107217|NCT01262872|12291708|FG005|COMPLETED|Step 2||191
11107218|NCT01262872|12291709|FG006|COMPLETED|Step 2||191
11107219|NCT01262872|12291710|FG007|COMPLETED|Step 2||194
11107220|NCT01262872|12291703|FG000|NOT COMPLETED|Step 2||0
11107221|NCT01262872|12291704|FG001|NOT COMPLETED|Step 2||0
11107222|NCT01262872|12291705|FG002|NOT COMPLETED|Step 2||9
11107223|NCT01262872|12291706|FG003|NOT COMPLETED|Step 2||10
11107224|NCT01262872|12291707|FG004|NOT COMPLETED|Step 2||5
11107225|NCT01262872|12291708|FG005|NOT COMPLETED|Step 2||9
11107226|NCT01262872|12291709|FG006|NOT COMPLETED|Step 2||9
11107227|NCT01262872|12291710|FG007|NOT COMPLETED|Step 2||6
11107228|NCT01262898|12291748|FG000|STARTED|Overall Study||21
11107229|NCT01262898|12291749|FG001|STARTED|Overall Study||18
11107230|NCT01262898|12291750|FG002|STARTED|Overall Study||18
11107231|NCT01262898|12291751|FG003|STARTED|Overall Study||22
11107232|NCT01262898|12291748|FG000|COMPLETED|Overall Study||18
11107233|NCT01262898|12291749|FG001|COMPLETED|Overall Study||16
11107234|NCT01262898|12291750|FG002|COMPLETED|Overall Study||18
11107235|NCT01262898|12291751|FG003|COMPLETED|Overall Study||22
11107236|NCT01262898|12291748|FG000|NOT COMPLETED|Overall Study||3
11107237|NCT01262898|12291749|FG001|NOT COMPLETED|Overall Study||2
11107238|NCT01262898|12291750|FG002|NOT COMPLETED|Overall Study||0
11107239|NCT01262898|12291751|FG003|NOT COMPLETED|Overall Study||0
11107240|NCT01262976|12291770|FG000|STARTED|Up to Month 2||40
11107241|NCT01262976|12291771|FG001|STARTED|Up to Month 2||40
11107242|NCT01262976|12291772|FG002|STARTED|Up to Month 2||40
11107243|NCT01262976|12291773|FG003|STARTED|Up to Month 2||40
11107244|NCT01262976|12291774|FG004|STARTED|Up to Month 2||40
11107245|NCT01262976|12291775|FG005|STARTED|Up to Month 2||40
11107246|NCT01262976|12291770|FG000|COMPLETED|Up to Month 2||37
11107247|NCT01262976|12291771|FG001|COMPLETED|Up to Month 2||39
11107248|NCT01262976|12291772|FG002|COMPLETED|Up to Month 2||39
11107249|NCT01262976|12291773|FG003|COMPLETED|Up to Month 2||38
11107250|NCT01262976|12291774|FG004|COMPLETED|Up to Month 2||38
11107251|NCT01262976|12291775|FG005|COMPLETED|Up to Month 2||36
11107252|NCT01262976|12291770|FG000|NOT COMPLETED|Up to Month 2||3
11107253|NCT01262976|12291771|FG001|NOT COMPLETED|Up to Month 2||1
11107254|NCT01262976|12291772|FG002|NOT COMPLETED|Up to Month 2||1
11107255|NCT01262976|12291773|FG003|NOT COMPLETED|Up to Month 2||2
11107256|NCT01262976|12291774|FG004|NOT COMPLETED|Up to Month 2||2
11107257|NCT01262976|12291775|FG005|NOT COMPLETED|Up to Month 2||4
11107258|NCT01262976|12291770|FG000|STARTED|Up to Month 7||40
11107259|NCT01262976|12291771|FG001|STARTED|Up to Month 7||40
11107260|NCT01262976|12291772|FG002|STARTED|Up to Month 7||40
11107261|NCT01262976|12291773|FG003|STARTED|Up to Month 7||40
11107262|NCT01262976|12291774|FG004|STARTED|Up to Month 7||40
11107263|NCT01262976|12291775|FG005|STARTED|Up to Month 7||40
11107264|NCT01262976|12291770|FG000|COMPLETED|Up to Month 7||35
11107265|NCT01262976|12291771|FG001|COMPLETED|Up to Month 7||40
11107266|NCT01262976|12291772|FG002|COMPLETED|Up to Month 7||34
11107267|NCT01262976|12291773|FG003|COMPLETED|Up to Month 7||34
10857711|NCT00702520|12023940|FG001|COMPLETED|Base Study P05788 - Follow-Up||8
11107268|NCT01262976|12291774|FG004|COMPLETED|Up to Month 7||38
11107269|NCT01262976|12291775|FG005|COMPLETED|Up to Month 7||36
11107270|NCT01262976|12291770|FG000|NOT COMPLETED|Up to Month 7||5
11107271|NCT01262976|12291771|FG001|NOT COMPLETED|Up to Month 7||0
11107272|NCT01262976|12291772|FG002|NOT COMPLETED|Up to Month 7||6
11107273|NCT01262976|12291773|FG003|NOT COMPLETED|Up to Month 7||6
11107274|NCT01262976|12291774|FG004|NOT COMPLETED|Up to Month 7||2
11107275|NCT01262976|12291775|FG005|NOT COMPLETED|Up to Month 7||4
11107276|NCT01262976|12291770|FG000|STARTED|Up to Year 1||40
11107277|NCT01262976|12291771|FG001|STARTED|Up to Year 1||40
11107278|NCT01262976|12291772|FG002|STARTED|Up to Year 1||40
11107279|NCT01262976|12291773|FG003|STARTED|Up to Year 1||40
11107280|NCT01262976|12291774|FG004|STARTED|Up to Year 1||40
11107281|NCT01262976|12291775|FG005|STARTED|Up to Year 1||40
11107282|NCT01262976|12291770|FG000|COMPLETED|Up to Year 1||31
10857712|NCT00702520|12023941|FG002|COMPLETED|Base Study P05788 - Follow-Up||0
10857713|NCT00702520|12023942|FG003|COMPLETED|Base Study P05788 - Follow-Up||0
10857714|NCT00702520|12023939|FG000|NOT COMPLETED|Base Study P05788 - Follow-Up||15
10857715|NCT00702520|12023940|FG001|NOT COMPLETED|Base Study P05788 - Follow-Up||10
10857716|NCT00702520|12023941|FG002|NOT COMPLETED|Base Study P05788 - Follow-Up||0
10857717|NCT00702520|12023942|FG003|NOT COMPLETED|Base Study P05788 - Follow-Up||0
10857718|NCT00702520|12023939|FG000|STARTED|Follow-up Study P05783||7
10857719|NCT00702520|12023940|FG001|STARTED|Follow-up Study P05783||8
10857720|NCT00702520|12023941|FG002|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
10857721|NCT00702520|12023942|FG003|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
10857722|NCT00702520|12023939|FG000|COMPLETED|Follow-up Study P05783||7
10857723|NCT00702520|12023940|FG001|COMPLETED|Follow-up Study P05783||8
10857724|NCT00702520|12023941|FG002|COMPLETED|Follow-up Study P05783||8
10857725|NCT00702520|12023942|FG003|COMPLETED|Follow-up Study P05783||11
10857726|NCT00702520|12023939|FG000|NOT COMPLETED|Follow-up Study P05783||0
10857727|NCT00702520|12023940|FG001|NOT COMPLETED|Follow-up Study P05783||0
11107283|NCT01262976|12291771|FG001|COMPLETED|Up to Year 1||39
11107284|NCT01262976|12291772|FG002|COMPLETED|Up to Year 1||37
11107285|NCT01262976|12291773|FG003|COMPLETED|Up to Year 1||36
11107286|NCT01262976|12291774|FG004|COMPLETED|Up to Year 1||29
11107287|NCT01262976|12291775|FG005|COMPLETED|Up to Year 1||31
11107288|NCT01262976|12291770|FG000|NOT COMPLETED|Up to Year 1||9
11107289|NCT01262976|12291771|FG001|NOT COMPLETED|Up to Year 1||1
11107290|NCT01262976|12291772|FG002|NOT COMPLETED|Up to Year 1||3
11107291|NCT01262976|12291773|FG003|NOT COMPLETED|Up to Year 1||4
11107292|NCT01262976|12291774|FG004|NOT COMPLETED|Up to Year 1||11
11107293|NCT01262976|12291775|FG005|NOT COMPLETED|Up to Year 1||9
11107294|NCT01262976|12291770|FG000|STARTED|Up to Year 2||40
11107295|NCT01262976|12291771|FG001|STARTED|Up to Year 2||40
11107296|NCT01262976|12291772|FG002|STARTED|Up to Year 2||40
11107297|NCT01262976|12291773|FG003|STARTED|Up to Year 2||40
11107298|NCT01262976|12291774|FG004|STARTED|Up to Year 2||40
11107299|NCT01262976|12291775|FG005|STARTED|Up to Year 2||40
11107300|NCT01262976|12291770|FG000|COMPLETED|Up to Year 2||35
11107301|NCT01262976|12291771|FG001|COMPLETED|Up to Year 2||39
11107302|NCT01262976|12291772|FG002|COMPLETED|Up to Year 2||35
11107303|NCT01262976|12291773|FG003|COMPLETED|Up to Year 2||36
11107304|NCT01262976|12291774|FG004|COMPLETED|Up to Year 2||36
11107305|NCT01262976|12291775|FG005|COMPLETED|Up to Year 2||35
11107306|NCT01262976|12291770|FG000|NOT COMPLETED|Up to Year 2||5
11107307|NCT01262976|12291771|FG001|NOT COMPLETED|Up to Year 2||1
11107308|NCT01262976|12291772|FG002|NOT COMPLETED|Up to Year 2||5
11107309|NCT01262976|12291773|FG003|NOT COMPLETED|Up to Year 2||4
11107310|NCT01262976|12291774|FG004|NOT COMPLETED|Up to Year 2||4
11107311|NCT01262976|12291775|FG005|NOT COMPLETED|Up to Year 2||5
11107312|NCT01262976|12291770|FG000|STARTED|Up to Year 3||40
11107313|NCT01262976|12291771|FG001|STARTED|Up to Year 3||40
11107314|NCT01262976|12291772|FG002|STARTED|Up to Year 3||40
11107315|NCT01262976|12291773|FG003|STARTED|Up to Year 3||40
11107316|NCT01262976|12291774|FG004|STARTED|Up to Year 3||40
11107317|NCT01262976|12291775|FG005|STARTED|Up to Year 3||40
11107318|NCT01262976|12291770|FG000|COMPLETED|Up to Year 3||34
11107319|NCT01262976|12291771|FG001|COMPLETED|Up to Year 3||38
11107320|NCT01262976|12291772|FG002|COMPLETED|Up to Year 3||33
11107321|NCT01262976|12291773|FG003|COMPLETED|Up to Year 3||35
11226570|NCT01998958|12418860|FG013|NOT COMPLETED|Period 1 (Panel A and B)||0
11226571|NCT01998958|12418861|FG014|NOT COMPLETED|Period 1 (Panel A and B)||0
11226572|NCT01998958|12418862|FG015|NOT COMPLETED|Period 1 (Panel A and B)||0
11107322|NCT01262976|12291774|FG004|COMPLETED|Up to Year 3||38
11107323|NCT01262976|12291775|FG005|COMPLETED|Up to Year 3||36
11107324|NCT01262976|12291770|FG000|NOT COMPLETED|Up to Year 3||6
11107325|NCT01262976|12291771|FG001|NOT COMPLETED|Up to Year 3||2
11107326|NCT01262976|12291772|FG002|NOT COMPLETED|Up to Year 3||7
11107327|NCT01262976|12291773|FG003|NOT COMPLETED|Up to Year 3||5
11107328|NCT01262976|12291774|FG004|NOT COMPLETED|Up to Year 3||2
11107329|NCT01262976|12291775|FG005|NOT COMPLETED|Up to Year 3||4
11107330|NCT01262989|12291790|FG000|STARTED|Period 1||20
11107331|NCT01262989|12291791|FG001|STARTED|Period 1||20
11107332|NCT01262989|12291790|FG000|COMPLETED|Period 1||19
11107333|NCT01262989|12291791|FG001|COMPLETED|Period 1||17
11107334|NCT01262989|12291790|FG000|NOT COMPLETED|Period 1||1
11107335|NCT01262989|12291791|FG001|NOT COMPLETED|Period 1||3
11107336|NCT01262989|12291790|FG000|STARTED|7-Day Washout Period||19
11226573|NCT01998958|12418863|FG016|NOT COMPLETED|Period 1 (Panel A and B)||0
11226574|NCT01998958|12418864|FG017|NOT COMPLETED|Period 1 (Panel A and B)||0
11226575|NCT01998958|12418865|FG018|NOT COMPLETED|Period 1 (Panel A and B)||0
10857728|NCT00702520|12023941|FG002|NOT COMPLETED|Follow-up Study P05783||0
10857729|NCT00702520|12023942|FG003|NOT COMPLETED|Follow-up Study P05783||0
10857730|NCT00702338|12023952|FG000|STARTED|Base Study (NCT00697255)||5
10857731|NCT00702338|12023953|FG001|STARTED|Base Study (NCT00697255)||3
10857732|NCT00702338|12023954|FG002|STARTED|Base Study (NCT00697255)||0
10857733|NCT00702338|12023952|FG000|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
10857734|NCT00702338|12023953|FG001|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
10857735|NCT00702338|12023954|FG002|COMPLETED|Base Study (NCT00697255)||0
10857736|NCT00702338|12023952|FG000|NOT COMPLETED|Base Study (NCT00697255)||3
10857737|NCT00702338|12023953|FG001|NOT COMPLETED|Base Study (NCT00697255)||2
10857738|NCT00702338|12023954|FG002|NOT COMPLETED|Base Study (NCT00697255)||0
10857739|NCT00702338|12023952|FG000|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
10857804|NCT00696878|12023988|FG000|COMPLETED|Overall Study||178
10857805|NCT00696878|12023988|FG000|NOT COMPLETED|Overall Study||504
11107337|NCT01262989|12291791|FG001|STARTED|7-Day Washout Period||17
11107338|NCT01262989|12291790|FG000|COMPLETED|7-Day Washout Period||19
11107339|NCT01262989|12291791|FG001|COMPLETED|7-Day Washout Period||17
11107340|NCT01262989|12291790|FG000|NOT COMPLETED|7-Day Washout Period||0
11107341|NCT01262989|12291791|FG001|NOT COMPLETED|7-Day Washout Period||0
10857740|NCT00702338|12023953|FG001|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
10857741|NCT00702338|12023954|FG002|STARTED|Follow-up Study: Expectant Mothers FU||0
10857742|NCT00702338|12023952|FG000|COMPLETED|Follow-up Study: Expectant Mothers FU||0
10857743|NCT00702338|12023953|FG001|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
10857744|NCT00702338|12023954|FG002|COMPLETED|Follow-up Study: Expectant Mothers FU||0
10857745|NCT00702338|12023952|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
10857746|NCT00702338|12023953|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
10857747|NCT00702338|12023954|FG002|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
10857748|NCT00702338|12023952|FG000|STARTED|Follow-up Study: Infant FU||0
10857749|NCT00702338|12023953|FG001|STARTED|Follow-up Study: Infant FU||0
10857750|NCT00702338|12023954|FG002|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
10857751|NCT00702338|12023952|FG000|COMPLETED|Follow-up Study: Infant FU||0
10857752|NCT00702338|12023953|FG001|COMPLETED|Follow-up Study: Infant FU||0
10857753|NCT00702338|12023954|FG002|COMPLETED|Follow-up Study: Infant FU||0
10857754|NCT00702338|12023952|FG000|NOT COMPLETED|Follow-up Study: Infant FU||0
10857755|NCT00702338|12023953|FG001|NOT COMPLETED|Follow-up Study: Infant FU||0
10857756|NCT00702338|12023954|FG002|NOT COMPLETED|Follow-up Study: Infant FU||2
10857757|NCT00702273|12023964|FG000|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
10857758|NCT00702273|12023965|FG001|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
10857759|NCT00702273|12023964|FG000|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
10857760|NCT00702273|12023965|FG001|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
10857761|NCT00702273|12023964|FG000|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
10857762|NCT00702273|12023965|FG001|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
10857763|NCT00702273|12023964|FG000|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
10857764|NCT00702273|12023965|FG001|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
10857765|NCT00702273|12023964|FG000|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
10857766|NCT00702273|12023965|FG001|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
10857767|NCT00702273|12023964|FG000|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
10857768|NCT00702273|12023965|FG001|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
10857769|NCT00702273|12023964|FG000|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
10857770|NCT00702273|12023965|FG001|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
10857771|NCT00702234|12023971|FG000|STARTED|Base Study (NCT00696878)||682
10857772|NCT00702234|12023972|FG001|STARTED|Base Study (NCT00696878)||0
10857773|NCT00702234|12023971|FG000|COMPLETED|Base Study (NCT00696878)||178
10857774|NCT00702234|12023972|FG001|COMPLETED|Base Study (NCT00696878)||0
10857775|NCT00702234|12023971|FG000|NOT COMPLETED|Base Study (NCT00696878)||504
10857776|NCT00702234|12023972|FG001|NOT COMPLETED|Base Study (NCT00696878)||0
10857777|NCT00702234|12023971|FG000|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
10857778|NCT00702234|12023972|FG001|STARTED|Follow-up Study: Expectant Mothers||0
10857779|NCT00702234|12023971|FG000|COMPLETED|Follow-up Study: Expectant Mothers||246
10857780|NCT00702234|12023972|FG001|COMPLETED|Follow-up Study: Expectant Mothers||0
10857781|NCT00702234|12023971|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
10857782|NCT00702234|12023972|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
10857783|NCT00702234|12023971|FG000|STARTED|Follow-up Study: Fetuses/Infants||0
10857784|NCT00702234|12023972|FG001|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
10857785|NCT00702234|12023971|FG000|Live Born Infants|Follow-up Study: Fetuses/Infants||0
10857786|NCT00702234|12023972|FG001|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
10857787|NCT00702234|12023971|FG000|COMPLETED|Follow-up Study: Fetuses/Infants||0
10857788|NCT00702234|12023972|FG001|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
10857789|NCT00702234|12023971|FG000|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
10857790|NCT00702234|12023972|FG001|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
10857791|NCT00697255|12023981|FG000|STARTED|Stage 1a||5
10857792|NCT00697255|12023982|FG001|STARTED|Stage 1a||0
10857793|NCT00697255|12023981|FG000|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
10857794|NCT00697255|12023982|FG001|COMPLETED|Stage 1a||0
10857795|NCT00697255|12023981|FG000|NOT COMPLETED|Stage 1a||3
10857796|NCT00697255|12023982|FG001|NOT COMPLETED|Stage 1a||0
10857797|NCT00697255|12023981|FG000|STARTED|Stage 1b||0
10857798|NCT00697255|12023982|FG001|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
10857799|NCT00697255|12023981|FG000|COMPLETED|Stage 1b||0
10857800|NCT00697255|12023982|FG001|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
10857801|NCT00697255|12023981|FG000|NOT COMPLETED|Stage 1b||0
10857802|NCT00697255|12023982|FG001|NOT COMPLETED|Stage 1b||2
10857803|NCT00696878|12023988|FG000|STARTED|Overall Study||682
10857806|NCT00696800|12023994|FG000|STARTED|Overall Study||757
10857807|NCT00696800|12023995|FG001|STARTED|Overall Study||752
10857808|NCT00696800|12023994|FG000|Treated (ITT)|Overall Study|The ITT group|756
10857809|NCT00696800|12023995|FG001|Treated (ITT)|Overall Study|The ITT group|750
10857810|NCT00696800|12023994|FG000|COMPLETED|Overall Study|Participants who had embryos transferred|672
10857811|NCT00696800|12023995|FG001|COMPLETED|Overall Study|Participants who had embryos transferred|704
10857812|NCT00696800|12023994|FG000|NOT COMPLETED|Overall Study||85
10857813|NCT00696800|12023995|FG001|NOT COMPLETED|Overall Study||48
10857814|NCT00616967|12024003|FG000|STARTED|Overall Study||6
10857815|NCT00616967|12024004|FG001|STARTED|Overall Study||31
10857816|NCT00616967|12024005|FG002|STARTED|Overall Study||31
10857817|NCT00616967|12024003|FG000|COMPLETED|Overall Study||6
11107342|NCT01262989|12291790|FG000|STARTED|Period 2||19
11107343|NCT01262989|12291791|FG001|STARTED|Period 2||17
11107344|NCT01262989|12291790|FG000|COMPLETED|Period 2||19
11107345|NCT01262989|12291791|FG001|COMPLETED|Period 2||16
11107346|NCT01262989|12291790|FG000|NOT COMPLETED|Period 2||0
11107347|NCT01262989|12291791|FG001|NOT COMPLETED|Period 2||1
11107348|NCT01263015|12291799|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||414
11107349|NCT01263015|12291800|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||419
11107350|NCT01263015|12291799|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
11107351|NCT01263015|12291800|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
11107352|NCT01263015|12291799|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
11107353|NCT01263015|12291800|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
11107354|NCT01263015|12291799|FG000|STARTED|Open-label Phase: 48 Weeks Duration||341
11107355|NCT01263015|12291800|FG001|STARTED|Open-label Phase: 48 Weeks Duration||309
11107356|NCT01263015|12291799|FG000|COMPLETED|Open-label Phase: 48 Weeks Duration||317
11107357|NCT01263015|12291800|FG001|COMPLETED|Open-label Phase: 48 Weeks Duration||278
11107358|NCT01263015|12291799|FG000|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
11107359|NCT01263015|12291800|FG001|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
11107360|NCT01263054|12291808|FG000|STARTED|Overall Study||29
11107361|NCT01263054|12291809|FG001|STARTED|Overall Study||34
11107362|NCT01263054|12291808|FG000|COMPLETED|Overall Study||24
11107363|NCT01263054|12291809|FG001|COMPLETED|Overall Study||28
11107364|NCT01263054|12291808|FG000|NOT COMPLETED|Overall Study||5
11107365|NCT01263054|12291809|FG001|NOT COMPLETED|Overall Study||6
11107366|NCT01263093|12291817|FG000|STARTED|Period 1||24
11107367|NCT01263093|12291818|FG001|STARTED|Period 1||23
11107368|NCT01263093|12291817|FG000|COMPLETED|Period 1||24
11107369|NCT01263093|12291818|FG001|COMPLETED|Period 1||23
11107370|NCT01263093|12291817|FG000|NOT COMPLETED|Period 1||0
11107371|NCT01263093|12291818|FG001|NOT COMPLETED|Period 1||0
11107372|NCT01263093|12291817|FG000|STARTED|Washout||24
11107373|NCT01263093|12291818|FG001|STARTED|Washout||23
11107374|NCT01263093|12291817|FG000|COMPLETED|Washout||23
11107375|NCT01263093|12291818|FG001|COMPLETED|Washout||23
11107376|NCT01263093|12291817|FG000|NOT COMPLETED|Washout||1
11107377|NCT01263093|12291818|FG001|NOT COMPLETED|Washout||0
11107378|NCT01263093|12291817|FG000|STARTED|Period 2||23
11107379|NCT01263093|12291818|FG001|STARTED|Period 2||23
11107380|NCT01263093|12291817|FG000|COMPLETED|Period 2||22
11107381|NCT01263093|12291818|FG001|COMPLETED|Period 2||23
11107382|NCT01263093|12291817|FG000|NOT COMPLETED|Period 2||1
11107383|NCT01263093|12291818|FG001|NOT COMPLETED|Period 2||0
11107384|NCT01263106|12291825|FG000|STARTED|Period 1 (7 Days)||11
11107385|NCT01263106|12291826|FG001|STARTED|Period 1 (7 Days)||10
11107386|NCT01263106|12291825|FG000|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11
11107387|NCT01263106|12291826|FG001|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10
11107388|NCT01263106|12291825|FG000|NOT COMPLETED|Period 1 (7 Days)||0
11107389|NCT01263106|12291826|FG001|NOT COMPLETED|Period 1 (7 Days)||0
11107390|NCT01263106|12291825|FG000|STARTED|Washout (at Least 7 Days)||11
11107391|NCT01263106|12291826|FG001|STARTED|Washout (at Least 7 Days)||10
11107392|NCT01263106|12291825|FG000|COMPLETED|Washout (at Least 7 Days)||10
11107393|NCT01263106|12291826|FG001|COMPLETED|Washout (at Least 7 Days)||9
11107394|NCT01263106|12291825|FG000|NOT COMPLETED|Washout (at Least 7 Days)||1
11107395|NCT01263106|12291826|FG001|NOT COMPLETED|Washout (at Least 7 Days)||1
11107396|NCT01263106|12291825|FG000|STARTED|Period 2 (7 Days)||10
11107397|NCT01263106|12291826|FG001|STARTED|Period 2 (7 Days)||9
11226576|NCT01998958|12418866|FG019|NOT COMPLETED|Period 1 (Panel A and B)||0
11226577|NCT01998958|12418867|FG020|NOT COMPLETED|Period 1 (Panel A and B)||0
11226578|NCT01998958|12418868|FG021|NOT COMPLETED|Period 1 (Panel A and B)||0
10857818|NCT00616967|12024004|FG001|COMPLETED|Overall Study||31
10857819|NCT00616967|12024005|FG002|COMPLETED|Overall Study||30
10857820|NCT00616967|12024003|FG000|NOT COMPLETED|Overall Study||0
10857821|NCT00616967|12024004|FG001|NOT COMPLETED|Overall Study||0
10857822|NCT00616967|12024005|FG002|NOT COMPLETED|Overall Study||1
10857823|NCT00461032|12024025|FG000|STARTED|Overall Study||582
10857824|NCT00461032|12024026|FG001|STARTED|Overall Study||580
10857825|NCT00461032|12024025|FG000|COMPLETED|Overall Study||545
10857826|NCT00461032|12024026|FG001|COMPLETED|Overall Study||536
10857827|NCT00461032|12024025|FG000|NOT COMPLETED|Overall Study||37
10857828|NCT00461032|12024026|FG001|NOT COMPLETED|Overall Study||44
10857829|NCT00442338|12024035|FG000|STARTED|Overall Study||30
10857830|NCT00442338|12024036|FG001|STARTED|Overall Study||30
10857831|NCT00442338|12024037|FG002|STARTED|Overall Study||31
10857832|NCT00442338|12024035|FG000|COMPLETED|Overall Study||30
11226579|NCT01998958|12418869|FG022|NOT COMPLETED|Period 1 (Panel A and B)||0
11226580|NCT01998958|12418870|FG023|NOT COMPLETED|Period 1 (Panel A and B)||0
11226581|NCT01998958|12418871|FG024|NOT COMPLETED|Period 1 (Panel A and B)||0
11226582|NCT01998958|12418872|FG025|NOT COMPLETED|Period 1 (Panel A and B)||0
11226583|NCT01998958|12418873|FG026|NOT COMPLETED|Period 1 (Panel A and B)||0
11226584|NCT01998958|12418874|FG027|NOT COMPLETED|Period 1 (Panel A and B)||0
11226585|NCT01998958|12418875|FG028|NOT COMPLETED|Period 1 (Panel A and B)||0
11226586|NCT01998958|12418876|FG029|NOT COMPLETED|Period 1 (Panel A and B)||0
11226587|NCT01998958|12418877|FG030|NOT COMPLETED|Period 1 (Panel A and B)||0
11226588|NCT01998958|12418878|FG031|NOT COMPLETED|Period 1 (Panel A and B)||0
11226589|NCT01998958|12418847|FG000|STARTED|Period 2 (Panel A and B)||0
11226590|NCT01998958|12418848|FG001|STARTED|Period 2 (Panel A and B)||0
11226591|NCT01998958|12418849|FG002|STARTED|Period 2 (Panel A and B)||0
11226592|NCT01998958|12418850|FG003|STARTED|Period 2 (Panel A and B)||0
11226593|NCT01998958|12418851|FG004|STARTED|Period 2 (Panel A and B)||0
11226594|NCT01998958|12418852|FG005|STARTED|Period 2 (Panel A and B)||0
11226595|NCT01998958|12418853|FG006|STARTED|Period 2 (Panel A and B)||0
11226596|NCT01998958|12418854|FG007|STARTED|Period 2 (Panel A and B)||6
11226597|NCT01998958|12418855|FG008|STARTED|Period 2 (Panel A and B)||4
11226598|NCT01998958|12418856|FG009|STARTED|Period 2 (Panel A and B)||8
11226599|NCT01998958|12418857|FG010|STARTED|Period 2 (Panel A and B)||9
11226600|NCT01998958|12418858|FG011|STARTED|Period 2 (Panel A and B)||5
11226601|NCT01998958|12418859|FG012|STARTED|Period 2 (Panel A and B)||8
11226602|NCT01998958|12418860|FG013|STARTED|Period 2 (Panel A and B)||11
11226603|NCT01998958|12418861|FG014|STARTED|Period 2 (Panel A and B)||12
11226604|NCT01998958|12418862|FG015|STARTED|Period 2 (Panel A and B)||5
11226605|NCT01998958|12418863|FG016|STARTED|Period 2 (Panel A and B)||8
11226606|NCT01998958|12418864|FG017|STARTED|Period 2 (Panel A and B)||5
11226607|NCT01998958|12418865|FG018|STARTED|Period 2 (Panel A and B)||3
11226608|NCT01998958|12418866|FG019|STARTED|Period 2 (Panel A and B)||11
11226609|NCT01998958|12418867|FG020|STARTED|Period 2 (Panel A and B)||9
11226610|NCT01998958|12418868|FG021|STARTED|Period 2 (Panel A and B)||0
11226611|NCT01998958|12418869|FG022|STARTED|Period 2 (Panel A and B)||0
11226612|NCT01998958|12418870|FG023|STARTED|Period 2 (Panel A and B)||0
11226613|NCT01998958|12418871|FG024|STARTED|Period 2 (Panel A and B)||0
11226614|NCT01998958|12418872|FG025|STARTED|Period 2 (Panel A and B)||0
11226615|NCT01998958|12418873|FG026|STARTED|Period 2 (Panel A and B)||0
11226616|NCT01998958|12418874|FG027|STARTED|Period 2 (Panel A and B)||0
11226617|NCT01998958|12418875|FG028|STARTED|Period 2 (Panel A and B)||0
11226618|NCT01998958|12418876|FG029|STARTED|Period 2 (Panel A and B)||0
11226619|NCT01998958|12418877|FG030|STARTED|Period 2 (Panel A and B)||0
11226620|NCT01998958|12418878|FG031|STARTED|Period 2 (Panel A and B)||0
11226621|NCT01998958|12418847|FG000|COMPLETED|Period 2 (Panel A and B)||0
11226622|NCT01998958|12418848|FG001|COMPLETED|Period 2 (Panel A and B)||0
11226623|NCT01998958|12418849|FG002|COMPLETED|Period 2 (Panel A and B)||0
11226624|NCT01998958|12418850|FG003|COMPLETED|Period 2 (Panel A and B)||0
11226625|NCT01998958|12418851|FG004|COMPLETED|Period 2 (Panel A and B)||0
11226626|NCT01998958|12418852|FG005|COMPLETED|Period 2 (Panel A and B)||0
11226627|NCT01998958|12418853|FG006|COMPLETED|Period 2 (Panel A and B)||0
11226628|NCT01998958|12418854|FG007|COMPLETED|Period 2 (Panel A and B)||6
11226629|NCT01998958|12418855|FG008|COMPLETED|Period 2 (Panel A and B)||4
11226630|NCT01998958|12418856|FG009|COMPLETED|Period 2 (Panel A and B)||8
11226631|NCT01998958|12418857|FG010|COMPLETED|Period 2 (Panel A and B)||8
11226632|NCT01998958|12418858|FG011|COMPLETED|Period 2 (Panel A and B)||5
11226633|NCT01998958|12418859|FG012|COMPLETED|Period 2 (Panel A and B)||8
11226634|NCT01998958|12418860|FG013|COMPLETED|Period 2 (Panel A and B)||11
10857833|NCT00442338|12024036|FG001|COMPLETED|Overall Study||30
10857834|NCT00442338|12024037|FG002|COMPLETED|Overall Study||31
11226635|NCT01998958|12418861|FG014|COMPLETED|Period 2 (Panel A and B)||10
11226636|NCT01998958|12418862|FG015|COMPLETED|Period 2 (Panel A and B)||5
11226637|NCT01998958|12418863|FG016|COMPLETED|Period 2 (Panel A and B)||8
11226638|NCT01998958|12418864|FG017|COMPLETED|Period 2 (Panel A and B)||5
11226639|NCT01998958|12418865|FG018|COMPLETED|Period 2 (Panel A and B)||2
10857835|NCT00442338|12024035|FG000|NOT COMPLETED|Overall Study||0
10857836|NCT00442338|12024036|FG001|NOT COMPLETED|Overall Study||0
10857837|NCT00442338|12024037|FG002|NOT COMPLETED|Overall Study||0
10857838|NCT00289874|12024047|FG000|STARTED|Overall Study||203
10857839|NCT00289874|12024048|FG001|STARTED|Overall Study||218
10857840|NCT00289874|12024047|FG000|COMPLETED|Overall Study||197
10857841|NCT00289874|12024048|FG001|COMPLETED|Overall Study||210
10857842|NCT00289874|12024047|FG000|NOT COMPLETED|Overall Study||6
10857843|NCT00289874|12024048|FG001|NOT COMPLETED|Overall Study||8
10857844|NCT00250458|12024056|FG000|STARTED|Overall Study||232
10857845|NCT00250458|12024057|FG001|STARTED|Overall Study||114
10857846|NCT00250458|12024056|FG000|COMPLETED|Overall Study||200
10857847|NCT00250458|12024057|FG001|COMPLETED|Overall Study||97
10857848|NCT00250458|12024056|FG000|NOT COMPLETED|Overall Study||32
10857849|NCT00250458|12024057|FG001|NOT COMPLETED|Overall Study||17
10857850|NCT00245570|12024063|FG000|STARTED|Treatment Period II||7
10857851|NCT00245570|12024064|FG001|STARTED|Treatment Period II||8
10857852|NCT00245570|12024065|FG002|STARTED|Treatment Period II||8
10857853|NCT00245570|12024066|FG003|STARTED|Treatment Period II||8
10857854|NCT00245570|12024067|FG004|STARTED|Treatment Period II||8
10857855|NCT00245570|12024068|FG005|STARTED|Treatment Period II||8
10857856|NCT00245570|12024063|FG000|COMPLETED|Treatment Period II||7
10857857|NCT00245570|12024064|FG001|COMPLETED|Treatment Period II||8
10857858|NCT00245570|12024065|FG002|COMPLETED|Treatment Period II||8
10857859|NCT00245570|12024066|FG003|COMPLETED|Treatment Period II||8
10857860|NCT00245570|12024067|FG004|COMPLETED|Treatment Period II||8
10857861|NCT00245570|12024068|FG005|COMPLETED|Treatment Period II||8
10857862|NCT00245570|12024063|FG000|NOT COMPLETED|Treatment Period II||0
10857863|NCT00245570|12024064|FG001|NOT COMPLETED|Treatment Period II||0
10857864|NCT00245570|12024065|FG002|NOT COMPLETED|Treatment Period II||0
10857865|NCT00245570|12024066|FG003|NOT COMPLETED|Treatment Period II||0
10857866|NCT00245570|12024067|FG004|NOT COMPLETED|Treatment Period II||0
10857867|NCT00245570|12024068|FG005|NOT COMPLETED|Treatment Period II||0
10857868|NCT00245570|12024063|FG000|STARTED|Washout Between Periods II and III||7
10857869|NCT00245570|12024064|FG001|STARTED|Washout Between Periods II and III||8
10857870|NCT00245570|12024065|FG002|STARTED|Washout Between Periods II and III||8
10857871|NCT00245570|12024066|FG003|STARTED|Washout Between Periods II and III||8
10857872|NCT00245570|12024067|FG004|STARTED|Washout Between Periods II and III||8
10857873|NCT00245570|12024068|FG005|STARTED|Washout Between Periods II and III||8
10857874|NCT00245570|12024063|FG000|COMPLETED|Washout Between Periods II and III||7
10857875|NCT00245570|12024064|FG001|COMPLETED|Washout Between Periods II and III||8
10857876|NCT00245570|12024065|FG002|COMPLETED|Washout Between Periods II and III||8
10857877|NCT00245570|12024066|FG003|COMPLETED|Washout Between Periods II and III||8
10857878|NCT00245570|12024067|FG004|COMPLETED|Washout Between Periods II and III||8
10857879|NCT00245570|12024068|FG005|COMPLETED|Washout Between Periods II and III||8
10857880|NCT00245570|12024063|FG000|NOT COMPLETED|Washout Between Periods II and III||0
10857881|NCT00245570|12024064|FG001|NOT COMPLETED|Washout Between Periods II and III||0
10857882|NCT00245570|12024065|FG002|NOT COMPLETED|Washout Between Periods II and III||0
10857883|NCT00245570|12024066|FG003|NOT COMPLETED|Washout Between Periods II and III||0
10857884|NCT00245570|12024067|FG004|NOT COMPLETED|Washout Between Periods II and III||0
10857885|NCT00245570|12024068|FG005|NOT COMPLETED|Washout Between Periods II and III||0
10857886|NCT00245570|12024063|FG000|STARTED|Treatment Period III||7
10857887|NCT00245570|12024064|FG001|STARTED|Treatment Period III||8
10857888|NCT00245570|12024065|FG002|STARTED|Treatment Period III||8
10857889|NCT00245570|12024066|FG003|STARTED|Treatment Period III||8
10857890|NCT00245570|12024067|FG004|STARTED|Treatment Period III||8
10857891|NCT00245570|12024068|FG005|STARTED|Treatment Period III||8
10857892|NCT00245570|12024063|FG000|COMPLETED|Treatment Period III||7
11226640|NCT01998958|12418866|FG019|COMPLETED|Period 2 (Panel A and B)||11
11226641|NCT01998958|12418867|FG020|COMPLETED|Period 2 (Panel A and B)||9
11226642|NCT01998958|12418868|FG021|COMPLETED|Period 2 (Panel A and B)||0
11226643|NCT01998958|12418869|FG022|COMPLETED|Period 2 (Panel A and B)||0
11226644|NCT01998958|12418870|FG023|COMPLETED|Period 2 (Panel A and B)||0
11226645|NCT01998958|12418871|FG024|COMPLETED|Period 2 (Panel A and B)||0
11226646|NCT01998958|12418872|FG025|COMPLETED|Period 2 (Panel A and B)||0
11226647|NCT01998958|12418873|FG026|COMPLETED|Period 2 (Panel A and B)||0
11226648|NCT01998958|12418874|FG027|COMPLETED|Period 2 (Panel A and B)||0
11226649|NCT01998958|12418875|FG028|COMPLETED|Period 2 (Panel A and B)||0
11226650|NCT01998958|12418876|FG029|COMPLETED|Period 2 (Panel A and B)||0
11226651|NCT01998958|12418877|FG030|COMPLETED|Period 2 (Panel A and B)||0
11226652|NCT01998958|12418878|FG031|COMPLETED|Period 2 (Panel A and B)||0
11226653|NCT01998958|12418847|FG000|NOT COMPLETED|Period 2 (Panel A and B)||0
11226654|NCT01998958|12418848|FG001|NOT COMPLETED|Period 2 (Panel A and B)||0
11226655|NCT01998958|12418849|FG002|NOT COMPLETED|Period 2 (Panel A and B)||0
11226656|NCT01998958|12418850|FG003|NOT COMPLETED|Period 2 (Panel A and B)||0
11226657|NCT01998958|12418851|FG004|NOT COMPLETED|Period 2 (Panel A and B)||0
11226658|NCT01998958|12418852|FG005|NOT COMPLETED|Period 2 (Panel A and B)||0
11226659|NCT01998958|12418853|FG006|NOT COMPLETED|Period 2 (Panel A and B)||0
11226660|NCT01998958|12418854|FG007|NOT COMPLETED|Period 2 (Panel A and B)||0
10857893|NCT00245570|12024064|FG001|COMPLETED|Treatment Period III||8
10857894|NCT00245570|12024065|FG002|COMPLETED|Treatment Period III||8
11226661|NCT01998958|12418855|FG008|NOT COMPLETED|Period 2 (Panel A and B)||0
11226662|NCT01998958|12418856|FG009|NOT COMPLETED|Period 2 (Panel A and B)||0
11226663|NCT01998958|12418857|FG010|NOT COMPLETED|Period 2 (Panel A and B)||1
11226664|NCT01998958|12418858|FG011|NOT COMPLETED|Period 2 (Panel A and B)||0
10857895|NCT00245570|12024066|FG003|COMPLETED|Treatment Period III||8
10857896|NCT00245570|12024067|FG004|COMPLETED|Treatment Period III||8
10857897|NCT00245570|12024068|FG005|COMPLETED|Treatment Period III||8
10857898|NCT00245570|12024063|FG000|NOT COMPLETED|Treatment Period III||0
10857899|NCT00245570|12024064|FG001|NOT COMPLETED|Treatment Period III||0
10857900|NCT00245570|12024065|FG002|NOT COMPLETED|Treatment Period III||0
10857901|NCT00245570|12024066|FG003|NOT COMPLETED|Treatment Period III||0
10857902|NCT00245570|12024067|FG004|NOT COMPLETED|Treatment Period III||0
10857903|NCT00245570|12024068|FG005|NOT COMPLETED|Treatment Period III||0
10857904|NCT00245570|12024063|FG000|STARTED|Washout Between Periods III and IV||7
10857905|NCT00245570|12024064|FG001|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
10857906|NCT00245570|12024065|FG002|STARTED|Washout Between Periods III and IV||8
10857907|NCT00245570|12024066|FG003|STARTED|Washout Between Periods III and IV||8
10857908|NCT00245570|12024067|FG004|STARTED|Washout Between Periods III and IV||8
10857909|NCT00245570|12024068|FG005|STARTED|Washout Between Periods III and IV||8
10857910|NCT00245570|12024063|FG000|COMPLETED|Washout Between Periods III and IV||7
10857911|NCT00245570|12024064|FG001|COMPLETED|Washout Between Periods III and IV||7
10857912|NCT00245570|12024065|FG002|COMPLETED|Washout Between Periods III and IV||8
10857913|NCT00245570|12024066|FG003|COMPLETED|Washout Between Periods III and IV||8
10857914|NCT00245570|12024067|FG004|COMPLETED|Washout Between Periods III and IV||8
10857915|NCT00245570|12024068|FG005|COMPLETED|Washout Between Periods III and IV||8
10857916|NCT00245570|12024063|FG000|NOT COMPLETED|Washout Between Periods III and IV||0
10857917|NCT00245570|12024064|FG001|NOT COMPLETED|Washout Between Periods III and IV||1
10857918|NCT00245570|12024065|FG002|NOT COMPLETED|Washout Between Periods III and IV||0
10857919|NCT00245570|12024066|FG003|NOT COMPLETED|Washout Between Periods III and IV||0
10857920|NCT00245570|12024067|FG004|NOT COMPLETED|Washout Between Periods III and IV||0
10857921|NCT00245570|12024068|FG005|NOT COMPLETED|Washout Between Periods III and IV||0
10857922|NCT00245570|12024063|FG000|STARTED|Treatment Period IV||7
10857923|NCT00245570|12024064|FG001|STARTED|Treatment Period IV||7
10857924|NCT00245570|12024065|FG002|STARTED|Treatment Period IV||8
10857925|NCT00245570|12024066|FG003|STARTED|Treatment Period IV||8
10857926|NCT00245570|12024067|FG004|STARTED|Treatment Period IV||8
10857927|NCT00245570|12024068|FG005|STARTED|Treatment Period IV||8
10857928|NCT00245570|12024063|FG000|COMPLETED|Treatment Period IV||7
10857929|NCT00245570|12024064|FG001|COMPLETED|Treatment Period IV||7
10857930|NCT00245570|12024065|FG002|COMPLETED|Treatment Period IV||8
10857931|NCT00245570|12024066|FG003|COMPLETED|Treatment Period IV||8
10857932|NCT00245570|12024067|FG004|COMPLETED|Treatment Period IV||8
10857933|NCT00245570|12024068|FG005|COMPLETED|Treatment Period IV||8
10857934|NCT00245570|12024063|FG000|NOT COMPLETED|Treatment Period IV||0
10857935|NCT00245570|12024064|FG001|NOT COMPLETED|Treatment Period IV||0
10857936|NCT00245570|12024065|FG002|NOT COMPLETED|Treatment Period IV||0
10857937|NCT00245570|12024066|FG003|NOT COMPLETED|Treatment Period IV||0
10857938|NCT00245570|12024067|FG004|NOT COMPLETED|Treatment Period IV||0
10857939|NCT00245570|12024068|FG005|NOT COMPLETED|Treatment Period IV||0
10857940|NCT00229970|12024082|FG000|STARTED|Overall Study||78
10857941|NCT00229970|12024083|FG001|STARTED|Overall Study||72
10857942|NCT00229970|12024084|FG002|STARTED|Overall Study||75
10857943|NCT00229970|12024082|FG000|COMPLETED|Overall Study||78
10857944|NCT00229970|12024083|FG001|COMPLETED|Overall Study||72
10857945|NCT00229970|12024084|FG002|COMPLETED|Overall Study||75
10857946|NCT00229970|12024082|FG000|NOT COMPLETED|Overall Study||0
10857947|NCT00229970|12024083|FG001|NOT COMPLETED|Overall Study||0
10857948|NCT00229970|12024084|FG002|NOT COMPLETED|Overall Study||0
10857949|NCT00092131|12024092|FG000|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
10857950|NCT00092131|12024093|FG001|STARTED|Treatment Period I||26
10857951|NCT00092131|12024092|FG000|COMPLETED|Treatment Period I||24
10857952|NCT00092131|12024093|FG001|COMPLETED|Treatment Period I||26
10857953|NCT00092131|12024092|FG000|NOT COMPLETED|Treatment Period I||1
10857954|NCT00092131|12024093|FG001|NOT COMPLETED|Treatment Period I||0
10857955|NCT00092131|12024092|FG000|STARTED|Treatment Period II||24
10857956|NCT00092131|12024093|FG001|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
10857957|NCT00092131|12024092|FG000|COMPLETED|Treatment Period II||24
10857958|NCT00092131|12024093|FG001|COMPLETED|Treatment Period II||25
10857959|NCT00092131|12024092|FG000|NOT COMPLETED|Treatment Period II||0
10857960|NCT00092131|12024093|FG001|NOT COMPLETED|Treatment Period II||1
10857961|NCT00092118|12024101|FG000|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
10857962|NCT00092118|12024102|FG001|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
10857963|NCT00092118|12024101|FG000|COMPLETED|Overall Study||906
10857964|NCT00092118|12024102|FG001|COMPLETED|Overall Study||913
10857965|NCT00092118|12024101|FG000|NOT COMPLETED|Overall Study||84
10857966|NCT00092118|12024102|FG001|NOT COMPLETED|Overall Study||89
10857967|NCT00090142|12024108|FG000|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
10857968|NCT00090142|12024109|FG001|STARTED|Treatment Period I||31
10857969|NCT00090142|12024108|FG000|COMPLETED|Treatment Period I||26
10857970|NCT00090142|12024109|FG001|COMPLETED|Treatment Period I||28
10857971|NCT00090142|12024108|FG000|NOT COMPLETED|Treatment Period I||5
10857972|NCT00090142|12024109|FG001|NOT COMPLETED|Treatment Period I||3
10857973|NCT00090142|12024108|FG000|STARTED|Treatment Period II||26
10857974|NCT00090142|12024109|FG001|STARTED|Treatment Period II||28
10857975|NCT00090142|12024108|FG000|COMPLETED|Treatment Period II||25
10857976|NCT00090142|12024109|FG001|COMPLETED|Treatment Period II||28
10857977|NCT00090142|12024108|FG000|NOT COMPLETED|Treatment Period II||1
10857978|NCT00090142|12024109|FG001|NOT COMPLETED|Treatment Period II||0
10857979|NCT00043108|12024115|FG000|STARTED|Overall Study||19
10857980|NCT00043108|12024115|FG000|COMPLETED|Overall Study||19
10857981|NCT00043108|12024115|FG000|NOT COMPLETED|Overall Study||0
10857982|NCT04771013|12024121|FG000|STARTED|Overall Study||22
10857983|NCT04771013|12024122|FG001|STARTED|Overall Study||22
10857984|NCT04771013|12024121|FG000|COMPLETED|Overall Study||20
10857985|NCT04771013|12024122|FG001|COMPLETED|Overall Study||16
10857986|NCT04771013|12024121|FG000|NOT COMPLETED|Overall Study||2
10857987|NCT04771013|12024122|FG001|NOT COMPLETED|Overall Study||6
10857988|NCT04497987|12024130|FG000|STARTED|Overall Study||592
10857989|NCT04497987|12024131|FG001|STARTED|Overall Study||588
10857990|NCT04497987|12024130|FG000|Received at Least One Dose of Study Drug|Overall Study||587
10857991|NCT04497987|12024131|FG001|Received at Least One Dose of Study Drug|Overall Study||588
10857992|NCT04497987|12024130|FG000|Prevention Population|Overall Study||485
10857993|NCT04497987|12024131|FG001|Prevention Population|Overall Study||487
10857994|NCT04497987|12024130|FG000|Treatment Population|Overall Study||68
10857995|NCT04497987|12024131|FG001|Treatment Population|Overall Study||66
10857996|NCT04497987|12024130|FG000|Serology Positive|Overall Study||36
10857997|NCT04497987|12024131|FG001|Serology Positive|Overall Study||35
10857998|NCT04497987|12024130|FG000|COMPLETED|Overall Study||493
10857999|NCT04497987|12024131|FG001|COMPLETED|Overall Study||521
10858000|NCT04497987|12024130|FG000|NOT COMPLETED|Overall Study||99
10858001|NCT04497987|12024131|FG001|NOT COMPLETED|Overall Study||67
10858079|NCT03180307|12024228|FG000|Safety Analysis Set|Overall Study||134
10858080|NCT03180307|12024229|FG001|Safety Analysis Set|Overall Study||16
10858081|NCT03180307|12024228|FG000|Full Analysis Set/ Intent to Image Set|Overall Study||134
10858082|NCT03180307|12024229|FG001|Full Analysis Set/ Intent to Image Set|Overall Study||0
10858083|NCT03180307|12024228|FG000|Per Protocol Analysis Set|Overall Study||106
10858084|NCT03180307|12024229|FG001|Per Protocol Analysis Set|Overall Study||0
10858085|NCT03180307|12024228|FG000|Pharmacokinetic Analysis Set|Overall Study||122
10858086|NCT03180307|12024229|FG001|Pharmacokinetic Analysis Set|Overall Study||6
10858087|NCT03180307|12024228|FG000|COMPLETED|Overall Study||128
10858088|NCT03180307|12024229|FG001|COMPLETED|Overall Study||6
10858089|NCT03180307|12024228|FG000|NOT COMPLETED|Overall Study||6
10858090|NCT03180307|12024229|FG001|NOT COMPLETED|Overall Study||0
10858091|NCT03151083|12024236|FG000|STARTED|Overall Study||27
10858092|NCT03151083|12024237|FG001|STARTED|Overall Study||20
10858093|NCT03151083|12024238|FG002|STARTED|Overall Study||30
10858094|NCT03151083|12024236|FG000|COMPLETED|Overall Study||25
10858095|NCT03151083|12024237|FG001|COMPLETED|Overall Study||19
10858096|NCT03151083|12024238|FG002|COMPLETED|Overall Study||26
10858097|NCT03151083|12024236|FG000|NOT COMPLETED|Overall Study||2
10858098|NCT03151083|12024237|FG001|NOT COMPLETED|Overall Study||1
10858099|NCT03151083|12024238|FG002|NOT COMPLETED|Overall Study||4
10858100|NCT02668822|12024248|FG000|STARTED|Overall Study||9
10858101|NCT02668822|12024249|FG001|STARTED|Overall Study||9
10858102|NCT02668822|12024248|FG000|COMPLETED|Overall Study||0
10858103|NCT02668822|12024249|FG001|COMPLETED|Overall Study||0
10858104|NCT02668822|12024248|FG000|NOT COMPLETED|Overall Study||9
10858105|NCT02668822|12024249|FG001|NOT COMPLETED|Overall Study||9
10858106|NCT02668783|12024257|FG000|STARTED|Overall Study||13
10858107|NCT02668783|12024258|FG001|STARTED|Overall Study||12
10858108|NCT02668783|12024257|FG000|Treated|Overall Study||13
10858109|NCT02668783|12024258|FG001|Treated|Overall Study||11
10858110|NCT02668783|12024257|FG000|COMPLETED|Overall Study||0
10858111|NCT02668783|12024258|FG001|COMPLETED|Overall Study||0
10858112|NCT02668783|12024257|FG000|NOT COMPLETED|Overall Study||13
10858113|NCT02668783|12024258|FG001|NOT COMPLETED|Overall Study||12
10858114|NCT02616146|12024266|FG000|STARTED|Overall Study||1512
11226665|NCT01998958|12418859|FG012|NOT COMPLETED|Period 2 (Panel A and B)||0
11226666|NCT01998958|12418860|FG013|NOT COMPLETED|Period 2 (Panel A and B)||0
11226667|NCT01998958|12418861|FG014|NOT COMPLETED|Period 2 (Panel A and B)||2
11226668|NCT01998958|12418862|FG015|NOT COMPLETED|Period 2 (Panel A and B)||0
11226669|NCT01998958|12418863|FG016|NOT COMPLETED|Period 2 (Panel A and B)||0
11226670|NCT01998958|12418864|FG017|NOT COMPLETED|Period 2 (Panel A and B)||0
11226671|NCT01998958|12418865|FG018|NOT COMPLETED|Period 2 (Panel A and B)||1
11226672|NCT01998958|12418866|FG019|NOT COMPLETED|Period 2 (Panel A and B)||0
11226673|NCT01998958|12418867|FG020|NOT COMPLETED|Period 2 (Panel A and B)||0
11226674|NCT01998958|12418868|FG021|NOT COMPLETED|Period 2 (Panel A and B)||0
11226675|NCT01998958|12418869|FG022|NOT COMPLETED|Period 2 (Panel A and B)||0
11226676|NCT01998958|12418870|FG023|NOT COMPLETED|Period 2 (Panel A and B)||0
11226677|NCT01998958|12418871|FG024|NOT COMPLETED|Period 2 (Panel A and B)||0
11226678|NCT01998958|12418872|FG025|NOT COMPLETED|Period 2 (Panel A and B)||0
10858115|NCT02616146|12024267|FG001|STARTED|Overall Study||504
10858116|NCT02616146|12024266|FG000|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0
10858117|NCT02616146|12024267|FG001|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0
10858118|NCT02616146|12024266|FG000|NOT COMPLETED|Overall Study||1512
10858119|NCT02616146|12024267|FG001|NOT COMPLETED|Overall Study||504
11107398|NCT01263106|12291825|FG000|COMPLETED|Period 2 (7 Days)||10
10858002|NCT04198584|12024140|FG000|STARTED|Overall Study||24
10858003|NCT04198584|12024141|FG001|STARTED|Overall Study||8
10858004|NCT04198584|12024140|FG000|Randomized to Wave 1|Overall Study||5
10858005|NCT04198584|12024141|FG001|Randomized to Wave 1|Overall Study||2
10858006|NCT04198584|12024140|FG000|Randomized to Wave 2|Overall Study||7
10858007|NCT04198584|12024141|FG001|Randomized to Wave 2|Overall Study||2
10858008|NCT04198584|12024140|FG000|Randomized to Wave 3|Overall Study||6
10858009|NCT04198584|12024141|FG001|Randomized to Wave 3|Overall Study||2
10858010|NCT04198584|12024140|FG000|Randomized to Wave 4|Overall Study||6
10858011|NCT04198584|12024141|FG001|Randomized to Wave 4|Overall Study||2
10858012|NCT04198584|12024140|FG000|Total Randomized|Overall Study||24
10858013|NCT04198584|12024141|FG001|Total Randomized|Overall Study||8
10858014|NCT04198584|12024140|FG000|Actually Received Treatment|Overall Study||21
10858015|NCT04198584|12024141|FG001|Actually Received Treatment|Overall Study||8
11107399|NCT01263106|12291826|FG001|COMPLETED|Period 2 (7 Days)||9
11107400|NCT01263106|12291825|FG000|NOT COMPLETED|Period 2 (7 Days)||0
11107401|NCT01263106|12291826|FG001|NOT COMPLETED|Period 2 (7 Days)||0
11107402|NCT01263119|12291835|FG000|STARTED|Period 1||18
11107403|NCT01263119|12291835|FG000|COMPLETED|Period 1||16
11107404|NCT01263119|12291835|FG000|NOT COMPLETED|Period 1||2
11107405|NCT01263119|12291835|FG000|STARTED|Period 2||16
11107406|NCT01263119|12291835|FG000|COMPLETED|Period 2||14
11107407|NCT01263119|12291835|FG000|NOT COMPLETED|Period 2||2
11107408|NCT01263132|12291845|FG000|STARTED|Overall Study||38
10858016|NCT04198584|12024140|FG000|COMPLETED|Overall Study||19
10858017|NCT04198584|12024141|FG001|COMPLETED|Overall Study||8
10858018|NCT04198584|12024140|FG000|NOT COMPLETED|Overall Study||5
10858019|NCT04198584|12024141|FG001|NOT COMPLETED|Overall Study||0
10858020|NCT04013932|12024154|FG000|STARTED|Overall Study||33
10858021|NCT04013932|12024155|FG001|STARTED|Overall Study||33
10858022|NCT04013932|12024154|FG000|COMPLETED|Overall Study||33
10858023|NCT04013932|12024155|FG001|COMPLETED|Overall Study||28
10858024|NCT04013932|12024154|FG000|NOT COMPLETED|Overall Study||0
10858025|NCT04013932|12024155|FG001|NOT COMPLETED|Overall Study||5
10858026|NCT03840616|12024165|FG000|STARTED|2-Week Induction Phase||147
10858027|NCT03840616|12024166|FG001|STARTED|2-Week Induction Phase||72
10858028|NCT03840616|12024165|FG000|COMPLETED|2-Week Induction Phase||123
10858029|NCT03840616|12024166|FG001|COMPLETED|2-Week Induction Phase||62
10858030|NCT03840616|12024165|FG000|NOT COMPLETED|2-Week Induction Phase||24
10858031|NCT03840616|12024166|FG001|NOT COMPLETED|2-Week Induction Phase||10
10858032|NCT03840616|12024165|FG000|STARTED|48-Week Maintenance Phase||123
10858033|NCT03840616|12024166|FG001|STARTED|48-Week Maintenance Phase||62
10858034|NCT03840616|12024165|FG000|COMPLETED|48-Week Maintenance Phase||112
10858035|NCT03840616|12024166|FG001|COMPLETED|48-Week Maintenance Phase||55
10858036|NCT03840616|12024165|FG000|NOT COMPLETED|48-Week Maintenance Phase||11
10858037|NCT03840616|12024166|FG001|NOT COMPLETED|48-Week Maintenance Phase||7
10858038|NCT03623373|12024174|FG000|STARTED|Overall Study||13
10858039|NCT03623373|12024174|FG000|COMPLETED|Overall Study||13
10858040|NCT03623373|12024174|FG000|NOT COMPLETED|Overall Study||0
10858041|NCT03581279|12024180|FG000|STARTED|Overall Study||18
10858042|NCT03581279|12024181|FG001|STARTED|Overall Study||0
10858043|NCT03581279|12024180|FG000|COMPLETED|Overall Study||16
10858044|NCT03581279|12024181|FG001|COMPLETED|Overall Study||0
10858045|NCT03581279|12024180|FG000|NOT COMPLETED|Overall Study||2
10858046|NCT03581279|12024181|FG001|NOT COMPLETED|Overall Study||0
10858047|NCT03512210|12024187|FG000|STARTED|Step 1: MINMON Intervention||400
10858048|NCT03512210|12024187|FG000|COMPLETED|Step 1: MINMON Intervention||396
10858049|NCT03512210|12024187|FG000|NOT COMPLETED|Step 1: MINMON Intervention||4
10858050|NCT03512210|12024187|FG000|STARTED|Step 2:Post-MINMON||396
10858051|NCT03512210|12024187|FG000|COMPLETED|Step 2:Post-MINMON||362
10858052|NCT03512210|12024187|FG000|NOT COMPLETED|Step 2:Post-MINMON||34
10858053|NCT03506412|12024193|FG000|STARTED|Overall Study||18
10858054|NCT03506412|12024194|FG001|STARTED|Overall Study||19
10858055|NCT03506412|12024193|FG000|COMPLETED|Overall Study||18
10858056|NCT03506412|12024194|FG001|COMPLETED|Overall Study||19
10858057|NCT03506412|12024193|FG000|NOT COMPLETED|Overall Study||0
10858058|NCT03506412|12024194|FG001|NOT COMPLETED|Overall Study||0
10858059|NCT03420768|12024203|FG000|STARTED|Overall Study||18
10858060|NCT03420768|12024204|FG001|STARTED|Overall Study||28
11226679|NCT01998958|12418873|FG026|NOT COMPLETED|Period 2 (Panel A and B)||0
11226680|NCT01998958|12418874|FG027|NOT COMPLETED|Period 2 (Panel A and B)||0
10858061|NCT03420768|12024205|FG002|STARTED|Overall Study||15
10858062|NCT03420768|12024203|FG000|COMPLETED|Overall Study||18
10858063|NCT03420768|12024204|FG001|COMPLETED|Overall Study||28
10858064|NCT03420768|12024205|FG002|COMPLETED|Overall Study||15
10858065|NCT03420768|12024203|FG000|NOT COMPLETED|Overall Study||0
10858066|NCT03420768|12024204|FG001|NOT COMPLETED|Overall Study||0
10858067|NCT03420768|12024205|FG002|NOT COMPLETED|Overall Study||0
10858068|NCT03395288|12024216|FG000|STARTED|Overall Study||28
10858069|NCT03395288|12024217|FG001|STARTED|Overall Study||29
10858070|NCT03395288|12024218|FG002|STARTED|Overall Study||4
10858071|NCT03395288|12024216|FG000|COMPLETED|Overall Study||19
10858072|NCT03395288|12024217|FG001|COMPLETED|Overall Study||25
11107409|NCT01263132|12291846|FG001|STARTED|Overall Study||37
11107410|NCT01263132|12291845|FG000|COMPLETED|Overall Study||38
11107411|NCT01263132|12291846|FG001|COMPLETED|Overall Study||37
11107412|NCT01263132|12291845|FG000|NOT COMPLETED|Overall Study||0
11107413|NCT01263132|12291846|FG001|NOT COMPLETED|Overall Study||0
11107414|NCT01263197|12291854|FG000|STARTED|First Intervention (Period 1)||8
11107415|NCT01263197|12291855|FG001|STARTED|First Intervention (Period 1)||8
11107416|NCT01263197|12291856|FG002|STARTED|First Intervention (Period 1)||8
10858073|NCT03395288|12024218|FG002|COMPLETED|Overall Study||3
10858074|NCT03395288|12024216|FG000|NOT COMPLETED|Overall Study||9
10858075|NCT03395288|12024217|FG001|NOT COMPLETED|Overall Study||4
10858076|NCT03395288|12024218|FG002|NOT COMPLETED|Overall Study||1
10858077|NCT03180307|12024228|FG000|STARTED|Overall Study||134
10858078|NCT03180307|12024229|FG001|STARTED|Overall Study||6
11107417|NCT01263197|12291857|FG003|STARTED|First Intervention (Period 1)||8
11107418|NCT01263197|12291858|FG004|STARTED|First Intervention (Period 1)||8
11107419|NCT01263197|12291859|FG005|STARTED|First Intervention (Period 1)||8
11107420|NCT01263197|12291854|FG000|COMPLETED|First Intervention (Period 1)||8
11107421|NCT01263197|12291855|FG001|COMPLETED|First Intervention (Period 1)||8
10858126|NCT02524288|12024286|FG000|STARTED|Overall Study||1941
10858127|NCT02524288|12024286|FG000|Treated|Overall Study||1936
10858128|NCT02524288|12024286|FG000|COMPLETED|Overall Study||0
10858129|NCT02524288|12024286|FG000|NOT COMPLETED|Overall Study||1941
11226681|NCT01998958|12418875|FG028|NOT COMPLETED|Period 2 (Panel A and B)||0
11226682|NCT01998958|12418876|FG029|NOT COMPLETED|Period 2 (Panel A and B)||0
11226683|NCT01998958|12418877|FG030|NOT COMPLETED|Period 2 (Panel A and B)||0
11226684|NCT01998958|12418878|FG031|NOT COMPLETED|Period 2 (Panel A and B)||0
11226685|NCT01998958|12418847|FG000|STARTED|Open Label Phase (Optional)||0
11226686|NCT01998958|12418848|FG001|STARTED|Open Label Phase (Optional)||0
11226687|NCT01998958|12418849|FG002|STARTED|Open Label Phase (Optional)||0
11226688|NCT01998958|12418850|FG003|STARTED|Open Label Phase (Optional)||0
11226689|NCT01998958|12418851|FG004|STARTED|Open Label Phase (Optional)||0
11226690|NCT01998958|12418852|FG005|STARTED|Open Label Phase (Optional)||0
11226691|NCT01998958|12418853|FG006|STARTED|Open Label Phase (Optional)||0
11226692|NCT01998958|12418854|FG007|STARTED|Open Label Phase (Optional)||0
11226693|NCT01998958|12418855|FG008|STARTED|Open Label Phase (Optional)||0
11226694|NCT01998958|12418856|FG009|STARTED|Open Label Phase (Optional)||0
11226695|NCT01998958|12418857|FG010|STARTED|Open Label Phase (Optional)||0
11226696|NCT01998958|12418858|FG011|STARTED|Open Label Phase (Optional)||0
11226697|NCT01998958|12418859|FG012|STARTED|Open Label Phase (Optional)||0
11226698|NCT01998958|12418860|FG013|STARTED|Open Label Phase (Optional)||0
11226699|NCT01998958|12418861|FG014|STARTED|Open Label Phase (Optional)||0
11226700|NCT01998958|12418862|FG015|STARTED|Open Label Phase (Optional)||0
11226701|NCT01998958|12418863|FG016|STARTED|Open Label Phase (Optional)||0
11226702|NCT01998958|12418864|FG017|STARTED|Open Label Phase (Optional)||0
11226703|NCT01998958|12418865|FG018|STARTED|Open Label Phase (Optional)||0
11226704|NCT01998958|12418866|FG019|STARTED|Open Label Phase (Optional)||0
11226705|NCT01998958|12418867|FG020|STARTED|Open Label Phase (Optional)||0
11226706|NCT01998958|12418868|FG021|STARTED|Open Label Phase (Optional)||10
11226707|NCT01998958|12418869|FG022|STARTED|Open Label Phase (Optional)||20
11226708|NCT01998958|12418870|FG023|STARTED|Open Label Phase (Optional)||27
11226709|NCT01998958|12418871|FG024|STARTED|Open Label Phase (Optional)||13
11226710|NCT01998958|12418872|FG025|STARTED|Open Label Phase (Optional)||7
11226711|NCT01998958|12418873|FG026|STARTED|Open Label Phase (Optional)||19
11226712|NCT01998958|12418874|FG027|STARTED|Open Label Phase (Optional)||0
11226713|NCT01998958|12418875|FG028|STARTED|Open Label Phase (Optional)||0
11226714|NCT01998958|12418876|FG029|STARTED|Open Label Phase (Optional)||0
11226715|NCT01998958|12418877|FG030|STARTED|Open Label Phase (Optional)||0
11226716|NCT01998958|12418878|FG031|STARTED|Open Label Phase (Optional)||0
11226717|NCT01998958|12418847|FG000|COMPLETED|Open Label Phase (Optional)||0
11226718|NCT01998958|12418848|FG001|COMPLETED|Open Label Phase (Optional)||0
11226719|NCT01998958|12418849|FG002|COMPLETED|Open Label Phase (Optional)||0
11226720|NCT01998958|12418850|FG003|COMPLETED|Open Label Phase (Optional)||0
11226721|NCT01998958|12418851|FG004|COMPLETED|Open Label Phase (Optional)||0
11226722|NCT01998958|12418852|FG005|COMPLETED|Open Label Phase (Optional)||0
11226723|NCT01998958|12418853|FG006|COMPLETED|Open Label Phase (Optional)||0
11226724|NCT01998958|12418854|FG007|COMPLETED|Open Label Phase (Optional)||0
11226725|NCT01998958|12418855|FG008|COMPLETED|Open Label Phase (Optional)||0
11226726|NCT01998958|12418856|FG009|COMPLETED|Open Label Phase (Optional)||0
11226727|NCT01998958|12418857|FG010|COMPLETED|Open Label Phase (Optional)||0
11226728|NCT01998958|12418858|FG011|COMPLETED|Open Label Phase (Optional)||0
11226729|NCT01998958|12418859|FG012|COMPLETED|Open Label Phase (Optional)||0
11226730|NCT01998958|12418860|FG013|COMPLETED|Open Label Phase (Optional)||0
11226731|NCT01998958|12418861|FG014|COMPLETED|Open Label Phase (Optional)||0
11226732|NCT01998958|12418862|FG015|COMPLETED|Open Label Phase (Optional)||0
11226733|NCT01998958|12418863|FG016|COMPLETED|Open Label Phase (Optional)||0
11226734|NCT01998958|12418864|FG017|COMPLETED|Open Label Phase (Optional)||0
11226735|NCT01998958|12418865|FG018|COMPLETED|Open Label Phase (Optional)||0
11226736|NCT01998958|12418866|FG019|COMPLETED|Open Label Phase (Optional)||0
11226737|NCT01998958|12418867|FG020|COMPLETED|Open Label Phase (Optional)||0
11226738|NCT01998958|12418868|FG021|COMPLETED|Open Label Phase (Optional)||7
11226739|NCT01998958|12418869|FG022|COMPLETED|Open Label Phase (Optional)||11
11226740|NCT01998958|12418870|FG023|COMPLETED|Open Label Phase (Optional)||23
11226741|NCT01998958|12418871|FG024|COMPLETED|Open Label Phase (Optional)||13
10858130|NCT02489942|12024290|FG000|STARTED|Overall Study||8145
10858131|NCT02489942|12024290|FG000|Case Report Form (CRF) Collected|Overall Study||8059
10858132|NCT02489942|12024290|FG000|Treated|Overall Study||8057
10858133|NCT02489942|12024290|FG000|COMPLETED|Overall Study||4729
10858134|NCT02489942|12024290|FG000|NOT COMPLETED|Overall Study||3416
10858135|NCT02409342|12024296|FG000|STARTED|Overall Study||287
10858136|NCT02409342|12024297|FG001|STARTED|Overall Study||285
10858137|NCT02409342|12024296|FG000|COMPLETED|Overall Study||0
10858138|NCT02409342|12024297|FG001|COMPLETED|Overall Study||0
10858139|NCT02409342|12024296|FG000|NOT COMPLETED|Overall Study||287
10858140|NCT02409342|12024297|FG001|NOT COMPLETED|Overall Study||285
10858141|NCT02293655|12024307|FG000|STARTED|Overall Study||92
10858142|NCT02293655|12024308|FG001|STARTED|Overall Study||17
10858143|NCT02293655|12024307|FG000|COMPLETED|Overall Study||85
10858144|NCT02293655|12024308|FG001|COMPLETED|Overall Study||15
10858145|NCT02293655|12024307|FG000|NOT COMPLETED|Overall Study||7
10858146|NCT02293655|12024308|FG001|NOT COMPLETED|Overall Study||2
10858147|NCT02275546|12024314|FG000|STARTED|Treatment Period 1||81
10858148|NCT02275546|12024315|FG001|STARTED|Treatment Period 1||83
10858149|NCT02275546|12024314|FG000|COMPLETED|Treatment Period 1||81
10858150|NCT02275546|12024315|FG001|COMPLETED|Treatment Period 1||83
10858151|NCT02275546|12024314|FG000|NOT COMPLETED|Treatment Period 1||0
10858152|NCT02275546|12024315|FG001|NOT COMPLETED|Treatment Period 1||0
10858153|NCT02275546|12024314|FG000|STARTED|Treatment Period 2||81
10858154|NCT02275546|12024315|FG001|STARTED|Treatment Period 2||83
10858155|NCT02275546|12024314|FG000|COMPLETED|Treatment Period 2||79
10858156|NCT02275546|12024315|FG001|COMPLETED|Treatment Period 2||81
10858157|NCT02275546|12024314|FG000|NOT COMPLETED|Treatment Period 2||2
10858158|NCT02275546|12024315|FG001|NOT COMPLETED|Treatment Period 2||2
10858159|NCT02077166|12024328|FG000|STARTED|Overall Study||12
10858160|NCT02077166|12024329|FG001|STARTED|Overall Study||7
10858161|NCT02077166|12024330|FG002|STARTED|Overall Study||9
10858162|NCT02077166|12024331|FG003|STARTED|Overall Study||9
10858163|NCT02077166|12024332|FG004|STARTED|Overall Study||8
10858164|NCT02077166|12024333|FG005|STARTED|Overall Study||55
10858165|NCT02077166|12024334|FG006|STARTED|Overall Study||34
10858166|NCT02077166|12024328|FG000|COMPLETED|Overall Study||0
10858167|NCT02077166|12024329|FG001|COMPLETED|Overall Study||0
10858168|NCT02077166|12024330|FG002|COMPLETED|Overall Study||0
10858169|NCT02077166|12024331|FG003|COMPLETED|Overall Study||0
10858170|NCT02077166|12024332|FG004|COMPLETED|Overall Study||0
10858171|NCT02077166|12024333|FG005|COMPLETED|Overall Study||0
10858172|NCT02077166|12024334|FG006|COMPLETED|Overall Study||0
10858173|NCT02077166|12024328|FG000|NOT COMPLETED|Overall Study||12
10858174|NCT02077166|12024329|FG001|NOT COMPLETED|Overall Study||7
10858175|NCT02077166|12024330|FG002|NOT COMPLETED|Overall Study||9
10858176|NCT02077166|12024331|FG003|NOT COMPLETED|Overall Study||9
10858177|NCT02077166|12024332|FG004|NOT COMPLETED|Overall Study||8
10858178|NCT02077166|12024333|FG005|NOT COMPLETED|Overall Study||55
10858179|NCT02077166|12024334|FG006|NOT COMPLETED|Overall Study||34
10858180|NCT01891344|12024359|FG000|STARTED|Overall Study||40
10858181|NCT01891344|12024360|FG001|STARTED|Overall Study||82
10858182|NCT01891344|12024361|FG002|STARTED|Overall Study||70
10858183|NCT01891344|12024362|FG003|STARTED|Overall Study||12
10858184|NCT01891344|12024363|FG004|STARTED|Overall Study||84
10858185|NCT01891344|12024364|FG005|STARTED|Overall Study||73
10858186|NCT01891344|12024365|FG006|STARTED|Overall Study||107
10858187|NCT01891344|12024366|FG007|STARTED|Overall Study||23
10858188|NCT01891344|12024359|FG000|COMPLETED|Overall Study||34
10858189|NCT01891344|12024360|FG001|COMPLETED|Overall Study||80
10858190|NCT01891344|12024361|FG002|COMPLETED|Overall Study||70
10858191|NCT01891344|12024362|FG003|COMPLETED|Overall Study||11
10858192|NCT01891344|12024363|FG004|COMPLETED|Overall Study||80
10858193|NCT01891344|12024364|FG005|COMPLETED|Overall Study||72
10858194|NCT01891344|12024365|FG006|COMPLETED|Overall Study||107
10858195|NCT01891344|12024366|FG007|COMPLETED|Overall Study||23
10858196|NCT01891344|12024359|FG000|NOT COMPLETED|Overall Study||6
10858197|NCT01891344|12024360|FG001|NOT COMPLETED|Overall Study||2
10858198|NCT01891344|12024361|FG002|NOT COMPLETED|Overall Study||0
10858199|NCT01891344|12024362|FG003|NOT COMPLETED|Overall Study||1
10858200|NCT01891344|12024363|FG004|NOT COMPLETED|Overall Study||4
10858201|NCT01891344|12024364|FG005|NOT COMPLETED|Overall Study||1
10858202|NCT01891344|12024365|FG006|NOT COMPLETED|Overall Study||0
10858203|NCT01891344|12024366|FG007|NOT COMPLETED|Overall Study||0
10858204|NCT01847274|12024388|FG000|STARTED|Overall Study||138
10858205|NCT01847274|12024389|FG001|STARTED|Overall Study||65
10858206|NCT01847274|12024390|FG002|STARTED|Overall Study||234
10858207|NCT01847274|12024391|FG003|STARTED|Overall Study||116
10858208|NCT01847274|12024388|FG000|COMPLETED|Overall Study||47
10858209|NCT01847274|12024389|FG001|COMPLETED|Overall Study||4
10858210|NCT01847274|12024390|FG002|COMPLETED|Overall Study||46
10858211|NCT01847274|12024391|FG003|COMPLETED|Overall Study||12
10858212|NCT01847274|12024388|FG000|NOT COMPLETED|Overall Study||91
10858213|NCT01847274|12024389|FG001|NOT COMPLETED|Overall Study||61
10858214|NCT01847274|12024390|FG002|NOT COMPLETED|Overall Study||188
10858215|NCT01847274|12024391|FG003|NOT COMPLETED|Overall Study||104
10858216|NCT01670656|12024406|FG000|STARTED|Overall Study||86
10858217|NCT01670656|12024407|FG001|STARTED|Overall Study||91
10858218|NCT01670656|12024408|FG002|STARTED|Overall Study||87
10858219|NCT01670656|12024409|FG003|STARTED|Overall Study||85
10858220|NCT01670656|12024410|FG004|STARTED|Overall Study||90
10858221|NCT01670656|12024406|FG000|Treated|Overall Study||86
10858222|NCT01670656|12024407|FG001|Treated|Overall Study||91
10858223|NCT01670656|12024408|FG002|Treated|Overall Study||86
10858224|NCT01670656|12024409|FG003|Treated|Overall Study||85
10858225|NCT01670656|12024410|FG004|Treated|Overall Study||90
10858226|NCT01670656|12024406|FG000|COMPLETED|Overall Study||83
10858227|NCT01670656|12024407|FG001|COMPLETED|Overall Study||84
10858228|NCT01670656|12024408|FG002|COMPLETED|Overall Study||79
10858229|NCT01670656|12024409|FG003|COMPLETED|Overall Study||79
10858230|NCT01670656|12024410|FG004|COMPLETED|Overall Study||79
10858231|NCT01670656|12024406|FG000|NOT COMPLETED|Overall Study||3
10858232|NCT01670656|12024407|FG001|NOT COMPLETED|Overall Study||7
10858233|NCT01670656|12024408|FG002|NOT COMPLETED|Overall Study||8
10858234|NCT01670656|12024409|FG003|NOT COMPLETED|Overall Study||6
10858235|NCT01670656|12024410|FG004|NOT COMPLETED|Overall Study||11
10858236|NCT01501955|12024424|FG000|STARTED|Overall Study||11
10858237|NCT01501955|12024425|FG001|STARTED|Overall Study||9
10858238|NCT01501955|12024424|FG000|Surgery|Overall Study||11
10858239|NCT01501955|12024425|FG001|Surgery|Overall Study||9
10858240|NCT01501955|12024424|FG000|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
10858241|NCT01501955|12024425|FG001|6 Weeks Postop|Overall Study||9
10858242|NCT01501955|12024424|FG000|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
10858243|NCT01501955|12024425|FG001|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
10858244|NCT01501955|12024424|FG000|2 Years Postop|Overall Study||9
10858245|NCT01501955|12024425|FG001|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
10858246|NCT01501955|12024424|FG000|COMPLETED|Overall Study||9
10858247|NCT01501955|12024425|FG001|COMPLETED|Overall Study||6
10858248|NCT01501955|12024424|FG000|NOT COMPLETED|Overall Study||2
10858249|NCT01501955|12024425|FG001|NOT COMPLETED|Overall Study||3
10858262|NCT01277211|12024442|FG000|STARTED|Overall Study||738
10858263|NCT01277211|12024443|FG001|STARTED|Overall Study||245
10858264|NCT01277211|12024442|FG000|Treated|Overall Study||714
10858265|NCT01277211|12024443|FG001|Treated|Overall Study||232
10858266|NCT01277211|12024442|FG000|COMPLETED|Overall Study||588
10858267|NCT01277211|12024443|FG001|COMPLETED|Overall Study||182
10858268|NCT01277211|12024442|FG000|NOT COMPLETED|Overall Study||150
10858269|NCT01277211|12024443|FG001|NOT COMPLETED|Overall Study||63
10858270|NCT01267812|12024449|FG000|STARTED|Overall Study||23
10858271|NCT01267812|12024449|FG000|COMPLETED|Overall Study||23
10858272|NCT01267812|12024449|FG000|NOT COMPLETED|Overall Study||0
10858273|NCT01244828|12024453|FG000|STARTED|Overall Study|Received study drug|157
10858274|NCT01244828|12024453|FG000|COMPLETED|Overall Study||79
10858275|NCT01244828|12024453|FG000|NOT COMPLETED|Overall Study||78
11107422|NCT01263197|12291856|FG002|COMPLETED|First Intervention (Period 1)||8
11107423|NCT01263197|12291857|FG003|COMPLETED|First Intervention (Period 1)||8
11107424|NCT01263197|12291858|FG004|COMPLETED|First Intervention (Period 1)||8
11107425|NCT01263197|12291859|FG005|COMPLETED|First Intervention (Period 1)||7
10858279|NCT01181778|12024461|FG000|STARTED|Overall Study||1919
10858280|NCT01181778|12024461|FG000|COMPLETED|Overall Study||1871
10858281|NCT01181778|12024461|FG000|NOT COMPLETED|Overall Study||48
10858282|NCT01047540|12024472|FG000|STARTED|Overall Study||34
10858283|NCT01047540|12024473|FG001|STARTED|Overall Study||32
10858284|NCT01047540|12024474|FG002|STARTED|Overall Study||29
10858285|NCT01047540|12024475|FG003|STARTED|Overall Study||31
10858286|NCT01047540|12024476|FG004|STARTED|Overall Study||30
10858287|NCT01047540|12024472|FG000|COMPLETED|Overall Study||29
10858288|NCT01047540|12024473|FG001|COMPLETED|Overall Study||32
10858289|NCT01047540|12024474|FG002|COMPLETED|Overall Study||26
10858290|NCT01047540|12024475|FG003|COMPLETED|Overall Study||31
10858291|NCT01047540|12024476|FG004|COMPLETED|Overall Study||29
10858292|NCT01047540|12024472|FG000|NOT COMPLETED|Overall Study||5
10858293|NCT01047540|12024473|FG001|NOT COMPLETED|Overall Study||0
10858294|NCT01047540|12024474|FG002|NOT COMPLETED|Overall Study||3
10858295|NCT01047540|12024475|FG003|NOT COMPLETED|Overall Study||0
10858296|NCT01047540|12024476|FG004|NOT COMPLETED|Overall Study||1
10858297|NCT01044056|12024491|FG000|STARTED|Overall Study||8
10858298|NCT01044056|12024492|FG001|STARTED|Overall Study||8
10858299|NCT01044056|12024493|FG002|STARTED|Overall Study||8
10858300|NCT01044056|12024491|FG000|COMPLETED|Overall Study||8
10858301|NCT01044056|12024492|FG001|COMPLETED|Overall Study||8
10858302|NCT01044056|12024493|FG002|COMPLETED|Overall Study||8
10858303|NCT01044056|12024491|FG000|NOT COMPLETED|Overall Study||0
10858304|NCT01044056|12024492|FG001|NOT COMPLETED|Overall Study||0
10858305|NCT01044056|12024493|FG002|NOT COMPLETED|Overall Study||0
10858306|NCT00944216|12024501|FG000|STARTED|Overall Study||1
10858307|NCT00944216|12024501|FG000|COMPLETED|Overall Study||1
10858308|NCT00944216|12024501|FG000|NOT COMPLETED|Overall Study||0
10858309|NCT00886691|12024508|FG000|STARTED|Overall Study||75
10858310|NCT00886691|12024509|FG001|STARTED|Overall Study||75
10858311|NCT00886691|12024508|FG000|COMPLETED|Overall Study||75
10858312|NCT00886691|12024509|FG001|COMPLETED|Overall Study||75
10858313|NCT00886691|12024508|FG000|NOT COMPLETED|Overall Study||0
10858314|NCT00886691|12024509|FG001|NOT COMPLETED|Overall Study||0
10858315|NCT00778999|12024521|FG000|STARTED|Overall Study||223
10858316|NCT00778999|12024522|FG001|STARTED|Overall Study||219
10858317|NCT00778999|12024521|FG000|COMPLETED|Overall Study||195
10858318|NCT00778999|12024522|FG001|COMPLETED|Overall Study||185
10858319|NCT00778999|12024521|FG000|NOT COMPLETED|Overall Study||28
10858320|NCT00778999|12024522|FG001|NOT COMPLETED|Overall Study||34
10858321|NCT00620464|12024530|FG000|STARTED|Overall Study||52
10858322|NCT00620464|12024531|FG001|STARTED|Overall Study||56
10858323|NCT00620464|12024530|FG000|COMPLETED|Overall Study||32
10858324|NCT00620464|12024531|FG001|COMPLETED|Overall Study||32
10858325|NCT00620464|12024530|FG000|NOT COMPLETED|Overall Study||20
10858326|NCT00620464|12024531|FG001|NOT COMPLETED|Overall Study||24
10858327|NCT00620035|12024537|FG000|STARTED|Overall Study||301
10858328|NCT00620035|12024537|FG000|COMPLETED|Overall Study||156
10858329|NCT00620035|12024537|FG000|NOT COMPLETED|Overall Study||145
10858330|NCT00210249|12024541|FG000|STARTED|Overall Study||364
10858331|NCT00210249|12024541|FG000|COMPLETED|Overall Study||348
10858332|NCT00210249|12024541|FG000|NOT COMPLETED|Overall Study||16
10858333|NCT03704142|12024549|FG000|STARTED|Overall Study||10
10858334|NCT03704142|12024550|FG001|STARTED|Overall Study||10
10858335|NCT03704142|12024551|FG002|STARTED|Overall Study||10
10858336|NCT03704142|12024552|FG003|STARTED|Overall Study||10
10858337|NCT03704142|12024549|FG000|COMPLETED|Overall Study||10
10858338|NCT03704142|12024550|FG001|COMPLETED|Overall Study||10
10858339|NCT03704142|12024551|FG002|COMPLETED|Overall Study||10
10858340|NCT03704142|12024552|FG003|COMPLETED|Overall Study||10
10858341|NCT03704142|12024549|FG000|NOT COMPLETED|Overall Study||0
10858342|NCT03704142|12024550|FG001|NOT COMPLETED|Overall Study||0
10858343|NCT03704142|12024551|FG002|NOT COMPLETED|Overall Study||0
10858344|NCT03704142|12024552|FG003|NOT COMPLETED|Overall Study||0
11107426|NCT01263197|12291854|FG000|NOT COMPLETED|First Intervention (Period 1)||0
11107427|NCT01263197|12291855|FG001|NOT COMPLETED|First Intervention (Period 1)||0
11107428|NCT01263197|12291856|FG002|NOT COMPLETED|First Intervention (Period 1)||0
11107429|NCT01263197|12291857|FG003|NOT COMPLETED|First Intervention (Period 1)||0
10858351|NCT03626168|12024573|FG000|STARTED|First Intervention (4 Weeks)||9
10858352|NCT03626168|12024574|FG001|STARTED|First Intervention (4 Weeks)||12
10858353|NCT03626168|12024573|FG000|COMPLETED|First Intervention (4 Weeks)||8
10858354|NCT03626168|12024574|FG001|COMPLETED|First Intervention (4 Weeks)||11
10858443|NCT03653026|12024666|FG000|STARTED|Part 2: Open-label Extension||0
10858355|NCT03626168|12024573|FG000|NOT COMPLETED|First Intervention (4 Weeks)||1
10858356|NCT03626168|12024574|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
10858357|NCT03626168|12024573|FG000|STARTED|Washout (2 Weeks)||8
10858358|NCT03626168|12024574|FG001|STARTED|Washout (2 Weeks)||11
10858359|NCT03626168|12024573|FG000|COMPLETED|Washout (2 Weeks)||8
10858360|NCT03626168|12024574|FG001|COMPLETED|Washout (2 Weeks)||11
10858361|NCT03626168|12024573|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10858362|NCT03626168|12024574|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10858363|NCT03626168|12024573|FG000|STARTED|Second Intervention (4 Weeks)||8
10858364|NCT03626168|12024574|FG001|STARTED|Second Intervention (4 Weeks)||11
10858365|NCT03626168|12024573|FG000|COMPLETED|Second Intervention (4 Weeks)||8
10858366|NCT03626168|12024574|FG001|COMPLETED|Second Intervention (4 Weeks)||9
10858367|NCT03626168|12024573|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10858368|NCT03626168|12024574|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2
10858369|NCT03597035|12024580|FG000|STARTED|Overall Study||8
10858370|NCT03597035|12024580|FG000|COMPLETED|Overall Study||4
10858371|NCT03597035|12024580|FG000|NOT COMPLETED|Overall Study||4
11107430|NCT01263197|12291858|FG004|NOT COMPLETED|First Intervention (Period 1)||0
11107431|NCT01263197|12291859|FG005|NOT COMPLETED|First Intervention (Period 1)||1
11107432|NCT01263197|12291854|FG000|STARTED|Washout Period 1||8
11107433|NCT01263197|12291855|FG001|STARTED|Washout Period 1||8
11107434|NCT01263197|12291856|FG002|STARTED|Washout Period 1||8
11107435|NCT01263197|12291857|FG003|STARTED|Washout Period 1||8
11107436|NCT01263197|12291858|FG004|STARTED|Washout Period 1||8
11107437|NCT01263197|12291859|FG005|STARTED|Washout Period 1||7
10858381|NCT04823221|12024598|FG000|STARTED|Overall Study||22
10858382|NCT04823221|12024598|FG000|COMPLETED|Overall Study||22
10858383|NCT04823221|12024598|FG000|NOT COMPLETED|Overall Study||0
10858384|NCT04579393|12024604|FG000|STARTED|Overall Study||30
10858385|NCT04579393|12024605|FG001|STARTED|Overall Study||29
10858386|NCT04579393|12024604|FG000|COMPLETED|Overall Study||27
10858387|NCT04579393|12024605|FG001|COMPLETED|Overall Study||24
10858388|NCT04579393|12024604|FG000|NOT COMPLETED|Overall Study||3
10858389|NCT04579393|12024605|FG001|NOT COMPLETED|Overall Study||5
10858409|NCT03796637|12024639|FG000|STARTED|Overall Study||6
10858410|NCT03796637|12024639|FG000|COMPLETED|Overall Study||6
10858411|NCT03796637|12024639|FG000|NOT COMPLETED|Overall Study||0
10858412|NCT03679884|12024648|FG000|STARTED|Overall Study||142
10858413|NCT03679884|12024649|FG001|STARTED|Overall Study||268
10858414|NCT03679884|12024650|FG002|STARTED|Overall Study||137
10858415|NCT03679884|12024651|FG003|STARTED|Overall Study||128
10858416|NCT03679884|12024652|FG004|STARTED|Overall Study||126
10858417|NCT03679884|12024648|FG000|COMPLETED|Overall Study||99
10858418|NCT03679884|12024649|FG001|COMPLETED|Overall Study||190
10858419|NCT03679884|12024650|FG002|COMPLETED|Overall Study||93
10858420|NCT03679884|12024651|FG003|COMPLETED|Overall Study||78
10858421|NCT03679884|12024652|FG004|COMPLETED|Overall Study||90
10858422|NCT03679884|12024648|FG000|NOT COMPLETED|Overall Study||43
10858423|NCT03679884|12024649|FG001|NOT COMPLETED|Overall Study||78
10858424|NCT03679884|12024650|FG002|NOT COMPLETED|Overall Study||44
10858425|NCT03679884|12024651|FG003|NOT COMPLETED|Overall Study||50
10858426|NCT03679884|12024652|FG004|NOT COMPLETED|Overall Study||36
10858427|NCT03653026|12024666|FG000|STARTED|Part 1: Placebo-controlled Period||345
10858428|NCT03653026|12024667|FG001|STARTED|Part 1: Placebo-controlled Period||177
10858429|NCT03653026|12024668|FG002|STARTED|Part 1: Placebo-controlled Period||0
10858430|NCT03653026|12024669|FG003|STARTED|Part 1: Placebo-controlled Period||0
10858431|NCT03653026|12024666|FG000|Received Treatment|Part 1: Placebo-controlled Period||344
10858432|NCT03653026|12024667|FG001|Received Treatment|Part 1: Placebo-controlled Period||177
10858433|NCT03653026|12024668|FG002|Received Treatment|Part 1: Placebo-controlled Period||0
10858434|NCT03653026|12024669|FG003|Received Treatment|Part 1: Placebo-controlled Period||0
10858435|NCT03653026|12024666|FG000|COMPLETED|Part 1: Placebo-controlled Period||334
10858436|NCT03653026|12024667|FG001|COMPLETED|Part 1: Placebo-controlled Period||164
10858437|NCT03653026|12024668|FG002|COMPLETED|Part 1: Placebo-controlled Period||0
10858438|NCT03653026|12024669|FG003|COMPLETED|Part 1: Placebo-controlled Period||0
10858439|NCT03653026|12024666|FG000|NOT COMPLETED|Part 1: Placebo-controlled Period||11
10858390|NCT04426656|12024614|FG000|STARTED|Overall Study||24
10858391|NCT04426656|12024615|FG001|STARTED|Overall Study||46
10858392|NCT04426656|12024614|FG000|COMPLETED|Overall Study||21
10858393|NCT04426656|12024615|FG001|COMPLETED|Overall Study||43
10858394|NCT04426656|12024614|FG000|NOT COMPLETED|Overall Study||3
10858395|NCT04426656|12024615|FG001|NOT COMPLETED|Overall Study||3
10858396|NCT04325906|12024623|FG000|STARTED|Overall Study||112
10858397|NCT04325906|12024624|FG001|STARTED|Overall Study||112
10858398|NCT04325906|12024623|FG000|COMPLETED|Overall Study||110
10858399|NCT04325906|12024624|FG001|COMPLETED|Overall Study||112
10858400|NCT04325906|12024623|FG000|NOT COMPLETED|Overall Study||2
10858401|NCT04325906|12024624|FG001|NOT COMPLETED|Overall Study||0
10858402|NCT04319445|12024630|FG000|STARTED|Overall Study||144
10858403|NCT04319445|12024630|FG000|COMPLETED|Overall Study||144
10858404|NCT04319445|12024630|FG000|NOT COMPLETED|Overall Study||0
10858405|NCT04203667|12024634|FG000|STARTED|Overall Study||66
10858406|NCT04203667|12024634|FG000|Per Protocol Population|Overall Study||45
10858407|NCT04203667|12024634|FG000|COMPLETED|Overall Study||62
10858408|NCT04203667|12024634|FG000|NOT COMPLETED|Overall Study||4
10858440|NCT03653026|12024667|FG001|NOT COMPLETED|Part 1: Placebo-controlled Period||13
10858441|NCT03653026|12024668|FG002|NOT COMPLETED|Part 1: Placebo-controlled Period||0
10858442|NCT03653026|12024669|FG003|NOT COMPLETED|Part 1: Placebo-controlled Period||0
10858444|NCT03653026|12024667|FG001|STARTED|Part 2: Open-label Extension||0
10858445|NCT03653026|12024668|FG002|STARTED|Part 2: Open-label Extension||68
10858446|NCT03653026|12024669|FG003|STARTED|Part 2: Open-label Extension||116
10858447|NCT03653026|12024666|FG000|COMPLETED|Part 2: Open-label Extension||0
10858448|NCT03653026|12024667|FG001|COMPLETED|Part 2: Open-label Extension||0
10858449|NCT03653026|12024668|FG002|COMPLETED|Part 2: Open-label Extension||65
10858450|NCT03653026|12024669|FG003|COMPLETED|Part 2: Open-label Extension||111
10858451|NCT03653026|12024666|FG000|NOT COMPLETED|Part 2: Open-label Extension||0
10858452|NCT03653026|12024667|FG001|NOT COMPLETED|Part 2: Open-label Extension||0
10858453|NCT03653026|12024668|FG002|NOT COMPLETED|Part 2: Open-label Extension||3
10858454|NCT03653026|12024669|FG003|NOT COMPLETED|Part 2: Open-label Extension||5
10858455|NCT03648827|12024677|FG000|STARTED|Overall Study||20
10858456|NCT03648827|12024677|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
10858457|NCT03648827|12024677|FG000|COMPLETED|Overall Study||20
10858458|NCT03648827|12024677|FG000|NOT COMPLETED|Overall Study||0
10858459|NCT03553498|12024683|FG000|STARTED|Overall Study||81
10858460|NCT03553498|12024684|FG001|STARTED|Overall Study||81
10858461|NCT03553498|12024683|FG000|COMPLETED|Overall Study||80
10858462|NCT03553498|12024684|FG001|COMPLETED|Overall Study||79
10858463|NCT03553498|12024683|FG000|NOT COMPLETED|Overall Study||1
10858464|NCT03553498|12024684|FG001|NOT COMPLETED|Overall Study||2
10858465|NCT03530293|12024692|FG000|STARTED|Pre-randomization||81
10858466|NCT03530293|12024693|FG001|STARTED|Pre-randomization||0
10858467|NCT03530293|12024694|FG002|STARTED|Pre-randomization||0
10858468|NCT03530293|12024692|FG000|Safety Analysis Set|Pre-randomization||80
10858469|NCT03530293|12024693|FG001|Safety Analysis Set|Pre-randomization||0
10858470|NCT03530293|12024694|FG002|Safety Analysis Set|Pre-randomization||0
10858471|NCT03530293|12024692|FG000|COMPLETED|Pre-randomization||57
10858472|NCT03530293|12024693|FG001|COMPLETED|Pre-randomization||0
10858473|NCT03530293|12024694|FG002|COMPLETED|Pre-randomization||0
10858474|NCT03530293|12024692|FG000|NOT COMPLETED|Pre-randomization||24
10858475|NCT03530293|12024693|FG001|NOT COMPLETED|Pre-randomization||0
10858476|NCT03530293|12024694|FG002|NOT COMPLETED|Pre-randomization||0
10858477|NCT03530293|12024692|FG000|STARTED|Randomized Withdrawal Period / Follow-up||0
10858478|NCT03530293|12024693|FG001|STARTED|Randomized Withdrawal Period / Follow-up||26
10858479|NCT03530293|12024694|FG002|STARTED|Randomized Withdrawal Period / Follow-up||26
10858480|NCT03530293|12024692|FG000|COMPLETED|Randomized Withdrawal Period / Follow-up||0
10858481|NCT03530293|12024693|FG001|COMPLETED|Randomized Withdrawal Period / Follow-up||9
10858482|NCT03530293|12024694|FG002|COMPLETED|Randomized Withdrawal Period / Follow-up||9
10858483|NCT03530293|12024692|FG000|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||0
10858484|NCT03530293|12024693|FG001|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||17
10858485|NCT03530293|12024694|FG002|NOT COMPLETED|Randomized Withdrawal Period / Follow-up||17
10858486|NCT03505749|12024703|FG000|STARTED|Overall Study||38
10858487|NCT03505749|12024704|FG001|STARTED|Overall Study||45
10858488|NCT03505749|12024703|FG000|COMPLETED|Overall Study||22
10858489|NCT03505749|12024704|FG001|COMPLETED|Overall Study||28
10858490|NCT03505749|12024703|FG000|NOT COMPLETED|Overall Study||16
10858491|NCT03505749|12024704|FG001|NOT COMPLETED|Overall Study||17
11107438|NCT01263197|12291854|FG000|COMPLETED|Washout Period 1||8
11107439|NCT01263197|12291855|FG001|COMPLETED|Washout Period 1||8
11107440|NCT01263197|12291856|FG002|COMPLETED|Washout Period 1||8
11107441|NCT01263197|12291857|FG003|COMPLETED|Washout Period 1||8
11107442|NCT01263197|12291858|FG004|COMPLETED|Washout Period 1||7
10858497|NCT03311269|12024719|FG000|STARTED|Overall Study||10
10858498|NCT03311269|12024720|FG001|STARTED|Overall Study||9
10858499|NCT03311269|12024719|FG000|COMPLETED|Overall Study||10
10858500|NCT03311269|12024720|FG001|COMPLETED|Overall Study||9
10858501|NCT03311269|12024719|FG000|NOT COMPLETED|Overall Study||0
10858502|NCT03311269|12024720|FG001|NOT COMPLETED|Overall Study||0
10858503|NCT03249376|12024728|FG000|STARTED|Overall Study|191 patients were randomized but only 188 patients received study drug. The number completed and discontinued is based on the 188 patients that received study drug.|188
10858504|NCT03249376|12024729|FG001|STARTED|Overall Study|190 patients were randomized but only 189 patients received study drug. The number completed and discontinued is based on the 189 patients that received study drug.|189
10858505|NCT03249376|12024728|FG000|COMPLETED|Overall Study||167
10858506|NCT03249376|12024729|FG001|COMPLETED|Overall Study||166
10858507|NCT03249376|12024728|FG000|NOT COMPLETED|Overall Study||21
10858508|NCT03249376|12024729|FG001|NOT COMPLETED|Overall Study||23
10858509|NCT03137381|12024739|FG000|STARTED|Overall Study||44
10858510|NCT03137381|12024740|FG001|STARTED|Overall Study||30
10858511|NCT03137381|12024741|FG002|STARTED|Overall Study||38
10858512|NCT03137381|12024742|FG003|STARTED|Overall Study||37
10858513|NCT03137381|12024739|FG000|Safety Population|Overall Study||44
10858514|NCT03137381|12024740|FG001|Safety Population|Overall Study||29
10858515|NCT03137381|12024741|FG002|Safety Population|Overall Study||38
10858516|NCT03137381|12024742|FG003|Safety Population|Overall Study||36
10858517|NCT03137381|12024739|FG000|COMPLETED|Overall Study||35
10858518|NCT03137381|12024740|FG001|COMPLETED|Overall Study||23
10858519|NCT03137381|12024741|FG002|COMPLETED|Overall Study||30
10858520|NCT03137381|12024742|FG003|COMPLETED|Overall Study||36
10858521|NCT03137381|12024739|FG000|NOT COMPLETED|Overall Study||9
10858522|NCT03137381|12024740|FG001|NOT COMPLETED|Overall Study||7
10858523|NCT03137381|12024741|FG002|NOT COMPLETED|Overall Study||8
10858524|NCT03137381|12024742|FG003|NOT COMPLETED|Overall Study||1
10858525|NCT03118570|12024757|FG000|STARTED|Overall Study||31
10858526|NCT03118570|12024758|FG001|STARTED|Overall Study||29
10858527|NCT03118570|12024759|FG002|STARTED|Overall Study||30
10858528|NCT03118570|12024760|FG003|STARTED|Overall Study||2
10858529|NCT03118570|12024761|FG004|STARTED|Overall Study||20
10858530|NCT03118570|12024757|FG000|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
10858531|NCT03118570|12024758|FG001|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
10858532|NCT03118570|12024759|FG002|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
10858533|NCT03118570|12024760|FG003|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
10858534|NCT03118570|12024761|FG004|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||19
10858535|NCT03118570|12024757|FG000|COMPLETED|Overall Study||26
10858536|NCT03118570|12024758|FG001|COMPLETED|Overall Study||22
10858537|NCT03118570|12024759|FG002|COMPLETED|Overall Study||25
10858538|NCT03118570|12024760|FG003|COMPLETED|Overall Study||2
10858539|NCT03118570|12024761|FG004|COMPLETED|Overall Study||15
10858540|NCT03118570|12024757|FG000|NOT COMPLETED|Overall Study||5
10858541|NCT03118570|12024758|FG001|NOT COMPLETED|Overall Study||7
10858542|NCT03118570|12024759|FG002|NOT COMPLETED|Overall Study||5
10858543|NCT03118570|12024760|FG003|NOT COMPLETED|Overall Study||0
10858544|NCT03118570|12024761|FG004|NOT COMPLETED|Overall Study||5
10858545|NCT03094416|12024774|FG000|STARTED|Run-in||66
10858546|NCT03094416|12024774|FG000|COMPLETED|Run-in||47
10858547|NCT03094416|12024774|FG000|NOT COMPLETED|Run-in||19
10858548|NCT03094416|12024774|FG000|STARTED|Treatment Period||47
10858549|NCT03094416|12024774|FG000|COMPLETED|Treatment Period||45
10858550|NCT03094416|12024774|FG000|NOT COMPLETED|Treatment Period||2
10858551|NCT02933671|12024781|FG000|STARTED|Overall Study||5
10858552|NCT02933671|12024782|FG001|STARTED|Overall Study||5
10858553|NCT02933671|12024781|FG000|COMPLETED|Overall Study||5
10858554|NCT02933671|12024782|FG001|COMPLETED|Overall Study||5
10858555|NCT02933671|12024781|FG000|NOT COMPLETED|Overall Study||0
10858556|NCT02933671|12024782|FG001|NOT COMPLETED|Overall Study||0
10858557|NCT02734667|12024790|FG000|STARTED|Overall Study||84
10858558|NCT02734667|12024791|FG001|STARTED|Overall Study||36
10858559|NCT02734667|12024790|FG000|Youth|Overall Study||42
10858560|NCT02734667|12024791|FG001|Youth|Overall Study||18
10858561|NCT02734667|12024790|FG000|Parent|Overall Study||42
10858562|NCT02734667|12024791|FG001|Parent|Overall Study||18
10858563|NCT02734667|12024790|FG000|COMPLETED|Overall Study||82
10858564|NCT02734667|12024791|FG001|COMPLETED|Overall Study||30
10858565|NCT02734667|12024790|FG000|NOT COMPLETED|Overall Study||2
10858566|NCT02734667|12024791|FG001|NOT COMPLETED|Overall Study||6
10858567|NCT02709317|12024799|FG000|STARTED|Overall Study||50
10858568|NCT02709317|12024800|FG001|STARTED|Overall Study||58
10858569|NCT02709317|12024799|FG000|COMPLETED|Overall Study||18
10858570|NCT02709317|12024800|FG001|COMPLETED|Overall Study||31
10858571|NCT02709317|12024799|FG000|NOT COMPLETED|Overall Study||32
10858572|NCT02709317|12024800|FG001|NOT COMPLETED|Overall Study||27
10858573|NCT02607930|12024808|FG000|STARTED|Double-Blinded Treatment Phase||316
10858574|NCT02607930|12024809|FG001|STARTED|Double-Blinded Treatment Phase||315
10858575|NCT02607930|12024810|FG002|STARTED|Double-Blinded Treatment Phase||0
10858576|NCT02607930|12024811|FG003|STARTED|Double-Blinded Treatment Phase||0
10858577|NCT02607930|12024808|FG000|COMPLETED|Double-Blinded Treatment Phase||262
10858578|NCT02607930|12024809|FG001|COMPLETED|Double-Blinded Treatment Phase||262
10858579|NCT02607930|12024810|FG002|COMPLETED|Double-Blinded Treatment Phase||0
10858580|NCT02607930|12024811|FG003|COMPLETED|Double-Blinded Treatment Phase||0
10858581|NCT02607930|12024808|FG000|NOT COMPLETED|Double-Blinded Treatment Phase||54
10858582|NCT02607930|12024809|FG001|NOT COMPLETED|Double-Blinded Treatment Phase||53
10858583|NCT02607930|12024810|FG002|NOT COMPLETED|Double-Blinded Treatment Phase||0
10858584|NCT02607930|12024811|FG003|NOT COMPLETED|Double-Blinded Treatment Phase||0
10858585|NCT02607930|12024808|FG000|STARTED|Open-Label B/F/TAF Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
10858586|NCT02607930|12024809|FG001|STARTED|Open-Label B/F/TAF Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
10858587|NCT02607930|12024810|FG002|STARTED|Open-Label B/F/TAF Extension Phase|10 participants from B/F/TAF arm did not enter the Open-Label Extension Phase.|252
10858588|NCT02607930|12024811|FG003|STARTED|Open-Label B/F/TAF Extension Phase|8 participants from the ABC/DTG/3TC arm did not enter the Open-Label Extension Phase.|254
10858589|NCT02607930|12024808|FG000|COMPLETED|Open-Label B/F/TAF Extension Phase||0
10858590|NCT02607930|12024809|FG001|COMPLETED|Open-Label B/F/TAF Extension Phase||0
10858591|NCT02607930|12024810|FG002|COMPLETED|Open-Label B/F/TAF Extension Phase||218
10858592|NCT02607930|12024811|FG003|COMPLETED|Open-Label B/F/TAF Extension Phase||221
10858593|NCT02607930|12024808|FG000|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||0
10858594|NCT02607930|12024809|FG001|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||0
10858595|NCT02607930|12024810|FG002|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||34
10858596|NCT02607930|12024811|FG003|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||33
11107443|NCT01263197|12291859|FG005|COMPLETED|Washout Period 1||7
11107444|NCT01263197|12291854|FG000|NOT COMPLETED|Washout Period 1||0
11107445|NCT01263197|12291855|FG001|NOT COMPLETED|Washout Period 1||0
11107446|NCT01263197|12291856|FG002|NOT COMPLETED|Washout Period 1||0
11107447|NCT01263197|12291857|FG003|NOT COMPLETED|Washout Period 1||0
11107448|NCT01263197|12291858|FG004|NOT COMPLETED|Washout Period 1||1
11107449|NCT01263197|12291859|FG005|NOT COMPLETED|Washout Period 1||0
11107450|NCT01263197|12291854|FG000|STARTED|Second Intervention (Period 2)||8
11107451|NCT01263197|12291855|FG001|STARTED|Second Intervention (Period 2)||8
11107452|NCT01263197|12291856|FG002|STARTED|Second Intervention (Period 2)||8
11107453|NCT01263197|12291857|FG003|STARTED|Second Intervention (Period 2)||8
11107454|NCT01263197|12291858|FG004|STARTED|Second Intervention (Period 2)||7
11107455|NCT01263197|12291859|FG005|STARTED|Second Intervention (Period 2)||7
11107456|NCT01263197|12291854|FG000|COMPLETED|Second Intervention (Period 2)||8
11107457|NCT01263197|12291855|FG001|COMPLETED|Second Intervention (Period 2)||8
11107458|NCT01263197|12291856|FG002|COMPLETED|Second Intervention (Period 2)||8
11107459|NCT01263197|12291857|FG003|COMPLETED|Second Intervention (Period 2)||8
11107460|NCT01263197|12291858|FG004|COMPLETED|Second Intervention (Period 2)||7
11107461|NCT01263197|12291859|FG005|COMPLETED|Second Intervention (Period 2)||7
11107462|NCT01263197|12291854|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
11107463|NCT01263197|12291855|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
11107464|NCT01263197|12291856|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
11107465|NCT01263197|12291857|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
11107466|NCT01263197|12291858|FG004|NOT COMPLETED|Second Intervention (Period 2)||0
10858625|NCT02476201|12024852|FG000|STARTED|Overall Study||105
10858626|NCT02476201|12024852|FG000|Implant Attempts|Overall Study||103
10858627|NCT02476201|12024852|FG000|Sucessful Implants|Overall Study||102
10858628|NCT02476201|12024852|FG000|6 Months Visit|Overall Study||82
10858629|NCT02476201|12024852|FG000|COMPLETED|Overall Study||79
10858630|NCT02476201|12024852|FG000|NOT COMPLETED|Overall Study||26
10858631|NCT01399658|12024857|FG000|STARTED|Overall Study||93
10858632|NCT01399658|12024857|FG000|COMPLETED|Overall Study||87
10858633|NCT01399658|12024857|FG000|NOT COMPLETED|Overall Study||6
10858634|NCT01397968|12024863|FG000|STARTED|Double-blind Period of Study YKP3089C013||113
10858635|NCT01397968|12024864|FG001|STARTED|Double-blind Period of Study YKP3089C013||109
10858636|NCT01397968|12024863|FG000|COMPLETED|Double-blind Period of Study YKP3089C013||102
10858637|NCT01397968|12024864|FG001|COMPLETED|Double-blind Period of Study YKP3089C013||99
10858638|NCT01397968|12024863|FG000|NOT COMPLETED|Double-blind Period of Study YKP3089C013||11
10858639|NCT01397968|12024864|FG001|NOT COMPLETED|Double-blind Period of Study YKP3089C013||10
10858640|NCT01397968|12024863|FG000|STARTED|Open-label Extension Study YKP3089C013|Not all subjects from double-blind rolled over to open-label.|76
10858641|NCT01397968|12024864|FG001|STARTED|Open-label Extension Study YKP3089C013|Not all subjects from double-blind rolled over to open-label.|73
10858642|NCT01397968|12024863|FG000|COMPLETED|Open-label Extension Study YKP3089C013||40
10858643|NCT01397968|12024864|FG001|COMPLETED|Open-label Extension Study YKP3089C013||37
10858644|NCT01397968|12024863|FG000|NOT COMPLETED|Open-label Extension Study YKP3089C013||36
10858645|NCT01397968|12024864|FG001|NOT COMPLETED|Open-label Extension Study YKP3089C013||36
10858646|NCT01365195|12024875|FG000|STARTED|Overall Study||6
10858647|NCT01365195|12024876|FG001|STARTED|Overall Study||8
10858648|NCT01365195|12024877|FG002|STARTED|Overall Study||7
10858649|NCT01365195|12024875|FG000|COMPLETED|Overall Study||6
10858650|NCT01365195|12024876|FG001|COMPLETED|Overall Study||8
10858651|NCT01365195|12024877|FG002|COMPLETED|Overall Study||7
10858652|NCT01365195|12024875|FG000|NOT COMPLETED|Overall Study||0
10858653|NCT01365195|12024876|FG001|NOT COMPLETED|Overall Study||0
10858654|NCT01365195|12024877|FG002|NOT COMPLETED|Overall Study||0
10858655|NCT00966953|12024889|FG000|STARTED|1st Intervention||6
10858656|NCT00966953|12024890|FG001|STARTED|1st Intervention||6
10858657|NCT00966953|12024891|FG002|STARTED|1st Intervention||6
10858658|NCT00966953|12024892|FG003|STARTED|1st Intervention||7
10858659|NCT00966953|12024889|FG000|COMPLETED|1st Intervention||6
10858660|NCT00966953|12024890|FG001|COMPLETED|1st Intervention||6
10858661|NCT00966953|12024891|FG002|COMPLETED|1st Intervention||6
10858662|NCT00966953|12024892|FG003|COMPLETED|1st Intervention||7
10858663|NCT00966953|12024889|FG000|NOT COMPLETED|1st Intervention||0
10858664|NCT00966953|12024890|FG001|NOT COMPLETED|1st Intervention||0
10858665|NCT00966953|12024891|FG002|NOT COMPLETED|1st Intervention||0
10858666|NCT00966953|12024892|FG003|NOT COMPLETED|1st Intervention||0
10858667|NCT00966953|12024889|FG000|STARTED|1 Week Washout After 1st Intervention||6
10858668|NCT00966953|12024890|FG001|STARTED|1 Week Washout After 1st Intervention||6
10858669|NCT00966953|12024891|FG002|STARTED|1 Week Washout After 1st Intervention||6
10858670|NCT00966953|12024892|FG003|STARTED|1 Week Washout After 1st Intervention||7
10858671|NCT00966953|12024889|FG000|COMPLETED|1 Week Washout After 1st Intervention||6
10858672|NCT00966953|12024890|FG001|COMPLETED|1 Week Washout After 1st Intervention||6
10858673|NCT00966953|12024891|FG002|COMPLETED|1 Week Washout After 1st Intervention||6
10858674|NCT00966953|12024892|FG003|COMPLETED|1 Week Washout After 1st Intervention||7
10858675|NCT00966953|12024889|FG000|NOT COMPLETED|1 Week Washout After 1st Intervention||0
10858676|NCT00966953|12024890|FG001|NOT COMPLETED|1 Week Washout After 1st Intervention||0
10858677|NCT00966953|12024891|FG002|NOT COMPLETED|1 Week Washout After 1st Intervention||0
10858678|NCT00966953|12024892|FG003|NOT COMPLETED|1 Week Washout After 1st Intervention||0
10858679|NCT00966953|12024889|FG000|STARTED|2nd Intervention||6
10858680|NCT00966953|12024890|FG001|STARTED|2nd Intervention||6
10858681|NCT00966953|12024891|FG002|STARTED|2nd Intervention||6
10858682|NCT00966953|12024892|FG003|STARTED|2nd Intervention||7
10858683|NCT00966953|12024889|FG000|COMPLETED|2nd Intervention||6
10858684|NCT00966953|12024890|FG001|COMPLETED|2nd Intervention||6
10858685|NCT00966953|12024891|FG002|COMPLETED|2nd Intervention||6
10858686|NCT00966953|12024892|FG003|COMPLETED|2nd Intervention||7
10858687|NCT00966953|12024889|FG000|NOT COMPLETED|2nd Intervention||0
10858688|NCT00966953|12024890|FG001|NOT COMPLETED|2nd Intervention||0
10858689|NCT00966953|12024891|FG002|NOT COMPLETED|2nd Intervention||0
10858690|NCT00966953|12024892|FG003|NOT COMPLETED|2nd Intervention||0
10858691|NCT00966953|12024889|FG000|STARTED|1 Week Washout After 2nd Intervention||6
10858692|NCT00966953|12024890|FG001|STARTED|1 Week Washout After 2nd Intervention||6
10858693|NCT00966953|12024891|FG002|STARTED|1 Week Washout After 2nd Intervention||6
10858694|NCT00966953|12024892|FG003|STARTED|1 Week Washout After 2nd Intervention||7
10858695|NCT00966953|12024889|FG000|COMPLETED|1 Week Washout After 2nd Intervention||6
10858696|NCT00966953|12024890|FG001|COMPLETED|1 Week Washout After 2nd Intervention||6
10858697|NCT00966953|12024891|FG002|COMPLETED|1 Week Washout After 2nd Intervention||6
10858698|NCT00966953|12024892|FG003|COMPLETED|1 Week Washout After 2nd Intervention||7
10858699|NCT00966953|12024889|FG000|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
10858700|NCT00966953|12024890|FG001|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
10858701|NCT00966953|12024891|FG002|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
10858702|NCT00966953|12024892|FG003|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
10858703|NCT00966953|12024889|FG000|STARTED|3rd Intervention Order||6
10858704|NCT00966953|12024890|FG001|STARTED|3rd Intervention Order||6
10858705|NCT00966953|12024891|FG002|STARTED|3rd Intervention Order||6
10858706|NCT00966953|12024892|FG003|STARTED|3rd Intervention Order||7
10858707|NCT00966953|12024889|FG000|COMPLETED|3rd Intervention Order||6
10858708|NCT00966953|12024890|FG001|COMPLETED|3rd Intervention Order||6
10858709|NCT00966953|12024891|FG002|COMPLETED|3rd Intervention Order||6
10858710|NCT00966953|12024892|FG003|COMPLETED|3rd Intervention Order||7
10858711|NCT00966953|12024889|FG000|NOT COMPLETED|3rd Intervention Order||0
10858712|NCT00966953|12024890|FG001|NOT COMPLETED|3rd Intervention Order||0
10858713|NCT00966953|12024891|FG002|NOT COMPLETED|3rd Intervention Order||0
10858714|NCT00966953|12024892|FG003|NOT COMPLETED|3rd Intervention Order||0
10858715|NCT00966953|12024889|FG000|STARTED|1 Week Washout After 3rd Intervention||6
10858716|NCT00966953|12024890|FG001|STARTED|1 Week Washout After 3rd Intervention||6
10858717|NCT00966953|12024891|FG002|STARTED|1 Week Washout After 3rd Intervention||6
10858718|NCT00966953|12024892|FG003|STARTED|1 Week Washout After 3rd Intervention||7
10858719|NCT00966953|12024889|FG000|COMPLETED|1 Week Washout After 3rd Intervention||6
10858720|NCT00966953|12024890|FG001|COMPLETED|1 Week Washout After 3rd Intervention||6
10858721|NCT00966953|12024891|FG002|COMPLETED|1 Week Washout After 3rd Intervention||6
10858722|NCT00966953|12024892|FG003|COMPLETED|1 Week Washout After 3rd Intervention||7
10858723|NCT00966953|12024889|FG000|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
10858724|NCT00966953|12024890|FG001|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
10858725|NCT00966953|12024891|FG002|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
10858726|NCT00966953|12024892|FG003|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
10858727|NCT00966953|12024889|FG000|STARTED|4th Intervention Order||6
10858728|NCT00966953|12024890|FG001|STARTED|4th Intervention Order||6
10858729|NCT00966953|12024891|FG002|STARTED|4th Intervention Order||6
10858730|NCT00966953|12024892|FG003|STARTED|4th Intervention Order||7
10858731|NCT00966953|12024889|FG000|COMPLETED|4th Intervention Order||6
11226742|NCT01998958|12418872|FG025|COMPLETED|Open Label Phase (Optional)||7
11226743|NCT01998958|12418873|FG026|COMPLETED|Open Label Phase (Optional)||19
11226744|NCT01998958|12418874|FG027|COMPLETED|Open Label Phase (Optional)||0
11226745|NCT01998958|12418875|FG028|COMPLETED|Open Label Phase (Optional)||0
11226746|NCT01998958|12418876|FG029|COMPLETED|Open Label Phase (Optional)||0
11226747|NCT01998958|12418877|FG030|COMPLETED|Open Label Phase (Optional)||0
11226748|NCT01998958|12418878|FG031|COMPLETED|Open Label Phase (Optional)||0
11226749|NCT01998958|12418847|FG000|NOT COMPLETED|Open Label Phase (Optional)||0
11226750|NCT01998958|12418848|FG001|NOT COMPLETED|Open Label Phase (Optional)||0
11226751|NCT01998958|12418849|FG002|NOT COMPLETED|Open Label Phase (Optional)||0
11226752|NCT01998958|12418850|FG003|NOT COMPLETED|Open Label Phase (Optional)||0
11226753|NCT01998958|12418851|FG004|NOT COMPLETED|Open Label Phase (Optional)||0
11226754|NCT01998958|12418852|FG005|NOT COMPLETED|Open Label Phase (Optional)||0
11226755|NCT01998958|12418853|FG006|NOT COMPLETED|Open Label Phase (Optional)||0
11226756|NCT01998958|12418854|FG007|NOT COMPLETED|Open Label Phase (Optional)||0
11226757|NCT01998958|12418855|FG008|NOT COMPLETED|Open Label Phase (Optional)||0
11226758|NCT01998958|12418856|FG009|NOT COMPLETED|Open Label Phase (Optional)||0
11226759|NCT01998958|12418857|FG010|NOT COMPLETED|Open Label Phase (Optional)||0
11226760|NCT01998958|12418858|FG011|NOT COMPLETED|Open Label Phase (Optional)||0
11226761|NCT01998958|12418859|FG012|NOT COMPLETED|Open Label Phase (Optional)||0
11226762|NCT01998958|12418860|FG013|NOT COMPLETED|Open Label Phase (Optional)||0
11226763|NCT01998958|12418861|FG014|NOT COMPLETED|Open Label Phase (Optional)||0
11226764|NCT01998958|12418862|FG015|NOT COMPLETED|Open Label Phase (Optional)||0
11226765|NCT01998958|12418863|FG016|NOT COMPLETED|Open Label Phase (Optional)||0
11226766|NCT01998958|12418864|FG017|NOT COMPLETED|Open Label Phase (Optional)||0
11226767|NCT01998958|12418865|FG018|NOT COMPLETED|Open Label Phase (Optional)||0
11226768|NCT01998958|12418866|FG019|NOT COMPLETED|Open Label Phase (Optional)||0
11226769|NCT01998958|12418867|FG020|NOT COMPLETED|Open Label Phase (Optional)||0
11226770|NCT01998958|12418868|FG021|NOT COMPLETED|Open Label Phase (Optional)||3
11226771|NCT01998958|12418869|FG022|NOT COMPLETED|Open Label Phase (Optional)||9
11226772|NCT01998958|12418870|FG023|NOT COMPLETED|Open Label Phase (Optional)||4
11226773|NCT01998958|12418871|FG024|NOT COMPLETED|Open Label Phase (Optional)||0
11226774|NCT01998958|12418872|FG025|NOT COMPLETED|Open Label Phase (Optional)||0
11226775|NCT01998958|12418873|FG026|NOT COMPLETED|Open Label Phase (Optional)||0
11226776|NCT01998958|12418874|FG027|NOT COMPLETED|Open Label Phase (Optional)||0
11226777|NCT01998958|12418875|FG028|NOT COMPLETED|Open Label Phase (Optional)||0
11226778|NCT01998958|12418876|FG029|NOT COMPLETED|Open Label Phase (Optional)||0
11226779|NCT01998958|12418877|FG030|NOT COMPLETED|Open Label Phase (Optional)||0
10858732|NCT00966953|12024890|FG001|COMPLETED|4th Intervention Order||6
11226780|NCT01998958|12418878|FG031|NOT COMPLETED|Open Label Phase (Optional)||0
10858733|NCT00966953|12024891|FG002|COMPLETED|4th Intervention Order||6
10858734|NCT00966953|12024892|FG003|COMPLETED|4th Intervention Order||7
10858735|NCT00966953|12024889|FG000|NOT COMPLETED|4th Intervention Order||0
10858736|NCT00966953|12024890|FG001|NOT COMPLETED|4th Intervention Order||0
10858737|NCT00966953|12024891|FG002|NOT COMPLETED|4th Intervention Order||0
10858738|NCT00966953|12024892|FG003|NOT COMPLETED|4th Intervention Order||0
10858739|NCT00961805|12024900|FG000|STARTED|Overall Study||40
10858740|NCT00961805|12024901|FG001|STARTED|Overall Study||40
10858741|NCT00961805|12024900|FG000|COMPLETED|Overall Study||40
10858742|NCT00961805|12024901|FG001|COMPLETED|Overall Study||40
10858743|NCT00961805|12024900|FG000|NOT COMPLETED|Overall Study||0
10858744|NCT00961805|12024901|FG001|NOT COMPLETED|Overall Study||0
10858745|NCT00950937|12024907|FG000|STARTED|Overall Study||14
10858746|NCT00950937|12024908|FG001|STARTED|Overall Study||14
10858747|NCT00950937|12024907|FG000|COMPLETED|Overall Study||14
10858748|NCT00950937|12024908|FG001|COMPLETED|Overall Study||14
10858749|NCT00950937|12024907|FG000|NOT COMPLETED|Overall Study||0
10858750|NCT00950937|12024908|FG001|NOT COMPLETED|Overall Study||0
10858751|NCT00948753|12024915|FG000|STARTED|Phase 1||7
10858752|NCT00948753|12024916|FG001|STARTED|Phase 1||6
10858753|NCT00948753|12024917|FG002|STARTED|Phase 1||0
10858754|NCT00948753|12024915|FG000|COMPLETED|Phase 1||7
10858755|NCT00948753|12024916|FG001|COMPLETED|Phase 1||6
10858756|NCT00948753|12024917|FG002|COMPLETED|Phase 1||0
10858757|NCT00948753|12024915|FG000|NOT COMPLETED|Phase 1||0
10858758|NCT00948753|12024916|FG001|NOT COMPLETED|Phase 1||0
10858759|NCT00948753|12024917|FG002|NOT COMPLETED|Phase 1||0
10858760|NCT00948753|12024915|FG000|STARTED|Phase 2||0
10858761|NCT00948753|12024916|FG001|STARTED|Phase 2||0
10858762|NCT00948753|12024917|FG002|STARTED|Phase 2||25
10858763|NCT00948753|12024915|FG000|COMPLETED|Phase 2||0
10858764|NCT00948753|12024916|FG001|COMPLETED|Phase 2||0
10858765|NCT00948753|12024917|FG002|COMPLETED|Phase 2||25
10858766|NCT00948753|12024915|FG000|NOT COMPLETED|Phase 2||0
10858767|NCT00948753|12024916|FG001|NOT COMPLETED|Phase 2||0
10858768|NCT00948753|12024917|FG002|NOT COMPLETED|Phase 2||0
10858769|NCT00947518|12024929|FG000|STARTED|Overall Study||20
10858770|NCT00947518|12024930|FG001|STARTED|Overall Study||20
10858771|NCT00947518|12024931|FG002|STARTED|Overall Study||20
10858772|NCT00947518|12024929|FG000|COMPLETED|Overall Study||20
10858773|NCT00947518|12024930|FG001|COMPLETED|Overall Study||20
10858774|NCT00947518|12024931|FG002|COMPLETED|Overall Study||20
10858775|NCT00947518|12024929|FG000|NOT COMPLETED|Overall Study||0
10858776|NCT00947518|12024930|FG001|NOT COMPLETED|Overall Study||0
10858777|NCT00947518|12024931|FG002|NOT COMPLETED|Overall Study||0
11226781|NCT01998958|12418847|FG000|STARTED|Follow-up Phase||0
11226782|NCT01998958|12418848|FG001|STARTED|Follow-up Phase||0
11226783|NCT01998958|12418849|FG002|STARTED|Follow-up Phase||0
11226784|NCT01998958|12418850|FG003|STARTED|Follow-up Phase||0
11226785|NCT01998958|12418851|FG004|STARTED|Follow-up Phase||0
11226786|NCT01998958|12418852|FG005|STARTED|Follow-up Phase||0
11226787|NCT01998958|12418853|FG006|STARTED|Follow-up Phase||0
11226788|NCT01998958|12418854|FG007|STARTED|Follow-up Phase||0
11226789|NCT01998958|12418855|FG008|STARTED|Follow-up Phase||0
11226790|NCT01998958|12418856|FG009|STARTED|Follow-up Phase||0
11226791|NCT01998958|12418857|FG010|STARTED|Follow-up Phase||0
11226792|NCT01998958|12418858|FG011|STARTED|Follow-up Phase||0
11226793|NCT01998958|12418859|FG012|STARTED|Follow-up Phase||0
11226794|NCT01998958|12418860|FG013|STARTED|Follow-up Phase||0
11226795|NCT01998958|12418861|FG014|STARTED|Follow-up Phase||0
11226796|NCT01998958|12418862|FG015|STARTED|Follow-up Phase||0
11226797|NCT01998958|12418863|FG016|STARTED|Follow-up Phase||0
11226798|NCT01998958|12418864|FG017|STARTED|Follow-up Phase||0
11226799|NCT01998958|12418865|FG018|STARTED|Follow-up Phase||0
11226800|NCT01998958|12418866|FG019|STARTED|Follow-up Phase||0
11226801|NCT01998958|12418867|FG020|STARTED|Follow-up Phase||0
11226802|NCT01998958|12418868|FG021|STARTED|Follow-up Phase||0
11107467|NCT01263197|12291859|FG005|NOT COMPLETED|Second Intervention (Period 2)||0
10858778|NCT00934921|12024938|FG000|STARTED|First Intervention||12
10858779|NCT00934921|12024939|FG001|STARTED|First Intervention||12
10858780|NCT00934921|12024938|FG000|COMPLETED|First Intervention||12
10858781|NCT00934921|12024939|FG001|COMPLETED|First Intervention||12
10858782|NCT00934921|12024938|FG000|NOT COMPLETED|First Intervention||0
10858783|NCT00934921|12024939|FG001|NOT COMPLETED|First Intervention||0
10858784|NCT00934921|12024938|FG000|STARTED|Second Intervention||12
10858785|NCT00934921|12024939|FG001|STARTED|Second Intervention||12
10858786|NCT00934921|12024938|FG000|COMPLETED|Second Intervention||12
10858787|NCT00934921|12024939|FG001|COMPLETED|Second Intervention||12
10858788|NCT00934921|12024938|FG000|NOT COMPLETED|Second Intervention||0
10858789|NCT00934921|12024939|FG001|NOT COMPLETED|Second Intervention||0
10858790|NCT00934180|12024945|FG000|STARTED|First Intervention||12
10858791|NCT00934180|12024946|FG001|STARTED|First Intervention||12
10858792|NCT00934180|12024945|FG000|COMPLETED|First Intervention||12
10858793|NCT00934180|12024946|FG001|COMPLETED|First Intervention||12
10858794|NCT00934180|12024945|FG000|NOT COMPLETED|First Intervention||0
10858795|NCT00934180|12024946|FG001|NOT COMPLETED|First Intervention||0
10858796|NCT00934180|12024945|FG000|STARTED|Second Intervention||12
11107468|NCT01263197|12291854|FG000|STARTED|Washout Period 2||8
11107469|NCT01263197|12291855|FG001|STARTED|Washout Period 2||8
11107470|NCT01263197|12291856|FG002|STARTED|Washout Period 2||8
11107471|NCT01263197|12291857|FG003|STARTED|Washout Period 2||8
11107472|NCT01263197|12291858|FG004|STARTED|Washout Period 2||7
11107473|NCT01263197|12291859|FG005|STARTED|Washout Period 2||7
11107474|NCT01263197|12291854|FG000|COMPLETED|Washout Period 2||8
10858797|NCT00934180|12024946|FG001|STARTED|Second Intervention||12
10858798|NCT00934180|12024945|FG000|COMPLETED|Second Intervention||12
10858799|NCT00934180|12024946|FG001|COMPLETED|Second Intervention||12
10858800|NCT00934180|12024945|FG000|NOT COMPLETED|Second Intervention||0
10858801|NCT00934180|12024946|FG001|NOT COMPLETED|Second Intervention||0
10858802|NCT00924833|12024953|FG000|STARTED|Overall Study||9
10858803|NCT00924833|12024954|FG001|STARTED|Overall Study||9
10858804|NCT00924833|12024955|FG002|STARTED|Overall Study||9
10858805|NCT00924833|12024953|FG000|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
10858806|NCT00924833|12024954|FG001|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
10858807|NCT00924833|12024955|FG002|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
10858808|NCT00924833|12024953|FG000|NOT COMPLETED|Overall Study||0
10858809|NCT00924833|12024954|FG001|NOT COMPLETED|Overall Study||0
10858810|NCT00924833|12024955|FG002|NOT COMPLETED|Overall Study||0
10858811|NCT00919893|12024962|FG000|STARTED|Overall Study||70
10858812|NCT00919893|12024963|FG001|STARTED|Overall Study||69
10858813|NCT00919893|12024962|FG000|COMPLETED|Overall Study||51
10858814|NCT00919893|12024963|FG001|COMPLETED|Overall Study||60
10858815|NCT00919893|12024962|FG000|NOT COMPLETED|Overall Study||19
10858816|NCT00919893|12024963|FG001|NOT COMPLETED|Overall Study||9
10858817|NCT00912158|12024970|FG000|STARTED|Overall Study||44
10858818|NCT00912158|12024971|FG001|STARTED|Overall Study||44
10858819|NCT00912158|12024972|FG002|STARTED|Overall Study||41
10858820|NCT00912158|12024970|FG000|COMPLETED|Overall Study||44
10858821|NCT00912158|12024971|FG001|COMPLETED|Overall Study||44
10858822|NCT00912158|12024972|FG002|COMPLETED|Overall Study||41
10858823|NCT00912158|12024970|FG000|NOT COMPLETED|Overall Study||0
10858824|NCT00912158|12024971|FG001|NOT COMPLETED|Overall Study||0
10858825|NCT00912158|12024972|FG002|NOT COMPLETED|Overall Study||0
10858826|NCT00911443|12024982|FG000|STARTED|Overall Study||97
10858827|NCT00911443|12024983|FG001|STARTED|Overall Study||97
10858828|NCT00911443|12024984|FG002|STARTED|Overall Study||98
10858829|NCT00911443|12024985|FG003|STARTED|Overall Study||99
10858830|NCT00911443|12024986|FG004|STARTED|Overall Study||97
10858831|NCT00911443|12024982|FG000|COMPLETED|Overall Study||97
10858832|NCT00911443|12024983|FG001|COMPLETED|Overall Study||97
10858833|NCT00911443|12024984|FG002|COMPLETED|Overall Study||98
10858834|NCT00911443|12024985|FG003|COMPLETED|Overall Study||99
10858835|NCT00911443|12024986|FG004|COMPLETED|Overall Study||97
10858836|NCT00911443|12024982|FG000|NOT COMPLETED|Overall Study||0
10858837|NCT00911443|12024983|FG001|NOT COMPLETED|Overall Study||0
10858838|NCT00911443|12024984|FG002|NOT COMPLETED|Overall Study||0
10858839|NCT00911443|12024985|FG003|NOT COMPLETED|Overall Study||0
10858840|NCT00911443|12024986|FG004|NOT COMPLETED|Overall Study||0
10858841|NCT00911274|12024995|FG000|STARTED|Period 1||27
10858842|NCT00911274|12024996|FG001|STARTED|Period 1||26
10858843|NCT00911274|12024995|FG000|COMPLETED|Period 1||27
10858844|NCT00911274|12024996|FG001|COMPLETED|Period 1||26
10858845|NCT00911274|12024995|FG000|NOT COMPLETED|Period 1||0
10858846|NCT00911274|12024996|FG001|NOT COMPLETED|Period 1||0
10858847|NCT00911274|12024995|FG000|STARTED|Period 2||27
10858848|NCT00911274|12024996|FG001|STARTED|Period 2||26
10858849|NCT00911274|12024995|FG000|COMPLETED|Period 2||27
10858850|NCT00911274|12024996|FG001|COMPLETED|Period 2||26
10858851|NCT00911274|12024995|FG000|NOT COMPLETED|Period 2||0
10858852|NCT00911274|12024996|FG001|NOT COMPLETED|Period 2||0
10858853|NCT00909753|12025002|FG000|STARTED|Period: First Intervention||46
10858854|NCT00909753|12025003|FG001|STARTED|Period: First Intervention||46
10858855|NCT00909753|12025002|FG000|COMPLETED|Period: First Intervention||46
10858856|NCT00909753|12025003|FG001|COMPLETED|Period: First Intervention||46
10858857|NCT00909753|12025002|FG000|NOT COMPLETED|Period: First Intervention||0
10858858|NCT00909753|12025003|FG001|NOT COMPLETED|Period: First Intervention||0
10858859|NCT00909753|12025002|FG000|STARTED|Period: Washout of 28 Days||46
10858860|NCT00909753|12025003|FG001|STARTED|Period: Washout of 28 Days||46
10858861|NCT00909753|12025002|FG000|COMPLETED|Period: Washout of 28 Days||44
10858862|NCT00909753|12025003|FG001|COMPLETED|Period: Washout of 28 Days||43
10858863|NCT00909753|12025002|FG000|NOT COMPLETED|Period: Washout of 28 Days||2
10858864|NCT00909753|12025003|FG001|NOT COMPLETED|Period: Washout of 28 Days||3
10858865|NCT00909753|12025002|FG000|STARTED|Period: Second Intervention||44
10858866|NCT00909753|12025003|FG001|STARTED|Period: Second Intervention||43
10858867|NCT00909753|12025002|FG000|COMPLETED|Period: Second Intervention||43
10858868|NCT00909753|12025003|FG001|COMPLETED|Period: Second Intervention||43
10858869|NCT00909753|12025002|FG000|NOT COMPLETED|Period: Second Intervention||1
10858870|NCT00909753|12025003|FG001|NOT COMPLETED|Period: Second Intervention||0
10858871|NCT00909649|12025009|FG000|STARTED|Overall Study||25
10858872|NCT00909649|12025010|FG001|STARTED|Overall Study||25
10858873|NCT00909649|12025009|FG000|COMPLETED|Overall Study||25
10858874|NCT00909649|12025010|FG001|COMPLETED|Overall Study||25
10858875|NCT00909649|12025009|FG000|NOT COMPLETED|Overall Study||0
10858876|NCT00909649|12025010|FG001|NOT COMPLETED|Overall Study||0
10858877|NCT00909610|12025016|FG000|STARTED|Period: First Intervention||40
10858878|NCT00909610|12025017|FG001|STARTED|Period: First Intervention||40
10858879|NCT00909610|12025016|FG000|COMPLETED|Period: First Intervention||40
10858880|NCT00909610|12025017|FG001|COMPLETED|Period: First Intervention||39
10858881|NCT00909610|12025016|FG000|NOT COMPLETED|Period: First Intervention||0
10858882|NCT00909610|12025017|FG001|NOT COMPLETED|Period: First Intervention||1
10858883|NCT00909610|12025016|FG000|STARTED|Period: Washout of 28 Days||40
10858884|NCT00909610|12025017|FG001|STARTED|Period: Washout of 28 Days||39
10858885|NCT00909610|12025016|FG000|COMPLETED|Period: Washout of 28 Days||37
10858886|NCT00909610|12025017|FG001|COMPLETED|Period: Washout of 28 Days||33
10858887|NCT00909610|12025016|FG000|NOT COMPLETED|Period: Washout of 28 Days||3
10858888|NCT00909610|12025017|FG001|NOT COMPLETED|Period: Washout of 28 Days||6
10858889|NCT00909610|12025016|FG000|STARTED|Period: Second Intervention||37
10858890|NCT00909610|12025017|FG001|STARTED|Period: Second Intervention||33
10858891|NCT00909610|12025016|FG000|COMPLETED|Period: Second Intervention||36
10858892|NCT00909610|12025017|FG001|COMPLETED|Period: Second Intervention||33
10858893|NCT00909610|12025016|FG000|NOT COMPLETED|Period: Second Intervention||1
10858894|NCT00909610|12025017|FG001|NOT COMPLETED|Period: Second Intervention||0
10858895|NCT00908648|12025024|FG000|STARTED|Overall Study||108
10858896|NCT00908648|12025025|FG001|STARTED|Overall Study||103
10858897|NCT00908648|12025024|FG000|COMPLETED|Overall Study||108
10858898|NCT00908648|12025025|FG001|COMPLETED|Overall Study||103
10858899|NCT00908648|12025024|FG000|NOT COMPLETED|Overall Study||0
10858900|NCT00908648|12025025|FG001|NOT COMPLETED|Overall Study||0
10858901|NCT00908128|12025031|FG000|STARTED|Period 1||20
10858902|NCT00908128|12025032|FG001|STARTED|Period 1||20
10858903|NCT00908128|12025031|FG000|COMPLETED|Period 1||20
10858904|NCT00908128|12025032|FG001|COMPLETED|Period 1||20
10858905|NCT00908128|12025031|FG000|NOT COMPLETED|Period 1||0
10858906|NCT00908128|12025032|FG001|NOT COMPLETED|Period 1||0
10858907|NCT00908128|12025031|FG000|STARTED|Period 2||20
10858908|NCT00908128|12025032|FG001|STARTED|Period 2||20
10858909|NCT00908128|12025031|FG000|COMPLETED|Period 2||20
10858910|NCT00908128|12025032|FG001|COMPLETED|Period 2||20
10858911|NCT00908128|12025031|FG000|NOT COMPLETED|Period 2||0
10858912|NCT00908128|12025032|FG001|NOT COMPLETED|Period 2||0
10858913|NCT00908128|12025031|FG000|STARTED|Period 3||20
10858914|NCT00908128|12025032|FG001|STARTED|Period 3||20
10858915|NCT00908128|12025031|FG000|COMPLETED|Period 3||20
10858916|NCT00908128|12025032|FG001|COMPLETED|Period 3||20
10858917|NCT00908128|12025031|FG000|NOT COMPLETED|Period 3||0
10858918|NCT00908128|12025032|FG001|NOT COMPLETED|Period 3||0
10858919|NCT00908128|12025031|FG000|STARTED|Period 4||20
10858920|NCT00908128|12025032|FG001|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
10858921|NCT00908128|12025031|FG000|COMPLETED|Period 4||20
10858922|NCT00908128|12025032|FG001|COMPLETED|Period 4||19
10858923|NCT00908128|12025031|FG000|NOT COMPLETED|Period 4||0
10858924|NCT00908128|12025032|FG001|NOT COMPLETED|Period 4||0
10858925|NCT00907907|12025038|FG000|STARTED|Period 1||20
10858926|NCT00907907|12025039|FG001|STARTED|Period 1||20
10858927|NCT00907907|12025038|FG000|COMPLETED|Period 1||20
10858928|NCT00907907|12025039|FG001|COMPLETED|Period 1||20
10858929|NCT00907907|12025038|FG000|NOT COMPLETED|Period 1||0
10858930|NCT00907907|12025039|FG001|NOT COMPLETED|Period 1||0
10858931|NCT00907907|12025038|FG000|STARTED|Period 2||20
10858932|NCT00907907|12025039|FG001|STARTED|Period 2||20
10858933|NCT00907907|12025038|FG000|COMPLETED|Period 2||20
10858934|NCT00907907|12025039|FG001|COMPLETED|Period 2||20
10858935|NCT00907907|12025038|FG000|NOT COMPLETED|Period 2||0
10858936|NCT00907907|12025039|FG001|NOT COMPLETED|Period 2||0
10858937|NCT00907907|12025038|FG000|STARTED|Period 3||20
10858938|NCT00907907|12025039|FG001|STARTED|Period 3||20
10858939|NCT00907907|12025038|FG000|COMPLETED|Period 3||20
10858940|NCT00907907|12025039|FG001|COMPLETED|Period 3||20
10858941|NCT00907907|12025038|FG000|NOT COMPLETED|Period 3||0
10858942|NCT00907907|12025039|FG001|NOT COMPLETED|Period 3||0
10858943|NCT00907907|12025038|FG000|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
10858944|NCT00907907|12025039|FG001|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
10858945|NCT00907907|12025038|FG000|COMPLETED|Period 4||19
10858946|NCT00907907|12025039|FG001|COMPLETED|Period 4||18
10858947|NCT00907907|12025038|FG000|NOT COMPLETED|Period 4||0
10858948|NCT00907907|12025039|FG001|NOT COMPLETED|Period 4||0
10858949|NCT00905606|12025045|FG000|STARTED|Period 1||15
10858950|NCT00905606|12025046|FG001|STARTED|Period 1||15
10858951|NCT00905606|12025045|FG000|COMPLETED|Period 1||15
10858952|NCT00905606|12025046|FG001|COMPLETED|Period 1||14
10858953|NCT00905606|12025045|FG000|NOT COMPLETED|Period 1||0
10858954|NCT00905606|12025046|FG001|NOT COMPLETED|Period 1||1
10858955|NCT00905606|12025045|FG000|STARTED|Washout||15
10858956|NCT00905606|12025046|FG001|STARTED|Washout||14
10858957|NCT00905606|12025045|FG000|COMPLETED|Washout||14
10858958|NCT00905606|12025046|FG001|COMPLETED|Washout||14
10858959|NCT00905606|12025045|FG000|NOT COMPLETED|Washout||1
10858960|NCT00905606|12025046|FG001|NOT COMPLETED|Washout||0
10858961|NCT00905606|12025045|FG000|STARTED|Period 2||14
10858962|NCT00905606|12025046|FG001|STARTED|Period 2||14
10858963|NCT00905606|12025045|FG000|COMPLETED|Period 2||14
10858964|NCT00905606|12025046|FG001|COMPLETED|Period 2||14
10858965|NCT00905606|12025045|FG000|NOT COMPLETED|Period 2||0
10858966|NCT00905606|12025046|FG001|NOT COMPLETED|Period 2||0
10858967|NCT00905567|12025052|FG000|STARTED|Period 1||12
10858968|NCT00905567|12025053|FG001|STARTED|Period 1||12
10858969|NCT00905567|12025052|FG000|COMPLETED|Period 1||12
10858970|NCT00905567|12025053|FG001|COMPLETED|Period 1||12
10858971|NCT00905567|12025052|FG000|NOT COMPLETED|Period 1||0
10858972|NCT00905567|12025053|FG001|NOT COMPLETED|Period 1||0
10858973|NCT00905567|12025052|FG000|STARTED|Washout||12
10858974|NCT00905567|12025053|FG001|STARTED|Washout||12
10858975|NCT00905567|12025052|FG000|COMPLETED|Washout||12
10858976|NCT00905567|12025053|FG001|COMPLETED|Washout||11
10858977|NCT00905567|12025052|FG000|NOT COMPLETED|Washout||0
10858978|NCT00905567|12025053|FG001|NOT COMPLETED|Washout||1
10858979|NCT00905567|12025052|FG000|STARTED|Period 2||12
10858980|NCT00905567|12025053|FG001|STARTED|Period 2||11
10858981|NCT00905567|12025052|FG000|COMPLETED|Period 2||12
10858982|NCT00905567|12025053|FG001|COMPLETED|Period 2||11
10858983|NCT00905567|12025052|FG000|NOT COMPLETED|Period 2||0
10858984|NCT00905567|12025053|FG001|NOT COMPLETED|Period 2||0
10858985|NCT00905346|12025059|FG000|STARTED|Period 1||12
10858986|NCT00905346|12025060|FG001|STARTED|Period 1||12
10858987|NCT00905346|12025059|FG000|COMPLETED|Period 1||11
10858988|NCT00905346|12025060|FG001|COMPLETED|Period 1||12
10858989|NCT00905346|12025059|FG000|NOT COMPLETED|Period 1||1
10858990|NCT00905346|12025060|FG001|NOT COMPLETED|Period 1||0
10858991|NCT00905346|12025059|FG000|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
10858992|NCT00905346|12025060|FG001|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
10858993|NCT00905346|12025059|FG000|COMPLETED|Period 2||10
10858994|NCT00905346|12025060|FG001|COMPLETED|Period 2||11
10858995|NCT00905346|12025059|FG000|NOT COMPLETED|Period 2||0
10858996|NCT00905346|12025060|FG001|NOT COMPLETED|Period 2||0
10858997|NCT00905164|12025066|FG000|STARTED|Period 1||12
10858998|NCT00905164|12025067|FG001|STARTED|Period 1||12
10858999|NCT00905164|12025066|FG000|COMPLETED|Period 1||12
10859000|NCT00905164|12025067|FG001|COMPLETED|Period 1||11
10859001|NCT00905164|12025066|FG000|NOT COMPLETED|Period 1||0
10859002|NCT00905164|12025067|FG001|NOT COMPLETED|Period 1||1
10859003|NCT00905164|12025066|FG000|STARTED|Period 2||12
10859004|NCT00905164|12025067|FG001|STARTED|Period 2||11
10859005|NCT00905164|12025066|FG000|COMPLETED|Period 2||12
10859006|NCT00905164|12025067|FG001|COMPLETED|Period 2||11
10859007|NCT00905164|12025066|FG000|NOT COMPLETED|Period 2||0
10859008|NCT00905164|12025067|FG001|NOT COMPLETED|Period 2||0
10859009|NCT00904943|12025073|FG000|STARTED|Period 1||9
11226803|NCT01998958|12418869|FG022|STARTED|Follow-up Phase||0
11226804|NCT01998958|12418870|FG023|STARTED|Follow-up Phase||0
11226805|NCT01998958|12418871|FG024|STARTED|Follow-up Phase||0
11226806|NCT01998958|12418872|FG025|STARTED|Follow-up Phase||0
11226807|NCT01998958|12418873|FG026|STARTED|Follow-up Phase||0
11226808|NCT01998958|12418874|FG027|STARTED|Follow-up Phase||1
11226809|NCT01998958|12418875|FG028|STARTED|Follow-up Phase||4
11226810|NCT01998958|12418876|FG029|STARTED|Follow-up Phase||12
11226811|NCT01998958|12418877|FG030|STARTED|Follow-up Phase||39
11226812|NCT01998958|12418878|FG031|STARTED|Follow-up Phase||42
11226813|NCT01998958|12418847|FG000|COMPLETED|Follow-up Phase||0
11226814|NCT01998958|12418848|FG001|COMPLETED|Follow-up Phase||0
11226815|NCT01998958|12418849|FG002|COMPLETED|Follow-up Phase||0
11226816|NCT01998958|12418850|FG003|COMPLETED|Follow-up Phase||0
11226817|NCT01998958|12418851|FG004|COMPLETED|Follow-up Phase||0
11226818|NCT01998958|12418852|FG005|COMPLETED|Follow-up Phase||0
11226819|NCT01998958|12418853|FG006|COMPLETED|Follow-up Phase||0
11226820|NCT01998958|12418854|FG007|COMPLETED|Follow-up Phase||0
11226821|NCT01998958|12418855|FG008|COMPLETED|Follow-up Phase||0
11226822|NCT01998958|12418856|FG009|COMPLETED|Follow-up Phase||0
11226823|NCT01998958|12418857|FG010|COMPLETED|Follow-up Phase||0
11226824|NCT01998958|12418858|FG011|COMPLETED|Follow-up Phase||0
11226825|NCT01998958|12418859|FG012|COMPLETED|Follow-up Phase||0
11226826|NCT01998958|12418860|FG013|COMPLETED|Follow-up Phase||0
11226827|NCT01998958|12418861|FG014|COMPLETED|Follow-up Phase||0
11226828|NCT01998958|12418862|FG015|COMPLETED|Follow-up Phase||0
10859010|NCT00904943|12025074|FG001|STARTED|Period 1||9
10859011|NCT00904943|12025073|FG000|COMPLETED|Period 1||9
10859012|NCT00904943|12025074|FG001|COMPLETED|Period 1||9
10859013|NCT00904943|12025073|FG000|NOT COMPLETED|Period 1||0
10859014|NCT00904943|12025074|FG001|NOT COMPLETED|Period 1||0
10859015|NCT00904943|12025073|FG000|STARTED|Period 2||9
10859016|NCT00904943|12025074|FG001|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
10859017|NCT00904943|12025073|FG000|COMPLETED|Period 2||9
10859018|NCT00904943|12025074|FG001|COMPLETED|Period 2||8
10859019|NCT00904943|12025073|FG000|NOT COMPLETED|Period 2||0
10859020|NCT00904943|12025074|FG001|NOT COMPLETED|Period 2||0
10859021|NCT00890591|12025078|FG000|STARTED|Overall Study||144
10859022|NCT00890591|12025078|FG000|COMPLETED|Overall Study||124
10859023|NCT00890591|12025078|FG000|NOT COMPLETED|Overall Study||20
11226829|NCT01998958|12418863|FG016|COMPLETED|Follow-up Phase||0
10859024|NCT00890409|12025086|FG000|STARTED|Overall Study||116
10859025|NCT00890409|12025087|FG001|STARTED|Overall Study||140
10859026|NCT00890409|12025086|FG000|COMPLETED|Overall Study||96
10859027|NCT00890409|12025087|FG001|COMPLETED|Overall Study||119
10859028|NCT00890409|12025086|FG000|NOT COMPLETED|Overall Study||20
10859029|NCT00890409|12025087|FG001|NOT COMPLETED|Overall Study||21
11226830|NCT01998958|12418864|FG017|COMPLETED|Follow-up Phase||0
11226831|NCT01998958|12418865|FG018|COMPLETED|Follow-up Phase||0
11226832|NCT01998958|12418866|FG019|COMPLETED|Follow-up Phase||0
11226833|NCT01998958|12418867|FG020|COMPLETED|Follow-up Phase||0
11226834|NCT01998958|12418868|FG021|COMPLETED|Follow-up Phase||0
11226835|NCT01998958|12418869|FG022|COMPLETED|Follow-up Phase||0
11226836|NCT01998958|12418870|FG023|COMPLETED|Follow-up Phase||0
11226837|NCT01998958|12418871|FG024|COMPLETED|Follow-up Phase||0
11226838|NCT01998958|12418872|FG025|COMPLETED|Follow-up Phase||0
11226839|NCT01998958|12418873|FG026|COMPLETED|Follow-up Phase||0
11226840|NCT01998958|12418874|FG027|COMPLETED|Follow-up Phase||1
11226841|NCT01998958|12418875|FG028|COMPLETED|Follow-up Phase||4
11226842|NCT01998958|12418876|FG029|COMPLETED|Follow-up Phase||12
11226843|NCT01998958|12418877|FG030|COMPLETED|Follow-up Phase||39
11226844|NCT01998958|12418878|FG031|COMPLETED|Follow-up Phase||42
11226845|NCT01998958|12418847|FG000|NOT COMPLETED|Follow-up Phase||0
11226846|NCT01998958|12418848|FG001|NOT COMPLETED|Follow-up Phase||0
11226847|NCT01998958|12418849|FG002|NOT COMPLETED|Follow-up Phase||0
11226848|NCT01998958|12418850|FG003|NOT COMPLETED|Follow-up Phase||0
11226849|NCT01998958|12418851|FG004|NOT COMPLETED|Follow-up Phase||0
11226850|NCT01998958|12418852|FG005|NOT COMPLETED|Follow-up Phase||0
11226851|NCT01998958|12418853|FG006|NOT COMPLETED|Follow-up Phase||0
11226852|NCT01998958|12418854|FG007|NOT COMPLETED|Follow-up Phase||0
11226853|NCT01998958|12418855|FG008|NOT COMPLETED|Follow-up Phase||0
11226854|NCT01998958|12418856|FG009|NOT COMPLETED|Follow-up Phase||0
11226855|NCT01998958|12418857|FG010|NOT COMPLETED|Follow-up Phase||0
11226856|NCT01998958|12418858|FG011|NOT COMPLETED|Follow-up Phase||0
11226857|NCT01998958|12418859|FG012|NOT COMPLETED|Follow-up Phase||0
11226858|NCT01998958|12418860|FG013|NOT COMPLETED|Follow-up Phase||0
11226859|NCT01998958|12418861|FG014|NOT COMPLETED|Follow-up Phase||0
11226860|NCT01998958|12418862|FG015|NOT COMPLETED|Follow-up Phase||0
11226861|NCT01998958|12418863|FG016|NOT COMPLETED|Follow-up Phase||0
11226862|NCT01998958|12418864|FG017|NOT COMPLETED|Follow-up Phase||0
11226863|NCT01998958|12418865|FG018|NOT COMPLETED|Follow-up Phase||0
11226864|NCT01998958|12418866|FG019|NOT COMPLETED|Follow-up Phase||0
11226865|NCT01998958|12418867|FG020|NOT COMPLETED|Follow-up Phase||0
11226866|NCT01998958|12418868|FG021|NOT COMPLETED|Follow-up Phase||0
11226867|NCT01998958|12418869|FG022|NOT COMPLETED|Follow-up Phase||0
11226868|NCT01998958|12418870|FG023|NOT COMPLETED|Follow-up Phase||0
11226869|NCT01998958|12418871|FG024|NOT COMPLETED|Follow-up Phase||0
11226870|NCT01998958|12418872|FG025|NOT COMPLETED|Follow-up Phase||0
11226871|NCT01998958|12418873|FG026|NOT COMPLETED|Follow-up Phase||0
11226872|NCT01998958|12418874|FG027|NOT COMPLETED|Follow-up Phase||0
11226873|NCT01998958|12418875|FG028|NOT COMPLETED|Follow-up Phase||0
11226874|NCT01998958|12418876|FG029|NOT COMPLETED|Follow-up Phase||0
11226875|NCT01998958|12418877|FG030|NOT COMPLETED|Follow-up Phase||0
11226876|NCT01998958|12418878|FG031|NOT COMPLETED|Follow-up Phase||0
11226877|NCT01998984|12418932|FG000|STARTED|Overall Study||55
11226878|NCT01998984|12418933|FG001|STARTED|Overall Study||59
11226879|NCT01998984|12418934|FG002|STARTED|Overall Study||49
11226880|NCT01998984|12418935|FG003|STARTED|Overall Study||61
11226881|NCT01998984|12418932|FG000|COMPLETED|Overall Study||55
11354972|NCT03075904|12551903|FG000|STARTED|Overall Study||8
11354973|NCT03075904|12551903|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
11354974|NCT03075904|12551903|FG000|COMPLETED|Overall Study||4
11354975|NCT03075904|12551903|FG000|NOT COMPLETED|Overall Study||4
11354976|NCT03076190|12551909|FG000|STARTED|Overall Study||50
11354977|NCT03076190|12551910|FG001|STARTED|Overall Study||77
11354978|NCT03076190|12551909|FG000|COMPLETED|Overall Study||32
11354979|NCT03076190|12551910|FG001|COMPLETED|Overall Study||36
11226882|NCT01998984|12418933|FG001|COMPLETED|Overall Study||58
11226883|NCT01998984|12418934|FG002|COMPLETED|Overall Study||48
11226884|NCT01998984|12418935|FG003|COMPLETED|Overall Study||58
11226885|NCT01998984|12418932|FG000|NOT COMPLETED|Overall Study||0
10859030|NCT00888355|12025095|FG000|STARTED|Overall Study||108
10859031|NCT00888355|12025096|FG001|STARTED|Overall Study||108
10859032|NCT00888355|12025097|FG002|STARTED|Overall Study||106
10859033|NCT00888355|12025098|FG003|STARTED|Overall Study||106
10859034|NCT00888355|12025095|FG000|COMPLETED|Overall Study||86
10859035|NCT00888355|12025096|FG001|COMPLETED|Overall Study||99
10859036|NCT00888355|12025097|FG002|COMPLETED|Overall Study||94
10859037|NCT00888355|12025098|FG003|COMPLETED|Overall Study||96
10859038|NCT00888355|12025095|FG000|NOT COMPLETED|Overall Study||22
10859039|NCT00888355|12025096|FG001|NOT COMPLETED|Overall Study||9
10859040|NCT00888355|12025097|FG002|NOT COMPLETED|Overall Study||12
10859041|NCT00888355|12025098|FG003|NOT COMPLETED|Overall Study||10
10859042|NCT00887250|12025107|FG000|STARTED|Overall Study||116
10859043|NCT00887250|12025108|FG001|STARTED|Overall Study||127
10859044|NCT00887250|12025109|FG002|STARTED|Overall Study||123
10859045|NCT00887250|12025107|FG000|COMPLETED|Overall Study||98
10859046|NCT00887250|12025108|FG001|COMPLETED|Overall Study||115
10859047|NCT00887250|12025109|FG002|COMPLETED|Overall Study||110
10859048|NCT00887250|12025107|FG000|NOT COMPLETED|Overall Study||18
10859049|NCT00887250|12025108|FG001|NOT COMPLETED|Overall Study||12
10859050|NCT00887250|12025109|FG002|NOT COMPLETED|Overall Study||13
10859051|NCT00886600|12025118|FG000|STARTED|Double-blind Monotherapy||32
10859052|NCT00886600|12025119|FG001|STARTED|Double-blind Monotherapy||29
10859053|NCT00886600|12025120|FG002|STARTED|Double-blind Monotherapy||30
10859054|NCT00886600|12025121|FG003|STARTED|Double-blind Monotherapy||31
10859055|NCT00886600|12025118|FG000|COMPLETED|Double-blind Monotherapy||30
10859056|NCT00886600|12025119|FG001|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
10859057|NCT00886600|12025120|FG002|COMPLETED|Double-blind Monotherapy||29
10859058|NCT00886600|12025121|FG003|COMPLETED|Double-blind Monotherapy||29
10859059|NCT00886600|12025118|FG000|NOT COMPLETED|Double-blind Monotherapy||2
10859060|NCT00886600|12025119|FG001|NOT COMPLETED|Double-blind Monotherapy||1
10859061|NCT00886600|12025120|FG002|NOT COMPLETED|Double-blind Monotherapy||1
11226886|NCT01998984|12418933|FG001|NOT COMPLETED|Overall Study||1
11226887|NCT01998984|12418934|FG002|NOT COMPLETED|Overall Study||1
11226888|NCT01998984|12418935|FG003|NOT COMPLETED|Overall Study||3
11226889|NCT01999114|12418950|FG000|STARTED|Overall Study||66
11226890|NCT01999114|12418951|FG001|STARTED|Overall Study||66
11226891|NCT01999114|12418952|FG002|STARTED|Overall Study||66
11226892|NCT01999114|12418953|FG003|STARTED|Overall Study||65
11226893|NCT01999114|12418954|FG004|STARTED|Overall Study||65
11226894|NCT01999114|12418950|FG000|COMPLETED|Overall Study||58
11226895|NCT01999114|12418951|FG001|COMPLETED|Overall Study||59
11226896|NCT01999114|12418952|FG002|COMPLETED|Overall Study||61
11226897|NCT01999114|12418953|FG003|COMPLETED|Overall Study||62
11226898|NCT01999114|12418954|FG004|COMPLETED|Overall Study||61
11226899|NCT01999114|12418950|FG000|NOT COMPLETED|Overall Study||8
11226900|NCT01999114|12418951|FG001|NOT COMPLETED|Overall Study||7
11226901|NCT01999114|12418952|FG002|NOT COMPLETED|Overall Study||5
11226902|NCT01999114|12418953|FG003|NOT COMPLETED|Overall Study||3
11226903|NCT01999114|12418954|FG004|NOT COMPLETED|Overall Study||4
11226904|NCT01999192|12418984|FG000|STARTED|Main Phase I||83
11226905|NCT01999192|12418985|FG001|STARTED|Main Phase I||80
11226906|NCT01999192|12418986|FG002|STARTED|Main Phase I||78
11226907|NCT01999192|12418987|FG003|STARTED|Main Phase I||80
11226908|NCT01999192|12418984|FG000|COMPLETED|Main Phase I||72
11226909|NCT01999192|12418985|FG001|COMPLETED|Main Phase I||70
11226910|NCT01999192|12418986|FG002|COMPLETED|Main Phase I||70
11226911|NCT01999192|12418987|FG003|COMPLETED|Main Phase I||72
11226912|NCT01999192|12418984|FG000|NOT COMPLETED|Main Phase I||11
11226913|NCT01999192|12418985|FG001|NOT COMPLETED|Main Phase I||10
11226914|NCT01999192|12418986|FG002|NOT COMPLETED|Main Phase I||8
11226915|NCT01999192|12418987|FG003|NOT COMPLETED|Main Phase I||8
11226916|NCT01999192|12418984|FG000|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
11226917|NCT01999192|12418985|FG001|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
11226918|NCT01999192|12418986|FG002|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
11226919|NCT01999192|12418987|FG003|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
11226920|NCT01999192|12418984|FG000|COMPLETED|Main Phase II||55
11226921|NCT01999192|12418985|FG001|COMPLETED|Main Phase II||66
11226922|NCT01999192|12418986|FG002|COMPLETED|Main Phase II||76
11226923|NCT01999192|12418987|FG003|COMPLETED|Main Phase II||43
11226924|NCT01999192|12418984|FG000|NOT COMPLETED|Main Phase II||9
11226925|NCT01999192|12418985|FG001|NOT COMPLETED|Main Phase II||9
11226926|NCT01999192|12418986|FG002|NOT COMPLETED|Main Phase II||22
11226927|NCT01999192|12418987|FG003|NOT COMPLETED|Main Phase II||1
11226928|NCT01999192|12418984|FG000|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
11226929|NCT01999192|12418985|FG001|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
11226930|NCT01999192|12418986|FG002|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
11226931|NCT01999192|12418987|FG003|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
10859062|NCT00886600|12025121|FG003|NOT COMPLETED|Double-blind Monotherapy||2
10859063|NCT00886600|12025118|FG000|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
10859064|NCT00886600|12025119|FG001|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
10859065|NCT00886600|12025120|FG002|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
10859066|NCT00886600|12025121|FG003|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
10859067|NCT00886600|12025118|FG000|COMPLETED|Combination Therapy Period||28
10859068|NCT00886600|12025119|FG001|COMPLETED|Combination Therapy Period||21
10859069|NCT00886600|12025120|FG002|COMPLETED|Combination Therapy Period||19
10859070|NCT00886600|12025121|FG003|COMPLETED|Combination Therapy Period||23
10859071|NCT00886600|12025118|FG000|NOT COMPLETED|Combination Therapy Period||0
10859072|NCT00886600|12025119|FG001|NOT COMPLETED|Combination Therapy Period||0
10859073|NCT00886600|12025120|FG002|NOT COMPLETED|Combination Therapy Period||2
10859074|NCT00886600|12025121|FG003|NOT COMPLETED|Combination Therapy Period||0
10859075|NCT00882440|12025134|FG000|STARTED|Overall Study||78
10859076|NCT00882440|12025135|FG001|STARTED|Overall Study||80
10859077|NCT00882440|12025136|FG002|STARTED|Overall Study||82
10859078|NCT00882440|12025137|FG003|STARTED|Overall Study||79
10859079|NCT00882440|12025138|FG004|STARTED|Overall Study||90
10859080|NCT00882440|12025139|FG005|STARTED|Overall Study||84
10859081|NCT00882440|12025140|FG006|STARTED|Overall Study||83
10859082|NCT00882440|12025134|FG000|COMPLETED|Overall Study||67
10859083|NCT00882440|12025135|FG001|COMPLETED|Overall Study||72
10859084|NCT00882440|12025136|FG002|COMPLETED|Overall Study||75
10859085|NCT00882440|12025137|FG003|COMPLETED|Overall Study||76
10859086|NCT00882440|12025138|FG004|COMPLETED|Overall Study||80
10859087|NCT00882440|12025139|FG005|COMPLETED|Overall Study||77
10859088|NCT00882440|12025140|FG006|COMPLETED|Overall Study||79
10859089|NCT00882440|12025134|FG000|NOT COMPLETED|Overall Study||11
10859090|NCT00882440|12025135|FG001|NOT COMPLETED|Overall Study||8
10859091|NCT00882440|12025136|FG002|NOT COMPLETED|Overall Study||7
10859092|NCT00882440|12025137|FG003|NOT COMPLETED|Overall Study||3
10859093|NCT00882440|12025138|FG004|NOT COMPLETED|Overall Study||10
10859094|NCT00882440|12025139|FG005|NOT COMPLETED|Overall Study||7
10859095|NCT00882440|12025140|FG006|NOT COMPLETED|Overall Study||4
10859096|NCT00872430|12025151|FG000|STARTED|First Intervention||10
10859097|NCT00872430|12025152|FG001|STARTED|First Intervention||10
10859098|NCT00872430|12025151|FG000|COMPLETED|First Intervention||10
10859099|NCT00872430|12025152|FG001|COMPLETED|First Intervention||10
10859100|NCT00872430|12025151|FG000|NOT COMPLETED|First Intervention||0
10859101|NCT00872430|12025152|FG001|NOT COMPLETED|First Intervention||0
10859102|NCT00872430|12025151|FG000|STARTED|Washout Period||10
10859103|NCT00872430|12025152|FG001|STARTED|Washout Period||10
10859104|NCT00872430|12025151|FG000|COMPLETED|Washout Period||10
10859105|NCT00872430|12025152|FG001|COMPLETED|Washout Period||10
10859106|NCT00872430|12025151|FG000|NOT COMPLETED|Washout Period||0
10859107|NCT00872430|12025152|FG001|NOT COMPLETED|Washout Period||0
10859108|NCT00872430|12025151|FG000|STARTED|Second Intervention||10
10859109|NCT00872430|12025152|FG001|STARTED|Second Intervention||10
10859110|NCT00872430|12025151|FG000|COMPLETED|Second Intervention||10
10859111|NCT00872430|12025152|FG001|COMPLETED|Second Intervention||10
10859112|NCT00872430|12025151|FG000|NOT COMPLETED|Second Intervention||0
10859113|NCT00872430|12025152|FG001|NOT COMPLETED|Second Intervention||0
10859114|NCT00870688|12025156|FG000|STARTED|Overall Study||82
10859115|NCT00870688|12025156|FG000|COMPLETED|Overall Study||78
10859116|NCT00870688|12025156|FG000|NOT COMPLETED|Overall Study||4
10859117|NCT00869128|12025159|FG000|STARTED|Overall Study||18
10859118|NCT00869128|12025160|FG001|STARTED|Overall Study||18
10859119|NCT00869128|12025159|FG000|COMPLETED|Overall Study||12
10859120|NCT00869128|12025160|FG001|COMPLETED|Overall Study||12
10859121|NCT00869128|12025159|FG000|NOT COMPLETED|Overall Study||6
10859122|NCT00869128|12025160|FG001|NOT COMPLETED|Overall Study||6
10859135|NCT00859521|12025191|FG000|STARTED|First Intervention||15
10859136|NCT00859521|12025192|FG001|STARTED|First Intervention||15
10859137|NCT00859521|12025191|FG000|COMPLETED|First Intervention||15
10859138|NCT00859521|12025192|FG001|COMPLETED|First Intervention||15
10859139|NCT00859521|12025191|FG000|NOT COMPLETED|First Intervention||0
11226932|NCT01999192|12418984|FG000|COMPLETED|Extension Phase||41
10859140|NCT00859521|12025192|FG001|NOT COMPLETED|First Intervention||0
10859141|NCT00859521|12025191|FG000|STARTED|Washout||15
10859142|NCT00859521|12025192|FG001|STARTED|Washout||15
10859143|NCT00859521|12025191|FG000|COMPLETED|Washout||15
10859144|NCT00859521|12025192|FG001|COMPLETED|Washout||14
10859145|NCT00859521|12025191|FG000|NOT COMPLETED|Washout||0
10859146|NCT00859521|12025192|FG001|NOT COMPLETED|Washout||1
10859147|NCT00859521|12025191|FG000|STARTED|Second Intervention||15
10859148|NCT00859521|12025192|FG001|STARTED|Second Intervention||14
10859149|NCT00859521|12025191|FG000|COMPLETED|Second Intervention||15
10859150|NCT00859521|12025192|FG001|COMPLETED|Second Intervention||14
10859151|NCT00859521|12025191|FG000|NOT COMPLETED|Second Intervention||0
10859152|NCT00859521|12025192|FG001|NOT COMPLETED|Second Intervention||0
10859153|NCT00859430|12025198|FG000|STARTED|First Intervention||11
11226933|NCT01999192|12418985|FG001|COMPLETED|Extension Phase||38
11107475|NCT01263197|12291855|FG001|COMPLETED|Washout Period 2||8
11107476|NCT01263197|12291856|FG002|COMPLETED|Washout Period 2||8
11107477|NCT01263197|12291857|FG003|COMPLETED|Washout Period 2||7
11107478|NCT01263197|12291858|FG004|COMPLETED|Washout Period 2||7
11107479|NCT01263197|12291859|FG005|COMPLETED|Washout Period 2||6
10859154|NCT00859430|12025199|FG001|STARTED|First Intervention||11
10859155|NCT00859430|12025198|FG000|COMPLETED|First Intervention||11
10859156|NCT00859430|12025199|FG001|COMPLETED|First Intervention||10
10859157|NCT00859430|12025198|FG000|NOT COMPLETED|First Intervention||0
10859158|NCT00859430|12025199|FG001|NOT COMPLETED|First Intervention||1
10859159|NCT00859430|12025198|FG000|STARTED|Second Intervention||11
10859160|NCT00859430|12025199|FG001|STARTED|Second Intervention||10
10859161|NCT00859430|12025198|FG000|COMPLETED|Second Intervention||11
10859162|NCT00859430|12025199|FG001|COMPLETED|Second Intervention||10
10859163|NCT00859430|12025198|FG000|NOT COMPLETED|Second Intervention||0
10859164|NCT00859430|12025199|FG001|NOT COMPLETED|Second Intervention||0
10859165|NCT00858702|12025205|FG000|STARTED|Overall Study||53
10859166|NCT00858702|12025206|FG001|STARTED|Overall Study||52
10859167|NCT00858702|12025205|FG000|COMPLETED|Overall Study||48
10859168|NCT00858702|12025206|FG001|COMPLETED|Overall Study||50
10859169|NCT00858702|12025205|FG000|NOT COMPLETED|Overall Study||5
10859170|NCT00858702|12025206|FG001|NOT COMPLETED|Overall Study||2
10859171|NCT00857285|12025214|FG000|STARTED|Overall Study||65
10859172|NCT00857285|12025215|FG001|STARTED|Overall Study||65
10859173|NCT00857285|12025214|FG000|COMPLETED|Overall Study||53
10859174|NCT00857285|12025215|FG001|COMPLETED|Overall Study||59
10859175|NCT00857285|12025214|FG000|NOT COMPLETED|Overall Study||12
10859176|NCT00857285|12025215|FG001|NOT COMPLETED|Overall Study||6
10859177|NCT00856934|12025222|FG000|STARTED|Overall Study||15
10859178|NCT00856934|12025223|FG001|STARTED|Overall Study||15
10859179|NCT00856934|12025224|FG002|STARTED|Overall Study||15
10859180|NCT00856934|12025222|FG000|COMPLETED|Overall Study||15
10859181|NCT00856934|12025223|FG001|COMPLETED|Overall Study||15
10859182|NCT00856934|12025224|FG002|COMPLETED|Overall Study||15
10859183|NCT00856934|12025222|FG000|NOT COMPLETED|Overall Study||0
10859184|NCT00856934|12025223|FG001|NOT COMPLETED|Overall Study||0
10859185|NCT00856934|12025224|FG002|NOT COMPLETED|Overall Study||0
11226934|NCT01999192|12418986|FG002|COMPLETED|Extension Phase||44
10859186|NCT00850174|12025231|FG000|STARTED|First Intervention||30
10859187|NCT00850174|12025232|FG001|STARTED|First Intervention||30
10859188|NCT00850174|12025231|FG000|COMPLETED|First Intervention||30
10859189|NCT00850174|12025232|FG001|COMPLETED|First Intervention||30
10859190|NCT00850174|12025231|FG000|NOT COMPLETED|First Intervention||0
10859191|NCT00850174|12025232|FG001|NOT COMPLETED|First Intervention||0
10859192|NCT00850174|12025231|FG000|STARTED|Washout: One Week||30
10859193|NCT00850174|12025232|FG001|STARTED|Washout: One Week||30
10859194|NCT00850174|12025231|FG000|COMPLETED|Washout: One Week||30
10859195|NCT00850174|12025232|FG001|COMPLETED|Washout: One Week||28
10859196|NCT00850174|12025231|FG000|NOT COMPLETED|Washout: One Week||0
10859197|NCT00850174|12025232|FG001|NOT COMPLETED|Washout: One Week||2
10859198|NCT00850174|12025231|FG000|STARTED|Second Intervention||30
10859199|NCT00850174|12025232|FG001|STARTED|Second Intervention||28
10859200|NCT00850174|12025231|FG000|COMPLETED|Second Intervention||29
10859201|NCT00850174|12025232|FG001|COMPLETED|Second Intervention||28
10859202|NCT00850174|12025231|FG000|NOT COMPLETED|Second Intervention||1
10859203|NCT00850174|12025232|FG001|NOT COMPLETED|Second Intervention||0
10859204|NCT00849862|12025238|FG000|STARTED|First Intervention||11
10859205|NCT00849862|12025239|FG001|STARTED|First Intervention||11
10859206|NCT00849862|12025238|FG000|COMPLETED|First Intervention||11
10859207|NCT00849862|12025239|FG001|COMPLETED|First Intervention||11
10859208|NCT00849862|12025238|FG000|NOT COMPLETED|First Intervention||0
10859209|NCT00849862|12025239|FG001|NOT COMPLETED|First Intervention||0
10859210|NCT00849862|12025238|FG000|STARTED|Washout: 7 Days||11
10859211|NCT00849862|12025239|FG001|STARTED|Washout: 7 Days||11
10859212|NCT00849862|12025238|FG000|COMPLETED|Washout: 7 Days||11
10859213|NCT00849862|12025239|FG001|COMPLETED|Washout: 7 Days||11
10859214|NCT00849862|12025238|FG000|NOT COMPLETED|Washout: 7 Days||0
10859215|NCT00849862|12025239|FG001|NOT COMPLETED|Washout: 7 Days||0
10859216|NCT00849862|12025238|FG000|STARTED|Second Intervention||11
10859217|NCT00849862|12025239|FG001|STARTED|Second Intervention||11
10859218|NCT00849862|12025238|FG000|COMPLETED|Second Intervention||11
10859219|NCT00849862|12025239|FG001|COMPLETED|Second Intervention||11
10859220|NCT00849862|12025238|FG000|NOT COMPLETED|Second Intervention||0
10859221|NCT00849862|12025239|FG001|NOT COMPLETED|Second Intervention||0
10859222|NCT00849797|12025245|FG000|STARTED|First Intervention||60
10859223|NCT00849797|12025246|FG001|STARTED|First Intervention||60
10859224|NCT00849797|12025245|FG000|COMPLETED|First Intervention||59
10859225|NCT00849797|12025246|FG001|COMPLETED|First Intervention||59
10859226|NCT00849797|12025245|FG000|NOT COMPLETED|First Intervention||1
10859227|NCT00849797|12025246|FG001|NOT COMPLETED|First Intervention||1
10859228|NCT00849797|12025245|FG000|STARTED|Washout: One Week||59
10859229|NCT00849797|12025246|FG001|STARTED|Washout: One Week||59
10859230|NCT00849797|12025245|FG000|COMPLETED|Washout: One Week||59
10859231|NCT00849797|12025246|FG001|COMPLETED|Washout: One Week||57
10859232|NCT00849797|12025245|FG000|NOT COMPLETED|Washout: One Week||0
10859233|NCT00849797|12025246|FG001|NOT COMPLETED|Washout: One Week||2
10859234|NCT00849797|12025245|FG000|STARTED|Second Intervention||59
10859235|NCT00849797|12025246|FG001|STARTED|Second Intervention||57
10859236|NCT00849797|12025245|FG000|COMPLETED|Second Intervention||59
10859237|NCT00849797|12025246|FG001|COMPLETED|Second Intervention||57
10859238|NCT00849797|12025245|FG000|NOT COMPLETED|Second Intervention||0
10859239|NCT00849797|12025246|FG001|NOT COMPLETED|Second Intervention||0
10859240|NCT00849485|12025253|FG000|STARTED|First Intervention||11
10859241|NCT00849485|12025254|FG001|STARTED|First Intervention||11
10859242|NCT00849485|12025253|FG000|COMPLETED|First Intervention||11
10859243|NCT00849485|12025254|FG001|COMPLETED|First Intervention||11
10859244|NCT00849485|12025253|FG000|NOT COMPLETED|First Intervention||0
10859245|NCT00849485|12025254|FG001|NOT COMPLETED|First Intervention||0
10859246|NCT00849485|12025253|FG000|STARTED|Washout: 7 Days||11
10859247|NCT00849485|12025254|FG001|STARTED|Washout: 7 Days||11
10859248|NCT00849485|12025253|FG000|COMPLETED|Washout: 7 Days||11
10859249|NCT00849485|12025254|FG001|COMPLETED|Washout: 7 Days||11
10859250|NCT00849485|12025253|FG000|NOT COMPLETED|Washout: 7 Days||0
10859251|NCT00849485|12025254|FG001|NOT COMPLETED|Washout: 7 Days||0
10859252|NCT00849485|12025253|FG000|STARTED|Second Intervention||11
10859253|NCT00849485|12025254|FG001|STARTED|Second Intervention||11
10859254|NCT00849485|12025253|FG000|COMPLETED|Second Intervention||11
10859255|NCT00849485|12025254|FG001|COMPLETED|Second Intervention||11
10859256|NCT00849485|12025253|FG000|NOT COMPLETED|Second Intervention||0
10859257|NCT00849485|12025254|FG001|NOT COMPLETED|Second Intervention||0
10859258|NCT00847405|12025260|FG000|STARTED|First Intervention||14
10859259|NCT00847405|12025261|FG001|STARTED|First Intervention||14
10859260|NCT00847405|12025260|FG000|COMPLETED|First Intervention||14
10859261|NCT00847405|12025261|FG001|COMPLETED|First Intervention||13
10859262|NCT00847405|12025260|FG000|NOT COMPLETED|First Intervention||0
10859263|NCT00847405|12025261|FG001|NOT COMPLETED|First Intervention||1
10859264|NCT00847405|12025260|FG000|STARTED|Washout of 7 Days||14
10859265|NCT00847405|12025261|FG001|STARTED|Washout of 7 Days||13
10859266|NCT00847405|12025260|FG000|COMPLETED|Washout of 7 Days||13
10859267|NCT00847405|12025261|FG001|COMPLETED|Washout of 7 Days||13
10859268|NCT00847405|12025260|FG000|NOT COMPLETED|Washout of 7 Days||1
10859269|NCT00847405|12025261|FG001|NOT COMPLETED|Washout of 7 Days||0
10859270|NCT00847405|12025260|FG000|STARTED|Second Intervention||13
10859271|NCT00847405|12025261|FG001|STARTED|Second Intervention||13
10859272|NCT00847405|12025260|FG000|COMPLETED|Second Intervention||13
10859273|NCT00847405|12025261|FG001|COMPLETED|Second Intervention||13
10859274|NCT00847405|12025260|FG000|NOT COMPLETED|Second Intervention||0
10859275|NCT00847405|12025261|FG001|NOT COMPLETED|Second Intervention||0
10859276|NCT00846885|12025267|FG000|STARTED|First Intervention||14
10859277|NCT00846885|12025268|FG001|STARTED|First Intervention||14
10859278|NCT00846885|12025267|FG000|COMPLETED|First Intervention||14
10859279|NCT00846885|12025268|FG001|COMPLETED|First Intervention||14
10859280|NCT00846885|12025267|FG000|NOT COMPLETED|First Intervention||0
10859281|NCT00846885|12025268|FG001|NOT COMPLETED|First Intervention||0
10859282|NCT00846885|12025267|FG000|STARTED|Washout of 7 Days||14
10859283|NCT00846885|12025268|FG001|STARTED|Washout of 7 Days||14
10859284|NCT00846885|12025267|FG000|COMPLETED|Washout of 7 Days||14
10859285|NCT00846885|12025268|FG001|COMPLETED|Washout of 7 Days||14
10859286|NCT00846885|12025267|FG000|NOT COMPLETED|Washout of 7 Days||0
10859287|NCT00846885|12025268|FG001|NOT COMPLETED|Washout of 7 Days||0
10859288|NCT00846885|12025267|FG000|STARTED|Second Intervention||14
10859289|NCT00846885|12025268|FG001|STARTED|Second Intervention||14
10859290|NCT00846885|12025267|FG000|COMPLETED|Second Intervention||14
10859291|NCT00846885|12025268|FG001|COMPLETED|Second Intervention||14
10859292|NCT00846885|12025267|FG000|NOT COMPLETED|Second Intervention||0
10859293|NCT00846885|12025268|FG001|NOT COMPLETED|Second Intervention||0
10859294|NCT00841815|12025274|FG000|STARTED|Period 1||14
10859295|NCT00841815|12025275|FG001|STARTED|Period 1||14
10859296|NCT00841815|12025274|FG000|COMPLETED|Period 1||14
10859297|NCT00841815|12025275|FG001|COMPLETED|Period 1||14
10859298|NCT00841815|12025274|FG000|NOT COMPLETED|Period 1||0
10859299|NCT00841815|12025275|FG001|NOT COMPLETED|Period 1||0
10859300|NCT00841815|12025274|FG000|STARTED|Washout||14
10859301|NCT00841815|12025275|FG001|STARTED|Washout||14
10859302|NCT00841815|12025274|FG000|COMPLETED|Washout||14
10859303|NCT00841815|12025275|FG001|COMPLETED|Washout||13
10859304|NCT00841815|12025274|FG000|NOT COMPLETED|Washout||0
10859305|NCT00841815|12025275|FG001|NOT COMPLETED|Washout||1
10859306|NCT00841815|12025274|FG000|STARTED|Period 2||14
10859307|NCT00841815|12025275|FG001|STARTED|Period 2||13
10859308|NCT00841815|12025274|FG000|COMPLETED|Period 2||14
10859309|NCT00841815|12025275|FG001|COMPLETED|Period 2||13
10859310|NCT00841815|12025274|FG000|NOT COMPLETED|Period 2||0
10859311|NCT00841815|12025275|FG001|NOT COMPLETED|Period 2||0
10859312|NCT00841698|12025282|FG000|STARTED|First Intervention||25
10859313|NCT00841698|12025283|FG001|STARTED|First Intervention||25
10859314|NCT00841698|12025282|FG000|COMPLETED|First Intervention||24
10859315|NCT00841698|12025283|FG001|COMPLETED|First Intervention||25
10859316|NCT00841698|12025282|FG000|NOT COMPLETED|First Intervention||1
10859317|NCT00841698|12025283|FG001|NOT COMPLETED|First Intervention||0
10859318|NCT00841698|12025282|FG000|STARTED|Washout: 2 Weeks||24
10859319|NCT00841698|12025283|FG001|STARTED|Washout: 2 Weeks||25
10859320|NCT00841698|12025282|FG000|COMPLETED|Washout: 2 Weeks||24
10859321|NCT00841698|12025283|FG001|COMPLETED|Washout: 2 Weeks||25
10859322|NCT00841698|12025282|FG000|NOT COMPLETED|Washout: 2 Weeks||0
10859323|NCT00841698|12025283|FG001|NOT COMPLETED|Washout: 2 Weeks||0
10859324|NCT00841698|12025282|FG000|STARTED|Second Intervention||24
10859325|NCT00841698|12025283|FG001|STARTED|Second Intervention||25
10859326|NCT00841698|12025282|FG000|COMPLETED|Second Intervention||24
10859327|NCT00841698|12025283|FG001|COMPLETED|Second Intervention||25
10859328|NCT00841698|12025282|FG000|NOT COMPLETED|Second Intervention||0
10859329|NCT00841698|12025283|FG001|NOT COMPLETED|Second Intervention||0
10859330|NCT00841659|12025289|FG000|STARTED|First Intervention||12
10859331|NCT00841659|12025290|FG001|STARTED|First Intervention||12
10859332|NCT00841659|12025289|FG000|COMPLETED|First Intervention||12
10859333|NCT00841659|12025290|FG001|COMPLETED|First Intervention||12
10859334|NCT00841659|12025289|FG000|NOT COMPLETED|First Intervention||0
10859335|NCT00841659|12025290|FG001|NOT COMPLETED|First Intervention||0
10859336|NCT00841659|12025289|FG000|STARTED|Washout: 2 Weeks||12
10859337|NCT00841659|12025290|FG001|STARTED|Washout: 2 Weeks||12
10859338|NCT00841659|12025289|FG000|COMPLETED|Washout: 2 Weeks||11
11107480|NCT01263197|12291854|FG000|NOT COMPLETED|Washout Period 2||0
11107481|NCT01263197|12291855|FG001|NOT COMPLETED|Washout Period 2||0
11107482|NCT01263197|12291856|FG002|NOT COMPLETED|Washout Period 2||0
10859339|NCT00841659|12025290|FG001|COMPLETED|Washout: 2 Weeks||12
10859340|NCT00841659|12025289|FG000|NOT COMPLETED|Washout: 2 Weeks||1
10859341|NCT00841659|12025290|FG001|NOT COMPLETED|Washout: 2 Weeks||0
10859342|NCT00841659|12025289|FG000|STARTED|Second Intervention||11
10859343|NCT00841659|12025290|FG001|STARTED|Second Intervention||12
10859344|NCT00841659|12025289|FG000|COMPLETED|Second Intervention||11
10859345|NCT00841659|12025290|FG001|COMPLETED|Second Intervention||12
10859346|NCT00841659|12025289|FG000|NOT COMPLETED|Second Intervention||0
10859347|NCT00841659|12025290|FG001|NOT COMPLETED|Second Intervention||0
10859348|NCT00841542|12025296|FG000|STARTED|Period 1||14
10859349|NCT00841542|12025297|FG001|STARTED|Period 1||14
10859350|NCT00841542|12025296|FG000|COMPLETED|Period 1||13
10859351|NCT00841542|12025297|FG001|COMPLETED|Period 1||14
10859352|NCT00841542|12025296|FG000|NOT COMPLETED|Period 1||1
10859353|NCT00841542|12025297|FG001|NOT COMPLETED|Period 1||0
10859354|NCT00841542|12025296|FG000|STARTED|Period 2||13
10859355|NCT00841542|12025297|FG001|STARTED|Period 2||14
10859356|NCT00841542|12025296|FG000|COMPLETED|Period 2||13
10859357|NCT00841542|12025297|FG001|COMPLETED|Period 2||14
10859358|NCT00841542|12025296|FG000|NOT COMPLETED|Period 2||0
10859359|NCT00841542|12025297|FG001|NOT COMPLETED|Period 2||0
10859360|NCT00840879|12025303|FG000|STARTED|First Intervention||14
10859361|NCT00840879|12025304|FG001|STARTED|First Intervention||14
10859362|NCT00840879|12025303|FG000|COMPLETED|First Intervention||14
10859363|NCT00840879|12025304|FG001|COMPLETED|First Intervention||14
10859364|NCT00840879|12025303|FG000|NOT COMPLETED|First Intervention||0
10859365|NCT00840879|12025304|FG001|NOT COMPLETED|First Intervention||0
10859366|NCT00840879|12025303|FG000|STARTED|Washout: 14 Days||14
10859367|NCT00840879|12025304|FG001|STARTED|Washout: 14 Days||14
10859368|NCT00840879|12025303|FG000|COMPLETED|Washout: 14 Days||14
10859369|NCT00840879|12025304|FG001|COMPLETED|Washout: 14 Days||14
10859370|NCT00840879|12025303|FG000|NOT COMPLETED|Washout: 14 Days||0
10859371|NCT00840879|12025304|FG001|NOT COMPLETED|Washout: 14 Days||0
10859372|NCT00840879|12025303|FG000|STARTED|Second Intervention||14
10859373|NCT00840879|12025304|FG001|STARTED|Second Intervention||14
10859374|NCT00840879|12025303|FG000|COMPLETED|Second Intervention||13
10859375|NCT00840879|12025304|FG001|COMPLETED|Second Intervention||14
10859376|NCT00840879|12025303|FG000|NOT COMPLETED|Second Intervention||1
10859377|NCT00840879|12025304|FG001|NOT COMPLETED|Second Intervention||0
10859378|NCT00840866|12025310|FG000|STARTED|First Intervention||20
10859379|NCT00840866|12025311|FG001|STARTED|First Intervention||19
10859380|NCT00840866|12025310|FG000|COMPLETED|First Intervention||20
10859381|NCT00840866|12025311|FG001|COMPLETED|First Intervention||19
10859382|NCT00840866|12025310|FG000|NOT COMPLETED|First Intervention||0
10859383|NCT00840866|12025311|FG001|NOT COMPLETED|First Intervention||0
10859384|NCT00840866|12025310|FG000|STARTED|Washout of 7 Days||20
10859385|NCT00840866|12025311|FG001|STARTED|Washout of 7 Days||19
10859386|NCT00840866|12025310|FG000|COMPLETED|Washout of 7 Days||20
10859387|NCT00840866|12025311|FG001|COMPLETED|Washout of 7 Days||19
10859388|NCT00840866|12025310|FG000|NOT COMPLETED|Washout of 7 Days||0
10859389|NCT00840866|12025311|FG001|NOT COMPLETED|Washout of 7 Days||0
10859390|NCT00840866|12025310|FG000|STARTED|Second Intervention||20
10859391|NCT00840866|12025311|FG001|STARTED|Second Intervention||19
10859392|NCT00840866|12025310|FG000|COMPLETED|Second Intervention||20
10859393|NCT00840866|12025311|FG001|COMPLETED|Second Intervention||19
11107483|NCT01263197|12291857|FG003|NOT COMPLETED|Washout Period 2||1
11107484|NCT01263197|12291858|FG004|NOT COMPLETED|Washout Period 2||0
11107485|NCT01263197|12291859|FG005|NOT COMPLETED|Washout Period 2||1
11107486|NCT01263197|12291854|FG000|STARTED|Third Intervention (Period 3)||8
11107487|NCT01263197|12291855|FG001|STARTED|Third Intervention (Period 3)||8
11107488|NCT01263197|12291856|FG002|STARTED|Third Intervention (Period 3)||8
11107489|NCT01263197|12291857|FG003|STARTED|Third Intervention (Period 3)||7
11107490|NCT01263197|12291858|FG004|STARTED|Third Intervention (Period 3)||7
11107491|NCT01263197|12291859|FG005|STARTED|Third Intervention (Period 3)||6
11107492|NCT01263197|12291854|FG000|COMPLETED|Third Intervention (Period 3)||8
11107493|NCT01263197|12291855|FG001|COMPLETED|Third Intervention (Period 3)||7
11107494|NCT01263197|12291856|FG002|COMPLETED|Third Intervention (Period 3)||8
11107495|NCT01263197|12291857|FG003|COMPLETED|Third Intervention (Period 3)||7
11107496|NCT01263197|12291858|FG004|COMPLETED|Third Intervention (Period 3)||7
11107497|NCT01263197|12291859|FG005|COMPLETED|Third Intervention (Period 3)||6
11107498|NCT01263197|12291854|FG000|NOT COMPLETED|Third Intervention (Period 3)||0
11107499|NCT01263197|12291855|FG001|NOT COMPLETED|Third Intervention (Period 3)||1
11107500|NCT01263197|12291856|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
11107501|NCT01263197|12291857|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
11107502|NCT01263197|12291858|FG004|NOT COMPLETED|Third Intervention (Period 3)||0
11107503|NCT01263197|12291859|FG005|NOT COMPLETED|Third Intervention (Period 3)||0
11107504|NCT01263223|12291873|FG000|STARTED|Period 1||12
11107505|NCT01263223|12291874|FG001|STARTED|Period 1||12
11107506|NCT01263223|12291873|FG000|COMPLETED|Period 1||12
11107507|NCT01263223|12291874|FG001|COMPLETED|Period 1||12
10859394|NCT00840866|12025310|FG000|NOT COMPLETED|Second Intervention||0
10859395|NCT00840866|12025311|FG001|NOT COMPLETED|Second Intervention||0
10859396|NCT00840840|12025317|FG000|STARTED|Period 1||24
10859397|NCT00840840|12025318|FG001|STARTED|Period 1||24
10859398|NCT00840840|12025317|FG000|COMPLETED|Period 1||24
10859399|NCT00840840|12025318|FG001|COMPLETED|Period 1||24
10859400|NCT00840840|12025317|FG000|NOT COMPLETED|Period 1||0
10859401|NCT00840840|12025318|FG001|NOT COMPLETED|Period 1||0
10859402|NCT00840840|12025317|FG000|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
10859403|NCT00840840|12025318|FG001|STARTED|Period 2||24
10859404|NCT00840840|12025317|FG000|COMPLETED|Period 2||23
10859405|NCT00840840|12025318|FG001|COMPLETED|Period 2||24
10859406|NCT00840840|12025317|FG000|NOT COMPLETED|Period 2||0
10859407|NCT00840840|12025318|FG001|NOT COMPLETED|Period 2||0
10859408|NCT00840632|12025324|FG000|STARTED|First Intervention||20
10859409|NCT00840632|12025325|FG001|STARTED|First Intervention||20
10859410|NCT00840632|12025324|FG000|COMPLETED|First Intervention||20
10859411|NCT00840632|12025325|FG001|COMPLETED|First Intervention||19
10859412|NCT00840632|12025324|FG000|NOT COMPLETED|First Intervention||0
10859413|NCT00840632|12025325|FG001|NOT COMPLETED|First Intervention||1
10859414|NCT00840632|12025324|FG000|STARTED|Washout||20
10859415|NCT00840632|12025325|FG001|STARTED|Washout||19
10859416|NCT00840632|12025324|FG000|COMPLETED|Washout||19
10859417|NCT00840632|12025325|FG001|COMPLETED|Washout||18
10859418|NCT00840632|12025324|FG000|NOT COMPLETED|Washout||1
10859419|NCT00840632|12025325|FG001|NOT COMPLETED|Washout||1
10859420|NCT00840632|12025324|FG000|STARTED|Second Intervention||19
10859421|NCT00840632|12025325|FG001|STARTED|Second Intervention||18
10859422|NCT00840632|12025324|FG000|COMPLETED|Second Intervention||19
10859423|NCT00840632|12025325|FG001|COMPLETED|Second Intervention||18
10859424|NCT00840632|12025324|FG000|NOT COMPLETED|Second Intervention||0
10859425|NCT00840632|12025325|FG001|NOT COMPLETED|Second Intervention||0
11107508|NCT01263223|12291873|FG000|NOT COMPLETED|Period 1||0
11107509|NCT01263223|12291874|FG001|NOT COMPLETED|Period 1||0
11107510|NCT01263223|12291873|FG000|STARTED|3-Day Washout||12
10859426|NCT00840476|12025331|FG000|STARTED|First Intervention||14
10859427|NCT00840476|12025332|FG001|STARTED|First Intervention||14
11226935|NCT01999192|12418987|FG003|COMPLETED|Extension Phase||0
11226936|NCT01999192|12418984|FG000|NOT COMPLETED|Extension Phase||13
11226937|NCT01999192|12418985|FG001|NOT COMPLETED|Extension Phase||18
11226938|NCT01999192|12418986|FG002|NOT COMPLETED|Extension Phase||24
11226939|NCT01999192|12418987|FG003|NOT COMPLETED|Extension Phase||0
11226940|NCT01999218|12419000|FG000|STARTED|Overall Study||448
10859428|NCT00840476|12025331|FG000|COMPLETED|First Intervention||14
10859429|NCT00840476|12025332|FG001|COMPLETED|First Intervention||14
10859430|NCT00840476|12025331|FG000|NOT COMPLETED|First Intervention||0
10859431|NCT00840476|12025332|FG001|NOT COMPLETED|First Intervention||0
10859432|NCT00840476|12025331|FG000|STARTED|Washout: 14 Days||14
10859433|NCT00840476|12025332|FG001|STARTED|Washout: 14 Days||14
10859434|NCT00840476|12025331|FG000|COMPLETED|Washout: 14 Days||14
10859435|NCT00840476|12025332|FG001|COMPLETED|Washout: 14 Days||14
10859436|NCT00840476|12025331|FG000|NOT COMPLETED|Washout: 14 Days||0
10859437|NCT00840476|12025332|FG001|NOT COMPLETED|Washout: 14 Days||0
10859438|NCT00840476|12025331|FG000|STARTED|Second Intervention||14
10859439|NCT00840476|12025332|FG001|STARTED|Second Intervention||14
10859440|NCT00840476|12025331|FG000|COMPLETED|Second Intervention||14
10859441|NCT00840476|12025332|FG001|COMPLETED|Second Intervention||14
10859442|NCT00840476|12025331|FG000|NOT COMPLETED|Second Intervention||0
10859443|NCT00840476|12025332|FG001|NOT COMPLETED|Second Intervention||0
10859444|NCT00840411|12025338|FG000|STARTED|First Intervention||33
10859445|NCT00840411|12025339|FG001|STARTED|First Intervention||33
10859446|NCT00840411|12025338|FG000|COMPLETED|First Intervention||32
10859447|NCT00840411|12025339|FG001|COMPLETED|First Intervention||33
10859448|NCT00840411|12025338|FG000|NOT COMPLETED|First Intervention||1
10859449|NCT00840411|12025339|FG001|NOT COMPLETED|First Intervention||0
10859450|NCT00840411|12025338|FG000|STARTED|Washout||32
10859451|NCT00840411|12025339|FG001|STARTED|Washout||33
10859452|NCT00840411|12025338|FG000|COMPLETED|Washout||31
10859453|NCT00840411|12025339|FG001|COMPLETED|Washout||33
10859454|NCT00840411|12025338|FG000|NOT COMPLETED|Washout||1
10859455|NCT00840411|12025339|FG001|NOT COMPLETED|Washout||0
10859456|NCT00840411|12025338|FG000|STARTED|Second Intervention||31
10859457|NCT00840411|12025339|FG001|STARTED|Second Intervention||33
10859458|NCT00840411|12025338|FG000|COMPLETED|Second Intervention||31
10859459|NCT00840411|12025339|FG001|COMPLETED|Second Intervention||33
10859460|NCT00840411|12025338|FG000|NOT COMPLETED|Second Intervention||0
10859461|NCT00840411|12025339|FG001|NOT COMPLETED|Second Intervention||0
10859462|NCT00840281|12025345|FG000|STARTED|First Intervention||19
10859463|NCT00840281|12025346|FG001|STARTED|First Intervention||19
10859464|NCT00840281|12025345|FG000|COMPLETED|First Intervention||19
10859465|NCT00840281|12025346|FG001|COMPLETED|First Intervention||19
10859466|NCT00840281|12025345|FG000|NOT COMPLETED|First Intervention||0
10859467|NCT00840281|12025346|FG001|NOT COMPLETED|First Intervention||0
10859468|NCT00840281|12025345|FG000|STARTED|Washout of 7 Days||19
10859469|NCT00840281|12025346|FG001|STARTED|Washout of 7 Days||19
10859470|NCT00840281|12025345|FG000|COMPLETED|Washout of 7 Days||19
10859471|NCT00840281|12025346|FG001|COMPLETED|Washout of 7 Days||19
10859472|NCT00840281|12025345|FG000|NOT COMPLETED|Washout of 7 Days||0
10859473|NCT00840281|12025346|FG001|NOT COMPLETED|Washout of 7 Days||0
10859474|NCT00840281|12025345|FG000|STARTED|Second Intervention||19
10859475|NCT00840281|12025346|FG001|STARTED|Second Intervention||19
10859476|NCT00840281|12025345|FG000|COMPLETED|Second Intervention||19
10859477|NCT00840281|12025346|FG001|COMPLETED|Second Intervention||19
10859478|NCT00840281|12025345|FG000|NOT COMPLETED|Second Intervention||0
10859479|NCT00840281|12025346|FG001|NOT COMPLETED|Second Intervention||0
10859480|NCT00840216|12025352|FG000|STARTED|First Intervention||11
10859481|NCT00840216|12025353|FG001|STARTED|First Intervention||11
10859482|NCT00840216|12025352|FG000|COMPLETED|First Intervention||11
10859483|NCT00840216|12025353|FG001|COMPLETED|First Intervention||11
10859484|NCT00840216|12025352|FG000|NOT COMPLETED|First Intervention||0
10859485|NCT00840216|12025353|FG001|NOT COMPLETED|First Intervention||0
10859486|NCT00840216|12025352|FG000|STARTED|Washout: 7 Days||11
10859487|NCT00840216|12025353|FG001|STARTED|Washout: 7 Days||11
10859488|NCT00840216|12025352|FG000|COMPLETED|Washout: 7 Days||10
10859489|NCT00840216|12025353|FG001|COMPLETED|Washout: 7 Days||11
10859490|NCT00840216|12025352|FG000|NOT COMPLETED|Washout: 7 Days||1
10859491|NCT00840216|12025353|FG001|NOT COMPLETED|Washout: 7 Days||0
10859492|NCT00840216|12025352|FG000|STARTED|Second Intervention||10
10859493|NCT00840216|12025353|FG001|STARTED|Second Intervention||11
10859494|NCT00840216|12025352|FG000|COMPLETED|Second Intervention||10
10859495|NCT00840216|12025353|FG001|COMPLETED|Second Intervention||11
10859496|NCT00840216|12025352|FG000|NOT COMPLETED|Second Intervention||0
10859497|NCT00840216|12025353|FG001|NOT COMPLETED|Second Intervention||0
10859498|NCT00840203|12025359|FG000|STARTED|First Intervention||37
10859499|NCT00840203|12025360|FG001|STARTED|First Intervention||35
10859500|NCT00840203|12025359|FG000|COMPLETED|First Intervention||36
10859501|NCT00840203|12025360|FG001|COMPLETED|First Intervention||34
10859502|NCT00840203|12025359|FG000|NOT COMPLETED|First Intervention||1
10859503|NCT00840203|12025360|FG001|NOT COMPLETED|First Intervention||1
10859504|NCT00840203|12025359|FG000|STARTED|Washout||36
10859505|NCT00840203|12025360|FG001|STARTED|Washout||34
10859506|NCT00840203|12025359|FG000|COMPLETED|Washout||35
10859507|NCT00840203|12025360|FG001|COMPLETED|Washout||34
10859508|NCT00840203|12025359|FG000|NOT COMPLETED|Washout||1
10859509|NCT00840203|12025360|FG001|NOT COMPLETED|Washout||0
10859510|NCT00840203|12025359|FG000|STARTED|Second Intervention||35
10859511|NCT00840203|12025360|FG001|STARTED|Second Intervention||34
10859512|NCT00840203|12025359|FG000|COMPLETED|Second Intervention||35
10859513|NCT00840203|12025360|FG001|COMPLETED|Second Intervention||34
10859514|NCT00840203|12025359|FG000|NOT COMPLETED|Second Intervention||0
10859515|NCT00840203|12025360|FG001|NOT COMPLETED|Second Intervention||0
10859516|NCT00840099|12025366|FG000|STARTED|Period 1||24
10859517|NCT00840099|12025367|FG001|STARTED|Period 1||24
10859518|NCT00840099|12025366|FG000|COMPLETED|Period 1||24
10859519|NCT00840099|12025367|FG001|COMPLETED|Period 1||24
10859520|NCT00840099|12025366|FG000|NOT COMPLETED|Period 1||0
10859521|NCT00840099|12025367|FG001|NOT COMPLETED|Period 1||0
10859522|NCT00840099|12025366|FG000|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
10859523|NCT00840099|12025367|FG001|STARTED|Period 2||24
10859524|NCT00840099|12025366|FG000|COMPLETED|Period 2||21
10859525|NCT00840099|12025367|FG001|COMPLETED|Period 2||24
10859526|NCT00840099|12025366|FG000|NOT COMPLETED|Period 2||0
10859527|NCT00840099|12025367|FG001|NOT COMPLETED|Period 2||0
10859528|NCT00840073|12025373|FG000|STARTED|First Intervention||25
10859529|NCT00840073|12025374|FG001|STARTED|First Intervention||25
10859530|NCT00840073|12025373|FG000|COMPLETED|First Intervention||25
10859531|NCT00840073|12025374|FG001|COMPLETED|First Intervention||25
10859532|NCT00840073|12025373|FG000|NOT COMPLETED|First Intervention||0
10859533|NCT00840073|12025374|FG001|NOT COMPLETED|First Intervention||0
10859534|NCT00840073|12025373|FG000|STARTED|Second Intervention||25
10859535|NCT00840073|12025374|FG001|STARTED|Second Intervention||25
10859536|NCT00840073|12025373|FG000|COMPLETED|Second Intervention||24
10859537|NCT00840073|12025374|FG001|COMPLETED|Second Intervention||24
10859538|NCT00840073|12025373|FG000|NOT COMPLETED|Second Intervention||1
10859539|NCT00840073|12025374|FG001|NOT COMPLETED|Second Intervention||1
11226941|NCT01999218|12419001|FG001|STARTED|Overall Study||441
11226942|NCT01999218|12419002|FG002|STARTED|Overall Study||437
11226943|NCT01999218|12419000|FG000|Treated|Overall Study||448
11226944|NCT01999218|12419001|FG001|Treated|Overall Study||440
11226945|NCT01999218|12419002|FG002|Treated|Overall Study||437
11226946|NCT01999218|12419000|FG000|Site Issue|Overall Study||445
11226947|NCT01999218|12419001|FG001|Site Issue|Overall Study||435
11226948|NCT01999218|12419002|FG002|Site Issue|Overall Study||435
11226949|NCT01999218|12419000|FG000|COMPLETED|Overall Study||339
11226950|NCT01999218|12419001|FG001|COMPLETED|Overall Study||340
11226951|NCT01999218|12419002|FG002|COMPLETED|Overall Study||327
11226952|NCT01999218|12419000|FG000|NOT COMPLETED|Overall Study||109
11226953|NCT01999218|12419001|FG001|NOT COMPLETED|Overall Study||101
11226954|NCT01999218|12419002|FG002|NOT COMPLETED|Overall Study||110
11226955|NCT01999231|12419014|FG000|STARTED|Overall Study||6
11226956|NCT01999231|12419015|FG001|STARTED|Overall Study||6
11226957|NCT01999231|12419016|FG002|STARTED|Overall Study||6
10859540|NCT00839930|12025380|FG000|STARTED|First Intervention||15
10859541|NCT00839930|12025381|FG001|STARTED|First Intervention||15
10859542|NCT00839930|12025380|FG000|COMPLETED|First Intervention||15
10859543|NCT00839930|12025381|FG001|COMPLETED|First Intervention||15
10859544|NCT00839930|12025380|FG000|NOT COMPLETED|First Intervention||0
10859545|NCT00839930|12025381|FG001|NOT COMPLETED|First Intervention||0
10859546|NCT00839930|12025380|FG000|STARTED|Washout: 7 Days||15
10859547|NCT00839930|12025381|FG001|STARTED|Washout: 7 Days||15
10859548|NCT00839930|12025380|FG000|COMPLETED|Washout: 7 Days||15
10859549|NCT00839930|12025381|FG001|COMPLETED|Washout: 7 Days||15
10859550|NCT00839930|12025380|FG000|NOT COMPLETED|Washout: 7 Days||0
10859551|NCT00839930|12025381|FG001|NOT COMPLETED|Washout: 7 Days||0
10859552|NCT00839930|12025380|FG000|STARTED|Second Intervention||15
11226958|NCT01999231|12419017|FG003|STARTED|Overall Study||6
11226959|NCT01999231|12419014|FG000|COMPLETED|Overall Study||6
11226960|NCT01999231|12419015|FG001|COMPLETED|Overall Study||6
11226961|NCT01999231|12419016|FG002|COMPLETED|Overall Study||6
11226962|NCT01999231|12419017|FG003|COMPLETED|Overall Study||6
11226963|NCT01999231|12419014|FG000|NOT COMPLETED|Overall Study||0
11226964|NCT01999231|12419015|FG001|NOT COMPLETED|Overall Study||0
11226965|NCT01999231|12419016|FG002|NOT COMPLETED|Overall Study||0
11226966|NCT01999231|12419017|FG003|NOT COMPLETED|Overall Study||0
11226967|NCT01999322|12419031|FG000|STARTED|Overall Study||25
11226968|NCT01999322|12419032|FG001|STARTED|Overall Study||12
11226969|NCT01999322|12419031|FG000|COMPLETED|Overall Study||24
11226970|NCT01999322|12419032|FG001|COMPLETED|Overall Study||12
11226971|NCT01999322|12419031|FG000|NOT COMPLETED|Overall Study||1
11226972|NCT01999322|12419032|FG001|NOT COMPLETED|Overall Study||0
11226973|NCT01999335|12419043|FG000|STARTED|Overall Study||3
11226974|NCT01999335|12419044|FG001|STARTED|Overall Study||1
11226975|NCT01999335|12419045|FG002|STARTED|Overall Study||7
11226976|NCT01999335|12419046|FG003|STARTED|Overall Study||10
11226977|NCT01999335|12419047|FG004|STARTED|Overall Study||12
11226978|NCT01999335|12419043|FG000|Received Study Treatment|Overall Study||3
11226979|NCT01999335|12419044|FG001|Received Study Treatment|Overall Study||1
11226980|NCT01999335|12419045|FG002|Received Study Treatment|Overall Study||7
11226981|NCT01999335|12419046|FG003|Received Study Treatment|Overall Study||10
11226982|NCT01999335|12419047|FG004|Received Study Treatment|Overall Study||10
11226983|NCT01999335|12419043|FG000|COMPLETED|Overall Study||3
11226984|NCT01999335|12419044|FG001|COMPLETED|Overall Study||1
11226985|NCT01999335|12419045|FG002|COMPLETED|Overall Study||7
11226986|NCT01999335|12419046|FG003|COMPLETED|Overall Study||10
11226987|NCT01999335|12419047|FG004|COMPLETED|Overall Study||10
11226988|NCT01999335|12419043|FG000|NOT COMPLETED|Overall Study||0
11226989|NCT01999335|12419044|FG001|NOT COMPLETED|Overall Study||0
11226990|NCT01999335|12419045|FG002|NOT COMPLETED|Overall Study||0
11226991|NCT01999335|12419046|FG003|NOT COMPLETED|Overall Study||0
11226992|NCT01999335|12419047|FG004|NOT COMPLETED|Overall Study||2
11226993|NCT01999348|12419062|FG000|STARTED|Overall Study||1553
11226994|NCT01999348|12419062|FG000|COMPLETED|Overall Study||1433
11226995|NCT01999348|12419062|FG000|NOT COMPLETED|Overall Study||120
11226996|NCT01999400|12419066|FG000|STARTED|First Intervention (1 Day)||6
11226997|NCT01999400|12419067|FG001|STARTED|First Intervention (1 Day)||6
11226998|NCT01999400|12419068|FG002|STARTED|First Intervention (1 Day)||5
11226999|NCT01999400|12419069|FG003|STARTED|First Intervention (1 Day)||5
11227000|NCT01999400|12419070|FG004|STARTED|First Intervention (1 Day)||4
11227001|NCT01999400|12419071|FG005|STARTED|First Intervention (1 Day)||4
11227002|NCT01999400|12419066|FG000|COMPLETED|First Intervention (1 Day)||4
11227003|NCT01999400|12419067|FG001|COMPLETED|First Intervention (1 Day)||4
11227004|NCT01999400|12419068|FG002|COMPLETED|First Intervention (1 Day)||3
11227005|NCT01999400|12419069|FG003|COMPLETED|First Intervention (1 Day)||2
11227006|NCT01999400|12419070|FG004|COMPLETED|First Intervention (1 Day)||4
11227007|NCT01999400|12419071|FG005|COMPLETED|First Intervention (1 Day)||3
10859553|NCT00839930|12025381|FG001|STARTED|Second Intervention||15
10859554|NCT00839930|12025380|FG000|COMPLETED|Second Intervention||15
10859555|NCT00839930|12025381|FG001|COMPLETED|Second Intervention||15
10859556|NCT00839930|12025380|FG000|NOT COMPLETED|Second Intervention||0
10859557|NCT00839930|12025381|FG001|NOT COMPLETED|Second Intervention||0
10859558|NCT00838630|12025387|FG000|STARTED|First Intervention||18
10859559|NCT00838630|12025388|FG001|STARTED|First Intervention||18
10859560|NCT00838630|12025387|FG000|COMPLETED|First Intervention||17
10859561|NCT00838630|12025388|FG001|COMPLETED|First Intervention||18
10859562|NCT00838630|12025387|FG000|NOT COMPLETED|First Intervention||1
10859563|NCT00838630|12025388|FG001|NOT COMPLETED|First Intervention||0
10859564|NCT00838630|12025387|FG000|STARTED|Washout: 7 Days||17
10859565|NCT00838630|12025388|FG001|STARTED|Washout: 7 Days||18
10859566|NCT00838630|12025387|FG000|COMPLETED|Washout: 7 Days||16
10859567|NCT00838630|12025388|FG001|COMPLETED|Washout: 7 Days||18
10859568|NCT00838630|12025387|FG000|NOT COMPLETED|Washout: 7 Days||1
10859569|NCT00838630|12025388|FG001|NOT COMPLETED|Washout: 7 Days||0
10859570|NCT00838630|12025387|FG000|STARTED|Second Intervention||16
10859571|NCT00838630|12025388|FG001|STARTED|Second Intervention||18
10859572|NCT00838630|12025387|FG000|COMPLETED|Second Intervention||16
10859573|NCT00838630|12025388|FG001|COMPLETED|Second Intervention||18
10859574|NCT00838630|12025387|FG000|NOT COMPLETED|Second Intervention||0
10859575|NCT00838630|12025388|FG001|NOT COMPLETED|Second Intervention||0
10859576|NCT00838279|12025394|FG000|STARTED|First Intervention||16
10859577|NCT00838279|12025395|FG001|STARTED|First Intervention||16
10859578|NCT00838279|12025394|FG000|COMPLETED|First Intervention||16
10859579|NCT00838279|12025395|FG001|COMPLETED|First Intervention||16
10859580|NCT00838279|12025394|FG000|NOT COMPLETED|First Intervention||0
10859581|NCT00838279|12025395|FG001|NOT COMPLETED|First Intervention||0
10859582|NCT00838279|12025394|FG000|STARTED|Washout||16
10859583|NCT00838279|12025395|FG001|STARTED|Washout||16
10859584|NCT00838279|12025394|FG000|COMPLETED|Washout||15
10859585|NCT00838279|12025395|FG001|COMPLETED|Washout||15
10859586|NCT00838279|12025394|FG000|NOT COMPLETED|Washout||1
10859587|NCT00838279|12025395|FG001|NOT COMPLETED|Washout||1
10859588|NCT00838279|12025394|FG000|STARTED|Second Intervention||15
10859589|NCT00838279|12025395|FG001|STARTED|Second Intervention||15
10859590|NCT00838279|12025394|FG000|COMPLETED|Second Intervention||15
10859591|NCT00838279|12025395|FG001|COMPLETED|Second Intervention||15
10859592|NCT00838279|12025394|FG000|NOT COMPLETED|Second Intervention||0
10859593|NCT00838279|12025395|FG001|NOT COMPLETED|Second Intervention||0
10859594|NCT00838136|12025401|FG000|STARTED|First Intervention||16
10859595|NCT00838136|12025402|FG001|STARTED|First Intervention||16
10859596|NCT00838136|12025401|FG000|COMPLETED|First Intervention||16
10859597|NCT00838136|12025402|FG001|COMPLETED|First Intervention||16
10859598|NCT00838136|12025401|FG000|NOT COMPLETED|First Intervention||0
10859599|NCT00838136|12025402|FG001|NOT COMPLETED|First Intervention||0
10859600|NCT00838136|12025401|FG000|STARTED|Second Intervention||16
10859601|NCT00838136|12025402|FG001|STARTED|Second Intervention||16
10859602|NCT00838136|12025401|FG000|COMPLETED|Second Intervention||16
10859603|NCT00838136|12025402|FG001|COMPLETED|Second Intervention||15
10859604|NCT00838136|12025401|FG000|NOT COMPLETED|Second Intervention||0
10859605|NCT00838136|12025402|FG001|NOT COMPLETED|Second Intervention||1
10859606|NCT00836901|12025408|FG000|STARTED|First Intervention||24
10859607|NCT00836901|12025409|FG001|STARTED|First Intervention||28
10859608|NCT00836901|12025408|FG000|COMPLETED|First Intervention||23
10859609|NCT00836901|12025409|FG001|COMPLETED|First Intervention||28
10859610|NCT00836901|12025408|FG000|NOT COMPLETED|First Intervention||1
10859611|NCT00836901|12025409|FG001|NOT COMPLETED|First Intervention||0
10859612|NCT00836901|12025408|FG000|STARTED|Second Intervention||23
10859613|NCT00836901|12025409|FG001|STARTED|Second Intervention||28
10859614|NCT00836901|12025408|FG000|COMPLETED|Second Intervention||23
10859615|NCT00836901|12025409|FG001|COMPLETED|Second Intervention||28
10859616|NCT00836901|12025408|FG000|NOT COMPLETED|Second Intervention||0
10859617|NCT00836901|12025409|FG001|NOT COMPLETED|Second Intervention||0
10859618|NCT00836706|12025415|FG000|STARTED|First Intervention||11
10859619|NCT00836706|12025416|FG001|STARTED|First Intervention||12
10859620|NCT00836706|12025415|FG000|COMPLETED|First Intervention||11
10859621|NCT00836706|12025416|FG001|COMPLETED|First Intervention||12
10859622|NCT00836706|12025415|FG000|NOT COMPLETED|First Intervention||0
10859623|NCT00836706|12025416|FG001|NOT COMPLETED|First Intervention||0
10859624|NCT00836706|12025415|FG000|STARTED|Washout: 7 Days||11
10859625|NCT00836706|12025416|FG001|STARTED|Washout: 7 Days||12
10859626|NCT00836706|12025415|FG000|COMPLETED|Washout: 7 Days||11
10859627|NCT00836706|12025416|FG001|COMPLETED|Washout: 7 Days||11
10859628|NCT00836706|12025415|FG000|NOT COMPLETED|Washout: 7 Days||0
10859629|NCT00836706|12025416|FG001|NOT COMPLETED|Washout: 7 Days||1
10859630|NCT00836706|12025415|FG000|STARTED|Second Intervention||11
10859631|NCT00836706|12025416|FG001|STARTED|Second Intervention||11
10859632|NCT00836706|12025415|FG000|COMPLETED|Second Intervention||11
10859633|NCT00836706|12025416|FG001|COMPLETED|Second Intervention||11
10859634|NCT00836706|12025415|FG000|NOT COMPLETED|Second Intervention||0
10859635|NCT00836706|12025416|FG001|NOT COMPLETED|Second Intervention||0
10859636|NCT00836472|12025422|FG000|STARTED|First Intervention||30
10859637|NCT00836472|12025423|FG001|STARTED|First Intervention||30
10859638|NCT00836472|12025422|FG000|COMPLETED|First Intervention||30
10859639|NCT00836472|12025423|FG001|COMPLETED|First Intervention||30
10859640|NCT00836472|12025422|FG000|NOT COMPLETED|First Intervention||0
10859641|NCT00836472|12025423|FG001|NOT COMPLETED|First Intervention||0
10859642|NCT00836472|12025422|FG000|STARTED|Washout||30
10859643|NCT00836472|12025423|FG001|STARTED|Washout||30
10859644|NCT00836472|12025422|FG000|COMPLETED|Washout||28
10859645|NCT00836472|12025423|FG001|COMPLETED|Washout||27
10859646|NCT00836472|12025422|FG000|NOT COMPLETED|Washout||2
10859647|NCT00836472|12025423|FG001|NOT COMPLETED|Washout||3
10859648|NCT00836472|12025422|FG000|STARTED|Second Intervention||28
10859649|NCT00836472|12025423|FG001|STARTED|Second Intervention||27
10859650|NCT00836472|12025422|FG000|COMPLETED|Second Intervention||28
10859651|NCT00836472|12025423|FG001|COMPLETED|Second Intervention||27
10859652|NCT00836472|12025422|FG000|NOT COMPLETED|Second Intervention||0
10859653|NCT00836472|12025423|FG001|NOT COMPLETED|Second Intervention||0
10859654|NCT00836056|12025429|FG000|STARTED|First Intervention||12
10859655|NCT00836056|12025430|FG001|STARTED|First Intervention||12
10859656|NCT00836056|12025429|FG000|COMPLETED|First Intervention||11
10859657|NCT00836056|12025430|FG001|COMPLETED|First Intervention||12
10859658|NCT00836056|12025429|FG000|NOT COMPLETED|First Intervention||1
10859659|NCT00836056|12025430|FG001|NOT COMPLETED|First Intervention||0
10859660|NCT00836056|12025429|FG000|STARTED|Washout: 7 Days||11
10859661|NCT00836056|12025430|FG001|STARTED|Washout: 7 Days||12
10859662|NCT00836056|12025429|FG000|COMPLETED|Washout: 7 Days||11
10859663|NCT00836056|12025430|FG001|COMPLETED|Washout: 7 Days||12
10859664|NCT00836056|12025429|FG000|NOT COMPLETED|Washout: 7 Days||0
10859665|NCT00836056|12025430|FG001|NOT COMPLETED|Washout: 7 Days||0
10859666|NCT00836056|12025429|FG000|STARTED|Second Intervention||11
10859667|NCT00836056|12025430|FG001|STARTED|Second Intervention||12
10859668|NCT00836056|12025429|FG000|COMPLETED|Second Intervention||11
10859669|NCT00836056|12025430|FG001|COMPLETED|Second Intervention||12
10859670|NCT00836056|12025429|FG000|NOT COMPLETED|Second Intervention||0
10859671|NCT00836056|12025430|FG001|NOT COMPLETED|Second Intervention||0
10859672|NCT00836004|12025436|FG000|STARTED|First Intervention||12
10859673|NCT00836004|12025437|FG001|STARTED|First Intervention||12
10859674|NCT00836004|12025436|FG000|COMPLETED|First Intervention||12
10859675|NCT00836004|12025437|FG001|COMPLETED|First Intervention||12
10859676|NCT00836004|12025436|FG000|NOT COMPLETED|First Intervention||0
10859677|NCT00836004|12025437|FG001|NOT COMPLETED|First Intervention||0
10859678|NCT00836004|12025436|FG000|STARTED|Washout: 7 Days||12
10859679|NCT00836004|12025437|FG001|STARTED|Washout: 7 Days||12
10859680|NCT00836004|12025436|FG000|COMPLETED|Washout: 7 Days||12
10859681|NCT00836004|12025437|FG001|COMPLETED|Washout: 7 Days||12
10859682|NCT00836004|12025436|FG000|NOT COMPLETED|Washout: 7 Days||0
10859683|NCT00836004|12025437|FG001|NOT COMPLETED|Washout: 7 Days||0
10859684|NCT00836004|12025436|FG000|STARTED|Second Intervention||12
11227008|NCT01999400|12419066|FG000|NOT COMPLETED|First Intervention (1 Day)||2
11227009|NCT01999400|12419067|FG001|NOT COMPLETED|First Intervention (1 Day)||2
11227010|NCT01999400|12419068|FG002|NOT COMPLETED|First Intervention (1 Day)||2
11227011|NCT01999400|12419069|FG003|NOT COMPLETED|First Intervention (1 Day)||3
11227012|NCT01999400|12419070|FG004|NOT COMPLETED|First Intervention (1 Day)||0
11227013|NCT01999400|12419071|FG005|NOT COMPLETED|First Intervention (1 Day)||1
11227014|NCT01999400|12419066|FG000|STARTED|Washout (10 Days)||5
11227015|NCT01999400|12419067|FG001|STARTED|Washout (10 Days)||4
11227016|NCT01999400|12419068|FG002|STARTED|Washout (10 Days)||3
11227017|NCT01999400|12419069|FG003|STARTED|Washout (10 Days)||2
11227018|NCT01999400|12419070|FG004|STARTED|Washout (10 Days)||3
11227019|NCT01999400|12419071|FG005|STARTED|Washout (10 Days)||3
11227020|NCT01999400|12419066|FG000|COMPLETED|Washout (10 Days)||5
11227021|NCT01999400|12419067|FG001|COMPLETED|Washout (10 Days)||4
11227022|NCT01999400|12419068|FG002|COMPLETED|Washout (10 Days)||3
11227023|NCT01999400|12419069|FG003|COMPLETED|Washout (10 Days)||2
11227024|NCT01999400|12419070|FG004|COMPLETED|Washout (10 Days)||3
11227025|NCT01999400|12419071|FG005|COMPLETED|Washout (10 Days)||3
11227026|NCT01999400|12419066|FG000|NOT COMPLETED|Washout (10 Days)||0
11227027|NCT01999400|12419067|FG001|NOT COMPLETED|Washout (10 Days)||0
11227028|NCT01999400|12419068|FG002|NOT COMPLETED|Washout (10 Days)||0
11227029|NCT01999400|12419069|FG003|NOT COMPLETED|Washout (10 Days)||0
11227030|NCT01999400|12419070|FG004|NOT COMPLETED|Washout (10 Days)||0
11227031|NCT01999400|12419071|FG005|NOT COMPLETED|Washout (10 Days)||0
11227032|NCT01999400|12419066|FG000|STARTED|Second Intervention (1 Day)||5
11227033|NCT01999400|12419067|FG001|STARTED|Second Intervention (1 Day)||4
11227034|NCT01999400|12419068|FG002|STARTED|Second Intervention (1 Day)||3
11227035|NCT01999400|12419069|FG003|STARTED|Second Intervention (1 Day)||2
11227036|NCT01999400|12419070|FG004|STARTED|Second Intervention (1 Day)||3
11227037|NCT01999400|12419071|FG005|STARTED|Second Intervention (1 Day)||3
11227038|NCT01999400|12419066|FG000|COMPLETED|Second Intervention (1 Day)||5
11227039|NCT01999400|12419067|FG001|COMPLETED|Second Intervention (1 Day)||4
11227040|NCT01999400|12419068|FG002|COMPLETED|Second Intervention (1 Day)||3
11227041|NCT01999400|12419069|FG003|COMPLETED|Second Intervention (1 Day)||2
11227042|NCT01999400|12419070|FG004|COMPLETED|Second Intervention (1 Day)||3
11227043|NCT01999400|12419071|FG005|COMPLETED|Second Intervention (1 Day)||3
11227044|NCT01999400|12419066|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11227045|NCT01999400|12419067|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11227046|NCT01999400|12419068|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
11227047|NCT01999400|12419069|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
11227048|NCT01999400|12419070|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
11227049|NCT01999400|12419071|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
10859685|NCT00836004|12025437|FG001|STARTED|Second Intervention||12
10859686|NCT00836004|12025436|FG000|COMPLETED|Second Intervention||12
10859687|NCT00836004|12025437|FG001|COMPLETED|Second Intervention||12
10859688|NCT00836004|12025436|FG000|NOT COMPLETED|Second Intervention||0
10859689|NCT00836004|12025437|FG001|NOT COMPLETED|Second Intervention||0
10859690|NCT00835991|12025443|FG000|STARTED|First Intervention||30
10859691|NCT00835991|12025444|FG001|STARTED|First Intervention||30
10859692|NCT00835991|12025443|FG000|COMPLETED|First Intervention||30
10859693|NCT00835991|12025444|FG001|COMPLETED|First Intervention||29
10859694|NCT00835991|12025443|FG000|NOT COMPLETED|First Intervention||0
10859695|NCT00835991|12025444|FG001|NOT COMPLETED|First Intervention||1
10859696|NCT00835991|12025443|FG000|STARTED|Washout||30
10859697|NCT00835991|12025444|FG001|STARTED|Washout||29
10859698|NCT00835991|12025443|FG000|COMPLETED|Washout||27
10859699|NCT00835991|12025444|FG001|COMPLETED|Washout||26
10859700|NCT00835991|12025443|FG000|NOT COMPLETED|Washout||3
10859701|NCT00835991|12025444|FG001|NOT COMPLETED|Washout||3
10859702|NCT00835991|12025443|FG000|STARTED|Second Intervention||27
10859703|NCT00835991|12025444|FG001|STARTED|Second Intervention||26
10859704|NCT00835991|12025443|FG000|COMPLETED|Second Intervention||27
10859705|NCT00835991|12025444|FG001|COMPLETED|Second Intervention||26
10859706|NCT00835991|12025443|FG000|NOT COMPLETED|Second Intervention||0
10859707|NCT00835991|12025444|FG001|NOT COMPLETED|Second Intervention||0
10859708|NCT00835796|12025450|FG000|STARTED|First Intervention||10
10859709|NCT00835796|12025451|FG001|STARTED|First Intervention||10
10859710|NCT00835796|12025450|FG000|COMPLETED|First Intervention||10
10859711|NCT00835796|12025451|FG001|COMPLETED|First Intervention||9
10859712|NCT00835796|12025450|FG000|NOT COMPLETED|First Intervention||0
10859713|NCT00835796|12025451|FG001|NOT COMPLETED|First Intervention||1
10859714|NCT00835796|12025450|FG000|STARTED|Washout||10
10859715|NCT00835796|12025451|FG001|STARTED|Washout||9
10859716|NCT00835796|12025450|FG000|COMPLETED|Washout||10
10859717|NCT00835796|12025451|FG001|COMPLETED|Washout||9
10859718|NCT00835796|12025450|FG000|NOT COMPLETED|Washout||0
10859719|NCT00835796|12025451|FG001|NOT COMPLETED|Washout||0
10859720|NCT00835796|12025450|FG000|STARTED|Second Intervention||10
10859721|NCT00835796|12025451|FG001|STARTED|Second Intervention||9
10859722|NCT00835796|12025450|FG000|COMPLETED|Second Intervention||10
10859723|NCT00835796|12025451|FG001|COMPLETED|Second Intervention||9
10859724|NCT00835796|12025450|FG000|NOT COMPLETED|Second Intervention||0
10859725|NCT00835796|12025451|FG001|NOT COMPLETED|Second Intervention||0
10859726|NCT00835705|12025457|FG000|STARTED|First Intervention||24
10859727|NCT00835705|12025458|FG001|STARTED|First Intervention||28
10859728|NCT00835705|12025457|FG000|COMPLETED|First Intervention||23
10859729|NCT00835705|12025458|FG001|COMPLETED|First Intervention||28
10859730|NCT00835705|12025457|FG000|NOT COMPLETED|First Intervention||1
10859731|NCT00835705|12025458|FG001|NOT COMPLETED|First Intervention||0
11227050|NCT01999400|12419066|FG000|STARTED|Washout (10 Days)||2
11227051|NCT01999400|12419067|FG001|STARTED|Washout (10 Days)||0
11227052|NCT01999400|12419068|FG002|STARTED|Washout (10 Days)||1
11227053|NCT01999400|12419069|FG003|STARTED|Washout (10 Days)||1
11227054|NCT01999400|12419070|FG004|STARTED|Washout (10 Days)||1
11227055|NCT01999400|12419071|FG005|STARTED|Washout (10 Days)||1
11227056|NCT01999400|12419066|FG000|COMPLETED|Washout (10 Days)||2
11227057|NCT01999400|12419067|FG001|COMPLETED|Washout (10 Days)||0
11227058|NCT01999400|12419068|FG002|COMPLETED|Washout (10 Days)||1
11227059|NCT01999400|12419069|FG003|COMPLETED|Washout (10 Days)||1
10859732|NCT00835705|12025457|FG000|STARTED|Second Intervention||23
10859733|NCT00835705|12025458|FG001|STARTED|Second Intervention||28
10859734|NCT00835705|12025457|FG000|COMPLETED|Second Intervention||22
10859735|NCT00835705|12025458|FG001|COMPLETED|Second Intervention||28
10859736|NCT00835705|12025457|FG000|NOT COMPLETED|Second Intervention||1
10859737|NCT00835705|12025458|FG001|NOT COMPLETED|Second Intervention||0
10859738|NCT00835692|12025464|FG000|STARTED|First Intervention||28
10859739|NCT00835692|12025465|FG001|STARTED|First Intervention||28
10859740|NCT00835692|12025464|FG000|COMPLETED|First Intervention||27
10859741|NCT00835692|12025465|FG001|COMPLETED|First Intervention||28
10859742|NCT00835692|12025464|FG000|NOT COMPLETED|First Intervention||1
10859743|NCT00835692|12025465|FG001|NOT COMPLETED|First Intervention||0
10859744|NCT00835692|12025464|FG000|STARTED|Washout||27
10859745|NCT00835692|12025465|FG001|STARTED|Washout||28
10859746|NCT00835692|12025464|FG000|COMPLETED|Washout||27
10859747|NCT00835692|12025465|FG001|COMPLETED|Washout||28
10859748|NCT00835692|12025464|FG000|NOT COMPLETED|Washout||0
10859749|NCT00835692|12025465|FG001|NOT COMPLETED|Washout||0
10859750|NCT00835692|12025464|FG000|STARTED|Second Intervention||27
10859751|NCT00835692|12025465|FG001|STARTED|Second Intervention||28
10859752|NCT00835692|12025464|FG000|COMPLETED|Second Intervention||27
10859753|NCT00835692|12025465|FG001|COMPLETED|Second Intervention||28
10859754|NCT00835692|12025464|FG000|NOT COMPLETED|Second Intervention||0
11107511|NCT01263223|12291874|FG001|STARTED|3-Day Washout||12
10859755|NCT00835692|12025465|FG001|NOT COMPLETED|Second Intervention||0
11107512|NCT01263223|12291873|FG000|COMPLETED|3-Day Washout||12
11107513|NCT01263223|12291874|FG001|COMPLETED|3-Day Washout||12
11107514|NCT01263223|12291873|FG000|NOT COMPLETED|3-Day Washout||0
11107515|NCT01263223|12291874|FG001|NOT COMPLETED|3-Day Washout||0
11107516|NCT01263223|12291873|FG000|STARTED|Period 2||12
11107517|NCT01263223|12291874|FG001|STARTED|Period 2||12
11107518|NCT01263223|12291873|FG000|COMPLETED|Period 2||12
11107519|NCT01263223|12291874|FG001|COMPLETED|Period 2||11
11107520|NCT01263223|12291873|FG000|NOT COMPLETED|Period 2||0
10859756|NCT00835666|12025471|FG000|STARTED|First Intervention||16
10859757|NCT00835666|12025472|FG001|STARTED|First Intervention||16
10859758|NCT00835666|12025471|FG000|COMPLETED|First Intervention||16
10859759|NCT00835666|12025472|FG001|COMPLETED|First Intervention||16
10859760|NCT00835666|12025471|FG000|NOT COMPLETED|First Intervention||0
10859761|NCT00835666|12025472|FG001|NOT COMPLETED|First Intervention||0
10859762|NCT00835666|12025471|FG000|STARTED|Washout||16
10859763|NCT00835666|12025472|FG001|STARTED|Washout||16
10859764|NCT00835666|12025471|FG000|COMPLETED|Washout||14
10859765|NCT00835666|12025472|FG001|COMPLETED|Washout||16
10859766|NCT00835666|12025471|FG000|NOT COMPLETED|Washout||2
10859767|NCT00835666|12025472|FG001|NOT COMPLETED|Washout||0
10859768|NCT00835666|12025471|FG000|STARTED|Second Intervention||14
10859769|NCT00835666|12025472|FG001|STARTED|Second Intervention||16
10859770|NCT00835666|12025471|FG000|COMPLETED|Second Intervention||14
10859771|NCT00835666|12025472|FG001|COMPLETED|Second Intervention||16
10859772|NCT00835666|12025471|FG000|NOT COMPLETED|Second Intervention||0
10859773|NCT00835666|12025472|FG001|NOT COMPLETED|Second Intervention||0
10859774|NCT00835640|12025478|FG000|STARTED|First Intervention||12
10859775|NCT00835640|12025479|FG001|STARTED|First Intervention||12
10859776|NCT00835640|12025478|FG000|COMPLETED|First Intervention||12
10859777|NCT00835640|12025479|FG001|COMPLETED|First Intervention||12
10859778|NCT00835640|12025478|FG000|NOT COMPLETED|First Intervention||0
10859779|NCT00835640|12025479|FG001|NOT COMPLETED|First Intervention||0
10859780|NCT00835640|12025478|FG000|STARTED|Washout of 7 Days||12
10859781|NCT00835640|12025479|FG001|STARTED|Washout of 7 Days||12
10859782|NCT00835640|12025478|FG000|COMPLETED|Washout of 7 Days||12
10859783|NCT00835640|12025479|FG001|COMPLETED|Washout of 7 Days||12
10859784|NCT00835640|12025478|FG000|NOT COMPLETED|Washout of 7 Days||0
10859785|NCT00835640|12025479|FG001|NOT COMPLETED|Washout of 7 Days||0
10859786|NCT00835640|12025478|FG000|STARTED|Second Intervention||12
10859787|NCT00835640|12025479|FG001|STARTED|Second Intervention||12
10859788|NCT00835640|12025478|FG000|COMPLETED|Second Intervention||11
10859789|NCT00835640|12025479|FG001|COMPLETED|Second Intervention||12
10859790|NCT00835640|12025478|FG000|NOT COMPLETED|Second Intervention||1
10859791|NCT00835640|12025479|FG001|NOT COMPLETED|Second Intervention||0
11227060|NCT01999400|12419070|FG004|COMPLETED|Washout (10 Days)||1
10859792|NCT00835614|12025485|FG000|STARTED|First Intervention||13
10859793|NCT00835614|12025486|FG001|STARTED|First Intervention||13
10859794|NCT00835614|12025485|FG000|COMPLETED|First Intervention||13
10859795|NCT00835614|12025486|FG001|COMPLETED|First Intervention||13
10859796|NCT00835614|12025485|FG000|NOT COMPLETED|First Intervention||0
10859797|NCT00835614|12025486|FG001|NOT COMPLETED|First Intervention||0
10859798|NCT00835614|12025485|FG000|STARTED|Washout of 7 Days||13
10859799|NCT00835614|12025486|FG001|STARTED|Washout of 7 Days||13
10859800|NCT00835614|12025485|FG000|COMPLETED|Washout of 7 Days||13
10859801|NCT00835614|12025486|FG001|COMPLETED|Washout of 7 Days||13
10859802|NCT00835614|12025485|FG000|NOT COMPLETED|Washout of 7 Days||0
10859803|NCT00835614|12025486|FG001|NOT COMPLETED|Washout of 7 Days||0
10859804|NCT00835614|12025485|FG000|STARTED|Second Intervention||13
10859805|NCT00835614|12025486|FG001|STARTED|Second Intervention||13
10859806|NCT00835614|12025485|FG000|COMPLETED|Second Intervention||13
10859807|NCT00835614|12025486|FG001|COMPLETED|Second Intervention||13
10859808|NCT00835614|12025485|FG000|NOT COMPLETED|Second Intervention||0
10859809|NCT00835614|12025486|FG001|NOT COMPLETED|Second Intervention||0
10859810|NCT00835588|12025492|FG000|STARTED|First Intervention||50
10859811|NCT00835588|12025493|FG001|STARTED|First Intervention||50
10859812|NCT00835588|12025492|FG000|COMPLETED|First Intervention||50
10859813|NCT00835588|12025493|FG001|COMPLETED|First Intervention||50
10859814|NCT00835588|12025492|FG000|NOT COMPLETED|First Intervention||0
10859815|NCT00835588|12025493|FG001|NOT COMPLETED|First Intervention||0
10859816|NCT00835588|12025492|FG000|STARTED|Washout: 5 Days||50
10859817|NCT00835588|12025493|FG001|STARTED|Washout: 5 Days||50
10859818|NCT00835588|12025492|FG000|COMPLETED|Washout: 5 Days||50
10859819|NCT00835588|12025493|FG001|COMPLETED|Washout: 5 Days||50
10859820|NCT00835588|12025492|FG000|NOT COMPLETED|Washout: 5 Days||0
10859821|NCT00835588|12025493|FG001|NOT COMPLETED|Washout: 5 Days||0
10859822|NCT00835588|12025492|FG000|STARTED|Second Intervention||50
10859823|NCT00835588|12025493|FG001|STARTED|Second Intervention||50
10859824|NCT00835588|12025492|FG000|COMPLETED|Second Intervention||50
10859825|NCT00835588|12025493|FG001|COMPLETED|Second Intervention||50
10859826|NCT00835588|12025492|FG000|NOT COMPLETED|Second Intervention||0
10859827|NCT00835588|12025493|FG001|NOT COMPLETED|Second Intervention||0
10859828|NCT00835575|12025499|FG000|STARTED|First Intervention||16
10859829|NCT00835575|12025500|FG001|STARTED|First Intervention||16
10859830|NCT00835575|12025499|FG000|COMPLETED|First Intervention||16
10859831|NCT00835575|12025500|FG001|COMPLETED|First Intervention||16
10859832|NCT00835575|12025499|FG000|NOT COMPLETED|First Intervention||0
10859833|NCT00835575|12025500|FG001|NOT COMPLETED|First Intervention||0
10859834|NCT00835575|12025499|FG000|STARTED|Washout of 14 Days||16
10859835|NCT00835575|12025500|FG001|STARTED|Washout of 14 Days||16
10859836|NCT00835575|12025499|FG000|COMPLETED|Washout of 14 Days||15
10859837|NCT00835575|12025500|FG001|COMPLETED|Washout of 14 Days||16
10859838|NCT00835575|12025499|FG000|NOT COMPLETED|Washout of 14 Days||1
10859839|NCT00835575|12025500|FG001|NOT COMPLETED|Washout of 14 Days||0
10859840|NCT00835575|12025499|FG000|STARTED|Second Intervention||15
10859841|NCT00835575|12025500|FG001|STARTED|Second Intervention||16
11107521|NCT01263223|12291874|FG001|NOT COMPLETED|Period 2||1
11107522|NCT01263223|12291873|FG000|STARTED|Period 3||12
10859842|NCT00835575|12025499|FG000|COMPLETED|Second Intervention||15
10859843|NCT00835575|12025500|FG001|COMPLETED|Second Intervention||16
10859844|NCT00835575|12025499|FG000|NOT COMPLETED|Second Intervention||0
10859845|NCT00835575|12025500|FG001|NOT COMPLETED|Second Intervention||0
10859846|NCT00835549|12025506|FG000|STARTED|First Intervention||16
10859847|NCT00835549|12025507|FG001|STARTED|First Intervention||16
10859848|NCT00835549|12025506|FG000|COMPLETED|First Intervention||16
10859849|NCT00835549|12025507|FG001|COMPLETED|First Intervention||16
10859850|NCT00835549|12025506|FG000|NOT COMPLETED|First Intervention||0
10859851|NCT00835549|12025507|FG001|NOT COMPLETED|First Intervention||0
10859852|NCT00835549|12025506|FG000|STARTED|Washout of 7 Days||16
10859853|NCT00835549|12025507|FG001|STARTED|Washout of 7 Days||16
10859854|NCT00835549|12025506|FG000|COMPLETED|Washout of 7 Days||14
10859855|NCT00835549|12025507|FG001|COMPLETED|Washout of 7 Days||16
10859856|NCT00835549|12025506|FG000|NOT COMPLETED|Washout of 7 Days||2
10859857|NCT00835549|12025507|FG001|NOT COMPLETED|Washout of 7 Days||0
10859858|NCT00835549|12025506|FG000|STARTED|Second Intervention||14
10859859|NCT00835549|12025507|FG001|STARTED|Second Intervention||16
10859860|NCT00835549|12025506|FG000|COMPLETED|Second Intervention||14
10859861|NCT00835549|12025507|FG001|COMPLETED|Second Intervention||16
10859862|NCT00835549|12025506|FG000|NOT COMPLETED|Second Intervention||0
10859863|NCT00835549|12025507|FG001|NOT COMPLETED|Second Intervention||0
10859864|NCT00835536|12025513|FG000|STARTED|First Intervention||13
10859865|NCT00835536|12025514|FG001|STARTED|First Intervention||14
10859866|NCT00835536|12025513|FG000|COMPLETED|First Intervention||13
10859867|NCT00835536|12025514|FG001|COMPLETED|First Intervention||14
10859868|NCT00835536|12025513|FG000|NOT COMPLETED|First Intervention||0
10859869|NCT00835536|12025514|FG001|NOT COMPLETED|First Intervention||0
10859870|NCT00835536|12025513|FG000|STARTED|Washout of 5 Weeks||13
10859871|NCT00835536|12025514|FG001|STARTED|Washout of 5 Weeks||14
10859872|NCT00835536|12025513|FG000|COMPLETED|Washout of 5 Weeks||12
10859873|NCT00835536|12025514|FG001|COMPLETED|Washout of 5 Weeks||14
10859874|NCT00835536|12025513|FG000|NOT COMPLETED|Washout of 5 Weeks||1
10859875|NCT00835536|12025514|FG001|NOT COMPLETED|Washout of 5 Weeks||0
10859876|NCT00835536|12025513|FG000|STARTED|Second Intervention||12
10859877|NCT00835536|12025514|FG001|STARTED|Second Intervention||14
10859878|NCT00835536|12025513|FG000|COMPLETED|Second Intervention||12
10859879|NCT00835536|12025514|FG001|COMPLETED|Second Intervention||14
10859880|NCT00835536|12025513|FG000|NOT COMPLETED|Second Intervention||0
10859881|NCT00835536|12025514|FG001|NOT COMPLETED|Second Intervention||0
10859882|NCT00835497|12025520|FG000|STARTED|First Intervention||20
10859883|NCT00835497|12025521|FG001|STARTED|First Intervention||20
10859884|NCT00835497|12025520|FG000|COMPLETED|First Intervention||20
10859885|NCT00835497|12025521|FG001|COMPLETED|First Intervention||20
10859886|NCT00835497|12025520|FG000|NOT COMPLETED|First Intervention||0
10859887|NCT00835497|12025521|FG001|NOT COMPLETED|First Intervention||0
10859888|NCT00835497|12025520|FG000|STARTED|Washout: 7 Days||20
10859889|NCT00835497|12025521|FG001|STARTED|Washout: 7 Days||20
10859890|NCT00835497|12025520|FG000|COMPLETED|Washout: 7 Days||20
10859891|NCT00835497|12025521|FG001|COMPLETED|Washout: 7 Days||20
10859892|NCT00835497|12025520|FG000|NOT COMPLETED|Washout: 7 Days||0
10859893|NCT00835497|12025521|FG001|NOT COMPLETED|Washout: 7 Days||0
10859894|NCT00835497|12025520|FG000|STARTED|Second Intervention||20
10859895|NCT00835497|12025521|FG001|STARTED|Second Intervention||20
10859896|NCT00835497|12025520|FG000|COMPLETED|Second Intervention||20
10859897|NCT00835497|12025521|FG001|COMPLETED|Second Intervention||20
10859898|NCT00835497|12025520|FG000|NOT COMPLETED|Second Intervention||0
10859899|NCT00835497|12025521|FG001|NOT COMPLETED|Second Intervention||0
10859900|NCT00835484|12025527|FG000|STARTED|First Intervention||16
10859901|NCT00835484|12025528|FG001|STARTED|First Intervention||16
10859902|NCT00835484|12025527|FG000|COMPLETED|First Intervention||16
10859903|NCT00835484|12025528|FG001|COMPLETED|First Intervention||16
10859904|NCT00835484|12025527|FG000|NOT COMPLETED|First Intervention||0
10859905|NCT00835484|12025528|FG001|NOT COMPLETED|First Intervention||0
10859906|NCT00835484|12025527|FG000|STARTED|Washout of 7 Days||16
10859907|NCT00835484|12025528|FG001|STARTED|Washout of 7 Days||16
10859908|NCT00835484|12025527|FG000|COMPLETED|Washout of 7 Days||16
10859909|NCT00835484|12025528|FG001|COMPLETED|Washout of 7 Days||16
10859910|NCT00835484|12025527|FG000|NOT COMPLETED|Washout of 7 Days||0
10859911|NCT00835484|12025528|FG001|NOT COMPLETED|Washout of 7 Days||0
10859912|NCT00835484|12025527|FG000|STARTED|Second Intervention||16
10859913|NCT00835484|12025528|FG001|STARTED|Second Intervention||16
10859914|NCT00835484|12025527|FG000|COMPLETED|Second Intervention||16
10859915|NCT00835484|12025528|FG001|COMPLETED|Second Intervention||16
10859916|NCT00835484|12025527|FG000|NOT COMPLETED|Second Intervention||0
10859917|NCT00835484|12025528|FG001|NOT COMPLETED|Second Intervention||0
10859918|NCT00835406|12025534|FG000|STARTED|Period: First Intervention||70
10859919|NCT00835406|12025535|FG001|STARTED|Period: First Intervention||70
10859920|NCT00835406|12025534|FG000|COMPLETED|Period: First Intervention||68
10859921|NCT00835406|12025535|FG001|COMPLETED|Period: First Intervention||69
10859922|NCT00835406|12025534|FG000|NOT COMPLETED|Period: First Intervention||2
10859923|NCT00835406|12025535|FG001|NOT COMPLETED|Period: First Intervention||1
10859924|NCT00835406|12025534|FG000|STARTED|Period: Washout of 7 Days||68
10859925|NCT00835406|12025535|FG001|STARTED|Period: Washout of 7 Days||69
10859926|NCT00835406|12025534|FG000|COMPLETED|Period: Washout of 7 Days||68
10859927|NCT00835406|12025535|FG001|COMPLETED|Period: Washout of 7 Days||67
10859928|NCT00835406|12025534|FG000|NOT COMPLETED|Period: Washout of 7 Days||0
10859929|NCT00835406|12025535|FG001|NOT COMPLETED|Period: Washout of 7 Days||2
10859930|NCT00835406|12025534|FG000|STARTED|Period: Second Intervention||68
10859931|NCT00835406|12025535|FG001|STARTED|Period: Second Intervention||67
10859932|NCT00835406|12025534|FG000|COMPLETED|Period: Second Intervention||68
10859933|NCT00835406|12025535|FG001|COMPLETED|Period: Second Intervention||67
10859934|NCT00835406|12025534|FG000|NOT COMPLETED|Period: Second Intervention||0
10859935|NCT00835406|12025535|FG001|NOT COMPLETED|Period: Second Intervention||0
10859936|NCT00835367|12025541|FG000|STARTED|First Intervention||34
10859937|NCT00835367|12025542|FG001|STARTED|First Intervention||34
10859938|NCT00835367|12025541|FG000|COMPLETED|First Intervention||34
10859939|NCT00835367|12025542|FG001|COMPLETED|First Intervention||34
10859940|NCT00835367|12025541|FG000|NOT COMPLETED|First Intervention||0
10859941|NCT00835367|12025542|FG001|NOT COMPLETED|First Intervention||0
10859942|NCT00835367|12025541|FG000|STARTED|Washout||34
10859943|NCT00835367|12025542|FG001|STARTED|Washout||34
10859944|NCT00835367|12025541|FG000|COMPLETED|Washout||31
10859945|NCT00835367|12025542|FG001|COMPLETED|Washout||34
10859946|NCT00835367|12025541|FG000|NOT COMPLETED|Washout||3
10859947|NCT00835367|12025542|FG001|NOT COMPLETED|Washout||0
10859948|NCT00835367|12025541|FG000|STARTED|Second Intervention||31
10859949|NCT00835367|12025542|FG001|STARTED|Second Intervention||34
10859950|NCT00835367|12025541|FG000|COMPLETED|Second Intervention||30
10859951|NCT00835367|12025542|FG001|COMPLETED|Second Intervention||33
10859952|NCT00835367|12025541|FG000|NOT COMPLETED|Second Intervention||1
10859953|NCT00835367|12025542|FG001|NOT COMPLETED|Second Intervention||1
10859954|NCT00835354|12025548|FG000|STARTED|First Intervention||13
10859955|NCT00835354|12025549|FG001|STARTED|First Intervention||13
10859956|NCT00835354|12025548|FG000|COMPLETED|First Intervention||13
10859957|NCT00835354|12025549|FG001|COMPLETED|First Intervention||12
10859958|NCT00835354|12025548|FG000|NOT COMPLETED|First Intervention||0
10859959|NCT00835354|12025549|FG001|NOT COMPLETED|First Intervention||1
10859960|NCT00835354|12025548|FG000|STARTED|Washout of 7 Days||13
10859961|NCT00835354|12025549|FG001|STARTED|Washout of 7 Days||12
10859962|NCT00835354|12025548|FG000|COMPLETED|Washout of 7 Days||13
10859963|NCT00835354|12025549|FG001|COMPLETED|Washout of 7 Days||12
10859964|NCT00835354|12025548|FG000|NOT COMPLETED|Washout of 7 Days||0
10859965|NCT00835354|12025549|FG001|NOT COMPLETED|Washout of 7 Days||0
10859966|NCT00835354|12025548|FG000|STARTED|Second Intervention||13
10859967|NCT00835354|12025549|FG001|STARTED|Second Intervention||12
10859968|NCT00835354|12025548|FG000|COMPLETED|Second Intervention||13
10859969|NCT00835354|12025549|FG001|COMPLETED|Second Intervention||12
10859970|NCT00835354|12025548|FG000|NOT COMPLETED|Second Intervention||0
10859971|NCT00835354|12025549|FG001|NOT COMPLETED|Second Intervention||0
10859972|NCT00835276|12025555|FG000|STARTED|First Intervention||24
10859973|NCT00835276|12025556|FG001|STARTED|First Intervention||24
10859974|NCT00835276|12025555|FG000|COMPLETED|First Intervention||24
10859975|NCT00835276|12025556|FG001|COMPLETED|First Intervention||24
10859976|NCT00835276|12025555|FG000|NOT COMPLETED|First Intervention||0
10859977|NCT00835276|12025556|FG001|NOT COMPLETED|First Intervention||0
10859978|NCT00835276|12025555|FG000|STARTED|Washout of 7 Days||24
10859979|NCT00835276|12025556|FG001|STARTED|Washout of 7 Days||24
10859980|NCT00835276|12025555|FG000|COMPLETED|Washout of 7 Days||24
10859981|NCT00835276|12025556|FG001|COMPLETED|Washout of 7 Days||24
10859982|NCT00835276|12025555|FG000|NOT COMPLETED|Washout of 7 Days||0
10859983|NCT00835276|12025556|FG001|NOT COMPLETED|Washout of 7 Days||0
10859984|NCT00835276|12025555|FG000|STARTED|Second Intervention||24
10859985|NCT00835276|12025556|FG001|STARTED|Second Intervention||24
10859986|NCT00835276|12025555|FG000|COMPLETED|Second Intervention||24
10859987|NCT00835276|12025556|FG001|COMPLETED|Second Intervention||24
10859988|NCT00835276|12025555|FG000|NOT COMPLETED|Second Intervention||0
10859989|NCT00835276|12025556|FG001|NOT COMPLETED|Second Intervention||0
10859990|NCT00835263|12025562|FG000|STARTED|First Intervention||16
10859991|NCT00835263|12025563|FG001|STARTED|First Intervention||16
10859992|NCT00835263|12025562|FG000|COMPLETED|First Intervention||16
10859993|NCT00835263|12025563|FG001|COMPLETED|First Intervention||16
10859994|NCT00835263|12025562|FG000|NOT COMPLETED|First Intervention||0
10859995|NCT00835263|12025563|FG001|NOT COMPLETED|First Intervention||0
10859996|NCT00835263|12025562|FG000|STARTED|Second Intervention||16
10859997|NCT00835263|12025563|FG001|STARTED|Second Intervention||16
10859998|NCT00835263|12025562|FG000|COMPLETED|Second Intervention||15
10859999|NCT00835263|12025563|FG001|COMPLETED|Second Intervention||16
10860000|NCT00835263|12025562|FG000|NOT COMPLETED|Second Intervention||1
10860001|NCT00835263|12025563|FG001|NOT COMPLETED|Second Intervention||0
10860002|NCT00835211|12025569|FG000|STARTED|First Intervention||24
10860003|NCT00835211|12025570|FG001|STARTED|First Intervention||24
10860004|NCT00835211|12025569|FG000|COMPLETED|First Intervention||24
10860005|NCT00835211|12025570|FG001|COMPLETED|First Intervention||23
10860006|NCT00835211|12025569|FG000|NOT COMPLETED|First Intervention||0
10860007|NCT00835211|12025570|FG001|NOT COMPLETED|First Intervention||1
10860008|NCT00835211|12025569|FG000|STARTED|Washout: 7 Days||24
10860009|NCT00835211|12025570|FG001|STARTED|Washout: 7 Days||23
10860010|NCT00835211|12025569|FG000|COMPLETED|Washout: 7 Days||21
10860011|NCT00835211|12025570|FG001|COMPLETED|Washout: 7 Days||22
10860012|NCT00835211|12025569|FG000|NOT COMPLETED|Washout: 7 Days||3
10860013|NCT00835211|12025570|FG001|NOT COMPLETED|Washout: 7 Days||1
10860014|NCT00835211|12025569|FG000|STARTED|Second Intervention||21
10860015|NCT00835211|12025570|FG001|STARTED|Second Intervention||22
10860016|NCT00835211|12025569|FG000|COMPLETED|Second Intervention||21
10860017|NCT00835211|12025570|FG001|COMPLETED|Second Intervention||22
10860018|NCT00835211|12025569|FG000|NOT COMPLETED|Second Intervention||0
10860019|NCT00835211|12025570|FG001|NOT COMPLETED|Second Intervention||0
10860020|NCT00835172|12025576|FG000|STARTED|First Intervention||16
10860021|NCT00835172|12025577|FG001|STARTED|First Intervention||16
10860022|NCT00835172|12025576|FG000|COMPLETED|First Intervention||16
10860023|NCT00835172|12025577|FG001|COMPLETED|First Intervention||16
10860024|NCT00835172|12025576|FG000|NOT COMPLETED|First Intervention||0
10860025|NCT00835172|12025577|FG001|NOT COMPLETED|First Intervention||0
10860026|NCT00835172|12025576|FG000|STARTED|Washout||16
10860027|NCT00835172|12025577|FG001|STARTED|Washout||16
10860028|NCT00835172|12025576|FG000|COMPLETED|Washout||16
10860029|NCT00835172|12025577|FG001|COMPLETED|Washout||15
10860030|NCT00835172|12025576|FG000|NOT COMPLETED|Washout||0
10860031|NCT00835172|12025577|FG001|NOT COMPLETED|Washout||1
10860032|NCT00835172|12025576|FG000|STARTED|Second Intervention||16
10860033|NCT00835172|12025577|FG001|STARTED|Second Intervention||15
10860034|NCT00835172|12025576|FG000|COMPLETED|Second Intervention||16
10860035|NCT00835172|12025577|FG001|COMPLETED|Second Intervention||15
10860036|NCT00835172|12025576|FG000|NOT COMPLETED|Second Intervention||0
10860037|NCT00835172|12025577|FG001|NOT COMPLETED|Second Intervention||0
10860038|NCT00835146|12025583|FG000|STARTED|First Intervention||14
10860039|NCT00835146|12025584|FG001|STARTED|First Intervention||14
10860040|NCT00835146|12025583|FG000|COMPLETED|First Intervention||14
10860041|NCT00835146|12025584|FG001|COMPLETED|First Intervention||14
10860042|NCT00835146|12025583|FG000|NOT COMPLETED|First Intervention||0
10860043|NCT00835146|12025584|FG001|NOT COMPLETED|First Intervention||0
10860044|NCT00835146|12025583|FG000|STARTED|Washout of 5 Weeks||14
10860045|NCT00835146|12025584|FG001|STARTED|Washout of 5 Weeks||14
10860046|NCT00835146|12025583|FG000|COMPLETED|Washout of 5 Weeks||14
10860047|NCT00835146|12025584|FG001|COMPLETED|Washout of 5 Weeks||14
10860048|NCT00835146|12025583|FG000|NOT COMPLETED|Washout of 5 Weeks||0
10860049|NCT00835146|12025584|FG001|NOT COMPLETED|Washout of 5 Weeks||0
10860050|NCT00835146|12025583|FG000|STARTED|Second Intervention||14
10860051|NCT00835146|12025584|FG001|STARTED|Second Intervention||14
10860052|NCT00835146|12025583|FG000|COMPLETED|Second Intervention||14
10860053|NCT00835146|12025584|FG001|COMPLETED|Second Intervention||14
10860054|NCT00835146|12025583|FG000|NOT COMPLETED|Second Intervention||0
10860055|NCT00835146|12025584|FG001|NOT COMPLETED|Second Intervention||0
10860056|NCT00835081|12025590|FG000|STARTED|First Intervention||13
10860057|NCT00835081|12025591|FG001|STARTED|First Intervention||13
10860058|NCT00835081|12025590|FG000|COMPLETED|First Intervention||13
10860059|NCT00835081|12025591|FG001|COMPLETED|First Intervention||13
10860060|NCT00835081|12025590|FG000|NOT COMPLETED|First Intervention||0
10860061|NCT00835081|12025591|FG001|NOT COMPLETED|First Intervention||0
10860062|NCT00835081|12025590|FG000|STARTED|Washout of 7 Days||13
10860063|NCT00835081|12025591|FG001|STARTED|Washout of 7 Days||13
10860064|NCT00835081|12025590|FG000|COMPLETED|Washout of 7 Days||12
10860065|NCT00835081|12025591|FG001|COMPLETED|Washout of 7 Days||13
10860066|NCT00835081|12025590|FG000|NOT COMPLETED|Washout of 7 Days||1
10860067|NCT00835081|12025591|FG001|NOT COMPLETED|Washout of 7 Days||0
10860068|NCT00835081|12025590|FG000|STARTED|Second Intervention||12
10860069|NCT00835081|12025591|FG001|STARTED|Second Intervention||13
10860070|NCT00835081|12025590|FG000|COMPLETED|Second Intervention||12
10860071|NCT00835081|12025591|FG001|COMPLETED|Second Intervention||13
10860072|NCT00835081|12025590|FG000|NOT COMPLETED|Second Intervention||0
10860073|NCT00835081|12025591|FG001|NOT COMPLETED|Second Intervention||0
10860074|NCT00835042|12025597|FG000|STARTED|First Intervention||30
10860075|NCT00835042|12025598|FG001|STARTED|First Intervention||28
10860076|NCT00835042|12025597|FG000|COMPLETED|First Intervention||26
10860077|NCT00835042|12025598|FG001|COMPLETED|First Intervention||26
10860078|NCT00835042|12025597|FG000|NOT COMPLETED|First Intervention||4
10860079|NCT00835042|12025598|FG001|NOT COMPLETED|First Intervention||2
10860080|NCT00835042|12025597|FG000|STARTED|Washout of 21 Days||26
10860081|NCT00835042|12025598|FG001|STARTED|Washout of 21 Days||26
10860082|NCT00835042|12025597|FG000|COMPLETED|Washout of 21 Days||26
10860083|NCT00835042|12025598|FG001|COMPLETED|Washout of 21 Days||24
10860084|NCT00835042|12025597|FG000|NOT COMPLETED|Washout of 21 Days||0
10860085|NCT00835042|12025598|FG001|NOT COMPLETED|Washout of 21 Days||2
10860086|NCT00835042|12025597|FG000|STARTED|Second Intervention||26
10860087|NCT00835042|12025598|FG001|STARTED|Second Intervention||24
10860088|NCT00835042|12025597|FG000|COMPLETED|Second Intervention||26
10860089|NCT00835042|12025598|FG001|COMPLETED|Second Intervention||24
10860090|NCT00835042|12025597|FG000|NOT COMPLETED|Second Intervention||0
10860091|NCT00835042|12025598|FG001|NOT COMPLETED|Second Intervention||0
10860092|NCT00834990|12025604|FG000|STARTED|First Intervention||12
10860093|NCT00834990|12025605|FG001|STARTED|First Intervention||11
10860094|NCT00834990|12025604|FG000|COMPLETED|First Intervention||12
10860095|NCT00834990|12025605|FG001|COMPLETED|First Intervention||11
10860096|NCT00834990|12025604|FG000|NOT COMPLETED|First Intervention||0
10860097|NCT00834990|12025605|FG001|NOT COMPLETED|First Intervention||0
10860098|NCT00834990|12025604|FG000|STARTED|Washout of 7 Days||12
10860099|NCT00834990|12025605|FG001|STARTED|Washout of 7 Days||11
10860100|NCT00834990|12025604|FG000|COMPLETED|Washout of 7 Days||12
10860101|NCT00834990|12025605|FG001|COMPLETED|Washout of 7 Days||11
10860102|NCT00834990|12025604|FG000|NOT COMPLETED|Washout of 7 Days||0
10860103|NCT00834990|12025605|FG001|NOT COMPLETED|Washout of 7 Days||0
10860104|NCT00834990|12025604|FG000|STARTED|Second Intervention||12
10860105|NCT00834990|12025605|FG001|STARTED|Second Intervention||11
10860106|NCT00834990|12025604|FG000|COMPLETED|Second Intervention||12
10860107|NCT00834990|12025605|FG001|COMPLETED|Second Intervention||11
10860108|NCT00834990|12025604|FG000|NOT COMPLETED|Second Intervention||0
10860109|NCT00834990|12025605|FG001|NOT COMPLETED|Second Intervention||0
10860110|NCT00834977|12025611|FG000|STARTED|First Intervention||24
10860111|NCT00834977|12025612|FG001|STARTED|First Intervention||24
10860112|NCT00834977|12025611|FG000|COMPLETED|First Intervention||24
10860113|NCT00834977|12025612|FG001|COMPLETED|First Intervention||24
10860114|NCT00834977|12025611|FG000|NOT COMPLETED|First Intervention||0
10860115|NCT00834977|12025612|FG001|NOT COMPLETED|First Intervention||0
10860116|NCT00834977|12025611|FG000|STARTED|Second Intervention||24
10860117|NCT00834977|12025612|FG001|STARTED|Second Intervention||24
10860118|NCT00834977|12025611|FG000|COMPLETED|Second Intervention||24
10860119|NCT00834977|12025612|FG001|COMPLETED|Second Intervention||24
10860120|NCT00834977|12025611|FG000|NOT COMPLETED|Second Intervention||0
10860121|NCT00834977|12025612|FG001|NOT COMPLETED|Second Intervention||0
10860122|NCT00834964|12025618|FG000|STARTED|First Intervention||15
10860123|NCT00834964|12025619|FG001|STARTED|First Intervention||15
10860124|NCT00834964|12025618|FG000|COMPLETED|First Intervention||15
10860125|NCT00834964|12025619|FG001|COMPLETED|First Intervention||15
10860126|NCT00834964|12025618|FG000|NOT COMPLETED|First Intervention||0
10860127|NCT00834964|12025619|FG001|NOT COMPLETED|First Intervention||0
10860128|NCT00834964|12025618|FG000|STARTED|Washout: 7 Days||15
10860129|NCT00834964|12025619|FG001|STARTED|Washout: 7 Days||15
10860130|NCT00834964|12025618|FG000|COMPLETED|Washout: 7 Days||15
10860131|NCT00834964|12025619|FG001|COMPLETED|Washout: 7 Days||15
10860132|NCT00834964|12025618|FG000|NOT COMPLETED|Washout: 7 Days||0
10860133|NCT00834964|12025619|FG001|NOT COMPLETED|Washout: 7 Days||0
10860134|NCT00834964|12025618|FG000|STARTED|Second Intervention||15
10860135|NCT00834964|12025619|FG001|STARTED|Second Intervention||15
10860136|NCT00834964|12025618|FG000|COMPLETED|Second Intervention||15
10860137|NCT00834964|12025619|FG001|COMPLETED|Second Intervention||15
10860138|NCT00834964|12025618|FG000|NOT COMPLETED|Second Intervention||0
10860139|NCT00834964|12025619|FG001|NOT COMPLETED|Second Intervention||0
10860140|NCT00834873|12025625|FG000|STARTED|First Intervention||12
10860141|NCT00834873|12025626|FG001|STARTED|First Intervention||12
10860142|NCT00834873|12025625|FG000|COMPLETED|First Intervention||12
10860143|NCT00834873|12025626|FG001|COMPLETED|First Intervention||11
10860144|NCT00834873|12025625|FG000|NOT COMPLETED|First Intervention||0
10860145|NCT00834873|12025626|FG001|NOT COMPLETED|First Intervention||1
10860146|NCT00834873|12025625|FG000|STARTED|Washout: 7 Days||12
10860147|NCT00834873|12025626|FG001|STARTED|Washout: 7 Days||11
10860148|NCT00834873|12025625|FG000|COMPLETED|Washout: 7 Days||12
10860149|NCT00834873|12025626|FG001|COMPLETED|Washout: 7 Days||11
10860150|NCT00834873|12025625|FG000|NOT COMPLETED|Washout: 7 Days||0
10860151|NCT00834873|12025626|FG001|NOT COMPLETED|Washout: 7 Days||0
10860152|NCT00834873|12025625|FG000|STARTED|Second Intervention||12
10860153|NCT00834873|12025626|FG001|STARTED|Second Intervention||11
10860154|NCT00834873|12025625|FG000|COMPLETED|Second Intervention||12
10860155|NCT00834873|12025626|FG001|COMPLETED|Second Intervention||11
10860156|NCT00834873|12025625|FG000|NOT COMPLETED|Second Intervention||0
10860157|NCT00834873|12025626|FG001|NOT COMPLETED|Second Intervention||0
10860158|NCT00834795|12025632|FG000|STARTED|First Intervention||18
10860159|NCT00834795|12025633|FG001|STARTED|First Intervention||18
10860160|NCT00834795|12025632|FG000|COMPLETED|First Intervention||18
10860161|NCT00834795|12025633|FG001|COMPLETED|First Intervention||18
10860162|NCT00834795|12025632|FG000|NOT COMPLETED|First Intervention||0
10860163|NCT00834795|12025633|FG001|NOT COMPLETED|First Intervention||0
10860164|NCT00834795|12025632|FG000|STARTED|Washout: 7 Days||18
10860165|NCT00834795|12025633|FG001|STARTED|Washout: 7 Days||18
10860166|NCT00834795|12025632|FG000|COMPLETED|Washout: 7 Days||18
10860167|NCT00834795|12025633|FG001|COMPLETED|Washout: 7 Days||17
10860168|NCT00834795|12025632|FG000|NOT COMPLETED|Washout: 7 Days||0
10860169|NCT00834795|12025633|FG001|NOT COMPLETED|Washout: 7 Days||1
10860170|NCT00834795|12025632|FG000|STARTED|Second Intervention||18
10860171|NCT00834795|12025633|FG001|STARTED|Second Intervention||17
10860172|NCT00834795|12025632|FG000|COMPLETED|Second Intervention||17
10860173|NCT00834795|12025633|FG001|COMPLETED|Second Intervention||17
10860174|NCT00834795|12025632|FG000|NOT COMPLETED|Second Intervention||1
10860175|NCT00834795|12025633|FG001|NOT COMPLETED|Second Intervention||0
10860176|NCT00834756|12025639|FG000|STARTED|First Intervention||18
10860177|NCT00834756|12025640|FG001|STARTED|First Intervention||18
10860178|NCT00834756|12025639|FG000|COMPLETED|First Intervention||17
10860179|NCT00834756|12025640|FG001|COMPLETED|First Intervention||18
10860180|NCT00834756|12025639|FG000|NOT COMPLETED|First Intervention||1
10860181|NCT00834756|12025640|FG001|NOT COMPLETED|First Intervention||0
10860182|NCT00834756|12025639|FG000|STARTED|Washout: 21 Days||17
10860183|NCT00834756|12025640|FG001|STARTED|Washout: 21 Days||18
10860184|NCT00834756|12025639|FG000|COMPLETED|Washout: 21 Days||16
10860185|NCT00834756|12025640|FG001|COMPLETED|Washout: 21 Days||18
10860186|NCT00834756|12025639|FG000|NOT COMPLETED|Washout: 21 Days||1
10860187|NCT00834756|12025640|FG001|NOT COMPLETED|Washout: 21 Days||0
10860188|NCT00834756|12025639|FG000|STARTED|Second Intervention||16
10860189|NCT00834756|12025640|FG001|STARTED|Second Intervention||18
10860190|NCT00834756|12025639|FG000|COMPLETED|Second Intervention||16
10860191|NCT00834756|12025640|FG001|COMPLETED|Second Intervention||18
10860192|NCT00834756|12025639|FG000|NOT COMPLETED|Second Intervention||0
10860193|NCT00834756|12025640|FG001|NOT COMPLETED|Second Intervention||0
10860194|NCT00834743|12025646|FG000|STARTED|First Intervention||16
10860195|NCT00834743|12025647|FG001|STARTED|First Intervention||16
10860196|NCT00834743|12025646|FG000|COMPLETED|First Intervention||16
10860197|NCT00834743|12025647|FG001|COMPLETED|First Intervention||16
10860198|NCT00834743|12025646|FG000|NOT COMPLETED|First Intervention||0
10860199|NCT00834743|12025647|FG001|NOT COMPLETED|First Intervention||0
10860200|NCT00834743|12025646|FG000|STARTED|Washout of 7 Days||16
10860201|NCT00834743|12025647|FG001|STARTED|Washout of 7 Days||16
10860202|NCT00834743|12025646|FG000|COMPLETED|Washout of 7 Days||16
10860203|NCT00834743|12025647|FG001|COMPLETED|Washout of 7 Days||16
10860204|NCT00834743|12025646|FG000|NOT COMPLETED|Washout of 7 Days||0
10860205|NCT00834743|12025647|FG001|NOT COMPLETED|Washout of 7 Days||0
10860206|NCT00834743|12025646|FG000|STARTED|Second Intervention||16
10860207|NCT00834743|12025647|FG001|STARTED|Second Intervention||16
10860208|NCT00834743|12025646|FG000|COMPLETED|Second Intervention||15
10860209|NCT00834743|12025647|FG001|COMPLETED|Second Intervention||16
10860210|NCT00834743|12025646|FG000|NOT COMPLETED|Second Intervention||1
10860211|NCT00834743|12025647|FG001|NOT COMPLETED|Second Intervention||0
10860212|NCT00834717|12025653|FG000|STARTED|First Intervention||20
10860213|NCT00834717|12025654|FG001|STARTED|First Intervention||20
11227061|NCT01999400|12419071|FG005|COMPLETED|Washout (10 Days)||1
10860214|NCT00834717|12025653|FG000|COMPLETED|First Intervention||19
10860215|NCT00834717|12025654|FG001|COMPLETED|First Intervention||19
10860216|NCT00834717|12025653|FG000|NOT COMPLETED|First Intervention||1
10860217|NCT00834717|12025654|FG001|NOT COMPLETED|First Intervention||1
10860218|NCT00834717|12025653|FG000|STARTED|Second Intervention||19
10860219|NCT00834717|12025654|FG001|STARTED|Second Intervention||19
10860220|NCT00834717|12025653|FG000|COMPLETED|Second Intervention||19
10860221|NCT00834717|12025654|FG001|COMPLETED|Second Intervention||19
10860222|NCT00834717|12025653|FG000|NOT COMPLETED|Second Intervention||0
10860223|NCT00834717|12025654|FG001|NOT COMPLETED|Second Intervention||0
10860224|NCT00834639|12025660|FG000|STARTED|First Intervention||12
10860225|NCT00834639|12025661|FG001|STARTED|First Intervention||12
10860226|NCT00834639|12025660|FG000|COMPLETED|First Intervention||12
10860227|NCT00834639|12025661|FG001|COMPLETED|First Intervention||12
10860228|NCT00834639|12025660|FG000|NOT COMPLETED|First Intervention||0
10860229|NCT00834639|12025661|FG001|NOT COMPLETED|First Intervention||0
10860230|NCT00834639|12025660|FG000|STARTED|Washout of 7 Days||12
10860231|NCT00834639|12025661|FG001|STARTED|Washout of 7 Days||12
10860232|NCT00834639|12025660|FG000|COMPLETED|Washout of 7 Days||12
10860233|NCT00834639|12025661|FG001|COMPLETED|Washout of 7 Days||12
10860234|NCT00834639|12025660|FG000|NOT COMPLETED|Washout of 7 Days||0
10860235|NCT00834639|12025661|FG001|NOT COMPLETED|Washout of 7 Days||0
10860236|NCT00834639|12025660|FG000|STARTED|Second Intervention||12
10860237|NCT00834639|12025661|FG001|STARTED|Second Intervention||12
10860238|NCT00834639|12025660|FG000|COMPLETED|Second Intervention||12
10860239|NCT00834639|12025661|FG001|COMPLETED|Second Intervention||10
10860240|NCT00834639|12025660|FG000|NOT COMPLETED|Second Intervention||0
10860241|NCT00834639|12025661|FG001|NOT COMPLETED|Second Intervention||2
10860242|NCT00834613|12025667|FG000|STARTED|First Intervention||16
10860243|NCT00834613|12025668|FG001|STARTED|First Intervention||16
10860244|NCT00834613|12025667|FG000|COMPLETED|First Intervention||15
10860245|NCT00834613|12025668|FG001|COMPLETED|First Intervention||16
10860246|NCT00834613|12025667|FG000|NOT COMPLETED|First Intervention||1
10860247|NCT00834613|12025668|FG001|NOT COMPLETED|First Intervention||0
10860248|NCT00834613|12025667|FG000|STARTED|Washout of 7 Days||15
10860249|NCT00834613|12025668|FG001|STARTED|Washout of 7 Days||16
10860250|NCT00834613|12025667|FG000|COMPLETED|Washout of 7 Days||15
10860251|NCT00834613|12025668|FG001|COMPLETED|Washout of 7 Days||16
10860252|NCT00834613|12025667|FG000|NOT COMPLETED|Washout of 7 Days||0
10860253|NCT00834613|12025668|FG001|NOT COMPLETED|Washout of 7 Days||0
10860254|NCT00834613|12025667|FG000|STARTED|Second Intervention||15
10860255|NCT00834613|12025668|FG001|STARTED|Second Intervention||16
10860256|NCT00834613|12025667|FG000|COMPLETED|Second Intervention||15
10860257|NCT00834613|12025668|FG001|COMPLETED|Second Intervention||16
10860258|NCT00834613|12025667|FG000|NOT COMPLETED|Second Intervention||0
10860259|NCT00834613|12025668|FG001|NOT COMPLETED|Second Intervention||0
10860260|NCT00834587|12025674|FG000|STARTED|First Intervention||20
10860261|NCT00834587|12025675|FG001|STARTED|First Intervention||20
10860262|NCT00834587|12025674|FG000|COMPLETED|First Intervention||20
10860263|NCT00834587|12025675|FG001|COMPLETED|First Intervention||20
10860264|NCT00834587|12025674|FG000|NOT COMPLETED|First Intervention||0
10860265|NCT00834587|12025675|FG001|NOT COMPLETED|First Intervention||0
10860266|NCT00834587|12025674|FG000|STARTED|Washout: 7 Days||20
10860267|NCT00834587|12025675|FG001|STARTED|Washout: 7 Days||20
10860268|NCT00834587|12025674|FG000|COMPLETED|Washout: 7 Days||19
10860269|NCT00834587|12025675|FG001|COMPLETED|Washout: 7 Days||20
10860270|NCT00834587|12025674|FG000|NOT COMPLETED|Washout: 7 Days||1
10860271|NCT00834587|12025675|FG001|NOT COMPLETED|Washout: 7 Days||0
10860272|NCT00834587|12025674|FG000|STARTED|Second Intervention||19
10860273|NCT00834587|12025675|FG001|STARTED|Second Intervention||20
10860274|NCT00834587|12025674|FG000|COMPLETED|Second Intervention||19
11107523|NCT01263223|12291874|FG001|STARTED|Period 3||11
11107524|NCT01263223|12291873|FG000|COMPLETED|Period 3||12
11107525|NCT01263223|12291874|FG001|COMPLETED|Period 3||11
11107526|NCT01263223|12291873|FG000|NOT COMPLETED|Period 3||0
11107527|NCT01263223|12291874|FG001|NOT COMPLETED|Period 3||0
11107528|NCT01263223|12291873|FG000|STARTED|7-day Follow-up||12
11107529|NCT01263223|12291874|FG001|STARTED|7-day Follow-up||11
11107530|NCT01263223|12291873|FG000|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
11107531|NCT01263223|12291874|FG001|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
11227062|NCT01999400|12419066|FG000|NOT COMPLETED|Washout (10 Days)||0
10860275|NCT00834587|12025675|FG001|COMPLETED|Second Intervention||20
10860276|NCT00834587|12025674|FG000|NOT COMPLETED|Second Intervention||0
10860277|NCT00834587|12025675|FG001|NOT COMPLETED|Second Intervention||0
10860278|NCT00834574|12025681|FG000|STARTED|First Intervention||16
10860279|NCT00834574|12025682|FG001|STARTED|First Intervention||16
10860280|NCT00834574|12025681|FG000|COMPLETED|First Intervention||16
10860281|NCT00834574|12025682|FG001|COMPLETED|First Intervention||16
10860282|NCT00834574|12025681|FG000|NOT COMPLETED|First Intervention||0
10860283|NCT00834574|12025682|FG001|NOT COMPLETED|First Intervention||0
10860284|NCT00834574|12025681|FG000|STARTED|Washout of 7 Days||16
10860285|NCT00834574|12025682|FG001|STARTED|Washout of 7 Days||16
10860286|NCT00834574|12025681|FG000|COMPLETED|Washout of 7 Days||16
10860287|NCT00834574|12025682|FG001|COMPLETED|Washout of 7 Days||16
10860288|NCT00834574|12025681|FG000|NOT COMPLETED|Washout of 7 Days||0
10860289|NCT00834574|12025682|FG001|NOT COMPLETED|Washout of 7 Days||0
10860290|NCT00834574|12025681|FG000|STARTED|Second Intervention||16
10860291|NCT00834574|12025682|FG001|STARTED|Second Intervention||16
10860292|NCT00834574|12025681|FG000|COMPLETED|Second Intervention||16
10860293|NCT00834574|12025682|FG001|COMPLETED|Second Intervention||16
10860294|NCT00834574|12025681|FG000|NOT COMPLETED|Second Intervention||0
10860295|NCT00834574|12025682|FG001|NOT COMPLETED|Second Intervention||0
10860296|NCT00834561|12025688|FG000|STARTED|First Intervention||16
10860297|NCT00834561|12025689|FG001|STARTED|First Intervention||16
10860298|NCT00834561|12025688|FG000|COMPLETED|First Intervention||16
10860299|NCT00834561|12025689|FG001|COMPLETED|First Intervention||16
10860300|NCT00834561|12025688|FG000|NOT COMPLETED|First Intervention||0
10860301|NCT00834561|12025689|FG001|NOT COMPLETED|First Intervention||0
10860302|NCT00834561|12025688|FG000|STARTED|Second Intervention||16
10860303|NCT00834561|12025689|FG001|STARTED|Second Intervention||16
10860304|NCT00834561|12025688|FG000|COMPLETED|Second Intervention||16
10860305|NCT00834561|12025689|FG001|COMPLETED|Second Intervention||16
10860306|NCT00834561|12025688|FG000|NOT COMPLETED|Second Intervention||0
10860307|NCT00834561|12025689|FG001|NOT COMPLETED|Second Intervention||0
10860308|NCT00834535|12025695|FG000|STARTED|First Intervention||16
10860309|NCT00834535|12025696|FG001|STARTED|First Intervention||16
10860310|NCT00834535|12025695|FG000|COMPLETED|First Intervention||16
11107532|NCT01263223|12291873|FG000|NOT COMPLETED|7-day Follow-up||1
10860311|NCT00834535|12025696|FG001|COMPLETED|First Intervention||16
10860312|NCT00834535|12025695|FG000|NOT COMPLETED|First Intervention||0
10860313|NCT00834535|12025696|FG001|NOT COMPLETED|First Intervention||0
10860314|NCT00834535|12025695|FG000|STARTED|Washout of 7 Days||16
10860315|NCT00834535|12025696|FG001|STARTED|Washout of 7 Days||16
10860316|NCT00834535|12025695|FG000|COMPLETED|Washout of 7 Days||16
10860317|NCT00834535|12025696|FG001|COMPLETED|Washout of 7 Days||16
10860318|NCT00834535|12025695|FG000|NOT COMPLETED|Washout of 7 Days||0
10860319|NCT00834535|12025696|FG001|NOT COMPLETED|Washout of 7 Days||0
10860320|NCT00834535|12025695|FG000|STARTED|Second Intervention||16
10860321|NCT00834535|12025696|FG001|STARTED|Second Intervention||16
11107533|NCT01263223|12291874|FG001|NOT COMPLETED|7-day Follow-up||1
11107534|NCT01263301|12291885|FG000|STARTED|Overall Study||5
11107535|NCT01263301|12291886|FG001|STARTED|Overall Study||11
11107536|NCT01263301|12291885|FG000|COMPLETED|Overall Study||5
11107537|NCT01263301|12291886|FG001|COMPLETED|Overall Study||11
11107538|NCT01263301|12291885|FG000|NOT COMPLETED|Overall Study||0
11107539|NCT01263301|12291886|FG001|NOT COMPLETED|Overall Study||0
11107540|NCT01263314|12291900|FG000|STARTED|Period 1||2
11107541|NCT01263314|12291901|FG001|STARTED|Period 1||2
11107542|NCT01263314|12291902|FG002|STARTED|Period 1||2
11107543|NCT01263314|12291903|FG003|STARTED|Period 1||2
11107544|NCT01263314|12291904|FG004|STARTED|Period 1||2
11107545|NCT01263314|12291905|FG005|STARTED|Period 1||2
11107546|NCT01263314|12291906|FG006|STARTED|Period 1||2
10860322|NCT00834535|12025695|FG000|COMPLETED|Second Intervention||16
10860323|NCT00834535|12025696|FG001|COMPLETED|Second Intervention||16
10860324|NCT00834535|12025695|FG000|NOT COMPLETED|Second Intervention||0
10860325|NCT00834535|12025696|FG001|NOT COMPLETED|Second Intervention||0
11227063|NCT01999400|12419067|FG001|NOT COMPLETED|Washout (10 Days)||0
11227064|NCT01999400|12419068|FG002|NOT COMPLETED|Washout (10 Days)||0
11227065|NCT01999400|12419069|FG003|NOT COMPLETED|Washout (10 Days)||0
11227066|NCT01999400|12419070|FG004|NOT COMPLETED|Washout (10 Days)||0
11227067|NCT01999400|12419071|FG005|NOT COMPLETED|Washout (10 Days)||0
11227068|NCT01999400|12419066|FG000|STARTED|Third Intervention (1 Day)||2
11227069|NCT01999400|12419067|FG001|STARTED|Third Intervention (1 Day)||0
11227070|NCT01999400|12419068|FG002|STARTED|Third Intervention (1 Day)||1
11227071|NCT01999400|12419069|FG003|STARTED|Third Intervention (1 Day)||1
10860326|NCT00834522|12025702|FG000|STARTED|First Intervention||40
10860327|NCT00834522|12025703|FG001|STARTED|First Intervention||40
10860328|NCT00834522|12025702|FG000|COMPLETED|First Intervention||40
10860329|NCT00834522|12025703|FG001|COMPLETED|First Intervention||40
10860330|NCT00834522|12025702|FG000|NOT COMPLETED|First Intervention||0
10860331|NCT00834522|12025703|FG001|NOT COMPLETED|First Intervention||0
10860332|NCT00834522|12025702|FG000|STARTED|Washout||40
10860333|NCT00834522|12025703|FG001|STARTED|Washout||40
10860334|NCT00834522|12025702|FG000|COMPLETED|Washout||37
10860335|NCT00834522|12025703|FG001|COMPLETED|Washout||39
10860336|NCT00834522|12025702|FG000|NOT COMPLETED|Washout||3
10860337|NCT00834522|12025703|FG001|NOT COMPLETED|Washout||1
10860338|NCT00834522|12025702|FG000|STARTED|Second Intervention||37
10860339|NCT00834522|12025703|FG001|STARTED|Second Intervention||39
10860340|NCT00834522|12025702|FG000|COMPLETED|Second Intervention||37
10860341|NCT00834522|12025703|FG001|COMPLETED|Second Intervention||39
10860342|NCT00834522|12025702|FG000|NOT COMPLETED|Second Intervention||0
10860343|NCT00834522|12025703|FG001|NOT COMPLETED|Second Intervention||0
10860344|NCT00834444|12025709|FG000|STARTED|First Intervention||18
10860345|NCT00834444|12025710|FG001|STARTED|First Intervention||18
10860346|NCT00834444|12025709|FG000|COMPLETED|First Intervention||17
10860347|NCT00834444|12025710|FG001|COMPLETED|First Intervention||17
10860348|NCT00834444|12025709|FG000|NOT COMPLETED|First Intervention||1
10860349|NCT00834444|12025710|FG001|NOT COMPLETED|First Intervention||1
10860350|NCT00834444|12025709|FG000|STARTED|Washout of 7 Days||17
10860351|NCT00834444|12025710|FG001|STARTED|Washout of 7 Days||17
10860352|NCT00834444|12025709|FG000|COMPLETED|Washout of 7 Days||17
10860353|NCT00834444|12025710|FG001|COMPLETED|Washout of 7 Days||16
11107547|NCT01263314|12291907|FG007|STARTED|Period 1||2
11107548|NCT01263314|12291900|FG000|COMPLETED|Period 1||2
11107549|NCT01263314|12291901|FG001|COMPLETED|Period 1||2
11227072|NCT01999400|12419070|FG004|STARTED|Third Intervention (1 Day)||1
11227073|NCT01999400|12419071|FG005|STARTED|Third Intervention (1 Day)||1
11227074|NCT01999400|12419066|FG000|COMPLETED|Third Intervention (1 Day)||2
11227075|NCT01999400|12419067|FG001|COMPLETED|Third Intervention (1 Day)||0
11227076|NCT01999400|12419068|FG002|COMPLETED|Third Intervention (1 Day)||1
11227077|NCT01999400|12419069|FG003|COMPLETED|Third Intervention (1 Day)||1
11227078|NCT01999400|12419070|FG004|COMPLETED|Third Intervention (1 Day)||1
11227079|NCT01999400|12419071|FG005|COMPLETED|Third Intervention (1 Day)||0
11227080|NCT01999400|12419066|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
11227081|NCT01999400|12419067|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
11227082|NCT01999400|12419068|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
11227083|NCT01999400|12419069|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
11227084|NCT01999400|12419070|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
11227085|NCT01999400|12419071|FG005|NOT COMPLETED|Third Intervention (1 Day)||1
11227086|NCT01999400|12419066|FG000|STARTED|Washout (10 Days)||1
11354980|NCT03076190|12551909|FG000|NOT COMPLETED|Overall Study||18
11354981|NCT03076190|12551910|FG001|NOT COMPLETED|Overall Study||41
11354982|NCT03076333|12551919|FG000|STARTED|Overall Study||3
11354983|NCT03076333|12551919|FG000|COMPLETED|Overall Study||3
11354984|NCT03076333|12551919|FG000|NOT COMPLETED|Overall Study||0
11354985|NCT03076359|12551925|FG000|STARTED|Overall Study||170
11354986|NCT03076359|12551926|FG001|STARTED|Overall Study||150
11354987|NCT03076359|12551925|FG000|COMPLETED|Overall Study||170
11354988|NCT03076359|12551926|FG001|COMPLETED|Overall Study||150
11354989|NCT03076359|12551925|FG000|NOT COMPLETED|Overall Study||0
11354990|NCT03076359|12551926|FG001|NOT COMPLETED|Overall Study||0
10860354|NCT00834444|12025709|FG000|NOT COMPLETED|Washout of 7 Days||0
10860355|NCT00834444|12025710|FG001|NOT COMPLETED|Washout of 7 Days||1
10860356|NCT00834444|12025709|FG000|STARTED|Second Intervention||17
10860357|NCT00834444|12025710|FG001|STARTED|Second Intervention||16
10860358|NCT00834444|12025709|FG000|COMPLETED|Second Intervention||16
10860359|NCT00834444|12025710|FG001|COMPLETED|Second Intervention||16
10860360|NCT00834444|12025709|FG000|NOT COMPLETED|Second Intervention||1
10860361|NCT00834444|12025710|FG001|NOT COMPLETED|Second Intervention||0
10860362|NCT00834431|12025716|FG000|STARTED|First Intervention||18
10860363|NCT00834431|12025717|FG001|STARTED|First Intervention||18
10860364|NCT00834431|12025716|FG000|COMPLETED|First Intervention||18
11354991|NCT03076515|12551936|FG000|STARTED|Overall Study||58
11354992|NCT03076515|12551937|FG001|STARTED|Overall Study||62
11354993|NCT03076515|12551936|FG000|COMPLETED|Overall Study||33
11354994|NCT03076515|12551937|FG001|COMPLETED|Overall Study||33
11354995|NCT03076515|12551936|FG000|NOT COMPLETED|Overall Study||25
11354996|NCT03076515|12551937|FG001|NOT COMPLETED|Overall Study||29
10860365|NCT00834431|12025717|FG001|COMPLETED|First Intervention||17
11354997|NCT03076970|12551943|FG000|STARTED|Period 1||7
11354998|NCT03076970|12551944|FG001|STARTED|Period 1||7
11354999|NCT03076970|12551945|FG002|STARTED|Period 1||7
10860366|NCT00834431|12025716|FG000|NOT COMPLETED|First Intervention||0
10860367|NCT00834431|12025717|FG001|NOT COMPLETED|First Intervention||1
10860368|NCT00834431|12025716|FG000|STARTED|Washout of 7 Days||18
10860369|NCT00834431|12025717|FG001|STARTED|Washout of 7 Days||17
10860370|NCT00834431|12025716|FG000|COMPLETED|Washout of 7 Days||18
10860371|NCT00834431|12025717|FG001|COMPLETED|Washout of 7 Days||16
10860372|NCT00834431|12025716|FG000|NOT COMPLETED|Washout of 7 Days||0
10860373|NCT00834431|12025717|FG001|NOT COMPLETED|Washout of 7 Days||1
10860374|NCT00834431|12025716|FG000|STARTED|Second Intervention||18
10860375|NCT00834431|12025717|FG001|STARTED|Second Intervention||16
10860376|NCT00834431|12025716|FG000|COMPLETED|Second Intervention||18
10860377|NCT00834431|12025717|FG001|COMPLETED|Second Intervention||16
10860378|NCT00834431|12025716|FG000|NOT COMPLETED|Second Intervention||0
10860379|NCT00834431|12025717|FG001|NOT COMPLETED|Second Intervention||0
10860380|NCT00834418|12025723|FG000|STARTED|Overall Study||42
10860381|NCT00834418|12025724|FG001|STARTED|Overall Study||42
10860382|NCT00834418|12025723|FG000|COMPLETED|Overall Study||42
10860383|NCT00834418|12025724|FG001|COMPLETED|Overall Study||40
10860384|NCT00834418|12025723|FG000|NOT COMPLETED|Overall Study||0
10860385|NCT00834418|12025724|FG001|NOT COMPLETED|Overall Study||2
10860386|NCT00834405|12025730|FG000|STARTED|Overall Study||20
10860387|NCT00834405|12025731|FG001|STARTED|Overall Study||17
10860388|NCT00834405|12025730|FG000|COMPLETED|Overall Study||20
10860389|NCT00834405|12025731|FG001|COMPLETED|Overall Study||17
10860390|NCT00834405|12025730|FG000|NOT COMPLETED|Overall Study||0
10860391|NCT00834405|12025731|FG001|NOT COMPLETED|Overall Study||0
10860392|NCT00834340|12025737|FG000|STARTED|First Intervention||16
10860393|NCT00834340|12025738|FG001|STARTED|First Intervention||16
10860394|NCT00834340|12025737|FG000|COMPLETED|First Intervention||16
10860395|NCT00834340|12025738|FG001|COMPLETED|First Intervention||16
10860396|NCT00834340|12025737|FG000|NOT COMPLETED|First Intervention||0
10860397|NCT00834340|12025738|FG001|NOT COMPLETED|First Intervention||0
10860398|NCT00834340|12025737|FG000|STARTED|Washout||16
10860399|NCT00834340|12025738|FG001|STARTED|Washout||16
10860400|NCT00834340|12025737|FG000|COMPLETED|Washout||14
10860401|NCT00834340|12025738|FG001|COMPLETED|Washout||16
10860402|NCT00834340|12025737|FG000|NOT COMPLETED|Washout||2
10860403|NCT00834340|12025738|FG001|NOT COMPLETED|Washout||0
10860404|NCT00834340|12025737|FG000|STARTED|Second Intervention||14
10860405|NCT00834340|12025738|FG001|STARTED|Second Intervention||16
10860406|NCT00834340|12025737|FG000|COMPLETED|Second Intervention||14
10860407|NCT00834340|12025738|FG001|COMPLETED|Second Intervention||16
10860408|NCT00834340|12025737|FG000|NOT COMPLETED|Second Intervention||0
10860409|NCT00834340|12025738|FG001|NOT COMPLETED|Second Intervention||0
10860410|NCT00834275|12025744|FG000|STARTED|First Intervention||13
10860411|NCT00834275|12025745|FG001|STARTED|First Intervention||13
10860412|NCT00834275|12025744|FG000|COMPLETED|First Intervention||13
10860413|NCT00834275|12025745|FG001|COMPLETED|First Intervention||13
10860414|NCT00834275|12025744|FG000|NOT COMPLETED|First Intervention||0
10860415|NCT00834275|12025745|FG001|NOT COMPLETED|First Intervention||0
10860416|NCT00834275|12025744|FG000|STARTED|Washout of 7 Days||13
10860417|NCT00834275|12025745|FG001|STARTED|Washout of 7 Days||13
10860418|NCT00834275|12025744|FG000|COMPLETED|Washout of 7 Days||13
10860419|NCT00834275|12025745|FG001|COMPLETED|Washout of 7 Days||13
10860420|NCT00834275|12025744|FG000|NOT COMPLETED|Washout of 7 Days||0
10860421|NCT00834275|12025745|FG001|NOT COMPLETED|Washout of 7 Days||0
10860422|NCT00834275|12025744|FG000|STARTED|Second Intervention||13
10860423|NCT00834275|12025745|FG001|STARTED|Second Intervention||13
10860424|NCT00834275|12025744|FG000|COMPLETED|Second Intervention||13
10860425|NCT00834275|12025745|FG001|COMPLETED|Second Intervention||13
10860426|NCT00834275|12025744|FG000|NOT COMPLETED|Second Intervention||0
10860427|NCT00834275|12025745|FG001|NOT COMPLETED|Second Intervention||0
10860428|NCT00834249|12025751|FG000|STARTED|First Intervention||9
10860429|NCT00834249|12025752|FG001|STARTED|First Intervention||9
10860430|NCT00834249|12025751|FG000|COMPLETED|First Intervention||9
10860431|NCT00834249|12025752|FG001|COMPLETED|First Intervention||9
10860432|NCT00834249|12025751|FG000|NOT COMPLETED|First Intervention||0
10860433|NCT00834249|12025752|FG001|NOT COMPLETED|First Intervention||0
10860434|NCT00834249|12025751|FG000|STARTED|Washout: 7 Days||9
10860435|NCT00834249|12025752|FG001|STARTED|Washout: 7 Days||9
10860436|NCT00834249|12025751|FG000|COMPLETED|Washout: 7 Days||8
10860437|NCT00834249|12025752|FG001|COMPLETED|Washout: 7 Days||8
10860438|NCT00834249|12025751|FG000|NOT COMPLETED|Washout: 7 Days||1
10860439|NCT00834249|12025752|FG001|NOT COMPLETED|Washout: 7 Days||1
10860440|NCT00834249|12025751|FG000|STARTED|Second Intervention||8
10860441|NCT00834249|12025752|FG001|STARTED|Second Intervention||8
10860442|NCT00834249|12025751|FG000|COMPLETED|Second Intervention||7
10860443|NCT00834249|12025752|FG001|COMPLETED|Second Intervention||8
10860444|NCT00834249|12025751|FG000|NOT COMPLETED|Second Intervention||1
10860445|NCT00834249|12025752|FG001|NOT COMPLETED|Second Intervention||0
10860446|NCT00834197|12025758|FG000|STARTED|First Intervention||16
10860447|NCT00834197|12025759|FG001|STARTED|First Intervention||16
10860448|NCT00834197|12025758|FG000|COMPLETED|First Intervention||16
10860449|NCT00834197|12025759|FG001|COMPLETED|First Intervention||16
10860450|NCT00834197|12025758|FG000|NOT COMPLETED|First Intervention||0
10860451|NCT00834197|12025759|FG001|NOT COMPLETED|First Intervention||0
10860452|NCT00834197|12025758|FG000|STARTED|Washout of 14 Days||16
10860453|NCT00834197|12025759|FG001|STARTED|Washout of 14 Days||16
10860454|NCT00834197|12025758|FG000|COMPLETED|Washout of 14 Days||16
10860455|NCT00834197|12025759|FG001|COMPLETED|Washout of 14 Days||16
10860456|NCT00834197|12025758|FG000|NOT COMPLETED|Washout of 14 Days||0
10860457|NCT00834197|12025759|FG001|NOT COMPLETED|Washout of 14 Days||0
10860458|NCT00834197|12025758|FG000|STARTED|Second Intervention||16
10860459|NCT00834197|12025759|FG001|STARTED|Second Intervention||16
10860460|NCT00834197|12025758|FG000|COMPLETED|Second Intervention||16
10860461|NCT00834197|12025759|FG001|COMPLETED|Second Intervention||16
10860462|NCT00834197|12025758|FG000|NOT COMPLETED|Second Intervention||0
10860463|NCT00834197|12025759|FG001|NOT COMPLETED|Second Intervention||0
10860464|NCT00834132|12025765|FG000|STARTED|First Intervention||12
10860465|NCT00834132|12025766|FG001|STARTED|First Intervention||12
10860466|NCT00834132|12025765|FG000|COMPLETED|First Intervention||12
10860467|NCT00834132|12025766|FG001|COMPLETED|First Intervention||12
10860468|NCT00834132|12025765|FG000|NOT COMPLETED|First Intervention||0
10860469|NCT00834132|12025766|FG001|NOT COMPLETED|First Intervention||0
10860470|NCT00834132|12025765|FG000|STARTED|Washout: 21 Days||12
10860471|NCT00834132|12025766|FG001|STARTED|Washout: 21 Days||12
10860472|NCT00834132|12025765|FG000|COMPLETED|Washout: 21 Days||12
10860473|NCT00834132|12025766|FG001|COMPLETED|Washout: 21 Days||12
10860474|NCT00834132|12025765|FG000|NOT COMPLETED|Washout: 21 Days||0
10860475|NCT00834132|12025766|FG001|NOT COMPLETED|Washout: 21 Days||0
10860476|NCT00834132|12025765|FG000|STARTED|Second Intervention||12
10860477|NCT00834132|12025766|FG001|STARTED|Second Intervention||12
10860478|NCT00834132|12025765|FG000|COMPLETED|Second Intervention||12
10860479|NCT00834132|12025766|FG001|COMPLETED|Second Intervention||12
10860480|NCT00834132|12025765|FG000|NOT COMPLETED|Second Intervention||0
10860481|NCT00834132|12025766|FG001|NOT COMPLETED|Second Intervention||0
10860482|NCT00834067|12025772|FG000|STARTED|First Intervention||30
10860483|NCT00834067|12025773|FG001|STARTED|First Intervention||30
10860484|NCT00834067|12025772|FG000|COMPLETED|First Intervention||30
10860485|NCT00834067|12025773|FG001|COMPLETED|First Intervention||30
10860486|NCT00834067|12025772|FG000|NOT COMPLETED|First Intervention||0
10860487|NCT00834067|12025773|FG001|NOT COMPLETED|First Intervention||0
10860488|NCT00834067|12025772|FG000|STARTED|Washout of 21 Days||30
10860489|NCT00834067|12025773|FG001|STARTED|Washout of 21 Days||30
10860490|NCT00834067|12025772|FG000|COMPLETED|Washout of 21 Days||30
10860491|NCT00834067|12025773|FG001|COMPLETED|Washout of 21 Days||29
10860492|NCT00834067|12025772|FG000|NOT COMPLETED|Washout of 21 Days||0
10860493|NCT00834067|12025773|FG001|NOT COMPLETED|Washout of 21 Days||1
10860494|NCT00834067|12025772|FG000|STARTED|Second Intervention||30
10860495|NCT00834067|12025773|FG001|STARTED|Second Intervention||29
10860496|NCT00834067|12025772|FG000|COMPLETED|Second Intervention||30
10860497|NCT00834067|12025773|FG001|COMPLETED|Second Intervention||29
10860498|NCT00834067|12025772|FG000|NOT COMPLETED|Second Intervention||0
10860499|NCT00834067|12025773|FG001|NOT COMPLETED|Second Intervention||0
10860500|NCT00833937|12025779|FG000|STARTED|First Intervention||12
10860501|NCT00833937|12025780|FG001|STARTED|First Intervention||12
10860502|NCT00833937|12025779|FG000|COMPLETED|First Intervention||12
10860503|NCT00833937|12025780|FG001|COMPLETED|First Intervention||12
10860504|NCT00833937|12025779|FG000|NOT COMPLETED|First Intervention||0
10860505|NCT00833937|12025780|FG001|NOT COMPLETED|First Intervention||0
10860506|NCT00833937|12025779|FG000|STARTED|Washout||12
10860507|NCT00833937|12025780|FG001|STARTED|Washout||12
10860508|NCT00833937|12025779|FG000|COMPLETED|Washout||11
10860509|NCT00833937|12025780|FG001|COMPLETED|Washout||12
10860510|NCT00833937|12025779|FG000|NOT COMPLETED|Washout||1
10860511|NCT00833937|12025780|FG001|NOT COMPLETED|Washout||0
10860512|NCT00833937|12025779|FG000|STARTED|Second Intervention||11
10860513|NCT00833937|12025780|FG001|STARTED|Second Intervention||12
10860514|NCT00833937|12025779|FG000|COMPLETED|Second Intervention||11
10860515|NCT00833937|12025780|FG001|COMPLETED|Second Intervention||12
10860516|NCT00833937|12025779|FG000|NOT COMPLETED|Second Intervention||0
10860517|NCT00833937|12025780|FG001|NOT COMPLETED|Second Intervention||0
10860518|NCT00833664|12025786|FG000|STARTED|First Intervention||11
10860519|NCT00833664|12025787|FG001|STARTED|First Intervention||11
10860520|NCT00833664|12025786|FG000|COMPLETED|First Intervention||11
10860521|NCT00833664|12025787|FG001|COMPLETED|First Intervention||11
10860522|NCT00833664|12025786|FG000|NOT COMPLETED|First Intervention||0
10860523|NCT00833664|12025787|FG001|NOT COMPLETED|First Intervention||0
10860524|NCT00833664|12025786|FG000|STARTED|Washout: 14 Days||11
10860525|NCT00833664|12025787|FG001|STARTED|Washout: 14 Days||11
10860526|NCT00833664|12025786|FG000|COMPLETED|Washout: 14 Days||10
10860527|NCT00833664|12025787|FG001|COMPLETED|Washout: 14 Days||11
10860528|NCT00833664|12025786|FG000|NOT COMPLETED|Washout: 14 Days||1
10860529|NCT00833664|12025787|FG001|NOT COMPLETED|Washout: 14 Days||0
10860530|NCT00833664|12025786|FG000|STARTED|Second Intervention||10
10860531|NCT00833664|12025787|FG001|STARTED|Second Intervention||11
10860532|NCT00833664|12025786|FG000|COMPLETED|Second Intervention||10
10860533|NCT00833664|12025787|FG001|COMPLETED|Second Intervention||11
10860534|NCT00833664|12025786|FG000|NOT COMPLETED|Second Intervention||0
10860535|NCT00833664|12025787|FG001|NOT COMPLETED|Second Intervention||0
10860536|NCT00833586|12025793|FG000|STARTED|First Intervention||14
10860537|NCT00833586|12025794|FG001|STARTED|First Intervention||14
10860538|NCT00833586|12025793|FG000|COMPLETED|First Intervention||14
10860539|NCT00833586|12025794|FG001|COMPLETED|First Intervention||14
10860540|NCT00833586|12025793|FG000|NOT COMPLETED|First Intervention||0
10860541|NCT00833586|12025794|FG001|NOT COMPLETED|First Intervention||0
10860542|NCT00833586|12025793|FG000|STARTED|Washout: 14 Days||14
10860543|NCT00833586|12025794|FG001|STARTED|Washout: 14 Days||14
10860544|NCT00833586|12025793|FG000|COMPLETED|Washout: 14 Days||14
10860545|NCT00833586|12025794|FG001|COMPLETED|Washout: 14 Days||14
10860546|NCT00833586|12025793|FG000|NOT COMPLETED|Washout: 14 Days||0
10860547|NCT00833586|12025794|FG001|NOT COMPLETED|Washout: 14 Days||0
10860548|NCT00833586|12025793|FG000|STARTED|Second Intervention||14
10860549|NCT00833586|12025794|FG001|STARTED|Second Intervention||14
10860550|NCT00833586|12025793|FG000|COMPLETED|Second Intervention||14
10860551|NCT00833586|12025794|FG001|COMPLETED|Second Intervention||14
10860552|NCT00833586|12025793|FG000|NOT COMPLETED|Second Intervention||0
10860553|NCT00833586|12025794|FG001|NOT COMPLETED|Second Intervention||0
10860554|NCT00833521|12025800|FG000|STARTED|First Intervention||19
10860555|NCT00833521|12025801|FG001|STARTED|First Intervention||19
10860556|NCT00833521|12025800|FG000|COMPLETED|First Intervention||19
10860557|NCT00833521|12025801|FG001|COMPLETED|First Intervention||19
10860558|NCT00833521|12025800|FG000|NOT COMPLETED|First Intervention||0
10860559|NCT00833521|12025801|FG001|NOT COMPLETED|First Intervention||0
10860560|NCT00833521|12025800|FG000|STARTED|Second Intervention||19
10860561|NCT00833521|12025801|FG001|STARTED|Second Intervention||19
10860562|NCT00833521|12025800|FG000|COMPLETED|Second Intervention||19
10860563|NCT00833521|12025801|FG001|COMPLETED|Second Intervention||19
10860564|NCT00833521|12025800|FG000|NOT COMPLETED|Second Intervention||0
10860565|NCT00833521|12025801|FG001|NOT COMPLETED|Second Intervention||0
10860566|NCT00830336|12025807|FG000|STARTED|First Intervention||40
10860567|NCT00830336|12025808|FG001|STARTED|First Intervention||40
10860568|NCT00830336|12025807|FG000|COMPLETED|First Intervention||40
10860569|NCT00830336|12025808|FG001|COMPLETED|First Intervention||40
10860570|NCT00830336|12025807|FG000|NOT COMPLETED|First Intervention||0
10860571|NCT00830336|12025808|FG001|NOT COMPLETED|First Intervention||0
10860572|NCT00830336|12025807|FG000|STARTED|Washout: 21 Days||40
10860573|NCT00830336|12025808|FG001|STARTED|Washout: 21 Days||40
10860574|NCT00830336|12025807|FG000|COMPLETED|Washout: 21 Days||39
10860575|NCT00830336|12025808|FG001|COMPLETED|Washout: 21 Days||40
10860576|NCT00830336|12025807|FG000|NOT COMPLETED|Washout: 21 Days||1
10860577|NCT00830336|12025808|FG001|NOT COMPLETED|Washout: 21 Days||0
10860578|NCT00830336|12025807|FG000|STARTED|Second Intervention||39
10860579|NCT00830336|12025808|FG001|STARTED|Second Intervention||40
10860580|NCT00830336|12025807|FG000|COMPLETED|Second Intervention||39
10860581|NCT00830336|12025808|FG001|COMPLETED|Second Intervention||40
10860582|NCT00830336|12025807|FG000|NOT COMPLETED|Second Intervention||0
10860583|NCT00830336|12025808|FG001|NOT COMPLETED|Second Intervention||0
10860584|NCT00830258|12025814|FG000|STARTED|First Intervention||30
10860585|NCT00830258|12025815|FG001|STARTED|First Intervention||30
10860586|NCT00830258|12025814|FG000|COMPLETED|First Intervention||29
10860587|NCT00830258|12025815|FG001|COMPLETED|First Intervention||30
10860588|NCT00830258|12025814|FG000|NOT COMPLETED|First Intervention||1
10860589|NCT00830258|12025815|FG001|NOT COMPLETED|First Intervention||0
10860590|NCT00830258|12025814|FG000|STARTED|Washout: 7 Days||29
10860591|NCT00830258|12025815|FG001|STARTED|Washout: 7 Days||30
10860592|NCT00830258|12025814|FG000|COMPLETED|Washout: 7 Days||28
10860593|NCT00830258|12025815|FG001|COMPLETED|Washout: 7 Days||30
10860594|NCT00830258|12025814|FG000|NOT COMPLETED|Washout: 7 Days||1
10860595|NCT00830258|12025815|FG001|NOT COMPLETED|Washout: 7 Days||0
10860596|NCT00830258|12025814|FG000|STARTED|Second Intervention||28
10860597|NCT00830258|12025815|FG001|STARTED|Second Intervention||30
10860598|NCT00830258|12025814|FG000|COMPLETED|Second Intervention||28
10860599|NCT00830258|12025815|FG001|COMPLETED|Second Intervention||30
10860600|NCT00830258|12025814|FG000|NOT COMPLETED|Second Intervention||0
10860601|NCT00830258|12025815|FG001|NOT COMPLETED|Second Intervention||0
10860602|NCT00830219|12025821|FG000|STARTED|First Intervention||23
10860603|NCT00830219|12025822|FG001|STARTED|First Intervention||23
10860604|NCT00830219|12025821|FG000|COMPLETED|First Intervention||23
10860605|NCT00830219|12025822|FG001|COMPLETED|First Intervention||23
10860606|NCT00830219|12025821|FG000|NOT COMPLETED|First Intervention||0
10860607|NCT00830219|12025822|FG001|NOT COMPLETED|First Intervention||0
10860608|NCT00830219|12025821|FG000|STARTED|Washout of 7 Days||23
10860609|NCT00830219|12025822|FG001|STARTED|Washout of 7 Days||23
10860610|NCT00830219|12025821|FG000|COMPLETED|Washout of 7 Days||22
10860611|NCT00830219|12025822|FG001|COMPLETED|Washout of 7 Days||22
10860612|NCT00830219|12025821|FG000|NOT COMPLETED|Washout of 7 Days||1
10860613|NCT00830219|12025822|FG001|NOT COMPLETED|Washout of 7 Days||1
10860614|NCT00830219|12025821|FG000|STARTED|Second Intervention||22
10860615|NCT00830219|12025822|FG001|STARTED|Second Intervention||22
10860616|NCT00830219|12025821|FG000|COMPLETED|Second Intervention||22
10860617|NCT00830219|12025822|FG001|COMPLETED|Second Intervention||22
10860618|NCT00830219|12025821|FG000|NOT COMPLETED|Second Intervention||0
10860619|NCT00830219|12025822|FG001|NOT COMPLETED|Second Intervention||0
10860620|NCT00830206|12025828|FG000|STARTED|First Intervention||40
10860621|NCT00830206|12025829|FG001|STARTED|First Intervention||40
10860622|NCT00830206|12025828|FG000|COMPLETED|First Intervention||40
10860623|NCT00830206|12025829|FG001|COMPLETED|First Intervention||40
10860624|NCT00830206|12025828|FG000|NOT COMPLETED|First Intervention||0
10860625|NCT00830206|12025829|FG001|NOT COMPLETED|First Intervention||0
10860626|NCT00830206|12025828|FG000|STARTED|Washout: 21 Days||40
11227087|NCT01999400|12419067|FG001|STARTED|Washout (10 Days)||0
11227088|NCT01999400|12419068|FG002|STARTED|Washout (10 Days)||1
11227089|NCT01999400|12419069|FG003|STARTED|Washout (10 Days)||0
11227090|NCT01999400|12419070|FG004|STARTED|Washout (10 Days)||0
11227091|NCT01999400|12419071|FG005|STARTED|Washout (10 Days)||0
11227092|NCT01999400|12419066|FG000|COMPLETED|Washout (10 Days)||1
11227093|NCT01999400|12419067|FG001|COMPLETED|Washout (10 Days)||0
11227094|NCT01999400|12419068|FG002|COMPLETED|Washout (10 Days)||1
11227095|NCT01999400|12419069|FG003|COMPLETED|Washout (10 Days)||0
11227096|NCT01999400|12419070|FG004|COMPLETED|Washout (10 Days)||0
11227097|NCT01999400|12419071|FG005|COMPLETED|Washout (10 Days)||0
11227098|NCT01999400|12419066|FG000|NOT COMPLETED|Washout (10 Days)||0
11227099|NCT01999400|12419067|FG001|NOT COMPLETED|Washout (10 Days)||0
11227100|NCT01999400|12419068|FG002|NOT COMPLETED|Washout (10 Days)||0
11227101|NCT01999400|12419069|FG003|NOT COMPLETED|Washout (10 Days)||0
11227102|NCT01999400|12419070|FG004|NOT COMPLETED|Washout (10 Days)||0
11227103|NCT01999400|12419071|FG005|NOT COMPLETED|Washout (10 Days)||0
11227104|NCT01999400|12419066|FG000|STARTED|Fourth Intervention (1 Day)||1
11227105|NCT01999400|12419067|FG001|STARTED|Fourth Intervention (1 Day)||0
11227106|NCT01999400|12419068|FG002|STARTED|Fourth Intervention (1 Day)||1
11227107|NCT01999400|12419069|FG003|STARTED|Fourth Intervention (1 Day)||0
11227108|NCT01999400|12419070|FG004|STARTED|Fourth Intervention (1 Day)||0
11227109|NCT01999400|12419071|FG005|STARTED|Fourth Intervention (1 Day)||0
11227110|NCT01999400|12419066|FG000|COMPLETED|Fourth Intervention (1 Day)||1
11227111|NCT01999400|12419067|FG001|COMPLETED|Fourth Intervention (1 Day)||0
11227112|NCT01999400|12419068|FG002|COMPLETED|Fourth Intervention (1 Day)||1
11227113|NCT01999400|12419069|FG003|COMPLETED|Fourth Intervention (1 Day)||0
11107550|NCT01263314|12291902|FG002|COMPLETED|Period 1||2
11107551|NCT01263314|12291903|FG003|COMPLETED|Period 1||2
11227114|NCT01999400|12419070|FG004|COMPLETED|Fourth Intervention (1 Day)||0
11227115|NCT01999400|12419071|FG005|COMPLETED|Fourth Intervention (1 Day)||0
11227116|NCT01999400|12419066|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
11227117|NCT01999400|12419067|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
11227118|NCT01999400|12419068|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
11227119|NCT01999400|12419069|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
11227120|NCT01999400|12419070|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0
11227121|NCT01999400|12419071|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0
11227122|NCT01999465|12419083|FG000|STARTED|Overall Study||10
11227123|NCT01999465|12419084|FG001|STARTED|Overall Study||10
11227124|NCT01999465|12419083|FG000|COMPLETED|Overall Study||10
11227125|NCT01999465|12419084|FG001|COMPLETED|Overall Study||7
11227126|NCT01999465|12419083|FG000|NOT COMPLETED|Overall Study||0
11227127|NCT01999465|12419084|FG001|NOT COMPLETED|Overall Study||3
11227128|NCT01999517|12419092|FG000|STARTED|Overall Study||68
11227129|NCT01999517|12419093|FG001|STARTED|Overall Study||54
11227130|NCT01999517|12419092|FG000|COMPLETED|Overall Study||68
11227131|NCT01999517|12419093|FG001|COMPLETED|Overall Study||54
11227132|NCT01999517|12419092|FG000|NOT COMPLETED|Overall Study||0
11227133|NCT01999517|12419093|FG001|NOT COMPLETED|Overall Study||0
11227134|NCT01999530|12419099|FG000|STARTED|Overall Study||20
11227135|NCT01999530|12419099|FG000|COMPLETED|Overall Study||7
11227136|NCT01999530|12419099|FG000|NOT COMPLETED|Overall Study||13
11227137|NCT01999777|12419105|FG000|STARTED|Overall Study||31
11355000|NCT03076970|12551946|FG003|STARTED|Period 1||7
10860627|NCT00830206|12025829|FG001|STARTED|Washout: 21 Days||40
10860628|NCT00830206|12025828|FG000|COMPLETED|Washout: 21 Days||39
10860629|NCT00830206|12025829|FG001|COMPLETED|Washout: 21 Days||39
10860630|NCT00830206|12025828|FG000|NOT COMPLETED|Washout: 21 Days||1
10860631|NCT00830206|12025829|FG001|NOT COMPLETED|Washout: 21 Days||1
10860632|NCT00830206|12025828|FG000|STARTED|Second Intervention||39
11227138|NCT01999777|12419106|FG001|STARTED|Overall Study||31
11227139|NCT01999777|12419105|FG000|COMPLETED|Overall Study||31
11227140|NCT01999777|12419106|FG001|COMPLETED|Overall Study||31
11227141|NCT01999777|12419105|FG000|NOT COMPLETED|Overall Study||0
11227142|NCT01999777|12419106|FG001|NOT COMPLETED|Overall Study||0
11227143|NCT01999868|12419115|FG000|STARTED|Lead-in Phase (Week 0 - 12)||45
11227144|NCT01999868|12419116|FG001|STARTED|Lead-in Phase (Week 0 - 12)||46
11227145|NCT01999868|12419117|FG002|STARTED|Lead-in Phase (Week 0 - 12)||17
10860633|NCT00830206|12025829|FG001|STARTED|Second Intervention||39
10860634|NCT00830206|12025828|FG000|COMPLETED|Second Intervention||39
10860635|NCT00830206|12025829|FG001|COMPLETED|Second Intervention||39
10860636|NCT00830206|12025828|FG000|NOT COMPLETED|Second Intervention||0
10860637|NCT00830206|12025829|FG001|NOT COMPLETED|Second Intervention||0
10860638|NCT00830024|12025835|FG000|STARTED|First Intervention||18
10860639|NCT00830024|12025836|FG001|STARTED|First Intervention||18
10860640|NCT00830024|12025835|FG000|COMPLETED|First Intervention||18
10860641|NCT00830024|12025836|FG001|COMPLETED|First Intervention||18
10860642|NCT00830024|12025835|FG000|NOT COMPLETED|First Intervention||0
10860643|NCT00830024|12025836|FG001|NOT COMPLETED|First Intervention||0
10860644|NCT00830024|12025835|FG000|STARTED|Washout: 7 Days||18
10860645|NCT00830024|12025836|FG001|STARTED|Washout: 7 Days||18
10860646|NCT00830024|12025835|FG000|COMPLETED|Washout: 7 Days||17
10860647|NCT00830024|12025836|FG001|COMPLETED|Washout: 7 Days||18
10860648|NCT00830024|12025835|FG000|NOT COMPLETED|Washout: 7 Days||1
10860649|NCT00830024|12025836|FG001|NOT COMPLETED|Washout: 7 Days||0
10860650|NCT00830024|12025835|FG000|STARTED|Second Intervention||17
10860651|NCT00830024|12025836|FG001|STARTED|Second Intervention||18
10860652|NCT00830024|12025835|FG000|COMPLETED|Second Intervention||17
10860653|NCT00830024|12025836|FG001|COMPLETED|Second Intervention||18
10860654|NCT00830024|12025835|FG000|NOT COMPLETED|Second Intervention||0
10860655|NCT00830024|12025836|FG001|NOT COMPLETED|Second Intervention||0
10860656|NCT00829998|12025842|FG000|STARTED|First Intervention||21
10860657|NCT00829998|12025843|FG001|STARTED|First Intervention||20
10860658|NCT00829998|12025842|FG000|COMPLETED|First Intervention||21
11107552|NCT01263314|12291904|FG004|COMPLETED|Period 1||2
11107553|NCT01263314|12291905|FG005|COMPLETED|Period 1||2
11107554|NCT01263314|12291906|FG006|COMPLETED|Period 1||2
11107555|NCT01263314|12291907|FG007|COMPLETED|Period 1||2
11107556|NCT01263314|12291900|FG000|NOT COMPLETED|Period 1||0
11107557|NCT01263314|12291901|FG001|NOT COMPLETED|Period 1||0
11107558|NCT01263314|12291902|FG002|NOT COMPLETED|Period 1||0
11107559|NCT01263314|12291903|FG003|NOT COMPLETED|Period 1||0
11107560|NCT01263314|12291904|FG004|NOT COMPLETED|Period 1||0
11107561|NCT01263314|12291905|FG005|NOT COMPLETED|Period 1||0
11107562|NCT01263314|12291906|FG006|NOT COMPLETED|Period 1||0
11107563|NCT01263314|12291907|FG007|NOT COMPLETED|Period 1||0
11107564|NCT01263314|12291900|FG000|STARTED|Period 2||2
11107565|NCT01263314|12291901|FG001|STARTED|Period 2||2
11227146|NCT01999868|12419115|FG000|COMPLETED|Lead-in Phase (Week 0 - 12)||45
11227147|NCT01999868|12419116|FG001|COMPLETED|Lead-in Phase (Week 0 - 12)||46
11227148|NCT01999868|12419117|FG002|COMPLETED|Lead-in Phase (Week 0 - 12)||12
11227149|NCT01999868|12419115|FG000|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
11227150|NCT01999868|12419116|FG001|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
11227151|NCT01999868|12419117|FG002|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||5
11227152|NCT01999868|12419115|FG000|STARTED|Blinded Treatment Phase (Week 12 - 40)||45
11227153|NCT01999868|12419116|FG001|STARTED|Blinded Treatment Phase (Week 12 - 40)||46
11227154|NCT01999868|12419117|FG002|STARTED|Blinded Treatment Phase (Week 12 - 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
11355001|NCT03076970|12551947|FG004|STARTED|Period 1||7
11107566|NCT01263314|12291902|FG002|STARTED|Period 2||2
11107567|NCT01263314|12291903|FG003|STARTED|Period 2||2
11107568|NCT01263314|12291904|FG004|STARTED|Period 2||2
11107569|NCT01263314|12291905|FG005|STARTED|Period 2||2
11107570|NCT01263314|12291906|FG006|STARTED|Period 2||2
11107571|NCT01263314|12291907|FG007|STARTED|Period 2||2
11107572|NCT01263314|12291900|FG000|COMPLETED|Period 2||2
11107573|NCT01263314|12291901|FG001|COMPLETED|Period 2||2
11107574|NCT01263314|12291902|FG002|COMPLETED|Period 2||2
11107575|NCT01263314|12291903|FG003|COMPLETED|Period 2||2
11107576|NCT01263314|12291904|FG004|COMPLETED|Period 2||2
11107577|NCT01263314|12291905|FG005|COMPLETED|Period 2||2
11227155|NCT01999868|12419115|FG000|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||27
11227156|NCT01999868|12419116|FG001|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||35
11227157|NCT01999868|12419117|FG002|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
11227158|NCT01999868|12419115|FG000|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||18
11227159|NCT01999868|12419116|FG001|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||11
11227160|NCT01999868|12419117|FG002|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
11227161|NCT01999868|12419115|FG000|STARTED|Blinded Observation Phase (Week 40 - 88)||27
11227162|NCT01999868|12419116|FG001|STARTED|Blinded Observation Phase (Week 40 - 88)||35
11227163|NCT01999868|12419117|FG002|STARTED|Blinded Observation Phase (Week 40 - 88)||0
11227164|NCT01999868|12419115|FG000|COMPLETED|Blinded Observation Phase (Week 40 - 88)||4
11227165|NCT01999868|12419116|FG001|COMPLETED|Blinded Observation Phase (Week 40 - 88)||6
11227166|NCT01999868|12419117|FG002|COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
11227167|NCT01999868|12419115|FG000|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||23
11227168|NCT01999868|12419116|FG001|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||29
11227169|NCT01999868|12419117|FG002|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
11227170|NCT01999894|12419125|FG000|STARTED|Overall Study||102
11227171|NCT01999894|12419125|FG000|COMPLETED|Overall Study||66
11227172|NCT01999894|12419125|FG000|NOT COMPLETED|Overall Study||36
10860659|NCT00829998|12025843|FG001|COMPLETED|First Intervention||20
10860660|NCT00829998|12025842|FG000|NOT COMPLETED|First Intervention||0
10860661|NCT00829998|12025843|FG001|NOT COMPLETED|First Intervention||0
10860662|NCT00829998|12025842|FG000|STARTED|Washout||21
10860663|NCT00829998|12025843|FG001|STARTED|Washout||20
11107578|NCT01263314|12291906|FG006|COMPLETED|Period 2||2
10860664|NCT00829998|12025842|FG000|COMPLETED|Washout||21
10860665|NCT00829998|12025843|FG001|COMPLETED|Washout||19
10860666|NCT00829998|12025842|FG000|NOT COMPLETED|Washout||0
10860667|NCT00829998|12025843|FG001|NOT COMPLETED|Washout||1
10860668|NCT00829998|12025842|FG000|STARTED|Second Intervention||21
10860669|NCT00829998|12025843|FG001|STARTED|Second Intervention||19
10860670|NCT00829998|12025842|FG000|COMPLETED|Second Intervention||21
10860671|NCT00829998|12025843|FG001|COMPLETED|Second Intervention||19
10860672|NCT00829998|12025842|FG000|NOT COMPLETED|Second Intervention||0
10860673|NCT00829998|12025843|FG001|NOT COMPLETED|Second Intervention||0
10860674|NCT00829868|12025849|FG000|STARTED|First Intervention||21
10860675|NCT00829868|12025850|FG001|STARTED|First Intervention||21
10860676|NCT00829868|12025849|FG000|COMPLETED|First Intervention||21
10860677|NCT00829868|12025850|FG001|COMPLETED|First Intervention||21
10860678|NCT00829868|12025849|FG000|NOT COMPLETED|First Intervention||0
11107579|NCT01263314|12291907|FG007|COMPLETED|Period 2||2
11227173|NCT01999920|12419132|FG000|STARTED|Overall Study||13
11227174|NCT01999920|12419133|FG001|STARTED|Overall Study||11
11227175|NCT01999920|12419132|FG000|COMPLETED|Overall Study||7
11227176|NCT01999920|12419133|FG001|COMPLETED|Overall Study||9
11227177|NCT01999920|12419132|FG000|NOT COMPLETED|Overall Study||6
11227178|NCT01999920|12419133|FG001|NOT COMPLETED|Overall Study||2
11227179|NCT01999946|12419142|FG000|STARTED|Overall Study||61
11227180|NCT01999946|12419143|FG001|STARTED|Overall Study||58
11227181|NCT01999946|12419144|FG002|STARTED|Overall Study||79
11227182|NCT01999946|12419142|FG000|COMPLETED|Overall Study||59
11227183|NCT01999946|12419143|FG001|COMPLETED|Overall Study||56
11227184|NCT01999946|12419144|FG002|COMPLETED|Overall Study||0
11227185|NCT01999946|12419142|FG000|NOT COMPLETED|Overall Study||2
11227186|NCT01999946|12419143|FG001|NOT COMPLETED|Overall Study||2
11227187|NCT01999946|12419144|FG002|NOT COMPLETED|Overall Study||79
11227188|NCT01999972|12419157|FG000|STARTED|Dose Escalation Part||5
11227189|NCT01999972|12419158|FG001|STARTED|Dose Escalation Part||3
11107580|NCT01263314|12291900|FG000|NOT COMPLETED|Period 2||0
11227190|NCT01999972|12419159|FG002|STARTED|Dose Escalation Part||5
11227191|NCT01999972|12419160|FG003|STARTED|Dose Escalation Part||11
11227192|NCT01999972|12419161|FG004|STARTED|Dose Escalation Part||0
11227193|NCT01999972|12419162|FG005|STARTED|Dose Escalation Part||0
11227194|NCT01999972|12419157|FG000|Treated|Dose Escalation Part||5
11227195|NCT01999972|12419158|FG001|Treated|Dose Escalation Part||3
11227196|NCT01999972|12419159|FG002|Treated|Dose Escalation Part||4
11227197|NCT01999972|12419160|FG003|Treated|Dose Escalation Part||10
11227198|NCT01999972|12419161|FG004|Treated|Dose Escalation Part||0
11227199|NCT01999972|12419162|FG005|Treated|Dose Escalation Part||0
11227200|NCT01999972|12419157|FG000|COMPLETED|Dose Escalation Part||0
11227201|NCT01999972|12419158|FG001|COMPLETED|Dose Escalation Part||0
11227202|NCT01999972|12419159|FG002|COMPLETED|Dose Escalation Part||0
11227203|NCT01999972|12419160|FG003|COMPLETED|Dose Escalation Part||0
11227204|NCT01999972|12419161|FG004|COMPLETED|Dose Escalation Part||0
11227205|NCT01999972|12419162|FG005|COMPLETED|Dose Escalation Part||0
11227206|NCT01999972|12419157|FG000|NOT COMPLETED|Dose Escalation Part||5
11227207|NCT01999972|12419158|FG001|NOT COMPLETED|Dose Escalation Part||3
11227208|NCT01999972|12419159|FG002|NOT COMPLETED|Dose Escalation Part||5
11227209|NCT01999972|12419160|FG003|NOT COMPLETED|Dose Escalation Part||11
11227210|NCT01999972|12419161|FG004|NOT COMPLETED|Dose Escalation Part||0
11227211|NCT01999972|12419162|FG005|NOT COMPLETED|Dose Escalation Part||0
11227212|NCT01999972|12419157|FG000|STARTED|Dose Expansion Part||0
11227213|NCT01999972|12419158|FG001|STARTED|Dose Expansion Part||0
11227214|NCT01999972|12419159|FG002|STARTED|Dose Expansion Part||0
11227215|NCT01999972|12419160|FG003|STARTED|Dose Expansion Part||0
11227216|NCT01999972|12419161|FG004|STARTED|Dose Expansion Part||21
11227217|NCT01999972|12419162|FG005|STARTED|Dose Expansion Part||7
11227218|NCT01999972|12419157|FG000|Treated|Dose Expansion Part||0
11227219|NCT01999972|12419158|FG001|Treated|Dose Expansion Part||0
11227220|NCT01999972|12419159|FG002|Treated|Dose Expansion Part||0
11227221|NCT01999972|12419160|FG003|Treated|Dose Expansion Part||0
11227222|NCT01999972|12419161|FG004|Treated|Dose Expansion Part||21
11227223|NCT01999972|12419162|FG005|Treated|Dose Expansion Part||7
11227224|NCT01999972|12419157|FG000|COMPLETED|Dose Expansion Part||0
11227225|NCT01999972|12419158|FG001|COMPLETED|Dose Expansion Part||0
11227226|NCT01999972|12419159|FG002|COMPLETED|Dose Expansion Part||0
11227227|NCT01999972|12419160|FG003|COMPLETED|Dose Expansion Part||0
11227228|NCT01999972|12419161|FG004|COMPLETED|Dose Expansion Part||0
11227229|NCT01999972|12419162|FG005|COMPLETED|Dose Expansion Part||0
11227230|NCT01999972|12419157|FG000|NOT COMPLETED|Dose Expansion Part||0
11227231|NCT01999972|12419158|FG001|NOT COMPLETED|Dose Expansion Part||0
11227232|NCT01999972|12419159|FG002|NOT COMPLETED|Dose Expansion Part||0
11227233|NCT01999972|12419160|FG003|NOT COMPLETED|Dose Expansion Part||0
11227234|NCT01999972|12419161|FG004|NOT COMPLETED|Dose Expansion Part||21
11227235|NCT01999972|12419162|FG005|NOT COMPLETED|Dose Expansion Part||7
11227236|NCT01999985|12419178|FG000|STARTED|Overall Study||8
11227237|NCT01999985|12419179|FG001|STARTED|Overall Study||3
11227238|NCT01999985|12419180|FG002|STARTED|Overall Study||14
11227239|NCT01999985|12419178|FG000|COMPLETED|Overall Study||8
11227240|NCT01999985|12419179|FG001|COMPLETED|Overall Study||3
11227241|NCT01999985|12419180|FG002|COMPLETED|Overall Study||14
11227242|NCT01999985|12419178|FG000|NOT COMPLETED|Overall Study||0
10860679|NCT00829868|12025850|FG001|NOT COMPLETED|First Intervention||0
10860680|NCT00829868|12025849|FG000|STARTED|Washout||21
11107581|NCT01263314|12291901|FG001|NOT COMPLETED|Period 2||0
11107582|NCT01263314|12291902|FG002|NOT COMPLETED|Period 2||0
11107583|NCT01263314|12291903|FG003|NOT COMPLETED|Period 2||0
11107584|NCT01263314|12291904|FG004|NOT COMPLETED|Period 2||0
11107585|NCT01263314|12291905|FG005|NOT COMPLETED|Period 2||0
11107586|NCT01263314|12291906|FG006|NOT COMPLETED|Period 2||0
11107587|NCT01263314|12291907|FG007|NOT COMPLETED|Period 2||0
11107588|NCT01263314|12291900|FG000|STARTED|Period 3||2
11107589|NCT01263314|12291901|FG001|STARTED|Period 3||2
10860681|NCT00829868|12025850|FG001|STARTED|Washout||21
11107590|NCT01263314|12291902|FG002|STARTED|Period 3||2
11107591|NCT01263314|12291903|FG003|STARTED|Period 3||2
11107592|NCT01263314|12291904|FG004|STARTED|Period 3||2
11107593|NCT01263314|12291905|FG005|STARTED|Period 3||2
11227243|NCT01999985|12419179|FG001|NOT COMPLETED|Overall Study||0
10860682|NCT00829868|12025849|FG000|COMPLETED|Washout||20
10860683|NCT00829868|12025850|FG001|COMPLETED|Washout||21
10860684|NCT00829868|12025849|FG000|NOT COMPLETED|Washout||1
10860685|NCT00829868|12025850|FG001|NOT COMPLETED|Washout||0
10860686|NCT00829868|12025849|FG000|STARTED|Second Intervention||20
10860687|NCT00829868|12025850|FG001|STARTED|Second Intervention||21
10860688|NCT00829868|12025849|FG000|COMPLETED|Second Intervention||20
10860689|NCT00829868|12025850|FG001|COMPLETED|Second Intervention||21
10860690|NCT00829868|12025849|FG000|NOT COMPLETED|Second Intervention||0
10860691|NCT00829868|12025850|FG001|NOT COMPLETED|Second Intervention||0
10860692|NCT00829790|12025856|FG000|STARTED|First Intervention||15
10860693|NCT00829790|12025857|FG001|STARTED|First Intervention||15
10860694|NCT00829790|12025856|FG000|COMPLETED|First Intervention||15
10860695|NCT00829790|12025857|FG001|COMPLETED|First Intervention||15
10860696|NCT00829790|12025856|FG000|NOT COMPLETED|First Intervention||0
10860697|NCT00829790|12025857|FG001|NOT COMPLETED|First Intervention||0
10860698|NCT00829790|12025856|FG000|STARTED|Washout of 14 Days||15
10860699|NCT00829790|12025857|FG001|STARTED|Washout of 14 Days||15
10860700|NCT00829790|12025856|FG000|COMPLETED|Washout of 14 Days||15
10860701|NCT00829790|12025857|FG001|COMPLETED|Washout of 14 Days||14
10860702|NCT00829790|12025856|FG000|NOT COMPLETED|Washout of 14 Days||0
10860703|NCT00829790|12025857|FG001|NOT COMPLETED|Washout of 14 Days||1
10860704|NCT00829790|12025856|FG000|STARTED|Second Intervention||15
10860705|NCT00829790|12025857|FG001|STARTED|Second Intervention||14
10860706|NCT00829790|12025856|FG000|COMPLETED|Second Intervention||15
10860707|NCT00829790|12025857|FG001|COMPLETED|Second Intervention||14
10860708|NCT00829790|12025856|FG000|NOT COMPLETED|Second Intervention||0
10860709|NCT00829790|12025857|FG001|NOT COMPLETED|Second Intervention||0
10860710|NCT00829764|12025863|FG000|STARTED|First Intervention||15
10860711|NCT00829764|12025864|FG001|STARTED|First Intervention||15
10860712|NCT00829764|12025863|FG000|COMPLETED|First Intervention||13
10860713|NCT00829764|12025864|FG001|COMPLETED|First Intervention||14
10860714|NCT00829764|12025863|FG000|NOT COMPLETED|First Intervention||2
10860715|NCT00829764|12025864|FG001|NOT COMPLETED|First Intervention||1
10860716|NCT00829764|12025863|FG000|STARTED|Washout of 14 Days||13
10860717|NCT00829764|12025864|FG001|STARTED|Washout of 14 Days||14
10860718|NCT00829764|12025863|FG000|COMPLETED|Washout of 14 Days||13
10860719|NCT00829764|12025864|FG001|COMPLETED|Washout of 14 Days||14
10860720|NCT00829764|12025863|FG000|NOT COMPLETED|Washout of 14 Days||0
10860721|NCT00829764|12025864|FG001|NOT COMPLETED|Washout of 14 Days||0
10860722|NCT00829764|12025863|FG000|STARTED|Second Intervention||13
10860723|NCT00829764|12025864|FG001|STARTED|Second Intervention||14
10860724|NCT00829764|12025863|FG000|COMPLETED|Second Intervention||13
10860725|NCT00829764|12025864|FG001|COMPLETED|Second Intervention||14
10860726|NCT00829764|12025863|FG000|NOT COMPLETED|Second Intervention||0
10860727|NCT00829764|12025864|FG001|NOT COMPLETED|Second Intervention||0
10860728|NCT00829712|12025870|FG000|STARTED|First Intervention||12
10860729|NCT00829712|12025871|FG001|STARTED|First Intervention||12
10860730|NCT00829712|12025870|FG000|COMPLETED|First Intervention||12
10860731|NCT00829712|12025871|FG001|COMPLETED|First Intervention||12
10860732|NCT00829712|12025870|FG000|NOT COMPLETED|First Intervention||0
10860733|NCT00829712|12025871|FG001|NOT COMPLETED|First Intervention||0
10860734|NCT00829712|12025870|FG000|STARTED|Washout of 7 Days||12
10860735|NCT00829712|12025871|FG001|STARTED|Washout of 7 Days||12
10860736|NCT00829712|12025870|FG000|COMPLETED|Washout of 7 Days||12
10860737|NCT00829712|12025871|FG001|COMPLETED|Washout of 7 Days||11
10860738|NCT00829712|12025870|FG000|NOT COMPLETED|Washout of 7 Days||0
10860739|NCT00829712|12025871|FG001|NOT COMPLETED|Washout of 7 Days||1
10860740|NCT00829712|12025870|FG000|STARTED|Second Intervention||12
10860741|NCT00829712|12025871|FG001|STARTED|Second Intervention||11
10860742|NCT00829712|12025870|FG000|COMPLETED|Second Intervention||12
10860743|NCT00829712|12025871|FG001|COMPLETED|Second Intervention||11
10860744|NCT00829712|12025870|FG000|NOT COMPLETED|Second Intervention||0
10860745|NCT00829712|12025871|FG001|NOT COMPLETED|Second Intervention||0
10860746|NCT00829686|12025877|FG000|STARTED|Overall Study||13
10860747|NCT00829686|12025878|FG001|STARTED|Overall Study||18
10860748|NCT00829686|12025877|FG000|COMPLETED|Overall Study||13
10860749|NCT00829686|12025878|FG001|COMPLETED|Overall Study||18
10860750|NCT00829686|12025877|FG000|NOT COMPLETED|Overall Study||0
10860751|NCT00829686|12025878|FG001|NOT COMPLETED|Overall Study||0
10860752|NCT00829673|12025884|FG000|STARTED|First Intervention||12
10860753|NCT00829673|12025885|FG001|STARTED|First Intervention||12
10860754|NCT00829673|12025884|FG000|COMPLETED|First Intervention||12
10860755|NCT00829673|12025885|FG001|COMPLETED|First Intervention||12
10860756|NCT00829673|12025884|FG000|NOT COMPLETED|First Intervention||0
10860757|NCT00829673|12025885|FG001|NOT COMPLETED|First Intervention||0
10860758|NCT00829673|12025884|FG000|STARTED|Washout of 7 Days||12
10860759|NCT00829673|12025885|FG001|STARTED|Washout of 7 Days||12
10860760|NCT00829673|12025884|FG000|COMPLETED|Washout of 7 Days||11
10860761|NCT00829673|12025885|FG001|COMPLETED|Washout of 7 Days||12
10860762|NCT00829673|12025884|FG000|NOT COMPLETED|Washout of 7 Days||1
10860763|NCT00829673|12025885|FG001|NOT COMPLETED|Washout of 7 Days||0
10860764|NCT00829673|12025884|FG000|STARTED|Second Intervention||11
10860765|NCT00829673|12025885|FG001|STARTED|Second Intervention||12
10860766|NCT00829673|12025884|FG000|COMPLETED|Second Intervention||11
10860767|NCT00829673|12025885|FG001|COMPLETED|Second Intervention||12
10860768|NCT00829673|12025884|FG000|NOT COMPLETED|Second Intervention||0
10860769|NCT00829673|12025885|FG001|NOT COMPLETED|Second Intervention||0
10860770|NCT00829530|12025891|FG000|STARTED|First Intervention||20
10860771|NCT00829530|12025892|FG001|STARTED|First Intervention||20
10860772|NCT00829530|12025891|FG000|COMPLETED|First Intervention||20
10860773|NCT00829530|12025892|FG001|COMPLETED|First Intervention||18
10860774|NCT00829530|12025891|FG000|NOT COMPLETED|First Intervention||0
10860775|NCT00829530|12025892|FG001|NOT COMPLETED|First Intervention||2
10860776|NCT00829530|12025891|FG000|STARTED|Washout of 42 Days||20
10860777|NCT00829530|12025892|FG001|STARTED|Washout of 42 Days||18
10860778|NCT00829530|12025891|FG000|COMPLETED|Washout of 42 Days||20
10860779|NCT00829530|12025892|FG001|COMPLETED|Washout of 42 Days||18
10860780|NCT00829530|12025891|FG000|NOT COMPLETED|Washout of 42 Days||0
10860781|NCT00829530|12025892|FG001|NOT COMPLETED|Washout of 42 Days||0
10860782|NCT00829530|12025891|FG000|STARTED|Second Intervention||20
10860783|NCT00829530|12025892|FG001|STARTED|Second Intervention||18
10860784|NCT00829530|12025891|FG000|COMPLETED|Second Intervention||19
10860785|NCT00829530|12025892|FG001|COMPLETED|Second Intervention||18
10860786|NCT00829530|12025891|FG000|NOT COMPLETED|Second Intervention||1
10860787|NCT00829530|12025892|FG001|NOT COMPLETED|Second Intervention||0
10860788|NCT00829504|12025898|FG000|STARTED|First Intervention||22
10860789|NCT00829504|12025899|FG001|STARTED|First Intervention||22
10860790|NCT00829504|12025898|FG000|COMPLETED|First Intervention||21
10860791|NCT00829504|12025899|FG001|COMPLETED|First Intervention||22
10860792|NCT00829504|12025898|FG000|NOT COMPLETED|First Intervention||1
10860793|NCT00829504|12025899|FG001|NOT COMPLETED|First Intervention||0
10860794|NCT00829504|12025898|FG000|STARTED|Washout of 7 Days||21
10860795|NCT00829504|12025899|FG001|STARTED|Washout of 7 Days||22
10860796|NCT00829504|12025898|FG000|COMPLETED|Washout of 7 Days||20
10860797|NCT00829504|12025899|FG001|COMPLETED|Washout of 7 Days||22
10860798|NCT00829504|12025898|FG000|NOT COMPLETED|Washout of 7 Days||1
10860799|NCT00829504|12025899|FG001|NOT COMPLETED|Washout of 7 Days||0
10860800|NCT00829504|12025898|FG000|STARTED|Second Intervention||20
10860801|NCT00829504|12025899|FG001|STARTED|Second Intervention||22
10860802|NCT00829504|12025898|FG000|COMPLETED|Second Intervention||19
10860803|NCT00829504|12025899|FG001|COMPLETED|Second Intervention||22
10860804|NCT00829504|12025898|FG000|NOT COMPLETED|Second Intervention||1
10860805|NCT00829504|12025899|FG001|NOT COMPLETED|Second Intervention||0
10860806|NCT00829452|12025905|FG000|STARTED|First Intervention||20
10860807|NCT00829452|12025906|FG001|STARTED|First Intervention||20
10860808|NCT00829452|12025905|FG000|COMPLETED|First Intervention||20
10860809|NCT00829452|12025906|FG001|COMPLETED|First Intervention||19
10860810|NCT00829452|12025905|FG000|NOT COMPLETED|First Intervention||0
10860811|NCT00829452|12025906|FG001|NOT COMPLETED|First Intervention||1
10860812|NCT00829452|12025905|FG000|STARTED|Washout of 42 Days||20
10860813|NCT00829452|12025906|FG001|STARTED|Washout of 42 Days||19
10860814|NCT00829452|12025905|FG000|COMPLETED|Washout of 42 Days||20
10860815|NCT00829452|12025906|FG001|COMPLETED|Washout of 42 Days||18
10860816|NCT00829452|12025905|FG000|NOT COMPLETED|Washout of 42 Days||0
10860817|NCT00829452|12025906|FG001|NOT COMPLETED|Washout of 42 Days||1
10860818|NCT00829452|12025905|FG000|STARTED|Second Intervention||20
10860819|NCT00829452|12025906|FG001|STARTED|Second Intervention||18
10860820|NCT00829452|12025905|FG000|COMPLETED|Second Intervention||20
10860821|NCT00829452|12025906|FG001|COMPLETED|Second Intervention||17
10860822|NCT00829452|12025905|FG000|NOT COMPLETED|Second Intervention||0
10860823|NCT00829452|12025906|FG001|NOT COMPLETED|Second Intervention||1
10860824|NCT00829426|12025912|FG000|STARTED|First Intervention||16
10860825|NCT00829426|12025913|FG001|STARTED|First Intervention||16
10860826|NCT00829426|12025912|FG000|COMPLETED|First Intervention||16
10860827|NCT00829426|12025913|FG001|COMPLETED|First Intervention||16
10860828|NCT00829426|12025912|FG000|NOT COMPLETED|First Intervention||0
10860829|NCT00829426|12025913|FG001|NOT COMPLETED|First Intervention||0
10860830|NCT00829426|12025912|FG000|STARTED|Washout: 7 Days||16
10860831|NCT00829426|12025913|FG001|STARTED|Washout: 7 Days||16
10860832|NCT00829426|12025912|FG000|COMPLETED|Washout: 7 Days||15
10860833|NCT00829426|12025913|FG001|COMPLETED|Washout: 7 Days||16
10860834|NCT00829426|12025912|FG000|NOT COMPLETED|Washout: 7 Days||1
10860835|NCT00829426|12025913|FG001|NOT COMPLETED|Washout: 7 Days||0
10860836|NCT00829426|12025912|FG000|STARTED|Second Intervention||15
10860837|NCT00829426|12025913|FG001|STARTED|Second Intervention||16
10860838|NCT00829426|12025912|FG000|COMPLETED|Second Intervention||15
10860839|NCT00829426|12025913|FG001|COMPLETED|Second Intervention||16
10860840|NCT00829426|12025912|FG000|NOT COMPLETED|Second Intervention||0
10860841|NCT00829426|12025913|FG001|NOT COMPLETED|Second Intervention||0
10860842|NCT00829309|12025919|FG000|STARTED|First Intervention||8
10860843|NCT00829309|12025920|FG001|STARTED|First Intervention||8
10860844|NCT00829309|12025919|FG000|COMPLETED|First Intervention||8
10860845|NCT00829309|12025920|FG001|COMPLETED|First Intervention||8
10860846|NCT00829309|12025919|FG000|NOT COMPLETED|First Intervention||0
10860847|NCT00829309|12025920|FG001|NOT COMPLETED|First Intervention||0
10860848|NCT00829309|12025919|FG000|STARTED|Washout: 7 Days||8
10860849|NCT00829309|12025920|FG001|STARTED|Washout: 7 Days||8
10860850|NCT00829309|12025919|FG000|COMPLETED|Washout: 7 Days||7
10860851|NCT00829309|12025920|FG001|COMPLETED|Washout: 7 Days||8
10860852|NCT00829309|12025919|FG000|NOT COMPLETED|Washout: 7 Days||1
10860853|NCT00829309|12025920|FG001|NOT COMPLETED|Washout: 7 Days||0
10860854|NCT00829309|12025919|FG000|STARTED|Second Intervention||7
10860855|NCT00829309|12025920|FG001|STARTED|Second Intervention||8
10860856|NCT00829309|12025919|FG000|COMPLETED|Second Intervention||7
10860857|NCT00829309|12025920|FG001|COMPLETED|Second Intervention||8
10860858|NCT00829309|12025919|FG000|NOT COMPLETED|Second Intervention||0
10860859|NCT00829309|12025920|FG001|NOT COMPLETED|Second Intervention||0
10860860|NCT00828321|12025926|FG000|STARTED|First Intervention||20
10860861|NCT00828321|12025927|FG001|STARTED|First Intervention||20
10860862|NCT00828321|12025926|FG000|COMPLETED|First Intervention||20
10860863|NCT00828321|12025927|FG001|COMPLETED|First Intervention||20
10860864|NCT00828321|12025926|FG000|NOT COMPLETED|First Intervention||0
10860865|NCT00828321|12025927|FG001|NOT COMPLETED|First Intervention||0
10860866|NCT00828321|12025926|FG000|STARTED|Washout of 42 Days||20
10860867|NCT00828321|12025927|FG001|STARTED|Washout of 42 Days||20
10860868|NCT00828321|12025926|FG000|COMPLETED|Washout of 42 Days||18
10860869|NCT00828321|12025927|FG001|COMPLETED|Washout of 42 Days||20
10860870|NCT00828321|12025926|FG000|NOT COMPLETED|Washout of 42 Days||2
10860871|NCT00828321|12025927|FG001|NOT COMPLETED|Washout of 42 Days||0
10860872|NCT00828321|12025926|FG000|STARTED|Second Intervention||18
10860873|NCT00828321|12025927|FG001|STARTED|Second Intervention||20
10860874|NCT00828321|12025926|FG000|COMPLETED|Second Intervention||18
10860875|NCT00828321|12025927|FG001|COMPLETED|Second Intervention||19
10860876|NCT00828321|12025926|FG000|NOT COMPLETED|Second Intervention||0
10860877|NCT00828321|12025927|FG001|NOT COMPLETED|Second Intervention||1
11107594|NCT01263314|12291906|FG006|STARTED|Period 3||2
11107595|NCT01263314|12291907|FG007|STARTED|Period 3||2
11107596|NCT01263314|12291900|FG000|COMPLETED|Period 3||2
11107597|NCT01263314|12291901|FG001|COMPLETED|Period 3||2
11107598|NCT01263314|12291902|FG002|COMPLETED|Period 3||2
11107599|NCT01263314|12291903|FG003|COMPLETED|Period 3||2
11107600|NCT01263314|12291904|FG004|COMPLETED|Period 3||2
11107601|NCT01263314|12291905|FG005|COMPLETED|Period 3||2
11107602|NCT01263314|12291906|FG006|COMPLETED|Period 3||2
11107603|NCT01263314|12291907|FG007|COMPLETED|Period 3||2
11107604|NCT01263314|12291900|FG000|NOT COMPLETED|Period 3||0
11107605|NCT01263314|12291901|FG001|NOT COMPLETED|Period 3||0
11107606|NCT01263314|12291902|FG002|NOT COMPLETED|Period 3||0
11107607|NCT01263314|12291903|FG003|NOT COMPLETED|Period 3||0
11107608|NCT01263314|12291904|FG004|NOT COMPLETED|Period 3||0
11107609|NCT01263314|12291905|FG005|NOT COMPLETED|Period 3||0
11107610|NCT01263314|12291906|FG006|NOT COMPLETED|Period 3||0
11107611|NCT01263314|12291907|FG007|NOT COMPLETED|Period 3||0
10860878|NCT00806403|12025933|FG000|STARTED|Overall Study||104
10860879|NCT00806403|12025934|FG001|STARTED|Overall Study||101
10860880|NCT00806403|12025933|FG000|COMPLETED|Overall Study||100
10860881|NCT00806403|12025934|FG001|COMPLETED|Overall Study||98
10860882|NCT00806403|12025933|FG000|NOT COMPLETED|Overall Study||4
10860883|NCT00806403|12025934|FG001|NOT COMPLETED|Overall Study||3
10860884|NCT00803517|12025940|FG000|STARTED|Overall Study||12
10860885|NCT00803517|12025941|FG001|STARTED|Overall Study||12
10860886|NCT00803517|12025940|FG000|COMPLETED|Overall Study||12
10860887|NCT00803517|12025941|FG001|COMPLETED|Overall Study||12
11107612|NCT01263444|12291931|FG000|STARTED|Overall Study||47
10860888|NCT00803517|12025940|FG000|NOT COMPLETED|Overall Study||0
10860889|NCT00803517|12025941|FG001|NOT COMPLETED|Overall Study||0
10860890|NCT00803413|12025949|FG000|STARTED|Overall Period||28
10860891|NCT00803413|12025950|FG001|STARTED|Overall Period||32
10860892|NCT00803413|12025951|FG002|STARTED|Overall Period||29
10860893|NCT00803413|12025952|FG003|STARTED|Overall Period||30
10860894|NCT00803413|12025949|FG000|COMPLETED|Overall Period||28
10860895|NCT00803413|12025950|FG001|COMPLETED|Overall Period||32
10860896|NCT00803413|12025951|FG002|COMPLETED|Overall Period||29
10860897|NCT00803413|12025952|FG003|COMPLETED|Overall Period||30
10860898|NCT00803413|12025949|FG000|NOT COMPLETED|Overall Period||0
10860899|NCT00803413|12025950|FG001|NOT COMPLETED|Overall Period||0
10860900|NCT00803413|12025951|FG002|NOT COMPLETED|Overall Period||0
10860901|NCT00803413|12025952|FG003|NOT COMPLETED|Overall Period||0
10860902|NCT00803114|12025960|FG000|STARTED|Overall Study||113
10860903|NCT00803114|12025961|FG001|STARTED|Overall Study||115
10860904|NCT00803114|12025960|FG000|COMPLETED|Overall Study||113
10860905|NCT00803114|12025961|FG001|COMPLETED|Overall Study||115
10860906|NCT00803114|12025960|FG000|NOT COMPLETED|Overall Study||0
10860907|NCT00803114|12025961|FG001|NOT COMPLETED|Overall Study||0
10860908|NCT00799292|12025967|FG000|STARTED|Overall Study||29
10860909|NCT00799292|12025968|FG001|STARTED|Overall Study||29
10860910|NCT00799292|12025967|FG000|COMPLETED|Overall Study||29
10860911|NCT00799292|12025968|FG001|COMPLETED|Overall Study||29
10860912|NCT00799292|12025967|FG000|NOT COMPLETED|Overall Study||0
10860913|NCT00799292|12025968|FG001|NOT COMPLETED|Overall Study||0
10860914|NCT00796523|12025974|FG000|STARTED|Overall Study||27
10860915|NCT00796523|12025975|FG001|STARTED|Overall Study||24
10860916|NCT00796523|12025974|FG000|COMPLETED|Overall Study||18
10860917|NCT00796523|12025975|FG001|COMPLETED|Overall Study||17
10860918|NCT00796523|12025974|FG000|NOT COMPLETED|Overall Study||9
10860919|NCT00796523|12025975|FG001|NOT COMPLETED|Overall Study||7
10860920|NCT00794924|12025981|FG000|STARTED|Overall Study|14 patients refused to start the study|174
10860921|NCT00794924|12025982|FG001|STARTED|Overall Study|14 patients refused to start the study|171
10860922|NCT00794924|12025981|FG000|COMPLETED|Overall Study||114
10860923|NCT00794924|12025982|FG001|COMPLETED|Overall Study||101
10860924|NCT00794924|12025981|FG000|NOT COMPLETED|Overall Study||60
10860925|NCT00794924|12025982|FG001|NOT COMPLETED|Overall Study||70
10860926|NCT00794677|12025988|FG000|STARTED|First Intervention||13
10860927|NCT00794677|12025989|FG001|STARTED|First Intervention||13
10860928|NCT00794677|12025988|FG000|COMPLETED|First Intervention||11
10860929|NCT00794677|12025989|FG001|COMPLETED|First Intervention||13
10860930|NCT00794677|12025988|FG000|NOT COMPLETED|First Intervention||2
10860931|NCT00794677|12025989|FG001|NOT COMPLETED|First Intervention||0
10860932|NCT00794677|12025988|FG000|STARTED|Second Intervention||11
10860933|NCT00794677|12025989|FG001|STARTED|Second Intervention||13
10860934|NCT00794677|12025988|FG000|COMPLETED|Second Intervention||11
10860935|NCT00794677|12025989|FG001|COMPLETED|Second Intervention||13
10860936|NCT00794677|12025988|FG000|NOT COMPLETED|Second Intervention||0
10860937|NCT00794677|12025989|FG001|NOT COMPLETED|Second Intervention||0
10860938|NCT00792116|12025995|FG000|STARTED|Overall Study||53
10860939|NCT00792116|12025996|FG001|STARTED|Overall Study||55
10860940|NCT00792116|12025995|FG000|COMPLETED|Overall Study||52
10860941|NCT00792116|12025996|FG001|COMPLETED|Overall Study||54
10860942|NCT00792116|12025995|FG000|NOT COMPLETED|Overall Study||1
10860943|NCT00792116|12025996|FG001|NOT COMPLETED|Overall Study||1
11107613|NCT01263444|12291931|FG000|COMPLETED|Overall Study||37
11107614|NCT01263444|12291931|FG000|NOT COMPLETED|Overall Study||10
10860944|NCT00758563|12026002|FG000|STARTED|Overall Study||7
10860945|NCT00758563|12026003|FG001|STARTED|Overall Study||8
10860946|NCT00758563|12026002|FG000|COMPLETED|Overall Study||7
10860947|NCT00758563|12026003|FG001|COMPLETED|Overall Study||8
10860948|NCT00758563|12026002|FG000|NOT COMPLETED|Overall Study||0
10860949|NCT00758563|12026003|FG001|NOT COMPLETED|Overall Study||0
10860950|NCT00758290|12026009|FG000|STARTED|Overall Study||11
10860951|NCT00758290|12026010|FG001|STARTED|Overall Study||12
10860952|NCT00758290|12026009|FG000|COMPLETED|Overall Study||11
10860953|NCT00758290|12026010|FG001|COMPLETED|Overall Study||12
10860954|NCT00758290|12026009|FG000|NOT COMPLETED|Overall Study||0
10860955|NCT00758290|12026010|FG001|NOT COMPLETED|Overall Study||0
10860956|NCT00756574|12026016|FG000|STARTED|Overall Study||225
10860957|NCT00756574|12026017|FG001|STARTED|Overall Study||221
10860958|NCT00756574|12026016|FG000|COMPLETED|Overall Study||212
11227244|NCT01999985|12419180|FG002|NOT COMPLETED|Overall Study||0
11227245|NCT02000154|12419186|FG000|STARTED|Overall Study||1
11227246|NCT02000154|12419186|FG000|COMPLETED|Overall Study||1
11227247|NCT02000154|12419186|FG000|NOT COMPLETED|Overall Study||0
11227248|NCT02000180|12419192|FG000|STARTED|Overall Study||18
11227249|NCT02000180|12419193|FG001|STARTED|Overall Study||19
11227250|NCT02000180|12419192|FG000|COMPLETED|Overall Study||18
11227251|NCT02000180|12419193|FG001|COMPLETED|Overall Study||19
11227252|NCT02000180|12419192|FG000|NOT COMPLETED|Overall Study||0
11227253|NCT02000180|12419193|FG001|NOT COMPLETED|Overall Study||0
11227254|NCT02000440|12419199|FG000|STARTED|Overall Study||17
11227255|NCT02000440|12419199|FG000|COMPLETED|Overall Study||13
11227256|NCT02000440|12419199|FG000|NOT COMPLETED|Overall Study||4
11227257|NCT02000531|12419205|FG000|STARTED|Overall Study||21
11227258|NCT02000531|12419206|FG001|STARTED|Overall Study||24
11227259|NCT02000531|12419205|FG000|Safety Population|Overall Study||21
11227260|NCT02000531|12419206|FG001|Safety Population|Overall Study||24
11227261|NCT02000531|12419205|FG000|COMPLETED|Overall Study||17
11227262|NCT02000531|12419206|FG001|COMPLETED|Overall Study||16
11227263|NCT02000531|12419205|FG000|NOT COMPLETED|Overall Study||4
11227264|NCT02000531|12419206|FG001|NOT COMPLETED|Overall Study||8
11227265|NCT02000583|12419214|FG000|STARTED|Overall Study||78
11227266|NCT02000583|12419215|FG001|STARTED|Overall Study||39
11227267|NCT02000583|12419214|FG000|COMPLETED|Overall Study||75
11227268|NCT02000583|12419215|FG001|COMPLETED|Overall Study||34
11227269|NCT02000583|12419214|FG000|NOT COMPLETED|Overall Study||3
11227270|NCT02000583|12419215|FG001|NOT COMPLETED|Overall Study||5
11227271|NCT02000752|12419223|FG000|STARTED|Overall Study||60
11227272|NCT02000752|12419224|FG001|STARTED|Overall Study||60
11227273|NCT02000752|12419223|FG000|COMPLETED|Overall Study||29
11227274|NCT02000752|12419224|FG001|COMPLETED|Overall Study||47
11227275|NCT02000752|12419223|FG000|NOT COMPLETED|Overall Study||31
11227276|NCT02000752|12419224|FG001|NOT COMPLETED|Overall Study||13
11227277|NCT02000817|12419234|FG000|STARTED|Overall Study||6
11227278|NCT02000817|12419235|FG001|STARTED|Overall Study||9
11227279|NCT02000817|12419236|FG002|STARTED|Overall Study||8
11227280|NCT02000817|12419237|FG003|STARTED|Overall Study||7
11227281|NCT02000817|12419234|FG000|COMPLETED|Overall Study||4
11227282|NCT02000817|12419235|FG001|COMPLETED|Overall Study||8
11227283|NCT02000817|12419236|FG002|COMPLETED|Overall Study||7
11227284|NCT02000817|12419237|FG003|COMPLETED|Overall Study||7
11227285|NCT02000817|12419234|FG000|NOT COMPLETED|Overall Study||2
11227286|NCT02000817|12419235|FG001|NOT COMPLETED|Overall Study||1
11227287|NCT02000817|12419236|FG002|NOT COMPLETED|Overall Study||1
11227288|NCT02000817|12419237|FG003|NOT COMPLETED|Overall Study||0
11227289|NCT02000908|12419252|FG000|STARTED|Overall Study||30
11227290|NCT02000908|12419253|FG001|STARTED|Overall Study||40
11227291|NCT02000908|12419252|FG000|COMPLETED|Overall Study||28
11227292|NCT02000908|12419253|FG001|COMPLETED|Overall Study||36
11227293|NCT02000908|12419252|FG000|NOT COMPLETED|Overall Study||2
11227294|NCT02000908|12419253|FG001|NOT COMPLETED|Overall Study||4
11227295|NCT02000921|12419262|FG000|STARTED|Overall Study||27
11227296|NCT02000921|12419263|FG001|STARTED|Overall Study||53
11227297|NCT02000921|12419264|FG002|STARTED|Overall Study||56
11227298|NCT02000921|12419262|FG000|COMPLETED|Overall Study||22
11227299|NCT02000921|12419263|FG001|COMPLETED|Overall Study||37
10860959|NCT00756574|12026017|FG001|COMPLETED|Overall Study||210
10860960|NCT00756574|12026016|FG000|NOT COMPLETED|Overall Study||13
10860961|NCT00756574|12026017|FG001|NOT COMPLETED|Overall Study||11
10860962|NCT00740727|12026021|FG000|STARTED|Overall Study||18
10860963|NCT00740727|12026021|FG000|COMPLETED|Overall Study||18
10860964|NCT00740727|12026021|FG000|NOT COMPLETED|Overall Study||0
10860965|NCT00740480|12026024|FG000|STARTED|Overall Study||25
10860966|NCT00740480|12026024|FG000|COMPLETED|Overall Study||23
10860967|NCT00740480|12026024|FG000|NOT COMPLETED|Overall Study||2
11227300|NCT02000921|12419264|FG002|COMPLETED|Overall Study||46
11227301|NCT02000921|12419262|FG000|NOT COMPLETED|Overall Study||5
11227302|NCT02000921|12419263|FG001|NOT COMPLETED|Overall Study||16
11227303|NCT02000921|12419264|FG002|NOT COMPLETED|Overall Study||10
11227304|NCT02000973|12419276|FG000|STARTED|Overall Study||20
11227305|NCT02000973|12419277|FG001|STARTED|Overall Study||20
11227306|NCT02000973|12419278|FG002|STARTED|Overall Study||20
11227307|NCT02000973|12419279|FG003|STARTED|Overall Study||20
11227308|NCT02000973|12419276|FG000|COMPLETED|Overall Study||20
11227309|NCT02000973|12419277|FG001|COMPLETED|Overall Study||20
11227310|NCT02000973|12419278|FG002|COMPLETED|Overall Study||20
11227311|NCT02000973|12419279|FG003|COMPLETED|Overall Study||20
10860968|NCT00724698|12026027|FG000|STARTED|Overall Study||3011
10860969|NCT00724698|12026027|FG000|COMPLETED|Overall Study||2921
10860970|NCT00724698|12026027|FG000|NOT COMPLETED|Overall Study||90
10860971|NCT00711555|12026030|FG000|STARTED|Overall Study||22
10860972|NCT00711555|12026030|FG000|COMPLETED|Overall Study||19
10860973|NCT00711555|12026030|FG000|NOT COMPLETED|Overall Study||3
10860974|NCT00676494|12026033|FG000|STARTED|Overall Study||172
10860975|NCT00676494|12026033|FG000|COMPLETED|Overall Study||158
10860976|NCT00676494|12026033|FG000|NOT COMPLETED|Overall Study||14
11227312|NCT02000973|12419276|FG000|NOT COMPLETED|Overall Study||0
11227313|NCT02000973|12419277|FG001|NOT COMPLETED|Overall Study||0
11227314|NCT02000973|12419278|FG002|NOT COMPLETED|Overall Study||0
11227315|NCT02000973|12419279|FG003|NOT COMPLETED|Overall Study||0
11227316|NCT02001051|12419291|FG000|STARTED|Overall Study||2
11227317|NCT02001051|12419292|FG001|STARTED|Overall Study||2
11227318|NCT02001051|12419291|FG000|COMPLETED|Overall Study||2
11227319|NCT02001051|12419292|FG001|COMPLETED|Overall Study||1
11227320|NCT02001051|12419291|FG000|NOT COMPLETED|Overall Study||0
11227321|NCT02001051|12419292|FG001|NOT COMPLETED|Overall Study||1
10860977|NCT00662389|12026036|FG000|STARTED|Overall Study||4
10860978|NCT00662389|12026036|FG000|COMPLETED|Overall Study||4
10860979|NCT00662389|12026036|FG000|NOT COMPLETED|Overall Study||0
10860980|NCT00659061|12026041|FG000|STARTED|Overall Study||308
10860981|NCT00659061|12026042|FG001|STARTED|Overall Study||302
10860982|NCT00659061|12026041|FG000|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
10860983|NCT00659061|12026042|FG001|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
10860984|NCT00659061|12026041|FG000|NOT COMPLETED|Overall Study||21
10860985|NCT00659061|12026042|FG001|NOT COMPLETED|Overall Study||15
10860986|NCT00654992|12026048|FG000|STARTED|Overall Study||36
10860987|NCT00654992|12026049|FG001|STARTED|Overall Study||35
10860988|NCT00654992|12026048|FG000|COMPLETED|Overall Study||36
10860989|NCT00654992|12026049|FG001|COMPLETED|Overall Study||35
10860990|NCT00654992|12026048|FG000|NOT COMPLETED|Overall Study||0
10860991|NCT00654992|12026049|FG001|NOT COMPLETED|Overall Study||0
10860992|NCT00581477|12026053|FG000|STARTED|Overall Study|8 patients were enrolled|8
10860993|NCT00581477|12026053|FG000|Dose Selection Trial With Droxidopa|Overall Study|2 patients had been treated with droxidopa prior to enrollment and their data is not included. Since droxidopa restores the norepinephrine that is absent in untreated patients with DBH deficiency, we present only the results for naive patients.|6
11107615|NCT01263470|12291941|FG000|STARTED|Overall Study||75
11107616|NCT01263470|12291942|FG001|STARTED|Overall Study||79
11107617|NCT01263470|12291943|FG002|STARTED|Overall Study||84
11107618|NCT01263470|12291944|FG003|STARTED|Overall Study||80
11107619|NCT01263470|12291945|FG004|STARTED|Overall Study||79
11107620|NCT01263470|12291946|FG005|STARTED|Overall Study||83
11107621|NCT01263470|12291941|FG000|COMPLETED|Overall Study||73
11107622|NCT01263470|12291942|FG001|COMPLETED|Overall Study||74
11107623|NCT01263470|12291943|FG002|COMPLETED|Overall Study||80
11107624|NCT01263470|12291944|FG003|COMPLETED|Overall Study||77
11107625|NCT01263470|12291945|FG004|COMPLETED|Overall Study||76
11107626|NCT01263470|12291946|FG005|COMPLETED|Overall Study||78
11107627|NCT01263470|12291941|FG000|NOT COMPLETED|Overall Study||2
11107628|NCT01263470|12291942|FG001|NOT COMPLETED|Overall Study||5
11107629|NCT01263470|12291943|FG002|NOT COMPLETED|Overall Study||4
11107630|NCT01263470|12291944|FG003|NOT COMPLETED|Overall Study||3
11107631|NCT01263470|12291945|FG004|NOT COMPLETED|Overall Study||3
11107632|NCT01263470|12291946|FG005|NOT COMPLETED|Overall Study||5
11107633|NCT01263483|12291963|FG000|STARTED|Overall Study||75
11107634|NCT01263483|12291964|FG001|STARTED|Overall Study||76
11107635|NCT01263483|12291965|FG002|STARTED|Overall Study||79
11107636|NCT01263483|12291963|FG000|COMPLETED|Overall Study||68
11107637|NCT01263483|12291964|FG001|COMPLETED|Overall Study||74
11107638|NCT01263483|12291965|FG002|COMPLETED|Overall Study||74
11107639|NCT01263483|12291963|FG000|NOT COMPLETED|Overall Study||7
11107640|NCT01263483|12291964|FG001|NOT COMPLETED|Overall Study||2
11107641|NCT01263483|12291965|FG002|NOT COMPLETED|Overall Study||5
11107642|NCT01263496|12291978|FG000|STARTED|Enrolled - Long-Term Extension Study||72
11107643|NCT01263496|12291979|FG001|STARTED|Enrolled - Long-Term Extension Study||75
11107644|NCT01263496|12291980|FG002|STARTED|Enrolled - Long-Term Extension Study||72
11107645|NCT01263496|12291981|FG003|STARTED|Enrolled - Long-Term Extension Study||75
11107646|NCT01263496|12291982|FG004|STARTED|Enrolled - Long-Term Extension Study||74
11107647|NCT01263496|12291983|FG005|STARTED|Enrolled - Long-Term Extension Study||17
11107648|NCT01263496|12291984|FG006|STARTED|Enrolled - Long-Term Extension Study||17
11107649|NCT01263496|12291985|FG007|STARTED|Enrolled - Long-Term Extension Study||18
11107650|NCT01263496|12291986|FG008|STARTED|Enrolled - Long-Term Extension Study||18
11107651|NCT01263496|12291978|FG000|COMPLETED|Enrolled - Long-Term Extension Study||71
11107652|NCT01263496|12291979|FG001|COMPLETED|Enrolled - Long-Term Extension Study||75
11107653|NCT01263496|12291980|FG002|COMPLETED|Enrolled - Long-Term Extension Study||72
11107654|NCT01263496|12291981|FG003|COMPLETED|Enrolled - Long-Term Extension Study||74
11107655|NCT01263496|12291982|FG004|COMPLETED|Enrolled - Long-Term Extension Study||72
11107656|NCT01263496|12291983|FG005|COMPLETED|Enrolled - Long-Term Extension Study||17
11227322|NCT02001064|12419300|FG000|STARTED|Overall Study||30
11227323|NCT02001064|12419301|FG001|STARTED|Overall Study||30
11227324|NCT02001064|12419300|FG000|COMPLETED|Overall Study||28
11227325|NCT02001064|12419301|FG001|COMPLETED|Overall Study||29
11227326|NCT02001064|12419300|FG000|NOT COMPLETED|Overall Study||2
11227327|NCT02001064|12419301|FG001|NOT COMPLETED|Overall Study||1
11227328|NCT02001181|12419309|FG000|STARTED|Overall Study||35
11227329|NCT02001181|12419310|FG001|STARTED|Overall Study||34
11227330|NCT02001181|12419309|FG000|COMPLETED|Overall Study||34
11227331|NCT02001181|12419310|FG001|COMPLETED|Overall Study||31
11227332|NCT02001181|12419309|FG000|NOT COMPLETED|Overall Study||1
11227333|NCT02001181|12419310|FG001|NOT COMPLETED|Overall Study||3
11227334|NCT02001194|12419320|FG000|STARTED|Intervention Period (13 Weeks)|17 teams|68
11227335|NCT02001194|12419321|FG001|STARTED|Intervention Period (13 Weeks)|20 teams|80
11227336|NCT02001194|12419322|FG002|STARTED|Intervention Period (13 Weeks)|19 teams|76
11227337|NCT02001194|12419323|FG003|STARTED|Intervention Period (13 Weeks)|20 teams|80
11227338|NCT02001194|12419320|FG000|COMPLETED|Intervention Period (13 Weeks)|16 teams|67
11227339|NCT02001194|12419321|FG001|COMPLETED|Intervention Period (13 Weeks)|20 teams|80
11227340|NCT02001194|12419322|FG002|COMPLETED|Intervention Period (13 Weeks)|19 teams|74
10860994|NCT00581477|12026053|FG000|Droxidopa 25 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 25 mg of Droxidopa.|6
10860995|NCT00581477|12026053|FG000|Droxidopa 50 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 50 mg of Droxidopa.|6
10860996|NCT00581477|12026053|FG000|Droxidopa 100 mg|Overall Study|Because dosing was individualized for the participants, only 4 of the 6 patients were administered 100 mg of Droxidopa.|6
10860997|NCT00581477|12026053|FG000|Droxidopa 200 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 200 mg of Droxidopa.|6
10860998|NCT00581477|12026053|FG000|Droxidopa 250 mg|Overall Study|Because dosing was individualized for the participants, only 2 of the 6 patients were administered 250 mg of Droxidopa.|6
10860999|NCT00581477|12026053|FG000|Droxidopa 300 mg|Overall Study|Because dosing was individualized for the participants, only 1 of the 6 patients was administered 300 mg of Droxidopa.|6
10861000|NCT00581477|12026053|FG000|COMPLETED|Overall Study||6
10861001|NCT00581477|12026053|FG000|NOT COMPLETED|Overall Study||2
11227341|NCT02001194|12419323|FG003|COMPLETED|Intervention Period (13 Weeks)|20 teams|78
11107657|NCT01263496|12291984|FG006|COMPLETED|Enrolled - Long-Term Extension Study||17
11107658|NCT01263496|12291985|FG007|COMPLETED|Enrolled - Long-Term Extension Study||18
11107659|NCT01263496|12291986|FG008|COMPLETED|Enrolled - Long-Term Extension Study||18
11227342|NCT02001194|12419320|FG000|NOT COMPLETED|Intervention Period (13 Weeks)||1
11227343|NCT02001194|12419321|FG001|NOT COMPLETED|Intervention Period (13 Weeks)||0
11227344|NCT02001194|12419322|FG002|NOT COMPLETED|Intervention Period (13 Weeks)||2
11227345|NCT02001194|12419323|FG003|NOT COMPLETED|Intervention Period (13 Weeks)||2
11227346|NCT02001194|12419320|FG000|STARTED|Follow-Up Period (13 Weeks)||67
11227347|NCT02001194|12419321|FG001|STARTED|Follow-Up Period (13 Weeks)||80
11227348|NCT02001194|12419322|FG002|STARTED|Follow-Up Period (13 Weeks)||74
11227349|NCT02001194|12419323|FG003|STARTED|Follow-Up Period (13 Weeks)||78
11227350|NCT02001194|12419320|FG000|COMPLETED|Follow-Up Period (13 Weeks)||64
11227351|NCT02001194|12419321|FG001|COMPLETED|Follow-Up Period (13 Weeks)||78
11227352|NCT02001194|12419322|FG002|COMPLETED|Follow-Up Period (13 Weeks)||73
11227353|NCT02001194|12419323|FG003|COMPLETED|Follow-Up Period (13 Weeks)||78
11227354|NCT02001194|12419320|FG000|NOT COMPLETED|Follow-Up Period (13 Weeks)||3
11227355|NCT02001194|12419321|FG001|NOT COMPLETED|Follow-Up Period (13 Weeks)||2
11227356|NCT02001194|12419322|FG002|NOT COMPLETED|Follow-Up Period (13 Weeks)||1
11227357|NCT02001194|12419323|FG003|NOT COMPLETED|Follow-Up Period (13 Weeks)||0
11227358|NCT02001558|12419335|FG000|STARTED|Overall Study||32
11227359|NCT02001558|12419336|FG001|STARTED|Overall Study||33
11227360|NCT02001558|12419335|FG000|COMPLETED|Overall Study||24
11227361|NCT02001558|12419336|FG001|COMPLETED|Overall Study||19
11227362|NCT02001558|12419335|FG000|NOT COMPLETED|Overall Study||8
11227363|NCT02001558|12419336|FG001|NOT COMPLETED|Overall Study||14
11227364|NCT02001688|12419345|FG000|STARTED|Overall Study||12
11227365|NCT02001688|12419346|FG001|STARTED|Overall Study||12
11227366|NCT02001688|12419347|FG002|STARTED|Overall Study||12
11227367|NCT02001688|12419345|FG000|COMPLETED|Overall Study||12
11227368|NCT02001688|12419346|FG001|COMPLETED|Overall Study||11
11227369|NCT02001688|12419347|FG002|COMPLETED|Overall Study||11
11227370|NCT02001688|12419345|FG000|NOT COMPLETED|Overall Study||0
11227371|NCT02001688|12419346|FG001|NOT COMPLETED|Overall Study||1
11227372|NCT02001688|12419347|FG002|NOT COMPLETED|Overall Study||1
11227373|NCT02001714|12419358|FG000|STARTED|Overall Study||232
11227374|NCT02001714|12419359|FG001|STARTED|Overall Study||231
11227375|NCT02001714|12419358|FG000|COMPLETED|Overall Study||210
11227376|NCT02001714|12419359|FG001|COMPLETED|Overall Study||219
11227377|NCT02001714|12419358|FG000|NOT COMPLETED|Overall Study||22
11227378|NCT02001714|12419359|FG001|NOT COMPLETED|Overall Study||12
11227379|NCT02001987|12419365|FG000|STARTED|Core Study Period (24 Weeks)||139
11227380|NCT02001987|12419365|FG000|COMPLETED|Core Study Period (24 Weeks)||116
11227381|NCT02001987|12419365|FG000|NOT COMPLETED|Core Study Period (24 Weeks)||23
10861002|NCT00554294|12026069|FG000|STARTED|Overall Study||1469
10861003|NCT00554294|12026070|FG001|STARTED|Overall Study||1721
10861004|NCT00554294|12026069|FG000|COMPLETED|Overall Study||1309
10861005|NCT00554294|12026070|FG001|COMPLETED|Overall Study||1641
10861006|NCT00554294|12026069|FG000|NOT COMPLETED|Overall Study||160
10861007|NCT00554294|12026070|FG001|NOT COMPLETED|Overall Study||80
10861008|NCT00554190|12026074|FG000|STARTED|Overall Study|29 subjects treated.|29
10861009|NCT00554190|12026074|FG000|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
10861010|NCT00554190|12026074|FG000|NOT COMPLETED|Overall Study||10
10861011|NCT00546273|12026083|FG000|STARTED|I||4
10861012|NCT00546273|12026084|FG001|STARTED|I||0
10861013|NCT00546273|12026085|FG002|STARTED|I||0
10861014|NCT00546273|12026086|FG003|STARTED|I||0
10861015|NCT00546273|12026087|FG004|STARTED|I||2
10861016|NCT00546273|12026083|FG000|COMPLETED|I||4
10861017|NCT00546273|12026084|FG001|COMPLETED|I||0
10861018|NCT00546273|12026085|FG002|COMPLETED|I||0
10861019|NCT00546273|12026086|FG003|COMPLETED|I||0
10861020|NCT00546273|12026087|FG004|COMPLETED|I||2
10861021|NCT00546273|12026083|FG000|NOT COMPLETED|I||0
10861022|NCT00546273|12026084|FG001|NOT COMPLETED|I||0
10861023|NCT00546273|12026085|FG002|NOT COMPLETED|I||0
10861024|NCT00546273|12026086|FG003|NOT COMPLETED|I||0
10861025|NCT00546273|12026087|FG004|NOT COMPLETED|I||0
10861026|NCT00546273|12026083|FG000|STARTED|II||0
10861027|NCT00546273|12026084|FG001|STARTED|II||4
10861028|NCT00546273|12026085|FG002|STARTED|II||0
10861029|NCT00546273|12026086|FG003|STARTED|II||0
10861030|NCT00546273|12026087|FG004|STARTED|II||2
10861031|NCT00546273|12026083|FG000|COMPLETED|II||0
10861032|NCT00546273|12026084|FG001|COMPLETED|II||4
10861033|NCT00546273|12026085|FG002|COMPLETED|II||0
10861034|NCT00546273|12026086|FG003|COMPLETED|II||0
10861035|NCT00546273|12026087|FG004|COMPLETED|II||2
10861036|NCT00546273|12026083|FG000|NOT COMPLETED|II||0
10861037|NCT00546273|12026084|FG001|NOT COMPLETED|II||0
10861038|NCT00546273|12026085|FG002|NOT COMPLETED|II||0
10861039|NCT00546273|12026086|FG003|NOT COMPLETED|II||0
10861040|NCT00546273|12026087|FG004|NOT COMPLETED|II||0
10861041|NCT00546273|12026083|FG000|STARTED|III||0
10861042|NCT00546273|12026084|FG001|STARTED|III||0
10861043|NCT00546273|12026085|FG002|STARTED|III||4
10861044|NCT00546273|12026086|FG003|STARTED|III||0
10861045|NCT00546273|12026087|FG004|STARTED|III||2
10861046|NCT00546273|12026083|FG000|COMPLETED|III||0
10861047|NCT00546273|12026084|FG001|COMPLETED|III||0
10861048|NCT00546273|12026085|FG002|COMPLETED|III||4
10861049|NCT00546273|12026086|FG003|COMPLETED|III||0
10861050|NCT00546273|12026087|FG004|COMPLETED|III||2
10861051|NCT00546273|12026083|FG000|NOT COMPLETED|III||0
10861052|NCT00546273|12026084|FG001|NOT COMPLETED|III||0
10861053|NCT00546273|12026085|FG002|NOT COMPLETED|III||0
10861054|NCT00546273|12026086|FG003|NOT COMPLETED|III||0
10861055|NCT00546273|12026087|FG004|NOT COMPLETED|III||0
10861056|NCT00546273|12026083|FG000|STARTED|IV||0
10861057|NCT00546273|12026084|FG001|STARTED|IV||0
10861058|NCT00546273|12026085|FG002|STARTED|IV||0
10861059|NCT00546273|12026086|FG003|STARTED|IV||4
10861060|NCT00546273|12026087|FG004|STARTED|IV||2
10861061|NCT00546273|12026083|FG000|COMPLETED|IV||0
10861062|NCT00546273|12026084|FG001|COMPLETED|IV||0
11107660|NCT01263496|12291978|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
11107661|NCT01263496|12291979|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11107662|NCT01263496|12291980|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11107663|NCT01263496|12291981|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
11107664|NCT01263496|12291982|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
11107665|NCT01263496|12291983|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11107666|NCT01263496|12291984|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11107667|NCT01263496|12291985|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11107668|NCT01263496|12291986|FG008|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11107669|NCT01263496|12291978|FG000|STARTED|Entered - Long-Term Extension Study||71
11107670|NCT01263496|12291979|FG001|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
11107671|NCT01263496|12291980|FG002|STARTED|Entered - Long-Term Extension Study||72
11107672|NCT01263496|12291981|FG003|STARTED|Entered - Long-Term Extension Study||74
11107673|NCT01263496|12291982|FG004|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
11107674|NCT01263496|12291983|FG005|STARTED|Entered - Long-Term Extension Study||17
11107675|NCT01263496|12291984|FG006|STARTED|Entered - Long-Term Extension Study||17
11107676|NCT01263496|12291985|FG007|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
11107677|NCT01263496|12291986|FG008|STARTED|Entered - Long-Term Extension Study||18
11107678|NCT01263496|12291978|FG000|COMPLETED|Entered - Long-Term Extension Study||62
11107679|NCT01263496|12291979|FG001|COMPLETED|Entered - Long-Term Extension Study||59
10861063|NCT00546273|12026085|FG002|COMPLETED|IV||0
10861064|NCT00546273|12026086|FG003|COMPLETED|IV||4
10861065|NCT00546273|12026087|FG004|COMPLETED|IV||2
10861066|NCT00546273|12026083|FG000|NOT COMPLETED|IV||0
10861067|NCT00546273|12026084|FG001|NOT COMPLETED|IV||0
10861068|NCT00546273|12026085|FG002|NOT COMPLETED|IV||0
10861069|NCT00546273|12026086|FG003|NOT COMPLETED|IV||0
10861070|NCT00546273|12026087|FG004|NOT COMPLETED|IV||0
10861071|NCT00529152|12026094|FG000|STARTED|Overall Study||100
10861072|NCT00529152|12026094|FG000|COMPLETED|Overall Study||95
10861073|NCT00529152|12026094|FG000|NOT COMPLETED|Overall Study||5
10861074|NCT00526227|12026097|FG000|STARTED|Overall Study||81
10861075|NCT00526227|12026097|FG000|COMPLETED|Overall Study||79
10861076|NCT00526227|12026097|FG000|NOT COMPLETED|Overall Study||2
10861077|NCT00513617|12026105|FG000|STARTED|Overall Study||36
10861078|NCT00513617|12026106|FG001|STARTED|Overall Study||35
10861079|NCT00513617|12026107|FG002|STARTED|Overall Study||38
10861080|NCT00513617|12026105|FG000|COMPLETED|Overall Study||25
10861081|NCT00513617|12026106|FG001|COMPLETED|Overall Study||25
10861082|NCT00513617|12026107|FG002|COMPLETED|Overall Study||30
10861083|NCT00513617|12026105|FG000|NOT COMPLETED|Overall Study||11
10861084|NCT00513617|12026106|FG001|NOT COMPLETED|Overall Study||10
10861085|NCT00513617|12026107|FG002|NOT COMPLETED|Overall Study||8
10861086|NCT00495222|12026112|FG000|STARTED|Overall Study||9
10861087|NCT00495222|12026112|FG000|COMPLETED|Overall Study||9
10861088|NCT00495222|12026112|FG000|NOT COMPLETED|Overall Study||0
10861089|NCT00495131|12026117|FG000|STARTED|Overall Study||154
10861090|NCT00495131|12026118|FG001|STARTED|Overall Study||154
10861091|NCT00495131|12026117|FG000|COMPLETED|Overall Study||147
10861092|NCT00495131|12026118|FG001|COMPLETED|Overall Study||148
10861093|NCT00495131|12026117|FG000|NOT COMPLETED|Overall Study||7
10861094|NCT00495131|12026118|FG001|NOT COMPLETED|Overall Study||6
10861095|NCT00491738|12026124|FG000|STARTED|Overall Study||7
10861096|NCT00491738|12026125|FG001|STARTED|Overall Study||9
10861097|NCT00491738|12026124|FG000|COMPLETED|Overall Study||7
10861098|NCT00491738|12026125|FG001|COMPLETED|Overall Study||9
10861099|NCT00491738|12026124|FG000|NOT COMPLETED|Overall Study||0
10861100|NCT00491738|12026125|FG001|NOT COMPLETED|Overall Study||0
10861101|NCT00484419|12026132|FG000|STARTED|Overall Study||57
10861102|NCT00484419|12026133|FG001|STARTED|Overall Study||56
10861103|NCT00484419|12026134|FG002|STARTED|Overall Study||56
10861104|NCT00484419|12026132|FG000|COMPLETED|Overall Study||45
10861105|NCT00484419|12026133|FG001|COMPLETED|Overall Study||51
10861106|NCT00484419|12026134|FG002|COMPLETED|Overall Study||45
10861107|NCT00484419|12026132|FG000|NOT COMPLETED|Overall Study||12
10861108|NCT00484419|12026133|FG001|NOT COMPLETED|Overall Study||5
10861109|NCT00484419|12026134|FG002|NOT COMPLETED|Overall Study||11
10861110|NCT00479258|12026141|FG000|STARTED|Overall Study||0
10861111|NCT00479258|12026142|FG001|STARTED|Overall Study||0
10861112|NCT00479258|12026141|FG000|COMPLETED|Overall Study||0
10861113|NCT00479258|12026142|FG001|COMPLETED|Overall Study||0
10861114|NCT00479258|12026141|FG000|NOT COMPLETED|Overall Study||0
10861115|NCT00479258|12026142|FG001|NOT COMPLETED|Overall Study||0
10861116|NCT00474188|12026146|FG000|STARTED|Overall Study||26
10861117|NCT00474188|12026146|FG000|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
10861118|NCT00474188|12026146|FG000|NOT COMPLETED|Overall Study||6
10861119|NCT00440531|12026152|FG000|STARTED|Overall Study||185
10861120|NCT00440531|12026153|FG001|STARTED|Overall Study||183
10861121|NCT00440531|12026154|FG002|STARTED|Overall Study||172
10861122|NCT00440531|12026152|FG000|Vaccination 1|Overall Study||183
10861123|NCT00440531|12026153|FG001|Vaccination 1|Overall Study||183
10861124|NCT00440531|12026154|FG002|Vaccination 1|Overall Study||172
10861125|NCT00440531|12026152|FG000|Vaccination 2|Overall Study||181
10861126|NCT00440531|12026153|FG001|Vaccination 2|Overall Study||182
10861127|NCT00440531|12026154|FG002|Vaccination 2|Overall Study||171
10861128|NCT00440531|12026152|FG000|Vaccination 3|Overall Study||176
10861129|NCT00440531|12026153|FG001|Vaccination 3|Overall Study||178
10861130|NCT00440531|12026154|FG002|Vaccination 3|Overall Study||166
10861131|NCT00440531|12026152|FG000|COMPLETED|Overall Study||175
10861132|NCT00440531|12026153|FG001|COMPLETED|Overall Study||178
10861133|NCT00440531|12026154|FG002|COMPLETED|Overall Study||165
10861134|NCT00440531|12026152|FG000|NOT COMPLETED|Overall Study||10
10861135|NCT00440531|12026153|FG001|NOT COMPLETED|Overall Study||5
10861136|NCT00440531|12026154|FG002|NOT COMPLETED|Overall Study||7
10861137|NCT00439738|12026162|FG000|STARTED|Overall Study||206
10861138|NCT00439738|12026163|FG001|STARTED|Overall Study||206
10861139|NCT00439738|12026162|FG000|COMPLETED|Overall Study||170
10861140|NCT00439738|12026163|FG001|COMPLETED|Overall Study||178
10861141|NCT00439738|12026162|FG000|NOT COMPLETED|Overall Study||36
10861142|NCT00439738|12026163|FG001|NOT COMPLETED|Overall Study||28
10861143|NCT00434226|12026169|FG000|STARTED|Overall Study||30
10861144|NCT00434226|12026170|FG001|STARTED|Overall Study||26
10861145|NCT00434226|12026169|FG000|COMPLETED|Overall Study||0
10861146|NCT00434226|12026170|FG001|COMPLETED|Overall Study||0
10861147|NCT00434226|12026169|FG000|NOT COMPLETED|Overall Study||30
10861148|NCT00434226|12026170|FG001|NOT COMPLETED|Overall Study||26
10861149|NCT00430950|12026176|FG000|STARTED|Overall Study||502
10861150|NCT00430950|12026177|FG001|STARTED|Overall Study||508
10861151|NCT00430950|12026176|FG000|COMPLETED|Overall Study||489
10861152|NCT00430950|12026177|FG001|COMPLETED|Overall Study||495
10861153|NCT00430950|12026176|FG000|NOT COMPLETED|Overall Study||13
10861154|NCT00430950|12026177|FG001|NOT COMPLETED|Overall Study||13
10861155|NCT00430508|12026185|FG000|STARTED|Overall Study||140
10861156|NCT00430508|12026186|FG001|STARTED|Overall Study||278
10861157|NCT00430508|12026187|FG002|STARTED|Overall Study||279
10861158|NCT00430508|12026188|FG003|STARTED|Overall Study||274
10861159|NCT00430508|12026185|FG000|COMPLETED|Overall Study||137
10861160|NCT00430508|12026186|FG001|COMPLETED|Overall Study||272
10861161|NCT00430508|12026187|FG002|COMPLETED|Overall Study||266
10861162|NCT00430508|12026188|FG003|COMPLETED|Overall Study||269
10861163|NCT00430508|12026185|FG000|NOT COMPLETED|Overall Study||3
10861164|NCT00430508|12026186|FG001|NOT COMPLETED|Overall Study||6
10861165|NCT00430508|12026187|FG002|NOT COMPLETED|Overall Study||13
10861166|NCT00430508|12026188|FG003|NOT COMPLETED|Overall Study||5
10861167|NCT00430092|12026197|FG000|STARTED|Overall Study||54
10861168|NCT00430092|12026198|FG001|STARTED|Overall Study||52
10861169|NCT00430092|12026199|FG002|STARTED|Overall Study||113
10861170|NCT00430092|12026197|FG000|COMPLETED|Overall Study||48
10861171|NCT00430092|12026198|FG001|COMPLETED|Overall Study||48
10861172|NCT00430092|12026199|FG002|COMPLETED|Overall Study||56
10861173|NCT00430092|12026197|FG000|NOT COMPLETED|Overall Study||6
10861174|NCT00430092|12026198|FG001|NOT COMPLETED|Overall Study||4
10861175|NCT00430092|12026199|FG002|NOT COMPLETED|Overall Study||57
10861176|NCT00429923|12026207|FG000|STARTED|Overall Study||57
10861177|NCT00429923|12026208|FG001|STARTED|Overall Study||55
10861178|NCT00429923|12026209|FG002|STARTED|Overall Study||107
10861179|NCT00429923|12026207|FG000|COMPLETED|Overall Study||52
10861180|NCT00429923|12026208|FG001|COMPLETED|Overall Study||51
10861181|NCT00429923|12026209|FG002|COMPLETED|Overall Study||68
10861182|NCT00429923|12026207|FG000|NOT COMPLETED|Overall Study||5
10861183|NCT00429923|12026208|FG001|NOT COMPLETED|Overall Study||4
10861184|NCT00429923|12026209|FG002|NOT COMPLETED|Overall Study||39
10861185|NCT00425100|12026214|FG000|STARTED|Overall Study||516
10861186|NCT00425100|12026214|FG000|COMPLETED|Overall Study||463
10861187|NCT00425100|12026214|FG000|NOT COMPLETED|Overall Study||53
10861188|NCT00415623|12026221|FG000|STARTED|Overall Study||154
10861189|NCT00415623|12026222|FG001|STARTED|Overall Study||151
10861190|NCT00415623|12026221|FG000|COMPLETED|Overall Study||149
10861191|NCT00415623|12026222|FG001|COMPLETED|Overall Study||146
10861192|NCT00415623|12026221|FG000|NOT COMPLETED|Overall Study||5
10861193|NCT00415623|12026222|FG001|NOT COMPLETED|Overall Study||5
10861194|NCT00412932|12026229|FG000|STARTED|Olmesartan (Olm) 20 mg||178
10861195|NCT00412932|12026229|FG000|COMPLETED|Olmesartan (Olm) 20 mg||171
10861196|NCT00412932|12026229|FG000|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
10861197|NCT00412932|12026229|FG000|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
10861198|NCT00412932|12026229|FG000|COMPLETED|Olmesartan 40 mg||161
10861199|NCT00412932|12026229|FG000|NOT COMPLETED|Olmesartan 40 mg||8
10861200|NCT00412932|12026229|FG000|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
10861201|NCT00412932|12026229|FG000|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
10861202|NCT00412932|12026229|FG000|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
10861203|NCT00412932|12026229|FG000|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
10861204|NCT00412932|12026229|FG000|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
10861205|NCT00412932|12026229|FG000|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
11227382|NCT02001987|12419365|FG000|STARTED|LTE Period (52 Weeks)||116
11227383|NCT02001987|12419365|FG000|COMPLETED|LTE Period (52 Weeks)||107
11227384|NCT02001987|12419365|FG000|NOT COMPLETED|LTE Period (52 Weeks)||9
11227385|NCT02002091|12419376|FG000|STARTED|Screening||122
11227386|NCT02002091|12419377|FG001|STARTED|Screening||205
11227387|NCT02002091|12419376|FG000|COMPLETED|Screening||109
11227388|NCT02002091|12419377|FG001|COMPLETED|Screening||191
11227389|NCT02002091|12419376|FG000|NOT COMPLETED|Screening||13
11227390|NCT02002091|12419377|FG001|NOT COMPLETED|Screening||14
11227391|NCT02002091|12419376|FG000|STARTED|One Year Follow up||109
11227392|NCT02002091|12419377|FG001|STARTED|One Year Follow up||191
11227393|NCT02002091|12419376|FG000|COMPLETED|One Year Follow up||109
11227394|NCT02002091|12419377|FG001|COMPLETED|One Year Follow up||191
11227395|NCT02002091|12419376|FG000|NOT COMPLETED|One Year Follow up||0
11227396|NCT02002091|12419377|FG001|NOT COMPLETED|One Year Follow up||0
11227397|NCT02002208|12419414|FG000|STARTED|Overall Study||69
11227398|NCT02002208|12419415|FG001|STARTED|Overall Study||70
11227399|NCT02002208|12419414|FG000|COMPLETED|Overall Study||32
11355002|NCT03076970|12551948|FG005|STARTED|Period 1||7
11227400|NCT02002208|12419415|FG001|COMPLETED|Overall Study||30
10861206|NCT00397254|12026232|FG000|STARTED|Overall Study||79
10861207|NCT00397254|12026233|FG001|STARTED|Overall Study||76
10861208|NCT00397254|12026232|FG000|COMPLETED|Overall Study||77
10861209|NCT00397254|12026233|FG001|COMPLETED|Overall Study||74
10861210|NCT00397254|12026232|FG000|NOT COMPLETED|Overall Study||2
10861211|NCT00397254|12026233|FG001|NOT COMPLETED|Overall Study||2
10861212|NCT00393068|12026237|FG000|STARTED|Overall Study||62
10861213|NCT00393068|12026237|FG000|COMPLETED|Overall Study||44
10861214|NCT00393068|12026237|FG000|NOT COMPLETED|Overall Study||18
10861215|NCT00385515|12026243|FG000|STARTED|Overall Study||57
10861216|NCT00385515|12026244|FG001|STARTED|Overall Study||24
10861217|NCT00385515|12026243|FG000|COMPLETED|Overall Study||53
10861218|NCT00385515|12026244|FG001|COMPLETED|Overall Study||21
10861219|NCT00385515|12026243|FG000|NOT COMPLETED|Overall Study||4
10861220|NCT00385515|12026244|FG001|NOT COMPLETED|Overall Study||3
10861221|NCT00362401|12026251|FG000|STARTED|Overall Study||15
10861222|NCT00362401|12026252|FG001|STARTED|Overall Study||29
10861223|NCT00362401|12026253|FG002|STARTED|Overall Study||40
10861224|NCT00362401|12026251|FG000|COMPLETED|Overall Study||15
10861225|NCT00362401|12026252|FG001|COMPLETED|Overall Study||29
10861226|NCT00362401|12026253|FG002|COMPLETED|Overall Study||40
10861227|NCT00362401|12026251|FG000|NOT COMPLETED|Overall Study||0
10861228|NCT00362401|12026252|FG001|NOT COMPLETED|Overall Study||0
10861229|NCT00362401|12026253|FG002|NOT COMPLETED|Overall Study||0
10861230|NCT00338104|12026261|FG000|STARTED|Overall Study||25
10861231|NCT00338104|12026262|FG001|STARTED|Overall Study||25
10861232|NCT00338104|12026263|FG002|STARTED|Overall Study||25
10861233|NCT00338104|12026261|FG000|COMPLETED|Overall Study||23
10861234|NCT00338104|12026262|FG001|COMPLETED|Overall Study||24
10861235|NCT00338104|12026263|FG002|COMPLETED|Overall Study||22
10861236|NCT00338104|12026261|FG000|NOT COMPLETED|Overall Study||2
10861237|NCT00338104|12026262|FG001|NOT COMPLETED|Overall Study||1
10861238|NCT00338104|12026263|FG002|NOT COMPLETED|Overall Study||3
10861239|NCT00336973|12026268|FG000|STARTED|Overall Study||66
10861240|NCT00336973|12026268|FG000|COMPLETED|Overall Study||33
10861241|NCT00336973|12026268|FG000|NOT COMPLETED|Overall Study||33
10861242|NCT00326183|12026273|FG000|STARTED|Overall Study||1453
10861243|NCT00326183|12026274|FG001|STARTED|Overall Study||347
10861244|NCT00326183|12026273|FG000|Vaccination 1 + Safety Follow-up|Overall Study||1453
10861245|NCT00326183|12026274|FG001|Vaccination 1 + Safety Follow-up|Overall Study||347
10861246|NCT00326183|12026273|FG000|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
10861247|NCT00326183|12026274|FG001|Postvaccination 1 Post-safety Follow-up|Overall Study||325
10861248|NCT00326183|12026273|FG000|Vaccination 2 + Safety Follow-up|Overall Study||1301
10861249|NCT00326183|12026274|FG001|Vaccination 2 + Safety Follow-up|Overall Study||292
10861250|NCT00326183|12026273|FG000|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
10861251|NCT00326183|12026274|FG001|Postvaccination 2 Post-safety Follow-up|Overall Study||271
10861252|NCT00326183|12026273|FG000|COMPLETED|Overall Study||1253
10861253|NCT00326183|12026274|FG001|COMPLETED|Overall Study||264
10861254|NCT00326183|12026273|FG000|NOT COMPLETED|Overall Study||200
10861255|NCT00326183|12026274|FG001|NOT COMPLETED|Overall Study||83
10861256|NCT00323037|12026280|FG000|STARTED|Overall Study|Number randomized|165
10861257|NCT00323037|12026281|FG001|STARTED|Overall Study|Number randomized|153
10861258|NCT00323037|12026280|FG000|COMPLETED|Overall Study||132
10861259|NCT00323037|12026281|FG001|COMPLETED|Overall Study||126
10861260|NCT00323037|12026280|FG000|NOT COMPLETED|Overall Study||33
10861261|NCT00323037|12026281|FG001|NOT COMPLETED|Overall Study||27
10861262|NCT00318656|12026287|FG000|STARTED|Overall Study||12
10861263|NCT00318656|12026288|FG001|STARTED|Overall Study||11
10861264|NCT00318656|12026287|FG000|COMPLETED|Overall Study||12
10861265|NCT00318656|12026288|FG001|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
10861266|NCT00318656|12026287|FG000|NOT COMPLETED|Overall Study||0
10861267|NCT00318656|12026288|FG001|NOT COMPLETED|Overall Study||2
10861268|NCT00301262|12026294|FG000|STARTED|Double Blind Phase (DB)||94
10861269|NCT00301262|12026295|FG001|STARTED|Double Blind Phase (DB)||82
11107680|NCT01263496|12291980|FG002|COMPLETED|Entered - Long-Term Extension Study||62
11107681|NCT01263496|12291981|FG003|COMPLETED|Entered - Long-Term Extension Study||68
11107682|NCT01263496|12291982|FG004|COMPLETED|Entered - Long-Term Extension Study||61
11107683|NCT01263496|12291983|FG005|COMPLETED|Entered - Long-Term Extension Study||16
11107684|NCT01263496|12291984|FG006|COMPLETED|Entered - Long-Term Extension Study||16
11107685|NCT01263496|12291985|FG007|COMPLETED|Entered - Long-Term Extension Study||16
11107686|NCT01263496|12291986|FG008|COMPLETED|Entered - Long-Term Extension Study||15
11107687|NCT01263496|12291978|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9
11107688|NCT01263496|12291979|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13
11107689|NCT01263496|12291980|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||10
11107690|NCT01263496|12291981|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||6
11107691|NCT01263496|12291982|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||10
11107692|NCT01263496|12291983|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||1
11107693|NCT01263496|12291984|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1
11107694|NCT01263496|12291985|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||1
11107695|NCT01263496|12291986|FG008|NOT COMPLETED|Entered - Long-Term Extension Study||3
11107696|NCT01263509|12292000|FG000|STARTED|Enrolled - Long-Term Extension Study||61
11107697|NCT01263509|12292001|FG001|STARTED|Enrolled - Long-Term Extension Study||60
10861270|NCT00301262|12026294|FG000|COMPLETED|Double Blind Phase (DB)||84
10861271|NCT00301262|12026295|FG001|COMPLETED|Double Blind Phase (DB)||69
10861272|NCT00301262|12026294|FG000|NOT COMPLETED|Double Blind Phase (DB)||10
10861273|NCT00301262|12026295|FG001|NOT COMPLETED|Double Blind Phase (DB)||13
10861274|NCT00301262|12026294|FG000|STARTED|Open Label Phase (OL)||83
10861275|NCT00301262|12026295|FG001|STARTED|Open Label Phase (OL)||69
10861276|NCT00301262|12026294|FG000|COMPLETED|Open Label Phase (OL)||79
10861277|NCT00301262|12026295|FG001|COMPLETED|Open Label Phase (OL)||67
10861278|NCT00301262|12026294|FG000|NOT COMPLETED|Open Label Phase (OL)||4
10861279|NCT00301262|12026295|FG001|NOT COMPLETED|Open Label Phase (OL)||2
10861280|NCT00283868|12026322|FG000|STARTED|Overall Study||111
10861281|NCT00283868|12026323|FG001|STARTED|Overall Study||111
10861282|NCT00283868|12026322|FG000|COMPLETED|Overall Study||104
10861283|NCT00283868|12026323|FG001|COMPLETED|Overall Study||103
10861284|NCT00283868|12026322|FG000|NOT COMPLETED|Overall Study||7
10861285|NCT00283868|12026323|FG001|NOT COMPLETED|Overall Study||8
10861286|NCT00282867|12026330|FG000|STARTED|Overall Study||24
10861287|NCT00282867|12026331|FG001|STARTED|Overall Study||25
10861288|NCT00282867|12026332|FG002|STARTED|Overall Study||25
10861289|NCT00282867|12026330|FG000|COMPLETED|Overall Study||23
10861290|NCT00282867|12026331|FG001|COMPLETED|Overall Study||24
10861291|NCT00282867|12026332|FG002|COMPLETED|Overall Study||25
10861292|NCT00282867|12026330|FG000|NOT COMPLETED|Overall Study||1
10861293|NCT00282867|12026331|FG001|NOT COMPLETED|Overall Study||1
10861294|NCT00282867|12026332|FG002|NOT COMPLETED|Overall Study||0
10861295|NCT00275340|12026339|FG000|STARTED|Overall Study||52
10861296|NCT00275340|12026340|FG001|STARTED|Overall Study||49
10861297|NCT00275340|12026339|FG000|COMPLETED|Overall Study||50
10861298|NCT00275340|12026340|FG001|COMPLETED|Overall Study||45
10861299|NCT00275340|12026339|FG000|NOT COMPLETED|Overall Study||2
10861300|NCT00275340|12026340|FG001|NOT COMPLETED|Overall Study||4
10861301|NCT00271544|12026344|FG000|STARTED|Overall Study|Total number of subjects enrolled.|190
10861302|NCT00271544|12026344|FG000|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
10861303|NCT00271544|12026344|FG000|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
10861304|NCT00271544|12026344|FG000|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
10861305|NCT00271544|12026344|FG000|NOT COMPLETED|Overall Study||20
11107698|NCT01263509|12292002|FG002|STARTED|Enrolled - Long-Term Extension Study||32
11227401|NCT02002208|12419414|FG000|NOT COMPLETED|Overall Study||37
11227402|NCT02002208|12419415|FG001|NOT COMPLETED|Overall Study||40
10861306|NCT00240500|12026366|FG000|STARTED|Overall Study||17
10861307|NCT00240500|12026367|FG001|STARTED|Overall Study||20
10861308|NCT00240500|12026368|FG002|STARTED|Overall Study||17
10861309|NCT00240500|12026369|FG003|STARTED|Overall Study||23
10861310|NCT00240500|12026370|FG004|STARTED|Overall Study||29
10861311|NCT00240500|12026371|FG005|STARTED|Overall Study||3
10861312|NCT00240500|12026366|FG000|COMPLETED|Overall Study||16
10861313|NCT00240500|12026367|FG001|COMPLETED|Overall Study||17
10861314|NCT00240500|12026368|FG002|COMPLETED|Overall Study||14
10861315|NCT00240500|12026369|FG003|COMPLETED|Overall Study||19
10861316|NCT00240500|12026370|FG004|COMPLETED|Overall Study||26
10861317|NCT00240500|12026371|FG005|COMPLETED|Overall Study||2
10861318|NCT00240500|12026366|FG000|NOT COMPLETED|Overall Study||1
10861319|NCT00240500|12026367|FG001|NOT COMPLETED|Overall Study||3
10861320|NCT00240500|12026368|FG002|NOT COMPLETED|Overall Study||3
10861321|NCT00240500|12026369|FG003|NOT COMPLETED|Overall Study||4
10861322|NCT00240500|12026370|FG004|NOT COMPLETED|Overall Study||3
10861323|NCT00240500|12026371|FG005|NOT COMPLETED|Overall Study||1
10861324|NCT00235326|12026381|FG000|STARTED|Overall Study||1575
10861325|NCT00235326|12026382|FG001|STARTED|Overall Study||2986
10861326|NCT00235326|12026381|FG000|COMPLETED|Overall Study||829
10861327|NCT00235326|12026382|FG001|COMPLETED|Overall Study||1586
11227403|NCT02002221|12419423|FG000|STARTED|Overall Study||78
11227404|NCT02002221|12419424|FG001|STARTED|Overall Study||78
11227405|NCT02002221|12419423|FG000|COMPLETED|Overall Study||76
11227406|NCT02002221|12419424|FG001|COMPLETED|Overall Study||75
11227407|NCT02002221|12419423|FG000|NOT COMPLETED|Overall Study||2
11227408|NCT02002221|12419424|FG001|NOT COMPLETED|Overall Study||3
11227409|NCT02002494|12419430|FG000|STARTED|Overall Study||27
11227410|NCT02002494|12419430|FG000|COMPLETED|Overall Study||27
11227411|NCT02002494|12419430|FG000|NOT COMPLETED|Overall Study||0
11227412|NCT02002533|12419447|FG000|STARTED|Overall Study||34
11227413|NCT02002533|12419448|FG001|STARTED|Overall Study||37
11227414|NCT02002533|12419447|FG000|COMPLETED|Overall Study||28
11227415|NCT02002533|12419448|FG001|COMPLETED|Overall Study||19
11227416|NCT02002533|12419447|FG000|NOT COMPLETED|Overall Study||6
11227417|NCT02002533|12419448|FG001|NOT COMPLETED|Overall Study||18
11227418|NCT02002650|12419457|FG000|STARTED|Overall Study||1297
11227419|NCT02002650|12419458|FG001|STARTED|Overall Study||1303
11227420|NCT02002650|12419457|FG000|COMPLETED|Overall Study||1297
11227421|NCT02002650|12419458|FG001|COMPLETED|Overall Study||1303
11227422|NCT02002650|12419457|FG000|NOT COMPLETED|Overall Study||0
11227423|NCT02002650|12419458|FG001|NOT COMPLETED|Overall Study||0
11227424|NCT02002689|12419465|FG000|STARTED|Overall Study||10
11227425|NCT02002689|12419465|FG000|COMPLETED|Overall Study||0
11227426|NCT02002689|12419465|FG000|NOT COMPLETED|Overall Study||10
11227427|NCT02002702|12419472|FG000|STARTED|Overall Study||16
11227428|NCT02002702|12419473|FG001|STARTED|Overall Study||15
11227429|NCT02002702|12419474|FG002|STARTED|Overall Study||15
11227430|NCT02002702|12419472|FG000|COMPLETED|Overall Study||16
11227431|NCT02002702|12419473|FG001|COMPLETED|Overall Study||15
11227432|NCT02002702|12419474|FG002|COMPLETED|Overall Study||15
11227433|NCT02002702|12419472|FG000|NOT COMPLETED|Overall Study||0
11227434|NCT02002702|12419473|FG001|NOT COMPLETED|Overall Study||0
11227435|NCT02002702|12419474|FG002|NOT COMPLETED|Overall Study||0
11227436|NCT02002767|12419484|FG000|STARTED|Overall Study||9
11227437|NCT02002767|12419485|FG001|STARTED|Overall Study||10
11227438|NCT02002767|12419484|FG000|COMPLETED|Overall Study||9
11227439|NCT02002767|12419485|FG001|COMPLETED|Overall Study||10
11227440|NCT02002767|12419484|FG000|NOT COMPLETED|Overall Study||0
11227441|NCT02002767|12419485|FG001|NOT COMPLETED|Overall Study||0
11227442|NCT02002832|12419493|FG000|STARTED|Overall Study||194
11227443|NCT02002832|12419494|FG001|STARTED|Overall Study||194
11227444|NCT02002832|12419493|FG000|COMPLETED|Overall Study||166
11227445|NCT02002832|12419494|FG001|COMPLETED|Overall Study||168
11227446|NCT02002832|12419493|FG000|NOT COMPLETED|Overall Study||28
11227447|NCT02002832|12419494|FG001|NOT COMPLETED|Overall Study||26
11227448|NCT02002871|12419501|FG000|STARTED|Overall Study||21
11227449|NCT02002871|12419501|FG000|COMPLETED|Overall Study||20
11227450|NCT02002871|12419501|FG000|NOT COMPLETED|Overall Study||1
11227451|NCT02002884|12419509|FG000|STARTED|Main Period (MP)||87
11227452|NCT02002884|12419510|FG001|STARTED|Main Period (MP)||88
11227453|NCT02002884|12419511|FG002|STARTED|Main Period (MP)||176
11227454|NCT02002884|12419512|FG003|STARTED|Main Period (MP)||0
11227455|NCT02002884|12419509|FG000|Treated|Main Period (MP)||87
11227456|NCT02002884|12419510|FG001|Treated|Main Period (MP)||87
11227457|NCT02002884|12419511|FG002|Treated|Main Period (MP)||176
11227458|NCT02002884|12419512|FG003|Treated|Main Period (MP)||0
11227459|NCT02002884|12419509|FG000|COMPLETED|Main Period (MP)||81
11227460|NCT02002884|12419510|FG001|COMPLETED|Main Period (MP)||82
11227461|NCT02002884|12419511|FG002|COMPLETED|Main Period (MP)||168
10861328|NCT00235326|12026381|FG000|NOT COMPLETED|Overall Study||746
10861329|NCT00235326|12026382|FG001|NOT COMPLETED|Overall Study||1400
10861330|NCT00232141|12026388|FG000|STARTED|Overall Study||151
10861331|NCT00232141|12026389|FG001|STARTED|Overall Study||151
10861332|NCT00232141|12026388|FG000|COMPLETED|Overall Study||120
10861333|NCT00232141|12026389|FG001|COMPLETED|Overall Study||125
10861334|NCT00232141|12026388|FG000|NOT COMPLETED|Overall Study||31
10861335|NCT00232141|12026389|FG001|NOT COMPLETED|Overall Study||26
10861336|NCT00231153|12026395|FG000|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
10861337|NCT00231153|12026396|FG001|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
10861338|NCT00231153|12026395|FG000|COMPLETED|Overall Study||690
10861339|NCT00231153|12026396|FG001|COMPLETED|Overall Study||720
10861340|NCT00231153|12026395|FG000|NOT COMPLETED|Overall Study||217
10861341|NCT00231153|12026396|FG001|NOT COMPLETED|Overall Study||188
10861342|NCT00224003|12026400|FG000|STARTED|Overall Study|First patient in: April 2, 2003|23
10861343|NCT00224003|12026400|FG000|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
10861344|NCT00224003|12026400|FG000|NOT COMPLETED|Overall Study||7
10861345|NCT00162942|12026405|FG000|STARTED|Overall Study||157
10861346|NCT00162942|12026406|FG001|STARTED|Overall Study||78
10861347|NCT00162942|12026405|FG000|Week 12|Overall Study||127
10861348|NCT00162942|12026406|FG001|Week 12|Overall Study||61
10861349|NCT00162942|12026405|FG000|COMPLETED|Overall Study||51
10861350|NCT00162942|12026406|FG001|COMPLETED|Overall Study||26
10861351|NCT00162942|12026405|FG000|NOT COMPLETED|Overall Study||106
10861352|NCT00162942|12026406|FG001|NOT COMPLETED|Overall Study||52
10861353|NCT00147290|12026412|FG000|STARTED|Overall Study||266
10861354|NCT00147290|12026413|FG001|STARTED|Overall Study||260
10861355|NCT00147290|12026412|FG000|COMPLETED|Overall Study||266
10861356|NCT00147290|12026413|FG001|COMPLETED|Overall Study||260
10861357|NCT00147290|12026412|FG000|NOT COMPLETED|Overall Study||0
10861358|NCT00147290|12026413|FG001|NOT COMPLETED|Overall Study||0
10861359|NCT00147277|12026419|FG000|STARTED|Overall Study||475
10861360|NCT00147277|12026420|FG001|STARTED|Overall Study||450
10861361|NCT00147277|12026419|FG000|COMPLETED|Overall Study||475
10861362|NCT00147277|12026420|FG001|COMPLETED|Overall Study||450
10861363|NCT00147277|12026419|FG000|NOT COMPLETED|Overall Study||0
10861364|NCT00147277|12026420|FG001|NOT COMPLETED|Overall Study||0
10861365|NCT00126776|12026426|FG000|STARTED|Overall Study||372
10861366|NCT00126776|12026427|FG001|STARTED|Overall Study||371
10861367|NCT00126776|12026426|FG000|COMPLETED|Overall Study||372
10861368|NCT00126776|12026427|FG001|COMPLETED|Overall Study||371
10861369|NCT00126776|12026426|FG000|NOT COMPLETED|Overall Study||0
10861370|NCT00126776|12026427|FG001|NOT COMPLETED|Overall Study||0
10861371|NCT00120042|12026434|FG000|STARTED|Overall Study||85
10861372|NCT00120042|12026435|FG001|STARTED|Overall Study||83
10861373|NCT00120042|12026436|FG002|STARTED|Overall Study||83
11227462|NCT02002884|12419512|FG003|COMPLETED|Main Period (MP)||0
11227463|NCT02002884|12419509|FG000|NOT COMPLETED|Main Period (MP)||6
11227464|NCT02002884|12419510|FG001|NOT COMPLETED|Main Period (MP)||6
11227465|NCT02002884|12419511|FG002|NOT COMPLETED|Main Period (MP)||8
10861374|NCT00120042|12026434|FG000|COMPLETED|Overall Study||85
10861375|NCT00120042|12026435|FG001|COMPLETED|Overall Study||83
10861376|NCT00120042|12026436|FG002|COMPLETED|Overall Study||83
10861377|NCT00120042|12026434|FG000|NOT COMPLETED|Overall Study||0
10861378|NCT00120042|12026435|FG001|NOT COMPLETED|Overall Study||0
10861379|NCT00120042|12026436|FG002|NOT COMPLETED|Overall Study||0
11227466|NCT02002884|12419512|FG003|NOT COMPLETED|Main Period (MP)||0
11227467|NCT02002884|12419509|FG000|STARTED|Open-Label Extension Period (OLEX)||0
11227468|NCT02002884|12419510|FG001|STARTED|Open-Label Extension Period (OLEX)||0
11227469|NCT02002884|12419511|FG002|STARTED|Open-Label Extension Period (OLEX)||0
11227470|NCT02002884|12419512|FG003|STARTED|Open-Label Extension Period (OLEX)||331
11227471|NCT02002884|12419509|FG000|COMPLETED|Open-Label Extension Period (OLEX)||0
11227472|NCT02002884|12419510|FG001|COMPLETED|Open-Label Extension Period (OLEX)||0
11227473|NCT02002884|12419511|FG002|COMPLETED|Open-Label Extension Period (OLEX)||0
11227474|NCT02002884|12419512|FG003|COMPLETED|Open-Label Extension Period (OLEX)||281
11227475|NCT02002884|12419509|FG000|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
11227476|NCT02002884|12419510|FG001|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
11227477|NCT02002884|12419511|FG002|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
11227478|NCT02002884|12419512|FG003|NOT COMPLETED|Open-Label Extension Period (OLEX)||50
10861380|NCT00106626|12026445|FG000|STARTED|Overall Study||13
10861381|NCT00106626|12026446|FG001|STARTED|Overall Study||9
10861382|NCT00106626|12026447|FG002|STARTED|Overall Study||14
10861383|NCT00106626|12026448|FG003|STARTED|Overall Study||16
10861384|NCT00106626|12026445|FG000|COMPLETED|Overall Study||3
10861385|NCT00106626|12026446|FG001|COMPLETED|Overall Study||3
10861386|NCT00106626|12026447|FG002|COMPLETED|Overall Study||2
10861387|NCT00106626|12026448|FG003|COMPLETED|Overall Study||3
10861388|NCT00106626|12026445|FG000|NOT COMPLETED|Overall Study||10
10861389|NCT00106626|12026446|FG001|NOT COMPLETED|Overall Study||6
10861390|NCT00106626|12026447|FG002|NOT COMPLETED|Overall Study||12
10861391|NCT00106626|12026448|FG003|NOT COMPLETED|Overall Study||13
10861392|NCT00089141|12026465|FG000|STARTED|Overall Study||74
10861393|NCT00089141|12026466|FG001|STARTED|Overall Study||77
10861394|NCT00089141|12026465|FG000|COMPLETED|Overall Study||56
10861395|NCT00089141|12026466|FG001|COMPLETED|Overall Study||53
10861396|NCT00089141|12026465|FG000|NOT COMPLETED|Overall Study||18
10861397|NCT00089141|12026466|FG001|NOT COMPLETED|Overall Study||24
10861398|NCT00083759|12026472|FG000|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
10861399|NCT00083759|12026473|FG001|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
10861400|NCT00083759|12026472|FG000|COMPLETED|Overall Study||66
10861401|NCT00083759|12026473|FG001|COMPLETED|Overall Study||66
10861402|NCT00083759|12026472|FG000|NOT COMPLETED|Overall Study||84
10861403|NCT00083759|12026473|FG001|NOT COMPLETED|Overall Study||83
10861404|NCT03513068|12026479|FG000|STARTED|Overall Study||54
10861405|NCT03513068|12026480|FG001|STARTED|Overall Study||54
10861406|NCT03513068|12026479|FG000|COMPLETED|Overall Study||49
10861407|NCT03513068|12026480|FG001|COMPLETED|Overall Study||48
10861408|NCT03513068|12026479|FG000|NOT COMPLETED|Overall Study||5
10861409|NCT03513068|12026480|FG001|NOT COMPLETED|Overall Study||6
10861410|NCT03507127|12026488|FG000|STARTED|Overall Study||3
10861411|NCT03507127|12026489|FG001|STARTED|Overall Study||2
10861412|NCT03507127|12026488|FG000|COMPLETED|Overall Study||1
10861413|NCT03507127|12026489|FG001|COMPLETED|Overall Study||1
10861414|NCT03507127|12026488|FG000|NOT COMPLETED|Overall Study||2
10861415|NCT03507127|12026489|FG001|NOT COMPLETED|Overall Study||1
10861416|NCT03502811|12026495|FG000|STARTED|Overall Study||1041
10861417|NCT03502811|12026495|FG000|COMPLETED|Overall Study||722
10861418|NCT03502811|12026495|FG000|NOT COMPLETED|Overall Study||319
10861419|NCT04789382|12026503|FG000|STARTED|First Wear Period (2 Hours)||9
10861420|NCT04789382|12026504|FG001|STARTED|First Wear Period (2 Hours)||9
10861421|NCT04789382|12026505|FG002|STARTED|First Wear Period (2 Hours)||9
10861422|NCT04789382|12026506|FG003|STARTED|First Wear Period (2 Hours)||9
10861423|NCT04789382|12026503|FG000|COMPLETED|First Wear Period (2 Hours)||9
10861424|NCT04789382|12026504|FG001|COMPLETED|First Wear Period (2 Hours)||9
10861425|NCT04789382|12026505|FG002|COMPLETED|First Wear Period (2 Hours)||9
10861426|NCT04789382|12026506|FG003|COMPLETED|First Wear Period (2 Hours)||9
10861427|NCT04789382|12026503|FG000|NOT COMPLETED|First Wear Period (2 Hours)||0
10861428|NCT04789382|12026504|FG001|NOT COMPLETED|First Wear Period (2 Hours)||0
10861429|NCT04789382|12026505|FG002|NOT COMPLETED|First Wear Period (2 Hours)||0
10861430|NCT04789382|12026506|FG003|NOT COMPLETED|First Wear Period (2 Hours)||0
10861431|NCT04789382|12026503|FG000|STARTED|Washout (Day of & Day Prior to Visit 3)||9
10861432|NCT04789382|12026504|FG001|STARTED|Washout (Day of & Day Prior to Visit 3)||9
10861433|NCT04789382|12026505|FG002|STARTED|Washout (Day of & Day Prior to Visit 3)||9
10861434|NCT04789382|12026506|FG003|STARTED|Washout (Day of & Day Prior to Visit 3)||9
10861435|NCT04789382|12026503|FG000|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
10861436|NCT04789382|12026504|FG001|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
10861437|NCT04789382|12026505|FG002|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
10861438|NCT04789382|12026506|FG003|COMPLETED|Washout (Day of & Day Prior to Visit 3)||9
10861439|NCT04789382|12026503|FG000|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
10861440|NCT04789382|12026504|FG001|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
10861441|NCT04789382|12026505|FG002|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
10861442|NCT04789382|12026506|FG003|NOT COMPLETED|Washout (Day of & Day Prior to Visit 3)||0
10861443|NCT04789382|12026503|FG000|STARTED|Second Wear Period (2 Hours)||9
10861444|NCT04789382|12026504|FG001|STARTED|Second Wear Period (2 Hours)||9
10861445|NCT04789382|12026505|FG002|STARTED|Second Wear Period (2 Hours)||9
10861446|NCT04789382|12026506|FG003|STARTED|Second Wear Period (2 Hours)||9
10861447|NCT04789382|12026503|FG000|COMPLETED|Second Wear Period (2 Hours)||9
10861448|NCT04789382|12026504|FG001|COMPLETED|Second Wear Period (2 Hours)||9
11227479|NCT02002936|12419522|FG000|STARTED|Overall Study||1
11227480|NCT02002936|12419522|FG000|COMPLETED|Overall Study||1
10861449|NCT04789382|12026505|FG002|COMPLETED|Second Wear Period (2 Hours)||9
10861450|NCT04789382|12026506|FG003|COMPLETED|Second Wear Period (2 Hours)||9
10861451|NCT04789382|12026503|FG000|NOT COMPLETED|Second Wear Period (2 Hours)||0
10861452|NCT04789382|12026504|FG001|NOT COMPLETED|Second Wear Period (2 Hours)||0
10861453|NCT04789382|12026505|FG002|NOT COMPLETED|Second Wear Period (2 Hours)||0
10861454|NCT04789382|12026506|FG003|NOT COMPLETED|Second Wear Period (2 Hours)||0
11227481|NCT02002936|12419522|FG000|NOT COMPLETED|Overall Study||0
11227482|NCT02002975|12419526|FG000|STARTED|Overall Study||18223
11227483|NCT02002975|12419526|FG000|COMPLETED|Overall Study||17651
10861465|NCT03530995|12026529|FG000|STARTED|Part 1 Period 1; Part 2 Period 1||35
10861466|NCT03530995|12026530|FG001|STARTED|Part 1 Period 1; Part 2 Period 1||38
10861467|NCT03530995|12026529|FG000|COMPLETED|Part 1 Period 1; Part 2 Period 1||35
10861468|NCT03530995|12026530|FG001|COMPLETED|Part 1 Period 1; Part 2 Period 1||38
10861469|NCT03530995|12026529|FG000|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0
10861470|NCT03530995|12026530|FG001|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0
10861471|NCT03530995|12026529|FG000|STARTED|Part 1 Period 2; Part 2 Period 2||35
10861472|NCT03530995|12026530|FG001|STARTED|Part 1 Period 2; Part 2 Period 2||38
10861473|NCT03530995|12026529|FG000|COMPLETED|Part 1 Period 2; Part 2 Period 2||35
10861474|NCT03530995|12026530|FG001|COMPLETED|Part 1 Period 2; Part 2 Period 2||38
10861475|NCT03530995|12026529|FG000|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0
10861476|NCT03530995|12026530|FG001|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0
10861477|NCT03530995|12026529|FG000|STARTED|Part 1 Period 3||35
10861478|NCT03530995|12026530|FG001|STARTED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0
10861479|NCT03530995|12026529|FG000|COMPLETED|Part 1 Period 3||32
10861480|NCT03530995|12026530|FG001|COMPLETED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0
10861481|NCT03530995|12026529|FG000|NOT COMPLETED|Part 1 Period 3||3
10861482|NCT03530995|12026530|FG001|NOT COMPLETED|Part 1 Period 3||0
10861483|NCT03530995|12026529|FG000|STARTED|Part 1 Period 4||32
10861484|NCT03530995|12026530|FG001|STARTED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0
10861485|NCT03530995|12026529|FG000|COMPLETED|Part 1 Period 4||30
10861486|NCT03530995|12026530|FG001|COMPLETED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0
10861487|NCT03530995|12026529|FG000|NOT COMPLETED|Part 1 Period 4||2
10861488|NCT03530995|12026530|FG001|NOT COMPLETED|Part 1 Period 4||0
10861489|NCT03373006|12026552|FG000|STARTED|Overall Study||20
10861490|NCT03373006|12026552|FG000|COMPLETED|Overall Study||20
10861491|NCT03373006|12026552|FG000|NOT COMPLETED|Overall Study||0
10861492|NCT03368937|12026556|FG000|STARTED|Overall Study||5
10861493|NCT03368937|12026556|FG000|COMPLETED|Overall Study||5
10861494|NCT03368937|12026556|FG000|NOT COMPLETED|Overall Study||0
10861495|NCT03204812|12026560|FG000|STARTED|Overall Study||26
10861496|NCT03204812|12026560|FG000|COMPLETED|Overall Study||23
10861497|NCT03204812|12026560|FG000|NOT COMPLETED|Overall Study||3
11107699|NCT01263509|12292003|FG003|STARTED|Enrolled - Long-Term Extension Study||26
11107700|NCT01263509|12292000|FG000|COMPLETED|Enrolled - Long-Term Extension Study||61
11107701|NCT01263509|12292001|FG001|COMPLETED|Enrolled - Long-Term Extension Study||60
10861501|NCT03072459|12026571|FG000|STARTED|Overall Study||128
10861502|NCT03072459|12026571|FG000|COMPLETED|Overall Study||126
10861503|NCT03072459|12026571|FG000|NOT COMPLETED|Overall Study||2
10861504|NCT03029234|12026575|FG000|STARTED|Overall Study||126
10861505|NCT03029234|12026575|FG000|Received Carfilzomib|Overall Study||123
11227484|NCT02002975|12419526|FG000|NOT COMPLETED|Overall Study||572
11227485|NCT02003014|12419530|FG000|STARTED|Overall Study||899
11227486|NCT02003014|12419530|FG000|COMPLETED|Overall Study||880
11227487|NCT02003014|12419530|FG000|NOT COMPLETED|Overall Study||19
11227488|NCT02003053|12419536|FG000|STARTED|Overall Study||4
11227489|NCT02003053|12419537|FG001|STARTED|Overall Study||3
10861506|NCT03029234|12026575|FG000|COMPLETED|Overall Study||27
10861507|NCT03029234|12026575|FG000|NOT COMPLETED|Overall Study||99
10861508|NCT03019406|12026583|FG000|STARTED|PAP: up to 25 Weeks||6
10861509|NCT03019406|12026584|FG001|STARTED|PAP: up to 25 Weeks||5
10861510|NCT03019406|12026585|FG002|STARTED|PAP: up to 25 Weeks||5
10861511|NCT03019406|12026586|FG003|STARTED|PAP: up to 25 Weeks||6
10861512|NCT03019406|12026583|FG000|Treated|PAP: up to 25 Weeks||6
10861513|NCT03019406|12026584|FG001|Treated|PAP: up to 25 Weeks||5
10861514|NCT03019406|12026585|FG002|Treated|PAP: up to 25 Weeks||5
10861515|NCT03019406|12026586|FG003|Treated|PAP: up to 25 Weeks||6
10861516|NCT03019406|12026583|FG000|COMPLETED|PAP: up to 25 Weeks||6
11107702|NCT01263509|12292002|FG002|COMPLETED|Enrolled - Long-Term Extension Study||32
11107703|NCT01263509|12292003|FG003|COMPLETED|Enrolled - Long-Term Extension Study||26
11107704|NCT01263509|12292000|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11107705|NCT01263509|12292001|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11107706|NCT01263509|12292002|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11107707|NCT01263509|12292003|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11107708|NCT01263509|12292000|FG000|STARTED|Entered - Long-Term Extension Study||61
11107709|NCT01263509|12292001|FG001|STARTED|Entered - Long-Term Extension Study||60
10861517|NCT03019406|12026584|FG001|COMPLETED|PAP: up to 25 Weeks||5
10861518|NCT03019406|12026585|FG002|COMPLETED|PAP: up to 25 Weeks||5
11227490|NCT02003053|12419536|FG000|COMPLETED|Overall Study||4
11227491|NCT02003053|12419537|FG001|COMPLETED|Overall Study||3
11227492|NCT02003053|12419536|FG000|NOT COMPLETED|Overall Study||0
11227493|NCT02003053|12419537|FG001|NOT COMPLETED|Overall Study||0
11227494|NCT02003183|12419545|FG000|STARTED|Overall Study||7
10861519|NCT03019406|12026586|FG003|COMPLETED|PAP: up to 25 Weeks||6
10861520|NCT03019406|12026583|FG000|NOT COMPLETED|PAP: up to 25 Weeks||0
10861521|NCT03019406|12026584|FG001|NOT COMPLETED|PAP: up to 25 Weeks||0
10861522|NCT03019406|12026585|FG002|NOT COMPLETED|PAP: up to 25 Weeks||0
10861523|NCT03019406|12026586|FG003|NOT COMPLETED|PAP: up to 25 Weeks||0
10861524|NCT03019406|12026583|FG000|STARTED|ETP: Ongoing From Week 26||6
10861525|NCT03019406|12026584|FG001|STARTED|ETP: Ongoing From Week 26||5
10861526|NCT03019406|12026585|FG002|STARTED|ETP: Ongoing From Week 26||5
10861527|NCT03019406|12026586|FG003|STARTED|ETP: Ongoing From Week 26|Participants who completed PAP and accepted to receive avalglucosidase alfa treatment in ETP.|3
10861528|NCT03019406|12026583|FG000|COMPLETED|ETP: Ongoing From Week 26||0
10861529|NCT03019406|12026584|FG001|COMPLETED|ETP: Ongoing From Week 26||0
10861530|NCT03019406|12026585|FG002|COMPLETED|ETP: Ongoing From Week 26||0
10861531|NCT03019406|12026586|FG003|COMPLETED|ETP: Ongoing From Week 26||0
10861532|NCT03019406|12026583|FG000|NOT COMPLETED|ETP: Ongoing From Week 26||6
10861533|NCT03019406|12026584|FG001|NOT COMPLETED|ETP: Ongoing From Week 26||5
10861534|NCT03019406|12026585|FG002|NOT COMPLETED|ETP: Ongoing From Week 26||5
10861535|NCT03019406|12026586|FG003|NOT COMPLETED|ETP: Ongoing From Week 26||3
10861536|NCT02874144|12026601|FG000|STARTED|Overall Study||22
10861537|NCT02874144|12026602|FG001|STARTED|Overall Study||21
10861538|NCT02874144|12026601|FG000|COMPLETED|Overall Study||19
10861539|NCT02874144|12026602|FG001|COMPLETED|Overall Study||16
10861540|NCT02874144|12026601|FG000|NOT COMPLETED|Overall Study||3
10861541|NCT02874144|12026602|FG001|NOT COMPLETED|Overall Study||5
10861542|NCT02611830|12026612|FG000|STARTED|OL Induction Phase||383
10861543|NCT02611830|12026613|FG001|STARTED|OL Induction Phase||0
10861544|NCT02611830|12026614|FG002|STARTED|OL Induction Phase||0
10861545|NCT02611830|12026615|FG003|STARTED|OL Induction Phase||0
10861546|NCT02611830|12026612|FG000|COMPLETED|OL Induction Phase||353
10861547|NCT02611830|12026613|FG001|COMPLETED|OL Induction Phase||0
10861548|NCT02611830|12026614|FG002|COMPLETED|OL Induction Phase||0
10861549|NCT02611830|12026615|FG003|COMPLETED|OL Induction Phase||0
10861550|NCT02611830|12026612|FG000|NOT COMPLETED|OL Induction Phase||30
10861551|NCT02611830|12026613|FG001|NOT COMPLETED|OL Induction Phase||0
10861552|NCT02611830|12026614|FG002|NOT COMPLETED|OL Induction Phase||0
10861553|NCT02611830|12026615|FG003|NOT COMPLETED|OL Induction Phase||0
10861554|NCT02611830|12026612|FG000|STARTED|Maintenance Phase||0
10861555|NCT02611830|12026613|FG001|STARTED|Maintenance Phase||56
10861556|NCT02611830|12026614|FG002|STARTED|Maintenance Phase||106
10861557|NCT02611830|12026615|FG003|STARTED|Maintenance Phase||54
10861558|NCT02611830|12026612|FG000|COMPLETED|Maintenance Phase||0
10861559|NCT02611830|12026613|FG001|COMPLETED|Maintenance Phase||20
10861560|NCT02611830|12026614|FG002|COMPLETED|Maintenance Phase||75
10861561|NCT02611830|12026615|FG003|COMPLETED|Maintenance Phase||39
10861562|NCT02611830|12026612|FG000|NOT COMPLETED|Maintenance Phase||0
10861563|NCT02611830|12026613|FG001|NOT COMPLETED|Maintenance Phase||36
10861564|NCT02611830|12026614|FG002|NOT COMPLETED|Maintenance Phase||31
10861565|NCT02611830|12026615|FG003|NOT COMPLETED|Maintenance Phase||15
10861566|NCT02611817|12026627|FG000|STARTED|Open-label Induction Phase||644
10861567|NCT02611817|12026628|FG001|STARTED|Open-label Induction Phase||0
10861568|NCT02611817|12026629|FG002|STARTED|Open-label Induction Phase||0
10861569|NCT02611817|12026627|FG000|COMPLETED|Open-label Induction Phase||594
10861570|NCT02611817|12026628|FG001|COMPLETED|Open-label Induction Phase||0
10861571|NCT02611817|12026629|FG002|COMPLETED|Open-label Induction Phase||0
10861572|NCT02611817|12026627|FG000|NOT COMPLETED|Open-label Induction Phase||50
10861573|NCT02611817|12026628|FG001|NOT COMPLETED|Open-label Induction Phase||0
10861574|NCT02611817|12026629|FG002|NOT COMPLETED|Open-label Induction Phase||0
10861575|NCT02611817|12026627|FG000|STARTED|Double-blind Maintenance Phase||0
10861576|NCT02611817|12026628|FG001|STARTED|Double-blind Maintenance Phase||135
10861577|NCT02611817|12026629|FG002|STARTED|Double-blind Maintenance Phase||275
10861578|NCT02611817|12026627|FG000|COMPLETED|Double-blind Maintenance Phase||0
10861579|NCT02611817|12026628|FG001|COMPLETED|Double-blind Maintenance Phase||73
10861580|NCT02611817|12026629|FG002|COMPLETED|Double-blind Maintenance Phase||168
10861581|NCT02611817|12026627|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
10861582|NCT02611817|12026628|FG001|NOT COMPLETED|Double-blind Maintenance Phase||62
10861583|NCT02611817|12026629|FG002|NOT COMPLETED|Double-blind Maintenance Phase||107
10861584|NCT02557139|12026639|FG000|STARTED|Overall Study||8
10861585|NCT02557139|12026640|FG001|STARTED|Overall Study||8
10861586|NCT02557139|12026641|FG002|STARTED|Overall Study||7
10861587|NCT02557139|12026639|FG000|COMPLETED|Overall Study||6
10861588|NCT02557139|12026640|FG001|COMPLETED|Overall Study||8
10861589|NCT02557139|12026641|FG002|COMPLETED|Overall Study||5
10861590|NCT02557139|12026639|FG000|NOT COMPLETED|Overall Study||2
10861591|NCT02557139|12026640|FG001|NOT COMPLETED|Overall Study||0
10861592|NCT02557139|12026641|FG002|NOT COMPLETED|Overall Study||2
10861593|NCT02211131|12026660|FG000|STARTED|Overall Study||74
10861594|NCT02211131|12026661|FG001|STARTED|Overall Study||76
10861595|NCT02211131|12026660|FG000|COMPLETED|Overall Study||0
10861596|NCT02211131|12026661|FG001|COMPLETED|Overall Study||0
10861597|NCT02211131|12026660|FG000|NOT COMPLETED|Overall Study||74
10861598|NCT02211131|12026661|FG001|NOT COMPLETED|Overall Study||76
10861599|NCT02186847|12026676|FG000|STARTED|Overall Study||84
10861600|NCT02186847|12026677|FG001|STARTED|Overall Study||86
10861601|NCT02186847|12026676|FG000|Eligible Population|Overall Study||81
10861602|NCT02186847|12026677|FG001|Eligible Population|Overall Study||86
10861603|NCT02186847|12026676|FG000|Eligible and Started Protocol Treatment|Overall Study||76
10861604|NCT02186847|12026677|FG001|Eligible and Started Protocol Treatment|Overall Study||82
10861605|NCT02186847|12026676|FG000|COMPLETED|Overall Study||81
10861606|NCT02186847|12026677|FG001|COMPLETED|Overall Study||86
10861607|NCT02186847|12026676|FG000|NOT COMPLETED|Overall Study||3
10861608|NCT02186847|12026677|FG001|NOT COMPLETED|Overall Study||0
10861609|NCT02101034|12026688|FG000|STARTED|Overall Study||3
10861610|NCT02101034|12026689|FG001|STARTED|Overall Study||6
10861611|NCT02101034|12026690|FG002|STARTED|Overall Study||31
10861612|NCT02101034|12026691|FG003|STARTED|Overall Study||32
10861613|NCT02101034|12026692|FG004|STARTED|Overall Study||24
10861614|NCT02101034|12026688|FG000|COMPLETED|Overall Study||3
10861615|NCT02101034|12026689|FG001|COMPLETED|Overall Study||6
10861616|NCT02101034|12026690|FG002|COMPLETED|Overall Study||30
10861617|NCT02101034|12026691|FG003|COMPLETED|Overall Study||32
10861618|NCT02101034|12026692|FG004|COMPLETED|Overall Study||24
10861619|NCT02101034|12026688|FG000|NOT COMPLETED|Overall Study||0
10861620|NCT02101034|12026689|FG001|NOT COMPLETED|Overall Study||0
10861621|NCT02101034|12026690|FG002|NOT COMPLETED|Overall Study||1
10861622|NCT02101034|12026691|FG003|NOT COMPLETED|Overall Study||0
10861623|NCT02101034|12026692|FG004|NOT COMPLETED|Overall Study||0
11107710|NCT01263509|12292002|FG002|STARTED|Entered - Long-Term Extension Study||32
11107711|NCT01263509|12292003|FG003|STARTED|Entered - Long-Term Extension Study||26
11107712|NCT01263509|12292000|FG000|COMPLETED|Entered - Long-Term Extension Study||53
11107713|NCT01263509|12292001|FG001|COMPLETED|Entered - Long-Term Extension Study||48
11107714|NCT01263509|12292002|FG002|COMPLETED|Entered - Long-Term Extension Study||27
11107715|NCT01263509|12292003|FG003|COMPLETED|Entered - Long-Term Extension Study||24
11107716|NCT01263509|12292000|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||8
11227495|NCT02003183|12419546|FG001|STARTED|Overall Study||17
10861632|NCT01865617|12026732|FG000|STARTED|Overall Study||39
10861633|NCT01865617|12026733|FG001|STARTED|Overall Study||5
10861634|NCT01865617|12026734|FG002|STARTED|Overall Study||2
10861635|NCT01865617|12026735|FG003|STARTED|Overall Study||1
10861636|NCT01865617|12026736|FG004|STARTED|Overall Study||18
10861637|NCT01865617|12026737|FG005|STARTED|Overall Study||5
10861638|NCT01865617|12026738|FG006|STARTED|Overall Study||22
10861639|NCT01865617|12026739|FG007|STARTED|Overall Study||1
10861640|NCT01865617|12026740|FG008|STARTED|Overall Study||20
10861641|NCT01865617|12026741|FG009|STARTED|Overall Study||5
10861642|NCT01865617|12026742|FG010|STARTED|Overall Study||49
10861643|NCT01865617|12026743|FG011|STARTED|Overall Study||10
10861644|NCT01865617|12026744|FG012|STARTED|Overall Study||20
10861645|NCT01865617|12026732|FG000|COMPLETED|Overall Study||9
10861646|NCT01865617|12026733|FG001|COMPLETED|Overall Study||2
10861647|NCT01865617|12026734|FG002|COMPLETED|Overall Study||1
10861648|NCT01865617|12026735|FG003|COMPLETED|Overall Study||0
10861649|NCT01865617|12026736|FG004|COMPLETED|Overall Study||11
10861650|NCT01865617|12026737|FG005|COMPLETED|Overall Study||4
10861651|NCT01865617|12026738|FG006|COMPLETED|Overall Study||10
10861652|NCT01865617|12026739|FG007|COMPLETED|Overall Study||0
10861653|NCT01865617|12026740|FG008|COMPLETED|Overall Study||9
10861654|NCT01865617|12026741|FG009|COMPLETED|Overall Study||2
10861655|NCT01865617|12026742|FG010|COMPLETED|Overall Study||17
10861656|NCT01865617|12026743|FG011|COMPLETED|Overall Study||4
10861657|NCT01865617|12026744|FG012|COMPLETED|Overall Study||7
10861658|NCT01865617|12026732|FG000|NOT COMPLETED|Overall Study||30
10861659|NCT01865617|12026733|FG001|NOT COMPLETED|Overall Study||3
10861660|NCT01865617|12026734|FG002|NOT COMPLETED|Overall Study||1
10861661|NCT01865617|12026735|FG003|NOT COMPLETED|Overall Study||1
10861662|NCT01865617|12026736|FG004|NOT COMPLETED|Overall Study||7
10861663|NCT01865617|12026737|FG005|NOT COMPLETED|Overall Study||1
10861664|NCT01865617|12026738|FG006|NOT COMPLETED|Overall Study||12
10861665|NCT01865617|12026739|FG007|NOT COMPLETED|Overall Study||1
10861666|NCT01865617|12026740|FG008|NOT COMPLETED|Overall Study||11
10861667|NCT01865617|12026741|FG009|NOT COMPLETED|Overall Study||3
10861668|NCT01865617|12026742|FG010|NOT COMPLETED|Overall Study||32
10861669|NCT01865617|12026743|FG011|NOT COMPLETED|Overall Study||6
10861670|NCT01865617|12026744|FG012|NOT COMPLETED|Overall Study||13
10861671|NCT01828112|12026777|FG000|STARTED|Overall Study||115
10861672|NCT01828112|12026778|FG001|STARTED|Overall Study||116
11227496|NCT02003183|12419545|FG000|COMPLETED|Overall Study||7
11227497|NCT02003183|12419546|FG001|COMPLETED|Overall Study||15
11227498|NCT02003183|12419545|FG000|NOT COMPLETED|Overall Study||0
11227499|NCT02003183|12419546|FG001|NOT COMPLETED|Overall Study||2
11227500|NCT02003352|12419552|FG000|STARTED|Overall Study||98
11227501|NCT02003352|12419552|FG000|COMPLETED|Overall Study||98
11227502|NCT02003352|12419552|FG000|NOT COMPLETED|Overall Study||0
11227503|NCT02003365|12419559|FG000|STARTED|Overall Study||10
11227504|NCT02003365|12419560|FG001|STARTED|Overall Study||30
11227505|NCT02003365|12419561|FG002|STARTED|Overall Study||10
11227506|NCT02003365|12419559|FG000|COMPLETED|Overall Study||10
11227507|NCT02003365|12419560|FG001|COMPLETED|Overall Study||30
11227508|NCT02003365|12419561|FG002|COMPLETED|Overall Study||9
11227509|NCT02003365|12419559|FG000|NOT COMPLETED|Overall Study||0
11227510|NCT02003365|12419560|FG001|NOT COMPLETED|Overall Study||0
11227511|NCT02003365|12419561|FG002|NOT COMPLETED|Overall Study||1
11227512|NCT02003391|12419571|FG000|STARTED|Overall Study||81
11227513|NCT02003391|12419572|FG001|STARTED|Overall Study||75
11227514|NCT02003391|12419571|FG000|Safety Population|Overall Study||81
11227515|NCT02003391|12419572|FG001|Safety Population|Overall Study||75
11227516|NCT02003391|12419571|FG000|Intent to Treat Population|Overall Study||78
11227517|NCT02003391|12419572|FG001|Intent to Treat Population|Overall Study||73
10861673|NCT01828112|12026777|FG000|Entered Extension Treatment Phase|Overall Study||0
10861674|NCT01828112|12026778|FG001|Entered Extension Treatment Phase|Overall Study||74
10861675|NCT01828112|12026777|FG000|Entered Post-treatment Follow-up Phase|Overall Study||7
10861676|NCT01828112|12026778|FG001|Entered Post-treatment Follow-up Phase|Overall Study||5
11227518|NCT02003391|12419571|FG000|COMPLETED|Overall Study||78
11227519|NCT02003391|12419572|FG001|COMPLETED|Overall Study||73
11227520|NCT02003391|12419571|FG000|NOT COMPLETED|Overall Study||3
11227521|NCT02003391|12419572|FG001|NOT COMPLETED|Overall Study||2
11227522|NCT02003404|12419578|FG000|STARTED|Overall Study||17
11227523|NCT02003404|12419578|FG000|COMPLETED|Overall Study||17
11227524|NCT02003404|12419578|FG000|NOT COMPLETED|Overall Study||0
11227525|NCT02003508|12419586|FG000|STARTED|Overall Study||179
11227526|NCT02003508|12419587|FG001|STARTED|Overall Study||166
11227527|NCT02003508|12419586|FG000|COMPLETED|Overall Study||179
11227528|NCT02003508|12419587|FG001|COMPLETED|Overall Study||166
11227529|NCT02003508|12419586|FG000|NOT COMPLETED|Overall Study||0
11227530|NCT02003508|12419587|FG001|NOT COMPLETED|Overall Study||0
10861677|NCT01828112|12026777|FG000|Entered Survival Follow-up Phase|Overall Study||61
10861678|NCT01828112|12026778|FG001|Entered Survival Follow-up Phase|Overall Study||19
10861679|NCT01828112|12026777|FG000|Discontinued From Study|Overall Study||14
10861680|NCT01828112|12026778|FG001|Discontinued From Study|Overall Study||10
10861681|NCT01828112|12026777|FG000|Untreated Patients|Overall Study||0
10861682|NCT01828112|12026778|FG001|Untreated Patients|Overall Study|untreated = did not receive study drug|3
10861683|NCT01828112|12026777|FG000|Untreated|Overall Study||0
10861684|NCT01828112|12026778|FG001|Untreated|Overall Study||3
10861685|NCT01828112|12026777|FG000|Treated|Overall Study||115
10861686|NCT01828112|12026778|FG001|Treated|Overall Study||113
10861687|NCT01828112|12026777|FG000|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
10861688|NCT01828112|12026778|FG001|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
10861689|NCT01828112|12026777|FG000|NOT COMPLETED|Overall Study||82
10861690|NCT01828112|12026778|FG001|NOT COMPLETED|Overall Study||108
10861691|NCT01733888|12026788|FG000|STARTED|Overall Study||20
10861692|NCT01733888|12026789|FG001|STARTED|Overall Study||20
10861693|NCT01733888|12026790|FG002|STARTED|Overall Study||20
10861694|NCT01733888|12026791|FG003|STARTED|Overall Study||20
11227531|NCT02003534|12419593|FG000|STARTED|Overall Study||376
11227532|NCT02003534|12419593|FG000|COMPLETED|Overall Study||329
11227533|NCT02003534|12419593|FG000|NOT COMPLETED|Overall Study||47
11227534|NCT02003573|12419600|FG000|STARTED|Overall Study|Started are treated patients|3
11227535|NCT02003573|12419601|FG001|STARTED|Overall Study|Started are treated patients|4
11227536|NCT02003573|12419602|FG002|STARTED|Overall Study|Started are treated patients|6
10861695|NCT01733888|12026788|FG000|COMPLETED|Overall Study||20
10861696|NCT01733888|12026789|FG001|COMPLETED|Overall Study||20
10861697|NCT01733888|12026790|FG002|COMPLETED|Overall Study||20
10861698|NCT01733888|12026791|FG003|COMPLETED|Overall Study||20
10861699|NCT01733888|12026788|FG000|NOT COMPLETED|Overall Study||0
10861700|NCT01733888|12026789|FG001|NOT COMPLETED|Overall Study||0
10861701|NCT01733888|12026790|FG002|NOT COMPLETED|Overall Study||0
10861702|NCT01733888|12026791|FG003|NOT COMPLETED|Overall Study||0
10861703|NCT01709981|12026803|FG000|STARTED|Overall Study||141
10861704|NCT01709981|12026804|FG001|STARTED|Overall Study||139
10861705|NCT01709981|12026803|FG000|COMPLETED|Overall Study||141
10861706|NCT01709981|12026804|FG001|COMPLETED|Overall Study||139
10861707|NCT01709981|12026803|FG000|NOT COMPLETED|Overall Study||0
10861708|NCT01709981|12026804|FG001|NOT COMPLETED|Overall Study||0
10861709|NCT01670500|12026812|FG000|STARTED|Overall Study||58
10861710|NCT01670500|12026813|FG001|STARTED|Overall Study||60
11107717|NCT01263509|12292001|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||12
11107718|NCT01263509|12292002|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||5
11107719|NCT01263509|12292003|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||2
11107720|NCT01263561|12292011|FG000|STARTED|Overall Study||31
11107721|NCT01263561|12292012|FG001|STARTED|Overall Study||33
11107722|NCT01263561|12292011|FG000|COMPLETED|Overall Study||30
11107723|NCT01263561|12292012|FG001|COMPLETED|Overall Study||31
11107724|NCT01263561|12292011|FG000|NOT COMPLETED|Overall Study||1
11107725|NCT01263561|12292012|FG001|NOT COMPLETED|Overall Study||2
11107726|NCT01263639|12292020|FG000|STARTED|Overall Study||107
11107727|NCT01263639|12292021|FG001|STARTED|Overall Study||121
11107728|NCT01263639|12292020|FG000|COMPLETED|Overall Study||34
11107729|NCT01263639|12292021|FG001|COMPLETED|Overall Study||42
11107730|NCT01263639|12292020|FG000|NOT COMPLETED|Overall Study||73
11107731|NCT01263639|12292021|FG001|NOT COMPLETED|Overall Study||79
11107732|NCT01263665|12292027|FG000|STARTED|Overall Study||71
11107733|NCT01263665|12292027|FG000|COMPLETED|Overall Study||62
11107734|NCT01263665|12292027|FG000|NOT COMPLETED|Overall Study||9
11107735|NCT01263691|12292037|FG000|STARTED|Overall Study||18
11107736|NCT01263691|12292038|FG001|STARTED|Overall Study||18
11107737|NCT01263691|12292039|FG002|STARTED|Overall Study||17
11107738|NCT01263691|12292040|FG003|STARTED|Overall Study||19
11107739|NCT01263691|12292041|FG004|STARTED|Overall Study||18
11107740|NCT01263691|12292042|FG005|STARTED|Overall Study||15
11107741|NCT01263691|12292037|FG000|COMPLETED|Overall Study||15
11107742|NCT01263691|12292038|FG001|COMPLETED|Overall Study||18
11107743|NCT01263691|12292039|FG002|COMPLETED|Overall Study||16
11107744|NCT01263691|12292040|FG003|COMPLETED|Overall Study||18
11107745|NCT01263691|12292041|FG004|COMPLETED|Overall Study||18
11107746|NCT01263691|12292042|FG005|COMPLETED|Overall Study||15
11107747|NCT01263691|12292037|FG000|NOT COMPLETED|Overall Study||3
11107748|NCT01263691|12292038|FG001|NOT COMPLETED|Overall Study||0
11107749|NCT01263691|12292039|FG002|NOT COMPLETED|Overall Study||1
11107750|NCT01263691|12292040|FG003|NOT COMPLETED|Overall Study||1
11107751|NCT01263691|12292041|FG004|NOT COMPLETED|Overall Study||0
11107752|NCT01263691|12292042|FG005|NOT COMPLETED|Overall Study||0
11107753|NCT01263704|12292077|FG000|STARTED|Overall Study||42
11107754|NCT01263704|12292077|FG000|COMPLETED|Overall Study||13
11107755|NCT01263704|12292077|FG000|NOT COMPLETED|Overall Study||29
11107756|NCT01263717|12292083|FG000|STARTED|Overall Study||28
11107757|NCT01263717|12292084|FG001|STARTED|Overall Study||26
11107758|NCT01263717|12292083|FG000|Baseline Visit|Overall Study||28
11227537|NCT02003573|12419600|FG000|COMPLETED|Overall Study||0
11227538|NCT02003573|12419601|FG001|COMPLETED|Overall Study||0
10861711|NCT01670500|12026812|FG000|COMPLETED|Overall Study|1 patient withdrew after 3 cycles; 5 patients received additional non-protocol chemo before surgery|57
11107759|NCT01263717|12292084|FG001|Baseline Visit|Overall Study||22
11107760|NCT01263717|12292083|FG000|COMPLETED|Overall Study||23
11107761|NCT01263717|12292084|FG001|COMPLETED|Overall Study||20
11107762|NCT01263717|12292083|FG000|NOT COMPLETED|Overall Study||5
11107763|NCT01263717|12292084|FG001|NOT COMPLETED|Overall Study||6
11107764|NCT01263782|12292094|FG000|STARTED|Overall Study||6
11107765|NCT01263782|12292095|FG001|STARTED|Overall Study||6
11107766|NCT01263782|12292096|FG002|STARTED|Overall Study||6
11107767|NCT01263782|12292097|FG003|STARTED|Overall Study||6
11107768|NCT01263782|12292094|FG000|COMPLETED|Overall Study||6
11107769|NCT01263782|12292095|FG001|COMPLETED|Overall Study||6
11107770|NCT01263782|12292096|FG002|COMPLETED|Overall Study||3
11107771|NCT01263782|12292097|FG003|COMPLETED|Overall Study||5
11107772|NCT01263782|12292094|FG000|NOT COMPLETED|Overall Study||0
11107773|NCT01263782|12292095|FG001|NOT COMPLETED|Overall Study||0
11107774|NCT01263782|12292096|FG002|NOT COMPLETED|Overall Study||3
11107775|NCT01263782|12292097|FG003|NOT COMPLETED|Overall Study||1
11107776|NCT01263873|12292109|FG000|STARTED|Overall Study||30
11107777|NCT01263873|12292110|FG001|STARTED|Overall Study||30
11107778|NCT01263873|12292109|FG000|COMPLETED|Overall Study||29
11107779|NCT01263873|12292110|FG001|COMPLETED|Overall Study||29
11107780|NCT01263873|12292109|FG000|NOT COMPLETED|Overall Study||1
11107781|NCT01263873|12292110|FG001|NOT COMPLETED|Overall Study||1
11107782|NCT01263925|12292118|FG000|STARTED|Overall Study||276
11107783|NCT01263925|12292119|FG001|STARTED|Overall Study||285
11107784|NCT01263925|12292118|FG000|Full Analysis Set|Overall Study||269
11107785|NCT01263925|12292119|FG001|Full Analysis Set|Overall Study||272
11107786|NCT01263925|12292118|FG000|COMPLETED|Overall Study||225
11107787|NCT01263925|12292119|FG001|COMPLETED|Overall Study||233
11107788|NCT01263925|12292118|FG000|NOT COMPLETED|Overall Study||51
11107789|NCT01263925|12292119|FG001|NOT COMPLETED|Overall Study||52
11107790|NCT01263938|12292125|FG000|STARTED|Overall Study||5
11107791|NCT01263938|12292125|FG000|COMPLETED|Overall Study||5
11107792|NCT01263938|12292125|FG000|NOT COMPLETED|Overall Study||0
11107793|NCT01264016|12292130|FG000|STARTED|Overall Study||96
11107794|NCT01264016|12292130|FG000|COMPLETED|Overall Study||94
11107795|NCT01264016|12292130|FG000|NOT COMPLETED|Overall Study||2
11107796|NCT01264081|12292135|FG000|STARTED|Participants Screened||34
11227539|NCT02003573|12419602|FG002|COMPLETED|Overall Study||0
11227540|NCT02003573|12419600|FG000|NOT COMPLETED|Overall Study||3
11227541|NCT02003573|12419601|FG001|NOT COMPLETED|Overall Study||4
11227542|NCT02003573|12419602|FG002|NOT COMPLETED|Overall Study||6
11227543|NCT02003625|12419614|FG000|STARTED|Overall Study||15
11227544|NCT02003625|12419615|FG001|STARTED|Overall Study||15
11227545|NCT02003625|12419614|FG000|Received Transplant|Overall Study||14
11227546|NCT02003625|12419615|FG001|Received Transplant|Overall Study||12
11227547|NCT02003625|12419614|FG000|COMPLETED|Overall Study||14
11227548|NCT02003625|12419615|FG001|COMPLETED|Overall Study||12
11227549|NCT02003625|12419614|FG000|NOT COMPLETED|Overall Study||1
11227550|NCT02003625|12419615|FG001|NOT COMPLETED|Overall Study||3
11227551|NCT02003638|12419623|FG000|STARTED|Overall Study||6
11227552|NCT02003638|12419624|FG001|STARTED|Overall Study||3
11227553|NCT02003638|12419623|FG000|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
11227554|NCT02003638|12419624|FG001|COMPLETED|Overall Study||3
11227555|NCT02003638|12419623|FG000|NOT COMPLETED|Overall Study||1
11227556|NCT02003638|12419624|FG001|NOT COMPLETED|Overall Study||0
11227557|NCT02003898|12419630|FG000|STARTED|Overall Study||372
11227558|NCT02003898|12419630|FG000|COMPLETED|Overall Study||305
11227559|NCT02003898|12419630|FG000|NOT COMPLETED|Overall Study||67
11227560|NCT02003911|12419636|FG000|STARTED|Overall Study||80
11227561|NCT02003911|12419637|FG001|STARTED|Overall Study||79
11107797|NCT01264081|12292135|FG000|COMPLETED|Participants Screened||4
11107798|NCT01264081|12292135|FG000|NOT COMPLETED|Participants Screened||30
11107799|NCT01264081|12292135|FG000|STARTED|Started Treatment||4
11107800|NCT01264081|12292135|FG000|COMPLETED|Started Treatment||2
11107801|NCT01264081|12292135|FG000|NOT COMPLETED|Started Treatment||2
11107802|NCT01264081|12292135|FG000|STARTED|Analysis||2
11107803|NCT01264081|12292135|FG000|COMPLETED|Analysis||2
11107804|NCT01264081|12292135|FG000|NOT COMPLETED|Analysis||0
11107805|NCT01264380|12292139|FG000|STARTED|Period A||8
11107806|NCT01264380|12292140|FG001|STARTED|Period A||8
11107807|NCT01264380|12292141|FG002|STARTED|Period A||0
11227562|NCT02003911|12419636|FG000|COMPLETED|Overall Study||78
11227563|NCT02003911|12419637|FG001|COMPLETED|Overall Study||72
11227564|NCT02003911|12419636|FG000|NOT COMPLETED|Overall Study||2
11227565|NCT02003911|12419637|FG001|NOT COMPLETED|Overall Study||7
11227566|NCT02003963|12419645|FG000|STARTED|Overall Study||22
11227567|NCT02003963|12419646|FG001|STARTED|Overall Study||19
11227568|NCT02003963|12419645|FG000|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
11227569|NCT02003963|12419646|FG001|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
11227570|NCT02003963|12419645|FG000|NOT COMPLETED|Overall Study||2
11227571|NCT02003963|12419646|FG001|NOT COMPLETED|Overall Study||1
11107808|NCT01264380|12292139|FG000|COMPLETED|Period A||8
11107809|NCT01264380|12292140|FG001|COMPLETED|Period A||8
11227572|NCT02004093|12419656|FG000|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
11227573|NCT02004093|12419657|FG001|STARTED|Overall Study||74
11227574|NCT02004093|12419656|FG000|COMPLETED|Overall Study||1
11227575|NCT02004093|12419657|FG001|COMPLETED|Overall Study||1
11227576|NCT02004093|12419656|FG000|NOT COMPLETED|Overall Study||74
11227577|NCT02004093|12419657|FG001|NOT COMPLETED|Overall Study||73
10861712|NCT01670500|12026813|FG001|COMPLETED|Overall Study|4 pts received <4 cycles of assigned chemo; 2 pts received add'l non-protocol chemo before surgery|60
10861713|NCT01670500|12026812|FG000|NOT COMPLETED|Overall Study||1
10861714|NCT01670500|12026813|FG001|NOT COMPLETED|Overall Study||0
11107810|NCT01264380|12292141|FG002|COMPLETED|Period A||0
11107811|NCT01264380|12292139|FG000|NOT COMPLETED|Period A||0
11107812|NCT01264380|12292140|FG001|NOT COMPLETED|Period A||0
11107813|NCT01264380|12292141|FG002|NOT COMPLETED|Period A||0
11107814|NCT01264380|12292139|FG000|STARTED|Period B||8
11107815|NCT01264380|12292140|FG001|STARTED|Period B||8
11107816|NCT01264380|12292141|FG002|STARTED|Period B||0
11107817|NCT01264380|12292139|FG000|COMPLETED|Period B||8
11107818|NCT01264380|12292140|FG001|COMPLETED|Period B||8
11107819|NCT01264380|12292141|FG002|COMPLETED|Period B||0
11107820|NCT01264380|12292139|FG000|NOT COMPLETED|Period B||0
11107821|NCT01264380|12292140|FG001|NOT COMPLETED|Period B||0
11107822|NCT01264380|12292141|FG002|NOT COMPLETED|Period B||0
11107823|NCT01264380|12292139|FG000|STARTED|Period C||0
10861729|NCT01453101|12026829|FG000|STARTED|Overall Study||54
10861730|NCT01453101|12026829|FG000|COMPLETED|Overall Study||54
10861731|NCT01453101|12026829|FG000|NOT COMPLETED|Overall Study||0
10861732|NCT04604184|12026835|FG000|STARTED|Overall Study||67
10861733|NCT04604184|12026836|FG001|STARTED|Overall Study||66
10861734|NCT04604184|12026835|FG000|Treated|Overall Study||65
10861735|NCT04604184|12026836|FG001|Treated|Overall Study||64
10861736|NCT04604184|12026835|FG000|COMPLETED|Overall Study||47
10861737|NCT04604184|12026836|FG001|COMPLETED|Overall Study||47
10861738|NCT04604184|12026835|FG000|NOT COMPLETED|Overall Study||20
10861739|NCT04604184|12026836|FG001|NOT COMPLETED|Overall Study||19
10861757|NCT03688555|12026865|FG000|STARTED|Run-in Period||10
10861758|NCT03688555|12026866|FG001|STARTED|Run-in Period||0
10861759|NCT03688555|12026867|FG002|STARTED|Run-in Period||0
10861760|NCT03688555|12026865|FG000|COMPLETED|Run-in Period||10
10861761|NCT03688555|12026866|FG001|COMPLETED|Run-in Period||0
10861762|NCT03688555|12026867|FG002|COMPLETED|Run-in Period||0
10861763|NCT03688555|12026865|FG000|NOT COMPLETED|Run-in Period||0
10861764|NCT03688555|12026866|FG001|NOT COMPLETED|Run-in Period||0
10861765|NCT03688555|12026867|FG002|NOT COMPLETED|Run-in Period||0
10861766|NCT03688555|12026865|FG000|STARTED|Treatment Period|All 10 participants that completed the run-in period were eligible to be randomized to ACT-774312 or placebo.|0
10861767|NCT03688555|12026866|FG001|STARTED|Treatment Period||7
10861768|NCT03688555|12026867|FG002|STARTED|Treatment Period||3
10861769|NCT03688555|12026865|FG000|COMPLETED|Treatment Period||0
10861770|NCT03688555|12026866|FG001|COMPLETED|Treatment Period||7
10861771|NCT03688555|12026867|FG002|COMPLETED|Treatment Period||2
10861772|NCT03688555|12026865|FG000|NOT COMPLETED|Treatment Period||0
10861773|NCT03688555|12026866|FG001|NOT COMPLETED|Treatment Period||0
10861774|NCT03688555|12026867|FG002|NOT COMPLETED|Treatment Period||1
10861775|NCT03593213|12026877|FG000|STARTED|Open-label Treatment Period (18 Weeks)|Out of 162 participants who completed Open-label Treatment Period, 159 participants were randomized to Double-blind treatment Period.|587
10861776|NCT03593213|12026878|FG001|STARTED|Open-label Treatment Period (18 Weeks)||0
10861777|NCT03593213|12026879|FG002|STARTED|Open-label Treatment Period (18 Weeks)||0
10861778|NCT03593213|12026880|FG003|STARTED|Open-label Treatment Period (18 Weeks)||0
10861779|NCT03593213|12026877|FG000|COMPLETED|Open-label Treatment Period (18 Weeks)||162
10861780|NCT03593213|12026878|FG001|COMPLETED|Open-label Treatment Period (18 Weeks)||0
10861781|NCT03593213|12026879|FG002|COMPLETED|Open-label Treatment Period (18 Weeks)||0
10861782|NCT03593213|12026880|FG003|COMPLETED|Open-label Treatment Period (18 Weeks)||0
10861783|NCT03593213|12026877|FG000|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||425
10861784|NCT03593213|12026878|FG001|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
10861785|NCT03593213|12026879|FG002|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
10861786|NCT03593213|12026880|FG003|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
10861787|NCT03593213|12026877|FG000|STARTED|Double-blind Treatment Period (26 Weeks)||0
10861788|NCT03593213|12026878|FG001|STARTED|Double-blind Treatment Period (26 Weeks)||54
10861789|NCT03593213|12026879|FG002|STARTED|Double-blind Treatment Period (26 Weeks)||49
10861790|NCT03593213|12026880|FG003|STARTED|Double-blind Treatment Period (26 Weeks)||56
11107824|NCT01264380|12292140|FG001|STARTED|Period C||0
11107825|NCT01264380|12292141|FG002|STARTED|Period C||16
10861791|NCT03593213|12026877|FG000|Safety Population|Double-blind Treatment Period (26 Weeks)||0
10861792|NCT03593213|12026878|FG001|Safety Population|Double-blind Treatment Period (26 Weeks)||53
10861793|NCT03593213|12026879|FG002|Safety Population|Double-blind Treatment Period (26 Weeks)||49
10861794|NCT03593213|12026880|FG003|Safety Population|Double-blind Treatment Period (26 Weeks)||54
10861795|NCT03593213|12026877|FG000|COMPLETED|Double-blind Treatment Period (26 Weeks)||0
10861796|NCT03593213|12026878|FG001|COMPLETED|Double-blind Treatment Period (26 Weeks)||14
10861797|NCT03593213|12026879|FG002|COMPLETED|Double-blind Treatment Period (26 Weeks)||16
10861798|NCT03593213|12026880|FG003|COMPLETED|Double-blind Treatment Period (26 Weeks)||21
11227578|NCT02004132|12419666|FG000|STARTED|Overall Study||12
11227579|NCT02004132|12419666|FG000|Received Study Drug|Overall Study||12
11227580|NCT02004132|12419666|FG000|COMPLETED|Overall Study||12
10861799|NCT03593213|12026877|FG000|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||0
11227581|NCT02004132|12419666|FG000|NOT COMPLETED|Overall Study||0
11227582|NCT02004158|12419670|FG000|STARTED|Overall Study||23
11227583|NCT02004158|12419670|FG000|COMPLETED|Overall Study||20
11227584|NCT02004158|12419670|FG000|NOT COMPLETED|Overall Study||3
10861800|NCT03593213|12026878|FG001|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||40
10861801|NCT03593213|12026879|FG002|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||33
10861802|NCT03593213|12026880|FG003|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||35
10861803|NCT03349723|12026901|FG000|STARTED|Overall Study||6
10861804|NCT03349723|12026902|FG001|STARTED|Overall Study||6
10861805|NCT03349723|12026903|FG002|STARTED|Overall Study||6
10861806|NCT03349723|12026904|FG003|STARTED|Overall Study||6
10861807|NCT03349723|12026905|FG004|STARTED|Overall Study||6
10861808|NCT03349723|12026906|FG005|STARTED|Overall Study||6
10861809|NCT03349723|12026907|FG006|STARTED|Overall Study||6
10861810|NCT03349723|12026908|FG007|STARTED|Overall Study||14
10861811|NCT03349723|12026901|FG000|COMPLETED|Overall Study||6
10861812|NCT03349723|12026902|FG001|COMPLETED|Overall Study||6
10861813|NCT03349723|12026903|FG002|COMPLETED|Overall Study||6
10861814|NCT03349723|12026904|FG003|COMPLETED|Overall Study||6
10861815|NCT03349723|12026905|FG004|COMPLETED|Overall Study||6
10861816|NCT03349723|12026906|FG005|COMPLETED|Overall Study||6
10861817|NCT03349723|12026907|FG006|COMPLETED|Overall Study||6
10861818|NCT03349723|12026908|FG007|COMPLETED|Overall Study||14
10861819|NCT03349723|12026901|FG000|NOT COMPLETED|Overall Study||0
10861820|NCT03349723|12026902|FG001|NOT COMPLETED|Overall Study||0
10861821|NCT03349723|12026903|FG002|NOT COMPLETED|Overall Study||0
11227585|NCT02004236|12419679|FG000|STARTED|Overall Study||75
10861740|NCT04368429|12026844|FG000|STARTED|Overall Study||180
10861741|NCT04368429|12026845|FG001|STARTED|Overall Study||180
10861742|NCT04368429|12026844|FG000|Safety Analysis Set|Overall Study||179
10861743|NCT04368429|12026845|FG001|Safety Analysis Set|Overall Study||180
10861744|NCT04368429|12026844|FG000|COMPLETED|Overall Study||179
10861745|NCT04368429|12026845|FG001|COMPLETED|Overall Study||180
10861746|NCT04368429|12026844|FG000|NOT COMPLETED|Overall Study||1
10861747|NCT04368429|12026845|FG001|NOT COMPLETED|Overall Study||0
10861748|NCT04266158|12026851|FG000|STARTED|Overall Study||0
10861749|NCT04266158|12026851|FG000|COMPLETED|Overall Study||0
10861750|NCT04266158|12026851|FG000|NOT COMPLETED|Overall Study||0
10861751|NCT04155840|12026855|FG000|STARTED|Overall Study||1
10861752|NCT04155840|12026855|FG000|COMPLETED|Overall Study||1
10861753|NCT04155840|12026855|FG000|NOT COMPLETED|Overall Study||0
10861754|NCT03865316|12026859|FG000|STARTED|Overall Study||108
10861755|NCT03865316|12026859|FG000|COMPLETED|Overall Study||100
10861756|NCT03865316|12026859|FG000|NOT COMPLETED|Overall Study||8
10861822|NCT03349723|12026904|FG003|NOT COMPLETED|Overall Study||0
10861823|NCT03349723|12026905|FG004|NOT COMPLETED|Overall Study||0
10861824|NCT03349723|12026906|FG005|NOT COMPLETED|Overall Study||0
10861825|NCT03349723|12026907|FG006|NOT COMPLETED|Overall Study||0
10861826|NCT03349723|12026908|FG007|NOT COMPLETED|Overall Study||0
10861827|NCT03248531|12026929|FG000|STARTED|Overall Study||22
10861828|NCT03248531|12026930|FG001|STARTED|Overall Study||22
10861829|NCT03248531|12026931|FG002|STARTED|Overall Study||46
10861830|NCT03248531|12026929|FG000|Completed Week 12|Overall Study||19
10861831|NCT03248531|12026930|FG001|Completed Week 12|Overall Study||18
10861832|NCT03248531|12026931|FG002|Completed Week 12|Overall Study||42
10861833|NCT03248531|12026929|FG000|COMPLETED|Overall Study||18
10861834|NCT03248531|12026930|FG001|COMPLETED|Overall Study||17
10861835|NCT03248531|12026931|FG002|COMPLETED|Overall Study||38
10861836|NCT03248531|12026929|FG000|NOT COMPLETED|Overall Study||4
10861837|NCT03248531|12026930|FG001|NOT COMPLETED|Overall Study||5
10861838|NCT03248531|12026931|FG002|NOT COMPLETED|Overall Study||8
10861839|NCT03205605|12026946|FG000|STARTED|Overall Study||13
10861840|NCT03205605|12026946|FG000|COMPLETED|Overall Study||12
10861841|NCT03205605|12026946|FG000|NOT COMPLETED|Overall Study||1
10861842|NCT02556736|12026956|FG000|STARTED|Overall Study||14
10861843|NCT02556736|12026956|FG000|COMPLETED|Overall Study||14
10861844|NCT02556736|12026956|FG000|NOT COMPLETED|Overall Study||0
10861845|NCT02484456|12026962|FG000|STARTED|First Treatment Period: Week 1||10
10861846|NCT02484456|12026963|FG001|STARTED|First Treatment Period: Week 1||9
10861847|NCT02484456|12026962|FG000|COMPLETED|First Treatment Period: Week 1||10
10861848|NCT02484456|12026963|FG001|COMPLETED|First Treatment Period: Week 1||9
10861849|NCT02484456|12026962|FG000|NOT COMPLETED|First Treatment Period: Week 1||0
10861850|NCT02484456|12026963|FG001|NOT COMPLETED|First Treatment Period: Week 1||0
10861851|NCT02484456|12026962|FG000|STARTED|First Treatment Period: Week 2||10
10861852|NCT02484456|12026963|FG001|STARTED|First Treatment Period: Week 2||9
11227586|NCT02004236|12419680|FG001|STARTED|Overall Study||75
10861853|NCT02484456|12026962|FG000|COMPLETED|First Treatment Period: Week 2||10
10861854|NCT02484456|12026963|FG001|COMPLETED|First Treatment Period: Week 2||9
10861855|NCT02484456|12026962|FG000|NOT COMPLETED|First Treatment Period: Week 2||0
10861856|NCT02484456|12026963|FG001|NOT COMPLETED|First Treatment Period: Week 2||0
10861857|NCT02484456|12026962|FG000|STARTED|Washout Period||10
10861858|NCT02484456|12026963|FG001|STARTED|Washout Period||9
10861859|NCT02484456|12026962|FG000|COMPLETED|Washout Period||10
10861860|NCT02484456|12026963|FG001|COMPLETED|Washout Period||8
10861861|NCT02484456|12026962|FG000|NOT COMPLETED|Washout Period||0
10861862|NCT02484456|12026963|FG001|NOT COMPLETED|Washout Period||1
10861863|NCT02484456|12026962|FG000|STARTED|Second Treatment Period: Week 1||10
10861864|NCT02484456|12026963|FG001|STARTED|Second Treatment Period: Week 1||8
10861865|NCT02484456|12026962|FG000|COMPLETED|Second Treatment Period: Week 1||9
10861866|NCT02484456|12026963|FG001|COMPLETED|Second Treatment Period: Week 1||7
10861867|NCT02484456|12026962|FG000|NOT COMPLETED|Second Treatment Period: Week 1||1
10861868|NCT02484456|12026963|FG001|NOT COMPLETED|Second Treatment Period: Week 1||1
10861869|NCT02484456|12026962|FG000|STARTED|Second Treatment Period: Week 2||9
10861870|NCT02484456|12026963|FG001|STARTED|Second Treatment Period: Week 2||7
10861871|NCT02484456|12026962|FG000|COMPLETED|Second Treatment Period: Week 2||9
10861872|NCT02484456|12026963|FG001|COMPLETED|Second Treatment Period: Week 2||6
10861873|NCT02484456|12026962|FG000|NOT COMPLETED|Second Treatment Period: Week 2||0
10861874|NCT02484456|12026963|FG001|NOT COMPLETED|Second Treatment Period: Week 2||1
11107826|NCT01264380|12292139|FG000|COMPLETED|Period C||0
11107827|NCT01264380|12292140|FG001|COMPLETED|Period C||0
11107828|NCT01264380|12292141|FG002|COMPLETED|Period C||2
11107829|NCT01264380|12292139|FG000|NOT COMPLETED|Period C||0
11107830|NCT01264380|12292140|FG001|NOT COMPLETED|Period C||0
11107831|NCT01264380|12292141|FG002|NOT COMPLETED|Period C||14
11107832|NCT01264419|12292149|FG000|STARTED|Overall Study||75
10861881|NCT02234323|12026979|FG000|STARTED|All Enrolled||108
10861882|NCT02234323|12026979|FG000|COMPLETED|All Enrolled|These participants received at least one dose of study drug.|103
10861883|NCT02234323|12026979|FG000|NOT COMPLETED|All Enrolled||5
10861884|NCT02234323|12026979|FG000|STARTED|All Treated||103
10861885|NCT02234323|12026979|FG000|Episodic Treatment Regimen|All Treated|Participants were treated in more than one regimen and counted in all categories wherever applicable|81
10861886|NCT02234323|12026979|FG000|Prophylactic Treatment Regimen|All Treated|69 participants among the 81 who started in episodic regimen, switched to the prophylactic regimen.|89
10861887|NCT02234323|12026979|FG000|Immune Tolerance Induction (ITI)|All Treated|1/81 on episodic and 14/89 on prophylactic regimen had inhibitors and were switched directly to ITI.|15
10861888|NCT02234323|12026979|FG000|COMPLETED|All Treated||85
10861889|NCT02234323|12026979|FG000|NOT COMPLETED|All Treated||18
10861890|NCT02220855|12026985|FG000|STARTED|Overall Study||14
10861891|NCT02220855|12026985|FG000|COMPLETED|Overall Study||0
10861892|NCT02220855|12026985|FG000|NOT COMPLETED|Overall Study||14
10861893|NCT01791595|12026996|FG000|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||3
10861894|NCT01791595|12026997|FG001|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861895|NCT01791595|12026998|FG002|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861896|NCT01791595|12026999|FG003|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861897|NCT01791595|12027000|FG004|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861898|NCT01791595|12027001|FG005|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861899|NCT01791595|12027002|FG006|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861900|NCT01791595|12026996|FG000|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861901|NCT01791595|12026997|FG001|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861902|NCT01791595|12026998|FG002|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861903|NCT01791595|12026999|FG003|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861904|NCT01791595|12027000|FG004|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861905|NCT01791595|12027001|FG005|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861906|NCT01791595|12027002|FG006|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861907|NCT01791595|12026996|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||3
10861908|NCT01791595|12026997|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861909|NCT01791595|12026998|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861910|NCT01791595|12026999|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861911|NCT01791595|12027000|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861912|NCT01791595|12027001|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861913|NCT01791595|12027002|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
10861914|NCT01791595|12026996|FG000|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861915|NCT01791595|12026997|FG001|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||5
10861916|NCT01791595|12026998|FG002|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861917|NCT01791595|12026999|FG003|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
11107833|NCT01264419|12292149|FG000|COMPLETED|Overall Study||72
11107834|NCT01264419|12292149|FG000|NOT COMPLETED|Overall Study||3
11107835|NCT01264601|12292155|FG000|STARTED|Overall Study||17
11107836|NCT01264601|12292156|FG001|STARTED|Overall Study||14
11107837|NCT01264601|12292155|FG000|COMPLETED|Overall Study||17
11107838|NCT01264601|12292156|FG001|COMPLETED|Overall Study||14
11107839|NCT01264601|12292155|FG000|NOT COMPLETED|Overall Study||0
11107840|NCT01264601|12292156|FG001|NOT COMPLETED|Overall Study||0
11107841|NCT01264614|12292164|FG000|STARTED|Overall Study||13
11107842|NCT01264614|12292165|FG001|STARTED|Overall Study||9
11107843|NCT01264614|12292164|FG000|COMPLETED|Overall Study||12
11107844|NCT01264614|12292165|FG001|COMPLETED|Overall Study||7
11107845|NCT01264614|12292164|FG000|NOT COMPLETED|Overall Study||1
11107846|NCT01264614|12292165|FG001|NOT COMPLETED|Overall Study||2
11107847|NCT01264705|12292174|FG000|STARTED|Overall Study||3
11107848|NCT01264705|12292175|FG001|STARTED|Overall Study||3
11107849|NCT01264705|12292176|FG002|STARTED|Overall Study||41
11107850|NCT01264705|12292174|FG000|COMPLETED|Overall Study||3
11107851|NCT01264705|12292175|FG001|COMPLETED|Overall Study||3
11107852|NCT01264705|12292176|FG002|COMPLETED|Overall Study||41
11107853|NCT01264705|12292174|FG000|NOT COMPLETED|Overall Study||0
11107854|NCT01264705|12292175|FG001|NOT COMPLETED|Overall Study||0
11107855|NCT01264705|12292176|FG002|NOT COMPLETED|Overall Study||0
11107856|NCT01264718|12292189|FG000|STARTED|Overall Study||172
11107857|NCT01264718|12292190|FG001|STARTED|Overall Study||157
11107858|NCT01264718|12292189|FG000|COMPLETED|Overall Study||123
11107859|NCT01264718|12292190|FG001|COMPLETED|Overall Study||114
11107860|NCT01264718|12292189|FG000|NOT COMPLETED|Overall Study||49
11107861|NCT01264718|12292190|FG001|NOT COMPLETED|Overall Study||43
11107862|NCT01264770|12292202|FG000|STARTED|Overall Study|Patients who received treatment|54
11107863|NCT01264770|12292203|FG001|STARTED|Overall Study|Patients who received treatment|48
11107864|NCT01264770|12292204|FG002|STARTED|Overall Study|Patients who received treatment|57
11107865|NCT01264770|12292205|FG003|STARTED|Overall Study|Patients who received treatment|54
11107866|NCT01264770|12292206|FG004|STARTED|Overall Study|Patients who received treatment|27
11107867|NCT01264770|12292207|FG005|STARTED|Overall Study|Patients who received treatment|25
11227587|NCT02004236|12419681|FG002|STARTED|Overall Study||75
11107868|NCT01264770|12292202|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
11107869|NCT01264770|12292203|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
11107870|NCT01264770|12292204|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
11107871|NCT01264770|12292205|FG003|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
10861918|NCT01791595|12027000|FG004|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861919|NCT01791595|12027001|FG005|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861920|NCT01791595|12027002|FG006|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861921|NCT01791595|12026996|FG000|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861922|NCT01791595|12026997|FG001|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861923|NCT01791595|12026998|FG002|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861924|NCT01791595|12026999|FG003|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861925|NCT01791595|12027000|FG004|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861926|NCT01791595|12027001|FG005|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861927|NCT01791595|12027002|FG006|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861928|NCT01791595|12026996|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861929|NCT01791595|12026997|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||5
10861930|NCT01791595|12026998|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861931|NCT01791595|12026999|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861932|NCT01791595|12027000|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861933|NCT01791595|12027001|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861934|NCT01791595|12027002|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
10861935|NCT01791595|12026996|FG000|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861936|NCT01791595|12026997|FG001|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861937|NCT01791595|12026998|FG002|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||8
10861938|NCT01791595|12026999|FG003|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861939|NCT01791595|12027000|FG004|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861940|NCT01791595|12027001|FG005|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861941|NCT01791595|12027002|FG006|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861942|NCT01791595|12026996|FG000|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861943|NCT01791595|12026997|FG001|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861944|NCT01791595|12026998|FG002|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861945|NCT01791595|12026999|FG003|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861946|NCT01791595|12027000|FG004|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861947|NCT01791595|12027001|FG005|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861948|NCT01791595|12027002|FG006|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861949|NCT01791595|12026996|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861950|NCT01791595|12026997|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861951|NCT01791595|12026998|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||8
10861952|NCT01791595|12026999|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861953|NCT01791595|12027000|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861954|NCT01791595|12027001|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861955|NCT01791595|12027002|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
10861956|NCT01791595|12026996|FG000|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861957|NCT01791595|12026997|FG001|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861958|NCT01791595|12026998|FG002|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861959|NCT01791595|12026999|FG003|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||5
10861960|NCT01791595|12027000|FG004|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861961|NCT01791595|12027001|FG005|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861962|NCT01791595|12027002|FG006|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861963|NCT01791595|12026996|FG000|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861964|NCT01791595|12026997|FG001|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861965|NCT01791595|12026998|FG002|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861966|NCT01791595|12026999|FG003|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||1
10861967|NCT01791595|12027000|FG004|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861968|NCT01791595|12027001|FG005|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861969|NCT01791595|12027002|FG006|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861970|NCT01791595|12026996|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861971|NCT01791595|12026997|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861972|NCT01791595|12026998|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861973|NCT01791595|12026999|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||4
10861974|NCT01791595|12027000|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861975|NCT01791595|12027001|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861976|NCT01791595|12027002|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
10861977|NCT01791595|12026996|FG000|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861978|NCT01791595|12026997|FG001|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861979|NCT01791595|12026998|FG002|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861980|NCT01791595|12026999|FG003|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861981|NCT01791595|12027000|FG004|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||11
10861982|NCT01791595|12027001|FG005|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861983|NCT01791595|12027002|FG006|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861984|NCT01791595|12026996|FG000|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861985|NCT01791595|12026997|FG001|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861986|NCT01791595|12026998|FG002|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
11107872|NCT01264770|12292206|FG004|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
11107873|NCT01264770|12292207|FG005|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
11107874|NCT01264770|12292202|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
11107875|NCT01264770|12292203|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
11107876|NCT01264770|12292204|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
11107877|NCT01264770|12292205|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
11107878|NCT01264770|12292206|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
10861987|NCT01791595|12026999|FG003|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861988|NCT01791595|12027000|FG004|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861989|NCT01791595|12027001|FG005|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861990|NCT01791595|12027002|FG006|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861991|NCT01791595|12026996|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861992|NCT01791595|12026997|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861993|NCT01791595|12026998|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861994|NCT01791595|12026999|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861995|NCT01791595|12027000|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||11
10861996|NCT01791595|12027001|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861997|NCT01791595|12027002|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
10861998|NCT01791595|12026996|FG000|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10861999|NCT01791595|12026997|FG001|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862000|NCT01791595|12026998|FG002|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862001|NCT01791595|12026999|FG003|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862002|NCT01791595|12027000|FG004|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862003|NCT01791595|12027001|FG005|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||8
10862004|NCT01791595|12027002|FG006|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862005|NCT01791595|12026996|FG000|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862006|NCT01791595|12026997|FG001|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862007|NCT01791595|12026998|FG002|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862008|NCT01791595|12026999|FG003|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862009|NCT01791595|12027000|FG004|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862010|NCT01791595|12027001|FG005|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862011|NCT01791595|12027002|FG006|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862012|NCT01791595|12026996|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862013|NCT01791595|12026997|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862014|NCT01791595|12026998|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862015|NCT01791595|12026999|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862016|NCT01791595|12027000|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862017|NCT01791595|12027001|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||8
10862018|NCT01791595|12027002|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
10862019|NCT01791595|12026996|FG000|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862020|NCT01791595|12026997|FG001|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
11227588|NCT02004236|12419679|FG000|COMPLETED|Overall Study||75
11227589|NCT02004236|12419680|FG001|COMPLETED|Overall Study||75
11227590|NCT02004236|12419681|FG002|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
11227591|NCT02004236|12419679|FG000|NOT COMPLETED|Overall Study||0
11227592|NCT02004236|12419680|FG001|NOT COMPLETED|Overall Study||0
11227593|NCT02004236|12419681|FG002|NOT COMPLETED|Overall Study||16
11227594|NCT02004262|12419696|FG000|STARTED|Overall Study||73
10862021|NCT01791595|12026998|FG002|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862022|NCT01791595|12026999|FG003|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
11107879|NCT01264770|12292207|FG005|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
11107880|NCT01264770|12292202|FG000|NOT COMPLETED|Overall Study||18
10862023|NCT01791595|12027000|FG004|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862024|NCT01791595|12027001|FG005|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862025|NCT01791595|12027002|FG006|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||11
10862026|NCT01791595|12026996|FG000|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862027|NCT01791595|12026997|FG001|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862028|NCT01791595|12026998|FG002|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862029|NCT01791595|12026999|FG003|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862030|NCT01791595|12027000|FG004|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862031|NCT01791595|12027001|FG005|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862032|NCT01791595|12027002|FG006|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||1
11227595|NCT02004262|12419697|FG001|STARTED|Overall Study||68
11227596|NCT02004262|12419698|FG002|STARTED|Overall Study||72
11227597|NCT02004262|12419699|FG003|STARTED|Overall Study||29
11227598|NCT02004262|12419700|FG004|STARTED|Overall Study||31
11227599|NCT02004262|12419701|FG005|STARTED|Overall Study||30
11227600|NCT02004262|12419696|FG000|Treated|Overall Study||68
11227601|NCT02004262|12419697|FG001|Treated|Overall Study||58
10862033|NCT01791595|12026996|FG000|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862034|NCT01791595|12026997|FG001|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862035|NCT01791595|12026998|FG002|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862036|NCT01791595|12026999|FG003|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
11227602|NCT02004262|12419698|FG002|Treated|Overall Study||43
11227603|NCT02004262|12419699|FG003|Treated|Overall Study||26
10862037|NCT01791595|12027000|FG004|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862038|NCT01791595|12027001|FG005|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
10862039|NCT01791595|12027002|FG006|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||10
10862040|NCT01192776|12027026|FG000|STARTED|Overall Study||95
10862041|NCT01192776|12027027|FG001|STARTED|Overall Study||90
10862042|NCT01192776|12027028|FG002|STARTED|Overall Study||96
10862043|NCT01192776|12027029|FG003|STARTED|Overall Study||83
10862044|NCT01192776|12027026|FG000|Died Prior to Discharge|Overall Study||7
10862045|NCT01192776|12027027|FG001|Died Prior to Discharge|Overall Study||13
10862046|NCT01192776|12027028|FG002|Died Prior to Discharge|Overall Study||15
10862047|NCT01192776|12027029|FG003|Died Prior to Discharge|Overall Study||14
10862048|NCT01192776|12027026|FG000|Died After Discharge|Overall Study||1
10862049|NCT01192776|12027027|FG001|Died After Discharge|Overall Study||2
10862050|NCT01192776|12027028|FG002|Died After Discharge|Overall Study||3
10862051|NCT01192776|12027029|FG003|Died After Discharge|Overall Study||1
10862052|NCT01192776|12027026|FG000|COMPLETED|Overall Study||84
10862053|NCT01192776|12027027|FG001|COMPLETED|Overall Study||69
10862054|NCT01192776|12027028|FG002|COMPLETED|Overall Study||75
10862055|NCT01192776|12027029|FG003|COMPLETED|Overall Study||63
10862056|NCT01192776|12027026|FG000|NOT COMPLETED|Overall Study||11
10862057|NCT01192776|12027027|FG001|NOT COMPLETED|Overall Study||21
10862058|NCT01192776|12027028|FG002|NOT COMPLETED|Overall Study||21
10862059|NCT01192776|12027029|FG003|NOT COMPLETED|Overall Study||20
11107881|NCT01264770|12292203|FG001|NOT COMPLETED|Overall Study||10
11107882|NCT01264770|12292204|FG002|NOT COMPLETED|Overall Study||16
11107883|NCT01264770|12292205|FG003|NOT COMPLETED|Overall Study||6
11107884|NCT01264770|12292206|FG004|NOT COMPLETED|Overall Study||8
11107885|NCT01264770|12292207|FG005|NOT COMPLETED|Overall Study||6
11107886|NCT01264887|12292227|FG000|STARTED|Overall Study||31
11227604|NCT02004262|12419700|FG004|Treated|Overall Study||29
11227605|NCT02004262|12419701|FG005|Treated|Overall Study||11
11227606|NCT02004262|12419696|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
11227607|NCT02004262|12419697|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
11227608|NCT02004262|12419698|FG002|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
11227609|NCT02004262|12419699|FG003|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
11227610|NCT02004262|12419700|FG004|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
11107887|NCT01264887|12292227|FG000|COMPLETED|Overall Study||0
11107888|NCT01264887|12292227|FG000|NOT COMPLETED|Overall Study||31
11107889|NCT01264939|12292235|FG000|STARTED|Overall Study||84
11107890|NCT01264939|12292236|FG001|STARTED|Overall Study||252
11107891|NCT01264939|12292235|FG000|COMPLETED|Overall Study||66
11107892|NCT01264939|12292236|FG001|COMPLETED|Overall Study||224
11107893|NCT01264939|12292235|FG000|NOT COMPLETED|Overall Study||18
11107894|NCT01264939|12292236|FG001|NOT COMPLETED|Overall Study||28
11107895|NCT01264952|12292245|FG000|STARTED|Overall Study||6
11107896|NCT01264952|12292246|FG001|STARTED|Overall Study||2
11107897|NCT01264952|12292247|FG002|STARTED|Overall Study||8
11107898|NCT01264952|12292245|FG000|COMPLETED|Overall Study||6
11107899|NCT01264952|12292246|FG001|COMPLETED|Overall Study||2
11107900|NCT01264952|12292247|FG002|COMPLETED|Overall Study||8
11107901|NCT01264952|12292245|FG000|NOT COMPLETED|Overall Study||0
11107902|NCT01264952|12292246|FG001|NOT COMPLETED|Overall Study||0
11107903|NCT01264952|12292247|FG002|NOT COMPLETED|Overall Study||0
11107904|NCT01265056|12292257|FG000|STARTED|Initial Study Period||26
11107905|NCT01265056|12292258|FG001|STARTED|Initial Study Period||27
11107906|NCT01265056|12292257|FG000|COMPLETED|Initial Study Period||24
11107907|NCT01265056|12292258|FG001|COMPLETED|Initial Study Period||25
11107908|NCT01265056|12292257|FG000|NOT COMPLETED|Initial Study Period||2
11227611|NCT02004262|12419701|FG005|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
11227612|NCT02004262|12419696|FG000|NOT COMPLETED|Overall Study||73
11227613|NCT02004262|12419697|FG001|NOT COMPLETED|Overall Study||68
11227614|NCT02004262|12419698|FG002|NOT COMPLETED|Overall Study||72
11227615|NCT02004262|12419699|FG003|NOT COMPLETED|Overall Study||29
11227616|NCT02004262|12419700|FG004|NOT COMPLETED|Overall Study||31
11227617|NCT02004262|12419701|FG005|NOT COMPLETED|Overall Study||30
11227618|NCT02004288|12419717|FG000|STARTED|Overall Study||15
11227619|NCT02004288|12419718|FG001|STARTED|Overall Study||16
11227620|NCT02004288|12419717|FG000|COMPLETED|Overall Study||14
11227621|NCT02004288|12419718|FG001|COMPLETED|Overall Study||15
11227622|NCT02004288|12419717|FG000|NOT COMPLETED|Overall Study||1
11227623|NCT02004288|12419718|FG001|NOT COMPLETED|Overall Study||1
11227624|NCT02004353|12419724|FG000|STARTED|Overall Study||1518
11227625|NCT02004353|12419724|FG000|COMPLETED|Overall Study||184
11227626|NCT02004353|12419724|FG000|NOT COMPLETED|Overall Study||1334
11227627|NCT02004366|12419733|FG000|STARTED|In-hospital||128
11107909|NCT01265056|12292258|FG001|NOT COMPLETED|Initial Study Period||2
11107910|NCT01265056|12292257|FG000|STARTED|Follow up||26
11107911|NCT01265056|12292258|FG001|STARTED|Follow up||27
11107912|NCT01265056|12292257|FG000|COMPLETED|Follow up||19
11227628|NCT02004366|12419734|FG001|STARTED|In-hospital||122
11227629|NCT02004366|12419735|FG002|STARTED|In-hospital||0
11227630|NCT02004366|12419736|FG003|STARTED|In-hospital||0
11227631|NCT02004366|12419737|FG004|STARTED|In-hospital||0
10862070|NCT03397264|12027055|FG000|STARTED|Overall Study||3
10862071|NCT03397264|12027056|FG001|STARTED|Overall Study||3
10862072|NCT03397264|12027057|FG002|STARTED|Overall Study||3
10862073|NCT03397264|12027058|FG003|STARTED|Overall Study||96
10862074|NCT03397264|12027059|FG004|STARTED|Overall Study||48
10862075|NCT03397264|12027055|FG000|COMPLETED|Overall Study||3
10862076|NCT03397264|12027056|FG001|COMPLETED|Overall Study||3
10862077|NCT03397264|12027057|FG002|COMPLETED|Overall Study||3
10862078|NCT03397264|12027058|FG003|COMPLETED|Overall Study||89
10862079|NCT03397264|12027059|FG004|COMPLETED|Overall Study||47
10862080|NCT03397264|12027055|FG000|NOT COMPLETED|Overall Study||0
10862081|NCT03397264|12027056|FG001|NOT COMPLETED|Overall Study||0
10862082|NCT03397264|12027057|FG002|NOT COMPLETED|Overall Study||0
10862083|NCT03397264|12027058|FG003|NOT COMPLETED|Overall Study||7
10862084|NCT03397264|12027059|FG004|NOT COMPLETED|Overall Study||1
10862085|NCT03392883|12027075|FG000|STARTED|Overall Study||1264
10862086|NCT03392883|12027076|FG001|STARTED|Overall Study||45
10862087|NCT03392883|12027077|FG002|STARTED|Overall Study||39
10862088|NCT03392883|12027075|FG000|COMPLETED|Overall Study||928
10862089|NCT03392883|12027076|FG001|COMPLETED|Overall Study||32
10862090|NCT03392883|12027077|FG002|COMPLETED|Overall Study||30
10862091|NCT03392883|12027075|FG000|NOT COMPLETED|Overall Study||336
10862092|NCT03392883|12027076|FG001|NOT COMPLETED|Overall Study||13
10862093|NCT03392883|12027077|FG002|NOT COMPLETED|Overall Study||9
10862094|NCT03376789|12027085|FG000|STARTED|Overall Study||108
10862095|NCT03376789|12027086|FG001|STARTED|Overall Study||111
10862096|NCT03376789|12027085|FG000|COMPLETED|Overall Study||103
10862097|NCT03376789|12027086|FG001|COMPLETED|Overall Study||102
10862098|NCT03376789|12027085|FG000|NOT COMPLETED|Overall Study||5
10862099|NCT03376789|12027086|FG001|NOT COMPLETED|Overall Study||9
10862100|NCT03342742|12027094|FG000|STARTED|Overall Study||15
10862101|NCT03342742|12027095|FG001|STARTED|Overall Study||13
10862102|NCT03342742|12027094|FG000|COMPLETED|Overall Study||13
10862103|NCT03342742|12027095|FG001|COMPLETED|Overall Study||11
10862104|NCT03342742|12027094|FG000|NOT COMPLETED|Overall Study||2
10862105|NCT03342742|12027095|FG001|NOT COMPLETED|Overall Study||2
11107913|NCT01265056|12292258|FG001|COMPLETED|Follow up||24
11107914|NCT01265056|12292257|FG000|NOT COMPLETED|Follow up||7
11107915|NCT01265056|12292258|FG001|NOT COMPLETED|Follow up||3
11107916|NCT01265394|12292264|FG000|STARTED|Overall Study||218
11107917|NCT01265394|12292264|FG000|COMPLETED|Overall Study||181
11107918|NCT01265394|12292264|FG000|NOT COMPLETED|Overall Study||37
10862112|NCT03307967|12027114|FG000|STARTED|Overall Study||40
10862113|NCT03307967|12027114|FG000|COMPLETED|Overall Study||36
10862114|NCT03307967|12027114|FG000|NOT COMPLETED|Overall Study||4
11107919|NCT01265420|12292269|FG000|STARTED|Overall Study||7
11107920|NCT01265420|12292269|FG000|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
11107921|NCT01265420|12292269|FG000|NOT COMPLETED|Overall Study||1
11107922|NCT01265446|12292275|FG000|STARTED|Overall Study||125
11107923|NCT01265446|12292276|FG001|STARTED|Overall Study||125
11107924|NCT01265446|12292275|FG000|COMPLETED|Overall Study||124
11107925|NCT01265446|12292276|FG001|COMPLETED|Overall Study||125
11107926|NCT01265446|12292275|FG000|NOT COMPLETED|Overall Study||1
11107927|NCT01265446|12292276|FG001|NOT COMPLETED|Overall Study||0
10862127|NCT03272711|12027139|FG000|STARTED|Overall Study||51
10862128|NCT03272711|12027140|FG001|STARTED|Overall Study||49
10862129|NCT03272711|12027139|FG000|COMPLETED|Overall Study||44
10862130|NCT03272711|12027140|FG001|COMPLETED|Overall Study||41
10862131|NCT03272711|12027139|FG000|NOT COMPLETED|Overall Study||7
10862132|NCT03272711|12027140|FG001|NOT COMPLETED|Overall Study||8
10862133|NCT03271983|12027146|FG000|STARTED|Overall Study|The plan was to do n=12 volunteers; however, funding was terminated due to pandemic so only 7 volunteers were completed.|7
10862134|NCT03271983|12027146|FG000|COMPLETED|Overall Study||7
10862135|NCT03271983|12027146|FG000|NOT COMPLETED|Overall Study||0
10862136|NCT03246789|12027156|FG000|STARTED|Overall Study||24
10862137|NCT03246789|12027157|FG001|STARTED|Overall Study||15
10862138|NCT03246789|12027156|FG000|COMPLETED|Overall Study||24
10862139|NCT03246789|12027157|FG001|COMPLETED|Overall Study||15
10862140|NCT03246789|12027156|FG000|NOT COMPLETED|Overall Study||0
10862141|NCT03246789|12027157|FG001|NOT COMPLETED|Overall Study||0
10862142|NCT03241225|12027165|FG000|STARTED|Overall Study||24
10862143|NCT03241225|12027166|FG001|STARTED|Overall Study||16
10862144|NCT03241225|12027165|FG000|COMPLETED|Overall Study||17
10862145|NCT03241225|12027166|FG001|COMPLETED|Overall Study||14
10862146|NCT03241225|12027165|FG000|NOT COMPLETED|Overall Study||7
10862147|NCT03241225|12027166|FG001|NOT COMPLETED|Overall Study||2
10862148|NCT03225846|12027179|FG000|STARTED|Overall Study||22
10862149|NCT03225846|12027180|FG001|STARTED|Overall Study||9
10862150|NCT03225846|12027181|FG002|STARTED|Overall Study||12
10862151|NCT03225846|12027182|FG003|STARTED|Overall Study||15
10862152|NCT03225846|12027183|FG004|STARTED|Overall Study||8
10862153|NCT03225846|12027184|FG005|STARTED|Overall Study||9
10862154|NCT03225846|12027185|FG006|STARTED|Overall Study||13
11107928|NCT01265498|12292284|FG000|STARTED|Overall Study||141
10862155|NCT03225846|12027179|FG000|Single Dose Period Only|Overall Study||6
10862156|NCT03225846|12027180|FG001|Single Dose Period Only|Overall Study||3
10862157|NCT03225846|12027181|FG002|Single Dose Period Only|Overall Study||4
10862158|NCT03225846|12027182|FG003|Single Dose Period Only|Overall Study||7
10862159|NCT03225846|12027183|FG004|Single Dose Period Only|Overall Study||8
10862160|NCT03225846|12027184|FG005|Single Dose Period Only|Overall Study||0
10862161|NCT03225846|12027185|FG006|Single Dose Period Only|Overall Study||4
10862162|NCT03225846|12027179|FG000|Multiple Dose Period Only|Overall Study||3
10862118|NCT03288129|12027124|FG000|STARTED|Overall Study||54
10862119|NCT03288129|12027124|FG000|COMPLETED|Overall Study||32
10862120|NCT03288129|12027124|FG000|NOT COMPLETED|Overall Study||22
10862163|NCT03225846|12027180|FG001|Multiple Dose Period Only|Overall Study||0
10862164|NCT03225846|12027181|FG002|Multiple Dose Period Only|Overall Study||3
10862165|NCT03225846|12027182|FG003|Multiple Dose Period Only|Overall Study||6
10862166|NCT03225846|12027183|FG004|Multiple Dose Period Only|Overall Study||0
10862167|NCT03225846|12027184|FG005|Multiple Dose Period Only|Overall Study||0
10862168|NCT03225846|12027185|FG006|Multiple Dose Period Only|Overall Study||4
10862169|NCT03225846|12027179|FG000|Single Dose and Multiple Dose|Overall Study||13
10862170|NCT03225846|12027180|FG001|Single Dose and Multiple Dose|Overall Study||6
10862171|NCT03225846|12027181|FG002|Single Dose and Multiple Dose|Overall Study||5
10862172|NCT03225846|12027182|FG003|Single Dose and Multiple Dose|Overall Study||2
10862173|NCT03225846|12027183|FG004|Single Dose and Multiple Dose|Overall Study||0
10862174|NCT03225846|12027184|FG005|Single Dose and Multiple Dose|Overall Study||9
10862175|NCT03225846|12027185|FG006|Single Dose and Multiple Dose|Overall Study||5
10862176|NCT03225846|12027179|FG000|COMPLETED|Overall Study||22
10862177|NCT03225846|12027180|FG001|COMPLETED|Overall Study||7
10862178|NCT03225846|12027181|FG002|COMPLETED|Overall Study||11
10862179|NCT03225846|12027182|FG003|COMPLETED|Overall Study||15
10862180|NCT03225846|12027183|FG004|COMPLETED|Overall Study||8
10862181|NCT03225846|12027184|FG005|COMPLETED|Overall Study||9
10862182|NCT03225846|12027185|FG006|COMPLETED|Overall Study||6
10862183|NCT03225846|12027179|FG000|NOT COMPLETED|Overall Study||0
10862184|NCT03225846|12027180|FG001|NOT COMPLETED|Overall Study||2
10862185|NCT03225846|12027181|FG002|NOT COMPLETED|Overall Study||1
10862186|NCT03225846|12027182|FG003|NOT COMPLETED|Overall Study||0
10862187|NCT03225846|12027183|FG004|NOT COMPLETED|Overall Study||0
10862188|NCT03225846|12027184|FG005|NOT COMPLETED|Overall Study||0
10862189|NCT03225846|12027185|FG006|NOT COMPLETED|Overall Study||7
11107929|NCT01265498|12292285|FG001|STARTED|Overall Study||142
11107930|NCT01265498|12292284|FG000|Both Baseline and Week 72 Biopsy|Overall Study||102
10862190|NCT03221270|12027212|FG000|STARTED|Overall Study||8
10862191|NCT03221270|12027213|FG001|STARTED|Overall Study||6
10862192|NCT03221270|12027214|FG002|STARTED|Overall Study||5
10862193|NCT03221270|12027215|FG003|STARTED|Overall Study||6
10862194|NCT03221270|12027212|FG000|Completed 5-Day Treatment|Overall Study||8
10862195|NCT03221270|12027213|FG001|Completed 5-Day Treatment|Overall Study||6
10862196|NCT03221270|12027214|FG002|Completed 5-Day Treatment|Overall Study||5
10862197|NCT03221270|12027215|FG003|Completed 5-Day Treatment|Overall Study||6
10862198|NCT03221270|12027212|FG000|Completed 8-Week Maintenance|Overall Study||4
10862199|NCT03221270|12027213|FG001|Completed 8-Week Maintenance|Overall Study||6
10862200|NCT03221270|12027214|FG002|Completed 8-Week Maintenance|Overall Study||5
10862201|NCT03221270|12027215|FG003|Completed 8-Week Maintenance|Overall Study||5
10862202|NCT03221270|12027212|FG000|COMPLETED|Overall Study||4
10862203|NCT03221270|12027213|FG001|COMPLETED|Overall Study||6
10862204|NCT03221270|12027214|FG002|COMPLETED|Overall Study||5
10862205|NCT03221270|12027215|FG003|COMPLETED|Overall Study||5
10862206|NCT03221270|12027212|FG000|NOT COMPLETED|Overall Study||4
10862207|NCT03221270|12027213|FG001|NOT COMPLETED|Overall Study||0
10862208|NCT03221270|12027214|FG002|NOT COMPLETED|Overall Study||0
10862209|NCT03221270|12027215|FG003|NOT COMPLETED|Overall Study||1
10862210|NCT03191903|12027228|FG000|STARTED|Overall Study||251
10862211|NCT03191903|12027229|FG001|STARTED|Overall Study||251
10862212|NCT03191903|12027230|FG002|STARTED|Overall Study||74
10862213|NCT03191903|12027228|FG000|Intent to Treat Population|Overall Study||251
10862214|NCT03191903|12027229|FG001|Intent to Treat Population|Overall Study||251
10862215|NCT03191903|12027230|FG002|Intent to Treat Population|Overall Study||74
10862216|NCT03191903|12027228|FG000|COMPLETED|Overall Study||244
10862217|NCT03191903|12027229|FG001|COMPLETED|Overall Study||246
10862218|NCT03191903|12027230|FG002|COMPLETED|Overall Study||70
10862219|NCT03191903|12027228|FG000|NOT COMPLETED|Overall Study||7
10862220|NCT03191903|12027229|FG001|NOT COMPLETED|Overall Study||5
10862221|NCT03191903|12027230|FG002|NOT COMPLETED|Overall Study||4
10862222|NCT03186794|12027243|FG000|STARTED|Overall Study||20
10862223|NCT03186794|12027243|FG000|COMPLETED|Overall Study||16
10862224|NCT03186794|12027243|FG000|NOT COMPLETED|Overall Study||4
10862225|NCT04289051|12027248|FG000|STARTED|Overall Study||13
10862226|NCT04289051|12027249|FG001|STARTED|Overall Study||13
10862227|NCT04289051|12027250|FG002|STARTED|Overall Study||13
10862228|NCT04289051|12027248|FG000|First Intervention (2 Weeks)|Overall Study||13
10862229|NCT04289051|12027249|FG001|First Intervention (2 Weeks)|Overall Study||13
10862230|NCT04289051|12027250|FG002|First Intervention (2 Weeks)|Overall Study||11
10862231|NCT04289051|12027248|FG000|Washout (1 Week)|Overall Study||13
10862232|NCT04289051|12027249|FG001|Washout (1 Week)|Overall Study||13
10862233|NCT04289051|12027250|FG002|Washout (1 Week)|Overall Study||11
10862234|NCT04289051|12027248|FG000|Second Intervention (2 Weeks)|Overall Study||13
10862235|NCT04289051|12027249|FG001|Second Intervention (2 Weeks)|Overall Study||13
10862236|NCT04289051|12027250|FG002|Second Intervention (2 Weeks)|Overall Study||11
10862237|NCT04289051|12027248|FG000|Washout (1 Week)|Overall Study||13
10862238|NCT04289051|12027249|FG001|Washout (1 Week)|Overall Study||13
10862239|NCT04289051|12027250|FG002|Washout (1 Week)|Overall Study||11
10862240|NCT04289051|12027248|FG000|Third Intervention (2 Weeks)|Overall Study||13
10862241|NCT04289051|12027249|FG001|Third Intervention (2 Weeks)|Overall Study||13
10862242|NCT04289051|12027250|FG002|Third Intervention (2 Weeks)|Overall Study||11
10862243|NCT04289051|12027248|FG000|COMPLETED|Overall Study||13
10862244|NCT04289051|12027249|FG001|COMPLETED|Overall Study||13
10862245|NCT04289051|12027250|FG002|COMPLETED|Overall Study||11
10862246|NCT04289051|12027248|FG000|NOT COMPLETED|Overall Study||0
11227632|NCT02004366|12419733|FG000|COMPLETED|In-hospital||128
11227633|NCT02004366|12419734|FG001|COMPLETED|In-hospital||122
11227634|NCT02004366|12419735|FG002|COMPLETED|In-hospital||0
11227635|NCT02004366|12419736|FG003|COMPLETED|In-hospital||0
11227636|NCT02004366|12419737|FG004|COMPLETED|In-hospital||0
11227637|NCT02004366|12419733|FG000|NOT COMPLETED|In-hospital||0
11227638|NCT02004366|12419734|FG001|NOT COMPLETED|In-hospital||0
11227639|NCT02004366|12419735|FG002|NOT COMPLETED|In-hospital||0
11227640|NCT02004366|12419736|FG003|NOT COMPLETED|In-hospital||0
11227641|NCT02004366|12419737|FG004|NOT COMPLETED|In-hospital||0
11227642|NCT02004366|12419733|FG000|STARTED|On Discharge||0
11227643|NCT02004366|12419734|FG001|STARTED|On Discharge||0
11227644|NCT02004366|12419735|FG002|STARTED|On Discharge||92
11227645|NCT02004366|12419736|FG003|STARTED|On Discharge||93
11227646|NCT02004366|12419737|FG004|STARTED|On Discharge||39
11227647|NCT02004366|12419733|FG000|COMPLETED|On Discharge||0
11227648|NCT02004366|12419734|FG001|COMPLETED|On Discharge||0
11227649|NCT02004366|12419735|FG002|COMPLETED|On Discharge||92
11227650|NCT02004366|12419736|FG003|COMPLETED|On Discharge||93
11227651|NCT02004366|12419737|FG004|COMPLETED|On Discharge||39
11227652|NCT02004366|12419733|FG000|NOT COMPLETED|On Discharge||0
11227653|NCT02004366|12419734|FG001|NOT COMPLETED|On Discharge||0
11227654|NCT02004366|12419735|FG002|NOT COMPLETED|On Discharge||0
11227655|NCT02004366|12419736|FG003|NOT COMPLETED|On Discharge||0
11227656|NCT02004366|12419737|FG004|NOT COMPLETED|On Discharge||0
11227657|NCT02004613|12419752|FG000|STARTED|Overall Study||400
11227658|NCT02004613|12419753|FG001|STARTED|Overall Study||398
10862247|NCT04289051|12027249|FG001|NOT COMPLETED|Overall Study||0
10862248|NCT04289051|12027250|FG002|NOT COMPLETED|Overall Study||2
10862249|NCT04210180|12027258|FG000|STARTED|Overall Study||25
10862250|NCT04210180|12027258|FG000|COMPLETED|Overall Study||23
10862251|NCT04210180|12027258|FG000|NOT COMPLETED|Overall Study||2
10862252|NCT04097223|12027262|FG000|STARTED|Overall Study||17464
10862253|NCT04097223|12027262|FG000|COMPLETED|Overall Study||17464
10862254|NCT04097223|12027262|FG000|NOT COMPLETED|Overall Study||0
10862255|NCT03675308|12027301|FG000|STARTED|Overall Study||481
10862256|NCT03675308|12027302|FG001|STARTED|Overall Study||483
10862257|NCT03675308|12027301|FG000|COMPLETED|Overall Study||467
10862258|NCT03675308|12027302|FG001|COMPLETED|Overall Study||473
10862259|NCT03675308|12027301|FG000|NOT COMPLETED|Overall Study||14
10862260|NCT03675308|12027302|FG001|NOT COMPLETED|Overall Study||10
10862261|NCT03573817|12027310|FG000|STARTED|Overall Study||63
10862262|NCT03573817|12027311|FG001|STARTED|Overall Study||59
10862263|NCT03573817|12027310|FG000|Randomized and Treated With Study Drug|Overall Study||63
10862264|NCT03573817|12027311|FG001|Randomized and Treated With Study Drug|Overall Study||59
10862265|NCT03573817|12027310|FG000|COMPLETED|Overall Study||62
10862266|NCT03573817|12027311|FG001|COMPLETED|Overall Study||55
10862267|NCT03573817|12027310|FG000|NOT COMPLETED|Overall Study||1
10862268|NCT03573817|12027311|FG001|NOT COMPLETED|Overall Study||4
11107931|NCT01265498|12292285|FG001|Both Baseline and Week 72 Biopsy|Overall Study||98
11107932|NCT01265498|12292284|FG000|COMPLETED|Overall Study||110
11107933|NCT01265498|12292285|FG001|COMPLETED|Overall Study||109
11107934|NCT01265498|12292284|FG000|NOT COMPLETED|Overall Study||31
11107935|NCT01265498|12292285|FG001|NOT COMPLETED|Overall Study||33
11107936|NCT01265511|12292293|FG000|STARTED|Overall Study||2
11107937|NCT01265511|12292294|FG001|STARTED|Overall Study||8
11107938|NCT01265511|12292293|FG000|COMPLETED|Overall Study||0
11107939|NCT01265511|12292294|FG001|COMPLETED|Overall Study||5
11107940|NCT01265511|12292293|FG000|NOT COMPLETED|Overall Study||2
11107941|NCT01265511|12292294|FG001|NOT COMPLETED|Overall Study||3
11107942|NCT01265524|12292302|FG000|STARTED|Overall Study||59
11107943|NCT01265524|12292303|FG001|STARTED|Overall Study||52
11227659|NCT02004613|12419752|FG000|COMPLETED|Overall Study||398
11107944|NCT01265524|12292302|FG000|COMPLETED|Overall Study||41
11107945|NCT01265524|12292303|FG001|COMPLETED|Overall Study||46
11107946|NCT01265524|12292302|FG000|NOT COMPLETED|Overall Study||18
11107947|NCT01265524|12292303|FG001|NOT COMPLETED|Overall Study||6
11107948|NCT01265537|12292311|FG000|STARTED|Overall Study||15
11107949|NCT01265537|12292312|FG001|STARTED|Overall Study||15
11107950|NCT01265537|12292311|FG000|COMPLETED|Overall Study||13
10862290|NCT03095456|12027349|FG000|STARTED|Overall Study||103
10862291|NCT03095456|12027350|FG001|STARTED|Overall Study||104
11227660|NCT02004613|12419753|FG001|COMPLETED|Overall Study||396
11227661|NCT02004613|12419752|FG000|NOT COMPLETED|Overall Study||2
11227662|NCT02004613|12419753|FG001|NOT COMPLETED|Overall Study||2
11227663|NCT02004847|12419761|FG000|STARTED|Overall Study||24
11227664|NCT02004847|12419762|FG001|STARTED|Overall Study||23
10862292|NCT03095456|12027349|FG000|COMPLETED|Overall Study||99
10862293|NCT03095456|12027350|FG001|COMPLETED|Overall Study||96
10862294|NCT03095456|12027349|FG000|NOT COMPLETED|Overall Study||4
10862295|NCT03095456|12027350|FG001|NOT COMPLETED|Overall Study||8
11227665|NCT02004847|12419761|FG000|COMPLETED|Overall Study||23
11227666|NCT02004847|12419762|FG001|COMPLETED|Overall Study||22
10862296|NCT03064113|12027360|FG000|STARTED|Intervention 1 (2 Days)||8
10862297|NCT03064113|12027361|FG001|STARTED|Intervention 1 (2 Days)||8
10862298|NCT03064113|12027362|FG002|STARTED|Intervention 1 (2 Days)||8
10862299|NCT03064113|12027363|FG003|STARTED|Intervention 1 (2 Days)||8
10862300|NCT03064113|12027360|FG000|COMPLETED|Intervention 1 (2 Days)||8
10862301|NCT03064113|12027361|FG001|COMPLETED|Intervention 1 (2 Days)||8
10862302|NCT03064113|12027362|FG002|COMPLETED|Intervention 1 (2 Days)||8
10862303|NCT03064113|12027363|FG003|COMPLETED|Intervention 1 (2 Days)||8
10862304|NCT03064113|12027360|FG000|NOT COMPLETED|Intervention 1 (2 Days)||0
10862305|NCT03064113|12027361|FG001|NOT COMPLETED|Intervention 1 (2 Days)||0
10862306|NCT03064113|12027362|FG002|NOT COMPLETED|Intervention 1 (2 Days)||0
10862307|NCT03064113|12027363|FG003|NOT COMPLETED|Intervention 1 (2 Days)||0
10862308|NCT03064113|12027360|FG000|STARTED|Washout (7 Days)||8
10862309|NCT03064113|12027361|FG001|STARTED|Washout (7 Days)||8
10862310|NCT03064113|12027362|FG002|STARTED|Washout (7 Days)||8
10862311|NCT03064113|12027363|FG003|STARTED|Washout (7 Days)||8
10862312|NCT03064113|12027360|FG000|COMPLETED|Washout (7 Days)||8
10862313|NCT03064113|12027361|FG001|COMPLETED|Washout (7 Days)||8
10862314|NCT03064113|12027362|FG002|COMPLETED|Washout (7 Days)||8
10862315|NCT03064113|12027363|FG003|COMPLETED|Washout (7 Days)||8
10862316|NCT03064113|12027360|FG000|NOT COMPLETED|Washout (7 Days)||0
10862317|NCT03064113|12027361|FG001|NOT COMPLETED|Washout (7 Days)||0
10862318|NCT03064113|12027362|FG002|NOT COMPLETED|Washout (7 Days)||0
10862319|NCT03064113|12027363|FG003|NOT COMPLETED|Washout (7 Days)||0
10862320|NCT03064113|12027360|FG000|STARTED|Intervention 2 (2 Days)||8
10862321|NCT03064113|12027361|FG001|STARTED|Intervention 2 (2 Days)||8
10862322|NCT03064113|12027362|FG002|STARTED|Intervention 2 (2 Days)||8
10862323|NCT03064113|12027363|FG003|STARTED|Intervention 2 (2 Days)||8
10862324|NCT03064113|12027360|FG000|COMPLETED|Intervention 2 (2 Days)||8
10862325|NCT03064113|12027361|FG001|COMPLETED|Intervention 2 (2 Days)||8
10862326|NCT03064113|12027362|FG002|COMPLETED|Intervention 2 (2 Days)||8
10862327|NCT03064113|12027363|FG003|COMPLETED|Intervention 2 (2 Days)||8
10862328|NCT03064113|12027360|FG000|NOT COMPLETED|Intervention 2 (2 Days)||0
10862329|NCT03064113|12027361|FG001|NOT COMPLETED|Intervention 2 (2 Days)||0
10862330|NCT03064113|12027362|FG002|NOT COMPLETED|Intervention 2 (2 Days)||0
10862331|NCT03064113|12027363|FG003|NOT COMPLETED|Intervention 2 (2 Days)||0
10862332|NCT03064113|12027360|FG000|STARTED|Washout (7 Days)||8
10862333|NCT03064113|12027361|FG001|STARTED|Washout (7 Days)||8
10862334|NCT03064113|12027362|FG002|STARTED|Washout (7 Days)||8
11355003|NCT03076970|12551943|FG000|Received at Least 1 Dose of Study Drug|Period 1||7
10862335|NCT03064113|12027363|FG003|STARTED|Washout (7 Days)||8
10862336|NCT03064113|12027360|FG000|COMPLETED|Washout (7 Days)||8
10862337|NCT03064113|12027361|FG001|COMPLETED|Washout (7 Days)||8
10862338|NCT03064113|12027362|FG002|COMPLETED|Washout (7 Days)||8
10862339|NCT03064113|12027363|FG003|COMPLETED|Washout (7 Days)||8
10862340|NCT03064113|12027360|FG000|NOT COMPLETED|Washout (7 Days)||0
11107951|NCT01265537|12292312|FG001|COMPLETED|Overall Study||13
11107952|NCT01265537|12292311|FG000|NOT COMPLETED|Overall Study||2
11107953|NCT01265537|12292312|FG001|NOT COMPLETED|Overall Study||2
11107954|NCT01265550|12292322|FG000|STARTED|Pre Randomization||0
11107955|NCT01265550|12292323|FG001|STARTED|Pre Randomization||0
11107956|NCT01265550|12292324|FG002|STARTED|Pre Randomization||0
11107957|NCT01265550|12292325|FG003|STARTED|Pre Randomization||366
11107958|NCT01265550|12292322|FG000|COMPLETED|Pre Randomization||0
11107959|NCT01265550|12292323|FG001|COMPLETED|Pre Randomization||0
11227667|NCT02004847|12419761|FG000|NOT COMPLETED|Overall Study||1
11227668|NCT02004847|12419762|FG001|NOT COMPLETED|Overall Study||1
11227669|NCT02004873|12419777|FG000|STARTED|Overall Study|Micra Implant Attempt|725
11227670|NCT02004873|12419777|FG000|Micra Implant Success|Overall Study||719
11227671|NCT02004873|12419777|FG000|COMPLETED|Overall Study|6-Month Follow-up|301
11227672|NCT02004873|12419777|FG000|NOT COMPLETED|Overall Study||424
11227673|NCT02004886|12419788|FG000|STARTED|Overall Study||19
11227674|NCT02004886|12419789|FG001|STARTED|Overall Study||18
11227675|NCT02004886|12419790|FG002|STARTED|Overall Study||18
11227676|NCT02004886|12419791|FG003|STARTED|Overall Study||19
11227677|NCT02004886|12419788|FG000|COMPLETED|Overall Study||18
11227678|NCT02004886|12419789|FG001|COMPLETED|Overall Study||17
11227679|NCT02004886|12419790|FG002|COMPLETED|Overall Study||18
11227680|NCT02004886|12419791|FG003|COMPLETED|Overall Study||19
11107960|NCT01265550|12292324|FG002|COMPLETED|Pre Randomization||0
11107961|NCT01265550|12292325|FG003|COMPLETED|Pre Randomization||78
11107962|NCT01265550|12292322|FG000|NOT COMPLETED|Pre Randomization||0
11107963|NCT01265550|12292323|FG001|NOT COMPLETED|Pre Randomization||0
11107964|NCT01265550|12292324|FG002|NOT COMPLETED|Pre Randomization||0
11107965|NCT01265550|12292325|FG003|NOT COMPLETED|Pre Randomization||288
11355004|NCT03076970|12551944|FG001|Received at Least 1 Dose of Study Drug|Period 1||7
11355005|NCT03076970|12551945|FG002|Received at Least 1 Dose of Study Drug|Period 1||7
11355006|NCT03076970|12551946|FG003|Received at Least 1 Dose of Study Drug|Period 1||7
10862341|NCT03064113|12027361|FG001|NOT COMPLETED|Washout (7 Days)||0
10862342|NCT03064113|12027362|FG002|NOT COMPLETED|Washout (7 Days)||0
11355007|NCT03076970|12551947|FG004|Received at Least 1 Dose of Study Drug|Period 1||7
10862343|NCT03064113|12027363|FG003|NOT COMPLETED|Washout (7 Days)||0
10862344|NCT03064113|12027360|FG000|STARTED|Intervention 3 (2 Days)||8
10862345|NCT03064113|12027361|FG001|STARTED|Intervention 3 (2 Days)||8
10862346|NCT03064113|12027362|FG002|STARTED|Intervention 3 (2 Days)||8
10862347|NCT03064113|12027363|FG003|STARTED|Intervention 3 (2 Days)||8
10862348|NCT03064113|12027360|FG000|COMPLETED|Intervention 3 (2 Days)||8
10862349|NCT03064113|12027361|FG001|COMPLETED|Intervention 3 (2 Days)||8
10862350|NCT03064113|12027362|FG002|COMPLETED|Intervention 3 (2 Days)||8
10862351|NCT03064113|12027363|FG003|COMPLETED|Intervention 3 (2 Days)||8
10862352|NCT03064113|12027360|FG000|NOT COMPLETED|Intervention 3 (2 Days)||0
10862353|NCT03064113|12027361|FG001|NOT COMPLETED|Intervention 3 (2 Days)||0
10862354|NCT03064113|12027362|FG002|NOT COMPLETED|Intervention 3 (2 Days)||0
10862355|NCT03064113|12027363|FG003|NOT COMPLETED|Intervention 3 (2 Days)||0
10862356|NCT03064113|12027360|FG000|STARTED|Washout (7 Days)||8
10862357|NCT03064113|12027361|FG001|STARTED|Washout (7 Days)||8
10862358|NCT03064113|12027362|FG002|STARTED|Washout (7 Days)||8
10862359|NCT03064113|12027363|FG003|STARTED|Washout (7 Days)||8
10862360|NCT03064113|12027360|FG000|COMPLETED|Washout (7 Days)||8
10862361|NCT03064113|12027361|FG001|COMPLETED|Washout (7 Days)||8
11355008|NCT03076970|12551948|FG005|Received at Least 1 Dose of Study Drug|Period 1||7
11355009|NCT03076970|12551943|FG000|COMPLETED|Period 1||7
11355010|NCT03076970|12551944|FG001|COMPLETED|Period 1||7
11355011|NCT03076970|12551945|FG002|COMPLETED|Period 1||7
11355012|NCT03076970|12551946|FG003|COMPLETED|Period 1||7
11355013|NCT03076970|12551947|FG004|COMPLETED|Period 1||7
11355014|NCT03076970|12551948|FG005|COMPLETED|Period 1||7
11355015|NCT03076970|12551943|FG000|NOT COMPLETED|Period 1||0
11355016|NCT03076970|12551944|FG001|NOT COMPLETED|Period 1||0
11355017|NCT03076970|12551945|FG002|NOT COMPLETED|Period 1||0
11355018|NCT03076970|12551946|FG003|NOT COMPLETED|Period 1||0
11355019|NCT03076970|12551947|FG004|NOT COMPLETED|Period 1||0
10862362|NCT03064113|12027362|FG002|COMPLETED|Washout (7 Days)||8
10862363|NCT03064113|12027363|FG003|COMPLETED|Washout (7 Days)||8
10862364|NCT03064113|12027360|FG000|NOT COMPLETED|Washout (7 Days)||0
10862365|NCT03064113|12027361|FG001|NOT COMPLETED|Washout (7 Days)||0
10862366|NCT03064113|12027362|FG002|NOT COMPLETED|Washout (7 Days)||0
10862367|NCT03064113|12027363|FG003|NOT COMPLETED|Washout (7 Days)||0
10862368|NCT03064113|12027360|FG000|STARTED|Intervention 4 (2 Days)||8
10862369|NCT03064113|12027361|FG001|STARTED|Intervention 4 (2 Days)||8
10862370|NCT03064113|12027362|FG002|STARTED|Intervention 4 (2 Days)||8
10862371|NCT03064113|12027363|FG003|STARTED|Intervention 4 (2 Days)||8
10862372|NCT03064113|12027360|FG000|COMPLETED|Intervention 4 (2 Days)||8
10862373|NCT03064113|12027361|FG001|COMPLETED|Intervention 4 (2 Days)||8
10862374|NCT03064113|12027362|FG002|COMPLETED|Intervention 4 (2 Days)||8
10862375|NCT03064113|12027363|FG003|COMPLETED|Intervention 4 (2 Days)||8
10862376|NCT03064113|12027360|FG000|NOT COMPLETED|Intervention 4 (2 Days)||0
10862377|NCT03064113|12027361|FG001|NOT COMPLETED|Intervention 4 (2 Days)||0
10862378|NCT03064113|12027362|FG002|NOT COMPLETED|Intervention 4 (2 Days)||0
10862379|NCT03064113|12027363|FG003|NOT COMPLETED|Intervention 4 (2 Days)||0
10862380|NCT03064113|12027360|FG000|STARTED|Washout (7 Days)||8
10862381|NCT03064113|12027361|FG001|STARTED|Washout (7 Days)||8
10862382|NCT03064113|12027362|FG002|STARTED|Washout (7 Days)||8
10862383|NCT03064113|12027363|FG003|STARTED|Washout (7 Days)||8
10862384|NCT03064113|12027360|FG000|COMPLETED|Washout (7 Days)||8
10862385|NCT03064113|12027361|FG001|COMPLETED|Washout (7 Days)||8
10862386|NCT03064113|12027362|FG002|COMPLETED|Washout (7 Days)||8
10862387|NCT03064113|12027363|FG003|COMPLETED|Washout (7 Days)||8
10862388|NCT03064113|12027360|FG000|NOT COMPLETED|Washout (7 Days)||0
10862389|NCT03064113|12027361|FG001|NOT COMPLETED|Washout (7 Days)||0
10862390|NCT03064113|12027362|FG002|NOT COMPLETED|Washout (7 Days)||0
10862391|NCT03064113|12027363|FG003|NOT COMPLETED|Washout (7 Days)||0
10862392|NCT02938013|12027376|FG000|STARTED|Overall Study||5
10862393|NCT02938013|12027377|FG001|STARTED|Overall Study||5
10862394|NCT02938013|12027378|FG002|STARTED|Overall Study||5
10862395|NCT02938013|12027376|FG000|COMPLETED|Overall Study||5
10862396|NCT02938013|12027377|FG001|COMPLETED|Overall Study||5
10862397|NCT02938013|12027378|FG002|COMPLETED|Overall Study||5
10862398|NCT02938013|12027376|FG000|NOT COMPLETED|Overall Study||0
10862399|NCT02938013|12027377|FG001|NOT COMPLETED|Overall Study||0
10862400|NCT02938013|12027378|FG002|NOT COMPLETED|Overall Study||0
10862401|NCT02919683|12027388|FG000|STARTED|Pre-Surgery Intervention||15
10862402|NCT02919683|12027389|FG001|STARTED|Pre-Surgery Intervention||15
10862403|NCT02919683|12027388|FG000|COMPLETED|Pre-Surgery Intervention||15
10862404|NCT02919683|12027389|FG001|COMPLETED|Pre-Surgery Intervention||15
10862405|NCT02919683|12027388|FG000|NOT COMPLETED|Pre-Surgery Intervention||0
10862406|NCT02919683|12027389|FG001|NOT COMPLETED|Pre-Surgery Intervention||0
11107966|NCT01265550|12292322|FG000|STARTED|Post Randomization||25
10862407|NCT02919683|12027388|FG000|STARTED|Post-Surgery Follow-Up||15
10862408|NCT02919683|12027389|FG001|STARTED|Post-Surgery Follow-Up||15
10862409|NCT02919683|12027388|FG000|COMPLETED|Post-Surgery Follow-Up||12
10862410|NCT02919683|12027389|FG001|COMPLETED|Post-Surgery Follow-Up||13
10862411|NCT02919683|12027388|FG000|NOT COMPLETED|Post-Surgery Follow-Up||3
11355020|NCT03076970|12551948|FG005|NOT COMPLETED|Period 1||0
11355021|NCT03076970|12551943|FG000|STARTED|Washout Period 1||7
11355022|NCT03076970|12551944|FG001|STARTED|Washout Period 1||7
11355023|NCT03076970|12551945|FG002|STARTED|Washout Period 1||7
10862412|NCT02919683|12027389|FG001|NOT COMPLETED|Post-Surgery Follow-Up||2
11107967|NCT01265550|12292323|FG001|STARTED|Post Randomization||27
11107968|NCT01265550|12292324|FG002|STARTED|Post Randomization||26
11107969|NCT01265550|12292325|FG003|STARTED|Post Randomization||0
10862416|NCT02790138|12027402|FG000|STARTED|Overall Study||51
10862417|NCT02790138|12027403|FG001|STARTED|Overall Study||51
10862418|NCT02790138|12027402|FG000|COMPLETED|Overall Study||30
10862419|NCT02790138|12027403|FG001|COMPLETED|Overall Study||32
10862420|NCT02790138|12027402|FG000|NOT COMPLETED|Overall Study||21
10862421|NCT02790138|12027403|FG001|NOT COMPLETED|Overall Study||19
10862422|NCT02642315|12027410|FG000|STARTED|Overall Study||10
10862423|NCT02642315|12027410|FG000|COMPLETED|Overall Study||8
10862424|NCT02642315|12027410|FG000|NOT COMPLETED|Overall Study||2
10862425|NCT02518139|12027417|FG000|STARTED|Overall Study||364
10862426|NCT02518139|12027418|FG001|STARTED|Overall Study||335
10862427|NCT02518139|12027419|FG002|STARTED|Overall Study||356
10862428|NCT02518139|12027417|FG000|COMPLETED|Overall Study||219
10862429|NCT02518139|12027418|FG001|COMPLETED|Overall Study||191
10862430|NCT02518139|12027419|FG002|COMPLETED|Overall Study||262
10862431|NCT02518139|12027417|FG000|NOT COMPLETED|Overall Study||145
10862432|NCT02518139|12027418|FG001|NOT COMPLETED|Overall Study||144
10862433|NCT02518139|12027419|FG002|NOT COMPLETED|Overall Study||94
10862434|NCT02514239|12027437|FG000|STARTED|Overall Study||5
10862435|NCT02514239|12027438|FG001|STARTED|Overall Study||4
10862436|NCT02514239|12027439|FG002|STARTED|Overall Study||3
10862437|NCT02514239|12027440|FG003|STARTED|Overall Study||3
10862438|NCT02514239|12027441|FG004|STARTED|Overall Study||3
10862439|NCT02514239|12027442|FG005|STARTED|Overall Study||5
10862440|NCT02514239|12027443|FG006|STARTED|Overall Study||4
10862441|NCT02514239|12027444|FG007|STARTED|Overall Study||3
10862442|NCT02514239|12027445|FG008|STARTED|Overall Study||10
10862443|NCT02514239|12027446|FG009|STARTED|Overall Study||3
10862444|NCT02514239|12027437|FG000|Treated|Overall Study||5
10862445|NCT02514239|12027438|FG001|Treated|Overall Study||3
10862446|NCT02514239|12027439|FG002|Treated|Overall Study||3
10862447|NCT02514239|12027440|FG003|Treated|Overall Study||3
10862448|NCT02514239|12027441|FG004|Treated|Overall Study||3
10862449|NCT02514239|12027442|FG005|Treated|Overall Study||5
10862450|NCT02514239|12027443|FG006|Treated|Overall Study||4
10862451|NCT02514239|12027444|FG007|Treated|Overall Study||3
10862452|NCT02514239|12027445|FG008|Treated|Overall Study||10
10862453|NCT02514239|12027446|FG009|Treated|Overall Study||3
10862454|NCT02514239|12027437|FG000|COMPLETED|Overall Study||0
10862455|NCT02514239|12027438|FG001|COMPLETED|Overall Study||0
10862456|NCT02514239|12027439|FG002|COMPLETED|Overall Study||1
10862457|NCT02514239|12027440|FG003|COMPLETED|Overall Study||0
10862458|NCT02514239|12027441|FG004|COMPLETED|Overall Study||0
10862459|NCT02514239|12027442|FG005|COMPLETED|Overall Study||1
10862460|NCT02514239|12027443|FG006|COMPLETED|Overall Study||0
10862461|NCT02514239|12027444|FG007|COMPLETED|Overall Study||0
10862462|NCT02514239|12027445|FG008|COMPLETED|Overall Study||2
10862463|NCT02514239|12027446|FG009|COMPLETED|Overall Study||0
10862464|NCT02514239|12027437|FG000|NOT COMPLETED|Overall Study||5
10862465|NCT02514239|12027438|FG001|NOT COMPLETED|Overall Study||4
10862466|NCT02514239|12027439|FG002|NOT COMPLETED|Overall Study||2
10862467|NCT02514239|12027440|FG003|NOT COMPLETED|Overall Study||3
10862468|NCT02514239|12027441|FG004|NOT COMPLETED|Overall Study||3
10862469|NCT02514239|12027442|FG005|NOT COMPLETED|Overall Study||4
10862470|NCT02514239|12027443|FG006|NOT COMPLETED|Overall Study||4
10862471|NCT02514239|12027444|FG007|NOT COMPLETED|Overall Study||3
10862472|NCT02514239|12027445|FG008|NOT COMPLETED|Overall Study||8
10862473|NCT02514239|12027446|FG009|NOT COMPLETED|Overall Study||3
10862474|NCT02512510|12027489|FG000|STARTED|Overall Study||205
10862475|NCT02512510|12027490|FG001|STARTED|Overall Study||197
10862476|NCT02512510|12027491|FG002|STARTED|Overall Study||209
10862477|NCT02512510|12027489|FG000|COMPLETED|Overall Study||163
10862478|NCT02512510|12027490|FG001|COMPLETED|Overall Study||162
10862479|NCT02512510|12027491|FG002|COMPLETED|Overall Study||157
10862480|NCT02512510|12027489|FG000|NOT COMPLETED|Overall Study||42
10862481|NCT02512510|12027490|FG001|NOT COMPLETED|Overall Study||35
10862482|NCT02512510|12027491|FG002|NOT COMPLETED|Overall Study||52
10862483|NCT02459080|12027502|FG000|STARTED|Overall Study||212
10862484|NCT02459080|12027503|FG001|STARTED|Overall Study||198
10862485|NCT02459080|12027504|FG002|STARTED|Overall Study||209
10862486|NCT02459080|12027502|FG000|COMPLETED|Overall Study||168
10862487|NCT02459080|12027503|FG001|COMPLETED|Overall Study||158
10862488|NCT02459080|12027504|FG002|COMPLETED|Overall Study||151
10862489|NCT02459080|12027502|FG000|NOT COMPLETED|Overall Study||44
10862490|NCT02459080|12027503|FG001|NOT COMPLETED|Overall Study||40
10862491|NCT02459080|12027504|FG002|NOT COMPLETED|Overall Study||58
10862492|NCT02245672|12027515|FG000|STARTED|Overall Study||512
10862493|NCT02245672|12027516|FG001|STARTED|Overall Study||513
10862494|NCT02245672|12027517|FG002|STARTED|Overall Study||103
10862495|NCT02245672|12027515|FG000|COMPLETED|Overall Study||499
10862496|NCT02245672|12027516|FG001|COMPLETED|Overall Study||500
10862497|NCT02245672|12027517|FG002|COMPLETED|Overall Study||98
10862498|NCT02245672|12027515|FG000|NOT COMPLETED|Overall Study||13
10862499|NCT02245672|12027516|FG001|NOT COMPLETED|Overall Study||13
10862500|NCT02245672|12027517|FG002|NOT COMPLETED|Overall Study||5
10862501|NCT02109172|12027525|FG000|STARTED|Overall Study||11
10862502|NCT02109172|12027526|FG001|STARTED|Overall Study||11
10862503|NCT02109172|12027527|FG002|STARTED|Overall Study||10
10862504|NCT02109172|12027528|FG003|STARTED|Overall Study||11
10862505|NCT02109172|12027529|FG004|STARTED|Overall Study||10
10862506|NCT02109172|12027530|FG005|STARTED|Overall Study||11
10862507|NCT02109172|12027525|FG000|COMPLETED|Overall Study||10
10862508|NCT02109172|12027526|FG001|COMPLETED|Overall Study||11
10862509|NCT02109172|12027527|FG002|COMPLETED|Overall Study||9
10862510|NCT02109172|12027528|FG003|COMPLETED|Overall Study||10
10862511|NCT02109172|12027529|FG004|COMPLETED|Overall Study||9
10862512|NCT02109172|12027530|FG005|COMPLETED|Overall Study||10
10862513|NCT02109172|12027525|FG000|NOT COMPLETED|Overall Study||1
10862514|NCT02109172|12027526|FG001|NOT COMPLETED|Overall Study||0
10862515|NCT02109172|12027527|FG002|NOT COMPLETED|Overall Study||1
10862516|NCT02109172|12027528|FG003|NOT COMPLETED|Overall Study||1
10862517|NCT02109172|12027529|FG004|NOT COMPLETED|Overall Study||1
10862518|NCT02109172|12027530|FG005|NOT COMPLETED|Overall Study||1
10862519|NCT02040792|12027543|FG000|STARTED|Overall Study||70
10862520|NCT02040792|12027544|FG001|STARTED|Overall Study||68
10862521|NCT02040792|12027545|FG002|STARTED|Overall Study||71
10862522|NCT02040792|12027546|FG003|STARTED|Overall Study||71
10862523|NCT02040792|12027547|FG004|STARTED|Overall Study||74
10862524|NCT02040792|12027543|FG000|COMPLETED|Overall Study||64
10862525|NCT02040792|12027544|FG001|COMPLETED|Overall Study||65
10862526|NCT02040792|12027545|FG002|COMPLETED|Overall Study||68
10862527|NCT02040792|12027546|FG003|COMPLETED|Overall Study||64
10862528|NCT02040792|12027547|FG004|COMPLETED|Overall Study||67
10862529|NCT02040792|12027543|FG000|NOT COMPLETED|Overall Study||6
10862530|NCT02040792|12027544|FG001|NOT COMPLETED|Overall Study||3
10862531|NCT02040792|12027545|FG002|NOT COMPLETED|Overall Study||3
10862532|NCT02040792|12027546|FG003|NOT COMPLETED|Overall Study||7
10862533|NCT02040792|12027547|FG004|NOT COMPLETED|Overall Study||7
10862534|NCT01979003|12027559|FG000|STARTED|Overall Study||100
10862535|NCT01979003|12027559|FG000|COMPLETED|Overall Study||72
10862536|NCT01979003|12027559|FG000|NOT COMPLETED|Overall Study||28
10862537|NCT01704404|12027563|FG000|STARTED|Overall Study||11
10862538|NCT01704404|12027564|FG001|STARTED|Overall Study||10
10862539|NCT01704404|12027565|FG002|STARTED|Overall Study||10
10862540|NCT01704404|12027566|FG003|STARTED|Overall Study||11
10862541|NCT01704404|12027567|FG004|STARTED|Overall Study||11
10862542|NCT01704404|12027568|FG005|STARTED|Overall Study||9
10862543|NCT01704404|12027563|FG000|COMPLETED|Overall Study||10
10862544|NCT01704404|12027564|FG001|COMPLETED|Overall Study||9
10862545|NCT01704404|12027565|FG002|COMPLETED|Overall Study||9
10862546|NCT01704404|12027566|FG003|COMPLETED|Overall Study||8
10862547|NCT01704404|12027567|FG004|COMPLETED|Overall Study||10
10862548|NCT01704404|12027568|FG005|COMPLETED|Overall Study||9
10862549|NCT01704404|12027563|FG000|NOT COMPLETED|Overall Study||1
10862550|NCT01704404|12027564|FG001|NOT COMPLETED|Overall Study||1
10862551|NCT01704404|12027565|FG002|NOT COMPLETED|Overall Study||1
10862552|NCT01704404|12027566|FG003|NOT COMPLETED|Overall Study||3
10862553|NCT01704404|12027567|FG004|NOT COMPLETED|Overall Study||1
10862554|NCT01704404|12027568|FG005|NOT COMPLETED|Overall Study||0
10862555|NCT01307813|12027584|FG000|STARTED|Overall Study||4
10862556|NCT01307813|12027584|FG000|COMPLETED|Overall Study||4
10862557|NCT01307813|12027584|FG000|NOT COMPLETED|Overall Study||0
10862558|NCT00799396|12027588|FG000|STARTED|Clopidogrel Treatment||682
10862559|NCT00799396|12027588|FG000|COMPLETED|Clopidogrel Treatment||669
10862560|NCT00799396|12027588|FG000|NOT COMPLETED|Clopidogrel Treatment||13
10862561|NCT00799396|12027588|FG000|STARTED|Clopidogrel Plus Aspirin||669
10862562|NCT00799396|12027588|FG000|COMPLETED|Clopidogrel Plus Aspirin||663
10862563|NCT00799396|12027588|FG000|NOT COMPLETED|Clopidogrel Plus Aspirin||6
10862564|NCT00069238|12027592|FG000|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
10862565|NCT00069238|12027593|FG001|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
10862566|NCT00069238|12027594|FG002|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
10862567|NCT00069238|12027592|FG000|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
10862568|NCT00069238|12027593|FG001|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
10862569|NCT00069238|12027594|FG002|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
10862570|NCT00069238|12027592|FG000|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
10862571|NCT00069238|12027593|FG001|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
10862572|NCT00069238|12027594|FG002|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
10862573|NCT00069238|12027592|FG000|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
10862574|NCT00069238|12027593|FG001|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
10862575|NCT00069238|12027594|FG002|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
10862576|NCT00069238|12027592|FG000|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
10862577|NCT00069238|12027593|FG001|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
10862578|NCT00069238|12027594|FG002|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
10862579|NCT00069238|12027592|FG000|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
10862580|NCT00069238|12027593|FG001|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
10862581|NCT00069238|12027594|FG002|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
10862582|NCT00069238|12027592|FG000|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
10862583|NCT00069238|12027593|FG001|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
10862584|NCT00069238|12027594|FG002|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
10862585|NCT00069238|12027592|FG000|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
10862586|NCT00069238|12027593|FG001|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
10862587|NCT00069238|12027594|FG002|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
10862588|NCT00069238|12027592|FG000|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
10862589|NCT00069238|12027593|FG001|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
10862590|NCT00069238|12027594|FG002|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
10862591|NCT03138499|12027601|FG000|STARTED|Overall Study||12
10862592|NCT03138499|12027602|FG001|STARTED|Overall Study||11
10862593|NCT03138499|12027601|FG000|COMPLETED|Overall Study||3
10862594|NCT03138499|12027602|FG001|COMPLETED|Overall Study||1
10862595|NCT03138499|12027601|FG000|NOT COMPLETED|Overall Study||9
10862596|NCT03138499|12027602|FG001|NOT COMPLETED|Overall Study||10
10862597|NCT04763044|12027613|FG000|STARTED|Period 1||3
10862598|NCT04763044|12027614|FG001|STARTED|Period 1||4
10862599|NCT04763044|12027615|FG002|STARTED|Period 1||4
10862600|NCT04763044|12027616|FG003|STARTED|Period 1||4
10862601|NCT04763044|12027613|FG000|COMPLETED|Period 1||3
10862602|NCT04763044|12027614|FG001|COMPLETED|Period 1||4
10862603|NCT04763044|12027615|FG002|COMPLETED|Period 1||4
10862604|NCT04763044|12027616|FG003|COMPLETED|Period 1||3
10862605|NCT04763044|12027613|FG000|NOT COMPLETED|Period 1||0
10862606|NCT04763044|12027614|FG001|NOT COMPLETED|Period 1||0
10862607|NCT04763044|12027615|FG002|NOT COMPLETED|Period 1||0
10862608|NCT04763044|12027616|FG003|NOT COMPLETED|Period 1||1
10862609|NCT04763044|12027613|FG000|STARTED|Period 2||3
10862610|NCT04763044|12027614|FG001|STARTED|Period 2||4
10862611|NCT04763044|12027615|FG002|STARTED|Period 2||4
10862612|NCT04763044|12027616|FG003|STARTED|Period 2||3
10862613|NCT04763044|12027613|FG000|COMPLETED|Period 2||3
10862614|NCT04763044|12027614|FG001|COMPLETED|Period 2||4
10862615|NCT04763044|12027615|FG002|COMPLETED|Period 2||4
10862616|NCT04763044|12027616|FG003|COMPLETED|Period 2||3
10862617|NCT04763044|12027613|FG000|NOT COMPLETED|Period 2||0
10862618|NCT04763044|12027614|FG001|NOT COMPLETED|Period 2||0
10862619|NCT04763044|12027615|FG002|NOT COMPLETED|Period 2||0
10862620|NCT04763044|12027616|FG003|NOT COMPLETED|Period 2||0
10862621|NCT04763044|12027613|FG000|STARTED|Period 3||3
10862622|NCT04763044|12027614|FG001|STARTED|Period 3||4
10862623|NCT04763044|12027615|FG002|STARTED|Period 3||4
10862624|NCT04763044|12027616|FG003|STARTED|Period 3||3
10862625|NCT04763044|12027613|FG000|COMPLETED|Period 3||3
10862626|NCT04763044|12027614|FG001|COMPLETED|Period 3||4
10862627|NCT04763044|12027615|FG002|COMPLETED|Period 3||4
10862628|NCT04763044|12027616|FG003|COMPLETED|Period 3||3
10862629|NCT04763044|12027613|FG000|NOT COMPLETED|Period 3||0
10862630|NCT04763044|12027614|FG001|NOT COMPLETED|Period 3||0
10862631|NCT04763044|12027615|FG002|NOT COMPLETED|Period 3||0
10862632|NCT04763044|12027616|FG003|NOT COMPLETED|Period 3||0
10862633|NCT04763044|12027613|FG000|STARTED|Period 4||3
10862634|NCT04763044|12027614|FG001|STARTED|Period 4||3
10862635|NCT04763044|12027615|FG002|STARTED|Period 4||4
10862636|NCT04763044|12027616|FG003|STARTED|Period 4||3
11107970|NCT01265550|12292322|FG000|COMPLETED|Post Randomization||10
11107971|NCT01265550|12292323|FG001|COMPLETED|Post Randomization||19
11107972|NCT01265550|12292324|FG002|COMPLETED|Post Randomization||6
11107973|NCT01265550|12292325|FG003|COMPLETED|Post Randomization||0
11107974|NCT01265550|12292322|FG000|NOT COMPLETED|Post Randomization||15
11107975|NCT01265550|12292323|FG001|NOT COMPLETED|Post Randomization||8
11107976|NCT01265550|12292324|FG002|NOT COMPLETED|Post Randomization||20
11227681|NCT02004886|12419788|FG000|NOT COMPLETED|Overall Study||1
11227682|NCT02004886|12419789|FG001|NOT COMPLETED|Overall Study||1
11227683|NCT02004886|12419790|FG002|NOT COMPLETED|Overall Study||0
11227684|NCT02004886|12419791|FG003|NOT COMPLETED|Overall Study||0
11227685|NCT02004977|12419803|FG000|STARTED|Overall Study||463
11227686|NCT02004977|12419804|FG001|STARTED|Overall Study||441
11227687|NCT02004977|12419803|FG000|COMPLETED|Overall Study||409
11227688|NCT02004977|12419804|FG001|COMPLETED|Overall Study||436
11227689|NCT02004977|12419803|FG000|NOT COMPLETED|Overall Study||54
11227690|NCT02004977|12419804|FG001|NOT COMPLETED|Overall Study||5
11227691|NCT02004990|12419810|FG000|STARTED|Overall Study||12
11227692|NCT02004990|12419810|FG000|COMPLETED|Overall Study||12
11227693|NCT02004990|12419810|FG000|NOT COMPLETED|Overall Study||0
11227694|NCT02005016|12419814|FG000|STARTED|Overall Study||46
10862637|NCT04763044|12027613|FG000|COMPLETED|Period 4||3
10862638|NCT04763044|12027614|FG001|COMPLETED|Period 4||3
10862639|NCT04763044|12027615|FG002|COMPLETED|Period 4||4
10862640|NCT04763044|12027616|FG003|COMPLETED|Period 4||3
10862641|NCT04763044|12027613|FG000|NOT COMPLETED|Period 4||0
10862642|NCT04763044|12027614|FG001|NOT COMPLETED|Period 4||0
10862643|NCT04763044|12027615|FG002|NOT COMPLETED|Period 4||0
10862644|NCT04763044|12027616|FG003|NOT COMPLETED|Period 4||0
10862645|NCT04763044|12027613|FG000|STARTED|Period 5||3
10862646|NCT04763044|12027614|FG001|STARTED|Period 5||3
10862647|NCT04763044|12027615|FG002|STARTED|Period 5||4
11107977|NCT01265550|12292325|FG003|NOT COMPLETED|Post Randomization||0
11107978|NCT01265563|12292344|FG000|STARTED|Overall Study||16
11107979|NCT01265563|12292345|FG001|STARTED|Overall Study||13
11107980|NCT01265563|12292346|FG002|STARTED|Overall Study||17
11107981|NCT01265563|12292347|FG003|STARTED|Overall Study||16
11107982|NCT01265563|12292348|FG004|STARTED|Overall Study||16
11107983|NCT01265563|12292344|FG000|COMPLETED|Overall Study||16
11107984|NCT01265563|12292345|FG001|COMPLETED|Overall Study||12
11107985|NCT01265563|12292346|FG002|COMPLETED|Overall Study||16
10862648|NCT04763044|12027616|FG003|STARTED|Period 5||3
10862649|NCT04763044|12027613|FG000|COMPLETED|Period 5||2
10862650|NCT04763044|12027614|FG001|COMPLETED|Period 5||3
10862651|NCT04763044|12027615|FG002|COMPLETED|Period 5||4
10862652|NCT04763044|12027616|FG003|COMPLETED|Period 5||3
10862653|NCT04763044|12027613|FG000|NOT COMPLETED|Period 5||1
10862654|NCT04763044|12027614|FG001|NOT COMPLETED|Period 5||0
10862655|NCT04763044|12027615|FG002|NOT COMPLETED|Period 5||0
10862656|NCT04763044|12027616|FG003|NOT COMPLETED|Period 5||0
11107986|NCT01265563|12292347|FG003|COMPLETED|Overall Study||16
11107987|NCT01265563|12292348|FG004|COMPLETED|Overall Study||14
11107988|NCT01265563|12292344|FG000|NOT COMPLETED|Overall Study||0
11107989|NCT01265563|12292345|FG001|NOT COMPLETED|Overall Study||1
11107990|NCT01265563|12292346|FG002|NOT COMPLETED|Overall Study||1
11107991|NCT01265563|12292347|FG003|NOT COMPLETED|Overall Study||0
10862663|NCT04466384|12027637|FG000|STARTED|First Phase||14
10862664|NCT04466384|12027638|FG001|STARTED|First Phase||10
10862665|NCT04466384|12027637|FG000|COMPLETED|First Phase||12
10862666|NCT04466384|12027638|FG001|COMPLETED|First Phase||10
10862667|NCT04466384|12027637|FG000|NOT COMPLETED|First Phase||2
10862668|NCT04466384|12027638|FG001|NOT COMPLETED|First Phase||0
10862669|NCT04466384|12027637|FG000|STARTED|Cross Over Phase||14
10862670|NCT04466384|12027638|FG001|STARTED|Cross Over Phase||10
10862671|NCT04466384|12027637|FG000|COMPLETED|Cross Over Phase||13
10862672|NCT04466384|12027638|FG001|COMPLETED|Cross Over Phase||9
10862673|NCT04466384|12027637|FG000|NOT COMPLETED|Cross Over Phase||1
10862674|NCT04466384|12027638|FG001|NOT COMPLETED|Cross Over Phase||1
11107992|NCT01265563|12292348|FG004|NOT COMPLETED|Overall Study||2
11107993|NCT01265615|12292369|FG000|STARTED|Overall Study||30
11107994|NCT01265615|12292370|FG001|STARTED|Overall Study||30
11107995|NCT01265615|12292371|FG002|STARTED|Overall Study||30
11107996|NCT01265615|12292372|FG003|STARTED|Overall Study||30
11107997|NCT01265615|12292369|FG000|COMPLETED|Overall Study||28
11107998|NCT01265615|12292370|FG001|COMPLETED|Overall Study||28
11107999|NCT01265615|12292371|FG002|COMPLETED|Overall Study||26
11108000|NCT01265615|12292372|FG003|COMPLETED|Overall Study||27
11108001|NCT01265615|12292369|FG000|NOT COMPLETED|Overall Study||2
11108002|NCT01265615|12292370|FG001|NOT COMPLETED|Overall Study||2
11108003|NCT01265615|12292371|FG002|NOT COMPLETED|Overall Study||4
11108004|NCT01265615|12292372|FG003|NOT COMPLETED|Overall Study||3
11108005|NCT01265667|12292384|FG000|STARTED|Overall Study||145
11108006|NCT01265667|12292385|FG001|STARTED|Overall Study||148
11108007|NCT01265667|12292384|FG000|COMPLETED|Overall Study||125
11108008|NCT01265667|12292385|FG001|COMPLETED|Overall Study||135
11108009|NCT01265667|12292384|FG000|NOT COMPLETED|Overall Study||20
10862693|NCT04428645|12027662|FG000|STARTED|Run in Visit Training (2 Hours)||25
10862694|NCT04428645|12027662|FG000|COMPLETED|Run in Visit Training (2 Hours)||25
10862695|NCT04428645|12027662|FG000|NOT COMPLETED|Run in Visit Training (2 Hours)||0
10862696|NCT04428645|12027662|FG000|STARTED|First at Home Period (~2 Weeks)||25
10862697|NCT04428645|12027662|FG000|COMPLETED|First at Home Period (~2 Weeks)||25
10862698|NCT04428645|12027662|FG000|NOT COMPLETED|First at Home Period (~2 Weeks)||0
10862699|NCT04428645|12027662|FG000|STARTED|DailyDose Training Visit (2 Hours)||25
10862700|NCT04428645|12027662|FG000|COMPLETED|DailyDose Training Visit (2 Hours)||25
10862701|NCT04428645|12027662|FG000|NOT COMPLETED|DailyDose Training Visit (2 Hours)||0
10862702|NCT04428645|12027662|FG000|STARTED|Second at Home Period (8 Weeks)||25
10862703|NCT04428645|12027662|FG000|COMPLETED|Second at Home Period (8 Weeks)||24
10862704|NCT04428645|12027662|FG000|NOT COMPLETED|Second at Home Period (8 Weeks)||1
10862705|NCT04428645|12027662|FG000|STARTED|Study Close-out Visit (30 Minutes)||24
10862706|NCT04428645|12027662|FG000|COMPLETED|Study Close-out Visit (30 Minutes)||24
10862707|NCT04428645|12027662|FG000|NOT COMPLETED|Study Close-out Visit (30 Minutes)||0
10862708|NCT04371471|12027666|FG000|STARTED|Overall Study||91
10862709|NCT04371471|12027666|FG000|COMPLETED|Overall Study||81
10862710|NCT04371471|12027666|FG000|NOT COMPLETED|Overall Study||10
10862711|NCT04157751|12027674|FG000|STARTED|Overall Study||265
10862712|NCT04157751|12027675|FG001|STARTED|Overall Study||265
10862713|NCT04157751|12027674|FG000|Treated|Overall Study||264
10862714|NCT04157751|12027675|FG001|Treated|Overall Study||260
10862715|NCT04157751|12027674|FG000|COMPLETED|Overall Study||202
10862716|NCT04157751|12027675|FG001|COMPLETED|Overall Study||208
10862717|NCT04157751|12027674|FG000|NOT COMPLETED|Overall Study||63
10862718|NCT04157751|12027675|FG001|NOT COMPLETED|Overall Study||57
10862719|NCT04151628|12027683|FG000|STARTED|Overall Study||8
10862720|NCT04151628|12027684|FG001|STARTED|Overall Study||64
10862721|NCT04151628|12027683|FG000|COMPLETED|Overall Study||8
10862722|NCT04151628|12027684|FG001|COMPLETED|Overall Study||64
10862723|NCT04151628|12027683|FG000|NOT COMPLETED|Overall Study||0
10862724|NCT04151628|12027684|FG001|NOT COMPLETED|Overall Study||0
10862725|NCT04086121|12027691|FG000|STARTED|Overall Study||14
10862726|NCT04086121|12027691|FG000|COMPLETED|Overall Study||0
10862727|NCT04086121|12027691|FG000|NOT COMPLETED|Overall Study||14
10862728|NCT04046328|12027696|FG000|STARTED|First Intervention (14 Days)||6
10862729|NCT04046328|12027697|FG001|STARTED|First Intervention (14 Days)||7
10862730|NCT04046328|12027696|FG000|COMPLETED|First Intervention (14 Days)||6
10862731|NCT04046328|12027697|FG001|COMPLETED|First Intervention (14 Days)||7
10862732|NCT04046328|12027696|FG000|NOT COMPLETED|First Intervention (14 Days)||0
10862733|NCT04046328|12027697|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10862734|NCT04046328|12027696|FG000|STARTED|Washout (14 Days)||6
11108010|NCT01265667|12292385|FG001|NOT COMPLETED|Overall Study||13
11108011|NCT01265719|12292393|FG000|STARTED|Overall Study||102
11108012|NCT01265719|12292394|FG001|STARTED|Overall Study||73
10862735|NCT04046328|12027697|FG001|STARTED|Washout (14 Days)||7
10862736|NCT04046328|12027696|FG000|COMPLETED|Washout (14 Days)||6
10862737|NCT04046328|12027697|FG001|COMPLETED|Washout (14 Days)||7
10862738|NCT04046328|12027696|FG000|NOT COMPLETED|Washout (14 Days)||0
11355024|NCT03076970|12551946|FG003|STARTED|Washout Period 1||7
10862739|NCT04046328|12027697|FG001|NOT COMPLETED|Washout (14 Days)||0
10862740|NCT04046328|12027696|FG000|STARTED|Second Intervention (14 Days)||6
10862741|NCT04046328|12027697|FG001|STARTED|Second Intervention (14 Days)||7
10862742|NCT04046328|12027696|FG000|COMPLETED|Second Intervention (14 Days)||6
10862743|NCT04046328|12027697|FG001|COMPLETED|Second Intervention (14 Days)||7
10862744|NCT04046328|12027696|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
10862745|NCT04046328|12027697|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
10862746|NCT03988205|12027703|FG000|STARTED|Overall Study||3
10862747|NCT03988205|12027703|FG000|COMPLETED|Overall Study||3
10862748|NCT03988205|12027703|FG000|NOT COMPLETED|Overall Study||0
10862749|NCT03965962|12027711|FG000|STARTED|Overall Study||320
10862750|NCT03965962|12027712|FG001|STARTED|Overall Study||107
10862751|NCT03965962|12027713|FG002|STARTED|Overall Study||107
10862752|NCT03965962|12027714|FG003|STARTED|Overall Study||106
10862753|NCT03965962|12027711|FG000|Vaccination 1 (Day 0)|Overall Study||318
10862754|NCT03965962|12027712|FG001|Vaccination 1 (Day 0)|Overall Study||107
10862755|NCT03965962|12027713|FG002|Vaccination 1 (Day 0)|Overall Study||107
10862756|NCT03965962|12027714|FG003|Vaccination 1 (Day 0)|Overall Study||106
10862757|NCT03965962|12027711|FG000|Vaccination 2 (Day 3)|Overall Study||317
10862758|NCT03965962|12027712|FG001|Vaccination 2 (Day 3)|Overall Study||104
10862759|NCT03965962|12027713|FG002|Vaccination 2 (Day 3)|Overall Study||107
11227695|NCT02005016|12419814|FG000|COMPLETED|Overall Study||44
11227696|NCT02005016|12419814|FG000|NOT COMPLETED|Overall Study||2
11227697|NCT02005029|12419820|FG000|STARTED|First Intervention (1 Day)||5
11227698|NCT02005029|12419821|FG001|STARTED|First Intervention (1 Day)||5
11227699|NCT02005029|12419820|FG000|COMPLETED|First Intervention (1 Day)||4
11227700|NCT02005029|12419821|FG001|COMPLETED|First Intervention (1 Day)||5
11227701|NCT02005029|12419820|FG000|NOT COMPLETED|First Intervention (1 Day)||1
11227702|NCT02005029|12419821|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11227703|NCT02005029|12419820|FG000|STARTED|Washout (2 Weeks)||4
11227704|NCT02005029|12419821|FG001|STARTED|Washout (2 Weeks)||5
11227705|NCT02005029|12419820|FG000|COMPLETED|Washout (2 Weeks)||4
11227706|NCT02005029|12419821|FG001|COMPLETED|Washout (2 Weeks)||5
11227707|NCT02005029|12419820|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11227708|NCT02005029|12419821|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11227709|NCT02005029|12419820|FG000|STARTED|Second Intervention (1 Day)||4
11227710|NCT02005029|12419821|FG001|STARTED|Second Intervention (1 Day)||5
11227711|NCT02005029|12419820|FG000|COMPLETED|Second Intervention (1 Day)||4
11227712|NCT02005029|12419821|FG001|COMPLETED|Second Intervention (1 Day)||5
11227713|NCT02005029|12419820|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11227714|NCT02005029|12419821|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11227715|NCT02005211|12419852|FG000|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
11227716|NCT02005211|12419853|FG001|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
11227717|NCT02005211|12419854|FG002|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
11227718|NCT02005211|12419855|FG003|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
11227719|NCT02005211|12419856|FG004|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
11227720|NCT02005211|12419857|FG005|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
11227721|NCT02005211|12419858|FG006|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
11227722|NCT02005211|12419852|FG000|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
11227723|NCT02005211|12419853|FG001|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
11227724|NCT02005211|12419854|FG002|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
11227725|NCT02005211|12419855|FG003|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
11227726|NCT02005211|12419856|FG004|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
11227727|NCT02005211|12419857|FG005|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
11227728|NCT02005211|12419858|FG006|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
11227729|NCT02005211|12419852|FG000|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
11227730|NCT02005211|12419853|FG001|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
11227731|NCT02005211|12419854|FG002|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
11227732|NCT02005211|12419855|FG003|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
11227733|NCT02005211|12419856|FG004|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
11227734|NCT02005211|12419857|FG005|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
11227735|NCT02005211|12419858|FG006|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
11227736|NCT02005211|12419852|FG000|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
11227737|NCT02005211|12419853|FG001|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
11227738|NCT02005211|12419854|FG002|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
11227739|NCT02005211|12419855|FG003|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
11227740|NCT02005211|12419856|FG004|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
11227741|NCT02005211|12419857|FG005|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
11227742|NCT02005211|12419858|FG006|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
10862760|NCT03965962|12027714|FG003|Vaccination 2 (Day 3)|Overall Study||106
10862761|NCT03965962|12027711|FG000|Vaccination 3 (Day 7)|Overall Study||311
11227743|NCT02005211|12419852|FG000|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
11227744|NCT02005211|12419853|FG001|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
11227745|NCT02005211|12419854|FG002|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
11227746|NCT02005211|12419855|FG003|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
11355025|NCT03076970|12551947|FG004|STARTED|Washout Period 1||7
11227747|NCT02005211|12419856|FG004|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
11227748|NCT02005211|12419857|FG005|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
11227749|NCT02005211|12419858|FG006|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
11227750|NCT02005211|12419852|FG000|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
11227751|NCT02005211|12419853|FG001|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
11227752|NCT02005211|12419854|FG002|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
11227753|NCT02005211|12419855|FG003|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
11227754|NCT02005211|12419856|FG004|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
10862762|NCT03965962|12027712|FG001|Vaccination 3 (Day 7)|Overall Study||103
10862763|NCT03965962|12027713|FG002|Vaccination 3 (Day 7)|Overall Study||105
10862764|NCT03965962|12027714|FG003|Vaccination 3 (Day 7)|Overall Study||105
10862765|NCT03965962|12027711|FG000|Vaccination 4 (Day 14)|Overall Study||301
10862766|NCT03965962|12027712|FG001|Vaccination 4 (Day 14)|Overall Study||101
10862767|NCT03965962|12027713|FG002|Vaccination 4 (Day 14)|Overall Study||101
10862768|NCT03965962|12027714|FG003|Vaccination 4 (Day 14)|Overall Study||103
10862769|NCT03965962|12027711|FG000|Vaccination 5 (Day 28)|Overall Study||294
10862770|NCT03965962|12027712|FG001|Vaccination 5 (Day 28)|Overall Study||98
10862771|NCT03965962|12027713|FG002|Vaccination 5 (Day 28)|Overall Study||97
10862772|NCT03965962|12027714|FG003|Vaccination 5 (Day 28)|Overall Study||98
10862773|NCT03965962|12027711|FG000|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to Group 4: VRVg-2 received vaccination in Group 1: VRVg-2+HRIG and were considered in Group 1 for safety analysis purpose.|320
10862774|NCT03965962|12027712|FG001|Safety Analysis Set (SafAS)|Overall Study||107
10862775|NCT03965962|12027713|FG002|Safety Analysis Set (SafAS)|Overall Study||107
10862776|NCT03965962|12027714|FG003|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to Group 4: VRVg-2 received vaccination in Group 1: VRVg-2+HRIG and were considered in Group 1 for safety analysis purpose.|104
10862777|NCT03965962|12027711|FG000|COMPLETED|Overall Study||295
10862778|NCT03965962|12027712|FG001|COMPLETED|Overall Study||102
10862779|NCT03965962|12027713|FG002|COMPLETED|Overall Study||97
10862780|NCT03965962|12027714|FG003|COMPLETED|Overall Study||100
10862781|NCT03965962|12027711|FG000|NOT COMPLETED|Overall Study||25
10862782|NCT03965962|12027712|FG001|NOT COMPLETED|Overall Study||5
10862783|NCT03965962|12027713|FG002|NOT COMPLETED|Overall Study||10
10862784|NCT03965962|12027714|FG003|NOT COMPLETED|Overall Study||6
11227755|NCT02005211|12419857|FG005|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
11108013|NCT01265719|12292393|FG000|COMPLETED|Overall Study||88
11108014|NCT01265719|12292394|FG001|COMPLETED|Overall Study||60
11108015|NCT01265719|12292393|FG000|NOT COMPLETED|Overall Study||14
11108016|NCT01265719|12292394|FG001|NOT COMPLETED|Overall Study||13
11108017|NCT01265797|12292402|FG000|STARTED|Run-in Month||34
11108018|NCT01265797|12292403|FG001|STARTED|Run-in Month||34
11108019|NCT01265797|12292402|FG000|COMPLETED|Run-in Month||34
11108020|NCT01265797|12292403|FG001|COMPLETED|Run-in Month||29
11108021|NCT01265797|12292402|FG000|NOT COMPLETED|Run-in Month||0
11108022|NCT01265797|12292403|FG001|NOT COMPLETED|Run-in Month||5
11108023|NCT01265797|12292402|FG000|STARTED|Blinded Month||34
11108024|NCT01265797|12292403|FG001|STARTED|Blinded Month||29
11108025|NCT01265797|12292402|FG000|COMPLETED|Blinded Month||24
11108026|NCT01265797|12292403|FG001|COMPLETED|Blinded Month||27
11108027|NCT01265797|12292402|FG000|NOT COMPLETED|Blinded Month||10
11108028|NCT01265797|12292403|FG001|NOT COMPLETED|Blinded Month||2
11108029|NCT01265797|12292402|FG000|STARTED|Open Label Month||24
11108030|NCT01265797|12292403|FG001|STARTED|Open Label Month||27
11108031|NCT01265797|12292402|FG000|COMPLETED|Open Label Month||24
11108032|NCT01265797|12292403|FG001|COMPLETED|Open Label Month||26
11108033|NCT01265797|12292402|FG000|NOT COMPLETED|Open Label Month||0
11108034|NCT01265797|12292403|FG001|NOT COMPLETED|Open Label Month||1
10862807|NCT03112590|12027755|FG000|STARTED|Overall Study||3
10862808|NCT03112590|12027756|FG001|STARTED|Overall Study||6
10862809|NCT03112590|12027757|FG002|STARTED|Overall Study||42
10862810|NCT03112590|12027755|FG000|COMPLETED|Overall Study||3
10862811|NCT03112590|12027756|FG001|COMPLETED|Overall Study||5
10862812|NCT03112590|12027757|FG002|COMPLETED|Overall Study||42
10862813|NCT03112590|12027755|FG000|NOT COMPLETED|Overall Study||0
10862814|NCT03112590|12027756|FG001|NOT COMPLETED|Overall Study||1
10862815|NCT03112590|12027757|FG002|NOT COMPLETED|Overall Study||0
10862816|NCT03086343|12027767|FG000|STARTED|Overall Study||309
10862817|NCT03086343|12027768|FG001|STARTED|Overall Study||303
10862818|NCT03086343|12027767|FG000|COMPLETED|Overall Study||277
10862819|NCT03086343|12027768|FG001|COMPLETED|Overall Study||278
10862820|NCT03086343|12027767|FG000|NOT COMPLETED|Overall Study||32
10862821|NCT03086343|12027768|FG001|NOT COMPLETED|Overall Study||25
11108035|NCT01265823|12292411|FG000|STARTED|Overall Study||150
11108036|NCT01265823|12292411|FG000|COMPLETED|Overall Study||143
11108037|NCT01265823|12292411|FG000|NOT COMPLETED|Overall Study||7
11108038|NCT01265875|12292419|FG000|STARTED|Overall Study||12
11108039|NCT01265875|12292419|FG000|COMPLETED|Overall Study||11
11108040|NCT01265875|12292419|FG000|NOT COMPLETED|Overall Study||1
11108041|NCT01265953|12292426|FG000|STARTED|Overall Study||50
11108042|NCT01265953|12292427|FG001|STARTED|Overall Study||48
11108043|NCT01265953|12292426|FG000|COMPLETED|Overall Study||45
11108044|NCT01265953|12292427|FG001|COMPLETED|Overall Study||45
11108045|NCT01265953|12292426|FG000|NOT COMPLETED|Overall Study||5
11108046|NCT01265953|12292427|FG001|NOT COMPLETED|Overall Study||3
11108047|NCT01265966|12292436|FG000|STARTED|Overall Study||47
11108048|NCT01265966|12292437|FG001|STARTED|Overall Study||41
11108049|NCT01265966|12292438|FG002|STARTED|Overall Study||29
10862834|NCT02657434|12027785|FG000|STARTED|Overall Study||286
10862835|NCT02657434|12027786|FG001|STARTED|Overall Study||292
10862836|NCT02657434|12027785|FG000|COMPLETED|Overall Study||0
10862837|NCT02657434|12027786|FG001|COMPLETED|Overall Study||0
10862838|NCT02657434|12027785|FG000|NOT COMPLETED|Overall Study||286
10862839|NCT02657434|12027786|FG001|NOT COMPLETED|Overall Study||292
11227756|NCT02005211|12419858|FG006|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
11227757|NCT02005250|12419883|FG000|STARTED|Overall Study||61
10862840|NCT02583269|12027798|FG000|STARTED|Overall Study||3
10862841|NCT02583269|12027799|FG001|STARTED|Overall Study||7
10862842|NCT02583269|12027800|FG002|STARTED|Overall Study||3
10862843|NCT02583269|12027801|FG003|STARTED|Overall Study||5
11227758|NCT02005250|12419884|FG001|STARTED|Overall Study||32
11227759|NCT02005250|12419883|FG000|COMPLETED|Overall Study||46
11227760|NCT02005250|12419884|FG001|COMPLETED|Overall Study||27
11227761|NCT02005250|12419883|FG000|NOT COMPLETED|Overall Study||15
11227762|NCT02005250|12419884|FG001|NOT COMPLETED|Overall Study||5
11227763|NCT02005276|12419894|FG000|STARTED|Overall Study||65
11227764|NCT02005276|12419895|FG001|STARTED|Overall Study||41
11227765|NCT02005276|12419896|FG002|STARTED|Overall Study||59
11227766|NCT02005276|12419897|FG003|STARTED|Overall Study||44
11227767|NCT02005276|12419894|FG000|Completed Intervention|Overall Study||61
11227768|NCT02005276|12419895|FG001|Completed Intervention|Overall Study||39
11227769|NCT02005276|12419896|FG002|Completed Intervention|Overall Study||56
11227770|NCT02005276|12419897|FG003|Completed Intervention|Overall Study||42
11227771|NCT02005276|12419894|FG000|COMPLETED|Overall Study||60
11227772|NCT02005276|12419895|FG001|COMPLETED|Overall Study||39
11227773|NCT02005276|12419896|FG002|COMPLETED|Overall Study||56
11227774|NCT02005276|12419897|FG003|COMPLETED|Overall Study||41
11227775|NCT02005276|12419894|FG000|NOT COMPLETED|Overall Study||5
11227776|NCT02005276|12419895|FG001|NOT COMPLETED|Overall Study||2
11227777|NCT02005276|12419896|FG002|NOT COMPLETED|Overall Study||3
11227778|NCT02005276|12419897|FG003|NOT COMPLETED|Overall Study||3
11227779|NCT02005354|12419911|FG000|STARTED|Overall Study||35
11227780|NCT02005354|12419912|FG001|STARTED|Overall Study||35
11227781|NCT02005354|12419911|FG000|COMPLETED|Overall Study||35
11227782|NCT02005354|12419912|FG001|COMPLETED|Overall Study||35
11227783|NCT02005354|12419911|FG000|NOT COMPLETED|Overall Study||0
11227784|NCT02005354|12419912|FG001|NOT COMPLETED|Overall Study||0
11227785|NCT02005393|12419918|FG000|STARTED|Overall Study||20
11227786|NCT02005393|12419918|FG000|COMPLETED|Overall Study||20
11227787|NCT02005393|12419918|FG000|NOT COMPLETED|Overall Study||0
11227788|NCT02005484|12419922|FG000|STARTED|Overall Study||6
11227789|NCT02005484|12419922|FG000|COMPLETED|Overall Study||2
11227790|NCT02005484|12419922|FG000|NOT COMPLETED|Overall Study||4
11227791|NCT02005510|12419928|FG000|STARTED|Randomized (Round 1)|Excludes 163 determined to be ineligible post-randomization due to delays in data warehouse update.|8120
11227792|NCT02005510|12419929|FG001|STARTED|Randomized (Round 1)|Excludes 196 determined to be ineligible post-randomization due to delays in data warehouse update.|8111
11227793|NCT02005510|12419928|FG000|COMPLETED|Randomized (Round 1)||8120
11227794|NCT02005510|12419929|FG001|COMPLETED|Randomized (Round 1)||8111
11227795|NCT02005510|12419928|FG000|NOT COMPLETED|Randomized (Round 1)||0
11227796|NCT02005510|12419929|FG001|NOT COMPLETED|Randomized (Round 1)||0
11227797|NCT02005510|12419928|FG000|STARTED|Rerandomized (Round 2)|Excludes 10 determined to be ineligible post-randomization due to delays in data warehouse update.|1631
11227798|NCT02005510|12419929|FG001|STARTED|Rerandomized (Round 2)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|1585
11227799|NCT02005510|12419928|FG000|COMPLETED|Rerandomized (Round 2)||1631
11355026|NCT03076970|12551948|FG005|STARTED|Washout Period 1||7
11355027|NCT03076970|12551943|FG000|COMPLETED|Washout Period 1||7
11355028|NCT03076970|12551944|FG001|COMPLETED|Washout Period 1||7
11355029|NCT03076970|12551945|FG002|COMPLETED|Washout Period 1||7
11355030|NCT03076970|12551946|FG003|COMPLETED|Washout Period 1||7
11355031|NCT03076970|12551947|FG004|COMPLETED|Washout Period 1||7
11355032|NCT03076970|12551948|FG005|COMPLETED|Washout Period 1||7
11355033|NCT03076970|12551943|FG000|NOT COMPLETED|Washout Period 1||0
11355034|NCT03076970|12551944|FG001|NOT COMPLETED|Washout Period 1||0
11355035|NCT03076970|12551945|FG002|NOT COMPLETED|Washout Period 1||0
11355036|NCT03076970|12551946|FG003|NOT COMPLETED|Washout Period 1||0
11355037|NCT03076970|12551947|FG004|NOT COMPLETED|Washout Period 1||0
11355038|NCT03076970|12551948|FG005|NOT COMPLETED|Washout Period 1||0
11355039|NCT03076970|12551943|FG000|STARTED|Period 2||7
11355040|NCT03076970|12551944|FG001|STARTED|Period 2||7
11355041|NCT03076970|12551945|FG002|STARTED|Period 2||7
11355042|NCT03076970|12551946|FG003|STARTED|Period 2||7
11355043|NCT03076970|12551947|FG004|STARTED|Period 2||7
11355044|NCT03076970|12551948|FG005|STARTED|Period 2||7
11355045|NCT03076970|12551943|FG000|COMPLETED|Period 2||7
11355046|NCT03076970|12551944|FG001|COMPLETED|Period 2||7
11355047|NCT03076970|12551945|FG002|COMPLETED|Period 2||7
11355048|NCT03076970|12551946|FG003|COMPLETED|Period 2||7
11355049|NCT03076970|12551947|FG004|COMPLETED|Period 2||7
11355050|NCT03076970|12551948|FG005|COMPLETED|Period 2||7
11355051|NCT03076970|12551943|FG000|NOT COMPLETED|Period 2||0
11355052|NCT03076970|12551944|FG001|NOT COMPLETED|Period 2||0
11355053|NCT03076970|12551945|FG002|NOT COMPLETED|Period 2||0
11355054|NCT03076970|12551946|FG003|NOT COMPLETED|Period 2||0
11355055|NCT03076970|12551947|FG004|NOT COMPLETED|Period 2||0
11355056|NCT03076970|12551948|FG005|NOT COMPLETED|Period 2||0
11355057|NCT03076970|12551943|FG000|STARTED|Washout Period 2||7
11355058|NCT03076970|12551944|FG001|STARTED|Washout Period 2||7
10862844|NCT02583269|12027802|FG004|STARTED|Overall Study||6
11227800|NCT02005510|12419929|FG001|COMPLETED|Rerandomized (Round 2)||1585
11227801|NCT02005510|12419928|FG000|NOT COMPLETED|Rerandomized (Round 2)||0
11227802|NCT02005510|12419929|FG001|NOT COMPLETED|Rerandomized (Round 2)||0
11227803|NCT02005510|12419928|FG000|STARTED|Rerandomized (Round 3)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|209
11227804|NCT02005510|12419929|FG001|STARTED|Rerandomized (Round 3)||195
11355059|NCT03076970|12551945|FG002|STARTED|Washout Period 2||7
11355060|NCT03076970|12551946|FG003|STARTED|Washout Period 2||7
11355061|NCT03076970|12551947|FG004|STARTED|Washout Period 2||7
11355062|NCT03076970|12551948|FG005|STARTED|Washout Period 2||7
10862845|NCT02583269|12027798|FG000|COMPLETED|Overall Study||2
10862846|NCT02583269|12027799|FG001|COMPLETED|Overall Study||7
10862847|NCT02583269|12027800|FG002|COMPLETED|Overall Study||3
10862848|NCT02583269|12027801|FG003|COMPLETED|Overall Study||5
10862849|NCT02583269|12027802|FG004|COMPLETED|Overall Study||6
10862850|NCT02583269|12027798|FG000|NOT COMPLETED|Overall Study||1
10862851|NCT02583269|12027799|FG001|NOT COMPLETED|Overall Study||0
10862852|NCT02583269|12027800|FG002|NOT COMPLETED|Overall Study||0
10862853|NCT02583269|12027801|FG003|NOT COMPLETED|Overall Study||0
10862854|NCT02583269|12027802|FG004|NOT COMPLETED|Overall Study||0
11108050|NCT01265966|12292436|FG000|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
11108051|NCT01265966|12292437|FG001|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
11108052|NCT01265966|12292438|FG002|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
11108053|NCT01265966|12292436|FG000|COMPLETED|Overall Study||44
11108054|NCT01265966|12292437|FG001|COMPLETED|Overall Study||39
11108055|NCT01265966|12292438|FG002|COMPLETED|Overall Study||27
10862861|NCT02576847|12027823|FG000|STARTED|Overall Study||307
10862862|NCT02576847|12027823|FG000|COMPLETED|Overall Study||170
10862863|NCT02576847|12027823|FG000|NOT COMPLETED|Overall Study||137
10862864|NCT02568566|12027827|FG000|STARTED|Overall Study||201
10862865|NCT02568566|12027827|FG000|COMPLETED|Overall Study||187
10862866|NCT02568566|12027827|FG000|NOT COMPLETED|Overall Study||14
11108056|NCT01265966|12292436|FG000|NOT COMPLETED|Overall Study||3
11108057|NCT01265966|12292437|FG001|NOT COMPLETED|Overall Study||2
11108058|NCT01265966|12292438|FG002|NOT COMPLETED|Overall Study||2
11108059|NCT01265992|12292446|FG000|STARTED|Overall Study||50
11108060|NCT01265992|12292446|FG000|Received Treatment|Overall Study||49
11108061|NCT01265992|12292446|FG000|COMPLETED|Overall Study||41
11108062|NCT01265992|12292446|FG000|NOT COMPLETED|Overall Study||9
11108063|NCT01266018|12292450|FG000|STARTED|Overall Study||9
11108064|NCT01266018|12292451|FG001|STARTED|Overall Study||13
10862876|NCT02428192|12027846|FG000|STARTED|Overall Study||12
10862877|NCT02428192|12027847|FG001|STARTED|Overall Study||8
10862878|NCT02428192|12027846|FG000|COMPLETED|Overall Study||0
10862879|NCT02428192|12027847|FG001|COMPLETED|Overall Study||7
10862880|NCT02428192|12027846|FG000|NOT COMPLETED|Overall Study||12
10862881|NCT02428192|12027847|FG001|NOT COMPLETED|Overall Study||1
10862882|NCT02425891|12027856|FG000|STARTED|Overall Study||451
10862883|NCT02425891|12027857|FG001|STARTED|Overall Study||451
11108065|NCT01266018|12292450|FG000|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
11108066|NCT01266018|12292451|FG001|COMPLETED|Overall Study||12
11227805|NCT02005510|12419928|FG000|COMPLETED|Rerandomized (Round 3)||209
11227806|NCT02005510|12419929|FG001|COMPLETED|Rerandomized (Round 3)||195
11227807|NCT02005510|12419928|FG000|NOT COMPLETED|Rerandomized (Round 3)||0
11227808|NCT02005510|12419929|FG001|NOT COMPLETED|Rerandomized (Round 3)||0
11227809|NCT02005536|12419935|FG000|STARTED|Overall Study||60
11227810|NCT02005536|12419935|FG000|COMPLETED|Overall Study||60
11227811|NCT02005536|12419935|FG000|NOT COMPLETED|Overall Study||0
11227812|NCT02005549|12419939|FG000|STARTED|Overall Study||18
11227813|NCT02005549|12419939|FG000|COMPLETED|Overall Study||18
11227814|NCT02005549|12419939|FG000|NOT COMPLETED|Overall Study||0
11227815|NCT02005562|12419945|FG000|STARTED|Overall Study||127
11227816|NCT02005562|12419946|FG001|STARTED|Overall Study||125
11227817|NCT02005562|12419945|FG000|Transplanted|Overall Study||126
11227818|NCT02005562|12419946|FG001|Transplanted|Overall Study||121
11227819|NCT02005562|12419945|FG000|COMPLETED|Overall Study||115
11227820|NCT02005562|12419946|FG001|COMPLETED|Overall Study||110
11227821|NCT02005562|12419945|FG000|NOT COMPLETED|Overall Study||12
11227822|NCT02005562|12419946|FG001|NOT COMPLETED|Overall Study||15
11227823|NCT02005601|12419954|FG000|STARTED|Overall Study||53
11227824|NCT02005601|12419955|FG001|STARTED|Overall Study||53
11227825|NCT02005601|12419954|FG000|COMPLETED|Overall Study||53
11227826|NCT02005601|12419955|FG001|COMPLETED|Overall Study||53
11227827|NCT02005601|12419954|FG000|NOT COMPLETED|Overall Study||0
11227828|NCT02005601|12419955|FG001|NOT COMPLETED|Overall Study||0
11227829|NCT02005627|12419963|FG000|STARTED|Overall Study||23
11355063|NCT03076970|12551943|FG000|COMPLETED|Washout Period 2||7
11355064|NCT03076970|12551944|FG001|COMPLETED|Washout Period 2||7
11355065|NCT03076970|12551945|FG002|COMPLETED|Washout Period 2||7
11355066|NCT03076970|12551946|FG003|COMPLETED|Washout Period 2||7
10862884|NCT02425891|12027856|FG000|COMPLETED|Overall Study||0
11108067|NCT01266018|12292450|FG000|NOT COMPLETED|Overall Study||1
11108068|NCT01266018|12292451|FG001|NOT COMPLETED|Overall Study||1
11108069|NCT01266070|12292457|FG000|STARTED|Overall Study||6
11108070|NCT01266070|12292457|FG000|COMPLETED|Overall Study||2
11108071|NCT01266070|12292457|FG000|NOT COMPLETED|Overall Study||4
11108072|NCT01266122|12292463|FG000|STARTED|Overall Study||48
11108073|NCT01266122|12292464|FG001|STARTED|Overall Study||48
11355067|NCT03076970|12551947|FG004|COMPLETED|Washout Period 2||6
11108074|NCT01266122|12292463|FG000|COMPLETED|Overall Study||42
11227830|NCT02005627|12419964|FG001|STARTED|Overall Study||23
11227831|NCT02005627|12419963|FG000|COMPLETED|Overall Study||21
11227832|NCT02005627|12419964|FG001|COMPLETED|Overall Study||19
11227833|NCT02005627|12419963|FG000|NOT COMPLETED|Overall Study||2
11227834|NCT02005627|12419964|FG001|NOT COMPLETED|Overall Study||4
11227835|NCT02005666|12419974|FG000|STARTED|Overall Study||338
11355068|NCT03076970|12551948|FG005|COMPLETED|Washout Period 2||7
10862885|NCT02425891|12027857|FG001|COMPLETED|Overall Study||0
10862886|NCT02425891|12027856|FG000|NOT COMPLETED|Overall Study||451
10862887|NCT02425891|12027857|FG001|NOT COMPLETED|Overall Study||451
11108075|NCT01266122|12292464|FG001|COMPLETED|Overall Study||42
11108076|NCT01266122|12292463|FG000|NOT COMPLETED|Overall Study||6
11108077|NCT01266122|12292464|FG001|NOT COMPLETED|Overall Study||6
11108078|NCT01266148|12292472|FG000|STARTED|Overall Study||56
11108079|NCT01266148|12292473|FG001|STARTED|Overall Study||59
11108080|NCT01266148|12292472|FG000|COMPLETED|Overall Study||49
11108081|NCT01266148|12292473|FG001|COMPLETED|Overall Study||56
11108082|NCT01266148|12292472|FG000|NOT COMPLETED|Overall Study||7
10862896|NCT02359838|12027876|FG000|STARTED|Overall Study||100
10862897|NCT02359838|12027877|FG001|STARTED|Overall Study||60
10862898|NCT02359838|12027876|FG000|COMPLETED|Overall Study||100
10862899|NCT02359838|12027877|FG001|COMPLETED|Overall Study||48
10862900|NCT02359838|12027876|FG000|NOT COMPLETED|Overall Study||0
10862901|NCT02359838|12027877|FG001|NOT COMPLETED|Overall Study||12
10862902|NCT02352948|12027889|FG000|STARTED|Overall Study||62
10862903|NCT02352948|12027890|FG001|STARTED|Overall Study||64
10862904|NCT02352948|12027891|FG002|STARTED|Overall Study||174
10862905|NCT02352948|12027892|FG003|STARTED|Overall Study||118
10862906|NCT02352948|12027893|FG004|STARTED|Overall Study||117
10862907|NCT02352948|12027894|FG005|STARTED|Overall Study||60
10862908|NCT02352948|12027889|FG000|Received Treatment|Overall Study||62
10862909|NCT02352948|12027890|FG001|Received Treatment|Overall Study||63
10862910|NCT02352948|12027891|FG002|Received Treatment|Overall Study||173
10862911|NCT02352948|12027892|FG003|Received Treatment|Overall Study||110
11108083|NCT01266148|12292473|FG001|NOT COMPLETED|Overall Study||3
11108084|NCT01266161|12292481|FG000|STARTED|Overall Study||52
11108085|NCT01266161|12292482|FG001|STARTED|Overall Study||54
11108086|NCT01266161|12292481|FG000|COMPLETED|Overall Study||48
11108087|NCT01266161|12292482|FG001|COMPLETED|Overall Study||53
11108088|NCT01266161|12292481|FG000|NOT COMPLETED|Overall Study||4
11108089|NCT01266161|12292482|FG001|NOT COMPLETED|Overall Study||1
11108090|NCT01266265|12292490|FG000|STARTED|Overall Study||666
11108091|NCT01266265|12292491|FG001|STARTED|Overall Study||667
11108092|NCT01266265|12292490|FG000|COMPLETED|Overall Study||461
11108093|NCT01266265|12292491|FG001|COMPLETED|Overall Study||477
11108094|NCT01266265|12292490|FG000|NOT COMPLETED|Overall Study||205
11108095|NCT01266265|12292491|FG001|NOT COMPLETED|Overall Study||190
11108096|NCT01266291|12292497|FG000|STARTED|Overall Study||1
11108097|NCT01266291|12292497|FG000|COMPLETED|Overall Study||0
11108098|NCT01266291|12292497|FG000|NOT COMPLETED|Overall Study||1
11108099|NCT01266317|12292501|FG000|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
11108100|NCT01266317|12292501|FG000|COMPLETED|Overall Study||7
11108101|NCT01266317|12292501|FG000|NOT COMPLETED|Overall Study||2
11108102|NCT01266447|12292505|FG000|STARTED|Overall Study||27
11108103|NCT01266447|12292505|FG000|COMPLETED|Overall Study|Eligible and treated patients|27
11108104|NCT01266447|12292505|FG000|NOT COMPLETED|Overall Study||0
11108105|NCT01266460|12292509|FG000|STARTED|Overall Study||50
11108106|NCT01266460|12292509|FG000|COMPLETED|Overall Study||16
11108107|NCT01266460|12292509|FG000|NOT COMPLETED|Overall Study||34
11108108|NCT01266590|12292513|FG000|STARTED|Overall Study||30
11108109|NCT01266590|12292513|FG000|COMPLETED|Overall Study||24
11108110|NCT01266590|12292513|FG000|NOT COMPLETED|Overall Study||6
11108111|NCT01266603|12292520|FG000|STARTED|Overall Study||44
11108112|NCT01266603|12292520|FG000|MAGE-A3 Positive Tumor|Overall Study||18
11108113|NCT01266603|12292520|FG000|Patients Evaluable for Safety|Overall Study||17
11108114|NCT01266603|12292520|FG000|Patients Evaluable for Response|Overall Study||16
11108115|NCT01266603|12292520|FG000|Continued to Maintenance- MAGE-A3|Overall Study||4
11108116|NCT01266603|12292520|FG000|Maintenance Completion|Overall Study||2
11108117|NCT01266603|12292520|FG000|COMPLETED|Overall Study||2
11108118|NCT01266603|12292520|FG000|NOT COMPLETED|Overall Study||42
11108119|NCT01266642|12292526|FG000|STARTED|Overall Study||149
11108120|NCT01266642|12292527|FG001|STARTED|Overall Study||138
11108121|NCT01266642|12292526|FG000|COMPLETED|Overall Study||149
11108122|NCT01266642|12292527|FG001|COMPLETED|Overall Study||137
11108123|NCT01266642|12292526|FG000|NOT COMPLETED|Overall Study||0
11108124|NCT01266642|12292527|FG001|NOT COMPLETED|Overall Study||1
11108125|NCT01266850|12292538|FG000|STARTED|Overall Study||242
11108126|NCT01266850|12292539|FG001|STARTED|Overall Study||248
11108127|NCT01266850|12292540|FG002|STARTED|Overall Study||238
11108128|NCT01266850|12292541|FG003|STARTED|Overall Study||329
11108129|NCT01266850|12292542|FG004|STARTED|Overall Study||327
11108130|NCT01266850|12292538|FG000|Received Second Vaccine|Overall Study||231
11108131|NCT01266850|12292539|FG001|Received Second Vaccine|Overall Study||233
11108132|NCT01266850|12292540|FG002|Received Second Vaccine|Overall Study||227
11108133|NCT01266850|12292541|FG003|Received Second Vaccine|Overall Study||311
11108134|NCT01266850|12292542|FG004|Received Second Vaccine|Overall Study||307
11108135|NCT01266850|12292538|FG000|Received Third Vaccine|Overall Study||221
11108136|NCT01266850|12292539|FG001|Received Third Vaccine|Overall Study||221
11108137|NCT01266850|12292540|FG002|Received Third Vaccine|Overall Study||217
11108138|NCT01266850|12292541|FG003|Received Third Vaccine|Overall Study||0
11227836|NCT02005666|12419975|FG001|STARTED|Overall Study||343
11227837|NCT02005666|12419976|FG002|STARTED|Overall Study||169
11227838|NCT02005666|12419974|FG000|COMPLETED|Overall Study||311
11227839|NCT02005666|12419975|FG001|COMPLETED|Overall Study||299
11227840|NCT02005666|12419976|FG002|COMPLETED|Overall Study||160
10862912|NCT02352948|12027893|FG004|Received Treatment|Overall Study||117
10862913|NCT02352948|12027894|FG005|Received Treatment|Overall Study||60
10862914|NCT02352948|12027889|FG000|Completed Study Treatment|Overall Study||15
10862915|NCT02352948|12027890|FG001|Completed Study Treatment|Overall Study||0
10862916|NCT02352948|12027891|FG002|Completed Study Treatment|Overall Study||36
10862917|NCT02352948|12027892|FG003|Completed Study Treatment|Overall Study||0
10862918|NCT02352948|12027893|FG004|Completed Study Treatment|Overall Study||23
10862919|NCT02352948|12027894|FG005|Completed Study Treatment|Overall Study||4
10862920|NCT02352948|12027889|FG000|COMPLETED|Overall Study||13
10862921|NCT02352948|12027890|FG001|COMPLETED|Overall Study||5
10862922|NCT02352948|12027891|FG002|COMPLETED|Overall Study||45
10862923|NCT02352948|12027892|FG003|COMPLETED|Overall Study||19
10862924|NCT02352948|12027893|FG004|COMPLETED|Overall Study||29
10862925|NCT02352948|12027894|FG005|COMPLETED|Overall Study||11
10862926|NCT02352948|12027889|FG000|NOT COMPLETED|Overall Study||49
10862927|NCT02352948|12027890|FG001|NOT COMPLETED|Overall Study||59
10862928|NCT02352948|12027891|FG002|NOT COMPLETED|Overall Study||129
10862929|NCT02352948|12027892|FG003|NOT COMPLETED|Overall Study||99
10862930|NCT02352948|12027893|FG004|NOT COMPLETED|Overall Study||88
10862931|NCT02352948|12027894|FG005|NOT COMPLETED|Overall Study||49
10862932|NCT02349893|12027914|FG000|STARTED|Overall Study||56
10862933|NCT02349893|12027914|FG000|COMPLETED|Overall Study||43
10862934|NCT02349893|12027914|FG000|NOT COMPLETED|Overall Study||13
10862935|NCT02315703|12027926|FG000|STARTED|Overall Study||50
10862936|NCT02315703|12027927|FG001|STARTED|Overall Study||49
10862937|NCT02315703|12027928|FG002|STARTED|Overall Study||49
10862938|NCT02315703|12027929|FG003|STARTED|Overall Study||48
10862939|NCT02315703|12027930|FG004|STARTED|Overall Study||49
10862940|NCT02315703|12027931|FG005|STARTED|Overall Study||49
10862941|NCT02315703|12027932|FG006|STARTED|Overall Study||50
10862942|NCT02315703|12027933|FG007|STARTED|Overall Study||49
10862943|NCT02315703|12027926|FG000|COMPLETED|Overall Study||44
10862944|NCT02315703|12027927|FG001|COMPLETED|Overall Study||39
10862945|NCT02315703|12027928|FG002|COMPLETED|Overall Study||44
10862946|NCT02315703|12027929|FG003|COMPLETED|Overall Study||39
10862947|NCT02315703|12027930|FG004|COMPLETED|Overall Study||41
10862948|NCT02315703|12027931|FG005|COMPLETED|Overall Study||43
10862949|NCT02315703|12027932|FG006|COMPLETED|Overall Study||37
10862950|NCT02315703|12027933|FG007|COMPLETED|Overall Study||42
10862951|NCT02315703|12027926|FG000|NOT COMPLETED|Overall Study||6
10862952|NCT02315703|12027927|FG001|NOT COMPLETED|Overall Study||10
10862953|NCT02315703|12027928|FG002|NOT COMPLETED|Overall Study||5
10862954|NCT02315703|12027929|FG003|NOT COMPLETED|Overall Study||9
10862955|NCT02315703|12027930|FG004|NOT COMPLETED|Overall Study||8
10862956|NCT02315703|12027931|FG005|NOT COMPLETED|Overall Study||6
10862957|NCT02315703|12027932|FG006|NOT COMPLETED|Overall Study||13
10862958|NCT02315703|12027933|FG007|NOT COMPLETED|Overall Study||7
11108139|NCT01266850|12292542|FG004|Received Third Vaccine|Overall Study||299
11108140|NCT01266850|12292538|FG000|COMPLETED|Overall Study||212
11108141|NCT01266850|12292539|FG001|COMPLETED|Overall Study||212
11108142|NCT01266850|12292540|FG002|COMPLETED|Overall Study||214
11108143|NCT01266850|12292541|FG003|COMPLETED|Overall Study||301
11108144|NCT01266850|12292542|FG004|COMPLETED|Overall Study||297
11108145|NCT01266850|12292538|FG000|NOT COMPLETED|Overall Study||30
11108146|NCT01266850|12292539|FG001|NOT COMPLETED|Overall Study||36
11108147|NCT01266850|12292540|FG002|NOT COMPLETED|Overall Study||24
11108148|NCT01266850|12292541|FG003|NOT COMPLETED|Overall Study||28
11108149|NCT01266850|12292542|FG004|NOT COMPLETED|Overall Study||30
11108150|NCT01266876|12292559|FG000|STARTED|Overall Study||15
10862971|NCT02214160|12027971|FG000|STARTED|Overall Study||24
10862972|NCT02214160|12027972|FG001|STARTED|Overall Study||37
10862973|NCT02214160|12027973|FG002|STARTED|Overall Study||33
10862974|NCT02214160|12027971|FG000|COMPLETED|Overall Study||20
10862975|NCT02214160|12027972|FG001|COMPLETED|Overall Study||29
10862976|NCT02214160|12027973|FG002|COMPLETED|Overall Study||23
10862977|NCT02214160|12027971|FG000|NOT COMPLETED|Overall Study||4
10862978|NCT02214160|12027972|FG001|NOT COMPLETED|Overall Study||8
11108151|NCT01266876|12292560|FG001|STARTED|Overall Study||15
11108152|NCT01266876|12292561|FG002|STARTED|Overall Study||16
11108153|NCT01266876|12292562|FG003|STARTED|Overall Study||15
11108154|NCT01266876|12292563|FG004|STARTED|Overall Study||16
11108155|NCT01266876|12292559|FG000|COMPLETED|Overall Study||15
11108156|NCT01266876|12292560|FG001|COMPLETED|Overall Study||15
11108157|NCT01266876|12292561|FG002|COMPLETED|Overall Study||16
11108158|NCT01266876|12292562|FG003|COMPLETED|Overall Study||14
11108159|NCT01266876|12292563|FG004|COMPLETED|Overall Study||16
11108160|NCT01266876|12292559|FG000|NOT COMPLETED|Overall Study||0
11108161|NCT01266876|12292560|FG001|NOT COMPLETED|Overall Study||0
11108162|NCT01266876|12292561|FG002|NOT COMPLETED|Overall Study||0
11108163|NCT01266876|12292562|FG003|NOT COMPLETED|Overall Study||1
11108164|NCT01266876|12292563|FG004|NOT COMPLETED|Overall Study||0
11227841|NCT02005666|12419974|FG000|NOT COMPLETED|Overall Study||27
11227842|NCT02005666|12419975|FG001|NOT COMPLETED|Overall Study||44
11227843|NCT02005666|12419976|FG002|NOT COMPLETED|Overall Study||9
11227844|NCT02005692|12419984|FG000|STARTED|Overall Study||70
11108165|NCT01266902|12292577|FG000|STARTED|Period 1 (Main Study)||119
11108166|NCT01266902|12292578|FG001|STARTED|Period 1 (Main Study)||363
10862979|NCT02214160|12027973|FG002|NOT COMPLETED|Overall Study||10
10862980|NCT02167945|12027985|FG000|STARTED|Overall Study||615
10862981|NCT02167945|12027985|FG000|COMPLETED|Overall Study||366
10862982|NCT02167945|12027985|FG000|NOT COMPLETED|Overall Study||249
10862983|NCT02128763|12027999|FG000|STARTED|Overall Study||349
10862984|NCT02128763|12028000|FG001|STARTED|Overall Study||186
10862985|NCT02128763|12027999|FG000|COMPLETED|Overall Study||329
10862986|NCT02128763|12028000|FG001|COMPLETED|Overall Study||170
10862987|NCT02128763|12027999|FG000|NOT COMPLETED|Overall Study||20
10862988|NCT02128763|12028000|FG001|NOT COMPLETED|Overall Study||16
10862989|NCT02074436|12028011|FG000|STARTED|Overall Study||15
10862990|NCT02074436|12028012|FG001|STARTED|Overall Study||14
10862991|NCT02074436|12028011|FG000|COMPLETED|Overall Study||15
10862992|NCT02074436|12028012|FG001|COMPLETED|Overall Study||14
10862993|NCT02074436|12028011|FG000|NOT COMPLETED|Overall Study||0
10862994|NCT02074436|12028012|FG001|NOT COMPLETED|Overall Study||0
10862995|NCT01991977|12028018|FG000|STARTED|Overall Study||91
10862996|NCT01991977|12028018|FG000|Received PET Tracer|Overall Study||84
10862997|NCT01991977|12028018|FG000|Received IMRT Treatment|Overall Study||79
10862998|NCT01991977|12028018|FG000|Evaluable for the Primary Outcome|Overall Study||39
10862999|NCT01991977|12028018|FG000|COMPLETED|Overall Study||79
10863000|NCT01991977|12028018|FG000|NOT COMPLETED|Overall Study||12
11108167|NCT01266902|12292579|FG002|STARTED|Period 1 (Main Study)||0
11108168|NCT01266902|12292577|FG000|COMPLETED|Period 1 (Main Study)||89
11108169|NCT01266902|12292578|FG001|COMPLETED|Period 1 (Main Study)||282
11108170|NCT01266902|12292579|FG002|COMPLETED|Period 1 (Main Study)||0
11108171|NCT01266902|12292577|FG000|NOT COMPLETED|Period 1 (Main Study)||30
11108172|NCT01266902|12292578|FG001|NOT COMPLETED|Period 1 (Main Study)||81
10863007|NCT01903733|12028037|FG000|STARTED|Overall Study||250
10863008|NCT01903733|12028038|FG001|STARTED|Overall Study||284
10863009|NCT01903733|12028039|FG002|STARTED|Overall Study||119
10863010|NCT01903733|12028040|FG003|STARTED|Overall Study||167
10863011|NCT01903733|12028037|FG000|Full Analysis Set|Overall Study||250
10863012|NCT01903733|12028038|FG001|Full Analysis Set|Overall Study||284
10863013|NCT01903733|12028039|FG002|Full Analysis Set|Overall Study||119
10863014|NCT01903733|12028040|FG003|Full Analysis Set|Overall Study||167
10863015|NCT01903733|12028037|FG000|Safety Analysis Set|Overall Study||248
10863016|NCT01903733|12028038|FG001|Safety Analysis Set|Overall Study||284
10863017|NCT01903733|12028039|FG002|Safety Analysis Set|Overall Study||119
10863018|NCT01903733|12028040|FG003|Safety Analysis Set|Overall Study||167
10863019|NCT01903733|12028037|FG000|Enrolled in B1871040|Overall Study||124
10863020|NCT01903733|12028038|FG001|Enrolled in B1871040|Overall Study||90
10863021|NCT01903733|12028039|FG002|Enrolled in B1871040|Overall Study||28
10863022|NCT01903733|12028040|FG003|Enrolled in B1871040|Overall Study||18
10863023|NCT01903733|12028037|FG000|Treated in B1871040|Overall Study||98
10863024|NCT01903733|12028038|FG001|Treated in B1871040|Overall Study||69
10863025|NCT01903733|12028039|FG002|Treated in B1871040|Overall Study||13
10863026|NCT01903733|12028040|FG003|Treated in B1871040|Overall Study||8
10863027|NCT01903733|12028037|FG000|COMPLETED|Overall Study||144
10863028|NCT01903733|12028038|FG001|COMPLETED|Overall Study||158
10863029|NCT01903733|12028039|FG002|COMPLETED|Overall Study||58
10863030|NCT01903733|12028040|FG003|COMPLETED|Overall Study||48
10863031|NCT01903733|12028037|FG000|NOT COMPLETED|Overall Study||106
10863032|NCT01903733|12028038|FG001|NOT COMPLETED|Overall Study||126
10863033|NCT01903733|12028039|FG002|NOT COMPLETED|Overall Study||61
10863034|NCT01903733|12028040|FG003|NOT COMPLETED|Overall Study||119
11108173|NCT01266902|12292579|FG002|NOT COMPLETED|Period 1 (Main Study)||0
11108174|NCT01266902|12292577|FG000|STARTED|Period 2 (After Protocol Amendment 3)||0
11108175|NCT01266902|12292578|FG001|STARTED|Period 2 (After Protocol Amendment 3)||0
11108176|NCT01266902|12292579|FG002|STARTED|Period 2 (After Protocol Amendment 3)||45
11108177|NCT01266902|12292577|FG000|COMPLETED|Period 2 (After Protocol Amendment 3)||0
11108178|NCT01266902|12292578|FG001|COMPLETED|Period 2 (After Protocol Amendment 3)||0
11108179|NCT01266902|12292579|FG002|COMPLETED|Period 2 (After Protocol Amendment 3)||37
11108180|NCT01266902|12292577|FG000|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
10863043|NCT01575548|12028071|FG000|STARTED|Overall Study||66
10863044|NCT01575548|12028072|FG001|STARTED|Overall Study||63
10863045|NCT01575548|12028071|FG000|Received Protocol Therapy|Overall Study||63
10863046|NCT01575548|12028072|FG001|Received Protocol Therapy|Overall Study||61
10863047|NCT01575548|12028071|FG000|COMPLETED|Overall Study||26
10863048|NCT01575548|12028072|FG001|COMPLETED|Overall Study||30
10863049|NCT01575548|12028071|FG000|NOT COMPLETED|Overall Study||40
10863050|NCT01575548|12028072|FG001|NOT COMPLETED|Overall Study||33
11108181|NCT01266902|12292578|FG001|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
11108182|NCT01266902|12292579|FG002|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||8
11108183|NCT01266967|12292589|FG000|STARTED|Overall Study||89
11108184|NCT01266967|12292590|FG001|STARTED|Overall Study||83
11108185|NCT01266967|12292589|FG000|COMPLETED|Overall Study||0
11108186|NCT01266967|12292590|FG001|COMPLETED|Overall Study||0
11108187|NCT01266967|12292589|FG000|NOT COMPLETED|Overall Study||89
11108188|NCT01266967|12292590|FG001|NOT COMPLETED|Overall Study||83
11108189|NCT01266993|12292601|FG000|STARTED|Persistence Phase (Month 32-44)||199
11108190|NCT01266993|12292602|FG001|STARTED|Persistence Phase (Month 32-44)||72
11108191|NCT01266993|12292601|FG000|COMPLETED|Persistence Phase (Month 32-44)||199
11108192|NCT01266993|12292602|FG001|COMPLETED|Persistence Phase (Month 32-44)||72
11108193|NCT01266993|12292601|FG000|NOT COMPLETED|Persistence Phase (Month 32-44)||0
11108194|NCT01266993|12292602|FG001|NOT COMPLETED|Persistence Phase (Month 32-44)||0
11108195|NCT01266993|12292601|FG000|STARTED|Persistence Phase (Month 44-56)||193
11108196|NCT01266993|12292602|FG001|STARTED|Persistence Phase (Month 44-56)||68
11108197|NCT01266993|12292601|FG000|COMPLETED|Persistence Phase (Month 44-56)||193
11108198|NCT01266993|12292602|FG001|COMPLETED|Persistence Phase (Month 44-56)||68
11108199|NCT01266993|12292601|FG000|NOT COMPLETED|Persistence Phase (Month 44-56)||0
11227845|NCT02005692|12419984|FG000|COMPLETED|Overall Study||63
11227846|NCT02005692|12419984|FG000|NOT COMPLETED|Overall Study||7
11227847|NCT02005887|12419991|FG000|STARTED|Overall Study||26
11227848|NCT02005887|12419992|FG001|STARTED|Overall Study||25
11227849|NCT02005887|12419991|FG000|COMPLETED|Overall Study||26
11227850|NCT02005887|12419992|FG001|COMPLETED|Overall Study||23
11227851|NCT02005887|12419991|FG000|NOT COMPLETED|Overall Study||0
11227852|NCT02005887|12419992|FG001|NOT COMPLETED|Overall Study||2
11227853|NCT02006056|12420000|FG000|STARTED|Overall Study||26
11227854|NCT02006056|12420001|FG001|STARTED|Overall Study||4
11227855|NCT02006056|12420000|FG000|COMPLETED|Overall Study||26
11227856|NCT02006056|12420001|FG001|COMPLETED|Overall Study||4
11227857|NCT02006056|12420000|FG000|NOT COMPLETED|Overall Study||0
11227858|NCT02006056|12420001|FG001|NOT COMPLETED|Overall Study||0
11355069|NCT03076970|12551943|FG000|NOT COMPLETED|Washout Period 2||0
11355070|NCT03076970|12551944|FG001|NOT COMPLETED|Washout Period 2||0
11355071|NCT03076970|12551945|FG002|NOT COMPLETED|Washout Period 2||0
11355072|NCT03076970|12551946|FG003|NOT COMPLETED|Washout Period 2||0
11355073|NCT03076970|12551947|FG004|NOT COMPLETED|Washout Period 2||1
11355074|NCT03076970|12551948|FG005|NOT COMPLETED|Washout Period 2||0
11355075|NCT03076970|12551943|FG000|STARTED|Period 3||7
11355076|NCT03076970|12551944|FG001|STARTED|Period 3||7
11108200|NCT01266993|12292602|FG001|NOT COMPLETED|Persistence Phase (Month 44-56)||0
11108201|NCT01266993|12292601|FG000|STARTED|Persistence Phase (Month 56-68)||193
11108202|NCT01266993|12292602|FG001|STARTED|Persistence Phase (Month 56-68)||67
11108203|NCT01266993|12292601|FG000|COMPLETED|Persistence Phase (Month 56-68)||193
11108204|NCT01266993|12292602|FG001|COMPLETED|Persistence Phase (Month 56-68)||67
11355077|NCT03076970|12551945|FG002|STARTED|Period 3||7
11355078|NCT03076970|12551946|FG003|STARTED|Period 3||7
11227859|NCT02006108|12420007|FG000|STARTED|Overall Study||21
11227860|NCT02006108|12420007|FG000|MR Imaging|Overall Study||19
11227861|NCT02006108|12420007|FG000|COMPLETED|Overall Study||19
11227862|NCT02006108|12420007|FG000|NOT COMPLETED|Overall Study||2
11108205|NCT01266993|12292601|FG000|NOT COMPLETED|Persistence Phase (Month 56-68)||0
11108206|NCT01266993|12292602|FG001|NOT COMPLETED|Persistence Phase (Month 56-68)||0
11108207|NCT01266993|12292601|FG000|STARTED|Booster Phase (Month 68-69)||179
11108208|NCT01266993|12292602|FG001|STARTED|Booster Phase (Month 68-69)||62
11108209|NCT01266993|12292601|FG000|COMPLETED|Booster Phase (Month 68-69)||174
11108210|NCT01266993|12292602|FG001|COMPLETED|Booster Phase (Month 68-69)||60
11108211|NCT01266993|12292601|FG000|NOT COMPLETED|Booster Phase (Month 68-69)||5
11108212|NCT01266993|12292602|FG001|NOT COMPLETED|Booster Phase (Month 68-69)||2
11108213|NCT01267019|12292611|FG000|STARTED|Overall Study||47
11108214|NCT01267019|12292612|FG001|STARTED|Overall Study||53
11108215|NCT01267019|12292613|FG002|STARTED|Overall Study||53
11108216|NCT01267019|12292611|FG000|COMPLETED|Overall Study||41
11108217|NCT01267019|12292612|FG001|COMPLETED|Overall Study||47
11108218|NCT01267019|12292613|FG002|COMPLETED|Overall Study||47
11108219|NCT01267019|12292611|FG000|NOT COMPLETED|Overall Study||6
11108220|NCT01267019|12292612|FG001|NOT COMPLETED|Overall Study||6
11108221|NCT01267019|12292613|FG002|NOT COMPLETED|Overall Study||6
11108222|NCT01267045|12292623|FG000|STARTED|2-month Outcomes||26
11108223|NCT01267045|12292624|FG001|STARTED|2-month Outcomes||29
11108224|NCT01267045|12292623|FG000|COMPLETED|2-month Outcomes||22
11108225|NCT01267045|12292624|FG001|COMPLETED|2-month Outcomes||26
11108226|NCT01267045|12292623|FG000|NOT COMPLETED|2-month Outcomes||4
11108227|NCT01267045|12292624|FG001|NOT COMPLETED|2-month Outcomes||3
11108228|NCT01267045|12292623|FG000|STARTED|6-month Outcome||22
11108229|NCT01267045|12292624|FG001|STARTED|6-month Outcome||26
11108230|NCT01267045|12292623|FG000|COMPLETED|6-month Outcome||22
11108231|NCT01267045|12292624|FG001|COMPLETED|6-month Outcome||23
11108232|NCT01267045|12292623|FG000|NOT COMPLETED|6-month Outcome||0
11108233|NCT01267045|12292624|FG001|NOT COMPLETED|6-month Outcome||3
11108234|NCT01267136|12292633|FG000|STARTED|Overall Study||42
11108235|NCT01267136|12292634|FG001|STARTED|Overall Study||42
11108236|NCT01267136|12292633|FG000|COMPLETED|Overall Study||38
11108237|NCT01267136|12292634|FG001|COMPLETED|Overall Study||36
11108238|NCT01267136|12292633|FG000|NOT COMPLETED|Overall Study||4
11108239|NCT01267136|12292634|FG001|NOT COMPLETED|Overall Study||6
11108240|NCT01267175|12292642|FG000|STARTED|Overall Study||31
11108241|NCT01267175|12292642|FG000|COMPLETED|Overall Study||29
11108242|NCT01267175|12292642|FG000|NOT COMPLETED|Overall Study||2
11108243|NCT01267201|12292646|FG000|STARTED|First Intervention Period||4
11108244|NCT01267201|12292647|FG001|STARTED|First Intervention Period||4
11108245|NCT01267201|12292648|FG002|STARTED|First Intervention Period||4
11108246|NCT01267201|12292649|FG003|STARTED|First Intervention Period||4
11108247|NCT01267201|12292650|FG004|STARTED|First Intervention Period||4
11108248|NCT01267201|12292651|FG005|STARTED|First Intervention Period||4
11108249|NCT01267201|12292646|FG000|COMPLETED|First Intervention Period||3
11108250|NCT01267201|12292647|FG001|COMPLETED|First Intervention Period||4
11108251|NCT01267201|12292648|FG002|COMPLETED|First Intervention Period||4
11108252|NCT01267201|12292649|FG003|COMPLETED|First Intervention Period||4
11108253|NCT01267201|12292650|FG004|COMPLETED|First Intervention Period||4
11108254|NCT01267201|12292651|FG005|COMPLETED|First Intervention Period||4
11108255|NCT01267201|12292646|FG000|NOT COMPLETED|First Intervention Period||1
11108256|NCT01267201|12292647|FG001|NOT COMPLETED|First Intervention Period||0
11108257|NCT01267201|12292648|FG002|NOT COMPLETED|First Intervention Period||0
11108258|NCT01267201|12292649|FG003|NOT COMPLETED|First Intervention Period||0
11108259|NCT01267201|12292650|FG004|NOT COMPLETED|First Intervention Period||0
11108260|NCT01267201|12292651|FG005|NOT COMPLETED|First Intervention Period||0
11108261|NCT01267201|12292646|FG000|STARTED|Washout Period (At Least 2 Days)||3
11108262|NCT01267201|12292647|FG001|STARTED|Washout Period (At Least 2 Days)||4
11108263|NCT01267201|12292648|FG002|STARTED|Washout Period (At Least 2 Days)||4
11108264|NCT01267201|12292649|FG003|STARTED|Washout Period (At Least 2 Days)||4
11108265|NCT01267201|12292650|FG004|STARTED|Washout Period (At Least 2 Days)||4
11108266|NCT01267201|12292651|FG005|STARTED|Washout Period (At Least 2 Days)||4
11108267|NCT01267201|12292646|FG000|COMPLETED|Washout Period (At Least 2 Days)||3
11108268|NCT01267201|12292647|FG001|COMPLETED|Washout Period (At Least 2 Days)||4
11108269|NCT01267201|12292648|FG002|COMPLETED|Washout Period (At Least 2 Days)||4
11108270|NCT01267201|12292649|FG003|COMPLETED|Washout Period (At Least 2 Days)||4
11108271|NCT01267201|12292650|FG004|COMPLETED|Washout Period (At Least 2 Days)||4
11108272|NCT01267201|12292651|FG005|COMPLETED|Washout Period (At Least 2 Days)||4
11108273|NCT01267201|12292646|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0
11108274|NCT01267201|12292647|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0
11108275|NCT01267201|12292648|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0
11108276|NCT01267201|12292649|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0
11108277|NCT01267201|12292650|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0
11108278|NCT01267201|12292651|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0
11108279|NCT01267201|12292646|FG000|STARTED|Second Intervention Period||3
11108280|NCT01267201|12292647|FG001|STARTED|Second Intervention Period||4
11108281|NCT01267201|12292648|FG002|STARTED|Second Intervention Period||4
11108282|NCT01267201|12292649|FG003|STARTED|Second Intervention Period||4
11108283|NCT01267201|12292650|FG004|STARTED|Second Intervention Period||4
11108284|NCT01267201|12292651|FG005|STARTED|Second Intervention Period||4
11108285|NCT01267201|12292646|FG000|COMPLETED|Second Intervention Period||3
11108286|NCT01267201|12292647|FG001|COMPLETED|Second Intervention Period||3
11108287|NCT01267201|12292648|FG002|COMPLETED|Second Intervention Period||4
11108288|NCT01267201|12292649|FG003|COMPLETED|Second Intervention Period||4
11108289|NCT01267201|12292650|FG004|COMPLETED|Second Intervention Period||4
11108290|NCT01267201|12292651|FG005|COMPLETED|Second Intervention Period||4
11108291|NCT01267201|12292646|FG000|NOT COMPLETED|Second Intervention Period||0
11108292|NCT01267201|12292647|FG001|NOT COMPLETED|Second Intervention Period||1
11108293|NCT01267201|12292648|FG002|NOT COMPLETED|Second Intervention Period||0
11108294|NCT01267201|12292649|FG003|NOT COMPLETED|Second Intervention Period||0
11108295|NCT01267201|12292650|FG004|NOT COMPLETED|Second Intervention Period||0
11108296|NCT01267201|12292651|FG005|NOT COMPLETED|Second Intervention Period||0
11108297|NCT01267201|12292646|FG000|STARTED|Washout Period (At Least 2 Days)||3
11108298|NCT01267201|12292647|FG001|STARTED|Washout Period (At Least 2 Days)||3
11108299|NCT01267201|12292648|FG002|STARTED|Washout Period (At Least 2 Days)||4
11108300|NCT01267201|12292649|FG003|STARTED|Washout Period (At Least 2 Days)||4
11108301|NCT01267201|12292650|FG004|STARTED|Washout Period (At Least 2 Days)||4
11108302|NCT01267201|12292651|FG005|STARTED|Washout Period (At Least 2 Days)||4
11108303|NCT01267201|12292646|FG000|COMPLETED|Washout Period (At Least 2 Days)||3
11108304|NCT01267201|12292647|FG001|COMPLETED|Washout Period (At Least 2 Days)||3
11108305|NCT01267201|12292648|FG002|COMPLETED|Washout Period (At Least 2 Days)||4
11108306|NCT01267201|12292649|FG003|COMPLETED|Washout Period (At Least 2 Days)||4
11108307|NCT01267201|12292650|FG004|COMPLETED|Washout Period (At Least 2 Days)||4
11108308|NCT01267201|12292651|FG005|COMPLETED|Washout Period (At Least 2 Days)||4
11108309|NCT01267201|12292646|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0
11108310|NCT01267201|12292647|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0
11108311|NCT01267201|12292648|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0
11108312|NCT01267201|12292649|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0
11108313|NCT01267201|12292650|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0
11108314|NCT01267201|12292651|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0
11108315|NCT01267201|12292646|FG000|STARTED|Third Intervention Period||3
11108316|NCT01267201|12292647|FG001|STARTED|Third Intervention Period||3
11108317|NCT01267201|12292648|FG002|STARTED|Third Intervention Period||4
11108318|NCT01267201|12292649|FG003|STARTED|Third Intervention Period||4
11108319|NCT01267201|12292650|FG004|STARTED|Third Intervention Period||4
11108320|NCT01267201|12292651|FG005|STARTED|Third Intervention Period||4
11108321|NCT01267201|12292646|FG000|COMPLETED|Third Intervention Period||3
11108322|NCT01267201|12292647|FG001|COMPLETED|Third Intervention Period||3
11108323|NCT01267201|12292648|FG002|COMPLETED|Third Intervention Period||4
11108324|NCT01267201|12292649|FG003|COMPLETED|Third Intervention Period||4
11108325|NCT01267201|12292650|FG004|COMPLETED|Third Intervention Period||4
11108326|NCT01267201|12292651|FG005|COMPLETED|Third Intervention Period||4
11108327|NCT01267201|12292646|FG000|NOT COMPLETED|Third Intervention Period||0
11108328|NCT01267201|12292647|FG001|NOT COMPLETED|Third Intervention Period||0
11108329|NCT01267201|12292648|FG002|NOT COMPLETED|Third Intervention Period||0
11108330|NCT01267201|12292649|FG003|NOT COMPLETED|Third Intervention Period||0
11108331|NCT01267201|12292650|FG004|NOT COMPLETED|Third Intervention Period||0
11108332|NCT01267201|12292651|FG005|NOT COMPLETED|Third Intervention Period||0
11108333|NCT01267227|12292663|FG000|STARTED|Overall Study||20
11108334|NCT01267227|12292664|FG001|STARTED|Overall Study||20
11108335|NCT01267227|12292665|FG002|STARTED|Overall Study||20
11108336|NCT01267227|12292666|FG003|STARTED|Overall Study||20
11108337|NCT01267227|12292663|FG000|COMPLETED|Overall Study||19
11108338|NCT01267227|12292664|FG001|COMPLETED|Overall Study||19
11108339|NCT01267227|12292665|FG002|COMPLETED|Overall Study||18
11108340|NCT01267227|12292666|FG003|COMPLETED|Overall Study||17
11108341|NCT01267227|12292663|FG000|NOT COMPLETED|Overall Study||1
11108342|NCT01267227|12292664|FG001|NOT COMPLETED|Overall Study||1
11108343|NCT01267227|12292665|FG002|NOT COMPLETED|Overall Study||2
11108344|NCT01267227|12292666|FG003|NOT COMPLETED|Overall Study||3
11108345|NCT01267240|12292680|FG000|STARTED|Overall Study||25
11108346|NCT01267240|12292680|FG000|COMPLETED|Overall Study||25
11108347|NCT01267240|12292680|FG000|NOT COMPLETED|Overall Study||0
11108348|NCT01267253|12292684|FG000|STARTED|Overall Study||31
11108349|NCT01267253|12292684|FG000|COMPLETED|Overall Study|Eligible and treated patients|28
11108350|NCT01267253|12292684|FG000|NOT COMPLETED|Overall Study||3
11108351|NCT01267266|12292688|FG000|STARTED|Enrollment Phase||33
11108352|NCT01267266|12292689|FG001|STARTED|Enrollment Phase||0
11108353|NCT01267266|12292688|FG000|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
11108354|NCT01267266|12292689|FG001|COMPLETED|Enrollment Phase||0
11108355|NCT01267266|12292688|FG000|NOT COMPLETED|Enrollment Phase||2
11108356|NCT01267266|12292689|FG001|NOT COMPLETED|Enrollment Phase||0
11108357|NCT01267266|12292688|FG000|STARTED|Lead-in Phase||31
11108358|NCT01267266|12292689|FG001|STARTED|Lead-in Phase||0
11108359|NCT01267266|12292688|FG000|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
11108360|NCT01267266|12292689|FG001|COMPLETED|Lead-in Phase||0
11108361|NCT01267266|12292688|FG000|NOT COMPLETED|Lead-in Phase||23
11108362|NCT01267266|12292689|FG001|NOT COMPLETED|Lead-in Phase||0
11108363|NCT01267266|12292688|FG000|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
11108364|NCT01267266|12292689|FG001|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
11108365|NCT01267266|12292688|FG000|COMPLETED|Randomized Phase||3
11108366|NCT01267266|12292689|FG001|COMPLETED|Randomized Phase||5
11108367|NCT01267266|12292688|FG000|NOT COMPLETED|Randomized Phase||0
11108368|NCT01267266|12292689|FG001|NOT COMPLETED|Randomized Phase||0
11108369|NCT01267279|12292700|FG000|STARTED|Overall Study||24
11108370|NCT01267279|12292701|FG001|STARTED|Overall Study||27
11108371|NCT01267279|12292700|FG000|COMPLETED|Overall Study||22
11108372|NCT01267279|12292701|FG001|COMPLETED|Overall Study||21
11108373|NCT01267279|12292700|FG000|NOT COMPLETED|Overall Study||2
11108374|NCT01267279|12292701|FG001|NOT COMPLETED|Overall Study||6
11108375|NCT01267292|12292709|FG000|STARTED|Overall Study||24
11108376|NCT01267292|12292710|FG001|STARTED|Overall Study||26
11108377|NCT01267292|12292709|FG000|COMPLETED|Overall Study||20
11108378|NCT01267292|12292710|FG001|COMPLETED|Overall Study||20
11108379|NCT01267292|12292709|FG000|NOT COMPLETED|Overall Study||4
11108380|NCT01267292|12292710|FG001|NOT COMPLETED|Overall Study||6
11108381|NCT01267422|12292716|FG000|STARTED|Intravitreal rAAV2-ND4 Injection||5
11108382|NCT01267422|12292717|FG001|STARTED|Intravitreal rAAV2-ND4 Injection||4
11108383|NCT01267422|12292716|FG000|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
11108384|NCT01267422|12292717|FG001|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
11108385|NCT01267422|12292716|FG000|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
11108386|NCT01267422|12292717|FG001|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
11108387|NCT01267422|12292716|FG000|STARTED|Safety and Efficacy Study||5
11108388|NCT01267422|12292717|FG001|STARTED|Safety and Efficacy Study||4
11108389|NCT01267422|12292716|FG000|COMPLETED|Safety and Efficacy Study||5
11108390|NCT01267422|12292717|FG001|COMPLETED|Safety and Efficacy Study||4
11108391|NCT01267422|12292716|FG000|NOT COMPLETED|Safety and Efficacy Study||0
11108392|NCT01267422|12292717|FG001|NOT COMPLETED|Safety and Efficacy Study||0
11108393|NCT01267656|12292735|FG000|STARTED|Overall Study||83
11108394|NCT01267656|12292736|FG001|STARTED|Overall Study||83
11108395|NCT01267656|12292735|FG000|COMPLETED|Overall Study||82
11108396|NCT01267656|12292736|FG001|COMPLETED|Overall Study||82
11108397|NCT01267656|12292735|FG000|NOT COMPLETED|Overall Study||1
11108398|NCT01267656|12292736|FG001|NOT COMPLETED|Overall Study||1
11108399|NCT01267864|12292745|FG000|STARTED|Overall Study||110
11108400|NCT01267864|12292746|FG001|STARTED|Overall Study||110
11108401|NCT01267864|12292747|FG002|STARTED|Overall Study||110
11108402|NCT01267864|12292745|FG000|COMPLETED|Overall Study||110
11108403|NCT01267864|12292746|FG001|COMPLETED|Overall Study||110
11108404|NCT01267864|12292747|FG002|COMPLETED|Overall Study||110
11108405|NCT01267864|12292745|FG000|NOT COMPLETED|Overall Study||0
11108406|NCT01267864|12292746|FG001|NOT COMPLETED|Overall Study||0
11108407|NCT01267864|12292747|FG002|NOT COMPLETED|Overall Study||0
11108408|NCT01267929|12292757|FG000|STARTED|Overall Study||15
11108409|NCT01267929|12292758|FG001|STARTED|Overall Study||15
11108410|NCT01267929|12292757|FG000|COMPLETED|Overall Study||15
11108411|NCT01267929|12292758|FG001|COMPLETED|Overall Study||15
11108412|NCT01267929|12292757|FG000|NOT COMPLETED|Overall Study||0
11108413|NCT01267929|12292758|FG001|NOT COMPLETED|Overall Study||0
11108414|NCT01267994|12292764|FG000|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
11108415|NCT01267994|12292764|FG000|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
11108416|NCT01267994|12292764|FG000|NOT COMPLETED|Overall Study||2
11108417|NCT01268046|12292773|FG000|STARTED|Overall Study||13
11108418|NCT01268046|12292774|FG001|STARTED|Overall Study||9
11108419|NCT01268046|12292775|FG002|STARTED|Overall Study||8
11108420|NCT01268046|12292776|FG003|STARTED|Overall Study||8
11108421|NCT01268046|12292773|FG000|COMPLETED|Overall Study||12
11108422|NCT01268046|12292774|FG001|COMPLETED|Overall Study||9
11108423|NCT01268046|12292775|FG002|COMPLETED|Overall Study||7
11108424|NCT01268046|12292776|FG003|COMPLETED|Overall Study||7
11108425|NCT01268046|12292773|FG000|NOT COMPLETED|Overall Study||1
11108426|NCT01268046|12292774|FG001|NOT COMPLETED|Overall Study||0
11108427|NCT01268046|12292775|FG002|NOT COMPLETED|Overall Study||1
11108428|NCT01268046|12292776|FG003|NOT COMPLETED|Overall Study||1
11108429|NCT01268059|12292790|FG000|STARTED|Overall Study||40
11108430|NCT01268059|12292791|FG001|STARTED|Overall Study|Arm applicable for both dose-determination (Phase 1b) and randomization phase (Phase 2) of study.|45
11108431|NCT01268059|12292792|FG002|STARTED|Overall Study||6
11108432|NCT01268059|12292793|FG003|STARTED|Overall Study||8
11108433|NCT01268059|12292790|FG000|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|12
11108434|NCT01268059|12292791|FG001|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|10
10863249|NCT01321073|12028120|FG000|STARTED|Overall Study||64
10863250|NCT01321073|12028120|FG000|COMPLETED|Overall Study||57
10863251|NCT01321073|12028120|FG000|NOT COMPLETED|Overall Study||7
11108435|NCT01268059|12292792|FG002|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
11108436|NCT01268059|12292793|FG003|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
11108437|NCT01268059|12292790|FG000|NOT COMPLETED|Overall Study||28
11108438|NCT01268059|12292791|FG001|NOT COMPLETED|Overall Study||35
11108439|NCT01268059|12292792|FG002|NOT COMPLETED|Overall Study||3
11108440|NCT01268059|12292793|FG003|NOT COMPLETED|Overall Study||5
11108441|NCT01268098|12292808|FG000|STARTED|Overall Study||19
11108442|NCT01268098|12292809|FG001|STARTED|Overall Study||23
11108443|NCT01268098|12292808|FG000|COMPLETED|Overall Study||18
11108444|NCT01268098|12292809|FG001|COMPLETED|Overall Study||23
11108445|NCT01268098|12292808|FG000|NOT COMPLETED|Overall Study||1
11108446|NCT01268098|12292809|FG001|NOT COMPLETED|Overall Study||0
11108447|NCT01268111|12292817|FG000|STARTED|Overall Study||6
11108448|NCT01268111|12292818|FG001|STARTED|Overall Study||6
11108449|NCT01268111|12292817|FG000|COMPLETED|Overall Study||6
11108450|NCT01268111|12292818|FG001|COMPLETED|Overall Study||6
11108451|NCT01268111|12292817|FG000|NOT COMPLETED|Overall Study||0
11108452|NCT01268111|12292818|FG001|NOT COMPLETED|Overall Study||0
11108453|NCT01268150|12292824|FG000|STARTED|Treatment Phase||56
11108454|NCT01268150|12292824|FG000|COMPLETED|Treatment Phase||28
11108455|NCT01268150|12292824|FG000|NOT COMPLETED|Treatment Phase||28
11108456|NCT01268150|12292824|FG000|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
11108457|NCT01268150|12292824|FG000|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
11108458|NCT01268150|12292824|FG000|COMPLETED|Extension Phase||1
11108459|NCT01268150|12292824|FG000|NOT COMPLETED|Extension Phase||27
11108460|NCT01268189|12292828|FG000|STARTED|Overall Study||20
11108461|NCT01268189|12292828|FG000|COMPLETED|Overall Study||17
11108462|NCT01268189|12292828|FG000|NOT COMPLETED|Overall Study||3
11108463|NCT01268267|12292834|FG000|STARTED|Overall Study||94
11108464|NCT01268267|12292834|FG000|COMPLETED|Overall Study||93
11108465|NCT01268267|12292834|FG000|NOT COMPLETED|Overall Study||1
11108466|NCT01268293|12292839|FG000|STARTED|Overall Study||9
11108467|NCT01268293|12292839|FG000|Completed Cycle 1|Overall Study||9
11108468|NCT01268293|12292839|FG000|COMPLETED|Overall Study||0
11108469|NCT01268293|12292839|FG000|NOT COMPLETED|Overall Study||9
11108470|NCT01268306|12292843|FG000|STARTED|Overall Study||8
11108471|NCT01268306|12292843|FG000|COMPLETED|Overall Study||7
11108472|NCT01268306|12292843|FG000|NOT COMPLETED|Overall Study||1
11108473|NCT01268488|12292847|FG000|STARTED|Overall Study||98
10863288|NCT01236547|12028172|FG000|STARTED|Overall Study||11
10863289|NCT01236547|12028173|FG001|STARTED|Overall Study||11
10863290|NCT01236547|12028174|FG002|STARTED|Overall Study||12
10863291|NCT01236547|12028175|FG003|STARTED|Overall Study||42
10863292|NCT01236547|12028176|FG004|STARTED|Overall Study||47
10863293|NCT01236547|12028172|FG000|Eligible|Overall Study||11
10863294|NCT01236547|12028173|FG001|Eligible|Overall Study||10
10863295|NCT01236547|12028174|FG002|Eligible|Overall Study||11
10863296|NCT01236547|12028175|FG003|Eligible|Overall Study||36
10863297|NCT01236547|12028176|FG004|Eligible|Overall Study||35
10863298|NCT01236547|12028172|FG000|Eligible and Started Study Treatment|Overall Study||11
10863299|NCT01236547|12028173|FG001|Eligible and Started Study Treatment|Overall Study||10
10863300|NCT01236547|12028174|FG002|Eligible and Started Study Treatment|Overall Study||11
10863301|NCT01236547|12028175|FG003|Eligible and Started Study Treatment|Overall Study||36
10863302|NCT01236547|12028176|FG004|Eligible and Started Study Treatment|Overall Study||34
10863303|NCT01236547|12028172|FG000|Eligible and Response Assessed|Overall Study||0
10863304|NCT01236547|12028173|FG001|Eligible and Response Assessed|Overall Study||0
10863305|NCT01236547|12028174|FG002|Eligible and Response Assessed|Overall Study||0
10863306|NCT01236547|12028175|FG003|Eligible and Response Assessed|Overall Study||23
10863307|NCT01236547|12028176|FG004|Eligible and Response Assessed|Overall Study||27
10863308|NCT01236547|12028172|FG000|COMPLETED|Overall Study||11
10863309|NCT01236547|12028173|FG001|COMPLETED|Overall Study||10
10863310|NCT01236547|12028174|FG002|COMPLETED|Overall Study||11
10863311|NCT01236547|12028175|FG003|COMPLETED|Overall Study||36
10863312|NCT01236547|12028176|FG004|COMPLETED|Overall Study||35
10863313|NCT01236547|12028172|FG000|NOT COMPLETED|Overall Study||0
10863314|NCT01236547|12028173|FG001|NOT COMPLETED|Overall Study||1
10863315|NCT01236547|12028174|FG002|NOT COMPLETED|Overall Study||1
10863316|NCT01236547|12028175|FG003|NOT COMPLETED|Overall Study||6
10863317|NCT01236547|12028176|FG004|NOT COMPLETED|Overall Study||12
11108474|NCT01268488|12292847|FG000|COMPLETED|Overall Study||93
11108475|NCT01268488|12292847|FG000|NOT COMPLETED|Overall Study||5
11108476|NCT01268501|12292852|FG000|STARTED|Overall Study||96
11108477|NCT01268501|12292852|FG000|COMPLETED|Overall Study||87
11108478|NCT01268501|12292852|FG000|NOT COMPLETED|Overall Study||9
11108479|NCT01268514|12292856|FG000|STARTED|Overall Study||115
11108480|NCT01268514|12292856|FG000|Participants Who Received the Device|Overall Study||114
11108481|NCT01268514|12292856|FG000|COMPLETED|Overall Study||74
11108482|NCT01268514|12292856|FG000|NOT COMPLETED|Overall Study||41
11108483|NCT01268527|12292864|FG000|STARTED|Overall Study||15
11108484|NCT01268527|12292865|FG001|STARTED|Overall Study||15
11108485|NCT01268527|12292864|FG000|COMPLETED|Overall Study||15
11108486|NCT01268527|12292865|FG001|COMPLETED|Overall Study||15
11108487|NCT01268527|12292864|FG000|NOT COMPLETED|Overall Study||0
11108488|NCT01268527|12292865|FG001|NOT COMPLETED|Overall Study||0
11108489|NCT01268553|12292884|FG000|STARTED|Overall Study||6
11108490|NCT01268553|12292884|FG000|COMPLETED|Overall Study||6
11108491|NCT01268553|12292884|FG000|NOT COMPLETED|Overall Study||0
10863336|NCT01038778|12028219|FG000|STARTED|Overall Study||3
10863337|NCT01038778|12028220|FG001|STARTED|Overall Study||8
10863338|NCT01038778|12028221|FG002|STARTED|Overall Study||36
10863339|NCT01038778|12028219|FG000|COMPLETED|Overall Study||3
10863340|NCT01038778|12028220|FG001|COMPLETED|Overall Study||6
10863341|NCT01038778|12028221|FG002|COMPLETED|Overall Study||33
10863342|NCT01038778|12028219|FG000|NOT COMPLETED|Overall Study||0
10863343|NCT01038778|12028220|FG001|NOT COMPLETED|Overall Study||2
10863344|NCT01038778|12028221|FG002|NOT COMPLETED|Overall Study||3
11108492|NCT01268566|12292888|FG000|STARTED|Overall Study||56
11108493|NCT01268566|12292888|FG000|COMPLETED|Overall Study||13
11108494|NCT01268566|12292888|FG000|NOT COMPLETED|Overall Study||43
11108495|NCT01268644|12292892|FG000|STARTED|Baseline Period (Week 0)||8
11108496|NCT01268644|12292892|FG000|COMPLETED|Baseline Period (Week 0)||8
11108497|NCT01268644|12292892|FG000|NOT COMPLETED|Baseline Period (Week 0)||0
11108498|NCT01268644|12292892|FG000|STARTED|Phase A (Weeks 0-12) Leptin Therapy||8
11108499|NCT01268644|12292892|FG000|COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||8
11108500|NCT01268644|12292892|FG000|NOT COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||0
11108501|NCT01268644|12292892|FG000|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7
11108502|NCT01268644|12292892|FG000|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7
11108503|NCT01268644|12292892|FG000|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0
11108504|NCT01268644|12292892|FG000|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7
11108505|NCT01268644|12292892|FG000|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7
11108506|NCT01268644|12292892|FG000|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0
11108507|NCT01268683|12292899|FG000|STARTED|Overall Study||10
11108508|NCT01268683|12292899|FG000|COMPLETED|Overall Study||8
11108509|NCT01268683|12292899|FG000|NOT COMPLETED|Overall Study||2
11108510|NCT01268891|12292905|FG000|STARTED|Overall Study||66
11108511|NCT01268891|12292906|FG001|STARTED|Overall Study||66
11108512|NCT01268891|12292905|FG000|COMPLETED|Overall Study||58
11108513|NCT01268891|12292906|FG001|COMPLETED|Overall Study||58
11227863|NCT02006121|12420013|FG000|STARTED|Double Blind Phase||54
11227864|NCT02006121|12420014|FG001|STARTED|Double Blind Phase||53
11227865|NCT02006121|12420013|FG000|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42
11227866|NCT02006121|12420014|FG001|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29
11227867|NCT02006121|12420013|FG000|NOT COMPLETED|Double Blind Phase||12
11108514|NCT01268891|12292905|FG000|NOT COMPLETED|Overall Study||8
11108515|NCT01268891|12292906|FG001|NOT COMPLETED|Overall Study||8
10863383|NCT00919763|12028290|FG000|STARTED|Overall Study||53
10863384|NCT00919763|12028291|FG001|STARTED|Overall Study||49
10863385|NCT00919763|12028290|FG000|COMPLETED|Overall Study||41
10863386|NCT00919763|12028291|FG001|COMPLETED|Overall Study||45
11108516|NCT01268943|12292916|FG000|STARTED|Overall Study||6
11108517|NCT01268943|12292917|FG001|STARTED|Overall Study||3
11108518|NCT01268943|12292918|FG002|STARTED|Overall Study||3
11108519|NCT01268943|12292919|FG003|STARTED|Overall Study||6
11108520|NCT01268943|12292916|FG000|COMPLETED|Overall Study||6
11108521|NCT01268943|12292917|FG001|COMPLETED|Overall Study||3
11108522|NCT01268943|12292918|FG002|COMPLETED|Overall Study||3
11108523|NCT01268943|12292919|FG003|COMPLETED|Overall Study||6
11108524|NCT01268943|12292916|FG000|NOT COMPLETED|Overall Study||0
11108525|NCT01268943|12292917|FG001|NOT COMPLETED|Overall Study||0
11108526|NCT01268943|12292918|FG002|NOT COMPLETED|Overall Study||0
11108527|NCT01268943|12292919|FG003|NOT COMPLETED|Overall Study||0
11108528|NCT01269047|12292932|FG000|STARTED|Overall Study||13
11108529|NCT01269047|12292933|FG001|STARTED|Overall Study||13
11108530|NCT01269047|12292934|FG002|STARTED|Overall Study||11
11108531|NCT01269047|12292932|FG000|COMPLETED|Overall Study||12
11108532|NCT01269047|12292933|FG001|COMPLETED|Overall Study||11
11108533|NCT01269047|12292934|FG002|COMPLETED|Overall Study||10
11108534|NCT01269047|12292932|FG000|NOT COMPLETED|Overall Study||1
11108535|NCT01269047|12292933|FG001|NOT COMPLETED|Overall Study||2
11108536|NCT01269047|12292934|FG002|NOT COMPLETED|Overall Study||1
11108537|NCT01269125|12292947|FG000|STARTED|Overall Study||60
11108538|NCT01269125|12292948|FG001|STARTED|Overall Study||60
11108539|NCT01269125|12292949|FG002|STARTED|Overall Study||60
11108540|NCT01269125|12292947|FG000|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
11108541|NCT01269125|12292948|FG001|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
11108542|NCT01269125|12292949|FG002|COMPLETED|Overall Study||60
11108543|NCT01269125|12292947|FG000|NOT COMPLETED|Overall Study||7
11108544|NCT01269125|12292948|FG001|NOT COMPLETED|Overall Study||5
11108545|NCT01269125|12292949|FG002|NOT COMPLETED|Overall Study||0
11108546|NCT01269346|12292957|FG000|STARTED|Treatment Phase||52
11108547|NCT01269346|12292957|FG000|Completed 6 Cycles|Treatment Phase||45
11108548|NCT01269346|12292957|FG000|COMPLETED|Treatment Phase||43
11108549|NCT01269346|12292957|FG000|NOT COMPLETED|Treatment Phase||9
11108550|NCT01269346|12292957|FG000|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
11108551|NCT01269346|12292957|FG000|COMPLETED|Extension Phase||0
11108552|NCT01269346|12292957|FG000|NOT COMPLETED|Extension Phase||43
11108553|NCT01269372|12292962|FG000|STARTED|Overall Study||30
11108554|NCT01269372|12292962|FG000|COMPLETED|Overall Study||30
11108555|NCT01269372|12292962|FG000|NOT COMPLETED|Overall Study||0
11108556|NCT01269385|12292971|FG000|STARTED|Overall Study||4
11108557|NCT01269385|12292972|FG001|STARTED|Overall Study||4
10863387|NCT00919763|12028290|FG000|NOT COMPLETED|Overall Study||12
10863388|NCT00919763|12028291|FG001|NOT COMPLETED|Overall Study||4
11108558|NCT01269385|12292973|FG002|STARTED|Overall Study||6
11108559|NCT01269385|12292974|FG003|STARTED|Overall Study||8
11108560|NCT01269385|12292971|FG000|COMPLETED|Overall Study||3
11108561|NCT01269385|12292972|FG001|COMPLETED|Overall Study||3
11108562|NCT01269385|12292973|FG002|COMPLETED|Overall Study||6
11108563|NCT01269385|12292974|FG003|COMPLETED|Overall Study||8
11108564|NCT01269385|12292971|FG000|NOT COMPLETED|Overall Study||1
11108565|NCT01269385|12292972|FG001|NOT COMPLETED|Overall Study||1
11108566|NCT01269385|12292973|FG002|NOT COMPLETED|Overall Study||0
11108567|NCT01269385|12292974|FG003|NOT COMPLETED|Overall Study||0
11108568|NCT01269710|12292984|FG000|STARTED|Overall Study||4
11108569|NCT01269710|12292984|FG000|Week 12|Overall Study||3
11108570|NCT01269710|12292984|FG000|Week 36|Overall Study||2
11108571|NCT01269710|12292984|FG000|COMPLETED|Overall Study|This refers to Week 52.|1
11108572|NCT01269710|12292984|FG000|NOT COMPLETED|Overall Study||3
11108573|NCT01269736|12292990|FG000|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
11108574|NCT01269736|12292991|FG001|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
11108575|NCT01269736|12292990|FG000|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
11108576|NCT01269736|12292991|FG001|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
11108577|NCT01269736|12292990|FG000|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
11108578|NCT01269736|12292991|FG001|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
11108579|NCT01269736|12292990|FG000|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
11108580|NCT01269736|12292991|FG001|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
11108581|NCT01269736|12292990|FG000|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
11108582|NCT01269736|12292991|FG001|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
11108583|NCT01269736|12292990|FG000|NOT COMPLETED|Nurses' Knowledge Assessments||0
11108584|NCT01269736|12292991|FG001|NOT COMPLETED|Nurses' Knowledge Assessments||0
11108585|NCT01269736|12292990|FG000|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
11108586|NCT01269736|12292991|FG001|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
11108587|NCT01269736|12292990|FG000|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
11108588|NCT01269736|12292991|FG001|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
11108589|NCT01269736|12292990|FG000|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
11108590|NCT01269736|12292991|FG001|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
11108591|NCT01269736|12292990|FG000|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
11108592|NCT01269736|12292991|FG001|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
11108593|NCT01269736|12292990|FG000|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
11108594|NCT01269736|12292991|FG001|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
11108595|NCT01269736|12292990|FG000|NOT COMPLETED|Patient Quality of Care Assessments||0
11108596|NCT01269736|12292991|FG001|NOT COMPLETED|Patient Quality of Care Assessments||0
11108597|NCT01269736|12292990|FG000|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
11108598|NCT01269736|12292991|FG001|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
11108599|NCT01269736|12292990|FG000|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
11108600|NCT01269736|12292991|FG001|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
11108601|NCT01269736|12292990|FG000|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
11108602|NCT01269736|12292991|FG001|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
11108603|NCT01269736|12292990|FG000|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
11108604|NCT01269736|12292991|FG001|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
11108605|NCT01269736|12292990|FG000|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
11108606|NCT01269736|12292991|FG001|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
11227868|NCT02006121|12420014|FG001|NOT COMPLETED|Double Blind Phase||24
11108607|NCT01269736|12292990|FG000|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
11108608|NCT01269736|12292991|FG001|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
11227869|NCT02006121|12420013|FG000|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84
11227870|NCT02006121|12420014|FG001|STARTED|Open Label Phase|No patients received placebo in the open label phase|0
11227871|NCT02006121|12420013|FG000|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59
11227872|NCT02006121|12420014|FG001|COMPLETED|Open Label Phase||0
11227873|NCT02006121|12420013|FG000|NOT COMPLETED|Open Label Phase||25
11227874|NCT02006121|12420014|FG001|NOT COMPLETED|Open Label Phase||0
10863476|NCT00390325|12028385|FG000|STARTED|Overall Study||5
10863477|NCT00390325|12028386|FG001|STARTED|Overall Study||16
10863478|NCT00390325|12028385|FG000|COMPLETED|Overall Study||5
10863479|NCT00390325|12028386|FG001|COMPLETED|Overall Study||16
10863480|NCT00390325|12028385|FG000|NOT COMPLETED|Overall Study||0
10863481|NCT00390325|12028386|FG001|NOT COMPLETED|Overall Study||0
11227875|NCT02006160|12420026|FG000|STARTED|Overall Study||45
11227876|NCT02006160|12420027|FG001|STARTED|Overall Study||16
11227877|NCT02006160|12420026|FG000|COMPLETED|Overall Study||41
11227878|NCT02006160|12420027|FG001|COMPLETED|Overall Study||16
11227879|NCT02006160|12420026|FG000|NOT COMPLETED|Overall Study||4
11227880|NCT02006160|12420027|FG001|NOT COMPLETED|Overall Study||0
11227881|NCT02006264|12420035|FG000|STARTED|Overall Study||15
11227882|NCT02006264|12420036|FG001|STARTED|Overall Study||15
11227883|NCT02006264|12420035|FG000|COMPLETED|Overall Study||14
11227884|NCT02006264|12420036|FG001|COMPLETED|Overall Study||15
11227885|NCT02006264|12420035|FG000|NOT COMPLETED|Overall Study||1
11227886|NCT02006264|12420036|FG001|NOT COMPLETED|Overall Study||0
11227887|NCT02006342|12420044|FG000|STARTED|Overall Study||20
11227888|NCT02006342|12420045|FG001|STARTED|Overall Study||20
11227889|NCT02006342|12420044|FG000|COMPLETED|Overall Study||19
11227890|NCT02006342|12420045|FG001|COMPLETED|Overall Study||20
11227891|NCT02006342|12420044|FG000|NOT COMPLETED|Overall Study||1
11227892|NCT02006342|12420045|FG001|NOT COMPLETED|Overall Study||0
11227893|NCT02006420|12420053|FG000|STARTED|Overall Study||24
11227894|NCT02006420|12420054|FG001|STARTED|Overall Study||21
11227895|NCT02006420|12420053|FG000|COMPLETED|Overall Study||24
11227896|NCT02006420|12420054|FG001|COMPLETED|Overall Study||21
11227897|NCT02006420|12420053|FG000|NOT COMPLETED|Overall Study||0
11227898|NCT02006420|12420054|FG001|NOT COMPLETED|Overall Study||0
11227899|NCT02006472|12420071|FG000|STARTED|Period 1 (Through Week 26)||82
11227900|NCT02006472|12420072|FG001|STARTED|Period 1 (Through Week 26)||81
11227901|NCT02006472|12420073|FG002|STARTED|Period 1 (Through Week 26)||82
11227902|NCT02006472|12420074|FG003|STARTED|Period 1 (Through Week 26)||81
11227903|NCT02006472|12420075|FG004|STARTED|Period 1 (Through Week 26)||82
11227904|NCT02006472|12420071|FG000|ITT|Period 1 (Through Week 26)||82
11227905|NCT02006472|12420072|FG001|ITT|Period 1 (Through Week 26)||81
11227906|NCT02006472|12420073|FG002|ITT|Period 1 (Through Week 26)||82
11227907|NCT02006472|12420074|FG003|ITT|Period 1 (Through Week 26)||81
11227908|NCT02006472|12420075|FG004|ITT|Period 1 (Through Week 26)||82
11227909|NCT02006472|12420071|FG000|FAS|Period 1 (Through Week 26)||81
11227910|NCT02006472|12420072|FG001|FAS|Period 1 (Through Week 26)||75
11227911|NCT02006472|12420073|FG002|FAS|Period 1 (Through Week 26)||79
11227912|NCT02006472|12420074|FG003|FAS|Period 1 (Through Week 26)||81
11227913|NCT02006472|12420075|FG004|FAS|Period 1 (Through Week 26)||81
11227914|NCT02006472|12420071|FG000|Safety Set|Period 1 (Through Week 26)||82
11227915|NCT02006472|12420072|FG001|Safety Set|Period 1 (Through Week 26)||81
11227916|NCT02006472|12420073|FG002|Safety Set|Period 1 (Through Week 26)||82
11227917|NCT02006472|12420074|FG003|Safety Set|Period 1 (Through Week 26)||81
11227918|NCT02006472|12420075|FG004|Safety Set|Period 1 (Through Week 26)||82
11227919|NCT02006472|12420071|FG000|COMPLETED|Period 1 (Through Week 26)||70
11227920|NCT02006472|12420072|FG001|COMPLETED|Period 1 (Through Week 26)||59
11108609|NCT01269801|12293001|FG000|STARTED|Overall Study||74
11108610|NCT01269801|12293002|FG001|STARTED|Overall Study||80
11108611|NCT01269801|12293001|FG000|COMPLETED|Overall Study||74
11108612|NCT01269801|12293002|FG001|COMPLETED|Overall Study||77
11108613|NCT01269801|12293001|FG000|NOT COMPLETED|Overall Study||0
11108614|NCT01269801|12293002|FG001|NOT COMPLETED|Overall Study||3
11108615|NCT01269918|12293010|FG000|STARTED|Overall Study||71
11108616|NCT01269918|12293011|FG001|STARTED|Overall Study||71
10863496|NCT00306917|12028418|FG000|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
10863497|NCT00306917|12028419|FG001|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
10863498|NCT00306917|12028418|FG000|Postoperative to 6 Month Follow up|Overall Study||93
10863499|NCT00306917|12028419|FG001|Postoperative to 6 Month Follow up|Overall Study||100
10863500|NCT00306917|12028418|FG000|12 Month Follow|Overall Study||86
10863501|NCT00306917|12028419|FG001|12 Month Follow|Overall Study||94
10863502|NCT00306917|12028418|FG000|24 Month Follow up|Overall Study||60
10863503|NCT00306917|12028419|FG001|24 Month Follow up|Overall Study||71
10863504|NCT00306917|12028418|FG000|36 Month Follow up|Overall Study||56
10863505|NCT00306917|12028419|FG001|36 Month Follow up|Overall Study||42
10863506|NCT00306917|12028418|FG000|48 Month Follow up|Overall Study||29
10863507|NCT00306917|12028419|FG001|48 Month Follow up|Overall Study||22
10863508|NCT00306917|12028418|FG000|60 Month Follow up|Overall Study||13
10863509|NCT00306917|12028419|FG001|60 Month Follow up|Overall Study||15
10863510|NCT00306917|12028418|FG000|COMPLETED|Overall Study||13
10863511|NCT00306917|12028419|FG001|COMPLETED|Overall Study||15
10863512|NCT00306917|12028418|FG000|NOT COMPLETED|Overall Study||108
10863513|NCT00306917|12028419|FG001|NOT COMPLETED|Overall Study||109
10863514|NCT00238420|12028427|FG000|STARTED|Overall Study||22
10863515|NCT00238420|12028428|FG001|STARTED|Overall Study||48
10863516|NCT00238420|12028427|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
10863517|NCT00238420|12028428|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
10863518|NCT00238420|12028427|FG000|NOT COMPLETED|Overall Study||1
10863519|NCT00238420|12028428|FG001|NOT COMPLETED|Overall Study||1
11108617|NCT01269918|12293010|FG000|COMPLETED|Overall Study||71
11108618|NCT01269918|12293011|FG001|COMPLETED|Overall Study||68
11108619|NCT01269918|12293010|FG000|NOT COMPLETED|Overall Study||0
11227921|NCT02006472|12420073|FG002|COMPLETED|Period 1 (Through Week 26)||65
11227922|NCT02006472|12420074|FG003|COMPLETED|Period 1 (Through Week 26)||67
11227923|NCT02006472|12420075|FG004|COMPLETED|Period 1 (Through Week 26)||62
11227924|NCT02006472|12420071|FG000|NOT COMPLETED|Period 1 (Through Week 26)||12
11108620|NCT01269918|12293011|FG001|NOT COMPLETED|Overall Study||3
11108621|NCT01270126|12293019|FG000|STARTED|Overall Study||12
11108622|NCT01270126|12293020|FG001|STARTED|Overall Study||10
11108623|NCT01270126|12293019|FG000|COMPLETED|Overall Study||12
11108624|NCT01270126|12293020|FG001|COMPLETED|Overall Study||10
11108625|NCT01270126|12293019|FG000|NOT COMPLETED|Overall Study||0
11108626|NCT01270126|12293020|FG001|NOT COMPLETED|Overall Study||0
11108627|NCT01270139|12293029|FG000|STARTED|Overall Study|Intention-to-treat population|60
11108628|NCT01270139|12293030|FG001|STARTED|Overall Study|Intention-to-treat population|60
11227925|NCT02006472|12420072|FG001|NOT COMPLETED|Period 1 (Through Week 26)||22
11227926|NCT02006472|12420073|FG002|NOT COMPLETED|Period 1 (Through Week 26)||17
11227927|NCT02006472|12420074|FG003|NOT COMPLETED|Period 1 (Through Week 26)||14
11227928|NCT02006472|12420075|FG004|NOT COMPLETED|Period 1 (Through Week 26)||20
11227929|NCT02006472|12420071|FG000|STARTED|Period 2 (Through Week 52)||57
11227930|NCT02006472|12420072|FG001|STARTED|Period 2 (Through Week 52)||49
11227931|NCT02006472|12420073|FG002|STARTED|Period 2 (Through Week 52)||54
11227932|NCT02006472|12420074|FG003|STARTED|Period 2 (Through Week 52)||56
11227933|NCT02006472|12420075|FG004|STARTED|Period 2 (Through Week 52)||46
11227934|NCT02006472|12420071|FG000|Started Treatment in Period 2|Period 2 (Through Week 52)||57
11227935|NCT02006472|12420072|FG001|Started Treatment in Period 2|Period 2 (Through Week 52)||49
11227936|NCT02006472|12420073|FG002|Started Treatment in Period 2|Period 2 (Through Week 52)||52
11227937|NCT02006472|12420074|FG003|Started Treatment in Period 2|Period 2 (Through Week 52)||56
11227938|NCT02006472|12420075|FG004|Started Treatment in Period 2|Period 2 (Through Week 52)||46
10863532|NCT03107208|12028460|FG000|STARTED|Overall Study||30
10863533|NCT03107208|12028461|FG001|STARTED|Overall Study||27
10863534|NCT03107208|12028460|FG000|Received Intervention|Overall Study||26
10863535|NCT03107208|12028461|FG001|Received Intervention|Overall Study||24
10863536|NCT03107208|12028460|FG000|COMPLETED|Overall Study||26
10863537|NCT03107208|12028461|FG001|COMPLETED|Overall Study||24
10863538|NCT03107208|12028460|FG000|NOT COMPLETED|Overall Study||4
10863539|NCT03107208|12028461|FG001|NOT COMPLETED|Overall Study||3
10863540|NCT04509739|12028467|FG000|STARTED|Overall Study||16
10863541|NCT04509739|12028467|FG000|COMPLETED|Overall Study||15
10863542|NCT04509739|12028467|FG000|NOT COMPLETED|Overall Study||1
10863543|NCT04391959|12028473|FG000|STARTED|Overall Study||16
10863544|NCT04391959|12028474|FG001|STARTED|Overall Study|One subject should have been excluded based upon Schirmer test = 0 mm at baseline < 5mm. Subject was removed from the study.|15
10863545|NCT04391959|12028473|FG000|COMPLETED|Overall Study||15
10863546|NCT04391959|12028474|FG001|COMPLETED|Overall Study||10
10863547|NCT04391959|12028473|FG000|NOT COMPLETED|Overall Study||1
10863548|NCT04391959|12028474|FG001|NOT COMPLETED|Overall Study||5
10863549|NCT04368364|12028483|FG000|STARTED|Overall Study||1
10863550|NCT04368364|12028484|FG001|STARTED|Overall Study||1
10863551|NCT04368364|12028485|FG002|STARTED|Overall Study||1
10863552|NCT04368364|12028483|FG000|COMPLETED|Overall Study||1
10863553|NCT04368364|12028484|FG001|COMPLETED|Overall Study||1
10863554|NCT04368364|12028485|FG002|COMPLETED|Overall Study||1
10863555|NCT04368364|12028483|FG000|NOT COMPLETED|Overall Study||0
10863556|NCT04368364|12028484|FG001|NOT COMPLETED|Overall Study||0
10863557|NCT04368364|12028485|FG002|NOT COMPLETED|Overall Study||0
10863558|NCT04244084|12028495|FG000|STARTED|Overall Study||118
10863559|NCT04244084|12028496|FG001|STARTED|Overall Study||122
10863560|NCT04244084|12028495|FG000|COMPLETED|Overall Study||118
10863561|NCT04244084|12028496|FG001|COMPLETED|Overall Study||122
10863562|NCT04244084|12028495|FG000|NOT COMPLETED|Overall Study||0
10863563|NCT04244084|12028496|FG001|NOT COMPLETED|Overall Study||0
10863564|NCT04189588|12028504|FG000|STARTED|Overall Study||17
10863565|NCT04189588|12028505|FG001|STARTED|Overall Study||17
10863566|NCT04189588|12028504|FG000|Completed Treatment|Overall Study||17
10863567|NCT04189588|12028505|FG001|Completed Treatment|Overall Study||17
10863568|NCT04189588|12028504|FG000|COMPLETED|Overall Study||17
10863569|NCT04189588|12028505|FG001|COMPLETED|Overall Study||15
10863570|NCT04189588|12028504|FG000|NOT COMPLETED|Overall Study||0
10863571|NCT04189588|12028505|FG001|NOT COMPLETED|Overall Study||2
10863572|NCT04150562|12028511|FG000|STARTED|Overall Study||2
10863573|NCT04150562|12028512|FG001|STARTED|Overall Study||0
10863574|NCT04150562|12028511|FG000|COMPLETED|Overall Study||2
10863575|NCT04150562|12028512|FG001|COMPLETED|Overall Study||0
10863576|NCT04150562|12028511|FG000|NOT COMPLETED|Overall Study||0
10863577|NCT04150562|12028512|FG001|NOT COMPLETED|Overall Study||0
10863578|NCT04115748|12028520|FG000|STARTED|Main Study (Up to 16 Weeks)||19
10863579|NCT04115748|12028521|FG001|STARTED|Main Study (Up to 16 Weeks)||19
10863580|NCT04115748|12028522|FG002|STARTED|Main Study (Up to 16 Weeks)||9
10863581|NCT04115748|12028523|FG003|STARTED|Main Study (Up to 16 Weeks)||20
10863582|NCT04115748|12028524|FG004|STARTED|Main Study (Up to 16 Weeks)||0
10863583|NCT04115748|12028525|FG005|STARTED|Main Study (Up to 16 Weeks)||0
10863584|NCT04115748|12028526|FG006|STARTED|Main Study (Up to 16 Weeks)||0
10863585|NCT04115748|12028527|FG007|STARTED|Main Study (Up to 16 Weeks)||0
10863586|NCT04115748|12028528|FG008|STARTED|Main Study (Up to 16 Weeks)||0
10863587|NCT04115748|12028529|FG009|STARTED|Main Study (Up to 16 Weeks)||0
10863588|NCT04115748|12028520|FG000|COMPLETED|Main Study (Up to 16 Weeks)||4
11108629|NCT01270139|12293031|FG002|STARTED|Overall Study|Intention-to-treat population|60
11108630|NCT01270139|12293029|FG000|COMPLETED|Overall Study|Pre-treatment evaluable population|42
11108631|NCT01270139|12293030|FG001|COMPLETED|Overall Study|Pre-treatment evaluable population|34
11227939|NCT02006472|12420071|FG000|COMPLETED|Period 2 (Through Week 52)||52
11227940|NCT02006472|12420072|FG001|COMPLETED|Period 2 (Through Week 52)||43
11108632|NCT01270139|12293031|FG002|COMPLETED|Overall Study|Pre-treatment evaluable population|40
11108633|NCT01270139|12293029|FG000|NOT COMPLETED|Overall Study||18
11108634|NCT01270139|12293030|FG001|NOT COMPLETED|Overall Study||26
11108635|NCT01270139|12293031|FG002|NOT COMPLETED|Overall Study||20
11108636|NCT01270256|12293048|FG000|STARTED|Overall Study||21
11108637|NCT01270256|12293049|FG001|STARTED|Overall Study||20
11108638|NCT01270256|12293048|FG000|COMPLETED|Overall Study||20
11108639|NCT01270256|12293049|FG001|COMPLETED|Overall Study||20
11108640|NCT01270256|12293048|FG000|NOT COMPLETED|Overall Study||1
11108641|NCT01270256|12293049|FG001|NOT COMPLETED|Overall Study||0
11108642|NCT01270321|12293058|FG000|STARTED|Overall Study||19
11108643|NCT01270321|12293059|FG001|STARTED|Overall Study||11
11108644|NCT01270321|12293060|FG002|STARTED|Overall Study||12
11108645|NCT01270321|12293058|FG000|COMPLETED|Overall Study||9
11108646|NCT01270321|12293059|FG001|COMPLETED|Overall Study||1
11108647|NCT01270321|12293060|FG002|COMPLETED|Overall Study||3
10863589|NCT04115748|12028521|FG001|COMPLETED|Main Study (Up to 16 Weeks)||3
10863590|NCT04115748|12028522|FG002|COMPLETED|Main Study (Up to 16 Weeks)||2
10863591|NCT04115748|12028523|FG003|COMPLETED|Main Study (Up to 16 Weeks)||4
10863592|NCT04115748|12028524|FG004|COMPLETED|Main Study (Up to 16 Weeks)||0
11108648|NCT01270321|12293058|FG000|NOT COMPLETED|Overall Study||10
11108649|NCT01270321|12293059|FG001|NOT COMPLETED|Overall Study||10
11108650|NCT01270321|12293060|FG002|NOT COMPLETED|Overall Study||9
11108651|NCT01270464|12293071|FG000|STARTED|Overall Study||105
11108652|NCT01270464|12293072|FG001|STARTED|Overall Study||104
11108653|NCT01270464|12293073|FG002|STARTED|Overall Study||106
10863593|NCT04115748|12028525|FG005|COMPLETED|Main Study (Up to 16 Weeks)||0
10863594|NCT04115748|12028526|FG006|COMPLETED|Main Study (Up to 16 Weeks)||0
10863595|NCT04115748|12028527|FG007|COMPLETED|Main Study (Up to 16 Weeks)||0
10863596|NCT04115748|12028528|FG008|COMPLETED|Main Study (Up to 16 Weeks)||0
10863597|NCT04115748|12028529|FG009|COMPLETED|Main Study (Up to 16 Weeks)||0
10863598|NCT04115748|12028520|FG000|NOT COMPLETED|Main Study (Up to 16 Weeks)||15
10863599|NCT04115748|12028521|FG001|NOT COMPLETED|Main Study (Up to 16 Weeks)||16
10863600|NCT04115748|12028522|FG002|NOT COMPLETED|Main Study (Up to 16 Weeks)||7
10863601|NCT04115748|12028523|FG003|NOT COMPLETED|Main Study (Up to 16 Weeks)||16
10863602|NCT04115748|12028524|FG004|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10863603|NCT04115748|12028525|FG005|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10863604|NCT04115748|12028526|FG006|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10863605|NCT04115748|12028527|FG007|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10863606|NCT04115748|12028528|FG008|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10863607|NCT04115748|12028529|FG009|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10863608|NCT04115748|12028520|FG000|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 200 mg.|0
10863609|NCT04115748|12028521|FG001|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 100 mg.|0
10863610|NCT04115748|12028522|FG002|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study were randomized in LTE phase to receive filgotinib 200 mg or 100 mg.|0
10863611|NCT04115748|12028523|FG003|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study were randomized in LTE phase to receive filgotinib 200 mg or 100 mg.|0
10863612|NCT04115748|12028524|FG004|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 200 mg.|4
10863613|NCT04115748|12028525|FG005|STARTED|LTE (After 16 Weeks to Week 50)|Participants who completed main study received filgotinib 100 mg.|3
10863614|NCT04115748|12028526|FG006|STARTED|LTE (After 16 Weeks to Week 50)|1 participant who received adalimumab injection and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|1
10863615|NCT04115748|12028527|FG007|STARTED|LTE (After 16 Weeks to Week 50)|1 participant who received adalimumab injection and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|1
10863616|NCT04115748|12028528|FG008|STARTED|LTE (After 16 Weeks to Week 50)|2 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|2
10863617|NCT04115748|12028529|FG009|STARTED|LTE (After 16 Weeks to Week 50)|2 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|2
10863618|NCT04115748|12028520|FG000|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863619|NCT04115748|12028521|FG001|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863620|NCT04115748|12028522|FG002|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863621|NCT04115748|12028523|FG003|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863622|NCT04115748|12028524|FG004|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863623|NCT04115748|12028525|FG005|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863624|NCT04115748|12028526|FG006|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863625|NCT04115748|12028527|FG007|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863626|NCT04115748|12028528|FG008|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863627|NCT04115748|12028529|FG009|COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863628|NCT04115748|12028520|FG000|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863629|NCT04115748|12028521|FG001|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863630|NCT04115748|12028522|FG002|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863631|NCT04115748|12028523|FG003|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||0
10863632|NCT04115748|12028524|FG004|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||4
10863633|NCT04115748|12028525|FG005|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||3
10863634|NCT04115748|12028526|FG006|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||1
10863635|NCT04115748|12028527|FG007|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||1
10863636|NCT04115748|12028528|FG008|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||2
10863637|NCT04115748|12028529|FG009|NOT COMPLETED|LTE (After 16 Weeks to Week 50)||2
10863638|NCT04044664|12028554|FG000|STARTED|Stage 1||103
10863639|NCT04044664|12028555|FG001|STARTED|Stage 1||26
10863640|NCT04044664|12028556|FG002|STARTED|Stage 1||23
10863641|NCT04044664|12028554|FG000|COMPLETED|Stage 1||86
10863642|NCT04044664|12028555|FG001|COMPLETED|Stage 1||19
10863643|NCT04044664|12028556|FG002|COMPLETED|Stage 1||20
10863644|NCT04044664|12028554|FG000|NOT COMPLETED|Stage 1||17
10863645|NCT04044664|12028555|FG001|NOT COMPLETED|Stage 1||7
10863646|NCT04044664|12028556|FG002|NOT COMPLETED|Stage 1||3
10863647|NCT04044664|12028554|FG000|STARTED|Stage 2||76
10863648|NCT04044664|12028555|FG001|STARTED|Stage 2||26
10863649|NCT04044664|12028556|FG002|STARTED|Stage 2||22
10863650|NCT04044664|12028554|FG000|From Placebo, Responder|Stage 2||20
10863651|NCT04044664|12028555|FG001|From Placebo, Responder|Stage 2||13
10863652|NCT04044664|12028556|FG002|From Placebo, Responder|Stage 2||11
10863653|NCT04044664|12028554|FG000|From Placebo, Non-Responder|Stage 2||18
10863654|NCT04044664|12028555|FG001|From Placebo, Non-Responder|Stage 2||13
10863655|NCT04044664|12028556|FG002|From Placebo, Non-Responder|Stage 2||11
10863656|NCT04044664|12028554|FG000|From NYX-783 (10 mg or 50 mg)|Stage 2||38
10863657|NCT04044664|12028555|FG001|From NYX-783 (10 mg or 50 mg)|Stage 2||0
10863658|NCT04044664|12028556|FG002|From NYX-783 (10 mg or 50 mg)|Stage 2||0
10863659|NCT04044664|12028554|FG000|COMPLETED|Stage 2||67
10863660|NCT04044664|12028555|FG001|COMPLETED|Stage 2||24
10863661|NCT04044664|12028556|FG002|COMPLETED|Stage 2||21
10863662|NCT04044664|12028554|FG000|NOT COMPLETED|Stage 2||9
10863663|NCT04044664|12028555|FG001|NOT COMPLETED|Stage 2||2
10863664|NCT04044664|12028556|FG002|NOT COMPLETED|Stage 2||1
10863665|NCT04009850|12028566|FG000|STARTED|Overall Study||3
10863666|NCT04009850|12028567|FG001|STARTED|Overall Study||0
10863667|NCT04009850|12028566|FG000|COMPLETED|Overall Study||3
10863668|NCT04009850|12028567|FG001|COMPLETED|Overall Study||0
10863669|NCT04009850|12028566|FG000|NOT COMPLETED|Overall Study||0
10863670|NCT04009850|12028567|FG001|NOT COMPLETED|Overall Study||0
10863671|NCT03994731|12028575|FG000|STARTED|Run-in Period (From Week -4 to Day 1)||100
10863672|NCT03994731|12028576|FG001|STARTED|Run-in Period (From Week -4 to Day 1)||52
10863673|NCT03994731|12028575|FG000|Took at Least 1 Dose of MTX or Placebo|Run-in Period (From Week -4 to Day 1)||98
10863674|NCT03994731|12028576|FG001|Took at Least 1 Dose of MTX or Placebo|Run-in Period (From Week -4 to Day 1)||51
11108654|NCT01270464|12293071|FG000|Safety Analysis Set|Overall Study||105
11227941|NCT02006472|12420073|FG002|COMPLETED|Period 2 (Through Week 52)||44
11227942|NCT02006472|12420074|FG003|COMPLETED|Period 2 (Through Week 52)||53
11227943|NCT02006472|12420075|FG004|COMPLETED|Period 2 (Through Week 52)||44
11227944|NCT02006472|12420071|FG000|NOT COMPLETED|Period 2 (Through Week 52)||5
11227945|NCT02006472|12420072|FG001|NOT COMPLETED|Period 2 (Through Week 52)||6
11227946|NCT02006472|12420073|FG002|NOT COMPLETED|Period 2 (Through Week 52)||10
11227947|NCT02006472|12420074|FG003|NOT COMPLETED|Period 2 (Through Week 52)||3
11227948|NCT02006472|12420075|FG004|NOT COMPLETED|Period 2 (Through Week 52)||2
11227949|NCT02006576|12420095|FG000|STARTED|Overall Study||35
11227950|NCT02006576|12420096|FG001|STARTED|Overall Study||51
11227951|NCT02006576|12420097|FG002|STARTED|Overall Study||32
11227952|NCT02006576|12420095|FG000|COMPLETED|Overall Study||17
11227953|NCT02006576|12420096|FG001|COMPLETED|Overall Study||44
11227954|NCT02006576|12420097|FG002|COMPLETED|Overall Study||15
11227955|NCT02006576|12420095|FG000|NOT COMPLETED|Overall Study||18
11227956|NCT02006576|12420096|FG001|NOT COMPLETED|Overall Study||7
11227957|NCT02006576|12420097|FG002|NOT COMPLETED|Overall Study||17
10863675|NCT03994731|12028575|FG000|COMPLETED|Run-in Period (From Week -4 to Day 1)||96
10863676|NCT03994731|12028576|FG001|COMPLETED|Run-in Period (From Week -4 to Day 1)||49
10863677|NCT03994731|12028575|FG000|NOT COMPLETED|Run-in Period (From Week -4 to Day 1)||4
11108655|NCT01270464|12293072|FG001|Safety Analysis Set|Overall Study||103
11108656|NCT01270464|12293073|FG002|Safety Analysis Set|Overall Study||103
11108657|NCT01270464|12293071|FG000|Full Analysis Set|Overall Study||105
11108658|NCT01270464|12293072|FG001|Full Analysis Set|Overall Study||103
11108659|NCT01270464|12293073|FG002|Full Analysis Set|Overall Study||103
11108660|NCT01270464|12293071|FG000|Pharmacokinetic Analysis Set|Overall Study||105
11108661|NCT01270464|12293072|FG001|Pharmacokinetic Analysis Set|Overall Study||103
11108662|NCT01270464|12293073|FG002|Pharmacokinetic Analysis Set|Overall Study||103
11108663|NCT01270464|12293071|FG000|COMPLETED|Overall Study||85
11108664|NCT01270464|12293072|FG001|COMPLETED|Overall Study||92
11108665|NCT01270464|12293073|FG002|COMPLETED|Overall Study||88
11108666|NCT01270464|12293071|FG000|NOT COMPLETED|Overall Study||20
11108667|NCT01270464|12293072|FG001|NOT COMPLETED|Overall Study||12
11108668|NCT01270464|12293073|FG002|NOT COMPLETED|Overall Study||18
11108669|NCT01270503|12293081|FG000|STARTED|Overall Study||538
11108670|NCT01270503|12293081|FG000|COMPLETED|Overall Study||537
11108671|NCT01270503|12293081|FG000|NOT COMPLETED|Overall Study||1
11227958|NCT02006641|12420108|FG000|STARTED|Overall Study||284
11227959|NCT02006641|12420109|FG001|STARTED|Overall Study||290
11227960|NCT02006641|12420110|FG002|STARTED|Overall Study||284
11227961|NCT02006641|12420108|FG000|Treated|Overall Study||282
11227962|NCT02006641|12420109|FG001|Treated|Overall Study||285
11227963|NCT02006641|12420110|FG002|Treated|Overall Study||281
11227964|NCT02006641|12420108|FG000|COMPLETED|Overall Study||258
10863678|NCT03994731|12028576|FG001|NOT COMPLETED|Run-in Period (From Week -4 to Day 1)||3
10863679|NCT03994731|12028575|FG000|STARTED|Pegloticase + IMM Period||96
10863680|NCT03994731|12028576|FG001|STARTED|Pegloticase + IMM Period||49
10863681|NCT03994731|12028575|FG000|Discontinued Study Treatment Early|Pegloticase + IMM Period||38
11227965|NCT02006641|12420109|FG001|COMPLETED|Overall Study||257
10863682|NCT03994731|12028576|FG001|Discontinued Study Treatment Early|Pegloticase + IMM Period||33
10863683|NCT03994731|12028575|FG000|COMPLETED|Pegloticase + IMM Period||76
10863684|NCT03994731|12028576|FG001|COMPLETED|Pegloticase + IMM Period||34
10863685|NCT03994731|12028575|FG000|NOT COMPLETED|Pegloticase + IMM Period||20
10863686|NCT03994731|12028576|FG001|NOT COMPLETED|Pegloticase + IMM Period||15
10863687|NCT03963895|12028588|FG000|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
10863688|NCT03963895|12028589|FG001|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
10863689|NCT03963895|12028590|FG002|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
11227966|NCT02006641|12420110|FG002|COMPLETED|Overall Study||248
11227967|NCT02006641|12420108|FG000|NOT COMPLETED|Overall Study||26
11227968|NCT02006641|12420109|FG001|NOT COMPLETED|Overall Study||33
11227969|NCT02006641|12420110|FG002|NOT COMPLETED|Overall Study||36
11227970|NCT02006654|12420120|FG000|STARTED|Overall Study||369
11227971|NCT02006654|12420121|FG001|STARTED|Overall Study||365
11227972|NCT02006654|12420120|FG000|Treated|Overall Study||365
11227973|NCT02006654|12420121|FG001|Treated|Overall Study||363
11227974|NCT02006654|12420120|FG000|COMPLETED|Overall Study||324
11227975|NCT02006654|12420121|FG001|COMPLETED|Overall Study||321
11227976|NCT02006654|12420120|FG000|NOT COMPLETED|Overall Study||45
11227977|NCT02006654|12420121|FG001|NOT COMPLETED|Overall Study||44
11227978|NCT02006667|12420128|FG000|STARTED|Overall Study||13
11227979|NCT02006667|12420128|FG000|COMPLETED|Overall Study||7
11227980|NCT02006667|12420128|FG000|NOT COMPLETED|Overall Study||6
11227981|NCT02006693|12420134|FG000|STARTED|Overall Study||112
11227982|NCT02006693|12420135|FG001|STARTED|Overall Study||87
11227983|NCT02006693|12420134|FG000|COMPLETED|Overall Study||84
11227984|NCT02006693|12420135|FG001|COMPLETED|Overall Study||74
11227985|NCT02006693|12420134|FG000|NOT COMPLETED|Overall Study||28
11227986|NCT02006693|12420135|FG001|NOT COMPLETED|Overall Study||13
11227987|NCT02006706|12420141|FG000|STARTED|Overall Study||15
11227988|NCT02006706|12420141|FG000|COMPLETED|Overall Study||14
11227989|NCT02006706|12420141|FG000|NOT COMPLETED|Overall Study||1
11227990|NCT02006719|12420147|FG000|STARTED|Overall Study||237
11227991|NCT02006719|12420148|FG001|STARTED|Overall Study||85
11227992|NCT02006719|12420147|FG000|COMPLETED|Overall Study||219
11227993|NCT02006719|12420148|FG001|COMPLETED|Overall Study||80
11227994|NCT02006719|12420147|FG000|NOT COMPLETED|Overall Study||18
11227995|NCT02006719|12420148|FG001|NOT COMPLETED|Overall Study||5
11227996|NCT02006732|12420158|FG000|STARTED|Overall Study||202
11227997|NCT02006732|12420159|FG001|STARTED|Overall Study||203
11227998|NCT02006732|12420160|FG002|STARTED|Overall Study||202
11227999|NCT02006732|12420161|FG003|STARTED|Overall Study||202
11228000|NCT02006732|12420158|FG000|COMPLETED|Overall Study||182
11228001|NCT02006732|12420159|FG001|COMPLETED|Overall Study||191
11228002|NCT02006732|12420160|FG002|COMPLETED|Overall Study||193
11228003|NCT02006732|12420161|FG003|COMPLETED|Overall Study||198
11228004|NCT02006732|12420158|FG000|NOT COMPLETED|Overall Study||20
11228005|NCT02006732|12420159|FG001|NOT COMPLETED|Overall Study||12
11228006|NCT02006732|12420160|FG002|NOT COMPLETED|Overall Study||9
11228007|NCT02006732|12420161|FG003|NOT COMPLETED|Overall Study||4
11228008|NCT02006758|12420171|FG000|STARTED|Overall Study|Total number of enrolled participants|68
11228009|NCT02006758|12420171|FG000|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67
11228010|NCT02006758|12420171|FG000|1-month Follow up|Overall Study|1-month follow up completed|66
11228011|NCT02006758|12420171|FG000|6-month Follow up|Overall Study|6-month follow up completed|60
11228012|NCT02006758|12420171|FG000|12-month Follow up|Overall Study|12-month follow up completed|55
11228013|NCT02006758|12420171|FG000|COMPLETED|Overall Study||55
11228014|NCT02006758|12420171|FG000|NOT COMPLETED|Overall Study||13
11228015|NCT02006836|12420179|FG000|STARTED|Case-control Period: Month 1- Month 6||20
11228016|NCT02006836|12420180|FG001|STARTED|Case-control Period: Month 1- Month 6||20
11228017|NCT02006836|12420181|FG002|STARTED|Case-control Period: Month 1- Month 6||0
11228018|NCT02006836|12420179|FG000|COMPLETED|Case-control Period: Month 1- Month 6||20
11228019|NCT02006836|12420180|FG001|COMPLETED|Case-control Period: Month 1- Month 6||20
11228020|NCT02006836|12420181|FG002|COMPLETED|Case-control Period: Month 1- Month 6||0
11228021|NCT02006836|12420179|FG000|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
11228022|NCT02006836|12420180|FG001|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
11228023|NCT02006836|12420181|FG002|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
11228024|NCT02006836|12420179|FG000|STARTED|Self-control Period: Month 7-month 12||0
10863690|NCT03963895|12028588|FG000|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
10863691|NCT03963895|12028589|FG001|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
10863692|NCT03963895|12028590|FG002|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
10863693|NCT03963895|12028588|FG000|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
10863694|NCT03963895|12028589|FG001|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
10863695|NCT03963895|12028590|FG002|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
10863696|NCT03963895|12028588|FG000|STARTED|Dosing Period (Study Day 1)||12
10863697|NCT03963895|12028589|FG001|STARTED|Dosing Period (Study Day 1)||12
10863698|NCT03963895|12028590|FG002|STARTED|Dosing Period (Study Day 1)||12
10863699|NCT03963895|12028588|FG000|COMPLETED|Dosing Period (Study Day 1)||12
10863700|NCT03963895|12028589|FG001|COMPLETED|Dosing Period (Study Day 1)||12
10863701|NCT03963895|12028590|FG002|COMPLETED|Dosing Period (Study Day 1)||12
10863702|NCT03963895|12028588|FG000|NOT COMPLETED|Dosing Period (Study Day 1)||0
10863703|NCT03963895|12028589|FG001|NOT COMPLETED|Dosing Period (Study Day 1)||0
10863704|NCT03963895|12028590|FG002|NOT COMPLETED|Dosing Period (Study Day 1)||0
10863705|NCT03963895|12028588|FG000|STARTED|Recovery Period (Study Day 3)||12
10863706|NCT03963895|12028589|FG001|STARTED|Recovery Period (Study Day 3)||12
10863707|NCT03963895|12028590|FG002|STARTED|Recovery Period (Study Day 3)||12
10863708|NCT03963895|12028588|FG000|COMPLETED|Recovery Period (Study Day 3)||12
10863709|NCT03963895|12028589|FG001|COMPLETED|Recovery Period (Study Day 3)||12
10863710|NCT03963895|12028590|FG002|COMPLETED|Recovery Period (Study Day 3)||12
10863711|NCT03963895|12028588|FG000|NOT COMPLETED|Recovery Period (Study Day 3)||0
10863712|NCT03963895|12028589|FG001|NOT COMPLETED|Recovery Period (Study Day 3)||0
10863713|NCT03963895|12028590|FG002|NOT COMPLETED|Recovery Period (Study Day 3)||0
10863714|NCT03963895|12028588|FG000|STARTED|Follow-up Period (Study Day 14)||12
10863715|NCT03963895|12028589|FG001|STARTED|Follow-up Period (Study Day 14)||12
10863716|NCT03963895|12028590|FG002|STARTED|Follow-up Period (Study Day 14)||12
10863717|NCT03963895|12028588|FG000|COMPLETED|Follow-up Period (Study Day 14)||12
10863718|NCT03963895|12028589|FG001|COMPLETED|Follow-up Period (Study Day 14)||11
10863719|NCT03963895|12028590|FG002|COMPLETED|Follow-up Period (Study Day 14)||12
10863720|NCT03963895|12028588|FG000|NOT COMPLETED|Follow-up Period (Study Day 14)||0
10863721|NCT03963895|12028589|FG001|NOT COMPLETED|Follow-up Period (Study Day 14)||1
10863722|NCT03963895|12028590|FG002|NOT COMPLETED|Follow-up Period (Study Day 14)||0
10863723|NCT03924622|12028604|FG000|STARTED|Overall Study||12
10863724|NCT03924622|12028605|FG001|STARTED|Overall Study||12
10863725|NCT03924622|12028606|FG002|STARTED|Overall Study||12
10863726|NCT03924622|12028607|FG003|STARTED|Overall Study||12
10863727|NCT03924622|12028608|FG004|STARTED|Overall Study||12
10863728|NCT03924622|12028609|FG005|STARTED|Overall Study||12
10863729|NCT03924622|12028604|FG000|COMPLETED|Overall Study||10
10863730|NCT03924622|12028605|FG001|COMPLETED|Overall Study||9
10863731|NCT03924622|12028606|FG002|COMPLETED|Overall Study||9
10863732|NCT03924622|12028607|FG003|COMPLETED|Overall Study||8
10863733|NCT03924622|12028608|FG004|COMPLETED|Overall Study||9
10863734|NCT03924622|12028609|FG005|COMPLETED|Overall Study||9
10863735|NCT03924622|12028604|FG000|NOT COMPLETED|Overall Study||2
10863736|NCT03924622|12028605|FG001|NOT COMPLETED|Overall Study||3
10863737|NCT03924622|12028606|FG002|NOT COMPLETED|Overall Study||3
10863738|NCT03924622|12028607|FG003|NOT COMPLETED|Overall Study||4
10863739|NCT03924622|12028608|FG004|NOT COMPLETED|Overall Study||3
10863740|NCT03924622|12028609|FG005|NOT COMPLETED|Overall Study||3
10863741|NCT03905811|12028625|FG000|STARTED|Overall Study||8
10863742|NCT03905811|12028626|FG001|STARTED|Overall Study||5
10863743|NCT03905811|12028625|FG000|COMPLETED|Overall Study||6
10863744|NCT03905811|12028626|FG001|COMPLETED|Overall Study||5
10863745|NCT03905811|12028625|FG000|NOT COMPLETED|Overall Study||2
10863746|NCT03905811|12028626|FG001|NOT COMPLETED|Overall Study||0
10863747|NCT03867396|12028632|FG000|STARTED|Intervention 1||8
10863748|NCT03867396|12028633|FG001|STARTED|Intervention 1||8
10863749|NCT03867396|12028634|FG002|STARTED|Intervention 1||7
10863750|NCT03867396|12028635|FG003|STARTED|Intervention 1||5
10863751|NCT03867396|12028636|FG004|STARTED|Intervention 1||7
10863752|NCT03867396|12028637|FG005|STARTED|Intervention 1||5
10863753|NCT03867396|12028632|FG000|Data Collection|Intervention 1||8
10863754|NCT03867396|12028633|FG001|Data Collection|Intervention 1||5
10863755|NCT03867396|12028634|FG002|Data Collection|Intervention 1||7
10863756|NCT03867396|12028635|FG003|Data Collection|Intervention 1||5
10863757|NCT03867396|12028636|FG004|Data Collection|Intervention 1||0
10863758|NCT03867396|12028637|FG005|Data Collection|Intervention 1||0
10863759|NCT03867396|12028632|FG000|COMPLETED|Intervention 1||8
10863760|NCT03867396|12028633|FG001|COMPLETED|Intervention 1||5
10863761|NCT03867396|12028634|FG002|COMPLETED|Intervention 1||7
10863762|NCT03867396|12028635|FG003|COMPLETED|Intervention 1||5
10863763|NCT03867396|12028636|FG004|COMPLETED|Intervention 1||0
10863764|NCT03867396|12028637|FG005|COMPLETED|Intervention 1||0
10863765|NCT03867396|12028632|FG000|NOT COMPLETED|Intervention 1||0
10863766|NCT03867396|12028633|FG001|NOT COMPLETED|Intervention 1||3
10863767|NCT03867396|12028634|FG002|NOT COMPLETED|Intervention 1||0
10863768|NCT03867396|12028635|FG003|NOT COMPLETED|Intervention 1||0
10863769|NCT03867396|12028636|FG004|NOT COMPLETED|Intervention 1||7
10863770|NCT03867396|12028637|FG005|NOT COMPLETED|Intervention 1||5
10863771|NCT03867396|12028632|FG000|STARTED|Intervention 2||8
11108672|NCT01270516|12293090|FG000|STARTED|Overall Study||20
11108673|NCT01270516|12293091|FG001|STARTED|Overall Study||17
11108674|NCT01270516|12293092|FG002|STARTED|Overall Study||18
11108675|NCT01270516|12293093|FG003|STARTED|Overall Study||18
11108676|NCT01270516|12293090|FG000|COMPLETED|Overall Study||17
11108677|NCT01270516|12293091|FG001|COMPLETED|Overall Study||13
11108678|NCT01270516|12293092|FG002|COMPLETED|Overall Study||13
10863772|NCT03867396|12028633|FG001|STARTED|Intervention 2||5
10863773|NCT03867396|12028634|FG002|STARTED|Intervention 2||7
10863774|NCT03867396|12028635|FG003|STARTED|Intervention 2||5
10863775|NCT03867396|12028636|FG004|STARTED|Intervention 2||0
10863776|NCT03867396|12028637|FG005|STARTED|Intervention 2||0
10863777|NCT03867396|12028632|FG000|COMPLETED|Intervention 2||8
10863778|NCT03867396|12028633|FG001|COMPLETED|Intervention 2||5
10863779|NCT03867396|12028634|FG002|COMPLETED|Intervention 2||7
10863780|NCT03867396|12028635|FG003|COMPLETED|Intervention 2||5
10863781|NCT03867396|12028636|FG004|COMPLETED|Intervention 2||0
10863782|NCT03867396|12028637|FG005|COMPLETED|Intervention 2||0
10863783|NCT03867396|12028632|FG000|NOT COMPLETED|Intervention 2||0
10863784|NCT03867396|12028633|FG001|NOT COMPLETED|Intervention 2||0
10863785|NCT03867396|12028634|FG002|NOT COMPLETED|Intervention 2||0
10863786|NCT03867396|12028635|FG003|NOT COMPLETED|Intervention 2||0
10863787|NCT03867396|12028636|FG004|NOT COMPLETED|Intervention 2||0
10863788|NCT03867396|12028637|FG005|NOT COMPLETED|Intervention 2||0
10863789|NCT03867396|12028632|FG000|STARTED|Intervention 3||8
10863790|NCT03867396|12028633|FG001|STARTED|Intervention 3||5
10863791|NCT03867396|12028634|FG002|STARTED|Intervention 3||7
10863792|NCT03867396|12028635|FG003|STARTED|Intervention 3||5
10863793|NCT03867396|12028636|FG004|STARTED|Intervention 3||0
10863794|NCT03867396|12028637|FG005|STARTED|Intervention 3||0
10863795|NCT03867396|12028632|FG000|COMPLETED|Intervention 3||8
10863796|NCT03867396|12028633|FG001|COMPLETED|Intervention 3||5
10863797|NCT03867396|12028634|FG002|COMPLETED|Intervention 3||7
10863798|NCT03867396|12028635|FG003|COMPLETED|Intervention 3||5
10863799|NCT03867396|12028636|FG004|COMPLETED|Intervention 3||0
10863800|NCT03867396|12028637|FG005|COMPLETED|Intervention 3||0
10863801|NCT03867396|12028632|FG000|NOT COMPLETED|Intervention 3||0
10863802|NCT03867396|12028633|FG001|NOT COMPLETED|Intervention 3||0
10863803|NCT03867396|12028634|FG002|NOT COMPLETED|Intervention 3||0
10863804|NCT03867396|12028635|FG003|NOT COMPLETED|Intervention 3||0
10863805|NCT03867396|12028636|FG004|NOT COMPLETED|Intervention 3||0
10863806|NCT03867396|12028637|FG005|NOT COMPLETED|Intervention 3||0
11108679|NCT01270516|12293093|FG003|COMPLETED|Overall Study||13
11108680|NCT01270516|12293090|FG000|NOT COMPLETED|Overall Study||3
11108681|NCT01270516|12293091|FG001|NOT COMPLETED|Overall Study||4
11108682|NCT01270516|12293092|FG002|NOT COMPLETED|Overall Study||5
11108683|NCT01270516|12293093|FG003|NOT COMPLETED|Overall Study||5
11108684|NCT01270529|12293106|FG000|STARTED|Overall Study||12
10863813|NCT03802513|12028657|FG000|STARTED|Overall Study||10
10863814|NCT03802513|12028657|FG000|COMPLETED|Overall Study||9
10863815|NCT03802513|12028657|FG000|NOT COMPLETED|Overall Study||1
11108685|NCT01270529|12293107|FG001|STARTED|Overall Study||7
11108686|NCT01270529|12293108|FG002|STARTED|Overall Study||25
11108687|NCT01270529|12293106|FG000|COMPLETED|Overall Study||12
11108688|NCT01270529|12293107|FG001|COMPLETED|Overall Study||7
11108689|NCT01270529|12293108|FG002|COMPLETED|Overall Study||25
11108690|NCT01270529|12293106|FG000|NOT COMPLETED|Overall Study||0
11108691|NCT01270529|12293107|FG001|NOT COMPLETED|Overall Study||0
11108692|NCT01270529|12293108|FG002|NOT COMPLETED|Overall Study||0
11108693|NCT01270542|12293118|FG000|STARTED|Overall Study||10
11108694|NCT01270542|12293119|FG001|STARTED|Overall Study||9
11108695|NCT01270542|12293118|FG000|COMPLETED|Overall Study||9
11108696|NCT01270542|12293119|FG001|COMPLETED|Overall Study||8
10863828|NCT03576716|12028682|FG000|STARTED|Overall Study||10
10863829|NCT03576716|12028683|FG001|STARTED|Overall Study||9
10863830|NCT03576716|12028682|FG000|COMPLETED|Overall Study||10
10863831|NCT03576716|12028683|FG001|COMPLETED|Overall Study||8
10863832|NCT03576716|12028682|FG000|NOT COMPLETED|Overall Study||0
10863833|NCT03576716|12028683|FG001|NOT COMPLETED|Overall Study||1
10863837|NCT03367819|12028695|FG000|STARTED|Overall Study||24
10863838|NCT03367819|12028696|FG001|STARTED|Overall Study||20
10863839|NCT03367819|12028695|FG000|COMPLETED|Overall Study||0
10863840|NCT03367819|12028696|FG001|COMPLETED|Overall Study||1
10863841|NCT03367819|12028695|FG000|NOT COMPLETED|Overall Study||24
10863842|NCT03367819|12028696|FG001|NOT COMPLETED|Overall Study||19
10863843|NCT03182868|12028712|FG000|STARTED|Overall Study||12
10863844|NCT03182868|12028713|FG001|STARTED|Overall Study||20
11108697|NCT01270542|12293118|FG000|NOT COMPLETED|Overall Study||1
11108698|NCT01270542|12293119|FG001|NOT COMPLETED|Overall Study||1
11108699|NCT01270555|12293125|FG000|STARTED|Overall Study||32
11108700|NCT01270555|12293125|FG000|COMPLETED|Overall Study||19
11108701|NCT01270555|12293125|FG000|NOT COMPLETED|Overall Study||13
11108702|NCT01270620|12293131|FG000|STARTED|Overall Study||50
11108703|NCT01270620|12293132|FG001|STARTED|Overall Study||50
11108704|NCT01270620|12293131|FG000|COMPLETED|Overall Study||49
11108705|NCT01270620|12293132|FG001|COMPLETED|Overall Study||47
11108706|NCT01270620|12293131|FG000|NOT COMPLETED|Overall Study||1
11108707|NCT01270620|12293132|FG001|NOT COMPLETED|Overall Study||3
11108708|NCT01270659|12293148|FG000|STARTED|Overall Study||6
11108709|NCT01270659|12293149|FG001|STARTED|Overall Study||25
11228025|NCT02006836|12420180|FG001|STARTED|Self-control Period: Month 7-month 12||0
11228026|NCT02006836|12420181|FG002|STARTED|Self-control Period: Month 7-month 12||19
11228027|NCT02006836|12420179|FG000|COMPLETED|Self-control Period: Month 7-month 12||0
11228028|NCT02006836|12420180|FG001|COMPLETED|Self-control Period: Month 7-month 12||0
11228029|NCT02006836|12420181|FG002|COMPLETED|Self-control Period: Month 7-month 12||19
11228030|NCT02006836|12420179|FG000|NOT COMPLETED|Self-control Period: Month 7-month 12||0
11228031|NCT02006836|12420180|FG001|NOT COMPLETED|Self-control Period: Month 7-month 12||0
11228032|NCT02006836|12420181|FG002|NOT COMPLETED|Self-control Period: Month 7-month 12||0
11228033|NCT02006888|12420194|FG000|STARTED|Overall Study||158
11228034|NCT02006888|12420195|FG001|STARTED|Overall Study||156
11228035|NCT02006888|12420196|FG002|STARTED|Overall Study||80
11228036|NCT02006888|12420194|FG000|COMPLETED|Overall Study||122
11228037|NCT02006888|12420195|FG001|COMPLETED|Overall Study||122
11228038|NCT02006888|12420196|FG002|COMPLETED|Overall Study||58
11228039|NCT02006888|12420194|FG000|NOT COMPLETED|Overall Study||36
11228040|NCT02006888|12420195|FG001|NOT COMPLETED|Overall Study||34
11108710|NCT01270659|12293150|FG002|STARTED|Overall Study||4
11108711|NCT01270659|12293151|FG003|STARTED|Overall Study||25
11108712|NCT01270659|12293148|FG000|COMPLETED|Overall Study||6
11108713|NCT01270659|12293149|FG001|COMPLETED|Overall Study||25
11108714|NCT01270659|12293150|FG002|COMPLETED|Overall Study||4
11108715|NCT01270659|12293151|FG003|COMPLETED|Overall Study||25
11108716|NCT01270659|12293148|FG000|NOT COMPLETED|Overall Study||0
11108717|NCT01270659|12293149|FG001|NOT COMPLETED|Overall Study||0
11108718|NCT01270659|12293150|FG002|NOT COMPLETED|Overall Study||0
11108719|NCT01270659|12293151|FG003|NOT COMPLETED|Overall Study||0
11108720|NCT01270711|12293169|FG000|STARTED|Part 1: Compliance||7537
11108721|NCT01270711|12293170|FG001|STARTED|Part 1: Compliance||6580
11108722|NCT01270711|12293171|FG002|STARTED|Part 1: Compliance||326
11108723|NCT01270711|12293172|FG003|STARTED|Part 1: Compliance||5486
11108724|NCT01270711|12293173|FG004|STARTED|Part 1: Compliance||2024
11108725|NCT01270711|12293174|FG005|STARTED|Part 1: Compliance||0
11108726|NCT01270711|12293175|FG006|STARTED|Part 1: Compliance||0
11108727|NCT01270711|12293176|FG007|STARTED|Part 1: Compliance||0
11228041|NCT02006888|12420196|FG002|NOT COMPLETED|Overall Study||22
11228042|NCT02006979|12420206|FG000|STARTED|Overall Study||14
11228043|NCT02006979|12420207|FG001|STARTED|Overall Study||13
11228044|NCT02006979|12420206|FG000|COMPLETED|Overall Study||13
10863845|NCT03182868|12028714|FG002|STARTED|Overall Study||21
10863846|NCT03182868|12028715|FG003|STARTED|Overall Study||1
10863847|NCT03182868|12028716|FG004|STARTED|Overall Study||24
10863848|NCT03182868|12028712|FG000|COMPLETED|Overall Study||9
10863849|NCT03182868|12028713|FG001|COMPLETED|Overall Study||20
10863850|NCT03182868|12028714|FG002|COMPLETED|Overall Study||17
10863851|NCT03182868|12028715|FG003|COMPLETED|Overall Study||0
10863852|NCT03182868|12028716|FG004|COMPLETED|Overall Study||16
10863853|NCT03182868|12028712|FG000|NOT COMPLETED|Overall Study||3
10863854|NCT03182868|12028713|FG001|NOT COMPLETED|Overall Study||0
10863855|NCT03182868|12028714|FG002|NOT COMPLETED|Overall Study||4
10863856|NCT03182868|12028715|FG003|NOT COMPLETED|Overall Study||1
10863857|NCT03182868|12028716|FG004|NOT COMPLETED|Overall Study||8
11108728|NCT01270711|12293169|FG000|COMPLETED|Part 1: Compliance||7537
11108729|NCT01270711|12293170|FG001|COMPLETED|Part 1: Compliance||6580
11108730|NCT01270711|12293171|FG002|COMPLETED|Part 1: Compliance||326
11108731|NCT01270711|12293172|FG003|COMPLETED|Part 1: Compliance||5486
11108732|NCT01270711|12293173|FG004|COMPLETED|Part 1: Compliance||2024
10863864|NCT03077620|12028741|FG000|STARTED|Overall Study||14
10863865|NCT03077620|12028742|FG001|STARTED|Overall Study||14
10863866|NCT03077620|12028743|FG002|STARTED|Overall Study||14
10863867|NCT03077620|12028744|FG003|STARTED|Overall Study||6
10863868|NCT03077620|12028741|FG000|COMPLETED|Overall Study||13
10863869|NCT03077620|12028742|FG001|COMPLETED|Overall Study||13
10863870|NCT03077620|12028743|FG002|COMPLETED|Overall Study||12
10863871|NCT03077620|12028744|FG003|COMPLETED|Overall Study||6
10863872|NCT03077620|12028741|FG000|NOT COMPLETED|Overall Study||1
10863873|NCT03077620|12028742|FG001|NOT COMPLETED|Overall Study||1
10863874|NCT03077620|12028743|FG002|NOT COMPLETED|Overall Study||2
10863875|NCT03077620|12028744|FG003|NOT COMPLETED|Overall Study||0
10863876|NCT03027414|12028757|FG000|STARTED|Overall Study||28
10863877|NCT03027414|12028758|FG001|STARTED|Overall Study||0
10863878|NCT03027414|12028759|FG002|STARTED|Overall Study||26
10863879|NCT03027414|12028757|FG000|COMPLETED|Overall Study||19
10863880|NCT03027414|12028758|FG001|COMPLETED|Overall Study||0
10863881|NCT03027414|12028759|FG002|COMPLETED|Overall Study||20
10863882|NCT03027414|12028757|FG000|NOT COMPLETED|Overall Study||9
10863883|NCT03027414|12028758|FG001|NOT COMPLETED|Overall Study||0
10863884|NCT03027414|12028759|FG002|NOT COMPLETED|Overall Study||6
10863885|NCT02951052|12028769|FG000|STARTED|Overall Study||308
10863886|NCT02951052|12028770|FG001|STARTED|Overall Study||308
10863887|NCT02951052|12028769|FG000|COMPLETED|Overall Study||281
10863888|NCT02951052|12028770|FG001|COMPLETED|Overall Study||290
10863889|NCT02951052|12028769|FG000|NOT COMPLETED|Overall Study||27
10863890|NCT02951052|12028770|FG001|NOT COMPLETED|Overall Study||18
10863891|NCT02724410|12028782|FG000|STARTED|Overall Study||44
10863892|NCT02724410|12028783|FG001|STARTED|Overall Study||38
10863893|NCT02724410|12028782|FG000|COMPLETED|Overall Study||44
10863894|NCT02724410|12028783|FG001|COMPLETED|Overall Study||38
10863895|NCT02724410|12028782|FG000|NOT COMPLETED|Overall Study||0
10863896|NCT02724410|12028783|FG001|NOT COMPLETED|Overall Study||0
10863897|NCT02598583|12028791|FG000|STARTED|Primary Evaluation Period||6
10863898|NCT02598583|12028792|FG001|STARTED|Primary Evaluation Period||7
10863899|NCT02598583|12028791|FG000|COMPLETED|Primary Evaluation Period||6
10863900|NCT02598583|12028792|FG001|COMPLETED|Primary Evaluation Period||7
10863901|NCT02598583|12028791|FG000|NOT COMPLETED|Primary Evaluation Period||0
10863902|NCT02598583|12028792|FG001|NOT COMPLETED|Primary Evaluation Period||0
10863903|NCT02598583|12028791|FG000|STARTED|Extension Period||6
10863904|NCT02598583|12028792|FG001|STARTED|Extension Period||7
10863905|NCT02598583|12028791|FG000|COMPLETED|Extension Period||5
10863906|NCT02598583|12028792|FG001|COMPLETED|Extension Period||7
10863907|NCT02598583|12028791|FG000|NOT COMPLETED|Extension Period||1
10863908|NCT02598583|12028792|FG001|NOT COMPLETED|Extension Period||0
10863909|NCT02550093|12028798|FG000|STARTED|Intervention 1||10
10863910|NCT02550093|12028799|FG001|STARTED|Intervention 1||10
10863911|NCT02550093|12028798|FG000|COMPLETED|Intervention 1||10
10863912|NCT02550093|12028799|FG001|COMPLETED|Intervention 1||10
10863913|NCT02550093|12028798|FG000|NOT COMPLETED|Intervention 1||0
10863914|NCT02550093|12028799|FG001|NOT COMPLETED|Intervention 1||0
10863915|NCT02550093|12028798|FG000|STARTED|Wash-out Period||10
10863916|NCT02550093|12028799|FG001|STARTED|Wash-out Period||10
10863917|NCT02550093|12028798|FG000|COMPLETED|Wash-out Period||10
10863918|NCT02550093|12028799|FG001|COMPLETED|Wash-out Period||10
10863919|NCT02550093|12028798|FG000|NOT COMPLETED|Wash-out Period||0
10863920|NCT02550093|12028799|FG001|NOT COMPLETED|Wash-out Period||0
10863921|NCT02550093|12028798|FG000|STARTED|Intervention 2||10
10863922|NCT02550093|12028799|FG001|STARTED|Intervention 2||10
10863923|NCT02550093|12028798|FG000|COMPLETED|Intervention 2||10
10863924|NCT02550093|12028799|FG001|COMPLETED|Intervention 2||10
10863925|NCT02550093|12028798|FG000|NOT COMPLETED|Intervention 2||0
10863926|NCT02550093|12028799|FG001|NOT COMPLETED|Intervention 2||0
10863927|NCT02536794|12028807|FG000|STARTED|Reached 1st Response Assessment||30
10863928|NCT02536794|12028807|FG000|Started Treatment|Reached 1st Response Assessment||30
10863929|NCT02536794|12028807|FG000|Attempted First Cycle|Reached 1st Response Assessment||30
10863930|NCT02536794|12028807|FG000|Attempted Second Cycle|Reached 1st Response Assessment||24
10863931|NCT02536794|12028807|FG000|Reached First Response|Reached 1st Response Assessment||24
10863932|NCT02536794|12028807|FG000|COMPLETED|Reached 1st Response Assessment||24
10863933|NCT02536794|12028807|FG000|NOT COMPLETED|Reached 1st Response Assessment||6
10863934|NCT02536794|12028807|FG000|STARTED|Continued Treatment After 1st Response||24
10863935|NCT02536794|12028807|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||16
10863936|NCT02536794|12028807|FG000|COMPLETED|Continued Treatment After 1st Response||16
10863937|NCT02536794|12028807|FG000|NOT COMPLETED|Continued Treatment After 1st Response||8
10863938|NCT02536794|12028807|FG000|STARTED|Follow up for 3 Years or Death|one patient did not go into follow up as treatment was discontinued due to a protocol violation|29
10863939|NCT02536794|12028807|FG000|COMPLETED|Follow up for 3 Years or Death||29
10863940|NCT02536794|12028807|FG000|NOT COMPLETED|Follow up for 3 Years or Death||0
10863941|NCT02463773|12028811|FG000|STARTED|Overall Study||14
10863942|NCT02463773|12028811|FG000|COMPLETED|Overall Study||14
10863943|NCT02463773|12028811|FG000|NOT COMPLETED|Overall Study||0
10863944|NCT02356575|12028817|FG000|STARTED|Overall Study||80
10863945|NCT02356575|12028818|FG001|STARTED|Overall Study||80
10863946|NCT02356575|12028817|FG000|COMPLETED|Overall Study||80
10863947|NCT02356575|12028818|FG001|COMPLETED|Overall Study||80
10863948|NCT02356575|12028817|FG000|NOT COMPLETED|Overall Study||0
10863949|NCT02356575|12028818|FG001|NOT COMPLETED|Overall Study||0
10863950|NCT02285114|12028827|FG000|STARTED|Overall Study||29
10863951|NCT02285114|12028828|FG001|STARTED|Overall Study||9
10863952|NCT02285114|12028829|FG002|STARTED|Overall Study||3
10863953|NCT02285114|12028827|FG000|COMPLETED|Overall Study||7
10863954|NCT02285114|12028828|FG001|COMPLETED|Overall Study||2
10863955|NCT02285114|12028829|FG002|COMPLETED|Overall Study||0
10863956|NCT02285114|12028827|FG000|NOT COMPLETED|Overall Study||22
10863957|NCT02285114|12028828|FG001|NOT COMPLETED|Overall Study||7
10863958|NCT02285114|12028829|FG002|NOT COMPLETED|Overall Study||3
10863959|NCT02263508|12028846|FG000|STARTED|Overall Study||21
10863960|NCT02263508|12028847|FG001|STARTED|Overall Study||346
10863961|NCT02263508|12028848|FG002|STARTED|Overall Study||346
10863962|NCT02263508|12028846|FG000|Received Talimogene Laherparepvec/Placebo|Overall Study||21
10863963|NCT02263508|12028847|FG001|Received Talimogene Laherparepvec/Placebo|Overall Study||345
10863964|NCT02263508|12028848|FG002|Received Talimogene Laherparepvec/Placebo|Overall Study||343
10863965|NCT02263508|12028846|FG000|Received Pembrolizumab|Overall Study||21
10863966|NCT02263508|12028847|FG001|Received Pembrolizumab|Overall Study||345
10863967|NCT02263508|12028848|FG002|Received Pembrolizumab|Overall Study||343
10863968|NCT02263508|12028846|FG000|COMPLETED|Overall Study||0
10863969|NCT02263508|12028847|FG001|COMPLETED|Overall Study||0
10863970|NCT02263508|12028848|FG002|COMPLETED|Overall Study||0
10863971|NCT02263508|12028846|FG000|NOT COMPLETED|Overall Study||21
10863972|NCT02263508|12028847|FG001|NOT COMPLETED|Overall Study||346
10863973|NCT02263508|12028848|FG002|NOT COMPLETED|Overall Study||346
10863974|NCT02246530|12028861|FG000|STARTED|Overall Study||9
10863975|NCT02246530|12028862|FG001|STARTED|Overall Study||2
10863976|NCT02246530|12028861|FG000|COMPLETED|Overall Study||5
10863977|NCT02246530|12028862|FG001|COMPLETED|Overall Study||2
10863978|NCT02246530|12028861|FG000|NOT COMPLETED|Overall Study||4
10863979|NCT02246530|12028862|FG001|NOT COMPLETED|Overall Study||0
10863980|NCT02002819|12028870|FG000|STARTED|Overall Study||17
10863981|NCT02002819|12028871|FG001|STARTED|Overall Study||17
10863982|NCT02002819|12028870|FG000|COMPLETED|Overall Study|4 Discontinued intervention because of participant's decision|13
10863983|NCT02002819|12028871|FG001|COMPLETED|Overall Study|"1 Discontinued intervention because of participant's decision~1 Excluded per protocol because of biomarkers inconsistent with AD"|15
10863984|NCT02002819|12028870|FG000|NOT COMPLETED|Overall Study||4
10863985|NCT02002819|12028871|FG001|NOT COMPLETED|Overall Study||2
10863986|NCT01936857|12028895|FG000|STARTED|Overall Study||141
10863987|NCT01936857|12028896|FG001|STARTED|Overall Study||140
10863988|NCT01936857|12028895|FG000|COMPLETED|Overall Study||107
10863989|NCT01936857|12028896|FG001|COMPLETED|Overall Study||115
10863990|NCT01936857|12028895|FG000|NOT COMPLETED|Overall Study||34
10863991|NCT01936857|12028896|FG001|NOT COMPLETED|Overall Study||25
10863992|NCT01865539|12028904|FG000|STARTED|Overall Study||21
10863993|NCT01865539|12028905|FG001|STARTED|Overall Study||30
10863994|NCT01865539|12028904|FG000|COMPLETED|Overall Study||21
10863995|NCT01865539|12028905|FG001|COMPLETED|Overall Study||30
10863996|NCT01865539|12028904|FG000|NOT COMPLETED|Overall Study||0
10863997|NCT01865539|12028905|FG001|NOT COMPLETED|Overall Study||0
10863998|NCT01715285|12028913|FG000|STARTED|Treatment Period||597
10863999|NCT01715285|12028914|FG001|STARTED|Treatment Period||602
10864000|NCT01715285|12028915|FG002|STARTED|Treatment Period||0
10864001|NCT01715285|12028913|FG000|ITT Population|Treatment Period||597
10864002|NCT01715285|12028914|FG001|ITT Population|Treatment Period||602
10864003|NCT01715285|12028915|FG002|ITT Population|Treatment Period||0
10864004|NCT01715285|12028913|FG000|Safety Population|Treatment Period||597
10864005|NCT01715285|12028914|FG001|Safety Population|Treatment Period||602
10864006|NCT01715285|12028915|FG002|Safety Population|Treatment Period||0
10864007|NCT01715285|12028913|FG000|COMPLETED|Treatment Period||0
10864008|NCT01715285|12028914|FG001|COMPLETED|Treatment Period||0
10864009|NCT01715285|12028915|FG002|COMPLETED|Treatment Period||0
10864010|NCT01715285|12028913|FG000|NOT COMPLETED|Treatment Period||597
10864011|NCT01715285|12028914|FG001|NOT COMPLETED|Treatment Period||602
10864012|NCT01715285|12028915|FG002|NOT COMPLETED|Treatment Period||0
10864013|NCT01715285|12028913|FG000|STARTED|Open-label (OL) Extension Phase||157
10864014|NCT01715285|12028914|FG001|STARTED|Open-label (OL) Extension Phase||0
10864015|NCT01715285|12028915|FG002|STARTED|Open-label (OL) Extension Phase||72
10864016|NCT01715285|12028913|FG000|COMPLETED|Open-label (OL) Extension Phase||0
10864017|NCT01715285|12028914|FG001|COMPLETED|Open-label (OL) Extension Phase||0
11228045|NCT02006979|12420207|FG001|COMPLETED|Overall Study||11
11228046|NCT02006979|12420206|FG000|NOT COMPLETED|Overall Study||1
11228047|NCT02006979|12420207|FG001|NOT COMPLETED|Overall Study||2
11228048|NCT02007070|12420213|FG000|STARTED|Overall Study||38
11228049|NCT02007070|12420213|FG000|COMPLETED|Overall Study|Completed 2 years of treatment.|5
11228050|NCT02007070|12420213|FG000|NOT COMPLETED|Overall Study||33
11228051|NCT02007096|12420219|FG000|STARTED|Overall Study||63
11228052|NCT02007096|12420220|FG001|STARTED|Overall Study||64
11228053|NCT02007096|12420219|FG000|COMPLETED|Overall Study||52
11228054|NCT02007096|12420220|FG001|COMPLETED|Overall Study||48
11228055|NCT02007096|12420219|FG000|NOT COMPLETED|Overall Study||11
11228056|NCT02007096|12420220|FG001|NOT COMPLETED|Overall Study||16
11228057|NCT02007109|12420226|FG000|STARTED|Overall Study||193
11228058|NCT02007109|12420226|FG000|PACU Analysis|Overall Study||184
11228059|NCT02007109|12420226|FG000|COMPLETED|Overall Study||82
11228060|NCT02007109|12420226|FG000|NOT COMPLETED|Overall Study||111
11228061|NCT02007200|12420233|FG000|STARTED|Overall Study||55
11228062|NCT02007200|12420233|FG000|COMPLETED|Overall Study||55
11228063|NCT02007200|12420233|FG000|NOT COMPLETED|Overall Study||0
11228064|NCT02007252|12420239|FG000|STARTED|Overall Study||31
11228065|NCT02007252|12420240|FG001|STARTED|Overall Study||33
11228066|NCT02007252|12420239|FG000|Safety Analysis Set|Overall Study||31
11228067|NCT02007252|12420240|FG001|Safety Analysis Set|Overall Study||33
11228068|NCT02007252|12420239|FG000|Pharmacodynamic Analysis Set|Overall Study||31
11228069|NCT02007252|12420240|FG001|Pharmacodynamic Analysis Set|Overall Study||33
11228070|NCT02007252|12420239|FG000|COMPLETED|Overall Study||20
11228071|NCT02007252|12420240|FG001|COMPLETED|Overall Study||22
11228072|NCT02007252|12420239|FG000|NOT COMPLETED|Overall Study||11
11228073|NCT02007252|12420240|FG001|NOT COMPLETED|Overall Study||11
11228074|NCT02007278|12420248|FG000|STARTED|Overall Study||20
11228075|NCT02007278|12420249|FG001|STARTED|Overall Study||20
11228076|NCT02007278|12420248|FG000|COMPLETED|Overall Study||18
11228077|NCT02007278|12420249|FG001|COMPLETED|Overall Study||17
11228078|NCT02007278|12420248|FG000|NOT COMPLETED|Overall Study||2
11228079|NCT02007278|12420249|FG001|NOT COMPLETED|Overall Study||3
11228080|NCT02007291|12420255|FG000|STARTED|Overall Study||48
11228081|NCT02007291|12420256|FG001|STARTED|Overall Study||23
11228082|NCT02007291|12420255|FG000|COMPLETED|Overall Study||48
11228083|NCT02007291|12420256|FG001|COMPLETED|Overall Study||23
11228084|NCT02007291|12420255|FG000|NOT COMPLETED|Overall Study||0
11228085|NCT02007291|12420256|FG001|NOT COMPLETED|Overall Study||0
11228086|NCT02007369|12420265|FG000|STARTED|Overall Study||42
11228087|NCT02007369|12420266|FG001|STARTED|Overall Study||40
10864018|NCT01715285|12028915|FG002|COMPLETED|Open-label (OL) Extension Phase||0
10864019|NCT01715285|12028913|FG000|NOT COMPLETED|Open-label (OL) Extension Phase||157
10864020|NCT01715285|12028914|FG001|NOT COMPLETED|Open-label (OL) Extension Phase||0
10864021|NCT01715285|12028915|FG002|NOT COMPLETED|Open-label (OL) Extension Phase||72
11108733|NCT01270711|12293174|FG005|COMPLETED|Part 1: Compliance||0
11108734|NCT01270711|12293175|FG006|COMPLETED|Part 1: Compliance||0
11108735|NCT01270711|12293176|FG007|COMPLETED|Part 1: Compliance||0
11108736|NCT01270711|12293169|FG000|NOT COMPLETED|Part 1: Compliance||0
11108737|NCT01270711|12293170|FG001|NOT COMPLETED|Part 1: Compliance||0
11108738|NCT01270711|12293171|FG002|NOT COMPLETED|Part 1: Compliance||0
11108739|NCT01270711|12293172|FG003|NOT COMPLETED|Part 1: Compliance||0
11108740|NCT01270711|12293173|FG004|NOT COMPLETED|Part 1: Compliance||0
11108741|NCT01270711|12293174|FG005|NOT COMPLETED|Part 1: Compliance||0
11108742|NCT01270711|12293175|FG006|NOT COMPLETED|Part 1: Compliance||0
11108743|NCT01270711|12293176|FG007|NOT COMPLETED|Part 1: Compliance||0
11108744|NCT01270711|12293169|FG000|STARTED|Part 2: Effectiveness||0
11108745|NCT01270711|12293170|FG001|STARTED|Part 2: Effectiveness||0
11108746|NCT01270711|12293171|FG002|STARTED|Part 2: Effectiveness||0
11108747|NCT01270711|12293172|FG003|STARTED|Part 2: Effectiveness||0
11108748|NCT01270711|12293173|FG004|STARTED|Part 2: Effectiveness||0
11108749|NCT01270711|12293174|FG005|STARTED|Part 2: Effectiveness||11
11108750|NCT01270711|12293175|FG006|STARTED|Part 2: Effectiveness||2
11108751|NCT01270711|12293176|FG007|STARTED|Part 2: Effectiveness||48
11108752|NCT01270711|12293169|FG000|COMPLETED|Part 2: Effectiveness||0
11108753|NCT01270711|12293170|FG001|COMPLETED|Part 2: Effectiveness||0
11108754|NCT01270711|12293171|FG002|COMPLETED|Part 2: Effectiveness||0
11108755|NCT01270711|12293172|FG003|COMPLETED|Part 2: Effectiveness||0
11108756|NCT01270711|12293173|FG004|COMPLETED|Part 2: Effectiveness||0
11108757|NCT01270711|12293174|FG005|COMPLETED|Part 2: Effectiveness||11
11108758|NCT01270711|12293175|FG006|COMPLETED|Part 2: Effectiveness||2
11108759|NCT01270711|12293176|FG007|COMPLETED|Part 2: Effectiveness||48
10864046|NCT04585776|12028940|FG000|STARTED|Overall Study||31
10864047|NCT04585776|12028940|FG000|Received Atleast 1 Dose of Study Drug|Overall Study||31
10864048|NCT04585776|12028940|FG000|COMPLETED|Overall Study||31
10864049|NCT04585776|12028940|FG000|NOT COMPLETED|Overall Study||0
10864050|NCT04209725|12028944|FG000|STARTED|Overall Study||1
10864051|NCT04209725|12028944|FG000|COMPLETED|Overall Study||0
10864052|NCT04209725|12028944|FG000|NOT COMPLETED|Overall Study||1
10864053|NCT04185909|12028948|FG000|STARTED|Overall Study||55
10864054|NCT04185909|12028948|FG000|COMPLETED|Overall Study||54
10864055|NCT04185909|12028948|FG000|NOT COMPLETED|Overall Study||1
10864056|NCT04076943|12028952|FG000|STARTED|Overall Study||92
10864057|NCT04076943|12028952|FG000|Received at Least 1 Dose of Study Drug|Overall Study||92
10864058|NCT04076943|12028952|FG000|COMPLETED|Overall Study||58
10864059|NCT04076943|12028952|FG000|NOT COMPLETED|Overall Study||34
10864060|NCT03982043|12028958|FG000|STARTED|Overall Study||43
10864061|NCT03982043|12028959|FG001|STARTED|Overall Study||4
10864062|NCT03982043|12028958|FG000|COMPLETED|Overall Study||43
10864063|NCT03982043|12028959|FG001|COMPLETED|Overall Study||4
10864064|NCT03982043|12028958|FG000|NOT COMPLETED|Overall Study||0
10864065|NCT03982043|12028959|FG001|NOT COMPLETED|Overall Study||0
10864066|NCT03332498|12028969|FG000|STARTED|Overall Study||4
10864067|NCT03332498|12028970|FG001|STARTED|Overall Study||4
10864068|NCT03332498|12028971|FG002|STARTED|Overall Study||32
10864069|NCT03332498|12028969|FG000|COMPLETED|Overall Study||4
10864070|NCT03332498|12028970|FG001|COMPLETED|Overall Study||4
10864071|NCT03332498|12028971|FG002|COMPLETED|Overall Study||30
10864072|NCT03332498|12028969|FG000|NOT COMPLETED|Overall Study||0
10864073|NCT03332498|12028970|FG001|NOT COMPLETED|Overall Study||0
10864074|NCT03332498|12028971|FG002|NOT COMPLETED|Overall Study||2
11108760|NCT01270711|12293169|FG000|NOT COMPLETED|Part 2: Effectiveness||0
11108761|NCT01270711|12293170|FG001|NOT COMPLETED|Part 2: Effectiveness||0
11108762|NCT01270711|12293171|FG002|NOT COMPLETED|Part 2: Effectiveness||0
11108763|NCT01270711|12293172|FG003|NOT COMPLETED|Part 2: Effectiveness||0
11108764|NCT01270711|12293173|FG004|NOT COMPLETED|Part 2: Effectiveness||0
11108765|NCT01270711|12293174|FG005|NOT COMPLETED|Part 2: Effectiveness||0
10864081|NCT02900976|12028989|FG000|STARTED|Overall Study||2
10864082|NCT02900976|12028990|FG001|STARTED|Overall Study||16
10864083|NCT02900976|12028989|FG000|COMPLETED|Overall Study||2
10864084|NCT02900976|12028990|FG001|COMPLETED|Overall Study||7
10864085|NCT02900976|12028989|FG000|NOT COMPLETED|Overall Study||0
10864086|NCT02900976|12028990|FG001|NOT COMPLETED|Overall Study||9
10864087|NCT02807350|12028999|FG000|STARTED|Overall Study||196
10864088|NCT02807350|12029000|FG001|STARTED|Overall Study||190
10864089|NCT02807350|12028999|FG000|6 mo Follow Up Visit|Overall Study||188
10864090|NCT02807350|12029000|FG001|6 mo Follow Up Visit|Overall Study||171
10864091|NCT02807350|12028999|FG000|12 mo Follow Up Visit|Overall Study||189
10864092|NCT02807350|12029000|FG001|12 mo Follow Up Visit|Overall Study||169
10864093|NCT02807350|12028999|FG000|15 mo Follow Up Visit|Overall Study||180
10864094|NCT02807350|12029000|FG001|15 mo Follow Up Visit|Overall Study||153
10864095|NCT02807350|12028999|FG000|COMPLETED|Overall Study||176
10864096|NCT02807350|12029000|FG001|COMPLETED|Overall Study||155
10864097|NCT02807350|12028999|FG000|NOT COMPLETED|Overall Study||20
10864098|NCT02807350|12029000|FG001|NOT COMPLETED|Overall Study||35
10864099|NCT02720185|12029006|FG000|STARTED|Overall Study||5
10864100|NCT02720185|12029006|FG000|COMPLETED|Overall Study||4
10864101|NCT02720185|12029006|FG000|NOT COMPLETED|Overall Study||1
10864102|NCT02710669|12029013|FG000|STARTED|Overall Study||85
10864103|NCT02710669|12029014|FG001|STARTED|Overall Study||86
10864104|NCT02710669|12029015|FG002|STARTED|Overall Study||21
10864105|NCT02710669|12029013|FG000|COMPLETED|Overall Study||71
10864106|NCT02710669|12029014|FG001|COMPLETED|Overall Study||75
10864107|NCT02710669|12029015|FG002|COMPLETED|Overall Study||19
10864108|NCT02710669|12029013|FG000|NOT COMPLETED|Overall Study||14
10864109|NCT02710669|12029014|FG001|NOT COMPLETED|Overall Study||11
10864110|NCT02710669|12029015|FG002|NOT COMPLETED|Overall Study||2
10864111|NCT02684461|12029026|FG000|STARTED|Overall Study||7
10864112|NCT02684461|12029027|FG001|STARTED|Overall Study||7
10864113|NCT02684461|12029028|FG002|STARTED|Overall Study||6
10864114|NCT02684461|12029026|FG000|COMPLETED|Overall Study||5
10864115|NCT02684461|12029027|FG001|COMPLETED|Overall Study||5
10864116|NCT02684461|12029028|FG002|COMPLETED|Overall Study||6
10864117|NCT02684461|12029026|FG000|NOT COMPLETED|Overall Study||2
10864118|NCT02684461|12029027|FG001|NOT COMPLETED|Overall Study||2
10864119|NCT02684461|12029028|FG002|NOT COMPLETED|Overall Study||0
11108766|NCT01270711|12293175|FG006|NOT COMPLETED|Part 2: Effectiveness||0
11108767|NCT01270711|12293176|FG007|NOT COMPLETED|Part 2: Effectiveness||0
11108768|NCT01270802|12293197|FG000|STARTED|Overall Study||15
11108769|NCT01270802|12293198|FG001|STARTED|Overall Study||15
11108770|NCT01270802|12293197|FG000|COMPLETED|Overall Study||13
11108771|NCT01270802|12293198|FG001|COMPLETED|Overall Study||14
11108772|NCT01270802|12293197|FG000|NOT COMPLETED|Overall Study||2
11108773|NCT01270802|12293198|FG001|NOT COMPLETED|Overall Study||1
11108774|NCT01270828|12293207|FG000|STARTED|Pregabalin CR SB||0
11108775|NCT01270828|12293208|FG001|STARTED|Pregabalin CR SB||0
11108776|NCT01270828|12293209|FG002|STARTED|Pregabalin CR SB||806
11108777|NCT01270828|12293207|FG000|COMPLETED|Pregabalin CR SB||0
11108778|NCT01270828|12293208|FG001|COMPLETED|Pregabalin CR SB||0
11108779|NCT01270828|12293209|FG002|COMPLETED|Pregabalin CR SB||660
11108780|NCT01270828|12293207|FG000|NOT COMPLETED|Pregabalin CR SB||0
11108781|NCT01270828|12293208|FG001|NOT COMPLETED|Pregabalin CR SB||0
11108782|NCT01270828|12293209|FG002|NOT COMPLETED|Pregabalin CR SB||146
11108783|NCT01270828|12293207|FG000|STARTED|Double Blind Phase||208
11108784|NCT01270828|12293208|FG001|STARTED|Double Blind Phase||205
10864138|NCT02368132|12029070|FG000|STARTED|Overall Study||112
10864139|NCT02368132|12029071|FG001|STARTED|Overall Study||122
10864140|NCT02368132|12029072|FG002|STARTED|Overall Study||85
10864141|NCT02368132|12029070|FG000|COMPLETED|Overall Study||32
10864142|NCT02368132|12029071|FG001|COMPLETED|Overall Study||71
10864143|NCT02368132|12029072|FG002|COMPLETED|Overall Study||50
10864144|NCT02368132|12029070|FG000|NOT COMPLETED|Overall Study||80
10864145|NCT02368132|12029071|FG001|NOT COMPLETED|Overall Study||51
10864146|NCT02368132|12029072|FG002|NOT COMPLETED|Overall Study||35
11108785|NCT01270828|12293209|FG002|STARTED|Double Blind Phase||0
11108786|NCT01270828|12293207|FG000|COMPLETED|Double Blind Phase||182
11108787|NCT01270828|12293208|FG001|COMPLETED|Double Blind Phase||160
11108788|NCT01270828|12293209|FG002|COMPLETED|Double Blind Phase||0
11108789|NCT01270828|12293207|FG000|NOT COMPLETED|Double Blind Phase||26
11108790|NCT01270828|12293208|FG001|NOT COMPLETED|Double Blind Phase||45
11108791|NCT01270828|12293209|FG002|NOT COMPLETED|Double Blind Phase||0
11108792|NCT01270841|12293221|FG000|STARTED|Overall Study||29
11108793|NCT01270841|12293222|FG001|STARTED|Overall Study||33
11108794|NCT01270841|12293223|FG002|STARTED|Overall Study||29
11108795|NCT01270841|12293224|FG003|STARTED|Overall Study||33
11108796|NCT01270841|12293221|FG000|COMPLETED|Overall Study||16
11108797|NCT01270841|12293222|FG001|COMPLETED|Overall Study||19
11108798|NCT01270841|12293223|FG002|COMPLETED|Overall Study||18
11108799|NCT01270841|12293224|FG003|COMPLETED|Overall Study||20
11228088|NCT02007369|12420267|FG002|STARTED|Overall Study||54
11228089|NCT02007369|12420265|FG000|COMPLETED|Overall Study||42
11108800|NCT01270841|12293221|FG000|NOT COMPLETED|Overall Study||13
11108801|NCT01270841|12293222|FG001|NOT COMPLETED|Overall Study||14
11108802|NCT01270841|12293223|FG002|NOT COMPLETED|Overall Study||11
11108803|NCT01270841|12293224|FG003|NOT COMPLETED|Overall Study||13
11108804|NCT01270867|12293236|FG000|STARTED|Overall Study||90
11108805|NCT01270867|12293237|FG001|STARTED|Overall Study||88
11108806|NCT01270867|12293236|FG000|COMPLETED|Overall Study||89
11108807|NCT01270867|12293237|FG001|COMPLETED|Overall Study||88
11108808|NCT01270867|12293236|FG000|NOT COMPLETED|Overall Study||1
11108809|NCT01270867|12293237|FG001|NOT COMPLETED|Overall Study||0
11108810|NCT01270880|12293243|FG000|STARTED|Overall Study||18
11108811|NCT01270880|12293243|FG000|COMPLETED|Overall Study||17
11108812|NCT01270880|12293243|FG000|NOT COMPLETED|Overall Study||1
11108813|NCT01270958|12293247|FG000|STARTED|Overall Study||60
11108814|NCT01270958|12293247|FG000|COMPLETED|Overall Study||56
10864165|NCT01119807|12029112|FG000|STARTED|Overall Study||67
10864166|NCT01119807|12029113|FG001|STARTED|Overall Study||51
10864167|NCT01119807|12029114|FG002|STARTED|Overall Study||64
10864168|NCT01119807|12029112|FG000|COMPLETED|Overall Study||67
10864169|NCT01119807|12029113|FG001|COMPLETED|Overall Study||51
10864170|NCT01119807|12029114|FG002|COMPLETED|Overall Study||64
10864171|NCT01119807|12029112|FG000|NOT COMPLETED|Overall Study||0
10864172|NCT01119807|12029113|FG001|NOT COMPLETED|Overall Study||0
10864173|NCT01119807|12029114|FG002|NOT COMPLETED|Overall Study||0
10864174|NCT01295944|12029122|FG000|STARTED|Overall Study||35
10864175|NCT01295944|12029122|FG000|COMPLETED|Overall Study||17
10864176|NCT01295944|12029122|FG000|NOT COMPLETED|Overall Study||18
10864177|NCT01285557|12029128|FG000|STARTED|Overall Study||239
10864178|NCT01285557|12029129|FG001|STARTED|Overall Study||122
10864179|NCT01285557|12029128|FG000|Treated|Overall Study||238
10864180|NCT01285557|12029129|FG001|Treated|Overall Study||121
10864181|NCT01285557|12029128|FG000|As Treated (AT) Population|Overall Study||230
10864182|NCT01285557|12029129|FG001|As Treated (AT) Population|Overall Study||118
10864183|NCT01285557|12029128|FG000|COMPLETED|Overall Study||0
10864184|NCT01285557|12029129|FG001|COMPLETED|Overall Study||0
10864185|NCT01285557|12029128|FG000|NOT COMPLETED|Overall Study||239
10864186|NCT01285557|12029129|FG001|NOT COMPLETED|Overall Study||122
10864187|NCT01032603|12029137|FG000|STARTED|Overall Study||101
10864188|NCT01032603|12029138|FG001|STARTED|Overall Study||96
10864189|NCT01032603|12029137|FG000|COMPLETED|Overall Study||86
10864190|NCT01032603|12029138|FG001|COMPLETED|Overall Study||77
10864191|NCT01032603|12029137|FG000|NOT COMPLETED|Overall Study||15
10864192|NCT01032603|12029138|FG001|NOT COMPLETED|Overall Study||19
10864193|NCT00977691|12029147|FG000|STARTED|Overall Study||3
10864194|NCT00977691|12029148|FG001|STARTED|Overall Study||8
10864195|NCT00977691|12029149|FG002|STARTED|Overall Study||12
10864196|NCT00977691|12029147|FG000|COMPLETED|Overall Study||3
10864197|NCT00977691|12029148|FG001|COMPLETED|Overall Study||7
10864198|NCT00977691|12029149|FG002|COMPLETED|Overall Study||12
10864199|NCT00977691|12029147|FG000|NOT COMPLETED|Overall Study||0
10864200|NCT00977691|12029148|FG001|NOT COMPLETED|Overall Study||1
10864201|NCT00977691|12029149|FG002|NOT COMPLETED|Overall Study||0
10864202|NCT00964002|12029159|FG000|STARTED|Overall Study||61
10864203|NCT00964002|12029159|FG000|Assessable for Safety|Overall Study|59 patients were assessable for safety, they received treatment at least once.|59
10864204|NCT00964002|12029159|FG000|COMPLETED|Overall Study||53
10864205|NCT00964002|12029159|FG000|NOT COMPLETED|Overall Study||8
10864206|NCT00887783|12029165|FG000|STARTED|Overall Study||58
10864207|NCT00887783|12029166|FG001|STARTED|Overall Study||59
10864208|NCT00887783|12029165|FG000|COMPLETED|Overall Study||58
10864209|NCT00887783|12029166|FG001|COMPLETED|Overall Study||59
10864210|NCT00887783|12029165|FG000|NOT COMPLETED|Overall Study||0
10864211|NCT00887783|12029166|FG001|NOT COMPLETED|Overall Study||0
10864212|NCT00790218|12029172|FG000|STARTED|Overall Study||6
10864213|NCT00790218|12029173|FG001|STARTED|Overall Study||6
10864214|NCT00790218|12029174|FG002|STARTED|Overall Study||7
10864215|NCT00790218|12029172|FG000|COMPLETED|Overall Study||5
10864216|NCT00790218|12029173|FG001|COMPLETED|Overall Study||6
10864217|NCT00790218|12029174|FG002|COMPLETED|Overall Study||7
10864218|NCT00790218|12029172|FG000|NOT COMPLETED|Overall Study||1
10864219|NCT00790218|12029173|FG001|NOT COMPLETED|Overall Study||0
10864220|NCT00790218|12029174|FG002|NOT COMPLETED|Overall Study||0
10864221|NCT00583778|12029184|FG000|STARTED|Overall Study||74
10864222|NCT00583778|12029185|FG001|STARTED|Overall Study||67
10864223|NCT00583778|12029184|FG000|COMPLETED|Overall Study||74
10864224|NCT00583778|12029185|FG001|COMPLETED|Overall Study||67
10864225|NCT00583778|12029184|FG000|NOT COMPLETED|Overall Study||0
10864226|NCT00583778|12029185|FG001|NOT COMPLETED|Overall Study||0
10864227|NCT00432094|12029191|FG000|STARTED|Overall Study||14
10864228|NCT00432094|12029192|FG001|STARTED|Overall Study||9
10864229|NCT00432094|12029191|FG000|COMPLETED|Overall Study||14
10864230|NCT00432094|12029192|FG001|COMPLETED|Overall Study||9
10864231|NCT00432094|12029191|FG000|NOT COMPLETED|Overall Study||0
10864232|NCT00432094|12029192|FG001|NOT COMPLETED|Overall Study||0
10864233|NCT00416351|12029202|FG000|STARTED|Overall Study||1
10864234|NCT00416351|12029203|FG001|STARTED|Overall Study||3
10864235|NCT00416351|12029204|FG002|STARTED|Overall Study||4
10864236|NCT00416351|12029205|FG003|STARTED|Overall Study||17
10864237|NCT00416351|12029206|FG004|STARTED|Overall Study||4
10864238|NCT00416351|12029202|FG000|COMPLETED|Overall Study||1
10864239|NCT00416351|12029203|FG001|COMPLETED|Overall Study||3
10864240|NCT00416351|12029204|FG002|COMPLETED|Overall Study||4
10864241|NCT00416351|12029205|FG003|COMPLETED|Overall Study||17
10864242|NCT00416351|12029206|FG004|COMPLETED|Overall Study||4
10864243|NCT00416351|12029202|FG000|NOT COMPLETED|Overall Study||0
10864244|NCT00416351|12029203|FG001|NOT COMPLETED|Overall Study||0
10864245|NCT00416351|12029204|FG002|NOT COMPLETED|Overall Study||0
10864246|NCT00416351|12029205|FG003|NOT COMPLETED|Overall Study||0
10864247|NCT00416351|12029206|FG004|NOT COMPLETED|Overall Study||0
10864248|NCT00145600|12029227|FG000|STARTED|Overall Study||91
10864249|NCT00145600|12029228|FG001|STARTED|Overall Study||46
10864250|NCT00145600|12029229|FG002|STARTED|Overall Study||13
10864251|NCT00145600|12029230|FG003|STARTED|Overall Study||146
10864252|NCT00145600|12029227|FG000|COMPLETED|Overall Study||83
10864253|NCT00145600|12029228|FG001|COMPLETED|Overall Study||36
10864254|NCT00145600|12029229|FG002|COMPLETED|Overall Study||8
10864255|NCT00145600|12029230|FG003|COMPLETED|Overall Study||130
10864256|NCT00145600|12029227|FG000|NOT COMPLETED|Overall Study||8
10864257|NCT00145600|12029228|FG001|NOT COMPLETED|Overall Study||10
10864258|NCT00145600|12029229|FG002|NOT COMPLETED|Overall Study||5
10864259|NCT00145600|12029230|FG003|NOT COMPLETED|Overall Study||16
10864260|NCT00072358|12029254|FG000|STARTED|Overall Study||291
10864261|NCT00072358|12029254|FG000|COMPLETED|Overall Study||291
10864262|NCT00072358|12029254|FG000|NOT COMPLETED|Overall Study||0
11108815|NCT01270958|12293247|FG000|NOT COMPLETED|Overall Study||4
11108816|NCT01270971|12293253|FG000|STARTED|Overall Study||400
11108817|NCT01270971|12293254|FG001|STARTED|Overall Study||194
11108818|NCT01270971|12293253|FG000|COMPLETED|Overall Study||348
11108819|NCT01270971|12293254|FG001|COMPLETED|Overall Study||171
11108820|NCT01270971|12293253|FG000|NOT COMPLETED|Overall Study||52
11108821|NCT01270971|12293254|FG001|NOT COMPLETED|Overall Study||23
11108822|NCT01271010|12293260|FG000|STARTED|Overall Study||89
11108823|NCT01271010|12293260|FG000|COMPLETED|Overall Study||28
11108824|NCT01271010|12293260|FG000|NOT COMPLETED|Overall Study||61
11108825|NCT01271036|12293266|FG000|STARTED|Overall Study||62
11108826|NCT01271036|12293267|FG001|STARTED|Overall Study||62
11108827|NCT01271036|12293266|FG000|COMPLETED|Overall Study||62
11108828|NCT01271036|12293267|FG001|COMPLETED|Overall Study||62
11108829|NCT01271036|12293266|FG000|NOT COMPLETED|Overall Study||0
11108830|NCT01271036|12293267|FG001|NOT COMPLETED|Overall Study||0
11108831|NCT01271244|12293275|FG000|STARTED|Overall Study||18
11108832|NCT01271244|12293276|FG001|STARTED|Overall Study||8
11108833|NCT01271244|12293275|FG000|COMPLETED|Overall Study||11
11108834|NCT01271244|12293276|FG001|COMPLETED|Overall Study||5
11108835|NCT01271244|12293275|FG000|NOT COMPLETED|Overall Study||7
11108836|NCT01271244|12293276|FG001|NOT COMPLETED|Overall Study||3
11108837|NCT01271413|12293284|FG000|STARTED|Overall Study||37
11108838|NCT01271413|12293285|FG001|STARTED|Overall Study||36
11108839|NCT01271413|12293284|FG000|COMPLETED|Overall Study||28
11108840|NCT01271413|12293285|FG001|COMPLETED|Overall Study||28
11108841|NCT01271413|12293284|FG000|NOT COMPLETED|Overall Study||9
11108842|NCT01271413|12293285|FG001|NOT COMPLETED|Overall Study||8
11108843|NCT01271452|12293293|FG000|STARTED|Overall Study||112
11108844|NCT01271452|12293294|FG001|STARTED|Overall Study||112
11108845|NCT01271452|12293293|FG000|COMPLETED|Overall Study||105
11108846|NCT01271452|12293294|FG001|COMPLETED|Overall Study||104
11108847|NCT01271452|12293293|FG000|NOT COMPLETED|Overall Study||7
11108848|NCT01271452|12293294|FG001|NOT COMPLETED|Overall Study||8
11108849|NCT01271504|12293304|FG000|STARTED|Overall Study||7
11108850|NCT01271504|12293305|FG001|STARTED|Overall Study||8
11108851|NCT01271504|12293306|FG002|STARTED|Overall Study||44
11108852|NCT01271504|12293307|FG003|STARTED|Overall Study||43
11108853|NCT01271504|12293304|FG000|Treated|Overall Study||7
11108854|NCT01271504|12293305|FG001|Treated|Overall Study||7
11108855|NCT01271504|12293306|FG002|Treated|Overall Study||42
11108856|NCT01271504|12293307|FG003|Treated|Overall Study||42
11108857|NCT01271504|12293304|FG000|COMPLETED|Overall Study||0
11108858|NCT01271504|12293305|FG001|COMPLETED|Overall Study||0
11108859|NCT01271504|12293306|FG002|COMPLETED|Overall Study||0
11108860|NCT01271504|12293307|FG003|COMPLETED|Overall Study||0
11108861|NCT01271504|12293304|FG000|NOT COMPLETED|Overall Study||7
11108862|NCT01271504|12293305|FG001|NOT COMPLETED|Overall Study||8
11108863|NCT01271504|12293306|FG002|NOT COMPLETED|Overall Study||44
11108864|NCT01271504|12293307|FG003|NOT COMPLETED|Overall Study||43
11108865|NCT01271543|12293329|FG000|STARTED|Overall Study||30
11108866|NCT01271543|12293330|FG001|STARTED|Overall Study||30
11108867|NCT01271543|12293329|FG000|COMPLETED|Overall Study||29
11108868|NCT01271543|12293330|FG001|COMPLETED|Overall Study||29
11108869|NCT01271543|12293329|FG000|NOT COMPLETED|Overall Study||1
11108870|NCT01271543|12293330|FG001|NOT COMPLETED|Overall Study||1
11108871|NCT01271686|12293337|FG000|STARTED|Overall Study||16
11108872|NCT01271686|12293337|FG000|COMPLETED|Overall Study||16
11108873|NCT01271686|12293337|FG000|NOT COMPLETED|Overall Study||0
11108874|NCT01271712|12293343|FG000|STARTED|Double Blind Treatment||133
11108875|NCT01271712|12293344|FG001|STARTED|Double Blind Treatment||66
11108876|NCT01271712|12293343|FG000|Participants Received Treatment|Double Blind Treatment||132
11108877|NCT01271712|12293344|FG001|Participants Received Treatment|Double Blind Treatment||66
11228090|NCT02007369|12420266|FG001|COMPLETED|Overall Study||40
10864263|NCT03089281|12029260|FG000|STARTED|Overall Study||225
10864264|NCT03089281|12029261|FG001|STARTED|Overall Study||215
10864265|NCT03089281|12029260|FG000|COMPLETED|Overall Study||197
10864266|NCT03089281|12029261|FG001|COMPLETED|Overall Study||198
10864267|NCT03089281|12029260|FG000|NOT COMPLETED|Overall Study||28
10864268|NCT03089281|12029261|FG001|NOT COMPLETED|Overall Study||17
10864269|NCT03085563|12029269|FG000|STARTED|Overall Study||19
10864270|NCT03085563|12029270|FG001|STARTED|Overall Study||41
10864271|NCT03085563|12029269|FG000|COMPLETED|Overall Study||19
10864272|NCT03085563|12029270|FG001|COMPLETED|Overall Study||41
10864273|NCT03085563|12029269|FG000|NOT COMPLETED|Overall Study||0
10864274|NCT03085563|12029270|FG001|NOT COMPLETED|Overall Study||0
10864275|NCT03084367|12029276|FG000|STARTED|Overall Study||500
10864276|NCT03084367|12029276|FG000|Analyzable iFR Pullback Assessment Post Angiographically Successful PCI|Overall Study||467
10864277|NCT03084367|12029276|FG000|COMPLETED|Overall Study||463
10864278|NCT03084367|12029276|FG000|NOT COMPLETED|Overall Study||37
10864291|NCT03056443|12029304|FG000|STARTED|Overall Study||13
10864292|NCT03056443|12029304|FG000|COMPLETED|Overall Study||13
10864293|NCT03056443|12029304|FG000|NOT COMPLETED|Overall Study||0
10864294|NCT03020225|12029311|FG000|STARTED|Overall Study||12
10864295|NCT03020225|12029312|FG001|STARTED|Overall Study||11
10864296|NCT03020225|12029313|FG002|STARTED|Overall Study||13
10864297|NCT03020225|12029311|FG000|COMPLETED|Overall Study||12
10864298|NCT03020225|12029312|FG001|COMPLETED|Overall Study||11
10864299|NCT03020225|12029313|FG002|COMPLETED|Overall Study||13
10864300|NCT03020225|12029311|FG000|NOT COMPLETED|Overall Study||0
10864301|NCT03020225|12029312|FG001|NOT COMPLETED|Overall Study||0
10864302|NCT03020225|12029313|FG002|NOT COMPLETED|Overall Study||0
10864303|NCT03004586|12029345|FG000|STARTED|Overall Study||31
10864304|NCT03004586|12029346|FG001|STARTED|Overall Study||30
10864305|NCT03004586|12029345|FG000|COMPLETED|Overall Study||31
10864306|NCT03004586|12029346|FG001|COMPLETED|Overall Study||30
10864307|NCT03004586|12029345|FG000|NOT COMPLETED|Overall Study||0
10864308|NCT03004586|12029346|FG001|NOT COMPLETED|Overall Study||0
10864309|NCT05110014|12029356|FG000|STARTED|Overall Study||12239
10864310|NCT05110014|12029357|FG001|STARTED|Overall Study||10787
10864311|NCT05110014|12029356|FG000|COMPLETED|Overall Study||12239
10864312|NCT05110014|12029357|FG001|COMPLETED|Overall Study||10787
10864313|NCT05110014|12029356|FG000|NOT COMPLETED|Overall Study||0
10864314|NCT05110014|12029357|FG001|NOT COMPLETED|Overall Study||0
10864318|NCT04218279|12029371|FG000|STARTED|Overall Study||316
10864319|NCT04218279|12029372|FG001|STARTED|Overall Study||362
10864320|NCT04218279|12029371|FG000|COMPLETED|Overall Study||211
10864321|NCT04218279|12029372|FG001|COMPLETED|Overall Study||225
10864322|NCT04218279|12029371|FG000|NOT COMPLETED|Overall Study||105
10864323|NCT04218279|12029372|FG001|NOT COMPLETED|Overall Study||137
10864324|NCT04167670|12029381|FG000|STARTED|Overall Study||349
10864325|NCT04167670|12029382|FG001|STARTED|Overall Study||349
10864326|NCT04167670|12029383|FG002|STARTED|Overall Study||348
10864327|NCT04167670|12029381|FG000|Received Study Drugs|Overall Study||348
10864328|NCT04167670|12029382|FG001|Received Study Drugs|Overall Study||346
10864329|NCT04167670|12029383|FG002|Received Study Drugs|Overall Study||345
10864330|NCT04167670|12029381|FG000|COMPLETED|Overall Study||334
10864331|NCT04167670|12029382|FG001|COMPLETED|Overall Study||331
10864332|NCT04167670|12029383|FG002|COMPLETED|Overall Study||334
10864333|NCT04167670|12029381|FG000|NOT COMPLETED|Overall Study||15
10864334|NCT04167670|12029382|FG001|NOT COMPLETED|Overall Study||18
10864335|NCT04167670|12029383|FG002|NOT COMPLETED|Overall Study||14
10864336|NCT04076917|12029391|FG000|STARTED|Overall Study||84
10864337|NCT04076917|12029391|FG000|COMPLETED|Overall Study||15
10864338|NCT04076917|12029391|FG000|NOT COMPLETED|Overall Study||69
10864412|NCT03205371|12029480|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||42
10864413|NCT03205371|12029481|FG005|Per-protocol Analysis Set (PPAS)|Overall Study||42
10864414|NCT03205371|12029482|FG006|Per-protocol Analysis Set (PPAS)|Overall Study||155
10864415|NCT03205371|12029483|FG007|Per-protocol Analysis Set (PPAS)|Overall Study||79
10864416|NCT03205371|12029484|FG008|Per-protocol Analysis Set (PPAS)|Overall Study||68
10864417|NCT03205371|12029485|FG009|Per-protocol Analysis Set (PPAS)|Overall Study||196
10864418|NCT03205371|12029486|FG010|Per-protocol Analysis Set (PPAS)|Overall Study||96
10864419|NCT03205371|12029487|FG011|Per-protocol Analysis Set (PPAS)|Overall Study||92
10864420|NCT03205371|12029476|FG000|COMPLETED|Overall Study||103
10864421|NCT03205371|12029477|FG001|COMPLETED|Overall Study||52
10864422|NCT03205371|12029478|FG002|COMPLETED|Overall Study||53
10864423|NCT03205371|12029479|FG003|COMPLETED|Overall Study||86
10864424|NCT03205371|12029480|FG004|COMPLETED|Overall Study||42
10864425|NCT03205371|12029481|FG005|COMPLETED|Overall Study||42
10864426|NCT03205371|12029482|FG006|COMPLETED|Overall Study||190
10864427|NCT03205371|12029483|FG007|COMPLETED|Overall Study||97
10864428|NCT03205371|12029484|FG008|COMPLETED|Overall Study||95
10864429|NCT03205371|12029485|FG009|COMPLETED|Overall Study||200
10864430|NCT03205371|12029486|FG010|COMPLETED|Overall Study||100
10864431|NCT03205371|12029487|FG011|COMPLETED|Overall Study||99
10864432|NCT03205371|12029476|FG000|NOT COMPLETED|Overall Study||4
10864433|NCT03205371|12029477|FG001|NOT COMPLETED|Overall Study||1
10864434|NCT03205371|12029478|FG002|NOT COMPLETED|Overall Study||0
10864435|NCT03205371|12029479|FG003|NOT COMPLETED|Overall Study||0
10864436|NCT03205371|12029480|FG004|NOT COMPLETED|Overall Study||0
10864437|NCT03205371|12029481|FG005|NOT COMPLETED|Overall Study||0
10864438|NCT03205371|12029482|FG006|NOT COMPLETED|Overall Study||10
10864439|NCT03205371|12029483|FG007|NOT COMPLETED|Overall Study||3
10864440|NCT03205371|12029484|FG008|NOT COMPLETED|Overall Study||5
10864279|NCT03082898|12029287|FG000|STARTED|Overall Study||27
10864280|NCT03082898|12029288|FG001|STARTED|Overall Study||12
10864281|NCT03082898|12029287|FG000|COMPLETED|Overall Study||24
10864282|NCT03082898|12029288|FG001|COMPLETED|Overall Study||11
10864283|NCT03082898|12029287|FG000|NOT COMPLETED|Overall Study||3
10864284|NCT03082898|12029288|FG001|NOT COMPLETED|Overall Study||1
10864285|NCT03082313|12029294|FG000|STARTED|Overall Study||12
10864286|NCT03082313|12029294|FG000|COMPLETED|Overall Study||12
10864287|NCT03082313|12029294|FG000|NOT COMPLETED|Overall Study||0
10864315|NCT04980040|12029365|FG000|STARTED|Overall Study||3623
10864316|NCT04980040|12029365|FG000|COMPLETED|Overall Study||3131
10864317|NCT04980040|12029365|FG000|NOT COMPLETED|Overall Study||492
10864339|NCT04000009|12029395|FG000|STARTED|Overall Study||235
10864340|NCT04000009|12029395|FG000|COMPLETED|Overall Study||70
10864341|NCT04000009|12029395|FG000|NOT COMPLETED|Overall Study||165
10864342|NCT03988335|12029401|FG000|STARTED|Overall Study||16
10864343|NCT03988335|12029402|FG001|STARTED|Overall Study||19
10864344|NCT03988335|12029401|FG000|COMPLETED|Overall Study||14
10864345|NCT03988335|12029402|FG001|COMPLETED|Overall Study||18
10864346|NCT03988335|12029401|FG000|NOT COMPLETED|Overall Study||2
10864347|NCT03988335|12029402|FG001|NOT COMPLETED|Overall Study||1
10864348|NCT03792737|12029411|FG000|STARTED|Overall Study||166
10864349|NCT03792737|12029412|FG001|STARTED|Overall Study||167
10864350|NCT03792737|12029413|FG002|STARTED|Overall Study||167
10864351|NCT03792737|12029411|FG000|Safety Analysis Set|Overall Study||162
10864352|NCT03792737|12029412|FG001|Safety Analysis Set|Overall Study|one subject didn't participate screen visit or randomize, but receive IP treatment by mistake.|161
10864353|NCT03792737|12029413|FG002|Safety Analysis Set|Overall Study||162
10864354|NCT03792737|12029411|FG000|Full Analysis Set|Overall Study||162
10864355|NCT03792737|12029412|FG001|Full Analysis Set|Overall Study||160
10864356|NCT03792737|12029413|FG002|Full Analysis Set|Overall Study||162
10864357|NCT03792737|12029411|FG000|COMPLETED|Overall Study||160
10864358|NCT03792737|12029412|FG001|COMPLETED|Overall Study||159
10864359|NCT03792737|12029413|FG002|COMPLETED|Overall Study||158
10864360|NCT03792737|12029411|FG000|NOT COMPLETED|Overall Study||6
10864361|NCT03792737|12029412|FG001|NOT COMPLETED|Overall Study||8
10864362|NCT03792737|12029413|FG002|NOT COMPLETED|Overall Study||9
11108878|NCT01271712|12293343|FG000|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
11108879|NCT01271712|12293344|FG001|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
11108880|NCT01271712|12293343|FG000|NOT COMPLETED|Double Blind Treatment||42
11108881|NCT01271712|12293344|FG001|NOT COMPLETED|Double Blind Treatment||8
11108882|NCT01271712|12293343|FG000|STARTED|Open Label Treatment||91
11108883|NCT01271712|12293344|FG001|STARTED|Open Label Treatment||58
11108884|NCT01271712|12293343|FG000|COMPLETED|Open Label Treatment||0
11108885|NCT01271712|12293344|FG001|COMPLETED|Open Label Treatment||0
11108886|NCT01271712|12293343|FG000|NOT COMPLETED|Open Label Treatment||91
11108887|NCT01271712|12293344|FG001|NOT COMPLETED|Open Label Treatment||58
11108888|NCT01271712|12293343|FG000|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
11108889|NCT01271712|12293344|FG001|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
11108890|NCT01271712|12293343|FG000|COMPLETED|Safety Follow-up||97
10864378|NCT03584464|12029454|FG000|STARTED|Overall Study||205
10864379|NCT03584464|12029454|FG000|COMPLETED|Overall Study|Number of subjects that competed 1 year follow up or had a CEC event|204
10864380|NCT03584464|12029454|FG000|NOT COMPLETED|Overall Study||1
10864381|NCT03441477|12029458|FG000|STARTED|Overall Study||225
10864382|NCT03441477|12029458|FG000|COMPLETED|Overall Study||224
10864383|NCT03441477|12029458|FG000|NOT COMPLETED|Overall Study||1
10864384|NCT03205371|12029476|FG000|STARTED|Overall Study||107
10864385|NCT03205371|12029477|FG001|STARTED|Overall Study||53
10864386|NCT03205371|12029478|FG002|STARTED|Overall Study||53
10864387|NCT03205371|12029479|FG003|STARTED|Overall Study||86
10864388|NCT03205371|12029480|FG004|STARTED|Overall Study||42
10864389|NCT03205371|12029481|FG005|STARTED|Overall Study||42
10864390|NCT03205371|12029482|FG006|STARTED|Overall Study||200
10864391|NCT03205371|12029483|FG007|STARTED|Overall Study||100
10864392|NCT03205371|12029484|FG008|STARTED|Overall Study||100
10864393|NCT03205371|12029485|FG009|STARTED|Overall Study||200
10864394|NCT03205371|12029486|FG010|STARTED|Overall Study||100
10864395|NCT03205371|12029487|FG011|STARTED|Overall Study||100
10864396|NCT03205371|12029476|FG000|Safety Analysis Set (SafAS)|Overall Study||103
10864397|NCT03205371|12029477|FG001|Safety Analysis Set (SafAS)|Overall Study||52
10864398|NCT03205371|12029478|FG002|Safety Analysis Set (SafAS)|Overall Study||53
10864399|NCT03205371|12029479|FG003|Safety Analysis Set (SafAS)|Overall Study||86
10864400|NCT03205371|12029480|FG004|Safety Analysis Set (SafAS)|Overall Study||42
10864401|NCT03205371|12029481|FG005|Safety Analysis Set (SafAS)|Overall Study||42
10864402|NCT03205371|12029482|FG006|Safety Analysis Set (SafAS)|Overall Study||200
10864403|NCT03205371|12029483|FG007|Safety Analysis Set (SafAS)|Overall Study||100
10864404|NCT03205371|12029484|FG008|Safety Analysis Set (SafAS)|Overall Study||100
10864405|NCT03205371|12029485|FG009|Safety Analysis Set (SafAS)|Overall Study||200
10864406|NCT03205371|12029486|FG010|Safety Analysis Set (SafAS)|Overall Study||100
10864407|NCT03205371|12029487|FG011|Safety Analysis Set (SafAS)|Overall Study||99
10864408|NCT03205371|12029476|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||92
10864409|NCT03205371|12029477|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||45
10864410|NCT03205371|12029478|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||50
10864411|NCT03205371|12029479|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||85
10864288|NCT03081767|12029298|FG000|STARTED|Overall Study||199
10864289|NCT03081767|12029298|FG000|COMPLETED|Overall Study||199
10864290|NCT03081767|12029298|FG000|NOT COMPLETED|Overall Study||0
10864441|NCT03205371|12029485|FG009|NOT COMPLETED|Overall Study||0
10864442|NCT03205371|12029486|FG010|NOT COMPLETED|Overall Study||0
10864443|NCT03205371|12029487|FG011|NOT COMPLETED|Overall Study||1
10864444|NCT03165721|12029536|FG000|STARTED|Overall Study||7
10864445|NCT03165721|12029537|FG001|STARTED|Overall Study||1
10864446|NCT03165721|12029538|FG002|STARTED|Overall Study||1
10864447|NCT03165721|12029536|FG000|COMPLETED|Overall Study||3
10864448|NCT03165721|12029537|FG001|COMPLETED|Overall Study||1
10864449|NCT03165721|12029538|FG002|COMPLETED|Overall Study||1
10864450|NCT03165721|12029536|FG000|NOT COMPLETED|Overall Study||4
10864451|NCT03165721|12029537|FG001|NOT COMPLETED|Overall Study||0
10864452|NCT03165721|12029538|FG002|NOT COMPLETED|Overall Study||0
11108891|NCT01271712|12293344|FG001|COMPLETED|Safety Follow-up||37
11108892|NCT01271712|12293343|FG000|NOT COMPLETED|Safety Follow-up||21
11108893|NCT01271712|12293344|FG001|NOT COMPLETED|Safety Follow-up||15
11108894|NCT01271712|12293343|FG000|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
11108895|NCT01271712|12293344|FG001|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
11108896|NCT01271712|12293343|FG000|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
11108897|NCT01271712|12293344|FG001|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
11108898|NCT01271712|12293343|FG000|NOT COMPLETED|Survival Follow-up||15
11108899|NCT01271712|12293344|FG001|NOT COMPLETED|Survival Follow-up||6
11108900|NCT01271725|12293353|FG000|STARTED|Part A|Started are the treated patients|74
11108901|NCT01271725|12293354|FG001|STARTED|Part A||0
11108902|NCT01271725|12293353|FG000|COMPLETED|Part A||39
11108903|NCT01271725|12293354|FG001|COMPLETED|Part A||0
11108904|NCT01271725|12293353|FG000|NOT COMPLETED|Part A||35
11108905|NCT01271725|12293354|FG001|NOT COMPLETED|Part A||0
11108906|NCT01271725|12293353|FG000|STARTED|Part B||0
11108907|NCT01271725|12293354|FG001|STARTED|Part B||39
11108908|NCT01271725|12293353|FG000|COMPLETED|Part B||0
11108909|NCT01271725|12293354|FG001|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27
11108910|NCT01271725|12293353|FG000|NOT COMPLETED|Part B||0
11108911|NCT01271725|12293354|FG001|NOT COMPLETED|Part B||12
11108912|NCT01271803|12293366|FG000|STARTED|Overall Study||66
11108913|NCT01271803|12293367|FG001|STARTED|Overall Study||63
11108914|NCT01271803|12293368|FG002|STARTED|Overall Study||2
11108915|NCT01271803|12293366|FG000|COMPLETED|Overall Study||11
11108916|NCT01271803|12293367|FG001|COMPLETED|Overall Study||24
11108917|NCT01271803|12293368|FG002|COMPLETED|Overall Study||0
11108918|NCT01271803|12293366|FG000|NOT COMPLETED|Overall Study||55
11108919|NCT01271803|12293367|FG001|NOT COMPLETED|Overall Study||39
11108920|NCT01271803|12293368|FG002|NOT COMPLETED|Overall Study||2
11108921|NCT01271855|12293415|FG000|STARTED|Overall Study||48
11108922|NCT01271855|12293416|FG001|STARTED|Overall Study||52
11108923|NCT01271855|12293415|FG000|COMPLETED|Overall Study||48
11108924|NCT01271855|12293416|FG001|COMPLETED|Overall Study||52
11108925|NCT01271855|12293415|FG000|NOT COMPLETED|Overall Study||0
11108926|NCT01271855|12293416|FG001|NOT COMPLETED|Overall Study||0
11108927|NCT01271868|12293422|FG000|STARTED|Pharmacokinetic Study||9
11108928|NCT01271868|12293422|FG000|COMPLETED|Pharmacokinetic Study||9
11108929|NCT01271868|12293422|FG000|NOT COMPLETED|Pharmacokinetic Study||0
11108930|NCT01271868|12293422|FG000|STARTED|Treatment Study||9
11108931|NCT01271868|12293422|FG000|COMPLETED|Treatment Study||9
11108932|NCT01271868|12293422|FG000|NOT COMPLETED|Treatment Study||0
11108933|NCT01271907|12293431|FG000|STARTED|Overall Study||3
11108934|NCT01271907|12293432|FG001|STARTED|Overall Study||0
11108935|NCT01271907|12293433|FG002|STARTED|Overall Study||0
11108936|NCT01271907|12293431|FG000|COMPLETED|Overall Study||3
11108937|NCT01271907|12293432|FG001|COMPLETED|Overall Study||0
11108938|NCT01271907|12293433|FG002|COMPLETED|Overall Study||0
11108939|NCT01271907|12293431|FG000|NOT COMPLETED|Overall Study||0
11108940|NCT01271907|12293432|FG001|NOT COMPLETED|Overall Study||0
11108941|NCT01271907|12293433|FG002|NOT COMPLETED|Overall Study||0
11108942|NCT01271933|12293441|FG000|STARTED|Single-Blind Phase||441
11108943|NCT01271933|12293442|FG001|STARTED|Single-Blind Phase||0
11108944|NCT01271933|12293443|FG002|STARTED|Single-Blind Phase||0
11108945|NCT01271933|12293441|FG000|COMPLETED|Single-Blind Phase||320
11108946|NCT01271933|12293442|FG001|COMPLETED|Single-Blind Phase||0
11108947|NCT01271933|12293443|FG002|COMPLETED|Single-Blind Phase||0
11108948|NCT01271933|12293441|FG000|NOT COMPLETED|Single-Blind Phase||121
11108949|NCT01271933|12293442|FG001|NOT COMPLETED|Single-Blind Phase||0
11108950|NCT01271933|12293443|FG002|NOT COMPLETED|Single-Blind Phase||0
11108951|NCT01271933|12293441|FG000|STARTED|Double-Blind Phase||0
11108952|NCT01271933|12293442|FG001|STARTED|Double-Blind Phase||63
11108953|NCT01271933|12293443|FG002|STARTED|Double-Blind Phase||59
11108954|NCT01271933|12293441|FG000|Treated|Double-Blind Phase||0
11108955|NCT01271933|12293442|FG001|Treated|Double-Blind Phase||63
11108956|NCT01271933|12293443|FG002|Treated|Double-Blind Phase||58
11108957|NCT01271933|12293441|FG000|COMPLETED|Double-Blind Phase||0
11108958|NCT01271933|12293442|FG001|COMPLETED|Double-Blind Phase||46
11108959|NCT01271933|12293443|FG002|COMPLETED|Double-Blind Phase||47
11108960|NCT01271933|12293441|FG000|NOT COMPLETED|Double-Blind Phase||0
11108961|NCT01271933|12293442|FG001|NOT COMPLETED|Double-Blind Phase||17
10864513|NCT02955797|12029606|FG000|STARTED|Overall Study||306
10864514|NCT02955797|12029607|FG001|STARTED|Overall Study||306
10864515|NCT02955797|12029608|FG002|STARTED|Overall Study||203
10864516|NCT02955797|12029609|FG003|STARTED|Overall Study||103
10864517|NCT02955797|12029606|FG000|Safety Analysis Set (SafAS)|Overall Study||303
10864518|NCT02955797|12029607|FG001|Safety Analysis Set (SafAS)|Overall Study||306
10864519|NCT02955797|12029608|FG002|Safety Analysis Set (SafAS)|Overall Study||203
10864520|NCT02955797|12029609|FG003|Safety Analysis Set (SafAS)|Overall Study||102
10864521|NCT02955797|12029606|FG000|Per Protocol Analysis Set (PPAS)|Overall Study||293
10864522|NCT02955797|12029607|FG001|Per Protocol Analysis Set (PPAS)|Overall Study||296
10864523|NCT02955797|12029608|FG002|Per Protocol Analysis Set (PPAS)|Overall Study||198
10864524|NCT02955797|12029609|FG003|Per Protocol Analysis Set (PPAS)|Overall Study||99
10864525|NCT02955797|12029606|FG000|COMPLETED|Overall Study||303
10864526|NCT02955797|12029607|FG001|COMPLETED|Overall Study||303
10864527|NCT02955797|12029608|FG002|COMPLETED|Overall Study||203
10864528|NCT02955797|12029609|FG003|COMPLETED|Overall Study||101
10864529|NCT02955797|12029606|FG000|NOT COMPLETED|Overall Study||3
10864530|NCT02955797|12029607|FG001|NOT COMPLETED|Overall Study||3
10864531|NCT02955797|12029608|FG002|NOT COMPLETED|Overall Study||0
10864532|NCT02955797|12029609|FG003|NOT COMPLETED|Overall Study||2
10864533|NCT02859415|12029624|FG000|STARTED|Overall Study||1
10864534|NCT02859415|12029625|FG001|STARTED|Overall Study||2
10864535|NCT02859415|12029624|FG000|COMPLETED|Overall Study||0
10864536|NCT02859415|12029625|FG001|COMPLETED|Overall Study||1
10864537|NCT02859415|12029624|FG000|NOT COMPLETED|Overall Study||1
10864538|NCT02859415|12029625|FG001|NOT COMPLETED|Overall Study||1
10864539|NCT02842866|12029634|FG000|STARTED|Overall Study||451
10864540|NCT02842866|12029635|FG001|STARTED|Overall Study||455
10864541|NCT02842866|12029634|FG000|Vaccinated|Overall Study||448
10864542|NCT02842866|12029635|FG001|Vaccinated|Overall Study||453
10864543|NCT02842866|12029634|FG000|COMPLETED|Overall Study||444
10864544|NCT02842866|12029635|FG001|COMPLETED|Overall Study||452
10864545|NCT02842866|12029634|FG000|NOT COMPLETED|Overall Study||7
10864546|NCT02842866|12029635|FG001|NOT COMPLETED|Overall Study||3
10864547|NCT02842853|12029645|FG000|STARTED|Overall Study||902
10864548|NCT02842853|12029646|FG001|STARTED|Overall Study||895
10864549|NCT02842853|12029647|FG002|STARTED|Overall Study||906
10864550|NCT02842853|12029648|FG003|STARTED|Overall Study||641
10864551|NCT02842853|12029645|FG000|Vaccinated|Overall Study||895
10864552|NCT02842853|12029646|FG001|Vaccinated|Overall Study||886
10864553|NCT02842853|12029647|FG002|Vaccinated|Overall Study||900
10864554|NCT02842853|12029648|FG003|Vaccinated|Overall Study||636
10864555|NCT02842853|12029645|FG000|Safety Analysis Set (SafAS)|Overall Study||895
10864556|NCT02842853|12029646|FG001|Safety Analysis Set (SafAS)|Overall Study||883
10864557|NCT02842853|12029647|FG002|Safety Analysis Set (SafAS)|Overall Study||898
10864558|NCT02842853|12029648|FG003|Safety Analysis Set (SafAS)|Overall Study||635
10864559|NCT02842853|12029645|FG000|COMPLETED|Overall Study||879
10864560|NCT02842853|12029646|FG001|COMPLETED|Overall Study||861
10864561|NCT02842853|12029647|FG002|COMPLETED|Overall Study||885
10864562|NCT02842853|12029648|FG003|COMPLETED|Overall Study||617
10864563|NCT02842853|12029645|FG000|NOT COMPLETED|Overall Study||23
10864564|NCT02842853|12029646|FG001|NOT COMPLETED|Overall Study||34
10864565|NCT02842853|12029647|FG002|NOT COMPLETED|Overall Study||21
10864566|NCT02842853|12029648|FG003|NOT COMPLETED|Overall Study||24
10864567|NCT02752906|12029662|FG000|STARTED|Overall Study||403
10864568|NCT02752906|12029663|FG001|STARTED|Overall Study||407
10864569|NCT02752906|12029662|FG000|Vaccinated|Overall Study||402
10864570|NCT02752906|12029663|FG001|Vaccinated|Overall Study||407
10864571|NCT02752906|12029662|FG000|COMPLETED|Overall Study||396
10864572|NCT02752906|12029663|FG001|COMPLETED|Overall Study||402
10864573|NCT02752906|12029662|FG000|NOT COMPLETED|Overall Study||7
10864574|NCT02752906|12029663|FG001|NOT COMPLETED|Overall Study||5
10864575|NCT02693691|12029669|FG000|STARTED|Primary Endpoint Analysis (First 12M)||234
10864576|NCT02693691|12029669|FG000|COMPLETED|Primary Endpoint Analysis (First 12M)||184
10864577|NCT02693691|12029669|FG000|NOT COMPLETED|Primary Endpoint Analysis (First 12M)||50
10864578|NCT02693691|12029669|FG000|STARTED|Extended Follow-Up (Until Last pt 12M)||184
10864579|NCT02693691|12029669|FG000|COMPLETED|Extended Follow-Up (Until Last pt 12M)||160
10864580|NCT02693691|12029669|FG000|NOT COMPLETED|Extended Follow-Up (Until Last pt 12M)||24
11228091|NCT02007369|12420267|FG002|COMPLETED|Overall Study||54
11228092|NCT02007369|12420265|FG000|NOT COMPLETED|Overall Study||0
11228093|NCT02007369|12420266|FG001|NOT COMPLETED|Overall Study||0
11228094|NCT02007369|12420267|FG002|NOT COMPLETED|Overall Study||0
11228095|NCT02007434|12420283|FG000|STARTED|Overall Study||17
11228096|NCT02007434|12420284|FG001|STARTED|Overall Study||4
10864581|NCT04889625|12029673|FG000|STARTED|Period 1||40
10864582|NCT04889625|12029674|FG001|STARTED|Period 1||38
10864583|NCT04889625|12029673|FG000|COMPLETED|Period 1||37
10864584|NCT04889625|12029674|FG001|COMPLETED|Period 1||34
10864585|NCT04889625|12029673|FG000|NOT COMPLETED|Period 1||3
10864586|NCT04889625|12029674|FG001|NOT COMPLETED|Period 1||4
10864587|NCT04889625|12029673|FG000|STARTED|Period 2||37
10864588|NCT04889625|12029674|FG001|STARTED|Period 2||34
10864589|NCT04889625|12029673|FG000|COMPLETED|Period 2||35
10864590|NCT04889625|12029674|FG001|COMPLETED|Period 2||33
10864591|NCT04889625|12029673|FG000|NOT COMPLETED|Period 2||2
10864592|NCT04889625|12029674|FG001|NOT COMPLETED|Period 2||1
10864593|NCT04889625|12029673|FG000|STARTED|Period 3||35
10864594|NCT04889625|12029674|FG001|STARTED|Period 3||33
10864595|NCT04889625|12029673|FG000|COMPLETED|Period 3||35
10864596|NCT04889625|12029674|FG001|COMPLETED|Period 3||33
10864597|NCT04889625|12029673|FG000|NOT COMPLETED|Period 3||0
10864598|NCT04889625|12029674|FG001|NOT COMPLETED|Period 3||0
10864599|NCT04653766|12029685|FG000|STARTED|Overall Study||6
10864600|NCT04653766|12029686|FG001|STARTED|Overall Study||6
10864601|NCT04653766|12029687|FG002|STARTED|Overall Study||6
10864602|NCT04653766|12029688|FG003|STARTED|Overall Study||6
10864603|NCT04653766|12029689|FG004|STARTED|Overall Study||8
10864604|NCT04653766|12029685|FG000|COMPLETED|Overall Study||6
10864605|NCT04653766|12029686|FG001|COMPLETED|Overall Study||6
10864606|NCT04653766|12029687|FG002|COMPLETED|Overall Study||6
10864607|NCT04653766|12029688|FG003|COMPLETED|Overall Study||6
10864608|NCT04653766|12029689|FG004|COMPLETED|Overall Study||8
10864609|NCT04653766|12029685|FG000|NOT COMPLETED|Overall Study||0
10864610|NCT04653766|12029686|FG001|NOT COMPLETED|Overall Study||0
10864611|NCT04653766|12029687|FG002|NOT COMPLETED|Overall Study||0
10864612|NCT04653766|12029688|FG003|NOT COMPLETED|Overall Study||0
10864613|NCT04653766|12029689|FG004|NOT COMPLETED|Overall Study||0
10864614|NCT04602000|12029715|FG000|STARTED|Overall Study||105
10864615|NCT04602000|12029716|FG001|STARTED|Overall Study||111
10864616|NCT04602000|12029717|FG002|STARTED|Overall Study||111
10864617|NCT04602000|12029718|FG003|STARTED|Overall Study||656
10864618|NCT04602000|12029719|FG004|STARTED|Overall Study||659
10864619|NCT04602000|12029715|FG000|COMPLETED|Overall Study||97
10864620|NCT04602000|12029716|FG001|COMPLETED|Overall Study||103
10864621|NCT04602000|12029717|FG002|COMPLETED|Overall Study||105
10864622|NCT04602000|12029718|FG003|COMPLETED|Overall Study||618
10864623|NCT04602000|12029719|FG004|COMPLETED|Overall Study||608
10864624|NCT04602000|12029715|FG000|NOT COMPLETED|Overall Study||8
10864625|NCT04602000|12029716|FG001|NOT COMPLETED|Overall Study||8
10864626|NCT04602000|12029717|FG002|NOT COMPLETED|Overall Study||6
10864627|NCT04602000|12029718|FG003|NOT COMPLETED|Overall Study||38
10864628|NCT04602000|12029719|FG004|NOT COMPLETED|Overall Study||51
10864629|NCT04540887|12029733|FG000|STARTED|Overall Study||10
10864630|NCT04540887|12029733|FG000|COMPLETED|Overall Study||8
10864631|NCT04540887|12029733|FG000|NOT COMPLETED|Overall Study||2
10864632|NCT04428333|12029740|FG000|STARTED|Overall Study||57
10864633|NCT04428333|12029741|FG001|STARTED|Overall Study||59
10864634|NCT04428333|12029740|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||52
10864635|NCT04428333|12029741|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||55
10864636|NCT04428333|12029740|FG000|Safety Population|Overall Study||50
10864637|NCT04428333|12029741|FG001|Safety Population|Overall Study||65
10864638|NCT04428333|12029740|FG000|COMPLETED|Overall Study||3
10864639|NCT04428333|12029741|FG001|COMPLETED|Overall Study||1
10864640|NCT04428333|12029740|FG000|NOT COMPLETED|Overall Study||54
10864641|NCT04428333|12029741|FG001|NOT COMPLETED|Overall Study||58
10864642|NCT04167085|12029749|FG000|STARTED|Baseline||13
10864643|NCT04167085|12029750|FG001|STARTED|Baseline||13
10864644|NCT04167085|12029749|FG000|Day 1|Baseline||12
10864645|NCT04167085|12029750|FG001|Day 1|Baseline||12
10864646|NCT04167085|12029749|FG000|COMPLETED|Baseline||11
10864647|NCT04167085|12029750|FG001|COMPLETED|Baseline||12
10864648|NCT04167085|12029749|FG000|NOT COMPLETED|Baseline||2
10864649|NCT04167085|12029750|FG001|NOT COMPLETED|Baseline||1
10864650|NCT04167085|12029749|FG000|STARTED|First Intervention (2 Months)||11
10864651|NCT04167085|12029750|FG001|STARTED|First Intervention (2 Months)||12
10864652|NCT04167085|12029749|FG000|COMPLETED|First Intervention (2 Months)||11
10864653|NCT04167085|12029750|FG001|COMPLETED|First Intervention (2 Months)||12
10864654|NCT04167085|12029749|FG000|NOT COMPLETED|First Intervention (2 Months)||0
10864655|NCT04167085|12029750|FG001|NOT COMPLETED|First Intervention (2 Months)||0
10864656|NCT04167085|12029749|FG000|STARTED|Washout (1 Month)||11
10864657|NCT04167085|12029750|FG001|STARTED|Washout (1 Month)||12
10864658|NCT04167085|12029749|FG000|COMPLETED|Washout (1 Month)||10
10864659|NCT04167085|12029750|FG001|COMPLETED|Washout (1 Month)||12
10864660|NCT04167085|12029749|FG000|NOT COMPLETED|Washout (1 Month)||1
10864661|NCT04167085|12029750|FG001|NOT COMPLETED|Washout (1 Month)||0
10864662|NCT04167085|12029749|FG000|STARTED|Second Intervention (2 Months)||10
10864663|NCT04167085|12029750|FG001|STARTED|Second Intervention (2 Months)||12
10864664|NCT04167085|12029749|FG000|COMPLETED|Second Intervention (2 Months)||10
10864665|NCT04167085|12029750|FG001|COMPLETED|Second Intervention (2 Months)||12
10864666|NCT04167085|12029749|FG000|NOT COMPLETED|Second Intervention (2 Months)||0
10864667|NCT04167085|12029750|FG001|NOT COMPLETED|Second Intervention (2 Months)||0
10864668|NCT04167085|12029749|FG000|STARTED|Washout (1 Month)||10
10864669|NCT04167085|12029750|FG001|STARTED|Washout (1 Month)||12
10864670|NCT04167085|12029749|FG000|COMPLETED|Washout (1 Month)||10
10864671|NCT04167085|12029750|FG001|COMPLETED|Washout (1 Month)||12
10864672|NCT04167085|12029749|FG000|NOT COMPLETED|Washout (1 Month)||0
10864673|NCT04167085|12029750|FG001|NOT COMPLETED|Washout (1 Month)||0
10864674|NCT04146467|12029758|FG000|STARTED|Overall Study||17
10864675|NCT04146467|12029759|FG001|STARTED|Overall Study||65
10864676|NCT04146467|12029758|FG000|COMPLETED|Overall Study||17
10864677|NCT04146467|12029759|FG001|COMPLETED|Overall Study||62
10864678|NCT04146467|12029758|FG000|NOT COMPLETED|Overall Study||0
10864679|NCT04146467|12029759|FG001|NOT COMPLETED|Overall Study||3
10864680|NCT04019613|12029768|FG000|STARTED|Overall Study||4
10864681|NCT04019613|12029768|FG000|COMPLETED|Overall Study||4
10864682|NCT04019613|12029768|FG000|NOT COMPLETED|Overall Study||0
10864683|NCT03912337|12029774|FG000|STARTED|Overall Study||15
10864684|NCT03912337|12029775|FG001|STARTED|Overall Study||14
10864685|NCT03912337|12029774|FG000|COMPLETED|Overall Study||13
10864686|NCT03912337|12029775|FG001|COMPLETED|Overall Study||13
10864687|NCT03912337|12029774|FG000|NOT COMPLETED|Overall Study||2
10864688|NCT03912337|12029775|FG001|NOT COMPLETED|Overall Study||1
11108962|NCT01271933|12293443|FG002|NOT COMPLETED|Double-Blind Phase||12
11108963|NCT01271946|12293455|FG000|STARTED|Overall Study||346
11108964|NCT01271946|12293456|FG001|STARTED|Overall Study||5
10864692|NCT03292588|12029789|FG000|STARTED|Overall Study||146
10864693|NCT03292588|12029790|FG001|STARTED|Overall Study||144
10864694|NCT03292588|12029789|FG000|COMPLETED|Overall Study||126
10864695|NCT03292588|12029790|FG001|COMPLETED|Overall Study||122
10864696|NCT03292588|12029789|FG000|NOT COMPLETED|Overall Study||20
10864697|NCT03292588|12029790|FG001|NOT COMPLETED|Overall Study||22
10864698|NCT03139318|12029798|FG000|STARTED|Overall Study||1
10864699|NCT03139318|12029798|FG000|COMPLETED|Overall Study||1
10864700|NCT03139318|12029798|FG000|NOT COMPLETED|Overall Study||0
10864701|NCT03131960|12029804|FG000|STARTED|Overall Study|1 participant missed the day one visit (V5) but remained in the study and returned for the day 90 assessment (V7).|53
10864702|NCT03131960|12029805|FG001|STARTED|Overall Study|1 discontinued treatment due to adverse event and inability to tolerate rehabilitation.|55
10864703|NCT03131960|12029804|FG000|COMPLETED|Overall Study||53
10864704|NCT03131960|12029805|FG001|COMPLETED|Overall Study||54
10864705|NCT03131960|12029804|FG000|NOT COMPLETED|Overall Study||0
10864706|NCT03131960|12029805|FG001|NOT COMPLETED|Overall Study||1
11108965|NCT01271946|12293455|FG000|COMPLETED|Overall Study||346
11108966|NCT01271946|12293456|FG001|COMPLETED|Overall Study||5
11108967|NCT01271946|12293455|FG000|NOT COMPLETED|Overall Study||0
11108968|NCT01271946|12293456|FG001|NOT COMPLETED|Overall Study||0
11108969|NCT01272011|12293479|FG000|STARTED|Overall Study||3
11108970|NCT01272011|12293480|FG001|STARTED|Overall Study||10
10864713|NCT03090737|12029820|FG000|STARTED|Overall Study||129
10864714|NCT03090737|12029820|FG000|COMPLETED|Overall Study||98
10864715|NCT03090737|12029820|FG000|NOT COMPLETED|Overall Study||31
10864716|NCT02906930|12029828|FG000|STARTED|Overall Study||175
10864717|NCT02906930|12029829|FG001|STARTED|Overall Study||175
10864718|NCT02906930|12029830|FG002|STARTED|Overall Study||175
10864719|NCT02906930|12029831|FG003|STARTED|Overall Study||178
10864720|NCT02906930|12029828|FG000|Full Analysis Set (FAS)|Overall Study||175
10864721|NCT02906930|12029829|FG001|Full Analysis Set (FAS)|Overall Study||175
10864722|NCT02906930|12029830|FG002|Full Analysis Set (FAS)|Overall Study||175
10864723|NCT02906930|12029831|FG003|Full Analysis Set (FAS)|Overall Study||178
10864724|NCT02906930|12029828|FG000|Safety Analysis Set (SAS)|Overall Study||175
10864725|NCT02906930|12029829|FG001|Safety Analysis Set (SAS)|Overall Study||175
10864726|NCT02906930|12029830|FG002|Safety Analysis Set (SAS)|Overall Study||175
10864727|NCT02906930|12029831|FG003|Safety Analysis Set (SAS)|Overall Study||178
10864728|NCT02906930|12029828|FG000|COMPLETED|Overall Study||169
10864729|NCT02906930|12029829|FG001|COMPLETED|Overall Study||161
10864730|NCT02906930|12029830|FG002|COMPLETED|Overall Study||163
10864731|NCT02906930|12029831|FG003|COMPLETED|Overall Study||170
10864732|NCT02906930|12029828|FG000|NOT COMPLETED|Overall Study||6
10864733|NCT02906930|12029829|FG001|NOT COMPLETED|Overall Study||14
10864734|NCT02906930|12029830|FG002|NOT COMPLETED|Overall Study||12
10864735|NCT02906930|12029831|FG003|NOT COMPLETED|Overall Study||8
11108971|NCT01272011|12293481|FG002|STARTED|Overall Study||3
11108972|NCT01272011|12293479|FG000|COMPLETED|Overall Study||3
11108973|NCT01272011|12293480|FG001|COMPLETED|Overall Study||8
11108974|NCT01272011|12293481|FG002|COMPLETED|Overall Study||3
11108975|NCT01272011|12293479|FG000|NOT COMPLETED|Overall Study||0
11108976|NCT01272011|12293480|FG001|NOT COMPLETED|Overall Study||2
11108977|NCT01272011|12293481|FG002|NOT COMPLETED|Overall Study||0
11108978|NCT01272076|12293489|FG000|STARTED|Overall Study||52
11108979|NCT01272076|12293489|FG000|COMPLETED|Overall Study||52
11108980|NCT01272076|12293489|FG000|NOT COMPLETED|Overall Study||0
11108981|NCT01272180|12293497|FG000|STARTED|Overall Study||120
11108982|NCT01272180|12293498|FG001|STARTED|Overall Study||121
11108983|NCT01272180|12293499|FG002|STARTED|Overall Study||122
11108984|NCT01272180|12293500|FG003|STARTED|Overall Study||121
11108985|NCT01272180|12293497|FG000|COMPLETED|Overall Study||103
11108986|NCT01272180|12293498|FG001|COMPLETED|Overall Study||100
11108987|NCT01272180|12293499|FG002|COMPLETED|Overall Study||109
11108988|NCT01272180|12293500|FG003|COMPLETED|Overall Study||107
11108989|NCT01272180|12293497|FG000|NOT COMPLETED|Overall Study||17
11108990|NCT01272180|12293498|FG001|NOT COMPLETED|Overall Study||21
11108991|NCT01272180|12293499|FG002|NOT COMPLETED|Overall Study||13
11108992|NCT01272180|12293500|FG003|NOT COMPLETED|Overall Study||14
11108993|NCT01272193|12293516|FG000|STARTED|Overall Study||147
11108994|NCT01272193|12293517|FG001|STARTED|Overall Study||149
11108995|NCT01272193|12293516|FG000|COMPLETED|Overall Study||137
11108996|NCT01272193|12293517|FG001|COMPLETED|Overall Study||137
11108997|NCT01272193|12293516|FG000|NOT COMPLETED|Overall Study||10
11108998|NCT01272193|12293517|FG001|NOT COMPLETED|Overall Study||12
11108999|NCT01272219|12293527|FG000|STARTED|Main Period: Week 0 to Week 56||959
11109000|NCT01272219|12293528|FG001|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
11109001|NCT01272219|12293529|FG002|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
11109002|NCT01272219|12293530|FG003|STARTED|Main Period: Week 0 to Week 56||487
11109003|NCT01272219|12293531|FG004|STARTED|Main Period: Week 0 to Week 56||1528
11109004|NCT01272219|12293532|FG005|STARTED|Main Period: Week 0 to Week 56||757
11109005|NCT01272219|12293527|FG000|Exposed|Main Period: Week 0 to Week 56||957
11109006|NCT01272219|12293528|FG001|Exposed|Main Period: Week 0 to Week 56||0
11109007|NCT01272219|12293529|FG002|Exposed|Main Period: Week 0 to Week 56||0
11109008|NCT01272219|12293530|FG003|Exposed|Main Period: Week 0 to Week 56||487
11109009|NCT01272219|12293531|FG004|Exposed|Main Period: Week 0 to Week 56||1524
11109010|NCT01272219|12293532|FG005|Exposed|Main Period: Week 0 to Week 56||755
11109011|NCT01272219|12293527|FG000|COMPLETED|Main Period: Week 0 to Week 56||679
11109012|NCT01272219|12293528|FG001|COMPLETED|Main Period: Week 0 to Week 56||0
11109013|NCT01272219|12293529|FG002|COMPLETED|Main Period: Week 0 to Week 56||0
11109014|NCT01272219|12293530|FG003|COMPLETED|Main Period: Week 0 to Week 56||296
11109015|NCT01272219|12293531|FG004|COMPLETED|Main Period: Week 0 to Week 56||1110
11109016|NCT01272219|12293532|FG005|COMPLETED|Main Period: Week 0 to Week 56||505
11109017|NCT01272219|12293527|FG000|NOT COMPLETED|Main Period: Week 0 to Week 56||280
11109018|NCT01272219|12293528|FG001|NOT COMPLETED|Main Period: Week 0 to Week 56||0
11109019|NCT01272219|12293529|FG002|NOT COMPLETED|Main Period: Week 0 to Week 56||0
11109020|NCT01272219|12293530|FG003|NOT COMPLETED|Main Period: Week 0 to Week 56||191
11109021|NCT01272219|12293531|FG004|NOT COMPLETED|Main Period: Week 0 to Week 56||418
11109022|NCT01272219|12293532|FG005|NOT COMPLETED|Main Period: Week 0 to Week 56||252
11109023|NCT01272219|12293527|FG000|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
11109024|NCT01272219|12293528|FG001|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
11109025|NCT01272219|12293529|FG002|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
11109026|NCT01272219|12293530|FG003|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
11109027|NCT01272219|12293531|FG004|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
11109028|NCT01272219|12293532|FG005|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
11109029|NCT01272219|12293527|FG000|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
11109030|NCT01272219|12293528|FG001|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
11109031|NCT01272219|12293529|FG002|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
11109032|NCT01272219|12293530|FG003|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
11109033|NCT01272219|12293531|FG004|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
11109034|NCT01272219|12293532|FG005|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
11109035|NCT01272219|12293527|FG000|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
11109036|NCT01272219|12293528|FG001|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
11109037|NCT01272219|12293529|FG002|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
11109038|NCT01272219|12293530|FG003|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
11109039|NCT01272219|12293531|FG004|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
11109040|NCT01272219|12293532|FG005|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
11109041|NCT01272219|12293527|FG000|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
11109042|NCT01272219|12293528|FG001|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
11109043|NCT01272219|12293529|FG002|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
11109044|NCT01272219|12293530|FG003|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
11109045|NCT01272219|12293531|FG004|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
11228097|NCT02007434|12420285|FG002|STARTED|Overall Study||17
11228098|NCT02007434|12420286|FG003|STARTED|Overall Study||4
11228099|NCT02007434|12420287|FG004|STARTED|Overall Study||16
11228100|NCT02007434|12420288|FG005|STARTED|Overall Study||4
11228101|NCT02007434|12420289|FG006|STARTED|Overall Study||18
11228102|NCT02007434|12420290|FG007|STARTED|Overall Study||4
11228103|NCT02007434|12420283|FG000|Received Treatment|Overall Study||17
11228104|NCT02007434|12420284|FG001|Received Treatment|Overall Study||3
11228105|NCT02007434|12420285|FG002|Received Treatment|Overall Study||17
11228106|NCT02007434|12420286|FG003|Received Treatment|Overall Study||4
11228107|NCT02007434|12420287|FG004|Received Treatment|Overall Study||16
11109046|NCT01272219|12293532|FG005|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
11109047|NCT01272219|12293527|FG000|Exposed|Main + Extension Period: Week 0-172||0
11109048|NCT01272219|12293528|FG001|Exposed|Main + Extension Period: Week 0-172||0
11109049|NCT01272219|12293529|FG002|Exposed|Main + Extension Period: Week 0-172||0
11228108|NCT02007434|12420288|FG005|Received Treatment|Overall Study||4
11228109|NCT02007434|12420289|FG006|Received Treatment|Overall Study||18
11228110|NCT02007434|12420290|FG007|Received Treatment|Overall Study||4
11109050|NCT01272219|12293530|FG003|Exposed|Main + Extension Period: Week 0-172||0
11109051|NCT01272219|12293531|FG004|Exposed|Main + Extension Period: Week 0-172||1501
11109052|NCT01272219|12293532|FG005|Exposed|Main + Extension Period: Week 0-172||747
11109053|NCT01272219|12293527|FG000|COMPLETED|Main + Extension Period: Week 0-172||0
11109054|NCT01272219|12293528|FG001|COMPLETED|Main + Extension Period: Week 0-172||0
11109055|NCT01272219|12293529|FG002|COMPLETED|Main + Extension Period: Week 0-172||0
11109056|NCT01272219|12293530|FG003|COMPLETED|Main + Extension Period: Week 0-172||0
11109057|NCT01272219|12293531|FG004|COMPLETED|Main + Extension Period: Week 0-172||783
11109058|NCT01272219|12293532|FG005|COMPLETED|Main + Extension Period: Week 0-172||327
11109059|NCT01272219|12293527|FG000|NOT COMPLETED|Main + Extension Period: Week 0-172||0
11109060|NCT01272219|12293528|FG001|NOT COMPLETED|Main + Extension Period: Week 0-172||0
11109061|NCT01272219|12293529|FG002|NOT COMPLETED|Main + Extension Period: Week 0-172||0
11109062|NCT01272219|12293530|FG003|NOT COMPLETED|Main + Extension Period: Week 0-172||0
11109063|NCT01272219|12293531|FG004|NOT COMPLETED|Main + Extension Period: Week 0-172||722
11109064|NCT01272219|12293532|FG005|NOT COMPLETED|Main + Extension Period: Week 0-172||422
11109065|NCT01272232|12293548|FG000|STARTED|Weeks 0-56||423
11109066|NCT01272232|12293549|FG001|STARTED|Weeks 0-56||211
11109067|NCT01272232|12293550|FG002|STARTED|Weeks 0-56||212
11109068|NCT01272232|12293548|FG000|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
11228111|NCT02007434|12420283|FG000|COMPLETED|Overall Study||16
11228112|NCT02007434|12420284|FG001|COMPLETED|Overall Study||3
11228113|NCT02007434|12420285|FG002|COMPLETED|Overall Study||16
11228114|NCT02007434|12420286|FG003|COMPLETED|Overall Study||4
11228115|NCT02007434|12420287|FG004|COMPLETED|Overall Study||16
11228116|NCT02007434|12420288|FG005|COMPLETED|Overall Study||4
11228117|NCT02007434|12420289|FG006|COMPLETED|Overall Study||18
11228118|NCT02007434|12420290|FG007|COMPLETED|Overall Study||4
11228119|NCT02007434|12420283|FG000|NOT COMPLETED|Overall Study||1
11228120|NCT02007434|12420284|FG001|NOT COMPLETED|Overall Study||1
11228121|NCT02007434|12420285|FG002|NOT COMPLETED|Overall Study||1
11228122|NCT02007434|12420286|FG003|NOT COMPLETED|Overall Study||0
11228123|NCT02007434|12420287|FG004|NOT COMPLETED|Overall Study||0
11228124|NCT02007434|12420288|FG005|NOT COMPLETED|Overall Study||0
11228125|NCT02007434|12420289|FG006|NOT COMPLETED|Overall Study||0
11228126|NCT02007434|12420290|FG007|NOT COMPLETED|Overall Study||0
11228127|NCT02007577|12420311|FG000|STARTED|Overall Study||27
11228128|NCT02007577|12420312|FG001|STARTED|Overall Study||14
11228129|NCT02007577|12420311|FG000|COMPLETED|Overall Study||26
11228130|NCT02007577|12420312|FG001|COMPLETED|Overall Study||13
11228131|NCT02007577|12420311|FG000|NOT COMPLETED|Overall Study||1
11228132|NCT02007577|12420312|FG001|NOT COMPLETED|Overall Study||1
11228133|NCT02007720|12420320|FG000|STARTED|Overall Study||436
11228134|NCT02007720|12420321|FG001|STARTED|Overall Study||440
11228135|NCT02007720|12420320|FG000|Full Analysis Set|Overall Study||433
11228136|NCT02007720|12420321|FG001|Full Analysis Set|Overall Study||437
11228137|NCT02007720|12420320|FG000|Safety Set|Overall Study||426
11228138|NCT02007720|12420321|FG001|Safety Set|Overall Study||432
11228139|NCT02007720|12420320|FG000|COMPLETED|Overall Study||354
11228140|NCT02007720|12420321|FG001|COMPLETED|Overall Study||368
11228141|NCT02007720|12420320|FG000|NOT COMPLETED|Overall Study||82
11228142|NCT02007720|12420321|FG001|NOT COMPLETED|Overall Study||72
11228143|NCT02007863|12420328|FG000|STARTED|Overall Study||2
11228144|NCT02007863|12420328|FG000|COMPLETED|Overall Study||2
11228145|NCT02007863|12420328|FG000|NOT COMPLETED|Overall Study||0
11228146|NCT02007954|12420332|FG000|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
11228147|NCT02007954|12420332|FG000|Completed First TACE|Overall Study||24
11228148|NCT02007954|12420332|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
11228149|NCT02007954|12420332|FG000|COMPLETED|Overall Study||17
11228150|NCT02007954|12420332|FG000|NOT COMPLETED|Overall Study||7
11228151|NCT02008149|12420339|FG000|STARTED|Overall Study||7
11228152|NCT02008149|12420340|FG001|STARTED|Overall Study||1
11228153|NCT02008149|12420341|FG002|STARTED|Overall Study||1
11228154|NCT02008149|12420339|FG000|COMPLETED|Overall Study||4
11109069|NCT01272232|12293549|FG001|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
11109070|NCT01272232|12293550|FG002|Exposed|Weeks 0-56||212
11109071|NCT01272232|12293548|FG000|COMPLETED|Weeks 0-56||324
11109072|NCT01272232|12293549|FG001|COMPLETED|Weeks 0-56||164
11109073|NCT01272232|12293550|FG002|COMPLETED|Weeks 0-56||140
11109074|NCT01272232|12293548|FG000|NOT COMPLETED|Weeks 0-56||99
11109075|NCT01272232|12293549|FG001|NOT COMPLETED|Weeks 0-56||47
11109076|NCT01272232|12293550|FG002|NOT COMPLETED|Weeks 0-56||72
11109077|NCT01272232|12293548|FG000|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
11109078|NCT01272232|12293549|FG001|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
11109079|NCT01272232|12293550|FG002|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
11109080|NCT01272232|12293548|FG000|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
11109081|NCT01272232|12293549|FG001|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
11109082|NCT01272232|12293550|FG002|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
11109083|NCT01272232|12293548|FG000|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
11109084|NCT01272232|12293549|FG001|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
11109085|NCT01272232|12293550|FG002|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
11109086|NCT01272245|12293558|FG000|STARTED|Overall Study||36
11109087|NCT01272245|12293558|FG000|COMPLETED|Overall Study||36
11109088|NCT01272245|12293558|FG000|NOT COMPLETED|Overall Study||0
11109089|NCT01272284|12293562|FG000|STARTED|3-month Follow-up Visit||113
11109090|NCT01272284|12293562|FG000|COMPLETED|3-month Follow-up Visit||112
11109091|NCT01272284|12293562|FG000|NOT COMPLETED|3-month Follow-up Visit||1
11109092|NCT01272284|12293562|FG000|STARTED|6-month Follow-up Visit||112
11109093|NCT01272284|12293562|FG000|COMPLETED|6-month Follow-up Visit||109
11109094|NCT01272284|12293562|FG000|NOT COMPLETED|6-month Follow-up Visit||3
11109095|NCT01272284|12293562|FG000|STARTED|12-month Follow-up Visit||109
11109096|NCT01272284|12293562|FG000|COMPLETED|12-month Follow-up Visit||105
11109097|NCT01272284|12293562|FG000|NOT COMPLETED|12-month Follow-up Visit||4
11109098|NCT01272388|12293569|FG000|STARTED|Overall Study||1
11109099|NCT01272388|12293570|FG001|STARTED|Overall Study||0
11109100|NCT01272388|12293569|FG000|COMPLETED|Overall Study||1
11109101|NCT01272388|12293570|FG001|COMPLETED|Overall Study||0
11109102|NCT01272388|12293569|FG000|NOT COMPLETED|Overall Study||0
11109103|NCT01272388|12293570|FG001|NOT COMPLETED|Overall Study||0
11228155|NCT02008149|12420340|FG001|COMPLETED|Overall Study||0
11228156|NCT02008149|12420341|FG002|COMPLETED|Overall Study||1
11228157|NCT02008149|12420339|FG000|NOT COMPLETED|Overall Study||3
11228158|NCT02008149|12420340|FG001|NOT COMPLETED|Overall Study||1
11228159|NCT02008149|12420341|FG002|NOT COMPLETED|Overall Study||0
11228160|NCT02008227|12420351|FG000|STARTED|Overall Study||612
11228161|NCT02008227|12420352|FG001|STARTED|Overall Study||613
11228162|NCT02008227|12420351|FG000|Treated|Overall Study||579
11228163|NCT02008227|12420352|FG001|Treated|Overall Study||608
11228164|NCT02008227|12420351|FG000|COMPLETED|Overall Study||0
11228165|NCT02008227|12420352|FG001|COMPLETED|Overall Study||0
11228166|NCT02008227|12420351|FG000|NOT COMPLETED|Overall Study||612
11228167|NCT02008227|12420352|FG001|NOT COMPLETED|Overall Study||613
11228168|NCT02008318|12420361|FG000|STARTED|Overall Study||41
11228169|NCT02008318|12420362|FG001|STARTED|Overall Study||2
11228170|NCT02008318|12420361|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41
11228171|NCT02008318|12420362|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2
11228172|NCT02008318|12420361|FG000|COMPLETED|Overall Study||29
11228173|NCT02008318|12420362|FG001|COMPLETED|Overall Study||1
11228174|NCT02008318|12420361|FG000|NOT COMPLETED|Overall Study||12
11228175|NCT02008318|12420362|FG001|NOT COMPLETED|Overall Study||1
11228176|NCT02008526|12420374|FG000|STARTED|Overall Study||94
11228177|NCT02008526|12420375|FG001|STARTED|Overall Study||99
11228178|NCT02008526|12420376|FG002|STARTED|Overall Study||93
11228179|NCT02008526|12420374|FG000|COMPLETED|Overall Study||86
11228180|NCT02008526|12420375|FG001|COMPLETED|Overall Study||85
11228181|NCT02008526|12420376|FG002|COMPLETED|Overall Study||84
11228182|NCT02008526|12420374|FG000|NOT COMPLETED|Overall Study||8
11228183|NCT02008526|12420375|FG001|NOT COMPLETED|Overall Study||14
11228184|NCT02008526|12420376|FG002|NOT COMPLETED|Overall Study||9
11228185|NCT02008565|12420388|FG000|STARTED|Overall Study||86
11228186|NCT02008565|12420389|FG001|STARTED|Overall Study||84
11228187|NCT02008565|12420390|FG002|STARTED|Overall Study||88
11228188|NCT02008565|12420391|FG003|STARTED|Overall Study||42
11228189|NCT02008565|12420388|FG000|COMPLETED|Overall Study||85
11228190|NCT02008565|12420389|FG001|COMPLETED|Overall Study||83
11228191|NCT02008565|12420390|FG002|COMPLETED|Overall Study||86
11228192|NCT02008565|12420391|FG003|COMPLETED|Overall Study||42
11228193|NCT02008565|12420388|FG000|NOT COMPLETED|Overall Study||1
11228194|NCT02008565|12420389|FG001|NOT COMPLETED|Overall Study||1
11228195|NCT02008565|12420390|FG002|NOT COMPLETED|Overall Study||2
11228196|NCT02008565|12420391|FG003|NOT COMPLETED|Overall Study||0
11228197|NCT02008617|12420405|FG000|STARTED|Overall Study||8
11228198|NCT02008617|12420406|FG001|STARTED|Overall Study||10
11228199|NCT02008617|12420405|FG000|COMPLETED|Overall Study||8
11228200|NCT02008617|12420406|FG001|COMPLETED|Overall Study||10
11109104|NCT01272583|12293578|FG000|STARTED|Overall Study||8
11109105|NCT01272583|12293579|FG001|STARTED|Overall Study||8
11228201|NCT02008617|12420405|FG000|NOT COMPLETED|Overall Study||0
11228202|NCT02008617|12420406|FG001|NOT COMPLETED|Overall Study||0
11228203|NCT02008682|12420414|FG000|STARTED|Overall Study||184
11228204|NCT02008682|12420415|FG001|STARTED|Overall Study||184
11228205|NCT02008682|12420414|FG000|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
11228206|NCT02008682|12420415|FG001|Exposed|Overall Study||184
11228207|NCT02008682|12420414|FG000|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
11228208|NCT02008682|12420415|FG001|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
11228209|NCT02008682|12420414|FG000|NOT COMPLETED|Overall Study||27
11228210|NCT02008682|12420415|FG001|NOT COMPLETED|Overall Study||14
11228211|NCT02008773|12420425|FG000|STARTED|Overall Study||40
11228212|NCT02008773|12420426|FG001|STARTED|Overall Study||34
11228213|NCT02008773|12420427|FG002|STARTED|Overall Study||46
11228214|NCT02008773|12420428|FG003|STARTED|Overall Study||50
11228215|NCT02008773|12420425|FG000|COMPLETED|Overall Study||27
11228216|NCT02008773|12420426|FG001|COMPLETED|Overall Study||25
11228217|NCT02008773|12420427|FG002|COMPLETED|Overall Study||32
11228218|NCT02008773|12420428|FG003|COMPLETED|Overall Study||38
11228219|NCT02008773|12420425|FG000|NOT COMPLETED|Overall Study||13
11109106|NCT01272583|12293578|FG000|COMPLETED|Overall Study||8
11228220|NCT02008773|12420426|FG001|NOT COMPLETED|Overall Study||9
11228221|NCT02008773|12420427|FG002|NOT COMPLETED|Overall Study||14
11228222|NCT02008773|12420428|FG003|NOT COMPLETED|Overall Study||12
11228223|NCT02008877|12420436|FG000|STARTED|Overall Study||3
11109107|NCT01272583|12293579|FG001|COMPLETED|Overall Study||8
11109108|NCT01272583|12293578|FG000|NOT COMPLETED|Overall Study||0
11109109|NCT01272583|12293579|FG001|NOT COMPLETED|Overall Study||0
11109110|NCT01272635|12293589|FG000|STARTED|Overall Study||153
11109111|NCT01272635|12293590|FG001|STARTED|Overall Study||154
11109112|NCT01272635|12293591|FG002|STARTED|Overall Study||148
11109113|NCT01272635|12293592|FG003|STARTED|Overall Study||152
11109114|NCT01272635|12293589|FG000|COMPLETED|Overall Study||122
11109115|NCT01272635|12293590|FG001|COMPLETED|Overall Study||134
11109116|NCT01272635|12293591|FG002|COMPLETED|Overall Study||117
11109117|NCT01272635|12293592|FG003|COMPLETED|Overall Study||129
11109118|NCT01272635|12293589|FG000|NOT COMPLETED|Overall Study||31
11109119|NCT01272635|12293590|FG001|NOT COMPLETED|Overall Study||20
11109120|NCT01272635|12293591|FG002|NOT COMPLETED|Overall Study||31
11109121|NCT01272635|12293592|FG003|NOT COMPLETED|Overall Study||23
11109122|NCT01272661|12293603|FG000|STARTED|Overall Study||413
11109123|NCT01272661|12293604|FG001|STARTED|Overall Study||497
11109124|NCT01272661|12293605|FG002|STARTED|Overall Study||386
11109125|NCT01272661|12293603|FG000|COMPLETED|Overall Study||287
11109126|NCT01272661|12293604|FG001|COMPLETED|Overall Study||288
11109127|NCT01272661|12293605|FG002|COMPLETED|Overall Study||314
11109128|NCT01272661|12293603|FG000|NOT COMPLETED|Overall Study||126
11109129|NCT01272661|12293604|FG001|NOT COMPLETED|Overall Study||209
11109130|NCT01272661|12293605|FG002|NOT COMPLETED|Overall Study||72
11109131|NCT01272804|12293619|FG000|STARTED|Overall Study||9
11109132|NCT01272804|12293620|FG001|STARTED|Overall Study||9
11109133|NCT01272804|12293621|FG002|STARTED|Overall Study||9
11109134|NCT01272804|12293622|FG003|STARTED|Overall Study||9
11109135|NCT01272804|12293623|FG004|STARTED|Overall Study||9
11109136|NCT01272804|12293624|FG005|STARTED|Overall Study||16
11109137|NCT01272804|12293619|FG000|COMPLETED|Overall Study||8
11109138|NCT01272804|12293620|FG001|COMPLETED|Overall Study||9
11109139|NCT01272804|12293621|FG002|COMPLETED|Overall Study||9
11109140|NCT01272804|12293622|FG003|COMPLETED|Overall Study||9
11109141|NCT01272804|12293623|FG004|COMPLETED|Overall Study||7
11109142|NCT01272804|12293624|FG005|COMPLETED|Overall Study||15
11109143|NCT01272804|12293619|FG000|NOT COMPLETED|Overall Study||1
11109144|NCT01272804|12293620|FG001|NOT COMPLETED|Overall Study||0
11109145|NCT01272804|12293621|FG002|NOT COMPLETED|Overall Study||0
11109146|NCT01272804|12293622|FG003|NOT COMPLETED|Overall Study||0
11109147|NCT01272804|12293623|FG004|NOT COMPLETED|Overall Study||2
11109148|NCT01272804|12293624|FG005|NOT COMPLETED|Overall Study||1
11109149|NCT01272830|12293640|FG000|STARTED|Overall Study||25
11109150|NCT01272830|12293641|FG001|STARTED|Overall Study||26
11109151|NCT01272830|12293640|FG000|COMPLETED|Overall Study||17
11109152|NCT01272830|12293641|FG001|COMPLETED|Overall Study||21
11109153|NCT01272830|12293640|FG000|NOT COMPLETED|Overall Study||8
11109154|NCT01272830|12293641|FG001|NOT COMPLETED|Overall Study||5
11109155|NCT01272869|12293649|FG000|STARTED|Period 1 (14 Days)||10
11109156|NCT01272869|12293650|FG001|STARTED|Period 1 (14 Days)||10
11109157|NCT01272869|12293649|FG000|COMPLETED|Period 1 (14 Days)||10
11109158|NCT01272869|12293650|FG001|COMPLETED|Period 1 (14 Days)||10
11109159|NCT01272869|12293649|FG000|NOT COMPLETED|Period 1 (14 Days)||0
11109160|NCT01272869|12293650|FG001|NOT COMPLETED|Period 1 (14 Days)||0
11109161|NCT01272869|12293649|FG000|STARTED|Period 2 (14 Days)||10
11109162|NCT01272869|12293650|FG001|STARTED|Period 2 (14 Days)||10
11109163|NCT01272869|12293649|FG000|COMPLETED|Period 2 (14 Days)||9
11109164|NCT01272869|12293650|FG001|COMPLETED|Period 2 (14 Days)||10
11109165|NCT01272869|12293649|FG000|NOT COMPLETED|Period 2 (14 Days)||1
11109166|NCT01272869|12293650|FG001|NOT COMPLETED|Period 2 (14 Days)||0
11109167|NCT01272882|12293656|FG000|STARTED|Overall Study||13
11109168|NCT01272882|12293656|FG000|COMPLETED|Overall Study||13
11109169|NCT01272882|12293656|FG000|NOT COMPLETED|Overall Study||0
11109170|NCT01272908|12293660|FG000|STARTED|Initial Treatment Period||120
11109171|NCT01272908|12293660|FG000|COMPLETED|Initial Treatment Period||112
11109172|NCT01272908|12293660|FG000|NOT COMPLETED|Initial Treatment Period||8
11109173|NCT01272908|12293660|FG000|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
11109174|NCT01272908|12293660|FG000|COMPLETED|Re-Treatment Period||71
11109175|NCT01272908|12293660|FG000|NOT COMPLETED|Re-Treatment Period||6
11109176|NCT01272921|12293668|FG000|STARTED|Overall Study||71
11109177|NCT01272921|12293669|FG001|STARTED|Overall Study||71
11109178|NCT01272921|12293668|FG000|COMPLETED|Overall Study||69
11109179|NCT01272921|12293669|FG001|COMPLETED|Overall Study||70
11109180|NCT01272921|12293668|FG000|NOT COMPLETED|Overall Study||2
11109181|NCT01272921|12293669|FG001|NOT COMPLETED|Overall Study||1
11109182|NCT01272934|12293679|FG000|STARTED|Overall Study||102
11109183|NCT01272934|12293680|FG001|STARTED|Overall Study||103
11109184|NCT01272934|12293679|FG000|COMPLETED|Overall Study||102
11109185|NCT01272934|12293680|FG001|COMPLETED|Overall Study||101
11109186|NCT01272934|12293679|FG000|NOT COMPLETED|Overall Study||0
11109187|NCT01272934|12293680|FG001|NOT COMPLETED|Overall Study||2
11109188|NCT01272947|12293689|FG000|STARTED|Overall Study||104
11109189|NCT01272947|12293690|FG001|STARTED|Overall Study||100
11109190|NCT01272947|12293689|FG000|COMPLETED|Overall Study||102
11109191|NCT01272947|12293690|FG001|COMPLETED|Overall Study||98
11109192|NCT01272947|12293689|FG000|NOT COMPLETED|Overall Study||2
11109193|NCT01272947|12293690|FG001|NOT COMPLETED|Overall Study||2
11109194|NCT01272960|12293698|FG000|STARTED|Overall Study||14
11109195|NCT01272960|12293699|FG001|STARTED|Overall Study||15
11109196|NCT01272960|12293698|FG000|COMPLETED|Overall Study||14
11109197|NCT01272960|12293699|FG001|COMPLETED|Overall Study||15
11109198|NCT01272960|12293698|FG000|NOT COMPLETED|Overall Study||0
11109199|NCT01272960|12293699|FG001|NOT COMPLETED|Overall Study||0
11109200|NCT01272999|12293710|FG000|STARTED|Overall Study||357
11109201|NCT01272999|12293711|FG001|STARTED|Overall Study||34
11109202|NCT01272999|12293710|FG000|COMPLETED|Overall Study||357
11109203|NCT01272999|12293711|FG001|COMPLETED|Overall Study||34
11109204|NCT01272999|12293710|FG000|NOT COMPLETED|Overall Study||0
11109205|NCT01272999|12293711|FG001|NOT COMPLETED|Overall Study||0
11109206|NCT01273038|12293719|FG000|STARTED|First Intervention (14 Days)||10
11109207|NCT01273038|12293720|FG001|STARTED|First Intervention (14 Days)||10
11109208|NCT01273038|12293719|FG000|COMPLETED|First Intervention (14 Days)||10
11109209|NCT01273038|12293720|FG001|COMPLETED|First Intervention (14 Days)||10
11109210|NCT01273038|12293719|FG000|NOT COMPLETED|First Intervention (14 Days)||0
11109211|NCT01273038|12293720|FG001|NOT COMPLETED|First Intervention (14 Days)||0
11109212|NCT01273038|12293719|FG000|STARTED|Second Intervention (14 Days)||10
11109213|NCT01273038|12293720|FG001|STARTED|Second Intervention (14 Days)||10
11109214|NCT01273038|12293719|FG000|COMPLETED|Second Intervention (14 Days)||10
11109215|NCT01273038|12293720|FG001|COMPLETED|Second Intervention (14 Days)||8
11109216|NCT01273038|12293719|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
11109217|NCT01273038|12293720|FG001|NOT COMPLETED|Second Intervention (14 Days)||2
11109218|NCT01273155|12293730|FG000|STARTED|Overall Study||14
11109219|NCT01273155|12293731|FG001|STARTED|Overall Study||12
11109220|NCT01273155|12293732|FG002|STARTED|Overall Study||18
11109221|NCT01273155|12293733|FG003|STARTED|Overall Study||5
11109222|NCT01273155|12293734|FG004|STARTED|Overall Study||5
11109223|NCT01273155|12293735|FG005|STARTED|Overall Study||10
11109224|NCT01273155|12293736|FG006|STARTED|Overall Study||8
11109225|NCT01273155|12293730|FG000|COMPLETED|Overall Study||12
11109226|NCT01273155|12293731|FG001|COMPLETED|Overall Study||8
11109227|NCT01273155|12293732|FG002|COMPLETED|Overall Study||6
11109228|NCT01273155|12293733|FG003|COMPLETED|Overall Study||4
10864944|NCT02863419|12029887|FG000|STARTED|Overall Study||285
10864945|NCT02863419|12029888|FG001|STARTED|Overall Study||284
10864946|NCT02863419|12029889|FG002|STARTED|Overall Study||142
10864947|NCT02863419|12029887|FG000|Full Analysis Set (FAS)|Overall Study||285
10864948|NCT02863419|12029888|FG001|Full Analysis Set (FAS)|Overall Study||284
10864949|NCT02863419|12029889|FG002|Full Analysis Set (FAS)|Overall Study||142
10864950|NCT02863419|12029887|FG000|Safety Analysis Set (SAS)|Overall Study||285
10864951|NCT02863419|12029888|FG001|Safety Analysis Set (SAS)|Overall Study||284
10864952|NCT02863419|12029889|FG002|Safety Analysis Set (SAS)|Overall Study||142
10864953|NCT02863419|12029887|FG000|COMPLETED|Overall Study||277
10864954|NCT02863419|12029888|FG001|COMPLETED|Overall Study||274
10864955|NCT02863419|12029889|FG002|COMPLETED|Overall Study||134
10864956|NCT02863419|12029887|FG000|NOT COMPLETED|Overall Study||8
10864957|NCT02863419|12029888|FG001|NOT COMPLETED|Overall Study||10
10864958|NCT02863419|12029889|FG002|NOT COMPLETED|Overall Study||8
10864959|NCT02863328|12029899|FG000|STARTED|Overall Study||411
10864960|NCT02863328|12029900|FG001|STARTED|Overall Study||410
10864961|NCT02863328|12029899|FG000|Full Analysis Set (FAS)|Overall Study||411
10864962|NCT02863328|12029900|FG001|Full Analysis Set (FAS)|Overall Study||410
10864963|NCT02863328|12029899|FG000|Safety Analysis Set (SAS)|Overall Study||410
10864964|NCT02863328|12029900|FG001|Safety Analysis Set (SAS)|Overall Study||409
10864965|NCT02863328|12029899|FG000|COMPLETED|Overall Study||400
10864966|NCT02863328|12029900|FG001|COMPLETED|Overall Study||387
10864967|NCT02863328|12029899|FG000|NOT COMPLETED|Overall Study||11
10864968|NCT02863328|12029900|FG001|NOT COMPLETED|Overall Study||23
10864969|NCT02849080|12029908|FG000|STARTED|Main Phase: 0 - 52 Weeks||253
10864970|NCT02849080|12029909|FG001|STARTED|Main Phase: 0 - 52 Weeks||251
10864971|NCT02849080|12029910|FG002|STARTED|Main Phase: 0 - 52 Weeks||0
10864972|NCT02849080|12029911|FG003|STARTED|Main Phase: 0 - 52 Weeks||0
10864973|NCT02849080|12029908|FG000|Exposed|Main Phase: 0 - 52 Weeks||253
10864974|NCT02849080|12029909|FG001|Exposed|Main Phase: 0 - 52 Weeks||250
11109229|NCT01273155|12293734|FG004|COMPLETED|Overall Study||3
11109230|NCT01273155|12293735|FG005|COMPLETED|Overall Study||5
11109231|NCT01273155|12293736|FG006|COMPLETED|Overall Study||2
11109232|NCT01273155|12293730|FG000|NOT COMPLETED|Overall Study||2
11109233|NCT01273155|12293731|FG001|NOT COMPLETED|Overall Study||4
11109234|NCT01273155|12293732|FG002|NOT COMPLETED|Overall Study||12
10864975|NCT02849080|12029910|FG002|Exposed|Main Phase: 0 - 52 Weeks||0
10864976|NCT02849080|12029911|FG003|Exposed|Main Phase: 0 - 52 Weeks||0
10864977|NCT02849080|12029908|FG000|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||253
10864978|NCT02849080|12029909|FG001|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||251
10864979|NCT02849080|12029910|FG002|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
10864980|NCT02849080|12029911|FG003|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
10864981|NCT02849080|12029908|FG000|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||253
10864982|NCT02849080|12029909|FG001|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||250
10864983|NCT02849080|12029910|FG002|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
10864984|NCT02849080|12029911|FG003|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
10864985|NCT02849080|12029908|FG000|COMPLETED|Main Phase: 0 - 52 Weeks||241
10864986|NCT02849080|12029909|FG001|COMPLETED|Main Phase: 0 - 52 Weeks||244
10864987|NCT02849080|12029910|FG002|COMPLETED|Main Phase: 0 - 52 Weeks||0
10864988|NCT02849080|12029911|FG003|COMPLETED|Main Phase: 0 - 52 Weeks||0
10864989|NCT02849080|12029908|FG000|NOT COMPLETED|Main Phase: 0 - 52 Weeks||12
10864990|NCT02849080|12029909|FG001|NOT COMPLETED|Main Phase: 0 - 52 Weeks||7
10864991|NCT02849080|12029910|FG002|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
10864992|NCT02849080|12029911|FG003|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
10864993|NCT02849080|12029908|FG000|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|185
10864994|NCT02849080|12029909|FG001|STARTED|Extension Phase: 53 - 104 Weeks||0
10864995|NCT02849080|12029910|FG002|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|100
10864996|NCT02849080|12029911|FG003|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|98
10864997|NCT02849080|12029908|FG000|Exposed|Extension Phase: 53 - 104 Weeks||184
10864998|NCT02849080|12029909|FG001|Exposed|Extension Phase: 53 - 104 Weeks||0
10864999|NCT02849080|12029910|FG002|Exposed|Extension Phase: 53 - 104 Weeks||100
10865000|NCT02849080|12029911|FG003|Exposed|Extension Phase: 53 - 104 Weeks||97
10865001|NCT02849080|12029908|FG000|COMPLETED|Extension Phase: 53 - 104 Weeks||182
10865002|NCT02849080|12029909|FG001|COMPLETED|Extension Phase: 53 - 104 Weeks||0
10865003|NCT02849080|12029910|FG002|COMPLETED|Extension Phase: 53 - 104 Weeks||99
10865004|NCT02849080|12029911|FG003|COMPLETED|Extension Phase: 53 - 104 Weeks||98
10865005|NCT02849080|12029908|FG000|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||3
10865006|NCT02849080|12029909|FG001|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
10865007|NCT02849080|12029910|FG002|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||1
10865008|NCT02849080|12029911|FG003|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
10865009|NCT02764762|12029923|FG000|STARTED|Overall Study||55
10865010|NCT02764762|12029923|FG000|COMPLETED|Overall Study||46
10865011|NCT02764762|12029923|FG000|NOT COMPLETED|Overall Study||9
11109235|NCT01273155|12293733|FG003|NOT COMPLETED|Overall Study||1
11109236|NCT01273155|12293734|FG004|NOT COMPLETED|Overall Study||2
11109237|NCT01273155|12293735|FG005|NOT COMPLETED|Overall Study||5
11109238|NCT01273155|12293736|FG006|NOT COMPLETED|Overall Study||6
11109239|NCT01273181|12293763|FG000|STARTED|Phase I, Dose 1||3
11109240|NCT01273181|12293764|FG001|STARTED|Phase I, Dose 1||0
11109241|NCT01273181|12293765|FG002|STARTED|Phase I, Dose 1||0
11109242|NCT01273181|12293766|FG003|STARTED|Phase I, Dose 1||0
11109243|NCT01273181|12293763|FG000|COMPLETED|Phase I, Dose 1||2
11109244|NCT01273181|12293764|FG001|COMPLETED|Phase I, Dose 1||0
11109245|NCT01273181|12293765|FG002|COMPLETED|Phase I, Dose 1||0
11109246|NCT01273181|12293766|FG003|COMPLETED|Phase I, Dose 1||0
10865024|NCT02692716|12029942|FG000|STARTED|Overall Study||1591
10865025|NCT02692716|12029943|FG001|STARTED|Overall Study||1592
10865026|NCT02692716|12029942|FG000|Full Analysis Set (FAS)|Overall Study||1591
10865027|NCT02692716|12029943|FG001|Full Analysis Set (FAS)|Overall Study||1592
10865028|NCT02692716|12029942|FG000|Exposed|Overall Study||1591
10865029|NCT02692716|12029943|FG001|Exposed|Overall Study||1591
10865030|NCT02692716|12029942|FG000|COMPLETED|Overall Study||1586
10865031|NCT02692716|12029943|FG001|COMPLETED|Overall Study||1586
10865032|NCT02692716|12029942|FG000|NOT COMPLETED|Overall Study||5
10865033|NCT02692716|12029943|FG001|NOT COMPLETED|Overall Study||6
10865034|NCT02607865|12029953|FG000|STARTED|Overall Study||466
10865035|NCT02607865|12029954|FG001|STARTED|Overall Study||466
10865036|NCT02607865|12029955|FG002|STARTED|Overall Study||465
10865037|NCT02607865|12029956|FG003|STARTED|Overall Study||467
10865038|NCT02607865|12029953|FG000|Full Analysis Set (FAS)|Overall Study||466
10865039|NCT02607865|12029954|FG001|Full Analysis Set (FAS)|Overall Study||465
10865040|NCT02607865|12029955|FG002|Full Analysis Set (FAS)|Overall Study||465
10865041|NCT02607865|12029956|FG003|Full Analysis Set (FAS)|Overall Study||467
10865042|NCT02607865|12029953|FG000|Safety Analysis Set (SAS)|Overall Study||466
10865043|NCT02607865|12029954|FG001|Safety Analysis Set (SAS)|Overall Study||464
10865044|NCT02607865|12029955|FG002|Safety Analysis Set (SAS)|Overall Study||465
10865045|NCT02607865|12029956|FG003|Safety Analysis Set (SAS)|Overall Study||466
10865046|NCT02607865|12029953|FG000|COMPLETED|Overall Study||433
10865047|NCT02607865|12029954|FG001|COMPLETED|Overall Study||436
11109247|NCT01273181|12293763|FG000|NOT COMPLETED|Phase I, Dose 1||1
11109248|NCT01273181|12293764|FG001|NOT COMPLETED|Phase I, Dose 1||0
11109249|NCT01273181|12293765|FG002|NOT COMPLETED|Phase I, Dose 1||0
11109250|NCT01273181|12293766|FG003|NOT COMPLETED|Phase I, Dose 1||0
11109251|NCT01273181|12293763|FG000|STARTED|Phase I, Dose 2||0
11109252|NCT01273181|12293764|FG001|STARTED|Phase I, Dose 2||3
11109253|NCT01273181|12293765|FG002|STARTED|Phase I, Dose 2||0
11109254|NCT01273181|12293766|FG003|STARTED|Phase I, Dose 2||0
11109255|NCT01273181|12293763|FG000|COMPLETED|Phase I, Dose 2||0
11109256|NCT01273181|12293764|FG001|COMPLETED|Phase I, Dose 2||2
11109257|NCT01273181|12293765|FG002|COMPLETED|Phase I, Dose 2||0
11109258|NCT01273181|12293766|FG003|COMPLETED|Phase I, Dose 2||0
11109259|NCT01273181|12293763|FG000|NOT COMPLETED|Phase I, Dose 2||0
11109260|NCT01273181|12293764|FG001|NOT COMPLETED|Phase I, Dose 2||1
11109261|NCT01273181|12293765|FG002|NOT COMPLETED|Phase I, Dose 2||0
10865048|NCT02607865|12029955|FG002|COMPLETED|Overall Study||438
10865049|NCT02607865|12029956|FG003|COMPLETED|Overall Study||451
10865050|NCT02607865|12029953|FG000|NOT COMPLETED|Overall Study||33
10865051|NCT02607865|12029954|FG001|NOT COMPLETED|Overall Study||30
10865052|NCT02607865|12029955|FG002|NOT COMPLETED|Overall Study||27
10865053|NCT02607865|12029956|FG003|NOT COMPLETED|Overall Study||16
11109262|NCT01273181|12293766|FG003|NOT COMPLETED|Phase I, Dose 2||0
11109263|NCT01273181|12293763|FG000|STARTED|Phase 2, Dose 1||0
11109264|NCT01273181|12293764|FG001|STARTED|Phase 2, Dose 1||0
11109265|NCT01273181|12293765|FG002|STARTED|Phase 2, Dose 1||2
11109266|NCT01273181|12293766|FG003|STARTED|Phase 2, Dose 1||0
11109267|NCT01273181|12293763|FG000|COMPLETED|Phase 2, Dose 1||0
11109268|NCT01273181|12293764|FG001|COMPLETED|Phase 2, Dose 1||0
11109269|NCT01273181|12293765|FG002|COMPLETED|Phase 2, Dose 1||1
11109270|NCT01273181|12293766|FG003|COMPLETED|Phase 2, Dose 1||0
10865060|NCT02486367|12029977|FG000|STARTED|Overall Study||30
10865061|NCT02486367|12029978|FG001|STARTED|Overall Study||30
10865062|NCT02486367|12029977|FG000|COMPLETED|Overall Study||30
10865063|NCT02486367|12029978|FG001|COMPLETED|Overall Study||30
10865064|NCT02486367|12029977|FG000|NOT COMPLETED|Overall Study||0
10865065|NCT02486367|12029978|FG001|NOT COMPLETED|Overall Study||0
10865066|NCT02430480|12029984|FG000|STARTED|Overall Study||39
10865067|NCT02430480|12029984|FG000|COMPLETED|Overall Study||36
10865068|NCT02430480|12029984|FG000|NOT COMPLETED|Overall Study||3
10865069|NCT02416622|12029994|FG000|STARTED|Overall Study||6
10865070|NCT02416622|12029995|FG001|STARTED|Overall Study||8
10865071|NCT02416622|12029996|FG002|STARTED|Overall Study||13
10865072|NCT02416622|12029994|FG000|Completed Month 12|Overall Study||6
10865073|NCT02416622|12029995|FG001|Completed Month 12|Overall Study||8
10865074|NCT02416622|12029996|FG002|Completed Month 12|Overall Study||13
10865075|NCT02416622|12029994|FG000|Started Long-Term Follow-Up|Overall Study||6
10865076|NCT02416622|12029995|FG001|Started Long-Term Follow-Up|Overall Study||8
10865077|NCT02416622|12029996|FG002|Started Long-Term Follow-Up|Overall Study||13
10865078|NCT02416622|12029994|FG000|COMPLETED|Overall Study||0
10865079|NCT02416622|12029995|FG001|COMPLETED|Overall Study||0
10865080|NCT02416622|12029996|FG002|COMPLETED|Overall Study||0
10865081|NCT02416622|12029994|FG000|NOT COMPLETED|Overall Study||6
10865082|NCT02416622|12029995|FG001|NOT COMPLETED|Overall Study||8
10865083|NCT02416622|12029996|FG002|NOT COMPLETED|Overall Study||13
11109271|NCT01273181|12293763|FG000|NOT COMPLETED|Phase 2, Dose 1||0
11109272|NCT01273181|12293764|FG001|NOT COMPLETED|Phase 2, Dose 1||0
11109273|NCT01273181|12293765|FG002|NOT COMPLETED|Phase 2, Dose 1||1
11109274|NCT01273181|12293766|FG003|NOT COMPLETED|Phase 2, Dose 1||0
11109275|NCT01273181|12293763|FG000|STARTED|Phase 2, Dose 2||0
11109276|NCT01273181|12293764|FG001|STARTED|Phase 2, Dose 2||0
11109277|NCT01273181|12293765|FG002|STARTED|Phase 2, Dose 2||0
11109278|NCT01273181|12293766|FG003|STARTED|Phase 2, Dose 2||1
11109279|NCT01273181|12293763|FG000|COMPLETED|Phase 2, Dose 2||0
11109280|NCT01273181|12293764|FG001|COMPLETED|Phase 2, Dose 2||0
11109281|NCT01273181|12293765|FG002|COMPLETED|Phase 2, Dose 2||0
11109282|NCT01273181|12293766|FG003|COMPLETED|Phase 2, Dose 2||0
10865096|NCT02226276|12030013|FG000|STARTED|Overall Study||10
10865097|NCT02226276|12030013|FG000|COMPLETED|Overall Study||10
10865098|NCT02226276|12030013|FG000|NOT COMPLETED|Overall Study||0
10865099|NCT02213068|12030020|FG000|STARTED|Overall Study||9
10865100|NCT02213068|12030021|FG001|STARTED|Overall Study||8
10865101|NCT02213068|12030022|FG002|STARTED|Overall Study||10
10865102|NCT02213068|12030020|FG000|COMPLETED|Overall Study||9
10865103|NCT02213068|12030021|FG001|COMPLETED|Overall Study||8
10865104|NCT02213068|12030022|FG002|COMPLETED|Overall Study||10
10865105|NCT02213068|12030020|FG000|NOT COMPLETED|Overall Study||0
10865106|NCT02213068|12030021|FG001|NOT COMPLETED|Overall Study||0
10865107|NCT02213068|12030022|FG002|NOT COMPLETED|Overall Study||0
11109283|NCT01273181|12293763|FG000|NOT COMPLETED|Phase 2, Dose 2||0
11109284|NCT01273181|12293764|FG001|NOT COMPLETED|Phase 2, Dose 2||0
11109285|NCT01273181|12293765|FG002|NOT COMPLETED|Phase 2, Dose 2||0
10865111|NCT01964430|12030036|FG000|STARTED|Overall Study||432
10865112|NCT01964430|12030037|FG001|STARTED|Overall Study||434
10865113|NCT01964430|12030036|FG000|Treated Population|Overall Study||429
10865114|NCT01964430|12030037|FG001|Treated Population|Overall Study||423
10865115|NCT01964430|12030036|FG000|COMPLETED|Overall Study||287
10865116|NCT01964430|12030037|FG001|COMPLETED|Overall Study||310
10865117|NCT01964430|12030036|FG000|NOT COMPLETED|Overall Study||145
10865118|NCT01964430|12030037|FG001|NOT COMPLETED|Overall Study||124
10865119|NCT01880957|12030045|FG000|STARTED|Overall Study||47
10865120|NCT01880957|12030046|FG001|STARTED|Overall Study||29
10865121|NCT01880957|12030045|FG000|COMPLETED|Overall Study||19
10865122|NCT01880957|12030046|FG001|COMPLETED|Overall Study||29
10865123|NCT01880957|12030045|FG000|NOT COMPLETED|Overall Study||28
10865124|NCT01880957|12030046|FG001|NOT COMPLETED|Overall Study||0
10865125|NCT01651403|12030063|FG000|STARTED|Double-Blind Period (Through Week 48/72)||60
10865126|NCT01651403|12030064|FG001|STARTED|Double-Blind Period (Through Week 48/72)||30
10865127|NCT01651403|12030063|FG000|COMPLETED|Double-Blind Period (Through Week 48/72)||56
10865128|NCT01651403|12030064|FG001|COMPLETED|Double-Blind Period (Through Week 48/72)||25
10865129|NCT01651403|12030063|FG000|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
11109286|NCT01273181|12293766|FG003|NOT COMPLETED|Phase 2, Dose 2||1
10865130|NCT01651403|12030064|FG001|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||5
10865131|NCT01651403|12030063|FG000|STARTED|Open-Label Phase (Weeks 49/73-192)||56
10865132|NCT01651403|12030064|FG001|STARTED|Open-Label Phase (Weeks 49/73-192)||25
10865133|NCT01651403|12030063|FG000|COMPLETED|Open-Label Phase (Weeks 49/73-192)||35
10865134|NCT01651403|12030064|FG001|COMPLETED|Open-Label Phase (Weeks 49/73-192)||11
10865135|NCT01651403|12030063|FG000|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||21
10865136|NCT01651403|12030064|FG001|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||14
11109287|NCT01273207|12293780|FG000|STARTED|Overall Study||7
11109288|NCT01273207|12293780|FG000|COMPLETED|Overall Study||2
11109289|NCT01273207|12293780|FG000|NOT COMPLETED|Overall Study||5
11109290|NCT01273519|12293787|FG000|STARTED|Overall Study||78
11109291|NCT01273519|12293788|FG001|STARTED|Overall Study||30
11109292|NCT01273519|12293789|FG002|STARTED|Overall Study||47
11109293|NCT01273519|12293787|FG000|COMPLETED|Overall Study||59
11109294|NCT01273519|12293788|FG001|COMPLETED|Overall Study||25
11109295|NCT01273519|12293789|FG002|COMPLETED|Overall Study||39
10865146|NCT01468896|12030093|FG000|STARTED|Overall Study||6
10865147|NCT01468896|12030094|FG001|STARTED|Overall Study||17
10865148|NCT01468896|12030093|FG000|COMPLETED|Overall Study||6
10865149|NCT01468896|12030094|FG001|COMPLETED|Overall Study||17
10865150|NCT01468896|12030093|FG000|NOT COMPLETED|Overall Study||0
10865151|NCT01468896|12030094|FG001|NOT COMPLETED|Overall Study||0
11109296|NCT01273519|12293787|FG000|NOT COMPLETED|Overall Study||19
11109297|NCT01273519|12293788|FG001|NOT COMPLETED|Overall Study||5
11109298|NCT01273519|12293789|FG002|NOT COMPLETED|Overall Study||8
11109299|NCT01273597|12293800|FG000|STARTED|Overall Study||60
11109300|NCT01273597|12293800|FG000|COMPLETED|Overall Study||52
11109301|NCT01273597|12293800|FG000|NOT COMPLETED|Overall Study||8
10865188|NCT01241786|12030149|FG000|STARTED|Overall Study||5
10865189|NCT01241786|12030149|FG000|COMPLETED|Overall Study||0
10865190|NCT01241786|12030149|FG000|NOT COMPLETED|Overall Study||5
11109302|NCT01273623|12293804|FG000|STARTED|Overall Study|met angiographic criteria|55
11109303|NCT01273623|12293804|FG000|COMPLETED|Overall Study|met IVUS criteria|26
11109304|NCT01273623|12293804|FG000|NOT COMPLETED|Overall Study||29
11109305|NCT01273766|12293813|FG000|STARTED|Overall Study||4
11109306|NCT01273766|12293814|FG001|STARTED|Overall Study||7
11109307|NCT01273766|12293815|FG002|STARTED|Overall Study||5
11109308|NCT01273766|12293813|FG000|COMPLETED|Overall Study||4
11109309|NCT01273766|12293814|FG001|COMPLETED|Overall Study||7
11109310|NCT01273766|12293815|FG002|COMPLETED|Overall Study||5
11109311|NCT01273766|12293813|FG000|NOT COMPLETED|Overall Study||0
11109312|NCT01273766|12293814|FG001|NOT COMPLETED|Overall Study||0
11109313|NCT01273766|12293815|FG002|NOT COMPLETED|Overall Study||0
11109314|NCT01273805|12293824|FG000|STARTED|Overall Study||10
11109315|NCT01273805|12293825|FG001|STARTED|Overall Study||10
11109316|NCT01273805|12293824|FG000|COMPLETED|Overall Study||0
11109317|NCT01273805|12293825|FG001|COMPLETED|Overall Study||0
11109318|NCT01273805|12293824|FG000|NOT COMPLETED|Overall Study||10
11109319|NCT01273805|12293825|FG001|NOT COMPLETED|Overall Study||10
11109320|NCT01273818|12293834|FG000|STARTED|Overall Study||100
11109321|NCT01273818|12293835|FG001|STARTED|Overall Study||100
11109322|NCT01273818|12293836|FG002|STARTED|Overall Study||100
11109323|NCT01273818|12293834|FG000|COMPLETED|Overall Study||87
11109324|NCT01273818|12293835|FG001|COMPLETED|Overall Study||98
11109325|NCT01273818|12293836|FG002|COMPLETED|Overall Study||91
11109326|NCT01273818|12293834|FG000|NOT COMPLETED|Overall Study||13
11109327|NCT01273818|12293835|FG001|NOT COMPLETED|Overall Study||2
11109328|NCT01273818|12293836|FG002|NOT COMPLETED|Overall Study||9
11109329|NCT01273857|12293846|FG000|STARTED|Overall Study||7
11109330|NCT01273857|12293847|FG001|STARTED|Overall Study||7
11109331|NCT01273857|12293846|FG000|COMPLETED|Overall Study||7
11109332|NCT01273857|12293847|FG001|COMPLETED|Overall Study||7
11109333|NCT01273857|12293846|FG000|NOT COMPLETED|Overall Study||0
11109334|NCT01273857|12293847|FG001|NOT COMPLETED|Overall Study||0
11109335|NCT01273883|12293853|FG000|STARTED|First Intervention|Received at least 1 dose of study drug.|19
11228224|NCT02008877|12420437|FG001|STARTED|Overall Study||7
11228225|NCT02008877|12420438|FG002|STARTED|Overall Study||10
11109336|NCT01273883|12293854|FG001|STARTED|First Intervention|Received at least 1 dose of study drug.|19
11109337|NCT01273883|12293853|FG000|COMPLETED|First Intervention||17
11109338|NCT01273883|12293854|FG001|COMPLETED|First Intervention||18
11109339|NCT01273883|12293853|FG000|NOT COMPLETED|First Intervention||2
11109340|NCT01273883|12293854|FG001|NOT COMPLETED|First Intervention||1
11109341|NCT01273883|12293853|FG000|STARTED|Washout Period of 2 Weeks||17
11109342|NCT01273883|12293854|FG001|STARTED|Washout Period of 2 Weeks||18
11109343|NCT01273883|12293853|FG000|COMPLETED|Washout Period of 2 Weeks||17
11109344|NCT01273883|12293854|FG001|COMPLETED|Washout Period of 2 Weeks||18
11109345|NCT01273883|12293853|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
11109346|NCT01273883|12293854|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
11109347|NCT01273883|12293853|FG000|STARTED|Second Intervention||17
11109348|NCT01273883|12293854|FG001|STARTED|Second Intervention||18
11109349|NCT01273883|12293853|FG000|COMPLETED|Second Intervention||15
11109350|NCT01273883|12293854|FG001|COMPLETED|Second Intervention||17
11109351|NCT01273883|12293853|FG000|NOT COMPLETED|Second Intervention||2
11109352|NCT01273883|12293854|FG001|NOT COMPLETED|Second Intervention||1
11109353|NCT01273896|12293860|FG000|STARTED|Overall Study||22
11109354|NCT01273896|12293860|FG000|COMPLETED|Overall Study||22
11109355|NCT01273896|12293860|FG000|NOT COMPLETED|Overall Study||0
11109356|NCT01274182|12293867|FG000|STARTED|Overall Study||133
11109357|NCT01274182|12293868|FG001|STARTED|Overall Study||87
11109358|NCT01274182|12293869|FG002|STARTED|Overall Study||92
11109359|NCT01274182|12293867|FG000|24 Weeks|Overall Study||123
11109360|NCT01274182|12293868|FG001|24 Weeks|Overall Study||83
11109361|NCT01274182|12293869|FG002|24 Weeks|Overall Study||84
11109362|NCT01274182|12293867|FG000|COMPLETED|Overall Study||112
11109363|NCT01274182|12293868|FG001|COMPLETED|Overall Study||69
11109364|NCT01274182|12293869|FG002|COMPLETED|Overall Study||80
10865254|NCT00606294|12030222|FG000|STARTED|Overall Study||197
10865255|NCT00606294|12030223|FG001|STARTED|Overall Study||19
10865256|NCT00606294|12030222|FG000|COMPLETED|Overall Study||161
10865257|NCT00606294|12030223|FG001|COMPLETED|Overall Study||19
10865258|NCT00606294|12030222|FG000|NOT COMPLETED|Overall Study||36
10865259|NCT00606294|12030223|FG001|NOT COMPLETED|Overall Study||0
11109365|NCT01274182|12293867|FG000|NOT COMPLETED|Overall Study||21
11109366|NCT01274182|12293868|FG001|NOT COMPLETED|Overall Study||18
11109367|NCT01274182|12293869|FG002|NOT COMPLETED|Overall Study||12
11109368|NCT01274338|12293887|FG000|STARTED|Overall Study||511
11109369|NCT01274338|12293888|FG001|STARTED|Overall Study||636
11109370|NCT01274338|12293889|FG002|STARTED|Overall Study||523
11109371|NCT01274338|12293890|FG003|STARTED|Overall Study||1
11109372|NCT01274338|12293891|FG004|STARTED|Overall Study||1
11109373|NCT01274338|12293892|FG005|STARTED|Overall Study||1
11109374|NCT01274338|12293887|FG000|Received Treatment|Overall Study||503
11109375|NCT01274338|12293888|FG001|Received Treatment|Overall Study||520
11109376|NCT01274338|12293889|FG002|Received Treatment|Overall Study||516
11109377|NCT01274338|12293890|FG003|Received Treatment|Overall Study||1
11109378|NCT01274338|12293891|FG004|Received Treatment|Overall Study||1
11109379|NCT01274338|12293892|FG005|Received Treatment|Overall Study||1
11109380|NCT01274338|12293887|FG000|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||110
11109381|NCT01274338|12293888|FG001|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||114
11109382|NCT01274338|12293889|FG002|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||97
11228226|NCT02008877|12420436|FG000|COMPLETED|Overall Study||3
11228227|NCT02008877|12420437|FG001|COMPLETED|Overall Study||6
11228228|NCT02008877|12420438|FG002|COMPLETED|Overall Study||10
11228229|NCT02008877|12420436|FG000|NOT COMPLETED|Overall Study||0
11228230|NCT02008877|12420437|FG001|NOT COMPLETED|Overall Study||1
11228231|NCT02008877|12420438|FG002|NOT COMPLETED|Overall Study||0
11228232|NCT02008890|12420450|FG000|STARTED|Period 1||80
11228233|NCT02008890|12420451|FG001|STARTED|Period 1||79
11228234|NCT02008890|12420452|FG002|STARTED|Period 1||78
11228235|NCT02008890|12420453|FG003|STARTED|Period 1||0
11228236|NCT02008890|12420454|FG004|STARTED|Period 1||0
11228237|NCT02008890|12420450|FG000|COMPLETED|Period 1||65
11228238|NCT02008890|12420451|FG001|COMPLETED|Period 1||64
11228239|NCT02008890|12420452|FG002|COMPLETED|Period 1||66
11228240|NCT02008890|12420453|FG003|COMPLETED|Period 1||0
11228241|NCT02008890|12420454|FG004|COMPLETED|Period 1||0
11228242|NCT02008890|12420450|FG000|NOT COMPLETED|Period 1||15
11228243|NCT02008890|12420451|FG001|NOT COMPLETED|Period 1||15
11228244|NCT02008890|12420452|FG002|NOT COMPLETED|Period 1||12
11228245|NCT02008890|12420453|FG003|NOT COMPLETED|Period 1||0
11228246|NCT02008890|12420454|FG004|NOT COMPLETED|Period 1||0
11228247|NCT02008890|12420450|FG000|STARTED|Period 2||65
11228248|NCT02008890|12420451|FG001|STARTED|Period 2||64
11228249|NCT02008890|12420452|FG002|STARTED|Period 2||10
11228250|NCT02008890|12420453|FG003|STARTED|Period 2||27
11228251|NCT02008890|12420454|FG004|STARTED|Period 2||28
11228252|NCT02008890|12420450|FG000|COMPLETED|Period 2||38
11228253|NCT02008890|12420451|FG001|COMPLETED|Period 2||49
11228254|NCT02008890|12420452|FG002|COMPLETED|Period 2||9
11228255|NCT02008890|12420453|FG003|COMPLETED|Period 2||13
11228256|NCT02008890|12420454|FG004|COMPLETED|Period 2||20
11228257|NCT02008890|12420450|FG000|NOT COMPLETED|Period 2||27
10865278|NCT00464178|12030247|FG000|STARTED|Overall Study||6
11109383|NCT01274338|12293890|FG003|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
11109384|NCT01274338|12293891|FG004|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
11109385|NCT01274338|12293892|FG005|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
11109386|NCT01274338|12293887|FG000|Data Available for FACIT-D Analysis|Overall Study||109
11109387|NCT01274338|12293888|FG001|Data Available for FACIT-D Analysis|Overall Study||114
11109388|NCT01274338|12293889|FG002|Data Available for FACIT-D Analysis|Overall Study||97
11109389|NCT01274338|12293890|FG003|Data Available for FACIT-D Analysis|Overall Study||0
11228258|NCT02008890|12420451|FG001|NOT COMPLETED|Period 2||15
11228259|NCT02008890|12420452|FG002|NOT COMPLETED|Period 2||1
11228260|NCT02008890|12420453|FG003|NOT COMPLETED|Period 2||14
11228261|NCT02008890|12420454|FG004|NOT COMPLETED|Period 2||8
11228262|NCT02008890|12420450|FG000|STARTED|Extension Period||31
11228263|NCT02008890|12420451|FG001|STARTED|Extension Period||36
11228264|NCT02008890|12420452|FG002|STARTED|Extension Period||0
11228265|NCT02008890|12420453|FG003|STARTED|Extension Period||10
11228266|NCT02008890|12420454|FG004|STARTED|Extension Period||17
10865279|NCT00464178|12030247|FG000|COMPLETED|Overall Study||4
10865280|NCT00464178|12030247|FG000|NOT COMPLETED|Overall Study||2
10865281|NCT00265798|12030252|FG000|STARTED|Overall Study||38
10865282|NCT00265798|12030252|FG000|COMPLETED|Overall Study||38
10865283|NCT00265798|12030252|FG000|NOT COMPLETED|Overall Study||0
11109390|NCT01274338|12293891|FG004|Data Available for FACIT-D Analysis|Overall Study||0
11109391|NCT01274338|12293892|FG005|Data Available for FACIT-D Analysis|Overall Study||0
11109392|NCT01274338|12293887|FG000|COMPLETED|Overall Study||108
11109393|NCT01274338|12293888|FG001|COMPLETED|Overall Study||182
11109394|NCT01274338|12293889|FG002|COMPLETED|Overall Study||198
11109395|NCT01274338|12293890|FG003|COMPLETED|Overall Study||0
11109396|NCT01274338|12293891|FG004|COMPLETED|Overall Study||0
11109397|NCT01274338|12293892|FG005|COMPLETED|Overall Study||1
11109398|NCT01274338|12293887|FG000|NOT COMPLETED|Overall Study||403
11109399|NCT01274338|12293888|FG001|NOT COMPLETED|Overall Study||454
11109400|NCT01274338|12293889|FG002|NOT COMPLETED|Overall Study||325
11109401|NCT01274338|12293890|FG003|NOT COMPLETED|Overall Study||1
11109402|NCT01274338|12293891|FG004|NOT COMPLETED|Overall Study||1
11109403|NCT01274338|12293892|FG005|NOT COMPLETED|Overall Study||0
11109404|NCT01274351|12293905|FG000|STARTED|Overall Study||112
11109405|NCT01274351|12293905|FG000|COMPLETED|Overall Study||92
11109406|NCT01274351|12293905|FG000|NOT COMPLETED|Overall Study||20
11109407|NCT01274520|12293911|FG000|STARTED|Overall Study||25
11109408|NCT01274520|12293912|FG001|STARTED|Overall Study||24
11109409|NCT01274520|12293911|FG000|COMPLETED|Overall Study||25
11109410|NCT01274520|12293912|FG001|COMPLETED|Overall Study||24
11109411|NCT01274520|12293911|FG000|NOT COMPLETED|Overall Study||0
11109412|NCT01274520|12293912|FG001|NOT COMPLETED|Overall Study||0
11109413|NCT01274585|12293923|FG000|STARTED|Overall Study||2
11109414|NCT01274585|12293924|FG001|STARTED|Overall Study||3
11109415|NCT01274585|12293923|FG000|COMPLETED|Overall Study||2
11109416|NCT01274585|12293924|FG001|COMPLETED|Overall Study||3
11109417|NCT01274585|12293923|FG000|NOT COMPLETED|Overall Study||0
11109418|NCT01274585|12293924|FG001|NOT COMPLETED|Overall Study||0
11109419|NCT01274637|12293932|FG000|STARTED|Overall Study||30
11109420|NCT01274637|12293933|FG001|STARTED|Overall Study||32
11109421|NCT01274637|12293932|FG000|COMPLETED|Overall Study||30
11109422|NCT01274637|12293933|FG001|COMPLETED|Overall Study||30
11109423|NCT01274637|12293932|FG000|NOT COMPLETED|Overall Study||0
11109424|NCT01274637|12293933|FG001|NOT COMPLETED|Overall Study||2
11109425|NCT01274715|12293939|FG000|STARTED|Overall Study||12
11109426|NCT01274715|12293939|FG000|Screened Out at Baseline|Overall Study||3
11109427|NCT01274715|12293939|FG000|COMPLETED|Overall Study||8
11109428|NCT01274715|12293939|FG000|NOT COMPLETED|Overall Study||4
11109429|NCT01274897|12293945|FG000|STARTED|Overall Study||297
11109430|NCT01274897|12293946|FG001|STARTED|Overall Study||153
11109431|NCT01274897|12293945|FG000|COMPLETED|Overall Study||297
11109432|NCT01274897|12293946|FG001|COMPLETED|Overall Study||153
11109433|NCT01274897|12293945|FG000|NOT COMPLETED|Overall Study||0
11109434|NCT01274897|12293946|FG001|NOT COMPLETED|Overall Study||0
11109435|NCT01275053|12293952|FG000|STARTED|Overall Study||12
11109436|NCT01275053|12293952|FG000|COMPLETED|Overall Study||12
11109437|NCT01275053|12293952|FG000|NOT COMPLETED|Overall Study||0
11228267|NCT02008890|12420450|FG000|COMPLETED|Extension Period||26
11228268|NCT02008890|12420451|FG001|COMPLETED|Extension Period||31
11228269|NCT02008890|12420452|FG002|COMPLETED|Extension Period||0
11228270|NCT02008890|12420453|FG003|COMPLETED|Extension Period||6
11228271|NCT02008890|12420454|FG004|COMPLETED|Extension Period||13
11228272|NCT02008890|12420450|FG000|NOT COMPLETED|Extension Period||5
11228273|NCT02008890|12420451|FG001|NOT COMPLETED|Extension Period||5
11228274|NCT02008890|12420452|FG002|NOT COMPLETED|Extension Period||0
11228275|NCT02008890|12420453|FG003|NOT COMPLETED|Extension Period||4
11228276|NCT02008890|12420454|FG004|NOT COMPLETED|Extension Period||4
11228277|NCT02008916|12420472|FG000|STARTED|Primary Assessment (up to Week 16)||74
11228278|NCT02008916|12420473|FG001|STARTED|Primary Assessment (up to Week 16)||76
11228279|NCT02008916|12420474|FG002|STARTED|Primary Assessment (up to Week 16)||76
11228280|NCT02008916|12420472|FG000|FAS|Primary Assessment (up to Week 16)||74
11228281|NCT02008916|12420473|FG001|FAS|Primary Assessment (up to Week 16)||76
11228282|NCT02008916|12420474|FG002|FAS|Primary Assessment (up to Week 16)||76
11228283|NCT02008916|12420472|FG000|Safety Set|Primary Assessment (up to Week 16)||74
11228284|NCT02008916|12420473|FG001|Safety Set|Primary Assessment (up to Week 16)||76
11228285|NCT02008916|12420474|FG002|Safety Set|Primary Assessment (up to Week 16)||75
11228286|NCT02008916|12420472|FG000|COMPLETED|Primary Assessment (up to Week 16)||74
11228287|NCT02008916|12420473|FG001|COMPLETED|Primary Assessment (up to Week 16)||75
11228288|NCT02008916|12420474|FG002|COMPLETED|Primary Assessment (up to Week 16)||73
11228289|NCT02008916|12420472|FG000|NOT COMPLETED|Primary Assessment (up to Week 16)||0
11228290|NCT02008916|12420473|FG001|NOT COMPLETED|Primary Assessment (up to Week 16)||1
11109438|NCT01275066|12293959|FG000|STARTED|Overall Study||60
11109439|NCT01275066|12293960|FG001|STARTED|Overall Study||59
11109440|NCT01275066|12293961|FG002|STARTED|Overall Study||58
11109441|NCT01275066|12293959|FG000|Treated|Overall Study||59
11109442|NCT01275066|12293960|FG001|Treated|Overall Study||59
11109443|NCT01275066|12293961|FG002|Treated|Overall Study||58
11109444|NCT01275066|12293959|FG000|COMPLETED|Overall Study||59
11109445|NCT01275066|12293960|FG001|COMPLETED|Overall Study||59
11109446|NCT01275066|12293961|FG002|COMPLETED|Overall Study||57
11109447|NCT01275066|12293959|FG000|NOT COMPLETED|Overall Study||1
11109448|NCT01275066|12293960|FG001|NOT COMPLETED|Overall Study||0
11109449|NCT01275066|12293961|FG002|NOT COMPLETED|Overall Study||1
11109450|NCT01275092|12293969|FG000|STARTED|Overall Study||164
11109451|NCT01275092|12293969|FG000|COMPLETED|Overall Study||164
10865292|NCT04516746|12030267|FG000|STARTED|Overall Study||21635
10865293|NCT04516746|12030268|FG001|STARTED|Overall Study||10816
10865294|NCT04516746|12030267|FG000|Participants Who Received First Dose|Overall Study||21583
10865295|NCT04516746|12030268|FG001|Participants Who Received First Dose|Overall Study||10796
10865296|NCT04516746|12030267|FG000|Participants Who Received Second Dose|Overall Study||20769
10865297|NCT04516746|12030268|FG001|Participants Who Received Second Dose|Overall Study||9951
10865298|NCT04516746|12030267|FG000|COMPLETED|Overall Study||0
10865299|NCT04516746|12030268|FG001|COMPLETED|Overall Study||0
10865300|NCT04516746|12030267|FG000|NOT COMPLETED|Overall Study||21635
10865301|NCT04516746|12030268|FG001|NOT COMPLETED|Overall Study||10816
10865302|NCT04447417|12030276|FG000|STARTED|Overall Study||26
10865303|NCT04447417|12030277|FG001|STARTED|Overall Study||26
10865304|NCT04447417|12030276|FG000|COMPLETED|Overall Study||23
10865305|NCT04447417|12030277|FG001|COMPLETED|Overall Study||26
10865306|NCT04447417|12030276|FG000|NOT COMPLETED|Overall Study||3
10865307|NCT04447417|12030277|FG001|NOT COMPLETED|Overall Study||0
10865308|NCT04427917|12030285|FG000|STARTED|Overall Study||2
10865309|NCT04427917|12030286|FG001|STARTED|Overall Study||6
10865310|NCT04427917|12030285|FG000|COMPLETED|Overall Study||2
10865311|NCT04427917|12030286|FG001|COMPLETED|Overall Study||6
10865312|NCT04427917|12030285|FG000|NOT COMPLETED|Overall Study||0
10865313|NCT04427917|12030286|FG001|NOT COMPLETED|Overall Study||0
10865314|NCT04418765|12030296|FG000|STARTED|Overall Study||299
10865315|NCT04418765|12030297|FG001|STARTED|Overall Study||299
10865316|NCT04418765|12030298|FG002|STARTED|Overall Study||294
10865317|NCT04418765|12030296|FG000|Received at Least 1 Dose of Study Drug|Overall Study||298
10865318|NCT04418765|12030297|FG001|Received at Least 1 Dose of Study Drug|Overall Study||299
10865319|NCT04418765|12030298|FG002|Received at Least 1 Dose of Study Drug|Overall Study||294
10865320|NCT04418765|12030296|FG000|COMPLETED|Overall Study||293
10865321|NCT04418765|12030297|FG001|COMPLETED|Overall Study||288
10865322|NCT04418765|12030298|FG002|COMPLETED|Overall Study||284
10865323|NCT04418765|12030296|FG000|NOT COMPLETED|Overall Study||6
10865324|NCT04418765|12030297|FG001|NOT COMPLETED|Overall Study||11
10865325|NCT04418765|12030298|FG002|NOT COMPLETED|Overall Study||10
10865326|NCT04415073|12030308|FG000|STARTED|Overall Study||0
10865327|NCT04415073|12030309|FG001|STARTED|Overall Study||0
10865328|NCT04415073|12030308|FG000|COMPLETED|Overall Study||0
10865329|NCT04415073|12030309|FG001|COMPLETED|Overall Study||0
10865330|NCT04415073|12030308|FG000|NOT COMPLETED|Overall Study||0
10865331|NCT04415073|12030309|FG001|NOT COMPLETED|Overall Study||0
10865332|NCT04343976|12030317|FG000|STARTED|Overall Study||7
10865333|NCT04343976|12030318|FG001|STARTED|Overall Study||7
10865334|NCT04343976|12030317|FG000|COMPLETED|Overall Study||7
10865335|NCT04343976|12030318|FG001|COMPLETED|Overall Study||6
10865336|NCT04343976|12030317|FG000|NOT COMPLETED|Overall Study||0
10865337|NCT04343976|12030318|FG001|NOT COMPLETED|Overall Study||1
11109452|NCT01275092|12293969|FG000|NOT COMPLETED|Overall Study||0
11109453|NCT01275131|12293977|FG000|STARTED|Period 1||11
11109454|NCT01275131|12293978|FG001|STARTED|Period 1||9
11109455|NCT01275131|12293979|FG002|STARTED|Period 1||13
11109456|NCT01275131|12293980|FG003|STARTED|Period 1||12
11109457|NCT01275131|12293977|FG000|Received at Least One Dose of Study Drug|Period 1||11
11109458|NCT01275131|12293978|FG001|Received at Least One Dose of Study Drug|Period 1||9
11109459|NCT01275131|12293979|FG002|Received at Least One Dose of Study Drug|Period 1||13
11109460|NCT01275131|12293980|FG003|Received at Least One Dose of Study Drug|Period 1||12
11109461|NCT01275131|12293977|FG000|COMPLETED|Period 1||9
10865348|NCT04000581|12030335|FG000|STARTED|Overall Study||5
10865349|NCT04000581|12030336|FG001|STARTED|Overall Study||12
10865350|NCT04000581|12030335|FG000|COMPLETED|Overall Study||5
10865351|NCT04000581|12030336|FG001|COMPLETED|Overall Study||11
10865352|NCT04000581|12030335|FG000|NOT COMPLETED|Overall Study||0
10865353|NCT04000581|12030336|FG001|NOT COMPLETED|Overall Study||1
10865354|NCT03935880|12030344|FG000|STARTED|Overall Study||9
10865355|NCT03935880|12030345|FG001|STARTED|Overall Study||11
10865356|NCT03935880|12030344|FG000|Completed Surgery|Overall Study||9
10865357|NCT03935880|12030345|FG001|Completed Surgery|Overall Study||10
10865358|NCT03935880|12030344|FG000|COMPLETED|Overall Study||9
10865359|NCT03935880|12030345|FG001|COMPLETED|Overall Study||10
10865360|NCT03935880|12030344|FG000|NOT COMPLETED|Overall Study||0
10865361|NCT03935880|12030345|FG001|NOT COMPLETED|Overall Study||1
10865362|NCT03834350|12030351|FG000|STARTED|Overall Study||71
10865363|NCT03834350|12030351|FG000|COMPLETED|Overall Study||70
10865364|NCT03834350|12030351|FG000|NOT COMPLETED|Overall Study||1
10865365|NCT03782103|12030356|FG000|STARTED|Overall Study||156
10865366|NCT03782103|12030356|FG000|ZP|Overall Study||156
10865367|NCT03782103|12030356|FG000|CP|Overall Study||156
10865368|NCT03782103|12030356|FG000|Vehicle|Overall Study||156
10865369|NCT03782103|12030356|FG000|COMPLETED|Overall Study||156
10865370|NCT03782103|12030356|FG000|NOT COMPLETED|Overall Study||0
10865371|NCT03761056|12030368|FG000|STARTED|Overall Study||42
10865372|NCT03761056|12030368|FG000|COMPLETED|Overall Study||0
10865373|NCT03761056|12030368|FG000|NOT COMPLETED|Overall Study||42
11109462|NCT01275131|12293978|FG001|COMPLETED|Period 1||9
11109463|NCT01275131|12293979|FG002|COMPLETED|Period 1||10
11109464|NCT01275131|12293980|FG003|COMPLETED|Period 1||10
10865377|NCT03710564|12030380|FG000|STARTED|Overall Study||356
10865378|NCT03710564|12030381|FG001|STARTED|Overall Study||179
10865379|NCT03710564|12030380|FG000|COMPLETED|Overall Study||172
10865380|NCT03710564|12030381|FG001|COMPLETED|Overall Study||86
10865381|NCT03710564|12030380|FG000|NOT COMPLETED|Overall Study||184
10865382|NCT03710564|12030381|FG001|NOT COMPLETED|Overall Study||93
10865383|NCT03693404|12030390|FG000|STARTED|Overall Study||109
10865384|NCT03693404|12030391|FG001|STARTED|Overall Study||81
10865385|NCT03693404|12030390|FG000|COMPLETED|Overall Study||108
10865386|NCT03693404|12030391|FG001|COMPLETED|Overall Study||75
10865387|NCT03693404|12030390|FG000|NOT COMPLETED|Overall Study||1
10865388|NCT03693404|12030391|FG001|NOT COMPLETED|Overall Study||6
10865389|NCT03660943|12030399|FG000|STARTED|Overall Study||145
10865390|NCT03660943|12030400|FG001|STARTED|Overall Study||187
10865391|NCT03660943|12030399|FG000|Treated|Overall Study||140
10865392|NCT03660943|12030400|FG001|Treated|Overall Study||184
10865393|NCT03660943|12030399|FG000|COMPLETED|Overall Study||109
10865394|NCT03660943|12030400|FG001|COMPLETED|Overall Study||134
10865395|NCT03660943|12030399|FG000|NOT COMPLETED|Overall Study||36
10865396|NCT03660943|12030400|FG001|NOT COMPLETED|Overall Study||53
10865397|NCT03658889|12030408|FG000|STARTED|Overall Study|Enrolled population|308
10865398|NCT03658889|12030409|FG001|STARTED|Overall Study||69
10865399|NCT03658889|12030408|FG000|COMPLETED|Overall Study|Analysis population|306
10865400|NCT03658889|12030409|FG001|COMPLETED|Overall Study||69
10865401|NCT03658889|12030408|FG000|NOT COMPLETED|Overall Study||2
10865402|NCT03658889|12030409|FG001|NOT COMPLETED|Overall Study||0
10865403|NCT03654885|12030416|FG000|STARTED|Overall Study|One eye, the worse eye, from each participant was selected as the study eye.|107
10865404|NCT03654885|12030417|FG001|STARTED|Overall Study|One eye, the worse eye, from each participant was selected as the study eye.|51
10865405|NCT03654885|12030416|FG000|Intent-to-Treat (ITT) Population|Overall Study||95
10865406|NCT03654885|12030417|FG001|Intent-to-Treat (ITT) Population|Overall Study||44
10865407|NCT03654885|12030416|FG000|Safety Population|Overall Study||95
10865408|NCT03654885|12030417|FG001|Safety Population|Overall Study||44
10865409|NCT03654885|12030416|FG000|COMPLETED|Overall Study||77
10865410|NCT03654885|12030417|FG001|COMPLETED|Overall Study||38
10865411|NCT03654885|12030416|FG000|NOT COMPLETED|Overall Study||30
10865412|NCT03654885|12030417|FG001|NOT COMPLETED|Overall Study||13
10865413|NCT03568461|12030423|FG000|STARTED|Overall Study||98
10865414|NCT03568461|12030423|FG000|Treated|Overall Study||97
10865415|NCT03568461|12030423|FG000|Discontinued Prior to Transfusion With Tisagenlecleucel|Overall Study||1
10865416|NCT03568461|12030423|FG000|COMPLETED|Overall Study||80
10865417|NCT03568461|12030423|FG000|NOT COMPLETED|Overall Study||18
11109465|NCT01275131|12293977|FG000|NOT COMPLETED|Period 1||2
11109466|NCT01275131|12293978|FG001|NOT COMPLETED|Period 1||0
11109467|NCT01275131|12293979|FG002|NOT COMPLETED|Period 1||3
11109468|NCT01275131|12293980|FG003|NOT COMPLETED|Period 1||2
11109469|NCT01275131|12293977|FG000|STARTED|5- to 14-Day Washout Period||9
11355079|NCT03076970|12551947|FG004|STARTED|Period 3||6
11355080|NCT03076970|12551948|FG005|STARTED|Period 3||7
11355081|NCT03076970|12551943|FG000|COMPLETED|Period 3||7
11355082|NCT03076970|12551944|FG001|COMPLETED|Period 3||7
11355083|NCT03076970|12551945|FG002|COMPLETED|Period 3||7
11355084|NCT03076970|12551946|FG003|COMPLETED|Period 3||7
11109470|NCT01275131|12293978|FG001|STARTED|5- to 14-Day Washout Period||9
10865424|NCT03500692|12030436|FG000|STARTED|Overall Study||500
10865425|NCT03500692|12030436|FG000|COMPLETED|Overall Study||391
10865426|NCT03500692|12030436|FG000|NOT COMPLETED|Overall Study||109
11109471|NCT01275131|12293979|FG002|STARTED|5- to 14-Day Washout Period||10
11109472|NCT01275131|12293980|FG003|STARTED|5- to 14-Day Washout Period||10
11109473|NCT01275131|12293977|FG000|COMPLETED|5- to 14-Day Washout Period||9
11109474|NCT01275131|12293978|FG001|COMPLETED|5- to 14-Day Washout Period||9
11109475|NCT01275131|12293979|FG002|COMPLETED|5- to 14-Day Washout Period||10
11109476|NCT01275131|12293980|FG003|COMPLETED|5- to 14-Day Washout Period||10
11109477|NCT01275131|12293977|FG000|NOT COMPLETED|5- to 14-Day Washout Period||0
11109478|NCT01275131|12293978|FG001|NOT COMPLETED|5- to 14-Day Washout Period||0
10865435|NCT03412747|12030452|FG000|STARTED|Initial Treatment Period: Wk0-Wk16||161
10865436|NCT03412747|12030453|FG001|STARTED|Initial Treatment Period: Wk0-Wk16||158
10865437|NCT03412747|12030454|FG002|STARTED|Initial Treatment Period: Wk0-Wk16||159
10865438|NCT03412747|12030452|FG000|COMPLETED|Initial Treatment Period: Wk0-Wk16||154
10865439|NCT03412747|12030453|FG001|COMPLETED|Initial Treatment Period: Wk0-Wk16||153
10865440|NCT03412747|12030454|FG002|COMPLETED|Initial Treatment Period: Wk0-Wk16||150
10865441|NCT03412747|12030452|FG000|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||7
10865442|NCT03412747|12030453|FG001|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||5
10865443|NCT03412747|12030454|FG002|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||9
10865444|NCT03412747|12030452|FG000|STARTED|Maintenance Treatment Period: Wk16-Wk24||154
10865445|NCT03412747|12030453|FG001|STARTED|Maintenance Treatment Period: Wk16-Wk24||153
10865446|NCT03412747|12030454|FG002|STARTED|Maintenance Treatment Period: Wk16-Wk24||150
10865447|NCT03412747|12030452|FG000|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||149
10865448|NCT03412747|12030453|FG001|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||152
10865449|NCT03412747|12030454|FG002|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||149
10865450|NCT03412747|12030452|FG000|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||5
10865451|NCT03412747|12030453|FG001|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||1
11355085|NCT03076970|12551947|FG004|COMPLETED|Period 3||5
11355086|NCT03076970|12551948|FG005|COMPLETED|Period 3||6
10865452|NCT03412747|12030454|FG002|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||1
10865453|NCT03412747|12030452|FG000|STARTED|Maintenance Treatment Period: Wk24-Wk56||149
10865454|NCT03412747|12030453|FG001|STARTED|Maintenance Treatment Period: Wk24-Wk56||152
10865455|NCT03412747|12030454|FG002|STARTED|Maintenance Treatment Period: Wk24-Wk56||149
10865456|NCT03412747|12030452|FG000|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||143
10865457|NCT03412747|12030453|FG001|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||143
10865458|NCT03412747|12030454|FG002|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||133
10865459|NCT03412747|12030452|FG000|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||6
10865460|NCT03412747|12030453|FG001|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||9
10865461|NCT03412747|12030454|FG002|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||16
10865462|NCT03326193|12030472|FG000|STARTED|Overall Study||105
10865463|NCT03326193|12030472|FG000|COMPLETED|Overall Study||52
10865464|NCT03326193|12030472|FG000|NOT COMPLETED|Overall Study||53
10865465|NCT03268382|12030480|FG000|STARTED|Overall Study||28
10865466|NCT03268382|12030481|FG001|STARTED|Overall Study||3
10865467|NCT03268382|12030482|FG002|STARTED|Overall Study||2
10865468|NCT03268382|12030483|FG003|STARTED|Overall Study||3
10865469|NCT03268382|12030480|FG000|COMPLETED|Overall Study||28
10865470|NCT03268382|12030481|FG001|COMPLETED|Overall Study||3
10865471|NCT03268382|12030482|FG002|COMPLETED|Overall Study||2
10865472|NCT03268382|12030483|FG003|COMPLETED|Overall Study||3
10865473|NCT03268382|12030480|FG000|NOT COMPLETED|Overall Study||0
10865474|NCT03268382|12030481|FG001|NOT COMPLETED|Overall Study||0
10865475|NCT03268382|12030482|FG002|NOT COMPLETED|Overall Study||0
10865476|NCT03268382|12030483|FG003|NOT COMPLETED|Overall Study||0
10865477|NCT03230292|12030493|FG000|STARTED|Overall Study||43
10865478|NCT03230292|12030493|FG000|COMPLETED|Overall Study||37
10865479|NCT03230292|12030493|FG000|NOT COMPLETED|Overall Study||6
10865480|NCT03227224|12030503|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||138
10865481|NCT03227224|12030504|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||33
10865482|NCT03227224|12030505|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||63
10865483|NCT03227224|12030506|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||53
10865484|NCT03227224|12030503|FG000|Treated|Double-blind Treatment Period (6 Weeks)||137
10865485|NCT03227224|12030504|FG001|Treated|Double-blind Treatment Period (6 Weeks)||33
10865486|NCT03227224|12030505|FG002|Treated|Double-blind Treatment Period (6 Weeks)||61
10865487|NCT03227224|12030506|FG003|Treated|Double-blind Treatment Period (6 Weeks)||52
10865488|NCT03227224|12030503|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||123
10865489|NCT03227224|12030504|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||27
10865490|NCT03227224|12030505|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||55
10865491|NCT03227224|12030506|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||46
10865492|NCT03227224|12030503|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||15
10865493|NCT03227224|12030504|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||6
10865494|NCT03227224|12030505|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||8
10865495|NCT03227224|12030506|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||7
10865496|NCT03227224|12030503|FG000|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|138
10865497|NCT03227224|12030504|FG001|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|33
10865498|NCT03227224|12030505|FG002|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|63
10865499|NCT03227224|12030506|FG003|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|53
10865500|NCT03227224|12030503|FG000|COMPLETED|Follow-up Phase (2 Weeks)||134
10865501|NCT03227224|12030504|FG001|COMPLETED|Follow-up Phase (2 Weeks)||29
10865502|NCT03227224|12030505|FG002|COMPLETED|Follow-up Phase (2 Weeks)||57
10865503|NCT03227224|12030506|FG003|COMPLETED|Follow-up Phase (2 Weeks)||50
10865504|NCT03227224|12030503|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
10865505|NCT03227224|12030504|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
10865506|NCT03227224|12030505|FG002|NOT COMPLETED|Follow-up Phase (2 Weeks)||6
10865507|NCT03227224|12030506|FG003|NOT COMPLETED|Follow-up Phase (2 Weeks)||3
10865508|NCT03202628|12030523|FG000|STARTED|Overall Study||8
10865509|NCT03202628|12030523|FG000|COMPLETED|Overall Study||8
10865510|NCT03202628|12030523|FG000|NOT COMPLETED|Overall Study||0
10865511|NCT03151746|12030529|FG000|STARTED|Overall Study||9
10865512|NCT03151746|12030530|FG001|STARTED|Overall Study||11
10865513|NCT03151746|12030529|FG000|COMPLETED|Overall Study||9
10865514|NCT03151746|12030530|FG001|COMPLETED|Overall Study||11
10865515|NCT03151746|12030529|FG000|NOT COMPLETED|Overall Study||0
10865516|NCT03151746|12030530|FG001|NOT COMPLETED|Overall Study||0
10865517|NCT03148496|12030540|FG000|STARTED|Overall Study||27
10865518|NCT03148496|12030541|FG001|STARTED|Overall Study||28
10865519|NCT03148496|12030542|FG002|STARTED|Overall Study||25
10865520|NCT03148496|12030543|FG003|STARTED|Overall Study||27
10865521|NCT03148496|12030540|FG000|COMPLETED|Overall Study||20
10865522|NCT03148496|12030541|FG001|COMPLETED|Overall Study||19
10865523|NCT03148496|12030542|FG002|COMPLETED|Overall Study||19
10865524|NCT03148496|12030543|FG003|COMPLETED|Overall Study||26
10865525|NCT03148496|12030540|FG000|NOT COMPLETED|Overall Study||7
10865526|NCT03148496|12030541|FG001|NOT COMPLETED|Overall Study||9
10865527|NCT03148496|12030542|FG002|NOT COMPLETED|Overall Study||6
10865528|NCT03148496|12030543|FG003|NOT COMPLETED|Overall Study||1
10865529|NCT03069352|12030559|FG000|STARTED|Overall Study||68
10865530|NCT03069352|12030560|FG001|STARTED|Overall Study||143
10865531|NCT03069352|12030559|FG000|Received Treatment|Overall Study||68
10865532|NCT03069352|12030560|FG001|Received Treatment|Overall Study||142
10865533|NCT03069352|12030559|FG000|COMPLETED|Overall Study||56
10865534|NCT03069352|12030560|FG001|COMPLETED|Overall Study||103
10865535|NCT03069352|12030559|FG000|NOT COMPLETED|Overall Study||12
10865536|NCT03069352|12030560|FG001|NOT COMPLETED|Overall Study||40
10865537|NCT03056040|12030568|FG000|STARTED|Primary Evaluation Period||97
10865538|NCT03056040|12030569|FG001|STARTED|Primary Evaluation Period||98
10865539|NCT03056040|12030568|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97
10865540|NCT03056040|12030569|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98
10865541|NCT03056040|12030568|FG000|COMPLETED|Primary Evaluation Period||96
10865542|NCT03056040|12030569|FG001|COMPLETED|Primary Evaluation Period||95
10865543|NCT03056040|12030568|FG000|NOT COMPLETED|Primary Evaluation Period||1
10865544|NCT03056040|12030569|FG001|NOT COMPLETED|Primary Evaluation Period||3
10865545|NCT03056040|12030568|FG000|STARTED|Extension Period||96
10865546|NCT03056040|12030569|FG001|STARTED|Extension Period||95
10865547|NCT03056040|12030568|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||96
10865548|NCT03056040|12030569|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||95
10865549|NCT03056040|12030568|FG000|COMPLETED|Extension Period||0
10865550|NCT03056040|12030569|FG001|COMPLETED|Extension Period||0
10865551|NCT03056040|12030568|FG000|NOT COMPLETED|Extension Period||96
10865552|NCT03056040|12030569|FG001|NOT COMPLETED|Extension Period||95
11109479|NCT01275131|12293979|FG002|NOT COMPLETED|5- to 14-Day Washout Period||0
11109480|NCT01275131|12293980|FG003|NOT COMPLETED|5- to 14-Day Washout Period||0
11109481|NCT01275131|12293977|FG000|STARTED|Period 2 (Crossover)||9
11109482|NCT01275131|12293978|FG001|STARTED|Period 2 (Crossover)||9
11109483|NCT01275131|12293979|FG002|STARTED|Period 2 (Crossover)||10
11109484|NCT01275131|12293980|FG003|STARTED|Period 2 (Crossover)||10
10865559|NCT03020589|12030590|FG000|STARTED|Overall Study||40
10865560|NCT03020589|12030591|FG001|STARTED|Overall Study||57
10865561|NCT03020589|12030590|FG000|COMPLETED|Overall Study||40
10865562|NCT03020589|12030591|FG001|COMPLETED|Overall Study||57
10865563|NCT03020589|12030590|FG000|NOT COMPLETED|Overall Study||0
10865564|NCT03020589|12030591|FG001|NOT COMPLETED|Overall Study||0
10865565|NCT03014635|12030599|FG000|STARTED|Overall Study||204
10865566|NCT03014635|12030600|FG001|STARTED|Overall Study||102
10865567|NCT03014635|12030599|FG000|COMPLETED|Overall Study||191
10865568|NCT03014635|12030600|FG001|COMPLETED|Overall Study||93
10865569|NCT03014635|12030599|FG000|NOT COMPLETED|Overall Study||13
10865570|NCT03014635|12030600|FG001|NOT COMPLETED|Overall Study||9
10865571|NCT03014622|12030608|FG000|STARTED|Overall Study||201
10865572|NCT03014622|12030609|FG001|STARTED|Overall Study||102
10865573|NCT03014622|12030608|FG000|COMPLETED|Overall Study||182
10865574|NCT03014622|12030609|FG001|COMPLETED|Overall Study||93
10865575|NCT03014622|12030608|FG000|NOT COMPLETED|Overall Study||19
10865576|NCT03014622|12030609|FG001|NOT COMPLETED|Overall Study||9
10865577|NCT03010527|12030619|FG000|STARTED|Overall Study||15
10865578|NCT03010527|12030620|FG001|STARTED|Overall Study||111
10865579|NCT03010527|12030621|FG002|STARTED|Overall Study||91
10865580|NCT03010527|12030619|FG000|COMPLETED|Overall Study||15
10865581|NCT03010527|12030620|FG001|COMPLETED|Overall Study||92
10865582|NCT03010527|12030621|FG002|COMPLETED|Overall Study||75
10865583|NCT03010527|12030619|FG000|NOT COMPLETED|Overall Study||0
10865584|NCT03010527|12030620|FG001|NOT COMPLETED|Overall Study||19
10865585|NCT03010527|12030621|FG002|NOT COMPLETED|Overall Study||16
10865586|NCT03007979|12030638|FG000|STARTED|Overall Study||55
10865587|NCT03007979|12030638|FG000|COMPLETED|Overall Study||54
10865588|NCT03007979|12030638|FG000|NOT COMPLETED|Overall Study||1
11109485|NCT01275131|12293977|FG000|COMPLETED|Period 2 (Crossover)||8
11109486|NCT01275131|12293978|FG001|COMPLETED|Period 2 (Crossover)||8
11109487|NCT01275131|12293979|FG002|COMPLETED|Period 2 (Crossover)||9
10865592|NCT02958865|12030653|FG000|STARTED|Induction Period (Day 1 to Week 8)||25
10865593|NCT02958865|12030654|FG001|STARTED|Induction Period (Day 1 to Week 8)||51
10865594|NCT02958865|12030655|FG002|STARTED|Induction Period (Day 1 to Week 8)||49
10865595|NCT02958865|12030656|FG003|STARTED|Induction Period (Day 1 to Week 8)||50
10865596|NCT02958865|12030657|FG004|STARTED|Induction Period (Day 1 to Week 8)||48
10865597|NCT02958865|12030658|FG005|STARTED|Induction Period (Day 1 to Week 8)||47
10865598|NCT02958865|12030659|FG006|STARTED|Induction Period (Day 1 to Week 8)||47
10865599|NCT02958865|12030660|FG007|STARTED|Induction Period (Day 1 to Week 8)||0
10865600|NCT02958865|12030661|FG008|STARTED|Induction Period (Day 1 to Week 8)||0
10865601|NCT02958865|12030662|FG009|STARTED|Induction Period (Day 1 to Week 8)||0
10865602|NCT02958865|12030663|FG010|STARTED|Induction Period (Day 1 to Week 8)||0
10865603|NCT02958865|12030664|FG011|STARTED|Induction Period (Day 1 to Week 8)||0
11109488|NCT01275131|12293980|FG003|COMPLETED|Period 2 (Crossover)||8
11109489|NCT01275131|12293977|FG000|NOT COMPLETED|Period 2 (Crossover)||1
11109490|NCT01275131|12293978|FG001|NOT COMPLETED|Period 2 (Crossover)||1
11109491|NCT01275131|12293979|FG002|NOT COMPLETED|Period 2 (Crossover)||1
11109492|NCT01275131|12293980|FG003|NOT COMPLETED|Period 2 (Crossover)||2
11109493|NCT01275144|12293998|FG000|STARTED|First Intervention (6 Days)||14
11109494|NCT01275144|12293999|FG001|STARTED|First Intervention (6 Days)||14
11109495|NCT01275144|12293998|FG000|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
11109496|NCT01275144|12293999|FG001|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
11109497|NCT01275144|12293998|FG000|COMPLETED|First Intervention (6 Days)||14
11109498|NCT01275144|12293999|FG001|COMPLETED|First Intervention (6 Days)||14
11109499|NCT01275144|12293998|FG000|NOT COMPLETED|First Intervention (6 Days)||0
11109500|NCT01275144|12293999|FG001|NOT COMPLETED|First Intervention (6 Days)||0
10865604|NCT02958865|12030665|FG012|STARTED|Induction Period (Day 1 to Week 8)||0
10865605|NCT02958865|12030666|FG013|STARTED|Induction Period (Day 1 to Week 8)||0
10865606|NCT02958865|12030667|FG014|STARTED|Induction Period (Day 1 to Week 8)||0
10865607|NCT02958865|12030668|FG015|STARTED|Induction Period (Day 1 to Week 8)||0
10865608|NCT02958865|12030653|FG000|COMPLETED|Induction Period (Day 1 to Week 8)||21
10865609|NCT02958865|12030654|FG001|COMPLETED|Induction Period (Day 1 to Week 8)||44
10865610|NCT02958865|12030655|FG002|COMPLETED|Induction Period (Day 1 to Week 8)||43
11228291|NCT02008916|12420474|FG002|NOT COMPLETED|Primary Assessment (up to Week 16)||3
11228292|NCT02008916|12420472|FG000|STARTED|Week 16 - 156||74
11228293|NCT02008916|12420473|FG001|STARTED|Week 16 - 156||75
11228294|NCT02008916|12420474|FG002|STARTED|Week 16 - 156||73
11228295|NCT02008916|12420472|FG000|COMPLETED|Week 16 - 156||55
11228296|NCT02008916|12420473|FG001|COMPLETED|Week 16 - 156||62
11228297|NCT02008916|12420474|FG002|COMPLETED|Week 16 - 156||63
11228298|NCT02008916|12420472|FG000|NOT COMPLETED|Week 16 - 156||19
11228299|NCT02008916|12420473|FG001|NOT COMPLETED|Week 16 - 156||13
11228300|NCT02008916|12420474|FG002|NOT COMPLETED|Week 16 - 156||10
11228301|NCT02008942|12420483|FG000|STARTED|First Intervention||27
11228302|NCT02008942|12420484|FG001|STARTED|First Intervention||30
11228303|NCT02008942|12420483|FG000|COMPLETED|First Intervention||27
11228304|NCT02008942|12420484|FG001|COMPLETED|First Intervention||30
11228305|NCT02008942|12420483|FG000|NOT COMPLETED|First Intervention||0
11228306|NCT02008942|12420484|FG001|NOT COMPLETED|First Intervention||0
11228307|NCT02008942|12420483|FG000|STARTED|Second Intervention||26
11228308|NCT02008942|12420484|FG001|STARTED|Second Intervention||30
11228309|NCT02008942|12420483|FG000|COMPLETED|Second Intervention||25
11228310|NCT02008942|12420484|FG001|COMPLETED|Second Intervention||30
11228311|NCT02008942|12420483|FG000|NOT COMPLETED|Second Intervention||1
11228312|NCT02008942|12420484|FG001|NOT COMPLETED|Second Intervention||0
11228313|NCT02009046|12420492|FG000|STARTED|Overall Study||1025
11228314|NCT02009046|12420493|FG001|STARTED|Overall Study||884
11228315|NCT02009046|12420492|FG000|SEI Curriculum Only|Overall Study||461
11228316|NCT02009046|12420493|FG001|SEI Curriculum Only|Overall Study||0
11228317|NCT02009046|12420492|FG000|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
11228318|NCT02009046|12420493|FG001|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
11228319|NCT02009046|12420492|FG000|Ctrl Curriculum Only|Overall Study||0
11228320|NCT02009046|12420493|FG001|Ctrl Curriculum Only|Overall Study||456
11228321|NCT02009046|12420492|FG000|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
11228322|NCT02009046|12420493|FG001|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
11228323|NCT02009046|12420492|FG000|COMPLETED|Overall Study||769
11228324|NCT02009046|12420493|FG001|COMPLETED|Overall Study||678
11228325|NCT02009046|12420492|FG000|NOT COMPLETED|Overall Study||256
11228326|NCT02009046|12420493|FG001|NOT COMPLETED|Overall Study||206
11228327|NCT02009163|12420507|FG000|STARTED|Open-label Period (Non-randomized)||418
11228328|NCT02009163|12420508|FG001|STARTED|Open-label Period (Non-randomized)||0
11228329|NCT02009163|12420509|FG002|STARTED|Open-label Period (Non-randomized)||0
11228330|NCT02009163|12420507|FG000|COMPLETED|Open-label Period (Non-randomized)||275
11228331|NCT02009163|12420508|FG001|COMPLETED|Open-label Period (Non-randomized)||0
11228332|NCT02009163|12420509|FG002|COMPLETED|Open-label Period (Non-randomized)||0
11228333|NCT02009163|12420507|FG000|NOT COMPLETED|Open-label Period (Non-randomized)||143
11228334|NCT02009163|12420508|FG001|NOT COMPLETED|Open-label Period (Non-randomized)||0
11228335|NCT02009163|12420509|FG002|NOT COMPLETED|Open-label Period (Non-randomized)||0
11228336|NCT02009163|12420507|FG000|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
11228337|NCT02009163|12420508|FG001|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
11228338|NCT02009163|12420509|FG002|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
11228339|NCT02009163|12420507|FG000|COMPLETED|Randomized-withdrawal Period||0
11228340|NCT02009163|12420508|FG001|COMPLETED|Randomized-withdrawal Period||50
11228341|NCT02009163|12420509|FG002|COMPLETED|Randomized-withdrawal Period||102
11228342|NCT02009163|12420507|FG000|NOT COMPLETED|Randomized-withdrawal Period||0
11228343|NCT02009163|12420508|FG001|NOT COMPLETED|Randomized-withdrawal Period||88
11228344|NCT02009163|12420509|FG002|NOT COMPLETED|Randomized-withdrawal Period||35
11228345|NCT02009332|12420525|FG000|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||3
11228346|NCT02009332|12420526|FG001|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228347|NCT02009332|12420527|FG002|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228348|NCT02009332|12420528|FG003|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228349|NCT02009332|12420529|FG004|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228350|NCT02009332|12420530|FG005|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228351|NCT02009332|12420525|FG000|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)|Cohort 1 completed 6-week treatment.|3
11228352|NCT02009332|12420526|FG001|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228353|NCT02009332|12420527|FG002|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228354|NCT02009332|12420528|FG003|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228355|NCT02009332|12420529|FG004|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228356|NCT02009332|12420530|FG005|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228357|NCT02009332|12420525|FG000|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228358|NCT02009332|12420526|FG001|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
10865611|NCT02958865|12030656|FG003|COMPLETED|Induction Period (Day 1 to Week 8)||41
10865612|NCT02958865|12030657|FG004|COMPLETED|Induction Period (Day 1 to Week 8)||45
10865613|NCT02958865|12030658|FG005|COMPLETED|Induction Period (Day 1 to Week 8)||43
10865614|NCT02958865|12030659|FG006|COMPLETED|Induction Period (Day 1 to Week 8)||44
10865615|NCT02958865|12030660|FG007|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865616|NCT02958865|12030661|FG008|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865617|NCT02958865|12030662|FG009|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865618|NCT02958865|12030663|FG010|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865619|NCT02958865|12030664|FG011|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865620|NCT02958865|12030665|FG012|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865621|NCT02958865|12030666|FG013|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865622|NCT02958865|12030667|FG014|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865623|NCT02958865|12030668|FG015|COMPLETED|Induction Period (Day 1 to Week 8)||0
10865624|NCT02958865|12030653|FG000|NOT COMPLETED|Induction Period (Day 1 to Week 8)||4
10865625|NCT02958865|12030654|FG001|NOT COMPLETED|Induction Period (Day 1 to Week 8)||7
10865626|NCT02958865|12030655|FG002|NOT COMPLETED|Induction Period (Day 1 to Week 8)||6
10865627|NCT02958865|12030656|FG003|NOT COMPLETED|Induction Period (Day 1 to Week 8)||9
10865628|NCT02958865|12030657|FG004|NOT COMPLETED|Induction Period (Day 1 to Week 8)||3
10865629|NCT02958865|12030658|FG005|NOT COMPLETED|Induction Period (Day 1 to Week 8)||4
10865630|NCT02958865|12030659|FG006|NOT COMPLETED|Induction Period (Day 1 to Week 8)||3
10865631|NCT02958865|12030660|FG007|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865632|NCT02958865|12030661|FG008|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865633|NCT02958865|12030662|FG009|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865634|NCT02958865|12030663|FG010|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865635|NCT02958865|12030664|FG011|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865636|NCT02958865|12030665|FG012|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865637|NCT02958865|12030666|FG013|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865638|NCT02958865|12030667|FG014|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865639|NCT02958865|12030668|FG015|NOT COMPLETED|Induction Period (Day 1 to Week 8)||0
10865640|NCT02958865|12030653|FG000|STARTED|Chronic Period (Week 8 to Week 32)||0
10865641|NCT02958865|12030654|FG001|STARTED|Chronic Period (Week 8 to Week 32)||0
10865642|NCT02958865|12030655|FG002|STARTED|Chronic Period (Week 8 to Week 32)||0
10865643|NCT02958865|12030656|FG003|STARTED|Chronic Period (Week 8 to Week 32)||0
10865644|NCT02958865|12030657|FG004|STARTED|Chronic Period (Week 8 to Week 32)||0
10865645|NCT02958865|12030658|FG005|STARTED|Chronic Period (Week 8 to Week 32)||0
10865646|NCT02958865|12030659|FG006|STARTED|Chronic Period (Week 8 to Week 32)||0
10865647|NCT02958865|12030660|FG007|STARTED|Chronic Period (Week 8 to Week 32)||35
10865648|NCT02958865|12030661|FG008|STARTED|Chronic Period (Week 8 to Week 32)||36
10865649|NCT02958865|12030662|FG009|STARTED|Chronic Period (Week 8 to Week 32)||39
10865650|NCT02958865|12030663|FG010|STARTED|Chronic Period (Week 8 to Week 32)||10
10865651|NCT02958865|12030664|FG011|STARTED|Chronic Period (Week 8 to Week 32)||38
10865652|NCT02958865|12030665|FG012|STARTED|Chronic Period (Week 8 to Week 32)||37
10865653|NCT02958865|12030666|FG013|STARTED|Chronic Period (Week 8 to Week 32)||39
10865654|NCT02958865|12030667|FG014|STARTED|Chronic Period (Week 8 to Week 32)||9
10865655|NCT02958865|12030668|FG015|STARTED|Chronic Period (Week 8 to Week 32)||37
10865656|NCT02958865|12030653|FG000|COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865657|NCT02958865|12030654|FG001|COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865658|NCT02958865|12030655|FG002|COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865659|NCT02958865|12030656|FG003|COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865660|NCT02958865|12030657|FG004|COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865661|NCT02958865|12030658|FG005|COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865662|NCT02958865|12030659|FG006|COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865663|NCT02958865|12030660|FG007|COMPLETED|Chronic Period (Week 8 to Week 32)||33
10865664|NCT02958865|12030661|FG008|COMPLETED|Chronic Period (Week 8 to Week 32)||33
10865665|NCT02958865|12030662|FG009|COMPLETED|Chronic Period (Week 8 to Week 32)||33
10865666|NCT02958865|12030663|FG010|COMPLETED|Chronic Period (Week 8 to Week 32)||10
10865667|NCT02958865|12030664|FG011|COMPLETED|Chronic Period (Week 8 to Week 32)||31
10865668|NCT02958865|12030665|FG012|COMPLETED|Chronic Period (Week 8 to Week 32)||26
10865669|NCT02958865|12030666|FG013|COMPLETED|Chronic Period (Week 8 to Week 32)||31
10865670|NCT02958865|12030667|FG014|COMPLETED|Chronic Period (Week 8 to Week 32)||5
10865671|NCT02958865|12030668|FG015|COMPLETED|Chronic Period (Week 8 to Week 32)||20
10865672|NCT02958865|12030653|FG000|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865673|NCT02958865|12030654|FG001|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865674|NCT02958865|12030655|FG002|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865675|NCT02958865|12030656|FG003|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865676|NCT02958865|12030657|FG004|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865677|NCT02958865|12030658|FG005|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865678|NCT02958865|12030659|FG006|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865679|NCT02958865|12030660|FG007|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||2
10865680|NCT02958865|12030661|FG008|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||3
10865681|NCT02958865|12030662|FG009|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||6
10865682|NCT02958865|12030663|FG010|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||0
10865683|NCT02958865|12030664|FG011|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||7
10865684|NCT02958865|12030665|FG012|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||11
10865685|NCT02958865|12030666|FG013|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||8
10865686|NCT02958865|12030667|FG014|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||4
10865687|NCT02958865|12030668|FG015|NOT COMPLETED|Chronic Period (Week 8 to Week 32)||17
10865688|NCT02949700|12030715|FG000|STARTED|Phase I||9
10865689|NCT02949700|12030716|FG001|STARTED|Phase I||3
10865690|NCT02949700|12030717|FG002|STARTED|Phase I||0
10865691|NCT02949700|12030718|FG003|STARTED|Phase I||0
10865692|NCT02949700|12030715|FG000|COMPLETED|Phase I||7
10865693|NCT02949700|12030716|FG001|COMPLETED|Phase I||2
10865694|NCT02949700|12030717|FG002|COMPLETED|Phase I||0
10865695|NCT02949700|12030718|FG003|COMPLETED|Phase I||0
10865696|NCT02949700|12030715|FG000|NOT COMPLETED|Phase I||2
10865697|NCT02949700|12030716|FG001|NOT COMPLETED|Phase I||1
10865698|NCT02949700|12030717|FG002|NOT COMPLETED|Phase I||0
10865699|NCT02949700|12030718|FG003|NOT COMPLETED|Phase I||0
10865700|NCT02949700|12030715|FG000|STARTED|Phase II||0
10865701|NCT02949700|12030716|FG001|STARTED|Phase II||0
10865702|NCT02949700|12030717|FG002|STARTED|Phase II|"All patients underwent a 2 week lead-in period in order to decrease the gastrointestinal toxicity associated with metformin. During this lead-in period, all patients started metformin at the dose of 500mg PO BID and increased to their assigned dose levels at the end of the lead-in period.~One patient, however, did not complete the lead-in period and was taken off study due to protocol violation, hence the assignment of this patient to the lead-in dose, or DL-1."|1
10865703|NCT02949700|12030718|FG003|STARTED|Phase II||12
10865704|NCT02949700|12030715|FG000|COMPLETED|Phase II||0
10865705|NCT02949700|12030716|FG001|COMPLETED|Phase II||0
10865706|NCT02949700|12030717|FG002|COMPLETED|Phase II||0
10865707|NCT02949700|12030718|FG003|COMPLETED|Phase II||7
10865708|NCT02949700|12030715|FG000|NOT COMPLETED|Phase II||0
10865709|NCT02949700|12030716|FG001|NOT COMPLETED|Phase II||0
10865710|NCT02949700|12030717|FG002|NOT COMPLETED|Phase II||1
10865711|NCT02949700|12030718|FG003|NOT COMPLETED|Phase II||5
10865712|NCT02905006|12030733|FG000|STARTED|Overall Study||42
10865713|NCT02905006|12030734|FG001|STARTED|Overall Study||39
10865714|NCT02905006|12030735|FG002|STARTED|Overall Study||43
10865715|NCT02905006|12030736|FG003|STARTED|Overall Study||40
10865716|NCT02905006|12030737|FG004|STARTED|Overall Study||43
10865717|NCT02905006|12030738|FG005|STARTED|Overall Study||43
10865718|NCT02905006|12030733|FG000|Completed Treatment Period|Overall Study||37
10865719|NCT02905006|12030734|FG001|Completed Treatment Period|Overall Study||36
10865720|NCT02905006|12030735|FG002|Completed Treatment Period|Overall Study||38
10865721|NCT02905006|12030736|FG003|Completed Treatment Period|Overall Study||34
10865722|NCT02905006|12030737|FG004|Completed Treatment Period|Overall Study||40
10865723|NCT02905006|12030738|FG005|Completed Treatment Period|Overall Study||39
10865724|NCT02905006|12030733|FG000|Enrolled in Extension Study (PS0011)|Overall Study||38
10865725|NCT02905006|12030734|FG001|Enrolled in Extension Study (PS0011)|Overall Study||35
10865726|NCT02905006|12030735|FG002|Enrolled in Extension Study (PS0011)|Overall Study||39
10865727|NCT02905006|12030736|FG003|Enrolled in Extension Study (PS0011)|Overall Study||38
10865728|NCT02905006|12030737|FG004|Enrolled in Extension Study (PS0011)|Overall Study||42
10865729|NCT02905006|12030738|FG005|Enrolled in Extension Study (PS0011)|Overall Study||40
10865730|NCT02905006|12030733|FG000|Entered Safety Follow-up Period|Overall Study||4
10865731|NCT02905006|12030734|FG001|Entered Safety Follow-up Period|Overall Study||4
10865732|NCT02905006|12030735|FG002|Entered Safety Follow-up Period|Overall Study||4
10865733|NCT02905006|12030736|FG003|Entered Safety Follow-up Period|Overall Study||2
10865734|NCT02905006|12030737|FG004|Entered Safety Follow-up Period|Overall Study||1
10865735|NCT02905006|12030738|FG005|Entered Safety Follow-up Period|Overall Study||3
10865736|NCT02905006|12030733|FG000|COMPLETED|Overall Study||37
10865737|NCT02905006|12030734|FG001|COMPLETED|Overall Study||36
10865738|NCT02905006|12030735|FG002|COMPLETED|Overall Study||38
10865739|NCT02905006|12030736|FG003|COMPLETED|Overall Study||34
10865740|NCT02905006|12030737|FG004|COMPLETED|Overall Study||40
10865741|NCT02905006|12030738|FG005|COMPLETED|Overall Study||39
10865742|NCT02905006|12030733|FG000|NOT COMPLETED|Overall Study||5
10865743|NCT02905006|12030734|FG001|NOT COMPLETED|Overall Study||3
10865744|NCT02905006|12030735|FG002|NOT COMPLETED|Overall Study||5
10865745|NCT02905006|12030736|FG003|NOT COMPLETED|Overall Study||6
10865746|NCT02905006|12030737|FG004|NOT COMPLETED|Overall Study||3
10865747|NCT02905006|12030738|FG005|NOT COMPLETED|Overall Study||4
10865748|NCT02833844|12030778|FG000|STARTED|Double-Blind Period||157
10865749|NCT02833844|12030779|FG001|STARTED|Double-Blind Period||310
11228359|NCT02009332|12420527|FG002|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228360|NCT02009332|12420528|FG003|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228361|NCT02009332|12420529|FG004|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228362|NCT02009332|12420530|FG005|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
11228363|NCT02009332|12420525|FG000|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
11228364|NCT02009332|12420526|FG001|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||4
11228365|NCT02009332|12420527|FG002|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
11228366|NCT02009332|12420528|FG003|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
11228367|NCT02009332|12420529|FG004|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
11228368|NCT02009332|12420530|FG005|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
11228369|NCT02009332|12420525|FG000|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
11228370|NCT02009332|12420526|FG001|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2 completed 6-week treatment.|3
11228371|NCT02009332|12420527|FG002|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2b stopped due to lack of enrollment.|1
11228372|NCT02009332|12420528|FG003|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
11228373|NCT02009332|12420529|FG004|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
11228374|NCT02009332|12420530|FG005|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
10865750|NCT02833844|12030778|FG000|Randomized and Treated|Double-Blind Period||157
10865751|NCT02833844|12030779|FG001|Randomized and Treated|Double-Blind Period||307
10865752|NCT02833844|12030778|FG000|COMPLETED|Double-Blind Period|completed double-blind period|155
10865753|NCT02833844|12030779|FG001|COMPLETED|Double-Blind Period|completed double-blind period|303
10865754|NCT02833844|12030778|FG000|NOT COMPLETED|Double-Blind Period||2
10865755|NCT02833844|12030779|FG001|NOT COMPLETED|Double-Blind Period||7
10865756|NCT02833844|12030778|FG000|STARTED|Open-Label Period|3 participants did not continue to open-label period|152
10865757|NCT02833844|12030779|FG001|STARTED|Open-Label Period||303
10865758|NCT02833844|12030778|FG000|Received Open-Label Study Drug|Open-Label Period||152
10865759|NCT02833844|12030779|FG001|Received Open-Label Study Drug|Open-Label Period||299
10865760|NCT02833844|12030778|FG000|COMPLETED|Open-Label Period||150
10865761|NCT02833844|12030779|FG001|COMPLETED|Open-Label Period||301
10865762|NCT02833844|12030778|FG000|NOT COMPLETED|Open-Label Period||2
10865763|NCT02833844|12030779|FG001|NOT COMPLETED|Open-Label Period||2
10865764|NCT02778399|12030793|FG000|STARTED|Up to Week 12 Treatment Period||54
10865765|NCT02778399|12030794|FG001|STARTED|Up to Week 12 Treatment Period||49
10865766|NCT02778399|12030795|FG002|STARTED|Up to Week 12 Treatment Period||57
10865767|NCT02778399|12030796|FG003|STARTED|Up to Week 12 Treatment Period||58
10865768|NCT02778399|12030797|FG004|STARTED|Up to Week 12 Treatment Period||53
10865769|NCT02778399|12030798|FG005|STARTED|Up to Week 12 Treatment Period||57
10865770|NCT02778399|12030793|FG000|Included in SAFETY SET|Up to Week 12 Treatment Period||54
10865771|NCT02778399|12030794|FG001|Included in SAFETY SET|Up to Week 12 Treatment Period||49
10865772|NCT02778399|12030795|FG002|Included in SAFETY SET|Up to Week 12 Treatment Period||57
10865773|NCT02778399|12030796|FG003|Included in SAFETY SET|Up to Week 12 Treatment Period||58
10865774|NCT02778399|12030797|FG004|Included in SAFETY SET|Up to Week 12 Treatment Period||52
10865775|NCT02778399|12030798|FG005|Included in SAFETY SET|Up to Week 12 Treatment Period||57
10865776|NCT02778399|12030793|FG000|Included in FAS|Up to Week 12 Treatment Period||53
10865777|NCT02778399|12030794|FG001|Included in FAS|Up to Week 12 Treatment Period||49
10865778|NCT02778399|12030795|FG002|Included in FAS|Up to Week 12 Treatment Period||56
10865779|NCT02778399|12030796|FG003|Included in FAS|Up to Week 12 Treatment Period||58
10865780|NCT02778399|12030797|FG004|Included in FAS|Up to Week 12 Treatment Period||51
10865781|NCT02778399|12030798|FG005|Included in FAS|Up to Week 12 Treatment Period||56
10865782|NCT02778399|12030793|FG000|COMPLETED|Up to Week 12 Treatment Period||45
10865783|NCT02778399|12030794|FG001|COMPLETED|Up to Week 12 Treatment Period||45
10865784|NCT02778399|12030795|FG002|COMPLETED|Up to Week 12 Treatment Period||53
10865785|NCT02778399|12030796|FG003|COMPLETED|Up to Week 12 Treatment Period||51
10865786|NCT02778399|12030797|FG004|COMPLETED|Up to Week 12 Treatment Period||45
10865787|NCT02778399|12030798|FG005|COMPLETED|Up to Week 12 Treatment Period||49
10865788|NCT02778399|12030793|FG000|NOT COMPLETED|Up to Week 12 Treatment Period||9
10865789|NCT02778399|12030794|FG001|NOT COMPLETED|Up to Week 12 Treatment Period||4
10865790|NCT02778399|12030795|FG002|NOT COMPLETED|Up to Week 12 Treatment Period||4
10865791|NCT02778399|12030796|FG003|NOT COMPLETED|Up to Week 12 Treatment Period||7
10865792|NCT02778399|12030797|FG004|NOT COMPLETED|Up to Week 12 Treatment Period||8
10865793|NCT02778399|12030798|FG005|NOT COMPLETED|Up to Week 12 Treatment Period||8
10865794|NCT02778399|12030793|FG000|STARTED|Week 12 to Week 24 Treatment Period||45
10865795|NCT02778399|12030794|FG001|STARTED|Week 12 to Week 24 Treatment Period||45
10865796|NCT02778399|12030795|FG002|STARTED|Week 12 to Week 24 Treatment Period||53
10865797|NCT02778399|12030796|FG003|STARTED|Week 12 to Week 24 Treatment Period||51
10865798|NCT02778399|12030797|FG004|STARTED|Week 12 to Week 24 Treatment Period||45
10865799|NCT02778399|12030798|FG005|STARTED|Week 12 to Week 24 Treatment Period||49
10865800|NCT02778399|12030793|FG000|COMPLETED|Week 12 to Week 24 Treatment Period||37
10865801|NCT02778399|12030794|FG001|COMPLETED|Week 12 to Week 24 Treatment Period||41
10865802|NCT02778399|12030795|FG002|COMPLETED|Week 12 to Week 24 Treatment Period||48
10865803|NCT02778399|12030796|FG003|COMPLETED|Week 12 to Week 24 Treatment Period||46
10865804|NCT02778399|12030797|FG004|COMPLETED|Week 12 to Week 24 Treatment Period||39
10865805|NCT02778399|12030798|FG005|COMPLETED|Week 12 to Week 24 Treatment Period||42
10865806|NCT02778399|12030793|FG000|NOT COMPLETED|Week 12 to Week 24 Treatment Period||8
10865807|NCT02778399|12030794|FG001|NOT COMPLETED|Week 12 to Week 24 Treatment Period||4
10865808|NCT02778399|12030795|FG002|NOT COMPLETED|Week 12 to Week 24 Treatment Period||5
10865809|NCT02778399|12030796|FG003|NOT COMPLETED|Week 12 to Week 24 Treatment Period||5
11109501|NCT01275144|12293998|FG000|STARTED|Washout (7 Days)||14
10865810|NCT02778399|12030797|FG004|NOT COMPLETED|Week 12 to Week 24 Treatment Period||6
10865811|NCT02778399|12030798|FG005|NOT COMPLETED|Week 12 to Week 24 Treatment Period||7
11109502|NCT01275144|12293999|FG001|STARTED|Washout (7 Days)||14
11109503|NCT01275144|12293998|FG000|COMPLETED|Washout (7 Days)||14
11109504|NCT01275144|12293999|FG001|COMPLETED|Washout (7 Days)||14
11109505|NCT01275144|12293998|FG000|NOT COMPLETED|Washout (7 Days)||0
11109506|NCT01275144|12293999|FG001|NOT COMPLETED|Washout (7 Days)||0
10865818|NCT02758717|12030826|FG000|STARTED|Overall Study||46
10865819|NCT02758717|12030826|FG000|COMPLETED|Overall Study||46
10865820|NCT02758717|12030826|FG000|NOT COMPLETED|Overall Study||0
10865821|NCT02701777|12030834|FG000|STARTED|Overall Study||17
10865822|NCT02701777|12030835|FG001|STARTED|Overall Study||16
10865823|NCT02701777|12030836|FG002|STARTED|Overall Study||16
10865824|NCT02701777|12030837|FG003|STARTED|Overall Study||13
10865825|NCT02701777|12030834|FG000|COMPLETED|Overall Study||13
10865826|NCT02701777|12030835|FG001|COMPLETED|Overall Study||13
10865827|NCT02701777|12030836|FG002|COMPLETED|Overall Study||12
10865828|NCT02701777|12030837|FG003|COMPLETED|Overall Study||11
10865829|NCT02701777|12030834|FG000|NOT COMPLETED|Overall Study||4
10865830|NCT02701777|12030835|FG001|NOT COMPLETED|Overall Study||3
10865831|NCT02701777|12030836|FG002|NOT COMPLETED|Overall Study||4
10865832|NCT02701777|12030837|FG003|NOT COMPLETED|Overall Study||2
10865833|NCT02633241|12030851|FG000|STARTED|Overall Study||30
10865834|NCT02633241|12030851|FG000|COMPLETED|Overall Study||27
10865835|NCT02633241|12030851|FG000|NOT COMPLETED|Overall Study||3
10865836|NCT02546674|12030857|FG000|STARTED|Overall Study||171
10865837|NCT02546674|12030857|FG000|COMPLETED|Overall Study||123
10865838|NCT02546674|12030857|FG000|NOT COMPLETED|Overall Study||48
10865839|NCT02520661|12030864|FG000|STARTED|Overall Study||992
10865840|NCT02520661|12030865|FG001|STARTED|Overall Study||987
10865841|NCT02520661|12030864|FG000|Removed Following Randomization|Overall Study||124
10865842|NCT02520661|12030865|FG001|Removed Following Randomization|Overall Study||99
10865843|NCT02520661|12030864|FG000|CTI Home Visit Scheduled|Overall Study||0
10865844|NCT02520661|12030865|FG001|CTI Home Visit Scheduled|Overall Study||863
10865845|NCT02520661|12030864|FG000|Participants in Dataset|Overall Study||893
10865846|NCT02520661|12030865|FG001|Participants in Dataset|Overall Study||863
10865847|NCT02520661|12030864|FG000|Participants Completing Home Visit|Overall Study||0
10865848|NCT02520661|12030865|FG001|Participants Completing Home Visit|Overall Study||726
10865849|NCT02520661|12030864|FG000|Participants With Primary Outcome Data (ITT)|Overall Study||886
10865850|NCT02520661|12030865|FG001|Participants With Primary Outcome Data (ITT)|Overall Study||860
10865851|NCT02520661|12030864|FG000|Participants With Primary Outcome Data (PP)|Overall Study||886
10865852|NCT02520661|12030865|FG001|Participants With Primary Outcome Data (PP)|Overall Study||725
10865853|NCT02520661|12030864|FG000|COMPLETED|Overall Study||886
10865854|NCT02520661|12030865|FG001|COMPLETED|Overall Study||860
10865855|NCT02520661|12030864|FG000|NOT COMPLETED|Overall Study||106
10865856|NCT02520661|12030865|FG001|NOT COMPLETED|Overall Study||127
10865857|NCT02511132|12030878|FG000|STARTED|Overall Study||5
10865858|NCT02511132|12030879|FG001|STARTED|Overall Study||8
10865859|NCT02511132|12030880|FG002|STARTED|Overall Study||9
10865860|NCT02511132|12030878|FG000|COMPLETED|Overall Study||5
10865861|NCT02511132|12030879|FG001|COMPLETED|Overall Study||7
10865862|NCT02511132|12030880|FG002|COMPLETED|Overall Study||9
10865863|NCT02511132|12030878|FG000|NOT COMPLETED|Overall Study||0
10865864|NCT02511132|12030879|FG001|NOT COMPLETED|Overall Study||1
10865865|NCT02511132|12030880|FG002|NOT COMPLETED|Overall Study||0
10865866|NCT02483585|12030891|FG000|STARTED|Double-blind Treatment Phase||291
10865867|NCT02483585|12030892|FG001|STARTED|Double-blind Treatment Phase||286
10865868|NCT02483585|12030891|FG000|Received Treatment|Double-blind Treatment Phase||289
10865869|NCT02483585|12030892|FG001|Received Treatment|Double-blind Treatment Phase||283
10865870|NCT02483585|12030891|FG000|COMPLETED|Double-blind Treatment Phase||275
10865871|NCT02483585|12030892|FG001|COMPLETED|Double-blind Treatment Phase||271
10865872|NCT02483585|12030891|FG000|NOT COMPLETED|Double-blind Treatment Phase||16
10865873|NCT02483585|12030892|FG001|NOT COMPLETED|Double-blind Treatment Phase||15
10865874|NCT02483585|12030891|FG000|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
10865875|NCT02483585|12030892|FG001|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
10865876|NCT02483585|12030891|FG000|COMPLETED|Open-label Treatment Phase||243
10865877|NCT02483585|12030892|FG001|COMPLETED|Open-label Treatment Phase||243
10865878|NCT02483585|12030891|FG000|NOT COMPLETED|Open-label Treatment Phase||27
10865879|NCT02483585|12030892|FG001|NOT COMPLETED|Open-label Treatment Phase||25
11109507|NCT01275144|12293998|FG000|STARTED|Second Intervention (6 Days)||14
11109508|NCT01275144|12293999|FG001|STARTED|Second Intervention (6 Days)||14
11109509|NCT01275144|12293998|FG000|COMPLETED|Second Intervention (6 Days)||13
11109510|NCT01275144|12293999|FG001|COMPLETED|Second Intervention (6 Days)||14
11109511|NCT01275144|12293998|FG000|NOT COMPLETED|Second Intervention (6 Days)||1
11109512|NCT01275144|12293999|FG001|NOT COMPLETED|Second Intervention (6 Days)||0
11109513|NCT01275170|12294015|FG000|STARTED|Part 1: Period 1||7
11109514|NCT01275170|12294016|FG001|STARTED|Part 1: Period 1||6
11109515|NCT01275170|12294017|FG002|STARTED|Part 1: Period 1||6
11109516|NCT01275170|12294018|FG003|STARTED|Part 1: Period 1||6
11109517|NCT01275170|12294019|FG004|STARTED|Part 1: Period 1||6
11109518|NCT01275170|12294020|FG005|STARTED|Part 1: Period 1||6
11109519|NCT01275170|12294021|FG006|STARTED|Part 1: Period 1||6
11109520|NCT01275170|12294022|FG007|STARTED|Part 1: Period 1||6
11109521|NCT01275170|12294015|FG000|Treated|Part 1: Period 1||6
11109522|NCT01275170|12294016|FG001|Treated|Part 1: Period 1||6
11109523|NCT01275170|12294017|FG002|Treated|Part 1: Period 1||6
11109524|NCT01275170|12294018|FG003|Treated|Part 1: Period 1||6
11109525|NCT01275170|12294019|FG004|Treated|Part 1: Period 1||6
11109526|NCT01275170|12294020|FG005|Treated|Part 1: Period 1||6
11109527|NCT01275170|12294021|FG006|Treated|Part 1: Period 1||6
11109528|NCT01275170|12294022|FG007|Treated|Part 1: Period 1||6
11109529|NCT01275170|12294015|FG000|COMPLETED|Part 1: Period 1||6
11109530|NCT01275170|12294016|FG001|COMPLETED|Part 1: Period 1||6
11109531|NCT01275170|12294017|FG002|COMPLETED|Part 1: Period 1||6
11109532|NCT01275170|12294018|FG003|COMPLETED|Part 1: Period 1||6
11109533|NCT01275170|12294019|FG004|COMPLETED|Part 1: Period 1||6
11109534|NCT01275170|12294020|FG005|COMPLETED|Part 1: Period 1||6
11109535|NCT01275170|12294021|FG006|COMPLETED|Part 1: Period 1||6
11355087|NCT03076970|12551943|FG000|NOT COMPLETED|Period 3||0
11355088|NCT03076970|12551944|FG001|NOT COMPLETED|Period 3||0
11109536|NCT01275170|12294022|FG007|COMPLETED|Part 1: Period 1||6
11109537|NCT01275170|12294015|FG000|NOT COMPLETED|Part 1: Period 1||1
11109538|NCT01275170|12294016|FG001|NOT COMPLETED|Part 1: Period 1||0
11109539|NCT01275170|12294017|FG002|NOT COMPLETED|Part 1: Period 1||0
11109540|NCT01275170|12294018|FG003|NOT COMPLETED|Part 1: Period 1||0
11109541|NCT01275170|12294019|FG004|NOT COMPLETED|Part 1: Period 1||0
11109542|NCT01275170|12294020|FG005|NOT COMPLETED|Part 1: Period 1||0
11109543|NCT01275170|12294021|FG006|NOT COMPLETED|Part 1: Period 1||0
11109544|NCT01275170|12294022|FG007|NOT COMPLETED|Part 1: Period 1||0
11109545|NCT01275170|12294015|FG000|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0
11109546|NCT01275170|12294016|FG001|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0
11109547|NCT01275170|12294017|FG002|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0
11109548|NCT01275170|12294018|FG003|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0
11109549|NCT01275170|12294019|FG004|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
11109550|NCT01275170|12294020|FG005|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
11109551|NCT01275170|12294021|FG006|STARTED|Part 1: Period 2||6
11109552|NCT01275170|12294022|FG007|STARTED|Part 1: Period 2||6
11109553|NCT01275170|12294015|FG000|COMPLETED|Part 1: Period 2||0
11109554|NCT01275170|12294016|FG001|COMPLETED|Part 1: Period 2||0
11109555|NCT01275170|12294017|FG002|COMPLETED|Part 1: Period 2||0
11109556|NCT01275170|12294018|FG003|COMPLETED|Part 1: Period 2||0
11109557|NCT01275170|12294019|FG004|COMPLETED|Part 1: Period 2||0
11109558|NCT01275170|12294020|FG005|COMPLETED|Part 1: Period 2||0
11109559|NCT01275170|12294021|FG006|COMPLETED|Part 1: Period 2||6
11109560|NCT01275170|12294022|FG007|COMPLETED|Part 1: Period 2||6
11109561|NCT01275170|12294015|FG000|NOT COMPLETED|Part 1: Period 2||0
11109562|NCT01275170|12294016|FG001|NOT COMPLETED|Part 1: Period 2||0
11109563|NCT01275170|12294017|FG002|NOT COMPLETED|Part 1: Period 2||0
11109564|NCT01275170|12294018|FG003|NOT COMPLETED|Part 1: Period 2||0
11109565|NCT01275170|12294019|FG004|NOT COMPLETED|Part 1: Period 2||0
11109566|NCT01275170|12294020|FG005|NOT COMPLETED|Part 1: Period 2||0
11109567|NCT01275170|12294021|FG006|NOT COMPLETED|Part 1: Period 2||0
11109568|NCT01275170|12294022|FG007|NOT COMPLETED|Part 1: Period 2||0
11109569|NCT01275170|12294015|FG000|STARTED|Part 2: Period 1||0
11109570|NCT01275170|12294016|FG001|STARTED|Part 2: Period 1||0
11109571|NCT01275170|12294017|FG002|STARTED|Part 2: Period 1||0
11109572|NCT01275170|12294018|FG003|STARTED|Part 2: Period 1||0
11109573|NCT01275170|12294019|FG004|STARTED|Part 2: Period 1||6
11109574|NCT01275170|12294020|FG005|STARTED|Part 2: Period 1||6
11109575|NCT01275170|12294021|FG006|STARTED|Part 2: Period 1||6
11109576|NCT01275170|12294022|FG007|STARTED|Part 2: Period 1||6
11109577|NCT01275170|12294015|FG000|COMPLETED|Part 2: Period 1||0
11109578|NCT01275170|12294016|FG001|COMPLETED|Part 2: Period 1||0
11109579|NCT01275170|12294017|FG002|COMPLETED|Part 2: Period 1||0
11109580|NCT01275170|12294018|FG003|COMPLETED|Part 2: Period 1||0
11109581|NCT01275170|12294019|FG004|COMPLETED|Part 2: Period 1||6
11109582|NCT01275170|12294020|FG005|COMPLETED|Part 2: Period 1||6
11109583|NCT01275170|12294021|FG006|COMPLETED|Part 2: Period 1||6
11109584|NCT01275170|12294022|FG007|COMPLETED|Part 2: Period 1||6
11109585|NCT01275170|12294015|FG000|NOT COMPLETED|Part 2: Period 1||0
11109586|NCT01275170|12294016|FG001|NOT COMPLETED|Part 2: Period 1||0
11109587|NCT01275170|12294017|FG002|NOT COMPLETED|Part 2: Period 1||0
11109588|NCT01275170|12294018|FG003|NOT COMPLETED|Part 2: Period 1||0
11109589|NCT01275170|12294019|FG004|NOT COMPLETED|Part 2: Period 1||0
11109590|NCT01275170|12294020|FG005|NOT COMPLETED|Part 2: Period 1||0
11109591|NCT01275170|12294021|FG006|NOT COMPLETED|Part 2: Period 1||0
11109592|NCT01275170|12294022|FG007|NOT COMPLETED|Part 2: Period 1||0
11109593|NCT01275170|12294015|FG000|STARTED|Part 2: Period 2||0
11109594|NCT01275170|12294016|FG001|STARTED|Part 2: Period 2||0
11109595|NCT01275170|12294017|FG002|STARTED|Part 2: Period 2||0
11109596|NCT01275170|12294018|FG003|STARTED|Part 2: Period 2||0
11109597|NCT01275170|12294019|FG004|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
11109598|NCT01275170|12294020|FG005|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0
11109599|NCT01275170|12294021|FG006|STARTED|Part 2: Period 2||6
11109600|NCT01275170|12294022|FG007|STARTED|Part 2: Period 2||6
11109601|NCT01275170|12294015|FG000|COMPLETED|Part 2: Period 2||0
11109602|NCT01275170|12294016|FG001|COMPLETED|Part 2: Period 2||0
11109603|NCT01275170|12294017|FG002|COMPLETED|Part 2: Period 2||0
11109604|NCT01275170|12294018|FG003|COMPLETED|Part 2: Period 2||0
11109605|NCT01275170|12294019|FG004|COMPLETED|Part 2: Period 2||0
11109606|NCT01275170|12294020|FG005|COMPLETED|Part 2: Period 2||0
11109607|NCT01275170|12294021|FG006|COMPLETED|Part 2: Period 2||6
11355089|NCT03076970|12551945|FG002|NOT COMPLETED|Period 3||0
11109608|NCT01275170|12294022|FG007|COMPLETED|Part 2: Period 2||6
11109609|NCT01275170|12294015|FG000|NOT COMPLETED|Part 2: Period 2||0
11109610|NCT01275170|12294016|FG001|NOT COMPLETED|Part 2: Period 2||0
11109611|NCT01275170|12294017|FG002|NOT COMPLETED|Part 2: Period 2||0
11109612|NCT01275170|12294018|FG003|NOT COMPLETED|Part 2: Period 2||0
11109613|NCT01275170|12294019|FG004|NOT COMPLETED|Part 2: Period 2||0
11109614|NCT01275170|12294020|FG005|NOT COMPLETED|Part 2: Period 2||0
11109615|NCT01275170|12294021|FG006|NOT COMPLETED|Part 2: Period 2||0
11355090|NCT03076970|12551946|FG003|NOT COMPLETED|Period 3||0
11109616|NCT01275170|12294022|FG007|NOT COMPLETED|Part 2: Period 2||0
11109617|NCT01275196|12294057|FG000|STARTED|Overall Study||133
11109618|NCT01275196|12294058|FG001|STARTED|Overall Study||134
11109619|NCT01275196|12294057|FG000|Intended to Continue Into Extension|Overall Study||112
11109620|NCT01275196|12294058|FG001|Intended to Continue Into Extension|Overall Study||113
11109621|NCT01275196|12294057|FG000|COMPLETED|Overall Study||113
11109622|NCT01275196|12294058|FG001|COMPLETED|Overall Study||113
11109623|NCT01275196|12294057|FG000|NOT COMPLETED|Overall Study||20
11109624|NCT01275196|12294058|FG001|NOT COMPLETED|Overall Study||21
11109625|NCT01275222|12294072|FG000|STARTED|Phase l by Treatment||13
11109626|NCT01275222|12294073|FG001|STARTED|Phase l by Treatment||13
11109627|NCT01275222|12294074|FG002|STARTED|Phase l by Treatment||5
11109628|NCT01275222|12294075|FG003|STARTED|Phase l by Treatment||11
11109629|NCT01275222|12294076|FG004|STARTED|Phase l by Treatment||0
11109630|NCT01275222|12294077|FG005|STARTED|Phase l by Treatment||0
11109631|NCT01275222|12294072|FG000|COMPLETED|Phase l by Treatment||0
11109632|NCT01275222|12294073|FG001|COMPLETED|Phase l by Treatment||0
11109633|NCT01275222|12294074|FG002|COMPLETED|Phase l by Treatment||0
11109634|NCT01275222|12294075|FG003|COMPLETED|Phase l by Treatment||0
11109635|NCT01275222|12294076|FG004|COMPLETED|Phase l by Treatment||0
11109636|NCT01275222|12294077|FG005|COMPLETED|Phase l by Treatment||0
11109637|NCT01275222|12294072|FG000|NOT COMPLETED|Phase l by Treatment||13
11109638|NCT01275222|12294073|FG001|NOT COMPLETED|Phase l by Treatment||13
11109639|NCT01275222|12294074|FG002|NOT COMPLETED|Phase l by Treatment||5
11109640|NCT01275222|12294075|FG003|NOT COMPLETED|Phase l by Treatment||11
11109641|NCT01275222|12294076|FG004|NOT COMPLETED|Phase l by Treatment||0
11109642|NCT01275222|12294077|FG005|NOT COMPLETED|Phase l by Treatment||0
11109643|NCT01275222|12294072|FG000|STARTED|Phase ll by Stratum||0
11109644|NCT01275222|12294073|FG001|STARTED|Phase ll by Stratum||0
10865943|NCT02399215|12030923|FG000|STARTED|Overall Study||32
10865944|NCT02399215|12030923|FG000|COMPLETED|Overall Study||30
10865945|NCT02399215|12030923|FG000|NOT COMPLETED|Overall Study||2
11109645|NCT01275222|12294074|FG002|STARTED|Phase ll by Stratum||0
11109646|NCT01275222|12294075|FG003|STARTED|Phase ll by Stratum||0
11109647|NCT01275222|12294076|FG004|STARTED|Phase ll by Stratum||28
11109648|NCT01275222|12294077|FG005|STARTED|Phase ll by Stratum||47
11109649|NCT01275222|12294072|FG000|COMPLETED|Phase ll by Stratum||0
11109650|NCT01275222|12294073|FG001|COMPLETED|Phase ll by Stratum||0
10865952|NCT02202577|12030939|FG000|STARTED|Overall Study||461
10865953|NCT02202577|12030940|FG001|STARTED|Overall Study||471
10865954|NCT02202577|12030939|FG000|COMPLETED|Overall Study||448
10865955|NCT02202577|12030940|FG001|COMPLETED|Overall Study||452
10865956|NCT02202577|12030939|FG000|NOT COMPLETED|Overall Study||13
10865957|NCT02202577|12030940|FG001|NOT COMPLETED|Overall Study||19
10865958|NCT02130427|12030946|FG000|STARTED|Overall Study||74
10865959|NCT02130427|12030946|FG000|COMPLETED|Overall Study||44
10865960|NCT02130427|12030946|FG000|NOT COMPLETED|Overall Study||30
10865961|NCT02015832|12030950|FG000|STARTED|Overall Study||454
10865962|NCT02015832|12030950|FG000|COMPLETED|Overall Study||443
10865963|NCT02015832|12030950|FG000|NOT COMPLETED|Overall Study||11
10865964|NCT01959698|12030966|FG000|STARTED|Overall Study||3
10865965|NCT01959698|12030967|FG001|STARTED|Overall Study||3
10865966|NCT01959698|12030968|FG002|STARTED|Overall Study||3
10865967|NCT01959698|12030969|FG003|STARTED|Overall Study||3
10865968|NCT01959698|12030970|FG004|STARTED|Overall Study||3
10865969|NCT01959698|12030971|FG005|STARTED|Overall Study||6
10865970|NCT01959698|12030972|FG006|STARTED|Overall Study||8
10865971|NCT01959698|12030966|FG000|COMPLETED|Overall Study||2
10865972|NCT01959698|12030967|FG001|COMPLETED|Overall Study||3
10865973|NCT01959698|12030968|FG002|COMPLETED|Overall Study||2
10865974|NCT01959698|12030969|FG003|COMPLETED|Overall Study||1
11228375|NCT02009332|12420525|FG000|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
11228376|NCT02009332|12420526|FG001|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
11228377|NCT02009332|12420527|FG002|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
11228378|NCT02009332|12420528|FG003|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
11228379|NCT02009332|12420529|FG004|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
11228380|NCT02009332|12420530|FG005|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
11228381|NCT02009332|12420525|FG000|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228382|NCT02009332|12420526|FG001|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228383|NCT02009332|12420527|FG002|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228384|NCT02009332|12420528|FG003|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||3
11228385|NCT02009332|12420529|FG004|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228386|NCT02009332|12420530|FG005|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228387|NCT02009332|12420525|FG000|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228388|NCT02009332|12420526|FG001|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228389|NCT02009332|12420527|FG002|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228390|NCT02009332|12420528|FG003|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)|Cohort 3 completed 6-week treatment.|3
11228391|NCT02009332|12420529|FG004|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228392|NCT02009332|12420530|FG005|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228393|NCT02009332|12420525|FG000|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228394|NCT02009332|12420526|FG001|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
10865975|NCT01959698|12030970|FG004|COMPLETED|Overall Study||3
10865976|NCT01959698|12030971|FG005|COMPLETED|Overall Study||3
10865977|NCT01959698|12030972|FG006|COMPLETED|Overall Study||4
10865978|NCT01959698|12030966|FG000|NOT COMPLETED|Overall Study||1
10865979|NCT01959698|12030967|FG001|NOT COMPLETED|Overall Study||0
10865980|NCT01959698|12030968|FG002|NOT COMPLETED|Overall Study||1
10865981|NCT01959698|12030969|FG003|NOT COMPLETED|Overall Study||2
10865982|NCT01959698|12030970|FG004|NOT COMPLETED|Overall Study||0
10865983|NCT01959698|12030971|FG005|NOT COMPLETED|Overall Study||3
10865984|NCT01959698|12030972|FG006|NOT COMPLETED|Overall Study||4
10865985|NCT01942837|12030989|FG000|STARTED|Overall Study||67
10865986|NCT01942837|12030989|FG000|COMPLETED|Overall Study||0
10865987|NCT01942837|12030989|FG000|NOT COMPLETED|Overall Study||67
10865988|NCT01906489|12030996|FG000|STARTED|Overall Study||138
10865989|NCT01906489|12030997|FG001|STARTED|Overall Study||72
10865990|NCT01906489|12030996|FG000|COMPLETED|Overall Study||112
10865991|NCT01906489|12030997|FG001|COMPLETED|Overall Study||63
10865992|NCT01906489|12030996|FG000|NOT COMPLETED|Overall Study||26
10865993|NCT01906489|12030997|FG001|NOT COMPLETED|Overall Study||9
11109651|NCT01275222|12294074|FG002|COMPLETED|Phase ll by Stratum||0
11109652|NCT01275222|12294075|FG003|COMPLETED|Phase ll by Stratum||0
10865994|NCT01855412|12031006|FG000|STARTED|Overall Study||501
10865995|NCT01855412|12031007|FG001|STARTED|Overall Study||603
10865996|NCT01855412|12031008|FG002|STARTED|Overall Study||100
10865997|NCT01855412|12031006|FG000|COMPLETED|Overall Study||289
10865998|NCT01855412|12031007|FG001|COMPLETED|Overall Study||260
10865999|NCT01855412|12031008|FG002|COMPLETED|Overall Study||24
10866000|NCT01855412|12031006|FG000|NOT COMPLETED|Overall Study||212
10866001|NCT01855412|12031007|FG001|NOT COMPLETED|Overall Study||343
10866002|NCT01855412|12031008|FG002|NOT COMPLETED|Overall Study||76
10866003|NCT01845805|12031024|FG000|STARTED|Overall Study||24
10866004|NCT01845805|12031025|FG001|STARTED|Overall Study||25
10866005|NCT01845805|12031024|FG000|COMPLETED|Overall Study||6
10866006|NCT01845805|12031025|FG001|COMPLETED|Overall Study||9
10866007|NCT01845805|12031024|FG000|NOT COMPLETED|Overall Study||18
10866008|NCT01845805|12031025|FG001|NOT COMPLETED|Overall Study||16
10866009|NCT01833754|12031034|FG000|STARTED|Overall Study||8
10866010|NCT01833754|12031035|FG001|STARTED|Overall Study||8
10866011|NCT01833754|12031036|FG002|STARTED|Overall Study||8
10866012|NCT01833754|12031034|FG000|COMPLETED|Overall Study||8
10866013|NCT01833754|12031035|FG001|COMPLETED|Overall Study||8
10866014|NCT01833754|12031036|FG002|COMPLETED|Overall Study||8
10866015|NCT01833754|12031034|FG000|NOT COMPLETED|Overall Study||0
10866016|NCT01833754|12031035|FG001|NOT COMPLETED|Overall Study||0
10866017|NCT01833754|12031036|FG002|NOT COMPLETED|Overall Study||0
10866018|NCT01808456|12031046|FG000|STARTED|Overall Study||30
10866019|NCT01808456|12031047|FG001|STARTED|Overall Study||32
10866020|NCT01808456|12031046|FG000|COMPLETED|Overall Study||26
10866021|NCT01808456|12031047|FG001|COMPLETED|Overall Study||30
10866022|NCT01808456|12031046|FG000|NOT COMPLETED|Overall Study||4
10866023|NCT01808456|12031047|FG001|NOT COMPLETED|Overall Study||2
10866024|NCT01764633|12031061|FG000|STARTED|Overall Study||13780
10866025|NCT01764633|12031062|FG001|STARTED|Overall Study||13784
10866026|NCT01764633|12031061|FG000|Received Treatment|Overall Study||13756
10866027|NCT01764633|12031062|FG001|Received Treatment|Overall Study||13769
10866028|NCT01764633|12031061|FG000|COMPLETED|Overall Study||13662
10866029|NCT01764633|12031062|FG001|COMPLETED|Overall Study||13691
10866030|NCT01764633|12031061|FG000|NOT COMPLETED|Overall Study||118
10866031|NCT01764633|12031062|FG001|NOT COMPLETED|Overall Study||93
10866032|NCT01744093|12031070|FG000|STARTED|Overall Study||18
10866033|NCT01744093|12031071|FG001|STARTED|Overall Study||9
10866034|NCT01744093|12031070|FG000|Treated|Overall Study||16
10866035|NCT01744093|12031071|FG001|Treated|Overall Study||8
10866036|NCT01744093|12031070|FG000|COMPLETED|Overall Study||12
10866037|NCT01744093|12031071|FG001|COMPLETED|Overall Study||8
10866038|NCT01744093|12031070|FG000|NOT COMPLETED|Overall Study||6
10866039|NCT01744093|12031071|FG001|NOT COMPLETED|Overall Study||1
11109653|NCT01275222|12294076|FG004|COMPLETED|Phase ll by Stratum||0
11228395|NCT02009332|12420527|FG002|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228396|NCT02009332|12420528|FG003|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228397|NCT02009332|12420529|FG004|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228398|NCT02009332|12420530|FG005|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
11228399|NCT02009332|12420525|FG000|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228400|NCT02009332|12420526|FG001|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228401|NCT02009332|12420527|FG002|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228402|NCT02009332|12420528|FG003|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228403|NCT02009332|12420529|FG004|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||4
11228404|NCT02009332|12420530|FG005|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228405|NCT02009332|12420525|FG000|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228406|NCT02009332|12420526|FG001|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228407|NCT02009332|12420527|FG002|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228408|NCT02009332|12420528|FG003|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228409|NCT02009332|12420529|FG004|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)|Cohort 4 completed 6-week treatment.|3
11109654|NCT01275222|12294077|FG005|COMPLETED|Phase ll by Stratum||1
11109655|NCT01275222|12294072|FG000|NOT COMPLETED|Phase ll by Stratum||0
11109656|NCT01275222|12294073|FG001|NOT COMPLETED|Phase ll by Stratum||0
11109657|NCT01275222|12294074|FG002|NOT COMPLETED|Phase ll by Stratum||0
11109658|NCT01275222|12294075|FG003|NOT COMPLETED|Phase ll by Stratum||0
11109659|NCT01275222|12294076|FG004|NOT COMPLETED|Phase ll by Stratum||28
11109660|NCT01275222|12294077|FG005|NOT COMPLETED|Phase ll by Stratum||46
11109661|NCT01275300|12294095|FG000|STARTED|1st Intervention (5 Days)||5
11109662|NCT01275300|12294096|FG001|STARTED|1st Intervention (5 Days)||4
11109663|NCT01275300|12294095|FG000|COMPLETED|1st Intervention (5 Days)||5
11109664|NCT01275300|12294096|FG001|COMPLETED|1st Intervention (5 Days)||4
11109665|NCT01275300|12294095|FG000|NOT COMPLETED|1st Intervention (5 Days)||0
11109666|NCT01275300|12294096|FG001|NOT COMPLETED|1st Intervention (5 Days)||0
11109667|NCT01275300|12294095|FG000|STARTED|Washout (14 Days)||5
11109668|NCT01275300|12294096|FG001|STARTED|Washout (14 Days)||4
11109669|NCT01275300|12294095|FG000|COMPLETED|Washout (14 Days)||5
11228410|NCT02009332|12420530|FG005|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228411|NCT02009332|12420525|FG000|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228412|NCT02009332|12420526|FG001|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228413|NCT02009332|12420527|FG002|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228414|NCT02009332|12420528|FG003|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228415|NCT02009332|12420529|FG004|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||1
11228416|NCT02009332|12420530|FG005|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
11228417|NCT02009332|12420525|FG000|STARTED|Phase 2 (Weeks 206-252)||0
11228418|NCT02009332|12420526|FG001|STARTED|Phase 2 (Weeks 206-252)||0
11228419|NCT02009332|12420527|FG002|STARTED|Phase 2 (Weeks 206-252)||0
11228420|NCT02009332|12420528|FG003|STARTED|Phase 2 (Weeks 206-252)||0
11228421|NCT02009332|12420529|FG004|STARTED|Phase 2 (Weeks 206-252)||0
11228422|NCT02009332|12420530|FG005|STARTED|Phase 2 (Weeks 206-252)||6
11228423|NCT02009332|12420525|FG000|COMPLETED|Phase 2 (Weeks 206-252)||0
11228424|NCT02009332|12420526|FG001|COMPLETED|Phase 2 (Weeks 206-252)||0
11228425|NCT02009332|12420527|FG002|COMPLETED|Phase 2 (Weeks 206-252)||0
11228426|NCT02009332|12420528|FG003|COMPLETED|Phase 2 (Weeks 206-252)||0
11228427|NCT02009332|12420529|FG004|COMPLETED|Phase 2 (Weeks 206-252)||0
11228428|NCT02009332|12420530|FG005|COMPLETED|Phase 2 (Weeks 206-252)|Phase 2 stopped due to lack of efficacy.|5
11228429|NCT02009332|12420525|FG000|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
11228430|NCT02009332|12420526|FG001|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
11228431|NCT02009332|12420527|FG002|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
11228432|NCT02009332|12420528|FG003|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
11228433|NCT02009332|12420529|FG004|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
11228434|NCT02009332|12420530|FG005|NOT COMPLETED|Phase 2 (Weeks 206-252)||1
11228435|NCT02009397|12420544|FG000|STARTED|Overall Study||26
11228436|NCT02009397|12420544|FG000|COMPLETED|Overall Study||6
11228437|NCT02009397|12420544|FG000|NOT COMPLETED|Overall Study||20
11228438|NCT02009501|12420550|FG000|STARTED|Overall Study||9
11228439|NCT02009501|12420551|FG001|STARTED|Overall Study||11
11228440|NCT02009501|12420550|FG000|COMPLETED|Overall Study||9
11228441|NCT02009501|12420551|FG001|COMPLETED|Overall Study||11
11228442|NCT02009501|12420550|FG000|NOT COMPLETED|Overall Study||0
11228443|NCT02009501|12420551|FG001|NOT COMPLETED|Overall Study||0
11228444|NCT02009696|12420557|FG000|STARTED|Overall Study||221
11228445|NCT02009696|12420557|FG000|COMPLETED|Overall Study||219
11228446|NCT02009696|12420557|FG000|NOT COMPLETED|Overall Study||2
11228447|NCT02009722|12420563|FG000|STARTED|Overall Study||41
11228448|NCT02009722|12420564|FG001|STARTED|Overall Study||43
11228449|NCT02009722|12420563|FG000|Received Intervention|Overall Study||41
11228450|NCT02009722|12420564|FG001|Received Intervention|Overall Study||42
11228451|NCT02009722|12420563|FG000|COMPLETED|Overall Study||40
11228452|NCT02009722|12420564|FG001|COMPLETED|Overall Study||40
11228453|NCT02009722|12420563|FG000|NOT COMPLETED|Overall Study||1
11228454|NCT02009722|12420564|FG001|NOT COMPLETED|Overall Study||3
11228455|NCT02009865|12420572|FG000|STARTED|Overall Study||81
11228456|NCT02009865|12420573|FG001|STARTED|Overall Study||81
11228457|NCT02009865|12420572|FG000|COMPLETED|Overall Study||80
11228458|NCT02009865|12420573|FG001|COMPLETED|Overall Study||76
11228459|NCT02009865|12420572|FG000|NOT COMPLETED|Overall Study||1
11228460|NCT02009865|12420573|FG001|NOT COMPLETED|Overall Study||5
11228461|NCT02009878|12420582|FG000|STARTED|Overall Study||10
11228462|NCT02009878|12420583|FG001|STARTED|Overall Study||11
11228463|NCT02009878|12420584|FG002|STARTED|Overall Study||9
11228464|NCT02009878|12420582|FG000|COMPLETED|Overall Study||10
11228465|NCT02009878|12420583|FG001|COMPLETED|Overall Study||10
11228466|NCT02009878|12420584|FG002|COMPLETED|Overall Study||9
11228467|NCT02009878|12420582|FG000|NOT COMPLETED|Overall Study||0
11228468|NCT02009878|12420583|FG001|NOT COMPLETED|Overall Study||1
11228469|NCT02009878|12420584|FG002|NOT COMPLETED|Overall Study||0
11228470|NCT02009930|12420592|FG000|STARTED|Overall Study|5 withdrawn|112
11228471|NCT02009930|12420592|FG000|COMPLETED|Overall Study||107
11228472|NCT02009930|12420592|FG000|NOT COMPLETED|Overall Study||5
11228473|NCT02010021|12420605|FG000|STARTED|Overall Study||10
11228474|NCT02010021|12420606|FG001|STARTED|Overall Study||7
11228475|NCT02010021|12420605|FG000|COMPLETED|Overall Study||10
11228476|NCT02010021|12420606|FG001|COMPLETED|Overall Study||7
11228477|NCT02010021|12420605|FG000|NOT COMPLETED|Overall Study||0
11228478|NCT02010021|12420606|FG001|NOT COMPLETED|Overall Study||0
11228479|NCT02010151|12420614|FG000|STARTED|Overall Study|January 2013 to December 2017|1498
11228480|NCT02010151|12420615|FG001|STARTED|Overall Study|January 2013 to December 2017|1696
11228481|NCT02010151|12420614|FG000|COMPLETED|Overall Study|Text message (TM) sent: 0|1498
11228482|NCT02010151|12420615|FG001|COMPLETED|Overall Study|TM sent: 598|1696
11228483|NCT02010151|12420614|FG000|NOT COMPLETED|Overall Study||0
11228484|NCT02010151|12420615|FG001|NOT COMPLETED|Overall Study||0
11109670|NCT01275300|12294096|FG001|COMPLETED|Washout (14 Days)||4
11109671|NCT01275300|12294095|FG000|NOT COMPLETED|Washout (14 Days)||0
11109672|NCT01275300|12294096|FG001|NOT COMPLETED|Washout (14 Days)||0
11109673|NCT01275300|12294095|FG000|STARTED|2nd Intervention(5 Days)||5
11109674|NCT01275300|12294096|FG001|STARTED|2nd Intervention(5 Days)||4
11109675|NCT01275300|12294095|FG000|COMPLETED|2nd Intervention(5 Days)||5
11109676|NCT01275300|12294096|FG001|COMPLETED|2nd Intervention(5 Days)||4
11109677|NCT01275300|12294095|FG000|NOT COMPLETED|2nd Intervention(5 Days)||0
11109678|NCT01275300|12294096|FG001|NOT COMPLETED|2nd Intervention(5 Days)||0
11109679|NCT01275300|12294095|FG000|STARTED|Washout (14 Days)||5
11109680|NCT01275300|12294096|FG001|STARTED|Washout (14 Days)||4
11109681|NCT01275300|12294095|FG000|COMPLETED|Washout (14 Days)||5
11109682|NCT01275300|12294096|FG001|COMPLETED|Washout (14 Days)||4
11109683|NCT01275300|12294095|FG000|NOT COMPLETED|Washout (14 Days)||0
11109684|NCT01275300|12294096|FG001|NOT COMPLETED|Washout (14 Days)||0
11228485|NCT02010203|12420626|FG000|STARTED|Overall Study||10
10866074|NCT01622868|12031135|FG000|STARTED|Overall Study||72
10866075|NCT01622868|12031136|FG001|STARTED|Overall Study||71
10866076|NCT01622868|12031135|FG000|Eligible|Overall Study||65
10866077|NCT01622868|12031136|FG001|Eligible|Overall Study||71
10866078|NCT01622868|12031135|FG000|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||63
11228486|NCT02010203|12420627|FG001|STARTED|Overall Study||26
10866079|NCT01622868|12031136|FG001|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||71
10866080|NCT01622868|12031135|FG000|COMPLETED|Overall Study||65
10866081|NCT01622868|12031136|FG001|COMPLETED|Overall Study||71
10866082|NCT01622868|12031135|FG000|NOT COMPLETED|Overall Study||7
10866083|NCT01622868|12031136|FG001|NOT COMPLETED|Overall Study||0
10866084|NCT01609790|12031145|FG000|STARTED|Overall Study||7
10866085|NCT01609790|12031146|FG001|STARTED|Overall Study||65
10866086|NCT01609790|12031147|FG002|STARTED|Overall Study||65
10866087|NCT01609790|12031145|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
10866088|NCT01609790|12031146|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
10866089|NCT01609790|12031147|FG002|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
10866090|NCT01609790|12031145|FG000|NOT COMPLETED|Overall Study||1
10866091|NCT01609790|12031146|FG001|NOT COMPLETED|Overall Study||7
11228487|NCT02010203|12420628|FG002|STARTED|Overall Study||26
11228488|NCT02010203|12420629|FG003|STARTED|Overall Study||26
11228489|NCT02010203|12420630|FG004|STARTED|Overall Study||16
11228490|NCT02010203|12420626|FG000|COMPLETED|Overall Study||10
11228491|NCT02010203|12420627|FG001|COMPLETED|Overall Study||17
11228492|NCT02010203|12420628|FG002|COMPLETED|Overall Study||16
11228493|NCT02010203|12420629|FG003|COMPLETED|Overall Study||23
11228494|NCT02010203|12420630|FG004|COMPLETED|Overall Study||3
11228495|NCT02010203|12420626|FG000|NOT COMPLETED|Overall Study||0
11228496|NCT02010203|12420627|FG001|NOT COMPLETED|Overall Study||9
11228497|NCT02010203|12420628|FG002|NOT COMPLETED|Overall Study||10
11228498|NCT02010203|12420629|FG003|NOT COMPLETED|Overall Study||3
11228499|NCT02010203|12420630|FG004|NOT COMPLETED|Overall Study||13
11228500|NCT02010216|12420642|FG000|STARTED|Overall Study||23
11228501|NCT02010216|12420642|FG000|COMPLETED|Overall Study||23
11228502|NCT02010216|12420642|FG000|NOT COMPLETED|Overall Study||0
11228503|NCT02010255|12420660|FG000|STARTED|Overall Study||28
11228504|NCT02010255|12420661|FG001|STARTED|Overall Study||28
11228505|NCT02010255|12420662|FG002|STARTED|Overall Study||25
11228506|NCT02010255|12420663|FG003|STARTED|Overall Study||26
11228507|NCT02010255|12420664|FG004|STARTED|Overall Study||52
11228508|NCT02010255|12420665|FG005|STARTED|Overall Study||49
11228509|NCT02010255|12420666|FG006|STARTED|Overall Study||34
11228510|NCT02010255|12420667|FG007|STARTED|Overall Study||33
11228511|NCT02010255|12420668|FG008|STARTED|Overall Study||22
11228512|NCT02010255|12420669|FG009|STARTED|Overall Study||23
11228513|NCT02010255|12420670|FG010|STARTED|Overall Study||3
11228514|NCT02010255|12420671|FG011|STARTED|Overall Study||5
11228515|NCT02010255|12420672|FG012|STARTED|Overall Study||3
11228516|NCT02010255|12420673|FG013|STARTED|Overall Study||3
11228517|NCT02010255|12420660|FG000|COMPLETED|Overall Study||22
11228518|NCT02010255|12420661|FG001|COMPLETED|Overall Study||26
11228519|NCT02010255|12420662|FG002|COMPLETED|Overall Study||18
11228520|NCT02010255|12420663|FG003|COMPLETED|Overall Study||20
11228521|NCT02010255|12420664|FG004|COMPLETED|Overall Study||48
11228522|NCT02010255|12420665|FG005|COMPLETED|Overall Study||49
11228523|NCT02010255|12420666|FG006|COMPLETED|Overall Study||33
11228524|NCT02010255|12420667|FG007|COMPLETED|Overall Study||32
11228525|NCT02010255|12420668|FG008|COMPLETED|Overall Study||21
11228526|NCT02010255|12420669|FG009|COMPLETED|Overall Study||23
11228527|NCT02010255|12420670|FG010|COMPLETED|Overall Study||1
11228528|NCT02010255|12420671|FG011|COMPLETED|Overall Study||4
11228529|NCT02010255|12420672|FG012|COMPLETED|Overall Study||3
11228530|NCT02010255|12420673|FG013|COMPLETED|Overall Study||2
11228531|NCT02010255|12420660|FG000|NOT COMPLETED|Overall Study||6
11228532|NCT02010255|12420661|FG001|NOT COMPLETED|Overall Study||2
11228533|NCT02010255|12420662|FG002|NOT COMPLETED|Overall Study||7
11228534|NCT02010255|12420663|FG003|NOT COMPLETED|Overall Study||6
11228535|NCT02010255|12420664|FG004|NOT COMPLETED|Overall Study||4
11228536|NCT02010255|12420665|FG005|NOT COMPLETED|Overall Study||0
10866092|NCT01609790|12031147|FG002|NOT COMPLETED|Overall Study||8
11109685|NCT01275300|12294095|FG000|STARTED|Phase 2: Open-label 6days)||5
11109686|NCT01275300|12294096|FG001|STARTED|Phase 2: Open-label 6days)||4
11109687|NCT01275300|12294095|FG000|COMPLETED|Phase 2: Open-label 6days)||5
11109688|NCT01275300|12294096|FG001|COMPLETED|Phase 2: Open-label 6days)||4
11109689|NCT01275300|12294095|FG000|NOT COMPLETED|Phase 2: Open-label 6days)||0
11109690|NCT01275300|12294096|FG001|NOT COMPLETED|Phase 2: Open-label 6days)||0
10866099|NCT01539811|12031166|FG000|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
10866100|NCT01539811|12031167|FG001|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
10866101|NCT01539811|12031166|FG000|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
10866102|NCT01539811|12031167|FG001|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
10866103|NCT01539811|12031166|FG000|NOT COMPLETED|Overall Study||0
10866104|NCT01539811|12031167|FG001|NOT COMPLETED|Overall Study||0
10866105|NCT01516879|12031175|FG000|STARTED|Overall Study||303
10866106|NCT01516879|12031176|FG001|STARTED|Overall Study||602
10866107|NCT01516879|12031175|FG000|Received Treatment|Overall Study||302
10866108|NCT01516879|12031176|FG001|Received Treatment|Overall Study||599
10866109|NCT01516879|12031175|FG000|COMPLETED|Overall Study||287
11109691|NCT01275339|12294106|FG000|STARTED|Overall Study||2
11109692|NCT01275339|12294107|FG001|STARTED|Overall Study||0
11109693|NCT01275339|12294108|FG002|STARTED|Overall Study||4
11109694|NCT01275339|12294109|FG003|STARTED|Overall Study||4
11109695|NCT01275339|12294106|FG000|COMPLETED|Overall Study||1
10866110|NCT01516879|12031176|FG001|COMPLETED|Overall Study||568
10866111|NCT01516879|12031175|FG000|NOT COMPLETED|Overall Study||16
10866112|NCT01516879|12031176|FG001|NOT COMPLETED|Overall Study||34
11109696|NCT01275339|12294107|FG001|COMPLETED|Overall Study||0
11109697|NCT01275339|12294108|FG002|COMPLETED|Overall Study||3
11109698|NCT01275339|12294109|FG003|COMPLETED|Overall Study||4
11109699|NCT01275339|12294106|FG000|NOT COMPLETED|Overall Study||1
11109700|NCT01275339|12294107|FG001|NOT COMPLETED|Overall Study||0
11109701|NCT01275339|12294108|FG002|NOT COMPLETED|Overall Study||1
11109702|NCT01275339|12294109|FG003|NOT COMPLETED|Overall Study||0
11109703|NCT01275365|12294123|FG000|STARTED|Overall Study||24
11109704|NCT01275365|12294124|FG001|STARTED|Overall Study||24
11109705|NCT01275365|12294125|FG002|STARTED|Overall Study||22
11109706|NCT01275365|12294126|FG003|STARTED|Overall Study||22
11109707|NCT01275365|12294123|FG000|COMPLETED|Overall Study||21
11109708|NCT01275365|12294124|FG001|COMPLETED|Overall Study||21
11109709|NCT01275365|12294125|FG002|COMPLETED|Overall Study||17
11109710|NCT01275365|12294126|FG003|COMPLETED|Overall Study||19
11109711|NCT01275365|12294123|FG000|NOT COMPLETED|Overall Study||3
11109712|NCT01275365|12294124|FG001|NOT COMPLETED|Overall Study||3
11109713|NCT01275365|12294125|FG002|NOT COMPLETED|Overall Study||5
10866131|NCT01261325|12031215|FG000|STARTED|Overall Study||263
10866132|NCT01261325|12031216|FG001|STARTED|Overall Study||254
10866133|NCT01261325|12031217|FG002|STARTED|Overall Study||251
10866134|NCT01261325|12031215|FG000|COMPLETED|Overall Study||246
10866135|NCT01261325|12031216|FG001|COMPLETED|Overall Study||225
10866136|NCT01261325|12031217|FG002|COMPLETED|Overall Study||225
10866137|NCT01261325|12031215|FG000|NOT COMPLETED|Overall Study||17
10866138|NCT01261325|12031216|FG001|NOT COMPLETED|Overall Study||29
10866139|NCT01261325|12031217|FG002|NOT COMPLETED|Overall Study||26
11109714|NCT01275365|12294126|FG003|NOT COMPLETED|Overall Study||3
11109715|NCT01275430|12294136|FG000|STARTED|Overall Study||27
11109716|NCT01275430|12294136|FG000|COMPLETED|Overall Study||18
11109717|NCT01275430|12294136|FG000|NOT COMPLETED|Overall Study||9
11109718|NCT01275586|12294141|FG000|STARTED|Overall Study||6
11109719|NCT01275586|12294141|FG000|COMPLETED|Overall Study||3
11109720|NCT01275586|12294141|FG000|NOT COMPLETED|Overall Study||3
11109721|NCT01275625|12294145|FG000|STARTED|Overall Study||77
11109722|NCT01275625|12294145|FG000|Treated|Overall Study||77
11109723|NCT01275625|12294145|FG000|COMPLETED|Overall Study||64
11109724|NCT01275625|12294145|FG000|NOT COMPLETED|Overall Study||13
11109725|NCT01275664|12294149|FG000|STARTED|Overall Study||4
11109726|NCT01275664|12294149|FG000|COMPLETED|Overall Study||4
11109727|NCT01275664|12294149|FG000|NOT COMPLETED|Overall Study||0
11109728|NCT01275755|12294155|FG000|STARTED|Run-in Placebo Period||41
11109729|NCT01275755|12294156|FG001|STARTED|Run-in Placebo Period||40
11109730|NCT01275755|12294155|FG000|COMPLETED|Run-in Placebo Period||41
11109731|NCT01275755|12294156|FG001|COMPLETED|Run-in Placebo Period||40
11109732|NCT01275755|12294155|FG000|NOT COMPLETED|Run-in Placebo Period||0
11109733|NCT01275755|12294156|FG001|NOT COMPLETED|Run-in Placebo Period||0
11109734|NCT01275755|12294155|FG000|STARTED|Double-blind Treatment Period||41
11109735|NCT01275755|12294156|FG001|STARTED|Double-blind Treatment Period||40
11109736|NCT01275755|12294155|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
11109737|NCT01275755|12294156|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
11109738|NCT01275755|12294155|FG000|COMPLETED|Double-blind Treatment Period||39
11109739|NCT01275755|12294156|FG001|COMPLETED|Double-blind Treatment Period||37
11109740|NCT01275755|12294155|FG000|NOT COMPLETED|Double-blind Treatment Period||2
11109741|NCT01275755|12294156|FG001|NOT COMPLETED|Double-blind Treatment Period||3
11109742|NCT01275755|12294155|FG000|STARTED|Run-out Placebo Period||39
11109743|NCT01275755|12294156|FG001|STARTED|Run-out Placebo Period||37
11109744|NCT01275755|12294155|FG000|COMPLETED|Run-out Placebo Period||38
11109745|NCT01275755|12294156|FG001|COMPLETED|Run-out Placebo Period||37
11109746|NCT01275755|12294155|FG000|NOT COMPLETED|Run-out Placebo Period||1
11109747|NCT01275755|12294156|FG001|NOT COMPLETED|Run-out Placebo Period||0
11109748|NCT01275833|12294164|FG000|STARTED|Overall Study||1
11109749|NCT01275833|12294165|FG001|STARTED|Overall Study||1
11109750|NCT01275833|12294164|FG000|COMPLETED|Overall Study||0
11109751|NCT01275833|12294165|FG001|COMPLETED|Overall Study||0
11109752|NCT01275833|12294164|FG000|NOT COMPLETED|Overall Study||1
11109753|NCT01275833|12294165|FG001|NOT COMPLETED|Overall Study||1
11109754|NCT01276041|12294171|FG000|STARTED|Overall Study||70
11109755|NCT01276041|12294171|FG000|COMPLETED|Overall Study||67
11109756|NCT01276041|12294171|FG000|NOT COMPLETED|Overall Study||3
11109757|NCT01276106|12294179|FG000|STARTED|Overall Study||65
11109758|NCT01276106|12294180|FG001|STARTED|Overall Study||64
11109759|NCT01276106|12294181|FG002|STARTED|Overall Study||65
11109760|NCT01276106|12294182|FG003|STARTED|Overall Study||65
11109761|NCT01276106|12294179|FG000|COMPLETED|Overall Study||53
11109762|NCT01276106|12294180|FG001|COMPLETED|Overall Study||55
11109763|NCT01276106|12294181|FG002|COMPLETED|Overall Study||49
11109764|NCT01276106|12294182|FG003|COMPLETED|Overall Study||52
10866191|NCT00746590|12031277|FG000|STARTED|Overall Study||1
10866192|NCT00746590|12031277|FG000|COMPLETED|Overall Study||0
10866193|NCT00746590|12031277|FG000|NOT COMPLETED|Overall Study||1
10866194|NCT00659711|12031283|FG000|STARTED|Overall Study||12
10866195|NCT00659711|12031284|FG001|STARTED|Overall Study||10
10866196|NCT00659711|12031283|FG000|COMPLETED|Overall Study||12
10866197|NCT00659711|12031284|FG001|COMPLETED|Overall Study||10
10866198|NCT00659711|12031283|FG000|NOT COMPLETED|Overall Study||0
11109765|NCT01276106|12294179|FG000|NOT COMPLETED|Overall Study||12
11228537|NCT02010255|12420666|FG006|NOT COMPLETED|Overall Study||1
11228538|NCT02010255|12420667|FG007|NOT COMPLETED|Overall Study||1
11228539|NCT02010255|12420668|FG008|NOT COMPLETED|Overall Study||1
11228540|NCT02010255|12420669|FG009|NOT COMPLETED|Overall Study||0
11228541|NCT02010255|12420670|FG010|NOT COMPLETED|Overall Study||2
11228542|NCT02010255|12420671|FG011|NOT COMPLETED|Overall Study||1
11228543|NCT02010255|12420672|FG012|NOT COMPLETED|Overall Study||0
11228544|NCT02010255|12420673|FG013|NOT COMPLETED|Overall Study||1
11228545|NCT02010359|12420730|FG000|STARTED|Overall Study||15
11228546|NCT02010359|12420731|FG001|STARTED|Overall Study||14
11228547|NCT02010359|12420730|FG000|COMPLETED|Overall Study||13
11228548|NCT02010359|12420731|FG001|COMPLETED|Overall Study||12
11228549|NCT02010359|12420730|FG000|NOT COMPLETED|Overall Study||2
11228550|NCT02010359|12420731|FG001|NOT COMPLETED|Overall Study||2
11228551|NCT02010567|12420742|FG000|STARTED|Overall Study||3
11228552|NCT02010567|12420743|FG001|STARTED|Overall Study||6
11228553|NCT02010567|12420744|FG002|STARTED|Overall Study||14
11228554|NCT02010567|12420745|FG003|STARTED|Overall Study||3
11228555|NCT02010567|12420746|FG004|STARTED|Overall Study||6
11355091|NCT03076970|12551947|FG004|NOT COMPLETED|Period 3||1
11355092|NCT03076970|12551948|FG005|NOT COMPLETED|Period 3||1
11355093|NCT03076970|12551943|FG000|STARTED|Washout Period 3||7
11355094|NCT03076970|12551944|FG001|STARTED|Washout Period 3||7
11355095|NCT03076970|12551945|FG002|STARTED|Washout Period 3||7
11355096|NCT03076970|12551946|FG003|STARTED|Washout Period 3||7
11355097|NCT03076970|12551947|FG004|STARTED|Washout Period 3||5
11355098|NCT03076970|12551948|FG005|STARTED|Washout Period 3||6
11355099|NCT03076970|12551943|FG000|COMPLETED|Washout Period 3||7
11355100|NCT03076970|12551944|FG001|COMPLETED|Washout Period 3||7
11355101|NCT03076970|12551945|FG002|COMPLETED|Washout Period 3||7
11355102|NCT03076970|12551946|FG003|COMPLETED|Washout Period 3||7
11355103|NCT03076970|12551947|FG004|COMPLETED|Washout Period 3||5
11355104|NCT03076970|12551948|FG005|COMPLETED|Washout Period 3||6
11355105|NCT03076970|12551943|FG000|NOT COMPLETED|Washout Period 3||0
11355106|NCT03076970|12551944|FG001|NOT COMPLETED|Washout Period 3||0
11355107|NCT03076970|12551945|FG002|NOT COMPLETED|Washout Period 3||0
11355108|NCT03076970|12551946|FG003|NOT COMPLETED|Washout Period 3||0
11355109|NCT03076970|12551947|FG004|NOT COMPLETED|Washout Period 3||0
11355110|NCT03076970|12551948|FG005|NOT COMPLETED|Washout Period 3||0
11355111|NCT03076983|12551961|FG000|STARTED|Overall Study||55
11355112|NCT03076983|12551962|FG001|STARTED|Overall Study||25
11355113|NCT03076983|12551961|FG000|COMPLETED|Overall Study||55
11355114|NCT03076983|12551962|FG001|COMPLETED|Overall Study||25
11355115|NCT03076983|12551961|FG000|NOT COMPLETED|Overall Study||0
11228556|NCT02010567|12420742|FG000|COMPLETED|Overall Study||3
11228557|NCT02010567|12420743|FG001|COMPLETED|Overall Study||6
11228558|NCT02010567|12420744|FG002|COMPLETED|Overall Study||13
11355116|NCT03076983|12551962|FG001|NOT COMPLETED|Overall Study||0
11355117|NCT03076996|12551968|FG000|STARTED|Overall Study||41
11355118|NCT03076996|12551968|FG000|COMPLETED|Overall Study||35
11355119|NCT03076996|12551968|FG000|NOT COMPLETED|Overall Study||6
11355120|NCT03077165|12551978|FG000|STARTED|Overall Study||21
11355121|NCT03077165|12551979|FG001|STARTED|Overall Study||22
11355122|NCT03077165|12551980|FG002|STARTED|Overall Study||20
11355123|NCT03077165|12551981|FG003|STARTED|Overall Study||19
11355124|NCT03077165|12551982|FG004|STARTED|Overall Study||19
10866199|NCT00659711|12031284|FG001|NOT COMPLETED|Overall Study||0
11109766|NCT01276106|12294180|FG001|NOT COMPLETED|Overall Study||9
11109767|NCT01276106|12294181|FG002|NOT COMPLETED|Overall Study||16
11109768|NCT01276106|12294182|FG003|NOT COMPLETED|Overall Study||13
11109769|NCT01276171|12294195|FG000|STARTED|Overall Study||249
11109770|NCT01276171|12294196|FG001|STARTED|Overall Study||244
11109771|NCT01276171|12294197|FG002|STARTED|Overall Study||256
11109772|NCT01276171|12294195|FG000|COMPLETED|Overall Study||249
11109773|NCT01276171|12294196|FG001|COMPLETED|Overall Study||244
10866208|NCT00490035|12031303|FG000|STARTED|Overall Study||100
10866209|NCT00490035|12031304|FG001|STARTED|Overall Study||99
10866210|NCT00490035|12031305|FG002|STARTED|Overall Study||100
10866211|NCT00490035|12031306|FG003|STARTED|Overall Study||100
10866212|NCT00490035|12031303|FG000|COMPLETED|Overall Study||92
10866213|NCT00490035|12031304|FG001|COMPLETED|Overall Study||93
10866214|NCT00490035|12031305|FG002|COMPLETED|Overall Study||88
10866215|NCT00490035|12031306|FG003|COMPLETED|Overall Study||94
11109774|NCT01276171|12294197|FG002|COMPLETED|Overall Study||256
11109775|NCT01276171|12294195|FG000|NOT COMPLETED|Overall Study||0
11109776|NCT01276171|12294196|FG001|NOT COMPLETED|Overall Study||0
11109777|NCT01276171|12294197|FG002|NOT COMPLETED|Overall Study||0
11109778|NCT01276184|12294207|FG000|STARTED|Overall Study||13
11109779|NCT01276184|12294208|FG001|STARTED|Overall Study||9
11355125|NCT03077165|12551983|FG005|STARTED|Overall Study||20
11355126|NCT03077165|12551978|FG000|COMPLETED|Overall Study||20
11355127|NCT03077165|12551979|FG001|COMPLETED|Overall Study||22
11109780|NCT01276184|12294207|FG000|COMPLETED|Overall Study||13
11109781|NCT01276184|12294208|FG001|COMPLETED|Overall Study||9
11109782|NCT01276184|12294207|FG000|NOT COMPLETED|Overall Study||0
11109783|NCT01276184|12294208|FG001|NOT COMPLETED|Overall Study||0
11109784|NCT01276197|12294216|FG000|STARTED|Overall Study||308
11109785|NCT01276197|12294217|FG001|STARTED|Overall Study||310
11109786|NCT01276197|12294216|FG000|COMPLETED|Overall Study||200
11109787|NCT01276197|12294217|FG001|COMPLETED|Overall Study||200
11109788|NCT01276197|12294216|FG000|NOT COMPLETED|Overall Study||108
11109789|NCT01276197|12294217|FG001|NOT COMPLETED|Overall Study||110
11109790|NCT01276223|12294226|FG000|STARTED|Overall Study||78
11109791|NCT01276223|12294227|FG001|STARTED|Overall Study||107
11109792|NCT01276223|12294228|FG002|STARTED|Overall Study||104
11109793|NCT01276223|12294226|FG000|COMPLETED|Overall Study||67
11109794|NCT01276223|12294227|FG001|COMPLETED|Overall Study||103
11109795|NCT01276223|12294228|FG002|COMPLETED|Overall Study||101
11109796|NCT01276223|12294226|FG000|NOT COMPLETED|Overall Study||11
11109797|NCT01276223|12294227|FG001|NOT COMPLETED|Overall Study||4
11109798|NCT01276223|12294228|FG002|NOT COMPLETED|Overall Study||3
10866216|NCT00490035|12031303|FG000|NOT COMPLETED|Overall Study||8
10866217|NCT00490035|12031304|FG001|NOT COMPLETED|Overall Study||6
10866218|NCT00490035|12031305|FG002|NOT COMPLETED|Overall Study||12
10866219|NCT00490035|12031306|FG003|NOT COMPLETED|Overall Study||6
10866220|NCT00464269|12031320|FG000|STARTED|Overall Study||99
10866221|NCT00464269|12031321|FG001|STARTED|Overall Study||99
10866222|NCT00464269|12031322|FG002|STARTED|Overall Study||100
10866223|NCT00464269|12031323|FG003|STARTED|Overall Study||102
11109799|NCT01276236|12294235|FG000|STARTED|Overall Study||13
11109800|NCT01276236|12294235|FG000|Week 36 Visit|Overall Study||13
11109801|NCT01276236|12294235|FG000|Week 56 Visit|Overall Study||9
11109802|NCT01276236|12294235|FG000|Week 76 Visit|Overall Study||8
11109803|NCT01276236|12294235|FG000|COMPLETED|Overall Study||7
11109804|NCT01276236|12294235|FG000|NOT COMPLETED|Overall Study||6
11109805|NCT01276288|12294239|FG000|STARTED|Overall Study||7
11109806|NCT01276288|12294240|FG001|STARTED|Overall Study||6
11109807|NCT01276288|12294241|FG002|STARTED|Overall Study||5
11109808|NCT01276288|12294242|FG003|STARTED|Overall Study||5
11109809|NCT01276288|12294239|FG000|Received EMPA|Overall Study||6
11109810|NCT01276288|12294240|FG001|Received EMPA|Overall Study||5
11109811|NCT01276288|12294241|FG002|Received EMPA|Overall Study||5
11109812|NCT01276288|12294242|FG003|Received EMPA|Overall Study||5
11109813|NCT01276288|12294239|FG000|Received EMPA+HCT|Overall Study||5
11109814|NCT01276288|12294240|FG001|Received EMPA+HCT|Overall Study||5
11109815|NCT01276288|12294241|FG002|Received EMPA+HCT|Overall Study||0
11109816|NCT01276288|12294242|FG003|Received EMPA+HCT|Overall Study||0
11109817|NCT01276288|12294239|FG000|Received EMPA+TOR|Overall Study||0
11109818|NCT01276288|12294240|FG001|Received EMPA+TOR|Overall Study||0
11109819|NCT01276288|12294241|FG002|Received EMPA+TOR|Overall Study||5
11109820|NCT01276288|12294242|FG003|Received EMPA+TOR|Overall Study||5
11109821|NCT01276288|12294239|FG000|COMPLETED|Overall Study||5
11109822|NCT01276288|12294240|FG001|COMPLETED|Overall Study||5
11109823|NCT01276288|12294241|FG002|COMPLETED|Overall Study||5
10866224|NCT00464269|12031320|FG000|COMPLETED|Overall Study||93
10866225|NCT00464269|12031321|FG001|COMPLETED|Overall Study||82
10866226|NCT00464269|12031322|FG002|COMPLETED|Overall Study||93
10866227|NCT00464269|12031323|FG003|COMPLETED|Overall Study||93
10866228|NCT00464269|12031320|FG000|NOT COMPLETED|Overall Study||6
10866229|NCT00464269|12031321|FG001|NOT COMPLETED|Overall Study||17
10866230|NCT00464269|12031322|FG002|NOT COMPLETED|Overall Study||7
10866231|NCT00464269|12031323|FG003|NOT COMPLETED|Overall Study||9
10866232|NCT00334815|12031337|FG000|STARTED|Overall Study||16
10866233|NCT00334815|12031338|FG001|STARTED|Overall Study||13
10866234|NCT00334815|12031337|FG000|COMPLETED|Overall Study||9
10866235|NCT00334815|12031338|FG001|COMPLETED|Overall Study||3
10866236|NCT00334815|12031337|FG000|NOT COMPLETED|Overall Study||7
10866237|NCT00334815|12031338|FG001|NOT COMPLETED|Overall Study||10
10866238|NCT00042289|12031393|FG000|STARTED|Overall Study||26
10866239|NCT00042289|12031394|FG001|STARTED|Overall Study||30
10866240|NCT00042289|12031395|FG002|STARTED|Overall Study||27
10866241|NCT00042289|12031396|FG003|STARTED|Overall Study||33
10866242|NCT00042289|12031397|FG004|STARTED|Overall Study||29
10866243|NCT00042289|12031398|FG005|STARTED|Overall Study||31
10866244|NCT00042289|12031399|FG006|STARTED|Overall Study||28
10866245|NCT00042289|12031400|FG007|STARTED|Overall Study||12
10866246|NCT00042289|12031401|FG008|STARTED|Overall Study||27
10866247|NCT00042289|12031402|FG009|STARTED|Overall Study||24
10866248|NCT00042289|12031403|FG010|STARTED|Overall Study||2
10866249|NCT00042289|12031404|FG011|STARTED|Overall Study||27
10866250|NCT00042289|12031405|FG012|STARTED|Overall Study||13
10866251|NCT00042289|12031406|FG013|STARTED|Overall Study||2
10866252|NCT00042289|12031407|FG014|STARTED|Overall Study||6
10866253|NCT00042289|12031408|FG015|STARTED|Overall Study||29
10866254|NCT00042289|12031409|FG016|STARTED|Overall Study||28
10866255|NCT00042289|12031410|FG017|STARTED|Overall Study||12
10866256|NCT00042289|12031411|FG018|STARTED|Overall Study||26
10866257|NCT00042289|12031412|FG019|STARTED|Overall Study||17
10866258|NCT00042289|12031413|FG020|STARTED|Overall Study||1
10866259|NCT00042289|12031414|FG021|STARTED|Overall Study||30
10866260|NCT00042289|12031415|FG022|STARTED|Overall Study||29
11109824|NCT01276288|12294242|FG003|COMPLETED|Overall Study||5
11109825|NCT01276288|12294239|FG000|NOT COMPLETED|Overall Study||2
11109826|NCT01276288|12294240|FG001|NOT COMPLETED|Overall Study||1
11109827|NCT01276288|12294241|FG002|NOT COMPLETED|Overall Study||0
10866261|NCT00042289|12031416|FG023|STARTED|Overall Study||22
10866262|NCT00042289|12031417|FG024|STARTED|Overall Study||18
10866263|NCT00042289|12031418|FG025|STARTED|Overall Study||21
10866264|NCT00042289|12031419|FG026|STARTED|Overall Study||28
10866265|NCT00042289|12031420|FG027|STARTED|Overall Study||25
10866266|NCT00042289|12031421|FG028|STARTED|Overall Study||29
10866267|NCT00042289|12031422|FG029|STARTED|Overall Study||25
10866268|NCT00042289|12031423|FG030|STARTED|Overall Study||1
10866269|NCT00042289|12031424|FG031|STARTED|Overall Study||35
10866270|NCT00042289|12031425|FG032|STARTED|Overall Study||43
10866271|NCT00042289|12031426|FG033|STARTED|Overall Study||16
10866272|NCT00042289|12031427|FG034|STARTED|Overall Study||12
10866273|NCT00042289|12031428|FG035|STARTED|Overall Study||32
10866274|NCT00042289|12031429|FG036|STARTED|Overall Study||36
10866275|NCT00042289|12031430|FG037|STARTED|Overall Study||38
10866276|NCT00042289|12031431|FG038|STARTED|Overall Study||35
10866277|NCT00042289|12031432|FG039|STARTED|Overall Study||18
10866278|NCT00042289|12031433|FG040|STARTED|Overall Study||26
10866279|NCT00042289|12031434|FG041|STARTED|Overall Study||25
10866280|NCT00042289|12031435|FG042|STARTED|Overall Study||32
10866281|NCT00042289|12031436|FG043|STARTED|Overall Study||25
10866282|NCT00042289|12031437|FG044|STARTED|Overall Study||27
10866283|NCT00042289|12031438|FG045|STARTED|Overall Study||27
10866284|NCT00042289|12031439|FG046|STARTED|Overall Study||28
10866285|NCT00042289|12031393|FG000|Infant Started|Overall Study||25
10866286|NCT00042289|12031394|FG001|Infant Started|Overall Study||30
10866287|NCT00042289|12031395|FG002|Infant Started|Overall Study||27
10866288|NCT00042289|12031396|FG003|Infant Started|Overall Study||32
10866289|NCT00042289|12031397|FG004|Infant Started|Overall Study||28
10866290|NCT00042289|12031398|FG005|Infant Started|Overall Study||31
10866291|NCT00042289|12031399|FG006|Infant Started|Overall Study||27
10866292|NCT00042289|12031400|FG007|Infant Started|Overall Study||12
10866293|NCT00042289|12031401|FG008|Infant Started|Overall Study||26
10866294|NCT00042289|12031402|FG009|Infant Started|Overall Study||23
10866295|NCT00042289|12031403|FG010|Infant Started|Overall Study||2
10866296|NCT00042289|12031404|FG011|Infant Started|Overall Study||27
10866297|NCT00042289|12031405|FG012|Infant Started|Overall Study||14
10866298|NCT00042289|12031406|FG013|Infant Started|Overall Study||0
10866299|NCT00042289|12031407|FG014|Infant Started|Overall Study||0
10866300|NCT00042289|12031408|FG015|Infant Started|Overall Study||0
10866301|NCT00042289|12031409|FG016|Infant Started|Overall Study||0
10866302|NCT00042289|12031410|FG017|Infant Started|Overall Study||0
10866303|NCT00042289|12031411|FG018|Infant Started|Overall Study||0
10866304|NCT00042289|12031412|FG019|Infant Started|Overall Study||0
10866305|NCT00042289|12031413|FG020|Infant Started|Overall Study||0
10866306|NCT00042289|12031414|FG021|Infant Started|Overall Study||9
10866307|NCT00042289|12031415|FG022|Infant Started|Overall Study||0
10866308|NCT00042289|12031416|FG023|Infant Started|Overall Study||22
10866309|NCT00042289|12031417|FG024|Infant Started|Overall Study||4
10866310|NCT00042289|12031418|FG025|Infant Started|Overall Study||5
10866311|NCT00042289|12031419|FG026|Infant Started|Overall Study||0
10866312|NCT00042289|12031420|FG027|Infant Started|Overall Study||21
10866313|NCT00042289|12031421|FG028|Infant Started|Overall Study||0
10866314|NCT00042289|12031422|FG029|Infant Started|Overall Study||21
10866315|NCT00042289|12031423|FG030|Infant Started|Overall Study||0
10866316|NCT00042289|12031424|FG031|Infant Started|Overall Study||0
10866317|NCT00042289|12031425|FG032|Infant Started|Overall Study||6
10866318|NCT00042289|12031426|FG033|Infant Started|Overall Study||6
10866319|NCT00042289|12031427|FG034|Infant Started|Overall Study||4
10866320|NCT00042289|12031428|FG035|Infant Started|Overall Study||0
10866321|NCT00042289|12031429|FG036|Infant Started|Overall Study||9
10866322|NCT00042289|12031430|FG037|Infant Started|Overall Study||38
10866323|NCT00042289|12031431|FG038|Infant Started|Overall Study||35
10866324|NCT00042289|12031432|FG039|Infant Started|Overall Study||0
10866325|NCT00042289|12031433|FG040|Infant Started|Overall Study||26
10866326|NCT00042289|12031434|FG041|Infant Started|Overall Study||25
10866327|NCT00042289|12031435|FG042|Infant Started|Overall Study||30
10866328|NCT00042289|12031436|FG043|Infant Started|Overall Study||0
10866329|NCT00042289|12031437|FG044|Infant Started|Overall Study||0
10866330|NCT00042289|12031438|FG045|Infant Started|Overall Study||0
10866331|NCT00042289|12031439|FG046|Infant Started|Overall Study||0
10866332|NCT00042289|12031393|FG000|Infant Completed|Overall Study||21
10866333|NCT00042289|12031394|FG001|Infant Completed|Overall Study||28
11109828|NCT01276288|12294242|FG003|NOT COMPLETED|Overall Study||0
11109829|NCT01276301|12294264|FG000|STARTED|First Intervention||8
11109830|NCT01276301|12294265|FG001|STARTED|First Intervention||8
11109831|NCT01276301|12294264|FG000|COMPLETED|First Intervention||8
11109832|NCT01276301|12294265|FG001|COMPLETED|First Intervention||8
11109833|NCT01276301|12294264|FG000|NOT COMPLETED|First Intervention||0
11109834|NCT01276301|12294265|FG001|NOT COMPLETED|First Intervention||0
11109835|NCT01276301|12294264|FG000|STARTED|Washout Period of 7 Days||8
11228559|NCT02010567|12420745|FG003|COMPLETED|Overall Study||3
11228560|NCT02010567|12420746|FG004|COMPLETED|Overall Study||5
11228561|NCT02010567|12420742|FG000|NOT COMPLETED|Overall Study||0
11228562|NCT02010567|12420743|FG001|NOT COMPLETED|Overall Study||0
11228563|NCT02010567|12420744|FG002|NOT COMPLETED|Overall Study||1
11228564|NCT02010567|12420745|FG003|NOT COMPLETED|Overall Study||0
11228565|NCT02010567|12420746|FG004|NOT COMPLETED|Overall Study||1
11109836|NCT01276301|12294265|FG001|STARTED|Washout Period of 7 Days||8
11109837|NCT01276301|12294264|FG000|COMPLETED|Washout Period of 7 Days||8
11228566|NCT02010632|12420756|FG000|STARTED|First Intervention (7 Days)||16
11228567|NCT02010632|12420757|FG001|STARTED|First Intervention (7 Days)||16
11228568|NCT02010632|12420756|FG000|COMPLETED|First Intervention (7 Days)||16
11228569|NCT02010632|12420757|FG001|COMPLETED|First Intervention (7 Days)||16
11228570|NCT02010632|12420756|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11228571|NCT02010632|12420757|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11228572|NCT02010632|12420756|FG000|STARTED|Wash Out Period (14 Days)||16
11228573|NCT02010632|12420757|FG001|STARTED|Wash Out Period (14 Days)||16
11228574|NCT02010632|12420756|FG000|COMPLETED|Wash Out Period (14 Days)||16
11228575|NCT02010632|12420757|FG001|COMPLETED|Wash Out Period (14 Days)||16
11228576|NCT02010632|12420756|FG000|NOT COMPLETED|Wash Out Period (14 Days)||0
11228577|NCT02010632|12420757|FG001|NOT COMPLETED|Wash Out Period (14 Days)||0
11228578|NCT02010632|12420756|FG000|STARTED|Second Intervention (7 Days)||16
11228579|NCT02010632|12420757|FG001|STARTED|Second Intervention (7 Days)||16
11228580|NCT02010632|12420756|FG000|COMPLETED|Second Intervention (7 Days)||15
11228581|NCT02010632|12420757|FG001|COMPLETED|Second Intervention (7 Days)||16
11228582|NCT02010632|12420756|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
11228583|NCT02010632|12420757|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11228584|NCT02010645|12420763|FG000|STARTED|Overall Study||6
11228585|NCT02010645|12420763|FG000|COMPLETED|Overall Study||6
11228586|NCT02010645|12420763|FG000|NOT COMPLETED|Overall Study||0
11228587|NCT02010684|12420769|FG000|STARTED|Overall Study||39
11228588|NCT02010684|12420770|FG001|STARTED|Overall Study||82
11228589|NCT02010684|12420769|FG000|COMPLETED|Overall Study||27
11228590|NCT02010684|12420770|FG001|COMPLETED|Overall Study||59
11228591|NCT02010684|12420769|FG000|NOT COMPLETED|Overall Study||12
11109838|NCT01276301|12294265|FG001|COMPLETED|Washout Period of 7 Days||8
11109839|NCT01276301|12294264|FG000|NOT COMPLETED|Washout Period of 7 Days||0
11109840|NCT01276301|12294265|FG001|NOT COMPLETED|Washout Period of 7 Days||0
10866334|NCT00042289|12031395|FG002|Infant Completed|Overall Study||27
10866335|NCT00042289|12031396|FG003|Infant Completed|Overall Study||29
10866336|NCT00042289|12031397|FG004|Infant Completed|Overall Study||26
10866337|NCT00042289|12031398|FG005|Infant Completed|Overall Study||25
10866338|NCT00042289|12031399|FG006|Infant Completed|Overall Study||26
10866339|NCT00042289|12031400|FG007|Infant Completed|Overall Study||10
11109841|NCT01276301|12294264|FG000|STARTED|Second Intervention||8
11109842|NCT01276301|12294265|FG001|STARTED|Second Intervention||8
10866340|NCT00042289|12031401|FG008|Infant Completed|Overall Study||25
10866341|NCT00042289|12031402|FG009|Infant Completed|Overall Study||20
10866342|NCT00042289|12031403|FG010|Infant Completed|Overall Study||2
10866343|NCT00042289|12031404|FG011|Infant Completed|Overall Study||24
10866344|NCT00042289|12031405|FG012|Infant Completed|Overall Study||11
10866345|NCT00042289|12031406|FG013|Infant Completed|Overall Study||0
10866346|NCT00042289|12031407|FG014|Infant Completed|Overall Study||0
10866347|NCT00042289|12031408|FG015|Infant Completed|Overall Study||0
10866348|NCT00042289|12031409|FG016|Infant Completed|Overall Study||0
10866349|NCT00042289|12031410|FG017|Infant Completed|Overall Study||0
10866350|NCT00042289|12031411|FG018|Infant Completed|Overall Study||0
10866351|NCT00042289|12031412|FG019|Infant Completed|Overall Study||0
10866352|NCT00042289|12031413|FG020|Infant Completed|Overall Study||0
10866353|NCT00042289|12031414|FG021|Infant Completed|Overall Study||9
10866354|NCT00042289|12031415|FG022|Infant Completed|Overall Study||0
10866355|NCT00042289|12031416|FG023|Infant Completed|Overall Study||20
10866356|NCT00042289|12031417|FG024|Infant Completed|Overall Study||3
10866357|NCT00042289|12031418|FG025|Infant Completed|Overall Study||5
10866358|NCT00042289|12031419|FG026|Infant Completed|Overall Study||0
10866359|NCT00042289|12031420|FG027|Infant Completed|Overall Study||20
10866360|NCT00042289|12031421|FG028|Infant Completed|Overall Study||0
10866361|NCT00042289|12031422|FG029|Infant Completed|Overall Study||21
10866362|NCT00042289|12031423|FG030|Infant Completed|Overall Study||0
10866363|NCT00042289|12031424|FG031|Infant Completed|Overall Study||0
10866364|NCT00042289|12031425|FG032|Infant Completed|Overall Study||6
10866365|NCT00042289|12031426|FG033|Infant Completed|Overall Study||4
10866366|NCT00042289|12031427|FG034|Infant Completed|Overall Study||4
10866367|NCT00042289|12031428|FG035|Infant Completed|Overall Study||0
10866368|NCT00042289|12031429|FG036|Infant Completed|Overall Study||8
10866369|NCT00042289|12031430|FG037|Infant Completed|Overall Study||35
10866370|NCT00042289|12031431|FG038|Infant Completed|Overall Study||34
10866371|NCT00042289|12031432|FG039|Infant Completed|Overall Study||0
10866372|NCT00042289|12031433|FG040|Infant Completed|Overall Study||26
10866373|NCT00042289|12031434|FG041|Infant Completed|Overall Study||21
10866374|NCT00042289|12031435|FG042|Infant Completed|Overall Study||27
11109843|NCT01276301|12294264|FG000|COMPLETED|Second Intervention||8
11109844|NCT01276301|12294265|FG001|COMPLETED|Second Intervention||8
11109845|NCT01276301|12294264|FG000|NOT COMPLETED|Second Intervention||0
11109846|NCT01276301|12294265|FG001|NOT COMPLETED|Second Intervention||0
11109847|NCT01276314|12294276|FG000|STARTED|Overall Study||48
11109848|NCT01276314|12294277|FG001|STARTED|Overall Study||43
11109849|NCT01276314|12294278|FG002|STARTED|Overall Study||22
11109850|NCT01276314|12294279|FG003|STARTED|Overall Study||22
11109851|NCT01276314|12294276|FG000|COMPLETED|Overall Study||38
11109852|NCT01276314|12294277|FG001|COMPLETED|Overall Study||33
11109853|NCT01276314|12294278|FG002|COMPLETED|Overall Study||18
11109854|NCT01276314|12294279|FG003|COMPLETED|Overall Study||17
11109855|NCT01276314|12294276|FG000|NOT COMPLETED|Overall Study||10
11109856|NCT01276314|12294277|FG001|NOT COMPLETED|Overall Study||10
11109857|NCT01276314|12294278|FG002|NOT COMPLETED|Overall Study||4
10866375|NCT00042289|12031436|FG043|Infant Completed|Overall Study||0
10866376|NCT00042289|12031437|FG044|Infant Completed|Overall Study||0
10866377|NCT00042289|12031438|FG045|Infant Completed|Overall Study||0
10866378|NCT00042289|12031439|FG046|Infant Completed|Overall Study||0
10866379|NCT00042289|12031393|FG000|COMPLETED|Overall Study||19
10866380|NCT00042289|12031394|FG001|COMPLETED|Overall Study||29
10866381|NCT00042289|12031395|FG002|COMPLETED|Overall Study||27
10866382|NCT00042289|12031396|FG003|COMPLETED|Overall Study||25
11228592|NCT02010684|12420770|FG001|NOT COMPLETED|Overall Study||23
11228593|NCT02010697|12420779|FG000|STARTED|Overall Study||1044
11228594|NCT02010697|12420780|FG001|STARTED|Overall Study||1038
11228595|NCT02010697|12420781|FG002|STARTED|Overall Study||1043
11228596|NCT02010697|12420779|FG000|COMPLETED|Overall Study||1044
11228597|NCT02010697|12420780|FG001|COMPLETED|Overall Study||1038
11228598|NCT02010697|12420781|FG002|COMPLETED|Overall Study||1043
11228599|NCT02010697|12420779|FG000|NOT COMPLETED|Overall Study||0
11228600|NCT02010697|12420780|FG001|NOT COMPLETED|Overall Study||0
11228601|NCT02010697|12420781|FG002|NOT COMPLETED|Overall Study||0
11228602|NCT02010775|12420794|FG000|STARTED|Overall Study||38
11228603|NCT02010775|12420795|FG001|STARTED|Overall Study||38
11228604|NCT02010775|12420796|FG002|STARTED|Overall Study||37
11228605|NCT02010775|12420797|FG003|STARTED|Overall Study||37
11228606|NCT02010775|12420798|FG004|STARTED|Overall Study||37
11228607|NCT02010775|12420794|FG000|COMPLETED|Overall Study||33
11228608|NCT02010775|12420795|FG001|COMPLETED|Overall Study||35
11228609|NCT02010775|12420796|FG002|COMPLETED|Overall Study||34
11228610|NCT02010775|12420797|FG003|COMPLETED|Overall Study||34
11228611|NCT02010775|12420798|FG004|COMPLETED|Overall Study||31
11228612|NCT02010775|12420794|FG000|NOT COMPLETED|Overall Study||5
11228613|NCT02010775|12420795|FG001|NOT COMPLETED|Overall Study||3
11228614|NCT02010775|12420796|FG002|NOT COMPLETED|Overall Study||3
11228615|NCT02010775|12420797|FG003|NOT COMPLETED|Overall Study||3
10866383|NCT00042289|12031397|FG004|COMPLETED|Overall Study||26
10866384|NCT00042289|12031398|FG005|COMPLETED|Overall Study||25
10866385|NCT00042289|12031399|FG006|COMPLETED|Overall Study||22
10866386|NCT00042289|12031400|FG007|COMPLETED|Overall Study||10
10866387|NCT00042289|12031401|FG008|COMPLETED|Overall Study||26
10866388|NCT00042289|12031402|FG009|COMPLETED|Overall Study||23
10866389|NCT00042289|12031403|FG010|COMPLETED|Overall Study||2
10866390|NCT00042289|12031404|FG011|COMPLETED|Overall Study||27
10866391|NCT00042289|12031405|FG012|COMPLETED|Overall Study||11
10866392|NCT00042289|12031406|FG013|COMPLETED|Overall Study||2
10866393|NCT00042289|12031407|FG014|COMPLETED|Overall Study||6
10866394|NCT00042289|12031408|FG015|COMPLETED|Overall Study||28
10866395|NCT00042289|12031409|FG016|COMPLETED|Overall Study||27
11228616|NCT02010775|12420798|FG004|NOT COMPLETED|Overall Study||6
11228617|NCT02010996|12420812|FG000|STARTED|Overall Study||36
11228618|NCT02010996|12420813|FG001|STARTED|Overall Study||36
11228619|NCT02010996|12420812|FG000|COMPLETED|Overall Study||36
11228620|NCT02010996|12420813|FG001|COMPLETED|Overall Study||36
11228621|NCT02010996|12420812|FG000|NOT COMPLETED|Overall Study||0
10866396|NCT00042289|12031410|FG017|COMPLETED|Overall Study||12
10866397|NCT00042289|12031411|FG018|COMPLETED|Overall Study||18
10866398|NCT00042289|12031412|FG019|COMPLETED|Overall Study||13
10866399|NCT00042289|12031413|FG020|COMPLETED|Overall Study||1
10866400|NCT00042289|12031414|FG021|COMPLETED|Overall Study||26
10866401|NCT00042289|12031415|FG022|COMPLETED|Overall Study||27
10866402|NCT00042289|12031416|FG023|COMPLETED|Overall Study||17
10866403|NCT00042289|12031417|FG024|COMPLETED|Overall Study||17
10866404|NCT00042289|12031418|FG025|COMPLETED|Overall Study||20
10866405|NCT00042289|12031419|FG026|COMPLETED|Overall Study||20
10866406|NCT00042289|12031420|FG027|COMPLETED|Overall Study||22
10866407|NCT00042289|12031421|FG028|COMPLETED|Overall Study||21
10866408|NCT00042289|12031422|FG029|COMPLETED|Overall Study||25
10866409|NCT00042289|12031423|FG030|COMPLETED|Overall Study||0
10866410|NCT00042289|12031424|FG031|COMPLETED|Overall Study||26
10866411|NCT00042289|12031425|FG032|COMPLETED|Overall Study||38
10866412|NCT00042289|12031426|FG033|COMPLETED|Overall Study||10
10866413|NCT00042289|12031427|FG034|COMPLETED|Overall Study||10
10866414|NCT00042289|12031428|FG035|COMPLETED|Overall Study||27
10866415|NCT00042289|12031429|FG036|COMPLETED|Overall Study||32
10866416|NCT00042289|12031430|FG037|COMPLETED|Overall Study||36
10866417|NCT00042289|12031431|FG038|COMPLETED|Overall Study||33
10866418|NCT00042289|12031432|FG039|COMPLETED|Overall Study||13
10866419|NCT00042289|12031433|FG040|COMPLETED|Overall Study||26
10866420|NCT00042289|12031434|FG041|COMPLETED|Overall Study||22
10866421|NCT00042289|12031435|FG042|COMPLETED|Overall Study||25
10866422|NCT00042289|12031436|FG043|COMPLETED|Overall Study||22
10866423|NCT00042289|12031437|FG044|COMPLETED|Overall Study||27
10866424|NCT00042289|12031438|FG045|COMPLETED|Overall Study||26
10866425|NCT00042289|12031439|FG046|COMPLETED|Overall Study||27
10866426|NCT00042289|12031393|FG000|NOT COMPLETED|Overall Study||7
10866427|NCT00042289|12031394|FG001|NOT COMPLETED|Overall Study||1
10866428|NCT00042289|12031395|FG002|NOT COMPLETED|Overall Study||0
10866429|NCT00042289|12031396|FG003|NOT COMPLETED|Overall Study||8
10866430|NCT00042289|12031397|FG004|NOT COMPLETED|Overall Study||3
10866431|NCT00042289|12031398|FG005|NOT COMPLETED|Overall Study||6
10866432|NCT00042289|12031399|FG006|NOT COMPLETED|Overall Study||6
10866433|NCT00042289|12031400|FG007|NOT COMPLETED|Overall Study||2
10866434|NCT00042289|12031401|FG008|NOT COMPLETED|Overall Study||1
10866435|NCT00042289|12031402|FG009|NOT COMPLETED|Overall Study||1
10866436|NCT00042289|12031403|FG010|NOT COMPLETED|Overall Study||0
10866437|NCT00042289|12031404|FG011|NOT COMPLETED|Overall Study||0
10866438|NCT00042289|12031405|FG012|NOT COMPLETED|Overall Study||2
10866439|NCT00042289|12031406|FG013|NOT COMPLETED|Overall Study||0
10866440|NCT00042289|12031407|FG014|NOT COMPLETED|Overall Study||0
10866441|NCT00042289|12031408|FG015|NOT COMPLETED|Overall Study||1
10866442|NCT00042289|12031409|FG016|NOT COMPLETED|Overall Study||1
10866443|NCT00042289|12031410|FG017|NOT COMPLETED|Overall Study||0
10866444|NCT00042289|12031411|FG018|NOT COMPLETED|Overall Study||8
10866445|NCT00042289|12031412|FG019|NOT COMPLETED|Overall Study||4
10866446|NCT00042289|12031413|FG020|NOT COMPLETED|Overall Study||0
10866447|NCT00042289|12031414|FG021|NOT COMPLETED|Overall Study||4
10866448|NCT00042289|12031415|FG022|NOT COMPLETED|Overall Study||2
10866449|NCT00042289|12031416|FG023|NOT COMPLETED|Overall Study||5
10866450|NCT00042289|12031417|FG024|NOT COMPLETED|Overall Study||1
10866451|NCT00042289|12031418|FG025|NOT COMPLETED|Overall Study||1
10866452|NCT00042289|12031419|FG026|NOT COMPLETED|Overall Study||8
10866453|NCT00042289|12031420|FG027|NOT COMPLETED|Overall Study||3
10866454|NCT00042289|12031421|FG028|NOT COMPLETED|Overall Study||8
10866455|NCT00042289|12031422|FG029|NOT COMPLETED|Overall Study||0
10866456|NCT00042289|12031423|FG030|NOT COMPLETED|Overall Study||1
10866457|NCT00042289|12031424|FG031|NOT COMPLETED|Overall Study||9
10866458|NCT00042289|12031425|FG032|NOT COMPLETED|Overall Study||5
10866459|NCT00042289|12031426|FG033|NOT COMPLETED|Overall Study||6
10866460|NCT00042289|12031427|FG034|NOT COMPLETED|Overall Study||2
10866461|NCT00042289|12031428|FG035|NOT COMPLETED|Overall Study||5
10866462|NCT00042289|12031429|FG036|NOT COMPLETED|Overall Study||4
10866463|NCT00042289|12031430|FG037|NOT COMPLETED|Overall Study||2
10866464|NCT00042289|12031431|FG038|NOT COMPLETED|Overall Study||2
10866465|NCT00042289|12031432|FG039|NOT COMPLETED|Overall Study||5
10866466|NCT00042289|12031433|FG040|NOT COMPLETED|Overall Study||0
10866467|NCT00042289|12031434|FG041|NOT COMPLETED|Overall Study||3
10866468|NCT00042289|12031435|FG042|NOT COMPLETED|Overall Study||7
10866469|NCT00042289|12031436|FG043|NOT COMPLETED|Overall Study||3
10866470|NCT00042289|12031437|FG044|NOT COMPLETED|Overall Study||0
10866471|NCT00042289|12031438|FG045|NOT COMPLETED|Overall Study||1
10866472|NCT00042289|12031439|FG046|NOT COMPLETED|Overall Study||1
10866473|NCT02540330|12031609|FG000|STARTED|Overall Study||2
10866474|NCT02540330|12031610|FG001|STARTED|Overall Study||1
10866475|NCT02540330|12031609|FG000|COMPLETED|Overall Study||2
10866476|NCT02540330|12031610|FG001|COMPLETED|Overall Study||1
10866477|NCT02540330|12031609|FG000|NOT COMPLETED|Overall Study||0
10866478|NCT02540330|12031610|FG001|NOT COMPLETED|Overall Study||0
10866479|NCT02417701|12031616|FG000|STARTED|Overall Study||34
10866480|NCT02417701|12031616|FG000|COMPLETED|Overall Study||34
10866481|NCT02417701|12031616|FG000|NOT COMPLETED|Overall Study||0
10866482|NCT02384993|12031625|FG000|STARTED|Overall Study||12
10866483|NCT02384993|12031626|FG001|STARTED|Overall Study||12
10866484|NCT02384993|12031625|FG000|COMPLETED|Overall Study||12
10866485|NCT02384993|12031626|FG001|COMPLETED|Overall Study||11
10866486|NCT02384993|12031625|FG000|NOT COMPLETED|Overall Study||0
10866487|NCT02384993|12031626|FG001|NOT COMPLETED|Overall Study||1
10866488|NCT02304302|12031635|FG000|STARTED|Overall Study||79
10866489|NCT02304302|12031636|FG001|STARTED|Overall Study||81
10866490|NCT02304302|12031635|FG000|COMPLETED|Overall Study||76
10866491|NCT02304302|12031636|FG001|COMPLETED|Overall Study||73
10866492|NCT02304302|12031635|FG000|NOT COMPLETED|Overall Study||3
10866493|NCT02304302|12031636|FG001|NOT COMPLETED|Overall Study||8
10866494|NCT02269670|12031646|FG000|STARTED|Overall Study||3
10866495|NCT02269670|12031646|FG000|COMPLETED|Overall Study||0
10866496|NCT02269670|12031646|FG000|NOT COMPLETED|Overall Study||3
10866500|NCT01860976|12031656|FG000|STARTED|Blinded Treatment||213
10866501|NCT01860976|12031657|FG001|STARTED|Blinded Treatment||211
10866502|NCT01860976|12031656|FG000|COMPLETED|Blinded Treatment||125
10866503|NCT01860976|12031657|FG001|COMPLETED|Blinded Treatment||98
10866504|NCT01860976|12031656|FG000|NOT COMPLETED|Blinded Treatment||88
10866505|NCT01860976|12031657|FG001|NOT COMPLETED|Blinded Treatment||113
10866506|NCT01860976|12031656|FG000|STARTED|Open-Label||197
10866507|NCT01860976|12031657|FG001|STARTED|Open-Label||185
10866508|NCT01860976|12031656|FG000|COMPLETED|Open-Label||169
10866509|NCT01860976|12031657|FG001|COMPLETED|Open-Label||166
10866510|NCT01860976|12031656|FG000|NOT COMPLETED|Open-Label||28
10866511|NCT01860976|12031657|FG001|NOT COMPLETED|Open-Label||19
10866512|NCT01860976|12031656|FG000|STARTED|Long Term Extension||106
10866513|NCT01860976|12031657|FG001|STARTED|Long Term Extension||0
10866514|NCT01860976|12031656|FG000|COMPLETED|Long Term Extension||81
10866515|NCT01860976|12031657|FG001|COMPLETED|Long Term Extension||0
10866516|NCT01860976|12031656|FG000|NOT COMPLETED|Long Term Extension||25
10866517|NCT01860976|12031657|FG001|NOT COMPLETED|Long Term Extension||0
10866518|NCT01761266|12031668|FG000|STARTED|Overall Study||478
10866519|NCT01761266|12031669|FG001|STARTED|Overall Study||476
10866520|NCT01761266|12031668|FG000|Treated|Overall Study||476
10866521|NCT01761266|12031669|FG001|Treated|Overall Study||475
10866522|NCT01761266|12031668|FG000|COMPLETED|Overall Study||0
10866523|NCT01761266|12031669|FG001|COMPLETED|Overall Study||0
10866524|NCT01761266|12031668|FG000|NOT COMPLETED|Overall Study||478
10866525|NCT01761266|12031669|FG001|NOT COMPLETED|Overall Study||476
10866526|NCT01550289|12031680|FG000|STARTED|Overall Study||128
10866527|NCT01550289|12031681|FG001|STARTED|Overall Study||61
10866528|NCT01550289|12031680|FG000|COMPLETED|Overall Study||115
10866529|NCT01550289|12031681|FG001|COMPLETED|Overall Study||57
10866530|NCT01550289|12031680|FG000|NOT COMPLETED|Overall Study||13
10866531|NCT01550289|12031681|FG001|NOT COMPLETED|Overall Study||4
10866532|NCT01346709|12031689|FG000|STARTED|Overall Study||5450
10866533|NCT01346709|12031689|FG000|COMPLETED|Overall Study||5099
10866534|NCT01346709|12031689|FG000|NOT COMPLETED|Overall Study||351
10866535|NCT01074190|12031696|FG000|STARTED|Overall Study||115
10866536|NCT01074190|12031697|FG001|STARTED|Overall Study||115
10866537|NCT01074190|12031698|FG002|STARTED|Overall Study||115
10866538|NCT01074190|12031696|FG000|COMPLETED|Overall Study||111
10866539|NCT01074190|12031697|FG001|COMPLETED|Overall Study||109
10866540|NCT01074190|12031698|FG002|COMPLETED|Overall Study||112
10866541|NCT01074190|12031696|FG000|NOT COMPLETED|Overall Study||4
10866542|NCT01074190|12031697|FG001|NOT COMPLETED|Overall Study||6
10866543|NCT01074190|12031698|FG002|NOT COMPLETED|Overall Study||3
10866544|NCT00875524|12031711|FG000|STARTED|Overall Study||120
10866545|NCT00875524|12031712|FG001|STARTED|Overall Study||60
10866546|NCT00875524|12031711|FG000|Received Vaccination 1|Overall Study||120
10866547|NCT00875524|12031712|FG001|Received Vaccination 1|Overall Study||60
10866548|NCT00875524|12031711|FG000|Received Vaccination 2|Overall Study||116
10866549|NCT00875524|12031712|FG001|Received Vaccination 2|Overall Study||58
10866550|NCT00875524|12031711|FG000|Received Vaccination 3|Overall Study||114
10866551|NCT00875524|12031712|FG001|Received Vaccination 3|Overall Study||58
10866552|NCT00875524|12031711|FG000|COMPLETED|Overall Study||112
10866553|NCT00875524|12031712|FG001|COMPLETED|Overall Study||54
10866554|NCT00875524|12031711|FG000|NOT COMPLETED|Overall Study||8
10866555|NCT00875524|12031712|FG001|NOT COMPLETED|Overall Study||6
10866556|NCT00842530|12031720|FG000|STARTED|Overall Study||2669
10866557|NCT00842530|12031721|FG001|STARTED|Overall Study||1333
10866558|NCT00842530|12031720|FG000|Received Vaccination 1|Overall Study||2666
10866559|NCT00842530|12031721|FG001|Received Vaccination 1|Overall Study||1331
10866560|NCT00842530|12031720|FG000|Received Vaccination 2|Overall Study||2584
10866561|NCT00842530|12031721|FG001|Received Vaccination 2|Overall Study||1300
10866562|NCT00842530|12031720|FG000|Received Vaccination 3|Overall Study||2557
10866563|NCT00842530|12031721|FG001|Received Vaccination 3|Overall Study||1282
10866564|NCT00842530|12031720|FG000|COMPLETED|Overall Study||2552
10866565|NCT00842530|12031721|FG001|COMPLETED|Overall Study||1276
10866566|NCT00842530|12031720|FG000|NOT COMPLETED|Overall Study||117
10866567|NCT00842530|12031721|FG001|NOT COMPLETED|Overall Study||57
10866568|NCT00788151|12031730|FG000|STARTED|Overall Study||200
10866569|NCT00788151|12031731|FG001|STARTED|Overall Study||100
10866570|NCT00788151|12031730|FG000|Received Vaccination 1|Overall Study||199
10866571|NCT00788151|12031731|FG001|Received Vaccination 1|Overall Study||99
10866572|NCT00788151|12031730|FG000|Received Vaccination 2|Overall Study||188
10866573|NCT00788151|12031731|FG001|Received Vaccination 2|Overall Study||92
11109858|NCT01276314|12294279|FG003|NOT COMPLETED|Overall Study||5
11109859|NCT01276327|12294291|FG000|STARTED|Overall Study||32
11109860|NCT01276327|12294292|FG001|STARTED|Overall Study||32
11109861|NCT01276327|12294291|FG000|COMPLETED|Overall Study||30
11109862|NCT01276327|12294292|FG001|COMPLETED|Overall Study||29
11109863|NCT01276327|12294291|FG000|NOT COMPLETED|Overall Study||2
11109864|NCT01276327|12294292|FG001|NOT COMPLETED|Overall Study||3
11109865|NCT01276353|12294300|FG000|STARTED|Double-blind||22
11109866|NCT01276353|12294301|FG001|STARTED|Double-blind||23
11109867|NCT01276353|12294300|FG000|COMPLETED|Double-blind||19
11109868|NCT01276353|12294301|FG001|COMPLETED|Double-blind||23
11109869|NCT01276353|12294300|FG000|NOT COMPLETED|Double-blind||3
11109870|NCT01276353|12294301|FG001|NOT COMPLETED|Double-blind||0
11109871|NCT01276353|12294300|FG000|STARTED|Extension||19
11109872|NCT01276353|12294301|FG001|STARTED|Extension||23
11109873|NCT01276353|12294300|FG000|COMPLETED|Extension||12
11109874|NCT01276353|12294301|FG001|COMPLETED|Extension||14
11109875|NCT01276353|12294300|FG000|NOT COMPLETED|Extension||7
11109876|NCT01276353|12294301|FG001|NOT COMPLETED|Extension||9
11109877|NCT01276379|12294313|FG000|STARTED|Overall Study||221
11109878|NCT01276379|12294313|FG000|COMPLETED|Overall Study||181
11109879|NCT01276379|12294313|FG000|NOT COMPLETED|Overall Study||40
11109880|NCT01276457|12294321|FG000|STARTED|Core Study||142
11109881|NCT01276457|12294322|FG001|STARTED|Core Study||143
11109882|NCT01276457|12294321|FG000|COMPLETED|Core Study||129
11109883|NCT01276457|12294322|FG001|COMPLETED|Core Study||123
11109884|NCT01276457|12294321|FG000|NOT COMPLETED|Core Study||13
11109885|NCT01276457|12294322|FG001|NOT COMPLETED|Core Study||20
11109886|NCT01276457|12294321|FG000|STARTED|Extension Study||111
11109887|NCT01276457|12294322|FG001|STARTED|Extension Study||112
11109888|NCT01276457|12294321|FG000|COMPLETED|Extension Study||105
11109889|NCT01276457|12294322|FG001|COMPLETED|Extension Study||110
11109890|NCT01276457|12294321|FG000|NOT COMPLETED|Extension Study||6
11109891|NCT01276457|12294322|FG001|NOT COMPLETED|Extension Study||2
11109892|NCT01276509|12294332|FG000|STARTED|Overall Study||66
11109893|NCT01276509|12294333|FG001|STARTED|Overall Study||65
11109894|NCT01276509|12294334|FG002|STARTED|Overall Study||68
11109895|NCT01276509|12294335|FG003|STARTED|Overall Study||63
11109896|NCT01276509|12294332|FG000|COMPLETED|Overall Study||53
11109897|NCT01276509|12294333|FG001|COMPLETED|Overall Study||53
11228622|NCT02010996|12420813|FG001|NOT COMPLETED|Overall Study||0
11228623|NCT02011113|12420823|FG000|STARTED|Overall Study||36
11109898|NCT01276509|12294334|FG002|COMPLETED|Overall Study||63
11109899|NCT01276509|12294335|FG003|COMPLETED|Overall Study||58
11109900|NCT01276509|12294332|FG000|NOT COMPLETED|Overall Study||13
11109901|NCT01276509|12294333|FG001|NOT COMPLETED|Overall Study||12
11109902|NCT01276509|12294334|FG002|NOT COMPLETED|Overall Study||5
11109903|NCT01276509|12294335|FG003|NOT COMPLETED|Overall Study||5
11228624|NCT02011113|12420823|FG000|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
11228625|NCT02011113|12420823|FG000|NOT COMPLETED|Overall Study||36
11228626|NCT02011386|12420828|FG000|STARTED|Overall Study||53
11228627|NCT02011386|12420828|FG000|COMPLETED|Overall Study||48
11228628|NCT02011386|12420828|FG000|NOT COMPLETED|Overall Study||5
11228629|NCT02011464|12420834|FG000|STARTED|Overall Study||10
11228630|NCT02011464|12420835|FG001|STARTED|Overall Study||10
11109904|NCT01276535|12294345|FG000|STARTED|Overall Study||12
11109905|NCT01276535|12294345|FG000|COMPLETED|Overall Study||12
11109906|NCT01276535|12294345|FG000|NOT COMPLETED|Overall Study||0
11109907|NCT01276639|12294352|FG000|STARTED|Week 0 to 16||363
11109908|NCT01276639|12294353|FG001|STARTED|Week 0 to 16||361
11109909|NCT01276639|12294354|FG002|STARTED|Week 0 to 16||177
11109910|NCT01276639|12294355|FG003|STARTED|Week 0 to 16||0
11109911|NCT01276639|12294356|FG004|STARTED|Week 0 to 16||0
11109912|NCT01276639|12294352|FG000|Treated|Week 0 to 16||363
11109913|NCT01276639|12294353|FG001|Treated|Week 0 to 16||360
11109914|NCT01276639|12294354|FG002|Treated|Week 0 to 16||177
11109915|NCT01276639|12294355|FG003|Treated|Week 0 to 16||0
11109916|NCT01276639|12294356|FG004|Treated|Week 0 to 16||0
11109917|NCT01276639|12294352|FG000|COMPLETED|Week 0 to 16||313
11109918|NCT01276639|12294353|FG001|COMPLETED|Week 0 to 16||320
11109919|NCT01276639|12294354|FG002|COMPLETED|Week 0 to 16||132
11109920|NCT01276639|12294355|FG003|COMPLETED|Week 0 to 16||0
11109921|NCT01276639|12294356|FG004|COMPLETED|Week 0 to 16||0
11109922|NCT01276639|12294352|FG000|NOT COMPLETED|Week 0 to 16||50
11228631|NCT02011464|12420834|FG000|COMPLETED|Overall Study||10
11228632|NCT02011464|12420835|FG001|COMPLETED|Overall Study||10
11228633|NCT02011464|12420834|FG000|NOT COMPLETED|Overall Study||0
11109923|NCT01276639|12294353|FG001|NOT COMPLETED|Week 0 to 16||41
11109924|NCT01276639|12294354|FG002|NOT COMPLETED|Week 0 to 16||45
11109925|NCT01276639|12294355|FG003|NOT COMPLETED|Week 0 to 16||0
11109926|NCT01276639|12294356|FG004|NOT COMPLETED|Week 0 to 16||0
11109927|NCT01276639|12294352|FG000|STARTED|Week 16 to 52||313
10866574|NCT00788151|12031730|FG000|Received Vaccination 3|Overall Study||186
10866575|NCT00788151|12031731|FG001|Received Vaccination 3|Overall Study||90
10866576|NCT00788151|12031730|FG000|COMPLETED|Overall Study||186
10866577|NCT00788151|12031731|FG001|COMPLETED|Overall Study||90
10866578|NCT00788151|12031730|FG000|NOT COMPLETED|Overall Study||14
10866579|NCT00788151|12031731|FG001|NOT COMPLETED|Overall Study||10
10866580|NCT00539591|12031740|FG000|STARTED|Overall Study||23
10866581|NCT00539591|12031741|FG001|STARTED|Overall Study||2
10866582|NCT00539591|12031742|FG002|STARTED|Overall Study||4
10866583|NCT00539591|12031740|FG000|COMPLETED|Overall Study||18
10866584|NCT00539591|12031741|FG001|COMPLETED|Overall Study||0
10866585|NCT00539591|12031742|FG002|COMPLETED|Overall Study||1
10866586|NCT00539591|12031740|FG000|NOT COMPLETED|Overall Study||5
10866587|NCT00539591|12031741|FG001|NOT COMPLETED|Overall Study||2
10866588|NCT00539591|12031742|FG002|NOT COMPLETED|Overall Study||3
11109928|NCT01276639|12294353|FG001|STARTED|Week 16 to 52||320
11109929|NCT01276639|12294354|FG002|STARTED|Week 16 to 52||0
11109930|NCT01276639|12294355|FG003|STARTED|Week 16 to 52||66
11109931|NCT01276639|12294356|FG004|STARTED|Week 16 to 52||66
11109932|NCT01276639|12294352|FG000|COMPLETED|Week 16 to 52||186
11109933|NCT01276639|12294353|FG001|COMPLETED|Week 16 to 52||219
11109934|NCT01276639|12294354|FG002|COMPLETED|Week 16 to 52||0
11109935|NCT01276639|12294355|FG003|COMPLETED|Week 16 to 52||50
11109936|NCT01276639|12294356|FG004|COMPLETED|Week 16 to 52||45
11109937|NCT01276639|12294352|FG000|NOT COMPLETED|Week 16 to 52||127
11109938|NCT01276639|12294353|FG001|NOT COMPLETED|Week 16 to 52||101
11109939|NCT01276639|12294354|FG002|NOT COMPLETED|Week 16 to 52||0
11109940|NCT01276639|12294355|FG003|NOT COMPLETED|Week 16 to 52||16
11109941|NCT01276639|12294356|FG004|NOT COMPLETED|Week 16 to 52||21
11109942|NCT01276652|12294374|FG000|STARTED|Period 1: Randomization||9
11109943|NCT01276652|12294375|FG001|STARTED|Period 1: Randomization||8
11109944|NCT01276652|12294376|FG002|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
11109945|NCT01276652|12294374|FG000|COMPLETED|Period 1: Randomization||9
11109946|NCT01276652|12294375|FG001|COMPLETED|Period 1: Randomization||8
11109947|NCT01276652|12294376|FG002|COMPLETED|Period 1: Randomization||0
11109948|NCT01276652|12294374|FG000|NOT COMPLETED|Period 1: Randomization||0
11109949|NCT01276652|12294375|FG001|NOT COMPLETED|Period 1: Randomization||0
11109950|NCT01276652|12294376|FG002|NOT COMPLETED|Period 1: Randomization||0
11109951|NCT01276652|12294374|FG000|STARTED|Period 2: Observational||9
11109952|NCT01276652|12294375|FG001|STARTED|Period 2: Observational||8
11109953|NCT01276652|12294376|FG002|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
11109954|NCT01276652|12294374|FG000|COMPLETED|Period 2: Observational||9
11109955|NCT01276652|12294375|FG001|COMPLETED|Period 2: Observational||8
11109956|NCT01276652|12294376|FG002|COMPLETED|Period 2: Observational||5
11109957|NCT01276652|12294374|FG000|NOT COMPLETED|Period 2: Observational||0
11109958|NCT01276652|12294375|FG001|NOT COMPLETED|Period 2: Observational||0
11109959|NCT01276652|12294376|FG002|NOT COMPLETED|Period 2: Observational||0
11109960|NCT01276756|12294391|FG000|STARTED|Overall Study||50
11109961|NCT01276756|12294392|FG001|STARTED|Overall Study||50
11109962|NCT01276756|12294391|FG000|COMPLETED|Overall Study||45
11109963|NCT01276756|12294392|FG001|COMPLETED|Overall Study||48
11109964|NCT01276756|12294391|FG000|NOT COMPLETED|Overall Study||5
11109965|NCT01276756|12294392|FG001|NOT COMPLETED|Overall Study||2
11109966|NCT01276821|12294400|FG000|STARTED|Overall Study||50
11109967|NCT01276821|12294401|FG001|STARTED|Overall Study||50
11109968|NCT01276821|12294400|FG000|COMPLETED|Overall Study||50
11109969|NCT01276821|12294401|FG001|COMPLETED|Overall Study||49
10866589|NCT04794751|12031778|FG000|STARTED|Period 1||38
10866590|NCT04794751|12031779|FG001|STARTED|Period 1||37
10866591|NCT04794751|12031778|FG000|COMPLETED|Period 1||36
10866592|NCT04794751|12031779|FG001|COMPLETED|Period 1||32
10866593|NCT04794751|12031778|FG000|NOT COMPLETED|Period 1||2
10866594|NCT04794751|12031779|FG001|NOT COMPLETED|Period 1||5
10866595|NCT04794751|12031778|FG000|STARTED|Period 2||36
10866596|NCT04794751|12031779|FG001|STARTED|Period 2||32
10866597|NCT04794751|12031778|FG000|COMPLETED|Period 2||35
10866598|NCT04794751|12031779|FG001|COMPLETED|Period 2||29
10866599|NCT04794751|12031778|FG000|NOT COMPLETED|Period 2||1
10866600|NCT04794751|12031779|FG001|NOT COMPLETED|Period 2||3
10866601|NCT04794751|12031778|FG000|STARTED|Period 3||35
10866602|NCT04794751|12031779|FG001|STARTED|Period 3||29
10866603|NCT04794751|12031778|FG000|COMPLETED|Period 3||35
10866604|NCT04794751|12031779|FG001|COMPLETED|Period 3||29
10866605|NCT04794751|12031778|FG000|NOT COMPLETED|Period 3||0
10866606|NCT04794751|12031779|FG001|NOT COMPLETED|Period 3||0
10866607|NCT04584645|12031787|FG000|STARTED|Overall Study||24570
10866608|NCT04584645|12031788|FG001|STARTED|Overall Study||24568
10866609|NCT04584645|12031787|FG000|COMPLETED|Overall Study||5575
10866610|NCT04584645|12031788|FG001|COMPLETED|Overall Study||5662
10866611|NCT04584645|12031787|FG000|NOT COMPLETED|Overall Study||18995
10866612|NCT04584645|12031788|FG001|NOT COMPLETED|Overall Study||18906
10866613|NCT04538170|12031814|FG000|STARTED|Overall Study||158
10866614|NCT04538170|12031815|FG001|STARTED|Overall Study||265
10866615|NCT04538170|12031814|FG000|COMPLETED|Overall Study||54
10866616|NCT04538170|12031815|FG001|COMPLETED|Overall Study||55
10866617|NCT04538170|12031814|FG000|NOT COMPLETED|Overall Study||104
10866618|NCT04538170|12031815|FG001|NOT COMPLETED|Overall Study||210
10866619|NCT04461015|12031827|FG000|STARTED|Overall Study||5
10866620|NCT04461015|12031828|FG001|STARTED|Overall Study||7
10866621|NCT04461015|12031827|FG000|COMPLETED|Overall Study||5
10866622|NCT04461015|12031828|FG001|COMPLETED|Overall Study||5
10866623|NCT04461015|12031827|FG000|NOT COMPLETED|Overall Study||0
11228634|NCT02011464|12420835|FG001|NOT COMPLETED|Overall Study||0
11228635|NCT02011490|12420856|FG000|STARTED|Part 1||8
11228636|NCT02011490|12420857|FG001|STARTED|Part 1||8
11228637|NCT02011490|12420858|FG002|STARTED|Part 1||8
11228638|NCT02011490|12420859|FG003|STARTED|Part 1||0
11228639|NCT02011490|12420860|FG004|STARTED|Part 1||0
11228640|NCT02011490|12420861|FG005|STARTED|Part 1||0
11228641|NCT02011490|12420856|FG000|COMPLETED|Part 1||8
11228642|NCT02011490|12420857|FG001|COMPLETED|Part 1||8
11228643|NCT02011490|12420858|FG002|COMPLETED|Part 1||8
11228644|NCT02011490|12420859|FG003|COMPLETED|Part 1||0
11228645|NCT02011490|12420860|FG004|COMPLETED|Part 1||0
11228646|NCT02011490|12420861|FG005|COMPLETED|Part 1||0
11228647|NCT02011490|12420856|FG000|NOT COMPLETED|Part 1||0
11228648|NCT02011490|12420857|FG001|NOT COMPLETED|Part 1||0
11228649|NCT02011490|12420858|FG002|NOT COMPLETED|Part 1||0
11228650|NCT02011490|12420859|FG003|NOT COMPLETED|Part 1||0
11228651|NCT02011490|12420860|FG004|NOT COMPLETED|Part 1||0
11228652|NCT02011490|12420861|FG005|NOT COMPLETED|Part 1||0
11228653|NCT02011490|12420856|FG000|STARTED|Part 2||0
11228654|NCT02011490|12420857|FG001|STARTED|Part 2||0
11228655|NCT02011490|12420858|FG002|STARTED|Part 2||0
11228656|NCT02011490|12420859|FG003|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
11228657|NCT02011490|12420860|FG004|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
11228658|NCT02011490|12420861|FG005|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
11228659|NCT02011490|12420856|FG000|COMPLETED|Part 2||0
11228660|NCT02011490|12420857|FG001|COMPLETED|Part 2||0
11228661|NCT02011490|12420858|FG002|COMPLETED|Part 2||0
11228662|NCT02011490|12420859|FG003|COMPLETED|Part 2||6
11228663|NCT02011490|12420860|FG004|COMPLETED|Part 2||6
11228664|NCT02011490|12420861|FG005|COMPLETED|Part 2||6
11228665|NCT02011490|12420856|FG000|NOT COMPLETED|Part 2||0
10866624|NCT04461015|12031828|FG001|NOT COMPLETED|Overall Study||2
10866625|NCT04380961|12031836|FG000|STARTED|Overall Study||140
10866626|NCT04380961|12031837|FG001|STARTED|Overall Study||72
10866627|NCT04380961|12031836|FG000|Treated|Overall Study||139
10866628|NCT04380961|12031837|FG001|Treated|Overall Study||70
10866629|NCT04380961|12031836|FG000|Participants Who Entered the Follow-up Phase|Overall Study||118
10866630|NCT04380961|12031837|FG001|Participants Who Entered the Follow-up Phase|Overall Study||57
10866631|NCT04380961|12031836|FG000|COMPLETED|Overall Study||96
10866632|NCT04380961|12031837|FG001|COMPLETED|Overall Study||43
10866633|NCT04380961|12031836|FG000|NOT COMPLETED|Overall Study||44
10866634|NCT04380961|12031837|FG001|NOT COMPLETED|Overall Study||29
10866635|NCT04341441|12031849|FG000|STARTED|Overall Study||197
10866636|NCT04341441|12031850|FG001|STARTED|Overall Study||201
10866637|NCT04341441|12031851|FG002|STARTED|Overall Study||200
10866638|NCT04341441|12031852|FG003|STARTED|Overall Study||26
10866639|NCT04341441|12031849|FG000|COMPLETED|Overall Study||188
10866640|NCT04341441|12031850|FG001|COMPLETED|Overall Study||199
10866641|NCT04341441|12031851|FG002|COMPLETED|Overall Study||191
11109970|NCT01276821|12294400|FG000|NOT COMPLETED|Overall Study||0
11109971|NCT01276821|12294401|FG001|NOT COMPLETED|Overall Study||1
11109972|NCT01276847|12294410|FG000|STARTED|Overall Study||10
11109973|NCT01276847|12294411|FG001|STARTED|Overall Study||10
11109974|NCT01276847|12294412|FG002|STARTED|Overall Study||20
11109975|NCT01276847|12294410|FG000|COMPLETED|Overall Study||9
11109976|NCT01276847|12294411|FG001|COMPLETED|Overall Study||10
11109977|NCT01276847|12294412|FG002|COMPLETED|Overall Study||20
11228666|NCT02011490|12420857|FG001|NOT COMPLETED|Part 2||0
11228667|NCT02011490|12420858|FG002|NOT COMPLETED|Part 2||0
10866642|NCT04341441|12031852|FG003|COMPLETED|Overall Study||26
10866643|NCT04341441|12031849|FG000|NOT COMPLETED|Overall Study||9
10866644|NCT04341441|12031850|FG001|NOT COMPLETED|Overall Study||2
10866645|NCT04341441|12031851|FG002|NOT COMPLETED|Overall Study||9
10866646|NCT04341441|12031852|FG003|NOT COMPLETED|Overall Study||0
10866647|NCT04332419|12031862|FG000|STARTED|Overall Study||11
10866648|NCT04332419|12031862|FG000|COMPLETED|Overall Study||10
10866649|NCT04332419|12031862|FG000|NOT COMPLETED|Overall Study||1
10866650|NCT04239872|12031866|FG000|STARTED|Overall Study||11
10866651|NCT04239872|12031867|FG001|STARTED|Overall Study||9
10866652|NCT04239872|12031866|FG000|COMPLETED|Overall Study||11
10866653|NCT04239872|12031867|FG001|COMPLETED|Overall Study||8
10866654|NCT04239872|12031866|FG000|NOT COMPLETED|Overall Study||0
10866655|NCT04239872|12031867|FG001|NOT COMPLETED|Overall Study||1
10866656|NCT04141917|12031875|FG000|STARTED|Surveillance Year 1||63
10866657|NCT04141917|12031876|FG001|STARTED|Surveillance Year 1||76
10866658|NCT04141917|12031877|FG002|STARTED|Surveillance Year 1||81
10866659|NCT04141917|12031878|FG003|STARTED|Surveillance Year 1||324
10866660|NCT04141917|12031875|FG000|COMPLETED|Surveillance Year 1||63
10866661|NCT04141917|12031876|FG001|COMPLETED|Surveillance Year 1||76
10866662|NCT04141917|12031877|FG002|COMPLETED|Surveillance Year 1||81
10866663|NCT04141917|12031878|FG003|COMPLETED|Surveillance Year 1||324
10866664|NCT04141917|12031875|FG000|NOT COMPLETED|Surveillance Year 1||0
10866665|NCT04141917|12031876|FG001|NOT COMPLETED|Surveillance Year 1||0
10866666|NCT04141917|12031877|FG002|NOT COMPLETED|Surveillance Year 1||0
10866667|NCT04141917|12031878|FG003|NOT COMPLETED|Surveillance Year 1||0
10866668|NCT04141917|12031875|FG000|STARTED|Surveillance + Test and Treat Year 1||358
10866669|NCT04141917|12031876|FG001|STARTED|Surveillance + Test and Treat Year 1||153
10866670|NCT04141917|12031877|FG002|STARTED|Surveillance + Test and Treat Year 1||82
10866671|NCT04141917|12031878|FG003|STARTED|Surveillance + Test and Treat Year 1||83
10866672|NCT04141917|12031875|FG000|COMPLETED|Surveillance + Test and Treat Year 1||358
10866673|NCT04141917|12031876|FG001|COMPLETED|Surveillance + Test and Treat Year 1||153
10866674|NCT04141917|12031877|FG002|COMPLETED|Surveillance + Test and Treat Year 1||82
10866675|NCT04141917|12031878|FG003|COMPLETED|Surveillance + Test and Treat Year 1||83
10866676|NCT04141917|12031875|FG000|NOT COMPLETED|Surveillance + Test and Treat Year 1||0
10866677|NCT04141917|12031876|FG001|NOT COMPLETED|Surveillance + Test and Treat Year 1||0
10866678|NCT04141917|12031877|FG002|NOT COMPLETED|Surveillance + Test and Treat Year 1||0
10866679|NCT04141917|12031878|FG003|NOT COMPLETED|Surveillance + Test and Treat Year 1||0
10866680|NCT04141917|12031875|FG000|STARTED|Summer Surveillance||73
10866681|NCT04141917|12031876|FG001|STARTED|Summer Surveillance||39
10866682|NCT04141917|12031877|FG002|STARTED|Summer Surveillance||54
10866683|NCT04141917|12031878|FG003|STARTED|Summer Surveillance||20
10866684|NCT04141917|12031875|FG000|COMPLETED|Summer Surveillance||73
10866685|NCT04141917|12031876|FG001|COMPLETED|Summer Surveillance||39
10866686|NCT04141917|12031877|FG002|COMPLETED|Summer Surveillance||54
10866687|NCT04141917|12031878|FG003|COMPLETED|Summer Surveillance||20
10866688|NCT04141917|12031875|FG000|NOT COMPLETED|Summer Surveillance||0
10866689|NCT04141917|12031876|FG001|NOT COMPLETED|Summer Surveillance||0
10866690|NCT04141917|12031877|FG002|NOT COMPLETED|Summer Surveillance||0
10866691|NCT04141917|12031878|FG003|NOT COMPLETED|Summer Surveillance||0
10866692|NCT04141917|12031875|FG000|STARTED|Surveillance Year 2||3
10866693|NCT04141917|12031876|FG001|STARTED|Surveillance Year 2||3
10866694|NCT04141917|12031877|FG002|STARTED|Surveillance Year 2||10
10866695|NCT04141917|12031878|FG003|STARTED|Surveillance Year 2||7
10866696|NCT04141917|12031875|FG000|COMPLETED|Surveillance Year 2||3
10866697|NCT04141917|12031876|FG001|COMPLETED|Surveillance Year 2||3
10866698|NCT04141917|12031877|FG002|COMPLETED|Surveillance Year 2||10
10866699|NCT04141917|12031878|FG003|COMPLETED|Surveillance Year 2||7
10866700|NCT04141917|12031875|FG000|NOT COMPLETED|Surveillance Year 2||0
10866701|NCT04141917|12031876|FG001|NOT COMPLETED|Surveillance Year 2||0
10866702|NCT04141917|12031877|FG002|NOT COMPLETED|Surveillance Year 2||0
10866703|NCT04141917|12031878|FG003|NOT COMPLETED|Surveillance Year 2||0
10866704|NCT04141917|12031875|FG000|STARTED|Surveillance + Test and Treat Year 2||62
10866705|NCT04141917|12031876|FG001|STARTED|Surveillance + Test and Treat Year 2||13
10866706|NCT04141917|12031877|FG002|STARTED|Surveillance + Test and Treat Year 2||3
10866707|NCT04141917|12031878|FG003|STARTED|Surveillance + Test and Treat Year 2||3
10866708|NCT04141917|12031875|FG000|COMPLETED|Surveillance + Test and Treat Year 2||62
10866709|NCT04141917|12031876|FG001|COMPLETED|Surveillance + Test and Treat Year 2||13
10866710|NCT04141917|12031877|FG002|COMPLETED|Surveillance + Test and Treat Year 2||3
10866711|NCT04141917|12031878|FG003|COMPLETED|Surveillance + Test and Treat Year 2||3
10866712|NCT04141917|12031875|FG000|NOT COMPLETED|Surveillance + Test and Treat Year 2||0
10866713|NCT04141917|12031876|FG001|NOT COMPLETED|Surveillance + Test and Treat Year 2||0
10866714|NCT04141917|12031877|FG002|NOT COMPLETED|Surveillance + Test and Treat Year 2||0
10866715|NCT04141917|12031878|FG003|NOT COMPLETED|Surveillance + Test and Treat Year 2||0
11109978|NCT01276847|12294410|FG000|NOT COMPLETED|Overall Study||1
10866716|NCT04091581|12031886|FG000|STARTED|Overall Study||10
10866717|NCT04091581|12031887|FG001|STARTED|Overall Study||11
10866718|NCT04091581|12031886|FG000|COMPLETED|Overall Study||10
10866719|NCT04091581|12031887|FG001|COMPLETED|Overall Study||10
10866720|NCT04091581|12031886|FG000|NOT COMPLETED|Overall Study||0
11109979|NCT01276847|12294411|FG001|NOT COMPLETED|Overall Study||0
11109980|NCT01276847|12294412|FG002|NOT COMPLETED|Overall Study||0
11109981|NCT01276860|12294421|FG000|STARTED|Overall Study||5
11109982|NCT01276860|12294422|FG001|STARTED|Overall Study||2
11109983|NCT01276860|12294421|FG000|COMPLETED|Overall Study||5
11109984|NCT01276860|12294422|FG001|COMPLETED|Overall Study||2
11109985|NCT01276860|12294421|FG000|NOT COMPLETED|Overall Study||0
11109986|NCT01276860|12294422|FG001|NOT COMPLETED|Overall Study||0
11109987|NCT01277042|12294430|FG000|STARTED|Overall Study||606
11109988|NCT01277042|12294431|FG001|STARTED|Overall Study||606
11109989|NCT01277042|12294430|FG000|COMPLETED|Overall Study||598
11109990|NCT01277042|12294431|FG001|COMPLETED|Overall Study||601
11228668|NCT02011490|12420859|FG003|NOT COMPLETED|Part 2||0
11228669|NCT02011490|12420860|FG004|NOT COMPLETED|Part 2||0
11228670|NCT02011490|12420861|FG005|NOT COMPLETED|Part 2||0
11228671|NCT02011516|12420877|FG000|STARTED|Overall Study||8
11228672|NCT02011516|12420878|FG001|STARTED|Overall Study||8
11228673|NCT02011516|12420877|FG000|COMPLETED|Overall Study||4
11228674|NCT02011516|12420878|FG001|COMPLETED|Overall Study||6
11228675|NCT02011516|12420877|FG000|NOT COMPLETED|Overall Study||4
11228676|NCT02011516|12420878|FG001|NOT COMPLETED|Overall Study||2
11228677|NCT02011893|12420884|FG000|STARTED|Enrollment to Randomization||173
11228678|NCT02011893|12420885|FG001|STARTED|Enrollment to Randomization||0
11228679|NCT02011893|12420886|FG002|STARTED|Enrollment to Randomization||0
11228680|NCT02011893|12420884|FG000|Baseline|Enrollment to Randomization||141
11228681|NCT02011893|12420885|FG001|Baseline|Enrollment to Randomization||0
11228682|NCT02011893|12420886|FG002|Baseline|Enrollment to Randomization||0
11228683|NCT02011893|12420884|FG000|Trial Stimulation Implant|Enrollment to Randomization||121
11228684|NCT02011893|12420885|FG001|Trial Stimulation Implant|Enrollment to Randomization||0
11228685|NCT02011893|12420886|FG002|Trial Stimulation Implant|Enrollment to Randomization||0
11228686|NCT02011893|12420884|FG000|Permanent Stimulation Implant|Enrollment to Randomization||101
11228687|NCT02011893|12420885|FG001|Permanent Stimulation Implant|Enrollment to Randomization||0
11228688|NCT02011893|12420886|FG002|Permanent Stimulation Implant|Enrollment to Randomization||0
11228689|NCT02011893|12420884|FG000|Randomization|Enrollment to Randomization||100
11228690|NCT02011893|12420885|FG001|Randomization|Enrollment to Randomization||0
11228691|NCT02011893|12420886|FG002|Randomization|Enrollment to Randomization||0
11228692|NCT02011893|12420884|FG000|COMPLETED|Enrollment to Randomization||100
11228693|NCT02011893|12420885|FG001|COMPLETED|Enrollment to Randomization||0
11228694|NCT02011893|12420886|FG002|COMPLETED|Enrollment to Randomization||0
11228695|NCT02011893|12420884|FG000|NOT COMPLETED|Enrollment to Randomization||73
11228696|NCT02011893|12420885|FG001|NOT COMPLETED|Enrollment to Randomization||0
11228697|NCT02011893|12420886|FG002|NOT COMPLETED|Enrollment to Randomization||0
11228698|NCT02011893|12420884|FG000|STARTED|Period 1 (Randomization to 12 Weeks)||0
11228699|NCT02011893|12420885|FG001|STARTED|Period 1 (Randomization to 12 Weeks)||45
11228700|NCT02011893|12420886|FG002|STARTED|Period 1 (Randomization to 12 Weeks)||55
11228701|NCT02011893|12420884|FG000|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
11228702|NCT02011893|12420885|FG001|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
11228703|NCT02011893|12420886|FG002|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
11228704|NCT02011893|12420884|FG000|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
11228705|NCT02011893|12420885|FG001|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
11228706|NCT02011893|12420886|FG002|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
11228707|NCT02011893|12420884|FG000|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
11228708|NCT02011893|12420885|FG001|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
11228709|NCT02011893|12420886|FG002|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
11228710|NCT02011893|12420884|FG000|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
11228711|NCT02011893|12420885|FG001|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
11228712|NCT02011893|12420886|FG002|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
11228713|NCT02011893|12420884|FG000|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
11228714|NCT02011893|12420885|FG001|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
11228715|NCT02011893|12420886|FG002|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
11228716|NCT02011893|12420884|FG000|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
11228717|NCT02011893|12420885|FG001|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
11228718|NCT02011893|12420886|FG002|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
11228719|NCT02011893|12420884|FG000|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
11228720|NCT02011893|12420885|FG001|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
11228721|NCT02011893|12420886|FG002|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
11228722|NCT02011893|12420884|FG000|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
11228723|NCT02011893|12420885|FG001|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
11228724|NCT02011893|12420886|FG002|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
11228725|NCT02011893|12420884|FG000|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
11228726|NCT02011893|12420885|FG001|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
11228727|NCT02011893|12420886|FG002|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
11228728|NCT02011945|12420894|FG000|STARTED|Overall Study||2
10866721|NCT04091581|12031887|FG001|NOT COMPLETED|Overall Study||1
10866722|NCT03986671|12031896|FG000|STARTED|Overall Study||36
10866723|NCT03986671|12031897|FG001|STARTED|Overall Study||9
10866724|NCT03986671|12031898|FG002|STARTED|Overall Study||5
10866725|NCT03986671|12031896|FG000|Passed a Screening Visit With ENT|Overall Study||6
10866726|NCT03986671|12031897|FG001|Passed a Screening Visit With ENT|Overall Study||5
10866727|NCT03986671|12031898|FG002|Passed a Screening Visit With ENT|Overall Study||5
10866728|NCT03986671|12031896|FG000|COMPLETED|Overall Study||6
10866729|NCT03986671|12031897|FG001|COMPLETED|Overall Study||5
11109991|NCT01277042|12294430|FG000|NOT COMPLETED|Overall Study||8
11109992|NCT01277042|12294431|FG001|NOT COMPLETED|Overall Study||5
10866730|NCT03986671|12031898|FG002|COMPLETED|Overall Study||5
10866731|NCT03986671|12031896|FG000|NOT COMPLETED|Overall Study||30
10866732|NCT03986671|12031897|FG001|NOT COMPLETED|Overall Study||4
11228729|NCT02011945|12420895|FG001|STARTED|Overall Study||13
11228730|NCT02011945|12420896|FG002|STARTED|Overall Study||16
11228731|NCT02011945|12420894|FG000|COMPLETED|Overall Study||0
11228732|NCT02011945|12420895|FG001|COMPLETED|Overall Study||3
11228733|NCT02011945|12420896|FG002|COMPLETED|Overall Study||6
11228734|NCT02011945|12420894|FG000|NOT COMPLETED|Overall Study||2
11228735|NCT02011945|12420895|FG001|NOT COMPLETED|Overall Study||10
11228736|NCT02011945|12420896|FG002|NOT COMPLETED|Overall Study||10
11228737|NCT02012192|12420906|FG000|STARTED|Overall Study||90
11228738|NCT02012192|12420907|FG001|STARTED|Overall Study||43
11228739|NCT02012192|12420906|FG000|COMPLETED|Overall Study||63
11228740|NCT02012192|12420907|FG001|COMPLETED|Overall Study||43
11228741|NCT02012192|12420906|FG000|NOT COMPLETED|Overall Study||27
11228742|NCT02012192|12420907|FG001|NOT COMPLETED|Overall Study||0
11228743|NCT02012218|12420918|FG000|STARTED|Overall Study||12
11228744|NCT02012218|12420919|FG001|STARTED|Overall Study||11
11228745|NCT02012218|12420920|FG002|STARTED|Overall Study||13
11228746|NCT02012218|12420921|FG003|STARTED|Overall Study||19
11228747|NCT02012218|12420922|FG004|STARTED|Overall Study||6
11228748|NCT02012218|12420918|FG000|COMPLETED|Overall Study||8
11228749|NCT02012218|12420919|FG001|COMPLETED|Overall Study||10
11228750|NCT02012218|12420920|FG002|COMPLETED|Overall Study||11
11228751|NCT02012218|12420921|FG003|COMPLETED|Overall Study||17
11228752|NCT02012218|12420922|FG004|COMPLETED|Overall Study||5
11228753|NCT02012218|12420918|FG000|NOT COMPLETED|Overall Study||4
11228754|NCT02012218|12420919|FG001|NOT COMPLETED|Overall Study||1
11228755|NCT02012218|12420920|FG002|NOT COMPLETED|Overall Study||2
11228756|NCT02012218|12420921|FG003|NOT COMPLETED|Overall Study||2
11228757|NCT02012218|12420922|FG004|NOT COMPLETED|Overall Study||1
11228758|NCT02012283|12420936|FG000|STARTED|First Intervention||10
11228759|NCT02012283|12420937|FG001|STARTED|First Intervention||10
11228760|NCT02012283|12420936|FG000|COMPLETED|First Intervention||10
11228761|NCT02012283|12420937|FG001|COMPLETED|First Intervention||10
11228762|NCT02012283|12420936|FG000|NOT COMPLETED|First Intervention||0
11228763|NCT02012283|12420937|FG001|NOT COMPLETED|First Intervention||0
11228764|NCT02012283|12420936|FG000|STARTED|Second Intervention||10
11228765|NCT02012283|12420937|FG001|STARTED|Second Intervention||10
11228766|NCT02012283|12420936|FG000|COMPLETED|Second Intervention||10
11228767|NCT02012283|12420937|FG001|COMPLETED|Second Intervention||10
11228768|NCT02012283|12420936|FG000|NOT COMPLETED|Second Intervention||0
11228769|NCT02012283|12420937|FG001|NOT COMPLETED|Second Intervention||0
11228770|NCT02012283|12420936|FG000|STARTED|Third Intervention||10
11228771|NCT02012283|12420937|FG001|STARTED|Third Intervention||10
11228772|NCT02012283|12420936|FG000|COMPLETED|Third Intervention||10
11228773|NCT02012283|12420937|FG001|COMPLETED|Third Intervention||10
11228774|NCT02012283|12420936|FG000|NOT COMPLETED|Third Intervention||0
11228775|NCT02012283|12420937|FG001|NOT COMPLETED|Third Intervention||0
11228776|NCT02012348|12420951|FG000|STARTED|Overall Study||10
11228777|NCT02012348|12420952|FG001|STARTED|Overall Study||10
11228778|NCT02012348|12420953|FG002|STARTED|Overall Study||10
11228779|NCT02012348|12420951|FG000|COMPLETED|Overall Study||10
11228780|NCT02012348|12420952|FG001|COMPLETED|Overall Study||10
11228781|NCT02012348|12420953|FG002|COMPLETED|Overall Study||10
11228782|NCT02012348|12420951|FG000|NOT COMPLETED|Overall Study||0
11228783|NCT02012348|12420952|FG001|NOT COMPLETED|Overall Study||0
11228784|NCT02012348|12420953|FG002|NOT COMPLETED|Overall Study||0
11228785|NCT02012452|12420963|FG000|STARTED|Overall Study||7
11228786|NCT02012452|12420964|FG001|STARTED|Overall Study||2
11228787|NCT02012452|12420963|FG000|COMPLETED|Overall Study||1
11228788|NCT02012452|12420964|FG001|COMPLETED|Overall Study||1
11228789|NCT02012452|12420963|FG000|NOT COMPLETED|Overall Study||6
11228790|NCT02012452|12420964|FG001|NOT COMPLETED|Overall Study||1
10866733|NCT03986671|12031898|FG002|NOT COMPLETED|Overall Study||0
11109993|NCT01277081|12294440|FG000|STARTED|Overall Study||100
11109994|NCT01277081|12294441|FG001|STARTED|Overall Study||100
11109995|NCT01277081|12294440|FG000|COMPLETED|Overall Study||100
11109996|NCT01277081|12294441|FG001|COMPLETED|Overall Study||100
11109997|NCT01277081|12294440|FG000|NOT COMPLETED|Overall Study||0
11109998|NCT01277081|12294441|FG001|NOT COMPLETED|Overall Study||0
11109999|NCT01277159|12294452|FG000|STARTED|Overall Study||21
11110000|NCT01277159|12294453|FG001|STARTED|Overall Study||22
11110001|NCT01277159|12294454|FG002|STARTED|Overall Study||22
11110002|NCT01277159|12294455|FG003|STARTED|Overall Study||22
11110003|NCT01277159|12294456|FG004|STARTED|Overall Study||21
10866734|NCT03850535|12031910|FG000|STARTED|Overall Study||4
10866735|NCT03850535|12031911|FG001|STARTED|Overall Study||9
10866736|NCT03850535|12031912|FG002|STARTED|Overall Study||6
10866737|NCT03850535|12031913|FG003|STARTED|Overall Study||4
10866738|NCT03850535|12031910|FG000|COMPLETED|Overall Study||0
10866739|NCT03850535|12031911|FG001|COMPLETED|Overall Study||0
10866740|NCT03850535|12031912|FG002|COMPLETED|Overall Study||0
10866741|NCT03850535|12031913|FG003|COMPLETED|Overall Study||0
10866742|NCT03850535|12031910|FG000|NOT COMPLETED|Overall Study||4
11110004|NCT01277159|12294452|FG000|COMPLETED|Overall Study||17
11110005|NCT01277159|12294453|FG001|COMPLETED|Overall Study||21
11228791|NCT02012491|12420972|FG000|STARTED|Overall Study||151
11228792|NCT02012491|12420973|FG001|STARTED|Overall Study||149
11228793|NCT02012491|12420972|FG000|COMPLETED|Overall Study||149
11228794|NCT02012491|12420973|FG001|COMPLETED|Overall Study||148
11228795|NCT02012491|12420972|FG000|NOT COMPLETED|Overall Study||2
10866743|NCT03850535|12031911|FG001|NOT COMPLETED|Overall Study||9
10866744|NCT03850535|12031912|FG002|NOT COMPLETED|Overall Study||6
10866745|NCT03850535|12031913|FG003|NOT COMPLETED|Overall Study||4
10866746|NCT03839628|12031923|FG000|STARTED|Overall Study||9
10866747|NCT03839628|12031923|FG000|COMPLETED|Overall Study||8
10866748|NCT03839628|12031923|FG000|NOT COMPLETED|Overall Study||1
10866749|NCT03791398|12031930|FG000|STARTED|Overall Study||13
10866750|NCT03791398|12031931|FG001|STARTED|Overall Study||0
10866751|NCT03791398|12031932|FG002|STARTED|Overall Study||0
10866752|NCT03791398|12031930|FG000|COMPLETED|Overall Study||11
10866753|NCT03791398|12031931|FG001|COMPLETED|Overall Study||0
10866754|NCT03791398|12031932|FG002|COMPLETED|Overall Study||0
10866755|NCT03791398|12031930|FG000|NOT COMPLETED|Overall Study||2
10866756|NCT03791398|12031931|FG001|NOT COMPLETED|Overall Study||0
10866757|NCT03791398|12031932|FG002|NOT COMPLETED|Overall Study||0
11110006|NCT01277159|12294454|FG002|COMPLETED|Overall Study||19
11110007|NCT01277159|12294455|FG003|COMPLETED|Overall Study||19
11110008|NCT01277159|12294456|FG004|COMPLETED|Overall Study||16
11110009|NCT01277159|12294452|FG000|NOT COMPLETED|Overall Study||4
11110010|NCT01277159|12294453|FG001|NOT COMPLETED|Overall Study||1
11110011|NCT01277159|12294454|FG002|NOT COMPLETED|Overall Study||3
11110012|NCT01277159|12294455|FG003|NOT COMPLETED|Overall Study||3
11110013|NCT01277159|12294456|FG004|NOT COMPLETED|Overall Study||5
11110014|NCT01277302|12294471|FG000|STARTED|7-Month Fixed Treatment Period||85
11110015|NCT01277302|12294472|FG001|STARTED|7-Month Fixed Treatment Period||86
11110016|NCT01277302|12294473|FG002|STARTED|7-Month Fixed Treatment Period||31
11110017|NCT01277302|12294471|FG000|COMPLETED|7-Month Fixed Treatment Period||85
11110018|NCT01277302|12294472|FG001|COMPLETED|7-Month Fixed Treatment Period||86
11110019|NCT01277302|12294473|FG002|COMPLETED|7-Month Fixed Treatment Period||19
10866773|NCT03726346|12031958|FG000|STARTED|Overall Study||39
10866774|NCT03726346|12031958|FG000|COMPLETED|Overall Study||39
10866775|NCT03726346|12031958|FG000|NOT COMPLETED|Overall Study||0
10866776|NCT03703882|12031964|FG000|STARTED|Overall Study||88
10866777|NCT03703882|12031965|FG001|STARTED|Overall Study||43
10866778|NCT03703882|12031964|FG000|COMPLETED|Overall Study||85
10866779|NCT03703882|12031965|FG001|COMPLETED|Overall Study||37
10866780|NCT03703882|12031964|FG000|NOT COMPLETED|Overall Study||3
10866781|NCT03703882|12031965|FG001|NOT COMPLETED|Overall Study||6
10866782|NCT03615040|12031973|FG000|STARTED|Overall Study||42
10866783|NCT03615040|12031974|FG001|STARTED|Overall Study||39
10866784|NCT03615040|12031973|FG000|COMPLETED|Overall Study||36
10866785|NCT03615040|12031974|FG001|COMPLETED|Overall Study||34
10866786|NCT03615040|12031973|FG000|NOT COMPLETED|Overall Study||6
10866787|NCT03615040|12031974|FG001|NOT COMPLETED|Overall Study||5
10866788|NCT03611075|12031989|FG000|STARTED|Overall Study||16
10866789|NCT03611075|12031990|FG001|STARTED|Overall Study||15
10866790|NCT03611075|12031991|FG002|STARTED|Overall Study||16
10866791|NCT03611075|12031992|FG003|STARTED|Overall Study||17
10866792|NCT03611075|12031993|FG004|STARTED|Overall Study||13
10866793|NCT03611075|12031994|FG005|STARTED|Overall Study||18
10866794|NCT03611075|12031995|FG006|STARTED|Overall Study||15
10866795|NCT03611075|12031996|FG007|STARTED|Overall Study||17
10866796|NCT03611075|12031997|FG008|STARTED|Overall Study||17
10866797|NCT03611075|12031989|FG000|COMPLETED|Overall Study||15
10866798|NCT03611075|12031990|FG001|COMPLETED|Overall Study||13
10866799|NCT03611075|12031991|FG002|COMPLETED|Overall Study||14
10866800|NCT03611075|12031992|FG003|COMPLETED|Overall Study||13
10866801|NCT03611075|12031993|FG004|COMPLETED|Overall Study||13
10866802|NCT03611075|12031994|FG005|COMPLETED|Overall Study||18
10866803|NCT03611075|12031995|FG006|COMPLETED|Overall Study||13
10866804|NCT03611075|12031996|FG007|COMPLETED|Overall Study||17
10866805|NCT03611075|12031997|FG008|COMPLETED|Overall Study||17
10866806|NCT03611075|12031989|FG000|NOT COMPLETED|Overall Study||1
10866807|NCT03611075|12031990|FG001|NOT COMPLETED|Overall Study||2
10866808|NCT03611075|12031991|FG002|NOT COMPLETED|Overall Study||2
10866809|NCT03611075|12031992|FG003|NOT COMPLETED|Overall Study||4
10866810|NCT03611075|12031993|FG004|NOT COMPLETED|Overall Study||0
10866811|NCT03611075|12031994|FG005|NOT COMPLETED|Overall Study||0
10866812|NCT03611075|12031995|FG006|NOT COMPLETED|Overall Study||2
10866813|NCT03611075|12031996|FG007|NOT COMPLETED|Overall Study||0
10866814|NCT03611075|12031997|FG008|NOT COMPLETED|Overall Study||0
10866815|NCT03595176|12032042|FG000|STARTED|Overall Study||47
10866816|NCT03595176|12032043|FG001|STARTED|Overall Study||384
10866817|NCT03595176|12032042|FG000|COMPLETED|Overall Study||47
10866818|NCT03595176|12032043|FG001|COMPLETED|Overall Study||381
10866819|NCT03595176|12032042|FG000|NOT COMPLETED|Overall Study||0
10866820|NCT03595176|12032043|FG001|NOT COMPLETED|Overall Study||3
10866821|NCT03541317|12032051|FG000|STARTED|Stage 1 of the Implementation||6
10866822|NCT03541317|12032052|FG001|STARTED|Stage 1 of the Implementation||37
10866823|NCT03541317|12032053|FG002|STARTED|Stage 1 of the Implementation||38
10866824|NCT03541317|12032054|FG003|STARTED|Stage 1 of the Implementation||9
10866825|NCT03541317|12032055|FG004|STARTED|Stage 1 of the Implementation||43
10866826|NCT03541317|12032056|FG005|STARTED|Stage 1 of the Implementation||36
10866827|NCT03541317|12032051|FG000|COMPLETED|Stage 1 of the Implementation||6
10866828|NCT03541317|12032052|FG001|COMPLETED|Stage 1 of the Implementation||37
10866829|NCT03541317|12032053|FG002|COMPLETED|Stage 1 of the Implementation||38
10866830|NCT03541317|12032054|FG003|COMPLETED|Stage 1 of the Implementation||9
10866831|NCT03541317|12032055|FG004|COMPLETED|Stage 1 of the Implementation||43
10866832|NCT03541317|12032056|FG005|COMPLETED|Stage 1 of the Implementation||36
10866833|NCT03541317|12032051|FG000|NOT COMPLETED|Stage 1 of the Implementation||0
10866834|NCT03541317|12032052|FG001|NOT COMPLETED|Stage 1 of the Implementation||0
10866835|NCT03541317|12032053|FG002|NOT COMPLETED|Stage 1 of the Implementation||0
10866836|NCT03541317|12032054|FG003|NOT COMPLETED|Stage 1 of the Implementation||0
10866837|NCT03541317|12032055|FG004|NOT COMPLETED|Stage 1 of the Implementation||0
10866838|NCT03541317|12032056|FG005|NOT COMPLETED|Stage 1 of the Implementation||0
10866839|NCT03541317|12032051|FG000|STARTED|Stage 2 of the Implementation||6
10866840|NCT03541317|12032052|FG001|STARTED|Stage 2 of the Implementation||37
10866841|NCT03541317|12032053|FG002|STARTED|Stage 2 of the Implementation||38
10866842|NCT03541317|12032054|FG003|STARTED|Stage 2 of the Implementation||9
10866843|NCT03541317|12032055|FG004|STARTED|Stage 2 of the Implementation||43
10866844|NCT03541317|12032056|FG005|STARTED|Stage 2 of the Implementation||36
10866845|NCT03541317|12032051|FG000|COMPLETED|Stage 2 of the Implementation||5
10866846|NCT03541317|12032052|FG001|COMPLETED|Stage 2 of the Implementation||37
10866847|NCT03541317|12032053|FG002|COMPLETED|Stage 2 of the Implementation||38
10866848|NCT03541317|12032054|FG003|COMPLETED|Stage 2 of the Implementation||9
10866849|NCT03541317|12032055|FG004|COMPLETED|Stage 2 of the Implementation||43
10866850|NCT03541317|12032056|FG005|COMPLETED|Stage 2 of the Implementation||36
10866851|NCT03541317|12032051|FG000|NOT COMPLETED|Stage 2 of the Implementation||1
10866852|NCT03541317|12032052|FG001|NOT COMPLETED|Stage 2 of the Implementation||0
10866853|NCT03541317|12032053|FG002|NOT COMPLETED|Stage 2 of the Implementation||0
10866854|NCT03541317|12032054|FG003|NOT COMPLETED|Stage 2 of the Implementation||0
10866855|NCT03541317|12032055|FG004|NOT COMPLETED|Stage 2 of the Implementation||0
10866856|NCT03541317|12032056|FG005|NOT COMPLETED|Stage 2 of the Implementation||0
10866857|NCT03523117|12032070|FG000|STARTED|Overall Study||40
10866858|NCT03523117|12032071|FG001|STARTED|Overall Study||39
10866859|NCT03523117|12032070|FG000|COMPLETED|Overall Study||39
10866860|NCT03523117|12032071|FG001|COMPLETED|Overall Study||37
10866861|NCT03523117|12032070|FG000|NOT COMPLETED|Overall Study||1
10866862|NCT03523117|12032071|FG001|NOT COMPLETED|Overall Study||2
10866863|NCT03400943|12032081|FG000|STARTED|Treatment Period 1||23
10866864|NCT03400943|12032082|FG001|STARTED|Treatment Period 1||23
10866865|NCT03400943|12032083|FG002|STARTED|Treatment Period 1||24
10866866|NCT03400943|12032084|FG003|STARTED|Treatment Period 1||23
10866867|NCT03400943|12032081|FG000|Treated|Treatment Period 1||18
10866868|NCT03400943|12032082|FG001|Treated|Treatment Period 1||21
10866869|NCT03400943|12032083|FG002|Treated|Treatment Period 1||20
10866870|NCT03400943|12032084|FG003|Treated|Treatment Period 1||20
10866871|NCT03400943|12032081|FG000|COMPLETED|Treatment Period 1||18
10866872|NCT03400943|12032082|FG001|COMPLETED|Treatment Period 1||21
10866873|NCT03400943|12032083|FG002|COMPLETED|Treatment Period 1||18
10866874|NCT03400943|12032084|FG003|COMPLETED|Treatment Period 1||18
10866875|NCT03400943|12032081|FG000|NOT COMPLETED|Treatment Period 1||5
10866876|NCT03400943|12032082|FG001|NOT COMPLETED|Treatment Period 1||2
10866877|NCT03400943|12032083|FG002|NOT COMPLETED|Treatment Period 1||6
10866878|NCT03400943|12032084|FG003|NOT COMPLETED|Treatment Period 1||5
10866879|NCT03400943|12032081|FG000|STARTED|Post-treatment Period 1||18
10866880|NCT03400943|12032082|FG001|STARTED|Post-treatment Period 1||0
10866881|NCT03400943|12032083|FG002|STARTED|Post-treatment Period 1||18
10866882|NCT03400943|12032084|FG003|STARTED|Post-treatment Period 1||18
10866883|NCT03400943|12032081|FG000|COMPLETED|Post-treatment Period 1||7
10866884|NCT03400943|12032082|FG001|COMPLETED|Post-treatment Period 1||0
10866885|NCT03400943|12032083|FG002|COMPLETED|Post-treatment Period 1||7
10866886|NCT03400943|12032084|FG003|COMPLETED|Post-treatment Period 1||5
10866887|NCT03400943|12032081|FG000|NOT COMPLETED|Post-treatment Period 1||11
10866888|NCT03400943|12032082|FG001|NOT COMPLETED|Post-treatment Period 1||0
10866889|NCT03400943|12032083|FG002|NOT COMPLETED|Post-treatment Period 1||11
10866890|NCT03400943|12032084|FG003|NOT COMPLETED|Post-treatment Period 1||13
10866891|NCT03400943|12032081|FG000|STARTED|Treatment Period 2||7
10866892|NCT03400943|12032082|FG001|STARTED|Treatment Period 2||21
10866893|NCT03400943|12032083|FG002|STARTED|Treatment Period 2||7
10866894|NCT03400943|12032084|FG003|STARTED|Treatment Period 2||5
10866895|NCT03400943|12032081|FG000|COMPLETED|Treatment Period 2||6
10866896|NCT03400943|12032082|FG001|COMPLETED|Treatment Period 2||13
10866897|NCT03400943|12032083|FG002|COMPLETED|Treatment Period 2||7
10866898|NCT03400943|12032084|FG003|COMPLETED|Treatment Period 2||5
10866899|NCT03400943|12032081|FG000|NOT COMPLETED|Treatment Period 2||1
10866900|NCT03400943|12032082|FG001|NOT COMPLETED|Treatment Period 2||8
10866901|NCT03400943|12032083|FG002|NOT COMPLETED|Treatment Period 2||0
10866902|NCT03400943|12032084|FG003|NOT COMPLETED|Treatment Period 2||0
10866903|NCT03400943|12032081|FG000|STARTED|Follow-up Period||7
10866904|NCT03400943|12032082|FG001|STARTED|Follow-up Period||15
10866905|NCT03400943|12032083|FG002|STARTED|Follow-up Period||7
10866906|NCT03400943|12032084|FG003|STARTED|Follow-up Period||5
10866907|NCT03400943|12032081|FG000|COMPLETED|Follow-up Period||6
10866908|NCT03400943|12032082|FG001|COMPLETED|Follow-up Period||15
10866909|NCT03400943|12032083|FG002|COMPLETED|Follow-up Period||7
10866910|NCT03400943|12032084|FG003|COMPLETED|Follow-up Period||5
10866911|NCT03400943|12032081|FG000|NOT COMPLETED|Follow-up Period||1
10866912|NCT03400943|12032082|FG001|NOT COMPLETED|Follow-up Period||0
10866913|NCT03400943|12032083|FG002|NOT COMPLETED|Follow-up Period||0
10866914|NCT03400943|12032084|FG003|NOT COMPLETED|Follow-up Period||0
10866915|NCT03396952|12032096|FG000|STARTED|Overall Study||27
10866916|NCT03396952|12032096|FG000|COMPLETED|Overall Study||27
10866917|NCT03396952|12032096|FG000|NOT COMPLETED|Overall Study||0
10866918|NCT03302234|12032102|FG000|STARTED|Overall Study||284
10866919|NCT03302234|12032103|FG001|STARTED|Overall Study||284
10866920|NCT03302234|12032102|FG000|COMPLETED|Overall Study||146
10866921|NCT03302234|12032103|FG001|COMPLETED|Overall Study||147
10866922|NCT03302234|12032102|FG000|NOT COMPLETED|Overall Study||138
10866923|NCT03302234|12032103|FG001|NOT COMPLETED|Overall Study||137
10866924|NCT03272763|12032110|FG000|STARTED|Overall Study||38
10866925|NCT03272763|12032110|FG000|COMPLETED|Overall Study||38
10866926|NCT03272763|12032110|FG000|NOT COMPLETED|Overall Study||0
10866927|NCT03232346|12032116|FG000|STARTED|Overall Study||6
10866928|NCT03232346|12032117|FG001|STARTED|Overall Study||5
10866929|NCT03232346|12032116|FG000|COMPLETED|Overall Study||2
10866930|NCT03232346|12032117|FG001|COMPLETED|Overall Study||3
10866931|NCT03232346|12032116|FG000|NOT COMPLETED|Overall Study||4
10866932|NCT03232346|12032117|FG001|NOT COMPLETED|Overall Study||2
10866933|NCT03208244|12032123|FG000|STARTED|Overall Study||33
10866934|NCT03208244|12032123|FG000|COMPLETED|Overall Study||32
10866935|NCT03208244|12032123|FG000|NOT COMPLETED|Overall Study||1
10866936|NCT03187379|12032129|FG000|STARTED|Overall Study||50
10866937|NCT03187379|12032130|FG001|STARTED|Overall Study||52
10866938|NCT03187379|12032129|FG000|COMPLETED|Overall Study||50
10866939|NCT03187379|12032130|FG001|COMPLETED|Overall Study||52
10866940|NCT03187379|12032129|FG000|NOT COMPLETED|Overall Study||0
10866941|NCT03187379|12032130|FG001|NOT COMPLETED|Overall Study||0
10866942|NCT03077360|12032139|FG000|STARTED|Overall Study||17
10866943|NCT03077360|12032140|FG001|STARTED|Overall Study||17
10866944|NCT03077360|12032141|FG002|STARTED|Overall Study||14
10866945|NCT03077360|12032139|FG000|COMPLETED|Overall Study||17
10866946|NCT03077360|12032140|FG001|COMPLETED|Overall Study||16
10866947|NCT03077360|12032141|FG002|COMPLETED|Overall Study||12
10866948|NCT03077360|12032139|FG000|NOT COMPLETED|Overall Study||0
10866949|NCT03077360|12032140|FG001|NOT COMPLETED|Overall Study||1
10866950|NCT03077360|12032141|FG002|NOT COMPLETED|Overall Study||2
10866951|NCT03050060|12032150|FG000|STARTED|Overall Study||20
10866952|NCT03050060|12032150|FG000|COMPLETED|Overall Study||5
10866953|NCT03050060|12032150|FG000|NOT COMPLETED|Overall Study||15
10866954|NCT02968381|12032156|FG000|STARTED|Overall Study||61
10866955|NCT02968381|12032157|FG001|STARTED|Overall Study||60
10866956|NCT02968381|12032156|FG000|COMPLETED|Overall Study||56
10866957|NCT02968381|12032157|FG001|COMPLETED|Overall Study||50
10866958|NCT02968381|12032156|FG000|NOT COMPLETED|Overall Study||5
10866959|NCT02968381|12032157|FG001|NOT COMPLETED|Overall Study||10
10866960|NCT02847637|12032167|FG000|STARTED|Overall Study||18
10866961|NCT02847637|12032168|FG001|STARTED|Overall Study||36
10866962|NCT02847637|12032169|FG002|STARTED|Overall Study||35
10866963|NCT02847637|12032170|FG003|STARTED|Overall Study||63
10866964|NCT02847637|12032167|FG000|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
10866965|NCT02847637|12032168|FG001|Completed 24 Weeks on No Prophylaxis|Overall Study||0
10866966|NCT02847637|12032169|FG002|Completed 24 Weeks on No Prophylaxis|Overall Study||0
10866967|NCT02847637|12032170|FG003|Completed 24 Weeks on No Prophylaxis|Overall Study||0
10866968|NCT02847637|12032167|FG000|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
10866969|NCT02847637|12032168|FG001|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
10866970|NCT02847637|12032169|FG002|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
10866971|NCT02847637|12032170|FG003|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
11228796|NCT02012491|12420973|FG001|NOT COMPLETED|Overall Study||1
11228797|NCT02012582|12420983|FG000|STARTED|Overall Study||8
11228798|NCT02012582|12420984|FG001|STARTED|Overall Study||8
11228799|NCT02012582|12420985|FG002|STARTED|Overall Study||8
11228800|NCT02012582|12420986|FG003|STARTED|Overall Study||8
11228801|NCT02012582|12420983|FG000|COMPLETED|Overall Study||8
11228802|NCT02012582|12420984|FG001|COMPLETED|Overall Study||8
11228803|NCT02012582|12420985|FG002|COMPLETED|Overall Study||8
11228804|NCT02012582|12420986|FG003|COMPLETED|Overall Study||7
11228805|NCT02012582|12420983|FG000|NOT COMPLETED|Overall Study||0
11228806|NCT02012582|12420984|FG001|NOT COMPLETED|Overall Study||0
11228807|NCT02012582|12420985|FG002|NOT COMPLETED|Overall Study||0
11228808|NCT02012582|12420986|FG003|NOT COMPLETED|Overall Study||1
11228809|NCT02012621|12420996|FG000|STARTED|Overall Study||807
11228810|NCT02012621|12420996|FG000|Visit 1 Completed|Overall Study||807
11228811|NCT02012621|12420996|FG000|Visit 2 Completed|Overall Study||688
11228812|NCT02012621|12420996|FG000|Visit 3 Completed|Overall Study||444
11228813|NCT02012621|12420996|FG000|COMPLETED|Overall Study||807
11228814|NCT02012621|12420996|FG000|NOT COMPLETED|Overall Study||0
11228815|NCT02012686|12421002|FG000|STARTED|Overall Study||50
11228816|NCT02012686|12421003|FG001|STARTED|Overall Study||50
11228817|NCT02012686|12421002|FG000|COMPLETED|Overall Study||50
11228818|NCT02012686|12421003|FG001|COMPLETED|Overall Study||48
11228819|NCT02012686|12421002|FG000|NOT COMPLETED|Overall Study||0
11228820|NCT02012686|12421003|FG001|NOT COMPLETED|Overall Study||2
11228821|NCT02012959|12421009|FG000|STARTED|Treatment Phase A||9
11228822|NCT02012959|12421010|FG001|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
11228823|NCT02012959|12421011|FG002|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
11228824|NCT02012959|12421012|FG003|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
11228825|NCT02012959|12421013|FG004|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
11228826|NCT02012959|12421009|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
11228827|NCT02012959|12421010|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
11228828|NCT02012959|12421011|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
11228829|NCT02012959|12421012|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
11228830|NCT02012959|12421013|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
11228831|NCT02012959|12421009|FG000|COMPLETED|Treatment Phase A||7
11228832|NCT02012959|12421010|FG001|COMPLETED|Treatment Phase A||0
11228833|NCT02012959|12421011|FG002|COMPLETED|Treatment Phase A||0
11228834|NCT02012959|12421012|FG003|COMPLETED|Treatment Phase A||0
11228835|NCT02012959|12421013|FG004|COMPLETED|Treatment Phase A||0
11228836|NCT02012959|12421009|FG000|NOT COMPLETED|Treatment Phase A||2
11228837|NCT02012959|12421010|FG001|NOT COMPLETED|Treatment Phase A||0
11228838|NCT02012959|12421011|FG002|NOT COMPLETED|Treatment Phase A||0
11228839|NCT02012959|12421012|FG003|NOT COMPLETED|Treatment Phase A||0
11228840|NCT02012959|12421013|FG004|NOT COMPLETED|Treatment Phase A||0
11228841|NCT02012959|12421009|FG000|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
11228842|NCT02012959|12421010|FG001|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
11228843|NCT02012959|12421011|FG002|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
11228844|NCT02012959|12421012|FG003|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator's discretion|1
11228845|NCT02012959|12421013|FG004|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
11355128|NCT03077165|12551980|FG002|COMPLETED|Overall Study||20
11355129|NCT03077165|12551981|FG003|COMPLETED|Overall Study||19
10866972|NCT02847637|12032167|FG000|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
10866973|NCT02847637|12032168|FG001|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
10866974|NCT02847637|12032169|FG002|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
10866975|NCT02847637|12032170|FG003|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
10866976|NCT02847637|12032167|FG000|COMPLETED|Overall Study||1
10866977|NCT02847637|12032168|FG001|COMPLETED|Overall Study||1
10866978|NCT02847637|12032169|FG002|COMPLETED|Overall Study||0
10866979|NCT02847637|12032170|FG003|COMPLETED|Overall Study||0
10866980|NCT02847637|12032167|FG000|NOT COMPLETED|Overall Study||17
10866981|NCT02847637|12032168|FG001|NOT COMPLETED|Overall Study||35
10866982|NCT02847637|12032169|FG002|NOT COMPLETED|Overall Study||35
10866983|NCT02847637|12032170|FG003|NOT COMPLETED|Overall Study||63
10866984|NCT02837042|12032190|FG000|STARTED|Overall Study||6
10866985|NCT02837042|12032190|FG000|COMPLETED|Overall Study||6
10866986|NCT02837042|12032190|FG000|NOT COMPLETED|Overall Study||0
10866987|NCT02770391|12032194|FG000|STARTED|Overall Study||54
10866988|NCT02770391|12032194|FG000|COMPLETED|Overall Study||48
10866989|NCT02770391|12032194|FG000|NOT COMPLETED|Overall Study||6
10866990|NCT02650986|12032202|FG000|STARTED|Overall Study||3
10866991|NCT02650986|12032203|FG001|STARTED|Overall Study||3
10866992|NCT02650986|12032204|FG002|STARTED|Overall Study||3
10866993|NCT02650986|12032205|FG003|STARTED|Overall Study||6
10866994|NCT02650986|12032202|FG000|COMPLETED|Overall Study||3
10866995|NCT02650986|12032203|FG001|COMPLETED|Overall Study||3
10866996|NCT02650986|12032204|FG002|COMPLETED|Overall Study||3
10866997|NCT02650986|12032205|FG003|COMPLETED|Overall Study||6
10866998|NCT02650986|12032202|FG000|NOT COMPLETED|Overall Study||0
10866999|NCT02650986|12032203|FG001|NOT COMPLETED|Overall Study||0
10867000|NCT02650986|12032204|FG002|NOT COMPLETED|Overall Study||0
10867001|NCT02650986|12032205|FG003|NOT COMPLETED|Overall Study||0
10867002|NCT02648724|12032222|FG000|STARTED|Overall Study||3
10867003|NCT02648724|12032223|FG001|STARTED|Overall Study||3
10867004|NCT02648724|12032224|FG002|STARTED|Overall Study||3
10867005|NCT02648724|12032225|FG003|STARTED|Overall Study||3
10867006|NCT02648724|12032226|FG004|STARTED|Overall Study||25
10867007|NCT02648724|12032227|FG005|STARTED|Overall Study||8
10867008|NCT02648724|12032228|FG006|STARTED|Overall Study||12
10867009|NCT02648724|12032222|FG000|COMPLETED|Overall Study||0
10867010|NCT02648724|12032223|FG001|COMPLETED|Overall Study||0
10867011|NCT02648724|12032224|FG002|COMPLETED|Overall Study||0
10867012|NCT02648724|12032225|FG003|COMPLETED|Overall Study||0
10867013|NCT02648724|12032226|FG004|COMPLETED|Overall Study||0
10867014|NCT02648724|12032227|FG005|COMPLETED|Overall Study||0
10867015|NCT02648724|12032228|FG006|COMPLETED|Overall Study||0
10867016|NCT02648724|12032222|FG000|NOT COMPLETED|Overall Study||3
10867017|NCT02648724|12032223|FG001|NOT COMPLETED|Overall Study||3
10867018|NCT02648724|12032224|FG002|NOT COMPLETED|Overall Study||3
10867019|NCT02648724|12032225|FG003|NOT COMPLETED|Overall Study||3
10867020|NCT02648724|12032226|FG004|NOT COMPLETED|Overall Study||25
10867021|NCT02648724|12032227|FG005|NOT COMPLETED|Overall Study||8
10867022|NCT02648724|12032228|FG006|NOT COMPLETED|Overall Study||12
11110020|NCT01277302|12294471|FG000|NOT COMPLETED|7-Month Fixed Treatment Period||0
11110021|NCT01277302|12294472|FG001|NOT COMPLETED|7-Month Fixed Treatment Period||0
11110022|NCT01277302|12294473|FG002|NOT COMPLETED|7-Month Fixed Treatment Period||12
11110023|NCT01277302|12294471|FG000|STARTED|8-Month Alternate Dose Regimen Period||85
11110024|NCT01277302|12294472|FG001|STARTED|8-Month Alternate Dose Regimen Period||86
11110025|NCT01277302|12294473|FG002|STARTED|8-Month Alternate Dose Regimen Period||19
11110026|NCT01277302|12294471|FG000|COMPLETED|8-Month Alternate Dose Regimen Period||80
11110027|NCT01277302|12294472|FG001|COMPLETED|8-Month Alternate Dose Regimen Period||82
11110028|NCT01277302|12294473|FG002|COMPLETED|8-Month Alternate Dose Regimen Period||13
11110029|NCT01277302|12294471|FG000|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
11110030|NCT01277302|12294472|FG001|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
11110031|NCT01277302|12294473|FG002|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
11110032|NCT01277341|12294485|FG000|STARTED|Overall Study||150
11110033|NCT01277341|12294486|FG001|STARTED|Overall Study||150
11110034|NCT01277341|12294487|FG002|STARTED|Overall Study||149
10867029|NCT02554474|12032271|FG000|STARTED|Overall Study||59
10867030|NCT02554474|12032272|FG001|STARTED|Overall Study||59
10867031|NCT02554474|12032271|FG000|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|56
10867032|NCT02554474|12032272|FG001|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|57
10867033|NCT02554474|12032271|FG000|NOT COMPLETED|Overall Study||3
10867034|NCT02554474|12032272|FG001|NOT COMPLETED|Overall Study||2
10867035|NCT02554318|12032280|FG000|STARTED|Overall Study||75
10867036|NCT02554318|12032281|FG001|STARTED|Overall Study||72
10867037|NCT02554318|12032280|FG000|COMPLETED|Overall Study||65
10867038|NCT02554318|12032281|FG001|COMPLETED|Overall Study||64
10867039|NCT02554318|12032280|FG000|NOT COMPLETED|Overall Study||10
10867040|NCT02554318|12032281|FG001|NOT COMPLETED|Overall Study||8
10867041|NCT02508532|12032294|FG000|STARTED|Part 1 - Dose Determining Period||6
10867042|NCT02508532|12032295|FG001|STARTED|Part 1 - Dose Determining Period||6
10867043|NCT02508532|12032296|FG002|STARTED|Part 1 - Dose Determining Period||6
10867044|NCT02508532|12032297|FG003|STARTED|Part 1 - Dose Determining Period||6
10867045|NCT02508532|12032298|FG004|STARTED|Part 1 - Dose Determining Period||6
10867046|NCT02508532|12032299|FG005|STARTED|Part 1 - Dose Determining Period||6
10867047|NCT02508532|12032300|FG006|STARTED|Part 1 - Dose Determining Period||7
10867048|NCT02508532|12032301|FG007|STARTED|Part 1 - Dose Determining Period||3
10867049|NCT02508532|12032302|FG008|STARTED|Part 1 - Dose Determining Period|This group includes patients enrolled in Part 1 and Part 2 at a starting dose of 300 or 400 mg QD. This group was not used to determine the MTD in Part 1|0
10867050|NCT02508532|12032294|FG000|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
11228846|NCT02012959|12421009|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
10867051|NCT02508532|12032295|FG001|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
10867052|NCT02508532|12032296|FG002|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
10867053|NCT02508532|12032297|FG003|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
10867054|NCT02508532|12032298|FG004|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
10867055|NCT02508532|12032299|FG005|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||6
10867056|NCT02508532|12032300|FG006|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||7
10867057|NCT02508532|12032301|FG007|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
10867058|NCT02508532|12032302|FG008|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
10867059|NCT02508532|12032294|FG000|COMPLETED|Part 1 - Dose Determining Period||6
10867060|NCT02508532|12032295|FG001|COMPLETED|Part 1 - Dose Determining Period||6
10867061|NCT02508532|12032296|FG002|COMPLETED|Part 1 - Dose Determining Period||6
10867062|NCT02508532|12032297|FG003|COMPLETED|Part 1 - Dose Determining Period||6
10867063|NCT02508532|12032298|FG004|COMPLETED|Part 1 - Dose Determining Period||6
10867064|NCT02508532|12032299|FG005|COMPLETED|Part 1 - Dose Determining Period||6
10867065|NCT02508532|12032300|FG006|COMPLETED|Part 1 - Dose Determining Period||6
10867066|NCT02508532|12032301|FG007|COMPLETED|Part 1 - Dose Determining Period||2
10867067|NCT02508532|12032302|FG008|COMPLETED|Part 1 - Dose Determining Period||0
10867068|NCT02508532|12032294|FG000|NOT COMPLETED|Part 1 - Dose Determining Period||0
10867069|NCT02508532|12032295|FG001|NOT COMPLETED|Part 1 - Dose Determining Period||0
10867070|NCT02508532|12032296|FG002|NOT COMPLETED|Part 1 - Dose Determining Period||0
10867071|NCT02508532|12032297|FG003|NOT COMPLETED|Part 1 - Dose Determining Period||0
10867072|NCT02508532|12032298|FG004|NOT COMPLETED|Part 1 - Dose Determining Period||0
10867073|NCT02508532|12032299|FG005|NOT COMPLETED|Part 1 - Dose Determining Period||0
10867074|NCT02508532|12032300|FG006|NOT COMPLETED|Part 1 - Dose Determining Period||1
10867075|NCT02508532|12032301|FG007|NOT COMPLETED|Part 1 - Dose Determining Period||1
10867076|NCT02508532|12032302|FG008|NOT COMPLETED|Part 1 - Dose Determining Period||0
10867077|NCT02508532|12032294|FG000|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
10867078|NCT02508532|12032295|FG001|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
10867079|NCT02508532|12032296|FG002|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
10867080|NCT02508532|12032297|FG003|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
10867081|NCT02508532|12032298|FG004|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
10867082|NCT02508532|12032299|FG005|STARTED|Part 2 - Treatment|"Part 1 Only:~6 Patients from this group are included in the 300 or 400 mg QD group."|0
10867083|NCT02508532|12032300|FG006|STARTED|Part 2 - Treatment|"Part 1 Only:~7 Patients from this group are included in the 300 or 400 mg QD group."|0
10867084|NCT02508532|12032301|FG007|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
10867085|NCT02508532|12032302|FG008|STARTED|Part 2 - Treatment|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
10867086|NCT02508532|12032294|FG000|COMPLETED|Part 2 - Treatment||0
10867087|NCT02508532|12032295|FG001|COMPLETED|Part 2 - Treatment||0
10867088|NCT02508532|12032296|FG002|COMPLETED|Part 2 - Treatment||0
10867089|NCT02508532|12032297|FG003|COMPLETED|Part 2 - Treatment||0
10867090|NCT02508532|12032298|FG004|COMPLETED|Part 2 - Treatment||0
10867091|NCT02508532|12032299|FG005|COMPLETED|Part 2 - Treatment||0
10867092|NCT02508532|12032300|FG006|COMPLETED|Part 2 - Treatment||0
10867093|NCT02508532|12032301|FG007|COMPLETED|Part 2 - Treatment||0
10867094|NCT02508532|12032302|FG008|COMPLETED|Part 2 - Treatment||0
10867095|NCT02508532|12032294|FG000|NOT COMPLETED|Part 2 - Treatment||0
10867096|NCT02508532|12032295|FG001|NOT COMPLETED|Part 2 - Treatment||0
10867097|NCT02508532|12032296|FG002|NOT COMPLETED|Part 2 - Treatment||0
10867098|NCT02508532|12032297|FG003|NOT COMPLETED|Part 2 - Treatment||0
10867099|NCT02508532|12032298|FG004|NOT COMPLETED|Part 2 - Treatment||0
10867100|NCT02508532|12032299|FG005|NOT COMPLETED|Part 2 - Treatment||0
11228847|NCT02012959|12421010|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
11228848|NCT02012959|12421011|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
11228849|NCT02012959|12421012|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
11228850|NCT02012959|12421013|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
11228851|NCT02012959|12421009|FG000|COMPLETED|Treatment Phase B||0
11228852|NCT02012959|12421010|FG001|COMPLETED|Treatment Phase B||2
11228853|NCT02012959|12421011|FG002|COMPLETED|Treatment Phase B||3
11228854|NCT02012959|12421012|FG003|COMPLETED|Treatment Phase B||1
11228855|NCT02012959|12421013|FG004|COMPLETED|Treatment Phase B||1
11228856|NCT02012959|12421009|FG000|NOT COMPLETED|Treatment Phase B||0
11228857|NCT02012959|12421010|FG001|NOT COMPLETED|Treatment Phase B||0
11228858|NCT02012959|12421011|FG002|NOT COMPLETED|Treatment Phase B||0
11228859|NCT02012959|12421012|FG003|NOT COMPLETED|Treatment Phase B||0
11355130|NCT03077165|12551982|FG004|COMPLETED|Overall Study||16
11355131|NCT03077165|12551983|FG005|COMPLETED|Overall Study||20
11355132|NCT03077165|12551978|FG000|NOT COMPLETED|Overall Study||1
11355133|NCT03077165|12551979|FG001|NOT COMPLETED|Overall Study||0
11355134|NCT03077165|12551980|FG002|NOT COMPLETED|Overall Study||0
11355135|NCT03077165|12551981|FG003|NOT COMPLETED|Overall Study||0
11355136|NCT03077165|12551982|FG004|NOT COMPLETED|Overall Study||3
11355137|NCT03077165|12551983|FG005|NOT COMPLETED|Overall Study||0
11355138|NCT03077607|12551999|FG000|STARTED|Period 1 (15 Days)||19
11355139|NCT03077607|12552000|FG001|STARTED|Period 1 (15 Days)||17
10867101|NCT02508532|12032300|FG006|NOT COMPLETED|Part 2 - Treatment||0
10867102|NCT02508532|12032301|FG007|NOT COMPLETED|Part 2 - Treatment||0
10867103|NCT02508532|12032302|FG008|NOT COMPLETED|Part 2 - Treatment||217
10867104|NCT02508532|12032294|FG000|STARTED|Part 1 and Part 2 End of Study||6
10867105|NCT02508532|12032295|FG001|STARTED|Part 1 and Part 2 End of Study||6
11228860|NCT02012959|12421013|FG004|NOT COMPLETED|Treatment Phase B||0
11228861|NCT02013037|12421023|FG000|STARTED|Overall Study||36
11228862|NCT02013037|12421023|FG000|COMPLETED|Overall Study||20
11228863|NCT02013037|12421023|FG000|NOT COMPLETED|Overall Study||16
11228864|NCT02013050|12421032|FG000|STARTED|Overall Study||42
11228865|NCT02013050|12421033|FG001|STARTED|Overall Study||41
11228866|NCT02013050|12421034|FG002|STARTED|Overall Study||3
11228867|NCT02013050|12421035|FG003|STARTED|Overall Study||23
11228868|NCT02013050|12421032|FG000|COMPLETED|Overall Study||38
11228869|NCT02013050|12421033|FG001|COMPLETED|Overall Study||36
11228870|NCT02013050|12421034|FG002|COMPLETED|Overall Study||3
11228871|NCT02013050|12421035|FG003|COMPLETED|Overall Study||19
11228872|NCT02013050|12421032|FG000|NOT COMPLETED|Overall Study||4
11228873|NCT02013050|12421033|FG001|NOT COMPLETED|Overall Study||5
11228874|NCT02013050|12421034|FG002|NOT COMPLETED|Overall Study||0
11228875|NCT02013050|12421035|FG003|NOT COMPLETED|Overall Study||4
11228876|NCT02013180|12421047|FG000|STARTED|Overall Study||119
11228877|NCT02013180|12421048|FG001|STARTED|Overall Study||361
11228878|NCT02013180|12421047|FG000|COMPLETED|Overall Study||119
11228879|NCT02013180|12421048|FG001|COMPLETED|Overall Study||361
11228880|NCT02013180|12421047|FG000|NOT COMPLETED|Overall Study||0
11228881|NCT02013180|12421048|FG001|NOT COMPLETED|Overall Study||0
11228882|NCT02013206|12421056|FG000|STARTED|Overall Study||29
11228883|NCT02013206|12421057|FG001|STARTED|Overall Study||23
11228884|NCT02013206|12421056|FG000|Received Study Drug|Overall Study||26
11228885|NCT02013206|12421057|FG001|Received Study Drug|Overall Study||23
11228886|NCT02013206|12421056|FG000|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
11228887|NCT02013206|12421057|FG001|COMPLETED|Overall Study||1
11228888|NCT02013206|12421056|FG000|NOT COMPLETED|Overall Study||27
11228889|NCT02013206|12421057|FG001|NOT COMPLETED|Overall Study||22
11228890|NCT02013245|12421067|FG000|STARTED|Overall Study||9
11228891|NCT02013245|12421068|FG001|STARTED|Overall Study||9
11228892|NCT02013245|12421069|FG002|STARTED|Overall Study||9
11228893|NCT02013245|12421070|FG003|STARTED|Overall Study||9
11228894|NCT02013245|12421067|FG000|COMPLETED|Overall Study||9
11228895|NCT02013245|12421068|FG001|COMPLETED|Overall Study||8
11228896|NCT02013245|12421069|FG002|COMPLETED|Overall Study||9
11228897|NCT02013245|12421070|FG003|COMPLETED|Overall Study||9
11228898|NCT02013245|12421067|FG000|NOT COMPLETED|Overall Study||0
11228899|NCT02013245|12421068|FG001|NOT COMPLETED|Overall Study||1
11228900|NCT02013245|12421069|FG002|NOT COMPLETED|Overall Study||0
11228901|NCT02013245|12421070|FG003|NOT COMPLETED|Overall Study||0
11228902|NCT02013375|12421080|FG000|STARTED|Overall Study||2
11228903|NCT02013375|12421080|FG000|COMPLETED|Overall Study||0
11228904|NCT02013375|12421080|FG000|NOT COMPLETED|Overall Study||2
11228905|NCT02013388|12421093|FG000|STARTED|Overall Study||9
11228906|NCT02013388|12421094|FG001|STARTED|Overall Study||6
11228907|NCT02013388|12421095|FG002|STARTED|Overall Study||6
11228908|NCT02013388|12421096|FG003|STARTED|Overall Study||6
11228909|NCT02013388|12421097|FG004|STARTED|Overall Study||6
11228910|NCT02013388|12421098|FG005|STARTED|Overall Study||6
11228911|NCT02013388|12421099|FG006|STARTED|Overall Study||6
11228912|NCT02013388|12421100|FG007|STARTED|Overall Study||4
11228913|NCT02013388|12421093|FG000|COMPLETED|Overall Study||8
11228914|NCT02013388|12421094|FG001|COMPLETED|Overall Study||6
11228915|NCT02013388|12421095|FG002|COMPLETED|Overall Study||6
11228916|NCT02013388|12421096|FG003|COMPLETED|Overall Study||6
11228917|NCT02013388|12421097|FG004|COMPLETED|Overall Study||5
11228918|NCT02013388|12421098|FG005|COMPLETED|Overall Study||6
11228919|NCT02013388|12421099|FG006|COMPLETED|Overall Study||6
11228920|NCT02013388|12421100|FG007|COMPLETED|Overall Study||4
11228921|NCT02013388|12421093|FG000|NOT COMPLETED|Overall Study||1
11228922|NCT02013388|12421094|FG001|NOT COMPLETED|Overall Study||0
11228923|NCT02013388|12421095|FG002|NOT COMPLETED|Overall Study||0
11228924|NCT02013388|12421096|FG003|NOT COMPLETED|Overall Study||0
11228925|NCT02013388|12421097|FG004|NOT COMPLETED|Overall Study||1
11228926|NCT02013388|12421098|FG005|NOT COMPLETED|Overall Study||0
11228927|NCT02013388|12421099|FG006|NOT COMPLETED|Overall Study||0
11228928|NCT02013388|12421100|FG007|NOT COMPLETED|Overall Study||0
11228929|NCT02013531|12421122|FG000|STARTED|Overall Study||37
11228930|NCT02013531|12421122|FG000|COMPLETED|Overall Study||32
11228931|NCT02013531|12421122|FG000|NOT COMPLETED|Overall Study||5
11228932|NCT02013544|12421128|FG000|STARTED|Overall Study||182
11228933|NCT02013544|12421129|FG001|STARTED|Overall Study||376
11228934|NCT02013544|12421128|FG000|Safety Population|Overall Study||180
11228935|NCT02013544|12421129|FG001|Safety Population|Overall Study||374
11228936|NCT02013544|12421128|FG000|ITT Population|Overall Study||157
11228937|NCT02013544|12421129|FG001|ITT Population|Overall Study||325
11228938|NCT02013544|12421128|FG000|COMPLETED|Overall Study||171
11228939|NCT02013544|12421129|FG001|COMPLETED|Overall Study||356
11228940|NCT02013544|12421128|FG000|NOT COMPLETED|Overall Study||11
11228941|NCT02013544|12421129|FG001|NOT COMPLETED|Overall Study||20
11228942|NCT02013609|12421135|FG000|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
10867106|NCT02508532|12032296|FG002|STARTED|Part 1 and Part 2 End of Study||6
10867107|NCT02508532|12032297|FG003|STARTED|Part 1 and Part 2 End of Study||6
10867108|NCT02508532|12032298|FG004|STARTED|Part 1 and Part 2 End of Study||6
10867109|NCT02508532|12032299|FG005|STARTED|Part 1 and Part 2 End of Study|These 6 patients are included in the 300 or 400 mg QD dose group|0
10867110|NCT02508532|12032300|FG006|STARTED|Part 1 and Part 2 End of Study|These 7 patients are included in the 300 or 400 mg QD dose group|0
10867111|NCT02508532|12032301|FG007|STARTED|Part 1 and Part 2 End of Study||3
10867112|NCT02508532|12032302|FG008|STARTED|Part 1 and Part 2 End of Study|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
10867113|NCT02508532|12032294|FG000|COMPLETED|Part 1 and Part 2 End of Study||0
10867114|NCT02508532|12032295|FG001|COMPLETED|Part 1 and Part 2 End of Study||0
10867115|NCT02508532|12032296|FG002|COMPLETED|Part 1 and Part 2 End of Study||0
10867116|NCT02508532|12032297|FG003|COMPLETED|Part 1 and Part 2 End of Study||0
10867117|NCT02508532|12032298|FG004|COMPLETED|Part 1 and Part 2 End of Study||0
10867118|NCT02508532|12032299|FG005|COMPLETED|Part 1 and Part 2 End of Study||0
10867119|NCT02508532|12032300|FG006|COMPLETED|Part 1 and Part 2 End of Study||0
10867120|NCT02508532|12032301|FG007|COMPLETED|Part 1 and Part 2 End of Study||0
10867121|NCT02508532|12032302|FG008|COMPLETED|Part 1 and Part 2 End of Study||0
10867122|NCT02508532|12032294|FG000|NOT COMPLETED|Part 1 and Part 2 End of Study||6
10867123|NCT02508532|12032295|FG001|NOT COMPLETED|Part 1 and Part 2 End of Study||6
10867124|NCT02508532|12032296|FG002|NOT COMPLETED|Part 1 and Part 2 End of Study||6
10867125|NCT02508532|12032297|FG003|NOT COMPLETED|Part 1 and Part 2 End of Study||6
10867126|NCT02508532|12032298|FG004|NOT COMPLETED|Part 1 and Part 2 End of Study||6
10867127|NCT02508532|12032299|FG005|NOT COMPLETED|Part 1 and Part 2 End of Study||0
10867128|NCT02508532|12032300|FG006|NOT COMPLETED|Part 1 and Part 2 End of Study||0
10867129|NCT02508532|12032301|FG007|NOT COMPLETED|Part 1 and Part 2 End of Study||3
10867130|NCT02508532|12032302|FG008|NOT COMPLETED|Part 1 and Part 2 End of Study||217
11110035|NCT01277341|12294488|FG003|STARTED|Overall Study||152
11110036|NCT01277341|12294485|FG000|COMPLETED|Overall Study||146
11110037|NCT01277341|12294486|FG001|COMPLETED|Overall Study||145
11110038|NCT01277341|12294487|FG002|COMPLETED|Overall Study||145
11110039|NCT01277341|12294488|FG003|COMPLETED|Overall Study||146
11110040|NCT01277341|12294485|FG000|NOT COMPLETED|Overall Study||4
11110041|NCT01277341|12294486|FG001|NOT COMPLETED|Overall Study||5
11110042|NCT01277341|12294487|FG002|NOT COMPLETED|Overall Study||4
10867139|NCT02426684|12032339|FG000|STARTED|Overall Study||17
10867140|NCT02426684|12032339|FG000|COMPLETED|Overall Study||16
10867141|NCT02426684|12032339|FG000|NOT COMPLETED|Overall Study||1
11110043|NCT01277341|12294488|FG003|NOT COMPLETED|Overall Study||6
11110044|NCT01277354|12294500|FG000|STARTED|Overall Study||1
11110045|NCT01277354|12294501|FG001|STARTED|Overall Study||1
11110046|NCT01277354|12294500|FG000|COMPLETED|Overall Study||1
11110047|NCT01277354|12294501|FG001|COMPLETED|Overall Study||1
11110048|NCT01277354|12294500|FG000|NOT COMPLETED|Overall Study||0
11110049|NCT01277354|12294501|FG001|NOT COMPLETED|Overall Study||0
11110050|NCT01277510|12294509|FG000|STARTED|Double-blind Phase||21
11110051|NCT01277510|12294510|FG001|STARTED|Double-blind Phase||22
11110052|NCT01277510|12294509|FG000|Received Investigational Product|Double-blind Phase||21
11110053|NCT01277510|12294510|FG001|Received Investigational Product|Double-blind Phase||22
11110054|NCT01277510|12294509|FG000|COMPLETED|Double-blind Phase|Completed investigational product|8
11110055|NCT01277510|12294510|FG001|COMPLETED|Double-blind Phase|Completed investigational product|4
11110056|NCT01277510|12294509|FG000|NOT COMPLETED|Double-blind Phase||13
11110057|NCT01277510|12294510|FG001|NOT COMPLETED|Double-blind Phase||18
11110058|NCT01277510|12294509|FG000|STARTED|Open-label Phase||8
11110059|NCT01277510|12294510|FG001|STARTED|Open-label Phase||4
11110060|NCT01277510|12294509|FG000|Received Investigational Product|Open-label Phase||6
11228943|NCT02013609|12421135|FG000|COMPLETED|Overall Study||29
11110061|NCT01277510|12294510|FG001|Received Investigational Product|Open-label Phase||4
10867160|NCT02337751|12032358|FG000|STARTED|Overall Study||95
10867161|NCT02337751|12032359|FG001|STARTED|Overall Study||103
10867162|NCT02337751|12032358|FG000|COMPLETED|Overall Study||84
10867163|NCT02337751|12032359|FG001|COMPLETED|Overall Study||87
10867164|NCT02337751|12032358|FG000|NOT COMPLETED|Overall Study||11
10867165|NCT02337751|12032359|FG001|NOT COMPLETED|Overall Study||16
10867166|NCT02337725|12032368|FG000|STARTED|Overall Study||126
10867167|NCT02337725|12032369|FG001|STARTED|Overall Study||118
10867168|NCT02337725|12032368|FG000|COMPLETED|Overall Study||100
10867169|NCT02337725|12032369|FG001|COMPLETED|Overall Study||110
10867170|NCT02337725|12032368|FG000|NOT COMPLETED|Overall Study||26
10867171|NCT02337725|12032369|FG001|NOT COMPLETED|Overall Study||8
10867172|NCT02332655|12032375|FG000|STARTED|Overall Study||5
10867173|NCT02332655|12032375|FG000|COMPLETED|Overall Study||4
10867174|NCT02332655|12032375|FG000|NOT COMPLETED|Overall Study||1
10867175|NCT02317705|12032379|FG000|STARTED|Overall Study||48
10867176|NCT02317705|12032379|FG000|Safety Population|Overall Study||44
10867177|NCT02317705|12032379|FG000|Modified Intent-to-Treat (mITT)|Overall Study||29
10867178|NCT02317705|12032379|FG000|COMPLETED|Overall Study||43
10867179|NCT02317705|12032379|FG000|NOT COMPLETED|Overall Study||5
10867180|NCT02272803|12032385|FG000|STARTED|Overall Study||40
10867181|NCT02272803|12032386|FG001|STARTED|Overall Study||42
10867182|NCT02272803|12032385|FG000|COMPLETED|Overall Study||0
10867183|NCT02272803|12032386|FG001|COMPLETED|Overall Study||0
10867184|NCT02272803|12032385|FG000|NOT COMPLETED|Overall Study||40
10867185|NCT02272803|12032386|FG001|NOT COMPLETED|Overall Study||42
10867186|NCT02240134|12032395|FG000|STARTED|Overall Study||176
10867187|NCT02240134|12032396|FG001|STARTED|Overall Study||176
10867188|NCT02240134|12032397|FG002|STARTED|Overall Study||171
10867189|NCT02240134|12032395|FG000|COMPLETED|Overall Study||126
10867190|NCT02240134|12032396|FG001|COMPLETED|Overall Study||123
10867191|NCT02240134|12032397|FG002|COMPLETED|Overall Study||118
10867192|NCT02240134|12032395|FG000|NOT COMPLETED|Overall Study||50
10867193|NCT02240134|12032396|FG001|NOT COMPLETED|Overall Study||53
10867194|NCT02240134|12032397|FG002|NOT COMPLETED|Overall Study||53
11110062|NCT01277510|12294509|FG000|COMPLETED|Open-label Phase|Completed investigational product|1
11110063|NCT01277510|12294510|FG001|COMPLETED|Open-label Phase|Completed investigational product|1
11110064|NCT01277510|12294509|FG000|NOT COMPLETED|Open-label Phase||7
11110065|NCT01277510|12294510|FG001|NOT COMPLETED|Open-label Phase||3
11110066|NCT01277523|12294521|FG000|STARTED|Overall Study||135
11110067|NCT01277523|12294522|FG001|STARTED|Overall Study||127
11110068|NCT01277523|12294523|FG002|STARTED|Overall Study||130
11110069|NCT01277523|12294521|FG000|COMPLETED|Overall Study||132
11110070|NCT01277523|12294522|FG001|COMPLETED|Overall Study||126
11110071|NCT01277523|12294523|FG002|COMPLETED|Overall Study||130
11110072|NCT01277523|12294521|FG000|NOT COMPLETED|Overall Study||3
11110073|NCT01277523|12294522|FG001|NOT COMPLETED|Overall Study||1
10867207|NCT02158585|12032414|FG000|STARTED|Overall Study||8
10867208|NCT02158585|12032415|FG001|STARTED|Overall Study||7
10867209|NCT02158585|12032414|FG000|COMPLETED|Overall Study||7
10867210|NCT02158585|12032415|FG001|COMPLETED|Overall Study||6
10867211|NCT02158585|12032414|FG000|NOT COMPLETED|Overall Study||1
10867212|NCT02158585|12032415|FG001|NOT COMPLETED|Overall Study||1
10867213|NCT02130687|12032425|FG000|STARTED|Washout||36
10867214|NCT02130687|12032426|FG001|STARTED|Washout||35
10867215|NCT02130687|12032427|FG002|STARTED|Washout||35
10867216|NCT02130687|12032425|FG000|COMPLETED|Washout||36
10867217|NCT02130687|12032426|FG001|COMPLETED|Washout||33
10867218|NCT02130687|12032427|FG002|COMPLETED|Washout||31
10867219|NCT02130687|12032425|FG000|NOT COMPLETED|Washout||0
10867220|NCT02130687|12032426|FG001|NOT COMPLETED|Washout||2
10867221|NCT02130687|12032427|FG002|NOT COMPLETED|Washout||4
10867222|NCT02130687|12032425|FG000|STARTED|Drug 1 Only||36
10867223|NCT02130687|12032426|FG001|STARTED|Drug 1 Only||33
10867224|NCT02130687|12032427|FG002|STARTED|Drug 1 Only||31
10867225|NCT02130687|12032425|FG000|COMPLETED|Drug 1 Only||33
10867226|NCT02130687|12032426|FG001|COMPLETED|Drug 1 Only||30
10867227|NCT02130687|12032427|FG002|COMPLETED|Drug 1 Only||30
10867228|NCT02130687|12032425|FG000|NOT COMPLETED|Drug 1 Only||3
10867229|NCT02130687|12032426|FG001|NOT COMPLETED|Drug 1 Only||3
10867230|NCT02130687|12032427|FG002|NOT COMPLETED|Drug 1 Only||1
10867231|NCT02130687|12032425|FG000|STARTED|Crossover Period 1||33
10867232|NCT02130687|12032426|FG001|STARTED|Crossover Period 1||30
10867233|NCT02130687|12032427|FG002|STARTED|Crossover Period 1||30
10867234|NCT02130687|12032425|FG000|COMPLETED|Crossover Period 1||33
10867235|NCT02130687|12032426|FG001|COMPLETED|Crossover Period 1||30
10867236|NCT02130687|12032427|FG002|COMPLETED|Crossover Period 1||30
10867237|NCT02130687|12032425|FG000|NOT COMPLETED|Crossover Period 1||0
10867238|NCT02130687|12032426|FG001|NOT COMPLETED|Crossover Period 1||0
10867239|NCT02130687|12032427|FG002|NOT COMPLETED|Crossover Period 1||0
10867240|NCT02130687|12032425|FG000|STARTED|Drug 1 Only Between Periods 1 and 2||33
10867241|NCT02130687|12032426|FG001|STARTED|Drug 1 Only Between Periods 1 and 2||30
10867242|NCT02130687|12032427|FG002|STARTED|Drug 1 Only Between Periods 1 and 2||30
10867243|NCT02130687|12032425|FG000|COMPLETED|Drug 1 Only Between Periods 1 and 2||33
10867244|NCT02130687|12032426|FG001|COMPLETED|Drug 1 Only Between Periods 1 and 2||26
10867245|NCT02130687|12032427|FG002|COMPLETED|Drug 1 Only Between Periods 1 and 2||29
10867246|NCT02130687|12032425|FG000|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||0
11110074|NCT01277523|12294523|FG002|NOT COMPLETED|Overall Study||0
11110075|NCT01277549|12294533|FG000|STARTED|Overall Study||41
11110076|NCT01277549|12294534|FG001|STARTED|Overall Study||29
10867247|NCT02130687|12032426|FG001|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||4
10867248|NCT02130687|12032427|FG002|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||1
10867249|NCT02130687|12032425|FG000|STARTED|Crossover Period 2||33
10867250|NCT02130687|12032426|FG001|STARTED|Crossover Period 2||26
10867251|NCT02130687|12032427|FG002|STARTED|Crossover Period 2||29
10867252|NCT02130687|12032425|FG000|COMPLETED|Crossover Period 2||33
10867253|NCT02130687|12032426|FG001|COMPLETED|Crossover Period 2||26
10867254|NCT02130687|12032427|FG002|COMPLETED|Crossover Period 2||29
10867255|NCT02130687|12032425|FG000|NOT COMPLETED|Crossover Period 2||0
10867256|NCT02130687|12032426|FG001|NOT COMPLETED|Crossover Period 2||0
10867257|NCT02130687|12032427|FG002|NOT COMPLETED|Crossover Period 2||0
10867258|NCT02130687|12032425|FG000|STARTED|Drug 1 Only Between Periods 2 and 3||33
10867259|NCT02130687|12032426|FG001|STARTED|Drug 1 Only Between Periods 2 and 3||26
10867260|NCT02130687|12032427|FG002|STARTED|Drug 1 Only Between Periods 2 and 3||29
10867261|NCT02130687|12032425|FG000|COMPLETED|Drug 1 Only Between Periods 2 and 3||33
10867262|NCT02130687|12032426|FG001|COMPLETED|Drug 1 Only Between Periods 2 and 3||25
10867263|NCT02130687|12032427|FG002|COMPLETED|Drug 1 Only Between Periods 2 and 3||27
10867264|NCT02130687|12032425|FG000|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||0
10867265|NCT02130687|12032426|FG001|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||1
10867266|NCT02130687|12032427|FG002|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||2
11110077|NCT01277549|12294533|FG000|COMPLETED|Overall Study||15
11110078|NCT01277549|12294534|FG001|COMPLETED|Overall Study||15
11110079|NCT01277549|12294533|FG000|NOT COMPLETED|Overall Study||26
11110080|NCT01277549|12294534|FG001|NOT COMPLETED|Overall Study||14
11110081|NCT01277601|12294547|FG000|STARTED|Overall Study||188
11110082|NCT01277601|12294548|FG001|STARTED|Overall Study||187
11110083|NCT01277601|12294549|FG002|STARTED|Overall Study||190
11110084|NCT01277601|12294550|FG003|STARTED|Overall Study||186
11110085|NCT01277601|12294547|FG000|COMPLETED|Overall Study||151
11110086|NCT01277601|12294548|FG001|COMPLETED|Overall Study||139
11110087|NCT01277601|12294549|FG002|COMPLETED|Overall Study||163
11228944|NCT02013609|12421135|FG000|NOT COMPLETED|Overall Study||18
11228945|NCT02013622|12421139|FG000|STARTED|Overall Study||49
11228946|NCT02013622|12421139|FG000|COMPLETED|Overall Study||25
11228947|NCT02013622|12421139|FG000|NOT COMPLETED|Overall Study||24
11228948|NCT02013674|12421145|FG000|STARTED|Overall Study||15
11228949|NCT02013674|12421146|FG001|STARTED|Overall Study||15
11228950|NCT02013674|12421145|FG000|COMPLETED|Overall Study||14
11228951|NCT02013674|12421146|FG001|COMPLETED|Overall Study||14
11228952|NCT02013674|12421145|FG000|NOT COMPLETED|Overall Study||1
11228953|NCT02013674|12421146|FG001|NOT COMPLETED|Overall Study||1
11228954|NCT02013687|12421156|FG000|STARTED|Overall Study||6
11228955|NCT02013687|12421157|FG001|STARTED|Overall Study||6
11228956|NCT02013687|12421158|FG002|STARTED|Overall Study||16
11228957|NCT02013687|12421159|FG003|STARTED|Overall Study||16
11228958|NCT02013687|12421156|FG000|COMPLETED|Overall Study||6
11228959|NCT02013687|12421157|FG001|COMPLETED|Overall Study||6
11228960|NCT02013687|12421158|FG002|COMPLETED|Overall Study||14
11228961|NCT02013687|12421159|FG003|COMPLETED|Overall Study||14
11228962|NCT02013687|12421156|FG000|NOT COMPLETED|Overall Study||0
11228963|NCT02013687|12421157|FG001|NOT COMPLETED|Overall Study||0
11228964|NCT02013687|12421158|FG002|NOT COMPLETED|Overall Study||2
11228965|NCT02013687|12421159|FG003|NOT COMPLETED|Overall Study||2
11228966|NCT02013765|12421173|FG000|STARTED|Overall Study||5
11228967|NCT02013765|12421173|FG000|COMPLETED|Overall Study||4
11228968|NCT02013765|12421173|FG000|NOT COMPLETED|Overall Study||1
11110088|NCT01277601|12294550|FG003|COMPLETED|Overall Study||150
11110089|NCT01277601|12294547|FG000|NOT COMPLETED|Overall Study||37
11110090|NCT01277601|12294548|FG001|NOT COMPLETED|Overall Study||48
11110091|NCT01277601|12294549|FG002|NOT COMPLETED|Overall Study||27
11110092|NCT01277601|12294550|FG003|NOT COMPLETED|Overall Study||36
11110093|NCT01277666|12294580|FG000|STARTED|Overall Study||203
11110094|NCT01277666|12294581|FG001|STARTED|Overall Study||203
11110095|NCT01277666|12294582|FG002|STARTED|Overall Study||202
11110096|NCT01277666|12294580|FG000|COMPLETED|Overall Study||158
11110097|NCT01277666|12294581|FG001|COMPLETED|Overall Study||144
11110098|NCT01277666|12294582|FG002|COMPLETED|Overall Study||153
11110099|NCT01277666|12294580|FG000|NOT COMPLETED|Overall Study||45
11228969|NCT02013778|12421177|FG000|STARTED|Overall Study||8
11228970|NCT02013778|12421177|FG000|COMPLETED|Overall Study||1
10867267|NCT02130687|12032425|FG000|STARTED|Crossover Period 3||33
10867268|NCT02130687|12032426|FG001|STARTED|Crossover Period 3||25
10867269|NCT02130687|12032427|FG002|STARTED|Crossover Period 3||27
10867270|NCT02130687|12032425|FG000|COMPLETED|Crossover Period 3||33
10867271|NCT02130687|12032426|FG001|COMPLETED|Crossover Period 3||25
10867272|NCT02130687|12032427|FG002|COMPLETED|Crossover Period 3||27
10867273|NCT02130687|12032425|FG000|NOT COMPLETED|Crossover Period 3||0
10867274|NCT02130687|12032426|FG001|NOT COMPLETED|Crossover Period 3||0
10867275|NCT02130687|12032427|FG002|NOT COMPLETED|Crossover Period 3||0
11110100|NCT01277666|12294581|FG001|NOT COMPLETED|Overall Study||59
11110101|NCT01277666|12294582|FG002|NOT COMPLETED|Overall Study||49
11110102|NCT01277718|12294590|FG000|STARTED|Period 1 - First Intervention||10
11110103|NCT01277718|12294591|FG001|STARTED|Period 1 - First Intervention||10
11110104|NCT01277718|12294590|FG000|COMPLETED|Period 1 - First Intervention||10
11110105|NCT01277718|12294591|FG001|COMPLETED|Period 1 - First Intervention||10
11228971|NCT02013778|12421177|FG000|NOT COMPLETED|Overall Study||7
11228972|NCT02013791|12421190|FG000|STARTED|Period 1||8
11228973|NCT02013791|12421191|FG001|STARTED|Period 1||8
11228974|NCT02013791|12421192|FG002|STARTED|Period 1||4
11228975|NCT02013791|12421193|FG003|STARTED|Period 1||8
11228976|NCT02013791|12421194|FG004|STARTED|Period 1||4
11228977|NCT02013791|12421195|FG005|STARTED|Period 1||8
11228978|NCT02013791|12421196|FG006|STARTED|Period 1||4
11228979|NCT02013791|12421197|FG007|STARTED|Period 1||8
11228980|NCT02013791|12421198|FG008|STARTED|Period 1||3
11228981|NCT02013791|12421190|FG000|COMPLETED|Period 1||8
11228982|NCT02013791|12421191|FG001|COMPLETED|Period 1||6
11110106|NCT01277718|12294590|FG000|NOT COMPLETED|Period 1 - First Intervention||0
11110107|NCT01277718|12294591|FG001|NOT COMPLETED|Period 1 - First Intervention||0
11228983|NCT02013791|12421192|FG002|COMPLETED|Period 1||4
11228984|NCT02013791|12421193|FG003|COMPLETED|Period 1||7
11228985|NCT02013791|12421194|FG004|COMPLETED|Period 1||4
11228986|NCT02013791|12421195|FG005|COMPLETED|Period 1||8
11228987|NCT02013791|12421196|FG006|COMPLETED|Period 1||3
10867276|NCT01994382|12032470|FG000|STARTED|Overall Study||3
10867277|NCT01994382|12032471|FG001|STARTED|Overall Study||6
10867278|NCT01994382|12032472|FG002|STARTED|Overall Study||7
10867279|NCT01994382|12032473|FG003|STARTED|Overall Study||3
10867280|NCT01994382|12032474|FG004|STARTED|Overall Study||3
10867281|NCT01994382|12032475|FG005|STARTED|Overall Study||3
10867282|NCT01994382|12032476|FG006|STARTED|Overall Study||4
10867283|NCT01994382|12032477|FG007|STARTED|Overall Study||6
10867284|NCT01994382|12032478|FG008|STARTED|Overall Study||3
10867285|NCT01994382|12032479|FG009|STARTED|Overall Study||5
10867286|NCT01994382|12032480|FG010|STARTED|Overall Study||42
10867287|NCT01994382|12032481|FG011|STARTED|Overall Study||12
10867288|NCT01994382|12032482|FG012|STARTED|Overall Study||26
10867289|NCT01994382|12032483|FG013|STARTED|Overall Study||6
10867290|NCT01994382|12032484|FG014|STARTED|Overall Study||28
10867291|NCT01994382|12032485|FG015|STARTED|Overall Study||65
10867292|NCT01994382|12032486|FG016|STARTED|Overall Study||41
10867293|NCT01994382|12032470|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10867294|NCT01994382|12032471|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
10867295|NCT01994382|12032472|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
10867296|NCT01994382|12032473|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10867297|NCT01994382|12032474|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
10867298|NCT01994382|12032475|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
10867299|NCT01994382|12032476|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4
10867300|NCT01994382|12032477|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
10867301|NCT01994382|12032478|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
10867302|NCT01994382|12032479|FG009|Received at Least 1 Dose of Study Drug|Overall Study||5
10867303|NCT01994382|12032480|FG010|Received at Least 1 Dose of Study Drug|Overall Study||42
10867304|NCT01994382|12032481|FG011|Received at Least 1 Dose of Study Drug|Overall Study||12
10867305|NCT01994382|12032482|FG012|Received at Least 1 Dose of Study Drug|Overall Study||26
10867306|NCT01994382|12032483|FG013|Received at Least 1 Dose of Study Drug|Overall Study||6
10867307|NCT01994382|12032484|FG014|Received at Least 1 Dose of Study Drug|Overall Study||28
10867308|NCT01994382|12032485|FG015|Received at Least 1 Dose of Study Drug|Overall Study||65
10867309|NCT01994382|12032486|FG016|Received at Least 1 Dose of Study Drug|Overall Study||41
10867310|NCT01994382|12032470|FG000|COMPLETED|Overall Study||0
10867311|NCT01994382|12032471|FG001|COMPLETED|Overall Study||0
10867312|NCT01994382|12032472|FG002|COMPLETED|Overall Study||0
10867313|NCT01994382|12032473|FG003|COMPLETED|Overall Study||0
10867314|NCT01994382|12032474|FG004|COMPLETED|Overall Study||0
10867315|NCT01994382|12032475|FG005|COMPLETED|Overall Study||0
10867316|NCT01994382|12032476|FG006|COMPLETED|Overall Study||0
10867317|NCT01994382|12032477|FG007|COMPLETED|Overall Study||0
10867318|NCT01994382|12032478|FG008|COMPLETED|Overall Study||0
10867319|NCT01994382|12032479|FG009|COMPLETED|Overall Study||0
10867320|NCT01994382|12032480|FG010|COMPLETED|Overall Study||0
10867321|NCT01994382|12032481|FG011|COMPLETED|Overall Study||0
10867322|NCT01994382|12032482|FG012|COMPLETED|Overall Study||0
10867323|NCT01994382|12032483|FG013|COMPLETED|Overall Study||0
10867324|NCT01994382|12032484|FG014|COMPLETED|Overall Study||0
10867325|NCT01994382|12032485|FG015|COMPLETED|Overall Study||0
11228988|NCT02013791|12421197|FG007|COMPLETED|Period 1||7
10867326|NCT01994382|12032486|FG016|COMPLETED|Overall Study||0
10867327|NCT01994382|12032470|FG000|NOT COMPLETED|Overall Study||3
10867328|NCT01994382|12032471|FG001|NOT COMPLETED|Overall Study||6
10867329|NCT01994382|12032472|FG002|NOT COMPLETED|Overall Study||7
10867330|NCT01994382|12032473|FG003|NOT COMPLETED|Overall Study||3
10867331|NCT01994382|12032474|FG004|NOT COMPLETED|Overall Study||3
10867332|NCT01994382|12032475|FG005|NOT COMPLETED|Overall Study||3
10867333|NCT01994382|12032476|FG006|NOT COMPLETED|Overall Study||4
10867334|NCT01994382|12032477|FG007|NOT COMPLETED|Overall Study||6
10867335|NCT01994382|12032478|FG008|NOT COMPLETED|Overall Study||3
10867336|NCT01994382|12032479|FG009|NOT COMPLETED|Overall Study||5
10867337|NCT01994382|12032480|FG010|NOT COMPLETED|Overall Study||42
10867338|NCT01994382|12032481|FG011|NOT COMPLETED|Overall Study||12
10867339|NCT01994382|12032482|FG012|NOT COMPLETED|Overall Study||26
10867340|NCT01994382|12032483|FG013|NOT COMPLETED|Overall Study||6
10867341|NCT01994382|12032484|FG014|NOT COMPLETED|Overall Study||28
10867342|NCT01994382|12032485|FG015|NOT COMPLETED|Overall Study||65
10867343|NCT01994382|12032486|FG016|NOT COMPLETED|Overall Study||41
10867344|NCT01896531|12032531|FG000|STARTED|Overall Study||71
10867345|NCT01896531|12032532|FG001|STARTED|Overall Study||82
10867346|NCT01896531|12032531|FG000|Treated|Overall Study||70
10867347|NCT01896531|12032532|FG001|Treated|Overall Study||82
10867348|NCT01896531|12032531|FG000|COMPLETED|Overall Study||0
10867349|NCT01896531|12032532|FG001|COMPLETED|Overall Study||0
10867350|NCT01896531|12032531|FG000|NOT COMPLETED|Overall Study||71
10867351|NCT01896531|12032532|FG001|NOT COMPLETED|Overall Study||82
10867384|NCT01719744|12032561|FG000|STARTED|Overall Study||25
10867385|NCT01719744|12032561|FG000|COMPLETED|Overall Study||25
10867386|NCT01719744|12032561|FG000|NOT COMPLETED|Overall Study||0
10867387|NCT01684722|12032569|FG000|STARTED|Overall Study||333
10867388|NCT01684722|12032570|FG001|STARTED|Overall Study||289
10867389|NCT01684722|12032571|FG002|STARTED|Overall Study||320
10867390|NCT01684722|12032572|FG003|STARTED|Overall Study||370
10867391|NCT01684722|12032569|FG000|COMPLETED|Overall Study||236
10867392|NCT01684722|12032570|FG001|COMPLETED|Overall Study||212
10867393|NCT01684722|12032571|FG002|COMPLETED|Overall Study||226
10867394|NCT01684722|12032572|FG003|COMPLETED|Overall Study||260
10867395|NCT01684722|12032569|FG000|NOT COMPLETED|Overall Study||97
11110108|NCT01277718|12294590|FG000|STARTED|Washout Period of 13 Days||10
11110109|NCT01277718|12294591|FG001|STARTED|Washout Period of 13 Days||10
11110110|NCT01277718|12294590|FG000|COMPLETED|Washout Period of 13 Days||10
11110111|NCT01277718|12294591|FG001|COMPLETED|Washout Period of 13 Days||10
11110112|NCT01277718|12294590|FG000|NOT COMPLETED|Washout Period of 13 Days||0
11110113|NCT01277718|12294591|FG001|NOT COMPLETED|Washout Period of 13 Days||0
11110114|NCT01277718|12294590|FG000|STARTED|Period 2 - Second Intervention||10
11110115|NCT01277718|12294591|FG001|STARTED|Period 2 - Second Intervention||10
11110116|NCT01277718|12294590|FG000|COMPLETED|Period 2 - Second Intervention||10
11110117|NCT01277718|12294591|FG001|COMPLETED|Period 2 - Second Intervention||7
11110118|NCT01277718|12294590|FG000|NOT COMPLETED|Period 2 - Second Intervention||0
11110119|NCT01277718|12294591|FG001|NOT COMPLETED|Period 2 - Second Intervention||3
11110120|NCT01277718|12294590|FG000|STARTED|Washout Period of 13 Days||10
11110121|NCT01277718|12294591|FG001|STARTED|Washout Period of 13 Days||7
11110122|NCT01277718|12294590|FG000|COMPLETED|Washout Period of 13 Days||10
11110123|NCT01277718|12294591|FG001|COMPLETED|Washout Period of 13 Days||7
11110124|NCT01277718|12294590|FG000|NOT COMPLETED|Washout Period of 13 Days||0
11110125|NCT01277718|12294591|FG001|NOT COMPLETED|Washout Period of 13 Days||0
11110126|NCT01277718|12294590|FG000|STARTED|Period 3 - Third Intervention||10
11110127|NCT01277718|12294591|FG001|STARTED|Period 3 - Third Intervention||7
11110128|NCT01277718|12294590|FG000|COMPLETED|Period 3 - Third Intervention||10
11110129|NCT01277718|12294591|FG001|COMPLETED|Period 3 - Third Intervention||7
11110130|NCT01277718|12294590|FG000|NOT COMPLETED|Period 3 - Third Intervention||0
11110131|NCT01277718|12294591|FG001|NOT COMPLETED|Period 3 - Third Intervention||0
11110132|NCT01277744|12294599|FG000|STARTED|Overall Study||22
11110133|NCT01277744|12294599|FG000|COMPLETED|Overall Study||20
11110134|NCT01277744|12294599|FG000|NOT COMPLETED|Overall Study||2
11110135|NCT01277757|12294603|FG000|STARTED|Overall Study||30
11110136|NCT01277757|12294603|FG000|COMPLETED|Overall Study||28
11110137|NCT01277757|12294603|FG000|NOT COMPLETED|Overall Study||2
11110138|NCT01277783|12294607|FG000|STARTED|Overall Study||138
11110139|NCT01277783|12294607|FG000|COMPLETED|Overall Study||138
11110140|NCT01277783|12294607|FG000|NOT COMPLETED|Overall Study||0
11110141|NCT01277861|12294614|FG000|STARTED|Overall Study||51
11110142|NCT01277861|12294615|FG001|STARTED|Overall Study||49
11110143|NCT01277861|12294614|FG000|COMPLETED|Overall Study||49
11110144|NCT01277861|12294615|FG001|COMPLETED|Overall Study||47
11110145|NCT01277861|12294614|FG000|NOT COMPLETED|Overall Study||2
11110146|NCT01277861|12294615|FG001|NOT COMPLETED|Overall Study||2
11110147|NCT01277887|12294625|FG000|STARTED|Pre-Quit Treatment Phase||9
11110148|NCT01277887|12294626|FG001|STARTED|Pre-Quit Treatment Phase||10
11110149|NCT01277887|12294625|FG000|Entered Study|Pre-Quit Treatment Phase||7
11110150|NCT01277887|12294626|FG001|Entered Study|Pre-Quit Treatment Phase||10
11110151|NCT01277887|12294625|FG000|COMPLETED|Pre-Quit Treatment Phase||6
11110152|NCT01277887|12294626|FG001|COMPLETED|Pre-Quit Treatment Phase||10
11110153|NCT01277887|12294625|FG000|NOT COMPLETED|Pre-Quit Treatment Phase||3
11110154|NCT01277887|12294626|FG001|NOT COMPLETED|Pre-Quit Treatment Phase||0
11110155|NCT01277887|12294625|FG000|STARTED|Post-Quit Treatment Phase||6
11110156|NCT01277887|12294626|FG001|STARTED|Post-Quit Treatment Phase||10
11110157|NCT01277887|12294625|FG000|COMPLETED|Post-Quit Treatment Phase||3
11110158|NCT01277887|12294626|FG001|COMPLETED|Post-Quit Treatment Phase||5
11110159|NCT01277887|12294625|FG000|NOT COMPLETED|Post-Quit Treatment Phase||3
11110160|NCT01277887|12294626|FG001|NOT COMPLETED|Post-Quit Treatment Phase||5
11110161|NCT01278030|12294634|FG000|STARTED|Overall Study||43
11110162|NCT01278030|12294635|FG001|STARTED|Overall Study||35
11110163|NCT01278030|12294634|FG000|COMPLETED|Overall Study||35
11110164|NCT01278030|12294635|FG001|COMPLETED|Overall Study||31
11110165|NCT01278030|12294634|FG000|NOT COMPLETED|Overall Study||8
11110166|NCT01278030|12294635|FG001|NOT COMPLETED|Overall Study||4
11110167|NCT01278160|12294643|FG000|STARTED|Overall Study||89
11110168|NCT01278160|12294644|FG001|STARTED|Overall Study||90
11110169|NCT01278160|12294643|FG000|COMPLETED|Overall Study||84
11110170|NCT01278160|12294644|FG001|COMPLETED|Overall Study||84
11110171|NCT01278160|12294643|FG000|NOT COMPLETED|Overall Study||5
11110172|NCT01278160|12294644|FG001|NOT COMPLETED|Overall Study||6
11110173|NCT01278173|12294650|FG000|STARTED|Overall Study||65
11110174|NCT01278173|12294650|FG000|COMPLETED|Overall Study||38
11110175|NCT01278173|12294650|FG000|NOT COMPLETED|Overall Study||27
11110176|NCT01278303|12294654|FG000|STARTED|Overall Study||82
11110177|NCT01278303|12294654|FG000|COMPLETED|Overall Study||82
11110178|NCT01278303|12294654|FG000|NOT COMPLETED|Overall Study||0
11110179|NCT01278342|12294661|FG000|STARTED|Overall Study||7
11110180|NCT01278342|12294662|FG001|STARTED|Overall Study||31
11110181|NCT01278342|12294663|FG002|STARTED|Overall Study||32
11110182|NCT01278342|12294661|FG000|COMPLETED|Overall Study||3
11110183|NCT01278342|12294662|FG001|COMPLETED|Overall Study||30
11110184|NCT01278342|12294663|FG002|COMPLETED|Overall Study||32
11110185|NCT01278342|12294661|FG000|NOT COMPLETED|Overall Study||4
11110186|NCT01278342|12294662|FG001|NOT COMPLETED|Overall Study||1
11110187|NCT01278342|12294663|FG002|NOT COMPLETED|Overall Study||0
11110188|NCT01278394|12294671|FG000|STARTED|Overall Study||29
11110189|NCT01278394|12294671|FG000|COMPLETED|Overall Study||28
11110190|NCT01278394|12294671|FG000|NOT COMPLETED|Overall Study||1
11110191|NCT01278407|12294678|FG000|STARTED|Confirmatory Phase||46
10867352|NCT01864603|12032540|FG000|STARTED|Stage 1|Describes # of participants who were residents and aged 15+yrs at baseline|79818
10867353|NCT01864603|12032541|FG001|STARTED|Stage 1|Describes # of participants who were residents and aged 15+yrs at baseline|70577
10867354|NCT01864603|12032540|FG000|COMPLETED|Stage 1||71028
10867355|NCT01864603|12032541|FG001|COMPLETED|Stage 1||62912
10867356|NCT01864603|12032540|FG000|NOT COMPLETED|Stage 1||8790
10867357|NCT01864603|12032541|FG001|NOT COMPLETED|Stage 1||7665
10867358|NCT01864603|12032540|FG000|STARTED|Stage 2|Describes # of participants who were residents and aged 15+yrs at the start of Stage 2|91533
10867359|NCT01864603|12032541|FG001|STARTED|Stage 2|Describes # of participants who were residents and aged 15+yrs at the start of Stage 2|92558
10867360|NCT01864603|12032540|FG000|COMPLETED|Stage 2||5477
10867361|NCT01864603|12032541|FG001|COMPLETED|Stage 2||0
10867362|NCT01864603|12032540|FG000|NOT COMPLETED|Stage 2||86056
10867363|NCT01864603|12032541|FG001|NOT COMPLETED|Stage 2||92558
11110192|NCT01278407|12294679|FG001|STARTED|Confirmatory Phase||47
11110193|NCT01278407|12294680|FG002|STARTED|Confirmatory Phase||49
11110194|NCT01278407|12294681|FG003|STARTED|Confirmatory Phase||0
11110195|NCT01278407|12294682|FG004|STARTED|Confirmatory Phase||0
11110196|NCT01278407|12294678|FG000|COMPLETED|Confirmatory Phase||37
11110197|NCT01278407|12294679|FG001|COMPLETED|Confirmatory Phase||31
11110198|NCT01278407|12294680|FG002|COMPLETED|Confirmatory Phase||43
11110199|NCT01278407|12294681|FG003|COMPLETED|Confirmatory Phase||0
11110200|NCT01278407|12294682|FG004|COMPLETED|Confirmatory Phase||0
11110201|NCT01278407|12294678|FG000|NOT COMPLETED|Confirmatory Phase||9
11110202|NCT01278407|12294679|FG001|NOT COMPLETED|Confirmatory Phase||16
11110203|NCT01278407|12294680|FG002|NOT COMPLETED|Confirmatory Phase||6
11110204|NCT01278407|12294681|FG003|NOT COMPLETED|Confirmatory Phase||0
11110205|NCT01278407|12294682|FG004|NOT COMPLETED|Confirmatory Phase||0
11110206|NCT01278407|12294678|FG000|STARTED|Extension Phase||0
11110207|NCT01278407|12294679|FG001|STARTED|Extension Phase||0
11110208|NCT01278407|12294680|FG002|STARTED|Extension Phase||0
11110209|NCT01278407|12294681|FG003|STARTED|Extension Phase||46
11110210|NCT01278407|12294682|FG004|STARTED|Extension Phase||96
11110211|NCT01278407|12294678|FG000|COMPLETED|Extension Phase||0
10867396|NCT01684722|12032570|FG001|NOT COMPLETED|Overall Study||77
10867397|NCT01684722|12032571|FG002|NOT COMPLETED|Overall Study||94
10867398|NCT01684722|12032572|FG003|NOT COMPLETED|Overall Study||110
11228989|NCT02013791|12421198|FG008|COMPLETED|Period 1||3
11228990|NCT02013791|12421190|FG000|NOT COMPLETED|Period 1||0
11228991|NCT02013791|12421191|FG001|NOT COMPLETED|Period 1||2
11228992|NCT02013791|12421192|FG002|NOT COMPLETED|Period 1||0
11228993|NCT02013791|12421193|FG003|NOT COMPLETED|Period 1||1
11228994|NCT02013791|12421194|FG004|NOT COMPLETED|Period 1||0
11228995|NCT02013791|12421195|FG005|NOT COMPLETED|Period 1||0
11228996|NCT02013791|12421196|FG006|NOT COMPLETED|Period 1||1
11228997|NCT02013791|12421197|FG007|NOT COMPLETED|Period 1||1
11228998|NCT02013791|12421198|FG008|NOT COMPLETED|Period 1||0
11228999|NCT02013791|12421190|FG000|STARTED|Period 2||0
11229000|NCT02013791|12421191|FG001|STARTED|Period 2||0
11110212|NCT01278407|12294679|FG001|COMPLETED|Extension Phase||0
11110213|NCT01278407|12294680|FG002|COMPLETED|Extension Phase||0
11110214|NCT01278407|12294681|FG003|COMPLETED|Extension Phase||34
11110215|NCT01278407|12294682|FG004|COMPLETED|Extension Phase||66
11110216|NCT01278407|12294678|FG000|NOT COMPLETED|Extension Phase||0
11110217|NCT01278407|12294679|FG001|NOT COMPLETED|Extension Phase||0
11110218|NCT01278407|12294680|FG002|NOT COMPLETED|Extension Phase||0
11110219|NCT01278407|12294681|FG003|NOT COMPLETED|Extension Phase||12
11229001|NCT02013791|12421192|FG002|STARTED|Period 2||2
11229002|NCT02013791|12421193|FG003|STARTED|Period 2||0
10867399|NCT01516346|12032590|FG000|STARTED|Overall Study||13
10867400|NCT01516346|12032591|FG001|STARTED|Overall Study||15
10867401|NCT01516346|12032592|FG002|STARTED|Overall Study||16
10867402|NCT01516346|12032590|FG000|COMPLETED|Overall Study||7
10867403|NCT01516346|12032591|FG001|COMPLETED|Overall Study||9
10867404|NCT01516346|12032592|FG002|COMPLETED|Overall Study||11
10867405|NCT01516346|12032590|FG000|NOT COMPLETED|Overall Study||6
10867406|NCT01516346|12032591|FG001|NOT COMPLETED|Overall Study||6
10867407|NCT01516346|12032592|FG002|NOT COMPLETED|Overall Study||5
10867408|NCT01399372|12032602|FG000|STARTED|Overall Study||47
10867409|NCT01399372|12032603|FG001|STARTED|Overall Study||44
10867410|NCT01399372|12032602|FG000|Eligible|Overall Study||44
10867411|NCT01399372|12032603|FG001|Eligible|Overall Study||43
10867412|NCT01399372|12032602|FG000|Eligible and Started Protocol Treatment|Overall Study||43
10867413|NCT01399372|12032603|FG001|Eligible and Started Protocol Treatment|Overall Study||43
10867414|NCT01399372|12032602|FG000|COMPLETED|Overall Study||44
10867415|NCT01399372|12032603|FG001|COMPLETED|Overall Study||43
10867416|NCT01399372|12032602|FG000|NOT COMPLETED|Overall Study||3
10867417|NCT01399372|12032603|FG001|NOT COMPLETED|Overall Study||1
10867418|NCT01303796|12032611|FG000|STARTED|Lead In Phase||21
10867419|NCT01303796|12032612|FG001|STARTED|Lead In Phase|Intend-to-Treat study subject population|0
10867420|NCT01303796|12032613|FG002|STARTED|Lead In Phase|Intend-to-Treat study subject population|0
10867421|NCT01303796|12032611|FG000|COMPLETED|Lead In Phase||21
10867422|NCT01303796|12032612|FG001|COMPLETED|Lead In Phase||0
10867423|NCT01303796|12032613|FG002|COMPLETED|Lead In Phase||0
10867424|NCT01303796|12032611|FG000|NOT COMPLETED|Lead In Phase||0
10867425|NCT01303796|12032612|FG001|NOT COMPLETED|Lead In Phase||0
10867426|NCT01303796|12032613|FG002|NOT COMPLETED|Lead In Phase||0
10867427|NCT01303796|12032611|FG000|STARTED|Randomized Phase III||0
10867428|NCT01303796|12032612|FG001|STARTED|Randomized Phase III||241
10867429|NCT01303796|12032613|FG002|STARTED|Randomized Phase III||241
10867430|NCT01303796|12032611|FG000|COMPLETED|Randomized Phase III||0
10867431|NCT01303796|12032612|FG001|COMPLETED|Randomized Phase III||241
10867432|NCT01303796|12032613|FG002|COMPLETED|Randomized Phase III||241
10867433|NCT01303796|12032611|FG000|NOT COMPLETED|Randomized Phase III||0
10867434|NCT01303796|12032612|FG001|NOT COMPLETED|Randomized Phase III||0
10867435|NCT01303796|12032613|FG002|NOT COMPLETED|Randomized Phase III||0
10867436|NCT01235923|12032622|FG000|STARTED|Overall Study||10
10867437|NCT01235923|12032623|FG001|STARTED|Overall Study||10
10867438|NCT01235923|12032622|FG000|COMPLETED|Overall Study||10
10867439|NCT01235923|12032623|FG001|COMPLETED|Overall Study||10
10867440|NCT01235923|12032622|FG000|NOT COMPLETED|Overall Study||0
10867441|NCT01235923|12032623|FG001|NOT COMPLETED|Overall Study||0
11110220|NCT01278407|12294682|FG004|NOT COMPLETED|Extension Phase||30
11110221|NCT01278485|12294692|FG000|STARTED|Overall Study||719
11110222|NCT01278485|12294692|FG000|COMPLETED|Overall Study||719
11110223|NCT01278485|12294692|FG000|NOT COMPLETED|Overall Study||0
11110224|NCT01278615|12294696|FG000|STARTED|Overall Study||16
11110225|NCT01278615|12294696|FG000|COMPLETED|Overall Study||14
10867448|NCT01082211|12032638|FG000|STARTED|Overall Study||65
10867449|NCT01082211|12032638|FG000|Has Baseline PT QOL Data|Overall Study||46
10867450|NCT01082211|12032638|FG000|Has Baseline MD QOL Data|Overall Study||44
10867451|NCT01082211|12032638|FG000|Has Baseline/12-month PT QOL Data|Overall Study||36
10867452|NCT01082211|12032638|FG000|Has Baseline/12-Month MD QOL Data|Overall Study||35
10867453|NCT01082211|12032638|FG000|Has Baseline/36-month PT QOL Data|Overall Study||32
10867454|NCT01082211|12032638|FG000|Has Baseline/36-Month MD QOL Data|Overall Study||27
10867455|NCT01082211|12032638|FG000|All Eligible Patients|Overall Study||58
10867456|NCT01082211|12032638|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
10867457|NCT01082211|12032638|FG000|NOT COMPLETED|Overall Study||7
10867458|NCT01080196|12032647|FG000|STARTED|Overall Study||68
10867459|NCT01080196|12032648|FG001|STARTED|Overall Study||66
10867460|NCT01080196|12032647|FG000|COMPLETED|Overall Study||68
10867461|NCT01080196|12032648|FG001|COMPLETED|Overall Study||66
10867462|NCT01080196|12032647|FG000|NOT COMPLETED|Overall Study||0
10867463|NCT01080196|12032648|FG001|NOT COMPLETED|Overall Study||0
10867464|NCT00976911|12032658|FG000|STARTED|Overall Study||182
10867465|NCT00976911|12032659|FG001|STARTED|Overall Study||179
10867466|NCT00976911|12032658|FG000|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
10867467|NCT00976911|12032659|FG001|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
10867468|NCT00976911|12032658|FG000|NOT COMPLETED|Overall Study||182
10867469|NCT00976911|12032659|FG001|NOT COMPLETED|Overall Study||179
10867470|NCT00712582|12032668|FG000|STARTED|Overall Study||60
10867471|NCT00712582|12032669|FG001|STARTED|Overall Study||32
10867472|NCT00712582|12032670|FG002|STARTED|Overall Study||4
10867473|NCT00712582|12032668|FG000|COMPLETED|Overall Study||60
10867474|NCT00712582|12032669|FG001|COMPLETED|Overall Study||32
10867475|NCT00712582|12032670|FG002|COMPLETED|Overall Study||4
10867476|NCT00712582|12032668|FG000|NOT COMPLETED|Overall Study||0
10867477|NCT00712582|12032669|FG001|NOT COMPLETED|Overall Study||0
10867478|NCT00712582|12032670|FG002|NOT COMPLETED|Overall Study||0
10867479|NCT00693238|12032680|FG000|STARTED|Overall Study||122
10867480|NCT00693238|12032681|FG001|STARTED|Overall Study||106
10867481|NCT00693238|12032680|FG000|COMPLETED|Overall Study||122
10867482|NCT00693238|12032681|FG001|COMPLETED|Overall Study||106
10867483|NCT00693238|12032680|FG000|NOT COMPLETED|Overall Study||0
10867484|NCT00693238|12032681|FG001|NOT COMPLETED|Overall Study||0
11110226|NCT01278615|12294696|FG000|NOT COMPLETED|Overall Study||2
11229003|NCT02013791|12421194|FG004|STARTED|Period 2||0
11229004|NCT02013791|12421195|FG005|STARTED|Period 2||0
11229005|NCT02013791|12421196|FG006|STARTED|Period 2||3
11229006|NCT02013791|12421197|FG007|STARTED|Period 2||0
11229007|NCT02013791|12421198|FG008|STARTED|Period 2||0
11229008|NCT02013791|12421190|FG000|COMPLETED|Period 2||0
11229009|NCT02013791|12421191|FG001|COMPLETED|Period 2||0
11229010|NCT02013791|12421192|FG002|COMPLETED|Period 2||2
11229011|NCT02013791|12421193|FG003|COMPLETED|Period 2||0
11229012|NCT02013791|12421194|FG004|COMPLETED|Period 2||0
11229013|NCT02013791|12421195|FG005|COMPLETED|Period 2||0
11229014|NCT02013791|12421196|FG006|COMPLETED|Period 2||3
11229015|NCT02013791|12421197|FG007|COMPLETED|Period 2||0
11229016|NCT02013791|12421198|FG008|COMPLETED|Period 2||0
11229017|NCT02013791|12421190|FG000|NOT COMPLETED|Period 2||0
11229018|NCT02013791|12421191|FG001|NOT COMPLETED|Period 2||0
11229019|NCT02013791|12421192|FG002|NOT COMPLETED|Period 2||0
11229020|NCT02013791|12421193|FG003|NOT COMPLETED|Period 2||0
11229021|NCT02013791|12421194|FG004|NOT COMPLETED|Period 2||0
11229022|NCT02013791|12421195|FG005|NOT COMPLETED|Period 2||0
11229023|NCT02013791|12421196|FG006|NOT COMPLETED|Period 2||0
11229024|NCT02013791|12421197|FG007|NOT COMPLETED|Period 2||0
11229025|NCT02013791|12421198|FG008|NOT COMPLETED|Period 2||0
11355140|NCT03077607|12551999|FG000|Treated (With Any Study Drug)|Period 1 (15 Days)||19
11355141|NCT03077607|12552000|FG001|Treated (With Any Study Drug)|Period 1 (15 Days)||17
11355142|NCT03077607|12551999|FG000|Received Talazoparib|Period 1 (15 Days)||19
11355143|NCT03077607|12552000|FG001|Received Talazoparib|Period 1 (15 Days)||17
11355144|NCT03077607|12551999|FG000|COMPLETED|Period 1 (15 Days)||17
11355145|NCT03077607|12552000|FG001|COMPLETED|Period 1 (15 Days)||17
11355146|NCT03077607|12551999|FG000|NOT COMPLETED|Period 1 (15 Days)||2
11355147|NCT03077607|12552000|FG001|NOT COMPLETED|Period 1 (15 Days)||0
11355148|NCT03077607|12551999|FG000|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
11355149|NCT03077607|12552000|FG001|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
11355150|NCT03077607|12551999|FG000|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
11355151|NCT03077607|12552000|FG001|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
11355152|NCT03077607|12551999|FG000|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
11355153|NCT03077607|12552000|FG001|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
11355154|NCT03077607|12551999|FG000|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14
11355155|NCT03077607|12552000|FG001|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
11355156|NCT03077607|12551999|FG000|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3
11355157|NCT03077607|12552000|FG001|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2
11355158|NCT03077646|12552020|FG000|STARTED|Overall Study||76
11355159|NCT03077646|12552021|FG001|STARTED|Overall Study||75
11355160|NCT03077646|12552022|FG002|STARTED|Overall Study||74
11355161|NCT03077646|12552020|FG000|COMPLETED|Overall Study|Of these 47, there were 25 paired samples for primary outcome|47
11355162|NCT03077646|12552021|FG001|COMPLETED|Overall Study|Of these 45, there were 27 paired samples for primary outcome|45
11355163|NCT03077646|12552022|FG002|COMPLETED|Overall Study|Of these 43, there were 20 paired samples for primary outcome|43
11355164|NCT03077646|12552020|FG000|NOT COMPLETED|Overall Study||29
11355165|NCT03077646|12552021|FG001|NOT COMPLETED|Overall Study||30
11355166|NCT03077646|12552022|FG002|NOT COMPLETED|Overall Study||31
11355167|NCT03077659|12552033|FG000|STARTED|Overall Study||3
11355168|NCT03077659|12552034|FG001|STARTED|Overall Study||3
11355169|NCT03077659|12552035|FG002|STARTED|Overall Study||10
11355170|NCT03077659|12552033|FG000|COMPLETED|Overall Study||3
11355171|NCT03077659|12552034|FG001|COMPLETED|Overall Study||3
11355172|NCT03077659|12552035|FG002|COMPLETED|Overall Study||9
11355173|NCT03077659|12552033|FG000|NOT COMPLETED|Overall Study||0
11355174|NCT03077659|12552034|FG001|NOT COMPLETED|Overall Study||0
11355175|NCT03077659|12552035|FG002|NOT COMPLETED|Overall Study||1
11355176|NCT03077711|12552048|FG000|STARTED|Overall Study||47
11355177|NCT03077711|12552049|FG001|STARTED|Overall Study||45
11355178|NCT03077711|12552048|FG000|COMPLETED|Overall Study||43
11355179|NCT03077711|12552049|FG001|COMPLETED|Overall Study||43
11355180|NCT03077711|12552048|FG000|NOT COMPLETED|Overall Study||4
11355181|NCT03077711|12552049|FG001|NOT COMPLETED|Overall Study||2
11355182|NCT03077724|12552059|FG000|STARTED|Overall Study||14
11355183|NCT03077724|12552060|FG001|STARTED|Overall Study||14
11355184|NCT03077724|12552059|FG000|COMPLETED|Overall Study||6
11110227|NCT01278745|12294702|FG000|STARTED|Overall Study||89
11110228|NCT01278745|12294703|FG001|STARTED|Overall Study||74
11110229|NCT01278745|12294704|FG002|STARTED|Overall Study||121
11110230|NCT01278745|12294705|FG003|STARTED|Overall Study||78
11110231|NCT01278745|12294702|FG000|COMPLETED|Overall Study||84
11110232|NCT01278745|12294703|FG001|COMPLETED|Overall Study||68
11110233|NCT01278745|12294704|FG002|COMPLETED|Overall Study||0
11110234|NCT01278745|12294705|FG003|COMPLETED|Overall Study||0
11110235|NCT01278745|12294702|FG000|NOT COMPLETED|Overall Study||5
11110236|NCT01278745|12294703|FG001|NOT COMPLETED|Overall Study||6
11110237|NCT01278745|12294704|FG002|NOT COMPLETED|Overall Study||121
11110238|NCT01278745|12294705|FG003|NOT COMPLETED|Overall Study||78
11110239|NCT01278797|12294713|FG000|STARTED|Period 1||14
11110240|NCT01278797|12294714|FG001|STARTED|Period 1||14
11110241|NCT01278797|12294713|FG000|COMPLETED|Period 1||13
11110242|NCT01278797|12294714|FG001|COMPLETED|Period 1||13
11355185|NCT03077724|12552060|FG001|COMPLETED|Overall Study||12
11355186|NCT03077724|12552059|FG000|NOT COMPLETED|Overall Study||8
11355187|NCT03077724|12552060|FG001|NOT COMPLETED|Overall Study||2
11110243|NCT01278797|12294713|FG000|NOT COMPLETED|Period 1||1
11110244|NCT01278797|12294714|FG001|NOT COMPLETED|Period 1||1
11110245|NCT01278797|12294713|FG000|STARTED|Washout Period of 21 Days||13
11110246|NCT01278797|12294714|FG001|STARTED|Washout Period of 21 Days||13
11110247|NCT01278797|12294713|FG000|COMPLETED|Washout Period of 21 Days||13
11110248|NCT01278797|12294714|FG001|COMPLETED|Washout Period of 21 Days||13
11110249|NCT01278797|12294713|FG000|NOT COMPLETED|Washout Period of 21 Days||0
11110250|NCT01278797|12294714|FG001|NOT COMPLETED|Washout Period of 21 Days||0
11110251|NCT01278797|12294713|FG000|STARTED|Period 2||13
11110252|NCT01278797|12294714|FG001|STARTED|Period 2||13
11110253|NCT01278797|12294713|FG000|COMPLETED|Period 2||13
11110254|NCT01278797|12294714|FG001|COMPLETED|Period 2||13
11110255|NCT01278797|12294713|FG000|NOT COMPLETED|Period 2||0
11110256|NCT01278797|12294714|FG001|NOT COMPLETED|Period 2||0
11110257|NCT01278862|12294722|FG000|STARTED|Overall Study||45
11110258|NCT01278862|12294723|FG001|STARTED|Overall Study||43
11110259|NCT01278862|12294722|FG000|COMPLETED|Overall Study||44
11110260|NCT01278862|12294723|FG001|COMPLETED|Overall Study||42
11110261|NCT01278862|12294722|FG000|NOT COMPLETED|Overall Study||1
11110262|NCT01278862|12294723|FG001|NOT COMPLETED|Overall Study||1
10867506|NCT00573131|12032718|FG000|STARTED|Overall Study||72
10867507|NCT00573131|12032719|FG001|STARTED|Overall Study||65
10867508|NCT00573131|12032718|FG000|COMPLETED|Overall Study||62
10867509|NCT00573131|12032719|FG001|COMPLETED|Overall Study||57
10867510|NCT00573131|12032718|FG000|NOT COMPLETED|Overall Study||10
10867511|NCT00573131|12032719|FG001|NOT COMPLETED|Overall Study||8
11110263|NCT01278927|12294733|FG000|STARTED|Overall Study||180
11110264|NCT01278927|12294734|FG001|STARTED|Overall Study||178
11110265|NCT01278927|12294735|FG002|STARTED|Overall Study||178
11110266|NCT01278927|12294736|FG003|STARTED|Overall Study||175
11110267|NCT01278927|12294733|FG000|COMPLETED|Overall Study||180
11110268|NCT01278927|12294734|FG001|COMPLETED|Overall Study||178
11110269|NCT01278927|12294735|FG002|COMPLETED|Overall Study||178
11110270|NCT01278927|12294736|FG003|COMPLETED|Overall Study||175
11110271|NCT01278927|12294733|FG000|NOT COMPLETED|Overall Study||0
11110272|NCT01278927|12294734|FG001|NOT COMPLETED|Overall Study||0
11110273|NCT01278927|12294735|FG002|NOT COMPLETED|Overall Study||0
11110274|NCT01278927|12294736|FG003|NOT COMPLETED|Overall Study||0
11110275|NCT01278953|12294749|FG000|STARTED|Overall Study||155
11110276|NCT01278953|12294750|FG001|STARTED|Overall Study||145
11110277|NCT01278953|12294749|FG000|COMPLETED|Overall Study||146
11110278|NCT01278953|12294750|FG001|COMPLETED|Overall Study||134
11110279|NCT01278953|12294749|FG000|NOT COMPLETED|Overall Study||9
11110280|NCT01278953|12294750|FG001|NOT COMPLETED|Overall Study||11
11110281|NCT01279044|12294759|FG000|STARTED|PHASE 1 - Formative||59
11110282|NCT01279044|12294760|FG001|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
11110283|NCT01279044|12294761|FG002|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
11110284|NCT01279044|12294759|FG000|COMPLETED|PHASE 1 - Formative||59
11110285|NCT01279044|12294760|FG001|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
11110286|NCT01279044|12294761|FG002|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
11110287|NCT01279044|12294759|FG000|NOT COMPLETED|PHASE 1 - Formative||0
11110288|NCT01279044|12294760|FG001|NOT COMPLETED|PHASE 1 - Formative||0
11110289|NCT01279044|12294761|FG002|NOT COMPLETED|PHASE 1 - Formative||0
11110290|NCT01279044|12294759|FG000|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
11110291|NCT01279044|12294760|FG001|STARTED|PHASE 2 - Randmonized Controlled Trial||162
11110292|NCT01279044|12294761|FG002|STARTED|PHASE 2 - Randmonized Controlled Trial||164
11110293|NCT01279044|12294759|FG000|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
11110294|NCT01279044|12294760|FG001|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
11110295|NCT01279044|12294761|FG002|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
11110296|NCT01279044|12294759|FG000|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
11110297|NCT01279044|12294760|FG001|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
11110298|NCT01279044|12294761|FG002|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
11110299|NCT01279057|12294770|FG000|STARTED|Overall Study||288
11110300|NCT01279057|12294771|FG001|STARTED|Overall Study||292
11110301|NCT01279057|12294772|FG002|STARTED|Overall Study||147
11110302|NCT01279057|12294770|FG000|Per-Protocol (PPP) Population|Overall Study||257
11110303|NCT01279057|12294771|FG001|Per-Protocol (PPP) Population|Overall Study||245
11110304|NCT01279057|12294772|FG002|Per-Protocol (PPP) Population|Overall Study||126
11110305|NCT01279057|12294770|FG000|Intent-to-Treat (ITT) Population|Overall Study||284
11110306|NCT01279057|12294771|FG001|Intent-to-Treat (ITT) Population|Overall Study||285
11110307|NCT01279057|12294772|FG002|Intent-to-Treat (ITT) Population|Overall Study||144
11110308|NCT01279057|12294770|FG000|COMPLETED|Overall Study||282
11110309|NCT01279057|12294771|FG001|COMPLETED|Overall Study||287
11110310|NCT01279057|12294772|FG002|COMPLETED|Overall Study||144
11110311|NCT01279057|12294770|FG000|NOT COMPLETED|Overall Study||6
11110312|NCT01279057|12294771|FG001|NOT COMPLETED|Overall Study||5
11110313|NCT01279057|12294772|FG002|NOT COMPLETED|Overall Study||3
11110314|NCT01279070|12294782|FG000|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
11110315|NCT01279070|12294783|FG001|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
10867512|NCT00533949|12032729|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
10867513|NCT00533949|12032730|FG001|STARTED|Overall Study||121
10867514|NCT00533949|12032731|FG002|STARTED|Overall Study||147
10867515|NCT00533949|12032732|FG003|STARTED|Overall Study||110
10867516|NCT00533949|12032729|FG000|COMPLETED|Overall Study||151
10867517|NCT00533949|12032730|FG001|COMPLETED|Overall Study||107
10867518|NCT00533949|12032731|FG002|COMPLETED|Overall Study||137
10867519|NCT00533949|12032732|FG003|COMPLETED|Overall Study||100
10867520|NCT00533949|12032729|FG000|NOT COMPLETED|Overall Study||15
10867521|NCT00533949|12032730|FG001|NOT COMPLETED|Overall Study||14
10867522|NCT00533949|12032731|FG002|NOT COMPLETED|Overall Study||10
10867523|NCT00533949|12032732|FG003|NOT COMPLETED|Overall Study||10
10867524|NCT00529763|12032753|FG000|STARTED|Overall Study||25
10867525|NCT00529763|12032754|FG001|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
10867526|NCT00529763|12032755|FG002|STARTED|Overall Study||59
10867527|NCT00529763|12032753|FG000|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
10867528|NCT00529763|12032754|FG001|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
10867529|NCT00529763|12032755|FG002|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
10867530|NCT00529763|12032753|FG000|NOT COMPLETED|Overall Study||10
10867531|NCT00529763|12032754|FG001|NOT COMPLETED|Overall Study||33
10867532|NCT00529763|12032755|FG002|NOT COMPLETED|Overall Study||7
10867533|NCT00479765|12032770|FG000|STARTED|Overall Study||4
10867534|NCT00479765|12032770|FG000|COMPLETED|Overall Study||0
10867535|NCT00479765|12032770|FG000|NOT COMPLETED|Overall Study||4
10867536|NCT00450411|12032774|FG000|STARTED|Overall Study||100
10867537|NCT00450411|12032774|FG000|Eligible and Started Protocol Treatment|Overall Study||92
10867538|NCT00450411|12032774|FG000|COMPLETED|Overall Study||92
10867539|NCT00450411|12032774|FG000|NOT COMPLETED|Overall Study||8
10867540|NCT00412880|12032778|FG000|STARTED|Overall Study||23
10867541|NCT00412880|12032778|FG000|COMPLETED|Overall Study||0
10867542|NCT00412880|12032778|FG000|NOT COMPLETED|Overall Study||23
10867543|NCT00376623|12032785|FG000|STARTED|Overall Study||49
10867544|NCT00376623|12032786|FG001|STARTED|Overall Study||26
10867545|NCT00376623|12032787|FG002|STARTED|Overall Study||21
10867546|NCT00376623|12032785|FG000|Treated With BI 2536|Overall Study||48
10867547|NCT00376623|12032786|FG001|Treated With BI 2536|Overall Study||26
10867548|NCT00376623|12032787|FG002|Treated With BI 2536|Overall Study||21
10867549|NCT00376623|12032785|FG000|COMPLETED|Overall Study||0
10867550|NCT00376623|12032786|FG001|COMPLETED|Overall Study||0
10867551|NCT00376623|12032787|FG002|COMPLETED|Overall Study||0
10867552|NCT00376623|12032785|FG000|NOT COMPLETED|Overall Study||49
10867553|NCT00376623|12032786|FG001|NOT COMPLETED|Overall Study||26
10867554|NCT00376623|12032787|FG002|NOT COMPLETED|Overall Study||21
10867555|NCT00288080|12032803|FG000|STARTED|Overall Study||307
10867556|NCT00288080|12032804|FG001|STARTED|Overall Study||305
10867557|NCT00288080|12032803|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
10867558|NCT00288080|12032804|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
10867559|NCT00288080|12032803|FG000|NOT COMPLETED|Overall Study||26
10867560|NCT00288080|12032804|FG001|NOT COMPLETED|Overall Study||23
10867561|NCT00194714|12032810|FG000|STARTED|Overall Study|Number of patients consented|22
10867562|NCT00194714|12032810|FG000|COMPLETED|Overall Study|Number of patients that received study treatment with the study vaccine|21
10867563|NCT00194714|12032810|FG000|NOT COMPLETED|Overall Study||1
11110316|NCT01279070|12294782|FG000|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
11110317|NCT01279070|12294783|FG001|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
11110318|NCT01279070|12294782|FG000|NOT COMPLETED|Overall Study||5
11110319|NCT01279070|12294783|FG001|NOT COMPLETED|Overall Study||4
11110320|NCT01279109|12294795|FG000|STARTED|Overall Study||68
11110321|NCT01279109|12294796|FG001|STARTED|Overall Study||67
11229026|NCT02013817|12421219|FG000|STARTED|Overall Study||43
11229027|NCT02013817|12421219|FG000|COMPLETED|Overall Study||16
10867570|NCT02878785|12032823|FG000|STARTED|Overall Study||3
10867571|NCT02878785|12032824|FG001|STARTED|Overall Study||0
10867572|NCT02878785|12032825|FG002|STARTED|Overall Study||0
10867573|NCT02878785|12032826|FG003|STARTED|Overall Study||0
10867574|NCT02878785|12032827|FG004|STARTED|Overall Study||0
10867575|NCT02878785|12032828|FG005|STARTED|Overall Study||0
10867576|NCT02878785|12032829|FG006|STARTED|Overall Study||0
10867577|NCT02878785|12032830|FG007|STARTED|Overall Study||0
10867578|NCT02878785|12032831|FG008|STARTED|Overall Study||3
10867579|NCT02878785|12032832|FG009|STARTED|Overall Study||7
11229028|NCT02013817|12421219|FG000|NOT COMPLETED|Overall Study||27
11229029|NCT02013830|12421223|FG000|STARTED|Overall Study||45
11229030|NCT02013830|12421223|FG000|COMPLETED|Overall Study||15
11229031|NCT02013830|12421223|FG000|NOT COMPLETED|Overall Study||30
11229032|NCT02014051|12421227|FG000|STARTED|Overall Study||3
11229033|NCT02014051|12421228|FG001|STARTED|Overall Study||6
11229034|NCT02014051|12421227|FG000|COMPLETED|Overall Study||2
11229035|NCT02014051|12421228|FG001|COMPLETED|Overall Study||5
11229036|NCT02014051|12421227|FG000|NOT COMPLETED|Overall Study||1
11229037|NCT02014051|12421228|FG001|NOT COMPLETED|Overall Study||1
11229038|NCT02014116|12421244|FG000|STARTED|Overall Study||3
11229039|NCT02014116|12421245|FG001|STARTED|Overall Study||4
11229040|NCT02014116|12421246|FG002|STARTED|Overall Study||3
11110322|NCT01279109|12294795|FG000|COMPLETED|Overall Study||55
11229041|NCT02014116|12421247|FG003|STARTED|Overall Study||7
11229042|NCT02014116|12421248|FG004|STARTED|Overall Study||2
11229043|NCT02014116|12421249|FG005|STARTED|Overall Study||16
11229044|NCT02014116|12421250|FG006|STARTED|Overall Study||1
11229045|NCT02014116|12421251|FG007|STARTED|Overall Study||5
11229046|NCT02014116|12421252|FG008|STARTED|Overall Study||10
11229047|NCT02014116|12421244|FG000|Received at Least One Dose of Study Drug|Overall Study||3
11229048|NCT02014116|12421245|FG001|Received at Least One Dose of Study Drug|Overall Study||4
11229049|NCT02014116|12421246|FG002|Received at Least One Dose of Study Drug|Overall Study||3
11229050|NCT02014116|12421247|FG003|Received at Least One Dose of Study Drug|Overall Study||7
11229051|NCT02014116|12421248|FG004|Received at Least One Dose of Study Drug|Overall Study||2
11229052|NCT02014116|12421249|FG005|Received at Least One Dose of Study Drug|Overall Study||16
11229053|NCT02014116|12421250|FG006|Received at Least One Dose of Study Drug|Overall Study||1
11229054|NCT02014116|12421251|FG007|Received at Least One Dose of Study Drug|Overall Study||5
11229055|NCT02014116|12421252|FG008|Received at Least One Dose of Study Drug|Overall Study||10
11229056|NCT02014116|12421244|FG000|COMPLETED|Overall Study||0
11229057|NCT02014116|12421245|FG001|COMPLETED|Overall Study||0
11229058|NCT02014116|12421246|FG002|COMPLETED|Overall Study||0
11229059|NCT02014116|12421247|FG003|COMPLETED|Overall Study||0
11229060|NCT02014116|12421248|FG004|COMPLETED|Overall Study||0
11229061|NCT02014116|12421249|FG005|COMPLETED|Overall Study||0
11229062|NCT02014116|12421250|FG006|COMPLETED|Overall Study||0
11229063|NCT02014116|12421251|FG007|COMPLETED|Overall Study||0
11229064|NCT02014116|12421252|FG008|COMPLETED|Overall Study||0
11229065|NCT02014116|12421244|FG000|NOT COMPLETED|Overall Study||3
11229066|NCT02014116|12421245|FG001|NOT COMPLETED|Overall Study||4
11229067|NCT02014116|12421246|FG002|NOT COMPLETED|Overall Study||3
11229068|NCT02014116|12421247|FG003|NOT COMPLETED|Overall Study||7
11229069|NCT02014116|12421248|FG004|NOT COMPLETED|Overall Study||2
11229070|NCT02014116|12421249|FG005|NOT COMPLETED|Overall Study||16
11229071|NCT02014116|12421250|FG006|NOT COMPLETED|Overall Study||1
11229072|NCT02014116|12421251|FG007|NOT COMPLETED|Overall Study||5
11229073|NCT02014116|12421252|FG008|NOT COMPLETED|Overall Study||10
11229074|NCT02014129|12421278|FG000|STARTED|Overall Study||3
11229075|NCT02014129|12421279|FG001|STARTED|Overall Study||3
11229076|NCT02014129|12421280|FG002|STARTED|Overall Study||6
11229077|NCT02014129|12421278|FG000|Received at Least One Dose of Study Drug|Overall Study||3
11229078|NCT02014129|12421279|FG001|Received at Least One Dose of Study Drug|Overall Study||3
11229079|NCT02014129|12421280|FG002|Received at Least One Dose of Study Drug|Overall Study||6
11229080|NCT02014129|12421278|FG000|COMPLETED|Overall Study||3
11229081|NCT02014129|12421279|FG001|COMPLETED|Overall Study||3
11229082|NCT02014129|12421280|FG002|COMPLETED|Overall Study||6
11229083|NCT02014129|12421278|FG000|NOT COMPLETED|Overall Study||0
11229084|NCT02014129|12421279|FG001|NOT COMPLETED|Overall Study||0
11229085|NCT02014129|12421280|FG002|NOT COMPLETED|Overall Study||0
11229086|NCT02014272|12421288|FG000|STARTED|Intervention Period 1||14
11229087|NCT02014272|12421289|FG001|STARTED|Intervention Period 1||14
11229088|NCT02014272|12421288|FG000|COMPLETED|Intervention Period 1||13
11229089|NCT02014272|12421289|FG001|COMPLETED|Intervention Period 1||13
11229090|NCT02014272|12421288|FG000|NOT COMPLETED|Intervention Period 1||1
11229091|NCT02014272|12421289|FG001|NOT COMPLETED|Intervention Period 1||1
11229092|NCT02014272|12421288|FG000|STARTED|Washout Period 1 (7 Days)||13
11229093|NCT02014272|12421289|FG001|STARTED|Washout Period 1 (7 Days)||13
11229094|NCT02014272|12421288|FG000|COMPLETED|Washout Period 1 (7 Days)||13
11229095|NCT02014272|12421289|FG001|COMPLETED|Washout Period 1 (7 Days)||13
11229096|NCT02014272|12421288|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
11229097|NCT02014272|12421289|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
11229098|NCT02014272|12421288|FG000|STARTED|Intervention Period 2||13
11229099|NCT02014272|12421289|FG001|STARTED|Intervention Period 2||13
11229100|NCT02014272|12421288|FG000|COMPLETED|Intervention Period 2||13
11229101|NCT02014272|12421289|FG001|COMPLETED|Intervention Period 2||13
11229102|NCT02014272|12421288|FG000|NOT COMPLETED|Intervention Period 2||0
11229103|NCT02014272|12421289|FG001|NOT COMPLETED|Intervention Period 2||0
10867580|NCT02878785|12032833|FG010|STARTED|Overall Study||3
10867581|NCT02878785|12032834|FG011|STARTED|Overall Study||3
10867582|NCT02878785|12032835|FG012|STARTED|Overall Study||3
10867583|NCT02878785|12032836|FG013|STARTED|Overall Study||3
10867584|NCT02878785|12032823|FG000|COMPLETED|Overall Study||3
10867585|NCT02878785|12032824|FG001|COMPLETED|Overall Study||0
10867586|NCT02878785|12032825|FG002|COMPLETED|Overall Study||0
10867587|NCT02878785|12032826|FG003|COMPLETED|Overall Study||0
10867588|NCT02878785|12032827|FG004|COMPLETED|Overall Study||0
10867589|NCT02878785|12032828|FG005|COMPLETED|Overall Study||0
10867590|NCT02878785|12032829|FG006|COMPLETED|Overall Study||0
10867591|NCT02878785|12032830|FG007|COMPLETED|Overall Study||0
10867592|NCT02878785|12032831|FG008|COMPLETED|Overall Study||3
10867593|NCT02878785|12032832|FG009|COMPLETED|Overall Study||7
10867594|NCT02878785|12032833|FG010|COMPLETED|Overall Study||3
10867595|NCT02878785|12032834|FG011|COMPLETED|Overall Study||3
10867596|NCT02878785|12032835|FG012|COMPLETED|Overall Study||3
10867597|NCT02878785|12032836|FG013|COMPLETED|Overall Study||3
10867598|NCT02878785|12032823|FG000|NOT COMPLETED|Overall Study||0
10867599|NCT02878785|12032824|FG001|NOT COMPLETED|Overall Study||0
10867600|NCT02878785|12032825|FG002|NOT COMPLETED|Overall Study||0
10867601|NCT02878785|12032826|FG003|NOT COMPLETED|Overall Study||0
10867602|NCT02878785|12032827|FG004|NOT COMPLETED|Overall Study||0
10867603|NCT02878785|12032828|FG005|NOT COMPLETED|Overall Study||0
10867604|NCT02878785|12032829|FG006|NOT COMPLETED|Overall Study||0
10867605|NCT02878785|12032830|FG007|NOT COMPLETED|Overall Study||0
10867606|NCT02878785|12032831|FG008|NOT COMPLETED|Overall Study||0
10867607|NCT02878785|12032832|FG009|NOT COMPLETED|Overall Study||0
10867608|NCT02878785|12032833|FG010|NOT COMPLETED|Overall Study||0
10867609|NCT02878785|12032834|FG011|NOT COMPLETED|Overall Study||0
10867610|NCT02878785|12032835|FG012|NOT COMPLETED|Overall Study||0
10867611|NCT02878785|12032836|FG013|NOT COMPLETED|Overall Study||0
10867612|NCT04794270|12032853|FG000|STARTED|Period 1||35
10867613|NCT04794270|12032854|FG001|STARTED|Period 1||36
10867614|NCT04794270|12032853|FG000|COMPLETED|Period 1||33
10867615|NCT04794270|12032854|FG001|COMPLETED|Period 1||36
10867616|NCT04794270|12032853|FG000|NOT COMPLETED|Period 1||2
10867617|NCT04794270|12032854|FG001|NOT COMPLETED|Period 1||0
10867618|NCT04794270|12032853|FG000|STARTED|Period 2||33
10867619|NCT04794270|12032854|FG001|STARTED|Period 2||36
10867620|NCT04794270|12032853|FG000|COMPLETED|Period 2||32
10867621|NCT04794270|12032854|FG001|COMPLETED|Period 2||36
11110323|NCT01279109|12294796|FG001|COMPLETED|Overall Study||55
11110324|NCT01279109|12294795|FG000|NOT COMPLETED|Overall Study||13
11110325|NCT01279109|12294796|FG001|NOT COMPLETED|Overall Study||12
11229104|NCT02014363|12421298|FG000|STARTED|Overall Study||55
11229105|NCT02014363|12421299|FG001|STARTED|Overall Study||54
11229106|NCT02014363|12421300|FG002|STARTED|Overall Study||55
11229107|NCT02014363|12421298|FG000|COMPLETED|Overall Study||38
11229108|NCT02014363|12421299|FG001|COMPLETED|Overall Study||35
10867622|NCT04794270|12032853|FG000|NOT COMPLETED|Period 2||1
10867623|NCT04794270|12032854|FG001|NOT COMPLETED|Period 2||0
10867624|NCT04701814|12032862|FG000|STARTED|Overall Study||20
11229109|NCT02014363|12421300|FG002|COMPLETED|Overall Study||31
11229110|NCT02014363|12421298|FG000|NOT COMPLETED|Overall Study||17
11229111|NCT02014363|12421299|FG001|NOT COMPLETED|Overall Study||19
11229112|NCT02014363|12421300|FG002|NOT COMPLETED|Overall Study||24
11229113|NCT02014376|12421311|FG000|STARTED|Overall Study||15
11229114|NCT02014376|12421312|FG001|STARTED|Overall Study||16
11229115|NCT02014376|12421313|FG002|STARTED|Overall Study||17
11229116|NCT02014376|12421311|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
11229117|NCT02014376|12421312|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
11229118|NCT02014376|12421313|FG002|Received at Least 1 Dose of Study Drug|Overall Study||17
11229119|NCT02014376|12421311|FG000|COMPLETED|Overall Study||12
11229120|NCT02014376|12421312|FG001|COMPLETED|Overall Study||15
11229121|NCT02014376|12421313|FG002|COMPLETED|Overall Study||17
11229122|NCT02014376|12421311|FG000|NOT COMPLETED|Overall Study||3
11229123|NCT02014376|12421312|FG001|NOT COMPLETED|Overall Study||1
11229124|NCT02014376|12421313|FG002|NOT COMPLETED|Overall Study||0
11229125|NCT02014402|12421325|FG000|STARTED|Overall Study||31
11229126|NCT02014402|12421326|FG001|STARTED|Overall Study||30
11229127|NCT02014402|12421327|FG002|STARTED|Overall Study||35
11229128|NCT02014402|12421328|FG003|STARTED|Overall Study||85
11229129|NCT02014402|12421325|FG000|Human Thrombin|Overall Study||20
11229130|NCT02014402|12421326|FG001|Human Thrombin|Overall Study||20
11229131|NCT02014402|12421327|FG002|Human Thrombin|Overall Study||23
11229132|NCT02014402|12421328|FG003|Human Thrombin|Overall Study||57
11229133|NCT02014402|12421325|FG000|Bovine Thrombin|Overall Study||11
11229134|NCT02014402|12421326|FG001|Bovine Thrombin|Overall Study||10
11229135|NCT02014402|12421327|FG002|Bovine Thrombin|Overall Study||12
11229136|NCT02014402|12421328|FG003|Bovine Thrombin|Overall Study||28
11229137|NCT02014402|12421325|FG000|COMPLETED|Overall Study||29
11229138|NCT02014402|12421326|FG001|COMPLETED|Overall Study||27
11229139|NCT02014402|12421327|FG002|COMPLETED|Overall Study||32
11229140|NCT02014402|12421328|FG003|COMPLETED|Overall Study||82
11229141|NCT02014402|12421325|FG000|NOT COMPLETED|Overall Study||2
11229142|NCT02014402|12421326|FG001|NOT COMPLETED|Overall Study||3
11229143|NCT02014402|12421327|FG002|NOT COMPLETED|Overall Study||3
11229144|NCT02014402|12421328|FG003|NOT COMPLETED|Overall Study||3
11229145|NCT02014441|12421345|FG000|STARTED|Overall Study||61
11229146|NCT02014441|12421345|FG000|Received Treatment|Overall Study||60
11229147|NCT02014441|12421345|FG000|COMPLETED|Overall Study||49
11229148|NCT02014441|12421345|FG000|NOT COMPLETED|Overall Study||12
11229149|NCT02014467|12421353|FG000|STARTED|Overall Study||365
11229150|NCT02014467|12421354|FG001|STARTED|Overall Study||119
11229151|NCT02014467|12421353|FG000|COMPLETED|Overall Study||340
11229152|NCT02014467|12421354|FG001|COMPLETED|Overall Study||112
11229153|NCT02014467|12421353|FG000|NOT COMPLETED|Overall Study||25
11229154|NCT02014467|12421354|FG001|NOT COMPLETED|Overall Study||7
11229155|NCT02014480|12421360|FG000|STARTED|Treatment Period 1 (14 Days)||35
11229156|NCT02014480|12421361|FG001|STARTED|Treatment Period 1 (14 Days)||35
11229157|NCT02014480|12421362|FG002|STARTED|Treatment Period 1 (14 Days)||34
11229158|NCT02014480|12421363|FG003|STARTED|Treatment Period 1 (14 Days)||34
11229159|NCT02014480|12421364|FG004|STARTED|Treatment Period 1 (14 Days)||35
11229160|NCT02014480|12421365|FG005|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
11229161|NCT02014480|12421360|FG000|COMPLETED|Treatment Period 1 (14 Days)||35
11229162|NCT02014480|12421361|FG001|COMPLETED|Treatment Period 1 (14 Days)||34
11229163|NCT02014480|12421362|FG002|COMPLETED|Treatment Period 1 (14 Days)||33
11229164|NCT02014480|12421363|FG003|COMPLETED|Treatment Period 1 (14 Days)||32
11229165|NCT02014480|12421364|FG004|COMPLETED|Treatment Period 1 (14 Days)||34
11229166|NCT02014480|12421365|FG005|COMPLETED|Treatment Period 1 (14 Days)||34
11229167|NCT02014480|12421360|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
11355188|NCT03077893|12552068|FG000|STARTED|Overall Study||18
11229168|NCT02014480|12421361|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
11229169|NCT02014480|12421362|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1
11355189|NCT03077893|12552069|FG001|STARTED|Overall Study||19
11110326|NCT01279187|12294804|FG000|STARTED|Overall Study||14
10867625|NCT04701814|12032863|FG001|STARTED|Overall Study||18
10867626|NCT04701814|12032862|FG000|COMPLETED|Overall Study||15
10867627|NCT04701814|12032863|FG001|COMPLETED|Overall Study||15
10867628|NCT04701814|12032862|FG000|NOT COMPLETED|Overall Study||5
10867629|NCT04701814|12032863|FG001|NOT COMPLETED|Overall Study||3
11110327|NCT01279187|12294805|FG001|STARTED|Overall Study||13
11110328|NCT01279187|12294804|FG000|COMPLETED|Overall Study||14
11110329|NCT01279187|12294805|FG001|COMPLETED|Overall Study||13
11110330|NCT01279187|12294804|FG000|NOT COMPLETED|Overall Study||0
11110331|NCT01279187|12294805|FG001|NOT COMPLETED|Overall Study||0
11110332|NCT01279200|12294813|FG000|STARTED|Overall Study||10
10867636|NCT04394286|12032883|FG000|STARTED|Overall Study||0
10867637|NCT04394286|12032884|FG001|STARTED|Overall Study||0
10867638|NCT04394286|12032885|FG002|STARTED|Overall Study||0
10867639|NCT04394286|12032883|FG000|COMPLETED|Overall Study||0
10867640|NCT04394286|12032884|FG001|COMPLETED|Overall Study||0
10867641|NCT04394286|12032885|FG002|COMPLETED|Overall Study||0
10867642|NCT04394286|12032883|FG000|NOT COMPLETED|Overall Study||0
10867643|NCT04394286|12032884|FG001|NOT COMPLETED|Overall Study||0
10867644|NCT04394286|12032885|FG002|NOT COMPLETED|Overall Study||0
10867645|NCT04327986|12032893|FG000|STARTED|Overall Study||3
10867646|NCT04327986|12032894|FG001|STARTED|Overall Study||0
10867647|NCT04327986|12032895|FG002|STARTED|Overall Study||0
10867648|NCT04327986|12032893|FG000|COMPLETED|Overall Study||0
10867649|NCT04327986|12032894|FG001|COMPLETED|Overall Study||0
10867650|NCT04327986|12032895|FG002|COMPLETED|Overall Study||0
10867651|NCT04327986|12032893|FG000|NOT COMPLETED|Overall Study||3
10867652|NCT04327986|12032894|FG001|NOT COMPLETED|Overall Study||0
10867653|NCT04327986|12032895|FG002|NOT COMPLETED|Overall Study||0
10867654|NCT04067843|12032901|FG000|STARTED|Overall Study||10
10867655|NCT04067843|12032902|FG001|STARTED|Overall Study||10
10867656|NCT04067843|12032901|FG000|COMPLETED|Overall Study||10
10867657|NCT04067843|12032902|FG001|COMPLETED|Overall Study||10
10867658|NCT04067843|12032901|FG000|NOT COMPLETED|Overall Study||0
10867659|NCT04067843|12032902|FG001|NOT COMPLETED|Overall Study||0
10867660|NCT04066738|12032910|FG000|STARTED|Overall Study||2
10867661|NCT04066738|12032910|FG000|COMPLETED|Overall Study||2
10867662|NCT04066738|12032910|FG000|NOT COMPLETED|Overall Study||0
10867663|NCT03933020|12032914|FG000|STARTED|Overall Study||0
10867664|NCT03933020|12032914|FG000|Received an Intervention|Overall Study||0
10867665|NCT03933020|12032914|FG000|COMPLETED|Overall Study||0
10867666|NCT03933020|12032914|FG000|NOT COMPLETED|Overall Study||0
10867667|NCT03793608|12032920|FG000|STARTED|Overall Study||1
10867668|NCT03793608|12032921|FG001|STARTED|Overall Study||24
10867669|NCT03793608|12032920|FG000|Treated|Overall Study||1
10867670|NCT03793608|12032921|FG001|Treated|Overall Study||24
10867671|NCT03793608|12032920|FG000|Safety Analysis Set (SAF)|Overall Study|1 participant randomized to placebo was not analyzed and thus excluded from analyses.|0
10867672|NCT03793608|12032921|FG001|Safety Analysis Set (SAF)|Overall Study||24
10867673|NCT03793608|12032920|FG000|COMPLETED|Overall Study||1
10867674|NCT03793608|12032921|FG001|COMPLETED|Overall Study||24
10867675|NCT03793608|12032920|FG000|NOT COMPLETED|Overall Study||0
10867676|NCT03793608|12032921|FG001|NOT COMPLETED|Overall Study||0
10867677|NCT03655054|12032926|FG000|STARTED|Overall Study||23
10867678|NCT03655054|12032926|FG000|COMPLETED|Overall Study||22
10867679|NCT03655054|12032926|FG000|NOT COMPLETED|Overall Study||1
10867680|NCT03601117|12032932|FG000|STARTED|Overall Study||20
10867681|NCT03601117|12032933|FG001|STARTED|Overall Study||2
10867682|NCT03601117|12032932|FG000|COMPLETED|Overall Study||17
10867683|NCT03601117|12032933|FG001|COMPLETED|Overall Study||1
10867684|NCT03601117|12032932|FG000|NOT COMPLETED|Overall Study||3
10867685|NCT03601117|12032933|FG001|NOT COMPLETED|Overall Study||1
10867686|NCT03542266|12032941|FG000|STARTED|Treatment Phase||21
10867687|NCT03542266|12032941|FG000|COMPLETED|Treatment Phase||18
10867688|NCT03542266|12032941|FG000|NOT COMPLETED|Treatment Phase||3
10867689|NCT03542266|12032941|FG000|STARTED|Post-treatment Follow-up Phase|Three subjects did not enter follow-up: 1 had PD at EOT, 2 withdrew consent|15
10867690|NCT03542266|12032941|FG000|COMPLETED|Post-treatment Follow-up Phase||0
10867691|NCT03542266|12032941|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||15
10867692|NCT03529409|12032948|FG000|STARTED|Randomized||30
10867693|NCT03529409|12032949|FG001|STARTED|Randomized||31
10867694|NCT03529409|12032950|FG002|STARTED|Randomized||5
10867695|NCT03529409|12032948|FG000|COMPLETED|Randomized||30
10867696|NCT03529409|12032949|FG001|COMPLETED|Randomized||31
10867697|NCT03529409|12032950|FG002|COMPLETED|Randomized||0
10867698|NCT03529409|12032948|FG000|NOT COMPLETED|Randomized||0
10867699|NCT03529409|12032949|FG001|NOT COMPLETED|Randomized||0
10867700|NCT03529409|12032950|FG002|NOT COMPLETED|Randomized||5
10867701|NCT03529409|12032948|FG000|STARTED|Post-treatment Assessment||30
10867702|NCT03529409|12032949|FG001|STARTED|Post-treatment Assessment||31
10867703|NCT03529409|12032950|FG002|STARTED|Post-treatment Assessment||0
10867704|NCT03529409|12032948|FG000|COMPLETED|Post-treatment Assessment||26
10867705|NCT03529409|12032949|FG001|COMPLETED|Post-treatment Assessment||26
10867706|NCT03529409|12032950|FG002|COMPLETED|Post-treatment Assessment||0
10867707|NCT03529409|12032948|FG000|NOT COMPLETED|Post-treatment Assessment||4
10867708|NCT03529409|12032949|FG001|NOT COMPLETED|Post-treatment Assessment||5
10867709|NCT03529409|12032950|FG002|NOT COMPLETED|Post-treatment Assessment||0
10867710|NCT03529409|12032948|FG000|STARTED|Follow-up Assessment|All participants were eligible for Follow-Up regardless of Post-Treatment attendance.|28
10867711|NCT03529409|12032949|FG001|STARTED|Follow-up Assessment|All participants (n=31) were eligible for Follow-Up regardless of Post-Treatment attendance|30
10867712|NCT03529409|12032950|FG002|STARTED|Follow-up Assessment||0
10867713|NCT03529409|12032948|FG000|COMPLETED|Follow-up Assessment||27
10867714|NCT03529409|12032949|FG001|COMPLETED|Follow-up Assessment||29
10867715|NCT03529409|12032950|FG002|COMPLETED|Follow-up Assessment||0
10867716|NCT03529409|12032948|FG000|NOT COMPLETED|Follow-up Assessment||1
10867717|NCT03529409|12032949|FG001|NOT COMPLETED|Follow-up Assessment||1
10867718|NCT03529409|12032950|FG002|NOT COMPLETED|Follow-up Assessment||0
10867719|NCT03516812|12032957|FG000|STARTED|Overall Study||36
10867720|NCT03516812|12032957|FG000|COMPLETED|Overall Study||30
10867721|NCT03516812|12032957|FG000|NOT COMPLETED|Overall Study||6
10867722|NCT03477396|12032961|FG000|STARTED|Overall Study||2
10867723|NCT03477396|12032961|FG000|COMPLETED|Overall Study||2
10867724|NCT03477396|12032961|FG000|NOT COMPLETED|Overall Study||0
10867725|NCT03463577|12032971|FG000|STARTED|Overall Study||16606
10867726|NCT03463577|12032972|FG001|STARTED|Overall Study||16606
10867727|NCT03463577|12032973|FG002|STARTED|Overall Study||65
10867728|NCT03463577|12032974|FG003|STARTED|Overall Study||16350
10867729|NCT03463577|12032975|FG004|STARTED|Overall Study||16088
10867730|NCT03463577|12032976|FG005|STARTED|Overall Study||68
10867731|NCT03463577|12032971|FG000|COMPLETED|Overall Study||16366
10867732|NCT03463577|12032972|FG001|COMPLETED|Overall Study||16166
10867733|NCT03463577|12032973|FG002|COMPLETED|Overall Study||65
10867734|NCT03463577|12032974|FG003|COMPLETED|Overall Study||16335
10867735|NCT03463577|12032975|FG004|COMPLETED|Overall Study||16071
10867736|NCT03463577|12032976|FG005|COMPLETED|Overall Study||68
10867737|NCT03463577|12032971|FG000|NOT COMPLETED|Overall Study||240
10867738|NCT03463577|12032972|FG001|NOT COMPLETED|Overall Study||440
10867739|NCT03463577|12032973|FG002|NOT COMPLETED|Overall Study||0
10867740|NCT03463577|12032974|FG003|NOT COMPLETED|Overall Study||15
10867741|NCT03463577|12032975|FG004|NOT COMPLETED|Overall Study||17
10867742|NCT03463577|12032976|FG005|NOT COMPLETED|Overall Study||0
10867743|NCT03373760|12032992|FG000|STARTED|Overall Study||58
10867744|NCT03373760|12032992|FG000|COMPLETED|Overall Study||0
10867745|NCT03373760|12032992|FG000|NOT COMPLETED|Overall Study||58
10867746|NCT03253627|12033001|FG000|STARTED|Overall Study||12
10867747|NCT03253627|12033002|FG001|STARTED|Overall Study||11
10867748|NCT03253627|12033001|FG000|Post-intervention|Overall Study||11
10867749|NCT03253627|12033002|FG001|Post-intervention|Overall Study||9
10867750|NCT03253627|12033001|FG000|COMPLETED|Overall Study||10
10867751|NCT03253627|12033002|FG001|COMPLETED|Overall Study||7
10867752|NCT03253627|12033001|FG000|NOT COMPLETED|Overall Study||2
10867753|NCT03253627|12033002|FG001|NOT COMPLETED|Overall Study||4
10867754|NCT03168555|12033008|FG000|STARTED|Visit 1 (Pro-operative)||23
10867755|NCT03168555|12033008|FG000|COMPLETED|Visit 1 (Pro-operative)||22
10867756|NCT03168555|12033008|FG000|NOT COMPLETED|Visit 1 (Pro-operative)||1
10867757|NCT03168555|12033008|FG000|STARTED|Visit 2 (Post-operative)||22
10867758|NCT03168555|12033008|FG000|COMPLETED|Visit 2 (Post-operative)||18
10867759|NCT03168555|12033008|FG000|NOT COMPLETED|Visit 2 (Post-operative)||4
11110333|NCT01279200|12294814|FG001|STARTED|Overall Study||11
11110334|NCT01279200|12294813|FG000|COMPLETED|Overall Study||8
11110335|NCT01279200|12294814|FG001|COMPLETED|Overall Study||4
11110336|NCT01279200|12294813|FG000|NOT COMPLETED|Overall Study||2
11110337|NCT01279200|12294814|FG001|NOT COMPLETED|Overall Study||7
11110338|NCT01279265|12294822|FG000|STARTED|Overall Study||13
11110339|NCT01279265|12294823|FG001|STARTED|Overall Study||17
11110340|NCT01279265|12294822|FG000|COMPLETED|Overall Study||9
11110341|NCT01279265|12294823|FG001|COMPLETED|Overall Study||11
11110342|NCT01279265|12294822|FG000|NOT COMPLETED|Overall Study||4
10867760|NCT03135119|12033017|FG000|STARTED|Overall Study||16
10867761|NCT03135119|12033018|FG001|STARTED|Overall Study||17
10867762|NCT03135119|12033017|FG000|COMPLETED|Overall Study||11
10867763|NCT03135119|12033018|FG001|COMPLETED|Overall Study||14
10867764|NCT03135119|12033017|FG000|NOT COMPLETED|Overall Study||5
10867765|NCT03135119|12033018|FG001|NOT COMPLETED|Overall Study||3
10867766|NCT03128411|12033024|FG000|STARTED|Treatment Phase||60
11229170|NCT02014480|12421363|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2
11229171|NCT02014480|12421364|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||1
11229172|NCT02014480|12421365|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||0
11229173|NCT02014480|12421360|FG000|STARTED|Washout Period 1 (10 to 14 Days)||35
11229174|NCT02014480|12421361|FG001|STARTED|Washout Period 1 (10 to 14 Days)||34
11229175|NCT02014480|12421362|FG002|STARTED|Washout Period 1 (10 to 14 Days)||33
11229176|NCT02014480|12421363|FG003|STARTED|Washout Period 1 (10 to 14 Days)||32
11229177|NCT02014480|12421364|FG004|STARTED|Washout Period 1 (10 to 14 Days)||34
11229178|NCT02014480|12421365|FG005|STARTED|Washout Period 1 (10 to 14 Days)||34
11229179|NCT02014480|12421360|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||35
11229180|NCT02014480|12421361|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||34
11229181|NCT02014480|12421362|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||32
11229182|NCT02014480|12421363|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||32
11229183|NCT02014480|12421364|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||34
11229184|NCT02014480|12421365|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||34
11229185|NCT02014480|12421360|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
11229186|NCT02014480|12421361|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
11229187|NCT02014480|12421362|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
11229188|NCT02014480|12421363|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
11229189|NCT02014480|12421364|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
11110343|NCT01279265|12294823|FG001|NOT COMPLETED|Overall Study||6
11110344|NCT01279317|12294831|FG000|STARTED|Period 1||6
11110345|NCT01279317|12294832|FG001|STARTED|Period 1||6
11229190|NCT02014480|12421365|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
11229191|NCT02014480|12421360|FG000|STARTED|Treatment Period 2 (14 Days)||35
11229192|NCT02014480|12421361|FG001|STARTED|Treatment Period 2 (14 Days)||34
11229193|NCT02014480|12421362|FG002|STARTED|Treatment Period 2 (14 Days)||32
11229194|NCT02014480|12421363|FG003|STARTED|Treatment Period 2 (14 Days)||32
11229195|NCT02014480|12421364|FG004|STARTED|Treatment Period 2 (14 Days)||34
11229196|NCT02014480|12421365|FG005|STARTED|Treatment Period 2 (14 Days)||34
11229197|NCT02014480|12421360|FG000|COMPLETED|Treatment Period 2 (14 Days)||34
11229198|NCT02014480|12421361|FG001|COMPLETED|Treatment Period 2 (14 Days)||33
11229199|NCT02014480|12421362|FG002|COMPLETED|Treatment Period 2 (14 Days)||30
11229200|NCT02014480|12421363|FG003|COMPLETED|Treatment Period 2 (14 Days)||31
11229201|NCT02014480|12421364|FG004|COMPLETED|Treatment Period 2 (14 Days)||34
11229202|NCT02014480|12421365|FG005|COMPLETED|Treatment Period 2 (14 Days)||34
11229203|NCT02014480|12421360|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1
11229204|NCT02014480|12421361|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
11229205|NCT02014480|12421362|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2
11229206|NCT02014480|12421363|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
11229207|NCT02014480|12421364|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
11229208|NCT02014480|12421365|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
10867767|NCT03128411|12033024|FG000|Received Treatment|Treatment Phase||60
10867768|NCT03128411|12033024|FG000|COMPLETED|Treatment Phase||36
10867769|NCT03128411|12033024|FG000|NOT COMPLETED|Treatment Phase||24
10867770|NCT03128411|12033024|FG000|STARTED|Long Term Follow-up Phase|Participants who discontinued treatment phase, entered in long term follow up phase.|24
10867771|NCT03128411|12033024|FG000|COMPLETED|Long Term Follow-up Phase||22
10867772|NCT03128411|12033024|FG000|NOT COMPLETED|Long Term Follow-up Phase||2
10867773|NCT03097328|12033028|FG000|STARTED|Overall Study||39
10867774|NCT03097328|12033028|FG000|Treated|Overall Study||38
10867775|NCT03097328|12033028|FG000|COMPLETED|Overall Study||0
10867776|NCT03097328|12033028|FG000|NOT COMPLETED|Overall Study||39
10867777|NCT03068715|12033034|FG000|STARTED|Overall Study||15
10867778|NCT03068715|12033035|FG001|STARTED|Overall Study||15
10867779|NCT03068715|12033034|FG000|COMPLETED|Overall Study||14
10867780|NCT03068715|12033035|FG001|COMPLETED|Overall Study||15
10867781|NCT03068715|12033034|FG000|NOT COMPLETED|Overall Study||1
10867782|NCT03068715|12033035|FG001|NOT COMPLETED|Overall Study||0
10867783|NCT02981472|12033045|FG000|STARTED|Pre-Treatment Period||129
10867784|NCT02981472|12033046|FG001|STARTED|Pre-Treatment Period||63
10867785|NCT02981472|12033045|FG000|COMPLETED|Pre-Treatment Period||126
11229209|NCT02014480|12421360|FG000|STARTED|Washout Period 2 (10 to 14 Days)||34
11229210|NCT02014480|12421361|FG001|STARTED|Washout Period 2 (10 to 14 Days)||33
11229211|NCT02014480|12421362|FG002|STARTED|Washout Period 2 (10 to 14 Days)||30
11229212|NCT02014480|12421363|FG003|STARTED|Washout Period 2 (10 to 14 Days)||31
11229213|NCT02014480|12421364|FG004|STARTED|Washout Period 2 (10 to 14 Days)||34
11229214|NCT02014480|12421365|FG005|STARTED|Washout Period 2 (10 to 14 Days)||34
11229215|NCT02014480|12421360|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||34
11229216|NCT02014480|12421361|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||33
11229217|NCT02014480|12421362|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||30
11229218|NCT02014480|12421363|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||31
11229219|NCT02014480|12421364|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||34
11229220|NCT02014480|12421365|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||34
11229221|NCT02014480|12421360|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
11229222|NCT02014480|12421361|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
11229223|NCT02014480|12421362|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
11229224|NCT02014480|12421363|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
11229225|NCT02014480|12421364|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
11229226|NCT02014480|12421365|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
11229227|NCT02014480|12421360|FG000|STARTED|Treatment Period 3 (14 Days)||34
11229228|NCT02014480|12421361|FG001|STARTED|Treatment Period 3 (14 Days)||33
11229229|NCT02014480|12421362|FG002|STARTED|Treatment Period 3 (14 Days)||30
11229230|NCT02014480|12421363|FG003|STARTED|Treatment Period 3 (14 Days)||31
11229231|NCT02014480|12421364|FG004|STARTED|Treatment Period 3 (14 Days)||34
11229232|NCT02014480|12421365|FG005|STARTED|Treatment Period 3 (14 Days)||34
11229233|NCT02014480|12421360|FG000|COMPLETED|Treatment Period 3 (14 Days)||34
11229234|NCT02014480|12421361|FG001|COMPLETED|Treatment Period 3 (14 Days)||32
11229235|NCT02014480|12421362|FG002|COMPLETED|Treatment Period 3 (14 Days)||29
11229236|NCT02014480|12421363|FG003|COMPLETED|Treatment Period 3 (14 Days)||31
11229237|NCT02014480|12421364|FG004|COMPLETED|Treatment Period 3 (14 Days)||34
11229238|NCT02014480|12421365|FG005|COMPLETED|Treatment Period 3 (14 Days)||32
11229239|NCT02014480|12421360|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11229240|NCT02014480|12421361|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1
11229241|NCT02014480|12421362|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
11229242|NCT02014480|12421363|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11229243|NCT02014480|12421364|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
11229244|NCT02014480|12421365|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2
11229245|NCT02014519|12421373|FG000|STARTED|Overall Study||2000
11229246|NCT02014519|12421373|FG000|COMPLETED|Overall Study||2000
11229247|NCT02014519|12421373|FG000|NOT COMPLETED|Overall Study||0
11229248|NCT02014584|12421387|FG000|STARTED|Double-Blind Period (24 Weeks)||59
11229249|NCT02014584|12421388|FG001|STARTED|Double-Blind Period (24 Weeks)||58
11229250|NCT02014584|12421389|FG002|STARTED|Double-Blind Period (24 Weeks)||0
10867786|NCT02981472|12033046|FG001|COMPLETED|Pre-Treatment Period||62
10867787|NCT02981472|12033045|FG000|NOT COMPLETED|Pre-Treatment Period||3
10867788|NCT02981472|12033046|FG001|NOT COMPLETED|Pre-Treatment Period||1
10867789|NCT02981472|12033045|FG000|STARTED|Treatment Period||126
10867790|NCT02981472|12033046|FG001|STARTED|Treatment Period||62
11110346|NCT01279317|12294831|FG000|COMPLETED|Period 1||6
11110347|NCT01279317|12294832|FG001|COMPLETED|Period 1||6
11110348|NCT01279317|12294831|FG000|NOT COMPLETED|Period 1||0
11110349|NCT01279317|12294832|FG001|NOT COMPLETED|Period 1||0
11110350|NCT01279317|12294831|FG000|STARTED|Washout||6
11110351|NCT01279317|12294832|FG001|STARTED|Washout||6
11110352|NCT01279317|12294831|FG000|COMPLETED|Washout||6
11110353|NCT01279317|12294832|FG001|COMPLETED|Washout||6
11110354|NCT01279317|12294831|FG000|NOT COMPLETED|Washout||0
11110355|NCT01279317|12294832|FG001|NOT COMPLETED|Washout||0
11110356|NCT01279317|12294831|FG000|STARTED|Period 2||6
11110357|NCT01279317|12294832|FG001|STARTED|Period 2||6
11110358|NCT01279317|12294831|FG000|COMPLETED|Period 2||6
10867791|NCT02981472|12033045|FG000|COMPLETED|Treatment Period||119
10867792|NCT02981472|12033046|FG001|COMPLETED|Treatment Period||60
10867793|NCT02981472|12033045|FG000|NOT COMPLETED|Treatment Period||7
10867794|NCT02981472|12033046|FG001|NOT COMPLETED|Treatment Period||2
10867795|NCT02853760|12033058|FG000|STARTED|First Intervention (3 Hours)||7
10867796|NCT02853760|12033059|FG001|STARTED|First Intervention (3 Hours)||10
10867797|NCT02853760|12033060|FG002|STARTED|First Intervention (3 Hours)||7
10867798|NCT02853760|12033061|FG003|STARTED|First Intervention (3 Hours)||8
10867799|NCT02853760|12033062|FG004|STARTED|First Intervention (3 Hours)||8
10867800|NCT02853760|12033063|FG005|STARTED|First Intervention (3 Hours)||7
10867801|NCT02853760|12033058|FG000|COMPLETED|First Intervention (3 Hours)||7
10867802|NCT02853760|12033059|FG001|COMPLETED|First Intervention (3 Hours)||10
10867803|NCT02853760|12033060|FG002|COMPLETED|First Intervention (3 Hours)||7
10867804|NCT02853760|12033061|FG003|COMPLETED|First Intervention (3 Hours)||8
10867805|NCT02853760|12033062|FG004|COMPLETED|First Intervention (3 Hours)||8
10867806|NCT02853760|12033063|FG005|COMPLETED|First Intervention (3 Hours)||7
10867807|NCT02853760|12033058|FG000|NOT COMPLETED|First Intervention (3 Hours)||0
10867808|NCT02853760|12033059|FG001|NOT COMPLETED|First Intervention (3 Hours)||0
10867809|NCT02853760|12033060|FG002|NOT COMPLETED|First Intervention (3 Hours)||0
10867810|NCT02853760|12033061|FG003|NOT COMPLETED|First Intervention (3 Hours)||0
10867811|NCT02853760|12033062|FG004|NOT COMPLETED|First Intervention (3 Hours)||0
10867812|NCT02853760|12033063|FG005|NOT COMPLETED|First Intervention (3 Hours)||0
10867813|NCT02853760|12033058|FG000|STARTED|Washout (1 Week)||7
10867814|NCT02853760|12033059|FG001|STARTED|Washout (1 Week)||10
10867815|NCT02853760|12033060|FG002|STARTED|Washout (1 Week)||7
10867816|NCT02853760|12033061|FG003|STARTED|Washout (1 Week)||8
10867817|NCT02853760|12033062|FG004|STARTED|Washout (1 Week)||8
10867818|NCT02853760|12033063|FG005|STARTED|Washout (1 Week)||7
10867819|NCT02853760|12033058|FG000|COMPLETED|Washout (1 Week)||7
10867820|NCT02853760|12033059|FG001|COMPLETED|Washout (1 Week)||10
10867821|NCT02853760|12033060|FG002|COMPLETED|Washout (1 Week)||6
11110359|NCT01279317|12294832|FG001|COMPLETED|Period 2||6
11110360|NCT01279317|12294831|FG000|NOT COMPLETED|Period 2||0
11110361|NCT01279317|12294832|FG001|NOT COMPLETED|Period 2||0
11110362|NCT01279343|12294839|FG000|STARTED|Overall Study||59
10867822|NCT02853760|12033061|FG003|COMPLETED|Washout (1 Week)||6
10867823|NCT02853760|12033062|FG004|COMPLETED|Washout (1 Week)||8
10867824|NCT02853760|12033063|FG005|COMPLETED|Washout (1 Week)||5
10867825|NCT02853760|12033058|FG000|NOT COMPLETED|Washout (1 Week)||0
10867826|NCT02853760|12033059|FG001|NOT COMPLETED|Washout (1 Week)||0
10867827|NCT02853760|12033060|FG002|NOT COMPLETED|Washout (1 Week)||1
10867828|NCT02853760|12033061|FG003|NOT COMPLETED|Washout (1 Week)||2
10867829|NCT02853760|12033062|FG004|NOT COMPLETED|Washout (1 Week)||0
10867830|NCT02853760|12033063|FG005|NOT COMPLETED|Washout (1 Week)||2
11110363|NCT01279343|12294840|FG001|STARTED|Overall Study||64
11110364|NCT01279343|12294839|FG000|COMPLETED|Overall Study||57
11110365|NCT01279343|12294840|FG001|COMPLETED|Overall Study||58
11110366|NCT01279343|12294839|FG000|NOT COMPLETED|Overall Study||2
11110367|NCT01279343|12294840|FG001|NOT COMPLETED|Overall Study||6
11110368|NCT01279447|12294848|FG000|STARTED|Overall Study||34
11110369|NCT01279447|12294849|FG001|STARTED|Overall Study||34
11110370|NCT01279447|12294848|FG000|COMPLETED|Overall Study||31
11110371|NCT01279447|12294849|FG001|COMPLETED|Overall Study||33
11110372|NCT01279447|12294848|FG000|NOT COMPLETED|Overall Study||3
11110373|NCT01279447|12294849|FG001|NOT COMPLETED|Overall Study||1
11110374|NCT01279486|12294855|FG000|STARTED|Overall Study||120
11110375|NCT01279486|12294855|FG000|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
11110376|NCT01279486|12294855|FG000|NOT COMPLETED|Overall Study||1
11110377|NCT01279564|12294861|FG000|STARTED|Overall Study||40
11110378|NCT01279564|12294862|FG001|STARTED|Overall Study||32
11110379|NCT01279564|12294861|FG000|COMPLETED|Overall Study||40
11110380|NCT01279564|12294862|FG001|COMPLETED|Overall Study||32
11110381|NCT01279564|12294861|FG000|NOT COMPLETED|Overall Study||0
11110382|NCT01279564|12294862|FG001|NOT COMPLETED|Overall Study||0
11110383|NCT01279681|12294870|FG000|STARTED|Overall Study||15
11110384|NCT01279681|12294871|FG001|STARTED|Overall Study||17
11110385|NCT01279681|12294870|FG000|COMPLETED|Overall Study||0
11110386|NCT01279681|12294871|FG001|COMPLETED|Overall Study||0
11110387|NCT01279681|12294870|FG000|NOT COMPLETED|Overall Study||15
11110388|NCT01279681|12294871|FG001|NOT COMPLETED|Overall Study||17
11110389|NCT01279850|12294877|FG000|STARTED|Overall Study||891
11110390|NCT01279850|12294877|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800
11110391|NCT01279850|12294877|FG000|NOT COMPLETED|Overall Study||91
11110392|NCT01279954|12294883|FG000|STARTED|Overall Study||5
11110393|NCT01279954|12294884|FG001|STARTED|Overall Study||5
11110394|NCT01279954|12294883|FG000|COMPLETED|Overall Study||2
11110395|NCT01279954|12294884|FG001|COMPLETED|Overall Study||1
11110396|NCT01279954|12294883|FG000|NOT COMPLETED|Overall Study||3
11110397|NCT01279954|12294884|FG001|NOT COMPLETED|Overall Study||4
11110398|NCT01280058|12294895|FG000|STARTED|Overall Study||36
11110399|NCT01280058|12294896|FG001|STARTED|Overall Study||37
11110400|NCT01280058|12294895|FG000|COMPLETED|Overall Study||36
10867831|NCT02853760|12033058|FG000|STARTED|Second Intervention (3 Hours)||7
10867832|NCT02853760|12033059|FG001|STARTED|Second Intervention (3 Hours)||10
10867833|NCT02853760|12033060|FG002|STARTED|Second Intervention (3 Hours)||6
10867834|NCT02853760|12033061|FG003|STARTED|Second Intervention (3 Hours)||6
10867835|NCT02853760|12033062|FG004|STARTED|Second Intervention (3 Hours)||8
10867836|NCT02853760|12033063|FG005|STARTED|Second Intervention (3 Hours)||5
10867837|NCT02853760|12033058|FG000|COMPLETED|Second Intervention (3 Hours)||7
10867838|NCT02853760|12033059|FG001|COMPLETED|Second Intervention (3 Hours)||10
10867839|NCT02853760|12033060|FG002|COMPLETED|Second Intervention (3 Hours)||6
10867840|NCT02853760|12033061|FG003|COMPLETED|Second Intervention (3 Hours)||6
10867841|NCT02853760|12033062|FG004|COMPLETED|Second Intervention (3 Hours)||8
10867842|NCT02853760|12033063|FG005|COMPLETED|Second Intervention (3 Hours)||5
10867843|NCT02853760|12033058|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0
10867844|NCT02853760|12033059|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0
10867845|NCT02853760|12033060|FG002|NOT COMPLETED|Second Intervention (3 Hours)||0
10867846|NCT02853760|12033061|FG003|NOT COMPLETED|Second Intervention (3 Hours)||0
10867847|NCT02853760|12033062|FG004|NOT COMPLETED|Second Intervention (3 Hours)||0
10867848|NCT02853760|12033063|FG005|NOT COMPLETED|Second Intervention (3 Hours)||0
10867849|NCT02853760|12033058|FG000|STARTED|Washout (1 Week)||7
10867850|NCT02853760|12033059|FG001|STARTED|Washout (1 Week)||10
10867851|NCT02853760|12033060|FG002|STARTED|Washout (1 Week)||6
10867852|NCT02853760|12033061|FG003|STARTED|Washout (1 Week)||6
10867853|NCT02853760|12033062|FG004|STARTED|Washout (1 Week)||8
10867854|NCT02853760|12033063|FG005|STARTED|Washout (1 Week)||5
10867855|NCT02853760|12033058|FG000|COMPLETED|Washout (1 Week)||7
10867856|NCT02853760|12033059|FG001|COMPLETED|Washout (1 Week)||10
10867857|NCT02853760|12033060|FG002|COMPLETED|Washout (1 Week)||6
10867858|NCT02853760|12033061|FG003|COMPLETED|Washout (1 Week)||6
10867859|NCT02853760|12033062|FG004|COMPLETED|Washout (1 Week)||8
10867860|NCT02853760|12033063|FG005|COMPLETED|Washout (1 Week)||5
10867861|NCT02853760|12033058|FG000|NOT COMPLETED|Washout (1 Week)||0
10867862|NCT02853760|12033059|FG001|NOT COMPLETED|Washout (1 Week)||0
10867863|NCT02853760|12033060|FG002|NOT COMPLETED|Washout (1 Week)||0
10867864|NCT02853760|12033061|FG003|NOT COMPLETED|Washout (1 Week)||0
10867865|NCT02853760|12033062|FG004|NOT COMPLETED|Washout (1 Week)||0
10867866|NCT02853760|12033063|FG005|NOT COMPLETED|Washout (1 Week)||0
10867867|NCT02853760|12033058|FG000|STARTED|Third Intervention (3 Hours)||7
10867868|NCT02853760|12033059|FG001|STARTED|Third Intervention (3 Hours)||10
11110401|NCT01280058|12294896|FG001|COMPLETED|Overall Study||37
11110402|NCT01280058|12294895|FG000|NOT COMPLETED|Overall Study||0
10867869|NCT02853760|12033060|FG002|STARTED|Third Intervention (3 Hours)||6
10867870|NCT02853760|12033061|FG003|STARTED|Third Intervention (3 Hours)||6
10867871|NCT02853760|12033062|FG004|STARTED|Third Intervention (3 Hours)||8
10867872|NCT02853760|12033063|FG005|STARTED|Third Intervention (3 Hours)||5
10867873|NCT02853760|12033058|FG000|COMPLETED|Third Intervention (3 Hours)||7
10867874|NCT02853760|12033059|FG001|COMPLETED|Third Intervention (3 Hours)||10
10867875|NCT02853760|12033060|FG002|COMPLETED|Third Intervention (3 Hours)||6
10867876|NCT02853760|12033061|FG003|COMPLETED|Third Intervention (3 Hours)||6
10867877|NCT02853760|12033062|FG004|COMPLETED|Third Intervention (3 Hours)||8
10867878|NCT02853760|12033063|FG005|COMPLETED|Third Intervention (3 Hours)||5
10867879|NCT02853760|12033058|FG000|NOT COMPLETED|Third Intervention (3 Hours)||0
10867880|NCT02853760|12033059|FG001|NOT COMPLETED|Third Intervention (3 Hours)||0
10867881|NCT02853760|12033060|FG002|NOT COMPLETED|Third Intervention (3 Hours)||0
10867882|NCT02853760|12033061|FG003|NOT COMPLETED|Third Intervention (3 Hours)||0
10867883|NCT02853760|12033062|FG004|NOT COMPLETED|Third Intervention (3 Hours)||0
10867884|NCT02853760|12033063|FG005|NOT COMPLETED|Third Intervention (3 Hours)||0
10867885|NCT02789657|12033075|FG000|STARTED|Overall Study||27
10867886|NCT02789657|12033076|FG001|STARTED|Overall Study||3
10867887|NCT02789657|12033077|FG002|STARTED|Overall Study||0
10867888|NCT02789657|12033078|FG003|STARTED|Overall Study||2
10867889|NCT02789657|12033075|FG000|COMPLETED|Overall Study||25
10867890|NCT02789657|12033076|FG001|COMPLETED|Overall Study||3
10867891|NCT02789657|12033077|FG002|COMPLETED|Overall Study||0
10867892|NCT02789657|12033078|FG003|COMPLETED|Overall Study||2
10867893|NCT02789657|12033075|FG000|NOT COMPLETED|Overall Study||2
10867894|NCT02789657|12033076|FG001|NOT COMPLETED|Overall Study||0
10867895|NCT02789657|12033077|FG002|NOT COMPLETED|Overall Study||0
10867896|NCT02789657|12033078|FG003|NOT COMPLETED|Overall Study||0
10867897|NCT02743871|12033101|FG000|STARTED|Overall Study||6
10867898|NCT02743871|12033102|FG001|STARTED|Overall Study||6
10867899|NCT02743871|12033103|FG002|STARTED|Overall Study||6
10867900|NCT02743871|12033104|FG003|STARTED|Overall Study||3
10867901|NCT02743871|12033105|FG004|STARTED|Overall Study||4
10867902|NCT02743871|12033106|FG005|STARTED|Overall Study||6
10867903|NCT02743871|12033107|FG006|STARTED|Overall Study||6
10867904|NCT02743871|12033108|FG007|STARTED|Overall Study||8
10867905|NCT02743871|12033109|FG008|STARTED|Overall Study||2
10867906|NCT02743871|12033110|FG009|STARTED|Overall Study||2
10867907|NCT02743871|12033111|FG010|STARTED|Overall Study||11
10867908|NCT02743871|12033112|FG011|STARTED|Overall Study||9
10867909|NCT02743871|12033113|FG012|STARTED|Overall Study||20
10867910|NCT02743871|12033114|FG013|STARTED|Overall Study||8
10867911|NCT02743871|12033101|FG000|COMPLETED|Overall Study||5
10867912|NCT02743871|12033102|FG001|COMPLETED|Overall Study||6
10867913|NCT02743871|12033103|FG002|COMPLETED|Overall Study||6
10867914|NCT02743871|12033104|FG003|COMPLETED|Overall Study||2
10867915|NCT02743871|12033105|FG004|COMPLETED|Overall Study||4
10867916|NCT02743871|12033106|FG005|COMPLETED|Overall Study||6
10867917|NCT02743871|12033107|FG006|COMPLETED|Overall Study||5
10867918|NCT02743871|12033108|FG007|COMPLETED|Overall Study||8
10867919|NCT02743871|12033109|FG008|COMPLETED|Overall Study||2
10867920|NCT02743871|12033110|FG009|COMPLETED|Overall Study||2
10867921|NCT02743871|12033111|FG010|COMPLETED|Overall Study||10
10867922|NCT02743871|12033112|FG011|COMPLETED|Overall Study||6
10867923|NCT02743871|12033113|FG012|COMPLETED|Overall Study||5
10867924|NCT02743871|12033114|FG013|COMPLETED|Overall Study||1
10867925|NCT02743871|12033101|FG000|NOT COMPLETED|Overall Study||1
10867926|NCT02743871|12033102|FG001|NOT COMPLETED|Overall Study||0
10867927|NCT02743871|12033103|FG002|NOT COMPLETED|Overall Study||0
10867928|NCT02743871|12033104|FG003|NOT COMPLETED|Overall Study||1
10867929|NCT02743871|12033105|FG004|NOT COMPLETED|Overall Study||0
10867930|NCT02743871|12033106|FG005|NOT COMPLETED|Overall Study||0
10867931|NCT02743871|12033107|FG006|NOT COMPLETED|Overall Study||1
10867932|NCT02743871|12033108|FG007|NOT COMPLETED|Overall Study||0
10867933|NCT02743871|12033109|FG008|NOT COMPLETED|Overall Study||0
10867934|NCT02743871|12033110|FG009|NOT COMPLETED|Overall Study||0
10867935|NCT02743871|12033111|FG010|NOT COMPLETED|Overall Study||1
10867936|NCT02743871|12033112|FG011|NOT COMPLETED|Overall Study||3
10867937|NCT02743871|12033113|FG012|NOT COMPLETED|Overall Study||15
10867938|NCT02743871|12033114|FG013|NOT COMPLETED|Overall Study||7
10867939|NCT02707198|12033159|FG000|STARTED|Overall Study||2
10867940|NCT02707198|12033160|FG001|STARTED|Overall Study||0
10867941|NCT02707198|12033161|FG002|STARTED|Overall Study||0
10867942|NCT02707198|12033159|FG000|COMPLETED|Overall Study||2
10867943|NCT02707198|12033160|FG001|COMPLETED|Overall Study||0
10867944|NCT02707198|12033161|FG002|COMPLETED|Overall Study||0
10867945|NCT02707198|12033159|FG000|NOT COMPLETED|Overall Study||0
10867946|NCT02707198|12033160|FG001|NOT COMPLETED|Overall Study||0
10867947|NCT02707198|12033161|FG002|NOT COMPLETED|Overall Study||0
11110403|NCT01280058|12294896|FG001|NOT COMPLETED|Overall Study||0
11110404|NCT01280110|12294906|FG000|STARTED|Overall Study||22
11110405|NCT01280110|12294907|FG001|STARTED|Overall Study||22
11110406|NCT01280110|12294906|FG000|COMPLETED|Overall Study||22
11110407|NCT01280110|12294907|FG001|COMPLETED|Overall Study||22
11110408|NCT01280110|12294906|FG000|NOT COMPLETED|Overall Study||0
11110409|NCT01280110|12294907|FG001|NOT COMPLETED|Overall Study||0
11110410|NCT01280123|12294918|FG000|STARTED|Overall Study||72
11110411|NCT01280123|12294919|FG001|STARTED|Overall Study||67
11110412|NCT01280123|12294920|FG002|STARTED|Overall Study||71
11110413|NCT01280123|12294918|FG000|COMPLETED|Overall Study||71
11229251|NCT02014584|12421390|FG003|STARTED|Double-Blind Period (24 Weeks)||0
11229252|NCT02014584|12421391|FG004|STARTED|Double-Blind Period (24 Weeks)||0
11229253|NCT02014584|12421392|FG005|STARTED|Double-Blind Period (24 Weeks)||0
11229254|NCT02014584|12421387|FG000|COMPLETED|Double-Blind Period (24 Weeks)||57
11229255|NCT02014584|12421388|FG001|COMPLETED|Double-Blind Period (24 Weeks)||52
11229256|NCT02014584|12421389|FG002|COMPLETED|Double-Blind Period (24 Weeks)||0
11229257|NCT02014584|12421390|FG003|COMPLETED|Double-Blind Period (24 Weeks)||0
11229258|NCT02014584|12421391|FG004|COMPLETED|Double-Blind Period (24 Weeks)||0
11229259|NCT02014584|12421392|FG005|COMPLETED|Double-Blind Period (24 Weeks)||0
11229260|NCT02014584|12421387|FG000|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
11229261|NCT02014584|12421388|FG001|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
11229262|NCT02014584|12421389|FG002|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
11229263|NCT02014584|12421390|FG003|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
11229264|NCT02014584|12421391|FG004|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
11229265|NCT02014584|12421392|FG005|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
11229266|NCT02014584|12421387|FG000|STARTED|Open-Label Period (24 Weeks)||0
11229267|NCT02014584|12421388|FG001|STARTED|Open-Label Period (24 Weeks)||0
11229268|NCT02014584|12421389|FG002|STARTED|Open-Label Period (24 Weeks)||49
10867951|NCT02614261|12033176|FG000|STARTED|Double-Blind Treatment Phase||559
10867952|NCT02614261|12033177|FG001|STARTED|Double-Blind Treatment Phase||279
10867953|NCT02614261|12033178|FG002|STARTED|Double-Blind Treatment Phase||279
10867954|NCT02614261|12033179|FG003|STARTED|Double-Blind Treatment Phase||0
10867955|NCT02614261|12033176|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||558
10867956|NCT02614261|12033177|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||278
11110414|NCT01280123|12294919|FG001|COMPLETED|Overall Study||63
11110415|NCT01280123|12294920|FG002|COMPLETED|Overall Study||70
11110416|NCT01280123|12294918|FG000|NOT COMPLETED|Overall Study||1
11110417|NCT01280123|12294919|FG001|NOT COMPLETED|Overall Study||4
11110418|NCT01280123|12294920|FG002|NOT COMPLETED|Overall Study||1
11110419|NCT01280201|12294928|FG000|STARTED|Overall Study||44
11110420|NCT01280201|12294928|FG000|COMPLETED|Overall Study||44
11110421|NCT01280201|12294928|FG000|NOT COMPLETED|Overall Study||0
11110422|NCT01280266|12294934|FG000|STARTED|First Intervention (Week 1-4)||15
11110423|NCT01280266|12294935|FG001|STARTED|First Intervention (Week 1-4)||14
11229269|NCT02014584|12421390|FG003|STARTED|Open-Label Period (24 Weeks)||48
11229270|NCT02014584|12421391|FG004|STARTED|Open-Label Period (24 Weeks)||0
11229271|NCT02014584|12421392|FG005|STARTED|Open-Label Period (24 Weeks)||0
11229272|NCT02014584|12421387|FG000|COMPLETED|Open-Label Period (24 Weeks)||0
11229273|NCT02014584|12421388|FG001|COMPLETED|Open-Label Period (24 Weeks)||0
11229274|NCT02014584|12421389|FG002|COMPLETED|Open-Label Period (24 Weeks)||44
11229275|NCT02014584|12421390|FG003|COMPLETED|Open-Label Period (24 Weeks)||47
11229276|NCT02014584|12421391|FG004|COMPLETED|Open-Label Period (24 Weeks)||0
11229277|NCT02014584|12421392|FG005|COMPLETED|Open-Label Period (24 Weeks)||0
11229278|NCT02014584|12421387|FG000|NOT COMPLETED|Open-Label Period (24 Weeks)||0
11229279|NCT02014584|12421388|FG001|NOT COMPLETED|Open-Label Period (24 Weeks)||0
11229280|NCT02014584|12421389|FG002|NOT COMPLETED|Open-Label Period (24 Weeks)||5
11229281|NCT02014584|12421390|FG003|NOT COMPLETED|Open-Label Period (24 Weeks)||1
11229282|NCT02014584|12421391|FG004|NOT COMPLETED|Open-Label Period (24 Weeks)||0
11229283|NCT02014584|12421392|FG005|NOT COMPLETED|Open-Label Period (24 Weeks)||0
11229284|NCT02014584|12421387|FG000|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
11229285|NCT02014584|12421388|FG001|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
11229286|NCT02014584|12421389|FG002|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
11229287|NCT02014584|12421390|FG003|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
11229288|NCT02014584|12421391|FG004|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
11229289|NCT02014584|12421392|FG005|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
11229290|NCT02014584|12421387|FG000|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
11229291|NCT02014584|12421388|FG001|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
11229292|NCT02014584|12421389|FG002|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
11229293|NCT02014584|12421390|FG003|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
11229294|NCT02014584|12421391|FG004|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
11229295|NCT02014584|12421392|FG005|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
11229296|NCT02014584|12421387|FG000|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
11229297|NCT02014584|12421388|FG001|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
11229298|NCT02014584|12421389|FG002|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
11229299|NCT02014584|12421390|FG003|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
11229300|NCT02014584|12421391|FG004|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
11229301|NCT02014584|12421392|FG005|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
11229302|NCT02014597|12421406|FG000|STARTED|Overall Study||12
11229303|NCT02014597|12421407|FG001|STARTED|Overall Study||11
11229304|NCT02014597|12421406|FG000|COMPLETED|Overall Study||10
11229305|NCT02014597|12421407|FG001|COMPLETED|Overall Study||10
11229306|NCT02014597|12421406|FG000|NOT COMPLETED|Overall Study||2
11229307|NCT02014597|12421407|FG001|NOT COMPLETED|Overall Study||1
11229308|NCT02014740|12421415|FG000|STARTED|Overall Study||55
11229309|NCT02014740|12421416|FG001|STARTED|Overall Study||45
11229310|NCT02014740|12421415|FG000|COMPLETED|Overall Study||49
11229311|NCT02014740|12421416|FG001|COMPLETED|Overall Study||40
11229312|NCT02014740|12421415|FG000|NOT COMPLETED|Overall Study||6
11355190|NCT03077893|12552068|FG000|COMPLETED|Overall Study||14
11110424|NCT01280266|12294934|FG000|COMPLETED|First Intervention (Week 1-4)||14
11110425|NCT01280266|12294935|FG001|COMPLETED|First Intervention (Week 1-4)||12
10867957|NCT02614261|12033178|FG002|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||277
10867958|NCT02614261|12033179|FG003|Received at Least One Dose of Study Drug|Double-Blind Treatment Phase||0
10867959|NCT02614261|12033176|FG000|Safety Population|Double-Blind Treatment Phase||558
10867960|NCT02614261|12033177|FG001|Safety Population|Double-Blind Treatment Phase|5 participants discontinued after receiving loading dose of 240mg. They were included under 240mg arm for safety analysis.|273
10867961|NCT02614261|12033178|FG002|Safety Population|Double-Blind Treatment Phase||282
10867962|NCT02614261|12033179|FG003|Safety Population|Double-Blind Treatment Phase||0
10867963|NCT02614261|12033176|FG000|COMPLETED|Double-Blind Treatment Phase||509
10867964|NCT02614261|12033177|FG001|COMPLETED|Double-Blind Treatment Phase||262
10867965|NCT02614261|12033178|FG002|COMPLETED|Double-Blind Treatment Phase||266
10867966|NCT02614261|12033179|FG003|COMPLETED|Double-Blind Treatment Phase||0
10867967|NCT02614261|12033176|FG000|NOT COMPLETED|Double-Blind Treatment Phase||50
10867968|NCT02614261|12033177|FG001|NOT COMPLETED|Double-Blind Treatment Phase||17
10867969|NCT02614261|12033178|FG002|NOT COMPLETED|Double-Blind Treatment Phase||13
10867970|NCT02614261|12033179|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
10867971|NCT02614261|12033176|FG000|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|501
10867972|NCT02614261|12033177|FG001|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|259
10867973|NCT02614261|12033178|FG002|STARTED|Open-Label Extension Phase|Participants from double-blind treatment phase had the option to enter the open-label extension phase or proceed directly to the follow-up phase.|262
10867974|NCT02614261|12033179|FG003|STARTED|Open-Label Extension Phase||0
10867975|NCT02614261|12033176|FG000|Safety Population|Open-Label Extension Phase||501
10867976|NCT02614261|12033177|FG001|Safety Population|Open-Label Extension Phase||259
10867977|NCT02614261|12033178|FG002|Safety Population|Open-Label Extension Phase||262
10867978|NCT02614261|12033179|FG003|Safety Population|Open-Label Extension Phase||0
10867979|NCT02614261|12033176|FG000|COMPLETED|Open-Label Extension Phase||413
10867980|NCT02614261|12033177|FG001|COMPLETED|Open-Label Extension Phase||204
10867981|NCT02614261|12033178|FG002|COMPLETED|Open-Label Extension Phase||208
10867982|NCT02614261|12033179|FG003|COMPLETED|Open-Label Extension Phase||0
10867983|NCT02614261|12033176|FG000|NOT COMPLETED|Open-Label Extension Phase||88
10867984|NCT02614261|12033177|FG001|NOT COMPLETED|Open-Label Extension Phase||55
10867985|NCT02614261|12033178|FG002|NOT COMPLETED|Open-Label Extension Phase||54
10867986|NCT02614261|12033179|FG003|NOT COMPLETED|Open-Label Extension Phase||0
10867987|NCT02614261|12033176|FG000|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|453
10867988|NCT02614261|12033177|FG001|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|228
10867989|NCT02614261|12033178|FG002|STARTED|Follow-up Phase|Participants from double-blind treatment or open-label extension phases entered the follow-up phase.|231
10867990|NCT02614261|12033179|FG003|STARTED|Follow-up Phase||0
10867991|NCT02614261|12033176|FG000|Entered From Double-blind Treatment Phase|Follow-up Phase||15
10867992|NCT02614261|12033177|FG001|Entered From Double-blind Treatment Phase|Follow-up Phase|1 among these participants discontinued from double-blind treatment phase after receiving 240mg loading dose and entered Follow-up phase.|5
10867993|NCT02614261|12033178|FG002|Entered From Double-blind Treatment Phase|Follow-up Phase||3
10867994|NCT02614261|12033179|FG003|Entered From Double-blind Treatment Phase|Follow-up Phase||0
10867995|NCT02614261|12033176|FG000|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||15
10867996|NCT02614261|12033177|FG001|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase|1 participant who discontinued from double-blind treatment phase after receiving 240mg loading dose and entered Follow-up phase was included under 240mg arm for safety analysis.|4
10867997|NCT02614261|12033178|FG002|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||4
11110426|NCT01280266|12294934|FG000|NOT COMPLETED|First Intervention (Week 1-4)||1
11110427|NCT01280266|12294935|FG001|NOT COMPLETED|First Intervention (Week 1-4)||2
11110428|NCT01280266|12294934|FG000|STARTED|Washout Period (Week 4-5)||14
11110429|NCT01280266|12294935|FG001|STARTED|Washout Period (Week 4-5)||12
11110430|NCT01280266|12294934|FG000|COMPLETED|Washout Period (Week 4-5)||14
11110431|NCT01280266|12294935|FG001|COMPLETED|Washout Period (Week 4-5)||12
11110432|NCT01280266|12294934|FG000|NOT COMPLETED|Washout Period (Week 4-5)||0
11110433|NCT01280266|12294935|FG001|NOT COMPLETED|Washout Period (Week 4-5)||0
11110434|NCT01280266|12294934|FG000|STARTED|Second Intervention (Week 5-9)||14
11110435|NCT01280266|12294935|FG001|STARTED|Second Intervention (Week 5-9)||12
11110436|NCT01280266|12294934|FG000|COMPLETED|Second Intervention (Week 5-9)||14
11110437|NCT01280266|12294935|FG001|COMPLETED|Second Intervention (Week 5-9)||12
11110438|NCT01280266|12294934|FG000|NOT COMPLETED|Second Intervention (Week 5-9)||0
11110439|NCT01280266|12294935|FG001|NOT COMPLETED|Second Intervention (Week 5-9)||0
10867998|NCT02614261|12033179|FG003|Safety Population (Entered From Double-blind Treatment Phase)|Follow-up Phase||0
10867999|NCT02614261|12033176|FG000|Entered From Open-label Extension Phase|Follow-up Phase||438
10868000|NCT02614261|12033177|FG001|Entered From Open-label Extension Phase|Follow-up Phase||223
10868001|NCT02614261|12033178|FG002|Entered From Open-label Extension Phase|Follow-up Phase||228
10868002|NCT02614261|12033179|FG003|Entered From Open-label Extension Phase|Follow-up Phase||0
10868003|NCT02614261|12033176|FG000|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||438
10868004|NCT02614261|12033177|FG001|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||223
10868005|NCT02614261|12033178|FG002|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||228
10868006|NCT02614261|12033179|FG003|Safety Population (Entered From Open-label Extension Phase)|Follow-up Phase||0
10868007|NCT02614261|12033176|FG000|COMPLETED|Follow-up Phase||421
10868008|NCT02614261|12033177|FG001|COMPLETED|Follow-up Phase||217
10868009|NCT02614261|12033178|FG002|COMPLETED|Follow-up Phase||217
10868010|NCT02614261|12033179|FG003|COMPLETED|Follow-up Phase||0
10868011|NCT02614261|12033176|FG000|NOT COMPLETED|Follow-up Phase||32
10868012|NCT02614261|12033177|FG001|NOT COMPLETED|Follow-up Phase||11
10868013|NCT02614261|12033178|FG002|NOT COMPLETED|Follow-up Phase||14
10868014|NCT02614261|12033179|FG003|NOT COMPLETED|Follow-up Phase||0
10868015|NCT02614261|12033176|FG000|STARTED|Israel Addendum|Main study arm.|0
10868016|NCT02614261|12033177|FG001|STARTED|Israel Addendum|Main study arm.|0
10868017|NCT02614261|12033178|FG002|STARTED|Israel Addendum|Main study arm.|0
10868018|NCT02614261|12033179|FG003|STARTED|Israel Addendum|Eligible participants from main study enrolled in Israel addendum.|29
10868019|NCT02614261|12033176|FG000|Safety Population|Israel Addendum||0
10868020|NCT02614261|12033177|FG001|Safety Population|Israel Addendum||0
10868021|NCT02614261|12033178|FG002|Safety Population|Israel Addendum||0
10868022|NCT02614261|12033179|FG003|Safety Population|Israel Addendum||29
10868023|NCT02614261|12033176|FG000|COMPLETED|Israel Addendum||0
10868024|NCT02614261|12033177|FG001|COMPLETED|Israel Addendum||0
10868025|NCT02614261|12033178|FG002|COMPLETED|Israel Addendum||0
10868026|NCT02614261|12033179|FG003|COMPLETED|Israel Addendum||25
10868027|NCT02614261|12033176|FG000|NOT COMPLETED|Israel Addendum||0
10868028|NCT02614261|12033177|FG001|NOT COMPLETED|Israel Addendum||0
10868029|NCT02614261|12033178|FG002|NOT COMPLETED|Israel Addendum||0
10868030|NCT02614261|12033179|FG003|NOT COMPLETED|Israel Addendum||4
11110440|NCT01280357|12294945|FG000|STARTED|Overall Study||60
11110441|NCT01280357|12294945|FG000|COMPLETED|Overall Study||34
11110442|NCT01280357|12294945|FG000|NOT COMPLETED|Overall Study||26
11110443|NCT01280409|12294954|FG000|STARTED|Overall Study||59
11110444|NCT01280409|12294955|FG001|STARTED|Overall Study||55
11110445|NCT01280409|12294954|FG000|COMPLETED|Overall Study||43
11110446|NCT01280409|12294955|FG001|COMPLETED|Overall Study||36
11110447|NCT01280409|12294954|FG000|NOT COMPLETED|Overall Study||16
11110448|NCT01280409|12294955|FG001|NOT COMPLETED|Overall Study||19
11110449|NCT01280552|12294963|FG000|STARTED|Overall Study||81
11110450|NCT01280552|12294964|FG001|STARTED|Overall Study||43
11110451|NCT01280552|12294963|FG000|COMPLETED|Overall Study|Survival is still being assessed|75
11110452|NCT01280552|12294964|FG001|COMPLETED|Overall Study||42
11110453|NCT01280552|12294963|FG000|NOT COMPLETED|Overall Study||6
11110454|NCT01280552|12294964|FG001|NOT COMPLETED|Overall Study||1
11110455|NCT01280591|12294977|FG000|STARTED|Overall Study||203
11110456|NCT01280591|12294978|FG001|STARTED|Overall Study||204
11229313|NCT02014740|12421416|FG001|NOT COMPLETED|Overall Study||5
11229314|NCT02015039|12421424|FG000|STARTED|Overall Study||6
11229315|NCT02015039|12421425|FG001|STARTED|Overall Study||7
11229316|NCT02015039|12421424|FG000|COMPLETED|Overall Study||6
11229317|NCT02015039|12421425|FG001|COMPLETED|Overall Study||6
11229318|NCT02015039|12421424|FG000|NOT COMPLETED|Overall Study||0
11229319|NCT02015039|12421425|FG001|NOT COMPLETED|Overall Study||1
11229320|NCT02015065|12421434|FG000|STARTED|Overall Study||2
11229321|NCT02015065|12421435|FG001|STARTED|Overall Study||5
11229322|NCT02015065|12421436|FG002|STARTED|Overall Study||2
11229323|NCT02015065|12421434|FG000|COMPLETED|Overall Study||1
11229324|NCT02015065|12421435|FG001|COMPLETED|Overall Study||3
11229325|NCT02015065|12421436|FG002|COMPLETED|Overall Study||1
11229326|NCT02015065|12421434|FG000|NOT COMPLETED|Overall Study||1
11229327|NCT02015065|12421435|FG001|NOT COMPLETED|Overall Study||2
11229328|NCT02015065|12421436|FG002|NOT COMPLETED|Overall Study||1
11229329|NCT02015104|12421446|FG000|STARTED|Overall Study||16
11229330|NCT02015104|12421447|FG001|STARTED|Overall Study||16
11229331|NCT02015104|12421446|FG000|COMPLETED|Overall Study||15
11229332|NCT02015104|12421447|FG001|COMPLETED|Overall Study||15
11229333|NCT02015104|12421446|FG000|NOT COMPLETED|Overall Study||1
11229334|NCT02015104|12421447|FG001|NOT COMPLETED|Overall Study||1
11229335|NCT02015195|12421463|FG000|STARTED|Overall Study||16
11229336|NCT02015195|12421464|FG001|STARTED|Overall Study||16
11229337|NCT02015195|12421465|FG002|STARTED|Overall Study||16
11229338|NCT02015195|12421466|FG003|STARTED|Overall Study||1
11229339|NCT02015195|12421467|FG004|STARTED|Overall Study||16
11229340|NCT02015195|12421468|FG005|STARTED|Overall Study||16
11229341|NCT02015195|12421469|FG006|STARTED|Overall Study||16
11229342|NCT02015195|12421463|FG000|COMPLETED|Overall Study||16
11229343|NCT02015195|12421464|FG001|COMPLETED|Overall Study||16
11229344|NCT02015195|12421465|FG002|COMPLETED|Overall Study||16
11229345|NCT02015195|12421466|FG003|COMPLETED|Overall Study||0
11229346|NCT02015195|12421467|FG004|COMPLETED|Overall Study||16
11229347|NCT02015195|12421468|FG005|COMPLETED|Overall Study||16
11110457|NCT01280591|12294979|FG002|STARTED|Overall Study||203
11229348|NCT02015195|12421469|FG006|COMPLETED|Overall Study||16
11229349|NCT02015195|12421463|FG000|NOT COMPLETED|Overall Study||0
11229350|NCT02015195|12421464|FG001|NOT COMPLETED|Overall Study||0
11229351|NCT02015195|12421465|FG002|NOT COMPLETED|Overall Study||0
11229352|NCT02015195|12421466|FG003|NOT COMPLETED|Overall Study||1
11229353|NCT02015195|12421467|FG004|NOT COMPLETED|Overall Study||0
11229354|NCT02015195|12421468|FG005|NOT COMPLETED|Overall Study||0
11229355|NCT02015195|12421469|FG006|NOT COMPLETED|Overall Study||0
11229356|NCT02015221|12421486|FG000|STARTED|Overall Study||41
11229357|NCT02015221|12421487|FG001|STARTED|Overall Study||40
11229358|NCT02015221|12421486|FG000|COMPLETED|Overall Study||32
11110458|NCT01280591|12294980|FG003|STARTED|Overall Study||102
10868046|NCT02513667|12033230|FG000|STARTED|Overall Study||8
10868047|NCT02513667|12033231|FG001|STARTED|Overall Study||6
10868048|NCT02513667|12033230|FG000|COMPLETED|Overall Study||8
10868049|NCT02513667|12033231|FG001|COMPLETED|Overall Study||5
10868050|NCT02513667|12033230|FG000|NOT COMPLETED|Overall Study||0
11110459|NCT01280591|12294977|FG000|COMPLETED|Overall Study||203
11110460|NCT01280591|12294978|FG001|COMPLETED|Overall Study||204
11110461|NCT01280591|12294979|FG002|COMPLETED|Overall Study||203
11110462|NCT01280591|12294980|FG003|COMPLETED|Overall Study||99
11110463|NCT01280591|12294977|FG000|NOT COMPLETED|Overall Study||0
11110464|NCT01280591|12294978|FG001|NOT COMPLETED|Overall Study||0
11110465|NCT01280591|12294979|FG002|NOT COMPLETED|Overall Study||0
11110466|NCT01280591|12294980|FG003|NOT COMPLETED|Overall Study||3
11110467|NCT01280604|12294992|FG000|STARTED|Overall Study||33
11110468|NCT01280604|12294993|FG001|STARTED|Overall Study||33
11110469|NCT01280604|12294992|FG000|Subjects Meeting All Inclusion Criteria|Overall Study||25
11110470|NCT01280604|12294993|FG001|Subjects Meeting All Inclusion Criteria|Overall Study||29
11110471|NCT01280604|12294992|FG000|COMPLETED|Overall Study||24
10868051|NCT02513667|12033231|FG001|NOT COMPLETED|Overall Study||1
10868052|NCT02415556|12033241|FG000|STARTED|Overall Study||57
10868053|NCT02415556|12033242|FG001|STARTED|Overall Study||58
10868054|NCT02415556|12033243|FG002|STARTED|Overall Study||65
10868055|NCT02415556|12033244|FG003|STARTED|Overall Study||64
10868056|NCT02415556|12033241|FG000|COMPLETED|Overall Study||32
10868057|NCT02415556|12033242|FG001|COMPLETED|Overall Study||37
10868058|NCT02415556|12033243|FG002|COMPLETED|Overall Study||43
10868059|NCT02415556|12033244|FG003|COMPLETED|Overall Study||44
10868060|NCT02415556|12033241|FG000|NOT COMPLETED|Overall Study||25
10868061|NCT02415556|12033242|FG001|NOT COMPLETED|Overall Study||21
10868062|NCT02415556|12033243|FG002|NOT COMPLETED|Overall Study||22
10868063|NCT02415556|12033244|FG003|NOT COMPLETED|Overall Study||20
10868064|NCT02389374|12033257|FG000|STARTED|Overall Study||55
10868065|NCT02389374|12033258|FG001|STARTED|Overall Study||115
10868066|NCT02389374|12033259|FG002|STARTED|Overall Study||11
10868067|NCT02389374|12033257|FG000|COMPLETED|Overall Study||46
10868068|NCT02389374|12033258|FG001|COMPLETED|Overall Study||87
10868069|NCT02389374|12033259|FG002|COMPLETED|Overall Study||10
10868070|NCT02389374|12033257|FG000|NOT COMPLETED|Overall Study||9
10868071|NCT02389374|12033258|FG001|NOT COMPLETED|Overall Study||28
10868072|NCT02389374|12033259|FG002|NOT COMPLETED|Overall Study||1
10868073|NCT02386839|12033270|FG000|STARTED|Overall Study||36
10868074|NCT02386839|12033271|FG001|STARTED|Overall Study||40
10868075|NCT02386839|12033270|FG000|COMPLETED|Overall Study||20
10868076|NCT02386839|12033271|FG001|COMPLETED|Overall Study||25
10868077|NCT02386839|12033270|FG000|NOT COMPLETED|Overall Study||16
10868078|NCT02386839|12033271|FG001|NOT COMPLETED|Overall Study||15
11110472|NCT01280604|12294993|FG001|COMPLETED|Overall Study||28
11110473|NCT01280604|12294992|FG000|NOT COMPLETED|Overall Study||9
11110474|NCT01280604|12294993|FG001|NOT COMPLETED|Overall Study||5
11110475|NCT01280617|12295001|FG000|STARTED|Overall Study||23
11110476|NCT01280617|12295002|FG001|STARTED|Overall Study||21
11110477|NCT01280617|12295001|FG000|COMPLETED|Overall Study||23
11110478|NCT01280617|12295002|FG001|COMPLETED|Overall Study||20
11110479|NCT01280617|12295001|FG000|NOT COMPLETED|Overall Study||0
11110480|NCT01280617|12295002|FG001|NOT COMPLETED|Overall Study||1
11110481|NCT01280656|12295011|FG000|STARTED|Overall Study||62
11110482|NCT01280656|12295012|FG001|STARTED|Overall Study||312
11110483|NCT01280656|12295013|FG002|STARTED|Overall Study||286
11110484|NCT01280656|12295011|FG000|COMPLETED|Overall Study||59
11110485|NCT01280656|12295012|FG001|COMPLETED|Overall Study||265
11110486|NCT01280656|12295013|FG002|COMPLETED|Overall Study||223
11110487|NCT01280656|12295011|FG000|NOT COMPLETED|Overall Study||3
11110488|NCT01280656|12295012|FG001|NOT COMPLETED|Overall Study||47
11110489|NCT01280656|12295013|FG002|NOT COMPLETED|Overall Study||63
10868097|NCT02312258|12033299|FG000|STARTED|Overall Study||281
10868098|NCT02312258|12033300|FG001|STARTED|Overall Study||425
10868099|NCT02312258|12033299|FG000|COMPLETED|Overall Study||30
10868100|NCT02312258|12033300|FG001|COMPLETED|Overall Study||66
10868101|NCT02312258|12033299|FG000|NOT COMPLETED|Overall Study||251
10868102|NCT02312258|12033300|FG001|NOT COMPLETED|Overall Study||359
10868103|NCT02213380|12033308|FG000|STARTED|Underwent Randomization||476
10868104|NCT02213380|12033309|FG001|STARTED|Underwent Randomization||474
10868105|NCT02213380|12033308|FG000|COMPLETED|Underwent Randomization||471
10868106|NCT02213380|12033309|FG001|COMPLETED|Underwent Randomization||471
10868107|NCT02213380|12033308|FG000|NOT COMPLETED|Underwent Randomization||5
10868108|NCT02213380|12033309|FG001|NOT COMPLETED|Underwent Randomization||3
10868109|NCT02213380|12033308|FG000|STARTED|Per-protocol Analysis||471
10868110|NCT02213380|12033309|FG001|STARTED|Per-protocol Analysis||471
10868111|NCT02213380|12033308|FG000|COMPLETED|Per-protocol Analysis||439
11110490|NCT01280695|12295026|FG000|STARTED|Overall Study||26
11110491|NCT01280695|12295027|FG001|STARTED|Overall Study||25
11110492|NCT01280695|12295028|FG002|STARTED|Overall Study||26
10868112|NCT02213380|12033309|FG001|COMPLETED|Per-protocol Analysis||435
10868113|NCT02213380|12033308|FG000|NOT COMPLETED|Per-protocol Analysis||32
10868114|NCT02213380|12033309|FG001|NOT COMPLETED|Per-protocol Analysis||36
11110493|NCT01280695|12295029|FG003|STARTED|Overall Study||26
11110494|NCT01280695|12295030|FG004|STARTED|Overall Study||26
11110495|NCT01280695|12295026|FG000|COMPLETED|Overall Study||26
11110496|NCT01280695|12295027|FG001|COMPLETED|Overall Study||24
11110497|NCT01280695|12295028|FG002|COMPLETED|Overall Study||21
11110498|NCT01280695|12295029|FG003|COMPLETED|Overall Study||22
10868121|NCT02113592|12033326|FG000|STARTED|Overall Study||433
10868122|NCT02113592|12033327|FG001|STARTED|Overall Study||417
10868123|NCT02113592|12033326|FG000|COMPLETED|Overall Study||414
10868124|NCT02113592|12033327|FG001|COMPLETED|Overall Study||402
10868125|NCT02113592|12033326|FG000|NOT COMPLETED|Overall Study||19
10868126|NCT02113592|12033327|FG001|NOT COMPLETED|Overall Study||15
11110499|NCT01280695|12295030|FG004|COMPLETED|Overall Study||24
11110500|NCT01280695|12295026|FG000|NOT COMPLETED|Overall Study||0
11110501|NCT01280695|12295027|FG001|NOT COMPLETED|Overall Study||1
11110502|NCT01280695|12295028|FG002|NOT COMPLETED|Overall Study||5
11110503|NCT01280695|12295029|FG003|NOT COMPLETED|Overall Study||4
11110504|NCT01280695|12295030|FG004|NOT COMPLETED|Overall Study||2
11110505|NCT01280721|12295042|FG000|STARTED|Overall Study||135
11110506|NCT01280721|12295042|FG000|COMPLETED|Overall Study||113
11110507|NCT01280721|12295042|FG000|NOT COMPLETED|Overall Study||22
11110508|NCT01280812|12295060|FG000|STARTED|Overall Study||70
11110509|NCT01280812|12295061|FG001|STARTED|Overall Study||71
11110510|NCT01280812|12295062|FG002|STARTED|Overall Study||69
11110511|NCT01280812|12295060|FG000|COMPLETED|Overall Study||67
11110512|NCT01280812|12295061|FG001|COMPLETED|Overall Study||69
11110513|NCT01280812|12295062|FG002|COMPLETED|Overall Study||68
11110514|NCT01280812|12295060|FG000|NOT COMPLETED|Overall Study||3
11110515|NCT01280812|12295061|FG001|NOT COMPLETED|Overall Study||2
11110516|NCT01280812|12295062|FG002|NOT COMPLETED|Overall Study||1
11110517|NCT01280903|12295073|FG000|STARTED|Overall Study||91
11110518|NCT01280903|12295074|FG001|STARTED|Overall Study||91
11110519|NCT01280903|12295073|FG000|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
11110520|NCT01280903|12295074|FG001|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
11110521|NCT01280903|12295073|FG000|NOT COMPLETED|Overall Study||23
10868151|NCT02075320|12033368|FG000|STARTED|Overall Study||50
10868152|NCT02075320|12033368|FG000|COMPLETED|Overall Study||48
10868153|NCT02075320|12033368|FG000|NOT COMPLETED|Overall Study||2
10868154|NCT02007512|12033376|FG000|STARTED|Double Blind Treatment Period||63
10868155|NCT02007512|12033377|FG001|STARTED|Double Blind Treatment Period||64
10868156|NCT02007512|12033378|FG002|STARTED|Double Blind Treatment Period||60
10868157|NCT02007512|12033379|FG003|STARTED|Double Blind Treatment Period||60
10868158|NCT02007512|12033376|FG000|Treated|Double Blind Treatment Period||62
10868159|NCT02007512|12033377|FG001|Treated|Double Blind Treatment Period||63
10868160|NCT02007512|12033378|FG002|Treated|Double Blind Treatment Period||60
10868161|NCT02007512|12033379|FG003|Treated|Double Blind Treatment Period||60
10868162|NCT02007512|12033376|FG000|COMPLETED|Double Blind Treatment Period||0
10868163|NCT02007512|12033377|FG001|COMPLETED|Double Blind Treatment Period||0
10868164|NCT02007512|12033378|FG002|COMPLETED|Double Blind Treatment Period||0
10868165|NCT02007512|12033379|FG003|COMPLETED|Double Blind Treatment Period||0
10868166|NCT02007512|12033376|FG000|NOT COMPLETED|Double Blind Treatment Period||63
10868167|NCT02007512|12033377|FG001|NOT COMPLETED|Double Blind Treatment Period||64
10868168|NCT02007512|12033378|FG002|NOT COMPLETED|Double Blind Treatment Period||60
10868169|NCT02007512|12033379|FG003|NOT COMPLETED|Double Blind Treatment Period||60
10868170|NCT02007512|12033376|FG000|STARTED|Open Label Treatment Period||0
10868171|NCT02007512|12033377|FG001|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
10868172|NCT02007512|12033378|FG002|STARTED|Open Label Treatment Period||0
10868173|NCT02007512|12033379|FG003|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
10868174|NCT02007512|12033376|FG000|COMPLETED|Open Label Treatment Period||0
10868175|NCT02007512|12033377|FG001|COMPLETED|Open Label Treatment Period||0
10868176|NCT02007512|12033378|FG002|COMPLETED|Open Label Treatment Period||0
10868177|NCT02007512|12033379|FG003|COMPLETED|Open Label Treatment Period||0
10868178|NCT02007512|12033376|FG000|NOT COMPLETED|Open Label Treatment Period||0
10868179|NCT02007512|12033377|FG001|NOT COMPLETED|Open Label Treatment Period||21
10868180|NCT02007512|12033378|FG002|NOT COMPLETED|Open Label Treatment Period||0
10868181|NCT02007512|12033379|FG003|NOT COMPLETED|Open Label Treatment Period||12
10868182|NCT01999179|12033392|FG000|STARTED|Overall Study||27
10868183|NCT01999179|12033392|FG000|COMPLETED|Overall Study||20
10868184|NCT01999179|12033392|FG000|NOT COMPLETED|Overall Study||7
10868185|NCT01858688|12033396|FG000|STARTED|Overall Study||101
10868186|NCT01858688|12033396|FG000|Biopsied at Baseline|Overall Study||97
10868187|NCT01858688|12033396|FG000|MRI Assessed|Overall Study||91
10868188|NCT01858688|12033396|FG000|COMPLETED|Overall Study||81
10868189|NCT01858688|12033396|FG000|NOT COMPLETED|Overall Study||20
10868190|NCT01796197|12033400|FG000|STARTED|Overall Study||23
10868191|NCT01796197|12033400|FG000|COMPLETED|Overall Study||21
10868192|NCT01796197|12033400|FG000|NOT COMPLETED|Overall Study||2
10868193|NCT01751906|12033406|FG000|STARTED|Overall Study||1322
10868194|NCT01751906|12033407|FG001|STARTED|Overall Study||686
10868195|NCT01751906|12033406|FG000|COMPLETED|Overall Study||1059
10868196|NCT01751906|12033407|FG001|COMPLETED|Overall Study||555
10868197|NCT01751906|12033406|FG000|NOT COMPLETED|Overall Study||263
10868198|NCT01751906|12033407|FG001|NOT COMPLETED|Overall Study||131
10868199|NCT01551550|12033415|FG000|STARTED|Overall Study||41
10868200|NCT01551550|12033416|FG001|STARTED|Overall Study||41
10868201|NCT01551550|12033415|FG000|COMPLETED|Overall Study||41
10868202|NCT01551550|12033416|FG001|COMPLETED|Overall Study||40
10868203|NCT01551550|12033415|FG000|NOT COMPLETED|Overall Study||0
10868204|NCT01551550|12033416|FG001|NOT COMPLETED|Overall Study||1
10868205|NCT01372254|12033424|FG000|STARTED|Overall Study||47
10868206|NCT01372254|12033425|FG001|STARTED|Overall Study||49
10868207|NCT01372254|12033424|FG000|COMPLETED|Overall Study||43
10868208|NCT01372254|12033425|FG001|COMPLETED|Overall Study||46
10868209|NCT01372254|12033424|FG000|NOT COMPLETED|Overall Study||4
10868210|NCT01372254|12033425|FG001|NOT COMPLETED|Overall Study||3
10868211|NCT01351766|12033431|FG000|STARTED|Overall Study||39
10868212|NCT01351766|12033431|FG000|COMPLETED|Overall Study||36
10868213|NCT01351766|12033431|FG000|NOT COMPLETED|Overall Study||3
10868214|NCT01199380|12033437|FG000|STARTED|Overall Study||88
10868215|NCT01199380|12033438|FG001|STARTED|Overall Study||96
10868216|NCT01199380|12033437|FG000|COMPLETED|Overall Study||78
10868217|NCT01199380|12033438|FG001|COMPLETED|Overall Study||81
10868218|NCT01199380|12033437|FG000|NOT COMPLETED|Overall Study||10
10868219|NCT01199380|12033438|FG001|NOT COMPLETED|Overall Study||15
10868220|NCT00810017|12033444|FG000|STARTED|Overall Study||2
10868221|NCT00810017|12033444|FG000|COMPLETED|Overall Study||0
10868222|NCT00810017|12033444|FG000|NOT COMPLETED|Overall Study||2
10868223|NCT00669669|12033448|FG000|STARTED|Overall Study||12
10868224|NCT00669669|12033448|FG000|COMPLETED|Overall Study||11
10868225|NCT00669669|12033448|FG000|NOT COMPLETED|Overall Study||1
11110522|NCT01280903|12295074|FG001|NOT COMPLETED|Overall Study||16
11110523|NCT01280942|12295082|FG000|STARTED|Overall Study||10120
11110524|NCT01280942|12295083|FG001|STARTED|Overall Study||9911
11110525|NCT01280942|12295082|FG000|COMPLETED|Overall Study||10120
11110526|NCT01280942|12295083|FG001|COMPLETED|Overall Study||9911
11110527|NCT01280942|12295082|FG000|NOT COMPLETED|Overall Study||0
11110528|NCT01280942|12295083|FG001|NOT COMPLETED|Overall Study||0
11110529|NCT01280955|12295089|FG000|STARTED|Overall Study||30
11110530|NCT01280955|12295089|FG000|COMPLETED|Overall Study||27
10868235|NCT00314366|12033475|FG000|STARTED|Overall Study||11
10868236|NCT00314366|12033476|FG001|STARTED|Overall Study||10
10868237|NCT00314366|12033475|FG000|COMPLETED|Overall Study||10
10868238|NCT00314366|12033476|FG001|COMPLETED|Overall Study||10
10868239|NCT00314366|12033475|FG000|NOT COMPLETED|Overall Study||1
10868240|NCT00314366|12033476|FG001|NOT COMPLETED|Overall Study||0
10868241|NCT00187226|12033491|FG000|STARTED|Overall Study||88
10868242|NCT00187226|12033492|FG001|STARTED|Overall Study||49
10868243|NCT00187226|12033493|FG002|STARTED|Overall Study||28
10868244|NCT00187226|12033494|FG003|STARTED|Overall Study||2
10868245|NCT00187226|12033495|FG004|STARTED|Overall Study||34
10868246|NCT00187226|12033496|FG005|STARTED|Overall Study||1
10868247|NCT00187226|12033491|FG000|COMPLETED|Overall Study||88
10868248|NCT00187226|12033492|FG001|COMPLETED|Overall Study||49
10868249|NCT00187226|12033493|FG002|COMPLETED|Overall Study||28
10868250|NCT00187226|12033494|FG003|COMPLETED|Overall Study||2
10868251|NCT00187226|12033495|FG004|COMPLETED|Overall Study||34
10868252|NCT00187226|12033496|FG005|COMPLETED|Overall Study||1
10868253|NCT00187226|12033491|FG000|NOT COMPLETED|Overall Study||0
10868254|NCT00187226|12033492|FG001|NOT COMPLETED|Overall Study||0
10868255|NCT00187226|12033493|FG002|NOT COMPLETED|Overall Study||0
10868256|NCT00187226|12033494|FG003|NOT COMPLETED|Overall Study||0
10868257|NCT00187226|12033495|FG004|NOT COMPLETED|Overall Study||0
10868258|NCT00187226|12033496|FG005|NOT COMPLETED|Overall Study||0
10868259|NCT00119847|12033512|FG000|STARTED|Overall Study||149
10868260|NCT00119847|12033513|FG001|STARTED|Overall Study||151
10868261|NCT00119847|12033512|FG000|COMPLETED|Overall Study||118
10868262|NCT00119847|12033513|FG001|COMPLETED|Overall Study||119
10868263|NCT00119847|12033512|FG000|NOT COMPLETED|Overall Study||31
10868264|NCT00119847|12033513|FG001|NOT COMPLETED|Overall Study||32
10868265|NCT04748783|12033524|FG000|STARTED|Overall Study||0
10868266|NCT04748783|12033525|FG001|STARTED|Overall Study||1
10868267|NCT04748783|12033526|FG002|STARTED|Overall Study||0
10868268|NCT04748783|12033527|FG003|STARTED|Overall Study||0
10868269|NCT04748783|12033528|FG004|STARTED|Overall Study||1
10868270|NCT04748783|12033524|FG000|COMPLETED|Overall Study||0
10868271|NCT04748783|12033525|FG001|COMPLETED|Overall Study||1
10868272|NCT04748783|12033526|FG002|COMPLETED|Overall Study||0
10868273|NCT04748783|12033527|FG003|COMPLETED|Overall Study||0
10868274|NCT04748783|12033528|FG004|COMPLETED|Overall Study||1
10868275|NCT04748783|12033524|FG000|NOT COMPLETED|Overall Study||0
10868276|NCT04748783|12033525|FG001|NOT COMPLETED|Overall Study||0
10868277|NCT04748783|12033526|FG002|NOT COMPLETED|Overall Study||0
10868278|NCT04748783|12033527|FG003|NOT COMPLETED|Overall Study||0
10868279|NCT04748783|12033528|FG004|NOT COMPLETED|Overall Study||0
11110531|NCT01280955|12295089|FG000|NOT COMPLETED|Overall Study||3
11110532|NCT01280968|12295097|FG000|STARTED|Overall Study||45
11110533|NCT01280968|12295098|FG001|STARTED|Overall Study||7
10868283|NCT04405570|12033549|FG000|STARTED|Overall Study||23
10868284|NCT04405570|12033550|FG001|STARTED|Overall Study||64
10868285|NCT04405570|12033551|FG002|STARTED|Overall Study||55
10868286|NCT04405570|12033552|FG003|STARTED|Overall Study||62
10868287|NCT04405570|12033549|FG000|Number of Subjects Randomized Not Dosed|Overall Study||0
10868288|NCT04405570|12033550|FG001|Number of Subjects Randomized Not Dosed|Overall Study||2
10868289|NCT04405570|12033551|FG002|Number of Subjects Randomized Not Dosed|Overall Study||0
10868379|NCT02153632|12033660|FG000|NOT COMPLETED|Overall Study||18
10868290|NCT04405570|12033552|FG003|Number of Subjects Randomized Not Dosed|Overall Study||0
10868291|NCT04405570|12033549|FG000|Number of Subjects in the Safety Population|Overall Study||23
10868292|NCT04405570|12033550|FG001|Number of Subjects in the Safety Population|Overall Study||62
10868293|NCT04405570|12033551|FG002|Number of Subjects in the Safety Population|Overall Study||55
10868294|NCT04405570|12033552|FG003|Number of Subjects in the Safety Population|Overall Study||62
10868295|NCT04405570|12033549|FG000|Number of Subjects in the mITT Population|Overall Study||23
10868296|NCT04405570|12033550|FG001|Number of Subjects in the mITT Population|Overall Study||61
10868297|NCT04405570|12033551|FG002|Number of Subjects in the mITT Population|Overall Study||53
10868298|NCT04405570|12033552|FG003|Number of Subjects in the mITT Population|Overall Study||61
10868299|NCT04405570|12033549|FG000|COMPLETED|Overall Study||23
10868300|NCT04405570|12033550|FG001|COMPLETED|Overall Study||59
10868301|NCT04405570|12033551|FG002|COMPLETED|Overall Study||52
10868302|NCT04405570|12033552|FG003|COMPLETED|Overall Study||61
10868303|NCT04405570|12033549|FG000|NOT COMPLETED|Overall Study||0
10868304|NCT04405570|12033550|FG001|NOT COMPLETED|Overall Study||5
10868305|NCT04405570|12033551|FG002|NOT COMPLETED|Overall Study||3
10868306|NCT04405570|12033552|FG003|NOT COMPLETED|Overall Study||1
10868307|NCT04135937|12033565|FG000|STARTED|Overall Study||12
10868308|NCT04135937|12033565|FG000|COMPLETED|Overall Study||9
10868309|NCT04135937|12033565|FG000|NOT COMPLETED|Overall Study||3
10868310|NCT03989232|12033571|FG000|STARTED|Overall Study||481
10868311|NCT03989232|12033572|FG001|STARTED|Overall Study||480
10868312|NCT03989232|12033571|FG000|Exposed|Overall Study||480
10868313|NCT03989232|12033572|FG001|Exposed|Overall Study||479
10868314|NCT03989232|12033571|FG000|Safety Analysis Set (SAS)|Overall Study||480
10868315|NCT03989232|12033572|FG001|Safety Analysis Set (SAS)|Overall Study||479
10868316|NCT03989232|12033571|FG000|Full Analysis Set (FAS)|Overall Study||481
10868317|NCT03989232|12033572|FG001|Full Analysis Set (FAS)|Overall Study||480
10868318|NCT03989232|12033571|FG000|COMPLETED|Overall Study||471
10868319|NCT03989232|12033572|FG001|COMPLETED|Overall Study||462
10868320|NCT03989232|12033571|FG000|NOT COMPLETED|Overall Study||10
10868321|NCT03989232|12033572|FG001|NOT COMPLETED|Overall Study||18
10868322|NCT03896295|12033580|FG000|STARTED|Overall Study||7
10868323|NCT03896295|12033581|FG001|STARTED|Overall Study||30
10868324|NCT03896295|12033580|FG000|COMPLETED|Overall Study||0
10868325|NCT03896295|12033581|FG001|COMPLETED|Overall Study||0
10868326|NCT03896295|12033580|FG000|NOT COMPLETED|Overall Study||7
10868327|NCT03896295|12033581|FG001|NOT COMPLETED|Overall Study||30
10868328|NCT03213457|12033595|FG000|STARTED|Overall Study||194
10868329|NCT03213457|12033596|FG001|STARTED|Overall Study||98
10868330|NCT03213457|12033597|FG002|STARTED|Overall Study||389
10868331|NCT03213457|12033595|FG000|Randomized and Treated|Overall Study||193
10868332|NCT03213457|12033596|FG001|Randomized and Treated|Overall Study||97
10868333|NCT03213457|12033597|FG002|Randomized and Treated|Overall Study||389
10868334|NCT03213457|12033595|FG000|COMPLETED|Overall Study||106
10868335|NCT03213457|12033596|FG001|COMPLETED|Overall Study||59
10868336|NCT03213457|12033597|FG002|COMPLETED|Overall Study||215
10868337|NCT03213457|12033595|FG000|NOT COMPLETED|Overall Study||88
10868338|NCT03213457|12033596|FG001|NOT COMPLETED|Overall Study||39
10868339|NCT03213457|12033597|FG002|NOT COMPLETED|Overall Study||174
10868340|NCT02982720|12033605|FG000|STARTED|Overall Study||4
10868341|NCT02982720|12033605|FG000|COMPLETED|Overall Study||0
10868342|NCT02982720|12033605|FG000|NOT COMPLETED|Overall Study||4
10868343|NCT02548754|12033611|FG000|STARTED|Overall Study||26
10868344|NCT02548754|12033612|FG001|STARTED|Overall Study||27
10868345|NCT02548754|12033611|FG000|COMPLETED|Overall Study||24
10868346|NCT02548754|12033612|FG001|COMPLETED|Overall Study||23
10868347|NCT02548754|12033611|FG000|NOT COMPLETED|Overall Study||2
10868348|NCT02548754|12033612|FG001|NOT COMPLETED|Overall Study||4
10868349|NCT02375672|12033618|FG000|STARTED|Overall Study||30
10868350|NCT02375672|12033618|FG000|COMPLETED|Overall Study||10
10868351|NCT02375672|12033618|FG000|NOT COMPLETED|Overall Study||20
10868352|NCT02329327|12033624|FG000|STARTED|Overall Study||477
10868353|NCT02329327|12033625|FG001|STARTED|Overall Study||2
10868354|NCT02329327|12033624|FG000|Received At Least 1 Dose of Study Drug|Overall Study||477
10868355|NCT02329327|12033625|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2
10868356|NCT02329327|12033624|FG000|Efficacy Population|Overall Study||347
10868357|NCT02329327|12033625|FG001|Efficacy Population|Overall Study||2
10868358|NCT02329327|12033624|FG000|Death|Overall Study||3
10868359|NCT02329327|12033625|FG001|Death|Overall Study||0
10868360|NCT02329327|12033624|FG000|COMPLETED|Overall Study||392
10868361|NCT02329327|12033625|FG001|COMPLETED|Overall Study||2
10868362|NCT02329327|12033624|FG000|NOT COMPLETED|Overall Study||85
10868363|NCT02329327|12033625|FG001|NOT COMPLETED|Overall Study||0
10868364|NCT02153645|12033647|FG000|STARTED|Overall Study||30
10868365|NCT02153645|12033648|FG001|STARTED|Overall Study||29
10868366|NCT02153645|12033649|FG002|STARTED|Overall Study||28
10868367|NCT02153645|12033647|FG000|COMPLETED|Overall Study||17
10868368|NCT02153645|12033648|FG001|COMPLETED|Overall Study||19
10868369|NCT02153645|12033649|FG002|COMPLETED|Overall Study||18
10868370|NCT02153645|12033647|FG000|NOT COMPLETED|Overall Study||13
10868371|NCT02153645|12033648|FG001|NOT COMPLETED|Overall Study||10
10868372|NCT02153645|12033649|FG002|NOT COMPLETED|Overall Study||10
10868373|NCT02153632|12033660|FG000|STARTED|Overall Study||45
10868374|NCT02153632|12033661|FG001|STARTED|Overall Study||46
10868375|NCT02153632|12033662|FG002|STARTED|Overall Study||44
10868376|NCT02153632|12033660|FG000|COMPLETED|Overall Study||27
10868377|NCT02153632|12033661|FG001|COMPLETED|Overall Study||27
10868378|NCT02153632|12033662|FG002|COMPLETED|Overall Study||25
10868380|NCT02153632|12033661|FG001|NOT COMPLETED|Overall Study||19
10868381|NCT02153632|12033662|FG002|NOT COMPLETED|Overall Study||19
10868382|NCT01689909|12033672|FG000|STARTED|Overall Study||51
10868383|NCT01689909|12033673|FG001|STARTED|Overall Study||52
10868384|NCT01689909|12033672|FG000|COMPLETED|Overall Study||51
10868385|NCT01689909|12033673|FG001|COMPLETED|Overall Study||52
10868386|NCT01689909|12033672|FG000|NOT COMPLETED|Overall Study||0
10868387|NCT01689909|12033673|FG001|NOT COMPLETED|Overall Study||0
10868388|NCT01566149|12033683|FG000|STARTED|Overall Study||24
10868389|NCT01566149|12033684|FG001|STARTED|Overall Study||25
10868390|NCT01566149|12033683|FG000|COMPLETED|Overall Study||21
10868391|NCT01566149|12033684|FG001|COMPLETED|Overall Study||23
10868392|NCT01566149|12033683|FG000|NOT COMPLETED|Overall Study||3
10868393|NCT01566149|12033684|FG001|NOT COMPLETED|Overall Study||2
10868394|NCT01481935|12033692|FG000|STARTED|Overall Study||97
10868395|NCT01481935|12033693|FG001|STARTED|Overall Study||93
10868396|NCT01481935|12033692|FG000|COMPLETED|Overall Study||97
10868397|NCT01481935|12033693|FG001|COMPLETED|Overall Study||93
10868398|NCT01481935|12033692|FG000|NOT COMPLETED|Overall Study||0
10868399|NCT01481935|12033693|FG001|NOT COMPLETED|Overall Study||0
10868400|NCT01386125|12033701|FG000|STARTED|Overall Study||375
11229359|NCT02015221|12421487|FG001|COMPLETED|Overall Study||34
11229360|NCT02015221|12421486|FG000|NOT COMPLETED|Overall Study||9
11229361|NCT02015221|12421487|FG001|NOT COMPLETED|Overall Study||6
11229362|NCT02015234|12421495|FG000|STARTED|Overall Study||79
11229363|NCT02015234|12421496|FG001|STARTED|Overall Study||79
11229364|NCT02015234|12421495|FG000|COMPLETED|Overall Study||43
11229365|NCT02015234|12421496|FG001|COMPLETED|Overall Study||54
11229366|NCT02015234|12421495|FG000|NOT COMPLETED|Overall Study||36
11229367|NCT02015234|12421496|FG001|NOT COMPLETED|Overall Study||25
11229368|NCT02015390|12421506|FG000|STARTED|Overall Study||9
11229369|NCT02015390|12421507|FG001|STARTED|Overall Study||7
11229370|NCT02015390|12421506|FG000|COMPLETED|Overall Study||8
11229371|NCT02015390|12421507|FG001|COMPLETED|Overall Study||3
11229372|NCT02015390|12421506|FG000|NOT COMPLETED|Overall Study||1
11229373|NCT02015390|12421507|FG001|NOT COMPLETED|Overall Study||4
11229374|NCT02015442|12421514|FG000|STARTED|First Intervention (7 Days)||5
11229375|NCT02015442|12421515|FG001|STARTED|First Intervention (7 Days)||4
11229376|NCT02015442|12421514|FG000|COMPLETED|First Intervention (7 Days)||5
11229377|NCT02015442|12421515|FG001|COMPLETED|First Intervention (7 Days)||4
11229378|NCT02015442|12421514|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11229379|NCT02015442|12421515|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11229380|NCT02015442|12421514|FG000|STARTED|Wash-out (4 Weeks)||5
11229381|NCT02015442|12421515|FG001|STARTED|Wash-out (4 Weeks)||4
11229382|NCT02015442|12421514|FG000|COMPLETED|Wash-out (4 Weeks)||5
11229383|NCT02015442|12421515|FG001|COMPLETED|Wash-out (4 Weeks)||4
11229384|NCT02015442|12421514|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
11229385|NCT02015442|12421515|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
11229386|NCT02015442|12421514|FG000|STARTED|Second Intervention (7 Days)||5
11229387|NCT02015442|12421515|FG001|STARTED|Second Intervention (7 Days)||4
11229388|NCT02015442|12421514|FG000|COMPLETED|Second Intervention (7 Days)||5
11229389|NCT02015442|12421515|FG001|COMPLETED|Second Intervention (7 Days)||4
11229390|NCT02015442|12421514|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
11229391|NCT02015442|12421515|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11229392|NCT02015481|12421521|FG000|STARTED|Overall Study||25
11229393|NCT02015481|12421521|FG000|COMPLETED|Overall Study||24
11229394|NCT02015481|12421521|FG000|NOT COMPLETED|Overall Study||1
11229395|NCT02015520|12421530|FG000|STARTED|Overall Study||40
11229396|NCT02015520|12421531|FG001|STARTED|Overall Study||21
11229397|NCT02015520|12421532|FG002|STARTED|Overall Study||42
11229398|NCT02015520|12421533|FG003|STARTED|Overall Study||40
11229399|NCT02015520|12421530|FG000|COMPLETED|Overall Study||35
11229400|NCT02015520|12421531|FG001|COMPLETED|Overall Study||17
11229401|NCT02015520|12421532|FG002|COMPLETED|Overall Study||35
11229402|NCT02015520|12421533|FG003|COMPLETED|Overall Study||36
11229403|NCT02015520|12421530|FG000|NOT COMPLETED|Overall Study||5
11229404|NCT02015520|12421531|FG001|NOT COMPLETED|Overall Study||4
11229405|NCT02015520|12421532|FG002|NOT COMPLETED|Overall Study||7
11229406|NCT02015520|12421533|FG003|NOT COMPLETED|Overall Study||4
11355191|NCT03077893|12552069|FG001|COMPLETED|Overall Study||16
11355192|NCT03077893|12552068|FG000|NOT COMPLETED|Overall Study||4
11355193|NCT03077893|12552069|FG001|NOT COMPLETED|Overall Study||3
11355194|NCT03077919|12552078|FG000|STARTED|Overall Study||74
11355195|NCT03077919|12552079|FG001|STARTED|Overall Study||39
11355196|NCT03077919|12552078|FG000|Week 2 Visit|Overall Study||74
11355197|NCT03077919|12552079|FG001|Week 2 Visit|Overall Study||39
11355198|NCT03077919|12552078|FG000|Week 4 Visit|Overall Study||73
11355199|NCT03077919|12552079|FG001|Week 4 Visit|Overall Study||38
11355200|NCT03077919|12552078|FG000|Week 6 Visit|Overall Study||73
11355201|NCT03077919|12552079|FG001|Week 6 Visit|Overall Study||38
11355202|NCT03077919|12552078|FG000|Week 8 Visit|Overall Study||71
11355203|NCT03077919|12552079|FG001|Week 8 Visit|Overall Study||38
11355204|NCT03077919|12552078|FG000|Final CAPS|Overall Study||70
11355205|NCT03077919|12552079|FG001|Final CAPS|Overall Study||38
11355206|NCT03077919|12552078|FG000|COMPLETED|Overall Study||70
11355207|NCT03077919|12552079|FG001|COMPLETED|Overall Study||38
11355208|NCT03077919|12552078|FG000|NOT COMPLETED|Overall Study||4
11355209|NCT03077919|12552079|FG001|NOT COMPLETED|Overall Study||1
11355210|NCT03078075|12552087|FG000|STARTED|Overall Study||111
11355211|NCT03078075|12552088|FG001|STARTED|Overall Study||114
11355212|NCT03078075|12552089|FG002|STARTED|Overall Study||59
11355213|NCT03078075|12552090|FG003|STARTED|Overall Study||10
11355214|NCT03078075|12552091|FG004|STARTED|Overall Study||109
11355215|NCT03078075|12552087|FG000|COMPLETED|Overall Study||106
11355216|NCT03078075|12552088|FG001|COMPLETED|Overall Study||103
11355217|NCT03078075|12552089|FG002|COMPLETED|Overall Study||19
11355218|NCT03078075|12552090|FG003|COMPLETED|Overall Study||9
11355219|NCT03078075|12552091|FG004|COMPLETED|Overall Study||78
11355220|NCT03078075|12552087|FG000|NOT COMPLETED|Overall Study||5
11355221|NCT03078075|12552088|FG001|NOT COMPLETED|Overall Study||11
11355222|NCT03078075|12552089|FG002|NOT COMPLETED|Overall Study||40
11355223|NCT03078075|12552090|FG003|NOT COMPLETED|Overall Study||1
11355224|NCT03078075|12552091|FG004|NOT COMPLETED|Overall Study||31
10868401|NCT01386125|12033702|FG001|STARTED|Overall Study||373
11229407|NCT02015546|12421546|FG000|STARTED|Overall Study||23
11229408|NCT02015546|12421547|FG001|STARTED|Overall Study||21
11229409|NCT02015546|12421548|FG002|STARTED|Overall Study||26
11229410|NCT02015546|12421546|FG000|COMPLETED|Overall Study||20
11229411|NCT02015546|12421547|FG001|COMPLETED|Overall Study||19
10868402|NCT01386125|12033701|FG000|COMPLETED|Overall Study||350
10868403|NCT01386125|12033702|FG001|COMPLETED|Overall Study||336
10868404|NCT01386125|12033701|FG000|NOT COMPLETED|Overall Study||25
10868405|NCT01386125|12033702|FG001|NOT COMPLETED|Overall Study||37
10868406|NCT01257568|12033708|FG000|STARTED|Overall Study||40
10868407|NCT01257568|12033708|FG000|COMPLETED|Overall Study||7
10868408|NCT01257568|12033708|FG000|NOT COMPLETED|Overall Study||33
10868409|NCT01165424|12033714|FG000|STARTED|Overall Study||80
10868410|NCT01165424|12033714|FG000|COMPLETED|Overall Study||76
10868411|NCT01165424|12033714|FG000|NOT COMPLETED|Overall Study||4
10868412|NCT01135134|12033720|FG000|STARTED|Overall Study||220
10868413|NCT01135134|12033721|FG001|STARTED|Overall Study||113
10868414|NCT01135134|12033720|FG000|COMPLETED|Overall Study||218
10868415|NCT01135134|12033721|FG001|COMPLETED|Overall Study||112
10868416|NCT01135134|12033720|FG000|NOT COMPLETED|Overall Study||2
10868417|NCT01135134|12033721|FG001|NOT COMPLETED|Overall Study||1
10868418|NCT00867165|12033729|FG000|STARTED|Overall Study||93
10868419|NCT00867165|12033730|FG001|STARTED|Overall Study||45
10868420|NCT00867165|12033729|FG000|COMPLETED|Overall Study||89
10868421|NCT00867165|12033730|FG001|COMPLETED|Overall Study||45
10868422|NCT00867165|12033729|FG000|NOT COMPLETED|Overall Study||4
10868423|NCT00867165|12033730|FG001|NOT COMPLETED|Overall Study||0
10868424|NCT00733005|12033738|FG000|STARTED|Overall Study||162
10868425|NCT00733005|12033739|FG001|STARTED|Overall Study||162
10868426|NCT00733005|12033738|FG000|COMPLETED|Overall Study||160
10868427|NCT00733005|12033739|FG001|COMPLETED|Overall Study||159
10868428|NCT00733005|12033738|FG000|NOT COMPLETED|Overall Study||2
10868429|NCT00733005|12033739|FG001|NOT COMPLETED|Overall Study||3
10868430|NCT00732381|12033747|FG000|STARTED|Overall Study||176
10868431|NCT00732381|12033748|FG001|STARTED|Overall Study||175
10868432|NCT00732381|12033747|FG000|COMPLETED|Overall Study||174
10868433|NCT00732381|12033748|FG001|COMPLETED|Overall Study||174
10868434|NCT00732381|12033747|FG000|NOT COMPLETED|Overall Study||2
10868435|NCT00732381|12033748|FG001|NOT COMPLETED|Overall Study||1
10868436|NCT00654095|12033754|FG000|STARTED|Overall Study||146
10868437|NCT00654095|12033754|FG000|COMPLETED|Overall Study||114
10868438|NCT00654095|12033754|FG000|NOT COMPLETED|Overall Study||32
10868439|NCT00653523|12033758|FG000|STARTED|Overall Study||151
10868440|NCT00653523|12033758|FG000|COMPLETED|Overall Study||132
10868441|NCT00653523|12033758|FG000|NOT COMPLETED|Overall Study||19
10868442|NCT00599027|12033764|FG000|STARTED|Overall Study||26
10868443|NCT00599027|12033765|FG001|STARTED|Overall Study||25
10868444|NCT00599027|12033764|FG000|COMPLETED|Overall Study||25
10868445|NCT00599027|12033765|FG001|COMPLETED|Overall Study||22
10868446|NCT00599027|12033764|FG000|NOT COMPLETED|Overall Study||1
10868447|NCT00599027|12033765|FG001|NOT COMPLETED|Overall Study||3
10868448|NCT00552032|12033773|FG000|STARTED|Overall Study||66
10868449|NCT00552032|12033774|FG001|STARTED|Overall Study||66
10868450|NCT00552032|12033773|FG000|COMPLETED|Overall Study||49
10868451|NCT00552032|12033774|FG001|COMPLETED|Overall Study||47
10868452|NCT00552032|12033773|FG000|NOT COMPLETED|Overall Study||17
10868453|NCT00552032|12033774|FG001|NOT COMPLETED|Overall Study||19
10868454|NCT00546052|12033780|FG000|STARTED|Overall Study||1738
10868455|NCT00546052|12033780|FG000|Week 4|Overall Study||1714
10868456|NCT00546052|12033780|FG000|Week 8|Overall Study||1680
10868457|NCT00546052|12033780|FG000|Week 12|Overall Study||1650
10868458|NCT00546052|12033780|FG000|Week 32|Overall Study||1583
10868459|NCT00546052|12033780|FG000|Week 52|Overall Study||1511
10868460|NCT00546052|12033780|FG000|COMPLETED|Overall Study||1511
10868461|NCT00546052|12033780|FG000|NOT COMPLETED|Overall Study||227
10868462|NCT00442117|12033789|FG000|STARTED|Overall Study||85
10868463|NCT00442117|12033790|FG001|STARTED|Overall Study||87
10868464|NCT00442117|12033789|FG000|COMPLETED|Overall Study||47
10868465|NCT00442117|12033790|FG001|COMPLETED|Overall Study||49
10868466|NCT00442117|12033789|FG000|NOT COMPLETED|Overall Study||38
10868467|NCT00442117|12033790|FG001|NOT COMPLETED|Overall Study||38
10868468|NCT00424008|12033798|FG000|STARTED|Overall Study||371
10868469|NCT00424008|12033799|FG001|STARTED|Overall Study||351
10868470|NCT00424008|12033798|FG000|COMPLETED|Overall Study||22
10868471|NCT00424008|12033799|FG001|COMPLETED|Overall Study||16
10868472|NCT00424008|12033798|FG000|NOT COMPLETED|Overall Study||349
11229412|NCT02015546|12421548|FG002|COMPLETED|Overall Study||22
11229413|NCT02015546|12421546|FG000|NOT COMPLETED|Overall Study||3
11229414|NCT02015546|12421547|FG001|NOT COMPLETED|Overall Study||2
11229415|NCT02015546|12421548|FG002|NOT COMPLETED|Overall Study||4
11229416|NCT02015637|12421558|FG000|STARTED|Overall Study||306
11229417|NCT02015637|12421559|FG001|STARTED|Overall Study||154
11229418|NCT02015637|12421558|FG000|COMPLETED|Overall Study||298
11229419|NCT02015637|12421559|FG001|COMPLETED|Overall Study||149
11229420|NCT02015637|12421558|FG000|NOT COMPLETED|Overall Study||8
11229421|NCT02015637|12421559|FG001|NOT COMPLETED|Overall Study||5
11229422|NCT02015676|12421568|FG000|STARTED|Overall Study||15
10868473|NCT00424008|12033799|FG001|NOT COMPLETED|Overall Study||335
11229423|NCT02015676|12421569|FG001|STARTED|Overall Study||48
10868474|NCT00423176|12033808|FG000|STARTED|Overall Study||114
10868475|NCT00423176|12033809|FG001|STARTED|Overall Study||123
10868476|NCT00423176|12033808|FG000|COMPLETED|Overall Study||98
10868477|NCT00423176|12033809|FG001|COMPLETED|Overall Study||94
11229424|NCT02015676|12421570|FG002|STARTED|Overall Study||6
10868478|NCT00423176|12033808|FG000|NOT COMPLETED|Overall Study||16
10868479|NCT00423176|12033809|FG001|NOT COMPLETED|Overall Study||29
10868480|NCT00383240|12033819|FG000|STARTED|Overall Study||191
10868481|NCT00383240|12033820|FG001|STARTED|Overall Study||192
10868482|NCT00383240|12033821|FG002|STARTED|Overall Study||202
10868483|NCT00383240|12033822|FG003|STARTED|Overall Study||196
10868484|NCT00383240|12033819|FG000|COMPLETED|Overall Study||156
10868485|NCT00383240|12033820|FG001|COMPLETED|Overall Study||159
10868486|NCT00383240|12033821|FG002|COMPLETED|Overall Study||117
10868487|NCT00383240|12033822|FG003|COMPLETED|Overall Study||119
10868488|NCT00383240|12033819|FG000|NOT COMPLETED|Overall Study||35
10868489|NCT00383240|12033820|FG001|NOT COMPLETED|Overall Study||33
10868490|NCT00383240|12033821|FG002|NOT COMPLETED|Overall Study||85
10868491|NCT00383240|12033822|FG003|NOT COMPLETED|Overall Study||77
10868492|NCT02797067|12033835|FG000|STARTED|Overall Study||685
10868493|NCT02797067|12033836|FG001|STARTED|Overall Study||685
10868494|NCT02797067|12033835|FG000|COMPLETED|Overall Study||685
10868495|NCT02797067|12033836|FG001|COMPLETED|Overall Study||685
10868496|NCT02797067|12033835|FG000|NOT COMPLETED|Overall Study||0
10868497|NCT02797067|12033836|FG001|NOT COMPLETED|Overall Study||0
10868498|NCT02787499|12033844|FG000|STARTED|Overall Study||423
10868499|NCT02787499|12033845|FG001|STARTED|Overall Study||417
10868500|NCT02787499|12033844|FG000|COMPLETED|Overall Study||423
10868501|NCT02787499|12033845|FG001|COMPLETED|Overall Study||417
10868502|NCT02787499|12033844|FG000|NOT COMPLETED|Overall Study||0
10868503|NCT02787499|12033845|FG001|NOT COMPLETED|Overall Study||0
10868504|NCT02765399|12033853|FG000|STARTED|Overall Study||16
10868505|NCT02765399|12033854|FG001|STARTED|Overall Study||7
10868506|NCT02765399|12033853|FG000|COMPLETED|Overall Study||15
10868507|NCT02765399|12033854|FG001|COMPLETED|Overall Study||7
10868508|NCT02765399|12033853|FG000|NOT COMPLETED|Overall Study||1
10868509|NCT02765399|12033854|FG001|NOT COMPLETED|Overall Study||0
11110534|NCT01280968|12295097|FG000|COMPLETED|Overall Study||27
11110535|NCT01280968|12295098|FG001|COMPLETED|Overall Study||4
11110536|NCT01280968|12295097|FG000|NOT COMPLETED|Overall Study||18
11110537|NCT01280968|12295098|FG001|NOT COMPLETED|Overall Study||3
11110538|NCT01280981|12295105|FG000|STARTED|Overall Study||288
11110539|NCT01280981|12295105|FG000|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
11110540|NCT01280981|12295105|FG000|COMPLETED|Overall Study||196
11110541|NCT01280981|12295105|FG000|NOT COMPLETED|Overall Study||92
10868518|NCT04468074|12033871|FG000|STARTED|Overall Study||31
10868519|NCT04468074|12033872|FG001|STARTED|Overall Study||30
10868520|NCT04468074|12033871|FG000|COMPLETED|Overall Study||30
10868521|NCT04468074|12033872|FG001|COMPLETED|Overall Study||30
10868522|NCT04468074|12033871|FG000|NOT COMPLETED|Overall Study||1
10868523|NCT04468074|12033872|FG001|NOT COMPLETED|Overall Study||0
11110542|NCT01281007|12295111|FG000|STARTED|Overall Study||75
11110543|NCT01281007|12295112|FG001|STARTED|Overall Study||75
11110544|NCT01281007|12295111|FG000|COMPLETED|Overall Study||71
11110545|NCT01281007|12295112|FG001|COMPLETED|Overall Study||67
11110546|NCT01281007|12295111|FG000|NOT COMPLETED|Overall Study||4
11110547|NCT01281007|12295112|FG001|NOT COMPLETED|Overall Study||8
11110548|NCT01281137|12295120|FG000|STARTED|Baseline Population||25
11110549|NCT01281137|12295121|FG001|STARTED|Baseline Population||79
10868532|NCT03894969|12033892|FG000|STARTED|Overall Study||134
10868533|NCT03894969|12033893|FG001|STARTED|Overall Study||134
10868534|NCT03894969|12033894|FG002|STARTED|Overall Study||122
10868535|NCT03894969|12033895|FG003|STARTED|Overall Study||135
10868536|NCT03894969|12033896|FG004|STARTED|Overall Study||16
10868537|NCT03894969|12033892|FG000|COMPLETED|Overall Study||129
10868538|NCT03894969|12033893|FG001|COMPLETED|Overall Study||129
10868539|NCT03894969|12033894|FG002|COMPLETED|Overall Study||118
10868540|NCT03894969|12033895|FG003|COMPLETED|Overall Study||128
10868541|NCT03894969|12033896|FG004|COMPLETED|Overall Study||2
10868542|NCT03894969|12033892|FG000|NOT COMPLETED|Overall Study||5
10868543|NCT03894969|12033893|FG001|NOT COMPLETED|Overall Study||5
10868544|NCT03894969|12033894|FG002|NOT COMPLETED|Overall Study||4
10868545|NCT03894969|12033895|FG003|NOT COMPLETED|Overall Study||7
10868546|NCT03894969|12033896|FG004|NOT COMPLETED|Overall Study||14
10868547|NCT03523273|12033912|FG000|STARTED|Overall Study||67
10868548|NCT03523273|12033913|FG001|STARTED|Overall Study||69
10868549|NCT03523273|12033912|FG000|COMPLETED|Overall Study||59
10868550|NCT03523273|12033913|FG001|COMPLETED|Overall Study||65
10868551|NCT03523273|12033912|FG000|NOT COMPLETED|Overall Study||8
10868552|NCT03523273|12033913|FG001|NOT COMPLETED|Overall Study||4
10868553|NCT03464136|12033921|FG000|STARTED|Overall Study||195
10868554|NCT03464136|12033922|FG001|STARTED|Overall Study||191
10868555|NCT03464136|12033921|FG000|COMPLETED|Overall Study||165
10868556|NCT03464136|12033922|FG001|COMPLETED|Overall Study||166
10868557|NCT03464136|12033921|FG000|NOT COMPLETED|Overall Study||30
10868558|NCT03464136|12033922|FG001|NOT COMPLETED|Overall Study||25
10868559|NCT03338816|12033930|FG000|STARTED|6-Month Double-blind Period||46
10868560|NCT03338816|12033931|FG001|STARTED|6-Month Double-blind Period||48
10868561|NCT03338816|12033932|FG002|STARTED|6-Month Double-blind Period||0
10868562|NCT03338816|12033933|FG003|STARTED|6-Month Double-blind Period||0
10868563|NCT03338816|12033930|FG000|COMPLETED|6-Month Double-blind Period||46
10868564|NCT03338816|12033931|FG001|COMPLETED|6-Month Double-blind Period|1 participant discontinued treatment during the 6-month DB period due to an adverse event but completed the 6-month DB Visit|48
10868565|NCT03338816|12033932|FG002|COMPLETED|6-Month Double-blind Period||0
10868566|NCT03338816|12033933|FG003|COMPLETED|6-Month Double-blind Period||0
10868567|NCT03338816|12033930|FG000|NOT COMPLETED|6-Month Double-blind Period||0
10868568|NCT03338816|12033931|FG001|NOT COMPLETED|6-Month Double-blind Period||0
10868569|NCT03338816|12033932|FG002|NOT COMPLETED|6-Month Double-blind Period||0
10868570|NCT03338816|12033933|FG003|NOT COMPLETED|6-Month Double-blind Period||0
10868571|NCT03338816|12033930|FG000|STARTED|6-Month DB + Open-Label Extension Period||0
10868572|NCT03338816|12033931|FG001|STARTED|6-Month DB + Open-Label Extension Period||0
10868573|NCT03338816|12033932|FG002|STARTED|6-Month DB + Open-Label Extension Period||46
10868574|NCT03338816|12033933|FG003|STARTED|6-Month DB + Open-Label Extension Period||47
10868575|NCT03338816|12033930|FG000|COMPLETED|6-Month DB + Open-Label Extension Period||0
10868576|NCT03338816|12033931|FG001|COMPLETED|6-Month DB + Open-Label Extension Period||0
10868577|NCT03338816|12033932|FG002|COMPLETED|6-Month DB + Open-Label Extension Period||38
10868578|NCT03338816|12033933|FG003|COMPLETED|6-Month DB + Open-Label Extension Period||41
10868579|NCT03338816|12033930|FG000|NOT COMPLETED|6-Month DB + Open-Label Extension Period||0
10868580|NCT03338816|12033931|FG001|NOT COMPLETED|6-Month DB + Open-Label Extension Period||0
10868581|NCT03338816|12033932|FG002|NOT COMPLETED|6-Month DB + Open-Label Extension Period||8
10868582|NCT03338816|12033933|FG003|NOT COMPLETED|6-Month DB + Open-Label Extension Period||6
10868583|NCT03318809|12033944|FG000|STARTED|Overall Study||6
10868584|NCT03318809|12033945|FG001|STARTED|Overall Study||6
10868585|NCT03318809|12033944|FG000|COMPLETED|Overall Study||6
10868586|NCT03318809|12033945|FG001|COMPLETED|Overall Study||6
10868587|NCT03318809|12033944|FG000|NOT COMPLETED|Overall Study||0
10868588|NCT03318809|12033945|FG001|NOT COMPLETED|Overall Study||0
10868589|NCT03317496|12033955|FG000|STARTED|Phase 1b Lead-in: Treatment||6
10868590|NCT03317496|12033956|FG001|STARTED|Phase 1b Lead-in: Treatment||13
10868591|NCT03317496|12033957|FG002|STARTED|Phase 1b Lead-in: Treatment||6
10868592|NCT03317496|12033958|FG003|STARTED|Phase 1b Lead-in: Treatment||6
10868593|NCT03317496|12033959|FG004|STARTED|Phase 1b Lead-in: Treatment||0
10868594|NCT03317496|12033955|FG000|COMPLETED|Phase 1b Lead-in: Treatment||0
10868595|NCT03317496|12033956|FG001|COMPLETED|Phase 1b Lead-in: Treatment||0
10868596|NCT03317496|12033957|FG002|COMPLETED|Phase 1b Lead-in: Treatment||0
10868597|NCT03317496|12033958|FG003|COMPLETED|Phase 1b Lead-in: Treatment||0
10868598|NCT03317496|12033959|FG004|COMPLETED|Phase 1b Lead-in: Treatment||0
10868599|NCT03317496|12033955|FG000|NOT COMPLETED|Phase 1b Lead-in: Treatment||6
10868600|NCT03317496|12033956|FG001|NOT COMPLETED|Phase 1b Lead-in: Treatment||13
10868601|NCT03317496|12033957|FG002|NOT COMPLETED|Phase 1b Lead-in: Treatment||6
10868602|NCT03317496|12033958|FG003|NOT COMPLETED|Phase 1b Lead-in: Treatment||6
10868603|NCT03317496|12033959|FG004|NOT COMPLETED|Phase 1b Lead-in: Treatment||0
10868604|NCT03317496|12033955|FG000|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|4
10868605|NCT03317496|12033956|FG001|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|11
10868606|NCT03317496|12033957|FG002|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|5
10868607|NCT03317496|12033958|FG003|STARTED|Phase 1b Lead-in: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|4
10868608|NCT03317496|12033959|FG004|STARTED|Phase 1b Lead-in: Follow-up||0
10868609|NCT03317496|12033955|FG000|COMPLETED|Phase 1b Lead-in: Follow-up||0
10868610|NCT03317496|12033956|FG001|COMPLETED|Phase 1b Lead-in: Follow-up||0
10868611|NCT03317496|12033957|FG002|COMPLETED|Phase 1b Lead-in: Follow-up||0
10868612|NCT03317496|12033958|FG003|COMPLETED|Phase 1b Lead-in: Follow-up||0
10868613|NCT03317496|12033959|FG004|COMPLETED|Phase 1b Lead-in: Follow-up||0
10868614|NCT03317496|12033955|FG000|NOT COMPLETED|Phase 1b Lead-in: Follow-up||4
10868615|NCT03317496|12033956|FG001|NOT COMPLETED|Phase 1b Lead-in: Follow-up||11
10868616|NCT03317496|12033957|FG002|NOT COMPLETED|Phase 1b Lead-in: Follow-up||5
10868617|NCT03317496|12033958|FG003|NOT COMPLETED|Phase 1b Lead-in: Follow-up||4
10868618|NCT03317496|12033959|FG004|NOT COMPLETED|Phase 1b Lead-in: Follow-up||0
10868619|NCT03317496|12033955|FG000|STARTED|Phase 2: Treatment|Participants of Phase 1b Lead-in: Avelumab 800 mg + Pemetrexed/Carboplatin did not enter Phase 2.|0
10868620|NCT03317496|12033956|FG001|STARTED|Phase 2: Treatment|Participants of Phase 1b Lead-in: Avelumab 800 mg + Gemcitabine/Cisplatin did not enter Phase 2.|0
10868621|NCT03317496|12033957|FG002|STARTED|Phase 2: Treatment|Participants of Phase 1b Lead-in: Avelumab 1200 mg + Pemetrexed/Carboplatin did not enter Phase 2.|0
10868622|NCT03317496|12033958|FG003|STARTED|Phase 2: Treatment|Participants of Phase 1b Lead-in: Avelumab 1200 mg + Gemcitabine/Cisplatin did not enter Phase 2.|0
10868623|NCT03317496|12033959|FG004|STARTED|Phase 2: Treatment|Additional participants were enrolled in Phase 2.|35
10868624|NCT03317496|12033955|FG000|COMPLETED|Phase 2: Treatment||0
10868625|NCT03317496|12033956|FG001|COMPLETED|Phase 2: Treatment||0
10868626|NCT03317496|12033957|FG002|COMPLETED|Phase 2: Treatment||0
10868627|NCT03317496|12033958|FG003|COMPLETED|Phase 2: Treatment||0
10868628|NCT03317496|12033959|FG004|COMPLETED|Phase 2: Treatment||0
10868629|NCT03317496|12033955|FG000|NOT COMPLETED|Phase 2: Treatment||0
10868630|NCT03317496|12033956|FG001|NOT COMPLETED|Phase 2: Treatment||0
10868631|NCT03317496|12033957|FG002|NOT COMPLETED|Phase 2: Treatment||0
10868632|NCT03317496|12033958|FG003|NOT COMPLETED|Phase 2: Treatment||0
10868633|NCT03317496|12033959|FG004|NOT COMPLETED|Phase 2: Treatment||35
10868634|NCT03317496|12033955|FG000|STARTED|Phase 2: Follow-up||0
10868635|NCT03317496|12033956|FG001|STARTED|Phase 2: Follow-up||0
10868636|NCT03317496|12033957|FG002|STARTED|Phase 2: Follow-up||0
10868637|NCT03317496|12033958|FG003|STARTED|Phase 2: Follow-up||0
10868638|NCT03317496|12033959|FG004|STARTED|Phase 2: Follow-up|Eligible participants entered follow-up period following discontinuation of study treatment.|25
10868639|NCT03317496|12033955|FG000|COMPLETED|Phase 2: Follow-up||0
10868640|NCT03317496|12033956|FG001|COMPLETED|Phase 2: Follow-up||0
10868641|NCT03317496|12033957|FG002|COMPLETED|Phase 2: Follow-up||0
10868642|NCT03317496|12033958|FG003|COMPLETED|Phase 2: Follow-up||0
10868643|NCT03317496|12033959|FG004|COMPLETED|Phase 2: Follow-up||0
10868644|NCT03317496|12033955|FG000|NOT COMPLETED|Phase 2: Follow-up||0
10868645|NCT03317496|12033956|FG001|NOT COMPLETED|Phase 2: Follow-up||0
10868646|NCT03317496|12033957|FG002|NOT COMPLETED|Phase 2: Follow-up||0
10868647|NCT03317496|12033958|FG003|NOT COMPLETED|Phase 2: Follow-up||0
10868648|NCT03317496|12033959|FG004|NOT COMPLETED|Phase 2: Follow-up||25
11110550|NCT01281137|12295120|FG000|COMPLETED|Baseline Population||25
11110551|NCT01281137|12295121|FG001|COMPLETED|Baseline Population||78
11110552|NCT01281137|12295120|FG000|NOT COMPLETED|Baseline Population||0
11110553|NCT01281137|12295121|FG001|NOT COMPLETED|Baseline Population||1
10868649|NCT03260894|12033972|FG000|STARTED|Overall Study||64
10868650|NCT03260894|12033973|FG001|STARTED|Overall Study||65
10868651|NCT03260894|12033972|FG000|Intention-to-Treat (ITT)|Overall Study||64
10868652|NCT03260894|12033973|FG001|Intention-to-Treat (ITT)|Overall Study||65
10868653|NCT03260894|12033972|FG000|All Subjects as Treated (ASaT)|Overall Study||64
10868654|NCT03260894|12033973|FG001|All Subjects as Treated (ASaT)|Overall Study||63
10868655|NCT03260894|12033972|FG000|COMPLETED|Overall Study||18
10868656|NCT03260894|12033973|FG001|COMPLETED|Overall Study||15
10868657|NCT03260894|12033972|FG000|NOT COMPLETED|Overall Study||46
10868658|NCT03260894|12033973|FG001|NOT COMPLETED|Overall Study||50
10868659|NCT03215810|12033979|FG000|STARTED|Overall Study||20
10868660|NCT03215810|12033979|FG000|COMPLETED|Overall Study||16
10868661|NCT03215810|12033979|FG000|NOT COMPLETED|Overall Study||4
10868662|NCT03123822|12033986|FG000|STARTED|Overall Study||1
10868663|NCT03123822|12033987|FG001|STARTED|Overall Study||1
10868664|NCT03123822|12033988|FG002|STARTED|Overall Study||3
10868665|NCT03123822|12033986|FG000|COMPLETED|Overall Study||1
10868666|NCT03123822|12033987|FG001|COMPLETED|Overall Study||1
10868667|NCT03123822|12033988|FG002|COMPLETED|Overall Study||3
10868668|NCT03123822|12033986|FG000|NOT COMPLETED|Overall Study||0
10868669|NCT03123822|12033987|FG001|NOT COMPLETED|Overall Study||0
10868670|NCT03123822|12033988|FG002|NOT COMPLETED|Overall Study||0
10868683|NCT03053102|12034021|FG000|STARTED|Study Part 1: 28-Day Treatment||10
10868684|NCT03053102|12034021|FG000|Received at Least 1 Dose of Study Drug|Study Part 1: 28-Day Treatment||10
10868685|NCT03053102|12034021|FG000|COMPLETED|Study Part 1: 28-Day Treatment||10
10868686|NCT03053102|12034021|FG000|NOT COMPLETED|Study Part 1: 28-Day Treatment||0
10868687|NCT03053102|12034021|FG000|STARTED|Study Part 2: 84-Day Treatment||10
10868688|NCT03053102|12034021|FG000|COMPLETED|Study Part 2: 84-Day Treatment||8
10868689|NCT03053102|12034021|FG000|NOT COMPLETED|Study Part 2: 84-Day Treatment||2
10868690|NCT02964078|12034026|FG000|STARTED|Overall Study||27
10868691|NCT02964078|12034026|FG000|COMPLETED|Overall Study||27
10868692|NCT02964078|12034026|FG000|NOT COMPLETED|Overall Study||0
11110554|NCT01281137|12295120|FG000|STARTED|Analysis Population (Baseline)||25
11110555|NCT01281137|12295121|FG001|STARTED|Analysis Population (Baseline)||78
11110556|NCT01281137|12295120|FG000|COMPLETED|Analysis Population (Baseline)||21
11110557|NCT01281137|12295121|FG001|COMPLETED|Analysis Population (Baseline)||69
11110558|NCT01281137|12295120|FG000|NOT COMPLETED|Analysis Population (Baseline)||4
11110559|NCT01281137|12295121|FG001|NOT COMPLETED|Analysis Population (Baseline)||9
11110560|NCT01281137|12295120|FG000|STARTED|Analysis Population (9 Months)||21
11110561|NCT01281137|12295121|FG001|STARTED|Analysis Population (9 Months)||69
11110562|NCT01281137|12295120|FG000|COMPLETED|Analysis Population (9 Months)||21
11110563|NCT01281137|12295121|FG001|COMPLETED|Analysis Population (9 Months)||64
10868705|NCT02920476|12034050|FG000|STARTED|Overall Study||4
10868706|NCT02920476|12034050|FG000|COMPLETED|Overall Study||3
10868707|NCT02920476|12034050|FG000|NOT COMPLETED|Overall Study||1
10868708|NCT02875860|12034056|FG000|STARTED|Overall Study||2
10868709|NCT02875860|12034057|FG001|STARTED|Overall Study||3
10868710|NCT02875860|12034056|FG000|COMPLETED|Overall Study||2
10868711|NCT02875860|12034057|FG001|COMPLETED|Overall Study||2
10868712|NCT02875860|12034056|FG000|NOT COMPLETED|Overall Study||0
10868713|NCT02875860|12034057|FG001|NOT COMPLETED|Overall Study||1
10868714|NCT02779855|12034066|FG000|STARTED|Overall Study||4
10868715|NCT02779855|12034067|FG001|STARTED|Overall Study||6
10868716|NCT02779855|12034068|FG002|STARTED|Overall Study||40
10868717|NCT02779855|12034066|FG000|COMPLETED|Overall Study||3
10868718|NCT02779855|12034067|FG001|COMPLETED|Overall Study||6
10868719|NCT02779855|12034068|FG002|COMPLETED|Overall Study||40
10868720|NCT02779855|12034066|FG000|NOT COMPLETED|Overall Study||1
10868721|NCT02779855|12034067|FG001|NOT COMPLETED|Overall Study||0
10868722|NCT02779855|12034068|FG002|NOT COMPLETED|Overall Study||0
10868723|NCT02663271|12034077|FG000|STARTED|Overall Study||9
10868724|NCT02663271|12034077|FG000|COMPLETED|Overall Study||3
10868725|NCT02663271|12034077|FG000|NOT COMPLETED|Overall Study||6
11110564|NCT01281137|12295120|FG000|NOT COMPLETED|Analysis Population (9 Months)||0
11110565|NCT01281137|12295121|FG001|NOT COMPLETED|Analysis Population (9 Months)||5
11110566|NCT01281137|12295120|FG000|STARTED|Analysis Population (10.5 Months)||21
11110567|NCT01281137|12295121|FG001|STARTED|Analysis Population (10.5 Months)||64
11110568|NCT01281137|12295120|FG000|COMPLETED|Analysis Population (10.5 Months)||20
11110569|NCT01281137|12295121|FG001|COMPLETED|Analysis Population (10.5 Months)||64
10868732|NCT02573493|12034094|FG000|STARTED|Overall Study||40
10868733|NCT02573493|12034095|FG001|STARTED|Overall Study||40
10868734|NCT02573493|12034096|FG002|STARTED|Overall Study||15
10868735|NCT02573493|12034097|FG003|STARTED|Overall Study||1
10868736|NCT02573493|12034094|FG000|COMPLETED|Overall Study||40
10868737|NCT02573493|12034095|FG001|COMPLETED|Overall Study||40
10868738|NCT02573493|12034096|FG002|COMPLETED|Overall Study||15
10868739|NCT02573493|12034097|FG003|COMPLETED|Overall Study||0
10868740|NCT02573493|12034094|FG000|NOT COMPLETED|Overall Study||0
10868741|NCT02573493|12034095|FG001|NOT COMPLETED|Overall Study||0
10868742|NCT02573493|12034096|FG002|NOT COMPLETED|Overall Study||0
10868743|NCT02573493|12034097|FG003|NOT COMPLETED|Overall Study||1
10868744|NCT02414607|12034123|FG000|STARTED|Overall Study||11
10868745|NCT02414607|12034124|FG001|STARTED|Overall Study||13
10868746|NCT02414607|12034123|FG000|COMPLETED|Overall Study||9
10868747|NCT02414607|12034124|FG001|COMPLETED|Overall Study||11
10868748|NCT02414607|12034123|FG000|NOT COMPLETED|Overall Study||2
10868749|NCT02414607|12034124|FG001|NOT COMPLETED|Overall Study||2
10868750|NCT02279173|12034130|FG000|STARTED|Overall Study||203
10868751|NCT02279173|12034130|FG000|Received Treatment|Overall Study||203
10868752|NCT02279173|12034130|FG000|Enrolled Under Protocol Supplement|Overall Study||79
10868753|NCT02279173|12034130|FG000|COMPLETED|Overall Study||109
10868754|NCT02279173|12034130|FG000|NOT COMPLETED|Overall Study||94
11110570|NCT01281137|12295120|FG000|NOT COMPLETED|Analysis Population (10.5 Months)||1
11110571|NCT01281137|12295121|FG001|NOT COMPLETED|Analysis Population (10.5 Months)||0
11110572|NCT01281137|12295120|FG000|STARTED|Analysis Population (12 Months)||20
11110573|NCT01281137|12295121|FG001|STARTED|Analysis Population (12 Months)||64
11110574|NCT01281137|12295120|FG000|COMPLETED|Analysis Population (12 Months)||19
11110575|NCT01281137|12295121|FG001|COMPLETED|Analysis Population (12 Months)||62
11110576|NCT01281137|12295120|FG000|NOT COMPLETED|Analysis Population (12 Months)||1
11110577|NCT01281137|12295121|FG001|NOT COMPLETED|Analysis Population (12 Months)||2
11110578|NCT01281189|12295147|FG000|STARTED|Overall Study||468
11110579|NCT01281189|12295148|FG001|STARTED|Overall Study||474
11110580|NCT01281189|12295147|FG000|COMPLETED|Overall Study||321
11110581|NCT01281189|12295148|FG001|COMPLETED|Overall Study||331
11110582|NCT01281189|12295147|FG000|NOT COMPLETED|Overall Study||147
11110583|NCT01281189|12295148|FG001|NOT COMPLETED|Overall Study||143
11110584|NCT01281202|12295156|FG000|STARTED|Overall Study||103
11110585|NCT01281202|12295157|FG001|STARTED|Overall Study||104
11110586|NCT01281202|12295156|FG000|COMPLETED|Overall Study||75
11110587|NCT01281202|12295157|FG001|COMPLETED|Overall Study||68
11110588|NCT01281202|12295156|FG000|NOT COMPLETED|Overall Study||28
11110589|NCT01281202|12295157|FG001|NOT COMPLETED|Overall Study||36
11110590|NCT01281306|12295172|FG000|STARTED|Overall Study||144
11110591|NCT01281306|12295173|FG001|STARTED|Overall Study||145
11110592|NCT01281306|12295174|FG002|STARTED|Overall Study||141
11110593|NCT01281306|12295175|FG003|STARTED|Overall Study||134
11110594|NCT01281306|12295176|FG004|STARTED|Overall Study||143
11110595|NCT01281306|12295177|FG005|STARTED|Overall Study||142
11110596|NCT01281306|12295178|FG006|STARTED|Overall Study||58
11110597|NCT01281306|12295172|FG000|Full Analysis Set|Overall Study||143
11110598|NCT01281306|12295173|FG001|Full Analysis Set|Overall Study||145
11110599|NCT01281306|12295174|FG002|Full Analysis Set|Overall Study||141
11110600|NCT01281306|12295175|FG003|Full Analysis Set|Overall Study||133
11110601|NCT01281306|12295176|FG004|Full Analysis Set|Overall Study||143
11110602|NCT01281306|12295177|FG005|Full Analysis Set|Overall Study||142
11110603|NCT01281306|12295178|FG006|Full Analysis Set|Overall Study||58
11110604|NCT01281306|12295172|FG000|Safety Set|Overall Study||143
11110605|NCT01281306|12295173|FG001|Safety Set|Overall Study||145
11110606|NCT01281306|12295174|FG002|Safety Set|Overall Study||141
11110607|NCT01281306|12295175|FG003|Safety Set|Overall Study||133
11110608|NCT01281306|12295176|FG004|Safety Set|Overall Study||143
11110609|NCT01281306|12295177|FG005|Safety Set|Overall Study||142
11110610|NCT01281306|12295178|FG006|Safety Set|Overall Study||58
11110611|NCT01281306|12295172|FG000|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
11110612|NCT01281306|12295173|FG001|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
11110613|NCT01281306|12295174|FG002|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
11229425|NCT02015676|12421568|FG000|COMPLETED|Overall Study||6
11229426|NCT02015676|12421569|FG001|COMPLETED|Overall Study||14
11229427|NCT02015676|12421570|FG002|COMPLETED|Overall Study||3
11229428|NCT02015676|12421568|FG000|NOT COMPLETED|Overall Study||9
11229429|NCT02015676|12421569|FG001|NOT COMPLETED|Overall Study||34
11229430|NCT02015676|12421570|FG002|NOT COMPLETED|Overall Study||3
11229431|NCT02015754|12421574|FG000|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
11229432|NCT02015754|12421574|FG000|Completed First TACE|Overall Study||14
11229433|NCT02015754|12421574|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
11110614|NCT01281306|12295175|FG003|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
11110615|NCT01281306|12295176|FG004|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
11110616|NCT01281306|12295177|FG005|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
11110617|NCT01281306|12295178|FG006|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
11110618|NCT01281306|12295172|FG000|COMPLETED|Overall Study||136
11110619|NCT01281306|12295173|FG001|COMPLETED|Overall Study||141
11110620|NCT01281306|12295174|FG002|COMPLETED|Overall Study||133
11110621|NCT01281306|12295175|FG003|COMPLETED|Overall Study||123
11110622|NCT01281306|12295176|FG004|COMPLETED|Overall Study||134
11110623|NCT01281306|12295177|FG005|COMPLETED|Overall Study||135
11110624|NCT01281306|12295178|FG006|COMPLETED|Overall Study||51
11110625|NCT01281306|12295172|FG000|NOT COMPLETED|Overall Study||8
11110626|NCT01281306|12295173|FG001|NOT COMPLETED|Overall Study||4
11110627|NCT01281306|12295174|FG002|NOT COMPLETED|Overall Study||8
11110628|NCT01281306|12295175|FG003|NOT COMPLETED|Overall Study||11
11110629|NCT01281306|12295176|FG004|NOT COMPLETED|Overall Study||9
11110630|NCT01281306|12295177|FG005|NOT COMPLETED|Overall Study||7
11110631|NCT01281306|12295178|FG006|NOT COMPLETED|Overall Study||7
11110632|NCT01281475|12295196|FG000|STARTED|Overall Study||33
11110633|NCT01281475|12295197|FG001|STARTED|Overall Study||34
11110634|NCT01281475|12295196|FG000|COMPLETED|Overall Study||29
11110635|NCT01281475|12295197|FG001|COMPLETED|Overall Study||26
11110636|NCT01281475|12295196|FG000|NOT COMPLETED|Overall Study||4
11110637|NCT01281475|12295197|FG001|NOT COMPLETED|Overall Study||8
11110638|NCT01281501|12295207|FG000|STARTED|Overall Study||44
11110639|NCT01281501|12295208|FG001|STARTED|Overall Study||43
11110640|NCT01281501|12295207|FG000|COMPLETED|Overall Study||44
11110641|NCT01281501|12295208|FG001|COMPLETED|Overall Study||43
11110642|NCT01281501|12295207|FG000|NOT COMPLETED|Overall Study||0
11110643|NCT01281501|12295208|FG001|NOT COMPLETED|Overall Study||0
11110644|NCT01281839|12295216|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
11229434|NCT02015754|12421574|FG000|COMPLETED|Overall Study||3
11229435|NCT02015754|12421574|FG000|NOT COMPLETED|Overall Study||11
11229436|NCT02015793|12421580|FG000|STARTED|Overall Study||15
11110645|NCT01281839|12295217|FG001|STARTED|Overall Study||133
11110646|NCT01281839|12295216|FG000|COMPLETED|Overall Study||250
11110647|NCT01281839|12295217|FG001|COMPLETED|Overall Study||119
11110648|NCT01281839|12295216|FG000|NOT COMPLETED|Overall Study||10
11110649|NCT01281839|12295217|FG001|NOT COMPLETED|Overall Study||14
11110650|NCT01281865|12295225|FG000|STARTED|Overall Study||12
11110651|NCT01281865|12295226|FG001|STARTED|Overall Study||2
11110652|NCT01281865|12295225|FG000|COMPLETED|Overall Study||9
11110653|NCT01281865|12295226|FG001|COMPLETED|Overall Study||1
11110654|NCT01281865|12295225|FG000|NOT COMPLETED|Overall Study||3
11110655|NCT01281865|12295226|FG001|NOT COMPLETED|Overall Study||1
11110656|NCT01281917|12295232|FG000|STARTED|Overall Study||40
11110657|NCT01281917|12295232|FG000|COMPLETED|Overall Study||39
11110658|NCT01281917|12295232|FG000|NOT COMPLETED|Overall Study||1
11110659|NCT01281956|12295236|FG000|STARTED|1st Intervention (3 Months)||5
11110660|NCT01281956|12295237|FG001|STARTED|1st Intervention (3 Months)||5
11110661|NCT01281956|12295236|FG000|COMPLETED|1st Intervention (3 Months)||5
11229437|NCT02015793|12421581|FG001|STARTED|Overall Study||15
11229438|NCT02015793|12421580|FG000|Completed Double-Blind Period|Overall Study||14
11229439|NCT02015793|12421581|FG001|Completed Double-Blind Period|Overall Study||14
11229440|NCT02015793|12421580|FG000|Entered Open-label Extension Period|Overall Study||13
11229441|NCT02015793|12421581|FG001|Entered Open-label Extension Period|Overall Study||14
11229442|NCT02015793|12421580|FG000|COMPLETED|Overall Study||11
11229443|NCT02015793|12421581|FG001|COMPLETED|Overall Study||11
11229444|NCT02015793|12421580|FG000|NOT COMPLETED|Overall Study||4
11229445|NCT02015793|12421581|FG001|NOT COMPLETED|Overall Study||4
11229446|NCT02015819|12421597|FG000|STARTED|Overall Study||3
11229447|NCT02015819|12421598|FG001|STARTED|Overall Study||3
11229448|NCT02015819|12421599|FG002|STARTED|Overall Study||3
11229449|NCT02015819|12421600|FG003|STARTED|Overall Study||7
11229450|NCT02015819|12421597|FG000|COMPLETED|Overall Study||3
11229451|NCT02015819|12421598|FG001|COMPLETED|Overall Study||3
11229452|NCT02015819|12421599|FG002|COMPLETED|Overall Study||3
11229453|NCT02015819|12421600|FG003|COMPLETED|Overall Study||6
11229454|NCT02015819|12421597|FG000|NOT COMPLETED|Overall Study||0
11229455|NCT02015819|12421598|FG001|NOT COMPLETED|Overall Study||0
11229456|NCT02015819|12421599|FG002|NOT COMPLETED|Overall Study||0
11229457|NCT02015819|12421600|FG003|NOT COMPLETED|Overall Study||1
11229458|NCT02016105|12421616|FG000|STARTED|TREATMENT PERIOD 1||231
11229459|NCT02016105|12421617|FG001|STARTED|TREATMENT PERIOD 1||234
11229460|NCT02016105|12421618|FG002|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
11229461|NCT02016105|12421619|FG003|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
11229462|NCT02016105|12421620|FG004|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
11229463|NCT02016105|12421621|FG005|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
11229464|NCT02016105|12421616|FG000|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
11229465|NCT02016105|12421617|FG001|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
11229466|NCT02016105|12421618|FG002|COMPLETED|TREATMENT PERIOD 1||0
11229467|NCT02016105|12421619|FG003|COMPLETED|TREATMENT PERIOD 1||0
11229468|NCT02016105|12421620|FG004|COMPLETED|TREATMENT PERIOD 1||0
11229469|NCT02016105|12421621|FG005|COMPLETED|TREATMENT PERIOD 1||0
11229470|NCT02016105|12421616|FG000|NOT COMPLETED|TREATMENT PERIOD 1||30
11229471|NCT02016105|12421617|FG001|NOT COMPLETED|TREATMENT PERIOD 1||33
11229472|NCT02016105|12421618|FG002|NOT COMPLETED|TREATMENT PERIOD 1||0
11229473|NCT02016105|12421619|FG003|NOT COMPLETED|TREATMENT PERIOD 1||0
11229474|NCT02016105|12421620|FG004|NOT COMPLETED|TREATMENT PERIOD 1||0
11229475|NCT02016105|12421621|FG005|NOT COMPLETED|TREATMENT PERIOD 1||0
11229476|NCT02016105|12421616|FG000|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
11229477|NCT02016105|12421617|FG001|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
11229478|NCT02016105|12421618|FG002|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
11229479|NCT02016105|12421619|FG003|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
11229480|NCT02016105|12421620|FG004|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
11229481|NCT02016105|12421621|FG005|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
11110662|NCT01281956|12295237|FG001|COMPLETED|1st Intervention (3 Months)||5
11110663|NCT01281956|12295236|FG000|NOT COMPLETED|1st Intervention (3 Months)||0
11110664|NCT01281956|12295237|FG001|NOT COMPLETED|1st Intervention (3 Months)||0
11110665|NCT01281956|12295236|FG000|STARTED|2nd Intervention (3 Months)||5
11110666|NCT01281956|12295237|FG001|STARTED|2nd Intervention (3 Months)||5
11110667|NCT01281956|12295236|FG000|COMPLETED|2nd Intervention (3 Months)||4
11110668|NCT01281956|12295237|FG001|COMPLETED|2nd Intervention (3 Months)||5
11110669|NCT01281956|12295236|FG000|NOT COMPLETED|2nd Intervention (3 Months)||1
11110670|NCT01281956|12295237|FG001|NOT COMPLETED|2nd Intervention (3 Months)||0
11110671|NCT01281969|12295248|FG000|STARTED|Overall Study||18
11110672|NCT01281969|12295249|FG001|STARTED|Overall Study||18
11110673|NCT01281969|12295250|FG002|STARTED|Overall Study||12
11110674|NCT01281969|12295248|FG000|COMPLETED|Overall Study||17
11110675|NCT01281969|12295249|FG001|COMPLETED|Overall Study||18
11110676|NCT01281969|12295250|FG002|COMPLETED|Overall Study||0
11110677|NCT01281969|12295248|FG000|NOT COMPLETED|Overall Study||1
11110678|NCT01281969|12295249|FG001|NOT COMPLETED|Overall Study||0
11110679|NCT01281969|12295250|FG002|NOT COMPLETED|Overall Study||12
11110680|NCT01282086|12295258|FG000|STARTED|Overall Study||1365
11110681|NCT01282086|12295258|FG000|COMPLETED|Overall Study||1365
11110682|NCT01282086|12295258|FG000|NOT COMPLETED|Overall Study||0
11110683|NCT01282138|12295265|FG000|STARTED|EEC||6
11110684|NCT01282138|12295266|FG001|STARTED|EEC||7
11110685|NCT01282138|12295265|FG000|COMPLETED|EEC||6
11110686|NCT01282138|12295266|FG001|COMPLETED|EEC||7
11110687|NCT01282138|12295265|FG000|NOT COMPLETED|EEC||0
11110688|NCT01282138|12295266|FG001|NOT COMPLETED|EEC||0
11110689|NCT01282138|12295265|FG000|STARTED|CAPT||6
11110690|NCT01282138|12295266|FG001|STARTED|CAPT||7
11110691|NCT01282138|12295265|FG000|COMPLETED|CAPT||6
11110692|NCT01282138|12295266|FG001|COMPLETED|CAPT||7
11110693|NCT01282138|12295265|FG000|NOT COMPLETED|CAPT||0
11110694|NCT01282138|12295266|FG001|NOT COMPLETED|CAPT||0
11110695|NCT01282164|12295274|FG000|STARTED|Overall Study||29
11110696|NCT01282164|12295275|FG001|STARTED|Overall Study||14
11110697|NCT01282164|12295274|FG000|COMPLETED|Overall Study||28
10868824|NCT01844505|12034175|FG000|STARTED|Overall Study||313
10868825|NCT01844505|12034176|FG001|STARTED|Overall Study||313
10868826|NCT01844505|12034177|FG002|STARTED|Overall Study||311
10868827|NCT01844505|12034175|FG000|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
10868828|NCT01844505|12034176|FG001|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
10868829|NCT01844505|12034177|FG002|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
10868830|NCT01844505|12034175|FG000|NOT COMPLETED|Overall Study||249
10868831|NCT01844505|12034176|FG001|NOT COMPLETED|Overall Study||269
10868832|NCT01844505|12034177|FG002|NOT COMPLETED|Overall Study||295
10868833|NCT01781390|12034188|FG000|STARTED|Overall Study||35
10868834|NCT01781390|12034189|FG001|STARTED|Overall Study||35
10868835|NCT01781390|12034190|FG002|STARTED|Overall Study||36
10868836|NCT01781390|12034188|FG000|COMPLETED|Overall Study||32
10868837|NCT01781390|12034189|FG001|COMPLETED|Overall Study||28
10868838|NCT01781390|12034190|FG002|COMPLETED|Overall Study||32
10868839|NCT01781390|12034188|FG000|NOT COMPLETED|Overall Study||3
10868840|NCT01781390|12034189|FG001|NOT COMPLETED|Overall Study||7
10868841|NCT01781390|12034190|FG002|NOT COMPLETED|Overall Study||4
10868842|NCT01701674|12034198|FG000|STARTED|Overall Study||13
10868843|NCT01701674|12034198|FG000|COMPLETED|Overall Study||12
11110698|NCT01282164|12295275|FG001|COMPLETED|Overall Study||14
11110699|NCT01282164|12295274|FG000|NOT COMPLETED|Overall Study||1
11110700|NCT01282164|12295275|FG001|NOT COMPLETED|Overall Study||0
11110701|NCT01282203|12295289|FG000|STARTED|Overall Study||1122
11110702|NCT01282203|12295289|FG000|COMPLETED|Overall Study||1121
11110703|NCT01282203|12295289|FG000|NOT COMPLETED|Overall Study||1
11110704|NCT01282229|12295296|FG000|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
11110705|NCT01282229|12295296|FG000|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
11110706|NCT01282229|12295296|FG000|NOT COMPLETED|Overall Study||2
10868844|NCT01701674|12034198|FG000|NOT COMPLETED|Overall Study||1
10868845|NCT01575860|12034202|FG000|STARTED|Overall Study||8
10868846|NCT01575860|12034202|FG000|COMPLETED|Overall Study||6
10868847|NCT01575860|12034202|FG000|NOT COMPLETED|Overall Study||2
10868848|NCT01402908|12034209|FG000|STARTED|Overall Study||258
10868849|NCT01402908|12034210|FG001|STARTED|Overall Study||261
10868850|NCT01402908|12034209|FG000|COMPLETED|Overall Study||224
10868851|NCT01402908|12034210|FG001|COMPLETED|Overall Study||243
10868852|NCT01402908|12034209|FG000|NOT COMPLETED|Overall Study||34
10868853|NCT01402908|12034210|FG001|NOT COMPLETED|Overall Study||18
10868854|NCT01397201|12034221|FG000|STARTED|Overall Study||6
10868855|NCT01397201|12034222|FG001|STARTED|Overall Study||6
10868856|NCT01397201|12034223|FG002|STARTED|Overall Study||6
10868857|NCT01397201|12034224|FG003|STARTED|Overall Study||7
10868858|NCT01397201|12034225|FG004|STARTED|Overall Study||5
11229482|NCT02016105|12421616|FG000|COMPLETED|TREATMENT PERIOD 2||0
11229483|NCT02016105|12421617|FG001|COMPLETED|TREATMENT PERIOD 2||0
11229484|NCT02016105|12421618|FG002|COMPLETED|TREATMENT PERIOD 2||57
11229485|NCT02016105|12421619|FG003|COMPLETED|TREATMENT PERIOD 2||116
11229486|NCT02016105|12421620|FG004|COMPLETED|TREATMENT PERIOD 2||59
11229487|NCT02016105|12421621|FG005|COMPLETED|TREATMENT PERIOD 2||112
11229488|NCT02016105|12421616|FG000|NOT COMPLETED|TREATMENT PERIOD 2||0
11229489|NCT02016105|12421617|FG001|NOT COMPLETED|TREATMENT PERIOD 2||0
10868859|NCT01397201|12034221|FG000|Treated|Overall Study||6
10868860|NCT01397201|12034222|FG001|Treated|Overall Study||6
10868861|NCT01397201|12034223|FG002|Treated|Overall Study||5
11110707|NCT01282242|12295316|FG000|STARTED|Overall Study||80
11110708|NCT01282242|12295317|FG001|STARTED|Overall Study||8
11110709|NCT01282242|12295316|FG000|COMPLETED|Overall Study||80
11110710|NCT01282242|12295317|FG001|COMPLETED|Overall Study||8
11110711|NCT01282242|12295316|FG000|NOT COMPLETED|Overall Study||0
11110712|NCT01282242|12295317|FG001|NOT COMPLETED|Overall Study||0
11110713|NCT01282294|12295323|FG000|STARTED|Overall Study||100
10868862|NCT01397201|12034224|FG003|Treated|Overall Study||7
10868863|NCT01397201|12034225|FG004|Treated|Overall Study||5
10868864|NCT01397201|12034221|FG000|COMPLETED|Overall Study||1
10868865|NCT01397201|12034222|FG001|COMPLETED|Overall Study||0
10868866|NCT01397201|12034223|FG002|COMPLETED|Overall Study||0
10868867|NCT01397201|12034224|FG003|COMPLETED|Overall Study||2
10868868|NCT01397201|12034225|FG004|COMPLETED|Overall Study||1
10868869|NCT01397201|12034221|FG000|NOT COMPLETED|Overall Study||5
10868870|NCT01397201|12034222|FG001|NOT COMPLETED|Overall Study||6
11110714|NCT01282294|12295323|FG000|Intra-operative|Overall Study||99
11110715|NCT01282294|12295323|FG000|Post-operative|Overall Study||99
11110716|NCT01282294|12295323|FG000|6 Weeks|Overall Study||95
11110717|NCT01282294|12295323|FG000|3 Months|Overall Study||95
11110718|NCT01282294|12295323|FG000|6 Months|Overall Study||94
11110719|NCT01282294|12295323|FG000|12 Months|Overall Study||86
11110720|NCT01282294|12295323|FG000|COMPLETED|Overall Study||81
11110721|NCT01282294|12295323|FG000|NOT COMPLETED|Overall Study||19
11110722|NCT01282372|12295327|FG000|STARTED|Overall Study||500
11110723|NCT01282372|12295327|FG000|COMPLETED|Overall Study||421
11110724|NCT01282372|12295327|FG000|NOT COMPLETED|Overall Study||79
11110725|NCT01282424|12295338|FG000|STARTED|Treatment Period (TP) (81 Months)||125
11110726|NCT01282424|12295338|FG000|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70
11110727|NCT01282424|12295338|FG000|Completed: Death|Treatment Period (TP) (81 Months)||9
11110728|NCT01282424|12295338|FG000|COMPLETED|Treatment Period (TP) (81 Months)||79
11110729|NCT01282424|12295338|FG000|NOT COMPLETED|Treatment Period (TP) (81 Months)||46
11110730|NCT01282424|12295338|FG000|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84
11110731|NCT01282424|12295338|FG000|COMPLETED|Long-term Follow-up Period (5 Years)||20
11110732|NCT01282424|12295338|FG000|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64
11110733|NCT01282463|12295345|FG000|STARTED|Overall Study||49
11110734|NCT01282463|12295346|FG001|STARTED|Overall Study||49
11110735|NCT01282463|12295347|FG002|STARTED|Overall Study||50
11110736|NCT01282463|12295345|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45
11110737|NCT01282463|12295346|FG001|Received at Least 1 Dose of Study Drug|Overall Study||46
11110738|NCT01282463|12295347|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49
11110739|NCT01282463|12295345|FG000|COMPLETED|Overall Study||41
11110740|NCT01282463|12295346|FG001|COMPLETED|Overall Study||45
11110741|NCT01282463|12295347|FG002|COMPLETED|Overall Study||46
11110742|NCT01282463|12295345|FG000|NOT COMPLETED|Overall Study||8
11110743|NCT01282463|12295346|FG001|NOT COMPLETED|Overall Study||4
11110744|NCT01282463|12295347|FG002|NOT COMPLETED|Overall Study||4
11110745|NCT01282476|12295363|FG000|STARTED|Overall Study||18
11110746|NCT01282476|12295363|FG000|COMPLETED|Overall Study||7
11110747|NCT01282476|12295363|FG000|NOT COMPLETED|Overall Study||11
11110748|NCT01282710|12295367|FG000|STARTED|Overall Study||20
11110749|NCT01282710|12295367|FG000|COMPLETED|Overall Study||20
11110750|NCT01282710|12295367|FG000|NOT COMPLETED|Overall Study||0
11110751|NCT01282723|12295371|FG000|STARTED|Overall Study||20
11110752|NCT01282723|12295371|FG000|COMPLETED|Overall Study||20
11110753|NCT01282723|12295371|FG000|NOT COMPLETED|Overall Study||0
11110754|NCT01282801|12295377|FG000|STARTED|First Intervention||9
11110755|NCT01282801|12295378|FG001|STARTED|First Intervention||9
11110756|NCT01282801|12295377|FG000|COMPLETED|First Intervention||9
11110757|NCT01282801|12295378|FG001|COMPLETED|First Intervention||9
11110758|NCT01282801|12295377|FG000|NOT COMPLETED|First Intervention||0
11110759|NCT01282801|12295378|FG001|NOT COMPLETED|First Intervention||0
11110760|NCT01282801|12295377|FG000|STARTED|Washout of 7 Days||9
11110761|NCT01282801|12295378|FG001|STARTED|Washout of 7 Days||9
11110762|NCT01282801|12295377|FG000|COMPLETED|Washout of 7 Days||9
11110763|NCT01282801|12295378|FG001|COMPLETED|Washout of 7 Days||9
11110764|NCT01282801|12295377|FG000|NOT COMPLETED|Washout of 7 Days||0
11110765|NCT01282801|12295378|FG001|NOT COMPLETED|Washout of 7 Days||0
11110766|NCT01282801|12295377|FG000|STARTED|Second Intervention||9
11110767|NCT01282801|12295378|FG001|STARTED|Second Intervention||9
11110768|NCT01282801|12295377|FG000|COMPLETED|Second Intervention||9
11110769|NCT01282801|12295378|FG001|COMPLETED|Second Intervention||8
11110770|NCT01282801|12295377|FG000|NOT COMPLETED|Second Intervention||0
11110771|NCT01282801|12295378|FG001|NOT COMPLETED|Second Intervention||1
11110772|NCT01282814|12295386|FG000|STARTED|First Intervention||12
11110773|NCT01282814|12295387|FG001|STARTED|First Intervention||12
11110774|NCT01282814|12295386|FG000|COMPLETED|First Intervention||12
11110775|NCT01282814|12295387|FG001|COMPLETED|First Intervention||9
11110776|NCT01282814|12295386|FG000|NOT COMPLETED|First Intervention||0
10868871|NCT01397201|12034223|FG002|NOT COMPLETED|Overall Study||6
11110777|NCT01282814|12295387|FG001|NOT COMPLETED|First Intervention||3
11110778|NCT01282814|12295386|FG000|STARTED|Washout of 7 Days||12
11110779|NCT01282814|12295387|FG001|STARTED|Washout of 7 Days||9
11110780|NCT01282814|12295386|FG000|COMPLETED|Washout of 7 Days||10
11110781|NCT01282814|12295387|FG001|COMPLETED|Washout of 7 Days||9
11110782|NCT01282814|12295386|FG000|NOT COMPLETED|Washout of 7 Days||2
11110783|NCT01282814|12295387|FG001|NOT COMPLETED|Washout of 7 Days||0
11110784|NCT01282814|12295386|FG000|STARTED|Second Intervention||10
11110785|NCT01282814|12295387|FG001|STARTED|Second Intervention||9
11110786|NCT01282814|12295386|FG000|COMPLETED|Second Intervention||10
11110787|NCT01282814|12295387|FG001|COMPLETED|Second Intervention||9
11110788|NCT01282814|12295386|FG000|NOT COMPLETED|Second Intervention||0
11110789|NCT01282814|12295387|FG001|NOT COMPLETED|Second Intervention||0
11110790|NCT01282866|12295393|FG000|STARTED|Overall Study||35
11229490|NCT02016105|12421618|FG002|NOT COMPLETED|TREATMENT PERIOD 2||6
11229491|NCT02016105|12421619|FG003|NOT COMPLETED|TREATMENT PERIOD 2||11
11229492|NCT02016105|12421620|FG004|NOT COMPLETED|TREATMENT PERIOD 2||4
10868872|NCT01397201|12034224|FG003|NOT COMPLETED|Overall Study||5
10868873|NCT01397201|12034225|FG004|NOT COMPLETED|Overall Study||4
10868874|NCT01397162|12034242|FG000|STARTED|Overall Study||8
10868875|NCT01397162|12034243|FG001|STARTED|Overall Study||5
10868876|NCT01397162|12034244|FG002|STARTED|Overall Study||4
10868877|NCT01397162|12034245|FG003|STARTED|Overall Study||6
10868878|NCT01397162|12034246|FG004|STARTED|Overall Study||6
10868879|NCT01397162|12034242|FG000|COMPLETED|Overall Study||1
10868880|NCT01397162|12034243|FG001|COMPLETED|Overall Study||1
10868881|NCT01397162|12034244|FG002|COMPLETED|Overall Study||1
10868882|NCT01397162|12034245|FG003|COMPLETED|Overall Study||1
10868883|NCT01397162|12034246|FG004|COMPLETED|Overall Study||3
10868884|NCT01397162|12034242|FG000|NOT COMPLETED|Overall Study||7
10868885|NCT01397162|12034243|FG001|NOT COMPLETED|Overall Study||4
10868886|NCT01397162|12034244|FG002|NOT COMPLETED|Overall Study||3
10868887|NCT01397162|12034245|FG003|NOT COMPLETED|Overall Study||5
10868888|NCT01397162|12034246|FG004|NOT COMPLETED|Overall Study||3
10868889|NCT01396278|12034268|FG000|STARTED|Overall Study||2
10868890|NCT01396278|12034269|FG001|STARTED|Overall Study||2
10868891|NCT01396278|12034270|FG002|STARTED|Overall Study||1
10868892|NCT01396278|12034271|FG003|STARTED|Overall Study||2
10868893|NCT01396278|12034272|FG004|STARTED|Overall Study||2
10868894|NCT01396278|12034268|FG000|COMPLETED|Overall Study||0
10868895|NCT01396278|12034269|FG001|COMPLETED|Overall Study||1
10868896|NCT01396278|12034270|FG002|COMPLETED|Overall Study||0
10868897|NCT01396278|12034271|FG003|COMPLETED|Overall Study||0
10868898|NCT01396278|12034272|FG004|COMPLETED|Overall Study||0
10868899|NCT01396278|12034268|FG000|NOT COMPLETED|Overall Study||2
10868900|NCT01396278|12034269|FG001|NOT COMPLETED|Overall Study||1
10868901|NCT01396278|12034270|FG002|NOT COMPLETED|Overall Study||1
10868902|NCT01396278|12034271|FG003|NOT COMPLETED|Overall Study||2
10868903|NCT01396278|12034272|FG004|NOT COMPLETED|Overall Study||2
10868904|NCT00783367|12034286|FG000|STARTED|Overall Study||27
10868905|NCT00783367|12034287|FG001|STARTED|Overall Study||23
10868906|NCT00783367|12034286|FG000|COMPLETED|Overall Study||27
10868907|NCT00783367|12034287|FG001|COMPLETED|Overall Study||23
10868908|NCT00783367|12034286|FG000|NOT COMPLETED|Overall Study||0
10868909|NCT00783367|12034287|FG001|NOT COMPLETED|Overall Study||0
10868910|NCT00247728|12034296|FG000|STARTED|Overall Study||58
11229493|NCT02016105|12421621|FG005|NOT COMPLETED|TREATMENT PERIOD 2||14
11229494|NCT02016105|12421616|FG000|STARTED|EXTENSION PERIOD||0
11229495|NCT02016105|12421617|FG001|STARTED|EXTENSION PERIOD||0
11229496|NCT02016105|12421618|FG002|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
11229497|NCT02016105|12421619|FG003|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
11229498|NCT02016105|12421620|FG004|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
11229499|NCT02016105|12421621|FG005|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
11229500|NCT02016105|12421616|FG000|COMPLETED|EXTENSION PERIOD||0
11229501|NCT02016105|12421617|FG001|COMPLETED|EXTENSION PERIOD||0
11229502|NCT02016105|12421618|FG002|COMPLETED|EXTENSION PERIOD||47
11229503|NCT02016105|12421619|FG003|COMPLETED|EXTENSION PERIOD||104
11229504|NCT02016105|12421620|FG004|COMPLETED|EXTENSION PERIOD||50
11229505|NCT02016105|12421621|FG005|COMPLETED|EXTENSION PERIOD||100
11229506|NCT02016105|12421616|FG000|NOT COMPLETED|EXTENSION PERIOD||0
11229507|NCT02016105|12421617|FG001|NOT COMPLETED|EXTENSION PERIOD||0
11229508|NCT02016105|12421618|FG002|NOT COMPLETED|EXTENSION PERIOD||5
11229509|NCT02016105|12421619|FG003|NOT COMPLETED|EXTENSION PERIOD||5
11229510|NCT02016105|12421620|FG004|NOT COMPLETED|EXTENSION PERIOD||6
11229511|NCT02016105|12421621|FG005|NOT COMPLETED|EXTENSION PERIOD||6
11229512|NCT02016170|12421638|FG000|STARTED|Overall Study||27
11229513|NCT02016170|12421639|FG001|STARTED|Overall Study||28
11229514|NCT02016170|12421640|FG002|STARTED|Overall Study||27
11229515|NCT02016170|12421638|FG000|COMPLETED|Overall Study||25
11229516|NCT02016170|12421639|FG001|COMPLETED|Overall Study||27
11229517|NCT02016170|12421640|FG002|COMPLETED|Overall Study||27
11229518|NCT02016170|12421638|FG000|NOT COMPLETED|Overall Study||2
11229519|NCT02016170|12421639|FG001|NOT COMPLETED|Overall Study||1
11229520|NCT02016170|12421640|FG002|NOT COMPLETED|Overall Study||0
11229521|NCT02016183|12421647|FG000|STARTED|Overall Study||3222
11229522|NCT02016183|12421647|FG000|COMPLETED|Overall Study||3157
11229523|NCT02016183|12421647|FG000|NOT COMPLETED|Overall Study||65
11229524|NCT02016235|12421654|FG000|STARTED|Overall Study||10
11229525|NCT02016235|12421655|FG001|STARTED|Overall Study||10
10868911|NCT00247728|12034297|FG001|STARTED|Overall Study||57
10868912|NCT00247728|12034298|FG002|STARTED|Overall Study||57
10868913|NCT00247728|12034296|FG000|COMPLETED|Overall Study||55
10868914|NCT00247728|12034297|FG001|COMPLETED|Overall Study||51
10868915|NCT00247728|12034298|FG002|COMPLETED|Overall Study||43
10868916|NCT00247728|12034296|FG000|NOT COMPLETED|Overall Study||3
10868917|NCT00247728|12034297|FG001|NOT COMPLETED|Overall Study||6
10868918|NCT00247728|12034298|FG002|NOT COMPLETED|Overall Study||14
11229526|NCT02016235|12421656|FG002|STARTED|Overall Study||10
11229527|NCT02016235|12421654|FG000|COMPLETED|Overall Study||10
11229528|NCT02016235|12421655|FG001|COMPLETED|Overall Study||10
11229529|NCT02016235|12421656|FG002|COMPLETED|Overall Study||10
11229530|NCT02016235|12421654|FG000|NOT COMPLETED|Overall Study||0
10868919|NCT00130442|12034310|FG000|STARTED|Overall Study||66
10868920|NCT00130442|12034311|FG001|STARTED|Overall Study||68
10868921|NCT00130442|12034310|FG000|COMPLETED|Overall Study||65
10868922|NCT00130442|12034311|FG001|COMPLETED|Overall Study||66
10868923|NCT00130442|12034310|FG000|NOT COMPLETED|Overall Study||1
10868924|NCT00130442|12034311|FG001|NOT COMPLETED|Overall Study||2
11110791|NCT01282866|12295393|FG000|COMPLETED|Overall Study||34
11110792|NCT01282866|12295393|FG000|NOT COMPLETED|Overall Study||1
11110793|NCT01283009|12295399|FG000|STARTED|Overall Study||287
11110794|NCT01283009|12295400|FG001|STARTED|Overall Study||297
11110795|NCT01283009|12295399|FG000|COMPLETED|Overall Study||169
11110796|NCT01283009|12295400|FG001|COMPLETED|Overall Study||180
11110797|NCT01283009|12295399|FG000|NOT COMPLETED|Overall Study||118
11110798|NCT01283009|12295400|FG001|NOT COMPLETED|Overall Study||117
11110799|NCT01283022|12295406|FG000|STARTED|Overall Study||24
11110800|NCT01283022|12295406|FG000|COMPLETED|Overall Study||24
11110801|NCT01283022|12295406|FG000|NOT COMPLETED|Overall Study||0
11110802|NCT01283035|12295411|FG000|STARTED|Overall Study||6
11110803|NCT01283035|12295411|FG000|COMPLETED|Overall Study||5
11110804|NCT01283035|12295411|FG000|NOT COMPLETED|Overall Study||1
11110805|NCT01283139|12295419|FG000|STARTED|Overall Study||108
11110806|NCT01283139|12295420|FG001|STARTED|Overall Study||108
11110807|NCT01283139|12295421|FG002|STARTED|Overall Study||109
11110808|NCT01283139|12295422|FG003|STARTED|Overall Study||107
11110809|NCT01283139|12295419|FG000|COMPLETED|Overall Study||91
11110810|NCT01283139|12295420|FG001|COMPLETED|Overall Study||90
11110811|NCT01283139|12295421|FG002|COMPLETED|Overall Study||91
11110812|NCT01283139|12295422|FG003|COMPLETED|Overall Study||92
11110813|NCT01283139|12295419|FG000|NOT COMPLETED|Overall Study||17
11110814|NCT01283139|12295420|FG001|NOT COMPLETED|Overall Study||18
11110815|NCT01283139|12295421|FG002|NOT COMPLETED|Overall Study||18
11110816|NCT01283139|12295422|FG003|NOT COMPLETED|Overall Study||15
11110817|NCT01283152|12295434|FG000|STARTED|Overall Study||25
11110818|NCT01283152|12295435|FG001|STARTED|Overall Study||25
11110819|NCT01283152|12295434|FG000|ITT Population|Overall Study||25
11110820|NCT01283152|12295435|FG001|ITT Population|Overall Study||25
11229531|NCT02016235|12421655|FG001|NOT COMPLETED|Overall Study||0
11229532|NCT02016235|12421656|FG002|NOT COMPLETED|Overall Study||0
11229533|NCT02016300|12421666|FG000|STARTED|Overall Study||12
11229534|NCT02016300|12421667|FG001|STARTED|Overall Study||12
11229535|NCT02016300|12421666|FG000|COMPLETED|Overall Study||12
11229536|NCT02016300|12421667|FG001|COMPLETED|Overall Study||9
11229537|NCT02016300|12421666|FG000|NOT COMPLETED|Overall Study||0
11229538|NCT02016300|12421667|FG001|NOT COMPLETED|Overall Study||3
11229539|NCT02016482|12421675|FG000|STARTED|Period A||108
11229540|NCT02016482|12421676|FG001|STARTED|Period A||109
11229541|NCT02016482|12421675|FG000|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
11229542|NCT02016482|12421676|FG001|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
11229543|NCT02016482|12421675|FG000|NOT COMPLETED|Period A||14
11229544|NCT02016482|12421676|FG001|NOT COMPLETED|Period A||15
11229545|NCT02016482|12421675|FG000|STARTED|Period B||94
11229546|NCT02016482|12421676|FG001|STARTED|Period B||94
11229547|NCT02016482|12421675|FG000|COMPLETED|Period B||81
11229548|NCT02016482|12421676|FG001|COMPLETED|Period B||87
11229549|NCT02016482|12421675|FG000|NOT COMPLETED|Period B||13
11229550|NCT02016482|12421676|FG001|NOT COMPLETED|Period B||7
11229551|NCT02016560|12421690|FG000|STARTED|Exploratory Phase||16
11229552|NCT02016560|12421691|FG001|STARTED|Exploratory Phase||58
11229553|NCT02016560|12421692|FG002|STARTED|Exploratory Phase||98
11229554|NCT02016560|12421693|FG003|STARTED|Exploratory Phase||51
11229555|NCT02016560|12421694|FG004|STARTED|Exploratory Phase||0
11229556|NCT02016560|12421695|FG005|STARTED|Exploratory Phase||0
11229557|NCT02016560|12421690|FG000|COMPLETED|Exploratory Phase||16
11229558|NCT02016560|12421691|FG001|COMPLETED|Exploratory Phase||54
11110821|NCT01283152|12295434|FG000|Study Treatment Received|Overall Study||25
11110822|NCT01283152|12295435|FG001|Study Treatment Received|Overall Study||25
11110823|NCT01283152|12295434|FG000|24-hr HESA Attempted|Overall Study||25
11229559|NCT02016560|12421692|FG002|COMPLETED|Exploratory Phase||62
11229560|NCT02016560|12421693|FG003|COMPLETED|Exploratory Phase||35
11229561|NCT02016560|12421694|FG004|COMPLETED|Exploratory Phase||0
11229562|NCT02016560|12421695|FG005|COMPLETED|Exploratory Phase||0
11110824|NCT01283152|12295435|FG001|24-hr HESA Attempted|Overall Study||25
11110825|NCT01283152|12295434|FG000|COMPLETED|Overall Study||23
10868925|NCT04539262|12034327|FG000|STARTED|Overall Study||12
10868926|NCT04539262|12034328|FG001|STARTED|Overall Study||13
10868927|NCT04539262|12034329|FG002|STARTED|Overall Study||12
10868928|NCT04539262|12034330|FG003|STARTED|Overall Study||12
10868929|NCT04539262|12034331|FG004|STARTED|Overall Study||12
10868930|NCT04539262|12034332|FG005|STARTED|Overall Study||13
10868931|NCT04539262|12034333|FG006|STARTED|Overall Study||62
10868932|NCT04539262|12034334|FG007|STARTED|Overall Study||20
10868933|NCT04539262|12034327|FG000|COMPLETED|Overall Study||12
10868934|NCT04539262|12034328|FG001|COMPLETED|Overall Study||12
10868935|NCT04539262|12034329|FG002|COMPLETED|Overall Study||11
10868936|NCT04539262|12034330|FG003|COMPLETED|Overall Study||11
10868937|NCT04539262|12034331|FG004|COMPLETED|Overall Study||12
10868938|NCT04539262|12034332|FG005|COMPLETED|Overall Study||13
10868939|NCT04539262|12034333|FG006|COMPLETED|Overall Study||61
10868940|NCT04539262|12034334|FG007|COMPLETED|Overall Study||20
10868941|NCT04539262|12034327|FG000|NOT COMPLETED|Overall Study||0
10868942|NCT04539262|12034328|FG001|NOT COMPLETED|Overall Study||1
10868943|NCT04539262|12034329|FG002|NOT COMPLETED|Overall Study||1
10868944|NCT04539262|12034330|FG003|NOT COMPLETED|Overall Study||1
10868945|NCT04539262|12034331|FG004|NOT COMPLETED|Overall Study||0
10868946|NCT04539262|12034332|FG005|NOT COMPLETED|Overall Study||0
10868947|NCT04539262|12034333|FG006|NOT COMPLETED|Overall Study||1
10868948|NCT04539262|12034334|FG007|NOT COMPLETED|Overall Study||0
10868994|NCT04079881|12034404|FG000|STARTED|Overall Study||1
10868995|NCT04079881|12034405|FG001|STARTED|Overall Study||0
10868996|NCT04079881|12034404|FG000|COMPLETED|Overall Study||1
10868997|NCT04079881|12034405|FG001|COMPLETED|Overall Study||0
10868998|NCT04079881|12034404|FG000|NOT COMPLETED|Overall Study||0
10868999|NCT04079881|12034405|FG001|NOT COMPLETED|Overall Study||0
11110826|NCT01283152|12295435|FG001|COMPLETED|Overall Study||25
11110827|NCT01283152|12295434|FG000|NOT COMPLETED|Overall Study||2
11110828|NCT01283152|12295435|FG001|NOT COMPLETED|Overall Study||0
11110829|NCT01283282|12295441|FG000|STARTED|First Intervention (6 Weeks)||25
11110830|NCT01283282|12295442|FG001|STARTED|First Intervention (6 Weeks)||23
11110831|NCT01283282|12295441|FG000|COMPLETED|First Intervention (6 Weeks)||22
11110832|NCT01283282|12295442|FG001|COMPLETED|First Intervention (6 Weeks)||19
11110833|NCT01283282|12295441|FG000|NOT COMPLETED|First Intervention (6 Weeks)||3
11110834|NCT01283282|12295442|FG001|NOT COMPLETED|First Intervention (6 Weeks)||4
10869010|NCT03868839|12034422|FG000|STARTED|Overall Study||6
10869011|NCT03868839|12034422|FG000|COMPLETED|Overall Study||5
10869012|NCT03868839|12034422|FG000|NOT COMPLETED|Overall Study||1
10869013|NCT03847974|12034426|FG000|STARTED|Overall Study||32
10869014|NCT03847974|12034426|FG000|COMPLETED|Overall Study||26
10869015|NCT03847974|12034426|FG000|NOT COMPLETED|Overall Study||6
10869016|NCT03787095|12034432|FG000|STARTED|Overall Study||4
10869017|NCT03787095|12034433|FG001|STARTED|Overall Study||1
10869018|NCT03787095|12034432|FG000|COMPLETED|Overall Study||4
10869019|NCT03787095|12034433|FG001|COMPLETED|Overall Study|Participant had final visit at study week 7 in accordance with decision from team after the study was closed.|1
10869020|NCT03787095|12034432|FG000|NOT COMPLETED|Overall Study||0
10869021|NCT03787095|12034433|FG001|NOT COMPLETED|Overall Study||0
10869022|NCT03746951|12034442|FG000|STARTED|Overall Study||8
10869023|NCT03746951|12034443|FG001|STARTED|Overall Study||7
10869024|NCT03746951|12034442|FG000|COMPLETED|Overall Study||8
10869025|NCT03746951|12034443|FG001|COMPLETED|Overall Study||7
10869026|NCT03746951|12034442|FG000|NOT COMPLETED|Overall Study||0
10869027|NCT03746951|12034443|FG001|NOT COMPLETED|Overall Study||0
10869028|NCT03685747|12034449|FG000|STARTED|Overall Study||4
10869029|NCT03685747|12034449|FG000|COMPLETED|Overall Study||4
10869030|NCT03685747|12034449|FG000|NOT COMPLETED|Overall Study||0
10869031|NCT03671148|12034455|FG000|STARTED|Overall Study||220
10869032|NCT03671148|12034456|FG001|STARTED|Overall Study||224
10869033|NCT03671148|12034455|FG000|Received Study Drug|Overall Study||219
10869034|NCT03671148|12034456|FG001|Received Study Drug|Overall Study||224
10869035|NCT03671148|12034455|FG000|COMPLETED|Overall Study||199
10869036|NCT03671148|12034456|FG001|COMPLETED|Overall Study||215
10869037|NCT03671148|12034455|FG000|NOT COMPLETED|Overall Study||21
10869038|NCT03671148|12034456|FG001|NOT COMPLETED|Overall Study||9
10869039|NCT03640949|12034464|FG000|STARTED|Overall Study||237
10869040|NCT03640949|12034465|FG001|STARTED|Overall Study||264
10869041|NCT03640949|12034464|FG000|COMPLETED|Overall Study||237
10869042|NCT03640949|12034465|FG001|COMPLETED|Overall Study||264
10869043|NCT03640949|12034464|FG000|NOT COMPLETED|Overall Study||0
10869044|NCT03640949|12034465|FG001|NOT COMPLETED|Overall Study||0
10869045|NCT03615508|12034471|FG000|STARTED|Overall Study||1
10869046|NCT03615508|12034471|FG000|COMPLETED|Overall Study||1
10869047|NCT03615508|12034471|FG000|NOT COMPLETED|Overall Study||0
11110835|NCT01283282|12295441|FG000|STARTED|Second Intervention (6 Weeks)||22
11110836|NCT01283282|12295442|FG001|STARTED|Second Intervention (6 Weeks)||19
11110837|NCT01283282|12295441|FG000|COMPLETED|Second Intervention (6 Weeks)||22
11110838|NCT01283282|12295442|FG001|COMPLETED|Second Intervention (6 Weeks)||19
11110839|NCT01283282|12295441|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
11110840|NCT01283282|12295442|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
11110841|NCT01283321|12295451|FG000|STARTED|Overall Study||10
11110842|NCT01283321|12295452|FG001|STARTED|Overall Study||10
11110843|NCT01283321|12295451|FG000|COMPLETED|Overall Study||10
11110844|NCT01283321|12295452|FG001|COMPLETED|Overall Study||10
11110845|NCT01283321|12295451|FG000|NOT COMPLETED|Overall Study||0
10869060|NCT03586687|12034497|FG000|STARTED|Overall Study||6
10869061|NCT03586687|12034498|FG001|STARTED|Overall Study||9
10868949|NCT04482439|12034355|FG000|STARTED|Overall Study||35
10868950|NCT04482439|12034355|FG000|COMPLETED|Overall Study||33
10868951|NCT04482439|12034355|FG000|NOT COMPLETED|Overall Study||2
10868952|NCT04465162|12034360|FG000|STARTED|Overall Study||73
10868953|NCT04465162|12034360|FG000|COMPLETED|Overall Study||73
10868954|NCT04465162|12034360|FG000|NOT COMPLETED|Overall Study||0
10868955|NCT04404725|12034364|FG000|STARTED|First Intervention||32
10868956|NCT04404725|12034365|FG001|STARTED|First Intervention||31
10868957|NCT04404725|12034364|FG000|COMPLETED|First Intervention||32
10868958|NCT04404725|12034365|FG001|COMPLETED|First Intervention||29
10868959|NCT04404725|12034364|FG000|NOT COMPLETED|First Intervention||0
10868960|NCT04404725|12034365|FG001|NOT COMPLETED|First Intervention||2
10868961|NCT04404725|12034364|FG000|STARTED|Second Intervention||32
10868962|NCT04404725|12034365|FG001|STARTED|Second Intervention||29
10868963|NCT04404725|12034364|FG000|COMPLETED|Second Intervention||31
10868964|NCT04404725|12034365|FG001|COMPLETED|Second Intervention||27
10868965|NCT04404725|12034364|FG000|NOT COMPLETED|Second Intervention||1
10868966|NCT04404725|12034365|FG001|NOT COMPLETED|Second Intervention||2
10868967|NCT04382586|12034373|FG000|STARTED|Overall Study||30
10868968|NCT04382586|12034374|FG001|STARTED|Overall Study||33
10868969|NCT04382586|12034373|FG000|COMPLETED|Overall Study||13
10868970|NCT04382586|12034374|FG001|COMPLETED|Overall Study||17
10868971|NCT04382586|12034373|FG000|NOT COMPLETED|Overall Study||17
10868972|NCT04382586|12034374|FG001|NOT COMPLETED|Overall Study||16
10868973|NCT04348656|12034382|FG000|STARTED|Overall Study||627
10868974|NCT04348656|12034383|FG001|STARTED|Overall Study||313
10868975|NCT04348656|12034382|FG000|Baseline Population|Overall Study||625
10868976|NCT04348656|12034383|FG001|Baseline Population|Overall Study||313
10868977|NCT04348656|12034382|FG000|Intention to Treat Analysis|Overall Study||614
10868978|NCT04348656|12034383|FG001|Intention to Treat Analysis|Overall Study||307
10868979|NCT04348656|12034382|FG000|Per Protocol Analysis|Overall Study||548
10868980|NCT04348656|12034383|FG001|Per Protocol Analysis|Overall Study||303
10868981|NCT04348656|12034382|FG000|COMPLETED|Overall Study||614
10868982|NCT04348656|12034383|FG001|COMPLETED|Overall Study||307
10868983|NCT04348656|12034382|FG000|NOT COMPLETED|Overall Study||13
10868984|NCT04348656|12034383|FG001|NOT COMPLETED|Overall Study||6
10868985|NCT04283253|12034389|FG000|STARTED|Overall Study||1
10868986|NCT04283253|12034389|FG000|COMPLETED|Overall Study||1
10868987|NCT04283253|12034389|FG000|NOT COMPLETED|Overall Study||0
10868988|NCT04246541|12034395|FG000|STARTED|Overall Study||25
10868989|NCT04246541|12034396|FG001|STARTED|Overall Study||23
10868990|NCT04246541|12034395|FG000|COMPLETED|Overall Study||22
10868991|NCT04246541|12034396|FG001|COMPLETED|Overall Study||20
10868992|NCT04246541|12034395|FG000|NOT COMPLETED|Overall Study||3
10868993|NCT04246541|12034396|FG001|NOT COMPLETED|Overall Study||3
10869062|NCT03586687|12034499|FG002|STARTED|Overall Study||4
10869063|NCT03586687|12034497|FG000|COMPLETED|Overall Study||6
10869064|NCT03586687|12034498|FG001|COMPLETED|Overall Study||9
10869065|NCT03586687|12034499|FG002|COMPLETED|Overall Study||4
10869066|NCT03586687|12034497|FG000|NOT COMPLETED|Overall Study||0
10869067|NCT03586687|12034498|FG001|NOT COMPLETED|Overall Study||0
10869068|NCT03586687|12034499|FG002|NOT COMPLETED|Overall Study||0
10869069|NCT03529773|12034547|FG000|STARTED|Overall Study||12
10869070|NCT03529773|12034548|FG001|STARTED|Overall Study||12
10869071|NCT03529773|12034549|FG002|STARTED|Overall Study||12
10869072|NCT03529773|12034550|FG003|STARTED|Overall Study||12
10869073|NCT03529773|12034551|FG004|STARTED|Overall Study||12
10869074|NCT03529773|12034552|FG005|STARTED|Overall Study||12
10869075|NCT03529773|12034553|FG006|STARTED|Overall Study||12
10869076|NCT03529773|12034554|FG007|STARTED|Overall Study||12
10869077|NCT03529773|12034555|FG008|STARTED|Overall Study||12
10869078|NCT03529773|12034556|FG009|STARTED|Overall Study||12
10869079|NCT03529773|12034557|FG010|STARTED|Overall Study||12
10869080|NCT03529773|12034558|FG011|STARTED|Overall Study||12
10869081|NCT03529773|12034559|FG012|STARTED|Overall Study||12
10869082|NCT03529773|12034560|FG013|STARTED|Overall Study||12
10869083|NCT03529773|12034561|FG014|STARTED|Overall Study||41
10869084|NCT03529773|12034562|FG015|STARTED|Overall Study||42
10869085|NCT03529773|12034563|FG016|STARTED|Overall Study||41
10869086|NCT03529773|12034564|FG017|STARTED|Overall Study||41
10869087|NCT03529773|12034565|FG018|STARTED|Overall Study||41
10869088|NCT03529773|12034566|FG019|STARTED|Overall Study||41
10869089|NCT03529773|12034567|FG020|STARTED|Overall Study||41
10869090|NCT03529773|12034568|FG021|STARTED|Overall Study||41
10869091|NCT03529773|12034569|FG022|STARTED|Overall Study||41
10869092|NCT03529773|12034570|FG023|STARTED|Overall Study||41
10869093|NCT03529773|12034571|FG024|STARTED|Overall Study||41
10869094|NCT03529773|12034572|FG025|STARTED|Overall Study||41
10869095|NCT03529773|12034573|FG026|STARTED|Overall Study||41
10869096|NCT03529773|12034574|FG027|STARTED|Overall Study||41
10869097|NCT03529773|12034575|FG028|STARTED|Overall Study||41
10869098|NCT03529773|12034576|FG029|STARTED|Overall Study||40
10869099|NCT03529773|12034577|FG030|STARTED|Overall Study||42
10869100|NCT03529773|12034578|FG031|STARTED|Overall Study||40
10869101|NCT03529773|12034579|FG032|STARTED|Overall Study||40
10869102|NCT03529773|12034580|FG033|STARTED|Overall Study||41
10869103|NCT03529773|12034581|FG034|STARTED|Overall Study||41
10869104|NCT03529773|12034582|FG035|STARTED|Overall Study||40
10869105|NCT03529773|12034583|FG036|STARTED|Overall Study||41
10869106|NCT03529773|12034584|FG037|STARTED|Overall Study||42
10869107|NCT03529773|12034585|FG038|STARTED|Overall Study||43
10869108|NCT03529773|12034586|FG039|STARTED|Overall Study||41
10869109|NCT03529773|12034547|FG000|COMPLETED|Overall Study||12
10869110|NCT03529773|12034548|FG001|COMPLETED|Overall Study||12
10869111|NCT03529773|12034549|FG002|COMPLETED|Overall Study||11
10869112|NCT03529773|12034550|FG003|COMPLETED|Overall Study||12
10869113|NCT03529773|12034551|FG004|COMPLETED|Overall Study||11
10869114|NCT03529773|12034552|FG005|COMPLETED|Overall Study||11
10869115|NCT03529773|12034553|FG006|COMPLETED|Overall Study||12
10869116|NCT03529773|12034554|FG007|COMPLETED|Overall Study||11
10869117|NCT03529773|12034555|FG008|COMPLETED|Overall Study||12
10869118|NCT03529773|12034556|FG009|COMPLETED|Overall Study||11
10869119|NCT03529773|12034557|FG010|COMPLETED|Overall Study||11
10869120|NCT03529773|12034558|FG011|COMPLETED|Overall Study||12
10869121|NCT03529773|12034559|FG012|COMPLETED|Overall Study||10
10869122|NCT03529773|12034560|FG013|COMPLETED|Overall Study||11
10869123|NCT03529773|12034561|FG014|COMPLETED|Overall Study||35
10869124|NCT03529773|12034562|FG015|COMPLETED|Overall Study||38
10869125|NCT03529773|12034563|FG016|COMPLETED|Overall Study||40
10869126|NCT03529773|12034564|FG017|COMPLETED|Overall Study||35
10869127|NCT03529773|12034565|FG018|COMPLETED|Overall Study||37
10869128|NCT03529773|12034566|FG019|COMPLETED|Overall Study||37
10869129|NCT03529773|12034567|FG020|COMPLETED|Overall Study||34
10869130|NCT03529773|12034568|FG021|COMPLETED|Overall Study||36
10869131|NCT03529773|12034569|FG022|COMPLETED|Overall Study||34
10869132|NCT03529773|12034570|FG023|COMPLETED|Overall Study||35
10869133|NCT03529773|12034571|FG024|COMPLETED|Overall Study||33
10869134|NCT03529773|12034572|FG025|COMPLETED|Overall Study||30
10869135|NCT03529773|12034573|FG026|COMPLETED|Overall Study||32
10869136|NCT03529773|12034574|FG027|COMPLETED|Overall Study||39
10869137|NCT03529773|12034575|FG028|COMPLETED|Overall Study||40
10869138|NCT03529773|12034576|FG029|COMPLETED|Overall Study||40
10869139|NCT03529773|12034577|FG030|COMPLETED|Overall Study||39
10869140|NCT03529773|12034578|FG031|COMPLETED|Overall Study||40
10869141|NCT03529773|12034579|FG032|COMPLETED|Overall Study||40
10869142|NCT03529773|12034580|FG033|COMPLETED|Overall Study||39
10869143|NCT03529773|12034581|FG034|COMPLETED|Overall Study||37
10869144|NCT03529773|12034582|FG035|COMPLETED|Overall Study||36
10869145|NCT03529773|12034583|FG036|COMPLETED|Overall Study||39
10869146|NCT03529773|12034584|FG037|COMPLETED|Overall Study||36
10869147|NCT03529773|12034585|FG038|COMPLETED|Overall Study||39
10869148|NCT03529773|12034586|FG039|COMPLETED|Overall Study||37
10869149|NCT03529773|12034547|FG000|NOT COMPLETED|Overall Study||0
10869150|NCT03529773|12034548|FG001|NOT COMPLETED|Overall Study||0
10869151|NCT03529773|12034549|FG002|NOT COMPLETED|Overall Study||1
10869152|NCT03529773|12034550|FG003|NOT COMPLETED|Overall Study||0
10869153|NCT03529773|12034551|FG004|NOT COMPLETED|Overall Study||1
10869154|NCT03529773|12034552|FG005|NOT COMPLETED|Overall Study||1
10869155|NCT03529773|12034553|FG006|NOT COMPLETED|Overall Study||0
10869156|NCT03529773|12034554|FG007|NOT COMPLETED|Overall Study||1
10869157|NCT03529773|12034555|FG008|NOT COMPLETED|Overall Study||0
10869158|NCT03529773|12034556|FG009|NOT COMPLETED|Overall Study||1
10869159|NCT03529773|12034557|FG010|NOT COMPLETED|Overall Study||1
10869160|NCT03529773|12034558|FG011|NOT COMPLETED|Overall Study||0
10869161|NCT03529773|12034559|FG012|NOT COMPLETED|Overall Study||2
10869162|NCT03529773|12034560|FG013|NOT COMPLETED|Overall Study||1
10869163|NCT03529773|12034561|FG014|NOT COMPLETED|Overall Study||6
10869164|NCT03529773|12034562|FG015|NOT COMPLETED|Overall Study||4
10869165|NCT03529773|12034563|FG016|NOT COMPLETED|Overall Study||1
10869166|NCT03529773|12034564|FG017|NOT COMPLETED|Overall Study||6
10869167|NCT03529773|12034565|FG018|NOT COMPLETED|Overall Study||4
10869168|NCT03529773|12034566|FG019|NOT COMPLETED|Overall Study||4
10869169|NCT03529773|12034567|FG020|NOT COMPLETED|Overall Study||7
10869170|NCT03529773|12034568|FG021|NOT COMPLETED|Overall Study||5
10869171|NCT03529773|12034569|FG022|NOT COMPLETED|Overall Study||7
10869172|NCT03529773|12034570|FG023|NOT COMPLETED|Overall Study||6
10869173|NCT03529773|12034571|FG024|NOT COMPLETED|Overall Study||8
10869174|NCT03529773|12034572|FG025|NOT COMPLETED|Overall Study||11
10869175|NCT03529773|12034573|FG026|NOT COMPLETED|Overall Study||9
10869176|NCT03529773|12034574|FG027|NOT COMPLETED|Overall Study||2
10869177|NCT03529773|12034575|FG028|NOT COMPLETED|Overall Study||1
10869178|NCT03529773|12034576|FG029|NOT COMPLETED|Overall Study||0
10869179|NCT03529773|12034577|FG030|NOT COMPLETED|Overall Study||3
10869180|NCT03529773|12034578|FG031|NOT COMPLETED|Overall Study||0
10869181|NCT03529773|12034579|FG032|NOT COMPLETED|Overall Study||0
10869182|NCT03529773|12034580|FG033|NOT COMPLETED|Overall Study||2
10869183|NCT03529773|12034581|FG034|NOT COMPLETED|Overall Study||4
10869184|NCT03529773|12034582|FG035|NOT COMPLETED|Overall Study||4
10869185|NCT03529773|12034583|FG036|NOT COMPLETED|Overall Study||2
10869186|NCT03529773|12034584|FG037|NOT COMPLETED|Overall Study||6
10869187|NCT03529773|12034585|FG038|NOT COMPLETED|Overall Study||4
10869188|NCT03529773|12034586|FG039|NOT COMPLETED|Overall Study||4
10869189|NCT03502070|12034689|FG000|STARTED|Overall Study||47
10869190|NCT03502070|12034689|FG000|COMPLETED|Overall Study||45
10869191|NCT03502070|12034689|FG000|NOT COMPLETED|Overall Study||2
10869192|NCT03485911|12034696|FG000|STARTED|Overall Study||41
10869193|NCT03485911|12034697|FG001|STARTED|Overall Study||40
10869194|NCT03485911|12034698|FG002|STARTED|Overall Study||40
10869195|NCT03485911|12034696|FG000|COMPLETED|Overall Study||40
10869196|NCT03485911|12034697|FG001|COMPLETED|Overall Study||38
10869197|NCT03485911|12034698|FG002|COMPLETED|Overall Study||36
10869198|NCT03485911|12034696|FG000|NOT COMPLETED|Overall Study||1
10869199|NCT03485911|12034697|FG001|NOT COMPLETED|Overall Study||2
10869200|NCT03485911|12034698|FG002|NOT COMPLETED|Overall Study||4
10869201|NCT03403634|12034706|FG000|STARTED|Overall Study|19 patients were accrued and completed consent.|19
10869202|NCT03403634|12034706|FG000|Treated|Overall Study|4 patients became ineligible prior to the start of treatment.|15
10869203|NCT03403634|12034706|FG000|COMPLETED|Overall Study||12
10869204|NCT03403634|12034706|FG000|NOT COMPLETED|Overall Study||7
10869205|NCT03382041|12034712|FG000|STARTED|Overall Study||7
10869206|NCT03382041|12034713|FG001|STARTED|Overall Study||13
10869207|NCT03382041|12034712|FG000|COMPLETED|Overall Study||3
10869208|NCT03382041|12034713|FG001|COMPLETED|Overall Study||4
10869209|NCT03382041|12034712|FG000|NOT COMPLETED|Overall Study||4
10869210|NCT03382041|12034713|FG001|NOT COMPLETED|Overall Study||9
10869211|NCT03201419|12034728|FG000|STARTED|Overall Study||60
10869212|NCT03201419|12034729|FG001|STARTED|Overall Study||27
10869213|NCT03201419|12034730|FG002|STARTED|Overall Study||24
10869214|NCT03201419|12034731|FG003|STARTED|Overall Study||14
10869215|NCT03201419|12034732|FG004|STARTED|Overall Study||13
10869216|NCT03201419|12034733|FG005|STARTED|Overall Study||34
10869217|NCT03201419|12034734|FG006|STARTED|Overall Study||87
10869218|NCT03201419|12034735|FG007|STARTED|Overall Study||26
10869219|NCT03201419|12034736|FG008|STARTED|Overall Study||17
10869220|NCT03201419|12034728|FG000|COMPLETED|Overall Study||52
10869221|NCT03201419|12034729|FG001|COMPLETED|Overall Study||24
10869222|NCT03201419|12034730|FG002|COMPLETED|Overall Study||22
10869223|NCT03201419|12034731|FG003|COMPLETED|Overall Study||14
10869224|NCT03201419|12034732|FG004|COMPLETED|Overall Study||12
10869225|NCT03201419|12034733|FG005|COMPLETED|Overall Study||33
10869226|NCT03201419|12034734|FG006|COMPLETED|Overall Study||81
10869227|NCT03201419|12034735|FG007|COMPLETED|Overall Study||25
10869228|NCT03201419|12034736|FG008|COMPLETED|Overall Study||15
10869229|NCT03201419|12034728|FG000|NOT COMPLETED|Overall Study||8
10869230|NCT03201419|12034729|FG001|NOT COMPLETED|Overall Study||3
10869231|NCT03201419|12034730|FG002|NOT COMPLETED|Overall Study||2
10869232|NCT03201419|12034731|FG003|NOT COMPLETED|Overall Study||0
10869233|NCT03201419|12034732|FG004|NOT COMPLETED|Overall Study||1
10869234|NCT03201419|12034733|FG005|NOT COMPLETED|Overall Study||1
10869235|NCT03201419|12034734|FG006|NOT COMPLETED|Overall Study||6
10869236|NCT03201419|12034735|FG007|NOT COMPLETED|Overall Study||1
10869237|NCT03201419|12034736|FG008|NOT COMPLETED|Overall Study||2
10869238|NCT03197766|12034772|FG000|STARTED|Overall Study||60
10869239|NCT03197766|12034773|FG001|STARTED|Overall Study||61
10869240|NCT03197766|12034772|FG000|COMPLETED|Overall Study||58
10869241|NCT03197766|12034773|FG001|COMPLETED|Overall Study||61
10869242|NCT03197766|12034772|FG000|NOT COMPLETED|Overall Study||2
10869243|NCT03197766|12034773|FG001|NOT COMPLETED|Overall Study||0
10869244|NCT05143801|12034779|FG000|STARTED|Overall Study||10
10869245|NCT05143801|12034779|FG000|COMPLETED|Overall Study||10
10869246|NCT05143801|12034779|FG000|NOT COMPLETED|Overall Study||0
10869247|NCT04516759|12034791|FG000|STARTED|Overall Study|excluding 2 subjects who were randomized but did not start treatment|80
10869248|NCT04516759|12034792|FG001|STARTED|Overall Study|excluding 1 subject who was randomized but did not start treatment|73
10869249|NCT04516759|12034791|FG000|COMPLETED|Overall Study||79
10869250|NCT04516759|12034792|FG001|COMPLETED|Overall Study||71
10869251|NCT04516759|12034791|FG000|NOT COMPLETED|Overall Study||1
10869252|NCT04516759|12034792|FG001|NOT COMPLETED|Overall Study||2
10869253|NCT03930446|12034800|FG000|STARTED|Overall Study||40
10869254|NCT03930446|12034801|FG001|STARTED|Overall Study||40
10869255|NCT03930446|12034800|FG000|COMPLETED|Overall Study||40
10869256|NCT03930446|12034801|FG001|COMPLETED|Overall Study||40
10869257|NCT03930446|12034800|FG000|NOT COMPLETED|Overall Study||0
10869258|NCT03930446|12034801|FG001|NOT COMPLETED|Overall Study||0
10869259|NCT03492099|12034807|FG000|STARTED|Overall Study||47
10869260|NCT03492099|12034807|FG000|COMPLETED|Overall Study||43
10869261|NCT03492099|12034807|FG000|NOT COMPLETED|Overall Study||4
10869262|NCT03409276|12034817|FG000|STARTED|Overall Study||2
10869263|NCT03409276|12034818|FG001|STARTED|Overall Study||10
10869264|NCT03409276|12034819|FG002|STARTED|Overall Study||6
10869265|NCT03409276|12034820|FG003|STARTED|Overall Study||21
10869266|NCT03409276|12034821|FG004|STARTED|Overall Study||21
10869267|NCT03409276|12034817|FG000|Month 2.5 Immunogenicity Cohort|Overall Study||2
10869268|NCT03409276|12034818|FG001|Month 2.5 Immunogenicity Cohort|Overall Study||10
10869269|NCT03409276|12034819|FG002|Month 2.5 Immunogenicity Cohort|Overall Study||0
10869270|NCT03409276|12034820|FG003|Month 2.5 Immunogenicity Cohort|Overall Study||0
10869271|NCT03409276|12034821|FG004|Month 2.5 Immunogenicity Cohort|Overall Study||0
10869272|NCT03409276|12034817|FG000|Month 8.5 Immunogenicity Cohort|Overall Study||0
10869273|NCT03409276|12034818|FG001|Month 8.5 Immunogenicity Cohort|Overall Study||0
10869274|NCT03409276|12034819|FG002|Month 8.5 Immunogenicity Cohort|Overall Study||6
10869275|NCT03409276|12034820|FG003|Month 8.5 Immunogenicity Cohort|Overall Study||19
10869276|NCT03409276|12034821|FG004|Month 8.5 Immunogenicity Cohort|Overall Study||16
10869277|NCT03409276|12034817|FG000|COMPLETED|Overall Study||2
10869278|NCT03409276|12034818|FG001|COMPLETED|Overall Study||10
10869279|NCT03409276|12034819|FG002|COMPLETED|Overall Study||6
11229563|NCT02016560|12421690|FG000|NOT COMPLETED|Exploratory Phase||0
10869280|NCT03409276|12034820|FG003|COMPLETED|Overall Study||19
10869281|NCT03409276|12034821|FG004|COMPLETED|Overall Study||18
10869282|NCT03409276|12034817|FG000|NOT COMPLETED|Overall Study||0
10869283|NCT03409276|12034818|FG001|NOT COMPLETED|Overall Study||0
10869284|NCT03409276|12034819|FG002|NOT COMPLETED|Overall Study||0
10869285|NCT03409276|12034820|FG003|NOT COMPLETED|Overall Study||2
10869286|NCT03409276|12034821|FG004|NOT COMPLETED|Overall Study||3
10869287|NCT03312907|12034840|FG000|STARTED|Overall Study||72
10869288|NCT03312907|12034841|FG001|STARTED|Overall Study||144
10869289|NCT03312907|12034842|FG002|STARTED|Overall Study||76
10869290|NCT03312907|12034840|FG000|COMPLETED|Overall Study||55
10869291|NCT03312907|12034841|FG001|COMPLETED|Overall Study||114
10869292|NCT03312907|12034842|FG002|COMPLETED|Overall Study||57
10869293|NCT03312907|12034840|FG000|NOT COMPLETED|Overall Study||17
10869294|NCT03312907|12034841|FG001|NOT COMPLETED|Overall Study||30
10869295|NCT03312907|12034842|FG002|NOT COMPLETED|Overall Study||19
10869296|NCT03148756|12034852|FG000|STARTED|Overall Study||0
10869297|NCT03148756|12034853|FG001|STARTED|Overall Study||2
10869298|NCT03148756|12034852|FG000|COMPLETED|Overall Study||0
10869299|NCT03148756|12034853|FG001|COMPLETED|Overall Study||1
10869300|NCT03148756|12034852|FG000|NOT COMPLETED|Overall Study||0
10869301|NCT03148756|12034853|FG001|NOT COMPLETED|Overall Study||1
10869302|NCT03079102|12034861|FG000|STARTED|Overall Study||30
10869303|NCT03079102|12034862|FG001|STARTED|Overall Study||27
10869304|NCT03079102|12034861|FG000|COMPLETED|Overall Study||30
10869305|NCT03079102|12034862|FG001|COMPLETED|Overall Study|One subject had study drug discontinued by the PI after 3h of therapy due to progressive hemodynamic deterioration (worsening hypotension and shock). Discontinuation of study drug did not impact this deterioration.|26
10869306|NCT03079102|12034861|FG000|NOT COMPLETED|Overall Study||0
10869307|NCT03079102|12034862|FG001|NOT COMPLETED|Overall Study||1
10869308|NCT02944513|12034870|FG000|STARTED|Overall Study||35
10869309|NCT02944513|12034871|FG001|STARTED|Overall Study||33
10869310|NCT02944513|12034870|FG000|COMPLETED|Overall Study||31
10869311|NCT02944513|12034871|FG001|COMPLETED|Overall Study||32
10869312|NCT02944513|12034870|FG000|NOT COMPLETED|Overall Study||4
10869313|NCT02944513|12034871|FG001|NOT COMPLETED|Overall Study||1
10869314|NCT02913222|12034879|FG000|STARTED|Overall Study||23
10869315|NCT02913222|12034880|FG001|STARTED|Overall Study||23
10869316|NCT02913222|12034879|FG000|COMPLETED|Overall Study||22
10869317|NCT02913222|12034880|FG001|COMPLETED|Overall Study||21
10869318|NCT02913222|12034879|FG000|NOT COMPLETED|Overall Study||1
10869319|NCT02913222|12034880|FG001|NOT COMPLETED|Overall Study||2
10869320|NCT02734433|12034888|FG000|STARTED|Overall Study||3
10869321|NCT02734433|12034889|FG001|STARTED|Overall Study||8
10869322|NCT02734433|12034888|FG000|COMPLETED|Overall Study||1
10869323|NCT02734433|12034889|FG001|COMPLETED|Overall Study||0
10869324|NCT02734433|12034888|FG000|NOT COMPLETED|Overall Study||2
10869325|NCT02734433|12034889|FG001|NOT COMPLETED|Overall Study||8
10869326|NCT02474927|12034895|FG000|STARTED|Overall Study||22
10869327|NCT02474927|12034895|FG000|COMPLETED|Overall Study||22
10869328|NCT02474927|12034895|FG000|NOT COMPLETED|Overall Study||0
10869329|NCT02145507|12034901|FG000|STARTED|First Donation||82
10869330|NCT02145507|12034902|FG001|STARTED|First Donation||88
10869331|NCT02145507|12034901|FG000|Randomized to Have Blood Processed With SOLX (IP)|First Donation||52
10869332|NCT02145507|12034902|FG001|Randomized to Have Blood Processed With SOLX (IP)|First Donation||51
10869333|NCT02145507|12034901|FG000|Randomized to Have Blood Processed With AS-3 (CP)|First Donation||30
10869334|NCT02145507|12034902|FG001|Randomized to Have Blood Processed With AS-3 (CP)|First Donation||37
10869335|NCT02145507|12034901|FG000|COMPLETED|First Donation||70
10869336|NCT02145507|12034902|FG001|COMPLETED|First Donation||67
10869337|NCT02145507|12034901|FG000|NOT COMPLETED|First Donation||12
10869338|NCT02145507|12034902|FG001|NOT COMPLETED|First Donation||21
10869339|NCT02145507|12034901|FG000|STARTED|Second Donation||65
10869340|NCT02145507|12034902|FG001|STARTED|Second Donation|Note: Of the 65 participants who started the second period in Arm 2, there were 3 screen failures, therefore only n=62 participants received their alternate procedure.|65
10869341|NCT02145507|12034901|FG000|Blood Processed With AS-3 (CP)|Second Donation||39
10869342|NCT02145507|12034902|FG001|Blood Processed With AS-3 (CP)|Second Donation||35
10869343|NCT02145507|12034901|FG000|Blood Processed With SOLX (IP)|Second Donation||26
10869344|NCT02145507|12034902|FG001|Blood Processed With SOLX (IP)|Second Donation||27
10869345|NCT02145507|12034901|FG000|COMPLETED|Second Donation||63
10869346|NCT02145507|12034902|FG001|COMPLETED|Second Donation||60
10869347|NCT02145507|12034901|FG000|NOT COMPLETED|Second Donation||2
10869348|NCT02145507|12034902|FG001|NOT COMPLETED|Second Donation||5
10869349|NCT02048722|12034913|FG000|STARTED|2 Cycles of Treatment||31
10869350|NCT02048722|12034913|FG000|Attempted 1st Cycle|2 Cycles of Treatment||31
10869351|NCT02048722|12034913|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||23
10869352|NCT02048722|12034913|FG000|COMPLETED|2 Cycles of Treatment||23
10869353|NCT02048722|12034913|FG000|NOT COMPLETED|2 Cycles of Treatment||8
10869354|NCT02048722|12034913|FG000|STARTED|Reached 1st Response/Continued Treatment||23
10869355|NCT02048722|12034913|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||23
10869356|NCT02048722|12034913|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||13
10869357|NCT02048722|12034913|FG000|COMPLETED|Reached 1st Response/Continued Treatment||13
10869358|NCT02048722|12034913|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||10
10869359|NCT02048722|12034913|FG000|STARTED|Follow up 5 Years or Cut of Timepoint||31
10869360|NCT02048722|12034913|FG000|COMPLETED|Follow up 5 Years or Cut of Timepoint||4
10869361|NCT02048722|12034913|FG000|NOT COMPLETED|Follow up 5 Years or Cut of Timepoint||27
10869362|NCT01896102|12034917|FG000|STARTED|Overall Study||32
10869363|NCT01896102|12034917|FG000|COMPLETED|Overall Study||29
10869364|NCT01896102|12034917|FG000|NOT COMPLETED|Overall Study||3
10869365|NCT01885078|12034930|FG000|STARTED|Treatment Period||451
10869366|NCT01885078|12034931|FG001|STARTED|Treatment Period||1091
10869367|NCT01885078|12034932|FG002|STARTED|Treatment Period||180
10869368|NCT01885078|12034933|FG003|STARTED|Treatment Period||403
10869369|NCT01885078|12034934|FG004|STARTED|Treatment Period||117
10869370|NCT01885078|12034935|FG005|STARTED|Treatment Period||331
10869371|NCT01885078|12034936|FG006|STARTED|Treatment Period||221
10869372|NCT01885078|12034937|FG007|STARTED|Treatment Period||83
10869373|NCT01885078|12034938|FG008|STARTED|Treatment Period||0
10869374|NCT01885078|12034939|FG009|STARTED|Treatment Period||0
10869375|NCT01885078|12034930|FG000|Received at Least Once Dose of Study Drug|Treatment Period||451
10869376|NCT01885078|12034931|FG001|Received at Least Once Dose of Study Drug|Treatment Period||1090
10869377|NCT01885078|12034932|FG002|Received at Least Once Dose of Study Drug|Treatment Period||180
10869378|NCT01885078|12034933|FG003|Received at Least Once Dose of Study Drug|Treatment Period||403
10869379|NCT01885078|12034934|FG004|Received at Least Once Dose of Study Drug|Treatment Period||117
10869380|NCT01885078|12034935|FG005|Received at Least Once Dose of Study Drug|Treatment Period||331
10869381|NCT01885078|12034936|FG006|Received at Least Once Dose of Study Drug|Treatment Period||221
10869382|NCT01885078|12034937|FG007|Received at Least Once Dose of Study Drug|Treatment Period||83
10869383|NCT01885078|12034938|FG008|Received at Least Once Dose of Study Drug|Treatment Period||0
10869384|NCT01885078|12034939|FG009|Received at Least Once Dose of Study Drug|Treatment Period||0
10869385|NCT01885078|12034930|FG000|COMPLETED|Treatment Period||19
10869386|NCT01885078|12034931|FG001|COMPLETED|Treatment Period||64
10869387|NCT01885078|12034932|FG002|COMPLETED|Treatment Period||49
10869388|NCT01885078|12034933|FG003|COMPLETED|Treatment Period||120
10869389|NCT01885078|12034934|FG004|COMPLETED|Treatment Period||27
10869390|NCT01885078|12034935|FG005|COMPLETED|Treatment Period||81
10869391|NCT01885078|12034936|FG006|COMPLETED|Treatment Period||0
10869392|NCT01885078|12034937|FG007|COMPLETED|Treatment Period||55
10869393|NCT01885078|12034938|FG008|COMPLETED|Treatment Period||0
10869394|NCT01885078|12034939|FG009|COMPLETED|Treatment Period||0
10869395|NCT01885078|12034930|FG000|NOT COMPLETED|Treatment Period||432
10869396|NCT01885078|12034931|FG001|NOT COMPLETED|Treatment Period||1027
10869397|NCT01885078|12034932|FG002|NOT COMPLETED|Treatment Period||131
10869398|NCT01885078|12034933|FG003|NOT COMPLETED|Treatment Period||283
10869399|NCT01885078|12034934|FG004|NOT COMPLETED|Treatment Period||90
10869400|NCT01885078|12034935|FG005|NOT COMPLETED|Treatment Period||250
10869401|NCT01885078|12034936|FG006|NOT COMPLETED|Treatment Period||221
10869402|NCT01885078|12034937|FG007|NOT COMPLETED|Treatment Period||28
10869403|NCT01885078|12034938|FG008|NOT COMPLETED|Treatment Period||0
10869404|NCT01885078|12034939|FG009|NOT COMPLETED|Treatment Period||0
10869405|NCT01885078|12034930|FG000|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
10869406|NCT01885078|12034931|FG001|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
10869407|NCT01885078|12034932|FG002|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
10869408|NCT01885078|12034933|FG003|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
10869409|NCT01885078|12034934|FG004|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
10869410|NCT01885078|12034935|FG005|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
10869411|NCT01885078|12034936|FG006|STARTED|Step-down Period||0
10869412|NCT01885078|12034937|FG007|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
10869413|NCT01885078|12034938|FG008|STARTED|Step-down Period|Eligible participants were offered the option of participating in the Step-Down Period.|592
10869414|NCT01885078|12034939|FG009|STARTED|Step-down Period|Eligible participants were offered the option of participating in the Step-Down Period.|594
10869415|NCT01885078|12034930|FG000|Complete Through Week 96|Step-down Period||0
10869416|NCT01885078|12034931|FG001|Complete Through Week 96|Step-down Period||0
10869417|NCT01885078|12034932|FG002|Complete Through Week 96|Step-down Period||0
10869418|NCT01885078|12034933|FG003|Complete Through Week 96|Step-down Period||0
10869419|NCT01885078|12034934|FG004|Complete Through Week 96|Step-down Period||0
10869420|NCT01885078|12034935|FG005|Complete Through Week 96|Step-down Period||0
10869421|NCT01885078|12034936|FG006|Complete Through Week 96|Step-down Period||0
10869422|NCT01885078|12034937|FG007|Complete Through Week 96|Step-down Period||0
10869423|NCT01885078|12034938|FG008|Complete Through Week 96|Step-down Period||407
10869424|NCT01885078|12034939|FG009|Complete Through Week 96|Step-down Period||455
10869425|NCT01885078|12034930|FG000|COMPLETED|Step-down Period||0
10869426|NCT01885078|12034931|FG001|COMPLETED|Step-down Period||0
10869427|NCT01885078|12034932|FG002|COMPLETED|Step-down Period||0
10869428|NCT01885078|12034933|FG003|COMPLETED|Step-down Period||0
10869429|NCT01885078|12034934|FG004|COMPLETED|Step-down Period||0
10869430|NCT01885078|12034935|FG005|COMPLETED|Step-down Period||0
10869431|NCT01885078|12034936|FG006|COMPLETED|Step-down Period||0
10869432|NCT01885078|12034937|FG007|COMPLETED|Step-down Period||0
10869433|NCT01885078|12034938|FG008|COMPLETED|Step-down Period||523
10869434|NCT01885078|12034939|FG009|COMPLETED|Step-down Period||533
10869435|NCT01885078|12034930|FG000|NOT COMPLETED|Step-down Period||0
10869436|NCT01885078|12034931|FG001|NOT COMPLETED|Step-down Period||0
10869437|NCT01885078|12034932|FG002|NOT COMPLETED|Step-down Period||0
10869438|NCT01885078|12034933|FG003|NOT COMPLETED|Step-down Period||0
10869439|NCT01885078|12034934|FG004|NOT COMPLETED|Step-down Period||0
10869440|NCT01885078|12034935|FG005|NOT COMPLETED|Step-down Period||0
10869441|NCT01885078|12034936|FG006|NOT COMPLETED|Step-down Period||0
10869442|NCT01885078|12034937|FG007|NOT COMPLETED|Step-down Period||0
10869443|NCT01885078|12034938|FG008|NOT COMPLETED|Step-down Period||69
10869444|NCT01885078|12034939|FG009|NOT COMPLETED|Step-down Period||61
10869445|NCT01047683|12034963|FG000|STARTED|Overall Study||76
10869446|NCT01047683|12034964|FG001|STARTED|Overall Study||76
10869447|NCT01047683|12034965|FG002|STARTED|Overall Study||77
10869448|NCT01047683|12034963|FG000|COMPLETED|Overall Study||71
10869449|NCT01047683|12034964|FG001|COMPLETED|Overall Study||70
10869450|NCT01047683|12034965|FG002|COMPLETED|Overall Study||74
10869451|NCT01047683|12034963|FG000|NOT COMPLETED|Overall Study||5
10869452|NCT01047683|12034964|FG001|NOT COMPLETED|Overall Study||6
10869453|NCT01047683|12034965|FG002|NOT COMPLETED|Overall Study||3
10869454|NCT01047501|12034976|FG000|STARTED|Overall Study||233
10869455|NCT01047501|12034977|FG001|STARTED|Overall Study||236
10869456|NCT01047501|12034978|FG002|STARTED|Overall Study||233
10869457|NCT01047501|12034976|FG000|COMPLETED|Overall Study||217
10869458|NCT01047501|12034977|FG001|COMPLETED|Overall Study||225
10869459|NCT01047501|12034978|FG002|COMPLETED|Overall Study||221
10869460|NCT01047501|12034976|FG000|NOT COMPLETED|Overall Study||16
10869461|NCT01047501|12034977|FG001|NOT COMPLETED|Overall Study||11
10869462|NCT01047501|12034978|FG002|NOT COMPLETED|Overall Study||12
10869463|NCT00981656|12034986|FG000|STARTED|Overall Study||37
10869464|NCT00981656|12034986|FG000|Eligible and Started Study Treatment|Overall Study||34
10869465|NCT00981656|12034986|FG000|COMPLETED|Overall Study||34
10869466|NCT00981656|12034986|FG000|NOT COMPLETED|Overall Study||3
10869467|NCT00838526|12034992|FG000|STARTED|Overall Study|Treated|59
10869468|NCT00838526|12034993|FG001|STARTED|Overall Study|Treated|176
10869469|NCT00838526|12034992|FG000|COMPLETED|Overall Study||35
10869470|NCT00838526|12034993|FG001|COMPLETED|Overall Study||137
10869471|NCT00838526|12034992|FG000|NOT COMPLETED|Overall Study||24
10869472|NCT00838526|12034993|FG001|NOT COMPLETED|Overall Study||39
10869473|NCT00126672|12034999|FG000|STARTED|Overall Study||36
10869474|NCT00126672|12034999|FG000|COMPLETED|Overall Study||28
10869475|NCT00126672|12034999|FG000|NOT COMPLETED|Overall Study||8
10869476|NCT03172780|12035006|FG000|STARTED|Overall Study||406
10869477|NCT03172780|12035007|FG001|STARTED|Overall Study||409
10869478|NCT03172780|12035008|FG002|STARTED|Overall Study||405
10869479|NCT03172780|12035006|FG000|COMPLETED|Overall Study||388
10869480|NCT03172780|12035007|FG001|COMPLETED|Overall Study||389
10869481|NCT03172780|12035008|FG002|COMPLETED|Overall Study||389
10869482|NCT03172780|12035006|FG000|NOT COMPLETED|Overall Study||18
10869483|NCT03172780|12035007|FG001|NOT COMPLETED|Overall Study||20
10869484|NCT03172780|12035008|FG002|NOT COMPLETED|Overall Study||16
10869485|NCT03151304|12035016|FG000|STARTED|Overall Study||64
10869486|NCT03151304|12035016|FG000|COMPLETED|Overall Study||0
10869487|NCT03151304|12035016|FG000|NOT COMPLETED|Overall Study||64
11110846|NCT01283321|12295452|FG001|NOT COMPLETED|Overall Study||0
11110847|NCT01283334|12295460|FG000|STARTED|Overall Study||20
11110848|NCT01283334|12295460|FG000|COMPLETED|Overall Study||13
11110849|NCT01283334|12295460|FG000|NOT COMPLETED|Overall Study||7
11110850|NCT01283386|12295468|FG000|STARTED|Overall Study||10
11110851|NCT01283386|12295469|FG001|STARTED|Overall Study||16
11110852|NCT01283386|12295468|FG000|COMPLETED|Overall Study||2
11110853|NCT01283386|12295469|FG001|COMPLETED|Overall Study||4
11110854|NCT01283386|12295468|FG000|NOT COMPLETED|Overall Study||8
11110855|NCT01283386|12295469|FG001|NOT COMPLETED|Overall Study||12
11110856|NCT01283464|12295477|FG000|STARTED|Overall Study||12
11110857|NCT01283464|12295478|FG001|STARTED|Overall Study||12
11110858|NCT01283464|12295477|FG000|COMPLETED|Overall Study||10
11110859|NCT01283464|12295478|FG001|COMPLETED|Overall Study||11
11110860|NCT01283464|12295477|FG000|NOT COMPLETED|Overall Study||2
11110861|NCT01283464|12295478|FG001|NOT COMPLETED|Overall Study||1
11110862|NCT01283516|12295493|FG000|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
11110863|NCT01283516|12295494|FG001|STARTED|Overall Study||2
11110864|NCT01283516|12295495|FG002|STARTED|Overall Study||3
11110865|NCT01283516|12295496|FG003|STARTED|Overall Study||3
11110866|NCT01283516|12295497|FG004|STARTED|Overall Study||14
11110867|NCT01283516|12295498|FG005|STARTED|Overall Study||10
11110868|NCT01283516|12295499|FG006|STARTED|Overall Study||10
11110869|NCT01283516|12295500|FG007|STARTED|Overall Study||5
11110870|NCT01283516|12295501|FG008|STARTED|Overall Study||255
11110871|NCT01283516|12295493|FG000|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
11110872|NCT01283516|12295494|FG001|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
11110873|NCT01283516|12295495|FG002|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
11110874|NCT01283516|12295496|FG003|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
11110875|NCT01283516|12295497|FG004|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
11110876|NCT01283516|12295498|FG005|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
11110877|NCT01283516|12295499|FG006|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
11110878|NCT01283516|12295500|FG007|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
11110879|NCT01283516|12295501|FG008|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
11110880|NCT01283516|12295493|FG000|Dose-Determining Set (DDS)|Overall Study||2
11110881|NCT01283516|12295494|FG001|Dose-Determining Set (DDS)|Overall Study||1
10869488|NCT03113409|12035020|FG000|STARTED|Overall Study||10
11110882|NCT01283516|12295495|FG002|Dose-Determining Set (DDS)|Overall Study||3
11110883|NCT01283516|12295496|FG003|Dose-Determining Set (DDS)|Overall Study||3
11110884|NCT01283516|12295497|FG004|Dose-Determining Set (DDS)|Overall Study||14
10869489|NCT03113409|12035021|FG001|STARTED|Overall Study|Study procedure was never started|0
10869490|NCT03113409|12035022|FG002|STARTED|Overall Study|Study procedure was never started|0
11229564|NCT02016560|12421691|FG001|NOT COMPLETED|Exploratory Phase||4
11229565|NCT02016560|12421692|FG002|NOT COMPLETED|Exploratory Phase||36
11229566|NCT02016560|12421693|FG003|NOT COMPLETED|Exploratory Phase||16
11229567|NCT02016560|12421694|FG004|NOT COMPLETED|Exploratory Phase||0
11229568|NCT02016560|12421695|FG005|NOT COMPLETED|Exploratory Phase||0
11229569|NCT02016560|12421690|FG000|STARTED|Confirmatory Phase||0
10869491|NCT03113409|12035020|FG000|COMPLETED|Overall Study||5
11229570|NCT02016560|12421691|FG001|STARTED|Confirmatory Phase||0
11229571|NCT02016560|12421692|FG002|STARTED|Confirmatory Phase||0
11229572|NCT02016560|12421693|FG003|STARTED|Confirmatory Phase||0
11229573|NCT02016560|12421694|FG004|STARTED|Confirmatory Phase||98
11229574|NCT02016560|12421695|FG005|STARTED|Confirmatory Phase||62
11229575|NCT02016560|12421690|FG000|COMPLETED|Confirmatory Phase||0
11229576|NCT02016560|12421691|FG001|COMPLETED|Confirmatory Phase||0
11229577|NCT02016560|12421692|FG002|COMPLETED|Confirmatory Phase||0
11229578|NCT02016560|12421693|FG003|COMPLETED|Confirmatory Phase||0
11229579|NCT02016560|12421694|FG004|COMPLETED|Confirmatory Phase||76
11229580|NCT02016560|12421695|FG005|COMPLETED|Confirmatory Phase||35
11229581|NCT02016560|12421690|FG000|NOT COMPLETED|Confirmatory Phase||0
11229582|NCT02016560|12421691|FG001|NOT COMPLETED|Confirmatory Phase||0
11229583|NCT02016560|12421692|FG002|NOT COMPLETED|Confirmatory Phase||0
11229584|NCT02016560|12421693|FG003|NOT COMPLETED|Confirmatory Phase||0
11229585|NCT02016560|12421694|FG004|NOT COMPLETED|Confirmatory Phase||22
11229586|NCT02016560|12421695|FG005|NOT COMPLETED|Confirmatory Phase||27
11229587|NCT02016612|12421721|FG000|STARTED|Overall Study||25
11229588|NCT02016612|12421722|FG001|STARTED|Overall Study||25
11229589|NCT02016612|12421723|FG002|STARTED|Overall Study||26
11229590|NCT02016612|12421724|FG003|STARTED|Overall Study||61
11229591|NCT02016612|12421721|FG000|COMPLETED|Overall Study||25
11229592|NCT02016612|12421722|FG001|COMPLETED|Overall Study||25
11229593|NCT02016612|12421723|FG002|COMPLETED|Overall Study||26
11229594|NCT02016612|12421724|FG003|COMPLETED|Overall Study||61
11229595|NCT02016612|12421721|FG000|NOT COMPLETED|Overall Study||0
11229596|NCT02016612|12421722|FG001|NOT COMPLETED|Overall Study||0
11229597|NCT02016612|12421723|FG002|NOT COMPLETED|Overall Study||0
11229598|NCT02016612|12421724|FG003|NOT COMPLETED|Overall Study||0
11229599|NCT02016625|12421736|FG000|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
11229600|NCT02016625|12421737|FG001|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
11229601|NCT02016625|12421736|FG000|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
11229602|NCT02016625|12421737|FG001|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
11229603|NCT02016625|12421736|FG000|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
11229604|NCT02016625|12421737|FG001|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
11229605|NCT02016625|12421736|FG000|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
11229606|NCT02016625|12421737|FG001|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
11229607|NCT02016625|12421736|FG000|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
11229608|NCT02016625|12421737|FG001|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
11229609|NCT02016625|12421736|FG000|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
11229610|NCT02016625|12421737|FG001|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
11229611|NCT02016690|12421753|FG000|STARTED|Overall Study||312
11229612|NCT02016690|12421753|FG000|Treated|Overall Study||312
11229613|NCT02016690|12421753|FG000|Safety Analysis Set (SAS)|Overall Study||304
11229614|NCT02016690|12421753|FG000|COMPLETED|Overall Study|(Effectiveness analysis set)|288
11229615|NCT02016690|12421753|FG000|NOT COMPLETED|Overall Study||24
11229616|NCT02016716|12421760|FG000|STARTED|Overall Study||53
11229617|NCT02016716|12421761|FG001|STARTED|Overall Study||118
11229618|NCT02016716|12421762|FG002|STARTED|Overall Study||123
11229619|NCT02016716|12421760|FG000|Received Study Treatment|Overall Study||53
11229620|NCT02016716|12421761|FG001|Received Study Treatment|Overall Study||118
11229621|NCT02016716|12421762|FG002|Received Study Treatment|Overall Study||123
11229622|NCT02016716|12421760|FG000|COMPLETED|Overall Study||47
11229623|NCT02016716|12421761|FG001|COMPLETED|Overall Study||110
11229624|NCT02016716|12421762|FG002|COMPLETED|Overall Study||117
11229625|NCT02016716|12421760|FG000|NOT COMPLETED|Overall Study||6
11229626|NCT02016716|12421761|FG001|NOT COMPLETED|Overall Study||8
11229627|NCT02016716|12421762|FG002|NOT COMPLETED|Overall Study||6
11229628|NCT02016755|12421771|FG000|STARTED|Overall Study||10
11229629|NCT02016755|12421771|FG000|Completed Month 18 Clinic Visit|Overall Study||5
11229630|NCT02016755|12421771|FG000|Completed Month 36 LTFU Questionnaire|Overall Study||3
11229631|NCT02016755|12421771|FG000|COMPLETED|Overall Study||3
11229632|NCT02016755|12421771|FG000|NOT COMPLETED|Overall Study||7
11229633|NCT02016885|12421780|FG000|STARTED|Overall Study||38
11229634|NCT02016885|12421781|FG001|STARTED|Overall Study||40
11229635|NCT02016885|12421782|FG002|STARTED|Overall Study||40
11229636|NCT02016885|12421783|FG003|STARTED|Overall Study||40
11229637|NCT02016885|12421784|FG004|STARTED|Overall Study||40
11229638|NCT02016885|12421780|FG000|COMPLETED|Overall Study||34
10869492|NCT03113409|12035021|FG001|COMPLETED|Overall Study||0
10869493|NCT03113409|12035022|FG002|COMPLETED|Overall Study||0
10869494|NCT03113409|12035020|FG000|NOT COMPLETED|Overall Study||5
10869495|NCT03113409|12035021|FG001|NOT COMPLETED|Overall Study||0
10869496|NCT03113409|12035022|FG002|NOT COMPLETED|Overall Study||0
10869497|NCT02953340|12035028|FG000|STARTED|Overall Study||118
10869498|NCT02953340|12035029|FG001|STARTED|Overall Study||119
10869499|NCT02953340|12035028|FG000|Safety Population|Overall Study||117
11229639|NCT02016885|12421781|FG001|COMPLETED|Overall Study||36
10869500|NCT02953340|12035029|FG001|Safety Population|Overall Study||118
10869501|NCT02953340|12035028|FG000|Entered Safety Follow-up Period|Overall Study||117
10869502|NCT02953340|12035029|FG001|Entered Safety Follow-up Period|Overall Study||118
10869503|NCT02953340|12035028|FG000|COMPLETED|Overall Study||96
10869504|NCT02953340|12035029|FG001|COMPLETED|Overall Study||85
10869505|NCT02953340|12035028|FG000|NOT COMPLETED|Overall Study||22
10869506|NCT02953340|12035029|FG001|NOT COMPLETED|Overall Study||34
10869507|NCT02855944|12035043|FG000|STARTED|Period 1: Treatment||233
10869508|NCT02855944|12035044|FG001|STARTED|Period 1: Treatment||116
10869509|NCT02855944|12035043|FG000|COMPLETED|Period 1: Treatment||188
10869510|NCT02855944|12035044|FG001|COMPLETED|Period 1: Treatment||108
10869511|NCT02855944|12035043|FG000|NOT COMPLETED|Period 1: Treatment||45
10869512|NCT02855944|12035044|FG001|NOT COMPLETED|Period 1: Treatment||8
10869513|NCT02855944|12035043|FG000|STARTED|Period 2: Crossover to Rucaparib||0
10869514|NCT02855944|12035044|FG001|STARTED|Period 2: Crossover to Rucaparib||74
10869515|NCT02855944|12035043|FG000|COMPLETED|Period 2: Crossover to Rucaparib||0
10869516|NCT02855944|12035044|FG001|COMPLETED|Period 2: Crossover to Rucaparib||47
10869517|NCT02855944|12035043|FG000|NOT COMPLETED|Period 2: Crossover to Rucaparib||0
10869518|NCT02855944|12035044|FG001|NOT COMPLETED|Period 2: Crossover to Rucaparib||27
10869519|NCT02851407|12035053|FG000|STARTED|Overall Study||190
10869520|NCT02851407|12035054|FG001|STARTED|Overall Study||182
10869521|NCT02851407|12035053|FG000|COMPLETED|Overall Study||120
10869522|NCT02851407|12035054|FG001|COMPLETED|Overall Study||121
10869523|NCT02851407|12035053|FG000|NOT COMPLETED|Overall Study||70
10869524|NCT02851407|12035054|FG001|NOT COMPLETED|Overall Study||61
10869525|NCT02707276|12035064|FG000|STARTED|Overall Study||3
10869526|NCT02707276|12035065|FG001|STARTED|Overall Study||5
10869527|NCT02707276|12035066|FG002|STARTED|Overall Study||3
10869528|NCT02707276|12035067|FG003|STARTED|Overall Study||2
10869529|NCT02707276|12035064|FG000|COMPLETED|Overall Study||3
10869530|NCT02707276|12035065|FG001|COMPLETED|Overall Study||5
10869531|NCT02707276|12035066|FG002|COMPLETED|Overall Study||3
10869532|NCT02707276|12035067|FG003|COMPLETED|Overall Study||2
10869533|NCT02707276|12035064|FG000|NOT COMPLETED|Overall Study||0
10869534|NCT02707276|12035065|FG001|NOT COMPLETED|Overall Study||0
10869535|NCT02707276|12035066|FG002|NOT COMPLETED|Overall Study||0
10869536|NCT02707276|12035067|FG003|NOT COMPLETED|Overall Study||0
10869537|NCT02666430|12035079|FG000|STARTED|Baseline||64
10869538|NCT02666430|12035080|FG001|STARTED|Baseline||63
10869539|NCT02666430|12035079|FG000|COMPLETED|Baseline||64
10869540|NCT02666430|12035080|FG001|COMPLETED|Baseline||63
10869541|NCT02666430|12035079|FG000|NOT COMPLETED|Baseline||0
10869542|NCT02666430|12035080|FG001|NOT COMPLETED|Baseline||0
11110885|NCT01283516|12295498|FG005|Dose-Determining Set (DDS)|Overall Study||8
11110886|NCT01283516|12295499|FG006|Dose-Determining Set (DDS)|Overall Study||10
11110887|NCT01283516|12295500|FG007|Dose-Determining Set (DDS)|Overall Study||5
11110888|NCT01283516|12295501|FG008|Dose-Determining Set (DDS)|Overall Study||8
11110889|NCT01283516|12295493|FG000|Non-NSCLC|Overall Study||0
11110890|NCT01283516|12295494|FG001|Non-NSCLC|Overall Study||1
11110891|NCT01283516|12295495|FG002|Non-NSCLC|Overall Study||1
11110892|NCT01283516|12295496|FG003|Non-NSCLC|Overall Study||0
11110893|NCT01283516|12295497|FG004|Non-NSCLC|Overall Study||2
11110894|NCT01283516|12295498|FG005|Non-NSCLC|Overall Study||0
11110895|NCT01283516|12295499|FG006|Non-NSCLC|Overall Study||1
11110896|NCT01283516|12295500|FG007|Non-NSCLC|Overall Study||0
11110897|NCT01283516|12295501|FG008|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9
11110898|NCT01283516|12295493|FG000|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0
11110899|NCT01283516|12295494|FG001|COMPLETED|Overall Study||0
11110900|NCT01283516|12295495|FG002|COMPLETED|Overall Study||0
11110901|NCT01283516|12295496|FG003|COMPLETED|Overall Study||0
11110902|NCT01283516|12295497|FG004|COMPLETED|Overall Study||0
11110903|NCT01283516|12295498|FG005|COMPLETED|Overall Study||0
11110904|NCT01283516|12295499|FG006|COMPLETED|Overall Study||0
11110905|NCT01283516|12295500|FG007|COMPLETED|Overall Study||0
11110906|NCT01283516|12295501|FG008|COMPLETED|Overall Study||0
11110907|NCT01283516|12295493|FG000|NOT COMPLETED|Overall Study||2
11110908|NCT01283516|12295494|FG001|NOT COMPLETED|Overall Study||2
11110909|NCT01283516|12295495|FG002|NOT COMPLETED|Overall Study||3
11110910|NCT01283516|12295496|FG003|NOT COMPLETED|Overall Study||3
11110911|NCT01283516|12295497|FG004|NOT COMPLETED|Overall Study||14
11110912|NCT01283516|12295498|FG005|NOT COMPLETED|Overall Study||10
11110913|NCT01283516|12295499|FG006|NOT COMPLETED|Overall Study||10
11110914|NCT01283516|12295500|FG007|NOT COMPLETED|Overall Study||5
11110915|NCT01283516|12295501|FG008|NOT COMPLETED|Overall Study||255
11110916|NCT01283542|12295529|FG000|STARTED|Main Phase||20
11110917|NCT01283542|12295529|FG000|Full Analysis Set (FAS)|Main Phase||20
11110918|NCT01283542|12295529|FG000|Safety Analysis Set|Main Phase||20
11110919|NCT01283542|12295529|FG000|COMPLETED|Main Phase||13
11110920|NCT01283542|12295529|FG000|NOT COMPLETED|Main Phase||7
11110921|NCT01283542|12295529|FG000|STARTED|Extension Phase||13
11110922|NCT01283542|12295529|FG000|Full Analysis Set (FAS)|Extension Phase||13
10869543|NCT02666430|12035079|FG000|STARTED|Period 1||64
10869544|NCT02666430|12035080|FG001|STARTED|Period 1||63
10869545|NCT02666430|12035079|FG000|COMPLETED|Period 1||63
10869546|NCT02666430|12035080|FG001|COMPLETED|Period 1||62
10869547|NCT02666430|12035079|FG000|NOT COMPLETED|Period 1||1
10869548|NCT02666430|12035080|FG001|NOT COMPLETED|Period 1||1
11110923|NCT01283542|12295529|FG000|Safety Analysis Set|Extension Phase||13
11110924|NCT01283542|12295529|FG000|COMPLETED|Extension Phase||10
10869549|NCT02666430|12035079|FG000|STARTED|Period 2||63
10869550|NCT02666430|12035080|FG001|STARTED|Period 2||62
10869551|NCT02666430|12035079|FG000|COMPLETED|Period 2||62
10869552|NCT02666430|12035080|FG001|COMPLETED|Period 2||58
10869553|NCT02666430|12035079|FG000|NOT COMPLETED|Period 2||1
10869554|NCT02666430|12035080|FG001|NOT COMPLETED|Period 2||4
10869555|NCT02666430|12035079|FG000|STARTED|Period 3||62
10869556|NCT02666430|12035080|FG001|STARTED|Period 3||58
10869557|NCT02666430|12035079|FG000|COMPLETED|Period 3||61
10869558|NCT02666430|12035080|FG001|COMPLETED|Period 3||58
10869559|NCT02666430|12035079|FG000|NOT COMPLETED|Period 3||1
10869560|NCT02666430|12035080|FG001|NOT COMPLETED|Period 3||0
10869561|NCT02643420|12035088|FG000|STARTED|Overall Study||196
10869562|NCT02643420|12035089|FG001|STARTED|Overall Study||210
10869563|NCT02643420|12035088|FG000|Safety Population|Overall Study|One participant was randomized to the Arm 2: Pegfilgrastim and TC but was inadvertently administered SPI-2012 on Cycle 1, Day 2 and was included in the Arm 1: SPI-2012 and TC for the Safety Population.|197
10869564|NCT02643420|12035089|FG001|Safety Population|Overall Study||208
10869565|NCT02643420|12035088|FG000|COMPLETED|Overall Study||142
10869566|NCT02643420|12035089|FG001|COMPLETED|Overall Study||145
10869567|NCT02643420|12035088|FG000|NOT COMPLETED|Overall Study||54
10869568|NCT02643420|12035089|FG001|NOT COMPLETED|Overall Study||65
11229640|NCT02016885|12421782|FG002|COMPLETED|Overall Study||39
11229641|NCT02016885|12421783|FG003|COMPLETED|Overall Study||30
11229642|NCT02016885|12421784|FG004|COMPLETED|Overall Study||39
11229643|NCT02016885|12421780|FG000|NOT COMPLETED|Overall Study||4
11229644|NCT02016885|12421781|FG001|NOT COMPLETED|Overall Study||4
11229645|NCT02016885|12421782|FG002|NOT COMPLETED|Overall Study||1
11229646|NCT02016885|12421783|FG003|NOT COMPLETED|Overall Study||10
11229647|NCT02016885|12421784|FG004|NOT COMPLETED|Overall Study||1
10869569|NCT02639559|12035103|FG000|STARTED|Overall Study||25
10869570|NCT02639559|12035104|FG001|STARTED|Overall Study||25
10869571|NCT02639559|12035103|FG000|COMPLETED|Overall Study||24
10869572|NCT02639559|12035104|FG001|COMPLETED|Overall Study||22
10869573|NCT02639559|12035103|FG000|NOT COMPLETED|Overall Study||1
10869574|NCT02639559|12035104|FG001|NOT COMPLETED|Overall Study||3
10869575|NCT02569476|12035110|FG000|STARTED|Overall Study||119
10869576|NCT02569476|12035110|FG000|COMPLETED|Overall Study||0
10869577|NCT02569476|12035110|FG000|NOT COMPLETED|Overall Study||119
10869578|NCT02549209|12035120|FG000|STARTED|Overall Study||46
10869579|NCT02549209|12035120|FG000|COMPLETED|Overall Study||46
10869580|NCT02549209|12035120|FG000|NOT COMPLETED|Overall Study||0
10869581|NCT02496676|12035126|FG000|STARTED|Phase 1 - Period 1||2
10869582|NCT02496676|12035127|FG001|STARTED|Phase 1 - Period 1||3
11110925|NCT01283542|12295529|FG000|NOT COMPLETED|Extension Phase||3
11110926|NCT01283555|12295551|FG000|STARTED|First Intervention||13
11110927|NCT01283555|12295552|FG001|STARTED|First Intervention||12
11110928|NCT01283555|12295551|FG000|COMPLETED|First Intervention||13
11110929|NCT01283555|12295552|FG001|COMPLETED|First Intervention||12
11110930|NCT01283555|12295551|FG000|NOT COMPLETED|First Intervention||0
11110931|NCT01283555|12295552|FG001|NOT COMPLETED|First Intervention||0
11110932|NCT01283555|12295551|FG000|STARTED|Washout Period of at Least 21 Days||13
11110933|NCT01283555|12295552|FG001|STARTED|Washout Period of at Least 21 Days||12
11110934|NCT01283555|12295551|FG000|COMPLETED|Washout Period of at Least 21 Days||13
11110935|NCT01283555|12295552|FG001|COMPLETED|Washout Period of at Least 21 Days||12
11110936|NCT01283555|12295551|FG000|NOT COMPLETED|Washout Period of at Least 21 Days||0
11110937|NCT01283555|12295552|FG001|NOT COMPLETED|Washout Period of at Least 21 Days||0
11110938|NCT01283555|12295551|FG000|STARTED|Second Intervention||13
11110939|NCT01283555|12295552|FG001|STARTED|Second Intervention||12
11110940|NCT01283555|12295551|FG000|COMPLETED|Second Intervention||13
11110941|NCT01283555|12295552|FG001|COMPLETED|Second Intervention||12
11110942|NCT01283555|12295551|FG000|NOT COMPLETED|Second Intervention||0
11229648|NCT02016898|12421798|FG000|STARTED|Overall Study||50
11229649|NCT02016898|12421799|FG001|STARTED|Overall Study||45
11229650|NCT02016898|12421798|FG000|COMPLETED|Overall Study||45
11229651|NCT02016898|12421799|FG001|COMPLETED|Overall Study||40
11229652|NCT02016898|12421798|FG000|NOT COMPLETED|Overall Study||5
11229653|NCT02016898|12421799|FG001|NOT COMPLETED|Overall Study||5
11229654|NCT02016963|12421805|FG000|STARTED|Overall Study||20
11229655|NCT02016963|12421805|FG000|COMPLETED|Overall Study||20
11229656|NCT02016963|12421805|FG000|NOT COMPLETED|Overall Study||0
11229657|NCT02017015|12421810|FG000|STARTED|Overall Study||83
11229658|NCT02017015|12421810|FG000|Safety Population|Overall Study||83
11229659|NCT02017015|12421810|FG000|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
11229660|NCT02017015|12421810|FG000|NOT COMPLETED|Overall Study||69
10869583|NCT02496676|12035126|FG000|COMPLETED|Phase 1 - Period 1||2
11229661|NCT02017093|12421817|FG000|STARTED|Overall Study||4
10869584|NCT02496676|12035127|FG001|COMPLETED|Phase 1 - Period 1||2
10869585|NCT02496676|12035126|FG000|NOT COMPLETED|Phase 1 - Period 1||0
10869586|NCT02496676|12035127|FG001|NOT COMPLETED|Phase 1 - Period 1||1
10869587|NCT02496676|12035126|FG000|STARTED|Phase 1 - Period 2||2
10869588|NCT02496676|12035127|FG001|STARTED|Phase 1 - Period 2||2
11229662|NCT02017093|12421818|FG001|STARTED|Overall Study||3
11229663|NCT02017093|12421817|FG000|COMPLETED|Overall Study||4
10869589|NCT02496676|12035126|FG000|COMPLETED|Phase 1 - Period 2||2
10869590|NCT02496676|12035127|FG001|COMPLETED|Phase 1 - Period 2||2
10869591|NCT02496676|12035126|FG000|NOT COMPLETED|Phase 1 - Period 2||0
10869592|NCT02496676|12035127|FG001|NOT COMPLETED|Phase 1 - Period 2||0
10869593|NCT02496676|12035126|FG000|STARTED|Washout Period||2
10869594|NCT02496676|12035127|FG001|STARTED|Washout Period||2
10869595|NCT02496676|12035126|FG000|COMPLETED|Washout Period||2
10869596|NCT02496676|12035127|FG001|COMPLETED|Washout Period||2
11110943|NCT01283555|12295552|FG001|NOT COMPLETED|Second Intervention||0
11110944|NCT01283581|12295565|FG000|STARTED|Overall Study||81
11110945|NCT01283581|12295566|FG001|STARTED|Overall Study||77
11110946|NCT01283581|12295567|FG002|STARTED|Overall Study||98
11110947|NCT01283581|12295565|FG000|COMPLETED|Overall Study||69
11110948|NCT01283581|12295566|FG001|COMPLETED|Overall Study||63
11110949|NCT01283581|12295567|FG002|COMPLETED|Overall Study||78
11110950|NCT01283581|12295565|FG000|NOT COMPLETED|Overall Study||12
11110951|NCT01283581|12295566|FG001|NOT COMPLETED|Overall Study||14
11110952|NCT01283581|12295567|FG002|NOT COMPLETED|Overall Study||20
11110953|NCT01283971|12295580|FG000|STARTED|Overall Study||48
11110954|NCT01283971|12295581|FG001|STARTED|Overall Study||48
11110955|NCT01283971|12295580|FG000|Intent to Treat Population|Overall Study||46
11110956|NCT01283971|12295581|FG001|Intent to Treat Population|Overall Study||48
11110957|NCT01283971|12295580|FG000|COMPLETED|Overall Study||33
11110958|NCT01283971|12295581|FG001|COMPLETED|Overall Study||36
11110959|NCT01283971|12295580|FG000|NOT COMPLETED|Overall Study||15
11110960|NCT01283971|12295581|FG001|NOT COMPLETED|Overall Study||12
11110961|NCT01284062|12295591|FG000|STARTED|Overall Study||21
11110962|NCT01284062|12295592|FG001|STARTED|Overall Study||21
11110963|NCT01284062|12295593|FG002|STARTED|Overall Study||21
11110964|NCT01284062|12295594|FG003|STARTED|Overall Study||21
11110965|NCT01284062|12295591|FG000|COMPLETED|Overall Study||10
11110966|NCT01284062|12295592|FG001|COMPLETED|Overall Study||13
11110967|NCT01284062|12295593|FG002|COMPLETED|Overall Study||15
11110968|NCT01284062|12295594|FG003|COMPLETED|Overall Study||7
11110969|NCT01284062|12295591|FG000|NOT COMPLETED|Overall Study||11
11110970|NCT01284062|12295592|FG001|NOT COMPLETED|Overall Study||8
11110971|NCT01284062|12295593|FG002|NOT COMPLETED|Overall Study||6
11110972|NCT01284062|12295594|FG003|NOT COMPLETED|Overall Study||14
11110973|NCT01284114|12295607|FG000|STARTED|Overall Study||23
11110974|NCT01284114|12295607|FG000|COMPLETED|Overall Study||19
11110975|NCT01284114|12295607|FG000|NOT COMPLETED|Overall Study||4
11110976|NCT01284127|12295612|FG000|STARTED|Overall Study||38
11110977|NCT01284127|12295612|FG000|COMPLETED|Overall Study||31
11110978|NCT01284127|12295612|FG000|NOT COMPLETED|Overall Study||7
11110979|NCT01284140|12295618|FG000|STARTED|Randomization and Intervention||11
11110980|NCT01284140|12295619|FG001|STARTED|Randomization and Intervention||11
11110981|NCT01284140|12295618|FG000|COMPLETED|Randomization and Intervention||11
11110982|NCT01284140|12295619|FG001|COMPLETED|Randomization and Intervention||11
11110983|NCT01284140|12295618|FG000|NOT COMPLETED|Randomization and Intervention||0
11110984|NCT01284140|12295619|FG001|NOT COMPLETED|Randomization and Intervention||0
11110985|NCT01284140|12295618|FG000|STARTED|Subjects With Paired 24hr Collections||11
11110986|NCT01284140|12295619|FG001|STARTED|Subjects With Paired 24hr Collections||11
11110987|NCT01284140|12295618|FG000|COMPLETED|Subjects With Paired 24hr Collections||6
11110988|NCT01284140|12295619|FG001|COMPLETED|Subjects With Paired 24hr Collections||5
11110989|NCT01284140|12295618|FG000|NOT COMPLETED|Subjects With Paired 24hr Collections||5
11110990|NCT01284140|12295619|FG001|NOT COMPLETED|Subjects With Paired 24hr Collections||6
11110991|NCT01284244|12295627|FG000|STARTED|Overall Study||18
11110992|NCT01284244|12295628|FG001|STARTED|Overall Study||18
11110993|NCT01284244|12295627|FG000|COMPLETED|Overall Study||18
11110994|NCT01284244|12295628|FG001|COMPLETED|Overall Study||18
11110995|NCT01284244|12295627|FG000|NOT COMPLETED|Overall Study||0
11110996|NCT01284244|12295628|FG001|NOT COMPLETED|Overall Study||0
11110997|NCT01284296|12295634|FG000|STARTED|Overall Study||20
11110998|NCT01284296|12295634|FG000|COMPLETED|Overall Study||20
11110999|NCT01284296|12295634|FG000|NOT COMPLETED|Overall Study||0
11111000|NCT01284335|12295652|FG000|STARTED|Overall Study||25
11111001|NCT01284335|12295653|FG001|STARTED|Overall Study||33
11111002|NCT01284335|12295654|FG002|STARTED|Overall Study||5
11111003|NCT01284335|12295655|FG003|STARTED|Overall Study||5
11111004|NCT01284335|12295656|FG004|STARTED|Overall Study||24
11111005|NCT01284335|12295657|FG005|STARTED|Overall Study||26
11111006|NCT01284335|12295658|FG006|STARTED|Overall Study||19
11111007|NCT01284335|12295659|FG007|STARTED|Overall Study||6
11111008|NCT01284335|12295660|FG008|STARTED|Overall Study||4
11111009|NCT01284335|12295661|FG009|STARTED|Overall Study||14
11111010|NCT01284335|12295662|FG010|STARTED|Overall Study||45
11111011|NCT01284335|12295663|FG011|STARTED|Overall Study||16
11111012|NCT01284335|12295664|FG012|STARTED|Overall Study||12
11111013|NCT01284335|12295652|FG000|Received at Least One Dose of Study Drug|Overall Study||25
11111014|NCT01284335|12295653|FG001|Received at Least One Dose of Study Drug|Overall Study||33
11111015|NCT01284335|12295654|FG002|Received at Least One Dose of Study Drug|Overall Study||5
11111016|NCT01284335|12295655|FG003|Received at Least One Dose of Study Drug|Overall Study||5
11111017|NCT01284335|12295656|FG004|Received at Least One Dose of Study Drug|Overall Study||24
11111018|NCT01284335|12295657|FG005|Received at Least One Dose of Study Drug|Overall Study||26
11111019|NCT01284335|12295658|FG006|Received at Least One Dose of Study Drug|Overall Study||19
11111020|NCT01284335|12295659|FG007|Received at Least One Dose of Study Drug|Overall Study||6
11111021|NCT01284335|12295660|FG008|Received at Least One Dose of Study Drug|Overall Study||4
11229664|NCT02017093|12421818|FG001|COMPLETED|Overall Study||3
11229665|NCT02017093|12421817|FG000|NOT COMPLETED|Overall Study||0
11229666|NCT02017093|12421818|FG001|NOT COMPLETED|Overall Study||0
11229667|NCT02017171|12421828|FG000|STARTED|Overall Study||267
11229668|NCT02017171|12421829|FG001|STARTED|Overall Study||263
11229669|NCT02017171|12421828|FG000|COMPLETED|Overall Study||205
11229670|NCT02017171|12421829|FG001|COMPLETED|Overall Study||217
11229671|NCT02017171|12421828|FG000|NOT COMPLETED|Overall Study||62
11229672|NCT02017171|12421829|FG001|NOT COMPLETED|Overall Study||46
11229673|NCT02017210|12421839|FG000|STARTED|Overall Study||17
11229674|NCT02017210|12421840|FG001|STARTED|Overall Study||20
10869597|NCT02496676|12035126|FG000|NOT COMPLETED|Washout Period||0
10869598|NCT02496676|12035127|FG001|NOT COMPLETED|Washout Period||0
10869599|NCT02496676|12035126|FG000|STARTED|Phase 2 - IV MgSO4||2
10869600|NCT02496676|12035127|FG001|STARTED|Phase 2 - IV MgSO4||2
10869601|NCT02496676|12035126|FG000|COMPLETED|Phase 2 - IV MgSO4||2
10869602|NCT02496676|12035127|FG001|COMPLETED|Phase 2 - IV MgSO4||1
10869603|NCT02496676|12035126|FG000|NOT COMPLETED|Phase 2 - IV MgSO4||0
10869604|NCT02496676|12035127|FG001|NOT COMPLETED|Phase 2 - IV MgSO4||1
10869605|NCT02496676|12035126|FG000|STARTED|Phase 2 - Oral Magnesium||2
10869606|NCT02496676|12035127|FG001|STARTED|Phase 2 - Oral Magnesium||1
10869607|NCT02496676|12035126|FG000|COMPLETED|Phase 2 - Oral Magnesium||2
10869608|NCT02496676|12035127|FG001|COMPLETED|Phase 2 - Oral Magnesium||1
10869609|NCT02496676|12035126|FG000|NOT COMPLETED|Phase 2 - Oral Magnesium||0
10869610|NCT02496676|12035127|FG001|NOT COMPLETED|Phase 2 - Oral Magnesium||0
10869611|NCT02494141|12035143|FG000|STARTED|Overall Study||34
10869612|NCT02494141|12035144|FG001|STARTED|Overall Study||34
10869613|NCT02494141|12035143|FG000|COMPLETED|Overall Study||28
10869614|NCT02494141|12035144|FG001|COMPLETED|Overall Study||29
10869615|NCT02494141|12035143|FG000|NOT COMPLETED|Overall Study||6
10869616|NCT02494141|12035144|FG001|NOT COMPLETED|Overall Study||5
10869617|NCT02412618|12035152|FG000|STARTED|Overall Study||50
10869618|NCT02412618|12035153|FG001|STARTED|Overall Study||50
10869619|NCT02412618|12035152|FG000|COMPLETED|Overall Study||48
10869620|NCT02412618|12035153|FG001|COMPLETED|Overall Study||48
10869621|NCT02412618|12035152|FG000|NOT COMPLETED|Overall Study||2
10869622|NCT02412618|12035153|FG001|NOT COMPLETED|Overall Study||2
10869623|NCT02373683|12035161|FG000|STARTED|Overall Study||6
10869624|NCT02373683|12035162|FG001|STARTED|Overall Study||4
10869625|NCT02373683|12035161|FG000|COMPLETED|Overall Study||6
10869626|NCT02373683|12035162|FG001|COMPLETED|Overall Study||4
10869627|NCT02373683|12035161|FG000|NOT COMPLETED|Overall Study||0
10869628|NCT02373683|12035162|FG001|NOT COMPLETED|Overall Study||0
10869629|NCT02351180|12035170|FG000|STARTED|Overall Study||8
10869630|NCT02351180|12035171|FG001|STARTED|Overall Study||8
10869631|NCT02351180|12035170|FG000|COMPLETED|Overall Study||7
10869632|NCT02351180|12035171|FG001|COMPLETED|Overall Study||8
10869633|NCT02351180|12035170|FG000|NOT COMPLETED|Overall Study||1
10869634|NCT02351180|12035171|FG001|NOT COMPLETED|Overall Study||0
10869635|NCT02337764|12035177|FG000|STARTED|Overall Study||222
10869636|NCT02337764|12035177|FG000|COMPLETED|Overall Study||162
10869637|NCT02337764|12035177|FG000|NOT COMPLETED|Overall Study||60
10869638|NCT02337738|12035184|FG000|STARTED|Overall Study||141
10869639|NCT02337738|12035185|FG001|STARTED|Overall Study||134
10869640|NCT02337738|12035186|FG002|STARTED|Overall Study||129
10869641|NCT02337738|12035184|FG000|COMPLETED|Overall Study||119
10869642|NCT02337738|12035185|FG001|COMPLETED|Overall Study||104
10869643|NCT02337738|12035186|FG002|COMPLETED|Overall Study||103
10869644|NCT02337738|12035184|FG000|NOT COMPLETED|Overall Study||22
10869645|NCT02337738|12035185|FG001|NOT COMPLETED|Overall Study||30
10869646|NCT02337738|12035186|FG002|NOT COMPLETED|Overall Study||26
10869647|NCT02332187|12035196|FG000|STARTED|Overall Study||5
10869648|NCT02332187|12035197|FG001|STARTED|Overall Study||10
10869649|NCT02332187|12035196|FG000|COMPLETED|Overall Study||3
10869650|NCT02332187|12035197|FG001|COMPLETED|Overall Study||7
10869651|NCT02332187|12035196|FG000|NOT COMPLETED|Overall Study||2
10869652|NCT02332187|12035197|FG001|NOT COMPLETED|Overall Study||3
10869653|NCT02227875|12035205|FG000|STARTED|Overall Study||277
10869654|NCT02227875|12035206|FG001|STARTED|Overall Study||283
10869655|NCT02227875|12035205|FG000|COMPLETED|Overall Study||240
10869656|NCT02227875|12035206|FG001|COMPLETED|Overall Study||250
10869657|NCT02227875|12035205|FG000|NOT COMPLETED|Overall Study||37
10869658|NCT02227875|12035206|FG001|NOT COMPLETED|Overall Study||33
10869659|NCT02227862|12035214|FG000|STARTED|Overall Study||280
10869660|NCT02227862|12035215|FG001|STARTED|Overall Study||278
10869661|NCT02227862|12035214|FG000|Week 24|Overall Study||269
10869662|NCT02227862|12035215|FG001|Week 24|Overall Study||263
10869663|NCT02227862|12035214|FG000|COMPLETED|Overall Study||261
10869664|NCT02227862|12035215|FG001|COMPLETED|Overall Study||256
10869665|NCT02227862|12035214|FG000|NOT COMPLETED|Overall Study||19
10869666|NCT02227862|12035215|FG001|NOT COMPLETED|Overall Study||22
10869667|NCT02200939|12035223|FG000|STARTED|Overall Study||33
10869668|NCT02200939|12035224|FG001|STARTED|Overall Study||115
10869669|NCT02200939|12035223|FG000|COMPLETED|Overall Study||31
10869670|NCT02200939|12035224|FG001|COMPLETED|Overall Study||104
10869671|NCT02200939|12035223|FG000|NOT COMPLETED|Overall Study||2
10869672|NCT02200939|12035224|FG001|NOT COMPLETED|Overall Study||11
10869673|NCT02108964|12035242|FG000|STARTED|Overall Study||17
10869674|NCT02108964|12035243|FG001|STARTED|Overall Study||38
10869675|NCT02108964|12035244|FG002|STARTED|Overall Study||73
11229675|NCT02017210|12421841|FG002|STARTED|Overall Study||20
10869676|NCT02108964|12035245|FG003|STARTED|Overall Study||8
10869677|NCT02108964|12035246|FG004|STARTED|Overall Study||28
10869678|NCT02108964|12035247|FG005|STARTED|Overall Study||5
10869679|NCT02108964|12035248|FG006|STARTED|Overall Study||11
10869680|NCT02108964|12035249|FG007|STARTED|Overall Study||45
10869681|NCT02108964|12035242|FG000|COMPLETED|Overall Study||3
10869682|NCT02108964|12035243|FG001|COMPLETED|Overall Study||6
10869683|NCT02108964|12035244|FG002|COMPLETED|Overall Study||8
10869684|NCT02108964|12035245|FG003|COMPLETED|Overall Study||2
10869685|NCT02108964|12035246|FG004|COMPLETED|Overall Study||3
10869686|NCT02108964|12035247|FG005|COMPLETED|Overall Study||0
10869687|NCT02108964|12035248|FG006|COMPLETED|Overall Study||0
10869688|NCT02108964|12035249|FG007|COMPLETED|Overall Study||33
10869689|NCT02108964|12035242|FG000|NOT COMPLETED|Overall Study||14
10869690|NCT02108964|12035243|FG001|NOT COMPLETED|Overall Study||32
10869691|NCT02108964|12035244|FG002|NOT COMPLETED|Overall Study||65
10869692|NCT02108964|12035245|FG003|NOT COMPLETED|Overall Study||6
10869693|NCT02108964|12035246|FG004|NOT COMPLETED|Overall Study||25
10869694|NCT02108964|12035247|FG005|NOT COMPLETED|Overall Study||5
10869695|NCT02108964|12035248|FG006|NOT COMPLETED|Overall Study||11
10869696|NCT02108964|12035249|FG007|NOT COMPLETED|Overall Study||12
10869697|NCT02022566|12035270|FG000|STARTED|Overall Study||227
10869698|NCT02022566|12035271|FG001|STARTED|Overall Study||90
10869699|NCT02022566|12035270|FG000|COMPLETED|Overall Study||169
10869700|NCT02022566|12035271|FG001|COMPLETED|Overall Study||49
10869701|NCT02022566|12035270|FG000|NOT COMPLETED|Overall Study||58
10869702|NCT02022566|12035271|FG001|NOT COMPLETED|Overall Study||41
10869703|NCT01989598|12035277|FG000|STARTED|Overall Study|Includes pts receiving Single agent Trametinib and pts who are receiving Trametinib with AKT Inhibitor GSK2141795|25
10869704|NCT01989598|12035277|FG000|Dual Therapy With Trametinib and GSK2141795|Overall Study|Patients with progressive disease or who achieve less than PR after 4 courses also received Akt inhibitor GSK2141795 PO daily on days 1-28 along with Tremetinib|12
10869705|NCT01989598|12035277|FG000|COMPLETED|Overall Study|Note: 25 patients enrolled, however, one patient unevaluable was not included in analysis|25
10869706|NCT01989598|12035277|FG000|NOT COMPLETED|Overall Study||0
10869707|NCT01939275|12035286|FG000|STARTED|Overall Study||8
10869708|NCT01939275|12035286|FG000|COMPLETED|Overall Study||8
10869709|NCT01939275|12035286|FG000|NOT COMPLETED|Overall Study||0
10869710|NCT01922895|12035292|FG000|STARTED|Overall Study||24
10869711|NCT01922895|12035293|FG001|STARTED|Overall Study||21
10869712|NCT01922895|12035292|FG000|COMPLETED|Overall Study||18
10869713|NCT01922895|12035293|FG001|COMPLETED|Overall Study||7
10869714|NCT01922895|12035292|FG000|NOT COMPLETED|Overall Study||6
10869715|NCT01922895|12035293|FG001|NOT COMPLETED|Overall Study||14
10869716|NCT01901289|12035299|FG000|STARTED|Overall Study||200
10869717|NCT01901289|12035299|FG000|12-Month Follow-up|Overall Study||194
10869718|NCT01901289|12035299|FG000|COMPLETED|Overall Study||115
10869719|NCT01901289|12035299|FG000|NOT COMPLETED|Overall Study||85
10869720|NCT01831895|12035303|FG000|STARTED|Overall Study||17
10869721|NCT01831895|12035303|FG000|COMPLETED|Overall Study||15
10869722|NCT01831895|12035303|FG000|NOT COMPLETED|Overall Study||2
10869723|NCT01831076|12035309|FG000|STARTED|Overall Study||31
10869724|NCT01831076|12035310|FG001|STARTED|Overall Study||5
10869725|NCT01831076|12035309|FG000|COMPLETED|Overall Study||30
10869726|NCT01831076|12035310|FG001|COMPLETED|Overall Study||4
10869727|NCT01831076|12035309|FG000|NOT COMPLETED|Overall Study||1
10869728|NCT01831076|12035310|FG001|NOT COMPLETED|Overall Study||1
11111022|NCT01284335|12295661|FG009|Received at Least One Dose of Study Drug|Overall Study||14
11111023|NCT01284335|12295662|FG010|Received at Least One Dose of Study Drug|Overall Study||45
11111024|NCT01284335|12295663|FG011|Received at Least One Dose of Study Drug|Overall Study||16
11111025|NCT01284335|12295664|FG012|Received at Least One Dose of Study Drug|Overall Study||12
11111026|NCT01284335|12295652|FG000|COMPLETED|Overall Study||25
11111027|NCT01284335|12295653|FG001|COMPLETED|Overall Study||33
11111028|NCT01284335|12295654|FG002|COMPLETED|Overall Study||5
11111029|NCT01284335|12295655|FG003|COMPLETED|Overall Study||5
11111030|NCT01284335|12295656|FG004|COMPLETED|Overall Study||24
11111031|NCT01284335|12295657|FG005|COMPLETED|Overall Study||26
11111032|NCT01284335|12295658|FG006|COMPLETED|Overall Study||19
10869729|NCT01595581|12035318|FG000|STARTED|Overall Study||7
10869730|NCT01595581|12035319|FG001|STARTED|Overall Study||7
10869731|NCT01595581|12035318|FG000|COMPLETED|Overall Study||6
10869732|NCT01595581|12035319|FG001|COMPLETED|Overall Study||7
10869733|NCT01595581|12035318|FG000|NOT COMPLETED|Overall Study||1
10869734|NCT01595581|12035319|FG001|NOT COMPLETED|Overall Study||0
10869735|NCT01514682|12035329|FG000|STARTED|Overall Study||19
10869736|NCT01514682|12035330|FG001|STARTED|Overall Study||20
10869737|NCT01514682|12035329|FG000|COMPLETED|Overall Study||13
10869738|NCT01514682|12035330|FG001|COMPLETED|Overall Study||14
10869739|NCT01514682|12035329|FG000|NOT COMPLETED|Overall Study||6
11229676|NCT02017210|12421839|FG000|COMPLETED|Overall Study||17
11229677|NCT02017210|12421840|FG001|COMPLETED|Overall Study||20
11229678|NCT02017210|12421841|FG002|COMPLETED|Overall Study||20
11229679|NCT02017210|12421839|FG000|NOT COMPLETED|Overall Study||0
11229680|NCT02017210|12421840|FG001|NOT COMPLETED|Overall Study||0
11229681|NCT02017210|12421841|FG002|NOT COMPLETED|Overall Study||0
11229682|NCT02017223|12421852|FG000|STARTED|Overall Study||12
11229683|NCT02017223|12421852|FG000|COMPLETED|Overall Study||10
10869740|NCT01514682|12035330|FG001|NOT COMPLETED|Overall Study||6
10869741|NCT01453140|12035336|FG000|STARTED|Overall Study|3 patients were enrolled|3
10869742|NCT01453140|12035336|FG000|COMPLETED|Overall Study|All three patients experienced grade 4 limiting toxicities (possible treatment related)|0
10869743|NCT01453140|12035336|FG000|NOT COMPLETED|Overall Study||3
10869744|NCT01408641|12035346|FG000|STARTED|Overall Study||1
10869745|NCT01408641|12035347|FG001|STARTED|Overall Study||0
10869746|NCT01408641|12035346|FG000|COMPLETED|Overall Study||0
10869747|NCT01408641|12035347|FG001|COMPLETED|Overall Study||0
10869748|NCT01408641|12035346|FG000|NOT COMPLETED|Overall Study||1
10869749|NCT01408641|12035347|FG001|NOT COMPLETED|Overall Study||0
10869750|NCT01032265|12035355|FG000|STARTED|Overall Study||126
10869751|NCT01032265|12035356|FG001|STARTED|Overall Study||124
10869752|NCT01032265|12035355|FG000|COMPLETED|Overall Study||113
10869753|NCT01032265|12035356|FG001|COMPLETED|Overall Study||107
10869754|NCT01032265|12035355|FG000|NOT COMPLETED|Overall Study||13
10869755|NCT01032265|12035356|FG001|NOT COMPLETED|Overall Study||17
10869756|NCT00653068|12035366|FG000|STARTED|Overall Study||70
10869757|NCT00653068|12035366|FG000|COMPLETED|Overall Study||20
10869758|NCT00653068|12035366|FG000|NOT COMPLETED|Overall Study||50
10869759|NCT00193479|12035373|FG000|STARTED|Induction Chemotherapy||51
10869760|NCT00193479|12035373|FG000|COMPLETED|Induction Chemotherapy||48
10869761|NCT00193479|12035373|FG000|NOT COMPLETED|Induction Chemotherapy||3
10869762|NCT00193479|12035373|FG000|STARTED|Maintenance Rituximab||48
10869763|NCT00193479|12035373|FG000|COMPLETED|Maintenance Rituximab||44
10869764|NCT00193479|12035373|FG000|NOT COMPLETED|Maintenance Rituximab||4
10869765|NCT00193427|12035377|FG000|STARTED|Overall Study||75
10869766|NCT00193427|12035377|FG000|COMPLETED|Overall Study||26
10869767|NCT00193427|12035377|FG000|NOT COMPLETED|Overall Study||49
10869768|NCT00193414|12035382|FG000|STARTED|Overall Study||72
10869769|NCT00193414|12035382|FG000|COMPLETED|Overall Study||14
10869770|NCT00193414|12035382|FG000|NOT COMPLETED|Overall Study||58
10869771|NCT00085735|12035392|FG000|STARTED|Overall Study||64
10869772|NCT00085735|12035393|FG001|STARTED|Overall Study||64
10869773|NCT00085735|12035394|FG002|STARTED|Overall Study||63
10869774|NCT00085735|12035395|FG003|STARTED|Overall Study||65
11111033|NCT01284335|12295659|FG007|COMPLETED|Overall Study||6
11111034|NCT01284335|12295660|FG008|COMPLETED|Overall Study||4
11111035|NCT01284335|12295661|FG009|COMPLETED|Overall Study||14
11111036|NCT01284335|12295662|FG010|COMPLETED|Overall Study||45
11111037|NCT01284335|12295663|FG011|COMPLETED|Overall Study||16
11111038|NCT01284335|12295664|FG012|COMPLETED|Overall Study||12
11111039|NCT01284335|12295652|FG000|NOT COMPLETED|Overall Study||0
11111040|NCT01284335|12295653|FG001|NOT COMPLETED|Overall Study||0
11111041|NCT01284335|12295654|FG002|NOT COMPLETED|Overall Study||0
11111042|NCT01284335|12295655|FG003|NOT COMPLETED|Overall Study||0
11111043|NCT01284335|12295656|FG004|NOT COMPLETED|Overall Study||0
11111044|NCT01284335|12295657|FG005|NOT COMPLETED|Overall Study||0
11111045|NCT01284335|12295658|FG006|NOT COMPLETED|Overall Study||0
11111046|NCT01284335|12295659|FG007|NOT COMPLETED|Overall Study||0
11111047|NCT01284335|12295660|FG008|NOT COMPLETED|Overall Study||0
11111048|NCT01284335|12295661|FG009|NOT COMPLETED|Overall Study||0
11111049|NCT01284335|12295662|FG010|NOT COMPLETED|Overall Study||0
11111050|NCT01284335|12295663|FG011|NOT COMPLETED|Overall Study||0
11111051|NCT01284335|12295664|FG012|NOT COMPLETED|Overall Study||0
11355225|NCT03078127|12552117|FG000|STARTED|First Intervention||4
11355226|NCT03078127|12552118|FG001|STARTED|First Intervention||3
11355227|NCT03078127|12552119|FG002|STARTED|First Intervention||3
11111052|NCT01284361|12295704|FG000|STARTED|Overall Study||91
11111053|NCT01284361|12295704|FG000|COMPLETED|Overall Study||82
11111054|NCT01284361|12295704|FG000|NOT COMPLETED|Overall Study||9
11111055|NCT01284426|12295711|FG000|STARTED|Overall Study||94
11111056|NCT01284426|12295711|FG000|COMPLETED|Overall Study||92
11111057|NCT01284426|12295711|FG000|NOT COMPLETED|Overall Study||2
11111058|NCT01284517|12295717|FG000|STARTED|Overall Study||180
11111059|NCT01284517|12295718|FG001|STARTED|Overall Study||176
11111060|NCT01284517|12295717|FG000|COMPLETED|Overall Study||148
11111061|NCT01284517|12295718|FG001|COMPLETED|Overall Study||140
11111062|NCT01284517|12295717|FG000|NOT COMPLETED|Overall Study||32
11229684|NCT02017223|12421852|FG000|NOT COMPLETED|Overall Study||2
11229685|NCT02017327|12421859|FG000|STARTED|Overall Study||122
11355228|NCT03078127|12552117|FG000|COMPLETED|First Intervention||4
10869775|NCT00085735|12035396|FG004|STARTED|Overall Study||147
10869776|NCT00085735|12035397|FG005|STARTED|Overall Study||146
10869777|NCT00085735|12035392|FG000|COMPLETED|Overall Study||52
10869778|NCT00085735|12035393|FG001|COMPLETED|Overall Study||54
11111063|NCT01284517|12295718|FG001|NOT COMPLETED|Overall Study||36
11111064|NCT01284621|12295724|FG000|STARTED|First Intervention (8 Days)||3
11111065|NCT01284621|12295725|FG001|STARTED|First Intervention (8 Days)||4
11111066|NCT01284621|12295726|FG002|STARTED|First Intervention (8 Days)||4
11111067|NCT01284621|12295727|FG003|STARTED|First Intervention (8 Days)||4
11111068|NCT01284621|12295728|FG004|STARTED|First Intervention (8 Days)||4
11111069|NCT01284621|12295729|FG005|STARTED|First Intervention (8 Days)||4
11111070|NCT01284621|12295724|FG000|COMPLETED|First Intervention (8 Days)||3
11111071|NCT01284621|12295725|FG001|COMPLETED|First Intervention (8 Days)||4
11111072|NCT01284621|12295726|FG002|COMPLETED|First Intervention (8 Days)||4
11111073|NCT01284621|12295727|FG003|COMPLETED|First Intervention (8 Days)||4
11111074|NCT01284621|12295728|FG004|COMPLETED|First Intervention (8 Days)||4
11111075|NCT01284621|12295729|FG005|COMPLETED|First Intervention (8 Days)||4
11111076|NCT01284621|12295724|FG000|NOT COMPLETED|First Intervention (8 Days)||0
11111077|NCT01284621|12295725|FG001|NOT COMPLETED|First Intervention (8 Days)||0
11111078|NCT01284621|12295726|FG002|NOT COMPLETED|First Intervention (8 Days)||0
11111079|NCT01284621|12295727|FG003|NOT COMPLETED|First Intervention (8 Days)||0
11111080|NCT01284621|12295728|FG004|NOT COMPLETED|First Intervention (8 Days)||0
11111081|NCT01284621|12295729|FG005|NOT COMPLETED|First Intervention (8 Days)||0
11111082|NCT01284621|12295724|FG000|STARTED|Washout Period 1 (7 Days)||3
11111083|NCT01284621|12295725|FG001|STARTED|Washout Period 1 (7 Days)||4
11111084|NCT01284621|12295726|FG002|STARTED|Washout Period 1 (7 Days)||4
11111085|NCT01284621|12295727|FG003|STARTED|Washout Period 1 (7 Days)||4
11111086|NCT01284621|12295728|FG004|STARTED|Washout Period 1 (7 Days)||4
11111087|NCT01284621|12295729|FG005|STARTED|Washout Period 1 (7 Days)||4
11111088|NCT01284621|12295724|FG000|COMPLETED|Washout Period 1 (7 Days)||3
11111089|NCT01284621|12295725|FG001|COMPLETED|Washout Period 1 (7 Days)||4
11111090|NCT01284621|12295726|FG002|COMPLETED|Washout Period 1 (7 Days)||4
11111091|NCT01284621|12295727|FG003|COMPLETED|Washout Period 1 (7 Days)||4
11111092|NCT01284621|12295728|FG004|COMPLETED|Washout Period 1 (7 Days)||3
11111093|NCT01284621|12295729|FG005|COMPLETED|Washout Period 1 (7 Days)||4
11111094|NCT01284621|12295724|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
11111095|NCT01284621|12295725|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
11111096|NCT01284621|12295726|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
11111097|NCT01284621|12295727|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
11111098|NCT01284621|12295728|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||1
11111099|NCT01284621|12295729|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
11111100|NCT01284621|12295724|FG000|STARTED|Second Intervention (8 Days)||3
11111101|NCT01284621|12295725|FG001|STARTED|Second Intervention (8 Days)||4
11111102|NCT01284621|12295726|FG002|STARTED|Second Intervention (8 Days)||4
11111103|NCT01284621|12295727|FG003|STARTED|Second Intervention (8 Days)||4
11111104|NCT01284621|12295728|FG004|STARTED|Second Intervention (8 Days)||3
11111105|NCT01284621|12295729|FG005|STARTED|Second Intervention (8 Days)||4
11111106|NCT01284621|12295724|FG000|COMPLETED|Second Intervention (8 Days)||3
11111107|NCT01284621|12295725|FG001|COMPLETED|Second Intervention (8 Days)||4
11111108|NCT01284621|12295726|FG002|COMPLETED|Second Intervention (8 Days)||4
11111109|NCT01284621|12295727|FG003|COMPLETED|Second Intervention (8 Days)||4
11111110|NCT01284621|12295728|FG004|COMPLETED|Second Intervention (8 Days)||3
11111111|NCT01284621|12295729|FG005|COMPLETED|Second Intervention (8 Days)||4
11111112|NCT01284621|12295724|FG000|NOT COMPLETED|Second Intervention (8 Days)||0
11111113|NCT01284621|12295725|FG001|NOT COMPLETED|Second Intervention (8 Days)||0
11111114|NCT01284621|12295726|FG002|NOT COMPLETED|Second Intervention (8 Days)||0
11111115|NCT01284621|12295727|FG003|NOT COMPLETED|Second Intervention (8 Days)||0
11111116|NCT01284621|12295728|FG004|NOT COMPLETED|Second Intervention (8 Days)||0
11111117|NCT01284621|12295729|FG005|NOT COMPLETED|Second Intervention (8 Days)||0
11111118|NCT01284621|12295724|FG000|STARTED|Washout Period 2 (7 Days)||3
11111119|NCT01284621|12295725|FG001|STARTED|Washout Period 2 (7 Days)||4
11111120|NCT01284621|12295726|FG002|STARTED|Washout Period 2 (7 Days)||4
11111121|NCT01284621|12295727|FG003|STARTED|Washout Period 2 (7 Days)||4
11111122|NCT01284621|12295728|FG004|STARTED|Washout Period 2 (7 Days)||3
11111123|NCT01284621|12295729|FG005|STARTED|Washout Period 2 (7 Days)||4
11111124|NCT01284621|12295724|FG000|COMPLETED|Washout Period 2 (7 Days)||3
11111125|NCT01284621|12295725|FG001|COMPLETED|Washout Period 2 (7 Days)||4
11111126|NCT01284621|12295726|FG002|COMPLETED|Washout Period 2 (7 Days)||4
11111127|NCT01284621|12295727|FG003|COMPLETED|Washout Period 2 (7 Days)||4
11111128|NCT01284621|12295728|FG004|COMPLETED|Washout Period 2 (7 Days)||3
11111129|NCT01284621|12295729|FG005|COMPLETED|Washout Period 2 (7 Days)||4
11111130|NCT01284621|12295724|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
11111131|NCT01284621|12295725|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
11111132|NCT01284621|12295726|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
11111133|NCT01284621|12295727|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
11111134|NCT01284621|12295728|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
11111135|NCT01284621|12295729|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
11111136|NCT01284621|12295724|FG000|STARTED|Third Intervention (8 Days)||3
11111137|NCT01284621|12295725|FG001|STARTED|Third Intervention (8 Days)||4
11111138|NCT01284621|12295726|FG002|STARTED|Third Intervention (8 Days)||4
11111139|NCT01284621|12295727|FG003|STARTED|Third Intervention (8 Days)||4
11229686|NCT02017327|12421860|FG001|STARTED|Overall Study||125
11229687|NCT02017327|12421861|FG002|STARTED|Overall Study||132
11229688|NCT02017327|12421859|FG000|COMPLETED|Overall Study||106
11229689|NCT02017327|12421860|FG001|COMPLETED|Overall Study||113
11229690|NCT02017327|12421861|FG002|COMPLETED|Overall Study||117
11229691|NCT02017327|12421859|FG000|NOT COMPLETED|Overall Study||16
10869779|NCT00085735|12035394|FG002|COMPLETED|Overall Study||46
10869780|NCT00085735|12035395|FG003|COMPLETED|Overall Study||46
10869781|NCT00085735|12035396|FG004|COMPLETED|Overall Study||105
10869782|NCT00085735|12035397|FG005|COMPLETED|Overall Study||115
10869783|NCT00085735|12035392|FG000|NOT COMPLETED|Overall Study||12
10869784|NCT00085735|12035393|FG001|NOT COMPLETED|Overall Study||10
10869785|NCT00085735|12035394|FG002|NOT COMPLETED|Overall Study||17
10869786|NCT00085735|12035395|FG003|NOT COMPLETED|Overall Study||19
10869787|NCT00085735|12035396|FG004|NOT COMPLETED|Overall Study||42
10869788|NCT00085735|12035397|FG005|NOT COMPLETED|Overall Study||31
10869789|NCT00003042|12035426|FG000|STARTED|Overall Study||14
10869790|NCT00003042|12035427|FG001|STARTED|Overall Study||27
10869791|NCT00003042|12035426|FG000|COMPLETED|Overall Study||14
10869792|NCT00003042|12035427|FG001|COMPLETED|Overall Study||27
10869793|NCT00003042|12035426|FG000|NOT COMPLETED|Overall Study||0
10869794|NCT00003042|12035427|FG001|NOT COMPLETED|Overall Study||0
11229692|NCT02017327|12421860|FG001|NOT COMPLETED|Overall Study||12
11229693|NCT02017327|12421861|FG002|NOT COMPLETED|Overall Study||15
10869795|NCT04399356|12035435|FG000|STARTED|Overall Study||36
10869796|NCT04399356|12035436|FG001|STARTED|Overall Study||37
10869797|NCT04399356|12035435|FG000|COMPLETED|Overall Study||33
10869798|NCT04399356|12035436|FG001|COMPLETED|Overall Study||34
10869799|NCT04399356|12035435|FG000|NOT COMPLETED|Overall Study||3
10869800|NCT04399356|12035436|FG001|NOT COMPLETED|Overall Study||3
10869801|NCT04350905|12035442|FG000|STARTED|Overall Study||42
10869802|NCT04350905|12035442|FG000|COMPLETED|Overall Study||41
10869803|NCT04350905|12035442|FG000|NOT COMPLETED|Overall Study||1
10869804|NCT04236635|12035446|FG000|STARTED|Overall Study||2
10869805|NCT04236635|12035447|FG001|STARTED|Overall Study||1
10869806|NCT04236635|12035448|FG002|STARTED|Overall Study||1
10869807|NCT04236635|12035449|FG003|STARTED|Overall Study||4
10869808|NCT04236635|12035450|FG004|STARTED|Overall Study||1
10869809|NCT04236635|12035451|FG005|STARTED|Overall Study||1
10869810|NCT04236635|12035446|FG000|Safety Population|Overall Study||2
10869811|NCT04236635|12035447|FG001|Safety Population|Overall Study||1
10869812|NCT04236635|12035448|FG002|Safety Population|Overall Study||1
10869813|NCT04236635|12035449|FG003|Safety Population|Overall Study||4
10869814|NCT04236635|12035450|FG004|Safety Population|Overall Study||1
10869815|NCT04236635|12035451|FG005|Safety Population|Overall Study||1
10869816|NCT04236635|12035446|FG000|Evaluable Population|Overall Study||2
10869817|NCT04236635|12035447|FG001|Evaluable Population|Overall Study||1
10869818|NCT04236635|12035448|FG002|Evaluable Population|Overall Study||1
10869819|NCT04236635|12035449|FG003|Evaluable Population|Overall Study||2
10869820|NCT04236635|12035450|FG004|Evaluable Population|Overall Study||1
10869821|NCT04236635|12035451|FG005|Evaluable Population|Overall Study||1
10869822|NCT04236635|12035446|FG000|COMPLETED|Overall Study||2
10869823|NCT04236635|12035447|FG001|COMPLETED|Overall Study||1
10869824|NCT04236635|12035448|FG002|COMPLETED|Overall Study||1
10869825|NCT04236635|12035449|FG003|COMPLETED|Overall Study||4
10869826|NCT04236635|12035450|FG004|COMPLETED|Overall Study||1
10869827|NCT04236635|12035451|FG005|COMPLETED|Overall Study||1
10869828|NCT04236635|12035446|FG000|NOT COMPLETED|Overall Study||0
10869829|NCT04236635|12035447|FG001|NOT COMPLETED|Overall Study||0
10869830|NCT04236635|12035448|FG002|NOT COMPLETED|Overall Study||0
10869831|NCT04236635|12035449|FG003|NOT COMPLETED|Overall Study||0
10869832|NCT04236635|12035450|FG004|NOT COMPLETED|Overall Study||0
10869833|NCT04236635|12035451|FG005|NOT COMPLETED|Overall Study||0
10869834|NCT04156399|12035466|FG000|STARTED|Overall Study||6
10869835|NCT04156399|12035466|FG000|COMPLETED|Overall Study|Of the six participants who started the study, two completed all 10 acupuncture sessions, two completed 9 sessions, and one completed 8 sessions. The three who completed 8 or 9 sessions were unable to complete due to the COVID-19 lockdowns, however, we were able to collect post-test measures for them. Finally, one participant was hospitalized (unrelated to acupuncture) and could not complete the study nor provide post-test measures.|2
10869836|NCT04156399|12035466|FG000|NOT COMPLETED|Overall Study||4
10869837|NCT04115228|12035470|FG000|STARTED|Overall Study||10
10869838|NCT04115228|12035470|FG000|COMPLETED|Overall Study||10
10869839|NCT04115228|12035470|FG000|NOT COMPLETED|Overall Study||0
10869840|NCT04052620|12035476|FG000|STARTED|Overall Study||150
10869841|NCT04052620|12035477|FG001|STARTED|Overall Study||152
10869842|NCT04052620|12035476|FG000|COMPLETED|Overall Study||143
10869843|NCT04052620|12035477|FG001|COMPLETED|Overall Study||145
10869844|NCT04052620|12035476|FG000|NOT COMPLETED|Overall Study||7
10869845|NCT04052620|12035477|FG001|NOT COMPLETED|Overall Study||7
11111140|NCT01284621|12295728|FG004|STARTED|Third Intervention (8 Days)||3
11355229|NCT03078127|12552118|FG001|COMPLETED|First Intervention||3
11355230|NCT03078127|12552119|FG002|COMPLETED|First Intervention||3
11355231|NCT03078127|12552117|FG000|NOT COMPLETED|First Intervention||0
11355232|NCT03078127|12552118|FG001|NOT COMPLETED|First Intervention||0
11355233|NCT03078127|12552119|FG002|NOT COMPLETED|First Intervention||0
11355234|NCT03078127|12552117|FG000|STARTED|Washout (3-21 Days)||4
11111141|NCT01284621|12295729|FG005|STARTED|Third Intervention (8 Days)||4
11111142|NCT01284621|12295724|FG000|COMPLETED|Third Intervention (8 Days)||3
11111143|NCT01284621|12295725|FG001|COMPLETED|Third Intervention (8 Days)||4
11111144|NCT01284621|12295726|FG002|COMPLETED|Third Intervention (8 Days)||4
11111145|NCT01284621|12295727|FG003|COMPLETED|Third Intervention (8 Days)||4
11229694|NCT02017444|12421871|FG000|STARTED|Overall Study||14
11229695|NCT02017444|12421872|FG001|STARTED|Overall Study||17
10869854|NCT03826667|12035492|FG000|STARTED|Overall Study||464
10869855|NCT03826667|12035492|FG000|HEALICOIL™ PK Preloaded Suture Anchors|Overall Study||193
10869856|NCT03826667|12035492|FG000|BIORAPTOR™ 2.3 PK Suture Anchors/BIORAPTOR™ Curved 2.3 PK Suture Anchors|Overall Study||41
10869857|NCT03826667|12035492|FG000|MULTIFIX™ S Ultra Knotless Fixation System|Overall Study||78
10869858|NCT03826667|12035492|FG000|FOOTPRINT™ Ultra PK Suture Anchors|Overall Study||136
10869859|NCT03826667|12035492|FG000|TWINFIX™ Ultra PK Suture Anchors/TWINFIX™ Ultra Preloaded and With Needles|Overall Study||57
10869860|NCT03826667|12035492|FG000|SPEEDSCREW™ Knotless Fixation System|Overall Study||59
10869861|NCT03826667|12035492|FG000|SpeedLock Knotless Fixation Device|Overall Study||18
10869862|NCT03826667|12035492|FG000|COMPLETED|Overall Study||443
10869863|NCT03826667|12035492|FG000|NOT COMPLETED|Overall Study||21
10869864|NCT03600909|12035505|FG000|STARTED|Overall Study||0
10869865|NCT03600909|12035506|FG001|STARTED|Overall Study||3
10869866|NCT03600909|12035507|FG002|STARTED|Overall Study||0
10869867|NCT03600909|12035505|FG000|COMPLETED|Overall Study||0
10869868|NCT03600909|12035506|FG001|COMPLETED|Overall Study||0
10869869|NCT03600909|12035507|FG002|COMPLETED|Overall Study||0
10869870|NCT03600909|12035505|FG000|NOT COMPLETED|Overall Study||0
11355235|NCT03078127|12552118|FG001|STARTED|Washout (3-21 Days)||3
10869871|NCT03600909|12035506|FG001|NOT COMPLETED|Overall Study||3
10869872|NCT03600909|12035507|FG002|NOT COMPLETED|Overall Study||0
11229696|NCT02017444|12421871|FG000|COMPLETED|Overall Study||12
11229697|NCT02017444|12421872|FG001|COMPLETED|Overall Study|NB: One participant did not complete primary outcome.|17
11229698|NCT02017444|12421871|FG000|NOT COMPLETED|Overall Study||2
11229699|NCT02017444|12421872|FG001|NOT COMPLETED|Overall Study||0
11229700|NCT02017535|12421882|FG000|STARTED|Overall Study||9
11229701|NCT02017535|12421883|FG001|STARTED|Overall Study||3
11229702|NCT02017535|12421884|FG002|STARTED|Overall Study||2
11229703|NCT02017535|12421885|FG003|STARTED|Overall Study||1
11229704|NCT02017535|12421882|FG000|COMPLETED|Overall Study||8
11229705|NCT02017535|12421883|FG001|COMPLETED|Overall Study||3
11229706|NCT02017535|12421884|FG002|COMPLETED|Overall Study||2
11229707|NCT02017535|12421885|FG003|COMPLETED|Overall Study||1
11229708|NCT02017535|12421882|FG000|NOT COMPLETED|Overall Study||1
11229709|NCT02017535|12421883|FG001|NOT COMPLETED|Overall Study||0
11229710|NCT02017535|12421884|FG002|NOT COMPLETED|Overall Study||0
11229711|NCT02017535|12421885|FG003|NOT COMPLETED|Overall Study||0
11229712|NCT02017574|12421897|FG000|STARTED|Overall Study||12
11229713|NCT02017574|12421898|FG001|STARTED|Overall Study||12
11229714|NCT02017574|12421897|FG000|COMPLETED|Overall Study||12
11229715|NCT02017574|12421898|FG001|COMPLETED|Overall Study||12
11229716|NCT02017574|12421897|FG000|NOT COMPLETED|Overall Study||0
11229717|NCT02017574|12421898|FG001|NOT COMPLETED|Overall Study||0
11229718|NCT02017860|12421904|FG000|STARTED|Overall Study||4
11229719|NCT02017860|12421904|FG000|COMPLETED|Overall Study||2
11229720|NCT02017860|12421904|FG000|NOT COMPLETED|Overall Study||2
11229721|NCT02017899|12421914|FG000|STARTED|Overall Study||8
11229722|NCT02017899|12421915|FG001|STARTED|Overall Study||9
11229723|NCT02017899|12421916|FG002|STARTED|Overall Study||8
11229724|NCT02017899|12421917|FG003|STARTED|Overall Study||8
11229725|NCT02017899|12421918|FG004|STARTED|Overall Study||9
11229726|NCT02017899|12421919|FG005|STARTED|Overall Study||8
11229727|NCT02017899|12421914|FG000|COMPLETED|Overall Study||8
11229728|NCT02017899|12421915|FG001|COMPLETED|Overall Study||9
11229729|NCT02017899|12421916|FG002|COMPLETED|Overall Study||8
11229730|NCT02017899|12421917|FG003|COMPLETED|Overall Study||7
11229731|NCT02017899|12421918|FG004|COMPLETED|Overall Study||8
11355236|NCT03078127|12552119|FG002|STARTED|Washout (3-21 Days)||3
11355237|NCT03078127|12552117|FG000|COMPLETED|Washout (3-21 Days)||4
11355238|NCT03078127|12552118|FG001|COMPLETED|Washout (3-21 Days)||3
11355239|NCT03078127|12552119|FG002|COMPLETED|Washout (3-21 Days)||3
11229732|NCT02017899|12421919|FG005|COMPLETED|Overall Study||8
11229733|NCT02017899|12421914|FG000|NOT COMPLETED|Overall Study||0
11229734|NCT02017899|12421915|FG001|NOT COMPLETED|Overall Study||0
11229735|NCT02017899|12421916|FG002|NOT COMPLETED|Overall Study||0
11229736|NCT02017899|12421917|FG003|NOT COMPLETED|Overall Study||1
11355240|NCT03078127|12552117|FG000|NOT COMPLETED|Washout (3-21 Days)||0
11111146|NCT01284621|12295728|FG004|COMPLETED|Third Intervention (8 Days)||3
11111147|NCT01284621|12295729|FG005|COMPLETED|Third Intervention (8 Days)||4
11111148|NCT01284621|12295724|FG000|NOT COMPLETED|Third Intervention (8 Days)||0
10869876|NCT03366428|12035523|FG000|STARTED|Overall Study||51
10869877|NCT03366428|12035523|FG000|COMPLETED|Overall Study||0
10869878|NCT03366428|12035523|FG000|NOT COMPLETED|Overall Study||51
10869879|NCT03221660|12035529|FG000|STARTED|Overall Study||50
10869880|NCT03221660|12035529|FG000|COMPLETED|Overall Study||50
10869881|NCT03221660|12035529|FG000|NOT COMPLETED|Overall Study||0
11111149|NCT01284621|12295725|FG001|NOT COMPLETED|Third Intervention (8 Days)||0
11111150|NCT01284621|12295726|FG002|NOT COMPLETED|Third Intervention (8 Days)||0
11111151|NCT01284621|12295727|FG003|NOT COMPLETED|Third Intervention (8 Days)||0
11111152|NCT01284621|12295728|FG004|NOT COMPLETED|Third Intervention (8 Days)||0
11111153|NCT01284621|12295729|FG005|NOT COMPLETED|Third Intervention (8 Days)||0
11111154|NCT01284634|12295743|FG000|STARTED|Overall Study||7
11111155|NCT01284634|12295744|FG001|STARTED|Overall Study||6
11111156|NCT01284634|12295745|FG002|STARTED|Overall Study||7
11111157|NCT01284634|12295746|FG003|STARTED|Overall Study||5
11111158|NCT01284634|12295743|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
11229737|NCT02017899|12421918|FG004|NOT COMPLETED|Overall Study||1
11229738|NCT02017899|12421919|FG005|NOT COMPLETED|Overall Study||0
11229739|NCT02018042|12421933|FG000|STARTED|Overall Study||15
11229740|NCT02018042|12421933|FG000|COMPLETED|Overall Study||14
11229741|NCT02018042|12421933|FG000|NOT COMPLETED|Overall Study||1
11229742|NCT02018107|12421937|FG000|STARTED|Overall Study||27
11229743|NCT02018107|12421937|FG000|COMPLETED|Overall Study||27
11229744|NCT02018107|12421937|FG000|NOT COMPLETED|Overall Study||0
11229745|NCT02018315|12421941|FG000|STARTED|Overall Study||14
11229746|NCT02018315|12421941|FG000|COMPLETED|Overall Study||14
11229747|NCT02018315|12421941|FG000|NOT COMPLETED|Overall Study||0
11229748|NCT02018445|12421945|FG000|STARTED|Overall Study||36
11229749|NCT02018445|12421945|FG000|COMPLETED|Overall Study||29
11229750|NCT02018445|12421945|FG000|NOT COMPLETED|Overall Study||7
11229751|NCT02018458|12421952|FG000|STARTED|Overall Study||10
11229752|NCT02018458|12421952|FG000|COMPLETED|Overall Study||6
11229753|NCT02018458|12421952|FG000|NOT COMPLETED|Overall Study||4
11229754|NCT02018562|12421958|FG000|STARTED|Overall Study||25
11229755|NCT02018562|12421959|FG001|STARTED|Overall Study||25
11229756|NCT02018562|12421958|FG000|COMPLETED|Overall Study||22
11229757|NCT02018562|12421959|FG001|COMPLETED|Overall Study||25
11229758|NCT02018562|12421958|FG000|NOT COMPLETED|Overall Study||3
11355241|NCT03078127|12552118|FG001|NOT COMPLETED|Washout (3-21 Days)||0
11355242|NCT03078127|12552119|FG002|NOT COMPLETED|Washout (3-21 Days)||0
11355243|NCT03078127|12552117|FG000|STARTED|Second Intervention||4
11355244|NCT03078127|12552118|FG001|STARTED|Second Intervention||3
11229759|NCT02018562|12421959|FG001|NOT COMPLETED|Overall Study||0
11229760|NCT02018627|12421967|FG000|STARTED|Overall Study||7
11229761|NCT02018627|12421968|FG001|STARTED|Overall Study||6
11229762|NCT02018627|12421967|FG000|COMPLETED|Overall Study||7
11229763|NCT02018627|12421968|FG001|COMPLETED|Overall Study||6
11229764|NCT02018627|12421967|FG000|NOT COMPLETED|Overall Study||0
11229765|NCT02018627|12421968|FG001|NOT COMPLETED|Overall Study||0
11229766|NCT02018653|12421976|FG000|STARTED|Overall Study||1
11355245|NCT03078127|12552119|FG002|STARTED|Second Intervention||3
11355246|NCT03078127|12552117|FG000|COMPLETED|Second Intervention||4
11355247|NCT03078127|12552118|FG001|COMPLETED|Second Intervention||3
11355248|NCT03078127|12552119|FG002|COMPLETED|Second Intervention||3
11355249|NCT03078127|12552117|FG000|NOT COMPLETED|Second Intervention||0
11355250|NCT03078127|12552118|FG001|NOT COMPLETED|Second Intervention||0
11355251|NCT03078127|12552119|FG002|NOT COMPLETED|Second Intervention||0
11355252|NCT03078127|12552117|FG000|STARTED|Washout (3-21 Days)||4
11355253|NCT03078127|12552118|FG001|STARTED|Washout (3-21 Days)||3
11355254|NCT03078127|12552119|FG002|STARTED|Washout (3-21 Days)||3
11355255|NCT03078127|12552117|FG000|COMPLETED|Washout (3-21 Days)||4
11355256|NCT03078127|12552118|FG001|COMPLETED|Washout (3-21 Days)||3
11355257|NCT03078127|12552119|FG002|COMPLETED|Washout (3-21 Days)||3
11355258|NCT03078127|12552117|FG000|NOT COMPLETED|Washout (3-21 Days)||0
11355259|NCT03078127|12552118|FG001|NOT COMPLETED|Washout (3-21 Days)||0
11355260|NCT03078127|12552119|FG002|NOT COMPLETED|Washout (3-21 Days)||0
11355261|NCT03078127|12552117|FG000|STARTED|Third Intervention||4
11355262|NCT03078127|12552118|FG001|STARTED|Third Intervention||3
11355263|NCT03078127|12552119|FG002|STARTED|Third Intervention||3
11355264|NCT03078127|12552117|FG000|COMPLETED|Third Intervention||4
11355265|NCT03078127|12552118|FG001|COMPLETED|Third Intervention||3
11355266|NCT03078127|12552119|FG002|COMPLETED|Third Intervention||3
11355267|NCT03078127|12552117|FG000|NOT COMPLETED|Third Intervention||0
11355268|NCT03078127|12552118|FG001|NOT COMPLETED|Third Intervention||0
11355269|NCT03078127|12552119|FG002|NOT COMPLETED|Third Intervention||0
11355270|NCT03078504|12552130|FG000|STARTED|Overall Study||6
11355271|NCT03078504|12552130|FG000|COMPLETED|Overall Study||6
11355272|NCT03078504|12552130|FG000|NOT COMPLETED|Overall Study||0
11355273|NCT03078556|12552136|FG000|STARTED|Treatment Period 1 (4 Days)||39
11355274|NCT03078556|12552137|FG001|STARTED|Treatment Period 1 (4 Days)||39
11355275|NCT03078556|12552138|FG002|STARTED|Treatment Period 1 (4 Days)||38
11355276|NCT03078556|12552139|FG003|STARTED|Treatment Period 1 (4 Days)||38
11355277|NCT03078556|12552136|FG000|COMPLETED|Treatment Period 1 (4 Days)||39
11355278|NCT03078556|12552137|FG001|COMPLETED|Treatment Period 1 (4 Days)||38
11111159|NCT01284634|12295744|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
11111160|NCT01284634|12295745|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
11111161|NCT01284634|12295746|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
11111162|NCT01284634|12295743|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||7
11229767|NCT02018653|12421977|FG001|STARTED|Overall Study||1
11229768|NCT02018653|12421976|FG000|COMPLETED|Overall Study||1
11229769|NCT02018653|12421977|FG001|COMPLETED|Overall Study||0
11229770|NCT02018653|12421976|FG000|NOT COMPLETED|Overall Study||0
11229771|NCT02018653|12421977|FG001|NOT COMPLETED|Overall Study||1
11229772|NCT02018809|12421987|FG000|STARTED|Overall Study||50
11229773|NCT02018809|12421988|FG001|STARTED|Overall Study||50
11229774|NCT02018809|12421989|FG002|STARTED|Overall Study||50
11229775|NCT02018809|12421990|FG003|STARTED|Overall Study||50
11229776|NCT02018809|12421987|FG000|COMPLETED|Overall Study||50
11229777|NCT02018809|12421988|FG001|COMPLETED|Overall Study||50
11229778|NCT02018809|12421989|FG002|COMPLETED|Overall Study||50
11229779|NCT02018809|12421990|FG003|COMPLETED|Overall Study||50
11229780|NCT02018809|12421987|FG000|NOT COMPLETED|Overall Study||0
11229781|NCT02018809|12421988|FG001|NOT COMPLETED|Overall Study||0
11229782|NCT02018809|12421989|FG002|NOT COMPLETED|Overall Study||0
11229783|NCT02018809|12421990|FG003|NOT COMPLETED|Overall Study||0
11229784|NCT02018822|12422002|FG000|STARTED|Overall Study||50
11229785|NCT02018822|12422003|FG001|STARTED|Overall Study||50
11229786|NCT02018822|12422004|FG002|STARTED|Overall Study||35
11229787|NCT02018822|12422002|FG000|COMPLETED|Overall Study||44
11229788|NCT02018822|12422003|FG001|COMPLETED|Overall Study||42
11229789|NCT02018822|12422004|FG002|COMPLETED|Overall Study||29
11229790|NCT02018822|12422002|FG000|NOT COMPLETED|Overall Study||6
11229791|NCT02018822|12422003|FG001|NOT COMPLETED|Overall Study||8
11229792|NCT02018822|12422004|FG002|NOT COMPLETED|Overall Study||6
11229793|NCT02018887|12422023|FG000|STARTED|Part A: Cohorts 1-2: Period 1||9
11229794|NCT02018887|12422024|FG001|STARTED|Part A: Cohorts 1-2: Period 1||9
11229795|NCT02018887|12422025|FG002|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
11111163|NCT01284634|12295744|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||6
11111164|NCT01284634|12295745|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||7
11111165|NCT01284634|12295746|FG003|Intent to Treat (ITT) Analysis Set|Overall Study||5
11111166|NCT01284634|12295743|FG000|COMPLETED|Overall Study||6
11111167|NCT01284634|12295744|FG001|COMPLETED|Overall Study||6
11111168|NCT01284634|12295745|FG002|COMPLETED|Overall Study||5
11355279|NCT03078556|12552138|FG002|COMPLETED|Treatment Period 1 (4 Days)||38
10869903|NCT02756611|12035546|FG000|STARTED|Overall Study||258
10869904|NCT02756611|12035546|FG000|COMPLETED|Overall Study||2
10869905|NCT02756611|12035546|FG000|NOT COMPLETED|Overall Study||256
10869906|NCT02724878|12035550|FG000|STARTED|Overall Study||65
10869907|NCT02724878|12035550|FG000|Treated|Overall Study||60
10869908|NCT02724878|12035550|FG000|Responders|Overall Study||20
10869909|NCT02724878|12035550|FG000|COMPLETED|Overall Study||0
10869910|NCT02724878|12035550|FG000|NOT COMPLETED|Overall Study||65
10869911|NCT02605993|12035558|FG000|STARTED|Treatment Period||6
10869912|NCT02605993|12035559|FG001|STARTED|Treatment Period||6
10869913|NCT02605993|12035560|FG002|STARTED|Treatment Period||7
10869914|NCT02605993|12035561|FG003|STARTED|Treatment Period||7
11355280|NCT03078556|12552139|FG003|COMPLETED|Treatment Period 1 (4 Days)||38
11355281|NCT03078556|12552136|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
10869915|NCT02605993|12035558|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||6
10869916|NCT02605993|12035559|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6
10869917|NCT02605993|12035560|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||7
10869918|NCT02605993|12035561|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||7
10869919|NCT02605993|12035558|FG000|COMPLETED|Treatment Period||6
10869920|NCT02605993|12035559|FG001|COMPLETED|Treatment Period||6
10869921|NCT02605993|12035560|FG002|COMPLETED|Treatment Period||7
10869922|NCT02605993|12035561|FG003|COMPLETED|Treatment Period||7
10869923|NCT02605993|12035558|FG000|NOT COMPLETED|Treatment Period||0
10869924|NCT02605993|12035559|FG001|NOT COMPLETED|Treatment Period||0
10869925|NCT02605993|12035560|FG002|NOT COMPLETED|Treatment Period||0
10869926|NCT02605993|12035561|FG003|NOT COMPLETED|Treatment Period||0
11111169|NCT01284634|12295746|FG003|COMPLETED|Overall Study||4
11111170|NCT01284634|12295743|FG000|NOT COMPLETED|Overall Study||1
11111171|NCT01284634|12295744|FG001|NOT COMPLETED|Overall Study||0
11111172|NCT01284634|12295745|FG002|NOT COMPLETED|Overall Study||2
11111173|NCT01284634|12295746|FG003|NOT COMPLETED|Overall Study||1
11111174|NCT01284959|12295759|FG000|STARTED|Overall Study||11
11111175|NCT01284959|12295760|FG001|STARTED|Overall Study||12
11111176|NCT01284959|12295761|FG002|STARTED|Overall Study||11
11111177|NCT01284959|12295759|FG000|COMPLETED|Overall Study||10
11111178|NCT01284959|12295760|FG001|COMPLETED|Overall Study||12
11111179|NCT01284959|12295761|FG002|COMPLETED|Overall Study||10
11111180|NCT01284959|12295759|FG000|NOT COMPLETED|Overall Study||1
11111181|NCT01284959|12295760|FG001|NOT COMPLETED|Overall Study||0
11111182|NCT01284959|12295761|FG002|NOT COMPLETED|Overall Study||1
11111183|NCT01285024|12295771|FG000|STARTED|Overall Study||49
11111184|NCT01285024|12295772|FG001|STARTED|Overall Study||60
11111185|NCT01285024|12295771|FG000|COMPLETED|Overall Study||49
11111186|NCT01285024|12295772|FG001|COMPLETED|Overall Study||60
11111187|NCT01285024|12295771|FG000|NOT COMPLETED|Overall Study||0
11111188|NCT01285024|12295772|FG001|NOT COMPLETED|Overall Study||0
11111189|NCT01285050|12295778|FG000|STARTED|Overall Study||20
11111190|NCT01285050|12295778|FG000|COMPLETED|Overall Study||19
11111191|NCT01285050|12295778|FG000|NOT COMPLETED|Overall Study||1
11111192|NCT01285076|12295783|FG000|STARTED|Overall Study||834
10869927|NCT02605993|12035558|FG000|STARTED|Extension Period||6
10869928|NCT02605993|12035559|FG001|STARTED|Extension Period||6
10869929|NCT02605993|12035560|FG002|STARTED|Extension Period||7
10869930|NCT02605993|12035561|FG003|STARTED|Extension Period||7
10869931|NCT02605993|12035558|FG000|COMPLETED|Extension Period||0
10869932|NCT02605993|12035559|FG001|COMPLETED|Extension Period||0
10869933|NCT02605993|12035560|FG002|COMPLETED|Extension Period||0
10869934|NCT02605993|12035561|FG003|COMPLETED|Extension Period||0
10869935|NCT02605993|12035558|FG000|NOT COMPLETED|Extension Period||6
10869936|NCT02605993|12035559|FG001|NOT COMPLETED|Extension Period||6
10869937|NCT02605993|12035560|FG002|NOT COMPLETED|Extension Period||7
10869938|NCT02605993|12035561|FG003|NOT COMPLETED|Extension Period||7
10869939|NCT02487095|12035576|FG000|STARTED|Phase I Dose Escalation||6
10869940|NCT02487095|12035577|FG001|STARTED|Phase I Dose Escalation||6
10869941|NCT02487095|12035578|FG002|STARTED|Phase I Dose Escalation||3
10869942|NCT02487095|12035579|FG003|STARTED|Phase I Dose Escalation||6
10869943|NCT02487095|12035580|FG004|STARTED|Phase I Dose Escalation||0
10869944|NCT02487095|12035576|FG000|COMPLETED|Phase I Dose Escalation||6
10869945|NCT02487095|12035577|FG001|COMPLETED|Phase I Dose Escalation||6
10869946|NCT02487095|12035578|FG002|COMPLETED|Phase I Dose Escalation||3
10869947|NCT02487095|12035579|FG003|COMPLETED|Phase I Dose Escalation||6
10869948|NCT02487095|12035580|FG004|COMPLETED|Phase I Dose Escalation||0
10869949|NCT02487095|12035576|FG000|NOT COMPLETED|Phase I Dose Escalation||0
10869950|NCT02487095|12035577|FG001|NOT COMPLETED|Phase I Dose Escalation||0
10869951|NCT02487095|12035578|FG002|NOT COMPLETED|Phase I Dose Escalation||0
10869952|NCT02487095|12035579|FG003|NOT COMPLETED|Phase I Dose Escalation||0
10869953|NCT02487095|12035580|FG004|NOT COMPLETED|Phase I Dose Escalation||0
10869954|NCT02487095|12035576|FG000|STARTED|Dose Expansion||0
10869955|NCT02487095|12035577|FG001|STARTED|Dose Expansion||0
10869956|NCT02487095|12035578|FG002|STARTED|Dose Expansion||0
10869957|NCT02487095|12035579|FG003|STARTED|Dose Expansion||0
10869958|NCT02487095|12035580|FG004|STARTED|Dose Expansion||41
10869959|NCT02487095|12035576|FG000|COMPLETED|Dose Expansion||0
10869960|NCT02487095|12035577|FG001|COMPLETED|Dose Expansion||0
10869961|NCT02487095|12035578|FG002|COMPLETED|Dose Expansion||0
10869962|NCT02487095|12035579|FG003|COMPLETED|Dose Expansion||0
10869963|NCT02487095|12035580|FG004|COMPLETED|Dose Expansion||40
10869964|NCT02487095|12035576|FG000|NOT COMPLETED|Dose Expansion||0
10869965|NCT02487095|12035577|FG001|NOT COMPLETED|Dose Expansion||0
10869966|NCT02487095|12035578|FG002|NOT COMPLETED|Dose Expansion||0
10869967|NCT02487095|12035579|FG003|NOT COMPLETED|Dose Expansion||0
10869968|NCT02487095|12035580|FG004|NOT COMPLETED|Dose Expansion||1
10869969|NCT02347917|12035602|FG000|STARTED|Overall Study||4
10869970|NCT02347917|12035603|FG001|STARTED|Overall Study||24
10869971|NCT02347917|12035602|FG000|Discontinued beforeBBI608 Administration|Overall Study||0
10869972|NCT02347917|12035603|FG001|Discontinued beforeBBI608 Administration|Overall Study||0
10869973|NCT02347917|12035602|FG000|Start BBI608 Administration|Overall Study||4
10869974|NCT02347917|12035603|FG001|Start BBI608 Administration|Overall Study||24
10869975|NCT02347917|12035602|FG000|Discontinued in DLT Evaluation Period|Overall Study||1
10869976|NCT02347917|12035603|FG001|Discontinued in DLT Evaluation Period|Overall Study||0
10869977|NCT02347917|12035602|FG000|Complete DLT Evaluation Period|Overall Study||3
10869978|NCT02347917|12035603|FG001|Complete DLT Evaluation Period|Overall Study||0
10869979|NCT02347917|12035602|FG000|Discontinued After BBI608 Administration|Overall Study||4
10869980|NCT02347917|12035603|FG001|Discontinued After BBI608 Administration|Overall Study||24
10869981|NCT02347917|12035602|FG000|Discontinued Before Survival Observation|Overall Study||0
10869982|NCT02347917|12035603|FG001|Discontinued Before Survival Observation|Overall Study||1
10869983|NCT02347917|12035602|FG000|COMPLETED|Overall Study||4
10869984|NCT02347917|12035603|FG001|COMPLETED|Overall Study||23
10869985|NCT02347917|12035602|FG000|NOT COMPLETED|Overall Study||0
10869986|NCT02347917|12035603|FG001|NOT COMPLETED|Overall Study||1
10869987|NCT02344108|12035617|FG000|STARTED|Overall Study||42
10869988|NCT02344108|12035617|FG000|COMPLETED|Overall Study||42
10869989|NCT02344108|12035617|FG000|NOT COMPLETED|Overall Study||0
10869990|NCT02335658|12035627|FG000|STARTED|Overall Study|97 subjects in Cohort 1 and 103 subjects in Cohort 2 started to receive DSP-5423P.|97
10869991|NCT02335658|12035628|FG001|STARTED|Overall Study||103
10869992|NCT02335658|12035627|FG000|COMPLETED|Overall Study|57 subjects in Cohort 1 and 59 subjects in Cohort 2 completed the study.|57
10869993|NCT02335658|12035628|FG001|COMPLETED|Overall Study||59
10869994|NCT02335658|12035627|FG000|NOT COMPLETED|Overall Study||40
10869995|NCT02335658|12035628|FG001|NOT COMPLETED|Overall Study||44
10869996|NCT02287584|12035639|FG000|STARTED|the Double-blind Phase||190
10869997|NCT02287584|12035640|FG001|STARTED|the Double-blind Phase||196
10869998|NCT02287584|12035641|FG002|STARTED|the Double-blind Phase||194
10869999|NCT02287584|12035642|FG003|STARTED|the Double-blind Phase||0
10870000|NCT02287584|12035643|FG004|STARTED|the Double-blind Phase||0
10870001|NCT02287584|12035644|FG005|STARTED|the Double-blind Phase||0
10870002|NCT02287584|12035639|FG000|COMPLETED|the Double-blind Phase||138
10870003|NCT02287584|12035640|FG001|COMPLETED|the Double-blind Phase||149
10870004|NCT02287584|12035641|FG002|COMPLETED|the Double-blind Phase||161
10870005|NCT02287584|12035642|FG003|COMPLETED|the Double-blind Phase||0
10870006|NCT02287584|12035643|FG004|COMPLETED|the Double-blind Phase||0
10870007|NCT02287584|12035644|FG005|COMPLETED|the Double-blind Phase||0
10870008|NCT02287584|12035639|FG000|NOT COMPLETED|the Double-blind Phase||52
10870009|NCT02287584|12035640|FG001|NOT COMPLETED|the Double-blind Phase||47
10870010|NCT02287584|12035641|FG002|NOT COMPLETED|the Double-blind Phase||33
10870011|NCT02287584|12035642|FG003|NOT COMPLETED|the Double-blind Phase||0
10870012|NCT02287584|12035643|FG004|NOT COMPLETED|the Double-blind Phase||0
10870013|NCT02287584|12035644|FG005|NOT COMPLETED|the Double-blind Phase||0
10870014|NCT02287584|12035639|FG000|STARTED|the Open-label Phase||0
10870015|NCT02287584|12035640|FG001|STARTED|the Open-label Phase||0
10870016|NCT02287584|12035641|FG002|STARTED|the Open-label Phase||0
10870017|NCT02287584|12035642|FG003|STARTED|the Open-label Phase||138
10870018|NCT02287584|12035643|FG004|STARTED|the Open-label Phase||149
10870019|NCT02287584|12035644|FG005|STARTED|the Open-label Phase||161
10870020|NCT02287584|12035639|FG000|Treated|the Open-label Phase||0
10870021|NCT02287584|12035640|FG001|Treated|the Open-label Phase||0
10870022|NCT02287584|12035641|FG002|Treated|the Open-label Phase||0
10870023|NCT02287584|12035642|FG003|Treated|the Open-label Phase||131
10870024|NCT02287584|12035643|FG004|Treated|the Open-label Phase||143
10870025|NCT02287584|12035644|FG005|Treated|the Open-label Phase||157
10870026|NCT02287584|12035639|FG000|COMPLETED|the Open-label Phase||0
10870027|NCT02287584|12035640|FG001|COMPLETED|the Open-label Phase||0
10870028|NCT02287584|12035641|FG002|COMPLETED|the Open-label Phase||0
10870029|NCT02287584|12035642|FG003|COMPLETED|the Open-label Phase||81
10870030|NCT02287584|12035643|FG004|COMPLETED|the Open-label Phase||87
10870031|NCT02287584|12035644|FG005|COMPLETED|the Open-label Phase||104
10870032|NCT02287584|12035639|FG000|NOT COMPLETED|the Open-label Phase||0
10870033|NCT02287584|12035640|FG001|NOT COMPLETED|the Open-label Phase||0
10870034|NCT02287584|12035641|FG002|NOT COMPLETED|the Open-label Phase||0
10870035|NCT02287584|12035642|FG003|NOT COMPLETED|the Open-label Phase||57
10870036|NCT02287584|12035643|FG004|NOT COMPLETED|the Open-label Phase||62
10870037|NCT02287584|12035644|FG005|NOT COMPLETED|the Open-label Phase||57
10870038|NCT02178566|12035660|FG000|STARTED|Overall Study||0
10870039|NCT02178566|12035661|FG001|STARTED|Overall Study|no data available|1
10870040|NCT02178566|12035660|FG000|COMPLETED|Overall Study||0
10870041|NCT02178566|12035661|FG001|COMPLETED|Overall Study|no data available|0
10870042|NCT02178566|12035660|FG000|NOT COMPLETED|Overall Study||0
10870043|NCT02178566|12035661|FG001|NOT COMPLETED|Overall Study||1
10870044|NCT02173301|12035671|FG000|STARTED|Overall Study||49
10870045|NCT02173301|12035672|FG001|STARTED|Overall Study||55
10870046|NCT02173301|12035673|FG002|STARTED|Overall Study||48
10870047|NCT02173301|12035674|FG003|STARTED|Overall Study||48
10870048|NCT02173301|12035671|FG000|COMPLETED|Overall Study||29
10870049|NCT02173301|12035672|FG001|COMPLETED|Overall Study||32
10870050|NCT02173301|12035673|FG002|COMPLETED|Overall Study||28
10870051|NCT02173301|12035674|FG003|COMPLETED|Overall Study||33
10870052|NCT02173301|12035671|FG000|NOT COMPLETED|Overall Study||20
10870053|NCT02173301|12035672|FG001|NOT COMPLETED|Overall Study||23
10870054|NCT02173301|12035673|FG002|NOT COMPLETED|Overall Study||20
10870055|NCT02173301|12035674|FG003|NOT COMPLETED|Overall Study||15
10870056|NCT01986114|12035684|FG000|STARTED|Overall Study||495
10870057|NCT01986114|12035684|FG000|COMPLETED|Overall Study||339
10870058|NCT01986114|12035684|FG000|NOT COMPLETED|Overall Study||156
10870059|NCT01986101|12035693|FG000|STARTED|Overall Study||172
10870060|NCT01986101|12035694|FG001|STARTED|Overall Study||184
10870061|NCT01986101|12035695|FG002|STARTED|Overall Study||169
10870062|NCT01986101|12035693|FG000|Intent-to-Treat Population|Overall Study||171
11111193|NCT01285076|12295783|FG000|COMPLETED|Overall Study||834
11111194|NCT01285076|12295783|FG000|NOT COMPLETED|Overall Study||0
11111195|NCT01285310|12295790|FG000|STARTED|Placebo Controlled Phase: Weeks 0-24||79
11111196|NCT01285310|12295791|FG001|STARTED|Placebo Controlled Phase: Weeks 0-24||82
11111197|NCT01285310|12295792|FG002|STARTED|Placebo Controlled Phase: Weeks 0-24||76
11111198|NCT01285310|12295793|FG003|STARTED|Placebo Controlled Phase: Weeks 0-24||0
11111199|NCT01285310|12295794|FG004|STARTED|Placebo Controlled Phase: Weeks 0-24||0
11111200|NCT01285310|12295790|FG000|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
11111201|NCT01285310|12295791|FG001|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
11111202|NCT01285310|12295792|FG002|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
11111203|NCT01285310|12295793|FG003|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
11111204|NCT01285310|12295794|FG004|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
11111205|NCT01285310|12295790|FG000|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
11111206|NCT01285310|12295791|FG001|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
11111207|NCT01285310|12295792|FG002|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
11111208|NCT01285310|12295793|FG003|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
11111209|NCT01285310|12295794|FG004|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
11111210|NCT01285310|12295790|FG000|STARTED|Active Treatment Phase: Weeks 25-52||0
11111211|NCT01285310|12295791|FG001|STARTED|Active Treatment Phase: Weeks 25-52||63
11111212|NCT01285310|12295792|FG002|STARTED|Active Treatment Phase: Weeks 25-52||60
11111213|NCT01285310|12295793|FG003|STARTED|Active Treatment Phase: Weeks 25-52||27
11111214|NCT01285310|12295794|FG004|STARTED|Active Treatment Phase: Weeks 25-52||42
11111215|NCT01285310|12295790|FG000|COMPLETED|Active Treatment Phase: Weeks 25-52||0
11111216|NCT01285310|12295791|FG001|COMPLETED|Active Treatment Phase: Weeks 25-52||31
11111217|NCT01285310|12295792|FG002|COMPLETED|Active Treatment Phase: Weeks 25-52||34
11111218|NCT01285310|12295793|FG003|COMPLETED|Active Treatment Phase: Weeks 25-52||17
11111219|NCT01285310|12295794|FG004|COMPLETED|Active Treatment Phase: Weeks 25-52||23
11111220|NCT01285310|12295790|FG000|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
11111221|NCT01285310|12295791|FG001|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
11111222|NCT01285310|12295792|FG002|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
10870063|NCT01986101|12035694|FG001|Intent-to-Treat Population|Overall Study||182
10870064|NCT01986101|12035695|FG002|Intent-to-Treat Population|Overall Study||169
10870065|NCT01986101|12035693|FG000|Safety Population|Overall Study||172
10870066|NCT01986101|12035694|FG001|Safety Population|Overall Study||184
10870067|NCT01986101|12035695|FG002|Safety Population|Overall Study||169
10870068|NCT01986101|12035693|FG000|COMPLETED|Overall Study||139
10870069|NCT01986101|12035694|FG001|COMPLETED|Overall Study||157
10870070|NCT01986101|12035695|FG002|COMPLETED|Overall Study||137
10870071|NCT01986101|12035693|FG000|NOT COMPLETED|Overall Study||33
10870072|NCT01986101|12035694|FG001|NOT COMPLETED|Overall Study||27
10870073|NCT01986101|12035695|FG002|NOT COMPLETED|Overall Study||32
10870074|NCT01972035|12035708|FG000|STARTED|Overall Study||66
10870075|NCT01972035|12035709|FG001|STARTED|Overall Study||71
10870076|NCT01972035|12035708|FG000|COMPLETED|Overall Study||27
10870077|NCT01972035|12035709|FG001|COMPLETED|Overall Study||44
10870078|NCT01972035|12035708|FG000|NOT COMPLETED|Overall Study||39
10870079|NCT01972035|12035709|FG001|NOT COMPLETED|Overall Study||27
10870080|NCT01955980|12035717|FG000|STARTED|Overall Study||10
10870081|NCT01955980|12035718|FG001|STARTED|Overall Study||9
10870082|NCT01955980|12035717|FG000|COMPLETED|Overall Study||10
10870083|NCT01955980|12035718|FG001|COMPLETED|Overall Study||9
10870084|NCT01955980|12035717|FG000|NOT COMPLETED|Overall Study||0
10870085|NCT01955980|12035718|FG001|NOT COMPLETED|Overall Study||0
10870086|NCT01946711|12035727|FG000|STARTED|Overall Study||8
10870087|NCT01946711|12035728|FG001|STARTED|Overall Study||6
10870088|NCT01946711|12035727|FG000|COMPLETED|Overall Study||8
10870089|NCT01946711|12035728|FG001|COMPLETED|Overall Study||6
10870090|NCT01946711|12035727|FG000|NOT COMPLETED|Overall Study||0
10870091|NCT01946711|12035728|FG001|NOT COMPLETED|Overall Study||0
10870092|NCT01891994|12035734|FG000|STARTED|Overall Study||40
10870093|NCT01891994|12035734|FG000|COMPLETED|Overall Study||40
10870094|NCT01891994|12035734|FG000|NOT COMPLETED|Overall Study||0
11111223|NCT01285310|12295793|FG003|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
11111224|NCT01285310|12295794|FG004|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
11111225|NCT01285323|12295834|FG000|STARTED|Overall Study||232
11111226|NCT01285323|12295835|FG001|STARTED|Overall Study||232
11355282|NCT03078556|12552137|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1
10870101|NCT01813305|12035749|FG000|STARTED|Overall Study||98
10870102|NCT01813305|12035750|FG001|STARTED|Overall Study||26
10870103|NCT01813305|12035749|FG000|COMPLETED|Overall Study||63
10870104|NCT01813305|12035750|FG001|COMPLETED|Overall Study||18
10870105|NCT01813305|12035749|FG000|NOT COMPLETED|Overall Study||35
10870106|NCT01813305|12035750|FG001|NOT COMPLETED|Overall Study||8
10870107|NCT01680965|12035762|FG000|STARTED|Overall Study||3
10870108|NCT01680965|12035763|FG001|STARTED|Overall Study||3
10870109|NCT01680965|12035764|FG002|STARTED|Overall Study||6
10870110|NCT01680965|12035765|FG003|STARTED|Overall Study||32
10870111|NCT01680965|12035762|FG000|COMPLETED|Overall Study||3
10870112|NCT01680965|12035763|FG001|COMPLETED|Overall Study||3
10870113|NCT01680965|12035764|FG002|COMPLETED|Overall Study||6
10870114|NCT01680965|12035765|FG003|COMPLETED|Overall Study||26
10870115|NCT01680965|12035762|FG000|NOT COMPLETED|Overall Study||0
10870116|NCT01680965|12035763|FG001|NOT COMPLETED|Overall Study||0
10870117|NCT01680965|12035764|FG002|NOT COMPLETED|Overall Study||0
10870118|NCT01680965|12035765|FG003|NOT COMPLETED|Overall Study||6
10870119|NCT01614912|12035773|FG000|STARTED|Overall Study||284
10870120|NCT01614912|12035773|FG000|COMPLETED|Overall Study||159
10870121|NCT01614912|12035773|FG000|NOT COMPLETED|Overall Study||125
10870122|NCT01614899|12035780|FG000|STARTED|Overall Study||150
10870123|NCT01614899|12035781|FG001|STARTED|Overall Study||155
10870124|NCT01614899|12035782|FG002|STARTED|Overall Study||152
10870125|NCT01614899|12035780|FG000|COMPLETED|Overall Study||106
10870126|NCT01614899|12035781|FG001|COMPLETED|Overall Study||116
10870127|NCT01614899|12035782|FG002|COMPLETED|Overall Study||110
10870128|NCT01614899|12035780|FG000|NOT COMPLETED|Overall Study||44
10870129|NCT01614899|12035781|FG001|NOT COMPLETED|Overall Study||39
10870130|NCT01614899|12035782|FG002|NOT COMPLETED|Overall Study||42
10870131|NCT00711269|12035794|FG000|STARTED|Overall Study||131
10870132|NCT00711269|12035795|FG001|STARTED|Overall Study||131
10870133|NCT00711269|12035796|FG002|STARTED|Overall Study||133
10870134|NCT00711269|12035797|FG003|STARTED|Overall Study||65
10870135|NCT00711269|12035794|FG000|COMPLETED|Overall Study||87
10870136|NCT00711269|12035795|FG001|COMPLETED|Overall Study||83
10870137|NCT00711269|12035796|FG002|COMPLETED|Overall Study||83
10870138|NCT00711269|12035797|FG003|COMPLETED|Overall Study||51
10870139|NCT00711269|12035794|FG000|NOT COMPLETED|Overall Study||44
10870140|NCT00711269|12035795|FG001|NOT COMPLETED|Overall Study||48
11111227|NCT01285323|12295834|FG000|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
11111228|NCT01285323|12295835|FG001|Full Analysis Set|Overall Study||232
11111229|NCT01285323|12295834|FG000|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
11111230|NCT01285323|12295835|FG001|Safety Analysis Set|Overall Study||232
11111231|NCT01285323|12295834|FG000|COMPLETED|Overall Study||199
11111232|NCT01285323|12295835|FG001|COMPLETED|Overall Study||202
11111233|NCT01285323|12295834|FG000|NOT COMPLETED|Overall Study||33
11111234|NCT01285323|12295835|FG001|NOT COMPLETED|Overall Study||30
11111235|NCT01285349|12295844|FG000|STARTED|Overall Study||190
11111236|NCT01285349|12295845|FG001|STARTED|Overall Study||190
11111237|NCT01285349|12295846|FG002|STARTED|Overall Study||184
11111238|NCT01285349|12295844|FG000|COMPLETED|Overall Study||163
11111239|NCT01285349|12295845|FG001|COMPLETED|Overall Study||170
11111240|NCT01285349|12295846|FG002|COMPLETED|Overall Study||157
11111241|NCT01285349|12295844|FG000|NOT COMPLETED|Overall Study||27
11111242|NCT01285349|12295845|FG001|NOT COMPLETED|Overall Study||20
11111243|NCT01285349|12295846|FG002|NOT COMPLETED|Overall Study||27
11111244|NCT01285401|12295857|FG000|STARTED|Overall Study||115
11111245|NCT01285401|12295858|FG001|STARTED|Overall Study||117
11111246|NCT01285401|12295857|FG000|Treated|Overall Study||113
11111247|NCT01285401|12295858|FG001|Treated|Overall Study||116
11111248|NCT01285401|12295857|FG000|COMPLETED|Overall Study||98
11111249|NCT01285401|12295858|FG001|COMPLETED|Overall Study||88
11111250|NCT01285401|12295857|FG000|NOT COMPLETED|Overall Study||17
11111251|NCT01285401|12295858|FG001|NOT COMPLETED|Overall Study||29
11111252|NCT01285427|12295864|FG000|STARTED|Overall Study||300
10870141|NCT00711269|12035796|FG002|NOT COMPLETED|Overall Study||50
10870142|NCT00711269|12035797|FG003|NOT COMPLETED|Overall Study||14
10870143|NCT00152477|12035811|FG000|STARTED|Chemotherapy Period||50
10870144|NCT00152477|12035812|FG001|STARTED|Chemotherapy Period||56
10870145|NCT00152477|12035813|FG002|STARTED|Chemotherapy Period||59
10870146|NCT00152477|12035811|FG000|Part II|Chemotherapy Period||50
10870147|NCT00152477|12035812|FG001|Part II|Chemotherapy Period||53
10870148|NCT00152477|12035813|FG002|Part II|Chemotherapy Period||53
10870149|NCT00152477|12035811|FG000|COMPLETED|Chemotherapy Period||22
10870150|NCT00152477|12035812|FG001|COMPLETED|Chemotherapy Period||34
10870151|NCT00152477|12035813|FG002|COMPLETED|Chemotherapy Period||39
10870152|NCT00152477|12035811|FG000|NOT COMPLETED|Chemotherapy Period||28
11111253|NCT01285427|12295864|FG000|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
10870153|NCT00152477|12035812|FG001|NOT COMPLETED|Chemotherapy Period||22
10870154|NCT00152477|12035813|FG002|NOT COMPLETED|Chemotherapy Period||20
10870155|NCT00152477|12035811|FG000|STARTED|Monotherapy Period|7 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|15
10870156|NCT00152477|12035812|FG001|STARTED|Monotherapy Period|5 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|29
10870157|NCT00152477|12035813|FG002|STARTED|Monotherapy Period|5 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|34
10870158|NCT00152477|12035811|FG000|Part II|Monotherapy Period||13
10870159|NCT00152477|12035812|FG001|Part II|Monotherapy Period||26
10870160|NCT00152477|12035813|FG002|Part II|Monotherapy Period||29
10870161|NCT00152477|12035811|FG000|COMPLETED|Monotherapy Period||0
10870162|NCT00152477|12035812|FG001|COMPLETED|Monotherapy Period||0
10870163|NCT00152477|12035813|FG002|COMPLETED|Monotherapy Period||0
10870164|NCT00152477|12035811|FG000|NOT COMPLETED|Monotherapy Period||15
10870165|NCT00152477|12035812|FG001|NOT COMPLETED|Monotherapy Period||29
10870166|NCT00152477|12035813|FG002|NOT COMPLETED|Monotherapy Period||34
11111254|NCT01285427|12295864|FG000|NOT COMPLETED|Overall Study||1
10870167|NCT04585646|12035824|FG000|STARTED|First Intervention||32
10870168|NCT04585646|12035825|FG001|STARTED|First Intervention||32
10870169|NCT04585646|12035824|FG000|COMPLETED|First Intervention||31
10870170|NCT04585646|12035825|FG001|COMPLETED|First Intervention||28
10870171|NCT04585646|12035824|FG000|NOT COMPLETED|First Intervention||1
10870172|NCT04585646|12035825|FG001|NOT COMPLETED|First Intervention||4
10870173|NCT04585646|12035824|FG000|STARTED|Second Intervention||31
10870174|NCT04585646|12035825|FG001|STARTED|Second Intervention||28
10870175|NCT04585646|12035824|FG000|COMPLETED|Second Intervention||31
11111255|NCT01285492|12295878|FG000|STARTED|Overall Study|All patients randomized to this group|121
10870176|NCT04585646|12035825|FG001|COMPLETED|Second Intervention||28
10870177|NCT04585646|12035824|FG000|NOT COMPLETED|Second Intervention||0
10870178|NCT04585646|12035825|FG001|NOT COMPLETED|Second Intervention||0
10870179|NCT04451330|12035834|FG000|STARTED|Overall Study||133
10870180|NCT04451330|12035835|FG001|STARTED|Overall Study||69
10870181|NCT04451330|12035834|FG000|COMPLETED|Overall Study||123
10870182|NCT04451330|12035835|FG001|COMPLETED|Overall Study||65
10870183|NCT04451330|12035834|FG000|NOT COMPLETED|Overall Study||10
10870184|NCT04451330|12035835|FG001|NOT COMPLETED|Overall Study||4
10870185|NCT04300010|12035844|FG000|STARTED|Overall Study||20
10870186|NCT04300010|12035845|FG001|STARTED|Overall Study||20
10870187|NCT04300010|12035846|FG002|STARTED|Overall Study||20
10870188|NCT04300010|12035847|FG003|STARTED|Overall Study||60
10870189|NCT04300010|12035844|FG000|COMPLETED|Overall Study||20
10870190|NCT04300010|12035845|FG001|COMPLETED|Overall Study||20
10870191|NCT04300010|12035846|FG002|COMPLETED|Overall Study||20
10870192|NCT04300010|12035847|FG003|COMPLETED|Overall Study||60
10870193|NCT04300010|12035844|FG000|NOT COMPLETED|Overall Study||0
10870194|NCT04300010|12035845|FG001|NOT COMPLETED|Overall Study||0
10870195|NCT04300010|12035846|FG002|NOT COMPLETED|Overall Study||0
10870196|NCT04300010|12035847|FG003|NOT COMPLETED|Overall Study||0
10870197|NCT04206670|12035858|FG000|STARTED|Overall Study||148
10870198|NCT04206670|12035859|FG001|STARTED|Overall Study||68
10870199|NCT04206670|12035858|FG000|COMPLETED|Overall Study||124
10870200|NCT04206670|12035859|FG001|COMPLETED|Overall Study||65
10870201|NCT04206670|12035858|FG000|NOT COMPLETED|Overall Study||24
10870202|NCT04206670|12035859|FG001|NOT COMPLETED|Overall Study||3
10870203|NCT04173962|12035868|FG000|STARTED|Overall Study||12
10870204|NCT04173962|12035869|FG001|STARTED|Overall Study||12
10870205|NCT04173962|12035868|FG000|COMPLETED|Overall Study||12
10870206|NCT04173962|12035869|FG001|COMPLETED|Overall Study||12
10870207|NCT04173962|12035868|FG000|NOT COMPLETED|Overall Study||0
10870208|NCT04173962|12035869|FG001|NOT COMPLETED|Overall Study||0
10870209|NCT04115189|12035877|FG000|STARTED|Overall Study||42
10870210|NCT04115189|12035878|FG001|STARTED|Overall Study||15
10870211|NCT04115189|12035877|FG000|COMPLETED|Overall Study||42
10870212|NCT04115189|12035878|FG001|COMPLETED|Overall Study||15
10870213|NCT04115189|12035877|FG000|NOT COMPLETED|Overall Study||0
10870214|NCT04115189|12035878|FG001|NOT COMPLETED|Overall Study||0
10870215|NCT04010695|12035888|FG000|STARTED|Overall Study||250
10870216|NCT04010695|12035888|FG000|COMPLETED|Overall Study||250
10870217|NCT04010695|12035888|FG000|NOT COMPLETED|Overall Study||0
10870218|NCT04003623|12035895|FG000|STARTED|Overall Study||1
10870219|NCT04003623|12035896|FG001|STARTED|Overall Study||0
10870220|NCT04003623|12035895|FG000|COMPLETED|Overall Study||0
10870221|NCT04003623|12035896|FG001|COMPLETED|Overall Study||0
10870222|NCT04003623|12035895|FG000|NOT COMPLETED|Overall Study||1
10870223|NCT04003623|12035896|FG001|NOT COMPLETED|Overall Study||0
10870224|NCT03967847|12035904|FG000|STARTED|Overall Study||21
10870225|NCT03967847|12035905|FG001|STARTED|Overall Study||23
10870226|NCT03967847|12035904|FG000|COMPLETED|Overall Study||21
10870227|NCT03967847|12035905|FG001|COMPLETED|Overall Study||23
10870228|NCT03967847|12035904|FG000|NOT COMPLETED|Overall Study||0
10870229|NCT03967847|12035905|FG001|NOT COMPLETED|Overall Study||0
10870230|NCT03828383|12035914|FG000|STARTED|Overall Study||41
10870231|NCT03828383|12035915|FG001|STARTED|Overall Study||37
10870232|NCT03828383|12035914|FG000|COMPLETED|Overall Study||34
10870233|NCT03828383|12035915|FG001|COMPLETED|Overall Study||30
10870234|NCT03828383|12035914|FG000|NOT COMPLETED|Overall Study||7
10870235|NCT03828383|12035915|FG001|NOT COMPLETED|Overall Study||7
11111256|NCT01285492|12295879|FG001|STARTED|Overall Study|All patients randomized to this group|39
11111257|NCT01285492|12295878|FG000|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
11111258|NCT01285492|12295879|FG001|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
11111259|NCT01285492|12295878|FG000|COMPLETED|Overall Study||104
11111260|NCT01285492|12295879|FG001|COMPLETED|Overall Study||38
11111261|NCT01285492|12295878|FG000|NOT COMPLETED|Overall Study||17
11111262|NCT01285492|12295879|FG001|NOT COMPLETED|Overall Study||1
11111263|NCT01285518|12295893|FG000|STARTED|Overall Study||10
11111264|NCT01285518|12295894|FG001|STARTED|Overall Study||10
11111265|NCT01285518|12295895|FG002|STARTED|Overall Study||10
11111266|NCT01285518|12295896|FG003|STARTED|Overall Study||10
11111267|NCT01285518|12295897|FG004|STARTED|Overall Study||10
11111268|NCT01285518|12295898|FG005|STARTED|Overall Study||10
11111269|NCT01285518|12295899|FG006|STARTED|Overall Study||10
11111270|NCT01285518|12295900|FG007|STARTED|Overall Study||14
11111271|NCT01285518|12295893|FG000|COMPLETED|Overall Study||10
11111272|NCT01285518|12295894|FG001|COMPLETED|Overall Study||10
11111273|NCT01285518|12295895|FG002|COMPLETED|Overall Study||10
10870254|NCT03717480|12035931|FG000|STARTED|Overall Study||2
10870255|NCT03717480|12035931|FG000|Receipt of Investigational Product/Study Treatment|Overall Study||1
10870256|NCT03717480|12035931|FG000|COMPLETED|Overall Study||1
10870257|NCT03717480|12035931|FG000|NOT COMPLETED|Overall Study||1
10870258|NCT03615066|12035938|FG000|STARTED|Main Study||26
10870259|NCT03615066|12035939|FG001|STARTED|Main Study||28
10870260|NCT03615066|12035940|FG002|STARTED|Main Study||13
10870261|NCT03615066|12035938|FG000|COMPLETED|Main Study|2 participants did not receive all doses of study treatments but were considered to have completed the Main Study because the participants entered the TFFU Phase.|26
10870262|NCT03615066|12035939|FG001|COMPLETED|Main Study|1 participant did not receive all doses of study treatments but was considered to have completed the Main Study because the participant entered the TFFU Phase.|27
10870263|NCT03615066|12035940|FG002|COMPLETED|Main Study||11
10870264|NCT03615066|12035938|FG000|NOT COMPLETED|Main Study||0
10870265|NCT03615066|12035939|FG001|NOT COMPLETED|Main Study||1
10870266|NCT03615066|12035940|FG002|NOT COMPLETED|Main Study||2
10870267|NCT03615066|12035938|FG000|STARTED|Treatment-free Follow-up (TFFU) Phase|13 participants who completed Main study did not enter TFFU phase.|13
10870268|NCT03615066|12035939|FG001|STARTED|Treatment-free Follow-up (TFFU) Phase|15 participants who completed Main study did not enter TFFU phase.|12
10870269|NCT03615066|12035940|FG002|STARTED|Treatment-free Follow-up (TFFU) Phase|9 participants who completed Main study did not enter TFFU phase.|2
10870270|NCT03615066|12035938|FG000|COMPLETED|Treatment-free Follow-up (TFFU) Phase||11
10870271|NCT03615066|12035939|FG001|COMPLETED|Treatment-free Follow-up (TFFU) Phase||11
10870272|NCT03615066|12035940|FG002|COMPLETED|Treatment-free Follow-up (TFFU) Phase||2
10870273|NCT03615066|12035938|FG000|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||2
10870274|NCT03615066|12035939|FG001|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||1
10870275|NCT03615066|12035940|FG002|NOT COMPLETED|Treatment-free Follow-up (TFFU) Phase||0
10870276|NCT03557931|12035955|FG000|STARTED|Overall Study||100
10870277|NCT03557931|12035956|FG001|STARTED|Overall Study||65
10870278|NCT03557931|12035957|FG002|STARTED|Overall Study||68
10870279|NCT03557931|12035955|FG000|COMPLETED|Overall Study||69
10870280|NCT03557931|12035956|FG001|COMPLETED|Overall Study||46
10870281|NCT03557931|12035957|FG002|COMPLETED|Overall Study||55
10870282|NCT03557931|12035955|FG000|NOT COMPLETED|Overall Study||31
10870283|NCT03557931|12035956|FG001|NOT COMPLETED|Overall Study||19
10870284|NCT03557931|12035957|FG002|NOT COMPLETED|Overall Study||13
10870285|NCT03251144|12035969|FG000|STARTED|Overall Study||15
10870286|NCT03251144|12035970|FG001|STARTED|Overall Study||11
10870287|NCT03251144|12035969|FG000|COMPLETED|Overall Study||15
10870288|NCT03251144|12035970|FG001|COMPLETED|Overall Study||11
10870289|NCT03251144|12035969|FG000|NOT COMPLETED|Overall Study||0
10870290|NCT03251144|12035970|FG001|NOT COMPLETED|Overall Study||0
10870291|NCT02596035|12035979|FG000|STARTED|Overall Study||97
10870292|NCT02596035|12035980|FG001|STARTED|Overall Study||44
10870293|NCT02596035|12035981|FG002|STARTED|Overall Study||1
10870294|NCT02596035|12035979|FG000|COMPLETED|Overall Study||11
10870295|NCT02596035|12035980|FG001|COMPLETED|Overall Study||0
10870296|NCT02596035|12035981|FG002|COMPLETED|Overall Study||0
10870297|NCT02596035|12035979|FG000|NOT COMPLETED|Overall Study||86
10870298|NCT02596035|12035980|FG001|NOT COMPLETED|Overall Study||44
10870299|NCT02596035|12035981|FG002|NOT COMPLETED|Overall Study||1
11111274|NCT01285518|12295896|FG003|COMPLETED|Overall Study||10
11111275|NCT01285518|12295897|FG004|COMPLETED|Overall Study||10
11111276|NCT01285518|12295898|FG005|COMPLETED|Overall Study||9
11111277|NCT01285518|12295899|FG006|COMPLETED|Overall Study||10
11111278|NCT01285518|12295900|FG007|COMPLETED|Overall Study||14
11111279|NCT01285518|12295893|FG000|NOT COMPLETED|Overall Study||0
11111280|NCT01285518|12295894|FG001|NOT COMPLETED|Overall Study||0
11111281|NCT01285518|12295895|FG002|NOT COMPLETED|Overall Study||0
11111282|NCT01285518|12295896|FG003|NOT COMPLETED|Overall Study||0
11111283|NCT01285518|12295897|FG004|NOT COMPLETED|Overall Study||0
11111284|NCT01285518|12295898|FG005|NOT COMPLETED|Overall Study||1
11111285|NCT01285518|12295899|FG006|NOT COMPLETED|Overall Study||0
11111286|NCT01285518|12295900|FG007|NOT COMPLETED|Overall Study||0
11111287|NCT01285609|12295921|FG000|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
11111288|NCT01285609|12295922|FG001|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
11111289|NCT01285609|12295921|FG000|Treated With Chemotherapy (1st Dose)|Randomized||475
11111290|NCT01285609|12295922|FG001|Treated With Chemotherapy (1st Dose)|Randomized||473
11111291|NCT01285609|12295921|FG000|COMPLETED|Randomized||388
11111292|NCT01285609|12295922|FG001|COMPLETED|Randomized||361
11111293|NCT01285609|12295921|FG000|NOT COMPLETED|Randomized||91
11111294|NCT01285609|12295922|FG001|NOT COMPLETED|Randomized||116
10870321|NCT02318095|12036004|FG000|STARTED|Overall Study||40
10870322|NCT02318095|12036004|FG000|COMPLETED|Overall Study||39
10870323|NCT02318095|12036004|FG000|NOT COMPLETED|Overall Study||1
10870324|NCT02155647|12036011|FG000|STARTED|Overall Study||88
10870325|NCT02155647|12036012|FG001|STARTED|Overall Study||116
10870326|NCT02155647|12036011|FG000|COMPLETED|Overall Study||47
10870327|NCT02155647|12036012|FG001|COMPLETED|Overall Study||64
10870328|NCT02155647|12036011|FG000|NOT COMPLETED|Overall Study||41
10870329|NCT02155647|12036012|FG001|NOT COMPLETED|Overall Study||52
11111295|NCT01285609|12295921|FG000|STARTED|Treated With Blinded Therapy||388
11111296|NCT01285609|12295922|FG001|STARTED|Treated With Blinded Therapy||361
11111297|NCT01285609|12295921|FG000|COMPLETED|Treated With Blinded Therapy||1
10870336|NCT01979211|12036031|FG000|STARTED|Overall Study||24
10870337|NCT01979211|12036031|FG000|COMPLETED|Overall Study||24
10870338|NCT01979211|12036031|FG000|NOT COMPLETED|Overall Study||0
10870339|NCT01904903|12036035|FG000|STARTED|Overall Study||31
10870340|NCT01904903|12036035|FG000|COMPLETED|Overall Study||30
10870341|NCT01904903|12036035|FG000|NOT COMPLETED|Overall Study||1
10870342|NCT01827384|12036053|FG000|STARTED|Overall Study||13
10870343|NCT01827384|12036054|FG001|STARTED|Overall Study||1
10870344|NCT01827384|12036055|FG002|STARTED|Overall Study||9
10870345|NCT01827384|12036056|FG003|STARTED|Overall Study||1
10870346|NCT01827384|12036057|FG004|STARTED|Overall Study||1
10870347|NCT01827384|12036058|FG005|STARTED|Overall Study||22
10870348|NCT01827384|12036059|FG006|STARTED|Overall Study||2
10870349|NCT01827384|12036060|FG007|STARTED|Overall Study||1
10870350|NCT01827384|12036061|FG008|STARTED|Overall Study||2
10870351|NCT01827384|12036062|FG009|STARTED|Overall Study||15
10870352|NCT01827384|12036063|FG010|STARTED|Overall Study||7
10870353|NCT01827384|12036064|FG011|STARTED|Overall Study||1
10870354|NCT01827384|12036065|FG012|STARTED|Overall Study||2
10870355|NCT01827384|12036066|FG013|STARTED|Overall Study||131
10870356|NCT01827384|12036053|FG000|COMPLETED|Overall Study||13
10870357|NCT01827384|12036054|FG001|COMPLETED|Overall Study||1
10870358|NCT01827384|12036055|FG002|COMPLETED|Overall Study||9
10870359|NCT01827384|12036056|FG003|COMPLETED|Overall Study||1
10870360|NCT01827384|12036057|FG004|COMPLETED|Overall Study||1
10870361|NCT01827384|12036058|FG005|COMPLETED|Overall Study||22
10870362|NCT01827384|12036059|FG006|COMPLETED|Overall Study||2
10870363|NCT01827384|12036060|FG007|COMPLETED|Overall Study||1
11111298|NCT01285609|12295922|FG001|COMPLETED|Treated With Blinded Therapy||2
11111299|NCT01285609|12295921|FG000|NOT COMPLETED|Treated With Blinded Therapy||387
11111300|NCT01285609|12295922|FG001|NOT COMPLETED|Treated With Blinded Therapy||359
11111301|NCT01285635|12295933|FG000|STARTED|First Intervention (2 Weeks)||13
11111302|NCT01285635|12295934|FG001|STARTED|First Intervention (2 Weeks)||11
11111303|NCT01285635|12295935|FG002|STARTED|First Intervention (2 Weeks)||11
11111304|NCT01285635|12295933|FG000|COMPLETED|First Intervention (2 Weeks)||13
11111305|NCT01285635|12295934|FG001|COMPLETED|First Intervention (2 Weeks)||11
11111306|NCT01285635|12295935|FG002|COMPLETED|First Intervention (2 Weeks)||11
11111307|NCT01285635|12295933|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
11111308|NCT01285635|12295934|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
11111309|NCT01285635|12295935|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0
10870364|NCT01827384|12036061|FG008|COMPLETED|Overall Study||2
10870365|NCT01827384|12036062|FG009|COMPLETED|Overall Study||15
10870366|NCT01827384|12036063|FG010|COMPLETED|Overall Study||7
10870367|NCT01827384|12036064|FG011|COMPLETED|Overall Study||1
10870368|NCT01827384|12036065|FG012|COMPLETED|Overall Study||2
10870369|NCT01827384|12036066|FG013|COMPLETED|Overall Study||0
10870370|NCT01827384|12036053|FG000|NOT COMPLETED|Overall Study||0
10870371|NCT01827384|12036054|FG001|NOT COMPLETED|Overall Study||0
10870372|NCT01827384|12036055|FG002|NOT COMPLETED|Overall Study||0
10870373|NCT01827384|12036056|FG003|NOT COMPLETED|Overall Study||0
10870374|NCT01827384|12036057|FG004|NOT COMPLETED|Overall Study||0
10870375|NCT01827384|12036058|FG005|NOT COMPLETED|Overall Study||0
10870376|NCT01827384|12036059|FG006|NOT COMPLETED|Overall Study||0
10870377|NCT01827384|12036060|FG007|NOT COMPLETED|Overall Study||0
10870378|NCT01827384|12036061|FG008|NOT COMPLETED|Overall Study||0
10870379|NCT01827384|12036062|FG009|NOT COMPLETED|Overall Study||0
10870380|NCT01827384|12036063|FG010|NOT COMPLETED|Overall Study||0
10870381|NCT01827384|12036064|FG011|NOT COMPLETED|Overall Study||0
10870382|NCT01827384|12036065|FG012|NOT COMPLETED|Overall Study||0
10870383|NCT01827384|12036066|FG013|NOT COMPLETED|Overall Study||131
10870384|NCT01778946|12036096|FG000|STARTED|Overall Study||7
10870385|NCT01778946|12036096|FG000|COMPLETED|Overall Study||4
10870386|NCT01778946|12036096|FG000|NOT COMPLETED|Overall Study||3
10870387|NCT01636258|12036102|FG000|STARTED|Overall Study||13
10870388|NCT01636258|12036103|FG001|STARTED|Overall Study||14
10870389|NCT01636258|12036102|FG000|COMPLETED|Overall Study||12
10870390|NCT01636258|12036103|FG001|COMPLETED|Overall Study||14
10870391|NCT01636258|12036102|FG000|NOT COMPLETED|Overall Study||1
10870392|NCT01636258|12036103|FG001|NOT COMPLETED|Overall Study||0
11111310|NCT01285635|12295933|FG000|STARTED|Second Intervention (10, 3 Week Cycles)||13
11111311|NCT01285635|12295934|FG001|STARTED|Second Intervention (10, 3 Week Cycles)||11
11111312|NCT01285635|12295935|FG002|STARTED|Second Intervention (10, 3 Week Cycles)||11
11111313|NCT01285635|12295933|FG000|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
11111314|NCT01285635|12295934|FG001|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
11355283|NCT03078556|12552138|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11355284|NCT03078556|12552139|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
11355285|NCT03078556|12552136|FG000|STARTED|Washout Period 1 (7 Days)||39
11355286|NCT03078556|12552137|FG001|STARTED|Washout Period 1 (7 Days)||38
11355287|NCT03078556|12552138|FG002|STARTED|Washout Period 1 (7 Days)||38
11111315|NCT01285635|12295935|FG002|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
11111316|NCT01285635|12295933|FG000|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
11111317|NCT01285635|12295934|FG001|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
11111318|NCT01285635|12295935|FG002|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
11111319|NCT01285713|12295948|FG000|STARTED|Overall Study||42
11111320|NCT01285713|12295949|FG001|STARTED|Overall Study||41
11111321|NCT01285713|12295948|FG000|COMPLETED|Overall Study||42
11111322|NCT01285713|12295949|FG001|COMPLETED|Overall Study||41
11111323|NCT01285713|12295948|FG000|NOT COMPLETED|Overall Study||0
11111324|NCT01285713|12295949|FG001|NOT COMPLETED|Overall Study||0
11229796|NCT02018887|12422026|FG003|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
11229797|NCT02018887|12422027|FG004|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
11229798|NCT02018887|12422028|FG005|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
11229799|NCT02018887|12422029|FG006|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
11229800|NCT02018887|12422030|FG007|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
11229801|NCT02018887|12422031|FG008|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
10870420|NCT01517802|12036164|FG000|STARTED|Overall Study||31
10870421|NCT01517802|12036164|FG000|COMPLETED|Overall Study||30
10870422|NCT01517802|12036164|FG000|NOT COMPLETED|Overall Study||1
10870423|NCT00455325|12036168|FG000|STARTED|Cohort 1: Placebo||35
10870424|NCT00455325|12036169|FG001|STARTED|Cohort 1: Placebo||0
10870425|NCT00455325|12036170|FG002|STARTED|Cohort 1: Placebo||0
10870426|NCT00455325|12036171|FG003|STARTED|Cohort 1: Placebo||0
10870427|NCT00455325|12036168|FG000|COMPLETED|Cohort 1: Placebo||27
10870428|NCT00455325|12036169|FG001|COMPLETED|Cohort 1: Placebo||0
11229802|NCT02018887|12422032|FG009|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
11229803|NCT02018887|12422033|FG010|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
11229804|NCT02018887|12422023|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
11229805|NCT02018887|12422024|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
11229806|NCT02018887|12422025|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
11229807|NCT02018887|12422026|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
11229808|NCT02018887|12422027|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
11229809|NCT02018887|12422028|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
11229810|NCT02018887|12422029|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
11229811|NCT02018887|12422030|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
11229812|NCT02018887|12422031|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
11229813|NCT02018887|12422032|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
11229814|NCT02018887|12422033|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
10870429|NCT00455325|12036170|FG002|COMPLETED|Cohort 1: Placebo||0
10870430|NCT00455325|12036171|FG003|COMPLETED|Cohort 1: Placebo||0
10870431|NCT00455325|12036168|FG000|NOT COMPLETED|Cohort 1: Placebo||8
10870432|NCT00455325|12036169|FG001|NOT COMPLETED|Cohort 1: Placebo||0
10870433|NCT00455325|12036170|FG002|NOT COMPLETED|Cohort 1: Placebo||0
10870434|NCT00455325|12036171|FG003|NOT COMPLETED|Cohort 1: Placebo||0
10870435|NCT00455325|12036168|FG000|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0
10870436|NCT00455325|12036169|FG001|STARTED|Cohort 2: 80 mg Chloroquine Weekly||27
10870437|NCT00455325|12036170|FG002|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0
10870438|NCT00455325|12036171|FG003|STARTED|Cohort 2: 80 mg Chloroquine Weekly||0
10870439|NCT00455325|12036168|FG000|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
10870440|NCT00455325|12036169|FG001|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||26
10870441|NCT00455325|12036170|FG002|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
10870442|NCT00455325|12036171|FG003|COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
10870443|NCT00455325|12036168|FG000|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
10870444|NCT00455325|12036169|FG001|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||1
10870445|NCT00455325|12036170|FG002|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
10870446|NCT00455325|12036171|FG003|NOT COMPLETED|Cohort 2: 80 mg Chloroquine Weekly||0
10870447|NCT00455325|12036168|FG000|STARTED|Cohort 3: 80 mg Chloroquine Daily||0
10870448|NCT00455325|12036169|FG001|STARTED|Cohort 3: 80 mg Chloroquine Daily||0
10870449|NCT00455325|12036170|FG002|STARTED|Cohort 3: 80 mg Chloroquine Daily||26
10870450|NCT00455325|12036171|FG003|STARTED|Cohort 3: 80 mg Chloroquine Daily||0
10870451|NCT00455325|12036168|FG000|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
10870452|NCT00455325|12036169|FG001|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
10870453|NCT00455325|12036170|FG002|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||25
10870454|NCT00455325|12036171|FG003|COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
10870455|NCT00455325|12036168|FG000|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
10870456|NCT00455325|12036169|FG001|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
10870457|NCT00455325|12036170|FG002|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||1
10870458|NCT00455325|12036171|FG003|NOT COMPLETED|Cohort 3: 80 mg Chloroquine Daily||0
10870459|NCT00455325|12036168|FG000|STARTED|Cohort 4: 250mg Chloroquine Daily||0
10870460|NCT00455325|12036169|FG001|STARTED|Cohort 4: 250mg Chloroquine Daily||0
10870461|NCT00455325|12036170|FG002|STARTED|Cohort 4: 250mg Chloroquine Daily||0
10870462|NCT00455325|12036171|FG003|STARTED|Cohort 4: 250mg Chloroquine Daily||25
10870463|NCT00455325|12036168|FG000|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
10870464|NCT00455325|12036169|FG001|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
10870465|NCT00455325|12036170|FG002|COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
10870466|NCT00455325|12036171|FG003|COMPLETED|Cohort 4: 250mg Chloroquine Daily||25
10870467|NCT00455325|12036168|FG000|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
10870468|NCT00455325|12036169|FG001|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
10870469|NCT00455325|12036170|FG002|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
10870470|NCT00455325|12036171|FG003|NOT COMPLETED|Cohort 4: 250mg Chloroquine Daily||0
10870471|NCT00321555|12036182|FG000|STARTED|Overall Study||15
10870472|NCT00321555|12036182|FG000|COMPLETED|Overall Study||9
10870473|NCT00321555|12036182|FG000|NOT COMPLETED|Overall Study||6
10870474|NCT04471935|12036186|FG000|STARTED|Overall Study||10
10870475|NCT04471935|12036186|FG000|COMPLETED|Overall Study||8
10870476|NCT04471935|12036186|FG000|NOT COMPLETED|Overall Study||2
10870477|NCT04180540|12036192|FG000|STARTED|Overall Study||55
10870478|NCT04180540|12036193|FG001|STARTED|Overall Study||54
10870479|NCT04180540|12036192|FG000|COMPLETED|Overall Study||53
10870480|NCT04180540|12036193|FG001|COMPLETED|Overall Study||54
10870481|NCT04180540|12036192|FG000|NOT COMPLETED|Overall Study||2
10870482|NCT04180540|12036193|FG001|NOT COMPLETED|Overall Study||0
10870483|NCT03912298|12036199|FG000|STARTED|Overall Study||7
10870484|NCT03912298|12036199|FG000|COMPLETED|Overall Study||7
10870485|NCT03912298|12036199|FG000|NOT COMPLETED|Overall Study||0
10870486|NCT04551677|12036206|FG000|STARTED|Overall Study||29
10870487|NCT04551677|12036207|FG001|STARTED|Overall Study||31
10870488|NCT04551677|12036208|FG002|STARTED|Overall Study||30
10870489|NCT04551677|12036206|FG000|Vaccinated|Overall Study||29
10870490|NCT04551677|12036207|FG001|Vaccinated|Overall Study||31
10870491|NCT04551677|12036208|FG002|Vaccinated|Overall Study||30
10870492|NCT04551677|12036206|FG000|COMPLETED|Overall Study||29
10870493|NCT04551677|12036207|FG001|COMPLETED|Overall Study||31
10870494|NCT04551677|12036208|FG002|COMPLETED|Overall Study||30
10870495|NCT04551677|12036206|FG000|NOT COMPLETED|Overall Study||0
10870496|NCT04551677|12036207|FG001|NOT COMPLETED|Overall Study||0
10870497|NCT04551677|12036208|FG002|NOT COMPLETED|Overall Study||0
10870498|NCT04498832|12036218|FG000|STARTED|Overall Study||1049
10870499|NCT04498832|12036219|FG001|STARTED|Overall Study||1051
10870500|NCT04498832|12036218|FG000|COMPLETED|Overall Study||1048
10870501|NCT04498832|12036219|FG001|COMPLETED|Overall Study||1047
10870502|NCT04498832|12036218|FG000|NOT COMPLETED|Overall Study||1
10870503|NCT04498832|12036219|FG001|NOT COMPLETED|Overall Study||4
10870504|NCT04109222|12036228|FG000|STARTED|Overall Study||30
10870505|NCT04109222|12036229|FG001|STARTED|Overall Study||30
10870506|NCT04109222|12036230|FG002|STARTED|Overall Study||30
10870507|NCT04109222|12036228|FG000|COMPLETED|Overall Study||29
10870508|NCT04109222|12036229|FG001|COMPLETED|Overall Study||30
10870509|NCT04109222|12036230|FG002|COMPLETED|Overall Study||30
11229815|NCT02018887|12422023|FG000|COMPLETED|Part A: Cohorts 1-2: Period 1||9
11229816|NCT02018887|12422024|FG001|COMPLETED|Part A: Cohorts 1-2: Period 1||9
11229817|NCT02018887|12422025|FG002|COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229818|NCT02018887|12422026|FG003|COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229819|NCT02018887|12422027|FG004|COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229820|NCT02018887|12422028|FG005|COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229821|NCT02018887|12422029|FG006|COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229822|NCT02018887|12422030|FG007|COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229823|NCT02018887|12422031|FG008|COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229824|NCT02018887|12422032|FG009|COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229825|NCT02018887|12422033|FG010|COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229826|NCT02018887|12422023|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229827|NCT02018887|12422024|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229828|NCT02018887|12422025|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229829|NCT02018887|12422026|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229830|NCT02018887|12422027|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229831|NCT02018887|12422028|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229832|NCT02018887|12422029|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229833|NCT02018887|12422030|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229834|NCT02018887|12422031|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229835|NCT02018887|12422032|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229836|NCT02018887|12422033|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
11229837|NCT02018887|12422023|FG000|STARTED|Part A: Cohorts 1-2: Period 2||9
11229838|NCT02018887|12422024|FG001|STARTED|Part A: Cohorts 1-2: Period 2||9
11229839|NCT02018887|12422025|FG002|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
11229840|NCT02018887|12422026|FG003|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
11229841|NCT02018887|12422027|FG004|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
11229842|NCT02018887|12422028|FG005|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
11229843|NCT02018887|12422029|FG006|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
11229844|NCT02018887|12422030|FG007|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
11229845|NCT02018887|12422031|FG008|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
11229846|NCT02018887|12422032|FG009|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
11229847|NCT02018887|12422033|FG010|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
11229848|NCT02018887|12422023|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
11229849|NCT02018887|12422024|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
11229850|NCT02018887|12422025|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
11229851|NCT02018887|12422026|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
11229852|NCT02018887|12422027|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
11229853|NCT02018887|12422028|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
10870510|NCT04109222|12036228|FG000|NOT COMPLETED|Overall Study||1
10870511|NCT04109222|12036229|FG001|NOT COMPLETED|Overall Study||0
10870512|NCT04109222|12036230|FG002|NOT COMPLETED|Overall Study||0
10870513|NCT04046939|12036242|FG000|STARTED|Screening Period||534
10870514|NCT04046939|12036243|FG001|STARTED|Screening Period||0
10870515|NCT04046939|12036244|FG002|STARTED|Screening Period||0
10870516|NCT04046939|12036245|FG003|STARTED|Screening Period||0
10870517|NCT04046939|12036242|FG000|Received Placebo During Run-In Period|Screening Period||144
10870518|NCT04046939|12036243|FG001|Received Placebo During Run-In Period|Screening Period||0
10870519|NCT04046939|12036244|FG002|Received Placebo During Run-In Period|Screening Period||0
10870520|NCT04046939|12036245|FG003|Received Placebo During Run-In Period|Screening Period||0
10870521|NCT04046939|12036242|FG000|COMPLETED|Screening Period||103
10870522|NCT04046939|12036243|FG001|COMPLETED|Screening Period||0
10870523|NCT04046939|12036244|FG002|COMPLETED|Screening Period||0
10870524|NCT04046939|12036245|FG003|COMPLETED|Screening Period||0
10870525|NCT04046939|12036242|FG000|NOT COMPLETED|Screening Period||431
10870526|NCT04046939|12036243|FG001|NOT COMPLETED|Screening Period||0
10870527|NCT04046939|12036244|FG002|NOT COMPLETED|Screening Period||0
10870528|NCT04046939|12036245|FG003|NOT COMPLETED|Screening Period||0
10870529|NCT04046939|12036242|FG000|STARTED|Primary Assessment Period||27
10870530|NCT04046939|12036243|FG001|STARTED|Primary Assessment Period||22
10870531|NCT04046939|12036244|FG002|STARTED|Primary Assessment Period||26
10870532|NCT04046939|12036245|FG003|STARTED|Primary Assessment Period||28
10870533|NCT04046939|12036242|FG000|COMPLETED|Primary Assessment Period||25
10870534|NCT04046939|12036243|FG001|COMPLETED|Primary Assessment Period||22
10870535|NCT04046939|12036244|FG002|COMPLETED|Primary Assessment Period||24
10870536|NCT04046939|12036245|FG003|COMPLETED|Primary Assessment Period||28
10870537|NCT04046939|12036242|FG000|NOT COMPLETED|Primary Assessment Period||2
10870538|NCT04046939|12036243|FG001|NOT COMPLETED|Primary Assessment Period||0
10870539|NCT04046939|12036244|FG002|NOT COMPLETED|Primary Assessment Period||2
10870540|NCT04046939|12036245|FG003|NOT COMPLETED|Primary Assessment Period||0
10870541|NCT04046939|12036242|FG000|STARTED|Eosinophil Recovery Period||25
10870542|NCT04046939|12036243|FG001|STARTED|Eosinophil Recovery Period||22
10870543|NCT04046939|12036244|FG002|STARTED|Eosinophil Recovery Period||24
10870544|NCT04046939|12036245|FG003|STARTED|Eosinophil Recovery Period||28
10870545|NCT04046939|12036242|FG000|COMPLETED|Eosinophil Recovery Period||24
10870546|NCT04046939|12036243|FG001|COMPLETED|Eosinophil Recovery Period||22
10870547|NCT04046939|12036244|FG002|COMPLETED|Eosinophil Recovery Period||24
10870548|NCT04046939|12036245|FG003|COMPLETED|Eosinophil Recovery Period||27
10870549|NCT04046939|12036242|FG000|NOT COMPLETED|Eosinophil Recovery Period||1
10870550|NCT04046939|12036243|FG001|NOT COMPLETED|Eosinophil Recovery Period||0
10870551|NCT04046939|12036244|FG002|NOT COMPLETED|Eosinophil Recovery Period||0
10870552|NCT04046939|12036245|FG003|NOT COMPLETED|Eosinophil Recovery Period||1
10870553|NCT03912259|12036263|FG000|STARTED|Overall Study||83
10870554|NCT03912259|12036264|FG001|STARTED|Overall Study||82
10870555|NCT03912259|12036263|FG000|COMPLETED|Overall Study||66
10870556|NCT03912259|12036264|FG001|COMPLETED|Overall Study||76
10870557|NCT03912259|12036263|FG000|NOT COMPLETED|Overall Study||17
10870558|NCT03912259|12036264|FG001|NOT COMPLETED|Overall Study||6
10870559|NCT03890367|12036274|FG000|STARTED|Overall Study||232
10870560|NCT03890367|12036275|FG001|STARTED|Overall Study||235
10870561|NCT03890367|12036276|FG002|STARTED|Overall Study||240
10870562|NCT03890367|12036274|FG000|Safety Analysis Set|Overall Study||230
10870563|NCT03890367|12036275|FG001|Safety Analysis Set|Overall Study||232
10870564|NCT03890367|12036276|FG002|Safety Analysis Set|Overall Study||239
10870565|NCT03890367|12036274|FG000|COMPLETED|Overall Study||228
10870566|NCT03890367|12036275|FG001|COMPLETED|Overall Study||229
10870567|NCT03890367|12036276|FG002|COMPLETED|Overall Study||239
10870568|NCT03890367|12036274|FG000|NOT COMPLETED|Overall Study||4
10870569|NCT03890367|12036275|FG001|NOT COMPLETED|Overall Study||6
10870570|NCT03890367|12036276|FG002|NOT COMPLETED|Overall Study||1
10870571|NCT03784898|12036284|FG000|STARTED|Overall Study||13
10870572|NCT03784898|12036284|FG000|COMPLETED|Overall Study||13
10870573|NCT03784898|12036284|FG000|NOT COMPLETED|Overall Study||0
10870574|NCT03607422|12036294|FG000|STARTED|Overall Study||242
10870575|NCT03607422|12036295|FG001|STARTED|Overall Study||243
10870576|NCT03607422|12036296|FG002|STARTED|Overall Study||247
10870577|NCT03607422|12036297|FG003|STARTED|Overall Study||60
10870578|NCT03607422|12036298|FG004|STARTED|Overall Study||58
10870579|NCT03607422|12036299|FG005|STARTED|Overall Study||62
10870580|NCT03607422|12036294|FG000|COMPLETED|Overall Study||204
10870581|NCT03607422|12036295|FG001|COMPLETED|Overall Study||233
10870582|NCT03607422|12036296|FG002|COMPLETED|Overall Study||235
10870583|NCT03607422|12036297|FG003|COMPLETED|Overall Study||55
10870584|NCT03607422|12036298|FG004|COMPLETED|Overall Study||55
10870585|NCT03607422|12036299|FG005|COMPLETED|Overall Study||59
10870586|NCT03607422|12036294|FG000|NOT COMPLETED|Overall Study||38
10870587|NCT03607422|12036295|FG001|NOT COMPLETED|Overall Study||10
10870588|NCT03607422|12036296|FG002|NOT COMPLETED|Overall Study||12
10870589|NCT03607422|12036297|FG003|NOT COMPLETED|Overall Study||5
10870590|NCT03607422|12036298|FG004|NOT COMPLETED|Overall Study||3
10870591|NCT03607422|12036299|FG005|NOT COMPLETED|Overall Study||3
10870592|NCT03600805|12036317|FG000|STARTED|Overall Study||28
10870593|NCT03600805|12036318|FG001|STARTED|Overall Study||14
10870594|NCT03600805|12036319|FG002|STARTED|Overall Study||14
10870595|NCT03600805|12036320|FG003|STARTED|Overall Study||27
10870596|NCT03600805|12036317|FG000|Week 52 Analysis Set Population|Overall Study||10
10870597|NCT03600805|12036318|FG001|Week 52 Analysis Set Population|Overall Study||6
10870598|NCT03600805|12036319|FG002|Week 52 Analysis Set Population|Overall Study||7
10870599|NCT03600805|12036320|FG003|Week 52 Analysis Set Population|Overall Study||13
10870600|NCT03600805|12036317|FG000|COMPLETED|Overall Study||9
10870601|NCT03600805|12036318|FG001|COMPLETED|Overall Study||6
10870602|NCT03600805|12036319|FG002|COMPLETED|Overall Study||6
10870603|NCT03600805|12036320|FG003|COMPLETED|Overall Study||8
10870604|NCT03600805|12036317|FG000|NOT COMPLETED|Overall Study||19
10870605|NCT03600805|12036318|FG001|NOT COMPLETED|Overall Study||8
10870606|NCT03600805|12036319|FG002|NOT COMPLETED|Overall Study||8
10870607|NCT03600805|12036320|FG003|NOT COMPLETED|Overall Study||19
10870608|NCT03584724|12036334|FG000|STARTED|Overall Study||25
10870609|NCT03584724|12036335|FG001|STARTED|Overall Study||24
10870610|NCT03584724|12036334|FG000|COMPLETED|Overall Study||18
10870611|NCT03584724|12036335|FG001|COMPLETED|Overall Study||23
10870612|NCT03584724|12036334|FG000|NOT COMPLETED|Overall Study||7
10870613|NCT03584724|12036335|FG001|NOT COMPLETED|Overall Study||1
10870614|NCT03434119|12036343|FG000|STARTED|Overall Study||116
10870615|NCT03434119|12036344|FG001|STARTED|Overall Study||125
10870616|NCT03434119|12036343|FG000|Treated|Overall Study||115
10870617|NCT03434119|12036344|FG001|Treated|Overall Study||125
10870618|NCT03434119|12036343|FG000|COMPLETED|Overall Study||9
10870619|NCT03434119|12036344|FG001|COMPLETED|Overall Study||12
10870620|NCT03434119|12036343|FG000|NOT COMPLETED|Overall Study||107
10870621|NCT03434119|12036344|FG001|NOT COMPLETED|Overall Study||113
10870622|NCT03417245|12036352|FG000|STARTED|Overall Study||40
10870623|NCT03417245|12036353|FG001|STARTED|Overall Study||80
10870624|NCT03417245|12036352|FG000|Treated|Overall Study||40
10870625|NCT03417245|12036353|FG001|Treated|Overall Study||79
10870626|NCT03417245|12036352|FG000|COMPLETED|Overall Study||37
10870627|NCT03417245|12036353|FG001|COMPLETED|Overall Study||79
10870628|NCT03417245|12036352|FG000|NOT COMPLETED|Overall Study||3
10870629|NCT03417245|12036353|FG001|NOT COMPLETED|Overall Study||1
10870630|NCT03417102|12036361|FG000|STARTED|Overall Study||19
10870631|NCT03417102|12036362|FG001|STARTED|Overall Study||38
10870632|NCT03417102|12036361|FG000|Safety Analysis Set|Overall Study||19
10870633|NCT03417102|12036362|FG001|Safety Analysis Set|Overall Study|3 participants were non-randomized but treated with Fitusiran considered in this arm for safety.|41
10870634|NCT03417102|12036361|FG000|COMPLETED|Overall Study||19
10870635|NCT03417102|12036362|FG001|COMPLETED|Overall Study||33
10870636|NCT03417102|12036361|FG000|NOT COMPLETED|Overall Study||0
10870637|NCT03417102|12036362|FG001|NOT COMPLETED|Overall Study||5
10870638|NCT03278626|12036368|FG000|STARTED|Overall Study||12
10870639|NCT03278626|12036368|FG000|COMPLETED|Overall Study||7
10870640|NCT03278626|12036368|FG000|NOT COMPLETED|Overall Study||5
10870641|NCT03211858|12036374|FG000|STARTED|Overall Study||301
10870642|NCT03211858|12036375|FG001|STARTED|Overall Study||296
10870643|NCT03211858|12036374|FG000|Treated|Overall Study||301
10870644|NCT03211858|12036375|FG001|Treated|Overall Study||296
10870645|NCT03211858|12036374|FG000|COMPLETED|Overall Study||264
10870646|NCT03211858|12036375|FG001|COMPLETED|Overall Study||263
10870647|NCT03211858|12036374|FG000|NOT COMPLETED|Overall Study||37
10870648|NCT03211858|12036375|FG001|NOT COMPLETED|Overall Study||33
10870649|NCT03093480|12036385|FG000|STARTED|Overall Study||16
10870650|NCT03093480|12036385|FG000|Tapering Period|Overall Study||10
10870651|NCT03093480|12036385|FG000|Follow-up Period|Overall Study||10
10870652|NCT03093480|12036385|FG000|COMPLETED|Overall Study||16
10870653|NCT03093480|12036385|FG000|NOT COMPLETED|Overall Study||0
10870654|NCT03077438|12036391|FG000|STARTED|Overall Study||499
10870655|NCT03077438|12036392|FG001|STARTED|Overall Study||501
10870656|NCT03077438|12036391|FG000|Safety Analysis Set (SafAS)|Overall Study||498
10870657|NCT03077438|12036392|FG001|Safety Analysis Set (SafAS)|Overall Study||494
10870658|NCT03077438|12036391|FG000|COMPLETED|Overall Study||487
10870659|NCT03077438|12036392|FG001|COMPLETED|Overall Study||487
10870660|NCT03077438|12036391|FG000|NOT COMPLETED|Overall Study||12
10870661|NCT03077438|12036392|FG001|NOT COMPLETED|Overall Study||14
10870662|NCT03045653|12036402|FG000|STARTED|Overall Study||30
10870663|NCT03045653|12036402|FG000|COMPLETED|Overall Study||30
10870664|NCT03045653|12036402|FG000|NOT COMPLETED|Overall Study||0
10870665|NCT02948959|12036408|FG000|STARTED|52 Weeks Treatment Period||135
10870666|NCT02948959|12036409|FG001|STARTED|52 Weeks Treatment Period||273
10870667|NCT02948959|12036408|FG000|Treated|52 Weeks Treatment Period||135
10870668|NCT02948959|12036409|FG001|Treated|52 Weeks Treatment Period||270
10870669|NCT02948959|12036408|FG000|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|134
10870670|NCT02948959|12036409|FG001|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|271
10870671|NCT02948959|12036408|FG000|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||114
10870672|NCT02948959|12036409|FG001|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||236
10870673|NCT02948959|12036408|FG000|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||84
10870674|NCT02948959|12036409|FG001|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||175
10870675|NCT02948959|12036408|FG000|COMPLETED|52 Weeks Treatment Period||130
10870676|NCT02948959|12036409|FG001|COMPLETED|52 Weeks Treatment Period||248
10870677|NCT02948959|12036408|FG000|NOT COMPLETED|52 Weeks Treatment Period||5
10870678|NCT02948959|12036409|FG001|NOT COMPLETED|52 Weeks Treatment Period||25
10870679|NCT02948959|12036408|FG000|STARTED|12 Weeks Follow-up Period||9
10870680|NCT02948959|12036409|FG001|STARTED|12 Weeks Follow-up Period||31
10870681|NCT02948959|12036408|FG000|COMPLETED|12 Weeks Follow-up Period||4
10870682|NCT02948959|12036409|FG001|COMPLETED|12 Weeks Follow-up Period||19
10870683|NCT02948959|12036408|FG000|NOT COMPLETED|12 Weeks Follow-up Period||5
10870684|NCT02948959|12036409|FG001|NOT COMPLETED|12 Weeks Follow-up Period||12
10870685|NCT02878603|12036425|FG000|STARTED|Overall Study||29
10870686|NCT02878603|12036426|FG001|STARTED|Overall Study||75
10870687|NCT02878603|12036425|FG000|COMPLETED|Overall Study||23
10870688|NCT02878603|12036426|FG001|COMPLETED|Overall Study||70
10870689|NCT02878603|12036425|FG000|NOT COMPLETED|Overall Study||6
10870690|NCT02878603|12036426|FG001|NOT COMPLETED|Overall Study||5
10870691|NCT02864407|12036432|FG000|STARTED|Overall Study||3223
10870692|NCT02864407|12036432|FG000|Effectiveness Analysis Set|Overall Study||2105
10870693|NCT02864407|12036432|FG000|Long-term Safety Analysis Set|Overall Study||813
10870694|NCT02864407|12036432|FG000|Long-term Effectiveness Analysis Set|Overall Study||767
10870695|NCT02864407|12036432|FG000|COMPLETED|Overall Study||3100
10870696|NCT02864407|12036432|FG000|NOT COMPLETED|Overall Study||123
10870697|NCT02846532|12036439|FG000|STARTED|Overall Study||12
10870698|NCT02846532|12036440|FG001|STARTED|Overall Study||66
10870699|NCT02846532|12036441|FG002|STARTED|Overall Study||34
10870700|NCT02846532|12036439|FG000|COMPLETED|Overall Study||11
10870701|NCT02846532|12036440|FG001|COMPLETED|Overall Study||63
10870702|NCT02846532|12036441|FG002|COMPLETED|Overall Study||33
10870703|NCT02846532|12036439|FG000|NOT COMPLETED|Overall Study||1
10870704|NCT02846532|12036440|FG001|NOT COMPLETED|Overall Study||3
10870705|NCT02846532|12036441|FG002|NOT COMPLETED|Overall Study||1
10870706|NCT02688933|12036451|FG000|STARTED|Overall Study||320
10870707|NCT02688933|12036452|FG001|STARTED|Overall Study||318
10870708|NCT02688933|12036451|FG000|COMPLETED|Overall Study||291
10870709|NCT02688933|12036452|FG001|COMPLETED|Overall Study||281
10870710|NCT02688933|12036451|FG000|NOT COMPLETED|Overall Study||29
10870711|NCT02688933|12036452|FG001|NOT COMPLETED|Overall Study||37
10870712|NCT02550197|12036460|FG000|STARTED|Overall Study||200
10870713|NCT02550197|12036461|FG001|STARTED|Overall Study||100
10870714|NCT02550197|12036460|FG000|COMPLETED|Overall Study||200
10870715|NCT02550197|12036461|FG001|COMPLETED|Overall Study||100
10870716|NCT02550197|12036460|FG000|NOT COMPLETED|Overall Study||0
10870717|NCT02550197|12036461|FG001|NOT COMPLETED|Overall Study||0
10870718|NCT02492165|12036471|FG000|STARTED|Overall Study||100
10870719|NCT02492165|12036472|FG001|STARTED|Overall Study||60
10870720|NCT02492165|12036473|FG002|STARTED|Overall Study||60
10870721|NCT02492165|12036474|FG003|STARTED|Overall Study||30
10870722|NCT02492165|12036471|FG000|COMPLETED|Overall Study||100
10870723|NCT02492165|12036472|FG001|COMPLETED|Overall Study||59
10870724|NCT02492165|12036473|FG002|COMPLETED|Overall Study||60
10870725|NCT02492165|12036474|FG003|COMPLETED|Overall Study||30
10870726|NCT02492165|12036471|FG000|NOT COMPLETED|Overall Study||0
10870727|NCT02492165|12036472|FG001|NOT COMPLETED|Overall Study||1
10870728|NCT02492165|12036473|FG002|NOT COMPLETED|Overall Study||0
10870729|NCT02492165|12036474|FG003|NOT COMPLETED|Overall Study||0
10870730|NCT02476006|12036484|FG000|STARTED|Overall Study||998
10870731|NCT02476006|12036484|FG000|Treated|Overall Study||994
10870732|NCT02476006|12036484|FG000|COMPLETED|Overall Study||878
10870733|NCT02476006|12036484|FG000|NOT COMPLETED|Overall Study||120
10870734|NCT02468414|12036490|FG000|STARTED|Overall Study||3
10870735|NCT02468414|12036491|FG001|STARTED|Overall Study||0
10870736|NCT02468414|12036490|FG000|Successfully Screened|Overall Study||2
10870737|NCT02468414|12036491|FG001|Successfully Screened|Overall Study||0
11111325|NCT01285791|12295958|FG000|STARTED|Overall Study||11
11111326|NCT01285791|12295959|FG001|STARTED|Overall Study||15
11111327|NCT01285791|12295960|FG002|STARTED|Overall Study||13
11111328|NCT01285791|12295958|FG000|COMPLETED|Overall Study||11
11111329|NCT01285791|12295959|FG001|COMPLETED|Overall Study||15
11111330|NCT01285791|12295960|FG002|COMPLETED|Overall Study||13
11111331|NCT01285791|12295958|FG000|NOT COMPLETED|Overall Study||0
11111332|NCT01285791|12295959|FG001|NOT COMPLETED|Overall Study||0
11111333|NCT01285791|12295960|FG002|NOT COMPLETED|Overall Study||0
10870738|NCT02468414|12036490|FG000|Harvesting|Overall Study||1
10870739|NCT02468414|12036491|FG001|Harvesting|Overall Study||0
10870740|NCT02468414|12036490|FG000|Implantation|Overall Study||1
10870741|NCT02468414|12036491|FG001|Implantation|Overall Study||0
10870742|NCT02468414|12036490|FG000|Safety Follow-up|Overall Study||0
10870743|NCT02468414|12036491|FG001|Safety Follow-up|Overall Study||0
10870744|NCT02468414|12036490|FG000|COMPLETED|Overall Study||0
10870745|NCT02468414|12036491|FG001|COMPLETED|Overall Study||0
10870746|NCT02468414|12036490|FG000|NOT COMPLETED|Overall Study||3
10870747|NCT02468414|12036491|FG001|NOT COMPLETED|Overall Study||0
10870748|NCT02462876|12036497|FG000|STARTED|Overall Study||60
10870749|NCT02462876|12036497|FG000|COMPLETED|Overall Study||33
10870750|NCT02462876|12036497|FG000|NOT COMPLETED|Overall Study||27
10870751|NCT02332590|12036503|FG000|STARTED|DB Period (up to 24 Weeks)||185
10870752|NCT02332590|12036504|FG001|STARTED|DB Period (up to 24 Weeks)||184
10870753|NCT02332590|12036503|FG000|Treated|DB Period (up to 24 Weeks)||184
10870754|NCT02332590|12036504|FG001|Treated|DB Period (up to 24 Weeks)||184
10870755|NCT02332590|12036503|FG000|COMPLETED|DB Period (up to 24 Weeks)|155 participants entered OLE period and 1 did not enroll.|156
10870756|NCT02332590|12036504|FG001|COMPLETED|DB Period (up to 24 Weeks)||165
10870757|NCT02332590|12036503|FG000|NOT COMPLETED|DB Period (up to 24 Weeks)||29
10870758|NCT02332590|12036504|FG001|NOT COMPLETED|DB Period (up to 24 Weeks)||19
10870759|NCT02332590|12036503|FG000|STARTED|OLE Period (Week 24 up to Week 300)||155
10870760|NCT02332590|12036504|FG001|STARTED|OLE Period (Week 24 up to Week 300)||165
10870761|NCT02332590|12036503|FG000|COMPLETED|OLE Period (Week 24 up to Week 300)||108
10870762|NCT02332590|12036504|FG001|COMPLETED|OLE Period (Week 24 up to Week 300)||120
10870763|NCT02332590|12036503|FG000|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||47
10870764|NCT02332590|12036504|FG001|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||45
10870765|NCT02255656|12036512|FG000|STARTED|Overall Study||1062
10870766|NCT02255656|12036512|FG000|COMPLETED|Overall Study||592
10870767|NCT02255656|12036512|FG000|NOT COMPLETED|Overall Study||470
10870768|NCT02134028|12036531|FG000|STARTED|Overall Study||111
10870769|NCT02134028|12036532|FG001|STARTED|Overall Study||421
10870770|NCT02134028|12036533|FG002|STARTED|Overall Study||517
10870771|NCT02134028|12036534|FG003|STARTED|Overall Study||1013
10870772|NCT02134028|12036535|FG004|STARTED|Overall Study||97
10870773|NCT02134028|12036536|FG005|STARTED|Overall Study||90
10870774|NCT02134028|12036537|FG006|STARTED|Overall Study||19
10870775|NCT02134028|12036538|FG007|STARTED|Overall Study||14
10870776|NCT02134028|12036531|FG000|COMPLETED|Overall Study||102
10870777|NCT02134028|12036532|FG001|COMPLETED|Overall Study||379
10870778|NCT02134028|12036533|FG002|COMPLETED|Overall Study||465
10870779|NCT02134028|12036534|FG003|COMPLETED|Overall Study||908
10870780|NCT02134028|12036535|FG004|COMPLETED|Overall Study||83
10870781|NCT02134028|12036536|FG005|COMPLETED|Overall Study||76
10870782|NCT02134028|12036537|FG006|COMPLETED|Overall Study||15
10870783|NCT02134028|12036538|FG007|COMPLETED|Overall Study||11
11111334|NCT01285843|12295970|FG000|STARTED|Overall Study||20
11111335|NCT01285843|12295971|FG001|STARTED|Overall Study||20
10870784|NCT02134028|12036531|FG000|NOT COMPLETED|Overall Study||9
10870785|NCT02134028|12036532|FG001|NOT COMPLETED|Overall Study||42
10870786|NCT02134028|12036533|FG002|NOT COMPLETED|Overall Study||52
10870787|NCT02134028|12036534|FG003|NOT COMPLETED|Overall Study||105
10870788|NCT02134028|12036535|FG004|NOT COMPLETED|Overall Study||14
10870789|NCT02134028|12036536|FG005|NOT COMPLETED|Overall Study||14
10870790|NCT02134028|12036537|FG006|NOT COMPLETED|Overall Study||4
10870791|NCT02134028|12036538|FG007|NOT COMPLETED|Overall Study||3
10870792|NCT02037620|12036558|FG000|STARTED|Overall Study||5
10870793|NCT02037620|12036558|FG000|COMPLETED|Overall Study||4
10870794|NCT02037620|12036558|FG000|NOT COMPLETED|Overall Study||1
10870795|NCT01900444|12036562|FG000|STARTED|Overall Study||119
10870796|NCT01900444|12036562|FG000|COMPLETED|Overall Study||116
10870797|NCT01900444|12036562|FG000|NOT COMPLETED|Overall Study||3
10870798|NCT01887912|12036568|FG000|STARTED|Overall Study||6201
10870799|NCT01887912|12036569|FG001|STARTED|Overall Study||3101
10870800|NCT01887912|12036568|FG000|Safety Population|Overall Study||6113
10870801|NCT01887912|12036569|FG001|Safety Population|Overall Study||3057
10870802|NCT01887912|12036568|FG000|COMPLETED|Overall Study||4809
10870803|NCT01887912|12036569|FG001|COMPLETED|Overall Study||2370
10870804|NCT01887912|12036568|FG000|NOT COMPLETED|Overall Study||1392
10870805|NCT01887912|12036569|FG001|NOT COMPLETED|Overall Study||731
10870806|NCT01751126|12036578|FG000|STARTED|Period I||57
10870807|NCT01751126|12036579|FG001|STARTED|Period I||54
10870808|NCT01751126|12036580|FG002|STARTED|Period I||58
10870809|NCT01751126|12036578|FG000|COMPLETED|Period I||51
10870810|NCT01751126|12036579|FG001|COMPLETED|Period I||43
10870811|NCT01751126|12036580|FG002|COMPLETED|Period I||49
10870812|NCT01751126|12036578|FG000|NOT COMPLETED|Period I||6
10870813|NCT01751126|12036579|FG001|NOT COMPLETED|Period I||11
10870814|NCT01751126|12036580|FG002|NOT COMPLETED|Period I||9
10870815|NCT01751126|12036578|FG000|STARTED|Period II||72
10870816|NCT01751126|12036579|FG001|STARTED|Period II||70
10870817|NCT01751126|12036580|FG002|STARTED|Period II|Following completion of the first period of the trial, all patients were to be administered NOVA22007 (High or Low dose) for a safety 8-month follow-up period.|0
10870818|NCT01751126|12036578|FG000|COMPLETED|Period II||72
10870819|NCT01751126|12036579|FG001|COMPLETED|Period II||70
10870820|NCT01751126|12036580|FG002|COMPLETED|Period II||0
10870821|NCT01751126|12036578|FG000|NOT COMPLETED|Period II||0
10870822|NCT01751126|12036579|FG001|NOT COMPLETED|Period II||0
10870823|NCT01751126|12036580|FG002|NOT COMPLETED|Period II||0
10870824|NCT01437423|12036602|FG000|STARTED|Overall Study||662
10870825|NCT01437423|12036602|FG000|COMPLETED|Overall Study||647
10870826|NCT01437423|12036602|FG000|NOT COMPLETED|Overall Study||15
10870827|NCT01410890|12036608|FG000|STARTED|Overall Study||10
10870828|NCT01410890|12036609|FG001|STARTED|Overall Study||11
10870829|NCT01410890|12036608|FG000|Treated|Overall Study||10
10870830|NCT01410890|12036609|FG001|Treated|Overall Study||10
10870831|NCT01410890|12036608|FG000|COMPLETED|Overall Study||10
10870832|NCT01410890|12036609|FG001|COMPLETED|Overall Study||10
10870833|NCT01410890|12036608|FG000|NOT COMPLETED|Overall Study||0
10870834|NCT01410890|12036609|FG001|NOT COMPLETED|Overall Study||1
10870835|NCT01190228|12036620|FG000|STARTED|Overall Study||349
10870836|NCT01190228|12036621|FG001|STARTED|Overall Study||46
10870837|NCT01190228|12036622|FG002|STARTED|Overall Study||59
10870838|NCT01190228|12036620|FG000|COMPLETED|Overall Study||344
10870839|NCT01190228|12036621|FG001|COMPLETED|Overall Study||46
10870840|NCT01190228|12036622|FG002|COMPLETED|Overall Study||59
10870841|NCT01190228|12036620|FG000|NOT COMPLETED|Overall Study||5
10870842|NCT01190228|12036621|FG001|NOT COMPLETED|Overall Study||0
10870843|NCT01190228|12036622|FG002|NOT COMPLETED|Overall Study||0
10870844|NCT01146652|12036634|FG000|STARTED|Overall Study||1912
10870845|NCT01146652|12036635|FG001|STARTED|Overall Study||111
10870846|NCT01146652|12036634|FG000|Treated|Overall Study||1910
10870847|NCT01146652|12036635|FG001|Treated|Overall Study||111
10870848|NCT01146652|12036634|FG000|Enrolled in the Sub-study|Overall Study||110
10870849|NCT01146652|12036635|FG001|Enrolled in the Sub-study|Overall Study||14
10870850|NCT01146652|12036634|FG000|Discontinued From the Sub-study|Overall Study||1
10870851|NCT01146652|12036635|FG001|Discontinued From the Sub-study|Overall Study||2
10870852|NCT01146652|12036634|FG000|Switched Back to Main Study|Overall Study||108
10870853|NCT01146652|12036635|FG001|Switched Back to Main Study|Overall Study||13
10870854|NCT01146652|12036634|FG000|COMPLETED|Overall Study||961
10870855|NCT01146652|12036635|FG001|COMPLETED|Overall Study||66
10870856|NCT01146652|12036634|FG000|NOT COMPLETED|Overall Study||951
10870857|NCT01146652|12036635|FG001|NOT COMPLETED|Overall Study||45
10870858|NCT01049035|12036655|FG000|STARTED|Overall Study||107
10870859|NCT01049035|12036656|FG001|STARTED|Overall Study||108
10870860|NCT01049035|12036657|FG002|STARTED|Overall Study||107
10870861|NCT01049035|12036658|FG003|STARTED|Overall Study||75
10870862|NCT01049035|12036659|FG004|STARTED|Overall Study||75
10870863|NCT01049035|12036660|FG005|STARTED|Overall Study||54
10870864|NCT01049035|12036661|FG006|STARTED|Overall Study||54
10870865|NCT01049035|12036655|FG000|Safety Population|Overall Study||104
10870866|NCT01049035|12036656|FG001|Safety Population|Overall Study||102
10870867|NCT01049035|12036657|FG002|Safety Population|Overall Study||100
10870868|NCT01049035|12036658|FG003|Safety Population|Overall Study||74
10870869|NCT01049035|12036659|FG004|Safety Population|Overall Study||70
10870870|NCT01049035|12036660|FG005|Safety Population|Overall Study||52
10870871|NCT01049035|12036661|FG006|Safety Population|Overall Study||49
10870872|NCT01049035|12036655|FG000|COMPLETED|Overall Study||74
10870873|NCT01049035|12036656|FG001|COMPLETED|Overall Study||87
10870874|NCT01049035|12036657|FG002|COMPLETED|Overall Study||80
10870875|NCT01049035|12036658|FG003|COMPLETED|Overall Study||64
10870876|NCT01049035|12036659|FG004|COMPLETED|Overall Study||71
10870877|NCT01049035|12036660|FG005|COMPLETED|Overall Study||42
10870878|NCT01049035|12036661|FG006|COMPLETED|Overall Study||39
10870879|NCT01049035|12036655|FG000|NOT COMPLETED|Overall Study||33
10870880|NCT01049035|12036656|FG001|NOT COMPLETED|Overall Study||21
10870881|NCT01049035|12036657|FG002|NOT COMPLETED|Overall Study||27
10870882|NCT01049035|12036658|FG003|NOT COMPLETED|Overall Study||11
10870883|NCT01049035|12036659|FG004|NOT COMPLETED|Overall Study||4
10870884|NCT01049035|12036660|FG005|NOT COMPLETED|Overall Study||12
10870885|NCT01049035|12036661|FG006|NOT COMPLETED|Overall Study||15
11111336|NCT01285843|12295970|FG000|COMPLETED|Overall Study||18
11111337|NCT01285843|12295971|FG001|COMPLETED|Overall Study||18
11111338|NCT01285843|12295970|FG000|NOT COMPLETED|Overall Study||2
11111339|NCT01285843|12295971|FG001|NOT COMPLETED|Overall Study||2
11111340|NCT01285908|12295977|FG000|STARTED|Baseline Measurement||6
11111341|NCT01285908|12295978|FG001|STARTED|Baseline Measurement||0
11111342|NCT01285908|12295979|FG002|STARTED|Baseline Measurement||0
11111343|NCT01285908|12295977|FG000|COMPLETED|Baseline Measurement||3
11111344|NCT01285908|12295978|FG001|COMPLETED|Baseline Measurement||0
11111345|NCT01285908|12295979|FG002|COMPLETED|Baseline Measurement||0
11111346|NCT01285908|12295977|FG000|NOT COMPLETED|Baseline Measurement||3
11111347|NCT01285908|12295978|FG001|NOT COMPLETED|Baseline Measurement||0
10870898|NCT00727090|12036693|FG000|STARTED|Overall Study||3
10870899|NCT00727090|12036694|FG001|STARTED|Overall Study||3
10870900|NCT00727090|12036693|FG000|COMPLETED|Overall Study||3
10870901|NCT00727090|12036694|FG001|COMPLETED|Overall Study||3
10870902|NCT00727090|12036693|FG000|NOT COMPLETED|Overall Study||0
10870903|NCT00727090|12036694|FG001|NOT COMPLETED|Overall Study||0
10870904|NCT00726063|12036704|FG000|STARTED|Overall Study|Number of implants= 239|122
10870905|NCT00726063|12036705|FG001|STARTED|Overall Study|Number of implants= 246|119
10870906|NCT00726063|12036704|FG000|COMPLETED|Overall Study|Number of implants =230|113
10870907|NCT00726063|12036705|FG001|COMPLETED|Overall Study|Number of implants = 239|112
10870908|NCT00726063|12036704|FG000|NOT COMPLETED|Overall Study||9
10870909|NCT00726063|12036705|FG001|NOT COMPLETED|Overall Study||7
11111348|NCT01285908|12295979|FG002|NOT COMPLETED|Baseline Measurement||0
11111349|NCT01285908|12295977|FG000|STARTED|Treatment Crossover||0
11111350|NCT01285908|12295978|FG001|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
11111351|NCT01285908|12295979|FG002|STARTED|Treatment Crossover||2
11111352|NCT01285908|12295977|FG000|COMPLETED|Treatment Crossover||0
11111353|NCT01285908|12295978|FG001|COMPLETED|Treatment Crossover||2
10870916|NCT00713206|12036722|FG000|STARTED|Overall Study||65
10870917|NCT00713206|12036723|FG001|STARTED|Overall Study||57
10870918|NCT00713206|12036722|FG000|COMPLETED|Overall Study||60
10870919|NCT00713206|12036723|FG001|COMPLETED|Overall Study||53
10870920|NCT00713206|12036722|FG000|NOT COMPLETED|Overall Study||5
10870921|NCT00713206|12036723|FG001|NOT COMPLETED|Overall Study||4
11229854|NCT02018887|12422029|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
11229855|NCT02018887|12422030|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
11229856|NCT02018887|12422031|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
11229857|NCT02018887|12422032|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
11229858|NCT02018887|12422033|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
11229859|NCT02018887|12422023|FG000|COMPLETED|Part A: Cohorts 1-2: Period 2||9
11229860|NCT02018887|12422024|FG001|COMPLETED|Part A: Cohorts 1-2: Period 2||9
10870922|NCT04654351|12036729|FG000|STARTED|Overall Study||2
10870923|NCT04654351|12036729|FG000|COMPLETED|Overall Study||2
10870924|NCT04654351|12036729|FG000|NOT COMPLETED|Overall Study||0
10870925|NCT04422990|12036736|FG000|STARTED|Overall Study||50
10870926|NCT04422990|12036737|FG001|STARTED|Overall Study||97
10870927|NCT04422990|12036736|FG000|COMPLETED|Overall Study||47
10870928|NCT04422990|12036737|FG001|COMPLETED|Overall Study||96
10870929|NCT04422990|12036736|FG000|NOT COMPLETED|Overall Study||3
10870930|NCT04422990|12036737|FG001|NOT COMPLETED|Overall Study||1
10870931|NCT04388319|12036746|FG000|STARTED|Enrolled in Study||26
10870932|NCT04388319|12036746|FG000|COMPLETED|Enrolled in Study||24
10870933|NCT04388319|12036746|FG000|NOT COMPLETED|Enrolled in Study||2
10870934|NCT04388319|12036746|FG000|STARTED|Treatment Period||24
10870935|NCT04388319|12036746|FG000|COMPLETED|Treatment Period||23
10870936|NCT04388319|12036746|FG000|NOT COMPLETED|Treatment Period||1
10870937|NCT04358549|12036752|FG000|STARTED|Overall Study||25
10870938|NCT04358549|12036753|FG001|STARTED|Overall Study||25
10870939|NCT04358549|12036752|FG000|ITT Population (Randomized Subjects)|Overall Study||25
10870940|NCT04358549|12036753|FG001|ITT Population (Randomized Subjects)|Overall Study||25
11111354|NCT01285908|12295979|FG002|COMPLETED|Treatment Crossover||2
11111355|NCT01285908|12295977|FG000|NOT COMPLETED|Treatment Crossover||0
11111356|NCT01285908|12295978|FG001|NOT COMPLETED|Treatment Crossover||0
11111357|NCT01285908|12295979|FG002|NOT COMPLETED|Treatment Crossover||0
11111358|NCT01285960|12296009|FG000|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108
11111359|NCT01285960|12296009|FG000|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102
11111360|NCT01285960|12296009|FG000|NOT COMPLETED|Overall Study||6
11111361|NCT01286012|12296015|FG000|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
11111362|NCT01286012|12296016|FG001|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
11111363|NCT01286012|12296015|FG000|COMPLETED|Overall Study||41
11111364|NCT01286012|12296016|FG001|COMPLETED|Overall Study||40
11111365|NCT01286012|12296015|FG000|NOT COMPLETED|Overall Study||13
11111366|NCT01286012|12296016|FG001|NOT COMPLETED|Overall Study||14
11111367|NCT01286077|12296025|FG000|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
11111368|NCT01286077|12296026|FG001|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
11111369|NCT01286077|12296025|FG000|COMPLETED|Overall Study||41
11111370|NCT01286077|12296026|FG001|COMPLETED|Overall Study||46
11111371|NCT01286077|12296025|FG000|NOT COMPLETED|Overall Study||10
11111372|NCT01286077|12296026|FG001|NOT COMPLETED|Overall Study||7
11111373|NCT01286129|12296034|FG000|STARTED|Overall Study||27
11111374|NCT01286129|12296035|FG001|STARTED|Overall Study||18
11111375|NCT01286129|12296034|FG000|COMPLETED|Overall Study||19
11111376|NCT01286129|12296035|FG001|COMPLETED|Overall Study||13
11111377|NCT01286129|12296034|FG000|NOT COMPLETED|Overall Study||8
11111378|NCT01286129|12296035|FG001|NOT COMPLETED|Overall Study||5
11111379|NCT01286168|12296043|FG000|STARTED|Overall Study||104
11111380|NCT01286168|12296043|FG000|COMPLETED|Overall Study||101
11111381|NCT01286168|12296043|FG000|NOT COMPLETED|Overall Study||3
11111382|NCT01286259|12296048|FG000|STARTED|Overall Study||16
11111383|NCT01286259|12296048|FG000|COMPLETED|Overall Study||16
11111384|NCT01286259|12296048|FG000|NOT COMPLETED|Overall Study||0
11111385|NCT01286311|12296054|FG000|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
11111386|NCT01286311|12296055|FG001|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
11111387|NCT01286311|12296054|FG000|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
11111388|NCT01286311|12296055|FG001|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
11111389|NCT01286311|12296054|FG000|NOT COMPLETED|Overall Study||14
11111390|NCT01286311|12296055|FG001|NOT COMPLETED|Overall Study||0
11111391|NCT01286324|12296063|FG000|STARTED|Overall Study||17
11111392|NCT01286324|12296064|FG001|STARTED|Overall Study||17
11111393|NCT01286324|12296063|FG000|COMPLETED|Overall Study||17
11111394|NCT01286324|12296064|FG001|COMPLETED|Overall Study||17
11111395|NCT01286324|12296063|FG000|NOT COMPLETED|Overall Study||0
11111396|NCT01286324|12296064|FG001|NOT COMPLETED|Overall Study||0
11111397|NCT01286402|12296072|FG000|STARTED|Overall Study||5
11111398|NCT01286402|12296073|FG001|STARTED|Overall Study||6
11111399|NCT01286402|12296072|FG000|COMPLETED|Overall Study||5
11111400|NCT01286402|12296073|FG001|COMPLETED|Overall Study||6
11111401|NCT01286402|12296072|FG000|NOT COMPLETED|Overall Study||0
11111402|NCT01286402|12296073|FG001|NOT COMPLETED|Overall Study||0
11111403|NCT01286441|12296083|FG000|STARTED|Overall Study||45
11111404|NCT01286441|12296084|FG001|STARTED|Overall Study||44
11111405|NCT01286441|12296085|FG002|STARTED|Overall Study||46
11111406|NCT01286441|12296086|FG003|STARTED|Overall Study||48
11229861|NCT02018887|12422025|FG002|COMPLETED|Part A: Cohorts 1-2: Period 2||0
11111407|NCT01286441|12296083|FG000|COMPLETED|Overall Study||38
11111408|NCT01286441|12296084|FG001|COMPLETED|Overall Study||37
11111409|NCT01286441|12296085|FG002|COMPLETED|Overall Study||39
11111410|NCT01286441|12296086|FG003|COMPLETED|Overall Study||37
11111411|NCT01286441|12296083|FG000|NOT COMPLETED|Overall Study||7
11229862|NCT02018887|12422026|FG003|COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229863|NCT02018887|12422027|FG004|COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229864|NCT02018887|12422028|FG005|COMPLETED|Part A: Cohorts 1-2: Period 2||0
10870941|NCT04358549|12036752|FG000|Safety Population (Patients Who Received Either Favipiravir + SOC or SOC Alone)|Overall Study||24
10870942|NCT04358549|12036753|FG001|Safety Population (Patients Who Received Either Favipiravir + SOC or SOC Alone)|Overall Study||25
10870943|NCT04358549|12036752|FG000|COMPLETED|Overall Study||15
10870944|NCT04358549|12036753|FG001|COMPLETED|Overall Study||17
10870945|NCT04358549|12036752|FG000|NOT COMPLETED|Overall Study||10
10870946|NCT04358549|12036753|FG001|NOT COMPLETED|Overall Study||8
11111412|NCT01286441|12296084|FG001|NOT COMPLETED|Overall Study||7
11111413|NCT01286441|12296085|FG002|NOT COMPLETED|Overall Study||7
11111414|NCT01286441|12296086|FG003|NOT COMPLETED|Overall Study||11
11111415|NCT01286454|12296096|FG000|STARTED|Part I- First Intervention Period||2
11111416|NCT01286454|12296097|FG001|STARTED|Part I- First Intervention Period||2
11111417|NCT01286454|12296098|FG002|STARTED|Part I- First Intervention Period||2
11111418|NCT01286454|12296099|FG003|STARTED|Part I- First Intervention Period||2
11111419|NCT01286454|12296100|FG004|STARTED|Part I- First Intervention Period||2
11111420|NCT01286454|12296101|FG005|STARTED|Part I- First Intervention Period||2
11111421|NCT01286454|12296102|FG006|STARTED|Part I- First Intervention Period||2
11111422|NCT01286454|12296103|FG007|STARTED|Part I- First Intervention Period||2
11111423|NCT01286454|12296104|FG008|STARTED|Part I- First Intervention Period||2
11111424|NCT01286454|12296105|FG009|STARTED|Part I- First Intervention Period||2
11111425|NCT01286454|12296106|FG010|STARTED|Part I- First Intervention Period||0
11111426|NCT01286454|12296096|FG000|COMPLETED|Part I- First Intervention Period||2
11111427|NCT01286454|12296097|FG001|COMPLETED|Part I- First Intervention Period||2
11111428|NCT01286454|12296098|FG002|COMPLETED|Part I- First Intervention Period||2
11111429|NCT01286454|12296099|FG003|COMPLETED|Part I- First Intervention Period||2
11111430|NCT01286454|12296100|FG004|COMPLETED|Part I- First Intervention Period||2
11111431|NCT01286454|12296101|FG005|COMPLETED|Part I- First Intervention Period||2
11111432|NCT01286454|12296102|FG006|COMPLETED|Part I- First Intervention Period||2
11111433|NCT01286454|12296103|FG007|COMPLETED|Part I- First Intervention Period||2
11111434|NCT01286454|12296104|FG008|COMPLETED|Part I- First Intervention Period||2
10870947|NCT04229888|12036759|FG000|STARTED|Overall Study||14
10870948|NCT04229888|12036759|FG000|COMPLETED|Overall Study||14
10870949|NCT04229888|12036759|FG000|NOT COMPLETED|Overall Study||0
10870950|NCT04221828|12036766|FG000|STARTED|Overall Study||1
10870951|NCT04221828|12036766|FG000|COMPLETED|Overall Study||1
10870952|NCT04221828|12036766|FG000|NOT COMPLETED|Overall Study||0
10870953|NCT04095416|12036772|FG000|STARTED|Overall Study||13
10870954|NCT04095416|12036773|FG001|STARTED|Overall Study||19
10870955|NCT04095416|12036772|FG000|COMPLETED|Overall Study||10
10870956|NCT04095416|12036773|FG001|COMPLETED|Overall Study||19
10870957|NCT04095416|12036772|FG000|NOT COMPLETED|Overall Study||3
10870958|NCT04095416|12036773|FG001|NOT COMPLETED|Overall Study||0
10870959|NCT04532099|12036782|FG000|STARTED|First Wear Period (30 Days)||33
10870960|NCT04532099|12036783|FG001|STARTED|First Wear Period (30 Days)||33
10870961|NCT04532099|12036784|FG002|STARTED|First Wear Period (30 Days)||66
10870962|NCT04532099|12036782|FG000|COMPLETED|First Wear Period (30 Days)||32
10870963|NCT04532099|12036783|FG001|COMPLETED|First Wear Period (30 Days)||33
10870964|NCT04532099|12036784|FG002|COMPLETED|First Wear Period (30 Days)||66
10870965|NCT04532099|12036782|FG000|NOT COMPLETED|First Wear Period (30 Days)||1
10870966|NCT04532099|12036783|FG001|NOT COMPLETED|First Wear Period (30 Days)||0
10870967|NCT04532099|12036784|FG002|NOT COMPLETED|First Wear Period (30 Days)||0
10870968|NCT04532099|12036782|FG000|STARTED|Second Wear Period (30 Days)||32
10870969|NCT04532099|12036783|FG001|STARTED|Second Wear Period (30 Days)||33
10870970|NCT04532099|12036784|FG002|STARTED|Second Wear Period (30 Days)|Part B is single product; therefore, only one wear period.|0
10870971|NCT04532099|12036782|FG000|COMPLETED|Second Wear Period (30 Days)||32
10870972|NCT04532099|12036783|FG001|COMPLETED|Second Wear Period (30 Days)||33
10870973|NCT04532099|12036784|FG002|COMPLETED|Second Wear Period (30 Days)||0
10870974|NCT04532099|12036782|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0
10870975|NCT04532099|12036783|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0
10870976|NCT04532099|12036784|FG002|NOT COMPLETED|Second Wear Period (30 Days)||0
10870977|NCT04385199|12036798|FG000|STARTED|Overall Study||20
10870978|NCT04385199|12036799|FG001|STARTED|Overall Study||10
10870979|NCT04385199|12036798|FG000|COMPLETED|Overall Study||19
10870980|NCT04385199|12036799|FG001|COMPLETED|Overall Study||10
10870981|NCT04385199|12036798|FG000|NOT COMPLETED|Overall Study||1
10870982|NCT04385199|12036799|FG001|NOT COMPLETED|Overall Study||0
11111435|NCT01286454|12296105|FG009|COMPLETED|Part I- First Intervention Period||2
11111436|NCT01286454|12296106|FG010|COMPLETED|Part I- First Intervention Period||0
11111437|NCT01286454|12296096|FG000|NOT COMPLETED|Part I- First Intervention Period||0
11111438|NCT01286454|12296097|FG001|NOT COMPLETED|Part I- First Intervention Period||0
11111439|NCT01286454|12296098|FG002|NOT COMPLETED|Part I- First Intervention Period||0
11111440|NCT01286454|12296099|FG003|NOT COMPLETED|Part I- First Intervention Period||0
11229865|NCT02018887|12422029|FG006|COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229866|NCT02018887|12422030|FG007|COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229867|NCT02018887|12422031|FG008|COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229868|NCT02018887|12422032|FG009|COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229869|NCT02018887|12422033|FG010|COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229870|NCT02018887|12422023|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229871|NCT02018887|12422024|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229872|NCT02018887|12422025|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229873|NCT02018887|12422026|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229874|NCT02018887|12422027|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229875|NCT02018887|12422028|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229876|NCT02018887|12422029|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229877|NCT02018887|12422030|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229878|NCT02018887|12422031|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
11355288|NCT03078556|12552139|FG003|STARTED|Washout Period 1 (7 Days)||38
11111441|NCT01286454|12296100|FG004|NOT COMPLETED|Part I- First Intervention Period||0
11111442|NCT01286454|12296101|FG005|NOT COMPLETED|Part I- First Intervention Period||0
11111443|NCT01286454|12296102|FG006|NOT COMPLETED|Part I- First Intervention Period||0
11111444|NCT01286454|12296103|FG007|NOT COMPLETED|Part I- First Intervention Period||0
10870993|NCT04311177|12036817|FG000|STARTED|Overall Study||58
10870994|NCT04311177|12036818|FG001|STARTED|Overall Study||59
10870995|NCT04311177|12036817|FG000|COMPLETED|Overall Study||50
11111445|NCT01286454|12296104|FG008|NOT COMPLETED|Part I- First Intervention Period||0
11111446|NCT01286454|12296105|FG009|NOT COMPLETED|Part I- First Intervention Period||0
11111447|NCT01286454|12296106|FG010|NOT COMPLETED|Part I- First Intervention Period||0
11111448|NCT01286454|12296096|FG000|STARTED|Washout Period (At Least 3 Days)||2
11111449|NCT01286454|12296097|FG001|STARTED|Washout Period (At Least 3 Days)||2
11111450|NCT01286454|12296098|FG002|STARTED|Washout Period (At Least 3 Days)||2
11111451|NCT01286454|12296099|FG003|STARTED|Washout Period (At Least 3 Days)||2
11111452|NCT01286454|12296100|FG004|STARTED|Washout Period (At Least 3 Days)||2
11111453|NCT01286454|12296101|FG005|STARTED|Washout Period (At Least 3 Days)||2
11111454|NCT01286454|12296102|FG006|STARTED|Washout Period (At Least 3 Days)||2
11111455|NCT01286454|12296103|FG007|STARTED|Washout Period (At Least 3 Days)||2
11111456|NCT01286454|12296104|FG008|STARTED|Washout Period (At Least 3 Days)||2
11111457|NCT01286454|12296105|FG009|STARTED|Washout Period (At Least 3 Days)||2
11111458|NCT01286454|12296106|FG010|STARTED|Washout Period (At Least 3 Days)||0
11111459|NCT01286454|12296096|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
10870996|NCT04311177|12036818|FG001|COMPLETED|Overall Study||55
10870997|NCT04311177|12036817|FG000|NOT COMPLETED|Overall Study||8
10870998|NCT04311177|12036818|FG001|NOT COMPLETED|Overall Study||4
10870999|NCT04241133|12036826|FG000|STARTED|Overall Study||44
10871000|NCT04241133|12036827|FG001|STARTED|Overall Study||34
10871001|NCT04241133|12036826|FG000|COMPLETED|Overall Study||30
10871002|NCT04241133|12036827|FG001|COMPLETED|Overall Study||0
10871003|NCT04241133|12036826|FG000|NOT COMPLETED|Overall Study||14
10871004|NCT04241133|12036827|FG001|NOT COMPLETED|Overall Study||34
10871005|NCT04190693|12036837|FG000|STARTED|Overall Study||4
10871006|NCT04190693|12036838|FG001|STARTED|Overall Study||7
10871007|NCT04190693|12036839|FG002|STARTED|Overall Study||12
10871008|NCT04190693|12036840|FG003|STARTED|Overall Study||7
10871009|NCT04190693|12036837|FG000|COMPLETED|Overall Study||4
10871010|NCT04190693|12036838|FG001|COMPLETED|Overall Study||7
10871011|NCT04190693|12036839|FG002|COMPLETED|Overall Study||12
10871012|NCT04190693|12036840|FG003|COMPLETED|Overall Study||7
10871013|NCT04190693|12036837|FG000|NOT COMPLETED|Overall Study||0
10871014|NCT04190693|12036838|FG001|NOT COMPLETED|Overall Study||0
10871015|NCT04190693|12036839|FG002|NOT COMPLETED|Overall Study||0
10871016|NCT04190693|12036840|FG003|NOT COMPLETED|Overall Study||0
10871017|NCT04170608|12036850|FG000|STARTED|Overall Study||10
10871018|NCT04170608|12036850|FG000|COMPLETED|Overall Study||10
10871019|NCT04170608|12036850|FG000|NOT COMPLETED|Overall Study||0
10871020|NCT04150068|12036857|FG000|STARTED|Functional Mono/Oral Lead-in (14 Days)||24
10871021|NCT04150068|12036858|FG001|STARTED|Functional Mono/Oral Lead-in (14 Days)||12
10871022|NCT04150068|12036859|FG002|STARTED|Functional Mono/Oral Lead-in (14 Days)||36
10871023|NCT04150068|12036857|FG000|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||24
10871024|NCT04150068|12036858|FG001|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||12
10871025|NCT04150068|12036859|FG002|COMPLETED|Functional Mono/Oral Lead-in (14 Days)||36
10871026|NCT04150068|12036857|FG000|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0
10871027|NCT04150068|12036858|FG001|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0
10871028|NCT04150068|12036859|FG002|NOT COMPLETED|Functional Mono/Oral Lead-in (14 Days)||0
10871029|NCT04150068|12036857|FG000|STARTED|Maintenance Period (Week 26 Analysis)||24
10871030|NCT04150068|12036858|FG001|STARTED|Maintenance Period (Week 26 Analysis)||12
10871031|NCT04150068|12036859|FG002|STARTED|Maintenance Period (Week 26 Analysis)||36
10871032|NCT04150068|12036857|FG000|COMPLETED|Maintenance Period (Week 26 Analysis)||0
10871033|NCT04150068|12036858|FG001|COMPLETED|Maintenance Period (Week 26 Analysis)||0
10871034|NCT04150068|12036859|FG002|COMPLETED|Maintenance Period (Week 26 Analysis)||0
10871035|NCT04150068|12036857|FG000|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||24
10871036|NCT04150068|12036858|FG001|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||12
10871037|NCT04150068|12036859|FG002|NOT COMPLETED|Maintenance Period (Week 26 Analysis)||36
10871038|NCT04133519|12036868|FG000|STARTED|Overall Study||188
10871039|NCT04133519|12036869|FG001|STARTED|Overall Study||190
10871040|NCT04133519|12036868|FG000|COMPLETED|Overall Study||182
10871041|NCT04133519|12036869|FG001|COMPLETED|Overall Study||184
10871042|NCT04133519|12036868|FG000|NOT COMPLETED|Overall Study||6
10871043|NCT04133519|12036869|FG001|NOT COMPLETED|Overall Study||6
10871044|NCT04118270|12036877|FG000|STARTED|Overall Study||37
10871045|NCT04118270|12036878|FG001|STARTED|Overall Study||13
10871046|NCT04118270|12036877|FG000|Completed Provider Accuracy Assessment|Overall Study|Only the Providers were eligible for completing the Provider Accuracy Assessment.|0
10871047|NCT04118270|12036878|FG001|Completed Provider Accuracy Assessment|Overall Study||10
10871048|NCT04118270|12036877|FG000|COMPLETED|Overall Study||37
10871049|NCT04118270|12036878|FG001|COMPLETED|Overall Study||13
10871050|NCT04118270|12036877|FG000|NOT COMPLETED|Overall Study||0
10871051|NCT04118270|12036878|FG001|NOT COMPLETED|Overall Study||0
10871052|NCT04098367|12036889|FG000|STARTED|Overall Study||63
11229879|NCT02018887|12422032|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229880|NCT02018887|12422033|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
11229881|NCT02018887|12422023|FG000|STARTED|Part A: Cohorts 1-2: Period 3||9
11229882|NCT02018887|12422024|FG001|STARTED|Part A: Cohorts 1-2: Period 3||9
11229883|NCT02018887|12422025|FG002|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
11229884|NCT02018887|12422026|FG003|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
11229885|NCT02018887|12422027|FG004|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
11229886|NCT02018887|12422028|FG005|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
11229887|NCT02018887|12422029|FG006|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
11229888|NCT02018887|12422030|FG007|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
11229889|NCT02018887|12422031|FG008|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
11229890|NCT02018887|12422032|FG009|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
11229891|NCT02018887|12422033|FG010|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
11229892|NCT02018887|12422023|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8
11229893|NCT02018887|12422024|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9
11229894|NCT02018887|12422025|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
11229895|NCT02018887|12422026|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
11229896|NCT02018887|12422027|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
11229897|NCT02018887|12422028|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
11229898|NCT02018887|12422029|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
11229899|NCT02018887|12422030|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
11229900|NCT02018887|12422031|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
11229901|NCT02018887|12422032|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
11229902|NCT02018887|12422033|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
11229903|NCT02018887|12422023|FG000|COMPLETED|Part A: Cohorts 1-2: Period 3||8
11229904|NCT02018887|12422024|FG001|COMPLETED|Part A: Cohorts 1-2: Period 3||9
11229905|NCT02018887|12422025|FG002|COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229906|NCT02018887|12422026|FG003|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10871053|NCT04098367|12036890|FG001|STARTED|Overall Study||65
10871054|NCT04098367|12036891|FG002|STARTED|Overall Study||65
10871055|NCT04098367|12036889|FG000|First Eye Implanted|Overall Study||63
10871056|NCT04098367|12036890|FG001|First Eye Implanted|Overall Study||65
11229907|NCT02018887|12422027|FG004|COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229908|NCT02018887|12422028|FG005|COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229909|NCT02018887|12422029|FG006|COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229910|NCT02018887|12422030|FG007|COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229911|NCT02018887|12422031|FG008|COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229912|NCT02018887|12422032|FG009|COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229913|NCT02018887|12422033|FG010|COMPLETED|Part A: Cohorts 1-2: Period 3||0
10871057|NCT04098367|12036891|FG002|First Eye Implanted|Overall Study||65
10871058|NCT04098367|12036889|FG000|Second Eye Implanted|Overall Study||63
10871059|NCT04098367|12036890|FG001|Second Eye Implanted|Overall Study||65
10871060|NCT04098367|12036891|FG002|Second Eye Implanted|Overall Study||63
10871061|NCT04098367|12036889|FG000|COMPLETED|Overall Study||61
10871062|NCT04098367|12036890|FG001|COMPLETED|Overall Study||60
10871063|NCT04098367|12036891|FG002|COMPLETED|Overall Study||61
10871064|NCT04098367|12036889|FG000|NOT COMPLETED|Overall Study||2
10871065|NCT04098367|12036890|FG001|NOT COMPLETED|Overall Study||5
10871066|NCT04098367|12036891|FG002|NOT COMPLETED|Overall Study||4
10871067|NCT04091087|12036908|FG000|STARTED|Overall Study||33
10871068|NCT04091087|12036909|FG001|STARTED|Overall Study||33
10871069|NCT04091087|12036908|FG000|Treated|Overall Study||32
10871070|NCT04091087|12036909|FG001|Treated|Overall Study||33
10871071|NCT04091087|12036908|FG000|COMPLETED|Overall Study||23
10871072|NCT04091087|12036909|FG001|COMPLETED|Overall Study||26
10871073|NCT04091087|12036908|FG000|NOT COMPLETED|Overall Study||10
10871074|NCT04091087|12036909|FG001|NOT COMPLETED|Overall Study||7
10871075|NCT04009629|12036917|FG000|STARTED|Overall Study||23
10871076|NCT04009629|12036918|FG001|STARTED|Overall Study||38
10871077|NCT04009629|12036917|FG000|COMPLETED|Overall Study||21
10871078|NCT04009629|12036918|FG001|COMPLETED|Overall Study||38
10871079|NCT04009629|12036917|FG000|NOT COMPLETED|Overall Study||2
10871080|NCT04009629|12036918|FG001|NOT COMPLETED|Overall Study||0
10871081|NCT03937908|12036927|FG000|STARTED|Overall Study||2
10871082|NCT03937908|12036928|FG001|STARTED|Overall Study||3
10871083|NCT03937908|12036927|FG000|COMPLETED|Overall Study||2
10871084|NCT03937908|12036928|FG001|COMPLETED|Overall Study||2
10871085|NCT03937908|12036927|FG000|NOT COMPLETED|Overall Study||0
10871086|NCT03937908|12036928|FG001|NOT COMPLETED|Overall Study||1
10871087|NCT03891264|12036934|FG000|STARTED|Overall Study||7
10871088|NCT03891264|12036934|FG000|Received Intervention|Overall Study||3
10871089|NCT03891264|12036934|FG000|COMPLETED|Overall Study||2
10871090|NCT03891264|12036934|FG000|NOT COMPLETED|Overall Study||5
10871091|NCT03839082|12036940|FG000|STARTED|Initial Randomization||33
10871092|NCT03839082|12036941|FG001|STARTED|Initial Randomization||37
10871093|NCT03839082|12036940|FG000|COMPLETED|Initial Randomization||7
10871094|NCT03839082|12036941|FG001|COMPLETED|Initial Randomization||12
10871095|NCT03839082|12036940|FG000|NOT COMPLETED|Initial Randomization||26
10871096|NCT03839082|12036941|FG001|NOT COMPLETED|Initial Randomization||25
10871097|NCT03839082|12036940|FG000|STARTED|Crossover to Other Arm||7
10871098|NCT03839082|12036941|FG001|STARTED|Crossover to Other Arm||12
10871099|NCT03839082|12036940|FG000|COMPLETED|Crossover to Other Arm||0
10871100|NCT03839082|12036941|FG001|COMPLETED|Crossover to Other Arm||0
10871101|NCT03839082|12036940|FG000|NOT COMPLETED|Crossover to Other Arm||7
10871102|NCT03839082|12036941|FG001|NOT COMPLETED|Crossover to Other Arm||12
10871103|NCT03835351|12036949|FG000|STARTED|Overall Study||241
10871104|NCT03835351|12036950|FG001|STARTED|Overall Study||250
10871105|NCT03835351|12036949|FG000|COMPLETED|Overall Study||241
10871106|NCT03835351|12036950|FG001|COMPLETED|Overall Study||250
10871107|NCT03835351|12036949|FG000|NOT COMPLETED|Overall Study||0
10871108|NCT03835351|12036950|FG001|NOT COMPLETED|Overall Study||0
11111460|NCT01286454|12296097|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
11111461|NCT01286454|12296098|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
11111462|NCT01286454|12296099|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
11111463|NCT01286454|12296100|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
11111464|NCT01286454|12296101|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
11111465|NCT01286454|12296102|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
11111466|NCT01286454|12296103|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
11111467|NCT01286454|12296104|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
11111468|NCT01286454|12296105|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
11111469|NCT01286454|12296106|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
10871119|NCT03823287|12036967|FG000|STARTED|Overall Study||334
10871120|NCT03823287|12036968|FG001|STARTED|Overall Study||337
10871121|NCT03823287|12036967|FG000|Received at Least One Dose of Study Drug|Overall Study||333
10871122|NCT03823287|12036968|FG001|Received at Least One Dose of Study Drug|Overall Study||336
10871123|NCT03823287|12036967|FG000|Completed up to Week 48|Overall Study||319
10871124|NCT03823287|12036968|FG001|Completed up to Week 48|Overall Study||323
10871125|NCT03823287|12036967|FG000|COMPLETED|Overall Study||0
10871126|NCT03823287|12036968|FG001|COMPLETED|Overall Study||0
10871127|NCT03823287|12036967|FG000|NOT COMPLETED|Overall Study||334
10871128|NCT03823287|12036968|FG001|NOT COMPLETED|Overall Study||337
10871129|NCT03815175|12036974|FG000|STARTED|Overall Study||1605
10871130|NCT03815175|12036974|FG000|COMPLETED|Overall Study||1439
10871131|NCT03815175|12036974|FG000|NOT COMPLETED|Overall Study||166
11111470|NCT01286454|12296096|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111471|NCT01286454|12296097|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111472|NCT01286454|12296098|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111473|NCT01286454|12296099|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111474|NCT01286454|12296100|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111475|NCT01286454|12296101|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111476|NCT01286454|12296102|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111477|NCT01286454|12296103|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111478|NCT01286454|12296104|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111479|NCT01286454|12296105|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10871144|NCT03794024|12036990|FG000|STARTED|Overall Study||1
10871145|NCT03794024|12036991|FG001|STARTED|Overall Study||0
10871146|NCT03794024|12036990|FG000|COMPLETED|Overall Study||0
10871147|NCT03794024|12036991|FG001|COMPLETED|Overall Study||0
10871148|NCT03794024|12036990|FG000|NOT COMPLETED|Overall Study||1
10871149|NCT03794024|12036991|FG001|NOT COMPLETED|Overall Study||0
10871150|NCT03770455|12036997|FG000|STARTED|Overall Study||5
10871151|NCT03770455|12036997|FG000|COMPLETED|Overall Study||5
10871152|NCT03770455|12036997|FG000|NOT COMPLETED|Overall Study||0
10871153|NCT03714178|12037001|FG000|STARTED|Overall Study||71
10871154|NCT03714178|12037001|FG000|COMPLETED|Overall Study||71
10871155|NCT03714178|12037001|FG000|NOT COMPLETED|Overall Study||0
10871156|NCT03709342|12037005|FG000|STARTED|Overall Study||7
10871157|NCT03709342|12037005|FG000|COMPLETED|Overall Study||7
10871158|NCT03709342|12037005|FG000|NOT COMPLETED|Overall Study||0
10871159|NCT03691623|12037015|FG000|STARTED|Overall Study||39
10871160|NCT03691623|12037016|FG001|STARTED|Overall Study||38
10871161|NCT03691623|12037017|FG002|STARTED|Overall Study||38
10871162|NCT03691623|12037018|FG003|STARTED|Overall Study||21
10871163|NCT03691623|12037019|FG004|STARTED|Overall Study||21
10871164|NCT03691623|12037020|FG005|STARTED|Overall Study||21
10871165|NCT03691623|12037015|FG000|Inoculated With Challenge Virus|Overall Study||39
10871166|NCT03691623|12037016|FG001|Inoculated With Challenge Virus|Overall Study||38
10871167|NCT03691623|12037017|FG002|Inoculated With Challenge Virus|Overall Study||38
10871168|NCT03691623|12037018|FG003|Inoculated With Challenge Virus|Overall Study||21
10871169|NCT03691623|12037019|FG004|Inoculated With Challenge Virus|Overall Study||21
10871170|NCT03691623|12037020|FG005|Inoculated With Challenge Virus|Overall Study||21
10871171|NCT03691623|12037015|FG000|Received Treatment|Overall Study||38
10871172|NCT03691623|12037016|FG001|Received Treatment|Overall Study||38
10871173|NCT03691623|12037017|FG002|Received Treatment|Overall Study||38
10871174|NCT03691623|12037018|FG003|Received Treatment|Overall Study||21
10871175|NCT03691623|12037019|FG004|Received Treatment|Overall Study||21
10871176|NCT03691623|12037020|FG005|Received Treatment|Overall Study||21
10871177|NCT03691623|12037015|FG000|COMPLETED|Overall Study||39
10871178|NCT03691623|12037016|FG001|COMPLETED|Overall Study||38
10871179|NCT03691623|12037017|FG002|COMPLETED|Overall Study||38
10871180|NCT03691623|12037018|FG003|COMPLETED|Overall Study||21
10871181|NCT03691623|12037019|FG004|COMPLETED|Overall Study||21
10871182|NCT03691623|12037020|FG005|COMPLETED|Overall Study||21
10871183|NCT03691623|12037015|FG000|NOT COMPLETED|Overall Study||0
10871184|NCT03691623|12037016|FG001|NOT COMPLETED|Overall Study||0
10871185|NCT03691623|12037017|FG002|NOT COMPLETED|Overall Study||0
10871186|NCT03691623|12037018|FG003|NOT COMPLETED|Overall Study||0
10871187|NCT03691623|12037019|FG004|NOT COMPLETED|Overall Study||0
10871188|NCT03691623|12037020|FG005|NOT COMPLETED|Overall Study||0
10871189|NCT03604549|12037039|FG000|STARTED|Overall Study||29
10871190|NCT03604549|12037040|FG001|STARTED|Overall Study||29
10871191|NCT03604549|12037039|FG000|COMPLETED|Overall Study||24
10871192|NCT03604549|12037040|FG001|COMPLETED|Overall Study||24
10871193|NCT03604549|12037039|FG000|NOT COMPLETED|Overall Study||5
10871194|NCT03604549|12037040|FG001|NOT COMPLETED|Overall Study||5
10871195|NCT03603639|12037046|FG000|STARTED|Treatment Period 1 (Day 1)||1
10871196|NCT03603639|12037047|FG001|STARTED|Treatment Period 1 (Day 1)||1
10871197|NCT03603639|12037048|FG002|STARTED|Treatment Period 1 (Day 1)||1
10871198|NCT03603639|12037049|FG003|STARTED|Treatment Period 1 (Day 1)||1
10871199|NCT03603639|12037050|FG004|STARTED|Treatment Period 1 (Day 1)||1
10871200|NCT03603639|12037051|FG005|STARTED|Treatment Period 1 (Day 1)||1
10871201|NCT03603639|12037046|FG000|COMPLETED|Treatment Period 1 (Day 1)||1
10871202|NCT03603639|12037047|FG001|COMPLETED|Treatment Period 1 (Day 1)||1
10871203|NCT03603639|12037048|FG002|COMPLETED|Treatment Period 1 (Day 1)||1
10871204|NCT03603639|12037049|FG003|COMPLETED|Treatment Period 1 (Day 1)||1
10871205|NCT03603639|12037050|FG004|COMPLETED|Treatment Period 1 (Day 1)||1
10871206|NCT03603639|12037051|FG005|COMPLETED|Treatment Period 1 (Day 1)||1
10871207|NCT03603639|12037046|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10871208|NCT03603639|12037047|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10871209|NCT03603639|12037048|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10871210|NCT03603639|12037049|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10871211|NCT03603639|12037050|FG004|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10871212|NCT03603639|12037051|FG005|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10871213|NCT03603639|12037046|FG000|STARTED|Washout Period (at Least 3 Weeks)||1
10871214|NCT03603639|12037047|FG001|STARTED|Washout Period (at Least 3 Weeks)||1
10871215|NCT03603639|12037048|FG002|STARTED|Washout Period (at Least 3 Weeks)||1
10871216|NCT03603639|12037049|FG003|STARTED|Washout Period (at Least 3 Weeks)||1
10871217|NCT03603639|12037050|FG004|STARTED|Washout Period (at Least 3 Weeks)||1
10871218|NCT03603639|12037051|FG005|STARTED|Washout Period (at Least 3 Weeks)||1
10871219|NCT03603639|12037046|FG000|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871220|NCT03603639|12037047|FG001|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871221|NCT03603639|12037048|FG002|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871222|NCT03603639|12037049|FG003|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871223|NCT03603639|12037050|FG004|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871224|NCT03603639|12037051|FG005|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871225|NCT03603639|12037046|FG000|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871226|NCT03603639|12037047|FG001|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871227|NCT03603639|12037048|FG002|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871228|NCT03603639|12037049|FG003|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871229|NCT03603639|12037050|FG004|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871230|NCT03603639|12037051|FG005|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871231|NCT03603639|12037046|FG000|STARTED|Treatment Period 2 (Day 1)||1
10871232|NCT03603639|12037047|FG001|STARTED|Treatment Period 2 (Day 1)||1
10871233|NCT03603639|12037048|FG002|STARTED|Treatment Period 2 (Day 1)||1
10871234|NCT03603639|12037049|FG003|STARTED|Treatment Period 2 (Day 1)||1
10871235|NCT03603639|12037050|FG004|STARTED|Treatment Period 2 (Day 1)||1
10871236|NCT03603639|12037051|FG005|STARTED|Treatment Period 2 (Day 1)||1
10871237|NCT03603639|12037046|FG000|COMPLETED|Treatment Period 2 (Day 1)||1
10871238|NCT03603639|12037047|FG001|COMPLETED|Treatment Period 2 (Day 1)||1
10871239|NCT03603639|12037048|FG002|COMPLETED|Treatment Period 2 (Day 1)||1
10871240|NCT03603639|12037049|FG003|COMPLETED|Treatment Period 2 (Day 1)||1
10871241|NCT03603639|12037050|FG004|COMPLETED|Treatment Period 2 (Day 1)||1
10871242|NCT03603639|12037051|FG005|COMPLETED|Treatment Period 2 (Day 1)||1
10871243|NCT03603639|12037046|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10871244|NCT03603639|12037047|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10871245|NCT03603639|12037048|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10871246|NCT03603639|12037049|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10871247|NCT03603639|12037050|FG004|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10871248|NCT03603639|12037051|FG005|NOT COMPLETED|Treatment Period 2 (Day 1)||0
10871249|NCT03603639|12037046|FG000|STARTED|Washout Period (at Least 3 Weeks)||1
10871250|NCT03603639|12037047|FG001|STARTED|Washout Period (at Least 3 Weeks)||1
10871251|NCT03603639|12037048|FG002|STARTED|Washout Period (at Least 3 Weeks)||1
10871252|NCT03603639|12037049|FG003|STARTED|Washout Period (at Least 3 Weeks)||1
10871253|NCT03603639|12037050|FG004|STARTED|Washout Period (at Least 3 Weeks)||1
10871254|NCT03603639|12037051|FG005|STARTED|Washout Period (at Least 3 Weeks)||1
10871255|NCT03603639|12037046|FG000|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871256|NCT03603639|12037047|FG001|COMPLETED|Washout Period (at Least 3 Weeks)||1
10871257|NCT03603639|12037048|FG002|COMPLETED|Washout Period (at Least 3 Weeks)||0
10871258|NCT03603639|12037049|FG003|COMPLETED|Washout Period (at Least 3 Weeks)||0
10871259|NCT03603639|12037050|FG004|COMPLETED|Washout Period (at Least 3 Weeks)||0
10871260|NCT03603639|12037051|FG005|COMPLETED|Washout Period (at Least 3 Weeks)||0
10871261|NCT03603639|12037046|FG000|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871262|NCT03603639|12037047|FG001|NOT COMPLETED|Washout Period (at Least 3 Weeks)||0
10871263|NCT03603639|12037048|FG002|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
10871264|NCT03603639|12037049|FG003|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
10871265|NCT03603639|12037050|FG004|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
10871266|NCT03603639|12037051|FG005|NOT COMPLETED|Washout Period (at Least 3 Weeks)||1
10871267|NCT03603639|12037046|FG000|STARTED|Treatment Period 3 (Day 1)||1
10871268|NCT03603639|12037047|FG001|STARTED|Treatment Period 3 (Day 1)||1
10871269|NCT03603639|12037048|FG002|STARTED|Treatment Period 3 (Day 1)||0
10871270|NCT03603639|12037049|FG003|STARTED|Treatment Period 3 (Day 1)||0
10871271|NCT03603639|12037050|FG004|STARTED|Treatment Period 3 (Day 1)||0
11111480|NCT01286454|12296106|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111481|NCT01286454|12296096|FG000|STARTED|Second Intervention Period||2
11111482|NCT01286454|12296097|FG001|STARTED|Second Intervention Period||2
11111483|NCT01286454|12296098|FG002|STARTED|Second Intervention Period||2
11111484|NCT01286454|12296099|FG003|STARTED|Second Intervention Period||2
11111485|NCT01286454|12296100|FG004|STARTED|Second Intervention Period||2
11111486|NCT01286454|12296101|FG005|STARTED|Second Intervention Period||2
11111487|NCT01286454|12296102|FG006|STARTED|Second Intervention Period||2
11111488|NCT01286454|12296103|FG007|STARTED|Second Intervention Period||2
11111489|NCT01286454|12296104|FG008|STARTED|Second Intervention Period||2
11111490|NCT01286454|12296105|FG009|STARTED|Second Intervention Period||2
11111491|NCT01286454|12296106|FG010|STARTED|Second Intervention Period||0
11111492|NCT01286454|12296096|FG000|COMPLETED|Second Intervention Period||2
11111493|NCT01286454|12296097|FG001|COMPLETED|Second Intervention Period||2
11111494|NCT01286454|12296098|FG002|COMPLETED|Second Intervention Period||2
11111495|NCT01286454|12296099|FG003|COMPLETED|Second Intervention Period||2
11111496|NCT01286454|12296100|FG004|COMPLETED|Second Intervention Period||2
11111497|NCT01286454|12296101|FG005|COMPLETED|Second Intervention Period||2
11111498|NCT01286454|12296102|FG006|COMPLETED|Second Intervention Period||2
11111499|NCT01286454|12296103|FG007|COMPLETED|Second Intervention Period||2
11111500|NCT01286454|12296104|FG008|COMPLETED|Second Intervention Period||2
11111501|NCT01286454|12296105|FG009|COMPLETED|Second Intervention Period||2
11111502|NCT01286454|12296106|FG010|COMPLETED|Second Intervention Period||0
11111503|NCT01286454|12296096|FG000|NOT COMPLETED|Second Intervention Period||0
11111504|NCT01286454|12296097|FG001|NOT COMPLETED|Second Intervention Period||0
11111505|NCT01286454|12296098|FG002|NOT COMPLETED|Second Intervention Period||0
11111506|NCT01286454|12296099|FG003|NOT COMPLETED|Second Intervention Period||0
11111507|NCT01286454|12296100|FG004|NOT COMPLETED|Second Intervention Period||0
11111508|NCT01286454|12296101|FG005|NOT COMPLETED|Second Intervention Period||0
11111509|NCT01286454|12296102|FG006|NOT COMPLETED|Second Intervention Period||0
11111510|NCT01286454|12296103|FG007|NOT COMPLETED|Second Intervention Period||0
11111511|NCT01286454|12296104|FG008|NOT COMPLETED|Second Intervention Period||0
11111512|NCT01286454|12296105|FG009|NOT COMPLETED|Second Intervention Period||0
11111513|NCT01286454|12296106|FG010|NOT COMPLETED|Second Intervention Period||0
11111514|NCT01286454|12296096|FG000|STARTED|Washout Period (At Least 3 Days)||2
11111515|NCT01286454|12296097|FG001|STARTED|Washout Period (At Least 3 Days)||2
11111516|NCT01286454|12296098|FG002|STARTED|Washout Period (At Least 3 Days)||2
11111517|NCT01286454|12296099|FG003|STARTED|Washout Period (At Least 3 Days)||2
11111518|NCT01286454|12296100|FG004|STARTED|Washout Period (At Least 3 Days)||2
11111519|NCT01286454|12296101|FG005|STARTED|Washout Period (At Least 3 Days)||2
11111520|NCT01286454|12296102|FG006|STARTED|Washout Period (At Least 3 Days)||2
11111521|NCT01286454|12296103|FG007|STARTED|Washout Period (At Least 3 Days)||2
11111522|NCT01286454|12296104|FG008|STARTED|Washout Period (At Least 3 Days)||2
11111523|NCT01286454|12296105|FG009|STARTED|Washout Period (At Least 3 Days)||2
11111524|NCT01286454|12296106|FG010|STARTED|Washout Period (At Least 3 Days)||0
11111525|NCT01286454|12296096|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
11111526|NCT01286454|12296097|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
11111527|NCT01286454|12296098|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
11111528|NCT01286454|12296099|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
11111529|NCT01286454|12296100|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
11111530|NCT01286454|12296101|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
11355289|NCT03078556|12552136|FG000|COMPLETED|Washout Period 1 (7 Days)||37
11111531|NCT01286454|12296102|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
11111532|NCT01286454|12296103|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
11111533|NCT01286454|12296104|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
11111534|NCT01286454|12296105|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
11111535|NCT01286454|12296106|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
11111536|NCT01286454|12296096|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111537|NCT01286454|12296097|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111538|NCT01286454|12296098|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111539|NCT01286454|12296099|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111540|NCT01286454|12296100|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111541|NCT01286454|12296101|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111542|NCT01286454|12296102|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111543|NCT01286454|12296103|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111544|NCT01286454|12296104|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111545|NCT01286454|12296105|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111546|NCT01286454|12296106|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111547|NCT01286454|12296096|FG000|STARTED|Third Intervention Period||2
11111548|NCT01286454|12296097|FG001|STARTED|Third Intervention Period||2
11111549|NCT01286454|12296098|FG002|STARTED|Third Intervention Period||2
10871272|NCT03603639|12037051|FG005|STARTED|Treatment Period 3 (Day 1)||0
10871273|NCT03603639|12037046|FG000|COMPLETED|Treatment Period 3 (Day 1)||1
10871274|NCT03603639|12037047|FG001|COMPLETED|Treatment Period 3 (Day 1)||1
10871275|NCT03603639|12037048|FG002|COMPLETED|Treatment Period 3 (Day 1)||0
10871276|NCT03603639|12037049|FG003|COMPLETED|Treatment Period 3 (Day 1)||0
10871277|NCT03603639|12037050|FG004|COMPLETED|Treatment Period 3 (Day 1)||0
10871278|NCT03603639|12037051|FG005|COMPLETED|Treatment Period 3 (Day 1)||0
10871279|NCT03603639|12037046|FG000|NOT COMPLETED|Treatment Period 3 (Day 1)||0
10871280|NCT03603639|12037047|FG001|NOT COMPLETED|Treatment Period 3 (Day 1)||0
10871281|NCT03603639|12037048|FG002|NOT COMPLETED|Treatment Period 3 (Day 1)||0
10871282|NCT03603639|12037049|FG003|NOT COMPLETED|Treatment Period 3 (Day 1)||0
10871283|NCT03603639|12037050|FG004|NOT COMPLETED|Treatment Period 3 (Day 1)||0
10871284|NCT03603639|12037051|FG005|NOT COMPLETED|Treatment Period 3 (Day 1)||0
10871285|NCT03587636|12037063|FG000|STARTED|Overall Study||39
10871286|NCT03587636|12037064|FG001|STARTED|Overall Study||38
10871287|NCT03587636|12037063|FG000|COMPLETED|Overall Study||37
10871288|NCT03587636|12037064|FG001|COMPLETED|Overall Study||33
10871289|NCT03587636|12037063|FG000|NOT COMPLETED|Overall Study||2
10871290|NCT03587636|12037064|FG001|NOT COMPLETED|Overall Study||5
10871291|NCT03574129|12037072|FG000|STARTED|Overall Study||578
10871292|NCT03574129|12037073|FG001|STARTED|Overall Study||488
10871293|NCT03574129|12037072|FG000|COMPLETED|Overall Study||506
10871294|NCT03574129|12037073|FG001|COMPLETED|Overall Study||440
10871295|NCT03574129|12037072|FG000|NOT COMPLETED|Overall Study||72
10871296|NCT03574129|12037073|FG001|NOT COMPLETED|Overall Study||48
10871297|NCT03573336|12037094|FG000|STARTED|Overall Study||2
10871298|NCT03573336|12037095|FG001|STARTED|Overall Study||4
10871299|NCT03573336|12037096|FG002|STARTED|Overall Study||2
10871300|NCT03573336|12037094|FG000|Treated|Overall Study||2
10871301|NCT03573336|12037095|FG001|Treated|Overall Study||4
10871302|NCT03573336|12037096|FG002|Treated|Overall Study||2
10871303|NCT03573336|12037094|FG000|COMPLETED|Overall Study||0
10871304|NCT03573336|12037095|FG001|COMPLETED|Overall Study||0
10871305|NCT03573336|12037096|FG002|COMPLETED|Overall Study||0
10871306|NCT03573336|12037094|FG000|NOT COMPLETED|Overall Study||2
10871307|NCT03573336|12037095|FG001|NOT COMPLETED|Overall Study||4
10871308|NCT03573336|12037096|FG002|NOT COMPLETED|Overall Study||2
10871309|NCT03570697|12037106|FG000|STARTED|Overall Study||82
10871310|NCT03570697|12037107|FG001|STARTED|Overall Study||82
10871311|NCT03570697|12037106|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81
10871312|NCT03570697|12037107|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80
10871313|NCT03570697|12037106|FG000|COMPLETED|Overall Study||76
10871314|NCT03570697|12037107|FG001|COMPLETED|Overall Study||79
10871315|NCT03570697|12037106|FG000|NOT COMPLETED|Overall Study||6
10871316|NCT03570697|12037107|FG001|NOT COMPLETED|Overall Study||3
10871317|NCT03548051|12037115|FG000|STARTED|Overall Study||6
10871318|NCT03548051|12037116|FG001|STARTED|Overall Study||4
10871319|NCT03548051|12037115|FG000|COMPLETED|Overall Study||4
10871320|NCT03548051|12037116|FG001|COMPLETED|Overall Study||3
10871321|NCT03548051|12037115|FG000|NOT COMPLETED|Overall Study||2
10871322|NCT03548051|12037116|FG001|NOT COMPLETED|Overall Study||1
10871323|NCT03525886|12037126|FG000|STARTED|Cohort 1 (50 mg QHS)||8
10871324|NCT03525886|12037127|FG001|STARTED|Cohort 1 (50 mg QHS)||0
10871325|NCT03525886|12037128|FG002|STARTED|Cohort 1 (50 mg QHS)||0
10871326|NCT03525886|12037129|FG003|STARTED|Cohort 1 (50 mg QHS)||0
10871327|NCT03525886|12037126|FG000|COMPLETED|Cohort 1 (50 mg QHS)||8
10871328|NCT03525886|12037127|FG001|COMPLETED|Cohort 1 (50 mg QHS)||0
10871329|NCT03525886|12037128|FG002|COMPLETED|Cohort 1 (50 mg QHS)||0
10871330|NCT03525886|12037129|FG003|COMPLETED|Cohort 1 (50 mg QHS)||0
10871331|NCT03525886|12037126|FG000|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
10871332|NCT03525886|12037127|FG001|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
10871333|NCT03525886|12037128|FG002|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
10871334|NCT03525886|12037129|FG003|NOT COMPLETED|Cohort 1 (50 mg QHS)||0
10871335|NCT03525886|12037126|FG000|STARTED|Cohort 2 (100 mg QHS)||0
10871336|NCT03525886|12037127|FG001|STARTED|Cohort 2 (100 mg QHS)||7
10871337|NCT03525886|12037128|FG002|STARTED|Cohort 2 (100 mg QHS)||0
10871338|NCT03525886|12037129|FG003|STARTED|Cohort 2 (100 mg QHS)||0
10871339|NCT03525886|12037126|FG000|COMPLETED|Cohort 2 (100 mg QHS)||0
10871340|NCT03525886|12037127|FG001|COMPLETED|Cohort 2 (100 mg QHS)||7
10871341|NCT03525886|12037128|FG002|COMPLETED|Cohort 2 (100 mg QHS)||0
10871342|NCT03525886|12037129|FG003|COMPLETED|Cohort 2 (100 mg QHS)||0
10871343|NCT03525886|12037126|FG000|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
10871344|NCT03525886|12037127|FG001|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
10871345|NCT03525886|12037128|FG002|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
10871346|NCT03525886|12037129|FG003|NOT COMPLETED|Cohort 2 (100 mg QHS)||0
10871347|NCT03525886|12037126|FG000|STARTED|Cohort 3 (100 mg QPM)||0
10871348|NCT03525886|12037127|FG001|STARTED|Cohort 3 (100 mg QPM)||0
10871349|NCT03525886|12037128|FG002|STARTED|Cohort 3 (100 mg QPM)||8
10871350|NCT03525886|12037129|FG003|STARTED|Cohort 3 (100 mg QPM)||0
10871351|NCT03525886|12037126|FG000|COMPLETED|Cohort 3 (100 mg QPM)||0
10871352|NCT03525886|12037127|FG001|COMPLETED|Cohort 3 (100 mg QPM)||0
10871353|NCT03525886|12037128|FG002|COMPLETED|Cohort 3 (100 mg QPM)||8
10871354|NCT03525886|12037129|FG003|COMPLETED|Cohort 3 (100 mg QPM)||0
10871355|NCT03525886|12037126|FG000|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
10871356|NCT03525886|12037127|FG001|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
10871357|NCT03525886|12037128|FG002|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
10871358|NCT03525886|12037129|FG003|NOT COMPLETED|Cohort 3 (100 mg QPM)||0
10871359|NCT03525886|12037126|FG000|STARTED|Cohort 4 (100 mg BID)||0
10871360|NCT03525886|12037127|FG001|STARTED|Cohort 4 (100 mg BID)||0
10871361|NCT03525886|12037128|FG002|STARTED|Cohort 4 (100 mg BID)||0
10871362|NCT03525886|12037129|FG003|STARTED|Cohort 4 (100 mg BID)||8
10871363|NCT03525886|12037126|FG000|COMPLETED|Cohort 4 (100 mg BID)||0
10871364|NCT03525886|12037127|FG001|COMPLETED|Cohort 4 (100 mg BID)||0
10871365|NCT03525886|12037128|FG002|COMPLETED|Cohort 4 (100 mg BID)||0
10871366|NCT03525886|12037129|FG003|COMPLETED|Cohort 4 (100 mg BID)||8
10871367|NCT03525886|12037126|FG000|NOT COMPLETED|Cohort 4 (100 mg BID)||0
10871368|NCT03525886|12037127|FG001|NOT COMPLETED|Cohort 4 (100 mg BID)||0
10871369|NCT03525886|12037128|FG002|NOT COMPLETED|Cohort 4 (100 mg BID)||0
10871370|NCT03525886|12037129|FG003|NOT COMPLETED|Cohort 4 (100 mg BID)||0
10871371|NCT03503318|12037142|FG000|STARTED|Overall Study||181
10871372|NCT03503318|12037143|FG001|STARTED|Overall Study||183
10871373|NCT03503318|12037144|FG002|STARTED|Overall Study||180
10871374|NCT03503318|12037142|FG000|Received at Least 1 Dose of Study Drug|Overall Study||179
10871375|NCT03503318|12037143|FG001|Received at Least 1 Dose of Study Drug|Overall Study||183
10871376|NCT03503318|12037144|FG002|Received at Least 1 Dose of Study Drug|Overall Study||180
10871377|NCT03503318|12037142|FG000|COMPLETED|Overall Study||142
10871378|NCT03503318|12037143|FG001|COMPLETED|Overall Study||144
10871379|NCT03503318|12037144|FG002|COMPLETED|Overall Study||140
10871380|NCT03503318|12037142|FG000|NOT COMPLETED|Overall Study||39
10871381|NCT03503318|12037143|FG001|NOT COMPLETED|Overall Study||39
10871382|NCT03503318|12037144|FG002|NOT COMPLETED|Overall Study||40
10871383|NCT03493854|12037154|FG000|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|252
10871384|NCT03493854|12037155|FG001|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|248
10871385|NCT03493854|12037154|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||252
10871386|NCT03493854|12037155|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||248
10871387|NCT03493854|12037154|FG000|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||242
10871388|NCT03493854|12037155|FG001|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||234
10871389|NCT03493854|12037154|FG000|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||10
10871390|NCT03493854|12037155|FG001|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||14
10871391|NCT03493854|12037154|FG000|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||242
10871392|NCT03493854|12037155|FG001|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||234
10871393|NCT03493854|12037154|FG000|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||239
10871394|NCT03493854|12037155|FG001|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||234
10871395|NCT03493854|12037154|FG000|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
10871396|NCT03493854|12037155|FG001|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
10871397|NCT03493854|12037154|FG000|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||242
10871398|NCT03493854|12037155|FG001|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||234
10871399|NCT03493854|12037154|FG000|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|19
10871400|NCT03493854|12037155|FG001|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|17
10871401|NCT03493854|12037154|FG000|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
10871402|NCT03493854|12037155|FG001|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
10871403|NCT03493854|12037154|FG000|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||19
10871404|NCT03493854|12037155|FG001|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||17
10871405|NCT03493451|12037164|FG000|STARTED|Overall Study||22
10871406|NCT03493451|12037165|FG001|STARTED|Overall Study||44
10871407|NCT03493451|12037166|FG002|STARTED|Overall Study||11
10871408|NCT03493451|12037164|FG000|COMPLETED|Overall Study||0
10871409|NCT03493451|12037165|FG001|COMPLETED|Overall Study||0
10871410|NCT03493451|12037166|FG002|COMPLETED|Overall Study||0
10871411|NCT03493451|12037164|FG000|NOT COMPLETED|Overall Study||22
10871412|NCT03493451|12037165|FG001|NOT COMPLETED|Overall Study||44
10871413|NCT03493451|12037166|FG002|NOT COMPLETED|Overall Study||11
10871414|NCT03476239|12037174|FG000|STARTED|Overall Study||121
10871415|NCT03476239|12037174|FG000|Received Blinatumomab|Overall Study||120
10871416|NCT03476239|12037174|FG000|Interim Analysis Set|Overall Study||90
10871417|NCT03476239|12037174|FG000|COMPLETED|Overall Study||23
10871418|NCT03476239|12037174|FG000|NOT COMPLETED|Overall Study||98
11111550|NCT01286454|12296099|FG003|STARTED|Third Intervention Period||2
11111551|NCT01286454|12296100|FG004|STARTED|Third Intervention Period||2
11111552|NCT01286454|12296101|FG005|STARTED|Third Intervention Period||2
11111553|NCT01286454|12296102|FG006|STARTED|Third Intervention Period||2
11111554|NCT01286454|12296103|FG007|STARTED|Third Intervention Period||2
11111555|NCT01286454|12296104|FG008|STARTED|Third Intervention Period||2
10871425|NCT03401749|12037190|FG000|STARTED|Overall Study||59
10871426|NCT03401749|12037191|FG001|STARTED|Overall Study||67
10871427|NCT03401749|12037192|FG002|STARTED|Overall Study||77
10871428|NCT03401749|12037190|FG000|COMPLETED|Overall Study||39
10871429|NCT03401749|12037191|FG001|COMPLETED|Overall Study||51
10871430|NCT03401749|12037192|FG002|COMPLETED|Overall Study||51
10871431|NCT03401749|12037190|FG000|NOT COMPLETED|Overall Study||20
10871432|NCT03401749|12037191|FG001|NOT COMPLETED|Overall Study||16
10871433|NCT03401749|12037192|FG002|NOT COMPLETED|Overall Study||26
10871434|NCT03337113|12037204|FG000|STARTED|Overall Study||13
10871435|NCT03337113|12037205|FG001|STARTED|Overall Study||12
10871436|NCT03337113|12037206|FG002|STARTED|Overall Study||12
10871437|NCT03337113|12037207|FG003|STARTED|Overall Study||13
10871438|NCT03337113|12037204|FG000|COMPLETED|Overall Study||12
10871439|NCT03337113|12037205|FG001|COMPLETED|Overall Study||9
10871440|NCT03337113|12037206|FG002|COMPLETED|Overall Study||11
10871441|NCT03337113|12037207|FG003|COMPLETED|Overall Study||11
10871442|NCT03337113|12037204|FG000|NOT COMPLETED|Overall Study||1
10871443|NCT03337113|12037205|FG001|NOT COMPLETED|Overall Study||3
10871444|NCT03337113|12037206|FG002|NOT COMPLETED|Overall Study||1
10871445|NCT03337113|12037207|FG003|NOT COMPLETED|Overall Study||2
11111556|NCT01286454|12296105|FG009|STARTED|Third Intervention Period||2
11111557|NCT01286454|12296106|FG010|STARTED|Third Intervention Period||0
11111558|NCT01286454|12296096|FG000|COMPLETED|Third Intervention Period||2
11111559|NCT01286454|12296097|FG001|COMPLETED|Third Intervention Period||2
11111560|NCT01286454|12296098|FG002|COMPLETED|Third Intervention Period||2
11111561|NCT01286454|12296099|FG003|COMPLETED|Third Intervention Period||2
11111562|NCT01286454|12296100|FG004|COMPLETED|Third Intervention Period||2
11111563|NCT01286454|12296101|FG005|COMPLETED|Third Intervention Period||2
11111564|NCT01286454|12296102|FG006|COMPLETED|Third Intervention Period||2
11111565|NCT01286454|12296103|FG007|COMPLETED|Third Intervention Period||2
11111566|NCT01286454|12296104|FG008|COMPLETED|Third Intervention Period||2
11111567|NCT01286454|12296105|FG009|COMPLETED|Third Intervention Period||2
11111568|NCT01286454|12296106|FG010|COMPLETED|Third Intervention Period||0
11111569|NCT01286454|12296096|FG000|NOT COMPLETED|Third Intervention Period||0
11111570|NCT01286454|12296097|FG001|NOT COMPLETED|Third Intervention Period||0
11111571|NCT01286454|12296098|FG002|NOT COMPLETED|Third Intervention Period||0
11111572|NCT01286454|12296099|FG003|NOT COMPLETED|Third Intervention Period||0
11111573|NCT01286454|12296100|FG004|NOT COMPLETED|Third Intervention Period||0
11111574|NCT01286454|12296101|FG005|NOT COMPLETED|Third Intervention Period||0
11111575|NCT01286454|12296102|FG006|NOT COMPLETED|Third Intervention Period||0
11111576|NCT01286454|12296103|FG007|NOT COMPLETED|Third Intervention Period||0
11111577|NCT01286454|12296104|FG008|NOT COMPLETED|Third Intervention Period||0
11111578|NCT01286454|12296105|FG009|NOT COMPLETED|Third Intervention Period||0
11111579|NCT01286454|12296106|FG010|NOT COMPLETED|Third Intervention Period||0
11111580|NCT01286454|12296096|FG000|STARTED|Washout Period (At Least 3 Days)||2
11111581|NCT01286454|12296097|FG001|STARTED|Washout Period (At Least 3 Days)||2
11111582|NCT01286454|12296098|FG002|STARTED|Washout Period (At Least 3 Days)||2
11111583|NCT01286454|12296099|FG003|STARTED|Washout Period (At Least 3 Days)||2
11111584|NCT01286454|12296100|FG004|STARTED|Washout Period (At Least 3 Days)||2
11111585|NCT01286454|12296101|FG005|STARTED|Washout Period (At Least 3 Days)||2
11111586|NCT01286454|12296102|FG006|STARTED|Washout Period (At Least 3 Days)||2
11111587|NCT01286454|12296103|FG007|STARTED|Washout Period (At Least 3 Days)||2
11111588|NCT01286454|12296104|FG008|STARTED|Washout Period (At Least 3 Days)||2
11111589|NCT01286454|12296105|FG009|STARTED|Washout Period (At Least 3 Days)||2
11111590|NCT01286454|12296106|FG010|STARTED|Washout Period (At Least 3 Days)||0
11111591|NCT01286454|12296096|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
11229914|NCT02018887|12422023|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1
11229915|NCT02018887|12422024|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229916|NCT02018887|12422025|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229917|NCT02018887|12422026|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229918|NCT02018887|12422027|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229919|NCT02018887|12422028|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229920|NCT02018887|12422029|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229921|NCT02018887|12422030|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229922|NCT02018887|12422031|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229923|NCT02018887|12422032|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229924|NCT02018887|12422033|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
11229925|NCT02018887|12422023|FG000|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
11229926|NCT02018887|12422024|FG001|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
11229927|NCT02018887|12422025|FG002|STARTED|Part B: Cohorts 3-7 Overall||15
11229928|NCT02018887|12422026|FG003|STARTED|Part B: Cohorts 3-7 Overall||9
11229929|NCT02018887|12422027|FG004|STARTED|Part B: Cohorts 3-7 Overall||9
11229930|NCT02018887|12422028|FG005|STARTED|Part B: Cohorts 3-7 Overall||9
11229931|NCT02018887|12422029|FG006|STARTED|Part B: Cohorts 3-7 Overall||9
11111592|NCT01286454|12296097|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
11111593|NCT01286454|12296098|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
11111594|NCT01286454|12296099|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
11111595|NCT01286454|12296100|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
11111596|NCT01286454|12296101|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
11111597|NCT01286454|12296102|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
11111598|NCT01286454|12296103|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
11111599|NCT01286454|12296104|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
11111600|NCT01286454|12296105|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
10871491|NCT03233048|12037241|FG000|STARTED|Overall Study||5
10871492|NCT03233048|12037241|FG000|COMPLETED|Overall Study||4
10871493|NCT03233048|12037241|FG000|NOT COMPLETED|Overall Study||1
10871494|NCT03138252|12037247|FG000|STARTED|Overall Study||90
10871495|NCT03138252|12037248|FG001|STARTED|Overall Study||90
10871496|NCT03138252|12037247|FG000|COMPLETED|Overall Study||90
10871497|NCT03138252|12037248|FG001|COMPLETED|Overall Study||90
10871498|NCT03138252|12037247|FG000|NOT COMPLETED|Overall Study||0
10871499|NCT03138252|12037248|FG001|NOT COMPLETED|Overall Study||0
11111601|NCT01286454|12296106|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
11111602|NCT01286454|12296096|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111603|NCT01286454|12296097|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111604|NCT01286454|12296098|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111605|NCT01286454|12296099|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111606|NCT01286454|12296100|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111607|NCT01286454|12296101|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111608|NCT01286454|12296102|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111609|NCT01286454|12296103|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111610|NCT01286454|12296104|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111611|NCT01286454|12296105|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11229932|NCT02018887|12422030|FG007|STARTED|Part B: Cohorts 3-7 Overall||9
11229933|NCT02018887|12422031|FG008|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0
11229934|NCT02018887|12422032|FG009|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
11229935|NCT02018887|12422033|FG010|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
11229936|NCT02018887|12422023|FG000|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
11229937|NCT02018887|12422024|FG001|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
11229938|NCT02018887|12422025|FG002|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15
11229939|NCT02018887|12422026|FG003|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
11229940|NCT02018887|12422027|FG004|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
11229941|NCT02018887|12422028|FG005|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
11229942|NCT02018887|12422029|FG006|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
11229943|NCT02018887|12422030|FG007|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
11229944|NCT02018887|12422031|FG008|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
11229945|NCT02018887|12422032|FG009|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
11229946|NCT02018887|12422033|FG010|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
11229947|NCT02018887|12422023|FG000|COMPLETED|Part B: Cohorts 3-7 Overall||0
11229948|NCT02018887|12422024|FG001|COMPLETED|Part B: Cohorts 3-7 Overall||0
11229949|NCT02018887|12422025|FG002|COMPLETED|Part B: Cohorts 3-7 Overall||15
11229950|NCT02018887|12422026|FG003|COMPLETED|Part B: Cohorts 3-7 Overall||9
11229951|NCT02018887|12422027|FG004|COMPLETED|Part B: Cohorts 3-7 Overall||8
11229952|NCT02018887|12422028|FG005|COMPLETED|Part B: Cohorts 3-7 Overall||9
11229953|NCT02018887|12422029|FG006|COMPLETED|Part B: Cohorts 3-7 Overall||8
11229954|NCT02018887|12422030|FG007|COMPLETED|Part B: Cohorts 3-7 Overall||5
11229955|NCT02018887|12422031|FG008|COMPLETED|Part B: Cohorts 3-7 Overall||0
11229956|NCT02018887|12422032|FG009|COMPLETED|Part B: Cohorts 3-7 Overall||0
11229957|NCT02018887|12422033|FG010|COMPLETED|Part B: Cohorts 3-7 Overall||0
11229958|NCT02018887|12422023|FG000|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
11229959|NCT02018887|12422024|FG001|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
11229960|NCT02018887|12422025|FG002|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
11229961|NCT02018887|12422026|FG003|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
11229962|NCT02018887|12422027|FG004|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
11229963|NCT02018887|12422028|FG005|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
11229964|NCT02018887|12422029|FG006|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
11229965|NCT02018887|12422030|FG007|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4
11229966|NCT02018887|12422031|FG008|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
11229967|NCT02018887|12422032|FG009|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
11229968|NCT02018887|12422033|FG010|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
11229969|NCT02018887|12422023|FG000|STARTED|Part C: Cohort 8 Overall||0
11229970|NCT02018887|12422024|FG001|STARTED|Part C: Cohort 8 Overall||0
11229971|NCT02018887|12422025|FG002|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0
11229972|NCT02018887|12422026|FG003|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
11355290|NCT03078556|12552137|FG001|COMPLETED|Washout Period 1 (7 Days)||36
11111612|NCT01286454|12296106|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111613|NCT01286454|12296096|FG000|STARTED|Fourth Intervention Period||2
11111614|NCT01286454|12296097|FG001|STARTED|Fourth Intervention Period||2
11111615|NCT01286454|12296098|FG002|STARTED|Fourth Intervention Period||2
11111616|NCT01286454|12296099|FG003|STARTED|Fourth Intervention Period||2
11111617|NCT01286454|12296100|FG004|STARTED|Fourth Intervention Period||2
11111618|NCT01286454|12296101|FG005|STARTED|Fourth Intervention Period||2
11111619|NCT01286454|12296102|FG006|STARTED|Fourth Intervention Period||2
11111620|NCT01286454|12296103|FG007|STARTED|Fourth Intervention Period||2
11111621|NCT01286454|12296104|FG008|STARTED|Fourth Intervention Period||2
11111622|NCT01286454|12296105|FG009|STARTED|Fourth Intervention Period||2
11111623|NCT01286454|12296106|FG010|STARTED|Fourth Intervention Period||0
11111624|NCT01286454|12296096|FG000|COMPLETED|Fourth Intervention Period||2
11111625|NCT01286454|12296097|FG001|COMPLETED|Fourth Intervention Period||2
11111626|NCT01286454|12296098|FG002|COMPLETED|Fourth Intervention Period||2
11111627|NCT01286454|12296099|FG003|COMPLETED|Fourth Intervention Period||2
11111628|NCT01286454|12296100|FG004|COMPLETED|Fourth Intervention Period||2
11111629|NCT01286454|12296101|FG005|COMPLETED|Fourth Intervention Period||2
11111630|NCT01286454|12296102|FG006|COMPLETED|Fourth Intervention Period||2
11111631|NCT01286454|12296103|FG007|COMPLETED|Fourth Intervention Period||2
11111632|NCT01286454|12296104|FG008|COMPLETED|Fourth Intervention Period||2
11111633|NCT01286454|12296105|FG009|COMPLETED|Fourth Intervention Period||2
11111634|NCT01286454|12296106|FG010|COMPLETED|Fourth Intervention Period||0
11111635|NCT01286454|12296096|FG000|NOT COMPLETED|Fourth Intervention Period||0
11111636|NCT01286454|12296097|FG001|NOT COMPLETED|Fourth Intervention Period||0
11111637|NCT01286454|12296098|FG002|NOT COMPLETED|Fourth Intervention Period||0
11111638|NCT01286454|12296099|FG003|NOT COMPLETED|Fourth Intervention Period||0
11111639|NCT01286454|12296100|FG004|NOT COMPLETED|Fourth Intervention Period||0
11111640|NCT01286454|12296101|FG005|NOT COMPLETED|Fourth Intervention Period||0
11111641|NCT01286454|12296102|FG006|NOT COMPLETED|Fourth Intervention Period||0
11111642|NCT01286454|12296103|FG007|NOT COMPLETED|Fourth Intervention Period||0
11111643|NCT01286454|12296104|FG008|NOT COMPLETED|Fourth Intervention Period||0
11111644|NCT01286454|12296105|FG009|NOT COMPLETED|Fourth Intervention Period||0
11111645|NCT01286454|12296106|FG010|NOT COMPLETED|Fourth Intervention Period||0
11111646|NCT01286454|12296096|FG000|STARTED|Washout Period (At Least 3 Days)||2
11111647|NCT01286454|12296097|FG001|STARTED|Washout Period (At Least 3 Days)||2
11355291|NCT03078556|12552138|FG002|COMPLETED|Washout Period 1 (7 Days)||37
11355292|NCT03078556|12552139|FG003|COMPLETED|Washout Period 1 (7 Days)||37
11355293|NCT03078556|12552136|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||2
11355294|NCT03078556|12552137|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||2
11355295|NCT03078556|12552138|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
11355296|NCT03078556|12552139|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
11111648|NCT01286454|12296098|FG002|STARTED|Washout Period (At Least 3 Days)||2
11229973|NCT02018887|12422027|FG004|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
11355297|NCT03078556|12552136|FG000|STARTED|Treatment Period 2 (4 Days)||37
11355298|NCT03078556|12552137|FG001|STARTED|Treatment Period 2 (4 Days)||36
11229974|NCT02018887|12422028|FG005|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
11229975|NCT02018887|12422029|FG006|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
11229976|NCT02018887|12422030|FG007|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
11229977|NCT02018887|12422031|FG008|STARTED|Part C: Cohort 8 Overall||10
11229978|NCT02018887|12422032|FG009|STARTED|Part C: Cohort 8 Overall||4
11229979|NCT02018887|12422033|FG010|STARTED|Part C: Cohort 8 Overall||7
11229980|NCT02018887|12422023|FG000|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
11229981|NCT02018887|12422024|FG001|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
11229982|NCT02018887|12422025|FG002|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
11229983|NCT02018887|12422026|FG003|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
11229984|NCT02018887|12422027|FG004|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
11229985|NCT02018887|12422028|FG005|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
11229986|NCT02018887|12422029|FG006|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
11229987|NCT02018887|12422030|FG007|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
11229988|NCT02018887|12422031|FG008|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10
11229989|NCT02018887|12422032|FG009|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4
11229990|NCT02018887|12422033|FG010|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7
11229991|NCT02018887|12422023|FG000|COMPLETED|Part C: Cohort 8 Overall||0
11229992|NCT02018887|12422024|FG001|COMPLETED|Part C: Cohort 8 Overall||0
11229993|NCT02018887|12422025|FG002|COMPLETED|Part C: Cohort 8 Overall||0
11229994|NCT02018887|12422026|FG003|COMPLETED|Part C: Cohort 8 Overall||0
11229995|NCT02018887|12422027|FG004|COMPLETED|Part C: Cohort 8 Overall||0
11229996|NCT02018887|12422028|FG005|COMPLETED|Part C: Cohort 8 Overall||0
11229997|NCT02018887|12422029|FG006|COMPLETED|Part C: Cohort 8 Overall||0
11111649|NCT01286454|12296099|FG003|STARTED|Washout Period (At Least 3 Days)||2
11111650|NCT01286454|12296100|FG004|STARTED|Washout Period (At Least 3 Days)||2
11111651|NCT01286454|12296101|FG005|STARTED|Washout Period (At Least 3 Days)||2
11111652|NCT01286454|12296102|FG006|STARTED|Washout Period (At Least 3 Days)||2
11111653|NCT01286454|12296103|FG007|STARTED|Washout Period (At Least 3 Days)||2
11111654|NCT01286454|12296104|FG008|STARTED|Washout Period (At Least 3 Days)||2
11111655|NCT01286454|12296105|FG009|STARTED|Washout Period (At Least 3 Days)||2
11111656|NCT01286454|12296106|FG010|STARTED|Washout Period (At Least 3 Days)||0
10871530|NCT02943993|12037291|FG000|STARTED|Overall Study|Disposition data are based on Baseline Analysis Set (BAS) defined as All-Documented Patient Set participants with any documentation at the Baseline data collection point who fulfil the BAS criteria.|2655
10871531|NCT02943993|12037291|FG000|COMPLETED|Overall Study||2325
10871532|NCT02943993|12037291|FG000|NOT COMPLETED|Overall Study||330
10871533|NCT02939989|12037297|FG000|STARTED|Overall Study||5
10871534|NCT02939989|12037298|FG001|STARTED|Overall Study||28
10871535|NCT02939989|12037297|FG000|COMPLETED|Overall Study||5
10871536|NCT02939989|12037298|FG001|COMPLETED|Overall Study||28
10871537|NCT02939989|12037297|FG000|NOT COMPLETED|Overall Study||0
10871538|NCT02939989|12037298|FG001|NOT COMPLETED|Overall Study||0
10871539|NCT02877134|12037313|FG000|STARTED|Overall Study||72
10871540|NCT02877134|12037314|FG001|STARTED|Overall Study||73
10871541|NCT02877134|12037315|FG002|STARTED|Overall Study||48
10871542|NCT02877134|12037316|FG003|STARTED|Overall Study||50
10871543|NCT02877134|12037317|FG004|STARTED|Overall Study||49
10871544|NCT02877134|12037318|FG005|STARTED|Overall Study||49
10871545|NCT02877134|12037319|FG006|STARTED|Overall Study||47
10871546|NCT02877134|12037313|FG000|Placebo Non Responders at Week 12|Overall Study||44
10871547|NCT02877134|12037314|FG001|Placebo Non Responders at Week 12|Overall Study||0
10871548|NCT02877134|12037315|FG002|Placebo Non Responders at Week 12|Overall Study||31
10871549|NCT02877134|12037316|FG003|Placebo Non Responders at Week 12|Overall Study||0
10871550|NCT02877134|12037317|FG004|Placebo Non Responders at Week 12|Overall Study||0
10871551|NCT02877134|12037318|FG005|Placebo Non Responders at Week 12|Overall Study||0
10871552|NCT02877134|12037319|FG006|Placebo Non Responders at Week 12|Overall Study||0
10871553|NCT02877134|12037313|FG000|COMPLETED|Overall Study||58
10871554|NCT02877134|12037314|FG001|COMPLETED|Overall Study||48
10871555|NCT02877134|12037315|FG002|COMPLETED|Overall Study||42
10871556|NCT02877134|12037316|FG003|COMPLETED|Overall Study||37
10871557|NCT02877134|12037317|FG004|COMPLETED|Overall Study||43
10871558|NCT02877134|12037318|FG005|COMPLETED|Overall Study||42
10871559|NCT02877134|12037319|FG006|COMPLETED|Overall Study||46
10871560|NCT02877134|12037313|FG000|NOT COMPLETED|Overall Study||14
10871561|NCT02877134|12037314|FG001|NOT COMPLETED|Overall Study||25
10871562|NCT02877134|12037315|FG002|NOT COMPLETED|Overall Study||6
10871563|NCT02877134|12037316|FG003|NOT COMPLETED|Overall Study||13
10871564|NCT02877134|12037317|FG004|NOT COMPLETED|Overall Study||6
10871565|NCT02877134|12037318|FG005|NOT COMPLETED|Overall Study||7
10871566|NCT02877134|12037319|FG006|NOT COMPLETED|Overall Study||1
10871567|NCT02762708|12037341|FG000|STARTED|Study 1 - RYGB vs Caloric Restriction||3
10871568|NCT02762708|12037342|FG001|STARTED|Study 1 - RYGB vs Caloric Restriction||9
10871569|NCT02762708|12037343|FG002|STARTED|Study 1 - RYGB vs Caloric Restriction||0
10871570|NCT02762708|12037344|FG003|STARTED|Study 1 - RYGB vs Caloric Restriction||0
10871571|NCT02762708|12037341|FG000|COMPLETED|Study 1 - RYGB vs Caloric Restriction||3
10871572|NCT02762708|12037342|FG001|COMPLETED|Study 1 - RYGB vs Caloric Restriction||7
10871573|NCT02762708|12037343|FG002|COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
10871574|NCT02762708|12037344|FG003|COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
10871575|NCT02762708|12037341|FG000|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
10871576|NCT02762708|12037342|FG001|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||2
10871577|NCT02762708|12037343|FG002|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
10871578|NCT02762708|12037344|FG003|NOT COMPLETED|Study 1 - RYGB vs Caloric Restriction||0
10871579|NCT02762708|12037341|FG000|STARTED|Study 2 - Exendin (9,39) Amide Study||0
10871580|NCT02762708|12037342|FG001|STARTED|Study 2 - Exendin (9,39) Amide Study||0
10871581|NCT02762708|12037343|FG002|STARTED|Study 2 - Exendin (9,39) Amide Study||1
10871582|NCT02762708|12037344|FG003|STARTED|Study 2 - Exendin (9,39) Amide Study||0
10871583|NCT02762708|12037341|FG000|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
10871584|NCT02762708|12037342|FG001|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
10871585|NCT02762708|12037343|FG002|COMPLETED|Study 2 - Exendin (9,39) Amide Study||1
10871586|NCT02762708|12037344|FG003|COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
10871587|NCT02762708|12037341|FG000|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
10871588|NCT02762708|12037342|FG001|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
10871589|NCT02762708|12037343|FG002|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
10871590|NCT02762708|12037344|FG003|NOT COMPLETED|Study 2 - Exendin (9,39) Amide Study||0
11111657|NCT01286454|12296096|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
11111658|NCT01286454|12296097|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
11111659|NCT01286454|12296098|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
11111660|NCT01286454|12296099|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
11111661|NCT01286454|12296100|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
11111662|NCT01286454|12296101|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
11111663|NCT01286454|12296102|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
11111664|NCT01286454|12296103|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
11111665|NCT01286454|12296104|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
11111666|NCT01286454|12296105|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
11111667|NCT01286454|12296106|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
11111668|NCT01286454|12296096|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
10871603|NCT02720952|12037363|FG000|STARTED|Overall Study||24
10871604|NCT02720952|12037363|FG000|COMPLETED|Overall Study||24
10871605|NCT02720952|12037363|FG000|NOT COMPLETED|Overall Study||0
11111669|NCT01286454|12296097|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111670|NCT01286454|12296098|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111671|NCT01286454|12296099|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111672|NCT01286454|12296100|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111673|NCT01286454|12296101|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111674|NCT01286454|12296102|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11229998|NCT02018887|12422030|FG007|COMPLETED|Part C: Cohort 8 Overall||0
11111675|NCT01286454|12296103|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111676|NCT01286454|12296104|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111677|NCT01286454|12296105|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111678|NCT01286454|12296106|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
11111679|NCT01286454|12296096|FG000|STARTED|Fifth Intervention Period||2
11111680|NCT01286454|12296097|FG001|STARTED|Fifth Intervention Period||2
10871624|NCT02557945|12037395|FG000|STARTED|Overall Study||3
10871625|NCT02557945|12037396|FG001|STARTED|Overall Study||3
10871626|NCT02557945|12037395|FG000|COMPLETED|Overall Study||3
10871627|NCT02557945|12037396|FG001|COMPLETED|Overall Study||3
10871628|NCT02557945|12037395|FG000|NOT COMPLETED|Overall Study||0
10871629|NCT02557945|12037396|FG001|NOT COMPLETED|Overall Study||0
10871630|NCT02553915|12037406|FG000|STARTED|Overall Study||15
10871631|NCT02553915|12037407|FG001|STARTED|Overall Study||15
10871632|NCT02553915|12037408|FG002|STARTED|Overall Study||15
10871633|NCT02553915|12037409|FG003|STARTED|Overall Study||16
10871634|NCT02553915|12037406|FG000|COMPLETED|Overall Study||11
10871635|NCT02553915|12037407|FG001|COMPLETED|Overall Study||14
10871636|NCT02553915|12037408|FG002|COMPLETED|Overall Study||12
10871637|NCT02553915|12037409|FG003|COMPLETED|Overall Study||13
10871638|NCT02553915|12037406|FG000|NOT COMPLETED|Overall Study||4
10871639|NCT02553915|12037407|FG001|NOT COMPLETED|Overall Study||1
10871640|NCT02553915|12037408|FG002|NOT COMPLETED|Overall Study||3
10871641|NCT02553915|12037409|FG003|NOT COMPLETED|Overall Study||3
10871642|NCT02550873|12037421|FG000|STARTED|Randomized Double Blind||78
10871643|NCT02550873|12037422|FG001|STARTED|Randomized Double Blind||39
10871644|NCT02550873|12037423|FG002|STARTED|Randomized Double Blind||0
10871645|NCT02550873|12037421|FG000|Received Treatment|Randomized Double Blind||77
10871646|NCT02550873|12037422|FG001|Received Treatment|Randomized Double Blind||39
10871647|NCT02550873|12037423|FG002|Received Treatment|Randomized Double Blind||0
10871648|NCT02550873|12037421|FG000|Continue to Open Label Extension|Randomized Double Blind||74
10871649|NCT02550873|12037422|FG001|Continue to Open Label Extension|Randomized Double Blind||37
10871650|NCT02550873|12037423|FG002|Continue to Open Label Extension|Randomized Double Blind||0
10871651|NCT02550873|12037421|FG000|COMPLETED|Randomized Double Blind||74
10871652|NCT02550873|12037422|FG001|COMPLETED|Randomized Double Blind||37
10871653|NCT02550873|12037423|FG002|COMPLETED|Randomized Double Blind||0
10871654|NCT02550873|12037421|FG000|NOT COMPLETED|Randomized Double Blind||4
10871655|NCT02550873|12037422|FG001|NOT COMPLETED|Randomized Double Blind||2
10871656|NCT02550873|12037423|FG002|NOT COMPLETED|Randomized Double Blind||0
10871657|NCT02550873|12037421|FG000|STARTED|Open Label Extension||0
10871658|NCT02550873|12037422|FG001|STARTED|Open Label Extension||0
10871659|NCT02550873|12037423|FG002|STARTED|Open Label Extension||111
10871660|NCT02550873|12037421|FG000|COMPLETED|Open Label Extension||0
10871661|NCT02550873|12037422|FG001|COMPLETED|Open Label Extension||0
10871662|NCT02550873|12037423|FG002|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
10871663|NCT02550873|12037421|FG000|NOT COMPLETED|Open Label Extension||0
10871664|NCT02550873|12037422|FG001|NOT COMPLETED|Open Label Extension||0
10871665|NCT02550873|12037423|FG002|NOT COMPLETED|Open Label Extension||111
10871666|NCT02542267|12037445|FG000|STARTED|Overall Study||108
10871667|NCT02542267|12037445|FG000|COMPLETED|Overall Study||53
10871668|NCT02542267|12037445|FG000|NOT COMPLETED|Overall Study||55
10871669|NCT02462603|12037449|FG000|STARTED|Overall Study||44
10871670|NCT02462603|12037449|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41
10871671|NCT02462603|12037449|FG000|EITT Population|Overall Study||40
10871672|NCT02462603|12037449|FG000|COMPLETED|Overall Study||40
10871673|NCT02462603|12037449|FG000|NOT COMPLETED|Overall Study||4
10871674|NCT02438410|12037453|FG000|STARTED|Overall Study||13
10871675|NCT02438410|12037453|FG000|COMPLETED|Overall Study||13
10871676|NCT02438410|12037453|FG000|NOT COMPLETED|Overall Study||0
10871677|NCT02420717|12037460|FG000|STARTED|Overall Study||5
10871678|NCT02420717|12037461|FG001|STARTED|Overall Study||3
10871679|NCT02420717|12037462|FG002|STARTED|Overall Study||3
10871680|NCT02420717|12037460|FG000|COMPLETED|Overall Study||3
10871681|NCT02420717|12037461|FG001|COMPLETED|Overall Study||3
10871682|NCT02420717|12037462|FG002|COMPLETED|Overall Study||3
10871683|NCT02420717|12037460|FG000|NOT COMPLETED|Overall Study||2
10871684|NCT02420717|12037461|FG001|NOT COMPLETED|Overall Study||0
10871685|NCT02420717|12037462|FG002|NOT COMPLETED|Overall Study||0
10871686|NCT02408068|12037470|FG000|STARTED|Treatment 1 (1.5 Days)||3
10871687|NCT02408068|12037471|FG001|STARTED|Treatment 1 (1.5 Days)||3
10871688|NCT02408068|12037472|FG002|STARTED|Treatment 1 (1.5 Days)||3
10871689|NCT02408068|12037473|FG003|STARTED|Treatment 1 (1.5 Days)||3
10871690|NCT02408068|12037474|FG004|STARTED|Treatment 1 (1.5 Days)||3
10871691|NCT02408068|12037475|FG005|STARTED|Treatment 1 (1.5 Days)||3
10871692|NCT02408068|12037470|FG000|COMPLETED|Treatment 1 (1.5 Days)||3
10871693|NCT02408068|12037471|FG001|COMPLETED|Treatment 1 (1.5 Days)||3
10871694|NCT02408068|12037472|FG002|COMPLETED|Treatment 1 (1.5 Days)||3
10871695|NCT02408068|12037473|FG003|COMPLETED|Treatment 1 (1.5 Days)||3
10871696|NCT02408068|12037474|FG004|COMPLETED|Treatment 1 (1.5 Days)||3
10871697|NCT02408068|12037475|FG005|COMPLETED|Treatment 1 (1.5 Days)||3
10871698|NCT02408068|12037470|FG000|NOT COMPLETED|Treatment 1 (1.5 Days)||0
10871699|NCT02408068|12037471|FG001|NOT COMPLETED|Treatment 1 (1.5 Days)||0
10871700|NCT02408068|12037472|FG002|NOT COMPLETED|Treatment 1 (1.5 Days)||0
10871701|NCT02408068|12037473|FG003|NOT COMPLETED|Treatment 1 (1.5 Days)||0
10871702|NCT02408068|12037474|FG004|NOT COMPLETED|Treatment 1 (1.5 Days)||0
10871703|NCT02408068|12037475|FG005|NOT COMPLETED|Treatment 1 (1.5 Days)||0
10871704|NCT02408068|12037470|FG000|STARTED|Washout Period 1 (7 Days)||3
10871705|NCT02408068|12037471|FG001|STARTED|Washout Period 1 (7 Days)||3
10871706|NCT02408068|12037472|FG002|STARTED|Washout Period 1 (7 Days)||3
10871707|NCT02408068|12037473|FG003|STARTED|Washout Period 1 (7 Days)||3
10871708|NCT02408068|12037474|FG004|STARTED|Washout Period 1 (7 Days)||3
10871709|NCT02408068|12037475|FG005|STARTED|Washout Period 1 (7 Days)||3
10871710|NCT02408068|12037470|FG000|COMPLETED|Washout Period 1 (7 Days)||3
10871711|NCT02408068|12037471|FG001|COMPLETED|Washout Period 1 (7 Days)||3
10871712|NCT02408068|12037472|FG002|COMPLETED|Washout Period 1 (7 Days)||3
10871713|NCT02408068|12037473|FG003|COMPLETED|Washout Period 1 (7 Days)||3
10871714|NCT02408068|12037474|FG004|COMPLETED|Washout Period 1 (7 Days)||3
10871715|NCT02408068|12037475|FG005|COMPLETED|Washout Period 1 (7 Days)||3
10871716|NCT02408068|12037470|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10871717|NCT02408068|12037471|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10871718|NCT02408068|12037472|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10871719|NCT02408068|12037473|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10871720|NCT02408068|12037474|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
10871721|NCT02408068|12037475|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
10871722|NCT02408068|12037470|FG000|STARTED|Treatment 2 (1.5 Days)||3
10871723|NCT02408068|12037471|FG001|STARTED|Treatment 2 (1.5 Days)||3
10871724|NCT02408068|12037472|FG002|STARTED|Treatment 2 (1.5 Days)||3
10871725|NCT02408068|12037473|FG003|STARTED|Treatment 2 (1.5 Days)||3
10871726|NCT02408068|12037474|FG004|STARTED|Treatment 2 (1.5 Days)||3
10871727|NCT02408068|12037475|FG005|STARTED|Treatment 2 (1.5 Days)||3
10871728|NCT02408068|12037470|FG000|COMPLETED|Treatment 2 (1.5 Days)||3
10871729|NCT02408068|12037471|FG001|COMPLETED|Treatment 2 (1.5 Days)||3
10871730|NCT02408068|12037472|FG002|COMPLETED|Treatment 2 (1.5 Days)||3
10871731|NCT02408068|12037473|FG003|COMPLETED|Treatment 2 (1.5 Days)||3
10871732|NCT02408068|12037474|FG004|COMPLETED|Treatment 2 (1.5 Days)||3
10871733|NCT02408068|12037475|FG005|COMPLETED|Treatment 2 (1.5 Days)||3
10871734|NCT02408068|12037470|FG000|NOT COMPLETED|Treatment 2 (1.5 Days)||0
10871735|NCT02408068|12037471|FG001|NOT COMPLETED|Treatment 2 (1.5 Days)||0
10871736|NCT02408068|12037472|FG002|NOT COMPLETED|Treatment 2 (1.5 Days)||0
10871737|NCT02408068|12037473|FG003|NOT COMPLETED|Treatment 2 (1.5 Days)||0
10871738|NCT02408068|12037474|FG004|NOT COMPLETED|Treatment 2 (1.5 Days)||0
10871739|NCT02408068|12037475|FG005|NOT COMPLETED|Treatment 2 (1.5 Days)||0
10871740|NCT02408068|12037470|FG000|STARTED|Washout Period 2 (7 Days)||3
10871741|NCT02408068|12037471|FG001|STARTED|Washout Period 2 (7 Days)||3
10871742|NCT02408068|12037472|FG002|STARTED|Washout Period 2 (7 Days)||3
10871743|NCT02408068|12037473|FG003|STARTED|Washout Period 2 (7 Days)||3
10871744|NCT02408068|12037474|FG004|STARTED|Washout Period 2 (7 Days)||3
10871745|NCT02408068|12037475|FG005|STARTED|Washout Period 2 (7 Days)||3
10871746|NCT02408068|12037470|FG000|COMPLETED|Washout Period 2 (7 Days)||3
10871747|NCT02408068|12037471|FG001|COMPLETED|Washout Period 2 (7 Days)||3
10871748|NCT02408068|12037472|FG002|COMPLETED|Washout Period 2 (7 Days)||3
10871749|NCT02408068|12037473|FG003|COMPLETED|Washout Period 2 (7 Days)||3
10871750|NCT02408068|12037474|FG004|COMPLETED|Washout Period 2 (7 Days)||3
10871751|NCT02408068|12037475|FG005|COMPLETED|Washout Period 2 (7 Days)||3
10871752|NCT02408068|12037470|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10871753|NCT02408068|12037471|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10871754|NCT02408068|12037472|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10871755|NCT02408068|12037473|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10871756|NCT02408068|12037474|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
10871757|NCT02408068|12037475|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
10871758|NCT02408068|12037470|FG000|STARTED|Treatment 3 (1.5 Days)||3
10871759|NCT02408068|12037471|FG001|STARTED|Treatment 3 (1.5 Days)||3
10871760|NCT02408068|12037472|FG002|STARTED|Treatment 3 (1.5 Days)||3
10871761|NCT02408068|12037473|FG003|STARTED|Treatment 3 (1.5 Days)||3
10871762|NCT02408068|12037474|FG004|STARTED|Treatment 3 (1.5 Days)||3
10871763|NCT02408068|12037475|FG005|STARTED|Treatment 3 (1.5 Days)||3
10871764|NCT02408068|12037470|FG000|COMPLETED|Treatment 3 (1.5 Days)||3
10871765|NCT02408068|12037471|FG001|COMPLETED|Treatment 3 (1.5 Days)||3
10871766|NCT02408068|12037472|FG002|COMPLETED|Treatment 3 (1.5 Days)||2
10871767|NCT02408068|12037473|FG003|COMPLETED|Treatment 3 (1.5 Days)||3
10871768|NCT02408068|12037474|FG004|COMPLETED|Treatment 3 (1.5 Days)||3
10871769|NCT02408068|12037475|FG005|COMPLETED|Treatment 3 (1.5 Days)||3
10871770|NCT02408068|12037470|FG000|NOT COMPLETED|Treatment 3 (1.5 Days)||0
10871771|NCT02408068|12037471|FG001|NOT COMPLETED|Treatment 3 (1.5 Days)||0
10871772|NCT02408068|12037472|FG002|NOT COMPLETED|Treatment 3 (1.5 Days)||1
10871773|NCT02408068|12037473|FG003|NOT COMPLETED|Treatment 3 (1.5 Days)||0
10871774|NCT02408068|12037474|FG004|NOT COMPLETED|Treatment 3 (1.5 Days)||0
10871775|NCT02408068|12037475|FG005|NOT COMPLETED|Treatment 3 (1.5 Days)||0
11111681|NCT01286454|12296098|FG002|STARTED|Fifth Intervention Period||2
11111682|NCT01286454|12296099|FG003|STARTED|Fifth Intervention Period||2
11111683|NCT01286454|12296100|FG004|STARTED|Fifth Intervention Period||2
11111684|NCT01286454|12296101|FG005|STARTED|Fifth Intervention Period||2
11111685|NCT01286454|12296102|FG006|STARTED|Fifth Intervention Period||2
11111686|NCT01286454|12296103|FG007|STARTED|Fifth Intervention Period||2
11111687|NCT01286454|12296104|FG008|STARTED|Fifth Intervention Period||2
11111688|NCT01286454|12296105|FG009|STARTED|Fifth Intervention Period||2
11111689|NCT01286454|12296106|FG010|STARTED|Fifth Intervention Period||0
11111690|NCT01286454|12296096|FG000|COMPLETED|Fifth Intervention Period||2
11111691|NCT01286454|12296097|FG001|COMPLETED|Fifth Intervention Period||2
11111692|NCT01286454|12296098|FG002|COMPLETED|Fifth Intervention Period||2
11111693|NCT01286454|12296099|FG003|COMPLETED|Fifth Intervention Period||2
11111694|NCT01286454|12296100|FG004|COMPLETED|Fifth Intervention Period||2
11111695|NCT01286454|12296101|FG005|COMPLETED|Fifth Intervention Period||2
11111696|NCT01286454|12296102|FG006|COMPLETED|Fifth Intervention Period||2
11111697|NCT01286454|12296103|FG007|COMPLETED|Fifth Intervention Period||2
11111698|NCT01286454|12296104|FG008|COMPLETED|Fifth Intervention Period||2
11111699|NCT01286454|12296105|FG009|COMPLETED|Fifth Intervention Period||2
11111700|NCT01286454|12296106|FG010|COMPLETED|Fifth Intervention Period||0
11111701|NCT01286454|12296096|FG000|NOT COMPLETED|Fifth Intervention Period||0
11111702|NCT01286454|12296097|FG001|NOT COMPLETED|Fifth Intervention Period||0
11111703|NCT01286454|12296098|FG002|NOT COMPLETED|Fifth Intervention Period||0
11111704|NCT01286454|12296099|FG003|NOT COMPLETED|Fifth Intervention Period||0
11111705|NCT01286454|12296100|FG004|NOT COMPLETED|Fifth Intervention Period||0
11111706|NCT01286454|12296101|FG005|NOT COMPLETED|Fifth Intervention Period||0
11111707|NCT01286454|12296102|FG006|NOT COMPLETED|Fifth Intervention Period||0
11111708|NCT01286454|12296103|FG007|NOT COMPLETED|Fifth Intervention Period||0
11111709|NCT01286454|12296104|FG008|NOT COMPLETED|Fifth Intervention Period||0
11111710|NCT01286454|12296105|FG009|NOT COMPLETED|Fifth Intervention Period||0
11111711|NCT01286454|12296106|FG010|NOT COMPLETED|Fifth Intervention Period||0
11111712|NCT01286454|12296096|FG000|STARTED|Washout Period (Approximately 2 Weeks)||2
11111713|NCT01286454|12296097|FG001|STARTED|Washout Period (Approximately 2 Weeks)||2
11111714|NCT01286454|12296098|FG002|STARTED|Washout Period (Approximately 2 Weeks)||2
11111715|NCT01286454|12296099|FG003|STARTED|Washout Period (Approximately 2 Weeks)||2
11111716|NCT01286454|12296100|FG004|STARTED|Washout Period (Approximately 2 Weeks)||2
11111717|NCT01286454|12296101|FG005|STARTED|Washout Period (Approximately 2 Weeks)||2
11111718|NCT01286454|12296102|FG006|STARTED|Washout Period (Approximately 2 Weeks)||2
11111719|NCT01286454|12296103|FG007|STARTED|Washout Period (Approximately 2 Weeks)||2
11111720|NCT01286454|12296104|FG008|STARTED|Washout Period (Approximately 2 Weeks)||2
11111721|NCT01286454|12296105|FG009|STARTED|Washout Period (Approximately 2 Weeks)||2
11111722|NCT01286454|12296106|FG010|STARTED|Washout Period (Approximately 2 Weeks)||0
11111723|NCT01286454|12296096|FG000|COMPLETED|Washout Period (Approximately 2 Weeks)||2
11111724|NCT01286454|12296097|FG001|COMPLETED|Washout Period (Approximately 2 Weeks)||2
11111725|NCT01286454|12296098|FG002|COMPLETED|Washout Period (Approximately 2 Weeks)||2
11111726|NCT01286454|12296099|FG003|COMPLETED|Washout Period (Approximately 2 Weeks)||2
11111727|NCT01286454|12296100|FG004|COMPLETED|Washout Period (Approximately 2 Weeks)||2
11111728|NCT01286454|12296101|FG005|COMPLETED|Washout Period (Approximately 2 Weeks)||2
11111729|NCT01286454|12296102|FG006|COMPLETED|Washout Period (Approximately 2 Weeks)||2
11111730|NCT01286454|12296103|FG007|COMPLETED|Washout Period (Approximately 2 Weeks)||2
11111731|NCT01286454|12296104|FG008|COMPLETED|Washout Period (Approximately 2 Weeks)||2
11111732|NCT01286454|12296105|FG009|COMPLETED|Washout Period (Approximately 2 Weeks)||2
11111733|NCT01286454|12296106|FG010|COMPLETED|Washout Period (Approximately 2 Weeks)||0
11111734|NCT01286454|12296096|FG000|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
11111735|NCT01286454|12296097|FG001|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
11111736|NCT01286454|12296098|FG002|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
11111737|NCT01286454|12296099|FG003|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
11111738|NCT01286454|12296100|FG004|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
11111739|NCT01286454|12296101|FG005|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
11111740|NCT01286454|12296102|FG006|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
11111741|NCT01286454|12296103|FG007|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
11111742|NCT01286454|12296104|FG008|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
11111743|NCT01286454|12296105|FG009|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
11111744|NCT01286454|12296106|FG010|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
11111745|NCT01286454|12296096|FG000|STARTED|Part II- Sixth Intervention Period||0
11111746|NCT01286454|12296097|FG001|STARTED|Part II- Sixth Intervention Period||0
11111747|NCT01286454|12296098|FG002|STARTED|Part II- Sixth Intervention Period||0
11111748|NCT01286454|12296099|FG003|STARTED|Part II- Sixth Intervention Period||0
11111749|NCT01286454|12296100|FG004|STARTED|Part II- Sixth Intervention Period||0
11111750|NCT01286454|12296101|FG005|STARTED|Part II- Sixth Intervention Period||0
11111751|NCT01286454|12296102|FG006|STARTED|Part II- Sixth Intervention Period||0
11111752|NCT01286454|12296103|FG007|STARTED|Part II- Sixth Intervention Period||0
11111753|NCT01286454|12296104|FG008|STARTED|Part II- Sixth Intervention Period||0
10871776|NCT02174861|12037486|FG000|STARTED|Overall Study||609
10871777|NCT02174861|12037486|FG000|Enrolled in CHU Substudy|Overall Study||53
10871778|NCT02174861|12037486|FG000|COMPLETED|Overall Study||451
10871779|NCT02174861|12037486|FG000|NOT COMPLETED|Overall Study||158
10871780|NCT02052739|12037494|FG000|STARTED|Overall Study||19
10871781|NCT02052739|12037495|FG001|STARTED|Overall Study||6
10871782|NCT02052739|12037494|FG000|COMPLETED|Overall Study||14
10871783|NCT02052739|12037495|FG001|COMPLETED|Overall Study||5
10871784|NCT02052739|12037494|FG000|NOT COMPLETED|Overall Study||5
10871785|NCT02052739|12037495|FG001|NOT COMPLETED|Overall Study||1
10871786|NCT01944020|12037505|FG000|STARTED|Overall Study||17
10871787|NCT01944020|12037506|FG001|STARTED|Overall Study||12
10871788|NCT01944020|12037505|FG000|COMPLETED|Overall Study||12
10871789|NCT01944020|12037506|FG001|COMPLETED|Overall Study||12
10871790|NCT01944020|12037505|FG000|NOT COMPLETED|Overall Study||5
10871791|NCT01944020|12037506|FG001|NOT COMPLETED|Overall Study||0
10871792|NCT01689519|12037514|FG000|STARTED|Intent to Treat||247
10871793|NCT01689519|12037515|FG001|STARTED|Intent to Treat||248
10871794|NCT01689519|12037514|FG000|COMPLETED|Intent to Treat||0
10871795|NCT01689519|12037515|FG001|COMPLETED|Intent to Treat||0
10871796|NCT01689519|12037514|FG000|NOT COMPLETED|Intent to Treat||247
10871797|NCT01689519|12037515|FG001|NOT COMPLETED|Intent to Treat||248
10871798|NCT01689519|12037514|FG000|STARTED|Safety Population||248
10871799|NCT01689519|12037515|FG001|STARTED|Safety Population||245
10871800|NCT01689519|12037514|FG000|COMPLETED|Safety Population||0
10871801|NCT01689519|12037515|FG001|COMPLETED|Safety Population||0
10871802|NCT01689519|12037514|FG000|NOT COMPLETED|Safety Population||248
10871803|NCT01689519|12037515|FG001|NOT COMPLETED|Safety Population||245
10871804|NCT01622088|12037521|FG000|STARTED|Overall Study||616
10871805|NCT01622088|12037521|FG000|COMPLETED|Overall Study||0
10871806|NCT01622088|12037521|FG000|NOT COMPLETED|Overall Study||616
10871807|NCT01486264|12037528|FG000|STARTED|Overall Study||142
10871808|NCT01486264|12037529|FG001|STARTED|Overall Study||141
10871809|NCT01486264|12037528|FG000|Treated|Overall Study||142
10871810|NCT01486264|12037529|FG001|Treated|Overall Study||140
10871811|NCT01486264|12037528|FG000|COMPLETED|Overall Study||113
10871812|NCT01486264|12037529|FG001|COMPLETED|Overall Study||94
10871813|NCT01486264|12037528|FG000|NOT COMPLETED|Overall Study||29
10871814|NCT01486264|12037529|FG001|NOT COMPLETED|Overall Study||47
10871815|NCT01419080|12037535|FG000|STARTED|Overall Study||797
10871816|NCT01419080|12037535|FG000|COMPLETED|Overall Study||666
10871817|NCT01419080|12037535|FG000|NOT COMPLETED|Overall Study||131
10871818|NCT01317160|12037543|FG000|STARTED|Overall Study||75
10871819|NCT01317160|12037544|FG001|STARTED|Overall Study||75
10871820|NCT01317160|12037543|FG000|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
10871821|NCT01317160|12037544|FG001|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
10871822|NCT01317160|12037543|FG000|COMPLETED|Overall Study||71
10871823|NCT01317160|12037544|FG001|COMPLETED|Overall Study||69
10871824|NCT01317160|12037543|FG000|NOT COMPLETED|Overall Study||4
10871825|NCT01317160|12037544|FG001|NOT COMPLETED|Overall Study||6
10871826|NCT01234532|12037550|FG000|STARTED|Overall Study||5
11229999|NCT02018887|12422031|FG008|COMPLETED|Part C: Cohort 8 Overall||7
11230000|NCT02018887|12422032|FG009|COMPLETED|Part C: Cohort 8 Overall||1
10871827|NCT01234532|12037550|FG000|COMPLETED|Overall Study||5
10871828|NCT01234532|12037550|FG000|NOT COMPLETED|Overall Study||0
10871829|NCT01154335|12037557|FG000|STARTED|Overall Study||7
10871830|NCT01154335|12037558|FG001|STARTED|Overall Study||6
10871831|NCT01154335|12037559|FG002|STARTED|Overall Study||5
10871832|NCT01154335|12037557|FG000|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
10871833|NCT01154335|12037558|FG001|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
10871834|NCT01154335|12037559|FG002|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
10871835|NCT01154335|12037557|FG000|NOT COMPLETED|Overall Study||7
10871836|NCT01154335|12037558|FG001|NOT COMPLETED|Overall Study||6
10871837|NCT01154335|12037559|FG002|NOT COMPLETED|Overall Study||5
10871838|NCT01143116|12037571|FG000|STARTED|Overall Study||10
10871839|NCT01143116|12037572|FG001|STARTED|Overall Study||10
10871840|NCT01143116|12037571|FG000|COMPLETED|Overall Study||10
10871841|NCT01143116|12037572|FG001|COMPLETED|Overall Study||10
10871842|NCT01143116|12037571|FG000|NOT COMPLETED|Overall Study||0
10871843|NCT01143116|12037572|FG001|NOT COMPLETED|Overall Study||0
10871844|NCT01094782|12037584|FG000|STARTED|Overall Study||39
10871845|NCT01094782|12037585|FG001|STARTED|Overall Study||39
10871846|NCT01094782|12037586|FG002|STARTED|Overall Study||34
10871847|NCT01094782|12037587|FG003|STARTED|Overall Study||56
10871848|NCT01094782|12037588|FG004|STARTED|Overall Study||42
10871849|NCT01094782|12037589|FG005|STARTED|Overall Study||38
10871850|NCT01094782|12037584|FG000|COMPLETED|Overall Study||31
10871851|NCT01094782|12037585|FG001|COMPLETED|Overall Study||29
10871852|NCT01094782|12037586|FG002|COMPLETED|Overall Study||31
10871853|NCT01094782|12037587|FG003|COMPLETED|Overall Study||45
10871854|NCT01094782|12037588|FG004|COMPLETED|Overall Study||31
10871855|NCT01094782|12037589|FG005|COMPLETED|Overall Study||30
10871856|NCT01094782|12037584|FG000|NOT COMPLETED|Overall Study||8
10871857|NCT01094782|12037585|FG001|NOT COMPLETED|Overall Study||10
10871858|NCT01094782|12037586|FG002|NOT COMPLETED|Overall Study||3
10871859|NCT01094782|12037587|FG003|NOT COMPLETED|Overall Study||11
10871860|NCT01094782|12037588|FG004|NOT COMPLETED|Overall Study||11
10871861|NCT01094782|12037589|FG005|NOT COMPLETED|Overall Study||8
10871862|NCT01033032|12037608|FG000|STARTED|Overall Study||3
10871863|NCT01033032|12037609|FG001|STARTED|Overall Study||3
10871864|NCT01033032|12037610|FG002|STARTED|Overall Study||3
10871865|NCT01033032|12037611|FG003|STARTED|Overall Study||6
10871866|NCT01033032|12037612|FG004|STARTED|Overall Study||63
10871867|NCT01033032|12037608|FG000|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
10871868|NCT01033032|12037609|FG001|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
10871869|NCT01033032|12037610|FG002|COMPLETED|Overall Study||3
10871870|NCT01033032|12037611|FG003|COMPLETED|Overall Study|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
10871871|NCT01033032|12037612|FG004|COMPLETED|Overall Study||0
10871872|NCT01033032|12037608|FG000|NOT COMPLETED|Overall Study||3
10871873|NCT01033032|12037609|FG001|NOT COMPLETED|Overall Study||3
10871874|NCT01033032|12037610|FG002|NOT COMPLETED|Overall Study||0
10871875|NCT01033032|12037611|FG003|NOT COMPLETED|Overall Study||6
10871876|NCT01033032|12037612|FG004|NOT COMPLETED|Overall Study||63
11230001|NCT02018887|12422033|FG010|COMPLETED|Part C: Cohort 8 Overall||6
11230002|NCT02018887|12422023|FG000|NOT COMPLETED|Part C: Cohort 8 Overall||0
11230003|NCT02018887|12422024|FG001|NOT COMPLETED|Part C: Cohort 8 Overall||0
11230004|NCT02018887|12422025|FG002|NOT COMPLETED|Part C: Cohort 8 Overall||0
11230005|NCT02018887|12422026|FG003|NOT COMPLETED|Part C: Cohort 8 Overall||0
11230006|NCT02018887|12422027|FG004|NOT COMPLETED|Part C: Cohort 8 Overall||0
11230007|NCT02018887|12422028|FG005|NOT COMPLETED|Part C: Cohort 8 Overall||0
11230008|NCT02018887|12422029|FG006|NOT COMPLETED|Part C: Cohort 8 Overall||0
11230009|NCT02018887|12422030|FG007|NOT COMPLETED|Part C: Cohort 8 Overall||0
10871877|NCT00932737|12037625|FG000|STARTED|Overall Study||87
10871878|NCT00932737|12037626|FG001|STARTED|Overall Study||88
10871879|NCT00932737|12037625|FG000|COMPLETED|Overall Study||86
10871880|NCT00932737|12037626|FG001|COMPLETED|Overall Study||87
10871881|NCT00932737|12037625|FG000|NOT COMPLETED|Overall Study||1
10871882|NCT00932737|12037626|FG001|NOT COMPLETED|Overall Study||1
10871883|NCT00893516|12037634|FG000|STARTED|Overall Study||0
10871884|NCT00893516|12037635|FG001|STARTED|Overall Study||0
10871885|NCT00893516|12037634|FG000|COMPLETED|Overall Study||0
10871886|NCT00893516|12037635|FG001|COMPLETED|Overall Study||0
10871887|NCT00893516|12037634|FG000|NOT COMPLETED|Overall Study||0
11230010|NCT02018887|12422031|FG008|NOT COMPLETED|Part C: Cohort 8 Overall||3
11230011|NCT02018887|12422032|FG009|NOT COMPLETED|Part C: Cohort 8 Overall||3
11230012|NCT02018887|12422033|FG010|NOT COMPLETED|Part C: Cohort 8 Overall||1
10871888|NCT00893516|12037635|FG001|NOT COMPLETED|Overall Study||0
10871889|NCT00848757|12037643|FG000|STARTED|Overall Study||65
10871890|NCT00848757|12037644|FG001|STARTED|Overall Study||65
10871891|NCT00848757|12037643|FG000|COMPLETED|Overall Study||61
10871892|NCT00848757|12037644|FG001|COMPLETED|Overall Study||61
10871893|NCT00848757|12037643|FG000|NOT COMPLETED|Overall Study||4
10871894|NCT00848757|12037644|FG001|NOT COMPLETED|Overall Study||4
10871895|NCT00710710|12037652|FG000|STARTED|Overall Study||45
10871896|NCT00710710|12037653|FG001|STARTED|Overall Study||44
10871897|NCT00710710|12037652|FG000|Treated|Overall Study||43
10871898|NCT00710710|12037653|FG001|Treated|Overall Study||43
10871899|NCT00710710|12037652|FG000|COMPLETED|Overall Study||0
10871900|NCT00710710|12037653|FG001|COMPLETED|Overall Study||0
10871901|NCT00710710|12037652|FG000|NOT COMPLETED|Overall Study||45
10871902|NCT00710710|12037653|FG001|NOT COMPLETED|Overall Study||44
10871912|NCT00551616|12037677|FG000|STARTED|Overall Study||1104
10871913|NCT00551616|12037678|FG001|STARTED|Overall Study||1117
10871914|NCT00551616|12037677|FG000|COMPLETED|Overall Study||1056
10871915|NCT00551616|12037678|FG001|COMPLETED|Overall Study||1077
10871916|NCT00551616|12037677|FG000|NOT COMPLETED|Overall Study||48
10871917|NCT00551616|12037678|FG001|NOT COMPLETED|Overall Study||40
11111754|NCT01286454|12296105|FG009|STARTED|Part II- Sixth Intervention Period||0
11111755|NCT01286454|12296106|FG010|STARTED|Part II- Sixth Intervention Period||20
11111756|NCT01286454|12296096|FG000|COMPLETED|Part II- Sixth Intervention Period||0
11230013|NCT02019069|12422099|FG000|STARTED|Overall Study||11
11230014|NCT02019069|12422099|FG000|COMPLETED|Overall Study||11
11230015|NCT02019069|12422099|FG000|NOT COMPLETED|Overall Study||0
11230016|NCT02019108|12422105|FG000|STARTED|Overall Study||40
11230017|NCT02019108|12422106|FG001|STARTED|Overall Study||39
10871921|NCT00492050|12037688|FG000|STARTED|Overall Study||37
10871922|NCT00492050|12037688|FG000|Inadequate Response to First Two Cycles|Overall Study||25
11230018|NCT02019108|12422105|FG000|Baseline (Week 0)|Overall Study||40
11230019|NCT02019108|12422106|FG001|Baseline (Week 0)|Overall Study||39
11230020|NCT02019108|12422105|FG000|Follow-up (Week 17)|Overall Study||38
11230021|NCT02019108|12422106|FG001|Follow-up (Week 17)|Overall Study||36
10871923|NCT00492050|12037688|FG000|Inadequate Response to First 3 Cycles|Overall Study||12
10871924|NCT00492050|12037688|FG000|If Adequate Response to First Two Cycles-participants Proceed to Stem Cell Collection|Overall Study||30
10871925|NCT00492050|12037688|FG000|COMPLETED|Overall Study||28
10871926|NCT00492050|12037688|FG000|NOT COMPLETED|Overall Study||9
10871927|NCT00456261|12037694|FG000|STARTED|Combination Therapy||55
10871928|NCT00456261|12037695|FG001|STARTED|Combination Therapy||55
10871929|NCT00456261|12037694|FG000|COMPLETED|Combination Therapy||3
10871930|NCT00456261|12037695|FG001|COMPLETED|Combination Therapy||29
10871931|NCT00456261|12037694|FG000|NOT COMPLETED|Combination Therapy||52
10871932|NCT00456261|12037695|FG001|NOT COMPLETED|Combination Therapy||26
10871933|NCT00456261|12037694|FG000|STARTED|Maintenance Therapy||3
10871934|NCT00456261|12037695|FG001|STARTED|Maintenance Therapy||29
10871935|NCT00456261|12037694|FG000|COMPLETED|Maintenance Therapy||3
10871936|NCT00456261|12037695|FG001|COMPLETED|Maintenance Therapy||29
10871937|NCT00456261|12037694|FG000|NOT COMPLETED|Maintenance Therapy||0
10871938|NCT00456261|12037695|FG001|NOT COMPLETED|Maintenance Therapy||0
11111757|NCT01286454|12296097|FG001|COMPLETED|Part II- Sixth Intervention Period||0
11111758|NCT01286454|12296098|FG002|COMPLETED|Part II- Sixth Intervention Period||0
11111759|NCT01286454|12296099|FG003|COMPLETED|Part II- Sixth Intervention Period||0
11111760|NCT01286454|12296100|FG004|COMPLETED|Part II- Sixth Intervention Period||0
11111761|NCT01286454|12296101|FG005|COMPLETED|Part II- Sixth Intervention Period||0
11111762|NCT01286454|12296102|FG006|COMPLETED|Part II- Sixth Intervention Period||0
11111763|NCT01286454|12296103|FG007|COMPLETED|Part II- Sixth Intervention Period||0
11111764|NCT01286454|12296104|FG008|COMPLETED|Part II- Sixth Intervention Period||0
11111765|NCT01286454|12296105|FG009|COMPLETED|Part II- Sixth Intervention Period||0
11111766|NCT01286454|12296106|FG010|COMPLETED|Part II- Sixth Intervention Period||20
11111767|NCT01286454|12296096|FG000|NOT COMPLETED|Part II- Sixth Intervention Period||0
11111768|NCT01286454|12296097|FG001|NOT COMPLETED|Part II- Sixth Intervention Period||0
11111769|NCT01286454|12296098|FG002|NOT COMPLETED|Part II- Sixth Intervention Period||0
11111770|NCT01286454|12296099|FG003|NOT COMPLETED|Part II- Sixth Intervention Period||0
11111771|NCT01286454|12296100|FG004|NOT COMPLETED|Part II- Sixth Intervention Period||0
11111772|NCT01286454|12296101|FG005|NOT COMPLETED|Part II- Sixth Intervention Period||0
10871939|NCT00448630|12037701|FG000|STARTED|Overall Study||328
10871940|NCT00448630|12037701|FG000|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
10871941|NCT00448630|12037701|FG000|NOT COMPLETED|Overall Study||27
10871942|NCT00345345|12037718|FG000|STARTED|Overall Study||29
10871943|NCT00345345|12037718|FG000|COMPLETED|Overall Study||27
10871944|NCT00345345|12037718|FG000|NOT COMPLETED|Overall Study||2
11111773|NCT01286454|12296102|FG006|NOT COMPLETED|Part II- Sixth Intervention Period||0
11111774|NCT01286454|12296103|FG007|NOT COMPLETED|Part II- Sixth Intervention Period||0
11111775|NCT01286454|12296104|FG008|NOT COMPLETED|Part II- Sixth Intervention Period||0
11111776|NCT01286454|12296105|FG009|NOT COMPLETED|Part II- Sixth Intervention Period||0
11111777|NCT01286454|12296106|FG010|NOT COMPLETED|Part II- Sixth Intervention Period||0
11111778|NCT01286480|12296122|FG000|STARTED|Overall Study||32
11111779|NCT01286480|12296123|FG001|STARTED|Overall Study||34
11111780|NCT01286480|12296122|FG000|COMPLETED|Overall Study||27
11111781|NCT01286480|12296123|FG001|COMPLETED|Overall Study||31
11111782|NCT01286480|12296122|FG000|NOT COMPLETED|Overall Study||5
11111783|NCT01286480|12296123|FG001|NOT COMPLETED|Overall Study||3
11111784|NCT01286493|12296129|FG000|STARTED|Overall Study||33
10871957|NCT00085982|12037767|FG000|STARTED|Overall Study||11
10871958|NCT00085982|12037767|FG000|COMPLETED|Overall Study||5
10871959|NCT00085982|12037767|FG000|NOT COMPLETED|Overall Study||6
10871960|NCT00061945|12037773|FG000|STARTED|Registration Through Course 3||119
10871961|NCT00061945|12037774|FG001|STARTED|Registration Through Course 3||181
10871962|NCT00061945|12037773|FG000|COMPLETED|Registration Through Course 3||25
10871963|NCT00061945|12037774|FG001|COMPLETED|Registration Through Course 3||66
11111785|NCT01286493|12296129|FG000|COMPLETED|Overall Study||30
11111786|NCT01286493|12296129|FG000|NOT COMPLETED|Overall Study||3
11111787|NCT01286558|12296135|FG000|STARTED|Overall Study||112
11111788|NCT01286558|12296136|FG001|STARTED|Overall Study||113
11111789|NCT01286558|12296135|FG000|COMPLETED|Overall Study||111
11111790|NCT01286558|12296136|FG001|COMPLETED|Overall Study||111
11111791|NCT01286558|12296135|FG000|NOT COMPLETED|Overall Study||1
11111792|NCT01286558|12296136|FG001|NOT COMPLETED|Overall Study||2
11111793|NCT01286740|12296142|FG000|STARTED|Overall Study||50
11111794|NCT01286740|12296142|FG000|Enrolled and Treated|Overall Study||49
11111795|NCT01286740|12296142|FG000|Week 12 (Primary Endpoint)|Overall Study||49
11111796|NCT01286740|12296142|FG000|COMPLETED|Overall Study||48
11111797|NCT01286740|12296142|FG000|NOT COMPLETED|Overall Study||2
11111798|NCT01286753|12296148|FG000|STARTED|Overall Study||26
11111799|NCT01286753|12296149|FG001|STARTED|Overall Study||25
11111800|NCT01286753|12296148|FG000|COMPLETED|Overall Study||0
11111801|NCT01286753|12296149|FG001|COMPLETED|Overall Study||0
11111802|NCT01286753|12296148|FG000|NOT COMPLETED|Overall Study||26
11111803|NCT01286753|12296149|FG001|NOT COMPLETED|Overall Study||25
11111804|NCT01286779|12296156|FG000|STARTED|Overall Study||115
11111805|NCT01286779|12296156|FG000|COMPLETED|Overall Study||96
11111806|NCT01286779|12296156|FG000|NOT COMPLETED|Overall Study||19
11111807|NCT01286805|12296172|FG000|STARTED|Overall Study||41
11111808|NCT01286805|12296173|FG001|STARTED|Overall Study||42
11111809|NCT01286805|12296172|FG000|COMPLETED|Overall Study||41
11111810|NCT01286805|12296173|FG001|COMPLETED|Overall Study||41
11230022|NCT02019108|12422105|FG000|Retention (Week 21)|Overall Study||35
11230023|NCT02019108|12422106|FG001|Retention (Week 21)|Overall Study||32
11230024|NCT02019108|12422105|FG000|COMPLETED|Overall Study||35
11230025|NCT02019108|12422106|FG001|COMPLETED|Overall Study||32
11230026|NCT02019108|12422105|FG000|NOT COMPLETED|Overall Study||5
11230027|NCT02019108|12422106|FG001|NOT COMPLETED|Overall Study||7
11230028|NCT02019264|12422114|FG000|STARTED|Overall Study||6000
11230029|NCT02019264|12422115|FG001|STARTED|Overall Study||6000
11230030|NCT02019264|12422114|FG000|Safety Analysis Set|Overall Study||5992
11230031|NCT02019264|12422115|FG001|Safety Analysis Set|Overall Study||5995
11230032|NCT02019264|12422114|FG000|COMPLETED|Overall Study||5752
11230033|NCT02019264|12422115|FG001|COMPLETED|Overall Study||5793
11230034|NCT02019264|12422114|FG000|NOT COMPLETED|Overall Study||248
11230035|NCT02019264|12422115|FG001|NOT COMPLETED|Overall Study||207
11230036|NCT02019277|12422121|FG000|STARTED|Overall Study||50
11230037|NCT02019277|12422121|FG000|COMPLETED|Overall Study||38
11230038|NCT02019277|12422121|FG000|NOT COMPLETED|Overall Study||12
11230039|NCT02019420|12422127|FG000|STARTED|Overall Study||366
11230040|NCT02019420|12422128|FG001|STARTED|Overall Study||360
11230041|NCT02019420|12422127|FG000|Treated|Overall Study||361
11230042|NCT02019420|12422128|FG001|Treated|Overall Study||357
11230043|NCT02019420|12422127|FG000|COMPLETED|Overall Study||258
11230044|NCT02019420|12422128|FG001|COMPLETED|Overall Study||254
11230045|NCT02019420|12422127|FG000|NOT COMPLETED|Overall Study||108
11230046|NCT02019420|12422128|FG001|NOT COMPLETED|Overall Study||106
11230047|NCT02019472|12422137|FG000|STARTED|Overall Study||186
11230048|NCT02019472|12422138|FG001|STARTED|Overall Study||186
10871964|NCT00061945|12037773|FG000|NOT COMPLETED|Registration Through Course 3||94
10871965|NCT00061945|12037774|FG001|NOT COMPLETED|Registration Through Course 3||115
10871966|NCT00061945|12037773|FG000|STARTED|Course IV: Alemtuzumab||25
10871967|NCT00061945|12037774|FG001|STARTED|Course IV: Alemtuzumab||66
10871968|NCT00061945|12037773|FG000|COMPLETED|Course IV: Alemtuzumab||18
10871969|NCT00061945|12037774|FG001|COMPLETED|Course IV: Alemtuzumab||50
10871970|NCT00061945|12037773|FG000|NOT COMPLETED|Course IV: Alemtuzumab||7
10871971|NCT00061945|12037774|FG001|NOT COMPLETED|Course IV: Alemtuzumab||16
10871972|NCT04018612|12037786|FG000|STARTED|Overall Study||44
10871973|NCT04018612|12037787|FG001|STARTED|Overall Study||44
10871974|NCT04018612|12037788|FG002|STARTED|Overall Study||22
10871975|NCT04018612|12037786|FG000|COMPLETED|Overall Study||43
10871976|NCT04018612|12037787|FG001|COMPLETED|Overall Study||44
10871977|NCT04018612|12037788|FG002|COMPLETED|Overall Study||21
10871978|NCT04018612|12037786|FG000|NOT COMPLETED|Overall Study||1
10871979|NCT04018612|12037787|FG001|NOT COMPLETED|Overall Study||0
10871980|NCT04018612|12037788|FG002|NOT COMPLETED|Overall Study||1
10871981|NCT03976648|12037798|FG000|STARTED|Overall Study||21
10871982|NCT03976648|12037799|FG001|STARTED|Overall Study||10
10871983|NCT03976648|12037798|FG000|COMPLETED|Overall Study||0
10871984|NCT03976648|12037799|FG001|COMPLETED|Overall Study||0
10871985|NCT03976648|12037798|FG000|NOT COMPLETED|Overall Study||21
10871986|NCT03976648|12037799|FG001|NOT COMPLETED|Overall Study||10
10871987|NCT03944486|12037805|FG000|STARTED|Overall Study||24
10871988|NCT03944486|12037805|FG000|COMPLETED|Overall Study||12
10871989|NCT03944486|12037805|FG000|NOT COMPLETED|Overall Study||12
10871990|NCT03619902|12037809|FG000|STARTED|Overall Study||8
10871991|NCT03619902|12037809|FG000|COMPLETED|Overall Study||6
10871992|NCT03619902|12037809|FG000|NOT COMPLETED|Overall Study||2
10871993|NCT03617523|12037818|FG000|STARTED|Overall Study||30
11230049|NCT02019472|12422139|FG002|STARTED|Overall Study||187
11230050|NCT02019472|12422137|FG000|COMPLETED|Overall Study||149
11230051|NCT02019472|12422138|FG001|COMPLETED|Overall Study||134
11230052|NCT02019472|12422139|FG002|COMPLETED|Overall Study||145
11230053|NCT02019472|12422137|FG000|NOT COMPLETED|Overall Study||37
11230054|NCT02019472|12422138|FG001|NOT COMPLETED|Overall Study||52
11230055|NCT02019472|12422139|FG002|NOT COMPLETED|Overall Study||42
11230056|NCT02019550|12422153|FG000|STARTED|Treatment Period 1 (4 Weeks)||46
11230057|NCT02019550|12422154|FG001|STARTED|Treatment Period 1 (4 Weeks)||51
11230058|NCT02019550|12422153|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||46
10871994|NCT03617523|12037819|FG001|STARTED|Overall Study||30
10871995|NCT03617523|12037820|FG002|STARTED|Overall Study||61
10871996|NCT03617523|12037821|FG003|STARTED|Overall Study||59
10871997|NCT03617523|12037822|FG004|STARTED|Overall Study||60
10871998|NCT03617523|12037818|FG000|COMPLETED|Overall Study||30
10871999|NCT03617523|12037819|FG001|COMPLETED|Overall Study||30
10872000|NCT03617523|12037820|FG002|COMPLETED|Overall Study||61
10872001|NCT03617523|12037821|FG003|COMPLETED|Overall Study||59
10872002|NCT03617523|12037822|FG004|COMPLETED|Overall Study||60
10872003|NCT03617523|12037818|FG000|NOT COMPLETED|Overall Study||0
10872004|NCT03617523|12037819|FG001|NOT COMPLETED|Overall Study||0
10872005|NCT03617523|12037820|FG002|NOT COMPLETED|Overall Study||0
10872006|NCT03617523|12037821|FG003|NOT COMPLETED|Overall Study||0
10872007|NCT03617523|12037822|FG004|NOT COMPLETED|Overall Study||0
11111811|NCT01286805|12296172|FG000|NOT COMPLETED|Overall Study||0
11111812|NCT01286805|12296173|FG001|NOT COMPLETED|Overall Study||1
11111813|NCT01286818|12296179|FG000|STARTED|Overall Study||6
11111814|NCT01286818|12296179|FG000|Completed DLT Assessment Period|Overall Study||5
11111815|NCT01286818|12296179|FG000|COMPLETED|Overall Study||6
11111816|NCT01286818|12296179|FG000|NOT COMPLETED|Overall Study||0
11111817|NCT01286870|12296183|FG000|STARTED|Overall Study||11
10872008|NCT03546192|12037841|FG000|STARTED|Overall Study||60
10872009|NCT03546192|12037842|FG001|STARTED|Overall Study||60
10872010|NCT03546192|12037841|FG000|COMPLETED|Overall Study||60
10872011|NCT03546192|12037842|FG001|COMPLETED|Overall Study||60
10872012|NCT03546192|12037841|FG000|NOT COMPLETED|Overall Study||0
10872013|NCT03546192|12037842|FG001|NOT COMPLETED|Overall Study||0
10872014|NCT03517449|12037850|FG000|STARTED|Overall Study||411
10872015|NCT03517449|12037851|FG001|STARTED|Overall Study||416
10872016|NCT03517449|12037850|FG000|Treated|Overall Study||406
10872017|NCT03517449|12037851|FG001|Treated|Overall Study||388
10872018|NCT03517449|12037850|FG000|COMPLETED|Overall Study||0
10872019|NCT03517449|12037851|FG001|COMPLETED|Overall Study||0
10872020|NCT03517449|12037850|FG000|NOT COMPLETED|Overall Study||411
10872021|NCT03517449|12037851|FG001|NOT COMPLETED|Overall Study||416
10872022|NCT03470922|12037859|FG000|STARTED|Overall Study||355
10872023|NCT03470922|12037860|FG001|STARTED|Overall Study||359
10872024|NCT03470922|12037859|FG000|COMPLETED|Overall Study||237
10872025|NCT03470922|12037860|FG001|COMPLETED|Overall Study||227
10872026|NCT03470922|12037859|FG000|NOT COMPLETED|Overall Study||118
10872027|NCT03470922|12037860|FG001|NOT COMPLETED|Overall Study||132
10872028|NCT03308825|12037870|FG000|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
10872029|NCT03308825|12037871|FG001|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
10872030|NCT03308825|12037872|FG002|STARTED|Overall Study||60
10872031|NCT03308825|12037873|FG003|STARTED|Overall Study||60
10872032|NCT03308825|12037870|FG000|COMPLETED|Overall Study||57
10872033|NCT03308825|12037871|FG001|COMPLETED|Overall Study||57
10872034|NCT03308825|12037872|FG002|COMPLETED|Overall Study||59
10872035|NCT03308825|12037873|FG003|COMPLETED|Overall Study||60
10872036|NCT03308825|12037870|FG000|NOT COMPLETED|Overall Study||2
10872037|NCT03308825|12037871|FG001|NOT COMPLETED|Overall Study||4
10872038|NCT03308825|12037872|FG002|NOT COMPLETED|Overall Study||1
10872039|NCT03308825|12037873|FG003|NOT COMPLETED|Overall Study||0
10872040|NCT02915302|12037889|FG000|STARTED|Overall Study||955
10872041|NCT02915302|12037890|FG001|STARTED|Overall Study||995
10872042|NCT02915302|12037889|FG000|Vaccinated (Safety Analysis Set)|Overall Study||949
10872043|NCT02915302|12037890|FG001|Vaccinated (Safety Analysis Set)|Overall Study||992
10872044|NCT02915302|12037889|FG000|COMPLETED|Overall Study||890
10872045|NCT02915302|12037890|FG001|COMPLETED|Overall Study||917
10872046|NCT02915302|12037889|FG000|NOT COMPLETED|Overall Study||65
10872047|NCT02915302|12037890|FG001|NOT COMPLETED|Overall Study||78
10872048|NCT02908269|12037899|FG000|STARTED|Overall Study||60
10872049|NCT02908269|12037900|FG001|STARTED|Overall Study||60
10872050|NCT02908269|12037901|FG002|STARTED|Overall Study||60
10872051|NCT02908269|12037899|FG000|COMPLETED|Overall Study||60
10872052|NCT02908269|12037900|FG001|COMPLETED|Overall Study||60
10872053|NCT02908269|12037901|FG002|COMPLETED|Overall Study||60
10872054|NCT02908269|12037899|FG000|NOT COMPLETED|Overall Study||0
10872055|NCT02908269|12037900|FG001|NOT COMPLETED|Overall Study||0
10872056|NCT02908269|12037901|FG002|NOT COMPLETED|Overall Study||0
10872057|NCT02744040|12037913|FG000|STARTED|Overall Study||28
10872058|NCT02744040|12037914|FG001|STARTED|Overall Study||51
10872059|NCT02744040|12037915|FG002|STARTED|Overall Study||72
10872060|NCT02744040|12037913|FG000|COMPLETED|Overall Study||22
10872061|NCT02744040|12037914|FG001|COMPLETED|Overall Study||40
10872062|NCT02744040|12037915|FG002|COMPLETED|Overall Study||50
10872063|NCT02744040|12037913|FG000|NOT COMPLETED|Overall Study||6
10872064|NCT02744040|12037914|FG001|NOT COMPLETED|Overall Study||11
10872065|NCT02744040|12037915|FG002|NOT COMPLETED|Overall Study||22
10872066|NCT02698826|12037923|FG000|STARTED|Overall Study||16
10872067|NCT02698826|12037923|FG000|COMPLETED|Overall Study||2
10872068|NCT02698826|12037923|FG000|NOT COMPLETED|Overall Study||14
10872069|NCT02617589|12037931|FG000|STARTED|All Randomized||280
10872070|NCT02617589|12037932|FG001|STARTED|All Randomized||280
10872071|NCT02617589|12037931|FG000|COMPLETED|All Randomized||278
10872072|NCT02617589|12037932|FG001|COMPLETED|All Randomized||275
10872073|NCT02617589|12037931|FG000|NOT COMPLETED|All Randomized||2
10872074|NCT02617589|12037932|FG001|NOT COMPLETED|All Randomized||5
10872075|NCT02617589|12037931|FG000|STARTED|Treatment Period||278
10872076|NCT02617589|12037932|FG001|STARTED|Treatment Period||275
10872077|NCT02617589|12037931|FG000|COMPLETED|Treatment Period||4
10872078|NCT02617589|12037932|FG001|COMPLETED|Treatment Period||1
10872079|NCT02617589|12037931|FG000|NOT COMPLETED|Treatment Period||274
10872080|NCT02617589|12037932|FG001|NOT COMPLETED|Treatment Period||274
10872081|NCT02614859|12037940|FG000|STARTED|Overall Study||9
10872082|NCT02614859|12037941|FG001|STARTED|Overall Study||20
10872083|NCT02614859|12037940|FG000|COMPLETED|Overall Study||9
10872084|NCT02614859|12037941|FG001|COMPLETED|Overall Study||19
10872085|NCT02614859|12037940|FG000|NOT COMPLETED|Overall Study||0
10872086|NCT02614859|12037941|FG001|NOT COMPLETED|Overall Study||1
11111818|NCT01286870|12296183|FG000|COMPLETED|Overall Study||11
11111819|NCT01286870|12296183|FG000|NOT COMPLETED|Overall Study||0
11111820|NCT01286987|12296202|FG000|STARTED|Part 1: Dose Escalation||3
11111821|NCT01286987|12296203|FG001|STARTED|Part 1: Dose Escalation||3
11111822|NCT01286987|12296204|FG002|STARTED|Part 1: Dose Escalation||3
11111823|NCT01286987|12296205|FG003|STARTED|Part 1: Dose Escalation||3
11111824|NCT01286987|12296206|FG004|STARTED|Part 1: Dose Escalation||3
11111825|NCT01286987|12296207|FG005|STARTED|Part 1: Dose Escalation||6
11111826|NCT01286987|12296208|FG006|STARTED|Part 1: Dose Escalation||6
11111827|NCT01286987|12296209|FG007|STARTED|Part 1: Dose Escalation||6
11111828|NCT01286987|12296210|FG008|STARTED|Part 1: Dose Escalation||6
11111829|NCT01286987|12296211|FG009|STARTED|Part 1: Dose Escalation||0
10872099|NCT02519348|12037973|FG000|STARTED|Overall Study||40
10872100|NCT02519348|12037974|FG001|STARTED|Overall Study||104
10872101|NCT02519348|12037975|FG002|STARTED|Overall Study||75
10872102|NCT02519348|12037976|FG003|STARTED|Overall Study||69
10872103|NCT02519348|12037977|FG004|STARTED|Overall Study||84
10872104|NCT02519348|12037978|FG005|STARTED|Overall Study||47
10872105|NCT02519348|12037979|FG006|STARTED|Overall Study||3
10872106|NCT02519348|12037980|FG007|STARTED|Overall Study||5
10872107|NCT02519348|12037981|FG008|STARTED|Overall Study||6
10872108|NCT02519348|12037973|FG000|Treated|Overall Study||40
10872109|NCT02519348|12037974|FG001|Treated|Overall Study||101
10872110|NCT02519348|12037975|FG002|Treated|Overall Study||74
10872111|NCT02519348|12037976|FG003|Treated|Overall Study||69
10872112|NCT02519348|12037977|FG004|Treated|Overall Study||82
10872113|NCT02519348|12037978|FG005|Treated|Overall Study||47
10872114|NCT02519348|12037979|FG006|Treated|Overall Study||3
10872115|NCT02519348|12037980|FG007|Treated|Overall Study||5
10872116|NCT02519348|12037981|FG008|Treated|Overall Study||5
10872117|NCT02519348|12037973|FG000|COMPLETED|Overall Study||0
10872118|NCT02519348|12037974|FG001|COMPLETED|Overall Study||0
10872119|NCT02519348|12037975|FG002|COMPLETED|Overall Study||0
10872120|NCT02519348|12037976|FG003|COMPLETED|Overall Study||0
10872121|NCT02519348|12037977|FG004|COMPLETED|Overall Study||0
10872122|NCT02519348|12037978|FG005|COMPLETED|Overall Study||0
10872123|NCT02519348|12037979|FG006|COMPLETED|Overall Study||0
10872124|NCT02519348|12037980|FG007|COMPLETED|Overall Study||0
10872125|NCT02519348|12037981|FG008|COMPLETED|Overall Study||0
10872126|NCT02519348|12037973|FG000|NOT COMPLETED|Overall Study||40
10872127|NCT02519348|12037974|FG001|NOT COMPLETED|Overall Study||104
10872128|NCT02519348|12037975|FG002|NOT COMPLETED|Overall Study||75
10872129|NCT02519348|12037976|FG003|NOT COMPLETED|Overall Study||69
10872130|NCT02519348|12037977|FG004|NOT COMPLETED|Overall Study||84
10872131|NCT02519348|12037978|FG005|NOT COMPLETED|Overall Study||47
10872132|NCT02519348|12037979|FG006|NOT COMPLETED|Overall Study||3
10872133|NCT02519348|12037980|FG007|NOT COMPLETED|Overall Study||5
10872134|NCT02519348|12037981|FG008|NOT COMPLETED|Overall Study||6
11111830|NCT01286987|12296212|FG010|STARTED|Part 1: Dose Escalation||0
11111831|NCT01286987|12296213|FG011|STARTED|Part 1: Dose Escalation||0
11111832|NCT01286987|12296214|FG012|STARTED|Part 1: Dose Escalation||0
11111833|NCT01286987|12296215|FG013|STARTED|Part 1: Dose Escalation||0
11111834|NCT01286987|12296216|FG014|STARTED|Part 1: Dose Escalation||0
11111835|NCT01286987|12296202|FG000|Colorectal Cancer|Part 1: Dose Escalation||1
11111836|NCT01286987|12296203|FG001|Colorectal Cancer|Part 1: Dose Escalation||0
11111837|NCT01286987|12296204|FG002|Colorectal Cancer|Part 1: Dose Escalation||1
11111838|NCT01286987|12296205|FG003|Colorectal Cancer|Part 1: Dose Escalation||0
11111839|NCT01286987|12296206|FG004|Colorectal Cancer|Part 1: Dose Escalation||0
10872135|NCT02429414|12038004|FG000|STARTED|Overall Study||42
10872136|NCT02429414|12038005|FG001|STARTED|Overall Study||38
10872137|NCT02429414|12038004|FG000|COMPLETED|Overall Study||42
10872138|NCT02429414|12038005|FG001|COMPLETED|Overall Study||37
10872139|NCT02429414|12038004|FG000|NOT COMPLETED|Overall Study||0
10872140|NCT02429414|12038005|FG001|NOT COMPLETED|Overall Study||1
10872141|NCT02267603|12038011|FG000|STARTED|Overall Study||50
10872142|NCT02267603|12038011|FG000|COMPLETED|Overall Study||6
10872143|NCT02267603|12038011|FG000|NOT COMPLETED|Overall Study||44
10872144|NCT02258659|12038015|FG000|STARTED|Overall Study||62
10872145|NCT02258659|12038015|FG000|COMPLETED|Overall Study||61
10872146|NCT02258659|12038015|FG000|NOT COMPLETED|Overall Study||1
10872147|NCT02111850|12038030|FG000|STARTED|Phase 1 Dose Escalation||1
10872148|NCT02111850|12038031|FG001|STARTED|Phase 1 Dose Escalation||1
10872149|NCT02111850|12038032|FG002|STARTED|Phase 1 Dose Escalation||1
10872150|NCT02111850|12038033|FG003|STARTED|Phase 1 Dose Escalation||1
10872151|NCT02111850|12038034|FG004|STARTED|Phase 1 Dose Escalation||2
10872152|NCT02111850|12038035|FG005|STARTED|Phase 1 Dose Escalation||1
10872153|NCT02111850|12038036|FG006|STARTED|Phase 1 Dose Escalation||1
10872154|NCT02111850|12038037|FG007|STARTED|Phase 1 Dose Escalation||1
11111840|NCT01286987|12296207|FG005|Colorectal Cancer|Part 1: Dose Escalation||0
11111841|NCT01286987|12296208|FG006|Colorectal Cancer|Part 1: Dose Escalation||0
11111842|NCT01286987|12296209|FG007|Colorectal Cancer|Part 1: Dose Escalation||0
11111843|NCT01286987|12296210|FG008|Colorectal Cancer|Part 1: Dose Escalation||0
11111844|NCT01286987|12296211|FG009|Colorectal Cancer|Part 1: Dose Escalation||0
11111845|NCT01286987|12296212|FG010|Colorectal Cancer|Part 1: Dose Escalation||0
11111846|NCT01286987|12296213|FG011|Colorectal Cancer|Part 1: Dose Escalation||0
11111847|NCT01286987|12296214|FG012|Colorectal Cancer|Part 1: Dose Escalation||0
11111848|NCT01286987|12296215|FG013|Colorectal Cancer|Part 1: Dose Escalation||0
11111849|NCT01286987|12296216|FG014|Colorectal Cancer|Part 1: Dose Escalation||0
11111850|NCT01286987|12296202|FG000|Prostate Cancer|Part 1: Dose Escalation||0
11111851|NCT01286987|12296203|FG001|Prostate Cancer|Part 1: Dose Escalation||0
11111852|NCT01286987|12296204|FG002|Prostate Cancer|Part 1: Dose Escalation||0
11111853|NCT01286987|12296205|FG003|Prostate Cancer|Part 1: Dose Escalation||0
11111854|NCT01286987|12296206|FG004|Prostate Cancer|Part 1: Dose Escalation||0
11111855|NCT01286987|12296207|FG005|Prostate Cancer|Part 1: Dose Escalation||1
11230059|NCT02019550|12422154|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||50
11230060|NCT02019550|12422153|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
11230061|NCT02019550|12422154|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
11230062|NCT02019550|12422153|FG000|STARTED|Treatment Period 2 (4 Weeks)||46
11230063|NCT02019550|12422154|FG001|STARTED|Treatment Period 2 (4 Weeks)||50
11230064|NCT02019550|12422153|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||46
11230065|NCT02019550|12422154|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||50
11230066|NCT02019550|12422153|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
11230067|NCT02019550|12422154|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
11230068|NCT02019563|12422164|FG000|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
11230069|NCT02019563|12422165|FG001|STARTED|Overall Study|72 incisors were treated in the RCT group|30
11230070|NCT02019563|12422164|FG000|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
11230071|NCT02019563|12422165|FG001|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
11230072|NCT02019563|12422164|FG000|NOT COMPLETED|Overall Study||0
11230073|NCT02019563|12422165|FG001|NOT COMPLETED|Overall Study||0
11230074|NCT02019602|12422175|FG000|STARTED|Screening Period||21
11230075|NCT02019602|12422176|FG001|STARTED|Screening Period||16
11230076|NCT02019602|12422175|FG000|COMPLETED|Screening Period||16
11230077|NCT02019602|12422176|FG001|COMPLETED|Screening Period||16
11230078|NCT02019602|12422175|FG000|NOT COMPLETED|Screening Period||5
11230079|NCT02019602|12422176|FG001|NOT COMPLETED|Screening Period||0
11230080|NCT02019602|12422175|FG000|STARTED|Sampling Period||16
11355299|NCT03078556|12552138|FG002|STARTED|Treatment Period 2 (4 Days)||37
11355300|NCT03078556|12552139|FG003|STARTED|Treatment Period 2 (4 Days)||37
11355301|NCT03078556|12552136|FG000|COMPLETED|Treatment Period 2 (4 Days)||37
11355302|NCT03078556|12552137|FG001|COMPLETED|Treatment Period 2 (4 Days)||36
11355303|NCT03078556|12552138|FG002|COMPLETED|Treatment Period 2 (4 Days)||37
11355304|NCT03078556|12552139|FG003|COMPLETED|Treatment Period 2 (4 Days)||37
11355305|NCT03078556|12552136|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11355306|NCT03078556|12552137|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11355307|NCT03078556|12552138|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11355308|NCT03078556|12552139|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
11355309|NCT03078556|12552136|FG000|STARTED|Washout Period 2 (7 Days)||9
11355310|NCT03078556|12552137|FG001|STARTED|Washout Period 2 (7 Days)||7
11355311|NCT03078556|12552138|FG002|STARTED|Washout Period 2 (7 Days)||7
11355312|NCT03078556|12552139|FG003|STARTED|Washout Period 2 (7 Days)||9
11355313|NCT03078556|12552136|FG000|COMPLETED|Washout Period 2 (7 Days)||9
11355314|NCT03078556|12552137|FG001|COMPLETED|Washout Period 2 (7 Days)||7
11355315|NCT03078556|12552138|FG002|COMPLETED|Washout Period 2 (7 Days)||7
11230081|NCT02019602|12422176|FG001|STARTED|Sampling Period||16
10872155|NCT02111850|12038038|FG008|STARTED|Phase 1 Dose Escalation||6
11230082|NCT02019602|12422175|FG000|COMPLETED|Sampling Period||16
11230083|NCT02019602|12422176|FG001|COMPLETED|Sampling Period||16
11230084|NCT02019602|12422175|FG000|NOT COMPLETED|Sampling Period||0
11230085|NCT02019602|12422176|FG001|NOT COMPLETED|Sampling Period||0
11230086|NCT02019667|12422183|FG000|STARTED|First Intervention (6 Months)||10
10872156|NCT02111850|12038039|FG009|STARTED|Phase 1 Dose Escalation||0
10872157|NCT02111850|12038040|FG010|STARTED|Phase 1 Dose Escalation||0
10872158|NCT02111850|12038030|FG000|COMPLETED|Phase 1 Dose Escalation||1
10872159|NCT02111850|12038031|FG001|COMPLETED|Phase 1 Dose Escalation||1
10872160|NCT02111850|12038032|FG002|COMPLETED|Phase 1 Dose Escalation||1
10872161|NCT02111850|12038033|FG003|COMPLETED|Phase 1 Dose Escalation||1
10872162|NCT02111850|12038034|FG004|COMPLETED|Phase 1 Dose Escalation||1
10872163|NCT02111850|12038035|FG005|COMPLETED|Phase 1 Dose Escalation||1
10872164|NCT02111850|12038036|FG006|COMPLETED|Phase 1 Dose Escalation||1
10872165|NCT02111850|12038037|FG007|COMPLETED|Phase 1 Dose Escalation||1
10872166|NCT02111850|12038038|FG008|COMPLETED|Phase 1 Dose Escalation||6
10872167|NCT02111850|12038039|FG009|COMPLETED|Phase 1 Dose Escalation||0
10872168|NCT02111850|12038040|FG010|COMPLETED|Phase 1 Dose Escalation||0
10872169|NCT02111850|12038030|FG000|NOT COMPLETED|Phase 1 Dose Escalation||0
10872170|NCT02111850|12038031|FG001|NOT COMPLETED|Phase 1 Dose Escalation||0
10872171|NCT02111850|12038032|FG002|NOT COMPLETED|Phase 1 Dose Escalation||0
10872172|NCT02111850|12038033|FG003|NOT COMPLETED|Phase 1 Dose Escalation||0
10872173|NCT02111850|12038034|FG004|NOT COMPLETED|Phase 1 Dose Escalation||1
10872174|NCT02111850|12038035|FG005|NOT COMPLETED|Phase 1 Dose Escalation||0
10872175|NCT02111850|12038036|FG006|NOT COMPLETED|Phase 1 Dose Escalation||0
10872176|NCT02111850|12038037|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0
10872177|NCT02111850|12038038|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0
10872178|NCT02111850|12038039|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0
10872179|NCT02111850|12038040|FG010|NOT COMPLETED|Phase 1 Dose Escalation||0
10872180|NCT02111850|12038030|FG000|STARTED|Phase 2 Maximum Tolerated Dose||0
10872181|NCT02111850|12038031|FG001|STARTED|Phase 2 Maximum Tolerated Dose||0
10872182|NCT02111850|12038032|FG002|STARTED|Phase 2 Maximum Tolerated Dose||0
10872183|NCT02111850|12038033|FG003|STARTED|Phase 2 Maximum Tolerated Dose||0
10872184|NCT02111850|12038034|FG004|STARTED|Phase 2 Maximum Tolerated Dose||0
10872185|NCT02111850|12038035|FG005|STARTED|Phase 2 Maximum Tolerated Dose||0
10872186|NCT02111850|12038036|FG006|STARTED|Phase 2 Maximum Tolerated Dose||0
10872187|NCT02111850|12038037|FG007|STARTED|Phase 2 Maximum Tolerated Dose||0
10872188|NCT02111850|12038038|FG008|STARTED|Phase 2 Maximum Tolerated Dose||0
10872189|NCT02111850|12038039|FG009|STARTED|Phase 2 Maximum Tolerated Dose||5
10872190|NCT02111850|12038040|FG010|STARTED|Phase 2 Maximum Tolerated Dose||1
10872191|NCT02111850|12038030|FG000|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872192|NCT02111850|12038031|FG001|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872193|NCT02111850|12038032|FG002|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872194|NCT02111850|12038033|FG003|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872195|NCT02111850|12038034|FG004|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872196|NCT02111850|12038035|FG005|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872197|NCT02111850|12038036|FG006|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872198|NCT02111850|12038037|FG007|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872199|NCT02111850|12038038|FG008|COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872200|NCT02111850|12038039|FG009|COMPLETED|Phase 2 Maximum Tolerated Dose||5
10872201|NCT02111850|12038040|FG010|COMPLETED|Phase 2 Maximum Tolerated Dose||1
10872202|NCT02111850|12038030|FG000|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872203|NCT02111850|12038031|FG001|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872204|NCT02111850|12038032|FG002|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872205|NCT02111850|12038033|FG003|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872206|NCT02111850|12038034|FG004|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872207|NCT02111850|12038035|FG005|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872208|NCT02111850|12038036|FG006|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872209|NCT02111850|12038037|FG007|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872210|NCT02111850|12038038|FG008|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872211|NCT02111850|12038039|FG009|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872212|NCT02111850|12038040|FG010|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
10872213|NCT01983553|12038068|FG000|STARTED|Overall Study||2131
10872214|NCT01983553|12038069|FG001|STARTED|Overall Study||1072
10872215|NCT01983553|12038068|FG000|COMPLETED|Overall Study||2131
10872216|NCT01983553|12038069|FG001|COMPLETED|Overall Study||1072
10872217|NCT01983553|12038068|FG000|NOT COMPLETED|Overall Study||0
10872218|NCT01983553|12038069|FG001|NOT COMPLETED|Overall Study||0
10872219|NCT01760291|12038075|FG000|STARTED|Overall Study||576
10872220|NCT01760291|12038075|FG000|COMPLETED|Overall Study||340
10872221|NCT01760291|12038075|FG000|NOT COMPLETED|Overall Study||236
10872222|NCT01483027|12038081|FG000|STARTED|Overall Study||215
10872223|NCT01483027|12038082|FG001|STARTED|Overall Study||213
10872224|NCT01483027|12038081|FG000|COMPLETED|Overall Study||169
11230087|NCT02019667|12422184|FG001|STARTED|First Intervention (6 Months)||9
11230088|NCT02019667|12422183|FG000|COMPLETED|First Intervention (6 Months)||10
11230089|NCT02019667|12422184|FG001|COMPLETED|First Intervention (6 Months)||8
11230090|NCT02019667|12422183|FG000|NOT COMPLETED|First Intervention (6 Months)||0
11230091|NCT02019667|12422184|FG001|NOT COMPLETED|First Intervention (6 Months)||1
11230092|NCT02019667|12422183|FG000|STARTED|Washout Period (9 Weeks)||10
11230093|NCT02019667|12422184|FG001|STARTED|Washout Period (9 Weeks)||8
11230094|NCT02019667|12422183|FG000|COMPLETED|Washout Period (9 Weeks)||10
11230095|NCT02019667|12422184|FG001|COMPLETED|Washout Period (9 Weeks)||8
10872225|NCT01483027|12038082|FG001|COMPLETED|Overall Study||153
11230096|NCT02019667|12422183|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0
11230097|NCT02019667|12422184|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0
10872226|NCT01483027|12038081|FG000|NOT COMPLETED|Overall Study||46
10872227|NCT01483027|12038082|FG001|NOT COMPLETED|Overall Study||60
10872228|NCT01472562|12038088|FG000|STARTED|Induction Phase (Week 1- 48)||38
10872229|NCT01472562|12038088|FG000|COMPLETED|Induction Phase (Week 1- 48)||27
10872230|NCT01472562|12038088|FG000|NOT COMPLETED|Induction Phase (Week 1- 48)||11
10872231|NCT01472562|12038088|FG000|STARTED|Maintenance Phase (Week 49 to PD)||27
10872232|NCT01472562|12038088|FG000|COMPLETED|Maintenance Phase (Week 49 to PD)||4
10872233|NCT01472562|12038088|FG000|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
10872234|NCT01379781|12038094|FG000|STARTED|Overall Study||27
10872235|NCT01379781|12038095|FG001|STARTED|Overall Study||27
10872236|NCT01379781|12038094|FG000|COMPLETED|Overall Study||16
10872237|NCT01379781|12038095|FG001|COMPLETED|Overall Study||19
10872238|NCT01379781|12038094|FG000|NOT COMPLETED|Overall Study||11
10872239|NCT01379781|12038095|FG001|NOT COMPLETED|Overall Study||8
10872240|NCT00135200|12038101|FG000|STARTED|Overall Study||16
10872241|NCT00135200|12038101|FG000|COMPLETED|Overall Study||16
10872242|NCT00135200|12038101|FG000|NOT COMPLETED|Overall Study||0
10872243|NCT02513394|12038107|FG000|STARTED|Overall Study||2896
10872244|NCT02513394|12038108|FG001|STARTED|Overall Study||2900
10872245|NCT02513394|12038107|FG000|COMPLETED|Overall Study||2884
10872246|NCT02513394|12038108|FG001|COMPLETED|Overall Study||2877
10872247|NCT02513394|12038107|FG000|NOT COMPLETED|Overall Study||12
10872248|NCT02513394|12038108|FG001|NOT COMPLETED|Overall Study||23
10872249|NCT02498132|12038117|FG000|STARTED|Overall Study||24
10872250|NCT02498132|12038118|FG001|STARTED|Overall Study||19
10872251|NCT02498132|12038119|FG002|STARTED|Overall Study||9
10872252|NCT02498132|12038117|FG000|COMPLETED|Overall Study||22
10872253|NCT02498132|12038118|FG001|COMPLETED|Overall Study||18
10872254|NCT02498132|12038119|FG002|COMPLETED|Overall Study||9
10872255|NCT02498132|12038117|FG000|NOT COMPLETED|Overall Study||2
10872256|NCT02498132|12038118|FG001|NOT COMPLETED|Overall Study||1
10872257|NCT02498132|12038119|FG002|NOT COMPLETED|Overall Study||0
10872258|NCT02450760|12038129|FG000|STARTED|Overall Study||15
10872259|NCT02450760|12038130|FG001|STARTED|Overall Study||18
10872260|NCT02450760|12038129|FG000|COMPLETED|Overall Study||15
10872261|NCT02450760|12038130|FG001|COMPLETED|Overall Study||18
10872262|NCT02450760|12038129|FG000|NOT COMPLETED|Overall Study||0
10872263|NCT02450760|12038130|FG001|NOT COMPLETED|Overall Study||0
10872264|NCT02445339|12038143|FG000|STARTED|Overall Study||25
10872265|NCT02445339|12038144|FG001|STARTED|Overall Study||25
10872266|NCT02445339|12038143|FG000|COMPLETED|Overall Study||13
10872267|NCT02445339|12038144|FG001|COMPLETED|Overall Study||10
10872268|NCT02445339|12038143|FG000|NOT COMPLETED|Overall Study||12
10872269|NCT02445339|12038144|FG001|NOT COMPLETED|Overall Study||15
10872270|NCT03618056|12038150|FG000|STARTED|Overall Study||1
10872271|NCT03618056|12038150|FG000|COMPLETED|Overall Study||1
10872272|NCT03618056|12038150|FG000|NOT COMPLETED|Overall Study||0
10872273|NCT03503617|12038156|FG000|STARTED|Overall Study||14
10872274|NCT03503617|12038157|FG001|STARTED|Overall Study||13
10872275|NCT03503617|12038156|FG000|COMPLETED|Overall Study||14
10872276|NCT03503617|12038157|FG001|COMPLETED|Overall Study||10
10872277|NCT03503617|12038156|FG000|NOT COMPLETED|Overall Study||0
11230098|NCT02019667|12422183|FG000|STARTED|2nd Intervention (6 Months)||10
11230099|NCT02019667|12422184|FG001|STARTED|2nd Intervention (6 Months)||8
11230100|NCT02019667|12422183|FG000|COMPLETED|2nd Intervention (6 Months)||10
11230101|NCT02019667|12422184|FG001|COMPLETED|2nd Intervention (6 Months)||6
11230102|NCT02019667|12422183|FG000|NOT COMPLETED|2nd Intervention (6 Months)||0
11230103|NCT02019667|12422184|FG001|NOT COMPLETED|2nd Intervention (6 Months)||2
11230104|NCT02019667|12422183|FG000|STARTED|Washout Period (9 Weeks)||10
11230105|NCT02019667|12422184|FG001|STARTED|Washout Period (9 Weeks)||6
11230106|NCT02019667|12422183|FG000|COMPLETED|Washout Period (9 Weeks)||10
11230107|NCT02019667|12422184|FG001|COMPLETED|Washout Period (9 Weeks)||6
11230108|NCT02019667|12422183|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0
11230109|NCT02019667|12422184|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0
11230110|NCT02019719|12422197|FG000|STARTED|Overall Study||19
11230111|NCT02019719|12422198|FG001|STARTED|Overall Study||19
11230112|NCT02019719|12422199|FG002|STARTED|Overall Study||20
11230113|NCT02019719|12422200|FG003|STARTED|Overall Study||19
11230114|NCT02019719|12422201|FG004|STARTED|Overall Study||20
11230115|NCT02019719|12422197|FG000|COMPLETED|Overall Study||13
11230116|NCT02019719|12422198|FG001|COMPLETED|Overall Study||18
11230117|NCT02019719|12422199|FG002|COMPLETED|Overall Study||20
11230118|NCT02019719|12422200|FG003|COMPLETED|Overall Study||17
11230119|NCT02019719|12422201|FG004|COMPLETED|Overall Study||18
11230120|NCT02019719|12422197|FG000|NOT COMPLETED|Overall Study||6
11230121|NCT02019719|12422198|FG001|NOT COMPLETED|Overall Study||1
11230122|NCT02019719|12422199|FG002|NOT COMPLETED|Overall Study||0
11230123|NCT02019719|12422200|FG003|NOT COMPLETED|Overall Study||2
11230124|NCT02019719|12422201|FG004|NOT COMPLETED|Overall Study||2
11230125|NCT02019758|12422222|FG000|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65
11230126|NCT02019758|12422223|FG001|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64
11230127|NCT02019758|12422222|FG000|Received Intervention|Overall Study||64
11230128|NCT02019758|12422223|FG001|Received Intervention|Overall Study||63
11230129|NCT02019758|12422222|FG000|Did Not Receive Intervention|Overall Study||1
11230130|NCT02019758|12422223|FG001|Did Not Receive Intervention|Overall Study||1
11230131|NCT02019758|12422222|FG000|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
10872278|NCT03503617|12038157|FG001|NOT COMPLETED|Overall Study||3
10872279|NCT03298867|12038165|FG000|STARTED|Double-Masked 24-Week Treatment Period||42
10872280|NCT03298867|12038166|FG001|STARTED|Double-Masked 24-Week Treatment Period||41
10872281|NCT03298867|12038165|FG000|COMPLETED|Double-Masked 24-Week Treatment Period|36 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|40
10872282|NCT03298867|12038166|FG001|COMPLETED|Double-Masked 24-Week Treatment Period|3 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|39
10872283|NCT03298867|12038165|FG000|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2
10872284|NCT03298867|12038166|FG001|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2
10872285|NCT03298867|12038165|FG000|STARTED|48-Week Follow-Up Period (Weeks 24-72)||4
10872286|NCT03298867|12038166|FG001|STARTED|48-Week Follow-Up Period (Weeks 24-72)||36
10872287|NCT03298867|12038165|FG000|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||3
10872288|NCT03298867|12038166|FG001|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||20
10872289|NCT03298867|12038165|FG000|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||1
10872290|NCT03298867|12038166|FG001|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||16
10872291|NCT03298867|12038165|FG000|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||3
10872292|NCT03298867|12038166|FG001|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||20
10872293|NCT03298867|12038165|FG000|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||3
10872294|NCT03298867|12038166|FG001|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||19
10872295|NCT03298867|12038165|FG000|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||0
10872296|NCT03298867|12038166|FG001|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||1
10872297|NCT03220581|12038174|FG000|STARTED|Overall Study||28
10872298|NCT03220581|12038175|FG001|STARTED|Overall Study||32
10872299|NCT03220581|12038174|FG000|COMPLETED|Overall Study||25
10872300|NCT03220581|12038175|FG001|COMPLETED|Overall Study||25
10872301|NCT03220581|12038174|FG000|NOT COMPLETED|Overall Study||3
10872302|NCT03220581|12038175|FG001|NOT COMPLETED|Overall Study||7
10872303|NCT03099486|12038183|FG000|STARTED|Overall Study||2
10872304|NCT03099486|12038183|FG000|COMPLETED|Overall Study||2
10872305|NCT03099486|12038183|FG000|NOT COMPLETED|Overall Study||0
11111856|NCT01286987|12296208|FG006|Prostate Cancer|Part 1: Dose Escalation||0
11111857|NCT01286987|12296209|FG007|Prostate Cancer|Part 1: Dose Escalation||0
11111858|NCT01286987|12296210|FG008|Prostate Cancer|Part 1: Dose Escalation||0
11111859|NCT01286987|12296211|FG009|Prostate Cancer|Part 1: Dose Escalation||0
11111860|NCT01286987|12296212|FG010|Prostate Cancer|Part 1: Dose Escalation||0
11111861|NCT01286987|12296213|FG011|Prostate Cancer|Part 1: Dose Escalation||0
11111862|NCT01286987|12296214|FG012|Prostate Cancer|Part 1: Dose Escalation||0
11111863|NCT01286987|12296215|FG013|Prostate Cancer|Part 1: Dose Escalation||0
10872314|NCT02768870|12038196|FG000|STARTED|Overall Study||26
10872315|NCT02768870|12038196|FG000|Implanted With Device|Overall Study||24
10872316|NCT02768870|12038196|FG000|COMPLETED|Overall Study||0
10872317|NCT02768870|12038196|FG000|NOT COMPLETED|Overall Study||26
11111864|NCT01286987|12296216|FG014|Prostate Cancer|Part 1: Dose Escalation||0
11111865|NCT01286987|12296202|FG000|Ewing Cancer|Part 1: Dose Escalation||0
11111866|NCT01286987|12296203|FG001|Ewing Cancer|Part 1: Dose Escalation||0
11111867|NCT01286987|12296204|FG002|Ewing Cancer|Part 1: Dose Escalation||0
11111868|NCT01286987|12296205|FG003|Ewing Cancer|Part 1: Dose Escalation||0
11111869|NCT01286987|12296206|FG004|Ewing Cancer|Part 1: Dose Escalation||0
11111870|NCT01286987|12296207|FG005|Ewing Cancer|Part 1: Dose Escalation||0
11111871|NCT01286987|12296208|FG006|Ewing Cancer|Part 1: Dose Escalation||0
11111872|NCT01286987|12296209|FG007|Ewing Cancer|Part 1: Dose Escalation||1
11111873|NCT01286987|12296210|FG008|Ewing Cancer|Part 1: Dose Escalation||1
11111874|NCT01286987|12296211|FG009|Ewing Cancer|Part 1: Dose Escalation||0
10872318|NCT02648698|12038202|FG000|STARTED|Overall Study||60
10872319|NCT02648698|12038203|FG001|STARTED|Overall Study||60
10872320|NCT02648698|12038202|FG000|COMPLETED|Overall Study||59
10872321|NCT02648698|12038203|FG001|COMPLETED|Overall Study||55
10872322|NCT02648698|12038202|FG000|NOT COMPLETED|Overall Study||1
11355316|NCT03078556|12552139|FG003|COMPLETED|Washout Period 2 (7 Days)||9
11355317|NCT03078556|12552136|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10872323|NCT02648698|12038203|FG001|NOT COMPLETED|Overall Study||5
11111875|NCT01286987|12296212|FG010|Ewing Cancer|Part 1: Dose Escalation||0
11111876|NCT01286987|12296213|FG011|Ewing Cancer|Part 1: Dose Escalation||0
11111877|NCT01286987|12296214|FG012|Ewing Cancer|Part 1: Dose Escalation||0
11111878|NCT01286987|12296215|FG013|Ewing Cancer|Part 1: Dose Escalation||0
11230132|NCT02019758|12422223|FG001|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
11230133|NCT02019758|12422222|FG000|COMPLETED|Overall Study||56
11230134|NCT02019758|12422223|FG001|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55
11230135|NCT02019758|12422222|FG000|NOT COMPLETED|Overall Study||9
11230136|NCT02019758|12422223|FG001|NOT COMPLETED|Overall Study||9
11230137|NCT02019888|12422232|FG000|STARTED|Overall Study||148
11230138|NCT02019888|12422233|FG001|STARTED|Overall Study||113
11230139|NCT02019888|12422234|FG002|STARTED|Overall Study||59
11230140|NCT02019888|12422232|FG000|COMPLETED|Overall Study||108
11230141|NCT02019888|12422233|FG001|COMPLETED|Overall Study||83
10872328|NCT02000882|12038213|FG000|STARTED|Overall Study||10
10872329|NCT02000882|12038213|FG000|COMPLETED|Overall Study||4
10872330|NCT02000882|12038213|FG000|NOT COMPLETED|Overall Study||6
10872331|NCT01654315|12038220|FG000|STARTED|Overall Study||15
10872332|NCT01654315|12038221|FG001|STARTED|Overall Study||10
10872333|NCT01654315|12038222|FG002|STARTED|Overall Study||9
10872334|NCT01654315|12038220|FG000|COMPLETED|Overall Study||15
10872335|NCT01654315|12038221|FG001|COMPLETED|Overall Study||10
10872336|NCT01654315|12038222|FG002|COMPLETED|Overall Study||9
10872337|NCT01654315|12038220|FG000|NOT COMPLETED|Overall Study||0
10872338|NCT01654315|12038221|FG001|NOT COMPLETED|Overall Study||0
10872339|NCT01654315|12038222|FG002|NOT COMPLETED|Overall Study||0
10872340|NCT01642004|12038232|FG000|STARTED|Randomization||135
10872341|NCT01642004|12038233|FG001|STARTED|Randomization||137
10872342|NCT01642004|12038232|FG000|COMPLETED|Randomization||131
10872343|NCT01642004|12038233|FG001|COMPLETED|Randomization||129
10872344|NCT01642004|12038232|FG000|NOT COMPLETED|Randomization||4
10872345|NCT01642004|12038233|FG001|NOT COMPLETED|Randomization||8
10872346|NCT01642004|12038232|FG000|STARTED|Treatment||131
10872347|NCT01642004|12038233|FG001|STARTED|Treatment||129
10872348|NCT01642004|12038232|FG000|COMPLETED|Treatment||21
10872349|NCT01642004|12038233|FG001|COMPLETED|Treatment||2
10872350|NCT01642004|12038232|FG000|NOT COMPLETED|Treatment||110
10872351|NCT01642004|12038233|FG001|NOT COMPLETED|Treatment||127
10872352|NCT01326104|12038241|FG000|STARTED|Overall Study||7
10872353|NCT01326104|12038242|FG001|STARTED|Overall Study||19
10872354|NCT01326104|12038241|FG000|COMPLETED|Overall Study||7
10872355|NCT01326104|12038242|FG001|COMPLETED|Overall Study||15
10872356|NCT01326104|12038241|FG000|NOT COMPLETED|Overall Study||0
10872357|NCT01326104|12038242|FG001|NOT COMPLETED|Overall Study||4
10872358|NCT01244815|12038252|FG000|STARTED|Overall Study|Randomized|101
10872359|NCT01244815|12038253|FG001|STARTED|Overall Study|Randomized|105
10872360|NCT01244815|12038254|FG002|STARTED|Overall Study|Randomized|99
10872361|NCT01244815|12038255|FG003|STARTED|Overall Study|Randomized|99
10872362|NCT01244815|12038252|FG000|Treated|Overall Study||101
10872363|NCT01244815|12038253|FG001|Treated|Overall Study||104
10872364|NCT01244815|12038254|FG002|Treated|Overall Study||99
10872365|NCT01244815|12038255|FG003|Treated|Overall Study||99
10872366|NCT01244815|12038252|FG000|COMPLETED|Overall Study||87
10872367|NCT01244815|12038253|FG001|COMPLETED|Overall Study||88
10872368|NCT01244815|12038254|FG002|COMPLETED|Overall Study||88
10872369|NCT01244815|12038255|FG003|COMPLETED|Overall Study||87
10872370|NCT01244815|12038252|FG000|NOT COMPLETED|Overall Study||14
10872371|NCT01244815|12038253|FG001|NOT COMPLETED|Overall Study||17
10872372|NCT01244815|12038254|FG002|NOT COMPLETED|Overall Study||11
10872373|NCT01244815|12038255|FG003|NOT COMPLETED|Overall Study||12
10872374|NCT01142596|12038267|FG000|STARTED|Overall Study||44
10872375|NCT01142596|12038268|FG001|STARTED|Overall Study||157
10872376|NCT01142596|12038267|FG000|COMPLETED|Overall Study||15
10872377|NCT01142596|12038268|FG001|COMPLETED|Overall Study||71
10872378|NCT01142596|12038267|FG000|NOT COMPLETED|Overall Study||29
10872379|NCT01142596|12038268|FG001|NOT COMPLETED|Overall Study||86
10872380|NCT01098110|12038277|FG000|STARTED|Overall Study|Randomized participants|176
10872381|NCT01098110|12038278|FG001|STARTED|Overall Study|Randomized participants|182
10872382|NCT01098110|12038279|FG002|STARTED|Overall Study|Randomized participants|174
10872383|NCT01098110|12038277|FG000|Treated|Overall Study|Received at least one dose of trial medication|175
10872384|NCT01098110|12038278|FG001|Treated|Overall Study|Received at least one dose of trial medication|181
10872385|NCT01098110|12038279|FG002|Treated|Overall Study|Received at least one dose of trial medication|174
10872386|NCT01098110|12038277|FG000|COMPLETED|Overall Study||114
10872387|NCT01098110|12038278|FG001|COMPLETED|Overall Study||109
10872388|NCT01098110|12038279|FG002|COMPLETED|Overall Study||80
11111879|NCT01286987|12296216|FG014|Ewing Cancer|Part 1: Dose Escalation||0
11111880|NCT01286987|12296202|FG000|Pancreatic Cancer|Part 1: Dose Escalation||1
11111881|NCT01286987|12296203|FG001|Pancreatic Cancer|Part 1: Dose Escalation||2
11111882|NCT01286987|12296204|FG002|Pancreatic Cancer|Part 1: Dose Escalation||0
10872389|NCT01098110|12038277|FG000|NOT COMPLETED|Overall Study||62
10872390|NCT01098110|12038278|FG001|NOT COMPLETED|Overall Study||73
10872391|NCT01098110|12038279|FG002|NOT COMPLETED|Overall Study||94
10872392|NCT01006265|12038291|FG000|STARTED|Overall Study||119
10872393|NCT01006265|12038292|FG001|STARTED|Overall Study||116
10872394|NCT01006265|12038293|FG002|STARTED|Overall Study||108
10872395|NCT01006265|12038294|FG003|STARTED|Overall Study||121
10872396|NCT01006265|12038291|FG000|Treated|Overall Study||119
10872397|NCT01006265|12038292|FG001|Treated|Overall Study||114
10872398|NCT01006265|12038293|FG002|Treated|Overall Study||108
10872399|NCT01006265|12038294|FG003|Treated|Overall Study||121
10872400|NCT01006265|12038291|FG000|COMPLETED|Overall Study||113
10872401|NCT01006265|12038292|FG001|COMPLETED|Overall Study||107
10872402|NCT01006265|12038293|FG002|COMPLETED|Overall Study||99
10872403|NCT01006265|12038294|FG003|COMPLETED|Overall Study||116
10872404|NCT01006265|12038291|FG000|NOT COMPLETED|Overall Study||6
10872405|NCT01006265|12038292|FG001|NOT COMPLETED|Overall Study||9
10872406|NCT01006265|12038293|FG002|NOT COMPLETED|Overall Study||9
10872407|NCT01006265|12038294|FG003|NOT COMPLETED|Overall Study||5
10872408|NCT00591227|12038306|FG000|STARTED|Overall Study||89
10872409|NCT00591227|12038307|FG001|STARTED|Overall Study||87
10872410|NCT00591227|12038306|FG000|COMPLETED|Overall Study||89
10872411|NCT00591227|12038307|FG001|COMPLETED|Overall Study||87
10872412|NCT00591227|12038306|FG000|NOT COMPLETED|Overall Study||0
11230142|NCT02019888|12422234|FG002|COMPLETED|Overall Study||54
11230143|NCT02019888|12422232|FG000|NOT COMPLETED|Overall Study||40
11230144|NCT02019888|12422233|FG001|NOT COMPLETED|Overall Study||30
11230145|NCT02019888|12422234|FG002|NOT COMPLETED|Overall Study||5
10872413|NCT00591227|12038307|FG001|NOT COMPLETED|Overall Study||0
10872414|NCT00534976|12038316|FG000|STARTED|Period 1: Placebo Run-in||33
10872415|NCT00534976|12038317|FG001|STARTED|Period 1: Placebo Run-in||33
10872416|NCT00534976|12038316|FG000|COMPLETED|Period 1: Placebo Run-in||33
10872417|NCT00534976|12038317|FG001|COMPLETED|Period 1: Placebo Run-in||33
10872418|NCT00534976|12038316|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0
10872419|NCT00534976|12038317|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0
11111883|NCT01286987|12296205|FG003|Pancreatic Cancer|Part 1: Dose Escalation||0
11111884|NCT01286987|12296206|FG004|Pancreatic Cancer|Part 1: Dose Escalation||0
11230146|NCT02019927|12422248|FG000|STARTED|Overall Study||46
10872420|NCT00534976|12038316|FG000|STARTED|Period 2: Treatment Montelukast/ Placebo||33
10872421|NCT00534976|12038317|FG001|STARTED|Period 2: Treatment Montelukast/ Placebo||33
10872422|NCT00534976|12038316|FG000|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
10872423|NCT00534976|12038317|FG001|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
10872424|NCT00534976|12038316|FG000|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
10872425|NCT00534976|12038317|FG001|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
10872426|NCT00534976|12038316|FG000|STARTED|Period 3: Crossover Placebo/ Montelukast||33
10872427|NCT00534976|12038317|FG001|STARTED|Period 3: Crossover Placebo/ Montelukast||32
10872428|NCT00534976|12038316|FG000|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
10872429|NCT00534976|12038317|FG001|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
10872430|NCT00534976|12038316|FG000|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
10872431|NCT00534976|12038317|FG001|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
10872432|NCT00337675|12038326|FG000|STARTED|Overall Study||589
10872433|NCT00337675|12038327|FG001|STARTED|Overall Study||591
10872434|NCT00337675|12038328|FG002|STARTED|Overall Study||591
10872435|NCT00337675|12038326|FG000|COMPLETED|Overall Study||492
10872436|NCT00337675|12038327|FG001|COMPLETED|Overall Study||488
10872437|NCT00337675|12038328|FG002|COMPLETED|Overall Study||492
10872438|NCT00337675|12038326|FG000|NOT COMPLETED|Overall Study||97
10872439|NCT00337675|12038327|FG001|NOT COMPLETED|Overall Study||103
10872440|NCT00337675|12038328|FG002|NOT COMPLETED|Overall Study||99
10872441|NCT00317772|12038340|FG000|STARTED|Overall Study||3
10872442|NCT00317772|12038341|FG001|STARTED|Overall Study||3
10872443|NCT00317772|12038342|FG002|STARTED|Overall Study||3
10872444|NCT00317772|12038343|FG003|STARTED|Overall Study||10
10872445|NCT00317772|12038340|FG000|COMPLETED|Overall Study||1
10872446|NCT00317772|12038341|FG001|COMPLETED|Overall Study||1
10872447|NCT00317772|12038342|FG002|COMPLETED|Overall Study||2
10872448|NCT00317772|12038343|FG003|COMPLETED|Overall Study||1
10872449|NCT00317772|12038340|FG000|NOT COMPLETED|Overall Study||2
10872450|NCT00317772|12038341|FG001|NOT COMPLETED|Overall Study||2
10872451|NCT00317772|12038342|FG002|NOT COMPLETED|Overall Study||1
10872452|NCT00317772|12038343|FG003|NOT COMPLETED|Overall Study||9
10872453|NCT00291486|12038359|FG000|STARTED|Overall Study||3
10872454|NCT00291486|12038360|FG001|STARTED|Overall Study||6
10872455|NCT00291486|12038361|FG002|STARTED|Overall Study||3
10872456|NCT00291486|12038362|FG003|STARTED|Overall Study||3
10872457|NCT00291486|12038363|FG004|STARTED|Overall Study||4
10872458|NCT00291486|12038359|FG000|COMPLETED|Overall Study||2
10872459|NCT00291486|12038360|FG001|COMPLETED|Overall Study||3
10872460|NCT00291486|12038361|FG002|COMPLETED|Overall Study||2
10872461|NCT00291486|12038362|FG003|COMPLETED|Overall Study||2
10872462|NCT00291486|12038363|FG004|COMPLETED|Overall Study||3
10872463|NCT00291486|12038359|FG000|NOT COMPLETED|Overall Study||1
10872464|NCT00291486|12038360|FG001|NOT COMPLETED|Overall Study||3
10872465|NCT00291486|12038361|FG002|NOT COMPLETED|Overall Study||1
10872466|NCT00291486|12038362|FG003|NOT COMPLETED|Overall Study||1
10872467|NCT00291486|12038363|FG004|NOT COMPLETED|Overall Study||1
10872468|NCT00284856|12038387|FG000|STARTED|Overall Study||347
10872469|NCT00284856|12038388|FG001|STARTED|Overall Study||336
11230147|NCT02019927|12422249|FG001|STARTED|Overall Study||23
10872470|NCT00284856|12038389|FG002|STARTED|Overall Study||336
10872471|NCT00284856|12038387|FG000|COMPLETED|Overall Study||296
10872472|NCT00284856|12038388|FG001|COMPLETED|Overall Study||286
10872473|NCT00284856|12038389|FG002|COMPLETED|Overall Study||276
10872474|NCT00284856|12038387|FG000|NOT COMPLETED|Overall Study||51
10872475|NCT00284856|12038388|FG001|NOT COMPLETED|Overall Study||50
10872476|NCT00284856|12038389|FG002|NOT COMPLETED|Overall Study||60
11111885|NCT01286987|12296207|FG005|Pancreatic Cancer|Part 1: Dose Escalation||0
11111886|NCT01286987|12296208|FG006|Pancreatic Cancer|Part 1: Dose Escalation||0
10872477|NCT00070707|12038399|FG000|STARTED|Overall Study||113
10872478|NCT00070707|12038400|FG001|STARTED|Overall Study||75
10872479|NCT00070707|12038399|FG000|COMPLETED|Overall Study||99
10872480|NCT00070707|12038400|FG001|COMPLETED|Overall Study||68
10872481|NCT00070707|12038399|FG000|NOT COMPLETED|Overall Study||14
10872482|NCT00070707|12038400|FG001|NOT COMPLETED|Overall Study||7
10872483|NCT02358993|12038408|FG000|STARTED|Overall Study||105
10872484|NCT02358993|12038409|FG001|STARTED|Overall Study||96
10872485|NCT02358993|12038408|FG000|COMPLETED|Overall Study||103
10872486|NCT02358993|12038409|FG001|COMPLETED|Overall Study||94
10872487|NCT02358993|12038408|FG000|NOT COMPLETED|Overall Study||2
10872488|NCT02358993|12038409|FG001|NOT COMPLETED|Overall Study||2
10872489|NCT03566199|12038415|FG000|STARTED|Overall Study||1
10872490|NCT03566199|12038416|FG001|STARTED|Overall Study||0
10872491|NCT03566199|12038417|FG002|STARTED|Overall Study||1
10872492|NCT03566199|12038418|FG003|STARTED|Overall Study||0
10872493|NCT03566199|12038419|FG004|STARTED|Overall Study||1
10872494|NCT03566199|12038420|FG005|STARTED|Overall Study||0
10872495|NCT03566199|12038421|FG006|STARTED|Overall Study||4
10872496|NCT03566199|12038422|FG007|STARTED|Overall Study||0
10872497|NCT03566199|12038415|FG000|COMPLETED|Overall Study||1
10872498|NCT03566199|12038416|FG001|COMPLETED|Overall Study||0
10872499|NCT03566199|12038417|FG002|COMPLETED|Overall Study||1
10872500|NCT03566199|12038418|FG003|COMPLETED|Overall Study||0
10872501|NCT03566199|12038419|FG004|COMPLETED|Overall Study||1
10872502|NCT03566199|12038420|FG005|COMPLETED|Overall Study||0
10872503|NCT03566199|12038421|FG006|COMPLETED|Overall Study||4
10872504|NCT03566199|12038422|FG007|COMPLETED|Overall Study||0
10872505|NCT03566199|12038415|FG000|NOT COMPLETED|Overall Study||0
10872506|NCT03566199|12038416|FG001|NOT COMPLETED|Overall Study||0
10872507|NCT03566199|12038417|FG002|NOT COMPLETED|Overall Study||0
10872508|NCT03566199|12038418|FG003|NOT COMPLETED|Overall Study||0
10872509|NCT03566199|12038419|FG004|NOT COMPLETED|Overall Study||0
10872510|NCT03566199|12038420|FG005|NOT COMPLETED|Overall Study||0
10872511|NCT03566199|12038421|FG006|NOT COMPLETED|Overall Study||0
10872512|NCT03566199|12038422|FG007|NOT COMPLETED|Overall Study||0
10872513|NCT04474197|12038430|FG000|STARTED|Overall Study||7
10872514|NCT04474197|12038431|FG001|STARTED|Overall Study||10
10872515|NCT04474197|12038432|FG002|STARTED|Overall Study||9
10872516|NCT04474197|12038433|FG003|STARTED|Overall Study||18
10872517|NCT04474197|12038430|FG000|COMPLETED|Overall Study||7
10872518|NCT04474197|12038431|FG001|COMPLETED|Overall Study||9
10872519|NCT04474197|12038432|FG002|COMPLETED|Overall Study||9
10872520|NCT04474197|12038433|FG003|COMPLETED|Overall Study||18
10872521|NCT04474197|12038430|FG000|NOT COMPLETED|Overall Study||0
10872522|NCT04474197|12038431|FG001|NOT COMPLETED|Overall Study||1
10872523|NCT04474197|12038432|FG002|NOT COMPLETED|Overall Study||0
10872524|NCT04474197|12038433|FG003|NOT COMPLETED|Overall Study||0
10872574|NCT03712345|12038511|FG000|STARTED|Overall Study||6
10872575|NCT03712345|12038512|FG001|STARTED|Overall Study||7
10872576|NCT03712345|12038513|FG002|STARTED|Overall Study|One participant was mistakenly randomized, but never treated because the participant was a screening failure.|7
10872577|NCT03712345|12038511|FG000|COMPLETED|Overall Study||6
10872578|NCT03712345|12038512|FG001|COMPLETED|Overall Study||7
10872579|NCT03712345|12038513|FG002|COMPLETED|Overall Study||6
10872580|NCT03712345|12038511|FG000|NOT COMPLETED|Overall Study||0
10872581|NCT03712345|12038512|FG001|NOT COMPLETED|Overall Study||0
10872582|NCT03712345|12038513|FG002|NOT COMPLETED|Overall Study||1
10872583|NCT03694275|12038523|FG000|STARTED|Overall Study||8
10872584|NCT03694275|12038524|FG001|STARTED|Overall Study||12
10872585|NCT03694275|12038523|FG000|COMPLETED|Overall Study||8
10872586|NCT03694275|12038524|FG001|COMPLETED|Overall Study||10
10872587|NCT03694275|12038523|FG000|NOT COMPLETED|Overall Study||0
10872588|NCT03694275|12038524|FG001|NOT COMPLETED|Overall Study||2
10872589|NCT03391232|12038533|FG000|STARTED|Part A - First Dose (1-12weeks)||5
10872590|NCT03391232|12038534|FG001|STARTED|Part A - First Dose (1-12weeks)||6
11111887|NCT01286987|12296209|FG007|Pancreatic Cancer|Part 1: Dose Escalation||0
11111888|NCT01286987|12296210|FG008|Pancreatic Cancer|Part 1: Dose Escalation||0
11111889|NCT01286987|12296211|FG009|Pancreatic Cancer|Part 1: Dose Escalation||0
11111890|NCT01286987|12296212|FG010|Pancreatic Cancer|Part 1: Dose Escalation||0
11111891|NCT01286987|12296213|FG011|Pancreatic Cancer|Part 1: Dose Escalation||0
11111892|NCT01286987|12296214|FG012|Pancreatic Cancer|Part 1: Dose Escalation||0
11111893|NCT01286987|12296215|FG013|Pancreatic Cancer|Part 1: Dose Escalation||0
11111894|NCT01286987|12296216|FG014|Pancreatic Cancer|Part 1: Dose Escalation||0
11111895|NCT01286987|12296202|FG000|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
11111896|NCT01286987|12296203|FG001|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
11111897|NCT01286987|12296204|FG002|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
11111898|NCT01286987|12296205|FG003|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
11111899|NCT01286987|12296206|FG004|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
10872591|NCT03391232|12038533|FG000|COMPLETED|Part A - First Dose (1-12weeks)|This cohort finished the trial here after 12 weeks.|5
10872592|NCT03391232|12038534|FG001|COMPLETED|Part A - First Dose (1-12weeks)|After interim analysis this cohort continued the trial.|6
10872593|NCT03391232|12038533|FG000|NOT COMPLETED|Part A - First Dose (1-12weeks)||0
10872594|NCT03391232|12038534|FG001|NOT COMPLETED|Part A - First Dose (1-12weeks)||0
10872595|NCT03391232|12038533|FG000|STARTED|Part B - Additional 2 Doses (13-38weeks)||0
10872596|NCT03391232|12038534|FG001|STARTED|Part B - Additional 2 Doses (13-38weeks)||6
10872597|NCT03391232|12038533|FG000|COMPLETED|Part B - Additional 2 Doses (13-38weeks)||0
10872525|NCT04369950|12038450|FG000|STARTED|Overall Study||22
10872526|NCT04369950|12038451|FG001|STARTED|Overall Study||22
10872527|NCT04369950|12038450|FG000|COMPLETED|Overall Study||20
10872528|NCT04369950|12038451|FG001|COMPLETED|Overall Study||20
10872529|NCT04369950|12038450|FG000|NOT COMPLETED|Overall Study||2
10872530|NCT04369950|12038451|FG001|NOT COMPLETED|Overall Study||2
10872531|NCT04070326|12038459|FG000|STARTED|Baseline Observation-12 Weeks Before TP||4
10872532|NCT04070326|12038460|FG001|STARTED|Baseline Observation-12 Weeks Before TP||17
10872533|NCT04070326|12038459|FG000|COMPLETED|Baseline Observation-12 Weeks Before TP||4
10872534|NCT04070326|12038460|FG001|COMPLETED|Baseline Observation-12 Weeks Before TP||17
10872535|NCT04070326|12038459|FG000|NOT COMPLETED|Baseline Observation-12 Weeks Before TP||0
10872536|NCT04070326|12038460|FG001|NOT COMPLETED|Baseline Observation-12 Weeks Before TP||0
10872537|NCT04070326|12038459|FG000|STARTED|Treatment Period A (Weeks 1 to 26)||4
10872538|NCT04070326|12038460|FG001|STARTED|Treatment Period A (Weeks 1 to 26)||17
10872539|NCT04070326|12038459|FG000|COMPLETED|Treatment Period A (Weeks 1 to 26)||3
10872540|NCT04070326|12038460|FG001|COMPLETED|Treatment Period A (Weeks 1 to 26)||17
10872541|NCT04070326|12038459|FG000|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||1
10872542|NCT04070326|12038460|FG001|NOT COMPLETED|Treatment Period A (Weeks 1 to 26)||0
10872543|NCT04070326|12038459|FG000|STARTED|Treatment Period B (Weeks 27 to 52)||3
10872544|NCT04070326|12038460|FG001|STARTED|Treatment Period B (Weeks 27 to 52)||17
10872545|NCT04070326|12038459|FG000|COMPLETED|Treatment Period B (Weeks 27 to 52)||3
10872546|NCT04070326|12038460|FG001|COMPLETED|Treatment Period B (Weeks 27 to 52)||17
10872547|NCT04070326|12038459|FG000|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0
10872548|NCT04070326|12038460|FG001|NOT COMPLETED|Treatment Period B (Weeks 27 to 52)||0
10872549|NCT04003610|12038471|FG000|STARTED|Overall Study||0
10872550|NCT04003610|12038472|FG001|STARTED|Overall Study||1
10872551|NCT04003610|12038473|FG002|STARTED|Overall Study||6
10872552|NCT04003610|12038471|FG000|COMPLETED|Overall Study||0
10872553|NCT04003610|12038472|FG001|COMPLETED|Overall Study||0
10872554|NCT04003610|12038473|FG002|COMPLETED|Overall Study||0
10872555|NCT04003610|12038471|FG000|NOT COMPLETED|Overall Study||0
10872556|NCT04003610|12038472|FG001|NOT COMPLETED|Overall Study||1
10872557|NCT04003610|12038473|FG002|NOT COMPLETED|Overall Study||6
10872558|NCT03920293|12038484|FG000|STARTED|Overall Study||86
10872559|NCT03920293|12038485|FG001|STARTED|Overall Study||89
10872560|NCT03920293|12038484|FG000|Received at Least 1 Dose of Study Drug|Overall Study||86
10872561|NCT03920293|12038485|FG001|Received at Least 1 Dose of Study Drug|Overall Study||89
10872562|NCT03920293|12038484|FG000|COMPLETED|Overall Study||79
10872563|NCT03920293|12038485|FG001|COMPLETED|Overall Study||83
10872564|NCT03920293|12038484|FG000|NOT COMPLETED|Overall Study||7
10872565|NCT03920293|12038485|FG001|NOT COMPLETED|Overall Study||6
10872566|NCT03907540|12038491|FG000|STARTED|Overall Study||5
10872567|NCT03907540|12038491|FG000|Completed Part 1|Overall Study||5
10872568|NCT03907540|12038491|FG000|Completed Part 2|Overall Study||5
10872569|NCT03907540|12038491|FG000|COMPLETED|Overall Study||5
10872570|NCT03907540|12038491|FG000|NOT COMPLETED|Overall Study||0
10872571|NCT03904108|12038504|FG000|STARTED|Overall Study||3
10872572|NCT03904108|12038504|FG000|COMPLETED|Overall Study||3
10872573|NCT03904108|12038504|FG000|NOT COMPLETED|Overall Study||0
10872598|NCT03391232|12038534|FG001|COMPLETED|Part B - Additional 2 Doses (13-38weeks)||3
10872599|NCT03391232|12038533|FG000|NOT COMPLETED|Part B - Additional 2 Doses (13-38weeks)||0
10872600|NCT03391232|12038534|FG001|NOT COMPLETED|Part B - Additional 2 Doses (13-38weeks)||3
10872601|NCT03323736|12038545|FG000|STARTED|Overall Study||241
10872602|NCT03323736|12038546|FG001|STARTED|Overall Study||59
10872603|NCT03323736|12038547|FG002|STARTED|Overall Study||70
10872604|NCT03323736|12038545|FG000|Treated|Overall Study||222
10872605|NCT03323736|12038546|FG001|Treated|Overall Study||47
10872606|NCT03323736|12038547|FG002|Treated|Overall Study||68
10872607|NCT03323736|12038545|FG000|COMPLETED|Overall Study||222
10872608|NCT03323736|12038546|FG001|COMPLETED|Overall Study||47
10872609|NCT03323736|12038547|FG002|COMPLETED|Overall Study||68
10872610|NCT03323736|12038545|FG000|NOT COMPLETED|Overall Study||19
10872611|NCT03323736|12038546|FG001|NOT COMPLETED|Overall Study||12
10872612|NCT03323736|12038547|FG002|NOT COMPLETED|Overall Study||2
11111900|NCT01286987|12296207|FG005|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
11111901|NCT01286987|12296208|FG006|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
11111902|NCT01286987|12296209|FG007|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
11111903|NCT01286987|12296210|FG008|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
11111904|NCT01286987|12296211|FG009|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
10872619|NCT03073980|12038569|FG000|STARTED|Overall Study||53
10872620|NCT03073980|12038570|FG001|STARTED|Overall Study||54
10872621|NCT03073980|12038571|FG002|STARTED|Overall Study||54
10872622|NCT03073980|12038569|FG000|COMPLETED|Overall Study||43
10872623|NCT03073980|12038570|FG001|COMPLETED|Overall Study||52
10872624|NCT03073980|12038571|FG002|COMPLETED|Overall Study||43
10872625|NCT03073980|12038569|FG000|NOT COMPLETED|Overall Study||10
10872626|NCT03073980|12038570|FG001|NOT COMPLETED|Overall Study||2
10872627|NCT03073980|12038571|FG002|NOT COMPLETED|Overall Study||11
11111905|NCT01286987|12296212|FG010|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
11111906|NCT01286987|12296213|FG011|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
11111907|NCT01286987|12296214|FG012|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
11111908|NCT01286987|12296215|FG013|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
11230148|NCT02019927|12422250|FG002|STARTED|Overall Study||9
11355318|NCT03078556|12552137|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10872634|NCT02544074|12038613|FG000|STARTED|Overall Study||1
10872635|NCT02544074|12038614|FG001|STARTED|Overall Study||1
10872636|NCT02544074|12038615|FG002|STARTED|Overall Study||1
10872637|NCT02544074|12038616|FG003|STARTED|Overall Study||1
10872638|NCT02544074|12038617|FG004|STARTED|Overall Study||4
10872639|NCT02544074|12038618|FG005|STARTED|Overall Study||1
10872640|NCT02544074|12038619|FG006|STARTED|Overall Study||2
10872641|NCT02544074|12038620|FG007|STARTED|Overall Study||4
10872642|NCT02544074|12038621|FG008|STARTED|Overall Study||6
10872643|NCT02544074|12038622|FG009|STARTED|Overall Study||2
10872644|NCT02544074|12038623|FG010|STARTED|Overall Study||2
10872645|NCT02544074|12038624|FG011|STARTED|Overall Study||3
10872646|NCT02544074|12038625|FG012|STARTED|Overall Study||4
10872647|NCT02544074|12038626|FG013|STARTED|Overall Study||5
10872648|NCT02544074|12038627|FG014|STARTED|Overall Study||5
10872649|NCT02544074|12038628|FG015|STARTED|Overall Study||8
10872650|NCT02544074|12038629|FG016|STARTED|Overall Study||6
10872651|NCT02544074|12038630|FG017|STARTED|Overall Study||3
10872652|NCT02544074|12038631|FG018|STARTED|Overall Study||4
10872653|NCT02544074|12038632|FG019|STARTED|Overall Study||3
10872654|NCT02544074|12038633|FG020|STARTED|Overall Study||3
10872655|NCT02544074|12038613|FG000|COMPLETED|Overall Study||1
10872656|NCT02544074|12038614|FG001|COMPLETED|Overall Study||0
10872657|NCT02544074|12038615|FG002|COMPLETED|Overall Study||1
10872658|NCT02544074|12038616|FG003|COMPLETED|Overall Study||1
10872659|NCT02544074|12038617|FG004|COMPLETED|Overall Study||4
10872660|NCT02544074|12038618|FG005|COMPLETED|Overall Study||0
10872661|NCT02544074|12038619|FG006|COMPLETED|Overall Study||2
10872662|NCT02544074|12038620|FG007|COMPLETED|Overall Study||4
10872663|NCT02544074|12038621|FG008|COMPLETED|Overall Study||6
10872664|NCT02544074|12038622|FG009|COMPLETED|Overall Study||1
10872665|NCT02544074|12038623|FG010|COMPLETED|Overall Study||2
10872666|NCT02544074|12038624|FG011|COMPLETED|Overall Study||3
10872667|NCT02544074|12038625|FG012|COMPLETED|Overall Study||4
10872668|NCT02544074|12038626|FG013|COMPLETED|Overall Study||5
10872669|NCT02544074|12038627|FG014|COMPLETED|Overall Study||5
10872670|NCT02544074|12038628|FG015|COMPLETED|Overall Study||8
10872671|NCT02544074|12038629|FG016|COMPLETED|Overall Study||6
10872672|NCT02544074|12038630|FG017|COMPLETED|Overall Study||3
10872673|NCT02544074|12038631|FG018|COMPLETED|Overall Study||4
10872674|NCT02544074|12038632|FG019|COMPLETED|Overall Study||3
10872675|NCT02544074|12038633|FG020|COMPLETED|Overall Study||3
10872676|NCT02544074|12038613|FG000|NOT COMPLETED|Overall Study||0
10872677|NCT02544074|12038614|FG001|NOT COMPLETED|Overall Study||1
10872678|NCT02544074|12038615|FG002|NOT COMPLETED|Overall Study||0
10872679|NCT02544074|12038616|FG003|NOT COMPLETED|Overall Study||0
10872680|NCT02544074|12038617|FG004|NOT COMPLETED|Overall Study||0
10872681|NCT02544074|12038618|FG005|NOT COMPLETED|Overall Study||1
10872682|NCT02544074|12038619|FG006|NOT COMPLETED|Overall Study||0
10872683|NCT02544074|12038620|FG007|NOT COMPLETED|Overall Study||0
10872684|NCT02544074|12038621|FG008|NOT COMPLETED|Overall Study||0
10872685|NCT02544074|12038622|FG009|NOT COMPLETED|Overall Study||1
10872686|NCT02544074|12038623|FG010|NOT COMPLETED|Overall Study||0
10872687|NCT02544074|12038624|FG011|NOT COMPLETED|Overall Study||0
10872688|NCT02544074|12038625|FG012|NOT COMPLETED|Overall Study||0
10872689|NCT02544074|12038626|FG013|NOT COMPLETED|Overall Study||0
10872690|NCT02544074|12038627|FG014|NOT COMPLETED|Overall Study||0
10872691|NCT02544074|12038628|FG015|NOT COMPLETED|Overall Study||0
10872692|NCT02544074|12038629|FG016|NOT COMPLETED|Overall Study||0
11355319|NCT03078556|12552138|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
11355320|NCT03078556|12552139|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10872693|NCT02544074|12038630|FG017|NOT COMPLETED|Overall Study||0
10872694|NCT02544074|12038631|FG018|NOT COMPLETED|Overall Study||0
10872695|NCT02544074|12038632|FG019|NOT COMPLETED|Overall Study||0
10872696|NCT02544074|12038633|FG020|NOT COMPLETED|Overall Study||0
10872697|NCT02317627|12038670|FG000|STARTED|Overall Study||13
10872698|NCT02317627|12038671|FG001|STARTED|Overall Study||13
10872699|NCT02317627|12038672|FG002|STARTED|Overall Study||12
10872700|NCT02317627|12038670|FG000|COMPLETED|Overall Study||11
10872701|NCT02317627|12038671|FG001|COMPLETED|Overall Study||8
10872702|NCT02317627|12038672|FG002|COMPLETED|Overall Study||8
10872703|NCT02317627|12038670|FG000|NOT COMPLETED|Overall Study||2
10872704|NCT02317627|12038671|FG001|NOT COMPLETED|Overall Study||5
10872705|NCT02317627|12038672|FG002|NOT COMPLETED|Overall Study||4
10872706|NCT01935128|12038686|FG000|STARTED|Overall Study||50
11355321|NCT03078556|12552136|FG000|STARTED|Treatment Period 3 (4 Days)||9
10872707|NCT01935128|12038686|FG000|COMPLETED|Overall Study||43
10872708|NCT01935128|12038686|FG000|NOT COMPLETED|Overall Study||7
10872709|NCT01909934|12038690|FG000|STARTED|Overall Study||50
10872710|NCT01909934|12038690|FG000|COMPLETED|Overall Study||0
10872711|NCT01909934|12038690|FG000|NOT COMPLETED|Overall Study||50
10872712|NCT01841359|12038694|FG000|STARTED|Overall Study||22
10872713|NCT01841359|12038694|FG000|COMPLETED|Overall Study||14
10872714|NCT01841359|12038694|FG000|NOT COMPLETED|Overall Study||8
10872715|NCT01459666|12038703|FG000|STARTED|Overall Study||5
10872716|NCT01459666|12038704|FG001|STARTED|Overall Study||4
10872717|NCT01459666|12038703|FG000|COMPLETED|Overall Study||0
10872718|NCT01459666|12038704|FG001|COMPLETED|Overall Study||0
10872719|NCT01459666|12038703|FG000|NOT COMPLETED|Overall Study||5
10872720|NCT01459666|12038704|FG001|NOT COMPLETED|Overall Study||4
10872721|NCT01369199|12038710|FG000|STARTED|Overall Study||28
10872722|NCT01369199|12038710|FG000|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
10872723|NCT01369199|12038710|FG000|COMPLETED|Overall Study||25
10872724|NCT01369199|12038710|FG000|NOT COMPLETED|Overall Study||3
10872725|NCT01368497|12038714|FG000|STARTED|Overall Study||60
10872726|NCT01368497|12038714|FG000|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
10872727|NCT01368497|12038714|FG000|COMPLETED|Overall Study||58
10872728|NCT01368497|12038714|FG000|NOT COMPLETED|Overall Study||2
11111909|NCT01286987|12296216|FG014|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
11111910|NCT01286987|12296202|FG000|Breast Cancer|Part 1: Dose Escalation||0
11111911|NCT01286987|12296203|FG001|Breast Cancer|Part 1: Dose Escalation||0
11111912|NCT01286987|12296204|FG002|Breast Cancer|Part 1: Dose Escalation||0
11111913|NCT01286987|12296205|FG003|Breast Cancer|Part 1: Dose Escalation||0
11111914|NCT01286987|12296206|FG004|Breast Cancer|Part 1: Dose Escalation||0
11111915|NCT01286987|12296207|FG005|Breast Cancer|Part 1: Dose Escalation||1
11111916|NCT01286987|12296208|FG006|Breast Cancer|Part 1: Dose Escalation||2
11111917|NCT01286987|12296209|FG007|Breast Cancer|Part 1: Dose Escalation||2
11111918|NCT01286987|12296210|FG008|Breast Cancer|Part 1: Dose Escalation||3
11111919|NCT01286987|12296211|FG009|Breast Cancer|Part 1: Dose Escalation||0
11111920|NCT01286987|12296212|FG010|Breast Cancer|Part 1: Dose Escalation||0
11111921|NCT01286987|12296213|FG011|Breast Cancer|Part 1: Dose Escalation||0
11111922|NCT01286987|12296214|FG012|Breast Cancer|Part 1: Dose Escalation||0
11111923|NCT01286987|12296215|FG013|Breast Cancer|Part 1: Dose Escalation||0
11111924|NCT01286987|12296216|FG014|Breast Cancer|Part 1: Dose Escalation||0
11111925|NCT01286987|12296202|FG000|COMPLETED|Part 1: Dose Escalation||0
11111926|NCT01286987|12296203|FG001|COMPLETED|Part 1: Dose Escalation||0
11111927|NCT01286987|12296204|FG002|COMPLETED|Part 1: Dose Escalation||0
11111928|NCT01286987|12296205|FG003|COMPLETED|Part 1: Dose Escalation||0
11111929|NCT01286987|12296206|FG004|COMPLETED|Part 1: Dose Escalation||0
10872729|NCT05096312|12038720|FG000|STARTED|Overall Study||11
10872730|NCT05096312|12038721|FG001|STARTED|Overall Study||12
10872731|NCT05096312|12038720|FG000|COMPLETED|Overall Study||8
10872732|NCT05096312|12038721|FG001|COMPLETED|Overall Study||8
10872733|NCT05096312|12038720|FG000|NOT COMPLETED|Overall Study||3
10872734|NCT05096312|12038721|FG001|NOT COMPLETED|Overall Study||4
11111930|NCT01286987|12296207|FG005|COMPLETED|Part 1: Dose Escalation||0
11111931|NCT01286987|12296208|FG006|COMPLETED|Part 1: Dose Escalation||1
11111932|NCT01286987|12296209|FG007|COMPLETED|Part 1: Dose Escalation||1
11111933|NCT01286987|12296210|FG008|COMPLETED|Part 1: Dose Escalation||0
10872741|NCT03560258|12038741|FG000|STARTED|Overall Study||22
10872742|NCT03560258|12038742|FG001|STARTED|Overall Study||11
10872743|NCT03560258|12038743|FG002|STARTED|Overall Study||12
10872744|NCT03560258|12038741|FG000|Received at Least 1 Dose of Treatment|Overall Study||22
10872745|NCT03560258|12038742|FG001|Received at Least 1 Dose of Treatment|Overall Study||10
10872746|NCT03560258|12038743|FG002|Received at Least 1 Dose of Treatment|Overall Study||12
10872747|NCT03560258|12038741|FG000|COMPLETED|Overall Study||19
10872748|NCT03560258|12038742|FG001|COMPLETED|Overall Study||10
10872749|NCT03560258|12038743|FG002|COMPLETED|Overall Study||11
10872750|NCT03560258|12038741|FG000|NOT COMPLETED|Overall Study||3
10872751|NCT03560258|12038742|FG001|NOT COMPLETED|Overall Study||1
10872752|NCT03560258|12038743|FG002|NOT COMPLETED|Overall Study||1
10872753|NCT03684304|12038753|FG000|STARTED|Overall Study||19
10872754|NCT03684304|12038754|FG001|STARTED|Overall Study||17
10872755|NCT03684304|12038753|FG000|COMPLETED|Overall Study||0
10872756|NCT03684304|12038754|FG001|COMPLETED|Overall Study||0
10872757|NCT03684304|12038753|FG000|NOT COMPLETED|Overall Study||19
10872758|NCT03684304|12038754|FG001|NOT COMPLETED|Overall Study||17
10872759|NCT03275168|12038762|FG000|STARTED|Overall Study||34
10872760|NCT03275168|12038763|FG001|STARTED|Overall Study||34
10872761|NCT03275168|12038762|FG000|COMPLETED|Overall Study||27
10872762|NCT03275168|12038763|FG001|COMPLETED|Overall Study||25
10872763|NCT03275168|12038762|FG000|NOT COMPLETED|Overall Study||7
10872764|NCT03275168|12038763|FG001|NOT COMPLETED|Overall Study||9
10872765|NCT04528641|12038775|FG000|STARTED|Overall Study||15
10872766|NCT04528641|12038776|FG001|STARTED|Overall Study||15
10872767|NCT04528641|12038777|FG002|STARTED|Overall Study||15
10872768|NCT04528641|12038778|FG003|STARTED|Overall Study||16
10872769|NCT04528641|12038779|FG004|STARTED|Overall Study||15
10872770|NCT04528641|12038780|FG005|STARTED|Overall Study||15
10872771|NCT04528641|12038775|FG000|COMPLETED|Overall Study||15
10872772|NCT04528641|12038776|FG001|COMPLETED|Overall Study||15
10872773|NCT04528641|12038777|FG002|COMPLETED|Overall Study||15
10872774|NCT04528641|12038778|FG003|COMPLETED|Overall Study||15
10872775|NCT04528641|12038779|FG004|COMPLETED|Overall Study||15
10872776|NCT04528641|12038780|FG005|COMPLETED|Overall Study||14
10872777|NCT04528641|12038775|FG000|NOT COMPLETED|Overall Study||0
10872778|NCT04528641|12038776|FG001|NOT COMPLETED|Overall Study||0
10872779|NCT04528641|12038777|FG002|NOT COMPLETED|Overall Study||0
10872780|NCT04528641|12038778|FG003|NOT COMPLETED|Overall Study||1
10872781|NCT04528641|12038779|FG004|NOT COMPLETED|Overall Study||0
10872782|NCT04528641|12038780|FG005|NOT COMPLETED|Overall Study||1
10872783|NCT04497883|12038799|FG000|STARTED|Treatment Period 1 (2 Days)||12
10872784|NCT04497883|12038800|FG001|STARTED|Treatment Period 1 (2 Days)||12
10872785|NCT04497883|12038801|FG002|STARTED|Treatment Period 1 (2 Days)||0
10872786|NCT04497883|12038802|FG003|STARTED|Treatment Period 1 (2 Days)||0
10872787|NCT04497883|12038799|FG000|COMPLETED|Treatment Period 1 (2 Days)||12
10872788|NCT04497883|12038800|FG001|COMPLETED|Treatment Period 1 (2 Days)||12
10872789|NCT04497883|12038801|FG002|COMPLETED|Treatment Period 1 (2 Days)||0
10872790|NCT04497883|12038802|FG003|COMPLETED|Treatment Period 1 (2 Days)||0
10872791|NCT04497883|12038799|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10872792|NCT04497883|12038800|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10872793|NCT04497883|12038801|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10872794|NCT04497883|12038802|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
10872795|NCT04497883|12038799|FG000|STARTED|Washout Period 1 (72 Hours)||12
10872796|NCT04497883|12038800|FG001|STARTED|Washout Period 1 (72 Hours)||12
10872797|NCT04497883|12038801|FG002|STARTED|Washout Period 1 (72 Hours)||0
10872798|NCT04497883|12038802|FG003|STARTED|Washout Period 1 (72 Hours)||0
10872799|NCT04497883|12038799|FG000|COMPLETED|Washout Period 1 (72 Hours)||12
10872800|NCT04497883|12038800|FG001|COMPLETED|Washout Period 1 (72 Hours)||12
10872801|NCT04497883|12038801|FG002|COMPLETED|Washout Period 1 (72 Hours)||0
10872802|NCT04497883|12038802|FG003|COMPLETED|Washout Period 1 (72 Hours)||0
10872803|NCT04497883|12038799|FG000|NOT COMPLETED|Washout Period 1 (72 Hours)||0
10872804|NCT04497883|12038800|FG001|NOT COMPLETED|Washout Period 1 (72 Hours)||0
10872805|NCT04497883|12038801|FG002|NOT COMPLETED|Washout Period 1 (72 Hours)||0
10872806|NCT04497883|12038802|FG003|NOT COMPLETED|Washout Period 1 (72 Hours)||0
10872807|NCT04497883|12038799|FG000|STARTED|Treatment Period 2 (2 Days)||0
10872808|NCT04497883|12038800|FG001|STARTED|Treatment Period 2 (2 Days)||0
10872809|NCT04497883|12038801|FG002|STARTED|Treatment Period 2 (2 Days)||6
10872810|NCT04497883|12038802|FG003|STARTED|Treatment Period 2 (2 Days)||6
10872811|NCT04497883|12038799|FG000|COMPLETED|Treatment Period 2 (2 Days)||0
10872812|NCT04497883|12038800|FG001|COMPLETED|Treatment Period 2 (2 Days)||0
10872813|NCT04497883|12038801|FG002|COMPLETED|Treatment Period 2 (2 Days)||6
10872814|NCT04497883|12038802|FG003|COMPLETED|Treatment Period 2 (2 Days)||6
10872815|NCT04497883|12038799|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10872816|NCT04497883|12038800|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10872817|NCT04497883|12038801|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
11111934|NCT01286987|12296211|FG009|COMPLETED|Part 1: Dose Escalation||0
11111935|NCT01286987|12296212|FG010|COMPLETED|Part 1: Dose Escalation||0
11111936|NCT01286987|12296213|FG011|COMPLETED|Part 1: Dose Escalation||0
11111937|NCT01286987|12296214|FG012|COMPLETED|Part 1: Dose Escalation||0
11111938|NCT01286987|12296215|FG013|COMPLETED|Part 1: Dose Escalation||0
11111939|NCT01286987|12296216|FG014|COMPLETED|Part 1: Dose Escalation||0
11111940|NCT01286987|12296202|FG000|NOT COMPLETED|Part 1: Dose Escalation||3
11111941|NCT01286987|12296203|FG001|NOT COMPLETED|Part 1: Dose Escalation||3
11111942|NCT01286987|12296204|FG002|NOT COMPLETED|Part 1: Dose Escalation||3
11111943|NCT01286987|12296205|FG003|NOT COMPLETED|Part 1: Dose Escalation||3
11111944|NCT01286987|12296206|FG004|NOT COMPLETED|Part 1: Dose Escalation||3
11111945|NCT01286987|12296207|FG005|NOT COMPLETED|Part 1: Dose Escalation||6
11111946|NCT01286987|12296208|FG006|NOT COMPLETED|Part 1: Dose Escalation||5
11111947|NCT01286987|12296209|FG007|NOT COMPLETED|Part 1: Dose Escalation||5
11111948|NCT01286987|12296210|FG008|NOT COMPLETED|Part 1: Dose Escalation||6
11111949|NCT01286987|12296211|FG009|NOT COMPLETED|Part 1: Dose Escalation||0
11111950|NCT01286987|12296212|FG010|NOT COMPLETED|Part 1: Dose Escalation||0
11111951|NCT01286987|12296213|FG011|NOT COMPLETED|Part 1: Dose Escalation||0
11111952|NCT01286987|12296214|FG012|NOT COMPLETED|Part 1: Dose Escalation||0
11111953|NCT01286987|12296215|FG013|NOT COMPLETED|Part 1: Dose Escalation||0
11111954|NCT01286987|12296216|FG014|NOT COMPLETED|Part 1: Dose Escalation||0
11111955|NCT01286987|12296202|FG000|STARTED|Part 2: Dose Expansion||0
11111956|NCT01286987|12296203|FG001|STARTED|Part 2: Dose Expansion||0
11111957|NCT01286987|12296204|FG002|STARTED|Part 2: Dose Expansion||0
11111958|NCT01286987|12296205|FG003|STARTED|Part 2: Dose Expansion||0
11230149|NCT02019927|12422251|FG003|STARTED|Overall Study||5
11230150|NCT02019927|12422252|FG004|STARTED|Overall Study||10
11230151|NCT02019927|12422253|FG005|STARTED|Overall Study||4
11230152|NCT02019927|12422248|FG000|COMPLETED|Overall Study||44
11230153|NCT02019927|12422249|FG001|COMPLETED|Overall Study||19
11230154|NCT02019927|12422250|FG002|COMPLETED|Overall Study||8
11230155|NCT02019927|12422251|FG003|COMPLETED|Overall Study||3
11230156|NCT02019927|12422252|FG004|COMPLETED|Overall Study||7
11230157|NCT02019927|12422253|FG005|COMPLETED|Overall Study||3
11230158|NCT02019927|12422248|FG000|NOT COMPLETED|Overall Study||2
11230159|NCT02019927|12422249|FG001|NOT COMPLETED|Overall Study||4
11230160|NCT02019927|12422250|FG002|NOT COMPLETED|Overall Study||1
11230161|NCT02019927|12422251|FG003|NOT COMPLETED|Overall Study||2
11230162|NCT02019927|12422252|FG004|NOT COMPLETED|Overall Study||3
11230163|NCT02019927|12422253|FG005|NOT COMPLETED|Overall Study||1
11230164|NCT02019940|12422271|FG000|STARTED|Overall Study||18
11230165|NCT02019940|12422271|FG000|COMPLETED|Overall Study||8
11230166|NCT02019940|12422271|FG000|NOT COMPLETED|Overall Study||10
11111959|NCT01286987|12296206|FG004|STARTED|Part 2: Dose Expansion||0
11111960|NCT01286987|12296207|FG005|STARTED|Part 2: Dose Expansion||0
11111961|NCT01286987|12296208|FG006|STARTED|Part 2: Dose Expansion||0
11111962|NCT01286987|12296209|FG007|STARTED|Part 2: Dose Expansion||0
11111963|NCT01286987|12296210|FG008|STARTED|Part 2: Dose Expansion||0
11111964|NCT01286987|12296211|FG009|STARTED|Part 2: Dose Expansion||12
11111965|NCT01286987|12296212|FG010|STARTED|Part 2: Dose Expansion||12
11111966|NCT01286987|12296213|FG011|STARTED|Part 2: Dose Expansion||11
11111967|NCT01286987|12296214|FG012|STARTED|Part 2: Dose Expansion||12
11111968|NCT01286987|12296215|FG013|STARTED|Part 2: Dose Expansion||24
11111969|NCT01286987|12296216|FG014|STARTED|Part 2: Dose Expansion||3
11111970|NCT01286987|12296202|FG000|Treated|Part 2: Dose Expansion||0
11111971|NCT01286987|12296203|FG001|Treated|Part 2: Dose Expansion||0
11111972|NCT01286987|12296204|FG002|Treated|Part 2: Dose Expansion||0
11111973|NCT01286987|12296205|FG003|Treated|Part 2: Dose Expansion||0
11111974|NCT01286987|12296206|FG004|Treated|Part 2: Dose Expansion||0
11111975|NCT01286987|12296207|FG005|Treated|Part 2: Dose Expansion||0
11111976|NCT01286987|12296208|FG006|Treated|Part 2: Dose Expansion||0
11111977|NCT01286987|12296209|FG007|Treated|Part 2: Dose Expansion||0
11111978|NCT01286987|12296210|FG008|Treated|Part 2: Dose Expansion||0
11111979|NCT01286987|12296211|FG009|Treated|Part 2: Dose Expansion||12
11111980|NCT01286987|12296212|FG010|Treated|Part 2: Dose Expansion||11
11111981|NCT01286987|12296213|FG011|Treated|Part 2: Dose Expansion||10
11111982|NCT01286987|12296214|FG012|Treated|Part 2: Dose Expansion||12
11111983|NCT01286987|12296215|FG013|Treated|Part 2: Dose Expansion||23
11111984|NCT01286987|12296216|FG014|Treated|Part 2: Dose Expansion||3
11111985|NCT01286987|12296202|FG000|COMPLETED|Part 2: Dose Expansion||0
11111986|NCT01286987|12296203|FG001|COMPLETED|Part 2: Dose Expansion||0
11111987|NCT01286987|12296204|FG002|COMPLETED|Part 2: Dose Expansion||0
11111988|NCT01286987|12296205|FG003|COMPLETED|Part 2: Dose Expansion||0
11111989|NCT01286987|12296206|FG004|COMPLETED|Part 2: Dose Expansion||0
11230167|NCT02019979|12422275|FG000|STARTED|Overall Study||14
10872818|NCT04497883|12038802|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
10872819|NCT04497883|12038799|FG000|STARTED|Washout Period 2 (72 Hours)||0
10872820|NCT04497883|12038800|FG001|STARTED|Washout Period 2 (72 Hours)||0
10872821|NCT04497883|12038801|FG002|STARTED|Washout Period 2 (72 Hours)||6
10872822|NCT04497883|12038802|FG003|STARTED|Washout Period 2 (72 Hours)||6
10872823|NCT04497883|12038799|FG000|COMPLETED|Washout Period 2 (72 Hours)||0
10872824|NCT04497883|12038800|FG001|COMPLETED|Washout Period 2 (72 Hours)||0
10872825|NCT04497883|12038801|FG002|COMPLETED|Washout Period 2 (72 Hours)||6
10872826|NCT04497883|12038802|FG003|COMPLETED|Washout Period 2 (72 Hours)||6
10872827|NCT04497883|12038799|FG000|NOT COMPLETED|Washout Period 2 (72 Hours)||0
10872828|NCT04497883|12038800|FG001|NOT COMPLETED|Washout Period 2 (72 Hours)||0
10872829|NCT04497883|12038801|FG002|NOT COMPLETED|Washout Period 2 (72 Hours)||0
10872830|NCT04497883|12038802|FG003|NOT COMPLETED|Washout Period 2 (72 Hours)||0
10872831|NCT04497883|12038799|FG000|STARTED|Treatment Period 3 (2 Days)||0
10872832|NCT04497883|12038800|FG001|STARTED|Treatment Period 3 (2 Days)||0
10872833|NCT04497883|12038801|FG002|STARTED|Treatment Period 3 (2 Days)||6
10872834|NCT04497883|12038802|FG003|STARTED|Treatment Period 3 (2 Days)||6
10872835|NCT04497883|12038799|FG000|COMPLETED|Treatment Period 3 (2 Days)||0
10872836|NCT04497883|12038800|FG001|COMPLETED|Treatment Period 3 (2 Days)||0
10872837|NCT04497883|12038801|FG002|COMPLETED|Treatment Period 3 (2 Days)||6
10872838|NCT04497883|12038802|FG003|COMPLETED|Treatment Period 3 (2 Days)||6
10872839|NCT04497883|12038799|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10872840|NCT04497883|12038800|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10872841|NCT04497883|12038801|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
10872842|NCT04497883|12038802|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
11230168|NCT02019979|12422275|FG000|COMPLETED|Overall Study||0
11230169|NCT02019979|12422275|FG000|NOT COMPLETED|Overall Study||14
11230170|NCT02020018|12422281|FG000|STARTED|Overall Study||272
11230171|NCT02020018|12422282|FG001|STARTED|Overall Study||1597
11230172|NCT02020018|12422281|FG000|COMPLETED|Overall Study||272
11230173|NCT02020018|12422282|FG001|COMPLETED|Overall Study||1597
11230174|NCT02020018|12422281|FG000|NOT COMPLETED|Overall Study||0
11230175|NCT02020018|12422282|FG001|NOT COMPLETED|Overall Study||0
11230176|NCT02020031|12422290|FG000|STARTED|Overall Study||11
11230177|NCT02020031|12422291|FG001|STARTED|Overall Study||11
11230178|NCT02020031|12422290|FG000|COMPLETED|Overall Study||10
11230179|NCT02020031|12422291|FG001|COMPLETED|Overall Study||10
11230180|NCT02020031|12422290|FG000|NOT COMPLETED|Overall Study||1
11230181|NCT02020031|12422291|FG001|NOT COMPLETED|Overall Study||1
11230182|NCT02020135|12422299|FG000|STARTED|Overall Study||9
11230183|NCT02020135|12422299|FG000|COMPLETED|Overall Study||0
11230184|NCT02020135|12422299|FG000|NOT COMPLETED|Overall Study||9
11230185|NCT02020252|12422305|FG000|STARTED|Overall Study||120
11230186|NCT02020252|12422305|FG000|COMPLETED|Overall Study||120
11230187|NCT02020252|12422305|FG000|NOT COMPLETED|Overall Study||0
11230188|NCT02020278|12422309|FG000|STARTED|Core Safety Follow-up Component||3
11230189|NCT02020278|12422309|FG000|COMPLETED|Core Safety Follow-up Component||3
11230190|NCT02020278|12422309|FG000|NOT COMPLETED|Core Safety Follow-up Component||0
11230191|NCT02020278|12422309|FG000|STARTED|Optional Tolvaptan Treatment Component||0
11230192|NCT02020278|12422309|FG000|COMPLETED|Optional Tolvaptan Treatment Component||0
11230193|NCT02020278|12422309|FG000|NOT COMPLETED|Optional Tolvaptan Treatment Component||0
11230194|NCT02020304|12422317|FG000|STARTED|Overall Study||30
11230195|NCT02020304|12422318|FG001|STARTED|Overall Study||28
11230196|NCT02020304|12422317|FG000|COMPLETED|Overall Study||27
11230197|NCT02020304|12422318|FG001|COMPLETED|Overall Study||26
11230198|NCT02020304|12422317|FG000|NOT COMPLETED|Overall Study||3
11230199|NCT02020304|12422318|FG001|NOT COMPLETED|Overall Study||2
11230200|NCT02020369|12422326|FG000|STARTED|Overall Study||14
11230201|NCT02020369|12422327|FG001|STARTED|Overall Study||13
11230202|NCT02020369|12422326|FG000|COMPLETED|Overall Study||11
11230203|NCT02020369|12422327|FG001|COMPLETED|Overall Study||11
11230204|NCT02020369|12422326|FG000|NOT COMPLETED|Overall Study||3
11230205|NCT02020369|12422327|FG001|NOT COMPLETED|Overall Study||2
11230206|NCT02020408|12422336|FG000|STARTED|Overall Study||88
11230207|NCT02020408|12422336|FG000|COMPLETED|Overall Study||85
11230208|NCT02020408|12422336|FG000|NOT COMPLETED|Overall Study||3
11230209|NCT02020512|12422346|FG000|STARTED|Overall Study||87
11230210|NCT02020512|12422346|FG000|COMPLETED|Overall Study||79
11230211|NCT02020512|12422346|FG000|NOT COMPLETED|Overall Study||8
11230212|NCT02020577|12422352|FG000|STARTED|Overall Study||3
11230213|NCT02020577|12422353|FG001|STARTED|Overall Study||55
11230214|NCT02020577|12422352|FG000|COMPLETED|Overall Study||0
11230215|NCT02020577|12422353|FG001|COMPLETED|Overall Study||0
11230216|NCT02020577|12422352|FG000|NOT COMPLETED|Overall Study||3
11230217|NCT02020577|12422353|FG001|NOT COMPLETED|Overall Study||55
11230218|NCT02020590|12422361|FG000|STARTED|Overall Study||22
11230219|NCT02020590|12422361|FG000|COMPLETED|Overall Study||22
11230220|NCT02020590|12422361|FG000|NOT COMPLETED|Overall Study||0
11230221|NCT02020616|12422372|FG000|STARTED|Overall Study||10
11230222|NCT02020616|12422373|FG001|STARTED|Overall Study||8
11230223|NCT02020616|12422374|FG002|STARTED|Overall Study||8
11230224|NCT02020616|12422375|FG003|STARTED|Overall Study||8
11230225|NCT02020616|12422376|FG004|STARTED|Overall Study||8
11230226|NCT02020616|12422377|FG005|STARTED|Overall Study||8
11230227|NCT02020616|12422378|FG006|STARTED|Overall Study||10
11230228|NCT02020616|12422372|FG000|Received at Least One Dose of Study Drug|Overall Study||10
11230229|NCT02020616|12422373|FG001|Received at Least One Dose of Study Drug|Overall Study||8
11230230|NCT02020616|12422374|FG002|Received at Least One Dose of Study Drug|Overall Study||8
11230231|NCT02020616|12422375|FG003|Received at Least One Dose of Study Drug|Overall Study||7
11230232|NCT02020616|12422376|FG004|Received at Least One Dose of Study Drug|Overall Study||8
11230233|NCT02020616|12422377|FG005|Received at Least One Dose of Study Drug|Overall Study||8
11230234|NCT02020616|12422378|FG006|Received at Least One Dose of Study Drug|Overall Study||10
11230235|NCT02020616|12422372|FG000|COMPLETED|Overall Study||10
11230236|NCT02020616|12422373|FG001|COMPLETED|Overall Study||7
11230237|NCT02020616|12422374|FG002|COMPLETED|Overall Study||6
11230238|NCT02020616|12422375|FG003|COMPLETED|Overall Study||6
11230239|NCT02020616|12422376|FG004|COMPLETED|Overall Study||6
11230240|NCT02020616|12422377|FG005|COMPLETED|Overall Study||3
11230241|NCT02020616|12422378|FG006|COMPLETED|Overall Study||6
11230242|NCT02020616|12422372|FG000|NOT COMPLETED|Overall Study||0
11230243|NCT02020616|12422373|FG001|NOT COMPLETED|Overall Study||1
11230244|NCT02020616|12422374|FG002|NOT COMPLETED|Overall Study||2
11230245|NCT02020616|12422375|FG003|NOT COMPLETED|Overall Study||2
11230246|NCT02020616|12422376|FG004|NOT COMPLETED|Overall Study||2
11230247|NCT02020616|12422377|FG005|NOT COMPLETED|Overall Study||5
11230248|NCT02020616|12422378|FG006|NOT COMPLETED|Overall Study||4
11230249|NCT02020785|12422410|FG000|STARTED|First Intervention (3 Weeks)||15
11230250|NCT02020785|12422411|FG001|STARTED|First Intervention (3 Weeks)||16
11230251|NCT02020785|12422410|FG000|COMPLETED|First Intervention (3 Weeks)||15
11230252|NCT02020785|12422411|FG001|COMPLETED|First Intervention (3 Weeks)||16
11230253|NCT02020785|12422410|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
11230254|NCT02020785|12422411|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
10872843|NCT04034238|12038816|FG000|STARTED|Dose Escalation Phase||7
10872844|NCT04034238|12038817|FG001|STARTED|Dose Escalation Phase||3
10872845|NCT04034238|12038818|FG002|STARTED|Dose Escalation Phase||0
10872846|NCT04034238|12038819|FG003|STARTED|Dose Escalation Phase||2
10872847|NCT04034238|12038816|FG000|COMPLETED|Dose Escalation Phase||6
10872848|NCT04034238|12038817|FG001|COMPLETED|Dose Escalation Phase||3
10872849|NCT04034238|12038818|FG002|COMPLETED|Dose Escalation Phase||0
10872850|NCT04034238|12038819|FG003|COMPLETED|Dose Escalation Phase||0
10872851|NCT04034238|12038816|FG000|NOT COMPLETED|Dose Escalation Phase||1
10872852|NCT04034238|12038817|FG001|NOT COMPLETED|Dose Escalation Phase||0
10872853|NCT04034238|12038818|FG002|NOT COMPLETED|Dose Escalation Phase||0
10872854|NCT04034238|12038819|FG003|NOT COMPLETED|Dose Escalation Phase||2
11111990|NCT01286987|12296207|FG005|COMPLETED|Part 2: Dose Expansion||0
11111991|NCT01286987|12296208|FG006|COMPLETED|Part 2: Dose Expansion||0
11230255|NCT02020785|12422410|FG000|STARTED|Second Intervention (3 Weeks)||15
11230256|NCT02020785|12422411|FG001|STARTED|Second Intervention (3 Weeks)||16
11230257|NCT02020785|12422410|FG000|COMPLETED|Second Intervention (3 Weeks)||15
11230258|NCT02020785|12422411|FG001|COMPLETED|Second Intervention (3 Weeks)||16
11230259|NCT02020785|12422410|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
11230260|NCT02020785|12422411|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
11111992|NCT01286987|12296209|FG007|COMPLETED|Part 2: Dose Expansion||0
11111993|NCT01286987|12296210|FG008|COMPLETED|Part 2: Dose Expansion||0
11111994|NCT01286987|12296211|FG009|COMPLETED|Part 2: Dose Expansion||1
11111995|NCT01286987|12296212|FG010|COMPLETED|Part 2: Dose Expansion||2
11111996|NCT01286987|12296213|FG011|COMPLETED|Part 2: Dose Expansion||1
11111997|NCT01286987|12296214|FG012|COMPLETED|Part 2: Dose Expansion||0
11111998|NCT01286987|12296215|FG013|COMPLETED|Part 2: Dose Expansion||0
11111999|NCT01286987|12296216|FG014|COMPLETED|Part 2: Dose Expansion||1
11230261|NCT02020863|12422417|FG000|STARTED|Overall Study||40
11230262|NCT02020863|12422417|FG000|COMPLETED|Overall Study||35
11230263|NCT02020863|12422417|FG000|NOT COMPLETED|Overall Study||5
11230264|NCT02020889|12422423|FG000|STARTED|Overall Study||68
11230265|NCT02020889|12422424|FG001|STARTED|Overall Study||68
11230266|NCT02020889|12422423|FG000|COMPLETED|Overall Study||61
11230267|NCT02020889|12422424|FG001|COMPLETED|Overall Study||65
11230268|NCT02020889|12422423|FG000|NOT COMPLETED|Overall Study||7
11230269|NCT02020889|12422424|FG001|NOT COMPLETED|Overall Study||3
11355322|NCT03078556|12552137|FG001|STARTED|Treatment Period 3 (4 Days)||7
11355323|NCT03078556|12552138|FG002|STARTED|Treatment Period 3 (4 Days)||7
11355324|NCT03078556|12552139|FG003|STARTED|Treatment Period 3 (4 Days)||9
11355325|NCT03078556|12552136|FG000|COMPLETED|Treatment Period 3 (4 Days)||9
11355326|NCT03078556|12552137|FG001|COMPLETED|Treatment Period 3 (4 Days)||7
11355327|NCT03078556|12552138|FG002|COMPLETED|Treatment Period 3 (4 Days)||7
11355328|NCT03078556|12552139|FG003|COMPLETED|Treatment Period 3 (4 Days)||9
11355329|NCT03078556|12552136|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0
11355330|NCT03078556|12552137|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0
11355331|NCT03078556|12552138|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0
11355332|NCT03078556|12552139|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0
11355333|NCT03078595|12552166|FG000|STARTED|Overall Study||24
11355334|NCT03078595|12552167|FG001|STARTED|Overall Study||24
11355335|NCT03078595|12552166|FG000|COMPLETED|Overall Study||24
11355336|NCT03078595|12552167|FG001|COMPLETED|Overall Study||24
11355337|NCT03078595|12552166|FG000|NOT COMPLETED|Overall Study||0
11355338|NCT03078595|12552167|FG001|NOT COMPLETED|Overall Study||0
11355339|NCT03078647|12552176|FG000|STARTED|Overall Study||17
11112000|NCT01286987|12296202|FG000|NOT COMPLETED|Part 2: Dose Expansion||0
11112001|NCT01286987|12296203|FG001|NOT COMPLETED|Part 2: Dose Expansion||0
11112002|NCT01286987|12296204|FG002|NOT COMPLETED|Part 2: Dose Expansion||0
11112003|NCT01286987|12296205|FG003|NOT COMPLETED|Part 2: Dose Expansion||0
11112004|NCT01286987|12296206|FG004|NOT COMPLETED|Part 2: Dose Expansion||0
11112005|NCT01286987|12296207|FG005|NOT COMPLETED|Part 2: Dose Expansion||0
10872855|NCT04034238|12038816|FG000|STARTED|Dose Expansion Phase||0
10872856|NCT04034238|12038817|FG001|STARTED|Dose Expansion Phase||0
10872857|NCT04034238|12038818|FG002|STARTED|Dose Expansion Phase||6
10872858|NCT04034238|12038819|FG003|STARTED|Dose Expansion Phase||1
10872859|NCT04034238|12038816|FG000|COMPLETED|Dose Expansion Phase||0
10872860|NCT04034238|12038817|FG001|COMPLETED|Dose Expansion Phase||0
10872861|NCT04034238|12038818|FG002|COMPLETED|Dose Expansion Phase||5
10872862|NCT04034238|12038819|FG003|COMPLETED|Dose Expansion Phase||0
10872863|NCT04034238|12038816|FG000|NOT COMPLETED|Dose Expansion Phase||0
10872864|NCT04034238|12038817|FG001|NOT COMPLETED|Dose Expansion Phase||0
10872865|NCT04034238|12038818|FG002|NOT COMPLETED|Dose Expansion Phase||1
10872866|NCT04034238|12038819|FG003|NOT COMPLETED|Dose Expansion Phase||1
10872867|NCT03984305|12038832|FG000|STARTED|Overall Study||23
10872868|NCT03984305|12038833|FG001|STARTED|Overall Study||18
10872869|NCT03984305|12038832|FG000|COMPLETED|Overall Study||0
10872870|NCT03984305|12038833|FG001|COMPLETED|Overall Study||0
10872871|NCT03984305|12038832|FG000|NOT COMPLETED|Overall Study||23
10872872|NCT03984305|12038833|FG001|NOT COMPLETED|Overall Study||18
10872873|NCT03982368|12038842|FG000|STARTED|Overall Study||87
10872874|NCT03982368|12038843|FG001|STARTED|Overall Study||86
10872875|NCT03982368|12038844|FG002|STARTED|Overall Study||88
10872876|NCT03982368|12038842|FG000|FAS Popuation|Overall Study||81
10872877|NCT03982368|12038843|FG001|FAS Popuation|Overall Study||82
10872878|NCT03982368|12038844|FG002|FAS Popuation|Overall Study||84
10872879|NCT03982368|12038842|FG000|PP Population|Overall Study||72
10872880|NCT03982368|12038843|FG001|PP Population|Overall Study||71
10872881|NCT03982368|12038844|FG002|PP Population|Overall Study||80
10872882|NCT03982368|12038842|FG000|COMPLETED|Overall Study||74
10872883|NCT03982368|12038843|FG001|COMPLETED|Overall Study||79
10872884|NCT03982368|12038844|FG002|COMPLETED|Overall Study||83
10872885|NCT03982368|12038842|FG000|NOT COMPLETED|Overall Study||13
10872886|NCT03982368|12038843|FG001|NOT COMPLETED|Overall Study||7
10872887|NCT03982368|12038844|FG002|NOT COMPLETED|Overall Study||5
10872888|NCT03952143|12038857|FG000|STARTED|Lead-In Period||628
11112006|NCT01286987|12296208|FG006|NOT COMPLETED|Part 2: Dose Expansion||0
11112007|NCT01286987|12296209|FG007|NOT COMPLETED|Part 2: Dose Expansion||0
11112008|NCT01286987|12296210|FG008|NOT COMPLETED|Part 2: Dose Expansion||0
11112009|NCT01286987|12296211|FG009|NOT COMPLETED|Part 2: Dose Expansion||11
11112010|NCT01286987|12296212|FG010|NOT COMPLETED|Part 2: Dose Expansion||10
11112011|NCT01286987|12296213|FG011|NOT COMPLETED|Part 2: Dose Expansion||10
11112012|NCT01286987|12296214|FG012|NOT COMPLETED|Part 2: Dose Expansion||12
11112013|NCT01286987|12296215|FG013|NOT COMPLETED|Part 2: Dose Expansion||24
11112014|NCT01286987|12296216|FG014|NOT COMPLETED|Part 2: Dose Expansion||2
11112015|NCT01287013|12296260|FG000|STARTED|Overall Study||32
10872889|NCT03952143|12038858|FG001|STARTED|Lead-In Period||0
10872890|NCT03952143|12038859|FG002|STARTED|Lead-In Period||0
10872891|NCT03952143|12038857|FG000|Participants Who Received at Least One Dose|Lead-In Period||628
10872892|NCT03952143|12038858|FG001|Participants Who Received at Least One Dose|Lead-In Period||0
10872893|NCT03952143|12038859|FG002|Participants Who Received at Least One Dose|Lead-In Period||0
10872894|NCT03952143|12038857|FG000|COMPLETED|Lead-In Period||595
10872895|NCT03952143|12038858|FG001|COMPLETED|Lead-In Period||0
10872896|NCT03952143|12038859|FG002|COMPLETED|Lead-In Period||0
10872897|NCT03952143|12038857|FG000|NOT COMPLETED|Lead-In Period||33
10872898|NCT03952143|12038858|FG001|NOT COMPLETED|Lead-In Period||0
10872899|NCT03952143|12038859|FG002|NOT COMPLETED|Lead-In Period||0
10872900|NCT03952143|12038857|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period|0
10872901|NCT03952143|12038858|FG001|STARTED|Treatment Period|Participants were randomized to either Insulin lispro or LY900014 in Treatment Period.|200
10872902|NCT03952143|12038859|FG002|STARTED|Treatment Period|Participants were randomized to either Insulin lispro or LY900014 in Treatment Period.|395
10872903|NCT03952143|12038857|FG000|Participants Who Received at Least One Dose|Treatment Period||0
10872904|NCT03952143|12038858|FG001|Participants Who Received at Least One Dose|Treatment Period||200
10872905|NCT03952143|12038859|FG002|Participants Who Received at Least One Dose|Treatment Period||395
10872906|NCT03952143|12038857|FG000|COMPLETED|Treatment Period||0
10872907|NCT03952143|12038858|FG001|COMPLETED|Treatment Period||191
10872908|NCT03952143|12038859|FG002|COMPLETED|Treatment Period||359
10872909|NCT03952143|12038857|FG000|NOT COMPLETED|Treatment Period||0
10872910|NCT03952143|12038858|FG001|NOT COMPLETED|Treatment Period||9
10872911|NCT03952143|12038859|FG002|NOT COMPLETED|Treatment Period||36
10872912|NCT03924752|12038866|FG000|STARTED|Overall Study||10
10872913|NCT03924752|12038866|FG000|COMPLETED|Overall Study||10
10872914|NCT03924752|12038866|FG000|NOT COMPLETED|Overall Study||0
10872915|NCT03829514|12038870|FG000|STARTED|Overall Study||10
10872916|NCT03829514|12038870|FG000|COMPLETED|Overall Study||10
11112016|NCT01287013|12296261|FG001|STARTED|Overall Study||34
11112017|NCT01287013|12296262|FG002|STARTED|Overall Study||21
11112018|NCT01287013|12296260|FG000|COMPLETED|Overall Study||29
11112019|NCT01287013|12296261|FG001|COMPLETED|Overall Study||29
11112020|NCT01287013|12296262|FG002|COMPLETED|Overall Study||0
11112021|NCT01287013|12296260|FG000|NOT COMPLETED|Overall Study||3
11112022|NCT01287013|12296261|FG001|NOT COMPLETED|Overall Study||5
11112023|NCT01287013|12296262|FG002|NOT COMPLETED|Overall Study||21
11112024|NCT01287039|12296272|FG000|STARTED|Overall Study||244
11112025|NCT01287039|12296273|FG001|STARTED|Overall Study||245
11112026|NCT01287039|12296272|FG000|COMPLETED|Overall Study||215
11112027|NCT01287039|12296273|FG001|COMPLETED|Overall Study||218
11112028|NCT01287039|12296272|FG000|NOT COMPLETED|Overall Study||29
11112029|NCT01287039|12296273|FG001|NOT COMPLETED|Overall Study||27
10872917|NCT03829514|12038870|FG000|NOT COMPLETED|Overall Study||0
10872918|NCT03691428|12038876|FG000|STARTED|Overall Study||48
10872919|NCT03691428|12038877|FG001|STARTED|Overall Study||42
10872920|NCT03691428|12038876|FG000|COMPLETED|Overall Study||42
10872921|NCT03691428|12038877|FG001|COMPLETED|Overall Study||34
10872922|NCT03691428|12038876|FG000|NOT COMPLETED|Overall Study||6
10872923|NCT03691428|12038877|FG001|NOT COMPLETED|Overall Study||8
10872924|NCT03685708|12038886|FG000|STARTED|Overall Study||14
10872925|NCT03685708|12038887|FG001|STARTED|Overall Study||18
10872926|NCT03685708|12038888|FG002|STARTED|Overall Study||46
10872927|NCT03685708|12038886|FG000|COMPLETED|Overall Study||13
10872928|NCT03685708|12038887|FG001|COMPLETED|Overall Study||16
10872929|NCT03685708|12038888|FG002|COMPLETED|Overall Study||37
10872930|NCT03685708|12038886|FG000|NOT COMPLETED|Overall Study||1
10872931|NCT03685708|12038887|FG001|NOT COMPLETED|Overall Study||2
10872932|NCT03685708|12038888|FG002|NOT COMPLETED|Overall Study||9
10872933|NCT03669588|12038898|FG000|STARTED|Overall Study||84
10872934|NCT03669588|12038899|FG001|STARTED|Overall Study||83
10872935|NCT03669588|12038898|FG000|COMPLETED|Overall Study||80
10872936|NCT03669588|12038899|FG001|COMPLETED|Overall Study||76
10872937|NCT03669588|12038898|FG000|NOT COMPLETED|Overall Study||4
10872938|NCT03669588|12038899|FG001|NOT COMPLETED|Overall Study||7
10872939|NCT03531632|12038908|FG000|STARTED|Overall Study||5
10872940|NCT03531632|12038909|FG001|STARTED|Overall Study||3
10872941|NCT03531632|12038910|FG002|STARTED|Overall Study||28
11112030|NCT01287065|12296279|FG000|STARTED|Treatment Period 1||4
11112031|NCT01287065|12296280|FG001|STARTED|Treatment Period 1||4
11112032|NCT01287065|12296281|FG002|STARTED|Treatment Period 1||4
11112033|NCT01287065|12296282|FG003|STARTED|Treatment Period 1||4
11112034|NCT01287065|12296283|FG004|STARTED|Treatment Period 1||5
11112035|NCT01287065|12296284|FG005|STARTED|Treatment Period 1||5
11112036|NCT01287065|12296279|FG000|COMPLETED|Treatment Period 1||4
11112037|NCT01287065|12296280|FG001|COMPLETED|Treatment Period 1||4
11112038|NCT01287065|12296281|FG002|COMPLETED|Treatment Period 1||4
11112039|NCT01287065|12296282|FG003|COMPLETED|Treatment Period 1||4
11112040|NCT01287065|12296283|FG004|COMPLETED|Treatment Period 1||4
11112041|NCT01287065|12296284|FG005|COMPLETED|Treatment Period 1||4
11112042|NCT01287065|12296279|FG000|NOT COMPLETED|Treatment Period 1||0
11112043|NCT01287065|12296280|FG001|NOT COMPLETED|Treatment Period 1||0
11112044|NCT01287065|12296281|FG002|NOT COMPLETED|Treatment Period 1||0
11112045|NCT01287065|12296282|FG003|NOT COMPLETED|Treatment Period 1||0
11112046|NCT01287065|12296283|FG004|NOT COMPLETED|Treatment Period 1||1
11112047|NCT01287065|12296284|FG005|NOT COMPLETED|Treatment Period 1||1
11112048|NCT01287065|12296279|FG000|STARTED|Washout Period 1||4
11112049|NCT01287065|12296280|FG001|STARTED|Washout Period 1||4
11112050|NCT01287065|12296281|FG002|STARTED|Washout Period 1||4
11112051|NCT01287065|12296282|FG003|STARTED|Washout Period 1||4
11112052|NCT01287065|12296283|FG004|STARTED|Washout Period 1||4
11112053|NCT01287065|12296284|FG005|STARTED|Washout Period 1||4
11112054|NCT01287065|12296279|FG000|COMPLETED|Washout Period 1||4
11112055|NCT01287065|12296280|FG001|COMPLETED|Washout Period 1||4
11112056|NCT01287065|12296281|FG002|COMPLETED|Washout Period 1||4
11112057|NCT01287065|12296282|FG003|COMPLETED|Washout Period 1||4
11112058|NCT01287065|12296283|FG004|COMPLETED|Washout Period 1||4
11112059|NCT01287065|12296284|FG005|COMPLETED|Washout Period 1||4
11112060|NCT01287065|12296279|FG000|NOT COMPLETED|Washout Period 1||0
11112061|NCT01287065|12296280|FG001|NOT COMPLETED|Washout Period 1||0
11112062|NCT01287065|12296281|FG002|NOT COMPLETED|Washout Period 1||0
11112063|NCT01287065|12296282|FG003|NOT COMPLETED|Washout Period 1||0
11112064|NCT01287065|12296283|FG004|NOT COMPLETED|Washout Period 1||0
11112065|NCT01287065|12296284|FG005|NOT COMPLETED|Washout Period 1||0
11112066|NCT01287065|12296279|FG000|STARTED|Treatment Period 2||4
11112067|NCT01287065|12296280|FG001|STARTED|Treatment Period 2||4
11112068|NCT01287065|12296281|FG002|STARTED|Treatment Period 2||4
11112069|NCT01287065|12296282|FG003|STARTED|Treatment Period 2||4
11112070|NCT01287065|12296283|FG004|STARTED|Treatment Period 2||4
11112071|NCT01287065|12296284|FG005|STARTED|Treatment Period 2||4
11112072|NCT01287065|12296279|FG000|COMPLETED|Treatment Period 2||4
11112073|NCT01287065|12296280|FG001|COMPLETED|Treatment Period 2||4
11112074|NCT01287065|12296281|FG002|COMPLETED|Treatment Period 2||4
11112075|NCT01287065|12296282|FG003|COMPLETED|Treatment Period 2||4
11112076|NCT01287065|12296283|FG004|COMPLETED|Treatment Period 2||4
11112077|NCT01287065|12296284|FG005|COMPLETED|Treatment Period 2||4
11112078|NCT01287065|12296279|FG000|NOT COMPLETED|Treatment Period 2||0
11112079|NCT01287065|12296280|FG001|NOT COMPLETED|Treatment Period 2||0
11112080|NCT01287065|12296281|FG002|NOT COMPLETED|Treatment Period 2||0
11112081|NCT01287065|12296282|FG003|NOT COMPLETED|Treatment Period 2||0
11112082|NCT01287065|12296283|FG004|NOT COMPLETED|Treatment Period 2||0
11112083|NCT01287065|12296284|FG005|NOT COMPLETED|Treatment Period 2||0
11112084|NCT01287065|12296279|FG000|STARTED|Washout Period 2||4
11112085|NCT01287065|12296280|FG001|STARTED|Washout Period 2||4
11112086|NCT01287065|12296281|FG002|STARTED|Washout Period 2||4
11112087|NCT01287065|12296282|FG003|STARTED|Washout Period 2||4
11112088|NCT01287065|12296283|FG004|STARTED|Washout Period 2||4
11112089|NCT01287065|12296284|FG005|STARTED|Washout Period 2||4
11112090|NCT01287065|12296279|FG000|COMPLETED|Washout Period 2||4
11112091|NCT01287065|12296280|FG001|COMPLETED|Washout Period 2||4
11112092|NCT01287065|12296281|FG002|COMPLETED|Washout Period 2||4
11112093|NCT01287065|12296282|FG003|COMPLETED|Washout Period 2||4
10872942|NCT03531632|12038908|FG000|Safety Population|Overall Study|At least 1 dose of study drug|5
10872943|NCT03531632|12038909|FG001|Safety Population|Overall Study||3
10872944|NCT03531632|12038910|FG002|Safety Population|Overall Study||28
10872945|NCT03531632|12038908|FG000|Response Evaluable Population|Overall Study|All patients who received at least one dose of any study drug, had baseline measurable disease, and had at least one post-baseline radiographic tumor assessment or discontinued treatment due to clearly documented, clinically progressive disease or death.|5
10872946|NCT03531632|12038909|FG001|Response Evaluable Population|Overall Study||3
10872947|NCT03531632|12038910|FG002|Response Evaluable Population|Overall Study||24
10872948|NCT03531632|12038908|FG000|COMPLETED|Overall Study||0
10872949|NCT03531632|12038909|FG001|COMPLETED|Overall Study||0
10872950|NCT03531632|12038910|FG002|COMPLETED|Overall Study||2
10872951|NCT03531632|12038908|FG000|NOT COMPLETED|Overall Study||5
10872952|NCT03531632|12038909|FG001|NOT COMPLETED|Overall Study||3
10872953|NCT03531632|12038910|FG002|NOT COMPLETED|Overall Study||26
10872954|NCT03488030|12038921|FG000|STARTED|Overall Study||101
10872955|NCT03488030|12038922|FG001|STARTED|Overall Study||145
10872956|NCT03488030|12038921|FG000|COMPLETED|Overall Study||101
10872957|NCT03488030|12038922|FG001|COMPLETED|Overall Study||145
10872958|NCT03488030|12038921|FG000|NOT COMPLETED|Overall Study||0
10872959|NCT03488030|12038922|FG001|NOT COMPLETED|Overall Study||0
11230270|NCT02020941|12422430|FG000|STARTED|Overall Study||10
11230271|NCT02020941|12422430|FG000|COMPLETED|Overall Study||2
11230272|NCT02020941|12422430|FG000|NOT COMPLETED|Overall Study||8
11230273|NCT02020967|12422436|FG000|STARTED|Overall Study||367
11230274|NCT02020967|12422436|FG000|Examined Participants|Overall Study||329
11230275|NCT02020967|12422436|FG000|COMPLETED|Overall Study||316
11230276|NCT02020967|12422436|FG000|NOT COMPLETED|Overall Study||51
11230277|NCT02021292|12422444|FG000|STARTED|Overall Study||40
11230278|NCT02021292|12422445|FG001|STARTED|Overall Study||40
11230279|NCT02021292|12422444|FG000|COMPLETED|Overall Study||40
11230280|NCT02021292|12422445|FG001|COMPLETED|Overall Study||37
11230281|NCT02021292|12422444|FG000|NOT COMPLETED|Overall Study||0
11230282|NCT02021292|12422445|FG001|NOT COMPLETED|Overall Study||3
11230283|NCT02021318|12422455|FG000|STARTED|Overall Study||323
11230284|NCT02021318|12422456|FG001|STARTED|Overall Study||293
11230285|NCT02021318|12422455|FG000|COMPLETED|Overall Study||250
11112094|NCT01287065|12296283|FG004|COMPLETED|Washout Period 2||4
11112095|NCT01287065|12296284|FG005|COMPLETED|Washout Period 2||4
11112096|NCT01287065|12296279|FG000|NOT COMPLETED|Washout Period 2||0
11112097|NCT01287065|12296280|FG001|NOT COMPLETED|Washout Period 2||0
11112098|NCT01287065|12296281|FG002|NOT COMPLETED|Washout Period 2||0
11112099|NCT01287065|12296282|FG003|NOT COMPLETED|Washout Period 2||0
11112100|NCT01287065|12296283|FG004|NOT COMPLETED|Washout Period 2||0
11112101|NCT01287065|12296284|FG005|NOT COMPLETED|Washout Period 2||0
11230286|NCT02021318|12422456|FG001|COMPLETED|Overall Study||230
10872963|NCT03206073|12038941|FG000|STARTED|Overall Study||4
10872964|NCT03206073|12038942|FG001|STARTED|Overall Study||12
10872965|NCT03206073|12038943|FG002|STARTED|Overall Study||4
10872966|NCT03206073|12038944|FG003|STARTED|Overall Study||14
10872967|NCT03206073|12038941|FG000|COMPLETED|Overall Study||3
10872968|NCT03206073|12038942|FG001|COMPLETED|Overall Study||11
10872969|NCT03206073|12038943|FG002|COMPLETED|Overall Study||0
10872970|NCT03206073|12038944|FG003|COMPLETED|Overall Study||14
10872971|NCT03206073|12038941|FG000|NOT COMPLETED|Overall Study||1
10872972|NCT03206073|12038942|FG001|NOT COMPLETED|Overall Study||1
10872973|NCT03206073|12038943|FG002|NOT COMPLETED|Overall Study||4
10872974|NCT03206073|12038944|FG003|NOT COMPLETED|Overall Study||0
10872975|NCT03195127|12038956|FG000|STARTED|Overall Study||15
10872976|NCT03195127|12038957|FG001|STARTED|Overall Study||18
10872977|NCT03195127|12038956|FG000|COMPLETED|Overall Study||15
10872978|NCT03195127|12038957|FG001|COMPLETED|Overall Study||17
10872979|NCT03195127|12038956|FG000|NOT COMPLETED|Overall Study||0
10872980|NCT03195127|12038957|FG001|NOT COMPLETED|Overall Study||1
10872981|NCT03102034|12038969|FG000|STARTED|Overall Study||21
10872982|NCT03102034|12038970|FG001|STARTED|Overall Study||11
10872983|NCT03102034|12038969|FG000|COMPLETED|Overall Study||20
10872984|NCT03102034|12038970|FG001|COMPLETED|Overall Study||11
10872985|NCT03102034|12038969|FG000|NOT COMPLETED|Overall Study||1
10872986|NCT03102034|12038970|FG001|NOT COMPLETED|Overall Study||0
10872987|NCT03076164|12038976|FG000|STARTED|Overall Study||24
10872988|NCT03076164|12038976|FG000|COMPLETED|Overall Study||24
10872989|NCT03076164|12038976|FG000|NOT COMPLETED|Overall Study||0
10872990|NCT02723864|12038987|FG000|STARTED|Overall Study||3
10872991|NCT02723864|12038988|FG001|STARTED|Overall Study||3
10872992|NCT02723864|12038989|FG002|STARTED|Overall Study||6
10872993|NCT02723864|12038990|FG003|STARTED|Overall Study||7
10872994|NCT02723864|12038991|FG004|STARTED|Overall Study||3
10872995|NCT02723864|12038992|FG005|STARTED|Overall Study||25
10872996|NCT02723864|12038993|FG006|STARTED|Overall Study||6
10872997|NCT02723864|12038987|FG000|COMPLETED|Overall Study||2
10872998|NCT02723864|12038988|FG001|COMPLETED|Overall Study||2
10872999|NCT02723864|12038989|FG002|COMPLETED|Overall Study||5
10873000|NCT02723864|12038990|FG003|COMPLETED|Overall Study||7
10873001|NCT02723864|12038991|FG004|COMPLETED|Overall Study||2
10873002|NCT02723864|12038992|FG005|COMPLETED|Overall Study||14
10873003|NCT02723864|12038993|FG006|COMPLETED|Overall Study||4
10873004|NCT02723864|12038987|FG000|NOT COMPLETED|Overall Study||1
10873005|NCT02723864|12038988|FG001|NOT COMPLETED|Overall Study||1
10873006|NCT02723864|12038989|FG002|NOT COMPLETED|Overall Study||1
10873007|NCT02723864|12038990|FG003|NOT COMPLETED|Overall Study||0
10873008|NCT02723864|12038991|FG004|NOT COMPLETED|Overall Study||1
10873009|NCT02723864|12038992|FG005|NOT COMPLETED|Overall Study||11
10873010|NCT02723864|12038993|FG006|NOT COMPLETED|Overall Study||2
10873011|NCT02701556|12039032|FG000|STARTED|Overall Study||198
10873012|NCT02701556|12039033|FG001|STARTED|Overall Study||198
10873013|NCT02701556|12039032|FG000|COMPLETED|Overall Study||175
10873014|NCT02701556|12039033|FG001|COMPLETED|Overall Study||178
10873015|NCT02701556|12039032|FG000|NOT COMPLETED|Overall Study||23
10873016|NCT02701556|12039033|FG001|NOT COMPLETED|Overall Study||20
10873017|NCT02691013|12039041|FG000|STARTED|Overall Study||61
10873018|NCT02691013|12039042|FG001|STARTED|Overall Study||59
10873019|NCT02691013|12039041|FG000|COMPLETED|Overall Study||58
10873020|NCT02691013|12039042|FG001|COMPLETED|Overall Study||59
10873021|NCT02691013|12039041|FG000|NOT COMPLETED|Overall Study||3
10873022|NCT02691013|12039042|FG001|NOT COMPLETED|Overall Study||0
10873023|NCT02597062|12039050|FG000|STARTED|Overall Study||76
10873024|NCT02597062|12039050|FG000|COMPLETED|Overall Study||75
11112102|NCT01287065|12296279|FG000|STARTED|Treatment Period 3||4
11112103|NCT01287065|12296280|FG001|STARTED|Treatment Period 3||4
11112104|NCT01287065|12296281|FG002|STARTED|Treatment Period 3||4
11112105|NCT01287065|12296282|FG003|STARTED|Treatment Period 3||4
11112106|NCT01287065|12296283|FG004|STARTED|Treatment Period 3||4
11112107|NCT01287065|12296284|FG005|STARTED|Treatment Period 3||4
11112108|NCT01287065|12296279|FG000|COMPLETED|Treatment Period 3||4
11112109|NCT01287065|12296280|FG001|COMPLETED|Treatment Period 3||4
11112110|NCT01287065|12296281|FG002|COMPLETED|Treatment Period 3||4
11112111|NCT01287065|12296282|FG003|COMPLETED|Treatment Period 3||4
11112112|NCT01287065|12296283|FG004|COMPLETED|Treatment Period 3||4
11112113|NCT01287065|12296284|FG005|COMPLETED|Treatment Period 3||4
11112114|NCT01287065|12296279|FG000|NOT COMPLETED|Treatment Period 3||0
11112115|NCT01287065|12296280|FG001|NOT COMPLETED|Treatment Period 3||0
11112116|NCT01287065|12296281|FG002|NOT COMPLETED|Treatment Period 3||0
10873025|NCT02597062|12039050|FG000|NOT COMPLETED|Overall Study||1
10873026|NCT02130882|12039056|FG000|STARTED|Overall Study||10
10873027|NCT02130882|12039057|FG001|STARTED|Overall Study||10
10873028|NCT02130882|12039056|FG000|COMPLETED|Overall Study||10
10873029|NCT02130882|12039057|FG001|COMPLETED|Overall Study||9
10873030|NCT02130882|12039056|FG000|NOT COMPLETED|Overall Study||0
10873031|NCT02130882|12039057|FG001|NOT COMPLETED|Overall Study||1
10873032|NCT01850563|12039065|FG000|STARTED|Overall Study||22
10873033|NCT01850563|12039066|FG001|STARTED|Overall Study||19
10873034|NCT01850563|12039065|FG000|HBO Treatment Completed|Overall Study||19
10873035|NCT01850563|12039066|FG001|HBO Treatment Completed|Overall Study||0
10873036|NCT01850563|12039065|FG000|COMPLETED|Overall Study||19
10873037|NCT01850563|12039066|FG001|COMPLETED|Overall Study||19
10873038|NCT01850563|12039065|FG000|NOT COMPLETED|Overall Study||3
10873039|NCT01850563|12039066|FG001|NOT COMPLETED|Overall Study||0
10873040|NCT01827111|12039073|FG000|STARTED|Overall Study||19
10873041|NCT01827111|12039073|FG000|COMPLETED|Overall Study||18
10873042|NCT01827111|12039073|FG000|NOT COMPLETED|Overall Study||1
10873043|NCT01437111|12039077|FG000|STARTED|Overall Study||200
10873044|NCT01437111|12039077|FG000|Treated Participants|Overall Study||198
10873045|NCT01437111|12039077|FG000|COMPLETED|Overall Study||182
10873046|NCT01437111|12039077|FG000|NOT COMPLETED|Overall Study||18
10873047|NCT01057121|12039086|FG000|STARTED|Phase I: 10 mg/Day Lenalidomide||3
10873048|NCT01057121|12039087|FG001|STARTED|Phase I: 10 mg/Day Lenalidomide||0
10873049|NCT01057121|12039088|FG002|STARTED|Phase I: 10 mg/Day Lenalidomide||0
10873050|NCT01057121|12039089|FG003|STARTED|Phase I: 10 mg/Day Lenalidomide||0
10873051|NCT01057121|12039090|FG004|STARTED|Phase I: 10 mg/Day Lenalidomide||0
10873052|NCT01057121|12039086|FG000|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
10873053|NCT01057121|12039087|FG001|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873054|NCT01057121|12039088|FG002|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873055|NCT01057121|12039089|FG003|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873056|NCT01057121|12039090|FG004|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873057|NCT01057121|12039086|FG000|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873058|NCT01057121|12039087|FG001|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873059|NCT01057121|12039088|FG002|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873060|NCT01057121|12039089|FG003|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873061|NCT01057121|12039090|FG004|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
10873062|NCT01057121|12039086|FG000|STARTED|Phase I: 15 mg/Day Lenolidomide||0
10873063|NCT01057121|12039087|FG001|STARTED|Phase I: 15 mg/Day Lenolidomide||3
10873064|NCT01057121|12039088|FG002|STARTED|Phase I: 15 mg/Day Lenolidomide||0
10873065|NCT01057121|12039089|FG003|STARTED|Phase I: 15 mg/Day Lenolidomide||0
10873066|NCT01057121|12039090|FG004|STARTED|Phase I: 15 mg/Day Lenolidomide||0
10873067|NCT01057121|12039086|FG000|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873068|NCT01057121|12039087|FG001|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
10873069|NCT01057121|12039088|FG002|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873070|NCT01057121|12039089|FG003|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873071|NCT01057121|12039090|FG004|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873072|NCT01057121|12039086|FG000|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873073|NCT01057121|12039087|FG001|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873074|NCT01057121|12039088|FG002|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873075|NCT01057121|12039089|FG003|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873076|NCT01057121|12039090|FG004|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
10873077|NCT01057121|12039086|FG000|STARTED|Phase I: 20 mg/Day Lenalidomide||0
10873078|NCT01057121|12039087|FG001|STARTED|Phase I: 20 mg/Day Lenalidomide||0
10873079|NCT01057121|12039088|FG002|STARTED|Phase I: 20 mg/Day Lenalidomide||3
10873080|NCT01057121|12039089|FG003|STARTED|Phase I: 20 mg/Day Lenalidomide||0
10873081|NCT01057121|12039090|FG004|STARTED|Phase I: 20 mg/Day Lenalidomide||0
10873082|NCT01057121|12039086|FG000|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873083|NCT01057121|12039087|FG001|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873084|NCT01057121|12039088|FG002|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
10873085|NCT01057121|12039089|FG003|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873086|NCT01057121|12039090|FG004|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873087|NCT01057121|12039086|FG000|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873088|NCT01057121|12039087|FG001|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873089|NCT01057121|12039088|FG002|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873090|NCT01057121|12039089|FG003|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873091|NCT01057121|12039090|FG004|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
10873092|NCT01057121|12039086|FG000|STARTED|Phase I: 25 mg/Day Lenalidomide||0
10873093|NCT01057121|12039087|FG001|STARTED|Phase I: 25 mg/Day Lenalidomide||0
10873094|NCT01057121|12039088|FG002|STARTED|Phase I: 25 mg/Day Lenalidomide||0
10873095|NCT01057121|12039089|FG003|STARTED|Phase I: 25 mg/Day Lenalidomide||6
10873096|NCT01057121|12039090|FG004|STARTED|Phase I: 25 mg/Day Lenalidomide||0
10873097|NCT01057121|12039086|FG000|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873098|NCT01057121|12039087|FG001|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873099|NCT01057121|12039088|FG002|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873100|NCT01057121|12039089|FG003|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
10873101|NCT01057121|12039090|FG004|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873102|NCT01057121|12039086|FG000|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873103|NCT01057121|12039087|FG001|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873104|NCT01057121|12039088|FG002|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873105|NCT01057121|12039089|FG003|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873106|NCT01057121|12039090|FG004|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
10873107|NCT01057121|12039086|FG000|STARTED|Phase II: 25 mg/Day Lenalidomide||0
10873108|NCT01057121|12039087|FG001|STARTED|Phase II: 25 mg/Day Lenalidomide||0
10873109|NCT01057121|12039088|FG002|STARTED|Phase II: 25 mg/Day Lenalidomide||0
10873110|NCT01057121|12039089|FG003|STARTED|Phase II: 25 mg/Day Lenalidomide||0
10873111|NCT01057121|12039090|FG004|STARTED|Phase II: 25 mg/Day Lenalidomide||23
10873112|NCT01057121|12039086|FG000|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873113|NCT01057121|12039087|FG001|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873114|NCT01057121|12039088|FG002|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873115|NCT01057121|12039089|FG003|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873116|NCT01057121|12039090|FG004|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
10873117|NCT01057121|12039086|FG000|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873118|NCT01057121|12039087|FG001|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873119|NCT01057121|12039088|FG002|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873120|NCT01057121|12039089|FG003|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873121|NCT01057121|12039090|FG004|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
10873122|NCT01004263|12039114|FG000|STARTED|Overall Study|Participants who took study drug|606
10873123|NCT01004263|12039114|FG000|COMPLETED|Overall Study||427
10873124|NCT01004263|12039114|FG000|NOT COMPLETED|Overall Study||179
10873125|NCT01001234|12039123|FG000|STARTED|Overall Study|Participants who were randomized to study drug|492
10873126|NCT01001234|12039124|FG001|STARTED|Overall Study|Participants who were randomized to study drug|31
10873127|NCT01001234|12039125|FG002|STARTED|Overall Study|Participants who were randomized to study drug|409
10873128|NCT01001234|12039126|FG003|STARTED|Overall Study|Participants who were randomized to study drug|410
10873129|NCT01001234|12039127|FG004|STARTED|Overall Study|Participants who were randomized to study drug|40
10873130|NCT01001234|12039123|FG000|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
10873131|NCT01001234|12039124|FG001|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
10873132|NCT01001234|12039125|FG002|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
10873133|NCT01001234|12039126|FG003|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
10873134|NCT01001234|12039127|FG004|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
10873135|NCT01001234|12039123|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|368
10873136|NCT01001234|12039124|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|23
10873137|NCT01001234|12039125|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|9
10873138|NCT01001234|12039126|FG003|Participants Not Treated|Overall Study|Participants who did not take study drug|5
10873139|NCT01001234|12039127|FG004|Participants Not Treated|Overall Study|Participants who did not take study drug|0
10873140|NCT01001234|12039123|FG000|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
10873141|NCT01001234|12039124|FG001|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
10873142|NCT01001234|12039125|FG002|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
10873143|NCT01001234|12039126|FG003|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
10873144|NCT01001234|12039127|FG004|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
10873145|NCT01001234|12039123|FG000|NOT COMPLETED|Overall Study||405
10873146|NCT01001234|12039124|FG001|NOT COMPLETED|Overall Study||26
10873147|NCT01001234|12039125|FG002|NOT COMPLETED|Overall Study||32
10873148|NCT01001234|12039126|FG003|NOT COMPLETED|Overall Study||25
10873149|NCT01001234|12039127|FG004|NOT COMPLETED|Overall Study||0
10873150|NCT00924170|12039135|FG000|STARTED|Overall Study||10
10873151|NCT00924170|12039136|FG001|STARTED|Overall Study||8
10873152|NCT00924170|12039135|FG000|COMPLETED|Overall Study||3
10873153|NCT00924170|12039136|FG001|COMPLETED|Overall Study||0
10873154|NCT00924170|12039135|FG000|NOT COMPLETED|Overall Study||7
10873155|NCT00924170|12039136|FG001|NOT COMPLETED|Overall Study||8
10873156|NCT00894556|12039151|FG000|STARTED|Baseline Phase||0
10873157|NCT00894556|12039152|FG001|STARTED|Baseline Phase||0
10873158|NCT00894556|12039153|FG002|STARTED|Baseline Phase||0
10873159|NCT00894556|12039154|FG003|STARTED|Baseline Phase||194
10873160|NCT00894556|12039151|FG000|COMPLETED|Baseline Phase||0
10873161|NCT00894556|12039152|FG001|COMPLETED|Baseline Phase||0
10873162|NCT00894556|12039153|FG002|COMPLETED|Baseline Phase||0
10873163|NCT00894556|12039154|FG003|COMPLETED|Baseline Phase||109
10873164|NCT00894556|12039151|FG000|NOT COMPLETED|Baseline Phase||0
10873165|NCT00894556|12039152|FG001|NOT COMPLETED|Baseline Phase||0
10873166|NCT00894556|12039153|FG002|NOT COMPLETED|Baseline Phase||0
10873167|NCT00894556|12039154|FG003|NOT COMPLETED|Baseline Phase||85
10873168|NCT00894556|12039151|FG000|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
10873169|NCT00894556|12039152|FG001|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
10873170|NCT00894556|12039153|FG002|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
10873171|NCT00894556|12039154|FG003|STARTED|Treatment Phase||0
10873172|NCT00894556|12039151|FG000|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
10873173|NCT00894556|12039152|FG001|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
10873174|NCT00894556|12039153|FG002|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
10873175|NCT00894556|12039154|FG003|COMPLETED|Treatment Phase||0
10873176|NCT00894556|12039151|FG000|NOT COMPLETED|Treatment Phase||4
10873177|NCT00894556|12039152|FG001|NOT COMPLETED|Treatment Phase||4
10873178|NCT00894556|12039153|FG002|NOT COMPLETED|Treatment Phase||1
10873179|NCT00894556|12039154|FG003|NOT COMPLETED|Treatment Phase||0
10873180|NCT00840177|12039164|FG000|STARTED|Overall Study||36
10873181|NCT00840177|12039165|FG001|STARTED|Overall Study||29
10873182|NCT00840177|12039166|FG002|STARTED|Overall Study||50
10873183|NCT00840177|12039164|FG000|Treated|Overall Study||36
10873184|NCT00840177|12039165|FG001|Treated|Overall Study||29
10873185|NCT00840177|12039166|FG002|Treated|Overall Study||46
10873186|NCT00840177|12039164|FG000|Assessed for AEs|Overall Study||35
10873187|NCT00840177|12039165|FG001|Assessed for AEs|Overall Study||29
10873188|NCT00840177|12039166|FG002|Assessed for AEs|Overall Study||46
10873189|NCT00840177|12039164|FG000|COMPLETED|Overall Study||18
10873190|NCT00840177|12039165|FG001|COMPLETED|Overall Study||20
10873191|NCT00840177|12039166|FG002|COMPLETED|Overall Study||39
10873192|NCT00840177|12039164|FG000|NOT COMPLETED|Overall Study||18
10873193|NCT00840177|12039165|FG001|NOT COMPLETED|Overall Study||9
10873194|NCT00840177|12039166|FG002|NOT COMPLETED|Overall Study||11
10873195|NCT00820950|12039179|FG000|STARTED|Overall Study||6
10873196|NCT00820950|12039180|FG001|STARTED|Overall Study||6
10873197|NCT00820950|12039181|FG002|STARTED|Overall Study||6
10873198|NCT00820950|12039182|FG003|STARTED|Overall Study||6
10873199|NCT00820950|12039183|FG004|STARTED|Overall Study||6
11230287|NCT02021318|12422455|FG000|NOT COMPLETED|Overall Study||73
11230288|NCT02021318|12422456|FG001|NOT COMPLETED|Overall Study||63
11230289|NCT02021331|12422465|FG000|STARTED|Overall Study||2
11230290|NCT02021331|12422466|FG001|STARTED|Overall Study||3
11230291|NCT02021331|12422465|FG000|COMPLETED|Overall Study||2
11230292|NCT02021331|12422466|FG001|COMPLETED|Overall Study||1
11230293|NCT02021331|12422465|FG000|NOT COMPLETED|Overall Study||0
11230294|NCT02021331|12422466|FG001|NOT COMPLETED|Overall Study||2
11230295|NCT02021461|12422472|FG000|STARTED|Overall Study||38
11230296|NCT02021461|12422472|FG000|COMPLETED|Overall Study||38
11230297|NCT02021461|12422472|FG000|NOT COMPLETED|Overall Study||0
11230298|NCT02021565|12422480|FG000|STARTED|Baseline Through Intervention||72
11230299|NCT02021565|12422481|FG001|STARTED|Baseline Through Intervention||54
11230300|NCT02021565|12422480|FG000|Caregivers|Baseline Through Intervention||36
11230301|NCT02021565|12422481|FG001|Caregivers|Baseline Through Intervention||27
11230302|NCT02021565|12422480|FG000|Care Recipients|Baseline Through Intervention||36
11230303|NCT02021565|12422481|FG001|Care Recipients|Baseline Through Intervention||27
11230304|NCT02021565|12422480|FG000|COMPLETED|Baseline Through Intervention||60
11230305|NCT02021565|12422481|FG001|COMPLETED|Baseline Through Intervention||36
11230306|NCT02021565|12422480|FG000|NOT COMPLETED|Baseline Through Intervention||12
11230307|NCT02021565|12422481|FG001|NOT COMPLETED|Baseline Through Intervention||18
11230308|NCT02021565|12422480|FG000|STARTED|3-month Follow-up||60
11230309|NCT02021565|12422481|FG001|STARTED|3-month Follow-up||36
11230310|NCT02021565|12422480|FG000|Caregivers|3-month Follow-up||30
11230311|NCT02021565|12422481|FG001|Caregivers|3-month Follow-up||18
11230312|NCT02021565|12422480|FG000|Care Recipients|3-month Follow-up||30
11230313|NCT02021565|12422481|FG001|Care Recipients|3-month Follow-up||18
11230314|NCT02021565|12422480|FG000|COMPLETED|3-month Follow-up||50
11230315|NCT02021565|12422481|FG001|COMPLETED|3-month Follow-up||34
11230316|NCT02021565|12422480|FG000|NOT COMPLETED|3-month Follow-up||10
11230317|NCT02021565|12422481|FG001|NOT COMPLETED|3-month Follow-up||2
11230318|NCT02021643|12422495|FG000|STARTED|Overall Study||156
11230319|NCT02021643|12422496|FG001|STARTED|Overall Study||290
11230320|NCT02021643|12422497|FG002|STARTED|Overall Study||11
11230321|NCT02021643|12422498|FG003|STARTED|Overall Study||230
11230322|NCT02021643|12422495|FG000|COMPLETED|Overall Study||147
11230323|NCT02021643|12422496|FG001|COMPLETED|Overall Study||280
11230324|NCT02021643|12422497|FG002|COMPLETED|Overall Study||11
11230325|NCT02021643|12422498|FG003|COMPLETED|Overall Study||218
11230326|NCT02021643|12422495|FG000|NOT COMPLETED|Overall Study||9
11230327|NCT02021643|12422496|FG001|NOT COMPLETED|Overall Study||10
11230328|NCT02021643|12422497|FG002|NOT COMPLETED|Overall Study||0
11230329|NCT02021643|12422498|FG003|NOT COMPLETED|Overall Study||12
11230330|NCT02021656|12422514|FG000|STARTED|Overall Study||384
11230331|NCT02021656|12422514|FG000|COMPLETED|Overall Study||378
11230332|NCT02021656|12422514|FG000|NOT COMPLETED|Overall Study||6
11230333|NCT02021669|12422524|FG000|STARTED|Overall Study||71
11230334|NCT02021669|12422525|FG001|STARTED|Overall Study||73
11230335|NCT02021669|12422524|FG000|COMPLETED|Overall Study||64
11230336|NCT02021669|12422525|FG001|COMPLETED|Overall Study||70
11230337|NCT02021669|12422524|FG000|NOT COMPLETED|Overall Study||7
11230338|NCT02021669|12422525|FG001|NOT COMPLETED|Overall Study||3
11230339|NCT02021929|12422533|FG000|STARTED|Overall Study||16
11230340|NCT02021929|12422534|FG001|STARTED|Overall Study||12
11230341|NCT02021929|12422533|FG000|COMPLETED|Overall Study||14
11230342|NCT02021929|12422534|FG001|COMPLETED|Overall Study||11
11230343|NCT02021929|12422533|FG000|NOT COMPLETED|Overall Study||2
11230344|NCT02021929|12422534|FG001|NOT COMPLETED|Overall Study||1
11230345|NCT02021942|12422540|FG000|STARTED|Overall Study||16
11230346|NCT02021942|12422540|FG000|COMPLETED|Overall Study||16
11230347|NCT02021942|12422540|FG000|NOT COMPLETED|Overall Study||0
11230348|NCT02021955|12422547|FG000|STARTED|Step 0|Provider attrition=2; Provider addition=3; Patient discharges=14|210
11230349|NCT02021955|12422548|FG001|STARTED|Step 0|Provider attrition=0; Provider addition=0; Patient discharges=0|0
11230350|NCT02021955|12422547|FG000|COMPLETED|Step 0||210
11230351|NCT02021955|12422548|FG001|COMPLETED|Step 0||0
11230352|NCT02021955|12422547|FG000|NOT COMPLETED|Step 0||0
11230353|NCT02021955|12422548|FG001|NOT COMPLETED|Step 0||0
11230354|NCT02021955|12422547|FG000|STARTED|Step 1|Provider attrition=20; Provider addition=2; Patient discharges=14|193
11230355|NCT02021955|12422548|FG001|STARTED|Step 1|Provider attrition=7; Provider addition=0; Patient discharges: 0|18
11230356|NCT02021955|12422547|FG000|COMPLETED|Step 1||193
11230357|NCT02021955|12422548|FG001|COMPLETED|Step 1||18
11230358|NCT02021955|12422547|FG000|NOT COMPLETED|Step 1||0
10873200|NCT00820950|12039184|FG005|STARTED|Overall Study||6
10873201|NCT00820950|12039185|FG006|STARTED|Overall Study||6
10873202|NCT00820950|12039186|FG007|STARTED|Overall Study||6
10873203|NCT00820950|12039187|FG008|STARTED|Overall Study||5
10873204|NCT00820950|12039188|FG009|STARTED|Overall Study||5
10873205|NCT00820950|12039179|FG000|COMPLETED|Overall Study||5
10873206|NCT00820950|12039180|FG001|COMPLETED|Overall Study||5
10873207|NCT00820950|12039181|FG002|COMPLETED|Overall Study||6
11230359|NCT02021955|12422548|FG001|NOT COMPLETED|Step 1||0
11230360|NCT02021955|12422547|FG000|STARTED|Step 2|Provider attrition=5; Provider addition=21; Patient discharges=12|165
10873208|NCT00820950|12039182|FG003|COMPLETED|Overall Study||6
10873209|NCT00820950|12039183|FG004|COMPLETED|Overall Study||6
10873210|NCT00820950|12039184|FG005|COMPLETED|Overall Study||6
10873211|NCT00820950|12039185|FG006|COMPLETED|Overall Study||5
10873212|NCT00820950|12039186|FG007|COMPLETED|Overall Study||5
10873213|NCT00820950|12039187|FG008|COMPLETED|Overall Study||5
10873214|NCT00820950|12039188|FG009|COMPLETED|Overall Study||5
10873215|NCT00820950|12039179|FG000|NOT COMPLETED|Overall Study||1
10873216|NCT00820950|12039180|FG001|NOT COMPLETED|Overall Study||1
10873217|NCT00820950|12039181|FG002|NOT COMPLETED|Overall Study||0
10873218|NCT00820950|12039182|FG003|NOT COMPLETED|Overall Study||0
10873219|NCT00820950|12039183|FG004|NOT COMPLETED|Overall Study||0
10873220|NCT00820950|12039184|FG005|NOT COMPLETED|Overall Study||0
10873221|NCT00820950|12039185|FG006|NOT COMPLETED|Overall Study||1
10873222|NCT00820950|12039186|FG007|NOT COMPLETED|Overall Study||1
10873223|NCT00820950|12039187|FG008|NOT COMPLETED|Overall Study||0
10873224|NCT00820950|12039188|FG009|NOT COMPLETED|Overall Study||0
10873225|NCT00806416|12039230|FG000|STARTED|Period 1 - Part I||107
10873226|NCT00806416|12039231|FG001|STARTED|Period 1 - Part I||107
10873227|NCT00806416|12039232|FG002|STARTED|Period 1 - Part I||0
10873228|NCT00806416|12039233|FG003|STARTED|Period 1 - Part I||0
10873229|NCT00806416|12039230|FG000|COMPLETED|Period 1 - Part I||104
10873230|NCT00806416|12039231|FG001|COMPLETED|Period 1 - Part I||103
10873231|NCT00806416|12039232|FG002|COMPLETED|Period 1 - Part I||0
10873232|NCT00806416|12039233|FG003|COMPLETED|Period 1 - Part I||0
10873233|NCT00806416|12039230|FG000|NOT COMPLETED|Period 1 - Part I||3
10873234|NCT00806416|12039231|FG001|NOT COMPLETED|Period 1 - Part I||4
10873235|NCT00806416|12039232|FG002|NOT COMPLETED|Period 1 - Part I||0
10873236|NCT00806416|12039233|FG003|NOT COMPLETED|Period 1 - Part I||0
10873237|NCT00806416|12039230|FG000|STARTED|Period 2 - Part I||104
10873238|NCT00806416|12039231|FG001|STARTED|Period 2 - Part I||103
10873239|NCT00806416|12039232|FG002|STARTED|Period 2 - Part I||0
10873240|NCT00806416|12039233|FG003|STARTED|Period 2 - Part I||0
10873241|NCT00806416|12039230|FG000|COMPLETED|Period 2 - Part I||104
10873242|NCT00806416|12039231|FG001|COMPLETED|Period 2 - Part I||103
10873243|NCT00806416|12039232|FG002|COMPLETED|Period 2 - Part I||0
10873244|NCT00806416|12039233|FG003|COMPLETED|Period 2 - Part I||0
10873245|NCT00806416|12039230|FG000|NOT COMPLETED|Period 2 - Part I||0
10873246|NCT00806416|12039231|FG001|NOT COMPLETED|Period 2 - Part I||0
10873247|NCT00806416|12039232|FG002|NOT COMPLETED|Period 2 - Part I||0
10873248|NCT00806416|12039233|FG003|NOT COMPLETED|Period 2 - Part I||0
10873249|NCT00806416|12039230|FG000|STARTED|Period 1 - Part II||0
10873250|NCT00806416|12039231|FG001|STARTED|Period 1 - Part II||0
10873251|NCT00806416|12039232|FG002|STARTED|Period 1 - Part II||14
10873252|NCT00806416|12039233|FG003|STARTED|Period 1 - Part II||16
10873253|NCT00806416|12039230|FG000|COMPLETED|Period 1 - Part II||0
10873254|NCT00806416|12039231|FG001|COMPLETED|Period 1 - Part II||0
10873255|NCT00806416|12039232|FG002|COMPLETED|Period 1 - Part II||14
10873256|NCT00806416|12039233|FG003|COMPLETED|Period 1 - Part II||14
10873257|NCT00806416|12039230|FG000|NOT COMPLETED|Period 1 - Part II||0
10873258|NCT00806416|12039231|FG001|NOT COMPLETED|Period 1 - Part II||0
10873259|NCT00806416|12039232|FG002|NOT COMPLETED|Period 1 - Part II||0
10873260|NCT00806416|12039233|FG003|NOT COMPLETED|Period 1 - Part II||2
10873261|NCT00806416|12039230|FG000|STARTED|Period 2 - Part II||0
10873262|NCT00806416|12039231|FG001|STARTED|Period 2 - Part II||0
10873263|NCT00806416|12039232|FG002|STARTED|Period 2 - Part II||14
11112117|NCT01287065|12296282|FG003|NOT COMPLETED|Treatment Period 3||0
11112118|NCT01287065|12296283|FG004|NOT COMPLETED|Treatment Period 3||0
11112119|NCT01287065|12296284|FG005|NOT COMPLETED|Treatment Period 3||0
11112120|NCT01287078|12296294|FG000|STARTED|Overall Study||20
11112121|NCT01287078|12296295|FG001|STARTED|Overall Study||3
11112122|NCT01287078|12296294|FG000|COMPLETED|Overall Study||10
11112123|NCT01287078|12296295|FG001|COMPLETED|Overall Study||1
11112124|NCT01287078|12296294|FG000|NOT COMPLETED|Overall Study||10
11112125|NCT01287078|12296295|FG001|NOT COMPLETED|Overall Study||2
11112126|NCT01287104|12296305|FG000|STARTED|Overall Study||4
11112127|NCT01287104|12296306|FG001|STARTED|Overall Study||7
11112128|NCT01287104|12296307|FG002|STARTED|Overall Study||12
11112129|NCT01287104|12296308|FG003|STARTED|Overall Study||11
11112130|NCT01287104|12296305|FG000|COMPLETED|Overall Study||3
11112131|NCT01287104|12296306|FG001|COMPLETED|Overall Study||2
11112132|NCT01287104|12296307|FG002|COMPLETED|Overall Study||5
11112133|NCT01287104|12296308|FG003|COMPLETED|Overall Study||8
11112134|NCT01287104|12296305|FG000|NOT COMPLETED|Overall Study||1
11112135|NCT01287104|12296306|FG001|NOT COMPLETED|Overall Study||5
11112136|NCT01287104|12296307|FG002|NOT COMPLETED|Overall Study||7
11112137|NCT01287104|12296308|FG003|NOT COMPLETED|Overall Study||3
11112138|NCT01287117|12296329|FG000|STARTED|Overall Study||80
11112139|NCT01287117|12296330|FG001|STARTED|Overall Study||78
10873264|NCT00806416|12039233|FG003|STARTED|Period 2 - Part II||14
10873265|NCT00806416|12039230|FG000|COMPLETED|Period 2 - Part II||0
10873266|NCT00806416|12039231|FG001|COMPLETED|Period 2 - Part II||0
11112140|NCT01287117|12296331|FG002|STARTED|Overall Study||80
11112141|NCT01287117|12296332|FG003|STARTED|Overall Study||81
10873267|NCT00806416|12039232|FG002|COMPLETED|Period 2 - Part II||14
10873268|NCT00806416|12039233|FG003|COMPLETED|Period 2 - Part II||14
10873269|NCT00806416|12039230|FG000|NOT COMPLETED|Period 2 - Part II||0
10873270|NCT00806416|12039231|FG001|NOT COMPLETED|Period 2 - Part II||0
10873271|NCT00806416|12039232|FG002|NOT COMPLETED|Period 2 - Part II||0
10873272|NCT00806416|12039233|FG003|NOT COMPLETED|Period 2 - Part II||0
11112142|NCT01287117|12296329|FG000|Received Treatment|Overall Study||80
11230361|NCT02021955|12422548|FG001|STARTED|Step 2|Provider attrition=2; Provider addition=5; Patient discharges=2|21
11230362|NCT02021955|12422547|FG000|COMPLETED|Step 2||165
11230363|NCT02021955|12422548|FG001|COMPLETED|Step 2||21
11230364|NCT02021955|12422547|FG000|NOT COMPLETED|Step 2||0
11230365|NCT02021955|12422548|FG001|NOT COMPLETED|Step 2||0
11230366|NCT02021955|12422547|FG000|STARTED|Step 3|Provider attrition=2; Provider addition=4; Patient discharges=5|175
11230367|NCT02021955|12422548|FG001|STARTED|Step 3|Provider attrition=0; Provider addition=3; Patient discharges=3|30
11230368|NCT02021955|12422547|FG000|COMPLETED|Step 3||175
11230369|NCT02021955|12422548|FG001|COMPLETED|Step 3||30
11230370|NCT02021955|12422547|FG000|NOT COMPLETED|Step 3||0
11230371|NCT02021955|12422548|FG001|NOT COMPLETED|Step 3||0
11230372|NCT02021955|12422547|FG000|STARTED|Step 4|Provider attrition=0; Provider addition=3; Patient discharges: 13|173
11230373|NCT02021955|12422548|FG001|STARTED|Step 4|Provider attrition=0; Provider addition=1; Patient discharges=0|37
11230374|NCT02021955|12422547|FG000|COMPLETED|Step 4||173
11230375|NCT02021955|12422548|FG001|COMPLETED|Step 4||37
11230376|NCT02021955|12422547|FG000|NOT COMPLETED|Step 4||0
11230377|NCT02021955|12422548|FG001|NOT COMPLETED|Step 4||0
11230378|NCT02021955|12422547|FG000|STARTED|Step 5|Provider attrition=3; Provider addition=0; Patient discharges=11|174
11230379|NCT02021955|12422548|FG001|STARTED|Step 5|Provider attrition=0; Provider addition=0; Patient discharges=2|40
11230380|NCT02021955|12422547|FG000|COMPLETED|Step 5||174
11230381|NCT02021955|12422548|FG001|COMPLETED|Step 5||40
11230382|NCT02021955|12422547|FG000|NOT COMPLETED|Step 5||0
11230383|NCT02021955|12422548|FG001|NOT COMPLETED|Step 5||0
11230384|NCT02021955|12422547|FG000|STARTED|Step 6|Provider attrition=0; Provider addition=2; Patient discharges=6|158
11230385|NCT02021955|12422548|FG001|STARTED|Step 6|Provider attrition=0; Provider addition=1; Patient discharges=1|53
11230386|NCT02021955|12422547|FG000|COMPLETED|Step 6||158
11230387|NCT02021955|12422548|FG001|COMPLETED|Step 6||53
11230388|NCT02021955|12422547|FG000|NOT COMPLETED|Step 6||0
11230389|NCT02021955|12422548|FG001|NOT COMPLETED|Step 6||0
11230390|NCT02021955|12422547|FG000|STARTED|Step 7|Provider attrition=0; Provider addition=2; Patient discharges=13|157
11230391|NCT02021955|12422548|FG001|STARTED|Step 7|Provider attrition=0; Provider addition=1; Patient discharges=2|57
11230392|NCT02021955|12422547|FG000|COMPLETED|Step 7||157
11230393|NCT02021955|12422548|FG001|COMPLETED|Step 7||57
11230394|NCT02021955|12422547|FG000|NOT COMPLETED|Step 7||0
10873273|NCT00729651|12039243|FG000|STARTED|Overall Study||173
10873274|NCT00729651|12039244|FG001|STARTED|Overall Study||170
10873275|NCT00729651|12039243|FG000|COMPLETED|Overall Study||154
10873276|NCT00729651|12039244|FG001|COMPLETED|Overall Study||152
10873277|NCT00729651|12039243|FG000|NOT COMPLETED|Overall Study||19
10873278|NCT00729651|12039244|FG001|NOT COMPLETED|Overall Study||18
10873279|NCT00698815|12039253|FG000|STARTED|Overall Study||42
10873280|NCT00698815|12039254|FG001|STARTED|Overall Study||47
10873281|NCT00698815|12039255|FG002|STARTED|Overall Study||41
10873282|NCT00698815|12039253|FG000|COMPLETED|Overall Study||32
10873283|NCT00698815|12039254|FG001|COMPLETED|Overall Study||33
10873284|NCT00698815|12039255|FG002|COMPLETED|Overall Study||31
10873285|NCT00698815|12039253|FG000|NOT COMPLETED|Overall Study||10
10873286|NCT00698815|12039254|FG001|NOT COMPLETED|Overall Study||14
10873287|NCT00698815|12039255|FG002|NOT COMPLETED|Overall Study||10
10873288|NCT00698022|12039266|FG000|STARTED|Overall Study||30
10873289|NCT00698022|12039267|FG001|STARTED|Overall Study||30
10873290|NCT00698022|12039268|FG002|STARTED|Overall Study||16
10873291|NCT00698022|12039266|FG000|COMPLETED|Overall Study||14
10873292|NCT00698022|12039267|FG001|COMPLETED|Overall Study||20
10873293|NCT00698022|12039268|FG002|COMPLETED|Overall Study||14
10873294|NCT00698022|12039266|FG000|NOT COMPLETED|Overall Study||16
10873295|NCT00698022|12039267|FG001|NOT COMPLETED|Overall Study||10
10873296|NCT00698022|12039268|FG002|NOT COMPLETED|Overall Study||2
10873297|NCT00692913|12039278|FG000|STARTED|Overall Study||257
10873298|NCT00692913|12039279|FG001|STARTED|Overall Study||258
10873299|NCT00692913|12039278|FG000|COMPLETED|Overall Study||228
10873300|NCT00692913|12039279|FG001|COMPLETED|Overall Study||228
10873301|NCT00692913|12039278|FG000|NOT COMPLETED|Overall Study||29
10873302|NCT00692913|12039279|FG001|NOT COMPLETED|Overall Study||30
10873303|NCT00617994|12039290|FG000|STARTED|Overall Study||5
10873304|NCT00617994|12039291|FG001|STARTED|Overall Study||5
10873305|NCT00617994|12039292|FG002|STARTED|Overall Study||5
10873306|NCT00617994|12039293|FG003|STARTED|Overall Study||5
10873307|NCT00617994|12039294|FG004|STARTED|Overall Study||5
10873308|NCT00617994|12039290|FG000|COMPLETED|Overall Study||5
10873309|NCT00617994|12039291|FG001|COMPLETED|Overall Study||5
10873310|NCT00617994|12039292|FG002|COMPLETED|Overall Study||5
10873311|NCT00617994|12039293|FG003|COMPLETED|Overall Study||5
10873312|NCT00617994|12039294|FG004|COMPLETED|Overall Study||5
10873313|NCT00617994|12039290|FG000|NOT COMPLETED|Overall Study||0
10873314|NCT00617994|12039291|FG001|NOT COMPLETED|Overall Study||0
10873315|NCT00617994|12039292|FG002|NOT COMPLETED|Overall Study||0
10873316|NCT00617994|12039293|FG003|NOT COMPLETED|Overall Study||0
10873317|NCT00617994|12039294|FG004|NOT COMPLETED|Overall Study||0
10873318|NCT00617708|12039325|FG000|STARTED|Overall Study||10
10873319|NCT00617708|12039326|FG001|STARTED|Overall Study||60
10873320|NCT00617708|12039327|FG002|STARTED|Overall Study||64
10873321|NCT00617708|12039325|FG000|Eligible and Began Protocol Therapy|Overall Study||9
10873322|NCT00617708|12039326|FG001|Eligible and Began Protocol Therapy|Overall Study||57
10873323|NCT00617708|12039327|FG002|Eligible and Began Protocol Therapy|Overall Study||59
10873324|NCT00617708|12039325|FG000|COMPLETED|Overall Study||0
10873325|NCT00617708|12039326|FG001|COMPLETED|Overall Study||0
10873326|NCT00617708|12039327|FG002|COMPLETED|Overall Study||0
10873327|NCT00617708|12039325|FG000|NOT COMPLETED|Overall Study||10
10873328|NCT00617708|12039326|FG001|NOT COMPLETED|Overall Study||60
10873329|NCT00617708|12039327|FG002|NOT COMPLETED|Overall Study||64
10873330|NCT00516737|12039339|FG000|STARTED|Overall Study||103
10873331|NCT00516737|12039340|FG001|STARTED|Overall Study||104
10873332|NCT00516737|12039339|FG000|COMPLETED|Overall Study||92
10873333|NCT00516737|12039340|FG001|COMPLETED|Overall Study||96
10873334|NCT00516737|12039339|FG000|NOT COMPLETED|Overall Study||11
10873335|NCT00516737|12039340|FG001|NOT COMPLETED|Overall Study||8
10873336|NCT00358527|12039348|FG000|STARTED|Overall Study||267
10873337|NCT00358527|12039349|FG001|STARTED|Overall Study||134
10873338|NCT00358527|12039348|FG000|COMPLETED|Overall Study||254
10873339|NCT00358527|12039349|FG001|COMPLETED|Overall Study||131
10873340|NCT00358527|12039348|FG000|NOT COMPLETED|Overall Study||13
10873341|NCT00358527|12039349|FG001|NOT COMPLETED|Overall Study||3
10873342|NCT00326898|12039358|FG000|STARTED|Overall Study||647
10873343|NCT00326898|12039359|FG001|STARTED|Overall Study||649
10873344|NCT00326898|12039360|FG002|STARTED|Overall Study||647
10873345|NCT00326898|12039358|FG000|Patients With Toxicity Data|Overall Study||625
10873346|NCT00326898|12039359|FG001|Patients With Toxicity Data|Overall Study||628
11230395|NCT02021955|12422548|FG001|NOT COMPLETED|Step 7||0
11230396|NCT02021955|12422547|FG000|STARTED|Step 8|Provider attrition=1; Provider addition=0; Patient discharges=9|144
10873347|NCT00326898|12039360|FG002|Patients With Toxicity Data|Overall Study||626
10873348|NCT00326898|12039358|FG000|Patients With Clear Cell Histology|Overall Study||542
10873349|NCT00326898|12039359|FG001|Patients With Clear Cell Histology|Overall Study||540
10873350|NCT00326898|12039360|FG002|Patients With Clear Cell Histology|Overall Study||540
10873351|NCT00326898|12039358|FG000|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
10873352|NCT00326898|12039359|FG001|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
10873353|NCT00326898|12039360|FG002|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
10873354|NCT00326898|12039358|FG000|COMPLETED|Overall Study||296
10873355|NCT00326898|12039359|FG001|COMPLETED|Overall Study||306
10873356|NCT00326898|12039360|FG002|COMPLETED|Overall Study||444
10873357|NCT00326898|12039358|FG000|NOT COMPLETED|Overall Study||351
10873358|NCT00326898|12039359|FG001|NOT COMPLETED|Overall Study||343
10873359|NCT00326898|12039360|FG002|NOT COMPLETED|Overall Study||203
10873360|NCT00156065|12039371|FG000|STARTED|Overall Study||51
10873361|NCT00156065|12039372|FG001|STARTED|Overall Study||93
10873362|NCT00156065|12039373|FG002|STARTED|Overall Study||43
10873363|NCT00156065|12039371|FG000|COMPLETED|Overall Study||20
10873364|NCT00156065|12039372|FG001|COMPLETED|Overall Study||30
10873365|NCT00156065|12039373|FG002|COMPLETED|Overall Study||16
10873366|NCT00156065|12039371|FG000|NOT COMPLETED|Overall Study||31
10873367|NCT00156065|12039372|FG001|NOT COMPLETED|Overall Study||63
10873368|NCT00156065|12039373|FG002|NOT COMPLETED|Overall Study||27
10873369|NCT00150176|12039383|FG000|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
10873370|NCT00150176|12039384|FG001|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
10873371|NCT00150176|12039383|FG000|COMPLETED|Overall Study||135
10873372|NCT00150176|12039384|FG001|COMPLETED|Overall Study||72
10873373|NCT00150176|12039383|FG000|NOT COMPLETED|Overall Study||59
10873374|NCT00150176|12039384|FG001|NOT COMPLETED|Overall Study||120
10873375|NCT00145509|12039393|FG000|STARTED|Overall Study||41
10873376|NCT00145509|12039394|FG001|STARTED|Overall Study||36
10873377|NCT00145509|12039393|FG000|COMPLETED|Overall Study||19
10873378|NCT00145509|12039394|FG001|COMPLETED|Overall Study||15
10873379|NCT00145509|12039393|FG000|NOT COMPLETED|Overall Study||22
10873380|NCT00145509|12039394|FG001|NOT COMPLETED|Overall Study||21
10873381|NCT00145496|12039402|FG000|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
10873382|NCT00145496|12039403|FG001|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
10873383|NCT00145496|12039402|FG000|COMPLETED|Overall Study||121
10873384|NCT00145496|12039403|FG001|COMPLETED|Overall Study||143
10873385|NCT00145496|12039402|FG000|NOT COMPLETED|Overall Study||123
10873386|NCT00145496|12039403|FG001|NOT COMPLETED|Overall Study||81
10873387|NCT00145470|12039411|FG000|STARTED|Overall Study||167
10873388|NCT00145470|12039412|FG001|STARTED|Overall Study||159
10873389|NCT00145470|12039411|FG000|Treated|Overall Study||166
10873390|NCT00145470|12039412|FG001|Treated|Overall Study||158
10873391|NCT00145470|12039411|FG000|COMPLETED|Overall Study||55
10873392|NCT00145470|12039412|FG001|COMPLETED|Overall Study||61
10873393|NCT00145470|12039411|FG000|NOT COMPLETED|Overall Study||112
10873394|NCT00145470|12039412|FG001|NOT COMPLETED|Overall Study||98
10873395|NCT00129402|12039420|FG000|STARTED|Start Period1 to End Period1 (Week 1-6)||43
10873396|NCT00129402|12039421|FG001|STARTED|Start Period1 to End Period1 (Week 1-6)||40
10873397|NCT00129402|12039422|FG002|STARTED|Start Period1 to End Period1 (Week 1-6)||43
10873398|NCT00129402|12039423|FG003|STARTED|Start Period1 to End Period1 (Week 1-6)||40
10873399|NCT00129402|12039424|FG004|STARTED|Start Period1 to End Period1 (Week 1-6)||40
10873400|NCT00129402|12039425|FG005|STARTED|Start Period1 to End Period1 (Week 1-6)||42
10873401|NCT00129402|12039426|FG006|STARTED|Start Period1 to End Period1 (Week 1-6)||0
10873402|NCT00129402|12039420|FG000|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
10873403|NCT00129402|12039421|FG001|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
10873404|NCT00129402|12039422|FG002|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
10873405|NCT00129402|12039423|FG003|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
10873406|NCT00129402|12039424|FG004|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
10873407|NCT00129402|12039425|FG005|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
10873408|NCT00129402|12039426|FG006|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
10873409|NCT00129402|12039420|FG000|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
10873410|NCT00129402|12039421|FG001|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
10873411|NCT00129402|12039422|FG002|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
10873412|NCT00129402|12039423|FG003|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
10873413|NCT00129402|12039424|FG004|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
10873414|NCT00129402|12039425|FG005|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
10873415|NCT00129402|12039426|FG006|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
10873416|NCT00129402|12039420|FG000|STARTED|Start Period2 to End Period2 (Week 7-33)||0
10873417|NCT00129402|12039421|FG001|STARTED|Start Period2 to End Period2 (Week 7-33)||0
10873418|NCT00129402|12039422|FG002|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
10873419|NCT00129402|12039423|FG003|STARTED|Start Period2 to End Period2 (Week 7-33)||0
10873420|NCT00129402|12039424|FG004|STARTED|Start Period2 to End Period2 (Week 7-33)||0
10873421|NCT00129402|12039425|FG005|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
10873422|NCT00129402|12039426|FG006|STARTED|Start Period2 to End Period2 (Week 7-33)||0
10873423|NCT00129402|12039420|FG000|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873424|NCT00129402|12039421|FG001|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873425|NCT00129402|12039422|FG002|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
10873426|NCT00129402|12039423|FG003|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873427|NCT00129402|12039424|FG004|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873428|NCT00129402|12039425|FG005|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
10873429|NCT00129402|12039426|FG006|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873430|NCT00129402|12039420|FG000|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873431|NCT00129402|12039421|FG001|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873432|NCT00129402|12039422|FG002|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
10873433|NCT00129402|12039423|FG003|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873434|NCT00129402|12039424|FG004|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873435|NCT00129402|12039425|FG005|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
10873436|NCT00129402|12039426|FG006|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
10873437|NCT00129402|12039420|FG000|STARTED|Start Period3 to End Period3(Week 34-53)||0
10873438|NCT00129402|12039421|FG001|STARTED|Start Period3 to End Period3(Week 34-53)||0
10873439|NCT00129402|12039422|FG002|STARTED|Start Period3 to End Period3(Week 34-53)||0
10873440|NCT00129402|12039423|FG003|STARTED|Start Period3 to End Period3(Week 34-53)||0
10873441|NCT00129402|12039424|FG004|STARTED|Start Period3 to End Period3(Week 34-53)||0
10873442|NCT00129402|12039425|FG005|STARTED|Start Period3 to End Period3(Week 34-53)||0
10873443|NCT00129402|12039426|FG006|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
10873444|NCT00129402|12039420|FG000|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873445|NCT00129402|12039421|FG001|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873446|NCT00129402|12039422|FG002|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873447|NCT00129402|12039423|FG003|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873448|NCT00129402|12039424|FG004|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873449|NCT00129402|12039425|FG005|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873450|NCT00129402|12039426|FG006|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
10873451|NCT00129402|12039420|FG000|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873452|NCT00129402|12039421|FG001|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873453|NCT00129402|12039422|FG002|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873454|NCT00129402|12039423|FG003|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873455|NCT00129402|12039424|FG004|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873456|NCT00129402|12039425|FG005|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
10873457|NCT00129402|12039426|FG006|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
10873458|NCT00101439|12039436|FG000|STARTED|Period 1||28
10873459|NCT00101439|12039437|FG001|STARTED|Period 1||30
10873460|NCT00101439|12039436|FG000|COMPLETED|Period 1||28
10873461|NCT00101439|12039437|FG001|COMPLETED|Period 1||30
10873462|NCT00101439|12039436|FG000|NOT COMPLETED|Period 1||0
10873463|NCT00101439|12039437|FG001|NOT COMPLETED|Period 1||0
10873464|NCT00101439|12039436|FG000|STARTED|Period 2||28
10873465|NCT00101439|12039437|FG001|STARTED|Period 2||30
10873466|NCT00101439|12039436|FG000|COMPLETED|Period 2||28
10873467|NCT00101439|12039437|FG001|COMPLETED|Period 2||28
10873468|NCT00101439|12039436|FG000|NOT COMPLETED|Period 2||0
10873469|NCT00101439|12039437|FG001|NOT COMPLETED|Period 2||2
10873470|NCT00096200|12039446|FG000|STARTED|Overall Study||9
10873471|NCT00096200|12039447|FG001|STARTED|Overall Study||30
10873472|NCT00096200|12039448|FG002|STARTED|Overall Study||5
10873473|NCT00096200|12039446|FG000|COMPLETED|Overall Study||8
10873474|NCT00096200|12039447|FG001|COMPLETED|Overall Study||23
10873475|NCT00096200|12039448|FG002|COMPLETED|Overall Study||5
10873476|NCT00096200|12039446|FG000|NOT COMPLETED|Overall Study||1
10873477|NCT00096200|12039447|FG001|NOT COMPLETED|Overall Study||7
10873478|NCT00096200|12039448|FG002|NOT COMPLETED|Overall Study||0
11112143|NCT01287117|12296330|FG001|Received Treatment|Overall Study||77
11112144|NCT01287117|12296331|FG002|Received Treatment|Overall Study||80
11112145|NCT01287117|12296332|FG003|Received Treatment|Overall Study||81
11112146|NCT01287117|12296329|FG000|COMPLETED|Overall Study||65
11112147|NCT01287117|12296330|FG001|COMPLETED|Overall Study||64
11112148|NCT01287117|12296331|FG002|COMPLETED|Overall Study||64
11112149|NCT01287117|12296332|FG003|COMPLETED|Overall Study||69
11112150|NCT01287117|12296329|FG000|NOT COMPLETED|Overall Study||15
11112151|NCT01287117|12296330|FG001|NOT COMPLETED|Overall Study||14
11112152|NCT01287117|12296331|FG002|NOT COMPLETED|Overall Study||16
11112153|NCT01287117|12296332|FG003|NOT COMPLETED|Overall Study||12
11112154|NCT01287195|12296342|FG000|STARTED|Overall Study||6
11112155|NCT01287195|12296342|FG000|COMPLETED|Overall Study||4
11112156|NCT01287195|12296342|FG000|NOT COMPLETED|Overall Study||2
11112157|NCT01287208|12296348|FG000|STARTED|Phase 1: Randomized Phase||52
11230397|NCT02021955|12422548|FG001|STARTED|Step 8|Provider attrition=0; Provider addition=0; Patient discharges=11|73
11230398|NCT02021955|12422547|FG000|COMPLETED|Step 8||144
11230399|NCT02021955|12422548|FG001|COMPLETED|Step 8||73
11230400|NCT02021955|12422547|FG000|NOT COMPLETED|Step 8||0
11230401|NCT02021955|12422548|FG001|NOT COMPLETED|Step 8||0
11230402|NCT02021955|12422547|FG000|STARTED|Step 9|Provider attrition=2; Provider addition=1; Patient discharges=9|139
11230403|NCT02021955|12422548|FG001|STARTED|Step 9|Provider attrition=1; Provider addition=0; Patient discharges=8|77
11230404|NCT02021955|12422547|FG000|COMPLETED|Step 9||139
11230405|NCT02021955|12422548|FG001|COMPLETED|Step 9||77
11230406|NCT02021955|12422547|FG000|NOT COMPLETED|Step 9||0
11112158|NCT01287208|12296349|FG001|STARTED|Phase 1: Randomized Phase||52
11112159|NCT01287208|12296348|FG000|COMPLETED|Phase 1: Randomized Phase||50
10873479|NCT03257267|12039458|FG000|STARTED|Overall Study||304
10873480|NCT03257267|12039459|FG001|STARTED|Overall Study||304
10873481|NCT03257267|12039458|FG000|Full Analysis Set (FAS)|Overall Study||304
10873482|NCT03257267|12039459|FG001|Full Analysis Set (FAS)|Overall Study||304
10873483|NCT03257267|12039458|FG000|Safety Analysis Set (SAF)|Overall Study||300
10873484|NCT03257267|12039459|FG001|Safety Analysis Set (SAF)|Overall Study||290
10873485|NCT03257267|12039458|FG000|Completed Treatment|Overall Study||13
10873486|NCT03257267|12039459|FG001|Completed Treatment|Overall Study||0
10873487|NCT03257267|12039458|FG000|COMPLETED|Overall Study||7
10873488|NCT03257267|12039459|FG001|COMPLETED|Overall Study||0
10873489|NCT03257267|12039458|FG000|NOT COMPLETED|Overall Study||297
10873490|NCT03257267|12039459|FG001|NOT COMPLETED|Overall Study||304
10873491|NCT04581811|12039467|FG000|STARTED|Overall Study||26
10873492|NCT04581811|12039468|FG001|STARTED|Overall Study||26
10873493|NCT04581811|12039467|FG000|COMPLETED|Overall Study||26
10873494|NCT04581811|12039468|FG001|COMPLETED|Overall Study||26
10873495|NCT04581811|12039467|FG000|NOT COMPLETED|Overall Study||0
10873496|NCT04581811|12039468|FG001|NOT COMPLETED|Overall Study||0
11112160|NCT01287208|12296349|FG001|COMPLETED|Phase 1: Randomized Phase||49
11112161|NCT01287208|12296348|FG000|NOT COMPLETED|Phase 1: Randomized Phase||2
11112162|NCT01287208|12296349|FG001|NOT COMPLETED|Phase 1: Randomized Phase||3
10873500|NCT04263987|12039480|FG000|STARTED|Overall Study||30
10873501|NCT04263987|12039481|FG001|STARTED|Overall Study||30
10873502|NCT04263987|12039480|FG000|COMPLETED|Overall Study||30
10873503|NCT04263987|12039481|FG001|COMPLETED|Overall Study||30
10873504|NCT04263987|12039480|FG000|NOT COMPLETED|Overall Study||0
10873505|NCT04263987|12039481|FG001|NOT COMPLETED|Overall Study||0
10873506|NCT04223830|12039487|FG000|STARTED|Overall Study||200
10873507|NCT04223830|12039487|FG000|COMPLETED|Overall Study||190
10873508|NCT04223830|12039487|FG000|NOT COMPLETED|Overall Study||10
11112163|NCT01287208|12296348|FG000|STARTED|Phase 2: Team Competition||50
11112164|NCT01287208|12296349|FG001|STARTED|Phase 2: Team Competition||49
11112165|NCT01287208|12296348|FG000|COMPLETED|Phase 2: Team Competition||50
11112166|NCT01287208|12296349|FG001|COMPLETED|Phase 2: Team Competition||49
11112167|NCT01287208|12296348|FG000|NOT COMPLETED|Phase 2: Team Competition||0
11112168|NCT01287208|12296349|FG001|NOT COMPLETED|Phase 2: Team Competition||0
10873515|NCT04153188|12039503|FG000|STARTED|Overall Study||17
10873516|NCT04153188|12039504|FG001|STARTED|Overall Study||13
10873517|NCT04153188|12039503|FG000|COMPLETED|Overall Study||14
10873518|NCT04153188|12039504|FG001|COMPLETED|Overall Study||11
10873519|NCT04153188|12039503|FG000|NOT COMPLETED|Overall Study||3
10873520|NCT04153188|12039504|FG001|NOT COMPLETED|Overall Study||2
10873521|NCT04108429|12039510|FG000|STARTED|Overall Study||117
10873522|NCT04108429|12039510|FG000|COMPLETED|Overall Study||117
10873523|NCT04108429|12039510|FG000|NOT COMPLETED|Overall Study||0
11112169|NCT01287221|12296359|FG000|STARTED|Overall Study||50
11112170|NCT01287221|12296360|FG001|STARTED|Overall Study||50
11112171|NCT01287221|12296359|FG000|Completed 3 Months Follow-up|Overall Study||49
11112172|NCT01287221|12296360|FG001|Completed 3 Months Follow-up|Overall Study||50
11112173|NCT01287221|12296359|FG000|Completed 6 Months Follow-up|Overall Study||47
11112174|NCT01287221|12296360|FG001|Completed 6 Months Follow-up|Overall Study||43
11112175|NCT01287221|12296359|FG000|Completed 9 Months Follow-up|Overall Study||42
11112176|NCT01287221|12296360|FG001|Completed 9 Months Follow-up|Overall Study||40
11112177|NCT01287221|12296359|FG000|Completed 12 Months Follow-up|Overall Study||40
11112178|NCT01287221|12296360|FG001|Completed 12 Months Follow-up|Overall Study||39
11112179|NCT01287221|12296359|FG000|COMPLETED|Overall Study||46
11112180|NCT01287221|12296360|FG001|COMPLETED|Overall Study||45
11112181|NCT01287221|12296359|FG000|NOT COMPLETED|Overall Study||4
11112182|NCT01287221|12296360|FG001|NOT COMPLETED|Overall Study||5
10873542|NCT04233008|12039531|FG000|STARTED|Overall Study||89
10873543|NCT04233008|12039532|FG001|STARTED|Overall Study||89
10873544|NCT04233008|12039531|FG000|COMPLETED|Overall Study||89
10873545|NCT04233008|12039532|FG001|COMPLETED|Overall Study||89
10873546|NCT04233008|12039531|FG000|NOT COMPLETED|Overall Study||0
10873547|NCT04233008|12039532|FG001|NOT COMPLETED|Overall Study||0
10873548|NCT04179786|12039540|FG000|STARTED|Overall Study||91
10873549|NCT04179786|12039540|FG000|COMPLETED|Overall Study||83
10873550|NCT04179786|12039540|FG000|NOT COMPLETED|Overall Study||8
10873551|NCT04140292|12039546|FG000|STARTED|Overall Study||33
10873552|NCT04140292|12039547|FG001|STARTED|Overall Study||42
10873553|NCT04140292|12039546|FG000|COMPLETED|Overall Study||29
10873554|NCT04140292|12039547|FG001|COMPLETED|Overall Study||26
10873555|NCT04140292|12039546|FG000|NOT COMPLETED|Overall Study||4
10873556|NCT04140292|12039547|FG001|NOT COMPLETED|Overall Study||16
10873557|NCT04064229|12039554|FG000|STARTED|Overall Study||99
10873558|NCT04064229|12039554|FG000|COMPLETED|Overall Study||99
10873559|NCT04064229|12039554|FG000|NOT COMPLETED|Overall Study||0
10873560|NCT03993938|12039560|FG000|STARTED|Overall Study||30
10873561|NCT03993938|12039560|FG000|COMPLETED|Overall Study||30
10873562|NCT03993938|12039560|FG000|NOT COMPLETED|Overall Study||0
11112183|NCT01287364|12296368|FG000|STARTED|Overall Study||94
11112184|NCT01287364|12296369|FG001|STARTED|Overall Study||91
11112185|NCT01287364|12296368|FG000|COMPLETED|Overall Study||85
11112186|NCT01287364|12296369|FG001|COMPLETED|Overall Study||81
11112187|NCT01287364|12296368|FG000|NOT COMPLETED|Overall Study||9
11112188|NCT01287364|12296369|FG001|NOT COMPLETED|Overall Study||10
10873569|NCT03740724|12039573|FG000|STARTED|Overall Study||1
10873570|NCT03740724|12039573|FG000|COMPLETED|Overall Study||0
10873571|NCT03740724|12039573|FG000|NOT COMPLETED|Overall Study||1
11112189|NCT01287377|12296391|FG000|STARTED|Overall Study||80
11112190|NCT01287377|12296392|FG001|STARTED|Overall Study||81
11112191|NCT01287377|12296393|FG002|STARTED|Overall Study||82
11112192|NCT01287377|12296391|FG000|COMPLETED|Overall Study|Study Complete|80
11112193|NCT01287377|12296392|FG001|COMPLETED|Overall Study|Study Complete|81
11112194|NCT01287377|12296393|FG002|COMPLETED|Overall Study|Study Complete|82
10873578|NCT03553836|12039591|FG000|STARTED|Overall Study||487
10873579|NCT03553836|12039592|FG001|STARTED|Overall Study||489
10873580|NCT03553836|12039591|FG000|Treated|Overall Study||483
10873581|NCT03553836|12039592|FG001|Treated|Overall Study||486
10873582|NCT03553836|12039591|FG000|Re-challenged or Switched-over to Pembrolizumab|Overall Study||1
10873583|NCT03553836|12039592|FG001|Re-challenged or Switched-over to Pembrolizumab|Overall Study||45
10873584|NCT03553836|12039591|FG000|COMPLETED|Overall Study||0
10873585|NCT03553836|12039592|FG001|COMPLETED|Overall Study||0
10873586|NCT03553836|12039591|FG000|NOT COMPLETED|Overall Study||487
10873587|NCT03553836|12039592|FG001|NOT COMPLETED|Overall Study||489
10873588|NCT02979522|12039601|FG000|STARTED|Overall Study||8
10873589|NCT02979522|12039602|FG001|STARTED|Overall Study||51
10873590|NCT02979522|12039601|FG000|COMPLETED|Overall Study||8
10873591|NCT02979522|12039602|FG001|COMPLETED|Overall Study||51
10873592|NCT02979522|12039601|FG000|NOT COMPLETED|Overall Study||0
10873593|NCT02979522|12039602|FG001|NOT COMPLETED|Overall Study||0
10873594|NCT02954237|12039614|FG000|STARTED|Overall Study||91
10873595|NCT02954237|12039614|FG000|COMPLETED|Overall Study||48
10873596|NCT02954237|12039614|FG000|NOT COMPLETED|Overall Study||43
11112195|NCT01287377|12296391|FG000|NOT COMPLETED|Overall Study||0
11112196|NCT01287377|12296392|FG001|NOT COMPLETED|Overall Study||0
11112197|NCT01287377|12296393|FG002|NOT COMPLETED|Overall Study||0
11112198|NCT01287403|12296401|FG000|STARTED|Diet Restriction (7 Days)||14
11112199|NCT01287403|12296401|FG000|COMPLETED|Diet Restriction (7 Days)||14
11112200|NCT01287403|12296401|FG000|NOT COMPLETED|Diet Restriction (7 Days)||0
10873603|NCT02714218|12039630|FG000|STARTED|Pre-Treatment Period||180
10873604|NCT02714218|12039631|FG001|STARTED|Pre-Treatment Period||180
10873605|NCT02714218|12039632|FG002|STARTED|Pre-Treatment Period||27
10873606|NCT02714218|12039630|FG000|COMPLETED|Pre-Treatment Period||180
10873607|NCT02714218|12039631|FG001|COMPLETED|Pre-Treatment Period||178
10873608|NCT02714218|12039632|FG002|COMPLETED|Pre-Treatment Period||27
10873609|NCT02714218|12039630|FG000|NOT COMPLETED|Pre-Treatment Period||0
10873610|NCT02714218|12039631|FG001|NOT COMPLETED|Pre-Treatment Period||2
10873611|NCT02714218|12039632|FG002|NOT COMPLETED|Pre-Treatment Period||0
10873612|NCT02714218|12039630|FG000|STARTED|Treatment Period||180
10873613|NCT02714218|12039631|FG001|STARTED|Treatment Period||178
10873614|NCT02714218|12039632|FG002|STARTED|Treatment Period||27
10873615|NCT02714218|12039630|FG000|COMPLETED|Treatment Period||6
10873616|NCT02714218|12039631|FG001|COMPLETED|Treatment Period||2
10873617|NCT02714218|12039632|FG002|COMPLETED|Treatment Period||2
10873618|NCT02714218|12039630|FG000|NOT COMPLETED|Treatment Period||174
10873619|NCT02714218|12039631|FG001|NOT COMPLETED|Treatment Period||176
10873620|NCT02714218|12039632|FG002|NOT COMPLETED|Treatment Period||25
11112201|NCT01287403|12296401|FG000|STARTED|1st Intervention (1 Day)||14
11112202|NCT01287403|12296401|FG000|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
11112203|NCT01287403|12296401|FG000|NOT COMPLETED|1st Intervention (1 Day)||1
11112204|NCT01287403|12296401|FG000|STARTED|Washout 7 Days||13
11112205|NCT01287403|12296401|FG000|COMPLETED|Washout 7 Days||13
11112206|NCT01287403|12296401|FG000|NOT COMPLETED|Washout 7 Days||0
11112207|NCT01287403|12296401|FG000|STARTED|2nd Intervention (1 Day)||13
11112208|NCT01287403|12296401|FG000|COMPLETED|2nd Intervention (1 Day)||13
11112209|NCT01287403|12296401|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0
11112210|NCT01287403|12296401|FG000|STARTED|Washout (7 Days)||13
11112211|NCT01287403|12296401|FG000|COMPLETED|Washout (7 Days)||13
11112212|NCT01287403|12296401|FG000|NOT COMPLETED|Washout (7 Days)||0
11112213|NCT01287403|12296401|FG000|STARTED|3rd Intervention (1 Day)||13
11112214|NCT01287403|12296401|FG000|COMPLETED|3rd Intervention (1 Day)||13
11112215|NCT01287403|12296401|FG000|NOT COMPLETED|3rd Intervention (1 Day)||0
10873635|NCT02652949|12039649|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
10873636|NCT02652949|12039649|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86
10873637|NCT02652949|12039649|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
10873638|NCT02652949|12039649|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
10873639|NCT02652949|12039649|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
10873640|NCT02652949|12039649|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
10873641|NCT02652949|12039649|FG000|STARTED|6-Month Follow-up Secondary Endpoint|Note that 6-month follow up is not mandatory for OUS subjects.|99
10873642|NCT02652949|12039649|FG000|COMPLETED|6-Month Follow-up Secondary Endpoint||91
10873643|NCT02652949|12039649|FG000|NOT COMPLETED|6-Month Follow-up Secondary Endpoint||8
10873644|NCT02652949|12039649|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91
10873645|NCT02652949|12039649|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87
10873646|NCT02652949|12039649|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
10873647|NCT02652949|12039649|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87
11230407|NCT02021955|12422548|FG001|NOT COMPLETED|Step 9||0
10873648|NCT02652949|12039649|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||53
10873649|NCT02652949|12039649|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||34
10873650|NCT02652949|12039649|FG000|STARTED|36-Month Follow-up Secondary Endpoint||53
10873651|NCT02652949|12039649|FG000|COMPLETED|36-Month Follow-up Secondary Endpoint||49
10873652|NCT02652949|12039649|FG000|NOT COMPLETED|36-Month Follow-up Secondary Endpoint||4
10873653|NCT02649439|12039661|FG000|STARTED|Overall Study||40
10873654|NCT02649439|12039662|FG001|STARTED|Overall Study||40
10873655|NCT02649439|12039661|FG000|COMPLETED|Overall Study||13
10873656|NCT02649439|12039662|FG001|COMPLETED|Overall Study||12
10873657|NCT02649439|12039661|FG000|NOT COMPLETED|Overall Study||27
10873658|NCT02649439|12039662|FG001|NOT COMPLETED|Overall Study||28
11112216|NCT01287403|12296401|FG000|STARTED|Washout (7 Days)||13
11112217|NCT01287403|12296401|FG000|COMPLETED|Washout (7 Days)||13
11112218|NCT01287403|12296401|FG000|NOT COMPLETED|Washout (7 Days)||0
11112219|NCT01287403|12296401|FG000|STARTED|4th Intervention (1 Day)||13
11112220|NCT01287403|12296401|FG000|COMPLETED|4th Intervention (1 Day)||13
11112221|NCT01287403|12296401|FG000|NOT COMPLETED|4th Intervention (1 Day)||0
11112222|NCT01287403|12296401|FG000|STARTED|Washout (7 Days)||13
11112223|NCT01287403|12296401|FG000|COMPLETED|Washout (7 Days)||13
11112224|NCT01287403|12296401|FG000|NOT COMPLETED|Washout (7 Days)||0
11112225|NCT01287403|12296401|FG000|STARTED|5th Intervention (1 Day)||13
11112226|NCT01287403|12296401|FG000|COMPLETED|5th Intervention (1 Day)||13
11112227|NCT01287403|12296401|FG000|NOT COMPLETED|5th Intervention (1 Day)||0
11112228|NCT01287403|12296401|FG000|STARTED|Washout (7 Days)||13
11112229|NCT01287403|12296401|FG000|COMPLETED|Washout (7 Days)||13
11112230|NCT01287403|12296401|FG000|NOT COMPLETED|Washout (7 Days)||0
10873674|NCT02579811|12039688|FG000|STARTED|Overall Study||40
10873675|NCT02579811|12039688|FG000|COMPLETED|Overall Study||40
10873676|NCT02579811|12039688|FG000|NOT COMPLETED|Overall Study||0
10873677|NCT02447718|12039694|FG000|STARTED|Overall Study||78
10873678|NCT02447718|12039695|FG001|STARTED|Overall Study||78
10873679|NCT02447718|12039694|FG000|Received Prevnar®13|Overall Study||74
10873680|NCT02447718|12039695|FG001|Received Prevnar®13|Overall Study|Do not receive vaccination|0
10873681|NCT02447718|12039694|FG000|Received Pediacel®|Overall Study||73
10873682|NCT02447718|12039695|FG001|Received Pediacel®|Overall Study|Do not receive vaccination|0
10873683|NCT02447718|12039694|FG000|Received Pneumovax® 23|Overall Study||73
10873684|NCT02447718|12039695|FG001|Received Pneumovax® 23|Overall Study|Do not receive vaccination|0
10873685|NCT02447718|12039694|FG000|COMPLETED|Overall Study||66
10873686|NCT02447718|12039695|FG001|COMPLETED|Overall Study||78
10873687|NCT02447718|12039694|FG000|NOT COMPLETED|Overall Study||12
10873688|NCT02447718|12039695|FG001|NOT COMPLETED|Overall Study||0
11112231|NCT01287403|12296401|FG000|STARTED|6th and Last Intervention (1 Day)||13
11112232|NCT01287403|12296401|FG000|COMPLETED|6th and Last Intervention (1 Day)||13
11112233|NCT01287403|12296401|FG000|NOT COMPLETED|6th and Last Intervention (1 Day)||0
11112234|NCT01287416|12296417|FG000|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
11112235|NCT01287416|12296418|FG001|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
11112236|NCT01287416|12296417|FG000|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
11112237|NCT01287416|12296418|FG001|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
11112238|NCT01287416|12296417|FG000|Post Training Questionnaire|Pre-post Training||26
11112239|NCT01287416|12296418|FG001|Post Training Questionnaire|Pre-post Training||23
11112240|NCT01287416|12296417|FG000|COMPLETED|Pre-post Training||26
11112241|NCT01287416|12296418|FG001|COMPLETED|Pre-post Training||23
11112242|NCT01287416|12296417|FG000|NOT COMPLETED|Pre-post Training||22
11112243|NCT01287416|12296418|FG001|NOT COMPLETED|Pre-post Training||25
11112244|NCT01287416|12296417|FG000|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
11112245|NCT01287416|12296418|FG001|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
11112246|NCT01287416|12296417|FG000|COMPLETED|6 Month Follow-up||28
10873710|NCT01938001|12039725|FG000|STARTED|Overall Study||178
10873711|NCT01938001|12039726|FG001|STARTED|Overall Study||180
10873712|NCT01938001|12039725|FG000|Participants Received Treatment|Overall Study||176
10873713|NCT01938001|12039726|FG001|Participants Received Treatment|Overall Study||180
10873714|NCT01938001|12039725|FG000|Completed Treatment|Overall Study||124
10873715|NCT01938001|12039726|FG001|Completed Treatment|Overall Study||110
10873716|NCT01938001|12039725|FG000|COMPLETED|Overall Study||135
10873717|NCT01938001|12039726|FG001|COMPLETED|Overall Study||133
10873718|NCT01938001|12039725|FG000|NOT COMPLETED|Overall Study||43
10873719|NCT01938001|12039726|FG001|NOT COMPLETED|Overall Study||47
10873720|NCT01529008|12039734|FG000|STARTED|Screening||35
10873721|NCT01529008|12039735|FG001|STARTED|Screening||33
10873722|NCT01529008|12039734|FG000|COMPLETED|Screening||35
10873723|NCT01529008|12039735|FG001|COMPLETED|Screening||33
10873724|NCT01529008|12039734|FG000|NOT COMPLETED|Screening||0
10873725|NCT01529008|12039735|FG001|NOT COMPLETED|Screening||0
10873726|NCT01529008|12039734|FG000|STARTED|Bone Marrow Harvesting||35
10873727|NCT01529008|12039735|FG001|STARTED|Bone Marrow Harvesting||33
10873728|NCT01529008|12039734|FG000|COMPLETED|Bone Marrow Harvesting||34
10873729|NCT01529008|12039735|FG001|COMPLETED|Bone Marrow Harvesting||30
10873730|NCT01529008|12039734|FG000|NOT COMPLETED|Bone Marrow Harvesting||1
10873731|NCT01529008|12039735|FG001|NOT COMPLETED|Bone Marrow Harvesting||3
10873732|NCT01529008|12039734|FG000|STARTED|Treatment||34
10873733|NCT01529008|12039735|FG001|STARTED|Treatment||30
10873734|NCT01529008|12039734|FG000|COMPLETED|Treatment||25
10873735|NCT01529008|12039735|FG001|COMPLETED|Treatment||29
10873736|NCT01529008|12039734|FG000|NOT COMPLETED|Treatment||9
10873737|NCT01529008|12039735|FG001|NOT COMPLETED|Treatment||1
10873738|NCT01529008|12039734|FG000|STARTED|Efficacy Analysis||25
10873739|NCT01529008|12039735|FG001|STARTED|Efficacy Analysis||29
10873740|NCT01529008|12039734|FG000|COMPLETED|Efficacy Analysis||23
10873741|NCT01529008|12039735|FG001|COMPLETED|Efficacy Analysis||26
10873742|NCT01529008|12039734|FG000|NOT COMPLETED|Efficacy Analysis||2
10873743|NCT01529008|12039735|FG001|NOT COMPLETED|Efficacy Analysis||3
10873744|NCT01484691|12039744|FG000|STARTED|Overall Study||21
10873745|NCT01484691|12039745|FG001|STARTED|Overall Study||22
10873746|NCT01484691|12039746|FG002|STARTED|Overall Study||12
10873747|NCT01484691|12039744|FG000|COMPLETED|Overall Study||20
10873748|NCT01484691|12039745|FG001|COMPLETED|Overall Study||19
10873749|NCT01484691|12039746|FG002|COMPLETED|Overall Study||10
10873750|NCT01484691|12039744|FG000|NOT COMPLETED|Overall Study||1
10873751|NCT01484691|12039745|FG001|NOT COMPLETED|Overall Study||3
10873752|NCT01484691|12039746|FG002|NOT COMPLETED|Overall Study||2
10873753|NCT01125371|12039758|FG000|STARTED|Overall Study||146
10873754|NCT01125371|12039759|FG001|STARTED|Overall Study||145
10873755|NCT01125371|12039760|FG002|STARTED|Overall Study||148
10873756|NCT01125371|12039758|FG000|3 Months Follow up|Overall Study||127
10873757|NCT01125371|12039759|FG001|3 Months Follow up|Overall Study||131
10873758|NCT01125371|12039760|FG002|3 Months Follow up|Overall Study||135
10873759|NCT01125371|12039758|FG000|6 Months Follow up|Overall Study||125
10873760|NCT01125371|12039759|FG001|6 Months Follow up|Overall Study||133
10873761|NCT01125371|12039760|FG002|6 Months Follow up|Overall Study||131
10873762|NCT01125371|12039758|FG000|12 Months Follow up|Overall Study||120
10873763|NCT01125371|12039759|FG001|12 Months Follow up|Overall Study||130
10873764|NCT01125371|12039760|FG002|12 Months Follow up|Overall Study||129
11112247|NCT01287416|12296418|FG001|COMPLETED|6 Month Follow-up||22
11112248|NCT01287416|12296417|FG000|NOT COMPLETED|6 Month Follow-up||3
11112249|NCT01287416|12296418|FG001|NOT COMPLETED|6 Month Follow-up||2
11112250|NCT01287520|12296433|FG000|STARTED|Overall Study||3
11112251|NCT01287520|12296434|FG001|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
11112252|NCT01287520|12296435|FG002|STARTED|Overall Study||5
11112253|NCT01287520|12296436|FG003|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
11112254|NCT01287520|12296437|FG004|STARTED|Overall Study||3
11112255|NCT01287520|12296438|FG005|STARTED|Overall Study||4
11112256|NCT01287520|12296439|FG006|STARTED|Overall Study||2
11112257|NCT01287520|12296440|FG007|STARTED|Overall Study||5
11112258|NCT01287520|12296441|FG008|STARTED|Overall Study||5
11112259|NCT01287520|12296433|FG000|COMPLETED|Overall Study||0
11112260|NCT01287520|12296434|FG001|COMPLETED|Overall Study||0
11112261|NCT01287520|12296435|FG002|COMPLETED|Overall Study||0
11112262|NCT01287520|12296436|FG003|COMPLETED|Overall Study||0
11112263|NCT01287520|12296437|FG004|COMPLETED|Overall Study||0
11112264|NCT01287520|12296438|FG005|COMPLETED|Overall Study||0
11112265|NCT01287520|12296439|FG006|COMPLETED|Overall Study||0
11112266|NCT01287520|12296440|FG007|COMPLETED|Overall Study||0
11112267|NCT01287520|12296441|FG008|COMPLETED|Overall Study||0
11112268|NCT01287520|12296433|FG000|NOT COMPLETED|Overall Study||3
11112269|NCT01287520|12296434|FG001|NOT COMPLETED|Overall Study||7
11112270|NCT01287520|12296435|FG002|NOT COMPLETED|Overall Study||5
11112271|NCT01287520|12296436|FG003|NOT COMPLETED|Overall Study||7
11112272|NCT01287520|12296437|FG004|NOT COMPLETED|Overall Study||3
11112273|NCT01287520|12296438|FG005|NOT COMPLETED|Overall Study||4
11112274|NCT01287520|12296439|FG006|NOT COMPLETED|Overall Study||2
11112275|NCT01287520|12296440|FG007|NOT COMPLETED|Overall Study||5
11112276|NCT01287520|12296441|FG008|NOT COMPLETED|Overall Study||5
11112277|NCT01287754|12296492|FG000|STARTED|Overall Study||3
11112278|NCT01287754|12296493|FG001|STARTED|Overall Study||21
11112279|NCT01287754|12296492|FG000|COMPLETED|Overall Study||0
11112280|NCT01287754|12296493|FG001|COMPLETED|Overall Study||0
11112281|NCT01287754|12296492|FG000|NOT COMPLETED|Overall Study||3
11112282|NCT01287754|12296493|FG001|NOT COMPLETED|Overall Study||21
11112283|NCT01287832|12296501|FG000|STARTED|Overall Study||6
11112284|NCT01287832|12296502|FG001|STARTED|Overall Study||5
11112285|NCT01287832|12296501|FG000|COMPLETED|Overall Study||5
11112286|NCT01287832|12296502|FG001|COMPLETED|Overall Study||4
11112287|NCT01287832|12296501|FG000|NOT COMPLETED|Overall Study||1
11112288|NCT01287832|12296502|FG001|NOT COMPLETED|Overall Study||1
11112289|NCT01287897|12296512|FG000|STARTED|Overall Study||70
11112290|NCT01287897|12296513|FG001|STARTED|Overall Study||69
11112291|NCT01287897|12296514|FG002|STARTED|Overall Study||71
11112292|NCT01287897|12296515|FG003|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
11112293|NCT01287897|12296512|FG000|Treated|Overall Study||69
11112294|NCT01287897|12296513|FG001|Treated|Overall Study||67
11112295|NCT01287897|12296514|FG002|Treated|Overall Study||71
10873765|NCT01125371|12039758|FG000|COMPLETED|Overall Study||120
10873766|NCT01125371|12039759|FG001|COMPLETED|Overall Study||130
10873767|NCT01125371|12039760|FG002|COMPLETED|Overall Study||129
10873768|NCT01125371|12039758|FG000|NOT COMPLETED|Overall Study||26
10873769|NCT01125371|12039759|FG001|NOT COMPLETED|Overall Study||15
10873770|NCT01125371|12039760|FG002|NOT COMPLETED|Overall Study||19
11230408|NCT02021955|12422547|FG000|STARTED|Step 10|Provider attrition=0; Provider addition=1; Patient discharges: 8|135
11230409|NCT02021955|12422548|FG001|STARTED|Step 10|Provider attrition=1; Provider addition=0; Patient discharges=5|79
11230410|NCT02021955|12422547|FG000|COMPLETED|Step 10||135
11230411|NCT02021955|12422548|FG001|COMPLETED|Step 10||79
11230412|NCT02021955|12422547|FG000|NOT COMPLETED|Step 10||0
11230413|NCT02021955|12422548|FG001|NOT COMPLETED|Step 10||0
11230414|NCT02021955|12422547|FG000|STARTED|Step 11|Provider attrition=1; Provider addition=0; Patient discharges=11|126
11230415|NCT02021955|12422548|FG001|STARTED|Step 11|Provider attrition=2; Provider addition=2; Patient discharges=7|88
11230416|NCT02021955|12422547|FG000|COMPLETED|Step 11||126
11230417|NCT02021955|12422548|FG001|COMPLETED|Step 11||88
11230418|NCT02021955|12422547|FG000|NOT COMPLETED|Step 11||0
11230419|NCT02021955|12422548|FG001|NOT COMPLETED|Step 11||0
11230420|NCT02021955|12422547|FG000|STARTED|Step 12|Provider attrition=1; Provider addition=0; Patient discharges=3|123
11230421|NCT02021955|12422548|FG001|STARTED|Step 12|Provider attrition=0; Provider addition=2; Patient discharges=1|90
11230422|NCT02021955|12422547|FG000|COMPLETED|Step 12||123
11230423|NCT02021955|12422548|FG001|COMPLETED|Step 12||90
11230424|NCT02021955|12422547|FG000|NOT COMPLETED|Step 12||0
11230425|NCT02021955|12422548|FG001|NOT COMPLETED|Step 12||0
11230426|NCT02021955|12422547|FG000|STARTED|Step 13|Provider attrition=10; Provider addition=0; Patient discharges=4|118
11230427|NCT02021955|12422548|FG001|STARTED|Step 13|Provider attrition=4; Provider addition=0; Patient discharges=5|96
11230428|NCT02021955|12422547|FG000|COMPLETED|Step 13||118
11230429|NCT02021955|12422548|FG001|COMPLETED|Step 13||96
11230430|NCT02021955|12422547|FG000|NOT COMPLETED|Step 13||0
11230431|NCT02021955|12422548|FG001|NOT COMPLETED|Step 13||0
11230432|NCT02021955|12422547|FG000|STARTED|Step 14|Provider attrition=1; Provider addition=9; Patient discharges=7|105
11230433|NCT02021955|12422548|FG001|STARTED|Step 14|Provider attrition=7; Provider addition=11; Patient discharges=3|95
11230434|NCT02021955|12422547|FG000|COMPLETED|Step 14||105
11230435|NCT02021955|12422548|FG001|COMPLETED|Step 14||95
11230436|NCT02021955|12422547|FG000|NOT COMPLETED|Step 14||0
11230437|NCT02021955|12422548|FG001|NOT COMPLETED|Step 14||0
10873771|NCT00400946|12039773|FG000|STARTED|Overall Study||231
10873772|NCT00400946|12039774|FG001|STARTED|Overall Study||232
10873773|NCT00400946|12039775|FG002|STARTED|Overall Study||42
10873774|NCT00400946|12039776|FG003|STARTED|Overall Study||51
10873775|NCT00400946|12039777|FG004|STARTED|Overall Study||244
10873776|NCT00400946|12039773|FG000|Evaluable for CNS Directed-Treatment|Overall Study||231
10873777|NCT00400946|12039774|FG001|Evaluable for CNS Directed-Treatment|Overall Study||232
10873778|NCT00400946|12039775|FG002|Evaluable for CNS Directed-Treatment|Overall Study||42
10873779|NCT00400946|12039776|FG003|Evaluable for CNS Directed-Treatment|Overall Study||21
10873780|NCT00400946|12039777|FG004|Evaluable for CNS Directed-Treatment|Overall Study||227
10873781|NCT00400946|12039773|FG000|Evaluable for Day 18 Marrow Morphology|Overall Study||158
10873782|NCT00400946|12039774|FG001|Evaluable for Day 18 Marrow Morphology|Overall Study||161
10873783|NCT00400946|12039775|FG002|Evaluable for Day 18 Marrow Morphology|Overall Study||19
10873784|NCT00400946|12039776|FG003|Evaluable for Day 18 Marrow Morphology|Overall Study||13
10873785|NCT00400946|12039777|FG004|Evaluable for Day 18 Marrow Morphology|Overall Study||152
10873786|NCT00400946|12039773|FG000|Evaluable for Day 32 MRD|Overall Study||166
10873787|NCT00400946|12039774|FG001|Evaluable for Day 32 MRD|Overall Study||167
10873788|NCT00400946|12039775|FG002|Evaluable for Day 32 MRD|Overall Study||33
10873789|NCT00400946|12039776|FG003|Evaluable for Day 32 MRD|Overall Study||12
10873790|NCT00400946|12039777|FG004|Evaluable for Day 32 MRD|Overall Study||168
10873791|NCT00400946|12039773|FG000|Eligible and Treated|Overall Study||231
10873792|NCT00400946|12039774|FG001|Eligible and Treated|Overall Study||232
10873793|NCT00400946|12039775|FG002|Eligible and Treated|Overall Study||42
10873794|NCT00400946|12039776|FG003|Eligible and Treated|Overall Study||46
10873795|NCT00400946|12039777|FG004|Eligible and Treated|Overall Study||243
10873796|NCT00400946|12039773|FG000|COMPLETED|Overall Study||217
10873797|NCT00400946|12039774|FG001|COMPLETED|Overall Study||221
10873798|NCT00400946|12039775|FG002|COMPLETED|Overall Study||40
10873799|NCT00400946|12039776|FG003|COMPLETED|Overall Study||4
10873800|NCT00400946|12039777|FG004|COMPLETED|Overall Study||206
11112296|NCT01287897|12296515|FG003|Treated|Overall Study||40
11112297|NCT01287897|12296512|FG000|Completed Treatment Period|Overall Study||58
11112298|NCT01287897|12296513|FG001|Completed Treatment Period|Overall Study||52
11112299|NCT01287897|12296514|FG002|Completed Treatment Period|Overall Study||58
10873801|NCT00400946|12039773|FG000|NOT COMPLETED|Overall Study||14
10873802|NCT00400946|12039774|FG001|NOT COMPLETED|Overall Study||11
10873803|NCT00400946|12039775|FG002|NOT COMPLETED|Overall Study||2
10873804|NCT00400946|12039776|FG003|NOT COMPLETED|Overall Study||47
10873805|NCT00400946|12039777|FG004|NOT COMPLETED|Overall Study||38
10873806|NCT00180414|12039797|FG000|STARTED|Overall Study||4
10873807|NCT00180414|12039798|FG001|STARTED|Overall Study||4
10873808|NCT00180414|12039797|FG000|COMPLETED|Overall Study||0
10873809|NCT00180414|12039798|FG001|COMPLETED|Overall Study||0
10873810|NCT00180414|12039797|FG000|NOT COMPLETED|Overall Study||4
10873811|NCT00180414|12039798|FG001|NOT COMPLETED|Overall Study||4
10873812|NCT04061915|12039806|FG000|STARTED|Overall Study||161
10873813|NCT04061915|12039807|FG001|STARTED|Overall Study||161
10873814|NCT04061915|12039806|FG000|COMPLETED|Overall Study||161
10873815|NCT04061915|12039807|FG001|COMPLETED|Overall Study||161
10873816|NCT04061915|12039806|FG000|NOT COMPLETED|Overall Study||0
10873817|NCT04061915|12039807|FG001|NOT COMPLETED|Overall Study||0
10873818|NCT03990766|12039816|FG000|STARTED|Overall Study||14
10873819|NCT03990766|12039817|FG001|STARTED|Overall Study||13
10873820|NCT03990766|12039816|FG000|COMPLETED|Overall Study||12
10873821|NCT03990766|12039817|FG001|COMPLETED|Overall Study||10
10873822|NCT03990766|12039816|FG000|NOT COMPLETED|Overall Study||2
10873823|NCT03990766|12039817|FG001|NOT COMPLETED|Overall Study||3
10873824|NCT03947333|12039825|FG000|STARTED|Overall Study||135
10873825|NCT03947333|12039826|FG001|STARTED|Overall Study||135
10873826|NCT03947333|12039825|FG000|COMPLETED|Overall Study||135
10873827|NCT03947333|12039826|FG001|COMPLETED|Overall Study||135
10873828|NCT03947333|12039825|FG000|NOT COMPLETED|Overall Study||0
10873829|NCT03947333|12039826|FG001|NOT COMPLETED|Overall Study||0
10873830|NCT03886220|12039835|FG000|STARTED|Treatment Period||28
10873831|NCT03886220|12039836|FG001|STARTED|Treatment Period||54
10873832|NCT03886220|12039835|FG000|COMPLETED|Treatment Period||23
10873833|NCT03886220|12039836|FG001|COMPLETED|Treatment Period||42
10873834|NCT03886220|12039835|FG000|NOT COMPLETED|Treatment Period||5
10873835|NCT03886220|12039836|FG001|NOT COMPLETED|Treatment Period||12
10873836|NCT03886220|12039835|FG000|STARTED|Post-Treatment Follow-Up Period||25
10873837|NCT03886220|12039836|FG001|STARTED|Post-Treatment Follow-Up Period||41
10873838|NCT03886220|12039835|FG000|COMPLETED|Post-Treatment Follow-Up Period||23
10873839|NCT03886220|12039836|FG001|COMPLETED|Post-Treatment Follow-Up Period||39
10873840|NCT03886220|12039835|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2
10873841|NCT03886220|12039836|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||2
11112300|NCT01287897|12296515|FG003|Completed Treatment Period|Overall Study||29
10873842|NCT03800979|12039842|FG000|STARTED|Overall Study||19
10873843|NCT03800979|12039842|FG000|COMPLETED|Overall Study||19
10873844|NCT03800979|12039842|FG000|NOT COMPLETED|Overall Study||0
10873845|NCT03794661|12039846|FG000|STARTED|Overall Study||8
10873846|NCT03794661|12039846|FG000|COMPLETED|Overall Study||8
10873847|NCT03794661|12039846|FG000|NOT COMPLETED|Overall Study||0
10873848|NCT03691909|12039850|FG000|STARTED|Overall Study||15
10873849|NCT03691909|12039850|FG000|Per Protocol Population Day 1|Overall Study||15
10873850|NCT03691909|12039850|FG000|Per Protocol Population Week 1|Overall Study||15
10873851|NCT03691909|12039850|FG000|Per Protocol Population Week 4|Overall Study||14
10873852|NCT03691909|12039850|FG000|Per Protocol Population Week 8|Overall Study||13
10873853|NCT03691909|12039850|FG000|Per Protocol Population Week 12|Overall Study||15
10873854|NCT03691909|12039850|FG000|Per Protocol Population Week 26|Overall Study||14
10873855|NCT03691909|12039850|FG000|Per Protocol Population Week 52|Overall Study||13
10873856|NCT03691909|12039850|FG000|COMPLETED|Overall Study||15
10873857|NCT03691909|12039850|FG000|NOT COMPLETED|Overall Study||0
11112301|NCT01287897|12296512|FG000|Completed Follow-up Period|Overall Study||3
11112302|NCT01287897|12296513|FG001|Completed Follow-up Period|Overall Study||8
11112303|NCT01287897|12296514|FG002|Completed Follow-up Period|Overall Study||3
11112304|NCT01287897|12296515|FG003|Completed Follow-up Period|Overall Study||4
11112305|NCT01287897|12296512|FG000|Enrolled in NCT01345318|Overall Study||56
11112306|NCT01287897|12296513|FG001|Enrolled in NCT01345318|Overall Study||50
11112307|NCT01287897|12296514|FG002|Enrolled in NCT01345318|Overall Study||56
11112308|NCT01287897|12296515|FG003|Enrolled in NCT01345318|Overall Study||29
11112309|NCT01287897|12296512|FG000|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
11112310|NCT01287897|12296513|FG001|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
11112311|NCT01287897|12296514|FG002|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
11112312|NCT01287897|12296515|FG003|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
11112313|NCT01287897|12296512|FG000|NOT COMPLETED|Overall Study||11
11112314|NCT01287897|12296513|FG001|NOT COMPLETED|Overall Study||11
11112315|NCT01287897|12296514|FG002|NOT COMPLETED|Overall Study||12
11112316|NCT01287897|12296515|FG003|NOT COMPLETED|Overall Study||7
11112317|NCT01288027|12296529|FG000|STARTED|Overall Study||16
11112318|NCT01288027|12296529|FG000|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
11112319|NCT01288027|12296529|FG000|COMPLETED|Overall Study||16
11112320|NCT01288027|12296529|FG000|NOT COMPLETED|Overall Study||0
11112321|NCT01288053|12296533|FG000|STARTED|Overall Study||9
11112322|NCT01288053|12296533|FG000|COMPLETED|Overall Study||8
11112323|NCT01288053|12296533|FG000|NOT COMPLETED|Overall Study||1
11112324|NCT01288079|12296541|FG000|STARTED|Overall Study||37
11112325|NCT01288079|12296542|FG001|STARTED|Overall Study||36
11112326|NCT01288079|12296543|FG002|STARTED|Overall Study||37
11112327|NCT01288079|12296544|FG003|STARTED|Overall Study||35
11112328|NCT01288079|12296541|FG000|COMPLETED|Overall Study||17
11112329|NCT01288079|12296542|FG001|COMPLETED|Overall Study||9
11112330|NCT01288079|12296543|FG002|COMPLETED|Overall Study||18
11112331|NCT01288079|12296544|FG003|COMPLETED|Overall Study||18
11112332|NCT01288079|12296541|FG000|NOT COMPLETED|Overall Study||20
11112333|NCT01288079|12296542|FG001|NOT COMPLETED|Overall Study||27
11112334|NCT01288079|12296543|FG002|NOT COMPLETED|Overall Study||19
11112335|NCT01288079|12296544|FG003|NOT COMPLETED|Overall Study||17
11112336|NCT01288209|12296556|FG000|STARTED|Overall Study||53
11112337|NCT01288209|12296557|FG001|STARTED|Overall Study||53
11112338|NCT01288209|12296556|FG000|COMPLETED|Overall Study||51
11112339|NCT01288209|12296557|FG001|COMPLETED|Overall Study||50
11112340|NCT01288209|12296556|FG000|NOT COMPLETED|Overall Study||2
11112341|NCT01288209|12296557|FG001|NOT COMPLETED|Overall Study||3
11112342|NCT01288287|12296563|FG000|STARTED|Overall Study||149
11112343|NCT01288287|12296563|FG000|Safety Set|Overall Study||147
11112344|NCT01288287|12296563|FG000|Full Analysis Set|Overall Study||111
11112345|NCT01288287|12296563|FG000|COMPLETED|Overall Study||103
11112346|NCT01288287|12296563|FG000|NOT COMPLETED|Overall Study||46
11112347|NCT01288430|12296578|FG000|STARTED|Part 1||2
11112348|NCT01288430|12296579|FG001|STARTED|Part 1||3
11112349|NCT01288430|12296580|FG002|STARTED|Part 1||5
11112350|NCT01288430|12296581|FG003|STARTED|Part 1||7
11112351|NCT01288430|12296582|FG004|STARTED|Part 1||3
11112352|NCT01288430|12296583|FG005|STARTED|Part 1||6
11112353|NCT01288430|12296584|FG006|STARTED|Part 1||7
11112354|NCT01288430|12296585|FG007|STARTED|Part 1||0
11112355|NCT01288430|12296586|FG008|STARTED|Part 1||0
11112356|NCT01288430|12296587|FG009|STARTED|Part 1||0
10873858|NCT03627091|12039858|FG000|STARTED|Overall Study||19
10873859|NCT03627091|12039859|FG001|STARTED|Overall Study||10
10873860|NCT03627091|12039860|FG002|STARTED|Overall Study||11
10873861|NCT03627091|12039858|FG000|COMPLETED|Overall Study||7
10873862|NCT03627091|12039859|FG001|COMPLETED|Overall Study||4
11112357|NCT01288430|12296578|FG000|COMPLETED|Part 1||0
10873863|NCT03627091|12039860|FG002|COMPLETED|Overall Study||6
10873864|NCT03627091|12039858|FG000|NOT COMPLETED|Overall Study||12
10873865|NCT03627091|12039859|FG001|NOT COMPLETED|Overall Study||6
10873866|NCT03627091|12039860|FG002|NOT COMPLETED|Overall Study||5
10873867|NCT03568318|12039875|FG000|STARTED|Overall Study||264
10873868|NCT03568318|12039876|FG001|STARTED|Overall Study||261
10873869|NCT03568318|12039877|FG002|STARTED|Overall Study||260
10873870|NCT03568318|12039878|FG003|STARTED|Overall Study||63
10873871|NCT03568318|12039879|FG004|STARTED|Overall Study||60
10873872|NCT03568318|12039880|FG005|STARTED|Overall Study||60
10873873|NCT03568318|12039875|FG000|Received Study Drug|Overall Study||264
10873874|NCT03568318|12039876|FG001|Received Study Drug|Overall Study||261
10873875|NCT03568318|12039877|FG002|Received Study Drug|Overall Study||260
10873876|NCT03568318|12039878|FG003|Received Study Drug|Overall Study||62
10873877|NCT03568318|12039879|FG004|Received Study Drug|Overall Study||60
10873878|NCT03568318|12039880|FG005|Received Study Drug|Overall Study||60
10873879|NCT03568318|12039875|FG000|COMPLETED|Overall Study||244
10873880|NCT03568318|12039876|FG001|COMPLETED|Overall Study||249
10873881|NCT03568318|12039877|FG002|COMPLETED|Overall Study||250
10873882|NCT03568318|12039878|FG003|COMPLETED|Overall Study||59
10873883|NCT03568318|12039879|FG004|COMPLETED|Overall Study||58
10873884|NCT03568318|12039880|FG005|COMPLETED|Overall Study||60
10873885|NCT03568318|12039875|FG000|NOT COMPLETED|Overall Study||20
10873886|NCT03568318|12039876|FG001|NOT COMPLETED|Overall Study||12
10873887|NCT03568318|12039877|FG002|NOT COMPLETED|Overall Study||10
10873888|NCT03568318|12039878|FG003|NOT COMPLETED|Overall Study||4
10873889|NCT03568318|12039879|FG004|NOT COMPLETED|Overall Study||2
10873890|NCT03568318|12039880|FG005|NOT COMPLETED|Overall Study||0
11112358|NCT01288430|12296579|FG001|COMPLETED|Part 1||0
11112359|NCT01288430|12296580|FG002|COMPLETED|Part 1||0
10873891|NCT03498560|12039894|FG000|STARTED|Overall Study||38
10873892|NCT03498560|12039894|FG000|Completed Baseline Assessment|Overall Study||32
10873893|NCT03498560|12039894|FG000|Completed PSG|Overall Study||25
10873894|NCT03498560|12039894|FG000|COMPLETED|Overall Study||17
10873895|NCT03498560|12039894|FG000|NOT COMPLETED|Overall Study||21
10873896|NCT03441360|12039902|FG000|STARTED|Overall Study||8
10873897|NCT03441360|12039903|FG001|STARTED|Overall Study||8
10873898|NCT03441360|12039904|FG002|STARTED|Overall Study||5
10873899|NCT03441360|12039902|FG000|COMPLETED|Overall Study||0
10873900|NCT03441360|12039903|FG001|COMPLETED|Overall Study||0
10873901|NCT03441360|12039904|FG002|COMPLETED|Overall Study||0
10873902|NCT03441360|12039902|FG000|NOT COMPLETED|Overall Study||8
10873903|NCT03441360|12039903|FG001|NOT COMPLETED|Overall Study||8
10873904|NCT03441360|12039904|FG002|NOT COMPLETED|Overall Study||5
10873905|NCT03368170|12039914|FG000|STARTED|Overall Study||39
10873906|NCT03368170|12039915|FG001|STARTED|Overall Study||36
10873907|NCT03368170|12039914|FG000|COMPLETED|Overall Study||37
10873908|NCT03368170|12039915|FG001|COMPLETED|Overall Study||35
10873909|NCT03368170|12039914|FG000|NOT COMPLETED|Overall Study||2
10873910|NCT03368170|12039915|FG001|NOT COMPLETED|Overall Study||1
10873911|NCT03336528|12039923|FG000|STARTED|Overall Study||92
10873912|NCT03336528|12039924|FG001|STARTED|Overall Study||88
10874001|NCT02921776|12040025|FG005|NOT COMPLETED|Overall Study||2
11112360|NCT01288430|12296581|FG003|COMPLETED|Part 1||0
11112361|NCT01288430|12296582|FG004|COMPLETED|Part 1||0
11112362|NCT01288430|12296583|FG005|COMPLETED|Part 1||0
11112363|NCT01288430|12296584|FG006|COMPLETED|Part 1||0
11112364|NCT01288430|12296585|FG007|COMPLETED|Part 1||0
11112365|NCT01288430|12296586|FG008|COMPLETED|Part 1||0
10873913|NCT03336528|12039923|FG000|Participated in Optional Outpatient Study|Overall Study||72
10873914|NCT03336528|12039924|FG001|Participated in Optional Outpatient Study|Overall Study||59
10873915|NCT03336528|12039923|FG000|COMPLETED|Overall Study||82
10873916|NCT03336528|12039924|FG001|COMPLETED|Overall Study||79
10873917|NCT03336528|12039923|FG000|NOT COMPLETED|Overall Study||10
10873918|NCT03336528|12039924|FG001|NOT COMPLETED|Overall Study||9
10873919|NCT03334409|12039934|FG000|STARTED|Overall Study||2
10873920|NCT03334409|12039935|FG001|STARTED|Overall Study||3
10873921|NCT03334409|12039934|FG000|COMPLETED|Overall Study||1
10873922|NCT03334409|12039935|FG001|COMPLETED|Overall Study||3
10873923|NCT03334409|12039934|FG000|NOT COMPLETED|Overall Study||1
10873924|NCT03334409|12039935|FG001|NOT COMPLETED|Overall Study||0
10873925|NCT03287843|12039943|FG000|STARTED|Overall Study||175
10873926|NCT03287843|12039944|FG001|STARTED|Overall Study||175
10873927|NCT03287843|12039943|FG000|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12
10873928|NCT03287843|12039944|FG001|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8
10873929|NCT03287843|12039943|FG000|Lost to Follow up|Overall Study||3
10873930|NCT03287843|12039944|FG001|Lost to Follow up|Overall Study||0
10873931|NCT03287843|12039943|FG000|COMPLETED|Overall Study||160
10873932|NCT03287843|12039944|FG001|COMPLETED|Overall Study||167
10873933|NCT03287843|12039943|FG000|NOT COMPLETED|Overall Study||15
10873934|NCT03287843|12039944|FG001|NOT COMPLETED|Overall Study||8
10873935|NCT03084536|12039953|FG000|STARTED|Overall Study||53
10873936|NCT03084536|12039954|FG001|STARTED|Overall Study||54
10873937|NCT03084536|12039955|FG002|STARTED|Overall Study||27
10873938|NCT03084536|12039953|FG000|COMPLETED|Overall Study||53
10873939|NCT03084536|12039954|FG001|COMPLETED|Overall Study||54
10873940|NCT03084536|12039955|FG002|COMPLETED|Overall Study||0
10873941|NCT03084536|12039953|FG000|NOT COMPLETED|Overall Study||0
10873942|NCT03084536|12039954|FG001|NOT COMPLETED|Overall Study||0
10873943|NCT03084536|12039955|FG002|NOT COMPLETED|Overall Study||27
10873944|NCT02996305|12039965|FG000|STARTED|Overall Study||29
10873945|NCT02996305|12039966|FG001|STARTED|Overall Study||29
10873946|NCT02996305|12039967|FG002|STARTED|Overall Study||30
10873947|NCT02996305|12039965|FG000|COMPLETED|Overall Study||26
10873948|NCT02996305|12039966|FG001|COMPLETED|Overall Study||27
10873949|NCT02996305|12039967|FG002|COMPLETED|Overall Study||25
10873950|NCT02996305|12039965|FG000|NOT COMPLETED|Overall Study||3
10873951|NCT02996305|12039966|FG001|NOT COMPLETED|Overall Study||2
10873952|NCT02996305|12039967|FG002|NOT COMPLETED|Overall Study||5
10873953|NCT02992119|12039982|FG000|STARTED|Overall Study||21
10873954|NCT02992119|12039983|FG001|STARTED|Overall Study||21
10873955|NCT02992119|12039984|FG002|STARTED|Overall Study||30
10873956|NCT02992119|12039985|FG003|STARTED|Overall Study||30
10873957|NCT02992119|12039986|FG004|STARTED|Overall Study||30
10873958|NCT02992119|12039987|FG005|STARTED|Overall Study||30
10873959|NCT02992119|12039988|FG006|STARTED|Overall Study||31
10873960|NCT02992119|12039982|FG000|COMPLETED|Overall Study||19
10873961|NCT02992119|12039983|FG001|COMPLETED|Overall Study||20
10873962|NCT02992119|12039984|FG002|COMPLETED|Overall Study||29
10873963|NCT02992119|12039985|FG003|COMPLETED|Overall Study||30
10873964|NCT02992119|12039986|FG004|COMPLETED|Overall Study||30
10873965|NCT02992119|12039987|FG005|COMPLETED|Overall Study||30
10873966|NCT02992119|12039988|FG006|COMPLETED|Overall Study||28
10873967|NCT02992119|12039982|FG000|NOT COMPLETED|Overall Study||2
10873968|NCT02992119|12039983|FG001|NOT COMPLETED|Overall Study||1
10873969|NCT02992119|12039984|FG002|NOT COMPLETED|Overall Study||1
10873970|NCT02992119|12039985|FG003|NOT COMPLETED|Overall Study||0
10873971|NCT02992119|12039986|FG004|NOT COMPLETED|Overall Study||0
10873972|NCT02992119|12039987|FG005|NOT COMPLETED|Overall Study||0
10873973|NCT02992119|12039988|FG006|NOT COMPLETED|Overall Study||3
10873974|NCT02988661|12040007|FG000|STARTED|Overall Study||168
10873975|NCT02988661|12040008|FG001|STARTED|Overall Study||531
10873976|NCT02988661|12040007|FG000|COMPLETED|Overall Study||165
10873977|NCT02988661|12040008|FG001|COMPLETED|Overall Study||447
10873978|NCT02988661|12040007|FG000|NOT COMPLETED|Overall Study||3
10873979|NCT02988661|12040008|FG001|NOT COMPLETED|Overall Study||84
10873980|NCT02921776|12040020|FG000|STARTED|Overall Study||13
10873981|NCT02921776|12040021|FG001|STARTED|Overall Study||23
10873982|NCT02921776|12040022|FG002|STARTED|Overall Study||7
10873983|NCT02921776|12040023|FG003|STARTED|Overall Study||31
10873984|NCT02921776|12040024|FG004|STARTED|Overall Study||32
10873985|NCT02921776|12040025|FG005|STARTED|Overall Study||7
10873986|NCT02921776|12040026|FG006|STARTED|Overall Study||18
10873987|NCT02921776|12040027|FG007|STARTED|Overall Study||16
10873988|NCT02921776|12040020|FG000|COMPLETED|Overall Study||11
10873989|NCT02921776|12040021|FG001|COMPLETED|Overall Study||15
10873990|NCT02921776|12040022|FG002|COMPLETED|Overall Study||7
10873991|NCT02921776|12040023|FG003|COMPLETED|Overall Study|Completed Primary outcome (daily measures) = 27 Completed Secondary outcomes (@ICU discharge) = 23|23
10873992|NCT02921776|12040024|FG004|COMPLETED|Overall Study|Completed Primary outcome (daily measures) = 27 Completed Secondary outcomes (@ICU discharge) = 26|26
10873993|NCT02921776|12040025|FG005|COMPLETED|Overall Study||5
10873994|NCT02921776|12040026|FG006|COMPLETED|Overall Study|"At discharge/ extubation =11~1-mos post-discharge = 8 3-mos post-discharge = 8"|7
10873995|NCT02921776|12040027|FG007|COMPLETED|Overall Study|"At discharge/ extubation =15~1-mos post-discharge = 12 3-mos post-discharge = 11"|9
10873996|NCT02921776|12040020|FG000|NOT COMPLETED|Overall Study||2
10873997|NCT02921776|12040021|FG001|NOT COMPLETED|Overall Study||8
10873998|NCT02921776|12040022|FG002|NOT COMPLETED|Overall Study||0
10873999|NCT02921776|12040023|FG003|NOT COMPLETED|Overall Study||8
10874000|NCT02921776|12040024|FG004|NOT COMPLETED|Overall Study||6
10874002|NCT02921776|12040026|FG006|NOT COMPLETED|Overall Study||11
10874003|NCT02921776|12040027|FG007|NOT COMPLETED|Overall Study||7
10874004|NCT02870348|12040051|FG000|STARTED|Overall Study||4
10874005|NCT02870348|12040051|FG000|COMPLETED|Overall Study||0
10874006|NCT02870348|12040051|FG000|NOT COMPLETED|Overall Study||4
10874007|NCT02841280|12040057|FG000|STARTED|Overall Study||81
10874008|NCT02841280|12040058|FG001|STARTED|Overall Study||79
10874009|NCT02841280|12040057|FG000|COMPLETED|Overall Study||67
10874010|NCT02841280|12040058|FG001|COMPLETED|Overall Study||73
10874011|NCT02841280|12040057|FG000|NOT COMPLETED|Overall Study||14
10874012|NCT02841280|12040058|FG001|NOT COMPLETED|Overall Study||6
10874013|NCT02786498|12040068|FG000|STARTED|Overall Study||27
10874014|NCT02786498|12040069|FG001|STARTED|Overall Study||24
10874015|NCT02786498|12040070|FG002|STARTED|Overall Study||24
10874016|NCT02786498|12040071|FG003|STARTED|Overall Study||27
10874017|NCT02786498|12040068|FG000|COMPLETED|Overall Study||25
10874018|NCT02786498|12040069|FG001|COMPLETED|Overall Study||24
10874019|NCT02786498|12040070|FG002|COMPLETED|Overall Study||24
10874020|NCT02786498|12040071|FG003|COMPLETED|Overall Study||26
10874021|NCT02786498|12040068|FG000|NOT COMPLETED|Overall Study||2
10874022|NCT02786498|12040069|FG001|NOT COMPLETED|Overall Study||0
10874023|NCT02786498|12040070|FG002|NOT COMPLETED|Overall Study||0
10874024|NCT02786498|12040071|FG003|NOT COMPLETED|Overall Study||1
10874025|NCT02771275|12040081|FG000|STARTED|Overall Study||13
10874026|NCT02771275|12040081|FG000|COMPLETED|Overall Study||0
10874027|NCT02771275|12040081|FG000|NOT COMPLETED|Overall Study||13
10874028|NCT02675426|12040088|FG000|STARTED|Overall Study||221
10874029|NCT02675426|12040089|FG001|STARTED|Overall Study||221
10874030|NCT02675426|12040090|FG002|STARTED|Overall Study||219
10874031|NCT02675426|12040088|FG000|Treated|Overall Study||221
10874032|NCT02675426|12040089|FG001|Treated|Overall Study||221
10874033|NCT02675426|12040090|FG002|Treated|Overall Study||219
10874034|NCT02675426|12040088|FG000|COMPLETED|Overall Study||208
10874035|NCT02675426|12040089|FG001|COMPLETED|Overall Study||213
10874036|NCT02675426|12040090|FG002|COMPLETED|Overall Study||201
10874037|NCT02675426|12040088|FG000|NOT COMPLETED|Overall Study||13
10874038|NCT02675426|12040089|FG001|NOT COMPLETED|Overall Study||8
10874039|NCT02675426|12040090|FG002|NOT COMPLETED|Overall Study||18
11112366|NCT01288430|12296587|FG009|COMPLETED|Part 1||0
11112367|NCT01288430|12296578|FG000|NOT COMPLETED|Part 1||2
11112368|NCT01288430|12296579|FG001|NOT COMPLETED|Part 1||3
11230438|NCT02021955|12422547|FG000|STARTED|Step 15|Provider attrition=0; Provider addition=0; Patient discharges=4|110
11230439|NCT02021955|12422548|FG001|STARTED|Step 15|Provider attrition=0; Provider addition=5; Patient discharges=5|102
11230440|NCT02021955|12422547|FG000|COMPLETED|Step 15||110
11230441|NCT02021955|12422548|FG001|COMPLETED|Step 15||102
11230442|NCT02021955|12422547|FG000|NOT COMPLETED|Step 15||0
11355340|NCT03078647|12552177|FG001|STARTED|Overall Study||11
11355341|NCT03078647|12552178|FG002|STARTED|Overall Study||3
11355342|NCT03078647|12552176|FG000|COMPLETED|Overall Study||17
11355343|NCT03078647|12552177|FG001|COMPLETED|Overall Study||10
11355344|NCT03078647|12552178|FG002|COMPLETED|Overall Study||3
11355345|NCT03078647|12552176|FG000|NOT COMPLETED|Overall Study||0
11355346|NCT03078647|12552177|FG001|NOT COMPLETED|Overall Study||1
11112369|NCT01288430|12296580|FG002|NOT COMPLETED|Part 1||5
11112370|NCT01288430|12296581|FG003|NOT COMPLETED|Part 1||7
11112371|NCT01288430|12296582|FG004|NOT COMPLETED|Part 1||3
11112372|NCT01288430|12296583|FG005|NOT COMPLETED|Part 1||6
11112373|NCT01288430|12296584|FG006|NOT COMPLETED|Part 1||7
11230443|NCT02021955|12422548|FG001|NOT COMPLETED|Step 15||0
11230444|NCT02021955|12422547|FG000|STARTED|Step 16|Provider attrition=0; Provider addition=0; Patient discharges=2|103
11112374|NCT01288430|12296585|FG007|NOT COMPLETED|Part 1||0
11112375|NCT01288430|12296586|FG008|NOT COMPLETED|Part 1||0
11112376|NCT01288430|12296587|FG009|NOT COMPLETED|Part 1||0
11112377|NCT01288430|12296578|FG000|STARTED|Part 2||0
11112378|NCT01288430|12296579|FG001|STARTED|Part 2||0
11112379|NCT01288430|12296580|FG002|STARTED|Part 2||0
11112380|NCT01288430|12296581|FG003|STARTED|Part 2||0
11112381|NCT01288430|12296582|FG004|STARTED|Part 2||0
11112382|NCT01288430|12296583|FG005|STARTED|Part 2||0
11112383|NCT01288430|12296584|FG006|STARTED|Part 2||0
11112384|NCT01288430|12296585|FG007|STARTED|Part 2||12
11112385|NCT01288430|12296586|FG008|STARTED|Part 2||12
11112386|NCT01288430|12296587|FG009|STARTED|Part 2||3
11112387|NCT01288430|12296578|FG000|COMPLETED|Part 2||0
11112388|NCT01288430|12296579|FG001|COMPLETED|Part 2||0
11112389|NCT01288430|12296580|FG002|COMPLETED|Part 2||0
11112390|NCT01288430|12296581|FG003|COMPLETED|Part 2||0
11112391|NCT01288430|12296582|FG004|COMPLETED|Part 2||0
11112392|NCT01288430|12296583|FG005|COMPLETED|Part 2||0
11112393|NCT01288430|12296584|FG006|COMPLETED|Part 2||0
11112394|NCT01288430|12296585|FG007|COMPLETED|Part 2||0
11112395|NCT01288430|12296586|FG008|COMPLETED|Part 2||0
11112396|NCT01288430|12296587|FG009|COMPLETED|Part 2||0
11112397|NCT01288430|12296578|FG000|NOT COMPLETED|Part 2||0
11112398|NCT01288430|12296579|FG001|NOT COMPLETED|Part 2||0
11112399|NCT01288430|12296580|FG002|NOT COMPLETED|Part 2||0
11112400|NCT01288430|12296581|FG003|NOT COMPLETED|Part 2||0
11112401|NCT01288430|12296582|FG004|NOT COMPLETED|Part 2||0
11112402|NCT01288430|12296583|FG005|NOT COMPLETED|Part 2||0
11112403|NCT01288430|12296584|FG006|NOT COMPLETED|Part 2||0
11112404|NCT01288430|12296585|FG007|NOT COMPLETED|Part 2||12
11112405|NCT01288430|12296586|FG008|NOT COMPLETED|Part 2||12
11112406|NCT01288430|12296587|FG009|NOT COMPLETED|Part 2||3
11230445|NCT02021955|12422548|FG001|STARTED|Step 16|Provider attrition=0; Provider addition=3; Patient discharges=3|114
11230446|NCT02021955|12422547|FG000|COMPLETED|Step 16||103
11112407|NCT01288443|12296620|FG000|STARTED|Overall Study|Randomized|31
11112408|NCT01288443|12296621|FG001|STARTED|Overall Study|Randomized|30
11112409|NCT01288443|12296622|FG002|STARTED|Overall Study|Randomized|31
11112410|NCT01288443|12296623|FG003|STARTED|Overall Study|Randomized|31
11112411|NCT01288443|12296624|FG004|STARTED|Overall Study|Randomized|30
11112412|NCT01288443|12296625|FG005|STARTED|Overall Study|Randomized|30
11112413|NCT01288443|12296620|FG000|Treated|Overall Study||31
11112414|NCT01288443|12296621|FG001|Treated|Overall Study||30
11112415|NCT01288443|12296622|FG002|Treated|Overall Study||31
11112416|NCT01288443|12296623|FG003|Treated|Overall Study||31
11112417|NCT01288443|12296624|FG004|Treated|Overall Study||29
11112418|NCT01288443|12296625|FG005|Treated|Overall Study||30
11112419|NCT01288443|12296620|FG000|COMPLETED|Overall Study||31
11112420|NCT01288443|12296621|FG001|COMPLETED|Overall Study||29
11112421|NCT01288443|12296622|FG002|COMPLETED|Overall Study||30
11112422|NCT01288443|12296623|FG003|COMPLETED|Overall Study||27
11112423|NCT01288443|12296624|FG004|COMPLETED|Overall Study||23
11112424|NCT01288443|12296625|FG005|COMPLETED|Overall Study||25
11112425|NCT01288443|12296620|FG000|NOT COMPLETED|Overall Study||0
11112426|NCT01288443|12296621|FG001|NOT COMPLETED|Overall Study||1
11112427|NCT01288443|12296622|FG002|NOT COMPLETED|Overall Study||1
11112428|NCT01288443|12296623|FG003|NOT COMPLETED|Overall Study||4
11112429|NCT01288443|12296624|FG004|NOT COMPLETED|Overall Study||7
11112430|NCT01288443|12296625|FG005|NOT COMPLETED|Overall Study||5
11112431|NCT01288469|12296642|FG000|STARTED|Overall Study|Randomized|31
11112432|NCT01288469|12296643|FG001|STARTED|Overall Study|Randomized|31
11112433|NCT01288469|12296644|FG002|STARTED|Overall Study|Randomized|30
11112434|NCT01288469|12296642|FG000|Treated|Overall Study||31
11112435|NCT01288469|12296643|FG001|Treated|Overall Study||31
11230447|NCT02021955|12422548|FG001|COMPLETED|Step 16||114
11230448|NCT02021955|12422547|FG000|NOT COMPLETED|Step 16||0
11230449|NCT02021955|12422548|FG001|NOT COMPLETED|Step 16||0
11230450|NCT02021955|12422547|FG000|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=8|99
11230451|NCT02021955|12422548|FG001|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=3|121
11230452|NCT02021955|12422547|FG000|COMPLETED|Step 17||99
11112436|NCT01288469|12296644|FG002|Treated|Overall Study||30
11112437|NCT01288469|12296642|FG000|COMPLETED|Overall Study||24
11112438|NCT01288469|12296643|FG001|COMPLETED|Overall Study||28
11112439|NCT01288469|12296644|FG002|COMPLETED|Overall Study||28
11230453|NCT02021955|12422548|FG001|COMPLETED|Step 17||121
11112440|NCT01288469|12296642|FG000|NOT COMPLETED|Overall Study||7
11112441|NCT01288469|12296643|FG001|NOT COMPLETED|Overall Study||3
11112442|NCT01288469|12296644|FG002|NOT COMPLETED|Overall Study||2
11112443|NCT01288521|12296654|FG000|STARTED|Overall Study||3
11112444|NCT01288521|12296655|FG001|STARTED|Overall Study||5
11112445|NCT01288521|12296654|FG000|COMPLETED|Overall Study||3
11112446|NCT01288521|12296655|FG001|COMPLETED|Overall Study||5
11112447|NCT01288521|12296654|FG000|NOT COMPLETED|Overall Study||0
11112448|NCT01288521|12296655|FG001|NOT COMPLETED|Overall Study||0
11112449|NCT01288534|12296661|FG000|STARTED|Overall Study||68
11112450|NCT01288534|12296661|FG000|COMPLETED|Overall Study||68
11112451|NCT01288534|12296661|FG000|NOT COMPLETED|Overall Study||0
11112452|NCT01288612|12296668|FG000|STARTED|Overall Study||150
11112453|NCT01288612|12296669|FG001|STARTED|Overall Study||151
11112454|NCT01288612|12296670|FG002|STARTED|Overall Study||158
11112455|NCT01288612|12296668|FG000|Contacted|Overall Study||139
11112456|NCT01288612|12296669|FG001|Contacted|Overall Study||135
11112457|NCT01288612|12296670|FG002|Contacted|Overall Study||138
11112458|NCT01288612|12296668|FG000|Agreed to Take Part|Overall Study||61
11112459|NCT01288612|12296669|FG001|Agreed to Take Part|Overall Study||72
11112460|NCT01288612|12296670|FG002|Agreed to Take Part|Overall Study||76
11112461|NCT01288612|12296668|FG000|COMPLETED|Overall Study||61
11112462|NCT01288612|12296669|FG001|COMPLETED|Overall Study||69
11112463|NCT01288612|12296670|FG002|COMPLETED|Overall Study||76
11112464|NCT01288612|12296668|FG000|NOT COMPLETED|Overall Study||89
11112465|NCT01288612|12296669|FG001|NOT COMPLETED|Overall Study||82
11112466|NCT01288612|12296670|FG002|NOT COMPLETED|Overall Study||82
11112467|NCT01288729|12296680|FG000|STARTED|Overall Study||10
11112468|NCT01288729|12296681|FG001|STARTED|Overall Study||10
11112469|NCT01288729|12296680|FG000|COMPLETED|Overall Study||9
11112470|NCT01288729|12296681|FG001|COMPLETED|Overall Study||10
11112471|NCT01288729|12296680|FG000|NOT COMPLETED|Overall Study||1
11112472|NCT01288729|12296681|FG001|NOT COMPLETED|Overall Study||0
11112473|NCT01288781|12296689|FG000|STARTED|Overall Study||11
11112474|NCT01288781|12296690|FG001|STARTED|Overall Study||12
11112475|NCT01288781|12296689|FG000|COMPLETED|Overall Study||11
11112476|NCT01288781|12296690|FG001|COMPLETED|Overall Study||12
11112477|NCT01288781|12296689|FG000|NOT COMPLETED|Overall Study||0
11112478|NCT01288781|12296690|FG001|NOT COMPLETED|Overall Study||0
11112479|NCT01288807|12296696|FG000|STARTED|Overall Study||8
11112480|NCT01288807|12296696|FG000|COMPLETED|Overall Study||8
11112481|NCT01288807|12296696|FG000|NOT COMPLETED|Overall Study||0
11112482|NCT01288833|12296702|FG000|STARTED|Overall Study||277
11112483|NCT01288833|12296703|FG001|STARTED|Overall Study||281
11112484|NCT01288833|12296702|FG000|COMPLETED|Overall Study||277
11112485|NCT01288833|12296703|FG001|COMPLETED|Overall Study||281
11112486|NCT01288833|12296702|FG000|NOT COMPLETED|Overall Study||0
11112487|NCT01288833|12296703|FG001|NOT COMPLETED|Overall Study||0
11112488|NCT01288859|12296709|FG000|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
11112489|NCT01288859|12296710|FG001|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
11230454|NCT02021955|12422547|FG000|NOT COMPLETED|Step 17||0
11230455|NCT02021955|12422548|FG001|NOT COMPLETED|Step 17||0
11112490|NCT01288859|12296711|FG002|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
11112491|NCT01288859|12296712|FG003|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
11112492|NCT01288859|12296713|FG004|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
11112493|NCT01288859|12296714|FG005|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
11112494|NCT01288859|12296709|FG000|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
11112495|NCT01288859|12296710|FG001|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
11112496|NCT01288859|12296711|FG002|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
11112497|NCT01288859|12296712|FG003|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
11112498|NCT01288859|12296713|FG004|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
11112499|NCT01288859|12296714|FG005|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
11112500|NCT01288859|12296709|FG000|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
11112501|NCT01288859|12296710|FG001|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
11112502|NCT01288859|12296711|FG002|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
11112503|NCT01288859|12296712|FG003|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
11112504|NCT01288859|12296713|FG004|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
11112505|NCT01288859|12296714|FG005|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
11112506|NCT01288859|12296709|FG000|STARTED|Washout Period of 1 Week||5
11112507|NCT01288859|12296710|FG001|STARTED|Washout Period of 1 Week||0
11112508|NCT01288859|12296711|FG002|STARTED|Washout Period of 1 Week||0
11112509|NCT01288859|12296712|FG003|STARTED|Washout Period of 1 Week||0
11112510|NCT01288859|12296713|FG004|STARTED|Washout Period of 1 Week||0
11112511|NCT01288859|12296714|FG005|STARTED|Washout Period of 1 Week||5
11112512|NCT01288859|12296709|FG000|COMPLETED|Washout Period of 1 Week||5
10874154|NCT02498444|12040162|FG000|STARTED|Overall Study||16
10874155|NCT02498444|12040163|FG001|STARTED|Overall Study||18
10874156|NCT02498444|12040162|FG000|COMPLETED|Overall Study||12
10874157|NCT02498444|12040163|FG001|COMPLETED|Overall Study||18
10874158|NCT02498444|12040162|FG000|NOT COMPLETED|Overall Study||4
10874159|NCT02498444|12040163|FG001|NOT COMPLETED|Overall Study||0
10874160|NCT02487108|12040173|FG000|STARTED|Overall Study||142
10874161|NCT02487108|12040174|FG001|STARTED|Overall Study||142
10874162|NCT02487108|12040175|FG002|STARTED|Overall Study||143
10874163|NCT02487108|12040176|FG003|STARTED|Overall Study||142
10874164|NCT02487108|12040173|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142
10874165|NCT02487108|12040174|FG001|Received at Least 1 Dose of Study Drug|Overall Study||142
10874166|NCT02487108|12040175|FG002|Received at Least 1 Dose of Study Drug|Overall Study||141
10874167|NCT02487108|12040176|FG003|Received at Least 1 Dose of Study Drug|Overall Study||142
10874168|NCT02487108|12040173|FG000|COMPLETED|Overall Study||126
10874169|NCT02487108|12040174|FG001|COMPLETED|Overall Study||126
10874170|NCT02487108|12040175|FG002|COMPLETED|Overall Study||117
10874171|NCT02487108|12040176|FG003|COMPLETED|Overall Study||131
10874172|NCT02487108|12040173|FG000|NOT COMPLETED|Overall Study||16
10874173|NCT02487108|12040174|FG001|NOT COMPLETED|Overall Study||16
10874174|NCT02487108|12040175|FG002|NOT COMPLETED|Overall Study||26
10874175|NCT02487108|12040176|FG003|NOT COMPLETED|Overall Study||11
10874176|NCT02455557|12040186|FG000|STARTED|Overall Study||66
10874177|NCT02455557|12040186|FG000|COMPLETED|Overall Study||64
10874178|NCT02455557|12040186|FG000|NOT COMPLETED|Overall Study||2
11112513|NCT01288859|12296710|FG001|COMPLETED|Washout Period of 1 Week||0
11112514|NCT01288859|12296711|FG002|COMPLETED|Washout Period of 1 Week||0
10874185|NCT02387996|12040199|FG000|STARTED|Overall Study||270
10874186|NCT02387996|12040199|FG000|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
10874187|NCT02387996|12040199|FG000|NOT COMPLETED|Overall Study||204
10874188|NCT02363010|12040206|FG000|STARTED|Overall Study||110
10874189|NCT02363010|12040207|FG001|STARTED|Overall Study||105
10874190|NCT02363010|12040208|FG002|STARTED|Overall Study||105
10874191|NCT02363010|12040206|FG000|COMPLETED|Overall Study||88
10874192|NCT02363010|12040207|FG001|COMPLETED|Overall Study||94
10874193|NCT02363010|12040208|FG002|COMPLETED|Overall Study||89
10874194|NCT02363010|12040206|FG000|NOT COMPLETED|Overall Study||22
10874195|NCT02363010|12040207|FG001|NOT COMPLETED|Overall Study||11
10874196|NCT02363010|12040208|FG002|NOT COMPLETED|Overall Study||16
10874197|NCT02351856|12040216|FG000|STARTED|Overall Study||8
10874198|NCT02351856|12040216|FG000|COMPLETED|Overall Study||0
10874199|NCT02351856|12040216|FG000|NOT COMPLETED|Overall Study||8
10874200|NCT02349386|12040224|FG000|STARTED|24-Week Double-Blind Main Study||9
10874201|NCT02349386|12040225|FG001|STARTED|24-Week Double-Blind Main Study||8
10874202|NCT02349386|12040226|FG002|STARTED|24-Week Double-Blind Main Study||9
10874203|NCT02349386|12040227|FG003|STARTED|24-Week Double-Blind Main Study||8
10874204|NCT02349386|12040224|FG000|COMPLETED|24-Week Double-Blind Main Study||3
10874205|NCT02349386|12040225|FG001|COMPLETED|24-Week Double-Blind Main Study||2
10874206|NCT02349386|12040226|FG002|COMPLETED|24-Week Double-Blind Main Study||4
10874207|NCT02349386|12040227|FG003|COMPLETED|24-Week Double-Blind Main Study||0
10874208|NCT02349386|12040224|FG000|NOT COMPLETED|24-Week Double-Blind Main Study||6
10874209|NCT02349386|12040225|FG001|NOT COMPLETED|24-Week Double-Blind Main Study||6
10874210|NCT02349386|12040226|FG002|NOT COMPLETED|24-Week Double-Blind Main Study||5
10874211|NCT02349386|12040227|FG003|NOT COMPLETED|24-Week Double-Blind Main Study||8
10874212|NCT02349386|12040224|FG000|STARTED|28-Week Double-Blind Optional Extension||3
10874213|NCT02349386|12040225|FG001|STARTED|28-Week Double-Blind Optional Extension||2
10874214|NCT02349386|12040226|FG002|STARTED|28-Week Double-Blind Optional Extension||4
10874215|NCT02349386|12040227|FG003|STARTED|28-Week Double-Blind Optional Extension||0
10874216|NCT02349386|12040224|FG000|COMPLETED|28-Week Double-Blind Optional Extension||1
10874217|NCT02349386|12040225|FG001|COMPLETED|28-Week Double-Blind Optional Extension||2
10874218|NCT02349386|12040226|FG002|COMPLETED|28-Week Double-Blind Optional Extension||1
10874219|NCT02349386|12040227|FG003|COMPLETED|28-Week Double-Blind Optional Extension||0
10874220|NCT02349386|12040224|FG000|NOT COMPLETED|28-Week Double-Blind Optional Extension||2
10874221|NCT02349386|12040225|FG001|NOT COMPLETED|28-Week Double-Blind Optional Extension||0
10874222|NCT02349386|12040226|FG002|NOT COMPLETED|28-Week Double-Blind Optional Extension||3
10874223|NCT02349386|12040227|FG003|NOT COMPLETED|28-Week Double-Blind Optional Extension||0
10874224|NCT02281500|12040237|FG000|STARTED|Overall Study||22
10874225|NCT02281500|12040237|FG000|COMPLETED|Overall Study||22
10874226|NCT02281500|12040237|FG000|NOT COMPLETED|Overall Study||0
11112515|NCT01288859|12296712|FG003|COMPLETED|Washout Period of 1 Week||0
11112516|NCT01288859|12296713|FG004|COMPLETED|Washout Period of 1 Week||0
11112517|NCT01288859|12296714|FG005|COMPLETED|Washout Period of 1 Week||5
11112518|NCT01288859|12296709|FG000|NOT COMPLETED|Washout Period of 1 Week||0
11112519|NCT01288859|12296710|FG001|NOT COMPLETED|Washout Period of 1 Week||0
11112520|NCT01288859|12296711|FG002|NOT COMPLETED|Washout Period of 1 Week||0
10874233|NCT01905384|12040252|FG000|STARTED|Overall Study||3
10874234|NCT01905384|12040253|FG001|STARTED|Overall Study||3
10874235|NCT01905384|12040252|FG000|COMPLETED|Overall Study||3
10874236|NCT01905384|12040253|FG001|COMPLETED|Overall Study||3
10874237|NCT01905384|12040252|FG000|NOT COMPLETED|Overall Study||0
10874238|NCT01905384|12040253|FG001|NOT COMPLETED|Overall Study||0
10874239|NCT01904032|12040261|FG000|STARTED|Overall Study||64
10874240|NCT01904032|12040262|FG001|STARTED|Overall Study||65
10874241|NCT01904032|12040261|FG000|COMPLETED|Overall Study||57
10874242|NCT01904032|12040262|FG001|COMPLETED|Overall Study||62
10874243|NCT01904032|12040261|FG000|NOT COMPLETED|Overall Study||7
10874244|NCT01904032|12040262|FG001|NOT COMPLETED|Overall Study||3
10874245|NCT01876953|12040270|FG000|STARTED|Overall Study||17
10874246|NCT01876953|12040271|FG001|STARTED|Overall Study||3
10874247|NCT01876953|12040270|FG000|COMPLETED|Overall Study||17
10874248|NCT01876953|12040271|FG001|COMPLETED|Overall Study||3
10874249|NCT01876953|12040270|FG000|NOT COMPLETED|Overall Study||0
10874250|NCT01876953|12040271|FG001|NOT COMPLETED|Overall Study||0
10874251|NCT01764711|12040279|FG000|STARTED|Overall Study||8
10874252|NCT01764711|12040280|FG001|STARTED|Overall Study||5
10874253|NCT01764711|12040279|FG000|COMPLETED|Overall Study||8
10874254|NCT01764711|12040280|FG001|COMPLETED|Overall Study||5
10874255|NCT01764711|12040279|FG000|NOT COMPLETED|Overall Study||0
10874256|NCT01764711|12040280|FG001|NOT COMPLETED|Overall Study||0
10874257|NCT01632878|12040288|FG000|STARTED|Screening||1531
10874258|NCT01632878|12040288|FG000|COMPLETED|Screening||1263
10874259|NCT01632878|12040288|FG000|NOT COMPLETED|Screening||268
10874260|NCT01632878|12040288|FG000|STARTED|Treatment||1263
10874261|NCT01632878|12040288|FG000|COMPLETED|Treatment||1105
10874262|NCT01632878|12040288|FG000|NOT COMPLETED|Treatment||158
10874263|NCT01275846|12040292|FG000|STARTED|Overall Study||26
10874264|NCT01275846|12040292|FG000|COMPLETED|Overall Study||25
10874265|NCT01275846|12040292|FG000|NOT COMPLETED|Overall Study||1
10874266|NCT01097005|12040296|FG000|STARTED|Overall Study|number of participants who were enrolled for this study.|466
10874267|NCT01097005|12040296|FG000|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
10874268|NCT01097005|12040296|FG000|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
10874269|NCT01097005|12040296|FG000|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
10874270|NCT01097005|12040296|FG000|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
10874271|NCT01097005|12040296|FG000|COMPLETED|Overall Study||101
10874272|NCT01097005|12040296|FG000|NOT COMPLETED|Overall Study||365
10874273|NCT01072682|12040302|FG000|STARTED|Overall Study||35
10874274|NCT01072682|12040302|FG000|COMPLETED|Overall Study||35
10874275|NCT01072682|12040302|FG000|NOT COMPLETED|Overall Study||0
10874276|NCT00931255|12040308|FG000|STARTED|Overall Study||17
10874277|NCT00931255|12040309|FG001|STARTED|Overall Study||15
10874278|NCT00931255|12040308|FG000|COMPLETED|Overall Study||15
10874279|NCT00931255|12040309|FG001|COMPLETED|Overall Study||12
10874280|NCT00931255|12040308|FG000|NOT COMPLETED|Overall Study||2
10874281|NCT00931255|12040309|FG001|NOT COMPLETED|Overall Study||3
10874282|NCT00540995|12040317|FG000|STARTED|Overall Study||23
10874283|NCT00540995|12040318|FG001|STARTED|Overall Study||2
10874284|NCT00540995|12040317|FG000|COMPLETED|Overall Study||23
10874285|NCT00540995|12040318|FG001|COMPLETED|Overall Study||2
10874286|NCT00540995|12040317|FG000|NOT COMPLETED|Overall Study||0
10874287|NCT00540995|12040318|FG001|NOT COMPLETED|Overall Study||0
10874288|NCT00418301|12040323|FG000|STARTED|Overall Study||15
10874289|NCT00418301|12040323|FG000|COMPLETED|Overall Study||12
10874290|NCT00418301|12040323|FG000|NOT COMPLETED|Overall Study||3
11112521|NCT01288859|12296712|FG003|NOT COMPLETED|Washout Period of 1 Week||0
11112522|NCT01288859|12296713|FG004|NOT COMPLETED|Washout Period of 1 Week||0
11112523|NCT01288859|12296714|FG005|NOT COMPLETED|Washout Period of 1 Week||0
11112524|NCT01288859|12296709|FG000|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
11112525|NCT01288859|12296710|FG001|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
11112526|NCT01288859|12296711|FG002|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
11112527|NCT01288859|12296712|FG003|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
10874291|NCT04498273|12040331|FG000|STARTED|Overall Study||165
10874292|NCT04498273|12040332|FG001|STARTED|Overall Study||164
10874293|NCT04498273|12040333|FG002|STARTED|Overall Study||164
10874294|NCT04498273|12040334|FG003|STARTED|Overall Study||164
10874295|NCT04498273|12040331|FG000|COMPLETED|Overall Study||134
10874296|NCT04498273|12040332|FG001|COMPLETED|Overall Study||140
10874297|NCT04498273|12040333|FG002|COMPLETED|Overall Study||143
10874298|NCT04498273|12040334|FG003|COMPLETED|Overall Study||133
10874299|NCT04498273|12040331|FG000|NOT COMPLETED|Overall Study||31
10874300|NCT04498273|12040332|FG001|NOT COMPLETED|Overall Study||24
10874301|NCT04498273|12040333|FG002|NOT COMPLETED|Overall Study||21
10874302|NCT04498273|12040334|FG003|NOT COMPLETED|Overall Study||31
10874309|NCT04537078|12040355|FG000|STARTED|Overall Study||45
10874310|NCT04537078|12040356|FG001|STARTED|Overall Study||45
10874311|NCT04537078|12040355|FG000|COMPLETED|Overall Study||41
10874312|NCT04537078|12040356|FG001|COMPLETED|Overall Study||42
10874313|NCT04537078|12040355|FG000|NOT COMPLETED|Overall Study||4
10874314|NCT04537078|12040356|FG001|NOT COMPLETED|Overall Study||3
10874315|NCT04425252|12040371|FG000|STARTED|Overall Study||8
10874316|NCT04425252|12040372|FG001|STARTED|Overall Study||15
10874317|NCT04425252|12040371|FG000|COMPLETED|Overall Study||4
10874318|NCT04425252|12040372|FG001|COMPLETED|Overall Study||13
10874319|NCT04425252|12040371|FG000|NOT COMPLETED|Overall Study||4
10874320|NCT04425252|12040372|FG001|NOT COMPLETED|Overall Study||2
10874321|NCT04368260|12040381|FG000|STARTED|Overall Study||40
10874322|NCT04368260|12040381|FG000|COMPLETED|Overall Study||40
10874323|NCT04368260|12040381|FG000|NOT COMPLETED|Overall Study||0
10874324|NCT03940326|12040389|FG000|STARTED|Overall Study||45
10874325|NCT03940326|12040390|FG001|STARTED|Overall Study||58
10874326|NCT03940326|12040389|FG000|COMPLETED|Overall Study||45
10874327|NCT03940326|12040390|FG001|COMPLETED|Overall Study||58
10874328|NCT03940326|12040389|FG000|NOT COMPLETED|Overall Study||0
10874329|NCT03940326|12040390|FG001|NOT COMPLETED|Overall Study||0
10874330|NCT03875313|12040401|FG000|STARTED|Overall Study||3
10874331|NCT03875313|12040402|FG001|STARTED|Overall Study||16
10874332|NCT03875313|12040403|FG002|STARTED|Overall Study||6
10874333|NCT03875313|12040404|FG003|STARTED|Overall Study||4
10874334|NCT03875313|12040405|FG004|STARTED|Overall Study||4
10874335|NCT03875313|12040401|FG000|COMPLETED|Overall Study||0
10874336|NCT03875313|12040402|FG001|COMPLETED|Overall Study||0
10874337|NCT03875313|12040403|FG002|COMPLETED|Overall Study||0
10874338|NCT03875313|12040404|FG003|COMPLETED|Overall Study||0
10874339|NCT03875313|12040405|FG004|COMPLETED|Overall Study||0
10874340|NCT03875313|12040401|FG000|NOT COMPLETED|Overall Study||3
10874341|NCT03875313|12040402|FG001|NOT COMPLETED|Overall Study||16
10874342|NCT03875313|12040403|FG002|NOT COMPLETED|Overall Study||6
10874343|NCT03875313|12040404|FG003|NOT COMPLETED|Overall Study||4
10874344|NCT03875313|12040405|FG004|NOT COMPLETED|Overall Study||4
10874345|NCT03694353|12040417|FG000|STARTED|Overall Study||37
10874346|NCT03694353|12040417|FG000|COMPLETED|Overall Study||35
10874347|NCT03694353|12040417|FG000|NOT COMPLETED|Overall Study||2
10874348|NCT03583554|12040421|FG000|STARTED|Period 1||4
10874349|NCT03583554|12040422|FG001|STARTED|Period 1||4
10874350|NCT03583554|12040423|FG002|STARTED|Period 1||4
10874351|NCT03583554|12040421|FG000|COMPLETED|Period 1||4
10874352|NCT03583554|12040422|FG001|COMPLETED|Period 1||4
10874353|NCT03583554|12040423|FG002|COMPLETED|Period 1||4
10874354|NCT03583554|12040421|FG000|NOT COMPLETED|Period 1||0
10874355|NCT03583554|12040422|FG001|NOT COMPLETED|Period 1||0
10874356|NCT03583554|12040423|FG002|NOT COMPLETED|Period 1||0
10874357|NCT03583554|12040421|FG000|STARTED|Period 2||4
10874358|NCT03583554|12040422|FG001|STARTED|Period 2||4
10874359|NCT03583554|12040423|FG002|STARTED|Period 2||4
10874360|NCT03583554|12040421|FG000|COMPLETED|Period 2||3
10874361|NCT03583554|12040422|FG001|COMPLETED|Period 2||4
10874362|NCT03583554|12040423|FG002|COMPLETED|Period 2||3
10874363|NCT03583554|12040421|FG000|NOT COMPLETED|Period 2||1
10874364|NCT03583554|12040422|FG001|NOT COMPLETED|Period 2||0
10874365|NCT03583554|12040423|FG002|NOT COMPLETED|Period 2||1
10874366|NCT03583554|12040421|FG000|STARTED|Period 3||3
10874367|NCT03583554|12040422|FG001|STARTED|Period 3||4
10874368|NCT03583554|12040423|FG002|STARTED|Period 3||3
10874369|NCT03583554|12040421|FG000|COMPLETED|Period 3||3
10874370|NCT03583554|12040422|FG001|COMPLETED|Period 3||4
10874371|NCT03583554|12040423|FG002|COMPLETED|Period 3||3
10874372|NCT03583554|12040421|FG000|NOT COMPLETED|Period 3||0
10874373|NCT03583554|12040422|FG001|NOT COMPLETED|Period 3||0
10874374|NCT03583554|12040423|FG002|NOT COMPLETED|Period 3||0
10874375|NCT03538717|12040434|FG000|STARTED|Overall Study||157
10874376|NCT03538717|12040434|FG000|COMPLETED|Overall Study||157
10874377|NCT03538717|12040434|FG000|NOT COMPLETED|Overall Study||0
10874378|NCT03408873|12040440|FG000|STARTED|Visit 1 Assessment (Baseline)||30
10874379|NCT03408873|12040440|FG000|COMPLETED|Visit 1 Assessment (Baseline)||27
10874380|NCT03408873|12040440|FG000|NOT COMPLETED|Visit 1 Assessment (Baseline)||3
10874381|NCT03408873|12040440|FG000|STARTED|Visit 2 Assessment||27
10874382|NCT03408873|12040440|FG000|COMPLETED|Visit 2 Assessment||26
10874383|NCT03408873|12040440|FG000|NOT COMPLETED|Visit 2 Assessment||1
10874384|NCT03408873|12040440|FG000|STARTED|Visit 3 Assessment||26
10874385|NCT03408873|12040440|FG000|COMPLETED|Visit 3 Assessment||25
10874386|NCT03408873|12040440|FG000|NOT COMPLETED|Visit 3 Assessment||1
10874387|NCT03408873|12040440|FG000|STARTED|Visit 4 Assessment||25
10874388|NCT03408873|12040440|FG000|COMPLETED|Visit 4 Assessment||23
10874389|NCT03408873|12040440|FG000|NOT COMPLETED|Visit 4 Assessment||2
10874390|NCT03408873|12040440|FG000|STARTED|Visit 5 Assessment||23
10874303|NCT05224453|12040346|FG000|STARTED|Overall Study||38
11230456|NCT02021955|12422547|FG000|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=6|96
11230457|NCT02021955|12422548|FG001|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=7|124
11230458|NCT02021955|12422547|FG000|COMPLETED|Step 18||96
11230459|NCT02021955|12422548|FG001|COMPLETED|Step 18||124
11230460|NCT02021955|12422547|FG000|NOT COMPLETED|Step 18||0
11230461|NCT02021955|12422548|FG001|NOT COMPLETED|Step 18||0
11230462|NCT02021955|12422547|FG000|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=5|94
11230463|NCT02021955|12422548|FG001|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=9|126
11230464|NCT02021955|12422547|FG000|COMPLETED|Step 19||94
11230465|NCT02021955|12422548|FG001|COMPLETED|Step 19||126
11230466|NCT02021955|12422547|FG000|NOT COMPLETED|Step 19||0
11230467|NCT02021955|12422548|FG001|NOT COMPLETED|Step 19||0
11230468|NCT02021955|12422547|FG000|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|92
11230469|NCT02021955|12422548|FG001|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|128
11230470|NCT02021955|12422547|FG000|COMPLETED|Step 20||92
11230471|NCT02021955|12422548|FG001|COMPLETED|Step 20||128
10874304|NCT05224453|12040347|FG001|STARTED|Overall Study||38
10874305|NCT05224453|12040346|FG000|COMPLETED|Overall Study||36
10874306|NCT05224453|12040347|FG001|COMPLETED|Overall Study||35
10874307|NCT05224453|12040346|FG000|NOT COMPLETED|Overall Study||2
10874308|NCT05224453|12040347|FG001|NOT COMPLETED|Overall Study||3
10874391|NCT03408873|12040440|FG000|COMPLETED|Visit 5 Assessment||22
10874392|NCT03408873|12040440|FG000|NOT COMPLETED|Visit 5 Assessment||1
10874393|NCT03408873|12040440|FG000|STARTED|Visit 6 Assessment||22
10874394|NCT03408873|12040440|FG000|COMPLETED|Visit 6 Assessment||21
10874395|NCT03408873|12040440|FG000|NOT COMPLETED|Visit 6 Assessment||1
10874396|NCT03408873|12040440|FG000|STARTED|Visit 7 Assessment||21
10874397|NCT03408873|12040440|FG000|COMPLETED|Visit 7 Assessment||21
10874398|NCT03408873|12040440|FG000|NOT COMPLETED|Visit 7 Assessment||0
11112528|NCT01288859|12296713|FG004|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
11112529|NCT01288859|12296714|FG005|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
11230472|NCT02021955|12422547|FG000|NOT COMPLETED|Step 20||0
10874402|NCT03096288|12040453|FG000|STARTED|Overall Study||19
10874403|NCT03096288|12040454|FG001|STARTED|Overall Study||18
10874404|NCT03096288|12040455|FG002|STARTED|Overall Study||22
10874405|NCT03096288|12040456|FG003|STARTED|Overall Study||25
10874406|NCT03096288|12040453|FG000|COMPLETED|Overall Study||19
10874407|NCT03096288|12040454|FG001|COMPLETED|Overall Study||17
10874408|NCT03096288|12040455|FG002|COMPLETED|Overall Study||22
10874409|NCT03096288|12040456|FG003|COMPLETED|Overall Study||24
10874410|NCT03096288|12040453|FG000|NOT COMPLETED|Overall Study||0
10874411|NCT03096288|12040454|FG001|NOT COMPLETED|Overall Study||1
10874412|NCT03096288|12040455|FG002|NOT COMPLETED|Overall Study||0
10874413|NCT03096288|12040456|FG003|NOT COMPLETED|Overall Study||1
10874414|NCT02919436|12040468|FG000|STARTED|Overall Study||305
10874415|NCT02919436|12040469|FG001|STARTED|Overall Study||305
10874416|NCT02919436|12040468|FG000|COMPLETED|Overall Study||245
10874417|NCT02919436|12040469|FG001|COMPLETED|Overall Study||252
10874418|NCT02919436|12040468|FG000|NOT COMPLETED|Overall Study||60
10874419|NCT02919436|12040469|FG001|NOT COMPLETED|Overall Study||53
10874420|NCT02135484|12040477|FG000|STARTED|Overall Study||25
10874421|NCT02135484|12040477|FG000|COMPLETED|Overall Study||25
10874422|NCT02135484|12040477|FG000|NOT COMPLETED|Overall Study||0
10874423|NCT02028884|12040483|FG000|STARTED|Double-blind Period||42
10874424|NCT02028884|12040484|FG001|STARTED|Double-blind Period||41
10874425|NCT02028884|12040483|FG000|COMPLETED|Double-blind Period||24
10874426|NCT02028884|12040484|FG001|COMPLETED|Double-blind Period||18
10874427|NCT02028884|12040483|FG000|NOT COMPLETED|Double-blind Period||18
10874428|NCT02028884|12040484|FG001|NOT COMPLETED|Double-blind Period||23
10874429|NCT02028884|12040483|FG000|STARTED|Open-label Extension Period||24
10874430|NCT02028884|12040484|FG001|STARTED|Open-label Extension Period||18
10874431|NCT02028884|12040483|FG000|COMPLETED|Open-label Extension Period||0
10874432|NCT02028884|12040484|FG001|COMPLETED|Open-label Extension Period||0
10874433|NCT02028884|12040483|FG000|NOT COMPLETED|Open-label Extension Period||24
10874434|NCT02028884|12040484|FG001|NOT COMPLETED|Open-label Extension Period||18
10874435|NCT01983774|12040495|FG000|STARTED|Overall Study||9
10874436|NCT01983774|12040496|FG001|STARTED|Overall Study||8
10874437|NCT01983774|12040495|FG000|COMPLETED|Overall Study||8
10874438|NCT01983774|12040496|FG001|COMPLETED|Overall Study||7
10874439|NCT01983774|12040495|FG000|NOT COMPLETED|Overall Study||1
10874440|NCT01983774|12040496|FG001|NOT COMPLETED|Overall Study||1
10874441|NCT01974206|12040506|FG000|STARTED|Overall Study||74
10874442|NCT01974206|12040507|FG001|STARTED|Overall Study||76
10874443|NCT01974206|12040506|FG000|Received Treatment|Overall Study||74
10874444|NCT01974206|12040507|FG001|Received Treatment|Overall Study||75
10874445|NCT01974206|12040506|FG000|COMPLETED|Overall Study||68
11230473|NCT02021955|12422548|FG001|NOT COMPLETED|Step 20||0
11230474|NCT02021955|12422547|FG000|STARTED|Step 21|Provider attrition=0; Provider addition=7; Patient discharges=1|88
11230475|NCT02021955|12422548|FG001|STARTED|Step 21|Provider attrition=0; Provider addition=12; Patient discharges=9|134
11230476|NCT02021955|12422547|FG000|COMPLETED|Step 21||88
11230477|NCT02021955|12422548|FG001|COMPLETED|Step 21||134
10874446|NCT01974206|12040507|FG001|COMPLETED|Overall Study||75
10874447|NCT01974206|12040506|FG000|NOT COMPLETED|Overall Study||6
10874448|NCT01974206|12040507|FG001|NOT COMPLETED|Overall Study||1
10874449|NCT01970865|12040530|FG000|STARTED|Overall Study||3
10874450|NCT01970865|12040531|FG001|STARTED|Overall Study||3
10874451|NCT01970865|12040532|FG002|STARTED|Overall Study||3
10874452|NCT01970865|12040533|FG003|STARTED|Overall Study||13
10874453|NCT01970865|12040534|FG004|STARTED|Overall Study||17
10874454|NCT01970865|12040535|FG005|STARTED|Overall Study||3
10874455|NCT01970865|12040536|FG006|STARTED|Overall Study||3
10874456|NCT01970865|12040537|FG007|STARTED|Overall Study||3
11112530|NCT01288859|12296709|FG000|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
11112531|NCT01288859|12296710|FG001|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
11112532|NCT01288859|12296711|FG002|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
11112533|NCT01288859|12296712|FG003|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
11112534|NCT01288859|12296713|FG004|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
11112535|NCT01288859|12296714|FG005|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
11112536|NCT01288859|12296709|FG000|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
11230478|NCT02021955|12422547|FG000|NOT COMPLETED|Step 21||0
11230479|NCT02021955|12422548|FG001|NOT COMPLETED|Step 21||0
11230480|NCT02021955|12422547|FG000|STARTED|Step 22|Provider attrition=0; Provider addition=0; Patient discharges=8|89
11230481|NCT02021955|12422548|FG001|STARTED|Step 22|Provider attrition=0; Provider addition=3; Patient discharges=8|152
11230482|NCT02021955|12422547|FG000|COMPLETED|Step 22||89
10874457|NCT01970865|12040538|FG008|STARTED|Overall Study||3
11112537|NCT01288859|12296710|FG001|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
11112538|NCT01288859|12296711|FG002|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
11112539|NCT01288859|12296712|FG003|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
11112540|NCT01288859|12296713|FG004|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
11112541|NCT01288859|12296714|FG005|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
11112542|NCT01288859|12296709|FG000|STARTED|Washout Period of 1 Week||5
11112543|NCT01288859|12296710|FG001|STARTED|Washout Period of 1 Week||0
11112544|NCT01288859|12296711|FG002|STARTED|Washout Period of 1 Week||0
11112545|NCT01288859|12296712|FG003|STARTED|Washout Period of 1 Week||0
11112546|NCT01288859|12296713|FG004|STARTED|Washout Period of 1 Week||0
11112547|NCT01288859|12296714|FG005|STARTED|Washout Period of 1 Week||5
11112548|NCT01288859|12296709|FG000|COMPLETED|Washout Period of 1 Week||5
11112549|NCT01288859|12296710|FG001|COMPLETED|Washout Period of 1 Week||0
11112550|NCT01288859|12296711|FG002|COMPLETED|Washout Period of 1 Week||0
11112551|NCT01288859|12296712|FG003|COMPLETED|Washout Period of 1 Week||0
11112552|NCT01288859|12296713|FG004|COMPLETED|Washout Period of 1 Week||0
11112553|NCT01288859|12296714|FG005|COMPLETED|Washout Period of 1 Week||5
11112554|NCT01288859|12296709|FG000|NOT COMPLETED|Washout Period of 1 Week||0
11112555|NCT01288859|12296710|FG001|NOT COMPLETED|Washout Period of 1 Week||0
11112556|NCT01288859|12296711|FG002|NOT COMPLETED|Washout Period of 1 Week||0
11112557|NCT01288859|12296712|FG003|NOT COMPLETED|Washout Period of 1 Week||0
11112558|NCT01288859|12296713|FG004|NOT COMPLETED|Washout Period of 1 Week||0
11112559|NCT01288859|12296714|FG005|NOT COMPLETED|Washout Period of 1 Week||0
11112560|NCT01288859|12296709|FG000|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
11112561|NCT01288859|12296710|FG001|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
11112562|NCT01288859|12296711|FG002|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
11112563|NCT01288859|12296712|FG003|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
11112564|NCT01288859|12296713|FG004|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
11112565|NCT01288859|12296714|FG005|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
11112566|NCT01288859|12296709|FG000|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
11112567|NCT01288859|12296710|FG001|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
11112568|NCT01288859|12296711|FG002|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
11112569|NCT01288859|12296712|FG003|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
11112570|NCT01288859|12296713|FG004|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
11112571|NCT01288859|12296714|FG005|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
11112572|NCT01288859|12296709|FG000|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
11112573|NCT01288859|12296710|FG001|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
11112574|NCT01288859|12296711|FG002|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
11112575|NCT01288859|12296712|FG003|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
11230483|NCT02021955|12422548|FG001|COMPLETED|Step 22||152
11230484|NCT02021955|12422547|FG000|NOT COMPLETED|Step 22||0
10874458|NCT01970865|12040539|FG009|STARTED|Overall Study||4
10874459|NCT01970865|12040540|FG010|STARTED|Overall Study||30
10874460|NCT01970865|12040541|FG011|STARTED|Overall Study||27
10874461|NCT01970865|12040542|FG012|STARTED|Overall Study||60
10874462|NCT01970865|12040543|FG013|STARTED|Overall Study||66
10874463|NCT01970865|12040544|FG014|STARTED|Overall Study||46
10874464|NCT01970865|12040545|FG015|STARTED|Overall Study||47
10874465|NCT01970865|12040546|FG016|STARTED|Overall Study||3
10874466|NCT01970865|12040530|FG000|Received Treatment|Overall Study||3
10874467|NCT01970865|12040531|FG001|Received Treatment|Overall Study||3
10874468|NCT01970865|12040532|FG002|Received Treatment|Overall Study||3
10874469|NCT01970865|12040533|FG003|Received Treatment|Overall Study||12
10874470|NCT01970865|12040534|FG004|Received Treatment|Overall Study||17
10874471|NCT01970865|12040535|FG005|Received Treatment|Overall Study||3
10874472|NCT01970865|12040536|FG006|Received Treatment|Overall Study||3
10874473|NCT01970865|12040537|FG007|Received Treatment|Overall Study||3
10874474|NCT01970865|12040538|FG008|Received Treatment|Overall Study||3
10874475|NCT01970865|12040539|FG009|Received Treatment|Overall Study||4
10874476|NCT01970865|12040540|FG010|Received Treatment|Overall Study||30
10874477|NCT01970865|12040541|FG011|Received Treatment|Overall Study||27
10874478|NCT01970865|12040542|FG012|Received Treatment|Overall Study||60
10874479|NCT01970865|12040543|FG013|Received Treatment|Overall Study||65
10874480|NCT01970865|12040544|FG014|Received Treatment|Overall Study||46
10874481|NCT01970865|12040545|FG015|Received Treatment|Overall Study||47
10874482|NCT01970865|12040546|FG016|Received Treatment|Overall Study||3
10874483|NCT01970865|12040530|FG000|COMPLETED|Overall Study||0
10874484|NCT01970865|12040531|FG001|COMPLETED|Overall Study||0
11112576|NCT01288859|12296713|FG004|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
11112577|NCT01288859|12296714|FG005|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
11112578|NCT01288859|12296709|FG000|STARTED|Washout Period of 1 Week||0
11112579|NCT01288859|12296710|FG001|STARTED|Washout Period of 1 Week||5
11112580|NCT01288859|12296711|FG002|STARTED|Washout Period of 1 Week||5
11112581|NCT01288859|12296712|FG003|STARTED|Washout Period of 1 Week||0
11112582|NCT01288859|12296713|FG004|STARTED|Washout Period of 1 Week||0
11112583|NCT01288859|12296714|FG005|STARTED|Washout Period of 1 Week||0
11112584|NCT01288859|12296709|FG000|COMPLETED|Washout Period of 1 Week||0
11112585|NCT01288859|12296710|FG001|COMPLETED|Washout Period of 1 Week||5
11112586|NCT01288859|12296711|FG002|COMPLETED|Washout Period of 1 Week||5
11112587|NCT01288859|12296712|FG003|COMPLETED|Washout Period of 1 Week||0
11112588|NCT01288859|12296713|FG004|COMPLETED|Washout Period of 1 Week||0
11112589|NCT01288859|12296714|FG005|COMPLETED|Washout Period of 1 Week||0
11112590|NCT01288859|12296709|FG000|NOT COMPLETED|Washout Period of 1 Week||0
11112591|NCT01288859|12296710|FG001|NOT COMPLETED|Washout Period of 1 Week||0
11112592|NCT01288859|12296711|FG002|NOT COMPLETED|Washout Period of 1 Week||0
11112593|NCT01288859|12296712|FG003|NOT COMPLETED|Washout Period of 1 Week||0
11112594|NCT01288859|12296713|FG004|NOT COMPLETED|Washout Period of 1 Week||0
11112595|NCT01288859|12296714|FG005|NOT COMPLETED|Washout Period of 1 Week||0
11112596|NCT01288859|12296709|FG000|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
11112597|NCT01288859|12296710|FG001|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
11112598|NCT01288859|12296711|FG002|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
11112599|NCT01288859|12296712|FG003|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
11112600|NCT01288859|12296713|FG004|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
11112601|NCT01288859|12296714|FG005|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
11112602|NCT01288859|12296709|FG000|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
11112603|NCT01288859|12296710|FG001|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
11112604|NCT01288859|12296711|FG002|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
11112605|NCT01288859|12296712|FG003|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
11112606|NCT01288859|12296713|FG004|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
11112607|NCT01288859|12296714|FG005|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
11112608|NCT01288859|12296709|FG000|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
11112609|NCT01288859|12296710|FG001|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
11112610|NCT01288859|12296711|FG002|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
11112611|NCT01288859|12296712|FG003|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
11112612|NCT01288859|12296713|FG004|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
11112613|NCT01288859|12296714|FG005|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
11112614|NCT01288859|12296709|FG000|STARTED|Washout Period of 1 Week||0
11112615|NCT01288859|12296710|FG001|STARTED|Washout Period of 1 Week||0
11112616|NCT01288859|12296711|FG002|STARTED|Washout Period of 1 Week||0
11112617|NCT01288859|12296712|FG003|STARTED|Washout Period of 1 Week||5
11112618|NCT01288859|12296713|FG004|STARTED|Washout Period of 1 Week||5
11112619|NCT01288859|12296714|FG005|STARTED|Washout Period of 1 Week||0
11112620|NCT01288859|12296709|FG000|COMPLETED|Washout Period of 1 Week||0
11112621|NCT01288859|12296710|FG001|COMPLETED|Washout Period of 1 Week||0
10874485|NCT01970865|12040532|FG002|COMPLETED|Overall Study||0
10874486|NCT01970865|12040533|FG003|COMPLETED|Overall Study||0
10874487|NCT01970865|12040534|FG004|COMPLETED|Overall Study||0
10874488|NCT01970865|12040535|FG005|COMPLETED|Overall Study||0
10874489|NCT01970865|12040536|FG006|COMPLETED|Overall Study||0
10874490|NCT01970865|12040537|FG007|COMPLETED|Overall Study||0
10874491|NCT01970865|12040538|FG008|COMPLETED|Overall Study||0
10874492|NCT01970865|12040539|FG009|COMPLETED|Overall Study||0
10874493|NCT01970865|12040540|FG010|COMPLETED|Overall Study||0
10874494|NCT01970865|12040541|FG011|COMPLETED|Overall Study||0
10874495|NCT01970865|12040542|FG012|COMPLETED|Overall Study||0
10874496|NCT01970865|12040543|FG013|COMPLETED|Overall Study||0
10874497|NCT01970865|12040544|FG014|COMPLETED|Overall Study||0
10874498|NCT01970865|12040545|FG015|COMPLETED|Overall Study||0
10874499|NCT01970865|12040546|FG016|COMPLETED|Overall Study||0
10874500|NCT01970865|12040530|FG000|NOT COMPLETED|Overall Study||3
10874501|NCT01970865|12040531|FG001|NOT COMPLETED|Overall Study||3
10874502|NCT01970865|12040532|FG002|NOT COMPLETED|Overall Study||3
10874503|NCT01970865|12040533|FG003|NOT COMPLETED|Overall Study||13
10874504|NCT01970865|12040534|FG004|NOT COMPLETED|Overall Study||17
10874505|NCT01970865|12040535|FG005|NOT COMPLETED|Overall Study||3
10874506|NCT01970865|12040536|FG006|NOT COMPLETED|Overall Study||3
10874507|NCT01970865|12040537|FG007|NOT COMPLETED|Overall Study||3
10874508|NCT01970865|12040538|FG008|NOT COMPLETED|Overall Study||3
10874509|NCT01970865|12040539|FG009|NOT COMPLETED|Overall Study||4
10874510|NCT01970865|12040540|FG010|NOT COMPLETED|Overall Study||30
10874511|NCT01970865|12040541|FG011|NOT COMPLETED|Overall Study||27
10874512|NCT01970865|12040542|FG012|NOT COMPLETED|Overall Study||60
10874513|NCT01970865|12040543|FG013|NOT COMPLETED|Overall Study||66
10874514|NCT01970865|12040544|FG014|NOT COMPLETED|Overall Study||46
10874515|NCT01970865|12040545|FG015|NOT COMPLETED|Overall Study||47
10874516|NCT01970865|12040546|FG016|NOT COMPLETED|Overall Study||3
10874517|NCT00589420|12040607|FG000|STARTED|Overall Study||18
10874518|NCT00589420|12040607|FG000|COMPLETED|Overall Study||17
10874519|NCT00589420|12040607|FG000|NOT COMPLETED|Overall Study||1
11112622|NCT01288859|12296711|FG002|COMPLETED|Washout Period of 1 Week||0
11230485|NCT02021955|12422548|FG001|NOT COMPLETED|Step 22||0
11230486|NCT02021955|12422547|FG000|STARTED|Step 23|Provider attrition=0; Provider addition=1; Patient discharges=3|69
11230487|NCT02021955|12422548|FG001|STARTED|Step 23|Provider attrition=0; Provider addition=0; Patient discharges=7|175
11230488|NCT02021955|12422547|FG000|COMPLETED|Step 23||69
11230489|NCT02021955|12422548|FG001|COMPLETED|Step 23||175
11230490|NCT02021955|12422547|FG000|NOT COMPLETED|Step 23||0
11230491|NCT02021955|12422548|FG001|NOT COMPLETED|Step 23||0
11230492|NCT02021955|12422547|FG000|STARTED|Step 24|Provider attrition=0; Provider addition=0; Patient discharges=4|62
11230493|NCT02021955|12422548|FG001|STARTED|Step 24|Provider attrition=1; Provider addition=1; Patient discharges=8|183
11230494|NCT02021955|12422547|FG000|COMPLETED|Step 24||62
11230495|NCT02021955|12422548|FG001|COMPLETED|Step 24||183
11230496|NCT02021955|12422547|FG000|NOT COMPLETED|Step 24||0
11230497|NCT02021955|12422548|FG001|NOT COMPLETED|Step 24||0
11230498|NCT02021955|12422547|FG000|STARTED|Step 25|Provider attrition=0; Provider addition=1; Patient discharges=0|37
11230499|NCT02021955|12422548|FG001|STARTED|Step 25|Provider attrition=1; Provider addition=0; Patient discharges=5|208
11230500|NCT02021955|12422547|FG000|COMPLETED|Step 25||37
11230501|NCT02021955|12422548|FG001|COMPLETED|Step 25||208
11230502|NCT02021955|12422547|FG000|NOT COMPLETED|Step 25||0
11230503|NCT02021955|12422548|FG001|NOT COMPLETED|Step 25||0
11230504|NCT02021955|12422547|FG000|STARTED|Step 26|Provider attrition=0; Provider addition=0; Patient discharges=2|30
11230505|NCT02021955|12422548|FG001|STARTED|Step 26|Provider attrition=0; Provider addition=23; Patient discharges=9|215
11230506|NCT02021955|12422547|FG000|COMPLETED|Step 26||30
11230507|NCT02021955|12422548|FG001|COMPLETED|Step 26||215
11230508|NCT02021955|12422547|FG000|NOT COMPLETED|Step 26||0
11230509|NCT02021955|12422548|FG001|NOT COMPLETED|Step 26||0
11230510|NCT02021955|12422547|FG000|STARTED|Step 27|Provider attrition=1; Provider addition=1; Patient discharges=0|25
11230511|NCT02021955|12422548|FG001|STARTED|Step 27|Provider attrition=1; Provider addition=4; Patient discharges=4|243
11230512|NCT02021955|12422547|FG000|COMPLETED|Step 27||25
11230513|NCT02021955|12422548|FG001|COMPLETED|Step 27||243
11230514|NCT02021955|12422547|FG000|NOT COMPLETED|Step 27||0
11230515|NCT02021955|12422548|FG001|NOT COMPLETED|Step 27||0
11230516|NCT02021955|12422547|FG000|STARTED|Step 28|Provider attrition=0; Provider addition=2; Patient discharges=0|15
11230517|NCT02021955|12422548|FG001|STARTED|Step 28|Provider attrition=3; Provider addition=6; Patient discharges=6|256
11230518|NCT02021955|12422547|FG000|COMPLETED|Step 28||15
11230519|NCT02021955|12422548|FG001|COMPLETED|Step 28||256
11230520|NCT02021955|12422547|FG000|NOT COMPLETED|Step 28||0
11230521|NCT02021955|12422548|FG001|NOT COMPLETED|Step 28||0
11230522|NCT02021955|12422547|FG000|STARTED|Step 29|Provider attrition=0; Provider addition=0; Patient discharges=0|10
11230523|NCT02021955|12422548|FG001|STARTED|Step 29|Provider attrition=1; Provider addition=2; Patient discharges=8|266
11230524|NCT02021955|12422547|FG000|COMPLETED|Step 29||10
11230525|NCT02021955|12422548|FG001|COMPLETED|Step 29||266
11230526|NCT02021955|12422547|FG000|NOT COMPLETED|Step 29||0
11230527|NCT02021955|12422548|FG001|NOT COMPLETED|Step 29||0
11230528|NCT02021955|12422547|FG000|STARTED|Step 30|Provider attrition=0; Provider addition=0; Patient discharges=0|0
11230529|NCT02021955|12422548|FG001|STARTED|Step 30|Provider attrition=0; Provider addition=1; Patient discharges=11|277
11230530|NCT02021955|12422547|FG000|COMPLETED|Step 30||0
11230531|NCT02021955|12422548|FG001|COMPLETED|Step 30||277
11230532|NCT02021955|12422547|FG000|NOT COMPLETED|Step 30||0
11230533|NCT02021955|12422548|FG001|NOT COMPLETED|Step 30||0
11230534|NCT02022007|12422557|FG000|STARTED|Overall Study||13
11230535|NCT02022007|12422558|FG001|STARTED|Overall Study||12
11230536|NCT02022007|12422559|FG002|STARTED|Overall Study||13
11230537|NCT02022007|12422557|FG000|COMPLETED|Overall Study||12
11230538|NCT02022007|12422558|FG001|COMPLETED|Overall Study||11
11230539|NCT02022007|12422559|FG002|COMPLETED|Overall Study||11
11230540|NCT02022007|12422557|FG000|NOT COMPLETED|Overall Study||1
11230541|NCT02022007|12422558|FG001|NOT COMPLETED|Overall Study||1
11230542|NCT02022007|12422559|FG002|NOT COMPLETED|Overall Study||2
11230543|NCT02022020|12422567|FG000|STARTED|Overall Study||220
11230544|NCT02022020|12422567|FG000|COMPLETED|Overall Study||220
11230545|NCT02022020|12422567|FG000|NOT COMPLETED|Overall Study||0
11230546|NCT02022085|12422571|FG000|STARTED|Overall Study||54
11230547|NCT02022085|12422571|FG000|COMPLETED|Overall Study||53
11230548|NCT02022085|12422571|FG000|NOT COMPLETED|Overall Study||1
11230549|NCT02022111|12422577|FG000|STARTED|Overall Study||196
11230550|NCT02022111|12422578|FG001|STARTED|Overall Study||208
11112623|NCT01288859|12296712|FG003|COMPLETED|Washout Period of 1 Week||5
11112624|NCT01288859|12296713|FG004|COMPLETED|Washout Period of 1 Week||5
11112625|NCT01288859|12296714|FG005|COMPLETED|Washout Period of 1 Week||0
11112626|NCT01288859|12296709|FG000|NOT COMPLETED|Washout Period of 1 Week||0
11112627|NCT01288859|12296710|FG001|NOT COMPLETED|Washout Period of 1 Week||0
11112628|NCT01288859|12296711|FG002|NOT COMPLETED|Washout Period of 1 Week||0
11112629|NCT01288859|12296712|FG003|NOT COMPLETED|Washout Period of 1 Week||0
11112630|NCT01288859|12296713|FG004|NOT COMPLETED|Washout Period of 1 Week||0
11112631|NCT01288859|12296714|FG005|NOT COMPLETED|Washout Period of 1 Week||0
11230551|NCT02022111|12422577|FG000|COMPLETED|Overall Study||186
11230552|NCT02022111|12422578|FG001|COMPLETED|Overall Study||193
11230553|NCT02022111|12422577|FG000|NOT COMPLETED|Overall Study||10
11230554|NCT02022111|12422578|FG001|NOT COMPLETED|Overall Study||15
11230555|NCT02022657|12422586|FG000|STARTED|Overall Study||10
11230556|NCT02022657|12422587|FG001|STARTED|Overall Study||8
11230557|NCT02022657|12422588|FG002|STARTED|Overall Study||9
10874520|NCT05043142|12040611|FG000|STARTED|Overall Study||3632
10874521|NCT05043142|12040611|FG000|COMPLETED|Overall Study||3443
10874522|NCT05043142|12040611|FG000|NOT COMPLETED|Overall Study||189
10874523|NCT04993339|12040617|FG000|STARTED|Overall Study||14
10874524|NCT04993339|12040618|FG001|STARTED|Overall Study||12
10874525|NCT04993339|12040617|FG000|COMPLETED|Overall Study||11
10874526|NCT04993339|12040618|FG001|COMPLETED|Overall Study||10
10874527|NCT04993339|12040617|FG000|NOT COMPLETED|Overall Study||3
10874528|NCT04993339|12040618|FG001|NOT COMPLETED|Overall Study||2
11112632|NCT01288859|12296709|FG000|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
11112633|NCT01288859|12296710|FG001|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
11112634|NCT01288859|12296711|FG002|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
11112635|NCT01288859|12296712|FG003|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
11112636|NCT01288859|12296713|FG004|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
11112637|NCT01288859|12296714|FG005|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
11112638|NCT01288859|12296709|FG000|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
11112639|NCT01288859|12296710|FG001|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
11112640|NCT01288859|12296711|FG002|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
11112641|NCT01288859|12296712|FG003|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
11112642|NCT01288859|12296713|FG004|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
11112643|NCT01288859|12296714|FG005|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
11112644|NCT01288859|12296709|FG000|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
11112645|NCT01288859|12296710|FG001|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
11112646|NCT01288859|12296711|FG002|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
11112647|NCT01288859|12296712|FG003|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
11112648|NCT01288859|12296713|FG004|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
11112649|NCT01288859|12296714|FG005|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
11112650|NCT01288859|12296709|FG000|STARTED|Washout Period of 1 Week||0
11112651|NCT01288859|12296710|FG001|STARTED|Washout Period of 1 Week||0
11112652|NCT01288859|12296711|FG002|STARTED|Washout Period of 1 Week||0
11112653|NCT01288859|12296712|FG003|STARTED|Washout Period of 1 Week||5
11112654|NCT01288859|12296713|FG004|STARTED|Washout Period of 1 Week||5
11112655|NCT01288859|12296714|FG005|STARTED|Washout Period of 1 Week||0
11112656|NCT01288859|12296709|FG000|COMPLETED|Washout Period of 1 Week||0
11112657|NCT01288859|12296710|FG001|COMPLETED|Washout Period of 1 Week||0
11112658|NCT01288859|12296711|FG002|COMPLETED|Washout Period of 1 Week||0
11112659|NCT01288859|12296712|FG003|COMPLETED|Washout Period of 1 Week||5
11112660|NCT01288859|12296713|FG004|COMPLETED|Washout Period of 1 Week||5
11112661|NCT01288859|12296714|FG005|COMPLETED|Washout Period of 1 Week||0
11112662|NCT01288859|12296709|FG000|NOT COMPLETED|Washout Period of 1 Week||0
11112663|NCT01288859|12296710|FG001|NOT COMPLETED|Washout Period of 1 Week||0
11112664|NCT01288859|12296711|FG002|NOT COMPLETED|Washout Period of 1 Week||0
11112665|NCT01288859|12296712|FG003|NOT COMPLETED|Washout Period of 1 Week||0
11112666|NCT01288859|12296713|FG004|NOT COMPLETED|Washout Period of 1 Week||0
11112667|NCT01288859|12296714|FG005|NOT COMPLETED|Washout Period of 1 Week||0
11112668|NCT01288859|12296709|FG000|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
11112669|NCT01288859|12296710|FG001|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
11112670|NCT01288859|12296711|FG002|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
11112671|NCT01288859|12296712|FG003|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
11112672|NCT01288859|12296713|FG004|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
11112673|NCT01288859|12296714|FG005|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
11112674|NCT01288859|12296709|FG000|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
11112675|NCT01288859|12296710|FG001|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
11355347|NCT03078647|12552178|FG002|NOT COMPLETED|Overall Study||0
11355348|NCT03078751|12552188|FG000|STARTED|Overall Study||26
11355349|NCT03078751|12552189|FG001|STARTED|Overall Study||28
11112676|NCT01288859|12296711|FG002|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
11112677|NCT01288859|12296712|FG003|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
11112678|NCT01288859|12296713|FG004|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
11112679|NCT01288859|12296714|FG005|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
11112680|NCT01288859|12296709|FG000|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
11112681|NCT01288859|12296710|FG001|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
11112682|NCT01288859|12296711|FG002|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
11112683|NCT01288859|12296712|FG003|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
11230558|NCT02022657|12422589|FG003|STARTED|Overall Study||8
11112684|NCT01288859|12296713|FG004|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
11112685|NCT01288859|12296714|FG005|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
11112686|NCT01288937|12296736|FG000|STARTED|Overall Study||4
11112687|NCT01288937|12296737|FG001|STARTED|Overall Study||2
11112688|NCT01288937|12296736|FG000|COMPLETED|Overall Study||3
11230559|NCT02022657|12422590|FG004|STARTED|Overall Study||8
11230560|NCT02022657|12422591|FG005|STARTED|Overall Study||9
11230561|NCT02022657|12422586|FG000|COMPLETED|Overall Study||8
11230562|NCT02022657|12422587|FG001|COMPLETED|Overall Study||8
11112689|NCT01288937|12296737|FG001|COMPLETED|Overall Study||2
11112690|NCT01288937|12296736|FG000|NOT COMPLETED|Overall Study||1
11112691|NCT01288937|12296737|FG001|NOT COMPLETED|Overall Study||0
11112692|NCT01288976|12296746|FG000|STARTED|Overall Study||567
11112693|NCT01288976|12296747|FG001|STARTED|Overall Study||49
11112694|NCT01288976|12296748|FG002|STARTED|Overall Study||105
11112695|NCT01288976|12296746|FG000|COMPLETED|Overall Study||389
11112696|NCT01288976|12296747|FG001|COMPLETED|Overall Study||22
11112697|NCT01288976|12296748|FG002|COMPLETED|Overall Study||85
11112698|NCT01288976|12296746|FG000|NOT COMPLETED|Overall Study||178
11112699|NCT01288976|12296747|FG001|NOT COMPLETED|Overall Study||27
11112700|NCT01288976|12296748|FG002|NOT COMPLETED|Overall Study||20
11112701|NCT01288989|12296759|FG000|STARTED|Overall Study||6
11112702|NCT01288989|12296760|FG001|STARTED|Overall Study||3
11112703|NCT01288989|12296761|FG002|STARTED|Overall Study||3
11112704|NCT01288989|12296762|FG003|STARTED|Overall Study||11
11112705|NCT01288989|12296763|FG004|STARTED|Overall Study||21
11112706|NCT01288989|12296759|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
11112707|NCT01288989|12296760|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
11112708|NCT01288989|12296761|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
11112709|NCT01288989|12296762|FG003|Received at Least 1 Dose of Study Drug|Overall Study||11
11112710|NCT01288989|12296763|FG004|Received at Least 1 Dose of Study Drug|Overall Study||21
11112711|NCT01288989|12296759|FG000|COMPLETED|Overall Study||5
11112712|NCT01288989|12296760|FG001|COMPLETED|Overall Study||3
11112713|NCT01288989|12296761|FG002|COMPLETED|Overall Study||3
11112714|NCT01288989|12296762|FG003|COMPLETED|Overall Study||10
11112715|NCT01288989|12296763|FG004|COMPLETED|Overall Study||15
11112716|NCT01288989|12296759|FG000|NOT COMPLETED|Overall Study||1
11112717|NCT01288989|12296760|FG001|NOT COMPLETED|Overall Study||0
11112718|NCT01288989|12296761|FG002|NOT COMPLETED|Overall Study||0
11112719|NCT01288989|12296762|FG003|NOT COMPLETED|Overall Study||1
11112720|NCT01288989|12296763|FG004|NOT COMPLETED|Overall Study||6
11112721|NCT01289015|12296783|FG000|STARTED|Overall Study||571
11112722|NCT01289015|12296784|FG001|STARTED|Overall Study||284
11112723|NCT01289015|12296783|FG000|COMPLETED|Overall Study||472
11112724|NCT01289015|12296784|FG001|COMPLETED|Overall Study||230
11112725|NCT01289015|12296783|FG000|NOT COMPLETED|Overall Study||99
11112726|NCT01289015|12296784|FG001|NOT COMPLETED|Overall Study||54
11112727|NCT01289028|12296790|FG000|STARTED|Overall Study||125
11112728|NCT01289028|12296790|FG000|COMPLETED|Overall Study||42
11112729|NCT01289028|12296790|FG000|NOT COMPLETED|Overall Study||83
11112730|NCT01289041|12296796|FG000|STARTED|Overall Study||70
11112731|NCT01289041|12296796|FG000|COMPLETED|Overall Study||0
11112732|NCT01289041|12296796|FG000|NOT COMPLETED|Overall Study||70
11112733|NCT01289067|12296802|FG000|STARTED|Overall Study||13
11112734|NCT01289067|12296802|FG000|COMPLETED|Overall Study||13
11112735|NCT01289067|12296802|FG000|NOT COMPLETED|Overall Study||0
11112736|NCT01289080|12296808|FG000|STARTED|Overall Study||9
11112737|NCT01289080|12296809|FG001|STARTED|Overall Study||10
11112738|NCT01289080|12296808|FG000|COMPLETED|Overall Study||9
11112739|NCT01289080|12296809|FG001|COMPLETED|Overall Study||10
11112740|NCT01289080|12296808|FG000|NOT COMPLETED|Overall Study||0
11112741|NCT01289080|12296809|FG001|NOT COMPLETED|Overall Study||0
11112742|NCT01289119|12296822|FG000|STARTED|Overall Study||93
11112743|NCT01289119|12296823|FG001|STARTED|Overall Study||92
11112744|NCT01289119|12296824|FG002|STARTED|Overall Study||98
11112745|NCT01289119|12296825|FG003|STARTED|Overall Study||99
11112746|NCT01289119|12296826|FG004|STARTED|Overall Study||63
11112747|NCT01289119|12296827|FG005|STARTED|Overall Study||61
11112748|NCT01289119|12296822|FG000|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
11112749|NCT01289119|12296823|FG001|Treated|Overall Study||92
11112750|NCT01289119|12296824|FG002|Treated|Overall Study||98
11112751|NCT01289119|12296825|FG003|Treated|Overall Study||99
11112752|NCT01289119|12296826|FG004|Treated|Overall Study||63
11112753|NCT01289119|12296827|FG005|Treated|Overall Study||61
11112754|NCT01289119|12296822|FG000|COMPLETED|Overall Study||84
11112755|NCT01289119|12296823|FG001|COMPLETED|Overall Study||83
11112756|NCT01289119|12296824|FG002|COMPLETED|Overall Study||89
11112757|NCT01289119|12296825|FG003|COMPLETED|Overall Study||93
11112758|NCT01289119|12296826|FG004|COMPLETED|Overall Study||58
11112759|NCT01289119|12296827|FG005|COMPLETED|Overall Study||57
11112760|NCT01289119|12296822|FG000|NOT COMPLETED|Overall Study||9
11112761|NCT01289119|12296823|FG001|NOT COMPLETED|Overall Study||9
11112762|NCT01289119|12296824|FG002|NOT COMPLETED|Overall Study||9
11112763|NCT01289119|12296825|FG003|NOT COMPLETED|Overall Study||6
11112764|NCT01289119|12296826|FG004|NOT COMPLETED|Overall Study||5
11112765|NCT01289119|12296827|FG005|NOT COMPLETED|Overall Study||4
11112766|NCT01289210|12296841|FG000|STARTED|Overall Study||2
11112767|NCT01289210|12296841|FG000|COMPLETED|Overall Study||1
11112768|NCT01289210|12296841|FG000|NOT COMPLETED|Overall Study||1
11112769|NCT01289275|12296849|FG000|STARTED|Overall Study||317
11112770|NCT01289275|12296850|FG001|STARTED|Overall Study||320
11112771|NCT01289275|12296851|FG002|STARTED|Overall Study||317
11112772|NCT01289275|12296852|FG003|STARTED|Overall Study||316
11112773|NCT01289275|12296849|FG000|COMPLETED|Overall Study||317
11112774|NCT01289275|12296850|FG001|COMPLETED|Overall Study||320
11112775|NCT01289275|12296851|FG002|COMPLETED|Overall Study||317
11112776|NCT01289275|12296852|FG003|COMPLETED|Overall Study||316
11112777|NCT01289275|12296849|FG000|NOT COMPLETED|Overall Study||0
11112778|NCT01289275|12296850|FG001|NOT COMPLETED|Overall Study||0
11112779|NCT01289275|12296851|FG002|NOT COMPLETED|Overall Study||0
11112780|NCT01289275|12296852|FG003|NOT COMPLETED|Overall Study||0
11112781|NCT01289353|12296866|FG000|STARTED|Overall Study||92
11112782|NCT01289353|12296866|FG000|COMPLETED|Overall Study||90
11112783|NCT01289353|12296866|FG000|NOT COMPLETED|Overall Study||2
11112784|NCT01289392|12296873|FG000|STARTED|Overall Study||9
11112785|NCT01289392|12296874|FG001|STARTED|Overall Study||9
11112786|NCT01289392|12296875|FG002|STARTED|Overall Study||7
11112787|NCT01289392|12296873|FG000|COMPLETED|Overall Study||9
11112788|NCT01289392|12296874|FG001|COMPLETED|Overall Study||9
11112789|NCT01289392|12296875|FG002|COMPLETED|Overall Study||7
11230563|NCT02022657|12422588|FG002|COMPLETED|Overall Study||8
11230564|NCT02022657|12422589|FG003|COMPLETED|Overall Study||8
11230565|NCT02022657|12422590|FG004|COMPLETED|Overall Study||8
11230566|NCT02022657|12422591|FG005|COMPLETED|Overall Study||8
11230567|NCT02022657|12422586|FG000|NOT COMPLETED|Overall Study||2
11230568|NCT02022657|12422587|FG001|NOT COMPLETED|Overall Study||0
11230569|NCT02022657|12422588|FG002|NOT COMPLETED|Overall Study||1
11230570|NCT02022657|12422589|FG003|NOT COMPLETED|Overall Study||0
11230571|NCT02022657|12422590|FG004|NOT COMPLETED|Overall Study||0
11230572|NCT02022657|12422591|FG005|NOT COMPLETED|Overall Study||1
11230573|NCT02022670|12422600|FG000|STARTED|Overall Study||11
11230574|NCT02022670|12422601|FG001|STARTED|Overall Study||10
11230575|NCT02022670|12422602|FG002|STARTED|Overall Study||12
11230576|NCT02022670|12422600|FG000|COMPLETED|Overall Study||10
11230577|NCT02022670|12422601|FG001|COMPLETED|Overall Study||10
11230578|NCT02022670|12422602|FG002|COMPLETED|Overall Study||11
11230579|NCT02022670|12422600|FG000|NOT COMPLETED|Overall Study||1
11230580|NCT02022670|12422601|FG001|NOT COMPLETED|Overall Study||0
11230581|NCT02022670|12422602|FG002|NOT COMPLETED|Overall Study||1
11230582|NCT02022735|12422611|FG000|STARTED|Overall Study||22
11230583|NCT02022735|12422611|FG000|COMPLETED|Overall Study||22
11230584|NCT02022735|12422611|FG000|NOT COMPLETED|Overall Study||0
11230585|NCT02022748|12422623|FG000|STARTED|Overall Study||8
11230586|NCT02022748|12422624|FG001|STARTED|Overall Study||6
11230587|NCT02022748|12422625|FG002|STARTED|Overall Study||13
11230588|NCT02022748|12422623|FG000|Subject Who Started Treatment|Overall Study||8
11230589|NCT02022748|12422624|FG001|Subject Who Started Treatment|Overall Study||6
11230590|NCT02022748|12422625|FG002|Subject Who Started Treatment|Overall Study||13
11230591|NCT02022748|12422623|FG000|Subjects Who Completed Treatment|Overall Study||7
11230592|NCT02022748|12422624|FG001|Subjects Who Completed Treatment|Overall Study||4
11230593|NCT02022748|12422625|FG002|Subjects Who Completed Treatment|Overall Study||13
11230594|NCT02022748|12422623|FG000|COMPLETED|Overall Study||7
11112790|NCT01289392|12296873|FG000|NOT COMPLETED|Overall Study||0
11112791|NCT01289392|12296874|FG001|NOT COMPLETED|Overall Study||0
11112792|NCT01289392|12296875|FG002|NOT COMPLETED|Overall Study||0
11112793|NCT01289418|12296886|FG000|STARTED|Day 8 Survey||6525
11112794|NCT01289418|12296886|FG000|COMPLETED|Day 8 Survey||4307
11112795|NCT01289418|12296886|FG000|NOT COMPLETED|Day 8 Survey||2218
11112796|NCT01289418|12296886|FG000|STARTED|Day 29 Survey||6525
11112797|NCT01289418|12296886|FG000|COMPLETED|Day 29 Survey||4057
11112798|NCT01289418|12296886|FG000|NOT COMPLETED|Day 29 Survey||2468
11112799|NCT01289431|12296899|FG000|STARTED|Overall Study||34
11112800|NCT01289431|12296900|FG001|STARTED|Overall Study||34
11112801|NCT01289431|12296901|FG002|STARTED|Overall Study||34
11112802|NCT01289431|12296902|FG003|STARTED|Overall Study||33
11112803|NCT01289431|12296903|FG004|STARTED|Overall Study||34
11112804|NCT01289431|12296904|FG005|STARTED|Overall Study||33
11112805|NCT01289431|12296905|FG006|STARTED|Overall Study||34
11112806|NCT01289431|12296899|FG000|COMPLETED|Overall Study||29
11112807|NCT01289431|12296900|FG001|COMPLETED|Overall Study||32
11112808|NCT01289431|12296901|FG002|COMPLETED|Overall Study||30
11112809|NCT01289431|12296902|FG003|COMPLETED|Overall Study||28
11230595|NCT02022748|12422624|FG001|COMPLETED|Overall Study||4
11230596|NCT02022748|12422625|FG002|COMPLETED|Overall Study||13
11112810|NCT01289431|12296903|FG004|COMPLETED|Overall Study||32
11112811|NCT01289431|12296904|FG005|COMPLETED|Overall Study||31
11112812|NCT01289431|12296905|FG006|COMPLETED|Overall Study||33
11112813|NCT01289431|12296899|FG000|NOT COMPLETED|Overall Study||5
11112814|NCT01289431|12296900|FG001|NOT COMPLETED|Overall Study||2
11112815|NCT01289431|12296901|FG002|NOT COMPLETED|Overall Study||4
11112816|NCT01289431|12296902|FG003|NOT COMPLETED|Overall Study||5
11112817|NCT01289431|12296903|FG004|NOT COMPLETED|Overall Study||2
11112818|NCT01289431|12296904|FG005|NOT COMPLETED|Overall Study||2
11112819|NCT01289431|12296905|FG006|NOT COMPLETED|Overall Study||1
11112820|NCT01289457|12296924|FG000|STARTED|Overall Study||12
11112821|NCT01289457|12296925|FG001|STARTED|Overall Study||157
11112822|NCT01289457|12296926|FG002|STARTED|Overall Study||113
11112823|NCT01289457|12296924|FG000|COMPLETED|Overall Study||12
11112824|NCT01289457|12296925|FG001|COMPLETED|Overall Study||157
11112825|NCT01289457|12296926|FG002|COMPLETED|Overall Study||113
11112826|NCT01289457|12296924|FG000|NOT COMPLETED|Overall Study||0
11112827|NCT01289457|12296925|FG001|NOT COMPLETED|Overall Study||0
11112828|NCT01289457|12296926|FG002|NOT COMPLETED|Overall Study||0
11112829|NCT01289522|12296934|FG000|STARTED|Overall Study||54
11112830|NCT01289522|12296934|FG000|COMPLETED|Overall Study||43
11112831|NCT01289522|12296934|FG000|NOT COMPLETED|Overall Study||11
11112832|NCT01289548|12296941|FG000|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
11112833|NCT01289548|12296942|FG001|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
11112834|NCT01289548|12296943|FG002|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
11230597|NCT02022748|12422623|FG000|NOT COMPLETED|Overall Study||1
11112835|NCT01289548|12296941|FG000|Donors|Overall Study||20
11112836|NCT01289548|12296942|FG001|Donors|Overall Study||20
11112837|NCT01289548|12296943|FG002|Donors|Overall Study||20
11112838|NCT01289548|12296941|FG000|Recipients|Overall Study||20
11112839|NCT01289548|12296942|FG001|Recipients|Overall Study||20
11112840|NCT01289548|12296943|FG002|Recipients|Overall Study||20
11112841|NCT01289548|12296941|FG000|COMPLETED|Overall Study||40
11112842|NCT01289548|12296942|FG001|COMPLETED|Overall Study||40
11112843|NCT01289548|12296943|FG002|COMPLETED|Overall Study||40
11112844|NCT01289548|12296941|FG000|NOT COMPLETED|Overall Study||0
11112845|NCT01289548|12296942|FG001|NOT COMPLETED|Overall Study||0
11112846|NCT01289548|12296943|FG002|NOT COMPLETED|Overall Study||0
11112847|NCT01289574|12296954|FG000|STARTED|Overall Study||58
11112848|NCT01289574|12296955|FG001|STARTED|Overall Study||60
11112849|NCT01289574|12296956|FG002|STARTED|Overall Study||63
11112850|NCT01289574|12296954|FG000|COMPLETED|Overall Study||51
11112851|NCT01289574|12296955|FG001|COMPLETED|Overall Study||57
11112852|NCT01289574|12296956|FG002|COMPLETED|Overall Study||60
11112853|NCT01289574|12296954|FG000|NOT COMPLETED|Overall Study||7
11112854|NCT01289574|12296955|FG001|NOT COMPLETED|Overall Study||3
11112855|NCT01289574|12296956|FG002|NOT COMPLETED|Overall Study||3
11112856|NCT01289639|12296968|FG000|STARTED|Overall Study||5
11230598|NCT02022748|12422624|FG001|NOT COMPLETED|Overall Study||2
11230599|NCT02022748|12422625|FG002|NOT COMPLETED|Overall Study||0
11230600|NCT02022826|12422633|FG000|STARTED|Overall Study||167
11230601|NCT02022826|12422633|FG000|COMPLETED|Overall Study||139
11230602|NCT02022826|12422633|FG000|NOT COMPLETED|Overall Study||28
11230603|NCT02023099|12422640|FG000|STARTED|Overall Study||215
11230604|NCT02023099|12422641|FG001|STARTED|Overall Study||106
11230605|NCT02023099|12422642|FG002|STARTED|Overall Study||42
11230606|NCT02023099|12422640|FG000|COMPLETED|Overall Study||212
11230607|NCT02023099|12422641|FG001|COMPLETED|Overall Study||106
11230608|NCT02023099|12422642|FG002|COMPLETED|Overall Study||39
11230609|NCT02023099|12422640|FG000|NOT COMPLETED|Overall Study||3
11230610|NCT02023099|12422641|FG001|NOT COMPLETED|Overall Study||0
11230611|NCT02023099|12422642|FG002|NOT COMPLETED|Overall Study||3
11230612|NCT02023112|12422652|FG000|STARTED|Overall Study||85
11230613|NCT02023112|12422653|FG001|STARTED|Overall Study||86
11230614|NCT02023112|12422652|FG000|COMPLETED|Overall Study||83
11230615|NCT02023112|12422653|FG001|COMPLETED|Overall Study||85
11230616|NCT02023112|12422652|FG000|NOT COMPLETED|Overall Study||2
11230617|NCT02023112|12422653|FG001|NOT COMPLETED|Overall Study||1
11230618|NCT02023125|12422663|FG000|STARTED|Period 1||9
11230619|NCT02023125|12422664|FG001|STARTED|Period 1||9
11230620|NCT02023125|12422665|FG002|STARTED|Period 1||24
11230621|NCT02023125|12422663|FG000|COMPLETED|Period 1||9
11230622|NCT02023125|12422664|FG001|COMPLETED|Period 1||9
11230623|NCT02023125|12422665|FG002|COMPLETED|Period 1||24
11230624|NCT02023125|12422663|FG000|NOT COMPLETED|Period 1||0
11230625|NCT02023125|12422664|FG001|NOT COMPLETED|Period 1||0
11230626|NCT02023125|12422665|FG002|NOT COMPLETED|Period 1||0
11230627|NCT02023125|12422663|FG000|STARTED|Washout Period||9
11230628|NCT02023125|12422664|FG001|STARTED|Washout Period||9
11230629|NCT02023125|12422665|FG002|STARTED|Washout Period||24
11230630|NCT02023125|12422663|FG000|COMPLETED|Washout Period||9
11230631|NCT02023125|12422664|FG001|COMPLETED|Washout Period||9
11230632|NCT02023125|12422665|FG002|COMPLETED|Washout Period||24
11230633|NCT02023125|12422663|FG000|NOT COMPLETED|Washout Period||0
11230634|NCT02023125|12422664|FG001|NOT COMPLETED|Washout Period||0
11112857|NCT01289639|12296969|FG001|STARTED|Overall Study||6
11112858|NCT01289639|12296970|FG002|STARTED|Overall Study||0
11112859|NCT01289639|12296968|FG000|COMPLETED|Overall Study||4
11112860|NCT01289639|12296969|FG001|COMPLETED|Overall Study||6
11112861|NCT01289639|12296970|FG002|COMPLETED|Overall Study||0
11112862|NCT01289639|12296968|FG000|NOT COMPLETED|Overall Study||1
11230635|NCT02023125|12422665|FG002|NOT COMPLETED|Washout Period||0
11230636|NCT02023125|12422663|FG000|STARTED|Period 2||9
11230637|NCT02023125|12422664|FG001|STARTED|Period 2||9
11230638|NCT02023125|12422665|FG002|STARTED|Period 2||24
11230639|NCT02023125|12422663|FG000|COMPLETED|Period 2||9
11230640|NCT02023125|12422664|FG001|COMPLETED|Period 2||9
11230641|NCT02023125|12422665|FG002|COMPLETED|Period 2||24
11230642|NCT02023125|12422663|FG000|NOT COMPLETED|Period 2||0
11230643|NCT02023125|12422664|FG001|NOT COMPLETED|Period 2||0
11230644|NCT02023125|12422665|FG002|NOT COMPLETED|Period 2||0
11230645|NCT02023151|12422677|FG000|STARTED|Overall Study||17
11230646|NCT02023151|12422677|FG000|COMPLETED|Overall Study||13
11230647|NCT02023151|12422677|FG000|NOT COMPLETED|Overall Study||4
11230648|NCT02023242|12422683|FG000|STARTED|Overall Study||75
11112863|NCT01289639|12296969|FG001|NOT COMPLETED|Overall Study||0
11112864|NCT01289639|12296970|FG002|NOT COMPLETED|Overall Study||0
11112865|NCT01289665|12296980|FG000|STARTED|Overall Study||60
11112866|NCT01289665|12296981|FG001|STARTED|Overall Study||60
11112867|NCT01289665|12296980|FG000|COMPLETED|Overall Study||59
11112868|NCT01289665|12296981|FG001|COMPLETED|Overall Study||60
11112869|NCT01289665|12296980|FG000|NOT COMPLETED|Overall Study||1
11112870|NCT01289665|12296981|FG001|NOT COMPLETED|Overall Study||0
11112871|NCT01289678|12296987|FG000|STARTED|Overall Study||18
11112872|NCT01289678|12296987|FG000|COMPLETED|Overall Study||12
11112873|NCT01289678|12296987|FG000|NOT COMPLETED|Overall Study||6
11112874|NCT01289782|12296993|FG000|STARTED|Overall Study||264
11112875|NCT01289782|12296994|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
11230649|NCT02023242|12422684|FG001|STARTED|Overall Study||77
11230650|NCT02023242|12422683|FG000|COMPLETED|Overall Study||72
11112876|NCT01289782|12296993|FG000|COMPLETED|Overall Study||239
11112877|NCT01289782|12296994|FG001|COMPLETED|Overall Study||118
11112878|NCT01289782|12296993|FG000|NOT COMPLETED|Overall Study||25
11112879|NCT01289782|12296994|FG001|NOT COMPLETED|Overall Study||12
11112880|NCT01289821|12297000|FG000|STARTED|Treatment Period||54
11112881|NCT01289821|12297000|FG000|Participants Received Regorafenib|Treatment Period||54
11112882|NCT01289821|12297000|FG000|COMPLETED|Treatment Period||0
11112883|NCT01289821|12297000|FG000|NOT COMPLETED|Treatment Period||54
11112884|NCT01289821|12297000|FG000|STARTED|Safety Follow-up Period||54
11112885|NCT01289821|12297000|FG000|COMPLETED|Safety Follow-up Period||49
11112886|NCT01289821|12297000|FG000|NOT COMPLETED|Safety Follow-up Period||5
11112887|NCT01289821|12297000|FG000|STARTED|Survival Follow-up Period||52
11112888|NCT01289821|12297000|FG000|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
11112889|NCT01289821|12297000|FG000|NOT COMPLETED|Survival Follow-up Period||18
11112890|NCT01289847|12297004|FG000|STARTED|Overall Study||25
11112891|NCT01289847|12297004|FG000|COMPLETED|Overall Study||24
11112892|NCT01289847|12297004|FG000|NOT COMPLETED|Overall Study||1
11112893|NCT01289912|12297010|FG000|STARTED|Overall Study||32
11112894|NCT01289912|12297011|FG001|STARTED|Overall Study||15
11112895|NCT01289912|12297010|FG000|COMPLETED|Overall Study||29
11112896|NCT01289912|12297011|FG001|COMPLETED|Overall Study||13
11112897|NCT01289912|12297010|FG000|NOT COMPLETED|Overall Study||3
11112898|NCT01289912|12297011|FG001|NOT COMPLETED|Overall Study||2
11112899|NCT01289990|12297040|FG000|STARTED|Overall Study||224
11112900|NCT01289990|12297041|FG001|STARTED|Overall Study||224
11112901|NCT01289990|12297042|FG002|STARTED|Overall Study||228
11112902|NCT01289990|12297043|FG003|STARTED|Overall Study||223
11112903|NCT01289990|12297044|FG004|STARTED|Overall Study||165
11112904|NCT01289990|12297045|FG005|STARTED|Overall Study||168
11112905|NCT01289990|12297046|FG006|STARTED|Overall Study||166
11112906|NCT01289990|12297047|FG007|STARTED|Overall Study||217
11112907|NCT01289990|12297048|FG008|STARTED|Overall Study||214
11112908|NCT01289990|12297049|FG009|STARTED|Overall Study||207
11112909|NCT01289990|12297050|FG010|STARTED|Overall Study||226
11112910|NCT01289990|12297051|FG011|STARTED|Overall Study||218
11112911|NCT01289990|12297052|FG012|STARTED|Overall Study||225
11112912|NCT01289990|12297040|FG000|COMPLETED|Overall Study||147
11112913|NCT01289990|12297041|FG001|COMPLETED|Overall Study||143
11112914|NCT01289990|12297042|FG002|COMPLETED|Overall Study||119
11112915|NCT01289990|12297043|FG003|COMPLETED|Overall Study||136
11112916|NCT01289990|12297044|FG004|COMPLETED|Overall Study||93
11112917|NCT01289990|12297045|FG005|COMPLETED|Overall Study||94
11112918|NCT01289990|12297046|FG006|COMPLETED|Overall Study||78
11112919|NCT01289990|12297047|FG007|COMPLETED|Overall Study||162
11112920|NCT01289990|12297048|FG008|COMPLETED|Overall Study||139
11112921|NCT01289990|12297049|FG009|COMPLETED|Overall Study||121
11112922|NCT01289990|12297050|FG010|COMPLETED|Overall Study||150
11112923|NCT01289990|12297051|FG011|COMPLETED|Overall Study||150
11112924|NCT01289990|12297052|FG012|COMPLETED|Overall Study||127
11112925|NCT01289990|12297040|FG000|NOT COMPLETED|Overall Study||77
11112926|NCT01289990|12297041|FG001|NOT COMPLETED|Overall Study||81
11112927|NCT01289990|12297042|FG002|NOT COMPLETED|Overall Study||109
11112928|NCT01289990|12297043|FG003|NOT COMPLETED|Overall Study||87
11112929|NCT01289990|12297044|FG004|NOT COMPLETED|Overall Study||72
11112930|NCT01289990|12297045|FG005|NOT COMPLETED|Overall Study||74
11112931|NCT01289990|12297046|FG006|NOT COMPLETED|Overall Study||88
11112932|NCT01289990|12297047|FG007|NOT COMPLETED|Overall Study||55
11112933|NCT01289990|12297048|FG008|NOT COMPLETED|Overall Study||75
11112934|NCT01289990|12297049|FG009|NOT COMPLETED|Overall Study||86
11112935|NCT01289990|12297050|FG010|NOT COMPLETED|Overall Study||76
11112936|NCT01289990|12297051|FG011|NOT COMPLETED|Overall Study||68
11112937|NCT01289990|12297052|FG012|NOT COMPLETED|Overall Study||98
11112938|NCT01290029|12297080|FG000|STARTED|Overall Study||14
11112939|NCT01290029|12297080|FG000|Received Study Treatment|Overall Study||12
11112940|NCT01290029|12297080|FG000|COMPLETED|Overall Study||12
11112941|NCT01290029|12297080|FG000|NOT COMPLETED|Overall Study||2
11112942|NCT01290068|12297086|FG000|STARTED|Overall Study||108
11112943|NCT01290068|12297087|FG001|STARTED|Overall Study||100
11112944|NCT01290068|12297086|FG000|Implanted|Overall Study||108
11112945|NCT01290068|12297087|FG001|Implanted|Overall Study||98
11112946|NCT01290068|12297086|FG000|COMPLETED|Overall Study||101
11112947|NCT01290068|12297087|FG001|COMPLETED|Overall Study||94
11112948|NCT01290068|12297086|FG000|NOT COMPLETED|Overall Study||7
11112949|NCT01290068|12297087|FG001|NOT COMPLETED|Overall Study||6
11112950|NCT01290094|12297093|FG000|STARTED|Overall Study||41
11112951|NCT01290094|12297093|FG000|COMPLETED|Overall Study||35
11112952|NCT01290094|12297093|FG000|NOT COMPLETED|Overall Study||6
11112953|NCT01290224|12297097|FG000|STARTED|Overall Study||10
11112954|NCT01290224|12297097|FG000|COMPLETED|Overall Study||5
11112955|NCT01290224|12297097|FG000|NOT COMPLETED|Overall Study||5
11112956|NCT01290237|12297105|FG000|STARTED|Overall Study||30
11230651|NCT02023242|12422684|FG001|COMPLETED|Overall Study||75
11230652|NCT02023242|12422683|FG000|NOT COMPLETED|Overall Study||3
11230653|NCT02023242|12422684|FG001|NOT COMPLETED|Overall Study||2
11230654|NCT02023268|12422692|FG000|STARTED|Overall Study||52
11230655|NCT02023268|12422693|FG001|STARTED|Overall Study||53
11230656|NCT02023268|12422692|FG000|COMPLETED|Overall Study||52
11230657|NCT02023268|12422693|FG001|COMPLETED|Overall Study||49
11230658|NCT02023268|12422692|FG000|NOT COMPLETED|Overall Study||0
11230659|NCT02023268|12422693|FG001|NOT COMPLETED|Overall Study||4
11230660|NCT02023411|12422701|FG000|STARTED|Overall Study||10
11230661|NCT02023411|12422702|FG001|STARTED|Overall Study||10
11230662|NCT02023411|12422701|FG000|COMPLETED|Overall Study||10
11230663|NCT02023411|12422702|FG001|COMPLETED|Overall Study||10
11230664|NCT02023411|12422701|FG000|NOT COMPLETED|Overall Study||0
11230665|NCT02023411|12422702|FG001|NOT COMPLETED|Overall Study||0
11230666|NCT02023515|12422711|FG000|STARTED|Overall Study||24
11230667|NCT02023515|12422712|FG001|STARTED|Overall Study||25
11230668|NCT02023515|12422711|FG000|COMPLETED|Overall Study||23
11230669|NCT02023515|12422712|FG001|COMPLETED|Overall Study||22
11230670|NCT02023515|12422711|FG000|NOT COMPLETED|Overall Study||1
11230671|NCT02023515|12422712|FG001|NOT COMPLETED|Overall Study||3
11230672|NCT02023697|12422721|FG000|STARTED|Treatment Period||130
11230673|NCT02023697|12422722|FG001|STARTED|Treatment Period||130
11230674|NCT02023697|12422723|FG002|STARTED|Treatment Period||131
11230675|NCT02023697|12422721|FG000|Received Treatment|Treatment Period||125
11230676|NCT02023697|12422722|FG001|Received Treatment|Treatment Period||124
11230677|NCT02023697|12422723|FG002|Received Treatment|Treatment Period||121
11230678|NCT02023697|12422721|FG000|COMPLETED|Treatment Period||84
11355350|NCT03078751|12552188|FG000|Untreated Participants|Overall Study||0
11355351|NCT03078751|12552189|FG001|Untreated Participants|Overall Study||4
11355352|NCT03078751|12552188|FG000|Safety Set|Overall Study||26
11355353|NCT03078751|12552189|FG001|Safety Set|Overall Study||24
11355354|NCT03078751|12552188|FG000|COMPLETED|Overall Study||13
11355355|NCT03078751|12552189|FG001|COMPLETED|Overall Study||0
11355356|NCT03078751|12552188|FG000|NOT COMPLETED|Overall Study||13
11355357|NCT03078751|12552189|FG001|NOT COMPLETED|Overall Study||28
11355358|NCT03078816|12552195|FG000|STARTED|Overall Study||5
11355359|NCT03078816|12552195|FG000|COMPLETED|Overall Study||4
11355360|NCT03078816|12552195|FG000|NOT COMPLETED|Overall Study||1
11355361|NCT03078907|12552201|FG000|STARTED|Overall Study||53
11355362|NCT03078907|12552202|FG001|STARTED|Overall Study||55
11355363|NCT03078907|12552201|FG000|COMPLETED|Overall Study||50
11355364|NCT03078907|12552202|FG001|COMPLETED|Overall Study||54
11355365|NCT03078907|12552201|FG000|NOT COMPLETED|Overall Study||3
11355366|NCT03078907|12552202|FG001|NOT COMPLETED|Overall Study||1
11355367|NCT03078946|12552210|FG000|STARTED|Overall Study||30
11355368|NCT03078946|12552211|FG001|STARTED|Overall Study||30
11355369|NCT03078946|12552210|FG000|COMPLETED|Overall Study||30
11355370|NCT03078946|12552211|FG001|COMPLETED|Overall Study||30
11355371|NCT03078946|12552210|FG000|NOT COMPLETED|Overall Study||0
11355372|NCT03078946|12552211|FG001|NOT COMPLETED|Overall Study||0
11355373|NCT03079375|12552220|FG000|STARTED|Overall Study||503
11355374|NCT03079375|12552221|FG001|STARTED|Overall Study||499
11355375|NCT03079375|12552222|FG002|STARTED|Overall Study||497
11355376|NCT03079375|12552220|FG000|COMPLETED|Overall Study||498
11355377|NCT03079375|12552221|FG001|COMPLETED|Overall Study||493
11355378|NCT03079375|12552222|FG002|COMPLETED|Overall Study||476
11112957|NCT01290237|12297106|FG001|STARTED|Overall Study||29
11112958|NCT01290237|12297105|FG000|COMPLETED|Overall Study||19
11112959|NCT01290237|12297106|FG001|COMPLETED|Overall Study||27
11112960|NCT01290237|12297105|FG000|NOT COMPLETED|Overall Study||11
11112961|NCT01290237|12297106|FG001|NOT COMPLETED|Overall Study||2
11112962|NCT01290263|12297116|FG000|STARTED|Overall Study||11
11112963|NCT01290263|12297117|FG001|STARTED|Overall Study||3
11112964|NCT01290263|12297118|FG002|STARTED|Overall Study||7
11112965|NCT01290263|12297119|FG003|STARTED|Overall Study||27
11112966|NCT01290263|12297120|FG004|STARTED|Overall Study||37
11112967|NCT01290263|12297116|FG000|COMPLETED|Overall Study||0
11112968|NCT01290263|12297117|FG001|COMPLETED|Overall Study||0
11112969|NCT01290263|12297118|FG002|COMPLETED|Overall Study||0
11112970|NCT01290263|12297119|FG003|COMPLETED|Overall Study||0
11112971|NCT01290263|12297120|FG004|COMPLETED|Overall Study||0
11112972|NCT01290263|12297116|FG000|NOT COMPLETED|Overall Study||11
11112973|NCT01290263|12297117|FG001|NOT COMPLETED|Overall Study||3
11112974|NCT01290263|12297118|FG002|NOT COMPLETED|Overall Study||7
11112975|NCT01290263|12297119|FG003|NOT COMPLETED|Overall Study||27
11112976|NCT01290263|12297120|FG004|NOT COMPLETED|Overall Study||37
11112977|NCT01290315|12297132|FG000|STARTED|Overall Study||14
11112978|NCT01290315|12297133|FG001|STARTED|Overall Study||12
11112979|NCT01290315|12297134|FG002|STARTED|Overall Study||10
11112980|NCT01290315|12297135|FG003|STARTED|Overall Study||13
11112981|NCT01290315|12297132|FG000|COMPLETED|Overall Study||11
11112982|NCT01290315|12297133|FG001|COMPLETED|Overall Study||9
11230679|NCT02023697|12422722|FG001|COMPLETED|Treatment Period||67
11230680|NCT02023697|12422723|FG002|COMPLETED|Treatment Period||29
11230681|NCT02023697|12422721|FG000|NOT COMPLETED|Treatment Period||46
11230682|NCT02023697|12422722|FG001|NOT COMPLETED|Treatment Period||63
11355379|NCT03079375|12552220|FG000|NOT COMPLETED|Overall Study||5
11355380|NCT03079375|12552221|FG001|NOT COMPLETED|Overall Study||6
11112983|NCT01290315|12297134|FG002|COMPLETED|Overall Study||10
11112984|NCT01290315|12297135|FG003|COMPLETED|Overall Study||8
11112985|NCT01290315|12297132|FG000|NOT COMPLETED|Overall Study||3
11112986|NCT01290315|12297133|FG001|NOT COMPLETED|Overall Study||3
11112987|NCT01290315|12297134|FG002|NOT COMPLETED|Overall Study||0
11112988|NCT01290315|12297135|FG003|NOT COMPLETED|Overall Study||5
11112989|NCT01290341|12297146|FG000|STARTED|Overall Study||573
11112990|NCT01290341|12297147|FG001|STARTED|Overall Study||287
11112991|NCT01290341|12297146|FG000|COMPLETED|Overall Study||481
11112992|NCT01290341|12297147|FG001|COMPLETED|Overall Study||258
11112993|NCT01290341|12297146|FG000|NOT COMPLETED|Overall Study||92
11112994|NCT01290341|12297147|FG001|NOT COMPLETED|Overall Study||29
11112995|NCT01290445|12297156|FG000|STARTED|Overall Study||335
11112996|NCT01290445|12297157|FG001|STARTED|Overall Study||78412
11112997|NCT01290445|12297158|FG002|STARTED|Overall Study||806438
11112998|NCT01290445|12297156|FG000|COMPLETED|Overall Study||335
11112999|NCT01290445|12297157|FG001|COMPLETED|Overall Study||78412
11113000|NCT01290445|12297158|FG002|COMPLETED|Overall Study||806438
11113001|NCT01290445|12297156|FG000|NOT COMPLETED|Overall Study||0
11113002|NCT01290445|12297157|FG001|NOT COMPLETED|Overall Study||0
11113003|NCT01290445|12297158|FG002|NOT COMPLETED|Overall Study||0
11113004|NCT01290484|12297166|FG000|STARTED|Overall Study||7
11113005|NCT01290484|12297166|FG000|COMPLETED|Overall Study||7
11113006|NCT01290484|12297166|FG000|NOT COMPLETED|Overall Study||0
11113007|NCT01290523|12297170|FG000|STARTED|Overall Study||14
11113008|NCT01290523|12297170|FG000|COMPLETED|Overall Study||11
11113009|NCT01290523|12297170|FG000|NOT COMPLETED|Overall Study||3
11113010|NCT01290536|12297174|FG000|STARTED|Overall Study||42
11113011|NCT01290536|12297174|FG000|COMPLETED|Overall Study||42
11113012|NCT01290536|12297174|FG000|NOT COMPLETED|Overall Study||0
11113013|NCT01290601|12297183|FG000|STARTED|Overall Study||46
11113014|NCT01290601|12297184|FG001|STARTED|Overall Study||24
11113015|NCT01290601|12297185|FG002|STARTED|Overall Study||0
11113016|NCT01290601|12297186|FG003|STARTED|Overall Study||0
11113017|NCT01290601|12297183|FG000|COMPLETED|Overall Study||35
11113018|NCT01290601|12297184|FG001|COMPLETED|Overall Study||19
11113019|NCT01290601|12297185|FG002|COMPLETED|Overall Study||0
11113020|NCT01290601|12297186|FG003|COMPLETED|Overall Study||0
11113021|NCT01290601|12297183|FG000|NOT COMPLETED|Overall Study||11
11113022|NCT01290601|12297184|FG001|NOT COMPLETED|Overall Study||5
11113023|NCT01290601|12297185|FG002|NOT COMPLETED|Overall Study||0
11113024|NCT01290601|12297186|FG003|NOT COMPLETED|Overall Study||0
11113025|NCT01290614|12297194|FG000|STARTED|Overall Study||1070
11113026|NCT01290614|12297195|FG001|STARTED|Overall Study||1129
11113027|NCT01290614|12297194|FG000|COMPLETED|Overall Study||518
11113028|NCT01290614|12297195|FG001|COMPLETED|Overall Study||1129
11113029|NCT01290614|12297194|FG000|NOT COMPLETED|Overall Study||552
11113030|NCT01290614|12297195|FG001|NOT COMPLETED|Overall Study||0
11113031|NCT01290627|12297204|FG000|STARTED|Overall Study||10
11113032|NCT01290627|12297205|FG001|STARTED|Overall Study||10
11113033|NCT01290627|12297206|FG002|STARTED|Overall Study||10
11113034|NCT01290627|12297204|FG000|COMPLETED|Overall Study||10
11113035|NCT01290627|12297205|FG001|COMPLETED|Overall Study||10
11113036|NCT01290627|12297206|FG002|COMPLETED|Overall Study||10
11113037|NCT01290627|12297204|FG000|NOT COMPLETED|Overall Study||0
11113038|NCT01290627|12297205|FG001|NOT COMPLETED|Overall Study||0
11113039|NCT01290627|12297206|FG002|NOT COMPLETED|Overall Study||0
11113040|NCT01290640|12297216|FG000|STARTED|Overall Study||12
11113041|NCT01290640|12297217|FG001|STARTED|Overall Study||10
11113042|NCT01290640|12297216|FG000|COMPLETED|Overall Study||12
11113043|NCT01290640|12297217|FG001|COMPLETED|Overall Study||10
11113044|NCT01290640|12297216|FG000|NOT COMPLETED|Overall Study||0
11113045|NCT01290640|12297217|FG001|NOT COMPLETED|Overall Study||0
11230683|NCT02023697|12422723|FG002|NOT COMPLETED|Treatment Period||102
11230684|NCT02023697|12422721|FG000|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
11230685|NCT02023697|12422722|FG001|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
11230686|NCT02023697|12422723|FG002|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
11230687|NCT02023697|12422721|FG000|COMPLETED|Active Follow-up Period||28
11230688|NCT02023697|12422722|FG001|COMPLETED|Active Follow-up Period||21
11230689|NCT02023697|12422723|FG002|COMPLETED|Active Follow-up Period||17
11230690|NCT02023697|12422721|FG000|NOT COMPLETED|Active Follow-up Period||92
11230691|NCT02023697|12422722|FG001|NOT COMPLETED|Active Follow-up Period||99
11230692|NCT02023697|12422723|FG002|NOT COMPLETED|Active Follow-up Period||99
11230693|NCT02023697|12422721|FG000|STARTED|Long-term Follow-up Period||28
11230694|NCT02023697|12422722|FG001|STARTED|Long-term Follow-up Period||21
11230695|NCT02023697|12422723|FG002|STARTED|Long-term Follow-up Period||17
11230696|NCT02023697|12422721|FG000|COMPLETED|Long-term Follow-up Period||0
11230697|NCT02023697|12422722|FG001|COMPLETED|Long-term Follow-up Period||0
11230698|NCT02023697|12422723|FG002|COMPLETED|Long-term Follow-up Period||0
11230699|NCT02023697|12422721|FG000|NOT COMPLETED|Long-term Follow-up Period||28
11230700|NCT02023697|12422722|FG001|NOT COMPLETED|Long-term Follow-up Period||21
11230701|NCT02023697|12422723|FG002|NOT COMPLETED|Long-term Follow-up Period||17
11230702|NCT02023801|12422738|FG000|STARTED|Overall Study|Treatment Attempted|24
11230703|NCT02023801|12422738|FG000|Treated|Overall Study|Treatment Completed|24
11230704|NCT02023801|12422738|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
11230705|NCT02023801|12422738|FG000|NOT COMPLETED|Overall Study||0
11230706|NCT02023866|12422742|FG000|STARTED|Overall Study||36
11230707|NCT02023866|12422742|FG000|COMPLETED|Overall Study||30
11230708|NCT02023866|12422742|FG000|NOT COMPLETED|Overall Study||6
11230709|NCT02023879|12422749|FG000|STARTED|Period 1: 24-Week Double-blind Treatment||58
11230710|NCT02023879|12422750|FG001|STARTED|Period 1: 24-Week Double-blind Treatment||116
11230711|NCT02023879|12422751|FG002|STARTED|Period 1: 24-Week Double-blind Treatment||59
11230712|NCT02023879|12422749|FG000|Treated|Period 1: 24-Week Double-blind Treatment||58
11230713|NCT02023879|12422750|FG001|Treated|Period 1: 24-Week Double-blind Treatment||115
11230714|NCT02023879|12422751|FG002|Treated|Period 1: 24-Week Double-blind Treatment||58
11230715|NCT02023879|12422749|FG000|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
11230716|NCT02023879|12422750|FG001|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
11230717|NCT02023879|12422751|FG002|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
11230718|NCT02023879|12422749|FG000|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
11230719|NCT02023879|12422750|FG001|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
11113046|NCT01290666|12297223|FG000|STARTED|Overall Study||93
11113047|NCT01290666|12297223|FG000|COMPLETED|Overall Study||55
11113048|NCT01290666|12297223|FG000|NOT COMPLETED|Overall Study||38
11113049|NCT01290679|12297229|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
11113050|NCT01290679|12297230|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
11113051|NCT01290679|12297229|FG000|COMPLETED|Overall Study||241
11113052|NCT01290679|12297230|FG001|COMPLETED|Overall Study||113
11113053|NCT01290679|12297229|FG000|NOT COMPLETED|Overall Study||16
11113054|NCT01290679|12297230|FG001|NOT COMPLETED|Overall Study||21
11113055|NCT01290731|12297236|FG000|STARTED|Overall Study||49
11113056|NCT01290731|12297236|FG000|COMPLETED|Overall Study||48
11113057|NCT01290731|12297236|FG000|NOT COMPLETED|Overall Study||1
11113058|NCT01290757|12297242|FG000|STARTED|Overall Study||90
11113059|NCT01290757|12297243|FG001|STARTED|Overall Study||90
11113060|NCT01290757|12297242|FG000|COMPLETED|Overall Study||88
11113061|NCT01290757|12297243|FG001|COMPLETED|Overall Study||88
11113062|NCT01290757|12297242|FG000|NOT COMPLETED|Overall Study||2
11113063|NCT01290757|12297243|FG001|NOT COMPLETED|Overall Study||2
11113064|NCT01290796|12297249|FG000|STARTED|Overall Study||153
11113065|NCT01290796|12297249|FG000|COMPLETED|Overall Study||123
11113066|NCT01290796|12297249|FG000|NOT COMPLETED|Overall Study||30
11113067|NCT01290874|12297255|FG000|STARTED|Overall Study||532
11113068|NCT01290874|12297256|FG001|STARTED|Overall Study||538
11113069|NCT01290874|12297255|FG000|COMPLETED|Overall Study||122
11113070|NCT01290874|12297256|FG001|COMPLETED|Overall Study||134
11113071|NCT01290874|12297255|FG000|NOT COMPLETED|Overall Study||410
11113072|NCT01290874|12297256|FG001|NOT COMPLETED|Overall Study||404
11113073|NCT01290887|12297265|FG000|STARTED|Overall Study||481
11113074|NCT01290887|12297266|FG001|STARTED|Overall Study||571
11113075|NCT01290887|12297265|FG000|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
11113076|NCT01290887|12297266|FG001|Safety Analysis Set|Overall Study||571
11113077|NCT01290887|12297265|FG000|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
11113078|NCT01290887|12297266|FG001|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
11113079|NCT01290887|12297265|FG000|NOT COMPLETED|Overall Study||466
11113080|NCT01290887|12297266|FG001|NOT COMPLETED|Overall Study||536
11113081|NCT01290913|12297272|FG000|STARTED|Overall Study||13
11113082|NCT01290913|12297272|FG000|COMPLETED|Overall Study||12
11113083|NCT01290913|12297272|FG000|NOT COMPLETED|Overall Study||1
11113084|NCT01290952|12297278|FG000|STARTED|Overall Study||204
11113085|NCT01290952|12297279|FG001|STARTED|Overall Study||207
11113086|NCT01290952|12297278|FG000|COMPLETED|Overall Study||192
11113087|NCT01290952|12297279|FG001|COMPLETED|Overall Study||193
11113088|NCT01290952|12297278|FG000|NOT COMPLETED|Overall Study||12
11113089|NCT01290952|12297279|FG001|NOT COMPLETED|Overall Study||14
11113090|NCT01290978|12297287|FG000|STARTED|Overall Study||22
11113091|NCT01290978|12297287|FG000|COMPLETED|Overall Study||22
11113092|NCT01290978|12297287|FG000|NOT COMPLETED|Overall Study||0
11113093|NCT01291017|12297292|FG000|STARTED|Overall Study||19
11113094|NCT01291017|12297292|FG000|COMPLETED|Overall Study||14
11113095|NCT01291017|12297292|FG000|NOT COMPLETED|Overall Study||5
11113096|NCT01291056|12297298|FG000|STARTED|Intervention One (Menstraution Day 3-7)||10
11113097|NCT01291056|12297299|FG001|STARTED|Intervention One (Menstraution Day 3-7)||10
11113098|NCT01291056|12297298|FG000|COMPLETED|Intervention One (Menstraution Day 3-7)||10
11113099|NCT01291056|12297299|FG001|COMPLETED|Intervention One (Menstraution Day 3-7)||10
11113100|NCT01291056|12297298|FG000|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
11113101|NCT01291056|12297299|FG001|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
11113102|NCT01291056|12297298|FG000|STARTED|Washout||10
11113103|NCT01291056|12297299|FG001|STARTED|Washout||10
11230720|NCT02023879|12422751|FG002|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
11355381|NCT03079375|12552222|FG002|NOT COMPLETED|Overall Study||21
11113104|NCT01291056|12297298|FG000|COMPLETED|Washout||10
11113105|NCT01291056|12297299|FG001|COMPLETED|Washout||10
11113106|NCT01291056|12297298|FG000|NOT COMPLETED|Washout||0
11113107|NCT01291056|12297299|FG001|NOT COMPLETED|Washout||0
11113108|NCT01291056|12297298|FG000|STARTED|Intervention Two (Menstration Days 3-7)||10
11113109|NCT01291056|12297299|FG001|STARTED|Intervention Two (Menstration Days 3-7)||10
11113110|NCT01291056|12297298|FG000|COMPLETED|Intervention Two (Menstration Days 3-7)||10
11113111|NCT01291056|12297299|FG001|COMPLETED|Intervention Two (Menstration Days 3-7)||10
11113112|NCT01291056|12297298|FG000|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
11113113|NCT01291056|12297299|FG001|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
11113114|NCT01291108|12297309|FG000|STARTED|Month 1 (Monotherapy)||65
11113115|NCT01291108|12297310|FG001|STARTED|Month 1 (Monotherapy)||0
11113116|NCT01291108|12297311|FG002|STARTED|Month 1 (Monotherapy)||0
11355382|NCT03079531|12552234|FG000|STARTED|Overall Study||24
11113117|NCT01291108|12297312|FG003|STARTED|Month 1 (Monotherapy)||60
11113118|NCT01291108|12297313|FG004|STARTED|Month 1 (Monotherapy)||0
11113119|NCT01291108|12297314|FG005|STARTED|Month 1 (Monotherapy)||0
11113120|NCT01291108|12297309|FG000|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
11113121|NCT01291108|12297310|FG001|COMPLETED|Month 1 (Monotherapy)||0
11113122|NCT01291108|12297311|FG002|COMPLETED|Month 1 (Monotherapy)||0
11113123|NCT01291108|12297312|FG003|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
11113124|NCT01291108|12297313|FG004|COMPLETED|Month 1 (Monotherapy)||0
11113125|NCT01291108|12297314|FG005|COMPLETED|Month 1 (Monotherapy)||0
11113126|NCT01291108|12297309|FG000|NOT COMPLETED|Month 1 (Monotherapy)||1
11113127|NCT01291108|12297310|FG001|NOT COMPLETED|Month 1 (Monotherapy)||0
11113128|NCT01291108|12297311|FG002|NOT COMPLETED|Month 1 (Monotherapy)||0
11113129|NCT01291108|12297312|FG003|NOT COMPLETED|Month 1 (Monotherapy)||0
11113130|NCT01291108|12297313|FG004|NOT COMPLETED|Month 1 (Monotherapy)||0
11113131|NCT01291108|12297314|FG005|NOT COMPLETED|Month 1 (Monotherapy)||0
11113132|NCT01291108|12297309|FG000|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
11113133|NCT01291108|12297310|FG001|STARTED|Month 2 (Adjunctive Therapy)||40
11113134|NCT01291108|12297311|FG002|STARTED|Month 2 (Adjunctive Therapy)||24
11113135|NCT01291108|12297312|FG003|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
11113136|NCT01291108|12297313|FG004|STARTED|Month 2 (Adjunctive Therapy)||34
11113137|NCT01291108|12297314|FG005|STARTED|Month 2 (Adjunctive Therapy)||26
11113138|NCT01291108|12297309|FG000|COMPLETED|Month 2 (Adjunctive Therapy)||0
11113139|NCT01291108|12297310|FG001|COMPLETED|Month 2 (Adjunctive Therapy)||38
11113140|NCT01291108|12297311|FG002|COMPLETED|Month 2 (Adjunctive Therapy)||24
11113141|NCT01291108|12297312|FG003|COMPLETED|Month 2 (Adjunctive Therapy)||0
11113142|NCT01291108|12297313|FG004|COMPLETED|Month 2 (Adjunctive Therapy)||34
11113143|NCT01291108|12297314|FG005|COMPLETED|Month 2 (Adjunctive Therapy)||25
11113144|NCT01291108|12297309|FG000|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
11113145|NCT01291108|12297310|FG001|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
11113146|NCT01291108|12297311|FG002|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
11113147|NCT01291108|12297312|FG003|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
11113148|NCT01291108|12297313|FG004|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
11113149|NCT01291108|12297314|FG005|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
11113150|NCT01291160|12297327|FG000|STARTED|Overall Study||66
11113151|NCT01291160|12297328|FG001|STARTED|Overall Study||64
11113152|NCT01291160|12297327|FG000|COMPLETED|Overall Study||48
11113153|NCT01291160|12297328|FG001|COMPLETED|Overall Study||48
11113154|NCT01291160|12297327|FG000|NOT COMPLETED|Overall Study||18
11113155|NCT01291160|12297328|FG001|NOT COMPLETED|Overall Study||16
11113156|NCT01291173|12297338|FG000|STARTED|Overall Study||64
11113157|NCT01291173|12297339|FG001|STARTED|Overall Study||66
11113158|NCT01291173|12297340|FG002|STARTED|Overall Study||65
11113159|NCT01291173|12297341|FG003|STARTED|Overall Study||65
11113160|NCT01291173|12297338|FG000|COMPLETED|Overall Study||47
11113161|NCT01291173|12297339|FG001|COMPLETED|Overall Study||51
11113162|NCT01291173|12297340|FG002|COMPLETED|Overall Study||52
11113163|NCT01291173|12297341|FG003|COMPLETED|Overall Study||52
11113164|NCT01291173|12297338|FG000|NOT COMPLETED|Overall Study||17
11113165|NCT01291173|12297339|FG001|NOT COMPLETED|Overall Study||15
11113166|NCT01291173|12297340|FG002|NOT COMPLETED|Overall Study||13
11113167|NCT01291173|12297341|FG003|NOT COMPLETED|Overall Study||13
11113168|NCT01291225|12297353|FG000|STARTED|Overall Study||151
11113169|NCT01291225|12297354|FG001|STARTED|Overall Study||160
11113170|NCT01291225|12297353|FG000|COMPLETED|Overall Study||66
11113171|NCT01291225|12297354|FG001|COMPLETED|Overall Study||121
11113172|NCT01291225|12297353|FG000|NOT COMPLETED|Overall Study||85
11113173|NCT01291225|12297354|FG001|NOT COMPLETED|Overall Study||39
11113174|NCT01291264|12297364|FG000|STARTED|Overall Study||260
11113175|NCT01291264|12297364|FG000|COMPLETED|Overall Study||260
11113176|NCT01291264|12297364|FG000|NOT COMPLETED|Overall Study||0
11113177|NCT01291277|12297370|FG000|STARTED|Overall Study||45
11113178|NCT01291277|12297371|FG001|STARTED|Overall Study||45
11113179|NCT01291277|12297370|FG000|COMPLETED|Overall Study||40
11113180|NCT01291277|12297371|FG001|COMPLETED|Overall Study||42
11113181|NCT01291277|12297370|FG000|NOT COMPLETED|Overall Study||5
11113182|NCT01291277|12297371|FG001|NOT COMPLETED|Overall Study||3
11113183|NCT01291498|12297377|FG000|STARTED|Overall Study||1
11113184|NCT01291498|12297377|FG000|COMPLETED|Overall Study||0
11113185|NCT01291498|12297377|FG000|NOT COMPLETED|Overall Study||1
11113186|NCT01291784|12297383|FG000|STARTED|Overall Study||1
11113187|NCT01291784|12297384|FG001|STARTED|Overall Study||1
11113188|NCT01291784|12297385|FG002|STARTED|Overall Study||1
11113189|NCT01291784|12297383|FG000|COMPLETED|Overall Study||1
11113190|NCT01291784|12297384|FG001|COMPLETED|Overall Study||0
11113191|NCT01291784|12297385|FG002|COMPLETED|Overall Study||1
11113192|NCT01291784|12297383|FG000|NOT COMPLETED|Overall Study||0
11113193|NCT01291784|12297384|FG001|NOT COMPLETED|Overall Study||1
11113194|NCT01291784|12297385|FG002|NOT COMPLETED|Overall Study||0
11113195|NCT01291836|12297393|FG000|STARTED|Overall Study||930
11113196|NCT01291836|12297394|FG001|STARTED|Overall Study||71
11113197|NCT01291836|12297393|FG000|COMPLETED|Overall Study||930
11113198|NCT01291836|12297394|FG001|COMPLETED|Overall Study||71
11113199|NCT01291836|12297393|FG000|NOT COMPLETED|Overall Study||0
11113200|NCT01291836|12297394|FG001|NOT COMPLETED|Overall Study||0
11113201|NCT01292005|12297402|FG000|STARTED|Overall Study||14
11113202|NCT01292005|12297403|FG001|STARTED|Overall Study||14
11113203|NCT01292005|12297402|FG000|COMPLETED|Overall Study||14
11113204|NCT01292005|12297403|FG001|COMPLETED|Overall Study||14
11113205|NCT01292005|12297402|FG000|NOT COMPLETED|Overall Study||0
11113206|NCT01292005|12297403|FG001|NOT COMPLETED|Overall Study||0
11113207|NCT01292057|12297411|FG000|STARTED|Overall Study||49
11113208|NCT01292057|12297412|FG001|STARTED|Overall Study||50
11113209|NCT01292057|12297411|FG000|COMPLETED|Overall Study||47
11113210|NCT01292057|12297412|FG001|COMPLETED|Overall Study||48
11113211|NCT01292057|12297411|FG000|NOT COMPLETED|Overall Study||2
11113212|NCT01292057|12297412|FG001|NOT COMPLETED|Overall Study||2
11113213|NCT01292135|12297420|FG000|STARTED|Overall Study||3
11113214|NCT01292135|12297421|FG001|STARTED|Overall Study||30
11230721|NCT02023879|12422749|FG000|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
11230722|NCT02023879|12422750|FG001|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
11230723|NCT02023879|12422751|FG002|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
11230724|NCT02023879|12422749|FG000|COMPLETED|Extension Open Label Treatment||46
11230725|NCT02023879|12422750|FG001|COMPLETED|Extension Open Label Treatment||89
11230726|NCT02023879|12422751|FG002|COMPLETED|Extension Open Label Treatment||43
11230727|NCT02023879|12422749|FG000|NOT COMPLETED|Extension Open Label Treatment||5
11230728|NCT02023879|12422750|FG001|NOT COMPLETED|Extension Open Label Treatment||17
11230729|NCT02023879|12422751|FG002|NOT COMPLETED|Extension Open Label Treatment||5
11230730|NCT02023918|12422766|FG000|STARTED|Overall Study||6
11230731|NCT02023918|12422766|FG000|COMPLETED|Overall Study||6
11230732|NCT02023918|12422766|FG000|NOT COMPLETED|Overall Study||0
11230733|NCT02023944|12422772|FG000|STARTED|Overall Study||25
11230734|NCT02023944|12422773|FG001|STARTED|Overall Study||25
11230735|NCT02023944|12422772|FG000|COMPLETED|Overall Study||25
11230736|NCT02023944|12422773|FG001|COMPLETED|Overall Study||24
11230737|NCT02023944|12422772|FG000|NOT COMPLETED|Overall Study||0
11230738|NCT02023944|12422773|FG001|NOT COMPLETED|Overall Study||1
11230739|NCT02023983|12422782|FG000|STARTED|Overall Study||76
11230740|NCT02023983|12422783|FG001|STARTED|Overall Study||75
11355383|NCT03079531|12552234|FG000|Attended ≥1 Post-baseline Visit|Overall Study||23
11230741|NCT02023983|12422782|FG000|COMPLETED|Overall Study||76
11230742|NCT02023983|12422783|FG001|COMPLETED|Overall Study||75
11230743|NCT02023983|12422782|FG000|NOT COMPLETED|Overall Study||0
11230744|NCT02023983|12422783|FG001|NOT COMPLETED|Overall Study||0
11230745|NCT02024165|12422789|FG000|STARTED|Overall Study||71
11230746|NCT02024165|12422789|FG000|COMPLETED|Overall Study||71
11230747|NCT02024165|12422789|FG000|NOT COMPLETED|Overall Study||0
11230748|NCT02024204|12422796|FG000|STARTED|Overall Study||49
11230749|NCT02024204|12422797|FG001|STARTED|Overall Study||11
11230750|NCT02024204|12422796|FG000|COMPLETED|Overall Study||49
11230751|NCT02024204|12422797|FG001|COMPLETED|Overall Study||11
11230752|NCT02024204|12422796|FG000|NOT COMPLETED|Overall Study||0
11230753|NCT02024204|12422797|FG001|NOT COMPLETED|Overall Study||0
11230754|NCT02024386|12422806|FG000|STARTED|Overall Study||6
11230755|NCT02024386|12422807|FG001|STARTED|Overall Study||11
11230756|NCT02024386|12422808|FG002|STARTED|Overall Study||5
11230757|NCT02024386|12422806|FG000|COMPLETED|Overall Study||6
11230758|NCT02024386|12422807|FG001|COMPLETED|Overall Study||11
11230759|NCT02024386|12422808|FG002|COMPLETED|Overall Study||5
11230760|NCT02024386|12422806|FG000|NOT COMPLETED|Overall Study||0
11230761|NCT02024386|12422807|FG001|NOT COMPLETED|Overall Study||0
11230762|NCT02024386|12422808|FG002|NOT COMPLETED|Overall Study||0
11230763|NCT02024477|12422819|FG000|STARTED|Overall Study||21
11230764|NCT02024477|12422820|FG001|STARTED|Overall Study||21
11230765|NCT02024477|12422819|FG000|COMPLETED|Overall Study||21
11230766|NCT02024477|12422820|FG001|COMPLETED|Overall Study||21
11230767|NCT02024477|12422819|FG000|NOT COMPLETED|Overall Study||0
11230768|NCT02024477|12422820|FG001|NOT COMPLETED|Overall Study||0
11230769|NCT02024646|12422829|FG000|STARTED|Overall Study||163
11230770|NCT02024646|12422830|FG001|STARTED|Overall Study||160
11230771|NCT02024646|12422831|FG002|STARTED|Overall Study||161
11230772|NCT02024646|12422829|FG000|COMPLETED|Overall Study||131
11230773|NCT02024646|12422830|FG001|COMPLETED|Overall Study||135
11355384|NCT03079531|12552234|FG000|COMPLETED|Overall Study||17
11230774|NCT02024646|12422831|FG002|COMPLETED|Overall Study||133
11230775|NCT02024646|12422829|FG000|NOT COMPLETED|Overall Study||32
11113215|NCT01292135|12297420|FG000|COMPLETED|Overall Study||3
11113216|NCT01292135|12297421|FG001|COMPLETED|Overall Study||21
11113217|NCT01292135|12297420|FG000|NOT COMPLETED|Overall Study||0
11113218|NCT01292135|12297421|FG001|NOT COMPLETED|Overall Study||9
11113219|NCT01292187|12297431|FG000|STARTED|Overall Study||86
11113220|NCT01292187|12297432|FG001|STARTED|Overall Study||43
11113221|NCT01292187|12297431|FG000|COMPLETED|Overall Study||69
11113222|NCT01292187|12297432|FG001|COMPLETED|Overall Study||30
11113223|NCT01292187|12297431|FG000|NOT COMPLETED|Overall Study||17
11113224|NCT01292187|12297432|FG001|NOT COMPLETED|Overall Study||13
11113225|NCT01292226|12297439|FG000|STARTED|Overall Study||45
11113226|NCT01292226|12297439|FG000|COMPLETED|Overall Study||32
11113227|NCT01292226|12297439|FG000|NOT COMPLETED|Overall Study||13
11113228|NCT01292239|12297445|FG000|STARTED|Overall Study||123
11113229|NCT01292239|12297446|FG001|STARTED|Overall Study||60
11113230|NCT01292239|12297445|FG000|COMPLETED|Overall Study||119
11113231|NCT01292239|12297446|FG001|COMPLETED|Overall Study||53
11113232|NCT01292239|12297445|FG000|NOT COMPLETED|Overall Study||4
11113233|NCT01292239|12297446|FG001|NOT COMPLETED|Overall Study||7
11230776|NCT02024646|12422830|FG001|NOT COMPLETED|Overall Study||25
11230777|NCT02024646|12422831|FG002|NOT COMPLETED|Overall Study||28
11230778|NCT02024698|12422839|FG000|STARTED|First Intervention (7 Days)||16
11230779|NCT02024698|12422840|FG001|STARTED|First Intervention (7 Days)||27
11230780|NCT02024698|12422839|FG000|COMPLETED|First Intervention (7 Days)||16
11230781|NCT02024698|12422840|FG001|COMPLETED|First Intervention (7 Days)||26
11230782|NCT02024698|12422839|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11230783|NCT02024698|12422840|FG001|NOT COMPLETED|First Intervention (7 Days)||1
11230784|NCT02024698|12422839|FG000|STARTED|Second Intervention (7 Days)||16
11230785|NCT02024698|12422840|FG001|STARTED|Second Intervention (7 Days)||26
11230786|NCT02024698|12422839|FG000|Received Etafilcon A Twice|Second Intervention (7 Days)||1
11230787|NCT02024698|12422840|FG001|Received Etafilcon A Twice|Second Intervention (7 Days)||0
11230788|NCT02024698|12422839|FG000|COMPLETED|Second Intervention (7 Days)||16
11230789|NCT02024698|12422840|FG001|COMPLETED|Second Intervention (7 Days)||26
11230790|NCT02024698|12422839|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
11230791|NCT02024698|12422840|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
11230792|NCT02024711|12422848|FG000|STARTED|Overall Study||130
11230793|NCT02024711|12422849|FG001|STARTED|Overall Study||132
11230794|NCT02024711|12422848|FG000|COMPLETED|Overall Study||129
11230795|NCT02024711|12422849|FG001|COMPLETED|Overall Study||128
11230796|NCT02024711|12422848|FG000|NOT COMPLETED|Overall Study||1
11230797|NCT02024711|12422849|FG001|NOT COMPLETED|Overall Study||4
11230798|NCT02024724|12422857|FG000|STARTED|Overall Study||30
11230799|NCT02024724|12422858|FG001|STARTED|Overall Study||30
11230800|NCT02024724|12422857|FG000|COMPLETED|Overall Study||29
11230801|NCT02024724|12422858|FG001|COMPLETED|Overall Study||30
11230802|NCT02024724|12422857|FG000|NOT COMPLETED|Overall Study||1
11230803|NCT02024724|12422858|FG001|NOT COMPLETED|Overall Study||0
11230804|NCT02024750|12422866|FG000|STARTED|Overall Study||106
11230805|NCT02024750|12422867|FG001|STARTED|Overall Study||108
11230806|NCT02024750|12422866|FG000|COMPLETED|Overall Study||104
11230807|NCT02024750|12422867|FG001|COMPLETED|Overall Study||107
11230808|NCT02024750|12422866|FG000|NOT COMPLETED|Overall Study||2
11230809|NCT02024750|12422867|FG001|NOT COMPLETED|Overall Study||1
11230810|NCT02024867|12422875|FG000|STARTED|Overall Study||134
11230811|NCT02024867|12422876|FG001|STARTED|Overall Study||131
11230812|NCT02024867|12422875|FG000|COMPLETED|Overall Study||125
11230813|NCT02024867|12422876|FG001|COMPLETED|Overall Study||124
11230814|NCT02024867|12422875|FG000|NOT COMPLETED|Overall Study||9
11230815|NCT02024867|12422876|FG001|NOT COMPLETED|Overall Study||7
11230816|NCT02024932|12422888|FG000|STARTED|Overall Study||2
11230817|NCT02024932|12422889|FG001|STARTED|Overall Study||4
11230818|NCT02024932|12422890|FG002|STARTED|Overall Study||2
11230819|NCT02024932|12422891|FG003|STARTED|Overall Study||2
11230820|NCT02024932|12422892|FG004|STARTED|Overall Study||18
11230821|NCT02024932|12422893|FG005|STARTED|Overall Study||9
11230822|NCT02024932|12422888|FG000|Safety Analysis Set|Overall Study||2
11230823|NCT02024932|12422889|FG001|Safety Analysis Set|Overall Study||4
11230824|NCT02024932|12422890|FG002|Safety Analysis Set|Overall Study||2
11230825|NCT02024932|12422891|FG003|Safety Analysis Set|Overall Study||2
11230826|NCT02024932|12422892|FG004|Safety Analysis Set|Overall Study||18
11230827|NCT02024932|12422893|FG005|Safety Analysis Set|Overall Study||9
11230828|NCT02024932|12422888|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||2
11230829|NCT02024932|12422889|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||4
11230830|NCT02024932|12422890|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
11230831|NCT02024932|12422891|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||2
11230832|NCT02024932|12422892|FG004|Pharmacokinetic (PK) Analysis Set|Overall Study||18
11230833|NCT02024932|12422893|FG005|Pharmacokinetic (PK) Analysis Set|Overall Study||0
11230834|NCT02024932|12422888|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||2
11230835|NCT02024932|12422889|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4
11230836|NCT02024932|12422890|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||2
11230837|NCT02024932|12422891|FG003|Pharmacodynamic (PD) Analysis Set|Overall Study||2
11230838|NCT02024932|12422892|FG004|Pharmacodynamic (PD) Analysis Set|Overall Study||18
11230839|NCT02024932|12422893|FG005|Pharmacodynamic (PD) Analysis Set|Overall Study||9
11230840|NCT02024932|12422888|FG000|COMPLETED|Overall Study||0
11230841|NCT02024932|12422889|FG001|COMPLETED|Overall Study||1
11230842|NCT02024932|12422890|FG002|COMPLETED|Overall Study||2
11230843|NCT02024932|12422891|FG003|COMPLETED|Overall Study||0
11230844|NCT02024932|12422892|FG004|COMPLETED|Overall Study||16
11230845|NCT02024932|12422893|FG005|COMPLETED|Overall Study||9
11230846|NCT02024932|12422888|FG000|NOT COMPLETED|Overall Study||2
11230847|NCT02024932|12422889|FG001|NOT COMPLETED|Overall Study||3
11230848|NCT02024932|12422890|FG002|NOT COMPLETED|Overall Study||0
11230849|NCT02024932|12422891|FG003|NOT COMPLETED|Overall Study||2
11230850|NCT02024932|12422892|FG004|NOT COMPLETED|Overall Study||2
11230851|NCT02024932|12422893|FG005|NOT COMPLETED|Overall Study||0
11230852|NCT02024971|12422913|FG000|STARTED|Overall Study||1103
11230853|NCT02024971|12422913|FG000|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
11230854|NCT02024971|12422913|FG000|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
11230855|NCT02024971|12422913|FG000|NOT COMPLETED|Overall Study||36
11230856|NCT02025075|12422919|FG000|STARTED|Overall Study||16
11230857|NCT02025075|12422920|FG001|STARTED|Overall Study||21
11230858|NCT02025075|12422919|FG000|COMPLETED|Overall Study||16
11230859|NCT02025075|12422920|FG001|COMPLETED|Overall Study||19
11230860|NCT02025075|12422919|FG000|NOT COMPLETED|Overall Study||0
11230861|NCT02025075|12422920|FG001|NOT COMPLETED|Overall Study||2
11230862|NCT02025179|12422935|FG000|STARTED|Overall Study||8
11230863|NCT02025179|12422936|FG001|STARTED|Overall Study||9
11230864|NCT02025179|12422937|FG002|STARTED|Overall Study||8
11230865|NCT02025179|12422935|FG000|COMPLETED|Overall Study||8
11230866|NCT02025179|12422936|FG001|COMPLETED|Overall Study||9
11230867|NCT02025179|12422937|FG002|COMPLETED|Overall Study||7
11230868|NCT02025179|12422935|FG000|NOT COMPLETED|Overall Study||0
11230869|NCT02025179|12422936|FG001|NOT COMPLETED|Overall Study||0
11230870|NCT02025179|12422937|FG002|NOT COMPLETED|Overall Study||1
11230871|NCT02025205|12422947|FG000|STARTED|Overall Study||43
11230872|NCT02025205|12422948|FG001|STARTED|Overall Study||50
11230873|NCT02025205|12422947|FG000|COMPLETED|Overall Study||40
11230874|NCT02025205|12422948|FG001|COMPLETED|Overall Study||47
11230875|NCT02025205|12422947|FG000|NOT COMPLETED|Overall Study||3
11230876|NCT02025205|12422948|FG001|NOT COMPLETED|Overall Study||3
11230877|NCT02025426|12422956|FG000|STARTED|Overall Study||9
11230878|NCT02025426|12422957|FG001|STARTED|Overall Study||4
11230879|NCT02025426|12422956|FG000|COMPLETED|Overall Study||9
11230880|NCT02025426|12422957|FG001|COMPLETED|Overall Study||4
11230881|NCT02025426|12422956|FG000|NOT COMPLETED|Overall Study||0
11230882|NCT02025426|12422957|FG001|NOT COMPLETED|Overall Study||0
11230883|NCT02025439|12422965|FG000|STARTED|Overall Study||2
11230884|NCT02025439|12422966|FG001|STARTED|Overall Study||2
11230885|NCT02025439|12422965|FG000|COMPLETED|Overall Study||2
11230886|NCT02025439|12422966|FG001|COMPLETED|Overall Study||2
11230887|NCT02025439|12422965|FG000|NOT COMPLETED|Overall Study||0
11230888|NCT02025439|12422966|FG001|NOT COMPLETED|Overall Study||0
11230889|NCT02025530|12422976|FG000|STARTED|Overall Study||296
11230890|NCT02025530|12422977|FG001|STARTED|Overall Study||734
11230891|NCT02025530|12422976|FG000|COMPLETED|Overall Study||291
11230892|NCT02025530|12422977|FG001|COMPLETED|Overall Study||733
11230893|NCT02025530|12422976|FG000|NOT COMPLETED|Overall Study||5
11230894|NCT02025530|12422977|FG001|NOT COMPLETED|Overall Study||1
11230895|NCT02025621|12422985|FG000|STARTED|Overall Study||442
11230896|NCT02025621|12422986|FG001|STARTED|Overall Study||440
11230897|NCT02025621|12422985|FG000|COMPLETED|Overall Study||428
11230898|NCT02025621|12422986|FG001|COMPLETED|Overall Study||421
11230899|NCT02025621|12422985|FG000|NOT COMPLETED|Overall Study||14
11230900|NCT02025621|12422986|FG001|NOT COMPLETED|Overall Study||19
11230901|NCT02025634|12422994|FG000|STARTED|Overall Study||65
11230902|NCT02025634|12422995|FG001|STARTED|Overall Study||54
11230903|NCT02025634|12422994|FG000|COMPLETED|Overall Study||65
11230904|NCT02025634|12422995|FG001|COMPLETED|Overall Study||54
11230905|NCT02025634|12422994|FG000|NOT COMPLETED|Overall Study||0
11230906|NCT02025634|12422995|FG001|NOT COMPLETED|Overall Study||0
11230907|NCT02025647|12423001|FG000|STARTED|Overall Study||139
11230908|NCT02025647|12423001|FG000|Session 1 (Narrative Module)|Overall Study||139
11230909|NCT02025647|12423001|FG000|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
11230910|NCT02025647|12423001|FG000|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
11230911|NCT02025647|12423001|FG000|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
11230912|NCT02025647|12423001|FG000|COMPLETED|Overall Study||139
11230913|NCT02025647|12423001|FG000|NOT COMPLETED|Overall Study||0
11230914|NCT02025725|12423007|FG000|STARTED|Overall Study||102
11230915|NCT02025725|12423008|FG001|STARTED|Overall Study||103
11230916|NCT02025725|12423007|FG000|COMPLETED|Overall Study||91
11230917|NCT02025725|12423008|FG001|COMPLETED|Overall Study||99
11230918|NCT02025725|12423007|FG000|NOT COMPLETED|Overall Study||11
11230919|NCT02025725|12423008|FG001|NOT COMPLETED|Overall Study||4
11230920|NCT02025751|12423018|FG000|STARTED|Overall Study||26
11230921|NCT02025751|12423019|FG001|STARTED|Overall Study||27
11230922|NCT02025751|12423018|FG000|COMPLETED|Overall Study||25
11230923|NCT02025751|12423019|FG001|COMPLETED|Overall Study||24
11230924|NCT02025751|12423018|FG000|NOT COMPLETED|Overall Study||1
11230925|NCT02025751|12423019|FG001|NOT COMPLETED|Overall Study||3
11230926|NCT02025829|12423027|FG000|STARTED|Overall Study||3
11230927|NCT02025829|12423028|FG001|STARTED|Overall Study||11
11230928|NCT02025829|12423027|FG000|COMPLETED|Overall Study||3
11230929|NCT02025829|12423028|FG001|COMPLETED|Overall Study||11
11230930|NCT02025829|12423027|FG000|NOT COMPLETED|Overall Study||0
11230931|NCT02025829|12423028|FG001|NOT COMPLETED|Overall Study||0
11230932|NCT02025907|12423037|FG000|STARTED|Overall Study|Participant flow is presented for safety population.|108
11230933|NCT02025907|12423038|FG001|STARTED|Overall Study|Participant flow is presented for safety population.|108
11230934|NCT02025907|12423037|FG000|COMPLETED|Overall Study||81
11230935|NCT02025907|12423038|FG001|COMPLETED|Overall Study||96
11230936|NCT02025907|12423037|FG000|NOT COMPLETED|Overall Study||27
11230937|NCT02025907|12423038|FG001|NOT COMPLETED|Overall Study||12
11230938|NCT02025985|12423049|FG000|STARTED|Overall Study||25
11230939|NCT02025985|12423050|FG001|STARTED|Overall Study||23
11230940|NCT02025985|12423051|FG002|STARTED|Overall Study||25
11230941|NCT02025985|12423052|FG003|STARTED|Overall Study||21
11230942|NCT02025985|12423053|FG004|STARTED|Overall Study||20
11230943|NCT02025985|12423049|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||23
11230944|NCT02025985|12423050|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||22
11230945|NCT02025985|12423051|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||25
11230946|NCT02025985|12423052|FG003|Modified Intent-to-treat(mITT)Population|Overall Study||21
11230947|NCT02025985|12423053|FG004|Modified Intent-to-treat(mITT)Population|Overall Study||20
11230948|NCT02025985|12423049|FG000|COMPLETED|Overall Study||0
11230949|NCT02025985|12423050|FG001|COMPLETED|Overall Study||0
11230950|NCT02025985|12423051|FG002|COMPLETED|Overall Study||0
11230951|NCT02025985|12423052|FG003|COMPLETED|Overall Study||0
11230952|NCT02025985|12423053|FG004|COMPLETED|Overall Study||0
11230953|NCT02025985|12423049|FG000|NOT COMPLETED|Overall Study||25
11230954|NCT02025985|12423050|FG001|NOT COMPLETED|Overall Study||23
11230955|NCT02025985|12423051|FG002|NOT COMPLETED|Overall Study||25
11230956|NCT02025985|12423052|FG003|NOT COMPLETED|Overall Study||21
11230957|NCT02025985|12423053|FG004|NOT COMPLETED|Overall Study||20
11230958|NCT02026011|12423069|FG000|STARTED|Allocation 1 (First Set of Medication)||46
11230959|NCT02026011|12423070|FG001|STARTED|Allocation 1 (First Set of Medication)||41
11230960|NCT02026011|12423069|FG000|COMPLETED|Allocation 1 (First Set of Medication)||38
11230961|NCT02026011|12423070|FG001|COMPLETED|Allocation 1 (First Set of Medication)||39
11230962|NCT02026011|12423069|FG000|NOT COMPLETED|Allocation 1 (First Set of Medication)||8
11230963|NCT02026011|12423070|FG001|NOT COMPLETED|Allocation 1 (First Set of Medication)||2
11230964|NCT02026011|12423069|FG000|STARTED|Allocation 2 (Second Set of Medication)||38
11230965|NCT02026011|12423070|FG001|STARTED|Allocation 2 (Second Set of Medication)||37
11230966|NCT02026011|12423069|FG000|COMPLETED|Allocation 2 (Second Set of Medication)||37
11230967|NCT02026011|12423070|FG001|COMPLETED|Allocation 2 (Second Set of Medication)||35
11230968|NCT02026011|12423069|FG000|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1
11230969|NCT02026011|12423070|FG001|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2
11230970|NCT02026063|12423081|FG000|STARTED|Overall Study||22
11230971|NCT02026063|12423082|FG001|STARTED|Overall Study||102
11230972|NCT02026063|12423081|FG000|COMPLETED|Overall Study||13
11230973|NCT02026063|12423082|FG001|COMPLETED|Overall Study||53
11230974|NCT02026063|12423081|FG000|NOT COMPLETED|Overall Study||9
11230975|NCT02026063|12423082|FG001|NOT COMPLETED|Overall Study||49
11230976|NCT02026141|12423091|FG000|STARTED|Overall Study||20
11230977|NCT02026141|12423092|FG001|STARTED|Overall Study||20
11230978|NCT02026141|12423091|FG000|COMPLETED|Overall Study||20
11230979|NCT02026141|12423092|FG001|COMPLETED|Overall Study||19
11230980|NCT02026141|12423091|FG000|NOT COMPLETED|Overall Study||0
11230981|NCT02026141|12423092|FG001|NOT COMPLETED|Overall Study||1
11230982|NCT02026193|12423100|FG000|STARTED|Overall Study||3
11230983|NCT02026193|12423101|FG001|STARTED|Overall Study||8
11230984|NCT02026193|12423100|FG000|COMPLETED|Overall Study||3
11230985|NCT02026193|12423101|FG001|COMPLETED|Overall Study||8
11230986|NCT02026193|12423100|FG000|NOT COMPLETED|Overall Study||0
11230987|NCT02026193|12423101|FG001|NOT COMPLETED|Overall Study||0
11230988|NCT02026206|12423109|FG000|STARTED|Overall Study||44
11230989|NCT02026206|12423110|FG001|STARTED|Overall Study||44
11230990|NCT02026206|12423109|FG000|COMPLETED|Overall Study||40
11230991|NCT02026206|12423110|FG001|COMPLETED|Overall Study||36
11230992|NCT02026206|12423109|FG000|NOT COMPLETED|Overall Study||4
11230993|NCT02026206|12423110|FG001|NOT COMPLETED|Overall Study||8
11230994|NCT02026258|12423118|FG000|STARTED|Randomized||20
11230995|NCT02026258|12423119|FG001|STARTED|Randomized||21
11230996|NCT02026258|12423118|FG000|COMPLETED|Randomized||16
11230997|NCT02026258|12423119|FG001|COMPLETED|Randomized||19
11230998|NCT02026258|12423118|FG000|NOT COMPLETED|Randomized||4
11230999|NCT02026258|12423119|FG001|NOT COMPLETED|Randomized||2
11231000|NCT02026258|12423118|FG000|STARTED|Recieved Allocated Intervention||16
11231001|NCT02026258|12423119|FG001|STARTED|Recieved Allocated Intervention||19
11231002|NCT02026258|12423118|FG000|COMPLETED|Recieved Allocated Intervention||15
11231003|NCT02026258|12423119|FG001|COMPLETED|Recieved Allocated Intervention||17
11231004|NCT02026258|12423118|FG000|NOT COMPLETED|Recieved Allocated Intervention||1
11231005|NCT02026258|12423119|FG001|NOT COMPLETED|Recieved Allocated Intervention||2
11231006|NCT02026297|12423128|FG000|STARTED|Overall Study||7
11231007|NCT02026297|12423129|FG001|STARTED|Overall Study||13
11231008|NCT02026297|12423128|FG000|COMPLETED|Overall Study||7
11231009|NCT02026297|12423129|FG001|COMPLETED|Overall Study||13
11231010|NCT02026297|12423128|FG000|NOT COMPLETED|Overall Study||0
11231011|NCT02026297|12423129|FG001|NOT COMPLETED|Overall Study||0
11231012|NCT02026453|12423138|FG000|STARTED|Overall Study||101
11231013|NCT02026453|12423139|FG001|STARTED|Overall Study||103
11231014|NCT02026453|12423140|FG002|STARTED|Overall Study||102
11231015|NCT02026453|12423138|FG000|COMPLETED|Overall Study||95
11231016|NCT02026453|12423139|FG001|COMPLETED|Overall Study||94
11231017|NCT02026453|12423140|FG002|COMPLETED|Overall Study||89
11231018|NCT02026453|12423138|FG000|NOT COMPLETED|Overall Study||6
11231019|NCT02026453|12423139|FG001|NOT COMPLETED|Overall Study||9
11231020|NCT02026453|12423140|FG002|NOT COMPLETED|Overall Study||13
11231021|NCT02026687|12423150|FG000|STARTED|Overall Study||40
11231022|NCT02026687|12423151|FG001|STARTED|Overall Study||40
11231023|NCT02026687|12423150|FG000|COMPLETED|Overall Study||39
11231024|NCT02026687|12423151|FG001|COMPLETED|Overall Study||38
11231025|NCT02026687|12423150|FG000|NOT COMPLETED|Overall Study||1
11231026|NCT02026687|12423151|FG001|NOT COMPLETED|Overall Study||2
11231027|NCT02027025|12423160|FG000|STARTED|Overall Study||48
11231028|NCT02027025|12423161|FG001|STARTED|Overall Study||47
11231029|NCT02027025|12423162|FG002|STARTED|Overall Study||47
11231030|NCT02027025|12423160|FG000|COMPLETED|Overall Study||47
11231031|NCT02027025|12423161|FG001|COMPLETED|Overall Study||42
11231032|NCT02027025|12423162|FG002|COMPLETED|Overall Study||46
11231033|NCT02027025|12423160|FG000|NOT COMPLETED|Overall Study||1
11231034|NCT02027025|12423161|FG001|NOT COMPLETED|Overall Study||5
11231035|NCT02027025|12423162|FG002|NOT COMPLETED|Overall Study||1
11231036|NCT02027311|12423183|FG000|STARTED|Overall Study||33
11231037|NCT02027311|12423184|FG001|STARTED|Overall Study||35
11231038|NCT02027311|12423183|FG000|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
11231039|NCT02027311|12423184|FG001|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
11231040|NCT02027311|12423183|FG000|NOT COMPLETED|Overall Study||3
11231041|NCT02027311|12423184|FG001|NOT COMPLETED|Overall Study||2
11231042|NCT02027376|12423192|FG000|STARTED|Overall Study||5
11231043|NCT02027376|12423193|FG001|STARTED|Overall Study||4
11231044|NCT02027376|12423194|FG002|STARTED|Overall Study||3
11231045|NCT02027376|12423192|FG000|COMPLETED|Overall Study||4
11231046|NCT02027376|12423193|FG001|COMPLETED|Overall Study||4
11231047|NCT02027376|12423194|FG002|COMPLETED|Overall Study||3
11231048|NCT02027376|12423192|FG000|NOT COMPLETED|Overall Study||1
11231049|NCT02027376|12423193|FG001|NOT COMPLETED|Overall Study||0
11231050|NCT02027376|12423194|FG002|NOT COMPLETED|Overall Study||0
11231051|NCT02027402|12423206|FG000|STARTED|Overall Study||98
11231052|NCT02027402|12423207|FG001|STARTED|Overall Study||100
11231053|NCT02027402|12423206|FG000|COMPLETED|Overall Study||94
11231054|NCT02027402|12423207|FG001|COMPLETED|Overall Study||99
11231055|NCT02027402|12423206|FG000|NOT COMPLETED|Overall Study||4
11231056|NCT02027402|12423207|FG001|NOT COMPLETED|Overall Study||1
11231057|NCT02027428|12423217|FG000|STARTED|Induction||427
11231058|NCT02027428|12423218|FG001|STARTED|Induction||0
11231059|NCT02027428|12423219|FG002|STARTED|Induction||0
11231060|NCT02027428|12423217|FG000|Received Study Drug|Induction||420
11231061|NCT02027428|12423218|FG001|Received Study Drug|Induction||0
11231062|NCT02027428|12423219|FG002|Received Study Drug|Induction||0
11231063|NCT02027428|12423217|FG000|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
11231064|NCT02027428|12423218|FG001|COMPLETED|Induction||0
11231065|NCT02027428|12423219|FG002|COMPLETED|Induction||0
11231066|NCT02027428|12423217|FG000|NOT COMPLETED|Induction||225
11231067|NCT02027428|12423218|FG001|NOT COMPLETED|Induction||0
11231068|NCT02027428|12423219|FG002|NOT COMPLETED|Induction||0
11231069|NCT02027428|12423217|FG000|STARTED|Maintenance||0
11231070|NCT02027428|12423218|FG001|STARTED|Maintenance||136
11231071|NCT02027428|12423219|FG002|STARTED|Maintenance||66
11231072|NCT02027428|12423217|FG000|COMPLETED|Maintenance||0
11231073|NCT02027428|12423218|FG001|COMPLETED|Maintenance||12
11231074|NCT02027428|12423219|FG002|COMPLETED|Maintenance||6
11231075|NCT02027428|12423217|FG000|NOT COMPLETED|Maintenance||0
11355385|NCT03079531|12552234|FG000|NOT COMPLETED|Overall Study||7
11355386|NCT03080142|12552240|FG000|STARTED|Overall Study||42
11231076|NCT02027428|12423218|FG001|NOT COMPLETED|Maintenance||124
11231077|NCT02027428|12423219|FG002|NOT COMPLETED|Maintenance||60
11231078|NCT02027428|12423217|FG000|STARTED|Survival Follow-up||0
11231079|NCT02027428|12423218|FG001|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|117
11231080|NCT02027428|12423219|FG002|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|55
11231081|NCT02027428|12423217|FG000|COMPLETED|Survival Follow-up||0
11231082|NCT02027428|12423218|FG001|COMPLETED|Survival Follow-up||38
11231083|NCT02027428|12423219|FG002|COMPLETED|Survival Follow-up||9
11231084|NCT02027428|12423217|FG000|NOT COMPLETED|Survival Follow-up||0
11231085|NCT02027428|12423218|FG001|NOT COMPLETED|Survival Follow-up||79
11231086|NCT02027428|12423219|FG002|NOT COMPLETED|Survival Follow-up||46
11231087|NCT02027545|12423244|FG000|STARTED|Overall Study||261
11231088|NCT02027545|12423245|FG001|STARTED|Overall Study||175
11231089|NCT02027545|12423244|FG000|COMPLETED|Overall Study||259
11231090|NCT02027545|12423245|FG001|COMPLETED|Overall Study||173
11231091|NCT02027545|12423244|FG000|NOT COMPLETED|Overall Study||2
11231092|NCT02027545|12423245|FG001|NOT COMPLETED|Overall Study||2
11231093|NCT02027558|12423253|FG000|STARTED|Overall Study||62
11231094|NCT02027558|12423254|FG001|STARTED|Overall Study||63
11231095|NCT02027558|12423253|FG000|Post-treatment|Overall Study||49
11231096|NCT02027558|12423254|FG001|Post-treatment|Overall Study||60
11231097|NCT02027558|12423253|FG000|3-month Follow-up|Overall Study||53
11231098|NCT02027558|12423254|FG001|3-month Follow-up|Overall Study||58
11231099|NCT02027558|12423253|FG000|6-month Follow-up|Overall Study||53
11231100|NCT02027558|12423254|FG001|6-month Follow-up|Overall Study||61
11231101|NCT02027558|12423253|FG000|COMPLETED|Overall Study||53
11231102|NCT02027558|12423254|FG001|COMPLETED|Overall Study||61
11231103|NCT02027558|12423253|FG000|NOT COMPLETED|Overall Study||9
11231104|NCT02027558|12423254|FG001|NOT COMPLETED|Overall Study||2
11231105|NCT02027623|12423264|FG000|STARTED|Overall Study||77
11231106|NCT02027623|12423265|FG001|STARTED|Overall Study||77
11231107|NCT02027623|12423264|FG000|COMPLETED|Overall Study||68
11231108|NCT02027623|12423265|FG001|COMPLETED|Overall Study||65
11231109|NCT02027623|12423264|FG000|NOT COMPLETED|Overall Study||9
11231110|NCT02027623|12423265|FG001|NOT COMPLETED|Overall Study||12
11231111|NCT02027701|12423272|FG000|STARTED|Overall Study||82
11231112|NCT02027701|12423272|FG000|COMPLETED|Overall Study||66
11231113|NCT02027701|12423272|FG000|NOT COMPLETED|Overall Study||16
11231114|NCT02027844|12423281|FG000|STARTED|Overall Study||39
11231115|NCT02027844|12423282|FG001|STARTED|Overall Study||39
11231116|NCT02027844|12423283|FG002|STARTED|Overall Study||39
11231117|NCT02027844|12423281|FG000|COMPLETED|Overall Study||34
11231118|NCT02027844|12423282|FG001|COMPLETED|Overall Study||33
11231119|NCT02027844|12423283|FG002|COMPLETED|Overall Study||37
11231120|NCT02027844|12423281|FG000|NOT COMPLETED|Overall Study||5
11231121|NCT02027844|12423282|FG001|NOT COMPLETED|Overall Study||6
11231122|NCT02027844|12423283|FG002|NOT COMPLETED|Overall Study||2
11231123|NCT02027883|12423293|FG000|STARTED|Overall Study||50
11231124|NCT02027883|12423294|FG001|STARTED|Overall Study||50
11231125|NCT02027883|12423293|FG000|COMPLETED|Overall Study||50
11231126|NCT02027883|12423294|FG001|COMPLETED|Overall Study||50
11231127|NCT02027883|12423293|FG000|NOT COMPLETED|Overall Study||0
11231128|NCT02027883|12423294|FG001|NOT COMPLETED|Overall Study||0
11231129|NCT02028065|12423307|FG000|STARTED|Randomization Through Start Treatment|Randomized|76
11231130|NCT02028065|12423308|FG001|STARTED|Randomization Through Start Treatment|Randomized|154
11231131|NCT02028065|12423309|FG002|STARTED|Randomization Through Start Treatment|Randomized|152
11231132|NCT02028065|12423307|FG000|COMPLETED|Randomization Through Start Treatment||75
11231133|NCT02028065|12423308|FG001|COMPLETED|Randomization Through Start Treatment||151
11231134|NCT02028065|12423309|FG002|COMPLETED|Randomization Through Start Treatment||149
11231135|NCT02028065|12423307|FG000|NOT COMPLETED|Randomization Through Start Treatment||1
11231136|NCT02028065|12423308|FG001|NOT COMPLETED|Randomization Through Start Treatment||3
11231137|NCT02028065|12423309|FG002|NOT COMPLETED|Randomization Through Start Treatment||3
11231138|NCT02028065|12423307|FG000|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
11231139|NCT02028065|12423308|FG001|STARTED|Treatment Through Study Completion||151
11231140|NCT02028065|12423309|FG002|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
11231141|NCT02028065|12423307|FG000|Received First Dose|Treatment Through Study Completion||76
11231142|NCT02028065|12423308|FG001|Received First Dose|Treatment Through Study Completion||151
11231143|NCT02028065|12423309|FG002|Received First Dose|Treatment Through Study Completion||148
11231144|NCT02028065|12423307|FG000|Received Second Dose|Treatment Through Study Completion||69
11231145|NCT02028065|12423308|FG001|Received Second Dose|Treatment Through Study Completion||140
11231146|NCT02028065|12423309|FG002|Received Second Dose|Treatment Through Study Completion||138
11231147|NCT02028065|12423307|FG000|Received Third Dose|Treatment Through Study Completion||64
11231148|NCT02028065|12423308|FG001|Received Third Dose|Treatment Through Study Completion||136
11231149|NCT02028065|12423309|FG002|Received Third Dose|Treatment Through Study Completion||134
11231150|NCT02028065|12423307|FG000|COMPLETED|Treatment Through Study Completion||64
11231151|NCT02028065|12423308|FG001|COMPLETED|Treatment Through Study Completion||136
11231152|NCT02028065|12423309|FG002|COMPLETED|Treatment Through Study Completion||134
11231153|NCT02028065|12423307|FG000|NOT COMPLETED|Treatment Through Study Completion||12
11231154|NCT02028065|12423308|FG001|NOT COMPLETED|Treatment Through Study Completion||15
11231155|NCT02028065|12423309|FG002|NOT COMPLETED|Treatment Through Study Completion||14
11231156|NCT02028169|12423317|FG000|STARTED|Overall Study||120
11231157|NCT02028169|12423317|FG000|COMPLETED|Overall Study||92
11231158|NCT02028169|12423317|FG000|NOT COMPLETED|Overall Study||28
11231159|NCT02028182|12423321|FG000|STARTED|Overall Study||22
11231160|NCT02028182|12423321|FG000|COMPLETED|Overall Study||20
11231161|NCT02028182|12423321|FG000|NOT COMPLETED|Overall Study||2
11231162|NCT02028208|12423329|FG000|STARTED|Overall Study||21
11231163|NCT02028208|12423330|FG001|STARTED|Overall Study||13
11231164|NCT02028208|12423331|FG002|STARTED|Overall Study||22
11231165|NCT02028208|12423329|FG000|COMPLETED|Overall Study||21
11231166|NCT02028208|12423330|FG001|COMPLETED|Overall Study||13
11231167|NCT02028208|12423331|FG002|COMPLETED|Overall Study||21
11231168|NCT02028208|12423329|FG000|NOT COMPLETED|Overall Study||0
11231169|NCT02028208|12423330|FG001|NOT COMPLETED|Overall Study||0
11231170|NCT02028208|12423331|FG002|NOT COMPLETED|Overall Study||1
11231171|NCT02028247|12423342|FG000|STARTED|Overall Study||77
11231172|NCT02028247|12423343|FG001|STARTED|Overall Study||71
11231173|NCT02028247|12423344|FG002|STARTED|Overall Study||19
11231174|NCT02028247|12423342|FG000|COMPLETED|Overall Study||67
11231175|NCT02028247|12423343|FG001|COMPLETED|Overall Study||59
11231176|NCT02028247|12423344|FG002|COMPLETED|Overall Study||15
11231177|NCT02028247|12423342|FG000|NOT COMPLETED|Overall Study||10
11231178|NCT02028247|12423343|FG001|NOT COMPLETED|Overall Study||12
11231179|NCT02028247|12423344|FG002|NOT COMPLETED|Overall Study||4
11231180|NCT02028325|12423352|FG000|STARTED|Overall Study||136
11231181|NCT02028325|12423352|FG000|COMPLETED|Overall Study||126
11231182|NCT02028325|12423352|FG000|NOT COMPLETED|Overall Study||10
11231183|NCT02028676|12423365|FG000|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
11231184|NCT02028676|12423366|FG001|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
11231185|NCT02028676|12423367|FG002|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
11231186|NCT02028676|12423368|FG003|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
11231187|NCT02028676|12423369|FG004|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
11231188|NCT02028676|12423370|FG005|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
11231189|NCT02028676|12423371|FG006|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
11231190|NCT02028676|12423372|FG007|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
11355387|NCT03080142|12552241|FG001|STARTED|Overall Study||44
11355388|NCT03080142|12552240|FG000|COMPLETED|Overall Study||42
11231191|NCT02028676|12423373|FG008|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
11231192|NCT02028676|12423365|FG000|COMPLETED|Initial Enrolment: CDM vs LCM||606
11231193|NCT02028676|12423366|FG001|COMPLETED|Initial Enrolment: CDM vs LCM||600
11231194|NCT02028676|12423367|FG002|COMPLETED|Initial Enrolment: CDM vs LCM||0
11231195|NCT02028676|12423368|FG003|COMPLETED|Initial Enrolment: CDM vs LCM||0
11231196|NCT02028676|12423369|FG004|COMPLETED|Initial Enrolment: CDM vs LCM||0
11231197|NCT02028676|12423370|FG005|COMPLETED|Initial Enrolment: CDM vs LCM||0
11231198|NCT02028676|12423371|FG006|COMPLETED|Initial Enrolment: CDM vs LCM||0
11231199|NCT02028676|12423372|FG007|COMPLETED|Initial Enrolment: CDM vs LCM||0
11231200|NCT02028676|12423373|FG008|COMPLETED|Initial Enrolment: CDM vs LCM||0
11231201|NCT02028676|12423365|FG000|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
11231202|NCT02028676|12423366|FG001|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
11231203|NCT02028676|12423367|FG002|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
11231204|NCT02028676|12423368|FG003|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
11231205|NCT02028676|12423369|FG004|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
11231206|NCT02028676|12423370|FG005|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
11231207|NCT02028676|12423371|FG006|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
11231208|NCT02028676|12423372|FG007|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
11231209|NCT02028676|12423373|FG008|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
11231210|NCT02028676|12423365|FG000|STARTED|Initial Enrolment: Induction ART||0
11231211|NCT02028676|12423366|FG001|STARTED|Initial Enrolment: Induction ART||0
11231212|NCT02028676|12423367|FG002|STARTED|Initial Enrolment: Induction ART||397
11231213|NCT02028676|12423368|FG003|STARTED|Initial Enrolment: Induction ART||404
11231214|NCT02028676|12423369|FG004|STARTED|Initial Enrolment: Induction ART||405
11231215|NCT02028676|12423370|FG005|STARTED|Initial Enrolment: Induction ART||0
11231216|NCT02028676|12423371|FG006|STARTED|Initial Enrolment: Induction ART||0
11231217|NCT02028676|12423372|FG007|STARTED|Initial Enrolment: Induction ART||0
11231218|NCT02028676|12423373|FG008|STARTED|Initial Enrolment: Induction ART||0
11231219|NCT02028676|12423365|FG000|COMPLETED|Initial Enrolment: Induction ART||0
11231220|NCT02028676|12423366|FG001|COMPLETED|Initial Enrolment: Induction ART||0
11231221|NCT02028676|12423367|FG002|COMPLETED|Initial Enrolment: Induction ART||397
11231222|NCT02028676|12423368|FG003|COMPLETED|Initial Enrolment: Induction ART||404
11231223|NCT02028676|12423369|FG004|COMPLETED|Initial Enrolment: Induction ART||405
11231224|NCT02028676|12423370|FG005|COMPLETED|Initial Enrolment: Induction ART||0
11231225|NCT02028676|12423371|FG006|COMPLETED|Initial Enrolment: Induction ART||0
11231226|NCT02028676|12423372|FG007|COMPLETED|Initial Enrolment: Induction ART||0
11231227|NCT02028676|12423373|FG008|COMPLETED|Initial Enrolment: Induction ART||0
11231228|NCT02028676|12423365|FG000|NOT COMPLETED|Initial Enrolment: Induction ART||0
11231229|NCT02028676|12423366|FG001|NOT COMPLETED|Initial Enrolment: Induction ART||0
11231230|NCT02028676|12423367|FG002|NOT COMPLETED|Initial Enrolment: Induction ART||0
11231231|NCT02028676|12423368|FG003|NOT COMPLETED|Initial Enrolment: Induction ART||0
11231232|NCT02028676|12423369|FG004|NOT COMPLETED|Initial Enrolment: Induction ART||0
11231233|NCT02028676|12423370|FG005|NOT COMPLETED|Initial Enrolment: Induction ART||0
11231234|NCT02028676|12423371|FG006|NOT COMPLETED|Initial Enrolment: Induction ART||0
11231235|NCT02028676|12423372|FG007|NOT COMPLETED|Initial Enrolment: Induction ART||0
11231236|NCT02028676|12423373|FG008|NOT COMPLETED|Initial Enrolment: Induction ART||0
11231237|NCT02028676|12423365|FG000|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
11231238|NCT02028676|12423366|FG001|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
11231239|NCT02028676|12423367|FG002|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
11231240|NCT02028676|12423368|FG003|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
11231241|NCT02028676|12423369|FG004|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
11231242|NCT02028676|12423370|FG005|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
11231243|NCT02028676|12423371|FG006|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
11231244|NCT02028676|12423372|FG007|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
11231245|NCT02028676|12423373|FG008|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
11231246|NCT02028676|12423365|FG000|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231247|NCT02028676|12423366|FG001|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231248|NCT02028676|12423367|FG002|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231249|NCT02028676|12423368|FG003|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231250|NCT02028676|12423369|FG004|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231251|NCT02028676|12423370|FG005|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
11231252|NCT02028676|12423371|FG006|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
11231253|NCT02028676|12423372|FG007|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231254|NCT02028676|12423373|FG008|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231255|NCT02028676|12423365|FG000|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231256|NCT02028676|12423366|FG001|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231257|NCT02028676|12423367|FG002|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231258|NCT02028676|12423368|FG003|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231259|NCT02028676|12423369|FG004|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231260|NCT02028676|12423370|FG005|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231261|NCT02028676|12423371|FG006|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231262|NCT02028676|12423372|FG007|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231263|NCT02028676|12423373|FG008|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
11231264|NCT02028676|12423365|FG000|STARTED|Subsequent Cotrimoxazole Randomization||0
11231265|NCT02028676|12423366|FG001|STARTED|Subsequent Cotrimoxazole Randomization||0
11231266|NCT02028676|12423367|FG002|STARTED|Subsequent Cotrimoxazole Randomization||0
11231267|NCT02028676|12423368|FG003|STARTED|Subsequent Cotrimoxazole Randomization||0
11231268|NCT02028676|12423369|FG004|STARTED|Subsequent Cotrimoxazole Randomization||0
11231269|NCT02028676|12423370|FG005|STARTED|Subsequent Cotrimoxazole Randomization||0
11231270|NCT02028676|12423371|FG006|STARTED|Subsequent Cotrimoxazole Randomization||0
11231271|NCT02028676|12423372|FG007|STARTED|Subsequent Cotrimoxazole Randomization||376
11231272|NCT02028676|12423373|FG008|STARTED|Subsequent Cotrimoxazole Randomization||382
11231273|NCT02028676|12423365|FG000|COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231274|NCT02028676|12423366|FG001|COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231275|NCT02028676|12423367|FG002|COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231276|NCT02028676|12423368|FG003|COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231277|NCT02028676|12423369|FG004|COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231278|NCT02028676|12423370|FG005|COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231279|NCT02028676|12423371|FG006|COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231280|NCT02028676|12423372|FG007|COMPLETED|Subsequent Cotrimoxazole Randomization||376
11231281|NCT02028676|12423373|FG008|COMPLETED|Subsequent Cotrimoxazole Randomization||382
11231282|NCT02028676|12423365|FG000|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231283|NCT02028676|12423366|FG001|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231284|NCT02028676|12423367|FG002|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231285|NCT02028676|12423368|FG003|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231286|NCT02028676|12423369|FG004|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231287|NCT02028676|12423370|FG005|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231288|NCT02028676|12423371|FG006|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231289|NCT02028676|12423372|FG007|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231290|NCT02028676|12423373|FG008|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
11231291|NCT02028715|12423399|FG000|STARTED|Overall Study||34
11231292|NCT02028715|12423400|FG001|STARTED|Overall Study||34
11231293|NCT02028715|12423399|FG000|COMPLETED|Overall Study||29
11231294|NCT02028715|12423400|FG001|COMPLETED|Overall Study||30
11231295|NCT02028715|12423399|FG000|NOT COMPLETED|Overall Study||5
11231296|NCT02028715|12423400|FG001|NOT COMPLETED|Overall Study||4
11231297|NCT02028754|12423408|FG000|STARTED|Overall Study||90
11231298|NCT02028754|12423409|FG001|STARTED|Overall Study||90
11231299|NCT02028754|12423408|FG000|COMPLETED|Overall Study||83
11231300|NCT02028754|12423409|FG001|COMPLETED|Overall Study||82
11231301|NCT02028754|12423408|FG000|NOT COMPLETED|Overall Study||7
11231302|NCT02028754|12423409|FG001|NOT COMPLETED|Overall Study||8
11231303|NCT02028767|12423415|FG000|STARTED|Treatment Period 1||16
10874529|NCT04992442|12040624|FG000|STARTED|Treatment Period 1||6
11231304|NCT02028767|12423416|FG001|STARTED|Treatment Period 1||16
11231305|NCT02028767|12423415|FG000|COMPLETED|Treatment Period 1||16
11231306|NCT02028767|12423416|FG001|COMPLETED|Treatment Period 1||16
11231307|NCT02028767|12423415|FG000|NOT COMPLETED|Treatment Period 1||0
11231308|NCT02028767|12423416|FG001|NOT COMPLETED|Treatment Period 1||0
11231309|NCT02028767|12423415|FG000|STARTED|Treatment Period 2||16
11231310|NCT02028767|12423416|FG001|STARTED|Treatment Period 2||16
11231311|NCT02028767|12423415|FG000|COMPLETED|Treatment Period 2||14
11231312|NCT02028767|12423416|FG001|COMPLETED|Treatment Period 2||16
11231313|NCT02028767|12423415|FG000|NOT COMPLETED|Treatment Period 2||2
11231314|NCT02028767|12423416|FG001|NOT COMPLETED|Treatment Period 2||0
11231315|NCT02028780|12423434|FG000|STARTED|Observation Phase||6
11231316|NCT02028780|12423435|FG001|STARTED|Observation Phase||2
11231317|NCT02028780|12423436|FG002|STARTED|Observation Phase||6
11231318|NCT02028780|12423437|FG003|STARTED|Observation Phase||6
11231319|NCT02028780|12423438|FG004|STARTED|Observation Phase||6
11231320|NCT02028780|12423439|FG005|STARTED|Observation Phase||6
11231321|NCT02028780|12423440|FG006|STARTED|Observation Phase||9
11231322|NCT02028780|12423441|FG007|STARTED|Observation Phase||3
11231323|NCT02028780|12423442|FG008|STARTED|Observation Phase||9
11231324|NCT02028780|12423443|FG009|STARTED|Observation Phase||9
11231325|NCT02028780|12423444|FG010|STARTED|Observation Phase||9
11231326|NCT02028780|12423445|FG011|STARTED|Observation Phase||9
11231327|NCT02028780|12423434|FG000|COMPLETED|Observation Phase||6
11231328|NCT02028780|12423435|FG001|COMPLETED|Observation Phase||2
11231329|NCT02028780|12423436|FG002|COMPLETED|Observation Phase||6
11231330|NCT02028780|12423437|FG003|COMPLETED|Observation Phase||6
11231331|NCT02028780|12423438|FG004|COMPLETED|Observation Phase||6
11231332|NCT02028780|12423439|FG005|COMPLETED|Observation Phase||6
11231333|NCT02028780|12423440|FG006|COMPLETED|Observation Phase||9
11231334|NCT02028780|12423441|FG007|COMPLETED|Observation Phase||3
11231335|NCT02028780|12423442|FG008|COMPLETED|Observation Phase||9
11231336|NCT02028780|12423443|FG009|COMPLETED|Observation Phase||9
11231337|NCT02028780|12423444|FG010|COMPLETED|Observation Phase||9
11231338|NCT02028780|12423445|FG011|COMPLETED|Observation Phase||9
11231339|NCT02028780|12423434|FG000|NOT COMPLETED|Observation Phase||0
11231340|NCT02028780|12423435|FG001|NOT COMPLETED|Observation Phase||0
11231341|NCT02028780|12423436|FG002|NOT COMPLETED|Observation Phase||0
11231342|NCT02028780|12423437|FG003|NOT COMPLETED|Observation Phase||0
11231343|NCT02028780|12423438|FG004|NOT COMPLETED|Observation Phase||0
11231344|NCT02028780|12423439|FG005|NOT COMPLETED|Observation Phase||0
11231345|NCT02028780|12423440|FG006|NOT COMPLETED|Observation Phase||0
11231346|NCT02028780|12423441|FG007|NOT COMPLETED|Observation Phase||0
11231347|NCT02028780|12423442|FG008|NOT COMPLETED|Observation Phase||0
11231348|NCT02028780|12423443|FG009|NOT COMPLETED|Observation Phase||0
11231349|NCT02028780|12423444|FG010|NOT COMPLETED|Observation Phase||0
11231350|NCT02028780|12423445|FG011|NOT COMPLETED|Observation Phase||0
11231351|NCT02028780|12423434|FG000|STARTED|Follow up Phase||6
11231352|NCT02028780|12423435|FG001|STARTED|Follow up Phase||2
11231353|NCT02028780|12423436|FG002|STARTED|Follow up Phase||6
11231354|NCT02028780|12423437|FG003|STARTED|Follow up Phase||6
11231355|NCT02028780|12423438|FG004|STARTED|Follow up Phase||6
11231356|NCT02028780|12423439|FG005|STARTED|Follow up Phase||6
11231357|NCT02028780|12423440|FG006|STARTED|Follow up Phase||9
11231358|NCT02028780|12423441|FG007|STARTED|Follow up Phase||3
11231359|NCT02028780|12423442|FG008|STARTED|Follow up Phase||9
11231360|NCT02028780|12423443|FG009|STARTED|Follow up Phase||9
11231361|NCT02028780|12423444|FG010|STARTED|Follow up Phase||9
11231362|NCT02028780|12423445|FG011|STARTED|Follow up Phase||9
11231363|NCT02028780|12423434|FG000|COMPLETED|Follow up Phase||6
11231364|NCT02028780|12423435|FG001|COMPLETED|Follow up Phase||2
11231365|NCT02028780|12423436|FG002|COMPLETED|Follow up Phase||6
11231366|NCT02028780|12423437|FG003|COMPLETED|Follow up Phase||6
11231367|NCT02028780|12423438|FG004|COMPLETED|Follow up Phase||6
11231368|NCT02028780|12423439|FG005|COMPLETED|Follow up Phase||6
11231369|NCT02028780|12423440|FG006|COMPLETED|Follow up Phase||9
11231370|NCT02028780|12423441|FG007|COMPLETED|Follow up Phase||3
11231371|NCT02028780|12423442|FG008|COMPLETED|Follow up Phase||9
11231372|NCT02028780|12423443|FG009|COMPLETED|Follow up Phase||9
11231373|NCT02028780|12423444|FG010|COMPLETED|Follow up Phase||9
11231374|NCT02028780|12423445|FG011|COMPLETED|Follow up Phase||9
11231375|NCT02028780|12423434|FG000|NOT COMPLETED|Follow up Phase||0
11231376|NCT02028780|12423435|FG001|NOT COMPLETED|Follow up Phase||0
11231377|NCT02028780|12423436|FG002|NOT COMPLETED|Follow up Phase||0
11231378|NCT02028780|12423437|FG003|NOT COMPLETED|Follow up Phase||0
11231379|NCT02028780|12423438|FG004|NOT COMPLETED|Follow up Phase||0
11231380|NCT02028780|12423439|FG005|NOT COMPLETED|Follow up Phase||0
11231381|NCT02028780|12423440|FG006|NOT COMPLETED|Follow up Phase||0
11231382|NCT02028780|12423441|FG007|NOT COMPLETED|Follow up Phase||0
11231383|NCT02028780|12423442|FG008|NOT COMPLETED|Follow up Phase||0
11231384|NCT02028780|12423443|FG009|NOT COMPLETED|Follow up Phase||0
11231385|NCT02028780|12423444|FG010|NOT COMPLETED|Follow up Phase||0
11231386|NCT02028780|12423445|FG011|NOT COMPLETED|Follow up Phase||0
11231387|NCT02028871|12423491|FG000|STARTED|Overall Study||14
11231388|NCT02028871|12423492|FG001|STARTED|Overall Study||12
11231389|NCT02028871|12423491|FG000|COMPLETED|Overall Study||10
11231390|NCT02028871|12423492|FG001|COMPLETED|Overall Study||9
11231391|NCT02028871|12423491|FG000|NOT COMPLETED|Overall Study||4
11231392|NCT02028871|12423492|FG001|NOT COMPLETED|Overall Study||3
11231393|NCT02029040|12423503|FG000|STARTED|Overall Study||27
11231394|NCT02029040|12423504|FG001|STARTED|Overall Study||25
11355389|NCT03080142|12552241|FG001|COMPLETED|Overall Study||44
11231395|NCT02029040|12423503|FG000|COMPLETED|Overall Study||27
11231396|NCT02029040|12423504|FG001|COMPLETED|Overall Study||25
11231397|NCT02029040|12423503|FG000|NOT COMPLETED|Overall Study||0
11231398|NCT02029040|12423504|FG001|NOT COMPLETED|Overall Study||0
11231399|NCT02029196|12423512|FG000|STARTED|Overall Study||306
11231400|NCT02029196|12423513|FG001|STARTED|Overall Study||102
11231401|NCT02029196|12423512|FG000|COMPLETED|Overall Study||286
11231402|NCT02029196|12423513|FG001|COMPLETED|Overall Study||101
11231403|NCT02029196|12423512|FG000|NOT COMPLETED|Overall Study||20
11231404|NCT02029196|12423513|FG001|NOT COMPLETED|Overall Study||1
11231405|NCT02029235|12423521|FG000|STARTED|Overall Study||34
11231406|NCT02029235|12423522|FG001|STARTED|Overall Study||31
11231407|NCT02029235|12423521|FG000|COMPLETED|Overall Study||30
11231408|NCT02029235|12423522|FG001|COMPLETED|Overall Study||30
11231409|NCT02029235|12423521|FG000|NOT COMPLETED|Overall Study||4
11355390|NCT03080142|12552240|FG000|NOT COMPLETED|Overall Study||0
11355391|NCT03080142|12552241|FG001|NOT COMPLETED|Overall Study||0
11355392|NCT03080454|12552247|FG000|STARTED|Baseline||26
11355393|NCT03080454|12552247|FG000|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24
11355394|NCT03080454|12552247|FG000|NOT COMPLETED|Baseline||2
11355395|NCT03080454|12552247|FG000|STARTED|Sham Doublestim (5days)||24
11355396|NCT03080454|12552247|FG000|COMPLETED|Sham Doublestim (5days)||24
11355397|NCT03080454|12552247|FG000|NOT COMPLETED|Sham Doublestim (5days)||0
11355398|NCT03080454|12552247|FG000|STARTED|Sham FU (7days)||24
10874530|NCT04992442|12040624|FG000|COMPLETED|Treatment Period 1||6
10874531|NCT04992442|12040624|FG000|NOT COMPLETED|Treatment Period 1||0
10874532|NCT04992442|12040624|FG000|STARTED|Washout Period||6
10874533|NCT04992442|12040624|FG000|COMPLETED|Washout Period||6
10874534|NCT04992442|12040624|FG000|NOT COMPLETED|Washout Period||0
10874535|NCT04992442|12040624|FG000|STARTED|Treatment Period 2||6
10874536|NCT04992442|12040624|FG000|COMPLETED|Treatment Period 2||6
10874537|NCT04992442|12040624|FG000|NOT COMPLETED|Treatment Period 2||0
11231410|NCT02029235|12423522|FG001|NOT COMPLETED|Overall Study||1
11231411|NCT02029274|12423532|FG000|STARTED|Overall Study||5
11231412|NCT02029274|12423533|FG001|STARTED|Overall Study||4
11231413|NCT02029274|12423534|FG002|STARTED|Overall Study||4
11231414|NCT02029274|12423535|FG003|STARTED|Overall Study||4
11231415|NCT02029274|12423532|FG000|Fixed Dose Period 2|Overall Study||5
11231416|NCT02029274|12423533|FG001|Fixed Dose Period 2|Overall Study||4
11231417|NCT02029274|12423534|FG002|Fixed Dose Period 2|Overall Study||4
11231418|NCT02029274|12423535|FG003|Fixed Dose Period 2|Overall Study||4
11231419|NCT02029274|12423532|FG000|COMPLETED|Overall Study||4
11231420|NCT02029274|12423533|FG001|COMPLETED|Overall Study||4
11231421|NCT02029274|12423534|FG002|COMPLETED|Overall Study||2
11231422|NCT02029274|12423535|FG003|COMPLETED|Overall Study||2
11231423|NCT02029274|12423532|FG000|NOT COMPLETED|Overall Study||1
11231424|NCT02029274|12423533|FG001|NOT COMPLETED|Overall Study||0
11231425|NCT02029274|12423534|FG002|NOT COMPLETED|Overall Study||2
11231426|NCT02029274|12423535|FG003|NOT COMPLETED|Overall Study||2
11231427|NCT02029417|12423549|FG000|STARTED|Overall Study||2
11231428|NCT02029417|12423549|FG000|COMPLETED|Overall Study||0
11231429|NCT02029417|12423549|FG000|NOT COMPLETED|Overall Study||2
11355399|NCT03080454|12552247|FG000|COMPLETED|Sham FU (7days)||24
11355400|NCT03080454|12552247|FG000|NOT COMPLETED|Sham FU (7days)||0
11355401|NCT03080454|12552247|FG000|STARTED|Anodal Doublestim (5 Days)||24
11355402|NCT03080454|12552247|FG000|COMPLETED|Anodal Doublestim (5 Days)||23
11355403|NCT03080454|12552247|FG000|NOT COMPLETED|Anodal Doublestim (5 Days)||1
11355404|NCT03080454|12552247|FG000|STARTED|Anodal FU (7 Days)||23
11355405|NCT03080454|12552247|FG000|COMPLETED|Anodal FU (7 Days)||19
11355406|NCT03080454|12552247|FG000|NOT COMPLETED|Anodal FU (7 Days)||4
11355407|NCT03080493|12552256|FG000|STARTED|Overall Study||61
11355408|NCT03080493|12552257|FG001|STARTED|Overall Study||60
11355409|NCT03080493|12552256|FG000|COMPLETED|Overall Study||60
11355410|NCT03080493|12552257|FG001|COMPLETED|Overall Study||58
11355411|NCT03080493|12552256|FG000|NOT COMPLETED|Overall Study||1
11355412|NCT03080493|12552257|FG001|NOT COMPLETED|Overall Study||2
11355413|NCT03080961|12552263|FG000|STARTED|Overall Study||46
11355414|NCT03080961|12552263|FG000|COMPLETED|Overall Study||43
11355415|NCT03080961|12552263|FG000|NOT COMPLETED|Overall Study||3
11355416|NCT03081117|12552274|FG000|STARTED|Overall Study||10
11355417|NCT03081117|12552275|FG001|STARTED|Overall Study||11
11355418|NCT03081117|12552274|FG000|Primary Outcome 1 (SAE)|Overall Study||10
11355419|NCT03081117|12552275|FG001|Primary Outcome 1 (SAE)|Overall Study||11
11355420|NCT03081117|12552274|FG000|Secondary Measures Collected at Week 24|Overall Study||8
11355421|NCT03081117|12552275|FG001|Secondary Measures Collected at Week 24|Overall Study||9
11355422|NCT03081117|12552274|FG000|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||7
11355423|NCT03081117|12552275|FG001|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||9
11355424|NCT03081117|12552274|FG000|COMPLETED|Overall Study||6
11355425|NCT03081117|12552275|FG001|COMPLETED|Overall Study||8
11355426|NCT03081117|12552274|FG000|NOT COMPLETED|Overall Study||4
11231430|NCT02029495|12423556|FG000|STARTED|Overall Study||159
11231431|NCT02029495|12423557|FG001|STARTED|Overall Study||158
11231432|NCT02029495|12423558|FG002|STARTED|Overall Study||161
11231433|NCT02029495|12423556|FG000|COMPLETED|Overall Study||158
11231434|NCT02029495|12423557|FG001|COMPLETED|Overall Study||158
11231435|NCT02029495|12423558|FG002|COMPLETED|Overall Study||159
11231436|NCT02029495|12423556|FG000|NOT COMPLETED|Overall Study||1
11231437|NCT02029495|12423557|FG001|NOT COMPLETED|Overall Study||0
11231438|NCT02029495|12423558|FG002|NOT COMPLETED|Overall Study||2
11231439|NCT02029521|12423568|FG000|STARTED|Overall Study||24
11231440|NCT02029521|12423569|FG001|STARTED|Overall Study||23
11231441|NCT02029521|12423568|FG000|COMPLETED|Overall Study||22
11231442|NCT02029521|12423569|FG001|COMPLETED|Overall Study||22
11231443|NCT02029521|12423568|FG000|NOT COMPLETED|Overall Study||2
11231444|NCT02029521|12423569|FG001|NOT COMPLETED|Overall Study||1
11231445|NCT02029638|12423581|FG000|STARTED|Overall Study||2
11231446|NCT02029638|12423582|FG001|STARTED|Overall Study||1
11231447|NCT02029638|12423583|FG002|STARTED|Overall Study||1
11231448|NCT02029638|12423581|FG000|COMPLETED|Overall Study||0
11231449|NCT02029638|12423582|FG001|COMPLETED|Overall Study||1
11231450|NCT02029638|12423583|FG002|COMPLETED|Overall Study||0
11231451|NCT02029638|12423581|FG000|NOT COMPLETED|Overall Study||2
11231452|NCT02029638|12423582|FG001|NOT COMPLETED|Overall Study||0
11231453|NCT02029638|12423583|FG002|NOT COMPLETED|Overall Study||1
11231454|NCT02029703|12423593|FG000|STARTED|Overall Study||20
11231455|NCT02029703|12423594|FG001|STARTED|Overall Study||22
11231456|NCT02029703|12423593|FG000|COMPLETED|Overall Study||20
11231457|NCT02029703|12423594|FG001|COMPLETED|Overall Study||22
11231458|NCT02029703|12423593|FG000|NOT COMPLETED|Overall Study||0
11231459|NCT02029703|12423594|FG001|NOT COMPLETED|Overall Study||0
11231460|NCT02029755|12423603|FG000|STARTED|Overall Study||36
11231461|NCT02029755|12423604|FG001|STARTED|Overall Study||36
11231462|NCT02029755|12423605|FG002|STARTED|Overall Study||36
11231463|NCT02029755|12423603|FG000|COMPLETED|Overall Study||36
11231464|NCT02029755|12423604|FG001|COMPLETED|Overall Study||36
11231465|NCT02029755|12423605|FG002|COMPLETED|Overall Study||36
11231466|NCT02029755|12423603|FG000|NOT COMPLETED|Overall Study||0
11231467|NCT02029755|12423604|FG001|NOT COMPLETED|Overall Study||0
11231468|NCT02029755|12423605|FG002|NOT COMPLETED|Overall Study||0
11231469|NCT02029872|12423615|FG000|STARTED|Overall Study||9
11231470|NCT02029872|12423616|FG001|STARTED|Overall Study||9
11231471|NCT02029872|12423615|FG000|COMPLETED|Overall Study||7
11231472|NCT02029872|12423616|FG001|COMPLETED|Overall Study||6
11231473|NCT02029872|12423615|FG000|NOT COMPLETED|Overall Study||2
11231474|NCT02029872|12423616|FG001|NOT COMPLETED|Overall Study||3
11231475|NCT02029911|12423622|FG000|STARTED|Overall Study|Treatment Attempted|60
11231476|NCT02029911|12423622|FG000|Treated|Overall Study|Treatment Completed|60
11231477|NCT02029911|12423622|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
11231478|NCT02029911|12423622|FG000|NOT COMPLETED|Overall Study||0
11231479|NCT02029976|12423628|FG000|STARTED|YR-1 Post Intervention vs Baseline||132
11231480|NCT02029976|12423629|FG001|STARTED|YR-1 Post Intervention vs Baseline||132
11231481|NCT02029976|12423628|FG000|COMPLETED|YR-1 Post Intervention vs Baseline||120
11231482|NCT02029976|12423629|FG001|COMPLETED|YR-1 Post Intervention vs Baseline||124
11231483|NCT02029976|12423628|FG000|NOT COMPLETED|YR-1 Post Intervention vs Baseline||12
11231484|NCT02029976|12423629|FG001|NOT COMPLETED|YR-1 Post Intervention vs Baseline||8
11231485|NCT02029976|12423628|FG000|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
11231486|NCT02029976|12423629|FG001|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
11231487|NCT02029976|12423628|FG000|COMPLETED|YR-2 Follow Up vs Baseline||122
11231488|NCT02029976|12423629|FG001|COMPLETED|YR-2 Follow Up vs Baseline||124
11231489|NCT02029976|12423628|FG000|NOT COMPLETED|YR-2 Follow Up vs Baseline||10
11231490|NCT02029976|12423629|FG001|NOT COMPLETED|YR-2 Follow Up vs Baseline||8
11231491|NCT02029989|12423637|FG000|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
11231492|NCT02029989|12423638|FG001|STARTED|Overall Study||60
11231493|NCT02029989|12423637|FG000|COMPLETED|Overall Study||45
11231494|NCT02029989|12423638|FG001|COMPLETED|Overall Study||49
11231495|NCT02029989|12423637|FG000|NOT COMPLETED|Overall Study||16
11231496|NCT02029989|12423638|FG001|NOT COMPLETED|Overall Study||11
11231497|NCT02030002|12423644|FG000|STARTED|Enrollment||49
11231498|NCT02030002|12423644|FG000|COMPLETED|Enrollment||44
11231499|NCT02030002|12423644|FG000|NOT COMPLETED|Enrollment||5
11231500|NCT02030002|12423644|FG000|STARTED|APC Flash-Free Adhesive Coated Appliance||44
11231501|NCT02030002|12423644|FG000|COMPLETED|APC Flash-Free Adhesive Coated Appliance||44
11231502|NCT02030002|12423644|FG000|NOT COMPLETED|APC Flash-Free Adhesive Coated Appliance||0
11231503|NCT02030002|12423644|FG000|STARTED|APC II Adhesive Coated Appliance System||44
11231504|NCT02030002|12423644|FG000|COMPLETED|APC II Adhesive Coated Appliance System||44
11231505|NCT02030002|12423644|FG000|NOT COMPLETED|APC II Adhesive Coated Appliance System||0
11231506|NCT02030002|12423644|FG000|STARTED|Follow-up||44
11231507|NCT02030002|12423644|FG000|COMPLETED|Follow-up||42
11231508|NCT02030002|12423644|FG000|NOT COMPLETED|Follow-up||2
11231509|NCT02030041|12423653|FG000|STARTED|Overall Study||11
11231510|NCT02030041|12423654|FG001|STARTED|Overall Study||11
11231511|NCT02030041|12423655|FG002|STARTED|Overall Study||11
11231512|NCT02030041|12423653|FG000|COMPLETED|Overall Study||9
11231513|NCT02030041|12423654|FG001|COMPLETED|Overall Study||9
11231514|NCT02030041|12423655|FG002|COMPLETED|Overall Study||10
11231515|NCT02030041|12423653|FG000|NOT COMPLETED|Overall Study||2
11231516|NCT02030041|12423654|FG001|NOT COMPLETED|Overall Study||2
11231517|NCT02030041|12423655|FG002|NOT COMPLETED|Overall Study||1
11231518|NCT02030080|12423667|FG000|STARTED|Overall Study|25 teams|100
11231519|NCT02030080|12423668|FG001|STARTED|Overall Study|16 teams|64
11231520|NCT02030080|12423669|FG002|STARTED|Overall Study|20 teams|80
11231521|NCT02030080|12423670|FG003|STARTED|Overall Study|11 teams|44
11231522|NCT02030080|12423667|FG000|COMPLETED|Overall Study||100
11231523|NCT02030080|12423668|FG001|COMPLETED|Overall Study||64
11231524|NCT02030080|12423669|FG002|COMPLETED|Overall Study||80
11231525|NCT02030080|12423670|FG003|COMPLETED|Overall Study||42
11231526|NCT02030080|12423667|FG000|NOT COMPLETED|Overall Study||0
11231527|NCT02030080|12423668|FG001|NOT COMPLETED|Overall Study||0
11231528|NCT02030080|12423669|FG002|NOT COMPLETED|Overall Study||0
11231529|NCT02030080|12423670|FG003|NOT COMPLETED|Overall Study||2
11231530|NCT02030119|12423684|FG000|STARTED|Overall Study||70
11231531|NCT02030119|12423685|FG001|STARTED|Overall Study||70
11231532|NCT02030119|12423686|FG002|STARTED|Overall Study||71
11231533|NCT02030119|12423687|FG003|STARTED|Overall Study||70
11231534|NCT02030119|12423684|FG000|COMPLETED|Overall Study||67
11231535|NCT02030119|12423685|FG001|COMPLETED|Overall Study||68
11231536|NCT02030119|12423686|FG002|COMPLETED|Overall Study||65
11231537|NCT02030119|12423687|FG003|COMPLETED|Overall Study||67
11231538|NCT02030119|12423684|FG000|NOT COMPLETED|Overall Study||3
11231539|NCT02030119|12423685|FG001|NOT COMPLETED|Overall Study||2
11231540|NCT02030119|12423686|FG002|NOT COMPLETED|Overall Study||6
11231541|NCT02030119|12423687|FG003|NOT COMPLETED|Overall Study||3
11231542|NCT02030288|12423699|FG000|STARTED|Overall Study||89
11231543|NCT02030288|12423700|FG001|STARTED|Overall Study||89
11231544|NCT02030288|12423699|FG000|COMPLETED|Overall Study||89
11231545|NCT02030288|12423700|FG001|COMPLETED|Overall Study||89
11231546|NCT02030288|12423699|FG000|NOT COMPLETED|Overall Study||0
11231547|NCT02030288|12423700|FG001|NOT COMPLETED|Overall Study||0
11231548|NCT02030405|12423710|FG000|STARTED|Overall Study||4
11231549|NCT02030405|12423710|FG000|COMPLETED|Overall Study||2
11231550|NCT02030405|12423710|FG000|NOT COMPLETED|Overall Study||2
11231551|NCT02030535|12423715|FG000|STARTED|Treatment Period 1 (1 Day)||53
11231552|NCT02030535|12423715|FG000|COMPLETED|Treatment Period 1 (1 Day)||53
11231553|NCT02030535|12423715|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
11231554|NCT02030535|12423715|FG000|STARTED|Washout Period 1 (21 Days)||53
11231555|NCT02030535|12423715|FG000|COMPLETED|Washout Period 1 (21 Days)||52
11231556|NCT02030535|12423715|FG000|NOT COMPLETED|Washout Period 1 (21 Days)||1
11231557|NCT02030535|12423715|FG000|STARTED|Treatment Period 2 (1 Day)||52
11231558|NCT02030535|12423715|FG000|COMPLETED|Treatment Period 2 (1 Day)||52
11231559|NCT02030535|12423715|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
11231560|NCT02030535|12423715|FG000|STARTED|Washout Period 2 (21 Days)||52
11355427|NCT03081117|12552275|FG001|NOT COMPLETED|Overall Study||3
11355428|NCT03081884|12552281|FG000|STARTED|Overall Study||61
11355429|NCT03081884|12552281|FG000|COMPLETED|Overall Study||57
11355430|NCT03081884|12552281|FG000|NOT COMPLETED|Overall Study||4
11355431|NCT03082196|12552288|FG000|STARTED|Overall Study||142
11355432|NCT03082196|12552289|FG001|STARTED|Overall Study||142
11355433|NCT03082196|12552288|FG000|COMPLETED|Overall Study||133
11355434|NCT03082196|12552289|FG001|COMPLETED|Overall Study||129
11355435|NCT03082196|12552288|FG000|NOT COMPLETED|Overall Study||9
11355436|NCT03082196|12552289|FG001|NOT COMPLETED|Overall Study||13
11355437|NCT03082261|12552295|FG000|STARTED|Overall Study||269
11355438|NCT03082261|12552295|FG000|COMPLETED|Overall Study||149
11355439|NCT03082261|12552295|FG000|NOT COMPLETED|Overall Study||120
11355440|NCT03082586|12552305|FG000|STARTED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
11355441|NCT03082586|12552306|FG001|STARTED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
11355442|NCT03082586|12552307|FG002|STARTED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
11355443|NCT03082586|12552308|FG003|STARTED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
11355444|NCT03082586|12552309|FG004|STARTED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
11355445|NCT03082586|12552310|FG005|STARTED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
11355446|NCT03082586|12552305|FG000|COMPLETED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
11355447|NCT03082586|12552306|FG001|COMPLETED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
11355448|NCT03082586|12552307|FG002|COMPLETED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
11355449|NCT03082586|12552308|FG003|COMPLETED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
11355450|NCT03082586|12552309|FG004|COMPLETED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
11355451|NCT03082586|12552310|FG005|COMPLETED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
11355452|NCT03082586|12552305|FG000|NOT COMPLETED|Overall Study||0
11355453|NCT03082586|12552306|FG001|NOT COMPLETED|Overall Study||0
11355454|NCT03082586|12552307|FG002|NOT COMPLETED|Overall Study||0
11355455|NCT03082586|12552308|FG003|NOT COMPLETED|Overall Study||0
11355456|NCT03082586|12552309|FG004|NOT COMPLETED|Overall Study||0
11355457|NCT03082586|12552310|FG005|NOT COMPLETED|Overall Study||0
11355458|NCT03082599|12552332|FG000|STARTED|Overall Study||40
11355459|NCT03082599|12552333|FG001|STARTED|Overall Study||39
11355460|NCT03082599|12552332|FG000|COMPLETED|Overall Study||39
11355461|NCT03082599|12552333|FG001|COMPLETED|Overall Study||39
11355462|NCT03082599|12552332|FG000|NOT COMPLETED|Overall Study||1
11231561|NCT02030535|12423715|FG000|COMPLETED|Washout Period 2 (21 Days)||52
11355463|NCT03082599|12552333|FG001|NOT COMPLETED|Overall Study||0
11355464|NCT03083093|12552341|FG000|STARTED|Overall Study||50
11355465|NCT03083093|12552342|FG001|STARTED|Overall Study||50
11355466|NCT03083093|12552341|FG000|COMPLETED|Overall Study||50
11355467|NCT03083093|12552342|FG001|COMPLETED|Overall Study||50
11355468|NCT03083093|12552341|FG000|NOT COMPLETED|Overall Study||0
11355469|NCT03083093|12552342|FG001|NOT COMPLETED|Overall Study||0
11355470|NCT03083132|12552350|FG000|STARTED|First 12 Weeks (Placebo vs Modafinil)||12
11355471|NCT03083132|12552351|FG001|STARTED|First 12 Weeks (Placebo vs Modafinil)||9
11355472|NCT03083132|12552350|FG000|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||12
11355473|NCT03083132|12552351|FG001|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||7
11355474|NCT03083132|12552350|FG000|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||0
11355475|NCT03083132|12552351|FG001|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||2
11355476|NCT03083132|12552350|FG000|STARTED|Last 12 Weeks (Drug for All Subjects)||12
11355477|NCT03083132|12552351|FG001|STARTED|Last 12 Weeks (Drug for All Subjects)||7
11355478|NCT03083132|12552350|FG000|COMPLETED|Last 12 Weeks (Drug for All Subjects)||11
11355479|NCT03083132|12552351|FG001|COMPLETED|Last 12 Weeks (Drug for All Subjects)||6
11355480|NCT03083132|12552350|FG000|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1
11355481|NCT03083132|12552351|FG001|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1
11355482|NCT03083379|12552359|FG000|STARTED|Overall Study||15
11355483|NCT03083379|12552360|FG001|STARTED|Overall Study||15
11355484|NCT03083379|12552359|FG000|COMPLETED|Overall Study||15
11355485|NCT03083379|12552360|FG001|COMPLETED|Overall Study||15
11355486|NCT03083379|12552359|FG000|NOT COMPLETED|Overall Study||0
11355487|NCT03083379|12552360|FG001|NOT COMPLETED|Overall Study||0
11355488|NCT03083470|12552371|FG000|STARTED|Overall Study||6
11355489|NCT03083470|12552372|FG001|STARTED|Overall Study||6
11355490|NCT03083470|12552373|FG002|STARTED|Overall Study||6
11355491|NCT03083470|12552374|FG003|STARTED|Overall Study||6
11355492|NCT03083470|12552375|FG004|STARTED|Overall Study||9
11355493|NCT03083470|12552371|FG000|COMPLETED|Overall Study||6
11355494|NCT03083470|12552372|FG001|COMPLETED|Overall Study||6
11355495|NCT03083470|12552373|FG002|COMPLETED|Overall Study||6
11355496|NCT03083470|12552374|FG003|COMPLETED|Overall Study||6
11355497|NCT03083470|12552375|FG004|COMPLETED|Overall Study||7
11355498|NCT03083470|12552371|FG000|NOT COMPLETED|Overall Study||0
11355499|NCT03083470|12552372|FG001|NOT COMPLETED|Overall Study||0
11231562|NCT02030535|12423715|FG000|NOT COMPLETED|Washout Period 2 (21 Days)||0
11231563|NCT02030535|12423715|FG000|STARTED|Treatment Period 3 (1 Day)||52
11231564|NCT02030535|12423715|FG000|COMPLETED|Treatment Period 3 (1 Day)||52
11231565|NCT02030535|12423715|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
11231566|NCT02030574|12423729|FG000|STARTED|Overall Study||2
11231567|NCT02030574|12423729|FG000|COMPLETED|Overall Study||2
11231568|NCT02030574|12423729|FG000|NOT COMPLETED|Overall Study||0
11231569|NCT02030600|12423735|FG000|STARTED|Treatment Period 1||361
11231570|NCT02030600|12423736|FG001|STARTED|Treatment Period 1||360
11231571|NCT02030600|12423735|FG000|Exposed|Treatment Period 1||356
11231572|NCT02030600|12423736|FG001|Exposed|Treatment Period 1||357
11231573|NCT02030600|12423735|FG000|COMPLETED|Treatment Period 1||308
11231574|NCT02030600|12423736|FG001|COMPLETED|Treatment Period 1||315
11231575|NCT02030600|12423735|FG000|NOT COMPLETED|Treatment Period 1||53
11355500|NCT03083470|12552373|FG002|NOT COMPLETED|Overall Study||0
11355501|NCT03083470|12552374|FG003|NOT COMPLETED|Overall Study||0
11355502|NCT03083470|12552375|FG004|NOT COMPLETED|Overall Study||2
11355503|NCT03083483|12552390|FG000|STARTED|Overall Study||24
11355504|NCT03083483|12552391|FG001|STARTED|Overall Study||22
11355505|NCT03083483|12552392|FG002|STARTED|Overall Study||23
11355506|NCT03083483|12552390|FG000|COMPLETED|Overall Study||20
11355507|NCT03083483|12552391|FG001|COMPLETED|Overall Study||20
11355508|NCT03083483|12552392|FG002|COMPLETED|Overall Study||20
11355509|NCT03083483|12552390|FG000|NOT COMPLETED|Overall Study||4
11355510|NCT03083483|12552391|FG001|NOT COMPLETED|Overall Study||2
11355511|NCT03083483|12552392|FG002|NOT COMPLETED|Overall Study||3
11355512|NCT03083639|12552402|FG000|STARTED|Intervention Period 1 (1 Day)||26
11355513|NCT03083639|12552403|FG001|STARTED|Intervention Period 1 (1 Day)||26
11113234|NCT01292252|12297454|FG000|STARTED|Overall Study||21
11113235|NCT01292252|12297455|FG001|STARTED|Overall Study||15
11113236|NCT01292252|12297454|FG000|COMPLETED|Overall Study||21
11113237|NCT01292252|12297455|FG001|COMPLETED|Overall Study||14
11113238|NCT01292252|12297454|FG000|NOT COMPLETED|Overall Study||0
11113239|NCT01292252|12297455|FG001|NOT COMPLETED|Overall Study||1
11113240|NCT01292304|12297461|FG000|STARTED|Overall Study||10
11113241|NCT01292304|12297461|FG000|COMPLETED|Overall Study||10
11113242|NCT01292304|12297461|FG000|NOT COMPLETED|Overall Study||0
11113243|NCT01292447|12297467|FG000|STARTED|Overall Study||75
11113244|NCT01292447|12297468|FG001|STARTED|Overall Study||75
11113245|NCT01292447|12297467|FG000|COMPLETED|Overall Study||73
11113246|NCT01292447|12297468|FG001|COMPLETED|Overall Study||72
11113247|NCT01292447|12297467|FG000|NOT COMPLETED|Overall Study||2
11113248|NCT01292447|12297468|FG001|NOT COMPLETED|Overall Study||3
11113249|NCT01292473|12297478|FG000|STARTED|Overall Study||79
11113250|NCT01292473|12297479|FG001|STARTED|Overall Study||82
11113251|NCT01292473|12297480|FG002|STARTED|Overall Study||83
11113252|NCT01292473|12297481|FG003|STARTED|Overall Study||79
11113253|NCT01292473|12297478|FG000|COMPLETED|Overall Study||74
11113254|NCT01292473|12297479|FG001|COMPLETED|Overall Study||75
11113255|NCT01292473|12297480|FG002|COMPLETED|Overall Study||74
11113256|NCT01292473|12297481|FG003|COMPLETED|Overall Study||67
11355514|NCT03083639|12552402|FG000|COMPLETED|Intervention Period 1 (1 Day)||26
11355515|NCT03083639|12552403|FG001|COMPLETED|Intervention Period 1 (1 Day)||26
11355516|NCT03083639|12552402|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0
11355517|NCT03083639|12552403|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0
11355518|NCT03083639|12552402|FG000|STARTED|Washout Period (at Least 6 Days)||26
11355519|NCT03083639|12552403|FG001|STARTED|Washout Period (at Least 6 Days)||26
11355520|NCT03083639|12552402|FG000|COMPLETED|Washout Period (at Least 6 Days)||25
11355521|NCT03083639|12552403|FG001|COMPLETED|Washout Period (at Least 6 Days)||25
11355522|NCT03083639|12552402|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||1
11355523|NCT03083639|12552403|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1
11355524|NCT03083639|12552402|FG000|STARTED|Intervention Period 2 (1 Day)||25
11355525|NCT03083639|12552403|FG001|STARTED|Intervention Period 2 (1 Day)||25
11355526|NCT03083639|12552402|FG000|COMPLETED|Intervention Period 2 (1 Day)||25
11355527|NCT03083639|12552403|FG001|COMPLETED|Intervention Period 2 (1 Day)||25
11355528|NCT03083639|12552402|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0
11355529|NCT03083639|12552403|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||0
11113257|NCT01292473|12297478|FG000|NOT COMPLETED|Overall Study||5
11113258|NCT01292473|12297479|FG001|NOT COMPLETED|Overall Study||7
11113259|NCT01292473|12297480|FG002|NOT COMPLETED|Overall Study||9
11113260|NCT01292473|12297481|FG003|NOT COMPLETED|Overall Study||12
11113261|NCT01292486|12297495|FG000|STARTED|Overall Study||32
11113262|NCT01292486|12297495|FG000|COMPLETED|Overall Study||26
11113263|NCT01292486|12297495|FG000|NOT COMPLETED|Overall Study||6
11113264|NCT01292538|12297502|FG000|STARTED|Overall Study||35
11113265|NCT01292538|12297503|FG001|STARTED|Overall Study||32
11231576|NCT02030600|12423736|FG001|NOT COMPLETED|Treatment Period 1||45
11231577|NCT02030600|12423735|FG000|STARTED|Treatment Period 2||308
11231578|NCT02030600|12423736|FG001|STARTED|Treatment Period 2||315
11231579|NCT02030600|12423735|FG000|COMPLETED|Treatment Period 2||283
11231580|NCT02030600|12423736|FG001|COMPLETED|Treatment Period 2||297
11231581|NCT02030600|12423735|FG000|NOT COMPLETED|Treatment Period 2||25
11231582|NCT02030600|12423736|FG001|NOT COMPLETED|Treatment Period 2||18
11231583|NCT02030821|12423748|FG000|STARTED|Overall Study||48
11231584|NCT02030821|12423749|FG001|STARTED|Overall Study||46
11231585|NCT02030821|12423750|FG002|STARTED|Overall Study||78
11231586|NCT02030821|12423751|FG003|STARTED|Overall Study||74
11231587|NCT02030821|12423748|FG000|COMPLETED|Overall Study||46
11231588|NCT02030821|12423749|FG001|COMPLETED|Overall Study||44
11231589|NCT02030821|12423750|FG002|COMPLETED|Overall Study||73
11231590|NCT02030821|12423751|FG003|COMPLETED|Overall Study||72
11231591|NCT02030821|12423748|FG000|NOT COMPLETED|Overall Study||2
11231592|NCT02030821|12423749|FG001|NOT COMPLETED|Overall Study||2
11231593|NCT02030821|12423750|FG002|NOT COMPLETED|Overall Study||5
11231594|NCT02030821|12423751|FG003|NOT COMPLETED|Overall Study||2
11231595|NCT02030834|12423764|FG000|STARTED|Overall Study||50
11231596|NCT02030834|12423765|FG001|STARTED|Overall Study||3
11231597|NCT02030834|12423766|FG002|STARTED|Overall Study||10
11231598|NCT02030834|12423764|FG000|COMPLETED|Overall Study||39
11231599|NCT02030834|12423765|FG001|COMPLETED|Overall Study||3
11231600|NCT02030834|12423766|FG002|COMPLETED|Overall Study||7
11231601|NCT02030834|12423764|FG000|NOT COMPLETED|Overall Study||11
11231602|NCT02030834|12423765|FG001|NOT COMPLETED|Overall Study||0
11231603|NCT02030834|12423766|FG002|NOT COMPLETED|Overall Study||3
11231604|NCT02030847|12423774|FG000|STARTED|Overall Study||42
11231605|NCT02030847|12423774|FG000|COMPLETED|Overall Study||5
11231606|NCT02030847|12423774|FG000|NOT COMPLETED|Overall Study||37
11231607|NCT02030886|12423781|FG000|STARTED|Overall Study||14
11231608|NCT02030886|12423782|FG001|STARTED|Overall Study||6
11231609|NCT02030886|12423781|FG000|COMPLETED|Overall Study||14
11231610|NCT02030886|12423782|FG001|COMPLETED|Overall Study||6
11231611|NCT02030886|12423781|FG000|NOT COMPLETED|Overall Study||0
11231612|NCT02030886|12423782|FG001|NOT COMPLETED|Overall Study||0
11231613|NCT02031146|12423792|FG000|STARTED|Overall Study||11
11231614|NCT02031146|12423793|FG001|STARTED|Overall Study||3
11231615|NCT02031146|12423794|FG002|STARTED|Overall Study||18
11231616|NCT02031146|12423795|FG003|STARTED|Overall Study||148
11231617|NCT02031146|12423796|FG004|STARTED|Overall Study||42
11231618|NCT02031146|12423797|FG005|STARTED|Overall Study||4
11231619|NCT02031146|12423798|FG006|STARTED|Overall Study||5
11231620|NCT02031146|12423792|FG000|Considered in Analysis|Overall Study||11
11231621|NCT02031146|12423793|FG001|Considered in Analysis|Overall Study||3
11231622|NCT02031146|12423794|FG002|Considered in Analysis|Overall Study||18
11231623|NCT02031146|12423795|FG003|Considered in Analysis|Overall Study||48
11231624|NCT02031146|12423796|FG004|Considered in Analysis|Overall Study||16
11231625|NCT02031146|12423797|FG005|Considered in Analysis|Overall Study||0
11231626|NCT02031146|12423798|FG006|Considered in Analysis|Overall Study||0
11231627|NCT02031146|12423792|FG000|COMPLETED|Overall Study||11
11231628|NCT02031146|12423793|FG001|COMPLETED|Overall Study||3
11231629|NCT02031146|12423794|FG002|COMPLETED|Overall Study||18
11231630|NCT02031146|12423795|FG003|COMPLETED|Overall Study||48
11231631|NCT02031146|12423796|FG004|COMPLETED|Overall Study||16
11231632|NCT02031146|12423797|FG005|COMPLETED|Overall Study||0
11231633|NCT02031146|12423798|FG006|COMPLETED|Overall Study||0
11231634|NCT02031146|12423792|FG000|NOT COMPLETED|Overall Study||0
11231635|NCT02031146|12423793|FG001|NOT COMPLETED|Overall Study||0
11231636|NCT02031146|12423794|FG002|NOT COMPLETED|Overall Study||0
11231637|NCT02031146|12423795|FG003|NOT COMPLETED|Overall Study||100
11113266|NCT01292538|12297502|FG000|COMPLETED|Overall Study||35
11113267|NCT01292538|12297503|FG001|COMPLETED|Overall Study||32
11231638|NCT02031146|12423796|FG004|NOT COMPLETED|Overall Study||26
11231639|NCT02031146|12423797|FG005|NOT COMPLETED|Overall Study||4
11231640|NCT02031146|12423798|FG006|NOT COMPLETED|Overall Study||5
11231641|NCT02031237|12423810|FG000|STARTED|Overall Study||14
11231642|NCT02031237|12423811|FG001|STARTED|Overall Study||35
11231643|NCT02031237|12423812|FG002|STARTED|Overall Study||3
11231644|NCT02031237|12423810|FG000|COMPLETED|Overall Study||9
11231645|NCT02031237|12423811|FG001|COMPLETED|Overall Study||21
11231646|NCT02031237|12423812|FG002|COMPLETED|Overall Study||0
11231647|NCT02031237|12423810|FG000|NOT COMPLETED|Overall Study||5
11231648|NCT02031237|12423811|FG001|NOT COMPLETED|Overall Study||14
11231649|NCT02031237|12423812|FG002|NOT COMPLETED|Overall Study||3
11231650|NCT02031276|12423822|FG000|STARTED|Period 1 Double-blind IV||39
11231651|NCT02031276|12423823|FG001|STARTED|Period 1 Double-blind IV||41
11231652|NCT02031276|12423824|FG002|STARTED|Period 1 Double-blind IV||41
11231653|NCT02031276|12423822|FG000|COMPLETED|Period 1 Double-blind IV||33
11231654|NCT02031276|12423823|FG001|COMPLETED|Period 1 Double-blind IV||35
11231655|NCT02031276|12423824|FG002|COMPLETED|Period 1 Double-blind IV||40
11231656|NCT02031276|12423822|FG000|NOT COMPLETED|Period 1 Double-blind IV||6
11231657|NCT02031276|12423823|FG001|NOT COMPLETED|Period 1 Double-blind IV||6
11231658|NCT02031276|12423824|FG002|NOT COMPLETED|Period 1 Double-blind IV||1
11231659|NCT02031276|12423822|FG000|STARTED|Period 2 Open-label Risankizumab IV||33
11355530|NCT03083769|12552411|FG000|STARTED|Overall Study||839
11355531|NCT03083769|12552412|FG001|STARTED|Overall Study||663
11231660|NCT02031276|12423823|FG001|STARTED|Period 2 Open-label Risankizumab IV||35
11231661|NCT02031276|12423824|FG002|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
11231662|NCT02031276|12423822|FG000|COMPLETED|Period 2 Open-label Risankizumab IV||29
11231663|NCT02031276|12423823|FG001|COMPLETED|Period 2 Open-label Risankizumab IV||33
11231664|NCT02031276|12423824|FG002|COMPLETED|Period 2 Open-label Risankizumab IV||38
11231665|NCT02031276|12423822|FG000|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
11231666|NCT02031276|12423823|FG001|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
11231667|NCT02031276|12423824|FG002|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
11231668|NCT02031276|12423822|FG000|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
11231669|NCT02031276|12423823|FG001|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
11231670|NCT02031276|12423824|FG002|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
11231671|NCT02031276|12423822|FG000|COMPLETED|Period 3 Open-label Risankizumab SC||16
11231672|NCT02031276|12423823|FG001|COMPLETED|Period 3 Open-label Risankizumab SC||19
11231673|NCT02031276|12423824|FG002|COMPLETED|Period 3 Open-label Risankizumab SC||19
11231674|NCT02031276|12423822|FG000|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
11231675|NCT02031276|12423823|FG001|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
11231676|NCT02031276|12423824|FG002|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
11231677|NCT02031302|12423838|FG000|STARTED|Overall Study||1014
11231678|NCT02031302|12423839|FG001|STARTED|Overall Study||50
11231679|NCT02031302|12423838|FG000|COMPLETED|Overall Study||850
11231680|NCT02031302|12423839|FG001|COMPLETED|Overall Study||50
11231681|NCT02031302|12423838|FG000|NOT COMPLETED|Overall Study||164
11231682|NCT02031302|12423839|FG001|NOT COMPLETED|Overall Study||0
11231683|NCT02031432|12423846|FG000|STARTED|Overall Study||76
11231684|NCT02031432|12423846|FG000|Completing the Titration Phase|Overall Study||67
11231685|NCT02031432|12423846|FG000|Completing the Treatment|Overall Study||39
11231686|NCT02031432|12423846|FG000|COMPLETED|Overall Study||38
11231687|NCT02031432|12423846|FG000|NOT COMPLETED|Overall Study||38
11231688|NCT02031458|12423853|FG000|STARTED|May 8, 2015 to January 11, 2019||138
11231689|NCT02031458|12423854|FG001|STARTED|May 8, 2015 to January 11, 2019||269
11231690|NCT02031458|12423855|FG002|STARTED|May 8, 2015 to January 11, 2019||252
11231691|NCT02031458|12423853|FG000|COMPLETED|May 8, 2015 to January 11, 2019||0
11231692|NCT02031458|12423854|FG001|COMPLETED|May 8, 2015 to January 11, 2019||0
11231693|NCT02031458|12423855|FG002|COMPLETED|May 8, 2015 to January 11, 2019||0
11231694|NCT02031458|12423853|FG000|NOT COMPLETED|May 8, 2015 to January 11, 2019||138
11231695|NCT02031458|12423854|FG001|NOT COMPLETED|May 8, 2015 to January 11, 2019||269
11231696|NCT02031458|12423855|FG002|NOT COMPLETED|May 8, 2015 to January 11, 2019||252
11231697|NCT02031458|12423853|FG000|STARTED|Baseline to May 8, 2015||139
11231698|NCT02031458|12423854|FG001|STARTED|Baseline to May 8, 2015||267
11231699|NCT02031458|12423855|FG002|STARTED|Baseline to May 8, 2015||253
11231700|NCT02031458|12423853|FG000|COMPLETED|Baseline to May 8, 2015||0
11231701|NCT02031458|12423854|FG001|COMPLETED|Baseline to May 8, 2015||0
11231702|NCT02031458|12423855|FG002|COMPLETED|Baseline to May 8, 2015||0
11231703|NCT02031458|12423853|FG000|NOT COMPLETED|Baseline to May 8, 2015||139
11231704|NCT02031458|12423854|FG001|NOT COMPLETED|Baseline to May 8, 2015||267
11231705|NCT02031458|12423855|FG002|NOT COMPLETED|Baseline to May 8, 2015||253
11231706|NCT02031471|12423865|FG000|STARTED|24 Week Treatment Period||57
11231707|NCT02031471|12423865|FG000|COMPLETED|24 Week Treatment Period||46
11231708|NCT02031471|12423865|FG000|NOT COMPLETED|24 Week Treatment Period||11
11231709|NCT02031471|12423865|FG000|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
11231710|NCT02031471|12423865|FG000|COMPLETED|Long Term Extension (LTE) Period||37
11231711|NCT02031471|12423865|FG000|NOT COMPLETED|Long Term Extension (LTE) Period||2
11231712|NCT02031536|12423871|FG000|STARTED|Overall Study||2
11231713|NCT02031536|12423872|FG001|STARTED|Overall Study||0
11231714|NCT02031536|12423871|FG000|COMPLETED|Overall Study||1
11355532|NCT03083769|12552411|FG000|COMPLETED|Overall Study||819
11231715|NCT02031536|12423872|FG001|COMPLETED|Overall Study||0
11231716|NCT02031536|12423871|FG000|NOT COMPLETED|Overall Study||1
11231717|NCT02031536|12423872|FG001|NOT COMPLETED|Overall Study||0
11231718|NCT02031627|12423881|FG000|STARTED|Overall Study||7
11231719|NCT02031627|12423882|FG001|STARTED|Overall Study||7
11231720|NCT02031627|12423883|FG002|STARTED|Overall Study||7
11231721|NCT02031627|12423881|FG000|COMPLETED|Overall Study||7
11231722|NCT02031627|12423882|FG001|COMPLETED|Overall Study||7
11231723|NCT02031627|12423883|FG002|COMPLETED|Overall Study||7
11231724|NCT02031627|12423881|FG000|NOT COMPLETED|Overall Study||0
11231725|NCT02031627|12423882|FG001|NOT COMPLETED|Overall Study||0
11231726|NCT02031627|12423883|FG002|NOT COMPLETED|Overall Study||0
11231727|NCT02031640|12423896|FG000|STARTED|Screening Period|Consented|1113
11231728|NCT02031640|12423897|FG001|STARTED|Screening Period||0
11231729|NCT02031640|12423898|FG002|STARTED|Screening Period||0
11231730|NCT02031640|12423899|FG003|STARTED|Screening Period||0
11231731|NCT02031640|12423900|FG004|STARTED|Screening Period||0
11231732|NCT02031640|12423901|FG005|STARTED|Screening Period||0
11231733|NCT02031640|12423896|FG000|COMPLETED|Screening Period||701
11231734|NCT02031640|12423897|FG001|COMPLETED|Screening Period||0
11231735|NCT02031640|12423898|FG002|COMPLETED|Screening Period||0
11231736|NCT02031640|12423899|FG003|COMPLETED|Screening Period||0
11231737|NCT02031640|12423900|FG004|COMPLETED|Screening Period||0
11231738|NCT02031640|12423901|FG005|COMPLETED|Screening Period||0
11231739|NCT02031640|12423896|FG000|NOT COMPLETED|Screening Period||412
11231740|NCT02031640|12423897|FG001|NOT COMPLETED|Screening Period||0
11231741|NCT02031640|12423898|FG002|NOT COMPLETED|Screening Period||0
11231742|NCT02031640|12423899|FG003|NOT COMPLETED|Screening Period||0
11231743|NCT02031640|12423900|FG004|NOT COMPLETED|Screening Period||0
11231744|NCT02031640|12423901|FG005|NOT COMPLETED|Screening Period||0
11231745|NCT02031640|12423896|FG000|STARTED|Run-In Period||701
11231746|NCT02031640|12423897|FG001|STARTED|Run-In Period||0
11231747|NCT02031640|12423898|FG002|STARTED|Run-In Period||0
11231748|NCT02031640|12423899|FG003|STARTED|Run-In Period||0
11231749|NCT02031640|12423900|FG004|STARTED|Run-In Period||0
11231750|NCT02031640|12423901|FG005|STARTED|Run-In Period||0
11231751|NCT02031640|12423896|FG000|COMPLETED|Run-In Period||532
11231752|NCT02031640|12423897|FG001|COMPLETED|Run-In Period||0
11231753|NCT02031640|12423898|FG002|COMPLETED|Run-In Period||0
11231754|NCT02031640|12423899|FG003|COMPLETED|Run-In Period||0
11231755|NCT02031640|12423900|FG004|COMPLETED|Run-In Period||0
11231756|NCT02031640|12423901|FG005|COMPLETED|Run-In Period||0
11231757|NCT02031640|12423896|FG000|NOT COMPLETED|Run-In Period||169
11231758|NCT02031640|12423897|FG001|NOT COMPLETED|Run-In Period||0
11231759|NCT02031640|12423898|FG002|NOT COMPLETED|Run-In Period||0
11231760|NCT02031640|12423899|FG003|NOT COMPLETED|Run-In Period||0
11231761|NCT02031640|12423900|FG004|NOT COMPLETED|Run-In Period||0
11231762|NCT02031640|12423901|FG005|NOT COMPLETED|Run-In Period||0
11231763|NCT02031640|12423896|FG000|STARTED|Double-blind Treatment Period||0
11231764|NCT02031640|12423897|FG001|STARTED|Double-blind Treatment Period||106
11231765|NCT02031640|12423898|FG002|STARTED|Double-blind Treatment Period||106
11231766|NCT02031640|12423899|FG003|STARTED|Double-blind Treatment Period||106
11231767|NCT02031640|12423900|FG004|STARTED|Double-blind Treatment Period||107
11231768|NCT02031640|12423901|FG005|STARTED|Double-blind Treatment Period||107
11231769|NCT02031640|12423896|FG000|Full Analysis Set|Double-blind Treatment Period||0
11231770|NCT02031640|12423897|FG001|Full Analysis Set|Double-blind Treatment Period||106
11231771|NCT02031640|12423898|FG002|Full Analysis Set|Double-blind Treatment Period||104
11231772|NCT02031640|12423899|FG003|Full Analysis Set|Double-blind Treatment Period||106
11231773|NCT02031640|12423900|FG004|Full Analysis Set|Double-blind Treatment Period||106
11231774|NCT02031640|12423901|FG005|Full Analysis Set|Double-blind Treatment Period||107
11231775|NCT02031640|12423896|FG000|COMPLETED|Double-blind Treatment Period||0
11231776|NCT02031640|12423897|FG001|COMPLETED|Double-blind Treatment Period||84
11231777|NCT02031640|12423898|FG002|COMPLETED|Double-blind Treatment Period||100
11231778|NCT02031640|12423899|FG003|COMPLETED|Double-blind Treatment Period||99
11231779|NCT02031640|12423900|FG004|COMPLETED|Double-blind Treatment Period||96
11231780|NCT02031640|12423901|FG005|COMPLETED|Double-blind Treatment Period||104
11231781|NCT02031640|12423896|FG000|NOT COMPLETED|Double-blind Treatment Period||0
11231782|NCT02031640|12423897|FG001|NOT COMPLETED|Double-blind Treatment Period||22
11231783|NCT02031640|12423898|FG002|NOT COMPLETED|Double-blind Treatment Period||6
11231784|NCT02031640|12423899|FG003|NOT COMPLETED|Double-blind Treatment Period||7
11231785|NCT02031640|12423900|FG004|NOT COMPLETED|Double-blind Treatment Period||11
11231786|NCT02031640|12423901|FG005|NOT COMPLETED|Double-blind Treatment Period||3
11231787|NCT02031679|12423922|FG000|STARTED|Overall Study||14
11231788|NCT02031679|12423923|FG001|STARTED|Overall Study||14
11231789|NCT02031679|12423922|FG000|COMPLETED|Overall Study||14
11231790|NCT02031679|12423923|FG001|COMPLETED|Overall Study||12
11231791|NCT02031679|12423922|FG000|NOT COMPLETED|Overall Study||0
11231792|NCT02031679|12423923|FG001|NOT COMPLETED|Overall Study||2
11231793|NCT02031770|12423929|FG000|STARTED|Overall Study||10
11231794|NCT02031770|12423930|FG001|STARTED|Overall Study||10
11231795|NCT02031770|12423929|FG000|COMPLETED|Overall Study||9
11231796|NCT02031770|12423930|FG001|COMPLETED|Overall Study||9
11231797|NCT02031770|12423929|FG000|NOT COMPLETED|Overall Study||1
11231798|NCT02031770|12423930|FG001|NOT COMPLETED|Overall Study||1
11231799|NCT02032173|12423936|FG000|STARTED|Overall Study||31
11231800|NCT02032173|12423936|FG000|Included Population - Main Group|Overall Study||31
11231801|NCT02032173|12423936|FG000|Rescue Group|Overall Study|1 participant moved to Rescue Group at M6 and trial discontinued before any data was collected.|1
11231802|NCT02032173|12423936|FG000|COMPLETED|Overall Study||0
11231803|NCT02032173|12423936|FG000|NOT COMPLETED|Overall Study||31
11231804|NCT02032212|12423944|FG000|STARTED|Overall Study||3
11231805|NCT02032212|12423945|FG001|STARTED|Overall Study||3
11231806|NCT02032212|12423946|FG002|STARTED|Overall Study||3
11231807|NCT02032212|12423947|FG003|STARTED|Overall Study||3
11231808|NCT02032212|12423944|FG000|COMPLETED|Overall Study||3
11231809|NCT02032212|12423945|FG001|COMPLETED|Overall Study||3
11231810|NCT02032212|12423946|FG002|COMPLETED|Overall Study||3
11231811|NCT02032212|12423947|FG003|COMPLETED|Overall Study||3
11231812|NCT02032212|12423944|FG000|NOT COMPLETED|Overall Study||0
11231813|NCT02032212|12423945|FG001|NOT COMPLETED|Overall Study||0
11231814|NCT02032212|12423946|FG002|NOT COMPLETED|Overall Study||0
11231815|NCT02032212|12423947|FG003|NOT COMPLETED|Overall Study||0
11231816|NCT02032238|12423959|FG000|STARTED|Overall Study||12
11231817|NCT02032238|12423960|FG001|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
11231818|NCT02032238|12423959|FG000|COMPLETED|Overall Study||10
11231819|NCT02032238|12423960|FG001|COMPLETED|Overall Study||0
11231820|NCT02032238|12423959|FG000|NOT COMPLETED|Overall Study||2
11231821|NCT02032238|12423960|FG001|NOT COMPLETED|Overall Study||0
11231822|NCT02032407|12423966|FG000|STARTED|Overall Study||68
11231823|NCT02032407|12423966|FG000|COMPLETED|Overall Study||63
11231824|NCT02032407|12423966|FG000|NOT COMPLETED|Overall Study||5
11231825|NCT02032420|12423972|FG000|STARTED|Overall Study||18
11231826|NCT02032420|12423973|FG001|STARTED|Overall Study||17
11231827|NCT02032420|12423972|FG000|COMPLETED|Overall Study||18
11231828|NCT02032420|12423973|FG001|COMPLETED|Overall Study||17
11231829|NCT02032420|12423972|FG000|NOT COMPLETED|Overall Study||0
11231830|NCT02032420|12423973|FG001|NOT COMPLETED|Overall Study||0
11231831|NCT02032433|12423981|FG000|STARTED|Overall Study||283
11231832|NCT02032433|12423982|FG001|STARTED|Overall Study||287
11231833|NCT02032433|12423981|FG000|COMPLETED|Overall Study||205
11231834|NCT02032433|12423982|FG001|COMPLETED|Overall Study||225
11231835|NCT02032433|12423981|FG000|NOT COMPLETED|Overall Study||78
11231836|NCT02032433|12423982|FG001|NOT COMPLETED|Overall Study||62
11231837|NCT02032550|12423990|FG000|STARTED|Overall Study||371
11231838|NCT02032550|12423991|FG001|STARTED|Overall Study||372
11231839|NCT02032550|12423990|FG000|COMPLETED|Overall Study||343
11231840|NCT02032550|12423991|FG001|COMPLETED|Overall Study||350
11231841|NCT02032550|12423990|FG000|NOT COMPLETED|Overall Study||28
11231842|NCT02032550|12423991|FG001|NOT COMPLETED|Overall Study||22
11231843|NCT02032641|12423997|FG000|STARTED|Overall Study|18 Brows enrolled for evaluation|9
11231844|NCT02032641|12423997|FG000|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
11231845|NCT02032641|12423997|FG000|NOT COMPLETED|Overall Study||1
11231846|NCT02032680|12424005|FG000|STARTED|Overall Study||22
11231847|NCT02032680|12424006|FG001|STARTED|Overall Study||8
11231848|NCT02032680|12424005|FG000|COMPLETED|Overall Study||16
11231849|NCT02032680|12424006|FG001|COMPLETED|Overall Study||7
11231850|NCT02032680|12424005|FG000|NOT COMPLETED|Overall Study||6
11231851|NCT02032680|12424006|FG001|NOT COMPLETED|Overall Study||1
11231852|NCT02032706|12424012|FG000|STARTED|Overall Study||36
11231853|NCT02032706|12424012|FG000|COMPLETED|Overall Study||30
11231854|NCT02032706|12424012|FG000|NOT COMPLETED|Overall Study||6
11231855|NCT02032758|12424018|FG000|STARTED|Overall Study||27
11231856|NCT02032758|12424019|FG001|STARTED|Overall Study||11
11231857|NCT02032758|12424018|FG000|COMPLETED|Overall Study||27
11231858|NCT02032758|12424019|FG001|COMPLETED|Overall Study||11
11231859|NCT02032758|12424018|FG000|NOT COMPLETED|Overall Study||0
11231860|NCT02032758|12424019|FG001|NOT COMPLETED|Overall Study||0
11231861|NCT02032875|12424027|FG000|STARTED|Treatment Period||53
11231862|NCT02032875|12424028|FG001|STARTED|Treatment Period||60
11231863|NCT02032875|12424027|FG000|COMPLETED|Treatment Period||52
11231864|NCT02032875|12424028|FG001|COMPLETED|Treatment Period||56
11231865|NCT02032875|12424027|FG000|NOT COMPLETED|Treatment Period||1
11231866|NCT02032875|12424028|FG001|NOT COMPLETED|Treatment Period||4
11231867|NCT02032875|12424027|FG000|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
11231868|NCT02032875|12424028|FG001|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
11231869|NCT02032875|12424027|FG000|COMPLETED|Follow-up Period||50
11231870|NCT02032875|12424028|FG001|COMPLETED|Follow-up Period||46
11231871|NCT02032875|12424027|FG000|NOT COMPLETED|Follow-up Period||3
11231872|NCT02032875|12424028|FG001|NOT COMPLETED|Follow-up Period||11
11231873|NCT02032888|12424038|FG000|STARTED|Treatment Period||101
11231874|NCT02032888|12424039|FG001|STARTED|Treatment Period||50
11231875|NCT02032888|12424040|FG002|STARTED|Treatment Period||52
11231876|NCT02032888|12424038|FG000|COMPLETED|Treatment Period||99
11231877|NCT02032888|12424039|FG001|COMPLETED|Treatment Period||48
11231878|NCT02032888|12424040|FG002|COMPLETED|Treatment Period||52
11231879|NCT02032888|12424038|FG000|NOT COMPLETED|Treatment Period||2
11231880|NCT02032888|12424039|FG001|NOT COMPLETED|Treatment Period||2
11231881|NCT02032888|12424040|FG002|NOT COMPLETED|Treatment Period||0
11231882|NCT02032888|12424038|FG000|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
11231883|NCT02032888|12424039|FG001|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
11231884|NCT02032888|12424040|FG002|STARTED|Follow-up Period||52
11231885|NCT02032888|12424038|FG000|COMPLETED|Follow-up Period||97
11231886|NCT02032888|12424039|FG001|COMPLETED|Follow-up Period||47
11231887|NCT02032888|12424040|FG002|COMPLETED|Follow-up Period||52
11231888|NCT02032888|12424038|FG000|NOT COMPLETED|Follow-up Period||3
11231889|NCT02032888|12424039|FG001|NOT COMPLETED|Follow-up Period||2
11231890|NCT02032888|12424040|FG002|NOT COMPLETED|Follow-up Period||0
11231891|NCT02032901|12424059|FG000|STARTED|Treatment Period (12 Weeks)||101
11231892|NCT02032901|12424060|FG001|STARTED|Treatment Period (12 Weeks)||51
11231893|NCT02032901|12424059|FG000|COMPLETED|Treatment Period (12 Weeks)||100
11231894|NCT02032901|12424060|FG001|COMPLETED|Treatment Period (12 Weeks)||51
11231895|NCT02032901|12424059|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||1
11231896|NCT02032901|12424060|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0
11231897|NCT02032901|12424059|FG000|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
11231898|NCT02032901|12424060|FG001|STARTED|Follow-Up Period (24 Weeks)||51
11231899|NCT02032901|12424059|FG000|COMPLETED|Follow-Up Period (24 Weeks)||101
11231900|NCT02032901|12424060|FG001|COMPLETED|Follow-Up Period (24 Weeks)||50
11231901|NCT02032901|12424059|FG000|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
11231902|NCT02032901|12424060|FG001|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
11231903|NCT02033005|12424071|FG000|STARTED|Overall Study||80
11231904|NCT02033005|12424072|FG001|STARTED|Overall Study||9
11231905|NCT02033005|12424073|FG002|STARTED|Overall Study||35
11231906|NCT02033005|12424071|FG000|COMPLETED|Overall Study||36
11231907|NCT02033005|12424072|FG001|COMPLETED|Overall Study||9
11231908|NCT02033005|12424073|FG002|COMPLETED|Overall Study||25
11231909|NCT02033005|12424071|FG000|NOT COMPLETED|Overall Study||44
11231910|NCT02033005|12424072|FG001|NOT COMPLETED|Overall Study||0
11231911|NCT02033005|12424073|FG002|NOT COMPLETED|Overall Study||10
11231912|NCT02033083|12424084|FG000|STARTED|Overall Study||90
11231913|NCT02033083|12424085|FG001|STARTED|Overall Study||90
11231914|NCT02033083|12424084|FG000|COMPLETED|Overall Study||89
11231915|NCT02033083|12424085|FG001|COMPLETED|Overall Study||89
11231916|NCT02033083|12424084|FG000|NOT COMPLETED|Overall Study||1
11231917|NCT02033083|12424085|FG001|NOT COMPLETED|Overall Study||1
11231918|NCT02033174|12424091|FG000|STARTED|First Intervention||8
11231919|NCT02033174|12424092|FG001|STARTED|First Intervention||8
11231920|NCT02033174|12424091|FG000|COMPLETED|First Intervention||8
11231921|NCT02033174|12424092|FG001|COMPLETED|First Intervention||8
11231922|NCT02033174|12424091|FG000|NOT COMPLETED|First Intervention||0
11231923|NCT02033174|12424092|FG001|NOT COMPLETED|First Intervention||0
11231924|NCT02033174|12424091|FG000|STARTED|Washout (1 Week)||8
11231925|NCT02033174|12424092|FG001|STARTED|Washout (1 Week)||8
11231926|NCT02033174|12424091|FG000|COMPLETED|Washout (1 Week)||8
11231927|NCT02033174|12424092|FG001|COMPLETED|Washout (1 Week)||8
11231928|NCT02033174|12424091|FG000|NOT COMPLETED|Washout (1 Week)||0
11231929|NCT02033174|12424092|FG001|NOT COMPLETED|Washout (1 Week)||0
11231930|NCT02033174|12424091|FG000|STARTED|Second Intervention||8
11231931|NCT02033174|12424092|FG001|STARTED|Second Intervention||8
11231932|NCT02033174|12424091|FG000|COMPLETED|Second Intervention||8
11231933|NCT02033174|12424092|FG001|COMPLETED|Second Intervention||8
11231934|NCT02033174|12424091|FG000|NOT COMPLETED|Second Intervention||0
11231935|NCT02033174|12424092|FG001|NOT COMPLETED|Second Intervention||0
11231936|NCT02033200|12424100|FG000|STARTED|Overall Study||40
11231937|NCT02033200|12424101|FG001|STARTED|Overall Study||40
11231938|NCT02033200|12424100|FG000|COMPLETED|Overall Study||40
11231939|NCT02033200|12424101|FG001|COMPLETED|Overall Study||40
11231940|NCT02033200|12424100|FG000|NOT COMPLETED|Overall Study||0
11231941|NCT02033200|12424101|FG001|NOT COMPLETED|Overall Study||0
11231942|NCT02033213|12424109|FG000|STARTED|Overall Study||8
11231943|NCT02033213|12424110|FG001|STARTED|Overall Study||8
11231944|NCT02033213|12424109|FG000|COMPLETED|Overall Study||8
11231945|NCT02033213|12424110|FG001|COMPLETED|Overall Study||8
11231946|NCT02033213|12424109|FG000|NOT COMPLETED|Overall Study||0
11231947|NCT02033213|12424110|FG001|NOT COMPLETED|Overall Study||0
11231948|NCT02033317|12424118|FG000|STARTED|Overall Study||6
11231949|NCT02033317|12424118|FG000|COMPLETED|Overall Study||6
11231950|NCT02033317|12424118|FG000|NOT COMPLETED|Overall Study||0
11231951|NCT02033369|12424124|FG000|STARTED|Overall Study||26
11231952|NCT02033369|12424125|FG001|STARTED|Overall Study||26
11231953|NCT02033369|12424124|FG000|COMPLETED|Overall Study||21
11231954|NCT02033369|12424125|FG001|COMPLETED|Overall Study||21
11231955|NCT02033369|12424124|FG000|NOT COMPLETED|Overall Study||5
11231956|NCT02033369|12424125|FG001|NOT COMPLETED|Overall Study||5
11231957|NCT02033382|12424131|FG000|STARTED|Overall Study||83
11231958|NCT02033382|12424132|FG001|STARTED|Overall Study||82
11231959|NCT02033382|12424131|FG000|COMPLETED|Overall Study||32
11231960|NCT02033382|12424132|FG001|COMPLETED|Overall Study||36
11231961|NCT02033382|12424131|FG000|NOT COMPLETED|Overall Study||51
11231962|NCT02033382|12424132|FG001|NOT COMPLETED|Overall Study||46
11231963|NCT02033499|12424145|FG000|STARTED|Overall Study||152
11231964|NCT02033499|12424146|FG001|STARTED|Overall Study||150
11231965|NCT02033499|12424147|FG002|STARTED|Overall Study||148
11231966|NCT02033499|12424145|FG000|COMPLETED|Overall Study||147
11231967|NCT02033499|12424146|FG001|COMPLETED|Overall Study||142
11231968|NCT02033499|12424147|FG002|COMPLETED|Overall Study||139
11231969|NCT02033499|12424145|FG000|NOT COMPLETED|Overall Study||5
11231970|NCT02033499|12424146|FG001|NOT COMPLETED|Overall Study||8
11231971|NCT02033499|12424147|FG002|NOT COMPLETED|Overall Study||9
11231972|NCT02033694|12424156|FG000|STARTED|Overall Study||1271
11231973|NCT02033694|12424156|FG000|COMPLETED|Overall Study||1271
11231974|NCT02033694|12424156|FG000|NOT COMPLETED|Overall Study||0
11231975|NCT02033759|12424163|FG000|STARTED|Overall Study||22
11231976|NCT02033759|12424164|FG001|STARTED|Overall Study||21
11231977|NCT02033759|12424163|FG000|COMPLETED|Overall Study||19
11231978|NCT02033759|12424164|FG001|COMPLETED|Overall Study||19
11231979|NCT02033759|12424163|FG000|NOT COMPLETED|Overall Study||3
11231980|NCT02033759|12424164|FG001|NOT COMPLETED|Overall Study||2
11231981|NCT02033850|12424172|FG000|STARTED|Overall Study||23
11231982|NCT02033850|12424173|FG001|STARTED|Overall Study||23
11231983|NCT02033850|12424172|FG000|COMPLETED|Overall Study||21
11231984|NCT02033850|12424173|FG001|COMPLETED|Overall Study||22
11231985|NCT02033850|12424172|FG000|NOT COMPLETED|Overall Study||2
11231986|NCT02033850|12424173|FG001|NOT COMPLETED|Overall Study||1
11231987|NCT02033876|12424181|FG000|STARTED|Overall Study||12
11231988|NCT02033876|12424182|FG001|STARTED|Overall Study||12
11231989|NCT02033876|12424181|FG000|COMPLETED|Overall Study||12
11231990|NCT02033876|12424182|FG001|COMPLETED|Overall Study||12
11231991|NCT02033876|12424181|FG000|NOT COMPLETED|Overall Study||0
11231992|NCT02033876|12424182|FG001|NOT COMPLETED|Overall Study||0
11231993|NCT02033889|12424191|FG000|STARTED|Overall Study||209
11231994|NCT02033889|12424192|FG001|STARTED|Overall Study||207
11231995|NCT02033889|12424193|FG002|STARTED|Overall Study||205
11231996|NCT02033889|12424191|FG000|COMPLETED|Overall Study||175
11231997|NCT02033889|12424192|FG001|COMPLETED|Overall Study||187
11231998|NCT02033889|12424193|FG002|COMPLETED|Overall Study||180
11231999|NCT02033889|12424191|FG000|NOT COMPLETED|Overall Study||34
11232000|NCT02033889|12424192|FG001|NOT COMPLETED|Overall Study||20
11232001|NCT02033889|12424193|FG002|NOT COMPLETED|Overall Study||25
11232002|NCT02033993|12424203|FG000|STARTED|Overall Study||99
11232003|NCT02033993|12424204|FG001|STARTED|Overall Study||100
11232004|NCT02033993|12424203|FG000|COMPLETED|Overall Study||96
11232005|NCT02033993|12424204|FG001|COMPLETED|Overall Study||91
11232006|NCT02033993|12424203|FG000|NOT COMPLETED|Overall Study||3
11232007|NCT02033993|12424204|FG001|NOT COMPLETED|Overall Study||9
11232008|NCT02034006|12424212|FG000|STARTED|Overall Study||200
11232009|NCT02034006|12424212|FG000|Once Treated Patients|Overall Study||70
11232010|NCT02034006|12424212|FG000|Re-treated Patients|Overall Study||130
11232011|NCT02034006|12424212|FG000|COMPLETED|Overall Study||186
11232012|NCT02034006|12424212|FG000|NOT COMPLETED|Overall Study||14
11232013|NCT02034019|12424221|FG000|STARTED|Overall Study||164
11232014|NCT02034019|12424222|FG001|STARTED|Overall Study||83
11232015|NCT02034019|12424221|FG000|COMPLETED|Overall Study||163
11232016|NCT02034019|12424222|FG001|COMPLETED|Overall Study||81
11232017|NCT02034019|12424221|FG000|NOT COMPLETED|Overall Study||1
11232018|NCT02034019|12424222|FG001|NOT COMPLETED|Overall Study||2
11232019|NCT02034058|12424228|FG000|STARTED|Overall Study|Study stopped early per pre-defined criteria for interim analysis.|152
11232020|NCT02034058|12424228|FG000|COMPLETED|Overall Study||149
11232021|NCT02034058|12424228|FG000|NOT COMPLETED|Overall Study||3
11232022|NCT02034162|12424234|FG000|STARTED|Double-blind||146
11232023|NCT02034162|12424235|FG001|STARTED|Double-blind||149
11232024|NCT02034162|12424236|FG002|STARTED|Double-blind||0
11232025|NCT02034162|12424234|FG000|COMPLETED|Double-blind||137
11232026|NCT02034162|12424235|FG001|COMPLETED|Double-blind||141
11232027|NCT02034162|12424236|FG002|COMPLETED|Double-blind||0
11232028|NCT02034162|12424234|FG000|NOT COMPLETED|Double-blind||9
11232029|NCT02034162|12424235|FG001|NOT COMPLETED|Double-blind||8
11232030|NCT02034162|12424236|FG002|NOT COMPLETED|Double-blind||0
11232031|NCT02034162|12424234|FG000|STARTED|Open-label||0
11232032|NCT02034162|12424235|FG001|STARTED|Open-label||0
11232033|NCT02034162|12424236|FG002|STARTED|Open-label||278
11232034|NCT02034162|12424234|FG000|COMPLETED|Open-label||0
11232035|NCT02034162|12424235|FG001|COMPLETED|Open-label||0
11232036|NCT02034162|12424236|FG002|COMPLETED|Open-label||278
11232037|NCT02034162|12424234|FG000|NOT COMPLETED|Open-label||0
11232038|NCT02034162|12424235|FG001|NOT COMPLETED|Open-label||0
11232039|NCT02034162|12424236|FG002|NOT COMPLETED|Open-label||0
11232040|NCT02034175|12424247|FG000|STARTED|Overall Study||190
11232041|NCT02034175|12424247|FG000|COMPLETED|Overall Study||190
11232042|NCT02034175|12424247|FG000|NOT COMPLETED|Overall Study||0
11232043|NCT02034409|12424253|FG000|STARTED|Sham Run-in Period||140
11232044|NCT02034409|12424254|FG001|STARTED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0
11232045|NCT02034409|12424253|FG000|COMPLETED|Sham Run-in Period||136
11232046|NCT02034409|12424254|FG001|COMPLETED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0
11232047|NCT02034409|12424253|FG000|NOT COMPLETED|Sham Run-in Period||4
11232048|NCT02034409|12424254|FG001|NOT COMPLETED|Sham Run-in Period||0
11232049|NCT02034409|12424253|FG000|STARTED|Sham-Controlled Treatment Period|Number started in Sham Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|67
11232050|NCT02034409|12424254|FG001|STARTED|Sham-Controlled Treatment Period|Number started in PLIUS Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|69
11232051|NCT02034409|12424253|FG000|COMPLETED|Sham-Controlled Treatment Period||55
11232052|NCT02034409|12424254|FG001|COMPLETED|Sham-Controlled Treatment Period||54
11232053|NCT02034409|12424253|FG000|NOT COMPLETED|Sham-Controlled Treatment Period||12
11232054|NCT02034409|12424254|FG001|NOT COMPLETED|Sham-Controlled Treatment Period||15
11232055|NCT02034435|12424262|FG000|STARTED|Overall Study||13
11232056|NCT02034435|12424263|FG001|STARTED|Overall Study||15
11232057|NCT02034435|12424264|FG002|STARTED|Overall Study||7
11232058|NCT02034435|12424265|FG003|STARTED|Overall Study||9
11232059|NCT02034435|12424262|FG000|Aim 1|Overall Study||13
11232060|NCT02034435|12424263|FG001|Aim 1|Overall Study||15
11232061|NCT02034435|12424264|FG002|Aim 1|Overall Study||0
11232062|NCT02034435|12424265|FG003|Aim 1|Overall Study||0
11355533|NCT03083769|12552412|FG001|COMPLETED|Overall Study||631
11355534|NCT03083769|12552411|FG000|NOT COMPLETED|Overall Study||20
11355535|NCT03083769|12552412|FG001|NOT COMPLETED|Overall Study||32
11355536|NCT03083847|12552428|FG000|STARTED|Pilot 1a||2
11355537|NCT03083847|12552429|FG001|STARTED|Pilot 1a||0
11355538|NCT03083847|12552430|FG002|STARTED|Pilot 1a||0
11355539|NCT03083847|12552431|FG003|STARTED|Pilot 1a||0
11355540|NCT03083847|12552432|FG004|STARTED|Pilot 1a||0
11355541|NCT03083847|12552433|FG005|STARTED|Pilot 1a||0
11355542|NCT03083847|12552434|FG006|STARTED|Pilot 1a||0
11355543|NCT03083847|12552435|FG007|STARTED|Pilot 1a||0
11355544|NCT03083847|12552436|FG008|STARTED|Pilot 1a||0
11355545|NCT03083847|12552437|FG009|STARTED|Pilot 1a||0
11355546|NCT03083847|12552428|FG000|COMPLETED|Pilot 1a||2
11355547|NCT03083847|12552429|FG001|COMPLETED|Pilot 1a||0
11355548|NCT03083847|12552430|FG002|COMPLETED|Pilot 1a||0
11355549|NCT03083847|12552431|FG003|COMPLETED|Pilot 1a||0
11355550|NCT03083847|12552432|FG004|COMPLETED|Pilot 1a||0
11355551|NCT03083847|12552433|FG005|COMPLETED|Pilot 1a||0
11355552|NCT03083847|12552434|FG006|COMPLETED|Pilot 1a||0
11355553|NCT03083847|12552435|FG007|COMPLETED|Pilot 1a||0
11355554|NCT03083847|12552436|FG008|COMPLETED|Pilot 1a||0
11355555|NCT03083847|12552437|FG009|COMPLETED|Pilot 1a||0
11355556|NCT03083847|12552428|FG000|NOT COMPLETED|Pilot 1a||0
11355557|NCT03083847|12552429|FG001|NOT COMPLETED|Pilot 1a||0
11355558|NCT03083847|12552430|FG002|NOT COMPLETED|Pilot 1a||0
11355559|NCT03083847|12552431|FG003|NOT COMPLETED|Pilot 1a||0
11355560|NCT03083847|12552432|FG004|NOT COMPLETED|Pilot 1a||0
11355561|NCT03083847|12552433|FG005|NOT COMPLETED|Pilot 1a||0
11355562|NCT03083847|12552434|FG006|NOT COMPLETED|Pilot 1a||0
11355563|NCT03083847|12552435|FG007|NOT COMPLETED|Pilot 1a||0
11355564|NCT03083847|12552436|FG008|NOT COMPLETED|Pilot 1a||0
11232063|NCT02034435|12424262|FG000|Aim 2|Overall Study||0
11232064|NCT02034435|12424263|FG001|Aim 2|Overall Study||0
11232065|NCT02034435|12424264|FG002|Aim 2|Overall Study||7
11232066|NCT02034435|12424265|FG003|Aim 2|Overall Study||9
11232067|NCT02034435|12424262|FG000|COMPLETED|Overall Study||11
11232068|NCT02034435|12424263|FG001|COMPLETED|Overall Study||13
11232069|NCT02034435|12424264|FG002|COMPLETED|Overall Study||7
11232070|NCT02034435|12424265|FG003|COMPLETED|Overall Study||8
11232071|NCT02034435|12424262|FG000|NOT COMPLETED|Overall Study||2
11232072|NCT02034435|12424263|FG001|NOT COMPLETED|Overall Study||2
11232073|NCT02034435|12424264|FG002|NOT COMPLETED|Overall Study||0
11232074|NCT02034435|12424265|FG003|NOT COMPLETED|Overall Study||1
11232075|NCT02034474|12424277|FG000|STARTED|Overall Study||19
11232076|NCT02034474|12424278|FG001|STARTED|Overall Study||17
11232077|NCT02034474|12424277|FG000|1 Dose|Overall Study||2
11232078|NCT02034474|12424278|FG001|1 Dose|Overall Study||4
11232079|NCT02034474|12424277|FG000|2 Doses|Overall Study||2
11232080|NCT02034474|12424278|FG001|2 Doses|Overall Study||0
11232081|NCT02034474|12424277|FG000|3 Doses|Overall Study||15
11232082|NCT02034474|12424278|FG001|3 Doses|Overall Study||13
11232083|NCT02034474|12424277|FG000|COMPLETED|Overall Study||15
11232084|NCT02034474|12424278|FG001|COMPLETED|Overall Study||13
11232085|NCT02034474|12424277|FG000|NOT COMPLETED|Overall Study||4
11232086|NCT02034474|12424278|FG001|NOT COMPLETED|Overall Study||4
11232087|NCT02034513|12424288|FG000|STARTED|Overall Study||249
11232088|NCT02034513|12424289|FG001|STARTED|Overall Study||252
11232089|NCT02034513|12424288|FG000|Exposed|Overall Study||249
11232090|NCT02034513|12424289|FG001|Exposed|Overall Study||251
11232091|NCT02034513|12424288|FG000|COMPLETED|Overall Study||200
11232092|NCT02034513|12424289|FG001|COMPLETED|Overall Study||195
11232093|NCT02034513|12424288|FG000|NOT COMPLETED|Overall Study||49
11232094|NCT02034513|12424289|FG001|NOT COMPLETED|Overall Study||57
11232095|NCT02034552|12424300|FG000|STARTED|Overall Study||22
11232096|NCT02034552|12424301|FG001|STARTED|Overall Study||24
11232097|NCT02034552|12424302|FG002|STARTED|Overall Study||22
11232098|NCT02034552|12424300|FG000|Received Treatment|Overall Study||19
11232099|NCT02034552|12424301|FG001|Received Treatment|Overall Study||22
11232100|NCT02034552|12424302|FG002|Received Treatment|Overall Study||22
11232101|NCT02034552|12424300|FG000|COMPLETED|Overall Study||8
11232102|NCT02034552|12424301|FG001|COMPLETED|Overall Study||4
11232103|NCT02034552|12424302|FG002|COMPLETED|Overall Study||5
11232104|NCT02034552|12424300|FG000|NOT COMPLETED|Overall Study||14
11232105|NCT02034552|12424301|FG001|NOT COMPLETED|Overall Study||20
11232106|NCT02034552|12424302|FG002|NOT COMPLETED|Overall Study||17
11232107|NCT02034565|12424310|FG000|STARTED|Overall Study||7
11232108|NCT02034565|12424311|FG001|STARTED|Overall Study||7
11232109|NCT02034565|12424310|FG000|COMPLETED|Overall Study||6
11232110|NCT02034565|12424311|FG001|COMPLETED|Overall Study||7
11232111|NCT02034565|12424310|FG000|NOT COMPLETED|Overall Study||1
11232112|NCT02034565|12424311|FG001|NOT COMPLETED|Overall Study||0
11232113|NCT02034578|12424319|FG000|STARTED|Overall Study||4
11232114|NCT02034578|12424320|FG001|STARTED|Overall Study||3
11232115|NCT02034578|12424321|FG002|STARTED|Overall Study||4
11232116|NCT02034578|12424322|FG003|STARTED|Overall Study||3
11232117|NCT02034578|12424323|FG004|STARTED|Overall Study||4
11232118|NCT02034578|12424324|FG005|STARTED|Overall Study||3
11232119|NCT02034578|12424319|FG000|COMPLETED|Overall Study||4
11232120|NCT02034578|12424320|FG001|COMPLETED|Overall Study||3
11232121|NCT02034578|12424321|FG002|COMPLETED|Overall Study||4
11232122|NCT02034578|12424322|FG003|COMPLETED|Overall Study||3
11232123|NCT02034578|12424323|FG004|COMPLETED|Overall Study||4
11355565|NCT03083847|12552437|FG009|NOT COMPLETED|Pilot 1a||0
11355566|NCT03083847|12552428|FG000|STARTED|Pilot Ib & 5a||0
11355567|NCT03083847|12552429|FG001|STARTED|Pilot Ib & 5a||2
11232124|NCT02034578|12424324|FG005|COMPLETED|Overall Study||3
11232125|NCT02034578|12424319|FG000|NOT COMPLETED|Overall Study||0
11232126|NCT02034578|12424320|FG001|NOT COMPLETED|Overall Study||0
11232127|NCT02034578|12424321|FG002|NOT COMPLETED|Overall Study||0
11232128|NCT02034578|12424322|FG003|NOT COMPLETED|Overall Study||0
11232129|NCT02034578|12424323|FG004|NOT COMPLETED|Overall Study||0
11232130|NCT02034578|12424324|FG005|NOT COMPLETED|Overall Study||0
11232131|NCT02034591|12424333|FG000|STARTED|Overall Study||4
11232132|NCT02034591|12424334|FG001|STARTED|Overall Study||3
11232133|NCT02034591|12424335|FG002|STARTED|Overall Study||4
11232134|NCT02034591|12424336|FG003|STARTED|Overall Study||3
11232135|NCT02034591|12424337|FG004|STARTED|Overall Study||4
11232136|NCT02034591|12424338|FG005|STARTED|Overall Study||3
11232137|NCT02034591|12424333|FG000|COMPLETED|Overall Study||4
11232138|NCT02034591|12424334|FG001|COMPLETED|Overall Study||3
11232139|NCT02034591|12424335|FG002|COMPLETED|Overall Study||4
11232140|NCT02034591|12424336|FG003|COMPLETED|Overall Study||3
11232141|NCT02034591|12424337|FG004|COMPLETED|Overall Study||3
11232142|NCT02034591|12424338|FG005|COMPLETED|Overall Study||3
11232143|NCT02034591|12424333|FG000|NOT COMPLETED|Overall Study||0
11232144|NCT02034591|12424334|FG001|NOT COMPLETED|Overall Study||0
11232145|NCT02034591|12424335|FG002|NOT COMPLETED|Overall Study||0
11232146|NCT02034591|12424336|FG003|NOT COMPLETED|Overall Study||0
11232147|NCT02034591|12424337|FG004|NOT COMPLETED|Overall Study||1
11232148|NCT02034591|12424338|FG005|NOT COMPLETED|Overall Study||0
11232149|NCT02034708|12424349|FG000|STARTED|First Contrast Agent Injection (1 Day)||138
11232150|NCT02034708|12424350|FG001|STARTED|First Contrast Agent Injection (1 Day)||130
11232151|NCT02034708|12424349|FG000|COMPLETED|First Contrast Agent Injection (1 Day)||138
11232152|NCT02034708|12424350|FG001|COMPLETED|First Contrast Agent Injection (1 Day)||130
11232153|NCT02034708|12424349|FG000|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
11232154|NCT02034708|12424350|FG001|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
11232155|NCT02034708|12424349|FG000|STARTED|Wash-out (From 2 Days up to 14 Days)||138
11232156|NCT02034708|12424350|FG001|STARTED|Wash-out (From 2 Days up to 14 Days)||130
11232157|NCT02034708|12424349|FG000|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
11232158|NCT02034708|12424350|FG001|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
11232159|NCT02034708|12424349|FG000|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
11232160|NCT02034708|12424350|FG001|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
11232161|NCT02034708|12424349|FG000|STARTED|Second Contrast Agent Injection (1 Day)||129
11232162|NCT02034708|12424350|FG001|STARTED|Second Contrast Agent Injection (1 Day)||120
11232163|NCT02034708|12424349|FG000|COMPLETED|Second Contrast Agent Injection (1 Day)||129
11232164|NCT02034708|12424350|FG001|COMPLETED|Second Contrast Agent Injection (1 Day)||120
11232165|NCT02034708|12424349|FG000|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
11232166|NCT02034708|12424350|FG001|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
11232167|NCT02034799|12424363|FG000|STARTED|Overall Study||129
11232168|NCT02034799|12424364|FG001|STARTED|Overall Study||127
11232169|NCT02034799|12424363|FG000|COMPLETED|Overall Study||127
11232170|NCT02034799|12424364|FG001|COMPLETED|Overall Study||123
11232171|NCT02034799|12424363|FG000|NOT COMPLETED|Overall Study||2
11232172|NCT02034799|12424364|FG001|NOT COMPLETED|Overall Study||4
11232173|NCT02034877|12424372|FG000|STARTED|Overall Study||200
11232174|NCT02034877|12424373|FG001|STARTED|Overall Study||999
11232175|NCT02034877|12424372|FG000|COMPLETED|Overall Study||200
11232176|NCT02034877|12424373|FG001|COMPLETED|Overall Study||993
11232177|NCT02034877|12424372|FG000|NOT COMPLETED|Overall Study||0
11232178|NCT02034877|12424373|FG001|NOT COMPLETED|Overall Study||6
11232179|NCT02034916|12424381|FG000|STARTED|Overall Study||49
11232180|NCT02034916|12424382|FG001|STARTED|Overall Study||35
11232181|NCT02034916|12424381|FG000|Treated|Overall Study||48
11232182|NCT02034916|12424382|FG001|Treated|Overall Study||35
11232183|NCT02034916|12424381|FG000|COMPLETED|Overall Study||0
11232184|NCT02034916|12424382|FG001|COMPLETED|Overall Study||0
11232185|NCT02034916|12424381|FG000|NOT COMPLETED|Overall Study||49
11232186|NCT02034916|12424382|FG001|NOT COMPLETED|Overall Study||35
11232187|NCT02035202|12424392|FG000|STARTED|Overall Study||85
11232188|NCT02035202|12424393|FG001|STARTED|Overall Study||85
11232189|NCT02035202|12424394|FG002|STARTED|Overall Study||85
11232190|NCT02035202|12424392|FG000|COMPLETED|Overall Study||77
11232191|NCT02035202|12424393|FG001|COMPLETED|Overall Study||69
11232192|NCT02035202|12424394|FG002|COMPLETED|Overall Study||83
11232193|NCT02035202|12424392|FG000|NOT COMPLETED|Overall Study||8
11232194|NCT02035202|12424393|FG001|NOT COMPLETED|Overall Study||16
11232195|NCT02035202|12424394|FG002|NOT COMPLETED|Overall Study||2
11232196|NCT02035267|12424406|FG000|STARTED|Overall Study||31
11232197|NCT02035267|12424407|FG001|STARTED|Overall Study||16
11232198|NCT02035267|12424408|FG002|STARTED|Overall Study||30
11232199|NCT02035267|12424409|FG003|STARTED|Overall Study||16
11232200|NCT02035267|12424406|FG000|COMPLETED|Overall Study||31
11232201|NCT02035267|12424407|FG001|COMPLETED|Overall Study||15
11232202|NCT02035267|12424408|FG002|COMPLETED|Overall Study||28
11232203|NCT02035267|12424409|FG003|COMPLETED|Overall Study||15
11232204|NCT02035267|12424406|FG000|NOT COMPLETED|Overall Study||0
11232205|NCT02035267|12424407|FG001|NOT COMPLETED|Overall Study||1
11232206|NCT02035267|12424408|FG002|NOT COMPLETED|Overall Study||2
11232207|NCT02035267|12424409|FG003|NOT COMPLETED|Overall Study||1
11232208|NCT02035332|12424421|FG000|STARTED|Overall Study|Treatment Attempted|21
11232209|NCT02035332|12424421|FG000|Treated|Overall Study|Treatment Completed|20
11232210|NCT02035332|12424421|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
11232211|NCT02035332|12424421|FG000|NOT COMPLETED|Overall Study||1
11232212|NCT02035345|12424425|FG000|STARTED|Overall Study||15
11232213|NCT02035345|12424425|FG000|COMPLETED|Overall Study||15
11232214|NCT02035345|12424425|FG000|NOT COMPLETED|Overall Study||0
11232215|NCT02035475|12424430|FG000|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
11232216|NCT02035475|12424430|FG000|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
11232217|NCT02035475|12424430|FG000|NOT COMPLETED|Overall Study||6
11232218|NCT02035553|12424438|FG000|STARTED|Overall Study||91
11232219|NCT02035553|12424439|FG001|STARTED|Overall Study||90
11232220|NCT02035553|12424438|FG000|COMPLETED|Overall Study||73
11232221|NCT02035553|12424439|FG001|COMPLETED|Overall Study||67
11232222|NCT02035553|12424438|FG000|NOT COMPLETED|Overall Study||18
11232223|NCT02035553|12424439|FG001|NOT COMPLETED|Overall Study||23
11232224|NCT02035696|12424449|FG000|STARTED|Overall Study||174
11232225|NCT02035696|12424450|FG001|STARTED|Overall Study||166
11232226|NCT02035696|12424451|FG002|STARTED|Overall Study||167
11232227|NCT02035696|12424452|FG003|STARTED|Overall Study||164
11232228|NCT02035696|12424449|FG000|COMPLETED|Overall Study||171
11232229|NCT02035696|12424450|FG001|COMPLETED|Overall Study||163
11232230|NCT02035696|12424451|FG002|COMPLETED|Overall Study||164
11232231|NCT02035696|12424452|FG003|COMPLETED|Overall Study||161
11232232|NCT02035696|12424449|FG000|NOT COMPLETED|Overall Study||3
11232233|NCT02035696|12424450|FG001|NOT COMPLETED|Overall Study||3
11232234|NCT02035696|12424451|FG002|NOT COMPLETED|Overall Study||3
11232235|NCT02035696|12424452|FG003|NOT COMPLETED|Overall Study||3
11232236|NCT02035748|12424466|FG000|STARTED|Overall Study||468
11232237|NCT02035748|12424466|FG000|COMPLETED|Overall Study||448
11232238|NCT02035748|12424466|FG000|NOT COMPLETED|Overall Study||20
11232239|NCT02036294|12424473|FG000|STARTED|Overall Study||120
11232240|NCT02036294|12424474|FG001|STARTED|Overall Study||120
11232241|NCT02036294|12424473|FG000|COMPLETED|Overall Study||111
11232242|NCT02036294|12424474|FG001|COMPLETED|Overall Study||109
11232243|NCT02036294|12424473|FG000|NOT COMPLETED|Overall Study||9
11232244|NCT02036294|12424474|FG001|NOT COMPLETED|Overall Study||11
11232245|NCT02036320|12424480|FG000|STARTED|Period 1||95
11232246|NCT02036320|12424481|FG001|STARTED|Period 1||95
11232247|NCT02036320|12424480|FG000|COMPLETED|Period 1||95
11232248|NCT02036320|12424481|FG001|COMPLETED|Period 1||95
11232249|NCT02036320|12424480|FG000|NOT COMPLETED|Period 1||0
11232250|NCT02036320|12424481|FG001|NOT COMPLETED|Period 1||0
11232251|NCT02036320|12424480|FG000|STARTED|Period 2||95
11232252|NCT02036320|12424481|FG001|STARTED|Period 2||95
11232253|NCT02036320|12424480|FG000|COMPLETED|Period 2||95
11232254|NCT02036320|12424481|FG001|COMPLETED|Period 2||95
11232255|NCT02036320|12424480|FG000|NOT COMPLETED|Period 2||0
11232256|NCT02036320|12424481|FG001|NOT COMPLETED|Period 2||0
11232257|NCT02036424|12424489|FG000|STARTED|Overall Study|23 study eyes, not number of subjects|23
11232258|NCT02036424|12424490|FG001|STARTED|Overall Study|27 study eyes, not number of subjects|27
11232259|NCT02036424|12424489|FG000|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
11232260|NCT02036424|12424490|FG001|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
11232261|NCT02036424|12424489|FG000|NOT COMPLETED|Overall Study||0
11232262|NCT02036424|12424490|FG001|NOT COMPLETED|Overall Study||0
11232263|NCT02036502|12424504|FG000|STARTED|Part 1:Dose Determination/Escalation||6
11232264|NCT02036502|12424505|FG001|STARTED|Part 1:Dose Determination/Escalation||4
11232265|NCT02036502|12424506|FG002|STARTED|Part 1:Dose Determination/Escalation||0
11232266|NCT02036502|12424507|FG003|STARTED|Part 1:Dose Determination/Escalation||0
11232267|NCT02036502|12424508|FG004|STARTED|Part 1:Dose Determination/Escalation||0
11232268|NCT02036502|12424509|FG005|STARTED|Part 1:Dose Determination/Escalation||0
11232269|NCT02036502|12424510|FG006|STARTED|Part 1:Dose Determination/Escalation||0
11232270|NCT02036502|12424511|FG007|STARTED|Part 1:Dose Determination/Escalation||0
11232271|NCT02036502|12424504|FG000|Treated|Part 1:Dose Determination/Escalation||6
11232272|NCT02036502|12424505|FG001|Treated|Part 1:Dose Determination/Escalation||3
11232273|NCT02036502|12424506|FG002|Treated|Part 1:Dose Determination/Escalation||0
11232274|NCT02036502|12424507|FG003|Treated|Part 1:Dose Determination/Escalation||0
11232275|NCT02036502|12424508|FG004|Treated|Part 1:Dose Determination/Escalation||0
11232276|NCT02036502|12424509|FG005|Treated|Part 1:Dose Determination/Escalation||0
11232277|NCT02036502|12424510|FG006|Treated|Part 1:Dose Determination/Escalation||0
11232278|NCT02036502|12424511|FG007|Treated|Part 1:Dose Determination/Escalation||0
11232279|NCT02036502|12424504|FG000|COMPLETED|Part 1:Dose Determination/Escalation||0
11232280|NCT02036502|12424505|FG001|COMPLETED|Part 1:Dose Determination/Escalation||0
11232281|NCT02036502|12424506|FG002|COMPLETED|Part 1:Dose Determination/Escalation||0
11232282|NCT02036502|12424507|FG003|COMPLETED|Part 1:Dose Determination/Escalation||0
11232283|NCT02036502|12424508|FG004|COMPLETED|Part 1:Dose Determination/Escalation||0
11232284|NCT02036502|12424509|FG005|COMPLETED|Part 1:Dose Determination/Escalation||0
11232285|NCT02036502|12424510|FG006|COMPLETED|Part 1:Dose Determination/Escalation||0
11232286|NCT02036502|12424511|FG007|COMPLETED|Part 1:Dose Determination/Escalation||0
11232287|NCT02036502|12424504|FG000|NOT COMPLETED|Part 1:Dose Determination/Escalation||6
11232288|NCT02036502|12424505|FG001|NOT COMPLETED|Part 1:Dose Determination/Escalation||4
11232289|NCT02036502|12424506|FG002|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
11232290|NCT02036502|12424507|FG003|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
11232291|NCT02036502|12424508|FG004|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
11232292|NCT02036502|12424509|FG005|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
11232293|NCT02036502|12424510|FG006|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
11355568|NCT03083847|12552430|FG002|STARTED|Pilot Ib & 5a||2
11232294|NCT02036502|12424511|FG007|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
11232295|NCT02036502|12424504|FG000|STARTED|Part 2:Dose Confirmation||0
11232296|NCT02036502|12424505|FG001|STARTED|Part 2:Dose Confirmation||0
11232297|NCT02036502|12424506|FG002|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|6
11232298|NCT02036502|12424507|FG003|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|2
11232299|NCT02036502|12424508|FG004|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|1
11232300|NCT02036502|12424509|FG005|STARTED|Part 2:Dose Confirmation||0
11232301|NCT02036502|12424510|FG006|STARTED|Part 2:Dose Confirmation||0
11232302|NCT02036502|12424511|FG007|STARTED|Part 2:Dose Confirmation||0
11232303|NCT02036502|12424504|FG000|Treated|Part 2:Dose Confirmation||0
11232304|NCT02036502|12424505|FG001|Treated|Part 2:Dose Confirmation||0
11232305|NCT02036502|12424506|FG002|Treated|Part 2:Dose Confirmation||6
11232306|NCT02036502|12424507|FG003|Treated|Part 2:Dose Confirmation||1
11232307|NCT02036502|12424508|FG004|Treated|Part 2:Dose Confirmation||1
11232308|NCT02036502|12424509|FG005|Treated|Part 2:Dose Confirmation||0
11232309|NCT02036502|12424510|FG006|Treated|Part 2:Dose Confirmation||0
11232310|NCT02036502|12424511|FG007|Treated|Part 2:Dose Confirmation||0
11232311|NCT02036502|12424504|FG000|COMPLETED|Part 2:Dose Confirmation||0
11232312|NCT02036502|12424505|FG001|COMPLETED|Part 2:Dose Confirmation||0
11232313|NCT02036502|12424506|FG002|COMPLETED|Part 2:Dose Confirmation||0
11232314|NCT02036502|12424507|FG003|COMPLETED|Part 2:Dose Confirmation||0
11232315|NCT02036502|12424508|FG004|COMPLETED|Part 2:Dose Confirmation||0
11232316|NCT02036502|12424509|FG005|COMPLETED|Part 2:Dose Confirmation||0
11232317|NCT02036502|12424510|FG006|COMPLETED|Part 2:Dose Confirmation||0
11232318|NCT02036502|12424511|FG007|COMPLETED|Part 2:Dose Confirmation||0
11232319|NCT02036502|12424504|FG000|NOT COMPLETED|Part 2:Dose Confirmation||0
11232320|NCT02036502|12424505|FG001|NOT COMPLETED|Part 2:Dose Confirmation||0
11232321|NCT02036502|12424506|FG002|NOT COMPLETED|Part 2:Dose Confirmation||6
11232322|NCT02036502|12424507|FG003|NOT COMPLETED|Part 2:Dose Confirmation||2
11232323|NCT02036502|12424508|FG004|NOT COMPLETED|Part 2:Dose Confirmation||1
11232324|NCT02036502|12424509|FG005|NOT COMPLETED|Part 2:Dose Confirmation||0
11232325|NCT02036502|12424510|FG006|NOT COMPLETED|Part 2:Dose Confirmation||0
11232326|NCT02036502|12424511|FG007|NOT COMPLETED|Part 2:Dose Confirmation||0
11232327|NCT02036502|12424504|FG000|STARTED|Part 3:Dose Expansion||0
11232328|NCT02036502|12424505|FG001|STARTED|Part 3:Dose Expansion||0
11232329|NCT02036502|12424506|FG002|STARTED|Part 3:Dose Expansion||0
11232330|NCT02036502|12424507|FG003|STARTED|Part 3:Dose Expansion||0
11232331|NCT02036502|12424508|FG004|STARTED|Part 3:Dose Expansion||0
11232332|NCT02036502|12424509|FG005|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|47
11232333|NCT02036502|12424510|FG006|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|1
11232334|NCT02036502|12424511|FG007|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|10
11232335|NCT02036502|12424504|FG000|Treated|Part 3:Dose Expansion||0
11232336|NCT02036502|12424505|FG001|Treated|Part 3:Dose Expansion||0
11232337|NCT02036502|12424506|FG002|Treated|Part 3:Dose Expansion||0
11232338|NCT02036502|12424507|FG003|Treated|Part 3:Dose Expansion||0
11232339|NCT02036502|12424508|FG004|Treated|Part 3:Dose Expansion||0
11355569|NCT03083847|12552431|FG003|STARTED|Pilot Ib & 5a||0
11355570|NCT03083847|12552432|FG004|STARTED|Pilot Ib & 5a||0
11355571|NCT03083847|12552433|FG005|STARTED|Pilot Ib & 5a||0
11355572|NCT03083847|12552434|FG006|STARTED|Pilot Ib & 5a||0
11355573|NCT03083847|12552435|FG007|STARTED|Pilot Ib & 5a||0
11355574|NCT03083847|12552436|FG008|STARTED|Pilot Ib & 5a||0
11355575|NCT03083847|12552437|FG009|STARTED|Pilot Ib & 5a||0
11355576|NCT03083847|12552428|FG000|COMPLETED|Pilot Ib & 5a||0
11355577|NCT03083847|12552429|FG001|COMPLETED|Pilot Ib & 5a||2
11355578|NCT03083847|12552430|FG002|COMPLETED|Pilot Ib & 5a||2
11355579|NCT03083847|12552431|FG003|COMPLETED|Pilot Ib & 5a||0
11355580|NCT03083847|12552432|FG004|COMPLETED|Pilot Ib & 5a||0
11355581|NCT03083847|12552433|FG005|COMPLETED|Pilot Ib & 5a||0
11355582|NCT03083847|12552434|FG006|COMPLETED|Pilot Ib & 5a||0
11355583|NCT03083847|12552435|FG007|COMPLETED|Pilot Ib & 5a||0
11355584|NCT03083847|12552436|FG008|COMPLETED|Pilot Ib & 5a||0
11355585|NCT03083847|12552437|FG009|COMPLETED|Pilot Ib & 5a||0
11355586|NCT03083847|12552428|FG000|NOT COMPLETED|Pilot Ib & 5a||0
11355587|NCT03083847|12552429|FG001|NOT COMPLETED|Pilot Ib & 5a||0
11232340|NCT02036502|12424509|FG005|Treated|Part 3:Dose Expansion||45
11232341|NCT02036502|12424510|FG006|Treated|Part 3:Dose Expansion||1
11232342|NCT02036502|12424511|FG007|Treated|Part 3:Dose Expansion||10
11232343|NCT02036502|12424504|FG000|COMPLETED|Part 3:Dose Expansion||0
11232344|NCT02036502|12424505|FG001|COMPLETED|Part 3:Dose Expansion||0
11232345|NCT02036502|12424506|FG002|COMPLETED|Part 3:Dose Expansion||0
11232346|NCT02036502|12424507|FG003|COMPLETED|Part 3:Dose Expansion||0
11232347|NCT02036502|12424508|FG004|COMPLETED|Part 3:Dose Expansion||0
11232348|NCT02036502|12424509|FG005|COMPLETED|Part 3:Dose Expansion||0
11232349|NCT02036502|12424510|FG006|COMPLETED|Part 3:Dose Expansion||0
11232350|NCT02036502|12424511|FG007|COMPLETED|Part 3:Dose Expansion||0
11355588|NCT03083847|12552430|FG002|NOT COMPLETED|Pilot Ib & 5a||0
11355589|NCT03083847|12552431|FG003|NOT COMPLETED|Pilot Ib & 5a||0
11113268|NCT01292538|12297502|FG000|NOT COMPLETED|Overall Study||0
11113269|NCT01292538|12297503|FG001|NOT COMPLETED|Overall Study||0
11113270|NCT01292603|12297514|FG000|STARTED|Part 1: Pilot Dose Selection Period||16
11355590|NCT03083847|12552432|FG004|NOT COMPLETED|Pilot Ib & 5a||0
11355591|NCT03083847|12552433|FG005|NOT COMPLETED|Pilot Ib & 5a||0
11355592|NCT03083847|12552434|FG006|NOT COMPLETED|Pilot Ib & 5a||0
11355593|NCT03083847|12552435|FG007|NOT COMPLETED|Pilot Ib & 5a||0
11355594|NCT03083847|12552436|FG008|NOT COMPLETED|Pilot Ib & 5a||0
11355595|NCT03083847|12552437|FG009|NOT COMPLETED|Pilot Ib & 5a||0
11355596|NCT03083847|12552428|FG000|STARTED|Pilot 1d & 5b||0
11355597|NCT03083847|12552429|FG001|STARTED|Pilot 1d & 5b||0
11355598|NCT03083847|12552430|FG002|STARTED|Pilot 1d & 5b||0
11355599|NCT03083847|12552431|FG003|STARTED|Pilot 1d & 5b||4
11355600|NCT03083847|12552432|FG004|STARTED|Pilot 1d & 5b||4
11355601|NCT03083847|12552433|FG005|STARTED|Pilot 1d & 5b||0
11355602|NCT03083847|12552434|FG006|STARTED|Pilot 1d & 5b||0
11355603|NCT03083847|12552435|FG007|STARTED|Pilot 1d & 5b||0
11355604|NCT03083847|12552436|FG008|STARTED|Pilot 1d & 5b||0
11355605|NCT03083847|12552437|FG009|STARTED|Pilot 1d & 5b||0
11355606|NCT03083847|12552428|FG000|COMPLETED|Pilot 1d & 5b||0
11355607|NCT03083847|12552429|FG001|COMPLETED|Pilot 1d & 5b||0
11355608|NCT03083847|12552430|FG002|COMPLETED|Pilot 1d & 5b||0
11355609|NCT03083847|12552431|FG003|COMPLETED|Pilot 1d & 5b||4
11355610|NCT03083847|12552432|FG004|COMPLETED|Pilot 1d & 5b||4
11355611|NCT03083847|12552433|FG005|COMPLETED|Pilot 1d & 5b||0
11355612|NCT03083847|12552434|FG006|COMPLETED|Pilot 1d & 5b||0
11355613|NCT03083847|12552435|FG007|COMPLETED|Pilot 1d & 5b||0
11355614|NCT03083847|12552436|FG008|COMPLETED|Pilot 1d & 5b||0
11355615|NCT03083847|12552437|FG009|COMPLETED|Pilot 1d & 5b||0
11355616|NCT03083847|12552428|FG000|NOT COMPLETED|Pilot 1d & 5b||0
11355617|NCT03083847|12552429|FG001|NOT COMPLETED|Pilot 1d & 5b||0
11355618|NCT03083847|12552430|FG002|NOT COMPLETED|Pilot 1d & 5b||0
11355619|NCT03083847|12552431|FG003|NOT COMPLETED|Pilot 1d & 5b||0
11355620|NCT03083847|12552432|FG004|NOT COMPLETED|Pilot 1d & 5b||0
11355621|NCT03083847|12552433|FG005|NOT COMPLETED|Pilot 1d & 5b||0
11355622|NCT03083847|12552434|FG006|NOT COMPLETED|Pilot 1d & 5b||0
11355623|NCT03083847|12552435|FG007|NOT COMPLETED|Pilot 1d & 5b||0
11355624|NCT03083847|12552436|FG008|NOT COMPLETED|Pilot 1d & 5b||0
11355625|NCT03083847|12552437|FG009|NOT COMPLETED|Pilot 1d & 5b||0
11355626|NCT03083847|12552428|FG000|STARTED|Main||0
11355627|NCT03083847|12552429|FG001|STARTED|Main||0
11355628|NCT03083847|12552430|FG002|STARTED|Main||0
11355629|NCT03083847|12552431|FG003|STARTED|Main||0
11355630|NCT03083847|12552432|FG004|STARTED|Main||0
11355631|NCT03083847|12552433|FG005|STARTED|Main||9
11355632|NCT03083847|12552434|FG006|STARTED|Main||10
11113271|NCT01292603|12297515|FG001|STARTED|Part 1: Pilot Dose Selection Period||17
11113272|NCT01292603|12297516|FG002|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
11113273|NCT01292603|12297517|FG003|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
11113274|NCT01292603|12297518|FG004|STARTED|Part 1: Pilot Dose Selection Period||0
11113275|NCT01292603|12297519|FG005|STARTED|Part 1: Pilot Dose Selection Period||0
11355633|NCT03083847|12552435|FG007|STARTED|Main||10
11355634|NCT03083847|12552436|FG008|STARTED|Main||4
11355635|NCT03083847|12552437|FG009|STARTED|Main||8
11355636|NCT03083847|12552428|FG000|COMPLETED|Main||0
11355637|NCT03083847|12552429|FG001|COMPLETED|Main||0
11355638|NCT03083847|12552430|FG002|COMPLETED|Main||0
11355639|NCT03083847|12552431|FG003|COMPLETED|Main||0
11355640|NCT03083847|12552432|FG004|COMPLETED|Main||0
11355641|NCT03083847|12552433|FG005|COMPLETED|Main||8
11355642|NCT03083847|12552434|FG006|COMPLETED|Main||9
11355643|NCT03083847|12552435|FG007|COMPLETED|Main||6
11355644|NCT03083847|12552436|FG008|COMPLETED|Main||4
11355645|NCT03083847|12552437|FG009|COMPLETED|Main||8
11113276|NCT01292603|12297514|FG000|COMPLETED|Part 1: Pilot Dose Selection Period||16
11232351|NCT02036502|12424504|FG000|NOT COMPLETED|Part 3:Dose Expansion||0
11355646|NCT03083847|12552428|FG000|NOT COMPLETED|Main||0
11355647|NCT03083847|12552429|FG001|NOT COMPLETED|Main||0
11355648|NCT03083847|12552430|FG002|NOT COMPLETED|Main||0
11355649|NCT03083847|12552431|FG003|NOT COMPLETED|Main||0
11355650|NCT03083847|12552432|FG004|NOT COMPLETED|Main||0
11355651|NCT03083847|12552433|FG005|NOT COMPLETED|Main||1
11355652|NCT03083847|12552434|FG006|NOT COMPLETED|Main||1
11355653|NCT03083847|12552435|FG007|NOT COMPLETED|Main||4
11355654|NCT03083847|12552436|FG008|NOT COMPLETED|Main||0
11355655|NCT03083847|12552437|FG009|NOT COMPLETED|Main||0
11355656|NCT03083990|12552467|FG000|STARTED|Overall Study||50
11355657|NCT03083990|12552468|FG001|STARTED|Overall Study||50
11355658|NCT03083990|12552467|FG000|COMPLETED|Overall Study||49
11355659|NCT03083990|12552468|FG001|COMPLETED|Overall Study||50
11355660|NCT03083990|12552467|FG000|NOT COMPLETED|Overall Study||1
11355661|NCT03083990|12552468|FG001|NOT COMPLETED|Overall Study||0
11232352|NCT02036502|12424505|FG001|NOT COMPLETED|Part 3:Dose Expansion||0
11232353|NCT02036502|12424506|FG002|NOT COMPLETED|Part 3:Dose Expansion||0
11232354|NCT02036502|12424507|FG003|NOT COMPLETED|Part 3:Dose Expansion||0
11232355|NCT02036502|12424508|FG004|NOT COMPLETED|Part 3:Dose Expansion||0
11232356|NCT02036502|12424509|FG005|NOT COMPLETED|Part 3:Dose Expansion||47
11232357|NCT02036502|12424510|FG006|NOT COMPLETED|Part 3:Dose Expansion||1
11232358|NCT02036502|12424511|FG007|NOT COMPLETED|Part 3:Dose Expansion||10
11232359|NCT02036515|12424534|FG000|STARTED|Overall Study||156
11232360|NCT02036515|12424535|FG001|STARTED|Overall Study||155
11232361|NCT02036515|12424536|FG002|STARTED|Overall Study||153
11232362|NCT02036515|12424534|FG000|Treated|Overall Study||156
11232363|NCT02036515|12424535|FG001|Treated|Overall Study||153
11355662|NCT03084302|12552474|FG000|STARTED|Overall Study||120
11355663|NCT03084302|12552474|FG000|COMPLETED|Overall Study||105
11355664|NCT03084302|12552474|FG000|NOT COMPLETED|Overall Study||15
11355665|NCT03084315|12552481|FG000|STARTED|Overall Study||116
11355666|NCT03084315|12552482|FG001|STARTED|Overall Study||118
11355667|NCT03084315|12552481|FG000|COMPLETED|Overall Study||106
11355668|NCT03084315|12552482|FG001|COMPLETED|Overall Study||109
11355669|NCT03084315|12552481|FG000|NOT COMPLETED|Overall Study||10
11355670|NCT03084315|12552482|FG001|NOT COMPLETED|Overall Study||9
10874538|NCT04929522|12040640|FG000|STARTED|Overall Study||40
10874539|NCT04929522|12040641|FG001|STARTED|Overall Study||40
10874540|NCT04929522|12040642|FG002|STARTED|Overall Study||40
10874541|NCT04929522|12040643|FG003|STARTED|Overall Study||40
10874542|NCT04929522|12040640|FG000|COMPLETED|Overall Study||40
10874543|NCT04929522|12040641|FG001|COMPLETED|Overall Study||40
10874544|NCT04929522|12040642|FG002|COMPLETED|Overall Study||40
10874545|NCT04929522|12040643|FG003|COMPLETED|Overall Study||40
10874546|NCT04929522|12040640|FG000|NOT COMPLETED|Overall Study||0
10874547|NCT04929522|12040641|FG001|NOT COMPLETED|Overall Study||0
10874548|NCT04929522|12040642|FG002|NOT COMPLETED|Overall Study||0
10874549|NCT04929522|12040643|FG003|NOT COMPLETED|Overall Study||0
11355671|NCT03084796|12552494|FG000|STARTED|Overall Study||121
11355672|NCT03084796|12552495|FG001|STARTED|Overall Study||123
11355673|NCT03084796|12552496|FG002|STARTED|Overall Study||122
11355674|NCT03084796|12552497|FG003|STARTED|Overall Study||123
11355675|NCT03084796|12552498|FG004|STARTED|Overall Study||121
11355676|NCT03084796|12552499|FG005|STARTED|Overall Study||123
11355677|NCT03084796|12552494|FG000|COMPLETED|Overall Study||114
11355678|NCT03084796|12552495|FG001|COMPLETED|Overall Study||113
11355679|NCT03084796|12552496|FG002|COMPLETED|Overall Study||110
11355680|NCT03084796|12552497|FG003|COMPLETED|Overall Study||119
11355681|NCT03084796|12552498|FG004|COMPLETED|Overall Study||110
11355682|NCT03084796|12552499|FG005|COMPLETED|Overall Study||116
11355683|NCT03084796|12552494|FG000|NOT COMPLETED|Overall Study||7
11355684|NCT03084796|12552495|FG001|NOT COMPLETED|Overall Study||10
11355685|NCT03084796|12552496|FG002|NOT COMPLETED|Overall Study||12
11355686|NCT03084796|12552497|FG003|NOT COMPLETED|Overall Study||4
11355687|NCT03084796|12552498|FG004|NOT COMPLETED|Overall Study||11
11355688|NCT03084796|12552499|FG005|NOT COMPLETED|Overall Study||7
11355689|NCT03085017|12552515|FG000|STARTED|Overall Study||30
11355690|NCT03085017|12552516|FG001|STARTED|Overall Study||27
11355691|NCT03085017|12552515|FG000|COMPLETED|Overall Study||30
11355692|NCT03085017|12552516|FG001|COMPLETED|Overall Study||24
11355693|NCT03085017|12552515|FG000|NOT COMPLETED|Overall Study||0
11355694|NCT03085017|12552516|FG001|NOT COMPLETED|Overall Study||3
11355695|NCT03085238|12552522|FG000|STARTED|Overall Study||23
11355696|NCT03085238|12552522|FG000|1 Month|Overall Study||23
11355697|NCT03085238|12552522|FG000|3 Months|Overall Study||22
11355698|NCT03085238|12552522|FG000|6 Months|Overall Study||19
11355699|NCT03085238|12552522|FG000|9 Months|Overall Study||16
11355700|NCT03085238|12552522|FG000|12 Months|Overall Study||14
11355701|NCT03085238|12552522|FG000|15 Months|Overall Study||11
11355702|NCT03085238|12552522|FG000|18 Months|Overall Study||7
11355703|NCT03085238|12552522|FG000|COMPLETED|Overall Study||19
11355704|NCT03085238|12552522|FG000|NOT COMPLETED|Overall Study||4
11355705|NCT03085758|12552538|FG000|STARTED|Overall Study||72
11355706|NCT03085758|12552539|FG001|STARTED|Overall Study||77
11355707|NCT03085758|12552540|FG002|STARTED|Overall Study||152
11355708|NCT03085758|12552538|FG000|COMPLETED|Overall Study||43
11355709|NCT03085758|12552539|FG001|COMPLETED|Overall Study||49
11355710|NCT03085758|12552540|FG002|COMPLETED|Overall Study||96
11355711|NCT03085758|12552538|FG000|NOT COMPLETED|Overall Study||29
11355712|NCT03085758|12552539|FG001|NOT COMPLETED|Overall Study||28
11355713|NCT03085758|12552540|FG002|NOT COMPLETED|Overall Study||56
11355714|NCT03085797|12552554|FG000|STARTED|Treatment Period (TP) (52 Weeks)||201
11355715|NCT03085797|12552555|FG001|STARTED|Treatment Period (TP) (52 Weeks)||206
11355716|NCT03085797|12552554|FG000|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||167
11355717|NCT03085797|12552555|FG001|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||183
11355718|NCT03085797|12552554|FG000|Not Completed IP|Treatment Period (TP) (52 Weeks)||34
11355719|NCT03085797|12552555|FG001|Not Completed IP|Treatment Period (TP) (52 Weeks)||23
11355720|NCT03085797|12552554|FG000|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
11355721|NCT03085797|12552555|FG001|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
11355722|NCT03085797|12552554|FG000|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||11
11355723|NCT03085797|12552555|FG001|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||5
11355724|NCT03085797|12552554|FG000|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||1
11355725|NCT03085797|12552555|FG001|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||0
11355726|NCT03085797|12552554|FG000|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
11355727|NCT03085797|12552555|FG001|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
11355728|NCT03085797|12552554|FG000|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||2
11355729|NCT03085797|12552555|FG001|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||1
11355730|NCT03085797|12552554|FG000|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||15
11355731|NCT03085797|12552555|FG001|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||12
11355732|NCT03085797|12552554|FG000|COMPLETED|Treatment Period (TP) (52 Weeks)||184
11355733|NCT03085797|12552555|FG001|COMPLETED|Treatment Period (TP) (52 Weeks)||189
11355734|NCT03085797|12552554|FG000|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
11355735|NCT03085797|12552555|FG001|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
11355736|NCT03085797|12552554|FG000|STARTED|No-treatment Follow-up Period (6 Months)|Only 65 Par. continued in FU to check maintenance of response after stopping treatment per protocol|65
11355737|NCT03085797|12552555|FG001|STARTED|No-treatment Follow-up Period (6 Months)|Only 69 Par. continued in FU to check maintenance of response after stopping treatment per protocol|69
11355738|NCT03085797|12552554|FG000|COMPLETED|No-treatment Follow-up Period (6 Months)||65
11355739|NCT03085797|12552555|FG001|COMPLETED|No-treatment Follow-up Period (6 Months)||68
11355740|NCT03085797|12552554|FG000|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||0
11355741|NCT03085797|12552555|FG001|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||1
11355742|NCT03085836|12552566|FG000|STARTED|Overall Study||12
11355743|NCT03085836|12552567|FG001|STARTED|Overall Study||11
11355744|NCT03085836|12552568|FG002|STARTED|Overall Study||10
11355745|NCT03085836|12552566|FG000|COMPLETED|Overall Study||12
11355746|NCT03085836|12552567|FG001|COMPLETED|Overall Study||11
11355747|NCT03085836|12552568|FG002|COMPLETED|Overall Study||10
11355748|NCT03085836|12552566|FG000|NOT COMPLETED|Overall Study||0
11355749|NCT03085836|12552567|FG001|NOT COMPLETED|Overall Study||0
11355750|NCT03085836|12552568|FG002|NOT COMPLETED|Overall Study||0
11355751|NCT03085927|12552580|FG000|STARTED|Overall Study||69
11355752|NCT03085927|12552581|FG001|STARTED|Overall Study||67
11355753|NCT03085927|12552580|FG000|Study Sessions|Overall Study|"Off Study reasons:~Child toxicity/side effects (n=1) Dyad withdrew (n=1) Dyad lost to follow-up (n=2)"|65
11355754|NCT03085927|12552581|FG001|Study Sessions|Overall Study|"Off Study reasons:~Dyad withdrew (n=3) Dyad became ineligible (n=1)"|63
11355755|NCT03085927|12552580|FG000|Time 2 Measures|Overall Study||65
11355756|NCT03085927|12552581|FG001|Time 2 Measures|Overall Study|"Off Study reasons:~Dyad withdrew (n=1)"|62
11355757|NCT03085927|12552580|FG000|COMPLETED|Overall Study|"Off Study reasons:~Death of child (n=1) Dyad lost to follow up (n=1)"|63
11355758|NCT03085927|12552581|FG001|COMPLETED|Overall Study|"Off Study reason:~Dyad lost to follow up (n=1)"|61
11355759|NCT03085927|12552580|FG000|NOT COMPLETED|Overall Study||6
11355760|NCT03085927|12552581|FG001|NOT COMPLETED|Overall Study||6
11355761|NCT03086018|12552589|FG000|STARTED|Field Testing||30
11355762|NCT03086018|12552589|FG000|COMPLETED|Field Testing||30
11355763|NCT03086018|12552589|FG000|NOT COMPLETED|Field Testing||0
11355764|NCT03086018|12552589|FG000|STARTED|Final Testing for End of Trial||30
11355765|NCT03086018|12552589|FG000|COMPLETED|Final Testing for End of Trial||28
11355766|NCT03086018|12552589|FG000|NOT COMPLETED|Final Testing for End of Trial||2
11355767|NCT03086057|12552599|FG000|STARTED|Stage 1: PrEP Uptake||55
11355768|NCT03086057|12552600|FG001|STARTED|Stage 1: PrEP Uptake||55
11355769|NCT03086057|12552601|FG002|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
11355770|NCT03086057|12552602|FG003|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
11355771|NCT03086057|12552599|FG000|COMPLETED|Stage 1: PrEP Uptake||44
11355772|NCT03086057|12552600|FG001|COMPLETED|Stage 1: PrEP Uptake||45
11355773|NCT03086057|12552601|FG002|COMPLETED|Stage 1: PrEP Uptake||0
11355774|NCT03086057|12552602|FG003|COMPLETED|Stage 1: PrEP Uptake||0
11355775|NCT03086057|12552599|FG000|NOT COMPLETED|Stage 1: PrEP Uptake||11
11355776|NCT03086057|12552600|FG001|NOT COMPLETED|Stage 1: PrEP Uptake||10
11355777|NCT03086057|12552601|FG002|NOT COMPLETED|Stage 1: PrEP Uptake||0
11355778|NCT03086057|12552602|FG003|NOT COMPLETED|Stage 1: PrEP Uptake||0
11355779|NCT03086057|12552599|FG000|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
11355780|NCT03086057|12552600|FG001|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
11355781|NCT03086057|12552601|FG002|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|17
11355782|NCT03086057|12552602|FG003|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|18
11355783|NCT03086057|12552599|FG000|COMPLETED|Stage 2: PrEP Adherence||0
11355784|NCT03086057|12552600|FG001|COMPLETED|Stage 2: PrEP Adherence||0
11355785|NCT03086057|12552601|FG002|COMPLETED|Stage 2: PrEP Adherence||11
11355786|NCT03086057|12552602|FG003|COMPLETED|Stage 2: PrEP Adherence||16
11355787|NCT03086057|12552599|FG000|NOT COMPLETED|Stage 2: PrEP Adherence||0
11355788|NCT03086057|12552600|FG001|NOT COMPLETED|Stage 2: PrEP Adherence||0
11355789|NCT03086057|12552601|FG002|NOT COMPLETED|Stage 2: PrEP Adherence||6
11355790|NCT03086057|12552602|FG003|NOT COMPLETED|Stage 2: PrEP Adherence||2
11355791|NCT03086135|12552612|FG000|STARTED|Overall Study||51
11355792|NCT03086135|12552612|FG000|COMPLETED|Overall Study||48
11355793|NCT03086135|12552612|FG000|NOT COMPLETED|Overall Study||3
11355794|NCT03086213|12552616|FG000|STARTED|Overall Study||24
11355795|NCT03086213|12552617|FG001|STARTED|Overall Study||24
11355796|NCT03086213|12552616|FG000|COMPLETED|Overall Study||24
11355797|NCT03086213|12552617|FG001|COMPLETED|Overall Study||24
11355798|NCT03086213|12552616|FG000|NOT COMPLETED|Overall Study||0
11355799|NCT03086213|12552617|FG001|NOT COMPLETED|Overall Study||0
11355800|NCT03086265|12552625|FG000|STARTED|Overall Study||10
11355801|NCT03086265|12552626|FG001|STARTED|Overall Study||10
11355802|NCT03086265|12552625|FG000|COMPLETED|Overall Study||10
11355803|NCT03086265|12552626|FG001|COMPLETED|Overall Study||10
11355804|NCT03086265|12552625|FG000|NOT COMPLETED|Overall Study||0
11355805|NCT03086265|12552626|FG001|NOT COMPLETED|Overall Study||0
11355806|NCT03086330|12552634|FG000|STARTED|Overall Study||151
11355807|NCT03086330|12552635|FG001|STARTED|Overall Study||151
11355808|NCT03086330|12552634|FG000|Exposed|Overall Study||150
11355809|NCT03086330|12552635|FG001|Exposed|Overall Study||151
11355810|NCT03086330|12552634|FG000|COMPLETED|Overall Study||147
11355811|NCT03086330|12552635|FG001|COMPLETED|Overall Study||147
11355812|NCT03086330|12552634|FG000|NOT COMPLETED|Overall Study||4
11355813|NCT03086330|12552635|FG001|NOT COMPLETED|Overall Study||4
11355814|NCT03086356|12552641|FG000|STARTED|Overall Study||12
11355815|NCT03086356|12552641|FG000|COMPLETED|Overall Study||12
11355816|NCT03086356|12552641|FG000|NOT COMPLETED|Overall Study||0
11355817|NCT03086408|12552647|FG000|STARTED|Overall Study||10
11355818|NCT03086408|12552648|FG001|STARTED|Overall Study||10
11355819|NCT03086408|12552647|FG000|COMPLETED|Overall Study||10
11355820|NCT03086408|12552648|FG001|COMPLETED|Overall Study||10
11355821|NCT03086408|12552647|FG000|NOT COMPLETED|Overall Study||0
11355822|NCT03086408|12552648|FG001|NOT COMPLETED|Overall Study||0
11355823|NCT03086447|12552656|FG000|STARTED|Overall Study||132
11355824|NCT03086447|12552657|FG001|STARTED|Overall Study||130
11355825|NCT03086447|12552656|FG000|COMPLETED|Overall Study||121
11355826|NCT03086447|12552657|FG001|COMPLETED|Overall Study||110
11355827|NCT03086447|12552656|FG000|NOT COMPLETED|Overall Study||11
11355828|NCT03086447|12552657|FG001|NOT COMPLETED|Overall Study||20
11355829|NCT03086460|12552663|FG000|STARTED|Study Participants||67
11355830|NCT03086460|12552663|FG000|Treatment A|Study Participants||39
11355831|NCT03086460|12552663|FG000|Treatment B|Study Participants||35
11355832|NCT03086460|12552663|FG000|Treatment C|Study Participants||37
11355833|NCT03086460|12552663|FG000|Treatment D|Study Participants||40
11355834|NCT03086460|12552663|FG000|Treatment E|Study Participants||40
11355835|NCT03086460|12552663|FG000|Treatment F|Study Participants||41
11355836|NCT03086460|12552663|FG000|COMPLETED|Study Participants||58
11355837|NCT03086460|12552663|FG000|NOT COMPLETED|Study Participants||9
11355838|NCT03086460|12552663|FG000|STARTED|Treatment A||39
11355839|NCT03086460|12552663|FG000|COMPLETED|Treatment A||35
11355840|NCT03086460|12552663|FG000|NOT COMPLETED|Treatment A||4
11355841|NCT03086460|12552663|FG000|STARTED|Treatment B||35
11355842|NCT03086460|12552663|FG000|COMPLETED|Treatment B||35
11355843|NCT03086460|12552663|FG000|NOT COMPLETED|Treatment B||0
11355844|NCT03086460|12552663|FG000|STARTED|Treatment C||37
11355845|NCT03086460|12552663|FG000|COMPLETED|Treatment C||35
11355846|NCT03086460|12552663|FG000|NOT COMPLETED|Treatment C||2
11355847|NCT03086460|12552663|FG000|STARTED|Treatment D||40
11355848|NCT03086460|12552663|FG000|COMPLETED|Treatment D||40
11355849|NCT03086460|12552663|FG000|NOT COMPLETED|Treatment D||0
11355850|NCT03086460|12552663|FG000|STARTED|Treatment E||40
11355851|NCT03086460|12552663|FG000|COMPLETED|Treatment E||36
11355852|NCT03086460|12552663|FG000|NOT COMPLETED|Treatment E||4
11355853|NCT03086460|12552663|FG000|STARTED|Treatment F||41
11355854|NCT03086460|12552663|FG000|COMPLETED|Treatment F||41
11355855|NCT03086460|12552663|FG000|NOT COMPLETED|Treatment F||0
11355856|NCT03086551|12552680|FG000|STARTED|First Intervention||5
11355857|NCT03086551|12552681|FG001|STARTED|First Intervention||5
11355858|NCT03086551|12552680|FG000|COMPLETED|First Intervention||4
11355859|NCT03086551|12552681|FG001|COMPLETED|First Intervention||4
11355860|NCT03086551|12552680|FG000|NOT COMPLETED|First Intervention||1
11355861|NCT03086551|12552681|FG001|NOT COMPLETED|First Intervention||1
11355862|NCT03086551|12552680|FG000|STARTED|Washout||4
11355863|NCT03086551|12552681|FG001|STARTED|Washout||4
11355864|NCT03086551|12552680|FG000|COMPLETED|Washout||1
11355865|NCT03086551|12552681|FG001|COMPLETED|Washout||1
11355866|NCT03086551|12552680|FG000|NOT COMPLETED|Washout||3
11355867|NCT03086551|12552681|FG001|NOT COMPLETED|Washout||3
11355868|NCT03086551|12552680|FG000|STARTED|Second Intervention||1
11355869|NCT03086551|12552681|FG001|STARTED|Second Intervention||1
11355870|NCT03086551|12552680|FG000|COMPLETED|Second Intervention||1
11355871|NCT03086551|12552681|FG001|COMPLETED|Second Intervention||1
11355872|NCT03086551|12552680|FG000|NOT COMPLETED|Second Intervention||0
11355873|NCT03086551|12552681|FG001|NOT COMPLETED|Second Intervention||0
11355874|NCT03086707|12552689|FG000|STARTED|Overall Study||7
11355875|NCT03086707|12552690|FG001|STARTED|Overall Study||7
11355876|NCT03086707|12552689|FG000|COMPLETED|Overall Study||7
11355877|NCT03086707|12552690|FG001|COMPLETED|Overall Study||7
11355878|NCT03086707|12552689|FG000|NOT COMPLETED|Overall Study||0
11355879|NCT03086707|12552690|FG001|NOT COMPLETED|Overall Study||0
11355880|NCT03087513|12552698|FG000|STARTED|First Intervention||40
11355881|NCT03087513|12552698|FG000|COMPLETED|First Intervention||40
11355882|NCT03087513|12552698|FG000|NOT COMPLETED|First Intervention||0
11355883|NCT03087513|12552698|FG000|STARTED|Second Intervention After 3 hr Washout||40
11355884|NCT03087513|12552698|FG000|COMPLETED|Second Intervention After 3 hr Washout||38
11355885|NCT03087513|12552698|FG000|NOT COMPLETED|Second Intervention After 3 hr Washout||2
11355886|NCT03087604|12552713|FG000|STARTED|Overall Study||50
11355887|NCT03087604|12552714|FG001|STARTED|Overall Study||50
11355888|NCT03087604|12552713|FG000|COMPLETED|Overall Study||50
11355889|NCT03087604|12552714|FG001|COMPLETED|Overall Study||50
11355890|NCT03087604|12552713|FG000|NOT COMPLETED|Overall Study||0
11355891|NCT03087604|12552714|FG001|NOT COMPLETED|Overall Study||0
11355892|NCT03087643|12552722|FG000|STARTED|Overall Study||26
11355893|NCT03087643|12552723|FG001|STARTED|Overall Study||25
11355894|NCT03087643|12552722|FG000|COMPLETED|Overall Study||22
11355895|NCT03087643|12552723|FG001|COMPLETED|Overall Study||19
11355896|NCT03087643|12552722|FG000|NOT COMPLETED|Overall Study||4
11355897|NCT03087643|12552723|FG001|NOT COMPLETED|Overall Study||6
11355898|NCT03087786|12552731|FG000|STARTED|Overall Study||50
11355899|NCT03087786|12552732|FG001|STARTED|Overall Study||50
11355900|NCT03087786|12552731|FG000|COMPLETED|Overall Study||48
11355901|NCT03087786|12552732|FG001|COMPLETED|Overall Study||50
11355902|NCT03087786|12552731|FG000|NOT COMPLETED|Overall Study||2
11355903|NCT03087786|12552732|FG001|NOT COMPLETED|Overall Study||0
11355904|NCT03087851|12552741|FG000|STARTED|Overall Study||20
11355905|NCT03087851|12552742|FG001|STARTED|Overall Study||20
11355906|NCT03087851|12552743|FG002|STARTED|Overall Study||21
11355907|NCT03087851|12552741|FG000|COMPLETED|Overall Study||20
11355908|NCT03087851|12552742|FG001|COMPLETED|Overall Study||19
11355909|NCT03087851|12552743|FG002|COMPLETED|Overall Study||19
11355910|NCT03087851|12552741|FG000|NOT COMPLETED|Overall Study||0
11355911|NCT03087851|12552742|FG001|NOT COMPLETED|Overall Study||1
11355912|NCT03087851|12552743|FG002|NOT COMPLETED|Overall Study||2
11355913|NCT03088267|12552751|FG000|STARTED|Overall Study||9
11355914|NCT03088267|12552752|FG001|STARTED|Overall Study||9
11355915|NCT03088267|12552751|FG000|COMPLETED|Overall Study||9
11355916|NCT03088267|12552752|FG001|COMPLETED|Overall Study||9
11355917|NCT03088267|12552751|FG000|NOT COMPLETED|Overall Study||0
11355918|NCT03088267|12552752|FG001|NOT COMPLETED|Overall Study||0
11355919|NCT03088345|12552761|FG000|STARTED|Overall Study||10
11355920|NCT03088345|12552762|FG001|STARTED|Overall Study||10
11355921|NCT03088345|12552761|FG000|COMPLETED|Overall Study||10
11355922|NCT03088345|12552762|FG001|COMPLETED|Overall Study||10
11355923|NCT03088345|12552761|FG000|NOT COMPLETED|Overall Study||0
11355924|NCT03088345|12552762|FG001|NOT COMPLETED|Overall Study||0
11355925|NCT03088748|12552770|FG000|STARTED|Overall Study||40
11355926|NCT03088748|12552771|FG001|STARTED|Overall Study||10
11355927|NCT03088748|12552770|FG000|COMPLETED|Overall Study||40
11355928|NCT03088748|12552771|FG001|COMPLETED|Overall Study||10
11355929|NCT03088748|12552770|FG000|NOT COMPLETED|Overall Study||0
11355930|NCT03088748|12552771|FG001|NOT COMPLETED|Overall Study||0
11355931|NCT03088800|12552780|FG000|STARTED|Overall Study||30
11355932|NCT03088800|12552781|FG001|STARTED|Overall Study||30
11355933|NCT03088800|12552782|FG002|STARTED|Overall Study||30
11355934|NCT03088800|12552780|FG000|COMPLETED|Overall Study||30
11355935|NCT03088800|12552781|FG001|COMPLETED|Overall Study||30
11355936|NCT03088800|12552782|FG002|COMPLETED|Overall Study||30
11355937|NCT03088800|12552780|FG000|NOT COMPLETED|Overall Study||0
11355938|NCT03088800|12552781|FG001|NOT COMPLETED|Overall Study||0
11355939|NCT03088800|12552782|FG002|NOT COMPLETED|Overall Study||0
11355940|NCT03088917|12552790|FG000|STARTED|Overall Study||106
11355941|NCT03088917|12552790|FG000|COMPLETED|Overall Study||10
11355942|NCT03088917|12552790|FG000|NOT COMPLETED|Overall Study||96
11355943|NCT03089047|12552798|FG000|STARTED|Overall Study||2
11355944|NCT03089047|12552799|FG001|STARTED|Overall Study||2
11355945|NCT03089047|12552798|FG000|COMPLETED|Overall Study||1
11355946|NCT03089047|12552799|FG001|COMPLETED|Overall Study||2
11355947|NCT03089047|12552798|FG000|NOT COMPLETED|Overall Study||1
11355948|NCT03089047|12552799|FG001|NOT COMPLETED|Overall Study||0
11355949|NCT03089216|12552809|FG000|STARTED|Overall Study||27
11355950|NCT03089216|12552810|FG001|STARTED|Overall Study||27
11355951|NCT03089216|12552811|FG002|STARTED|Overall Study||27
11355952|NCT03089216|12552812|FG003|STARTED|Overall Study||27
11355953|NCT03089216|12552809|FG000|COMPLETED|Overall Study||27
11355954|NCT03089216|12552810|FG001|COMPLETED|Overall Study||27
11355955|NCT03089216|12552811|FG002|COMPLETED|Overall Study||27
11355956|NCT03089216|12552812|FG003|COMPLETED|Overall Study||26
11355957|NCT03089216|12552809|FG000|NOT COMPLETED|Overall Study||0
11355958|NCT03089216|12552810|FG001|NOT COMPLETED|Overall Study||0
11355959|NCT03089216|12552811|FG002|NOT COMPLETED|Overall Study||0
11355960|NCT03089216|12552812|FG003|NOT COMPLETED|Overall Study||1
11355961|NCT03089580|12552826|FG000|STARTED|Overall Study||14
11355962|NCT03089580|12552826|FG000|COMPLETED|Overall Study||12
11355963|NCT03089580|12552826|FG000|NOT COMPLETED|Overall Study||2
11355964|NCT03089697|12552834|FG000|STARTED|Overall Study||13
11355965|NCT03089697|12552835|FG001|STARTED|Overall Study||12
11355966|NCT03089697|12552834|FG000|COMPLETED|Overall Study||11
11355967|NCT03089697|12552835|FG001|COMPLETED|Overall Study||10
11355968|NCT03089697|12552834|FG000|NOT COMPLETED|Overall Study||2
11355969|NCT03089697|12552835|FG001|NOT COMPLETED|Overall Study||2
11355970|NCT03089879|12552844|FG000|STARTED|Overall Study||7
11355971|NCT03089879|12552845|FG001|STARTED|Overall Study||2
11355972|NCT03089879|12552846|FG002|STARTED|Overall Study||26
11355973|NCT03089879|12552844|FG000|COMPLETED|Overall Study||7
11355974|NCT03089879|12552845|FG001|COMPLETED|Overall Study||2
11355975|NCT03089879|12552846|FG002|COMPLETED|Overall Study||26
11355976|NCT03089879|12552844|FG000|NOT COMPLETED|Overall Study||0
11355977|NCT03089879|12552845|FG001|NOT COMPLETED|Overall Study||0
11355978|NCT03089879|12552846|FG002|NOT COMPLETED|Overall Study||0
11355979|NCT03089944|12552855|FG000|STARTED|Overall Study||343
11355980|NCT03089944|12552855|FG000|COMPLETED|Overall Study||331
11355981|NCT03089944|12552855|FG000|NOT COMPLETED|Overall Study||12
11355982|NCT03090100|12552861|FG000|STARTED|Overall Study||534
11355983|NCT03090100|12552862|FG001|STARTED|Overall Study||514
11355984|NCT03090100|12552861|FG000|Treated|Overall Study||534
11355985|NCT03090100|12552862|FG001|Treated|Overall Study||511
11355986|NCT03090100|12552861|FG000|COMPLETED|Overall Study||507
11355987|NCT03090100|12552862|FG001|COMPLETED|Overall Study||466
11355988|NCT03090100|12552861|FG000|NOT COMPLETED|Overall Study||27
11355989|NCT03090100|12552862|FG001|NOT COMPLETED|Overall Study||48
11355990|NCT03090256|12552868|FG000|STARTED|Overall Study||68
11355991|NCT03090256|12552868|FG000|COMPLETED|Overall Study||68
11355992|NCT03090256|12552868|FG000|NOT COMPLETED|Overall Study||0
11355993|NCT03090620|12552875|FG000|STARTED|Overall Study||9
11355994|NCT03090620|12552876|FG001|STARTED|Overall Study||10
11355995|NCT03090620|12552875|FG000|COMPLETED|Overall Study||9
11355996|NCT03090620|12552876|FG001|COMPLETED|Overall Study||10
11355997|NCT03090620|12552875|FG000|NOT COMPLETED|Overall Study||0
11355998|NCT03090620|12552876|FG001|NOT COMPLETED|Overall Study||0
11355999|NCT03090958|12552882|FG000|STARTED|Overall Study||20
11356000|NCT03090958|12552882|FG000|COMPLETED|Overall Study||20
11356001|NCT03090958|12552882|FG000|NOT COMPLETED|Overall Study||0
11356002|NCT03091179|12552888|FG000|STARTED|Overall Study||10
11356003|NCT03091179|12552889|FG001|STARTED|Overall Study||10
11356004|NCT03091179|12552888|FG000|COMPLETED|Overall Study||10
11356005|NCT03091179|12552889|FG001|COMPLETED|Overall Study||10
11356006|NCT03091179|12552888|FG000|NOT COMPLETED|Overall Study||0
11356007|NCT03091179|12552889|FG001|NOT COMPLETED|Overall Study||0
11356008|NCT03091348|12552897|FG000|STARTED|Overall Study||2
11356009|NCT03091348|12552898|FG001|STARTED|Overall Study||2
11356010|NCT03091348|12552897|FG000|COMPLETED|Overall Study||0
11356011|NCT03091348|12552898|FG001|COMPLETED|Overall Study||1
11356012|NCT03091348|12552897|FG000|NOT COMPLETED|Overall Study||2
11356013|NCT03091348|12552898|FG001|NOT COMPLETED|Overall Study||1
11356014|NCT03091361|12552905|FG000|STARTED|Overall Study||30
11356015|NCT03091361|12552905|FG000|COMPLETED|Overall Study||30
11356016|NCT03091361|12552905|FG000|NOT COMPLETED|Overall Study||0
11356017|NCT03091400|12552911|FG000|STARTED|Phase 1 - 6 Weeks||5
11356018|NCT03091400|12552912|FG001|STARTED|Phase 1 - 6 Weeks||6
11356019|NCT03091400|12552911|FG000|COMPLETED|Phase 1 - 6 Weeks||5
11356020|NCT03091400|12552912|FG001|COMPLETED|Phase 1 - 6 Weeks||6
11356021|NCT03091400|12552911|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||0
11356022|NCT03091400|12552912|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||0
11356023|NCT03091400|12552911|FG000|STARTED|Washout - 2 Weeks||5
11356024|NCT03091400|12552912|FG001|STARTED|Washout - 2 Weeks||6
11356025|NCT03091400|12552911|FG000|COMPLETED|Washout - 2 Weeks||4
11356026|NCT03091400|12552912|FG001|COMPLETED|Washout - 2 Weeks||6
11356027|NCT03091400|12552911|FG000|NOT COMPLETED|Washout - 2 Weeks||1
11356028|NCT03091400|12552912|FG001|NOT COMPLETED|Washout - 2 Weeks||0
11356029|NCT03091400|12552911|FG000|STARTED|Phase 2 - 6 Weeks||4
11356030|NCT03091400|12552912|FG001|STARTED|Phase 2 - 6 Weeks||6
11356031|NCT03091400|12552911|FG000|COMPLETED|Phase 2 - 6 Weeks||4
11356032|NCT03091400|12552912|FG001|COMPLETED|Phase 2 - 6 Weeks||6
11356033|NCT03091400|12552911|FG000|NOT COMPLETED|Phase 2 - 6 Weeks||0
11356034|NCT03091400|12552912|FG001|NOT COMPLETED|Phase 2 - 6 Weeks||0
11356035|NCT03091439|12552920|FG000|STARTED|Overall Study||1
11356036|NCT03091439|12552921|FG001|STARTED|Overall Study||0
11356037|NCT03091439|12552920|FG000|COMPLETED|Overall Study||0
11356038|NCT03091439|12552921|FG001|COMPLETED|Overall Study||0
10874550|NCT04927858|12040653|FG000|STARTED|Overall Study||460558
11356039|NCT03091439|12552920|FG000|NOT COMPLETED|Overall Study||1
11356040|NCT03091439|12552921|FG001|NOT COMPLETED|Overall Study||0
11356041|NCT03091478|12552927|FG000|STARTED|Overall Study||13
11356042|NCT03091478|12552927|FG000|COMPLETED|Overall Study||13
11356043|NCT03091478|12552927|FG000|NOT COMPLETED|Overall Study||0
11356044|NCT03091673|12552934|FG000|STARTED|First Dose||31
11356045|NCT03091673|12552935|FG001|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
11356046|NCT03091673|12552934|FG000|COMPLETED|First Dose||31
11356047|NCT03091673|12552935|FG001|COMPLETED|First Dose||0
11356048|NCT03091673|12552934|FG000|NOT COMPLETED|First Dose||0
11356049|NCT03091673|12552935|FG001|NOT COMPLETED|First Dose||0
11356050|NCT03091673|12552934|FG000|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
11356051|NCT03091673|12552935|FG001|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
11356052|NCT03091673|12552934|FG000|COMPLETED|Second Dose||0
11356053|NCT03091673|12552935|FG001|COMPLETED|Second Dose||11
11356054|NCT03091673|12552934|FG000|NOT COMPLETED|Second Dose||0
11356055|NCT03091673|12552935|FG001|NOT COMPLETED|Second Dose||0
11356056|NCT03091738|12552946|FG000|STARTED|Overall Study||10
11356057|NCT03091738|12552946|FG000|COMPLETED|Overall Study||8
11356058|NCT03091738|12552946|FG000|NOT COMPLETED|Overall Study||2
11356059|NCT03091751|12552950|FG000|STARTED|Overall Study||22
11356060|NCT03091751|12552950|FG000|COMPLETED|Overall Study||22
11356061|NCT03091751|12552950|FG000|NOT COMPLETED|Overall Study||0
11356062|NCT03091777|12552957|FG000|STARTED|Overall Study||289
11356063|NCT03091777|12552958|FG001|STARTED|Overall Study||288
11356064|NCT03091777|12552959|FG002|STARTED|Overall Study||294
11356065|NCT03091777|12552957|FG000|COMPLETED|Overall Study||257
11356066|NCT03091777|12552958|FG001|COMPLETED|Overall Study||255
11356067|NCT03091777|12552959|FG002|COMPLETED|Overall Study||257
11356068|NCT03091777|12552957|FG000|NOT COMPLETED|Overall Study||32
11356069|NCT03091777|12552958|FG001|NOT COMPLETED|Overall Study||33
11356070|NCT03091777|12552959|FG002|NOT COMPLETED|Overall Study||37
11356071|NCT03091920|12552970|FG000|STARTED|Overall Study||6
11356072|NCT03091920|12552971|FG001|STARTED|Overall Study||10
11356073|NCT03091920|12552972|FG002|STARTED|Overall Study||10
11356074|NCT03091920|12552970|FG000|COMPLETED|Overall Study||6
11356075|NCT03091920|12552971|FG001|COMPLETED|Overall Study||9
11356076|NCT03091920|12552972|FG002|COMPLETED|Overall Study||10
11356077|NCT03091920|12552970|FG000|NOT COMPLETED|Overall Study||0
11356078|NCT03091920|12552971|FG001|NOT COMPLETED|Overall Study||1
11356079|NCT03091920|12552972|FG002|NOT COMPLETED|Overall Study||0
11356080|NCT03092024|12552988|FG000|STARTED|Overall Study||24
11356081|NCT03092024|12552989|FG001|STARTED|Overall Study||16
11356082|NCT03092024|12552988|FG000|COMPLETED|Overall Study||24
11356083|NCT03092024|12552989|FG001|COMPLETED|Overall Study||16
11356084|NCT03092024|12552988|FG000|NOT COMPLETED|Overall Study||0
11356085|NCT03092024|12552989|FG001|NOT COMPLETED|Overall Study||0
11356086|NCT03092089|12552995|FG000|STARTED|Overall Study||15
11356087|NCT03092089|12552995|FG000|COMPLETED|Overall Study||15
11356088|NCT03092089|12552995|FG000|NOT COMPLETED|Overall Study||0
11356089|NCT03092375|12553003|FG000|STARTED|Overall Study||78
11356090|NCT03092375|12553004|FG001|STARTED|Overall Study||49
11356091|NCT03092375|12553005|FG002|STARTED|Overall Study||21
11356092|NCT03092375|12553006|FG003|STARTED|Overall Study||29
11356093|NCT03092375|12553003|FG000|COMPLETED|Overall Study||78
11356094|NCT03092375|12553004|FG001|COMPLETED|Overall Study||48
11356095|NCT03092375|12553005|FG002|COMPLETED|Overall Study||20
11356096|NCT03092375|12553006|FG003|COMPLETED|Overall Study||29
11356097|NCT03092375|12553003|FG000|NOT COMPLETED|Overall Study||0
11356098|NCT03092375|12553004|FG001|NOT COMPLETED|Overall Study||1
11356099|NCT03092375|12553005|FG002|NOT COMPLETED|Overall Study||1
11356100|NCT03092375|12553006|FG003|NOT COMPLETED|Overall Study||0
11356101|NCT03092479|12553025|FG000|STARTED|Overall Study||24
11356102|NCT03092479|12553026|FG001|STARTED|Overall Study||26
11356103|NCT03092479|12553025|FG000|COMPLETED|Overall Study||17
11356104|NCT03092479|12553026|FG001|COMPLETED|Overall Study||24
11356105|NCT03092479|12553025|FG000|NOT COMPLETED|Overall Study||7
11356106|NCT03092479|12553026|FG001|NOT COMPLETED|Overall Study||2
11356107|NCT03092726|12553034|FG000|STARTED|Overall Study||88
11356108|NCT03092726|12553035|FG001|STARTED|Overall Study||95
11356109|NCT03092726|12553034|FG000|Treated|Overall Study||88
11356110|NCT03092726|12553035|FG001|Treated|Overall Study||95
11356111|NCT03092726|12553034|FG000|COMPLETED|Overall Study||79
11356112|NCT03092726|12553035|FG001|COMPLETED|Overall Study||81
11356113|NCT03092726|12553034|FG000|NOT COMPLETED|Overall Study||9
11356114|NCT03092726|12553035|FG001|NOT COMPLETED|Overall Study||14
11356115|NCT03092752|12553041|FG000|STARTED|Overall Study||523585
11356116|NCT03092752|12553041|FG000|COMPLETED|Overall Study||162116
11356117|NCT03092752|12553041|FG000|NOT COMPLETED|Overall Study||361469
11356118|NCT03092791|12553070|FG000|STARTED|Overall Study||20
11356119|NCT03092791|12553071|FG001|STARTED|Overall Study||20
11356120|NCT03092791|12553072|FG002|STARTED|Overall Study||30
10874551|NCT04927858|12040653|FG000|Treated With Empagliflozin|Overall Study||16985
10874552|NCT04927858|12040653|FG000|COMPLETED|Overall Study||460558
10874553|NCT04927858|12040653|FG000|NOT COMPLETED|Overall Study||0
10874554|NCT04919161|12040660|FG000|STARTED|Overall Study||16
10874555|NCT04919161|12040661|FG001|STARTED|Overall Study||16
10874556|NCT04919161|12040660|FG000|COMPLETED|Overall Study||15
10874557|NCT04919161|12040661|FG001|COMPLETED|Overall Study||14
10874558|NCT04919161|12040660|FG000|NOT COMPLETED|Overall Study||1
10874559|NCT04919161|12040661|FG001|NOT COMPLETED|Overall Study||2
10874560|NCT04912700|12040692|FG000|STARTED|Overall Study||10880
10874561|NCT04912700|12040693|FG001|STARTED|Overall Study||825
10874562|NCT04912700|12040694|FG002|STARTED|Overall Study||129
10874563|NCT04912700|12040692|FG000|COMPLETED|Overall Study||10880
10874564|NCT04912700|12040693|FG001|COMPLETED|Overall Study||825
10874565|NCT04912700|12040694|FG002|COMPLETED|Overall Study||129
10874566|NCT04912700|12040692|FG000|NOT COMPLETED|Overall Study||0
10874567|NCT04912700|12040693|FG001|NOT COMPLETED|Overall Study||0
10874568|NCT04912700|12040694|FG002|NOT COMPLETED|Overall Study||0
11113277|NCT01292603|12297515|FG001|COMPLETED|Part 1: Pilot Dose Selection Period||17
11113278|NCT01292603|12297516|FG002|COMPLETED|Part 1: Pilot Dose Selection Period||23
11113279|NCT01292603|12297517|FG003|COMPLETED|Part 1: Pilot Dose Selection Period||0
11113280|NCT01292603|12297518|FG004|COMPLETED|Part 1: Pilot Dose Selection Period||0
11113281|NCT01292603|12297519|FG005|COMPLETED|Part 1: Pilot Dose Selection Period||0
11113282|NCT01292603|12297514|FG000|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
11113283|NCT01292603|12297515|FG001|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
11113284|NCT01292603|12297516|FG002|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
11113285|NCT01292603|12297517|FG003|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
11113286|NCT01292603|12297518|FG004|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
11113287|NCT01292603|12297519|FG005|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
11113288|NCT01292603|12297514|FG000|STARTED|Part 1: Regular Follow-Up Period||16
11113289|NCT01292603|12297515|FG001|STARTED|Part 1: Regular Follow-Up Period||17
11113290|NCT01292603|12297516|FG002|STARTED|Part 1: Regular Follow-Up Period||23
11113291|NCT01292603|12297517|FG003|STARTED|Part 1: Regular Follow-Up Period||8
11113292|NCT01292603|12297518|FG004|STARTED|Part 1: Regular Follow-Up Period||0
11113293|NCT01292603|12297519|FG005|STARTED|Part 1: Regular Follow-Up Period||0
11113294|NCT01292603|12297514|FG000|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
11113295|NCT01292603|12297515|FG001|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
11113296|NCT01292603|12297516|FG002|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
11113297|NCT01292603|12297517|FG003|COMPLETED|Part 1: Regular Follow-Up Period||7
11113298|NCT01292603|12297518|FG004|COMPLETED|Part 1: Regular Follow-Up Period||0
11113299|NCT01292603|12297519|FG005|COMPLETED|Part 1: Regular Follow-Up Period||0
10874569|NCT04912297|12040704|FG000|STARTED|Overall Study||99
10874570|NCT04912297|12040705|FG001|STARTED|Overall Study||87
10874571|NCT04912297|12040704|FG000|COMPLETED|Overall Study||68
10874572|NCT04912297|12040705|FG001|COMPLETED|Overall Study||54
10874573|NCT04912297|12040704|FG000|NOT COMPLETED|Overall Study||31
10874574|NCT04912297|12040705|FG001|NOT COMPLETED|Overall Study||33
10874581|NCT04904640|12040720|FG000|STARTED|Overall Study||150
10874582|NCT04904640|12040720|FG000|COMPLETED|Overall Study||150
10874583|NCT04904640|12040720|FG000|NOT COMPLETED|Overall Study||0
11113300|NCT01292603|12297514|FG000|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
10874575|NCT04910165|12040713|FG000|STARTED|Overall Study||50
10874576|NCT04910165|12040714|FG001|STARTED|Overall Study||50
10874577|NCT04910165|12040713|FG000|COMPLETED|Overall Study||50
10874578|NCT04910165|12040714|FG001|COMPLETED|Overall Study||50
10874579|NCT04910165|12040713|FG000|NOT COMPLETED|Overall Study||0
10874580|NCT04910165|12040714|FG001|NOT COMPLETED|Overall Study||0
10874584|NCT04901897|12040731|FG000|STARTED|Overall Study||398
10874585|NCT04901897|12040732|FG001|STARTED|Overall Study||202
10874586|NCT04901897|12040733|FG002|STARTED|Overall Study||205
10874587|NCT04901897|12040731|FG000|COMPLETED|Overall Study||393
10874588|NCT04901897|12040732|FG001|COMPLETED|Overall Study||200
10874589|NCT04901897|12040733|FG002|COMPLETED|Overall Study||203
10874590|NCT04901897|12040731|FG000|NOT COMPLETED|Overall Study||5
10874591|NCT04901897|12040732|FG001|NOT COMPLETED|Overall Study||2
10874592|NCT04901897|12040733|FG002|NOT COMPLETED|Overall Study||2
11113301|NCT01292603|12297515|FG001|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
11113302|NCT01292603|12297516|FG002|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
11232364|NCT02036515|12424536|FG002|Treated|Overall Study||153
11113303|NCT01292603|12297517|FG003|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
11113304|NCT01292603|12297518|FG004|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
11113305|NCT01292603|12297519|FG005|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
11113306|NCT01292603|12297514|FG000|STARTED|Part 2: Dose Confirmation Period||0
11113307|NCT01292603|12297515|FG001|STARTED|Part 2: Dose Confirmation Period||0
10874593|NCT04891874|12040743|FG000|STARTED|Overall Study|Participants in this period were recruited from August 1, 2015 to December 31, 2016.|38
10874594|NCT04891874|12040744|FG001|STARTED|Overall Study||38
10874595|NCT04891874|12040743|FG000|COMPLETED|Overall Study||38
10874596|NCT04891874|12040744|FG001|COMPLETED|Overall Study||38
10874597|NCT04891874|12040743|FG000|NOT COMPLETED|Overall Study||0
10874598|NCT04891874|12040744|FG001|NOT COMPLETED|Overall Study||0
10874599|NCT04883541|12040752|FG000|STARTED|Overall Study||46
10874600|NCT04883541|12040753|FG001|STARTED|Overall Study||69
10874601|NCT04883541|12040752|FG000|COMPLETED|Overall Study||30
10874602|NCT04883541|12040753|FG001|COMPLETED|Overall Study||60
10874603|NCT04883541|12040752|FG000|NOT COMPLETED|Overall Study||16
10874604|NCT04883541|12040753|FG001|NOT COMPLETED|Overall Study||9
10874605|NCT04881968|12040759|FG000|STARTED|Overall Study||1261
10874606|NCT04881968|12040759|FG000|COMPLETED|Overall Study||1261
10874607|NCT04881968|12040759|FG000|NOT COMPLETED|Overall Study||0
10874608|NCT04486560|12040763|FG000|STARTED|Overall Study||51
10874609|NCT04486560|12040763|FG000|COMPLETED|Overall Study||50
10874610|NCT04486560|12040763|FG000|NOT COMPLETED|Overall Study||1
10874611|NCT04357782|12040769|FG000|STARTED|Overall Study||10
10874612|NCT04357782|12040770|FG001|STARTED|Overall Study||10
10874613|NCT04357782|12040769|FG000|COMPLETED|Overall Study||9
10874614|NCT04357782|12040770|FG001|COMPLETED|Overall Study||8
10874615|NCT04357782|12040769|FG000|NOT COMPLETED|Overall Study||1
10874616|NCT04357782|12040770|FG001|NOT COMPLETED|Overall Study||2
10874617|NCT04090658|12040778|FG000|STARTED|Overall Study||20
11113308|NCT01292603|12297516|FG002|STARTED|Part 2: Dose Confirmation Period||0
11113309|NCT01292603|12297517|FG003|STARTED|Part 2: Dose Confirmation Period||0
11113310|NCT01292603|12297518|FG004|STARTED|Part 2: Dose Confirmation Period||88
11113311|NCT01292603|12297519|FG005|STARTED|Part 2: Dose Confirmation Period||88
11113312|NCT01292603|12297514|FG000|COMPLETED|Part 2: Dose Confirmation Period||0
10874618|NCT04090658|12040779|FG001|STARTED|Overall Study||20
10874619|NCT04090658|12040778|FG000|COMPLETED|Overall Study||20
10874620|NCT04090658|12040779|FG001|COMPLETED|Overall Study||20
10874621|NCT04090658|12040778|FG000|NOT COMPLETED|Overall Study||0
10874622|NCT04090658|12040779|FG001|NOT COMPLETED|Overall Study||0
11113313|NCT01292603|12297515|FG001|COMPLETED|Part 2: Dose Confirmation Period||0
11113314|NCT01292603|12297516|FG002|COMPLETED|Part 2: Dose Confirmation Period||0
11113315|NCT01292603|12297517|FG003|COMPLETED|Part 2: Dose Confirmation Period||0
11113316|NCT01292603|12297518|FG004|COMPLETED|Part 2: Dose Confirmation Period||72
11232365|NCT02036515|12424534|FG000|COMPLETED|Overall Study||151
11232366|NCT02036515|12424535|FG001|COMPLETED|Overall Study||143
11232367|NCT02036515|12424536|FG002|COMPLETED|Overall Study||139
11232368|NCT02036515|12424534|FG000|NOT COMPLETED|Overall Study||5
11232369|NCT02036515|12424535|FG001|NOT COMPLETED|Overall Study||12
11232370|NCT02036515|12424536|FG002|NOT COMPLETED|Overall Study||14
10874623|NCT03811028|12040787|FG000|STARTED|Overall Study||3
10874624|NCT03811028|12040788|FG001|STARTED|Overall Study||3
10874625|NCT03811028|12040787|FG000|COMPLETED|Overall Study||3
10874626|NCT03811028|12040788|FG001|COMPLETED|Overall Study||3
10874627|NCT03811028|12040787|FG000|NOT COMPLETED|Overall Study||0
10874628|NCT03811028|12040788|FG001|NOT COMPLETED|Overall Study||0
10874629|NCT03760068|12040797|FG000|STARTED|Overall Study||238
10874630|NCT03760068|12040798|FG001|STARTED|Overall Study||240
10874631|NCT03760068|12040797|FG000|COMPLETED|Overall Study||224
10874632|NCT03760068|12040798|FG001|COMPLETED|Overall Study||217
10874633|NCT03760068|12040797|FG000|NOT COMPLETED|Overall Study||14
10874634|NCT03760068|12040798|FG001|NOT COMPLETED|Overall Study||23
10874635|NCT03742986|12040807|FG000|STARTED|Overall Study||4
10874636|NCT03742986|12040808|FG001|STARTED|Overall Study||4
10874637|NCT03742986|12040807|FG000|COMPLETED|Overall Study||4
10874638|NCT03742986|12040808|FG001|COMPLETED|Overall Study||4
10874639|NCT03742986|12040807|FG000|NOT COMPLETED|Overall Study||0
11232371|NCT02036541|12424544|FG000|STARTED|Overall Study||65
11232372|NCT02036541|12424544|FG000|Completed Endpoint Visit|Overall Study||54
10874640|NCT03742986|12040808|FG001|NOT COMPLETED|Overall Study||0
10874641|NCT03628781|12040816|FG000|STARTED|Overall Study||85
10874642|NCT03628781|12040817|FG001|STARTED|Overall Study||84
11113317|NCT01292603|12297519|FG005|COMPLETED|Part 2: Dose Confirmation Period||73
11113318|NCT01292603|12297514|FG000|NOT COMPLETED|Part 2: Dose Confirmation Period||0
11113319|NCT01292603|12297515|FG001|NOT COMPLETED|Part 2: Dose Confirmation Period||0
11113320|NCT01292603|12297516|FG002|NOT COMPLETED|Part 2: Dose Confirmation Period||0
11113321|NCT01292603|12297517|FG003|NOT COMPLETED|Part 2: Dose Confirmation Period||0
11113322|NCT01292603|12297518|FG004|NOT COMPLETED|Part 2: Dose Confirmation Period||16
11113323|NCT01292603|12297519|FG005|NOT COMPLETED|Part 2: Dose Confirmation Period||15
11113324|NCT01292603|12297514|FG000|STARTED|Part 2: Regular Follow-Up||0
11113325|NCT01292603|12297515|FG001|STARTED|Part 2: Regular Follow-Up||0
11113326|NCT01292603|12297516|FG002|STARTED|Part 2: Regular Follow-Up||0
11113327|NCT01292603|12297517|FG003|STARTED|Part 2: Regular Follow-Up||0
11113328|NCT01292603|12297518|FG004|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
11113329|NCT01292603|12297519|FG005|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
11113330|NCT01292603|12297514|FG000|COMPLETED|Part 2: Regular Follow-Up||0
11113331|NCT01292603|12297515|FG001|COMPLETED|Part 2: Regular Follow-Up||0
11113332|NCT01292603|12297516|FG002|COMPLETED|Part 2: Regular Follow-Up||0
11113333|NCT01292603|12297517|FG003|COMPLETED|Part 2: Regular Follow-Up||0
11113334|NCT01292603|12297518|FG004|COMPLETED|Part 2: Regular Follow-Up||68
11113335|NCT01292603|12297519|FG005|COMPLETED|Part 2: Regular Follow-Up||75
11113336|NCT01292603|12297514|FG000|NOT COMPLETED|Part 2: Regular Follow-Up||0
11113337|NCT01292603|12297515|FG001|NOT COMPLETED|Part 2: Regular Follow-Up||0
11113338|NCT01292603|12297516|FG002|NOT COMPLETED|Part 2: Regular Follow-Up||0
11113339|NCT01292603|12297517|FG003|NOT COMPLETED|Part 2: Regular Follow-Up||0
11113340|NCT01292603|12297518|FG004|NOT COMPLETED|Part 2: Regular Follow-Up||19
11113341|NCT01292603|12297519|FG005|NOT COMPLETED|Part 2: Regular Follow-Up||12
11113342|NCT01292603|12297514|FG000|STARTED|Overall Survival Status||16
11113343|NCT01292603|12297515|FG001|STARTED|Overall Survival Status||17
11113344|NCT01292603|12297516|FG002|STARTED|Overall Survival Status||23
11113345|NCT01292603|12297517|FG003|STARTED|Overall Survival Status||8
11113346|NCT01292603|12297518|FG004|STARTED|Overall Survival Status||88
11113347|NCT01292603|12297519|FG005|STARTED|Overall Survival Status||88
11113348|NCT01292603|12297514|FG000|COMPLETED|Overall Survival Status||13
11113349|NCT01292603|12297515|FG001|COMPLETED|Overall Survival Status||16
11113350|NCT01292603|12297516|FG002|COMPLETED|Overall Survival Status||20
11113351|NCT01292603|12297517|FG003|COMPLETED|Overall Survival Status||7
11113352|NCT01292603|12297518|FG004|COMPLETED|Overall Survival Status||72
11113353|NCT01292603|12297519|FG005|COMPLETED|Overall Survival Status||78
11113354|NCT01292603|12297514|FG000|NOT COMPLETED|Overall Survival Status||3
11113355|NCT01292603|12297515|FG001|NOT COMPLETED|Overall Survival Status||1
11113356|NCT01292603|12297516|FG002|NOT COMPLETED|Overall Survival Status||3
11113357|NCT01292603|12297517|FG003|NOT COMPLETED|Overall Survival Status||1
11113358|NCT01292603|12297518|FG004|NOT COMPLETED|Overall Survival Status||16
11113359|NCT01292603|12297519|FG005|NOT COMPLETED|Overall Survival Status||10
11113360|NCT01292629|12297540|FG000|STARTED|Overall Study||125
11113361|NCT01292629|12297540|FG000|COMPLETED|Overall Study||125
11113362|NCT01292629|12297540|FG000|NOT COMPLETED|Overall Study||0
11113363|NCT01292642|12297545|FG000|STARTED|Overall Study||12
11113364|NCT01292642|12297545|FG000|COMPLETED|Overall Study||7
11113365|NCT01292642|12297545|FG000|NOT COMPLETED|Overall Study||5
11113366|NCT01292746|12297553|FG000|STARTED|Overall Study||14
11113367|NCT01292746|12297553|FG000|COMPLETED|Overall Study||14
11113368|NCT01292746|12297553|FG000|NOT COMPLETED|Overall Study||0
11113369|NCT01292798|12297557|FG000|STARTED|Overall Study||43
11113370|NCT01292798|12297557|FG000|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
11113371|NCT01292798|12297557|FG000|COMPLETED|Overall Study||43
11113372|NCT01292798|12297557|FG000|NOT COMPLETED|Overall Study||0
11113373|NCT01292837|12297561|FG000|STARTED|Overall Study||13
11113374|NCT01292837|12297561|FG000|COMPLETED|Overall Study||11
11113375|NCT01292837|12297561|FG000|NOT COMPLETED|Overall Study||2
11113376|NCT01292876|12297565|FG000|STARTED|Overall Study||17
11113377|NCT01292876|12297565|FG000|COMPLETED|Overall Study||13
11113378|NCT01292876|12297565|FG000|NOT COMPLETED|Overall Study||4
11113379|NCT01292928|12297571|FG000|STARTED|Overall Study||299
11113380|NCT01292928|12297571|FG000|Completed 12-Month Clinical Follow-up|Overall Study||266
11113381|NCT01292928|12297571|FG000|COMPLETED|Overall Study||275
11113382|NCT01292928|12297571|FG000|NOT COMPLETED|Overall Study||24
11113383|NCT01293006|12297581|FG000|STARTED|Period 1||11
11113384|NCT01293006|12297582|FG001|STARTED|Period 1||2
11113385|NCT01293006|12297583|FG002|STARTED|Period 1||9
11113386|NCT01293006|12297584|FG003|STARTED|Period 1||3
11113387|NCT01293006|12297581|FG000|COMPLETED|Period 1||11
11113388|NCT01293006|12297582|FG001|COMPLETED|Period 1||2
11113389|NCT01293006|12297583|FG002|COMPLETED|Period 1||9
10874643|NCT03628781|12040816|FG000|6-month Timepoint|Overall Study||63
11113390|NCT01293006|12297584|FG003|COMPLETED|Period 1||3
11113391|NCT01293006|12297581|FG000|NOT COMPLETED|Period 1||0
11113392|NCT01293006|12297582|FG001|NOT COMPLETED|Period 1||0
11113393|NCT01293006|12297583|FG002|NOT COMPLETED|Period 1||0
11113394|NCT01293006|12297584|FG003|NOT COMPLETED|Period 1||0
11113395|NCT01293006|12297581|FG000|STARTED|Washout||11
11113396|NCT01293006|12297582|FG001|STARTED|Washout||2
11113397|NCT01293006|12297583|FG002|STARTED|Washout||9
11113398|NCT01293006|12297584|FG003|STARTED|Washout||3
11113399|NCT01293006|12297581|FG000|COMPLETED|Washout||11
11113400|NCT01293006|12297582|FG001|COMPLETED|Washout||2
11113401|NCT01293006|12297583|FG002|COMPLETED|Washout||9
10874644|NCT03628781|12040817|FG001|6-month Timepoint|Overall Study||79
10874645|NCT03628781|12040816|FG000|12-month Timepoint|Overall Study||53
10874646|NCT03628781|12040817|FG001|12-month Timepoint|Overall Study||75
10874647|NCT03628781|12040816|FG000|COMPLETED|Overall Study||53
10874648|NCT03628781|12040817|FG001|COMPLETED|Overall Study||75
10874649|NCT03628781|12040816|FG000|NOT COMPLETED|Overall Study||32
10874650|NCT03628781|12040817|FG001|NOT COMPLETED|Overall Study||9
10874651|NCT03560206|12040825|FG000|STARTED|Overall Study||158
10874652|NCT03560206|12040826|FG001|STARTED|Overall Study||158
10874653|NCT03560206|12040825|FG000|COMPLETED|Overall Study||108
10874654|NCT03560206|12040826|FG001|COMPLETED|Overall Study||140
10874655|NCT03560206|12040825|FG000|NOT COMPLETED|Overall Study||50
10874656|NCT03560206|12040826|FG001|NOT COMPLETED|Overall Study||18
10874657|NCT03340766|12040835|FG000|STARTED|Overall Study||12
10874658|NCT03340766|12040836|FG001|STARTED|Overall Study||10
10874659|NCT03340766|12040837|FG002|STARTED|Overall Study||9
10874660|NCT03340766|12040835|FG000|Received Blinatumomab|Overall Study||12
10874661|NCT03340766|12040836|FG001|Received Blinatumomab|Overall Study||10
11113402|NCT01293006|12297584|FG003|COMPLETED|Washout||3
10874662|NCT03340766|12040837|FG002|Received Blinatumomab|Overall Study||9
10874663|NCT03340766|12040835|FG000|Received Pembrolizumab|Overall Study||10
10874664|NCT03340766|12040836|FG001|Received Pembrolizumab|Overall Study||7
10874665|NCT03340766|12040837|FG002|Received Pembrolizumab|Overall Study||7
10874666|NCT03340766|12040835|FG000|COMPLETED|Overall Study||1
10874667|NCT03340766|12040836|FG001|COMPLETED|Overall Study||0
10874668|NCT03340766|12040837|FG002|COMPLETED|Overall Study||0
10874669|NCT03340766|12040835|FG000|NOT COMPLETED|Overall Study||11
10874670|NCT03340766|12040836|FG001|NOT COMPLETED|Overall Study||10
10874671|NCT03340766|12040837|FG002|NOT COMPLETED|Overall Study||9
11113403|NCT01293006|12297581|FG000|NOT COMPLETED|Washout||0
11113404|NCT01293006|12297582|FG001|NOT COMPLETED|Washout||0
11113405|NCT01293006|12297583|FG002|NOT COMPLETED|Washout||0
11113406|NCT01293006|12297584|FG003|NOT COMPLETED|Washout||0
11113407|NCT01293006|12297581|FG000|STARTED|Period 2||11
11113408|NCT01293006|12297582|FG001|STARTED|Period 2||2
11113409|NCT01293006|12297583|FG002|STARTED|Period 2||9
11113410|NCT01293006|12297584|FG003|STARTED|Period 2||3
11113411|NCT01293006|12297581|FG000|COMPLETED|Period 2||10
11113412|NCT01293006|12297582|FG001|COMPLETED|Period 2||2
11113413|NCT01293006|12297583|FG002|COMPLETED|Period 2||9
11113414|NCT01293006|12297584|FG003|COMPLETED|Period 2||3
11113415|NCT01293006|12297581|FG000|NOT COMPLETED|Period 2||1
11113416|NCT01293006|12297582|FG001|NOT COMPLETED|Period 2||0
11113417|NCT01293006|12297583|FG002|NOT COMPLETED|Period 2||0
11113418|NCT01293006|12297584|FG003|NOT COMPLETED|Period 2||0
11113419|NCT01293032|12297603|FG000|STARTED|Recurrence Score(RS)Assigned/Randomized||12
11113420|NCT01293032|12297604|FG001|STARTED|Recurrence Score(RS)Assigned/Randomized||17
11113421|NCT01293032|12297605|FG002|STARTED|Recurrence Score(RS)Assigned/Randomized||16
11113422|NCT01293032|12297606|FG003|STARTED|Recurrence Score(RS)Assigned/Randomized||14
11113423|NCT01293032|12297603|FG000|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
11113424|NCT01293032|12297604|FG001|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
11113425|NCT01293032|12297605|FG002|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
11113426|NCT01293032|12297606|FG003|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
11113427|NCT01293032|12297603|FG000|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
11113428|NCT01293032|12297604|FG001|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
11113429|NCT01293032|12297605|FG002|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
11113430|NCT01293032|12297606|FG003|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
11113431|NCT01293032|12297603|FG000|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
11113432|NCT01293032|12297604|FG001|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
10874675|NCT02706847|12040858|FG000|STARTED|Day 1 to Week 12||85
10874676|NCT02706847|12040859|FG001|STARTED|Day 1 to Week 12||84
10874677|NCT02706847|12040860|FG002|STARTED|Day 1 to Week 12||165
11113433|NCT01293032|12297605|FG002|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
10874678|NCT02706847|12040861|FG003|STARTED|Day 1 to Week 12||165
10874679|NCT02706847|12040858|FG000|Received Study Treatment|Day 1 to Week 12||85
10874680|NCT02706847|12040859|FG001|Received Study Treatment|Day 1 to Week 12||84
10874681|NCT02706847|12040860|FG002|Received Study Treatment|Day 1 to Week 12||164
10874682|NCT02706847|12040861|FG003|Received Study Treatment|Day 1 to Week 12||165
10874683|NCT02706847|12040858|FG000|COMPLETED|Day 1 to Week 12||75
10874684|NCT02706847|12040859|FG001|COMPLETED|Day 1 to Week 12||76
10874685|NCT02706847|12040860|FG002|COMPLETED|Day 1 to Week 12||157
10874686|NCT02706847|12040861|FG003|COMPLETED|Day 1 to Week 12||149
10874687|NCT02706847|12040858|FG000|NOT COMPLETED|Day 1 to Week 12||10
10874688|NCT02706847|12040859|FG001|NOT COMPLETED|Day 1 to Week 12||8
10874689|NCT02706847|12040860|FG002|NOT COMPLETED|Day 1 to Week 12||8
10874690|NCT02706847|12040861|FG003|NOT COMPLETED|Day 1 to Week 12||16
10874691|NCT02706847|12040858|FG000|STARTED|Week 12 to Week 24||75
10874692|NCT02706847|12040859|FG001|STARTED|Week 12 to Week 24||76
10874693|NCT02706847|12040860|FG002|STARTED|Week 12 to Week 24||157
10874694|NCT02706847|12040861|FG003|STARTED|Week 12 to Week 24||149
10874695|NCT02706847|12040858|FG000|Received Study Treatment|Week 12 to Week 24||72
10874696|NCT02706847|12040859|FG001|Received Study Treatment|Week 12 to Week 24||75
10874697|NCT02706847|12040860|FG002|Received Study Treatment|Week 12 to Week 24||156
10874698|NCT02706847|12040861|FG003|Received Study Treatment|Week 12 to Week 24||148
10874699|NCT02706847|12040858|FG000|COMPLETED|Week 12 to Week 24||72
10874700|NCT02706847|12040859|FG001|COMPLETED|Week 12 to Week 24||74
10874701|NCT02706847|12040860|FG002|COMPLETED|Week 12 to Week 24||153
10874702|NCT02706847|12040861|FG003|COMPLETED|Week 12 to Week 24||135
10874703|NCT02706847|12040858|FG000|NOT COMPLETED|Week 12 to Week 24||3
10874704|NCT02706847|12040859|FG001|NOT COMPLETED|Week 12 to Week 24||2
10874705|NCT02706847|12040860|FG002|NOT COMPLETED|Week 12 to Week 24||4
10874706|NCT02706847|12040861|FG003|NOT COMPLETED|Week 12 to Week 24||14
10874707|NCT02564900|12040886|FG000|STARTED|Dose Escalation||3
10874708|NCT02564900|12040887|FG001|STARTED|Dose Escalation||3
10874709|NCT02564900|12040888|FG002|STARTED|Dose Escalation||3
10874710|NCT02564900|12040889|FG003|STARTED|Dose Escalation||6
10874711|NCT02564900|12040890|FG004|STARTED|Dose Escalation||6
10874712|NCT02564900|12040891|FG005|STARTED|Dose Escalation||6
10874713|NCT02564900|12040892|FG006|STARTED|Dose Escalation||0
10874714|NCT02564900|12040893|FG007|STARTED|Dose Escalation||0
10874715|NCT02564900|12040894|FG008|STARTED|Dose Escalation||0
10874716|NCT02564900|12040895|FG009|STARTED|Dose Escalation||0
10874717|NCT02564900|12040896|FG010|STARTED|Dose Escalation||0
10874718|NCT02564900|12040897|FG011|STARTED|Dose Escalation||0
10874719|NCT02564900|12040898|FG012|STARTED|Dose Escalation||0
10874720|NCT02564900|12040899|FG013|STARTED|Dose Escalation||0
10874721|NCT02564900|12040900|FG014|STARTED|Dose Escalation||0
10874722|NCT02564900|12040886|FG000|COMPLETED|Dose Escalation||0
10874723|NCT02564900|12040887|FG001|COMPLETED|Dose Escalation||0
10874724|NCT02564900|12040888|FG002|COMPLETED|Dose Escalation||0
10874725|NCT02564900|12040889|FG003|COMPLETED|Dose Escalation||0
10874726|NCT02564900|12040890|FG004|COMPLETED|Dose Escalation||0
10874727|NCT02564900|12040891|FG005|COMPLETED|Dose Escalation||0
10874728|NCT02564900|12040892|FG006|COMPLETED|Dose Escalation||0
10874729|NCT02564900|12040893|FG007|COMPLETED|Dose Escalation||0
10874730|NCT02564900|12040894|FG008|COMPLETED|Dose Escalation||0
10874731|NCT02564900|12040895|FG009|COMPLETED|Dose Escalation||0
10874732|NCT02564900|12040896|FG010|COMPLETED|Dose Escalation||0
10874733|NCT02564900|12040897|FG011|COMPLETED|Dose Escalation||0
10874734|NCT02564900|12040898|FG012|COMPLETED|Dose Escalation||0
10874735|NCT02564900|12040899|FG013|COMPLETED|Dose Escalation||0
10874736|NCT02564900|12040900|FG014|COMPLETED|Dose Escalation||0
10874737|NCT02564900|12040886|FG000|NOT COMPLETED|Dose Escalation||3
10874738|NCT02564900|12040887|FG001|NOT COMPLETED|Dose Escalation||3
10874739|NCT02564900|12040888|FG002|NOT COMPLETED|Dose Escalation||3
10874740|NCT02564900|12040889|FG003|NOT COMPLETED|Dose Escalation||6
10874741|NCT02564900|12040890|FG004|NOT COMPLETED|Dose Escalation||6
10874742|NCT02564900|12040891|FG005|NOT COMPLETED|Dose Escalation||6
10874743|NCT02564900|12040892|FG006|NOT COMPLETED|Dose Escalation||0
10874744|NCT02564900|12040893|FG007|NOT COMPLETED|Dose Escalation||0
10874745|NCT02564900|12040894|FG008|NOT COMPLETED|Dose Escalation||0
10874746|NCT02564900|12040895|FG009|NOT COMPLETED|Dose Escalation||0
10874747|NCT02564900|12040896|FG010|NOT COMPLETED|Dose Escalation||0
10874748|NCT02564900|12040897|FG011|NOT COMPLETED|Dose Escalation||0
10874749|NCT02564900|12040898|FG012|NOT COMPLETED|Dose Escalation||0
10874750|NCT02564900|12040899|FG013|NOT COMPLETED|Dose Escalation||0
10874751|NCT02564900|12040900|FG014|NOT COMPLETED|Dose Escalation||0
10874752|NCT02564900|12040886|FG000|STARTED|Dose Expansion||0
10874753|NCT02564900|12040887|FG001|STARTED|Dose Expansion||0
10874754|NCT02564900|12040888|FG002|STARTED|Dose Expansion||0
10874755|NCT02564900|12040889|FG003|STARTED|Dose Expansion||0
10874756|NCT02564900|12040890|FG004|STARTED|Dose Expansion||0
10874757|NCT02564900|12040891|FG005|STARTED|Dose Expansion||0
10874758|NCT02564900|12040892|FG006|STARTED|Dose Expansion||49
10874759|NCT02564900|12040893|FG007|STARTED|Dose Expansion||62
10874760|NCT02564900|12040894|FG008|STARTED|Dose Expansion||20
10874761|NCT02564900|12040895|FG009|STARTED|Dose Expansion||33
10874762|NCT02564900|12040896|FG010|STARTED|Dose Expansion||17
10874763|NCT02564900|12040897|FG011|STARTED|Dose Expansion||24
10874764|NCT02564900|12040898|FG012|STARTED|Dose Expansion||18
10874765|NCT02564900|12040899|FG013|STARTED|Dose Expansion||20
10874766|NCT02564900|12040900|FG014|STARTED|Dose Expansion||22
10874767|NCT02564900|12040886|FG000|Enrolled, But Not Dosed|Dose Expansion||0
10874768|NCT02564900|12040887|FG001|Enrolled, But Not Dosed|Dose Expansion||0
10874769|NCT02564900|12040888|FG002|Enrolled, But Not Dosed|Dose Expansion||0
10874770|NCT02564900|12040889|FG003|Enrolled, But Not Dosed|Dose Expansion||0
10874771|NCT02564900|12040890|FG004|Enrolled, But Not Dosed|Dose Expansion||0
10874772|NCT02564900|12040891|FG005|Enrolled, But Not Dosed|Dose Expansion||0
10874773|NCT02564900|12040892|FG006|Enrolled, But Not Dosed|Dose Expansion||1
11113434|NCT01293032|12297606|FG003|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
11113435|NCT01293032|12297603|FG000|STARTED|Treatment||12
11113436|NCT01293032|12297604|FG001|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
11113437|NCT01293032|12297605|FG002|STARTED|Treatment||11
11113438|NCT01293032|12297606|FG003|STARTED|Treatment||14
11113439|NCT01293032|12297603|FG000|COMPLETED|Treatment||10
11113440|NCT01293032|12297604|FG001|COMPLETED|Treatment||14
11113441|NCT01293032|12297605|FG002|COMPLETED|Treatment||10
11113442|NCT01293032|12297606|FG003|COMPLETED|Treatment||13
11113443|NCT01293032|12297603|FG000|NOT COMPLETED|Treatment||2
11113444|NCT01293032|12297604|FG001|NOT COMPLETED|Treatment||5
11113445|NCT01293032|12297605|FG002|NOT COMPLETED|Treatment||1
11113446|NCT01293032|12297606|FG003|NOT COMPLETED|Treatment||1
11113447|NCT01293084|12297613|FG000|STARTED|Overall Study||17
11113448|NCT01293084|12297613|FG000|COMPLETED|Overall Study||12
11113449|NCT01293084|12297613|FG000|NOT COMPLETED|Overall Study||5
11113450|NCT01293240|12297619|FG000|STARTED|Overall Study||117
11113451|NCT01293240|12297619|FG000|COMPLETED|Overall Study||115
11113452|NCT01293240|12297619|FG000|NOT COMPLETED|Overall Study||2
11113453|NCT01293396|12297623|FG000|STARTED|First Intervention||6
11113454|NCT01293396|12297624|FG001|STARTED|First Intervention||7
11113455|NCT01293396|12297625|FG002|STARTED|First Intervention||7
11113456|NCT01293396|12297623|FG000|COMPLETED|First Intervention||6
11113457|NCT01293396|12297624|FG001|COMPLETED|First Intervention||7
11113458|NCT01293396|12297625|FG002|COMPLETED|First Intervention||7
11113459|NCT01293396|12297623|FG000|NOT COMPLETED|First Intervention||0
11113460|NCT01293396|12297624|FG001|NOT COMPLETED|First Intervention||0
11113461|NCT01293396|12297625|FG002|NOT COMPLETED|First Intervention||0
11113462|NCT01293396|12297623|FG000|STARTED|Wash Out Period 1 (3 Days)||6
11113463|NCT01293396|12297624|FG001|STARTED|Wash Out Period 1 (3 Days)||7
11113464|NCT01293396|12297625|FG002|STARTED|Wash Out Period 1 (3 Days)||7
11113465|NCT01293396|12297623|FG000|COMPLETED|Wash Out Period 1 (3 Days)||6
11113466|NCT01293396|12297624|FG001|COMPLETED|Wash Out Period 1 (3 Days)||7
11113467|NCT01293396|12297625|FG002|COMPLETED|Wash Out Period 1 (3 Days)||7
11113468|NCT01293396|12297623|FG000|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
11113469|NCT01293396|12297624|FG001|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
11113470|NCT01293396|12297625|FG002|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
10874774|NCT02564900|12040893|FG007|Enrolled, But Not Dosed|Dose Expansion||1
10874775|NCT02564900|12040894|FG008|Enrolled, But Not Dosed|Dose Expansion||0
10874776|NCT02564900|12040895|FG009|Enrolled, But Not Dosed|Dose Expansion||0
10874777|NCT02564900|12040896|FG010|Enrolled, But Not Dosed|Dose Expansion||0
10874778|NCT02564900|12040897|FG011|Enrolled, But Not Dosed|Dose Expansion||0
10874779|NCT02564900|12040898|FG012|Enrolled, But Not Dosed|Dose Expansion||0
10874780|NCT02564900|12040899|FG013|Enrolled, But Not Dosed|Dose Expansion||0
10874781|NCT02564900|12040900|FG014|Enrolled, But Not Dosed|Dose Expansion||1
10874782|NCT02564900|12040886|FG000|COMPLETED|Dose Expansion||0
10874783|NCT02564900|12040887|FG001|COMPLETED|Dose Expansion||0
10874784|NCT02564900|12040888|FG002|COMPLETED|Dose Expansion||0
10874785|NCT02564900|12040889|FG003|COMPLETED|Dose Expansion||0
11113471|NCT01293396|12297623|FG000|STARTED|Second Intervention||5
11113472|NCT01293396|12297624|FG001|STARTED|Second Intervention||5
11113473|NCT01293396|12297625|FG002|STARTED|Second Intervention||10
11113474|NCT01293396|12297623|FG000|COMPLETED|Second Intervention||5
11113475|NCT01293396|12297624|FG001|COMPLETED|Second Intervention||5
11113476|NCT01293396|12297625|FG002|COMPLETED|Second Intervention||10
11113477|NCT01293396|12297623|FG000|NOT COMPLETED|Second Intervention||0
11113478|NCT01293396|12297624|FG001|NOT COMPLETED|Second Intervention||0
11113479|NCT01293396|12297625|FG002|NOT COMPLETED|Second Intervention||0
11113480|NCT01293396|12297623|FG000|STARTED|Wash Out Period 2 (3 Days)||5
11113481|NCT01293396|12297624|FG001|STARTED|Wash Out Period 2 (3 Days)||5
11113482|NCT01293396|12297625|FG002|STARTED|Wash Out Period 2 (3 Days)||10
11113483|NCT01293396|12297623|FG000|COMPLETED|Wash Out Period 2 (3 Days)||5
11113484|NCT01293396|12297624|FG001|COMPLETED|Wash Out Period 2 (3 Days)||5
11113485|NCT01293396|12297625|FG002|COMPLETED|Wash Out Period 2 (3 Days)||10
11113486|NCT01293396|12297623|FG000|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
11113487|NCT01293396|12297624|FG001|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
11113488|NCT01293396|12297625|FG002|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
11113489|NCT01293396|12297623|FG000|STARTED|Third Intervention||9
11113490|NCT01293396|12297624|FG001|STARTED|Third Intervention||8
11113491|NCT01293396|12297625|FG002|STARTED|Third Intervention||3
11113492|NCT01293396|12297623|FG000|COMPLETED|Third Intervention||9
11113493|NCT01293396|12297624|FG001|COMPLETED|Third Intervention||8
11113494|NCT01293396|12297625|FG002|COMPLETED|Third Intervention||3
11113495|NCT01293396|12297623|FG000|NOT COMPLETED|Third Intervention||0
11113496|NCT01293396|12297624|FG001|NOT COMPLETED|Third Intervention||0
11113497|NCT01293396|12297625|FG002|NOT COMPLETED|Third Intervention||0
11113498|NCT01293539|12297633|FG000|STARTED|Overall Study||10
11113499|NCT01293539|12297633|FG000|COMPLETED|Overall Study||9
11113500|NCT01293539|12297633|FG000|NOT COMPLETED|Overall Study||1
11113501|NCT01293695|12297639|FG000|STARTED|Overall Study||93
11113502|NCT01293695|12297640|FG001|STARTED|Overall Study||94
11113503|NCT01293695|12297639|FG000|COMPLETED|Overall Study||78
11113504|NCT01293695|12297640|FG001|COMPLETED|Overall Study||87
11113505|NCT01293695|12297639|FG000|NOT COMPLETED|Overall Study||15
11113506|NCT01293695|12297640|FG001|NOT COMPLETED|Overall Study||7
11113507|NCT01293825|12297649|FG000|STARTED|Overall Study||30
11113508|NCT01293825|12297649|FG000|COMPLETED|Overall Study||20
11113509|NCT01293825|12297649|FG000|NOT COMPLETED|Overall Study||10
11113510|NCT01293968|12297655|FG000|STARTED|Overall Study||20
11113511|NCT01293968|12297656|FG001|STARTED|Overall Study||17
11113512|NCT01293968|12297655|FG000|COMPLETED|Overall Study||17
11113513|NCT01293968|12297656|FG001|COMPLETED|Overall Study||14
11113514|NCT01293968|12297655|FG000|NOT COMPLETED|Overall Study||3
11113515|NCT01293968|12297656|FG001|NOT COMPLETED|Overall Study||3
11113516|NCT01294098|12297665|FG000|STARTED|Overall Study||0
11113517|NCT01294098|12297666|FG001|STARTED|Overall Study||1
11113518|NCT01294098|12297667|FG002|STARTED|Overall Study||1
11113519|NCT01294098|12297665|FG000|COMPLETED|Overall Study||0
11113520|NCT01294098|12297666|FG001|COMPLETED|Overall Study||0
11113521|NCT01294098|12297667|FG002|COMPLETED|Overall Study||0
11113522|NCT01294098|12297665|FG000|NOT COMPLETED|Overall Study||0
11113523|NCT01294098|12297666|FG001|NOT COMPLETED|Overall Study||1
11113524|NCT01294098|12297667|FG002|NOT COMPLETED|Overall Study||1
11113525|NCT01294150|12297677|FG000|STARTED|Overall Study||140
11113526|NCT01294150|12297678|FG001|STARTED|Overall Study||66
11113527|NCT01294150|12297677|FG000|COMPLETED|Overall Study||138
11113528|NCT01294150|12297678|FG001|COMPLETED|Overall Study||64
11113529|NCT01294150|12297677|FG000|NOT COMPLETED|Overall Study||2
11113530|NCT01294150|12297678|FG001|NOT COMPLETED|Overall Study||2
11113531|NCT01294163|12297689|FG000|STARTED|Overall Study||178
11113532|NCT01294163|12297690|FG001|STARTED|Overall Study||165
11113533|NCT01294163|12297691|FG002|STARTED|Overall Study||166
11113534|NCT01294163|12297689|FG000|COMPLETED|Overall Study||177
11113535|NCT01294163|12297690|FG001|COMPLETED|Overall Study||165
11113536|NCT01294163|12297691|FG002|COMPLETED|Overall Study||163
11113537|NCT01294163|12297689|FG000|NOT COMPLETED|Overall Study||1
11113538|NCT01294163|12297690|FG001|NOT COMPLETED|Overall Study||0
11113539|NCT01294163|12297691|FG002|NOT COMPLETED|Overall Study||3
11113540|NCT01294228|12297698|FG000|STARTED|Overall Study||1001
11113541|NCT01294228|12297698|FG000|COMPLETED|Overall Study||1001
11113542|NCT01294228|12297698|FG000|NOT COMPLETED|Overall Study||0
11113543|NCT01294241|12297702|FG000|STARTED|Overall Study||10
11113544|NCT01294241|12297702|FG000|COMPLETED|Overall Study||10
11113545|NCT01294241|12297702|FG000|NOT COMPLETED|Overall Study||0
11113546|NCT01294267|12297708|FG000|STARTED|Overall Study||20
11113547|NCT01294267|12297708|FG000|COMPLETED|Overall Study||20
11113548|NCT01294267|12297708|FG000|NOT COMPLETED|Overall Study||0
11113549|NCT01294306|12297714|FG000|STARTED|Overall Study||45
11113550|NCT01294306|12297715|FG001|STARTED|Overall Study||35
11113551|NCT01294306|12297714|FG000|COMPLETED|Overall Study||45
11113552|NCT01294306|12297715|FG001|COMPLETED|Overall Study||35
11113553|NCT01294306|12297714|FG000|NOT COMPLETED|Overall Study||0
11113554|NCT01294306|12297715|FG001|NOT COMPLETED|Overall Study||0
11113555|NCT01294319|12297729|FG000|STARTED|Overall Study||4
11113556|NCT01294319|12297730|FG001|STARTED|Overall Study||6
11113557|NCT01294319|12297731|FG002|STARTED|Overall Study||5
11113558|NCT01294319|12297732|FG003|STARTED|Overall Study||5
11113559|NCT01294319|12297733|FG004|STARTED|Overall Study||5
11113560|NCT01294319|12297734|FG005|STARTED|Overall Study||4
11113561|NCT01294319|12297735|FG006|STARTED|Overall Study||5
11113562|NCT01294319|12297736|FG007|STARTED|Overall Study||5
11113563|NCT01294319|12297729|FG000|COMPLETED|Overall Study||4
11113564|NCT01294319|12297730|FG001|COMPLETED|Overall Study||6
11113565|NCT01294319|12297731|FG002|COMPLETED|Overall Study||5
11113566|NCT01294319|12297732|FG003|COMPLETED|Overall Study||5
11113567|NCT01294319|12297733|FG004|COMPLETED|Overall Study||5
11113568|NCT01294319|12297734|FG005|COMPLETED|Overall Study||4
11113569|NCT01294319|12297735|FG006|COMPLETED|Overall Study||5
11113570|NCT01294319|12297736|FG007|COMPLETED|Overall Study||5
11113571|NCT01294319|12297729|FG000|NOT COMPLETED|Overall Study||0
11113572|NCT01294319|12297730|FG001|NOT COMPLETED|Overall Study||0
11113573|NCT01294319|12297731|FG002|NOT COMPLETED|Overall Study||0
11113574|NCT01294319|12297732|FG003|NOT COMPLETED|Overall Study||0
11113575|NCT01294319|12297733|FG004|NOT COMPLETED|Overall Study||0
11113576|NCT01294319|12297734|FG005|NOT COMPLETED|Overall Study||0
11113577|NCT01294319|12297735|FG006|NOT COMPLETED|Overall Study||0
11113578|NCT01294319|12297736|FG007|NOT COMPLETED|Overall Study||0
11113579|NCT01294358|12297743|FG000|STARTED|Cohort 1: 5/11/11-11/9/11||4
11113580|NCT01294358|12297744|FG001|STARTED|Cohort 1: 5/11/11-11/9/11||0
11113581|NCT01294358|12297745|FG002|STARTED|Cohort 1: 5/11/11-11/9/11||0
11113582|NCT01294358|12297746|FG003|STARTED|Cohort 1: 5/11/11-11/9/11||0
11113583|NCT01294358|12297747|FG004|STARTED|Cohort 1: 5/11/11-11/9/11||0
11113584|NCT01294358|12297743|FG000|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
11113585|NCT01294358|12297744|FG001|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
11113586|NCT01294358|12297745|FG002|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
11113587|NCT01294358|12297746|FG003|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
11113588|NCT01294358|12297747|FG004|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
11113589|NCT01294358|12297743|FG000|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
11113590|NCT01294358|12297744|FG001|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
11113591|NCT01294358|12297745|FG002|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
10874786|NCT02564900|12040890|FG004|COMPLETED|Dose Expansion||0
10874787|NCT02564900|12040891|FG005|COMPLETED|Dose Expansion||0
10874788|NCT02564900|12040892|FG006|COMPLETED|Dose Expansion||0
10874789|NCT02564900|12040893|FG007|COMPLETED|Dose Expansion||0
10874790|NCT02564900|12040894|FG008|COMPLETED|Dose Expansion||0
10874791|NCT02564900|12040895|FG009|COMPLETED|Dose Expansion||0
10874792|NCT02564900|12040896|FG010|COMPLETED|Dose Expansion||0
10874793|NCT02564900|12040897|FG011|COMPLETED|Dose Expansion||0
10874794|NCT02564900|12040898|FG012|COMPLETED|Dose Expansion||0
10874795|NCT02564900|12040899|FG013|COMPLETED|Dose Expansion||0
11113592|NCT01294358|12297746|FG003|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
11113593|NCT01294358|12297747|FG004|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
10874796|NCT02564900|12040900|FG014|COMPLETED|Dose Expansion||0
10874797|NCT02564900|12040886|FG000|NOT COMPLETED|Dose Expansion||0
10874798|NCT02564900|12040887|FG001|NOT COMPLETED|Dose Expansion||0
10874799|NCT02564900|12040888|FG002|NOT COMPLETED|Dose Expansion||0
10874800|NCT02564900|12040889|FG003|NOT COMPLETED|Dose Expansion||0
10874801|NCT02564900|12040890|FG004|NOT COMPLETED|Dose Expansion||0
10874802|NCT02564900|12040891|FG005|NOT COMPLETED|Dose Expansion||0
10874803|NCT02564900|12040892|FG006|NOT COMPLETED|Dose Expansion||49
10874804|NCT02564900|12040893|FG007|NOT COMPLETED|Dose Expansion||62
10874805|NCT02564900|12040894|FG008|NOT COMPLETED|Dose Expansion||20
10874806|NCT02564900|12040895|FG009|NOT COMPLETED|Dose Expansion||33
10874807|NCT02564900|12040896|FG010|NOT COMPLETED|Dose Expansion||17
10874808|NCT02564900|12040897|FG011|NOT COMPLETED|Dose Expansion||24
10874809|NCT02564900|12040898|FG012|NOT COMPLETED|Dose Expansion||18
10874810|NCT02564900|12040899|FG013|NOT COMPLETED|Dose Expansion||20
10874811|NCT02564900|12040900|FG014|NOT COMPLETED|Dose Expansion||22
10874812|NCT02561299|12040943|FG000|STARTED|Overall Study||32
10874813|NCT02561299|12040944|FG001|STARTED|Overall Study||34
10874814|NCT02561299|12040943|FG000|COMPLETED|Overall Study||27
10874815|NCT02561299|12040944|FG001|COMPLETED|Overall Study||28
10874816|NCT02561299|12040943|FG000|NOT COMPLETED|Overall Study||5
10874817|NCT02561299|12040944|FG001|NOT COMPLETED|Overall Study||6
10874818|NCT02548143|12040952|FG000|STARTED|Overall Study||6
10874819|NCT02548143|12040953|FG001|STARTED|Overall Study||6
10874820|NCT02548143|12040952|FG000|COMPLETED|Overall Study||5
10874821|NCT02548143|12040953|FG001|COMPLETED|Overall Study||5
10874822|NCT02548143|12040952|FG000|NOT COMPLETED|Overall Study||1
10874823|NCT02548143|12040953|FG001|NOT COMPLETED|Overall Study||1
10874824|NCT02448680|12040961|FG000|STARTED|Overall Study||12
10874825|NCT02448680|12040962|FG001|STARTED|Overall Study||13
10874826|NCT02448680|12040961|FG000|COMPLETED|Overall Study||11
10874827|NCT02448680|12040962|FG001|COMPLETED|Overall Study||10
10874828|NCT02448680|12040961|FG000|NOT COMPLETED|Overall Study||1
10874829|NCT02448680|12040962|FG001|NOT COMPLETED|Overall Study||3
11113594|NCT01294358|12297743|FG000|STARTED|Cohort 2: 6/9/11-9/17/12||0
11113595|NCT01294358|12297744|FG001|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
11356121|NCT03092791|12553073|FG003|STARTED|Overall Study||30
11356122|NCT03092791|12553074|FG004|STARTED|Overall Study||60
11356123|NCT03092791|12553075|FG005|STARTED|Overall Study||60
11356124|NCT03092791|12553076|FG006|STARTED|Overall Study||60
11356125|NCT03092791|12553077|FG007|STARTED|Overall Study||60
11356126|NCT03092791|12553070|FG000|COMPLETED|Overall Study||20
11356127|NCT03092791|12553071|FG001|COMPLETED|Overall Study||20
11356128|NCT03092791|12553072|FG002|COMPLETED|Overall Study||30
11356129|NCT03092791|12553073|FG003|COMPLETED|Overall Study||30
11356130|NCT03092791|12553074|FG004|COMPLETED|Overall Study||0
11356131|NCT03092791|12553075|FG005|COMPLETED|Overall Study||0
11356132|NCT03092791|12553076|FG006|COMPLETED|Overall Study||0
11356133|NCT03092791|12553077|FG007|COMPLETED|Overall Study||0
11113596|NCT01294358|12297745|FG002|STARTED|Cohort 2: 6/9/11-9/17/12||0
11113597|NCT01294358|12297746|FG003|STARTED|Cohort 2: 6/9/11-9/17/12||0
11113598|NCT01294358|12297747|FG004|STARTED|Cohort 2: 6/9/11-9/17/12||0
11113599|NCT01294358|12297743|FG000|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
11113600|NCT01294358|12297744|FG001|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
11113601|NCT01294358|12297745|FG002|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
11113602|NCT01294358|12297746|FG003|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
11113603|NCT01294358|12297747|FG004|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
11113604|NCT01294358|12297743|FG000|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
11113605|NCT01294358|12297744|FG001|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
11113606|NCT01294358|12297745|FG002|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
11113607|NCT01294358|12297746|FG003|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
11113608|NCT01294358|12297747|FG004|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
11113609|NCT01294358|12297743|FG000|STARTED|Cohort 3: 12/1/11-10/6/12||0
11113610|NCT01294358|12297744|FG001|STARTED|Cohort 3: 12/1/11-10/6/12||0
11113611|NCT01294358|12297745|FG002|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
11113612|NCT01294358|12297746|FG003|STARTED|Cohort 3: 12/1/11-10/6/12||0
11113613|NCT01294358|12297747|FG004|STARTED|Cohort 3: 12/1/11-10/6/12||0
11113614|NCT01294358|12297743|FG000|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
11113615|NCT01294358|12297744|FG001|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
11113616|NCT01294358|12297745|FG002|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
11113617|NCT01294358|12297746|FG003|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
11113618|NCT01294358|12297747|FG004|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
11113619|NCT01294358|12297743|FG000|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
11113620|NCT01294358|12297744|FG001|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
11113621|NCT01294358|12297745|FG002|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
11113622|NCT01294358|12297746|FG003|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
11113623|NCT01294358|12297747|FG004|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
11113624|NCT01294358|12297743|FG000|STARTED|Cohort 4: 12/30/11-2/17/17||0
11113625|NCT01294358|12297744|FG001|STARTED|Cohort 4: 12/30/11-2/17/17||0
11113626|NCT01294358|12297745|FG002|STARTED|Cohort 4: 12/30/11-2/17/17||0
11113627|NCT01294358|12297746|FG003|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
11113628|NCT01294358|12297747|FG004|STARTED|Cohort 4: 12/30/11-2/17/17||0
11113629|NCT01294358|12297743|FG000|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
11113630|NCT01294358|12297744|FG001|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
10874830|NCT02352103|12040972|FG000|STARTED|Overall Study||60
10874831|NCT02352103|12040973|FG001|STARTED|Overall Study||60
10874832|NCT02352103|12040972|FG000|COMPLETED|Overall Study||60
10874833|NCT02352103|12040973|FG001|COMPLETED|Overall Study||59
10874834|NCT02352103|12040972|FG000|NOT COMPLETED|Overall Study||0
10874835|NCT02352103|12040973|FG001|NOT COMPLETED|Overall Study||1
10874836|NCT02273362|12040982|FG000|STARTED|Overall Study||5
10874837|NCT02273362|12040983|FG001|STARTED|Overall Study||6
10874838|NCT02273362|12040984|FG002|STARTED|Overall Study||14
10874839|NCT02273362|12040982|FG000|COMPLETED|Overall Study||5
10874840|NCT02273362|12040983|FG001|COMPLETED|Overall Study||6
10874841|NCT02273362|12040984|FG002|COMPLETED|Overall Study||14
10874842|NCT02273362|12040982|FG000|NOT COMPLETED|Overall Study||0
10874843|NCT02273362|12040983|FG001|NOT COMPLETED|Overall Study||0
10874844|NCT02273362|12040984|FG002|NOT COMPLETED|Overall Study||0
11113631|NCT01294358|12297745|FG002|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
11113632|NCT01294358|12297746|FG003|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
11113633|NCT01294358|12297747|FG004|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
11113634|NCT01294358|12297743|FG000|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
11113635|NCT01294358|12297744|FG001|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
11113636|NCT01294358|12297745|FG002|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
11113637|NCT01294358|12297746|FG003|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
11113638|NCT01294358|12297747|FG004|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
11113639|NCT01294358|12297743|FG000|STARTED|Cohort 5: 3/8/12-3/9/12||0
11113640|NCT01294358|12297744|FG001|STARTED|Cohort 5: 3/8/12-3/9/12||0
11113641|NCT01294358|12297745|FG002|STARTED|Cohort 5: 3/8/12-3/9/12||0
11113642|NCT01294358|12297746|FG003|STARTED|Cohort 5: 3/8/12-3/9/12||0
11113643|NCT01294358|12297747|FG004|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
11113644|NCT01294358|12297743|FG000|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
11113645|NCT01294358|12297744|FG001|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
11113646|NCT01294358|12297745|FG002|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
11113647|NCT01294358|12297746|FG003|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
11113648|NCT01294358|12297747|FG004|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
11113649|NCT01294358|12297743|FG000|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
11113650|NCT01294358|12297744|FG001|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
11113651|NCT01294358|12297745|FG002|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
11113652|NCT01294358|12297746|FG003|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
11113653|NCT01294358|12297747|FG004|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
11113654|NCT01294371|12297764|FG000|STARTED|Overall Study||391
11113655|NCT01294371|12297764|FG000|Treated|Overall Study||390
11113656|NCT01294371|12297764|FG000|COMPLETED|Overall Study||357
11113657|NCT01294371|12297764|FG000|NOT COMPLETED|Overall Study||34
11113658|NCT01294384|12297774|FG000|STARTED|Overall Study||101
11113659|NCT01294384|12297775|FG001|STARTED|Overall Study||100
11113660|NCT01294384|12297776|FG002|STARTED|Overall Study||104
11113661|NCT01294384|12297774|FG000|COMPLETED|Overall Study||97
11113662|NCT01294384|12297775|FG001|COMPLETED|Overall Study||94
11113663|NCT01294384|12297776|FG002|COMPLETED|Overall Study||95
11113664|NCT01294384|12297774|FG000|NOT COMPLETED|Overall Study||4
11113665|NCT01294384|12297775|FG001|NOT COMPLETED|Overall Study||6
11113666|NCT01294384|12297776|FG002|NOT COMPLETED|Overall Study||9
11113667|NCT01294397|12297784|FG000|STARTED|Overall Study||19
11113668|NCT01294397|12297784|FG000|COMPLETED|Overall Study||17
11113669|NCT01294397|12297784|FG000|NOT COMPLETED|Overall Study||2
11113670|NCT01294423|12297793|FG000|STARTED|Overall Study||86
11113671|NCT01294423|12297794|FG001|STARTED|Overall Study||88
11113672|NCT01294423|12297795|FG002|STARTED|Overall Study||87
11113673|NCT01294423|12297793|FG000|COMPLETED|Overall Study||81
11113674|NCT01294423|12297794|FG001|COMPLETED|Overall Study||79
11113675|NCT01294423|12297795|FG002|COMPLETED|Overall Study||79
11113676|NCT01294423|12297793|FG000|NOT COMPLETED|Overall Study||5
10874845|NCT02178358|12040995|FG000|STARTED|Overall Study||20
10874846|NCT02178358|12040996|FG001|STARTED|Overall Study||74
10874847|NCT02178358|12040997|FG002|STARTED|Overall Study||38
10874848|NCT02178358|12040995|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
10874849|NCT02178358|12040996|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
10874850|NCT02178358|12040997|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38
10874851|NCT02178358|12040995|FG000|COMPLETED|Overall Study||19
10874852|NCT02178358|12040996|FG001|COMPLETED|Overall Study||72
10874853|NCT02178358|12040997|FG002|COMPLETED|Overall Study||36
10874854|NCT02178358|12040995|FG000|NOT COMPLETED|Overall Study||1
10874855|NCT02178358|12040996|FG001|NOT COMPLETED|Overall Study||2
10874856|NCT02178358|12040997|FG002|NOT COMPLETED|Overall Study||2
10874857|NCT02073279|12041008|FG000|STARTED|Double-blind Period||32
10874858|NCT02073279|12041009|FG001|STARTED|Double-blind Period||63
10874859|NCT02073279|12041008|FG000|COMPLETED|Double-blind Period||17
10874860|NCT02073279|12041009|FG001|COMPLETED|Double-blind Period||16
10874861|NCT02073279|12041008|FG000|NOT COMPLETED|Double-blind Period||15
10874862|NCT02073279|12041009|FG001|NOT COMPLETED|Double-blind Period||47
10874863|NCT02073279|12041008|FG000|STARTED|Open-label Extension Period||17
10874864|NCT02073279|12041009|FG001|STARTED|Open-label Extension Period||16
10874865|NCT02073279|12041008|FG000|COMPLETED|Open-label Extension Period||0
10874866|NCT02073279|12041009|FG001|COMPLETED|Open-label Extension Period||0
10874867|NCT02073279|12041008|FG000|NOT COMPLETED|Open-label Extension Period||17
10874868|NCT02073279|12041009|FG001|NOT COMPLETED|Open-label Extension Period||16
10874869|NCT01544127|12041021|FG000|STARTED|Overall Study||33
10874870|NCT01544127|12041022|FG001|STARTED|Overall Study||33
10874871|NCT01544127|12041023|FG002|STARTED|Overall Study||66
10874872|NCT01544127|12041021|FG000|COMPLETED|Overall Study||22
10874873|NCT01544127|12041022|FG001|COMPLETED|Overall Study||27
10874874|NCT01544127|12041023|FG002|COMPLETED|Overall Study||52
10874875|NCT01544127|12041021|FG000|NOT COMPLETED|Overall Study||11
10874876|NCT01544127|12041022|FG001|NOT COMPLETED|Overall Study||6
10874877|NCT01544127|12041023|FG002|NOT COMPLETED|Overall Study||14
10874878|NCT00806390|12041034|FG000|STARTED|Overall Study||7
10874879|NCT00806390|12041035|FG001|STARTED|Overall Study||8
10874880|NCT00806390|12041034|FG000|COMPLETED|Overall Study||7
10874881|NCT00806390|12041035|FG001|COMPLETED|Overall Study||8
10874882|NCT00806390|12041034|FG000|NOT COMPLETED|Overall Study||0
10874883|NCT00806390|12041035|FG001|NOT COMPLETED|Overall Study||0
10874884|NCT00566618|12041041|FG000|STARTED|Overall Study||1
10874885|NCT00566618|12041042|FG001|STARTED|Overall Study||6
10874886|NCT00566618|12041043|FG002|STARTED|Overall Study||18
10874887|NCT00566618|12041041|FG000|COMPLETED|Overall Study||0
10874888|NCT00566618|12041042|FG001|COMPLETED|Overall Study||0
10874889|NCT00566618|12041043|FG002|COMPLETED|Overall Study||0
10874890|NCT00566618|12041041|FG000|NOT COMPLETED|Overall Study||1
10874891|NCT00566618|12041042|FG001|NOT COMPLETED|Overall Study||6
10874892|NCT00566618|12041043|FG002|NOT COMPLETED|Overall Study||18
10874893|NCT00442559|12041050|FG000|STARTED|Overall Study||100
10874894|NCT00442559|12041051|FG001|STARTED|Overall Study||91
10874895|NCT00442559|12041050|FG000|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
10874896|NCT00442559|12041051|FG001|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
10874897|NCT00442559|12041050|FG000|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
10874898|NCT00442559|12041051|FG001|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
10874899|NCT00442559|12041050|FG000|NOT COMPLETED|Overall Study||34
10874900|NCT00442559|12041051|FG001|NOT COMPLETED|Overall Study||35
10874901|NCT00117338|12041065|FG000|STARTED|Overall Study||145
10874902|NCT00117338|12041066|FG001|STARTED|Overall Study||131
10874903|NCT00117338|12041065|FG000|COMPLETED|Overall Study||140
10874904|NCT00117338|12041066|FG001|COMPLETED|Overall Study||127
10874905|NCT00117338|12041065|FG000|NOT COMPLETED|Overall Study||5
10874906|NCT00117338|12041066|FG001|NOT COMPLETED|Overall Study||4
11356134|NCT03092791|12553070|FG000|NOT COMPLETED|Overall Study||0
11356135|NCT03092791|12553071|FG001|NOT COMPLETED|Overall Study||0
11356136|NCT03092791|12553072|FG002|NOT COMPLETED|Overall Study||0
11356137|NCT03092791|12553073|FG003|NOT COMPLETED|Overall Study||0
11356138|NCT03092791|12553074|FG004|NOT COMPLETED|Overall Study||60
11356139|NCT03092791|12553075|FG005|NOT COMPLETED|Overall Study||60
10874907|NCT04851314|12041074|FG000|STARTED|Overall Study||55
11113677|NCT01294423|12297794|FG001|NOT COMPLETED|Overall Study||9
11113678|NCT01294423|12297795|FG002|NOT COMPLETED|Overall Study||8
11113679|NCT01294436|12297805|FG000|STARTED|Overall Study||249
11113680|NCT01294436|12297806|FG001|STARTED|Overall Study||479
11113681|NCT01294436|12297805|FG000|COMPLETED|Overall Study||221
11113682|NCT01294436|12297806|FG001|COMPLETED|Overall Study||409
11113683|NCT01294436|12297805|FG000|NOT COMPLETED|Overall Study||28
11113684|NCT01294436|12297806|FG001|NOT COMPLETED|Overall Study||70
11113685|NCT01294449|12297814|FG000|STARTED|Overall Study||156
11113686|NCT01294449|12297815|FG001|STARTED|Overall Study||252
11113687|NCT01294449|12297814|FG000|Consent to Registry|Overall Study||149
11113688|NCT01294449|12297815|FG001|Consent to Registry|Overall Study||245
11113689|NCT01294449|12297814|FG000|COMPLETED|Overall Study||144
11113690|NCT01294449|12297815|FG001|COMPLETED|Overall Study||237
11113691|NCT01294449|12297814|FG000|NOT COMPLETED|Overall Study||12
11113692|NCT01294449|12297815|FG001|NOT COMPLETED|Overall Study||15
11113693|NCT01294462|12297823|FG000|STARTED|Overall Study||401
11113694|NCT01294462|12297824|FG001|STARTED|Overall Study||400
11113695|NCT01294462|12297823|FG000|Received Randomized Treatment|Overall Study||387
11113696|NCT01294462|12297824|FG001|Received Randomized Treatment|Overall Study||380
11113697|NCT01294462|12297823|FG000|COMPLETED|Overall Study||335
11113698|NCT01294462|12297824|FG001|COMPLETED|Overall Study||337
11113699|NCT01294462|12297823|FG000|NOT COMPLETED|Overall Study||66
11113700|NCT01294462|12297824|FG001|NOT COMPLETED|Overall Study||63
11113701|NCT01294514|12297830|FG000|STARTED|Overall Study||27
11113702|NCT01294514|12297830|FG000|COMPLETED|Overall Study||26
11113703|NCT01294514|12297830|FG000|NOT COMPLETED|Overall Study||1
11113704|NCT01294553|12297838|FG000|STARTED|Overall Study||982
10874908|NCT04851314|12041075|FG001|STARTED|Overall Study||55
10874909|NCT04851314|12041074|FG000|COMPLETED|Overall Study||52
10874910|NCT04851314|12041075|FG001|COMPLETED|Overall Study||51
10874911|NCT04851314|12041074|FG000|NOT COMPLETED|Overall Study||3
10874912|NCT04851314|12041075|FG001|NOT COMPLETED|Overall Study||4
10874913|NCT04845633|12041085|FG000|STARTED|Overall Study||12
10874914|NCT04845633|12041086|FG001|STARTED|Overall Study||12
10874915|NCT04845633|12041087|FG002|STARTED|Overall Study||12
10874916|NCT04845633|12041088|FG003|STARTED|Overall Study||12
10874917|NCT04845633|12041085|FG000|COMPLETED|Overall Study||12
10874918|NCT04845633|12041086|FG001|COMPLETED|Overall Study||12
10874919|NCT04845633|12041087|FG002|COMPLETED|Overall Study||12
10874920|NCT04845633|12041088|FG003|COMPLETED|Overall Study||12
10874921|NCT04845633|12041085|FG000|NOT COMPLETED|Overall Study||0
10874922|NCT04845633|12041086|FG001|NOT COMPLETED|Overall Study||0
10874923|NCT04845633|12041087|FG002|NOT COMPLETED|Overall Study||0
10874924|NCT04845633|12041088|FG003|NOT COMPLETED|Overall Study||0
10874925|NCT04823494|12041102|FG000|STARTED|Overall Study||21
10874926|NCT04823494|12041103|FG001|STARTED|Overall Study||19
10874927|NCT04823494|12041102|FG000|COMPLETED|Overall Study||19
10874928|NCT04823494|12041103|FG001|COMPLETED|Overall Study||18
10874929|NCT04823494|12041102|FG000|NOT COMPLETED|Overall Study||2
10874930|NCT04823494|12041103|FG001|NOT COMPLETED|Overall Study||1
10874934|NCT04814459|12041119|FG000|STARTED|Overall Study||72
10874935|NCT04814459|12041120|FG001|STARTED|Overall Study||72
10874936|NCT04814459|12041119|FG000|COMPLETED|Overall Study||72
10874937|NCT04814459|12041120|FG001|COMPLETED|Overall Study||72
10874938|NCT04814459|12041119|FG000|NOT COMPLETED|Overall Study||0
10874939|NCT04814459|12041120|FG001|NOT COMPLETED|Overall Study||0
10874940|NCT04799782|12041126|FG000|STARTED|First Intervention||8
10874941|NCT04799782|12041127|FG001|STARTED|First Intervention||7
10874942|NCT04799782|12041126|FG000|COMPLETED|First Intervention||8
10874943|NCT04799782|12041127|FG001|COMPLETED|First Intervention||7
10874944|NCT04799782|12041126|FG000|NOT COMPLETED|First Intervention||0
10874945|NCT04799782|12041127|FG001|NOT COMPLETED|First Intervention||0
10874946|NCT04799782|12041126|FG000|STARTED|Washout||8
10874947|NCT04799782|12041127|FG001|STARTED|Washout||7
10874948|NCT04799782|12041126|FG000|COMPLETED|Washout||6
10874949|NCT04799782|12041127|FG001|COMPLETED|Washout||4
10874950|NCT04799782|12041126|FG000|NOT COMPLETED|Washout||2
10874951|NCT04799782|12041127|FG001|NOT COMPLETED|Washout||3
10874952|NCT04799782|12041126|FG000|STARTED|Second Intervention||6
10874953|NCT04799782|12041127|FG001|STARTED|Second Intervention||4
10874954|NCT04799782|12041126|FG000|COMPLETED|Second Intervention||6
10874955|NCT04799782|12041127|FG001|COMPLETED|Second Intervention||4
10874956|NCT04799782|12041126|FG000|NOT COMPLETED|Second Intervention||0
10874957|NCT04799782|12041127|FG001|NOT COMPLETED|Second Intervention||0
11113705|NCT01294553|12297838|FG000|COMPLETED|Overall Study||713
11113706|NCT01294553|12297838|FG000|NOT COMPLETED|Overall Study||269
11113707|NCT01294579|12297843|FG000|STARTED|Overall Study||49
11113708|NCT01294579|12297843|FG000|COMPLETED|Overall Study||14
11113709|NCT01294579|12297843|FG000|NOT COMPLETED|Overall Study||35
11113710|NCT01294592|12297849|FG000|STARTED|Overall Study||369
11113711|NCT01294592|12297850|FG001|STARTED|Overall Study||373
11113712|NCT01294592|12297849|FG000|COMPLETED|Overall Study||292
11113713|NCT01294592|12297850|FG001|COMPLETED|Overall Study||300
11113714|NCT01294592|12297849|FG000|NOT COMPLETED|Overall Study||77
11113715|NCT01294592|12297850|FG001|NOT COMPLETED|Overall Study||73
11113716|NCT01294644|12297862|FG000|STARTED|Overall Study||121
11113717|NCT01294644|12297863|FG001|STARTED|Overall Study||122
11113718|NCT01294644|12297864|FG002|STARTED|Overall Study||117
11113719|NCT01294644|12297862|FG000|Received Treatment|Overall Study||118
11113720|NCT01294644|12297863|FG001|Received Treatment|Overall Study||122
11113721|NCT01294644|12297864|FG002|Received Treatment|Overall Study||114
11113722|NCT01294644|12297862|FG000|COMPLETED|Overall Study||111
11113723|NCT01294644|12297863|FG001|COMPLETED|Overall Study||112
11113724|NCT01294644|12297864|FG002|COMPLETED|Overall Study||103
10874931|NCT04821245|12041111|FG000|STARTED|Overall Study||36
10874932|NCT04821245|12041111|FG000|COMPLETED|Overall Study||27
10874933|NCT04821245|12041111|FG000|NOT COMPLETED|Overall Study||9
11113725|NCT01294644|12297862|FG000|NOT COMPLETED|Overall Study||10
11113726|NCT01294644|12297863|FG001|NOT COMPLETED|Overall Study||10
11113727|NCT01294644|12297864|FG002|NOT COMPLETED|Overall Study||14
11113728|NCT01294683|12297874|FG000|STARTED|Precrossover (Periods I/II)||489
11113729|NCT01294683|12297875|FG001|STARTED|Precrossover (Periods I/II)||488
11113730|NCT01294683|12297874|FG000|Treated|Precrossover (Periods I/II)||486
11113731|NCT01294683|12297875|FG001|Treated|Precrossover (Periods I/II)||486
11113732|NCT01294683|12297874|FG000|COMPLETED|Precrossover (Periods I/II)||232
11113733|NCT01294683|12297875|FG001|COMPLETED|Precrossover (Periods I/II)||222
11113734|NCT01294683|12297874|FG000|NOT COMPLETED|Precrossover (Periods I/II)||257
11113735|NCT01294683|12297875|FG001|NOT COMPLETED|Precrossover (Periods I/II)||266
11113736|NCT01294683|12297874|FG000|STARTED|Post Crossover (Period III)||232
11113737|NCT01294683|12297875|FG001|STARTED|Post Crossover (Period III)||222
11113738|NCT01294683|12297874|FG000|COMPLETED|Post Crossover (Period III)||199
11113739|NCT01294683|12297875|FG001|COMPLETED|Post Crossover (Period III)||190
11113740|NCT01294683|12297874|FG000|NOT COMPLETED|Post Crossover (Period III)||33
11113741|NCT01294683|12297875|FG001|NOT COMPLETED|Post Crossover (Period III)||32
11113742|NCT01294709|12297887|FG000|STARTED|Period 1||31
11113743|NCT01294709|12297888|FG001|STARTED|Period 1||33
11113744|NCT01294709|12297887|FG000|COMPLETED|Period 1||30
11113745|NCT01294709|12297888|FG001|COMPLETED|Period 1||32
11113746|NCT01294709|12297887|FG000|NOT COMPLETED|Period 1||1
11113747|NCT01294709|12297888|FG001|NOT COMPLETED|Period 1||1
11113748|NCT01294709|12297887|FG000|STARTED|Washout Period||30
11113749|NCT01294709|12297888|FG001|STARTED|Washout Period||32
11113750|NCT01294709|12297887|FG000|COMPLETED|Washout Period||29
11113751|NCT01294709|12297888|FG001|COMPLETED|Washout Period||31
11113752|NCT01294709|12297887|FG000|NOT COMPLETED|Washout Period||1
11113753|NCT01294709|12297888|FG001|NOT COMPLETED|Washout Period||1
11113754|NCT01294709|12297887|FG000|STARTED|Period 2||29
11113755|NCT01294709|12297888|FG001|STARTED|Period 2||31
11113756|NCT01294709|12297887|FG000|COMPLETED|Period 2||28
11113757|NCT01294709|12297888|FG001|COMPLETED|Period 2||31
11113758|NCT01294709|12297887|FG000|NOT COMPLETED|Period 2||1
11113759|NCT01294709|12297888|FG001|NOT COMPLETED|Period 2||0
11113760|NCT01294748|12297901|FG000|STARTED|Overall Study||123
11113761|NCT01294748|12297902|FG001|STARTED|Overall Study||61
11113762|NCT01294748|12297901|FG000|COMPLETED|Overall Study|At 270 days|118
11113763|NCT01294748|12297902|FG001|COMPLETED|Overall Study|At 270 days|59
11113764|NCT01294748|12297901|FG000|NOT COMPLETED|Overall Study||5
11113765|NCT01294748|12297902|FG001|NOT COMPLETED|Overall Study||2
11113766|NCT01294787|12297908|FG000|STARTED|Period 1||12
11113767|NCT01294787|12297909|FG001|STARTED|Period 1||16
11113768|NCT01294787|12297910|FG002|STARTED|Period 1||14
11113769|NCT01294787|12297911|FG003|STARTED|Period 1||12
11113770|NCT01294787|12297912|FG004|STARTED|Period 1||16
11113771|NCT01294787|12297913|FG005|STARTED|Period 1|One randomized participant did not receive study drug|15
11113772|NCT01294787|12297908|FG000|COMPLETED|Period 1||12
11113773|NCT01294787|12297909|FG001|COMPLETED|Period 1||16
11113774|NCT01294787|12297910|FG002|COMPLETED|Period 1||13
11113775|NCT01294787|12297911|FG003|COMPLETED|Period 1||11
11113776|NCT01294787|12297912|FG004|COMPLETED|Period 1||14
11113777|NCT01294787|12297913|FG005|COMPLETED|Period 1||13
11113778|NCT01294787|12297908|FG000|NOT COMPLETED|Period 1||0
11113779|NCT01294787|12297909|FG001|NOT COMPLETED|Period 1||0
11113780|NCT01294787|12297910|FG002|NOT COMPLETED|Period 1||1
11113781|NCT01294787|12297911|FG003|NOT COMPLETED|Period 1||1
11113782|NCT01294787|12297912|FG004|NOT COMPLETED|Period 1||2
11113783|NCT01294787|12297913|FG005|NOT COMPLETED|Period 1||2
11113784|NCT01294787|12297908|FG000|STARTED|Period 2||12
11113785|NCT01294787|12297909|FG001|STARTED|Period 2||16
11113786|NCT01294787|12297910|FG002|STARTED|Period 2||13
11113787|NCT01294787|12297911|FG003|STARTED|Period 2||11
11113788|NCT01294787|12297912|FG004|STARTED|Period 2||14
11113789|NCT01294787|12297913|FG005|STARTED|Period 2||13
11113790|NCT01294787|12297908|FG000|COMPLETED|Period 2||12
11113791|NCT01294787|12297909|FG001|COMPLETED|Period 2||13
11113792|NCT01294787|12297910|FG002|COMPLETED|Period 2||13
11113793|NCT01294787|12297911|FG003|COMPLETED|Period 2||9
11113794|NCT01294787|12297912|FG004|COMPLETED|Period 2||14
11113795|NCT01294787|12297913|FG005|COMPLETED|Period 2||13
11113796|NCT01294787|12297908|FG000|NOT COMPLETED|Period 2||0
11113797|NCT01294787|12297909|FG001|NOT COMPLETED|Period 2||3
11113798|NCT01294787|12297910|FG002|NOT COMPLETED|Period 2||0
11113799|NCT01294787|12297911|FG003|NOT COMPLETED|Period 2||2
11113800|NCT01294787|12297912|FG004|NOT COMPLETED|Period 2||0
11113801|NCT01294787|12297913|FG005|NOT COMPLETED|Period 2||0
11113802|NCT01294787|12297908|FG000|STARTED|Period 3||12
11113803|NCT01294787|12297909|FG001|STARTED|Period 3||13
11113804|NCT01294787|12297910|FG002|STARTED|Period 3||13
11113805|NCT01294787|12297911|FG003|STARTED|Period 3||9
11113806|NCT01294787|12297912|FG004|STARTED|Period 3||14
11113807|NCT01294787|12297913|FG005|STARTED|Period 3||13
11113808|NCT01294787|12297908|FG000|COMPLETED|Period 3||12
11113809|NCT01294787|12297909|FG001|COMPLETED|Period 3||13
11113810|NCT01294787|12297910|FG002|COMPLETED|Period 3||13
11113811|NCT01294787|12297911|FG003|COMPLETED|Period 3||9
11113812|NCT01294787|12297912|FG004|COMPLETED|Period 3||13
11113813|NCT01294787|12297913|FG005|COMPLETED|Period 3||13
11113814|NCT01294787|12297908|FG000|NOT COMPLETED|Period 3||0
11113815|NCT01294787|12297909|FG001|NOT COMPLETED|Period 3||0
11113816|NCT01294787|12297910|FG002|NOT COMPLETED|Period 3||0
11113817|NCT01294787|12297911|FG003|NOT COMPLETED|Period 3||0
11113818|NCT01294787|12297912|FG004|NOT COMPLETED|Period 3||1
11113819|NCT01294787|12297913|FG005|NOT COMPLETED|Period 3||0
11113820|NCT01294800|12297928|FG000|STARTED|Overall Study||111
11113821|NCT01294800|12297929|FG001|STARTED|Overall Study||113
11113822|NCT01294800|12297930|FG002|STARTED|Overall Study||113
11113823|NCT01294800|12297931|FG003|STARTED|Overall Study||113
11113824|NCT01294800|12297928|FG000|COMPLETED|Overall Study||100
11113825|NCT01294800|12297929|FG001|COMPLETED|Overall Study||103
11113826|NCT01294800|12297930|FG002|COMPLETED|Overall Study||96
11113827|NCT01294800|12297931|FG003|COMPLETED|Overall Study||97
11113828|NCT01294800|12297928|FG000|NOT COMPLETED|Overall Study||11
11113829|NCT01294800|12297929|FG001|NOT COMPLETED|Overall Study||10
11113830|NCT01294800|12297930|FG002|NOT COMPLETED|Overall Study||17
11113831|NCT01294800|12297931|FG003|NOT COMPLETED|Overall Study||16
11113832|NCT01294917|12297941|FG000|STARTED|Overall Study||42
11113833|NCT01294917|12297941|FG000|Received Investigational MPS|Overall Study||36
11113834|NCT01294917|12297941|FG000|Received Clear Care|Overall Study||36
11113835|NCT01294917|12297941|FG000|Received OptiFree RepleniSH MPS|Overall Study||36
11113836|NCT01294917|12297941|FG000|COMPLETED|Overall Study||36
11113837|NCT01294917|12297941|FG000|NOT COMPLETED|Overall Study||6
11113838|NCT01295034|12297949|FG000|STARTED|Overall Study||32
11113839|NCT01295034|12297950|FG001|STARTED|Overall Study||30
11113840|NCT01295034|12297949|FG000|COMPLETED|Overall Study||27
11113841|NCT01295034|12297950|FG001|COMPLETED|Overall Study||25
11113842|NCT01295034|12297949|FG000|NOT COMPLETED|Overall Study||5
11113843|NCT01295034|12297950|FG001|NOT COMPLETED|Overall Study||5
11113844|NCT01295112|12297959|FG000|STARTED|Overall Study||35
11113845|NCT01295112|12297960|FG001|STARTED|Overall Study||33
11113846|NCT01295112|12297959|FG000|COMPLETED|Overall Study||35
11113847|NCT01295112|12297960|FG001|COMPLETED|Overall Study||33
11113848|NCT01295112|12297959|FG000|NOT COMPLETED|Overall Study||0
11113849|NCT01295112|12297960|FG001|NOT COMPLETED|Overall Study||0
11113850|NCT01295216|12297968|FG000|STARTED|Overall Study||316
11113851|NCT01295216|12297969|FG001|STARTED|Overall Study||321
11113852|NCT01295216|12297968|FG000|COMPLETED|Overall Study||266
11113853|NCT01295216|12297969|FG001|COMPLETED|Overall Study||287
11113854|NCT01295216|12297968|FG000|NOT COMPLETED|Overall Study||50
11113855|NCT01295216|12297969|FG001|NOT COMPLETED|Overall Study||34
11113856|NCT01295281|12297977|FG000|STARTED|First Intervention (7 Days)||53
11113857|NCT01295281|12297978|FG001|STARTED|First Intervention (7 Days)||52
11113858|NCT01295281|12297977|FG000|COMPLETED|First Intervention (7 Days)||53
11113859|NCT01295281|12297978|FG001|COMPLETED|First Intervention (7 Days)||51
11113860|NCT01295281|12297977|FG000|NOT COMPLETED|First Intervention (7 Days)||0
11113861|NCT01295281|12297978|FG001|NOT COMPLETED|First Intervention (7 Days)||1
11113862|NCT01295281|12297977|FG000|STARTED|Second Intervention (7days)||53
11113863|NCT01295281|12297978|FG001|STARTED|Second Intervention (7days)||51
11113864|NCT01295281|12297977|FG000|COMPLETED|Second Intervention (7days)||53
11113865|NCT01295281|12297978|FG001|COMPLETED|Second Intervention (7days)||51
11113866|NCT01295281|12297977|FG000|NOT COMPLETED|Second Intervention (7days)||0
11113867|NCT01295281|12297978|FG001|NOT COMPLETED|Second Intervention (7days)||0
11113868|NCT01295320|12297984|FG000|STARTED|Overall Study||129
11113869|NCT01295320|12297984|FG000|COMPLETED|Overall Study||119
11113870|NCT01295320|12297984|FG000|NOT COMPLETED|Overall Study||10
11113871|NCT01295515|12297988|FG000|STARTED|Overall Study||7
11113872|NCT01295515|12297988|FG000|COMPLETED|Overall Study||7
11113873|NCT01295515|12297988|FG000|NOT COMPLETED|Overall Study||0
11113874|NCT01295580|12297994|FG000|STARTED|Overall Study||174
11113875|NCT01295580|12297995|FG001|STARTED|Overall Study||175
11113876|NCT01295580|12297994|FG000|COMPLETED|Overall Study||164
11113877|NCT01295580|12297995|FG001|COMPLETED|Overall Study||167
11113878|NCT01295580|12297994|FG000|NOT COMPLETED|Overall Study||10
11113879|NCT01295580|12297995|FG001|NOT COMPLETED|Overall Study||8
11113880|NCT01295671|12298004|FG000|STARTED|Overall Study||67
11113881|NCT01295671|12298005|FG001|STARTED|Overall Study||67
11113882|NCT01295671|12298006|FG002|STARTED|Overall Study||69
11113883|NCT01295671|12298004|FG000|COMPLETED|Overall Study||60
11113884|NCT01295671|12298005|FG001|COMPLETED|Overall Study||60
11113885|NCT01295671|12298006|FG002|COMPLETED|Overall Study||66
11113886|NCT01295671|12298004|FG000|NOT COMPLETED|Overall Study||7
11113887|NCT01295671|12298005|FG001|NOT COMPLETED|Overall Study||7
11113888|NCT01295671|12298006|FG002|NOT COMPLETED|Overall Study||3
11113889|NCT01295710|12298016|FG000|STARTED|Overall Study|Randomized and treated|126
11113890|NCT01295710|12298017|FG001|STARTED|Overall Study|Randomized and treated|128
11113891|NCT01295710|12298016|FG000|COMPLETED|Overall Study||48
11113892|NCT01295710|12298017|FG001|COMPLETED|Overall Study||78
11113893|NCT01295710|12298016|FG000|NOT COMPLETED|Overall Study||78
11113894|NCT01295710|12298017|FG001|NOT COMPLETED|Overall Study||50
11113895|NCT01295814|12298025|FG000|STARTED|Overall Study||22
11113896|NCT01295814|12298026|FG001|STARTED|Overall Study||21
11113897|NCT01295814|12298025|FG000|COMPLETED|Overall Study||20
11113898|NCT01295814|12298026|FG001|COMPLETED|Overall Study||19
11113899|NCT01295814|12298025|FG000|NOT COMPLETED|Overall Study||2
11113900|NCT01295814|12298026|FG001|NOT COMPLETED|Overall Study||2
11113901|NCT01295827|12298044|FG000|STARTED|Overall Study||4
11113902|NCT01295827|12298045|FG001|STARTED|Overall Study||3
11113903|NCT01295827|12298046|FG002|STARTED|Overall Study||12
11113904|NCT01295827|12298047|FG003|STARTED|Overall Study||4
11113905|NCT01295827|12298048|FG004|STARTED|Overall Study||3
11113906|NCT01295827|12298049|FG005|STARTED|Overall Study||6
11113907|NCT01295827|12298050|FG006|STARTED|Overall Study||164
11113908|NCT01295827|12298051|FG007|STARTED|Overall Study||321
11113909|NCT01295827|12298052|FG008|STARTED|Overall Study||183
11113910|NCT01295827|12298053|FG009|STARTED|Overall Study||61
11113911|NCT01295827|12298054|FG010|STARTED|Overall Study||296
11113912|NCT01295827|12298055|FG011|STARTED|Overall Study||203
11232373|NCT02036541|12424544|FG000|COMPLETED|Overall Study||49
11232374|NCT02036541|12424544|FG000|NOT COMPLETED|Overall Study||16
11232375|NCT02036580|12424551|FG000|STARTED|Overall Study||8
11232376|NCT02036580|12424552|FG001|STARTED|Overall Study||8
11232377|NCT02036580|12424553|FG002|STARTED|Overall Study||4
11232378|NCT02036580|12424551|FG000|COMPLETED|Overall Study||7
11232379|NCT02036580|12424552|FG001|COMPLETED|Overall Study||7
11232380|NCT02036580|12424553|FG002|COMPLETED|Overall Study||4
11113913|NCT01295827|12298056|FG012|STARTED|Overall Study||0
11113914|NCT01295827|12298057|FG013|STARTED|Overall Study||0
11113915|NCT01295827|12298058|FG014|STARTED|Overall Study||0
11113916|NCT01295827|12298044|FG000|Treated (All Treated Population)|Overall Study||4
11113917|NCT01295827|12298045|FG001|Treated (All Treated Population)|Overall Study||3
11113918|NCT01295827|12298046|FG002|Treated (All Treated Population)|Overall Study||10
11113919|NCT01295827|12298047|FG003|Treated (All Treated Population)|Overall Study||4
11113920|NCT01295827|12298048|FG004|Treated (All Treated Population)|Overall Study||3
11113921|NCT01295827|12298049|FG005|Treated (All Treated Population)|Overall Study||6
11113922|NCT01295827|12298050|FG006|Treated (All Treated Population)|Overall Study||162
11113923|NCT01295827|12298051|FG007|Treated (All Treated Population)|Overall Study||313
11113924|NCT01295827|12298052|FG008|Treated (All Treated Population)|Overall Study||180
11113925|NCT01295827|12298053|FG009|Treated (All Treated Population)|Overall Study||61
11113926|NCT01295827|12298054|FG010|Treated (All Treated Population)|Overall Study||287
11113927|NCT01295827|12298055|FG011|Treated (All Treated Population)|Overall Study||202
11113928|NCT01295827|12298056|FG012|Treated (All Treated Population)|Overall Study||0
11113929|NCT01295827|12298057|FG013|Treated (All Treated Population)|Overall Study||0
11113930|NCT01295827|12298058|FG014|Treated (All Treated Population)|Overall Study||0
11113931|NCT01295827|12298044|FG000|COMPLETED|Overall Study||0
11113932|NCT01295827|12298045|FG001|COMPLETED|Overall Study||0
11113933|NCT01295827|12298046|FG002|COMPLETED|Overall Study||0
11113934|NCT01295827|12298047|FG003|COMPLETED|Overall Study||0
11113935|NCT01295827|12298048|FG004|COMPLETED|Overall Study||1
11113936|NCT01295827|12298049|FG005|COMPLETED|Overall Study||0
11113937|NCT01295827|12298050|FG006|COMPLETED|Overall Study||18
11113938|NCT01295827|12298051|FG007|COMPLETED|Overall Study||24
11113939|NCT01295827|12298052|FG008|COMPLETED|Overall Study||14
11113940|NCT01295827|12298053|FG009|COMPLETED|Overall Study||6
11113941|NCT01295827|12298054|FG010|COMPLETED|Overall Study||20
11113942|NCT01295827|12298055|FG011|COMPLETED|Overall Study||17
11113943|NCT01295827|12298056|FG012|COMPLETED|Overall Study||0
11113944|NCT01295827|12298057|FG013|COMPLETED|Overall Study||0
11113945|NCT01295827|12298058|FG014|COMPLETED|Overall Study||0
11113946|NCT01295827|12298044|FG000|NOT COMPLETED|Overall Study||4
11113947|NCT01295827|12298045|FG001|NOT COMPLETED|Overall Study||3
11113948|NCT01295827|12298046|FG002|NOT COMPLETED|Overall Study||12
11113949|NCT01295827|12298047|FG003|NOT COMPLETED|Overall Study||4
11113950|NCT01295827|12298048|FG004|NOT COMPLETED|Overall Study||2
11113951|NCT01295827|12298049|FG005|NOT COMPLETED|Overall Study||6
11113952|NCT01295827|12298050|FG006|NOT COMPLETED|Overall Study||146
11113953|NCT01295827|12298051|FG007|NOT COMPLETED|Overall Study||297
11113954|NCT01295827|12298052|FG008|NOT COMPLETED|Overall Study||169
11113955|NCT01295827|12298053|FG009|NOT COMPLETED|Overall Study||55
11113956|NCT01295827|12298054|FG010|NOT COMPLETED|Overall Study||276
11113957|NCT01295827|12298055|FG011|NOT COMPLETED|Overall Study||186
11113958|NCT01295827|12298056|FG012|NOT COMPLETED|Overall Study||0
11113959|NCT01295827|12298057|FG013|NOT COMPLETED|Overall Study||0
11113960|NCT01295827|12298058|FG014|NOT COMPLETED|Overall Study||0
11113961|NCT01295840|12298111|FG000|STARTED|Overall Study||51
11113962|NCT01295840|12298111|FG000|COMPLETED|Overall Study||50
11113963|NCT01295840|12298111|FG000|NOT COMPLETED|Overall Study||1
11113964|NCT01295879|12298117|FG000|STARTED|Overall Study||29
11113965|NCT01295879|12298117|FG000|COMPLETED|Overall Study||29
11113966|NCT01295879|12298117|FG000|NOT COMPLETED|Overall Study||0
11113967|NCT01295905|12298123|FG000|STARTED|Overall Study||60
11113968|NCT01295905|12298124|FG001|STARTED|Overall Study||30
11113969|NCT01295905|12298123|FG000|COMPLETED|Overall Study||58
11113970|NCT01295905|12298124|FG001|COMPLETED|Overall Study||30
11113971|NCT01295905|12298123|FG000|NOT COMPLETED|Overall Study||2
11113972|NCT01295905|12298124|FG001|NOT COMPLETED|Overall Study||0
11113973|NCT01296035|12298130|FG000|STARTED|Overall Study||8
11113974|NCT01296035|12298130|FG000|COMPLETED|Overall Study||7
11113975|NCT01296035|12298130|FG000|NOT COMPLETED|Overall Study||1
11113976|NCT01296152|12298134|FG000|STARTED|Overall Study||25
11113977|NCT01296152|12298134|FG000|COMPLETED|Overall Study||24
11113978|NCT01296152|12298134|FG000|NOT COMPLETED|Overall Study||1
11113979|NCT01296191|12298140|FG000|STARTED|Overall Study||60
11113980|NCT01296191|12298141|FG001|STARTED|Overall Study||60
11113981|NCT01296191|12298140|FG000|COMPLETED|Overall Study||57
11113982|NCT01296191|12298141|FG001|COMPLETED|Overall Study||59
11113983|NCT01296191|12298140|FG000|NOT COMPLETED|Overall Study||3
11113984|NCT01296191|12298141|FG001|NOT COMPLETED|Overall Study||1
11113985|NCT01296347|12298149|FG000|STARTED|Allocation||38
11113986|NCT01296347|12298150|FG001|STARTED|Allocation||39
11113987|NCT01296347|12298149|FG000|COMPLETED|Allocation||35
11113988|NCT01296347|12298150|FG001|COMPLETED|Allocation||35
11113989|NCT01296347|12298149|FG000|NOT COMPLETED|Allocation||3
11113990|NCT01296347|12298150|FG001|NOT COMPLETED|Allocation||4
11113991|NCT01296347|12298149|FG000|STARTED|6 Week Follow up||35
11113992|NCT01296347|12298150|FG001|STARTED|6 Week Follow up||35
11113993|NCT01296347|12298149|FG000|COMPLETED|6 Week Follow up||35
11113994|NCT01296347|12298150|FG001|COMPLETED|6 Week Follow up||34
11113995|NCT01296347|12298149|FG000|NOT COMPLETED|6 Week Follow up||0
11113996|NCT01296347|12298150|FG001|NOT COMPLETED|6 Week Follow up||1
11113997|NCT01296347|12298149|FG000|STARTED|3 Month Follow up||35
11113998|NCT01296347|12298150|FG001|STARTED|3 Month Follow up||34
11113999|NCT01296347|12298149|FG000|COMPLETED|3 Month Follow up||34
11114000|NCT01296347|12298150|FG001|COMPLETED|3 Month Follow up||33
11114001|NCT01296347|12298149|FG000|NOT COMPLETED|3 Month Follow up||1
11114002|NCT01296347|12298150|FG001|NOT COMPLETED|3 Month Follow up||1
11114003|NCT01296347|12298149|FG000|STARTED|6 Month Follow up||34
11114004|NCT01296347|12298150|FG001|STARTED|6 Month Follow up||33
11114005|NCT01296347|12298149|FG000|COMPLETED|6 Month Follow up||32
11114006|NCT01296347|12298150|FG001|COMPLETED|6 Month Follow up||31
11114007|NCT01296347|12298149|FG000|NOT COMPLETED|6 Month Follow up||2
11114008|NCT01296347|12298150|FG001|NOT COMPLETED|6 Month Follow up||2
11114009|NCT01296347|12298149|FG000|STARTED|12 Month Follow up||32
11114010|NCT01296347|12298150|FG001|STARTED|12 Month Follow up||31
11114011|NCT01296347|12298149|FG000|COMPLETED|12 Month Follow up||28
11114012|NCT01296347|12298150|FG001|COMPLETED|12 Month Follow up||28
11114013|NCT01296347|12298149|FG000|NOT COMPLETED|12 Month Follow up||4
11114014|NCT01296347|12298150|FG001|NOT COMPLETED|12 Month Follow up||3
11114015|NCT01296360|12298161|FG000|STARTED|Overall Study||150
11114016|NCT01296360|12298162|FG001|STARTED|Overall Study||150
11114017|NCT01296360|12298161|FG000|Visit 2 (Month 12)|Overall Study|booster was administered|148
11114018|NCT01296360|12298162|FG001|Visit 2 (Month 12)|Overall Study||149
11114019|NCT01296360|12298161|FG000|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
11114020|NCT01296360|12298162|FG001|Visit 2a (Month 13)|Overall Study||0
11114021|NCT01296360|12298161|FG000|COMPLETED|Overall Study||144
11232381|NCT02036580|12424551|FG000|NOT COMPLETED|Overall Study||1
11232382|NCT02036580|12424552|FG001|NOT COMPLETED|Overall Study||1
11114022|NCT01296360|12298162|FG001|COMPLETED|Overall Study||142
11114023|NCT01296360|12298161|FG000|NOT COMPLETED|Overall Study||6
11114024|NCT01296360|12298162|FG001|NOT COMPLETED|Overall Study||8
11114025|NCT01296412|12298170|FG000|STARTED|Overall Study||326
11114026|NCT01296412|12298171|FG001|STARTED|Overall Study||327
11114027|NCT01296412|12298170|FG000|COMPLETED|Overall Study||275
11114028|NCT01296412|12298171|FG001|COMPLETED|Overall Study||257
11114029|NCT01296412|12298170|FG000|NOT COMPLETED|Overall Study||51
11114030|NCT01296412|12298171|FG001|NOT COMPLETED|Overall Study||70
11114031|NCT01296542|12298179|FG000|STARTED|Overall Study||30
11232383|NCT02036580|12424553|FG002|NOT COMPLETED|Overall Study||0
11232384|NCT02036645|12424573|FG000|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12
11232385|NCT02036645|12424574|FG001|STARTED|SAD Cohorts : Study Part 1||3
11232386|NCT02036645|12424575|FG002|STARTED|SAD Cohorts : Study Part 1||6
11232387|NCT02036645|12424576|FG003|STARTED|SAD Cohorts : Study Part 1||6
11114032|NCT01296542|12298180|FG001|STARTED|Overall Study||30
11114033|NCT01296542|12298179|FG000|COMPLETED|Overall Study||30
11114034|NCT01296542|12298180|FG001|COMPLETED|Overall Study||28
11114035|NCT01296542|12298179|FG000|NOT COMPLETED|Overall Study||0
11232388|NCT02036645|12424577|FG004|STARTED|SAD Cohorts : Study Part 1||6
11232389|NCT02036645|12424578|FG005|STARTED|SAD Cohorts : Study Part 1||6
11114036|NCT01296542|12298180|FG001|NOT COMPLETED|Overall Study||2
11114037|NCT01296568|12298186|FG000|STARTED|[^14C]LY2603618 Single Dose and Washout||3
11114038|NCT01296568|12298186|FG000|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
11114039|NCT01296568|12298186|FG000|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
11114040|NCT01296568|12298186|FG000|STARTED|Continued Access Phase||3
11114041|NCT01296568|12298186|FG000|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
11114042|NCT01296568|12298186|FG000|NOT COMPLETED|Continued Access Phase||3
11114043|NCT01296646|12298194|FG000|STARTED|Overall Study||40
11114044|NCT01296646|12298195|FG001|STARTED|Overall Study||40
11114045|NCT01296646|12298194|FG000|COMPLETED|Overall Study||29
11114046|NCT01296646|12298195|FG001|COMPLETED|Overall Study||29
11114047|NCT01296646|12298194|FG000|NOT COMPLETED|Overall Study||11
11114048|NCT01296646|12298195|FG001|NOT COMPLETED|Overall Study||11
11232390|NCT02036645|12424579|FG006|STARTED|SAD Cohorts : Study Part 1||6
11232391|NCT02036645|12424580|FG007|STARTED|SAD Cohorts : Study Part 1||0
11232392|NCT02036645|12424581|FG008|STARTED|SAD Cohorts : Study Part 1||0
11232393|NCT02036645|12424582|FG009|STARTED|SAD Cohorts : Study Part 1||0
11232394|NCT02036645|12424583|FG010|STARTED|SAD Cohorts : Study Part 1||0
11232395|NCT02036645|12424584|FG011|STARTED|SAD Cohorts : Study Part 1||0
11232396|NCT02036645|12424573|FG000|COMPLETED|SAD Cohorts : Study Part 1||12
11232397|NCT02036645|12424574|FG001|COMPLETED|SAD Cohorts : Study Part 1||3
11232398|NCT02036645|12424575|FG002|COMPLETED|SAD Cohorts : Study Part 1||6
11232399|NCT02036645|12424576|FG003|COMPLETED|SAD Cohorts : Study Part 1||5
11232400|NCT02036645|12424577|FG004|COMPLETED|SAD Cohorts : Study Part 1||6
11232401|NCT02036645|12424578|FG005|COMPLETED|SAD Cohorts : Study Part 1||6
11232402|NCT02036645|12424579|FG006|COMPLETED|SAD Cohorts : Study Part 1||5
11232403|NCT02036645|12424580|FG007|COMPLETED|SAD Cohorts : Study Part 1||0
11232404|NCT02036645|12424581|FG008|COMPLETED|SAD Cohorts : Study Part 1||0
11232405|NCT02036645|12424582|FG009|COMPLETED|SAD Cohorts : Study Part 1||0
11232406|NCT02036645|12424583|FG010|COMPLETED|SAD Cohorts : Study Part 1||0
11232407|NCT02036645|12424584|FG011|COMPLETED|SAD Cohorts : Study Part 1||0
11232408|NCT02036645|12424573|FG000|NOT COMPLETED|SAD Cohorts : Study Part 1||0
11232409|NCT02036645|12424574|FG001|NOT COMPLETED|SAD Cohorts : Study Part 1||0
11232410|NCT02036645|12424575|FG002|NOT COMPLETED|SAD Cohorts : Study Part 1||0
11232411|NCT02036645|12424576|FG003|NOT COMPLETED|SAD Cohorts : Study Part 1||1
11232412|NCT02036645|12424577|FG004|NOT COMPLETED|SAD Cohorts : Study Part 1||0
11232413|NCT02036645|12424578|FG005|NOT COMPLETED|SAD Cohorts : Study Part 1||0
11232414|NCT02036645|12424579|FG006|NOT COMPLETED|SAD Cohorts : Study Part 1||1
11232415|NCT02036645|12424580|FG007|NOT COMPLETED|SAD Cohorts : Study Part 1||0
11232416|NCT02036645|12424581|FG008|NOT COMPLETED|SAD Cohorts : Study Part 1||0
11232417|NCT02036645|12424582|FG009|NOT COMPLETED|SAD Cohorts : Study Part 1||0
11232418|NCT02036645|12424583|FG010|NOT COMPLETED|SAD Cohorts : Study Part 1||0
11232419|NCT02036645|12424584|FG011|NOT COMPLETED|SAD Cohorts : Study Part 1||0
11232420|NCT02036645|12424573|FG000|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0
11114049|NCT01296672|12298203|FG000|STARTED|Overall Study||306
11114050|NCT01296672|12298204|FG001|STARTED|Overall Study||77
11114051|NCT01296672|12298203|FG000|COMPLETED|Overall Study||233
11114052|NCT01296672|12298204|FG001|COMPLETED|Overall Study||59
11114053|NCT01296672|12298203|FG000|NOT COMPLETED|Overall Study||73
11114054|NCT01296672|12298204|FG001|NOT COMPLETED|Overall Study||18
11114055|NCT01296698|12298214|FG000|STARTED|Overall Study||244
11114056|NCT01296698|12298215|FG001|STARTED|Overall Study||13
11114057|NCT01296698|12298214|FG000|COMPLETED|Overall Study||0
11114058|NCT01296698|12298215|FG001|COMPLETED|Overall Study||0
11114059|NCT01296698|12298214|FG000|NOT COMPLETED|Overall Study||244
11114060|NCT01296698|12298215|FG001|NOT COMPLETED|Overall Study||13
11114061|NCT01296763|12298224|FG000|STARTED|Overall Study||7
11114062|NCT01296763|12298225|FG001|STARTED|Overall Study||5
11114063|NCT01296763|12298226|FG002|STARTED|Overall Study||6
11114064|NCT01296763|12298224|FG000|COMPLETED|Overall Study||7
11114065|NCT01296763|12298225|FG001|COMPLETED|Overall Study||5
11114066|NCT01296763|12298226|FG002|COMPLETED|Overall Study||6
11114067|NCT01296763|12298224|FG000|NOT COMPLETED|Overall Study||0
11114068|NCT01296763|12298225|FG001|NOT COMPLETED|Overall Study||0
11114069|NCT01296763|12298226|FG002|NOT COMPLETED|Overall Study||0
11114070|NCT01296815|12298236|FG000|STARTED|Overall Study||7
11114071|NCT01296815|12298237|FG001|STARTED|Overall Study||7
11114072|NCT01296815|12298236|FG000|COMPLETED|Overall Study||7
11114073|NCT01296815|12298237|FG001|COMPLETED|Overall Study||7
11114074|NCT01296815|12298236|FG000|NOT COMPLETED|Overall Study||0
11114075|NCT01296815|12298237|FG001|NOT COMPLETED|Overall Study||0
11114076|NCT01296841|12298245|FG000|STARTED|Overall Study||19
11114077|NCT01296841|12298246|FG001|STARTED|Overall Study||15
11114078|NCT01296841|12298245|FG000|COMPLETED|Overall Study||19
11114079|NCT01296841|12298246|FG001|COMPLETED|Overall Study||15
11114080|NCT01296841|12298245|FG000|NOT COMPLETED|Overall Study||0
11114081|NCT01296841|12298246|FG001|NOT COMPLETED|Overall Study||0
11114082|NCT01296932|12298263|FG000|STARTED|Overall Study||3
11114083|NCT01296932|12298264|FG001|STARTED|Overall Study||3
11114084|NCT01296932|12298265|FG002|STARTED|Overall Study||6
11114085|NCT01296932|12298266|FG003|STARTED|Overall Study||6
11114086|NCT01296932|12298267|FG004|STARTED|Overall Study||3
11114087|NCT01296932|12298268|FG005|STARTED|Overall Study||3
11114088|NCT01296932|12298269|FG006|STARTED|Overall Study||6
11114089|NCT01296932|12298270|FG007|STARTED|Overall Study||3
11232421|NCT02036645|12424574|FG001|STARTED|MAD Cohorts: Study Part 2||0
11232422|NCT02036645|12424575|FG002|STARTED|MAD Cohorts: Study Part 2||0
11232423|NCT02036645|12424576|FG003|STARTED|MAD Cohorts: Study Part 2||0
11114090|NCT01296932|12298271|FG008|STARTED|Overall Study||4
11114091|NCT01296932|12298263|FG000|COMPLETED|Overall Study||0
11114092|NCT01296932|12298264|FG001|COMPLETED|Overall Study||0
11114093|NCT01296932|12298265|FG002|COMPLETED|Overall Study||0
11114094|NCT01296932|12298266|FG003|COMPLETED|Overall Study||0
11114095|NCT01296932|12298267|FG004|COMPLETED|Overall Study||0
11114096|NCT01296932|12298268|FG005|COMPLETED|Overall Study||0
11114097|NCT01296932|12298269|FG006|COMPLETED|Overall Study||0
11114098|NCT01296932|12298270|FG007|COMPLETED|Overall Study||1
11114099|NCT01296932|12298271|FG008|COMPLETED|Overall Study||0
11114100|NCT01296932|12298263|FG000|NOT COMPLETED|Overall Study||3
11114101|NCT01296932|12298264|FG001|NOT COMPLETED|Overall Study||3
11114102|NCT01296932|12298265|FG002|NOT COMPLETED|Overall Study||6
11114103|NCT01296932|12298266|FG003|NOT COMPLETED|Overall Study||6
11114104|NCT01296932|12298267|FG004|NOT COMPLETED|Overall Study||3
11114105|NCT01296932|12298268|FG005|NOT COMPLETED|Overall Study||3
11114106|NCT01296932|12298269|FG006|NOT COMPLETED|Overall Study||6
11114107|NCT01296932|12298270|FG007|NOT COMPLETED|Overall Study||2
11114108|NCT01296932|12298271|FG008|NOT COMPLETED|Overall Study||4
11114109|NCT01297062|12298298|FG000|STARTED|Overall Study||15
11114110|NCT01297062|12298299|FG001|STARTED|Overall Study||14
11114111|NCT01297062|12298300|FG002|STARTED|Overall Study||14
11114112|NCT01297062|12298301|FG003|STARTED|Overall Study||14
11114113|NCT01297062|12298302|FG004|STARTED|Overall Study||15
11114114|NCT01297062|12298303|FG005|STARTED|Overall Study||14
11114115|NCT01297062|12298304|FG006|STARTED|Overall Study||8
11114116|NCT01297062|12298298|FG000|Intent to Treat (ITT)|Overall Study||15
11114117|NCT01297062|12298299|FG001|Intent to Treat (ITT)|Overall Study||14
11114118|NCT01297062|12298300|FG002|Intent to Treat (ITT)|Overall Study||14
11114119|NCT01297062|12298301|FG003|Intent to Treat (ITT)|Overall Study||14
11114120|NCT01297062|12298302|FG004|Intent to Treat (ITT)|Overall Study||15
11114121|NCT01297062|12298303|FG005|Intent to Treat (ITT)|Overall Study||14
11114122|NCT01297062|12298304|FG006|Intent to Treat (ITT)|Overall Study||0
11114123|NCT01297062|12298298|FG000|Evaluable Population|Overall Study||11
11114124|NCT01297062|12298299|FG001|Evaluable Population|Overall Study||12
11114125|NCT01297062|12298300|FG002|Evaluable Population|Overall Study||12
11114126|NCT01297062|12298301|FG003|Evaluable Population|Overall Study||13
11114127|NCT01297062|12298302|FG004|Evaluable Population|Overall Study||13
11114128|NCT01297062|12298303|FG005|Evaluable Population|Overall Study||13
11114129|NCT01297062|12298304|FG006|Evaluable Population|Overall Study||0
11114130|NCT01297062|12298298|FG000|COMPLETED|Overall Study||11
11114131|NCT01297062|12298299|FG001|COMPLETED|Overall Study||13
11114132|NCT01297062|12298300|FG002|COMPLETED|Overall Study||12
11114133|NCT01297062|12298301|FG003|COMPLETED|Overall Study||13
11114134|NCT01297062|12298302|FG004|COMPLETED|Overall Study||13
11114135|NCT01297062|12298303|FG005|COMPLETED|Overall Study||13
11232424|NCT02036645|12424577|FG004|STARTED|MAD Cohorts: Study Part 2||0
11114136|NCT01297062|12298304|FG006|COMPLETED|Overall Study||0
11114137|NCT01297062|12298298|FG000|NOT COMPLETED|Overall Study||4
11114138|NCT01297062|12298299|FG001|NOT COMPLETED|Overall Study||1
11114139|NCT01297062|12298300|FG002|NOT COMPLETED|Overall Study||2
11114140|NCT01297062|12298301|FG003|NOT COMPLETED|Overall Study||1
11114141|NCT01297062|12298302|FG004|NOT COMPLETED|Overall Study||2
11114142|NCT01297062|12298303|FG005|NOT COMPLETED|Overall Study||1
11114143|NCT01297062|12298304|FG006|NOT COMPLETED|Overall Study||8
11114144|NCT01297244|12298314|FG000|STARTED|Overall Study||90
11114145|NCT01297244|12298315|FG001|STARTED|Overall Study||15
11114146|NCT01297244|12298314|FG000|COMPLETED|Overall Study||55
11114147|NCT01297244|12298315|FG001|COMPLETED|Overall Study||9
11114148|NCT01297244|12298314|FG000|NOT COMPLETED|Overall Study||35
11114149|NCT01297244|12298315|FG001|NOT COMPLETED|Overall Study||6
11114150|NCT01297257|12298322|FG000|STARTED|Overall Study||7740
11114151|NCT01297257|12298322|FG000|COMPLETED|Overall Study||7740
11114152|NCT01297257|12298322|FG000|NOT COMPLETED|Overall Study||0
11114153|NCT01297270|12298330|FG000|STARTED|Overall Study||262
11114154|NCT01297270|12298331|FG001|STARTED|Overall Study||264
11114155|NCT01297270|12298332|FG002|STARTED|Overall Study||132
11114156|NCT01297270|12298330|FG000|COMPLETED|Overall Study||217
11114157|NCT01297270|12298331|FG001|COMPLETED|Overall Study||192
11114158|NCT01297270|12298332|FG002|COMPLETED|Overall Study||103
11114159|NCT01297270|12298330|FG000|NOT COMPLETED|Overall Study||45
11356140|NCT03092791|12553076|FG006|NOT COMPLETED|Overall Study||60
11356141|NCT03092791|12553077|FG007|NOT COMPLETED|Overall Study||60
11356142|NCT03092934|12553099|FG000|STARTED|Overall Study||8
11356143|NCT03092934|12553100|FG001|STARTED|Overall Study||2
11356144|NCT03092934|12553101|FG002|STARTED|Overall Study||2
11356145|NCT03092934|12553102|FG003|STARTED|Overall Study||1
11114160|NCT01297270|12298331|FG001|NOT COMPLETED|Overall Study||72
11356146|NCT03092934|12553099|FG000|Received at Least One Dose of Study Drug|Overall Study||8
11114161|NCT01297270|12298332|FG002|NOT COMPLETED|Overall Study||29
11114162|NCT01297283|12298340|FG000|STARTED|Overall Study||195
11114163|NCT01297283|12298340|FG000|COMPLETED|Overall Study||176
11114164|NCT01297283|12298340|FG000|NOT COMPLETED|Overall Study||19
11114165|NCT01297309|12298344|FG000|STARTED|Overall Study||51
11114166|NCT01297309|12298344|FG000|Treated|Overall Study||49
11114167|NCT01297309|12298344|FG000|Started Extension Period|Overall Study||46
11114168|NCT01297309|12298344|FG000|COMPLETED|Overall Study||37
11114169|NCT01297309|12298344|FG000|NOT COMPLETED|Overall Study||14
11114170|NCT01297322|12298350|FG000|STARTED|Overall Study||142
11114171|NCT01297322|12298351|FG001|STARTED|Overall Study||278
11114172|NCT01297322|12298350|FG000|COMPLETED|Overall Study||141
11114173|NCT01297322|12298351|FG001|COMPLETED|Overall Study||274
11114174|NCT01297322|12298350|FG000|NOT COMPLETED|Overall Study||1
11114175|NCT01297322|12298351|FG001|NOT COMPLETED|Overall Study||4
11114176|NCT01297335|12298358|FG000|STARTED|Overall Study||10
11114177|NCT01297335|12298358|FG000|COMPLETED|Overall Study||10
11114178|NCT01297335|12298358|FG000|NOT COMPLETED|Overall Study||0
11114179|NCT01297348|12298366|FG000|STARTED|Overall Study||12281
11114180|NCT01297348|12298367|FG001|STARTED|Overall Study||586401
11114181|NCT01297348|12298366|FG000|COMPLETED|Overall Study||12281
11114182|NCT01297348|12298367|FG001|COMPLETED|Overall Study||586401
11114183|NCT01297348|12298366|FG000|NOT COMPLETED|Overall Study||0
11114184|NCT01297348|12298367|FG001|NOT COMPLETED|Overall Study||0
11114185|NCT01297465|12298376|FG000|STARTED|Overall Study||99
11114186|NCT01297465|12298377|FG001|STARTED|Overall Study||103
11114187|NCT01297465|12298376|FG000|COMPLETED|Overall Study||91
11114188|NCT01297465|12298377|FG001|COMPLETED|Overall Study||93
11114189|NCT01297465|12298376|FG000|NOT COMPLETED|Overall Study||8
11114190|NCT01297465|12298377|FG001|NOT COMPLETED|Overall Study||10
11114191|NCT01297491|12298385|FG000|STARTED|Overall Study||30
11114192|NCT01297491|12298386|FG001|STARTED|Overall Study||33
11114193|NCT01297491|12298385|FG000|COMPLETED|Overall Study||0
11114194|NCT01297491|12298386|FG001|COMPLETED|Overall Study||0
11114195|NCT01297491|12298385|FG000|NOT COMPLETED|Overall Study||30
11114196|NCT01297491|12298386|FG001|NOT COMPLETED|Overall Study||33
11114197|NCT01297504|12298392|FG000|STARTED|Overall Study||464
11114198|NCT01297504|12298392|FG000|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
11114199|NCT01297504|12298392|FG000|COMPLETED|Overall Study||397
11114200|NCT01297504|12298392|FG000|NOT COMPLETED|Overall Study||67
11114201|NCT01297517|12298403|FG000|STARTED|Overall Study||214
11114202|NCT01297517|12298404|FG001|STARTED|Overall Study||226
11114203|NCT01297517|12298405|FG002|STARTED|Overall Study||220
11114204|NCT01297517|12298403|FG000|COMPLETED|Overall Study||187
11114205|NCT01297517|12298404|FG001|COMPLETED|Overall Study||214
11114206|NCT01297517|12298405|FG002|COMPLETED|Overall Study||193
11114207|NCT01297517|12298403|FG000|NOT COMPLETED|Overall Study||27
11114208|NCT01297517|12298404|FG001|NOT COMPLETED|Overall Study||12
11114209|NCT01297517|12298405|FG002|NOT COMPLETED|Overall Study||27
11114210|NCT01297595|12298413|FG000|STARTED|First Intervention Period||11
11114211|NCT01297595|12298414|FG001|STARTED|First Intervention Period||11
11114212|NCT01297595|12298413|FG000|COMPLETED|First Intervention Period||11
11114213|NCT01297595|12298414|FG001|COMPLETED|First Intervention Period||11
11114214|NCT01297595|12298413|FG000|NOT COMPLETED|First Intervention Period||0
11114215|NCT01297595|12298414|FG001|NOT COMPLETED|First Intervention Period||0
11114216|NCT01297595|12298413|FG000|STARTED|Washout Period (At Least 14 Days)||11
11114217|NCT01297595|12298414|FG001|STARTED|Washout Period (At Least 14 Days)||11
11114218|NCT01297595|12298413|FG000|COMPLETED|Washout Period (At Least 14 Days)||11
11114219|NCT01297595|12298414|FG001|COMPLETED|Washout Period (At Least 14 Days)||11
11114220|NCT01297595|12298413|FG000|NOT COMPLETED|Washout Period (At Least 14 Days)||0
11114221|NCT01297595|12298414|FG001|NOT COMPLETED|Washout Period (At Least 14 Days)||0
11114222|NCT01297595|12298413|FG000|STARTED|Second Intervention Period||11
11114223|NCT01297595|12298414|FG001|STARTED|Second Intervention Period||11
11114224|NCT01297595|12298413|FG000|COMPLETED|Second Intervention Period||11
11114225|NCT01297595|12298414|FG001|COMPLETED|Second Intervention Period||11
11114226|NCT01297595|12298413|FG000|NOT COMPLETED|Second Intervention Period||0
11114227|NCT01297595|12298414|FG001|NOT COMPLETED|Second Intervention Period||0
11114228|NCT01297920|12298423|FG000|STARTED|Overall Study||221
11114229|NCT01297920|12298424|FG001|STARTED|Overall Study||234
11114230|NCT01297920|12298425|FG002|STARTED|Overall Study||235
11114231|NCT01297920|12298423|FG000|COMPLETED|Overall Study||163
11114232|NCT01297920|12298424|FG001|COMPLETED|Overall Study||207
11114233|NCT01297920|12298425|FG002|COMPLETED|Overall Study||178
11114234|NCT01297920|12298423|FG000|NOT COMPLETED|Overall Study||58
11114235|NCT01297920|12298424|FG001|NOT COMPLETED|Overall Study||27
11114236|NCT01297920|12298425|FG002|NOT COMPLETED|Overall Study||57
11114237|NCT01297959|12298435|FG000|STARTED|Overall Study||261
11114238|NCT01297959|12298436|FG001|STARTED|Overall Study||242
11114239|NCT01297959|12298435|FG000|COMPLETED|Overall Study||241
11114240|NCT01297959|12298436|FG001|COMPLETED|Overall Study||226
11114241|NCT01297959|12298435|FG000|NOT COMPLETED|Overall Study||20
11114242|NCT01297959|12298436|FG001|NOT COMPLETED|Overall Study||16
11114243|NCT01297985|12298444|FG000|STARTED|Overall Study||212
11114244|NCT01297985|12298445|FG001|STARTED|Overall Study||216
11114245|NCT01297985|12298444|FG000|COMPLETED|Overall Study||157
11114246|NCT01297985|12298445|FG001|COMPLETED|Overall Study||163
11114247|NCT01297985|12298444|FG000|NOT COMPLETED|Overall Study||55
11114248|NCT01297985|12298445|FG001|NOT COMPLETED|Overall Study||53
11232425|NCT02036645|12424578|FG005|STARTED|MAD Cohorts: Study Part 2||0
11232426|NCT02036645|12424579|FG006|STARTED|MAD Cohorts: Study Part 2||0
11232427|NCT02036645|12424580|FG007|STARTED|MAD Cohorts: Study Part 2||8
11232428|NCT02036645|12424581|FG008|STARTED|MAD Cohorts: Study Part 2||6
11114249|NCT01298063|12298456|FG000|STARTED|Overall Study||8
11114250|NCT01298063|12298457|FG001|STARTED|Overall Study||3
11114251|NCT01298063|12298458|FG002|STARTED|Overall Study||8
11232429|NCT02036645|12424582|FG009|STARTED|MAD Cohorts: Study Part 2||6
11114252|NCT01298063|12298459|FG003|STARTED|Overall Study||8
11114253|NCT01298063|12298460|FG004|STARTED|Overall Study||8
11114254|NCT01298063|12298456|FG000|COMPLETED|Overall Study||8
11114255|NCT01298063|12298457|FG001|COMPLETED|Overall Study||3
11114256|NCT01298063|12298458|FG002|COMPLETED|Overall Study||8
11114257|NCT01298063|12298459|FG003|COMPLETED|Overall Study||8
11114258|NCT01298063|12298460|FG004|COMPLETED|Overall Study||8
11114259|NCT01298063|12298456|FG000|NOT COMPLETED|Overall Study||0
11114260|NCT01298063|12298457|FG001|NOT COMPLETED|Overall Study||0
11114261|NCT01298063|12298458|FG002|NOT COMPLETED|Overall Study||0
11114262|NCT01298063|12298459|FG003|NOT COMPLETED|Overall Study||0
11114263|NCT01298063|12298460|FG004|NOT COMPLETED|Overall Study||0
11114264|NCT01298128|12298475|FG000|STARTED|Overall Study||35
11114265|NCT01298128|12298476|FG001|STARTED|Overall Study||35
11114266|NCT01298128|12298475|FG000|COMPLETED|Overall Study||26
11114267|NCT01298128|12298476|FG001|COMPLETED|Overall Study||27
11114268|NCT01298128|12298475|FG000|NOT COMPLETED|Overall Study||9
11114269|NCT01298128|12298476|FG001|NOT COMPLETED|Overall Study||8
11114270|NCT01298141|12298482|FG000|STARTED|Overall Study||171
11114271|NCT01298141|12298482|FG000|Treated|Overall Study||167
11114272|NCT01298141|12298482|FG000|COMPLETED|Overall Study||140
11114273|NCT01298141|12298482|FG000|NOT COMPLETED|Overall Study||31
11114274|NCT01298167|12298488|FG000|STARTED|Overall Study||6
11114275|NCT01298167|12298489|FG001|STARTED|Overall Study||8
11114276|NCT01298167|12298488|FG000|COMPLETED|Overall Study||5
11114277|NCT01298167|12298489|FG001|COMPLETED|Overall Study||8
11114278|NCT01298167|12298488|FG000|NOT COMPLETED|Overall Study||1
11114279|NCT01298167|12298489|FG001|NOT COMPLETED|Overall Study||0
11114280|NCT01298193|12298495|FG000|STARTED|Observational Phase (First Cycle)||212
11114281|NCT01298193|12298495|FG000|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185
11114282|NCT01298193|12298495|FG000|NOT COMPLETED|Observational Phase (First Cycle)||27
11114283|NCT01298193|12298495|FG000|STARTED|Efficacy Phase (Second Cycle)||24
11114284|NCT01298193|12298495|FG000|COMPLETED|Efficacy Phase (Second Cycle)||23
11114285|NCT01298193|12298495|FG000|NOT COMPLETED|Efficacy Phase (Second Cycle)||1
11114286|NCT01298219|12298504|FG000|STARTED|Overall Study||219
11114287|NCT01298219|12298505|FG001|STARTED|Overall Study||220
11114288|NCT01298219|12298504|FG000|Intention to Treat (ITT)|Overall Study||219
11114289|NCT01298219|12298505|FG001|Intention to Treat (ITT)|Overall Study||220
11114290|NCT01298219|12298504|FG000|Safety Analysis Set|Overall Study||219
11114291|NCT01298219|12298505|FG001|Safety Analysis Set|Overall Study||220
11114292|NCT01298219|12298504|FG000|COMPLETED|Overall Study||169
11114293|NCT01298219|12298505|FG001|COMPLETED|Overall Study||184
11114294|NCT01298219|12298504|FG000|NOT COMPLETED|Overall Study||50
11114295|NCT01298219|12298505|FG001|NOT COMPLETED|Overall Study||36
11232430|NCT02036645|12424583|FG010|STARTED|MAD Cohorts: Study Part 2||6
11114296|NCT01298323|12298513|FG000|STARTED|Overall Study||102
11114297|NCT01298323|12298514|FG001|STARTED|Overall Study||103
11114298|NCT01298323|12298513|FG000|Ongoing|Overall Study||55
11114299|NCT01298323|12298514|FG001|Ongoing|Overall Study||55
11114300|NCT01298323|12298513|FG000|COMPLETED|Overall Study||16
11114301|NCT01298323|12298514|FG001|COMPLETED|Overall Study||15
11114302|NCT01298323|12298513|FG000|NOT COMPLETED|Overall Study||86
11114303|NCT01298323|12298514|FG001|NOT COMPLETED|Overall Study||88
11232431|NCT02036645|12424584|FG011|STARTED|MAD Cohorts: Study Part 2||6
11114304|NCT01298362|12298522|FG000|STARTED|Overall Study||124
11114305|NCT01298362|12298523|FG001|STARTED|Overall Study||166
11114306|NCT01298362|12298522|FG000|COMPLETED|Overall Study||86
11114307|NCT01298362|12298523|FG001|COMPLETED|Overall Study||123
11114308|NCT01298362|12298522|FG000|NOT COMPLETED|Overall Study||38
11114309|NCT01298362|12298523|FG001|NOT COMPLETED|Overall Study||43
11114310|NCT01298492|12298531|FG000|STARTED|Overall Study||268
11114311|NCT01298492|12298531|FG000|COMPLETED|Overall Study||149
11114312|NCT01298492|12298531|FG000|NOT COMPLETED|Overall Study||119
11114313|NCT01298518|12298538|FG000|STARTED|Overall Study||16
11114314|NCT01298518|12298539|FG001|STARTED|Overall Study||16
11114315|NCT01298518|12298540|FG002|STARTED|Overall Study||16
11114316|NCT01298518|12298538|FG000|COMPLETED|Overall Study||16
11114317|NCT01298518|12298539|FG001|COMPLETED|Overall Study||16
11114318|NCT01298518|12298540|FG002|COMPLETED|Overall Study||15
11114319|NCT01298518|12298538|FG000|NOT COMPLETED|Overall Study||0
11114320|NCT01298518|12298539|FG001|NOT COMPLETED|Overall Study||0
11114321|NCT01298518|12298540|FG002|NOT COMPLETED|Overall Study||1
11114322|NCT01298531|12298550|FG000|STARTED|Overall Study||42
11114323|NCT01298531|12298551|FG001|STARTED|Overall Study||48
11114324|NCT01298531|12298550|FG000|COMPLETED|Overall Study||33
11114325|NCT01298531|12298551|FG001|COMPLETED|Overall Study||41
11114326|NCT01298531|12298550|FG000|NOT COMPLETED|Overall Study||9
11232432|NCT02036645|12424573|FG000|COMPLETED|MAD Cohorts: Study Part 2||0
11114327|NCT01298531|12298551|FG001|NOT COMPLETED|Overall Study||7
11114328|NCT01298544|12298558|FG000|STARTED|Overall Study||335
11114329|NCT01298544|12298558|FG000|COMPLETED|Overall Study||335
11114330|NCT01298544|12298558|FG000|NOT COMPLETED|Overall Study||0
11114331|NCT01298570|12298566|FG000|STARTED|Overall Study||120
11114332|NCT01298570|12298567|FG001|STARTED|Overall Study||61
11232433|NCT02036645|12424574|FG001|COMPLETED|MAD Cohorts: Study Part 2||0
11114333|NCT01298570|12298566|FG000|COMPLETED|Overall Study||0
11114334|NCT01298570|12298567|FG001|COMPLETED|Overall Study||0
11232434|NCT02036645|12424575|FG002|COMPLETED|MAD Cohorts: Study Part 2||0
11232435|NCT02036645|12424576|FG003|COMPLETED|MAD Cohorts: Study Part 2||0
11232436|NCT02036645|12424577|FG004|COMPLETED|MAD Cohorts: Study Part 2||0
11232437|NCT02036645|12424578|FG005|COMPLETED|MAD Cohorts: Study Part 2||0
11232438|NCT02036645|12424579|FG006|COMPLETED|MAD Cohorts: Study Part 2||0
11232439|NCT02036645|12424580|FG007|COMPLETED|MAD Cohorts: Study Part 2||8
11232440|NCT02036645|12424581|FG008|COMPLETED|MAD Cohorts: Study Part 2||6
11232441|NCT02036645|12424582|FG009|COMPLETED|MAD Cohorts: Study Part 2||6
11232442|NCT02036645|12424583|FG010|COMPLETED|MAD Cohorts: Study Part 2||6
11232443|NCT02036645|12424584|FG011|COMPLETED|MAD Cohorts: Study Part 2||6
11232444|NCT02036645|12424573|FG000|NOT COMPLETED|MAD Cohorts: Study Part 2||0
11232445|NCT02036645|12424574|FG001|NOT COMPLETED|MAD Cohorts: Study Part 2||0
11114335|NCT01298570|12298566|FG000|NOT COMPLETED|Overall Study||120
11114336|NCT01298570|12298567|FG001|NOT COMPLETED|Overall Study||61
11114337|NCT01298596|12298575|FG000|STARTED|Overall Study||200
11114338|NCT01298596|12298576|FG001|STARTED|Overall Study||200
11114339|NCT01298596|12298575|FG000|COMPLETED|Overall Study||172
11114340|NCT01298596|12298576|FG001|COMPLETED|Overall Study||167
11114341|NCT01298596|12298575|FG000|NOT COMPLETED|Overall Study||28
11114342|NCT01298596|12298576|FG001|NOT COMPLETED|Overall Study||33
11114343|NCT01298648|12298582|FG000|STARTED|Overall Study||1716
11114344|NCT01298648|12298582|FG000|COMPLETED|Overall Study||1693
11114345|NCT01298648|12298582|FG000|NOT COMPLETED|Overall Study||23
11114346|NCT01298661|12298589|FG000|STARTED|Overall Study||33
11114347|NCT01298661|12298590|FG001|STARTED|Overall Study||24
11114348|NCT01298661|12298591|FG002|STARTED|Overall Study||34
11114349|NCT01298661|12298589|FG000|COMPLETED|Overall Study||31
11114350|NCT01298661|12298590|FG001|COMPLETED|Overall Study||24
11114351|NCT01298661|12298591|FG002|COMPLETED|Overall Study||32
11114352|NCT01298661|12298589|FG000|NOT COMPLETED|Overall Study||2
11114353|NCT01298661|12298590|FG001|NOT COMPLETED|Overall Study||0
11114354|NCT01298661|12298591|FG002|NOT COMPLETED|Overall Study||2
11114355|NCT01298700|12298602|FG000|STARTED|Overall Study||403
11114356|NCT01298700|12298603|FG001|STARTED|Overall Study||403
11114357|NCT01298700|12298602|FG000|Safety Population: Received Study Drug|Overall Study||400
11114358|NCT01298700|12298603|FG001|Safety Population: Received Study Drug|Overall Study||398
11114359|NCT01298700|12298602|FG000|COMPLETED|Overall Study||302
11114360|NCT01298700|12298603|FG001|COMPLETED|Overall Study||303
11114361|NCT01298700|12298602|FG000|NOT COMPLETED|Overall Study||101
11114362|NCT01298700|12298603|FG001|NOT COMPLETED|Overall Study||100
11114363|NCT01298752|12298611|FG000|STARTED|Overall Study||120
11114364|NCT01298752|12298612|FG001|STARTED|Overall Study||57
11114365|NCT01298752|12298611|FG000|COMPLETED|Overall Study||77
11114366|NCT01298752|12298612|FG001|COMPLETED|Overall Study||31
11114367|NCT01298752|12298611|FG000|NOT COMPLETED|Overall Study||43
11114368|NCT01298752|12298612|FG001|NOT COMPLETED|Overall Study||26
11114369|NCT01298765|12298618|FG000|STARTED|Titration Period||302
11114370|NCT01298765|12298618|FG000|COMPLETED|Titration Period||226
11114371|NCT01298765|12298618|FG000|NOT COMPLETED|Titration Period||76
11114372|NCT01298765|12298618|FG000|STARTED|Long-Term Treatment Period||226
11114373|NCT01298765|12298618|FG000|COMPLETED|Long-Term Treatment Period||127
11114374|NCT01298765|12298618|FG000|NOT COMPLETED|Long-Term Treatment Period||99
11114375|NCT01298778|12298624|FG000|STARTED|Overall Study||33
11114376|NCT01298778|12298625|FG001|STARTED|Overall Study||36
11114377|NCT01298778|12298624|FG000|COMPLETED|Overall Study||30
11114378|NCT01298778|12298625|FG001|COMPLETED|Overall Study||30
11114379|NCT01298778|12298624|FG000|NOT COMPLETED|Overall Study||3
11114380|NCT01298778|12298625|FG001|NOT COMPLETED|Overall Study||6
11114381|NCT01298999|12298635|FG000|STARTED|Overall Study||13
11114382|NCT01298999|12298636|FG001|STARTED|Overall Study||11
11114383|NCT01298999|12298635|FG000|COMPLETED|Overall Study||10
11114384|NCT01298999|12298636|FG001|COMPLETED|Overall Study||10
11114385|NCT01298999|12298635|FG000|NOT COMPLETED|Overall Study||3
11114386|NCT01298999|12298636|FG001|NOT COMPLETED|Overall Study||1
11114387|NCT01299025|12298644|FG000|STARTED|Overall Study||42
11114388|NCT01299025|12298645|FG001|STARTED|Overall Study||42
11114389|NCT01299025|12298644|FG000|COMPLETED|Overall Study||39
11114390|NCT01299025|12298645|FG001|COMPLETED|Overall Study||41
11114391|NCT01299025|12298644|FG000|NOT COMPLETED|Overall Study||3
11114392|NCT01299025|12298645|FG001|NOT COMPLETED|Overall Study||1
11114393|NCT01299038|12298653|FG000|STARTED|Overall Study|Consented|10
11114394|NCT01299038|12298654|FG001|STARTED|Overall Study|Consented|10
11114395|NCT01299038|12298653|FG000|COMPLETED|Overall Study|Evaluable|9
11114396|NCT01299038|12298654|FG001|COMPLETED|Overall Study|Evaluable|10
11114397|NCT01299038|12298653|FG000|NOT COMPLETED|Overall Study||1
11114398|NCT01299038|12298654|FG001|NOT COMPLETED|Overall Study||0
11114399|NCT01299077|12298660|FG000|STARTED|Overall Study||478
11114400|NCT01299077|12298660|FG000|COMPLETED|Overall Study||478
11114401|NCT01299077|12298660|FG000|NOT COMPLETED|Overall Study||0
11114402|NCT01299090|12298664|FG000|STARTED|Overall Study||49
11114403|NCT01299090|12298664|FG000|COMPLETED|Overall Study||49
11114404|NCT01299090|12298664|FG000|NOT COMPLETED|Overall Study||0
11114405|NCT01299103|12298671|FG000|STARTED|Overall Study||15
11114406|NCT01299103|12298672|FG001|STARTED|Overall Study||15
11114407|NCT01299103|12298673|FG002|STARTED|Overall Study||10
11114408|NCT01299103|12298671|FG000|COMPLETED|Overall Study||15
11114409|NCT01299103|12298672|FG001|COMPLETED|Overall Study||13
11114410|NCT01299103|12298673|FG002|COMPLETED|Overall Study||8
11114411|NCT01299103|12298671|FG000|NOT COMPLETED|Overall Study||0
11114412|NCT01299103|12298672|FG001|NOT COMPLETED|Overall Study||2
11114413|NCT01299103|12298673|FG002|NOT COMPLETED|Overall Study||2
11114414|NCT01299116|12298684|FG000|STARTED|Overall Study||522
11114415|NCT01299116|12298685|FG001|STARTED|Overall Study||177
11114416|NCT01299116|12298686|FG002|STARTED|Overall Study||195
11114417|NCT01299116|12298684|FG000|COMPLETED|Overall Study||457
11114418|NCT01299116|12298685|FG001|COMPLETED|Overall Study||168
11114419|NCT01299116|12298686|FG002|COMPLETED|Overall Study||184
11114420|NCT01299116|12298684|FG000|NOT COMPLETED|Overall Study||65
11114421|NCT01299116|12298685|FG001|NOT COMPLETED|Overall Study||9
11114422|NCT01299116|12298686|FG002|NOT COMPLETED|Overall Study||11
11114423|NCT01299272|12298697|FG000|STARTED|Acute Open-label (OL) Period||1249
11114424|NCT01299272|12298698|FG001|STARTED|Acute Open-label (OL) Period||0
11114425|NCT01299272|12298699|FG002|STARTED|Acute Open-label (OL) Period||0
11114426|NCT01299272|12298700|FG003|STARTED|Acute Open-label (OL) Period||0
11114427|NCT01299272|12298697|FG000|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
11114428|NCT01299272|12298698|FG001|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
11114429|NCT01299272|12298699|FG002|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
11114430|NCT01299272|12298700|FG003|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
11114431|NCT01299272|12298697|FG000|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
11114432|NCT01299272|12298698|FG001|COMPLETED|Acute Open-label (OL) Period||0
11114433|NCT01299272|12298699|FG002|COMPLETED|Acute Open-label (OL) Period||0
11114434|NCT01299272|12298700|FG003|COMPLETED|Acute Open-label (OL) Period||0
11114435|NCT01299272|12298697|FG000|NOT COMPLETED|Acute Open-label (OL) Period||414
11114436|NCT01299272|12298698|FG001|NOT COMPLETED|Acute Open-label (OL) Period||0
11114437|NCT01299272|12298699|FG002|NOT COMPLETED|Acute Open-label (OL) Period||0
11114438|NCT01299272|12298700|FG003|NOT COMPLETED|Acute Open-label (OL) Period||0
11114439|NCT01299272|12298697|FG000|STARTED|Stabilization Open-label (OL) Period||0
11114440|NCT01299272|12298698|FG001|STARTED|Stabilization Open-label (OL) Period||835
11114441|NCT01299272|12298699|FG002|STARTED|Stabilization Open-label (OL) Period||0
11114442|NCT01299272|12298700|FG003|STARTED|Stabilization Open-label (OL) Period||0
11114443|NCT01299272|12298697|FG000|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
11114444|NCT01299272|12298698|FG001|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
11114445|NCT01299272|12298699|FG002|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
11114446|NCT01299272|12298700|FG003|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
11114447|NCT01299272|12298697|FG000|COMPLETED|Stabilization Open-label (OL) Period||0
11114448|NCT01299272|12298698|FG001|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
11114449|NCT01299272|12298699|FG002|COMPLETED|Stabilization Open-label (OL) Period||0
11114450|NCT01299272|12298700|FG003|COMPLETED|Stabilization Open-label (OL) Period||0
11114451|NCT01299272|12298697|FG000|NOT COMPLETED|Stabilization Open-label (OL) Period||0
11114452|NCT01299272|12298698|FG001|NOT COMPLETED|Stabilization Open-label (OL) Period||249
11114453|NCT01299272|12298699|FG002|NOT COMPLETED|Stabilization Open-label (OL) Period||0
11232446|NCT02036645|12424575|FG002|NOT COMPLETED|MAD Cohorts: Study Part 2||0
11114454|NCT01299272|12298700|FG003|NOT COMPLETED|Stabilization Open-label (OL) Period||0
11114455|NCT01299272|12298697|FG000|STARTED|Double-blind (DB) Randomized Period||0
11114456|NCT01299272|12298698|FG001|STARTED|Double-blind (DB) Randomized Period||0
11114457|NCT01299272|12298699|FG002|STARTED|Double-blind (DB) Randomized Period||294
11114458|NCT01299272|12298700|FG003|STARTED|Double-blind (DB) Randomized Period||292
11114459|NCT01299272|12298697|FG000|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
11114460|NCT01299272|12298698|FG001|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
11114461|NCT01299272|12298699|FG002|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
11114462|NCT01299272|12298700|FG003|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
11114463|NCT01299272|12298697|FG000|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
11114464|NCT01299272|12298698|FG001|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
11114465|NCT01299272|12298699|FG002|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
11114466|NCT01299272|12298700|FG003|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
11114467|NCT01299272|12298697|FG000|COMPLETED|Double-blind (DB) Randomized Period||0
11114468|NCT01299272|12298698|FG001|COMPLETED|Double-blind (DB) Randomized Period||0
11114469|NCT01299272|12298699|FG002|COMPLETED|Double-blind (DB) Randomized Period||224
11114470|NCT01299272|12298700|FG003|COMPLETED|Double-blind (DB) Randomized Period||234
11114471|NCT01299272|12298697|FG000|NOT COMPLETED|Double-blind (DB) Randomized Period||0
11114472|NCT01299272|12298698|FG001|NOT COMPLETED|Double-blind (DB) Randomized Period||0
11114473|NCT01299272|12298699|FG002|NOT COMPLETED|Double-blind (DB) Randomized Period||70
11114474|NCT01299272|12298700|FG003|NOT COMPLETED|Double-blind (DB) Randomized Period||58
11114475|NCT01299285|12298714|FG000|STARTED|Overall Study||6
11114476|NCT01299285|12298714|FG000|COMPLETED|Overall Study||6
11114477|NCT01299285|12298714|FG000|NOT COMPLETED|Overall Study||0
11114478|NCT01299376|12298722|FG000|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
11114479|NCT01299376|12298723|FG001|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
11114480|NCT01299376|12298722|FG000|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
11114481|NCT01299376|12298723|FG001|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
11114482|NCT01299376|12298722|FG000|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
11114483|NCT01299376|12298723|FG001|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
11114484|NCT01299376|12298722|FG000|STARTED|Extension (Weeks 9 to 52)||134
11114485|NCT01299376|12298723|FG001|STARTED|Extension (Weeks 9 to 52)||133
11114486|NCT01299376|12298722|FG000|COMPLETED|Extension (Weeks 9 to 52)||124
11114487|NCT01299376|12298723|FG001|COMPLETED|Extension (Weeks 9 to 52)||118
11114488|NCT01299376|12298722|FG000|NOT COMPLETED|Extension (Weeks 9 to 52)||10
11114489|NCT01299376|12298723|FG001|NOT COMPLETED|Extension (Weeks 9 to 52)||15
11114490|NCT01299389|12298735|FG000|STARTED|Double-blind||164
11114491|NCT01299389|12298736|FG001|STARTED|Double-blind||159
11114492|NCT01299389|12298737|FG002|STARTED|Double-blind||0
11114493|NCT01299389|12298738|FG003|STARTED|Double-blind||0
11114494|NCT01299389|12298735|FG000|COMPLETED|Double-blind||55
11114495|NCT01299389|12298736|FG001|COMPLETED|Double-blind||95
11114496|NCT01299389|12298737|FG002|COMPLETED|Double-blind||0
11114497|NCT01299389|12298738|FG003|COMPLETED|Double-blind||0
11114498|NCT01299389|12298735|FG000|NOT COMPLETED|Double-blind||109
11114499|NCT01299389|12298736|FG001|NOT COMPLETED|Double-blind||64
11114500|NCT01299389|12298737|FG002|NOT COMPLETED|Double-blind||0
11114501|NCT01299389|12298738|FG003|NOT COMPLETED|Double-blind||0
11114502|NCT01299389|12298735|FG000|STARTED|Post-observational||0
11114503|NCT01299389|12298736|FG001|STARTED|Post-observational||0
11114504|NCT01299389|12298737|FG002|STARTED|Post-observational||156
11114505|NCT01299389|12298738|FG003|STARTED|Post-observational||155
11114506|NCT01299389|12298735|FG000|COMPLETED|Post-observational||0
11114507|NCT01299389|12298736|FG001|COMPLETED|Post-observational||0
11114508|NCT01299389|12298737|FG002|COMPLETED|Post-observational||144
11114509|NCT01299389|12298738|FG003|COMPLETED|Post-observational||149
11114510|NCT01299389|12298735|FG000|NOT COMPLETED|Post-observational||0
11114511|NCT01299389|12298736|FG001|NOT COMPLETED|Post-observational||0
11114512|NCT01299389|12298737|FG002|NOT COMPLETED|Post-observational||12
11114513|NCT01299389|12298738|FG003|NOT COMPLETED|Post-observational||6
11114514|NCT01299454|12298751|FG000|STARTED|Overall Study||8
11114515|NCT01299454|12298752|FG001|STARTED|Overall Study||8
11114516|NCT01299454|12298753|FG002|STARTED|Overall Study||6
11232447|NCT02036645|12424576|FG003|NOT COMPLETED|MAD Cohorts: Study Part 2||0
11114517|NCT01299454|12298754|FG003|STARTED|Overall Study||23
11114518|NCT01299454|12298751|FG000|COMPLETED|Overall Study||8
11114519|NCT01299454|12298752|FG001|COMPLETED|Overall Study||8
11114520|NCT01299454|12298753|FG002|COMPLETED|Overall Study||6
11114521|NCT01299454|12298754|FG003|COMPLETED|Overall Study||23
11114522|NCT01299454|12298751|FG000|NOT COMPLETED|Overall Study||0
11114523|NCT01299454|12298752|FG001|NOT COMPLETED|Overall Study||0
11114524|NCT01299454|12298753|FG002|NOT COMPLETED|Overall Study||0
11114525|NCT01299454|12298754|FG003|NOT COMPLETED|Overall Study||0
11114526|NCT01299480|12298795|FG000|STARTED|Overall Study||427
11114527|NCT01299480|12298796|FG001|STARTED|Overall Study||430
11114528|NCT01299480|12298797|FG002|STARTED|Overall Study||427
11114529|NCT01299480|12298798|FG003|STARTED|Overall Study||286
11114530|NCT01299480|12298799|FG004|STARTED|Overall Study||143
11114531|NCT01299480|12298795|FG000|COMPLETED|Overall Study||385
11114532|NCT01299480|12298796|FG001|COMPLETED|Overall Study||395
11114533|NCT01299480|12298797|FG002|COMPLETED|Overall Study||386
11114534|NCT01299480|12298798|FG003|COMPLETED|Overall Study||261
11114535|NCT01299480|12298799|FG004|COMPLETED|Overall Study||123
11114536|NCT01299480|12298795|FG000|NOT COMPLETED|Overall Study||42
11114537|NCT01299480|12298796|FG001|NOT COMPLETED|Overall Study||35
11114538|NCT01299480|12298797|FG002|NOT COMPLETED|Overall Study||41
11114539|NCT01299480|12298798|FG003|NOT COMPLETED|Overall Study||25
11114540|NCT01299480|12298799|FG004|NOT COMPLETED|Overall Study||20
11114541|NCT01299571|12298812|FG000|STARTED|Overall Study||3977
11114542|NCT01299571|12298812|FG000|COMPLETED|Overall Study||3870
11114543|NCT01299571|12298812|FG000|NOT COMPLETED|Overall Study||107
11114544|NCT01299584|12298817|FG000|STARTED|Overall Study||775
11114545|NCT01299584|12298817|FG000|COMPLETED|Overall Study||766
11114546|NCT01299584|12298817|FG000|NOT COMPLETED|Overall Study||9
11114547|NCT01299610|12298824|FG000|STARTED|Overall Study||10
11114548|NCT01299610|12298825|FG001|STARTED|Overall Study||5
11114549|NCT01299610|12298826|FG002|STARTED|Overall Study||10
11114550|NCT01299610|12298824|FG000|COMPLETED|Overall Study||10
11114551|NCT01299610|12298825|FG001|COMPLETED|Overall Study||5
11114552|NCT01299610|12298826|FG002|COMPLETED|Overall Study||10
11114553|NCT01299610|12298824|FG000|NOT COMPLETED|Overall Study||0
11114554|NCT01299610|12298825|FG001|NOT COMPLETED|Overall Study||0
11114555|NCT01299610|12298826|FG002|NOT COMPLETED|Overall Study||0
11114556|NCT01299727|12298841|FG000|STARTED|Overall Study||4
11114557|NCT01299727|12298842|FG001|STARTED|Overall Study||4
11114558|NCT01299727|12298843|FG002|STARTED|Overall Study||4
11114559|NCT01299727|12298841|FG000|COMPLETED|Overall Study||0
11114560|NCT01299727|12298842|FG001|COMPLETED|Overall Study||0
11114561|NCT01299727|12298843|FG002|COMPLETED|Overall Study||0
11114562|NCT01299727|12298841|FG000|NOT COMPLETED|Overall Study||4
11114563|NCT01299727|12298842|FG001|NOT COMPLETED|Overall Study||4
11114564|NCT01299727|12298843|FG002|NOT COMPLETED|Overall Study||4
11114565|NCT01299766|12298853|FG000|STARTED|Overall Study||111
11114566|NCT01299766|12298854|FG001|STARTED|Overall Study||110
11114567|NCT01299766|12298853|FG000|COMPLETED|Overall Study||77
11114568|NCT01299766|12298854|FG001|COMPLETED|Overall Study||87
11114569|NCT01299766|12298853|FG000|NOT COMPLETED|Overall Study||34
11114570|NCT01299766|12298854|FG001|NOT COMPLETED|Overall Study||23
11114571|NCT01299805|12298862|FG000|STARTED|Overall Study||12
11114572|NCT01299805|12298863|FG001|STARTED|Overall Study||5
11114573|NCT01299805|12298862|FG000|COMPLETED|Overall Study||10
11114574|NCT01299805|12298863|FG001|COMPLETED|Overall Study||5
11114575|NCT01299805|12298862|FG000|NOT COMPLETED|Overall Study||2
11114576|NCT01299805|12298863|FG001|NOT COMPLETED|Overall Study||0
11114577|NCT01299896|12298871|FG000|STARTED|Overall Study||319
11114578|NCT01299896|12298872|FG001|STARTED|Overall Study||314
11114579|NCT01299896|12298871|FG000|COMPLETED|Overall Study||318
11114580|NCT01299896|12298872|FG001|COMPLETED|Overall Study||296
11114581|NCT01299896|12298871|FG000|NOT COMPLETED|Overall Study||1
11114582|NCT01299896|12298872|FG001|NOT COMPLETED|Overall Study||18
11114583|NCT01299909|12298881|FG000|STARTED|Overall Study||68
11114584|NCT01299909|12298882|FG001|STARTED|Overall Study||67
11114585|NCT01299909|12298883|FG002|STARTED|Overall Study||40
11114586|NCT01299909|12298881|FG000|COMPLETED|Overall Study||46
11114587|NCT01299909|12298882|FG001|COMPLETED|Overall Study||49
11114588|NCT01299909|12298883|FG002|COMPLETED|Overall Study||23
11114589|NCT01299909|12298881|FG000|NOT COMPLETED|Overall Study||22
11114590|NCT01299909|12298882|FG001|NOT COMPLETED|Overall Study||18
11114591|NCT01299909|12298883|FG002|NOT COMPLETED|Overall Study||17
11114592|NCT01299961|12298890|FG000|STARTED|Overall Study||25
11114593|NCT01299961|12298890|FG000|COMPLETED|Overall Study||19
11114594|NCT01299961|12298890|FG000|NOT COMPLETED|Overall Study||6
11114595|NCT01300052|12298896|FG000|STARTED|Overall Study||46
11114596|NCT01300052|12298897|FG001|STARTED|Overall Study||22
11114597|NCT01300052|12298896|FG000|COMPLETED|Overall Study||40
11114598|NCT01300052|12298897|FG001|COMPLETED|Overall Study||19
11114599|NCT01300052|12298896|FG000|NOT COMPLETED|Overall Study||6
11114600|NCT01300052|12298897|FG001|NOT COMPLETED|Overall Study||3
11114601|NCT01300065|12298905|FG000|STARTED|Overall Study||221
11114602|NCT01300065|12298906|FG001|STARTED|Overall Study||220
11114603|NCT01300065|12298905|FG000|COMPLETED|Overall Study||215
11114604|NCT01300065|12298906|FG001|COMPLETED|Overall Study||217
11114605|NCT01300065|12298905|FG000|NOT COMPLETED|Overall Study||6
11114606|NCT01300065|12298906|FG001|NOT COMPLETED|Overall Study||3
11114607|NCT01300234|12298914|FG000|STARTED|Overall Study||257
11114608|NCT01300234|12298915|FG001|STARTED|Overall Study||255
11114609|NCT01300234|12298914|FG000|COMPLETED|Overall Study||229
11114610|NCT01300234|12298915|FG001|COMPLETED|Overall Study||228
11114611|NCT01300234|12298914|FG000|NOT COMPLETED|Overall Study||28
11114612|NCT01300234|12298915|FG001|NOT COMPLETED|Overall Study||27
11114613|NCT01300247|12298934|FG000|STARTED|Overall Study||21
11114614|NCT01300247|12298935|FG001|STARTED|Overall Study||20
11114615|NCT01300247|12298934|FG000|COMPLETED|Overall Study||17
11114616|NCT01300247|12298935|FG001|COMPLETED|Overall Study||18
11114617|NCT01300247|12298934|FG000|NOT COMPLETED|Overall Study||4
11114618|NCT01300247|12298935|FG001|NOT COMPLETED|Overall Study||2
11114619|NCT01300260|12298943|FG000|STARTED|Period 1 of Study: First Intervention||15
11114620|NCT01300260|12298944|FG001|STARTED|Period 1 of Study: First Intervention||17
11114621|NCT01300260|12298943|FG000|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
11114622|NCT01300260|12298944|FG001|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
11114623|NCT01300260|12298943|FG000|COMPLETED|Period 1 of Study: First Intervention||14
11114624|NCT01300260|12298944|FG001|COMPLETED|Period 1 of Study: First Intervention||16
11114625|NCT01300260|12298943|FG000|NOT COMPLETED|Period 1 of Study: First Intervention||1
11114626|NCT01300260|12298944|FG001|NOT COMPLETED|Period 1 of Study: First Intervention||1
11114627|NCT01300260|12298943|FG000|STARTED|Washout Period of at Least 28 Days||14
11114628|NCT01300260|12298944|FG001|STARTED|Washout Period of at Least 28 Days||16
11114629|NCT01300260|12298943|FG000|COMPLETED|Washout Period of at Least 28 Days||14
11114630|NCT01300260|12298944|FG001|COMPLETED|Washout Period of at Least 28 Days||16
11114631|NCT01300260|12298943|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0
11114632|NCT01300260|12298944|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0
11114633|NCT01300260|12298943|FG000|STARTED|Period 2 of Study: Second Intervention||14
11114634|NCT01300260|12298944|FG001|STARTED|Period 2 of Study: Second Intervention||16
11114635|NCT01300260|12298943|FG000|COMPLETED|Period 2 of Study: Second Intervention||14
11114636|NCT01300260|12298944|FG001|COMPLETED|Period 2 of Study: Second Intervention||15
11114637|NCT01300260|12298943|FG000|NOT COMPLETED|Period 2 of Study: Second Intervention||0
11114638|NCT01300260|12298944|FG001|NOT COMPLETED|Period 2 of Study: Second Intervention||1
11114639|NCT01300286|12298961|FG000|STARTED|Overall Study||23
11114640|NCT01300286|12298961|FG000|COMPLETED|Overall Study||22
11114641|NCT01300286|12298961|FG000|NOT COMPLETED|Overall Study||1
11114642|NCT01300338|12298968|FG000|STARTED|Overall Study||25
11114643|NCT01300338|12298969|FG001|STARTED|Overall Study||25
11114644|NCT01300338|12298968|FG000|COMPLETED|Overall Study||20
11114645|NCT01300338|12298969|FG001|COMPLETED|Overall Study||25
11114646|NCT01300338|12298968|FG000|NOT COMPLETED|Overall Study||5
11114647|NCT01300338|12298969|FG001|NOT COMPLETED|Overall Study||0
11114648|NCT01300351|12298977|FG000|STARTED|Overall Study||111
11114649|NCT01300351|12298978|FG001|STARTED|Overall Study||110
11114650|NCT01300351|12298977|FG000|Received Study Treatment|Overall Study||109
11114651|NCT01300351|12298978|FG001|Received Study Treatment|Overall Study||110
11114652|NCT01300351|12298977|FG000|COMPLETED|Overall Study||75
11114653|NCT01300351|12298978|FG001|COMPLETED|Overall Study||72
11114654|NCT01300351|12298977|FG000|NOT COMPLETED|Overall Study||36
11114655|NCT01300351|12298978|FG001|NOT COMPLETED|Overall Study||38
11114656|NCT01300455|12298986|FG000|STARTED|Period 1||13
11114657|NCT01300455|12298987|FG001|STARTED|Period 1||13
11114658|NCT01300455|12298986|FG000|COMPLETED|Period 1||13
11114659|NCT01300455|12298987|FG001|COMPLETED|Period 1||13
11114660|NCT01300455|12298986|FG000|NOT COMPLETED|Period 1||0
11114661|NCT01300455|12298987|FG001|NOT COMPLETED|Period 1||0
11114662|NCT01300455|12298986|FG000|STARTED|Washout||13
11114663|NCT01300455|12298987|FG001|STARTED|Washout||13
11114664|NCT01300455|12298986|FG000|COMPLETED|Washout||12
11114665|NCT01300455|12298987|FG001|COMPLETED|Washout||13
11114666|NCT01300455|12298986|FG000|NOT COMPLETED|Washout||1
11114667|NCT01300455|12298987|FG001|NOT COMPLETED|Washout||0
11114668|NCT01300455|12298986|FG000|STARTED|Period 2||12
11114669|NCT01300455|12298987|FG001|STARTED|Period 2||13
11114670|NCT01300455|12298986|FG000|COMPLETED|Period 2||12
11114671|NCT01300455|12298987|FG001|COMPLETED|Period 2||13
11114672|NCT01300455|12298986|FG000|NOT COMPLETED|Period 2||0
11114673|NCT01300455|12298987|FG001|NOT COMPLETED|Period 2||0
11114674|NCT01300546|12298995|FG000|STARTED|Overall Study||19
11114675|NCT01300546|12298996|FG001|STARTED|Overall Study||20
11114676|NCT01300546|12298995|FG000|COMPLETED|Overall Study||18
11114677|NCT01300546|12298996|FG001|COMPLETED|Overall Study||14
11114678|NCT01300546|12298995|FG000|NOT COMPLETED|Overall Study||1
11114679|NCT01300546|12298996|FG001|NOT COMPLETED|Overall Study||6
11114680|NCT01300559|12299004|FG000|STARTED|Overall Study||30
11114681|NCT01300559|12299005|FG001|STARTED|Overall Study||30
11114682|NCT01300559|12299004|FG000|COMPLETED|Overall Study||30
11114683|NCT01300559|12299005|FG001|COMPLETED|Overall Study||30
11114684|NCT01300559|12299004|FG000|NOT COMPLETED|Overall Study||0
11114685|NCT01300559|12299005|FG001|NOT COMPLETED|Overall Study||0
11114686|NCT01300572|12299011|FG000|STARTED|Overall Study||16
11114687|NCT01300572|12299011|FG000|COMPLETED|Overall Study||15
11114688|NCT01300572|12299011|FG000|NOT COMPLETED|Overall Study||1
11114689|NCT01300624|12299016|FG000|STARTED|Overall Study||11
11114690|NCT01300624|12299016|FG000|COMPLETED|Overall Study||11
11114691|NCT01300624|12299016|FG000|NOT COMPLETED|Overall Study||0
11114692|NCT01300650|12299021|FG000|STARTED|Overall Study||8
11114693|NCT01300650|12299021|FG000|COMPLETED|Overall Study||7
11114694|NCT01300650|12299021|FG000|NOT COMPLETED|Overall Study||1
11114695|NCT01300728|12299028|FG000|STARTED|Overall Study||26
11114696|NCT01300728|12299029|FG001|STARTED|Overall Study||26
11114697|NCT01300728|12299028|FG000|COMPLETED|Overall Study||24
11114698|NCT01300728|12299029|FG001|COMPLETED|Overall Study||25
11114699|NCT01300728|12299028|FG000|NOT COMPLETED|Overall Study||2
11114700|NCT01300728|12299029|FG001|NOT COMPLETED|Overall Study||1
11114701|NCT01300741|12299035|FG000|STARTED|Overall Study||75
11114702|NCT01300741|12299035|FG000|COMPLETED|Overall Study||72
11114703|NCT01300741|12299035|FG000|NOT COMPLETED|Overall Study||3
11114704|NCT01300767|12299041|FG000|STARTED|Overall Study||74
11356147|NCT03092934|12553100|FG001|Received at Least One Dose of Study Drug|Overall Study||2
11356148|NCT03092934|12553101|FG002|Received at Least One Dose of Study Drug|Overall Study||2
11356149|NCT03092934|12553102|FG003|Received at Least One Dose of Study Drug|Overall Study||1
11356150|NCT03092934|12553099|FG000|COMPLETED|Overall Study||8
11356151|NCT03092934|12553100|FG001|COMPLETED|Overall Study||2
11356152|NCT03092934|12553101|FG002|COMPLETED|Overall Study||2
11356153|NCT03092934|12553102|FG003|COMPLETED|Overall Study||1
11356154|NCT03092934|12553099|FG000|NOT COMPLETED|Overall Study||0
11356155|NCT03092934|12553100|FG001|NOT COMPLETED|Overall Study||0
11356156|NCT03092934|12553101|FG002|NOT COMPLETED|Overall Study||0
11356157|NCT03092934|12553102|FG003|NOT COMPLETED|Overall Study||0
11356158|NCT03092960|12553114|FG000|STARTED|Overall Study||212
11114705|NCT01300767|12299041|FG000|COMPLETED|Overall Study||70
11114706|NCT01300767|12299041|FG000|NOT COMPLETED|Overall Study||4
11114707|NCT01300819|12299049|FG000|STARTED|Overall Study||125
11114708|NCT01300819|12299050|FG001|STARTED|Overall Study||224
11114709|NCT01300819|12299049|FG000|COMPLETED|Overall Study||103
11114710|NCT01300819|12299050|FG001|COMPLETED|Overall Study||180
11114711|NCT01300819|12299049|FG000|NOT COMPLETED|Overall Study||22
11114712|NCT01300819|12299050|FG001|NOT COMPLETED|Overall Study||44
11114713|NCT01300923|12299056|FG000|STARTED|Overall Study||12
11114714|NCT01300923|12299057|FG001|STARTED|Overall Study||2
11114715|NCT01300923|12299056|FG000|COMPLETED|Overall Study||12
11114716|NCT01300923|12299057|FG001|COMPLETED|Overall Study||0
11114717|NCT01300923|12299056|FG000|NOT COMPLETED|Overall Study||0
11114718|NCT01300923|12299057|FG001|NOT COMPLETED|Overall Study||2
11114719|NCT01300949|12299065|FG000|STARTED|Overall Study||154
11114720|NCT01300949|12299066|FG001|STARTED|Overall Study||125
11114721|NCT01300949|12299067|FG002|STARTED|Overall Study||35
11114722|NCT01300949|12299065|FG000|COMPLETED|Overall Study||154
11232448|NCT02036645|12424577|FG004|NOT COMPLETED|MAD Cohorts: Study Part 2||0
11232449|NCT02036645|12424578|FG005|NOT COMPLETED|MAD Cohorts: Study Part 2||0
11232450|NCT02036645|12424579|FG006|NOT COMPLETED|MAD Cohorts: Study Part 2||0
11114723|NCT01300949|12299066|FG001|COMPLETED|Overall Study||125
11114724|NCT01300949|12299067|FG002|COMPLETED|Overall Study||35
11114725|NCT01300949|12299065|FG000|NOT COMPLETED|Overall Study||0
11114726|NCT01300949|12299066|FG001|NOT COMPLETED|Overall Study||0
11114727|NCT01300949|12299067|FG002|NOT COMPLETED|Overall Study||0
11114728|NCT01301001|12299075|FG000|STARTED|First Intervention||44
11114729|NCT01301001|12299076|FG001|STARTED|First Intervention||45
11114730|NCT01301001|12299075|FG000|COMPLETED|First Intervention||34
11114731|NCT01301001|12299076|FG001|COMPLETED|First Intervention||36
11114732|NCT01301001|12299075|FG000|NOT COMPLETED|First Intervention||10
11114733|NCT01301001|12299076|FG001|NOT COMPLETED|First Intervention||9
11114734|NCT01301001|12299075|FG000|STARTED|Washout (2 Weeks)||34
11114735|NCT01301001|12299076|FG001|STARTED|Washout (2 Weeks)||36
11232451|NCT02036645|12424580|FG007|NOT COMPLETED|MAD Cohorts: Study Part 2||0
11232452|NCT02036645|12424581|FG008|NOT COMPLETED|MAD Cohorts: Study Part 2||0
11232453|NCT02036645|12424582|FG009|NOT COMPLETED|MAD Cohorts: Study Part 2||0
11232454|NCT02036645|12424583|FG010|NOT COMPLETED|MAD Cohorts: Study Part 2||0
11232455|NCT02036645|12424584|FG011|NOT COMPLETED|MAD Cohorts: Study Part 2||0
11232456|NCT02036775|12424622|FG000|STARTED|Treatment Period 1 (6 Days)||4
11232457|NCT02036775|12424623|FG001|STARTED|Treatment Period 1 (6 Days)||4
11232458|NCT02036775|12424624|FG002|STARTED|Treatment Period 1 (6 Days)||4
11232459|NCT02036775|12424625|FG003|STARTED|Treatment Period 1 (6 Days)||4
11232460|NCT02036775|12424626|FG004|STARTED|Treatment Period 1 (6 Days)||4
11232461|NCT02036775|12424627|FG005|STARTED|Treatment Period 1 (6 Days)||4
11232462|NCT02036775|12424622|FG000|COMPLETED|Treatment Period 1 (6 Days)||4
11232463|NCT02036775|12424623|FG001|COMPLETED|Treatment Period 1 (6 Days)||4
11232464|NCT02036775|12424624|FG002|COMPLETED|Treatment Period 1 (6 Days)||4
11232465|NCT02036775|12424625|FG003|COMPLETED|Treatment Period 1 (6 Days)||4
11232466|NCT02036775|12424626|FG004|COMPLETED|Treatment Period 1 (6 Days)||4
11232467|NCT02036775|12424627|FG005|COMPLETED|Treatment Period 1 (6 Days)||4
11232468|NCT02036775|12424622|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0
11232469|NCT02036775|12424623|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0
11232470|NCT02036775|12424624|FG002|NOT COMPLETED|Treatment Period 1 (6 Days)||0
11232471|NCT02036775|12424625|FG003|NOT COMPLETED|Treatment Period 1 (6 Days)||0
11232472|NCT02036775|12424626|FG004|NOT COMPLETED|Treatment Period 1 (6 Days)||0
11232473|NCT02036775|12424627|FG005|NOT COMPLETED|Treatment Period 1 (6 Days)||0
11114736|NCT01301001|12299075|FG000|COMPLETED|Washout (2 Weeks)||34
11114737|NCT01301001|12299076|FG001|COMPLETED|Washout (2 Weeks)||36
11114738|NCT01301001|12299075|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11114739|NCT01301001|12299076|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11114740|NCT01301001|12299075|FG000|STARTED|Second Intervention||34
11114741|NCT01301001|12299076|FG001|STARTED|Second Intervention||36
11114742|NCT01301001|12299075|FG000|COMPLETED|Second Intervention||30
11114743|NCT01301001|12299076|FG001|COMPLETED|Second Intervention||36
11114744|NCT01301001|12299075|FG000|NOT COMPLETED|Second Intervention||4
11114745|NCT01301001|12299076|FG001|NOT COMPLETED|Second Intervention||0
11114746|NCT01301027|12299085|FG000|STARTED|Overall Study||48
11114747|NCT01301027|12299086|FG001|STARTED|Overall Study||47
11114748|NCT01301027|12299085|FG000|COMPLETED|Overall Study||40
11114749|NCT01301027|12299086|FG001|COMPLETED|Overall Study||37
11114750|NCT01301027|12299085|FG000|NOT COMPLETED|Overall Study||8
11114751|NCT01301027|12299086|FG001|NOT COMPLETED|Overall Study||10
11114752|NCT01301066|12299094|FG000|STARTED|Overall Study||126
11114753|NCT01301066|12299095|FG001|STARTED|Overall Study||126
11114754|NCT01301066|12299094|FG000|COMPLETED|Overall Study||99
11114755|NCT01301066|12299095|FG001|COMPLETED|Overall Study||91
11114756|NCT01301066|12299094|FG000|NOT COMPLETED|Overall Study||27
11114757|NCT01301066|12299095|FG001|NOT COMPLETED|Overall Study||35
11114758|NCT01301079|12299103|FG000|STARTED|Overall Study||30
11114759|NCT01301079|12299104|FG001|STARTED|Overall Study||30
11114760|NCT01301079|12299103|FG000|COMPLETED|Overall Study||28
11114761|NCT01301079|12299104|FG001|COMPLETED|Overall Study||28
11114762|NCT01301079|12299103|FG000|NOT COMPLETED|Overall Study||2
11114763|NCT01301079|12299104|FG001|NOT COMPLETED|Overall Study||2
11114764|NCT01301092|12299117|FG000|STARTED|Overall Study||6
11114765|NCT01301092|12299118|FG001|STARTED|Overall Study||16
11114766|NCT01301092|12299119|FG002|STARTED|Overall Study||8
11114767|NCT01301092|12299117|FG000|COMPLETED|Overall Study||6
11114768|NCT01301092|12299118|FG001|COMPLETED|Overall Study||16
11114769|NCT01301092|12299119|FG002|COMPLETED|Overall Study||7
11114770|NCT01301092|12299117|FG000|NOT COMPLETED|Overall Study||0
11114771|NCT01301092|12299118|FG001|NOT COMPLETED|Overall Study||0
11114772|NCT01301092|12299119|FG002|NOT COMPLETED|Overall Study||1
11114773|NCT01301183|12299134|FG000|STARTED|Overall Study||38
11114774|NCT01301183|12299135|FG001|STARTED|Overall Study||37
11114775|NCT01301183|12299134|FG000|COMPLETED|Overall Study||12
11114776|NCT01301183|12299135|FG001|COMPLETED|Overall Study||21
11114777|NCT01301183|12299134|FG000|NOT COMPLETED|Overall Study||26
11114778|NCT01301183|12299135|FG001|NOT COMPLETED|Overall Study||16
11114779|NCT01301274|12299143|FG000|STARTED|Overall Study||34
11114780|NCT01301274|12299144|FG001|STARTED|Overall Study||32
11114781|NCT01301274|12299143|FG000|COMPLETED|Overall Study||32
11114782|NCT01301274|12299144|FG001|COMPLETED|Overall Study||31
11114783|NCT01301274|12299143|FG000|NOT COMPLETED|Overall Study||2
11114784|NCT01301274|12299144|FG001|NOT COMPLETED|Overall Study||1
11114785|NCT01301391|12299155|FG000|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
11114786|NCT01301391|12299155|FG000|COMPLETED|Overall Study||4
11114787|NCT01301391|12299155|FG000|NOT COMPLETED|Overall Study||26
11114788|NCT01301456|12299171|FG000|STARTED|Stage 1||15
11114789|NCT01301456|12299172|FG001|STARTED|Stage 1||5
11114790|NCT01301456|12299173|FG002|STARTED|Stage 1||6
11114791|NCT01301456|12299174|FG003|STARTED|Stage 1||6
11114792|NCT01301456|12299175|FG004|STARTED|Stage 1||7
11114793|NCT01301456|12299176|FG005|STARTED|Stage 1||5
11114794|NCT01301456|12299177|FG006|STARTED|Stage 1||8
11114795|NCT01301456|12299178|FG007|STARTED|Stage 1||0
11114796|NCT01301456|12299179|FG008|STARTED|Stage 1||0
11114797|NCT01301456|12299180|FG009|STARTED|Stage 1||0
11114798|NCT01301456|12299181|FG010|STARTED|Stage 1||0
11232474|NCT02036775|12424622|FG000|STARTED|Treatment Period 2 (6 Days)||4
11232475|NCT02036775|12424623|FG001|STARTED|Treatment Period 2 (6 Days)||4
11232476|NCT02036775|12424624|FG002|STARTED|Treatment Period 2 (6 Days)||4
11232477|NCT02036775|12424625|FG003|STARTED|Treatment Period 2 (6 Days)||4
11232478|NCT02036775|12424626|FG004|STARTED|Treatment Period 2 (6 Days)||4
11232479|NCT02036775|12424627|FG005|STARTED|Treatment Period 2 (6 Days)||4
11232480|NCT02036775|12424622|FG000|COMPLETED|Treatment Period 2 (6 Days)||4
11232481|NCT02036775|12424623|FG001|COMPLETED|Treatment Period 2 (6 Days)||4
11232482|NCT02036775|12424624|FG002|COMPLETED|Treatment Period 2 (6 Days)||4
11232483|NCT02036775|12424625|FG003|COMPLETED|Treatment Period 2 (6 Days)||4
11232484|NCT02036775|12424626|FG004|COMPLETED|Treatment Period 2 (6 Days)||4
11232485|NCT02036775|12424627|FG005|COMPLETED|Treatment Period 2 (6 Days)||3
11232486|NCT02036775|12424622|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0
11232487|NCT02036775|12424623|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0
11232488|NCT02036775|12424624|FG002|NOT COMPLETED|Treatment Period 2 (6 Days)||0
11232489|NCT02036775|12424625|FG003|NOT COMPLETED|Treatment Period 2 (6 Days)||0
11232490|NCT02036775|12424626|FG004|NOT COMPLETED|Treatment Period 2 (6 Days)||0
11232491|NCT02036775|12424627|FG005|NOT COMPLETED|Treatment Period 2 (6 Days)||1
11232492|NCT02036775|12424622|FG000|STARTED|Treatment Period 3 (6 Days)||4
11232493|NCT02036775|12424623|FG001|STARTED|Treatment Period 3 (6 Days)||4
11232494|NCT02036775|12424624|FG002|STARTED|Treatment Period 3 (6 Days)||4
11232495|NCT02036775|12424625|FG003|STARTED|Treatment Period 3 (6 Days)||4
11232496|NCT02036775|12424626|FG004|STARTED|Treatment Period 3 (6 Days)||4
11232497|NCT02036775|12424627|FG005|STARTED|Treatment Period 3 (6 Days)||3
11114799|NCT01301456|12299182|FG011|STARTED|Stage 1||0
11114800|NCT01301456|12299171|FG000|Received Treatment|Stage 1||15
11114801|NCT01301456|12299172|FG001|Received Treatment|Stage 1||5
11114802|NCT01301456|12299173|FG002|Received Treatment|Stage 1||6
11114803|NCT01301456|12299174|FG003|Received Treatment|Stage 1||6
11114804|NCT01301456|12299175|FG004|Received Treatment|Stage 1||7
11114805|NCT01301456|12299176|FG005|Received Treatment|Stage 1||5
11114806|NCT01301456|12299177|FG006|Received Treatment|Stage 1||7
11114807|NCT01301456|12299178|FG007|Received Treatment|Stage 1||0
11114808|NCT01301456|12299179|FG008|Received Treatment|Stage 1||0
11114809|NCT01301456|12299180|FG009|Received Treatment|Stage 1||0
11114810|NCT01301456|12299181|FG010|Received Treatment|Stage 1||0
11114811|NCT01301456|12299182|FG011|Received Treatment|Stage 1||0
11114812|NCT01301456|12299171|FG000|COMPLETED|Stage 1||15
11114813|NCT01301456|12299172|FG001|COMPLETED|Stage 1||5
11114814|NCT01301456|12299173|FG002|COMPLETED|Stage 1||5
11114815|NCT01301456|12299174|FG003|COMPLETED|Stage 1||6
11114816|NCT01301456|12299175|FG004|COMPLETED|Stage 1||6
11114817|NCT01301456|12299176|FG005|COMPLETED|Stage 1||5
11114818|NCT01301456|12299177|FG006|COMPLETED|Stage 1||7
11114819|NCT01301456|12299178|FG007|COMPLETED|Stage 1||0
11114820|NCT01301456|12299179|FG008|COMPLETED|Stage 1||0
11114821|NCT01301456|12299180|FG009|COMPLETED|Stage 1||0
11114822|NCT01301456|12299181|FG010|COMPLETED|Stage 1||0
11114823|NCT01301456|12299182|FG011|COMPLETED|Stage 1||0
11114824|NCT01301456|12299171|FG000|NOT COMPLETED|Stage 1||0
11114825|NCT01301456|12299172|FG001|NOT COMPLETED|Stage 1||0
11114826|NCT01301456|12299173|FG002|NOT COMPLETED|Stage 1||1
11114827|NCT01301456|12299174|FG003|NOT COMPLETED|Stage 1||0
11114828|NCT01301456|12299175|FG004|NOT COMPLETED|Stage 1||1
11114829|NCT01301456|12299176|FG005|NOT COMPLETED|Stage 1||0
11114830|NCT01301456|12299177|FG006|NOT COMPLETED|Stage 1||1
11114831|NCT01301456|12299178|FG007|NOT COMPLETED|Stage 1||0
11114832|NCT01301456|12299179|FG008|NOT COMPLETED|Stage 1||0
11114833|NCT01301456|12299180|FG009|NOT COMPLETED|Stage 1||0
11114834|NCT01301456|12299181|FG010|NOT COMPLETED|Stage 1||0
11114835|NCT01301456|12299182|FG011|NOT COMPLETED|Stage 1||0
11114836|NCT01301456|12299171|FG000|STARTED|Stage 2||0
11114837|NCT01301456|12299172|FG001|STARTED|Stage 2||0
11114838|NCT01301456|12299173|FG002|STARTED|Stage 2||0
11114839|NCT01301456|12299174|FG003|STARTED|Stage 2||0
11114840|NCT01301456|12299175|FG004|STARTED|Stage 2||0
11114841|NCT01301456|12299176|FG005|STARTED|Stage 2||0
11114842|NCT01301456|12299177|FG006|STARTED|Stage 2||0
11114843|NCT01301456|12299178|FG007|STARTED|Stage 2||7
11232498|NCT02036775|12424622|FG000|COMPLETED|Treatment Period 3 (6 Days)||4
11114844|NCT01301456|12299179|FG008|STARTED|Stage 2||5
11114845|NCT01301456|12299180|FG009|STARTED|Stage 2||7
11114846|NCT01301456|12299181|FG010|STARTED|Stage 2||7
11114847|NCT01301456|12299182|FG011|STARTED|Stage 2||6
11114848|NCT01301456|12299171|FG000|Received Treatment|Stage 2||0
11114849|NCT01301456|12299172|FG001|Received Treatment|Stage 2||0
11114850|NCT01301456|12299173|FG002|Received Treatment|Stage 2||0
11114851|NCT01301456|12299174|FG003|Received Treatment|Stage 2||0
11114852|NCT01301456|12299175|FG004|Received Treatment|Stage 2||0
11114853|NCT01301456|12299176|FG005|Received Treatment|Stage 2||0
11232499|NCT02036775|12424623|FG001|COMPLETED|Treatment Period 3 (6 Days)||4
11114854|NCT01301456|12299177|FG006|Received Treatment|Stage 2||0
11114855|NCT01301456|12299178|FG007|Received Treatment|Stage 2||7
11114856|NCT01301456|12299179|FG008|Received Treatment|Stage 2||5
11114857|NCT01301456|12299180|FG009|Received Treatment|Stage 2||7
11114858|NCT01301456|12299181|FG010|Received Treatment|Stage 2||7
11114859|NCT01301456|12299182|FG011|Received Treatment|Stage 2||6
11114860|NCT01301456|12299171|FG000|COMPLETED|Stage 2||0
11114861|NCT01301456|12299172|FG001|COMPLETED|Stage 2||0
11114862|NCT01301456|12299173|FG002|COMPLETED|Stage 2||0
11114863|NCT01301456|12299174|FG003|COMPLETED|Stage 2||0
11114864|NCT01301456|12299175|FG004|COMPLETED|Stage 2||0
11114865|NCT01301456|12299176|FG005|COMPLETED|Stage 2||0
11114866|NCT01301456|12299177|FG006|COMPLETED|Stage 2||0
11114867|NCT01301456|12299178|FG007|COMPLETED|Stage 2||7
11114868|NCT01301456|12299179|FG008|COMPLETED|Stage 2||5
11114869|NCT01301456|12299180|FG009|COMPLETED|Stage 2||7
11114870|NCT01301456|12299181|FG010|COMPLETED|Stage 2||6
11114871|NCT01301456|12299182|FG011|COMPLETED|Stage 2||6
11114872|NCT01301456|12299171|FG000|NOT COMPLETED|Stage 2||0
11114873|NCT01301456|12299172|FG001|NOT COMPLETED|Stage 2||0
11114874|NCT01301456|12299173|FG002|NOT COMPLETED|Stage 2||0
11114875|NCT01301456|12299174|FG003|NOT COMPLETED|Stage 2||0
11114876|NCT01301456|12299175|FG004|NOT COMPLETED|Stage 2||0
11114877|NCT01301456|12299176|FG005|NOT COMPLETED|Stage 2||0
11114878|NCT01301456|12299177|FG006|NOT COMPLETED|Stage 2||0
11114879|NCT01301456|12299178|FG007|NOT COMPLETED|Stage 2||0
11114880|NCT01301456|12299179|FG008|NOT COMPLETED|Stage 2||0
11114881|NCT01301456|12299180|FG009|NOT COMPLETED|Stage 2||0
11114882|NCT01301456|12299181|FG010|NOT COMPLETED|Stage 2||1
11114883|NCT01301456|12299182|FG011|NOT COMPLETED|Stage 2||0
11114884|NCT01301508|12299228|FG000|STARTED|Overall Study||21
11114885|NCT01301508|12299229|FG001|STARTED|Overall Study||25
11114886|NCT01301508|12299228|FG000|COMPLETED|Overall Study||20
11114887|NCT01301508|12299229|FG001|COMPLETED|Overall Study||22
11114888|NCT01301508|12299228|FG000|NOT COMPLETED|Overall Study||1
11114889|NCT01301508|12299229|FG001|NOT COMPLETED|Overall Study||3
11114890|NCT01301625|12299235|FG000|STARTED|Overall Study||78
11114891|NCT01301625|12299235|FG000|COMPLETED|Overall Study||43
11114892|NCT01301625|12299235|FG000|NOT COMPLETED|Overall Study||35
11114893|NCT01301729|12299239|FG000|STARTED|Overall Study||32
11114894|NCT01301729|12299239|FG000|COMPLETED|Overall Study||28
11114895|NCT01301729|12299239|FG000|NOT COMPLETED|Overall Study||4
11114896|NCT01301742|12299244|FG000|STARTED|First Intervention||9
11114897|NCT01301742|12299245|FG001|STARTED|First Intervention||9
11114898|NCT01301742|12299244|FG000|COMPLETED|First Intervention||9
11114899|NCT01301742|12299245|FG001|COMPLETED|First Intervention||9
11114900|NCT01301742|12299244|FG000|NOT COMPLETED|First Intervention||0
11114901|NCT01301742|12299245|FG001|NOT COMPLETED|First Intervention||0
11114902|NCT01301742|12299244|FG000|STARTED|Washout Period of at Least 7 Days||9
11114903|NCT01301742|12299245|FG001|STARTED|Washout Period of at Least 7 Days||9
11114904|NCT01301742|12299244|FG000|COMPLETED|Washout Period of at Least 7 Days||9
11114905|NCT01301742|12299245|FG001|COMPLETED|Washout Period of at Least 7 Days||9
11114906|NCT01301742|12299244|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0
11114907|NCT01301742|12299245|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
11114908|NCT01301742|12299244|FG000|STARTED|Second Intervention||9
11114909|NCT01301742|12299245|FG001|STARTED|Second Intervention||9
11114910|NCT01301742|12299244|FG000|COMPLETED|Second Intervention||9
11114911|NCT01301742|12299245|FG001|COMPLETED|Second Intervention||9
11114912|NCT01301742|12299244|FG000|NOT COMPLETED|Second Intervention||0
11114913|NCT01301742|12299245|FG001|NOT COMPLETED|Second Intervention||0
11114914|NCT01301833|12299256|FG000|STARTED|Overall Study||212
11114915|NCT01301833|12299257|FG001|STARTED|Overall Study||80
11114916|NCT01301833|12299258|FG002|STARTED|Overall Study||95
11114917|NCT01301833|12299259|FG003|STARTED|Overall Study||75
11114918|NCT01301833|12299256|FG000|COMPLETED|Overall Study||197
11114919|NCT01301833|12299257|FG001|COMPLETED|Overall Study||72
11114920|NCT01301833|12299258|FG002|COMPLETED|Overall Study||88
11114921|NCT01301833|12299259|FG003|COMPLETED|Overall Study||68
11114922|NCT01301833|12299256|FG000|NOT COMPLETED|Overall Study||15
11114923|NCT01301833|12299257|FG001|NOT COMPLETED|Overall Study||8
11114924|NCT01301833|12299258|FG002|NOT COMPLETED|Overall Study||7
11114925|NCT01301833|12299259|FG003|NOT COMPLETED|Overall Study||7
11114926|NCT01301950|12299271|FG000|STARTED|Overall Study||15
11114927|NCT01301950|12299272|FG001|STARTED|Overall Study||15
11114928|NCT01301950|12299271|FG000|COMPLETED|Overall Study||15
11114929|NCT01301950|12299272|FG001|COMPLETED|Overall Study||14
11114930|NCT01301950|12299271|FG000|NOT COMPLETED|Overall Study||0
11114931|NCT01301950|12299272|FG001|NOT COMPLETED|Overall Study||1
11232500|NCT02036775|12424624|FG002|COMPLETED|Treatment Period 3 (6 Days)||4
11232501|NCT02036775|12424625|FG003|COMPLETED|Treatment Period 3 (6 Days)||4
11232502|NCT02036775|12424626|FG004|COMPLETED|Treatment Period 3 (6 Days)||4
11232503|NCT02036775|12424627|FG005|COMPLETED|Treatment Period 3 (6 Days)||3
11232504|NCT02036775|12424622|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0
11232505|NCT02036775|12424623|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||0
11232506|NCT02036775|12424624|FG002|NOT COMPLETED|Treatment Period 3 (6 Days)||0
11232507|NCT02036775|12424625|FG003|NOT COMPLETED|Treatment Period 3 (6 Days)||0
11232508|NCT02036775|12424626|FG004|NOT COMPLETED|Treatment Period 3 (6 Days)||0
11232509|NCT02036775|12424627|FG005|NOT COMPLETED|Treatment Period 3 (6 Days)||0
11232510|NCT02036840|12424635|FG000|STARTED|Overall Study||513
11232511|NCT02036840|12424635|FG000|COMPLETED|Overall Study||513
11232512|NCT02036840|12424635|FG000|NOT COMPLETED|Overall Study||0
11232513|NCT02036853|12424641|FG000|STARTED|Overall Study||6
11232514|NCT02036853|12424642|FG001|STARTED|Overall Study||14
11232515|NCT02036853|12424641|FG000|COMPLETED|Overall Study||6
11232516|NCT02036853|12424642|FG001|COMPLETED|Overall Study||8
11232517|NCT02036853|12424641|FG000|NOT COMPLETED|Overall Study||0
11232518|NCT02036853|12424642|FG001|NOT COMPLETED|Overall Study||6
11232519|NCT02037061|12424650|FG000|STARTED|Overall Study||22
11114932|NCT01302041|12299278|FG000|STARTED|Overall Study||67
11114933|NCT01302041|12299278|FG000|Treatment Received|Overall Study||67
11114934|NCT01302041|12299278|FG000|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
11114935|NCT01302041|12299278|FG000|NOT COMPLETED|Overall Study||40
11114936|NCT01302054|12299283|FG000|STARTED|Tolterodine Open-Label Run-In Phase||990
11114937|NCT01302054|12299284|FG001|STARTED|Tolterodine Open-Label Run-In Phase||0
11114938|NCT01302054|12299285|FG002|STARTED|Tolterodine Open-Label Run-In Phase||0
11114939|NCT01302054|12299283|FG000|COMPLETED|Tolterodine Open-Label Run-In Phase||611
11114940|NCT01302054|12299284|FG001|COMPLETED|Tolterodine Open-Label Run-In Phase||0
11114941|NCT01302054|12299285|FG002|COMPLETED|Tolterodine Open-Label Run-In Phase||0
11114942|NCT01302054|12299283|FG000|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
11114943|NCT01302054|12299284|FG001|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
11114944|NCT01302054|12299285|FG002|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
11114945|NCT01302054|12299283|FG000|STARTED|Between Open-Label and Double Blind||611
11114946|NCT01302054|12299284|FG001|STARTED|Between Open-Label and Double Blind||0
11114947|NCT01302054|12299285|FG002|STARTED|Between Open-Label and Double Blind||0
11114948|NCT01302054|12299283|FG000|COMPLETED|Between Open-Label and Double Blind||609
11114949|NCT01302054|12299284|FG001|COMPLETED|Between Open-Label and Double Blind||0
11114950|NCT01302054|12299285|FG002|COMPLETED|Between Open-Label and Double Blind||0
11114951|NCT01302054|12299283|FG000|NOT COMPLETED|Between Open-Label and Double Blind||2
11114952|NCT01302054|12299284|FG001|NOT COMPLETED|Between Open-Label and Double Blind||0
11114953|NCT01302054|12299285|FG002|NOT COMPLETED|Between Open-Label and Double Blind||0
11114954|NCT01302054|12299283|FG000|STARTED|Double-Blind Treatment Phase||0
11114955|NCT01302054|12299284|FG001|STARTED|Double-Blind Treatment Phase||308
11114956|NCT01302054|12299285|FG002|STARTED|Double-Blind Treatment Phase||301
11114957|NCT01302054|12299283|FG000|COMPLETED|Double-Blind Treatment Phase||0
11114958|NCT01302054|12299284|FG001|COMPLETED|Double-Blind Treatment Phase||281
11114959|NCT01302054|12299285|FG002|COMPLETED|Double-Blind Treatment Phase||255
11114960|NCT01302054|12299283|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
11114961|NCT01302054|12299284|FG001|NOT COMPLETED|Double-Blind Treatment Phase||27
11114962|NCT01302054|12299285|FG002|NOT COMPLETED|Double-Blind Treatment Phase||46
11114963|NCT01302067|12299297|FG000|STARTED|Overall Study||790
11114964|NCT01302067|12299298|FG001|STARTED|Overall Study||386
11114965|NCT01302067|12299299|FG002|STARTED|Overall Study||779
11114966|NCT01302067|12299297|FG000|COMPLETED|Overall Study||712
11114967|NCT01302067|12299298|FG001|COMPLETED|Overall Study||352
11114968|NCT01302067|12299299|FG002|COMPLETED|Overall Study||681
11114969|NCT01302067|12299297|FG000|NOT COMPLETED|Overall Study||78
11114970|NCT01302067|12299298|FG001|NOT COMPLETED|Overall Study||34
11114971|NCT01302067|12299299|FG002|NOT COMPLETED|Overall Study||98
11114972|NCT01302080|12299310|FG000|STARTED|Overall Study|Out of 696 participants, 1 participant started treatment with another antidepressant alone or along with psychotherapy.|696
11114973|NCT01302080|12299311|FG001|STARTED|Overall Study|Out of 245 participants, 2 participants started treatment with another antidepressant alone or along with psychotherapy.|245
11114974|NCT01302080|12299310|FG000|COMPLETED|Overall Study||330
11114975|NCT01302080|12299311|FG001|COMPLETED|Overall Study||102
11114976|NCT01302080|12299310|FG000|NOT COMPLETED|Overall Study||366
11114977|NCT01302080|12299311|FG001|NOT COMPLETED|Overall Study||143
11114978|NCT01302119|12299343|FG000|STARTED|Overall Study||399
11114979|NCT01302119|12299344|FG001|STARTED|Overall Study||205
11114980|NCT01302119|12299343|FG000|COMPLETED|Overall Study||349
11114981|NCT01302119|12299344|FG001|COMPLETED|Overall Study||177
11114982|NCT01302119|12299343|FG000|NOT COMPLETED|Overall Study||50
11114983|NCT01302119|12299344|FG001|NOT COMPLETED|Overall Study||28
11114984|NCT01302366|12299350|FG000|STARTED|Overall Study||20
11114985|NCT01302366|12299350|FG000|COMPLETED|Overall Study||15
11114986|NCT01302366|12299350|FG000|NOT COMPLETED|Overall Study||5
11114987|NCT01302379|12299358|FG000|STARTED|Overall Study||83
11114988|NCT01302379|12299359|FG001|STARTED|Overall Study||83
11114989|NCT01302379|12299360|FG002|STARTED|Overall Study||84
11114990|NCT01302379|12299361|FG003|STARTED|Overall Study||83
11114991|NCT01302379|12299358|FG000|COMPLETED|Overall Study||76
11114992|NCT01302379|12299359|FG001|COMPLETED|Overall Study||78
11114993|NCT01302379|12299360|FG002|COMPLETED|Overall Study||80
11114994|NCT01302379|12299361|FG003|COMPLETED|Overall Study||79
11114995|NCT01302379|12299358|FG000|NOT COMPLETED|Overall Study||7
11114996|NCT01302379|12299359|FG001|NOT COMPLETED|Overall Study||5
11114997|NCT01302379|12299360|FG002|NOT COMPLETED|Overall Study||4
11114998|NCT01302379|12299361|FG003|NOT COMPLETED|Overall Study||4
11114999|NCT01302392|12299371|FG000|STARTED|Overall Study||158
11115000|NCT01302392|12299372|FG001|STARTED|Overall Study||157
11115001|NCT01302392|12299371|FG000|Treated|Overall Study||153
11115002|NCT01302392|12299372|FG001|Treated|Overall Study||157
11115003|NCT01302392|12299371|FG000|COMPLETED|Overall Study||151
11115004|NCT01302392|12299372|FG001|COMPLETED|Overall Study||156
11115005|NCT01302392|12299371|FG000|NOT COMPLETED|Overall Study||7
11115006|NCT01302392|12299372|FG001|NOT COMPLETED|Overall Study||1
11115007|NCT01302418|12299378|FG000|STARTED|Overall Study||272
11115008|NCT01302418|12299378|FG000|COMPLETED|Overall Study||254
11115009|NCT01302418|12299378|FG000|NOT COMPLETED|Overall Study||18
11115010|NCT01302483|12299384|FG000|STARTED|Overall Study||30
11115011|NCT01302483|12299385|FG001|STARTED|Overall Study||15
11115012|NCT01302483|12299384|FG000|COMPLETED|Overall Study||30
11115013|NCT01302483|12299385|FG001|COMPLETED|Overall Study||15
11115014|NCT01302483|12299384|FG000|NOT COMPLETED|Overall Study||0
11115015|NCT01302483|12299385|FG001|NOT COMPLETED|Overall Study||0
11115016|NCT01302548|12299399|FG000|STARTED|Overall Study||14
11115017|NCT01302548|12299400|FG001|STARTED|Overall Study||19
11115018|NCT01302548|12299399|FG000|COMPLETED|Overall Study||12
11115019|NCT01302548|12299400|FG001|COMPLETED|Overall Study||18
11115020|NCT01302548|12299399|FG000|NOT COMPLETED|Overall Study||2
11115021|NCT01302548|12299400|FG001|NOT COMPLETED|Overall Study||1
11115022|NCT01302691|12299408|FG000|STARTED|Overall Study||164
11115023|NCT01302691|12299409|FG001|STARTED|Overall Study||163
11115024|NCT01302691|12299408|FG000|COMPLETED|Overall Study||154
11115025|NCT01302691|12299409|FG001|COMPLETED|Overall Study||157
11115026|NCT01302691|12299408|FG000|NOT COMPLETED|Overall Study||10
11115027|NCT01302691|12299409|FG001|NOT COMPLETED|Overall Study||6
11115028|NCT01302743|12299418|FG000|STARTED|Overall Study||7
11115029|NCT01302743|12299419|FG001|STARTED|Overall Study||8
11115030|NCT01302743|12299420|FG002|STARTED|Overall Study||10
11115031|NCT01302743|12299418|FG000|COMPLETED|Overall Study||6
11115032|NCT01302743|12299419|FG001|COMPLETED|Overall Study||7
11115033|NCT01302743|12299420|FG002|COMPLETED|Overall Study||8
11115034|NCT01302743|12299418|FG000|NOT COMPLETED|Overall Study||1
11115035|NCT01302743|12299419|FG001|NOT COMPLETED|Overall Study||1
11115036|NCT01302743|12299420|FG002|NOT COMPLETED|Overall Study||2
11115037|NCT01302808|12299432|FG000|STARTED|Overall Study||3
11115038|NCT01302808|12299433|FG001|STARTED|Overall Study||7
11115039|NCT01302808|12299434|FG002|STARTED|Overall Study||4
11115040|NCT01302808|12299435|FG003|STARTED|Overall Study||3
11115041|NCT01302808|12299432|FG000|COMPLETED|Overall Study||3
11115042|NCT01302808|12299433|FG001|COMPLETED|Overall Study||7
11115043|NCT01302808|12299434|FG002|COMPLETED|Overall Study||4
11115044|NCT01302808|12299435|FG003|COMPLETED|Overall Study||3
11115045|NCT01302808|12299432|FG000|NOT COMPLETED|Overall Study||0
11115046|NCT01302808|12299433|FG001|NOT COMPLETED|Overall Study||0
11115047|NCT01302808|12299434|FG002|NOT COMPLETED|Overall Study||0
11115048|NCT01302808|12299435|FG003|NOT COMPLETED|Overall Study||0
11115049|NCT01302860|12299447|FG000|STARTED|Overall Study||17
11115050|NCT01302860|12299447|FG000|COMPLETED|Overall Study||17
11115051|NCT01302860|12299447|FG000|NOT COMPLETED|Overall Study||0
11115052|NCT01302899|12299453|FG000|STARTED|Period 1 (Day 1 to End of Week 6)||4
11115053|NCT01302899|12299454|FG001|STARTED|Period 1 (Day 1 to End of Week 6)||4
11115054|NCT01302899|12299453|FG000|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
11115055|NCT01302899|12299454|FG001|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
11115056|NCT01302899|12299453|FG000|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
11115057|NCT01302899|12299454|FG001|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
11115058|NCT01302899|12299453|FG000|STARTED|Period 2 (Weeks 7 to 12)||4
11115059|NCT01302899|12299454|FG001|STARTED|Period 2 (Weeks 7 to 12)||4
11115060|NCT01302899|12299453|FG000|COMPLETED|Period 2 (Weeks 7 to 12)||3
11115061|NCT01302899|12299454|FG001|COMPLETED|Period 2 (Weeks 7 to 12)||3
11115062|NCT01302899|12299453|FG000|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
11115063|NCT01302899|12299454|FG001|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
11115064|NCT01302899|12299453|FG000|STARTED|Period 3 (Weeks 13 to 18)||3
11115065|NCT01302899|12299454|FG001|STARTED|Period 3 (Weeks 13 to 18)||3
11115066|NCT01302899|12299453|FG000|COMPLETED|Period 3 (Weeks 13 to 18)||3
11115067|NCT01302899|12299454|FG001|COMPLETED|Period 3 (Weeks 13 to 18)||3
11115068|NCT01302899|12299453|FG000|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
11115069|NCT01302899|12299454|FG001|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
11115070|NCT01302899|12299453|FG000|STARTED|Period 4 (Weeks 19 to 26)||3
11115071|NCT01302899|12299454|FG001|STARTED|Period 4 (Weeks 19 to 26)||3
11115072|NCT01302899|12299453|FG000|COMPLETED|Period 4 (Weeks 19 to 26)||3
11115073|NCT01302899|12299454|FG001|COMPLETED|Period 4 (Weeks 19 to 26)||3
11115074|NCT01302899|12299453|FG000|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
11115075|NCT01302899|12299454|FG001|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
11115076|NCT01302938|12299466|FG000|STARTED|Overall Study||12
11115077|NCT01302938|12299467|FG001|STARTED|Overall Study||6
11115078|NCT01302938|12299466|FG000|COMPLETED|Overall Study||10
11115079|NCT01302938|12299467|FG001|COMPLETED|Overall Study||6
11115080|NCT01302938|12299466|FG000|NOT COMPLETED|Overall Study||2
11115081|NCT01302938|12299467|FG001|NOT COMPLETED|Overall Study||0
11115082|NCT01302964|12299476|FG000|STARTED|Overall Study||20
11115083|NCT01302964|12299477|FG001|STARTED|Overall Study||10
11115084|NCT01302964|12299476|FG000|COMPLETED|Overall Study||19
11115085|NCT01302964|12299477|FG001|COMPLETED|Overall Study||10
11115086|NCT01302964|12299476|FG000|NOT COMPLETED|Overall Study||1
11115087|NCT01302964|12299477|FG001|NOT COMPLETED|Overall Study||0
11115088|NCT01303068|12299485|FG000|STARTED|Overall Study||6
11115089|NCT01303068|12299486|FG001|STARTED|Overall Study||6
11115090|NCT01303068|12299485|FG000|COMPLETED|Overall Study||6
11115091|NCT01303068|12299486|FG001|COMPLETED|Overall Study||6
11115092|NCT01303068|12299485|FG000|NOT COMPLETED|Overall Study||0
11115093|NCT01303068|12299486|FG001|NOT COMPLETED|Overall Study||0
11115094|NCT01303159|12299492|FG000|STARTED|Overall Study||29
11115095|NCT01303159|12299492|FG000|COMPLETED|Overall Study||6
11115096|NCT01303159|12299492|FG000|NOT COMPLETED|Overall Study||23
11115097|NCT01303172|12299498|FG000|STARTED|Overall Study||75
11115098|NCT01303172|12299499|FG001|STARTED|Overall Study||35
11115099|NCT01303172|12299498|FG000|COMPLETED|Overall Study||12
11115100|NCT01303172|12299499|FG001|COMPLETED|Overall Study||1
11115101|NCT01303172|12299498|FG000|NOT COMPLETED|Overall Study||63
11115102|NCT01303172|12299499|FG001|NOT COMPLETED|Overall Study||34
11115103|NCT01303224|12299510|FG000|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
11115104|NCT01303224|12299511|FG001|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
11115105|NCT01303224|12299512|FG002|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
11115106|NCT01303224|12299513|FG003|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
11115107|NCT01303224|12299510|FG000|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
11115108|NCT01303224|12299511|FG001|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
11115109|NCT01303224|12299512|FG002|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
11115110|NCT01303224|12299513|FG003|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
11115111|NCT01303224|12299510|FG000|COMPLETED|Overall Study||130
11115112|NCT01303224|12299511|FG001|COMPLETED|Overall Study||131
11115113|NCT01303224|12299512|FG002|COMPLETED|Overall Study||133
11115114|NCT01303224|12299513|FG003|COMPLETED|Overall Study||133
11115115|NCT01303224|12299510|FG000|NOT COMPLETED|Overall Study||11
11115116|NCT01303224|12299511|FG001|NOT COMPLETED|Overall Study||11
11115117|NCT01303224|12299512|FG002|NOT COMPLETED|Overall Study||6
11115118|NCT01303224|12299513|FG003|NOT COMPLETED|Overall Study||10
11115119|NCT01303380|12299523|FG000|STARTED|Overall Study||9
11115120|NCT01303380|12299523|FG000|COMPLETED|Overall Study||8
11115121|NCT01303380|12299523|FG000|NOT COMPLETED|Overall Study||1
11115122|NCT01303406|12299529|FG000|STARTED|Overall Study||13
11115123|NCT01303406|12299530|FG001|STARTED|Overall Study||16
11115124|NCT01303406|12299529|FG000|COMPLETED|Overall Study||13
11115125|NCT01303406|12299530|FG001|COMPLETED|Overall Study||15
11115126|NCT01303406|12299529|FG000|NOT COMPLETED|Overall Study||0
11115127|NCT01303406|12299530|FG001|NOT COMPLETED|Overall Study||1
11115128|NCT01303419|12299536|FG000|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224
11115129|NCT01303419|12299536|FG000|COMPLETED|Overall Study||128
11115130|NCT01303419|12299536|FG000|NOT COMPLETED|Overall Study||96
11115131|NCT01303445|12299540|FG000|STARTED|First Intervention (7 Days)||30
11115132|NCT01303445|12299541|FG001|STARTED|First Intervention (7 Days)||30
11115133|NCT01303445|12299540|FG000|COMPLETED|First Intervention (7 Days)||29
11115134|NCT01303445|12299541|FG001|COMPLETED|First Intervention (7 Days)||30
11115135|NCT01303445|12299540|FG000|NOT COMPLETED|First Intervention (7 Days)||1
11115136|NCT01303445|12299541|FG001|NOT COMPLETED|First Intervention (7 Days)||0
11115137|NCT01303445|12299540|FG000|STARTED|Second Intervention (7 Days)||29
11115138|NCT01303445|12299541|FG001|STARTED|Second Intervention (7 Days)||30
11115139|NCT01303445|12299540|FG000|COMPLETED|Second Intervention (7 Days)||28
11115140|NCT01303445|12299541|FG001|COMPLETED|Second Intervention (7 Days)||28
11115141|NCT01303445|12299540|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
11115142|NCT01303445|12299541|FG001|NOT COMPLETED|Second Intervention (7 Days)||2
11115143|NCT01303445|12299540|FG000|STARTED|Washout (14 Days)||28
11115144|NCT01303445|12299541|FG001|STARTED|Washout (14 Days)||28
11115145|NCT01303445|12299540|FG000|COMPLETED|Washout (14 Days)||27
11115146|NCT01303445|12299541|FG001|COMPLETED|Washout (14 Days)||26
11115147|NCT01303445|12299540|FG000|NOT COMPLETED|Washout (14 Days)||1
11115148|NCT01303445|12299541|FG001|NOT COMPLETED|Washout (14 Days)||2
11115149|NCT01303445|12299540|FG000|STARTED|Third Intervention (7 Days)||27
11115150|NCT01303445|12299541|FG001|STARTED|Third Intervention (7 Days)||26
11115151|NCT01303445|12299540|FG000|COMPLETED|Third Intervention (7 Days)||27
11115152|NCT01303445|12299541|FG001|COMPLETED|Third Intervention (7 Days)||26
11115153|NCT01303445|12299540|FG000|NOT COMPLETED|Third Intervention (7 Days)||0
11115154|NCT01303445|12299541|FG001|NOT COMPLETED|Third Intervention (7 Days)||0
11115155|NCT01303445|12299540|FG000|STARTED|Fourth Intervention (7 Days)||27
11115156|NCT01303445|12299541|FG001|STARTED|Fourth Intervention (7 Days)||26
11115157|NCT01303445|12299540|FG000|COMPLETED|Fourth Intervention (7 Days)||26
11115158|NCT01303445|12299541|FG001|COMPLETED|Fourth Intervention (7 Days)||26
11115159|NCT01303445|12299540|FG000|NOT COMPLETED|Fourth Intervention (7 Days)||1
11115160|NCT01303445|12299541|FG001|NOT COMPLETED|Fourth Intervention (7 Days)||0
11115161|NCT01303445|12299540|FG000|STARTED|Follow-up Period (14 Days)||26
11115162|NCT01303445|12299541|FG001|STARTED|Follow-up Period (14 Days)||26
11115163|NCT01303445|12299540|FG000|COMPLETED|Follow-up Period (14 Days)||26
11115164|NCT01303445|12299541|FG001|COMPLETED|Follow-up Period (14 Days)||25
11115165|NCT01303445|12299540|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0
11115166|NCT01303445|12299541|FG001|NOT COMPLETED|Follow-up Period (14 Days)||1
11115167|NCT01303510|12299553|FG000|STARTED|Overall Study||55
11115168|NCT01303510|12299554|FG001|STARTED|Overall Study||56
11115169|NCT01303510|12299553|FG000|COMPLETED|Overall Study||54
11115170|NCT01303510|12299554|FG001|COMPLETED|Overall Study||56
11115171|NCT01303510|12299553|FG000|NOT COMPLETED|Overall Study||1
11115172|NCT01303510|12299554|FG001|NOT COMPLETED|Overall Study||0
11115173|NCT01303627|12299562|FG000|STARTED|Overall Study||21
11115174|NCT01303627|12299563|FG001|STARTED|Overall Study||21
11115175|NCT01303627|12299562|FG000|COMPLETED|Overall Study||21
11115176|NCT01303627|12299563|FG001|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
11115177|NCT01303627|12299562|FG000|NOT COMPLETED|Overall Study||0
11115178|NCT01303627|12299563|FG001|NOT COMPLETED|Overall Study||1
11115179|NCT01303744|12299573|FG000|STARTED|Overall Study||24
11115180|NCT01303744|12299574|FG001|STARTED|Overall Study||24
11115181|NCT01303744|12299575|FG002|STARTED|Overall Study||24
11115182|NCT01303744|12299576|FG003|STARTED|Overall Study||24
11115183|NCT01303744|12299573|FG000|COMPLETED|Overall Study||24
11115184|NCT01303744|12299574|FG001|COMPLETED|Overall Study||24
11115185|NCT01303744|12299575|FG002|COMPLETED|Overall Study||24
11115186|NCT01303744|12299576|FG003|COMPLETED|Overall Study||24
11115187|NCT01303744|12299573|FG000|NOT COMPLETED|Overall Study||0
11115188|NCT01303744|12299574|FG001|NOT COMPLETED|Overall Study||0
11115189|NCT01303744|12299575|FG002|NOT COMPLETED|Overall Study||0
11115190|NCT01303744|12299576|FG003|NOT COMPLETED|Overall Study||0
11115191|NCT01303835|12299588|FG000|STARTED|Overall Study||54
11115192|NCT01303835|12299589|FG001|STARTED|Overall Study||56
11115193|NCT01303835|12299588|FG000|COMPLETED|Overall Study||35
11115194|NCT01303835|12299589|FG001|COMPLETED|Overall Study||31
11115195|NCT01303835|12299588|FG000|NOT COMPLETED|Overall Study||19
11115196|NCT01303835|12299589|FG001|NOT COMPLETED|Overall Study||25
11115197|NCT01303861|12299600|FG000|STARTED|Overall Study||109
11115198|NCT01303861|12299601|FG001|STARTED|Overall Study||50
11115199|NCT01303861|12299602|FG002|STARTED|Overall Study||55
11115200|NCT01303861|12299603|FG003|STARTED|Overall Study||113
11115201|NCT01303861|12299600|FG000|Finished Treatment Phase|Overall Study||71
11115202|NCT01303861|12299601|FG001|Finished Treatment Phase|Overall Study||34
11115203|NCT01303861|12299602|FG002|Finished Treatment Phase|Overall Study||39
11115204|NCT01303861|12299603|FG003|Finished Treatment Phase|Overall Study||72
11115205|NCT01303861|12299600|FG000|COMPLETED|Overall Study||51
11115206|NCT01303861|12299601|FG001|COMPLETED|Overall Study||25
11115207|NCT01303861|12299602|FG002|COMPLETED|Overall Study||19
11115208|NCT01303861|12299603|FG003|COMPLETED|Overall Study||54
11115209|NCT01303861|12299600|FG000|NOT COMPLETED|Overall Study||58
11115210|NCT01303861|12299601|FG001|NOT COMPLETED|Overall Study||25
11115211|NCT01303861|12299602|FG002|NOT COMPLETED|Overall Study||36
11115212|NCT01303861|12299603|FG003|NOT COMPLETED|Overall Study||59
11115213|NCT01303939|12299616|FG000|STARTED|Overall Study||22
11115214|NCT01303939|12299617|FG001|STARTED|Overall Study||15
11115215|NCT01303939|12299616|FG000|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
11115216|NCT01303939|12299617|FG001|COMPLETED|Overall Study||15
11115217|NCT01303939|12299616|FG000|NOT COMPLETED|Overall Study||7
11115218|NCT01303939|12299617|FG001|NOT COMPLETED|Overall Study||0
11115219|NCT01303965|12299627|FG000|STARTED|Overall Study||3
11115220|NCT01303965|12299628|FG001|STARTED|Overall Study||11
11115221|NCT01303965|12299627|FG000|COMPLETED|Overall Study||0
11115222|NCT01303965|12299628|FG001|COMPLETED|Overall Study||1
11115223|NCT01303965|12299627|FG000|NOT COMPLETED|Overall Study||3
11115224|NCT01303965|12299628|FG001|NOT COMPLETED|Overall Study||10
11115225|NCT01304082|12299634|FG000|STARTED|Overall Study||3
11115226|NCT01304082|12299635|FG001|STARTED|Overall Study||2
11115227|NCT01304082|12299636|FG002|STARTED|Overall Study||11
11115228|NCT01304082|12299637|FG003|STARTED|Overall Study||8
11115229|NCT01304082|12299638|FG004|STARTED|Overall Study||5
11115230|NCT01304082|12299634|FG000|First Intervention|Overall Study||3
11115231|NCT01304082|12299635|FG001|First Intervention|Overall Study||2
11115232|NCT01304082|12299636|FG002|First Intervention|Overall Study||11
11115233|NCT01304082|12299637|FG003|First Intervention|Overall Study||8
11115234|NCT01304082|12299638|FG004|First Intervention|Overall Study||5
11115235|NCT01304082|12299634|FG000|Second Intervention|Overall Study||3
11115236|NCT01304082|12299635|FG001|Second Intervention|Overall Study||2
11115237|NCT01304082|12299636|FG002|Second Intervention|Overall Study||11
11115238|NCT01304082|12299637|FG003|Second Intervention|Overall Study||8
11115239|NCT01304082|12299638|FG004|Second Intervention|Overall Study||5
11115240|NCT01304082|12299634|FG000|Third Intervention|Overall Study||3
11115241|NCT01304082|12299635|FG001|Third Intervention|Overall Study||2
11115242|NCT01304082|12299636|FG002|Third Intervention|Overall Study||11
11115243|NCT01304082|12299637|FG003|Third Intervention|Overall Study||8
11115244|NCT01304082|12299638|FG004|Third Intervention|Overall Study||5
11115245|NCT01304082|12299634|FG000|COMPLETED|Overall Study||3
11115246|NCT01304082|12299635|FG001|COMPLETED|Overall Study||2
11115247|NCT01304082|12299636|FG002|COMPLETED|Overall Study||11
11115248|NCT01304082|12299637|FG003|COMPLETED|Overall Study||8
11115249|NCT01304082|12299638|FG004|COMPLETED|Overall Study||5
11115250|NCT01304082|12299634|FG000|NOT COMPLETED|Overall Study||0
11115251|NCT01304082|12299635|FG001|NOT COMPLETED|Overall Study||0
11115252|NCT01304082|12299636|FG002|NOT COMPLETED|Overall Study||0
11115253|NCT01304082|12299637|FG003|NOT COMPLETED|Overall Study||0
11115254|NCT01304082|12299638|FG004|NOT COMPLETED|Overall Study||0
11115255|NCT01304147|12299646|FG000|STARTED|First Intervention (7days)||10
11115256|NCT01304147|12299647|FG001|STARTED|First Intervention (7days)||10
11115257|NCT01304147|12299646|FG000|COMPLETED|First Intervention (7days)||10
11115258|NCT01304147|12299647|FG001|COMPLETED|First Intervention (7days)||10
11115259|NCT01304147|12299646|FG000|NOT COMPLETED|First Intervention (7days)||0
11115260|NCT01304147|12299647|FG001|NOT COMPLETED|First Intervention (7days)||0
11115261|NCT01304147|12299646|FG000|STARTED|Washout (1 Day)||10
11115262|NCT01304147|12299647|FG001|STARTED|Washout (1 Day)||10
11115263|NCT01304147|12299646|FG000|COMPLETED|Washout (1 Day)||10
11115264|NCT01304147|12299647|FG001|COMPLETED|Washout (1 Day)||10
11115265|NCT01304147|12299646|FG000|NOT COMPLETED|Washout (1 Day)||0
11115266|NCT01304147|12299647|FG001|NOT COMPLETED|Washout (1 Day)||0
11115267|NCT01304147|12299646|FG000|STARTED|Second Intervention (7days)||10
11115268|NCT01304147|12299647|FG001|STARTED|Second Intervention (7days)||10
11115269|NCT01304147|12299646|FG000|COMPLETED|Second Intervention (7days)||9
11115270|NCT01304147|12299647|FG001|COMPLETED|Second Intervention (7days)||9
11115271|NCT01304147|12299646|FG000|NOT COMPLETED|Second Intervention (7days)||1
11115272|NCT01304147|12299647|FG001|NOT COMPLETED|Second Intervention (7days)||1
11115273|NCT01304238|12299663|FG000|STARTED|Overall Study||32
11115274|NCT01304238|12299664|FG001|STARTED|Overall Study||4
11115275|NCT01304238|12299665|FG002|STARTED|Overall Study||46
11115276|NCT01304238|12299666|FG003|STARTED|Overall Study||78
11115277|NCT01304238|12299667|FG004|STARTED|Overall Study||11
11115278|NCT01304238|12299668|FG005|STARTED|Overall Study||11
11115279|NCT01304238|12299669|FG006|STARTED|Overall Study||5
11115280|NCT01304238|12299670|FG007|STARTED|Overall Study||4
11115281|NCT01304238|12299671|FG008|STARTED|Overall Study||1
11115282|NCT01304238|12299672|FG009|STARTED|Overall Study||3
11115283|NCT01304238|12299663|FG000|COMPLETED|Overall Study||32
11115284|NCT01304238|12299664|FG001|COMPLETED|Overall Study||4
11115285|NCT01304238|12299665|FG002|COMPLETED|Overall Study||46
11115286|NCT01304238|12299666|FG003|COMPLETED|Overall Study||78
11115287|NCT01304238|12299667|FG004|COMPLETED|Overall Study||11
11115288|NCT01304238|12299668|FG005|COMPLETED|Overall Study||11
11115289|NCT01304238|12299669|FG006|COMPLETED|Overall Study||5
11115290|NCT01304238|12299670|FG007|COMPLETED|Overall Study||4
11115291|NCT01304238|12299671|FG008|COMPLETED|Overall Study||1
11115292|NCT01304238|12299672|FG009|COMPLETED|Overall Study||3
11115293|NCT01304238|12299663|FG000|NOT COMPLETED|Overall Study||0
11115294|NCT01304238|12299664|FG001|NOT COMPLETED|Overall Study||0
11115295|NCT01304238|12299665|FG002|NOT COMPLETED|Overall Study||0
11115296|NCT01304238|12299666|FG003|NOT COMPLETED|Overall Study||0
11115297|NCT01304238|12299667|FG004|NOT COMPLETED|Overall Study||0
11115298|NCT01304238|12299668|FG005|NOT COMPLETED|Overall Study||0
11115299|NCT01304238|12299669|FG006|NOT COMPLETED|Overall Study||0
11115300|NCT01304238|12299670|FG007|NOT COMPLETED|Overall Study||0
11115301|NCT01304238|12299671|FG008|NOT COMPLETED|Overall Study||0
11115302|NCT01304238|12299672|FG009|NOT COMPLETED|Overall Study||0
11115303|NCT01304277|12299694|FG000|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
11115304|NCT01304277|12299694|FG000|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
11115305|NCT01304277|12299694|FG000|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
11115306|NCT01304277|12299694|FG000|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
11115307|NCT01304277|12299694|FG000|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
11115308|NCT01304277|12299694|FG000|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
11115309|NCT01304329|12299701|FG000|STARTED|First Intervention (3 Days)||3
11115310|NCT01304329|12299702|FG001|STARTED|First Intervention (3 Days)||3
11115311|NCT01304329|12299703|FG002|STARTED|First Intervention (3 Days)||3
11115312|NCT01304329|12299704|FG003|STARTED|First Intervention (3 Days)||3
11115313|NCT01304329|12299705|FG004|STARTED|First Intervention (3 Days)||3
11115314|NCT01304329|12299706|FG005|STARTED|First Intervention (3 Days)||3
11115315|NCT01304329|12299701|FG000|COMPLETED|First Intervention (3 Days)||3
11115316|NCT01304329|12299702|FG001|COMPLETED|First Intervention (3 Days)||3
11115317|NCT01304329|12299703|FG002|COMPLETED|First Intervention (3 Days)||3
11115318|NCT01304329|12299704|FG003|COMPLETED|First Intervention (3 Days)||3
11115319|NCT01304329|12299705|FG004|COMPLETED|First Intervention (3 Days)||3
11115320|NCT01304329|12299706|FG005|COMPLETED|First Intervention (3 Days)||3
11115321|NCT01304329|12299701|FG000|NOT COMPLETED|First Intervention (3 Days)||0
11115322|NCT01304329|12299702|FG001|NOT COMPLETED|First Intervention (3 Days)||0
11115323|NCT01304329|12299703|FG002|NOT COMPLETED|First Intervention (3 Days)||0
11115324|NCT01304329|12299704|FG003|NOT COMPLETED|First Intervention (3 Days)||0
11115325|NCT01304329|12299705|FG004|NOT COMPLETED|First Intervention (3 Days)||0
11115326|NCT01304329|12299706|FG005|NOT COMPLETED|First Intervention (3 Days)||0
11115327|NCT01304329|12299701|FG000|STARTED|Second Intervention (3 Days)||3
11115328|NCT01304329|12299702|FG001|STARTED|Second Intervention (3 Days)||3
11232520|NCT02037061|12424651|FG001|STARTED|Overall Study||24
11115329|NCT01304329|12299703|FG002|STARTED|Second Intervention (3 Days)||3
11115330|NCT01304329|12299704|FG003|STARTED|Second Intervention (3 Days)||3
11115331|NCT01304329|12299705|FG004|STARTED|Second Intervention (3 Days)||3
11115332|NCT01304329|12299706|FG005|STARTED|Second Intervention (3 Days)||3
11115333|NCT01304329|12299701|FG000|COMPLETED|Second Intervention (3 Days)||3
11115334|NCT01304329|12299702|FG001|COMPLETED|Second Intervention (3 Days)||3
11115335|NCT01304329|12299703|FG002|COMPLETED|Second Intervention (3 Days)||3
11115336|NCT01304329|12299704|FG003|COMPLETED|Second Intervention (3 Days)||3
11115337|NCT01304329|12299705|FG004|COMPLETED|Second Intervention (3 Days)||3
11115338|NCT01304329|12299706|FG005|COMPLETED|Second Intervention (3 Days)||3
11115339|NCT01304329|12299701|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
11115340|NCT01304329|12299702|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
11115341|NCT01304329|12299703|FG002|NOT COMPLETED|Second Intervention (3 Days)||0
11115342|NCT01304329|12299704|FG003|NOT COMPLETED|Second Intervention (3 Days)||0
11115343|NCT01304329|12299705|FG004|NOT COMPLETED|Second Intervention (3 Days)||0
11115344|NCT01304329|12299706|FG005|NOT COMPLETED|Second Intervention (3 Days)||0
11115345|NCT01304329|12299701|FG000|STARTED|Third Intervention (3 Days)||3
11115346|NCT01304329|12299702|FG001|STARTED|Third Intervention (3 Days)||3
11115347|NCT01304329|12299703|FG002|STARTED|Third Intervention (3 Days)||3
11115348|NCT01304329|12299704|FG003|STARTED|Third Intervention (3 Days)||3
11115349|NCT01304329|12299705|FG004|STARTED|Third Intervention (3 Days)||3
11115350|NCT01304329|12299706|FG005|STARTED|Third Intervention (3 Days)||3
11115351|NCT01304329|12299701|FG000|COMPLETED|Third Intervention (3 Days)||3
11115352|NCT01304329|12299702|FG001|COMPLETED|Third Intervention (3 Days)||2
11115353|NCT01304329|12299703|FG002|COMPLETED|Third Intervention (3 Days)||3
11115354|NCT01304329|12299704|FG003|COMPLETED|Third Intervention (3 Days)||3
11115355|NCT01304329|12299705|FG004|COMPLETED|Third Intervention (3 Days)||3
11115356|NCT01304329|12299706|FG005|COMPLETED|Third Intervention (3 Days)||3
11115357|NCT01304329|12299701|FG000|NOT COMPLETED|Third Intervention (3 Days)||0
11115358|NCT01304329|12299702|FG001|NOT COMPLETED|Third Intervention (3 Days)||1
11115359|NCT01304329|12299703|FG002|NOT COMPLETED|Third Intervention (3 Days)||0
11115360|NCT01304329|12299704|FG003|NOT COMPLETED|Third Intervention (3 Days)||0
11115361|NCT01304329|12299705|FG004|NOT COMPLETED|Third Intervention (3 Days)||0
11115362|NCT01304329|12299706|FG005|NOT COMPLETED|Third Intervention (3 Days)||0
11115363|NCT01304407|12299714|FG000|STARTED|Overall Study||29
11115364|NCT01304407|12299714|FG000|COMPLETED|Overall Study||29
11115365|NCT01304407|12299714|FG000|NOT COMPLETED|Overall Study||0
11115366|NCT01304498|12299720|FG000|STARTED|Overall Study||300
11115367|NCT01304498|12299721|FG001|STARTED|Overall Study||300
11115368|NCT01304498|12299720|FG000|Received ≥1 Dose|Overall Study||300
11115369|NCT01304498|12299721|FG001|Received ≥1 Dose|Overall Study||300
11115370|NCT01304498|12299720|FG000|COMPLETED|Overall Study||294
11115371|NCT01304498|12299721|FG001|COMPLETED|Overall Study||295
11115372|NCT01304498|12299720|FG000|NOT COMPLETED|Overall Study||6
11115373|NCT01304498|12299721|FG001|NOT COMPLETED|Overall Study||5
11115374|NCT01304589|12299727|FG000|STARTED|Overall Study||31
11115375|NCT01304589|12299727|FG000|COMPLETED|Overall Study||18
11115376|NCT01304589|12299727|FG000|NOT COMPLETED|Overall Study||13
11115377|NCT01304641|12299734|FG000|STARTED|Overall Study||11470
11115378|NCT01304641|12299735|FG001|STARTED|Overall Study||20132
11115379|NCT01304641|12299734|FG000|COMPLETED|Overall Study||11470
11115380|NCT01304641|12299735|FG001|COMPLETED|Overall Study||20132
11115381|NCT01304641|12299734|FG000|NOT COMPLETED|Overall Study||0
11115382|NCT01304641|12299735|FG001|NOT COMPLETED|Overall Study||0
11115383|NCT01304693|12299746|FG000|STARTED|Overall Study||10
11115384|NCT01304693|12299747|FG001|STARTED|Overall Study||35
11115385|NCT01304693|12299748|FG002|STARTED|Overall Study||48
11115386|NCT01304693|12299749|FG003|STARTED|Overall Study||40
11115387|NCT01304693|12299750|FG004|STARTED|Overall Study||61
11115388|NCT01304693|12299746|FG000|COMPLETED|Overall Study||10
11115389|NCT01304693|12299747|FG001|COMPLETED|Overall Study||35
11115390|NCT01304693|12299748|FG002|COMPLETED|Overall Study||47
11115391|NCT01304693|12299749|FG003|COMPLETED|Overall Study||39
11115392|NCT01304693|12299750|FG004|COMPLETED|Overall Study||60
11115393|NCT01304693|12299746|FG000|NOT COMPLETED|Overall Study||0
11232521|NCT02037061|12424650|FG000|COMPLETED|Overall Study||22
11232522|NCT02037061|12424651|FG001|COMPLETED|Overall Study||24
11232523|NCT02037061|12424650|FG000|NOT COMPLETED|Overall Study||0
11232524|NCT02037061|12424651|FG001|NOT COMPLETED|Overall Study||0
11115394|NCT01304693|12299747|FG001|NOT COMPLETED|Overall Study||0
11115395|NCT01304693|12299748|FG002|NOT COMPLETED|Overall Study||1
11356159|NCT03092960|12553115|FG001|STARTED|Overall Study||212
11232525|NCT02037165|12424664|FG000|STARTED|Period 1 (2 Days)|randomized subjects|5
11232526|NCT02037165|12424665|FG001|STARTED|Period 1 (2 Days)|randomized subjects|5
11232527|NCT02037165|12424666|FG002|STARTED|Period 1 (2 Days)|randomized subjects|5
11232528|NCT02037165|12424667|FG003|STARTED|Period 1 (2 Days)|randomized subjects|5
11232529|NCT02037165|12424668|FG004|STARTED|Period 1 (2 Days)|randomized subjects|5
11232530|NCT02037165|12424664|FG000|COMPLETED|Period 1 (2 Days)||5
11232531|NCT02037165|12424665|FG001|COMPLETED|Period 1 (2 Days)||5
11232532|NCT02037165|12424666|FG002|COMPLETED|Period 1 (2 Days)||5
11232533|NCT02037165|12424667|FG003|COMPLETED|Period 1 (2 Days)||5
11232534|NCT02037165|12424668|FG004|COMPLETED|Period 1 (2 Days)||5
11232535|NCT02037165|12424664|FG000|NOT COMPLETED|Period 1 (2 Days)||0
11232536|NCT02037165|12424665|FG001|NOT COMPLETED|Period 1 (2 Days)||0
11232537|NCT02037165|12424666|FG002|NOT COMPLETED|Period 1 (2 Days)||0
11232538|NCT02037165|12424667|FG003|NOT COMPLETED|Period 1 (2 Days)||0
11232539|NCT02037165|12424668|FG004|NOT COMPLETED|Period 1 (2 Days)||0
11232540|NCT02037165|12424664|FG000|STARTED|Washout Period 1 (6 Days)||5
11232541|NCT02037165|12424665|FG001|STARTED|Washout Period 1 (6 Days)||5
11232542|NCT02037165|12424666|FG002|STARTED|Washout Period 1 (6 Days)||5
11232543|NCT02037165|12424667|FG003|STARTED|Washout Period 1 (6 Days)||5
11232544|NCT02037165|12424668|FG004|STARTED|Washout Period 1 (6 Days)||5
11232545|NCT02037165|12424664|FG000|COMPLETED|Washout Period 1 (6 Days)||5
11232546|NCT02037165|12424665|FG001|COMPLETED|Washout Period 1 (6 Days)||5
11232547|NCT02037165|12424666|FG002|COMPLETED|Washout Period 1 (6 Days)||5
11232548|NCT02037165|12424667|FG003|COMPLETED|Washout Period 1 (6 Days)||5
11232549|NCT02037165|12424668|FG004|COMPLETED|Washout Period 1 (6 Days)||5
11232550|NCT02037165|12424664|FG000|NOT COMPLETED|Washout Period 1 (6 Days)||0
11115396|NCT01304693|12299749|FG003|NOT COMPLETED|Overall Study||1
11232551|NCT02037165|12424665|FG001|NOT COMPLETED|Washout Period 1 (6 Days)||0
11115397|NCT01304693|12299750|FG004|NOT COMPLETED|Overall Study||1
11115398|NCT01304706|12299762|FG000|STARTED|Overall Study||121
11115399|NCT01304706|12299762|FG000|COMPLETED|Overall Study||104
11115400|NCT01304706|12299762|FG000|NOT COMPLETED|Overall Study||17
11115401|NCT01304940|12299768|FG000|STARTED|Overall Study||25
11115402|NCT01304940|12299769|FG001|STARTED|Overall Study||25
11115403|NCT01304940|12299768|FG000|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
11115404|NCT01304940|12299769|FG001|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
11115405|NCT01304940|12299768|FG000|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22
11115406|NCT01304940|12299769|FG001|COMPLETED|Overall Study||25
11115407|NCT01304940|12299768|FG000|NOT COMPLETED|Overall Study||3
11115408|NCT01304940|12299769|FG001|NOT COMPLETED|Overall Study||0
11115409|NCT01304966|12299775|FG000|STARTED|Overall Study||15
11115410|NCT01304966|12299775|FG000|COMPLETED|Overall Study||15
11115411|NCT01304966|12299775|FG000|NOT COMPLETED|Overall Study||0
11115412|NCT01305044|12299783|FG000|STARTED|Overall Study||32
11115413|NCT01305044|12299784|FG001|STARTED|Overall Study||31
11115414|NCT01305044|12299783|FG000|COMPLETED|Overall Study||29
11115415|NCT01305044|12299784|FG001|COMPLETED|Overall Study||25
11115416|NCT01305044|12299783|FG000|NOT COMPLETED|Overall Study||3
11115417|NCT01305044|12299784|FG001|NOT COMPLETED|Overall Study||6
11115418|NCT01305200|12299793|FG000|STARTED|Overall Study||111
11115419|NCT01305200|12299794|FG001|STARTED|Overall Study||112
11115420|NCT01305200|12299795|FG002|STARTED|Overall Study||3
11115421|NCT01305200|12299793|FG000|COMPLETED|Overall Study||82
11115422|NCT01305200|12299794|FG001|COMPLETED|Overall Study||81
11115423|NCT01305200|12299795|FG002|COMPLETED|Overall Study||0
11115424|NCT01305200|12299793|FG000|NOT COMPLETED|Overall Study||29
11115425|NCT01305200|12299794|FG001|NOT COMPLETED|Overall Study||31
11115426|NCT01305200|12299795|FG002|NOT COMPLETED|Overall Study||3
11115427|NCT01305213|12299803|FG000|STARTED|Overall Study||53
11115428|NCT01305213|12299804|FG001|STARTED|Overall Study||54
11115429|NCT01305213|12299803|FG000|COMPLETED|Overall Study||53
11115430|NCT01305213|12299804|FG001|COMPLETED|Overall Study||54
11115431|NCT01305213|12299803|FG000|NOT COMPLETED|Overall Study||0
11115432|NCT01305213|12299804|FG001|NOT COMPLETED|Overall Study||0
11115433|NCT01305239|12299813|FG000|STARTED|Overall Study||398
11115434|NCT01305239|12299813|FG000|Safety Set|Overall Study||397
11115435|NCT01305239|12299813|FG000|Intent to Treat Population|Overall Study||287
11115436|NCT01305239|12299813|FG000|COMPLETED|Overall Study||375
11115437|NCT01305239|12299813|FG000|NOT COMPLETED|Overall Study||23
11115438|NCT01305252|12299819|FG000|STARTED|Overall Study||10
11115439|NCT01305252|12299820|FG001|STARTED|Overall Study||11
11115440|NCT01305252|12299819|FG000|COMPLETED|Overall Study||9
11115441|NCT01305252|12299820|FG001|COMPLETED|Overall Study||11
11115442|NCT01305252|12299819|FG000|NOT COMPLETED|Overall Study||1
11115443|NCT01305252|12299820|FG001|NOT COMPLETED|Overall Study||0
11115444|NCT01305265|12299832|FG000|STARTED|Overall Study||71
11115445|NCT01305265|12299833|FG001|STARTED|Overall Study||70
11115446|NCT01305265|12299832|FG000|COMPLETED|Overall Study||69
11115447|NCT01305265|12299833|FG001|COMPLETED|Overall Study||64
11115448|NCT01305265|12299832|FG000|NOT COMPLETED|Overall Study||2
11115449|NCT01305265|12299833|FG001|NOT COMPLETED|Overall Study||6
11115450|NCT01305356|12299841|FG000|STARTED|Overall Study||132
11115451|NCT01305356|12299842|FG001|STARTED|Overall Study||167
11115452|NCT01305356|12299841|FG000|COMPLETED|Overall Study||132
11115453|NCT01305356|12299842|FG001|COMPLETED|Overall Study||167
11115454|NCT01305356|12299841|FG000|NOT COMPLETED|Overall Study||0
11115455|NCT01305356|12299842|FG001|NOT COMPLETED|Overall Study||0
11115456|NCT01305408|12299850|FG000|STARTED|Overall Study||199
11115457|NCT01305408|12299851|FG001|STARTED|Overall Study||200
11115458|NCT01305408|12299850|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
11115459|NCT01305408|12299851|FG001|Safety Population|Overall Study|Treated participants.|200
11115460|NCT01305408|12299850|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
11115461|NCT01305408|12299851|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
11115462|NCT01305408|12299850|FG000|COMPLETED|Overall Study||167
11115463|NCT01305408|12299851|FG001|COMPLETED|Overall Study||169
11115464|NCT01305408|12299850|FG000|NOT COMPLETED|Overall Study||32
11115465|NCT01305408|12299851|FG001|NOT COMPLETED|Overall Study||31
11115466|NCT01305473|12299857|FG000|STARTED|Overall Study||90
11115467|NCT01305473|12299857|FG000|COMPLETED|Overall Study||90
11115468|NCT01305473|12299857|FG000|NOT COMPLETED|Overall Study||0
11115469|NCT01305564|12299861|FG000|STARTED|Overall Study||200
11115470|NCT01305564|12299861|FG000|COMPLETED|Overall Study||163
11115471|NCT01305564|12299861|FG000|NOT COMPLETED|Overall Study||37
11115472|NCT01305577|12299879|FG000|STARTED|Overall Study||120
11115473|NCT01305577|12299880|FG001|STARTED|Overall Study||121
11115474|NCT01305577|12299881|FG002|STARTED|Overall Study||122
11115475|NCT01305577|12299879|FG000|Received Treatment|Overall Study||119
11115476|NCT01305577|12299880|FG001|Received Treatment|Overall Study||121
11115477|NCT01305577|12299881|FG002|Received Treatment|Overall Study||122
11115478|NCT01305577|12299879|FG000|COMPLETED|Overall Study||107
11115479|NCT01305577|12299880|FG001|COMPLETED|Overall Study||110
11115480|NCT01305577|12299881|FG002|COMPLETED|Overall Study||112
11115481|NCT01305577|12299879|FG000|NOT COMPLETED|Overall Study||13
11115482|NCT01305577|12299880|FG001|NOT COMPLETED|Overall Study||11
11115483|NCT01305577|12299881|FG002|NOT COMPLETED|Overall Study||10
11115484|NCT01305655|12299889|FG000|STARTED|Overall Study|July 2008|47
11356160|NCT03092960|12553114|FG000|COMPLETED|Overall Study||180
11356161|NCT03092960|12553115|FG001|COMPLETED|Overall Study||186
11356162|NCT03092960|12553114|FG000|NOT COMPLETED|Overall Study||32
11356163|NCT03092960|12553115|FG001|NOT COMPLETED|Overall Study||26
11356164|NCT03093025|12553124|FG000|STARTED|Overall Study||16
11356165|NCT03093025|12553125|FG001|STARTED|Overall Study|One participant did not take any dose of investigational product after randomization.|17
11356166|NCT03093025|12553126|FG002|STARTED|Overall Study||18
11356167|NCT03093025|12553124|FG000|COMPLETED|Overall Study||12
11356168|NCT03093025|12553125|FG001|COMPLETED|Overall Study||15
11356169|NCT03093025|12553126|FG002|COMPLETED|Overall Study||16
11356170|NCT03093025|12553124|FG000|NOT COMPLETED|Overall Study||4
11356171|NCT03093025|12553125|FG001|NOT COMPLETED|Overall Study||2
11356172|NCT03093025|12553126|FG002|NOT COMPLETED|Overall Study||2
11356173|NCT03093181|12553137|FG000|STARTED|Overall Study||44
11356174|NCT03093181|12553138|FG001|STARTED|Overall Study||44
11356175|NCT03093181|12553139|FG002|STARTED|Overall Study||44
11356176|NCT03093181|12553137|FG000|COMPLETED|Overall Study||41
11232552|NCT02037165|12424666|FG002|NOT COMPLETED|Washout Period 1 (6 Days)||0
11232553|NCT02037165|12424667|FG003|NOT COMPLETED|Washout Period 1 (6 Days)||0
11232554|NCT02037165|12424668|FG004|NOT COMPLETED|Washout Period 1 (6 Days)||0
11232555|NCT02037165|12424664|FG000|STARTED|Period 2 (2 Days)||5
11232556|NCT02037165|12424665|FG001|STARTED|Period 2 (2 Days)||5
11232557|NCT02037165|12424666|FG002|STARTED|Period 2 (2 Days)||5
11232558|NCT02037165|12424667|FG003|STARTED|Period 2 (2 Days)||5
11232559|NCT02037165|12424668|FG004|STARTED|Period 2 (2 Days)||5
11232560|NCT02037165|12424664|FG000|COMPLETED|Period 2 (2 Days)||5
11232561|NCT02037165|12424665|FG001|COMPLETED|Period 2 (2 Days)||5
11232562|NCT02037165|12424666|FG002|COMPLETED|Period 2 (2 Days)||5
11232563|NCT02037165|12424667|FG003|COMPLETED|Period 2 (2 Days)||5
11232564|NCT02037165|12424668|FG004|COMPLETED|Period 2 (2 Days)||5
11232565|NCT02037165|12424664|FG000|NOT COMPLETED|Period 2 (2 Days)||0
11232566|NCT02037165|12424665|FG001|NOT COMPLETED|Period 2 (2 Days)||0
11115485|NCT01305655|12299889|FG000|COMPLETED|Overall Study|December 31, 2014|47
11115486|NCT01305655|12299889|FG000|NOT COMPLETED|Overall Study||0
11115487|NCT01305772|12299895|FG000|STARTED|Overall Study||5
11115488|NCT01305772|12299896|FG001|STARTED|Overall Study||1
11115489|NCT01305772|12299895|FG000|Genomic Screening + Biopsy #1|Overall Study||5
11115490|NCT01305772|12299896|FG001|Genomic Screening + Biopsy #1|Overall Study||1
11115491|NCT01305772|12299895|FG000|Research PET/CT #1|Overall Study||5
11115492|NCT01305772|12299896|FG001|Research PET/CT #1|Overall Study||1
11115493|NCT01305772|12299895|FG000|Panitumumab Dose #1|Overall Study||5
11115494|NCT01305772|12299896|FG001|Panitumumab Dose #1|Overall Study||1
11115495|NCT01305772|12299895|FG000|Research PET/CT #2|Overall Study||5
11115496|NCT01305772|12299896|FG001|Research PET/CT #2|Overall Study||1
11115497|NCT01305772|12299895|FG000|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
11115498|NCT01305772|12299896|FG001|Surgery/Biopsy #2|Overall Study||1
11115499|NCT01305772|12299895|FG000|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
11115500|NCT01305772|12299896|FG001|RT + Panitumumab Dose #2 / #3|Overall Study||1
11115501|NCT01305772|12299895|FG000|COMPLETED|Overall Study||5
11115502|NCT01305772|12299896|FG001|COMPLETED|Overall Study||1
11115503|NCT01305772|12299895|FG000|NOT COMPLETED|Overall Study||0
11115504|NCT01305772|12299896|FG001|NOT COMPLETED|Overall Study||0
11115505|NCT01305811|12299903|FG000|STARTED|Overall Study||52
11115506|NCT01305811|12299904|FG001|STARTED|Overall Study||52
11115507|NCT01305811|12299903|FG000|COMPLETED|Overall Study||44
11115508|NCT01305811|12299904|FG001|COMPLETED|Overall Study||41
11115509|NCT01305811|12299903|FG000|NOT COMPLETED|Overall Study||8
11115510|NCT01305811|12299904|FG001|NOT COMPLETED|Overall Study||11
11115511|NCT01305941|12299912|FG000|STARTED|Overall Study||32
11115512|NCT01305941|12299912|FG000|COMPLETED|Overall Study||22
11115513|NCT01305941|12299912|FG000|NOT COMPLETED|Overall Study||10
11115514|NCT01306032|12299922|FG000|STARTED|First Intervention||22
11115515|NCT01306032|12299923|FG001|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
11115516|NCT01306032|12299924|FG002|STARTED|First Intervention||37
11115517|NCT01306032|12299925|FG003|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
11115518|NCT01306032|12299926|FG004|STARTED|First Intervention||2
11115519|NCT01306032|12299927|FG005|STARTED|First Intervention||2
11115520|NCT01306032|12299922|FG000|COMPLETED|First Intervention||21
11115521|NCT01306032|12299923|FG001|COMPLETED|First Intervention||18
11115522|NCT01306032|12299924|FG002|COMPLETED|First Intervention||35
11115523|NCT01306032|12299925|FG003|COMPLETED|First Intervention||37
11115524|NCT01306032|12299926|FG004|COMPLETED|First Intervention||0
11115525|NCT01306032|12299927|FG005|COMPLETED|First Intervention||0
11115526|NCT01306032|12299922|FG000|NOT COMPLETED|First Intervention||1
11115527|NCT01306032|12299923|FG001|NOT COMPLETED|First Intervention||2
11115528|NCT01306032|12299924|FG002|NOT COMPLETED|First Intervention||2
11115529|NCT01306032|12299925|FG003|NOT COMPLETED|First Intervention||1
11115530|NCT01306032|12299926|FG004|NOT COMPLETED|First Intervention||2
11115531|NCT01306032|12299927|FG005|NOT COMPLETED|First Intervention||2
11115532|NCT01306032|12299922|FG000|STARTED|Disease Progression/Crossover||0
11115533|NCT01306032|12299923|FG001|STARTED|Disease Progression/Crossover||16
11115534|NCT01306032|12299924|FG002|STARTED|Disease Progression/Crossover||0
11115535|NCT01306032|12299925|FG003|STARTED|Disease Progression/Crossover||29
11115536|NCT01306032|12299926|FG004|STARTED|Disease Progression/Crossover||0
11115537|NCT01306032|12299927|FG005|STARTED|Disease Progression/Crossover||0
11115538|NCT01306032|12299922|FG000|COMPLETED|Disease Progression/Crossover||0
11115539|NCT01306032|12299923|FG001|COMPLETED|Disease Progression/Crossover||14
11115540|NCT01306032|12299924|FG002|COMPLETED|Disease Progression/Crossover||0
11115541|NCT01306032|12299925|FG003|COMPLETED|Disease Progression/Crossover||26
11115542|NCT01306032|12299926|FG004|COMPLETED|Disease Progression/Crossover||0
11115543|NCT01306032|12299927|FG005|COMPLETED|Disease Progression/Crossover||0
11115544|NCT01306032|12299922|FG000|NOT COMPLETED|Disease Progression/Crossover||0
11115545|NCT01306032|12299923|FG001|NOT COMPLETED|Disease Progression/Crossover||2
11115546|NCT01306032|12299924|FG002|NOT COMPLETED|Disease Progression/Crossover||0
11115547|NCT01306032|12299925|FG003|NOT COMPLETED|Disease Progression/Crossover||3
11115548|NCT01306032|12299926|FG004|NOT COMPLETED|Disease Progression/Crossover||0
11115549|NCT01306032|12299927|FG005|NOT COMPLETED|Disease Progression/Crossover||0
11115550|NCT01306058|12299953|FG000|STARTED|Overall Study||27
11115551|NCT01306058|12299953|FG000|COMPLETED|Overall Study||25
11115552|NCT01306058|12299953|FG000|NOT COMPLETED|Overall Study||2
11115553|NCT01306162|12299961|FG000|STARTED|Period 1||9
11115554|NCT01306162|12299962|FG001|STARTED|Period 1||9
11115555|NCT01306162|12299963|FG002|STARTED|Period 1||9
11115556|NCT01306162|12299964|FG003|STARTED|Period 1||9
11115557|NCT01306162|12299961|FG000|COMPLETED|Period 1||9
11115558|NCT01306162|12299962|FG001|COMPLETED|Period 1||9
11115559|NCT01306162|12299963|FG002|COMPLETED|Period 1||9
11115560|NCT01306162|12299964|FG003|COMPLETED|Period 1||8
11115561|NCT01306162|12299961|FG000|NOT COMPLETED|Period 1||0
11115562|NCT01306162|12299962|FG001|NOT COMPLETED|Period 1||0
11115563|NCT01306162|12299963|FG002|NOT COMPLETED|Period 1||0
11115564|NCT01306162|12299964|FG003|NOT COMPLETED|Period 1||1
11115565|NCT01306162|12299961|FG000|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
11115566|NCT01306162|12299962|FG001|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
11115567|NCT01306162|12299963|FG002|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
11115568|NCT01306162|12299964|FG003|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
11115569|NCT01306162|12299961|FG000|COMPLETED|Washout 1||9
11115570|NCT01306162|12299962|FG001|COMPLETED|Washout 1||8
11115571|NCT01306162|12299963|FG002|COMPLETED|Washout 1||9
11115572|NCT01306162|12299964|FG003|COMPLETED|Washout 1||8
11115573|NCT01306162|12299961|FG000|NOT COMPLETED|Washout 1||0
11115574|NCT01306162|12299962|FG001|NOT COMPLETED|Washout 1||1
11115575|NCT01306162|12299963|FG002|NOT COMPLETED|Washout 1||0
11115576|NCT01306162|12299964|FG003|NOT COMPLETED|Washout 1||0
11115577|NCT01306162|12299961|FG000|STARTED|Period 2|No washout phase after Period 2.|9
11115578|NCT01306162|12299962|FG001|STARTED|Period 2|No washout phase after Period 2.|8
11115579|NCT01306162|12299963|FG002|STARTED|Period 2|No washout phase after Period 2.|9
11115580|NCT01306162|12299964|FG003|STARTED|Period 2|No washout phase after Period 2.|8
11115581|NCT01306162|12299961|FG000|COMPLETED|Period 2||9
11115582|NCT01306162|12299962|FG001|COMPLETED|Period 2||8
11115583|NCT01306162|12299963|FG002|COMPLETED|Period 2||9
11115584|NCT01306162|12299964|FG003|COMPLETED|Period 2||8
11115585|NCT01306162|12299961|FG000|NOT COMPLETED|Period 2||0
11115586|NCT01306162|12299962|FG001|NOT COMPLETED|Period 2||0
11115587|NCT01306162|12299963|FG002|NOT COMPLETED|Period 2||0
11115588|NCT01306162|12299964|FG003|NOT COMPLETED|Period 2||0
11115589|NCT01306162|12299961|FG000|STARTED|Period 3||9
11115590|NCT01306162|12299962|FG001|STARTED|Period 3||8
11115591|NCT01306162|12299963|FG002|STARTED|Period 3||9
11115592|NCT01306162|12299964|FG003|STARTED|Period 3||8
11115593|NCT01306162|12299961|FG000|COMPLETED|Period 3||9
11115594|NCT01306162|12299962|FG001|COMPLETED|Period 3||8
11115595|NCT01306162|12299963|FG002|COMPLETED|Period 3||9
11115596|NCT01306162|12299964|FG003|COMPLETED|Period 3||8
11115597|NCT01306162|12299961|FG000|NOT COMPLETED|Period 3||0
11115598|NCT01306162|12299962|FG001|NOT COMPLETED|Period 3||0
11115599|NCT01306162|12299963|FG002|NOT COMPLETED|Period 3||0
11115600|NCT01306162|12299964|FG003|NOT COMPLETED|Period 3||0
11115601|NCT01306162|12299961|FG000|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
11115602|NCT01306162|12299962|FG001|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
11115603|NCT01306162|12299963|FG002|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
11115604|NCT01306162|12299964|FG003|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
11115605|NCT01306162|12299961|FG000|COMPLETED|Washout 2||9
11115606|NCT01306162|12299962|FG001|COMPLETED|Washout 2||8
11115607|NCT01306162|12299963|FG002|COMPLETED|Washout 2||9
11115608|NCT01306162|12299964|FG003|COMPLETED|Washout 2||8
11115609|NCT01306162|12299961|FG000|NOT COMPLETED|Washout 2||0
11115610|NCT01306162|12299962|FG001|NOT COMPLETED|Washout 2||0
11115611|NCT01306162|12299963|FG002|NOT COMPLETED|Washout 2||0
11115612|NCT01306162|12299964|FG003|NOT COMPLETED|Washout 2||0
11115613|NCT01306162|12299961|FG000|STARTED|Period 4||9
11115614|NCT01306162|12299962|FG001|STARTED|Period 4||8
11115615|NCT01306162|12299963|FG002|STARTED|Period 4||9
11115616|NCT01306162|12299964|FG003|STARTED|Period 4||8
11115617|NCT01306162|12299961|FG000|COMPLETED|Period 4||9
11115618|NCT01306162|12299962|FG001|COMPLETED|Period 4||8
11115619|NCT01306162|12299963|FG002|COMPLETED|Period 4||9
11115620|NCT01306162|12299964|FG003|COMPLETED|Period 4||8
11115621|NCT01306162|12299961|FG000|NOT COMPLETED|Period 4||0
11115622|NCT01306162|12299962|FG001|NOT COMPLETED|Period 4||0
11115623|NCT01306162|12299963|FG002|NOT COMPLETED|Period 4||0
11115624|NCT01306162|12299964|FG003|NOT COMPLETED|Period 4||0
11115625|NCT01306175|12299977|FG000|STARTED|First Intervention||20
11115626|NCT01306175|12299977|FG000|COMPLETED|First Intervention||20
11115627|NCT01306175|12299977|FG000|NOT COMPLETED|First Intervention||0
11115628|NCT01306175|12299977|FG000|STARTED|Washout Period of at Least 14 Days||20
11115629|NCT01306175|12299977|FG000|COMPLETED|Washout Period of at Least 14 Days||20
11115630|NCT01306175|12299977|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
11115631|NCT01306175|12299977|FG000|STARTED|Second Intervention||20
11115632|NCT01306175|12299977|FG000|COMPLETED|Second Intervention||20
11115633|NCT01306175|12299977|FG000|NOT COMPLETED|Second Intervention||0
11115634|NCT01306201|12299983|FG000|STARTED|Overall Study||63
11115635|NCT01306201|12299983|FG000|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
11115636|NCT01306201|12299983|FG000|NOT COMPLETED|Overall Study||10
11115637|NCT01306214|12299994|FG000|STARTED|Overall Study||189
11115638|NCT01306214|12299995|FG001|STARTED|Overall Study||187
11115639|NCT01306214|12299996|FG002|STARTED|Overall Study||190
11115640|NCT01306214|12299994|FG000|COMPLETED|Overall Study||161
11115641|NCT01306214|12299995|FG001|COMPLETED|Overall Study||159
11115642|NCT01306214|12299996|FG002|COMPLETED|Overall Study||168
11115643|NCT01306214|12299994|FG000|NOT COMPLETED|Overall Study||28
11115644|NCT01306214|12299995|FG001|NOT COMPLETED|Overall Study||28
11115645|NCT01306214|12299996|FG002|NOT COMPLETED|Overall Study||22
11115646|NCT01306253|12300006|FG000|STARTED|Overall Study||57
11115647|NCT01306253|12300007|FG001|STARTED|Overall Study||57
11115648|NCT01306253|12300006|FG000|COMPLETED|Overall Study||56
11115649|NCT01306253|12300007|FG001|COMPLETED|Overall Study||56
11115650|NCT01306253|12300006|FG000|NOT COMPLETED|Overall Study||1
11115651|NCT01306253|12300007|FG001|NOT COMPLETED|Overall Study||1
11115652|NCT01306292|12300015|FG000|STARTED|First Injection||10
11115653|NCT01306292|12300016|FG001|STARTED|First Injection||8
11115654|NCT01306292|12300017|FG002|STARTED|First Injection||8
11115655|NCT01306292|12300018|FG003|STARTED|First Injection||10
11115656|NCT01306292|12300015|FG000|COMPLETED|First Injection||10
11115657|NCT01306292|12300016|FG001|COMPLETED|First Injection||8
11115658|NCT01306292|12300017|FG002|COMPLETED|First Injection||8
11115659|NCT01306292|12300018|FG003|COMPLETED|First Injection||10
11115660|NCT01306292|12300015|FG000|NOT COMPLETED|First Injection||0
11115661|NCT01306292|12300016|FG001|NOT COMPLETED|First Injection||0
11115662|NCT01306292|12300017|FG002|NOT COMPLETED|First Injection||0
11115663|NCT01306292|12300018|FG003|NOT COMPLETED|First Injection||0
11115664|NCT01306292|12300015|FG000|STARTED|Washout (at Least 10 Minutes)||10
11115665|NCT01306292|12300016|FG001|STARTED|Washout (at Least 10 Minutes)||8
11115666|NCT01306292|12300017|FG002|STARTED|Washout (at Least 10 Minutes)||8
11115667|NCT01306292|12300018|FG003|STARTED|Washout (at Least 10 Minutes)||10
11115668|NCT01306292|12300015|FG000|COMPLETED|Washout (at Least 10 Minutes)||10
11232567|NCT02037165|12424666|FG002|NOT COMPLETED|Period 2 (2 Days)||0
11232568|NCT02037165|12424667|FG003|NOT COMPLETED|Period 2 (2 Days)||0
11232569|NCT02037165|12424668|FG004|NOT COMPLETED|Period 2 (2 Days)||0
11232570|NCT02037165|12424664|FG000|STARTED|Washout Period 2 (6 Days)||5
11232571|NCT02037165|12424665|FG001|STARTED|Washout Period 2 (6 Days)||5
11232572|NCT02037165|12424666|FG002|STARTED|Washout Period 2 (6 Days)||5
11232573|NCT02037165|12424667|FG003|STARTED|Washout Period 2 (6 Days)||5
11232574|NCT02037165|12424668|FG004|STARTED|Washout Period 2 (6 Days)||5
11232575|NCT02037165|12424664|FG000|COMPLETED|Washout Period 2 (6 Days)||5
11232576|NCT02037165|12424665|FG001|COMPLETED|Washout Period 2 (6 Days)||5
11232577|NCT02037165|12424666|FG002|COMPLETED|Washout Period 2 (6 Days)||5
11232578|NCT02037165|12424667|FG003|COMPLETED|Washout Period 2 (6 Days)||5
11232579|NCT02037165|12424668|FG004|COMPLETED|Washout Period 2 (6 Days)||5
11232580|NCT02037165|12424664|FG000|NOT COMPLETED|Washout Period 2 (6 Days)||0
11232581|NCT02037165|12424665|FG001|NOT COMPLETED|Washout Period 2 (6 Days)||0
11232582|NCT02037165|12424666|FG002|NOT COMPLETED|Washout Period 2 (6 Days)||0
11232583|NCT02037165|12424667|FG003|NOT COMPLETED|Washout Period 2 (6 Days)||0
11232584|NCT02037165|12424668|FG004|NOT COMPLETED|Washout Period 2 (6 Days)||0
11232585|NCT02037165|12424664|FG000|STARTED|Period 3 (2 Days)||5
11232586|NCT02037165|12424665|FG001|STARTED|Period 3 (2 Days)||5
11232587|NCT02037165|12424666|FG002|STARTED|Period 3 (2 Days)||5
11232588|NCT02037165|12424667|FG003|STARTED|Period 3 (2 Days)||5
11232589|NCT02037165|12424668|FG004|STARTED|Period 3 (2 Days)||5
11232590|NCT02037165|12424664|FG000|COMPLETED|Period 3 (2 Days)||5
11232591|NCT02037165|12424665|FG001|COMPLETED|Period 3 (2 Days)||5
11232592|NCT02037165|12424666|FG002|COMPLETED|Period 3 (2 Days)||5
11232593|NCT02037165|12424667|FG003|COMPLETED|Period 3 (2 Days)||5
11232594|NCT02037165|12424668|FG004|COMPLETED|Period 3 (2 Days)||5
11232595|NCT02037165|12424664|FG000|NOT COMPLETED|Period 3 (2 Days)||0
11232596|NCT02037165|12424665|FG001|NOT COMPLETED|Period 3 (2 Days)||0
11232597|NCT02037165|12424666|FG002|NOT COMPLETED|Period 3 (2 Days)||0
11232598|NCT02037165|12424667|FG003|NOT COMPLETED|Period 3 (2 Days)||0
11232599|NCT02037165|12424668|FG004|NOT COMPLETED|Period 3 (2 Days)||0
11232600|NCT02037165|12424664|FG000|STARTED|Washout Period 3 (6 Days)||5
11232601|NCT02037165|12424665|FG001|STARTED|Washout Period 3 (6 Days)||5
11232602|NCT02037165|12424666|FG002|STARTED|Washout Period 3 (6 Days)||5
11232603|NCT02037165|12424667|FG003|STARTED|Washout Period 3 (6 Days)||5
11232604|NCT02037165|12424668|FG004|STARTED|Washout Period 3 (6 Days)||5
11232605|NCT02037165|12424664|FG000|COMPLETED|Washout Period 3 (6 Days)||5
11232606|NCT02037165|12424665|FG001|COMPLETED|Washout Period 3 (6 Days)||5
11232607|NCT02037165|12424666|FG002|COMPLETED|Washout Period 3 (6 Days)||5
11232608|NCT02037165|12424667|FG003|COMPLETED|Washout Period 3 (6 Days)||5
11232609|NCT02037165|12424668|FG004|COMPLETED|Washout Period 3 (6 Days)||5
11115669|NCT01306292|12300016|FG001|COMPLETED|Washout (at Least 10 Minutes)||8
11115670|NCT01306292|12300017|FG002|COMPLETED|Washout (at Least 10 Minutes)||8
11115671|NCT01306292|12300018|FG003|COMPLETED|Washout (at Least 10 Minutes)||10
11115672|NCT01306292|12300015|FG000|NOT COMPLETED|Washout (at Least 10 Minutes)||0
11115673|NCT01306292|12300016|FG001|NOT COMPLETED|Washout (at Least 10 Minutes)||0
11115674|NCT01306292|12300017|FG002|NOT COMPLETED|Washout (at Least 10 Minutes)||0
11115675|NCT01306292|12300018|FG003|NOT COMPLETED|Washout (at Least 10 Minutes)||0
11115676|NCT01306292|12300015|FG000|STARTED|Second Injection||10
11115677|NCT01306292|12300016|FG001|STARTED|Second Injection||8
11115678|NCT01306292|12300017|FG002|STARTED|Second Injection||8
11115679|NCT01306292|12300018|FG003|STARTED|Second Injection||10
11115680|NCT01306292|12300015|FG000|COMPLETED|Second Injection||10
11115681|NCT01306292|12300016|FG001|COMPLETED|Second Injection||8
11115682|NCT01306292|12300017|FG002|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
11115683|NCT01306292|12300018|FG003|COMPLETED|Second Injection||10
11115684|NCT01306292|12300015|FG000|NOT COMPLETED|Second Injection||0
11115685|NCT01306292|12300016|FG001|NOT COMPLETED|Second Injection||0
11115686|NCT01306292|12300017|FG002|NOT COMPLETED|Second Injection||1
11115687|NCT01306292|12300018|FG003|NOT COMPLETED|Second Injection||0
11115688|NCT01306305|12300028|FG000|STARTED|Overall Study||55
11115689|NCT01306305|12300029|FG001|STARTED|Overall Study||55
11115690|NCT01306305|12300028|FG000|COMPLETED|Overall Study||53
11115691|NCT01306305|12300029|FG001|COMPLETED|Overall Study||55
11115692|NCT01306305|12300028|FG000|NOT COMPLETED|Overall Study||2
11115693|NCT01306305|12300029|FG001|NOT COMPLETED|Overall Study||0
11115694|NCT01306617|12300038|FG000|STARTED|Overall Study||19
11115695|NCT01306617|12300039|FG001|STARTED|Overall Study||14
11115696|NCT01306617|12300040|FG002|STARTED|Overall Study||17
11115697|NCT01306617|12300038|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|18
11115698|NCT01306617|12300039|FG001|COMPLETED|Overall Study|The number of participants who completed study drug|13
11115699|NCT01306617|12300040|FG002|COMPLETED|Overall Study|The number of participants who completed study drug|12
11115700|NCT01306617|12300038|FG000|NOT COMPLETED|Overall Study||1
11115701|NCT01306617|12300039|FG001|NOT COMPLETED|Overall Study||1
11115702|NCT01306617|12300040|FG002|NOT COMPLETED|Overall Study||5
11115703|NCT01306643|12300048|FG000|STARTED|Overall Study||18
11115704|NCT01306643|12300048|FG000|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
11115705|NCT01306643|12300048|FG000|NOT COMPLETED|Overall Study||13
11115706|NCT01306656|12300054|FG000|STARTED|Overall Study||7
11115707|NCT01306656|12300055|FG001|STARTED|Overall Study||2
11115708|NCT01306656|12300054|FG000|COMPLETED|Overall Study||6
11115709|NCT01306656|12300055|FG001|COMPLETED|Overall Study||2
11115710|NCT01306656|12300054|FG000|NOT COMPLETED|Overall Study||1
11115711|NCT01306656|12300055|FG001|NOT COMPLETED|Overall Study||0
11115712|NCT01306877|12300065|FG000|STARTED|Overall Study||78
11115713|NCT01306877|12300066|FG001|STARTED|Overall Study||71
11115714|NCT01306877|12300065|FG000|COMPLETED|Overall Study||75
11115715|NCT01306877|12300066|FG001|COMPLETED|Overall Study||67
11115716|NCT01306877|12300065|FG000|NOT COMPLETED|Overall Study||3
11115717|NCT01306877|12300066|FG001|NOT COMPLETED|Overall Study||4
11115718|NCT01306890|12300072|FG000|STARTED|Overall Study||1976
11115719|NCT01306890|12300072|FG000|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457
11115720|NCT01306890|12300072|FG000|NOT COMPLETED|Overall Study||1519
11115721|NCT01306942|12300079|FG000|STARTED|Phase I||6
11115722|NCT01306942|12300080|FG001|STARTED|Phase I||4
11115723|NCT01306942|12300081|FG002|STARTED|Phase I||0
11115724|NCT01306942|12300082|FG003|STARTED|Phase I||0
11115725|NCT01306942|12300079|FG000|COMPLETED|Phase I||1
11115726|NCT01306942|12300080|FG001|COMPLETED|Phase I||1
11115727|NCT01306942|12300081|FG002|COMPLETED|Phase I||0
11115728|NCT01306942|12300082|FG003|COMPLETED|Phase I||0
11115729|NCT01306942|12300079|FG000|NOT COMPLETED|Phase I||5
11115730|NCT01306942|12300080|FG001|NOT COMPLETED|Phase I||3
11115731|NCT01306942|12300081|FG002|NOT COMPLETED|Phase I||0
11115732|NCT01306942|12300082|FG003|NOT COMPLETED|Phase I||0
11115733|NCT01306942|12300079|FG000|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2
11115734|NCT01306942|12300080|FG001|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0
11115735|NCT01306942|12300081|FG002|STARTED|Phase II||0
11115736|NCT01306942|12300082|FG003|STARTED|Phase II||27
11115737|NCT01306942|12300079|FG000|COMPLETED|Phase II||0
11115738|NCT01306942|12300080|FG001|COMPLETED|Phase II||0
11115739|NCT01306942|12300081|FG002|COMPLETED|Phase II||0
11115740|NCT01306942|12300082|FG003|COMPLETED|Phase II||11
11115741|NCT01306942|12300079|FG000|NOT COMPLETED|Phase II||2
11115742|NCT01306942|12300080|FG001|NOT COMPLETED|Phase II||0
11115743|NCT01306942|12300081|FG002|NOT COMPLETED|Phase II||0
11115744|NCT01306942|12300082|FG003|NOT COMPLETED|Phase II||16
11115745|NCT01306968|12300098|FG000|STARTED|Overall Study||7
11115746|NCT01306968|12300099|FG001|STARTED|Overall Study||23
11115747|NCT01306968|12300100|FG002|STARTED|Overall Study||24
11115748|NCT01306968|12300101|FG003|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
11115749|NCT01306968|12300098|FG000|COMPLETED|Overall Study||6
11115750|NCT01306968|12300099|FG001|COMPLETED|Overall Study||20
11115751|NCT01306968|12300100|FG002|COMPLETED|Overall Study||23
11115752|NCT01306968|12300101|FG003|COMPLETED|Overall Study||21
11115753|NCT01306968|12300098|FG000|NOT COMPLETED|Overall Study||1
11115754|NCT01306968|12300099|FG001|NOT COMPLETED|Overall Study||3
11115755|NCT01306968|12300100|FG002|NOT COMPLETED|Overall Study||1
11115756|NCT01306968|12300101|FG003|NOT COMPLETED|Overall Study||4
11115757|NCT01307007|12300115|FG000|STARTED|Overall Study||25
11115758|NCT01307007|12300116|FG001|STARTED|Overall Study||30
11115759|NCT01307007|12300115|FG000|COMPLETED|Overall Study||25
11115760|NCT01307007|12300116|FG001|COMPLETED|Overall Study||30
11115761|NCT01307007|12300115|FG000|NOT COMPLETED|Overall Study||0
11115762|NCT01307007|12300116|FG001|NOT COMPLETED|Overall Study||0
11115763|NCT01307020|12300132|FG000|STARTED|Overall Study||61
11115764|NCT01307020|12300133|FG001|STARTED|Overall Study||63
11115765|NCT01307020|12300134|FG002|STARTED|Overall Study||63
11115766|NCT01307020|12300135|FG003|STARTED|Overall Study||61
11115767|NCT01307020|12300136|FG004|STARTED|Overall Study||60
11115768|NCT01307020|12300137|FG005|STARTED|Overall Study||61
11115769|NCT01307020|12300138|FG006|STARTED|Overall Study||59
11115770|NCT01307020|12300139|FG007|STARTED|Overall Study||60
11115771|NCT01307020|12300140|FG008|STARTED|Overall Study||61
11115772|NCT01307020|12300141|FG009|STARTED|Overall Study||62
11115773|NCT01307020|12300132|FG000|Safety Population|Overall Study||61
11115774|NCT01307020|12300133|FG001|Safety Population|Overall Study||63
11115775|NCT01307020|12300134|FG002|Safety Population|Overall Study||63
11115776|NCT01307020|12300135|FG003|Safety Population|Overall Study||61
11115777|NCT01307020|12300136|FG004|Safety Population|Overall Study||60
11115778|NCT01307020|12300137|FG005|Safety Population|Overall Study||61
11115779|NCT01307020|12300138|FG006|Safety Population|Overall Study||59
11115780|NCT01307020|12300139|FG007|Safety Population|Overall Study||60
11115781|NCT01307020|12300140|FG008|Safety Population|Overall Study||61
11115782|NCT01307020|12300141|FG009|Safety Population|Overall Study||62
11115783|NCT01307020|12300132|FG000|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
11115784|NCT01307020|12300133|FG001|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
11115785|NCT01307020|12300134|FG002|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
11115786|NCT01307020|12300135|FG003|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
11115787|NCT01307020|12300136|FG004|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
11115788|NCT01307020|12300137|FG005|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
11115789|NCT01307020|12300138|FG006|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
11115790|NCT01307020|12300139|FG007|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
11115791|NCT01307020|12300140|FG008|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
11115792|NCT01307020|12300141|FG009|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
11115793|NCT01307020|12300132|FG000|COMPLETED|Overall Study||61
11115794|NCT01307020|12300133|FG001|COMPLETED|Overall Study||62
11115795|NCT01307020|12300134|FG002|COMPLETED|Overall Study||62
11115796|NCT01307020|12300135|FG003|COMPLETED|Overall Study||60
11115797|NCT01307020|12300136|FG004|COMPLETED|Overall Study||60
11115798|NCT01307020|12300137|FG005|COMPLETED|Overall Study||61
11115799|NCT01307020|12300138|FG006|COMPLETED|Overall Study||58
11115800|NCT01307020|12300139|FG007|COMPLETED|Overall Study||60
11115801|NCT01307020|12300140|FG008|COMPLETED|Overall Study||61
11115802|NCT01307020|12300141|FG009|COMPLETED|Overall Study||62
11115803|NCT01307020|12300132|FG000|NOT COMPLETED|Overall Study||0
11115804|NCT01307020|12300133|FG001|NOT COMPLETED|Overall Study||1
11115805|NCT01307020|12300134|FG002|NOT COMPLETED|Overall Study||1
11115806|NCT01307020|12300135|FG003|NOT COMPLETED|Overall Study||1
11115807|NCT01307020|12300136|FG004|NOT COMPLETED|Overall Study||0
11115808|NCT01307020|12300137|FG005|NOT COMPLETED|Overall Study||0
11115809|NCT01307020|12300138|FG006|NOT COMPLETED|Overall Study||1
11115810|NCT01307020|12300139|FG007|NOT COMPLETED|Overall Study||0
11115811|NCT01307020|12300140|FG008|NOT COMPLETED|Overall Study||0
11115812|NCT01307020|12300141|FG009|NOT COMPLETED|Overall Study||0
11115813|NCT01307098|12300166|FG000|STARTED|Overall Study||3
11115814|NCT01307098|12300167|FG001|STARTED|Overall Study||3
11115815|NCT01307098|12300168|FG002|STARTED|Overall Study||3
11115816|NCT01307098|12300166|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
11115817|NCT01307098|12300167|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
11115818|NCT01307098|12300168|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
11115819|NCT01307098|12300166|FG000|COMPLETED|Overall Study||3
11115820|NCT01307098|12300167|FG001|COMPLETED|Overall Study||3
11115821|NCT01307098|12300168|FG002|COMPLETED|Overall Study||3
11115822|NCT01307098|12300166|FG000|NOT COMPLETED|Overall Study||0
11115823|NCT01307098|12300167|FG001|NOT COMPLETED|Overall Study||0
11115824|NCT01307098|12300168|FG002|NOT COMPLETED|Overall Study||0
11115825|NCT01307111|12300179|FG000|STARTED|IUD Insertion||42
11115826|NCT01307111|12300180|FG001|STARTED|IUD Insertion||40
11115827|NCT01307111|12300179|FG000|COMPLETED|IUD Insertion||40
11115828|NCT01307111|12300180|FG001|COMPLETED|IUD Insertion||40
11115829|NCT01307111|12300179|FG000|NOT COMPLETED|IUD Insertion||2
11115830|NCT01307111|12300180|FG001|NOT COMPLETED|IUD Insertion||0
11115831|NCT01307111|12300179|FG000|STARTED|1-2 Week IUD Check up||40
11115832|NCT01307111|12300180|FG001|STARTED|1-2 Week IUD Check up||40
11115833|NCT01307111|12300179|FG000|COMPLETED|1-2 Week IUD Check up||38
11115834|NCT01307111|12300180|FG001|COMPLETED|1-2 Week IUD Check up||38
11115835|NCT01307111|12300179|FG000|NOT COMPLETED|1-2 Week IUD Check up||2
11115836|NCT01307111|12300180|FG001|NOT COMPLETED|1-2 Week IUD Check up||2
11115837|NCT01307267|12300209|FG000|STARTED|Overall Study||4
11115838|NCT01307267|12300210|FG001|STARTED|Overall Study||3
11115839|NCT01307267|12300211|FG002|STARTED|Overall Study||6
11115840|NCT01307267|12300212|FG003|STARTED|Overall Study||4
11115841|NCT01307267|12300213|FG004|STARTED|Overall Study||3
11115842|NCT01307267|12300214|FG005|STARTED|Overall Study||42
11115843|NCT01307267|12300215|FG006|STARTED|Overall Study||3
11115844|NCT01307267|12300216|FG007|STARTED|Overall Study||4
11115845|NCT01307267|12300217|FG008|STARTED|Overall Study||31
11115846|NCT01307267|12300218|FG009|STARTED|Overall Study||5
11115847|NCT01307267|12300219|FG010|STARTED|Overall Study||6
11115848|NCT01307267|12300220|FG011|STARTED|Overall Study||11
11115849|NCT01307267|12300221|FG012|STARTED|Overall Study||3
11115850|NCT01307267|12300222|FG013|STARTED|Overall Study||3
11115851|NCT01307267|12300223|FG014|STARTED|Overall Study||4
11115852|NCT01307267|12300224|FG015|STARTED|Overall Study||3
11115853|NCT01307267|12300225|FG016|STARTED|Overall Study||3
11115854|NCT01307267|12300226|FG017|STARTED|Overall Study||3
11115855|NCT01307267|12300227|FG018|STARTED|Overall Study||4
11115856|NCT01307267|12300228|FG019|STARTED|Overall Study||32
11232610|NCT02037165|12424664|FG000|NOT COMPLETED|Washout Period 3 (6 Days)||0
11232611|NCT02037165|12424665|FG001|NOT COMPLETED|Washout Period 3 (6 Days)||0
11115857|NCT01307267|12300229|FG020|STARTED|Overall Study||3
11115858|NCT01307267|12300230|FG021|STARTED|Overall Study||5
11115859|NCT01307267|12300231|FG022|STARTED|Overall Study||4
11115860|NCT01307267|12300209|FG000|COMPLETED|Overall Study||0
11115861|NCT01307267|12300210|FG001|COMPLETED|Overall Study||0
11115862|NCT01307267|12300211|FG002|COMPLETED|Overall Study||1
11115863|NCT01307267|12300212|FG003|COMPLETED|Overall Study||1
11115864|NCT01307267|12300213|FG004|COMPLETED|Overall Study||2
11115865|NCT01307267|12300214|FG005|COMPLETED|Overall Study||1
11115866|NCT01307267|12300215|FG006|COMPLETED|Overall Study||1
11115867|NCT01307267|12300216|FG007|COMPLETED|Overall Study||0
11115868|NCT01307267|12300217|FG008|COMPLETED|Overall Study||1
11115869|NCT01307267|12300218|FG009|COMPLETED|Overall Study||0
11115870|NCT01307267|12300219|FG010|COMPLETED|Overall Study||0
11115871|NCT01307267|12300220|FG011|COMPLETED|Overall Study||0
11115872|NCT01307267|12300221|FG012|COMPLETED|Overall Study||2
11115873|NCT01307267|12300222|FG013|COMPLETED|Overall Study||3
11115874|NCT01307267|12300223|FG014|COMPLETED|Overall Study||2
11115875|NCT01307267|12300224|FG015|COMPLETED|Overall Study||2
11115876|NCT01307267|12300225|FG016|COMPLETED|Overall Study||2
11115877|NCT01307267|12300226|FG017|COMPLETED|Overall Study||2
11115878|NCT01307267|12300227|FG018|COMPLETED|Overall Study||2
11115879|NCT01307267|12300228|FG019|COMPLETED|Overall Study||0
11115880|NCT01307267|12300229|FG020|COMPLETED|Overall Study||0
11115881|NCT01307267|12300230|FG021|COMPLETED|Overall Study||0
11115882|NCT01307267|12300231|FG022|COMPLETED|Overall Study||0
11115883|NCT01307267|12300209|FG000|NOT COMPLETED|Overall Study||4
11115884|NCT01307267|12300210|FG001|NOT COMPLETED|Overall Study||3
11115885|NCT01307267|12300211|FG002|NOT COMPLETED|Overall Study||5
11115886|NCT01307267|12300212|FG003|NOT COMPLETED|Overall Study||3
11115887|NCT01307267|12300213|FG004|NOT COMPLETED|Overall Study||1
11115888|NCT01307267|12300214|FG005|NOT COMPLETED|Overall Study||41
11115889|NCT01307267|12300215|FG006|NOT COMPLETED|Overall Study||2
11115890|NCT01307267|12300216|FG007|NOT COMPLETED|Overall Study||4
11115891|NCT01307267|12300217|FG008|NOT COMPLETED|Overall Study||30
11115892|NCT01307267|12300218|FG009|NOT COMPLETED|Overall Study||5
11115893|NCT01307267|12300219|FG010|NOT COMPLETED|Overall Study||6
11115894|NCT01307267|12300220|FG011|NOT COMPLETED|Overall Study||11
11115895|NCT01307267|12300221|FG012|NOT COMPLETED|Overall Study||1
11115896|NCT01307267|12300222|FG013|NOT COMPLETED|Overall Study||0
11115897|NCT01307267|12300223|FG014|NOT COMPLETED|Overall Study||2
11115898|NCT01307267|12300224|FG015|NOT COMPLETED|Overall Study||1
11115899|NCT01307267|12300225|FG016|NOT COMPLETED|Overall Study||1
11115900|NCT01307267|12300226|FG017|NOT COMPLETED|Overall Study||1
11115901|NCT01307267|12300227|FG018|NOT COMPLETED|Overall Study||2
11115902|NCT01307267|12300228|FG019|NOT COMPLETED|Overall Study||32
11115903|NCT01307267|12300229|FG020|NOT COMPLETED|Overall Study||3
11115904|NCT01307267|12300230|FG021|NOT COMPLETED|Overall Study||5
11115905|NCT01307267|12300231|FG022|NOT COMPLETED|Overall Study||4
11115906|NCT01307319|12300293|FG000|STARTED|Overall Study|Randomized|239
11115907|NCT01307319|12300294|FG001|STARTED|Overall Study|Randomized|242
11115908|NCT01307319|12300295|FG002|STARTED|Overall Study|Randomized|234
11115909|NCT01307319|12300293|FG000|Safety Population|Overall Study||239
11115910|NCT01307319|12300294|FG001|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
11115911|NCT01307319|12300295|FG002|Safety Population|Overall Study||234
11115912|NCT01307319|12300293|FG000|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
11115913|NCT01307319|12300294|FG001|ITT Population|Overall Study||241
11115914|NCT01307319|12300295|FG002|ITT Population|Overall Study||234
11115915|NCT01307319|12300293|FG000|COMPLETED|Overall Study||235
11115916|NCT01307319|12300294|FG001|COMPLETED|Overall Study||234
11115917|NCT01307319|12300295|FG002|COMPLETED|Overall Study||227
11115918|NCT01307319|12300293|FG000|NOT COMPLETED|Overall Study||4
11115919|NCT01307319|12300294|FG001|NOT COMPLETED|Overall Study||8
11115920|NCT01307319|12300295|FG002|NOT COMPLETED|Overall Study||7
11115921|NCT01307397|12300303|FG000|STARTED|Overall Study||3219
11115922|NCT01307397|12300303|FG000|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
11115923|NCT01307397|12300303|FG000|NOT COMPLETED|Overall Study||0
11115924|NCT01307449|12300311|FG000|STARTED|Overall Study||33
11115925|NCT01307449|12300312|FG001|STARTED|Overall Study||33
11115926|NCT01307449|12300313|FG002|STARTED|Overall Study||11
11115927|NCT01307449|12300314|FG003|STARTED|Overall Study||11
11115928|NCT01307449|12300311|FG000|COMPLETED|Overall Study||32
11115929|NCT01307449|12300312|FG001|COMPLETED|Overall Study||33
11115930|NCT01307449|12300313|FG002|COMPLETED|Overall Study||11
11115931|NCT01307449|12300314|FG003|COMPLETED|Overall Study||11
11115932|NCT01307449|12300311|FG000|NOT COMPLETED|Overall Study||1
11115933|NCT01307449|12300312|FG001|NOT COMPLETED|Overall Study||0
11115934|NCT01307449|12300313|FG002|NOT COMPLETED|Overall Study||0
11115935|NCT01307449|12300314|FG003|NOT COMPLETED|Overall Study||0
11115936|NCT01307462|12300324|FG000|STARTED|Overall Study||36
11115937|NCT01307462|12300324|FG000|COMPLETED|Overall Study||35
11115938|NCT01307462|12300324|FG000|NOT COMPLETED|Overall Study||1
11115939|NCT01307501|12300328|FG000|STARTED|Overall Study||40
11115940|NCT01307501|12300328|FG000|Intent-to-Treat (ITT) Population|Overall Study||40
11115941|NCT01307501|12300328|FG000|COMPLETED|Overall Study||17
11115942|NCT01307501|12300328|FG000|NOT COMPLETED|Overall Study||23
11115943|NCT01307579|12300334|FG000|STARTED|Overall Study||257
11115944|NCT01307579|12300335|FG001|STARTED|Overall Study||260
11115945|NCT01307579|12300334|FG000|COMPLETED|Overall Study||117
11115946|NCT01307579|12300335|FG001|COMPLETED|Overall Study||115
11115947|NCT01307579|12300334|FG000|NOT COMPLETED|Overall Study||140
11115948|NCT01307579|12300335|FG001|NOT COMPLETED|Overall Study||145
11115949|NCT01307618|12300343|FG000|STARTED|Overall Study||5
11115950|NCT01307618|12300344|FG001|STARTED|Overall Study||5
11115951|NCT01307618|12300343|FG000|COMPLETED|Overall Study||5
11115952|NCT01307618|12300344|FG001|COMPLETED|Overall Study||5
11115953|NCT01307618|12300343|FG000|NOT COMPLETED|Overall Study||0
11115954|NCT01307618|12300344|FG001|NOT COMPLETED|Overall Study||0
11115955|NCT01307748|12300353|FG000|STARTED|Overall Study||31
11115956|NCT01307748|12300354|FG001|STARTED|Overall Study||31
11115957|NCT01307748|12300355|FG002|STARTED|Overall Study||30
11115958|NCT01307748|12300353|FG000|COMPLETED|Overall Study||31
11115959|NCT01307748|12300354|FG001|COMPLETED|Overall Study||31
11115960|NCT01307748|12300355|FG002|COMPLETED|Overall Study||30
11115961|NCT01307748|12300353|FG000|NOT COMPLETED|Overall Study||0
11115962|NCT01307748|12300354|FG001|NOT COMPLETED|Overall Study||0
11115963|NCT01307748|12300355|FG002|NOT COMPLETED|Overall Study||0
11115964|NCT01307891|12300371|FG000|STARTED|Overall Study||42
11115965|NCT01307891|12300372|FG001|STARTED|Overall Study||22
11115966|NCT01307891|12300371|FG000|COMPLETED|Overall Study||39
11115967|NCT01307891|12300372|FG001|COMPLETED|Overall Study||21
11115968|NCT01307891|12300371|FG000|NOT COMPLETED|Overall Study||3
11115969|NCT01307891|12300372|FG001|NOT COMPLETED|Overall Study||1
11115970|NCT01307930|12300378|FG000|STARTED|Overall Study||20
11115971|NCT01307930|12300378|FG000|COMPLETED|Overall Study||18
11115972|NCT01307930|12300378|FG000|NOT COMPLETED|Overall Study||2
11115973|NCT01307956|12300382|FG000|STARTED|Overall Study||11
11115974|NCT01307956|12300382|FG000|COMPLETED|Overall Study||11
11115975|NCT01307956|12300382|FG000|NOT COMPLETED|Overall Study||0
11115976|NCT01308008|12300388|FG000|STARTED|4 Weeks||71
11115977|NCT01308008|12300389|FG001|STARTED|4 Weeks||73
11115978|NCT01308008|12300388|FG000|COMPLETED|4 Weeks||62
11115979|NCT01308008|12300389|FG001|COMPLETED|4 Weeks||71
11115980|NCT01308008|12300388|FG000|NOT COMPLETED|4 Weeks||9
11115981|NCT01308008|12300389|FG001|NOT COMPLETED|4 Weeks||2
11115982|NCT01308008|12300388|FG000|STARTED|6 Months||62
11115983|NCT01308008|12300389|FG001|STARTED|6 Months||71
11115984|NCT01308008|12300388|FG000|COMPLETED|6 Months||54
11115985|NCT01308008|12300389|FG001|COMPLETED|6 Months||62
11115986|NCT01308008|12300388|FG000|NOT COMPLETED|6 Months||8
11115987|NCT01308008|12300389|FG001|NOT COMPLETED|6 Months||9
11115988|NCT01308008|12300388|FG000|STARTED|12 Months||54
11115989|NCT01308008|12300389|FG001|STARTED|12 Months||62
11115990|NCT01308008|12300388|FG000|COMPLETED|12 Months||46
11115991|NCT01308008|12300389|FG001|COMPLETED|12 Months||58
11115992|NCT01308008|12300388|FG000|NOT COMPLETED|12 Months||8
11115993|NCT01308008|12300389|FG001|NOT COMPLETED|12 Months||4
11115994|NCT01308060|12300397|FG000|STARTED|Part A||252
11115995|NCT01308060|12300398|FG001|STARTED|Part A||83
11115996|NCT01308060|12300397|FG000|COMPLETED|Part A||238
11115997|NCT01308060|12300398|FG001|COMPLETED|Part A||77
11115998|NCT01308060|12300397|FG000|NOT COMPLETED|Part A||14
11115999|NCT01308060|12300398|FG001|NOT COMPLETED|Part A||6
11116000|NCT01308060|12300397|FG000|STARTED|Part B||238
11116001|NCT01308060|12300398|FG001|STARTED|Part B||77
11116002|NCT01308060|12300397|FG000|COMPLETED|Part B||219
11116003|NCT01308060|12300398|FG001|COMPLETED|Part B||69
11116004|NCT01308060|12300397|FG000|NOT COMPLETED|Part B||19
11116005|NCT01308060|12300398|FG001|NOT COMPLETED|Part B||8
11116006|NCT01308294|12300408|FG000|STARTED|Cycle 1||10
11116007|NCT01308294|12300409|FG001|STARTED|Cycle 1||6
11232612|NCT02037165|12424666|FG002|NOT COMPLETED|Washout Period 3 (6 Days)||0
11232613|NCT02037165|12424667|FG003|NOT COMPLETED|Washout Period 3 (6 Days)||0
11232614|NCT02037165|12424668|FG004|NOT COMPLETED|Washout Period 3 (6 Days)||0
11232615|NCT02037165|12424664|FG000|STARTED|Period 4 (2 Days)||5
11232616|NCT02037165|12424665|FG001|STARTED|Period 4 (2 Days)||5
11232617|NCT02037165|12424666|FG002|STARTED|Period 4 (2 Days)||5
11232618|NCT02037165|12424667|FG003|STARTED|Period 4 (2 Days)||5
11232619|NCT02037165|12424668|FG004|STARTED|Period 4 (2 Days)||5
11232620|NCT02037165|12424664|FG000|COMPLETED|Period 4 (2 Days)||5
11232621|NCT02037165|12424665|FG001|COMPLETED|Period 4 (2 Days)||5
11116008|NCT01308294|12300410|FG002|STARTED|Cycle 1||0
11116009|NCT01308294|12300408|FG000|COMPLETED|Cycle 1||10
11116010|NCT01308294|12300409|FG001|COMPLETED|Cycle 1||6
11232622|NCT02037165|12424666|FG002|COMPLETED|Period 4 (2 Days)||5
11232623|NCT02037165|12424667|FG003|COMPLETED|Period 4 (2 Days)||5
11232624|NCT02037165|12424668|FG004|COMPLETED|Period 4 (2 Days)||5
11232625|NCT02037165|12424664|FG000|NOT COMPLETED|Period 4 (2 Days)||0
11116011|NCT01308294|12300410|FG002|COMPLETED|Cycle 1||0
11116012|NCT01308294|12300408|FG000|NOT COMPLETED|Cycle 1||0
11116013|NCT01308294|12300409|FG001|NOT COMPLETED|Cycle 1||0
11116014|NCT01308294|12300410|FG002|NOT COMPLETED|Cycle 1||0
11116015|NCT01308294|12300408|FG000|STARTED|Cycle 2||10
11116016|NCT01308294|12300409|FG001|STARTED|Cycle 2||6
11116017|NCT01308294|12300410|FG002|STARTED|Cycle 2||0
11116018|NCT01308294|12300408|FG000|COMPLETED|Cycle 2||10
11116019|NCT01308294|12300409|FG001|COMPLETED|Cycle 2||5
11116020|NCT01308294|12300410|FG002|COMPLETED|Cycle 2||0
11116021|NCT01308294|12300408|FG000|NOT COMPLETED|Cycle 2||0
11116022|NCT01308294|12300409|FG001|NOT COMPLETED|Cycle 2||1
11116023|NCT01308294|12300410|FG002|NOT COMPLETED|Cycle 2||0
11116024|NCT01308294|12300408|FG000|STARTED|Cycle 3||10
11116025|NCT01308294|12300409|FG001|STARTED|Cycle 3||5
11116026|NCT01308294|12300410|FG002|STARTED|Cycle 3||0
11116027|NCT01308294|12300408|FG000|COMPLETED|Cycle 3||10
11116028|NCT01308294|12300409|FG001|COMPLETED|Cycle 3||4
11116029|NCT01308294|12300410|FG002|COMPLETED|Cycle 3||0
11116030|NCT01308294|12300408|FG000|NOT COMPLETED|Cycle 3||0
11116031|NCT01308294|12300409|FG001|NOT COMPLETED|Cycle 3||1
11116032|NCT01308294|12300410|FG002|NOT COMPLETED|Cycle 3||0
11116033|NCT01308424|12300423|FG000|STARTED|Baseline Eligibility||242
11116034|NCT01308424|12300424|FG001|STARTED|Baseline Eligibility||0
11116035|NCT01308424|12300425|FG002|STARTED|Baseline Eligibility||0
11116036|NCT01308424|12300423|FG000|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
11116037|NCT01308424|12300424|FG001|COMPLETED|Baseline Eligibility||0
11116038|NCT01308424|12300425|FG002|COMPLETED|Baseline Eligibility||0
11116039|NCT01308424|12300423|FG000|NOT COMPLETED|Baseline Eligibility||71
11116040|NCT01308424|12300424|FG001|NOT COMPLETED|Baseline Eligibility||0
11116041|NCT01308424|12300425|FG002|NOT COMPLETED|Baseline Eligibility||0
11116042|NCT01308424|12300423|FG000|STARTED|Randomization||0
11116043|NCT01308424|12300424|FG001|STARTED|Randomization||87
11116044|NCT01308424|12300425|FG002|STARTED|Randomization||84
11116045|NCT01308424|12300423|FG000|COMPLETED|Randomization||0
11116046|NCT01308424|12300424|FG001|COMPLETED|Randomization||84
11116047|NCT01308424|12300425|FG002|COMPLETED|Randomization||82
11116048|NCT01308424|12300423|FG000|NOT COMPLETED|Randomization||0
11116049|NCT01308424|12300424|FG001|NOT COMPLETED|Randomization||3
11116050|NCT01308424|12300425|FG002|NOT COMPLETED|Randomization||2
11116051|NCT01308450|12300432|FG000|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
11116052|NCT01308450|12300432|FG000|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
11116053|NCT01308450|12300432|FG000|NOT COMPLETED|Overall Study||2
11116054|NCT01308463|12300436|FG000|STARTED|Overall Study||29
11116055|NCT01308463|12300436|FG000|6 Months|Overall Study||23
11116056|NCT01308463|12300436|FG000|1 Year|Overall Study||21
11116057|NCT01308463|12300436|FG000|2 Years|Overall Study||18
11116058|NCT01308463|12300436|FG000|3 Years|Overall Study||17
11116059|NCT01308463|12300436|FG000|4 Years|Overall Study||20
11116060|NCT01308463|12300436|FG000|5 Years|Overall Study||20
11116061|NCT01308463|12300436|FG000|6 Years|Overall Study||11
11116062|NCT01308463|12300436|FG000|7 Years|Overall Study||12
11116063|NCT01308463|12300436|FG000|8 Years|Overall Study||14
11116064|NCT01308463|12300436|FG000|9 Years|Overall Study||11
11116065|NCT01308463|12300436|FG000|10 Years|Overall Study||8
11116066|NCT01308463|12300436|FG000|11 Years|Overall Study||8
11116067|NCT01308463|12300436|FG000|12 Years|Overall Study||2
11116068|NCT01308463|12300436|FG000|COMPLETED|Overall Study||0
11116069|NCT01308463|12300436|FG000|NOT COMPLETED|Overall Study||29
11116070|NCT01308476|12300442|FG000|STARTED|Overall Study|Entered and treated.|48
11116071|NCT01308476|12300443|FG001|STARTED|Overall Study|Entered and treated.|47
11116072|NCT01308476|12300442|FG000|COMPLETED|Overall Study||45
11116073|NCT01308476|12300443|FG001|COMPLETED|Overall Study||45
11116074|NCT01308476|12300442|FG000|NOT COMPLETED|Overall Study||3
11116075|NCT01308476|12300443|FG001|NOT COMPLETED|Overall Study||2
11232626|NCT02037165|12424665|FG001|NOT COMPLETED|Period 4 (2 Days)||0
11232627|NCT02037165|12424666|FG002|NOT COMPLETED|Period 4 (2 Days)||0
11232628|NCT02037165|12424667|FG003|NOT COMPLETED|Period 4 (2 Days)||0
11232629|NCT02037165|12424668|FG004|NOT COMPLETED|Period 4 (2 Days)||0
11232630|NCT02037165|12424664|FG000|STARTED|Washout Period 4 (6 Days)||5
11232631|NCT02037165|12424665|FG001|STARTED|Washout Period 4 (6 Days)||5
11232632|NCT02037165|12424666|FG002|STARTED|Washout Period 4 (6 Days)||5
11232633|NCT02037165|12424667|FG003|STARTED|Washout Period 4 (6 Days)||5
11232634|NCT02037165|12424668|FG004|STARTED|Washout Period 4 (6 Days)||5
11232635|NCT02037165|12424664|FG000|COMPLETED|Washout Period 4 (6 Days)||5
11232636|NCT02037165|12424665|FG001|COMPLETED|Washout Period 4 (6 Days)||5
11232637|NCT02037165|12424666|FG002|COMPLETED|Washout Period 4 (6 Days)||5
11232638|NCT02037165|12424667|FG003|COMPLETED|Washout Period 4 (6 Days)||5
11232639|NCT02037165|12424668|FG004|COMPLETED|Washout Period 4 (6 Days)||4
11232640|NCT02037165|12424664|FG000|NOT COMPLETED|Washout Period 4 (6 Days)||0
11232641|NCT02037165|12424665|FG001|NOT COMPLETED|Washout Period 4 (6 Days)||0
11232642|NCT02037165|12424666|FG002|NOT COMPLETED|Washout Period 4 (6 Days)||0
11232643|NCT02037165|12424667|FG003|NOT COMPLETED|Washout Period 4 (6 Days)||0
11232644|NCT02037165|12424668|FG004|NOT COMPLETED|Washout Period 4 (6 Days)||1
11232645|NCT02037165|12424664|FG000|STARTED|Period 5 (2 Days)||5
11232646|NCT02037165|12424665|FG001|STARTED|Period 5 (2 Days)||5
11232647|NCT02037165|12424666|FG002|STARTED|Period 5 (2 Days)||5
11232648|NCT02037165|12424667|FG003|STARTED|Period 5 (2 Days)||5
11232649|NCT02037165|12424668|FG004|STARTED|Period 5 (2 Days)||4
11232650|NCT02037165|12424664|FG000|COMPLETED|Period 5 (2 Days)||5
11232651|NCT02037165|12424665|FG001|COMPLETED|Period 5 (2 Days)||5
11232652|NCT02037165|12424666|FG002|COMPLETED|Period 5 (2 Days)||5
11232653|NCT02037165|12424667|FG003|COMPLETED|Period 5 (2 Days)||5
11232654|NCT02037165|12424668|FG004|COMPLETED|Period 5 (2 Days)||4
11232655|NCT02037165|12424664|FG000|NOT COMPLETED|Period 5 (2 Days)||0
11232656|NCT02037165|12424665|FG001|NOT COMPLETED|Period 5 (2 Days)||0
11232657|NCT02037165|12424666|FG002|NOT COMPLETED|Period 5 (2 Days)||0
11232658|NCT02037165|12424667|FG003|NOT COMPLETED|Period 5 (2 Days)||0
11232659|NCT02037165|12424668|FG004|NOT COMPLETED|Period 5 (2 Days)||0
11232660|NCT02037204|12424684|FG000|STARTED|Overall Study||35
11232661|NCT02037204|12424684|FG000|COMPLETED|Overall Study||35
11232662|NCT02037204|12424684|FG000|NOT COMPLETED|Overall Study||0
11232663|NCT02037230|12424693|FG000|STARTED|Overall Study||1
11232664|NCT02037230|12424694|FG001|STARTED|Overall Study||13
11232665|NCT02037230|12424695|FG002|STARTED|Overall Study||9
11232666|NCT02037230|12424696|FG003|STARTED|Overall Study||11
11232667|NCT02037230|12424693|FG000|Completed 4 Cycles of Treatment|Overall Study||1
11232668|NCT02037230|12424694|FG001|Completed 4 Cycles of Treatment|Overall Study||9
11232669|NCT02037230|12424695|FG002|Completed 4 Cycles of Treatment|Overall Study||7
11232670|NCT02037230|12424696|FG003|Completed 4 Cycles of Treatment|Overall Study||9
11232671|NCT02037230|12424693|FG000|COMPLETED|Overall Study||0
11232672|NCT02037230|12424694|FG001|COMPLETED|Overall Study||7
11232673|NCT02037230|12424695|FG002|COMPLETED|Overall Study||3
11232674|NCT02037230|12424696|FG003|COMPLETED|Overall Study||5
11232675|NCT02037230|12424693|FG000|NOT COMPLETED|Overall Study||1
11232676|NCT02037230|12424694|FG001|NOT COMPLETED|Overall Study||6
11232677|NCT02037230|12424695|FG002|NOT COMPLETED|Overall Study||6
11232678|NCT02037230|12424696|FG003|NOT COMPLETED|Overall Study||6
11232679|NCT02037256|12424709|FG000|STARTED|Overall Study||3
11232680|NCT02037256|12424710|FG001|STARTED|Overall Study||20
11232681|NCT02037256|12424709|FG000|COMPLETED|Overall Study||3
11232682|NCT02037256|12424710|FG001|COMPLETED|Overall Study||17
11232683|NCT02037256|12424709|FG000|NOT COMPLETED|Overall Study||0
11232684|NCT02037256|12424710|FG001|NOT COMPLETED|Overall Study||3
11232685|NCT02037295|12424722|FG000|STARTED|Phase 1: Crossover UF and OF||9
11232686|NCT02037295|12424723|FG001|STARTED|Phase 1: Crossover UF and OF||7
11232687|NCT02037295|12424724|FG002|STARTED|Phase 1: Crossover UF and OF||4
11232688|NCT02037295|12424725|FG003|STARTED|Phase 1: Crossover UF and OF||7
11232689|NCT02037295|12424722|FG000|COMPLETED|Phase 1: Crossover UF and OF||9
11232690|NCT02037295|12424723|FG001|COMPLETED|Phase 1: Crossover UF and OF||7
11232691|NCT02037295|12424724|FG002|COMPLETED|Phase 1: Crossover UF and OF||4
11232692|NCT02037295|12424725|FG003|COMPLETED|Phase 1: Crossover UF and OF||7
11232693|NCT02037295|12424722|FG000|NOT COMPLETED|Phase 1: Crossover UF and OF||0
11232694|NCT02037295|12424723|FG001|NOT COMPLETED|Phase 1: Crossover UF and OF||0
11232695|NCT02037295|12424724|FG002|NOT COMPLETED|Phase 1: Crossover UF and OF||0
11232696|NCT02037295|12424725|FG003|NOT COMPLETED|Phase 1: Crossover UF and OF||0
11232697|NCT02037295|12424722|FG000|STARTED|Phase 2: Vancomycin and Placebo||9
11232698|NCT02037295|12424723|FG001|STARTED|Phase 2: Vancomycin and Placebo||7
11232699|NCT02037295|12424724|FG002|STARTED|Phase 2: Vancomycin and Placebo||4
11232700|NCT02037295|12424725|FG003|STARTED|Phase 2: Vancomycin and Placebo||7
11232701|NCT02037295|12424722|FG000|COMPLETED|Phase 2: Vancomycin and Placebo||8
11232702|NCT02037295|12424723|FG001|COMPLETED|Phase 2: Vancomycin and Placebo||7
11232703|NCT02037295|12424724|FG002|COMPLETED|Phase 2: Vancomycin and Placebo||4
11232704|NCT02037295|12424725|FG003|COMPLETED|Phase 2: Vancomycin and Placebo||6
11232705|NCT02037295|12424722|FG000|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
11232706|NCT02037295|12424723|FG001|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
11232707|NCT02037295|12424724|FG002|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
11116076|NCT01308567|12300452|FG000|STARTED|Overall Study|Randomized|391
11116077|NCT01308567|12300453|FG001|STARTED|Overall Study|Randomized|389
11116078|NCT01308567|12300454|FG002|STARTED|Overall Study|Randomized|388
11116079|NCT01308567|12300452|FG000|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
11116080|NCT01308567|12300453|FG001|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
11116081|NCT01308567|12300454|FG002|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
11116082|NCT01308567|12300452|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
11116083|NCT01308567|12300453|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
11116084|NCT01308567|12300454|FG002|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
11116085|NCT01308567|12300452|FG000|NOT COMPLETED|Overall Study||2
11116086|NCT01308567|12300453|FG001|NOT COMPLETED|Overall Study||4
11116087|NCT01308567|12300454|FG002|NOT COMPLETED|Overall Study||4
11116088|NCT01308580|12300464|FG000|STARTED|Overall Study||598
11116089|NCT01308580|12300465|FG001|STARTED|Overall Study||602
11116090|NCT01308580|12300464|FG000|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
11116091|NCT01308580|12300465|FG001|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
11116092|NCT01308580|12300464|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
11116093|NCT01308580|12300465|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
11116094|NCT01308580|12300464|FG000|NOT COMPLETED|Overall Study||12
11116095|NCT01308580|12300465|FG001|NOT COMPLETED|Overall Study||7
11116096|NCT01308736|12300474|FG000|STARTED|Overall Study||31
11116097|NCT01308736|12300475|FG001|STARTED|Overall Study||32
11116098|NCT01308736|12300474|FG000|COMPLETED|Overall Study||25
11116099|NCT01308736|12300475|FG001|COMPLETED|Overall Study||27
11116100|NCT01308736|12300474|FG000|NOT COMPLETED|Overall Study||6
11116101|NCT01308736|12300475|FG001|NOT COMPLETED|Overall Study||5
11116102|NCT01308749|12300483|FG000|STARTED|Period 1: Double Blind Treatment||12
11116103|NCT01308749|12300484|FG001|STARTED|Period 1: Double Blind Treatment||13
11116104|NCT01308749|12300483|FG000|COMPLETED|Period 1: Double Blind Treatment||11
11116105|NCT01308749|12300484|FG001|COMPLETED|Period 1: Double Blind Treatment||13
11116106|NCT01308749|12300483|FG000|NOT COMPLETED|Period 1: Double Blind Treatment||1
11116107|NCT01308749|12300484|FG001|NOT COMPLETED|Period 1: Double Blind Treatment||0
11116108|NCT01308749|12300483|FG000|STARTED|Period 2: Open Label Treatment||11
11116109|NCT01308749|12300484|FG001|STARTED|Period 2: Open Label Treatment||13
11116110|NCT01308749|12300483|FG000|COMPLETED|Period 2: Open Label Treatment||11
11116111|NCT01308749|12300484|FG001|COMPLETED|Period 2: Open Label Treatment||11
11116112|NCT01308749|12300483|FG000|NOT COMPLETED|Period 2: Open Label Treatment||0
11116113|NCT01308749|12300484|FG001|NOT COMPLETED|Period 2: Open Label Treatment||2
11116114|NCT01308762|12300507|FG000|STARTED|Overall Study||6
11116115|NCT01308762|12300508|FG001|STARTED|Overall Study||7
11232708|NCT02037295|12424725|FG003|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
11232709|NCT02037347|12424737|FG000|STARTED|Overall Study||1
11232710|NCT02037347|12424737|FG000|COMPLETED|Overall Study||1
11232711|NCT02037347|12424737|FG000|NOT COMPLETED|Overall Study||0
11232712|NCT02037425|12424741|FG000|STARTED|Overall Study||44
11232713|NCT02037425|12424741|FG000|Randomized to Treatment|Overall Study||32
11232714|NCT02037425|12424741|FG000|COMPLETED|Overall Study||18
11232715|NCT02037425|12424741|FG000|NOT COMPLETED|Overall Study||26
11232716|NCT02037438|12424749|FG000|STARTED|Overall Study||920
11232717|NCT02037438|12424750|FG001|STARTED|Overall Study||916
11232718|NCT02037438|12424749|FG000|COMPLETED|Overall Study||574
11232719|NCT02037438|12424750|FG001|COMPLETED|Overall Study||561
11232720|NCT02037438|12424749|FG000|NOT COMPLETED|Overall Study||346
11232721|NCT02037438|12424750|FG001|NOT COMPLETED|Overall Study||355
11232722|NCT02037477|12424760|FG000|STARTED|Treatment Period 1||5
11232723|NCT02037477|12424761|FG001|STARTED|Treatment Period 1||5
11232724|NCT02037477|12424762|FG002|STARTED|Treatment Period 1||5
11232725|NCT02037477|12424763|FG003|STARTED|Treatment Period 1||5
11232726|NCT02037477|12424760|FG000|COMPLETED|Treatment Period 1||5
11232727|NCT02037477|12424761|FG001|COMPLETED|Treatment Period 1||5
11232728|NCT02037477|12424762|FG002|COMPLETED|Treatment Period 1||4
11232729|NCT02037477|12424763|FG003|COMPLETED|Treatment Period 1||5
11232730|NCT02037477|12424760|FG000|NOT COMPLETED|Treatment Period 1||0
11232731|NCT02037477|12424761|FG001|NOT COMPLETED|Treatment Period 1||0
11232732|NCT02037477|12424762|FG002|NOT COMPLETED|Treatment Period 1||1
11232733|NCT02037477|12424763|FG003|NOT COMPLETED|Treatment Period 1||0
11232734|NCT02037477|12424760|FG000|STARTED|Treatment Period 2||5
11232735|NCT02037477|12424761|FG001|STARTED|Treatment Period 2||5
11232736|NCT02037477|12424762|FG002|STARTED|Treatment Period 2||4
11232737|NCT02037477|12424763|FG003|STARTED|Treatment Period 2||5
11232738|NCT02037477|12424760|FG000|COMPLETED|Treatment Period 2||5
11232739|NCT02037477|12424761|FG001|COMPLETED|Treatment Period 2||5
11232740|NCT02037477|12424762|FG002|COMPLETED|Treatment Period 2||4
11232741|NCT02037477|12424763|FG003|COMPLETED|Treatment Period 2||5
11232742|NCT02037477|12424760|FG000|NOT COMPLETED|Treatment Period 2||0
11232743|NCT02037477|12424761|FG001|NOT COMPLETED|Treatment Period 2||0
11232744|NCT02037477|12424762|FG002|NOT COMPLETED|Treatment Period 2||0
11232745|NCT02037477|12424763|FG003|NOT COMPLETED|Treatment Period 2||0
11232746|NCT02037555|12424775|FG000|STARTED|Overall Study||213
11232747|NCT02037555|12424776|FG001|STARTED|Overall Study||212
11232748|NCT02037555|12424775|FG000|Dosed|Overall Study||201
11232749|NCT02037555|12424776|FG001|Dosed|Overall Study||198
11232750|NCT02037555|12424775|FG000|Dosed and Operated On|Overall Study||200
11232751|NCT02037555|12424776|FG001|Dosed and Operated On|Overall Study||196
11232752|NCT02037555|12424775|FG000|COMPLETED|Overall Study||190
11232753|NCT02037555|12424776|FG001|COMPLETED|Overall Study||191
11232754|NCT02037555|12424775|FG000|NOT COMPLETED|Overall Study||23
11232755|NCT02037555|12424776|FG001|NOT COMPLETED|Overall Study||21
11232756|NCT02037568|12424784|FG000|STARTED|Overall Study||83
11232757|NCT02037568|12424785|FG001|STARTED|Overall Study||76
11232758|NCT02037568|12424784|FG000|Month 1.5 (Post Transplantation)|Overall Study||79
11232759|NCT02037568|12424785|FG001|Month 1.5 (Post Transplantation)|Overall Study||76
11232760|NCT02037568|12424784|FG000|Month 3 (Post Transplantation)|Overall Study||66
11232761|NCT02037568|12424785|FG001|Month 3 (Post Transplantation)|Overall Study||62
11232762|NCT02037568|12424784|FG000|Month 6 (Post Transplantation)|Overall Study||63
11232763|NCT02037568|12424785|FG001|Month 6 (Post Transplantation)|Overall Study||52
11232764|NCT02037568|12424784|FG000|COMPLETED|Overall Study||47
11232765|NCT02037568|12424785|FG001|COMPLETED|Overall Study||37
11232766|NCT02037568|12424784|FG000|NOT COMPLETED|Overall Study||36
11232767|NCT02037568|12424785|FG001|NOT COMPLETED|Overall Study||39
11232768|NCT02037607|12424791|FG000|STARTED|Overall Study||100
11232769|NCT02037607|12424791|FG000|COMPLETED|Overall Study||91
11232770|NCT02037607|12424791|FG000|NOT COMPLETED|Overall Study||9
11232771|NCT02037776|12424797|FG000|STARTED|Overall Study||61
11232772|NCT02037776|12424798|FG001|STARTED|Overall Study||64
11116116|NCT01308762|12300509|FG002|STARTED|Overall Study||6
11116117|NCT01308762|12300507|FG000|COMPLETED|Overall Study||6
11116118|NCT01308762|12300508|FG001|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
11116119|NCT01308762|12300509|FG002|COMPLETED|Overall Study||6
11116120|NCT01308762|12300507|FG000|NOT COMPLETED|Overall Study||0
11116121|NCT01308762|12300508|FG001|NOT COMPLETED|Overall Study||1
11116122|NCT01308762|12300509|FG002|NOT COMPLETED|Overall Study||0
11116123|NCT01308788|12300522|FG000|STARTED|6-month Treatment||14
11116124|NCT01308788|12300523|FG001|STARTED|6-month Treatment||21
11116125|NCT01308788|12300522|FG000|COMPLETED|6-month Treatment||14
11116126|NCT01308788|12300523|FG001|COMPLETED|6-month Treatment||21
11116127|NCT01308788|12300522|FG000|NOT COMPLETED|6-month Treatment||0
11116128|NCT01308788|12300523|FG001|NOT COMPLETED|6-month Treatment||0
11116129|NCT01308788|12300522|FG000|STARTED|2-year Treatment||14
11116130|NCT01308788|12300523|FG001|STARTED|2-year Treatment||21
11116131|NCT01308788|12300522|FG000|COMPLETED|2-year Treatment||10
11116132|NCT01308788|12300523|FG001|COMPLETED|2-year Treatment||10
11232773|NCT02037776|12424797|FG000|COMPLETED|Overall Study||56
11232774|NCT02037776|12424798|FG001|COMPLETED|Overall Study||60
11232775|NCT02037776|12424797|FG000|NOT COMPLETED|Overall Study||5
11232776|NCT02037776|12424798|FG001|NOT COMPLETED|Overall Study||4
11232777|NCT02037893|12424808|FG000|STARTED|Overall Study||32
11232778|NCT02037893|12424809|FG001|STARTED|Overall Study||25
11232779|NCT02037893|12424810|FG002|STARTED|Overall Study||27
11232780|NCT02037893|12424811|FG003|STARTED|Overall Study||28
11232781|NCT02037893|12424808|FG000|COMPLETED|Overall Study||32
11232782|NCT02037893|12424809|FG001|COMPLETED|Overall Study||25
11232783|NCT02037893|12424810|FG002|COMPLETED|Overall Study||26
11232784|NCT02037893|12424811|FG003|COMPLETED|Overall Study||28
11232785|NCT02037893|12424808|FG000|NOT COMPLETED|Overall Study||0
11232786|NCT02037893|12424809|FG001|NOT COMPLETED|Overall Study||0
11232787|NCT02037893|12424810|FG002|NOT COMPLETED|Overall Study||1
11232788|NCT02037893|12424811|FG003|NOT COMPLETED|Overall Study||0
11232789|NCT02037984|12424829|FG000|STARTED|Overall Study||20
11232790|NCT02037984|12424830|FG001|STARTED|Overall Study||20
11232791|NCT02037984|12424831|FG002|STARTED|Overall Study||50
11232792|NCT02037984|12424832|FG003|STARTED|Overall Study||51
11232793|NCT02037984|12424833|FG004|STARTED|Overall Study||50
11232794|NCT02037984|12424834|FG005|STARTED|Overall Study||49
11232795|NCT02037984|12424835|FG006|STARTED|Overall Study||50
11232796|NCT02037984|12424836|FG007|STARTED|Overall Study||51
11232797|NCT02037984|12424829|FG000|COMPLETED|Overall Study||19
11232798|NCT02037984|12424830|FG001|COMPLETED|Overall Study||20
11232799|NCT02037984|12424831|FG002|COMPLETED|Overall Study||38
11232800|NCT02037984|12424832|FG003|COMPLETED|Overall Study||30
11232801|NCT02037984|12424833|FG004|COMPLETED|Overall Study||38
11232802|NCT02037984|12424834|FG005|COMPLETED|Overall Study||37
11232803|NCT02037984|12424835|FG006|COMPLETED|Overall Study||33
11232804|NCT02037984|12424836|FG007|COMPLETED|Overall Study||39
11232805|NCT02037984|12424829|FG000|NOT COMPLETED|Overall Study||1
11232806|NCT02037984|12424830|FG001|NOT COMPLETED|Overall Study||0
11232807|NCT02037984|12424831|FG002|NOT COMPLETED|Overall Study||12
11232808|NCT02037984|12424832|FG003|NOT COMPLETED|Overall Study||21
11232809|NCT02037984|12424833|FG004|NOT COMPLETED|Overall Study||12
11232810|NCT02037984|12424834|FG005|NOT COMPLETED|Overall Study||12
11232811|NCT02037984|12424835|FG006|NOT COMPLETED|Overall Study||17
11232812|NCT02037984|12424836|FG007|NOT COMPLETED|Overall Study||12
11232813|NCT02038010|12424864|FG000|STARTED|Completed 1st Cycle and Started Cycle 2||11
11232814|NCT02038010|12424865|FG001|STARTED|Completed 1st Cycle and Started Cycle 2||6
11232815|NCT02038010|12424866|FG002|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
11232816|NCT02038010|12424867|FG003|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
11232817|NCT02038010|12424864|FG000|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||11
11232818|NCT02038010|12424865|FG001|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||5
11232819|NCT02038010|12424866|FG002|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
11232820|NCT02038010|12424867|FG003|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
11232821|NCT02038010|12424864|FG000|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||10
11232822|NCT02038010|12424865|FG001|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||4
11232823|NCT02038010|12424866|FG002|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
11232824|NCT02038010|12424867|FG003|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
11232825|NCT02038010|12424864|FG000|COMPLETED|Completed 1st Cycle and Started Cycle 2||10
11232826|NCT02038010|12424865|FG001|COMPLETED|Completed 1st Cycle and Started Cycle 2||4
11232827|NCT02038010|12424866|FG002|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
11232828|NCT02038010|12424867|FG003|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
11232829|NCT02038010|12424864|FG000|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||1
11232830|NCT02038010|12424865|FG001|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||2
11232831|NCT02038010|12424866|FG002|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
11232832|NCT02038010|12424867|FG003|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
11232833|NCT02038010|12424864|FG000|STARTED|Completed 3 Cycles/Reached 1st Response||10
11232834|NCT02038010|12424865|FG001|STARTED|Completed 3 Cycles/Reached 1st Response||4
11232835|NCT02038010|12424866|FG002|STARTED|Completed 3 Cycles/Reached 1st Response||0
11232836|NCT02038010|12424867|FG003|STARTED|Completed 3 Cycles/Reached 1st Response||0
11356177|NCT03093181|12553138|FG001|COMPLETED|Overall Study||42
11116133|NCT01308788|12300522|FG000|NOT COMPLETED|2-year Treatment||4
11116134|NCT01308788|12300523|FG001|NOT COMPLETED|2-year Treatment||11
11116135|NCT01308814|12300531|FG000|STARTED|Overall Study||86
11116136|NCT01308814|12300532|FG001|STARTED|Overall Study||86
11116137|NCT01308814|12300531|FG000|COMPLETED|Overall Study||69
11116138|NCT01308814|12300532|FG001|COMPLETED|Overall Study||63
11116139|NCT01308814|12300531|FG000|NOT COMPLETED|Overall Study||17
11116140|NCT01308814|12300532|FG001|NOT COMPLETED|Overall Study||23
11116141|NCT01308840|12300538|FG000|STARTED|Overall Study||31
11116142|NCT01308840|12300538|FG000|COMPLETED|Overall Study||31
11116143|NCT01308840|12300538|FG000|NOT COMPLETED|Overall Study||0
11116144|NCT01308918|12300542|FG000|STARTED|Overall Study||50
11116145|NCT01308918|12300542|FG000|COMPLETED|Overall Study||50
11116146|NCT01308918|12300542|FG000|NOT COMPLETED|Overall Study||0
11116147|NCT01309100|12300546|FG000|STARTED|Overall Study||144
11116148|NCT01309100|12300546|FG000|COMPLETED|Overall Study||142
11116149|NCT01309100|12300546|FG000|NOT COMPLETED|Overall Study||2
11116150|NCT01309165|12300555|FG000|STARTED|Overall Study||19
11116151|NCT01309165|12300556|FG001|STARTED|Overall Study||16
11116152|NCT01309165|12300555|FG000|Received Allocated Intervention|Overall Study||16
11116153|NCT01309165|12300556|FG001|Received Allocated Intervention|Overall Study||14
11116154|NCT01309165|12300555|FG000|Included in Primary Analysis|Overall Study||14
11116155|NCT01309165|12300556|FG001|Included in Primary Analysis|Overall Study||12
11116156|NCT01309165|12300555|FG000|COMPLETED|Overall Study||13
11116157|NCT01309165|12300556|FG001|COMPLETED|Overall Study||9
11116158|NCT01309165|12300555|FG000|NOT COMPLETED|Overall Study||6
11116159|NCT01309165|12300556|FG001|NOT COMPLETED|Overall Study||7
11116160|NCT01309204|12300565|FG000|STARTED|Overall Study||452
11116161|NCT01309204|12300566|FG001|STARTED|Overall Study||436
11116162|NCT01309204|12300565|FG000|COMPLETED|Overall Study||385
11116163|NCT01309204|12300566|FG001|COMPLETED|Overall Study||361
11116164|NCT01309204|12300565|FG000|NOT COMPLETED|Overall Study||67
11116165|NCT01309204|12300566|FG001|NOT COMPLETED|Overall Study||75
11116166|NCT01309243|12300574|FG000|STARTED|Randomized Phase Through Week 96||400
11116167|NCT01309243|12300575|FG001|STARTED|Randomized Phase Through Week 96||399
11116168|NCT01309243|12300574|FG000|Randomized and Treated|Randomized Phase Through Week 96||394
11116169|NCT01309243|12300575|FG001|Randomized and Treated|Randomized Phase Through Week 96||392
11116170|NCT01309243|12300574|FG000|COMPLETED|Randomized Phase Through Week 96||316
11116171|NCT01309243|12300575|FG001|COMPLETED|Randomized Phase Through Week 96||290
11116172|NCT01309243|12300574|FG000|NOT COMPLETED|Randomized Phase Through Week 96||84
11116173|NCT01309243|12300575|FG001|NOT COMPLETED|Randomized Phase Through Week 96||109
11116174|NCT01309243|12300574|FG000|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
11116175|NCT01309243|12300575|FG001|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
11116176|NCT01309243|12300574|FG000|COMPLETED|Extension Phase||34
11116177|NCT01309243|12300575|FG001|COMPLETED|Extension Phase||117
11116178|NCT01309243|12300574|FG000|NOT COMPLETED|Extension Phase||6
11116179|NCT01309243|12300575|FG001|NOT COMPLETED|Extension Phase||0
11116180|NCT01309269|12300581|FG000|STARTED|Overall Study||1085
11116181|NCT01309269|12300581|FG000|Treated|Overall Study||978
11116182|NCT01309269|12300581|FG000|COMPLETED|Overall Study||245
11116183|NCT01309269|12300581|FG000|NOT COMPLETED|Overall Study||840
11116184|NCT01309282|12300585|FG000|STARTED|Overall Study||9
11116185|NCT01309282|12300585|FG000|COMPLETED|Overall Study||8
11116186|NCT01309282|12300585|FG000|NOT COMPLETED|Overall Study||1
11116187|NCT01309308|12300591|FG000|STARTED|Overall Study||75
11116188|NCT01309308|12300592|FG001|STARTED|Overall Study||75
11116189|NCT01309308|12300591|FG000|COMPLETED|Overall Study||69
11116190|NCT01309308|12300592|FG001|COMPLETED|Overall Study||71
11116191|NCT01309308|12300591|FG000|NOT COMPLETED|Overall Study||6
11116192|NCT01309308|12300592|FG001|NOT COMPLETED|Overall Study||4
11116193|NCT01309360|12300601|FG000|STARTED|Overall Study||40
11116194|NCT01309360|12300602|FG001|STARTED|Overall Study||40
11116195|NCT01309360|12300603|FG002|STARTED|Overall Study||40
11116196|NCT01309360|12300601|FG000|COMPLETED|Overall Study||40
11116197|NCT01309360|12300602|FG001|COMPLETED|Overall Study||40
11116198|NCT01309360|12300603|FG002|COMPLETED|Overall Study||40
11116199|NCT01309360|12300601|FG000|NOT COMPLETED|Overall Study||0
11116200|NCT01309360|12300602|FG001|NOT COMPLETED|Overall Study||0
11116201|NCT01309360|12300603|FG002|NOT COMPLETED|Overall Study||0
11116202|NCT01309386|12300613|FG000|STARTED|Overall Study||50
11116203|NCT01309386|12300614|FG001|STARTED|Overall Study||50
11116204|NCT01309386|12300613|FG000|COMPLETED|Overall Study||28
11116205|NCT01309386|12300614|FG001|COMPLETED|Overall Study||29
11116206|NCT01309386|12300613|FG000|NOT COMPLETED|Overall Study||22
11116207|NCT01309386|12300614|FG001|NOT COMPLETED|Overall Study||21
11116208|NCT01309451|12300622|FG000|STARTED|Overall Study|unit of measure is number of eyes|19
11116209|NCT01309451|12300623|FG001|STARTED|Overall Study|unit of measure is number of eyes|21
11116210|NCT01309451|12300622|FG000|COMPLETED|Overall Study|unit of measure is number of eyes|17
11116211|NCT01309451|12300623|FG001|COMPLETED|Overall Study|unit of measure is number of eyes|18
11116212|NCT01309451|12300622|FG000|NOT COMPLETED|Overall Study||2
11116213|NCT01309451|12300623|FG001|NOT COMPLETED|Overall Study||3
11116214|NCT01309646|12300633|FG000|STARTED|Overall Study||224
11116215|NCT01309646|12300634|FG001|STARTED|Overall Study||227
11116216|NCT01309646|12300633|FG000|COMPLETED|Overall Study||224
11116217|NCT01309646|12300634|FG001|COMPLETED|Overall Study||227
11116218|NCT01309646|12300633|FG000|NOT COMPLETED|Overall Study||0
11116219|NCT01309646|12300634|FG001|NOT COMPLETED|Overall Study||0
11116220|NCT01309659|12300642|FG000|STARTED|Overall Study||9
11116221|NCT01309659|12300643|FG001|STARTED|Overall Study||10
11116222|NCT01309659|12300642|FG000|COMPLETED|Overall Study||9
11116223|NCT01309659|12300643|FG001|COMPLETED|Overall Study||9
11116224|NCT01309659|12300642|FG000|NOT COMPLETED|Overall Study||0
11116225|NCT01309659|12300643|FG001|NOT COMPLETED|Overall Study||1
11116226|NCT01309737|12300652|FG000|STARTED|Week 0 to 16||383
11116227|NCT01309737|12300653|FG001|STARTED|Week 0 to 16||381
11116228|NCT01309737|12300654|FG002|STARTED|Week 0 to 16||196
11116229|NCT01309737|12300655|FG003|STARTED|Week 0 to 16||0
11116230|NCT01309737|12300656|FG004|STARTED|Week 0 to 16||0
11116231|NCT01309737|12300652|FG000|Treated|Week 0 to 16||382
11116232|NCT01309737|12300653|FG001|Treated|Week 0 to 16||381
11116233|NCT01309737|12300654|FG002|Treated|Week 0 to 16||196
11116234|NCT01309737|12300655|FG003|Treated|Week 0 to 16||0
11116235|NCT01309737|12300656|FG004|Treated|Week 0 to 16||0
11116236|NCT01309737|12300652|FG000|COMPLETED|Week 0 to 16||331
11116237|NCT01309737|12300653|FG001|COMPLETED|Week 0 to 16||341
11116238|NCT01309737|12300654|FG002|COMPLETED|Week 0 to 16||152
11116239|NCT01309737|12300655|FG003|COMPLETED|Week 0 to 16||0
11116240|NCT01309737|12300656|FG004|COMPLETED|Week 0 to 16||0
11116241|NCT01309737|12300652|FG000|NOT COMPLETED|Week 0 to 16||52
11116242|NCT01309737|12300653|FG001|NOT COMPLETED|Week 0 to 16||40
11116243|NCT01309737|12300654|FG002|NOT COMPLETED|Week 0 to 16||44
11116244|NCT01309737|12300655|FG003|NOT COMPLETED|Week 0 to 16||0
11116245|NCT01309737|12300656|FG004|NOT COMPLETED|Week 0 to 16||0
11116246|NCT01309737|12300652|FG000|STARTED|Week 16 to 52||331
11116247|NCT01309737|12300653|FG001|STARTED|Week 16 to 52||341
11116248|NCT01309737|12300654|FG002|STARTED|Week 16 to 52||0
11116249|NCT01309737|12300655|FG003|STARTED|Week 16 to 52||75
11116250|NCT01309737|12300656|FG004|STARTED|Week 16 to 52||77
11116251|NCT01309737|12300652|FG000|COMPLETED|Week 16 to 52||198
11116252|NCT01309737|12300653|FG001|COMPLETED|Week 16 to 52||238
11116253|NCT01309737|12300654|FG002|COMPLETED|Week 16 to 52||0
11116254|NCT01309737|12300655|FG003|COMPLETED|Week 16 to 52||41
11116255|NCT01309737|12300656|FG004|COMPLETED|Week 16 to 52||44
11116256|NCT01309737|12300652|FG000|NOT COMPLETED|Week 16 to 52||133
11116257|NCT01309737|12300653|FG001|NOT COMPLETED|Week 16 to 52||103
11116258|NCT01309737|12300654|FG002|NOT COMPLETED|Week 16 to 52||0
11116259|NCT01309737|12300655|FG003|NOT COMPLETED|Week 16 to 52||34
11116260|NCT01309737|12300656|FG004|NOT COMPLETED|Week 16 to 52||33
11116261|NCT01309802|12300681|FG000|STARTED|Overall Study||25
11116262|NCT01309802|12300682|FG001|STARTED|Overall Study||23
11116263|NCT01309802|12300681|FG000|COMPLETED|Overall Study||13
11116264|NCT01309802|12300682|FG001|COMPLETED|Overall Study||14
11116265|NCT01309802|12300681|FG000|NOT COMPLETED|Overall Study||12
11116266|NCT01309802|12300682|FG001|NOT COMPLETED|Overall Study||9
11116267|NCT01309828|12300690|FG000|STARTED|Overall Study||77
11116268|NCT01309828|12300691|FG001|STARTED|Overall Study||76
11116269|NCT01309828|12300690|FG000|COMPLETED|Overall Study||61
11116270|NCT01309828|12300691|FG001|COMPLETED|Overall Study||60
11116271|NCT01309828|12300690|FG000|NOT COMPLETED|Overall Study||16
11116272|NCT01309828|12300691|FG001|NOT COMPLETED|Overall Study||16
11116273|NCT01309841|12300700|FG000|STARTED|Overall Study||217
11116274|NCT01309841|12300701|FG001|STARTED|Overall Study||218
11116275|NCT01309841|12300702|FG002|STARTED|Overall Study||217
11116276|NCT01309841|12300700|FG000|COMPLETED|Overall Study||178
11116277|NCT01309841|12300701|FG001|COMPLETED|Overall Study||177
11116278|NCT01309841|12300702|FG002|COMPLETED|Overall Study||180
11116279|NCT01309841|12300700|FG000|NOT COMPLETED|Overall Study||39
11116280|NCT01309841|12300701|FG001|NOT COMPLETED|Overall Study||41
11116281|NCT01309841|12300702|FG002|NOT COMPLETED|Overall Study||37
11116282|NCT01309867|12300710|FG000|STARTED|Overall Study||151
11116283|NCT01309867|12300711|FG001|STARTED|Overall Study||151
11116284|NCT01309867|12300710|FG000|COMPLETED|Overall Study||148
11116285|NCT01309867|12300711|FG001|COMPLETED|Overall Study||139
11116286|NCT01309867|12300710|FG000|NOT COMPLETED|Overall Study||3
11116287|NCT01309867|12300711|FG001|NOT COMPLETED|Overall Study||12
11116288|NCT01309880|12300717|FG000|STARTED|Overall Study||33
11116289|NCT01309880|12300718|FG001|STARTED|Overall Study||33
11116290|NCT01309880|12300717|FG000|COMPLETED|Overall Study||33
11116291|NCT01309880|12300718|FG001|COMPLETED|Overall Study||33
11116292|NCT01309880|12300717|FG000|NOT COMPLETED|Overall Study||0
11116293|NCT01309880|12300718|FG001|NOT COMPLETED|Overall Study||0
11116294|NCT01309893|12300724|FG000|STARTED|Week 1 - First Intervention||33
11116295|NCT01309893|12300725|FG001|STARTED|Week 1 - First Intervention||33
11116296|NCT01309893|12300724|FG000|COMPLETED|Week 1 - First Intervention||33
11116297|NCT01309893|12300725|FG001|COMPLETED|Week 1 - First Intervention||33
11116298|NCT01309893|12300724|FG000|NOT COMPLETED|Week 1 - First Intervention||0
11116299|NCT01309893|12300725|FG001|NOT COMPLETED|Week 1 - First Intervention||0
11116300|NCT01309893|12300724|FG000|STARTED|Week 2 - Crossover Intervention||33
11116301|NCT01309893|12300725|FG001|STARTED|Week 2 - Crossover Intervention||33
11116302|NCT01309893|12300724|FG000|COMPLETED|Week 2 - Crossover Intervention||32
11116303|NCT01309893|12300725|FG001|COMPLETED|Week 2 - Crossover Intervention||32
11116304|NCT01309893|12300724|FG000|NOT COMPLETED|Week 2 - Crossover Intervention||1
11116305|NCT01309893|12300725|FG001|NOT COMPLETED|Week 2 - Crossover Intervention||1
11116306|NCT01309906|12300731|FG000|STARTED|Overall Study||33
11116307|NCT01309906|12300732|FG001|STARTED|Overall Study||33
11116308|NCT01309906|12300731|FG000|COMPLETED|Overall Study||32
11116309|NCT01309906|12300732|FG001|COMPLETED|Overall Study||32
11116310|NCT01309906|12300731|FG000|NOT COMPLETED|Overall Study||1
11116311|NCT01309906|12300732|FG001|NOT COMPLETED|Overall Study||1
11116312|NCT01309919|12300740|FG000|STARTED|Overall Study||75
11116313|NCT01309919|12300741|FG001|STARTED|Overall Study||75
11116314|NCT01309919|12300740|FG000|COMPLETED|Overall Study||58
11116315|NCT01309919|12300741|FG001|COMPLETED|Overall Study||27
11116316|NCT01309919|12300740|FG000|NOT COMPLETED|Overall Study||17
11116317|NCT01309919|12300741|FG001|NOT COMPLETED|Overall Study||48
11116318|NCT01309997|12300749|FG000|STARTED|Overall Study||35
11116319|NCT01309997|12300750|FG001|STARTED|Overall Study||37
11116320|NCT01309997|12300749|FG000|Remained on First Arm Only|Overall Study||16
11116321|NCT01309997|12300750|FG001|Remained on First Arm Only|Overall Study||14
11116322|NCT01309997|12300749|FG000|Crossed Over to Second Arm|Overall Study||19
11116323|NCT01309997|12300750|FG001|Crossed Over to Second Arm|Overall Study||23
11116324|NCT01309997|12300749|FG000|COMPLETED|Overall Study||30
11116325|NCT01309997|12300750|FG001|COMPLETED|Overall Study||31
11116326|NCT01309997|12300749|FG000|NOT COMPLETED|Overall Study||5
11116327|NCT01309997|12300750|FG001|NOT COMPLETED|Overall Study||6
11116328|NCT01310036|12300767|FG000|STARTED|Overall Study||208
11116329|NCT01310036|12300767|FG000|COMPLETED|Overall Study||6
11116330|NCT01310036|12300767|FG000|NOT COMPLETED|Overall Study||202
11116331|NCT01310075|12300773|FG000|STARTED|Overall Study||45
11116332|NCT01310075|12300774|FG001|STARTED|Overall Study||45
11116333|NCT01310075|12300773|FG000|COMPLETED|Overall Study||31
11116334|NCT01310075|12300774|FG001|COMPLETED|Overall Study||35
11116335|NCT01310075|12300773|FG000|NOT COMPLETED|Overall Study||14
11116336|NCT01310075|12300774|FG001|NOT COMPLETED|Overall Study||10
11116337|NCT01310127|12300782|FG000|STARTED|Overall Study||12
11116338|NCT01310127|12300783|FG001|STARTED|Overall Study||11
11116339|NCT01310127|12300782|FG000|COMPLETED|Overall Study||10
11116340|NCT01310127|12300783|FG001|COMPLETED|Overall Study||10
11116341|NCT01310127|12300782|FG000|NOT COMPLETED|Overall Study||2
11116342|NCT01310127|12300783|FG001|NOT COMPLETED|Overall Study||1
11116343|NCT01310179|12300789|FG000|STARTED|Overall Study||12
11116344|NCT01310179|12300789|FG000|COMPLETED|Overall Study||12
11116345|NCT01310179|12300789|FG000|NOT COMPLETED|Overall Study||0
11116346|NCT01310231|12300795|FG000|STARTED|Overall Study||22
11116347|NCT01310231|12300796|FG001|STARTED|Overall Study||18
11116348|NCT01310231|12300795|FG000|Received Intervention|Overall Study||22
11116349|NCT01310231|12300796|FG001|Received Intervention|Overall Study||17
11116350|NCT01310231|12300795|FG000|Discontinued Intervention|Overall Study||0
11116351|NCT01310231|12300796|FG001|Discontinued Intervention|Overall Study||1
11116352|NCT01310231|12300795|FG000|Analyzed for Survival|Overall Study||22
11116353|NCT01310231|12300796|FG001|Analyzed for Survival|Overall Study||18
11116354|NCT01310231|12300795|FG000|Analyzed for Response, Toxicity, QOL|Overall Study||22
11116355|NCT01310231|12300796|FG001|Analyzed for Response, Toxicity, QOL|Overall Study||17
11116356|NCT01310231|12300795|FG000|COMPLETED|Overall Study||22
11116357|NCT01310231|12300796|FG001|COMPLETED|Overall Study||17
11116358|NCT01310231|12300795|FG000|NOT COMPLETED|Overall Study||0
11116359|NCT01310231|12300796|FG001|NOT COMPLETED|Overall Study||1
11116360|NCT01310400|12300805|FG000|STARTED|Overall Study||452
11116361|NCT01310400|12300806|FG001|STARTED|Overall Study||452
11116362|NCT01310400|12300807|FG002|STARTED|Overall Study||452
11116363|NCT01310400|12300805|FG000|COMPLETED|Overall Study||424
11116364|NCT01310400|12300806|FG001|COMPLETED|Overall Study||420
11116365|NCT01310400|12300807|FG002|COMPLETED|Overall Study||422
11116366|NCT01310400|12300805|FG000|NOT COMPLETED|Overall Study||28
11116367|NCT01310400|12300806|FG001|NOT COMPLETED|Overall Study||32
11116368|NCT01310400|12300807|FG002|NOT COMPLETED|Overall Study||30
11116369|NCT01310413|12300824|FG000|STARTED|Day 0 to Day 385||199
11116370|NCT01310413|12300825|FG001|STARTED|Day 0 to Day 385||198
11116371|NCT01310413|12300826|FG002|STARTED|Day 0 to Day 385||210
11116372|NCT01310413|12300827|FG003|STARTED|Day 0 to Day 385||75
11116373|NCT01310413|12300828|FG004|STARTED|Day 0 to Day 385||76
11116374|NCT01310413|12300829|FG005|STARTED|Day 0 to Day 385||80
11116375|NCT01310413|12300830|FG006|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
11116376|NCT01310413|12300824|FG000|COMPLETED|Day 0 to Day 385||172
11116377|NCT01310413|12300825|FG001|COMPLETED|Day 0 to Day 385||190
11116378|NCT01310413|12300826|FG002|COMPLETED|Day 0 to Day 385||203
11116379|NCT01310413|12300827|FG003|COMPLETED|Day 0 to Day 385||67
11116380|NCT01310413|12300828|FG004|COMPLETED|Day 0 to Day 385||73
11116381|NCT01310413|12300829|FG005|COMPLETED|Day 0 to Day 385||77
11116382|NCT01310413|12300830|FG006|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
11116383|NCT01310413|12300824|FG000|NOT COMPLETED|Day 0 to Day 385||27
11116384|NCT01310413|12300825|FG001|NOT COMPLETED|Day 0 to Day 385||8
11116385|NCT01310413|12300826|FG002|NOT COMPLETED|Day 0 to Day 385||7
11116386|NCT01310413|12300827|FG003|NOT COMPLETED|Day 0 to Day 385||8
11116387|NCT01310413|12300828|FG004|NOT COMPLETED|Day 0 to Day 385||3
11116388|NCT01310413|12300829|FG005|NOT COMPLETED|Day 0 to Day 385||3
11116389|NCT01310413|12300830|FG006|NOT COMPLETED|Day 0 to Day 385||0
11116390|NCT01310413|12300824|FG000|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
11116391|NCT01310413|12300825|FG001|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
11116392|NCT01310413|12300826|FG002|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
11116393|NCT01310413|12300827|FG003|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
11116394|NCT01310413|12300828|FG004|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
11116395|NCT01310413|12300829|FG005|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
11116396|NCT01310413|12300830|FG006|STARTED|From Day U0 to Day U385|Upto Day U42|155
11116397|NCT01310413|12300824|FG000|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
11116398|NCT01310413|12300825|FG001|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
11116399|NCT01310413|12300826|FG002|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
11116400|NCT01310413|12300827|FG003|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
11116401|NCT01310413|12300828|FG004|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
11116402|NCT01310413|12300829|FG005|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
11116403|NCT01310413|12300830|FG006|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
11116404|NCT01310413|12300824|FG000|NOT COMPLETED|From Day U0 to Day U385||0
11116405|NCT01310413|12300825|FG001|NOT COMPLETED|From Day U0 to Day U385||0
11116406|NCT01310413|12300826|FG002|NOT COMPLETED|From Day U0 to Day U385||0
11116407|NCT01310413|12300827|FG003|NOT COMPLETED|From Day U0 to Day U385||0
11116408|NCT01310413|12300828|FG004|NOT COMPLETED|From Day U0 to Day U385||0
11116409|NCT01310413|12300829|FG005|NOT COMPLETED|From Day U0 to Day U385||0
11116410|NCT01310413|12300830|FG006|NOT COMPLETED|From Day U0 to Day U385||3
11116411|NCT01310582|12300861|FG000|STARTED|Overall Study||31
11116412|NCT01310582|12300862|FG001|STARTED|Overall Study||26
11116413|NCT01310582|12300861|FG000|COMPLETED|Overall Study||31
11116414|NCT01310582|12300862|FG001|COMPLETED|Overall Study||26
11116415|NCT01310582|12300861|FG000|NOT COMPLETED|Overall Study||0
11116416|NCT01310582|12300862|FG001|NOT COMPLETED|Overall Study||0
11116417|NCT01310699|12300870|FG000|STARTED|Overall Study||132
11116418|NCT01310699|12300871|FG001|STARTED|Overall Study||149
11116419|NCT01310699|12300870|FG000|COMPLETED|Overall Study||128
11116420|NCT01310699|12300871|FG001|COMPLETED|Overall Study||143
11116421|NCT01310699|12300870|FG000|NOT COMPLETED|Overall Study||4
11116422|NCT01310699|12300871|FG001|NOT COMPLETED|Overall Study||6
11116423|NCT01310777|12300882|FG000|STARTED|Overall Study||193
11116424|NCT01310777|12300883|FG001|STARTED|Overall Study||192
11116425|NCT01310777|12300884|FG002|STARTED|Overall Study||175
11116426|NCT01310777|12300882|FG000|COMPLETED|Overall Study||160
11116427|NCT01310777|12300883|FG001|COMPLETED|Overall Study||178
11116428|NCT01310777|12300884|FG002|COMPLETED|Overall Study||145
11116429|NCT01310777|12300882|FG000|NOT COMPLETED|Overall Study||33
11116430|NCT01310777|12300883|FG001|NOT COMPLETED|Overall Study||14
11116431|NCT01310777|12300884|FG002|NOT COMPLETED|Overall Study||30
11116432|NCT01310855|12300894|FG000|STARTED|Overall Study||19
11116433|NCT01310855|12300895|FG001|STARTED|Overall Study||19
11116434|NCT01310855|12300894|FG000|COMPLETED|Overall Study||19
11116435|NCT01310855|12300895|FG001|COMPLETED|Overall Study||19
11116436|NCT01310855|12300894|FG000|NOT COMPLETED|Overall Study||0
11116437|NCT01310855|12300895|FG001|NOT COMPLETED|Overall Study||0
11116438|NCT01310868|12300901|FG000|STARTED|Overall Study||72
11116439|NCT01310868|12300901|FG000|COMPLETED|Overall Study||59
11116440|NCT01310868|12300901|FG000|NOT COMPLETED|Overall Study||13
11116441|NCT01311024|12300907|FG000|STARTED|Overall Study||1530
11116442|NCT01311024|12300908|FG001|STARTED|Overall Study||811
11116443|NCT01311024|12300907|FG000|COMPLETED|Overall Study||1495
11116444|NCT01311024|12300908|FG001|COMPLETED|Overall Study||789
11116445|NCT01311024|12300907|FG000|NOT COMPLETED|Overall Study||35
11116446|NCT01311024|12300908|FG001|NOT COMPLETED|Overall Study||22
11116447|NCT01311102|12300916|FG000|STARTED|Overall Study||20
11116448|NCT01311102|12300917|FG001|STARTED|Overall Study||20
11116449|NCT01311102|12300916|FG000|COMPLETED|Overall Study||20
11116450|NCT01311102|12300917|FG001|COMPLETED|Overall Study||20
11116451|NCT01311102|12300916|FG000|NOT COMPLETED|Overall Study||0
11116452|NCT01311102|12300917|FG001|NOT COMPLETED|Overall Study||0
11116453|NCT01311362|12300925|FG000|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
11116454|NCT01311362|12300925|FG000|COMPLETED|Ambrisentan Single Dose||20
11116455|NCT01311362|12300925|FG000|NOT COMPLETED|Ambrisentan Single Dose||0
11116456|NCT01311362|12300925|FG000|STARTED|Ambrisentan Steady-state||20
11116457|NCT01311362|12300925|FG000|COMPLETED|Ambrisentan Steady-state||20
11116458|NCT01311362|12300925|FG000|NOT COMPLETED|Ambrisentan Steady-state||0
11116459|NCT01311362|12300925|FG000|STARTED|Ambrisentan and SJW||20
11116460|NCT01311362|12300925|FG000|COMPLETED|Ambrisentan and SJW||20
11116461|NCT01311362|12300925|FG000|NOT COMPLETED|Ambrisentan and SJW||0
11116462|NCT01311505|12300934|FG000|STARTED|First Intervention Period||10
11116463|NCT01311505|12300935|FG001|STARTED|First Intervention Period||11
11116464|NCT01311505|12300934|FG000|COMPLETED|First Intervention Period||10
11116465|NCT01311505|12300935|FG001|COMPLETED|First Intervention Period||10
11116466|NCT01311505|12300934|FG000|NOT COMPLETED|First Intervention Period||0
11116467|NCT01311505|12300935|FG001|NOT COMPLETED|First Intervention Period||1
11116468|NCT01311505|12300934|FG000|STARTED|Washout Period (at Least 7 Days)||10
11116469|NCT01311505|12300935|FG001|STARTED|Washout Period (at Least 7 Days)||10
11116470|NCT01311505|12300934|FG000|COMPLETED|Washout Period (at Least 7 Days)||10
11116471|NCT01311505|12300935|FG001|COMPLETED|Washout Period (at Least 7 Days)||10
11116472|NCT01311505|12300934|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11116473|NCT01311505|12300935|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11116474|NCT01311505|12300934|FG000|STARTED|Second Intervention Period||10
11116475|NCT01311505|12300935|FG001|STARTED|Second Intervention Period||10
11116476|NCT01311505|12300934|FG000|COMPLETED|Second Intervention Period||10
11116477|NCT01311505|12300935|FG001|COMPLETED|Second Intervention Period||10
11116478|NCT01311505|12300934|FG000|NOT COMPLETED|Second Intervention Period||0
11116479|NCT01311505|12300935|FG001|NOT COMPLETED|Second Intervention Period||0
11116480|NCT01311557|12300946|FG000|STARTED|Overall Study||651
11116481|NCT01311557|12300947|FG001|STARTED|Overall Study||651
11116482|NCT01311557|12300946|FG000|COMPLETED|Overall Study||646
11116483|NCT01311557|12300947|FG001|COMPLETED|Overall Study||645
11116484|NCT01311557|12300946|FG000|NOT COMPLETED|Overall Study||5
11116485|NCT01311557|12300947|FG001|NOT COMPLETED|Overall Study||6
11116486|NCT01311648|12300956|FG000|STARTED|Main Study||51
11116487|NCT01311648|12300957|FG001|STARTED|Main Study||43
11116488|NCT01311648|12300956|FG000|Started 0-<6 Years|Main Study||25
11116489|NCT01311648|12300957|FG001|Started 0-<6 Years|Main Study||43
11116490|NCT01311648|12300956|FG000|Started 6-12 Years|Main Study||26
11116491|NCT01311648|12300957|FG001|Started 6-12 Years|Main Study||0
11116492|NCT01311648|12300956|FG000|COMPLETED|Main Study||51
11116493|NCT01311648|12300957|FG001|COMPLETED|Main Study||22
11116494|NCT01311648|12300956|FG000|NOT COMPLETED|Main Study||0
11116495|NCT01311648|12300957|FG001|NOT COMPLETED|Main Study||21
11116496|NCT01311648|12300956|FG000|STARTED|Extension Study||46
11116497|NCT01311648|12300957|FG001|STARTED|Extension Study||36
11116498|NCT01311648|12300956|FG000|COMPLETED|Extension Study||45
11116499|NCT01311648|12300957|FG001|COMPLETED|Extension Study||25
11116500|NCT01311648|12300956|FG000|NOT COMPLETED|Extension Study||1
11116501|NCT01311648|12300957|FG001|NOT COMPLETED|Extension Study||11
11116502|NCT01311661|12300970|FG000|STARTED|Overall Study|Entered and treated|206
11116503|NCT01311661|12300970|FG000|Received Placebo|Overall Study||201
11116504|NCT01311661|12300970|FG000|Received Olo 2.5 mcg Bid|Overall Study||101
11116505|NCT01311661|12300970|FG000|Received Olo 5 mcg qd|Overall Study||101
11116506|NCT01311661|12300970|FG000|Received Olo 5 mcg Bid|Overall Study||101
11116507|NCT01311661|12300970|FG000|Received Olo 10 mcg qd|Overall Study||102
11116508|NCT01311661|12300970|FG000|COMPLETED|Overall Study||199
11116509|NCT01311661|12300970|FG000|NOT COMPLETED|Overall Study||7
11116510|NCT01311674|12300984|FG000|STARTED|Overall Study||72
11116511|NCT01311674|12300985|FG001|STARTED|Overall Study||69
11116512|NCT01311674|12300984|FG000|COMPLETED|Overall Study||28
11116513|NCT01311674|12300985|FG001|COMPLETED|Overall Study||29
11116514|NCT01311674|12300984|FG000|NOT COMPLETED|Overall Study||44
11116515|NCT01311674|12300985|FG001|NOT COMPLETED|Overall Study||40
11116516|NCT01311687|12300994|FG000|STARTED|Treatment Phase||302
11116517|NCT01311687|12300995|FG001|STARTED|Treatment Phase||153
11116518|NCT01311687|12300994|FG000|Received Study Drug|Treatment Phase||300
11116519|NCT01311687|12300995|FG001|Received Study Drug|Treatment Phase||150
11116520|NCT01311687|12300994|FG000|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
11116521|NCT01311687|12300995|FG001|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
11116522|NCT01311687|12300994|FG000|COMPLETED|Treatment Phase||302
11116523|NCT01311687|12300995|FG001|COMPLETED|Treatment Phase||153
11116524|NCT01311687|12300994|FG000|NOT COMPLETED|Treatment Phase||0
11116525|NCT01311687|12300995|FG001|NOT COMPLETED|Treatment Phase||0
11116526|NCT01311687|12300994|FG000|STARTED|PFS Follow-up Phase||11
11116527|NCT01311687|12300995|FG001|STARTED|PFS Follow-up Phase||8
11116528|NCT01311687|12300994|FG000|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
11116529|NCT01311687|12300995|FG001|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
11116530|NCT01311687|12300994|FG000|COMPLETED|PFS Follow-up Phase||11
11116531|NCT01311687|12300995|FG001|COMPLETED|PFS Follow-up Phase||8
11116532|NCT01311687|12300994|FG000|NOT COMPLETED|PFS Follow-up Phase||0
11116533|NCT01311687|12300995|FG001|NOT COMPLETED|PFS Follow-up Phase||0
11116534|NCT01311895|12301006|FG000|STARTED|Overall Study||175
11116535|NCT01311895|12301007|FG001|STARTED|Overall Study||175
11116536|NCT01311895|12301006|FG000|COMPLETED|Overall Study||175
11116537|NCT01311895|12301007|FG001|COMPLETED|Overall Study||175
11356178|NCT03093181|12553139|FG002|COMPLETED|Overall Study||41
11356179|NCT03093181|12553137|FG000|NOT COMPLETED|Overall Study||3
11356180|NCT03093181|12553138|FG001|NOT COMPLETED|Overall Study||2
11356181|NCT03093181|12553139|FG002|NOT COMPLETED|Overall Study||3
11356182|NCT03093207|12553149|FG000|STARTED|Overall Study||17
11356183|NCT03093207|12553150|FG001|STARTED|Overall Study||17
11116538|NCT01311895|12301006|FG000|NOT COMPLETED|Overall Study||0
11116539|NCT01311895|12301007|FG001|NOT COMPLETED|Overall Study||0
11116540|NCT01312038|12301015|FG000|STARTED|Overall Study||13
11116541|NCT01312038|12301016|FG001|STARTED|Overall Study||12
11116542|NCT01312038|12301015|FG000|COMPLETED|Overall Study||13
11116543|NCT01312038|12301016|FG001|COMPLETED|Overall Study||12
11116544|NCT01312038|12301015|FG000|NOT COMPLETED|Overall Study||0
11116545|NCT01312038|12301016|FG001|NOT COMPLETED|Overall Study||0
11116546|NCT01312129|12301024|FG000|STARTED|First Intervention (24 Hours)||6
11116547|NCT01312129|12301025|FG001|STARTED|First Intervention (24 Hours)||7
11116548|NCT01312129|12301024|FG000|Control Cue|First Intervention (24 Hours)||6
11116549|NCT01312129|12301025|FG001|Control Cue|First Intervention (24 Hours)||7
11116550|NCT01312129|12301024|FG000|Alcohol Cue|First Intervention (24 Hours)||6
11116551|NCT01312129|12301025|FG001|Alcohol Cue|First Intervention (24 Hours)||7
11356184|NCT03093207|12553149|FG000|COMPLETED|Overall Study||17
11116552|NCT01312129|12301024|FG000|COMPLETED|First Intervention (24 Hours)||6
11116553|NCT01312129|12301025|FG001|COMPLETED|First Intervention (24 Hours)||7
11116554|NCT01312129|12301024|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
11116555|NCT01312129|12301025|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
11116556|NCT01312129|12301024|FG000|STARTED|Washout (1 Week)||6
11116557|NCT01312129|12301025|FG001|STARTED|Washout (1 Week)||7
11116558|NCT01312129|12301024|FG000|COMPLETED|Washout (1 Week)||6
11116559|NCT01312129|12301025|FG001|COMPLETED|Washout (1 Week)||7
11116560|NCT01312129|12301024|FG000|NOT COMPLETED|Washout (1 Week)||0
11116561|NCT01312129|12301025|FG001|NOT COMPLETED|Washout (1 Week)||0
11116562|NCT01312129|12301024|FG000|STARTED|Second Intervention (24 Hours)||6
11116563|NCT01312129|12301025|FG001|STARTED|Second Intervention (24 Hours)||7
11116564|NCT01312129|12301024|FG000|Control Cue|Second Intervention (24 Hours)||6
11116565|NCT01312129|12301025|FG001|Control Cue|Second Intervention (24 Hours)||6
11116566|NCT01312129|12301024|FG000|Alcohol Cue|Second Intervention (24 Hours)||6
11116567|NCT01312129|12301025|FG001|Alcohol Cue|Second Intervention (24 Hours)||6
11116568|NCT01312129|12301024|FG000|COMPLETED|Second Intervention (24 Hours)||6
11116569|NCT01312129|12301025|FG001|COMPLETED|Second Intervention (24 Hours)||6
11116570|NCT01312129|12301024|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
11116571|NCT01312129|12301025|FG001|NOT COMPLETED|Second Intervention (24 Hours)||1
11116572|NCT01312181|12301034|FG000|STARTED|Overall Study||80
11116573|NCT01312181|12301035|FG001|STARTED|Overall Study||77
11116574|NCT01312181|12301036|FG002|STARTED|Overall Study||83
11116575|NCT01312181|12301034|FG000|COMPLETED|Overall Study||78
11116576|NCT01312181|12301035|FG001|COMPLETED|Overall Study||71
11116577|NCT01312181|12301036|FG002|COMPLETED|Overall Study||75
11116578|NCT01312181|12301034|FG000|NOT COMPLETED|Overall Study||2
11116579|NCT01312181|12301035|FG001|NOT COMPLETED|Overall Study||6
11232837|NCT02038010|12424864|FG000|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||10
11232838|NCT02038010|12424865|FG001|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||4
11232839|NCT02038010|12424866|FG002|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
11232840|NCT02038010|12424867|FG003|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
11232841|NCT02038010|12424864|FG000|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||9
11232842|NCT02038010|12424865|FG001|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||3
11232843|NCT02038010|12424866|FG002|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
11232844|NCT02038010|12424867|FG003|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
11232845|NCT02038010|12424864|FG000|COMPLETED|Completed 3 Cycles/Reached 1st Response||9
11232846|NCT02038010|12424865|FG001|COMPLETED|Completed 3 Cycles/Reached 1st Response||3
11232847|NCT02038010|12424866|FG002|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
11232848|NCT02038010|12424867|FG003|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
11232849|NCT02038010|12424864|FG000|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
11232850|NCT02038010|12424865|FG001|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
11232851|NCT02038010|12424866|FG002|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
11232852|NCT02038010|12424867|FG003|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
11232853|NCT02038010|12424864|FG000|STARTED|Follow Up||11
11116580|NCT01312181|12301036|FG002|NOT COMPLETED|Overall Study||8
11116581|NCT01312233|12301047|FG000|STARTED|Overall Study||44
11116582|NCT01312233|12301048|FG001|STARTED|Overall Study||44
11116583|NCT01312233|12301049|FG002|STARTED|Overall Study||43
11116584|NCT01312233|12301047|FG000|COMPLETED|Overall Study||42
11116585|NCT01312233|12301048|FG001|COMPLETED|Overall Study||44
11116586|NCT01312233|12301049|FG002|COMPLETED|Overall Study||36
11116587|NCT01312233|12301047|FG000|NOT COMPLETED|Overall Study||2
11116588|NCT01312233|12301048|FG001|NOT COMPLETED|Overall Study||0
11116589|NCT01312233|12301049|FG002|NOT COMPLETED|Overall Study||7
11116590|NCT01312272|12301059|FG000|STARTED|Overall Study||12
11116591|NCT01312272|12301060|FG001|STARTED|Overall Study||12
11116592|NCT01312272|12301059|FG000|COMPLETED|Overall Study||12
11232854|NCT02038010|12424865|FG001|STARTED|Follow Up||6
11232855|NCT02038010|12424866|FG002|STARTED|Follow Up||0
11232856|NCT02038010|12424867|FG003|STARTED|Follow Up||0
11232857|NCT02038010|12424864|FG000|COMPLETED|Follow Up||4
11232858|NCT02038010|12424865|FG001|COMPLETED|Follow Up||3
11232859|NCT02038010|12424866|FG002|COMPLETED|Follow Up||0
11232860|NCT02038010|12424867|FG003|COMPLETED|Follow Up||0
11232861|NCT02038010|12424864|FG000|NOT COMPLETED|Follow Up||7
11232862|NCT02038010|12424865|FG001|NOT COMPLETED|Follow Up||3
11232863|NCT02038010|12424866|FG002|NOT COMPLETED|Follow Up||0
11232864|NCT02038010|12424867|FG003|NOT COMPLETED|Follow Up||0
11232865|NCT02038023|12424875|FG000|STARTED|Overall Study||74
11232866|NCT02038023|12424875|FG000|COMPLETED|Overall Study||73
11232867|NCT02038023|12424875|FG000|NOT COMPLETED|Overall Study||1
11232868|NCT02038036|12424883|FG000|STARTED|Core Study||74
11232869|NCT02038036|12424884|FG001|STARTED|Core Study||75
11232870|NCT02038036|12424883|FG000|Full Analysis Set|Core Study||74
11232871|NCT02038036|12424884|FG001|Full Analysis Set|Core Study||75
11116593|NCT01312272|12301060|FG001|COMPLETED|Overall Study||11
11116594|NCT01312272|12301059|FG000|NOT COMPLETED|Overall Study||0
11116595|NCT01312272|12301060|FG001|NOT COMPLETED|Overall Study||1
11116596|NCT01312389|12301069|FG000|STARTED|Phase 1||3
11116597|NCT01312389|12301070|FG001|STARTED|Phase 1||0
11116598|NCT01312389|12301071|FG002|STARTED|Phase 1||0
11116599|NCT01312389|12301069|FG000|COMPLETED|Phase 1||3
11116600|NCT01312389|12301070|FG001|COMPLETED|Phase 1||0
11116601|NCT01312389|12301071|FG002|COMPLETED|Phase 1||0
11116602|NCT01312389|12301069|FG000|NOT COMPLETED|Phase 1||0
11116603|NCT01312389|12301070|FG001|NOT COMPLETED|Phase 1||0
11116604|NCT01312389|12301071|FG002|NOT COMPLETED|Phase 1||0
11116605|NCT01312389|12301069|FG000|STARTED|Phase 2||0
11116606|NCT01312389|12301070|FG001|STARTED|Phase 2||0
11116607|NCT01312389|12301071|FG002|STARTED|Phase 2||0
11116608|NCT01312389|12301069|FG000|COMPLETED|Phase 2||0
11116609|NCT01312389|12301070|FG001|COMPLETED|Phase 2||0
11116610|NCT01312389|12301071|FG002|COMPLETED|Phase 2||0
11116611|NCT01312389|12301069|FG000|NOT COMPLETED|Phase 2||0
11116612|NCT01312389|12301070|FG001|NOT COMPLETED|Phase 2||0
11116613|NCT01312389|12301071|FG002|NOT COMPLETED|Phase 2||0
11116614|NCT01312467|12301079|FG000|STARTED|Overall Study||45
11116615|NCT01312467|12301079|FG000|COMPLETED|Overall Study||32
11116616|NCT01312467|12301079|FG000|NOT COMPLETED|Overall Study||13
11116617|NCT01312519|12301086|FG000|STARTED|Overall Study||26
11116618|NCT01312519|12301087|FG001|STARTED|Overall Study||24
11116619|NCT01312519|12301086|FG000|COMPLETED|Overall Study||26
11116620|NCT01312519|12301087|FG001|COMPLETED|Overall Study||24
11116621|NCT01312519|12301086|FG000|NOT COMPLETED|Overall Study||0
11116622|NCT01312519|12301087|FG001|NOT COMPLETED|Overall Study||0
11116623|NCT01312675|12301095|FG000|STARTED|Overall Study||9
11116624|NCT01312675|12301096|FG001|STARTED|Overall Study||7
11116625|NCT01312675|12301095|FG000|COMPLETED|Overall Study||9
11116626|NCT01312675|12301096|FG001|COMPLETED|Overall Study||7
11116627|NCT01312675|12301095|FG000|NOT COMPLETED|Overall Study||0
11116628|NCT01312675|12301096|FG001|NOT COMPLETED|Overall Study||0
11116629|NCT01312766|12301104|FG000|STARTED|Overall Study||135
11116630|NCT01312766|12301105|FG001|STARTED|Overall Study||135
11116631|NCT01312766|12301104|FG000|COMPLETED|Overall Study||129
11116632|NCT01312766|12301105|FG001|COMPLETED|Overall Study||130
11116633|NCT01312766|12301104|FG000|NOT COMPLETED|Overall Study||6
11116634|NCT01312766|12301105|FG001|NOT COMPLETED|Overall Study||5
11116635|NCT01312779|12301111|FG000|STARTED|Overall Study||39
11116636|NCT01312779|12301111|FG000|Implanted With Device|Overall Study||12
11116637|NCT01312779|12301111|FG000|COMPLETED|Overall Study||7
11116638|NCT01312779|12301111|FG000|NOT COMPLETED|Overall Study||32
11116639|NCT01312805|12301126|FG000|STARTED|Overall Study||1016
11116640|NCT01312805|12301127|FG001|STARTED|Overall Study||1082
11116641|NCT01312805|12301126|FG000|COMPLETED|Overall Study||1016
11116642|NCT01312805|12301127|FG001|COMPLETED|Overall Study||1082
11116643|NCT01312805|12301126|FG000|NOT COMPLETED|Overall Study||0
11116644|NCT01312805|12301127|FG001|NOT COMPLETED|Overall Study||0
11116645|NCT01312818|12301133|FG000|STARTED|Overall Study||2
11116646|NCT01312818|12301133|FG000|COMPLETED|Overall Study||2
11116647|NCT01312818|12301133|FG000|NOT COMPLETED|Overall Study||0
11116648|NCT01312844|12301141|FG000|STARTED|Overall Study||4
11116649|NCT01312844|12301142|FG001|STARTED|Overall Study||3
11116650|NCT01312844|12301141|FG000|COMPLETED|Overall Study||4
11116651|NCT01312844|12301142|FG001|COMPLETED|Overall Study||3
11116652|NCT01312844|12301141|FG000|NOT COMPLETED|Overall Study||0
11116653|NCT01312844|12301142|FG001|NOT COMPLETED|Overall Study||0
11116654|NCT01312909|12301151|FG000|STARTED|Overall Study||109
11116655|NCT01312909|12301152|FG001|STARTED|Overall Study||103
11116656|NCT01312909|12301153|FG002|STARTED|Overall Study||100
11116657|NCT01312909|12301151|FG000|Treated|Overall Study||108
11116658|NCT01312909|12301152|FG001|Treated|Overall Study||100
11116659|NCT01312909|12301153|FG002|Treated|Overall Study||99
11116660|NCT01312909|12301151|FG000|COMPLETED|Overall Study||67
11116661|NCT01312909|12301152|FG001|COMPLETED|Overall Study||67
11116662|NCT01312909|12301153|FG002|COMPLETED|Overall Study||53
11116663|NCT01312909|12301151|FG000|NOT COMPLETED|Overall Study||42
11232872|NCT02038036|12424883|FG000|Crossover Set|Core Study||0
11232873|NCT02038036|12424884|FG001|Crossover Set|Core Study||58
11232874|NCT02038036|12424883|FG000|COMPLETED|Core Study||59
11232875|NCT02038036|12424884|FG001|COMPLETED|Core Study||61
11232876|NCT02038036|12424883|FG000|NOT COMPLETED|Core Study||15
11232877|NCT02038036|12424884|FG001|NOT COMPLETED|Core Study||14
11232878|NCT02038036|12424883|FG000|STARTED|Crossover Period||0
11116664|NCT01312909|12301152|FG001|NOT COMPLETED|Overall Study||36
11116665|NCT01312909|12301153|FG002|NOT COMPLETED|Overall Study||47
11116666|NCT01312948|12301161|FG000|STARTED|Overall Study||6
11116667|NCT01312948|12301161|FG000|COMPLETED|Overall Study||6
11116668|NCT01312948|12301161|FG000|NOT COMPLETED|Overall Study||0
11116669|NCT01312961|12301170|FG000|STARTED|Overall Study||52
11116670|NCT01312961|12301171|FG001|STARTED|Overall Study||52
11116671|NCT01312961|12301170|FG000|Treated|Overall Study||52
11116672|NCT01312961|12301171|FG001|Treated|Overall Study||52
11116673|NCT01312961|12301170|FG000|COMPLETED|Overall Study||35
11116674|NCT01312961|12301171|FG001|COMPLETED|Overall Study||45
11116675|NCT01312961|12301170|FG000|NOT COMPLETED|Overall Study||17
11116676|NCT01312961|12301171|FG001|NOT COMPLETED|Overall Study||7
11116677|NCT01313039|12301178|FG000|STARTED|Overall Study||4
11232879|NCT02038036|12424884|FG001|STARTED|Crossover Period|58 participants were eligible to crossover to the ruxolitinib arm|58
11232880|NCT02038036|12424883|FG000|COMPLETED|Crossover Period||0
11232881|NCT02038036|12424884|FG001|COMPLETED|Crossover Period||38
11232882|NCT02038036|12424883|FG000|NOT COMPLETED|Crossover Period||0
11232883|NCT02038036|12424884|FG001|NOT COMPLETED|Crossover Period||20
11232884|NCT02038049|12424895|FG000|STARTED|Overall Study||4
11232885|NCT02038049|12424896|FG001|STARTED|Overall Study||4
11232886|NCT02038049|12424895|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||4
11232887|NCT02038049|12424896|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4
11232888|NCT02038049|12424895|FG000|COMPLETED|Overall Study||3
11232889|NCT02038049|12424896|FG001|COMPLETED|Overall Study||4
11232890|NCT02038049|12424895|FG000|NOT COMPLETED|Overall Study||1
11232891|NCT02038049|12424896|FG001|NOT COMPLETED|Overall Study||0
11232892|NCT02038075|12424908|FG000|STARTED|Overall Study||76
11232893|NCT02038075|12424909|FG001|STARTED|Overall Study||76
11232894|NCT02038075|12424908|FG000|COMPLETED|Overall Study||73
11232895|NCT02038075|12424909|FG001|COMPLETED|Overall Study||76
11232896|NCT02038075|12424908|FG000|NOT COMPLETED|Overall Study||3
11232897|NCT02038075|12424909|FG001|NOT COMPLETED|Overall Study||0
11232898|NCT02038179|12424915|FG000|STARTED|Phase 1 (4 Weeks)||52
11232899|NCT02038179|12424916|FG001|STARTED|Phase 1 (4 Weeks)||47
11232900|NCT02038179|12424915|FG000|COMPLETED|Phase 1 (4 Weeks)||48
11232901|NCT02038179|12424916|FG001|COMPLETED|Phase 1 (4 Weeks)||42
11232902|NCT02038179|12424915|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||4
11232903|NCT02038179|12424916|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5
11232904|NCT02038179|12424915|FG000|STARTED|Washout (2-4 Weeks)||48
11232905|NCT02038179|12424916|FG001|STARTED|Washout (2-4 Weeks)||42
11232906|NCT02038179|12424915|FG000|COMPLETED|Washout (2-4 Weeks)||46
11232907|NCT02038179|12424916|FG001|COMPLETED|Washout (2-4 Weeks)||40
11232908|NCT02038179|12424915|FG000|NOT COMPLETED|Washout (2-4 Weeks)||2
11232909|NCT02038179|12424916|FG001|NOT COMPLETED|Washout (2-4 Weeks)||2
11232910|NCT02038179|12424915|FG000|STARTED|Phase 2 (4 Weeks)||46
11232911|NCT02038179|12424916|FG001|STARTED|Phase 2 (4 Weeks)||40
11232912|NCT02038179|12424915|FG000|COMPLETED|Phase 2 (4 Weeks)||44
11232913|NCT02038179|12424916|FG001|COMPLETED|Phase 2 (4 Weeks)||38
11232914|NCT02038179|12424915|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||2
11232915|NCT02038179|12424916|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||2
11232916|NCT02038218|12424924|FG000|STARTED|Overall Study|Drug tolerated - Arm 1: No liver disease - 98.7 mg/m2. No alterations of liver functions.|22
11232917|NCT02038218|12424925|FG001|STARTED|Overall Study|Drug tolerated - Arm 2: liver involvement - 85.5 mg/m2. No alterations of liver functions.|7
11232918|NCT02038218|12424924|FG000|COMPLETED|Overall Study|22 patients are included in a publication in progress|22
11232919|NCT02038218|12424925|FG001|COMPLETED|Overall Study|5 patients are included in a publication in progress|7
11232920|NCT02038218|12424924|FG000|NOT COMPLETED|Overall Study||0
11232921|NCT02038218|12424925|FG001|NOT COMPLETED|Overall Study||0
11116678|NCT01313039|12301178|FG000|COMPLETED|Overall Study||2
11232922|NCT02038543|12424935|FG000|STARTED|Overall Study||7
11232923|NCT02038543|12424936|FG001|STARTED|Overall Study||4
11232924|NCT02038543|12424937|FG002|STARTED|Overall Study||8
11232925|NCT02038543|12424938|FG003|STARTED|Overall Study||3
11232926|NCT02038543|12424935|FG000|COMPLETED|Overall Study||7
11232927|NCT02038543|12424936|FG001|COMPLETED|Overall Study||4
11232928|NCT02038543|12424937|FG002|COMPLETED|Overall Study||8
11232929|NCT02038543|12424938|FG003|COMPLETED|Overall Study||1
11232930|NCT02038543|12424935|FG000|NOT COMPLETED|Overall Study||0
11232931|NCT02038543|12424936|FG001|NOT COMPLETED|Overall Study||0
11116679|NCT01313039|12301178|FG000|NOT COMPLETED|Overall Study||2
11116680|NCT01313078|12301182|FG000|STARTED|Overall Study||4
11116681|NCT01313078|12301182|FG000|COMPLETED|Overall Study||1
11116682|NCT01313078|12301182|FG000|NOT COMPLETED|Overall Study||3
11116683|NCT01313117|12301186|FG000|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
11116684|NCT01313117|12301186|FG000|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
11116685|NCT01313117|12301186|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
11116686|NCT01313117|12301186|FG000|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
11116687|NCT01313117|12301186|FG000|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
11116688|NCT01313117|12301186|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
11116689|NCT01313117|12301186|FG000|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
11116690|NCT01313117|12301186|FG000|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
11116691|NCT01313117|12301186|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
11116692|NCT01313117|12301186|FG000|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
11116693|NCT01313117|12301186|FG000|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
11116694|NCT01313117|12301186|FG000|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
11116695|NCT01313117|12301186|FG000|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
11116696|NCT01313117|12301186|FG000|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
11116697|NCT01313117|12301186|FG000|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
11116698|NCT01313182|12301193|FG000|STARTED|Overall Study||842
11116699|NCT01313182|12301194|FG001|STARTED|Overall Study||855
11116700|NCT01313182|12301193|FG000|COMPLETED|Overall Study||776
11116701|NCT01313182|12301194|FG001|COMPLETED|Overall Study||763
11116702|NCT01313182|12301193|FG000|NOT COMPLETED|Overall Study||66
11116703|NCT01313182|12301194|FG001|NOT COMPLETED|Overall Study||92
11116704|NCT01313208|12301202|FG000|STARTED|Double-blind Phase (Weeks 1 - 12)||104
11116705|NCT01313208|12301203|FG001|STARTED|Double-blind Phase (Weeks 1 - 12)||106
11116706|NCT01313208|12301202|FG000|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
11116707|NCT01313208|12301203|FG001|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
11116708|NCT01313208|12301202|FG000|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
11116709|NCT01313208|12301203|FG001|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
11116710|NCT01313208|12301202|FG000|STARTED|Open-label Phase (Weeks 13 - 24)||98
11116711|NCT01313208|12301203|FG001|STARTED|Open-label Phase (Weeks 13 - 24)||101
11116712|NCT01313208|12301202|FG000|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
11116713|NCT01313208|12301203|FG001|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
11116714|NCT01313208|12301202|FG000|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
11116715|NCT01313208|12301203|FG001|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
11116716|NCT01313221|12301214|FG000|STARTED|Overall Study||144
11116717|NCT01313221|12301215|FG001|STARTED|Overall Study||143
11116718|NCT01313221|12301216|FG002|STARTED|Overall Study||23
11116719|NCT01313221|12301214|FG000|Randomized|Overall Study||144
11116720|NCT01313221|12301215|FG001|Randomized|Overall Study||143
11116721|NCT01313221|12301216|FG002|Randomized|Overall Study||0
11116722|NCT01313221|12301214|FG000|COMPLETED|Overall Study||132
11116723|NCT01313221|12301215|FG001|COMPLETED|Overall Study||135
11116724|NCT01313221|12301216|FG002|COMPLETED|Overall Study||0
11116725|NCT01313221|12301214|FG000|NOT COMPLETED|Overall Study||12
11116726|NCT01313221|12301215|FG001|NOT COMPLETED|Overall Study||8
11116727|NCT01313221|12301216|FG002|NOT COMPLETED|Overall Study||23
11116728|NCT01313286|12301224|FG000|STARTED|Period 1||8
11116729|NCT01313286|12301225|FG001|STARTED|Period 1||8
11116730|NCT01313286|12301224|FG000|COMPLETED|Period 1||6
11116731|NCT01313286|12301225|FG001|COMPLETED|Period 1||8
11116732|NCT01313286|12301224|FG000|NOT COMPLETED|Period 1||2
11116733|NCT01313286|12301225|FG001|NOT COMPLETED|Period 1||0
11116734|NCT01313286|12301224|FG000|STARTED|Period 2||6
11116735|NCT01313286|12301225|FG001|STARTED|Period 2||8
11116736|NCT01313286|12301224|FG000|COMPLETED|Period 2||6
11116737|NCT01313286|12301225|FG001|COMPLETED|Period 2||8
11116738|NCT01313286|12301224|FG000|NOT COMPLETED|Period 2||0
11116739|NCT01313286|12301225|FG001|NOT COMPLETED|Period 2||0
11116740|NCT01313494|12301233|FG000|STARTED|Overall Study||313
11116741|NCT01313494|12301234|FG001|STARTED|Overall Study||313
11116742|NCT01313494|12301233|FG000|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
11116743|NCT01313494|12301234|FG001|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
11116744|NCT01313494|12301233|FG000|COMPLETED|Overall Study||246
11116745|NCT01313494|12301234|FG001|COMPLETED|Overall Study||263
11116746|NCT01313494|12301233|FG000|NOT COMPLETED|Overall Study||67
11116747|NCT01313494|12301234|FG001|NOT COMPLETED|Overall Study||50
11116748|NCT01313507|12301240|FG000|STARTED|Overall Study||21
11116749|NCT01313507|12301240|FG000|COMPLETED|Overall Study||21
11116750|NCT01313507|12301240|FG000|NOT COMPLETED|Overall Study||0
11116751|NCT01313520|12301246|FG000|STARTED|Overall Study||30
11116752|NCT01313520|12301247|FG001|STARTED|Overall Study||31
11116753|NCT01313520|12301246|FG000|COMPLETED|Overall Study||30
11116754|NCT01313520|12301247|FG001|COMPLETED|Overall Study||31
11116755|NCT01313520|12301246|FG000|NOT COMPLETED|Overall Study||0
11116756|NCT01313520|12301247|FG001|NOT COMPLETED|Overall Study||0
11116757|NCT01313559|12301257|FG000|STARTED|Overall Study||4
11116758|NCT01313559|12301258|FG001|STARTED|Overall Study||2
11116759|NCT01313559|12301257|FG000|COMPLETED|Overall Study||0
11116760|NCT01313559|12301258|FG001|COMPLETED|Overall Study||0
11116761|NCT01313559|12301257|FG000|NOT COMPLETED|Overall Study||4
11116762|NCT01313559|12301258|FG001|NOT COMPLETED|Overall Study||2
11116763|NCT01313624|12301266|FG000|STARTED|Double-Blind Phase||134
11116764|NCT01313624|12301267|FG001|STARTED|Double-Blind Phase||132
11116765|NCT01313624|12301266|FG000|COMPLETED|Double-Blind Phase||96
11116766|NCT01313624|12301267|FG001|COMPLETED|Double-Blind Phase||122
11116767|NCT01313624|12301266|FG000|NOT COMPLETED|Double-Blind Phase||38
11116768|NCT01313624|12301267|FG001|NOT COMPLETED|Double-Blind Phase||10
11116769|NCT01313624|12301266|FG000|STARTED|Open-Label Phase||96
11116770|NCT01313624|12301267|FG001|STARTED|Open-Label Phase||122
11116771|NCT01313624|12301266|FG000|COMPLETED|Open-Label Phase||92
11116772|NCT01313624|12301267|FG001|COMPLETED|Open-Label Phase||109
11116773|NCT01313624|12301266|FG000|NOT COMPLETED|Open-Label Phase||4
11116774|NCT01313624|12301267|FG001|NOT COMPLETED|Open-Label Phase||13
11116775|NCT01313637|12301279|FG000|STARTED|Overall Study||275
11116776|NCT01313637|12301280|FG001|STARTED|Overall Study||407
11116777|NCT01313637|12301281|FG002|STARTED|Overall Study||404
11116778|NCT01313637|12301282|FG003|STARTED|Overall Study||403
11232932|NCT02038543|12424937|FG002|NOT COMPLETED|Overall Study||0
11232933|NCT02038543|12424938|FG003|NOT COMPLETED|Overall Study||2
11232934|NCT02038569|12424948|FG000|STARTED|Overall Study||107
11232935|NCT02038569|12424948|FG000|COMPLETED|Overall Study||102
11232936|NCT02038569|12424948|FG000|NOT COMPLETED|Overall Study||5
11232937|NCT02038647|12424955|FG000|STARTED|Overall Study||89
11232938|NCT02038647|12424956|FG001|STARTED|Overall Study||89
11232939|NCT02038647|12424955|FG000|COMPLETED|Overall Study||0
11232940|NCT02038647|12424956|FG001|COMPLETED|Overall Study||0
11232941|NCT02038647|12424955|FG000|NOT COMPLETED|Overall Study||89
11232942|NCT02038647|12424956|FG001|NOT COMPLETED|Overall Study||89
11232943|NCT02038764|12424967|FG000|STARTED|Overall Study||7
11232944|NCT02038764|12424968|FG001|STARTED|Overall Study||8
11232945|NCT02038764|12424969|FG002|STARTED|Overall Study||9
11232946|NCT02038764|12424970|FG003|STARTED|Overall Study||5
11232947|NCT02038764|12424971|FG004|STARTED|Overall Study||8
11232948|NCT02038764|12424967|FG000|COMPLETED|Overall Study||6
11232949|NCT02038764|12424968|FG001|COMPLETED|Overall Study||7
11232950|NCT02038764|12424969|FG002|COMPLETED|Overall Study||7
11232951|NCT02038764|12424970|FG003|COMPLETED|Overall Study||5
11232952|NCT02038764|12424971|FG004|COMPLETED|Overall Study||7
11232953|NCT02038764|12424967|FG000|NOT COMPLETED|Overall Study||1
11232954|NCT02038764|12424968|FG001|NOT COMPLETED|Overall Study||1
11232955|NCT02038764|12424969|FG002|NOT COMPLETED|Overall Study||2
11232956|NCT02038764|12424970|FG003|NOT COMPLETED|Overall Study||0
11232957|NCT02038764|12424971|FG004|NOT COMPLETED|Overall Study||1
11232958|NCT02038790|12424987|FG000|STARTED|Day 0 - First Treatment||16
11232959|NCT02038790|12424988|FG001|STARTED|Day 0 - First Treatment||17
11232960|NCT02038790|12424987|FG000|COMPLETED|Day 0 - First Treatment||15
11232961|NCT02038790|12424988|FG001|COMPLETED|Day 0 - First Treatment||16
11232962|NCT02038790|12424987|FG000|NOT COMPLETED|Day 0 - First Treatment||1
11232963|NCT02038790|12424988|FG001|NOT COMPLETED|Day 0 - First Treatment||1
11232964|NCT02038790|12424987|FG000|STARTED|Day 1 - Second Treatment||15
11232965|NCT02038790|12424988|FG001|STARTED|Day 1 - Second Treatment||16
11232966|NCT02038790|12424987|FG000|COMPLETED|Day 1 - Second Treatment||15
11232967|NCT02038790|12424988|FG001|COMPLETED|Day 1 - Second Treatment||16
11232968|NCT02038790|12424987|FG000|NOT COMPLETED|Day 1 - Second Treatment||0
11232969|NCT02038790|12424988|FG001|NOT COMPLETED|Day 1 - Second Treatment||0
11232970|NCT02038829|12424995|FG000|STARTED|Treatment Period 1||8
11232971|NCT02038829|12424996|FG001|STARTED|Treatment Period 1||8
11232972|NCT02038829|12424997|FG002|STARTED|Treatment Period 1||8
11232973|NCT02038829|12424998|FG003|STARTED|Treatment Period 1||8
11232974|NCT02038829|12424999|FG004|STARTED|Treatment Period 1||8
11232975|NCT02038829|12425000|FG005|STARTED|Treatment Period 1||8
11232976|NCT02038829|12425001|FG006|STARTED|Treatment Period 1||8
11232977|NCT02038829|12425002|FG007|STARTED|Treatment Period 1||8
11232978|NCT02038829|12425003|FG008|STARTED|Treatment Period 1||8
11232979|NCT02038829|12425004|FG009|STARTED|Treatment Period 1||8
11232980|NCT02038829|12425005|FG010|STARTED|Treatment Period 1||8
11232981|NCT02038829|12425006|FG011|STARTED|Treatment Period 1||8
11232982|NCT02038829|12424995|FG000|COMPLETED|Treatment Period 1||8
11232983|NCT02038829|12424996|FG001|COMPLETED|Treatment Period 1||8
11232984|NCT02038829|12424997|FG002|COMPLETED|Treatment Period 1||8
11232985|NCT02038829|12424998|FG003|COMPLETED|Treatment Period 1||8
11232986|NCT02038829|12424999|FG004|COMPLETED|Treatment Period 1||8
11232987|NCT02038829|12425000|FG005|COMPLETED|Treatment Period 1||8
11232988|NCT02038829|12425001|FG006|COMPLETED|Treatment Period 1||8
11232989|NCT02038829|12425002|FG007|COMPLETED|Treatment Period 1||8
11232990|NCT02038829|12425003|FG008|COMPLETED|Treatment Period 1||8
11232991|NCT02038829|12425004|FG009|COMPLETED|Treatment Period 1||8
11232992|NCT02038829|12425005|FG010|COMPLETED|Treatment Period 1||8
11232993|NCT02038829|12425006|FG011|COMPLETED|Treatment Period 1||8
11232994|NCT02038829|12424995|FG000|NOT COMPLETED|Treatment Period 1||0
11232995|NCT02038829|12424996|FG001|NOT COMPLETED|Treatment Period 1||0
11232996|NCT02038829|12424997|FG002|NOT COMPLETED|Treatment Period 1||0
11232997|NCT02038829|12424998|FG003|NOT COMPLETED|Treatment Period 1||0
11232998|NCT02038829|12424999|FG004|NOT COMPLETED|Treatment Period 1||0
11232999|NCT02038829|12425000|FG005|NOT COMPLETED|Treatment Period 1||0
11116779|NCT01313637|12301279|FG000|COMPLETED|Overall Study||183
11116780|NCT01313637|12301280|FG001|COMPLETED|Overall Study||312
11116781|NCT01313637|12301281|FG002|COMPLETED|Overall Study||298
11116782|NCT01313637|12301282|FG003|COMPLETED|Overall Study||325
11116783|NCT01313637|12301279|FG000|NOT COMPLETED|Overall Study||92
11116784|NCT01313637|12301280|FG001|NOT COMPLETED|Overall Study||95
11116785|NCT01313637|12301281|FG002|NOT COMPLETED|Overall Study||106
11116786|NCT01313637|12301282|FG003|NOT COMPLETED|Overall Study||78
11116787|NCT01313650|12301296|FG000|STARTED|Overall Study||280
11116788|NCT01313650|12301297|FG001|STARTED|Overall Study||418
11116789|NCT01313650|12301298|FG002|STARTED|Overall Study||421
11116790|NCT01313650|12301299|FG003|STARTED|Overall Study||413
11116791|NCT01313650|12301296|FG000|COMPLETED|Overall Study||204
11116792|NCT01313650|12301297|FG001|COMPLETED|Overall Study||324
11116793|NCT01313650|12301298|FG002|COMPLETED|Overall Study||318
11116794|NCT01313650|12301299|FG003|COMPLETED|Overall Study||332
11116795|NCT01313650|12301296|FG000|NOT COMPLETED|Overall Study||76
11233000|NCT02038829|12425001|FG006|NOT COMPLETED|Treatment Period 1||0
11233001|NCT02038829|12425002|FG007|NOT COMPLETED|Treatment Period 1||0
11233002|NCT02038829|12425003|FG008|NOT COMPLETED|Treatment Period 1||0
11233003|NCT02038829|12425004|FG009|NOT COMPLETED|Treatment Period 1||0
11233004|NCT02038829|12425005|FG010|NOT COMPLETED|Treatment Period 1||0
11233005|NCT02038829|12425006|FG011|NOT COMPLETED|Treatment Period 1||0
11233006|NCT02038829|12424995|FG000|STARTED|Washout Period 1||8
11233007|NCT02038829|12424996|FG001|STARTED|Washout Period 1||8
11233008|NCT02038829|12424997|FG002|STARTED|Washout Period 1||8
11116796|NCT01313650|12301297|FG001|NOT COMPLETED|Overall Study||94
11116797|NCT01313650|12301298|FG002|NOT COMPLETED|Overall Study||103
11116798|NCT01313650|12301299|FG003|NOT COMPLETED|Overall Study||81
11116799|NCT01313663|12301311|FG000|STARTED|Overall Study||9
11116800|NCT01313663|12301312|FG001|STARTED|Overall Study||11
11116801|NCT01313663|12301311|FG000|COMPLETED|Overall Study||5
11116802|NCT01313663|12301312|FG001|COMPLETED|Overall Study||3
11116803|NCT01313663|12301311|FG000|NOT COMPLETED|Overall Study||4
11116804|NCT01313663|12301312|FG001|NOT COMPLETED|Overall Study||8
11116805|NCT01313676|12301322|FG000|STARTED|Overall Study||4131
11116806|NCT01313676|12301323|FG001|STARTED|Overall Study||4157
11116807|NCT01313676|12301324|FG002|STARTED|Overall Study||4140
11116808|NCT01313676|12301325|FG003|STARTED|Overall Study||4140
11116809|NCT01313676|12301322|FG000|COMPLETED|Overall Study||2881
11116810|NCT01313676|12301323|FG001|COMPLETED|Overall Study||3044
11116811|NCT01313676|12301324|FG002|COMPLETED|Overall Study||3052
11116812|NCT01313676|12301325|FG003|COMPLETED|Overall Study||3146
11116813|NCT01313676|12301322|FG000|NOT COMPLETED|Overall Study||1250
11116814|NCT01313676|12301323|FG001|NOT COMPLETED|Overall Study||1113
11116815|NCT01313676|12301324|FG002|NOT COMPLETED|Overall Study||1088
11116816|NCT01313676|12301325|FG003|NOT COMPLETED|Overall Study||994
11116817|NCT01313728|12301336|FG000|STARTED|Informed Consent to Baseline||26
11116818|NCT01313728|12301336|FG000|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
11116819|NCT01313728|12301336|FG000|NOT COMPLETED|Informed Consent to Baseline||1
11233009|NCT02038829|12424998|FG003|STARTED|Washout Period 1||8
11233010|NCT02038829|12424999|FG004|STARTED|Washout Period 1||8
11233011|NCT02038829|12425000|FG005|STARTED|Washout Period 1||8
11233012|NCT02038829|12425001|FG006|STARTED|Washout Period 1||8
11233013|NCT02038829|12425002|FG007|STARTED|Washout Period 1||8
11233014|NCT02038829|12425003|FG008|STARTED|Washout Period 1||8
11233015|NCT02038829|12425004|FG009|STARTED|Washout Period 1||8
11233016|NCT02038829|12425005|FG010|STARTED|Washout Period 1||8
11233017|NCT02038829|12425006|FG011|STARTED|Washout Period 1||8
11356185|NCT03093207|12553150|FG001|COMPLETED|Overall Study||17
11356186|NCT03093207|12553149|FG000|NOT COMPLETED|Overall Study||0
11356187|NCT03093207|12553150|FG001|NOT COMPLETED|Overall Study||0
11356188|NCT03093272|12553156|FG000|STARTED|Overall Study||9
11356189|NCT03093272|12553156|FG000|COMPLETED|Overall Study||9
11356190|NCT03093272|12553156|FG000|NOT COMPLETED|Overall Study||0
11356191|NCT03093324|12553162|FG000|STARTED|Overall Study||254
11356192|NCT03093324|12553163|FG001|STARTED|Overall Study||252
11356193|NCT03093324|12553162|FG000|Safety Population|Overall Study||253
11356194|NCT03093324|12553163|FG001|Safety Population|Overall Study||251
11356195|NCT03093324|12553162|FG000|COMPLETED|Overall Study||245
11356196|NCT03093324|12553163|FG001|COMPLETED|Overall Study||233
11356197|NCT03093324|12553162|FG000|NOT COMPLETED|Overall Study||9
11356198|NCT03093324|12553163|FG001|NOT COMPLETED|Overall Study||19
11356199|NCT03093415|12553172|FG000|STARTED|Assessed for Eligibility --> Enrollment||165
11356200|NCT03093415|12553173|FG001|STARTED|Assessed for Eligibility --> Enrollment||135
11356201|NCT03093415|12553174|FG002|STARTED|Assessed for Eligibility --> Enrollment||50
11356202|NCT03093415|12553172|FG000|COMPLETED|Assessed for Eligibility --> Enrollment||25
11356203|NCT03093415|12553173|FG001|COMPLETED|Assessed for Eligibility --> Enrollment||25
11356204|NCT03093415|12553174|FG002|COMPLETED|Assessed for Eligibility --> Enrollment||50
11356205|NCT03093415|12553172|FG000|NOT COMPLETED|Assessed for Eligibility --> Enrollment||140
11356206|NCT03093415|12553173|FG001|NOT COMPLETED|Assessed for Eligibility --> Enrollment||110
11356207|NCT03093415|12553174|FG002|NOT COMPLETED|Assessed for Eligibility --> Enrollment||0
11356208|NCT03093415|12553172|FG000|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
11356209|NCT03093415|12553173|FG001|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
11356210|NCT03093415|12553174|FG002|STARTED|Enrollment to SVR12 Results|Prespecified 50 participants enrolled.|50
11356211|NCT03093415|12553172|FG000|COMPLETED|Enrollment to SVR12 Results||24
11356212|NCT03093415|12553173|FG001|COMPLETED|Enrollment to SVR12 Results||17
11356213|NCT03093415|12553174|FG002|COMPLETED|Enrollment to SVR12 Results||47
11356214|NCT03093415|12553172|FG000|NOT COMPLETED|Enrollment to SVR12 Results||1
11356215|NCT03093415|12553173|FG001|NOT COMPLETED|Enrollment to SVR12 Results||8
11356216|NCT03093415|12553174|FG002|NOT COMPLETED|Enrollment to SVR12 Results||3
11356217|NCT03093454|12553184|FG000|STARTED|Overall Study||28
11356218|NCT03093454|12553185|FG001|STARTED|Overall Study||30
11356219|NCT03093454|12553184|FG000|COMPLETED|Overall Study||22
11356220|NCT03093454|12553185|FG001|COMPLETED|Overall Study||27
11356221|NCT03093454|12553184|FG000|NOT COMPLETED|Overall Study||6
11356222|NCT03093454|12553185|FG001|NOT COMPLETED|Overall Study||3
11356223|NCT03093662|12553193|FG000|STARTED|First Intervention (3 Minutes)||18
11356224|NCT03093662|12553194|FG001|STARTED|First Intervention (3 Minutes)||19
11356225|NCT03093662|12553193|FG000|COMPLETED|First Intervention (3 Minutes)||18
11356226|NCT03093662|12553194|FG001|COMPLETED|First Intervention (3 Minutes)||19
11356227|NCT03093662|12553193|FG000|NOT COMPLETED|First Intervention (3 Minutes)||0
11356228|NCT03093662|12553194|FG001|NOT COMPLETED|First Intervention (3 Minutes)||0
11356229|NCT03093662|12553193|FG000|STARTED|Washout Period (5 Minutes)||18
11356230|NCT03093662|12553194|FG001|STARTED|Washout Period (5 Minutes)||19
11356231|NCT03093662|12553193|FG000|COMPLETED|Washout Period (5 Minutes)||18
11116820|NCT01313728|12301336|FG000|STARTED|Baseline to Completion||25
11116821|NCT01313728|12301336|FG000|COMPLETED|Baseline to Completion||25
11233018|NCT02038829|12424995|FG000|COMPLETED|Washout Period 1||8
11233019|NCT02038829|12424996|FG001|COMPLETED|Washout Period 1||8
11233020|NCT02038829|12424997|FG002|COMPLETED|Washout Period 1||8
11233021|NCT02038829|12424998|FG003|COMPLETED|Washout Period 1||8
11356232|NCT03093662|12553194|FG001|COMPLETED|Washout Period (5 Minutes)||19
11356233|NCT03093662|12553193|FG000|NOT COMPLETED|Washout Period (5 Minutes)||0
11356234|NCT03093662|12553194|FG001|NOT COMPLETED|Washout Period (5 Minutes)||0
11356235|NCT03093662|12553193|FG000|STARTED|Second Intervention (3 Minutes)||18
11356236|NCT03093662|12553194|FG001|STARTED|Second Intervention (3 Minutes)||19
11356237|NCT03093662|12553193|FG000|COMPLETED|Second Intervention (3 Minutes)||18
11356238|NCT03093662|12553194|FG001|COMPLETED|Second Intervention (3 Minutes)||19
11356239|NCT03093662|12553193|FG000|NOT COMPLETED|Second Intervention (3 Minutes)||0
11356240|NCT03093662|12553194|FG001|NOT COMPLETED|Second Intervention (3 Minutes)||0
11356241|NCT03093870|12553203|FG000|STARTED|Overall Study||24
11356242|NCT03093870|12553204|FG001|STARTED|Overall Study||64
11233022|NCT02038829|12424999|FG004|COMPLETED|Washout Period 1||7
11233023|NCT02038829|12425000|FG005|COMPLETED|Washout Period 1||8
11233024|NCT02038829|12425001|FG006|COMPLETED|Washout Period 1||8
11233025|NCT02038829|12425002|FG007|COMPLETED|Washout Period 1||8
11233026|NCT02038829|12425003|FG008|COMPLETED|Washout Period 1||8
11233027|NCT02038829|12425004|FG009|COMPLETED|Washout Period 1||8
11233028|NCT02038829|12425005|FG010|COMPLETED|Washout Period 1||8
11233029|NCT02038829|12425006|FG011|COMPLETED|Washout Period 1||8
11233030|NCT02038829|12424995|FG000|NOT COMPLETED|Washout Period 1||0
11233031|NCT02038829|12424996|FG001|NOT COMPLETED|Washout Period 1||0
11233032|NCT02038829|12424997|FG002|NOT COMPLETED|Washout Period 1||0
11233033|NCT02038829|12424998|FG003|NOT COMPLETED|Washout Period 1||0
11233034|NCT02038829|12424999|FG004|NOT COMPLETED|Washout Period 1||1
11233035|NCT02038829|12425000|FG005|NOT COMPLETED|Washout Period 1||0
11233036|NCT02038829|12425001|FG006|NOT COMPLETED|Washout Period 1||0
11233037|NCT02038829|12425002|FG007|NOT COMPLETED|Washout Period 1||0
11233038|NCT02038829|12425003|FG008|NOT COMPLETED|Washout Period 1||0
11233039|NCT02038829|12425004|FG009|NOT COMPLETED|Washout Period 1||0
11233040|NCT02038829|12425005|FG010|NOT COMPLETED|Washout Period 1||0
11233041|NCT02038829|12425006|FG011|NOT COMPLETED|Washout Period 1||0
11233042|NCT02038829|12424995|FG000|STARTED|Treatment Period 2||8
11233043|NCT02038829|12424996|FG001|STARTED|Treatment Period 2||8
11233044|NCT02038829|12424997|FG002|STARTED|Treatment Period 2||8
11233045|NCT02038829|12424998|FG003|STARTED|Treatment Period 2||8
11233046|NCT02038829|12424999|FG004|STARTED|Treatment Period 2||7
11233047|NCT02038829|12425000|FG005|STARTED|Treatment Period 2||8
11233048|NCT02038829|12425001|FG006|STARTED|Treatment Period 2||8
11233049|NCT02038829|12425002|FG007|STARTED|Treatment Period 2||8
11233050|NCT02038829|12425003|FG008|STARTED|Treatment Period 2||8
11233051|NCT02038829|12425004|FG009|STARTED|Treatment Period 2||8
11233052|NCT02038829|12425005|FG010|STARTED|Treatment Period 2||8
11233053|NCT02038829|12425006|FG011|STARTED|Treatment Period 2||8
11233054|NCT02038829|12424995|FG000|COMPLETED|Treatment Period 2||7
11233055|NCT02038829|12424996|FG001|COMPLETED|Treatment Period 2||8
11233056|NCT02038829|12424997|FG002|COMPLETED|Treatment Period 2||8
11233057|NCT02038829|12424998|FG003|COMPLETED|Treatment Period 2||8
11233058|NCT02038829|12424999|FG004|COMPLETED|Treatment Period 2||7
11233059|NCT02038829|12425000|FG005|COMPLETED|Treatment Period 2||8
11233060|NCT02038829|12425001|FG006|COMPLETED|Treatment Period 2||8
11233061|NCT02038829|12425002|FG007|COMPLETED|Treatment Period 2||8
11233062|NCT02038829|12425003|FG008|COMPLETED|Treatment Period 2||8
11233063|NCT02038829|12425004|FG009|COMPLETED|Treatment Period 2||8
11233064|NCT02038829|12425005|FG010|COMPLETED|Treatment Period 2||7
11233065|NCT02038829|12425006|FG011|COMPLETED|Treatment Period 2||8
11233066|NCT02038829|12424995|FG000|NOT COMPLETED|Treatment Period 2||1
11233067|NCT02038829|12424996|FG001|NOT COMPLETED|Treatment Period 2||0
11233068|NCT02038829|12424997|FG002|NOT COMPLETED|Treatment Period 2||0
11233069|NCT02038829|12424998|FG003|NOT COMPLETED|Treatment Period 2||0
11233070|NCT02038829|12424999|FG004|NOT COMPLETED|Treatment Period 2||0
11233071|NCT02038829|12425000|FG005|NOT COMPLETED|Treatment Period 2||0
11233072|NCT02038829|12425001|FG006|NOT COMPLETED|Treatment Period 2||0
11233073|NCT02038829|12425002|FG007|NOT COMPLETED|Treatment Period 2||0
11233074|NCT02038829|12425003|FG008|NOT COMPLETED|Treatment Period 2||0
11233075|NCT02038829|12425004|FG009|NOT COMPLETED|Treatment Period 2||0
11233076|NCT02038829|12425005|FG010|NOT COMPLETED|Treatment Period 2||1
11233077|NCT02038829|12425006|FG011|NOT COMPLETED|Treatment Period 2||0
11233078|NCT02038829|12424995|FG000|STARTED|Washout Period 2||7
11233079|NCT02038829|12424996|FG001|STARTED|Washout Period 2||8
11233080|NCT02038829|12424997|FG002|STARTED|Washout Period 2||8
11233081|NCT02038829|12424998|FG003|STARTED|Washout Period 2||8
11233082|NCT02038829|12424999|FG004|STARTED|Washout Period 2||7
11233083|NCT02038829|12425000|FG005|STARTED|Washout Period 2||8
11233084|NCT02038829|12425001|FG006|STARTED|Washout Period 2||8
11233085|NCT02038829|12425002|FG007|STARTED|Washout Period 2||8
11233086|NCT02038829|12425003|FG008|STARTED|Washout Period 2||8
11233087|NCT02038829|12425004|FG009|STARTED|Washout Period 2||8
11233088|NCT02038829|12425005|FG010|STARTED|Washout Period 2||7
11233089|NCT02038829|12425006|FG011|STARTED|Washout Period 2||8
11233090|NCT02038829|12424995|FG000|COMPLETED|Washout Period 2||7
11233091|NCT02038829|12424996|FG001|COMPLETED|Washout Period 2||8
11233092|NCT02038829|12424997|FG002|COMPLETED|Washout Period 2||8
11233093|NCT02038829|12424998|FG003|COMPLETED|Washout Period 2||8
11233094|NCT02038829|12424999|FG004|COMPLETED|Washout Period 2||7
11233095|NCT02038829|12425000|FG005|COMPLETED|Washout Period 2||7
11356243|NCT03093870|12553205|FG002|STARTED|Overall Study||63
11356244|NCT03093870|12553203|FG000|COMPLETED|Overall Study||0
11233096|NCT02038829|12425001|FG006|COMPLETED|Washout Period 2||8
11233097|NCT02038829|12425002|FG007|COMPLETED|Washout Period 2||8
11233098|NCT02038829|12425003|FG008|COMPLETED|Washout Period 2||7
11233099|NCT02038829|12425004|FG009|COMPLETED|Washout Period 2||8
11233100|NCT02038829|12425005|FG010|COMPLETED|Washout Period 2||7
11233101|NCT02038829|12425006|FG011|COMPLETED|Washout Period 2||8
11233102|NCT02038829|12424995|FG000|NOT COMPLETED|Washout Period 2||0
11356245|NCT03093870|12553204|FG001|COMPLETED|Overall Study||23
11233103|NCT02038829|12424996|FG001|NOT COMPLETED|Washout Period 2||0
11233104|NCT02038829|12424997|FG002|NOT COMPLETED|Washout Period 2||0
11233105|NCT02038829|12424998|FG003|NOT COMPLETED|Washout Period 2||0
11233106|NCT02038829|12424999|FG004|NOT COMPLETED|Washout Period 2||0
11233107|NCT02038829|12425000|FG005|NOT COMPLETED|Washout Period 2||1
11233108|NCT02038829|12425001|FG006|NOT COMPLETED|Washout Period 2||0
11233109|NCT02038829|12425002|FG007|NOT COMPLETED|Washout Period 2||0
11233110|NCT02038829|12425003|FG008|NOT COMPLETED|Washout Period 2||1
11233111|NCT02038829|12425004|FG009|NOT COMPLETED|Washout Period 2||0
11233112|NCT02038829|12425005|FG010|NOT COMPLETED|Washout Period 2||0
11233113|NCT02038829|12425006|FG011|NOT COMPLETED|Washout Period 2||0
11233114|NCT02038829|12424995|FG000|STARTED|Treatment Period 3||7
11233115|NCT02038829|12424996|FG001|STARTED|Treatment Period 3||8
11233116|NCT02038829|12424997|FG002|STARTED|Treatment Period 3||8
11233117|NCT02038829|12424998|FG003|STARTED|Treatment Period 3||8
11233118|NCT02038829|12424999|FG004|STARTED|Treatment Period 3||7
11233119|NCT02038829|12425000|FG005|STARTED|Treatment Period 3||7
11233120|NCT02038829|12425001|FG006|STARTED|Treatment Period 3||8
11233121|NCT02038829|12425002|FG007|STARTED|Treatment Period 3||8
11233122|NCT02038829|12425003|FG008|STARTED|Treatment Period 3||7
11233123|NCT02038829|12425004|FG009|STARTED|Treatment Period 3||8
11233124|NCT02038829|12425005|FG010|STARTED|Treatment Period 3||7
11233125|NCT02038829|12425006|FG011|STARTED|Treatment Period 3||8
11233126|NCT02038829|12424995|FG000|COMPLETED|Treatment Period 3||7
11233127|NCT02038829|12424996|FG001|COMPLETED|Treatment Period 3||8
11233128|NCT02038829|12424997|FG002|COMPLETED|Treatment Period 3||8
11233129|NCT02038829|12424998|FG003|COMPLETED|Treatment Period 3||8
11233130|NCT02038829|12424999|FG004|COMPLETED|Treatment Period 3||7
11233131|NCT02038829|12425000|FG005|COMPLETED|Treatment Period 3||7
11233132|NCT02038829|12425001|FG006|COMPLETED|Treatment Period 3||8
11233133|NCT02038829|12425002|FG007|COMPLETED|Treatment Period 3||8
11233134|NCT02038829|12425003|FG008|COMPLETED|Treatment Period 3||7
11233135|NCT02038829|12425004|FG009|COMPLETED|Treatment Period 3||8
11233136|NCT02038829|12425005|FG010|COMPLETED|Treatment Period 3||7
11233137|NCT02038829|12425006|FG011|COMPLETED|Treatment Period 3||8
11233138|NCT02038829|12424995|FG000|NOT COMPLETED|Treatment Period 3||0
11233139|NCT02038829|12424996|FG001|NOT COMPLETED|Treatment Period 3||0
11233140|NCT02038829|12424997|FG002|NOT COMPLETED|Treatment Period 3||0
11233141|NCT02038829|12424998|FG003|NOT COMPLETED|Treatment Period 3||0
11233142|NCT02038829|12424999|FG004|NOT COMPLETED|Treatment Period 3||0
11233143|NCT02038829|12425000|FG005|NOT COMPLETED|Treatment Period 3||0
11233144|NCT02038829|12425001|FG006|NOT COMPLETED|Treatment Period 3||0
11233145|NCT02038829|12425002|FG007|NOT COMPLETED|Treatment Period 3||0
11233146|NCT02038829|12425003|FG008|NOT COMPLETED|Treatment Period 3||0
11233147|NCT02038829|12425004|FG009|NOT COMPLETED|Treatment Period 3||0
11233148|NCT02038829|12425005|FG010|NOT COMPLETED|Treatment Period 3||0
11233149|NCT02038829|12425006|FG011|NOT COMPLETED|Treatment Period 3||0
11233150|NCT02038829|12424995|FG000|STARTED|Washout Period 3||7
11233151|NCT02038829|12424996|FG001|STARTED|Washout Period 3||8
11233152|NCT02038829|12424997|FG002|STARTED|Washout Period 3||8
11233153|NCT02038829|12424998|FG003|STARTED|Washout Period 3||8
11233154|NCT02038829|12424999|FG004|STARTED|Washout Period 3||7
11233155|NCT02038829|12425000|FG005|STARTED|Washout Period 3||7
11233156|NCT02038829|12425001|FG006|STARTED|Washout Period 3||8
11233157|NCT02038829|12425002|FG007|STARTED|Washout Period 3||8
11233158|NCT02038829|12425003|FG008|STARTED|Washout Period 3||7
11233159|NCT02038829|12425004|FG009|STARTED|Washout Period 3||8
11233160|NCT02038829|12425005|FG010|STARTED|Washout Period 3||7
11233161|NCT02038829|12425006|FG011|STARTED|Washout Period 3||8
11233162|NCT02038829|12424995|FG000|COMPLETED|Washout Period 3||7
11233163|NCT02038829|12424996|FG001|COMPLETED|Washout Period 3||8
11233164|NCT02038829|12424997|FG002|COMPLETED|Washout Period 3||8
11233165|NCT02038829|12424998|FG003|COMPLETED|Washout Period 3||8
11233166|NCT02038829|12424999|FG004|COMPLETED|Washout Period 3||7
11233167|NCT02038829|12425000|FG005|COMPLETED|Washout Period 3||7
11233168|NCT02038829|12425001|FG006|COMPLETED|Washout Period 3||8
11233169|NCT02038829|12425002|FG007|COMPLETED|Washout Period 3||8
11233170|NCT02038829|12425003|FG008|COMPLETED|Washout Period 3||7
11233171|NCT02038829|12425004|FG009|COMPLETED|Washout Period 3||8
11233172|NCT02038829|12425005|FG010|COMPLETED|Washout Period 3||7
11233173|NCT02038829|12425006|FG011|COMPLETED|Washout Period 3||8
11233174|NCT02038829|12424995|FG000|NOT COMPLETED|Washout Period 3||0
11233175|NCT02038829|12424996|FG001|NOT COMPLETED|Washout Period 3||0
11233176|NCT02038829|12424997|FG002|NOT COMPLETED|Washout Period 3||0
11233177|NCT02038829|12424998|FG003|NOT COMPLETED|Washout Period 3||0
11233178|NCT02038829|12424999|FG004|NOT COMPLETED|Washout Period 3||0
11233179|NCT02038829|12425000|FG005|NOT COMPLETED|Washout Period 3||0
11233180|NCT02038829|12425001|FG006|NOT COMPLETED|Washout Period 3||0
11233181|NCT02038829|12425002|FG007|NOT COMPLETED|Washout Period 3||0
11233182|NCT02038829|12425003|FG008|NOT COMPLETED|Washout Period 3||0
11233183|NCT02038829|12425004|FG009|NOT COMPLETED|Washout Period 3||0
11233184|NCT02038829|12425005|FG010|NOT COMPLETED|Washout Period 3||0
11233185|NCT02038829|12425006|FG011|NOT COMPLETED|Washout Period 3||0
11233186|NCT02038829|12424995|FG000|STARTED|Treatment Period 4||7
11233187|NCT02038829|12424996|FG001|STARTED|Treatment Period 4||8
11233188|NCT02038829|12424997|FG002|STARTED|Treatment Period 4||8
11233189|NCT02038829|12424998|FG003|STARTED|Treatment Period 4||8
11233190|NCT02038829|12424999|FG004|STARTED|Treatment Period 4||7
11233191|NCT02038829|12425000|FG005|STARTED|Treatment Period 4||7
11233192|NCT02038829|12425001|FG006|STARTED|Treatment Period 4||8
11233193|NCT02038829|12425002|FG007|STARTED|Treatment Period 4||8
11233194|NCT02038829|12425003|FG008|STARTED|Treatment Period 4||7
11233195|NCT02038829|12425004|FG009|STARTED|Treatment Period 4||8
11233196|NCT02038829|12425005|FG010|STARTED|Treatment Period 4||7
11233197|NCT02038829|12425006|FG011|STARTED|Treatment Period 4||8
11233198|NCT02038829|12424995|FG000|COMPLETED|Treatment Period 4||7
11233199|NCT02038829|12424996|FG001|COMPLETED|Treatment Period 4||7
11233200|NCT02038829|12424997|FG002|COMPLETED|Treatment Period 4||8
11233201|NCT02038829|12424998|FG003|COMPLETED|Treatment Period 4||8
11233202|NCT02038829|12424999|FG004|COMPLETED|Treatment Period 4||7
11233203|NCT02038829|12425000|FG005|COMPLETED|Treatment Period 4||7
11233204|NCT02038829|12425001|FG006|COMPLETED|Treatment Period 4||8
11233205|NCT02038829|12425002|FG007|COMPLETED|Treatment Period 4||8
11233206|NCT02038829|12425003|FG008|COMPLETED|Treatment Period 4||7
11233207|NCT02038829|12425004|FG009|COMPLETED|Treatment Period 4||8
11233208|NCT02038829|12425005|FG010|COMPLETED|Treatment Period 4||7
11233209|NCT02038829|12425006|FG011|COMPLETED|Treatment Period 4||8
11233210|NCT02038829|12424995|FG000|NOT COMPLETED|Treatment Period 4||0
11233211|NCT02038829|12424996|FG001|NOT COMPLETED|Treatment Period 4||1
11233212|NCT02038829|12424997|FG002|NOT COMPLETED|Treatment Period 4||0
11233213|NCT02038829|12424998|FG003|NOT COMPLETED|Treatment Period 4||0
11233214|NCT02038829|12424999|FG004|NOT COMPLETED|Treatment Period 4||0
11233215|NCT02038829|12425000|FG005|NOT COMPLETED|Treatment Period 4||0
11233216|NCT02038829|12425001|FG006|NOT COMPLETED|Treatment Period 4||0
11233217|NCT02038829|12425002|FG007|NOT COMPLETED|Treatment Period 4||0
11233218|NCT02038829|12425003|FG008|NOT COMPLETED|Treatment Period 4||0
11233219|NCT02038829|12425004|FG009|NOT COMPLETED|Treatment Period 4||0
11233220|NCT02038829|12425005|FG010|NOT COMPLETED|Treatment Period 4||0
11233221|NCT02038829|12425006|FG011|NOT COMPLETED|Treatment Period 4||0
11233222|NCT02038829|12424995|FG000|STARTED|Washout Period 4||7
11233223|NCT02038829|12424996|FG001|STARTED|Washout Period 4||7
11233224|NCT02038829|12424997|FG002|STARTED|Washout Period 4||8
11233225|NCT02038829|12424998|FG003|STARTED|Washout Period 4||8
11233226|NCT02038829|12424999|FG004|STARTED|Washout Period 4||7
11233227|NCT02038829|12425000|FG005|STARTED|Washout Period 4||7
11233228|NCT02038829|12425001|FG006|STARTED|Washout Period 4||8
11233229|NCT02038829|12425002|FG007|STARTED|Washout Period 4||8
11233230|NCT02038829|12425003|FG008|STARTED|Washout Period 4||7
11233231|NCT02038829|12425004|FG009|STARTED|Washout Period 4||8
11233232|NCT02038829|12425005|FG010|STARTED|Washout Period 4||7
11233233|NCT02038829|12425006|FG011|STARTED|Washout Period 4||8
11233234|NCT02038829|12424995|FG000|COMPLETED|Washout Period 4||7
11233235|NCT02038829|12424996|FG001|COMPLETED|Washout Period 4||7
11233236|NCT02038829|12424997|FG002|COMPLETED|Washout Period 4||8
11233237|NCT02038829|12424998|FG003|COMPLETED|Washout Period 4||8
11233238|NCT02038829|12424999|FG004|COMPLETED|Washout Period 4||7
11233239|NCT02038829|12425000|FG005|COMPLETED|Washout Period 4||7
11233240|NCT02038829|12425001|FG006|COMPLETED|Washout Period 4||7
11233241|NCT02038829|12425002|FG007|COMPLETED|Washout Period 4||8
11233242|NCT02038829|12425003|FG008|COMPLETED|Washout Period 4||7
11233243|NCT02038829|12425004|FG009|COMPLETED|Washout Period 4||8
11233244|NCT02038829|12425005|FG010|COMPLETED|Washout Period 4||7
11233245|NCT02038829|12425006|FG011|COMPLETED|Washout Period 4||8
11233246|NCT02038829|12424995|FG000|NOT COMPLETED|Washout Period 4||0
11233247|NCT02038829|12424996|FG001|NOT COMPLETED|Washout Period 4||0
11233248|NCT02038829|12424997|FG002|NOT COMPLETED|Washout Period 4||0
11233249|NCT02038829|12424998|FG003|NOT COMPLETED|Washout Period 4||0
11233250|NCT02038829|12424999|FG004|NOT COMPLETED|Washout Period 4||0
11233251|NCT02038829|12425000|FG005|NOT COMPLETED|Washout Period 4||0
11233252|NCT02038829|12425001|FG006|NOT COMPLETED|Washout Period 4||1
11233253|NCT02038829|12425002|FG007|NOT COMPLETED|Washout Period 4||0
11233254|NCT02038829|12425003|FG008|NOT COMPLETED|Washout Period 4||0
11233255|NCT02038829|12425004|FG009|NOT COMPLETED|Washout Period 4||0
11233256|NCT02038829|12425005|FG010|NOT COMPLETED|Washout Period 4||0
11233257|NCT02038829|12425006|FG011|NOT COMPLETED|Washout Period 4||0
11233258|NCT02038829|12424995|FG000|STARTED|Treatment Period 5||7
11233259|NCT02038829|12424996|FG001|STARTED|Treatment Period 5||7
11233260|NCT02038829|12424997|FG002|STARTED|Treatment Period 5||8
11233261|NCT02038829|12424998|FG003|STARTED|Treatment Period 5||8
11233262|NCT02038829|12424999|FG004|STARTED|Treatment Period 5||7
11233263|NCT02038829|12425000|FG005|STARTED|Treatment Period 5||7
11233264|NCT02038829|12425001|FG006|STARTED|Treatment Period 5||7
11233265|NCT02038829|12425002|FG007|STARTED|Treatment Period 5||8
11233266|NCT02038829|12425003|FG008|STARTED|Treatment Period 5||7
11233267|NCT02038829|12425004|FG009|STARTED|Treatment Period 5||8
11233268|NCT02038829|12425005|FG010|STARTED|Treatment Period 5||7
11233269|NCT02038829|12425006|FG011|STARTED|Treatment Period 5||8
11233270|NCT02038829|12424995|FG000|COMPLETED|Treatment Period 5||7
11233271|NCT02038829|12424996|FG001|COMPLETED|Treatment Period 5||7
11233272|NCT02038829|12424997|FG002|COMPLETED|Treatment Period 5||8
11233273|NCT02038829|12424998|FG003|COMPLETED|Treatment Period 5||8
11233274|NCT02038829|12424999|FG004|COMPLETED|Treatment Period 5||7
11233275|NCT02038829|12425000|FG005|COMPLETED|Treatment Period 5||7
11233276|NCT02038829|12425001|FG006|COMPLETED|Treatment Period 5||7
11233277|NCT02038829|12425002|FG007|COMPLETED|Treatment Period 5||8
11233278|NCT02038829|12425003|FG008|COMPLETED|Treatment Period 5||7
11233279|NCT02038829|12425004|FG009|COMPLETED|Treatment Period 5||8
11233280|NCT02038829|12425005|FG010|COMPLETED|Treatment Period 5||7
11233281|NCT02038829|12425006|FG011|COMPLETED|Treatment Period 5||8
11233282|NCT02038829|12424995|FG000|NOT COMPLETED|Treatment Period 5||0
11233283|NCT02038829|12424996|FG001|NOT COMPLETED|Treatment Period 5||0
11233284|NCT02038829|12424997|FG002|NOT COMPLETED|Treatment Period 5||0
11233285|NCT02038829|12424998|FG003|NOT COMPLETED|Treatment Period 5||0
11233286|NCT02038829|12424999|FG004|NOT COMPLETED|Treatment Period 5||0
11233287|NCT02038829|12425000|FG005|NOT COMPLETED|Treatment Period 5||0
11233288|NCT02038829|12425001|FG006|NOT COMPLETED|Treatment Period 5||0
11233289|NCT02038829|12425002|FG007|NOT COMPLETED|Treatment Period 5||0
11233290|NCT02038829|12425003|FG008|NOT COMPLETED|Treatment Period 5||0
11233291|NCT02038829|12425004|FG009|NOT COMPLETED|Treatment Period 5||0
11233292|NCT02038829|12425005|FG010|NOT COMPLETED|Treatment Period 5||0
11233293|NCT02038829|12425006|FG011|NOT COMPLETED|Treatment Period 5||0
11233294|NCT02038829|12424995|FG000|STARTED|Washout Period 5||7
11233295|NCT02038829|12424996|FG001|STARTED|Washout Period 5||7
11233296|NCT02038829|12424997|FG002|STARTED|Washout Period 5||8
11233297|NCT02038829|12424998|FG003|STARTED|Washout Period 5||8
11233298|NCT02038829|12424999|FG004|STARTED|Washout Period 5||7
11233299|NCT02038829|12425000|FG005|STARTED|Washout Period 5||7
11233300|NCT02038829|12425001|FG006|STARTED|Washout Period 5||7
11233301|NCT02038829|12425002|FG007|STARTED|Washout Period 5||8
11233302|NCT02038829|12425003|FG008|STARTED|Washout Period 5||7
11233303|NCT02038829|12425004|FG009|STARTED|Washout Period 5||8
11233304|NCT02038829|12425005|FG010|STARTED|Washout Period 5||7
11233305|NCT02038829|12425006|FG011|STARTED|Washout Period 5||8
11233306|NCT02038829|12424995|FG000|COMPLETED|Washout Period 5||7
11233307|NCT02038829|12424996|FG001|COMPLETED|Washout Period 5||7
11233308|NCT02038829|12424997|FG002|COMPLETED|Washout Period 5||8
11233309|NCT02038829|12424998|FG003|COMPLETED|Washout Period 5||8
11233310|NCT02038829|12424999|FG004|COMPLETED|Washout Period 5||7
11233311|NCT02038829|12425000|FG005|COMPLETED|Washout Period 5||7
11233312|NCT02038829|12425001|FG006|COMPLETED|Washout Period 5||7
11233313|NCT02038829|12425002|FG007|COMPLETED|Washout Period 5||8
11233314|NCT02038829|12425003|FG008|COMPLETED|Washout Period 5||7
11233315|NCT02038829|12425004|FG009|COMPLETED|Washout Period 5||8
11233316|NCT02038829|12425005|FG010|COMPLETED|Washout Period 5||7
11233317|NCT02038829|12425006|FG011|COMPLETED|Washout Period 5||8
11233318|NCT02038829|12424995|FG000|NOT COMPLETED|Washout Period 5||0
11233319|NCT02038829|12424996|FG001|NOT COMPLETED|Washout Period 5||0
11233320|NCT02038829|12424997|FG002|NOT COMPLETED|Washout Period 5||0
11233321|NCT02038829|12424998|FG003|NOT COMPLETED|Washout Period 5||0
11233322|NCT02038829|12424999|FG004|NOT COMPLETED|Washout Period 5||0
11233323|NCT02038829|12425000|FG005|NOT COMPLETED|Washout Period 5||0
11233324|NCT02038829|12425001|FG006|NOT COMPLETED|Washout Period 5||0
11233325|NCT02038829|12425002|FG007|NOT COMPLETED|Washout Period 5||0
11233326|NCT02038829|12425003|FG008|NOT COMPLETED|Washout Period 5||0
11233327|NCT02038829|12425004|FG009|NOT COMPLETED|Washout Period 5||0
11233328|NCT02038829|12425005|FG010|NOT COMPLETED|Washout Period 5||0
11233329|NCT02038829|12425006|FG011|NOT COMPLETED|Washout Period 5||0
11233330|NCT02038829|12424995|FG000|STARTED|Treatment Period 6||7
11233331|NCT02038829|12424996|FG001|STARTED|Treatment Period 6||7
11233332|NCT02038829|12424997|FG002|STARTED|Treatment Period 6||8
11233333|NCT02038829|12424998|FG003|STARTED|Treatment Period 6||8
11233334|NCT02038829|12424999|FG004|STARTED|Treatment Period 6||7
11233335|NCT02038829|12425000|FG005|STARTED|Treatment Period 6||7
11233336|NCT02038829|12425001|FG006|STARTED|Treatment Period 6||7
11233337|NCT02038829|12425002|FG007|STARTED|Treatment Period 6||8
11233338|NCT02038829|12425003|FG008|STARTED|Treatment Period 6||7
11233339|NCT02038829|12425004|FG009|STARTED|Treatment Period 6||8
11233340|NCT02038829|12425005|FG010|STARTED|Treatment Period 6||7
11233341|NCT02038829|12425006|FG011|STARTED|Treatment Period 6||8
11233342|NCT02038829|12424995|FG000|COMPLETED|Treatment Period 6||7
11233343|NCT02038829|12424996|FG001|COMPLETED|Treatment Period 6||7
11233344|NCT02038829|12424997|FG002|COMPLETED|Treatment Period 6||7
11233345|NCT02038829|12424998|FG003|COMPLETED|Treatment Period 6||8
11233346|NCT02038829|12424999|FG004|COMPLETED|Treatment Period 6||7
11233347|NCT02038829|12425000|FG005|COMPLETED|Treatment Period 6||7
11233348|NCT02038829|12425001|FG006|COMPLETED|Treatment Period 6||7
11233349|NCT02038829|12425002|FG007|COMPLETED|Treatment Period 6||8
11233350|NCT02038829|12425003|FG008|COMPLETED|Treatment Period 6||7
11233351|NCT02038829|12425004|FG009|COMPLETED|Treatment Period 6||8
11233352|NCT02038829|12425005|FG010|COMPLETED|Treatment Period 6||7
11233353|NCT02038829|12425006|FG011|COMPLETED|Treatment Period 6||8
11233354|NCT02038829|12424995|FG000|NOT COMPLETED|Treatment Period 6||0
11233355|NCT02038829|12424996|FG001|NOT COMPLETED|Treatment Period 6||0
11233356|NCT02038829|12424997|FG002|NOT COMPLETED|Treatment Period 6||1
11233357|NCT02038829|12424998|FG003|NOT COMPLETED|Treatment Period 6||0
11233358|NCT02038829|12424999|FG004|NOT COMPLETED|Treatment Period 6||0
11233359|NCT02038829|12425000|FG005|NOT COMPLETED|Treatment Period 6||0
11233360|NCT02038829|12425001|FG006|NOT COMPLETED|Treatment Period 6||0
11233361|NCT02038829|12425002|FG007|NOT COMPLETED|Treatment Period 6||0
11233362|NCT02038829|12425003|FG008|NOT COMPLETED|Treatment Period 6||0
11233363|NCT02038829|12425004|FG009|NOT COMPLETED|Treatment Period 6||0
11233364|NCT02038829|12425005|FG010|NOT COMPLETED|Treatment Period 6||0
11233365|NCT02038829|12425006|FG011|NOT COMPLETED|Treatment Period 6||0
11233366|NCT02038881|12425024|FG000|STARTED|Overall Study||27
11233367|NCT02038881|12425025|FG001|STARTED|Overall Study||29
11233368|NCT02038881|12425026|FG002|STARTED|Overall Study||31
11233369|NCT02038881|12425024|FG000|COMPLETED|Overall Study||24
11233370|NCT02038881|12425025|FG001|COMPLETED|Overall Study||29
11233371|NCT02038881|12425026|FG002|COMPLETED|Overall Study||30
11233372|NCT02038881|12425024|FG000|NOT COMPLETED|Overall Study||3
11233373|NCT02038881|12425025|FG001|NOT COMPLETED|Overall Study||0
11233374|NCT02038881|12425026|FG002|NOT COMPLETED|Overall Study||1
11233375|NCT02038894|12425039|FG000|STARTED|Overall Study||60
11233376|NCT02038894|12425040|FG001|STARTED|Overall Study||58
11233377|NCT02038894|12425041|FG002|STARTED|Overall Study||61
11233378|NCT02038894|12425039|FG000|COMPLETED|Overall Study||60
11233379|NCT02038894|12425040|FG001|COMPLETED|Overall Study||58
11233380|NCT02038894|12425041|FG002|COMPLETED|Overall Study||61
11233381|NCT02038894|12425039|FG000|NOT COMPLETED|Overall Study||0
11233382|NCT02038894|12425040|FG001|NOT COMPLETED|Overall Study||0
11233383|NCT02038894|12425041|FG002|NOT COMPLETED|Overall Study||0
11233384|NCT02038907|12425067|FG000|STARTED|Overall Study||30
11233385|NCT02038907|12425068|FG001|STARTED|Overall Study||30
11233386|NCT02038907|12425069|FG002|STARTED|Overall Study||30
11233387|NCT02038907|12425070|FG003|STARTED|Overall Study||31
11233388|NCT02038907|12425071|FG004|STARTED|Overall Study||30
11233389|NCT02038907|12425072|FG005|STARTED|Overall Study||31
11233390|NCT02038907|12425073|FG006|STARTED|Overall Study||30
11233391|NCT02038907|12425074|FG007|STARTED|Overall Study||32
11233392|NCT02038907|12425075|FG008|STARTED|Overall Study||29
11233393|NCT02038907|12425076|FG009|STARTED|Overall Study||30
11233394|NCT02038907|12425077|FG010|STARTED|Overall Study||29
11233395|NCT02038907|12425078|FG011|STARTED|Overall Study||28
11233396|NCT02038907|12425079|FG012|STARTED|Overall Study||29
11233397|NCT02038907|12425080|FG013|STARTED|Overall Study||31
11233398|NCT02038907|12425067|FG000|COMPLETED|Overall Study||30
11233399|NCT02038907|12425068|FG001|COMPLETED|Overall Study||30
11233400|NCT02038907|12425069|FG002|COMPLETED|Overall Study||30
11233401|NCT02038907|12425070|FG003|COMPLETED|Overall Study||31
11233402|NCT02038907|12425071|FG004|COMPLETED|Overall Study||30
11233403|NCT02038907|12425072|FG005|COMPLETED|Overall Study||31
11233404|NCT02038907|12425073|FG006|COMPLETED|Overall Study||30
11233405|NCT02038907|12425074|FG007|COMPLETED|Overall Study||32
11233406|NCT02038907|12425075|FG008|COMPLETED|Overall Study||29
11233407|NCT02038907|12425076|FG009|COMPLETED|Overall Study||30
11233408|NCT02038907|12425077|FG010|COMPLETED|Overall Study||27
11233409|NCT02038907|12425078|FG011|COMPLETED|Overall Study||28
11233410|NCT02038907|12425079|FG012|COMPLETED|Overall Study||29
11233411|NCT02038907|12425080|FG013|COMPLETED|Overall Study||31
11233412|NCT02038907|12425067|FG000|NOT COMPLETED|Overall Study||0
11233413|NCT02038907|12425068|FG001|NOT COMPLETED|Overall Study||0
11233414|NCT02038907|12425069|FG002|NOT COMPLETED|Overall Study||0
11233415|NCT02038907|12425070|FG003|NOT COMPLETED|Overall Study||0
11233416|NCT02038907|12425071|FG004|NOT COMPLETED|Overall Study||0
11233417|NCT02038907|12425072|FG005|NOT COMPLETED|Overall Study||0
11233418|NCT02038907|12425073|FG006|NOT COMPLETED|Overall Study||0
11233419|NCT02038907|12425074|FG007|NOT COMPLETED|Overall Study||0
11233420|NCT02038907|12425075|FG008|NOT COMPLETED|Overall Study||0
11233421|NCT02038907|12425076|FG009|NOT COMPLETED|Overall Study||0
11233422|NCT02038907|12425077|FG010|NOT COMPLETED|Overall Study||2
11233423|NCT02038907|12425078|FG011|NOT COMPLETED|Overall Study||0
11233424|NCT02038907|12425079|FG012|NOT COMPLETED|Overall Study||0
11233425|NCT02038907|12425080|FG013|NOT COMPLETED|Overall Study||0
11233426|NCT02038920|12425114|FG000|STARTED|Induction Phase (Week 0 to 14)||79
11233427|NCT02038920|12425115|FG001|STARTED|Induction Phase (Week 0 to 14)||78
11233428|NCT02038920|12425116|FG002|STARTED|Induction Phase (Week 0 to 14)||0
11233429|NCT02038920|12425117|FG003|STARTED|Induction Phase (Week 0 to 14)||0
11233430|NCT02038920|12425118|FG004|STARTED|Induction Phase (Week 0 to 14)||0
11233431|NCT02038920|12425119|FG005|STARTED|Induction Phase (Week 0 to 14)||0
11233432|NCT02038920|12425114|FG000|COMPLETED|Induction Phase (Week 0 to 14)||73
11233433|NCT02038920|12425115|FG001|COMPLETED|Induction Phase (Week 0 to 14)||66
11233434|NCT02038920|12425116|FG002|COMPLETED|Induction Phase (Week 0 to 14)||0
11233435|NCT02038920|12425117|FG003|COMPLETED|Induction Phase (Week 0 to 14)||0
11233436|NCT02038920|12425118|FG004|COMPLETED|Induction Phase (Week 0 to 14)||0
11233437|NCT02038920|12425119|FG005|COMPLETED|Induction Phase (Week 0 to 14)||0
11233438|NCT02038920|12425114|FG000|NOT COMPLETED|Induction Phase (Week 0 to 14)||6
11233439|NCT02038920|12425115|FG001|NOT COMPLETED|Induction Phase (Week 0 to 14)||12
11233440|NCT02038920|12425116|FG002|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
11233441|NCT02038920|12425117|FG003|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
11233442|NCT02038920|12425118|FG004|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
11233443|NCT02038920|12425119|FG005|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
11233444|NCT02038920|12425114|FG000|STARTED|Maintenance Phase (Week 14 to 60)||0
11233445|NCT02038920|12425115|FG001|STARTED|Maintenance Phase (Week 14 to 60)||0
11233446|NCT02038920|12425116|FG002|STARTED|Maintenance Phase (Week 14 to 60)||12
11233447|NCT02038920|12425117|FG003|STARTED|Maintenance Phase (Week 14 to 60)||12
11233448|NCT02038920|12425118|FG004|STARTED|Maintenance Phase (Week 14 to 60)||17
11233449|NCT02038920|12425119|FG005|STARTED|Maintenance Phase (Week 14 to 60)||0
11233450|NCT02038920|12425114|FG000|COMPLETED|Maintenance Phase (Week 14 to 60)||0
11233451|NCT02038920|12425115|FG001|COMPLETED|Maintenance Phase (Week 14 to 60)||0
11233452|NCT02038920|12425116|FG002|COMPLETED|Maintenance Phase (Week 14 to 60)||7
11233453|NCT02038920|12425117|FG003|COMPLETED|Maintenance Phase (Week 14 to 60)||4
11233454|NCT02038920|12425118|FG004|COMPLETED|Maintenance Phase (Week 14 to 60)||5
11233455|NCT02038920|12425119|FG005|COMPLETED|Maintenance Phase (Week 14 to 60)||0
11233456|NCT02038920|12425114|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
11233457|NCT02038920|12425115|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
11233458|NCT02038920|12425116|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5
11233459|NCT02038920|12425117|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8
11233460|NCT02038920|12425118|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12
11233461|NCT02038920|12425119|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
11233462|NCT02038920|12425114|FG000|STARTED|Open Label Cohort (Week 10 to 154)||0
11233463|NCT02038920|12425115|FG001|STARTED|Open Label Cohort (Week 10 to 154)||0
11233464|NCT02038920|12425116|FG002|STARTED|Open Label Cohort (Week 10 to 154)||0
11233465|NCT02038920|12425117|FG003|STARTED|Open Label Cohort (Week 10 to 154)||0
11233466|NCT02038920|12425118|FG004|STARTED|Open Label Cohort (Week 10 to 154)||0
11233467|NCT02038920|12425119|FG005|STARTED|Open Label Cohort (Week 10 to 154)||134
11233468|NCT02038920|12425114|FG000|COMPLETED|Open Label Cohort (Week 10 to 154)||0
11233469|NCT02038920|12425115|FG001|COMPLETED|Open Label Cohort (Week 10 to 154)||0
11233470|NCT02038920|12425116|FG002|COMPLETED|Open Label Cohort (Week 10 to 154)||0
11233471|NCT02038920|12425117|FG003|COMPLETED|Open Label Cohort (Week 10 to 154)||0
11233472|NCT02038920|12425118|FG004|COMPLETED|Open Label Cohort (Week 10 to 154)||0
11233473|NCT02038920|12425119|FG005|COMPLETED|Open Label Cohort (Week 10 to 154)||57
11233474|NCT02038920|12425114|FG000|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
11233475|NCT02038920|12425115|FG001|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
11233476|NCT02038920|12425116|FG002|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
11233477|NCT02038920|12425117|FG003|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
11233478|NCT02038920|12425118|FG004|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
11233479|NCT02038920|12425119|FG005|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77
11233480|NCT02038933|12425138|FG000|STARTED|Overall Study||121
11233481|NCT02038933|12425138|FG000|COMPLETED|Overall Study||0
11233482|NCT02038933|12425138|FG000|NOT COMPLETED|Overall Study||121
11233483|NCT02038959|12425145|FG000|STARTED|Overall Study||98
11233484|NCT02038959|12425146|FG001|STARTED|Overall Study||97
11233485|NCT02038959|12425145|FG000|COMPLETED|Overall Study||92
11233486|NCT02038959|12425146|FG001|COMPLETED|Overall Study||89
11233487|NCT02038959|12425145|FG000|NOT COMPLETED|Overall Study||6
11233488|NCT02038959|12425146|FG001|NOT COMPLETED|Overall Study||8
11233489|NCT02039115|12425154|FG000|STARTED|Overall Study||1
11233490|NCT02039115|12425155|FG001|STARTED|Overall Study||0
11233491|NCT02039115|12425154|FG000|COMPLETED|Overall Study||1
11233492|NCT02039115|12425155|FG001|COMPLETED|Overall Study||0
11233493|NCT02039115|12425154|FG000|NOT COMPLETED|Overall Study||0
11233494|NCT02039115|12425155|FG001|NOT COMPLETED|Overall Study||0
11233495|NCT02039219|12425163|FG000|STARTED|Treatment||11
11233496|NCT02039219|12425164|FG001|STARTED|Treatment||8
11233497|NCT02039219|12425163|FG000|COMPLETED|Treatment||7
11233498|NCT02039219|12425164|FG001|COMPLETED|Treatment||6
11233499|NCT02039219|12425163|FG000|NOT COMPLETED|Treatment||4
11233500|NCT02039219|12425164|FG001|NOT COMPLETED|Treatment||2
11233501|NCT02039219|12425163|FG000|STARTED|Follow up||7
11233502|NCT02039219|12425164|FG001|STARTED|Follow up||6
11233503|NCT02039219|12425163|FG000|COMPLETED|Follow up||7
11233504|NCT02039219|12425164|FG001|COMPLETED|Follow up||5
11233505|NCT02039219|12425163|FG000|NOT COMPLETED|Follow up||0
11233506|NCT02039219|12425164|FG001|NOT COMPLETED|Follow up||1
11233507|NCT02039375|12425170|FG000|STARTED|Overall Study||35
11233508|NCT02039375|12425170|FG000|COMPLETED|Overall Study||33
11233509|NCT02039375|12425170|FG000|NOT COMPLETED|Overall Study||2
11233510|NCT02039414|12425176|FG000|STARTED|Overall Study||22
11233511|NCT02039414|12425177|FG001|STARTED|Overall Study||18
11233512|NCT02039414|12425176|FG000|COMPLETED|Overall Study||16
11233513|NCT02039414|12425177|FG001|COMPLETED|Overall Study||16
11233514|NCT02039414|12425176|FG000|NOT COMPLETED|Overall Study||6
11233515|NCT02039414|12425177|FG001|NOT COMPLETED|Overall Study||2
11233516|NCT02039427|12425187|FG000|STARTED|Overall Study||48
11233517|NCT02039427|12425188|FG001|STARTED|Overall Study||48
11233518|NCT02039427|12425189|FG002|STARTED|Overall Study||48
11233519|NCT02039427|12425190|FG003|STARTED|Overall Study||48
11233520|NCT02039427|12425187|FG000|COMPLETED|Overall Study||45
11233521|NCT02039427|12425188|FG001|COMPLETED|Overall Study||47
11233522|NCT02039427|12425189|FG002|COMPLETED|Overall Study||45
11233523|NCT02039427|12425190|FG003|COMPLETED|Overall Study||43
11233524|NCT02039427|12425187|FG000|NOT COMPLETED|Overall Study||3
11233525|NCT02039427|12425188|FG001|NOT COMPLETED|Overall Study||1
11233526|NCT02039427|12425189|FG002|NOT COMPLETED|Overall Study||3
11233527|NCT02039427|12425190|FG003|NOT COMPLETED|Overall Study||5
11233528|NCT02039505|12425207|FG000|STARTED|Induction Phase (Week 0 to Week 14)||82
11233529|NCT02039505|12425208|FG001|STARTED|Induction Phase (Week 0 to Week 14)||164
11233530|NCT02039505|12425209|FG002|STARTED|Induction Phase (Week 0 to Week 14)||46
11233531|NCT02039505|12425210|FG003|STARTED|Induction Phase (Week 0 to Week 14)||0
11233532|NCT02039505|12425211|FG004|STARTED|Induction Phase (Week 0 to Week 14)||0
11233533|NCT02039505|12425212|FG005|STARTED|Induction Phase (Week 0 to Week 14)||0
11233534|NCT02039505|12425213|FG006|STARTED|Induction Phase (Week 0 to Week 14)||0
11233535|NCT02039505|12425207|FG000|COMPLETED|Induction Phase (Week 0 to Week 14)||78
11233536|NCT02039505|12425208|FG001|COMPLETED|Induction Phase (Week 0 to Week 14)||155
11233537|NCT02039505|12425209|FG002|COMPLETED|Induction Phase (Week 0 to Week 14)||36
11233538|NCT02039505|12425210|FG003|COMPLETED|Induction Phase (Week 0 to Week 14)||0
11233539|NCT02039505|12425211|FG004|COMPLETED|Induction Phase (Week 0 to Week 14)||0
11233540|NCT02039505|12425212|FG005|COMPLETED|Induction Phase (Week 0 to Week 14)||0
11233541|NCT02039505|12425213|FG006|COMPLETED|Induction Phase (Week 0 to Week 14)||0
11233542|NCT02039505|12425207|FG000|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4
11233543|NCT02039505|12425208|FG001|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9
11233544|NCT02039505|12425209|FG002|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10
11233545|NCT02039505|12425210|FG003|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
11233546|NCT02039505|12425211|FG004|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
11233547|NCT02039505|12425212|FG005|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
11233548|NCT02039505|12425213|FG006|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
11233549|NCT02039505|12425207|FG000|STARTED|Maintenance Phase (Week 14 to Week 60)||0
11233550|NCT02039505|12425208|FG001|STARTED|Maintenance Phase (Week 14 to Week 60)||0
11233551|NCT02039505|12425209|FG002|STARTED|Maintenance Phase (Week 14 to Week 60)||0
11233552|NCT02039505|12425210|FG003|STARTED|Maintenance Phase (Week 14 to Week 60)||42
11233553|NCT02039505|12425211|FG004|STARTED|Maintenance Phase (Week 14 to Week 60)||41
11233554|NCT02039505|12425212|FG005|STARTED|Maintenance Phase (Week 14 to Week 60)||26
11233555|NCT02039505|12425213|FG006|STARTED|Maintenance Phase (Week 14 to Week 60)||0
11233556|NCT02039505|12425207|FG000|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
11233557|NCT02039505|12425208|FG001|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
11233558|NCT02039505|12425209|FG002|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
11233559|NCT02039505|12425210|FG003|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18
11233560|NCT02039505|12425211|FG004|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30
11233561|NCT02039505|12425212|FG005|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12
11233562|NCT02039505|12425213|FG006|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
11233563|NCT02039505|12425207|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
11233564|NCT02039505|12425208|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
11233565|NCT02039505|12425209|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
11233566|NCT02039505|12425210|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24
11233567|NCT02039505|12425211|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11
11233568|NCT02039505|12425212|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14
11233569|NCT02039505|12425213|FG006|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
11233570|NCT02039505|12425207|FG000|STARTED|Open-Label (Week 10 up to Week 154)||0
11233571|NCT02039505|12425208|FG001|STARTED|Open-Label (Week 10 up to Week 154)||0
11233572|NCT02039505|12425209|FG002|STARTED|Open-Label (Week 10 up to Week 154)||0
11233573|NCT02039505|12425210|FG003|STARTED|Open-Label (Week 10 up to Week 154)||0
11233574|NCT02039505|12425211|FG004|STARTED|Open-Label (Week 10 up to Week 154)||0
11233575|NCT02039505|12425212|FG005|STARTED|Open-Label (Week 10 up to Week 154)||0
11233576|NCT02039505|12425213|FG006|STARTED|Open-Label (Week 10 up to Week 154)||259
11233577|NCT02039505|12425207|FG000|COMPLETED|Open-Label (Week 10 up to Week 154)||0
11233578|NCT02039505|12425208|FG001|COMPLETED|Open-Label (Week 10 up to Week 154)||0
11233579|NCT02039505|12425209|FG002|COMPLETED|Open-Label (Week 10 up to Week 154)||0
11233580|NCT02039505|12425210|FG003|COMPLETED|Open-Label (Week 10 up to Week 154)||0
11233581|NCT02039505|12425211|FG004|COMPLETED|Open-Label (Week 10 up to Week 154)||0
11233582|NCT02039505|12425212|FG005|COMPLETED|Open-Label (Week 10 up to Week 154)||0
11233583|NCT02039505|12425213|FG006|COMPLETED|Open-Label (Week 10 up to Week 154)||188
11233584|NCT02039505|12425207|FG000|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
11233585|NCT02039505|12425208|FG001|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
11233586|NCT02039505|12425209|FG002|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
11233587|NCT02039505|12425210|FG003|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
11233588|NCT02039505|12425211|FG004|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
11233589|NCT02039505|12425212|FG005|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
11233590|NCT02039505|12425213|FG006|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71
11233591|NCT02039674|12425247|FG000|STARTED|Overall Study||13
11233592|NCT02039674|12425248|FG001|STARTED|Overall Study||12
11233593|NCT02039674|12425249|FG002|STARTED|Overall Study||12
11233594|NCT02039674|12425250|FG003|STARTED|Overall Study||13
11233595|NCT02039674|12425251|FG004|STARTED|Overall Study||12
11233596|NCT02039674|12425252|FG005|STARTED|Overall Study||12
11233597|NCT02039674|12425253|FG006|STARTED|Overall Study||3
11233598|NCT02039674|12425254|FG007|STARTED|Overall Study||3
11233599|NCT02039674|12425255|FG008|STARTED|Overall Study||12
11233600|NCT02039674|12425256|FG009|STARTED|Overall Study||12
11233601|NCT02039674|12425257|FG010|STARTED|Overall Study||7
11233602|NCT02039674|12425258|FG011|STARTED|Overall Study||60
11233603|NCT02039674|12425259|FG012|STARTED|Overall Study||63
11233604|NCT02039674|12425260|FG013|STARTED|Overall Study||33
11233605|NCT02039674|12425247|FG000|Treated|Overall Study||13
11233606|NCT02039674|12425248|FG001|Treated|Overall Study||12
11233607|NCT02039674|12425249|FG002|Treated|Overall Study||11
11233608|NCT02039674|12425250|FG003|Treated|Overall Study||13
11233609|NCT02039674|12425251|FG004|Treated|Overall Study||12
11233610|NCT02039674|12425252|FG005|Treated|Overall Study||12
11233611|NCT02039674|12425253|FG006|Treated|Overall Study||3
11233612|NCT02039674|12425254|FG007|Treated|Overall Study||3
11233613|NCT02039674|12425255|FG008|Treated|Overall Study||12
11233614|NCT02039674|12425256|FG009|Treated|Overall Study||12
11233615|NCT02039674|12425257|FG010|Treated|Overall Study||7
11233616|NCT02039674|12425258|FG011|Treated|Overall Study||59
11233617|NCT02039674|12425259|FG012|Treated|Overall Study||62
11233618|NCT02039674|12425260|FG013|Treated|Overall Study||33
11233619|NCT02039674|12425247|FG000|COMPLETED|Overall Study||1
11233620|NCT02039674|12425248|FG001|COMPLETED|Overall Study||0
11233621|NCT02039674|12425249|FG002|COMPLETED|Overall Study||0
11233622|NCT02039674|12425250|FG003|COMPLETED|Overall Study||0
11233623|NCT02039674|12425251|FG004|COMPLETED|Overall Study||0
11233624|NCT02039674|12425252|FG005|COMPLETED|Overall Study||0
11233625|NCT02039674|12425253|FG006|COMPLETED|Overall Study||0
11233626|NCT02039674|12425254|FG007|COMPLETED|Overall Study||0
11233627|NCT02039674|12425255|FG008|COMPLETED|Overall Study||0
11233628|NCT02039674|12425256|FG009|COMPLETED|Overall Study||0
11233629|NCT02039674|12425257|FG010|COMPLETED|Overall Study||0
11233630|NCT02039674|12425258|FG011|COMPLETED|Overall Study||0
11233631|NCT02039674|12425259|FG012|COMPLETED|Overall Study||0
11233632|NCT02039674|12425260|FG013|COMPLETED|Overall Study||0
11233633|NCT02039674|12425247|FG000|NOT COMPLETED|Overall Study||12
11233634|NCT02039674|12425248|FG001|NOT COMPLETED|Overall Study||12
11233635|NCT02039674|12425249|FG002|NOT COMPLETED|Overall Study||12
11233636|NCT02039674|12425250|FG003|NOT COMPLETED|Overall Study||13
11233637|NCT02039674|12425251|FG004|NOT COMPLETED|Overall Study||12
11233638|NCT02039674|12425252|FG005|NOT COMPLETED|Overall Study||12
11233639|NCT02039674|12425253|FG006|NOT COMPLETED|Overall Study||3
11233640|NCT02039674|12425254|FG007|NOT COMPLETED|Overall Study||3
11233641|NCT02039674|12425255|FG008|NOT COMPLETED|Overall Study||12
11233642|NCT02039674|12425256|FG009|NOT COMPLETED|Overall Study||12
11233643|NCT02039674|12425257|FG010|NOT COMPLETED|Overall Study||7
11233644|NCT02039674|12425258|FG011|NOT COMPLETED|Overall Study||60
11233645|NCT02039674|12425259|FG012|NOT COMPLETED|Overall Study||63
11233646|NCT02039674|12425260|FG013|NOT COMPLETED|Overall Study||33
11233647|NCT02039687|12425297|FG000|STARTED|Overall Study||16
11233648|NCT02039687|12425298|FG001|STARTED|Overall Study||16
11233649|NCT02039687|12425299|FG002|STARTED|Overall Study||16
11233650|NCT02039687|12425300|FG003|STARTED|Overall Study||16
11233651|NCT02039687|12425297|FG000|COMPLETED|Overall Study||16
11233652|NCT02039687|12425298|FG001|COMPLETED|Overall Study||15
11233653|NCT02039687|12425299|FG002|COMPLETED|Overall Study||13
11233654|NCT02039687|12425300|FG003|COMPLETED|Overall Study||16
11233655|NCT02039687|12425297|FG000|NOT COMPLETED|Overall Study||0
11233656|NCT02039687|12425298|FG001|NOT COMPLETED|Overall Study||1
11233657|NCT02039687|12425299|FG002|NOT COMPLETED|Overall Study||3
11233658|NCT02039687|12425300|FG003|NOT COMPLETED|Overall Study||0
11233659|NCT02039726|12425312|FG000|STARTED|Overall Study||245
11233660|NCT02039726|12425313|FG001|STARTED|Overall Study||122
11233661|NCT02039726|12425312|FG000|Ongoing (as of Data Cutoff)|Overall Study||45
11233662|NCT02039726|12425313|FG001|Ongoing (as of Data Cutoff)|Overall Study||16
11233663|NCT02039726|12425312|FG000|Did Not Receive Treatment|Overall Study||4
11233664|NCT02039726|12425313|FG001|Did Not Receive Treatment|Overall Study||28
11233665|NCT02039726|12425312|FG000|COMPLETED|Overall Study||200
11233666|NCT02039726|12425313|FG001|COMPLETED|Overall Study||106
11233667|NCT02039726|12425312|FG000|NOT COMPLETED|Overall Study||45
11233668|NCT02039726|12425313|FG001|NOT COMPLETED|Overall Study||16
11233669|NCT02039778|12425319|FG000|STARTED|Overall Study||4
11233670|NCT02039778|12425319|FG000|COMPLETED|Overall Study||0
11233671|NCT02039778|12425319|FG000|NOT COMPLETED|Overall Study||4
11233672|NCT02039817|12425325|FG000|STARTED|Overall Study||8
11233673|NCT02039817|12425326|FG001|STARTED|Overall Study||8
11233674|NCT02039817|12425325|FG000|COMPLETED|Overall Study||8
11233675|NCT02039817|12425326|FG001|COMPLETED|Overall Study||8
11233676|NCT02039817|12425325|FG000|NOT COMPLETED|Overall Study||0
11233677|NCT02039817|12425326|FG001|NOT COMPLETED|Overall Study||0
11233678|NCT02039856|12425333|FG000|STARTED|Overall Study||2720
11233679|NCT02039856|12425334|FG001|STARTED|Overall Study||1180
11233680|NCT02039856|12425333|FG000|Baseline Started - Patients|Overall Study||2183
11233681|NCT02039856|12425334|FG001|Baseline Started - Patients|Overall Study||919
11233682|NCT02039856|12425333|FG000|Baseline Completed - Patients|Overall Study||953
11233683|NCT02039856|12425334|FG001|Baseline Completed - Patients|Overall Study||442
11233684|NCT02039856|12425333|FG000|Baseline Started - Providers/Staff|Overall Study||537
11233685|NCT02039856|12425334|FG001|Baseline Started - Providers/Staff|Overall Study||261
11116822|NCT01313728|12301336|FG000|NOT COMPLETED|Baseline to Completion||0
11116823|NCT01313767|12301343|FG000|STARTED|Overall Study||98
11116824|NCT01313767|12301344|FG001|STARTED|Overall Study||98
11116825|NCT01313767|12301343|FG000|COMPLETED|Overall Study||91
11116826|NCT01313767|12301344|FG001|COMPLETED|Overall Study||96
11116827|NCT01313767|12301343|FG000|NOT COMPLETED|Overall Study||7
11116828|NCT01313767|12301344|FG001|NOT COMPLETED|Overall Study||2
11116829|NCT01313780|12301352|FG000|STARTED|Overall Study|FAS|58
11116830|NCT01313780|12301353|FG001|STARTED|Overall Study|FAS|59
11116831|NCT01313780|12301352|FG000|COMPLETED|Overall Study|PPS|33
11116832|NCT01313780|12301353|FG001|COMPLETED|Overall Study|PPS|31
11116833|NCT01313780|12301352|FG000|NOT COMPLETED|Overall Study||25
11116834|NCT01313780|12301353|FG001|NOT COMPLETED|Overall Study||28
11116835|NCT01313858|12301362|FG000|STARTED|Overall Study||524
11116836|NCT01313858|12301363|FG001|STARTED|Overall Study||546
11116837|NCT01313858|12301364|FG002|STARTED|Overall Study||543
11116838|NCT01313858|12301362|FG000|COMPLETED|Overall Study||238
11116839|NCT01313858|12301363|FG001|COMPLETED|Overall Study||276
11116840|NCT01313858|12301364|FG002|COMPLETED|Overall Study||305
11116841|NCT01313858|12301362|FG000|NOT COMPLETED|Overall Study||286
11116842|NCT01313858|12301363|FG001|NOT COMPLETED|Overall Study||270
11116843|NCT01313858|12301364|FG002|NOT COMPLETED|Overall Study||238
11116844|NCT01313884|12301370|FG000|STARTED|Overall Study||3
11116845|NCT01313884|12301370|FG000|COMPLETED|Overall Study||2
11116846|NCT01313884|12301370|FG000|NOT COMPLETED|Overall Study||1
11116847|NCT01313897|12301374|FG000|STARTED|Overall Study||10
11116848|NCT01313897|12301374|FG000|COMPLETED|Overall Study||8
11116849|NCT01313897|12301374|FG000|NOT COMPLETED|Overall Study||2
11116850|NCT01313910|12301378|FG000|STARTED|Overall Study||8
11116851|NCT01313910|12301378|FG000|COMPLETED|Overall Study||8
11116852|NCT01313910|12301378|FG000|NOT COMPLETED|Overall Study||0
11116853|NCT01313936|12301384|FG000|STARTED|Overall Study||6
11116854|NCT01313936|12301385|FG001|STARTED|Overall Study||26
11116855|NCT01313936|12301384|FG000|COMPLETED|Overall Study||6
11116856|NCT01313936|12301385|FG001|COMPLETED|Overall Study||26
11116857|NCT01313936|12301384|FG000|NOT COMPLETED|Overall Study||0
11116858|NCT01313936|12301385|FG001|NOT COMPLETED|Overall Study||0
11116859|NCT01314001|12301400|FG000|STARTED|Overall Study||215
11116860|NCT01314001|12301401|FG001|STARTED|Overall Study||193
11116861|NCT01314001|12301402|FG002|STARTED|Overall Study||227
11116862|NCT01314001|12301403|FG003|STARTED|Overall Study||191
11116863|NCT01314001|12301404|FG004|STARTED|Overall Study||220
11116864|NCT01314001|12301405|FG005|STARTED|Overall Study||200
11116865|NCT01314001|12301400|FG000|End-of-Treatment Visit|Overall Study||156
11116866|NCT01314001|12301401|FG001|End-of-Treatment Visit|Overall Study||141
11116867|NCT01314001|12301402|FG002|End-of-Treatment Visit|Overall Study||179
11116868|NCT01314001|12301403|FG003|End-of-Treatment Visit|Overall Study||146
11116869|NCT01314001|12301404|FG004|End-of-Treatment Visit|Overall Study||174
11116870|NCT01314001|12301405|FG005|End-of-Treatment Visit|Overall Study||160
11116871|NCT01314001|12301400|FG000|6-Month Follow Up Survey|Overall Study||146
11116872|NCT01314001|12301401|FG001|6-Month Follow Up Survey|Overall Study||137
11116873|NCT01314001|12301402|FG002|6-Month Follow Up Survey|Overall Study||165
11116874|NCT01314001|12301403|FG003|6-Month Follow Up Survey|Overall Study||135
11116875|NCT01314001|12301404|FG004|6-Month Follow Up Survey|Overall Study||157
11116876|NCT01314001|12301405|FG005|6-Month Follow Up Survey|Overall Study||139
11116877|NCT01314001|12301400|FG000|COMPLETED|Overall Study||140
11116878|NCT01314001|12301401|FG001|COMPLETED|Overall Study||124
11116879|NCT01314001|12301402|FG002|COMPLETED|Overall Study||158
11116880|NCT01314001|12301403|FG003|COMPLETED|Overall Study||122
11116881|NCT01314001|12301404|FG004|COMPLETED|Overall Study||148
11116882|NCT01314001|12301405|FG005|COMPLETED|Overall Study||129
11116883|NCT01314001|12301400|FG000|NOT COMPLETED|Overall Study||75
11116884|NCT01314001|12301401|FG001|NOT COMPLETED|Overall Study||69
11116885|NCT01314001|12301402|FG002|NOT COMPLETED|Overall Study||69
11116886|NCT01314001|12301403|FG003|NOT COMPLETED|Overall Study||69
11116887|NCT01314001|12301404|FG004|NOT COMPLETED|Overall Study||72
11116888|NCT01314001|12301405|FG005|NOT COMPLETED|Overall Study||71
11116889|NCT01314014|12301419|FG000|STARTED|Overall Study||22
11116890|NCT01314014|12301419|FG000|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
11116891|NCT01314014|12301419|FG000|NOT COMPLETED|Overall Study||0
11116892|NCT01314105|12301425|FG000|STARTED|Overall Study||7
11116893|NCT01314105|12301426|FG001|STARTED|Overall Study||12
11116894|NCT01314105|12301425|FG000|COMPLETED|Overall Study||0
11116895|NCT01314105|12301426|FG001|COMPLETED|Overall Study||0
11116896|NCT01314105|12301425|FG000|NOT COMPLETED|Overall Study||7
11116897|NCT01314105|12301426|FG001|NOT COMPLETED|Overall Study||12
11116898|NCT01314261|12301438|FG000|STARTED|Overall Study||9
11116899|NCT01314261|12301439|FG001|STARTED|Overall Study||9
11116900|NCT01314261|12301440|FG002|STARTED|Overall Study||10
11116901|NCT01314261|12301441|FG003|STARTED|Overall Study||9
11116902|NCT01314261|12301438|FG000|Discontinued ABT-267 or Placebo|Overall Study||1
11116903|NCT01314261|12301439|FG001|Discontinued ABT-267 or Placebo|Overall Study||0
11116904|NCT01314261|12301440|FG002|Discontinued ABT-267 or Placebo|Overall Study||1
11116905|NCT01314261|12301441|FG003|Discontinued ABT-267 or Placebo|Overall Study||0
11116906|NCT01314261|12301438|FG000|Discontinued pegIFN/RBV|Overall Study||1
11116907|NCT01314261|12301439|FG001|Discontinued pegIFN/RBV|Overall Study||4
11116908|NCT01314261|12301440|FG002|Discontinued pegIFN/RBV|Overall Study||5
11116909|NCT01314261|12301441|FG003|Discontinued pegIFN/RBV|Overall Study||1
11116910|NCT01314261|12301438|FG000|COMPLETED|Overall Study||7
11116911|NCT01314261|12301439|FG001|COMPLETED|Overall Study||5
11116912|NCT01314261|12301440|FG002|COMPLETED|Overall Study||7
11116913|NCT01314261|12301441|FG003|COMPLETED|Overall Study||6
11116914|NCT01314261|12301438|FG000|NOT COMPLETED|Overall Study||2
11116915|NCT01314261|12301439|FG001|NOT COMPLETED|Overall Study||4
11116916|NCT01314261|12301440|FG002|NOT COMPLETED|Overall Study||3
11116917|NCT01314261|12301441|FG003|NOT COMPLETED|Overall Study||3
11116918|NCT01314417|12301451|FG000|STARTED|Overall Study||2
11116919|NCT01314417|12301451|FG000|COMPLETED|Overall Study||2
11116920|NCT01314417|12301451|FG000|NOT COMPLETED|Overall Study||0
11116921|NCT01314443|12301459|FG000|STARTED|Overall Study||18
11116922|NCT01314443|12301460|FG001|STARTED|Overall Study||19
11116923|NCT01314443|12301461|FG002|STARTED|Overall Study||15
11116924|NCT01314443|12301462|FG003|STARTED|Overall Study||15
11116925|NCT01314443|12301459|FG000|COMPLETED|Overall Study||14
11116926|NCT01314443|12301460|FG001|COMPLETED|Overall Study||16
11116927|NCT01314443|12301461|FG002|COMPLETED|Overall Study||13
11116928|NCT01314443|12301462|FG003|COMPLETED|Overall Study||13
11116929|NCT01314443|12301459|FG000|NOT COMPLETED|Overall Study||4
11116930|NCT01314443|12301460|FG001|NOT COMPLETED|Overall Study||3
11116931|NCT01314443|12301461|FG002|NOT COMPLETED|Overall Study||2
11116932|NCT01314443|12301462|FG003|NOT COMPLETED|Overall Study||2
11233686|NCT02039856|12425333|FG000|Baseline Completed -Providers/Staff|Overall Study||194
11233687|NCT02039856|12425334|FG001|Baseline Completed -Providers/Staff|Overall Study||94
11233688|NCT02039856|12425333|FG000|Total Baseline Completed|Overall Study||1147
11233689|NCT02039856|12425334|FG001|Total Baseline Completed|Overall Study||536
11233690|NCT02039856|12425333|FG000|12-month Started-patients|Overall Study||953
11233691|NCT02039856|12425334|FG001|12-month Started-patients|Overall Study||442
11233692|NCT02039856|12425333|FG000|12-month Completed- Patients|Overall Study||580
11233693|NCT02039856|12425334|FG001|12-month Completed- Patients|Overall Study||241
11233694|NCT02039856|12425333|FG000|12-month Providers/Staff|Overall Study||0
11233695|NCT02039856|12425334|FG001|12-month Providers/Staff|Overall Study||0
11233696|NCT02039856|12425333|FG000|24-month Started|Overall Study||1518
11233697|NCT02039856|12425334|FG001|24-month Started|Overall Study||746
11233698|NCT02039856|12425333|FG000|24-month Started - Patients|Overall Study||953
11233699|NCT02039856|12425334|FG001|24-month Started - Patients|Overall Study||442
11233700|NCT02039856|12425333|FG000|24-month Completed - Patients|Overall Study||519
11233701|NCT02039856|12425334|FG001|24-month Completed - Patients|Overall Study||222
11233702|NCT02039856|12425333|FG000|24-month Started Providers/Staff|Overall Study||565
11233703|NCT02039856|12425334|FG001|24-month Started Providers/Staff|Overall Study||304
11233704|NCT02039856|12425333|FG000|24-month Completed Providers/Staff|Overall Study||174
11233705|NCT02039856|12425334|FG001|24-month Completed Providers/Staff|Overall Study||105
11233706|NCT02039856|12425333|FG000|Total 24-month Completed|Overall Study||693
11233707|NCT02039856|12425334|FG001|Total 24-month Completed|Overall Study||327
11233708|NCT02039856|12425333|FG000|COMPLETED|Overall Study||693
11233709|NCT02039856|12425334|FG001|COMPLETED|Overall Study||327
11233710|NCT02039856|12425333|FG000|NOT COMPLETED|Overall Study||2027
11233711|NCT02039856|12425334|FG001|NOT COMPLETED|Overall Study||853
11233712|NCT02039908|12425342|FG000|STARTED|Phase 1-Summer||129
11233713|NCT02039908|12425343|FG001|STARTED|Phase 1-Summer||138
11233714|NCT02039908|12425344|FG002|STARTED|Phase 1-Summer||0
11233715|NCT02039908|12425345|FG003|STARTED|Phase 1-Summer||0
11233716|NCT02039908|12425342|FG000|COMPLETED|Phase 1-Summer||116
11233717|NCT02039908|12425343|FG001|COMPLETED|Phase 1-Summer||132
11233718|NCT02039908|12425344|FG002|COMPLETED|Phase 1-Summer||0
11116933|NCT01314703|12301472|FG000|STARTED|Overall Study||35
11116934|NCT01314703|12301472|FG000|Signed Informed Consent|Overall Study||35
11116935|NCT01314703|12301472|FG000|Completed Screen Visit|Overall Study||33
11116936|NCT01314703|12301472|FG000|Completed Treatment Visit|Overall Study||27
11116937|NCT01314703|12301472|FG000|Completed Study|Overall Study||27
11116938|NCT01314703|12301472|FG000|Excluded Prior to Screening Baseline|Overall Study||2
11116939|NCT01314703|12301472|FG000|Non Qualified Bacterial Screening Counts|Overall Study||3
11116940|NCT01314703|12301472|FG000|Discontinued When Enrollment Completed|Overall Study||3
11116941|NCT01314703|12301472|FG000|COMPLETED|Overall Study||27
11116942|NCT01314703|12301472|FG000|NOT COMPLETED|Overall Study||8
11116943|NCT01314716|12301479|FG000|STARTED|Double-Blind Phase||136
11116944|NCT01314716|12301480|FG001|STARTED|Double-Blind Phase||138
11116945|NCT01314716|12301479|FG000|Randomized and Treated|Double-Blind Phase||135
11116946|NCT01314716|12301480|FG001|Randomized and Treated|Double-Blind Phase||137
11116947|NCT01314716|12301479|FG000|COMPLETED|Double-Blind Phase||119
11233719|NCT02039908|12425345|FG003|COMPLETED|Phase 1-Summer||0
11233720|NCT02039908|12425342|FG000|NOT COMPLETED|Phase 1-Summer||13
11233721|NCT02039908|12425343|FG001|NOT COMPLETED|Phase 1-Summer||6
11233722|NCT02039908|12425344|FG002|NOT COMPLETED|Phase 1-Summer||0
11233723|NCT02039908|12425345|FG003|NOT COMPLETED|Phase 1-Summer||0
11233724|NCT02039908|12425342|FG000|STARTED|Phase 2-School Year||0
11233725|NCT02039908|12425343|FG001|STARTED|Phase 2-School Year||0
11233726|NCT02039908|12425344|FG002|STARTED|Phase 2-School Year||121
11233727|NCT02039908|12425345|FG003|STARTED|Phase 2-School Year||124
11233728|NCT02039908|12425342|FG000|COMPLETED|Phase 2-School Year||0
11233729|NCT02039908|12425343|FG001|COMPLETED|Phase 2-School Year||0
11233730|NCT02039908|12425344|FG002|COMPLETED|Phase 2-School Year||109
11233731|NCT02039908|12425345|FG003|COMPLETED|Phase 2-School Year||116
11233732|NCT02039908|12425342|FG000|NOT COMPLETED|Phase 2-School Year||0
11233733|NCT02039908|12425343|FG001|NOT COMPLETED|Phase 2-School Year||0
11233734|NCT02039908|12425344|FG002|NOT COMPLETED|Phase 2-School Year||12
11233735|NCT02039908|12425345|FG003|NOT COMPLETED|Phase 2-School Year||8
11233736|NCT02039947|12425357|FG000|STARTED|Overall Study||76
11233737|NCT02039947|12425358|FG001|STARTED|Overall Study||16
11233738|NCT02039947|12425359|FG002|STARTED|Overall Study||16
11233739|NCT02039947|12425360|FG003|STARTED|Overall Study||17
11233740|NCT02039947|12425357|FG000|COMPLETED|Overall Study||76
11233741|NCT02039947|12425358|FG001|COMPLETED|Overall Study||16
11233742|NCT02039947|12425359|FG002|COMPLETED|Overall Study||16
11233743|NCT02039947|12425360|FG003|COMPLETED|Overall Study||17
11233744|NCT02039947|12425357|FG000|NOT COMPLETED|Overall Study||0
11233745|NCT02039947|12425358|FG001|NOT COMPLETED|Overall Study||0
11233746|NCT02039947|12425359|FG002|NOT COMPLETED|Overall Study||0
11233747|NCT02039947|12425360|FG003|NOT COMPLETED|Overall Study||0
11233748|NCT02040077|12425377|FG000|STARTED|Overall Study||27
11233749|NCT02040077|12425378|FG001|STARTED|Overall Study||24
11233750|NCT02040077|12425379|FG002|STARTED|Overall Study||25
11233751|NCT02040077|12425377|FG000|COMPLETED|Overall Study||27
11233752|NCT02040077|12425378|FG001|COMPLETED|Overall Study||24
11233753|NCT02040077|12425379|FG002|COMPLETED|Overall Study||25
11233754|NCT02040077|12425377|FG000|NOT COMPLETED|Overall Study||0
11233755|NCT02040077|12425378|FG001|NOT COMPLETED|Overall Study||0
11233756|NCT02040077|12425379|FG002|NOT COMPLETED|Overall Study||0
11233757|NCT02040090|12425390|FG000|STARTED|Overall Study||59
11233758|NCT02040090|12425391|FG001|STARTED|Overall Study||59
11233759|NCT02040090|12425390|FG000|COMPLETED|Overall Study||56
11233760|NCT02040090|12425391|FG001|COMPLETED|Overall Study||57
11233761|NCT02040090|12425390|FG000|NOT COMPLETED|Overall Study||3
11233762|NCT02040090|12425391|FG001|NOT COMPLETED|Overall Study||2
11233763|NCT02040116|12425397|FG000|STARTED|Overall Study||19
11233764|NCT02040116|12425397|FG000|COMPLETED|Overall Study||19
11233765|NCT02040116|12425397|FG000|NOT COMPLETED|Overall Study||0
11233766|NCT02040259|12425405|FG000|STARTED|Overall Study||2008
11233767|NCT02040259|12425405|FG000|COMPLETED|Overall Study||1645
11233768|NCT02040259|12425405|FG000|NOT COMPLETED|Overall Study||363
11233769|NCT02040298|12425413|FG000|STARTED|First Intervention (3 Months)||25
11233770|NCT02040298|12425414|FG001|STARTED|First Intervention (3 Months)||25
11233771|NCT02040298|12425413|FG000|COMPLETED|First Intervention (3 Months)||25
11233772|NCT02040298|12425414|FG001|COMPLETED|First Intervention (3 Months)||25
11116948|NCT01314716|12301480|FG001|COMPLETED|Double-Blind Phase||123
11116949|NCT01314716|12301479|FG000|NOT COMPLETED|Double-Blind Phase||17
11116950|NCT01314716|12301480|FG001|NOT COMPLETED|Double-Blind Phase||15
11116951|NCT01314716|12301479|FG000|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
11116952|NCT01314716|12301480|FG001|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
11116953|NCT01314716|12301479|FG000|COMPLETED|Open-Label Phase||102
11116954|NCT01314716|12301480|FG001|COMPLETED|Open-Label Phase||98
11116955|NCT01314716|12301479|FG000|NOT COMPLETED|Open-Label Phase||10
11116956|NCT01314716|12301480|FG001|NOT COMPLETED|Open-Label Phase||12
11116957|NCT01314742|12301490|FG000|STARTED|Overall Study||20
11116958|NCT01314742|12301491|FG001|STARTED|Overall Study||21
11116959|NCT01314742|12301490|FG000|COMPLETED|Overall Study||20
11116960|NCT01314742|12301491|FG001|COMPLETED|Overall Study||21
11116961|NCT01314742|12301490|FG000|NOT COMPLETED|Overall Study||0
11116962|NCT01314742|12301491|FG001|NOT COMPLETED|Overall Study||0
11116963|NCT01314872|12301510|FG000|STARTED|Treatment Period 1||141
11116964|NCT01314872|12301511|FG001|STARTED|Treatment Period 1||144
11116965|NCT01314872|12301512|FG002|STARTED|Treatment Period 1||134
11116966|NCT01314872|12301513|FG003|STARTED|Treatment Period 1||150
11116967|NCT01314872|12301514|FG004|STARTED|Treatment Period 1||149
11116968|NCT01314872|12301515|FG005|STARTED|Treatment Period 1||135
11116969|NCT01314872|12301516|FG006|STARTED|Treatment Period 1||134
11116970|NCT01314872|12301517|FG007|STARTED|Treatment Period 1||64
11116971|NCT01314872|12301518|FG008|STARTED|Treatment Period 1||112
11116972|NCT01314872|12301519|FG009|STARTED|Treatment Period 1||122
11116973|NCT01314872|12301520|FG010|STARTED|Treatment Period 1||110
11116974|NCT01314872|12301521|FG011|STARTED|Treatment Period 1||0
11116975|NCT01314872|12301522|FG012|STARTED|Treatment Period 1||0
11116976|NCT01314872|12301523|FG013|STARTED|Treatment Period 1||0
11116977|NCT01314872|12301524|FG014|STARTED|Treatment Period 1||0
11116978|NCT01314872|12301510|FG000|COMPLETED|Treatment Period 1||131
11116979|NCT01314872|12301511|FG001|COMPLETED|Treatment Period 1||138
11116980|NCT01314872|12301512|FG002|COMPLETED|Treatment Period 1||128
11116981|NCT01314872|12301513|FG003|COMPLETED|Treatment Period 1||143
11116982|NCT01314872|12301514|FG004|COMPLETED|Treatment Period 1||142
11116983|NCT01314872|12301515|FG005|COMPLETED|Treatment Period 1||128
11116984|NCT01314872|12301516|FG006|COMPLETED|Treatment Period 1||126
11116985|NCT01314872|12301517|FG007|COMPLETED|Treatment Period 1||57
11116986|NCT01314872|12301518|FG008|COMPLETED|Treatment Period 1||106
11116987|NCT01314872|12301519|FG009|COMPLETED|Treatment Period 1||118
11116988|NCT01314872|12301520|FG010|COMPLETED|Treatment Period 1||107
11116989|NCT01314872|12301521|FG011|COMPLETED|Treatment Period 1||0
11116990|NCT01314872|12301522|FG012|COMPLETED|Treatment Period 1||0
11116991|NCT01314872|12301523|FG013|COMPLETED|Treatment Period 1||0
11116992|NCT01314872|12301524|FG014|COMPLETED|Treatment Period 1||0
11116993|NCT01314872|12301510|FG000|NOT COMPLETED|Treatment Period 1||10
11116994|NCT01314872|12301511|FG001|NOT COMPLETED|Treatment Period 1||6
11116995|NCT01314872|12301512|FG002|NOT COMPLETED|Treatment Period 1||6
11116996|NCT01314872|12301513|FG003|NOT COMPLETED|Treatment Period 1||7
11116997|NCT01314872|12301514|FG004|NOT COMPLETED|Treatment Period 1||7
11233773|NCT02040298|12425413|FG000|NOT COMPLETED|First Intervention (3 Months)||0
11233774|NCT02040298|12425414|FG001|NOT COMPLETED|First Intervention (3 Months)||0
11233775|NCT02040298|12425413|FG000|STARTED|Second Intervention (2 Months)||25
11233776|NCT02040298|12425414|FG001|STARTED|Second Intervention (2 Months)||25
11233777|NCT02040298|12425413|FG000|COMPLETED|Second Intervention (2 Months)||25
11233778|NCT02040298|12425414|FG001|COMPLETED|Second Intervention (2 Months)||25
11233779|NCT02040298|12425413|FG000|NOT COMPLETED|Second Intervention (2 Months)||0
11233780|NCT02040298|12425414|FG001|NOT COMPLETED|Second Intervention (2 Months)||0
11233781|NCT02040428|12425428|FG000|STARTED|Overall Study||75
11233782|NCT02040428|12425429|FG001|STARTED|Overall Study||81
11233783|NCT02040428|12425428|FG000|Intent to Treat (Randomized Subjects)|Overall Study||76
11233784|NCT02040428|12425429|FG001|Intent to Treat (Randomized Subjects)|Overall Study||80
11233785|NCT02040428|12425428|FG000|COMPLETED|Overall Study||70
11233786|NCT02040428|12425429|FG001|COMPLETED|Overall Study||77
11233787|NCT02040428|12425428|FG000|NOT COMPLETED|Overall Study||5
11233788|NCT02040428|12425429|FG001|NOT COMPLETED|Overall Study||4
11233789|NCT02040532|12425435|FG000|STARTED|Overall Study||32
11233790|NCT02040532|12425435|FG000|Received at Least One Dose of Medication|Overall Study||26
11233791|NCT02040532|12425435|FG000|COMPLETED|Overall Study||20
11233792|NCT02040532|12425435|FG000|NOT COMPLETED|Overall Study||12
11233793|NCT02040623|12425442|FG000|STARTED|Overall Study||11
11233794|NCT02040623|12425443|FG001|STARTED|Overall Study||12
11233795|NCT02040623|12425444|FG002|STARTED|Overall Study||12
11233796|NCT02040623|12425442|FG000|COMPLETED|Overall Study||7
11233797|NCT02040623|12425443|FG001|COMPLETED|Overall Study||6
11233798|NCT02040623|12425444|FG002|COMPLETED|Overall Study||10
11233799|NCT02040623|12425442|FG000|NOT COMPLETED|Overall Study||4
11233800|NCT02040623|12425443|FG001|NOT COMPLETED|Overall Study||6
11233801|NCT02040623|12425444|FG002|NOT COMPLETED|Overall Study||2
11233802|NCT02040766|12425457|FG000|STARTED|Overall Study||127
11116998|NCT01314872|12301515|FG005|NOT COMPLETED|Treatment Period 1||7
11116999|NCT01314872|12301516|FG006|NOT COMPLETED|Treatment Period 1||8
11117000|NCT01314872|12301517|FG007|NOT COMPLETED|Treatment Period 1||7
11117001|NCT01314872|12301518|FG008|NOT COMPLETED|Treatment Period 1||6
11117002|NCT01314872|12301519|FG009|NOT COMPLETED|Treatment Period 1||4
11117003|NCT01314872|12301520|FG010|NOT COMPLETED|Treatment Period 1||3
11117004|NCT01314872|12301521|FG011|NOT COMPLETED|Treatment Period 1||0
11117005|NCT01314872|12301522|FG012|NOT COMPLETED|Treatment Period 1||0
11117006|NCT01314872|12301523|FG013|NOT COMPLETED|Treatment Period 1||0
11117007|NCT01314872|12301524|FG014|NOT COMPLETED|Treatment Period 1||0
11117008|NCT01314872|12301510|FG000|STARTED|Period 2||0
11117009|NCT01314872|12301511|FG001|STARTED|Period 2||0
11117010|NCT01314872|12301512|FG002|STARTED|Period 2||0
11117011|NCT01314872|12301513|FG003|STARTED|Period 2||0
11117012|NCT01314872|12301514|FG004|STARTED|Period 2||0
11117013|NCT01314872|12301515|FG005|STARTED|Period 2||0
11117014|NCT01314872|12301516|FG006|STARTED|Period 2||0
11117015|NCT01314872|12301517|FG007|STARTED|Period 2||0
11117016|NCT01314872|12301518|FG008|STARTED|Period 2||0
11117017|NCT01314872|12301519|FG009|STARTED|Period 2||0
11117018|NCT01314872|12301520|FG010|STARTED|Period 2||0
11117019|NCT01314872|12301521|FG011|STARTED|Period 2||223
11117020|NCT01314872|12301522|FG012|STARTED|Period 2||248
11117021|NCT01314872|12301523|FG013|STARTED|Period 2||240
11117022|NCT01314872|12301524|FG014|STARTED|Period 2||134
11233803|NCT02040766|12425458|FG001|STARTED|Overall Study||126
11233804|NCT02040766|12425459|FG002|STARTED|Overall Study||125
11233805|NCT02040766|12425460|FG003|STARTED|Overall Study||125
11233806|NCT02040766|12425461|FG004|STARTED|Overall Study||125
11117023|NCT01314872|12301510|FG000|COMPLETED|Period 2||0
11117024|NCT01314872|12301511|FG001|COMPLETED|Period 2||0
11117025|NCT01314872|12301512|FG002|COMPLETED|Period 2||0
11117026|NCT01314872|12301513|FG003|COMPLETED|Period 2||0
11117027|NCT01314872|12301514|FG004|COMPLETED|Period 2||0
11117028|NCT01314872|12301515|FG005|COMPLETED|Period 2||0
11117029|NCT01314872|12301516|FG006|COMPLETED|Period 2||0
11117030|NCT01314872|12301517|FG007|COMPLETED|Period 2||0
11117031|NCT01314872|12301518|FG008|COMPLETED|Period 2||0
11117032|NCT01314872|12301519|FG009|COMPLETED|Period 2||0
11117033|NCT01314872|12301520|FG010|COMPLETED|Period 2||0
11117034|NCT01314872|12301521|FG011|COMPLETED|Period 2||175
11117035|NCT01314872|12301522|FG012|COMPLETED|Period 2||188
11117036|NCT01314872|12301523|FG013|COMPLETED|Period 2||187
11117037|NCT01314872|12301524|FG014|COMPLETED|Period 2||110
11117038|NCT01314872|12301510|FG000|NOT COMPLETED|Period 2||0
11117039|NCT01314872|12301511|FG001|NOT COMPLETED|Period 2||0
11117040|NCT01314872|12301512|FG002|NOT COMPLETED|Period 2||0
11117041|NCT01314872|12301513|FG003|NOT COMPLETED|Period 2||0
11117042|NCT01314872|12301514|FG004|NOT COMPLETED|Period 2||0
11117043|NCT01314872|12301515|FG005|NOT COMPLETED|Period 2||0
11117044|NCT01314872|12301516|FG006|NOT COMPLETED|Period 2||0
11117045|NCT01314872|12301517|FG007|NOT COMPLETED|Period 2||0
11117046|NCT01314872|12301518|FG008|NOT COMPLETED|Period 2||0
11117047|NCT01314872|12301519|FG009|NOT COMPLETED|Period 2||0
11117048|NCT01314872|12301520|FG010|NOT COMPLETED|Period 2||0
11117049|NCT01314872|12301521|FG011|NOT COMPLETED|Period 2||48
11117050|NCT01314872|12301522|FG012|NOT COMPLETED|Period 2||60
11117051|NCT01314872|12301523|FG013|NOT COMPLETED|Period 2||53
11117052|NCT01314872|12301524|FG014|NOT COMPLETED|Period 2||24
11117053|NCT01314911|12301558|FG000|STARTED|Overall Study||278
11117054|NCT01314911|12301559|FG001|STARTED|Overall Study||280
11117055|NCT01314911|12301558|FG000|COMPLETED|Overall Study||273
11117056|NCT01314911|12301559|FG001|COMPLETED|Overall Study||274
11117057|NCT01314911|12301558|FG000|NOT COMPLETED|Overall Study||5
11117058|NCT01314911|12301559|FG001|NOT COMPLETED|Overall Study||6
11117059|NCT01314963|12301565|FG000|STARTED|Overall Study||50
11117060|NCT01314963|12301565|FG000|COMPLETED|Overall Study||50
11117061|NCT01314963|12301565|FG000|NOT COMPLETED|Overall Study||0
11117062|NCT01315002|12301571|FG000|STARTED|Overall Study||61
11117063|NCT01315002|12301572|FG001|STARTED|Overall Study||60
11117064|NCT01315002|12301571|FG000|COMPLETED|Overall Study||56
11117065|NCT01315002|12301572|FG001|COMPLETED|Overall Study||55
11117066|NCT01315002|12301571|FG000|NOT COMPLETED|Overall Study||5
11117067|NCT01315002|12301572|FG001|NOT COMPLETED|Overall Study||5
11117068|NCT01315028|12301580|FG000|STARTED|Overall Study||10
11117069|NCT01315028|12301581|FG001|STARTED|Overall Study||10
11117070|NCT01315028|12301580|FG000|COMPLETED|Overall Study||9
11117071|NCT01315028|12301581|FG001|COMPLETED|Overall Study||9
11117072|NCT01315028|12301580|FG000|NOT COMPLETED|Overall Study||1
11117073|NCT01315028|12301581|FG001|NOT COMPLETED|Overall Study||1
11117074|NCT01315132|12301587|FG000|STARTED|Overall Study||47
11117075|NCT01315132|12301587|FG000|COMPLETED|Overall Study||46
11117076|NCT01315132|12301587|FG000|NOT COMPLETED|Overall Study||1
11117077|NCT01315145|12301593|FG000|STARTED|Overall Study||122
11117078|NCT01315145|12301594|FG001|STARTED|Overall Study||16
11117079|NCT01315145|12301593|FG000|COMPLETED|Overall Study||105
11117080|NCT01315145|12301594|FG001|COMPLETED|Overall Study||11
11117081|NCT01315145|12301593|FG000|NOT COMPLETED|Overall Study||17
11117082|NCT01315145|12301594|FG001|NOT COMPLETED|Overall Study||5
11117083|NCT01315158|12301602|FG000|STARTED|Overall Study||17
11117084|NCT01315158|12301603|FG001|STARTED|Overall Study||19
11117085|NCT01315158|12301602|FG000|COMPLETED|Overall Study||17
11117086|NCT01315158|12301603|FG001|COMPLETED|Overall Study||19
11117087|NCT01315158|12301602|FG000|NOT COMPLETED|Overall Study||0
11117088|NCT01315158|12301603|FG001|NOT COMPLETED|Overall Study||0
11117089|NCT01315236|12301611|FG000|STARTED|Double-blind Phase||44
11117090|NCT01315236|12301612|FG001|STARTED|Double-blind Phase||45
11117091|NCT01315236|12301611|FG000|COMPLETED|Double-blind Phase||40
11117092|NCT01315236|12301612|FG001|COMPLETED|Double-blind Phase||45
11117093|NCT01315236|12301611|FG000|NOT COMPLETED|Double-blind Phase||4
11117094|NCT01315236|12301612|FG001|NOT COMPLETED|Double-blind Phase||0
11117095|NCT01315236|12301611|FG000|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35
11117096|NCT01315236|12301612|FG001|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43
11117097|NCT01315236|12301611|FG000|COMPLETED|Open-label Phase||34
11117098|NCT01315236|12301612|FG001|COMPLETED|Open-label Phase||41
11117099|NCT01315236|12301611|FG000|NOT COMPLETED|Open-label Phase||1
11117100|NCT01315236|12301612|FG001|NOT COMPLETED|Open-label Phase||2
11117101|NCT01315236|12301611|FG000|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27
11117102|NCT01315236|12301612|FG001|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32
11117103|NCT01315236|12301611|FG000|COMPLETED|12-Month Follow-up Period||26
11117104|NCT01315236|12301612|FG001|COMPLETED|12-Month Follow-up Period||31
11117105|NCT01315236|12301611|FG000|NOT COMPLETED|12-Month Follow-up Period||1
11117106|NCT01315236|12301612|FG001|NOT COMPLETED|12-Month Follow-up Period||1
11117107|NCT01315249|12301622|FG000|STARTED|Overall Study||259
11117108|NCT01315249|12301623|FG001|STARTED|Overall Study||264
11117109|NCT01315249|12301622|FG000|COMPLETED|Overall Study||215
11117110|NCT01315249|12301623|FG001|COMPLETED|Overall Study||217
11117111|NCT01315249|12301622|FG000|NOT COMPLETED|Overall Study||44
11117112|NCT01315249|12301623|FG001|NOT COMPLETED|Overall Study||47
11117113|NCT01315574|12301631|FG000|STARTED|Overall Study||7
11117114|NCT01315574|12301632|FG001|STARTED|Overall Study||7
11117115|NCT01315574|12301631|FG000|COMPLETED|Overall Study||7
11117116|NCT01315574|12301632|FG001|COMPLETED|Overall Study||7
11117117|NCT01315574|12301631|FG000|NOT COMPLETED|Overall Study||0
11117118|NCT01315574|12301632|FG001|NOT COMPLETED|Overall Study||0
11117119|NCT01315665|12301640|FG000|STARTED|Overall Study||10
11117120|NCT01315665|12301641|FG001|STARTED|Overall Study||5
11117121|NCT01315665|12301640|FG000|COMPLETED|Overall Study||10
11117122|NCT01315665|12301641|FG001|COMPLETED|Overall Study||5
11117123|NCT01315665|12301640|FG000|NOT COMPLETED|Overall Study||0
11117124|NCT01315665|12301641|FG001|NOT COMPLETED|Overall Study||0
11117125|NCT01315678|12301651|FG000|STARTED|Overall Study||148
11117126|NCT01315678|12301652|FG001|STARTED|Overall Study||146
11117127|NCT01315678|12301651|FG000|COMPLETED|Overall Study||134
11117128|NCT01315678|12301652|FG001|COMPLETED|Overall Study||140
11117129|NCT01315678|12301651|FG000|NOT COMPLETED|Overall Study||14
11117130|NCT01315678|12301652|FG001|NOT COMPLETED|Overall Study||6
11117131|NCT01315847|12301662|FG000|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
11117132|NCT01315847|12301663|FG001|STARTED|Part I, Period 1||0
11117133|NCT01315847|12301662|FG000|Received Telcagepant|Part I, Period 1||5
11117134|NCT01315847|12301663|FG001|Received Telcagepant|Part I, Period 1||0
11117135|NCT01315847|12301662|FG000|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
11117136|NCT01315847|12301663|FG001|Received [11C]MK-4232|Part I, Period 1||0
11117137|NCT01315847|12301662|FG000|COMPLETED|Part I, Period 1||2
11117138|NCT01315847|12301663|FG001|COMPLETED|Part I, Period 1||0
11117139|NCT01315847|12301662|FG000|NOT COMPLETED|Part I, Period 1||3
11117140|NCT01315847|12301663|FG001|NOT COMPLETED|Part I, Period 1||0
11117141|NCT01315847|12301662|FG000|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
11117142|NCT01315847|12301663|FG001|STARTED|Part I, Period 2||0
11117143|NCT01315847|12301662|FG000|Received Telcagepant|Part I, Period 2||3
11117144|NCT01315847|12301663|FG001|Received Telcagepant|Part I, Period 2||0
11117145|NCT01315847|12301662|FG000|Received [11C]MK-4232|Part I, Period 2||3
11117146|NCT01315847|12301663|FG001|Received [11C]MK-4232|Part I, Period 2||0
11117147|NCT01315847|12301662|FG000|COMPLETED|Part I, Period 2||3
11117148|NCT01315847|12301663|FG001|COMPLETED|Part I, Period 2||0
11117149|NCT01315847|12301662|FG000|NOT COMPLETED|Part I, Period 2||0
11117150|NCT01315847|12301663|FG001|NOT COMPLETED|Part I, Period 2||0
11117151|NCT01315847|12301662|FG000|STARTED|Part III, Period 1||0
11117152|NCT01315847|12301663|FG001|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
11117153|NCT01315847|12301662|FG000|Received Telcagepant|Part III, Period 1||0
11117154|NCT01315847|12301663|FG001|Received Telcagepant|Part III, Period 1||4
11117155|NCT01315847|12301662|FG000|Received [11C]MK-4232|Part III, Period 1||0
11117156|NCT01315847|12301663|FG001|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
11117157|NCT01315847|12301662|FG000|COMPLETED|Part III, Period 1||0
11117158|NCT01315847|12301663|FG001|COMPLETED|Part III, Period 1||3
11117159|NCT01315847|12301662|FG000|NOT COMPLETED|Part III, Period 1||0
11117160|NCT01315847|12301663|FG001|NOT COMPLETED|Part III, Period 1||1
11117161|NCT01315847|12301662|FG000|STARTED|Part III, Period 2||0
11117162|NCT01315847|12301663|FG001|STARTED|Part III, Period 2||3
11117163|NCT01315847|12301662|FG000|Received Telcagepant|Part III, Period 2||0
11117164|NCT01315847|12301663|FG001|Received Telcagepant|Part III, Period 2||3
11117165|NCT01315847|12301662|FG000|Received [11C]MK-4232|Part III, Period 2||0
11117166|NCT01315847|12301663|FG001|Received [11C]MK-4232|Part III, Period 2||3
11117167|NCT01315847|12301662|FG000|COMPLETED|Part III, Period 2||0
11117168|NCT01315847|12301663|FG001|COMPLETED|Part III, Period 2||3
11117169|NCT01315847|12301662|FG000|NOT COMPLETED|Part III, Period 2||0
11117170|NCT01315847|12301663|FG001|NOT COMPLETED|Part III, Period 2||0
11117171|NCT01316042|12301671|FG000|STARTED|Overall Study||2
11117172|NCT01316042|12301672|FG001|STARTED|Overall Study||2
11117173|NCT01316042|12301671|FG000|COMPLETED|Overall Study||2
11117174|NCT01316042|12301672|FG001|COMPLETED|Overall Study||1
11233807|NCT02040766|12425457|FG000|COMPLETED|Overall Study||109
11117175|NCT01316042|12301671|FG000|NOT COMPLETED|Overall Study||0
11117176|NCT01316042|12301672|FG001|NOT COMPLETED|Overall Study||1
11117177|NCT01316055|12301681|FG000|STARTED|Overall Study||13
11117178|NCT01316055|12301682|FG001|STARTED|Overall Study||17
11117179|NCT01316055|12301683|FG002|STARTED|Overall Study||12
11117180|NCT01316055|12301681|FG000|COMPLETED|Overall Study||12
11117181|NCT01316055|12301682|FG001|COMPLETED|Overall Study||17
11117182|NCT01316055|12301683|FG002|COMPLETED|Overall Study||12
11117183|NCT01316055|12301681|FG000|NOT COMPLETED|Overall Study||1
11117184|NCT01316055|12301682|FG001|NOT COMPLETED|Overall Study||0
11117185|NCT01316055|12301683|FG002|NOT COMPLETED|Overall Study||0
11117186|NCT01316211|12301696|FG000|STARTED|Overall Study||116
11117187|NCT01316211|12301697|FG001|STARTED|Overall Study||123
11117188|NCT01316211|12301696|FG000|COMPLETED|Overall Study||105
11117189|NCT01316211|12301697|FG001|COMPLETED|Overall Study||111
11117190|NCT01316211|12301696|FG000|NOT COMPLETED|Overall Study||11
11117191|NCT01316211|12301697|FG001|NOT COMPLETED|Overall Study||12
11117192|NCT01316224|12301703|FG000|STARTED|Overall Study||52
11117193|NCT01316224|12301703|FG000|Completed Visit 1 to Dermatologist|Overall Study||52
11117194|NCT01316224|12301703|FG000|Completed Visit 1 to Rheumatologist|Overall Study||49
11117195|NCT01316224|12301703|FG000|Completed Visit 2 to Dermatologist|Overall Study||51
11117196|NCT01316224|12301703|FG000|Completed Visit 3 to Dermatologist|Overall Study||48
11117197|NCT01316224|12301703|FG000|Completed Visit 3 to Rheumatologist|Overall Study||39
11117198|NCT01316224|12301703|FG000|Completed Visit 4 to Dermatologist|Overall Study||42
11117199|NCT01316224|12301703|FG000|Completed Visit 4 to Rheumatologist|Overall Study||28
11117200|NCT01316224|12301703|FG000|COMPLETED|Overall Study||42
11117201|NCT01316224|12301703|FG000|NOT COMPLETED|Overall Study||10
11117202|NCT01316263|12301709|FG000|STARTED|Overall Study||7
11117203|NCT01316263|12301710|FG001|STARTED|Overall Study||14
11117204|NCT01316263|12301709|FG000|Received Any Study Drug|Overall Study||7
11117205|NCT01316263|12301710|FG001|Received Any Study Drug|Overall Study||14
11117206|NCT01316263|12301709|FG000|COMPLETED|Overall Study||7
11117207|NCT01316263|12301710|FG001|COMPLETED|Overall Study||14
11117208|NCT01316263|12301709|FG000|NOT COMPLETED|Overall Study||0
11117209|NCT01316263|12301710|FG001|NOT COMPLETED|Overall Study||0
11117210|NCT01316276|12301718|FG000|STARTED|Overall Study||206
11117211|NCT01316276|12301718|FG000|COMPLETED|Overall Study||139
11117212|NCT01316276|12301718|FG000|NOT COMPLETED|Overall Study||67
11117213|NCT01316302|12301725|FG000|STARTED|Overall Study||30
11117214|NCT01316302|12301726|FG001|STARTED|Overall Study||33
11117215|NCT01316302|12301725|FG000|COMPLETED|Overall Study||20
11117216|NCT01316302|12301726|FG001|COMPLETED|Overall Study||22
11117217|NCT01316302|12301725|FG000|NOT COMPLETED|Overall Study||10
11117218|NCT01316302|12301726|FG001|NOT COMPLETED|Overall Study||11
11117219|NCT01316315|12301736|FG000|STARTED|Sequence 1||7
11117220|NCT01316315|12301737|FG001|STARTED|Sequence 1||7
11117221|NCT01316315|12301736|FG000|COMPLETED|Sequence 1||7
11117222|NCT01316315|12301737|FG001|COMPLETED|Sequence 1||7
11117223|NCT01316315|12301736|FG000|NOT COMPLETED|Sequence 1||0
11117224|NCT01316315|12301737|FG001|NOT COMPLETED|Sequence 1||0
11117225|NCT01316315|12301736|FG000|STARTED|Sequence 2||7
11117226|NCT01316315|12301737|FG001|STARTED|Sequence 2||7
11117227|NCT01316315|12301736|FG000|COMPLETED|Sequence 2||7
11117228|NCT01316315|12301737|FG001|COMPLETED|Sequence 2||7
11117229|NCT01316315|12301736|FG000|NOT COMPLETED|Sequence 2||0
11117230|NCT01316315|12301737|FG001|NOT COMPLETED|Sequence 2||0
11117231|NCT01316341|12301748|FG000|STARTED|Overall Study||6
11117232|NCT01316341|12301749|FG001|STARTED|Overall Study||9
11117233|NCT01316341|12301750|FG002|STARTED|Overall Study||9
11117234|NCT01316341|12301748|FG000|COMPLETED|Overall Study||6
11117235|NCT01316341|12301749|FG001|COMPLETED|Overall Study||9
11117236|NCT01316341|12301750|FG002|COMPLETED|Overall Study||9
11117237|NCT01316341|12301748|FG000|NOT COMPLETED|Overall Study||0
11117238|NCT01316341|12301749|FG001|NOT COMPLETED|Overall Study||0
11117239|NCT01316341|12301750|FG002|NOT COMPLETED|Overall Study||0
11117240|NCT01316380|12301770|FG000|STARTED|Overall Study||156
11117241|NCT01316380|12301771|FG001|STARTED|Overall Study||154
11117242|NCT01316380|12301772|FG002|STARTED|Overall Study||155
11117243|NCT01316380|12301770|FG000|COMPLETED|Overall Study||154
11117244|NCT01316380|12301771|FG001|COMPLETED|Overall Study||149
11117245|NCT01316380|12301772|FG002|COMPLETED|Overall Study||152
11117246|NCT01316380|12301770|FG000|NOT COMPLETED|Overall Study||2
11117247|NCT01316380|12301771|FG001|NOT COMPLETED|Overall Study||5
11117248|NCT01316380|12301772|FG002|NOT COMPLETED|Overall Study||3
11117249|NCT01316419|12301780|FG000|STARTED|Overall Study||2089
11117250|NCT01316419|12301780|FG000|COMPLETED|Overall Study||1824
11117251|NCT01316419|12301780|FG000|NOT COMPLETED|Overall Study||265
11117252|NCT01316510|12301786|FG000|STARTED|Overall Study||12
11117253|NCT01316510|12301787|FG001|STARTED|Overall Study||12
11117254|NCT01316510|12301786|FG000|COMPLETED|Overall Study||12
11117255|NCT01316510|12301787|FG001|COMPLETED|Overall Study||12
11117256|NCT01316510|12301786|FG000|NOT COMPLETED|Overall Study||0
11117257|NCT01316510|12301787|FG001|NOT COMPLETED|Overall Study||0
11117258|NCT01316575|12301795|FG000|STARTED|Overall Study||20
11117259|NCT01316575|12301796|FG001|STARTED|Overall Study||20
11117260|NCT01316575|12301795|FG000|COMPLETED|Overall Study||18
11117261|NCT01316575|12301796|FG001|COMPLETED|Overall Study||19
11117262|NCT01316575|12301795|FG000|NOT COMPLETED|Overall Study||2
11117263|NCT01316575|12301796|FG001|NOT COMPLETED|Overall Study||1
11117264|NCT01316614|12301802|FG000|STARTED|Overall Study||137
11117265|NCT01316614|12301802|FG000|COMPLETED|Overall Study||100
11117266|NCT01316614|12301802|FG000|NOT COMPLETED|Overall Study||37
11117267|NCT01316692|12301807|FG000|STARTED|Overall Study||12
11117268|NCT01316692|12301807|FG000|COMPLETED|Overall Study||0
11117269|NCT01316692|12301807|FG000|NOT COMPLETED|Overall Study||12
11117270|NCT01316770|12301811|FG000|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
11117271|NCT01316770|12301812|FG001|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
11117272|NCT01316770|12301811|FG000|COMPLETED|Overall Study||9
11117273|NCT01316770|12301812|FG001|COMPLETED|Overall Study||9
11117274|NCT01316770|12301811|FG000|NOT COMPLETED|Overall Study||0
11117275|NCT01316770|12301812|FG001|NOT COMPLETED|Overall Study||0
11117276|NCT01316887|12301825|FG000|STARTED|Overall Study||109
11117277|NCT01316887|12301826|FG001|STARTED|Overall Study||227
11117278|NCT01316887|12301827|FG002|STARTED|Overall Study||226
11117279|NCT01316887|12301825|FG000|COMPLETED|Overall Study||66
11117280|NCT01316887|12301826|FG001|COMPLETED|Overall Study||133
11117281|NCT01316887|12301827|FG002|COMPLETED|Overall Study||143
11117282|NCT01316887|12301825|FG000|NOT COMPLETED|Overall Study||43
11117283|NCT01316887|12301826|FG001|NOT COMPLETED|Overall Study||94
11117284|NCT01316887|12301827|FG002|NOT COMPLETED|Overall Study||83
11117285|NCT01316900|12301840|FG000|STARTED|Overall Study||209
11117286|NCT01316900|12301841|FG001|STARTED|Overall Study||212
11117287|NCT01316900|12301842|FG002|STARTED|Overall Study||214
11117288|NCT01316900|12301843|FG003|STARTED|Overall Study||208
11117289|NCT01316900|12301840|FG000|COMPLETED|Overall Study||165
11117290|NCT01316900|12301841|FG001|COMPLETED|Overall Study||181
11117291|NCT01316900|12301842|FG002|COMPLETED|Overall Study||173
11117292|NCT01316900|12301843|FG003|COMPLETED|Overall Study||177
11117293|NCT01316900|12301840|FG000|NOT COMPLETED|Overall Study||44
11117294|NCT01316900|12301841|FG001|NOT COMPLETED|Overall Study||31
11117295|NCT01316900|12301842|FG002|NOT COMPLETED|Overall Study||41
11117296|NCT01316900|12301843|FG003|NOT COMPLETED|Overall Study||31
11117297|NCT01316913|12301857|FG000|STARTED|Overall Study||222
11117298|NCT01316913|12301858|FG001|STARTED|Overall Study||217
11117299|NCT01316913|12301859|FG002|STARTED|Overall Study||215
11117300|NCT01316913|12301860|FG003|STARTED|Overall Study||215
11117301|NCT01316913|12301857|FG000|COMPLETED|Overall Study||165
11117302|NCT01316913|12301858|FG001|COMPLETED|Overall Study||163
11117303|NCT01316913|12301859|FG002|COMPLETED|Overall Study||166
11117304|NCT01316913|12301860|FG003|COMPLETED|Overall Study||176
11117305|NCT01316913|12301857|FG000|NOT COMPLETED|Overall Study||57
11117306|NCT01316913|12301858|FG001|NOT COMPLETED|Overall Study||54
11117307|NCT01316913|12301859|FG002|NOT COMPLETED|Overall Study||49
11117308|NCT01316913|12301860|FG003|NOT COMPLETED|Overall Study||39
11117309|NCT01316926|12301871|FG000|STARTED|Period 1||30
11117310|NCT01316926|12301872|FG001|STARTED|Period 1||30
11117311|NCT01316926|12301871|FG000|COMPLETED|Period 1||30
11117312|NCT01316926|12301872|FG001|COMPLETED|Period 1||30
11117313|NCT01316926|12301871|FG000|NOT COMPLETED|Period 1||0
11117314|NCT01316926|12301872|FG001|NOT COMPLETED|Period 1||0
11117315|NCT01316926|12301871|FG000|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
11117316|NCT01316926|12301872|FG001|STARTED|Period 2||30
11117317|NCT01316926|12301871|FG000|COMPLETED|Period 2||29
11117318|NCT01316926|12301872|FG001|COMPLETED|Period 2||30
11117319|NCT01316926|12301871|FG000|NOT COMPLETED|Period 2||0
11117320|NCT01316926|12301872|FG001|NOT COMPLETED|Period 2||0
11117321|NCT01316939|12301882|FG000|STARTED|Overall Study||76
11117322|NCT01316939|12301883|FG001|STARTED|Overall Study||77
11117323|NCT01316939|12301884|FG002|STARTED|Overall Study||76
11117324|NCT01316939|12301882|FG000|COMPLETED|Overall Study||13
11117325|NCT01316939|12301883|FG001|COMPLETED|Overall Study||9
11117326|NCT01316939|12301884|FG002|COMPLETED|Overall Study||7
11117327|NCT01316939|12301882|FG000|NOT COMPLETED|Overall Study||63
11117328|NCT01316939|12301883|FG001|NOT COMPLETED|Overall Study||68
11117329|NCT01316939|12301884|FG002|NOT COMPLETED|Overall Study||69
11117330|NCT01317004|12301894|FG000|STARTED|Overall Study||51
11117331|NCT01317004|12301895|FG001|STARTED|Overall Study||14
11117332|NCT01317004|12301894|FG000|Safety Set|Overall Study||50
11117333|NCT01317004|12301895|FG001|Safety Set|Overall Study||11
11117334|NCT01317004|12301894|FG000|COMPLETED|Overall Study||47
11117335|NCT01317004|12301895|FG001|COMPLETED|Overall Study||5
11117336|NCT01317004|12301894|FG000|NOT COMPLETED|Overall Study||4
11117337|NCT01317004|12301895|FG001|NOT COMPLETED|Overall Study||9
11117338|NCT01317030|12301903|FG000|STARTED|Overall Study||12
11117339|NCT01317030|12301904|FG001|STARTED|Overall Study||13
11117340|NCT01317030|12301903|FG000|COMPLETED|Overall Study||12
11117341|NCT01317030|12301904|FG001|COMPLETED|Overall Study||13
11117342|NCT01317030|12301903|FG000|NOT COMPLETED|Overall Study||0
11117343|NCT01317030|12301904|FG001|NOT COMPLETED|Overall Study||0
11117344|NCT01317095|12301912|FG000|STARTED|Overall Study||39
11117345|NCT01317095|12301913|FG001|STARTED|Overall Study||41
11117346|NCT01317095|12301912|FG000|COMPLETED|Overall Study||39
11117347|NCT01317095|12301913|FG001|COMPLETED|Overall Study||41
11117348|NCT01317095|12301912|FG000|NOT COMPLETED|Overall Study||0
11117349|NCT01317095|12301913|FG001|NOT COMPLETED|Overall Study||0
11117350|NCT01317199|12301923|FG000|STARTED|Dose-escalation Phase 1||14
11117351|NCT01317199|12301924|FG001|STARTED|Dose-escalation Phase 1||0
11117352|NCT01317199|12301925|FG002|STARTED|Dose-escalation Phase 1||0
11117353|NCT01317199|12301926|FG003|STARTED|Dose-escalation Phase 1||0
11117354|NCT01317199|12301923|FG000|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
11117355|NCT01317199|12301924|FG001|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
11117356|NCT01317199|12301925|FG002|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
11117357|NCT01317199|12301926|FG003|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
11117358|NCT01317199|12301923|FG000|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
11117359|NCT01317199|12301924|FG001|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
11117360|NCT01317199|12301925|FG002|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
11117361|NCT01317199|12301926|FG003|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
11117362|NCT01317199|12301923|FG000|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
11117363|NCT01317199|12301924|FG001|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
11117364|NCT01317199|12301925|FG002|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
11117365|NCT01317199|12301926|FG003|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
11117366|NCT01317199|12301923|FG000|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
11117367|NCT01317199|12301924|FG001|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
11117368|NCT01317199|12301925|FG002|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
11117369|NCT01317199|12301926|FG003|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
11117370|NCT01317199|12301923|FG000|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
11117371|NCT01317199|12301924|FG001|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
11117372|NCT01317199|12301925|FG002|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
11117373|NCT01317199|12301926|FG003|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
11117374|NCT01317199|12301923|FG000|COMPLETED|Dose-escalation Phase 1||7
11117375|NCT01317199|12301924|FG001|COMPLETED|Dose-escalation Phase 1||0
11117376|NCT01317199|12301925|FG002|COMPLETED|Dose-escalation Phase 1||0
11117377|NCT01317199|12301926|FG003|COMPLETED|Dose-escalation Phase 1||0
11117378|NCT01317199|12301923|FG000|NOT COMPLETED|Dose-escalation Phase 1||7
11117379|NCT01317199|12301924|FG001|NOT COMPLETED|Dose-escalation Phase 1||0
11117380|NCT01317199|12301925|FG002|NOT COMPLETED|Dose-escalation Phase 1||0
11117381|NCT01317199|12301926|FG003|NOT COMPLETED|Dose-escalation Phase 1||0
11117382|NCT01317199|12301923|FG000|STARTED|Randomized Phase 2||0
11117383|NCT01317199|12301924|FG001|STARTED|Randomized Phase 2||24
11117384|NCT01317199|12301925|FG002|STARTED|Randomized Phase 2||56
11117385|NCT01317199|12301926|FG003|STARTED|Randomized Phase 2||49
11117386|NCT01317199|12301923|FG000|COMPLETED|Randomized Phase 2||0
11117387|NCT01317199|12301924|FG001|COMPLETED|Randomized Phase 2||13
11117388|NCT01317199|12301925|FG002|COMPLETED|Randomized Phase 2||35
11117389|NCT01317199|12301926|FG003|COMPLETED|Randomized Phase 2||32
11117390|NCT01317199|12301923|FG000|NOT COMPLETED|Randomized Phase 2||0
11117391|NCT01317199|12301924|FG001|NOT COMPLETED|Randomized Phase 2||11
11117392|NCT01317199|12301925|FG002|NOT COMPLETED|Randomized Phase 2||21
11117393|NCT01317199|12301926|FG003|NOT COMPLETED|Randomized Phase 2||17
11117394|NCT01317277|12301945|FG000|STARTED|Overall Study||50
11117395|NCT01317277|12301946|FG001|STARTED|Overall Study||25
11117396|NCT01317277|12301945|FG000|COMPLETED|Overall Study||43
11117397|NCT01317277|12301946|FG001|COMPLETED|Overall Study||23
11117398|NCT01317277|12301945|FG000|NOT COMPLETED|Overall Study||7
11117399|NCT01317277|12301946|FG001|NOT COMPLETED|Overall Study||2
11117400|NCT01317472|12301954|FG000|STARTED|Overall Study||9
11117401|NCT01317472|12301955|FG001|STARTED|Overall Study||2
11117402|NCT01317472|12301954|FG000|COMPLETED|Overall Study||7
11117403|NCT01317472|12301955|FG001|COMPLETED|Overall Study||2
11117404|NCT01317472|12301954|FG000|NOT COMPLETED|Overall Study||2
11117405|NCT01317472|12301955|FG001|NOT COMPLETED|Overall Study||0
11117406|NCT01317550|12301965|FG000|STARTED|Overall Study||5
11117407|NCT01317550|12301966|FG001|STARTED|Overall Study||3
11117408|NCT01317550|12301967|FG002|STARTED|Overall Study||3
11117409|NCT01317550|12301968|FG003|STARTED|Overall Study||3
11117410|NCT01317550|12301965|FG000|COMPLETED|Overall Study||3
11117411|NCT01317550|12301966|FG001|COMPLETED|Overall Study||3
11117412|NCT01317550|12301967|FG002|COMPLETED|Overall Study||3
11117413|NCT01317550|12301968|FG003|COMPLETED|Overall Study||3
11117414|NCT01317550|12301965|FG000|NOT COMPLETED|Overall Study||2
11117415|NCT01317550|12301966|FG001|NOT COMPLETED|Overall Study||0
11117416|NCT01317550|12301967|FG002|NOT COMPLETED|Overall Study||0
11117417|NCT01317550|12301968|FG003|NOT COMPLETED|Overall Study||0
11117418|NCT01317615|12301978|FG000|STARTED|Overall Study||49
11117419|NCT01317615|12301978|FG000|COMPLETED|Overall Study||0
11117420|NCT01317615|12301978|FG000|NOT COMPLETED|Overall Study||49
11117421|NCT01317641|12301991|FG000|STARTED|Overall Study||4
11117422|NCT01317641|12301992|FG001|STARTED|Overall Study||7
11117423|NCT01317641|12301993|FG002|STARTED|Overall Study||3
11117424|NCT01317641|12301994|FG003|STARTED|Overall Study||4
11117425|NCT01317641|12301995|FG004|STARTED|Overall Study||3
11117426|NCT01317641|12301996|FG005|STARTED|Overall Study||3
11117427|NCT01317641|12301997|FG006|STARTED|Overall Study||38
11117428|NCT01317641|12301998|FG007|STARTED|Overall Study||38
11117429|NCT01317641|12301999|FG008|STARTED|Overall Study||36
11117430|NCT01317641|12301991|FG000|COMPLETED|Overall Study||3
11117431|NCT01317641|12301992|FG001|COMPLETED|Overall Study||6
11117432|NCT01317641|12301993|FG002|COMPLETED|Overall Study||3
11117433|NCT01317641|12301994|FG003|COMPLETED|Overall Study||3
11117434|NCT01317641|12301995|FG004|COMPLETED|Overall Study||3
11117435|NCT01317641|12301996|FG005|COMPLETED|Overall Study||3
11117436|NCT01317641|12301997|FG006|COMPLETED|Overall Study||35
11117437|NCT01317641|12301998|FG007|COMPLETED|Overall Study||33
11117438|NCT01317641|12301999|FG008|COMPLETED|Overall Study||31
11117439|NCT01317641|12301991|FG000|NOT COMPLETED|Overall Study||1
11117440|NCT01317641|12301992|FG001|NOT COMPLETED|Overall Study||1
11117441|NCT01317641|12301993|FG002|NOT COMPLETED|Overall Study||0
11117442|NCT01317641|12301994|FG003|NOT COMPLETED|Overall Study||1
11117443|NCT01317641|12301995|FG004|NOT COMPLETED|Overall Study||0
11117444|NCT01317641|12301996|FG005|NOT COMPLETED|Overall Study||0
11117445|NCT01317641|12301997|FG006|NOT COMPLETED|Overall Study||3
11117446|NCT01317641|12301998|FG007|NOT COMPLETED|Overall Study||5
11117447|NCT01317641|12301999|FG008|NOT COMPLETED|Overall Study||5
11117448|NCT01317667|12302038|FG000|STARTED|Overall Study||10
11117449|NCT01317667|12302039|FG001|STARTED|Overall Study||10
11117450|NCT01317667|12302040|FG002|STARTED|Overall Study||10
11117451|NCT01317667|12302038|FG000|COMPLETED|Overall Study||10
11117452|NCT01317667|12302039|FG001|COMPLETED|Overall Study||10
11117453|NCT01317667|12302040|FG002|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
11117454|NCT01317667|12302038|FG000|NOT COMPLETED|Overall Study||0
11117455|NCT01317667|12302039|FG001|NOT COMPLETED|Overall Study||0
11117456|NCT01317667|12302040|FG002|NOT COMPLETED|Overall Study||0
11117457|NCT01317797|12302051|FG000|STARTED|Overall Study||8
11117458|NCT01317797|12302052|FG001|STARTED|Overall Study||7
11117459|NCT01317797|12302053|FG002|STARTED|Overall Study||9
11117460|NCT01317797|12302051|FG000|COMPLETED|Overall Study||8
11117461|NCT01317797|12302052|FG001|COMPLETED|Overall Study||6
11117462|NCT01317797|12302053|FG002|COMPLETED|Overall Study||8
11117463|NCT01317797|12302051|FG000|NOT COMPLETED|Overall Study||0
11117464|NCT01317797|12302052|FG001|NOT COMPLETED|Overall Study||1
11117465|NCT01317797|12302053|FG002|NOT COMPLETED|Overall Study||1
11117466|NCT01317901|12302063|FG000|STARTED|Overall Study||6
11117467|NCT01317901|12302064|FG001|STARTED|Overall Study||6
11117468|NCT01317901|12302063|FG000|COMPLETED|Overall Study||6
11117469|NCT01317901|12302064|FG001|COMPLETED|Overall Study||6
11117470|NCT01317901|12302063|FG000|NOT COMPLETED|Overall Study||0
11117471|NCT01317901|12302064|FG001|NOT COMPLETED|Overall Study||0
11117472|NCT01317940|12302076|FG000|STARTED|Overall Study||19
11117473|NCT01317940|12302077|FG001|STARTED|Overall Study||10
11117474|NCT01317940|12302078|FG002|STARTED|Overall Study||20
11117475|NCT01317940|12302079|FG003|STARTED|Overall Study||6
11117476|NCT01317940|12302080|FG004|STARTED|Overall Study||13
11117477|NCT01317940|12302081|FG005|STARTED|Overall Study||4
11117478|NCT01317940|12302076|FG000|COMPLETED|Overall Study||18
11117479|NCT01317940|12302077|FG001|COMPLETED|Overall Study||10
11117480|NCT01317940|12302078|FG002|COMPLETED|Overall Study||15
11117481|NCT01317940|12302079|FG003|COMPLETED|Overall Study||5
11117482|NCT01317940|12302080|FG004|COMPLETED|Overall Study||12
11117483|NCT01317940|12302081|FG005|COMPLETED|Overall Study||4
11117484|NCT01317940|12302076|FG000|NOT COMPLETED|Overall Study||1
11117485|NCT01317940|12302077|FG001|NOT COMPLETED|Overall Study||0
11117486|NCT01317940|12302078|FG002|NOT COMPLETED|Overall Study||5
11117487|NCT01317940|12302079|FG003|NOT COMPLETED|Overall Study||1
11117488|NCT01317940|12302080|FG004|NOT COMPLETED|Overall Study||1
11117489|NCT01317940|12302081|FG005|NOT COMPLETED|Overall Study||0
11117490|NCT01318018|12302098|FG000|STARTED|Overall Study||10
11117491|NCT01318018|12302099|FG001|STARTED|Overall Study||10
11117492|NCT01318018|12302098|FG000|COMPLETED|Overall Study||10
11117493|NCT01318018|12302099|FG001|COMPLETED|Overall Study||10
11117494|NCT01318018|12302098|FG000|NOT COMPLETED|Overall Study||0
11117495|NCT01318018|12302099|FG001|NOT COMPLETED|Overall Study||0
11117496|NCT01318070|12302108|FG000|STARTED|Overall Study||111
11117497|NCT01318070|12302109|FG001|STARTED|Overall Study||113
11117498|NCT01318070|12302110|FG002|STARTED|Overall Study||115
11117499|NCT01318070|12302108|FG000|COMPLETED|Overall Study||109
11117500|NCT01318070|12302109|FG001|COMPLETED|Overall Study||111
11117501|NCT01318070|12302110|FG002|COMPLETED|Overall Study||108
11117502|NCT01318070|12302108|FG000|NOT COMPLETED|Overall Study||2
11117503|NCT01318070|12302109|FG001|NOT COMPLETED|Overall Study||2
11117504|NCT01318070|12302110|FG002|NOT COMPLETED|Overall Study||7
11117505|NCT01318083|12302121|FG000|STARTED|Overall Study||105
11117506|NCT01318083|12302122|FG001|STARTED|Overall Study||104
11117507|NCT01318083|12302123|FG002|STARTED|Overall Study||103
11117508|NCT01318083|12302121|FG000|COMPLETED|Overall Study||99
11117509|NCT01318083|12302122|FG001|COMPLETED|Overall Study||102
11233808|NCT02040766|12425458|FG001|COMPLETED|Overall Study||116
11117510|NCT01318083|12302123|FG002|COMPLETED|Overall Study||98
11117511|NCT01318083|12302121|FG000|NOT COMPLETED|Overall Study||6
11117512|NCT01318083|12302122|FG001|NOT COMPLETED|Overall Study||2
11117513|NCT01318083|12302123|FG002|NOT COMPLETED|Overall Study||5
11117514|NCT01318109|12302134|FG000|STARTED|Overall Study||92
11117515|NCT01318109|12302135|FG001|STARTED|Overall Study||96
11117516|NCT01318109|12302136|FG002|STARTED|Overall Study||100
11117517|NCT01318109|12302134|FG000|COMPLETED|Overall Study||91
11117518|NCT01318109|12302135|FG001|COMPLETED|Overall Study||93
11117519|NCT01318109|12302136|FG002|COMPLETED|Overall Study||100
11117520|NCT01318109|12302134|FG000|NOT COMPLETED|Overall Study||1
11117521|NCT01318109|12302135|FG001|NOT COMPLETED|Overall Study||3
11117522|NCT01318109|12302136|FG002|NOT COMPLETED|Overall Study||0
11117523|NCT01318122|12302146|FG000|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
11117524|NCT01318122|12302147|FG001|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
11117525|NCT01318122|12302148|FG002|STARTED|Enrolled - Long-Term Extension Study||57
11117526|NCT01318122|12302149|FG003|STARTED|Enrolled - Long-Term Extension Study||53
11117527|NCT01318122|12302146|FG000|COMPLETED|Enrolled - Long-Term Extension Study||105
11117528|NCT01318122|12302147|FG001|COMPLETED|Enrolled - Long-Term Extension Study||110
11117529|NCT01318122|12302148|FG002|COMPLETED|Enrolled - Long-Term Extension Study||55
11117530|NCT01318122|12302149|FG003|COMPLETED|Enrolled - Long-Term Extension Study||52
11117531|NCT01318122|12302146|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
11117532|NCT01318122|12302147|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11117533|NCT01318122|12302148|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
11117534|NCT01318122|12302149|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
11117535|NCT01318122|12302146|FG000|STARTED|Entered - Long-Term Extension Study||105
11117536|NCT01318122|12302147|FG001|STARTED|Entered - Long-Term Extension Study||110
11117537|NCT01318122|12302148|FG002|STARTED|Entered - Long-Term Extension Study||55
11117538|NCT01318122|12302149|FG003|STARTED|Entered - Long-Term Extension Study||52
11117539|NCT01318122|12302146|FG000|COMPLETED|Entered - Long-Term Extension Study||96
11117540|NCT01318122|12302147|FG001|COMPLETED|Entered - Long-Term Extension Study||99
11117541|NCT01318122|12302148|FG002|COMPLETED|Entered - Long-Term Extension Study||49
11117542|NCT01318122|12302149|FG003|COMPLETED|Entered - Long-Term Extension Study||48
11117543|NCT01318122|12302146|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9
11117544|NCT01318122|12302147|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||11
11117545|NCT01318122|12302148|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||6
11117546|NCT01318122|12302149|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||4
11117547|NCT01318135|12302159|FG000|STARTED|Enrolled - Long-Term Extension Study||99
11117548|NCT01318135|12302160|FG001|STARTED|Enrolled - Long-Term Extension Study||102
11117549|NCT01318135|12302161|FG002|STARTED|Enrolled - Long-Term Extension Study||46
11117550|NCT01318135|12302162|FG003|STARTED|Enrolled - Long-Term Extension Study||49
11117551|NCT01318135|12302163|FG004|STARTED|Enrolled - Long-Term Extension Study||91
11117552|NCT01318135|12302164|FG005|STARTED|Enrolled - Long-Term Extension Study||90
11117553|NCT01318135|12302165|FG006|STARTED|Enrolled - Long-Term Extension Study||50
11117554|NCT01318135|12302166|FG007|STARTED|Enrolled - Long-Term Extension Study||49
11117555|NCT01318135|12302159|FG000|COMPLETED|Enrolled - Long-Term Extension Study||97
11117556|NCT01318135|12302160|FG001|COMPLETED|Enrolled - Long-Term Extension Study||102
11117557|NCT01318135|12302161|FG002|COMPLETED|Enrolled - Long-Term Extension Study||46
11117558|NCT01318135|12302162|FG003|COMPLETED|Enrolled - Long-Term Extension Study||49
11117559|NCT01318135|12302163|FG004|COMPLETED|Enrolled - Long-Term Extension Study||91
11117560|NCT01318135|12302164|FG005|COMPLETED|Enrolled - Long-Term Extension Study||90
11117561|NCT01318135|12302165|FG006|COMPLETED|Enrolled - Long-Term Extension Study||50
11117562|NCT01318135|12302166|FG007|COMPLETED|Enrolled - Long-Term Extension Study||49
11117563|NCT01318135|12302159|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
11117564|NCT01318135|12302160|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11117565|NCT01318135|12302161|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11117566|NCT01318135|12302162|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11117567|NCT01318135|12302163|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11117568|NCT01318135|12302164|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11117569|NCT01318135|12302165|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11117570|NCT01318135|12302166|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
11117571|NCT01318135|12302159|FG000|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
11117572|NCT01318135|12302160|FG001|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
11117573|NCT01318135|12302161|FG002|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
11117574|NCT01318135|12302162|FG003|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
11117575|NCT01318135|12302163|FG004|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
11117576|NCT01318135|12302164|FG005|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
11117577|NCT01318135|12302165|FG006|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
11117578|NCT01318135|12302166|FG007|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
11117579|NCT01318135|12302159|FG000|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
11117580|NCT01318135|12302160|FG001|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
11117581|NCT01318135|12302161|FG002|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
11117582|NCT01318135|12302162|FG003|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
11117583|NCT01318135|12302163|FG004|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
11117584|NCT01318135|12302164|FG005|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
11117585|NCT01318135|12302165|FG006|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
11117586|NCT01318135|12302166|FG007|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
11117587|NCT01318135|12302159|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||17
11117588|NCT01318135|12302160|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13
11117589|NCT01318135|12302161|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||8
11117590|NCT01318135|12302162|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||7
11117591|NCT01318135|12302163|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||9
11117592|NCT01318135|12302164|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||4
11117593|NCT01318135|12302165|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1
11117594|NCT01318135|12302166|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||3
11117595|NCT01318278|12302179|FG000|STARTED|Overall Study||10
11117596|NCT01318278|12302180|FG001|STARTED|Overall Study||10
11117597|NCT01318278|12302181|FG002|STARTED|Overall Study||50
11117598|NCT01318278|12302179|FG000|COMPLETED|Overall Study||10
11117599|NCT01318278|12302180|FG001|COMPLETED|Overall Study||10
11117600|NCT01318278|12302181|FG002|COMPLETED|Overall Study||50
11117601|NCT01318278|12302179|FG000|NOT COMPLETED|Overall Study||0
11117602|NCT01318278|12302180|FG001|NOT COMPLETED|Overall Study||0
11117603|NCT01318278|12302181|FG002|NOT COMPLETED|Overall Study||0
11117604|NCT01318356|12302193|FG000|STARTED|Overall Study||51
11117605|NCT01318356|12302194|FG001|STARTED|Overall Study||52
11117606|NCT01318356|12302195|FG002|STARTED|Overall Study||52
11117607|NCT01318356|12302193|FG000|COMPLETED|Overall Study||43
11117608|NCT01318356|12302194|FG001|COMPLETED|Overall Study||49
11117609|NCT01318356|12302195|FG002|COMPLETED|Overall Study||50
11117610|NCT01318356|12302193|FG000|NOT COMPLETED|Overall Study||8
11117611|NCT01318356|12302194|FG001|NOT COMPLETED|Overall Study||3
11117612|NCT01318356|12302195|FG002|NOT COMPLETED|Overall Study||2
11117613|NCT01318382|12302203|FG000|STARTED|Overall Study||302
11117614|NCT01318382|12302203|FG000|COMPLETED|Overall Study||289
11117615|NCT01318382|12302203|FG000|NOT COMPLETED|Overall Study||13
11117616|NCT01318408|12302208|FG000|STARTED|Overall Study||24
11117617|NCT01318408|12302208|FG000|COMPLETED|Overall Study||16
11117618|NCT01318408|12302208|FG000|NOT COMPLETED|Overall Study||8
11117619|NCT01318499|12302215|FG000|STARTED|Overall Study||540
11117620|NCT01318499|12302216|FG001|STARTED|Overall Study||534
11117621|NCT01318499|12302217|FG002|STARTED|Overall Study||268
11117622|NCT01318499|12302215|FG000|COMPLETED|Overall Study||475
11117623|NCT01318499|12302216|FG001|COMPLETED|Overall Study||458
11117624|NCT01318499|12302217|FG002|COMPLETED|Overall Study||121
11117625|NCT01318499|12302215|FG000|NOT COMPLETED|Overall Study||65
11117626|NCT01318499|12302216|FG001|NOT COMPLETED|Overall Study||76
11117627|NCT01318499|12302217|FG002|NOT COMPLETED|Overall Study||147
11117628|NCT01318512|12302227|FG000|STARTED|Titration Period (4 Months)||340
11117629|NCT01318512|12302227|FG000|COMPLETED|Titration Period (4 Months)||340
11117630|NCT01318512|12302227|FG000|NOT COMPLETED|Titration Period (4 Months)||0
11117631|NCT01318512|12302227|FG000|STARTED|Maintenance Period (6 Months)||340
11117632|NCT01318512|12302227|FG000|COMPLETED|Maintenance Period (6 Months)||329
11117633|NCT01318512|12302227|FG000|NOT COMPLETED|Maintenance Period (6 Months)||11
11117634|NCT01318538|12302235|FG000|STARTED|Overall Study||52
11117635|NCT01318538|12302236|FG001|STARTED|Overall Study||106
11117636|NCT01318538|12302237|FG002|STARTED|Overall Study||8
11117637|NCT01318538|12302235|FG000|COMPLETED|Overall Study||52
11117638|NCT01318538|12302236|FG001|COMPLETED|Overall Study||106
11117639|NCT01318538|12302237|FG002|COMPLETED|Overall Study||8
11117640|NCT01318538|12302235|FG000|NOT COMPLETED|Overall Study||0
11117641|NCT01318538|12302236|FG001|NOT COMPLETED|Overall Study||0
11117642|NCT01318538|12302237|FG002|NOT COMPLETED|Overall Study||0
11117643|NCT01318577|12302247|FG000|STARTED|Overall Study||224
11117644|NCT01318577|12302248|FG001|STARTED|Overall Study||220
11117645|NCT01318577|12302247|FG000|COMPLETED|Overall Study||211
11117646|NCT01318577|12302248|FG001|COMPLETED|Overall Study||212
11117647|NCT01318577|12302247|FG000|NOT COMPLETED|Overall Study||13
11117648|NCT01318577|12302248|FG001|NOT COMPLETED|Overall Study||8
11117649|NCT01318694|12302258|FG000|STARTED|Overall Study||275
11117650|NCT01318694|12302259|FG001|STARTED|Overall Study||270
11117651|NCT01318694|12302260|FG002|STARTED|Overall Study||268
11117652|NCT01318694|12302261|FG003|STARTED|Overall Study||268
11117653|NCT01318694|12302258|FG000|Full Analysis Set|Overall Study||274
11117654|NCT01318694|12302259|FG001|Full Analysis Set|Overall Study||270
11117655|NCT01318694|12302260|FG002|Full Analysis Set|Overall Study||265
11117656|NCT01318694|12302261|FG003|Full Analysis Set|Overall Study||268
11117657|NCT01318694|12302258|FG000|Safety Set|Overall Study||273
11117658|NCT01318694|12302259|FG001|Safety Set|Overall Study||268
11117659|NCT01318694|12302260|FG002|Safety Set|Overall Study||265
11117660|NCT01318694|12302261|FG003|Safety Set|Overall Study||265
11117661|NCT01318694|12302258|FG000|COMPLETED|Overall Study||223
11117662|NCT01318694|12302259|FG001|COMPLETED|Overall Study||212
11117663|NCT01318694|12302260|FG002|COMPLETED|Overall Study||225
11117664|NCT01318694|12302261|FG003|COMPLETED|Overall Study||200
11117665|NCT01318694|12302258|FG000|NOT COMPLETED|Overall Study||52
11117666|NCT01318694|12302259|FG001|NOT COMPLETED|Overall Study||58
11117667|NCT01318694|12302260|FG002|NOT COMPLETED|Overall Study||43
11117668|NCT01318694|12302261|FG003|NOT COMPLETED|Overall Study||68
11117669|NCT01318733|12302271|FG000|STARTED|Overall Study||449
11117670|NCT01318733|12302271|FG000|COMPLETED|Overall Study||279
11117671|NCT01318733|12302271|FG000|NOT COMPLETED|Overall Study||170
11117672|NCT01318811|12302277|FG000|STARTED|Overall Study||4
11117673|NCT01318811|12302278|FG001|STARTED|Overall Study||8
11117674|NCT01318811|12302277|FG000|COMPLETED|Overall Study||3
11117675|NCT01318811|12302278|FG001|COMPLETED|Overall Study||4
11117676|NCT01318811|12302277|FG000|NOT COMPLETED|Overall Study||1
11117677|NCT01318811|12302278|FG001|NOT COMPLETED|Overall Study||4
11117678|NCT01318876|12302284|FG000|STARTED|Day 8 Survey||7645
11117679|NCT01318876|12302284|FG000|COMPLETED|Day 8 Survey||5825
11117680|NCT01318876|12302284|FG000|NOT COMPLETED|Day 8 Survey||1820
11233809|NCT02040766|12425459|FG002|COMPLETED|Overall Study||113
11233810|NCT02040766|12425460|FG003|COMPLETED|Overall Study||112
11233811|NCT02040766|12425461|FG004|COMPLETED|Overall Study||112
11233812|NCT02040766|12425457|FG000|NOT COMPLETED|Overall Study||18
11233813|NCT02040766|12425458|FG001|NOT COMPLETED|Overall Study||10
11233814|NCT02040766|12425459|FG002|NOT COMPLETED|Overall Study||12
11233815|NCT02040766|12425460|FG003|NOT COMPLETED|Overall Study||13
11233816|NCT02040766|12425461|FG004|NOT COMPLETED|Overall Study||13
11233817|NCT02040779|12425477|FG000|STARTED|Overall Study||91
11233818|NCT02040779|12425478|FG001|STARTED|Overall Study||90
11233819|NCT02040779|12425479|FG002|STARTED|Overall Study||92
11233820|NCT02040779|12425477|FG000|Full Analysis Set (FAS)|Overall Study||90
11233821|NCT02040779|12425478|FG001|Full Analysis Set (FAS)|Overall Study||88
11233822|NCT02040779|12425479|FG002|Full Analysis Set (FAS)|Overall Study||92
11233823|NCT02040779|12425477|FG000|COMPLETED|Overall Study||79
11233824|NCT02040779|12425478|FG001|COMPLETED|Overall Study||83
11233825|NCT02040779|12425479|FG002|COMPLETED|Overall Study||88
11233826|NCT02040779|12425477|FG000|NOT COMPLETED|Overall Study||12
11233827|NCT02040779|12425478|FG001|NOT COMPLETED|Overall Study||7
11233828|NCT02040779|12425479|FG002|NOT COMPLETED|Overall Study||4
11233829|NCT02040805|12425489|FG000|STARTED|Overall Study||160
11233830|NCT02040805|12425490|FG001|STARTED|Overall Study||163
11233831|NCT02040805|12425489|FG000|COMPLETED|Overall Study||118
11233832|NCT02040805|12425490|FG001|COMPLETED|Overall Study||113
11233833|NCT02040805|12425489|FG000|NOT COMPLETED|Overall Study||42
11233834|NCT02040805|12425490|FG001|NOT COMPLETED|Overall Study||50
11233835|NCT02040844|12425499|FG000|STARTED|Overall Study||138
11233836|NCT02040844|12425500|FG001|STARTED|Overall Study||148
11233837|NCT02040844|12425501|FG002|STARTED|Overall Study||144
11233838|NCT02040844|12425499|FG000|COMPLETED|Overall Study||88
11233839|NCT02040844|12425500|FG001|COMPLETED|Overall Study||109
11233840|NCT02040844|12425501|FG002|COMPLETED|Overall Study||97
11233841|NCT02040844|12425499|FG000|NOT COMPLETED|Overall Study||50
11233842|NCT02040844|12425500|FG001|NOT COMPLETED|Overall Study||39
11233843|NCT02040844|12425501|FG002|NOT COMPLETED|Overall Study||47
11233844|NCT02040870|12425509|FG000|STARTED|Overall Study||103
11233845|NCT02040870|12425509|FG000|Entered Post-treatment Follow-up|Overall Study||2
11233846|NCT02040870|12425509|FG000|Entered Survival Follow-up|Overall Study||75
11233847|NCT02040870|12425509|FG000|Discontinue From Study|Overall Study||26
11233848|NCT02040870|12425509|FG000|COMPLETED|Overall Study||0
11233849|NCT02040870|12425509|FG000|NOT COMPLETED|Overall Study||103
11233850|NCT02041091|12425515|FG000|STARTED|Treatment||112
11233851|NCT02041091|12425516|FG001|STARTED|Treatment||114
11233852|NCT02041091|12425515|FG000|Received At Least One Dose of Study Drug|Treatment||112
11233853|NCT02041091|12425516|FG001|Received At Least One Dose of Study Drug|Treatment||114
11233854|NCT02041091|12425515|FG000|Participated in Follow Up|Treatment||106
11233855|NCT02041091|12425516|FG001|Participated in Follow Up|Treatment||96
11233856|NCT02041091|12425515|FG000|COMPLETED|Treatment||90
11233857|NCT02041091|12425516|FG001|COMPLETED|Treatment||91
11233858|NCT02041091|12425515|FG000|NOT COMPLETED|Treatment||22
11233859|NCT02041091|12425516|FG001|NOT COMPLETED|Treatment||23
11233860|NCT02041091|12425515|FG000|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
11233861|NCT02041091|12425516|FG001|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
11233862|NCT02041091|12425515|FG000|COMPLETED|Optional Safety Extension Period||0
11233863|NCT02041091|12425516|FG001|COMPLETED|Optional Safety Extension Period||0
11233864|NCT02041091|12425515|FG000|NOT COMPLETED|Optional Safety Extension Period||85
11233865|NCT02041091|12425516|FG001|NOT COMPLETED|Optional Safety Extension Period||82
11233866|NCT02041104|12425530|FG000|STARTED|Overall Study||28
11233867|NCT02041104|12425531|FG001|STARTED|Overall Study||23
11233868|NCT02041104|12425530|FG000|COMPLETED|Overall Study||27
11233869|NCT02041104|12425531|FG001|COMPLETED|Overall Study||16
11233870|NCT02041104|12425530|FG000|NOT COMPLETED|Overall Study||1
11233871|NCT02041104|12425531|FG001|NOT COMPLETED|Overall Study||7
11233872|NCT02041221|12425545|FG000|STARTED|Part 1||6
11233873|NCT02041221|12425546|FG001|STARTED|Part 1||6
11233874|NCT02041221|12425547|FG002|STARTED|Part 1||6
11233875|NCT02041221|12425548|FG003|STARTED|Part 1||6
11233876|NCT02041221|12425549|FG004|STARTED|Part 1||6
11233877|NCT02041221|12425550|FG005|STARTED|Part 1||10
11233878|NCT02041221|12425545|FG000|COMPLETED|Part 1||6
11233879|NCT02041221|12425546|FG001|COMPLETED|Part 1||6
11233880|NCT02041221|12425547|FG002|COMPLETED|Part 1||6
11233881|NCT02041221|12425548|FG003|COMPLETED|Part 1||6
11233882|NCT02041221|12425549|FG004|COMPLETED|Part 1||6
11233883|NCT02041221|12425550|FG005|COMPLETED|Part 1||10
11233884|NCT02041221|12425545|FG000|NOT COMPLETED|Part 1||0
11233885|NCT02041221|12425546|FG001|NOT COMPLETED|Part 1||0
11233886|NCT02041221|12425547|FG002|NOT COMPLETED|Part 1||0
11233887|NCT02041221|12425548|FG003|NOT COMPLETED|Part 1||0
11233888|NCT02041221|12425549|FG004|NOT COMPLETED|Part 1||0
11233889|NCT02041221|12425550|FG005|NOT COMPLETED|Part 1||0
11233890|NCT02041221|12425545|FG000|STARTED|Part 2||6
11233891|NCT02041221|12425546|FG001|STARTED|Part 2||6
11233892|NCT02041221|12425547|FG002|STARTED|Part 2||6
11233893|NCT02041221|12425548|FG003|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
11233894|NCT02041221|12425549|FG004|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
11233895|NCT02041221|12425550|FG005|STARTED|Part 2||6
11233896|NCT02041221|12425545|FG000|COMPLETED|Part 2||6
11233897|NCT02041221|12425546|FG001|COMPLETED|Part 2||6
11233898|NCT02041221|12425547|FG002|COMPLETED|Part 2||5
11233899|NCT02041221|12425548|FG003|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
11233900|NCT02041221|12425549|FG004|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
11233901|NCT02041221|12425550|FG005|COMPLETED|Part 2||6
11233902|NCT02041221|12425545|FG000|NOT COMPLETED|Part 2||0
11233903|NCT02041221|12425546|FG001|NOT COMPLETED|Part 2||0
11233904|NCT02041221|12425547|FG002|NOT COMPLETED|Part 2||1
11233905|NCT02041221|12425548|FG003|NOT COMPLETED|Part 2||0
11233906|NCT02041221|12425549|FG004|NOT COMPLETED|Part 2||0
11233907|NCT02041221|12425550|FG005|NOT COMPLETED|Part 2||0
11233908|NCT02041286|12425564|FG000|STARTED|Overall Study||136
11233909|NCT02041286|12425564|FG000|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
11233910|NCT02041286|12425564|FG000|NOT COMPLETED|Overall Study||1
11233911|NCT02041299|12425572|FG000|STARTED|Overall Study||152
11233912|NCT02041299|12425573|FG001|STARTED|Overall Study|Two participants double-enrolled under different subject numbers so were each counted twice.|78
11233913|NCT02041299|12425572|FG000|COMPLETED|Overall Study||106
11233914|NCT02041299|12425573|FG001|COMPLETED|Overall Study||58
11233915|NCT02041299|12425572|FG000|NOT COMPLETED|Overall Study||46
11233916|NCT02041299|12425573|FG001|NOT COMPLETED|Overall Study||20
11233917|NCT02041325|12425585|FG000|STARTED|Overall Study||22
11233918|NCT02041325|12425586|FG001|STARTED|Overall Study||16
11233919|NCT02041325|12425585|FG000|COMPLETED|Overall Study||19
11233920|NCT02041325|12425586|FG001|COMPLETED|Overall Study||13
11233921|NCT02041325|12425585|FG000|NOT COMPLETED|Overall Study||3
11233922|NCT02041325|12425586|FG001|NOT COMPLETED|Overall Study||3
11233923|NCT02041377|12425596|FG000|STARTED|Overall Study||134
11233924|NCT02041377|12425596|FG000|COMPLETED|Overall Study||134
11233925|NCT02041377|12425596|FG000|NOT COMPLETED|Overall Study||0
11233926|NCT02041429|12425604|FG000|STARTED|Overall Study||3
11233927|NCT02041429|12425605|FG001|STARTED|Overall Study||4
11233928|NCT02041429|12425606|FG002|STARTED|Overall Study||7
11233929|NCT02041429|12425607|FG003|STARTED|Overall Study||6
11233930|NCT02041429|12425604|FG000|Treated|Overall Study||3
11233931|NCT02041429|12425605|FG001|Treated|Overall Study||3
11233932|NCT02041429|12425606|FG002|Treated|Overall Study||7
11233933|NCT02041429|12425607|FG003|Treated|Overall Study||6
11233934|NCT02041429|12425604|FG000|Evaluable for Dose Limiting Toxicity|Overall Study||3
11233935|NCT02041429|12425605|FG001|Evaluable for Dose Limiting Toxicity|Overall Study||3
11233936|NCT02041429|12425606|FG002|Evaluable for Dose Limiting Toxicity|Overall Study||6
11233937|NCT02041429|12425607|FG003|Evaluable for Dose Limiting Toxicity|Overall Study||6
11233938|NCT02041429|12425604|FG000|COMPLETED|Overall Study||0
11233939|NCT02041429|12425605|FG001|COMPLETED|Overall Study||0
11233940|NCT02041429|12425606|FG002|COMPLETED|Overall Study||0
11233941|NCT02041429|12425607|FG003|COMPLETED|Overall Study||0
11233942|NCT02041429|12425604|FG000|NOT COMPLETED|Overall Study||3
11233943|NCT02041429|12425605|FG001|NOT COMPLETED|Overall Study||4
11233944|NCT02041429|12425606|FG002|NOT COMPLETED|Overall Study||7
11233945|NCT02041429|12425607|FG003|NOT COMPLETED|Overall Study||6
11233946|NCT02041494|12425624|FG000|STARTED|Overall Study||82
11233947|NCT02041494|12425625|FG001|STARTED|Overall Study||83
11233948|NCT02041494|12425624|FG000|COMPLETED|Overall Study||63
11233949|NCT02041494|12425625|FG001|COMPLETED|Overall Study||63
11233950|NCT02041494|12425624|FG000|NOT COMPLETED|Overall Study||19
11233951|NCT02041494|12425625|FG001|NOT COMPLETED|Overall Study||20
11233952|NCT02041520|12425634|FG000|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
11233953|NCT02041520|12425635|FG001|STARTED|Overall Study|35 patients randomly assigned to placebo|35
11233954|NCT02041520|12425634|FG000|COMPLETED|Overall Study||29
11233955|NCT02041520|12425635|FG001|COMPLETED|Overall Study||28
11233956|NCT02041520|12425634|FG000|NOT COMPLETED|Overall Study||6
11233957|NCT02041520|12425635|FG001|NOT COMPLETED|Overall Study||7
11233958|NCT02041702|12425645|FG000|STARTED|Overall Study||140
11233959|NCT02041702|12425646|FG001|STARTED|Overall Study||143
11233960|NCT02041702|12425645|FG000|Pre MRI Scan/ Pre Waitng|Overall Study||129
11233961|NCT02041702|12425646|FG001|Pre MRI Scan/ Pre Waitng|Overall Study||140
11233962|NCT02041702|12425645|FG000|Post MRI Scan/ Post Waiting|Overall Study||129
11233963|NCT02041702|12425646|FG001|Post MRI Scan/ Post Waiting|Overall Study||140
11233964|NCT02041702|12425645|FG000|COMPLETED|Overall Study||129
11233965|NCT02041702|12425646|FG001|COMPLETED|Overall Study||134
11233966|NCT02041702|12425645|FG000|NOT COMPLETED|Overall Study||11
11233967|NCT02041702|12425646|FG001|NOT COMPLETED|Overall Study||9
11233968|NCT02041923|12425654|FG000|STARTED|Overall Study||102
11233969|NCT02041923|12425655|FG001|STARTED|Overall Study||96
11233970|NCT02041923|12425654|FG000|COMPLETED|Overall Study||76
11233971|NCT02041923|12425655|FG001|COMPLETED|Overall Study||66
11233972|NCT02041923|12425654|FG000|NOT COMPLETED|Overall Study||26
11233973|NCT02041923|12425655|FG001|NOT COMPLETED|Overall Study||30
11233974|NCT02041962|12425665|FG000|STARTED|Overall Study||123
11233975|NCT02041962|12425666|FG001|STARTED|Overall Study||115
11233976|NCT02041962|12425665|FG000|Participants Completing 6 mo. f/up|Overall Study||69
11233977|NCT02041962|12425666|FG001|Participants Completing 6 mo. f/up|Overall Study||44
11233978|NCT02041962|12425665|FG000|Participants Completing 12 mo. f/up|Overall Study||42
11233979|NCT02041962|12425666|FG001|Participants Completing 12 mo. f/up|Overall Study||31
11233980|NCT02041962|12425665|FG000|COMPLETED|Overall Study||42
11233981|NCT02041962|12425666|FG001|COMPLETED|Overall Study||31
11233982|NCT02041962|12425665|FG000|NOT COMPLETED|Overall Study||81
11233983|NCT02041962|12425666|FG001|NOT COMPLETED|Overall Study||84
11233984|NCT02042014|12425672|FG000|STARTED|Overall Study||8
11233985|NCT02042014|12425672|FG000|COMPLETED|Overall Study||0
11233986|NCT02042014|12425672|FG000|NOT COMPLETED|Overall Study||8
11233987|NCT02042131|12425679|FG000|STARTED|Overall Study||32
11233988|NCT02042131|12425680|FG001|STARTED|Overall Study||32
11233989|NCT02042131|12425681|FG002|STARTED|Overall Study||33
11233990|NCT02042131|12425679|FG000|COMPLETED|Overall Study||32
11233991|NCT02042131|12425680|FG001|COMPLETED|Overall Study||32
11233992|NCT02042131|12425681|FG002|COMPLETED|Overall Study||33
11233993|NCT02042131|12425679|FG000|NOT COMPLETED|Overall Study||0
11233994|NCT02042131|12425680|FG001|NOT COMPLETED|Overall Study||0
11233995|NCT02042131|12425681|FG002|NOT COMPLETED|Overall Study||0
11233996|NCT02042183|12425693|FG000|STARTED|Overall Study||404
11233997|NCT02042183|12425694|FG001|STARTED|Overall Study||202
11233998|NCT02042183|12425693|FG000|Safety Population|Overall Study||400
11233999|NCT02042183|12425694|FG001|Safety Population|Overall Study||195
11234000|NCT02042183|12425693|FG000|Modified Intent-to-treat (mITT)|Overall Study||399
11234001|NCT02042183|12425694|FG001|Modified Intent-to-treat (mITT)|Overall Study||195
11234002|NCT02042183|12425693|FG000|COMPLETED|Overall Study||339
11234003|NCT02042183|12425694|FG001|COMPLETED|Overall Study||166
11234004|NCT02042183|12425693|FG000|NOT COMPLETED|Overall Study||65
11234005|NCT02042183|12425694|FG001|NOT COMPLETED|Overall Study||36
11234006|NCT02042274|12425702|FG000|STARTED|Overall Study||12
11234007|NCT02042274|12425702|FG000|COMPLETED|Overall Study||12
11234008|NCT02042274|12425702|FG000|NOT COMPLETED|Overall Study||0
11234009|NCT02042404|12425706|FG000|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
11234010|NCT02042404|12425707|FG001|STARTED|Overall Study||5
11234011|NCT02042404|12425706|FG000|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
11234012|NCT02042404|12425707|FG001|COMPLETED|Overall Study||5
11234013|NCT02042404|12425706|FG000|NOT COMPLETED|Overall Study||5
11234014|NCT02042404|12425707|FG001|NOT COMPLETED|Overall Study||0
11234015|NCT02042443|12425716|FG000|STARTED|Overall Study||27
11234016|NCT02042443|12425717|FG001|STARTED|Overall Study||26
11234017|NCT02042443|12425716|FG000|Eligible and Analyzable|Overall Study||24
11234018|NCT02042443|12425717|FG001|Eligible and Analyzable|Overall Study||20
11234019|NCT02042443|12425716|FG000|COMPLETED|Overall Study||0
11234020|NCT02042443|12425717|FG001|COMPLETED|Overall Study||0
11234021|NCT02042443|12425716|FG000|NOT COMPLETED|Overall Study||27
11234022|NCT02042443|12425717|FG001|NOT COMPLETED|Overall Study||26
11234023|NCT02042534|12425726|FG000|STARTED|Overall Study||101
11234024|NCT02042534|12425727|FG001|STARTED|Overall Study||94
11234025|NCT02042534|12425726|FG000|COMPLETED|Overall Study||101
11234026|NCT02042534|12425727|FG001|COMPLETED|Overall Study||94
11234027|NCT02042534|12425726|FG000|NOT COMPLETED|Overall Study||0
11234028|NCT02042534|12425727|FG001|NOT COMPLETED|Overall Study||0
11234029|NCT02042872|12425735|FG000|STARTED|Overall Study||8
11234030|NCT02042872|12425736|FG001|STARTED|Overall Study||13
11234031|NCT02042872|12425735|FG000|COMPLETED|Overall Study||8
11234032|NCT02042872|12425736|FG001|COMPLETED|Overall Study||8
11234033|NCT02042872|12425735|FG000|NOT COMPLETED|Overall Study||0
11234034|NCT02042872|12425736|FG001|NOT COMPLETED|Overall Study||5
11234035|NCT02042911|12425742|FG000|STARTED|Overall Study||10
11234036|NCT02042911|12425742|FG000|COMPLETED|Overall Study||9
11234037|NCT02042911|12425742|FG000|NOT COMPLETED|Overall Study||1
11234038|NCT02043015|12425746|FG000|STARTED|Overall Study||115
11234039|NCT02043015|12425746|FG000|COMPLETED|Overall Study||87
11356246|NCT03093870|12553205|FG002|COMPLETED|Overall Study||22
11356247|NCT03093870|12553203|FG000|NOT COMPLETED|Overall Study||24
11356248|NCT03093870|12553204|FG001|NOT COMPLETED|Overall Study||41
11356249|NCT03093870|12553205|FG002|NOT COMPLETED|Overall Study||41
11356250|NCT03094195|12553216|FG000|STARTED|Double-Blind Treatment Period (DB)||43
11356251|NCT03094195|12553217|FG001|STARTED|Double-Blind Treatment Period (DB)||43
11356252|NCT03094195|12553218|FG002|STARTED|Double-Blind Treatment Period (DB)||43
11356253|NCT03094195|12553219|FG003|STARTED|Double-Blind Treatment Period (DB)||0
11356254|NCT03094195|12553220|FG004|STARTED|Double-Blind Treatment Period (DB)||0
11356255|NCT03094195|12553221|FG005|STARTED|Double-Blind Treatment Period (DB)||0
11356256|NCT03094195|12553222|FG006|STARTED|Double-Blind Treatment Period (DB)||0
11356257|NCT03094195|12553223|FG007|STARTED|Double-Blind Treatment Period (DB)||0
11356258|NCT03094195|12553216|FG000|COMPLETED|Double-Blind Treatment Period (DB)||28
11356259|NCT03094195|12553217|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30
11356260|NCT03094195|12553218|FG002|COMPLETED|Double-Blind Treatment Period (DB)||29
11356261|NCT03094195|12553219|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0
11356262|NCT03094195|12553220|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0
11356263|NCT03094195|12553221|FG005|COMPLETED|Double-Blind Treatment Period (DB)||0
11356264|NCT03094195|12553222|FG006|COMPLETED|Double-Blind Treatment Period (DB)||0
11356265|NCT03094195|12553223|FG007|COMPLETED|Double-Blind Treatment Period (DB)||0
11356266|NCT03094195|12553216|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||15
11356267|NCT03094195|12553217|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||13
11356268|NCT03094195|12553218|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||14
11356269|NCT03094195|12553219|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
11356270|NCT03094195|12553220|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
11356271|NCT03094195|12553221|FG005|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
11356272|NCT03094195|12553222|FG006|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
11356273|NCT03094195|12553223|FG007|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
11356274|NCT03094195|12553216|FG000|STARTED|Treatment Withdrawal Period (TW)||0
11356275|NCT03094195|12553217|FG001|STARTED|Treatment Withdrawal Period (TW)||0
11234040|NCT02043015|12425746|FG000|NOT COMPLETED|Overall Study||28
11234041|NCT02043132|12425754|FG000|STARTED|Overall Study||58
11234042|NCT02043132|12425755|FG001|STARTED|Overall Study||58
11234043|NCT02043132|12425754|FG000|COMPLETED|Overall Study||53
11234044|NCT02043132|12425755|FG001|COMPLETED|Overall Study||49
11234045|NCT02043132|12425754|FG000|NOT COMPLETED|Overall Study||5
11234046|NCT02043132|12425755|FG001|NOT COMPLETED|Overall Study||9
11234047|NCT02043145|12425764|FG000|STARTED|Overall Study||55
11234048|NCT02043145|12425765|FG001|STARTED|Overall Study||247
11234049|NCT02043145|12425766|FG002|STARTED|Overall Study||425
11234050|NCT02043145|12425764|FG000|COMPLETED|Overall Study||55
11234051|NCT02043145|12425765|FG001|COMPLETED|Overall Study||247
11234052|NCT02043145|12425766|FG002|COMPLETED|Overall Study||425
11234053|NCT02043145|12425764|FG000|NOT COMPLETED|Overall Study||0
11234054|NCT02043145|12425765|FG001|NOT COMPLETED|Overall Study||0
11234055|NCT02043145|12425766|FG002|NOT COMPLETED|Overall Study||0
11234056|NCT02043197|12425776|FG000|STARTED|Overall Study||300
11234057|NCT02043197|12425776|FG000|COMPLETED|Overall Study||292
11234058|NCT02043197|12425776|FG000|NOT COMPLETED|Overall Study||8
11234059|NCT02043301|12425783|FG000|STARTED|Overall Study||25
11234060|NCT02043301|12425784|FG001|STARTED|Overall Study||25
11234061|NCT02043301|12425785|FG002|STARTED|Overall Study||25
11234062|NCT02043301|12425783|FG000|COMPLETED|Overall Study||25
11234063|NCT02043301|12425784|FG001|COMPLETED|Overall Study||24
11234064|NCT02043301|12425785|FG002|COMPLETED|Overall Study||25
11234065|NCT02043301|12425783|FG000|NOT COMPLETED|Overall Study||0
11234066|NCT02043301|12425784|FG001|NOT COMPLETED|Overall Study||1
11234067|NCT02043301|12425785|FG002|NOT COMPLETED|Overall Study||0
11234068|NCT02043366|12425799|FG000|STARTED|Overall Study||30
11234069|NCT02043366|12425800|FG001|STARTED|Overall Study||30
11234070|NCT02043366|12425801|FG002|STARTED|Overall Study||30
11234071|NCT02043366|12425802|FG003|STARTED|Overall Study||30
11234072|NCT02043366|12425803|FG004|STARTED|Overall Study||30
11234073|NCT02043366|12425804|FG005|STARTED|Overall Study||30
11234074|NCT02043366|12425799|FG000|COMPLETED|Overall Study||28
11234075|NCT02043366|12425800|FG001|COMPLETED|Overall Study||28
11234076|NCT02043366|12425801|FG002|COMPLETED|Overall Study||28
11234077|NCT02043366|12425802|FG003|COMPLETED|Overall Study||28
11234078|NCT02043366|12425803|FG004|COMPLETED|Overall Study||28
11234079|NCT02043366|12425804|FG005|COMPLETED|Overall Study||28
11234080|NCT02043366|12425799|FG000|NOT COMPLETED|Overall Study||2
11234081|NCT02043366|12425800|FG001|NOT COMPLETED|Overall Study||2
11234082|NCT02043366|12425801|FG002|NOT COMPLETED|Overall Study||2
11234083|NCT02043366|12425802|FG003|NOT COMPLETED|Overall Study||2
11234084|NCT02043366|12425803|FG004|NOT COMPLETED|Overall Study||2
11234085|NCT02043366|12425804|FG005|NOT COMPLETED|Overall Study||2
11234086|NCT02043379|12425822|FG000|STARTED|Overall Study||30
11234087|NCT02043379|12425823|FG001|STARTED|Overall Study||20
11234088|NCT02043379|12425822|FG000|COMPLETED|Overall Study||30
11234089|NCT02043379|12425823|FG001|COMPLETED|Overall Study||20
11234090|NCT02043379|12425822|FG000|NOT COMPLETED|Overall Study||0
11234091|NCT02043379|12425823|FG001|NOT COMPLETED|Overall Study||0
11234092|NCT02043509|12425831|FG000|STARTED|Baseline to 1st Follow-up||203
11234093|NCT02043509|12425832|FG001|STARTED|Baseline to 1st Follow-up||204
11234094|NCT02043509|12425831|FG000|COMPLETED|Baseline to 1st Follow-up||138
11234095|NCT02043509|12425832|FG001|COMPLETED|Baseline to 1st Follow-up||157
11234096|NCT02043509|12425831|FG000|NOT COMPLETED|Baseline to 1st Follow-up||65
11234097|NCT02043509|12425832|FG001|NOT COMPLETED|Baseline to 1st Follow-up||47
11234098|NCT02043509|12425831|FG000|STARTED|Baseline to 2nd Follow-up||203
11234099|NCT02043509|12425832|FG001|STARTED|Baseline to 2nd Follow-up||204
11234100|NCT02043509|12425831|FG000|COMPLETED|Baseline to 2nd Follow-up||129
11234101|NCT02043509|12425832|FG001|COMPLETED|Baseline to 2nd Follow-up||132
11234102|NCT02043509|12425831|FG000|NOT COMPLETED|Baseline to 2nd Follow-up||74
11234103|NCT02043509|12425832|FG001|NOT COMPLETED|Baseline to 2nd Follow-up||72
11234104|NCT02043548|12425840|FG000|STARTED|Overall Study||18
11234105|NCT02043548|12425841|FG001|STARTED|Overall Study||18
11234106|NCT02043548|12425840|FG000|COMPLETED|Overall Study||17
11234107|NCT02043548|12425841|FG001|COMPLETED|Overall Study||17
11234108|NCT02043548|12425840|FG000|NOT COMPLETED|Overall Study||1
11234109|NCT02043548|12425841|FG001|NOT COMPLETED|Overall Study||1
11234110|NCT02043574|12425849|FG000|STARTED|Overall Study||25
11234111|NCT02043574|12425850|FG001|STARTED|Overall Study||26
11234112|NCT02043574|12425849|FG000|COMPLETED|Overall Study||19
11234113|NCT02043574|12425850|FG001|COMPLETED|Overall Study||20
11234114|NCT02043574|12425849|FG000|NOT COMPLETED|Overall Study||6
11234115|NCT02043574|12425850|FG001|NOT COMPLETED|Overall Study||6
11234116|NCT02043652|12425857|FG000|STARTED|Overall Study||119
11234117|NCT02043652|12425857|FG000|COMPLETED|Overall Study||93
11234118|NCT02043652|12425857|FG000|NOT COMPLETED|Overall Study||26
11234119|NCT02043704|12425863|FG000|STARTED|Overall Study||50
11234120|NCT02043704|12425864|FG001|STARTED|Overall Study||50
11234121|NCT02043704|12425863|FG000|COMPLETED|Overall Study||47
11234122|NCT02043704|12425864|FG001|COMPLETED|Overall Study||43
11234123|NCT02043704|12425863|FG000|NOT COMPLETED|Overall Study||3
11234124|NCT02043704|12425864|FG001|NOT COMPLETED|Overall Study||7
11234125|NCT02043782|12425870|FG000|STARTED|Period 1||7
11234126|NCT02043782|12425871|FG001|STARTED|Period 1||6
11234127|NCT02043782|12425872|FG002|STARTED|Period 1||7
11234128|NCT02043782|12425873|FG003|STARTED|Period 1||6
11234129|NCT02043782|12425874|FG004|STARTED|Period 1||6
11234130|NCT02043782|12425875|FG005|STARTED|Period 1||6
11234131|NCT02043782|12425870|FG000|COMPLETED|Period 1||7
11234132|NCT02043782|12425871|FG001|COMPLETED|Period 1||6
11234133|NCT02043782|12425872|FG002|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
11234134|NCT02043782|12425873|FG003|COMPLETED|Period 1||6
11234135|NCT02043782|12425874|FG004|COMPLETED|Period 1||6
11234136|NCT02043782|12425875|FG005|COMPLETED|Period 1||6
11234137|NCT02043782|12425870|FG000|NOT COMPLETED|Period 1||0
11356276|NCT03094195|12553218|FG002|STARTED|Treatment Withdrawal Period (TW)||0
11356277|NCT03094195|12553219|FG003|STARTED|Treatment Withdrawal Period (TW)||13
11356278|NCT03094195|12553220|FG004|STARTED|Treatment Withdrawal Period (TW)||13
11356279|NCT03094195|12553221|FG005|STARTED|Treatment Withdrawal Period (TW)||15
11356280|NCT03094195|12553222|FG006|STARTED|Treatment Withdrawal Period (TW)||13
11356281|NCT03094195|12553223|FG007|STARTED|Treatment Withdrawal Period (TW)||26
11356282|NCT03094195|12553216|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0
11356283|NCT03094195|12553217|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0
11356284|NCT03094195|12553218|FG002|COMPLETED|Treatment Withdrawal Period (TW)||0
11234138|NCT02043782|12425871|FG001|NOT COMPLETED|Period 1||0
11234139|NCT02043782|12425872|FG002|NOT COMPLETED|Period 1||1
11356285|NCT03094195|12553219|FG003|COMPLETED|Treatment Withdrawal Period (TW)||13
11356286|NCT03094195|12553220|FG004|COMPLETED|Treatment Withdrawal Period (TW)||13
11356287|NCT03094195|12553221|FG005|COMPLETED|Treatment Withdrawal Period (TW)||15
11356288|NCT03094195|12553222|FG006|COMPLETED|Treatment Withdrawal Period (TW)||13
11356289|NCT03094195|12553223|FG007|COMPLETED|Treatment Withdrawal Period (TW)||26
11356290|NCT03094195|12553216|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
11356291|NCT03094195|12553217|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
11356292|NCT03094195|12553218|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
11356293|NCT03094195|12553219|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
11356294|NCT03094195|12553220|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
11356295|NCT03094195|12553221|FG005|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
11356296|NCT03094195|12553222|FG006|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
11356297|NCT03094195|12553223|FG007|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
11356298|NCT03094325|12553241|FG000|STARTED|Overall Study||10
11356299|NCT03094325|12553241|FG000|TEE Before Cardiopulmonary Bypass|Overall Study||10
11356300|NCT03094325|12553241|FG000|OPIE Before Cardiopulmonary Bypass|Overall Study||10
11356301|NCT03094325|12553241|FG000|TEE After Cardiopulmonary Bypass|Overall Study||10
11356302|NCT03094325|12553241|FG000|OPIE After Cardiopulmonary Bypass|Overall Study||10
11356303|NCT03094325|12553241|FG000|COMPLETED|Overall Study||10
11356304|NCT03094325|12553241|FG000|NOT COMPLETED|Overall Study||0
11356305|NCT03094611|12553247|FG000|STARTED|Overall Study||4
11356306|NCT03094611|12553247|FG000|COMPLETED|Overall Study||2
11356307|NCT03094611|12553247|FG000|NOT COMPLETED|Overall Study||2
11356308|NCT03094806|12553253|FG000|STARTED|Overall Study||44
11356309|NCT03094806|12553254|FG001|STARTED|Overall Study||47
11356310|NCT03094806|12553253|FG000|COMPLETED|Overall Study||44
11356311|NCT03094806|12553254|FG001|COMPLETED|Overall Study||47
11356312|NCT03094806|12553253|FG000|NOT COMPLETED|Overall Study||0
11356313|NCT03094806|12553254|FG001|NOT COMPLETED|Overall Study||0
11356314|NCT03095027|12553260|FG000|STARTED|Period 1, First Week of Wear||27
11356315|NCT03095027|12553261|FG001|STARTED|Period 1, First Week of Wear||24
11356316|NCT03095027|12553260|FG000|COMPLETED|Period 1, First Week of Wear||27
11356317|NCT03095027|12553261|FG001|COMPLETED|Period 1, First Week of Wear||24
11356318|NCT03095027|12553260|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
11356319|NCT03095027|12553261|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
11356320|NCT03095027|12553260|FG000|STARTED|Period 2, Second Week of Wear||27
11356321|NCT03095027|12553261|FG001|STARTED|Period 2, Second Week of Wear||24
11356322|NCT03095027|12553260|FG000|COMPLETED|Period 2, Second Week of Wear||26
11356323|NCT03095027|12553261|FG001|COMPLETED|Period 2, Second Week of Wear||24
11356324|NCT03095027|12553260|FG000|NOT COMPLETED|Period 2, Second Week of Wear||1
11356325|NCT03095027|12553261|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
11356326|NCT03095053|12553269|FG000|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109
11356327|NCT03095053|12553270|FG001|STARTED|Overall Study|All blastocysts scored morphologically|111
11356328|NCT03095053|12553269|FG000|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80
11356329|NCT03095053|12553270|FG001|COMPLETED|Overall Study||111
11356330|NCT03095053|12553269|FG000|NOT COMPLETED|Overall Study||29
11356331|NCT03095053|12553270|FG001|NOT COMPLETED|Overall Study||0
11356332|NCT03095508|12553278|FG000|STARTED|Overall Study||114
11356333|NCT03095508|12553279|FG001|STARTED|Overall Study||115
11356334|NCT03095508|12553278|FG000|Per Protocol Population|Overall Study||112
11356335|NCT03095508|12553279|FG001|Per Protocol Population|Overall Study||111
11356336|NCT03095508|12553278|FG000|Safety Population|Overall Study||114
11356337|NCT03095508|12553279|FG001|Safety Population|Overall Study||115
11356338|NCT03095508|12553278|FG000|ITT Population|Overall Study||114
11356339|NCT03095508|12553279|FG001|ITT Population|Overall Study||115
11356340|NCT03095508|12553278|FG000|COMPLETED|Overall Study||114
11356341|NCT03095508|12553279|FG001|COMPLETED|Overall Study||114
11356342|NCT03095508|12553278|FG000|NOT COMPLETED|Overall Study||0
11356343|NCT03095508|12553279|FG001|NOT COMPLETED|Overall Study||1
11356344|NCT03095521|12553287|FG000|STARTED|Overall Study||115
11356345|NCT03095521|12553288|FG001|STARTED|Overall Study||113
11356346|NCT03095521|12553287|FG000|Intent to Treat Population ITT|Overall Study||115
11356347|NCT03095521|12553288|FG001|Intent to Treat Population ITT|Overall Study||113
11356348|NCT03095521|12553287|FG000|Per Protocol Population PP|Overall Study||113
11234140|NCT02043782|12425873|FG003|NOT COMPLETED|Period 1||0
11234141|NCT02043782|12425874|FG004|NOT COMPLETED|Period 1||0
11234142|NCT02043782|12425875|FG005|NOT COMPLETED|Period 1||0
11234143|NCT02043782|12425870|FG000|STARTED|Period 2||7
11234144|NCT02043782|12425871|FG001|STARTED|Period 2||6
11234145|NCT02043782|12425872|FG002|STARTED|Period 2||6
11234146|NCT02043782|12425873|FG003|STARTED|Period 2||6
11234147|NCT02043782|12425874|FG004|STARTED|Period 2||6
11234148|NCT02043782|12425875|FG005|STARTED|Period 2||6
11234149|NCT02043782|12425870|FG000|COMPLETED|Period 2||7
11234150|NCT02043782|12425871|FG001|COMPLETED|Period 2||6
11234151|NCT02043782|12425872|FG002|COMPLETED|Period 2||6
11234152|NCT02043782|12425873|FG003|COMPLETED|Period 2||6
11234153|NCT02043782|12425874|FG004|COMPLETED|Period 2||6
11234154|NCT02043782|12425875|FG005|COMPLETED|Period 2||6
11234155|NCT02043782|12425870|FG000|NOT COMPLETED|Period 2||0
11234156|NCT02043782|12425871|FG001|NOT COMPLETED|Period 2||0
11234157|NCT02043782|12425872|FG002|NOT COMPLETED|Period 2||0
11234158|NCT02043782|12425873|FG003|NOT COMPLETED|Period 2||0
11234159|NCT02043782|12425874|FG004|NOT COMPLETED|Period 2||0
11234160|NCT02043782|12425875|FG005|NOT COMPLETED|Period 2||0
11234161|NCT02043782|12425870|FG000|STARTED|Period 3||7
11234162|NCT02043782|12425871|FG001|STARTED|Period 3||6
11234163|NCT02043782|12425872|FG002|STARTED|Period 3||6
11234164|NCT02043782|12425873|FG003|STARTED|Period 3||6
11234165|NCT02043782|12425874|FG004|STARTED|Period 3||6
11234166|NCT02043782|12425875|FG005|STARTED|Period 3||6
11234167|NCT02043782|12425870|FG000|COMPLETED|Period 3||7
11234168|NCT02043782|12425871|FG001|COMPLETED|Period 3||6
11234169|NCT02043782|12425872|FG002|COMPLETED|Period 3||6
11234170|NCT02043782|12425873|FG003|COMPLETED|Period 3||6
11234171|NCT02043782|12425874|FG004|COMPLETED|Period 3||6
11234172|NCT02043782|12425875|FG005|COMPLETED|Period 3||6
11234173|NCT02043782|12425870|FG000|NOT COMPLETED|Period 3||0
11234174|NCT02043782|12425871|FG001|NOT COMPLETED|Period 3||0
11234175|NCT02043782|12425872|FG002|NOT COMPLETED|Period 3||0
11234176|NCT02043782|12425873|FG003|NOT COMPLETED|Period 3||0
11234177|NCT02043782|12425874|FG004|NOT COMPLETED|Period 3||0
11234178|NCT02043782|12425875|FG005|NOT COMPLETED|Period 3||0
11234179|NCT02043808|12425885|FG000|STARTED|Overall Study||12793
11234180|NCT02043808|12425886|FG001|STARTED|Overall Study||12793
11234181|NCT02043808|12425885|FG000|COMPLETED|Overall Study||12793
11234182|NCT02043808|12425886|FG001|COMPLETED|Overall Study||12793
11234183|NCT02043808|12425885|FG000|NOT COMPLETED|Overall Study||0
11234184|NCT02043808|12425886|FG001|NOT COMPLETED|Overall Study||0
11234185|NCT02043899|12425892|FG000|STARTED|Overall Study||36
11234186|NCT02043899|12425892|FG000|Underwent Routine [123I]mIBG Planar and SPECT/CT Imaging|Overall Study||32
11234187|NCT02043899|12425892|FG000|Underwent [124I]mIBG PET/CT Imaging|Overall Study||9
11234188|NCT02043899|12425892|FG000|COMPLETED|Overall Study||9
11234189|NCT02043899|12425892|FG000|NOT COMPLETED|Overall Study||27
11234190|NCT02043938|12425896|FG000|STARTED|Overall Study||46
11234191|NCT02043938|12425896|FG000|COMPLETED|Overall Study||36
11234192|NCT02043938|12425896|FG000|NOT COMPLETED|Overall Study||10
11234193|NCT02044094|12425903|FG000|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
11234194|NCT02044094|12425903|FG000|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
11234195|NCT02044094|12425903|FG000|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
11234196|NCT02044094|12425903|FG000|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
11234197|NCT02044094|12425903|FG000|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
11234198|NCT02044094|12425903|FG000|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
11234199|NCT02044094|12425903|FG000|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
11234200|NCT02044094|12425903|FG000|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
11356349|NCT03095521|12553288|FG001|Per Protocol Population PP|Overall Study||107
11356350|NCT03095521|12553287|FG000|Safety Population|Overall Study||115
11356351|NCT03095521|12553288|FG001|Safety Population|Overall Study||113
11356352|NCT03095521|12553287|FG000|COMPLETED|Overall Study||115
11356353|NCT03095521|12553288|FG001|COMPLETED|Overall Study||111
11356354|NCT03095521|12553287|FG000|NOT COMPLETED|Overall Study||0
11356355|NCT03095521|12553288|FG001|NOT COMPLETED|Overall Study||2
11356356|NCT03095599|12553296|FG000|STARTED|Overall Study||741
11356357|NCT03095599|12553297|FG001|STARTED|Overall Study||148
11356358|NCT03095599|12553296|FG000|Withdrawal Before Vaccination|Overall Study||1
11356359|NCT03095599|12553297|FG001|Withdrawal Before Vaccination|Overall Study||0
11356360|NCT03095599|12553296|FG000|Vaccinated|Overall Study||740
11356361|NCT03095599|12553297|FG001|Vaccinated|Overall Study||148
11356362|NCT03095599|12553296|FG000|COMPLETED|Overall Study||738
11356363|NCT03095599|12553297|FG001|COMPLETED|Overall Study||148
11356364|NCT03095599|12553296|FG000|NOT COMPLETED|Overall Study||3
11356365|NCT03095599|12553297|FG001|NOT COMPLETED|Overall Study||0
11356366|NCT03095638|12553307|FG000|STARTED|P1: Period 1 (4 Days)||7
11356367|NCT03095638|12553308|FG001|STARTED|P1: Period 1 (4 Days)||7
11356368|NCT03095638|12553309|FG002|STARTED|P1: Period 1 (4 Days)||0
11356369|NCT03095638|12553310|FG003|STARTED|P1: Period 1 (4 Days)||0
11356370|NCT03095638|12553311|FG004|STARTED|P1: Period 1 (4 Days)||0
11356371|NCT03095638|12553312|FG005|STARTED|P1: Period 1 (4 Days)||0
11356372|NCT03095638|12553313|FG006|STARTED|P1: Period 1 (4 Days)||0
11356373|NCT03095638|12553314|FG007|STARTED|P1: Period 1 (4 Days)||0
11356374|NCT03095638|12553307|FG000|COMPLETED|P1: Period 1 (4 Days)||7
11356375|NCT03095638|12553308|FG001|COMPLETED|P1: Period 1 (4 Days)||7
11356376|NCT03095638|12553309|FG002|COMPLETED|P1: Period 1 (4 Days)||0
11356377|NCT03095638|12553310|FG003|COMPLETED|P1: Period 1 (4 Days)||0
11356378|NCT03095638|12553311|FG004|COMPLETED|P1: Period 1 (4 Days)||0
11356379|NCT03095638|12553312|FG005|COMPLETED|P1: Period 1 (4 Days)||0
11356380|NCT03095638|12553313|FG006|COMPLETED|P1: Period 1 (4 Days)||0
11356381|NCT03095638|12553314|FG007|COMPLETED|P1: Period 1 (4 Days)||0
11356382|NCT03095638|12553307|FG000|NOT COMPLETED|P1: Period 1 (4 Days)||0
11356383|NCT03095638|12553308|FG001|NOT COMPLETED|P1: Period 1 (4 Days)||0
11356384|NCT03095638|12553309|FG002|NOT COMPLETED|P1: Period 1 (4 Days)||0
11356385|NCT03095638|12553310|FG003|NOT COMPLETED|P1: Period 1 (4 Days)||0
11356386|NCT03095638|12553311|FG004|NOT COMPLETED|P1: Period 1 (4 Days)||0
11356387|NCT03095638|12553312|FG005|NOT COMPLETED|P1: Period 1 (4 Days)||0
11356388|NCT03095638|12553313|FG006|NOT COMPLETED|P1: Period 1 (4 Days)||0
11356389|NCT03095638|12553314|FG007|NOT COMPLETED|P1: Period 1 (4 Days)||0
11356390|NCT03095638|12553307|FG000|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
11356391|NCT03095638|12553308|FG001|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
11356392|NCT03095638|12553309|FG002|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
11356393|NCT03095638|12553310|FG003|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
11356394|NCT03095638|12553311|FG004|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
11356395|NCT03095638|12553312|FG005|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
11356396|NCT03095638|12553313|FG006|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
11356397|NCT03095638|12553314|FG007|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
11234201|NCT02044159|12425920|FG000|STARTED|Overall Study||27
11234202|NCT02044159|12425921|FG001|STARTED|Overall Study||30
11234203|NCT02044159|12425920|FG000|COMPLETED|Overall Study||23
11234204|NCT02044159|12425921|FG001|COMPLETED|Overall Study||26
11234205|NCT02044159|12425920|FG000|NOT COMPLETED|Overall Study||4
11234206|NCT02044159|12425921|FG001|NOT COMPLETED|Overall Study||4
11234207|NCT02044367|12425930|FG000|STARTED|Overall Study||9
11234208|NCT02044367|12425931|FG001|STARTED|Overall Study||9
11234209|NCT02044367|12425932|FG002|STARTED|Overall Study||9
11234210|NCT02044367|12425933|FG003|STARTED|Overall Study||9
11234211|NCT02044367|12425934|FG004|STARTED|Overall Study||9
11234212|NCT02044367|12425935|FG005|STARTED|Overall Study||9
11234213|NCT02044367|12425930|FG000|COMPLETED|Overall Study||9
11234214|NCT02044367|12425931|FG001|COMPLETED|Overall Study||9
11234215|NCT02044367|12425932|FG002|COMPLETED|Overall Study||9
11234216|NCT02044367|12425933|FG003|COMPLETED|Overall Study||9
11234217|NCT02044367|12425934|FG004|COMPLETED|Overall Study||9
11234218|NCT02044367|12425935|FG005|COMPLETED|Overall Study||9
11234219|NCT02044367|12425930|FG000|NOT COMPLETED|Overall Study||0
11234220|NCT02044367|12425931|FG001|NOT COMPLETED|Overall Study||0
11234221|NCT02044367|12425932|FG002|NOT COMPLETED|Overall Study||0
11234222|NCT02044367|12425933|FG003|NOT COMPLETED|Overall Study||0
11234223|NCT02044367|12425934|FG004|NOT COMPLETED|Overall Study||0
11234224|NCT02044367|12425935|FG005|NOT COMPLETED|Overall Study||0
11234225|NCT02044380|12425947|FG000|STARTED|Overall Study|Started are the treated patients|14
11234226|NCT02044380|12425947|FG000|COMPLETED|Overall Study||14
11234227|NCT02044380|12425947|FG000|NOT COMPLETED|Overall Study||0
11234228|NCT02044393|12425953|FG000|STARTED|Period 1||10
11234229|NCT02044393|12425954|FG001|STARTED|Period 1||10
11234230|NCT02044393|12425953|FG000|COMPLETED|Period 1||10
11234231|NCT02044393|12425954|FG001|COMPLETED|Period 1||10
11234232|NCT02044393|12425953|FG000|NOT COMPLETED|Period 1||0
11234233|NCT02044393|12425954|FG001|NOT COMPLETED|Period 1||0
11234234|NCT02044393|12425953|FG000|STARTED|Period 2||10
11234235|NCT02044393|12425954|FG001|STARTED|Period 2||10
11234236|NCT02044393|12425953|FG000|COMPLETED|Period 2||10
11234237|NCT02044393|12425954|FG001|COMPLETED|Period 2||10
11234238|NCT02044393|12425953|FG000|NOT COMPLETED|Period 2||0
11234239|NCT02044393|12425954|FG001|NOT COMPLETED|Period 2||0
11234240|NCT02044419|12425967|FG000|STARTED|First Intervention||11
11234241|NCT02044419|12425968|FG001|STARTED|First Intervention||10
11356398|NCT03095638|12553307|FG000|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
11356399|NCT03095638|12553308|FG001|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
11356400|NCT03095638|12553309|FG002|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
11356401|NCT03095638|12553310|FG003|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
11356402|NCT03095638|12553311|FG004|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
11356403|NCT03095638|12553312|FG005|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
11234242|NCT02044419|12425969|FG002|STARTED|First Intervention||11
11234243|NCT02044419|12425967|FG000|COMPLETED|First Intervention||11
11117681|NCT01318876|12302284|FG000|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
11117682|NCT01318876|12302284|FG000|COMPLETED|Day 29 Survey||5724
11234244|NCT02044419|12425968|FG001|COMPLETED|First Intervention||9
11234245|NCT02044419|12425969|FG002|COMPLETED|First Intervention||10
11234246|NCT02044419|12425967|FG000|NOT COMPLETED|First Intervention||0
11234247|NCT02044419|12425968|FG001|NOT COMPLETED|First Intervention||1
11234248|NCT02044419|12425969|FG002|NOT COMPLETED|First Intervention||1
11234249|NCT02044419|12425967|FG000|STARTED|Second Intervention||11
11234250|NCT02044419|12425968|FG001|STARTED|Second Intervention||9
11234251|NCT02044419|12425969|FG002|STARTED|Second Intervention||10
11234252|NCT02044419|12425967|FG000|COMPLETED|Second Intervention||11
11234253|NCT02044419|12425968|FG001|COMPLETED|Second Intervention||9
11234254|NCT02044419|12425969|FG002|COMPLETED|Second Intervention||10
11234255|NCT02044419|12425967|FG000|NOT COMPLETED|Second Intervention||0
11234256|NCT02044419|12425968|FG001|NOT COMPLETED|Second Intervention||0
11234257|NCT02044419|12425969|FG002|NOT COMPLETED|Second Intervention||0
11234258|NCT02044419|12425967|FG000|STARTED|Third Intervention||11
11234259|NCT02044419|12425968|FG001|STARTED|Third Intervention||9
11234260|NCT02044419|12425969|FG002|STARTED|Third Intervention||10
11234261|NCT02044419|12425967|FG000|COMPLETED|Third Intervention||11
11234262|NCT02044419|12425968|FG001|COMPLETED|Third Intervention||9
11234263|NCT02044419|12425969|FG002|COMPLETED|Third Intervention||10
11234264|NCT02044419|12425967|FG000|NOT COMPLETED|Third Intervention||0
11234265|NCT02044419|12425968|FG001|NOT COMPLETED|Third Intervention||0
11234266|NCT02044419|12425969|FG002|NOT COMPLETED|Third Intervention||0
11234267|NCT02044458|12425979|FG000|STARTED|Overall Study||65
11234268|NCT02044458|12425980|FG001|STARTED|Overall Study||69
11234269|NCT02044458|12425979|FG000|COMPLETED|Overall Study||62
11234270|NCT02044458|12425980|FG001|COMPLETED|Overall Study||61
11234271|NCT02044458|12425979|FG000|NOT COMPLETED|Overall Study||3
11234272|NCT02044458|12425980|FG001|NOT COMPLETED|Overall Study||8
11234273|NCT02044510|12425988|FG000|STARTED|Overall Study||16
11234274|NCT02044510|12425989|FG001|STARTED|Overall Study||16
11234275|NCT02044510|12425988|FG000|COMPLETED|Overall Study||15
11234276|NCT02044510|12425989|FG001|COMPLETED|Overall Study||14
11234277|NCT02044510|12425988|FG000|NOT COMPLETED|Overall Study||1
11234278|NCT02044510|12425989|FG001|NOT COMPLETED|Overall Study||2
11234279|NCT02044796|12425997|FG000|STARTED|Overall Study||9
11234280|NCT02044796|12425998|FG001|STARTED|Overall Study||9
11234281|NCT02044796|12425999|FG002|STARTED|Overall Study||9
11234282|NCT02044796|12426000|FG003|STARTED|Overall Study||6
11234283|NCT02044796|12426001|FG004|STARTED|Overall Study||10
11234284|NCT02044796|12426002|FG005|STARTED|Overall Study||6
11234285|NCT02044796|12426003|FG006|STARTED|Overall Study||6
11234286|NCT02044796|12426004|FG007|STARTED|Overall Study||4
11234287|NCT02044796|12426005|FG008|STARTED|Overall Study||106
11234288|NCT02044796|12426006|FG009|STARTED|Overall Study||34
11234289|NCT02044796|12425997|FG000|COMPLETED|Overall Study||9
11234290|NCT02044796|12425998|FG001|COMPLETED|Overall Study||9
11234291|NCT02044796|12425999|FG002|COMPLETED|Overall Study||9
11234292|NCT02044796|12426000|FG003|COMPLETED|Overall Study||6
11234293|NCT02044796|12426001|FG004|COMPLETED|Overall Study||10
11234294|NCT02044796|12426002|FG005|COMPLETED|Overall Study||6
11234295|NCT02044796|12426003|FG006|COMPLETED|Overall Study||6
11234296|NCT02044796|12426004|FG007|COMPLETED|Overall Study||4
11234297|NCT02044796|12426005|FG008|COMPLETED|Overall Study||106
11234298|NCT02044796|12426006|FG009|COMPLETED|Overall Study||34
11234299|NCT02044796|12425997|FG000|NOT COMPLETED|Overall Study||0
11234300|NCT02044796|12425998|FG001|NOT COMPLETED|Overall Study||0
11234301|NCT02044796|12425999|FG002|NOT COMPLETED|Overall Study||0
11234302|NCT02044796|12426000|FG003|NOT COMPLETED|Overall Study||0
11234303|NCT02044796|12426001|FG004|NOT COMPLETED|Overall Study||0
11234304|NCT02044796|12426002|FG005|NOT COMPLETED|Overall Study||0
11234305|NCT02044796|12426003|FG006|NOT COMPLETED|Overall Study||0
11234306|NCT02044796|12426004|FG007|NOT COMPLETED|Overall Study||0
11234307|NCT02044796|12426005|FG008|NOT COMPLETED|Overall Study||0
11234308|NCT02044796|12426006|FG009|NOT COMPLETED|Overall Study||0
11234309|NCT02044874|12426027|FG000|STARTED|Overall Study||201
11234310|NCT02044874|12426028|FG001|STARTED|Overall Study||202
11234311|NCT02044874|12426029|FG002|STARTED|Overall Study||200
11234312|NCT02044874|12426027|FG000|COMPLETED|Overall Study||171
11234313|NCT02044874|12426028|FG001|COMPLETED|Overall Study||147
11234314|NCT02044874|12426029|FG002|COMPLETED|Overall Study||140
11234315|NCT02044874|12426027|FG000|NOT COMPLETED|Overall Study||30
11234316|NCT02044874|12426028|FG001|NOT COMPLETED|Overall Study||55
11234317|NCT02044874|12426029|FG002|NOT COMPLETED|Overall Study||60
11117683|NCT01318876|12302284|FG000|NOT COMPLETED|Day 29 Survey||1825
11117684|NCT01318902|12302292|FG000|STARTED|Overall Study||6
11117685|NCT01318902|12302293|FG001|STARTED|Overall Study||5
11117686|NCT01318902|12302294|FG002|STARTED|Overall Study||5
11117687|NCT01318902|12302295|FG003|STARTED|Overall Study||11
11117688|NCT01318902|12302292|FG000|COMPLETED|Overall Study||5
11117689|NCT01318902|12302293|FG001|COMPLETED|Overall Study||2
11117690|NCT01318902|12302294|FG002|COMPLETED|Overall Study||3
11117691|NCT01318902|12302295|FG003|COMPLETED|Overall Study||5
11117692|NCT01318902|12302292|FG000|NOT COMPLETED|Overall Study||1
11117693|NCT01318902|12302293|FG001|NOT COMPLETED|Overall Study||3
11234318|NCT02044991|12426041|FG000|STARTED|Overall Study||2
11234319|NCT02044991|12426042|FG001|STARTED|Overall Study||0
11117694|NCT01318902|12302294|FG002|NOT COMPLETED|Overall Study||2
11117695|NCT01318902|12302295|FG003|NOT COMPLETED|Overall Study||6
11117696|NCT01318915|12302307|FG000|STARTED|Overall Study||10
11117697|NCT01318915|12302307|FG000|COMPLETED|Overall Study||9
11117698|NCT01318915|12302307|FG000|NOT COMPLETED|Overall Study||1
11117699|NCT01318967|12302313|FG000|STARTED|Overall Study||10
11117700|NCT01318967|12302313|FG000|COMPLETED|Overall Study||10
11117701|NCT01318967|12302313|FG000|NOT COMPLETED|Overall Study||0
11117702|NCT01319045|12302318|FG000|STARTED|Overall Study||5
11117703|NCT01319045|12302318|FG000|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
11117704|NCT01319045|12302318|FG000|NOT COMPLETED|Overall Study||2
11117705|NCT01319110|12302324|FG000|STARTED|Overall Study||5
11117706|NCT01319110|12302325|FG001|STARTED|Overall Study||5
11117707|NCT01319110|12302324|FG000|COMPLETED|Overall Study||5
11117708|NCT01319110|12302325|FG001|COMPLETED|Overall Study||5
11117709|NCT01319110|12302324|FG000|NOT COMPLETED|Overall Study||0
11117710|NCT01319110|12302325|FG001|NOT COMPLETED|Overall Study||0
11117711|NCT01319318|12302331|FG000|STARTED|Overall Study||25
11117712|NCT01319318|12302331|FG000|COMPLETED|Overall Study||25
11117713|NCT01319318|12302331|FG000|NOT COMPLETED|Overall Study||0
11117714|NCT01319383|12302335|FG000|STARTED|Overall Study||12
11117715|NCT01319383|12302336|FG001|STARTED|Overall Study||13
11117716|NCT01319383|12302335|FG000|Step 1|Overall Study||8
11234320|NCT02044991|12426041|FG000|COMPLETED|Overall Study||2
11234321|NCT02044991|12426042|FG001|COMPLETED|Overall Study||0
11234322|NCT02044991|12426041|FG000|NOT COMPLETED|Overall Study||0
11234323|NCT02044991|12426042|FG001|NOT COMPLETED|Overall Study||0
11234324|NCT02045095|12426048|FG000|STARTED|Overall Study||3
11234325|NCT02045095|12426049|FG001|STARTED|Overall Study||4
11117717|NCT01319383|12302336|FG001|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
11117718|NCT01319383|12302335|FG000|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
11117719|NCT01319383|12302336|FG001|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
11117720|NCT01319383|12302335|FG000|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
11117721|NCT01319383|12302336|FG001|Step 2|Overall Study||0
11117722|NCT01319383|12302335|FG000|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
11117723|NCT01319383|12302336|FG001|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
11117724|NCT01319383|12302335|FG000|Step 4|Overall Study|Arm 1 did not have a Step 4|0
11117725|NCT01319383|12302336|FG001|Step 4|Overall Study|Only 3/6 completed the study.|3
11117726|NCT01319383|12302335|FG000|COMPLETED|Overall Study||0
11117727|NCT01319383|12302336|FG001|COMPLETED|Overall Study||3
11117728|NCT01319383|12302335|FG000|NOT COMPLETED|Overall Study||12
11117729|NCT01319383|12302336|FG001|NOT COMPLETED|Overall Study||10
11117730|NCT01319396|12302353|FG000|STARTED|Overall Study||24
11117731|NCT01319396|12302353|FG000|COMPLETED|Overall Study||24
11117732|NCT01319396|12302353|FG000|NOT COMPLETED|Overall Study||0
11117733|NCT01319422|12302359|FG000|STARTED|Overall Study||20
11117734|NCT01319422|12302360|FG001|STARTED|Overall Study||20
11117735|NCT01319422|12302359|FG000|COMPLETED|Overall Study||19
11117736|NCT01319422|12302360|FG001|COMPLETED|Overall Study||20
11117737|NCT01319422|12302359|FG000|NOT COMPLETED|Overall Study||1
11117738|NCT01319422|12302360|FG001|NOT COMPLETED|Overall Study||0
11117739|NCT01319500|12302368|FG000|STARTED|Overall Study||1187
11117740|NCT01319500|12302369|FG001|STARTED|Overall Study||2589
11117741|NCT01319500|12302368|FG000|COMPLETED|Overall Study||1187
11117742|NCT01319500|12302369|FG001|COMPLETED|Overall Study||2589
11117743|NCT01319500|12302368|FG000|NOT COMPLETED|Overall Study||0
11117744|NCT01319500|12302369|FG001|NOT COMPLETED|Overall Study||0
11117745|NCT01319539|12302380|FG000|STARTED|Overall Study||12
11117746|NCT01319539|12302380|FG000|COMPLETED|Overall Study||12
11117747|NCT01319539|12302380|FG000|NOT COMPLETED|Overall Study||0
11117748|NCT01319552|12302386|FG000|STARTED|Overall Study||14
11117749|NCT01319552|12302386|FG000|COMPLETED|Overall Study||14
11117750|NCT01319552|12302386|FG000|NOT COMPLETED|Overall Study||0
11117751|NCT01319617|12302391|FG000|STARTED|Overall Study||41
11117752|NCT01319617|12302391|FG000|COMPLETED|Overall Study||40
11117753|NCT01319617|12302391|FG000|NOT COMPLETED|Overall Study||1
11117754|NCT01319721|12302397|FG000|STARTED|Overall Study|The unit of measure is eyes.|48
11117755|NCT01319721|12302398|FG001|STARTED|Overall Study|The unit of measure is eyes.|48
11117756|NCT01319721|12302397|FG000|COMPLETED|Overall Study|The unit of measure is eyes.|47
11117757|NCT01319721|12302398|FG001|COMPLETED|Overall Study|The unit of measure is eyes.|42
11117758|NCT01319721|12302397|FG000|NOT COMPLETED|Overall Study||1
11117759|NCT01319721|12302398|FG001|NOT COMPLETED|Overall Study||6
11117760|NCT01319773|12302409|FG000|STARTED|Overall Study||10
11117761|NCT01319773|12302410|FG001|STARTED|Overall Study||10
11117762|NCT01319773|12302411|FG002|STARTED|Overall Study||8
11117763|NCT01319773|12302412|FG003|STARTED|Overall Study||8
11117764|NCT01319773|12302413|FG004|STARTED|Overall Study||8
11117765|NCT01319773|12302409|FG000|COMPLETED|Overall Study||10
11117766|NCT01319773|12302410|FG001|COMPLETED|Overall Study||10
11117767|NCT01319773|12302411|FG002|COMPLETED|Overall Study||8
11117768|NCT01319773|12302412|FG003|COMPLETED|Overall Study||8
11117769|NCT01319773|12302413|FG004|COMPLETED|Overall Study||8
11117770|NCT01319773|12302409|FG000|NOT COMPLETED|Overall Study||0
11117771|NCT01319773|12302410|FG001|NOT COMPLETED|Overall Study||0
11117772|NCT01319773|12302411|FG002|NOT COMPLETED|Overall Study||0
11117773|NCT01319773|12302412|FG003|NOT COMPLETED|Overall Study||0
11117774|NCT01319773|12302413|FG004|NOT COMPLETED|Overall Study||0
11117775|NCT01319799|12302423|FG000|STARTED|Overall Study||10
11117776|NCT01319799|12302423|FG000|COMPLETED|Overall Study||10
11117777|NCT01319799|12302423|FG000|NOT COMPLETED|Overall Study||0
11117778|NCT01319812|12302429|FG000|STARTED|Overall Study||161
11117779|NCT01319812|12302430|FG001|STARTED|Overall Study||302
11117780|NCT01319812|12302429|FG000|COMPLETED|Overall Study||145
11117781|NCT01319812|12302430|FG001|COMPLETED|Overall Study||280
11117782|NCT01319812|12302429|FG000|NOT COMPLETED|Overall Study||16
11117783|NCT01319812|12302430|FG001|NOT COMPLETED|Overall Study||22
11117784|NCT01319851|12302443|FG000|STARTED|Overall Study||3
11117785|NCT01319851|12302443|FG000|COMPLETED|Overall Study||3
11117786|NCT01319851|12302443|FG000|NOT COMPLETED|Overall Study||0
11117787|NCT01319877|12302449|FG000|STARTED|Overall Study||453
11117788|NCT01319877|12302450|FG001|STARTED|Overall Study||153
11117789|NCT01319877|12302449|FG000|COMPLETED|Overall Study||345
11117790|NCT01319877|12302450|FG001|COMPLETED|Overall Study||108
11117791|NCT01319877|12302449|FG000|NOT COMPLETED|Overall Study||108
11117792|NCT01319877|12302450|FG001|NOT COMPLETED|Overall Study||45
11117793|NCT01319929|12302457|FG000|STARTED|First Treatment Period (4 Weeks)||20
11117794|NCT01319929|12302458|FG001|STARTED|First Treatment Period (4 Weeks)||19
11117795|NCT01319929|12302457|FG000|COMPLETED|First Treatment Period (4 Weeks)||17
11117796|NCT01319929|12302458|FG001|COMPLETED|First Treatment Period (4 Weeks)||17
11117797|NCT01319929|12302457|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||3
11117798|NCT01319929|12302458|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||2
11117799|NCT01319929|12302457|FG000|STARTED|Washout Period (3 Weeks)||17
11117800|NCT01319929|12302458|FG001|STARTED|Washout Period (3 Weeks)||17
11117801|NCT01319929|12302457|FG000|COMPLETED|Washout Period (3 Weeks)||17
11117802|NCT01319929|12302458|FG001|COMPLETED|Washout Period (3 Weeks)||17
11117803|NCT01319929|12302457|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
11117804|NCT01319929|12302458|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
11117805|NCT01319929|12302457|FG000|STARTED|Second Treatment Period (4 Weeks)||17
11117806|NCT01319929|12302458|FG001|STARTED|Second Treatment Period (4 Weeks)||17
11117807|NCT01319929|12302457|FG000|COMPLETED|Second Treatment Period (4 Weeks)||16
11117808|NCT01319929|12302458|FG001|COMPLETED|Second Treatment Period (4 Weeks)||16
11117809|NCT01319929|12302457|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
11117810|NCT01319929|12302458|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
11117811|NCT01319994|12302467|FG000|STARTED|Overall Study||26
11117812|NCT01319994|12302468|FG001|STARTED|Overall Study||27
11117813|NCT01319994|12302467|FG000|Abto Keep Appoinment Shedule|Overall Study||23
11117814|NCT01319994|12302468|FG001|Abto Keep Appoinment Shedule|Overall Study||24
11117815|NCT01319994|12302467|FG000|Tolerated at Least 1.7g/Day Dose|Overall Study||19
11117816|NCT01319994|12302468|FG001|Tolerated at Least 1.7g/Day Dose|Overall Study||24
11117817|NCT01319994|12302467|FG000|Glucocorticoid Dose as Inc Cri|Overall Study||19
11117818|NCT01319994|12302468|FG001|Glucocorticoid Dose as Inc Cri|Overall Study||22
11117819|NCT01319994|12302467|FG000|Did Not Develop Overt Diabetes|Overall Study||19
11117820|NCT01319994|12302468|FG001|Did Not Develop Overt Diabetes|Overall Study||21
11117821|NCT01319994|12302467|FG000|COMPLETED|Overall Study||19
11117822|NCT01319994|12302468|FG001|COMPLETED|Overall Study||21
11117823|NCT01319994|12302467|FG000|NOT COMPLETED|Overall Study||7
11117824|NCT01319994|12302468|FG001|NOT COMPLETED|Overall Study||6
11117825|NCT01320033|12302477|FG000|STARTED|Overall Study||216
11117826|NCT01320033|12302478|FG001|STARTED|Overall Study||224
11117827|NCT01320033|12302479|FG002|STARTED|Overall Study||222
11117828|NCT01320033|12302477|FG000|COMPLETED|Overall Study||158
11117829|NCT01320033|12302478|FG001|COMPLETED|Overall Study||160
11117830|NCT01320033|12302479|FG002|COMPLETED|Overall Study||169
11117831|NCT01320033|12302477|FG000|NOT COMPLETED|Overall Study||58
11117832|NCT01320033|12302478|FG001|NOT COMPLETED|Overall Study||64
11117833|NCT01320033|12302479|FG002|NOT COMPLETED|Overall Study||53
11117834|NCT01320085|12302490|FG000|STARTED|Overall Study||41
11117835|NCT01320085|12302491|FG001|STARTED|Overall Study||117
11117836|NCT01320085|12302492|FG002|STARTED|Overall Study||25
11117837|NCT01320085|12302490|FG000|COMPLETED|Overall Study||0
11117838|NCT01320085|12302491|FG001|COMPLETED|Overall Study||0
11117839|NCT01320085|12302492|FG002|COMPLETED|Overall Study||0
11117840|NCT01320085|12302490|FG000|NOT COMPLETED|Overall Study||41
11117841|NCT01320085|12302491|FG001|NOT COMPLETED|Overall Study||117
11117842|NCT01320085|12302492|FG002|NOT COMPLETED|Overall Study||25
11117843|NCT01320137|12302502|FG000|STARTED|Overall Study||40
11117844|NCT01320137|12302503|FG001|STARTED|Overall Study||40
11117845|NCT01320137|12302502|FG000|COMPLETED|Overall Study||40
11117846|NCT01320137|12302503|FG001|COMPLETED|Overall Study||40
11117847|NCT01320137|12302502|FG000|NOT COMPLETED|Overall Study||0
11117848|NCT01320137|12302503|FG001|NOT COMPLETED|Overall Study||0
11117849|NCT01320150|12302511|FG000|STARTED|Overall Study||311
11117850|NCT01320150|12302511|FG000|PPP|Overall Study||34
11117851|NCT01320150|12302511|FG000|Non-PPP|Overall Study||211
11117852|NCT01320150|12302511|FG000|COMPLETED|Overall Study||245
11117853|NCT01320150|12302511|FG000|NOT COMPLETED|Overall Study||66
11117854|NCT01320202|12302517|FG000|STARTED|Overall Study||152
11117855|NCT01320202|12302518|FG001|STARTED|Overall Study||153
11117856|NCT01320202|12302517|FG000|Comp 48 Wks in St 2|Overall Study||27
11117857|NCT01320202|12302518|FG001|Comp 48 Wks in St 2|Overall Study||27
11117858|NCT01320202|12302517|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
11117859|NCT01320202|12302518|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
11117860|NCT01320202|12302517|FG000|Enrolled in St 3|Overall Study||98
11117861|NCT01320202|12302518|FG001|Enrolled in St 3|Overall Study||109
11117862|NCT01320202|12302517|FG000|Completed St 3|Overall Study||79
11117863|NCT01320202|12302518|FG001|Completed St 3|Overall Study||82
11117864|NCT01320202|12302517|FG000|COMPLETED|Overall Study||96
11117865|NCT01320202|12302518|FG001|COMPLETED|Overall Study||109
11117866|NCT01320202|12302517|FG000|NOT COMPLETED|Overall Study||56
11117867|NCT01320202|12302518|FG001|NOT COMPLETED|Overall Study||44
11117868|NCT01320293|12302527|FG000|STARTED|Overall Study||18
11117869|NCT01320293|12302527|FG000|COMPLETED|Overall Study||16
11117870|NCT01320293|12302527|FG000|NOT COMPLETED|Overall Study||2
11117871|NCT01320553|12302535|FG000|STARTED|Overall Study||31
11117872|NCT01320553|12302536|FG001|STARTED|Overall Study||30
11117873|NCT01320553|12302537|FG002|STARTED|Overall Study||31
11117874|NCT01320553|12302538|FG003|STARTED|Overall Study||30
11117875|NCT01320553|12302535|FG000|COMPLETED|Overall Study||30
11117876|NCT01320553|12302536|FG001|COMPLETED|Overall Study||26
11117877|NCT01320553|12302537|FG002|COMPLETED|Overall Study||29
11117878|NCT01320553|12302538|FG003|COMPLETED|Overall Study||29
11117879|NCT01320553|12302535|FG000|NOT COMPLETED|Overall Study||1
11117880|NCT01320553|12302536|FG001|NOT COMPLETED|Overall Study||4
11117881|NCT01320553|12302537|FG002|NOT COMPLETED|Overall Study||2
11117882|NCT01320553|12302538|FG003|NOT COMPLETED|Overall Study||1
11117883|NCT01320722|12302553|FG000|STARTED|Overall Study||46
11117884|NCT01320722|12302554|FG001|STARTED|Overall Study||47
11117885|NCT01320722|12302555|FG002|STARTED|Overall Study||47
11117886|NCT01320722|12302556|FG003|STARTED|Overall Study||49
11117887|NCT01320722|12302557|FG004|STARTED|Overall Study||53
11117888|NCT01320722|12302553|FG000|Received Intervention|Overall Study||43
11117889|NCT01320722|12302554|FG001|Received Intervention|Overall Study||45
11117890|NCT01320722|12302555|FG002|Received Intervention|Overall Study||46
11117891|NCT01320722|12302556|FG003|Received Intervention|Overall Study||48
11117892|NCT01320722|12302557|FG004|Received Intervention|Overall Study||51
11117893|NCT01320722|12302553|FG000|COMPLETED|Overall Study||43
11117894|NCT01320722|12302554|FG001|COMPLETED|Overall Study||41
11117895|NCT01320722|12302555|FG002|COMPLETED|Overall Study||40
11117896|NCT01320722|12302556|FG003|COMPLETED|Overall Study||35
11117897|NCT01320722|12302557|FG004|COMPLETED|Overall Study||45
11117898|NCT01320722|12302553|FG000|NOT COMPLETED|Overall Study||3
11117899|NCT01320722|12302554|FG001|NOT COMPLETED|Overall Study||6
11117900|NCT01320722|12302555|FG002|NOT COMPLETED|Overall Study||7
11117901|NCT01320722|12302556|FG003|NOT COMPLETED|Overall Study||14
11117902|NCT01320722|12302557|FG004|NOT COMPLETED|Overall Study||8
11117903|NCT01320735|12302572|FG000|STARTED|Overall Study||300
11117904|NCT01320735|12302572|FG000|COMPLETED|Overall Study||194
11117905|NCT01320735|12302572|FG000|NOT COMPLETED|Overall Study||106
11117906|NCT01320826|12302576|FG000|STARTED|Overall Study||577
11117907|NCT01320826|12302576|FG000|COMPLETED|Overall Study||577
11117908|NCT01320826|12302576|FG000|NOT COMPLETED|Overall Study||0
11234326|NCT02045095|12426050|FG002|STARTED|Overall Study||4
11234327|NCT02045095|12426051|FG003|STARTED|Overall Study||4
11234328|NCT02045095|12426052|FG004|STARTED|Overall Study||5
11234329|NCT02045095|12426053|FG005|STARTED|Overall Study||8
11234330|NCT02045095|12426054|FG006|STARTED|Overall Study||1
11234331|NCT02045095|12426048|FG000|COMPLETED|Overall Study||0
11234332|NCT02045095|12426049|FG001|COMPLETED|Overall Study||0
11234333|NCT02045095|12426050|FG002|COMPLETED|Overall Study||0
11234334|NCT02045095|12426051|FG003|COMPLETED|Overall Study||0
11234335|NCT02045095|12426052|FG004|COMPLETED|Overall Study||0
11234336|NCT02045095|12426053|FG005|COMPLETED|Overall Study||0
11234337|NCT02045095|12426054|FG006|COMPLETED|Overall Study||0
11234338|NCT02045095|12426048|FG000|NOT COMPLETED|Overall Study||3
11234339|NCT02045095|12426049|FG001|NOT COMPLETED|Overall Study||4
11234340|NCT02045095|12426050|FG002|NOT COMPLETED|Overall Study||4
11234341|NCT02045095|12426051|FG003|NOT COMPLETED|Overall Study||4
11234342|NCT02045095|12426052|FG004|NOT COMPLETED|Overall Study||5
11234343|NCT02045095|12426053|FG005|NOT COMPLETED|Overall Study||8
11234344|NCT02045095|12426054|FG006|NOT COMPLETED|Overall Study||1
11234345|NCT02045108|12426074|FG000|STARTED|Overall Study||22
11234346|NCT02045108|12426075|FG001|STARTED|Overall Study||15
11234347|NCT02045108|12426076|FG002|STARTED|Overall Study||20
11234348|NCT02045108|12426077|FG003|STARTED|Overall Study||20
11234349|NCT02045108|12426074|FG000|COMPLETED|Overall Study||21
11234350|NCT02045108|12426075|FG001|COMPLETED|Overall Study||12
11234351|NCT02045108|12426076|FG002|COMPLETED|Overall Study||18
11234352|NCT02045108|12426077|FG003|COMPLETED|Overall Study||19
11234353|NCT02045108|12426074|FG000|NOT COMPLETED|Overall Study||1
11234354|NCT02045108|12426075|FG001|NOT COMPLETED|Overall Study||3
11234355|NCT02045108|12426076|FG002|NOT COMPLETED|Overall Study||2
11234356|NCT02045108|12426077|FG003|NOT COMPLETED|Overall Study||1
11234357|NCT02045212|12426089|FG000|STARTED|Overall Study||13
11234358|NCT02045212|12426090|FG001|STARTED|Overall Study||9
11234359|NCT02045212|12426089|FG000|COMPLETED|Overall Study||11
11234360|NCT02045212|12426090|FG001|COMPLETED|Overall Study||8
11234361|NCT02045212|12426089|FG000|NOT COMPLETED|Overall Study||2
11234362|NCT02045212|12426090|FG001|NOT COMPLETED|Overall Study||1
11234363|NCT02045238|12426102|FG000|STARTED|Overall Study||16
11234364|NCT02045238|12426103|FG001|STARTED|Overall Study||15
11234365|NCT02045238|12426102|FG000|COMPLETED|Overall Study||9
11234366|NCT02045238|12426103|FG001|COMPLETED|Overall Study||14
11234367|NCT02045238|12426102|FG000|NOT COMPLETED|Overall Study||7
11234368|NCT02045238|12426103|FG001|NOT COMPLETED|Overall Study||1
11234369|NCT02045264|12426109|FG000|STARTED|Overall Study||12
11234370|NCT02045264|12426109|FG000|COMPLETED|Overall Study||12
11234371|NCT02045264|12426109|FG000|NOT COMPLETED|Overall Study||0
11234372|NCT02045277|12426117|FG000|STARTED|Overall Study||59
11234373|NCT02045277|12426118|FG001|STARTED|Overall Study||63
11234374|NCT02045277|12426119|FG002|STARTED|Overall Study||59
11234375|NCT02045277|12426120|FG003|STARTED|Overall Study||31
11234376|NCT02045277|12426117|FG000|COMPLETED|Overall Study||55
11234377|NCT02045277|12426118|FG001|COMPLETED|Overall Study||62
11234378|NCT02045277|12426119|FG002|COMPLETED|Overall Study||47
11234379|NCT02045277|12426120|FG003|COMPLETED|Overall Study||29
11234380|NCT02045277|12426117|FG000|NOT COMPLETED|Overall Study||4
11234381|NCT02045277|12426118|FG001|NOT COMPLETED|Overall Study||1
11234382|NCT02045277|12426119|FG002|NOT COMPLETED|Overall Study||12
11234383|NCT02045277|12426120|FG003|NOT COMPLETED|Overall Study||2
11234384|NCT02045433|12426130|FG000|STARTED|Overall Study||16
11234385|NCT02045433|12426130|FG000|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15
11234386|NCT02045433|12426130|FG000|NOT COMPLETED|Overall Study||1
11234387|NCT02045511|12426136|FG000|STARTED|Overall Study||8
11234388|NCT02045511|12426137|FG001|STARTED|Overall Study||7
11234389|NCT02045511|12426136|FG000|COMPLETED|Overall Study||8
11234390|NCT02045511|12426137|FG001|COMPLETED|Overall Study||7
11234391|NCT02045511|12426136|FG000|NOT COMPLETED|Overall Study||0
11234392|NCT02045511|12426137|FG001|NOT COMPLETED|Overall Study||0
11234393|NCT02045732|12426145|FG000|STARTED|Overall Study||1
11234394|NCT02045732|12426146|FG001|STARTED|Overall Study||3
11234395|NCT02045732|12426145|FG000|COMPLETED|Overall Study||0
11234396|NCT02045732|12426146|FG001|COMPLETED|Overall Study||2
11234397|NCT02045732|12426145|FG000|NOT COMPLETED|Overall Study||1
11234398|NCT02045732|12426146|FG001|NOT COMPLETED|Overall Study||1
11234399|NCT02045836|12426154|FG000|STARTED|Overall Study||432
11234400|NCT02045836|12426155|FG001|STARTED|Overall Study||433
11234401|NCT02045836|12426154|FG000|COMPLETED|Overall Study||423
11234402|NCT02045836|12426155|FG001|COMPLETED|Overall Study||419
11234403|NCT02045836|12426154|FG000|NOT COMPLETED|Overall Study||9
11234404|NCT02045836|12426155|FG001|NOT COMPLETED|Overall Study||14
11234405|NCT02045862|12426165|FG000|STARTED|Overall Study||306
11234406|NCT02045862|12426166|FG001|STARTED|Overall Study||305
11234407|NCT02045862|12426167|FG002|STARTED|Overall Study||1218
11234408|NCT02045862|12426165|FG000|Treated|Overall Study||306
11234409|NCT02045862|12426166|FG001|Treated|Overall Study||303
11234410|NCT02045862|12426167|FG002|Treated|Overall Study||1210
11234411|NCT02045862|12426165|FG000|COMPLETED|Overall Study||267
11234412|NCT02045862|12426166|FG001|COMPLETED|Overall Study||265
11234413|NCT02045862|12426167|FG002|COMPLETED|Overall Study||1092
11234414|NCT02045862|12426165|FG000|NOT COMPLETED|Overall Study||39
11234415|NCT02045862|12426166|FG001|NOT COMPLETED|Overall Study||40
11234416|NCT02045862|12426167|FG002|NOT COMPLETED|Overall Study||126
11234417|NCT02045875|12426177|FG000|STARTED|Overall Study||27
11234418|NCT02045875|12426178|FG001|STARTED|Overall Study||23
11234419|NCT02045875|12426177|FG000|COMPLETED|Overall Study||20
11234420|NCT02045875|12426178|FG001|COMPLETED|Overall Study||20
11234421|NCT02045875|12426177|FG000|NOT COMPLETED|Overall Study||7
11234422|NCT02045875|12426178|FG001|NOT COMPLETED|Overall Study||3
11234423|NCT02045979|12426187|FG000|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
11234424|NCT02045979|12426188|FG001|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
11234425|NCT02045979|12426189|FG002|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
11234426|NCT02045979|12426187|FG000|COMPLETED|Overall Study||106
11234427|NCT02045979|12426188|FG001|COMPLETED|Overall Study||107
11234428|NCT02045979|12426189|FG002|COMPLETED|Overall Study||107
11234429|NCT02045979|12426187|FG000|NOT COMPLETED|Overall Study||2
11234430|NCT02045979|12426188|FG001|NOT COMPLETED|Overall Study||1
11234431|NCT02045979|12426189|FG002|NOT COMPLETED|Overall Study||1
11234432|NCT02046005|12426200|FG000|STARTED|Overall Study||80
11234433|NCT02046005|12426201|FG001|STARTED|Overall Study||78
11234434|NCT02046005|12426202|FG002|STARTED|Overall Study||80
11234435|NCT02046005|12426200|FG000|COMPLETED|Overall Study||72
11234436|NCT02046005|12426201|FG001|COMPLETED|Overall Study||71
11234437|NCT02046005|12426202|FG002|COMPLETED|Overall Study||70
11234438|NCT02046005|12426200|FG000|NOT COMPLETED|Overall Study||8
11234439|NCT02046005|12426201|FG001|NOT COMPLETED|Overall Study||7
11234440|NCT02046005|12426202|FG002|NOT COMPLETED|Overall Study||10
11234441|NCT02046070|12426213|FG000|STARTED|Overall Study||36
11234442|NCT02046070|12426214|FG001|STARTED|Overall Study||34
11234443|NCT02046070|12426215|FG002|STARTED|Overall Study||78
11234444|NCT02046070|12426213|FG000|COMPLETED|Overall Study||4
11234445|NCT02046070|12426214|FG001|COMPLETED|Overall Study||6
11234446|NCT02046070|12426215|FG002|COMPLETED|Overall Study||8
11234447|NCT02046070|12426213|FG000|NOT COMPLETED|Overall Study||32
11234448|NCT02046070|12426214|FG001|NOT COMPLETED|Overall Study||28
11234449|NCT02046070|12426215|FG002|NOT COMPLETED|Overall Study||70
11234450|NCT02046122|12426223|FG000|STARTED|Overall Study||17
11234451|NCT02046122|12426223|FG000|COMPLETED|Overall Study||8
11234452|NCT02046122|12426223|FG000|NOT COMPLETED|Overall Study||9
11234453|NCT02046135|12426229|FG000|STARTED|Overall Study||26
11234454|NCT02046135|12426230|FG001|STARTED|Overall Study||25
11117909|NCT01320943|12302593|FG000|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
11234455|NCT02046135|12426229|FG000|COMPLETED|Overall Study||26
11234456|NCT02046135|12426230|FG001|COMPLETED|Overall Study||25
11234457|NCT02046135|12426229|FG000|NOT COMPLETED|Overall Study||0
11234458|NCT02046135|12426230|FG001|NOT COMPLETED|Overall Study||0
11234459|NCT02046148|12426238|FG000|STARTED|Overall Study||49
11234460|NCT02046148|12426239|FG001|STARTED|Overall Study||26
11234461|NCT02046148|12426238|FG000|COMPLETED|Overall Study||48
11234462|NCT02046148|12426239|FG001|COMPLETED|Overall Study||23
11234463|NCT02046148|12426238|FG000|NOT COMPLETED|Overall Study||1
11117910|NCT01320943|12302594|FG001|STARTED|Overall Study||22
11117911|NCT01320943|12302593|FG000|COMPLETED|Overall Study||20
11117912|NCT01320943|12302594|FG001|COMPLETED|Overall Study||20
11117913|NCT01320943|12302593|FG000|NOT COMPLETED|Overall Study||1
11117914|NCT01320943|12302594|FG001|NOT COMPLETED|Overall Study||2
11117915|NCT01321151|12302609|FG000|STARTED|Overall Study|The boxer was treated once-a-day for 30 days.|6
11117916|NCT01321151|12302610|FG001|STARTED|Overall Study|The boxer was treated with once-a-day for 30 days.|6
11117917|NCT01321151|12302609|FG000|COMPLETED|Overall Study||6
11117918|NCT01321151|12302610|FG001|COMPLETED|Overall Study||6
11117919|NCT01321151|12302609|FG000|NOT COMPLETED|Overall Study||0
11117920|NCT01321151|12302610|FG001|NOT COMPLETED|Overall Study||0
11117921|NCT01321177|12302618|FG000|STARTED|Overall Study||223
11117922|NCT01321177|12302619|FG001|STARTED|Overall Study||181
11117923|NCT01321177|12302618|FG000|COMPLETED|Overall Study||147
11117924|NCT01321177|12302619|FG001|COMPLETED|Overall Study||84
11117925|NCT01321177|12302618|FG000|NOT COMPLETED|Overall Study||76
11117926|NCT01321177|12302619|FG001|NOT COMPLETED|Overall Study||97
11117927|NCT01321437|12302625|FG000|STARTED|Overall Study||11
11117928|NCT01321437|12302625|FG000|COMPLETED|Overall Study||11
11117929|NCT01321437|12302625|FG000|NOT COMPLETED|Overall Study||0
11117930|NCT01321541|12302631|FG000|STARTED|Overall Study||155
11117931|NCT01321541|12302632|FG001|STARTED|Overall Study||157
11117932|NCT01321541|12302631|FG000|COMPLETED|Overall Study||72
11117933|NCT01321541|12302632|FG001|COMPLETED|Overall Study||61
11117934|NCT01321541|12302631|FG000|NOT COMPLETED|Overall Study||83
11117935|NCT01321541|12302632|FG001|NOT COMPLETED|Overall Study||96
11117936|NCT01321554|12302640|FG000|STARTED|Randomization Phase||261
11117937|NCT01321554|12302641|FG001|STARTED|Randomization Phase||131
11117938|NCT01321554|12302642|FG002|STARTED|Randomization Phase||0
11117939|NCT01321554|12302643|FG003|STARTED|Randomization Phase||0
11117940|NCT01321554|12302640|FG000|COMPLETED|Randomization Phase||261
11117941|NCT01321554|12302641|FG001|COMPLETED|Randomization Phase||131
11117942|NCT01321554|12302642|FG002|COMPLETED|Randomization Phase||0
11117943|NCT01321554|12302643|FG003|COMPLETED|Randomization Phase||0
11117944|NCT01321554|12302640|FG000|NOT COMPLETED|Randomization Phase||0
11117945|NCT01321554|12302641|FG001|NOT COMPLETED|Randomization Phase||0
11117946|NCT01321554|12302642|FG002|NOT COMPLETED|Randomization Phase||0
11117947|NCT01321554|12302643|FG003|NOT COMPLETED|Randomization Phase||0
11117948|NCT01321554|12302640|FG000|STARTED|OOL Lenvatinib Treatment Period||0
11117949|NCT01321554|12302641|FG001|STARTED|OOL Lenvatinib Treatment Period||0
11117950|NCT01321554|12302642|FG002|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|85
11117951|NCT01321554|12302643|FG003|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|30
11117952|NCT01321554|12302640|FG000|COMPLETED|OOL Lenvatinib Treatment Period||0
11117953|NCT01321554|12302641|FG001|COMPLETED|OOL Lenvatinib Treatment Period||0
11117954|NCT01321554|12302642|FG002|COMPLETED|OOL Lenvatinib Treatment Period||85
11117955|NCT01321554|12302643|FG003|COMPLETED|OOL Lenvatinib Treatment Period||30
11117956|NCT01321554|12302640|FG000|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
11117957|NCT01321554|12302641|FG001|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
11117958|NCT01321554|12302642|FG002|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
11117959|NCT01321554|12302643|FG003|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
11117960|NCT01321606|12302653|FG000|STARTED|Overall Study||18
11117961|NCT01321606|12302654|FG001|STARTED|Overall Study||32
11117962|NCT01321606|12302655|FG002|STARTED|Overall Study||34
11117963|NCT01321606|12302656|FG003|STARTED|Overall Study||29
11117964|NCT01321606|12302653|FG000|COMPLETED|Overall Study||18
11117965|NCT01321606|12302654|FG001|COMPLETED|Overall Study||32
11117966|NCT01321606|12302655|FG002|COMPLETED|Overall Study||34
11117967|NCT01321606|12302656|FG003|COMPLETED|Overall Study||28
11117968|NCT01321606|12302653|FG000|NOT COMPLETED|Overall Study||0
11117969|NCT01321606|12302654|FG001|NOT COMPLETED|Overall Study||0
11117970|NCT01321606|12302655|FG002|NOT COMPLETED|Overall Study||0
11117971|NCT01321606|12302656|FG003|NOT COMPLETED|Overall Study||1
11117972|NCT01321710|12302669|FG000|STARTED|Overall Study||50
11117973|NCT01321710|12302670|FG001|STARTED|Overall Study||58
11117974|NCT01321710|12302671|FG002|STARTED|Overall Study||44
11117975|NCT01321710|12302669|FG000|COMPLETED|Overall Study||46
11117976|NCT01321710|12302670|FG001|COMPLETED|Overall Study||53
11117977|NCT01321710|12302671|FG002|COMPLETED|Overall Study||44
11117978|NCT01321710|12302669|FG000|NOT COMPLETED|Overall Study||4
11117979|NCT01321710|12302670|FG001|NOT COMPLETED|Overall Study||5
11117980|NCT01321710|12302671|FG002|NOT COMPLETED|Overall Study||0
11117981|NCT01321723|12302684|FG000|STARTED|Overall Study||32
11117982|NCT01321723|12302685|FG001|STARTED|Overall Study||33
11117983|NCT01321723|12302686|FG002|STARTED|Overall Study||32
11117984|NCT01321723|12302684|FG000|COMPLETED|Overall Study||27
11117985|NCT01321723|12302685|FG001|COMPLETED|Overall Study||28
11117986|NCT01321723|12302686|FG002|COMPLETED|Overall Study||28
11117987|NCT01321723|12302684|FG000|NOT COMPLETED|Overall Study||5
11117988|NCT01321723|12302685|FG001|NOT COMPLETED|Overall Study||5
11117989|NCT01321723|12302686|FG002|NOT COMPLETED|Overall Study||4
11117990|NCT01321749|12302696|FG000|STARTED|Overall Study||51
11117991|NCT01321749|12302697|FG001|STARTED|Overall Study||52
11117992|NCT01321749|12302696|FG000|COMPLETED|Overall Study||38
11117993|NCT01321749|12302697|FG001|COMPLETED|Overall Study||30
11117994|NCT01321749|12302696|FG000|NOT COMPLETED|Overall Study||13
11117995|NCT01321749|12302697|FG001|NOT COMPLETED|Overall Study||22
11117996|NCT01321879|12302703|FG000|STARTED|Overall Study||39
11117997|NCT01321879|12302703|FG000|COMPLETED|Overall Study||25
11117998|NCT01321879|12302703|FG000|NOT COMPLETED|Overall Study||14
11117999|NCT01322009|12302709|FG000|STARTED|Overall Study||7
11118000|NCT01322009|12302710|FG001|STARTED|Overall Study||7
11118001|NCT01322009|12302709|FG000|COMPLETED|Overall Study||7
11118002|NCT01322009|12302710|FG001|COMPLETED|Overall Study||4
11118003|NCT01322009|12302709|FG000|NOT COMPLETED|Overall Study||0
11118004|NCT01322009|12302710|FG001|NOT COMPLETED|Overall Study||3
11118005|NCT01322022|12302718|FG000|STARTED|Overall Study||20
11118006|NCT01322022|12302719|FG001|STARTED|Overall Study||20
11118007|NCT01322022|12302718|FG000|Week 4|Overall Study||15
11118008|NCT01322022|12302719|FG001|Week 4|Overall Study||18
11118009|NCT01322022|12302718|FG000|COMPLETED|Overall Study||15
11118010|NCT01322022|12302719|FG001|COMPLETED|Overall Study||18
11118011|NCT01322022|12302718|FG000|NOT COMPLETED|Overall Study||5
11118012|NCT01322022|12302719|FG001|NOT COMPLETED|Overall Study||2
11118013|NCT01322048|12302727|FG000|STARTED|Overall Study||21
11118014|NCT01322048|12302728|FG001|STARTED|Overall Study||26
11118015|NCT01322048|12302727|FG000|COMPLETED|Overall Study||21
11118016|NCT01322048|12302728|FG001|COMPLETED|Overall Study||26
11118017|NCT01322048|12302727|FG000|NOT COMPLETED|Overall Study||0
11118018|NCT01322048|12302728|FG001|NOT COMPLETED|Overall Study||0
11118019|NCT01322347|12302736|FG000|STARTED|Overall Study||147
11118020|NCT01322347|12302737|FG001|STARTED|Overall Study||147
11118021|NCT01322347|12302736|FG000|Completed 48 Wks in St 2|Overall Study||28
11118022|NCT01322347|12302737|FG001|Completed 48 Wks in St 2|Overall Study||22
11118023|NCT01322347|12302736|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
11118024|NCT01322347|12302737|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
11118025|NCT01322347|12302736|FG000|Enrolled in St 3|Overall Study||101
11118026|NCT01322347|12302737|FG001|Enrolled in St 3|Overall Study||113
11118027|NCT01322347|12302736|FG000|Completed St 3|Overall Study||82
11118028|NCT01322347|12302737|FG001|Completed St 3|Overall Study||86
11118029|NCT01322347|12302736|FG000|COMPLETED|Overall Study||96
11118030|NCT01322347|12302737|FG001|COMPLETED|Overall Study||112
11118031|NCT01322347|12302736|FG000|NOT COMPLETED|Overall Study||51
11118032|NCT01322347|12302737|FG001|NOT COMPLETED|Overall Study||35
11118033|NCT01322360|12302744|FG000|STARTED|Overall Study||50
11118034|NCT01322360|12302744|FG000|COMPLETED|Overall Study||50
11118035|NCT01322360|12302744|FG000|NOT COMPLETED|Overall Study||0
11118036|NCT01322386|12302751|FG000|STARTED|Overall Study||10
11118037|NCT01322386|12302752|FG001|STARTED|Overall Study||11
11118038|NCT01322386|12302751|FG000|COMPLETED|Overall Study||10
11118039|NCT01322386|12302752|FG001|COMPLETED|Overall Study||9
11118040|NCT01322386|12302751|FG000|NOT COMPLETED|Overall Study||0
11118041|NCT01322386|12302752|FG001|NOT COMPLETED|Overall Study||2
11118042|NCT01322490|12302763|FG000|STARTED|Treatment Period||432
11118043|NCT01322490|12302764|FG001|STARTED|Treatment Period||432
11118044|NCT01322490|12302765|FG002|STARTED|Treatment Period||433
11118045|NCT01322490|12302763|FG000|Treated|Treatment Period||429
11118046|NCT01322490|12302764|FG001|Treated|Treatment Period||429
11118047|NCT01322490|12302765|FG002|Treated|Treatment Period||428
11118048|NCT01322490|12302763|FG000|COMPLETED|Treatment Period||300
11118049|NCT01322490|12302764|FG001|COMPLETED|Treatment Period||279
11118050|NCT01322490|12302765|FG002|COMPLETED|Treatment Period||280
11118051|NCT01322490|12302763|FG000|NOT COMPLETED|Treatment Period||132
11118052|NCT01322490|12302764|FG001|NOT COMPLETED|Treatment Period||153
11118053|NCT01322490|12302765|FG002|NOT COMPLETED|Treatment Period||153
11118054|NCT01322490|12302763|FG000|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409
11118055|NCT01322490|12302764|FG001|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408
11118056|NCT01322490|12302765|FG002|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413
11118057|NCT01322490|12302763|FG000|COMPLETED|Long Term Follow-up Period||0
11118058|NCT01322490|12302764|FG001|COMPLETED|Long Term Follow-up Period||0
11118059|NCT01322490|12302765|FG002|COMPLETED|Long Term Follow-up Period||0
11118060|NCT01322490|12302763|FG000|NOT COMPLETED|Long Term Follow-up Period||409
11118061|NCT01322490|12302764|FG001|NOT COMPLETED|Long Term Follow-up Period||408
11118062|NCT01322490|12302765|FG002|NOT COMPLETED|Long Term Follow-up Period||413
11118063|NCT01322594|12302779|FG000|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
11118064|NCT01322594|12302780|FG001|STARTED|Overall Study||3
11118065|NCT01322594|12302781|FG002|STARTED|Overall Study||3
11118066|NCT01322594|12302782|FG003|STARTED|Overall Study||6
11118067|NCT01322594|12302783|FG004|STARTED|Overall Study||7
11118068|NCT01322594|12302784|FG005|STARTED|Overall Study||6
11118069|NCT01322594|12302779|FG000|COMPLETED|Overall Study||6
11118070|NCT01322594|12302780|FG001|COMPLETED|Overall Study||3
11118071|NCT01322594|12302781|FG002|COMPLETED|Overall Study||3
11118072|NCT01322594|12302782|FG003|COMPLETED|Overall Study||6
11118073|NCT01322594|12302783|FG004|COMPLETED|Overall Study||7
11118074|NCT01322594|12302784|FG005|COMPLETED|Overall Study||6
11118075|NCT01322594|12302779|FG000|NOT COMPLETED|Overall Study||0
11118076|NCT01322594|12302780|FG001|NOT COMPLETED|Overall Study||0
11118077|NCT01322594|12302781|FG002|NOT COMPLETED|Overall Study||0
11118078|NCT01322594|12302782|FG003|NOT COMPLETED|Overall Study||0
11118079|NCT01322594|12302783|FG004|NOT COMPLETED|Overall Study||0
11118080|NCT01322594|12302784|FG005|NOT COMPLETED|Overall Study||0
11118081|NCT01322607|12302800|FG000|STARTED|Overall Study||11
11118082|NCT01322607|12302801|FG001|STARTED|Overall Study||9
11118083|NCT01322607|12302800|FG000|COMPLETED|Overall Study||10
11118084|NCT01322607|12302801|FG001|COMPLETED|Overall Study||9
11118085|NCT01322607|12302800|FG000|NOT COMPLETED|Overall Study||1
11118086|NCT01322607|12302801|FG001|NOT COMPLETED|Overall Study||0
11118087|NCT01322633|12302809|FG000|STARTED|Overall Study||34178
11118088|NCT01322633|12302810|FG001|STARTED|Overall Study||27686
11118089|NCT01322633|12302809|FG000|COMPLETED|Overall Study||34178
11118090|NCT01322633|12302810|FG001|COMPLETED|Overall Study||27686
11118091|NCT01322633|12302809|FG000|NOT COMPLETED|Overall Study||0
11118092|NCT01322633|12302810|FG001|NOT COMPLETED|Overall Study||0
11118093|NCT01322815|12302818|FG000|STARTED|Overall Study||7
11118094|NCT01322815|12302819|FG001|STARTED|Overall Study||4
11118095|NCT01322815|12302818|FG000|COMPLETED|Overall Study||7
11118096|NCT01322815|12302819|FG001|COMPLETED|Overall Study||4
11118097|NCT01322815|12302818|FG000|NOT COMPLETED|Overall Study||0
11118098|NCT01322815|12302819|FG001|NOT COMPLETED|Overall Study||0
11118099|NCT01322841|12302827|FG000|STARTED|Overall Study||1116
11118100|NCT01322841|12302828|FG001|STARTED|Overall Study||1123
11118101|NCT01322841|12302827|FG000|COMPLETED|Overall Study||1116
11118102|NCT01322841|12302828|FG001|COMPLETED|Overall Study||1123
11118103|NCT01322841|12302827|FG000|NOT COMPLETED|Overall Study||0
11118104|NCT01322841|12302828|FG001|NOT COMPLETED|Overall Study||0
11118105|NCT01322945|12302836|FG000|STARTED|Overall Study||52
11118106|NCT01322945|12302837|FG001|STARTED|Overall Study||42
11118107|NCT01322945|12302836|FG000|COMPLETED|Overall Study||52
11118108|NCT01322945|12302837|FG001|COMPLETED|Overall Study||42
11118109|NCT01322945|12302836|FG000|NOT COMPLETED|Overall Study||0
11118110|NCT01322945|12302837|FG001|NOT COMPLETED|Overall Study||0
11118111|NCT01323010|12302847|FG000|STARTED|Overall Study||60
11118112|NCT01323010|12302848|FG001|STARTED|Overall Study||59
11118113|NCT01323010|12302847|FG000|COMPLETED|Overall Study||60
11118114|NCT01323010|12302848|FG001|COMPLETED|Overall Study||59
11118115|NCT01323010|12302847|FG000|NOT COMPLETED|Overall Study||0
11118116|NCT01323010|12302848|FG001|NOT COMPLETED|Overall Study||0
11118117|NCT01323140|12302866|FG000|STARTED|Overall Study||40
11118118|NCT01323140|12302866|FG000|COMPLETED|Overall Study||38
11118119|NCT01323140|12302866|FG000|NOT COMPLETED|Overall Study||2
11118120|NCT01323153|12302872|FG000|STARTED|Overall Study||150
11118121|NCT01323153|12302873|FG001|STARTED|Overall Study||150
11118122|NCT01323153|12302872|FG000|COMPLETED|Overall Study||133
11118123|NCT01323153|12302873|FG001|COMPLETED|Overall Study||142
11118124|NCT01323153|12302872|FG000|NOT COMPLETED|Overall Study||17
11118125|NCT01323153|12302873|FG001|NOT COMPLETED|Overall Study||8
11118126|NCT01323192|12302881|FG000|STARTED|Overall Study||143
11118127|NCT01323192|12302882|FG001|STARTED|Overall Study||141
11118128|NCT01323192|12302881|FG000|COMPLETED|Overall Study||134
11118129|NCT01323192|12302882|FG001|COMPLETED|Overall Study||135
11118130|NCT01323192|12302881|FG000|NOT COMPLETED|Overall Study||9
11118131|NCT01323192|12302882|FG001|NOT COMPLETED|Overall Study||6
11118132|NCT01323270|12302890|FG000|STARTED|Overall Study||373
11118133|NCT01323270|12302891|FG001|STARTED|Overall Study||376
11118134|NCT01323270|12302890|FG000|COMPLETED|Overall Study||330
11118135|NCT01323270|12302891|FG001|COMPLETED|Overall Study||347
11118136|NCT01323270|12302890|FG000|NOT COMPLETED|Overall Study||43
11118137|NCT01323270|12302891|FG001|NOT COMPLETED|Overall Study||29
11118138|NCT01323387|12302898|FG000|STARTED|Overall Study||178
11118139|NCT01323387|12302898|FG000|COMPLETED|Overall Study||94
11118140|NCT01323387|12302898|FG000|NOT COMPLETED|Overall Study||84
11118141|NCT01323478|12302904|FG000|STARTED|Overall Study||71
11118142|NCT01323478|12302904|FG000|COMPLETED|Overall Study||47
11118143|NCT01323478|12302904|FG000|NOT COMPLETED|Overall Study||24
11118144|NCT01323517|12302908|FG000|STARTED|Overall Study||26
11118145|NCT01323517|12302908|FG000|COMPLETED|Overall Study||26
11118146|NCT01323517|12302908|FG000|NOT COMPLETED|Overall Study||0
11118147|NCT01323530|12302919|FG000|STARTED|Phase 1b (Dose Escalation Phase)||8
11118148|NCT01323530|12302920|FG001|STARTED|Phase 1b (Dose Escalation Phase)||6
11118149|NCT01323530|12302921|FG002|STARTED|Phase 1b (Dose Escalation Phase)||5
11118150|NCT01323530|12302922|FG003|STARTED|Phase 1b (Dose Escalation Phase)||3
11118151|NCT01323530|12302923|FG004|STARTED|Phase 1b (Dose Escalation Phase)||6
11118152|NCT01323530|12302924|FG005|STARTED|Phase 1b (Dose Escalation Phase)||6
11118153|NCT01323530|12302925|FG006|STARTED|Phase 1b (Dose Escalation Phase)||0
11118154|NCT01323530|12302919|FG000|COMPLETED|Phase 1b (Dose Escalation Phase)||5
11118155|NCT01323530|12302920|FG001|COMPLETED|Phase 1b (Dose Escalation Phase)||4
11118156|NCT01323530|12302921|FG002|COMPLETED|Phase 1b (Dose Escalation Phase)||4
11118157|NCT01323530|12302922|FG003|COMPLETED|Phase 1b (Dose Escalation Phase)||3
11118158|NCT01323530|12302923|FG004|COMPLETED|Phase 1b (Dose Escalation Phase)||3
11118159|NCT01323530|12302924|FG005|COMPLETED|Phase 1b (Dose Escalation Phase)||3
11118160|NCT01323530|12302925|FG006|COMPLETED|Phase 1b (Dose Escalation Phase)||0
11118161|NCT01323530|12302919|FG000|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
11118162|NCT01323530|12302920|FG001|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||2
11118163|NCT01323530|12302921|FG002|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||1
11118164|NCT01323530|12302922|FG003|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
11118165|NCT01323530|12302923|FG004|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
11118166|NCT01323530|12302924|FG005|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
11118167|NCT01323530|12302925|FG006|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
11118168|NCT01323530|12302919|FG000|STARTED|Phase 2 (Dose-confirmation Phase)||0
11118169|NCT01323530|12302920|FG001|STARTED|Phase 2 (Dose-confirmation Phase)||0
11118170|NCT01323530|12302921|FG002|STARTED|Phase 2 (Dose-confirmation Phase)||0
11118171|NCT01323530|12302922|FG003|STARTED|Phase 2 (Dose-confirmation Phase)||0
11118172|NCT01323530|12302923|FG004|STARTED|Phase 2 (Dose-confirmation Phase)||0
11118173|NCT01323530|12302924|FG005|STARTED|Phase 2 (Dose-confirmation Phase)||0
11118174|NCT01323530|12302925|FG006|STARTED|Phase 2 (Dose-confirmation Phase)||42
11118175|NCT01323530|12302919|FG000|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
11118176|NCT01323530|12302920|FG001|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
11118177|NCT01323530|12302921|FG002|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
11118178|NCT01323530|12302922|FG003|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
11118179|NCT01323530|12302923|FG004|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
11118180|NCT01323530|12302924|FG005|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
11118181|NCT01323530|12302925|FG006|COMPLETED|Phase 2 (Dose-confirmation Phase)||25
11118182|NCT01323530|12302919|FG000|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
11118183|NCT01323530|12302920|FG001|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
11118184|NCT01323530|12302921|FG002|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
11118185|NCT01323530|12302922|FG003|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
11118186|NCT01323530|12302923|FG004|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
11118187|NCT01323530|12302924|FG005|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
11118188|NCT01323530|12302925|FG006|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||17
11118189|NCT01323582|12302944|FG000|STARTED|Weeks 1-4 (First Period)||12
11118190|NCT01323582|12302945|FG001|STARTED|Weeks 1-4 (First Period)||14
11118191|NCT01323582|12302944|FG000|COMPLETED|Weeks 1-4 (First Period)||10
11118192|NCT01323582|12302945|FG001|COMPLETED|Weeks 1-4 (First Period)||12
11118193|NCT01323582|12302944|FG000|NOT COMPLETED|Weeks 1-4 (First Period)||2
11118194|NCT01323582|12302945|FG001|NOT COMPLETED|Weeks 1-4 (First Period)||2
11118195|NCT01323582|12302944|FG000|STARTED|Weeks 5-7 (Washout)||10
11118196|NCT01323582|12302945|FG001|STARTED|Weeks 5-7 (Washout)||12
11118197|NCT01323582|12302944|FG000|COMPLETED|Weeks 5-7 (Washout)||10
11118198|NCT01323582|12302945|FG001|COMPLETED|Weeks 5-7 (Washout)||11
11118199|NCT01323582|12302944|FG000|NOT COMPLETED|Weeks 5-7 (Washout)||0
11118200|NCT01323582|12302945|FG001|NOT COMPLETED|Weeks 5-7 (Washout)||1
11118201|NCT01323582|12302944|FG000|STARTED|Weeks 8-11 (Period 2)||10
11118202|NCT01323582|12302945|FG001|STARTED|Weeks 8-11 (Period 2)||11
11118203|NCT01323582|12302944|FG000|COMPLETED|Weeks 8-11 (Period 2)||10
11118204|NCT01323582|12302945|FG001|COMPLETED|Weeks 8-11 (Period 2)||10
11118205|NCT01323582|12302944|FG000|NOT COMPLETED|Weeks 8-11 (Period 2)||0
11118206|NCT01323582|12302945|FG001|NOT COMPLETED|Weeks 8-11 (Period 2)||1
11118207|NCT01323595|12302955|FG000|STARTED|Overall Study||39
11118208|NCT01323595|12302956|FG001|STARTED|Overall Study||39
11118209|NCT01323595|12302955|FG000|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
11118210|NCT01323595|12302956|FG001|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
11118211|NCT01323595|12302955|FG000|NOT COMPLETED|Overall Study||23
11118212|NCT01323595|12302956|FG001|NOT COMPLETED|Overall Study||21
11118213|NCT01323621|12302966|FG000|STARTED|2-week, Single-blind Run In Period||739
11118214|NCT01323621|12302967|FG001|STARTED|2-week, Single-blind Run In Period||0
11118215|NCT01323621|12302968|FG002|STARTED|2-week, Single-blind Run In Period||0
11118216|NCT01323621|12302966|FG000|COMPLETED|2-week, Single-blind Run In Period||511
11118217|NCT01323621|12302967|FG001|COMPLETED|2-week, Single-blind Run In Period||0
11118218|NCT01323621|12302968|FG002|COMPLETED|2-week, Single-blind Run In Period||0
11118219|NCT01323621|12302966|FG000|NOT COMPLETED|2-week, Single-blind Run In Period||228
11118220|NCT01323621|12302967|FG001|NOT COMPLETED|2-week, Single-blind Run In Period||0
11118221|NCT01323621|12302968|FG002|NOT COMPLETED|2-week, Single-blind Run In Period||0
11118222|NCT01323621|12302966|FG000|STARTED|12-week, Double-blind Treatment Period||0
11118223|NCT01323621|12302967|FG001|STARTED|12-week, Double-blind Treatment Period||252
11356404|NCT03095638|12553313|FG006|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
11356405|NCT03095638|12553314|FG007|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
11356406|NCT03095638|12553307|FG000|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
11356407|NCT03095638|12553308|FG001|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
11356408|NCT03095638|12553309|FG002|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
11356409|NCT03095638|12553310|FG003|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
11356410|NCT03095638|12553311|FG004|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
11356411|NCT03095638|12553312|FG005|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
11356412|NCT03095638|12553313|FG006|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
11356413|NCT03095638|12553314|FG007|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
11356414|NCT03095638|12553307|FG000|STARTED|P1: Period 2 (4 Days)||7
11356415|NCT03095638|12553308|FG001|STARTED|P1: Period 2 (4 Days)||7
11118224|NCT01323621|12302968|FG002|STARTED|12-week, Double-blind Treatment Period||259
11118225|NCT01323621|12302966|FG000|COMPLETED|12-week, Double-blind Treatment Period||0
11118226|NCT01323621|12302967|FG001|COMPLETED|12-week, Double-blind Treatment Period||237
11118227|NCT01323621|12302968|FG002|COMPLETED|12-week, Double-blind Treatment Period||239
11118228|NCT01323621|12302966|FG000|NOT COMPLETED|12-week, Double-blind Treatment Period||0
11118229|NCT01323621|12302967|FG001|NOT COMPLETED|12-week, Double-blind Treatment Period||15
11118230|NCT01323621|12302968|FG002|NOT COMPLETED|12-week, Double-blind Treatment Period||20
11118231|NCT01323634|12302976|FG000|STARTED|2-week Run-in Period||733
11118232|NCT01323634|12302977|FG001|STARTED|2-week Run-in Period||0
11118233|NCT01323634|12302978|FG002|STARTED|2-week Run-in Period||0
11118234|NCT01323634|12302976|FG000|COMPLETED|2-week Run-in Period||521
11118235|NCT01323634|12302977|FG001|COMPLETED|2-week Run-in Period||0
11118236|NCT01323634|12302978|FG002|COMPLETED|2-week Run-in Period||0
11118237|NCT01323634|12302976|FG000|NOT COMPLETED|2-week Run-in Period||212
11118238|NCT01323634|12302977|FG001|NOT COMPLETED|2-week Run-in Period||0
11118239|NCT01323634|12302978|FG002|NOT COMPLETED|2-week Run-in Period||0
11118240|NCT01323634|12302976|FG000|STARTED|Double-Blind (DB) Treatment Period||0
11118241|NCT01323634|12302977|FG001|STARTED|Double-Blind (DB) Treatment Period||260
11118242|NCT01323634|12302978|FG002|STARTED|Double-Blind (DB) Treatment Period||261
11118243|NCT01323634|12302976|FG000|COMPLETED|Double-Blind (DB) Treatment Period||0
11118244|NCT01323634|12302977|FG001|COMPLETED|Double-Blind (DB) Treatment Period||235
11118245|NCT01323634|12302978|FG002|COMPLETED|Double-Blind (DB) Treatment Period||239
11118246|NCT01323634|12302976|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
11118247|NCT01323634|12302977|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
11118248|NCT01323634|12302978|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
11118249|NCT01323647|12302986|FG000|STARTED|Overall Study||470
11118250|NCT01323647|12302987|FG001|STARTED|Overall Study||487
11118251|NCT01323647|12302986|FG000|COMPLETED|Overall Study||461
11118252|NCT01323647|12302987|FG001|COMPLETED|Overall Study||487
11118253|NCT01323647|12302986|FG000|NOT COMPLETED|Overall Study||9
11118254|NCT01323647|12302987|FG001|NOT COMPLETED|Overall Study||0
11118255|NCT01323660|12302993|FG000|STARTED|Treatment Period 1 (12 Weeks)||84
11118256|NCT01323660|12302994|FG001|STARTED|Treatment Period 1 (12 Weeks)||22
11118257|NCT01323660|12302995|FG002|STARTED|Treatment Period 1 (12 Weeks)||24
11118258|NCT01323660|12302996|FG003|STARTED|Treatment Period 1 (12 Weeks)||36
11118259|NCT01323660|12302997|FG004|STARTED|Treatment Period 1 (12 Weeks)||71
11118260|NCT01323660|12302998|FG005|STARTED|Treatment Period 1 (12 Weeks)||70
11118261|NCT01323660|12302993|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||65
11118262|NCT01323660|12302994|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21
11118263|NCT01323660|12302995|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||19
11118264|NCT01323660|12302996|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||31
11118265|NCT01323660|12302997|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||61
11118266|NCT01323660|12302998|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||61
11118267|NCT01323660|12302993|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
11118268|NCT01323660|12302994|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
11118269|NCT01323660|12302995|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
11118270|NCT01323660|12302996|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
11118271|NCT01323660|12302997|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
11118272|NCT01323660|12302998|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
11118273|NCT01323660|12302993|FG000|STARTED|Washout Period (14 Days)||65
11118274|NCT01323660|12302994|FG001|STARTED|Washout Period (14 Days)||21
11118275|NCT01323660|12302995|FG002|STARTED|Washout Period (14 Days)||19
11118276|NCT01323660|12302996|FG003|STARTED|Washout Period (14 Days)||31
11118277|NCT01323660|12302997|FG004|STARTED|Washout Period (14 Days)||61
11118278|NCT01323660|12302998|FG005|STARTED|Washout Period (14 Days)||61
11118279|NCT01323660|12302993|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
11118280|NCT01323660|12302994|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
11118281|NCT01323660|12302995|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
11118282|NCT01323660|12302996|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
11118283|NCT01323660|12302997|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
11118284|NCT01323660|12302998|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
11118285|NCT01323660|12302993|FG000|NOT COMPLETED|Washout Period (14 Days)||0
11118286|NCT01323660|12302994|FG001|NOT COMPLETED|Washout Period (14 Days)||0
11118287|NCT01323660|12302995|FG002|NOT COMPLETED|Washout Period (14 Days)||1
11118288|NCT01323660|12302996|FG003|NOT COMPLETED|Washout Period (14 Days)||3
11118289|NCT01323660|12302997|FG004|NOT COMPLETED|Washout Period (14 Days)||3
11118290|NCT01323660|12302998|FG005|NOT COMPLETED|Washout Period (14 Days)||2
11118291|NCT01323660|12302993|FG000|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|67
11118292|NCT01323660|12302994|FG001|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|18
11118293|NCT01323660|12302995|FG002|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|17
11118294|NCT01323660|12302996|FG003|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|28
11118295|NCT01323660|12302997|FG004|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|59
11118296|NCT01323660|12302998|FG005|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|58
11118297|NCT01323660|12302993|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||55
11118298|NCT01323660|12302994|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||17
11118299|NCT01323660|12302995|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||14
11118300|NCT01323660|12302996|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||25
11118301|NCT01323660|12302997|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||55
11118302|NCT01323660|12302998|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||51
11118303|NCT01323660|12302993|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
11118304|NCT01323660|12302994|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
11118305|NCT01323660|12302995|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
11118306|NCT01323660|12302996|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
11118307|NCT01323660|12302997|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
11118308|NCT01323660|12302998|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
11118309|NCT01323673|12303014|FG000|STARTED|Overall Study||62
11118310|NCT01323673|12303015|FG001|STARTED|Overall Study||63
11118311|NCT01323673|12303014|FG000|COMPLETED|Overall Study||59
11118312|NCT01323673|12303015|FG001|COMPLETED|Overall Study||58
11118313|NCT01323673|12303014|FG000|NOT COMPLETED|Overall Study||3
11118314|NCT01323673|12303015|FG001|NOT COMPLETED|Overall Study||5
11118315|NCT01323777|12303021|FG000|STARTED|Overall Study||65
11118316|NCT01323777|12303021|FG000|COMPLETED|Overall Study||65
11118317|NCT01323777|12303021|FG000|NOT COMPLETED|Overall Study||0
11118318|NCT01323790|12303035|FG000|STARTED|Overall Study||233
11118319|NCT01323790|12303036|FG001|STARTED|Overall Study||234
11118320|NCT01323790|12303037|FG002|STARTED|Overall Study||233
11118321|NCT01323790|12303035|FG000|COMPLETED|Overall Study||178
11118322|NCT01323790|12303036|FG001|COMPLETED|Overall Study||174
11118323|NCT01323790|12303037|FG002|COMPLETED|Overall Study||188
11118324|NCT01323790|12303035|FG000|NOT COMPLETED|Overall Study||55
11118325|NCT01323790|12303036|FG001|NOT COMPLETED|Overall Study||60
11118326|NCT01323790|12303037|FG002|NOT COMPLETED|Overall Study||45
11118327|NCT01323855|12303050|FG000|STARTED|Overall Study||9
11118328|NCT01323855|12303051|FG001|STARTED|Overall Study||9
11118329|NCT01323855|12303052|FG002|STARTED|Overall Study||8
11118330|NCT01323855|12303053|FG003|STARTED|Overall Study||9
11118331|NCT01323855|12303054|FG004|STARTED|Overall Study||11
11118332|NCT01323855|12303050|FG000|COMPLETED|Overall Study||9
11118333|NCT01323855|12303051|FG001|COMPLETED|Overall Study||9
11118334|NCT01323855|12303052|FG002|COMPLETED|Overall Study||8
11118335|NCT01323855|12303053|FG003|COMPLETED|Overall Study||9
11118336|NCT01323855|12303054|FG004|COMPLETED|Overall Study||11
11118337|NCT01323855|12303050|FG000|NOT COMPLETED|Overall Study||0
11118338|NCT01323855|12303051|FG001|NOT COMPLETED|Overall Study||0
11118339|NCT01323855|12303052|FG002|NOT COMPLETED|Overall Study||0
11118340|NCT01323855|12303053|FG003|NOT COMPLETED|Overall Study||0
11118341|NCT01323855|12303054|FG004|NOT COMPLETED|Overall Study||0
11118342|NCT01323920|12303066|FG000|STARTED|Overall Study||35
11118343|NCT01323920|12303066|FG000|COMPLETED|Overall Study||29
11118344|NCT01323920|12303066|FG000|NOT COMPLETED|Overall Study||6
11118345|NCT01323946|12303073|FG000|STARTED|Overall Study||46
11118346|NCT01323946|12303074|FG001|STARTED|Overall Study||34
11118347|NCT01323946|12303075|FG002|STARTED|Overall Study||33
11118348|NCT01323946|12303073|FG000|COMPLETED|Overall Study||43
11118349|NCT01323946|12303074|FG001|COMPLETED|Overall Study||31
11118350|NCT01323946|12303075|FG002|COMPLETED|Overall Study||33
11118351|NCT01323946|12303073|FG000|NOT COMPLETED|Overall Study||3
11118352|NCT01323946|12303074|FG001|NOT COMPLETED|Overall Study||3
11118353|NCT01323946|12303075|FG002|NOT COMPLETED|Overall Study||0
11118354|NCT01323959|12303088|FG000|STARTED|Overall Study||67
11118355|NCT01323959|12303089|FG001|STARTED|Overall Study||72
11118356|NCT01323959|12303090|FG002|STARTED|Overall Study||72
11118357|NCT01323959|12303088|FG000|COMPLETED|Overall Study||67
11118358|NCT01323959|12303089|FG001|COMPLETED|Overall Study||72
11118359|NCT01323959|12303090|FG002|COMPLETED|Overall Study||72
11118360|NCT01323959|12303088|FG000|NOT COMPLETED|Overall Study||0
11118361|NCT01323959|12303089|FG001|NOT COMPLETED|Overall Study||0
11118362|NCT01323959|12303090|FG002|NOT COMPLETED|Overall Study||0
11234464|NCT02046148|12426239|FG001|NOT COMPLETED|Overall Study||3
11234465|NCT02046174|12426245|FG000|STARTED|Overall Study||42
11234466|NCT02046174|12426246|FG001|STARTED|Overall Study||3
11234467|NCT02046174|12426245|FG000|COMPLETED|Overall Study||41
11234468|NCT02046174|12426246|FG001|COMPLETED|Overall Study||3
11234469|NCT02046174|12426245|FG000|NOT COMPLETED|Overall Study||1
11234470|NCT02046174|12426246|FG001|NOT COMPLETED|Overall Study||0
11234471|NCT02046200|12426331|FG000|STARTED|First Intervention (1 Day)||5
11234472|NCT02046200|12426332|FG001|STARTED|First Intervention (1 Day)||6
11118363|NCT01323972|12303102|FG000|STARTED|Overall Study||81
11118364|NCT01323972|12303103|FG001|STARTED|Overall Study||79
11118365|NCT01323972|12303104|FG002|STARTED|Overall Study||80
11118366|NCT01323972|12303105|FG003|STARTED|Overall Study||80
11118367|NCT01323972|12303102|FG000|COMPLETED|Overall Study||79
11118368|NCT01323972|12303103|FG001|COMPLETED|Overall Study||76
11118369|NCT01323972|12303104|FG002|COMPLETED|Overall Study||78
11118370|NCT01323972|12303105|FG003|COMPLETED|Overall Study||79
11234473|NCT02046200|12426331|FG000|COMPLETED|First Intervention (1 Day)||5
11234474|NCT02046200|12426332|FG001|COMPLETED|First Intervention (1 Day)||6
11356416|NCT03095638|12553309|FG002|STARTED|P1: Period 2 (4 Days)||0
11356417|NCT03095638|12553310|FG003|STARTED|P1: Period 2 (4 Days)||0
11356418|NCT03095638|12553311|FG004|STARTED|P1: Period 2 (4 Days)||0
11356419|NCT03095638|12553312|FG005|STARTED|P1: Period 2 (4 Days)||0
11356420|NCT03095638|12553313|FG006|STARTED|P1: Period 2 (4 Days)||0
11356421|NCT03095638|12553314|FG007|STARTED|P1: Period 2 (4 Days)||0
11356422|NCT03095638|12553307|FG000|COMPLETED|P1: Period 2 (4 Days)||7
11356423|NCT03095638|12553308|FG001|COMPLETED|P1: Period 2 (4 Days)||7
11356424|NCT03095638|12553309|FG002|COMPLETED|P1: Period 2 (4 Days)||0
11356425|NCT03095638|12553310|FG003|COMPLETED|P1: Period 2 (4 Days)||0
11356426|NCT03095638|12553311|FG004|COMPLETED|P1: Period 2 (4 Days)||0
11356427|NCT03095638|12553312|FG005|COMPLETED|P1: Period 2 (4 Days)||0
11356428|NCT03095638|12553313|FG006|COMPLETED|P1: Period 2 (4 Days)||0
11356429|NCT03095638|12553314|FG007|COMPLETED|P1: Period 2 (4 Days)||0
11356430|NCT03095638|12553307|FG000|NOT COMPLETED|P1: Period 2 (4 Days)||0
11356431|NCT03095638|12553308|FG001|NOT COMPLETED|P1: Period 2 (4 Days)||0
11356432|NCT03095638|12553309|FG002|NOT COMPLETED|P1: Period 2 (4 Days)||0
11356433|NCT03095638|12553310|FG003|NOT COMPLETED|P1: Period 2 (4 Days)||0
11356434|NCT03095638|12553311|FG004|NOT COMPLETED|P1: Period 2 (4 Days)||0
11356435|NCT03095638|12553312|FG005|NOT COMPLETED|P1: Period 2 (4 Days)||0
11356436|NCT03095638|12553313|FG006|NOT COMPLETED|P1: Period 2 (4 Days)||0
11356437|NCT03095638|12553314|FG007|NOT COMPLETED|P1: Period 2 (4 Days)||0
11356438|NCT03095638|12553307|FG000|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
11356439|NCT03095638|12553308|FG001|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
11356440|NCT03095638|12553309|FG002|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
11356441|NCT03095638|12553310|FG003|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
11356442|NCT03095638|12553311|FG004|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
11356443|NCT03095638|12553312|FG005|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
11356444|NCT03095638|12553313|FG006|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
11356445|NCT03095638|12553314|FG007|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
11356446|NCT03095638|12553307|FG000|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
11356447|NCT03095638|12553308|FG001|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
11356448|NCT03095638|12553309|FG002|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
11356449|NCT03095638|12553310|FG003|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
11356450|NCT03095638|12553311|FG004|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
11356451|NCT03095638|12553312|FG005|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
11356452|NCT03095638|12553313|FG006|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
11356453|NCT03095638|12553314|FG007|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
11118371|NCT01323972|12303102|FG000|NOT COMPLETED|Overall Study||2
11118372|NCT01323972|12303103|FG001|NOT COMPLETED|Overall Study||3
11356454|NCT03095638|12553307|FG000|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
11356455|NCT03095638|12553308|FG001|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
11356456|NCT03095638|12553309|FG002|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
11356457|NCT03095638|12553310|FG003|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
11356458|NCT03095638|12553311|FG004|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
11356459|NCT03095638|12553312|FG005|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
11356460|NCT03095638|12553313|FG006|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
11356461|NCT03095638|12553314|FG007|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
11356462|NCT03095638|12553307|FG000|STARTED|P2: Period 1 (4 Days)||0
11356463|NCT03095638|12553308|FG001|STARTED|P2: Period 1 (4 Days)||0
11356464|NCT03095638|12553309|FG002|STARTED|P2: Period 1 (4 Days)||4
11356465|NCT03095638|12553310|FG003|STARTED|P2: Period 1 (4 Days)||4
11356466|NCT03095638|12553311|FG004|STARTED|P2: Period 1 (4 Days)||4
11356467|NCT03095638|12553312|FG005|STARTED|P2: Period 1 (4 Days)||4
11356468|NCT03095638|12553313|FG006|STARTED|P2: Period 1 (4 Days)||4
11356469|NCT03095638|12553314|FG007|STARTED|P2: Period 1 (4 Days)||4
11356470|NCT03095638|12553307|FG000|COMPLETED|P2: Period 1 (4 Days)||0
11356471|NCT03095638|12553308|FG001|COMPLETED|P2: Period 1 (4 Days)||0
11356472|NCT03095638|12553309|FG002|COMPLETED|P2: Period 1 (4 Days)||4
11356473|NCT03095638|12553310|FG003|COMPLETED|P2: Period 1 (4 Days)||4
11356474|NCT03095638|12553311|FG004|COMPLETED|P2: Period 1 (4 Days)||4
11356475|NCT03095638|12553312|FG005|COMPLETED|P2: Period 1 (4 Days)||4
11356476|NCT03095638|12553313|FG006|COMPLETED|P2: Period 1 (4 Days)||4
11356477|NCT03095638|12553314|FG007|COMPLETED|P2: Period 1 (4 Days)||4
11356478|NCT03095638|12553307|FG000|NOT COMPLETED|P2: Period 1 (4 Days)||0
11356479|NCT03095638|12553308|FG001|NOT COMPLETED|P2: Period 1 (4 Days)||0
11356480|NCT03095638|12553309|FG002|NOT COMPLETED|P2: Period 1 (4 Days)||0
11356481|NCT03095638|12553310|FG003|NOT COMPLETED|P2: Period 1 (4 Days)||0
11356482|NCT03095638|12553311|FG004|NOT COMPLETED|P2: Period 1 (4 Days)||0
11356483|NCT03095638|12553312|FG005|NOT COMPLETED|P2: Period 1 (4 Days)||0
11356484|NCT03095638|12553313|FG006|NOT COMPLETED|P2: Period 1 (4 Days)||0
11356485|NCT03095638|12553314|FG007|NOT COMPLETED|P2: Period 1 (4 Days)||0
11356486|NCT03095638|12553307|FG000|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
11356487|NCT03095638|12553308|FG001|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
11356488|NCT03095638|12553309|FG002|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
11356489|NCT03095638|12553310|FG003|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
11356490|NCT03095638|12553311|FG004|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
11356491|NCT03095638|12553312|FG005|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
11356492|NCT03095638|12553313|FG006|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
11356493|NCT03095638|12553314|FG007|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
11356494|NCT03095638|12553307|FG000|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
11356495|NCT03095638|12553308|FG001|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
11356496|NCT03095638|12553309|FG002|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
11356497|NCT03095638|12553310|FG003|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
11356498|NCT03095638|12553311|FG004|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
11356499|NCT03095638|12553312|FG005|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
11356500|NCT03095638|12553313|FG006|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
11356501|NCT03095638|12553314|FG007|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
11356502|NCT03095638|12553307|FG000|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
11356503|NCT03095638|12553308|FG001|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
11356504|NCT03095638|12553309|FG002|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
11356505|NCT03095638|12553310|FG003|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
11356506|NCT03095638|12553311|FG004|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
11356507|NCT03095638|12553312|FG005|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
11356508|NCT03095638|12553313|FG006|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
11356509|NCT03095638|12553314|FG007|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
11356510|NCT03095638|12553307|FG000|STARTED|P2: Period 2 (4 Days)||0
11356511|NCT03095638|12553308|FG001|STARTED|P2: Period 2 (4 Days)||0
11356512|NCT03095638|12553309|FG002|STARTED|P2: Period 2 (4 Days)||4
11356513|NCT03095638|12553310|FG003|STARTED|P2: Period 2 (4 Days)||4
11356514|NCT03095638|12553311|FG004|STARTED|P2: Period 2 (4 Days)||4
11356515|NCT03095638|12553312|FG005|STARTED|P2: Period 2 (4 Days)||4
11356516|NCT03095638|12553313|FG006|STARTED|P2: Period 2 (4 Days)||4
11356517|NCT03095638|12553314|FG007|STARTED|P2: Period 2 (4 Days)||4
11356518|NCT03095638|12553307|FG000|COMPLETED|P2: Period 2 (4 Days)||0
11356519|NCT03095638|12553308|FG001|COMPLETED|P2: Period 2 (4 Days)||0
11356520|NCT03095638|12553309|FG002|COMPLETED|P2: Period 2 (4 Days)||4
11356521|NCT03095638|12553310|FG003|COMPLETED|P2: Period 2 (4 Days)||4
11356522|NCT03095638|12553311|FG004|COMPLETED|P2: Period 2 (4 Days)||4
11356523|NCT03095638|12553312|FG005|COMPLETED|P2: Period 2 (4 Days)||4
11356524|NCT03095638|12553313|FG006|COMPLETED|P2: Period 2 (4 Days)||4
11356525|NCT03095638|12553314|FG007|COMPLETED|P2: Period 2 (4 Days)||4
11356526|NCT03095638|12553307|FG000|NOT COMPLETED|P2: Period 2 (4 Days)||0
11356527|NCT03095638|12553308|FG001|NOT COMPLETED|P2: Period 2 (4 Days)||0
11356528|NCT03095638|12553309|FG002|NOT COMPLETED|P2: Period 2 (4 Days)||0
11356529|NCT03095638|12553310|FG003|NOT COMPLETED|P2: Period 2 (4 Days)||0
11356530|NCT03095638|12553311|FG004|NOT COMPLETED|P2: Period 2 (4 Days)||0
11356531|NCT03095638|12553312|FG005|NOT COMPLETED|P2: Period 2 (4 Days)||0
11356532|NCT03095638|12553313|FG006|NOT COMPLETED|P2: Period 2 (4 Days)||0
11356533|NCT03095638|12553314|FG007|NOT COMPLETED|P2: Period 2 (4 Days)||0
11356534|NCT03095638|12553307|FG000|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
11356535|NCT03095638|12553308|FG001|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
11356536|NCT03095638|12553309|FG002|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
11356537|NCT03095638|12553310|FG003|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
11356538|NCT03095638|12553311|FG004|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
11356539|NCT03095638|12553312|FG005|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
11356540|NCT03095638|12553313|FG006|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
11356541|NCT03095638|12553314|FG007|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
11356542|NCT03095638|12553307|FG000|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
11356543|NCT03095638|12553308|FG001|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
11356544|NCT03095638|12553309|FG002|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
11356545|NCT03095638|12553310|FG003|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
11356546|NCT03095638|12553311|FG004|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
11356547|NCT03095638|12553312|FG005|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
11356548|NCT03095638|12553313|FG006|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
11356549|NCT03095638|12553314|FG007|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
11356550|NCT03095638|12553307|FG000|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
11356551|NCT03095638|12553308|FG001|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
11356552|NCT03095638|12553309|FG002|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
11356553|NCT03095638|12553310|FG003|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
11356554|NCT03095638|12553311|FG004|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
11356555|NCT03095638|12553312|FG005|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
11356556|NCT03095638|12553313|FG006|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
11356557|NCT03095638|12553314|FG007|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
11356558|NCT03095638|12553307|FG000|STARTED|P2: Period 3 (4 Days)||0
11356559|NCT03095638|12553308|FG001|STARTED|P2: Period 3 (4 Days)||0
11356560|NCT03095638|12553309|FG002|STARTED|P2: Period 3 (4 Days)||4
11356561|NCT03095638|12553310|FG003|STARTED|P2: Period 3 (4 Days)||4
11356562|NCT03095638|12553311|FG004|STARTED|P2: Period 3 (4 Days)||4
11356563|NCT03095638|12553312|FG005|STARTED|P2: Period 3 (4 Days)||4
11356564|NCT03095638|12553313|FG006|STARTED|P2: Period 3 (4 Days)||4
11356565|NCT03095638|12553314|FG007|STARTED|P2: Period 3 (4 Days)||4
11356566|NCT03095638|12553307|FG000|COMPLETED|P2: Period 3 (4 Days)||0
11356567|NCT03095638|12553308|FG001|COMPLETED|P2: Period 3 (4 Days)||0
11356568|NCT03095638|12553309|FG002|COMPLETED|P2: Period 3 (4 Days)||4
11356569|NCT03095638|12553310|FG003|COMPLETED|P2: Period 3 (4 Days)||4
11356570|NCT03095638|12553311|FG004|COMPLETED|P2: Period 3 (4 Days)||4
11356571|NCT03095638|12553312|FG005|COMPLETED|P2: Period 3 (4 Days)||4
11356572|NCT03095638|12553313|FG006|COMPLETED|P2: Period 3 (4 Days)||4
11356573|NCT03095638|12553314|FG007|COMPLETED|P2: Period 3 (4 Days)||4
11356574|NCT03095638|12553307|FG000|NOT COMPLETED|P2: Period 3 (4 Days)||0
11356575|NCT03095638|12553308|FG001|NOT COMPLETED|P2: Period 3 (4 Days)||0
11356576|NCT03095638|12553309|FG002|NOT COMPLETED|P2: Period 3 (4 Days)||0
11356577|NCT03095638|12553310|FG003|NOT COMPLETED|P2: Period 3 (4 Days)||0
11356578|NCT03095638|12553311|FG004|NOT COMPLETED|P2: Period 3 (4 Days)||0
11356579|NCT03095638|12553312|FG005|NOT COMPLETED|P2: Period 3 (4 Days)||0
11356580|NCT03095638|12553313|FG006|NOT COMPLETED|P2: Period 3 (4 Days)||0
11356581|NCT03095638|12553314|FG007|NOT COMPLETED|P2: Period 3 (4 Days)||0
11356582|NCT03095638|12553307|FG000|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
11356583|NCT03095638|12553308|FG001|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
11356584|NCT03095638|12553309|FG002|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
11356585|NCT03095638|12553310|FG003|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
11356586|NCT03095638|12553311|FG004|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
11356587|NCT03095638|12553312|FG005|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
11356588|NCT03095638|12553313|FG006|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
11356589|NCT03095638|12553314|FG007|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
11356590|NCT03095638|12553307|FG000|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
11356591|NCT03095638|12553308|FG001|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
11356592|NCT03095638|12553309|FG002|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
11356593|NCT03095638|12553310|FG003|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
11356594|NCT03095638|12553311|FG004|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
11356595|NCT03095638|12553312|FG005|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
11356596|NCT03095638|12553313|FG006|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
11356597|NCT03095638|12553314|FG007|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
11356598|NCT03095638|12553307|FG000|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
11356599|NCT03095638|12553308|FG001|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
11356600|NCT03095638|12553309|FG002|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
11356601|NCT03095638|12553310|FG003|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
11356602|NCT03095638|12553311|FG004|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
11356603|NCT03095638|12553312|FG005|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
11356604|NCT03095638|12553313|FG006|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
11356605|NCT03095638|12553314|FG007|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
11356606|NCT03095651|12553342|FG000|STARTED|Overall Study||6
11356607|NCT03095651|12553343|FG001|STARTED|Overall Study||6
11356608|NCT03095651|12553344|FG002|STARTED|Overall Study||0
11356609|NCT03095651|12553345|FG003|STARTED|Overall Study||4
11356610|NCT03095651|12553346|FG004|STARTED|Overall Study||0
11356611|NCT03095651|12553347|FG005|STARTED|Overall Study||7
11356612|NCT03095651|12553348|FG006|STARTED|Overall Study||6
11356613|NCT03095651|12553349|FG007|STARTED|Overall Study||4
11356614|NCT03095651|12553342|FG000|COMPLETED|Overall Study||5
11356615|NCT03095651|12553343|FG001|COMPLETED|Overall Study||5
11356616|NCT03095651|12553344|FG002|COMPLETED|Overall Study||0
11356617|NCT03095651|12553345|FG003|COMPLETED|Overall Study||3
11356618|NCT03095651|12553346|FG004|COMPLETED|Overall Study||0
11356619|NCT03095651|12553347|FG005|COMPLETED|Overall Study||6
11356620|NCT03095651|12553348|FG006|COMPLETED|Overall Study||6
11356621|NCT03095651|12553349|FG007|COMPLETED|Overall Study||4
11356622|NCT03095651|12553342|FG000|NOT COMPLETED|Overall Study||1
11356623|NCT03095651|12553343|FG001|NOT COMPLETED|Overall Study||1
11356624|NCT03095651|12553344|FG002|NOT COMPLETED|Overall Study||0
11356625|NCT03095651|12553345|FG003|NOT COMPLETED|Overall Study||1
11356626|NCT03095651|12553346|FG004|NOT COMPLETED|Overall Study||0
11356627|NCT03095651|12553347|FG005|NOT COMPLETED|Overall Study||1
11356628|NCT03095651|12553348|FG006|NOT COMPLETED|Overall Study||0
11356629|NCT03095651|12553349|FG007|NOT COMPLETED|Overall Study||0
11356630|NCT03095885|12553367|FG000|STARTED|Overall Study||22
11356631|NCT03095885|12553367|FG000|COMPLETED|Overall Study||22
11356632|NCT03095885|12553367|FG000|NOT COMPLETED|Overall Study||0
11356633|NCT03095976|12553371|FG000|STARTED|Overall Study||4
11356634|NCT03095976|12553371|FG000|COMPLETED|Overall Study||4
11356635|NCT03095976|12553371|FG000|NOT COMPLETED|Overall Study||0
11356636|NCT03096314|12553377|FG000|STARTED|Screened Vitamin D Deficient||690
11356637|NCT03096314|12553378|FG001|STARTED|Screened Vitamin D Deficient|2 randomized but not included in analysis; 1 treated but inadequate consent and 1 withdrew.|668
11356638|NCT03096314|12553377|FG000|COMPLETED|Screened Vitamin D Deficient||681
11356639|NCT03096314|12553378|FG001|COMPLETED|Screened Vitamin D Deficient||656
11356640|NCT03096314|12553377|FG000|NOT COMPLETED|Screened Vitamin D Deficient||9
11118373|NCT01323972|12303104|FG002|NOT COMPLETED|Overall Study||2
11118374|NCT01323972|12303105|FG003|NOT COMPLETED|Overall Study||1
11118375|NCT01323998|12303122|FG000|STARTED|Overall Study||200631
11118376|NCT01323998|12303123|FG001|STARTED|Overall Study||18681
11118377|NCT01323998|12303124|FG002|STARTED|Overall Study||10294
11118378|NCT01323998|12303125|FG003|STARTED|Overall Study||12052
11234475|NCT02046200|12426331|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11234476|NCT02046200|12426332|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11234477|NCT02046200|12426331|FG000|STARTED|Second Intervention (1 Day)||5
11234478|NCT02046200|12426332|FG001|STARTED|Second Intervention (1 Day)||6
11234479|NCT02046200|12426331|FG000|COMPLETED|Second Intervention (1 Day)||5
11234480|NCT02046200|12426332|FG001|COMPLETED|Second Intervention (1 Day)||6
11234481|NCT02046200|12426331|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11234482|NCT02046200|12426332|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11234483|NCT02046265|12426350|FG000|STARTED|Overall Study||17
11234484|NCT02046265|12426351|FG001|STARTED|Overall Study||17
11234485|NCT02046265|12426352|FG002|STARTED|Overall Study||12
11118379|NCT01323998|12303126|FG004|STARTED|Overall Study||6735
11118380|NCT01323998|12303122|FG000|COMPLETED|Overall Study||200631
11118381|NCT01323998|12303123|FG001|COMPLETED|Overall Study||18681
11118382|NCT01323998|12303124|FG002|COMPLETED|Overall Study||10294
11118383|NCT01323998|12303125|FG003|COMPLETED|Overall Study||12052
11118384|NCT01323998|12303126|FG004|COMPLETED|Overall Study||6735
11234486|NCT02046265|12426353|FG003|STARTED|Overall Study||14
11234487|NCT02046265|12426350|FG000|COMPLETED|Overall Study||16
11234488|NCT02046265|12426351|FG001|COMPLETED|Overall Study||15
11234489|NCT02046265|12426352|FG002|COMPLETED|Overall Study||10
11234490|NCT02046265|12426353|FG003|COMPLETED|Overall Study||12
11234491|NCT02046265|12426350|FG000|NOT COMPLETED|Overall Study||1
11234492|NCT02046265|12426351|FG001|NOT COMPLETED|Overall Study||2
11234493|NCT02046265|12426352|FG002|NOT COMPLETED|Overall Study||2
11234494|NCT02046265|12426353|FG003|NOT COMPLETED|Overall Study||2
11234495|NCT02046317|12426365|FG000|STARTED|Overall Study||4
11234496|NCT02046317|12426366|FG001|STARTED|Overall Study||8
11234497|NCT02046317|12426365|FG000|COMPLETED|Overall Study||4
11234498|NCT02046317|12426366|FG001|COMPLETED|Overall Study||8
11234499|NCT02046317|12426365|FG000|NOT COMPLETED|Overall Study||0
11234500|NCT02046317|12426366|FG001|NOT COMPLETED|Overall Study||0
11234501|NCT02046369|12426374|FG000|STARTED|Overall Study||176
11234502|NCT02046369|12426375|FG001|STARTED|Overall Study||174
11234503|NCT02046369|12426374|FG000|COMPLETED|Overall Study||162
11234504|NCT02046369|12426375|FG001|COMPLETED|Overall Study||156
11234505|NCT02046369|12426374|FG000|NOT COMPLETED|Overall Study||14
11234506|NCT02046369|12426375|FG001|NOT COMPLETED|Overall Study||18
11234507|NCT02046382|12426383|FG000|STARTED|Overall Study||65
11234508|NCT02046382|12426384|FG001|STARTED|Overall Study||67
11234509|NCT02046382|12426383|FG000|COMPLETED|Overall Study||57
11234510|NCT02046382|12426384|FG001|COMPLETED|Overall Study||47
11234511|NCT02046382|12426383|FG000|NOT COMPLETED|Overall Study||8
11234512|NCT02046382|12426384|FG001|NOT COMPLETED|Overall Study||20
11234513|NCT02046525|12426392|FG000|STARTED|Overall Study||5
11234514|NCT02046525|12426393|FG001|STARTED|Overall Study||5
11234515|NCT02046525|12426392|FG000|COMPLETED|Overall Study||5
11234516|NCT02046525|12426393|FG001|COMPLETED|Overall Study||5
11234517|NCT02046525|12426392|FG000|NOT COMPLETED|Overall Study||0
11234518|NCT02046525|12426393|FG001|NOT COMPLETED|Overall Study||0
11234519|NCT02046564|12426401|FG000|STARTED|Overall Study||209
11234520|NCT02046564|12426402|FG001|STARTED|Overall Study||203
11234521|NCT02046564|12426401|FG000|COMPLETED|Overall Study||194
11234522|NCT02046564|12426402|FG001|COMPLETED|Overall Study||183
11234523|NCT02046564|12426401|FG000|NOT COMPLETED|Overall Study||15
11234524|NCT02046564|12426402|FG001|NOT COMPLETED|Overall Study||20
11234525|NCT02046603|12426410|FG000|STARTED|Overall Study||22
11234526|NCT02046603|12426411|FG001|STARTED|Overall Study||140
11234527|NCT02046603|12426410|FG000|Received at Least 1 Dose of Tocilizumab|Overall Study||21
11234528|NCT02046603|12426411|FG001|Received at Least 1 Dose of Tocilizumab|Overall Study||140
11234529|NCT02046603|12426410|FG000|COMPLETED|Overall Study||7
11234530|NCT02046603|12426411|FG001|COMPLETED|Overall Study||65
11234531|NCT02046603|12426410|FG000|NOT COMPLETED|Overall Study||15
11234532|NCT02046603|12426411|FG001|NOT COMPLETED|Overall Study||75
11234533|NCT02046616|12426418|FG000|STARTED|24-Week Treatment Period||133
11234534|NCT02046616|12426418|FG000|COMPLETED|24-Week Treatment Period||114
11234535|NCT02046616|12426418|FG000|NOT COMPLETED|24-Week Treatment Period||19
11234536|NCT02046616|12426418|FG000|STARTED|8-Week FU Period||114
11234537|NCT02046616|12426418|FG000|COMPLETED|8-Week FU Period||113
11234538|NCT02046616|12426418|FG000|NOT COMPLETED|8-Week FU Period||1
11234539|NCT02046772|12426424|FG000|STARTED|Overall Study||30
11234540|NCT02046772|12426425|FG001|STARTED|Overall Study||33
11234541|NCT02046772|12426424|FG000|COMPLETED|Overall Study||30
11234542|NCT02046772|12426425|FG001|COMPLETED|Overall Study||33
11234543|NCT02046772|12426424|FG000|NOT COMPLETED|Overall Study||0
11234544|NCT02046772|12426425|FG001|NOT COMPLETED|Overall Study||0
11234545|NCT02046863|12426431|FG000|STARTED|Overall Study||7
11234546|NCT02046863|12426431|FG000|COMPLETED|Overall Study||7
11234547|NCT02046863|12426431|FG000|NOT COMPLETED|Overall Study||0
11234548|NCT02046902|12426438|FG000|STARTED|Overall Study||336
11234549|NCT02046902|12426439|FG001|STARTED|Overall Study||113
11234550|NCT02046902|12426440|FG002|STARTED|Overall Study||137
11234551|NCT02046902|12426438|FG000|COMPLETED|Overall Study||336
11234552|NCT02046902|12426439|FG001|COMPLETED|Overall Study||113
11234553|NCT02046902|12426440|FG002|COMPLETED|Overall Study||137
11234554|NCT02046902|12426438|FG000|NOT COMPLETED|Overall Study||0
11234555|NCT02046902|12426439|FG001|NOT COMPLETED|Overall Study||0
11234556|NCT02046902|12426440|FG002|NOT COMPLETED|Overall Study||0
11234557|NCT02046941|12426448|FG000|STARTED|Overall Study||17
11234558|NCT02046941|12426448|FG000|COMPLETED|Overall Study||10
11234559|NCT02046941|12426448|FG000|NOT COMPLETED|Overall Study||7
11234560|NCT02046980|12426455|FG000|STARTED|Overall Study||72
11234561|NCT02046980|12426456|FG001|STARTED|Overall Study||72
11234562|NCT02046980|12426457|FG002|STARTED|Overall Study||73
11234563|NCT02046980|12426455|FG000|COMPLETED|Overall Study||70
11234564|NCT02046980|12426456|FG001|COMPLETED|Overall Study||67
11234565|NCT02046980|12426457|FG002|COMPLETED|Overall Study||72
11234566|NCT02046980|12426455|FG000|NOT COMPLETED|Overall Study||2
11234567|NCT02046980|12426456|FG001|NOT COMPLETED|Overall Study||5
11234568|NCT02046980|12426457|FG002|NOT COMPLETED|Overall Study||1
11234569|NCT02046993|12426467|FG000|STARTED|Overall Study||105
11234570|NCT02046993|12426468|FG001|STARTED|Overall Study||105
11234571|NCT02046993|12426467|FG000|3rd Month|Overall Study||104
11234572|NCT02046993|12426468|FG001|3rd Month|Overall Study||97
11234573|NCT02046993|12426467|FG000|6th Month|Overall Study||102
11234574|NCT02046993|12426468|FG001|6th Month|Overall Study||94
11234575|NCT02046993|12426467|FG000|COMPLETED|Overall Study||102
11234576|NCT02046993|12426468|FG001|COMPLETED|Overall Study||94
11234577|NCT02046993|12426467|FG000|NOT COMPLETED|Overall Study||3
11234578|NCT02046993|12426468|FG001|NOT COMPLETED|Overall Study||11
11234579|NCT02047032|12426478|FG000|STARTED|Overall Study||250
11234580|NCT02047032|12426479|FG001|STARTED|Overall Study||250
11234581|NCT02047032|12426478|FG000|COMPLETED|Overall Study||245
11234582|NCT02047032|12426479|FG001|COMPLETED|Overall Study||235
11234583|NCT02047032|12426478|FG000|NOT COMPLETED|Overall Study||5
11234584|NCT02047032|12426479|FG001|NOT COMPLETED|Overall Study||15
11234585|NCT02047045|12426489|FG000|STARTED|Baseline||280
11234586|NCT02047045|12426490|FG001|STARTED|Baseline||280
11234587|NCT02047045|12426489|FG000|COMPLETED|Baseline||277
11234588|NCT02047045|12426490|FG001|COMPLETED|Baseline||278
11234589|NCT02047045|12426489|FG000|NOT COMPLETED|Baseline||3
11234590|NCT02047045|12426490|FG001|NOT COMPLETED|Baseline||2
11234591|NCT02047045|12426489|FG000|STARTED|Treatment Period (8 Weeks )||277
11234592|NCT02047045|12426490|FG001|STARTED|Treatment Period (8 Weeks )||278
11234593|NCT02047045|12426489|FG000|COMPLETED|Treatment Period (8 Weeks )||266
11234594|NCT02047045|12426490|FG001|COMPLETED|Treatment Period (8 Weeks )||263
11234595|NCT02047045|12426489|FG000|NOT COMPLETED|Treatment Period (8 Weeks )||11
11234596|NCT02047045|12426490|FG001|NOT COMPLETED|Treatment Period (8 Weeks )||15
11234597|NCT02047045|12426489|FG000|STARTED|Follow-up Period (24 Weeks)||266
11234598|NCT02047045|12426490|FG001|STARTED|Follow-up Period (24 Weeks)||263
11234599|NCT02047045|12426489|FG000|COMPLETED|Follow-up Period (24 Weeks)||265
11234600|NCT02047045|12426490|FG001|COMPLETED|Follow-up Period (24 Weeks)||262
11234601|NCT02047045|12426489|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1
11234602|NCT02047045|12426490|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||1
11234603|NCT02047110|12426500|FG000|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
11234604|NCT02047110|12426501|FG001|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
11234605|NCT02047110|12426502|FG002|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39
11234606|NCT02047110|12426503|FG003|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
11234607|NCT02047110|12426500|FG000|COMPLETED|DB Treatment Period up to Week 24||35
11234608|NCT02047110|12426501|FG001|COMPLETED|DB Treatment Period up to Week 24||38
11234609|NCT02047110|12426502|FG002|COMPLETED|DB Treatment Period up to Week 24||36
11234610|NCT02047110|12426503|FG003|COMPLETED|DB Treatment Period up to Week 24||38
11234611|NCT02047110|12426500|FG000|NOT COMPLETED|DB Treatment Period up to Week 24||5
11234612|NCT02047110|12426501|FG001|NOT COMPLETED|DB Treatment Period up to Week 24||2
11234613|NCT02047110|12426502|FG002|NOT COMPLETED|DB Treatment Period up to Week 24||3
11234614|NCT02047110|12426503|FG003|NOT COMPLETED|DB Treatment Period up to Week 24||2
11234615|NCT02047110|12426500|FG000|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9
11234616|NCT02047110|12426501|FG001|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17
11234617|NCT02047110|12426502|FG002|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13
11234618|NCT02047110|12426503|FG003|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12
11234619|NCT02047110|12426500|FG000|COMPLETED|DB (Week 12 up to Week 24)||9
11234620|NCT02047110|12426501|FG001|COMPLETED|DB (Week 12 up to Week 24)||15
11234621|NCT02047110|12426502|FG002|COMPLETED|DB (Week 12 up to Week 24)||12
11234622|NCT02047110|12426503|FG003|COMPLETED|DB (Week 12 up to Week 24)||12
11234623|NCT02047110|12426500|FG000|NOT COMPLETED|DB (Week 12 up to Week 24)||0
11234624|NCT02047110|12426501|FG001|NOT COMPLETED|DB (Week 12 up to Week 24)||2
11234625|NCT02047110|12426502|FG002|NOT COMPLETED|DB (Week 12 up to Week 24)||1
11234626|NCT02047110|12426503|FG003|NOT COMPLETED|DB (Week 12 up to Week 24)||0
11234627|NCT02047110|12426500|FG000|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26
11234628|NCT02047110|12426501|FG001|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21
11234629|NCT02047110|12426502|FG002|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23
11234630|NCT02047110|12426503|FG003|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26
11234631|NCT02047110|12426500|FG000|COMPLETED|Escape Treatment Period||23
11234632|NCT02047110|12426501|FG001|COMPLETED|Escape Treatment Period||15
11234633|NCT02047110|12426502|FG002|COMPLETED|Escape Treatment Period||20
11234634|NCT02047110|12426503|FG003|COMPLETED|Escape Treatment Period||24
11234635|NCT02047110|12426500|FG000|NOT COMPLETED|Escape Treatment Period||3
11234636|NCT02047110|12426501|FG001|NOT COMPLETED|Escape Treatment Period||6
11234637|NCT02047110|12426502|FG002|NOT COMPLETED|Escape Treatment Period||3
11234638|NCT02047110|12426503|FG003|NOT COMPLETED|Escape Treatment Period||2
11234639|NCT02047110|12426500|FG000|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4
11234640|NCT02047110|12426501|FG001|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8
11234641|NCT02047110|12426502|FG002|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5
11234642|NCT02047110|12426503|FG003|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9
11234643|NCT02047110|12426500|FG000|COMPLETED|OLE Treatment Period||4
11234644|NCT02047110|12426501|FG001|COMPLETED|OLE Treatment Period||8
11234645|NCT02047110|12426502|FG002|COMPLETED|OLE Treatment Period||4
11234646|NCT02047110|12426503|FG003|COMPLETED|OLE Treatment Period||9
11234647|NCT02047110|12426500|FG000|NOT COMPLETED|OLE Treatment Period||0
11234648|NCT02047110|12426501|FG001|NOT COMPLETED|OLE Treatment Period||0
11234649|NCT02047110|12426502|FG002|NOT COMPLETED|OLE Treatment Period||1
11234650|NCT02047110|12426503|FG003|NOT COMPLETED|OLE Treatment Period||0
11234651|NCT02047227|12426522|FG000|STARTED|Overall Study||462
11234652|NCT02047227|12426523|FG001|STARTED|Overall Study||477
11234653|NCT02047227|12426522|FG000|Completed Ovarian Stimulation Phase|Overall Study||424
11234654|NCT02047227|12426523|FG001|Completed Ovarian Stimulation Phase|Overall Study||440
11234655|NCT02047227|12426522|FG000|COMPLETED|Overall Study||318
11234656|NCT02047227|12426523|FG001|COMPLETED|Overall Study||347
11234657|NCT02047227|12426522|FG000|NOT COMPLETED|Overall Study||144
11234658|NCT02047227|12426523|FG001|NOT COMPLETED|Overall Study||130
11234659|NCT02047253|12426529|FG000|STARTED|Overall Study||28
11234660|NCT02047253|12426529|FG000|COMPLETED|Overall Study||20
11234661|NCT02047253|12426529|FG000|NOT COMPLETED|Overall Study||8
11234662|NCT02047305|12426533|FG000|STARTED|Overall Study||96
11234663|NCT02047305|12426533|FG000|COMPLETED|Overall Study||96
11234664|NCT02047305|12426533|FG000|NOT COMPLETED|Overall Study||0
11234665|NCT02047318|12426537|FG000|STARTED|Core Study Period||19
11234666|NCT02047318|12426537|FG000|Received MRX 14 ug/kg/Day|Core Study Period||6
11234667|NCT02047318|12426537|FG000|Received MRX 35 ug/kg/Day|Core Study Period||6
11234668|NCT02047318|12426537|FG000|Received MRX 70 ug/kg/Day|Core Study Period||6
11234669|NCT02047318|12426537|FG000|Received MRX 140 ug/kg/Day|Core Study Period||11
11234670|NCT02047318|12426537|FG000|Received MRX 280 ug/kg/Day|Core Study Period||19
11234671|NCT02047318|12426537|FG000|COMPLETED|Core Study Period||7
11234672|NCT02047318|12426537|FG000|NOT COMPLETED|Core Study Period||12
11234673|NCT02047318|12426537|FG000|STARTED|52-week Follow-up Treatment Period||6
11234674|NCT02047318|12426537|FG000|COMPLETED|52-week Follow-up Treatment Period||6
11234675|NCT02047318|12426537|FG000|NOT COMPLETED|52-week Follow-up Treatment Period||0
11234676|NCT02047318|12426537|FG000|STARTED|Long-term Follow-up Treatment Period||7
11234677|NCT02047318|12426537|FG000|Received MRX 280 ug/kg/Day|Long-term Follow-up Treatment Period||7
11234678|NCT02047318|12426537|FG000|Received 420 ug/kg/Day|Long-term Follow-up Treatment Period||5
11234679|NCT02047318|12426537|FG000|Received 560 ug/kg/Day|Long-term Follow-up Treatment Period||5
11234680|NCT02047318|12426537|FG000|COMPLETED|Long-term Follow-up Treatment Period||6
11234681|NCT02047318|12426537|FG000|NOT COMPLETED|Long-term Follow-up Treatment Period||1
11234682|NCT02047344|12426554|FG000|STARTED|Overall Study|one patient is not evaluable in process. however, evaluable to safety report.|16
11234683|NCT02047344|12426555|FG001|STARTED|Overall Study||15
11234684|NCT02047344|12426554|FG000|COMPLETED|Overall Study||16
11234685|NCT02047344|12426555|FG001|COMPLETED|Overall Study||15
11234686|NCT02047344|12426554|FG000|NOT COMPLETED|Overall Study||0
11234687|NCT02047344|12426555|FG001|NOT COMPLETED|Overall Study||0
11234688|NCT02047500|12426567|FG000|STARTED|Overall Study||19
11234689|NCT02047500|12426567|FG000|COMPLETED|Overall Study||0
11234690|NCT02047500|12426567|FG000|NOT COMPLETED|Overall Study||19
11234691|NCT02047604|12426577|FG000|STARTED|Overall Study||6
11234692|NCT02047604|12426578|FG001|STARTED|Overall Study||7
11234693|NCT02047604|12426579|FG002|STARTED|Overall Study||6
11234694|NCT02047604|12426580|FG003|STARTED|Overall Study||6
11234695|NCT02047604|12426581|FG004|STARTED|Overall Study||6
11234696|NCT02047604|12426582|FG005|STARTED|Overall Study||10
11234697|NCT02047604|12426577|FG000|COMPLETED|Overall Study||6
11234698|NCT02047604|12426578|FG001|COMPLETED|Overall Study||7
11234699|NCT02047604|12426579|FG002|COMPLETED|Overall Study||6
11234700|NCT02047604|12426580|FG003|COMPLETED|Overall Study||6
11234701|NCT02047604|12426581|FG004|COMPLETED|Overall Study||5
11234702|NCT02047604|12426582|FG005|COMPLETED|Overall Study||9
11234703|NCT02047604|12426577|FG000|NOT COMPLETED|Overall Study||0
11234704|NCT02047604|12426578|FG001|NOT COMPLETED|Overall Study||0
11234705|NCT02047604|12426579|FG002|NOT COMPLETED|Overall Study||0
11234706|NCT02047604|12426580|FG003|NOT COMPLETED|Overall Study||0
11234707|NCT02047604|12426581|FG004|NOT COMPLETED|Overall Study||1
11234708|NCT02047604|12426582|FG005|NOT COMPLETED|Overall Study||1
11234709|NCT02047643|12426596|FG000|STARTED|Overall Study||9
11234710|NCT02047643|12426597|FG001|STARTED|Overall Study||9
11234711|NCT02047643|12426596|FG000|COMPLETED|Overall Study||9
11234712|NCT02047643|12426597|FG001|COMPLETED|Overall Study||9
11234713|NCT02047643|12426596|FG000|NOT COMPLETED|Overall Study||0
11234714|NCT02047643|12426597|FG001|NOT COMPLETED|Overall Study||0
11234715|NCT02047734|12426606|FG000|STARTED|Overall Study||443
11234716|NCT02047734|12426607|FG001|STARTED|Overall Study||443
11234717|NCT02047734|12426608|FG002|STARTED|Overall Study||434
11234718|NCT02047734|12426606|FG000|Received Treatment|Overall Study|One participant received ozanimod 0.5 mg in error|441
11234719|NCT02047734|12426607|FG001|Received Treatment|Overall Study|One participant received ozanimod 1.0 mg in error|439
11234720|NCT02047734|12426608|FG002|Received Treatment|Overall Study||433
11234721|NCT02047734|12426606|FG000|COMPLETED|Overall Study||376
11234722|NCT02047734|12426607|FG001|COMPLETED|Overall Study||374
11234723|NCT02047734|12426608|FG002|COMPLETED|Overall Study||388
11234724|NCT02047734|12426606|FG000|NOT COMPLETED|Overall Study||67
11234725|NCT02047734|12426607|FG001|NOT COMPLETED|Overall Study||69
11234726|NCT02047734|12426608|FG002|NOT COMPLETED|Overall Study||46
11234727|NCT02047903|12426616|FG000|STARTED|Overall Study||161
11234728|NCT02047903|12426616|FG000|Treated|Overall Study||152
11234729|NCT02047903|12426616|FG000|COMPLETED|Overall Study||102
11234730|NCT02047903|12426616|FG000|NOT COMPLETED|Overall Study||59
11234731|NCT02047981|12426622|FG000|STARTED|MORDOR Stage I Year 1-2||97047
11234732|NCT02047981|12426623|FG001|STARTED|MORDOR Stage I Year 1-2||93191
11234733|NCT02047981|12426622|FG000|COMPLETED|MORDOR Stage I Year 1-2||87650
11234734|NCT02047981|12426623|FG001|COMPLETED|MORDOR Stage I Year 1-2||84474
11234735|NCT02047981|12426622|FG000|NOT COMPLETED|MORDOR Stage I Year 1-2||9397
11234736|NCT02047981|12426623|FG001|NOT COMPLETED|MORDOR Stage I Year 1-2||8717
11234737|NCT02047981|12426622|FG000|STARTED|MORDOR Stage II Year 3||37497
11234738|NCT02047981|12426623|FG001|STARTED|MORDOR Stage II Year 3||33294
11234739|NCT02047981|12426622|FG000|COMPLETED|MORDOR Stage II Year 3||34611
11234740|NCT02047981|12426623|FG001|COMPLETED|MORDOR Stage II Year 3||30931
11234741|NCT02047981|12426622|FG000|NOT COMPLETED|MORDOR Stage II Year 3||2886
11234742|NCT02047981|12426623|FG001|NOT COMPLETED|MORDOR Stage II Year 3||2363
11234743|NCT02048072|12426629|FG000|STARTED|Overall Study||33
11234744|NCT02048072|12426629|FG000|COMPLETED|Overall Study||29
11234745|NCT02048072|12426629|FG000|NOT COMPLETED|Overall Study||4
11234746|NCT02048241|12426635|FG000|STARTED|Overall Study||5
11234747|NCT02048241|12426636|FG001|STARTED|Overall Study||6
11234748|NCT02048241|12426635|FG000|COMPLETED|Overall Study||5
11234749|NCT02048241|12426636|FG001|COMPLETED|Overall Study||5
11234750|NCT02048241|12426635|FG000|NOT COMPLETED|Overall Study||0
11234751|NCT02048241|12426636|FG001|NOT COMPLETED|Overall Study||1
11234752|NCT02048670|12426644|FG000|STARTED|Overall Study||6
11234753|NCT02048670|12426645|FG001|STARTED|Overall Study||6
11234754|NCT02048670|12426644|FG000|COMPLETED|Overall Study||6
11234755|NCT02048670|12426645|FG001|COMPLETED|Overall Study||6
11234756|NCT02048670|12426644|FG000|NOT COMPLETED|Overall Study||0
11234757|NCT02048670|12426645|FG001|NOT COMPLETED|Overall Study||0
11234758|NCT02048826|12426653|FG000|STARTED|Overall Study||16
11234759|NCT02048826|12426654|FG001|STARTED|Overall Study||15
11234760|NCT02048826|12426653|FG000|COMPLETED|Overall Study||15
11234761|NCT02048826|12426654|FG001|COMPLETED|Overall Study||15
11234762|NCT02048826|12426653|FG000|NOT COMPLETED|Overall Study||1
11234763|NCT02048826|12426654|FG001|NOT COMPLETED|Overall Study||0
11234764|NCT02048878|12426662|FG000|STARTED|Overall Study||13
11234765|NCT02048878|12426663|FG001|STARTED|Overall Study||15
11234766|NCT02048878|12426662|FG000|COMPLETED|Overall Study||12
11234767|NCT02048878|12426663|FG001|COMPLETED|Overall Study||12
11234768|NCT02048878|12426662|FG000|NOT COMPLETED|Overall Study||1
11234769|NCT02048878|12426663|FG001|NOT COMPLETED|Overall Study||3
11234770|NCT02048891|12426671|FG000|STARTED|Overall Study||2
11234771|NCT02048891|12426672|FG001|STARTED|Overall Study||1
11234772|NCT02048891|12426671|FG000|COMPLETED|Overall Study||2
11234773|NCT02048891|12426672|FG001|COMPLETED|Overall Study||1
11234774|NCT02048891|12426671|FG000|NOT COMPLETED|Overall Study||0
11234775|NCT02048891|12426672|FG001|NOT COMPLETED|Overall Study||0
11234776|NCT02049151|12426680|FG000|STARTED|Overall Study|2 subjects did not receive treatment|15
11234777|NCT02049151|12426681|FG001|STARTED|Overall Study|1 subject did not receive treatment|17
11234778|NCT02049151|12426680|FG000|COMPLETED|Overall Study||15
11234779|NCT02049151|12426681|FG001|COMPLETED|Overall Study||17
11234780|NCT02049151|12426680|FG000|NOT COMPLETED|Overall Study||0
11234781|NCT02049151|12426681|FG001|NOT COMPLETED|Overall Study||0
11234782|NCT02049307|12426689|FG000|STARTED|Overall Study||52
11234783|NCT02049307|12426690|FG001|STARTED|Overall Study||56
11234784|NCT02049307|12426689|FG000|COMPLETED|Overall Study||50
11234785|NCT02049307|12426690|FG001|COMPLETED|Overall Study||55
11234786|NCT02049307|12426689|FG000|NOT COMPLETED|Overall Study||2
11234787|NCT02049307|12426690|FG001|NOT COMPLETED|Overall Study||1
11234788|NCT02049385|12426698|FG000|STARTED|First Intervention||4
11234789|NCT02049385|12426699|FG001|STARTED|First Intervention||2
11234790|NCT02049385|12426698|FG000|COMPLETED|First Intervention||1
11234791|NCT02049385|12426699|FG001|COMPLETED|First Intervention||2
11234792|NCT02049385|12426698|FG000|NOT COMPLETED|First Intervention||3
11234793|NCT02049385|12426699|FG001|NOT COMPLETED|First Intervention||0
11234794|NCT02049385|12426698|FG000|STARTED|Second Intervention||1
11234795|NCT02049385|12426699|FG001|STARTED|Second Intervention||2
11234796|NCT02049385|12426698|FG000|COMPLETED|Second Intervention||1
11234797|NCT02049385|12426699|FG001|COMPLETED|Second Intervention||0
11234798|NCT02049385|12426698|FG000|NOT COMPLETED|Second Intervention||0
11234799|NCT02049385|12426699|FG001|NOT COMPLETED|Second Intervention||2
11234800|NCT02049437|12426707|FG000|STARTED|Period 1||17
11234801|NCT02049437|12426708|FG001|STARTED|Period 1||17
11234802|NCT02049437|12426707|FG000|COMPLETED|Period 1||15
11234803|NCT02049437|12426708|FG001|COMPLETED|Period 1|Dropout due to low trough levels|16
11234804|NCT02049437|12426707|FG000|NOT COMPLETED|Period 1||2
11234805|NCT02049437|12426708|FG001|NOT COMPLETED|Period 1||1
11234806|NCT02049437|12426707|FG000|STARTED|Washout 1||15
11234807|NCT02049437|12426708|FG001|STARTED|Washout 1||16
11234808|NCT02049437|12426707|FG000|COMPLETED|Washout 1||15
11234809|NCT02049437|12426708|FG001|COMPLETED|Washout 1||16
11234810|NCT02049437|12426707|FG000|NOT COMPLETED|Washout 1||0
11234811|NCT02049437|12426708|FG001|NOT COMPLETED|Washout 1||0
11234812|NCT02049437|12426707|FG000|STARTED|Period 2||15
11234813|NCT02049437|12426708|FG001|STARTED|Period 2||16
11234814|NCT02049437|12426707|FG000|COMPLETED|Period 2||15
11234815|NCT02049437|12426708|FG001|COMPLETED|Period 2||16
11234816|NCT02049437|12426707|FG000|NOT COMPLETED|Period 2||0
11234817|NCT02049437|12426708|FG001|NOT COMPLETED|Period 2||0
11234818|NCT02049437|12426707|FG000|STARTED|Washout 2||15
11234819|NCT02049437|12426708|FG001|STARTED|Washout 2||16
11234820|NCT02049437|12426707|FG000|COMPLETED|Washout 2||15
11234821|NCT02049437|12426708|FG001|COMPLETED|Washout 2||16
11234822|NCT02049437|12426707|FG000|NOT COMPLETED|Washout 2||0
11234823|NCT02049437|12426708|FG001|NOT COMPLETED|Washout 2||0
11234824|NCT02049450|12426714|FG000|STARTED|Overall Study||30
11234825|NCT02049450|12426714|FG000|Discontinued Treatment Prior to Week 30|Overall Study||4
11234826|NCT02049450|12426714|FG000|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
11234827|NCT02049450|12426714|FG000|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
11234828|NCT02049450|12426714|FG000|NOT COMPLETED|Overall Study||4
11234829|NCT02049476|12426725|FG000|STARTED|Overall Study|First patient enrolled on 1/31/2014|20
11234830|NCT02049476|12426725|FG000|COMPLETED|Overall Study|20th patient completed the study|20
11234831|NCT02049476|12426725|FG000|NOT COMPLETED|Overall Study||0
11234832|NCT02049502|12426729|FG000|STARTED|Overall Study||8
11234833|NCT02049502|12426729|FG000|COMPLETED|Overall Study||8
11234834|NCT02049502|12426729|FG000|NOT COMPLETED|Overall Study||0
11234835|NCT02049749|12426735|FG000|STARTED|Overall Study|40 children plus 40 caregivers|80
11234836|NCT02049749|12426736|FG001|STARTED|Overall Study|80 children plus 80 caregivers|160
11234837|NCT02049749|12426735|FG000|COMPLETED|Overall Study||80
11234838|NCT02049749|12426736|FG001|COMPLETED|Overall Study|80 children plus 80 caregivers|160
11234839|NCT02049749|12426735|FG000|NOT COMPLETED|Overall Study||0
11234840|NCT02049749|12426736|FG001|NOT COMPLETED|Overall Study||0
11234841|NCT02049814|12426745|FG000|STARTED|Overall Study||248
11234842|NCT02049814|12426746|FG001|STARTED|Overall Study||246
11234843|NCT02049814|12426745|FG000|Safety Set|Overall Study||248
11234844|NCT02049814|12426746|FG001|Safety Set|Overall Study||245
11234845|NCT02049814|12426745|FG000|COMPLETED|Overall Study||219
11234846|NCT02049814|12426746|FG001|COMPLETED|Overall Study||219
11234847|NCT02049814|12426745|FG000|NOT COMPLETED|Overall Study||29
11234848|NCT02049814|12426746|FG001|NOT COMPLETED|Overall Study||27
11234849|NCT02049866|12426752|FG000|STARTED|Overall Study||33
11234850|NCT02049866|12426752|FG000|COMPLETED|Overall Study||32
11234851|NCT02049866|12426752|FG000|NOT COMPLETED|Overall Study||1
11234852|NCT02049931|12426759|FG000|STARTED|Overall Study||20
11234853|NCT02049931|12426760|FG001|STARTED|Overall Study||20
11234854|NCT02049931|12426761|FG002|STARTED|Overall Study||20
11234855|NCT02049931|12426759|FG000|COMPLETED|Overall Study||17
11234856|NCT02049931|12426760|FG001|COMPLETED|Overall Study||15
11234857|NCT02049931|12426761|FG002|COMPLETED|Overall Study||17
11234858|NCT02049931|12426759|FG000|NOT COMPLETED|Overall Study||3
11234859|NCT02049931|12426760|FG001|NOT COMPLETED|Overall Study||5
11234860|NCT02049931|12426761|FG002|NOT COMPLETED|Overall Study||3
11234861|NCT02049944|12426769|FG000|STARTED|Overall Study||30
11234862|NCT02049944|12426769|FG000|Obese (BMI 30-40kg/m^2)|Overall Study||14
11234863|NCT02049944|12426769|FG000|Extremely Obese (BMI >40kg/m^2)|Overall Study||14
11234864|NCT02049944|12426769|FG000|COMPLETED|Overall Study||28
11234865|NCT02049944|12426769|FG000|NOT COMPLETED|Overall Study||2
11234866|NCT02049957|12426782|FG000|STARTED|Overall Study||6
11234867|NCT02049957|12426783|FG001|STARTED|Overall Study||6
11234868|NCT02049957|12426784|FG002|STARTED|Overall Study||3
11234869|NCT02049957|12426785|FG003|STARTED|Overall Study||3
11234870|NCT02049957|12426786|FG004|STARTED|Overall Study||6
11234871|NCT02049957|12426787|FG005|STARTED|Overall Study||43
11234872|NCT02049957|12426788|FG006|STARTED|Overall Study||8
11234873|NCT02049957|12426789|FG007|STARTED|Overall Study||35
11234874|NCT02049957|12426790|FG008|STARTED|Overall Study||8
11234875|NCT02049957|12426782|FG000|COMPLETED|Overall Study||0
11234876|NCT02049957|12426783|FG001|COMPLETED|Overall Study||0
11234877|NCT02049957|12426784|FG002|COMPLETED|Overall Study||0
11234878|NCT02049957|12426785|FG003|COMPLETED|Overall Study||0
11234879|NCT02049957|12426786|FG004|COMPLETED|Overall Study||0
11234880|NCT02049957|12426787|FG005|COMPLETED|Overall Study||0
11234881|NCT02049957|12426788|FG006|COMPLETED|Overall Study||0
11234882|NCT02049957|12426789|FG007|COMPLETED|Overall Study||0
11234883|NCT02049957|12426790|FG008|COMPLETED|Overall Study||0
11234884|NCT02049957|12426782|FG000|NOT COMPLETED|Overall Study||6
11234885|NCT02049957|12426783|FG001|NOT COMPLETED|Overall Study||6
11234886|NCT02049957|12426784|FG002|NOT COMPLETED|Overall Study||3
11234887|NCT02049957|12426785|FG003|NOT COMPLETED|Overall Study||3
11234888|NCT02049957|12426786|FG004|NOT COMPLETED|Overall Study||6
11234889|NCT02049957|12426787|FG005|NOT COMPLETED|Overall Study||43
11234890|NCT02049957|12426788|FG006|NOT COMPLETED|Overall Study||8
11234891|NCT02049957|12426789|FG007|NOT COMPLETED|Overall Study||35
11234892|NCT02049957|12426790|FG008|NOT COMPLETED|Overall Study||8
11234893|NCT02050048|12426812|FG000|STARTED|Overall Study||14
11234894|NCT02050048|12426813|FG001|STARTED|Overall Study||12
11234895|NCT02050048|12426812|FG000|COMPLETED|Overall Study||9
11234896|NCT02050048|12426813|FG001|COMPLETED|Overall Study||10
11234897|NCT02050048|12426812|FG000|NOT COMPLETED|Overall Study||5
11234898|NCT02050048|12426813|FG001|NOT COMPLETED|Overall Study||2
11234899|NCT02050321|12426819|FG000|STARTED|Overall Study||2
11234900|NCT02050321|12426819|FG000|COMPLETED|Overall Study||0
11234901|NCT02050321|12426819|FG000|NOT COMPLETED|Overall Study||2
11234902|NCT02050334|12426825|FG000|STARTED|Overall Study||9
11234903|NCT02050334|12426826|FG001|STARTED|Overall Study||9
11234904|NCT02050334|12426825|FG000|COMPLETED|Overall Study||9
11234905|NCT02050334|12426826|FG001|COMPLETED|Overall Study||9
11234906|NCT02050334|12426825|FG000|NOT COMPLETED|Overall Study||0
11234907|NCT02050334|12426826|FG001|NOT COMPLETED|Overall Study||0
11234908|NCT02050373|12426835|FG000|STARTED|Overall Study||34
11234909|NCT02050373|12426836|FG001|STARTED|Overall Study||34
11234910|NCT02050373|12426835|FG000|COMPLETED|Overall Study||27
11234911|NCT02050373|12426836|FG001|COMPLETED|Overall Study||24
11234912|NCT02050373|12426835|FG000|NOT COMPLETED|Overall Study||7
11234913|NCT02050373|12426836|FG001|NOT COMPLETED|Overall Study||10
11234914|NCT02050841|12426843|FG000|STARTED|Overall Study||50
11234915|NCT02050841|12426843|FG000|COMPLETED|Overall Study||49
11234916|NCT02050841|12426843|FG000|NOT COMPLETED|Overall Study||1
11234917|NCT02051296|12426855|FG000|STARTED|Overall Study||66
11234918|NCT02051296|12426856|FG001|STARTED|Overall Study||65
11234919|NCT02051296|12426855|FG000|Received Allocated Intervention|Overall Study||59
11234920|NCT02051296|12426856|FG001|Received Allocated Intervention|Overall Study||58
11234921|NCT02051296|12426855|FG000|COMPLETED|Overall Study||58
11234922|NCT02051296|12426856|FG001|COMPLETED|Overall Study||56
11234923|NCT02051296|12426855|FG000|NOT COMPLETED|Overall Study||8
11234924|NCT02051296|12426856|FG001|NOT COMPLETED|Overall Study||9
11234925|NCT02051335|12426866|FG000|STARTED|Period 1||7
11234926|NCT02051335|12426867|FG001|STARTED|Period 1||7
11234927|NCT02051335|12426868|FG002|STARTED|Period 1||7
11234928|NCT02051335|12426869|FG003|STARTED|Period 1||6
11234929|NCT02051335|12426866|FG000|COMPLETED|Period 1||7
11234930|NCT02051335|12426867|FG001|COMPLETED|Period 1||7
11234931|NCT02051335|12426868|FG002|COMPLETED|Period 1||7
11234932|NCT02051335|12426869|FG003|COMPLETED|Period 1||6
11234933|NCT02051335|12426866|FG000|NOT COMPLETED|Period 1||0
11234934|NCT02051335|12426867|FG001|NOT COMPLETED|Period 1||0
11234935|NCT02051335|12426868|FG002|NOT COMPLETED|Period 1||0
11234936|NCT02051335|12426869|FG003|NOT COMPLETED|Period 1||0
11234937|NCT02051335|12426866|FG000|STARTED|Period 2||7
11234938|NCT02051335|12426867|FG001|STARTED|Period 2||7
11234939|NCT02051335|12426868|FG002|STARTED|Period 2||7
11234940|NCT02051335|12426869|FG003|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
11234941|NCT02051335|12426866|FG000|COMPLETED|Period 2||7
11234942|NCT02051335|12426867|FG001|COMPLETED|Period 2||7
11234943|NCT02051335|12426868|FG002|COMPLETED|Period 2||7
11234944|NCT02051335|12426869|FG003|COMPLETED|Period 2||4
11234945|NCT02051335|12426866|FG000|NOT COMPLETED|Period 2||0
11234946|NCT02051335|12426867|FG001|NOT COMPLETED|Period 2||0
11234947|NCT02051335|12426868|FG002|NOT COMPLETED|Period 2||0
11234948|NCT02051335|12426869|FG003|NOT COMPLETED|Period 2||0
11234949|NCT02051335|12426866|FG000|STARTED|Period 3||7
11234950|NCT02051335|12426867|FG001|STARTED|Period 3||7
11234951|NCT02051335|12426868|FG002|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
11234952|NCT02051335|12426869|FG003|STARTED|Period 3||4
11234953|NCT02051335|12426866|FG000|COMPLETED|Period 3||7
11234954|NCT02051335|12426867|FG001|COMPLETED|Period 3||7
11234955|NCT02051335|12426868|FG002|COMPLETED|Period 3||5
11234956|NCT02051335|12426869|FG003|COMPLETED|Period 3||4
11234957|NCT02051335|12426866|FG000|NOT COMPLETED|Period 3||0
11234958|NCT02051335|12426867|FG001|NOT COMPLETED|Period 3||0
11234959|NCT02051335|12426868|FG002|NOT COMPLETED|Period 3||0
11234960|NCT02051335|12426869|FG003|NOT COMPLETED|Period 3||0
11234961|NCT02051335|12426866|FG000|STARTED|Period 4||7
11234962|NCT02051335|12426867|FG001|STARTED|Period 4||7
11234963|NCT02051335|12426868|FG002|STARTED|Period 4||5
11234964|NCT02051335|12426869|FG003|STARTED|Period 4||4
11234965|NCT02051335|12426866|FG000|COMPLETED|Period 4||7
11234966|NCT02051335|12426867|FG001|COMPLETED|Period 4||7
11234967|NCT02051335|12426868|FG002|COMPLETED|Period 4||5
11234968|NCT02051335|12426869|FG003|COMPLETED|Period 4||4
11234969|NCT02051335|12426866|FG000|NOT COMPLETED|Period 4||0
11234970|NCT02051335|12426867|FG001|NOT COMPLETED|Period 4||0
11234971|NCT02051335|12426868|FG002|NOT COMPLETED|Period 4||0
11234972|NCT02051335|12426869|FG003|NOT COMPLETED|Period 4||0
11234973|NCT02051426|12426881|FG000|STARTED|First Intervention||16
11234974|NCT02051426|12426882|FG001|STARTED|First Intervention||19
11234975|NCT02051426|12426881|FG000|COMPLETED|First Intervention||16
11234976|NCT02051426|12426882|FG001|COMPLETED|First Intervention||19
11234977|NCT02051426|12426881|FG000|NOT COMPLETED|First Intervention||0
11234978|NCT02051426|12426882|FG001|NOT COMPLETED|First Intervention||0
11234979|NCT02051426|12426881|FG000|STARTED|Washout Period of 1 Month||16
11234980|NCT02051426|12426882|FG001|STARTED|Washout Period of 1 Month||19
11234981|NCT02051426|12426881|FG000|COMPLETED|Washout Period of 1 Month||16
11234982|NCT02051426|12426882|FG001|COMPLETED|Washout Period of 1 Month||19
11234983|NCT02051426|12426881|FG000|NOT COMPLETED|Washout Period of 1 Month||0
11234984|NCT02051426|12426882|FG001|NOT COMPLETED|Washout Period of 1 Month||0
11234985|NCT02051426|12426881|FG000|STARTED|Second Intervention||16
11234986|NCT02051426|12426882|FG001|STARTED|Second Intervention||19
11234987|NCT02051426|12426881|FG000|COMPLETED|Second Intervention||16
11234988|NCT02051426|12426882|FG001|COMPLETED|Second Intervention||19
11234989|NCT02051426|12426881|FG000|NOT COMPLETED|Second Intervention||0
11234990|NCT02051426|12426882|FG001|NOT COMPLETED|Second Intervention||0
11234991|NCT02051452|12426890|FG000|STARTED|Overall Study||16
11234992|NCT02051452|12426891|FG001|STARTED|Overall Study||16
11234993|NCT02051452|12426890|FG000|COMPLETED|Overall Study||16
11234994|NCT02051452|12426891|FG001|COMPLETED|Overall Study||16
11234995|NCT02051452|12426890|FG000|NOT COMPLETED|Overall Study||0
11234996|NCT02051452|12426891|FG001|NOT COMPLETED|Overall Study||0
11234997|NCT02051595|12426897|FG000|STARTED|Overall Study||25
11234998|NCT02051595|12426897|FG000|COMPLETED|Overall Study||25
11234999|NCT02051595|12426897|FG000|NOT COMPLETED|Overall Study||0
11235000|NCT02051686|12426903|FG000|STARTED|Overall Study||42
11235001|NCT02051686|12426904|FG001|STARTED|Overall Study||46
11235002|NCT02051686|12426903|FG000|COMPLETED|Overall Study||42
11235003|NCT02051686|12426904|FG001|COMPLETED|Overall Study||46
11235004|NCT02051686|12426903|FG000|NOT COMPLETED|Overall Study||0
11235005|NCT02051686|12426904|FG001|NOT COMPLETED|Overall Study||0
11235006|NCT02051764|12426912|FG000|STARTED|Overall Study||16
11235007|NCT02051764|12426913|FG001|STARTED|Overall Study||28
11235008|NCT02051764|12426912|FG000|COMPLETED|Overall Study||16
11235009|NCT02051764|12426913|FG001|COMPLETED|Overall Study||21
11235010|NCT02051764|12426912|FG000|NOT COMPLETED|Overall Study||0
11235011|NCT02051764|12426913|FG001|NOT COMPLETED|Overall Study||7
11235012|NCT02051790|12426919|FG000|STARTED|Overall Study||241
11235013|NCT02051790|12426919|FG000|COMPLETED|Overall Study||241
11235014|NCT02051790|12426919|FG000|NOT COMPLETED|Overall Study||0
11235015|NCT02051816|12426927|FG000|STARTED|Overall Study||37
11235016|NCT02051816|12426928|FG001|STARTED|Overall Study||40
11235017|NCT02051816|12426929|FG002|STARTED|Overall Study||37
11235018|NCT02051816|12426930|FG003|STARTED|Overall Study||36
11235019|NCT02051816|12426927|FG000|COMPLETED|Overall Study||37
11235020|NCT02051816|12426928|FG001|COMPLETED|Overall Study||40
11235021|NCT02051816|12426929|FG002|COMPLETED|Overall Study||37
11235022|NCT02051816|12426930|FG003|COMPLETED|Overall Study||36
11235023|NCT02051816|12426927|FG000|NOT COMPLETED|Overall Study||0
11235024|NCT02051816|12426928|FG001|NOT COMPLETED|Overall Study||0
11235025|NCT02051816|12426929|FG002|NOT COMPLETED|Overall Study||0
11235026|NCT02051816|12426930|FG003|NOT COMPLETED|Overall Study||0
11235027|NCT02052011|12426946|FG000|STARTED|Overall Study||21
11235028|NCT02052011|12426947|FG001|STARTED|Overall Study||10
11235029|NCT02052011|12426946|FG000|COMPLETED|Overall Study||17
11235030|NCT02052011|12426947|FG001|COMPLETED|Overall Study||8
11235031|NCT02052011|12426946|FG000|NOT COMPLETED|Overall Study||4
11235032|NCT02052011|12426947|FG001|NOT COMPLETED|Overall Study||2
11235033|NCT02052141|12426955|FG000|STARTED|Intervention Period 1||5
11235034|NCT02052141|12426956|FG001|STARTED|Intervention Period 1||7
11235035|NCT02052141|12426955|FG000|COMPLETED|Intervention Period 1||5
11235036|NCT02052141|12426956|FG001|COMPLETED|Intervention Period 1||7
11235037|NCT02052141|12426955|FG000|NOT COMPLETED|Intervention Period 1||0
11235038|NCT02052141|12426956|FG001|NOT COMPLETED|Intervention Period 1||0
11235039|NCT02052141|12426955|FG000|STARTED|Intervention Period 2||5
11235040|NCT02052141|12426956|FG001|STARTED|Intervention Period 2||7
11235041|NCT02052141|12426955|FG000|COMPLETED|Intervention Period 2||5
11235042|NCT02052141|12426956|FG001|COMPLETED|Intervention Period 2||7
11235043|NCT02052141|12426955|FG000|NOT COMPLETED|Intervention Period 2||0
11235044|NCT02052141|12426956|FG001|NOT COMPLETED|Intervention Period 2||0
11235045|NCT02052310|12426964|FG000|STARTED|Overall Study||522
11235046|NCT02052310|12426965|FG001|STARTED|Overall Study||521
11235047|NCT02052310|12426964|FG000|Received at Least 1 Dose of Study Drug|Overall Study||522
11235048|NCT02052310|12426965|FG001|Received at Least 1 Dose of Study Drug|Overall Study||517
11235049|NCT02052310|12426964|FG000|COMPLETED|Overall Study||307
11235050|NCT02052310|12426965|FG001|COMPLETED|Overall Study||309
11235051|NCT02052310|12426964|FG000|NOT COMPLETED|Overall Study||215
11235052|NCT02052310|12426965|FG001|NOT COMPLETED|Overall Study||212
11235053|NCT02052414|12426971|FG000|STARTED|Overall Study||34
11235054|NCT02052414|12426971|FG000|COMPLETED|Overall Study||17
11235055|NCT02052414|12426971|FG000|NOT COMPLETED|Overall Study||17
11235056|NCT02052440|12426978|FG000|STARTED|Overall Study||50
11235057|NCT02052440|12426979|FG001|STARTED|Overall Study||52
11235058|NCT02052440|12426978|FG000|COMPLETED|Overall Study||50
11235059|NCT02052440|12426979|FG001|COMPLETED|Overall Study||51
11235060|NCT02052440|12426978|FG000|NOT COMPLETED|Overall Study||0
11235061|NCT02052440|12426979|FG001|NOT COMPLETED|Overall Study||1
11235062|NCT02052466|12426985|FG000|STARTED|Overall Study||32
11235063|NCT02052466|12426985|FG000|COMPLETED|Overall Study||30
11235064|NCT02052466|12426985|FG000|NOT COMPLETED|Overall Study||2
11235065|NCT02052544|12426989|FG000|STARTED|Overall Study|First Subject In|123
11235066|NCT02052544|12426989|FG000|COMPLETED|Overall Study|Last Subject Out|123
11235067|NCT02052544|12426989|FG000|NOT COMPLETED|Overall Study||0
11235068|NCT02052557|12426996|FG000|STARTED|Overall Study||26
11235069|NCT02052557|12426997|FG001|STARTED|Overall Study||25
11235070|NCT02052557|12426996|FG000|COMPLETED|Overall Study||26
11235071|NCT02052557|12426997|FG001|COMPLETED|Overall Study||25
11235072|NCT02052557|12426996|FG000|NOT COMPLETED|Overall Study||0
11235073|NCT02052557|12426997|FG001|NOT COMPLETED|Overall Study||0
11235074|NCT02052596|12427007|FG000|STARTED|Active Phase||412
11235075|NCT02052596|12427008|FG001|STARTED|Active Phase||418
11235076|NCT02052596|12427007|FG000|COMPLETED|Active Phase||396
11235077|NCT02052596|12427008|FG001|COMPLETED|Active Phase||398
11235078|NCT02052596|12427007|FG000|NOT COMPLETED|Active Phase||16
11235079|NCT02052596|12427008|FG001|NOT COMPLETED|Active Phase||20
11235080|NCT02052596|12427007|FG000|STARTED|Safety Phase||412
11235081|NCT02052596|12427008|FG001|STARTED|Safety Phase||418
11235082|NCT02052596|12427007|FG000|COMPLETED|Safety Phase||385
11235083|NCT02052596|12427008|FG001|COMPLETED|Safety Phase||383
11235084|NCT02052596|12427007|FG000|NOT COMPLETED|Safety Phase||27
11235085|NCT02052596|12427008|FG001|NOT COMPLETED|Safety Phase||35
11356641|NCT03096314|12553378|FG001|NOT COMPLETED|Screened Vitamin D Deficient||12
11356642|NCT03096314|12553377|FG000|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|538
11356643|NCT03096314|12553378|FG001|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|540
11356644|NCT03096314|12553377|FG000|COMPLETED|Confirmed Vitamin D Deficient||531
11356645|NCT03096314|12553378|FG001|COMPLETED|Confirmed Vitamin D Deficient||528
11356646|NCT03096314|12553377|FG000|NOT COMPLETED|Confirmed Vitamin D Deficient||7
11356647|NCT03096314|12553378|FG001|NOT COMPLETED|Confirmed Vitamin D Deficient||12
11356648|NCT03096353|12553386|FG000|STARTED|Period 1||15
11356649|NCT03096353|12553387|FG001|STARTED|Period 1||13
11356650|NCT03096353|12553386|FG000|COMPLETED|Period 1||12
11356651|NCT03096353|12553387|FG001|COMPLETED|Period 1||12
11356652|NCT03096353|12553386|FG000|NOT COMPLETED|Period 1||3
11356653|NCT03096353|12553387|FG001|NOT COMPLETED|Period 1||1
11356654|NCT03096353|12553386|FG000|STARTED|Period 2||12
11356655|NCT03096353|12553387|FG001|STARTED|Period 2||12
11356656|NCT03096353|12553386|FG000|COMPLETED|Period 2||12
11356657|NCT03096353|12553387|FG001|COMPLETED|Period 2||12
11356658|NCT03096353|12553386|FG000|NOT COMPLETED|Period 2||0
11356659|NCT03096353|12553387|FG001|NOT COMPLETED|Period 2||0
11356660|NCT03096444|12553393|FG000|STARTED|Overall Study||13
11356661|NCT03096444|12553393|FG000|COMPLETED|Overall Study||13
11235086|NCT02052635|12427016|FG000|STARTED|Overall Study||7
11235087|NCT02052635|12427017|FG001|STARTED|Overall Study||6
11235088|NCT02052635|12427016|FG000|COMPLETED|Overall Study||7
11235089|NCT02052635|12427017|FG001|COMPLETED|Overall Study||6
11235090|NCT02052635|12427016|FG000|NOT COMPLETED|Overall Study||0
11235091|NCT02052635|12427017|FG001|NOT COMPLETED|Overall Study||0
11235092|NCT02052661|12427023|FG000|STARTED|Overall Study||300
11235093|NCT02052661|12427023|FG000|COMPLETED|Overall Study||300
11235094|NCT02052661|12427023|FG000|NOT COMPLETED|Overall Study||0
11235095|NCT02052752|12427030|FG000|STARTED|Overall Study||30
11235096|NCT02052752|12427031|FG001|STARTED|Overall Study||30
11235097|NCT02052752|12427032|FG002|STARTED|Overall Study||30
11235098|NCT02052752|12427030|FG000|COMPLETED|Overall Study||30
11235099|NCT02052752|12427031|FG001|COMPLETED|Overall Study||30
11235100|NCT02052752|12427032|FG002|COMPLETED|Overall Study||30
11235101|NCT02052752|12427030|FG000|NOT COMPLETED|Overall Study||0
11235102|NCT02052752|12427031|FG001|NOT COMPLETED|Overall Study||0
11235103|NCT02052752|12427032|FG002|NOT COMPLETED|Overall Study||0
11235104|NCT02052895|12427044|FG000|STARTED|Overall Study||196
11235105|NCT02052895|12427045|FG001|STARTED|Overall Study||15
11235106|NCT02052895|12427046|FG002|STARTED|Overall Study||15
11235107|NCT02052895|12427044|FG000|COMPLETED|Overall Study||196
11235108|NCT02052895|12427045|FG001|COMPLETED|Overall Study||15
11235109|NCT02052895|12427046|FG002|COMPLETED|Overall Study||15
11235110|NCT02052895|12427044|FG000|NOT COMPLETED|Overall Study||0
11235111|NCT02052895|12427045|FG001|NOT COMPLETED|Overall Study||0
11235112|NCT02052895|12427046|FG002|NOT COMPLETED|Overall Study||0
11235113|NCT02052960|12427055|FG000|STARTED|Overall Study||117
11235114|NCT02052960|12427056|FG001|STARTED|Overall Study||123
11235115|NCT02052960|12427055|FG000|Treated Patients|Overall Study||115
11235116|NCT02052960|12427056|FG001|Treated Patients|Overall Study||122
11235117|NCT02052960|12427055|FG000|COMPLETED|Overall Study||63
11235118|NCT02052960|12427056|FG001|COMPLETED|Overall Study||77
11235119|NCT02052960|12427055|FG000|NOT COMPLETED|Overall Study||54
11235120|NCT02052960|12427056|FG001|NOT COMPLETED|Overall Study||46
11235121|NCT02053077|12427065|FG000|STARTED|Overall Study||150
11235122|NCT02053077|12427065|FG000|COMPLETED|Overall Study||150
11235123|NCT02053077|12427065|FG000|NOT COMPLETED|Overall Study||0
11235124|NCT02053168|12427069|FG000|STARTED|Overall Study||25
11235125|NCT02053168|12427069|FG000|COMPLETED|Overall Study||22
11235126|NCT02053168|12427069|FG000|NOT COMPLETED|Overall Study||3
11235127|NCT02053259|12427077|FG000|STARTED|Overall Study||25
11235128|NCT02053259|12427078|FG001|STARTED|Overall Study||24
11235129|NCT02053259|12427079|FG002|STARTED|Overall Study||24
11235130|NCT02053259|12427080|FG003|STARTED|Overall Study||23
11235131|NCT02053259|12427077|FG000|COMPLETED|Overall Study||25
11235132|NCT02053259|12427078|FG001|COMPLETED|Overall Study||24
11235133|NCT02053259|12427079|FG002|COMPLETED|Overall Study||24
11235134|NCT02053259|12427080|FG003|COMPLETED|Overall Study||23
11235135|NCT02053259|12427077|FG000|NOT COMPLETED|Overall Study||0
11235136|NCT02053259|12427078|FG001|NOT COMPLETED|Overall Study||0
11235137|NCT02053259|12427079|FG002|NOT COMPLETED|Overall Study||0
11235138|NCT02053259|12427080|FG003|NOT COMPLETED|Overall Study||0
11235139|NCT02053376|12427090|FG000|STARTED|Overall Study||43
11235140|NCT02053376|12427090|FG000|COMPLETED|Overall Study||43
11235141|NCT02053376|12427090|FG000|NOT COMPLETED|Overall Study||0
11235142|NCT02053493|12427096|FG000|STARTED|Overall Study||51
11235143|NCT02053493|12427097|FG001|STARTED|Overall Study||59
11235144|NCT02053493|12427096|FG000|COMPLETED|Overall Study||50
11235145|NCT02053493|12427097|FG001|COMPLETED|Overall Study||58
11235146|NCT02053493|12427096|FG000|NOT COMPLETED|Overall Study||1
11235147|NCT02053493|12427097|FG001|NOT COMPLETED|Overall Study||1
11235148|NCT02053610|12427105|FG000|STARTED|Overall Study||330
11235149|NCT02053610|12427106|FG001|STARTED|Overall Study||333
11235150|NCT02053610|12427105|FG000|Received Study Drug|Overall Study||326
11235151|NCT02053610|12427106|FG001|Received Study Drug|Overall Study||331
11235152|NCT02053610|12427105|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|288
11235153|NCT02053610|12427106|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|266
11235154|NCT02053610|12427105|FG000|NOT COMPLETED|Overall Study||42
11235155|NCT02053610|12427106|FG001|NOT COMPLETED|Overall Study||67
11235156|NCT02053753|12427114|FG000|STARTED|Overall Study||72
11235157|NCT02053753|12427115|FG001|STARTED|Overall Study||74
11235158|NCT02053753|12427114|FG000|Received Treatment|Overall Study||71
11235159|NCT02053753|12427115|FG001|Received Treatment|Overall Study||71
11235160|NCT02053753|12427114|FG000|COMPLETED|Overall Study||65
11235161|NCT02053753|12427115|FG001|COMPLETED|Overall Study||66
11235162|NCT02053753|12427114|FG000|NOT COMPLETED|Overall Study||7
11235163|NCT02053753|12427115|FG001|NOT COMPLETED|Overall Study||8
11235164|NCT02054130|12427125|FG000|STARTED|Overall Study||138
11235165|NCT02054130|12427126|FG001|STARTED|Overall Study||138
11235166|NCT02054130|12427127|FG002|STARTED|Overall Study||137
11235167|NCT02054130|12427128|FG003|STARTED|Overall Study||137
11235168|NCT02054130|12427125|FG000|COMPLETED|Overall Study||130
11235169|NCT02054130|12427126|FG001|COMPLETED|Overall Study||127
11235170|NCT02054130|12427127|FG002|COMPLETED|Overall Study||122
11235171|NCT02054130|12427128|FG003|COMPLETED|Overall Study||115
11235172|NCT02054130|12427125|FG000|NOT COMPLETED|Overall Study||8
11235173|NCT02054130|12427126|FG001|NOT COMPLETED|Overall Study||11
11235174|NCT02054130|12427127|FG002|NOT COMPLETED|Overall Study||15
11235175|NCT02054130|12427128|FG003|NOT COMPLETED|Overall Study||22
11235176|NCT02054156|12427143|FG000|STARTED|Overall Study||110
11235177|NCT02054156|12427144|FG001|STARTED|Overall Study||111
11235178|NCT02054156|12427143|FG000|COMPLETED|Overall Study||35
11235179|NCT02054156|12427144|FG001|COMPLETED|Overall Study||30
11235180|NCT02054156|12427143|FG000|NOT COMPLETED|Overall Study||75
11235181|NCT02054156|12427144|FG001|NOT COMPLETED|Overall Study||81
11235182|NCT02054325|12427152|FG000|STARTED|Overall Study||51
11235183|NCT02054325|12427153|FG001|STARTED|Overall Study||55
11235184|NCT02054325|12427152|FG000|COMPLETED|Overall Study||43
11235185|NCT02054325|12427153|FG001|COMPLETED|Overall Study||50
11235186|NCT02054325|12427152|FG000|NOT COMPLETED|Overall Study||8
11235187|NCT02054325|12427153|FG001|NOT COMPLETED|Overall Study||5
11235188|NCT02054338|12427161|FG000|STARTED|Overall Study||503
11235189|NCT02054338|12427162|FG001|STARTED|Overall Study||501
11235190|NCT02054338|12427161|FG000|COMPLETED|Overall Study||0
11235191|NCT02054338|12427162|FG001|COMPLETED|Overall Study||0
11235192|NCT02054338|12427161|FG000|NOT COMPLETED|Overall Study||503
11235193|NCT02054338|12427162|FG001|NOT COMPLETED|Overall Study||501
11235194|NCT02054481|12427172|FG000|STARTED|Overall Study||43
11235195|NCT02054481|12427173|FG001|STARTED|Overall Study||41
11235196|NCT02054481|12427174|FG002|STARTED|Overall Study||42
11235197|NCT02054481|12427175|FG003|STARTED|Overall Study||40
11235198|NCT02054481|12427172|FG000|COMPLETED|Overall Study||39
11235199|NCT02054481|12427173|FG001|COMPLETED|Overall Study||39
11235200|NCT02054481|12427174|FG002|COMPLETED|Overall Study||40
11235201|NCT02054481|12427175|FG003|COMPLETED|Overall Study||39
11235202|NCT02054481|12427172|FG000|NOT COMPLETED|Overall Study||4
11235203|NCT02054481|12427173|FG001|NOT COMPLETED|Overall Study||2
11235204|NCT02054481|12427174|FG002|NOT COMPLETED|Overall Study||2
11235205|NCT02054481|12427175|FG003|NOT COMPLETED|Overall Study||1
11235206|NCT02054520|12427192|FG000|STARTED|Overall Study||11
11235207|NCT02054520|12427193|FG001|STARTED|Overall Study||16
11235208|NCT02054520|12427194|FG002|STARTED|Overall Study||6
11235209|NCT02054520|12427195|FG003|STARTED|Overall Study||6
11235210|NCT02054520|12427196|FG004|STARTED|Overall Study||5
11235211|NCT02054520|12427197|FG005|STARTED|Overall Study||3
11235212|NCT02054520|12427192|FG000|COMPLETED|Overall Study||2
11235213|NCT02054520|12427193|FG001|COMPLETED|Overall Study||11
11235214|NCT02054520|12427194|FG002|COMPLETED|Overall Study||0
11235215|NCT02054520|12427195|FG003|COMPLETED|Overall Study||0
11235216|NCT02054520|12427196|FG004|COMPLETED|Overall Study||0
11235217|NCT02054520|12427197|FG005|COMPLETED|Overall Study||0
11235218|NCT02054520|12427192|FG000|NOT COMPLETED|Overall Study||9
11235219|NCT02054520|12427193|FG001|NOT COMPLETED|Overall Study||5
11235220|NCT02054520|12427194|FG002|NOT COMPLETED|Overall Study||6
11235221|NCT02054520|12427195|FG003|NOT COMPLETED|Overall Study||6
11235222|NCT02054520|12427196|FG004|NOT COMPLETED|Overall Study||5
11235223|NCT02054520|12427197|FG005|NOT COMPLETED|Overall Study||3
11235224|NCT02054572|12427211|FG000|STARTED|Overall Study||6
11235225|NCT02054572|12427211|FG000|COMPLETED|Overall Study||6
11235226|NCT02054572|12427211|FG000|NOT COMPLETED|Overall Study||0
11235227|NCT02054702|12427217|FG000|STARTED|Overall Study||64
11235228|NCT02054702|12427218|FG001|STARTED|Overall Study||33
11235229|NCT02054702|12427217|FG000|COMPLETED|Overall Study||40
11235230|NCT02054702|12427218|FG001|COMPLETED|Overall Study||21
11235231|NCT02054702|12427217|FG000|NOT COMPLETED|Overall Study||24
11235232|NCT02054702|12427218|FG001|NOT COMPLETED|Overall Study||12
11235233|NCT02054715|12427226|FG000|STARTED|Baseline/Follow-up 1||219
11235234|NCT02054715|12427227|FG001|STARTED|Baseline/Follow-up 1||199
11235235|NCT02054715|12427226|FG000|COMPLETED|Baseline/Follow-up 1||211
11235236|NCT02054715|12427227|FG001|COMPLETED|Baseline/Follow-up 1||192
11235237|NCT02054715|12427226|FG000|NOT COMPLETED|Baseline/Follow-up 1||8
11235238|NCT02054715|12427227|FG001|NOT COMPLETED|Baseline/Follow-up 1||7
11235239|NCT02054715|12427226|FG000|STARTED|Follow-up 2||211
11235240|NCT02054715|12427227|FG001|STARTED|Follow-up 2||192
11235241|NCT02054715|12427226|FG000|COMPLETED|Follow-up 2||192
11235242|NCT02054715|12427227|FG001|COMPLETED|Follow-up 2||173
11235243|NCT02054715|12427226|FG000|NOT COMPLETED|Follow-up 2||19
11235244|NCT02054715|12427227|FG001|NOT COMPLETED|Follow-up 2||19
11235245|NCT02054754|12427235|FG000|STARTED|Overall Study||6
11235246|NCT02054754|12427236|FG001|STARTED|Overall Study||6
11235247|NCT02054754|12427237|FG002|STARTED|Overall Study||6
11235248|NCT02054754|12427238|FG003|STARTED|Overall Study||6
11235249|NCT02054754|12427239|FG004|STARTED|Overall Study||6
11235250|NCT02054754|12427240|FG005|STARTED|Overall Study||10
11235251|NCT02054754|12427235|FG000|COMPLETED|Overall Study||6
11235252|NCT02054754|12427236|FG001|COMPLETED|Overall Study||6
11235253|NCT02054754|12427237|FG002|COMPLETED|Overall Study||6
11235254|NCT02054754|12427238|FG003|COMPLETED|Overall Study||6
11235255|NCT02054754|12427239|FG004|COMPLETED|Overall Study||6
11235256|NCT02054754|12427240|FG005|COMPLETED|Overall Study||10
11235257|NCT02054754|12427235|FG000|NOT COMPLETED|Overall Study||0
11235258|NCT02054754|12427236|FG001|NOT COMPLETED|Overall Study||0
11235259|NCT02054754|12427237|FG002|NOT COMPLETED|Overall Study||0
11235260|NCT02054754|12427238|FG003|NOT COMPLETED|Overall Study||0
11235261|NCT02054754|12427239|FG004|NOT COMPLETED|Overall Study||0
11235262|NCT02054754|12427240|FG005|NOT COMPLETED|Overall Study||0
11235263|NCT02054897|12427258|FG000|STARTED|Overall Study||129
11235264|NCT02054897|12427259|FG001|STARTED|Overall Study||130
11235265|NCT02054897|12427260|FG002|STARTED|Overall Study||129
11235266|NCT02054897|12427258|FG000|Exposed|Overall Study||128
11235267|NCT02054897|12427259|FG001|Exposed|Overall Study||130
11235268|NCT02054897|12427260|FG002|Exposed|Overall Study||129
11235269|NCT02054897|12427258|FG000|COMPLETED|Overall Study||119
11235270|NCT02054897|12427259|FG001|COMPLETED|Overall Study||123
11235271|NCT02054897|12427260|FG002|COMPLETED|Overall Study||117
11235272|NCT02054897|12427258|FG000|NOT COMPLETED|Overall Study||10
11235273|NCT02054897|12427259|FG001|NOT COMPLETED|Overall Study||7
11235274|NCT02054897|12427260|FG002|NOT COMPLETED|Overall Study||12
11235275|NCT02055118|12427271|FG000|STARTED|Overall Study||15
11235276|NCT02055118|12427272|FG001|STARTED|Overall Study||34
11235277|NCT02055118|12427273|FG002|STARTED|Overall Study||9
11235278|NCT02055118|12427271|FG000|COMPLETED|Overall Study||15
11235279|NCT02055118|12427272|FG001|COMPLETED|Overall Study||32
11235280|NCT02055118|12427273|FG002|COMPLETED|Overall Study||9
11235281|NCT02055118|12427271|FG000|NOT COMPLETED|Overall Study||0
11235282|NCT02055118|12427272|FG001|NOT COMPLETED|Overall Study||2
11235283|NCT02055118|12427273|FG002|NOT COMPLETED|Overall Study||0
11235284|NCT02055157|12427286|FG000|STARTED|Initial 6 Months||8
11235285|NCT02055157|12427287|FG001|STARTED|Initial 6 Months||8
11235286|NCT02055157|12427288|FG002|STARTED|Initial 6 Months||10
11235287|NCT02055157|12427289|FG003|STARTED|Initial 6 Months||9
11235288|NCT02055157|12427286|FG000|COMPLETED|Initial 6 Months||7
11235289|NCT02055157|12427287|FG001|COMPLETED|Initial 6 Months||7
11235290|NCT02055157|12427288|FG002|COMPLETED|Initial 6 Months||10
11235291|NCT02055157|12427289|FG003|COMPLETED|Initial 6 Months||8
11235292|NCT02055157|12427286|FG000|NOT COMPLETED|Initial 6 Months||1
11235293|NCT02055157|12427287|FG001|NOT COMPLETED|Initial 6 Months||1
11235294|NCT02055157|12427288|FG002|NOT COMPLETED|Initial 6 Months||0
11235295|NCT02055157|12427289|FG003|NOT COMPLETED|Initial 6 Months||1
11235296|NCT02055157|12427286|FG000|STARTED|18-month Extension||7
11235297|NCT02055157|12427287|FG001|STARTED|18-month Extension||7
11235298|NCT02055157|12427288|FG002|STARTED|18-month Extension||10
11235299|NCT02055157|12427289|FG003|STARTED|18-month Extension||8
11235300|NCT02055157|12427286|FG000|COMPLETED|18-month Extension||6
11235301|NCT02055157|12427287|FG001|COMPLETED|18-month Extension||6
11235302|NCT02055157|12427288|FG002|COMPLETED|18-month Extension||10
11235303|NCT02055157|12427289|FG003|COMPLETED|18-month Extension||8
11235304|NCT02055157|12427286|FG000|NOT COMPLETED|18-month Extension||1
11235305|NCT02055157|12427287|FG001|NOT COMPLETED|18-month Extension||1
11235306|NCT02055157|12427288|FG002|NOT COMPLETED|18-month Extension||0
11235307|NCT02055157|12427289|FG003|NOT COMPLETED|18-month Extension||0
11235308|NCT02055352|12427312|FG000|STARTED|Overall Study||109
11235309|NCT02055352|12427313|FG001|STARTED|Overall Study||113
11235310|NCT02055352|12427312|FG000|Per-Protocol Set (PPS)|Overall Study||108
11235311|NCT02055352|12427313|FG001|Per-Protocol Set (PPS)|Overall Study||111
11235312|NCT02055352|12427312|FG000|COMPLETED|Overall Study||103
11235313|NCT02055352|12427313|FG001|COMPLETED|Overall Study||96
11235314|NCT02055352|12427312|FG000|NOT COMPLETED|Overall Study||6
11235315|NCT02055352|12427313|FG001|NOT COMPLETED|Overall Study||17
11235316|NCT02055365|12427319|FG000|STARTED|Overall Study||10
11235317|NCT02055365|12427319|FG000|COMPLETED|Overall Study||9
11235318|NCT02055365|12427319|FG000|NOT COMPLETED|Overall Study||1
11235319|NCT02055404|12427330|FG000|STARTED|Overall Study||3
11235320|NCT02055404|12427330|FG000|COMPLETED|Overall Study||3
11235321|NCT02055404|12427330|FG000|NOT COMPLETED|Overall Study||0
11235322|NCT02055430|12427345|FG000|STARTED|Overall Study||45
11235323|NCT02055430|12427346|FG001|STARTED|Overall Study||45
11235324|NCT02055430|12427345|FG000|COMPLETED|Overall Study||45
11235325|NCT02055430|12427346|FG001|COMPLETED|Overall Study||45
11235326|NCT02055430|12427345|FG000|NOT COMPLETED|Overall Study||0
11235327|NCT02055430|12427346|FG001|NOT COMPLETED|Overall Study||0
11235328|NCT02055638|12427354|FG000|STARTED|Overall Study||49
11235329|NCT02055638|12427355|FG001|STARTED|Overall Study||48
11235330|NCT02055638|12427354|FG000|COMPLETED|Overall Study||39
11235331|NCT02055638|12427355|FG001|COMPLETED|Overall Study||40
11235332|NCT02055638|12427354|FG000|NOT COMPLETED|Overall Study||10
11235333|NCT02055638|12427355|FG001|NOT COMPLETED|Overall Study||8
11235334|NCT02055781|12427364|FG000|STARTED|Overall Study||104
11235335|NCT02055781|12427365|FG001|STARTED|Overall Study||107
11235336|NCT02055781|12427366|FG002|STARTED|Overall Study||100
11235337|NCT02055781|12427364|FG000|COMPLETED|Overall Study||62
11235338|NCT02055781|12427365|FG001|COMPLETED|Overall Study||79
11235339|NCT02055781|12427366|FG002|COMPLETED|Overall Study||63
11235340|NCT02055781|12427364|FG000|NOT COMPLETED|Overall Study||42
11235341|NCT02055781|12427365|FG001|NOT COMPLETED|Overall Study||28
11235342|NCT02055781|12427366|FG002|NOT COMPLETED|Overall Study||37
11235343|NCT02055820|12427384|FG000|STARTED|Phase I: Dose-Finding||7
11235344|NCT02055820|12427385|FG001|STARTED|Phase I: Dose-Finding||3
11235345|NCT02055820|12427386|FG002|STARTED|Phase I: Dose-Finding||8
11235346|NCT02055820|12427387|FG003|STARTED|Phase I: Dose-Finding||6
11235347|NCT02055820|12427388|FG004|STARTED|Phase I: Dose-Finding||0
11235348|NCT02055820|12427389|FG005|STARTED|Phase I: Dose-Finding||7
11235349|NCT02055820|12427390|FG006|STARTED|Phase I: Dose-Finding||7
11235350|NCT02055820|12427391|FG007|STARTED|Phase I: Dose-Finding||6
11235351|NCT02055820|12427392|FG008|STARTED|Phase I: Dose-Finding||6
11235352|NCT02055820|12427393|FG009|STARTED|Phase I: Dose-Finding||6
11235353|NCT02055820|12427384|FG000|COMPLETED|Phase I: Dose-Finding||6
11235354|NCT02055820|12427385|FG001|COMPLETED|Phase I: Dose-Finding||3
11235355|NCT02055820|12427386|FG002|COMPLETED|Phase I: Dose-Finding||7
11235356|NCT02055820|12427387|FG003|COMPLETED|Phase I: Dose-Finding||3
11235357|NCT02055820|12427388|FG004|COMPLETED|Phase I: Dose-Finding||0
11235358|NCT02055820|12427389|FG005|COMPLETED|Phase I: Dose-Finding||5
11235359|NCT02055820|12427390|FG006|COMPLETED|Phase I: Dose-Finding||5
11235360|NCT02055820|12427391|FG007|COMPLETED|Phase I: Dose-Finding||6
11235361|NCT02055820|12427392|FG008|COMPLETED|Phase I: Dose-Finding||6
11235362|NCT02055820|12427393|FG009|COMPLETED|Phase I: Dose-Finding||6
11235363|NCT02055820|12427384|FG000|NOT COMPLETED|Phase I: Dose-Finding||1
11235364|NCT02055820|12427385|FG001|NOT COMPLETED|Phase I: Dose-Finding||0
11235365|NCT02055820|12427386|FG002|NOT COMPLETED|Phase I: Dose-Finding||1
11235366|NCT02055820|12427387|FG003|NOT COMPLETED|Phase I: Dose-Finding||3
11235367|NCT02055820|12427388|FG004|NOT COMPLETED|Phase I: Dose-Finding||0
11235368|NCT02055820|12427389|FG005|NOT COMPLETED|Phase I: Dose-Finding||2
11235369|NCT02055820|12427390|FG006|NOT COMPLETED|Phase I: Dose-Finding||2
11235370|NCT02055820|12427391|FG007|NOT COMPLETED|Phase I: Dose-Finding||0
11235371|NCT02055820|12427392|FG008|NOT COMPLETED|Phase I: Dose-Finding||0
11235372|NCT02055820|12427393|FG009|NOT COMPLETED|Phase I: Dose-Finding||0
11235373|NCT02055820|12427384|FG000|STARTED|Phase II: Expansion||0
11235374|NCT02055820|12427385|FG001|STARTED|Phase II: Expansion||0
11235375|NCT02055820|12427386|FG002|STARTED|Phase II: Expansion||0
11235376|NCT02055820|12427387|FG003|STARTED|Phase II: Expansion||0
11235377|NCT02055820|12427388|FG004|STARTED|Phase II: Expansion||208
11235378|NCT02055820|12427389|FG005|STARTED|Phase II: Expansion||0
11235379|NCT02055820|12427390|FG006|STARTED|Phase II: Expansion||0
11235380|NCT02055820|12427391|FG007|STARTED|Phase II: Expansion||0
11235381|NCT02055820|12427392|FG008|STARTED|Phase II: Expansion||0
11235382|NCT02055820|12427393|FG009|STARTED|Phase II: Expansion||0
11235383|NCT02055820|12427384|FG000|COMPLETED|Phase II: Expansion||0
11235384|NCT02055820|12427385|FG001|COMPLETED|Phase II: Expansion||0
11235385|NCT02055820|12427386|FG002|COMPLETED|Phase II: Expansion||0
11235386|NCT02055820|12427387|FG003|COMPLETED|Phase II: Expansion||0
11235387|NCT02055820|12427388|FG004|COMPLETED|Phase II: Expansion||159
11235388|NCT02055820|12427389|FG005|COMPLETED|Phase II: Expansion||0
11235389|NCT02055820|12427390|FG006|COMPLETED|Phase II: Expansion||0
11235390|NCT02055820|12427391|FG007|COMPLETED|Phase II: Expansion||0
11235391|NCT02055820|12427392|FG008|COMPLETED|Phase II: Expansion||0
11235392|NCT02055820|12427393|FG009|COMPLETED|Phase II: Expansion||0
11235393|NCT02055820|12427384|FG000|NOT COMPLETED|Phase II: Expansion||0
11235394|NCT02055820|12427385|FG001|NOT COMPLETED|Phase II: Expansion||0
11235395|NCT02055820|12427386|FG002|NOT COMPLETED|Phase II: Expansion||0
11235396|NCT02055820|12427387|FG003|NOT COMPLETED|Phase II: Expansion||0
11235397|NCT02055820|12427388|FG004|NOT COMPLETED|Phase II: Expansion||49
11235398|NCT02055820|12427389|FG005|NOT COMPLETED|Phase II: Expansion||0
11235399|NCT02055820|12427390|FG006|NOT COMPLETED|Phase II: Expansion||0
11235400|NCT02055820|12427391|FG007|NOT COMPLETED|Phase II: Expansion||0
11235401|NCT02055820|12427392|FG008|NOT COMPLETED|Phase II: Expansion||0
11235402|NCT02055820|12427393|FG009|NOT COMPLETED|Phase II: Expansion||0
11235403|NCT02055898|12427437|FG000|STARTED|First Intervention (5 Days)||7
11235404|NCT02055898|12427438|FG001|STARTED|First Intervention (5 Days)||6
11235405|NCT02055898|12427437|FG000|COMPLETED|First Intervention (5 Days)||5
11235406|NCT02055898|12427438|FG001|COMPLETED|First Intervention (5 Days)||5
11235407|NCT02055898|12427437|FG000|NOT COMPLETED|First Intervention (5 Days)||2
11235408|NCT02055898|12427438|FG001|NOT COMPLETED|First Intervention (5 Days)||1
11235409|NCT02055898|12427437|FG000|STARTED|Washout (at Least 14 Days)||5
11235410|NCT02055898|12427438|FG001|STARTED|Washout (at Least 14 Days)||5
11235411|NCT02055898|12427437|FG000|COMPLETED|Washout (at Least 14 Days)||5
11235412|NCT02055898|12427438|FG001|COMPLETED|Washout (at Least 14 Days)||5
11235413|NCT02055898|12427437|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
11235414|NCT02055898|12427438|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
11235415|NCT02055898|12427437|FG000|STARTED|Second Intervention (5 Days)||5
11235416|NCT02055898|12427438|FG001|STARTED|Second Intervention (5 Days)||5
11235417|NCT02055898|12427437|FG000|COMPLETED|Second Intervention (5 Days)||5
11235418|NCT02055898|12427438|FG001|COMPLETED|Second Intervention (5 Days)||5
11235419|NCT02055898|12427437|FG000|NOT COMPLETED|Second Intervention (5 Days)||0
11235420|NCT02055898|12427438|FG001|NOT COMPLETED|Second Intervention (5 Days)||0
11235421|NCT02055976|12427453|FG000|STARTED|Overall Study||25
11235422|NCT02055976|12427454|FG001|STARTED|Overall Study||24
11235423|NCT02055976|12427455|FG002|STARTED|Overall Study||24
11235424|NCT02055976|12427456|FG003|STARTED|Overall Study||26
11235425|NCT02055976|12427457|FG004|STARTED|Overall Study||22
11235426|NCT02055976|12427458|FG005|STARTED|Overall Study||25
11235427|NCT02055976|12427459|FG006|STARTED|Overall Study||25
11235428|NCT02055976|12427460|FG007|STARTED|Overall Study||24
11235429|NCT02055976|12427461|FG008|STARTED|Overall Study||23
11235430|NCT02055976|12427453|FG000|COMPLETED|Overall Study||25
11235431|NCT02055976|12427454|FG001|COMPLETED|Overall Study||24
11235432|NCT02055976|12427455|FG002|COMPLETED|Overall Study||23
11235433|NCT02055976|12427456|FG003|COMPLETED|Overall Study||25
11235434|NCT02055976|12427457|FG004|COMPLETED|Overall Study||22
11235435|NCT02055976|12427458|FG005|COMPLETED|Overall Study||24
11235436|NCT02055976|12427459|FG006|COMPLETED|Overall Study||23
11235437|NCT02055976|12427460|FG007|COMPLETED|Overall Study||24
11235438|NCT02055976|12427461|FG008|COMPLETED|Overall Study||23
11235439|NCT02055976|12427453|FG000|NOT COMPLETED|Overall Study||0
11235440|NCT02055976|12427454|FG001|NOT COMPLETED|Overall Study||0
11235441|NCT02055976|12427455|FG002|NOT COMPLETED|Overall Study||1
11235442|NCT02055976|12427456|FG003|NOT COMPLETED|Overall Study||1
11235443|NCT02055976|12427457|FG004|NOT COMPLETED|Overall Study||0
11235444|NCT02055976|12427458|FG005|NOT COMPLETED|Overall Study||1
11235445|NCT02055976|12427459|FG006|NOT COMPLETED|Overall Study||2
11235446|NCT02055976|12427460|FG007|NOT COMPLETED|Overall Study||0
11235447|NCT02055976|12427461|FG008|NOT COMPLETED|Overall Study||0
11235448|NCT02056171|12427490|FG000|STARTED|Overall Study||3
11235449|NCT02056171|12427491|FG001|STARTED|Overall Study||3
11235450|NCT02056171|12427490|FG000|COMPLETED|Overall Study||3
11235451|NCT02056171|12427491|FG001|COMPLETED|Overall Study||3
11235452|NCT02056171|12427490|FG000|NOT COMPLETED|Overall Study||0
11235453|NCT02056171|12427491|FG001|NOT COMPLETED|Overall Study||0
11235454|NCT02056288|12427499|FG000|STARTED|In-Hospital Data||40
11235455|NCT02056288|12427500|FG001|STARTED|In-Hospital Data||38
11235456|NCT02056288|12427499|FG000|COMPLETED|In-Hospital Data||35
11235457|NCT02056288|12427500|FG001|COMPLETED|In-Hospital Data||38
11235458|NCT02056288|12427499|FG000|NOT COMPLETED|In-Hospital Data||5
11235459|NCT02056288|12427500|FG001|NOT COMPLETED|In-Hospital Data||0
11235460|NCT02056288|12427499|FG000|STARTED|48-Hour Post-Discharge Data||35
11235461|NCT02056288|12427500|FG001|STARTED|48-Hour Post-Discharge Data||38
11235462|NCT02056288|12427499|FG000|COMPLETED|48-Hour Post-Discharge Data||21
11235463|NCT02056288|12427500|FG001|COMPLETED|48-Hour Post-Discharge Data||18
11235464|NCT02056288|12427499|FG000|NOT COMPLETED|48-Hour Post-Discharge Data||14
11235465|NCT02056288|12427500|FG001|NOT COMPLETED|48-Hour Post-Discharge Data||20
11235466|NCT02056301|12427508|FG000|STARTED|Overall Study||33
11235467|NCT02056301|12427509|FG001|STARTED|Overall Study||29
11235468|NCT02056301|12427508|FG000|COMPLETED|Overall Study||31
11235469|NCT02056301|12427509|FG001|COMPLETED|Overall Study||23
11235470|NCT02056301|12427508|FG000|NOT COMPLETED|Overall Study||2
11235471|NCT02056301|12427509|FG001|NOT COMPLETED|Overall Study||6
11235472|NCT02056340|12427517|FG000|STARTED|Overall Study||59
11235473|NCT02056340|12427518|FG001|STARTED|Overall Study||57
11235474|NCT02056340|12427517|FG000|COMPLETED|Overall Study||52
11235475|NCT02056340|12427518|FG001|COMPLETED|Overall Study||46
11235476|NCT02056340|12427517|FG000|NOT COMPLETED|Overall Study||7
11235477|NCT02056340|12427518|FG001|NOT COMPLETED|Overall Study||11
11235478|NCT02056392|12427530|FG000|STARTED|Overall Study||10
11235479|NCT02056392|12427531|FG001|STARTED|Overall Study||9
11235480|NCT02056392|12427532|FG002|STARTED|Overall Study||9
11235481|NCT02056392|12427533|FG003|STARTED|Overall Study||9
11235482|NCT02056392|12427534|FG004|STARTED|Overall Study||8
11235483|NCT02056392|12427535|FG005|STARTED|Overall Study||9
11235484|NCT02056392|12427530|FG000|COMPLETED|Overall Study||8
11235485|NCT02056392|12427531|FG001|COMPLETED|Overall Study||8
11235486|NCT02056392|12427532|FG002|COMPLETED|Overall Study||6
11235487|NCT02056392|12427533|FG003|COMPLETED|Overall Study||9
11235488|NCT02056392|12427534|FG004|COMPLETED|Overall Study||7
11235489|NCT02056392|12427535|FG005|COMPLETED|Overall Study||9
11235490|NCT02056392|12427530|FG000|NOT COMPLETED|Overall Study||2
11235491|NCT02056392|12427531|FG001|NOT COMPLETED|Overall Study||1
11235492|NCT02056392|12427532|FG002|NOT COMPLETED|Overall Study||3
11235493|NCT02056392|12427533|FG003|NOT COMPLETED|Overall Study||0
11235494|NCT02056392|12427534|FG004|NOT COMPLETED|Overall Study||1
11235495|NCT02056392|12427535|FG005|NOT COMPLETED|Overall Study||0
11235496|NCT02056431|12427545|FG000|STARTED|Overall Study||604
11235497|NCT02056431|12427546|FG001|STARTED|Overall Study||666
11235498|NCT02056431|12427545|FG000|COMPLETED|Overall Study||560
11235499|NCT02056431|12427546|FG001|COMPLETED|Overall Study||619
11235500|NCT02056431|12427545|FG000|NOT COMPLETED|Overall Study||44
11235501|NCT02056431|12427546|FG001|NOT COMPLETED|Overall Study||47
11235502|NCT02056626|12427558|FG000|STARTED|Overall Study||13
11235503|NCT02056626|12427559|FG001|STARTED|Overall Study||13
11235504|NCT02056626|12427560|FG002|STARTED|Overall Study||4
11235505|NCT02056626|12427561|FG003|STARTED|Overall Study||14
11235506|NCT02056626|12427558|FG000|COMPLETED|Overall Study||10
11235507|NCT02056626|12427559|FG001|COMPLETED|Overall Study||12
11235508|NCT02056626|12427560|FG002|COMPLETED|Overall Study||4
11235509|NCT02056626|12427561|FG003|COMPLETED|Overall Study||14
11235510|NCT02056626|12427558|FG000|NOT COMPLETED|Overall Study||3
11235511|NCT02056626|12427559|FG001|NOT COMPLETED|Overall Study||1
11235512|NCT02056626|12427560|FG002|NOT COMPLETED|Overall Study||0
11235513|NCT02056626|12427561|FG003|NOT COMPLETED|Overall Study||0
11235514|NCT02056639|12427573|FG000|STARTED|Overall Study||23
11235515|NCT02056639|12427574|FG001|STARTED|Overall Study||23
11235516|NCT02056639|12427573|FG000|COMPLETED|Overall Study||23
11235517|NCT02056639|12427574|FG001|COMPLETED|Overall Study||23
11235518|NCT02056639|12427573|FG000|NOT COMPLETED|Overall Study||0
11235519|NCT02056639|12427574|FG001|NOT COMPLETED|Overall Study||0
11235520|NCT02056652|12427584|FG000|STARTED|Overall Study||61
11235521|NCT02056652|12427585|FG001|STARTED|Overall Study||61
11235522|NCT02056652|12427584|FG000|COMPLETED|Overall Study||60
11235523|NCT02056652|12427585|FG001|COMPLETED|Overall Study||58
11235524|NCT02056652|12427584|FG000|NOT COMPLETED|Overall Study||1
11235525|NCT02056652|12427585|FG001|NOT COMPLETED|Overall Study||3
11235526|NCT02056834|12427591|FG000|STARTED|Overall Study||36
11235527|NCT02056834|12427591|FG000|6 Weeks|Overall Study||34
11235528|NCT02056834|12427591|FG000|6 Months|Overall Study||31
11235529|NCT02056834|12427591|FG000|COMPLETED|Overall Study||29
11235530|NCT02056834|12427591|FG000|NOT COMPLETED|Overall Study||7
11235531|NCT02057042|12427598|FG000|STARTED|Overall Study||163
11235532|NCT02057042|12427599|FG001|STARTED|Overall Study||167
11235533|NCT02057042|12427598|FG000|COMPLETED|Overall Study||118
11235534|NCT02057042|12427599|FG001|COMPLETED|Overall Study||101
11235535|NCT02057042|12427598|FG000|NOT COMPLETED|Overall Study||45
11235536|NCT02057042|12427599|FG001|NOT COMPLETED|Overall Study||66
11235537|NCT02057068|12427607|FG000|STARTED|Overall Study||60
11235538|NCT02057068|12427608|FG001|STARTED|Overall Study||36
11235539|NCT02057068|12427607|FG000|COMPLETED|Overall Study||52
11235540|NCT02057068|12427608|FG001|COMPLETED|Overall Study||28
11235541|NCT02057068|12427607|FG000|NOT COMPLETED|Overall Study||8
11235542|NCT02057068|12427608|FG001|NOT COMPLETED|Overall Study||8
11235543|NCT02057081|12427618|FG000|STARTED|Overall Study||136
11235544|NCT02057081|12427619|FG001|STARTED|Overall Study||112
11235545|NCT02057081|12427618|FG000|Completed Baseline|Overall Study||88
11235546|NCT02057081|12427619|FG001|Completed Baseline|Overall Study||80
11235547|NCT02057081|12427618|FG000|Post-Treatment Assessment|Overall Study||58
11235548|NCT02057081|12427619|FG001|Post-Treatment Assessment|Overall Study||52
11235549|NCT02057081|12427618|FG000|COMPLETED|Overall Study||46
11235550|NCT02057081|12427619|FG001|COMPLETED|Overall Study||44
11235551|NCT02057081|12427618|FG000|NOT COMPLETED|Overall Study||90
11235552|NCT02057081|12427619|FG001|NOT COMPLETED|Overall Study||68
11235553|NCT02057198|12427628|FG000|STARTED|Overall Study||11
11235554|NCT02057198|12427629|FG001|STARTED|Overall Study||11
11235555|NCT02057198|12427630|FG002|STARTED|Overall Study||11
11235556|NCT02057198|12427628|FG000|COMPLETED|Overall Study||11
11235557|NCT02057198|12427629|FG001|COMPLETED|Overall Study||10
11235558|NCT02057198|12427630|FG002|COMPLETED|Overall Study||10
11235559|NCT02057198|12427628|FG000|NOT COMPLETED|Overall Study||0
11235560|NCT02057198|12427629|FG001|NOT COMPLETED|Overall Study||1
11235561|NCT02057198|12427630|FG002|NOT COMPLETED|Overall Study||1
11235562|NCT02057250|12427642|FG000|STARTED|AID Assessment Phase||56
11235563|NCT02057250|12427643|FG001|STARTED|AID Assessment Phase||53
11235564|NCT02057250|12427644|FG002|STARTED|AID Assessment Phase||52
11235565|NCT02057250|12427645|FG003|STARTED|AID Assessment Phase||56
11235566|NCT02057250|12427646|FG004|STARTED|AID Assessment Phase||0
11235567|NCT02057250|12427642|FG000|COMPLETED|AID Assessment Phase||52
11235568|NCT02057250|12427643|FG001|COMPLETED|AID Assessment Phase||50
11235569|NCT02057250|12427644|FG002|COMPLETED|AID Assessment Phase||45
11235570|NCT02057250|12427645|FG003|COMPLETED|AID Assessment Phase||54
11235571|NCT02057250|12427646|FG004|COMPLETED|AID Assessment Phase||0
11235572|NCT02057250|12427642|FG000|NOT COMPLETED|AID Assessment Phase||4
11235573|NCT02057250|12427643|FG001|NOT COMPLETED|AID Assessment Phase||3
11235574|NCT02057250|12427644|FG002|NOT COMPLETED|AID Assessment Phase||7
11235575|NCT02057250|12427645|FG003|NOT COMPLETED|AID Assessment Phase||2
11235576|NCT02057250|12427646|FG004|NOT COMPLETED|AID Assessment Phase||0
11235577|NCT02057250|12427642|FG000|STARTED|Extension Phase||0
11235578|NCT02057250|12427643|FG001|STARTED|Extension Phase||0
11235579|NCT02057250|12427644|FG002|STARTED|Extension Phase||0
11235580|NCT02057250|12427645|FG003|STARTED|Extension Phase||0
11235581|NCT02057250|12427646|FG004|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
11235582|NCT02057250|12427642|FG000|Treated|Extension Phase||0
11235583|NCT02057250|12427643|FG001|Treated|Extension Phase||0
11235584|NCT02057250|12427644|FG002|Treated|Extension Phase||0
11235585|NCT02057250|12427645|FG003|Treated|Extension Phase||0
11235586|NCT02057250|12427646|FG004|Treated|Extension Phase||188
11235587|NCT02057250|12427642|FG000|COMPLETED|Extension Phase||0
11235588|NCT02057250|12427643|FG001|COMPLETED|Extension Phase||0
11235589|NCT02057250|12427644|FG002|COMPLETED|Extension Phase||0
11235590|NCT02057250|12427645|FG003|COMPLETED|Extension Phase||0
11235591|NCT02057250|12427646|FG004|COMPLETED|Extension Phase||156
11235592|NCT02057250|12427642|FG000|NOT COMPLETED|Extension Phase||0
11235593|NCT02057250|12427643|FG001|NOT COMPLETED|Extension Phase||0
11235594|NCT02057250|12427644|FG002|NOT COMPLETED|Extension Phase||0
11235595|NCT02057250|12427645|FG003|NOT COMPLETED|Extension Phase||0
11235596|NCT02057250|12427646|FG004|NOT COMPLETED|Extension Phase||36
11235597|NCT02057393|12427658|FG000|STARTED|Overall Study||89
11235598|NCT02057393|12427658|FG000|COMPLETED|Overall Study||87
11235599|NCT02057393|12427658|FG000|NOT COMPLETED|Overall Study||2
11235600|NCT02057406|12427665|FG000|STARTED|Overall Study||36
11235601|NCT02057406|12427666|FG001|STARTED|Overall Study||36
11235602|NCT02057406|12427667|FG002|STARTED|Overall Study||36
11235603|NCT02057406|12427665|FG000|COMPLETED|Overall Study||35
11235604|NCT02057406|12427666|FG001|COMPLETED|Overall Study||33
11235605|NCT02057406|12427667|FG002|COMPLETED|Overall Study||32
11235606|NCT02057406|12427665|FG000|NOT COMPLETED|Overall Study||1
11235607|NCT02057406|12427666|FG001|NOT COMPLETED|Overall Study||3
11235608|NCT02057406|12427667|FG002|NOT COMPLETED|Overall Study||4
11235609|NCT02057458|12427675|FG000|STARTED|Recruited for Participation||8
11235610|NCT02057458|12427676|FG001|STARTED|Recruited for Participation||8
11235611|NCT02057458|12427677|FG002|STARTED|Recruited for Participation||3
11235612|NCT02057458|12427675|FG000|COMPLETED|Recruited for Participation||8
11235613|NCT02057458|12427676|FG001|COMPLETED|Recruited for Participation||8
11235614|NCT02057458|12427677|FG002|COMPLETED|Recruited for Participation||3
11235615|NCT02057458|12427675|FG000|NOT COMPLETED|Recruited for Participation||0
11235616|NCT02057458|12427676|FG001|NOT COMPLETED|Recruited for Participation||0
11235617|NCT02057458|12427677|FG002|NOT COMPLETED|Recruited for Participation||0
11235618|NCT02057458|12427675|FG000|STARTED|Met Inclusion Criteria||8
11235619|NCT02057458|12427676|FG001|STARTED|Met Inclusion Criteria||8
11235620|NCT02057458|12427677|FG002|STARTED|Met Inclusion Criteria||3
11235621|NCT02057458|12427675|FG000|COMPLETED|Met Inclusion Criteria||8
11235622|NCT02057458|12427676|FG001|COMPLETED|Met Inclusion Criteria||7
11235623|NCT02057458|12427677|FG002|COMPLETED|Met Inclusion Criteria||3
11235624|NCT02057458|12427675|FG000|NOT COMPLETED|Met Inclusion Criteria||0
11235625|NCT02057458|12427676|FG001|NOT COMPLETED|Met Inclusion Criteria||1
11235626|NCT02057458|12427677|FG002|NOT COMPLETED|Met Inclusion Criteria||0
11235627|NCT02057458|12427675|FG000|STARTED|Acute Study (1 Hour): First Intervention||8
11235628|NCT02057458|12427676|FG001|STARTED|Acute Study (1 Hour): First Intervention||7
11235629|NCT02057458|12427677|FG002|STARTED|Acute Study (1 Hour): First Intervention||0
11235630|NCT02057458|12427675|FG000|COMPLETED|Acute Study (1 Hour): First Intervention||6
11235631|NCT02057458|12427676|FG001|COMPLETED|Acute Study (1 Hour): First Intervention||7
11235632|NCT02057458|12427677|FG002|COMPLETED|Acute Study (1 Hour): First Intervention||0
11235633|NCT02057458|12427675|FG000|NOT COMPLETED|Acute Study (1 Hour): First Intervention||2
11235634|NCT02057458|12427676|FG001|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
11235635|NCT02057458|12427677|FG002|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
11235636|NCT02057458|12427675|FG000|STARTED|Acute Study (1 Hour): Second Int.||6
11235637|NCT02057458|12427676|FG001|STARTED|Acute Study (1 Hour): Second Int.||7
11235638|NCT02057458|12427677|FG002|STARTED|Acute Study (1 Hour): Second Int.||0
11235639|NCT02057458|12427675|FG000|COMPLETED|Acute Study (1 Hour): Second Int.||6
11235640|NCT02057458|12427676|FG001|COMPLETED|Acute Study (1 Hour): Second Int.||7
11235641|NCT02057458|12427677|FG002|COMPLETED|Acute Study (1 Hour): Second Int.||0
11235642|NCT02057458|12427675|FG000|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
11235643|NCT02057458|12427676|FG001|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
11235644|NCT02057458|12427677|FG002|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
11235645|NCT02057458|12427675|FG000|STARTED|Sub-Chronic Study (4 Weeks)||6
11235646|NCT02057458|12427676|FG001|STARTED|Sub-Chronic Study (4 Weeks)||7
11235647|NCT02057458|12427677|FG002|STARTED|Sub-Chronic Study (4 Weeks)||3
11235648|NCT02057458|12427675|FG000|COMPLETED|Sub-Chronic Study (4 Weeks)||5
11235649|NCT02057458|12427676|FG001|COMPLETED|Sub-Chronic Study (4 Weeks)||7
11235650|NCT02057458|12427677|FG002|COMPLETED|Sub-Chronic Study (4 Weeks)||3
11235651|NCT02057458|12427675|FG000|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||1
11235652|NCT02057458|12427676|FG001|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
11235653|NCT02057458|12427677|FG002|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
11235654|NCT02057523|12427707|FG000|STARTED|Overall Study||2
11235655|NCT02057523|12427707|FG000|COMPLETED|Overall Study||0
11235656|NCT02057523|12427707|FG000|NOT COMPLETED|Overall Study||2
11235657|NCT02057549|12427713|FG000|STARTED|Overall Study||18
11235658|NCT02057549|12427714|FG001|STARTED|Overall Study||18
11235659|NCT02057549|12427713|FG000|COMPLETED|Overall Study||15
11235660|NCT02057549|12427714|FG001|COMPLETED|Overall Study||18
11235661|NCT02057549|12427713|FG000|NOT COMPLETED|Overall Study||3
11235662|NCT02057549|12427714|FG001|NOT COMPLETED|Overall Study||0
11235663|NCT02057575|12427724|FG000|STARTED|Overall Study||74
11235664|NCT02057575|12427725|FG001|STARTED|Overall Study||73
11235665|NCT02057575|12427726|FG002|STARTED|Overall Study||78
11235666|NCT02057575|12427727|FG003|STARTED|Overall Study||73
11235667|NCT02057575|12427724|FG000|COMPLETED|Overall Study||73
11235668|NCT02057575|12427725|FG001|COMPLETED|Overall Study||69
11235669|NCT02057575|12427726|FG002|COMPLETED|Overall Study||78
11235670|NCT02057575|12427727|FG003|COMPLETED|Overall Study||72
11235671|NCT02057575|12427724|FG000|NOT COMPLETED|Overall Study||1
11235672|NCT02057575|12427725|FG001|NOT COMPLETED|Overall Study||4
11235673|NCT02057575|12427726|FG002|NOT COMPLETED|Overall Study||0
11235674|NCT02057575|12427727|FG003|NOT COMPLETED|Overall Study||1
11235675|NCT02057640|12427739|FG000|STARTED|Weeks 1-4|1 extra participant accidentally treated at DL1 (in addition to initial 3).|4
11235676|NCT02057640|12427740|FG001|STARTED|Weeks 1-4||3
11235677|NCT02057640|12427739|FG000|COMPLETED|Weeks 1-4||4
11235678|NCT02057640|12427740|FG001|COMPLETED|Weeks 1-4||3
11235679|NCT02057640|12427739|FG000|NOT COMPLETED|Weeks 1-4||0
11235680|NCT02057640|12427740|FG001|NOT COMPLETED|Weeks 1-4||0
11235681|NCT02057640|12427739|FG000|STARTED|Phase II Portion of Study at DL2||0
11235682|NCT02057640|12427740|FG001|STARTED|Phase II Portion of Study at DL2||9
11235683|NCT02057640|12427739|FG000|COMPLETED|Phase II Portion of Study at DL2||0
11235684|NCT02057640|12427740|FG001|COMPLETED|Phase II Portion of Study at DL2||9
11235685|NCT02057640|12427739|FG000|NOT COMPLETED|Phase II Portion of Study at DL2||0
11235686|NCT02057640|12427740|FG001|NOT COMPLETED|Phase II Portion of Study at DL2||0
11235687|NCT02057666|12427749|FG000|STARTED|Double Blind Treatment Period||96
11235688|NCT02057666|12427750|FG001|STARTED|Double Blind Treatment Period||50
11235689|NCT02057666|12427749|FG000|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|0
11235690|NCT02057666|12427750|FG001|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|6
11235691|NCT02057666|12427749|FG000|NOT COMPLETED|Double Blind Treatment Period||96
11235692|NCT02057666|12427750|FG001|NOT COMPLETED|Double Blind Treatment Period||44
11235693|NCT02057666|12427749|FG000|STARTED|Open-Label Treatment Period||0
11235694|NCT02057666|12427750|FG001|STARTED|Open-Label Treatment Period||6
11235695|NCT02057666|12427749|FG000|COMPLETED|Open-Label Treatment Period||0
11235696|NCT02057666|12427750|FG001|COMPLETED|Open-Label Treatment Period||0
11235697|NCT02057666|12427749|FG000|NOT COMPLETED|Open-Label Treatment Period||0
11235698|NCT02057666|12427750|FG001|NOT COMPLETED|Open-Label Treatment Period||6
11235699|NCT02057692|12427760|FG000|STARTED|Overall Study||8
11235700|NCT02057692|12427761|FG001|STARTED|Overall Study||11
11235701|NCT02057692|12427762|FG002|STARTED|Overall Study||6
11235702|NCT02057692|12427763|FG003|STARTED|Overall Study||12
11235703|NCT02057692|12427760|FG000|COMPLETED|Overall Study||7
11235704|NCT02057692|12427761|FG001|COMPLETED|Overall Study||11
11235705|NCT02057692|12427762|FG002|COMPLETED|Overall Study||6
11235706|NCT02057692|12427763|FG003|COMPLETED|Overall Study||11
11235707|NCT02057692|12427760|FG000|NOT COMPLETED|Overall Study||1
11235708|NCT02057692|12427761|FG001|NOT COMPLETED|Overall Study||0
11235709|NCT02057692|12427762|FG002|NOT COMPLETED|Overall Study||0
11235710|NCT02057692|12427763|FG003|NOT COMPLETED|Overall Study||1
11235711|NCT02057718|12427781|FG000|STARTED|Completed Study Treatment Through Wk. 72||8
11235712|NCT02057718|12427782|FG001|STARTED|Completed Study Treatment Through Wk. 72||25
11235713|NCT02057718|12427781|FG000|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||6
11235714|NCT02057718|12427782|FG001|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||16
11235715|NCT02057718|12427781|FG000|COMPLETED|Completed Study Treatment Through Wk. 72||6
11235716|NCT02057718|12427782|FG001|COMPLETED|Completed Study Treatment Through Wk. 72||16
11235717|NCT02057718|12427781|FG000|NOT COMPLETED|Completed Study Treatment Through Wk. 72||2
11235718|NCT02057718|12427782|FG001|NOT COMPLETED|Completed Study Treatment Through Wk. 72||9
11235719|NCT02057718|12427781|FG000|STARTED|Optional Follow-up Treatment Period||6
11235720|NCT02057718|12427782|FG001|STARTED|Optional Follow-up Treatment Period||16
11235721|NCT02057718|12427781|FG000|COMPLETED|Optional Follow-up Treatment Period||4
11235722|NCT02057718|12427782|FG001|COMPLETED|Optional Follow-up Treatment Period||8
11235723|NCT02057718|12427781|FG000|NOT COMPLETED|Optional Follow-up Treatment Period||2
11235724|NCT02057718|12427782|FG001|NOT COMPLETED|Optional Follow-up Treatment Period||8
11235725|NCT02057757|12427790|FG000|STARTED|Overall Study||131
11235726|NCT02057757|12427791|FG001|STARTED|Overall Study||129
11235727|NCT02057757|12427790|FG000|Intent to Treat|Overall Study||130
11235728|NCT02057757|12427791|FG001|Intent to Treat|Overall Study||127
11235729|NCT02057757|12427790|FG000|COMPLETED|Overall Study||117
11235730|NCT02057757|12427791|FG001|COMPLETED|Overall Study||121
11235731|NCT02057757|12427790|FG000|NOT COMPLETED|Overall Study||14
11235732|NCT02057757|12427791|FG001|NOT COMPLETED|Overall Study||8
11235733|NCT02057835|12427811|FG000|STARTED|Overall Study||8
11235734|NCT02057835|12427812|FG001|STARTED|Overall Study||6
11235735|NCT02057835|12427813|FG002|STARTED|Overall Study||6
11235736|NCT02057835|12427814|FG003|STARTED|Overall Study||6
11235737|NCT02057835|12427815|FG004|STARTED|Overall Study||6
11235738|NCT02057835|12427816|FG005|STARTED|Overall Study||8
11235739|NCT02057835|12427817|FG006|STARTED|Overall Study||6
11235740|NCT02057835|12427818|FG007|STARTED|Overall Study||6
11235741|NCT02057835|12427819|FG008|STARTED|Overall Study||6
11235742|NCT02057835|12427820|FG009|STARTED|Overall Study||6
11235743|NCT02057835|12427811|FG000|COMPLETED|Overall Study||8
11235744|NCT02057835|12427812|FG001|COMPLETED|Overall Study||4
11235745|NCT02057835|12427813|FG002|COMPLETED|Overall Study||6
11235746|NCT02057835|12427814|FG003|COMPLETED|Overall Study||6
11235747|NCT02057835|12427815|FG004|COMPLETED|Overall Study||6
11235748|NCT02057835|12427816|FG005|COMPLETED|Overall Study||8
11235749|NCT02057835|12427817|FG006|COMPLETED|Overall Study||6
11235750|NCT02057835|12427818|FG007|COMPLETED|Overall Study||6
11235751|NCT02057835|12427819|FG008|COMPLETED|Overall Study||6
11235752|NCT02057835|12427820|FG009|COMPLETED|Overall Study||6
11235753|NCT02057835|12427811|FG000|NOT COMPLETED|Overall Study||0
11235754|NCT02057835|12427812|FG001|NOT COMPLETED|Overall Study||2
11235755|NCT02057835|12427813|FG002|NOT COMPLETED|Overall Study||0
11118385|NCT01323998|12303122|FG000|NOT COMPLETED|Overall Study||0
11118386|NCT01323998|12303123|FG001|NOT COMPLETED|Overall Study||0
11118387|NCT01323998|12303124|FG002|NOT COMPLETED|Overall Study||0
11118388|NCT01323998|12303125|FG003|NOT COMPLETED|Overall Study||0
11118389|NCT01323998|12303126|FG004|NOT COMPLETED|Overall Study||0
11118390|NCT01324024|12303138|FG000|STARTED|First Intervention (4 Weeks)||18
11235756|NCT02057835|12427814|FG003|NOT COMPLETED|Overall Study||0
11235757|NCT02057835|12427815|FG004|NOT COMPLETED|Overall Study||0
11235758|NCT02057835|12427816|FG005|NOT COMPLETED|Overall Study||0
11235759|NCT02057835|12427817|FG006|NOT COMPLETED|Overall Study||0
11235760|NCT02057835|12427818|FG007|NOT COMPLETED|Overall Study||0
11235761|NCT02057835|12427819|FG008|NOT COMPLETED|Overall Study||0
11235762|NCT02057835|12427820|FG009|NOT COMPLETED|Overall Study||0
11235763|NCT02057939|12427849|FG000|STARTED|Overall Study||38
11235764|NCT02057939|12427849|FG000|COMPLETED|Overall Study||37
11235765|NCT02057939|12427849|FG000|NOT COMPLETED|Overall Study||1
11235766|NCT02057952|12427856|FG000|STARTED|Overall Study||51
11235767|NCT02057952|12427857|FG001|STARTED|Overall Study||49
11235768|NCT02057952|12427858|FG002|STARTED|Overall Study||50
11235769|NCT02057952|12427856|FG000|COMPLETED|Overall Study||43
11235770|NCT02057952|12427857|FG001|COMPLETED|Overall Study||39
11235771|NCT02057952|12427858|FG002|COMPLETED|Overall Study||28
11235772|NCT02057952|12427856|FG000|NOT COMPLETED|Overall Study||8
11235773|NCT02057952|12427857|FG001|NOT COMPLETED|Overall Study||10
11235774|NCT02057952|12427858|FG002|NOT COMPLETED|Overall Study||22
11235775|NCT02058069|12427866|FG000|STARTED|Overall Study||100
11235776|NCT02058069|12427866|FG000|COMPLETED|Overall Study||89
11235777|NCT02058069|12427866|FG000|NOT COMPLETED|Overall Study||11
11235778|NCT02058095|12427872|FG000|STARTED|Overall Study||15
11235779|NCT02058095|12427873|FG001|STARTED|Overall Study||7
11235780|NCT02058095|12427872|FG000|COMPLETED|Overall Study||14
11235781|NCT02058095|12427873|FG001|COMPLETED|Overall Study||7
11235782|NCT02058095|12427872|FG000|NOT COMPLETED|Overall Study||1
11235783|NCT02058095|12427873|FG001|NOT COMPLETED|Overall Study||0
11235784|NCT02058108|12427881|FG000|STARTED|Overall Study||43
11235785|NCT02058108|12427882|FG001|STARTED|Overall Study||10
11235786|NCT02058108|12427881|FG000|Switched to Telbivudine After Week 24|Overall Study||0
11235787|NCT02058108|12427882|FG001|Switched to Telbivudine After Week 24|Overall Study||5
11235788|NCT02058108|12427881|FG000|COMPLETED|Overall Study||2
11235789|NCT02058108|12427882|FG001|COMPLETED|Overall Study||0
11235790|NCT02058108|12427881|FG000|NOT COMPLETED|Overall Study||41
11118391|NCT01324024|12303139|FG001|STARTED|First Intervention (4 Weeks)||17
11118392|NCT01324024|12303138|FG000|COMPLETED|First Intervention (4 Weeks)||18
11118393|NCT01324024|12303139|FG001|COMPLETED|First Intervention (4 Weeks)||17
11118394|NCT01324024|12303138|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
11118395|NCT01324024|12303139|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
11235791|NCT02058108|12427882|FG001|NOT COMPLETED|Overall Study||10
11235792|NCT02058147|12427893|FG000|STARTED|Overall Study||469
11235793|NCT02058147|12427894|FG001|STARTED|Overall Study||467
11235794|NCT02058147|12427895|FG002|STARTED|Overall Study||234
11235795|NCT02058147|12427893|FG000|Treated|Overall Study||469
11235796|NCT02058147|12427894|FG001|Treated|Overall Study||467
11118396|NCT01324024|12303138|FG000|STARTED|Washout (2 Weeks)||18
11118397|NCT01324024|12303139|FG001|STARTED|Washout (2 Weeks)||17
11118398|NCT01324024|12303138|FG000|COMPLETED|Washout (2 Weeks)||18
11118399|NCT01324024|12303139|FG001|COMPLETED|Washout (2 Weeks)||17
11118400|NCT01324024|12303138|FG000|NOT COMPLETED|Washout (2 Weeks)||0
11118401|NCT01324024|12303139|FG001|NOT COMPLETED|Washout (2 Weeks)||0
11235797|NCT02058147|12427895|FG002|Treated|Overall Study||233
11235798|NCT02058147|12427893|FG000|COMPLETED|Overall Study||440
11235799|NCT02058147|12427894|FG001|COMPLETED|Overall Study||440
11235800|NCT02058147|12427895|FG002|COMPLETED|Overall Study||205
11235801|NCT02058147|12427893|FG000|NOT COMPLETED|Overall Study||29
11235802|NCT02058147|12427894|FG001|NOT COMPLETED|Overall Study||27
11235803|NCT02058147|12427895|FG002|NOT COMPLETED|Overall Study||29
11235804|NCT02058160|12427905|FG000|STARTED|Overall Study||367
11235805|NCT02058160|12427906|FG001|STARTED|Overall Study||369
11235806|NCT02058160|12427905|FG000|Treated|Overall Study||365
11235807|NCT02058160|12427906|FG001|Treated|Overall Study||365
11235808|NCT02058160|12427905|FG000|COMPLETED|Overall Study||336
11235809|NCT02058160|12427906|FG001|COMPLETED|Overall Study||355
11235810|NCT02058160|12427905|FG000|NOT COMPLETED|Overall Study||31
11235811|NCT02058160|12427906|FG001|NOT COMPLETED|Overall Study||14
11235812|NCT02058251|12427914|FG000|STARTED|Overall Study||35
11235813|NCT02058251|12427915|FG001|STARTED|Overall Study||38
11235814|NCT02058251|12427914|FG000|COMPLETED|Overall Study||35
11235815|NCT02058251|12427915|FG001|COMPLETED|Overall Study||38
11235816|NCT02058251|12427914|FG000|NOT COMPLETED|Overall Study||0
11235817|NCT02058251|12427915|FG001|NOT COMPLETED|Overall Study||0
11235818|NCT02058290|12427923|FG000|STARTED|Overall Study||77
11235819|NCT02058290|12427924|FG001|STARTED|Overall Study||45
11235820|NCT02058290|12427923|FG000|COMPLETED|Overall Study||66
11235821|NCT02058290|12427924|FG001|COMPLETED|Overall Study||36
11235822|NCT02058290|12427923|FG000|NOT COMPLETED|Overall Study||11
11235823|NCT02058290|12427924|FG001|NOT COMPLETED|Overall Study||9
11235824|NCT02058368|12427932|FG000|STARTED|Overall Study||302
11235825|NCT02058368|12427933|FG001|STARTED|Overall Study||305
11235826|NCT02058368|12427932|FG000|COMPLETED|Overall Study||261
11235827|NCT02058368|12427933|FG001|COMPLETED|Overall Study||251
11235828|NCT02058368|12427932|FG000|NOT COMPLETED|Overall Study||41
11235829|NCT02058368|12427933|FG001|NOT COMPLETED|Overall Study||54
11235830|NCT02058498|12427939|FG000|STARTED|Overall Study||12
11235831|NCT02058498|12427939|FG000|6 Weeks|Overall Study||8
11235832|NCT02058498|12427939|FG000|COMPLETED|Overall Study||8
11235833|NCT02058498|12427939|FG000|NOT COMPLETED|Overall Study||4
11235834|NCT02058511|12427943|FG000|STARTED|Overall Study||24
11235835|NCT02058511|12427943|FG000|COMPLETED|Overall Study||24
11235836|NCT02058511|12427943|FG000|NOT COMPLETED|Overall Study||0
11235837|NCT02058563|12427949|FG000|STARTED|Overall Study||454
11235838|NCT02058563|12427950|FG001|STARTED|Overall Study||457
11235839|NCT02058563|12427949|FG000|COMPLETED|Overall Study||426
11235840|NCT02058563|12427950|FG001|COMPLETED|Overall Study||433
11235841|NCT02058563|12427949|FG000|NOT COMPLETED|Overall Study||28
11235842|NCT02058563|12427950|FG001|NOT COMPLETED|Overall Study||24
11235843|NCT02058589|12427958|FG000|STARTED|Overall Study||132
11235844|NCT02058589|12427959|FG001|STARTED|Overall Study||132
11235845|NCT02058589|12427958|FG000|COMPLETED|Overall Study||130
11235846|NCT02058589|12427959|FG001|COMPLETED|Overall Study||130
11235847|NCT02058589|12427958|FG000|NOT COMPLETED|Overall Study||2
11235848|NCT02058589|12427959|FG001|NOT COMPLETED|Overall Study||2
11235849|NCT02058628|12427969|FG000|STARTED|Overall Study||111
11235850|NCT02058628|12427970|FG001|STARTED|Overall Study||110
11235851|NCT02058628|12427969|FG000|COMPLETED|Overall Study||104
11235852|NCT02058628|12427970|FG001|COMPLETED|Overall Study||102
11235853|NCT02058628|12427969|FG000|NOT COMPLETED|Overall Study||7
11235854|NCT02058628|12427970|FG001|NOT COMPLETED|Overall Study||8
11235855|NCT02058836|12427981|FG000|STARTED|Overall Study||4
11235856|NCT02058836|12427982|FG001|STARTED|Overall Study||4
11235857|NCT02058836|12427981|FG000|COMPLETED|Overall Study||3
11235858|NCT02058836|12427982|FG001|COMPLETED|Overall Study||3
11235859|NCT02058836|12427981|FG000|NOT COMPLETED|Overall Study||1
11235860|NCT02058836|12427982|FG001|NOT COMPLETED|Overall Study||1
11235861|NCT02058849|12427990|FG000|STARTED|Overall Study||11
11235862|NCT02058849|12427991|FG001|STARTED|Overall Study||2
11235863|NCT02058849|12427990|FG000|COMPLETED|Overall Study||4
11235864|NCT02058849|12427991|FG001|COMPLETED|Overall Study||1
11235865|NCT02058849|12427990|FG000|NOT COMPLETED|Overall Study||7
11235866|NCT02058849|12427991|FG001|NOT COMPLETED|Overall Study||1
11235867|NCT02058940|12427997|FG000|STARTED|Overall Study||8
11118402|NCT01324024|12303138|FG000|STARTED|Second Intervention (4 Weeks)||18
11118403|NCT01324024|12303139|FG001|STARTED|Second Intervention (4 Weeks)||17
11118404|NCT01324024|12303138|FG000|COMPLETED|Second Intervention (4 Weeks)||16
11118405|NCT01324024|12303139|FG001|COMPLETED|Second Intervention (4 Weeks)||16
11118406|NCT01324024|12303138|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||2
11235868|NCT02058940|12427997|FG000|COMPLETED|Overall Study||7
11235869|NCT02058940|12427997|FG000|NOT COMPLETED|Overall Study||1
11235870|NCT02058966|12428001|FG000|STARTED|Open-Label Methamphetamine||19
11235871|NCT02058966|12428001|FG000|Received Methamphetamine|Open-Label Methamphetamine||18
11235872|NCT02058966|12428001|FG000|COMPLETED|Open-Label Methamphetamine||18
11235873|NCT02058966|12428001|FG000|NOT COMPLETED|Open-Label Methamphetamine||1
11235874|NCT02058966|12428001|FG000|STARTED|First Intervention||15
11235875|NCT02058966|12428001|FG000|Received Placebo-Placebo|First Intervention||3
11235876|NCT02058966|12428001|FG000|Received Placebo-Meth|First Intervention||4
11235877|NCT02058966|12428001|FG000|Received Entacapone-Placebo|First Intervention||2
11235878|NCT02058966|12428001|FG000|Received Entacapone-Meth|First Intervention||5
11235879|NCT02058966|12428001|FG000|COMPLETED|First Intervention||14
11235880|NCT02058966|12428001|FG000|NOT COMPLETED|First Intervention||1
11235881|NCT02058966|12428001|FG000|STARTED|Second Intervention||13
11235882|NCT02058966|12428001|FG000|Received Placebo-Placebo|Second Intervention||2
11235883|NCT02058966|12428001|FG000|Received Placebo-Meth|Second Intervention||2
11235884|NCT02058966|12428001|FG000|Received Entacapone-Placebo|Second Intervention||6
11235885|NCT02058966|12428001|FG000|Received Entacapone-Meth|Second Intervention||3
11235886|NCT02058966|12428001|FG000|COMPLETED|Second Intervention||13
11235887|NCT02058966|12428001|FG000|NOT COMPLETED|Second Intervention||0
11235888|NCT02058966|12428001|FG000|STARTED|Third Intervention||12
11235889|NCT02058966|12428001|FG000|Received Placebo-Placebo|Third Intervention||4
11235890|NCT02058966|12428001|FG000|Received Placebo-Meth|Third Intervention||4
11235891|NCT02058966|12428001|FG000|Received Entacapone-Placebo|Third Intervention||1
11235892|NCT02058966|12428001|FG000|Received Entacapone-Meth|Third Intervention||3
11235893|NCT02058966|12428001|FG000|COMPLETED|Third Intervention||12
11235894|NCT02058966|12428001|FG000|NOT COMPLETED|Third Intervention||0
11235895|NCT02058966|12428001|FG000|STARTED|Fourth Intervention||12
11235896|NCT02058966|12428001|FG000|Received Placebo-Placebo|Fourth Intervention||4
11235897|NCT02058966|12428001|FG000|Received Placebo-Meth|Fourth Intervention||3
11235898|NCT02058966|12428001|FG000|Received Entacapone-Placebo|Fourth Intervention||3
11235899|NCT02058966|12428001|FG000|Received Entacapone-Meth|Fourth Intervention||2
11235900|NCT02058966|12428001|FG000|COMPLETED|Fourth Intervention||12
11235901|NCT02058966|12428001|FG000|NOT COMPLETED|Fourth Intervention||0
11235902|NCT02058992|12428013|FG000|STARTED|Overall Study||3339
11235903|NCT02058992|12428013|FG000|COMPLETED|Overall Study||3223
11235904|NCT02058992|12428013|FG000|NOT COMPLETED|Overall Study||116
11235905|NCT02059005|12428019|FG000|STARTED|Overall Study||49
11235906|NCT02059005|12428020|FG001|STARTED|Overall Study||48
11235907|NCT02059005|12428019|FG000|3 Month Assessment|Overall Study||37
11235908|NCT02059005|12428020|FG001|3 Month Assessment|Overall Study||33
11235909|NCT02059005|12428019|FG000|6 Month Assessment|Overall Study||29
11235910|NCT02059005|12428020|FG001|6 Month Assessment|Overall Study||24
11235911|NCT02059005|12428019|FG000|COMPLETED|Overall Study||29
11235912|NCT02059005|12428020|FG001|COMPLETED|Overall Study||24
11235913|NCT02059005|12428019|FG000|NOT COMPLETED|Overall Study||20
11235914|NCT02059005|12428020|FG001|NOT COMPLETED|Overall Study||24
11235915|NCT02059057|12428028|FG000|STARTED|Overall Study||102
11235916|NCT02059057|12428028|FG000|COMPLETED|Overall Study||87
11235917|NCT02059057|12428028|FG000|NOT COMPLETED|Overall Study||15
11235918|NCT02059070|12428035|FG000|STARTED|Overall Study||19
11235919|NCT02059070|12428036|FG001|STARTED|Overall Study||20
11235920|NCT02059070|12428035|FG000|COMPLETED|Overall Study||14
11235921|NCT02059070|12428036|FG001|COMPLETED|Overall Study||16
11235922|NCT02059070|12428035|FG000|NOT COMPLETED|Overall Study||5
11235923|NCT02059070|12428036|FG001|NOT COMPLETED|Overall Study||4
11235924|NCT02059135|12428044|FG000|STARTED|Maternal Follow-up (ITT Population)||62
11235925|NCT02059135|12428045|FG001|STARTED|Maternal Follow-up (ITT Population)||58
11235926|NCT02059135|12428044|FG000|COMPLETED|Maternal Follow-up (ITT Population)||59
11235927|NCT02059135|12428045|FG001|COMPLETED|Maternal Follow-up (ITT Population)||51
11235928|NCT02059135|12428044|FG000|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
11235929|NCT02059135|12428045|FG001|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
11235930|NCT02059135|12428044|FG000|STARTED|Neonatal Follow-up (Safety Population)||60
11235931|NCT02059135|12428045|FG001|STARTED|Neonatal Follow-up (Safety Population)||54
11235932|NCT02059135|12428044|FG000|COMPLETED|Neonatal Follow-up (Safety Population)||56
11235933|NCT02059135|12428045|FG001|COMPLETED|Neonatal Follow-up (Safety Population)||50
11235934|NCT02059135|12428044|FG000|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
11235935|NCT02059135|12428045|FG001|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
11235936|NCT02059148|12428053|FG000|STARTED|Treatment 1||4
11235937|NCT02059148|12428054|FG001|STARTED|Treatment 1||4
11235938|NCT02059148|12428055|FG002|STARTED|Treatment 1||4
11235939|NCT02059148|12428056|FG003|STARTED|Treatment 1||4
11235940|NCT02059148|12428057|FG004|STARTED|Treatment 1||4
11235941|NCT02059148|12428058|FG005|STARTED|Treatment 1||4
11235942|NCT02059148|12428053|FG000|COMPLETED|Treatment 1||4
11235943|NCT02059148|12428054|FG001|COMPLETED|Treatment 1||4
11235944|NCT02059148|12428055|FG002|COMPLETED|Treatment 1||4
11235945|NCT02059148|12428056|FG003|COMPLETED|Treatment 1||4
11235946|NCT02059148|12428057|FG004|COMPLETED|Treatment 1||4
11235947|NCT02059148|12428058|FG005|COMPLETED|Treatment 1||3
11235948|NCT02059148|12428053|FG000|NOT COMPLETED|Treatment 1||0
11235949|NCT02059148|12428054|FG001|NOT COMPLETED|Treatment 1||0
11235950|NCT02059148|12428055|FG002|NOT COMPLETED|Treatment 1||0
11235951|NCT02059148|12428056|FG003|NOT COMPLETED|Treatment 1||0
11235952|NCT02059148|12428057|FG004|NOT COMPLETED|Treatment 1||0
11235953|NCT02059148|12428058|FG005|NOT COMPLETED|Treatment 1||1
11235954|NCT02059148|12428053|FG000|STARTED|Treatment 2||4
11235955|NCT02059148|12428054|FG001|STARTED|Treatment 2||4
11235956|NCT02059148|12428055|FG002|STARTED|Treatment 2||4
11235957|NCT02059148|12428056|FG003|STARTED|Treatment 2||4
11235958|NCT02059148|12428057|FG004|STARTED|Treatment 2||4
11235959|NCT02059148|12428058|FG005|STARTED|Treatment 2||3
11235960|NCT02059148|12428053|FG000|COMPLETED|Treatment 2||4
11235961|NCT02059148|12428054|FG001|COMPLETED|Treatment 2||4
11235962|NCT02059148|12428055|FG002|COMPLETED|Treatment 2||4
11235963|NCT02059148|12428056|FG003|COMPLETED|Treatment 2||4
11235964|NCT02059148|12428057|FG004|COMPLETED|Treatment 2||4
11235965|NCT02059148|12428058|FG005|COMPLETED|Treatment 2||3
11235966|NCT02059148|12428053|FG000|NOT COMPLETED|Treatment 2||0
11235967|NCT02059148|12428054|FG001|NOT COMPLETED|Treatment 2||0
11235968|NCT02059148|12428055|FG002|NOT COMPLETED|Treatment 2||0
11235969|NCT02059148|12428056|FG003|NOT COMPLETED|Treatment 2||0
11235970|NCT02059148|12428057|FG004|NOT COMPLETED|Treatment 2||0
11235971|NCT02059148|12428058|FG005|NOT COMPLETED|Treatment 2||0
11235972|NCT02059148|12428053|FG000|STARTED|Treatment 3||4
11235973|NCT02059148|12428054|FG001|STARTED|Treatment 3||4
11235974|NCT02059148|12428055|FG002|STARTED|Treatment 3||4
11235975|NCT02059148|12428056|FG003|STARTED|Treatment 3||4
11235976|NCT02059148|12428057|FG004|STARTED|Treatment 3||4
11235977|NCT02059148|12428058|FG005|STARTED|Treatment 3||3
11235978|NCT02059148|12428053|FG000|COMPLETED|Treatment 3||4
11235979|NCT02059148|12428054|FG001|COMPLETED|Treatment 3||4
11235980|NCT02059148|12428055|FG002|COMPLETED|Treatment 3||4
11235981|NCT02059148|12428056|FG003|COMPLETED|Treatment 3||4
11235982|NCT02059148|12428057|FG004|COMPLETED|Treatment 3||4
11235983|NCT02059148|12428058|FG005|COMPLETED|Treatment 3||3
11235984|NCT02059148|12428053|FG000|NOT COMPLETED|Treatment 3||0
11235985|NCT02059148|12428054|FG001|NOT COMPLETED|Treatment 3||0
11235986|NCT02059148|12428055|FG002|NOT COMPLETED|Treatment 3||0
11235987|NCT02059148|12428056|FG003|NOT COMPLETED|Treatment 3||0
11235988|NCT02059148|12428057|FG004|NOT COMPLETED|Treatment 3||0
11235989|NCT02059148|12428058|FG005|NOT COMPLETED|Treatment 3||0
11235990|NCT02059161|12428071|FG000|STARTED|Overall Study||245
11235991|NCT02059161|12428072|FG001|STARTED|Overall Study||263
11235992|NCT02059161|12428071|FG000|Treated|Overall Study||241
11235993|NCT02059161|12428072|FG001|Treated|Overall Study||258
11235994|NCT02059161|12428071|FG000|COMPLETED|Overall Study||196
11235995|NCT02059161|12428072|FG001|COMPLETED|Overall Study||222
11235996|NCT02059161|12428071|FG000|NOT COMPLETED|Overall Study||49
11235997|NCT02059161|12428072|FG001|NOT COMPLETED|Overall Study||41
11235998|NCT02059174|12428078|FG000|STARTED|Period 1||37
11235999|NCT02059174|12428079|FG001|STARTED|Period 1||39
11236000|NCT02059174|12428078|FG000|COMPLETED|Period 1||37
11236001|NCT02059174|12428079|FG001|COMPLETED|Period 1||37
11236002|NCT02059174|12428078|FG000|NOT COMPLETED|Period 1||0
11236003|NCT02059174|12428079|FG001|NOT COMPLETED|Period 1||2
11236004|NCT02059174|12428078|FG000|STARTED|Period 2||37
11236005|NCT02059174|12428079|FG001|STARTED|Period 2||37
11236006|NCT02059174|12428078|FG000|COMPLETED|Period 2||36
11236007|NCT02059174|12428079|FG001|COMPLETED|Period 2||35
11236008|NCT02059174|12428078|FG000|NOT COMPLETED|Period 2||1
11236009|NCT02059174|12428079|FG001|NOT COMPLETED|Period 2||2
11236010|NCT02059174|12428078|FG000|STARTED|Period 3||36
11236011|NCT02059174|12428079|FG001|STARTED|Period 3||35
11236012|NCT02059174|12428078|FG000|COMPLETED|Period 3||35
11236013|NCT02059174|12428079|FG001|COMPLETED|Period 3||35
11236014|NCT02059174|12428078|FG000|NOT COMPLETED|Period 3||1
11236015|NCT02059174|12428079|FG001|NOT COMPLETED|Period 3||0
11236016|NCT02059174|12428078|FG000|STARTED|Period 4||35
11236017|NCT02059174|12428079|FG001|STARTED|Period 4||35
11236018|NCT02059174|12428078|FG000|COMPLETED|Period 4||35
11236019|NCT02059174|12428079|FG001|COMPLETED|Period 4||35
11236020|NCT02059174|12428078|FG000|NOT COMPLETED|Period 4||0
11236021|NCT02059174|12428079|FG001|NOT COMPLETED|Period 4||0
11236022|NCT02059187|12428087|FG000|STARTED|Overall Study||265
11236023|NCT02059187|12428088|FG001|STARTED|Overall Study||266
11236024|NCT02059187|12428087|FG000|COMPLETED|Overall Study||240
11236025|NCT02059187|12428088|FG001|COMPLETED|Overall Study||244
11236026|NCT02059187|12428087|FG000|NOT COMPLETED|Overall Study||25
11236027|NCT02059187|12428088|FG001|NOT COMPLETED|Overall Study||22
11236028|NCT02059213|12428096|FG000|STARTED|Overall Study||20
11236029|NCT02059213|12428097|FG001|STARTED|Overall Study||42
11236030|NCT02059213|12428096|FG000|Initiated Treatment|Overall Study||20
11236031|NCT02059213|12428097|FG001|Initiated Treatment|Overall Study||40
11236032|NCT02059213|12428096|FG000|COMPLETED|Overall Study||20
11236033|NCT02059213|12428097|FG001|COMPLETED|Overall Study||40
11236034|NCT02059213|12428096|FG000|NOT COMPLETED|Overall Study||0
11236035|NCT02059213|12428097|FG001|NOT COMPLETED|Overall Study||2
11236036|NCT02059239|12428108|FG000|STARTED|Overall Study||18
11236037|NCT02059239|12428109|FG001|STARTED|Overall Study||16
11236038|NCT02059239|12428108|FG000|COMPLETED|Overall Study||16
11236039|NCT02059239|12428109|FG001|COMPLETED|Overall Study||13
11236040|NCT02059239|12428108|FG000|NOT COMPLETED|Overall Study||2
11236041|NCT02059239|12428109|FG001|NOT COMPLETED|Overall Study||3
11236042|NCT02059278|12428118|FG000|STARTED|Overall Study||165
11236043|NCT02059278|12428119|FG001|STARTED|Overall Study||170
11236044|NCT02059278|12428118|FG000|COMPLETED|Overall Study||162
11236045|NCT02059278|12428119|FG001|COMPLETED|Overall Study||166
11236046|NCT02059278|12428118|FG000|NOT COMPLETED|Overall Study||3
11236047|NCT02059278|12428119|FG001|NOT COMPLETED|Overall Study||4
11236048|NCT02059291|12428134|FG000|STARTED|Epoch 2||31
11236049|NCT02059291|12428135|FG001|STARTED|Epoch 2||32
11236050|NCT02059291|12428136|FG002|STARTED|Epoch 2||37
11236051|NCT02059291|12428137|FG003|STARTED|Epoch 2||35
11236052|NCT02059291|12428138|FG004|STARTED|Epoch 2||22
11236053|NCT02059291|12428139|FG005|STARTED|Epoch 2||24
11236054|NCT02059291|12428140|FG006|STARTED|Epoch 2||2
11236055|NCT02059291|12428141|FG007|STARTED|Epoch 2||2
11236056|NCT02059291|12428142|FG008|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
11236057|NCT02059291|12428143|FG009|STARTED|Epoch 2||0
11236058|NCT02059291|12428144|FG010|STARTED|Epoch 2||0
11236059|NCT02059291|12428145|FG011|STARTED|Epoch 2||0
11236060|NCT02059291|12428146|FG012|STARTED|Epoch 2||0
11236061|NCT02059291|12428147|FG013|STARTED|Epoch 2||0
11236062|NCT02059291|12428148|FG014|STARTED|Epoch 2||0
11236063|NCT02059291|12428149|FG015|STARTED|Epoch 2||0
11236064|NCT02059291|12428150|FG016|STARTED|Epoch 2||0
11236065|NCT02059291|12428151|FG017|STARTED|Epoch 2||0
11236066|NCT02059291|12428152|FG018|STARTED|Epoch 2||0
11236067|NCT02059291|12428153|FG019|STARTED|Epoch 2||0
11236068|NCT02059291|12428154|FG020|STARTED|Epoch 2||0
11236069|NCT02059291|12428155|FG021|STARTED|Epoch 2||0
11236070|NCT02059291|12428156|FG022|STARTED|Epoch 2||0
11236071|NCT02059291|12428157|FG023|STARTED|Epoch 2||0
11236072|NCT02059291|12428158|FG024|STARTED|Epoch 2||0
11236073|NCT02059291|12428134|FG000|COMPLETED|Epoch 2||31
11236074|NCT02059291|12428135|FG001|COMPLETED|Epoch 2||31
11236075|NCT02059291|12428136|FG002|COMPLETED|Epoch 2||36
11236076|NCT02059291|12428137|FG003|COMPLETED|Epoch 2||33
11236077|NCT02059291|12428138|FG004|COMPLETED|Epoch 2||22
11236078|NCT02059291|12428139|FG005|COMPLETED|Epoch 2||22
11236079|NCT02059291|12428140|FG006|COMPLETED|Epoch 2||2
11236080|NCT02059291|12428141|FG007|COMPLETED|Epoch 2||1
11236081|NCT02059291|12428142|FG008|COMPLETED|Epoch 2||16
11236082|NCT02059291|12428143|FG009|COMPLETED|Epoch 2||0
11236083|NCT02059291|12428144|FG010|COMPLETED|Epoch 2||0
11236084|NCT02059291|12428145|FG011|COMPLETED|Epoch 2||0
11236085|NCT02059291|12428146|FG012|COMPLETED|Epoch 2||0
11236086|NCT02059291|12428147|FG013|COMPLETED|Epoch 2||0
11236087|NCT02059291|12428148|FG014|COMPLETED|Epoch 2||0
11236088|NCT02059291|12428149|FG015|COMPLETED|Epoch 2||0
11236089|NCT02059291|12428150|FG016|COMPLETED|Epoch 2||0
11236090|NCT02059291|12428151|FG017|COMPLETED|Epoch 2||0
11236091|NCT02059291|12428152|FG018|COMPLETED|Epoch 2||0
11236092|NCT02059291|12428153|FG019|COMPLETED|Epoch 2||0
11236093|NCT02059291|12428154|FG020|COMPLETED|Epoch 2||0
11236094|NCT02059291|12428155|FG021|COMPLETED|Epoch 2||0
11236095|NCT02059291|12428156|FG022|COMPLETED|Epoch 2||0
11236096|NCT02059291|12428157|FG023|COMPLETED|Epoch 2||0
11236097|NCT02059291|12428158|FG024|COMPLETED|Epoch 2||0
11236098|NCT02059291|12428134|FG000|NOT COMPLETED|Epoch 2||0
11236099|NCT02059291|12428135|FG001|NOT COMPLETED|Epoch 2||1
11236100|NCT02059291|12428136|FG002|NOT COMPLETED|Epoch 2||1
11236101|NCT02059291|12428137|FG003|NOT COMPLETED|Epoch 2||2
11236102|NCT02059291|12428138|FG004|NOT COMPLETED|Epoch 2||0
11236103|NCT02059291|12428139|FG005|NOT COMPLETED|Epoch 2||2
11236104|NCT02059291|12428140|FG006|NOT COMPLETED|Epoch 2||0
11236105|NCT02059291|12428141|FG007|NOT COMPLETED|Epoch 2||1
11236106|NCT02059291|12428142|FG008|NOT COMPLETED|Epoch 2||2
11236107|NCT02059291|12428143|FG009|NOT COMPLETED|Epoch 2||0
11236108|NCT02059291|12428144|FG010|NOT COMPLETED|Epoch 2||0
11236109|NCT02059291|12428145|FG011|NOT COMPLETED|Epoch 2||0
11236110|NCT02059291|12428146|FG012|NOT COMPLETED|Epoch 2||0
11236111|NCT02059291|12428147|FG013|NOT COMPLETED|Epoch 2||0
11236112|NCT02059291|12428148|FG014|NOT COMPLETED|Epoch 2||0
11236113|NCT02059291|12428149|FG015|NOT COMPLETED|Epoch 2||0
11236114|NCT02059291|12428150|FG016|NOT COMPLETED|Epoch 2||0
11236115|NCT02059291|12428151|FG017|NOT COMPLETED|Epoch 2||0
11236116|NCT02059291|12428152|FG018|NOT COMPLETED|Epoch 2||0
11236117|NCT02059291|12428153|FG019|NOT COMPLETED|Epoch 2||0
11236118|NCT02059291|12428154|FG020|NOT COMPLETED|Epoch 2||0
11236119|NCT02059291|12428155|FG021|NOT COMPLETED|Epoch 2||0
11236120|NCT02059291|12428156|FG022|NOT COMPLETED|Epoch 2||0
11236121|NCT02059291|12428157|FG023|NOT COMPLETED|Epoch 2||0
11236122|NCT02059291|12428158|FG024|NOT COMPLETED|Epoch 2||0
11236123|NCT02059291|12428134|FG000|STARTED|Epoch 3||0
11236124|NCT02059291|12428135|FG001|STARTED|Epoch 3||0
11236125|NCT02059291|12428136|FG002|STARTED|Epoch 3||0
11236126|NCT02059291|12428137|FG003|STARTED|Epoch 3||0
11236127|NCT02059291|12428138|FG004|STARTED|Epoch 3||0
11236128|NCT02059291|12428139|FG005|STARTED|Epoch 3||0
11236129|NCT02059291|12428140|FG006|STARTED|Epoch 3||2
11236130|NCT02059291|12428141|FG007|STARTED|Epoch 3||1
11236131|NCT02059291|12428142|FG008|STARTED|Epoch 3|Presented in Epoch 2.|0
11236132|NCT02059291|12428143|FG009|STARTED|Epoch 3||9
11236133|NCT02059291|12428144|FG010|STARTED|Epoch 3||10
11236134|NCT02059291|12428145|FG011|STARTED|Epoch 3||6
11236135|NCT02059291|12428146|FG012|STARTED|Epoch 3||7
11236136|NCT02059291|12428147|FG013|STARTED|Epoch 3||4
11236137|NCT02059291|12428148|FG014|STARTED|Epoch 3||5
11236138|NCT02059291|12428149|FG015|STARTED|Epoch 3||126
11236139|NCT02059291|12428150|FG016|STARTED|Epoch 3||0
11236140|NCT02059291|12428151|FG017|STARTED|Epoch 3||0
11236141|NCT02059291|12428152|FG018|STARTED|Epoch 3||0
11236142|NCT02059291|12428153|FG019|STARTED|Epoch 3||0
11236143|NCT02059291|12428154|FG020|STARTED|Epoch 3||0
11236144|NCT02059291|12428155|FG021|STARTED|Epoch 3||0
11236145|NCT02059291|12428156|FG022|STARTED|Epoch 3||0
11236146|NCT02059291|12428157|FG023|STARTED|Epoch 3||0
11236147|NCT02059291|12428158|FG024|STARTED|Epoch 3||0
11236148|NCT02059291|12428134|FG000|COMPLETED|Epoch 3||0
11236149|NCT02059291|12428135|FG001|COMPLETED|Epoch 3||0
11236150|NCT02059291|12428136|FG002|COMPLETED|Epoch 3||0
11236151|NCT02059291|12428137|FG003|COMPLETED|Epoch 3||0
11236152|NCT02059291|12428138|FG004|COMPLETED|Epoch 3||0
11236153|NCT02059291|12428139|FG005|COMPLETED|Epoch 3||0
11236154|NCT02059291|12428140|FG006|COMPLETED|Epoch 3||2
11236155|NCT02059291|12428141|FG007|COMPLETED|Epoch 3||1
11236156|NCT02059291|12428142|FG008|COMPLETED|Epoch 3||0
11236157|NCT02059291|12428143|FG009|COMPLETED|Epoch 3||9
11236158|NCT02059291|12428144|FG010|COMPLETED|Epoch 3||10
11236159|NCT02059291|12428145|FG011|COMPLETED|Epoch 3||6
11236160|NCT02059291|12428146|FG012|COMPLETED|Epoch 3||7
11236161|NCT02059291|12428147|FG013|COMPLETED|Epoch 3||3
11236162|NCT02059291|12428148|FG014|COMPLETED|Epoch 3||5
11236163|NCT02059291|12428149|FG015|COMPLETED|Epoch 3||120
11236164|NCT02059291|12428150|FG016|COMPLETED|Epoch 3||0
11236165|NCT02059291|12428151|FG017|COMPLETED|Epoch 3||0
11236166|NCT02059291|12428152|FG018|COMPLETED|Epoch 3||0
11236167|NCT02059291|12428153|FG019|COMPLETED|Epoch 3||0
11236168|NCT02059291|12428154|FG020|COMPLETED|Epoch 3||0
11236169|NCT02059291|12428155|FG021|COMPLETED|Epoch 3||0
11236170|NCT02059291|12428156|FG022|COMPLETED|Epoch 3||0
11236171|NCT02059291|12428157|FG023|COMPLETED|Epoch 3||0
11236172|NCT02059291|12428158|FG024|COMPLETED|Epoch 3||0
11236173|NCT02059291|12428134|FG000|NOT COMPLETED|Epoch 3||0
11236174|NCT02059291|12428135|FG001|NOT COMPLETED|Epoch 3||0
11236175|NCT02059291|12428136|FG002|NOT COMPLETED|Epoch 3||0
11236176|NCT02059291|12428137|FG003|NOT COMPLETED|Epoch 3||0
11236177|NCT02059291|12428138|FG004|NOT COMPLETED|Epoch 3||0
11236178|NCT02059291|12428139|FG005|NOT COMPLETED|Epoch 3||0
11236179|NCT02059291|12428140|FG006|NOT COMPLETED|Epoch 3||0
11236180|NCT02059291|12428141|FG007|NOT COMPLETED|Epoch 3||0
11236181|NCT02059291|12428142|FG008|NOT COMPLETED|Epoch 3||0
11236182|NCT02059291|12428143|FG009|NOT COMPLETED|Epoch 3||0
11236183|NCT02059291|12428144|FG010|NOT COMPLETED|Epoch 3||0
11236184|NCT02059291|12428145|FG011|NOT COMPLETED|Epoch 3||0
11236185|NCT02059291|12428146|FG012|NOT COMPLETED|Epoch 3||0
11236186|NCT02059291|12428147|FG013|NOT COMPLETED|Epoch 3||1
11236187|NCT02059291|12428148|FG014|NOT COMPLETED|Epoch 3||0
11236188|NCT02059291|12428149|FG015|NOT COMPLETED|Epoch 3||6
11236189|NCT02059291|12428150|FG016|NOT COMPLETED|Epoch 3||0
11236190|NCT02059291|12428151|FG017|NOT COMPLETED|Epoch 3||0
11236191|NCT02059291|12428152|FG018|NOT COMPLETED|Epoch 3||0
11236192|NCT02059291|12428153|FG019|NOT COMPLETED|Epoch 3||0
11236193|NCT02059291|12428154|FG020|NOT COMPLETED|Epoch 3||0
11236194|NCT02059291|12428155|FG021|NOT COMPLETED|Epoch 3||0
11236195|NCT02059291|12428156|FG022|NOT COMPLETED|Epoch 3||0
11236196|NCT02059291|12428157|FG023|NOT COMPLETED|Epoch 3||0
11236197|NCT02059291|12428158|FG024|NOT COMPLETED|Epoch 3||0
11236198|NCT02059291|12428134|FG000|STARTED|Epoch 4||0
11236199|NCT02059291|12428135|FG001|STARTED|Epoch 4||0
11236200|NCT02059291|12428136|FG002|STARTED|Epoch 4||0
11236201|NCT02059291|12428137|FG003|STARTED|Epoch 4||0
11236202|NCT02059291|12428138|FG004|STARTED|Epoch 4||0
11236203|NCT02059291|12428139|FG005|STARTED|Epoch 4||0
11236204|NCT02059291|12428140|FG006|STARTED|Epoch 4||0
11236205|NCT02059291|12428141|FG007|STARTED|Epoch 4||0
11236206|NCT02059291|12428142|FG008|STARTED|Epoch 4||0
11236207|NCT02059291|12428143|FG009|STARTED|Epoch 4||0
11236208|NCT02059291|12428144|FG010|STARTED|Epoch 4||0
11236209|NCT02059291|12428145|FG011|STARTED|Epoch 4||0
11236210|NCT02059291|12428146|FG012|STARTED|Epoch 4||0
11236211|NCT02059291|12428147|FG013|STARTED|Epoch 4||0
11236212|NCT02059291|12428148|FG014|STARTED|Epoch 4||0
11236213|NCT02059291|12428149|FG015|STARTED|Epoch 4||0
11236214|NCT02059291|12428150|FG016|STARTED|Epoch 4||43
11236215|NCT02059291|12428151|FG017|STARTED|Epoch 4||14
11236216|NCT02059291|12428152|FG018|STARTED|Epoch 4||2
11236217|NCT02059291|12428153|FG019|STARTED|Epoch 4||18
11236218|NCT02059291|12428154|FG020|STARTED|Epoch 4||34
11236219|NCT02059291|12428155|FG021|STARTED|Epoch 4||14
11236220|NCT02059291|12428156|FG022|STARTED|Epoch 4||31
11236221|NCT02059291|12428157|FG023|STARTED|Epoch 4||22
11236222|NCT02059291|12428158|FG024|STARTED|Epoch 4||0
11236223|NCT02059291|12428134|FG000|COMPLETED|Epoch 4||0
11236224|NCT02059291|12428135|FG001|COMPLETED|Epoch 4||0
11236225|NCT02059291|12428136|FG002|COMPLETED|Epoch 4||0
11236226|NCT02059291|12428137|FG003|COMPLETED|Epoch 4||0
11236227|NCT02059291|12428138|FG004|COMPLETED|Epoch 4||0
11236228|NCT02059291|12428139|FG005|COMPLETED|Epoch 4||0
11236229|NCT02059291|12428140|FG006|COMPLETED|Epoch 4||0
11236230|NCT02059291|12428141|FG007|COMPLETED|Epoch 4||0
11236231|NCT02059291|12428142|FG008|COMPLETED|Epoch 4||0
11236232|NCT02059291|12428143|FG009|COMPLETED|Epoch 4||0
11236233|NCT02059291|12428144|FG010|COMPLETED|Epoch 4||0
11236234|NCT02059291|12428145|FG011|COMPLETED|Epoch 4||0
11236235|NCT02059291|12428146|FG012|COMPLETED|Epoch 4||0
11236236|NCT02059291|12428147|FG013|COMPLETED|Epoch 4||0
11236237|NCT02059291|12428148|FG014|COMPLETED|Epoch 4||0
11236238|NCT02059291|12428149|FG015|COMPLETED|Epoch 4||0
11236239|NCT02059291|12428150|FG016|COMPLETED|Epoch 4||41
11236240|NCT02059291|12428151|FG017|COMPLETED|Epoch 4||14
11236241|NCT02059291|12428152|FG018|COMPLETED|Epoch 4||2
11236242|NCT02059291|12428153|FG019|COMPLETED|Epoch 4||18
11236243|NCT02059291|12428154|FG020|COMPLETED|Epoch 4||33
11236244|NCT02059291|12428155|FG021|COMPLETED|Epoch 4||14
11236245|NCT02059291|12428156|FG022|COMPLETED|Epoch 4||30
11236246|NCT02059291|12428157|FG023|COMPLETED|Epoch 4||21
11236247|NCT02059291|12428158|FG024|COMPLETED|Epoch 4||0
11236248|NCT02059291|12428134|FG000|NOT COMPLETED|Epoch 4||0
11236249|NCT02059291|12428135|FG001|NOT COMPLETED|Epoch 4||0
11236250|NCT02059291|12428136|FG002|NOT COMPLETED|Epoch 4||0
11236251|NCT02059291|12428137|FG003|NOT COMPLETED|Epoch 4||0
11236252|NCT02059291|12428138|FG004|NOT COMPLETED|Epoch 4||0
11236253|NCT02059291|12428139|FG005|NOT COMPLETED|Epoch 4||0
11236254|NCT02059291|12428140|FG006|NOT COMPLETED|Epoch 4||0
11236255|NCT02059291|12428141|FG007|NOT COMPLETED|Epoch 4||0
11236256|NCT02059291|12428142|FG008|NOT COMPLETED|Epoch 4||0
11236257|NCT02059291|12428143|FG009|NOT COMPLETED|Epoch 4||0
11236258|NCT02059291|12428144|FG010|NOT COMPLETED|Epoch 4||0
11236259|NCT02059291|12428145|FG011|NOT COMPLETED|Epoch 4||0
11236260|NCT02059291|12428146|FG012|NOT COMPLETED|Epoch 4||0
11236261|NCT02059291|12428147|FG013|NOT COMPLETED|Epoch 4||0
11236262|NCT02059291|12428148|FG014|NOT COMPLETED|Epoch 4||0
11236263|NCT02059291|12428149|FG015|NOT COMPLETED|Epoch 4||0
11236264|NCT02059291|12428150|FG016|NOT COMPLETED|Epoch 4||2
11236265|NCT02059291|12428151|FG017|NOT COMPLETED|Epoch 4||0
11236266|NCT02059291|12428152|FG018|NOT COMPLETED|Epoch 4||0
11236267|NCT02059291|12428153|FG019|NOT COMPLETED|Epoch 4||0
11236268|NCT02059291|12428154|FG020|NOT COMPLETED|Epoch 4||1
11236269|NCT02059291|12428155|FG021|NOT COMPLETED|Epoch 4||0
11236270|NCT02059291|12428156|FG022|NOT COMPLETED|Epoch 4||1
11236271|NCT02059291|12428157|FG023|NOT COMPLETED|Epoch 4||1
11236272|NCT02059291|12428158|FG024|NOT COMPLETED|Epoch 4||0
11236273|NCT02059395|12428188|FG000|STARTED|Overall Study||22
11236274|NCT02059395|12428189|FG001|STARTED|Overall Study||27
11236275|NCT02059395|12428188|FG000|COMPLETED|Overall Study||20
11236276|NCT02059395|12428189|FG001|COMPLETED|Overall Study||23
11236277|NCT02059395|12428188|FG000|NOT COMPLETED|Overall Study||2
11236278|NCT02059395|12428189|FG001|NOT COMPLETED|Overall Study||4
11236279|NCT02059408|12428198|FG000|STARTED|Overall Study||604
11236280|NCT02059408|12428199|FG001|STARTED|Overall Study||599
11236281|NCT02059408|12428200|FG002|STARTED|Overall Study||616
11236282|NCT02059408|12428198|FG000|COMPLETED|Overall Study||604
11236283|NCT02059408|12428199|FG001|COMPLETED|Overall Study||269
11236284|NCT02059408|12428200|FG002|COMPLETED|Overall Study||258
11236285|NCT02059408|12428198|FG000|NOT COMPLETED|Overall Study||0
11236286|NCT02059408|12428199|FG001|NOT COMPLETED|Overall Study||330
11236287|NCT02059408|12428200|FG002|NOT COMPLETED|Overall Study||358
11236288|NCT02059434|12428219|FG000|STARTED|Period 1 (After Screening/run-in Period)||2
11236289|NCT02059434|12428220|FG001|STARTED|Period 1 (After Screening/run-in Period)||2
11236290|NCT02059434|12428221|FG002|STARTED|Period 1 (After Screening/run-in Period)||2
11236291|NCT02059434|12428222|FG003|STARTED|Period 1 (After Screening/run-in Period)||2
11236292|NCT02059434|12428223|FG004|STARTED|Period 1 (After Screening/run-in Period)||2
11236293|NCT02059434|12428224|FG005|STARTED|Period 1 (After Screening/run-in Period)||2
11236294|NCT02059434|12428225|FG006|STARTED|Period 1 (After Screening/run-in Period)||2
11236295|NCT02059434|12428226|FG007|STARTED|Period 1 (After Screening/run-in Period)||3
11236296|NCT02059434|12428227|FG008|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
11236297|NCT02059434|12428219|FG000|COMPLETED|Period 1 (After Screening/run-in Period)||2
11236298|NCT02059434|12428220|FG001|COMPLETED|Period 1 (After Screening/run-in Period)||2
11236299|NCT02059434|12428221|FG002|COMPLETED|Period 1 (After Screening/run-in Period)||2
11236300|NCT02059434|12428222|FG003|COMPLETED|Period 1 (After Screening/run-in Period)||2
11236301|NCT02059434|12428223|FG004|COMPLETED|Period 1 (After Screening/run-in Period)||2
11236302|NCT02059434|12428224|FG005|COMPLETED|Period 1 (After Screening/run-in Period)||2
11236303|NCT02059434|12428225|FG006|COMPLETED|Period 1 (After Screening/run-in Period)||2
11236304|NCT02059434|12428226|FG007|COMPLETED|Period 1 (After Screening/run-in Period)||3
11236305|NCT02059434|12428227|FG008|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
11236306|NCT02059434|12428219|FG000|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
11236307|NCT02059434|12428220|FG001|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
11236308|NCT02059434|12428221|FG002|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
11236309|NCT02059434|12428222|FG003|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
11236310|NCT02059434|12428223|FG004|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
11236311|NCT02059434|12428224|FG005|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
11236312|NCT02059434|12428225|FG006|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
11236313|NCT02059434|12428226|FG007|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
11236314|NCT02059434|12428227|FG008|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
11236315|NCT02059434|12428219|FG000|STARTED|Washout Between Periods 1 and 2||2
11236316|NCT02059434|12428220|FG001|STARTED|Washout Between Periods 1 and 2||2
11236317|NCT02059434|12428221|FG002|STARTED|Washout Between Periods 1 and 2||2
11236318|NCT02059434|12428222|FG003|STARTED|Washout Between Periods 1 and 2||2
11236319|NCT02059434|12428223|FG004|STARTED|Washout Between Periods 1 and 2||2
11236320|NCT02059434|12428224|FG005|STARTED|Washout Between Periods 1 and 2||2
11236321|NCT02059434|12428225|FG006|STARTED|Washout Between Periods 1 and 2||2
11236322|NCT02059434|12428226|FG007|STARTED|Washout Between Periods 1 and 2||3
11236323|NCT02059434|12428227|FG008|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
11236324|NCT02059434|12428219|FG000|COMPLETED|Washout Between Periods 1 and 2||2
11236325|NCT02059434|12428220|FG001|COMPLETED|Washout Between Periods 1 and 2||2
11236326|NCT02059434|12428221|FG002|COMPLETED|Washout Between Periods 1 and 2||2
11236327|NCT02059434|12428222|FG003|COMPLETED|Washout Between Periods 1 and 2||2
11236328|NCT02059434|12428223|FG004|COMPLETED|Washout Between Periods 1 and 2||2
11236329|NCT02059434|12428224|FG005|COMPLETED|Washout Between Periods 1 and 2||2
11236330|NCT02059434|12428225|FG006|COMPLETED|Washout Between Periods 1 and 2||2
11236331|NCT02059434|12428226|FG007|COMPLETED|Washout Between Periods 1 and 2||2
11236332|NCT02059434|12428227|FG008|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
11236333|NCT02059434|12428219|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0
11236334|NCT02059434|12428220|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0
11236335|NCT02059434|12428221|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0
11236336|NCT02059434|12428222|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0
11236337|NCT02059434|12428223|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0
11236338|NCT02059434|12428224|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0
11236339|NCT02059434|12428225|FG006|NOT COMPLETED|Washout Between Periods 1 and 2||0
11236340|NCT02059434|12428226|FG007|NOT COMPLETED|Washout Between Periods 1 and 2||1
11236341|NCT02059434|12428227|FG008|NOT COMPLETED|Washout Between Periods 1 and 2||0
11236342|NCT02059434|12428219|FG000|STARTED|Period 2||2
11236343|NCT02059434|12428220|FG001|STARTED|Period 2||2
11236344|NCT02059434|12428221|FG002|STARTED|Period 2||2
11236345|NCT02059434|12428222|FG003|STARTED|Period 2||2
11236346|NCT02059434|12428223|FG004|STARTED|Period 2||2
11236347|NCT02059434|12428224|FG005|STARTED|Period 2||2
11236348|NCT02059434|12428225|FG006|STARTED|Period 2||2
11236349|NCT02059434|12428226|FG007|STARTED|Period 2||2
11236350|NCT02059434|12428227|FG008|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
11236351|NCT02059434|12428219|FG000|COMPLETED|Period 2||2
11236352|NCT02059434|12428220|FG001|COMPLETED|Period 2||2
11236353|NCT02059434|12428221|FG002|COMPLETED|Period 2||2
11236354|NCT02059434|12428222|FG003|COMPLETED|Period 2||2
11236355|NCT02059434|12428223|FG004|COMPLETED|Period 2||2
11236356|NCT02059434|12428224|FG005|COMPLETED|Period 2||2
11236357|NCT02059434|12428225|FG006|COMPLETED|Period 2||2
11236358|NCT02059434|12428226|FG007|COMPLETED|Period 2||2
11236359|NCT02059434|12428227|FG008|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
11236360|NCT02059434|12428219|FG000|NOT COMPLETED|Period 2||0
11236361|NCT02059434|12428220|FG001|NOT COMPLETED|Period 2||0
11236362|NCT02059434|12428221|FG002|NOT COMPLETED|Period 2||0
11236363|NCT02059434|12428222|FG003|NOT COMPLETED|Period 2||0
11236364|NCT02059434|12428223|FG004|NOT COMPLETED|Period 2||0
11236365|NCT02059434|12428224|FG005|NOT COMPLETED|Period 2||0
11236366|NCT02059434|12428225|FG006|NOT COMPLETED|Period 2||0
11236367|NCT02059434|12428226|FG007|NOT COMPLETED|Period 2||0
11236368|NCT02059434|12428227|FG008|NOT COMPLETED|Period 2||0
11236369|NCT02059434|12428219|FG000|STARTED|Washout Between Periods 2 and 3||2
11236370|NCT02059434|12428220|FG001|STARTED|Washout Between Periods 2 and 3||2
11236371|NCT02059434|12428221|FG002|STARTED|Washout Between Periods 2 and 3||2
11236372|NCT02059434|12428222|FG003|STARTED|Washout Between Periods 2 and 3||2
11236373|NCT02059434|12428223|FG004|STARTED|Washout Between Periods 2 and 3||2
11236374|NCT02059434|12428224|FG005|STARTED|Washout Between Periods 2 and 3||2
11236375|NCT02059434|12428225|FG006|STARTED|Washout Between Periods 2 and 3||2
11236376|NCT02059434|12428226|FG007|STARTED|Washout Between Periods 2 and 3||2
11236377|NCT02059434|12428227|FG008|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
11236378|NCT02059434|12428219|FG000|COMPLETED|Washout Between Periods 2 and 3||2
11236379|NCT02059434|12428220|FG001|COMPLETED|Washout Between Periods 2 and 3||2
11236380|NCT02059434|12428221|FG002|COMPLETED|Washout Between Periods 2 and 3||2
11236381|NCT02059434|12428222|FG003|COMPLETED|Washout Between Periods 2 and 3||2
11236382|NCT02059434|12428223|FG004|COMPLETED|Washout Between Periods 2 and 3||2
11236383|NCT02059434|12428224|FG005|COMPLETED|Washout Between Periods 2 and 3||2
11236384|NCT02059434|12428225|FG006|COMPLETED|Washout Between Periods 2 and 3||2
11236385|NCT02059434|12428226|FG007|COMPLETED|Washout Between Periods 2 and 3||2
11236386|NCT02059434|12428227|FG008|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
11236387|NCT02059434|12428219|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0
11236388|NCT02059434|12428220|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0
11236389|NCT02059434|12428221|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0
11236390|NCT02059434|12428222|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0
11236391|NCT02059434|12428223|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0
11236392|NCT02059434|12428224|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0
11236393|NCT02059434|12428225|FG006|NOT COMPLETED|Washout Between Periods 2 and 3||0
11236394|NCT02059434|12428226|FG007|NOT COMPLETED|Washout Between Periods 2 and 3||0
11236395|NCT02059434|12428227|FG008|NOT COMPLETED|Washout Between Periods 2 and 3||0
11236396|NCT02059434|12428219|FG000|STARTED|Period 3||2
11236397|NCT02059434|12428220|FG001|STARTED|Period 3||2
11236398|NCT02059434|12428221|FG002|STARTED|Period 3||2
11236399|NCT02059434|12428222|FG003|STARTED|Period 3||2
11236400|NCT02059434|12428223|FG004|STARTED|Period 3||2
11236401|NCT02059434|12428224|FG005|STARTED|Period 3||2
11236402|NCT02059434|12428225|FG006|STARTED|Period 3||2
11236403|NCT02059434|12428226|FG007|STARTED|Period 3||2
11236404|NCT02059434|12428227|FG008|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
11236405|NCT02059434|12428219|FG000|COMPLETED|Period 3||2
11236406|NCT02059434|12428220|FG001|COMPLETED|Period 3||2
11236407|NCT02059434|12428221|FG002|COMPLETED|Period 3||2
11236408|NCT02059434|12428222|FG003|COMPLETED|Period 3||2
11236409|NCT02059434|12428223|FG004|COMPLETED|Period 3||2
11236410|NCT02059434|12428224|FG005|COMPLETED|Period 3||2
11236411|NCT02059434|12428225|FG006|COMPLETED|Period 3||2
11236412|NCT02059434|12428226|FG007|COMPLETED|Period 3||2
11236413|NCT02059434|12428227|FG008|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
11236414|NCT02059434|12428219|FG000|NOT COMPLETED|Period 3||0
11236415|NCT02059434|12428220|FG001|NOT COMPLETED|Period 3||0
11236416|NCT02059434|12428221|FG002|NOT COMPLETED|Period 3||0
11236417|NCT02059434|12428222|FG003|NOT COMPLETED|Period 3||0
11236418|NCT02059434|12428223|FG004|NOT COMPLETED|Period 3||0
11236419|NCT02059434|12428224|FG005|NOT COMPLETED|Period 3||0
11236420|NCT02059434|12428225|FG006|NOT COMPLETED|Period 3||0
11236421|NCT02059434|12428226|FG007|NOT COMPLETED|Period 3||0
11236422|NCT02059434|12428227|FG008|NOT COMPLETED|Period 3||0
11236423|NCT02059434|12428219|FG000|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236424|NCT02059434|12428220|FG001|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236425|NCT02059434|12428221|FG002|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236426|NCT02059434|12428222|FG003|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236427|NCT02059434|12428223|FG004|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236428|NCT02059434|12428224|FG005|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236429|NCT02059434|12428225|FG006|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236430|NCT02059434|12428226|FG007|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236431|NCT02059434|12428227|FG008|STARTED|Period 4 (After Screening/run-in Period)||38
11236432|NCT02059434|12428219|FG000|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236433|NCT02059434|12428220|FG001|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236434|NCT02059434|12428221|FG002|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236435|NCT02059434|12428222|FG003|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236436|NCT02059434|12428223|FG004|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236437|NCT02059434|12428224|FG005|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236438|NCT02059434|12428225|FG006|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236439|NCT02059434|12428226|FG007|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
11236440|NCT02059434|12428227|FG008|COMPLETED|Period 4 (After Screening/run-in Period)||38
11236441|NCT02059434|12428219|FG000|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
11236442|NCT02059434|12428220|FG001|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
11236443|NCT02059434|12428221|FG002|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
11236444|NCT02059434|12428222|FG003|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
11236445|NCT02059434|12428223|FG004|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
11236446|NCT02059434|12428224|FG005|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
11236447|NCT02059434|12428225|FG006|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
11236448|NCT02059434|12428226|FG007|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
11236449|NCT02059434|12428227|FG008|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
11236450|NCT02059434|12428219|FG000|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236451|NCT02059434|12428220|FG001|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236452|NCT02059434|12428221|FG002|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236453|NCT02059434|12428222|FG003|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236454|NCT02059434|12428223|FG004|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236455|NCT02059434|12428224|FG005|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236456|NCT02059434|12428225|FG006|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236457|NCT02059434|12428226|FG007|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236458|NCT02059434|12428227|FG008|STARTED|Washout Between Periods 4 and 5||38
11236459|NCT02059434|12428219|FG000|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236460|NCT02059434|12428220|FG001|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236461|NCT02059434|12428221|FG002|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236462|NCT02059434|12428222|FG003|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236463|NCT02059434|12428223|FG004|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236464|NCT02059434|12428224|FG005|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236465|NCT02059434|12428225|FG006|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236466|NCT02059434|12428226|FG007|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
11236467|NCT02059434|12428227|FG008|COMPLETED|Washout Between Periods 4 and 5||37
11236468|NCT02059434|12428219|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0
11236469|NCT02059434|12428220|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0
11236470|NCT02059434|12428221|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0
11236471|NCT02059434|12428222|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0
11236472|NCT02059434|12428223|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0
11236473|NCT02059434|12428224|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0
11236474|NCT02059434|12428225|FG006|NOT COMPLETED|Washout Between Periods 4 and 5||0
11236475|NCT02059434|12428226|FG007|NOT COMPLETED|Washout Between Periods 4 and 5||0
11236476|NCT02059434|12428227|FG008|NOT COMPLETED|Washout Between Periods 4 and 5||1
11236477|NCT02059434|12428219|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
11236478|NCT02059434|12428220|FG001|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
11236479|NCT02059434|12428221|FG002|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
11236480|NCT02059434|12428222|FG003|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
11236481|NCT02059434|12428223|FG004|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
11236482|NCT02059434|12428224|FG005|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
11236483|NCT02059434|12428225|FG006|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
11236484|NCT02059434|12428226|FG007|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
11236485|NCT02059434|12428227|FG008|STARTED|Period 5||37
11236486|NCT02059434|12428219|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
11236487|NCT02059434|12428220|FG001|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
11236488|NCT02059434|12428221|FG002|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
11236489|NCT02059434|12428222|FG003|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
11236490|NCT02059434|12428223|FG004|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
11236491|NCT02059434|12428224|FG005|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
11236492|NCT02059434|12428225|FG006|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
11236493|NCT02059434|12428226|FG007|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
11236494|NCT02059434|12428227|FG008|COMPLETED|Period 5||37
11236495|NCT02059434|12428219|FG000|NOT COMPLETED|Period 5||0
11236496|NCT02059434|12428220|FG001|NOT COMPLETED|Period 5||0
11236497|NCT02059434|12428221|FG002|NOT COMPLETED|Period 5||0
11236498|NCT02059434|12428222|FG003|NOT COMPLETED|Period 5||0
11236499|NCT02059434|12428223|FG004|NOT COMPLETED|Period 5||0
11236500|NCT02059434|12428224|FG005|NOT COMPLETED|Period 5||0
11236501|NCT02059434|12428225|FG006|NOT COMPLETED|Period 5||0
11236502|NCT02059434|12428226|FG007|NOT COMPLETED|Period 5||0
11236503|NCT02059434|12428227|FG008|NOT COMPLETED|Period 5||0
11236504|NCT02059434|12428219|FG000|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236505|NCT02059434|12428220|FG001|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236506|NCT02059434|12428221|FG002|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236507|NCT02059434|12428222|FG003|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236508|NCT02059434|12428223|FG004|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236509|NCT02059434|12428224|FG005|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236510|NCT02059434|12428225|FG006|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236511|NCT02059434|12428226|FG007|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236512|NCT02059434|12428227|FG008|STARTED|Washout Between Periods 5 and 6||37
11236513|NCT02059434|12428219|FG000|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236514|NCT02059434|12428220|FG001|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236515|NCT02059434|12428221|FG002|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236516|NCT02059434|12428222|FG003|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236517|NCT02059434|12428223|FG004|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236518|NCT02059434|12428224|FG005|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236519|NCT02059434|12428225|FG006|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236520|NCT02059434|12428226|FG007|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
11236521|NCT02059434|12428227|FG008|COMPLETED|Washout Between Periods 5 and 6||37
11236522|NCT02059434|12428219|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0
11236523|NCT02059434|12428220|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0
11236524|NCT02059434|12428221|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0
11236525|NCT02059434|12428222|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0
11236526|NCT02059434|12428223|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0
11236527|NCT02059434|12428224|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0
11236528|NCT02059434|12428225|FG006|NOT COMPLETED|Washout Between Periods 5 and 6||0
11236529|NCT02059434|12428226|FG007|NOT COMPLETED|Washout Between Periods 5 and 6||0
11236530|NCT02059434|12428227|FG008|NOT COMPLETED|Washout Between Periods 5 and 6||0
11236531|NCT02059434|12428219|FG000|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
11236532|NCT02059434|12428220|FG001|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
11236533|NCT02059434|12428221|FG002|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
11236534|NCT02059434|12428222|FG003|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
11236535|NCT02059434|12428223|FG004|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
11236536|NCT02059434|12428224|FG005|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
11236537|NCT02059434|12428225|FG006|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
11236538|NCT02059434|12428226|FG007|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
11236539|NCT02059434|12428227|FG008|STARTED|Period 6||37
11236540|NCT02059434|12428219|FG000|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
11236541|NCT02059434|12428220|FG001|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
11236542|NCT02059434|12428221|FG002|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
11236543|NCT02059434|12428222|FG003|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
11236544|NCT02059434|12428223|FG004|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
11236545|NCT02059434|12428224|FG005|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
11236546|NCT02059434|12428225|FG006|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
11236547|NCT02059434|12428226|FG007|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
11236548|NCT02059434|12428227|FG008|COMPLETED|Period 6||37
11236549|NCT02059434|12428219|FG000|NOT COMPLETED|Period 6||0
11236550|NCT02059434|12428220|FG001|NOT COMPLETED|Period 6||0
11236551|NCT02059434|12428221|FG002|NOT COMPLETED|Period 6||0
11236552|NCT02059434|12428222|FG003|NOT COMPLETED|Period 6||0
11236553|NCT02059434|12428223|FG004|NOT COMPLETED|Period 6||0
11236554|NCT02059434|12428224|FG005|NOT COMPLETED|Period 6||0
11236555|NCT02059434|12428225|FG006|NOT COMPLETED|Period 6||0
11236556|NCT02059434|12428226|FG007|NOT COMPLETED|Period 6||0
11236557|NCT02059434|12428227|FG008|NOT COMPLETED|Period 6||0
11236558|NCT02059434|12428219|FG000|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236559|NCT02059434|12428220|FG001|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236560|NCT02059434|12428221|FG002|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236561|NCT02059434|12428222|FG003|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236562|NCT02059434|12428223|FG004|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236563|NCT02059434|12428224|FG005|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236564|NCT02059434|12428225|FG006|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236565|NCT02059434|12428226|FG007|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236566|NCT02059434|12428227|FG008|STARTED|Washout Between Periods 6 and 7||37
11236567|NCT02059434|12428219|FG000|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236568|NCT02059434|12428220|FG001|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236569|NCT02059434|12428221|FG002|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236570|NCT02059434|12428222|FG003|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236571|NCT02059434|12428223|FG004|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236572|NCT02059434|12428224|FG005|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236573|NCT02059434|12428225|FG006|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236574|NCT02059434|12428226|FG007|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
11236575|NCT02059434|12428227|FG008|COMPLETED|Washout Between Periods 6 and 7||36
11236576|NCT02059434|12428219|FG000|NOT COMPLETED|Washout Between Periods 6 and 7||0
11236577|NCT02059434|12428220|FG001|NOT COMPLETED|Washout Between Periods 6 and 7||0
11236578|NCT02059434|12428221|FG002|NOT COMPLETED|Washout Between Periods 6 and 7||0
11236579|NCT02059434|12428222|FG003|NOT COMPLETED|Washout Between Periods 6 and 7||0
11236580|NCT02059434|12428223|FG004|NOT COMPLETED|Washout Between Periods 6 and 7||0
11236581|NCT02059434|12428224|FG005|NOT COMPLETED|Washout Between Periods 6 and 7||0
11236582|NCT02059434|12428225|FG006|NOT COMPLETED|Washout Between Periods 6 and 7||0
11236583|NCT02059434|12428226|FG007|NOT COMPLETED|Washout Between Periods 6 and 7||0
11236584|NCT02059434|12428227|FG008|NOT COMPLETED|Washout Between Periods 6 and 7||1
11236585|NCT02059434|12428219|FG000|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
11236586|NCT02059434|12428220|FG001|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
11236587|NCT02059434|12428221|FG002|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
11236588|NCT02059434|12428222|FG003|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
11236589|NCT02059434|12428223|FG004|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
11236590|NCT02059434|12428224|FG005|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
11236591|NCT02059434|12428225|FG006|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
11236592|NCT02059434|12428226|FG007|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
11236593|NCT02059434|12428227|FG008|STARTED|Period 7||36
11236594|NCT02059434|12428219|FG000|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
11236595|NCT02059434|12428220|FG001|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
11236596|NCT02059434|12428221|FG002|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
11236597|NCT02059434|12428222|FG003|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
11236598|NCT02059434|12428223|FG004|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
11236599|NCT02059434|12428224|FG005|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
11236600|NCT02059434|12428225|FG006|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
11236601|NCT02059434|12428226|FG007|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
11236602|NCT02059434|12428227|FG008|COMPLETED|Period 7||36
11236603|NCT02059434|12428219|FG000|NOT COMPLETED|Period 7||0
11236604|NCT02059434|12428220|FG001|NOT COMPLETED|Period 7||0
11236605|NCT02059434|12428221|FG002|NOT COMPLETED|Period 7||0
11236606|NCT02059434|12428222|FG003|NOT COMPLETED|Period 7||0
11236607|NCT02059434|12428223|FG004|NOT COMPLETED|Period 7||0
11236608|NCT02059434|12428224|FG005|NOT COMPLETED|Period 7||0
11236609|NCT02059434|12428225|FG006|NOT COMPLETED|Period 7||0
11236610|NCT02059434|12428226|FG007|NOT COMPLETED|Period 7||0
11236611|NCT02059434|12428227|FG008|NOT COMPLETED|Period 7||0
11236612|NCT02059434|12428219|FG000|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236613|NCT02059434|12428220|FG001|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236614|NCT02059434|12428221|FG002|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236615|NCT02059434|12428222|FG003|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236616|NCT02059434|12428223|FG004|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236617|NCT02059434|12428224|FG005|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236618|NCT02059434|12428225|FG006|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236619|NCT02059434|12428226|FG007|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236620|NCT02059434|12428227|FG008|STARTED|Washout Between Periods 7 and 8||36
11236621|NCT02059434|12428219|FG000|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236622|NCT02059434|12428220|FG001|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236623|NCT02059434|12428221|FG002|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236624|NCT02059434|12428222|FG003|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236625|NCT02059434|12428223|FG004|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236626|NCT02059434|12428224|FG005|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236627|NCT02059434|12428225|FG006|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236628|NCT02059434|12428226|FG007|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
11236629|NCT02059434|12428227|FG008|COMPLETED|Washout Between Periods 7 and 8||34
11236630|NCT02059434|12428219|FG000|NOT COMPLETED|Washout Between Periods 7 and 8||0
11236631|NCT02059434|12428220|FG001|NOT COMPLETED|Washout Between Periods 7 and 8||0
11236632|NCT02059434|12428221|FG002|NOT COMPLETED|Washout Between Periods 7 and 8||0
11236633|NCT02059434|12428222|FG003|NOT COMPLETED|Washout Between Periods 7 and 8||0
11236634|NCT02059434|12428223|FG004|NOT COMPLETED|Washout Between Periods 7 and 8||0
11236635|NCT02059434|12428224|FG005|NOT COMPLETED|Washout Between Periods 7 and 8||0
11236636|NCT02059434|12428225|FG006|NOT COMPLETED|Washout Between Periods 7 and 8||0
11236637|NCT02059434|12428226|FG007|NOT COMPLETED|Washout Between Periods 7 and 8||0
11236638|NCT02059434|12428227|FG008|NOT COMPLETED|Washout Between Periods 7 and 8||2
11236639|NCT02059434|12428219|FG000|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
11236640|NCT02059434|12428220|FG001|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
11236641|NCT02059434|12428221|FG002|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
11236642|NCT02059434|12428222|FG003|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
11236643|NCT02059434|12428223|FG004|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
11236644|NCT02059434|12428224|FG005|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
11236645|NCT02059434|12428225|FG006|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
11236646|NCT02059434|12428226|FG007|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
11236647|NCT02059434|12428227|FG008|STARTED|Period 8||34
11236648|NCT02059434|12428219|FG000|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
11236649|NCT02059434|12428220|FG001|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
11236650|NCT02059434|12428221|FG002|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
11236651|NCT02059434|12428222|FG003|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
11236652|NCT02059434|12428223|FG004|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
11236653|NCT02059434|12428224|FG005|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
11236654|NCT02059434|12428225|FG006|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
11236655|NCT02059434|12428226|FG007|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
11236656|NCT02059434|12428227|FG008|COMPLETED|Period 8||34
11236657|NCT02059434|12428219|FG000|NOT COMPLETED|Period 8||0
11236658|NCT02059434|12428220|FG001|NOT COMPLETED|Period 8||0
11236659|NCT02059434|12428221|FG002|NOT COMPLETED|Period 8||0
11236660|NCT02059434|12428222|FG003|NOT COMPLETED|Period 8||0
11236661|NCT02059434|12428223|FG004|NOT COMPLETED|Period 8||0
11236662|NCT02059434|12428224|FG005|NOT COMPLETED|Period 8||0
11236663|NCT02059434|12428225|FG006|NOT COMPLETED|Period 8||0
11236664|NCT02059434|12428226|FG007|NOT COMPLETED|Period 8||0
11236665|NCT02059434|12428227|FG008|NOT COMPLETED|Period 8||0
11236666|NCT02059512|12428258|FG000|STARTED|Overall Study||46
11236667|NCT02059512|12428259|FG001|STARTED|Overall Study||34
11236668|NCT02059512|12428260|FG002|STARTED|Overall Study||37
11236669|NCT02059512|12428258|FG000|COMPLETED|Overall Study||37
11236670|NCT02059512|12428259|FG001|COMPLETED|Overall Study||25
11236671|NCT02059512|12428260|FG002|COMPLETED|Overall Study||23
11236672|NCT02059512|12428258|FG000|NOT COMPLETED|Overall Study||9
11236673|NCT02059512|12428259|FG001|NOT COMPLETED|Overall Study||9
11236674|NCT02059512|12428260|FG002|NOT COMPLETED|Overall Study||14
11236675|NCT02059642|12428286|FG000|STARTED|Overall Study||148
11236676|NCT02059642|12428287|FG001|STARTED|Overall Study||152
11236677|NCT02059642|12428286|FG000|COMPLETED|Overall Study||121
11236678|NCT02059642|12428287|FG001|COMPLETED|Overall Study||128
11236679|NCT02059642|12428286|FG000|NOT COMPLETED|Overall Study||27
11236680|NCT02059642|12428287|FG001|NOT COMPLETED|Overall Study||24
11236681|NCT02059902|12428295|FG000|STARTED|Overall Study||18
11236682|NCT02059902|12428296|FG001|STARTED|Overall Study||18
11236683|NCT02059902|12428295|FG000|COMPLETED|Overall Study||14
11236684|NCT02059902|12428296|FG001|COMPLETED|Overall Study||14
11236685|NCT02059902|12428295|FG000|NOT COMPLETED|Overall Study||4
11236686|NCT02059902|12428296|FG001|NOT COMPLETED|Overall Study||4
11236687|NCT02059928|12428302|FG000|STARTED|Overall Study||20
11236688|NCT02059928|12428302|FG000|COMPLETED|Overall Study||20
11236689|NCT02059928|12428302|FG000|NOT COMPLETED|Overall Study||0
11356662|NCT03096444|12553393|FG000|NOT COMPLETED|Overall Study||0
11356663|NCT03096483|12553405|FG000|STARTED|Overall Study||12
11356664|NCT03096483|12553405|FG000|COMPLETED|Overall Study||11
11356665|NCT03096483|12553405|FG000|NOT COMPLETED|Overall Study||1
11356666|NCT03096730|12553414|FG000|STARTED|Overall Study||30
11356667|NCT03096730|12553415|FG001|STARTED|Overall Study||30
11356668|NCT03096730|12553416|FG002|STARTED|Overall Study||30
11356669|NCT03096730|12553417|FG003|STARTED|Overall Study||30
11356670|NCT03096730|12553418|FG004|STARTED|Overall Study||30
11356671|NCT03096730|12553414|FG000|COMPLETED|Overall Study||27
11356672|NCT03096730|12553415|FG001|COMPLETED|Overall Study||27
11356673|NCT03096730|12553416|FG002|COMPLETED|Overall Study||27
11356674|NCT03096730|12553417|FG003|COMPLETED|Overall Study||27
11356675|NCT03096730|12553418|FG004|COMPLETED|Overall Study||27
11236690|NCT02059980|12428308|FG000|STARTED|Overall Study||18
11236691|NCT02059980|12428309|FG001|STARTED|Overall Study||15
11236692|NCT02059980|12428308|FG000|COMPLETED|Overall Study||16
11236693|NCT02059980|12428309|FG001|COMPLETED|Overall Study||14
11236694|NCT02059980|12428308|FG000|NOT COMPLETED|Overall Study||2
11236695|NCT02059980|12428309|FG001|NOT COMPLETED|Overall Study||1
11236696|NCT02059993|12428317|FG000|STARTED|Overall Study||42
11236697|NCT02059993|12428318|FG001|STARTED|Overall Study||41
11236698|NCT02059993|12428317|FG000|COMPLETED|Overall Study||40
11236699|NCT02059993|12428318|FG001|COMPLETED|Overall Study||37
11236700|NCT02059993|12428317|FG000|NOT COMPLETED|Overall Study||2
11236701|NCT02059993|12428318|FG001|NOT COMPLETED|Overall Study||4
11236702|NCT02060058|12428327|FG000|STARTED|Overall Study||4
11236703|NCT02060058|12428328|FG001|STARTED|Overall Study||0
11236704|NCT02060058|12428329|FG002|STARTED|Overall Study||8
11236705|NCT02060058|12428327|FG000|COMPLETED|Overall Study||4
11236706|NCT02060058|12428328|FG001|COMPLETED|Overall Study||0
11236707|NCT02060058|12428329|FG002|COMPLETED|Overall Study||8
11236708|NCT02060058|12428327|FG000|NOT COMPLETED|Overall Study||0
11236709|NCT02060058|12428328|FG001|NOT COMPLETED|Overall Study||0
11236710|NCT02060058|12428329|FG002|NOT COMPLETED|Overall Study||0
11236711|NCT02060370|12428338|FG000|STARTED|Overall Study||60
11236712|NCT02060370|12428338|FG000|COMPLETED|Overall Study||59
11236713|NCT02060370|12428338|FG000|NOT COMPLETED|Overall Study||1
11236714|NCT02060383|12428347|FG000|STARTED|Core Phase||38
11236715|NCT02060383|12428348|FG001|STARTED|Core Phase||43
11236716|NCT02060383|12428349|FG002|STARTED|Core Phase||19
11236717|NCT02060383|12428350|FG003|STARTED|Core Phase||46
11236718|NCT02060383|12428351|FG004|STARTED|Core Phase||103
11236719|NCT02060383|12428347|FG000|Completed Core/Entered Extension|Core Phase||17
11236720|NCT02060383|12428348|FG001|Completed Core/Entered Extension|Core Phase||17
11236721|NCT02060383|12428349|FG002|Completed Core/Entered Extension|Core Phase||10
11236722|NCT02060383|12428350|FG003|Completed Core/Entered Extension|Core Phase||21
11236723|NCT02060383|12428351|FG004|Completed Core/Entered Extension|Core Phase||53
11236724|NCT02060383|12428347|FG000|Completed Core/Did Not Enter Extension|Core Phase||18
11236725|NCT02060383|12428348|FG001|Completed Core/Did Not Enter Extension|Core Phase||20
11236726|NCT02060383|12428349|FG002|Completed Core/Did Not Enter Extension|Core Phase||9
11236727|NCT02060383|12428350|FG003|Completed Core/Did Not Enter Extension|Core Phase||18
11236728|NCT02060383|12428351|FG004|Completed Core/Did Not Enter Extension|Core Phase||42
11236729|NCT02060383|12428347|FG000|COMPLETED|Core Phase||35
11236730|NCT02060383|12428348|FG001|COMPLETED|Core Phase||37
11236731|NCT02060383|12428349|FG002|COMPLETED|Core Phase||19
11236732|NCT02060383|12428350|FG003|COMPLETED|Core Phase||39
11236733|NCT02060383|12428351|FG004|COMPLETED|Core Phase||95
11236734|NCT02060383|12428347|FG000|NOT COMPLETED|Core Phase||3
11236735|NCT02060383|12428348|FG001|NOT COMPLETED|Core Phase||6
11236736|NCT02060383|12428349|FG002|NOT COMPLETED|Core Phase||0
11236737|NCT02060383|12428350|FG003|NOT COMPLETED|Core Phase||7
11236738|NCT02060383|12428351|FG004|NOT COMPLETED|Core Phase||8
11236739|NCT02060383|12428347|FG000|STARTED|Extension Phase||17
11236740|NCT02060383|12428348|FG001|STARTED|Extension Phase||17
11236741|NCT02060383|12428349|FG002|STARTED|Extension Phase||10
11236742|NCT02060383|12428350|FG003|STARTED|Extension Phase||21
11236743|NCT02060383|12428351|FG004|STARTED|Extension Phase||53
11236744|NCT02060383|12428347|FG000|COMPLETED|Extension Phase||14
11236745|NCT02060383|12428348|FG001|COMPLETED|Extension Phase||14
11236746|NCT02060383|12428349|FG002|COMPLETED|Extension Phase||7
11236747|NCT02060383|12428350|FG003|COMPLETED|Extension Phase||19
11236748|NCT02060383|12428351|FG004|COMPLETED|Extension Phase||46
11236749|NCT02060383|12428347|FG000|NOT COMPLETED|Extension Phase||3
11236750|NCT02060383|12428348|FG001|NOT COMPLETED|Extension Phase||3
11236751|NCT02060383|12428349|FG002|NOT COMPLETED|Extension Phase||3
11236752|NCT02060383|12428350|FG003|NOT COMPLETED|Extension Phase||2
11236753|NCT02060383|12428351|FG004|NOT COMPLETED|Extension Phase||7
11236754|NCT02060461|12428363|FG000|STARTED|Overall Study||33
11236755|NCT02060461|12428363|FG000|COMPLETED|Overall Study||33
11236756|NCT02060461|12428363|FG000|NOT COMPLETED|Overall Study||0
11236757|NCT02060526|12428372|FG000|STARTED|Overall Study||7
11236758|NCT02060526|12428373|FG001|STARTED|Overall Study||7
11236759|NCT02060526|12428374|FG002|STARTED|Overall Study||7
11236760|NCT02060526|12428372|FG000|COMPLETED|Overall Study||7
11236761|NCT02060526|12428373|FG001|COMPLETED|Overall Study||7
11236762|NCT02060526|12428374|FG002|COMPLETED|Overall Study||7
11236763|NCT02060526|12428372|FG000|NOT COMPLETED|Overall Study||0
11236764|NCT02060526|12428373|FG001|NOT COMPLETED|Overall Study||0
11236765|NCT02060526|12428374|FG002|NOT COMPLETED|Overall Study||0
11236766|NCT02060539|12428384|FG000|STARTED|Overall Study||19
11236767|NCT02060539|12428384|FG000|COMPLETED|Overall Study||19
11236768|NCT02060539|12428384|FG000|NOT COMPLETED|Overall Study||0
11236769|NCT02060838|12428390|FG000|STARTED|Overall Study||28
11236770|NCT02060838|12428391|FG001|STARTED|Overall Study||22
11236771|NCT02060838|12428390|FG000|COMPLETED|Overall Study||28
11236772|NCT02060838|12428391|FG001|COMPLETED|Overall Study||22
11236773|NCT02060838|12428390|FG000|NOT COMPLETED|Overall Study||0
11236774|NCT02060838|12428391|FG001|NOT COMPLETED|Overall Study||0
11236775|NCT02060890|12428397|FG000|STARTED|Overall Study||20
11236776|NCT02060890|12428397|FG000|COMPLETED|Overall Study||16
11236777|NCT02060890|12428397|FG000|NOT COMPLETED|Overall Study||4
11236778|NCT02060903|12428404|FG000|STARTED|Overall Study||187
11236779|NCT02060903|12428405|FG001|STARTED|Overall Study||192
11236780|NCT02060903|12428404|FG000|COMPLETED|Overall Study||183
11236781|NCT02060903|12428405|FG001|COMPLETED|Overall Study||185
11236782|NCT02060903|12428404|FG000|NOT COMPLETED|Overall Study||4
11236783|NCT02060903|12428405|FG001|NOT COMPLETED|Overall Study||7
11236784|NCT02061202|12428413|FG000|STARTED|Overall Study||36
11236785|NCT02061202|12428414|FG001|STARTED|Overall Study||18
11236786|NCT02061202|12428413|FG000|COMPLETED|Overall Study||35
11236787|NCT02061202|12428414|FG001|COMPLETED|Overall Study||17
11236788|NCT02061202|12428413|FG000|NOT COMPLETED|Overall Study||1
11236789|NCT02061202|12428414|FG001|NOT COMPLETED|Overall Study||1
11236790|NCT02061280|12428422|FG000|STARTED|Overall Study||71
11236791|NCT02061280|12428423|FG001|STARTED|Overall Study||37
11236792|NCT02061280|12428422|FG000|Randomized to Treatment|Overall Study||54
11236793|NCT02061280|12428423|FG001|Randomized to Treatment|Overall Study||25
11236794|NCT02061280|12428422|FG000|COMPLETED|Overall Study||53
11236795|NCT02061280|12428423|FG001|COMPLETED|Overall Study||25
11236796|NCT02061280|12428422|FG000|NOT COMPLETED|Overall Study||18
11236797|NCT02061280|12428423|FG001|NOT COMPLETED|Overall Study||12
11236798|NCT02061384|12428434|FG000|STARTED|Overall Study||10
11236799|NCT02061384|12428435|FG001|STARTED|Overall Study||10
11236800|NCT02061384|12428434|FG000|COMPLETED|Overall Study||10
11236801|NCT02061384|12428435|FG001|COMPLETED|Overall Study||10
11236802|NCT02061384|12428434|FG000|NOT COMPLETED|Overall Study||0
11236803|NCT02061384|12428435|FG001|NOT COMPLETED|Overall Study||0
11236804|NCT02061397|12428441|FG000|STARTED|Simvastatin 20 mg Oral Daily for 2 Month||10
11236805|NCT02061397|12428441|FG000|COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||10
11236806|NCT02061397|12428441|FG000|NOT COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||0
11236807|NCT02061397|12428441|FG000|STARTED|Simvastatin 40 mg Oral Daily for 2 Month||10
11236808|NCT02061397|12428441|FG000|COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||10
11236809|NCT02061397|12428441|FG000|NOT COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||0
11236810|NCT02061540|12428445|FG000|STARTED|Overall Study||27
11236811|NCT02061540|12428445|FG000|Down-Titrated on LUM001 During the Study|Overall Study||5
11236812|NCT02061540|12428445|FG000|COMPLETED|Overall Study||23
11236813|NCT02061540|12428445|FG000|NOT COMPLETED|Overall Study||4
11236814|NCT02061592|12428456|FG000|STARTED|Period 1||66
11236815|NCT02061592|12428457|FG001|STARTED|Period 1||62
11236816|NCT02061592|12428456|FG000|COMPLETED|Period 1||64
11236817|NCT02061592|12428457|FG001|COMPLETED|Period 1||62
11236818|NCT02061592|12428456|FG000|NOT COMPLETED|Period 1||2
11236819|NCT02061592|12428457|FG001|NOT COMPLETED|Period 1||0
11236820|NCT02061592|12428456|FG000|STARTED|Period 2||64
11236821|NCT02061592|12428457|FG001|STARTED|Period 2||62
11236822|NCT02061592|12428456|FG000|COMPLETED|Period 2||64
11236823|NCT02061592|12428457|FG001|COMPLETED|Period 2||61
11236824|NCT02061592|12428456|FG000|NOT COMPLETED|Period 2||0
11236825|NCT02061592|12428457|FG001|NOT COMPLETED|Period 2||1
11236826|NCT02061683|12428465|FG000|STARTED|Overall Study||263
11236827|NCT02061683|12428465|FG000|COMPLETED|Overall Study||203
11236828|NCT02061683|12428465|FG000|NOT COMPLETED|Overall Study||60
11236829|NCT02061696|12428471|FG000|STARTED|Overall Study||17
11236830|NCT02061696|12428472|FG001|STARTED|Overall Study||22
11236831|NCT02061696|12428471|FG000|COMPLETED|Overall Study||17
11236832|NCT02061696|12428472|FG001|COMPLETED|Overall Study||22
11236833|NCT02061696|12428471|FG000|NOT COMPLETED|Overall Study||0
11236834|NCT02061696|12428472|FG001|NOT COMPLETED|Overall Study||0
11236835|NCT02061748|12428480|FG000|STARTED|Overall Study||7646
11236836|NCT02061748|12428481|FG001|STARTED|Overall Study||30853
11236837|NCT02061748|12428480|FG000|COMPLETED|Overall Study||7646
11236838|NCT02061748|12428481|FG001|COMPLETED|Overall Study||30853
11236839|NCT02061748|12428480|FG000|NOT COMPLETED|Overall Study||0
11236840|NCT02061748|12428481|FG001|NOT COMPLETED|Overall Study||0
11236841|NCT02061774|12428489|FG000|STARTED|Overall Study||10
11236842|NCT02061774|12428490|FG001|STARTED|Overall Study||11
11236843|NCT02061774|12428489|FG000|COMPLETED|Overall Study||10
11236844|NCT02061774|12428490|FG001|COMPLETED|Overall Study||11
11236845|NCT02061774|12428489|FG000|NOT COMPLETED|Overall Study||0
11236846|NCT02061774|12428490|FG001|NOT COMPLETED|Overall Study||0
11236847|NCT02061813|12428496|FG000|STARTED|Overall Study||40
11236848|NCT02061813|12428496|FG000|Abametapir Lotion|Overall Study||40
11236849|NCT02061813|12428496|FG000|Vehicle Lotion|Overall Study||40
11236850|NCT02061813|12428496|FG000|Saline 0.9%|Overall Study||40
11236851|NCT02061813|12428496|FG000|SLS 0.2%|Overall Study||40
11236852|NCT02061813|12428496|FG000|COMPLETED|Overall Study||37
11236853|NCT02061813|12428496|FG000|NOT COMPLETED|Overall Study||3
11236854|NCT02061969|12428505|FG000|STARTED|Overall Study||73
11236855|NCT02061969|12428506|FG001|STARTED|Overall Study||67
11236856|NCT02061969|12428505|FG000|COMPLETED|Overall Study||73
11236857|NCT02061969|12428506|FG001|COMPLETED|Overall Study||67
11236858|NCT02061969|12428505|FG000|NOT COMPLETED|Overall Study||0
11236859|NCT02061969|12428506|FG001|NOT COMPLETED|Overall Study||0
11236860|NCT02062008|12428512|FG000|STARTED|Overall Study||2
11236861|NCT02062008|12428512|FG000|COMPLETED|Overall Study||2
11236862|NCT02062008|12428512|FG000|NOT COMPLETED|Overall Study||0
11236863|NCT02062151|12428516|FG000|STARTED|Overall Study||21
11236864|NCT02062151|12428516|FG000|COMPLETED|Overall Study||20
11236865|NCT02062151|12428516|FG000|NOT COMPLETED|Overall Study||1
11236866|NCT02062177|12428522|FG000|STARTED|Overall Study||70
11236867|NCT02062177|12428523|FG001|STARTED|Overall Study||70
11236868|NCT02062177|12428522|FG000|COMPLETED|Overall Study||70
11236869|NCT02062177|12428523|FG001|COMPLETED|Overall Study||70
11236870|NCT02062177|12428522|FG000|NOT COMPLETED|Overall Study||0
11236871|NCT02062177|12428523|FG001|NOT COMPLETED|Overall Study||0
11236872|NCT02062294|12428529|FG000|STARTED|Overall Study||14
11236873|NCT02062294|12428529|FG000|COMPLETED|Overall Study||14
11236874|NCT02062294|12428529|FG000|NOT COMPLETED|Overall Study||0
11236875|NCT02062359|12428533|FG000|STARTED|Overall Study||2
11236876|NCT02062359|12428533|FG000|COMPLETED|Overall Study||2
11236877|NCT02062359|12428533|FG000|NOT COMPLETED|Overall Study||0
11236878|NCT02062385|12428541|FG000|STARTED|Overall Study||1620
11236879|NCT02062385|12428542|FG001|STARTED|Overall Study||1620
11236880|NCT02062385|12428543|FG002|STARTED|Overall Study||400
11236881|NCT02062385|12428544|FG003|STARTED|Overall Study||400
11236882|NCT02062385|12428541|FG000|Received Vaccination 1|Overall Study||1618
11236883|NCT02062385|12428542|FG001|Received Vaccination 1|Overall Study||1619
11236884|NCT02062385|12428543|FG002|Received Vaccination 1|Overall Study||400
11236885|NCT02062385|12428544|FG003|Received Vaccination 1|Overall Study||400
11236886|NCT02062385|12428541|FG000|Received Vaccination 2|Overall Study||1554
11236887|NCT02062385|12428542|FG001|Received Vaccination 2|Overall Study||1566
11236888|NCT02062385|12428543|FG002|Received Vaccination 2|Overall Study||392
11236889|NCT02062385|12428544|FG003|Received Vaccination 2|Overall Study||393
11236890|NCT02062385|12428541|FG000|Received Vaccination 3|Overall Study||1543
11236891|NCT02062385|12428542|FG001|Received Vaccination 3|Overall Study||1554
11236892|NCT02062385|12428543|FG002|Received Vaccination 3|Overall Study||389
11236893|NCT02062385|12428544|FG003|Received Vaccination 3|Overall Study||392
11236894|NCT02062385|12428541|FG000|COMPLETED|Overall Study||1542
11236895|NCT02062385|12428542|FG001|COMPLETED|Overall Study||1555
11236896|NCT02062385|12428543|FG002|COMPLETED|Overall Study||388
11236897|NCT02062385|12428544|FG003|COMPLETED|Overall Study||391
11236898|NCT02062385|12428541|FG000|NOT COMPLETED|Overall Study||78
11236899|NCT02062385|12428542|FG001|NOT COMPLETED|Overall Study||65
11236900|NCT02062385|12428543|FG002|NOT COMPLETED|Overall Study||12
11236901|NCT02062385|12428544|FG003|NOT COMPLETED|Overall Study||9
11236902|NCT02062398|12428552|FG000|STARTED|Overall Study||13
11236903|NCT02062398|12428552|FG000|COMPLETED|Overall Study||12
11236904|NCT02062398|12428552|FG000|NOT COMPLETED|Overall Study||1
11236905|NCT02062437|12428556|FG000|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
11236906|NCT02062437|12428556|FG000|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
11236907|NCT02062437|12428556|FG000|NOT COMPLETED|Overall Study||52
11236908|NCT02062450|12428562|FG000|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
11236909|NCT02062450|12428562|FG000|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
11236910|NCT02062450|12428562|FG000|COMPLETED|Overall Study||255
11236911|NCT02062450|12428562|FG000|NOT COMPLETED|Overall Study||124
11236912|NCT02062502|12428572|FG000|STARTED|Overall Study||306
11236913|NCT02062502|12428573|FG001|STARTED|Overall Study||305
11236914|NCT02062502|12428572|FG000|Vaccinated Dose 1|Overall Study||306
11236915|NCT02062502|12428573|FG001|Vaccinated Dose 1|Overall Study||305
11236916|NCT02062502|12428572|FG000|COMPLETED|Overall Study||263
11236917|NCT02062502|12428573|FG001|COMPLETED|Overall Study||270
11236918|NCT02062502|12428572|FG000|NOT COMPLETED|Overall Study||43
11236919|NCT02062502|12428573|FG001|NOT COMPLETED|Overall Study||35
11236920|NCT02062580|12428581|FG000|STARTED|Overall Study||71
11236921|NCT02062580|12428582|FG001|STARTED|Overall Study||78
11236922|NCT02062580|12428581|FG000|COMPLETED|Overall Study||59
11236923|NCT02062580|12428582|FG001|COMPLETED|Overall Study||65
11236924|NCT02062580|12428581|FG000|NOT COMPLETED|Overall Study||12
11236925|NCT02062580|12428582|FG001|NOT COMPLETED|Overall Study||13
11236926|NCT02062593|12428590|FG000|STARTED|Overall Study||105
11236927|NCT02062593|12428591|FG001|STARTED|Overall Study||95
11236928|NCT02062593|12428590|FG000|COMPLETED|Overall Study||105
11236929|NCT02062593|12428591|FG001|COMPLETED|Overall Study||91
11236930|NCT02062593|12428590|FG000|NOT COMPLETED|Overall Study||0
11236931|NCT02062593|12428591|FG001|NOT COMPLETED|Overall Study||4
11236932|NCT02062606|12428597|FG000|STARTED|Overall Study||188
11236933|NCT02062606|12428597|FG000|COMPLETED|Overall Study||99
11236934|NCT02062606|12428597|FG000|NOT COMPLETED|Overall Study||89
11236935|NCT02062632|12428630|FG000|STARTED|Overall Study||3
11236936|NCT02062632|12428630|FG000|COMPLETED|Overall Study||2
11236937|NCT02062632|12428630|FG000|NOT COMPLETED|Overall Study||1
11236938|NCT02062645|12428634|FG000|STARTED|Overall Study||115
11236939|NCT02062645|12428634|FG000|COMPLETED|Overall Study||100
11236940|NCT02062645|12428634|FG000|NOT COMPLETED|Overall Study||15
11236941|NCT02062658|12428638|FG000|STARTED|Overall Study||10
11236942|NCT02062658|12428638|FG000|COMPLETED|Overall Study||8
11236943|NCT02062658|12428638|FG000|NOT COMPLETED|Overall Study||2
11236944|NCT02062710|12428642|FG000|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
11236945|NCT02062710|12428643|FG001|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
11236946|NCT02062710|12428644|FG002|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
11236947|NCT02062710|12428645|FG003|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
11236948|NCT02062710|12428646|FG004|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
11236949|NCT02062710|12428647|FG005|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
11236950|NCT02062710|12428642|FG000|COMPLETED|Overall Study||3
11236951|NCT02062710|12428643|FG001|COMPLETED|Overall Study||4
11236952|NCT02062710|12428644|FG002|COMPLETED|Overall Study||5
11236953|NCT02062710|12428645|FG003|COMPLETED|Overall Study||3
11236954|NCT02062710|12428646|FG004|COMPLETED|Overall Study||3
11236955|NCT02062710|12428647|FG005|COMPLETED|Overall Study||4
11236956|NCT02062710|12428642|FG000|NOT COMPLETED|Overall Study||0
11236957|NCT02062710|12428643|FG001|NOT COMPLETED|Overall Study||0
11236958|NCT02062710|12428644|FG002|NOT COMPLETED|Overall Study||0
11236959|NCT02062710|12428645|FG003|NOT COMPLETED|Overall Study||0
11236960|NCT02062710|12428646|FG004|NOT COMPLETED|Overall Study||0
11236961|NCT02062710|12428647|FG005|NOT COMPLETED|Overall Study||0
11236962|NCT02062801|12428657|FG000|STARTED|Overall Study||301
11236963|NCT02062801|12428658|FG001|STARTED|Overall Study||301
11236964|NCT02062801|12428657|FG000|COMPLETED|Overall Study||299
11236965|NCT02062801|12428658|FG001|COMPLETED|Overall Study||297
11236966|NCT02062801|12428657|FG000|NOT COMPLETED|Overall Study||2
11236967|NCT02062801|12428658|FG001|NOT COMPLETED|Overall Study||4
11236968|NCT02062879|12428666|FG000|STARTED|Overall Study||10
11236969|NCT02062879|12428667|FG001|STARTED|Overall Study||10
11236970|NCT02062879|12428666|FG000|COMPLETED|Overall Study||6
11236971|NCT02062879|12428667|FG001|COMPLETED|Overall Study||9
11236972|NCT02062879|12428666|FG000|NOT COMPLETED|Overall Study||4
11236973|NCT02062879|12428667|FG001|NOT COMPLETED|Overall Study||1
11236974|NCT02062905|12428675|FG000|STARTED|Overall Study||35
11236975|NCT02062905|12428676|FG001|STARTED|Overall Study||33
11236976|NCT02062905|12428675|FG000|COMPLETED|Overall Study||28
11236977|NCT02062905|12428676|FG001|COMPLETED|Overall Study||31
11236978|NCT02062905|12428675|FG000|NOT COMPLETED|Overall Study||7
11236979|NCT02062905|12428676|FG001|NOT COMPLETED|Overall Study||2
11236980|NCT02063035|12428684|FG000|STARTED|Overall Study||12
11236981|NCT02063035|12428685|FG001|STARTED|Overall Study||17
11236982|NCT02063035|12428684|FG000|COMPLETED|Overall Study||12
11236983|NCT02063035|12428685|FG001|COMPLETED|Overall Study||17
11236984|NCT02063035|12428684|FG000|NOT COMPLETED|Overall Study||0
11236985|NCT02063035|12428685|FG001|NOT COMPLETED|Overall Study||0
11236986|NCT02063087|12428693|FG000|STARTED|Emergency Department Intervention||493
11236987|NCT02063087|12428694|FG001|STARTED|Emergency Department Intervention||478
11236988|NCT02063087|12428693|FG000|COMPLETED|Emergency Department Intervention||493
11236989|NCT02063087|12428694|FG001|COMPLETED|Emergency Department Intervention||478
11236990|NCT02063087|12428693|FG000|NOT COMPLETED|Emergency Department Intervention||0
11236991|NCT02063087|12428694|FG001|NOT COMPLETED|Emergency Department Intervention||0
11236992|NCT02063087|12428693|FG000|STARTED|7 Day Follow-up||493
11236993|NCT02063087|12428694|FG001|STARTED|7 Day Follow-up||478
11236994|NCT02063087|12428693|FG000|COMPLETED|7 Day Follow-up||493
11236995|NCT02063087|12428694|FG001|COMPLETED|7 Day Follow-up||478
11236996|NCT02063087|12428693|FG000|NOT COMPLETED|7 Day Follow-up||0
11236997|NCT02063087|12428694|FG001|NOT COMPLETED|7 Day Follow-up||0
11236998|NCT02063178|12428702|FG000|STARTED|Overall Study||124
11236999|NCT02063178|12428703|FG001|STARTED|Overall Study||124
11237000|NCT02063178|12428702|FG000|COMPLETED|Overall Study||95
11237001|NCT02063178|12428703|FG001|COMPLETED|Overall Study||77
11237002|NCT02063178|12428702|FG000|NOT COMPLETED|Overall Study||29
11237003|NCT02063178|12428703|FG001|NOT COMPLETED|Overall Study||47
11237004|NCT02063217|12428716|FG000|STARTED|Overall Study||12
11237005|NCT02063217|12428717|FG001|STARTED|Overall Study||12
11237006|NCT02063217|12428718|FG002|STARTED|Overall Study||12
11237007|NCT02063217|12428716|FG000|COMPLETED|Overall Study||11
11237008|NCT02063217|12428717|FG001|COMPLETED|Overall Study||12
11237009|NCT02063217|12428718|FG002|COMPLETED|Overall Study||12
11237010|NCT02063217|12428716|FG000|NOT COMPLETED|Overall Study||1
11237011|NCT02063217|12428717|FG001|NOT COMPLETED|Overall Study||0
11237012|NCT02063217|12428718|FG002|NOT COMPLETED|Overall Study||0
11237013|NCT02063230|12428730|FG000|STARTED|Overall Study||8
11237014|NCT02063230|12428731|FG001|STARTED|Overall Study||8
11237015|NCT02063230|12428732|FG002|STARTED|Overall Study||8
11237016|NCT02063230|12428733|FG003|STARTED|Overall Study||8
11237017|NCT02063230|12428730|FG000|Received Treatment|Overall Study||8
11237018|NCT02063230|12428731|FG001|Received Treatment|Overall Study||8
11237019|NCT02063230|12428732|FG002|Received Treatment|Overall Study||8
11237020|NCT02063230|12428733|FG003|Received Treatment|Overall Study||8
11237021|NCT02063230|12428730|FG000|COMPLETED|Overall Study||8
11237022|NCT02063230|12428731|FG001|COMPLETED|Overall Study||8
11237023|NCT02063230|12428732|FG002|COMPLETED|Overall Study||8
11237024|NCT02063230|12428733|FG003|COMPLETED|Overall Study||8
11237025|NCT02063230|12428730|FG000|NOT COMPLETED|Overall Study||0
11237026|NCT02063230|12428731|FG001|NOT COMPLETED|Overall Study||0
11237027|NCT02063230|12428732|FG002|NOT COMPLETED|Overall Study||0
11237028|NCT02063230|12428733|FG003|NOT COMPLETED|Overall Study||0
11237029|NCT02063516|12428745|FG000|STARTED|Overall Study||40
11237030|NCT02063516|12428746|FG001|STARTED|Overall Study||40
11237031|NCT02063516|12428745|FG000|COMPLETED|Overall Study||40
11237032|NCT02063516|12428746|FG001|COMPLETED|Overall Study||40
11237033|NCT02063516|12428745|FG000|NOT COMPLETED|Overall Study||0
11237034|NCT02063516|12428746|FG001|NOT COMPLETED|Overall Study||0
11237035|NCT02063659|12428755|FG000|STARTED|Double-Blind Treatment Period||26
11237036|NCT02063659|12428756|FG001|STARTED|Double-Blind Treatment Period||25
11237037|NCT02063659|12428757|FG002|STARTED|Double-Blind Treatment Period||25
11237038|NCT02063659|12428758|FG003|STARTED|Double-Blind Treatment Period||0
11237039|NCT02063659|12428755|FG000|COMPLETED|Double-Blind Treatment Period||24
11237040|NCT02063659|12428756|FG001|COMPLETED|Double-Blind Treatment Period||22
11237041|NCT02063659|12428757|FG002|COMPLETED|Double-Blind Treatment Period||22
11237042|NCT02063659|12428758|FG003|COMPLETED|Double-Blind Treatment Period||0
11237043|NCT02063659|12428755|FG000|NOT COMPLETED|Double-Blind Treatment Period||2
11237044|NCT02063659|12428756|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
11237045|NCT02063659|12428757|FG002|NOT COMPLETED|Double-Blind Treatment Period||3
11237046|NCT02063659|12428758|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
11237047|NCT02063659|12428755|FG000|STARTED|Open-Label Extension Period (OLE)||0
11237048|NCT02063659|12428756|FG001|STARTED|Open-Label Extension Period (OLE)||0
11237049|NCT02063659|12428757|FG002|STARTED|Open-Label Extension Period (OLE)||0
11237050|NCT02063659|12428758|FG003|STARTED|Open-Label Extension Period (OLE)||67
11237051|NCT02063659|12428755|FG000|COMPLETED|Open-Label Extension Period (OLE)||0
11237052|NCT02063659|12428756|FG001|COMPLETED|Open-Label Extension Period (OLE)||0
11237053|NCT02063659|12428757|FG002|COMPLETED|Open-Label Extension Period (OLE)||0
11237054|NCT02063659|12428758|FG003|COMPLETED|Open-Label Extension Period (OLE)||47
11237055|NCT02063659|12428755|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0
11237056|NCT02063659|12428756|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0
11237057|NCT02063659|12428757|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0
11237058|NCT02063659|12428758|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||20
11237059|NCT02063672|12428774|FG000|STARTED|Overall Study||53
11237060|NCT02063672|12428775|FG001|STARTED|Overall Study||29
11237061|NCT02063672|12428774|FG000|COMPLETED|Overall Study||18
11237062|NCT02063672|12428775|FG001|COMPLETED|Overall Study||7
11237063|NCT02063672|12428774|FG000|NOT COMPLETED|Overall Study||35
11237064|NCT02063672|12428775|FG001|NOT COMPLETED|Overall Study||22
11237065|NCT02063698|12428783|FG000|STARTED|Overall Study||15
11237066|NCT02063698|12428784|FG001|STARTED|Overall Study||15
11237067|NCT02063698|12428783|FG000|COMPLETED|Overall Study||14
11237068|NCT02063698|12428784|FG001|COMPLETED|Overall Study||13
11237069|NCT02063698|12428783|FG000|NOT COMPLETED|Overall Study||1
11237070|NCT02063698|12428784|FG001|NOT COMPLETED|Overall Study||2
11237071|NCT02063737|12428792|FG000|STARTED|Overall Study||52
11237072|NCT02063737|12428793|FG001|STARTED|Overall Study||48
11237073|NCT02063737|12428792|FG000|COMPLETED|Overall Study||41
11237074|NCT02063737|12428793|FG001|COMPLETED|Overall Study||44
11237075|NCT02063737|12428792|FG000|NOT COMPLETED|Overall Study||11
11237076|NCT02063737|12428793|FG001|NOT COMPLETED|Overall Study||4
11237077|NCT02063828|12428802|FG000|STARTED|Overall Study||14
11237078|NCT02063828|12428803|FG001|STARTED|Overall Study||14
11237079|NCT02063828|12428804|FG002|STARTED|Overall Study||18
11237080|NCT02063828|12428802|FG000|Week 6|Overall Study||11
11237081|NCT02063828|12428803|FG001|Week 6|Overall Study||9
11237082|NCT02063828|12428804|FG002|Week 6|Overall Study||14
11237083|NCT02063828|12428802|FG000|COMPLETED|Overall Study||10
11237084|NCT02063828|12428803|FG001|COMPLETED|Overall Study||8
11237085|NCT02063828|12428804|FG002|COMPLETED|Overall Study||14
11237086|NCT02063828|12428802|FG000|NOT COMPLETED|Overall Study||4
11237087|NCT02063828|12428803|FG001|NOT COMPLETED|Overall Study||6
11237088|NCT02063828|12428804|FG002|NOT COMPLETED|Overall Study||4
11237089|NCT02063854|12428819|FG000|STARTED|Overall Study||199
11237090|NCT02063854|12428820|FG001|STARTED|Overall Study||66
11237091|NCT02063854|12428821|FG002|STARTED|Overall Study||206
11237092|NCT02063854|12428822|FG003|STARTED|Overall Study||68
11237093|NCT02063854|12428823|FG004|STARTED|Overall Study||65
11237094|NCT02063854|12428824|FG005|STARTED|Overall Study||201
11237095|NCT02063854|12428825|FG006|STARTED|Overall Study||66
11237096|NCT02063854|12428819|FG000|Full Analysis Set: Received Study Drug|Overall Study||199
11237097|NCT02063854|12428820|FG001|Full Analysis Set: Received Study Drug|Overall Study||66
11237098|NCT02063854|12428821|FG002|Full Analysis Set: Received Study Drug|Overall Study||206
11237099|NCT02063854|12428822|FG003|Full Analysis Set: Received Study Drug|Overall Study||68
11237100|NCT02063854|12428823|FG004|Full Analysis Set: Received Study Drug|Overall Study||65
11237101|NCT02063854|12428824|FG005|Full Analysis Set: Received Study Drug|Overall Study||200
11237102|NCT02063854|12428825|FG006|Full Analysis Set: Received Study Drug|Overall Study||66
11237103|NCT02063854|12428819|FG000|COMPLETED|Overall Study||178
11237104|NCT02063854|12428820|FG001|COMPLETED|Overall Study||54
11237105|NCT02063854|12428821|FG002|COMPLETED|Overall Study||176
11237106|NCT02063854|12428822|FG003|COMPLETED|Overall Study||58
11237107|NCT02063854|12428823|FG004|COMPLETED|Overall Study||54
11237108|NCT02063854|12428824|FG005|COMPLETED|Overall Study||170
11237109|NCT02063854|12428825|FG006|COMPLETED|Overall Study||60
11237110|NCT02063854|12428819|FG000|NOT COMPLETED|Overall Study||21
11237111|NCT02063854|12428820|FG001|NOT COMPLETED|Overall Study||12
11237112|NCT02063854|12428821|FG002|NOT COMPLETED|Overall Study||30
11237113|NCT02063854|12428822|FG003|NOT COMPLETED|Overall Study||10
11237114|NCT02063854|12428823|FG004|NOT COMPLETED|Overall Study||11
11237115|NCT02063854|12428824|FG005|NOT COMPLETED|Overall Study||31
11237116|NCT02063854|12428825|FG006|NOT COMPLETED|Overall Study||6
11237117|NCT02063867|12428845|FG000|STARTED|Overall Study||156889
11237118|NCT02063867|12428846|FG001|STARTED|Overall Study||183013
11237119|NCT02063867|12428845|FG000|COMPLETED|Overall Study||152598
11237120|NCT02063867|12428846|FG001|COMPLETED|Overall Study||180048
11237121|NCT02063867|12428845|FG000|NOT COMPLETED|Overall Study||4291
11237122|NCT02063867|12428846|FG001|NOT COMPLETED|Overall Study||2965
11237123|NCT02063880|12428854|FG000|STARTED|Overall Study||90
11237124|NCT02063880|12428855|FG001|STARTED|Overall Study||93
11237125|NCT02063880|12428854|FG000|COMPLETED|Overall Study||62
11237126|NCT02063880|12428855|FG001|COMPLETED|Overall Study||66
11237127|NCT02063880|12428854|FG000|NOT COMPLETED|Overall Study||28
11237128|NCT02063880|12428855|FG001|NOT COMPLETED|Overall Study||27
11237129|NCT02063984|12428863|FG000|STARTED|Overall Study||29
11237130|NCT02063984|12428864|FG001|STARTED|Overall Study||30
11237131|NCT02063984|12428863|FG000|COMPLETED|Overall Study||23
11237132|NCT02063984|12428864|FG001|COMPLETED|Overall Study||25
11237133|NCT02063984|12428863|FG000|NOT COMPLETED|Overall Study||6
11237134|NCT02063984|12428864|FG001|NOT COMPLETED|Overall Study||5
11237135|NCT02064166|12428876|FG000|STARTED|Overall Study||9
11237136|NCT02064166|12428877|FG001|STARTED|Overall Study||6
11237137|NCT02064166|12428876|FG000|COMPLETED|Overall Study||8
11237138|NCT02064166|12428877|FG001|COMPLETED|Overall Study||6
11237139|NCT02064166|12428876|FG000|NOT COMPLETED|Overall Study||1
11237140|NCT02064166|12428877|FG001|NOT COMPLETED|Overall Study||0
11237141|NCT02064205|12428905|FG000|STARTED|Overall Study||32
11237142|NCT02064205|12428905|FG000|Condition A|Overall Study||32
11237143|NCT02064205|12428905|FG000|Condition B|Overall Study||32
11237144|NCT02064205|12428905|FG000|Condition C|Overall Study||31
11237145|NCT02064205|12428905|FG000|Condition D|Overall Study||32
11237146|NCT02064205|12428905|FG000|COMPLETED|Overall Study||31
11237147|NCT02064205|12428905|FG000|NOT COMPLETED|Overall Study||1
11237148|NCT02064231|12428921|FG000|STARTED|First Test Period (Test A or Test C)||14
11237149|NCT02064231|12428922|FG001|STARTED|First Test Period (Test A or Test C)||12
11237150|NCT02064231|12428923|FG002|STARTED|First Test Period (Test A or Test C)||1
11237151|NCT02064231|12428924|FG003|STARTED|First Test Period (Test A or Test C)||1
11237152|NCT02064231|12428921|FG000|COMPLETED|First Test Period (Test A or Test C)||7
11237153|NCT02064231|12428922|FG001|COMPLETED|First Test Period (Test A or Test C)||8
11237154|NCT02064231|12428923|FG002|COMPLETED|First Test Period (Test A or Test C)||0
11237155|NCT02064231|12428924|FG003|COMPLETED|First Test Period (Test A or Test C)||1
11237156|NCT02064231|12428921|FG000|NOT COMPLETED|First Test Period (Test A or Test C)||7
11237157|NCT02064231|12428922|FG001|NOT COMPLETED|First Test Period (Test A or Test C)||4
11237158|NCT02064231|12428923|FG002|NOT COMPLETED|First Test Period (Test A or Test C)||1
11237159|NCT02064231|12428924|FG003|NOT COMPLETED|First Test Period (Test A or Test C)||0
11237160|NCT02064231|12428921|FG000|STARTED|Second Test Period (Test B or Test D)||7
11237161|NCT02064231|12428922|FG001|STARTED|Second Test Period (Test B or Test D)||8
11237162|NCT02064231|12428923|FG002|STARTED|Second Test Period (Test B or Test D)||0
11237163|NCT02064231|12428924|FG003|STARTED|Second Test Period (Test B or Test D)||1
11237164|NCT02064231|12428921|FG000|COMPLETED|Second Test Period (Test B or Test D)||6
11237165|NCT02064231|12428922|FG001|COMPLETED|Second Test Period (Test B or Test D)||7
11237166|NCT02064231|12428923|FG002|COMPLETED|Second Test Period (Test B or Test D)||0
11237167|NCT02064231|12428924|FG003|COMPLETED|Second Test Period (Test B or Test D)||1
11237168|NCT02064231|12428921|FG000|NOT COMPLETED|Second Test Period (Test B or Test D)||1
11237169|NCT02064231|12428922|FG001|NOT COMPLETED|Second Test Period (Test B or Test D)||1
11237170|NCT02064231|12428923|FG002|NOT COMPLETED|Second Test Period (Test B or Test D)||0
11237171|NCT02064231|12428924|FG003|NOT COMPLETED|Second Test Period (Test B or Test D)||0
11237172|NCT02064231|12428921|FG000|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
11237173|NCT02064231|12428922|FG001|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
11237174|NCT02064231|12428923|FG002|STARTED|Third Test Period (Own Product)||0
11237175|NCT02064231|12428924|FG003|STARTED|Third Test Period (Own Product)||1
11237176|NCT02064231|12428921|FG000|COMPLETED|Third Test Period (Own Product)||8
11237177|NCT02064231|12428922|FG001|COMPLETED|Third Test Period (Own Product)||8
11237178|NCT02064231|12428923|FG002|COMPLETED|Third Test Period (Own Product)||0
11237179|NCT02064231|12428924|FG003|COMPLETED|Third Test Period (Own Product)||1
11237180|NCT02064231|12428921|FG000|NOT COMPLETED|Third Test Period (Own Product)||0
11237181|NCT02064231|12428922|FG001|NOT COMPLETED|Third Test Period (Own Product)||0
11237182|NCT02064231|12428923|FG002|NOT COMPLETED|Third Test Period (Own Product)||0
11237183|NCT02064231|12428924|FG003|NOT COMPLETED|Third Test Period (Own Product)||0
11237184|NCT02064270|12428938|FG000|STARTED|Overall Study||263
11237185|NCT02064270|12428939|FG001|STARTED|Overall Study||263
11237186|NCT02064270|12428938|FG000|COMPLETED|Overall Study||201
11237187|NCT02064270|12428939|FG001|COMPLETED|Overall Study||231
11237188|NCT02064270|12428938|FG000|NOT COMPLETED|Overall Study||62
11237189|NCT02064270|12428939|FG001|NOT COMPLETED|Overall Study||32
11237190|NCT02064439|12428948|FG000|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
11237191|NCT02064439|12428949|FG001|STARTED|Overall Study|FAS, randomized and received study medication|1107
11237192|NCT02064439|12428950|FG002|STARTED|Overall Study|FAS, randomized and received study medication|1131
11237193|NCT02064439|12428948|FG000|COMPLETED|Overall Study||984
11237194|NCT02064439|12428949|FG001|COMPLETED|Overall Study||969
11237195|NCT02064439|12428950|FG002|COMPLETED|Overall Study||949
11237196|NCT02064439|12428948|FG000|NOT COMPLETED|Overall Study||143
11237197|NCT02064439|12428949|FG001|NOT COMPLETED|Overall Study||138
11237198|NCT02064439|12428950|FG002|NOT COMPLETED|Overall Study||182
11237199|NCT02064582|12428958|FG000|STARTED|Overall Study||7
11237200|NCT02064582|12428958|FG000|COMPLETED|Overall Study||7
11237201|NCT02064582|12428958|FG000|NOT COMPLETED|Overall Study||0
11237202|NCT02064816|12428964|FG000|STARTED|Overall Study||104
11237203|NCT02064816|12428965|FG001|STARTED|Overall Study||96
11237204|NCT02064816|12428964|FG000|COMPLETED|Overall Study||96
11237205|NCT02064816|12428965|FG001|COMPLETED|Overall Study||88
11237206|NCT02064816|12428964|FG000|NOT COMPLETED|Overall Study||8
11237207|NCT02064816|12428965|FG001|NOT COMPLETED|Overall Study||8
11237208|NCT02064855|12428971|FG000|STARTED|Overall Study||108
11237209|NCT02064855|12428971|FG000|COMPLETED|Overall Study||53
11237210|NCT02064855|12428971|FG000|NOT COMPLETED|Overall Study||55
11237211|NCT02064868|12429020|FG000|STARTED|Overall Study||1756
11237212|NCT02064868|12429021|FG001|STARTED|Overall Study||894
11237213|NCT02064868|12429020|FG000|Full Analysis Set|Overall Study||1756
11237214|NCT02064868|12429021|FG001|Full Analysis Set|Overall Study||894
11237215|NCT02064868|12429020|FG000|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729
11237216|NCT02064868|12429021|FG001|Safety Set|Overall Study||894
11237217|NCT02064868|12429020|FG000|Per Protocol Set|Overall Study||1155
11237218|NCT02064868|12429021|FG001|Per Protocol Set|Overall Study||627
11237219|NCT02064868|12429020|FG000|COMPLETED|Overall Study||1722
11237220|NCT02064868|12429021|FG001|COMPLETED|Overall Study||881
11237221|NCT02064868|12429020|FG000|NOT COMPLETED|Overall Study||34
11237222|NCT02064868|12429021|FG001|NOT COMPLETED|Overall Study||13
11237223|NCT02064894|12429030|FG000|STARTED|Overall Study|"Received allocated intervention (n=98)~Did not receive intervention (n=1)"|99
11237224|NCT02064894|12429031|FG001|STARTED|Overall Study|"Received allocated intervention (n=198)~Did not receive allocated intervention (n=3)"|201
11237225|NCT02064894|12429032|FG002|STARTED|Overall Study|"Received allocated intervention (n=199)~Did not receive allocated intervention (n=2)"|201
11237226|NCT02064894|12429030|FG000|Available at T-60|Overall Study||91
11237227|NCT02064894|12429031|FG001|Available at T-60|Overall Study||188
11237228|NCT02064894|12429032|FG002|Available at T-60|Overall Study||177
11237229|NCT02064894|12429030|FG000|Avalaible at T-90|Overall Study||74
11237230|NCT02064894|12429031|FG001|Avalaible at T-90|Overall Study||134
11237231|NCT02064894|12429032|FG002|Avalaible at T-90|Overall Study||129
11237232|NCT02064894|12429030|FG000|COMPLETED|Overall Study||56
11237233|NCT02064894|12429031|FG001|COMPLETED|Overall Study||99
11237234|NCT02064894|12429032|FG002|COMPLETED|Overall Study||86
11237235|NCT02064894|12429030|FG000|NOT COMPLETED|Overall Study||43
11237236|NCT02064894|12429031|FG001|NOT COMPLETED|Overall Study||102
11237237|NCT02064894|12429032|FG002|NOT COMPLETED|Overall Study||115
11237238|NCT02064907|12429042|FG000|STARTED|Period 1||26
11237239|NCT02064907|12429043|FG001|STARTED|Period 1||26
11237240|NCT02064907|12429042|FG000|COMPLETED|Period 1||26
11237241|NCT02064907|12429043|FG001|COMPLETED|Period 1||26
11237242|NCT02064907|12429042|FG000|NOT COMPLETED|Period 1||0
11237243|NCT02064907|12429043|FG001|NOT COMPLETED|Period 1||0
11237244|NCT02064907|12429042|FG000|STARTED|Period 2||26
11237245|NCT02064907|12429043|FG001|STARTED|Period 2||26
11237246|NCT02064907|12429042|FG000|COMPLETED|Period 2||26
11237247|NCT02064907|12429043|FG001|COMPLETED|Period 2||26
11237248|NCT02064907|12429042|FG000|NOT COMPLETED|Period 2||0
11237249|NCT02064907|12429043|FG001|NOT COMPLETED|Period 2||0
11237250|NCT02064920|12429051|FG000|STARTED|Overall Study||6
11237251|NCT02064920|12429052|FG001|STARTED|Overall Study||30
11237252|NCT02064920|12429051|FG000|Treated|Overall Study||6
11237253|NCT02064920|12429052|FG001|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
11237254|NCT02064920|12429051|FG000|COMPLETED|Overall Study||5
11237255|NCT02064920|12429052|FG001|COMPLETED|Overall Study||21
11237256|NCT02064920|12429051|FG000|NOT COMPLETED|Overall Study||1
11237257|NCT02064920|12429052|FG001|NOT COMPLETED|Overall Study||9
11237258|NCT02064959|12429060|FG000|STARTED|Overall Study||16
11237259|NCT02064959|12429061|FG001|STARTED|Overall Study||16
11237260|NCT02064959|12429060|FG000|COMPLETED|Overall Study||16
11237261|NCT02064959|12429061|FG001|COMPLETED|Overall Study||16
11237262|NCT02064959|12429060|FG000|NOT COMPLETED|Overall Study||0
11237263|NCT02064959|12429061|FG001|NOT COMPLETED|Overall Study||0
11237264|NCT02064985|12429070|FG000|STARTED|Overall Study||12
11237265|NCT02064985|12429071|FG001|STARTED|Overall Study||12
11237266|NCT02064985|12429072|FG002|STARTED|Overall Study||12
11237267|NCT02064985|12429070|FG000|COMPLETED|Overall Study||12
11237268|NCT02064985|12429071|FG001|COMPLETED|Overall Study||12
11237269|NCT02064985|12429072|FG002|COMPLETED|Overall Study||12
11237270|NCT02064985|12429070|FG000|NOT COMPLETED|Overall Study||0
11237271|NCT02064985|12429071|FG001|NOT COMPLETED|Overall Study||0
11237272|NCT02064985|12429072|FG002|NOT COMPLETED|Overall Study||0
11237273|NCT02065245|12429087|FG000|STARTED|Infusion 1||5
11237274|NCT02065245|12429088|FG001|STARTED|Infusion 1||5
11237275|NCT02065245|12429089|FG002|STARTED|Infusion 1||5
11237276|NCT02065245|12429090|FG003|STARTED|Infusion 1||10
11237277|NCT02065245|12429091|FG004|STARTED|Infusion 1||10
11237278|NCT02065245|12429092|FG005|STARTED|Infusion 1||10
11237279|NCT02065245|12429093|FG006|STARTED|Infusion 1||20
11237280|NCT02065245|12429087|FG000|COMPLETED|Infusion 1||5
11237281|NCT02065245|12429088|FG001|COMPLETED|Infusion 1||5
11237282|NCT02065245|12429089|FG002|COMPLETED|Infusion 1||4
11237283|NCT02065245|12429090|FG003|COMPLETED|Infusion 1||10
11237284|NCT02065245|12429091|FG004|COMPLETED|Infusion 1||9
11237285|NCT02065245|12429092|FG005|COMPLETED|Infusion 1||10
11237286|NCT02065245|12429093|FG006|COMPLETED|Infusion 1||19
11237287|NCT02065245|12429087|FG000|NOT COMPLETED|Infusion 1||0
11237288|NCT02065245|12429088|FG001|NOT COMPLETED|Infusion 1||0
11237289|NCT02065245|12429089|FG002|NOT COMPLETED|Infusion 1||1
11237290|NCT02065245|12429090|FG003|NOT COMPLETED|Infusion 1||0
11237291|NCT02065245|12429091|FG004|NOT COMPLETED|Infusion 1||1
11237292|NCT02065245|12429092|FG005|NOT COMPLETED|Infusion 1||0
11237293|NCT02065245|12429093|FG006|NOT COMPLETED|Infusion 1||1
11237294|NCT02065245|12429087|FG000|STARTED|Infusion 2||5
11237295|NCT02065245|12429088|FG001|STARTED|Infusion 2||5
11237296|NCT02065245|12429089|FG002|STARTED|Infusion 2||2
11237297|NCT02065245|12429090|FG003|STARTED|Infusion 2||0
11237298|NCT02065245|12429091|FG004|STARTED|Infusion 2||0
11237299|NCT02065245|12429092|FG005|STARTED|Infusion 2||6
11237300|NCT02065245|12429093|FG006|STARTED|Infusion 2||12
11237301|NCT02065245|12429087|FG000|COMPLETED|Infusion 2||5
11237302|NCT02065245|12429088|FG001|COMPLETED|Infusion 2||5
11237303|NCT02065245|12429089|FG002|COMPLETED|Infusion 2||2
11237304|NCT02065245|12429090|FG003|COMPLETED|Infusion 2||0
11237305|NCT02065245|12429091|FG004|COMPLETED|Infusion 2||0
11237306|NCT02065245|12429092|FG005|COMPLETED|Infusion 2||6
11237307|NCT02065245|12429093|FG006|COMPLETED|Infusion 2||11
11237308|NCT02065245|12429087|FG000|NOT COMPLETED|Infusion 2||0
11237309|NCT02065245|12429088|FG001|NOT COMPLETED|Infusion 2||0
11237310|NCT02065245|12429089|FG002|NOT COMPLETED|Infusion 2||0
11237311|NCT02065245|12429090|FG003|NOT COMPLETED|Infusion 2||0
11237312|NCT02065245|12429091|FG004|NOT COMPLETED|Infusion 2||0
11237313|NCT02065245|12429092|FG005|NOT COMPLETED|Infusion 2||0
11237314|NCT02065245|12429093|FG006|NOT COMPLETED|Infusion 2||1
11237315|NCT02065245|12429087|FG000|STARTED|Infusion 3||3
11237316|NCT02065245|12429088|FG001|STARTED|Infusion 3||5
11237317|NCT02065245|12429089|FG002|STARTED|Infusion 3||1
11237318|NCT02065245|12429090|FG003|STARTED|Infusion 3||0
11237319|NCT02065245|12429091|FG004|STARTED|Infusion 3||0
11237320|NCT02065245|12429092|FG005|STARTED|Infusion 3||0
11237321|NCT02065245|12429093|FG006|STARTED|Infusion 3||0
11237322|NCT02065245|12429087|FG000|COMPLETED|Infusion 3||2
11237323|NCT02065245|12429088|FG001|COMPLETED|Infusion 3||4
11237324|NCT02065245|12429089|FG002|COMPLETED|Infusion 3||1
11237325|NCT02065245|12429090|FG003|COMPLETED|Infusion 3||0
11237326|NCT02065245|12429091|FG004|COMPLETED|Infusion 3||0
11237327|NCT02065245|12429092|FG005|COMPLETED|Infusion 3||0
11237328|NCT02065245|12429093|FG006|COMPLETED|Infusion 3||0
11237329|NCT02065245|12429087|FG000|NOT COMPLETED|Infusion 3||1
11237330|NCT02065245|12429088|FG001|NOT COMPLETED|Infusion 3||1
11237331|NCT02065245|12429089|FG002|NOT COMPLETED|Infusion 3||0
11237332|NCT02065245|12429090|FG003|NOT COMPLETED|Infusion 3||0
11237333|NCT02065245|12429091|FG004|NOT COMPLETED|Infusion 3||0
11237334|NCT02065245|12429092|FG005|NOT COMPLETED|Infusion 3||0
11237335|NCT02065245|12429093|FG006|NOT COMPLETED|Infusion 3||0
11237336|NCT02065245|12429087|FG000|STARTED|Infusion 4||1
11237337|NCT02065245|12429088|FG001|STARTED|Infusion 4||2
11237338|NCT02065245|12429089|FG002|STARTED|Infusion 4||1
11237339|NCT02065245|12429090|FG003|STARTED|Infusion 4||0
11237340|NCT02065245|12429091|FG004|STARTED|Infusion 4||0
11237341|NCT02065245|12429092|FG005|STARTED|Infusion 4||0
11237342|NCT02065245|12429093|FG006|STARTED|Infusion 4||0
11237343|NCT02065245|12429087|FG000|COMPLETED|Infusion 4||1
11237344|NCT02065245|12429088|FG001|COMPLETED|Infusion 4||2
11237345|NCT02065245|12429089|FG002|COMPLETED|Infusion 4||1
11237346|NCT02065245|12429090|FG003|COMPLETED|Infusion 4||0
11237347|NCT02065245|12429091|FG004|COMPLETED|Infusion 4||0
11237348|NCT02065245|12429092|FG005|COMPLETED|Infusion 4||0
11237349|NCT02065245|12429093|FG006|COMPLETED|Infusion 4||0
11237350|NCT02065245|12429087|FG000|NOT COMPLETED|Infusion 4||0
11237351|NCT02065245|12429088|FG001|NOT COMPLETED|Infusion 4||0
11237352|NCT02065245|12429089|FG002|NOT COMPLETED|Infusion 4||0
11237353|NCT02065245|12429090|FG003|NOT COMPLETED|Infusion 4||0
11237354|NCT02065245|12429091|FG004|NOT COMPLETED|Infusion 4||0
11237355|NCT02065245|12429092|FG005|NOT COMPLETED|Infusion 4||0
11237356|NCT02065245|12429093|FG006|NOT COMPLETED|Infusion 4||0
11237357|NCT02065336|12429117|FG000|STARTED|Main Study||6
11237358|NCT02065336|12429118|FG001|STARTED|Main Study||6
11237359|NCT02065336|12429119|FG002|STARTED|Main Study||6
11237360|NCT02065336|12429120|FG003|STARTED|Main Study||6
11237361|NCT02065336|12429121|FG004|STARTED|Main Study||6
11237362|NCT02065336|12429122|FG005|STARTED|Main Study||6
11237363|NCT02065336|12429123|FG006|STARTED|Main Study||12
11237364|NCT02065336|12429124|FG007|STARTED|Main Study||10
11237365|NCT02065336|12429125|FG008|STARTED|Main Study||0
11237366|NCT02065336|12429126|FG009|STARTED|Main Study||0
11237367|NCT02065336|12429117|FG000|COMPLETED|Main Study||6
11237368|NCT02065336|12429118|FG001|COMPLETED|Main Study||6
11237369|NCT02065336|12429119|FG002|COMPLETED|Main Study||6
11237370|NCT02065336|12429120|FG003|COMPLETED|Main Study||6
11237371|NCT02065336|12429121|FG004|COMPLETED|Main Study||6
11237372|NCT02065336|12429122|FG005|COMPLETED|Main Study||6
11237373|NCT02065336|12429123|FG006|COMPLETED|Main Study||12
11237374|NCT02065336|12429124|FG007|COMPLETED|Main Study||10
11237375|NCT02065336|12429125|FG008|COMPLETED|Main Study||0
11237376|NCT02065336|12429126|FG009|COMPLETED|Main Study||0
11237377|NCT02065336|12429117|FG000|NOT COMPLETED|Main Study||0
11237378|NCT02065336|12429118|FG001|NOT COMPLETED|Main Study||0
11237379|NCT02065336|12429119|FG002|NOT COMPLETED|Main Study||0
11237380|NCT02065336|12429120|FG003|NOT COMPLETED|Main Study||0
11237381|NCT02065336|12429121|FG004|NOT COMPLETED|Main Study||0
11237382|NCT02065336|12429122|FG005|NOT COMPLETED|Main Study||0
11237383|NCT02065336|12429123|FG006|NOT COMPLETED|Main Study||0
11237384|NCT02065336|12429124|FG007|NOT COMPLETED|Main Study||0
11237385|NCT02065336|12429125|FG008|NOT COMPLETED|Main Study||0
11237386|NCT02065336|12429126|FG009|NOT COMPLETED|Main Study||0
11237387|NCT02065336|12429117|FG000|STARTED|Extension Phase||0
11237388|NCT02065336|12429118|FG001|STARTED|Extension Phase||0
11237389|NCT02065336|12429119|FG002|STARTED|Extension Phase||0
11237390|NCT02065336|12429120|FG003|STARTED|Extension Phase||0
11237391|NCT02065336|12429121|FG004|STARTED|Extension Phase||0
11237392|NCT02065336|12429122|FG005|STARTED|Extension Phase||0
11237393|NCT02065336|12429123|FG006|STARTED|Extension Phase||0
11237394|NCT02065336|12429124|FG007|STARTED|Extension Phase||0
11237395|NCT02065336|12429125|FG008|STARTED|Extension Phase||2
11237396|NCT02065336|12429126|FG009|STARTED|Extension Phase||8
11237397|NCT02065336|12429117|FG000|COMPLETED|Extension Phase||0
11237398|NCT02065336|12429118|FG001|COMPLETED|Extension Phase||0
11237399|NCT02065336|12429119|FG002|COMPLETED|Extension Phase||0
11237400|NCT02065336|12429120|FG003|COMPLETED|Extension Phase||0
11237401|NCT02065336|12429121|FG004|COMPLETED|Extension Phase||0
11237402|NCT02065336|12429122|FG005|COMPLETED|Extension Phase||0
11237403|NCT02065336|12429123|FG006|COMPLETED|Extension Phase||0
11237404|NCT02065336|12429124|FG007|COMPLETED|Extension Phase||0
11237405|NCT02065336|12429125|FG008|COMPLETED|Extension Phase||0
11237406|NCT02065336|12429126|FG009|COMPLETED|Extension Phase||0
11237407|NCT02065336|12429117|FG000|NOT COMPLETED|Extension Phase||0
11237408|NCT02065336|12429118|FG001|NOT COMPLETED|Extension Phase||0
11237409|NCT02065336|12429119|FG002|NOT COMPLETED|Extension Phase||0
11237410|NCT02065336|12429120|FG003|NOT COMPLETED|Extension Phase||0
11237411|NCT02065336|12429121|FG004|NOT COMPLETED|Extension Phase||0
11237412|NCT02065336|12429122|FG005|NOT COMPLETED|Extension Phase||0
11237413|NCT02065336|12429123|FG006|NOT COMPLETED|Extension Phase||0
11237414|NCT02065336|12429124|FG007|NOT COMPLETED|Extension Phase||0
11237415|NCT02065336|12429125|FG008|NOT COMPLETED|Extension Phase||2
11237416|NCT02065336|12429126|FG009|NOT COMPLETED|Extension Phase||8
11237417|NCT02065453|12429159|FG000|STARTED|Overall Study||27
11237418|NCT02065453|12429160|FG001|STARTED|Overall Study||25
11237419|NCT02065453|12429159|FG000|COMPLETED|Overall Study||24
11237420|NCT02065453|12429160|FG001|COMPLETED|Overall Study||21
11237421|NCT02065453|12429159|FG000|NOT COMPLETED|Overall Study||3
11237422|NCT02065453|12429160|FG001|NOT COMPLETED|Overall Study||4
11237423|NCT02065479|12429167|FG000|STARTED|Overall Study||33
11237424|NCT02065479|12429168|FG001|STARTED|Overall Study||32
11237425|NCT02065479|12429167|FG000|COMPLETED|Overall Study||33
11237426|NCT02065479|12429168|FG001|COMPLETED|Overall Study||32
11237427|NCT02065479|12429167|FG000|NOT COMPLETED|Overall Study||0
11237428|NCT02065479|12429168|FG001|NOT COMPLETED|Overall Study||0
11237429|NCT02065518|12429178|FG000|STARTED|Overall Study||19
11237430|NCT02065518|12429179|FG001|STARTED|Overall Study||19
11237431|NCT02065518|12429180|FG002|STARTED|Overall Study||20
11237432|NCT02065518|12429181|FG003|STARTED|Overall Study||20
11237433|NCT02065518|12429178|FG000|COMPLETED|Overall Study||13
11237434|NCT02065518|12429179|FG001|COMPLETED|Overall Study||11
11237435|NCT02065518|12429180|FG002|COMPLETED|Overall Study||11
11237436|NCT02065518|12429181|FG003|COMPLETED|Overall Study||15
11237437|NCT02065518|12429178|FG000|NOT COMPLETED|Overall Study||6
11237438|NCT02065518|12429179|FG001|NOT COMPLETED|Overall Study||8
11237439|NCT02065518|12429180|FG002|NOT COMPLETED|Overall Study||9
11237440|NCT02065518|12429181|FG003|NOT COMPLETED|Overall Study||5
11237441|NCT02065557|12429194|FG000|STARTED|Induction Period||32
11237442|NCT02065557|12429195|FG001|STARTED|Induction Period||51
11237443|NCT02065557|12429196|FG002|STARTED|Induction Period||18
11237444|NCT02065557|12429197|FG003|STARTED|Induction Period||0
11237445|NCT02065557|12429198|FG004|STARTED|Induction Period||0
11237446|NCT02065557|12429199|FG005|STARTED|Induction Period||0
11237447|NCT02065557|12429194|FG000|Enrolled in Main Study|Induction Period||30
11237448|NCT02065557|12429195|FG001|Enrolled in Main Study|Induction Period||47
11237449|NCT02065557|12429196|FG002|Enrolled in Main Study|Induction Period||16
11237450|NCT02065557|12429197|FG003|Enrolled in Main Study|Induction Period||0
11237451|NCT02065557|12429198|FG004|Enrolled in Main Study|Induction Period||0
11237452|NCT02065557|12429199|FG005|Enrolled in Main Study|Induction Period||0
11237453|NCT02065557|12429194|FG000|Enrolled in Japan Sub-study|Induction Period||2
11237454|NCT02065557|12429195|FG001|Enrolled in Japan Sub-study|Induction Period||4
11237455|NCT02065557|12429196|FG002|Enrolled in Japan Sub-study|Induction Period||2
11237456|NCT02065557|12429197|FG003|Enrolled in Japan Sub-study|Induction Period||0
11237457|NCT02065557|12429198|FG004|Enrolled in Japan Sub-study|Induction Period||0
11237458|NCT02065557|12429199|FG005|Enrolled in Japan Sub-study|Induction Period||0
11237459|NCT02065557|12429194|FG000|COMPLETED|Induction Period||22
11237460|NCT02065557|12429195|FG001|COMPLETED|Induction Period||43
11237461|NCT02065557|12429196|FG002|COMPLETED|Induction Period||16
11237462|NCT02065557|12429197|FG003|COMPLETED|Induction Period||0
11237463|NCT02065557|12429198|FG004|COMPLETED|Induction Period||0
11237464|NCT02065557|12429199|FG005|COMPLETED|Induction Period||0
11237465|NCT02065557|12429194|FG000|NOT COMPLETED|Induction Period||10
11237466|NCT02065557|12429195|FG001|NOT COMPLETED|Induction Period||8
11237467|NCT02065557|12429196|FG002|NOT COMPLETED|Induction Period||2
11237468|NCT02065557|12429197|FG003|NOT COMPLETED|Induction Period||0
11237469|NCT02065557|12429198|FG004|NOT COMPLETED|Induction Period||0
11237470|NCT02065557|12429199|FG005|NOT COMPLETED|Induction Period||0
11237471|NCT02065557|12429194|FG000|STARTED|Maintenance Period||0
11237472|NCT02065557|12429195|FG001|STARTED|Maintenance Period||0
11237473|NCT02065557|12429196|FG002|STARTED|Maintenance Period||0
11237474|NCT02065557|12429197|FG003|STARTED|Maintenance Period||12
11237475|NCT02065557|12429198|FG004|STARTED|Maintenance Period||33
11237476|NCT02065557|12429199|FG005|STARTED|Maintenance Period||36
11237477|NCT02065557|12429194|FG000|COMPLETED|Maintenance Period||0
11237478|NCT02065557|12429195|FG001|COMPLETED|Maintenance Period||0
11237479|NCT02065557|12429196|FG002|COMPLETED|Maintenance Period||0
11237480|NCT02065557|12429197|FG003|COMPLETED|Maintenance Period||11
11237481|NCT02065557|12429198|FG004|COMPLETED|Maintenance Period||25
11237482|NCT02065557|12429199|FG005|COMPLETED|Maintenance Period||32
11237483|NCT02065557|12429194|FG000|NOT COMPLETED|Maintenance Period||0
11237484|NCT02065557|12429195|FG001|NOT COMPLETED|Maintenance Period||0
11237485|NCT02065557|12429196|FG002|NOT COMPLETED|Maintenance Period||0
11237486|NCT02065557|12429197|FG003|NOT COMPLETED|Maintenance Period||1
11237487|NCT02065557|12429198|FG004|NOT COMPLETED|Maintenance Period||8
11237488|NCT02065557|12429199|FG005|NOT COMPLETED|Maintenance Period||4
11237489|NCT02065570|12429226|FG000|STARTED|Induction Study||206
11237490|NCT02065570|12429227|FG001|STARTED|Induction Study||308
11237491|NCT02065570|12429228|FG002|STARTED|Induction Study||0
11237492|NCT02065570|12429229|FG003|STARTED|Induction Study||0
11237493|NCT02065570|12429226|FG000|COMPLETED|Induction Study||192
11237494|NCT02065570|12429227|FG001|COMPLETED|Induction Study||287
11356676|NCT03096730|12553414|FG000|NOT COMPLETED|Overall Study||3
11356677|NCT03096730|12553415|FG001|NOT COMPLETED|Overall Study||3
11356678|NCT03096730|12553416|FG002|NOT COMPLETED|Overall Study||3
11356679|NCT03096730|12553417|FG003|NOT COMPLETED|Overall Study||3
11356680|NCT03096730|12553418|FG004|NOT COMPLETED|Overall Study||3
11356681|NCT03096847|12553433|FG000|STARTED|Overall Study||319
11356682|NCT03096847|12553434|FG001|STARTED|Overall Study||26
11356683|NCT03096847|12553435|FG002|STARTED|Overall Study||157
11356684|NCT03096847|12553433|FG000|Full Analysis Set|Overall Study||307
11356685|NCT03096847|12553434|FG001|Full Analysis Set|Overall Study||26
11356686|NCT03096847|12553435|FG002|Full Analysis Set|Overall Study||154
11356687|NCT03096847|12553433|FG000|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|100
11356688|NCT03096847|12553434|FG001|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|6
11356689|NCT03096847|12553435|FG002|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|19
11356690|NCT03096847|12553433|FG000|NOT COMPLETED|Overall Study||219
11356691|NCT03096847|12553434|FG001|NOT COMPLETED|Overall Study||20
11356692|NCT03096847|12553435|FG002|NOT COMPLETED|Overall Study||138
11356693|NCT03096873|12553453|FG000|STARTED|Overall Study||20
11356694|NCT03096873|12553454|FG001|STARTED|Overall Study||20
11356695|NCT03096873|12553453|FG000|COMPLETED|Overall Study||20
11356696|NCT03096873|12553454|FG001|COMPLETED|Overall Study||20
11356697|NCT03096873|12553453|FG000|NOT COMPLETED|Overall Study||0
11356698|NCT03096873|12553454|FG001|NOT COMPLETED|Overall Study||0
11356699|NCT03097029|12553462|FG000|STARTED|Overall Study||15
11356700|NCT03097029|12553462|FG000|COMPLETED|Overall Study||14
11356701|NCT03097029|12553462|FG000|NOT COMPLETED|Overall Study||1
11356702|NCT03097133|12553468|FG000|STARTED|Overall Study||115
11356703|NCT03097133|12553469|FG001|STARTED|Overall Study||115
11356704|NCT03097133|12553468|FG000|Treated|Overall Study||113
11356705|NCT03097133|12553469|FG001|Treated|Overall Study||114
11356706|NCT03097133|12553468|FG000|COMPLETED|Overall Study||85
11356707|NCT03097133|12553469|FG001|COMPLETED|Overall Study||81
11356708|NCT03097133|12553468|FG000|NOT COMPLETED|Overall Study||30
11356709|NCT03097133|12553469|FG001|NOT COMPLETED|Overall Study||34
11356710|NCT03097289|12553475|FG000|STARTED|Overall Study||32
11356711|NCT03097289|12553475|FG000|COMPLETED|Overall Study||26
11356712|NCT03097289|12553475|FG000|NOT COMPLETED|Overall Study||6
11356713|NCT03097315|12553480|FG000|STARTED|Overall Study||38
11356714|NCT03097315|12553480|FG000|Intention-to-Treat Population|Overall Study||38
11356715|NCT03097315|12553480|FG000|Safety Population|Overall Study||38
11356716|NCT03097315|12553480|FG000|COMPLETED|Overall Study||37
11356717|NCT03097315|12553480|FG000|NOT COMPLETED|Overall Study||1
11356718|NCT03097341|12553489|FG000|STARTED|Overall Study||4
11356719|NCT03097341|12553490|FG001|STARTED|Overall Study||4
11356720|NCT03097341|12553491|FG002|STARTED|Overall Study||4
11356721|NCT03097341|12553492|FG003|STARTED|Overall Study||4
11356722|NCT03097341|12553493|FG004|STARTED|Overall Study||5
11356723|NCT03097341|12553489|FG000|COMPLETED|Overall Study||4
11356724|NCT03097341|12553490|FG001|COMPLETED|Overall Study||4
11356725|NCT03097341|12553491|FG002|COMPLETED|Overall Study||4
11356726|NCT03097341|12553492|FG003|COMPLETED|Overall Study||4
11356727|NCT03097341|12553493|FG004|COMPLETED|Overall Study||5
11356728|NCT03097341|12553489|FG000|NOT COMPLETED|Overall Study||0
11356729|NCT03097341|12553490|FG001|NOT COMPLETED|Overall Study||0
11356730|NCT03097341|12553491|FG002|NOT COMPLETED|Overall Study||0
11356731|NCT03097341|12553492|FG003|NOT COMPLETED|Overall Study||0
11356732|NCT03097341|12553493|FG004|NOT COMPLETED|Overall Study||0
11356733|NCT03097484|12553507|FG000|STARTED|Overall Study||19
11356734|NCT03097484|12553508|FG001|STARTED|Overall Study||19
11356735|NCT03097484|12553507|FG000|COMPLETED|Overall Study||19
11356736|NCT03097484|12553508|FG001|COMPLETED|Overall Study||19
11356737|NCT03097484|12553507|FG000|NOT COMPLETED|Overall Study||0
11356738|NCT03097484|12553508|FG001|NOT COMPLETED|Overall Study||0
11356739|NCT03097588|12553514|FG000|STARTED|Overall Study||43
11356740|NCT03097588|12553514|FG000|COMPLETED|Overall Study||42
11356741|NCT03097588|12553514|FG000|NOT COMPLETED|Overall Study||1
11356742|NCT03097614|12553518|FG000|STARTED|Overall Study||57
11356743|NCT03097614|12553518|FG000|COMPLETED|Overall Study||54
11356744|NCT03097614|12553518|FG000|NOT COMPLETED|Overall Study||3
11356745|NCT03097653|12553524|FG000|STARTED|Overall Study||472
11356746|NCT03097653|12553525|FG001|STARTED|Overall Study||529
11356747|NCT03097653|12553524|FG000|COMPLETED|Overall Study||472
11356748|NCT03097653|12553525|FG001|COMPLETED|Overall Study||529
11356749|NCT03097653|12553524|FG000|NOT COMPLETED|Overall Study||0
11237495|NCT02065570|12429228|FG002|COMPLETED|Induction Study||0
11237496|NCT02065570|12429229|FG003|COMPLETED|Induction Study||0
11237497|NCT02065570|12429226|FG000|NOT COMPLETED|Induction Study||14
11237498|NCT02065570|12429227|FG001|NOT COMPLETED|Induction Study||21
11237499|NCT02065570|12429228|FG002|NOT COMPLETED|Induction Study||0
11237500|NCT02065570|12429229|FG003|NOT COMPLETED|Induction Study||0
11237501|NCT02065570|12429226|FG000|STARTED|Maintenance Study||0
11237502|NCT02065570|12429227|FG001|STARTED|Maintenance Study||0
11356750|NCT03097653|12553525|FG001|NOT COMPLETED|Overall Study||0
11356751|NCT03097861|12553534|FG000|STARTED|Overall Study||145
11356752|NCT03097861|12553535|FG001|STARTED|Overall Study||276
11237503|NCT02065570|12429228|FG002|STARTED|Maintenance Study||109
11237504|NCT02065570|12429229|FG003|STARTED|Maintenance Study||109
11237505|NCT02065570|12429226|FG000|COMPLETED|Maintenance Study||0
11237506|NCT02065570|12429227|FG001|COMPLETED|Maintenance Study||0
11237507|NCT02065570|12429228|FG002|COMPLETED|Maintenance Study||87
11237508|NCT02065570|12429229|FG003|COMPLETED|Maintenance Study||90
11237509|NCT02065570|12429226|FG000|NOT COMPLETED|Maintenance Study||0
11237510|NCT02065570|12429227|FG001|NOT COMPLETED|Maintenance Study||0
11356753|NCT03097861|12553536|FG002|STARTED|Overall Study||131
11356754|NCT03097861|12553534|FG000|Safety Population|Overall Study||143
11356755|NCT03097861|12553535|FG001|Safety Population|Overall Study||275
11356756|NCT03097861|12553536|FG002|Safety Population|Overall Study||130
11356757|NCT03097861|12553534|FG000|Modified Intent to Treat|Overall Study||143
11356758|NCT03097861|12553535|FG001|Modified Intent to Treat|Overall Study||275
11356759|NCT03097861|12553536|FG002|Modified Intent to Treat|Overall Study||130
11356760|NCT03097861|12553534|FG000|Completers|Overall Study||129
11356761|NCT03097861|12553535|FG001|Completers|Overall Study||255
11356762|NCT03097861|12553536|FG002|Completers|Overall Study||121
11356763|NCT03097861|12553534|FG000|Per-protocol Population (PP)|Overall Study||126
11356764|NCT03097861|12553535|FG001|Per-protocol Population (PP)|Overall Study||234
11356765|NCT03097861|12553536|FG002|Per-protocol Population (PP)|Overall Study||113
11356766|NCT03097861|12553534|FG000|COMPLETED|Overall Study||138
11356767|NCT03097861|12553535|FG001|COMPLETED|Overall Study||254
11356768|NCT03097861|12553536|FG002|COMPLETED|Overall Study||122
11356769|NCT03097861|12553534|FG000|NOT COMPLETED|Overall Study||7
11356770|NCT03097861|12553535|FG001|NOT COMPLETED|Overall Study||22
11356771|NCT03097861|12553536|FG002|NOT COMPLETED|Overall Study||9
11356772|NCT03098030|12553550|FG000|STARTED|Overall Study||12
11356773|NCT03098030|12553551|FG001|STARTED|Overall Study||187
11356774|NCT03098030|12553552|FG002|STARTED|Overall Study||190
11356775|NCT03098030|12553553|FG003|STARTED|Overall Study||94
11356776|NCT03098030|12553550|FG000|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|2
11356777|NCT03098030|12553551|FG001|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
11356778|NCT03098030|12553552|FG002|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
11356779|NCT03098030|12553553|FG003|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|9
11356780|NCT03098030|12553550|FG000|NOT COMPLETED|Overall Study||10
11356781|NCT03098030|12553551|FG001|NOT COMPLETED|Overall Study||163
11356782|NCT03098030|12553552|FG002|NOT COMPLETED|Overall Study||166
11356783|NCT03098030|12553553|FG003|NOT COMPLETED|Overall Study||85
11356784|NCT03098173|12553564|FG000|STARTED|Overall Study||81
11356785|NCT03098173|12553565|FG001|STARTED|Overall Study||81
11356786|NCT03098173|12553564|FG000|COMPLETED|Overall Study||80
11356787|NCT03098173|12553565|FG001|COMPLETED|Overall Study||79
11356788|NCT03098173|12553564|FG000|NOT COMPLETED|Overall Study||1
11356789|NCT03098173|12553565|FG001|NOT COMPLETED|Overall Study||2
11356790|NCT03098420|12553576|FG000|STARTED|Overall Study||7
11356791|NCT03098420|12553577|FG001|STARTED|Overall Study||9
11356792|NCT03098420|12553578|FG002|STARTED|Overall Study||13
11356793|NCT03098420|12553576|FG000|COMPLETED|Overall Study||7
11356794|NCT03098420|12553577|FG001|COMPLETED|Overall Study||9
11356795|NCT03098420|12553578|FG002|COMPLETED|Overall Study||13
11356796|NCT03098420|12553576|FG000|NOT COMPLETED|Overall Study||0
11356797|NCT03098420|12553577|FG001|NOT COMPLETED|Overall Study||0
11356798|NCT03098420|12553578|FG002|NOT COMPLETED|Overall Study||0
11356799|NCT03098433|12553586|FG000|STARTED|Overall Study||22
11356800|NCT03098433|12553586|FG000|COMPLETED|Overall Study||12
11356801|NCT03098433|12553586|FG000|NOT COMPLETED|Overall Study||10
11356802|NCT03098550|12553594|FG000|STARTED|Overall Study||41
11356803|NCT03098550|12553595|FG001|STARTED|Overall Study||21
11356804|NCT03098550|12553596|FG002|STARTED|Overall Study||43
11356805|NCT03098550|12553594|FG000|COMPLETED|Overall Study||0
11356806|NCT03098550|12553595|FG001|COMPLETED|Overall Study||1
11356807|NCT03098550|12553596|FG002|COMPLETED|Overall Study||0
11356808|NCT03098550|12553594|FG000|NOT COMPLETED|Overall Study||41
11356809|NCT03098550|12553595|FG001|NOT COMPLETED|Overall Study||20
11356810|NCT03098550|12553596|FG002|NOT COMPLETED|Overall Study||43
11356811|NCT03098615|12553608|FG000|STARTED|Overall Study||19
11356812|NCT03098615|12553608|FG000|COMPLETED|Overall Study||17
11356813|NCT03098615|12553608|FG000|NOT COMPLETED|Overall Study||2
11356814|NCT03098641|12553613|FG000|STARTED|Overall Study||272
11356815|NCT03098641|12553613|FG000|COMPLETED|Overall Study||220
11356816|NCT03098641|12553613|FG000|NOT COMPLETED|Overall Study||52
11356817|NCT03098745|12553617|FG000|STARTED|Day 1||7
11356818|NCT03098745|12553618|FG001|STARTED|Day 1||3
11356819|NCT03098745|12553619|FG002|STARTED|Day 1||8
11356820|NCT03098745|12553620|FG003|STARTED|Day 1||8
11356821|NCT03098745|12553621|FG004|STARTED|Day 1||10
11356822|NCT03098745|12553622|FG005|STARTED|Day 1||4
11237511|NCT02065570|12429228|FG002|NOT COMPLETED|Maintenance Study||22
11356823|NCT03098745|12553617|FG000|COMPLETED|Day 1||7
11356824|NCT03098745|12553618|FG001|COMPLETED|Day 1||3
11356825|NCT03098745|12553619|FG002|COMPLETED|Day 1||8
11356826|NCT03098745|12553620|FG003|COMPLETED|Day 1||8
11356827|NCT03098745|12553621|FG004|COMPLETED|Day 1||10
11237512|NCT02065570|12429229|FG003|NOT COMPLETED|Maintenance Study||19
11237513|NCT02065622|12429242|FG000|STARTED|Induction Study||379
11237514|NCT02065622|12429243|FG001|STARTED|Induction Study||573
11237515|NCT02065622|12429244|FG002|STARTED|Induction Study||0
11237516|NCT02065622|12429245|FG003|STARTED|Induction Study||0
11356828|NCT03098745|12553622|FG005|COMPLETED|Day 1||4
11356829|NCT03098745|12553617|FG000|NOT COMPLETED|Day 1||0
11356830|NCT03098745|12553618|FG001|NOT COMPLETED|Day 1||0
11356831|NCT03098745|12553619|FG002|NOT COMPLETED|Day 1||0
11356832|NCT03098745|12553620|FG003|NOT COMPLETED|Day 1||0
11356833|NCT03098745|12553621|FG004|NOT COMPLETED|Day 1||0
11356834|NCT03098745|12553622|FG005|NOT COMPLETED|Day 1||0
11356835|NCT03098745|12553617|FG000|STARTED|Day 2||7
11356836|NCT03098745|12553618|FG001|STARTED|Day 2||3
11356837|NCT03098745|12553619|FG002|STARTED|Day 2||8
11356838|NCT03098745|12553620|FG003|STARTED|Day 2||8
11356839|NCT03098745|12553621|FG004|STARTED|Day 2||10
11356840|NCT03098745|12553622|FG005|STARTED|Day 2||4
11356841|NCT03098745|12553617|FG000|COMPLETED|Day 2||7
11356842|NCT03098745|12553618|FG001|COMPLETED|Day 2||3
11356843|NCT03098745|12553619|FG002|COMPLETED|Day 2||8
11356844|NCT03098745|12553620|FG003|COMPLETED|Day 2||8
11356845|NCT03098745|12553621|FG004|COMPLETED|Day 2||10
11356846|NCT03098745|12553622|FG005|COMPLETED|Day 2||4
11356847|NCT03098745|12553617|FG000|NOT COMPLETED|Day 2||0
11356848|NCT03098745|12553618|FG001|NOT COMPLETED|Day 2||0
11356849|NCT03098745|12553619|FG002|NOT COMPLETED|Day 2||0
11356850|NCT03098745|12553620|FG003|NOT COMPLETED|Day 2||0
11356851|NCT03098745|12553621|FG004|NOT COMPLETED|Day 2||0
11356852|NCT03098745|12553622|FG005|NOT COMPLETED|Day 2||0
11356853|NCT03098745|12553617|FG000|STARTED|Day 3||7
11356854|NCT03098745|12553618|FG001|STARTED|Day 3||3
11356855|NCT03098745|12553619|FG002|STARTED|Day 3||8
11356856|NCT03098745|12553620|FG003|STARTED|Day 3||8
11356857|NCT03098745|12553621|FG004|STARTED|Day 3||10
11356858|NCT03098745|12553622|FG005|STARTED|Day 3||4
11356859|NCT03098745|12553617|FG000|COMPLETED|Day 3||7
11356860|NCT03098745|12553618|FG001|COMPLETED|Day 3||3
11356861|NCT03098745|12553619|FG002|COMPLETED|Day 3||8
11356862|NCT03098745|12553620|FG003|COMPLETED|Day 3||8
11356863|NCT03098745|12553621|FG004|COMPLETED|Day 3||10
11356864|NCT03098745|12553622|FG005|COMPLETED|Day 3||4
11356865|NCT03098745|12553617|FG000|NOT COMPLETED|Day 3||0
11356866|NCT03098745|12553618|FG001|NOT COMPLETED|Day 3||0
11356867|NCT03098745|12553619|FG002|NOT COMPLETED|Day 3||0
11356868|NCT03098745|12553620|FG003|NOT COMPLETED|Day 3||0
11356869|NCT03098745|12553621|FG004|NOT COMPLETED|Day 3||0
11356870|NCT03098745|12553622|FG005|NOT COMPLETED|Day 3||0
11356871|NCT03098966|12553631|FG000|STARTED|Overall Study||368
11356872|NCT03098966|12553631|FG000|COMPLETED|Overall Study||368
11356873|NCT03098966|12553631|FG000|NOT COMPLETED|Overall Study||0
11356874|NCT03098979|12553641|FG000|STARTED|Overall Study||76
11356875|NCT03098979|12553642|FG001|STARTED|Overall Study||27
11356876|NCT03098979|12553643|FG002|STARTED|Overall Study||50
11356877|NCT03098979|12553644|FG003|STARTED|Overall Study||51
11356878|NCT03098979|12553645|FG004|STARTED|Overall Study||50
11356879|NCT03098979|12553646|FG005|STARTED|Overall Study||51
11356880|NCT03098979|12553641|FG000|COMPLETED|Overall Study||70
11356881|NCT03098979|12553642|FG001|COMPLETED|Overall Study||25
11356882|NCT03098979|12553643|FG002|COMPLETED|Overall Study||46
11356883|NCT03098979|12553644|FG003|COMPLETED|Overall Study||46
11356884|NCT03098979|12553645|FG004|COMPLETED|Overall Study||41
11356885|NCT03098979|12553646|FG005|COMPLETED|Overall Study||47
11356886|NCT03098979|12553641|FG000|NOT COMPLETED|Overall Study||6
11356887|NCT03098979|12553642|FG001|NOT COMPLETED|Overall Study||2
11356888|NCT03098979|12553643|FG002|NOT COMPLETED|Overall Study||4
11356889|NCT03098979|12553644|FG003|NOT COMPLETED|Overall Study||5
11356890|NCT03098979|12553645|FG004|NOT COMPLETED|Overall Study||9
11356891|NCT03098979|12553646|FG005|NOT COMPLETED|Overall Study||4
11356892|NCT03099096|12553660|FG000|STARTED|Overall Study||159
11356893|NCT03099096|12553660|FG000|COMPLETED|Overall Study||157
11356894|NCT03099096|12553660|FG000|NOT COMPLETED|Overall Study||2
11356895|NCT03099161|12553667|FG000|STARTED|Overall Study||3
11356896|NCT03099161|12553668|FG001|STARTED|Overall Study||4
11356897|NCT03099161|12553669|FG002|STARTED|Overall Study||3
11356898|NCT03099161|12553667|FG000|COMPLETED|Overall Study||0
11356899|NCT03099161|12553668|FG001|COMPLETED|Overall Study||0
11356900|NCT03099161|12553669|FG002|COMPLETED|Overall Study||0
11356901|NCT03099161|12553667|FG000|NOT COMPLETED|Overall Study||3
11356902|NCT03099161|12553668|FG001|NOT COMPLETED|Overall Study||4
11356903|NCT03099161|12553669|FG002|NOT COMPLETED|Overall Study||3
11356904|NCT03099187|12553679|FG000|STARTED|Double-blind Treatment||127
11356905|NCT03099187|12553680|FG001|STARTED|Double-blind Treatment||126
11356906|NCT03099187|12553681|FG002|STARTED|Double-blind Treatment||0
11356907|NCT03099187|12553682|FG003|STARTED|Double-blind Treatment||0
11356908|NCT03099187|12553679|FG000|COMPLETED|Double-blind Treatment||94
11356909|NCT03099187|12553680|FG001|COMPLETED|Double-blind Treatment||110
11356910|NCT03099187|12553681|FG002|COMPLETED|Double-blind Treatment||0
11356911|NCT03099187|12553682|FG003|COMPLETED|Double-blind Treatment||0
11356912|NCT03099187|12553679|FG000|NOT COMPLETED|Double-blind Treatment||33
11356913|NCT03099187|12553680|FG001|NOT COMPLETED|Double-blind Treatment||16
11356914|NCT03099187|12553681|FG002|NOT COMPLETED|Double-blind Treatment||0
11356915|NCT03099187|12553682|FG003|NOT COMPLETED|Double-blind Treatment||0
11356916|NCT03099187|12553679|FG000|STARTED|12-month Safety Follow-up||0
11356917|NCT03099187|12553680|FG001|STARTED|12-month Safety Follow-up||0
11356918|NCT03099187|12553681|FG002|STARTED|12-month Safety Follow-up||94
11356919|NCT03099187|12553682|FG003|STARTED|12-month Safety Follow-up||110
11356920|NCT03099187|12553679|FG000|COMPLETED|12-month Safety Follow-up||0
11356921|NCT03099187|12553680|FG001|COMPLETED|12-month Safety Follow-up||0
11356922|NCT03099187|12553681|FG002|COMPLETED|12-month Safety Follow-up||75
11356923|NCT03099187|12553682|FG003|COMPLETED|12-month Safety Follow-up||84
11356924|NCT03099187|12553679|FG000|NOT COMPLETED|12-month Safety Follow-up||0
11356925|NCT03099187|12553680|FG001|NOT COMPLETED|12-month Safety Follow-up||0
11356926|NCT03099187|12553681|FG002|NOT COMPLETED|12-month Safety Follow-up||19
11356927|NCT03099187|12553682|FG003|NOT COMPLETED|12-month Safety Follow-up||26
11356928|NCT03099369|12553694|FG000|STARTED|Overall Study||11
11356929|NCT03099369|12553695|FG001|STARTED|Overall Study||9
11356930|NCT03099369|12553694|FG000|COMPLETED|Overall Study||5
11356931|NCT03099369|12553695|FG001|COMPLETED|Overall Study||5
11356932|NCT03099369|12553694|FG000|NOT COMPLETED|Overall Study||6
11356933|NCT03099369|12553695|FG001|NOT COMPLETED|Overall Study||4
11356934|NCT03099538|12553702|FG000|STARTED|Overall Study||4
11356935|NCT03099538|12553702|FG000|COMPLETED|Overall Study||1
11356936|NCT03099538|12553702|FG000|NOT COMPLETED|Overall Study||3
11356937|NCT03099655|12553706|FG000|STARTED|Overall Study||440
11356938|NCT03099655|12553706|FG000|COMPLETED|Overall Study|6-Month visit with original 4798 lead implanted|379
11356939|NCT03099655|12553706|FG000|NOT COMPLETED|Overall Study||61
11356940|NCT03099694|12553715|FG000|STARTED|Overall Study||170
11356941|NCT03099694|12553716|FG001|STARTED|Overall Study||170
11356942|NCT03099694|12553715|FG000|COMPLETED|Overall Study||150
11356943|NCT03099694|12553716|FG001|COMPLETED|Overall Study||152
11356944|NCT03099694|12553715|FG000|NOT COMPLETED|Overall Study||20
11356945|NCT03099694|12553716|FG001|NOT COMPLETED|Overall Study||18
11356946|NCT03100058|12553732|FG000|STARTED|Epoch 3 (24 Weeks of Treatment)||38
11356947|NCT03100058|12553733|FG001|STARTED|Epoch 3 (24 Weeks of Treatment)||38
11356948|NCT03100058|12553734|FG002|STARTED|Epoch 3 (24 Weeks of Treatment)||38
11356949|NCT03100058|12553735|FG003|STARTED|Epoch 3 (24 Weeks of Treatment)||77
11356950|NCT03100058|12553736|FG004|STARTED|Epoch 3 (24 Weeks of Treatment)||38
11356951|NCT03100058|12553737|FG005|STARTED|Epoch 3 (24 Weeks of Treatment)||39
11356952|NCT03100058|12553738|FG006|STARTED|Epoch 3 (24 Weeks of Treatment)||38
11356953|NCT03100058|12553739|FG007|STARTED|Epoch 3 (24 Weeks of Treatment)||76
11356954|NCT03100058|12553740|FG008|STARTED|Epoch 3 (24 Weeks of Treatment)||78
11356955|NCT03100058|12553741|FG009|STARTED|Epoch 3 (24 Weeks of Treatment)||0
11356956|NCT03100058|12553742|FG010|STARTED|Epoch 3 (24 Weeks of Treatment)||0
11356957|NCT03100058|12553743|FG011|STARTED|Epoch 3 (24 Weeks of Treatment)||0
11356958|NCT03100058|12553744|FG012|STARTED|Epoch 3 (24 Weeks of Treatment)||0
11356959|NCT03100058|12553732|FG000|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35
11356960|NCT03100058|12553733|FG001|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31
11356961|NCT03100058|12553734|FG002|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29
11356962|NCT03100058|12553735|FG003|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63
11356963|NCT03100058|12553736|FG004|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36
11356964|NCT03100058|12553737|FG005|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37
11356965|NCT03100058|12553738|FG006|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30
11356966|NCT03100058|12553739|FG007|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60
11356967|NCT03100058|12553740|FG008|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73
11356968|NCT03100058|12553741|FG009|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
11356969|NCT03100058|12553742|FG010|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
11356970|NCT03100058|12553743|FG011|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
11356971|NCT03100058|12553744|FG012|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
11356972|NCT03100058|12553732|FG000|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3
11356973|NCT03100058|12553733|FG001|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7
11356974|NCT03100058|12553734|FG002|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9
11356975|NCT03100058|12553735|FG003|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14
11356976|NCT03100058|12553736|FG004|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
11356977|NCT03100058|12553737|FG005|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
11356978|NCT03100058|12553738|FG006|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8
11356979|NCT03100058|12553739|FG007|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16
11356980|NCT03100058|12553740|FG008|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5
11356981|NCT03100058|12553741|FG009|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
11356982|NCT03100058|12553742|FG010|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
11356983|NCT03100058|12553743|FG011|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
11356984|NCT03100058|12553744|FG012|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
11356985|NCT03100058|12553732|FG000|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
11356986|NCT03100058|12553733|FG001|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
11356987|NCT03100058|12553734|FG002|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
11356988|NCT03100058|12553735|FG003|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
11356989|NCT03100058|12553736|FG004|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
11356990|NCT03100058|12553737|FG005|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
11356991|NCT03100058|12553738|FG006|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
11356992|NCT03100058|12553739|FG007|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
11356993|NCT03100058|12553740|FG008|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
11356994|NCT03100058|12553741|FG009|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158
11356995|NCT03100058|12553742|FG010|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163
11356996|NCT03100058|12553743|FG011|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39
11356997|NCT03100058|12553744|FG012|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34
11356998|NCT03100058|12553732|FG000|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11356999|NCT03100058|12553733|FG001|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357000|NCT03100058|12553734|FG002|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357001|NCT03100058|12553735|FG003|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357002|NCT03100058|12553736|FG004|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357003|NCT03100058|12553737|FG005|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357004|NCT03100058|12553738|FG006|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357005|NCT03100058|12553739|FG007|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357006|NCT03100058|12553740|FG008|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357007|NCT03100058|12553741|FG009|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153
11357008|NCT03100058|12553742|FG010|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148
11357009|NCT03100058|12553743|FG011|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36
11357010|NCT03100058|12553744|FG012|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30
11357011|NCT03100058|12553732|FG000|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357012|NCT03100058|12553733|FG001|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357013|NCT03100058|12553734|FG002|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357014|NCT03100058|12553735|FG003|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357015|NCT03100058|12553736|FG004|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357016|NCT03100058|12553737|FG005|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357017|NCT03100058|12553738|FG006|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357018|NCT03100058|12553739|FG007|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357019|NCT03100058|12553740|FG008|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
11357020|NCT03100058|12553741|FG009|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5
11357021|NCT03100058|12553742|FG010|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15
11357022|NCT03100058|12553743|FG011|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3
11357023|NCT03100058|12553744|FG012|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4
11357024|NCT03100123|12553775|FG000|STARTED|Overall Study||0
11357025|NCT03100123|12553776|FG001|STARTED|Overall Study||1
11357026|NCT03100123|12553775|FG000|COMPLETED|Overall Study||0
11357027|NCT03100123|12553776|FG001|COMPLETED|Overall Study||1
11357028|NCT03100123|12553775|FG000|NOT COMPLETED|Overall Study||0
11357029|NCT03100123|12553776|FG001|NOT COMPLETED|Overall Study||0
11357030|NCT03100344|12553791|FG000|STARTED|Overall Study||57
11357031|NCT03100344|12553792|FG001|STARTED|Overall Study||55
11357032|NCT03100344|12553793|FG002|STARTED|Overall Study||57
11357033|NCT03100344|12553794|FG003|STARTED|Overall Study||57
11357034|NCT03100344|12553791|FG000|COMPLETED|Overall Study||43
11357035|NCT03100344|12553792|FG001|COMPLETED|Overall Study||44
11357036|NCT03100344|12553793|FG002|COMPLETED|Overall Study||50
11357037|NCT03100344|12553794|FG003|COMPLETED|Overall Study||45
11357038|NCT03100344|12553791|FG000|NOT COMPLETED|Overall Study||14
11357039|NCT03100344|12553792|FG001|NOT COMPLETED|Overall Study||11
11357040|NCT03100344|12553793|FG002|NOT COMPLETED|Overall Study||7
11357041|NCT03100344|12553794|FG003|NOT COMPLETED|Overall Study||12
11357042|NCT03100500|12553805|FG000|STARTED|Overall Study||51
11357043|NCT03100500|12553805|FG000|COMPLETED|Overall Study||51
11357044|NCT03100500|12553805|FG000|NOT COMPLETED|Overall Study||0
11357045|NCT03100825|12553809|FG000|STARTED|Overall Study||94
11357046|NCT03100825|12553809|FG000|COMPLETED|Overall Study||86
11357047|NCT03100825|12553809|FG000|NOT COMPLETED|Overall Study||8
11357048|NCT03100838|12553813|FG000|STARTED|Overall Study||16
11357049|NCT03100838|12553814|FG001|STARTED|Overall Study||16
11357050|NCT03100838|12553815|FG002|STARTED|Overall Study||16
11357051|NCT03100838|12553816|FG003|STARTED|Overall Study||16
11357052|NCT03100838|12553813|FG000|COMPLETED|Overall Study||14
11357053|NCT03100838|12553814|FG001|COMPLETED|Overall Study||14
11357054|NCT03100838|12553815|FG002|COMPLETED|Overall Study||14
11357055|NCT03100838|12553816|FG003|COMPLETED|Overall Study||15
11357056|NCT03100838|12553813|FG000|NOT COMPLETED|Overall Study||2
11357057|NCT03100838|12553814|FG001|NOT COMPLETED|Overall Study||2
11357058|NCT03100838|12553815|FG002|NOT COMPLETED|Overall Study||2
11357059|NCT03100838|12553816|FG003|NOT COMPLETED|Overall Study||1
11357060|NCT03100864|12553826|FG000|STARTED|Overall Study||8
11357061|NCT03100864|12553826|FG000|COMPLETED|Overall Study||8
11357062|NCT03100864|12553826|FG000|NOT COMPLETED|Overall Study||0
11357063|NCT03100942|12553834|FG000|STARTED|Randomized Treatment Period||38
11357064|NCT03100942|12553835|FG001|STARTED|Randomized Treatment Period||38
11357065|NCT03100942|12553836|FG002|STARTED|Randomized Treatment Period||39
11357066|NCT03100942|12553837|FG003|STARTED|Randomized Treatment Period||37
11357067|NCT03100942|12553838|FG004|STARTED|Randomized Treatment Period||0
11357068|NCT03100942|12553839|FG005|STARTED|Randomized Treatment Period||0
11357069|NCT03100942|12553840|FG006|STARTED|Randomized Treatment Period||0
11357070|NCT03100942|12553834|FG000|COMPLETED|Randomized Treatment Period||26
11357071|NCT03100942|12553835|FG001|COMPLETED|Randomized Treatment Period||29
11357072|NCT03100942|12553836|FG002|COMPLETED|Randomized Treatment Period||33
11357073|NCT03100942|12553837|FG003|COMPLETED|Randomized Treatment Period||32
11357074|NCT03100942|12553838|FG004|COMPLETED|Randomized Treatment Period||0
11357075|NCT03100942|12553839|FG005|COMPLETED|Randomized Treatment Period||0
11357076|NCT03100942|12553840|FG006|COMPLETED|Randomized Treatment Period||0
11357077|NCT03100942|12553834|FG000|NOT COMPLETED|Randomized Treatment Period||12
11357078|NCT03100942|12553835|FG001|NOT COMPLETED|Randomized Treatment Period||9
11357079|NCT03100942|12553836|FG002|NOT COMPLETED|Randomized Treatment Period||6
11357080|NCT03100942|12553837|FG003|NOT COMPLETED|Randomized Treatment Period||5
11357081|NCT03100942|12553838|FG004|NOT COMPLETED|Randomized Treatment Period||0
11357082|NCT03100942|12553839|FG005|NOT COMPLETED|Randomized Treatment Period||0
11357083|NCT03100942|12553840|FG006|NOT COMPLETED|Randomized Treatment Period||0
11357084|NCT03100942|12553834|FG000|STARTED|Placebo Arm Re-Randomized||0
11357085|NCT03100942|12553835|FG001|STARTED|Placebo Arm Re-Randomized||0
11357086|NCT03100942|12553836|FG002|STARTED|Placebo Arm Re-Randomized||0
11357087|NCT03100942|12553837|FG003|STARTED|Placebo Arm Re-Randomized||0
11357088|NCT03100942|12553838|FG004|STARTED|Placebo Arm Re-Randomized||10
11357089|NCT03100942|12553839|FG005|STARTED|Placebo Arm Re-Randomized||12
11357090|NCT03100942|12553840|FG006|STARTED|Placebo Arm Re-Randomized||10
11357091|NCT03100942|12553834|FG000|COMPLETED|Placebo Arm Re-Randomized||0
11357092|NCT03100942|12553835|FG001|COMPLETED|Placebo Arm Re-Randomized||0
11357093|NCT03100942|12553836|FG002|COMPLETED|Placebo Arm Re-Randomized||0
11357094|NCT03100942|12553837|FG003|COMPLETED|Placebo Arm Re-Randomized||0
11357095|NCT03100942|12553838|FG004|COMPLETED|Placebo Arm Re-Randomized||10
11357096|NCT03100942|12553839|FG005|COMPLETED|Placebo Arm Re-Randomized||12
11357097|NCT03100942|12553840|FG006|COMPLETED|Placebo Arm Re-Randomized||9
11357098|NCT03100942|12553834|FG000|NOT COMPLETED|Placebo Arm Re-Randomized||0
11357099|NCT03100942|12553835|FG001|NOT COMPLETED|Placebo Arm Re-Randomized||0
11357100|NCT03100942|12553836|FG002|NOT COMPLETED|Placebo Arm Re-Randomized||0
11357101|NCT03100942|12553837|FG003|NOT COMPLETED|Placebo Arm Re-Randomized||0
11357102|NCT03100942|12553838|FG004|NOT COMPLETED|Placebo Arm Re-Randomized||0
11357103|NCT03100942|12553839|FG005|NOT COMPLETED|Placebo Arm Re-Randomized||0
11357104|NCT03100942|12553840|FG006|NOT COMPLETED|Placebo Arm Re-Randomized||1
11357105|NCT03100968|12553855|FG000|STARTED|Overall Study||75
11357106|NCT03100968|12553856|FG001|STARTED|Overall Study||75
11357107|NCT03100968|12553855|FG000|COMPLETED|Overall Study||75
11357108|NCT03100968|12553856|FG001|COMPLETED|Overall Study||75
11357109|NCT03100968|12553855|FG000|NOT COMPLETED|Overall Study||0
11357110|NCT03100968|12553856|FG001|NOT COMPLETED|Overall Study||0
11357111|NCT03101020|12553864|FG000|STARTED|Overall Study||10
11357112|NCT03101020|12553865|FG001|STARTED|Overall Study||10
11357113|NCT03101020|12553864|FG000|COMPLETED|Overall Study||9
11357114|NCT03101020|12553865|FG001|COMPLETED|Overall Study||7
11357115|NCT03101020|12553864|FG000|NOT COMPLETED|Overall Study||1
11357116|NCT03101020|12553865|FG001|NOT COMPLETED|Overall Study||3
11357117|NCT03101033|12553873|FG000|STARTED|Overall Study||32
11357118|NCT03101033|12553874|FG001|STARTED|Overall Study||60
11357119|NCT03101033|12553873|FG000|COMPLETED|Overall Study||27
11357120|NCT03101033|12553874|FG001|COMPLETED|Overall Study||51
11357121|NCT03101033|12553873|FG000|NOT COMPLETED|Overall Study||5
11357122|NCT03101033|12553874|FG001|NOT COMPLETED|Overall Study||9
11357123|NCT03101111|12553882|FG000|STARTED|Overall Study|First subject signed ICF (MV-CHIK group)|26
11357124|NCT03101111|12553883|FG001|STARTED|Overall Study|First subject signed ICF (MMR group)|8
11357125|NCT03101111|12553882|FG000|COMPLETED|Overall Study|End of Study Visit|23
11357126|NCT03101111|12553883|FG001|COMPLETED|Overall Study|End of Study Visit|7
11357127|NCT03101111|12553882|FG000|NOT COMPLETED|Overall Study||3
11357128|NCT03101111|12553883|FG001|NOT COMPLETED|Overall Study||1
11357129|NCT03101150|12553895|FG000|STARTED|Overall Study||86
11357130|NCT03101150|12553896|FG001|STARTED|Overall Study||93
11357131|NCT03101150|12553895|FG000|COMPLETED|Overall Study||81
11357132|NCT03101150|12553896|FG001|COMPLETED|Overall Study||83
11357133|NCT03101150|12553895|FG000|NOT COMPLETED|Overall Study||5
11357134|NCT03101150|12553896|FG001|NOT COMPLETED|Overall Study||10
11357135|NCT03101241|12553904|FG000|STARTED|Overall Study||48
11357136|NCT03101241|12553905|FG001|STARTED|Overall Study||47
11357137|NCT03101241|12553904|FG000|COMPLETED|Overall Study||37
11357138|NCT03101241|12553905|FG001|COMPLETED|Overall Study||42
11357139|NCT03101241|12553904|FG000|NOT COMPLETED|Overall Study||11
11357140|NCT03101241|12553905|FG001|NOT COMPLETED|Overall Study||5
11357141|NCT03101267|12553914|FG000|STARTED|Primary Study Period||50
11357142|NCT03101267|12553915|FG001|STARTED|Primary Study Period||50
11357143|NCT03101267|12553916|FG002|STARTED|Primary Study Period||50
11357144|NCT03101267|12553914|FG000|COMPLETED|Primary Study Period||47
11357145|NCT03101267|12553915|FG001|COMPLETED|Primary Study Period||48
11357146|NCT03101267|12553916|FG002|COMPLETED|Primary Study Period||47
11357147|NCT03101267|12553914|FG000|NOT COMPLETED|Primary Study Period||3
11357148|NCT03101267|12553915|FG001|NOT COMPLETED|Primary Study Period||2
11357149|NCT03101267|12553916|FG002|NOT COMPLETED|Primary Study Period||3
11357150|NCT03101267|12553914|FG000|STARTED|Pollinosis Symptoms Survey Period||47
11357151|NCT03101267|12553915|FG001|STARTED|Pollinosis Symptoms Survey Period||48
11357152|NCT03101267|12553916|FG002|STARTED|Pollinosis Symptoms Survey Period||47
11357153|NCT03101267|12553914|FG000|COMPLETED|Pollinosis Symptoms Survey Period||47
11357154|NCT03101267|12553915|FG001|COMPLETED|Pollinosis Symptoms Survey Period||48
11357155|NCT03101267|12553916|FG002|COMPLETED|Pollinosis Symptoms Survey Period||47
11357156|NCT03101267|12553914|FG000|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
11357157|NCT03101267|12553915|FG001|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
11357158|NCT03101267|12553916|FG002|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
11357159|NCT03101293|12553926|FG000|STARTED|Intervention Period 1||7
11357160|NCT03101293|12553927|FG001|STARTED|Intervention Period 1||8
11357161|NCT03101293|12553926|FG000|COMPLETED|Intervention Period 1||7
11357162|NCT03101293|12553927|FG001|COMPLETED|Intervention Period 1||8
11357163|NCT03101293|12553926|FG000|NOT COMPLETED|Intervention Period 1||0
11357164|NCT03101293|12553927|FG001|NOT COMPLETED|Intervention Period 1||0
11357165|NCT03101293|12553926|FG000|STARTED|Washout Period (at Least 7 Days)||7
11357166|NCT03101293|12553927|FG001|STARTED|Washout Period (at Least 7 Days)||8
11357167|NCT03101293|12553926|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
11357168|NCT03101293|12553927|FG001|COMPLETED|Washout Period (at Least 7 Days)||8
11357169|NCT03101293|12553926|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||1
11357170|NCT03101293|12553927|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
11357171|NCT03101293|12553926|FG000|STARTED|Intervention Period 2||6
11357172|NCT03101293|12553927|FG001|STARTED|Intervention Period 2||8
11357173|NCT03101293|12553926|FG000|COMPLETED|Intervention Period 2||6
11357174|NCT03101293|12553927|FG001|COMPLETED|Intervention Period 2||8
11357175|NCT03101293|12553926|FG000|NOT COMPLETED|Intervention Period 2||0
11357176|NCT03101293|12553927|FG001|NOT COMPLETED|Intervention Period 2||0
11357177|NCT03101358|12553937|FG000|STARTED|Overall Study||4
11357178|NCT03101358|12553938|FG001|STARTED|Overall Study||3
11357179|NCT03101358|12553939|FG002|STARTED|Overall Study||5
11357180|NCT03101358|12553940|FG003|STARTED|Overall Study||11
11357181|NCT03101358|12553937|FG000|Completed All Dosing|Overall Study||3
11357182|NCT03101358|12553938|FG001|Completed All Dosing|Overall Study||3
11357183|NCT03101358|12553939|FG002|Completed All Dosing|Overall Study||3
11357184|NCT03101358|12553940|FG003|Completed All Dosing|Overall Study||10
11357185|NCT03101358|12553937|FG000|COMPLETED|Overall Study||1
11357186|NCT03101358|12553938|FG001|COMPLETED|Overall Study||3
11357187|NCT03101358|12553939|FG002|COMPLETED|Overall Study||3
11357188|NCT03101358|12553940|FG003|COMPLETED|Overall Study||5
11357189|NCT03101358|12553937|FG000|NOT COMPLETED|Overall Study||3
11357190|NCT03101358|12553938|FG001|NOT COMPLETED|Overall Study||0
11357191|NCT03101358|12553939|FG002|NOT COMPLETED|Overall Study||2
11357192|NCT03101358|12553940|FG003|NOT COMPLETED|Overall Study||6
11357193|NCT03101371|12553953|FG000|STARTED|Overall Study||48
11357194|NCT03101371|12553954|FG001|STARTED|Overall Study||51
11357195|NCT03101371|12553953|FG000|COMPLETED|Overall Study||45
11357196|NCT03101371|12553954|FG001|COMPLETED|Overall Study||45
11357197|NCT03101371|12553953|FG000|NOT COMPLETED|Overall Study||3
11357198|NCT03101371|12553954|FG001|NOT COMPLETED|Overall Study||6
11357199|NCT03101462|12553962|FG000|STARTED|Overall Study||19
11357200|NCT03101462|12553963|FG001|STARTED|Overall Study||19
11357201|NCT03101462|12553962|FG000|COMPLETED|Overall Study||18
11357202|NCT03101462|12553963|FG001|COMPLETED|Overall Study||18
11357203|NCT03101462|12553962|FG000|NOT COMPLETED|Overall Study||1
11357204|NCT03101462|12553963|FG001|NOT COMPLETED|Overall Study||1
11357205|NCT03101514|12553969|FG000|STARTED|Overall Study||53
11357206|NCT03101514|12553969|FG000|COMPLETED|Overall Study||46
11357207|NCT03101514|12553969|FG000|NOT COMPLETED|Overall Study||7
11357208|NCT03101592|12553976|FG000|STARTED|Overall Study||3123
11357209|NCT03101592|12553977|FG001|STARTED|Overall Study||2896
11357210|NCT03101592|12553978|FG002|STARTED|Overall Study||3099
11357211|NCT03101592|12553976|FG000|COMPLETED|Overall Study||3012
11357212|NCT03101592|12553977|FG001|COMPLETED|Overall Study||2726
11357213|NCT03101592|12553978|FG002|COMPLETED|Overall Study||2981
11357214|NCT03101592|12553976|FG000|NOT COMPLETED|Overall Study||111
11357215|NCT03101592|12553977|FG001|NOT COMPLETED|Overall Study||170
11357216|NCT03101592|12553978|FG002|NOT COMPLETED|Overall Study||118
11357217|NCT03102190|12553992|FG000|STARTED|Overall Study||6
11357218|NCT03102190|12553992|FG000|COMPLETED|Overall Study||6
11357219|NCT03102190|12553992|FG000|NOT COMPLETED|Overall Study||0
11357220|NCT03102411|12553996|FG000|STARTED|Overall Study||1881
11357221|NCT03102411|12553996|FG000|COMPLETED|Overall Study||1718
11237517|NCT02065622|12429246|FG004|STARTED|Induction Study||0
11237518|NCT02065622|12429242|FG000|Enrolled in Main Study|Induction Study||340
11237519|NCT02065622|12429243|FG001|Enrolled in Main Study|Induction Study||512
11237520|NCT02065622|12429244|FG002|Enrolled in Main Study|Induction Study||0
11237521|NCT02065622|12429245|FG003|Enrolled in Main Study|Induction Study||0
11237522|NCT02065622|12429246|FG004|Enrolled in Main Study|Induction Study||0
11237523|NCT02065622|12429242|FG000|Enrolled in Japan Sub-Study|Induction Study||39
11237524|NCT02065622|12429243|FG001|Enrolled in Japan Sub-Study|Induction Study||61
11237525|NCT02065622|12429244|FG002|Enrolled in Japan Sub-Study|Induction Study||0
11237526|NCT02065622|12429245|FG003|Enrolled in Japan Sub-Study|Induction Study||0
11237527|NCT02065622|12429246|FG004|Enrolled in Japan Sub-Study|Induction Study||0
11237528|NCT02065622|12429242|FG000|COMPLETED|Induction Study||332
11237529|NCT02065622|12429243|FG001|COMPLETED|Induction Study||514
11237530|NCT02065622|12429244|FG002|COMPLETED|Induction Study||0
11237531|NCT02065622|12429245|FG003|COMPLETED|Induction Study||0
11237532|NCT02065622|12429246|FG004|COMPLETED|Induction Study||0
11237533|NCT02065622|12429242|FG000|NOT COMPLETED|Induction Study||47
11237534|NCT02065622|12429243|FG001|NOT COMPLETED|Induction Study||59
11237535|NCT02065622|12429244|FG002|NOT COMPLETED|Induction Study||0
11237536|NCT02065622|12429245|FG003|NOT COMPLETED|Induction Study||0
11237537|NCT02065622|12429246|FG004|NOT COMPLETED|Induction Study||0
11237538|NCT02065622|12429242|FG000|STARTED|Maintenance Study||0
11237539|NCT02065622|12429243|FG001|STARTED|Maintenance Study||0
11237540|NCT02065622|12429244|FG002|STARTED|Maintenance Study||345
11237541|NCT02065622|12429245|FG003|STARTED|Maintenance Study||350
11237542|NCT02065622|12429246|FG004|STARTED|Maintenance Study||151
11237543|NCT02065622|12429242|FG000|COMPLETED|Maintenance Study||0
11237544|NCT02065622|12429243|FG001|COMPLETED|Maintenance Study||0
11237545|NCT02065622|12429244|FG002|COMPLETED|Maintenance Study||221
11237546|NCT02065622|12429245|FG003|COMPLETED|Maintenance Study||246
11237547|NCT02065622|12429246|FG004|COMPLETED|Maintenance Study||105
11237548|NCT02065622|12429242|FG000|NOT COMPLETED|Maintenance Study||0
11237549|NCT02065622|12429243|FG001|NOT COMPLETED|Maintenance Study||0
11237550|NCT02065622|12429244|FG002|NOT COMPLETED|Maintenance Study||124
11237551|NCT02065622|12429245|FG003|NOT COMPLETED|Maintenance Study||104
11237552|NCT02065622|12429246|FG004|NOT COMPLETED|Maintenance Study||46
11237553|NCT02065687|12429263|FG000|STARTED|Overall Study||234
11237554|NCT02065687|12429264|FG001|STARTED|Overall Study||235
11237555|NCT02065687|12429263|FG000|COMPLETED|Overall Study||234
11237556|NCT02065687|12429264|FG001|COMPLETED|Overall Study||235
11237557|NCT02065687|12429263|FG000|NOT COMPLETED|Overall Study||0
11237558|NCT02065687|12429264|FG001|NOT COMPLETED|Overall Study||0
11237559|NCT02065713|12429272|FG000|STARTED|Overall Study||23
11237560|NCT02065713|12429273|FG001|STARTED|Overall Study||21
11237561|NCT02065713|12429272|FG000|COMPLETED|Overall Study||22
11237562|NCT02065713|12429273|FG001|COMPLETED|Overall Study||20
11237563|NCT02065713|12429272|FG000|NOT COMPLETED|Overall Study||1
11237564|NCT02065713|12429273|FG001|NOT COMPLETED|Overall Study||1
11237565|NCT02065791|12429281|FG000|STARTED|Overall Study||2199
11237566|NCT02065791|12429282|FG001|STARTED|Overall Study||2202
11237567|NCT02065791|12429281|FG000|Treated|Overall Study||2197
11237568|NCT02065791|12429282|FG001|Treated|Overall Study||2200
11237569|NCT02065791|12429281|FG000|COMPLETED|Overall Study||2174
11237570|NCT02065791|12429282|FG001|COMPLETED|Overall Study||2187
11237571|NCT02065791|12429281|FG000|NOT COMPLETED|Overall Study||25
11237572|NCT02065791|12429282|FG001|NOT COMPLETED|Overall Study||15
11237573|NCT02065895|12429288|FG000|STARTED|Overall Study||1
11237574|NCT02065895|12429289|FG001|STARTED|Overall Study||3
11237575|NCT02065895|12429290|FG002|STARTED|Overall Study||1
11237576|NCT02065895|12429291|FG003|STARTED|Overall Study||1
11237577|NCT02065895|12429292|FG004|STARTED|Overall Study||1
11237578|NCT02065895|12429293|FG005|STARTED|Overall Study||1
11237579|NCT02065895|12429288|FG000|COMPLETED|Overall Study||0
11237580|NCT02065895|12429289|FG001|COMPLETED|Overall Study||2
11237581|NCT02065895|12429290|FG002|COMPLETED|Overall Study||1
11237582|NCT02065895|12429291|FG003|COMPLETED|Overall Study||0
11237583|NCT02065895|12429292|FG004|COMPLETED|Overall Study||1
11237584|NCT02065895|12429293|FG005|COMPLETED|Overall Study||1
11237585|NCT02065895|12429288|FG000|NOT COMPLETED|Overall Study||1
11237586|NCT02065895|12429289|FG001|NOT COMPLETED|Overall Study||1
11237587|NCT02065895|12429290|FG002|NOT COMPLETED|Overall Study||0
11237588|NCT02065895|12429291|FG003|NOT COMPLETED|Overall Study||1
11237589|NCT02065895|12429292|FG004|NOT COMPLETED|Overall Study||0
11237590|NCT02065895|12429293|FG005|NOT COMPLETED|Overall Study||0
11237591|NCT02066051|12429310|FG000|STARTED|Overall Study||8
11237592|NCT02066051|12429310|FG000|COMPLETED|Overall Study||7
11237593|NCT02066051|12429310|FG000|NOT COMPLETED|Overall Study||1
11237594|NCT02066129|12429316|FG000|STARTED|Overall Study||127
11237595|NCT02066129|12429317|FG001|STARTED|Overall Study||127
11237596|NCT02066129|12429316|FG000|COMPLETED|Overall Study||98
11237597|NCT02066129|12429317|FG001|COMPLETED|Overall Study||94
11237598|NCT02066129|12429316|FG000|NOT COMPLETED|Overall Study||29
11237599|NCT02066129|12429317|FG001|NOT COMPLETED|Overall Study||33
11237600|NCT02066233|12429325|FG000|STARTED|EG Scan II (Day 1)||50
11237601|NCT02066233|12429326|FG001|STARTED|EG Scan II (Day 1)||50
11237602|NCT02066233|12429325|FG000|COMPLETED|EG Scan II (Day 1)||44
11237603|NCT02066233|12429326|FG001|COMPLETED|EG Scan II (Day 1)||44
11237604|NCT02066233|12429325|FG000|NOT COMPLETED|EG Scan II (Day 1)||6
11237605|NCT02066233|12429326|FG001|NOT COMPLETED|EG Scan II (Day 1)||6
11237606|NCT02066233|12429325|FG000|STARTED|Standard Endoscopy (Day 2)||44
11237607|NCT02066233|12429326|FG001|STARTED|Standard Endoscopy (Day 2)||44
11237608|NCT02066233|12429325|FG000|COMPLETED|Standard Endoscopy (Day 2)||44
11237609|NCT02066233|12429326|FG001|COMPLETED|Standard Endoscopy (Day 2)||44
11237610|NCT02066233|12429325|FG000|NOT COMPLETED|Standard Endoscopy (Day 2)||0
11237611|NCT02066233|12429326|FG001|NOT COMPLETED|Standard Endoscopy (Day 2)||0
11237612|NCT02066298|12429338|FG000|STARTED|Overall Study||49
11237613|NCT02066298|12429339|FG001|STARTED|Overall Study||48
11237614|NCT02066298|12429340|FG002|STARTED|Overall Study||50
11237615|NCT02066298|12429341|FG003|STARTED|Overall Study||51
11237616|NCT02066298|12429342|FG004|STARTED|Overall Study||47
11237617|NCT02066298|12429343|FG005|STARTED|Overall Study||50
11237618|NCT02066298|12429338|FG000|Completed 1st Period|Overall Study||44
11237619|NCT02066298|12429339|FG001|Completed 1st Period|Overall Study||47
11237620|NCT02066298|12429340|FG002|Completed 1st Period|Overall Study||45
11237621|NCT02066298|12429341|FG003|Completed 1st Period|Overall Study||48
11237622|NCT02066298|12429342|FG004|Completed 1st Period|Overall Study||46
11237623|NCT02066298|12429343|FG005|Completed 1st Period|Overall Study||45
11237624|NCT02066298|12429338|FG000|Completed 2nd Period|Overall Study||41
11237625|NCT02066298|12429339|FG001|Completed 2nd Period|Overall Study||41
11237626|NCT02066298|12429340|FG002|Completed 2nd Period|Overall Study||41
11237627|NCT02066298|12429341|FG003|Completed 2nd Period|Overall Study||46
11237628|NCT02066298|12429342|FG004|Completed 2nd Period|Overall Study||42
11237629|NCT02066298|12429343|FG005|Completed 2nd Period|Overall Study||41
11237630|NCT02066298|12429338|FG000|Completed 3rd Period|Overall Study||40
11237631|NCT02066298|12429339|FG001|Completed 3rd Period|Overall Study||40
11237632|NCT02066298|12429340|FG002|Completed 3rd Period|Overall Study||40
11237633|NCT02066298|12429341|FG003|Completed 3rd Period|Overall Study||45
11237634|NCT02066298|12429342|FG004|Completed 3rd Period|Overall Study||38
11237635|NCT02066298|12429343|FG005|Completed 3rd Period|Overall Study||38
11237636|NCT02066298|12429338|FG000|COMPLETED|Overall Study||40
11237637|NCT02066298|12429339|FG001|COMPLETED|Overall Study||40
11237638|NCT02066298|12429340|FG002|COMPLETED|Overall Study||40
11237639|NCT02066298|12429341|FG003|COMPLETED|Overall Study||45
11237640|NCT02066298|12429342|FG004|COMPLETED|Overall Study||38
11237641|NCT02066298|12429343|FG005|COMPLETED|Overall Study||38
11237642|NCT02066298|12429338|FG000|NOT COMPLETED|Overall Study||9
11237643|NCT02066298|12429339|FG001|NOT COMPLETED|Overall Study||8
11237644|NCT02066298|12429340|FG002|NOT COMPLETED|Overall Study||10
11237645|NCT02066298|12429341|FG003|NOT COMPLETED|Overall Study||6
11237646|NCT02066298|12429342|FG004|NOT COMPLETED|Overall Study||9
11237647|NCT02066298|12429343|FG005|NOT COMPLETED|Overall Study||12
11237648|NCT02066311|12429355|FG000|STARTED|Overall Study||15
11237649|NCT02066311|12429355|FG000|COMPLETED|Overall Study|Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy.|10
11237650|NCT02066311|12429355|FG000|NOT COMPLETED|Overall Study||5
11237651|NCT02066389|12429365|FG000|STARTED|Overall Study||50
11237652|NCT02066389|12429366|FG001|STARTED|Overall Study||50
11237653|NCT02066389|12429367|FG002|STARTED|Overall Study||50
11237654|NCT02066389|12429368|FG003|STARTED|Overall Study||50
11237655|NCT02066389|12429369|FG004|STARTED|Overall Study||50
11237656|NCT02066389|12429370|FG005|STARTED|Overall Study||50
11237657|NCT02066389|12429365|FG000|Received Study Drug|Overall Study||50
11237658|NCT02066389|12429366|FG001|Received Study Drug|Overall Study||50
11237659|NCT02066389|12429367|FG002|Received Study Drug|Overall Study||50
11237660|NCT02066389|12429368|FG003|Received Study Drug|Overall Study||50
11237661|NCT02066389|12429369|FG004|Received Study Drug|Overall Study||50
11237662|NCT02066389|12429370|FG005|Received Study Drug|Overall Study||49
11237663|NCT02066389|12429365|FG000|COMPLETED|Overall Study||45
11237664|NCT02066389|12429366|FG001|COMPLETED|Overall Study||49
11237665|NCT02066389|12429367|FG002|COMPLETED|Overall Study||44
11237666|NCT02066389|12429368|FG003|COMPLETED|Overall Study||47
11237667|NCT02066389|12429369|FG004|COMPLETED|Overall Study||43
11237668|NCT02066389|12429370|FG005|COMPLETED|Overall Study||45
11237669|NCT02066389|12429365|FG000|NOT COMPLETED|Overall Study||5
11237670|NCT02066389|12429366|FG001|NOT COMPLETED|Overall Study||1
11237671|NCT02066389|12429367|FG002|NOT COMPLETED|Overall Study||6
11237672|NCT02066389|12429368|FG003|NOT COMPLETED|Overall Study||3
11237673|NCT02066389|12429369|FG004|NOT COMPLETED|Overall Study||7
11237674|NCT02066389|12429370|FG005|NOT COMPLETED|Overall Study||5
11237675|NCT02066402|12429386|FG000|STARTED|Overall Study||300
11237676|NCT02066402|12429387|FG001|STARTED|Overall Study||298
11237677|NCT02066402|12429386|FG000|Participants Received Treatment|Overall Study||292
11237678|NCT02066402|12429387|FG001|Participants Received Treatment|Overall Study||297
11237679|NCT02066402|12429386|FG000|Completed Study Treatment Period|Overall Study||261
11237680|NCT02066402|12429387|FG001|Completed Study Treatment Period|Overall Study||256
11237681|NCT02066402|12429386|FG000|COMPLETED|Overall Study||274
11237682|NCT02066402|12429387|FG001|COMPLETED|Overall Study||275
11237683|NCT02066402|12429386|FG000|NOT COMPLETED|Overall Study||26
11237684|NCT02066402|12429387|FG001|NOT COMPLETED|Overall Study||23
11237685|NCT02066467|12429393|FG000|STARTED|Overall Study||863
11237686|NCT02066467|12429393|FG000|COMPLETED|Overall Study||648
11237687|NCT02066467|12429393|FG000|NOT COMPLETED|Overall Study||215
11237688|NCT02066727|12429399|FG000|STARTED|Overall Study||30
11237689|NCT02066727|12429400|FG001|STARTED|Overall Study||30
11237690|NCT02066727|12429399|FG000|COMPLETED|Overall Study||30
11237691|NCT02066727|12429400|FG001|COMPLETED|Overall Study||30
11237692|NCT02066727|12429399|FG000|NOT COMPLETED|Overall Study||0
11237693|NCT02066727|12429400|FG001|NOT COMPLETED|Overall Study||0
11237694|NCT02066740|12429406|FG000|STARTED|Overall Study||34
11237695|NCT02066740|12429406|FG000|COMPLETED|Overall Study||32
11237696|NCT02066740|12429406|FG000|NOT COMPLETED|Overall Study||2
11237697|NCT02066792|12429414|FG000|STARTED|Overall Study||40
11237698|NCT02066792|12429415|FG001|STARTED|Overall Study||38
11237699|NCT02066792|12429416|FG002|STARTED|Overall Study||38
11237700|NCT02066792|12429417|FG003|STARTED|Overall Study||36
11237701|NCT02066792|12429414|FG000|COMPLETED|Overall Study||33
11237702|NCT02066792|12429415|FG001|COMPLETED|Overall Study||33
11237703|NCT02066792|12429416|FG002|COMPLETED|Overall Study||30
11237704|NCT02066792|12429417|FG003|COMPLETED|Overall Study||27
11237705|NCT02066792|12429414|FG000|NOT COMPLETED|Overall Study||7
11237706|NCT02066792|12429415|FG001|NOT COMPLETED|Overall Study||5
11237707|NCT02066792|12429416|FG002|NOT COMPLETED|Overall Study||8
11237708|NCT02066792|12429417|FG003|NOT COMPLETED|Overall Study||9
11237709|NCT02066857|12429429|FG000|STARTED|Overall Study||1
11237710|NCT02066857|12429430|FG001|STARTED|Overall Study||4
11237711|NCT02066857|12429429|FG000|COMPLETED|Overall Study||0
11237712|NCT02066857|12429430|FG001|COMPLETED|Overall Study||3
11237713|NCT02066857|12429429|FG000|NOT COMPLETED|Overall Study||1
11237714|NCT02066857|12429430|FG001|NOT COMPLETED|Overall Study||1
11237715|NCT02066896|12429439|FG000|STARTED|Overall Study||33
11237716|NCT02066896|12429440|FG001|STARTED|Overall Study||33
11237717|NCT02066896|12429439|FG000|COMPLETED|Overall Study||33
11237718|NCT02066896|12429440|FG001|COMPLETED|Overall Study||33
11237719|NCT02066896|12429439|FG000|NOT COMPLETED|Overall Study||0
11237720|NCT02066896|12429440|FG001|NOT COMPLETED|Overall Study||0
11237721|NCT02066922|12429446|FG000|STARTED|Overall Study||15
11237722|NCT02066922|12429446|FG000|COMPLETED|Overall Study||14
11237723|NCT02066922|12429446|FG000|NOT COMPLETED|Overall Study||1
11237724|NCT02067000|12429453|FG000|STARTED|Overall Study||217
11237725|NCT02067000|12429453|FG000|COMPLETED|Overall Study||167
11237726|NCT02067000|12429453|FG000|NOT COMPLETED|Overall Study||50
11237727|NCT02067039|12429459|FG000|STARTED|Overall Study||1325
11237728|NCT02067039|12429460|FG001|STARTED|Overall Study||1340
11237729|NCT02067039|12429459|FG000|3 Month Survey|Overall Study||824
11237730|NCT02067039|12429460|FG001|3 Month Survey|Overall Study||766
11237731|NCT02067039|12429459|FG000|6 Month Survey|Overall Study||735
11237732|NCT02067039|12429460|FG001|6 Month Survey|Overall Study||756
11237733|NCT02067039|12429459|FG000|9 Month Survey|Overall Study||748
11237734|NCT02067039|12429460|FG001|9 Month Survey|Overall Study||838
11237735|NCT02067039|12429459|FG000|COMPLETED|Overall Study||752
11237736|NCT02067039|12429460|FG001|COMPLETED|Overall Study||832
11237737|NCT02067039|12429459|FG000|NOT COMPLETED|Overall Study||573
11237738|NCT02067039|12429460|FG001|NOT COMPLETED|Overall Study||508
11357222|NCT03102411|12553996|FG000|NOT COMPLETED|Overall Study||163
11357223|NCT03102437|12554003|FG000|STARTED|Overall Study||70
11357224|NCT03102437|12554004|FG001|STARTED|Overall Study||36
11357225|NCT03102437|12554003|FG000|COMPLETED|Overall Study||65
11357226|NCT03102437|12554004|FG001|COMPLETED|Overall Study||36
11357227|NCT03102437|12554003|FG000|NOT COMPLETED|Overall Study||5
11357228|NCT03102437|12554004|FG001|NOT COMPLETED|Overall Study||0
11237739|NCT02067273|12429470|FG000|STARTED|Overall Study||5
11237740|NCT02067273|12429471|FG001|STARTED|Overall Study||15
11237741|NCT02067273|12429470|FG000|COMPLETED|Overall Study||5
11237742|NCT02067273|12429471|FG001|COMPLETED|Overall Study||12
11237743|NCT02067273|12429470|FG000|NOT COMPLETED|Overall Study||0
11237744|NCT02067273|12429471|FG001|NOT COMPLETED|Overall Study||3
11237745|NCT02067468|12429480|FG000|STARTED|Overall Study||882
11237746|NCT02067468|12429481|FG001|STARTED|Overall Study||890
11237747|NCT02067468|12429482|FG002|STARTED|Overall Study||889
11237748|NCT02067468|12429480|FG000|Followed-up Through Medical Records|Overall Study||882
11237749|NCT02067468|12429481|FG001|Followed-up Through Medical Records|Overall Study||890
11237750|NCT02067468|12429482|FG002|Followed-up Through Medical Records|Overall Study||889
11237751|NCT02067468|12429480|FG000|Had at Least One Routine Colposcopy|Overall Study||772
11237752|NCT02067468|12429481|FG001|Had at Least One Routine Colposcopy|Overall Study||372
11237753|NCT02067468|12429482|FG002|Had at Least One Routine Colposcopy|Overall Study||462
11237754|NCT02067468|12429480|FG000|COMPLETED|Overall Study||882
11237755|NCT02067468|12429481|FG001|COMPLETED|Overall Study||890
11237756|NCT02067468|12429482|FG002|COMPLETED|Overall Study||889
11237757|NCT02067468|12429480|FG000|NOT COMPLETED|Overall Study||0
11237758|NCT02067468|12429481|FG001|NOT COMPLETED|Overall Study||0
11237759|NCT02067468|12429482|FG002|NOT COMPLETED|Overall Study||0
11237760|NCT02067533|12429492|FG000|STARTED|Overall Study||45
11237761|NCT02067533|12429493|FG001|STARTED|Overall Study||46
11237762|NCT02067533|12429492|FG000|COMPLETED|Overall Study||41
11237763|NCT02067533|12429493|FG001|COMPLETED|Overall Study||44
11237764|NCT02067533|12429492|FG000|NOT COMPLETED|Overall Study||4
11237765|NCT02067533|12429493|FG001|NOT COMPLETED|Overall Study||2
11237766|NCT02067585|12429502|FG000|STARTED|Overall Study||16
11237767|NCT02067585|12429503|FG001|STARTED|Overall Study||16
11237768|NCT02067585|12429504|FG002|STARTED|Overall Study||16
11237769|NCT02067585|12429502|FG000|COMPLETED|Overall Study||16
11237770|NCT02067585|12429503|FG001|COMPLETED|Overall Study||16
11237771|NCT02067585|12429504|FG002|COMPLETED|Overall Study||16
11237772|NCT02067585|12429502|FG000|NOT COMPLETED|Overall Study||0
11237773|NCT02067585|12429503|FG001|NOT COMPLETED|Overall Study||0
11237774|NCT02067585|12429504|FG002|NOT COMPLETED|Overall Study||0
11237775|NCT02067663|12429514|FG000|STARTED|Overall Study||68
11237776|NCT02067663|12429515|FG001|STARTED|Overall Study||55
11237777|NCT02067663|12429514|FG000|COMPLETED|Overall Study||55
11237778|NCT02067663|12429515|FG001|COMPLETED|Overall Study||41
11237779|NCT02067663|12429514|FG000|NOT COMPLETED|Overall Study||13
11237780|NCT02067663|12429515|FG001|NOT COMPLETED|Overall Study||14
11118407|NCT01324024|12303139|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
11118408|NCT01324102|12303151|FG000|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
11118409|NCT01324102|12303152|FG001|STARTED|Overall Study|Yoga group 4 and 6|12
11118410|NCT01324102|12303151|FG000|COMPLETED|Overall Study||10
11118411|NCT01324102|12303152|FG001|COMPLETED|Overall Study||6
11118412|NCT01324102|12303151|FG000|NOT COMPLETED|Overall Study||1
11118413|NCT01324102|12303152|FG001|NOT COMPLETED|Overall Study||6
11118414|NCT01324128|12303161|FG000|STARTED|Stage 1||710
11118415|NCT01324128|12303162|FG001|STARTED|Stage 1||349
10874958|NCT05105711|12041133|FG000|STARTED|Overall Study||21
10874959|NCT05105711|12041133|FG000|COMPLETED|Overall Study||19
10874960|NCT05105711|12041133|FG000|NOT COMPLETED|Overall Study||2
10874961|NCT04762771|12041139|FG000|STARTED|Overall Study||1
10874962|NCT04762771|12041140|FG001|STARTED|Overall Study||1
10874963|NCT04762771|12041139|FG000|COMPLETED|Overall Study||1
10874964|NCT04762771|12041140|FG001|COMPLETED|Overall Study||1
10874965|NCT04762771|12041139|FG000|NOT COMPLETED|Overall Study||0
10874966|NCT04762771|12041140|FG001|NOT COMPLETED|Overall Study||0
11118416|NCT01324128|12303163|FG002|STARTED|Stage 1||0
11118417|NCT01324128|12303164|FG003|STARTED|Stage 1||0
11118418|NCT01324128|12303161|FG000|COMPLETED|Stage 1||515
11118419|NCT01324128|12303162|FG001|COMPLETED|Stage 1||293
11118420|NCT01324128|12303163|FG002|COMPLETED|Stage 1||0
11118421|NCT01324128|12303164|FG003|COMPLETED|Stage 1||0
10874973|NCT04481035|12041161|FG000|STARTED|Period 1||3
10874974|NCT04481035|12041162|FG001|STARTED|Period 1||2
10874975|NCT04481035|12041161|FG000|COMPLETED|Period 1||3
10874976|NCT04481035|12041162|FG001|COMPLETED|Period 1||2
10874977|NCT04481035|12041161|FG000|NOT COMPLETED|Period 1||0
10874978|NCT04481035|12041162|FG001|NOT COMPLETED|Period 1||0
10874979|NCT04481035|12041161|FG000|STARTED|Period 2||3
10874980|NCT04481035|12041162|FG001|STARTED|Period 2||2
11118422|NCT01324128|12303161|FG000|NOT COMPLETED|Stage 1||195
10874981|NCT04481035|12041161|FG000|COMPLETED|Period 2||3
10874982|NCT04481035|12041162|FG001|COMPLETED|Period 2||2
10874983|NCT04481035|12041161|FG000|NOT COMPLETED|Period 2||0
10874984|NCT04481035|12041162|FG001|NOT COMPLETED|Period 2||0
10874985|NCT04480749|12041170|FG000|STARTED|Overall Study||50
10874986|NCT04480749|12041171|FG001|STARTED|Overall Study||50
10874987|NCT04480749|12041170|FG000|COMPLETED|Overall Study||50
10874988|NCT04480749|12041171|FG001|COMPLETED|Overall Study||50
10874989|NCT04480749|12041170|FG000|NOT COMPLETED|Overall Study||0
10874990|NCT04480749|12041171|FG001|NOT COMPLETED|Overall Study||0
10874991|NCT04426695|12041195|FG000|STARTED|Overall Study||21
10874992|NCT04426695|12041196|FG001|STARTED|Overall Study||19
10874993|NCT04426695|12041197|FG002|STARTED|Overall Study||20
10874994|NCT04426695|12041198|FG003|STARTED|Overall Study||208
10874995|NCT04426695|12041199|FG004|STARTED|Overall Study||211
10874996|NCT04426695|12041200|FG005|STARTED|Overall Study||210
10874997|NCT04426695|12041201|FG006|STARTED|Overall Study||251
10874998|NCT04426695|12041202|FG007|STARTED|Overall Study||252
10874999|NCT04426695|12041203|FG008|STARTED|Overall Study||252
10875000|NCT04426695|12041204|FG009|STARTED|Overall Study||201
10875001|NCT04426695|12041205|FG010|STARTED|Overall Study||205
10875002|NCT04426695|12041206|FG011|STARTED|Overall Study||203
10875003|NCT04426695|12041207|FG012|STARTED|Overall Study||52
10875004|NCT04426695|12041208|FG013|STARTED|Overall Study||58
10875005|NCT04426695|12041209|FG014|STARTED|Overall Study||54
10875006|NCT04426695|12041210|FG015|STARTED|Overall Study||12
10875007|NCT04426695|12041211|FG016|STARTED|Overall Study||12
10875008|NCT04426695|12041212|FG017|STARTED|Overall Study||11
10875009|NCT04426695|12041195|FG000|Treated|Overall Study||18
10875010|NCT04426695|12041196|FG001|Treated|Overall Study||18
10875011|NCT04426695|12041197|FG002|Treated|Overall Study||20
10875012|NCT04426695|12041198|FG003|Treated|Overall Study||204
10875013|NCT04426695|12041199|FG004|Treated|Overall Study||206
10875014|NCT04426695|12041200|FG005|Treated|Overall Study||205
10875015|NCT04426695|12041201|FG006|Treated|Overall Study||247
10875016|NCT04426695|12041202|FG007|Treated|Overall Study||246
10875017|NCT04426695|12041203|FG008|Treated|Overall Study||246
10875018|NCT04426695|12041204|FG009|Treated|Overall Study||198
10875019|NCT04426695|12041205|FG010|Treated|Overall Study||202
10875020|NCT04426695|12041206|FG011|Treated|Overall Study||197
10875021|NCT04426695|12041207|FG012|Treated|Overall Study||51
10875022|NCT04426695|12041208|FG013|Treated|Overall Study||56
10875023|NCT04426695|12041209|FG014|Treated|Overall Study||54
10875024|NCT04426695|12041210|FG015|Treated|Overall Study||12
10875025|NCT04426695|12041211|FG016|Treated|Overall Study||12
10875026|NCT04426695|12041212|FG017|Treated|Overall Study||11
10875027|NCT04426695|12041195|FG000|COMPLETED|Overall Study||13
10875028|NCT04426695|12041196|FG001|COMPLETED|Overall Study||12
10875029|NCT04426695|12041197|FG002|COMPLETED|Overall Study||16
10875030|NCT04426695|12041198|FG003|COMPLETED|Overall Study||146
10875031|NCT04426695|12041199|FG004|COMPLETED|Overall Study||153
10875032|NCT04426695|12041200|FG005|COMPLETED|Overall Study||148
10875033|NCT04426695|12041201|FG006|COMPLETED|Overall Study||186
10875034|NCT04426695|12041202|FG007|COMPLETED|Overall Study||195
10875035|NCT04426695|12041203|FG008|COMPLETED|Overall Study||189
10875036|NCT04426695|12041204|FG009|COMPLETED|Overall Study||157
10875037|NCT04426695|12041205|FG010|COMPLETED|Overall Study||165
10875038|NCT04426695|12041206|FG011|COMPLETED|Overall Study||166
10875039|NCT04426695|12041207|FG012|COMPLETED|Overall Study||33
10875040|NCT04426695|12041208|FG013|COMPLETED|Overall Study||28
10875041|NCT04426695|12041209|FG014|COMPLETED|Overall Study||31
10875042|NCT04426695|12041210|FG015|COMPLETED|Overall Study||5
10875043|NCT04426695|12041211|FG016|COMPLETED|Overall Study||4
10875044|NCT04426695|12041212|FG017|COMPLETED|Overall Study||7
10875045|NCT04426695|12041195|FG000|NOT COMPLETED|Overall Study||8
10875046|NCT04426695|12041196|FG001|NOT COMPLETED|Overall Study||7
10875047|NCT04426695|12041197|FG002|NOT COMPLETED|Overall Study||4
10875048|NCT04426695|12041198|FG003|NOT COMPLETED|Overall Study||62
10875049|NCT04426695|12041199|FG004|NOT COMPLETED|Overall Study||58
10875050|NCT04426695|12041200|FG005|NOT COMPLETED|Overall Study||62
10875051|NCT04426695|12041201|FG006|NOT COMPLETED|Overall Study||65
10875052|NCT04426695|12041202|FG007|NOT COMPLETED|Overall Study||57
10875053|NCT04426695|12041203|FG008|NOT COMPLETED|Overall Study||63
10875054|NCT04426695|12041204|FG009|NOT COMPLETED|Overall Study||44
10875055|NCT04426695|12041205|FG010|NOT COMPLETED|Overall Study||40
10875056|NCT04426695|12041206|FG011|NOT COMPLETED|Overall Study||37
10875057|NCT04426695|12041207|FG012|NOT COMPLETED|Overall Study||19
10875058|NCT04426695|12041208|FG013|NOT COMPLETED|Overall Study||30
10875059|NCT04426695|12041209|FG014|NOT COMPLETED|Overall Study||23
10875060|NCT04426695|12041210|FG015|NOT COMPLETED|Overall Study||7
10875061|NCT04426695|12041211|FG016|NOT COMPLETED|Overall Study||8
10875062|NCT04426695|12041212|FG017|NOT COMPLETED|Overall Study||4
10875063|NCT04209400|12041289|FG000|STARTED|Overall Study||50
10875064|NCT04209400|12041290|FG001|STARTED|Overall Study||50
10875065|NCT04209400|12041289|FG000|COMPLETED|Overall Study||50
10875066|NCT04209400|12041290|FG001|COMPLETED|Overall Study||49
10875067|NCT04209400|12041289|FG000|NOT COMPLETED|Overall Study||0
10875068|NCT04209400|12041290|FG001|NOT COMPLETED|Overall Study||1
10875069|NCT04153435|12041298|FG000|STARTED|Overall Study||197
10875070|NCT04153435|12041299|FG001|STARTED|Overall Study||200
10875071|NCT04153435|12041298|FG000|COMPLETED|Overall Study||197
10875072|NCT04153435|12041299|FG001|COMPLETED|Overall Study||200
10875073|NCT04153435|12041298|FG000|NOT COMPLETED|Overall Study||0
10875074|NCT04153435|12041299|FG001|NOT COMPLETED|Overall Study||0
11118423|NCT01324128|12303162|FG001|NOT COMPLETED|Stage 1||56
11118424|NCT01324128|12303163|FG002|NOT COMPLETED|Stage 1||0
11118425|NCT01324128|12303164|FG003|NOT COMPLETED|Stage 1||0
11118426|NCT01324128|12303161|FG000|STARTED|Stage 2||0
11118427|NCT01324128|12303162|FG001|STARTED|Stage 2||0
11118428|NCT01324128|12303163|FG002|STARTED|Stage 2||50
11118429|NCT01324128|12303164|FG003|STARTED|Stage 2||49
11118430|NCT01324128|12303161|FG000|COMPLETED|Stage 2||0
11118431|NCT01324128|12303162|FG001|COMPLETED|Stage 2||0
11118432|NCT01324128|12303163|FG002|COMPLETED|Stage 2||42
11118433|NCT01324128|12303164|FG003|COMPLETED|Stage 2||46
11118434|NCT01324128|12303161|FG000|NOT COMPLETED|Stage 2||0
11118435|NCT01324128|12303162|FG001|NOT COMPLETED|Stage 2||0
11118436|NCT01324128|12303163|FG002|NOT COMPLETED|Stage 2||8
11118437|NCT01324128|12303164|FG003|NOT COMPLETED|Stage 2||3
11118438|NCT01324141|12303174|FG000|STARTED|Overall Study||6
11118439|NCT01324141|12303174|FG000|COMPLETED|Overall Study||4
11118440|NCT01324141|12303174|FG000|NOT COMPLETED|Overall Study||2
11118441|NCT01324232|12303192|FG000|STARTED|Overall Study||49
11118442|NCT01324232|12303193|FG001|STARTED|Overall Study||53
11118443|NCT01324232|12303194|FG002|STARTED|Overall Study||54
11118444|NCT01324232|12303195|FG003|STARTED|Overall Study||53
11118445|NCT01324232|12303192|FG000|COMPLETED|Overall Study||44
11118446|NCT01324232|12303193|FG001|COMPLETED|Overall Study||42
11118447|NCT01324232|12303194|FG002|COMPLETED|Overall Study||41
11118448|NCT01324232|12303195|FG003|COMPLETED|Overall Study||42
11118449|NCT01324232|12303192|FG000|NOT COMPLETED|Overall Study||5
11118450|NCT01324232|12303193|FG001|NOT COMPLETED|Overall Study||11
11118451|NCT01324232|12303194|FG002|NOT COMPLETED|Overall Study||13
11118452|NCT01324232|12303195|FG003|NOT COMPLETED|Overall Study||11
11118453|NCT01324271|12303210|FG000|STARTED|Overall Study||57
11118454|NCT01324271|12303211|FG001|STARTED|Overall Study||28
11118455|NCT01324271|12303210|FG000|COMPLETED|Overall Study||53
11118456|NCT01324271|12303211|FG001|COMPLETED|Overall Study||28
11118457|NCT01324271|12303210|FG000|NOT COMPLETED|Overall Study||4
11118458|NCT01324271|12303211|FG001|NOT COMPLETED|Overall Study||0
11118459|NCT01324310|12303217|FG000|STARTED|Overall Study||15
11118460|NCT01324310|12303217|FG000|COMPLETED|Overall Study||13
11118461|NCT01324310|12303217|FG000|NOT COMPLETED|Overall Study||2
11118462|NCT01324323|12303223|FG000|STARTED|Overall Study||14
11118463|NCT01324323|12303223|FG000|COMPLETED|Overall Study||13
11118464|NCT01324323|12303223|FG000|NOT COMPLETED|Overall Study||1
11118465|NCT01324349|12303237|FG000|STARTED|Overall Study||32
11118466|NCT01324349|12303238|FG001|STARTED|Overall Study||18
11118467|NCT01324349|12303237|FG000|COMPLETED|Overall Study||31
11118468|NCT01324349|12303238|FG001|COMPLETED|Overall Study||16
11118469|NCT01324349|12303237|FG000|NOT COMPLETED|Overall Study||1
11118470|NCT01324349|12303238|FG001|NOT COMPLETED|Overall Study||2
11118471|NCT01324388|12303247|FG000|STARTED|Part 1 of Study||23
11118472|NCT01324388|12303248|FG001|STARTED|Part 1 of Study||8
11118473|NCT01324388|12303249|FG002|STARTED|Part 1 of Study||0
11118474|NCT01324388|12303250|FG003|STARTED|Part 1 of Study||0
11118475|NCT01324388|12303247|FG000|Received at Least 1 Dose|Part 1 of Study||23
11118476|NCT01324388|12303248|FG001|Received at Least 1 Dose|Part 1 of Study||8
11118477|NCT01324388|12303249|FG002|Received at Least 1 Dose|Part 1 of Study||0
11118478|NCT01324388|12303250|FG003|Received at Least 1 Dose|Part 1 of Study||0
11118479|NCT01324388|12303247|FG000|COMPLETED|Part 1 of Study||19
11118480|NCT01324388|12303248|FG001|COMPLETED|Part 1 of Study||6
11118481|NCT01324388|12303249|FG002|COMPLETED|Part 1 of Study||0
11118482|NCT01324388|12303250|FG003|COMPLETED|Part 1 of Study||0
10875135|NCT04067492|12041348|FG000|STARTED|Overall Study||15
10875136|NCT04067492|12041349|FG001|STARTED|Overall Study||6
10875137|NCT04067492|12041350|FG002|STARTED|Overall Study||6
10875138|NCT04067492|12041351|FG003|STARTED|Overall Study||6
10875139|NCT04067492|12041352|FG004|STARTED|Overall Study||5
10875140|NCT04067492|12041353|FG005|STARTED|Overall Study||9
10875141|NCT04067492|12041348|FG000|COMPLETED|Overall Study||15
10875142|NCT04067492|12041349|FG001|COMPLETED|Overall Study||5
10875143|NCT04067492|12041350|FG002|COMPLETED|Overall Study||6
10875144|NCT04067492|12041351|FG003|COMPLETED|Overall Study||5
10875145|NCT04067492|12041352|FG004|COMPLETED|Overall Study||5
10875146|NCT04067492|12041353|FG005|COMPLETED|Overall Study||8
10875147|NCT04067492|12041348|FG000|NOT COMPLETED|Overall Study||0
10875148|NCT04067492|12041349|FG001|NOT COMPLETED|Overall Study||1
10875149|NCT04067492|12041350|FG002|NOT COMPLETED|Overall Study||0
10875150|NCT04067492|12041351|FG003|NOT COMPLETED|Overall Study||1
10875151|NCT04067492|12041352|FG004|NOT COMPLETED|Overall Study||0
10875152|NCT04067492|12041353|FG005|NOT COMPLETED|Overall Study||1
11118483|NCT01324388|12303247|FG000|NOT COMPLETED|Part 1 of Study||4
11118484|NCT01324388|12303248|FG001|NOT COMPLETED|Part 1 of Study||2
11118485|NCT01324388|12303249|FG002|NOT COMPLETED|Part 1 of Study||0
11118486|NCT01324388|12303250|FG003|NOT COMPLETED|Part 1 of Study||0
11118487|NCT01324388|12303247|FG000|STARTED|Part 2 of Study: First Intervention||0
11118488|NCT01324388|12303248|FG001|STARTED|Part 2 of Study: First Intervention||0
11118489|NCT01324388|12303249|FG002|STARTED|Part 2 of Study: First Intervention||10
11118490|NCT01324388|12303250|FG003|STARTED|Part 2 of Study: First Intervention||10
11118491|NCT01324388|12303247|FG000|COMPLETED|Part 2 of Study: First Intervention||0
11118492|NCT01324388|12303248|FG001|COMPLETED|Part 2 of Study: First Intervention||0
11118493|NCT01324388|12303249|FG002|COMPLETED|Part 2 of Study: First Intervention||10
11118494|NCT01324388|12303250|FG003|COMPLETED|Part 2 of Study: First Intervention||9
11118495|NCT01324388|12303247|FG000|NOT COMPLETED|Part 2 of Study: First Intervention||0
11118496|NCT01324388|12303248|FG001|NOT COMPLETED|Part 2 of Study: First Intervention||0
11118497|NCT01324388|12303249|FG002|NOT COMPLETED|Part 2 of Study: First Intervention||0
11118498|NCT01324388|12303250|FG003|NOT COMPLETED|Part 2 of Study: First Intervention||1
11118499|NCT01324388|12303247|FG000|STARTED|Part 2: Washout of at Least 21 Days||0
11118500|NCT01324388|12303248|FG001|STARTED|Part 2: Washout of at Least 21 Days||0
11118501|NCT01324388|12303249|FG002|STARTED|Part 2: Washout of at Least 21 Days||10
11118502|NCT01324388|12303250|FG003|STARTED|Part 2: Washout of at Least 21 Days||9
11118503|NCT01324388|12303247|FG000|COMPLETED|Part 2: Washout of at Least 21 Days||0
11118504|NCT01324388|12303248|FG001|COMPLETED|Part 2: Washout of at Least 21 Days||0
11118505|NCT01324388|12303249|FG002|COMPLETED|Part 2: Washout of at Least 21 Days||10
11118506|NCT01324388|12303250|FG003|COMPLETED|Part 2: Washout of at Least 21 Days||9
11118507|NCT01324388|12303247|FG000|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
10875165|NCT03788967|12041379|FG000|STARTED|Overall Study||685
10875166|NCT03788967|12041380|FG001|STARTED|Overall Study||687
10875167|NCT03788967|12041379|FG000|Micro-Intent-to-Treat (ITT) Population|Overall Study||449
10875168|NCT03788967|12041380|FG001|Micro-Intent-to-Treat (ITT) Population|Overall Study||419
10875169|NCT03788967|12041379|FG000|COMPLETED|Overall Study||653
10875170|NCT03788967|12041380|FG001|COMPLETED|Overall Study||663
10875171|NCT03788967|12041379|FG000|NOT COMPLETED|Overall Study||32
10875172|NCT03788967|12041380|FG001|NOT COMPLETED|Overall Study||24
10875173|NCT03721172|12041390|FG000|STARTED|Placebo-controlled Phase||298
10875174|NCT03721172|12041391|FG001|STARTED|Placebo-controlled Phase||297
10875175|NCT03721172|12041392|FG002|STARTED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
10875176|NCT03721172|12041390|FG000|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
10875177|NCT03721172|12041391|FG001|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
10875178|NCT03721172|12041392|FG002|Received at Least 1 Dose of Treatment|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
10875179|NCT03721172|12041390|FG000|COMPLETED|Placebo-controlled Phase||246
10875180|NCT03721172|12041391|FG001|COMPLETED|Placebo-controlled Phase||258
10875181|NCT03721172|12041392|FG002|COMPLETED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
10875182|NCT03721172|12041390|FG000|NOT COMPLETED|Placebo-controlled Phase||52
10875183|NCT03721172|12041391|FG001|NOT COMPLETED|Placebo-controlled Phase||39
10875184|NCT03721172|12041392|FG002|NOT COMPLETED|Placebo-controlled Phase||0
10875185|NCT03721172|12041390|FG000|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10875186|NCT03721172|12041391|FG001|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10875187|NCT03721172|12041392|FG002|STARTED|Apremilast Extension Phase|1 participant did not enter the extension phase due to physician decision.|503
10875188|NCT03721172|12041390|FG000|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10875189|NCT03721172|12041391|FG001|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10875190|NCT03721172|12041392|FG002|Received at Least 1 Dose|Apremilast Extension Phase||503
10875191|NCT03721172|12041390|FG000|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10875192|NCT03721172|12041391|FG001|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
10875193|NCT03721172|12041392|FG002|COMPLETED|Apremilast Extension Phase||437
10875194|NCT03721172|12041390|FG000|NOT COMPLETED|Apremilast Extension Phase||0
10875195|NCT03721172|12041391|FG001|NOT COMPLETED|Apremilast Extension Phase||0
10875196|NCT03721172|12041392|FG002|NOT COMPLETED|Apremilast Extension Phase||66
10875197|NCT03692052|12041400|FG000|STARTED|Core Period (Day 1 to Week 24)||20
10875198|NCT03692052|12041400|FG000|COMPLETED|Core Period (Day 1 to Week 24)||19
10875199|NCT03692052|12041400|FG000|NOT COMPLETED|Core Period (Day 1 to Week 24)||1
10875200|NCT03692052|12041400|FG000|STARTED|Extension Period (Week 25 to 10 Years)||19
10875201|NCT03692052|12041400|FG000|COMPLETED|Extension Period (Week 25 to 10 Years)||0
10875202|NCT03692052|12041400|FG000|NOT COMPLETED|Extension Period (Week 25 to 10 Years)||19
10875203|NCT03596918|12041404|FG000|STARTED|Overall Study||10
10875204|NCT03596918|12041404|FG000|COMPLETED|Overall Study||10
10875205|NCT03596918|12041404|FG000|NOT COMPLETED|Overall Study||0
11118508|NCT01324388|12303248|FG001|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
11118509|NCT01324388|12303249|FG002|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
11118510|NCT01324388|12303250|FG003|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
10875209|NCT03529669|12041412|FG000|STARTED|Overall Study||41
10875210|NCT03529669|12041412|FG000|COMPLETED|Overall Study||41
10875211|NCT03529669|12041412|FG000|NOT COMPLETED|Overall Study||0
11118511|NCT01324388|12303247|FG000|STARTED|Part 2 of Study: Second Intervention||0
11118512|NCT01324388|12303248|FG001|STARTED|Part 2 of Study: Second Intervention||0
11118513|NCT01324388|12303249|FG002|STARTED|Part 2 of Study: Second Intervention||10
11118514|NCT01324388|12303250|FG003|STARTED|Part 2 of Study: Second Intervention||9
11118515|NCT01324388|12303247|FG000|COMPLETED|Part 2 of Study: Second Intervention||0
11118516|NCT01324388|12303248|FG001|COMPLETED|Part 2 of Study: Second Intervention||0
11118517|NCT01324388|12303249|FG002|COMPLETED|Part 2 of Study: Second Intervention||9
11118518|NCT01324388|12303250|FG003|COMPLETED|Part 2 of Study: Second Intervention||9
10875224|NCT03410992|12041431|FG000|STARTED|Initial Treatment Period: up to Wk16||86
10875225|NCT03410992|12041432|FG001|STARTED|Initial Treatment Period: up to Wk16||349
10875226|NCT03410992|12041433|FG002|STARTED|Initial Treatment Period: up to Wk16||0
10875227|NCT03410992|12041434|FG003|STARTED|Initial Treatment Period: up to Wk16||0
10875228|NCT03410992|12041435|FG004|STARTED|Initial Treatment Period: up to Wk16||0
10875229|NCT03410992|12041436|FG005|STARTED|Initial Treatment Period: up to Wk16||0
10875230|NCT03410992|12041437|FG006|STARTED|Initial Treatment Period: up to Wk16||0
10875231|NCT03410992|12041438|FG007|STARTED|Initial Treatment Period: up to Wk16||0
10875232|NCT03410992|12041439|FG008|STARTED|Initial Treatment Period: up to Wk16||0
10875233|NCT03410992|12041440|FG009|STARTED|Initial Treatment Period: up to Wk16||0
10875234|NCT03410992|12041441|FG010|STARTED|Initial Treatment Period: up to Wk16||0
10875235|NCT03410992|12041431|FG000|COMPLETED|Initial Treatment Period: up to Wk16||82
10875236|NCT03410992|12041432|FG001|COMPLETED|Initial Treatment Period: up to Wk16||340
10875237|NCT03410992|12041433|FG002|COMPLETED|Initial Treatment Period: up to Wk16||0
10875238|NCT03410992|12041434|FG003|COMPLETED|Initial Treatment Period: up to Wk16||0
10875239|NCT03410992|12041435|FG004|COMPLETED|Initial Treatment Period: up to Wk16||0
10875240|NCT03410992|12041436|FG005|COMPLETED|Initial Treatment Period: up to Wk16||0
10875241|NCT03410992|12041437|FG006|COMPLETED|Initial Treatment Period: up to Wk16||0
10875242|NCT03410992|12041438|FG007|COMPLETED|Initial Treatment Period: up to Wk16||0
10875243|NCT03410992|12041439|FG008|COMPLETED|Initial Treatment Period: up to Wk16||0
10875244|NCT03410992|12041440|FG009|COMPLETED|Initial Treatment Period: up to Wk16||0
10875245|NCT03410992|12041441|FG010|COMPLETED|Initial Treatment Period: up to Wk16||0
10875246|NCT03410992|12041431|FG000|NOT COMPLETED|Initial Treatment Period: up to Wk16||4
10875247|NCT03410992|12041432|FG001|NOT COMPLETED|Initial Treatment Period: up to Wk16||9
10875248|NCT03410992|12041433|FG002|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875249|NCT03410992|12041434|FG003|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875250|NCT03410992|12041435|FG004|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875251|NCT03410992|12041436|FG005|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875252|NCT03410992|12041437|FG006|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875253|NCT03410992|12041438|FG007|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875254|NCT03410992|12041439|FG008|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875255|NCT03410992|12041440|FG009|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875256|NCT03410992|12041441|FG010|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
10875257|NCT03410992|12041431|FG000|STARTED|Week 16 Assessment||82
10875258|NCT03410992|12041432|FG001|STARTED|Week 16 Assessment||340
10875259|NCT03410992|12041433|FG002|STARTED|Week 16 Assessment||0
10875260|NCT03410992|12041434|FG003|STARTED|Week 16 Assessment||0
10875261|NCT03410992|12041435|FG004|STARTED|Week 16 Assessment||0
10875262|NCT03410992|12041436|FG005|STARTED|Week 16 Assessment||0
10875263|NCT03410992|12041437|FG006|STARTED|Week 16 Assessment||0
10875264|NCT03410992|12041438|FG007|STARTED|Week 16 Assessment||0
10875265|NCT03410992|12041439|FG008|STARTED|Week 16 Assessment||0
10875266|NCT03410992|12041440|FG009|STARTED|Week 16 Assessment||0
10875267|NCT03410992|12041441|FG010|STARTED|Week 16 Assessment||0
10875268|NCT03410992|12041431|FG000|Received Escape Treatment|Week 16 Assessment||81
10875269|NCT03410992|12041432|FG001|Received Escape Treatment|Week 16 Assessment||23
10875270|NCT03410992|12041433|FG002|Received Escape Treatment|Week 16 Assessment||0
10875271|NCT03410992|12041434|FG003|Received Escape Treatment|Week 16 Assessment||0
10875272|NCT03410992|12041435|FG004|Received Escape Treatment|Week 16 Assessment||0
10875273|NCT03410992|12041436|FG005|Received Escape Treatment|Week 16 Assessment||0
10875274|NCT03410992|12041437|FG006|Received Escape Treatment|Week 16 Assessment||0
10875275|NCT03410992|12041438|FG007|Received Escape Treatment|Week 16 Assessment||0
10875276|NCT03410992|12041439|FG008|Received Escape Treatment|Week 16 Assessment||0
10875277|NCT03410992|12041440|FG009|Received Escape Treatment|Week 16 Assessment||0
10875278|NCT03410992|12041441|FG010|Received Escape Treatment|Week 16 Assessment||0
10875279|NCT03410992|12041431|FG000|COMPLETED|Week 16 Assessment||1
10875280|NCT03410992|12041432|FG001|COMPLETED|Week 16 Assessment||311
10875281|NCT03410992|12041433|FG002|COMPLETED|Week 16 Assessment||0
10875282|NCT03410992|12041434|FG003|COMPLETED|Week 16 Assessment||0
10875283|NCT03410992|12041435|FG004|COMPLETED|Week 16 Assessment||0
10875284|NCT03410992|12041436|FG005|COMPLETED|Week 16 Assessment||0
10875285|NCT03410992|12041437|FG006|COMPLETED|Week 16 Assessment||0
10875286|NCT03410992|12041438|FG007|COMPLETED|Week 16 Assessment||0
10875287|NCT03410992|12041439|FG008|COMPLETED|Week 16 Assessment||0
10875288|NCT03410992|12041440|FG009|COMPLETED|Week 16 Assessment||0
10875289|NCT03410992|12041441|FG010|COMPLETED|Week 16 Assessment||0
10875290|NCT03410992|12041431|FG000|NOT COMPLETED|Week 16 Assessment||81
10875291|NCT03410992|12041432|FG001|NOT COMPLETED|Week 16 Assessment||29
10875292|NCT03410992|12041433|FG002|NOT COMPLETED|Week 16 Assessment||0
10875293|NCT03410992|12041434|FG003|NOT COMPLETED|Week 16 Assessment||0
10875294|NCT03410992|12041435|FG004|NOT COMPLETED|Week 16 Assessment||0
10875295|NCT03410992|12041436|FG005|NOT COMPLETED|Week 16 Assessment||0
10875296|NCT03410992|12041437|FG006|NOT COMPLETED|Week 16 Assessment||0
10875297|NCT03410992|12041438|FG007|NOT COMPLETED|Week 16 Assessment||0
10875298|NCT03410992|12041439|FG008|NOT COMPLETED|Week 16 Assessment||0
10875299|NCT03410992|12041440|FG009|NOT COMPLETED|Week 16 Assessment||0
10875300|NCT03410992|12041441|FG010|NOT COMPLETED|Week 16 Assessment||0
10875301|NCT03410992|12041431|FG000|STARTED|Randomized-Withdrawal Period: up to Wk56||0
10875302|NCT03410992|12041432|FG001|STARTED|Randomized-Withdrawal Period: up to Wk56||0
10875303|NCT03410992|12041433|FG002|STARTED|Randomized-Withdrawal Period: up to Wk56||1
10875304|NCT03410992|12041434|FG003|STARTED|Randomized-Withdrawal Period: up to Wk56||105
10875305|NCT03410992|12041435|FG004|STARTED|Randomized-Withdrawal Period: up to Wk56||100
10875306|NCT03410992|12041436|FG005|STARTED|Randomized-Withdrawal Period: up to Wk56||106
10875307|NCT03410992|12041437|FG006|STARTED|Randomized-Withdrawal Period: up to Wk56||0
10875308|NCT03410992|12041438|FG007|STARTED|Randomized-Withdrawal Period: up to Wk56||0
10875309|NCT03410992|12041439|FG008|STARTED|Randomized-Withdrawal Period: up to Wk56||0
10875310|NCT03410992|12041440|FG009|STARTED|Randomized-Withdrawal Period: up to Wk56||0
10875311|NCT03410992|12041441|FG010|STARTED|Randomized-Withdrawal Period: up to Wk56||0
10875312|NCT03410992|12041431|FG000|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875313|NCT03410992|12041432|FG001|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875314|NCT03410992|12041433|FG002|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875315|NCT03410992|12041434|FG003|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||67
10875316|NCT03410992|12041435|FG004|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||4
10875317|NCT03410992|12041436|FG005|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||7
10875318|NCT03410992|12041437|FG006|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875319|NCT03410992|12041438|FG007|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875320|NCT03410992|12041439|FG008|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875321|NCT03410992|12041440|FG009|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875322|NCT03410992|12041441|FG010|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
10875323|NCT03410992|12041431|FG000|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875324|NCT03410992|12041432|FG001|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875325|NCT03410992|12041433|FG002|COMPLETED|Randomized-Withdrawal Period: up to Wk56||1
10875326|NCT03410992|12041434|FG003|COMPLETED|Randomized-Withdrawal Period: up to Wk56||33
10875327|NCT03410992|12041435|FG004|COMPLETED|Randomized-Withdrawal Period: up to Wk56||93
10875328|NCT03410992|12041436|FG005|COMPLETED|Randomized-Withdrawal Period: up to Wk56||94
10875329|NCT03410992|12041437|FG006|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875330|NCT03410992|12041438|FG007|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875331|NCT03410992|12041439|FG008|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875332|NCT03410992|12041440|FG009|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875333|NCT03410992|12041441|FG010|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875334|NCT03410992|12041431|FG000|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875335|NCT03410992|12041432|FG001|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875336|NCT03410992|12041433|FG002|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875337|NCT03410992|12041434|FG003|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||72
10875338|NCT03410992|12041435|FG004|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||7
10875339|NCT03410992|12041436|FG005|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||12
10875340|NCT03410992|12041437|FG006|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875341|NCT03410992|12041438|FG007|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875342|NCT03410992|12041439|FG008|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875343|NCT03410992|12041440|FG009|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875344|NCT03410992|12041441|FG010|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
10875345|NCT03410992|12041431|FG000|STARTED|Escape Treatment: 12 Weeks||0
10875346|NCT03410992|12041432|FG001|STARTED|Escape Treatment: 12 Weeks||0
10875347|NCT03410992|12041433|FG002|STARTED|Escape Treatment: 12 Weeks||0
10875348|NCT03410992|12041434|FG003|STARTED|Escape Treatment: 12 Weeks||0
10875349|NCT03410992|12041435|FG004|STARTED|Escape Treatment: 12 Weeks||0
10875350|NCT03410992|12041436|FG005|STARTED|Escape Treatment: 12 Weeks||0
10875351|NCT03410992|12041437|FG006|STARTED|Escape Treatment: 12 Weeks||81
10875352|NCT03410992|12041438|FG007|STARTED|Escape Treatment: 12 Weeks||23
10875353|NCT03410992|12041439|FG008|STARTED|Escape Treatment: 12 Weeks||67
10875354|NCT03410992|12041440|FG009|STARTED|Escape Treatment: 12 Weeks||4
10875355|NCT03410992|12041441|FG010|STARTED|Escape Treatment: 12 Weeks||7
10875356|NCT03410992|12041431|FG000|COMPLETED|Escape Treatment: 12 Weeks||0
10875357|NCT03410992|12041432|FG001|COMPLETED|Escape Treatment: 12 Weeks||0
10875358|NCT03410992|12041433|FG002|COMPLETED|Escape Treatment: 12 Weeks||0
10875359|NCT03410992|12041434|FG003|COMPLETED|Escape Treatment: 12 Weeks||0
10875360|NCT03410992|12041435|FG004|COMPLETED|Escape Treatment: 12 Weeks||0
10875361|NCT03410992|12041436|FG005|COMPLETED|Escape Treatment: 12 Weeks||0
10875362|NCT03410992|12041437|FG006|COMPLETED|Escape Treatment: 12 Weeks||81
10875363|NCT03410992|12041438|FG007|COMPLETED|Escape Treatment: 12 Weeks||22
10875364|NCT03410992|12041439|FG008|COMPLETED|Escape Treatment: 12 Weeks||66
10875365|NCT03410992|12041440|FG009|COMPLETED|Escape Treatment: 12 Weeks||4
10875366|NCT03410992|12041441|FG010|COMPLETED|Escape Treatment: 12 Weeks||7
10875367|NCT03410992|12041431|FG000|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875368|NCT03410992|12041432|FG001|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875369|NCT03410992|12041433|FG002|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875370|NCT03410992|12041434|FG003|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875371|NCT03410992|12041435|FG004|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875372|NCT03410992|12041436|FG005|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875373|NCT03410992|12041437|FG006|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875374|NCT03410992|12041438|FG007|NOT COMPLETED|Escape Treatment: 12 Weeks||1
10875375|NCT03410992|12041439|FG008|NOT COMPLETED|Escape Treatment: 12 Weeks||1
10875376|NCT03410992|12041440|FG009|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875377|NCT03410992|12041441|FG010|NOT COMPLETED|Escape Treatment: 12 Weeks||0
10875378|NCT03370133|12041474|FG000|STARTED|Initial Treatment Period (WK 16)||83
10875379|NCT03370133|12041475|FG001|STARTED|Initial Treatment Period (WK 16)||321
10875380|NCT03370133|12041476|FG002|STARTED|Initial Treatment Period (WK 16)||163
10875381|NCT03370133|12041477|FG003|STARTED|Initial Treatment Period (WK 16)||0
10875382|NCT03370133|12041478|FG004|STARTED|Initial Treatment Period (WK 16)||0
10875383|NCT03370133|12041479|FG005|STARTED|Initial Treatment Period (WK 16)||0
10875384|NCT03370133|12041474|FG000|COMPLETED|Initial Treatment Period (WK 16)||74
10875385|NCT03370133|12041475|FG001|COMPLETED|Initial Treatment Period (WK 16)||306
10875386|NCT03370133|12041476|FG002|COMPLETED|Initial Treatment Period (WK 16)||157
10875387|NCT03370133|12041477|FG003|COMPLETED|Initial Treatment Period (WK 16)||0
10875388|NCT03370133|12041478|FG004|COMPLETED|Initial Treatment Period (WK 16)||0
10875389|NCT03370133|12041479|FG005|COMPLETED|Initial Treatment Period (WK 16)||0
10875390|NCT03370133|12041474|FG000|NOT COMPLETED|Initial Treatment Period (WK 16)||9
10875391|NCT03370133|12041475|FG001|NOT COMPLETED|Initial Treatment Period (WK 16)||15
10875392|NCT03370133|12041476|FG002|NOT COMPLETED|Initial Treatment Period (WK 16)||6
10875393|NCT03370133|12041477|FG003|NOT COMPLETED|Initial Treatment Period (WK 16)||0
10875394|NCT03370133|12041478|FG004|NOT COMPLETED|Initial Treatment Period (WK 16)||0
10875395|NCT03370133|12041479|FG005|NOT COMPLETED|Initial Treatment Period (WK 16)||0
10875396|NCT03370133|12041474|FG000|STARTED|Maintenance Treatment Period (WK 52)||0
10875397|NCT03370133|12041475|FG001|STARTED|Maintenance Treatment Period (WK 52)||0
10875398|NCT03370133|12041476|FG002|STARTED|Maintenance Treatment Period (WK 52)||0
10875399|NCT03370133|12041477|FG003|STARTED|Maintenance Treatment Period (WK 52)||74
10875400|NCT03370133|12041478|FG004|STARTED|Maintenance Treatment Period (WK 52)||306
10875401|NCT03370133|12041479|FG005|STARTED|Maintenance Treatment Period (WK 52)||157
10875402|NCT03370133|12041474|FG000|COMPLETED|Maintenance Treatment Period (WK 52)||0
10875403|NCT03370133|12041475|FG001|COMPLETED|Maintenance Treatment Period (WK 52)||0
10875404|NCT03370133|12041476|FG002|COMPLETED|Maintenance Treatment Period (WK 52)||0
10875405|NCT03370133|12041477|FG003|COMPLETED|Maintenance Treatment Period (WK 52)||69
10875406|NCT03370133|12041478|FG004|COMPLETED|Maintenance Treatment Period (WK 52)||283
10875407|NCT03370133|12041479|FG005|COMPLETED|Maintenance Treatment Period (WK 52)||141
10875408|NCT03370133|12041474|FG000|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
10875409|NCT03370133|12041475|FG001|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
10875410|NCT03370133|12041476|FG002|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
10875411|NCT03370133|12041477|FG003|NOT COMPLETED|Maintenance Treatment Period (WK 52)||5
10875412|NCT03370133|12041478|FG004|NOT COMPLETED|Maintenance Treatment Period (WK 52)||23
10875413|NCT03370133|12041479|FG005|NOT COMPLETED|Maintenance Treatment Period (WK 52)||16
11118519|NCT01324388|12303247|FG000|NOT COMPLETED|Part 2 of Study: Second Intervention||0
11118520|NCT01324388|12303248|FG001|NOT COMPLETED|Part 2 of Study: Second Intervention||0
11118521|NCT01324388|12303249|FG002|NOT COMPLETED|Part 2 of Study: Second Intervention||1
11118522|NCT01324388|12303250|FG003|NOT COMPLETED|Part 2 of Study: Second Intervention||0
11118523|NCT01324401|12303264|FG000|STARTED|Overall Study||4
11118524|NCT01324401|12303265|FG001|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
10875420|NCT03291587|12041508|FG000|STARTED|Overall Study|5 were found ineligible after baseline|523
10875421|NCT03291587|12041509|FG001|STARTED|Overall Study|1 was found ineligible after baseline|571
10875422|NCT03291587|12041508|FG000|14 Day Follow-up|Overall Study|32 could not be reached, 1 not interested, 4 too busy to participate, 1 site withdrew, 1 previously consented and removed from study, 1 personal health reasons|483
10875423|NCT03291587|12041509|FG001|14 Day Follow-up|Overall Study|22 could not be reached, 1 too busy to participate, 1 not interested in participating.|547
10875424|NCT03291587|12041508|FG000|3 Month Follow-up|Overall Study|63 could not be reached, 2 refused to answer, 2 expired, 4 not interested in participating, 1 personal health reasons|445
10875425|NCT03291587|12041509|FG001|3 Month Follow-up|Overall Study|26 could not be reached, 2 expired, and 3 not interested in participating|538
10875426|NCT03291587|12041508|FG000|COMPLETED|Overall Study|62 could not be reached, 3 refused to answer, 2 not interested in participating, 1 personal health reason|442
10875427|NCT03291587|12041509|FG001|COMPLETED|Overall Study|43 could not be reached,2 refused to answer, 2 expired, and 2 not interested in participating|514
10875428|NCT03291587|12041508|FG000|NOT COMPLETED|Overall Study||81
10875429|NCT03291587|12041509|FG001|NOT COMPLETED|Overall Study||57
10875430|NCT03283982|12041518|FG000|STARTED|Overall Study||39
10875431|NCT03283982|12041519|FG001|STARTED|Overall Study||36
10875432|NCT03283982|12041518|FG000|COMPLETED|Overall Study||39
10875433|NCT03283982|12041519|FG001|COMPLETED|Overall Study||36
10875434|NCT03283982|12041518|FG000|NOT COMPLETED|Overall Study||0
10875435|NCT03283982|12041519|FG001|NOT COMPLETED|Overall Study||0
11118525|NCT01324401|12303264|FG000|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
11118526|NCT01324401|12303265|FG001|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
11118527|NCT01324401|12303264|FG000|NOT COMPLETED|Overall Study||1
11118528|NCT01324401|12303265|FG001|NOT COMPLETED|Overall Study||6
11118529|NCT01324440|12303273|FG000|STARTED|Overall Study||32
11118530|NCT01324440|12303274|FG001|STARTED|Overall Study||32
11118531|NCT01324440|12303273|FG000|COMPLETED|Overall Study||32
11118532|NCT01324440|12303274|FG001|COMPLETED|Overall Study||31
11118533|NCT01324440|12303273|FG000|NOT COMPLETED|Overall Study||0
10875448|NCT02948829|12041543|FG000|STARTED|Overall Study||200
10875449|NCT02948829|12041543|FG000|COMPLETED|Overall Study||184
10875450|NCT02948829|12041543|FG000|NOT COMPLETED|Overall Study||16
10875451|NCT02866643|12041564|FG000|STARTED|Overall Study||48
10875452|NCT02866643|12041565|FG001|STARTED|Overall Study||47
10875453|NCT02866643|12041564|FG000|Intent-to-Treat (ITT) Population|Overall Study||38
10875454|NCT02866643|12041565|FG001|Intent-to-Treat (ITT) Population|Overall Study||39
10875455|NCT02866643|12041564|FG000|Per Protocol Population|Overall Study||35
10875456|NCT02866643|12041565|FG001|Per Protocol Population|Overall Study||35
10875457|NCT02866643|12041564|FG000|COMPLETED|Overall Study||35
10875458|NCT02866643|12041565|FG001|COMPLETED|Overall Study||35
10875459|NCT02866643|12041564|FG000|NOT COMPLETED|Overall Study||13
10875460|NCT02866643|12041565|FG001|NOT COMPLETED|Overall Study||12
10875461|NCT02819518|12041578|FG000|STARTED|Overall Study||11
10875462|NCT02819518|12041579|FG001|STARTED|Overall Study||14
10875463|NCT02819518|12041580|FG002|STARTED|Overall Study||10
10875464|NCT02819518|12041581|FG003|STARTED|Overall Study||566
10875465|NCT02819518|12041582|FG004|STARTED|Overall Study||281
10875466|NCT02819518|12041578|FG000|COMPLETED|Overall Study||0
10875467|NCT02819518|12041579|FG001|COMPLETED|Overall Study||0
10875468|NCT02819518|12041580|FG002|COMPLETED|Overall Study||0
10875469|NCT02819518|12041581|FG003|COMPLETED|Overall Study||0
10875470|NCT02819518|12041582|FG004|COMPLETED|Overall Study||0
10875471|NCT02819518|12041578|FG000|NOT COMPLETED|Overall Study||11
10875472|NCT02819518|12041579|FG001|NOT COMPLETED|Overall Study||14
10875473|NCT02819518|12041580|FG002|NOT COMPLETED|Overall Study||10
10875474|NCT02819518|12041581|FG003|NOT COMPLETED|Overall Study||566
10875475|NCT02819518|12041582|FG004|NOT COMPLETED|Overall Study||281
10875476|NCT02767856|12041598|FG000|STARTED|Overall Study||18
10875477|NCT02767856|12041599|FG001|STARTED|Overall Study||14
10875478|NCT02767856|12041598|FG000|COMPLETED|Overall Study||7
10875479|NCT02767856|12041599|FG001|COMPLETED|Overall Study||12
10875480|NCT02767856|12041598|FG000|NOT COMPLETED|Overall Study||11
10875481|NCT02767856|12041599|FG001|NOT COMPLETED|Overall Study||2
11118534|NCT01324440|12303274|FG001|NOT COMPLETED|Overall Study||1
11118535|NCT01324453|12303282|FG000|STARTED|Overall Study||54
11118536|NCT01324453|12303283|FG001|STARTED|Overall Study||49
11118537|NCT01324453|12303282|FG000|COMPLETED|Overall Study||54
11118538|NCT01324453|12303283|FG001|COMPLETED|Overall Study||49
11118539|NCT01324453|12303282|FG000|NOT COMPLETED|Overall Study||0
11118540|NCT01324453|12303283|FG001|NOT COMPLETED|Overall Study||0
11118541|NCT01324518|12303292|FG000|STARTED|Overall Study||33
11118542|NCT01324518|12303293|FG001|STARTED|Overall Study||33
11118543|NCT01324518|12303294|FG002|STARTED|Overall Study||34
11118544|NCT01324518|12303292|FG000|COMPLETED|Overall Study||28
11118545|NCT01324518|12303293|FG001|COMPLETED|Overall Study||30
10875494|NCT02719691|12041621|FG000|STARTED|Overall Study||3
10875495|NCT02719691|12041622|FG001|STARTED|Overall Study||4
10875496|NCT02719691|12041623|FG002|STARTED|Overall Study||7
10875497|NCT02719691|12041624|FG003|STARTED|Overall Study||2
10875498|NCT02719691|12041625|FG004|STARTED|Overall Study||10
10875499|NCT02719691|12041626|FG005|STARTED|Overall Study||10
10875500|NCT02719691|12041627|FG006|STARTED|Overall Study||11
10875501|NCT02719691|12041621|FG000|COMPLETED|Overall Study||3
10875502|NCT02719691|12041622|FG001|COMPLETED|Overall Study||4
10875503|NCT02719691|12041623|FG002|COMPLETED|Overall Study||6
10875504|NCT02719691|12041624|FG003|COMPLETED|Overall Study||2
10875505|NCT02719691|12041625|FG004|COMPLETED|Overall Study||10
10875506|NCT02719691|12041626|FG005|COMPLETED|Overall Study||9
10875507|NCT02719691|12041627|FG006|COMPLETED|Overall Study||11
10875508|NCT02719691|12041621|FG000|NOT COMPLETED|Overall Study||0
10875509|NCT02719691|12041622|FG001|NOT COMPLETED|Overall Study||0
10875510|NCT02719691|12041623|FG002|NOT COMPLETED|Overall Study||1
10875511|NCT02719691|12041624|FG003|NOT COMPLETED|Overall Study||0
10875512|NCT02719691|12041625|FG004|NOT COMPLETED|Overall Study||0
10875513|NCT02719691|12041626|FG005|NOT COMPLETED|Overall Study||1
10875514|NCT02719691|12041627|FG006|NOT COMPLETED|Overall Study||0
10875515|NCT02613507|12041646|FG000|STARTED|Overall Study||338
10875516|NCT02613507|12041647|FG001|STARTED|Overall Study||166
10875517|NCT02613507|12041646|FG000|COMPLETED|Overall Study||50
10875518|NCT02613507|12041647|FG001|COMPLETED|Overall Study||2
10875519|NCT02613507|12041646|FG000|NOT COMPLETED|Overall Study||288
10875520|NCT02613507|12041647|FG001|NOT COMPLETED|Overall Study||164
10875521|NCT02586857|12041655|FG000|STARTED|Overall Study||15
10875522|NCT02586857|12041656|FG001|STARTED|Overall Study||9
10875523|NCT02586857|12041655|FG000|Enrolled|Overall Study||15
10875524|NCT02586857|12041656|FG001|Enrolled|Overall Study||9
10875525|NCT02586857|12041655|FG000|Received Study Medication|Overall Study||15
10875526|NCT02586857|12041656|FG001|Received Study Medication|Overall Study||9
10875527|NCT02586857|12041655|FG000|Discontinued Study|Overall Study||14
10875528|NCT02586857|12041656|FG001|Discontinued Study|Overall Study||9
10875529|NCT02586857|12041655|FG000|COMPLETED|Overall Study||14
10875530|NCT02586857|12041656|FG001|COMPLETED|Overall Study||9
10875531|NCT02586857|12041655|FG000|NOT COMPLETED|Overall Study||1
10875532|NCT02586857|12041656|FG001|NOT COMPLETED|Overall Study||0
10875533|NCT02412228|12041662|FG000|STARTED|Overall Study||12
10875534|NCT02412228|12041662|FG000|COMPLETED|Overall Study||12
10875535|NCT02412228|12041662|FG000|NOT COMPLETED|Overall Study||0
10875536|NCT02410213|12041666|FG000|STARTED|Overall Study||16
10875537|NCT02410213|12041667|FG001|STARTED|Overall Study||19
10875538|NCT02410213|12041666|FG000|COMPLETED|Overall Study||16
10875539|NCT02410213|12041667|FG001|COMPLETED|Overall Study||19
10875540|NCT02410213|12041666|FG000|NOT COMPLETED|Overall Study||0
10875541|NCT02410213|12041667|FG001|NOT COMPLETED|Overall Study||0
11118546|NCT01324518|12303294|FG002|COMPLETED|Overall Study||33
11118547|NCT01324518|12303292|FG000|NOT COMPLETED|Overall Study||5
11118548|NCT01324518|12303293|FG001|NOT COMPLETED|Overall Study||3
11118549|NCT01324518|12303294|FG002|NOT COMPLETED|Overall Study||1
11118550|NCT01324570|12303304|FG000|STARTED|Overall Study||6
11118551|NCT01324570|12303305|FG001|STARTED|Overall Study||35
11118552|NCT01324570|12303304|FG000|COMPLETED|Overall Study||2
11118553|NCT01324570|12303305|FG001|COMPLETED|Overall Study||21
11118554|NCT01324570|12303304|FG000|NOT COMPLETED|Overall Study||4
11118555|NCT01324570|12303305|FG001|NOT COMPLETED|Overall Study||14
11118556|NCT01324622|12303315|FG000|STARTED|Overall Study||13
11118557|NCT01324622|12303316|FG001|STARTED|Overall Study||11
11118558|NCT01324622|12303315|FG000|COMPLETED|Overall Study||4
11118559|NCT01324622|12303316|FG001|COMPLETED|Overall Study||4
11118560|NCT01324622|12303315|FG000|NOT COMPLETED|Overall Study||9
11118561|NCT01324622|12303316|FG001|NOT COMPLETED|Overall Study||7
11118562|NCT01324687|12303325|FG000|STARTED|Overall Study||1058
11118563|NCT01324687|12303326|FG001|STARTED|Overall Study||494
11118564|NCT01324687|12303325|FG000|COMPLETED|Overall Study||1058
11118565|NCT01324687|12303326|FG001|COMPLETED|Overall Study||479
11118566|NCT01324687|12303325|FG000|NOT COMPLETED|Overall Study||0
11118567|NCT01324687|12303326|FG001|NOT COMPLETED|Overall Study||15
11118568|NCT01324700|12303336|FG000|STARTED|Overall Study||22
11118569|NCT01324700|12303337|FG001|STARTED|Overall Study||20
11118570|NCT01324700|12303338|FG002|STARTED|Overall Study||49
11118571|NCT01324700|12303339|FG003|STARTED|Overall Study||48
11118572|NCT01324700|12303336|FG000|COMPLETED|Overall Study||13
11118573|NCT01324700|12303337|FG001|COMPLETED|Overall Study||16
11118574|NCT01324700|12303338|FG002|COMPLETED|Overall Study||33
10875569|NCT02339506|12041684|FG000|STARTED|Period 1 (Placebo or Cosyntropin)||12
10875570|NCT02339506|12041685|FG001|STARTED|Period 1 (Placebo or Cosyntropin)||11
10875571|NCT02339506|12041684|FG000|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
10875572|NCT02339506|12041685|FG001|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
10875573|NCT02339506|12041684|FG000|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
10875574|NCT02339506|12041685|FG001|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
10875575|NCT02339506|12041684|FG000|STARTED|Washout (Period 2)||12
10875576|NCT02339506|12041685|FG001|STARTED|Washout (Period 2)||10
10875577|NCT02339506|12041684|FG000|COMPLETED|Washout (Period 2)||10
10875578|NCT02339506|12041685|FG001|COMPLETED|Washout (Period 2)||10
10875579|NCT02339506|12041684|FG000|NOT COMPLETED|Washout (Period 2)||2
10875580|NCT02339506|12041685|FG001|NOT COMPLETED|Washout (Period 2)||0
10875581|NCT02339506|12041684|FG000|STARTED|Period 3 (Placebo or Cosyntropin)||10
10875582|NCT02339506|12041685|FG001|STARTED|Period 3 (Placebo or Cosyntropin)||10
10875583|NCT02339506|12041684|FG000|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
10875584|NCT02339506|12041685|FG001|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
10875585|NCT02339506|12041684|FG000|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
10875586|NCT02339506|12041685|FG001|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
10875587|NCT02324504|12041691|FG000|STARTED|Overall Study||60
10875588|NCT02324504|12041691|FG000|COMPLETED|Overall Study||60
10875589|NCT02324504|12041691|FG000|NOT COMPLETED|Overall Study||0
10875590|NCT02206048|12041698|FG000|STARTED|Overall Study||9
10875591|NCT02206048|12041698|FG000|COMPLETED|Overall Study||8
10875592|NCT02206048|12041698|FG000|NOT COMPLETED|Overall Study||1
10875593|NCT02203305|12041705|FG000|STARTED|Overall Study||20
10875594|NCT02203305|12041706|FG001|STARTED|Overall Study||3
10875595|NCT02203305|12041707|FG002|STARTED|Overall Study||20
10875596|NCT02203305|12041705|FG000|COMPLETED|Overall Study||20
10875597|NCT02203305|12041706|FG001|COMPLETED|Overall Study||3
10875598|NCT02203305|12041707|FG002|COMPLETED|Overall Study||19
10875599|NCT02203305|12041705|FG000|NOT COMPLETED|Overall Study||0
10875600|NCT02203305|12041706|FG001|NOT COMPLETED|Overall Study||0
10875601|NCT02203305|12041707|FG002|NOT COMPLETED|Overall Study||1
10875602|NCT02068885|12041720|FG000|STARTED|Overall Study||57
10875603|NCT02068885|12041721|FG001|STARTED|Overall Study||53
10875604|NCT02068885|12041722|FG002|STARTED|Overall Study||54
10875605|NCT02068885|12041720|FG000|Provided Data at Midpoint Test Phase|Overall Study||56
10875606|NCT02068885|12041721|FG001|Provided Data at Midpoint Test Phase|Overall Study||50
10875607|NCT02068885|12041722|FG002|Provided Data at Midpoint Test Phase|Overall Study||48
10875608|NCT02068885|12041720|FG000|Provided Data at End of Test Phase|Overall Study||54
10875609|NCT02068885|12041721|FG001|Provided Data at End of Test Phase|Overall Study||48
10875610|NCT02068885|12041722|FG002|Provided Data at End of Test Phase|Overall Study||46
10875611|NCT02068885|12041720|FG000|Included in Intention-to-treat Analysis|Overall Study||56
10875612|NCT02068885|12041721|FG001|Included in Intention-to-treat Analysis|Overall Study||52
10875613|NCT02068885|12041722|FG002|Included in Intention-to-treat Analysis|Overall Study||54
10875614|NCT02068885|12041720|FG000|COMPLETED|Overall Study||54
10875615|NCT02068885|12041721|FG001|COMPLETED|Overall Study||48
10875616|NCT02068885|12041722|FG002|COMPLETED|Overall Study||46
10875617|NCT02068885|12041720|FG000|NOT COMPLETED|Overall Study||3
10875618|NCT02068885|12041721|FG001|NOT COMPLETED|Overall Study||5
10875619|NCT02068885|12041722|FG002|NOT COMPLETED|Overall Study||8
10875628|NCT01565941|12041745|FG000|STARTED|Overall Study||360
10875629|NCT01565941|12041746|FG001|STARTED|Overall Study||353
10875630|NCT01565941|12041745|FG000|COMPLETED|Overall Study||349
10875631|NCT01565941|12041746|FG001|COMPLETED|Overall Study||349
10875632|NCT01565941|12041745|FG000|NOT COMPLETED|Overall Study||11
11118575|NCT01324700|12303339|FG003|COMPLETED|Overall Study||37
11118576|NCT01324700|12303336|FG000|NOT COMPLETED|Overall Study||9
11118577|NCT01324700|12303337|FG001|NOT COMPLETED|Overall Study||4
11118578|NCT01324700|12303338|FG002|NOT COMPLETED|Overall Study||16
11118579|NCT01324700|12303339|FG003|NOT COMPLETED|Overall Study||11
11118580|NCT01324830|12303368|FG000|STARTED|Overall Study||3
10875633|NCT01565941|12041746|FG001|NOT COMPLETED|Overall Study||4
11118581|NCT01324830|12303369|FG001|STARTED|Overall Study||3
11118582|NCT01324830|12303370|FG002|STARTED|Overall Study||3
11118583|NCT01324830|12303371|FG003|STARTED|Overall Study||3
11118584|NCT01324830|12303372|FG004|STARTED|Overall Study||7
11118585|NCT01324830|12303373|FG005|STARTED|Overall Study||7
11118586|NCT01324830|12303374|FG006|STARTED|Overall Study||3
11118587|NCT01324830|12303375|FG007|STARTED|Overall Study||3
11118588|NCT01324830|12303376|FG008|STARTED|Overall Study||5
11118589|NCT01324830|12303377|FG009|STARTED|Overall Study||6
11118590|NCT01324830|12303378|FG010|STARTED|Overall Study||4
11118591|NCT01324830|12303379|FG011|STARTED|Overall Study||1
11118592|NCT01324830|12303380|FG012|STARTED|Overall Study||1
11118593|NCT01324830|12303381|FG013|STARTED|Overall Study||1
11118594|NCT01324830|12303382|FG014|STARTED|Overall Study||1
11118595|NCT01324830|12303383|FG015|STARTED|Overall Study||3
11118596|NCT01324830|12303384|FG016|STARTED|Overall Study||3
11118597|NCT01324830|12303385|FG017|STARTED|Overall Study||6
11118598|NCT01324830|12303386|FG018|STARTED|Overall Study||6
10875652|NCT00676715|12041784|FG000|STARTED|Overall Study||54
10875653|NCT00676715|12041785|FG001|STARTED|Overall Study||55
10875654|NCT00676715|12041786|FG002|STARTED|Overall Study||55
10875655|NCT00676715|12041787|FG003|STARTED|Overall Study||54
10875656|NCT00676715|12041784|FG000|COMPLETED|Overall Study||14
10875657|NCT00676715|12041785|FG001|COMPLETED|Overall Study||8
10875658|NCT00676715|12041786|FG002|COMPLETED|Overall Study||14
10875659|NCT00676715|12041787|FG003|COMPLETED|Overall Study||14
10875660|NCT00676715|12041784|FG000|NOT COMPLETED|Overall Study||40
10875661|NCT00676715|12041785|FG001|NOT COMPLETED|Overall Study||47
10875662|NCT00676715|12041786|FG002|NOT COMPLETED|Overall Study||41
10875663|NCT00676715|12041787|FG003|NOT COMPLETED|Overall Study||40
10875664|NCT00443599|12041799|FG000|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
10875665|NCT00443599|12041800|FG001|STARTED|Overall Study|Randomly Assigned to Standard Care|493
10875666|NCT00443599|12041799|FG000|COMPLETED|Overall Study|Included in per-protocol analysis|490
10875667|NCT00443599|12041800|FG001|COMPLETED|Overall Study|Included in per-protocol analysis|490
10875668|NCT00443599|12041799|FG000|NOT COMPLETED|Overall Study||6
10875669|NCT00443599|12041800|FG001|NOT COMPLETED|Overall Study||3
10875670|NCT04753034|12041808|FG000|STARTED|Overall Study||31
10875671|NCT04753034|12041809|FG001|STARTED|Overall Study||32
10875672|NCT04753034|12041808|FG000|COMPLETED|Overall Study||29
10875673|NCT04753034|12041809|FG001|COMPLETED|Overall Study||31
10875674|NCT04753034|12041808|FG000|NOT COMPLETED|Overall Study||2
10875675|NCT04753034|12041809|FG001|NOT COMPLETED|Overall Study||1
10875676|NCT04638673|12041817|FG000|STARTED|Overall Study||6
10875677|NCT04638673|12041818|FG001|STARTED|Overall Study||6
10875678|NCT04638673|12041817|FG000|COMPLETED|Overall Study||6
10875679|NCT04638673|12041818|FG001|COMPLETED|Overall Study||6
10875680|NCT04638673|12041817|FG000|NOT COMPLETED|Overall Study||0
10875681|NCT04638673|12041818|FG001|NOT COMPLETED|Overall Study||0
10875682|NCT04531098|12041827|FG000|STARTED|Stage I||0
10875683|NCT04531098|12041828|FG001|STARTED|Stage I||67
10875684|NCT04531098|12041829|FG002|STARTED|Stage I||134
10875685|NCT04531098|12041827|FG000|COMPLETED|Stage I||0
10875686|NCT04531098|12041828|FG001|COMPLETED|Stage I||62
10875687|NCT04531098|12041829|FG002|COMPLETED|Stage I||116
10875688|NCT04531098|12041827|FG000|NOT COMPLETED|Stage I||0
10875689|NCT04531098|12041828|FG001|NOT COMPLETED|Stage I||5
10875690|NCT04531098|12041829|FG002|NOT COMPLETED|Stage I||18
10875691|NCT04531098|12041827|FG000|STARTED|Stage II||134
10875692|NCT04531098|12041828|FG001|STARTED|Stage II||67
10875693|NCT04531098|12041829|FG002|STARTED|Stage II||0
10875694|NCT04531098|12041827|FG000|COMPLETED|Stage II||121
10875695|NCT04531098|12041828|FG001|COMPLETED|Stage II||57
10875696|NCT04531098|12041829|FG002|COMPLETED|Stage II||0
10875697|NCT04531098|12041827|FG000|NOT COMPLETED|Stage II||13
10875698|NCT04531098|12041828|FG001|NOT COMPLETED|Stage II||10
10875699|NCT04531098|12041829|FG002|NOT COMPLETED|Stage II||0
10875700|NCT04484857|12041837|FG000|STARTED|Overall Study||283
10875701|NCT04484857|12041837|FG000|Received at Least 1 Dose of Study Drug|Overall Study||283
10875702|NCT04484857|12041837|FG000|Full Analysis Set|Overall Study||282
10875703|NCT04484857|12041837|FG000|COMPLETED|Overall Study||36
10875704|NCT04484857|12041837|FG000|NOT COMPLETED|Overall Study||247
10875705|NCT04434560|12041843|FG000|STARTED|Overall Study||1
10875706|NCT04434560|12041844|FG001|STARTED|Overall Study||0
10875707|NCT04434560|12041843|FG000|COMPLETED|Overall Study||1
10875708|NCT04434560|12041844|FG001|COMPLETED|Overall Study||0
10875709|NCT04434560|12041843|FG000|NOT COMPLETED|Overall Study||0
10875710|NCT04434560|12041844|FG001|NOT COMPLETED|Overall Study||0
10875711|NCT04382053|12041852|FG000|STARTED|Overall Study||71
10875712|NCT04382053|12041853|FG001|STARTED|Overall Study||72
10875713|NCT04382053|12041852|FG000|Safety Analysis Set|Overall Study|One participant that was randomized to the DFV890 + SoC arm did not attend any post-baseline visit|70
10875714|NCT04382053|12041853|FG001|Safety Analysis Set|Overall Study||72
10875715|NCT04382053|12041852|FG000|PD Analysis Set|Overall Study||62
10875716|NCT04382053|12041853|FG001|PD Analysis Set|Overall Study||68
10875717|NCT04382053|12041852|FG000|COMPLETED|Overall Study||62
10875718|NCT04382053|12041853|FG001|COMPLETED|Overall Study||59
10875719|NCT04382053|12041852|FG000|NOT COMPLETED|Overall Study||9
10875720|NCT04382053|12041853|FG001|NOT COMPLETED|Overall Study||13
10875721|NCT04353817|12041862|FG000|STARTED|Overall Study||61
10875722|NCT04353817|12041863|FG001|STARTED|Overall Study||60
10875723|NCT04353817|12041862|FG000|COMPLETED|Overall Study||61
10875724|NCT04353817|12041863|FG001|COMPLETED|Overall Study||59
10875725|NCT04353817|12041862|FG000|NOT COMPLETED|Overall Study||0
10875726|NCT04353817|12041863|FG001|NOT COMPLETED|Overall Study||1
10875727|NCT04278755|12041869|FG000|STARTED|Overall Study||8
10875728|NCT04278755|12041869|FG000|COMPLETED|Overall Study||7
10875729|NCT04278755|12041869|FG000|NOT COMPLETED|Overall Study||1
10875730|NCT04225221|12041875|FG000|STARTED|Lupron and Placebo Baseline (6 Weeks)||6
10875731|NCT04225221|12041876|FG001|STARTED|Lupron and Placebo Baseline (6 Weeks)||4
10875732|NCT04225221|12041875|FG000|COMPLETED|Lupron and Placebo Baseline (6 Weeks)||5
10875733|NCT04225221|12041876|FG001|COMPLETED|Lupron and Placebo Baseline (6 Weeks)||4
10875734|NCT04225221|12041875|FG000|NOT COMPLETED|Lupron and Placebo Baseline (6 Weeks)||1
10875735|NCT04225221|12041876|FG001|NOT COMPLETED|Lupron and Placebo Baseline (6 Weeks)||0
10875736|NCT04225221|12041875|FG000|STARTED|First Intervention (2 Weeks)||6
10875737|NCT04225221|12041876|FG001|STARTED|First Intervention (2 Weeks)||4
10875738|NCT04225221|12041875|FG000|COMPLETED|First Intervention (2 Weeks)||6
10875739|NCT04225221|12041876|FG001|COMPLETED|First Intervention (2 Weeks)||4
10875740|NCT04225221|12041875|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10875741|NCT04225221|12041876|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10875742|NCT04225221|12041875|FG000|STARTED|Washout (2 Weeks)||5
10875743|NCT04225221|12041876|FG001|STARTED|Washout (2 Weeks)||4
10875744|NCT04225221|12041875|FG000|COMPLETED|Washout (2 Weeks)||4
10875745|NCT04225221|12041876|FG001|COMPLETED|Washout (2 Weeks)||4
10875746|NCT04225221|12041875|FG000|NOT COMPLETED|Washout (2 Weeks)||1
10875747|NCT04225221|12041876|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10875748|NCT04225221|12041875|FG000|STARTED|Second Intervention (2 Weeks)||5
10875749|NCT04225221|12041876|FG001|STARTED|Second Intervention (2 Weeks)||4
10875750|NCT04225221|12041875|FG000|COMPLETED|Second Intervention (2 Weeks)||5
10875751|NCT04225221|12041876|FG001|COMPLETED|Second Intervention (2 Weeks)||4
10875752|NCT04225221|12041875|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10875753|NCT04225221|12041876|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10875754|NCT04087720|12041883|FG000|STARTED|Overall Study||20
10875755|NCT04087720|12041883|FG000|COMPLETED|Overall Study||15
10875756|NCT04087720|12041883|FG000|NOT COMPLETED|Overall Study||5
10875757|NCT03951766|12041887|FG000|STARTED|Treatment Phase||100
10875758|NCT03951766|12041887|FG000|COMPLETED|Treatment Phase||99
10875759|NCT03951766|12041887|FG000|NOT COMPLETED|Treatment Phase||1
10875760|NCT03951766|12041887|FG000|STARTED|Follow-up Phase||99
10875761|NCT03951766|12041887|FG000|COMPLETED|Follow-up Phase||89
10875762|NCT03951766|12041887|FG000|NOT COMPLETED|Follow-up Phase||10
11118599|NCT01324830|12303368|FG000|COMPLETED|Overall Study||0
11118600|NCT01324830|12303369|FG001|COMPLETED|Overall Study||0
11118601|NCT01324830|12303370|FG002|COMPLETED|Overall Study||0
11118602|NCT01324830|12303371|FG003|COMPLETED|Overall Study||0
11118603|NCT01324830|12303372|FG004|COMPLETED|Overall Study||0
11118604|NCT01324830|12303373|FG005|COMPLETED|Overall Study||0
11118605|NCT01324830|12303374|FG006|COMPLETED|Overall Study||0
11118606|NCT01324830|12303375|FG007|COMPLETED|Overall Study||0
11118607|NCT01324830|12303376|FG008|COMPLETED|Overall Study||0
11118608|NCT01324830|12303377|FG009|COMPLETED|Overall Study||0
11118609|NCT01324830|12303378|FG010|COMPLETED|Overall Study||0
11118610|NCT01324830|12303379|FG011|COMPLETED|Overall Study||0
11118611|NCT01324830|12303380|FG012|COMPLETED|Overall Study||0
11118612|NCT01324830|12303381|FG013|COMPLETED|Overall Study||0
11118613|NCT01324830|12303382|FG014|COMPLETED|Overall Study||0
10875778|NCT03737110|12041919|FG000|STARTED|Run-in (RI) Period||86
10875779|NCT03737110|12041920|FG001|STARTED|Run-in (RI) Period||0
10875780|NCT03737110|12041921|FG002|STARTED|Run-in (RI) Period||0
10875781|NCT03737110|12041919|FG000|Continue to RW Period|Run-in (RI) Period||61
10875782|NCT03737110|12041920|FG001|Continue to RW Period|Run-in (RI) Period||0
10875783|NCT03737110|12041921|FG002|Continue to RW Period|Run-in (RI) Period||0
10875784|NCT03737110|12041919|FG000|Continue Directly to LTE Period|Run-in (RI) Period||15
10875785|NCT03737110|12041920|FG001|Continue Directly to LTE Period|Run-in (RI) Period||0
10875786|NCT03737110|12041921|FG002|Continue Directly to LTE Period|Run-in (RI) Period||0
10875787|NCT03737110|12041919|FG000|COMPLETED|Run-in (RI) Period||76
10875788|NCT03737110|12041920|FG001|COMPLETED|Run-in (RI) Period||0
10875789|NCT03737110|12041921|FG002|COMPLETED|Run-in (RI) Period||0
10875790|NCT03737110|12041919|FG000|NOT COMPLETED|Run-in (RI) Period||10
10875791|NCT03737110|12041920|FG001|NOT COMPLETED|Run-in (RI) Period||0
10875792|NCT03737110|12041921|FG002|NOT COMPLETED|Run-in (RI) Period||0
10875793|NCT03737110|12041919|FG000|STARTED|Randomized Withdrawal (RW) Period||0
10875794|NCT03737110|12041920|FG001|STARTED|Randomized Withdrawal (RW) Period||30
10875795|NCT03737110|12041921|FG002|STARTED|Randomized Withdrawal (RW) Period||31
10875796|NCT03737110|12041919|FG000|COMPLETED|Randomized Withdrawal (RW) Period||0
10875797|NCT03737110|12041920|FG001|COMPLETED|Randomized Withdrawal (RW) Period||29
10875798|NCT03737110|12041921|FG002|COMPLETED|Randomized Withdrawal (RW) Period||30
10875799|NCT03737110|12041919|FG000|NOT COMPLETED|Randomized Withdrawal (RW) Period||0
10875800|NCT03737110|12041920|FG001|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
10875801|NCT03737110|12041921|FG002|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
10875802|NCT03737110|12041919|FG000|STARTED|Long-Term Extension (LTE) Period|Participants who entered the LTE directly from RI after protocol-specified 22 adjudicated pericarditis recurrence events had accrued.|15
10875803|NCT03737110|12041920|FG001|STARTED|Long-Term Extension (LTE) Period|1 participant withdrew consent prior to entering LTE.|29
10875804|NCT03737110|12041921|FG002|STARTED|Long-Term Extension (LTE) Period||30
10875805|NCT03737110|12041919|FG000|COMPLETED|Long-Term Extension (LTE) Period||0
10875806|NCT03737110|12041920|FG001|COMPLETED|Long-Term Extension (LTE) Period||0
11118614|NCT01324830|12303383|FG015|COMPLETED|Overall Study||0
10875807|NCT03737110|12041921|FG002|COMPLETED|Long-Term Extension (LTE) Period||0
10875808|NCT03737110|12041919|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||15
10875809|NCT03737110|12041920|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||29
10875810|NCT03737110|12041921|FG002|NOT COMPLETED|Long-Term Extension (LTE) Period||30
10875811|NCT03660488|12041941|FG000|STARTED|Overall Study||31
10875812|NCT03660488|12041942|FG001|STARTED|Overall Study||27
10875813|NCT03660488|12041941|FG000|COMPLETED|Overall Study||31
10875814|NCT03660488|12041942|FG001|COMPLETED|Overall Study||27
10875815|NCT03660488|12041941|FG000|NOT COMPLETED|Overall Study||0
10875816|NCT03660488|12041942|FG001|NOT COMPLETED|Overall Study||0
10875817|NCT03653091|12041950|FG000|STARTED|First 24 Weeks||6
10875818|NCT03653091|12041951|FG001|STARTED|First 24 Weeks||3
10875819|NCT03653091|12041950|FG000|Intent-to-Treat|First 24 Weeks||6
10875820|NCT03653091|12041951|FG001|Intent-to-Treat|First 24 Weeks||3
10875821|NCT03653091|12041950|FG000|As-Treated|First 24 Weeks||5
10875822|NCT03653091|12041951|FG001|As-Treated|First 24 Weeks||4
10875823|NCT03653091|12041950|FG000|Safety|First 24 Weeks||5
10875824|NCT03653091|12041951|FG001|Safety|First 24 Weeks||4
10875825|NCT03653091|12041950|FG000|COMPLETED|First 24 Weeks||6
10875826|NCT03653091|12041951|FG001|COMPLETED|First 24 Weeks||3
10875827|NCT03653091|12041950|FG000|NOT COMPLETED|First 24 Weeks||0
10875828|NCT03653091|12041951|FG001|NOT COMPLETED|First 24 Weeks||0
10875829|NCT03653091|12041950|FG000|STARTED|Second 24 Weeks||5
10875830|NCT03653091|12041951|FG001|STARTED|Second 24 Weeks||4
10875831|NCT03653091|12041950|FG000|Crossed Over to DMR at Week 24|Second 24 Weeks||0
10875832|NCT03653091|12041951|FG001|Crossed Over to DMR at Week 24|Second 24 Weeks||3
10875833|NCT03653091|12041950|FG000|COMPLETED|Second 24 Weeks||5
10875834|NCT03653091|12041951|FG001|COMPLETED|Second 24 Weeks||3
10875835|NCT03653091|12041950|FG000|NOT COMPLETED|Second 24 Weeks||0
10875836|NCT03653091|12041951|FG001|NOT COMPLETED|Second 24 Weeks||1
10875837|NCT03649477|12041961|FG000|STARTED|Overall Study||44
10875838|NCT03649477|12041962|FG001|STARTED|Overall Study||43
10875839|NCT03649477|12041963|FG002|STARTED|Overall Study||43
10875840|NCT03649477|12041961|FG000|COMPLETED|Overall Study||42
10875841|NCT03649477|12041962|FG001|COMPLETED|Overall Study||43
10875842|NCT03649477|12041963|FG002|COMPLETED|Overall Study||43
10875843|NCT03649477|12041961|FG000|NOT COMPLETED|Overall Study||2
10875844|NCT03649477|12041962|FG001|NOT COMPLETED|Overall Study||0
10875845|NCT03649477|12041963|FG002|NOT COMPLETED|Overall Study||0
10875846|NCT03631706|12041973|FG000|STARTED|Overall Study||152
10875847|NCT03631706|12041974|FG001|STARTED|Overall Study||152
10875848|NCT03631706|12041973|FG000|Treated|Overall Study||151
10875849|NCT03631706|12041974|FG001|Treated|Overall Study||152
10875850|NCT03631706|12041973|FG000|COMPLETED|Overall Study||60
10875851|NCT03631706|12041974|FG001|COMPLETED|Overall Study||54
10875852|NCT03631706|12041973|FG000|NOT COMPLETED|Overall Study||92
10875853|NCT03631706|12041974|FG001|NOT COMPLETED|Overall Study||98
10875854|NCT03615482|12041982|FG000|STARTED|Overall Study||600
10875855|NCT03615482|12041983|FG001|STARTED|Overall Study||600
10875856|NCT03615482|12041982|FG000|Vaccinated|Overall Study||599
10875857|NCT03615482|12041983|FG001|Vaccinated|Overall Study||598
10875858|NCT03615482|12041982|FG000|COMPLETED|Overall Study||583
10875859|NCT03615482|12041983|FG001|COMPLETED|Overall Study||583
10875860|NCT03615482|12041982|FG000|NOT COMPLETED|Overall Study||17
10875861|NCT03615482|12041983|FG001|NOT COMPLETED|Overall Study||17
10875862|NCT03572933|12041991|FG000|STARTED|Overall Study||51
10875863|NCT03572933|12041992|FG001|STARTED|Overall Study||50
10875864|NCT03572933|12041991|FG000|COMPLETED|Overall Study||47
10875865|NCT03572933|12041992|FG001|COMPLETED|Overall Study||48
10875866|NCT03572933|12041991|FG000|NOT COMPLETED|Overall Study||4
10875867|NCT03572933|12041992|FG001|NOT COMPLETED|Overall Study||2
10875868|NCT03557892|12042000|FG000|STARTED|Overall Study||14
10875869|NCT03557892|12042001|FG001|STARTED|Overall Study||14
10875870|NCT03557892|12042000|FG000|COMPLETED|Overall Study||14
10875871|NCT03557892|12042001|FG001|COMPLETED|Overall Study||14
10875872|NCT03557892|12042000|FG000|NOT COMPLETED|Overall Study||0
10875873|NCT03557892|12042001|FG001|NOT COMPLETED|Overall Study||0
10875874|NCT03526861|12042010|FG000|STARTED|Initial Treatment Period||101
10875875|NCT03526861|12042011|FG001|STARTED|Initial Treatment Period||100
10875876|NCT03526861|12042012|FG002|STARTED|Initial Treatment Period||100
10875877|NCT03526861|12042013|FG003|STARTED|Initial Treatment Period||0
10875878|NCT03526861|12042014|FG004|STARTED|Initial Treatment Period||0
10875879|NCT03526861|12042015|FG005|STARTED|Initial Treatment Period||0
10875880|NCT03526861|12042016|FG006|STARTED|Initial Treatment Period||0
10875881|NCT03526861|12042017|FG007|STARTED|Initial Treatment Period||0
10875882|NCT03526861|12042018|FG008|STARTED|Initial Treatment Period||0
10875883|NCT03526861|12042010|FG000|COMPLETED|Initial Treatment Period||94
10875884|NCT03526861|12042011|FG001|COMPLETED|Initial Treatment Period||93
10875885|NCT03526861|12042012|FG002|COMPLETED|Initial Treatment Period||86
10875886|NCT03526861|12042013|FG003|COMPLETED|Initial Treatment Period||0
10875887|NCT03526861|12042014|FG004|COMPLETED|Initial Treatment Period||0
10875888|NCT03526861|12042015|FG005|COMPLETED|Initial Treatment Period||0
10875889|NCT03526861|12042016|FG006|COMPLETED|Initial Treatment Period||0
10875890|NCT03526861|12042017|FG007|COMPLETED|Initial Treatment Period||0
10875891|NCT03526861|12042018|FG008|COMPLETED|Initial Treatment Period||0
10875892|NCT03526861|12042010|FG000|NOT COMPLETED|Initial Treatment Period||7
10875893|NCT03526861|12042011|FG001|NOT COMPLETED|Initial Treatment Period||7
10875894|NCT03526861|12042012|FG002|NOT COMPLETED|Initial Treatment Period||14
10875895|NCT03526861|12042013|FG003|NOT COMPLETED|Initial Treatment Period||0
10875896|NCT03526861|12042014|FG004|NOT COMPLETED|Initial Treatment Period||0
10875897|NCT03526861|12042015|FG005|NOT COMPLETED|Initial Treatment Period||0
10875898|NCT03526861|12042016|FG006|NOT COMPLETED|Initial Treatment Period||0
10875899|NCT03526861|12042017|FG007|NOT COMPLETED|Initial Treatment Period||0
10875900|NCT03526861|12042018|FG008|NOT COMPLETED|Initial Treatment Period||0
10875901|NCT03526861|12042010|FG000|STARTED|Maintenance Treatment Period||0
10875902|NCT03526861|12042011|FG001|STARTED|Maintenance Treatment Period||0
10875903|NCT03526861|12042012|FG002|STARTED|Maintenance Treatment Period||0
10875904|NCT03526861|12042013|FG003|STARTED|Maintenance Treatment Period||13
10875905|NCT03526861|12042014|FG004|STARTED|Maintenance Treatment Period||14
10875906|NCT03526861|12042015|FG005|STARTED|Maintenance Treatment Period||12
10875907|NCT03526861|12042016|FG006|STARTED|Maintenance Treatment Period||14
10875908|NCT03526861|12042017|FG007|STARTED|Maintenance Treatment Period||6
10875909|NCT03526861|12042018|FG008|STARTED|Maintenance Treatment Period||0
10875910|NCT03526861|12042010|FG000|COMPLETED|Maintenance Treatment Period||0
10875911|NCT03526861|12042011|FG001|COMPLETED|Maintenance Treatment Period||0
10875912|NCT03526861|12042012|FG002|COMPLETED|Maintenance Treatment Period||0
10875913|NCT03526861|12042013|FG003|COMPLETED|Maintenance Treatment Period||5
10875914|NCT03526861|12042014|FG004|COMPLETED|Maintenance Treatment Period||8
10875915|NCT03526861|12042015|FG005|COMPLETED|Maintenance Treatment Period||8
10875916|NCT03526861|12042016|FG006|COMPLETED|Maintenance Treatment Period||8
10875917|NCT03526861|12042017|FG007|COMPLETED|Maintenance Treatment Period||4
10875918|NCT03526861|12042018|FG008|COMPLETED|Maintenance Treatment Period||0
10875919|NCT03526861|12042010|FG000|NOT COMPLETED|Maintenance Treatment Period||0
10875920|NCT03526861|12042011|FG001|NOT COMPLETED|Maintenance Treatment Period||0
10875921|NCT03526861|12042012|FG002|NOT COMPLETED|Maintenance Treatment Period||0
10875922|NCT03526861|12042013|FG003|NOT COMPLETED|Maintenance Treatment Period||8
10875923|NCT03526861|12042014|FG004|NOT COMPLETED|Maintenance Treatment Period||6
10875924|NCT03526861|12042015|FG005|NOT COMPLETED|Maintenance Treatment Period||4
10875925|NCT03526861|12042016|FG006|NOT COMPLETED|Maintenance Treatment Period||6
10875926|NCT03526861|12042017|FG007|NOT COMPLETED|Maintenance Treatment Period||2
10875927|NCT03526861|12042018|FG008|NOT COMPLETED|Maintenance Treatment Period||0
10875928|NCT03526861|12042010|FG000|STARTED|Open-label Treatment Period||0
10875929|NCT03526861|12042011|FG001|STARTED|Open-label Treatment Period||0
10875930|NCT03526861|12042012|FG002|STARTED|Open-label Treatment Period||0
10875931|NCT03526861|12042013|FG003|STARTED|Open-label Treatment Period||0
10875932|NCT03526861|12042014|FG004|STARTED|Open-label Treatment Period||0
10875933|NCT03526861|12042015|FG005|STARTED|Open-label Treatment Period||0
10875934|NCT03526861|12042016|FG006|STARTED|Open-label Treatment Period||0
10875935|NCT03526861|12042017|FG007|STARTED|Open-label Treatment Period||0
10875936|NCT03526861|12042018|FG008|STARTED|Open-label Treatment Period|226 subjects transferred to open-label treatment at Week 16. 24 subjects transferred to open-label treatment between Week 16 and Week 52.|242
10875937|NCT03526861|12042010|FG000|COMPLETED|Open-label Treatment Period||0
10875938|NCT03526861|12042011|FG001|COMPLETED|Open-label Treatment Period||0
10875939|NCT03526861|12042012|FG002|COMPLETED|Open-label Treatment Period||0
10875940|NCT03526861|12042013|FG003|COMPLETED|Open-label Treatment Period||0
10875941|NCT03526861|12042014|FG004|COMPLETED|Open-label Treatment Period||0
10875942|NCT03526861|12042015|FG005|COMPLETED|Open-label Treatment Period||0
10875943|NCT03526861|12042016|FG006|COMPLETED|Open-label Treatment Period||0
10875944|NCT03526861|12042017|FG007|COMPLETED|Open-label Treatment Period||0
10875945|NCT03526861|12042018|FG008|COMPLETED|Open-label Treatment Period||214
10875946|NCT03526861|12042010|FG000|NOT COMPLETED|Open-label Treatment Period||0
10875947|NCT03526861|12042011|FG001|NOT COMPLETED|Open-label Treatment Period||0
10875948|NCT03526861|12042012|FG002|NOT COMPLETED|Open-label Treatment Period||0
10875949|NCT03526861|12042013|FG003|NOT COMPLETED|Open-label Treatment Period||0
10875950|NCT03526861|12042014|FG004|NOT COMPLETED|Open-label Treatment Period||0
10875951|NCT03526861|12042015|FG005|NOT COMPLETED|Open-label Treatment Period||0
10875952|NCT03526861|12042016|FG006|NOT COMPLETED|Open-label Treatment Period||0
10875953|NCT03526861|12042017|FG007|NOT COMPLETED|Open-label Treatment Period||0
10875954|NCT03526861|12042018|FG008|NOT COMPLETED|Open-label Treatment Period||28
10875955|NCT03515226|12042040|FG000|STARTED|Overall Study||10
10875956|NCT03515226|12042041|FG001|STARTED|Overall Study||15
10875957|NCT03515226|12042040|FG000|COMPLETED|Overall Study||8
10875958|NCT03515226|12042041|FG001|COMPLETED|Overall Study||11
10875959|NCT03515226|12042040|FG000|NOT COMPLETED|Overall Study||2
10875960|NCT03515226|12042041|FG001|NOT COMPLETED|Overall Study||4
10875961|NCT03429049|12042050|FG000|STARTED|Overall Study||138
10875962|NCT03429049|12042051|FG001|STARTED|Overall Study||194
10875963|NCT03429049|12042050|FG000|Treated|Overall Study||136
10875964|NCT03429049|12042051|FG001|Treated|Overall Study||189
10875965|NCT03429049|12042050|FG000|COMPLETED|Overall Study||110
10875966|NCT03429049|12042051|FG001|COMPLETED|Overall Study||152
10875967|NCT03429049|12042050|FG000|NOT COMPLETED|Overall Study||28
10875968|NCT03429049|12042051|FG001|NOT COMPLETED|Overall Study||42
10875969|NCT03395639|12042059|FG000|STARTED|Main Treatment Period (0 to 4 Months)||110
10875970|NCT03395639|12042060|FG001|STARTED|Main Treatment Period (0 to 4 Months)||58
10875971|NCT03395639|12042061|FG002|STARTED|Main Treatment Period (0 to 4 Months)||0
10875972|NCT03395639|12042059|FG000|Modified Intent to Treat Population|Main Treatment Period (0 to 4 Months)||109
10875973|NCT03395639|12042060|FG001|Modified Intent to Treat Population|Main Treatment Period (0 to 4 Months)||58
10875974|NCT03395639|12042061|FG002|Modified Intent to Treat Population|Main Treatment Period (0 to 4 Months)||0
10875975|NCT03395639|12042059|FG000|COMPLETED|Main Treatment Period (0 to 4 Months)||107
10875976|NCT03395639|12042060|FG001|COMPLETED|Main Treatment Period (0 to 4 Months)||55
10875977|NCT03395639|12042061|FG002|COMPLETED|Main Treatment Period (0 to 4 Months)||0
10875978|NCT03395639|12042059|FG000|NOT COMPLETED|Main Treatment Period (0 to 4 Months)||3
10875979|NCT03395639|12042060|FG001|NOT COMPLETED|Main Treatment Period (0 to 4 Months)||3
10875980|NCT03395639|12042061|FG002|NOT COMPLETED|Main Treatment Period (0 to 4 Months)||0
10875981|NCT03395639|12042059|FG000|STARTED|Extension Period (4-13 Months)||0
10875982|NCT03395639|12042060|FG001|STARTED|Extension Period (4-13 Months)||0
10875983|NCT03395639|12042061|FG002|STARTED|Extension Period (4-13 Months)|15 participants who completed the Main Treatment Period did not participate in the Extension Period|147
10875984|NCT03395639|12042059|FG000|COMPLETED|Extension Period (4-13 Months)||0
10875985|NCT03395639|12042060|FG001|COMPLETED|Extension Period (4-13 Months)||0
10875986|NCT03395639|12042061|FG002|COMPLETED|Extension Period (4-13 Months)||144
10875987|NCT03395639|12042059|FG000|NOT COMPLETED|Extension Period (4-13 Months)||0
10875988|NCT03395639|12042060|FG001|NOT COMPLETED|Extension Period (4-13 Months)||0
10875989|NCT03395639|12042061|FG002|NOT COMPLETED|Extension Period (4-13 Months)||3
10875990|NCT03381274|12042073|FG000|STARTED|Overall Study||5
10875991|NCT03381274|12042074|FG001|STARTED|Overall Study||21
10875992|NCT03381274|12042075|FG002|STARTED|Overall Study||6
10875993|NCT03381274|12042076|FG003|STARTED|Overall Study||6
10875994|NCT03381274|12042077|FG004|STARTED|Overall Study||5
10875995|NCT03381274|12042073|FG000|COMPLETED|Overall Study||0
10875996|NCT03381274|12042074|FG001|COMPLETED|Overall Study||0
10875997|NCT03381274|12042075|FG002|COMPLETED|Overall Study||0
10875998|NCT03381274|12042076|FG003|COMPLETED|Overall Study||0
10875999|NCT03381274|12042077|FG004|COMPLETED|Overall Study||0
10876000|NCT03381274|12042073|FG000|NOT COMPLETED|Overall Study||5
10876001|NCT03381274|12042074|FG001|NOT COMPLETED|Overall Study||21
10876002|NCT03381274|12042075|FG002|NOT COMPLETED|Overall Study||6
10876003|NCT03381274|12042076|FG003|NOT COMPLETED|Overall Study||6
10876004|NCT03381274|12042077|FG004|NOT COMPLETED|Overall Study||5
11118615|NCT01324830|12303384|FG016|COMPLETED|Overall Study||0
11118616|NCT01324830|12303385|FG017|COMPLETED|Overall Study||0
11118617|NCT01324830|12303386|FG018|COMPLETED|Overall Study||0
10876008|NCT03338894|12042097|FG000|STARTED|Overall Study||66
10876009|NCT03338894|12042097|FG000|COMPLETED|Overall Study||56
10876010|NCT03338894|12042097|FG000|NOT COMPLETED|Overall Study||10
11118618|NCT01324830|12303368|FG000|NOT COMPLETED|Overall Study||3
11118619|NCT01324830|12303369|FG001|NOT COMPLETED|Overall Study||3
11118620|NCT01324830|12303370|FG002|NOT COMPLETED|Overall Study||3
11118621|NCT01324830|12303371|FG003|NOT COMPLETED|Overall Study||3
11118622|NCT01324830|12303372|FG004|NOT COMPLETED|Overall Study||7
11118623|NCT01324830|12303373|FG005|NOT COMPLETED|Overall Study||7
10876017|NCT03253926|12042109|FG000|STARTED|Overall Study||7
10876018|NCT03253926|12042110|FG001|STARTED|Overall Study||8
10876019|NCT03253926|12042109|FG000|COMPLETED|Overall Study||7
10876020|NCT03253926|12042110|FG001|COMPLETED|Overall Study||8
10876021|NCT03253926|12042109|FG000|NOT COMPLETED|Overall Study||0
10876022|NCT03253926|12042110|FG001|NOT COMPLETED|Overall Study||0
10876023|NCT03199963|12042118|FG000|STARTED|Blinded Phase - Overall Study||149
10876024|NCT03199963|12042119|FG001|STARTED|Blinded Phase - Overall Study||74
10876025|NCT03199963|12042118|FG000|Received at Least 1 Gel Application|Blinded Phase - Overall Study||149
10876026|NCT03199963|12042119|FG001|Received at Least 1 Gel Application|Blinded Phase - Overall Study||73
10876027|NCT03199963|12042118|FG000|COMPLETED|Blinded Phase - Overall Study||16
10876028|NCT03199963|12042119|FG001|COMPLETED|Blinded Phase - Overall Study||8
10876029|NCT03199963|12042118|FG000|NOT COMPLETED|Blinded Phase - Overall Study||133
10876030|NCT03199963|12042119|FG001|NOT COMPLETED|Blinded Phase - Overall Study||66
10876031|NCT03199963|12042118|FG000|STARTED|Optional Open-Label Phase - BHR-700||7
10876032|NCT03199963|12042119|FG001|STARTED|Optional Open-Label Phase - BHR-700||6
10876033|NCT03199963|12042118|FG000|COMPLETED|Optional Open-Label Phase - BHR-700||0
10876034|NCT03199963|12042119|FG001|COMPLETED|Optional Open-Label Phase - BHR-700||0
10876035|NCT03199963|12042118|FG000|NOT COMPLETED|Optional Open-Label Phase - BHR-700||7
10876036|NCT03199963|12042119|FG001|NOT COMPLETED|Optional Open-Label Phase - BHR-700||6
10876037|NCT03132636|12042133|FG000|STARTED|Overall Study||54
10876038|NCT03132636|12042134|FG001|STARTED|Overall Study||84
10876039|NCT03132636|12042133|FG000|COMPLETED|Overall Study||1
10876040|NCT03132636|12042134|FG001|COMPLETED|Overall Study||9
10876041|NCT03132636|12042133|FG000|NOT COMPLETED|Overall Study||53
10876042|NCT03132636|12042134|FG001|NOT COMPLETED|Overall Study||75
10876043|NCT03116399|12042142|FG000|STARTED|Overall Study||128
10876044|NCT03116399|12042143|FG001|STARTED|Overall Study||120
10876045|NCT03116399|12042142|FG000|6-month|Overall Study||98
10876046|NCT03116399|12042143|FG001|6-month|Overall Study||108
10876047|NCT03116399|12042142|FG000|9-month|Overall Study||91
10876048|NCT03116399|12042143|FG001|9-month|Overall Study||101
10876049|NCT03116399|12042142|FG000|COMPLETED|Overall Study||88
10876050|NCT03116399|12042143|FG001|COMPLETED|Overall Study||96
10876051|NCT03116399|12042142|FG000|NOT COMPLETED|Overall Study||40
10876052|NCT03116399|12042143|FG001|NOT COMPLETED|Overall Study||24
10876053|NCT03085680|12042151|FG000|STARTED|Overall Study||9
10876054|NCT03085680|12042152|FG001|STARTED|Overall Study||8
10876055|NCT03085680|12042151|FG000|COMPLETED|Overall Study||9
10876056|NCT03085680|12042152|FG001|COMPLETED|Overall Study||8
10876057|NCT03085680|12042151|FG000|NOT COMPLETED|Overall Study||0
10876058|NCT03085680|12042152|FG001|NOT COMPLETED|Overall Study||0
10876059|NCT03065218|12042158|FG000|STARTED|Overall Study||4
11118624|NCT01324830|12303374|FG006|NOT COMPLETED|Overall Study||3
11118625|NCT01324830|12303375|FG007|NOT COMPLETED|Overall Study||3
11118626|NCT01324830|12303376|FG008|NOT COMPLETED|Overall Study||5
10876060|NCT03065218|12042158|FG000|COMPLETED|Overall Study||4
10876061|NCT03065218|12042158|FG000|NOT COMPLETED|Overall Study||0
10876062|NCT03029598|12042162|FG000|STARTED|Overall Study||29
10876063|NCT03029598|12042162|FG000|COMPLETED|Overall Study||29
10876064|NCT03029598|12042162|FG000|NOT COMPLETED|Overall Study||0
10876065|NCT02961374|12042166|FG000|STARTED|Overall Study||46
10876066|NCT02961374|12042166|FG000|COMPLETED|Overall Study||42
10876067|NCT02961374|12042166|FG000|NOT COMPLETED|Overall Study||4
10876068|NCT02946788|12042172|FG000|STARTED|Overall Study||8
10876069|NCT02946788|12042173|FG001|STARTED|Overall Study||10
10876070|NCT02946788|12042172|FG000|COMPLETED|Overall Study|October 2017|8
10876071|NCT02946788|12042173|FG001|COMPLETED|Overall Study|October 2017|9
10876072|NCT02946788|12042172|FG000|NOT COMPLETED|Overall Study||0
10876073|NCT02946788|12042173|FG001|NOT COMPLETED|Overall Study||1
10876074|NCT02904954|12042181|FG000|STARTED|Neoadjuvant (Preoperative) to Surgery||30
10876075|NCT02904954|12042182|FG001|STARTED|Neoadjuvant (Preoperative) to Surgery||30
10876076|NCT02904954|12042181|FG000|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed 2 neoadjuvant cycles. Surgical resection was not performed in 4 participants.|26
10876077|NCT02904954|12042182|FG001|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed the first neoadjuvant Durvalumab cycle combined with SBRT. Three subjects did not receive the 2nd cycle. Surgical resection was not performed in 4 participants.|26
10876078|NCT02904954|12042181|FG000|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
10876079|NCT02904954|12042182|FG001|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
10876080|NCT02904954|12042181|FG000|STARTED|Adjuvant Durvalumab||26
10876081|NCT02904954|12042182|FG001|STARTED|Adjuvant Durvalumab||26
10876082|NCT02904954|12042181|FG000|COMPLETED|Adjuvant Durvalumab||6
10876083|NCT02904954|12042182|FG001|COMPLETED|Adjuvant Durvalumab||11
10876084|NCT02904954|12042181|FG000|NOT COMPLETED|Adjuvant Durvalumab||20
10876085|NCT02904954|12042182|FG001|NOT COMPLETED|Adjuvant Durvalumab||15
11118627|NCT01324830|12303377|FG009|NOT COMPLETED|Overall Study||6
11118628|NCT01324830|12303378|FG010|NOT COMPLETED|Overall Study||4
11118629|NCT01324830|12303379|FG011|NOT COMPLETED|Overall Study||1
11118630|NCT01324830|12303380|FG012|NOT COMPLETED|Overall Study||1
11118631|NCT01324830|12303381|FG013|NOT COMPLETED|Overall Study||1
11118632|NCT01324830|12303382|FG014|NOT COMPLETED|Overall Study||1
11118633|NCT01324830|12303383|FG015|NOT COMPLETED|Overall Study||3
11118634|NCT01324830|12303384|FG016|NOT COMPLETED|Overall Study||3
11118635|NCT01324830|12303385|FG017|NOT COMPLETED|Overall Study||6
11118636|NCT01324830|12303386|FG018|NOT COMPLETED|Overall Study||6
11118637|NCT01324882|12303434|FG000|STARTED|Overall Study|27 patients were randomized to this arm.|27
11118638|NCT01324882|12303435|FG001|STARTED|Overall Study|30 patients were randomized to this arm|30
11118639|NCT01324882|12303434|FG000|COMPLETED|Overall Study|27 patients had the colonoscopy|27
11118640|NCT01324882|12303435|FG001|COMPLETED|Overall Study|30 patients had the colonoscopy|30
11118641|NCT01324882|12303434|FG000|NOT COMPLETED|Overall Study||0
11118642|NCT01324882|12303435|FG001|NOT COMPLETED|Overall Study||0
11118643|NCT01324947|12303443|FG000|STARTED|Overall Study||74
11118644|NCT01324947|12303443|FG000|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
11118645|NCT01324947|12303443|FG000|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
11118646|NCT01324947|12303443|FG000|COMPLETED|Overall Study||0
11118647|NCT01324947|12303443|FG000|NOT COMPLETED|Overall Study||74
11118648|NCT01324999|12303449|FG000|STARTED|Overall Study||12
11118649|NCT01324999|12303449|FG000|COMPLETED|Overall Study||7
11118650|NCT01324999|12303449|FG000|NOT COMPLETED|Overall Study||5
11118651|NCT01325181|12303455|FG000|STARTED|Overall Study||18
11118652|NCT01325181|12303456|FG001|STARTED|Overall Study||16
10876112|NCT02784431|12042218|FG000|STARTED|Overall Study||20
10876113|NCT02784431|12042218|FG000|COMPLETED|Overall Study||0
10876114|NCT02784431|12042218|FG000|NOT COMPLETED|Overall Study||20
10876118|NCT02634307|12042229|FG000|STARTED|Overall Study||593
10876119|NCT02634307|12042230|FG001|STARTED|Overall Study||239
10876120|NCT02634307|12042231|FG002|STARTED|Overall Study||225
10876121|NCT02634307|12042229|FG000|Safety Population|Overall Study||593
10876122|NCT02634307|12042230|FG001|Safety Population|Overall Study||239
10876123|NCT02634307|12042231|FG002|Safety Population|Overall Study||225
10876124|NCT02634307|12042229|FG000|Full Analysis Set (FAS) Population|Overall Study||582
10876125|NCT02634307|12042230|FG001|Full Analysis Set (FAS) Population|Overall Study||235
10876126|NCT02634307|12042231|FG002|Full Analysis Set (FAS) Population|Overall Study||224
10876127|NCT02634307|12042229|FG000|COMPLETED|Overall Study||468
10876128|NCT02634307|12042230|FG001|COMPLETED|Overall Study||168
10876129|NCT02634307|12042231|FG002|COMPLETED|Overall Study||164
10876130|NCT02634307|12042229|FG000|NOT COMPLETED|Overall Study||125
10876131|NCT02634307|12042230|FG001|NOT COMPLETED|Overall Study||71
10876132|NCT02634307|12042231|FG002|NOT COMPLETED|Overall Study||61
10876136|NCT02575339|12042246|FG000|STARTED|Study Treatment||7
10876137|NCT02575339|12042247|FG001|STARTED|Study Treatment|This study was terminated at Phase I.|4
10876138|NCT02575339|12042248|FG002|STARTED|Study Treatment|This study was terminated at Phase I.|0
10876139|NCT02575339|12042246|FG000|COMPLETED|Study Treatment||0
10876140|NCT02575339|12042247|FG001|COMPLETED|Study Treatment||0
10876141|NCT02575339|12042248|FG002|COMPLETED|Study Treatment||0
10876142|NCT02575339|12042246|FG000|NOT COMPLETED|Study Treatment||7
10876143|NCT02575339|12042247|FG001|NOT COMPLETED|Study Treatment||4
10876144|NCT02575339|12042248|FG002|NOT COMPLETED|Study Treatment||0
10876145|NCT02575339|12042246|FG000|STARTED|Follow up||7
10876146|NCT02575339|12042247|FG001|STARTED|Follow up||4
10876147|NCT02575339|12042248|FG002|STARTED|Follow up||0
10876148|NCT02575339|12042246|FG000|COMPLETED|Follow up||0
10876149|NCT02575339|12042247|FG001|COMPLETED|Follow up||0
10876150|NCT02575339|12042248|FG002|COMPLETED|Follow up||0
10876151|NCT02575339|12042246|FG000|NOT COMPLETED|Follow up||7
10876152|NCT02575339|12042247|FG001|NOT COMPLETED|Follow up||4
10876153|NCT02575339|12042248|FG002|NOT COMPLETED|Follow up||0
10876154|NCT02521415|12042260|FG000|STARTED|Overall Study||43
10876155|NCT02521415|12042261|FG001|STARTED|Overall Study||44
10876156|NCT02521415|12042260|FG000|COMPLETED|Overall Study||43
10876157|NCT02521415|12042261|FG001|COMPLETED|Overall Study||44
10876158|NCT02521415|12042260|FG000|NOT COMPLETED|Overall Study||0
10876159|NCT02521415|12042261|FG001|NOT COMPLETED|Overall Study||0
11118653|NCT01325181|12303455|FG000|COMPLETED|Overall Study||18
11118654|NCT01325181|12303456|FG001|COMPLETED|Overall Study||14
11118655|NCT01325181|12303455|FG000|NOT COMPLETED|Overall Study||0
11118656|NCT01325181|12303456|FG001|NOT COMPLETED|Overall Study||2
11118657|NCT01325207|12303468|FG000|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
11118658|NCT01325207|12303469|FG001|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
11118659|NCT01325207|12303470|FG002|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
11118660|NCT01325207|12303471|FG003|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
11118661|NCT01325207|12303472|FG004|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7
11118662|NCT01325207|12303473|FG005|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19
11118663|NCT01325207|12303468|FG000|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
11118664|NCT01325207|12303469|FG001|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
11118665|NCT01325207|12303470|FG002|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
11118666|NCT01325207|12303471|FG003|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
11118667|NCT01325207|12303472|FG004|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5
11118668|NCT01325207|12303473|FG005|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19
11118669|NCT01325207|12303468|FG000|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
11118670|NCT01325207|12303469|FG001|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
11118671|NCT01325207|12303470|FG002|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
11118672|NCT01325207|12303471|FG003|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
11118673|NCT01325207|12303472|FG004|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2
10876181|NCT02367105|12042299|FG000|STARTED|Overall Study||41
10876182|NCT02367105|12042300|FG001|STARTED|Overall Study||42
10876183|NCT02367105|12042299|FG000|COMPLETED|Overall Study||36
10876184|NCT02367105|12042300|FG001|COMPLETED|Overall Study||34
10876185|NCT02367105|12042299|FG000|NOT COMPLETED|Overall Study||5
10876186|NCT02367105|12042300|FG001|NOT COMPLETED|Overall Study||8
11118674|NCT01325207|12303473|FG005|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
11118675|NCT01325207|12303468|FG000|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
11118676|NCT01325207|12303469|FG001|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
11118677|NCT01325207|12303470|FG002|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
11118678|NCT01325207|12303471|FG003|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
11118679|NCT01325207|12303472|FG004|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5
10876193|NCT02282020|12042323|FG000|STARTED|Overall Study||178
10876194|NCT02282020|12042324|FG001|STARTED|Overall Study||88
10876195|NCT02282020|12042323|FG000|Received Treatment|Overall Study||178
10876196|NCT02282020|12042324|FG001|Received Treatment|Overall Study||76
10876197|NCT02282020|12042323|FG000|COMPLETED|Overall Study||19
10876198|NCT02282020|12042324|FG001|COMPLETED|Overall Study||0
10876199|NCT02282020|12042323|FG000|NOT COMPLETED|Overall Study||159
10876200|NCT02282020|12042324|FG001|NOT COMPLETED|Overall Study||88
11118680|NCT01325207|12303473|FG005|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19
11118681|NCT01325207|12303468|FG000|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
11118682|NCT01325207|12303469|FG001|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
10876204|NCT02243631|12042337|FG000|STARTED|Overall Study||3
10876205|NCT02243631|12042338|FG001|STARTED|Overall Study||5
10876206|NCT02243631|12042337|FG000|COMPLETED|Overall Study||3
10876207|NCT02243631|12042338|FG001|COMPLETED|Overall Study||4
10876208|NCT02243631|12042337|FG000|NOT COMPLETED|Overall Study||0
10876209|NCT02243631|12042338|FG001|NOT COMPLETED|Overall Study||1
10876210|NCT02213926|12042344|FG000|STARTED|Overall Study||124
10876211|NCT02213926|12042344|FG000|COMPLETED|Overall Study||0
10876212|NCT02213926|12042344|FG000|NOT COMPLETED|Overall Study||124
11118683|NCT01325207|12303470|FG002|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
11118684|NCT01325207|12303471|FG003|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
11118685|NCT01325207|12303472|FG004|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3
11118686|NCT01325207|12303473|FG005|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14
10876217|NCT02066181|12042354|FG000|STARTED|Overall Study||50
10876218|NCT02066181|12042355|FG001|STARTED|Overall Study||37
10876219|NCT02066181|12042354|FG000|Crossed Over|Overall Study||0
10876220|NCT02066181|12042355|FG001|Crossed Over|Overall Study||28
10876221|NCT02066181|12042354|FG000|COMPLETED|Overall Study||49
10876222|NCT02066181|12042355|FG001|COMPLETED|Overall Study||36
10876223|NCT02066181|12042354|FG000|NOT COMPLETED|Overall Study||1
10876224|NCT02066181|12042355|FG001|NOT COMPLETED|Overall Study||1
11118687|NCT01325207|12303468|FG000|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
11118688|NCT01325207|12303469|FG001|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
11118689|NCT01325207|12303470|FG002|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
10876228|NCT02041533|12042370|FG000|STARTED|Overall Study||271
10876229|NCT02041533|12042371|FG001|STARTED|Overall Study||270
10876230|NCT02041533|12042370|FG000|Began Treatment|Overall Study||267
10876231|NCT02041533|12042371|FG001|Began Treatment|Overall Study||263
10876232|NCT02041533|12042370|FG000|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
10876233|NCT02041533|12042371|FG001|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
10876234|NCT02041533|12042370|FG000|NOT COMPLETED|Overall Study||228
10876235|NCT02041533|12042371|FG001|NOT COMPLETED|Overall Study||258
10876236|NCT01963728|12042379|FG000|STARTED|Overall Study||0
10876237|NCT01963728|12042380|FG001|STARTED|Overall Study||1
10876238|NCT01963728|12042379|FG000|COMPLETED|Overall Study|study terminated early|0
10876239|NCT01963728|12042380|FG001|COMPLETED|Overall Study|study terminated early|0
10876240|NCT01963728|12042379|FG000|NOT COMPLETED|Overall Study||0
10876241|NCT01963728|12042380|FG001|NOT COMPLETED|Overall Study||1
11118690|NCT01325207|12303471|FG003|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
11118691|NCT01325207|12303472|FG004|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
11118692|NCT01325207|12303473|FG005|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5
11118693|NCT01325207|12303468|FG000|STARTED|Started 9th Week/Cycle 3 of Treatment||2
11118694|NCT01325207|12303469|FG001|STARTED|Started 9th Week/Cycle 3 of Treatment||2
11118695|NCT01325207|12303470|FG002|STARTED|Started 9th Week/Cycle 3 of Treatment||1
11118696|NCT01325207|12303471|FG003|STARTED|Started 9th Week/Cycle 3 of Treatment||1
11118697|NCT01325207|12303472|FG004|STARTED|Started 9th Week/Cycle 3 of Treatment||3
11118698|NCT01325207|12303473|FG005|STARTED|Started 9th Week/Cycle 3 of Treatment||14
11118699|NCT01325207|12303468|FG000|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
11118700|NCT01325207|12303469|FG001|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
11118701|NCT01325207|12303470|FG002|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
11118702|NCT01325207|12303471|FG003|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
11118703|NCT01325207|12303472|FG004|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3
11118704|NCT01325207|12303473|FG005|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9
11118705|NCT01325207|12303468|FG000|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
11118706|NCT01325207|12303469|FG001|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2
11118707|NCT01325207|12303470|FG002|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
11118708|NCT01325207|12303471|FG003|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
11118709|NCT01325207|12303472|FG004|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
11118710|NCT01325207|12303473|FG005|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5
11118711|NCT01325207|12303468|FG000|STARTED|Follow-up Every 3 Months Until Death||3
11118712|NCT01325207|12303469|FG001|STARTED|Follow-up Every 3 Months Until Death||3
11118713|NCT01325207|12303470|FG002|STARTED|Follow-up Every 3 Months Until Death||1
11118714|NCT01325207|12303471|FG003|STARTED|Follow-up Every 3 Months Until Death||1
11118715|NCT01325207|12303472|FG004|STARTED|Follow-up Every 3 Months Until Death||7
11118716|NCT01325207|12303473|FG005|STARTED|Follow-up Every 3 Months Until Death||19
11118717|NCT01325207|12303468|FG000|COMPLETED|Follow-up Every 3 Months Until Death||3
11118718|NCT01325207|12303469|FG001|COMPLETED|Follow-up Every 3 Months Until Death||3
11118719|NCT01325207|12303470|FG002|COMPLETED|Follow-up Every 3 Months Until Death||1
11118720|NCT01325207|12303471|FG003|COMPLETED|Follow-up Every 3 Months Until Death||1
11118721|NCT01325207|12303472|FG004|COMPLETED|Follow-up Every 3 Months Until Death||6
11118722|NCT01325207|12303473|FG005|COMPLETED|Follow-up Every 3 Months Until Death||18
11118723|NCT01325207|12303468|FG000|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
11118724|NCT01325207|12303469|FG001|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
11118725|NCT01325207|12303470|FG002|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
11118726|NCT01325207|12303471|FG003|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
11118727|NCT01325207|12303472|FG004|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
11118728|NCT01325207|12303473|FG005|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
11118729|NCT01325311|12303490|FG000|STARTED|Overall Study||8
11118730|NCT01325311|12303491|FG001|STARTED|Overall Study||7
11118731|NCT01325311|12303490|FG000|COMPLETED|Overall Study||8
11118732|NCT01325311|12303491|FG001|COMPLETED|Overall Study||7
11118733|NCT01325311|12303490|FG000|NOT COMPLETED|Overall Study||0
11118734|NCT01325311|12303491|FG001|NOT COMPLETED|Overall Study||0
11118735|NCT01325337|12303502|FG000|STARTED|Overall Study||61
11118736|NCT01325337|12303503|FG001|STARTED|Overall Study||61
11118737|NCT01325337|12303504|FG002|STARTED|Overall Study||62
11118738|NCT01325337|12303505|FG003|STARTED|Overall Study||62
11118739|NCT01325337|12303506|FG004|STARTED|Overall Study||61
11118740|NCT01325337|12303502|FG000|COMPLETED|Overall Study||56
11118741|NCT01325337|12303503|FG001|COMPLETED|Overall Study||52
11118742|NCT01325337|12303504|FG002|COMPLETED|Overall Study||53
11118743|NCT01325337|12303505|FG003|COMPLETED|Overall Study||52
11118744|NCT01325337|12303506|FG004|COMPLETED|Overall Study||53
11118745|NCT01325337|12303502|FG000|NOT COMPLETED|Overall Study||5
11118746|NCT01325337|12303503|FG001|NOT COMPLETED|Overall Study||9
11118747|NCT01325337|12303504|FG002|NOT COMPLETED|Overall Study||9
11118748|NCT01325337|12303505|FG003|NOT COMPLETED|Overall Study||10
11118749|NCT01325337|12303506|FG004|NOT COMPLETED|Overall Study||8
11118750|NCT01325350|12303523|FG000|STARTED|Overall Study||61
11118751|NCT01325350|12303524|FG001|STARTED|Overall Study||61
11118752|NCT01325350|12303525|FG002|STARTED|Overall Study||61
11118753|NCT01325350|12303526|FG003|STARTED|Overall Study||61
11118754|NCT01325350|12303527|FG004|STARTED|Overall Study||62
11118755|NCT01325350|12303523|FG000|COMPLETED|Overall Study||55
11118756|NCT01325350|12303524|FG001|COMPLETED|Overall Study||56
11118757|NCT01325350|12303525|FG002|COMPLETED|Overall Study||44
11118758|NCT01325350|12303526|FG003|COMPLETED|Overall Study||52
11118759|NCT01325350|12303527|FG004|COMPLETED|Overall Study||50
11118760|NCT01325350|12303523|FG000|NOT COMPLETED|Overall Study||6
11118761|NCT01325350|12303524|FG001|NOT COMPLETED|Overall Study||5
11118762|NCT01325350|12303525|FG002|NOT COMPLETED|Overall Study||17
11118763|NCT01325350|12303526|FG003|NOT COMPLETED|Overall Study||9
11118764|NCT01325350|12303527|FG004|NOT COMPLETED|Overall Study||12
11118765|NCT01325428|12303539|FG000|STARTED|Part A||26
11118766|NCT01325428|12303539|FG000|COMPLETED|Part A||10
11118767|NCT01325428|12303539|FG000|NOT COMPLETED|Part A||16
11118768|NCT01325428|12303539|FG000|STARTED|Part B||10
11118769|NCT01325428|12303539|FG000|COMPLETED|Part B||7
11118770|NCT01325428|12303539|FG000|NOT COMPLETED|Part B||3
11118771|NCT01325493|12303550|FG000|STARTED|Overall Study||30
11118772|NCT01325493|12303551|FG001|STARTED|Overall Study||24
11118773|NCT01325493|12303550|FG000|COMPLETED|Overall Study||29
11118774|NCT01325493|12303551|FG001|COMPLETED|Overall Study||21
11118775|NCT01325493|12303550|FG000|NOT COMPLETED|Overall Study||1
11118776|NCT01325493|12303551|FG001|NOT COMPLETED|Overall Study||3
11118777|NCT01325532|12303559|FG000|STARTED|Overall Study||17
11118778|NCT01325532|12303560|FG001|STARTED|Overall Study||13
11118779|NCT01325532|12303559|FG000|COMPLETED|Overall Study||15
11118780|NCT01325532|12303560|FG001|COMPLETED|Overall Study||13
11118781|NCT01325532|12303559|FG000|NOT COMPLETED|Overall Study||2
11118782|NCT01325532|12303560|FG001|NOT COMPLETED|Overall Study||0
11118783|NCT01325584|12303566|FG000|STARTED|Overall Study||12
11118784|NCT01325584|12303566|FG000|COMPLETED|Overall Study||11
11118785|NCT01325584|12303566|FG000|NOT COMPLETED|Overall Study||1
11118786|NCT01325623|12303570|FG000|STARTED|Overall Study||31
11118787|NCT01325623|12303570|FG000|COMPLETED|Overall Study||28
11118788|NCT01325623|12303570|FG000|NOT COMPLETED|Overall Study||3
11118789|NCT01325701|12303609|FG000|STARTED|Overall Study||70
11118790|NCT01325701|12303610|FG001|STARTED|Overall Study||8
11118791|NCT01325701|12303609|FG000|COMPLETED|Overall Study||49
11118792|NCT01325701|12303610|FG001|COMPLETED|Overall Study||5
11118793|NCT01325701|12303609|FG000|NOT COMPLETED|Overall Study||21
11118794|NCT01325701|12303610|FG001|NOT COMPLETED|Overall Study||3
11118795|NCT01325714|12303619|FG000|STARTED|Overall Study||101
11118796|NCT01325714|12303620|FG001|STARTED|Overall Study||102
11118797|NCT01325714|12303619|FG000|3 Month Assessment|Overall Study||82
11118798|NCT01325714|12303620|FG001|3 Month Assessment|Overall Study||86
11118799|NCT01325714|12303619|FG000|6 Month Asessment|Overall Study||75
11118800|NCT01325714|12303620|FG001|6 Month Asessment|Overall Study||82
11118801|NCT01325714|12303619|FG000|12 Month Assessment|Overall Study||67
11118802|NCT01325714|12303620|FG001|12 Month Assessment|Overall Study||71
11118803|NCT01325714|12303619|FG000|COMPLETED|Overall Study||67
11118804|NCT01325714|12303620|FG001|COMPLETED|Overall Study||71
11118805|NCT01325714|12303619|FG000|NOT COMPLETED|Overall Study||34
11118806|NCT01325714|12303620|FG001|NOT COMPLETED|Overall Study||31
11118807|NCT01325792|12303628|FG000|STARTED|Overall Study||104
11118808|NCT01325792|12303628|FG000|COMPLETED|Overall Study||87
11118809|NCT01325792|12303628|FG000|NOT COMPLETED|Overall Study||17
11118810|NCT01325870|12303635|FG000|STARTED|Overall Study||18
11118811|NCT01325870|12303636|FG001|STARTED|Overall Study||16
11118812|NCT01325870|12303637|FG002|STARTED|Overall Study||14
11118813|NCT01325870|12303635|FG000|COMPLETED|Overall Study||7
11118814|NCT01325870|12303636|FG001|COMPLETED|Overall Study||3
11118815|NCT01325870|12303637|FG002|COMPLETED|Overall Study||6
11118816|NCT01325870|12303635|FG000|NOT COMPLETED|Overall Study||11
11118817|NCT01325870|12303636|FG001|NOT COMPLETED|Overall Study||13
11118818|NCT01325870|12303637|FG002|NOT COMPLETED|Overall Study||8
11118819|NCT01326026|12303647|FG000|STARTED|Overall Study||111
11118820|NCT01326026|12303648|FG001|STARTED|Overall Study||111
11118821|NCT01326026|12303647|FG000|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
11118822|NCT01326026|12303648|FG001|Exposed|Overall Study||111
11118823|NCT01326026|12303647|FG000|COMPLETED|Overall Study||99
11118824|NCT01326026|12303648|FG001|COMPLETED|Overall Study||98
11118825|NCT01326026|12303647|FG000|NOT COMPLETED|Overall Study||12
11118826|NCT01326026|12303648|FG001|NOT COMPLETED|Overall Study||13
11118827|NCT01326481|12303654|FG000|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4
11118828|NCT01326481|12303654|FG000|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3
11118829|NCT01326481|12303654|FG000|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1
11118830|NCT01326481|12303654|FG000|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
11118831|NCT01326481|12303654|FG000|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
11118832|NCT01326481|12303654|FG000|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0
11118833|NCT01326533|12303662|FG000|STARTED|Overall Study||17
11118834|NCT01326533|12303663|FG001|STARTED|Overall Study||15
11118835|NCT01326533|12303662|FG000|COMPLETED|Overall Study||13
11118836|NCT01326533|12303663|FG001|COMPLETED|Overall Study||15
11118837|NCT01326533|12303662|FG000|NOT COMPLETED|Overall Study||4
11118838|NCT01326533|12303663|FG001|NOT COMPLETED|Overall Study||0
11118839|NCT01326546|12303671|FG000|STARTED|Overall Study||189
11118840|NCT01326546|12303672|FG001|STARTED|Overall Study||189
11118841|NCT01326546|12303671|FG000|COMPLETED|Overall Study||172
11118842|NCT01326546|12303672|FG001|COMPLETED|Overall Study||176
11118843|NCT01326546|12303671|FG000|NOT COMPLETED|Overall Study||17
11118844|NCT01326546|12303672|FG001|NOT COMPLETED|Overall Study||13
11118845|NCT01326702|12303685|FG000|STARTED|Overall Study||3
11118846|NCT01326702|12303686|FG001|STARTED|Overall Study||3
11118847|NCT01326702|12303687|FG002|STARTED|Overall Study||6
11118848|NCT01326702|12303688|FG003|STARTED|Overall Study||4
11118849|NCT01326702|12303689|FG004|STARTED|Overall Study||5
11118850|NCT01326702|12303690|FG005|STARTED|Overall Study||15
11118851|NCT01326702|12303691|FG006|STARTED|Overall Study||7
11118852|NCT01326702|12303685|FG000|COMPLETED|Overall Study||1
11118853|NCT01326702|12303686|FG001|COMPLETED|Overall Study||1
11118854|NCT01326702|12303687|FG002|COMPLETED|Overall Study||1
11118855|NCT01326702|12303688|FG003|COMPLETED|Overall Study||1
11118856|NCT01326702|12303689|FG004|COMPLETED|Overall Study||1
11118857|NCT01326702|12303690|FG005|COMPLETED|Overall Study||7
11118858|NCT01326702|12303691|FG006|COMPLETED|Overall Study||0
11118859|NCT01326702|12303685|FG000|NOT COMPLETED|Overall Study||2
11118860|NCT01326702|12303686|FG001|NOT COMPLETED|Overall Study||2
11118861|NCT01326702|12303687|FG002|NOT COMPLETED|Overall Study||5
11118862|NCT01326702|12303688|FG003|NOT COMPLETED|Overall Study||3
11118863|NCT01326702|12303689|FG004|NOT COMPLETED|Overall Study||4
11118864|NCT01326702|12303690|FG005|NOT COMPLETED|Overall Study||8
11118865|NCT01326702|12303691|FG006|NOT COMPLETED|Overall Study||7
11118866|NCT01326728|12303712|FG000|STARTED|Overall Study||47
11118867|NCT01326728|12303713|FG001|STARTED|Overall Study||9
11118868|NCT01326728|12303712|FG000|COMPLETED|Overall Study||0
11118869|NCT01326728|12303713|FG001|COMPLETED|Overall Study||0
11118870|NCT01326728|12303712|FG000|NOT COMPLETED|Overall Study||47
11118871|NCT01326728|12303713|FG001|NOT COMPLETED|Overall Study||9
11118872|NCT01326780|12303722|FG000|STARTED|Overall Study||106
11118873|NCT01326780|12303723|FG001|STARTED|Overall Study||109
11118874|NCT01326780|12303724|FG002|STARTED|Overall Study||109
11118875|NCT01326780|12303725|FG003|STARTED|Overall Study||107
11118876|NCT01326780|12303722|FG000|COMPLETED|Overall Study||93
11118877|NCT01326780|12303723|FG001|COMPLETED|Overall Study||100
11118878|NCT01326780|12303724|FG002|COMPLETED|Overall Study||103
11118879|NCT01326780|12303725|FG003|COMPLETED|Overall Study||94
11118880|NCT01326780|12303722|FG000|NOT COMPLETED|Overall Study||13
11118881|NCT01326780|12303723|FG001|NOT COMPLETED|Overall Study||9
11118882|NCT01326780|12303724|FG002|NOT COMPLETED|Overall Study||6
11118883|NCT01326780|12303725|FG003|NOT COMPLETED|Overall Study||13
11118884|NCT01326910|12303737|FG000|STARTED|Overall Study||45
11118885|NCT01326910|12303738|FG001|STARTED|Overall Study||45
11118886|NCT01326910|12303737|FG000|COMPLETED|Overall Study||41
11118887|NCT01326910|12303738|FG001|COMPLETED|Overall Study||42
11118888|NCT01326910|12303737|FG000|NOT COMPLETED|Overall Study||4
11118889|NCT01326910|12303738|FG001|NOT COMPLETED|Overall Study||3
11118890|NCT01326962|12303744|FG000|STARTED|Overall Study||28
11118891|NCT01326962|12303744|FG000|COMPLETED|Overall Study||21
11118892|NCT01326962|12303744|FG000|NOT COMPLETED|Overall Study||7
11118893|NCT01327053|12303750|FG000|STARTED|Overall Study||79
11118894|NCT01327053|12303751|FG001|STARTED|Overall Study||151
11118895|NCT01327053|12303750|FG000|Untreated|Overall Study||0
11118896|NCT01327053|12303751|FG001|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1
11118897|NCT01327053|12303750|FG000|Patients Cont. to Next Phase of Trial|Overall Study||52
11118898|NCT01327053|12303751|FG001|Patients Cont. to Next Phase of Trial|Overall Study||89
11118899|NCT01327053|12303750|FG000|Survival Follow-up|Overall Study||33
11118900|NCT01327053|12303751|FG001|Survival Follow-up|Overall Study||49
11118901|NCT01327053|12303750|FG000|Post-treatment Follow-up|Overall Study||19
11118902|NCT01327053|12303751|FG001|Post-treatment Follow-up|Overall Study||40
11118903|NCT01327053|12303750|FG000|COMPLETED|Overall Study||0
11118904|NCT01327053|12303751|FG001|COMPLETED|Overall Study||0
11118905|NCT01327053|12303750|FG000|NOT COMPLETED|Overall Study||79
11118906|NCT01327053|12303751|FG001|NOT COMPLETED|Overall Study||151
11118907|NCT01327157|12303763|FG000|STARTED|01-90||7
11118908|NCT01327157|12303764|FG001|STARTED|01-90||7
11118909|NCT01327157|12303763|FG000|COMPLETED|01-90||7
11118910|NCT01327157|12303764|FG001|COMPLETED|01-90||7
11118911|NCT01327157|12303763|FG000|NOT COMPLETED|01-90||0
11118912|NCT01327157|12303764|FG001|NOT COMPLETED|01-90||0
11118913|NCT01327157|12303763|FG000|STARTED|91-180||7
11118914|NCT01327157|12303764|FG001|STARTED|91-180||0
11118915|NCT01327157|12303763|FG000|COMPLETED|91-180||7
11118916|NCT01327157|12303764|FG001|COMPLETED|91-180||0
11118917|NCT01327157|12303763|FG000|NOT COMPLETED|91-180||0
11118918|NCT01327157|12303764|FG001|NOT COMPLETED|91-180||0
11118919|NCT01327274|12303775|FG000|STARTED|Overall Study||15
11118920|NCT01327274|12303775|FG000|COMPLETED|Overall Study||15
11118921|NCT01327274|12303775|FG000|NOT COMPLETED|Overall Study||0
11118922|NCT01327300|12303780|FG000|STARTED|First Intervention (12 Weeks)||5
11118923|NCT01327300|12303781|FG001|STARTED|First Intervention (12 Weeks)||2
11118924|NCT01327300|12303780|FG000|COMPLETED|First Intervention (12 Weeks)||5
11118925|NCT01327300|12303781|FG001|COMPLETED|First Intervention (12 Weeks)||2
11118926|NCT01327300|12303780|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
11118927|NCT01327300|12303781|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
11118928|NCT01327300|12303780|FG000|STARTED|Washout (3 Weeks)||5
11118929|NCT01327300|12303781|FG001|STARTED|Washout (3 Weeks)||2
11118930|NCT01327300|12303780|FG000|COMPLETED|Washout (3 Weeks)||4
11118931|NCT01327300|12303781|FG001|COMPLETED|Washout (3 Weeks)||2
11118932|NCT01327300|12303780|FG000|NOT COMPLETED|Washout (3 Weeks)||1
11118933|NCT01327300|12303781|FG001|NOT COMPLETED|Washout (3 Weeks)||0
11118934|NCT01327300|12303780|FG000|STARTED|Second Intervention (12 Weeks)||4
11118935|NCT01327300|12303781|FG001|STARTED|Second Intervention (12 Weeks)||2
11118936|NCT01327300|12303780|FG000|COMPLETED|Second Intervention (12 Weeks)||4
11118937|NCT01327300|12303781|FG001|COMPLETED|Second Intervention (12 Weeks)||2
11118938|NCT01327300|12303780|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
11118939|NCT01327300|12303781|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
11118940|NCT01327313|12303801|FG000|STARTED|Overall Study||8
11118941|NCT01327313|12303802|FG001|STARTED|Overall Study||6
11118942|NCT01327313|12303803|FG002|STARTED|Overall Study||6
11118943|NCT01327313|12303804|FG003|STARTED|Overall Study||7
10876481|NCT01696981|12042541|FG000|STARTED|Overall Study||77455
10876482|NCT01696981|12042542|FG001|STARTED|Overall Study||77445
10876483|NCT01696981|12042541|FG000|COMPLETED|Overall Study||76254
10876484|NCT01696981|12042542|FG001|COMPLETED|Overall Study||67071
10876485|NCT01696981|12042541|FG000|NOT COMPLETED|Overall Study||1201
10876486|NCT01696981|12042542|FG001|NOT COMPLETED|Overall Study||10374
11118944|NCT01327313|12303801|FG000|COMPLETED|Overall Study||8
11118945|NCT01327313|12303802|FG001|COMPLETED|Overall Study||6
11118946|NCT01327313|12303803|FG002|COMPLETED|Overall Study||6
11118947|NCT01327313|12303804|FG003|COMPLETED|Overall Study||7
11118948|NCT01327313|12303801|FG000|NOT COMPLETED|Overall Study||0
11118949|NCT01327313|12303802|FG001|NOT COMPLETED|Overall Study||0
11118950|NCT01327313|12303803|FG002|NOT COMPLETED|Overall Study||0
11118951|NCT01327313|12303804|FG003|NOT COMPLETED|Overall Study||0
11118952|NCT01327339|12303814|FG000|STARTED|Overall Study||755
11118953|NCT01327339|12303814|FG000|COMPLETED|Overall Study||747
11118954|NCT01327339|12303814|FG000|NOT COMPLETED|Overall Study||8
11118955|NCT01327482|12303818|FG000|STARTED|Overall Study||10
11118956|NCT01327482|12303818|FG000|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
11118957|NCT01327482|12303818|FG000|NOT COMPLETED|Overall Study||1
10876502|NCT01467466|12042577|FG000|STARTED|Overall Study||1300
10876503|NCT01467466|12042578|FG001|STARTED|Overall Study||1292
10876504|NCT01467466|12042579|FG002|STARTED|Overall Study||1294
10876505|NCT01467466|12042580|FG003|STARTED|Overall Study||1291
10876506|NCT01467466|12042577|FG000|COMPLETED|Overall Study||1191
10876507|NCT01467466|12042578|FG001|COMPLETED|Overall Study||1188
10876508|NCT01467466|12042579|FG002|COMPLETED|Overall Study||1190
10876509|NCT01467466|12042580|FG003|COMPLETED|Overall Study||1203
10876510|NCT01467466|12042577|FG000|NOT COMPLETED|Overall Study||109
10876511|NCT01467466|12042578|FG001|NOT COMPLETED|Overall Study||104
10876512|NCT01467466|12042579|FG002|NOT COMPLETED|Overall Study||104
10876513|NCT01467466|12042580|FG003|NOT COMPLETED|Overall Study||88
10876514|NCT01463072|12042590|FG000|STARTED|Overall Study||40
10876515|NCT01463072|12042590|FG000|COMPLETED|Overall Study||40
10876516|NCT01463072|12042590|FG000|NOT COMPLETED|Overall Study||0
11118958|NCT01327495|12303828|FG000|STARTED|Overall Study||10
11118959|NCT01327495|12303829|FG001|STARTED|Overall Study||11
11118960|NCT01327495|12303830|FG002|STARTED|Overall Study||10
11118961|NCT01327495|12303831|FG003|STARTED|Overall Study||9
11118962|NCT01327495|12303832|FG004|STARTED|Overall Study||11
11118963|NCT01327495|12303833|FG005|STARTED|Overall Study||11
11118964|NCT01327495|12303828|FG000|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
11118965|NCT01327495|12303829|FG001|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
11118966|NCT01327495|12303830|FG002|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
11118967|NCT01327495|12303831|FG003|COMPLETED|Overall Study||9
11118968|NCT01327495|12303832|FG004|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
11118969|NCT01327495|12303833|FG005|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
11118970|NCT01327495|12303828|FG000|NOT COMPLETED|Overall Study||2
11118971|NCT01327495|12303829|FG001|NOT COMPLETED|Overall Study||2
11118972|NCT01327495|12303830|FG002|NOT COMPLETED|Overall Study||2
11118973|NCT01327495|12303831|FG003|NOT COMPLETED|Overall Study||0
11118974|NCT01327495|12303832|FG004|NOT COMPLETED|Overall Study||3
11118975|NCT01327495|12303833|FG005|NOT COMPLETED|Overall Study||2
11118976|NCT01327508|12303855|FG000|STARTED|Overall Study||30
11118977|NCT01327508|12303856|FG001|STARTED|Overall Study||30
11118978|NCT01327508|12303855|FG000|COMPLETED|Overall Study||30
11118979|NCT01327508|12303856|FG001|COMPLETED|Overall Study||30
11118980|NCT01327508|12303855|FG000|NOT COMPLETED|Overall Study||0
11118981|NCT01327508|12303856|FG001|NOT COMPLETED|Overall Study||0
11118982|NCT01327547|12303864|FG000|STARTED|Overall Study||70
11118983|NCT01327547|12303865|FG001|STARTED|Overall Study||67
11118984|NCT01327547|12303864|FG000|Randomized and Not Treated|Overall Study||0
11118985|NCT01327547|12303865|FG001|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
11118986|NCT01327547|12303864|FG000|COMPLETED|Overall Study||50
11118987|NCT01327547|12303865|FG001|COMPLETED|Overall Study||45
11118988|NCT01327547|12303864|FG000|NOT COMPLETED|Overall Study||20
11118989|NCT01327547|12303865|FG001|NOT COMPLETED|Overall Study||22
11118990|NCT01327573|12303882|FG000|STARTED|Overall Study||11
11118991|NCT01327573|12303883|FG001|STARTED|Overall Study||5
11118992|NCT01327573|12303882|FG000|Received Treatment/Control as Allocated|Overall Study||10
11118993|NCT01327573|12303883|FG001|Received Treatment/Control as Allocated|Overall Study||5
11118994|NCT01327573|12303882|FG000|COMPLETED|Overall Study||8
11118995|NCT01327573|12303883|FG001|COMPLETED|Overall Study||4
11118996|NCT01327573|12303882|FG000|NOT COMPLETED|Overall Study||3
11118997|NCT01327573|12303883|FG001|NOT COMPLETED|Overall Study||1
11118998|NCT01327599|12303890|FG000|STARTED|Overall Study||60
11118999|NCT01327599|12303890|FG000|COMPLETED|Overall Study||57
11119000|NCT01327599|12303890|FG000|NOT COMPLETED|Overall Study||3
11119001|NCT01327612|12303901|FG000|STARTED|Overall Study||2
11119002|NCT01327612|12303902|FG001|STARTED|Overall Study||1
11119003|NCT01327612|12303903|FG002|STARTED|Overall Study||1
11119004|NCT01327612|12303904|FG003|STARTED|Overall Study||1
11119005|NCT01327612|12303905|FG004|STARTED|Overall Study||2
11119006|NCT01327612|12303906|FG005|STARTED|Overall Study||3
11119007|NCT01327612|12303907|FG006|STARTED|Overall Study||2
11119008|NCT01327612|12303901|FG000|COMPLETED|Overall Study||1
11119009|NCT01327612|12303902|FG001|COMPLETED|Overall Study||0
11119010|NCT01327612|12303903|FG002|COMPLETED|Overall Study||0
11119011|NCT01327612|12303904|FG003|COMPLETED|Overall Study||0
11119012|NCT01327612|12303905|FG004|COMPLETED|Overall Study||0
11119013|NCT01327612|12303906|FG005|COMPLETED|Overall Study||0
11119014|NCT01327612|12303907|FG006|COMPLETED|Overall Study||0
11119015|NCT01327612|12303901|FG000|NOT COMPLETED|Overall Study||1
11119016|NCT01327612|12303902|FG001|NOT COMPLETED|Overall Study||1
11119017|NCT01327612|12303903|FG002|NOT COMPLETED|Overall Study||1
11119018|NCT01327612|12303904|FG003|NOT COMPLETED|Overall Study||1
11119019|NCT01327612|12303905|FG004|NOT COMPLETED|Overall Study||2
11119020|NCT01327612|12303906|FG005|NOT COMPLETED|Overall Study||3
11119021|NCT01327612|12303907|FG006|NOT COMPLETED|Overall Study||2
11119022|NCT01327677|12303926|FG000|STARTED|Overall Study||68
11119023|NCT01327677|12303927|FG001|STARTED|Overall Study||69
11119024|NCT01327677|12303926|FG000|COMPLETED|Overall Study||48
11119025|NCT01327677|12303927|FG001|COMPLETED|Overall Study||56
11119026|NCT01327677|12303926|FG000|NOT COMPLETED|Overall Study||20
11119027|NCT01327677|12303927|FG001|NOT COMPLETED|Overall Study||13
11119028|NCT01327703|12303935|FG000|STARTED|First Treatment Period||42
11119029|NCT01327703|12303936|FG001|STARTED|First Treatment Period||45
11119030|NCT01327703|12303935|FG000|COMPLETED|First Treatment Period||42
11119031|NCT01327703|12303936|FG001|COMPLETED|First Treatment Period||45
11119032|NCT01327703|12303935|FG000|NOT COMPLETED|First Treatment Period||0
11119033|NCT01327703|12303936|FG001|NOT COMPLETED|First Treatment Period||0
11119034|NCT01327703|12303935|FG000|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
11119035|NCT01327703|12303936|FG001|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
11119036|NCT01327703|12303935|FG000|COMPLETED|Second Treatment Period||39
11119037|NCT01327703|12303936|FG001|COMPLETED|Second Treatment Period||42
11119038|NCT01327703|12303935|FG000|NOT COMPLETED|Second Treatment Period||1
11119039|NCT01327703|12303936|FG001|NOT COMPLETED|Second Treatment Period||2
11119040|NCT01327846|12303949|FG000|STARTED|Core Phase||2263
11119041|NCT01327846|12303950|FG001|STARTED|Core Phase||2284
11119042|NCT01327846|12303951|FG002|STARTED|Core Phase||2170
11119043|NCT01327846|12303952|FG003|STARTED|Core Phase||3344
11119044|NCT01327846|12303949|FG000|COMPLETED|Core Phase||2235
11119045|NCT01327846|12303950|FG001|COMPLETED|Core Phase||2252
11119046|NCT01327846|12303951|FG002|COMPLETED|Core Phase||2144
11119047|NCT01327846|12303952|FG003|COMPLETED|Core Phase||3311
11119048|NCT01327846|12303949|FG000|NOT COMPLETED|Core Phase||28
11119049|NCT01327846|12303950|FG001|NOT COMPLETED|Core Phase||32
11119050|NCT01327846|12303951|FG002|NOT COMPLETED|Core Phase||26
11119051|NCT01327846|12303952|FG003|NOT COMPLETED|Core Phase||33
11119052|NCT01327846|12303949|FG000|STARTED|Extension Phase||1267
11119053|NCT01327846|12303950|FG001|STARTED|Extension Phase||1287
11119054|NCT01327846|12303951|FG002|STARTED|Extension Phase||1279
11119055|NCT01327846|12303952|FG003|STARTED|Extension Phase||1944
11119056|NCT01327846|12303949|FG000|Stopped/Discontinued Study at Washout|Extension Phase||127
11119057|NCT01327846|12303950|FG001|Stopped/Discontinued Study at Washout|Extension Phase||97
11119058|NCT01327846|12303951|FG002|Stopped/Discontinued Study at Washout|Extension Phase||137
11119059|NCT01327846|12303952|FG003|Stopped/Discontinued Study at Washout|Extension Phase||178
11119060|NCT01327846|12303949|FG000|Completed Treatment Period|Extension Phase||41
11119061|NCT01327846|12303950|FG001|Completed Treatment Period|Extension Phase||45
11119062|NCT01327846|12303951|FG002|Completed Treatment Period|Extension Phase||49
11119063|NCT01327846|12303952|FG003|Completed Treatment Period|Extension Phase||60
11119064|NCT01327846|12303949|FG000|Details Missing|Extension Phase||0
11119065|NCT01327846|12303950|FG001|Details Missing|Extension Phase||1
11119066|NCT01327846|12303951|FG002|Details Missing|Extension Phase||1
11119067|NCT01327846|12303952|FG003|Details Missing|Extension Phase||0
11119068|NCT01327846|12303949|FG000|COMPLETED|Extension Phase||168
11119069|NCT01327846|12303950|FG001|COMPLETED|Extension Phase||143
11119070|NCT01327846|12303951|FG002|COMPLETED|Extension Phase||187
11119071|NCT01327846|12303952|FG003|COMPLETED|Extension Phase||238
11119072|NCT01327846|12303949|FG000|NOT COMPLETED|Extension Phase||1099
11119073|NCT01327846|12303950|FG001|NOT COMPLETED|Extension Phase||1144
11119074|NCT01327846|12303951|FG002|NOT COMPLETED|Extension Phase||1092
11119075|NCT01327846|12303952|FG003|NOT COMPLETED|Extension Phase||1706
11119076|NCT01327885|12303965|FG000|STARTED|Overall Study||228
11119077|NCT01327885|12303966|FG001|STARTED|Overall Study||224
11119078|NCT01327885|12303965|FG000|COMPLETED|Overall Study||0
11119079|NCT01327885|12303966|FG001|COMPLETED|Overall Study||0
11119080|NCT01327885|12303965|FG000|NOT COMPLETED|Overall Study||228
11119081|NCT01327885|12303966|FG001|NOT COMPLETED|Overall Study||224
11119082|NCT01327963|12303973|FG000|STARTED|Overall Study||110
11119083|NCT01327963|12303973|FG000|COMPLETED|Overall Study|110 participants signed informed consent to be included in the study.|110
11119084|NCT01327963|12303973|FG000|NOT COMPLETED|Overall Study||0
11119085|NCT01327976|12303981|FG000|STARTED|Overall Study||162
11119086|NCT01327976|12303982|FG001|STARTED|Overall Study||77
11119087|NCT01327976|12303981|FG000|COMPLETED|Overall Study||154
11119088|NCT01327976|12303982|FG001|COMPLETED|Overall Study||70
11119089|NCT01327976|12303981|FG000|NOT COMPLETED|Overall Study||8
11119090|NCT01327976|12303982|FG001|NOT COMPLETED|Overall Study||7
11119091|NCT01327989|12303990|FG000|STARTED|Overall Study||202
11119092|NCT01327989|12303990|FG000|COMPLETED|Overall Study||188
11119093|NCT01327989|12303990|FG000|NOT COMPLETED|Overall Study||14
11119094|NCT01328002|12303994|FG000|STARTED|Open-Label Period||116
11119095|NCT01328002|12303995|FG001|STARTED|Open-Label Period||0
11119096|NCT01328002|12303994|FG000|COMPLETED|Open-Label Period||20
11119097|NCT01328002|12303995|FG001|COMPLETED|Open-Label Period||0
11119098|NCT01328002|12303994|FG000|NOT COMPLETED|Open-Label Period||96
11119099|NCT01328002|12303995|FG001|NOT COMPLETED|Open-Label Period||0
11119100|NCT01328002|12303994|FG000|STARTED|Double-Blind Period||14
11119101|NCT01328002|12303995|FG001|STARTED|Double-Blind Period||6
11119102|NCT01328002|12303994|FG000|COMPLETED|Double-Blind Period||12
11119103|NCT01328002|12303995|FG001|COMPLETED|Double-Blind Period||6
11119104|NCT01328002|12303994|FG000|NOT COMPLETED|Double-Blind Period||2
11119105|NCT01328002|12303995|FG001|NOT COMPLETED|Double-Blind Period||0
11119106|NCT01328041|12304002|FG000|STARTED|Overall Study||183
11119107|NCT01328041|12304002|FG000|COMPLETED|Overall Study||126
11119108|NCT01328041|12304002|FG000|NOT COMPLETED|Overall Study||57
11119109|NCT01328054|12304006|FG000|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
11119110|NCT01328054|12304007|FG001|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
11119111|NCT01328054|12304006|FG000|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
11119112|NCT01328054|12304007|FG001|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
11119113|NCT01328054|12304006|FG000|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
11119114|NCT01328054|12304007|FG001|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
11119115|NCT01328054|12304006|FG000|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
11119116|NCT01328054|12304007|FG001|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
11119117|NCT01328054|12304006|FG000|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
11119118|NCT01328054|12304007|FG001|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
11119119|NCT01328054|12304006|FG000|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
11119120|NCT01328054|12304007|FG001|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
11119121|NCT01328080|12304019|FG000|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
11119122|NCT01328080|12304019|FG000|COMPLETED|Overall Study||6
11119123|NCT01328080|12304019|FG000|NOT COMPLETED|Overall Study||5
11119124|NCT01328158|12304023|FG000|STARTED|Overall Study||220
11119125|NCT01328158|12304023|FG000|COMPLETED|Overall Study||220
11119126|NCT01328158|12304023|FG000|NOT COMPLETED|Overall Study||0
11119127|NCT01328184|12304030|FG000|STARTED|Overall Study||18
11119128|NCT01328184|12304030|FG000|COMPLETED|Overall Study||18
11119129|NCT01328184|12304030|FG000|NOT COMPLETED|Overall Study||0
11119130|NCT01328249|12304038|FG000|STARTED|Overall Study||55
11119131|NCT01328249|12304039|FG001|STARTED|Overall Study||26
11119132|NCT01328249|12304038|FG000|COMPLETED|Overall Study||48
11119133|NCT01328249|12304039|FG001|COMPLETED|Overall Study||23
11119134|NCT01328249|12304038|FG000|NOT COMPLETED|Overall Study||7
11119135|NCT01328249|12304039|FG001|NOT COMPLETED|Overall Study||3
10876733|NCT01318317|12042669|FG000|STARTED|Overall Study||1
10876734|NCT01318317|12042670|FG001|STARTED|Overall Study||4
10876735|NCT01318317|12042671|FG002|STARTED|Overall Study||3
10876736|NCT01318317|12042669|FG000|COMPLETED|Overall Study||1
10876737|NCT01318317|12042670|FG001|COMPLETED|Overall Study||4
10876738|NCT01318317|12042671|FG002|COMPLETED|Overall Study||3
10876739|NCT01318317|12042669|FG000|NOT COMPLETED|Overall Study||0
10876740|NCT01318317|12042670|FG001|NOT COMPLETED|Overall Study||0
10876741|NCT01318317|12042671|FG002|NOT COMPLETED|Overall Study||0
11119136|NCT01328366|12304047|FG000|STARTED|Overall Study||153
11119137|NCT01328366|12304047|FG000|COMPLETED|Overall Study||143
11119138|NCT01328366|12304047|FG000|NOT COMPLETED|Overall Study||10
11119139|NCT01328379|12304054|FG000|STARTED|Overall Study||143
11119140|NCT01328379|12304055|FG001|STARTED|Overall Study||144
11119141|NCT01328379|12304056|FG002|STARTED|Overall Study||143
11119142|NCT01328379|12304054|FG000|COMPLETED|Overall Study||142
11119143|NCT01328379|12304055|FG001|COMPLETED|Overall Study||144
11119144|NCT01328379|12304056|FG002|COMPLETED|Overall Study||143
11119145|NCT01328379|12304054|FG000|NOT COMPLETED|Overall Study||1
11119146|NCT01328379|12304055|FG001|NOT COMPLETED|Overall Study||0
11119147|NCT01328379|12304056|FG002|NOT COMPLETED|Overall Study||0
11119148|NCT01328405|12304066|FG000|STARTED|Overall Study||52
11119149|NCT01328405|12304067|FG001|STARTED|Overall Study||48
11119150|NCT01328405|12304066|FG000|COMPLETED|Overall Study||52
11119151|NCT01328405|12304067|FG001|COMPLETED|Overall Study||48
11119152|NCT01328405|12304066|FG000|NOT COMPLETED|Overall Study||0
11119153|NCT01328405|12304067|FG001|NOT COMPLETED|Overall Study||0
11119154|NCT01328431|12304075|FG000|STARTED|Baseline||390
11119155|NCT01328431|12304076|FG001|STARTED|Baseline||390
11119156|NCT01328431|12304075|FG000|COMPLETED|Baseline||390
11119157|NCT01328431|12304076|FG001|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
11119158|NCT01328431|12304075|FG000|NOT COMPLETED|Baseline||0
11119159|NCT01328431|12304076|FG001|NOT COMPLETED|Baseline||2
11119160|NCT01328431|12304075|FG000|STARTED|1 Month (1M)||390
11119161|NCT01328431|12304076|FG001|STARTED|1 Month (1M)||388
11119162|NCT01328431|12304075|FG000|COMPLETED|1 Month (1M)||335
11119163|NCT01328431|12304076|FG001|COMPLETED|1 Month (1M)||330
11119164|NCT01328431|12304075|FG000|NOT COMPLETED|1 Month (1M)||55
11119165|NCT01328431|12304076|FG001|NOT COMPLETED|1 Month (1M)||58
11119166|NCT01328431|12304075|FG000|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
11119167|NCT01328431|12304076|FG001|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
11119168|NCT01328431|12304075|FG000|COMPLETED|3 Month (3M)||313
11119169|NCT01328431|12304076|FG001|COMPLETED|3 Month (3M)||316
11119170|NCT01328431|12304075|FG000|NOT COMPLETED|3 Month (3M)||77
11119171|NCT01328431|12304076|FG001|NOT COMPLETED|3 Month (3M)||72
11119172|NCT01328431|12304075|FG000|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
11119173|NCT01328431|12304076|FG001|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
11119174|NCT01328431|12304075|FG000|COMPLETED|12 Month (12M)||304
11119175|NCT01328431|12304076|FG001|COMPLETED|12 Month (12M)||289
11119176|NCT01328431|12304075|FG000|NOT COMPLETED|12 Month (12M)||84
11119177|NCT01328431|12304076|FG001|NOT COMPLETED|12 Month (12M)||97
11119178|NCT01328444|12304082|FG000|STARTED|Treatment Period 1 (12 Weeks)||94
11119179|NCT01328444|12304083|FG001|STARTED|Treatment Period 1 (12 Weeks)||26
11119180|NCT01328444|12304084|FG002|STARTED|Treatment Period 1 (12 Weeks)||28
11119181|NCT01328444|12304085|FG003|STARTED|Treatment Period 1 (12 Weeks)||41
11119182|NCT01328444|12304086|FG004|STARTED|Treatment Period 1 (12 Weeks)||81
11119183|NCT01328444|12304087|FG005|STARTED|Treatment Period 1 (12 Weeks)||78
11119184|NCT01328444|12304082|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||83
11119185|NCT01328444|12304083|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21
11119186|NCT01328444|12304084|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||25
11119187|NCT01328444|12304085|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||33
11119188|NCT01328444|12304086|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||67
11119189|NCT01328444|12304087|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||72
11119190|NCT01328444|12304082|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
11119191|NCT01328444|12304083|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
11119192|NCT01328444|12304084|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
11119193|NCT01328444|12304085|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
11119194|NCT01328444|12304086|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
11119195|NCT01328444|12304087|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
11119196|NCT01328444|12304082|FG000|STARTED|Washout Period (14 Days)||83
11119197|NCT01328444|12304083|FG001|STARTED|Washout Period (14 Days)||21
11119198|NCT01328444|12304084|FG002|STARTED|Washout Period (14 Days)||25
11119199|NCT01328444|12304085|FG003|STARTED|Washout Period (14 Days)||33
11119200|NCT01328444|12304086|FG004|STARTED|Washout Period (14 Days)||67
11119201|NCT01328444|12304087|FG005|STARTED|Washout Period (14 Days)||72
11119202|NCT01328444|12304082|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
11119203|NCT01328444|12304083|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
11119204|NCT01328444|12304084|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
11119205|NCT01328444|12304085|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
11119206|NCT01328444|12304086|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
11119207|NCT01328444|12304087|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
11119208|NCT01328444|12304082|FG000|NOT COMPLETED|Washout Period (14 Days)||1
11119209|NCT01328444|12304083|FG001|NOT COMPLETED|Washout Period (14 Days)||1
11119210|NCT01328444|12304084|FG002|NOT COMPLETED|Washout Period (14 Days)||0
11119211|NCT01328444|12304085|FG003|NOT COMPLETED|Washout Period (14 Days)||1
11119212|NCT01328444|12304086|FG004|NOT COMPLETED|Washout Period (14 Days)||1
11119213|NCT01328444|12304087|FG005|NOT COMPLETED|Washout Period (14 Days)||4
11119214|NCT01328444|12304082|FG000|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
11119215|NCT01328444|12304083|FG001|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
11119216|NCT01328444|12304084|FG002|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
11119217|NCT01328444|12304085|FG003|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
11119218|NCT01328444|12304086|FG004|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
11119219|NCT01328444|12304087|FG005|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
11119220|NCT01328444|12304082|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||65
11119221|NCT01328444|12304083|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||22
11119222|NCT01328444|12304084|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||19
11119223|NCT01328444|12304085|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||30
11119224|NCT01328444|12304086|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||63
11119225|NCT01328444|12304087|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||59
11119226|NCT01328444|12304082|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
11119227|NCT01328444|12304083|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
11119228|NCT01328444|12304084|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
11119229|NCT01328444|12304085|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
11119230|NCT01328444|12304086|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
11119231|NCT01328444|12304087|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
11119232|NCT01328496|12304103|FG000|STARTED|Overall Study||10
11119233|NCT01328496|12304104|FG001|STARTED|Overall Study||4
10876846|NCT01121224|12042800|FG000|STARTED|Overall Study||305
10876847|NCT01121224|12042801|FG001|STARTED|Overall Study||292
10876848|NCT01121224|12042800|FG000|COMPLETED|Overall Study||280
10876849|NCT01121224|12042801|FG001|COMPLETED|Overall Study||275
10876850|NCT01121224|12042800|FG000|NOT COMPLETED|Overall Study||25
10876851|NCT01121224|12042801|FG001|NOT COMPLETED|Overall Study||17
11119234|NCT01328496|12304103|FG000|COMPLETED|Overall Study||9
11119235|NCT01328496|12304104|FG001|COMPLETED|Overall Study||4
11119236|NCT01328496|12304103|FG000|NOT COMPLETED|Overall Study||1
11119237|NCT01328496|12304104|FG001|NOT COMPLETED|Overall Study||0
11119238|NCT01328535|12304113|FG000|STARTED|Overall Study||25
11119239|NCT01328535|12304113|FG000|COMPLETED|Overall Study||24
11119240|NCT01328535|12304113|FG000|NOT COMPLETED|Overall Study||1
11119241|NCT01328548|12304121|FG000|STARTED|Overall Study||191
11119242|NCT01328548|12304122|FG001|STARTED|Overall Study||50
11119243|NCT01328548|12304121|FG000|COMPLETED|Overall Study||187
11119244|NCT01328548|12304122|FG001|COMPLETED|Overall Study||50
11119245|NCT01328548|12304121|FG000|NOT COMPLETED|Overall Study||4
11119246|NCT01328548|12304122|FG001|NOT COMPLETED|Overall Study||0
11119247|NCT01328574|12304128|FG000|STARTED|Overall Study||13
11119248|NCT01328574|12304128|FG000|COMPLETED|Overall Study||12
11119249|NCT01328574|12304128|FG000|NOT COMPLETED|Overall Study||1
11119250|NCT01328717|12304137|FG000|STARTED|Overall Study||78
11119251|NCT01328717|12304137|FG000|COMPLETED|Overall Study||77
11119252|NCT01328717|12304137|FG000|NOT COMPLETED|Overall Study||1
11119253|NCT01328743|12304143|FG000|STARTED|Overall Study||91
11119254|NCT01328743|12304144|FG001|STARTED|Overall Study||89
11119255|NCT01328743|12304143|FG000|COMPLETED|Overall Study||82
11119256|NCT01328743|12304144|FG001|COMPLETED|Overall Study||79
11119257|NCT01328743|12304143|FG000|NOT COMPLETED|Overall Study||9
11119258|NCT01328743|12304144|FG001|NOT COMPLETED|Overall Study||10
11119259|NCT01328756|12304150|FG000|STARTED|Overall Study||314
11119260|NCT01328756|12304150|FG000|COMPLETED|Overall Study||191
11119261|NCT01328756|12304150|FG000|NOT COMPLETED|Overall Study||123
11119262|NCT01328769|12304156|FG000|STARTED|Overall Study||25
11119263|NCT01328769|12304157|FG001|STARTED|Overall Study||24
11119264|NCT01328769|12304156|FG000|COMPLETED|Overall Study||25
11119265|NCT01328769|12304157|FG001|COMPLETED|Overall Study||23
11119266|NCT01328769|12304156|FG000|NOT COMPLETED|Overall Study||0
11119267|NCT01328769|12304157|FG001|NOT COMPLETED|Overall Study||1
11119268|NCT01328782|12304166|FG000|STARTED|Overall Study||43
11119269|NCT01328782|12304167|FG001|STARTED|Overall Study||42
11119270|NCT01328782|12304168|FG002|STARTED|Overall Study||39
11119271|NCT01328782|12304166|FG000|COMPLETED|Overall Study||43
10876900|NCT01062425|12042859|FG000|STARTED|Overall Study||55
10876901|NCT01062425|12042860|FG001|STARTED|Overall Study||103
10876902|NCT01062425|12042859|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
10876903|NCT01062425|12042860|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
10876904|NCT01062425|12042859|FG000|NOT COMPLETED|Overall Study||3
10876905|NCT01062425|12042860|FG001|NOT COMPLETED|Overall Study||6
11119272|NCT01328782|12304167|FG001|COMPLETED|Overall Study||42
11119273|NCT01328782|12304168|FG002|COMPLETED|Overall Study||39
11119274|NCT01328782|12304166|FG000|NOT COMPLETED|Overall Study||0
11119275|NCT01328782|12304167|FG001|NOT COMPLETED|Overall Study||0
11119276|NCT01328782|12304168|FG002|NOT COMPLETED|Overall Study||0
11119277|NCT01328873|12304176|FG000|STARTED|Overall Study||49
11119278|NCT01328873|12304176|FG000|COMPLETED|Overall Study||49
11119279|NCT01328873|12304176|FG000|NOT COMPLETED|Overall Study||0
11119280|NCT01328951|12304184|FG000|STARTED|Overall Study||321
11119281|NCT01328951|12304185|FG001|STARTED|Overall Study||322
11119282|NCT01328951|12304184|FG000|COMPLETED|Overall Study||0
11119283|NCT01328951|12304185|FG001|COMPLETED|Overall Study||0
11119284|NCT01328951|12304184|FG000|NOT COMPLETED|Overall Study||321
11119285|NCT01328951|12304185|FG001|NOT COMPLETED|Overall Study||322
11119286|NCT01328964|12304198|FG000|STARTED|Overall Study||2212
11119287|NCT01328964|12304199|FG001|STARTED|Overall Study||3270
11119288|NCT01328964|12304200|FG002|STARTED|Overall Study||4424
11119289|NCT01328964|12304198|FG000|COMPLETED|Overall Study||2212
11119290|NCT01328964|12304199|FG001|COMPLETED|Overall Study||3270
11119291|NCT01328964|12304200|FG002|COMPLETED|Overall Study||4424
11119292|NCT01328964|12304198|FG000|NOT COMPLETED|Overall Study||0
11119293|NCT01328964|12304199|FG001|NOT COMPLETED|Overall Study||0
11119294|NCT01328964|12304200|FG002|NOT COMPLETED|Overall Study||0
11119295|NCT01329029|12304210|FG000|STARTED|Overall Study||973
11119296|NCT01329029|12304211|FG001|STARTED|Overall Study||972
11119297|NCT01329029|12304210|FG000|Full Analysis Set (FAS)|Overall Study||969
11119298|NCT01329029|12304211|FG001|Full Analysis Set (FAS)|Overall Study||966
11119299|NCT01329029|12304210|FG000|Safety Population|Overall Study||968
11119300|NCT01329029|12304211|FG001|Safety Population|Overall Study||967
11119301|NCT01329029|12304210|FG000|COMPLETED|Overall Study||704
11119302|NCT01329029|12304211|FG001|COMPLETED|Overall Study||780
11119303|NCT01329029|12304210|FG000|NOT COMPLETED|Overall Study||269
11119304|NCT01329029|12304211|FG001|NOT COMPLETED|Overall Study||192
11119305|NCT01329185|12304219|FG000|STARTED|Overall Study||10
11119306|NCT01329185|12304220|FG001|STARTED|Overall Study||7
11119307|NCT01329185|12304219|FG000|CMV Disease|Overall Study||1
11119308|NCT01329185|12304220|FG001|CMV Disease|Overall Study||0
11119309|NCT01329185|12304219|FG000|PTLD|Overall Study||1
11119310|NCT01329185|12304220|FG001|PTLD|Overall Study||0
11119311|NCT01329185|12304219|FG000|COMPLETED|Overall Study||10
11119312|NCT01329185|12304220|FG001|COMPLETED|Overall Study||7
11119313|NCT01329185|12304219|FG000|NOT COMPLETED|Overall Study||0
11119314|NCT01329185|12304220|FG001|NOT COMPLETED|Overall Study||0
11119315|NCT01329198|12304228|FG000|STARTED|Overall Study||3
11119316|NCT01329198|12304229|FG001|STARTED|Overall Study||2
11119317|NCT01329198|12304228|FG000|COMPLETED|Overall Study||3
11119318|NCT01329198|12304229|FG001|COMPLETED|Overall Study||2
11119319|NCT01329198|12304228|FG000|NOT COMPLETED|Overall Study||0
11119320|NCT01329198|12304229|FG001|NOT COMPLETED|Overall Study||0
11119321|NCT01329263|12304242|FG000|STARTED|Overall Study||15
11119322|NCT01329263|12304243|FG001|STARTED|Overall Study||45
11119323|NCT01329263|12304242|FG000|Completed Period 1 Own Menthol|Overall Study||15
11119324|NCT01329263|12304243|FG001|Completed Period 1 Own Menthol|Overall Study||45
11119325|NCT01329263|12304242|FG000|Completed Period 2 Own or CCrush Menthol|Overall Study||10
11119326|NCT01329263|12304243|FG001|Completed Period 2 Own or CCrush Menthol|Overall Study||30
11119327|NCT01329263|12304242|FG000|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
11119328|NCT01329263|12304243|FG001|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
11119329|NCT01329263|12304242|FG000|COMPLETED|Overall Study||10
11119330|NCT01329263|12304243|FG001|COMPLETED|Overall Study||22
11119331|NCT01329263|12304242|FG000|NOT COMPLETED|Overall Study||5
11119332|NCT01329263|12304243|FG001|NOT COMPLETED|Overall Study||23
11119333|NCT01329328|12304254|FG000|STARTED|Overall Study||15
11119334|NCT01329328|12304255|FG001|STARTED|Overall Study||17
11119335|NCT01329328|12304256|FG002|STARTED|Overall Study||18
11119336|NCT01329328|12304254|FG000|COMPLETED|Overall Study||13
11119337|NCT01329328|12304255|FG001|COMPLETED|Overall Study||13
11119338|NCT01329328|12304256|FG002|COMPLETED|Overall Study||15
11119339|NCT01329328|12304254|FG000|NOT COMPLETED|Overall Study||2
11119340|NCT01329328|12304255|FG001|NOT COMPLETED|Overall Study||4
11119341|NCT01329328|12304256|FG002|NOT COMPLETED|Overall Study||3
11119342|NCT01329380|12304264|FG000|STARTED|Overall Study||403
11119343|NCT01329380|12304264|FG000|Safety Population|Overall Study||396
11119344|NCT01329380|12304264|FG000|COMPLETED|Overall Study||374
11119345|NCT01329380|12304264|FG000|NOT COMPLETED|Overall Study||29
11119346|NCT01329419|12304268|FG000|STARTED|Overall Study||4393
11119347|NCT01329419|12304268|FG000|COMPLETED|Overall Study||4158
11119348|NCT01329419|12304268|FG000|NOT COMPLETED|Overall Study||235
11119349|NCT01329562|12304275|FG000|STARTED|Overall Study||20
11119350|NCT01329562|12304276|FG001|STARTED|Overall Study||21
11119351|NCT01329562|12304275|FG000|COMPLETED|Overall Study||11
11119352|NCT01329562|12304276|FG001|COMPLETED|Overall Study||14
11119353|NCT01329562|12304275|FG000|NOT COMPLETED|Overall Study||9
11119354|NCT01329562|12304276|FG001|NOT COMPLETED|Overall Study||7
11119355|NCT01329679|12304284|FG000|STARTED|Overall Study||13
11119356|NCT01329679|12304285|FG001|STARTED|Overall Study||13
11119357|NCT01329679|12304284|FG000|COMPLETED|Overall Study||13
11119358|NCT01329679|12304285|FG001|COMPLETED|Overall Study||13
11119359|NCT01329679|12304284|FG000|NOT COMPLETED|Overall Study||0
11119360|NCT01329679|12304285|FG001|NOT COMPLETED|Overall Study||0
11119361|NCT01329848|12304293|FG000|STARTED|Overall Study||83
11119362|NCT01329848|12304293|FG000|COMPLETED|Overall Study||54
11119363|NCT01329848|12304293|FG000|NOT COMPLETED|Overall Study||29
11119364|NCT01329900|12304297|FG000|STARTED|Overall Study||50
11119365|NCT01329900|12304297|FG000|COMPLETED|Overall Study||49
11119366|NCT01329900|12304297|FG000|NOT COMPLETED|Overall Study||1
11119367|NCT01329939|12304305|FG000|STARTED|Overall Study||7
11119368|NCT01329939|12304306|FG001|STARTED|Overall Study||5
11119369|NCT01329939|12304307|FG002|STARTED|Overall Study||5
11119370|NCT01329939|12304308|FG003|STARTED|Overall Study||9
11119371|NCT01329939|12304305|FG000|COMPLETED|Overall Study||4
11119372|NCT01329939|12304306|FG001|COMPLETED|Overall Study||4
11119373|NCT01329939|12304307|FG002|COMPLETED|Overall Study||4
11119374|NCT01329939|12304308|FG003|COMPLETED|Overall Study||4
11119375|NCT01329939|12304305|FG000|NOT COMPLETED|Overall Study||3
11119376|NCT01329939|12304306|FG001|NOT COMPLETED|Overall Study||1
11119377|NCT01329939|12304307|FG002|NOT COMPLETED|Overall Study||1
11119378|NCT01329939|12304308|FG003|NOT COMPLETED|Overall Study||5
11119379|NCT01329978|12304321|FG000|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
11119380|NCT01329978|12304322|FG001|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
11119381|NCT01329978|12304323|FG002|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
11119382|NCT01329978|12304324|FG003|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
11119383|NCT01329978|12304325|FG004|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
11119384|NCT01329978|12304321|FG000|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
11119385|NCT01329978|12304322|FG001|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
11119386|NCT01329978|12304323|FG002|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
11119387|NCT01329978|12304324|FG003|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
11119388|NCT01329978|12304325|FG004|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
11119389|NCT01329978|12304321|FG000|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
11119390|NCT01329978|12304322|FG001|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
11119391|NCT01329978|12304323|FG002|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
11119392|NCT01329978|12304324|FG003|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
11119393|NCT01329978|12304325|FG004|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
11119394|NCT01329978|12304321|FG000|STARTED|Rerandomization Treatment Period||0
11119395|NCT01329978|12304322|FG001|STARTED|Rerandomization Treatment Period||0
11119396|NCT01329978|12304323|FG002|STARTED|Rerandomization Treatment Period||0
11119397|NCT01329978|12304324|FG003|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
11119398|NCT01329978|12304325|FG004|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
11119399|NCT01329978|12304321|FG000|COMPLETED|Rerandomization Treatment Period||0
11119400|NCT01329978|12304322|FG001|COMPLETED|Rerandomization Treatment Period||0
11119401|NCT01329978|12304323|FG002|COMPLETED|Rerandomization Treatment Period||0
11119402|NCT01329978|12304324|FG003|COMPLETED|Rerandomization Treatment Period||70
11119403|NCT01329978|12304325|FG004|COMPLETED|Rerandomization Treatment Period||71
11119404|NCT01329978|12304321|FG000|NOT COMPLETED|Rerandomization Treatment Period||0
11119405|NCT01329978|12304322|FG001|NOT COMPLETED|Rerandomization Treatment Period||0
11119406|NCT01329978|12304323|FG002|NOT COMPLETED|Rerandomization Treatment Period||0
11119407|NCT01329978|12304324|FG003|NOT COMPLETED|Rerandomization Treatment Period||5
11119408|NCT01329978|12304325|FG004|NOT COMPLETED|Rerandomization Treatment Period||4
11119409|NCT01330017|12304342|FG000|STARTED|Overall Study||109
11119410|NCT01330017|12304343|FG001|STARTED|Overall Study||108
11119411|NCT01330017|12304344|FG002|STARTED|Overall Study||107
11119412|NCT01330017|12304345|FG003|STARTED|Overall Study||112
11119413|NCT01330017|12304346|FG004|STARTED|Overall Study||103
11119414|NCT01330017|12304342|FG000|COMPLETED|Overall Study||104
11119415|NCT01330017|12304343|FG001|COMPLETED|Overall Study||104
11119416|NCT01330017|12304344|FG002|COMPLETED|Overall Study||99
11119417|NCT01330017|12304345|FG003|COMPLETED|Overall Study||100
11119418|NCT01330017|12304346|FG004|COMPLETED|Overall Study||100
11119419|NCT01330017|12304342|FG000|NOT COMPLETED|Overall Study||5
11119420|NCT01330017|12304343|FG001|NOT COMPLETED|Overall Study||4
11119421|NCT01330017|12304344|FG002|NOT COMPLETED|Overall Study||8
11119422|NCT01330017|12304345|FG003|NOT COMPLETED|Overall Study||12
11119423|NCT01330017|12304346|FG004|NOT COMPLETED|Overall Study||3
11119424|NCT01330030|12304360|FG000|STARTED|Overall Study||121
11119425|NCT01330030|12304361|FG001|STARTED|Overall Study||122
11119426|NCT01330030|12304360|FG000|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
11119427|NCT01330030|12304361|FG001|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
11119428|NCT01330030|12304360|FG000|NOT COMPLETED|Overall Study||16
11119429|NCT01330030|12304361|FG001|NOT COMPLETED|Overall Study||17
11119430|NCT01330043|12304369|FG000|STARTED|Overall Study||111
11119431|NCT01330043|12304370|FG001|STARTED|Overall Study||112
11119432|NCT01330043|12304369|FG000|COMPLETED|Overall Study||111
11119433|NCT01330043|12304370|FG001|COMPLETED|Overall Study||108
11119434|NCT01330043|12304369|FG000|NOT COMPLETED|Overall Study||0
11119435|NCT01330043|12304370|FG001|NOT COMPLETED|Overall Study||4
11119436|NCT01330108|12304376|FG000|STARTED|Overall Study||32
11119437|NCT01330108|12304376|FG000|COMPLETED|Overall Study||28
10877066|NCT00593840|12043052|FG000|STARTED|Overall Study||73
10877067|NCT00593840|12043052|FG000|COMPLETED|Overall Study||72
10877068|NCT00593840|12043052|FG000|NOT COMPLETED|Overall Study||1
11119438|NCT01330108|12304376|FG000|NOT COMPLETED|Overall Study||4
11119439|NCT01330134|12304382|FG000|STARTED|Overall Study||244
11119440|NCT01330134|12304383|FG001|STARTED|Overall Study||237
11119441|NCT01330134|12304382|FG000|COMPLETED|Overall Study||244
11119442|NCT01330134|12304383|FG001|COMPLETED|Overall Study||237
11119443|NCT01330134|12304382|FG000|NOT COMPLETED|Overall Study||0
11119444|NCT01330134|12304383|FG001|NOT COMPLETED|Overall Study||0
11119445|NCT01330290|12304389|FG000|STARTED|Overall Study||148
11119446|NCT01330290|12304389|FG000|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
11119447|NCT01330290|12304389|FG000|NOT COMPLETED|Overall Study||0
11119448|NCT01330303|12304393|FG000|STARTED|Period 1||20
11119449|NCT01330303|12304394|FG001|STARTED|Period 1||20
11119450|NCT01330303|12304393|FG000|COMPLETED|Period 1||19
11119451|NCT01330303|12304394|FG001|COMPLETED|Period 1||18
11119452|NCT01330303|12304393|FG000|NOT COMPLETED|Period 1||1
11119453|NCT01330303|12304394|FG001|NOT COMPLETED|Period 1||2
11119454|NCT01330303|12304393|FG000|STARTED|7-Day Washout Period||19
11119455|NCT01330303|12304394|FG001|STARTED|7-Day Washout Period||18
11119456|NCT01330303|12304393|FG000|COMPLETED|7-Day Washout Period||19
11119457|NCT01330303|12304394|FG001|COMPLETED|7-Day Washout Period||18
11119458|NCT01330303|12304393|FG000|NOT COMPLETED|7-Day Washout Period||0
11119459|NCT01330303|12304394|FG001|NOT COMPLETED|7-Day Washout Period||0
11119460|NCT01330303|12304393|FG000|STARTED|Period 2||19
11119461|NCT01330303|12304394|FG001|STARTED|Period 2||18
11119462|NCT01330303|12304393|FG000|COMPLETED|Period 2||19
11119463|NCT01330303|12304394|FG001|COMPLETED|Period 2||18
11119464|NCT01330303|12304393|FG000|NOT COMPLETED|Period 2||0
11119465|NCT01330303|12304394|FG001|NOT COMPLETED|Period 2||0
11119466|NCT01330316|12304403|FG000|STARTED|Overall Study||43
11119467|NCT01330316|12304404|FG001|STARTED|Overall Study||75
11119468|NCT01330316|12304403|FG000|COMPLETED|Overall Study||41
11119469|NCT01330316|12304404|FG001|COMPLETED|Overall Study||60
11119470|NCT01330316|12304403|FG000|NOT COMPLETED|Overall Study||2
11119471|NCT01330316|12304404|FG001|NOT COMPLETED|Overall Study||15
11119472|NCT01330355|12304412|FG000|STARTED|Overall Study||16
11119473|NCT01330355|12304413|FG001|STARTED|Overall Study||17
11119474|NCT01330355|12304412|FG000|COMPLETED|Overall Study||16
11119475|NCT01330355|12304413|FG001|COMPLETED|Overall Study||17
11119476|NCT01330355|12304412|FG000|NOT COMPLETED|Overall Study||0
11119477|NCT01330355|12304413|FG001|NOT COMPLETED|Overall Study||0
11119478|NCT01330381|12304421|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||107
11119479|NCT01330381|12304422|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||108
11119480|NCT01330381|12304423|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||0
11119481|NCT01330381|12304421|FG000|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
11119482|NCT01330381|12304422|FG001|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
11119483|NCT01330381|12304423|FG002|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
11119484|NCT01330381|12304421|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
11119485|NCT01330381|12304422|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
11119486|NCT01330381|12304423|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
11119487|NCT01330381|12304421|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
11119488|NCT01330381|12304422|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
11119489|NCT01330381|12304423|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
11119490|NCT01330381|12304421|FG000|STARTED|Open-label Treatment Period (16 Weeks)||98
11119491|NCT01330381|12304422|FG001|STARTED|Open-label Treatment Period (16 Weeks)||0
11119492|NCT01330381|12304423|FG002|STARTED|Open-label Treatment Period (16 Weeks)||99
11119493|NCT01330381|12304421|FG000|COMPLETED|Open-label Treatment Period (16 Weeks)||88
11119494|NCT01330381|12304422|FG001|COMPLETED|Open-label Treatment Period (16 Weeks)||0
11119495|NCT01330381|12304423|FG002|COMPLETED|Open-label Treatment Period (16 Weeks)||81
11119496|NCT01330381|12304421|FG000|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
11119497|NCT01330381|12304422|FG001|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
11119498|NCT01330381|12304423|FG002|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
11119499|NCT01330394|12304434|FG000|STARTED|Overall Study||17
11119500|NCT01330394|12304435|FG001|STARTED|Overall Study||16
11119501|NCT01330394|12304434|FG000|COMPLETED|Overall Study||17
11119502|NCT01330394|12304435|FG001|COMPLETED|Overall Study||16
11119503|NCT01330394|12304434|FG000|NOT COMPLETED|Overall Study||0
11119504|NCT01330394|12304435|FG001|NOT COMPLETED|Overall Study||0
11119505|NCT01330420|12304441|FG000|STARTED|Overall Study||28
11119506|NCT01330420|12304441|FG000|COMPLETED|Overall Study||24
11119507|NCT01330420|12304441|FG000|NOT COMPLETED|Overall Study||4
11119508|NCT01330433|12304447|FG000|STARTED|Overall Study||16
11119509|NCT01330433|12304448|FG001|STARTED|Overall Study||19
11119510|NCT01330433|12304447|FG000|COMPLETED|Overall Study||14
11119511|NCT01330433|12304448|FG001|COMPLETED|Overall Study||16
11119512|NCT01330433|12304447|FG000|NOT COMPLETED|Overall Study||2
11119513|NCT01330433|12304448|FG001|NOT COMPLETED|Overall Study||3
11119514|NCT01330459|12304456|FG000|STARTED|Overall Study||61
11119515|NCT01330459|12304457|FG001|STARTED|Overall Study||60
11119516|NCT01330459|12304456|FG000|COMPLETED|Overall Study||61
11119517|NCT01330459|12304457|FG001|COMPLETED|Overall Study||58
11119518|NCT01330459|12304456|FG000|NOT COMPLETED|Overall Study||0
11119519|NCT01330459|12304457|FG001|NOT COMPLETED|Overall Study||2
11119520|NCT01330628|12304467|FG000|STARTED|Overall Study||170
11119521|NCT01330628|12304468|FG001|STARTED|Overall Study||82
11119522|NCT01330628|12304467|FG000|30 Day Follow-up|Overall Study||165
11119523|NCT01330628|12304468|FG001|30 Day Follow-up|Overall Study||73
11119524|NCT01330628|12304467|FG000|6 Month Follow-up|Overall Study||135
11119525|NCT01330628|12304468|FG001|6 Month Follow-up|Overall Study||60
11119526|NCT01330628|12304467|FG000|COMPLETED|Overall Study||100
11119527|NCT01330628|12304468|FG001|COMPLETED|Overall Study||42
11119528|NCT01330628|12304467|FG000|NOT COMPLETED|Overall Study||70
11119529|NCT01330628|12304468|FG001|NOT COMPLETED|Overall Study||40
11119530|NCT01330914|12304474|FG000|STARTED|Overall Study||55
11119531|NCT01330914|12304474|FG000|COMPLETED|Overall Study||48
11119532|NCT01330914|12304474|FG000|NOT COMPLETED|Overall Study||7
11119533|NCT01330953|12304483|FG000|STARTED|Overall Study||8
11119534|NCT01330953|12304484|FG001|STARTED|Overall Study||6
11119535|NCT01330953|12304485|FG002|STARTED|Overall Study||6
11119536|NCT01330953|12304486|FG003|STARTED|Overall Study||6
11119537|NCT01330953|12304487|FG004|STARTED|Overall Study||6
11119538|NCT01330953|12304483|FG000|COMPLETED|Overall Study||8
11119539|NCT01330953|12304484|FG001|COMPLETED|Overall Study||6
11119540|NCT01330953|12304485|FG002|COMPLETED|Overall Study||6
11119541|NCT01330953|12304486|FG003|COMPLETED|Overall Study||6
11119542|NCT01330953|12304487|FG004|COMPLETED|Overall Study||6
11119543|NCT01330953|12304483|FG000|NOT COMPLETED|Overall Study||0
11119544|NCT01330953|12304484|FG001|NOT COMPLETED|Overall Study||0
11119545|NCT01330953|12304485|FG002|NOT COMPLETED|Overall Study||0
11119546|NCT01330953|12304486|FG003|NOT COMPLETED|Overall Study||0
11119547|NCT01330953|12304487|FG004|NOT COMPLETED|Overall Study||0
11119548|NCT01330966|12304504|FG000|STARTED|Overall Study||47
11119549|NCT01330966|12304504|FG000|COMPLETED|Overall Study|Tumor responses evaluable in 42 of 47 pts; 5 pts discontinued prior to first tumor assessment.|42
11119550|NCT01330966|12304504|FG000|NOT COMPLETED|Overall Study||5
11119551|NCT01331005|12304510|FG000|STARTED|Overall Study||64
11119552|NCT01331005|12304511|FG001|STARTED|Overall Study||61
11119553|NCT01331005|12304510|FG000|COMPLETED|Overall Study||60
11119554|NCT01331005|12304511|FG001|COMPLETED|Overall Study||57
11119555|NCT01331005|12304510|FG000|NOT COMPLETED|Overall Study||4
11119556|NCT01331005|12304511|FG001|NOT COMPLETED|Overall Study||4
10877226|NCT00381641|12043121|FG000|STARTED|Overall Study||38
10877227|NCT00381641|12043122|FG001|STARTED|Overall Study||25
10877228|NCT00381641|12043121|FG000|COMPLETED|Overall Study||38
10877229|NCT00381641|12043122|FG001|COMPLETED|Overall Study||23
10877230|NCT00381641|12043121|FG000|NOT COMPLETED|Overall Study||0
10877231|NCT00381641|12043122|FG001|NOT COMPLETED|Overall Study||2
10877276|NCT05439460|12043181|FG000|STARTED|First Intervention (Approx 5h on Study)||5
10877277|NCT05439460|12043182|FG001|STARTED|First Intervention (Approx 5h on Study)||0
10877278|NCT05439460|12043183|FG002|STARTED|First Intervention (Approx 5h on Study)||0
10877279|NCT05439460|12043181|FG000|COMPLETED|First Intervention (Approx 5h on Study)||5
10877280|NCT05439460|12043182|FG001|COMPLETED|First Intervention (Approx 5h on Study)||0
10877281|NCT05439460|12043183|FG002|COMPLETED|First Intervention (Approx 5h on Study)||0
10877282|NCT05439460|12043181|FG000|NOT COMPLETED|First Intervention (Approx 5h on Study)||0
10877283|NCT05439460|12043182|FG001|NOT COMPLETED|First Intervention (Approx 5h on Study)||0
10877284|NCT05439460|12043183|FG002|NOT COMPLETED|First Intervention (Approx 5h on Study)||0
10877285|NCT05439460|12043181|FG000|STARTED|Second Intervention (Approx 5h on Study)||0
10877286|NCT05439460|12043182|FG001|STARTED|Second Intervention (Approx 5h on Study)||5
10877287|NCT05439460|12043183|FG002|STARTED|Second Intervention (Approx 5h on Study)||0
10877288|NCT05439460|12043181|FG000|COMPLETED|Second Intervention (Approx 5h on Study)||0
10877289|NCT05439460|12043182|FG001|COMPLETED|Second Intervention (Approx 5h on Study)||5
10877290|NCT05439460|12043183|FG002|COMPLETED|Second Intervention (Approx 5h on Study)||0
10877291|NCT05439460|12043181|FG000|NOT COMPLETED|Second Intervention (Approx 5h on Study)||0
10877292|NCT05439460|12043182|FG001|NOT COMPLETED|Second Intervention (Approx 5h on Study)||0
10877293|NCT05439460|12043183|FG002|NOT COMPLETED|Second Intervention (Approx 5h on Study)||0
10877294|NCT05439460|12043181|FG000|STARTED|Third Intervention (Approx 5h on Study)||0
10877295|NCT05439460|12043182|FG001|STARTED|Third Intervention (Approx 5h on Study)||0
10877296|NCT05439460|12043183|FG002|STARTED|Third Intervention (Approx 5h on Study)||5
10877297|NCT05439460|12043181|FG000|COMPLETED|Third Intervention (Approx 5h on Study)||0
10877298|NCT05439460|12043182|FG001|COMPLETED|Third Intervention (Approx 5h on Study)||0
10877299|NCT05439460|12043183|FG002|COMPLETED|Third Intervention (Approx 5h on Study)||5
10877300|NCT05439460|12043181|FG000|NOT COMPLETED|Third Intervention (Approx 5h on Study)||0
10877301|NCT05439460|12043182|FG001|NOT COMPLETED|Third Intervention (Approx 5h on Study)||0
10877302|NCT05439460|12043183|FG002|NOT COMPLETED|Third Intervention (Approx 5h on Study)||0
10877303|NCT05405244|12043191|FG000|STARTED|First Intervention (Single 1-Day Visit)||28
10877304|NCT05405244|12043192|FG001|STARTED|First Intervention (Single 1-Day Visit)||27
10877305|NCT05405244|12043191|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||28
10877306|NCT05405244|12043192|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||27
10877307|NCT05405244|12043191|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
10877308|NCT05405244|12043192|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
10877309|NCT05405244|12043191|FG000|STARTED|Washout (2 Weeks)||28
10877310|NCT05405244|12043192|FG001|STARTED|Washout (2 Weeks)||27
10877311|NCT05405244|12043191|FG000|COMPLETED|Washout (2 Weeks)||24
10877312|NCT05405244|12043192|FG001|COMPLETED|Washout (2 Weeks)||26
10877313|NCT05405244|12043191|FG000|NOT COMPLETED|Washout (2 Weeks)||4
10877314|NCT05405244|12043192|FG001|NOT COMPLETED|Washout (2 Weeks)||1
10877315|NCT05405244|12043191|FG000|STARTED|Second Intervention (Single 1-Day Visit)||24
10877316|NCT05405244|12043192|FG001|STARTED|Second Intervention (Single 1-Day Visit)||26
10877317|NCT05405244|12043191|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||24
10877318|NCT05405244|12043192|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||26
10877319|NCT05405244|12043191|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
10877320|NCT05405244|12043192|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
10877321|NCT05271175|12043205|FG000|STARTED|Treatment||34
10877322|NCT05271175|12043206|FG001|STARTED|Treatment||33
10877323|NCT05271175|12043207|FG002|STARTED|Treatment||37
10877324|NCT05271175|12043205|FG000|COMPLETED|Treatment||29
10877325|NCT05271175|12043206|FG001|COMPLETED|Treatment||30
10877326|NCT05271175|12043207|FG002|COMPLETED|Treatment||30
10877327|NCT05271175|12043205|FG000|NOT COMPLETED|Treatment||5
10877328|NCT05271175|12043206|FG001|NOT COMPLETED|Treatment||3
10877329|NCT05271175|12043207|FG002|NOT COMPLETED|Treatment||7
10877330|NCT05271175|12043205|FG000|STARTED|One Week Follow up||29
10877331|NCT05271175|12043206|FG001|STARTED|One Week Follow up||30
10877332|NCT05271175|12043207|FG002|STARTED|One Week Follow up||30
10877333|NCT05271175|12043205|FG000|COMPLETED|One Week Follow up||19
10877334|NCT05271175|12043206|FG001|COMPLETED|One Week Follow up||23
10877335|NCT05271175|12043207|FG002|COMPLETED|One Week Follow up||25
10877336|NCT05271175|12043205|FG000|NOT COMPLETED|One Week Follow up||10
10877337|NCT05271175|12043206|FG001|NOT COMPLETED|One Week Follow up||7
10877338|NCT05271175|12043207|FG002|NOT COMPLETED|One Week Follow up||5
10877339|NCT05271175|12043205|FG000|STARTED|One Month Follow up||29
10877340|NCT05271175|12043206|FG001|STARTED|One Month Follow up||30
10877341|NCT05271175|12043207|FG002|STARTED|One Month Follow up||30
10877342|NCT05271175|12043205|FG000|COMPLETED|One Month Follow up||17
10877343|NCT05271175|12043206|FG001|COMPLETED|One Month Follow up||23
10877344|NCT05271175|12043207|FG002|COMPLETED|One Month Follow up||21
10877345|NCT05271175|12043205|FG000|NOT COMPLETED|One Month Follow up||12
10877346|NCT05271175|12043206|FG001|NOT COMPLETED|One Month Follow up||7
10877347|NCT05271175|12043207|FG002|NOT COMPLETED|One Month Follow up||9
10877348|NCT05271175|12043205|FG000|STARTED|Six Months Follow up||29
10877349|NCT05271175|12043206|FG001|STARTED|Six Months Follow up||30
10877350|NCT05271175|12043207|FG002|STARTED|Six Months Follow up||30
10877351|NCT05271175|12043205|FG000|COMPLETED|Six Months Follow up||21
10877352|NCT05271175|12043206|FG001|COMPLETED|Six Months Follow up||28
10877353|NCT05271175|12043207|FG002|COMPLETED|Six Months Follow up||28
10877354|NCT05271175|12043205|FG000|NOT COMPLETED|Six Months Follow up||8
10877355|NCT05271175|12043206|FG001|NOT COMPLETED|Six Months Follow up||2
10877356|NCT05271175|12043207|FG002|NOT COMPLETED|Six Months Follow up||2
10877357|NCT05200455|12043215|FG000|STARTED|Overall Study||34
10877358|NCT05200455|12043215|FG000|COMPLETED|Overall Study||30
10877359|NCT05200455|12043215|FG000|NOT COMPLETED|Overall Study||4
10877360|NCT05097144|12043220|FG000|STARTED|Overall Study||36
10877361|NCT05097144|12043220|FG000|COMPLETED|Overall Study||36
10877362|NCT05097144|12043220|FG000|NOT COMPLETED|Overall Study||0
10877363|NCT05091528|12043228|FG000|STARTED|Overall Study||0
10877364|NCT05091528|12043229|FG001|STARTED|Overall Study||1
10877365|NCT05091528|12043230|FG002|STARTED|Overall Study||0
10877366|NCT05091528|12043231|FG003|STARTED|Overall Study||1
10877367|NCT05091528|12043228|FG000|COMPLETED|Overall Study||0
10877368|NCT05091528|12043229|FG001|COMPLETED|Overall Study||0
10877369|NCT05091528|12043230|FG002|COMPLETED|Overall Study||0
10877370|NCT05091528|12043231|FG003|COMPLETED|Overall Study||0
10877371|NCT05091528|12043228|FG000|NOT COMPLETED|Overall Study||0
10877372|NCT05091528|12043229|FG001|NOT COMPLETED|Overall Study||1
10877373|NCT05091528|12043230|FG002|NOT COMPLETED|Overall Study||0
10877374|NCT05091528|12043231|FG003|NOT COMPLETED|Overall Study||1
10877375|NCT05090852|12043239|FG000|STARTED|Overall Study||31
10877376|NCT05090852|12043239|FG000|COMPLETED|Overall Study||26
10877377|NCT05090852|12043239|FG000|NOT COMPLETED|Overall Study||5
10877378|NCT05084885|12043243|FG000|STARTED|Baseline||3
10877379|NCT05084885|12043244|FG001|STARTED|Baseline||13
10877380|NCT05084885|12043243|FG000|COMPLETED|Baseline||3
10877381|NCT05084885|12043244|FG001|COMPLETED|Baseline|At the 12 month follow-up all people who completed the initial survey were again asked to complete the same measures. Only the baseline vs 12-month data is available. This was not a planned group, but was conducted during covid lockdown and we had no online access to the participants who had completed the survey. Our REB agree that we could use their data because they had consented to all followup survey at the beginning of the study.|13
10877382|NCT05084885|12043243|FG000|NOT COMPLETED|Baseline||0
10877383|NCT05084885|12043244|FG001|NOT COMPLETED|Baseline||0
10877384|NCT05084885|12043243|FG000|STARTED|Post Treatment||3
10877385|NCT05084885|12043244|FG001|STARTED|Post Treatment|None of the Non-Treatment group were asked to complete the post treatment survey.|0
10877386|NCT05084885|12043243|FG000|COMPLETED|Post Treatment||2
10877387|NCT05084885|12043244|FG001|COMPLETED|Post Treatment||0
10877388|NCT05084885|12043243|FG000|NOT COMPLETED|Post Treatment||1
10877389|NCT05084885|12043244|FG001|NOT COMPLETED|Post Treatment||0
10877390|NCT05084885|12043243|FG000|STARTED|Follow-up||2
10877391|NCT05084885|12043244|FG001|STARTED|Follow-up|At the 12 month follow-up all people who completed the initial survey were again asked to complete the same measures. Only the baseline vs 12-month data is available. This was not a planned group, but was conducted during covid lockdown and we had no online access to the participants who had completed the survey. Our REB agree that we could use their data because they had consented to all followup survey at the beginning of the study.|13
10877392|NCT05084885|12043243|FG000|COMPLETED|Follow-up||2
10877393|NCT05084885|12043244|FG001|COMPLETED|Follow-up||8
10877394|NCT05084885|12043243|FG000|NOT COMPLETED|Follow-up||0
10877395|NCT05084885|12043244|FG001|NOT COMPLETED|Follow-up||5
10877396|NCT05050318|12043253|FG000|STARTED|Overall Study||29
10877397|NCT05050318|12043254|FG001|STARTED|Overall Study||31
10877398|NCT05050318|12043255|FG002|STARTED|Overall Study||30
10877399|NCT05050318|12043253|FG000|Vaccinated|Overall Study||28
10877400|NCT05050318|12043254|FG001|Vaccinated|Overall Study||31
10877401|NCT05050318|12043255|FG002|Vaccinated|Overall Study||30
10877402|NCT05050318|12043253|FG000|COMPLETED|Overall Study||28
10877403|NCT05050318|12043254|FG001|COMPLETED|Overall Study||31
10877404|NCT05050318|12043255|FG002|COMPLETED|Overall Study||30
10877405|NCT05050318|12043253|FG000|NOT COMPLETED|Overall Study||1
10877406|NCT05050318|12043254|FG001|NOT COMPLETED|Overall Study||0
10877407|NCT05050318|12043255|FG002|NOT COMPLETED|Overall Study||0
10877408|NCT04942925|12043265|FG000|STARTED|First Wear Period (8 -0/+3 Days)||32
10877409|NCT04942925|12043266|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
10877410|NCT04942925|12043265|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||32
10877411|NCT04942925|12043266|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||26
10877412|NCT04942925|12043265|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
10877413|NCT04942925|12043266|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||2
10877414|NCT04942925|12043265|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||32
10877415|NCT04942925|12043266|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||26
10877416|NCT04942925|12043265|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||32
10877417|NCT04942925|12043266|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||26
10877418|NCT04942925|12043265|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
10877419|NCT04942925|12043266|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
10877420|NCT04908488|12043277|FG000|STARTED|First Wear Period (8 -0/+3 Days)||56
10877421|NCT04908488|12043278|FG001|STARTED|First Wear Period (8 -0/+3 Days)||58
10877422|NCT04908488|12043277|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||55
10877423|NCT04908488|12043278|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||58
10877424|NCT04908488|12043277|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||1
10877425|NCT04908488|12043278|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
10877426|NCT04908488|12043277|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||55
10877427|NCT04908488|12043278|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||58
10877428|NCT04908488|12043277|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||54
10877429|NCT04908488|12043278|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||58
10877430|NCT04908488|12043277|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||1
10877431|NCT04908488|12043278|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
10877432|NCT04899440|12043289|FG000|STARTED|Overall Study||15
10877433|NCT04899440|12043290|FG001|STARTED|Overall Study||15
10877434|NCT04899440|12043289|FG000|COMPLETED|Overall Study||15
10877435|NCT04899440|12043290|FG001|COMPLETED|Overall Study||15
10877436|NCT04899440|12043289|FG000|NOT COMPLETED|Overall Study||0
10877437|NCT04899440|12043290|FG001|NOT COMPLETED|Overall Study||0
10877438|NCT04899232|12043299|FG000|STARTED|Screening Period||20
10877439|NCT04899232|12043300|FG001|STARTED|Screening Period||20
10877440|NCT04899232|12043301|FG002|STARTED|Screening Period||12
10877441|NCT04899232|12043299|FG000|COMPLETED|Screening Period||15
10877442|NCT04899232|12043300|FG001|COMPLETED|Screening Period||20
10877443|NCT04899232|12043301|FG002|COMPLETED|Screening Period||12
10877444|NCT04899232|12043299|FG000|NOT COMPLETED|Screening Period||5
10877445|NCT04899232|12043300|FG001|NOT COMPLETED|Screening Period||0
10877446|NCT04899232|12043301|FG002|NOT COMPLETED|Screening Period||0
10877447|NCT04899232|12043299|FG000|STARTED|Treatment Period||15
10877448|NCT04899232|12043300|FG001|STARTED|Treatment Period||20
10877449|NCT04899232|12043301|FG002|STARTED|Treatment Period||12
10877450|NCT04899232|12043299|FG000|COMPLETED|Treatment Period||15
10877451|NCT04899232|12043300|FG001|COMPLETED|Treatment Period||20
10877452|NCT04899232|12043301|FG002|COMPLETED|Treatment Period||12
10877453|NCT04899232|12043299|FG000|NOT COMPLETED|Treatment Period||0
10877454|NCT04899232|12043300|FG001|NOT COMPLETED|Treatment Period||0
10877455|NCT04899232|12043301|FG002|NOT COMPLETED|Treatment Period||0
10877456|NCT04885296|12043309|FG000|STARTED|Period 1||117
10877457|NCT04885296|12043310|FG001|STARTED|Period 1||110
10877458|NCT04885296|12043309|FG000|COMPLETED|Period 1||112
10877459|NCT04885296|12043310|FG001|COMPLETED|Period 1||108
10877460|NCT04885296|12043309|FG000|NOT COMPLETED|Period 1||5
10877461|NCT04885296|12043310|FG001|NOT COMPLETED|Period 1||2
10877462|NCT04885296|12043309|FG000|STARTED|Period 2||112
10877463|NCT04885296|12043310|FG001|STARTED|Period 2||108
10877464|NCT04885296|12043309|FG000|COMPLETED|Period 2||112
10877465|NCT04885296|12043310|FG001|COMPLETED|Period 2||107
10877466|NCT04885296|12043309|FG000|NOT COMPLETED|Period 2||0
10877467|NCT04885296|12043310|FG001|NOT COMPLETED|Period 2||1
10877468|NCT04862065|12043319|FG000|STARTED|Screening||15581
10877469|NCT04862065|12043320|FG001|STARTED|Screening||403
10877470|NCT04862065|12043321|FG002|STARTED|Screening||404
10877471|NCT04862065|12043319|FG000|COMPLETED|Screening||15526
10877472|NCT04862065|12043320|FG001|COMPLETED|Screening||403
10877473|NCT04862065|12043321|FG002|COMPLETED|Screening||404
10877474|NCT04862065|12043319|FG000|NOT COMPLETED|Screening||55
10877475|NCT04862065|12043320|FG001|NOT COMPLETED|Screening||0
10877476|NCT04862065|12043321|FG002|NOT COMPLETED|Screening||0
10877477|NCT04862065|12043319|FG000|STARTED|Follow-Up||6
10877478|NCT04862065|12043320|FG001|STARTED|Follow-Up||0
10877479|NCT04862065|12043321|FG002|STARTED|Follow-Up||0
10877480|NCT04862065|12043319|FG000|COMPLETED|Follow-Up||3
10877481|NCT04862065|12043320|FG001|COMPLETED|Follow-Up||0
10877482|NCT04862065|12043321|FG002|COMPLETED|Follow-Up||0
10877483|NCT04862065|12043319|FG000|NOT COMPLETED|Follow-Up||3
10877484|NCT04862065|12043320|FG001|NOT COMPLETED|Follow-Up||0
10877485|NCT04862065|12043321|FG002|NOT COMPLETED|Follow-Up||0
10877486|NCT04824365|12043329|FG000|STARTED|Overall Study||15
10877487|NCT04824365|12043330|FG001|STARTED|Overall Study||15
10877488|NCT04824365|12043329|FG000|COMPLETED|Overall Study||15
10877489|NCT04824365|12043330|FG001|COMPLETED|Overall Study||15
10877490|NCT04824365|12043329|FG000|NOT COMPLETED|Overall Study||0
10877491|NCT04824365|12043330|FG001|NOT COMPLETED|Overall Study||0
10877492|NCT04822701|12043338|FG000|STARTED|Overall Study||4
10877493|NCT04822701|12043339|FG001|STARTED|Overall Study||1
10877494|NCT04822701|12043338|FG000|Treated|Overall Study||2
10877495|NCT04822701|12043339|FG001|Treated|Overall Study||1
10877496|NCT04822701|12043338|FG000|COMPLETED|Overall Study||0
10877497|NCT04822701|12043339|FG001|COMPLETED|Overall Study||1
10877498|NCT04822701|12043338|FG000|NOT COMPLETED|Overall Study||4
10877499|NCT04822701|12043339|FG001|NOT COMPLETED|Overall Study||0
10877500|NCT04784897|12043348|FG000|STARTED|Overall Study||60
10877501|NCT04784897|12043349|FG001|STARTED|Overall Study||16
10877502|NCT04784897|12043350|FG002|STARTED|Overall Study||44
10877503|NCT04784897|12043348|FG000|COMPLETED|Overall Study||56
10877504|NCT04784897|12043349|FG001|COMPLETED|Overall Study||14
10877505|NCT04784897|12043350|FG002|COMPLETED|Overall Study||42
10877506|NCT04784897|12043348|FG000|NOT COMPLETED|Overall Study||4
10877507|NCT04784897|12043349|FG001|NOT COMPLETED|Overall Study||2
10877508|NCT04784897|12043350|FG002|NOT COMPLETED|Overall Study||2
10877509|NCT04774328|12043364|FG000|STARTED|Overall Study||10
10877510|NCT04774328|12043365|FG001|STARTED|Overall Study||12
10877511|NCT04774328|12043366|FG002|STARTED|Overall Study||12
10877512|NCT04774328|12043364|FG000|Follow-up to 29 Days Post Surgery|Overall Study||10
10877513|NCT04774328|12043365|FG001|Follow-up to 29 Days Post Surgery|Overall Study||12
10877514|NCT04774328|12043366|FG002|Follow-up to 29 Days Post Surgery|Overall Study||12
10877515|NCT04774328|12043364|FG000|COMPLETED|Overall Study||10
10877516|NCT04774328|12043365|FG001|COMPLETED|Overall Study||12
10877517|NCT04774328|12043366|FG002|COMPLETED|Overall Study||12
10877518|NCT04774328|12043364|FG000|NOT COMPLETED|Overall Study||0
10877519|NCT04774328|12043365|FG001|NOT COMPLETED|Overall Study||0
10877520|NCT04774328|12043366|FG002|NOT COMPLETED|Overall Study||0
10877521|NCT04764669|12043379|FG000|STARTED|Overall Study||10
10877522|NCT04764669|12043380|FG001|STARTED|Overall Study||11
10877523|NCT04764669|12043381|FG002|STARTED|Overall Study||10
10877524|NCT04764669|12043382|FG003|STARTED|Overall Study||3
10877525|NCT04764669|12043379|FG000|COMPLETED|Overall Study||7
10877526|NCT04764669|12043380|FG001|COMPLETED|Overall Study||11
10877527|NCT04764669|12043381|FG002|COMPLETED|Overall Study||8
10877528|NCT04764669|12043382|FG003|COMPLETED|Overall Study||3
10877529|NCT04764669|12043379|FG000|NOT COMPLETED|Overall Study||3
10877530|NCT04764669|12043380|FG001|NOT COMPLETED|Overall Study||0
10877531|NCT04764669|12043381|FG002|NOT COMPLETED|Overall Study||2
10877532|NCT04764669|12043382|FG003|NOT COMPLETED|Overall Study||0
10877533|NCT04757805|12043392|FG000|STARTED|Overall Study||50
10877534|NCT04757805|12043392|FG000|COMPLETED|Overall Study||50
10877535|NCT04757805|12043392|FG000|NOT COMPLETED|Overall Study||0
10877536|NCT04741503|12043398|FG000|STARTED|Initial Enrollment||160
10877537|NCT04741503|12043399|FG001|STARTED|Initial Enrollment||164
10877538|NCT04741503|12043400|FG002|STARTED|Initial Enrollment||953
10877539|NCT04741503|12043398|FG000|COMPLETED|Initial Enrollment||160
10877540|NCT04741503|12043399|FG001|COMPLETED|Initial Enrollment||164
10877541|NCT04741503|12043400|FG002|COMPLETED|Initial Enrollment||0
10877542|NCT04741503|12043398|FG000|NOT COMPLETED|Initial Enrollment||0
10877543|NCT04741503|12043399|FG001|NOT COMPLETED|Initial Enrollment||0
10877544|NCT04741503|12043400|FG002|NOT COMPLETED|Initial Enrollment||953
10877545|NCT04741503|12043398|FG000|STARTED|Met Protocol Criteria for Data Inclusion||160
10877546|NCT04741503|12043399|FG001|STARTED|Met Protocol Criteria for Data Inclusion||164
10877547|NCT04741503|12043400|FG002|STARTED|Met Protocol Criteria for Data Inclusion||0
10877548|NCT04741503|12043398|FG000|COMPLETED|Met Protocol Criteria for Data Inclusion||137
10877549|NCT04741503|12043399|FG001|COMPLETED|Met Protocol Criteria for Data Inclusion||147
10877550|NCT04741503|12043400|FG002|COMPLETED|Met Protocol Criteria for Data Inclusion||0
10877551|NCT04741503|12043398|FG000|NOT COMPLETED|Met Protocol Criteria for Data Inclusion||23
10877552|NCT04741503|12043399|FG001|NOT COMPLETED|Met Protocol Criteria for Data Inclusion||17
10877553|NCT04741503|12043400|FG002|NOT COMPLETED|Met Protocol Criteria for Data Inclusion||0
10877554|NCT04734873|12043409|FG000|STARTED|Overall Study||16
10877555|NCT04734873|12043410|FG001|STARTED|Overall Study||14
10877556|NCT04734873|12043411|FG002|STARTED|Overall Study||12
10877557|NCT04734873|12043409|FG000|COMPLETED|Overall Study||14
10877558|NCT04734873|12043410|FG001|COMPLETED|Overall Study||11
10877559|NCT04734873|12043411|FG002|COMPLETED|Overall Study||9
10877560|NCT04734873|12043409|FG000|NOT COMPLETED|Overall Study||2
10877561|NCT04734873|12043410|FG001|NOT COMPLETED|Overall Study||3
10877562|NCT04734873|12043411|FG002|NOT COMPLETED|Overall Study||3
10877563|NCT04724967|12043419|FG000|STARTED|Overall Study||528
10877564|NCT04724967|12043419|FG000|COMPLETED|Overall Study||528
10877565|NCT04724967|12043419|FG000|NOT COMPLETED|Overall Study||0
10877566|NCT04724733|12043426|FG000|STARTED|Overall Study||22
10877567|NCT04724733|12043427|FG001|STARTED|Overall Study||22
10877568|NCT04724733|12043428|FG002|STARTED|Overall Study||23
10877569|NCT04724733|12043426|FG000|4 Weeks|Overall Study||22
10877570|NCT04724733|12043427|FG001|4 Weeks|Overall Study||21
10877571|NCT04724733|12043428|FG002|4 Weeks|Overall Study||23
10877572|NCT04724733|12043426|FG000|COMPLETED|Overall Study||21
10877573|NCT04724733|12043427|FG001|COMPLETED|Overall Study||21
10877574|NCT04724733|12043428|FG002|COMPLETED|Overall Study||22
10877575|NCT04724733|12043426|FG000|NOT COMPLETED|Overall Study||1
10877576|NCT04724733|12043427|FG001|NOT COMPLETED|Overall Study||1
10877577|NCT04724733|12043428|FG002|NOT COMPLETED|Overall Study||1
10877578|NCT04716010|12043440|FG000|STARTED|Overall Study||1039
10877579|NCT04716010|12043441|FG001|STARTED|Overall Study||1040
10877580|NCT04716010|12043442|FG002|STARTED|Overall Study||1039
10877581|NCT04716010|12043443|FG003|STARTED|Overall Study||1042
10877582|NCT04716010|12043440|FG000|COMPLETED|Overall Study||887
10877583|NCT04716010|12043441|FG001|COMPLETED|Overall Study||891
10877584|NCT04716010|12043442|FG002|COMPLETED|Overall Study||874
10877585|NCT04716010|12043443|FG003|COMPLETED|Overall Study||866
10877586|NCT04716010|12043440|FG000|NOT COMPLETED|Overall Study||152
10877587|NCT04716010|12043441|FG001|NOT COMPLETED|Overall Study||149
10877588|NCT04716010|12043442|FG002|NOT COMPLETED|Overall Study||165
10877589|NCT04716010|12043443|FG003|NOT COMPLETED|Overall Study||176
10877590|NCT04713748|12043453|FG000|STARTED|Overall Study||135
10877591|NCT04713748|12043453|FG000|COMPLETED|Overall Study||100
10877592|NCT04713748|12043453|FG000|NOT COMPLETED|Overall Study||35
10877593|NCT04699812|12043461|FG000|STARTED|Overall Study||78
10877594|NCT04699812|12043462|FG001|STARTED|Overall Study||82
10877595|NCT04699812|12043463|FG002|STARTED|Overall Study||366
10877596|NCT04699812|12043464|FG003|STARTED|Overall Study||47
10877597|NCT04699812|12043461|FG000|COMPLETED|Overall Study||70
10877598|NCT04699812|12043462|FG001|COMPLETED|Overall Study||64
10877599|NCT04699812|12043463|FG002|COMPLETED|Overall Study||304
10877600|NCT04699812|12043464|FG003|COMPLETED|Overall Study||45
10877601|NCT04699812|12043461|FG000|NOT COMPLETED|Overall Study||8
10877602|NCT04699812|12043462|FG001|NOT COMPLETED|Overall Study||18
10877603|NCT04699812|12043463|FG002|NOT COMPLETED|Overall Study||62
10877604|NCT04699812|12043464|FG003|NOT COMPLETED|Overall Study||2
10877605|NCT04685811|12043479|FG000|STARTED|Overall Study||16
10877606|NCT04685811|12043479|FG000|COMPLETED|Overall Study||16
10877607|NCT04685811|12043479|FG000|NOT COMPLETED|Overall Study||0
10877608|NCT04668274|12043487|FG000|STARTED|Part 1 Study Period 1||21
10877609|NCT04668274|12043488|FG001|STARTED|Part 1 Study Period 1||0
10877610|NCT04668274|12043489|FG002|STARTED|Part 1 Study Period 1||0
10877611|NCT04668274|12043490|FG003|STARTED|Part 1 Study Period 1||0
10877612|NCT04668274|12043487|FG000|COMPLETED|Part 1 Study Period 1||16
10877613|NCT04668274|12043488|FG001|COMPLETED|Part 1 Study Period 1||0
10877614|NCT04668274|12043489|FG002|COMPLETED|Part 1 Study Period 1||0
10877615|NCT04668274|12043490|FG003|COMPLETED|Part 1 Study Period 1||0
10877616|NCT04668274|12043487|FG000|NOT COMPLETED|Part 1 Study Period 1||5
10877617|NCT04668274|12043488|FG001|NOT COMPLETED|Part 1 Study Period 1||0
10877618|NCT04668274|12043489|FG002|NOT COMPLETED|Part 1 Study Period 1||0
10877619|NCT04668274|12043490|FG003|NOT COMPLETED|Part 1 Study Period 1||0
10877620|NCT04668274|12043487|FG000|STARTED|Part 1 Study Period 2||0
10877621|NCT04668274|12043488|FG001|STARTED|Part 1 Study Period 2||16
10877622|NCT04668274|12043489|FG002|STARTED|Part 1 Study Period 2||0
10877623|NCT04668274|12043490|FG003|STARTED|Part 1 Study Period 2||0
10877624|NCT04668274|12043487|FG000|COMPLETED|Part 1 Study Period 2||0
10877625|NCT04668274|12043488|FG001|COMPLETED|Part 1 Study Period 2||15
10877626|NCT04668274|12043489|FG002|COMPLETED|Part 1 Study Period 2||0
10877627|NCT04668274|12043490|FG003|COMPLETED|Part 1 Study Period 2||0
10877628|NCT04668274|12043487|FG000|NOT COMPLETED|Part 1 Study Period 2||0
10877629|NCT04668274|12043488|FG001|NOT COMPLETED|Part 1 Study Period 2||1
10877630|NCT04668274|12043489|FG002|NOT COMPLETED|Part 1 Study Period 2||0
10877631|NCT04668274|12043490|FG003|NOT COMPLETED|Part 1 Study Period 2||0
10877632|NCT04668274|12043487|FG000|STARTED|Part 1 Study Period 3||0
10877633|NCT04668274|12043488|FG001|STARTED|Part 1 Study Period 3||0
10877634|NCT04668274|12043489|FG002|STARTED|Part 1 Study Period 3||18
10877635|NCT04668274|12043490|FG003|STARTED|Part 1 Study Period 3||0
10877636|NCT04668274|12043487|FG000|COMPLETED|Part 1 Study Period 3||0
10877637|NCT04668274|12043488|FG001|COMPLETED|Part 1 Study Period 3||0
10877638|NCT04668274|12043489|FG002|COMPLETED|Part 1 Study Period 3|3 participants were directly enrolled in Study Period 3 in addition to the 15 participants from the Study Period 2.|15
10877639|NCT04668274|12043490|FG003|COMPLETED|Part 1 Study Period 3||0
10877640|NCT04668274|12043487|FG000|NOT COMPLETED|Part 1 Study Period 3||0
10877641|NCT04668274|12043488|FG001|NOT COMPLETED|Part 1 Study Period 3||0
10877642|NCT04668274|12043489|FG002|NOT COMPLETED|Part 1 Study Period 3||3
10877643|NCT04668274|12043490|FG003|NOT COMPLETED|Part 1 Study Period 3||0
10877644|NCT04668274|12043487|FG000|STARTED|Part 2 Study Period 4||0
10877645|NCT04668274|12043488|FG001|STARTED|Part 2 Study Period 4||0
10877646|NCT04668274|12043489|FG002|STARTED|Part 2 Study Period 4||0
10877647|NCT04668274|12043490|FG003|STARTED|Part 2 Study Period 4||15
10877648|NCT04668274|12043487|FG000|COMPLETED|Part 2 Study Period 4||0
10877649|NCT04668274|12043488|FG001|COMPLETED|Part 2 Study Period 4||0
10877650|NCT04668274|12043489|FG002|COMPLETED|Part 2 Study Period 4||0
10877651|NCT04668274|12043490|FG003|COMPLETED|Part 2 Study Period 4||14
10877652|NCT04668274|12043487|FG000|NOT COMPLETED|Part 2 Study Period 4||0
10877653|NCT04668274|12043488|FG001|NOT COMPLETED|Part 2 Study Period 4||0
10877654|NCT04668274|12043489|FG002|NOT COMPLETED|Part 2 Study Period 4||0
10877655|NCT04668274|12043490|FG003|NOT COMPLETED|Part 2 Study Period 4||1
10877656|NCT04666051|12043505|FG000|STARTED|Overall Study||16
10877657|NCT04666051|12043506|FG001|STARTED|Overall Study||16
10877658|NCT04666051|12043505|FG000|COMPLETED|Overall Study||16
10877659|NCT04666051|12043506|FG001|COMPLETED|Overall Study||16
10877660|NCT04666051|12043505|FG000|NOT COMPLETED|Overall Study||0
10877661|NCT04666051|12043506|FG001|NOT COMPLETED|Overall Study||0
10877662|NCT04664153|12043516|FG000|STARTED|Overall Study||34
10877663|NCT04664153|12043517|FG001|STARTED|Overall Study||36
10877664|NCT04664153|12043518|FG002|STARTED|Overall Study||17
10877665|NCT04664153|12043519|FG003|STARTED|Overall Study||17
10877666|NCT04664153|12043516|FG000|COMPLETED|Overall Study||27
10877667|NCT04664153|12043517|FG001|COMPLETED|Overall Study||33
10877668|NCT04664153|12043518|FG002|COMPLETED|Overall Study||13
10877669|NCT04664153|12043519|FG003|COMPLETED|Overall Study||15
10877670|NCT04664153|12043516|FG000|NOT COMPLETED|Overall Study||7
10877671|NCT04664153|12043517|FG001|NOT COMPLETED|Overall Study||3
10877672|NCT04664153|12043518|FG002|NOT COMPLETED|Overall Study||4
10877673|NCT04664153|12043519|FG003|NOT COMPLETED|Overall Study||2
10877674|NCT04663295|12043531|FG000|STARTED|Run-in Period||65
10877675|NCT04663295|12043531|FG000|COMPLETED|Run-in Period||62
10877676|NCT04663295|12043531|FG000|NOT COMPLETED|Run-in Period||3
10877677|NCT04663295|12043531|FG000|STARTED|Overall Study Period||62
10877678|NCT04663295|12043531|FG000|COMPLETED|Overall Study Period||60
10877679|NCT04663295|12043531|FG000|NOT COMPLETED|Overall Study Period||2
10877680|NCT04662671|12043542|FG000|STARTED|Overall Study||20
10877681|NCT04662671|12043543|FG001|STARTED|Overall Study||11
10877682|NCT04662671|12043542|FG000|COMPLETED|Overall Study||20
10877683|NCT04662671|12043543|FG001|COMPLETED|Overall Study||11
10877684|NCT04662671|12043542|FG000|NOT COMPLETED|Overall Study||0
10877685|NCT04662671|12043543|FG001|NOT COMPLETED|Overall Study||0
10877686|NCT04650282|12043553|FG000|STARTED|Overall Study||1
10877687|NCT04650282|12043554|FG001|STARTED|Overall Study||1
10877688|NCT04650282|12043553|FG000|COMPLETED|Overall Study||1
10877689|NCT04650282|12043554|FG001|COMPLETED|Overall Study||1
10877690|NCT04650282|12043553|FG000|NOT COMPLETED|Overall Study||0
10877691|NCT04650282|12043554|FG001|NOT COMPLETED|Overall Study||0
10877692|NCT04646369|12043563|FG000|STARTED|Overall Study||23
10877693|NCT04646369|12043564|FG001|STARTED|Overall Study||38
10877694|NCT04646369|12043565|FG002|STARTED|Overall Study||39
10877695|NCT04646369|12043563|FG000|COMPLETED|Overall Study||23
10877696|NCT04646369|12043564|FG001|COMPLETED|Overall Study||38
10877697|NCT04646369|12043565|FG002|COMPLETED|Overall Study||39
10877698|NCT04646369|12043563|FG000|NOT COMPLETED|Overall Study||0
10877699|NCT04646369|12043564|FG001|NOT COMPLETED|Overall Study||0
10877700|NCT04646369|12043565|FG002|NOT COMPLETED|Overall Study||0
10877701|NCT04646148|12043590|FG000|STARTED|Overall Study||0
10877702|NCT04646148|12043591|FG001|STARTED|Overall Study||1
10877703|NCT04646148|12043592|FG002|STARTED|Overall Study||0
10877704|NCT04646148|12043593|FG003|STARTED|Overall Study||1
10877705|NCT04646148|12043594|FG004|STARTED|Overall Study||1
10877706|NCT04646148|12043595|FG005|STARTED|Overall Study||2
10877707|NCT04646148|12043596|FG006|STARTED|Overall Study||1
10877708|NCT04646148|12043597|FG007|STARTED|Overall Study||2
10877709|NCT04646148|12043598|FG008|STARTED|Overall Study||1
10877710|NCT04646148|12043599|FG009|STARTED|Overall Study||2
10877711|NCT04646148|12043600|FG010|STARTED|Overall Study||1
10877712|NCT04646148|12043601|FG011|STARTED|Overall Study||2
10877713|NCT04646148|12043602|FG012|STARTED|Overall Study||1
10877714|NCT04646148|12043603|FG013|STARTED|Overall Study||1
10877715|NCT04646148|12043604|FG014|STARTED|Overall Study||2
10877716|NCT04646148|12043605|FG015|STARTED|Overall Study||2
10877717|NCT04646148|12043590|FG000|COMPLETED|Overall Study||0
10877718|NCT04646148|12043591|FG001|COMPLETED|Overall Study||0
10877719|NCT04646148|12043592|FG002|COMPLETED|Overall Study||0
10877720|NCT04646148|12043593|FG003|COMPLETED|Overall Study||1
10877721|NCT04646148|12043594|FG004|COMPLETED|Overall Study||0
10877722|NCT04646148|12043595|FG005|COMPLETED|Overall Study||1
10877723|NCT04646148|12043596|FG006|COMPLETED|Overall Study||0
10877724|NCT04646148|12043597|FG007|COMPLETED|Overall Study||1
10877725|NCT04646148|12043598|FG008|COMPLETED|Overall Study||1
10877726|NCT04646148|12043599|FG009|COMPLETED|Overall Study||2
10877727|NCT04646148|12043600|FG010|COMPLETED|Overall Study||1
10877728|NCT04646148|12043601|FG011|COMPLETED|Overall Study||2
10877729|NCT04646148|12043602|FG012|COMPLETED|Overall Study||1
10877730|NCT04646148|12043603|FG013|COMPLETED|Overall Study||1
10877731|NCT04646148|12043604|FG014|COMPLETED|Overall Study||2
10877732|NCT04646148|12043605|FG015|COMPLETED|Overall Study||0
10877733|NCT04646148|12043590|FG000|NOT COMPLETED|Overall Study||0
10877734|NCT04646148|12043591|FG001|NOT COMPLETED|Overall Study||1
10877735|NCT04646148|12043592|FG002|NOT COMPLETED|Overall Study||0
10877736|NCT04646148|12043593|FG003|NOT COMPLETED|Overall Study||0
10877737|NCT04646148|12043594|FG004|NOT COMPLETED|Overall Study||1
10877738|NCT04646148|12043595|FG005|NOT COMPLETED|Overall Study||1
10877739|NCT04646148|12043596|FG006|NOT COMPLETED|Overall Study||1
10877740|NCT04646148|12043597|FG007|NOT COMPLETED|Overall Study||1
10877741|NCT04646148|12043598|FG008|NOT COMPLETED|Overall Study||0
10877742|NCT04646148|12043599|FG009|NOT COMPLETED|Overall Study||0
10877743|NCT04646148|12043600|FG010|NOT COMPLETED|Overall Study||0
10877744|NCT04646148|12043601|FG011|NOT COMPLETED|Overall Study||0
10877745|NCT04646148|12043602|FG012|NOT COMPLETED|Overall Study||0
10877746|NCT04646148|12043603|FG013|NOT COMPLETED|Overall Study||0
10877747|NCT04646148|12043604|FG014|NOT COMPLETED|Overall Study||0
10877748|NCT04646148|12043605|FG015|NOT COMPLETED|Overall Study||2
10877749|NCT04645264|12043643|FG000|STARTED|Overall Study||3
10877750|NCT04645264|12043644|FG001|STARTED|Overall Study||2
10877751|NCT04645264|12043645|FG002|STARTED|Overall Study||2
10877752|NCT04645264|12043643|FG000|COMPLETED|Overall Study||3
10877753|NCT04645264|12043644|FG001|COMPLETED|Overall Study||2
10877754|NCT04645264|12043645|FG002|COMPLETED|Overall Study||2
10877755|NCT04645264|12043643|FG000|NOT COMPLETED|Overall Study||0
10877756|NCT04645264|12043644|FG001|NOT COMPLETED|Overall Study||0
10877757|NCT04645264|12043645|FG002|NOT COMPLETED|Overall Study||0
10877758|NCT04636398|12043653|FG000|STARTED|Overall Study||29
10877759|NCT04636398|12043653|FG000|COMPLETED|Overall Study||29
10877760|NCT04636398|12043653|FG000|NOT COMPLETED|Overall Study||0
10877761|NCT04623242|12043662|FG000|STARTED|Overall Study||52
10877762|NCT04623242|12043663|FG001|STARTED|Overall Study||52
10877763|NCT04623242|12043664|FG002|STARTED|Overall Study||40
10877764|NCT04623242|12043665|FG003|STARTED|Overall Study||49
10877765|NCT04623242|12043666|FG004|STARTED|Overall Study||69
10877766|NCT04623242|12043662|FG000|COMPLETED|Overall Study||39
10877767|NCT04623242|12043663|FG001|COMPLETED|Overall Study||36
10877768|NCT04623242|12043664|FG002|COMPLETED|Overall Study||30
10877769|NCT04623242|12043665|FG003|COMPLETED|Overall Study||26
10877770|NCT04623242|12043666|FG004|COMPLETED|Overall Study||69
10877771|NCT04623242|12043662|FG000|NOT COMPLETED|Overall Study||13
10877772|NCT04623242|12043663|FG001|NOT COMPLETED|Overall Study||16
10877773|NCT04623242|12043664|FG002|NOT COMPLETED|Overall Study||10
10877774|NCT04623242|12043665|FG003|NOT COMPLETED|Overall Study||23
10877775|NCT04623242|12043666|FG004|NOT COMPLETED|Overall Study||0
10877776|NCT04619992|12043683|FG000|STARTED|Overall Study||55
10877777|NCT04619992|12043684|FG001|STARTED|Overall Study||7
10877778|NCT04619992|12043683|FG000|COMPLETED|Overall Study||54
10877779|NCT04619992|12043684|FG001|COMPLETED|Overall Study||7
10877780|NCT04619992|12043683|FG000|NOT COMPLETED|Overall Study||1
10877781|NCT04619992|12043684|FG001|NOT COMPLETED|Overall Study||0
10877782|NCT04606199|12043690|FG000|STARTED|Overall Study||53
10877783|NCT04606199|12043690|FG000|COMPLETED|Overall Study||51
10877784|NCT04606199|12043690|FG000|NOT COMPLETED|Overall Study||2
10877785|NCT04590495|12043698|FG000|STARTED|Overall Study||21
10877786|NCT04590495|12043699|FG001|STARTED|Overall Study||19
10877787|NCT04590495|12043698|FG000|COMPLETED|Overall Study||21
10877788|NCT04590495|12043699|FG001|COMPLETED|Overall Study||19
10877789|NCT04590495|12043698|FG000|NOT COMPLETED|Overall Study||0
10877790|NCT04590495|12043699|FG001|NOT COMPLETED|Overall Study||0
10877791|NCT04589559|12043705|FG000|STARTED|Overall Study||10
10877792|NCT04589559|12043705|FG000|COMPLETED|Overall Study||10
10877793|NCT04589559|12043705|FG000|NOT COMPLETED|Overall Study||0
10877794|NCT04587453|12043711|FG000|STARTED|Treatment Period (Week 0 to Week 16)||53
10877795|NCT04587453|12043712|FG001|STARTED|Treatment Period (Week 0 to Week 16)||53
10877796|NCT04587453|12043711|FG000|Full Analysis Set|Treatment Period (Week 0 to Week 16)||53
10877797|NCT04587453|12043712|FG001|Full Analysis Set|Treatment Period (Week 0 to Week 16)||53
10877798|NCT04587453|12043711|FG000|Safety Analysis Set|Treatment Period (Week 0 to Week 16)||53
10877799|NCT04587453|12043712|FG001|Safety Analysis Set|Treatment Period (Week 0 to Week 16)||53
10877800|NCT04587453|12043711|FG000|COMPLETED|Treatment Period (Week 0 to Week 16)||53
10877801|NCT04587453|12043712|FG001|COMPLETED|Treatment Period (Week 0 to Week 16)||52
10877802|NCT04587453|12043711|FG000|NOT COMPLETED|Treatment Period (Week 0 to Week 16)||0
10877803|NCT04587453|12043712|FG001|NOT COMPLETED|Treatment Period (Week 0 to Week 16)||1
10877804|NCT04587453|12043711|FG000|STARTED|Safety Follow-up (Week 16 to Week 20)||8
10877805|NCT04587453|12043712|FG001|STARTED|Safety Follow-up (Week 16 to Week 20)||3
10877806|NCT04587453|12043711|FG000|Not Started|Safety Follow-up (Week 16 to Week 20)||45
10877807|NCT04587453|12043712|FG001|Not Started|Safety Follow-up (Week 16 to Week 20)||49
10877808|NCT04587453|12043711|FG000|Safety Follow-up Analysis Set|Safety Follow-up (Week 16 to Week 20)||8
10877809|NCT04587453|12043712|FG001|Safety Follow-up Analysis Set|Safety Follow-up (Week 16 to Week 20)|1 subject prematurely discontinued treatment before Week 16, but did have contact after last exposure date and was therefore included in the safety follow-up analysis set.|4
10877810|NCT04587453|12043711|FG000|COMPLETED|Safety Follow-up (Week 16 to Week 20)|1 participant transferred to ECZTEND (LP0162-1337) at the safety follow-up visit.|8
10877811|NCT04587453|12043712|FG001|COMPLETED|Safety Follow-up (Week 16 to Week 20)||3
10877812|NCT04587453|12043711|FG000|NOT COMPLETED|Safety Follow-up (Week 16 to Week 20)||0
10877813|NCT04587453|12043712|FG001|NOT COMPLETED|Safety Follow-up (Week 16 to Week 20)||0
10877814|NCT04584970|12043722|FG000|STARTED|Overall Study||11
10877815|NCT04584970|12043723|FG001|STARTED|Overall Study||12
10877816|NCT04584970|12043722|FG000|COMPLETED|Overall Study||10
10877817|NCT04584970|12043723|FG001|COMPLETED|Overall Study||9
10877818|NCT04584970|12043722|FG000|NOT COMPLETED|Overall Study||1
10877819|NCT04584970|12043723|FG001|NOT COMPLETED|Overall Study||3
10877820|NCT04584346|12043731|FG000|STARTED|Phase 1 - Inpatient (Blinded)||7
10877821|NCT04584346|12043732|FG001|STARTED|Phase 1 - Inpatient (Blinded)||9
10877822|NCT04584346|12043731|FG000|COMPLETED|Phase 1 - Inpatient (Blinded)||7
10877823|NCT04584346|12043732|FG001|COMPLETED|Phase 1 - Inpatient (Blinded)||9
10877824|NCT04584346|12043731|FG000|NOT COMPLETED|Phase 1 - Inpatient (Blinded)||0
10877825|NCT04584346|12043732|FG001|NOT COMPLETED|Phase 1 - Inpatient (Blinded)||0
10877826|NCT04584346|12043731|FG000|STARTED|Phase 2 - At Home (Unblinded)||7
10877827|NCT04584346|12043732|FG001|STARTED|Phase 2 - At Home (Unblinded)||9
10877828|NCT04584346|12043731|FG000|COMPLETED|Phase 2 - At Home (Unblinded)||7
10877829|NCT04584346|12043732|FG001|COMPLETED|Phase 2 - At Home (Unblinded)||8
10877830|NCT04584346|12043731|FG000|NOT COMPLETED|Phase 2 - At Home (Unblinded)||0
10877831|NCT04584346|12043732|FG001|NOT COMPLETED|Phase 2 - At Home (Unblinded)||1
10877832|NCT04583709|12043740|FG000|STARTED|Overall Study||20
10877833|NCT04583709|12043740|FG000|COMPLETED|Overall Study||20
10877834|NCT04583709|12043740|FG000|NOT COMPLETED|Overall Study||0
10877835|NCT04580303|12043746|FG000|STARTED|Overall Study||7
10877836|NCT04580303|12043747|FG001|STARTED|Overall Study||9
10877837|NCT04580303|12043748|FG002|STARTED|Overall Study||9
10877838|NCT04580303|12043749|FG003|STARTED|Overall Study||10
10877839|NCT04580303|12043746|FG000|COMPLETED|Overall Study||7
10877840|NCT04580303|12043747|FG001|COMPLETED|Overall Study||8
10877841|NCT04580303|12043748|FG002|COMPLETED|Overall Study||8
10877842|NCT04580303|12043749|FG003|COMPLETED|Overall Study||10
10877843|NCT04580303|12043746|FG000|NOT COMPLETED|Overall Study||0
10877844|NCT04580303|12043747|FG001|NOT COMPLETED|Overall Study||1
10877845|NCT04580303|12043748|FG002|NOT COMPLETED|Overall Study||1
10877846|NCT04580303|12043749|FG003|NOT COMPLETED|Overall Study||0
10877847|NCT04575584|12043765|FG000|STARTED|Overall Study||75
10877848|NCT04575584|12043766|FG001|STARTED|Overall Study||75
10877849|NCT04575584|12043767|FG002|STARTED|Overall Study||76
10877850|NCT04575584|12043768|FG003|STARTED|Overall Study||78
10877851|NCT04575584|12043769|FG004|STARTED|Overall Study|Study terminated prior to initiating Part 2|0
10877852|NCT04575584|12043770|FG005|STARTED|Overall Study|Study terminated prior to initiating Part 2|0
10877853|NCT04575584|12043765|FG000|Treated|Overall Study||73
10877854|NCT04575584|12043766|FG001|Treated|Overall Study||73
10877855|NCT04575584|12043767|FG002|Treated|Overall Study||72
10877856|NCT04575584|12043768|FG003|Treated|Overall Study||75
10877857|NCT04575584|12043769|FG004|Treated|Overall Study||0
10877858|NCT04575584|12043770|FG005|Treated|Overall Study||0
10877859|NCT04575584|12043765|FG000|COMPLETED|Overall Study||61
10877860|NCT04575584|12043766|FG001|COMPLETED|Overall Study||60
10877861|NCT04575584|12043767|FG002|COMPLETED|Overall Study||63
10877862|NCT04575584|12043768|FG003|COMPLETED|Overall Study||70
10877863|NCT04575584|12043769|FG004|COMPLETED|Overall Study||0
10877864|NCT04575584|12043770|FG005|COMPLETED|Overall Study||0
10877865|NCT04575584|12043765|FG000|NOT COMPLETED|Overall Study||14
10877866|NCT04575584|12043766|FG001|NOT COMPLETED|Overall Study||15
10877867|NCT04575584|12043767|FG002|NOT COMPLETED|Overall Study||13
10877868|NCT04575584|12043768|FG003|NOT COMPLETED|Overall Study||8
10877869|NCT04575584|12043769|FG004|NOT COMPLETED|Overall Study||0
10877870|NCT04575584|12043770|FG005|NOT COMPLETED|Overall Study||0
10877871|NCT04571515|12043789|FG000|STARTED|Overall Study||22
10877872|NCT04571515|12043790|FG001|STARTED|Overall Study||24
10877873|NCT04571515|12043791|FG002|STARTED|Overall Study||23
10877874|NCT04571515|12043792|FG003|STARTED|Overall Study||23
10877875|NCT04571515|12043793|FG004|STARTED|Overall Study||22
10877876|NCT04571515|12043789|FG000|COMPLETED|Overall Study||21
10877877|NCT04571515|12043790|FG001|COMPLETED|Overall Study||24
10877878|NCT04571515|12043791|FG002|COMPLETED|Overall Study||23
10877879|NCT04571515|12043792|FG003|COMPLETED|Overall Study||23
10877880|NCT04571515|12043793|FG004|COMPLETED|Overall Study||19
10877881|NCT04571515|12043789|FG000|NOT COMPLETED|Overall Study||1
10877882|NCT04571515|12043790|FG001|NOT COMPLETED|Overall Study||0
10877883|NCT04571515|12043791|FG002|NOT COMPLETED|Overall Study||0
10877884|NCT04571515|12043792|FG003|NOT COMPLETED|Overall Study||0
10877885|NCT04571515|12043793|FG004|NOT COMPLETED|Overall Study||3
10877886|NCT04567225|12043807|FG000|STARTED|Overall Study||39
10877887|NCT04567225|12043808|FG001|STARTED|Overall Study||0
10877888|NCT04567225|12043807|FG000|COMPLETED|Overall Study|Study withdrawn. The study was closed due to lack of proper resource availability. Since study could not be completed as planned, participants did not complete follow-up.|0
10877889|NCT04567225|12043808|FG001|COMPLETED|Overall Study|The study was closed due to lack of proper resource availability. Since study could not be completed as planned, this chart review portion was not completed and no analysis was performed.|0
10877890|NCT04567225|12043807|FG000|NOT COMPLETED|Overall Study||39
10877891|NCT04567225|12043808|FG001|NOT COMPLETED|Overall Study||0
10877892|NCT04562155|12043818|FG000|STARTED|Overall Study||75
10877893|NCT04562155|12043819|FG001|STARTED|Overall Study||78
10877894|NCT04562155|12043820|FG002|STARTED|Overall Study||80
10877895|NCT04562155|12043821|FG003|STARTED|Overall Study||77
10877896|NCT04562155|12043818|FG000|COMPLETED|Overall Study||64
10877897|NCT04562155|12043819|FG001|COMPLETED|Overall Study||69
10877898|NCT04562155|12043820|FG002|COMPLETED|Overall Study||67
10877899|NCT04562155|12043821|FG003|COMPLETED|Overall Study||71
10877900|NCT04562155|12043818|FG000|NOT COMPLETED|Overall Study||11
10877901|NCT04562155|12043819|FG001|NOT COMPLETED|Overall Study||9
10877902|NCT04562155|12043820|FG002|NOT COMPLETED|Overall Study||13
10877903|NCT04562155|12043821|FG003|NOT COMPLETED|Overall Study||6
10877904|NCT04560686|12043831|FG000|STARTED|Overall Study||1
10877905|NCT04560686|12043831|FG000|COMPLETED|Overall Study||1
10877906|NCT04560686|12043831|FG000|NOT COMPLETED|Overall Study||0
10877907|NCT04552743|12043835|FG000|STARTED|Overall Study||25
10877908|NCT04552743|12043835|FG000|COMPLETED|Overall Study||25
10877909|NCT04552743|12043835|FG000|NOT COMPLETED|Overall Study||0
10877910|NCT04551014|12043842|FG000|STARTED|Overall Study||105
10877911|NCT04551014|12043843|FG001|STARTED|Overall Study||109
10877912|NCT04551014|12043842|FG000|COMPLETED|Overall Study||105
10877913|NCT04551014|12043843|FG001|COMPLETED|Overall Study||109
10877914|NCT04551014|12043842|FG000|NOT COMPLETED|Overall Study||0
10877915|NCT04551014|12043843|FG001|NOT COMPLETED|Overall Study||0
10877916|NCT04546724|12043851|FG000|STARTED|Overall Study||3082
10877917|NCT04546724|12043852|FG001|STARTED|Overall Study||1033
10877918|NCT04546724|12043851|FG000|COMPLETED|Overall Study||2959
10877919|NCT04546724|12043852|FG001|COMPLETED|Overall Study||998
10877920|NCT04546724|12043851|FG000|NOT COMPLETED|Overall Study||123
10877921|NCT04546724|12043852|FG001|NOT COMPLETED|Overall Study||35
10877922|NCT04542525|12043862|FG000|STARTED|Overall Study||32
10877923|NCT04542525|12043862|FG000|Attempted Implantation|Overall Study||32
10877924|NCT04542525|12043862|FG000|Successful Implantation|Overall Study||32
10877925|NCT04542525|12043862|FG000|COMPLETED|Overall Study||32
10877926|NCT04542525|12043862|FG000|NOT COMPLETED|Overall Study||0
10877927|NCT04539275|12043871|FG000|STARTED|Overall Study||35
10877928|NCT04539275|12043872|FG001|STARTED|Overall Study||40
10877929|NCT04539275|12043871|FG000|Received Study Product|Overall Study||32
10877930|NCT04539275|12043872|FG001|Received Study Product|Overall Study||40
10877931|NCT04539275|12043871|FG000|COMPLETED|Overall Study||29
10877932|NCT04539275|12043872|FG001|COMPLETED|Overall Study||35
10877933|NCT04539275|12043871|FG000|NOT COMPLETED|Overall Study||6
10877934|NCT04539275|12043872|FG001|NOT COMPLETED|Overall Study||5
10877935|NCT04537806|12043880|FG000|STARTED|Overall Study||15
10877936|NCT04537806|12043881|FG001|STARTED|Overall Study||14
10877937|NCT04537806|12043880|FG000|Safety Analysis Set|Overall Study||14
10877938|NCT04537806|12043881|FG001|Safety Analysis Set|Overall Study||14
10877939|NCT04537806|12043880|FG000|Full Analysis Set|Overall Study||14
10877940|NCT04537806|12043881|FG001|Full Analysis Set|Overall Study||14
10877941|NCT04537806|12043880|FG000|COMPLETED|Overall Study||13
10877942|NCT04537806|12043881|FG001|COMPLETED|Overall Study||13
10877943|NCT04537806|12043880|FG000|NOT COMPLETED|Overall Study||2
10877944|NCT04537806|12043881|FG001|NOT COMPLETED|Overall Study||1
10877945|NCT04535947|12043889|FG000|STARTED|Overall Study||76
10877946|NCT04535947|12043890|FG001|STARTED|Overall Study||77
10877947|NCT04535947|12043889|FG000|COMPLETED|Overall Study||72
10877948|NCT04535947|12043890|FG001|COMPLETED|Overall Study||72
10877949|NCT04535947|12043889|FG000|NOT COMPLETED|Overall Study||4
10877950|NCT04535947|12043890|FG001|NOT COMPLETED|Overall Study||5
10877951|NCT04529850|12043896|FG000|STARTED|Overall Study||37
10877952|NCT04529850|12043896|FG000|COMPLETED|Overall Study||32
10877953|NCT04529850|12043896|FG000|NOT COMPLETED|Overall Study||5
10877954|NCT04529096|12043902|FG000|STARTED|Overall Study||100
10877955|NCT04529096|12043903|FG001|STARTED|Overall Study||49
10877956|NCT04529096|12043902|FG000|Received at Least 1 Dose of Study Drug|Overall Study||100
10877957|NCT04529096|12043903|FG001|Received at Least 1 Dose of Study Drug|Overall Study||49
10877958|NCT04529096|12043902|FG000|COMPLETED|Overall Study||86
10877959|NCT04529096|12043903|FG001|COMPLETED|Overall Study||43
10877960|NCT04529096|12043902|FG000|NOT COMPLETED|Overall Study||14
10877961|NCT04529096|12043903|FG001|NOT COMPLETED|Overall Study||6
10877962|NCT04527471|12043911|FG000|STARTED|Overall Study||30
10877963|NCT04527471|12043912|FG001|STARTED|Overall Study||15
10877964|NCT04527471|12043911|FG000|Hospitalized up to 7 Days|Overall Study||24
10877965|NCT04527471|12043912|FG001|Hospitalized up to 7 Days|Overall Study||12
10877966|NCT04527471|12043911|FG000|Hospitalized for > 7 Days|Overall Study||6
10877967|NCT04527471|12043912|FG001|Hospitalized for > 7 Days|Overall Study||3
10877968|NCT04527471|12043911|FG000|COMPLETED|Overall Study||28
10877969|NCT04527471|12043912|FG001|COMPLETED|Overall Study||15
10877970|NCT04527471|12043911|FG000|NOT COMPLETED|Overall Study||2
10877971|NCT04527471|12043912|FG001|NOT COMPLETED|Overall Study||0
10877972|NCT04513652|12043920|FG000|STARTED|Overall Study||60
10877973|NCT04513652|12043921|FG001|STARTED|Overall Study||60
10877974|NCT04513652|12043920|FG000|COMPLETED|Overall Study||60
10877975|NCT04513652|12043921|FG001|COMPLETED|Overall Study||60
10877976|NCT04513652|12043920|FG000|NOT COMPLETED|Overall Study||0
10877977|NCT04513652|12043921|FG001|NOT COMPLETED|Overall Study||0
10877978|NCT04511208|12043927|FG000|STARTED|First Surgery||8
10877979|NCT04511208|12043928|FG001|STARTED|First Surgery||7
10877980|NCT04511208|12043929|FG002|STARTED|First Surgery||8
10877981|NCT04511208|12043930|FG003|STARTED|First Surgery||7
10877982|NCT04511208|12043927|FG000|COMPLETED|First Surgery||8
10877983|NCT04511208|12043928|FG001|COMPLETED|First Surgery||7
10877984|NCT04511208|12043929|FG002|COMPLETED|First Surgery||8
10877985|NCT04511208|12043930|FG003|COMPLETED|First Surgery||7
10877986|NCT04511208|12043927|FG000|NOT COMPLETED|First Surgery||0
10877987|NCT04511208|12043928|FG001|NOT COMPLETED|First Surgery||0
10877988|NCT04511208|12043929|FG002|NOT COMPLETED|First Surgery||0
10877989|NCT04511208|12043930|FG003|NOT COMPLETED|First Surgery||0
10877990|NCT04511208|12043927|FG000|STARTED|Second Surgery||8
10877991|NCT04511208|12043928|FG001|STARTED|Second Surgery||7
10877992|NCT04511208|12043929|FG002|STARTED|Second Surgery||8
10877993|NCT04511208|12043930|FG003|STARTED|Second Surgery||7
10877994|NCT04511208|12043927|FG000|COMPLETED|Second Surgery||8
10877995|NCT04511208|12043928|FG001|COMPLETED|Second Surgery||7
10877996|NCT04511208|12043929|FG002|COMPLETED|Second Surgery||8
10877997|NCT04511208|12043930|FG003|COMPLETED|Second Surgery||7
10877998|NCT04511208|12043927|FG000|NOT COMPLETED|Second Surgery||0
10877999|NCT04511208|12043928|FG001|NOT COMPLETED|Second Surgery||0
10878000|NCT04511208|12043929|FG002|NOT COMPLETED|Second Surgery||0
10878001|NCT04511208|12043930|FG003|NOT COMPLETED|Second Surgery||0
10878002|NCT04511208|12043927|FG000|STARTED|Third Surgery||8
10878003|NCT04511208|12043928|FG001|STARTED|Third Surgery||7
10878004|NCT04511208|12043929|FG002|STARTED|Third Surgery||8
10878005|NCT04511208|12043930|FG003|STARTED|Third Surgery||7
10878006|NCT04511208|12043927|FG000|COMPLETED|Third Surgery||8
10878007|NCT04511208|12043928|FG001|COMPLETED|Third Surgery||7
10878008|NCT04511208|12043929|FG002|COMPLETED|Third Surgery||8
10878009|NCT04511208|12043930|FG003|COMPLETED|Third Surgery||7
10878010|NCT04511208|12043927|FG000|NOT COMPLETED|Third Surgery||0
10878011|NCT04511208|12043928|FG001|NOT COMPLETED|Third Surgery||0
10878012|NCT04511208|12043929|FG002|NOT COMPLETED|Third Surgery||0
10878013|NCT04511208|12043930|FG003|NOT COMPLETED|Third Surgery||0
10878014|NCT04511208|12043927|FG000|STARTED|Forth Surgery||8
10878015|NCT04511208|12043928|FG001|STARTED|Forth Surgery||7
10878016|NCT04511208|12043929|FG002|STARTED|Forth Surgery||8
10878017|NCT04511208|12043930|FG003|STARTED|Forth Surgery||7
10878018|NCT04511208|12043927|FG000|COMPLETED|Forth Surgery||8
10878019|NCT04511208|12043928|FG001|COMPLETED|Forth Surgery||7
10878020|NCT04511208|12043929|FG002|COMPLETED|Forth Surgery||8
10878021|NCT04511208|12043930|FG003|COMPLETED|Forth Surgery||7
10878022|NCT04511208|12043927|FG000|NOT COMPLETED|Forth Surgery||0
10878023|NCT04511208|12043928|FG001|NOT COMPLETED|Forth Surgery||0
10878024|NCT04511208|12043929|FG002|NOT COMPLETED|Forth Surgery||0
10878025|NCT04511208|12043930|FG003|NOT COMPLETED|Forth Surgery||0
10878026|NCT04510922|12043936|FG000|STARTED|Overall Study||9
10878027|NCT04510922|12043936|FG000|COMPLETED|Overall Study||9
10878028|NCT04510922|12043936|FG000|NOT COMPLETED|Overall Study||0
10878029|NCT04505722|12043942|FG000|STARTED|Overall Study||22174
10878030|NCT04505722|12043943|FG001|STARTED|Overall Study||22150
10878031|NCT04505722|12043942|FG000|Vaccinated|Overall Study||21898
10878032|NCT04505722|12043943|FG001|Vaccinated|Overall Study||21890
10878033|NCT04505722|12043942|FG000|Participants in Entire Double Blind Phase|Overall Study||21894
10878034|NCT04505722|12043943|FG001|Participants in Entire Double Blind Phase|Overall Study||21882
10878035|NCT04505722|12043942|FG000|COMPLETED|Overall Study||0
10878036|NCT04505722|12043943|FG001|COMPLETED|Overall Study||0
10878037|NCT04505722|12043942|FG000|NOT COMPLETED|Overall Study||22174
10878038|NCT04505722|12043943|FG001|NOT COMPLETED|Overall Study||22150
10878039|NCT04498169|12043951|FG000|STARTED|Modified Intent-to-Treat Population||20
10878040|NCT04498169|12043952|FG001|STARTED|Modified Intent-to-Treat Population||20
10878041|NCT04498169|12043951|FG000|COMPLETED|Modified Intent-to-Treat Population||19
10878042|NCT04498169|12043952|FG001|COMPLETED|Modified Intent-to-Treat Population||19
10878043|NCT04498169|12043951|FG000|NOT COMPLETED|Modified Intent-to-Treat Population||1
10878044|NCT04498169|12043952|FG001|NOT COMPLETED|Modified Intent-to-Treat Population||1
10878045|NCT04498169|12043951|FG000|STARTED|Safety Population||20
10878046|NCT04498169|12043952|FG001|STARTED|Safety Population||20
10878047|NCT04498169|12043951|FG000|COMPLETED|Safety Population||19
10878048|NCT04498169|12043952|FG001|COMPLETED|Safety Population||19
10878049|NCT04498169|12043951|FG000|NOT COMPLETED|Safety Population||1
10878050|NCT04498169|12043952|FG001|NOT COMPLETED|Safety Population||1
10878051|NCT04498169|12043951|FG000|STARTED|Per-Protocol Population||18
10878052|NCT04498169|12043952|FG001|STARTED|Per-Protocol Population||16
10878053|NCT04498169|12043951|FG000|COMPLETED|Per-Protocol Population||18
10878054|NCT04498169|12043952|FG001|COMPLETED|Per-Protocol Population||15
10878055|NCT04498169|12043951|FG000|NOT COMPLETED|Per-Protocol Population||0
10878056|NCT04498169|12043952|FG001|NOT COMPLETED|Per-Protocol Population||1
10878057|NCT04498169|12043951|FG000|STARTED|Study Completion||20
10878058|NCT04498169|12043952|FG001|STARTED|Study Completion||20
10878059|NCT04498169|12043951|FG000|COMPLETED|Study Completion||19
10878060|NCT04498169|12043952|FG001|COMPLETED|Study Completion||19
10878061|NCT04498169|12043951|FG000|NOT COMPLETED|Study Completion||1
10878062|NCT04498169|12043952|FG001|NOT COMPLETED|Study Completion||1
10878063|NCT04496414|12043958|FG000|STARTED|Overall Study||50
10878064|NCT04496414|12043958|FG000|COMPLETED|Overall Study||50
10878065|NCT04496414|12043958|FG000|NOT COMPLETED|Overall Study||0
10878066|NCT04490499|12043962|FG000|STARTED|Overall Study||207
10878067|NCT04490499|12043962|FG000|Vaccinated|Overall Study||205
10878068|NCT04490499|12043962|FG000|COMPLETED|Overall Study||205
10878069|NCT04490499|12043962|FG000|NOT COMPLETED|Overall Study||2
10878070|NCT04482647|12043966|FG000|STARTED|Overall Study||100
10878071|NCT04482647|12043966|FG000|COMPLETED|Overall Study||88
10878072|NCT04482647|12043966|FG000|NOT COMPLETED|Overall Study||12
10878073|NCT04476108|12043972|FG000|STARTED|Overall Study||84
10878074|NCT04476108|12043973|FG001|STARTED|Overall Study||41
10878075|NCT04476108|12043972|FG000|Received at Least 1 Dose of Study Drug|Overall Study||83
10878076|NCT04476108|12043973|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
10878077|NCT04476108|12043972|FG000|COMPLETED|Overall Study||76
10878078|NCT04476108|12043973|FG001|COMPLETED|Overall Study||38
10878079|NCT04476108|12043972|FG000|NOT COMPLETED|Overall Study||8
10878080|NCT04476108|12043973|FG001|NOT COMPLETED|Overall Study||3
10878081|NCT04470622|12043981|FG000|STARTED|Overall Study||12
10878082|NCT04470622|12043982|FG001|STARTED|Overall Study||14
10878083|NCT04470622|12043981|FG000|COMPLETED|Overall Study||12
10878084|NCT04470622|12043982|FG001|COMPLETED|Overall Study||11
10878085|NCT04470622|12043981|FG000|NOT COMPLETED|Overall Study||0
10878086|NCT04470622|12043982|FG001|NOT COMPLETED|Overall Study||3
10878087|NCT04464421|12043990|FG000|STARTED|Overall Study||24
10878088|NCT04464421|12043991|FG001|STARTED|Overall Study||24
10878089|NCT04464421|12043990|FG000|COMPLETED|Overall Study||22
10878090|NCT04464421|12043991|FG001|COMPLETED|Overall Study||22
10878091|NCT04464421|12043990|FG000|NOT COMPLETED|Overall Study||2
10878092|NCT04464421|12043991|FG001|NOT COMPLETED|Overall Study||2
10878093|NCT04458090|12043999|FG000|STARTED|Overall Study||72
10878094|NCT04458090|12044000|FG001|STARTED|Overall Study||72
10878095|NCT04458090|12043999|FG000|COMPLETED|Overall Study||72
10878096|NCT04458090|12044000|FG001|COMPLETED|Overall Study||72
10878097|NCT04458090|12043999|FG000|NOT COMPLETED|Overall Study||0
10878098|NCT04458090|12044000|FG001|NOT COMPLETED|Overall Study||0
10878099|NCT04456959|12044006|FG000|STARTED|Overall Study||28
10878100|NCT04456959|12044006|FG000|COMPLETED|Overall Study||28
10878101|NCT04456959|12044006|FG000|NOT COMPLETED|Overall Study||0
10878102|NCT04456686|12044012|FG000|STARTED|Overall Study||78
10878103|NCT04456686|12044013|FG001|STARTED|Overall Study||39
10878104|NCT04456686|12044012|FG000|Received at Least 1 Dose of Study Drug|Overall Study||77
10878105|NCT04456686|12044013|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
10878106|NCT04456686|12044012|FG000|COMPLETED|Overall Study||63
10878107|NCT04456686|12044013|FG001|COMPLETED|Overall Study||32
10878108|NCT04456686|12044012|FG000|NOT COMPLETED|Overall Study||15
10878109|NCT04456686|12044013|FG001|NOT COMPLETED|Overall Study||7
10878110|NCT04447404|12044021|FG000|STARTED|Overall Study||2
10878111|NCT04447404|12044022|FG001|STARTED|Overall Study||0
10878112|NCT04447404|12044021|FG000|COMPLETED|Overall Study||0
10878113|NCT04447404|12044022|FG001|COMPLETED|Overall Study||0
10878114|NCT04447404|12044021|FG000|NOT COMPLETED|Overall Study||2
10878115|NCT04447404|12044022|FG001|NOT COMPLETED|Overall Study||0
10878116|NCT04439344|12044028|FG000|STARTED|Overall Study||53
10878117|NCT04439344|12044028|FG000|Started Protocol Therapy|Overall Study||50
10878118|NCT04439344|12044028|FG000|Eligible|Overall Study||47
10878119|NCT04439344|12044028|FG000|COMPLETED|Overall Study||0
10878120|NCT04439344|12044028|FG000|NOT COMPLETED|Overall Study||53
10878121|NCT04439279|12044032|FG000|STARTED|Overall Study||35
10878122|NCT04439279|12044032|FG000|Started Protocol Therapy|Overall Study||35
10878123|NCT04439279|12044032|FG000|Eligible|Overall Study||33
10878124|NCT04439279|12044032|FG000|Reported Adverse Events Data|Overall Study|Adverse event was not assessed on one patient before discontinuing therapy due to withdraw/refusal|34
10878125|NCT04439279|12044032|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerability.|0
10878126|NCT04439279|12044032|FG000|NOT COMPLETED|Overall Study||35
10878127|NCT04439266|12044036|FG000|STARTED|Overall Study||5
10878128|NCT04439266|12044036|FG000|Eligible|Overall Study||4
10878129|NCT04439266|12044036|FG000|COMPLETED|Overall Study||0
10878130|NCT04439266|12044036|FG000|NOT COMPLETED|Overall Study||5
10878131|NCT04439253|12044040|FG000|STARTED|Overall Study||4
10878132|NCT04439253|12044040|FG000|COMPLETED|Overall Study||0
10878133|NCT04439253|12044040|FG000|NOT COMPLETED|Overall Study||4
10878134|NCT04439123|12044044|FG000|STARTED|Overall Study|All 35 patients enrolled were eligible and treated in the arm|35
10878135|NCT04439123|12044044|FG000|COMPLETED|Overall Study||0
10878136|NCT04439123|12044044|FG000|NOT COMPLETED|Overall Study||35
10878137|NCT04439110|12044048|FG000|STARTED|Overall Study||38
10878138|NCT04439110|12044048|FG000|Eligible|Overall Study||36
10878139|NCT04439110|12044048|FG000|COMPLETED|Overall Study||0
10878140|NCT04439110|12044048|FG000|NOT COMPLETED|Overall Study||38
10878141|NCT04438499|12044052|FG000|STARTED|Overall Study|31 participants represent the sensitivity analysis (intent to treat) population. Since there was a lack of efficacy in one participant which was determined to be due to anatomical factors (catheterization was unsuccessful), one additional participant was enrolled to meet the minimum requirement of 30 primary analysis population participants.|31
10878142|NCT04438499|12044052|FG000|COMPLETED|Overall Study|29 of 31 participants completed the study. One enrolled participant did not complete the study due to anatomical factors preventing catheterization and this participant was replaced to meet the minimum required 30 primary analysis population participants. A second enrolled participant did not complete the study due to a device deficiency and failure of the catheter during the procedure.|29
10878143|NCT04438499|12044052|FG000|NOT COMPLETED|Overall Study||2
10878144|NCT04435665|12044060|FG000|STARTED|Overall Study||12
10878145|NCT04435665|12044061|FG001|STARTED|Overall Study||11
10878146|NCT04435665|12044062|FG002|STARTED|Overall Study||12
10878147|NCT04435665|12044063|FG003|STARTED|Overall Study||13
10878148|NCT04435665|12044060|FG000|COMPLETED|Overall Study||12
10878149|NCT04435665|12044061|FG001|COMPLETED|Overall Study||11
10878150|NCT04435665|12044062|FG002|COMPLETED|Overall Study||12
10878151|NCT04435665|12044063|FG003|COMPLETED|Overall Study||12
10878152|NCT04435665|12044060|FG000|NOT COMPLETED|Overall Study||0
10878153|NCT04435665|12044061|FG001|NOT COMPLETED|Overall Study||0
10878154|NCT04435665|12044062|FG002|NOT COMPLETED|Overall Study||0
10878155|NCT04435665|12044063|FG003|NOT COMPLETED|Overall Study||1
10878156|NCT04427501|12044083|FG000|STARTED|Overall Study||156
10878157|NCT04427501|12044084|FG001|STARTED|Overall Study||101
10878158|NCT04427501|12044085|FG002|STARTED|Overall Study||107
10878159|NCT04427501|12044086|FG003|STARTED|Overall Study||101
10878160|NCT04427501|12044087|FG004|STARTED|Overall Study||112
10878161|NCT04427501|12044088|FG005|STARTED|Overall Study|Participants in Placebo for Phase 3: 2800 mg Bamlanivimab + 2800 mg Etesevimab and Phase 3: 700 mg Bamlanivimab + 1400 mg Etesevimab were combined to avoid double counting.|776
10878162|NCT04427501|12044089|FG006|STARTED|Overall Study||518
10878163|NCT04427501|12044090|FG007|STARTED|Overall Study||513
10878164|NCT04427501|12044091|FG008|STARTED|Overall Study||141
10878165|NCT04427501|12044092|FG009|STARTED|Overall Study||213
10878166|NCT04427501|12044083|FG000|Received at Least One Dose of Study Drug|Overall Study||156
10878167|NCT04427501|12044084|FG001|Received at Least One Dose of Study Drug|Overall Study||101
10878168|NCT04427501|12044085|FG002|Received at Least One Dose of Study Drug|Overall Study||107
10878169|NCT04427501|12044086|FG003|Received at Least One Dose of Study Drug|Overall Study||101
10878170|NCT04427501|12044087|FG004|Received at Least One Dose of Study Drug|Overall Study||112
10878171|NCT04427501|12044088|FG005|Received at Least One Dose of Study Drug|Overall Study||776
10878172|NCT04427501|12044089|FG006|Received at Least One Dose of Study Drug|Overall Study||518
10878173|NCT04427501|12044090|FG007|Received at Least One Dose of Study Drug|Overall Study||513
10878174|NCT04427501|12044091|FG008|Received at Least One Dose of Study Drug|Overall Study||141
10878175|NCT04427501|12044092|FG009|Received at Least One Dose of Study Drug|Overall Study||213
10878176|NCT04427501|12044083|FG000|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878177|NCT04427501|12044084|FG001|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878178|NCT04427501|12044085|FG002|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878179|NCT04427501|12044086|FG003|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878180|NCT04427501|12044087|FG004|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878181|NCT04427501|12044088|FG005|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||517
10878182|NCT04427501|12044089|FG006|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878183|NCT04427501|12044090|FG007|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878184|NCT04427501|12044091|FG008|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878185|NCT04427501|12044092|FG009|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
10878186|NCT04427501|12044083|FG000|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878187|NCT04427501|12044084|FG001|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878188|NCT04427501|12044085|FG002|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878189|NCT04427501|12044086|FG003|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878190|NCT04427501|12044087|FG004|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878191|NCT04427501|12044088|FG005|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||776
10878192|NCT04427501|12044089|FG006|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878193|NCT04427501|12044090|FG007|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878194|NCT04427501|12044091|FG008|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878195|NCT04427501|12044092|FG009|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
10878196|NCT04427501|12044083|FG000|COMPLETED|Overall Study||141
10878197|NCT04427501|12044084|FG001|COMPLETED|Overall Study||95
10878198|NCT04427501|12044085|FG002|COMPLETED|Overall Study||103
10878199|NCT04427501|12044086|FG003|COMPLETED|Overall Study||98
10878200|NCT04427501|12044087|FG004|COMPLETED|Overall Study||103
10878201|NCT04427501|12044088|FG005|COMPLETED|Overall Study||719
10878202|NCT04427501|12044089|FG006|COMPLETED|Overall Study||485
10878203|NCT04427501|12044090|FG007|COMPLETED|Overall Study||496
10878204|NCT04427501|12044091|FG008|COMPLETED|Overall Study||135
10878205|NCT04427501|12044092|FG009|COMPLETED|Overall Study||207
10878206|NCT04427501|12044083|FG000|NOT COMPLETED|Overall Study||15
10878207|NCT04427501|12044084|FG001|NOT COMPLETED|Overall Study||6
10878208|NCT04427501|12044085|FG002|NOT COMPLETED|Overall Study||4
10878209|NCT04427501|12044086|FG003|NOT COMPLETED|Overall Study||3
10878210|NCT04427501|12044087|FG004|NOT COMPLETED|Overall Study||9
10878211|NCT04427501|12044088|FG005|NOT COMPLETED|Overall Study||57
10878212|NCT04427501|12044089|FG006|NOT COMPLETED|Overall Study||33
10878213|NCT04427501|12044090|FG007|NOT COMPLETED|Overall Study||17
10878214|NCT04427501|12044091|FG008|NOT COMPLETED|Overall Study||6
10878215|NCT04427501|12044092|FG009|NOT COMPLETED|Overall Study||6
10878216|NCT04426630|12044125|FG000|STARTED|Overall Study||72
10878217|NCT04426630|12044125|FG000|COMPLETED|Overall Study||66
10878218|NCT04426630|12044125|FG000|NOT COMPLETED|Overall Study||6
10878219|NCT04421027|12044131|FG000|STARTED|Treatment Period||761
10878220|NCT04421027|12044132|FG001|STARTED|Treatment Period||764
10878221|NCT04421027|12044133|FG002|STARTED|Treatment Period||0
10878222|NCT04421027|12044134|FG003|STARTED|Treatment Period||0
10878223|NCT04421027|12044131|FG000|Received at Least One Dose of Study Drug|Treatment Period||752
10878224|NCT04421027|12044132|FG001|Received at Least One Dose of Study Drug|Treatment Period||750
10878225|NCT04421027|12044133|FG002|Received at Least One Dose of Study Drug|Treatment Period||0
10878226|NCT04421027|12044134|FG003|Received at Least One Dose of Study Drug|Treatment Period||0
10878227|NCT04421027|12044131|FG000|COMPLETED|Treatment Period||604
10878228|NCT04421027|12044132|FG001|COMPLETED|Treatment Period||644
10878229|NCT04421027|12044133|FG002|COMPLETED|Treatment Period||0
10878230|NCT04421027|12044134|FG003|COMPLETED|Treatment Period||0
10878231|NCT04421027|12044131|FG000|NOT COMPLETED|Treatment Period||157
10878232|NCT04421027|12044132|FG001|NOT COMPLETED|Treatment Period||120
10878233|NCT04421027|12044133|FG002|NOT COMPLETED|Treatment Period||0
10878234|NCT04421027|12044134|FG003|NOT COMPLETED|Treatment Period||0
10878235|NCT04421027|12044131|FG000|STARTED|Follow-Up Period||0
10878236|NCT04421027|12044132|FG001|STARTED|Follow-Up Period||0
10878237|NCT04421027|12044133|FG002|STARTED|Follow-Up Period||613
10878238|NCT04421027|12044134|FG003|STARTED|Follow-Up Period||645
10878239|NCT04421027|12044131|FG000|COMPLETED|Follow-Up Period||0
10878240|NCT04421027|12044132|FG001|COMPLETED|Follow-Up Period||0
10878241|NCT04421027|12044133|FG002|COMPLETED|Follow-Up Period||588
10878242|NCT04421027|12044134|FG003|COMPLETED|Follow-Up Period|One participants study disposition case report form was not completed, therefore the participant appeared as 'ongoing' at Day 60. The participant completed Day 60 Clinical Status Assessment (CSA) and is considered as completing the study.|615
10878243|NCT04421027|12044131|FG000|NOT COMPLETED|Follow-Up Period||0
10878244|NCT04421027|12044132|FG001|NOT COMPLETED|Follow-Up Period||0
10878245|NCT04421027|12044133|FG002|NOT COMPLETED|Follow-Up Period||25
10878246|NCT04421027|12044134|FG003|NOT COMPLETED|Follow-Up Period||30
10878247|NCT04413552|12044152|FG000|STARTED|Overall Study||6
10878248|NCT04413552|12044153|FG001|STARTED|Overall Study||6
10878249|NCT04413552|12044154|FG002|STARTED|Overall Study||6
10878250|NCT04413552|12044155|FG003|STARTED|Overall Study||6
10878251|NCT04413552|12044156|FG004|STARTED|Overall Study||6
10878252|NCT04413552|12044157|FG005|STARTED|Overall Study||6
10878253|NCT04413552|12044158|FG006|STARTED|Overall Study||7
10878254|NCT04413552|12044159|FG007|STARTED|Overall Study||6
10878255|NCT04413552|12044160|FG008|STARTED|Overall Study||16
10878256|NCT04413552|12044161|FG009|STARTED|Overall Study||8
10878257|NCT04413552|12044152|FG000|Received Study Drug|Overall Study||6
10878258|NCT04413552|12044153|FG001|Received Study Drug|Overall Study||6
10878259|NCT04413552|12044154|FG002|Received Study Drug|Overall Study||6
10878260|NCT04413552|12044155|FG003|Received Study Drug|Overall Study||6
10878261|NCT04413552|12044156|FG004|Received Study Drug|Overall Study||6
10878262|NCT04413552|12044157|FG005|Received Study Drug|Overall Study||6
10878263|NCT04413552|12044158|FG006|Received Study Drug|Overall Study||6
10878264|NCT04413552|12044159|FG007|Received Study Drug|Overall Study||6
10878265|NCT04413552|12044160|FG008|Received Study Drug|Overall Study||16
10878266|NCT04413552|12044161|FG009|Received Study Drug|Overall Study||8
10878267|NCT04413552|12044152|FG000|COMPLETED|Overall Study||6
10878268|NCT04413552|12044153|FG001|COMPLETED|Overall Study||6
10878269|NCT04413552|12044154|FG002|COMPLETED|Overall Study||6
10878270|NCT04413552|12044155|FG003|COMPLETED|Overall Study||6
10878271|NCT04413552|12044156|FG004|COMPLETED|Overall Study||6
10878272|NCT04413552|12044157|FG005|COMPLETED|Overall Study||6
10878273|NCT04413552|12044158|FG006|COMPLETED|Overall Study||6
10878274|NCT04413552|12044159|FG007|COMPLETED|Overall Study||6
10878275|NCT04413552|12044160|FG008|COMPLETED|Overall Study||16
10878276|NCT04413552|12044161|FG009|COMPLETED|Overall Study||8
10878277|NCT04413552|12044152|FG000|NOT COMPLETED|Overall Study||0
10878278|NCT04413552|12044153|FG001|NOT COMPLETED|Overall Study||0
10878279|NCT04413552|12044154|FG002|NOT COMPLETED|Overall Study||0
10878280|NCT04413552|12044155|FG003|NOT COMPLETED|Overall Study||0
10878281|NCT04413552|12044156|FG004|NOT COMPLETED|Overall Study||0
10878282|NCT04413552|12044157|FG005|NOT COMPLETED|Overall Study||0
10878283|NCT04413552|12044158|FG006|NOT COMPLETED|Overall Study||1
10878284|NCT04413552|12044159|FG007|NOT COMPLETED|Overall Study||0
10878285|NCT04413552|12044160|FG008|NOT COMPLETED|Overall Study||0
10878286|NCT04413552|12044161|FG009|NOT COMPLETED|Overall Study||0
10878287|NCT04412707|12044189|FG000|STARTED|Cycle 1||14
10878288|NCT04412707|12044190|FG001|STARTED|Cycle 1||13
10878289|NCT04412707|12044189|FG000|Discontinued|Cycle 1||1
10878290|NCT04412707|12044190|FG001|Discontinued|Cycle 1||5
10878291|NCT04412707|12044189|FG000|COMPLETED|Cycle 1||13
10878292|NCT04412707|12044190|FG001|COMPLETED|Cycle 1||8
10878293|NCT04412707|12044189|FG000|NOT COMPLETED|Cycle 1||1
10878294|NCT04412707|12044190|FG001|NOT COMPLETED|Cycle 1||5
10878295|NCT04412707|12044189|FG000|STARTED|Cycle 2||13
10878296|NCT04412707|12044190|FG001|STARTED|Cycle 2||8
10878297|NCT04412707|12044189|FG000|Discontinued|Cycle 2||3
10878298|NCT04412707|12044190|FG001|Discontinued|Cycle 2||1
10878299|NCT04412707|12044189|FG000|COMPLETED|Cycle 2||10
10878300|NCT04412707|12044190|FG001|COMPLETED|Cycle 2||7
10878301|NCT04412707|12044189|FG000|NOT COMPLETED|Cycle 2||3
10878302|NCT04412707|12044190|FG001|NOT COMPLETED|Cycle 2||1
10878303|NCT04412707|12044189|FG000|STARTED|Cycle 3 to End of Study (EOS)||10
10878304|NCT04412707|12044190|FG001|STARTED|Cycle 3 to End of Study (EOS)||7
10878305|NCT04412707|12044189|FG000|Ongoing in Study at Data Cut|Cycle 3 to End of Study (EOS)||0
10878306|NCT04412707|12044190|FG001|Ongoing in Study at Data Cut|Cycle 3 to End of Study (EOS)||0
10878307|NCT04412707|12044189|FG000|Discontinued Study in Cycle 3 or Later|Cycle 3 to End of Study (EOS)||10
10878308|NCT04412707|12044190|FG001|Discontinued Study in Cycle 3 or Later|Cycle 3 to End of Study (EOS)||7
10878309|NCT04412707|12044189|FG000|COMPLETED|Cycle 3 to End of Study (EOS)||0
10878310|NCT04412707|12044190|FG001|COMPLETED|Cycle 3 to End of Study (EOS)||0
10878311|NCT04412707|12044189|FG000|NOT COMPLETED|Cycle 3 to End of Study (EOS)||10
10878312|NCT04412707|12044190|FG001|NOT COMPLETED|Cycle 3 to End of Study (EOS)||7
10878313|NCT04410198|12044196|FG000|STARTED|Overall Study||203
10878314|NCT04410198|12044196|FG000|Received at Least 1 Dose of Study Drug|Overall Study||203
10878315|NCT04410198|12044196|FG000|Full Analysis Set|Overall Study||201
10878316|NCT04410198|12044196|FG000|COMPLETED|Overall Study||166
10878317|NCT04410198|12044196|FG000|NOT COMPLETED|Overall Study||37
10878318|NCT04404010|12044202|FG000|STARTED|Overall Study|1 participant was mistakenly consented, enrolled and randomized as part of study. After randomization, but prior to study testing we realized the participant was not eligible (they were not a PGY4 or 5), therefore they were excluded prior to any further study procedures commenced. Therefore, only 9 participants completed all study procedures/were followed for purposes of study.|10
10878319|NCT04404010|12044203|FG001|STARTED|Overall Study||9
10878320|NCT04404010|12044202|FG000|COMPLETED|Overall Study||9
10878321|NCT04404010|12044203|FG001|COMPLETED|Overall Study||9
10878322|NCT04404010|12044202|FG000|NOT COMPLETED|Overall Study||1
10878323|NCT04404010|12044203|FG001|NOT COMPLETED|Overall Study||0
10878324|NCT04401423|12044213|FG000|STARTED|Overall Study||11
10878325|NCT04401423|12044214|FG001|STARTED|Overall Study||11
10878326|NCT04401423|12044213|FG000|COMPLETED|Overall Study||6
10878327|NCT04401423|12044214|FG001|COMPLETED|Overall Study||9
10878328|NCT04401423|12044213|FG000|NOT COMPLETED|Overall Study||5
10878329|NCT04401423|12044214|FG001|NOT COMPLETED|Overall Study||2
10878330|NCT04398134|12044226|FG000|STARTED|Overall Study||32
10878331|NCT04398134|12044227|FG001|STARTED|Overall Study||11
10878332|NCT04398134|12044228|FG002|STARTED|Overall Study||33
10878333|NCT04398134|12044229|FG003|STARTED|Overall Study||12
10878334|NCT04398134|12044226|FG000|COMPLETED|Overall Study||0
10878335|NCT04398134|12044227|FG001|COMPLETED|Overall Study||0
10878336|NCT04398134|12044228|FG002|COMPLETED|Overall Study||0
10878337|NCT04398134|12044229|FG003|COMPLETED|Overall Study||0
10878338|NCT04398134|12044226|FG000|NOT COMPLETED|Overall Study||32
10878339|NCT04398134|12044227|FG001|NOT COMPLETED|Overall Study||11
10878340|NCT04398134|12044228|FG002|NOT COMPLETED|Overall Study||33
10878341|NCT04398134|12044229|FG003|NOT COMPLETED|Overall Study||12
10878342|NCT04398030|12044239|FG000|STARTED|Treatment Period 1 (1 Week)||3
10878343|NCT04398030|12044240|FG001|STARTED|Treatment Period 1 (1 Week)||4
10878344|NCT04398030|12044239|FG000|COMPLETED|Treatment Period 1 (1 Week)||3
10878345|NCT04398030|12044240|FG001|COMPLETED|Treatment Period 1 (1 Week)||3
10878346|NCT04398030|12044239|FG000|NOT COMPLETED|Treatment Period 1 (1 Week)||0
10878347|NCT04398030|12044240|FG001|NOT COMPLETED|Treatment Period 1 (1 Week)||1
10878348|NCT04398030|12044239|FG000|STARTED|Washout (2 Weeks)||3
10878349|NCT04398030|12044240|FG001|STARTED|Washout (2 Weeks)||3
10878350|NCT04398030|12044239|FG000|COMPLETED|Washout (2 Weeks)||3
10878351|NCT04398030|12044240|FG001|COMPLETED|Washout (2 Weeks)||3
10878352|NCT04398030|12044239|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10878353|NCT04398030|12044240|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10878354|NCT04398030|12044239|FG000|STARTED|Treatment Period 2 (1 Week)||3
10878355|NCT04398030|12044240|FG001|STARTED|Treatment Period 2 (1 Week)||3
10878356|NCT04398030|12044239|FG000|COMPLETED|Treatment Period 2 (1 Week)||2
10878357|NCT04398030|12044240|FG001|COMPLETED|Treatment Period 2 (1 Week)||3
10878358|NCT04398030|12044239|FG000|NOT COMPLETED|Treatment Period 2 (1 Week)||1
10878359|NCT04398030|12044240|FG001|NOT COMPLETED|Treatment Period 2 (1 Week)||0
10878360|NCT04396847|12044248|FG000|STARTED|Overall Study||1
10878361|NCT04396847|12044249|FG001|STARTED|Overall Study||0
10878362|NCT04396847|12044248|FG000|COMPLETED|Overall Study||1
10878363|NCT04396847|12044249|FG001|COMPLETED|Overall Study||0
10878364|NCT04396847|12044248|FG000|NOT COMPLETED|Overall Study||0
10878365|NCT04396847|12044249|FG001|NOT COMPLETED|Overall Study||0
10878366|NCT04390191|12044257|FG000|STARTED|Overall Study||1
10878367|NCT04390191|12044258|FG001|STARTED|Overall Study||3
10878368|NCT04390191|12044257|FG000|COMPLETED|Overall Study||0
10878369|NCT04390191|12044258|FG001|COMPLETED|Overall Study||3
10878370|NCT04390191|12044257|FG000|NOT COMPLETED|Overall Study||1
10878371|NCT04390191|12044258|FG001|NOT COMPLETED|Overall Study||0
10878372|NCT04389840|12044270|FG000|STARTED|Overall Study||6
10878373|NCT04389840|12044271|FG001|STARTED|Overall Study||6
10878374|NCT04389840|12044272|FG002|STARTED|Overall Study||8
10878375|NCT04389840|12044273|FG003|STARTED|Overall Study||4
10878376|NCT04389840|12044274|FG004|STARTED|Overall Study||2
10878377|NCT04389840|12044275|FG005|STARTED|Overall Study||1
10878378|NCT04389840|12044270|FG000|Intent-to-Treat Analysis Set|Overall Study||6
10878379|NCT04389840|12044271|FG001|Intent-to-Treat Analysis Set|Overall Study||6
10878380|NCT04389840|12044272|FG002|Intent-to-Treat Analysis Set|Overall Study||8
10878381|NCT04389840|12044273|FG003|Intent-to-Treat Analysis Set|Overall Study||4
10878382|NCT04389840|12044274|FG004|Intent-to-Treat Analysis Set|Overall Study||2
10878383|NCT04389840|12044275|FG005|Intent-to-Treat Analysis Set|Overall Study||1
10878384|NCT04389840|12044270|FG000|Safety Analysis Set|Overall Study||6
10878385|NCT04389840|12044271|FG001|Safety Analysis Set|Overall Study||6
10878386|NCT04389840|12044272|FG002|Safety Analysis Set|Overall Study||8
10878387|NCT04389840|12044273|FG003|Safety Analysis Set|Overall Study|The excluded subject was randomized to receive placebo but never received treatment due to consent withdrawal.|3
10878388|NCT04389840|12044274|FG004|Safety Analysis Set|Overall Study||2
10878389|NCT04389840|12044275|FG005|Safety Analysis Set|Overall Study||1
10878390|NCT04389840|12044270|FG000|COMPLETED|Overall Study||4
10878391|NCT04389840|12044271|FG001|COMPLETED|Overall Study||5
10878392|NCT04389840|12044272|FG002|COMPLETED|Overall Study||8
10878393|NCT04389840|12044273|FG003|COMPLETED|Overall Study||3
10878394|NCT04389840|12044274|FG004|COMPLETED|Overall Study||1
10878395|NCT04389840|12044275|FG005|COMPLETED|Overall Study||1
10878396|NCT04389840|12044270|FG000|NOT COMPLETED|Overall Study||2
10878397|NCT04389840|12044271|FG001|NOT COMPLETED|Overall Study||1
10878398|NCT04389840|12044272|FG002|NOT COMPLETED|Overall Study||0
10878399|NCT04389840|12044273|FG003|NOT COMPLETED|Overall Study||1
10878400|NCT04389840|12044274|FG004|NOT COMPLETED|Overall Study||1
10878401|NCT04389840|12044275|FG005|NOT COMPLETED|Overall Study||0
10878402|NCT04388826|12044291|FG000|STARTED|Overall Study||19
10878403|NCT04388826|12044292|FG001|STARTED|Overall Study||20
10878404|NCT04388826|12044291|FG000|COMPLETED|Overall Study||15
10878405|NCT04388826|12044292|FG001|COMPLETED|Overall Study||18
10878406|NCT04388826|12044291|FG000|NOT COMPLETED|Overall Study||4
10878407|NCT04388826|12044292|FG001|NOT COMPLETED|Overall Study||2
10878408|NCT04382651|12044300|FG000|STARTED|Overall Study||69
10878409|NCT04382651|12044301|FG001|STARTED|Overall Study||71
10878410|NCT04382651|12044300|FG000|Safety Analysis Set|Overall Study||68
10878411|NCT04382651|12044301|FG001|Safety Analysis Set|Overall Study||70
10878412|NCT04382651|12044300|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||63
10878413|NCT04382651|12044301|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||0
10878414|NCT04382651|12044300|FG000|COMPLETED|Overall Study||38
10878415|NCT04382651|12044301|FG001|COMPLETED|Overall Study||43
10878416|NCT04382651|12044300|FG000|NOT COMPLETED|Overall Study||31
10878417|NCT04382651|12044301|FG001|NOT COMPLETED|Overall Study||28
10878418|NCT04382066|12044311|FG000|STARTED|Overall Study||15
10878419|NCT04382066|12044312|FG001|STARTED|Overall Study||15
10878420|NCT04382066|12044313|FG002|STARTED|Overall Study||15
10878421|NCT04382066|12044311|FG000|Completed 3-day Treatment|Overall Study||14
10878422|NCT04382066|12044312|FG001|Completed 3-day Treatment|Overall Study||15
10878423|NCT04382066|12044313|FG002|Completed 3-day Treatment|Overall Study||15
10878424|NCT04382066|12044311|FG000|COMPLETED|Overall Study||13
10878425|NCT04382066|12044312|FG001|COMPLETED|Overall Study||15
10878426|NCT04382066|12044313|FG002|COMPLETED|Overall Study||14
10878427|NCT04382066|12044311|FG000|NOT COMPLETED|Overall Study||2
10878428|NCT04382066|12044312|FG001|NOT COMPLETED|Overall Study||0
10878429|NCT04382066|12044313|FG002|NOT COMPLETED|Overall Study||1
10878430|NCT04375878|12044331|FG000|STARTED|Crossover First and Second Interventions||7
10878431|NCT04375878|12044332|FG001|STARTED|Crossover First and Second Interventions||7
10878432|NCT04375878|12044333|FG002|STARTED|Crossover First and Second Interventions||6
10878433|NCT04375878|12044334|FG003|STARTED|Crossover First and Second Interventions||7
10878434|NCT04375878|12044335|FG004|STARTED|Crossover First and Second Interventions||0
10878435|NCT04375878|12044336|FG005|STARTED|Crossover First and Second Interventions||0
10878436|NCT04375878|12044331|FG000|COMPLETED|Crossover First and Second Interventions||6
10878437|NCT04375878|12044332|FG001|COMPLETED|Crossover First and Second Interventions||6
10878438|NCT04375878|12044333|FG002|COMPLETED|Crossover First and Second Interventions||5
10878439|NCT04375878|12044334|FG003|COMPLETED|Crossover First and Second Interventions||7
10878440|NCT04375878|12044335|FG004|COMPLETED|Crossover First and Second Interventions||0
10878441|NCT04375878|12044336|FG005|COMPLETED|Crossover First and Second Interventions||0
10878442|NCT04375878|12044331|FG000|NOT COMPLETED|Crossover First and Second Interventions||1
10878443|NCT04375878|12044332|FG001|NOT COMPLETED|Crossover First and Second Interventions||1
10878444|NCT04375878|12044333|FG002|NOT COMPLETED|Crossover First and Second Interventions||1
10878445|NCT04375878|12044334|FG003|NOT COMPLETED|Crossover First and Second Interventions||0
10878446|NCT04375878|12044335|FG004|NOT COMPLETED|Crossover First and Second Interventions||0
10878447|NCT04375878|12044336|FG005|NOT COMPLETED|Crossover First and Second Interventions||0
10878448|NCT04375878|12044331|FG000|STARTED|Extension Phase|Only patients who completed period 1(Crossover: First and Second interventions) were eligible for participation in period 2.|0
10878449|NCT04375878|12044332|FG001|STARTED|Extension Phase|Only patients who completed period 1(Crossover: First and Second interventions) were eligible for participation in period 2.|0
10878450|NCT04375878|12044333|FG002|STARTED|Extension Phase|Only patients who completed period 1(Crossover: First and Second interventions) were eligible for participation in period 2.|0
10878451|NCT04375878|12044334|FG003|STARTED|Extension Phase|Only patients who completed period 1(Crossover: First and Second interventions) were eligible for participation in period 2.|0
10878452|NCT04375878|12044335|FG004|STARTED|Extension Phase|Although 24 participants were eligible for the Extension, not all elected to participate.|9
10878453|NCT04375878|12044336|FG005|STARTED|Extension Phase|Although 24 participants were eligible for the Extension, not all elected to participate.|8
10878454|NCT04375878|12044331|FG000|COMPLETED|Extension Phase||0
10878455|NCT04375878|12044332|FG001|COMPLETED|Extension Phase||0
10878456|NCT04375878|12044333|FG002|COMPLETED|Extension Phase||0
10878457|NCT04375878|12044334|FG003|COMPLETED|Extension Phase||0
10878458|NCT04375878|12044335|FG004|COMPLETED|Extension Phase||8
10878459|NCT04375878|12044336|FG005|COMPLETED|Extension Phase||8
10878460|NCT04375878|12044331|FG000|NOT COMPLETED|Extension Phase||0
10878461|NCT04375878|12044332|FG001|NOT COMPLETED|Extension Phase||0
10878462|NCT04375878|12044333|FG002|NOT COMPLETED|Extension Phase||0
10878463|NCT04375878|12044334|FG003|NOT COMPLETED|Extension Phase||0
10878464|NCT04375878|12044335|FG004|NOT COMPLETED|Extension Phase||1
10878465|NCT04375878|12044336|FG005|NOT COMPLETED|Extension Phase||0
10878466|NCT04363736|12044358|FG000|STARTED|Overall Study||49
10878467|NCT04363736|12044359|FG001|STARTED|Overall Study||48
10878468|NCT04363736|12044358|FG000|COMPLETED|Overall Study||30
10878469|NCT04363736|12044359|FG001|COMPLETED|Overall Study||35
10878470|NCT04363736|12044358|FG000|NOT COMPLETED|Overall Study||19
10878471|NCT04363736|12044359|FG001|NOT COMPLETED|Overall Study||13
10878472|NCT04354428|12044370|FG000|STARTED|Overall Study||83
10878473|NCT04354428|12044371|FG001|STARTED|Overall Study||71
10878474|NCT04354428|12044372|FG002|STARTED|Overall Study||77
10878475|NCT04354428|12044373|FG003|STARTED|Overall Study||29
10878476|NCT04354428|12044374|FG004|STARTED|Overall Study||29
10878477|NCT04354428|12044370|FG000|Completed Enrollment|Overall Study||80
10878478|NCT04354428|12044371|FG001|Completed Enrollment|Overall Study||65
10878479|NCT04354428|12044372|FG002|Completed Enrollment|Overall Study||74
10878480|NCT04354428|12044373|FG003|Completed Enrollment|Overall Study||27
10878481|NCT04354428|12044374|FG004|Completed Enrollment|Overall Study||28
10878482|NCT04354428|12044370|FG000|COMPLETED|Overall Study||75
10878483|NCT04354428|12044371|FG001|COMPLETED|Overall Study||62
10878484|NCT04354428|12044372|FG002|COMPLETED|Overall Study||71
10878485|NCT04354428|12044373|FG003|COMPLETED|Overall Study||19
10878486|NCT04354428|12044374|FG004|COMPLETED|Overall Study||25
10878487|NCT04354428|12044370|FG000|NOT COMPLETED|Overall Study||8
10878488|NCT04354428|12044371|FG001|NOT COMPLETED|Overall Study||9
10878489|NCT04354428|12044372|FG002|NOT COMPLETED|Overall Study||6
10878490|NCT04354428|12044373|FG003|NOT COMPLETED|Overall Study||10
10878491|NCT04354428|12044374|FG004|NOT COMPLETED|Overall Study||4
10878492|NCT04353596|12044388|FG000|STARTED|Overall Study||109
10878493|NCT04353596|12044389|FG001|STARTED|Overall Study||107
10878494|NCT04353596|12044388|FG000|Per Protocol|Overall Study||104
10878495|NCT04353596|12044389|FG001|Per Protocol|Overall Study||100
10878496|NCT04353596|12044388|FG000|COMPLETED|Overall Study||104
10878497|NCT04353596|12044389|FG001|COMPLETED|Overall Study||100
10878498|NCT04353596|12044388|FG000|NOT COMPLETED|Overall Study||5
10878499|NCT04353596|12044389|FG001|NOT COMPLETED|Overall Study||7
10878500|NCT04352439|12044395|FG000|STARTED|Overall Study||19
10878501|NCT04352439|12044395|FG000|COMPLETED|Overall Study||19
10878502|NCT04352439|12044395|FG000|NOT COMPLETED|Overall Study||0
10878503|NCT04350008|12044399|FG000|STARTED|Overall Study||110
10878504|NCT04350008|12044399|FG000|COMPLETED|Overall Study||110
10878505|NCT04350008|12044399|FG000|NOT COMPLETED|Overall Study||0
10878506|NCT04328077|12044407|FG000|STARTED|Overall Study||26
10878507|NCT04328077|12044408|FG001|STARTED|Overall Study||25
10878508|NCT04328077|12044409|FG002|STARTED|Overall Study||26
10878509|NCT04328077|12044410|FG003|STARTED|Overall Study||24
10878510|NCT04328077|12044407|FG000|COMPLETED|Overall Study||26
10878511|NCT04328077|12044408|FG001|COMPLETED|Overall Study||23
10878512|NCT04328077|12044409|FG002|COMPLETED|Overall Study||25
10878513|NCT04328077|12044410|FG003|COMPLETED|Overall Study||21
10878514|NCT04328077|12044407|FG000|NOT COMPLETED|Overall Study||0
10878515|NCT04328077|12044408|FG001|NOT COMPLETED|Overall Study||2
10878516|NCT04328077|12044409|FG002|NOT COMPLETED|Overall Study||1
10878517|NCT04328077|12044410|FG003|NOT COMPLETED|Overall Study||3
10878518|NCT04325828|12044426|FG000|STARTED|Overall Study||31
10878519|NCT04325828|12044426|FG000|COMPLETED|Overall Study||5
10878520|NCT04325828|12044426|FG000|NOT COMPLETED|Overall Study||26
10878521|NCT04318093|12044432|FG000|STARTED|Overall Study||13
10878522|NCT04318093|12044433|FG001|STARTED|Overall Study||12
10878523|NCT04318093|12044432|FG000|COMPLETED|Overall Study||10
10878524|NCT04318093|12044433|FG001|COMPLETED|Overall Study||9
10878525|NCT04318093|12044432|FG000|NOT COMPLETED|Overall Study||3
10878526|NCT04318093|12044433|FG001|NOT COMPLETED|Overall Study||3
10878527|NCT04314284|12044442|FG000|STARTED|Overall Study||69
10878528|NCT04314284|12044443|FG001|STARTED|Overall Study||81
10878529|NCT04314284|12044442|FG000|COMPLETED|Overall Study||65
10878530|NCT04314284|12044443|FG001|COMPLETED|Overall Study||68
10878531|NCT04314284|12044442|FG000|NOT COMPLETED|Overall Study||4
10878532|NCT04314284|12044443|FG001|NOT COMPLETED|Overall Study||13
10878533|NCT04298853|12044451|FG000|STARTED|Overall Study||9
10878534|NCT04298853|12044452|FG001|STARTED|Overall Study||8
10878535|NCT04298853|12044451|FG000|COMPLETED|Overall Study||9
10878536|NCT04298853|12044452|FG001|COMPLETED|Overall Study||8
10878537|NCT04298853|12044451|FG000|NOT COMPLETED|Overall Study||0
10878538|NCT04298853|12044452|FG001|NOT COMPLETED|Overall Study||0
10878539|NCT04283149|12044460|FG000|STARTED|Overall Study||327
10878540|NCT04283149|12044461|FG001|STARTED|Overall Study||327
10878541|NCT04283149|12044460|FG000|Postoperative Month 6|Overall Study||321
10878542|NCT04283149|12044461|FG001|Postoperative Month 6|Overall Study||321
10878543|NCT04283149|12044460|FG000|COMPLETED|Overall Study||0
10878544|NCT04283149|12044461|FG001|COMPLETED|Overall Study||0
10878545|NCT04283149|12044460|FG000|NOT COMPLETED|Overall Study||327
10878546|NCT04283149|12044461|FG001|NOT COMPLETED|Overall Study||327
10878547|NCT04281784|12044470|FG000|STARTED|Overall Study||1255
10878548|NCT04281784|12044471|FG001|STARTED|Overall Study||1257
10878549|NCT04281784|12044470|FG000|COMPLETED|Overall Study||1255
10878550|NCT04281784|12044471|FG001|COMPLETED|Overall Study||1257
10878551|NCT04281784|12044470|FG000|NOT COMPLETED|Overall Study||0
10878552|NCT04281784|12044471|FG001|NOT COMPLETED|Overall Study||0
10878553|NCT04274686|12044477|FG000|STARTED|Overall Study||13
10878554|NCT04274686|12044478|FG001|STARTED|Overall Study||12
10878555|NCT04274686|12044477|FG000|COMPLETED|Overall Study||12
10878556|NCT04274686|12044478|FG001|COMPLETED|Overall Study||12
10878557|NCT04274686|12044477|FG000|NOT COMPLETED|Overall Study||1
10878558|NCT04274686|12044478|FG001|NOT COMPLETED|Overall Study||0
10878559|NCT04253236|12044486|FG000|STARTED|Overall Study||5
10878560|NCT04253236|12044487|FG001|STARTED|Overall Study||0
10878561|NCT04253236|12044486|FG000|COMPLETED|Overall Study||2
10878562|NCT04253236|12044487|FG001|COMPLETED|Overall Study||0
10878563|NCT04253236|12044486|FG000|NOT COMPLETED|Overall Study||3
10878564|NCT04253236|12044487|FG001|NOT COMPLETED|Overall Study||0
10878565|NCT04252586|12044493|FG000|STARTED|Overall Study||21
10878566|NCT04252586|12044493|FG000|COMPLETED|Overall Study||0
10878567|NCT04252586|12044493|FG000|NOT COMPLETED|Overall Study||21
10878568|NCT04247425|12044498|FG000|STARTED|Overall Study||10
10878569|NCT04247425|12044498|FG000|COMPLETED|Overall Study||9
10878570|NCT04247425|12044498|FG000|NOT COMPLETED|Overall Study||1
10878571|NCT04245709|12044502|FG000|STARTED|Overall Study||25
10878572|NCT04245709|12044502|FG000|COMPLETED|Overall Study||11
10878573|NCT04245709|12044502|FG000|NOT COMPLETED|Overall Study||14
10878574|NCT04242173|12044506|FG000|STARTED|Overall Study||3
10878575|NCT04242173|12044506|FG000|COMPLETED|Overall Study||3
10878576|NCT04242173|12044506|FG000|NOT COMPLETED|Overall Study||0
10878577|NCT04236141|12044512|FG000|STARTED|Overall Study||28
10878578|NCT04236141|12044513|FG001|STARTED|Overall Study||14
10878579|NCT04236141|12044512|FG000|Safety Population|Overall Study||27
10878580|NCT04236141|12044513|FG001|Safety Population|Overall Study||14
10878581|NCT04236141|12044512|FG000|Pharmacokinetic-Evaluable Population|Overall Study||27
10878582|NCT04236141|12044513|FG001|Pharmacokinetic-Evaluable Population|Overall Study||0
10878583|NCT04236141|12044512|FG000|Immunogenicity-Evaluable Population (Baseline Evaluable)|Overall Study||27
10878584|NCT04236141|12044513|FG001|Immunogenicity-Evaluable Population (Baseline Evaluable)|Overall Study||14
10878585|NCT04236141|12044512|FG000|Immunogenicity-Evaluable Population (Post-Baseline Evaluable)|Overall Study||24
10878586|NCT04236141|12044513|FG001|Immunogenicity-Evaluable Population (Post-Baseline Evaluable)|Overall Study||0
10878587|NCT04236141|12044512|FG000|COMPLETED|Overall Study||15
10878588|NCT04236141|12044513|FG001|COMPLETED|Overall Study||5
10878589|NCT04236141|12044512|FG000|NOT COMPLETED|Overall Study||13
10878590|NCT04236141|12044513|FG001|NOT COMPLETED|Overall Study||9
10878591|NCT04233580|12044521|FG000|STARTED|Overall Study||20
10878592|NCT04233580|12044522|FG001|STARTED|Overall Study||20
10878593|NCT04233580|12044521|FG000|COMPLETED|Overall Study||15
10878594|NCT04233580|12044522|FG001|COMPLETED|Overall Study||16
10878595|NCT04233580|12044521|FG000|NOT COMPLETED|Overall Study||5
10878596|NCT04233580|12044522|FG001|NOT COMPLETED|Overall Study||4
10878597|NCT04232943|12044531|FG000|STARTED|Overall Study||32
10878598|NCT04232943|12044532|FG001|STARTED|Overall Study||33
10878599|NCT04232943|12044533|FG002|STARTED|Overall Study||22
10878600|NCT04232943|12044531|FG000|Received Study Vaccination|Overall Study||30
10878601|NCT04232943|12044532|FG001|Received Study Vaccination|Overall Study||30
10878602|NCT04232943|12044533|FG002|Received Study Vaccination|Overall Study||20
10878603|NCT04232943|12044531|FG000|Received bOPV Challenge on Day 29|Overall Study||29
10878604|NCT04232943|12044532|FG001|Received bOPV Challenge on Day 29|Overall Study||30
10878605|NCT04232943|12044533|FG002|Received bOPV Challenge on Day 29|Overall Study||20
10878606|NCT04232943|12044531|FG000|COMPLETED|Overall Study||29
10878607|NCT04232943|12044532|FG001|COMPLETED|Overall Study||29
10878608|NCT04232943|12044533|FG002|COMPLETED|Overall Study||20
10878609|NCT04232943|12044531|FG000|NOT COMPLETED|Overall Study||3
10878610|NCT04232943|12044532|FG001|NOT COMPLETED|Overall Study||4
10878611|NCT04232943|12044533|FG002|NOT COMPLETED|Overall Study||2
10878612|NCT04230876|12044544|FG000|STARTED|Overall Study||15
10878613|NCT04230876|12044545|FG001|STARTED|Overall Study||15
10878614|NCT04230876|12044544|FG000|COMPLETED|Overall Study||14
10878615|NCT04230876|12044545|FG001|COMPLETED|Overall Study||14
10878616|NCT04230876|12044544|FG000|NOT COMPLETED|Overall Study||1
10878617|NCT04230876|12044545|FG001|NOT COMPLETED|Overall Study||1
10878618|NCT04230213|12044551|FG000|STARTED|TP1: Week 0 (Day 1) to Week 10||445
10878619|NCT04230213|12044552|FG001|STARTED|TP1: Week 0 (Day 1) to Week 10||0
10878620|NCT04230213|12044553|FG002|STARTED|TP1: Week 0 (Day 1) to Week 10||0
10878621|NCT04230213|12044551|FG000|COMPLETED|TP1: Week 0 (Day 1) to Week 10||427
10878622|NCT04230213|12044552|FG001|COMPLETED|TP1: Week 0 (Day 1) to Week 10||0
10878623|NCT04230213|12044553|FG002|COMPLETED|TP1: Week 0 (Day 1) to Week 10||0
10878624|NCT04230213|12044551|FG000|NOT COMPLETED|TP1: Week 0 (Day 1) to Week 10||18
10878625|NCT04230213|12044552|FG001|NOT COMPLETED|TP1: Week 0 (Day 1) to Week 10||0
10878626|NCT04230213|12044553|FG002|NOT COMPLETED|TP1: Week 0 (Day 1) to Week 10||0
10878627|NCT04230213|12044551|FG000|STARTED|TP2: Week 10 to Week 16|TP1 ended when participants were randomized to Switching and Non-switching Arms|0
10878628|NCT04230213|12044552|FG001|STARTED|TP2: Week 10 to Week 16|Participants who completed TP1 were randomized to Switching arm.|213
10878629|NCT04230213|12044553|FG002|STARTED|TP2: Week 10 to Week 16|Participants who completed TP1 were randomized to Non-switching arm.|214
10878630|NCT04230213|12044551|FG000|COMPLETED|TP2: Week 10 to Week 16||0
10878631|NCT04230213|12044552|FG001|COMPLETED|TP2: Week 10 to Week 16||211
10878632|NCT04230213|12044553|FG002|COMPLETED|TP2: Week 10 to Week 16||211
10878633|NCT04230213|12044551|FG000|NOT COMPLETED|TP2: Week 10 to Week 16||0
10878634|NCT04230213|12044552|FG001|NOT COMPLETED|TP2: Week 10 to Week 16||2
10878635|NCT04230213|12044553|FG002|NOT COMPLETED|TP2: Week 10 to Week 16||3
10878636|NCT04230213|12044551|FG000|STARTED|TP3: Week 16 to Week 22||0
10878637|NCT04230213|12044552|FG001|STARTED|TP3: Week 16 to Week 22||211
10878638|NCT04230213|12044553|FG002|STARTED|TP3: Week 16 to Week 22||211
10878639|NCT04230213|12044551|FG000|COMPLETED|TP3: Week 16 to Week 22||0
10878640|NCT04230213|12044552|FG001|COMPLETED|TP3: Week 16 to Week 22||210
10878641|NCT04230213|12044553|FG002|COMPLETED|TP3: Week 16 to Week 22||204
10878642|NCT04230213|12044551|FG000|NOT COMPLETED|TP3: Week 16 to Week 22||0
10878643|NCT04230213|12044552|FG001|NOT COMPLETED|TP3: Week 16 to Week 22||1
10878644|NCT04230213|12044553|FG002|NOT COMPLETED|TP3: Week 16 to Week 22||7
10878645|NCT04230213|12044551|FG000|STARTED|TP4: Week 22 to Week 32||0
10878646|NCT04230213|12044552|FG001|STARTED|TP4: Week 22 to Week 32||210
10878647|NCT04230213|12044553|FG002|STARTED|TP4: Week 22 to Week 32||204
10878648|NCT04230213|12044551|FG000|COMPLETED|TP4: Week 22 to Week 32||0
10878649|NCT04230213|12044552|FG001|COMPLETED|TP4: Week 22 to Week 32||202
10878650|NCT04230213|12044553|FG002|COMPLETED|TP4: Week 22 to Week 32||196
10878651|NCT04230213|12044551|FG000|NOT COMPLETED|TP4: Week 22 to Week 32||0
10878652|NCT04230213|12044552|FG001|NOT COMPLETED|TP4: Week 22 to Week 32||8
10878653|NCT04230213|12044553|FG002|NOT COMPLETED|TP4: Week 22 to Week 32||8
10878654|NCT04230213|12044551|FG000|STARTED|Follow up: Week 32 to Week 36||0
10878655|NCT04230213|12044552|FG001|STARTED|Follow up: Week 32 to Week 36||202
10878656|NCT04230213|12044553|FG002|STARTED|Follow up: Week 32 to Week 36||196
10878657|NCT04230213|12044551|FG000|COMPLETED|Follow up: Week 32 to Week 36||0
10878658|NCT04230213|12044552|FG001|COMPLETED|Follow up: Week 32 to Week 36||201
10878659|NCT04230213|12044553|FG002|COMPLETED|Follow up: Week 32 to Week 36||194
10878660|NCT04230213|12044551|FG000|NOT COMPLETED|Follow up: Week 32 to Week 36||0
10878661|NCT04230213|12044552|FG001|NOT COMPLETED|Follow up: Week 32 to Week 36||1
10878662|NCT04230213|12044553|FG002|NOT COMPLETED|Follow up: Week 32 to Week 36||2
10878663|NCT04223791|12044563|FG000|STARTED|Overall Study||322
10878664|NCT04223791|12044564|FG001|STARTED|Overall Study||321
10878665|NCT04223791|12044563|FG000|Treated|Overall Study||322
10878666|NCT04223791|12044564|FG001|Treated|Overall Study||319
10878667|NCT04223791|12044563|FG000|COMPLETED|Overall Study||0
10878668|NCT04223791|12044564|FG001|COMPLETED|Overall Study||0
10878669|NCT04223791|12044563|FG000|NOT COMPLETED|Overall Study||322
10878670|NCT04223791|12044564|FG001|NOT COMPLETED|Overall Study||321
10878671|NCT04223778|12044572|FG000|STARTED|Overall Study||336
10878672|NCT04223778|12044573|FG001|STARTED|Overall Study||336
10878673|NCT04223778|12044572|FG000|COMPLETED|Overall Study||0
10878674|NCT04223778|12044573|FG001|COMPLETED|Overall Study||0
10878675|NCT04223778|12044572|FG000|NOT COMPLETED|Overall Study||336
10878676|NCT04223778|12044573|FG001|NOT COMPLETED|Overall Study||336
10878677|NCT04218695|12044581|FG000|STARTED|Overall Study||17
10878678|NCT04218695|12044582|FG001|STARTED|Overall Study||15
10878679|NCT04218695|12044581|FG000|COMPLETED|Overall Study||16
10878680|NCT04218695|12044582|FG001|COMPLETED|Overall Study||15
10878681|NCT04218695|12044581|FG000|NOT COMPLETED|Overall Study||1
10878682|NCT04218695|12044582|FG001|NOT COMPLETED|Overall Study||0
10878683|NCT04213989|12044590|FG000|STARTED|Overall Study||18
10878684|NCT04213989|12044591|FG001|STARTED|Overall Study||18
10878685|NCT04213989|12044590|FG000|COMPLETED|Overall Study||14
10878686|NCT04213989|12044591|FG001|COMPLETED|Overall Study||12
10878687|NCT04213989|12044590|FG000|NOT COMPLETED|Overall Study||4
10878688|NCT04213989|12044591|FG001|NOT COMPLETED|Overall Study||6
10878689|NCT04209075|12044599|FG000|STARTED|Overall Study||4
10878690|NCT04209075|12044600|FG001|STARTED|Overall Study||2
10878691|NCT04209075|12044599|FG000|COMPLETED|Overall Study||4
10878692|NCT04209075|12044600|FG001|COMPLETED|Overall Study||2
10878693|NCT04209075|12044599|FG000|NOT COMPLETED|Overall Study||0
10878694|NCT04209075|12044600|FG001|NOT COMPLETED|Overall Study||0
10878695|NCT04206085|12044611|FG000|STARTED|Overall Study||13
10878696|NCT04206085|12044612|FG001|STARTED|Overall Study||13
10878697|NCT04206085|12044613|FG002|STARTED|Overall Study||12
10878698|NCT04206085|12044611|FG000|COMPLETED|Overall Study||13
10878699|NCT04206085|12044612|FG001|COMPLETED|Overall Study||12
10878700|NCT04206085|12044613|FG002|COMPLETED|Overall Study||11
10878701|NCT04206085|12044611|FG000|NOT COMPLETED|Overall Study||0
10878702|NCT04206085|12044612|FG001|NOT COMPLETED|Overall Study||1
10878703|NCT04206085|12044613|FG002|NOT COMPLETED|Overall Study||1
10878704|NCT04202679|12044623|FG000|STARTED|Overall Study||82
10878705|NCT04202679|12044624|FG001|STARTED|Overall Study||78
10878706|NCT04202679|12044623|FG000|Treated|Overall Study||82
10878707|NCT04202679|12044624|FG001|Treated|Overall Study||77
10878708|NCT04202679|12044623|FG000|COMPLETED|Overall Study||57
10878709|NCT04202679|12044624|FG001|COMPLETED|Overall Study||75
10878710|NCT04202679|12044623|FG000|NOT COMPLETED|Overall Study||25
10878711|NCT04202679|12044624|FG001|NOT COMPLETED|Overall Study||3
10878712|NCT04189952|12044631|FG000|STARTED|Treatment Period||2
10878713|NCT04189952|12044631|FG000|COMPLETED|Treatment Period||2
10878714|NCT04189952|12044631|FG000|NOT COMPLETED|Treatment Period||0
10878715|NCT04189952|12044631|FG000|STARTED|Follow-up Period||2
10878716|NCT04189952|12044631|FG000|COMPLETED|Follow-up Period||0
10878717|NCT04189952|12044631|FG000|NOT COMPLETED|Follow-up Period||2
10878718|NCT04188392|12044635|FG000|STARTED|Overall Study||6
10878719|NCT04188392|12044635|FG000|Sleep Studies 1 and 2|Overall Study||6
10878720|NCT04188392|12044635|FG000|Mid-point Visit (Treatment Week-3)|Overall Study||6
10878721|NCT04188392|12044635|FG000|Sleep Study 3|Overall Study|1 subject could not complete sleep study 3 due to hospital-wide shut-downs during the COVID pandemic.|5
10878722|NCT04188392|12044635|FG000|COMPLETED|Overall Study||6
10878723|NCT04188392|12044635|FG000|NOT COMPLETED|Overall Study||0
10878724|NCT04182880|12044641|FG000|STARTED|Overall Study||5
10878725|NCT04182880|12044642|FG001|STARTED|Overall Study||15
10878726|NCT04182880|12044641|FG000|COMPLETED|Overall Study||4
10878727|NCT04182880|12044642|FG001|COMPLETED|Overall Study||15
10878728|NCT04182880|12044641|FG000|NOT COMPLETED|Overall Study||1
10878729|NCT04182880|12044642|FG001|NOT COMPLETED|Overall Study||0
10878742|NCT04178967|12044667|FG000|STARTED|Overall Study||150
10878743|NCT04178967|12044668|FG001|STARTED|Overall Study||295
10878744|NCT04178967|12044667|FG000|Received at Least One Dose of Study Drug|Overall Study||149
10878745|NCT04178967|12044668|FG001|Received at Least One Dose of Study Drug|Overall Study||295
10878746|NCT04178967|12044667|FG000|Re-randomized to Maintenance Blinded Treatment|Overall Study||25
10878747|NCT04178967|12044668|FG001|Re-randomized to Maintenance Blinded Treatment|Overall Study||148
10878748|NCT04178967|12044667|FG000|Enrolled to Escape Arm at Week 16|Overall Study||108
10878749|NCT04178967|12044668|FG001|Enrolled to Escape Arm at Week 16|Overall Study||125
10878750|NCT04178967|12044667|FG000|COMPLETED|Overall Study||133
10878751|NCT04178967|12044668|FG001|COMPLETED|Overall Study||273
10878752|NCT04178967|12044667|FG000|NOT COMPLETED|Overall Study||17
10878753|NCT04178967|12044668|FG001|NOT COMPLETED|Overall Study||22
10878754|NCT04176601|12044674|FG000|STARTED|Overall Study||30
10878755|NCT04176601|12044674|FG000|COMPLETED|Overall Study||25
10878756|NCT04176601|12044674|FG000|NOT COMPLETED|Overall Study||5
10878757|NCT04175392|12044680|FG000|STARTED|Overall Study||7
10878758|NCT04175392|12044681|FG001|STARTED|Overall Study||7
10878759|NCT04175392|12044680|FG000|COMPLETED|Overall Study||4
10878760|NCT04175392|12044681|FG001|COMPLETED|Overall Study||5
10878761|NCT04175392|12044680|FG000|NOT COMPLETED|Overall Study||3
10878762|NCT04175392|12044681|FG001|NOT COMPLETED|Overall Study||2
10878763|NCT04173572|12044689|FG000|STARTED|Overall Study||24
10878764|NCT04173572|12044690|FG001|STARTED|Overall Study||26
10878765|NCT04173572|12044689|FG000|Cohort 1|Overall Study||7
10878766|NCT04173572|12044690|FG001|Cohort 1|Overall Study||6
10878767|NCT04173572|12044689|FG000|Cohort 2|Overall Study||8
10878768|NCT04173572|12044690|FG001|Cohort 2|Overall Study||12
10878769|NCT04173572|12044689|FG000|Cohort 3|Overall Study||9
10878770|NCT04173572|12044690|FG001|Cohort 3|Overall Study||8
10878771|NCT04173572|12044689|FG000|COMPLETED|Overall Study||20
10878772|NCT04173572|12044690|FG001|COMPLETED|Overall Study||20
10878773|NCT04173572|12044689|FG000|NOT COMPLETED|Overall Study||4
10878774|NCT04173572|12044690|FG001|NOT COMPLETED|Overall Study||6
10878775|NCT04172831|12044698|FG000|STARTED|Overall Study||248
10878776|NCT04172831|12044699|FG001|STARTED|Overall Study||255
10878777|NCT04172831|12044698|FG000|COMPLETED|Overall Study||204
10878778|NCT04172831|12044699|FG001|COMPLETED|Overall Study||213
10878779|NCT04172831|12044698|FG000|NOT COMPLETED|Overall Study||44
10878780|NCT04172831|12044699|FG001|NOT COMPLETED|Overall Study||42
10878781|NCT04169373|12044709|FG000|STARTED|Overall Study||209
10878782|NCT04169373|12044710|FG001|STARTED|Overall Study||211
10878783|NCT04169373|12044711|FG002|STARTED|Overall Study||158
10878784|NCT04169373|12044712|FG003|STARTED|Overall Study||156
10878785|NCT04169373|12044709|FG000|Received Study Drug|Overall Study||209
10878786|NCT04169373|12044710|FG001|Received Study Drug|Overall Study||211
10878787|NCT04169373|12044711|FG002|Received Study Drug|Overall Study||157
10878788|NCT04169373|12044712|FG003|Received Study Drug|Overall Study||156
10878789|NCT04169373|12044709|FG000|COMPLETED|Overall Study||204
10878790|NCT04169373|12044710|FG001|COMPLETED|Overall Study||206
10878791|NCT04169373|12044711|FG002|COMPLETED|Overall Study||149
10878792|NCT04169373|12044712|FG003|COMPLETED|Overall Study||142
10878793|NCT04169373|12044709|FG000|NOT COMPLETED|Overall Study||5
10878794|NCT04169373|12044710|FG001|NOT COMPLETED|Overall Study||5
10878795|NCT04169373|12044711|FG002|NOT COMPLETED|Overall Study||9
10878796|NCT04169373|12044712|FG003|NOT COMPLETED|Overall Study||14
10878797|NCT04168775|12044722|FG000|STARTED|Overall Study||80
10878798|NCT04168775|12044722|FG000|COMPLETED|Overall Study||75
10878799|NCT04168775|12044722|FG000|NOT COMPLETED|Overall Study||5
10878800|NCT04168190|12044731|FG000|STARTED|Overall Study||30
10878801|NCT04168190|12044732|FG001|STARTED|Overall Study||30
10878802|NCT04168190|12044733|FG002|STARTED|Overall Study||30
10878803|NCT04168190|12044734|FG003|STARTED|Overall Study||254
10878804|NCT04168190|12044735|FG004|STARTED|Overall Study||256
10878805|NCT04168190|12044731|FG000|Treated|Overall Study||30
10878806|NCT04168190|12044732|FG001|Treated|Overall Study||30
10878807|NCT04168190|12044733|FG002|Treated|Overall Study||30
10878808|NCT04168190|12044734|FG003|Treated|Overall Study||254
10878809|NCT04168190|12044735|FG004|Treated|Overall Study||254
10878810|NCT04168190|12044731|FG000|COMPLETED|Overall Study||29
10878811|NCT04168190|12044732|FG001|COMPLETED|Overall Study||29
10878812|NCT04168190|12044733|FG002|COMPLETED|Overall Study||30
10878813|NCT04168190|12044734|FG003|COMPLETED|Overall Study||244
10878814|NCT04168190|12044735|FG004|COMPLETED|Overall Study||247
10878815|NCT04168190|12044731|FG000|NOT COMPLETED|Overall Study||1
10878816|NCT04168190|12044732|FG001|NOT COMPLETED|Overall Study||1
10878817|NCT04168190|12044733|FG002|NOT COMPLETED|Overall Study||0
10878818|NCT04168190|12044734|FG003|NOT COMPLETED|Overall Study||10
10878819|NCT04168190|12044735|FG004|NOT COMPLETED|Overall Study||9
10878820|NCT04166630|12044749|FG000|STARTED|Overall Study||5
10878821|NCT04166630|12044750|FG001|STARTED|Overall Study||17
10878822|NCT04166630|12044749|FG000|COMPLETED|Overall Study||5
10878823|NCT04166630|12044750|FG001|COMPLETED|Overall Study||16
10878824|NCT04166630|12044749|FG000|NOT COMPLETED|Overall Study||0
10878825|NCT04166630|12044750|FG001|NOT COMPLETED|Overall Study||1
10878826|NCT04165824|12044756|FG000|STARTED|Overall Study||185
10878827|NCT04165824|12044756|FG000|COMPLETED|Overall Study||139
10878828|NCT04165824|12044756|FG000|NOT COMPLETED|Overall Study||46
10878829|NCT04161131|12044760|FG000|STARTED|Overall Study||28
10878830|NCT04161131|12044760|FG000|Completed Baseline Surveys|Overall Study||27
10878831|NCT04161131|12044760|FG000|Received Intervention|Overall Study||22
10878832|NCT04161131|12044760|FG000|COMPLETED|Overall Study||22
10878833|NCT04161131|12044760|FG000|NOT COMPLETED|Overall Study||6
10878834|NCT04160078|12044764|FG000|STARTED|Overall Study||18
10878835|NCT04160078|12044764|FG000|COMPLETED|Overall Study||18
10878836|NCT04160078|12044764|FG000|NOT COMPLETED|Overall Study||0
10878837|NCT04154293|12044771|FG000|STARTED|Overall Study||12
10878838|NCT04154293|12044772|FG001|STARTED|Overall Study||11
10878839|NCT04154293|12044773|FG002|STARTED|Overall Study||11
10878840|NCT04154293|12044771|FG000|Number Who Received at Least 1 Dose|Overall Study||12
10878841|NCT04154293|12044772|FG001|Number Who Received at Least 1 Dose|Overall Study||11
10878842|NCT04154293|12044773|FG002|Number Who Received at Least 1 Dose|Overall Study||10
10878843|NCT04154293|12044771|FG000|COMPLETED|Overall Study||10
10878844|NCT04154293|12044772|FG001|COMPLETED|Overall Study||8
10878845|NCT04154293|12044773|FG002|COMPLETED|Overall Study||9
10878846|NCT04154293|12044771|FG000|NOT COMPLETED|Overall Study||2
10878847|NCT04154293|12044772|FG001|NOT COMPLETED|Overall Study||3
10878848|NCT04154293|12044773|FG002|NOT COMPLETED|Overall Study||2
10878849|NCT04152200|12044783|FG000|STARTED|Primary Analysis Period||6
10878850|NCT04152200|12044784|FG001|STARTED|Primary Analysis Period||15
10878851|NCT04152200|12044783|FG000|COMPLETED|Primary Analysis Period||6
10878852|NCT04152200|12044784|FG001|COMPLETED|Primary Analysis Period||15
10878853|NCT04152200|12044783|FG000|NOT COMPLETED|Primary Analysis Period||0
10878854|NCT04152200|12044784|FG001|NOT COMPLETED|Primary Analysis Period||0
10878855|NCT04152200|12044783|FG000|STARTED|Long-term Extension Period||6
10878856|NCT04152200|12044784|FG001|STARTED|Long-term Extension Period||15
10878857|NCT04152200|12044783|FG000|COMPLETED|Long-term Extension Period||0
10878858|NCT04152200|12044784|FG001|COMPLETED|Long-term Extension Period||0
10878859|NCT04152200|12044783|FG000|NOT COMPLETED|Long-term Extension Period||6
10878860|NCT04152200|12044784|FG001|NOT COMPLETED|Long-term Extension Period||15
10878861|NCT04146363|12044794|FG000|STARTED|Overall Study||141
10878862|NCT04146363|12044795|FG001|STARTED|Overall Study||283
10878863|NCT04146363|12044794|FG000|Received at Least One Dose of Study Drug|Overall Study||141
10878864|NCT04146363|12044795|FG001|Received at Least One Dose of Study Drug|Overall Study||282
10878865|NCT04146363|12044794|FG000|Re-randomized to Maintenance Blinded Treatment|Overall Study||24
10878866|NCT04146363|12044795|FG001|Re-randomized to Maintenance Blinded Treatment|Overall Study||157
10878867|NCT04146363|12044794|FG000|Enrolled to Escape Arm at Week 16|Overall Study||96
10878868|NCT04146363|12044795|FG001|Enrolled to Escape Arm at Week 16|Overall Study||106
10878869|NCT04146363|12044794|FG000|COMPLETED|Overall Study||120
10878870|NCT04146363|12044795|FG001|COMPLETED|Overall Study||263
10878871|NCT04146363|12044794|FG000|NOT COMPLETED|Overall Study||21
10878872|NCT04146363|12044795|FG001|NOT COMPLETED|Overall Study||20
10878873|NCT04142034|12044804|FG000|STARTED|Recruitment Period||535
10878874|NCT04142034|12044805|FG001|STARTED|Recruitment Period||23
10878875|NCT04142034|12044806|FG002|STARTED|Recruitment Period||0
10878876|NCT04142034|12044807|FG003|STARTED|Recruitment Period||0
10878877|NCT04142034|12044804|FG000|COMPLETED|Recruitment Period|The recruitment period included a hiatus in recruitment due to the pandemic|99
10878878|NCT04142034|12044805|FG001|COMPLETED|Recruitment Period|The recruitment period included a hiatus in recruitment due to the pandemic|5
10878879|NCT04142034|12044806|FG002|COMPLETED|Recruitment Period|the intervention arm is only relevant during period 2|0
10878880|NCT04142034|12044807|FG003|COMPLETED|Recruitment Period|intervention arm is only relevant in period 2|0
10878881|NCT04142034|12044804|FG000|NOT COMPLETED|Recruitment Period||436
10878882|NCT04142034|12044805|FG001|NOT COMPLETED|Recruitment Period||18
10878883|NCT04142034|12044806|FG002|NOT COMPLETED|Recruitment Period||0
10878884|NCT04142034|12044807|FG003|NOT COMPLETED|Recruitment Period||0
10878885|NCT04142034|12044804|FG000|STARTED|Intervention Period|Recruitment method is only relevant in period 1|0
10878886|NCT04142034|12044805|FG001|STARTED|Intervention Period|Recruitment method is only relevant in period 1|0
10878887|NCT04142034|12044806|FG002|STARTED|Intervention Period|There were 104 participants recruited into the intervention part of the study; half were randomized to the iAmHealthy + newsletter behavioral intervention.|52
10878888|NCT04142034|12044807|FG003|STARTED|Intervention Period|There were 104 participants recruited into the intervention part of the study; half were randomized to the Newsletter intervention.|52
10878889|NCT04142034|12044804|FG000|COMPLETED|Intervention Period||0
10878890|NCT04142034|12044805|FG001|COMPLETED|Intervention Period||0
10878891|NCT04142034|12044806|FG002|COMPLETED|Intervention Period||45
10878892|NCT04142034|12044807|FG003|COMPLETED|Intervention Period||50
10878893|NCT04142034|12044804|FG000|NOT COMPLETED|Intervention Period||0
10878894|NCT04142034|12044805|FG001|NOT COMPLETED|Intervention Period||0
10878895|NCT04142034|12044806|FG002|NOT COMPLETED|Intervention Period||7
10878896|NCT04142034|12044807|FG003|NOT COMPLETED|Intervention Period||2
10878897|NCT04132804|12044815|FG000|STARTED|Overall Study||31
10878898|NCT04132804|12044815|FG000|COMPLETED|Overall Study||20
10878899|NCT04132804|12044815|FG000|NOT COMPLETED|Overall Study||11
10878900|NCT04130919|12044822|FG000|STARTED|Blinded Treatment Phase||7
10878901|NCT04130919|12044823|FG001|STARTED|Blinded Treatment Phase||6
10878902|NCT04130919|12044824|FG002|STARTED|Blinded Treatment Phase||6
10878903|NCT04130919|12044825|FG003|STARTED|Blinded Treatment Phase||0
10878904|NCT04130919|12044826|FG004|STARTED|Blinded Treatment Phase||0
10878905|NCT04130919|12044827|FG005|STARTED|Blinded Treatment Phase||0
10878906|NCT04130919|12044822|FG000|COMPLETED|Blinded Treatment Phase||5
10878907|NCT04130919|12044823|FG001|COMPLETED|Blinded Treatment Phase||4
10878908|NCT04130919|12044824|FG002|COMPLETED|Blinded Treatment Phase||3
10878909|NCT04130919|12044825|FG003|COMPLETED|Blinded Treatment Phase||0
10878910|NCT04130919|12044826|FG004|COMPLETED|Blinded Treatment Phase||0
10878911|NCT04130919|12044827|FG005|COMPLETED|Blinded Treatment Phase||0
10878912|NCT04130919|12044822|FG000|NOT COMPLETED|Blinded Treatment Phase||2
10878913|NCT04130919|12044823|FG001|NOT COMPLETED|Blinded Treatment Phase||2
10878914|NCT04130919|12044824|FG002|NOT COMPLETED|Blinded Treatment Phase||3
10878915|NCT04130919|12044825|FG003|NOT COMPLETED|Blinded Treatment Phase||0
10878916|NCT04130919|12044826|FG004|NOT COMPLETED|Blinded Treatment Phase||0
10878917|NCT04130919|12044827|FG005|NOT COMPLETED|Blinded Treatment Phase||0
10878918|NCT04130919|12044822|FG000|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|0
10878919|NCT04130919|12044823|FG001|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|0
10878920|NCT04130919|12044824|FG002|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|0
10878921|NCT04130919|12044825|FG003|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|4
10878922|NCT04130919|12044826|FG004|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|3
10879009|NCT04093414|12044888|FG001|NOT COMPLETED|6month Follow up||3
10878923|NCT04130919|12044827|FG005|STARTED|Open-label Treatment Phase|Participants who completed the Blinded Treatment phase and did not achieve the clinical response per modified MCS at Week 10 entered in Open-label Treatment phase to receive tilpisertib 300 mg.|3
10878924|NCT04130919|12044822|FG000|COMPLETED|Open-label Treatment Phase||0
10878925|NCT04130919|12044823|FG001|COMPLETED|Open-label Treatment Phase||0
10878926|NCT04130919|12044824|FG002|COMPLETED|Open-label Treatment Phase||0
10878927|NCT04130919|12044825|FG003|COMPLETED|Open-label Treatment Phase||1
10878928|NCT04130919|12044826|FG004|COMPLETED|Open-label Treatment Phase||1
10878929|NCT04130919|12044827|FG005|COMPLETED|Open-label Treatment Phase||0
10878930|NCT04130919|12044822|FG000|NOT COMPLETED|Open-label Treatment Phase||0
10878931|NCT04130919|12044823|FG001|NOT COMPLETED|Open-label Treatment Phase||0
10878932|NCT04130919|12044824|FG002|NOT COMPLETED|Open-label Treatment Phase||0
10878933|NCT04130919|12044825|FG003|NOT COMPLETED|Open-label Treatment Phase||3
10878934|NCT04130919|12044826|FG004|NOT COMPLETED|Open-label Treatment Phase||2
10878935|NCT04130919|12044827|FG005|NOT COMPLETED|Open-label Treatment Phase||3
10878936|NCT04128696|12044843|FG000|STARTED|Overall Study||158
10878937|NCT04128696|12044844|FG001|STARTED|Overall Study||157
10878938|NCT04128696|12044843|FG000|Modified Intent to Treat (mITT) Population|Overall Study||157
10878939|NCT04128696|12044844|FG001|Modified Intent to Treat (mITT) Population|Overall Study||156
10878940|NCT04128696|12044843|FG000|Safety Population|Overall Study||159
10878941|NCT04128696|12044844|FG001|Safety Population|Overall Study||156
10878942|NCT04128696|12044843|FG000|COMPLETED|Overall Study||51
10878943|NCT04128696|12044844|FG001|COMPLETED|Overall Study||38
10878944|NCT04128696|12044843|FG000|NOT COMPLETED|Overall Study||107
10878945|NCT04128696|12044844|FG001|NOT COMPLETED|Overall Study||119
10878946|NCT04128267|12044850|FG000|STARTED|Overall Study||32
10878947|NCT04128267|12044850|FG000|COMPLETED|Overall Study||17
10878948|NCT04128267|12044850|FG000|NOT COMPLETED|Overall Study||15
10878949|NCT04124926|12044856|FG000|STARTED|Healing Phase||514
10878950|NCT04124926|12044857|FG001|STARTED|Healing Phase||513
10878951|NCT04124926|12044858|FG002|STARTED|Healing Phase||0
10878952|NCT04124926|12044859|FG003|STARTED|Healing Phase||0
10878953|NCT04124926|12044860|FG004|STARTED|Healing Phase||0
10878954|NCT04124926|12044856|FG000|Treated With Study Drug|Healing Phase||514
10878955|NCT04124926|12044857|FG001|Treated With Study Drug|Healing Phase||510
10878956|NCT04124926|12044858|FG002|Treated With Study Drug|Healing Phase||0
10878957|NCT04124926|12044859|FG003|Treated With Study Drug|Healing Phase||0
10878958|NCT04124926|12044860|FG004|Treated With Study Drug|Healing Phase||0
10878959|NCT04124926|12044856|FG000|COMPLETED|Healing Phase||483
10878960|NCT04124926|12044857|FG001|COMPLETED|Healing Phase||481
10878961|NCT04124926|12044858|FG002|COMPLETED|Healing Phase||0
10878962|NCT04124926|12044859|FG003|COMPLETED|Healing Phase||0
10878963|NCT04124926|12044860|FG004|COMPLETED|Healing Phase||0
10878964|NCT04124926|12044856|FG000|NOT COMPLETED|Healing Phase||31
10878965|NCT04124926|12044857|FG001|NOT COMPLETED|Healing Phase||32
10878966|NCT04124926|12044858|FG002|NOT COMPLETED|Healing Phase||0
10878967|NCT04124926|12044859|FG003|NOT COMPLETED|Healing Phase||0
10878968|NCT04124926|12044860|FG004|NOT COMPLETED|Healing Phase||0
10878969|NCT04124926|12044856|FG000|STARTED|Maintenance Phase||0
10878970|NCT04124926|12044857|FG001|STARTED|Maintenance Phase||0
10878971|NCT04124926|12044858|FG002|STARTED|Maintenance Phase||298
10878972|NCT04124926|12044859|FG003|STARTED|Maintenance Phase||298
10878973|NCT04124926|12044860|FG004|STARTED|Maintenance Phase||297
10878974|NCT04124926|12044856|FG000|Treated With Study Drug|Maintenance Phase||0
10878975|NCT04124926|12044857|FG001|Treated With Study Drug|Maintenance Phase||0
10878976|NCT04124926|12044858|FG002|Treated With Study Drug|Maintenance Phase||296
10878977|NCT04124926|12044859|FG003|Treated With Study Drug|Maintenance Phase||296
10878978|NCT04124926|12044860|FG004|Treated With Study Drug|Maintenance Phase||297
10878979|NCT04124926|12044856|FG000|COMPLETED|Maintenance Phase||0
10878980|NCT04124926|12044857|FG001|COMPLETED|Maintenance Phase||0
10878981|NCT04124926|12044858|FG002|COMPLETED|Maintenance Phase||274
10878982|NCT04124926|12044859|FG003|COMPLETED|Maintenance Phase||269
10878983|NCT04124926|12044860|FG004|COMPLETED|Maintenance Phase||269
10878984|NCT04124926|12044856|FG000|NOT COMPLETED|Maintenance Phase||0
10878985|NCT04124926|12044857|FG001|NOT COMPLETED|Maintenance Phase||0
10878986|NCT04124926|12044858|FG002|NOT COMPLETED|Maintenance Phase||24
10878987|NCT04124926|12044859|FG003|NOT COMPLETED|Maintenance Phase||29
10878988|NCT04124926|12044860|FG004|NOT COMPLETED|Maintenance Phase||28
10878989|NCT04123067|12044874|FG000|STARTED|Overall Study||0
10878990|NCT04123067|12044875|FG001|STARTED|Overall Study||1
10878991|NCT04123067|12044874|FG000|COMPLETED|Overall Study||0
10878992|NCT04123067|12044875|FG001|COMPLETED|Overall Study||0
10878993|NCT04123067|12044874|FG000|NOT COMPLETED|Overall Study||0
10878994|NCT04123067|12044875|FG001|NOT COMPLETED|Overall Study||1
10878995|NCT04096001|12044881|FG000|STARTED|Overall Study||101
10878996|NCT04096001|12044881|FG000|COMPLETED|Overall Study||51
10878997|NCT04096001|12044881|FG000|NOT COMPLETED|Overall Study||50
10878998|NCT04093414|12044887|FG000|STARTED|3 Month Follow up||3
10878999|NCT04093414|12044888|FG001|STARTED|3 Month Follow up||6
10879000|NCT04093414|12044887|FG000|COMPLETED|3 Month Follow up||3
10879001|NCT04093414|12044888|FG001|COMPLETED|3 Month Follow up||5
10879002|NCT04093414|12044887|FG000|NOT COMPLETED|3 Month Follow up||0
10879003|NCT04093414|12044888|FG001|NOT COMPLETED|3 Month Follow up||1
10879004|NCT04093414|12044887|FG000|STARTED|6month Follow up||3
10879005|NCT04093414|12044888|FG001|STARTED|6month Follow up||5
10879006|NCT04093414|12044887|FG000|COMPLETED|6month Follow up||2
10879007|NCT04093414|12044888|FG001|COMPLETED|6month Follow up||2
10879008|NCT04093414|12044887|FG000|NOT COMPLETED|6month Follow up||1
10879010|NCT04093414|12044887|FG000|STARTED|12 Month Follow up||2
10879011|NCT04093414|12044888|FG001|STARTED|12 Month Follow up||2
10879012|NCT04093414|12044887|FG000|COMPLETED|12 Month Follow up||2
10879013|NCT04093414|12044888|FG001|COMPLETED|12 Month Follow up||2
10879014|NCT04093414|12044887|FG000|NOT COMPLETED|12 Month Follow up||0
10879015|NCT04093414|12044888|FG001|NOT COMPLETED|12 Month Follow up||0
10879016|NCT04091360|12044900|FG000|STARTED|Part A (R, PC, PG) Single Dose||6
10879017|NCT04091360|12044901|FG001|STARTED|Part A (R, PC, PG) Single Dose||7
10879018|NCT04091360|12044902|FG002|STARTED|Part A (R, PC, PG) Single Dose||6
10879019|NCT04091360|12044903|FG003|STARTED|Part A (R, PC, PG) Single Dose||7
10879020|NCT04091360|12044904|FG004|STARTED|Part A (R, PC, PG) Single Dose||7
10879021|NCT04091360|12044905|FG005|STARTED|Part A (R, PC, PG) Single Dose||7
10879022|NCT04091360|12044906|FG006|STARTED|Part A (R, PC, PG) Single Dose||0
10879023|NCT04091360|12044907|FG007|STARTED|Part A (R, PC, PG) Single Dose||0
10879024|NCT04091360|12044908|FG008|STARTED|Part A (R, PC, PG) Single Dose||0
10879025|NCT04091360|12044909|FG009|STARTED|Part A (R, PC, PG) Single Dose||0
10879026|NCT04091360|12044900|FG000|COMPLETED|Part A (R, PC, PG) Single Dose||6
10879027|NCT04091360|12044901|FG001|COMPLETED|Part A (R, PC, PG) Single Dose||7
10879028|NCT04091360|12044902|FG002|COMPLETED|Part A (R, PC, PG) Single Dose||6
10879029|NCT04091360|12044903|FG003|COMPLETED|Part A (R, PC, PG) Single Dose||7
10879030|NCT04091360|12044904|FG004|COMPLETED|Part A (R, PC, PG) Single Dose||7
10879031|NCT04091360|12044905|FG005|COMPLETED|Part A (R, PC, PG) Single Dose||7
10879032|NCT04091360|12044906|FG006|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879033|NCT04091360|12044907|FG007|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879034|NCT04091360|12044908|FG008|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879035|NCT04091360|12044909|FG009|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879036|NCT04091360|12044900|FG000|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879037|NCT04091360|12044901|FG001|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879038|NCT04091360|12044902|FG002|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879039|NCT04091360|12044903|FG003|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879040|NCT04091360|12044904|FG004|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879041|NCT04091360|12044905|FG005|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879042|NCT04091360|12044906|FG006|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879043|NCT04091360|12044907|FG007|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879044|NCT04091360|12044908|FG008|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879045|NCT04091360|12044909|FG009|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879046|NCT04091360|12044900|FG000|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879047|NCT04091360|12044901|FG001|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879048|NCT04091360|12044902|FG002|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879049|NCT04091360|12044903|FG003|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879050|NCT04091360|12044904|FG004|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879051|NCT04091360|12044905|FG005|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879052|NCT04091360|12044906|FG006|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||8
10879053|NCT04091360|12044907|FG007|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||7
10879054|NCT04091360|12044908|FG008|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||7
10879055|NCT04091360|12044909|FG009|STARTED|Part B (R, PC, XO) Twice Daily for 7 Day||6
10879056|NCT04091360|12044900|FG000|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879057|NCT04091360|12044901|FG001|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879058|NCT04091360|12044902|FG002|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879059|NCT04091360|12044903|FG003|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879060|NCT04091360|12044904|FG004|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879061|NCT04091360|12044905|FG005|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879062|NCT04091360|12044906|FG006|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||6
10879063|NCT04091360|12044907|FG007|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||6
10879064|NCT04091360|12044908|FG008|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||6
10879065|NCT04091360|12044909|FG009|COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||4
10879066|NCT04091360|12044900|FG000|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879067|NCT04091360|12044901|FG001|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879068|NCT04091360|12044902|FG002|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879069|NCT04091360|12044903|FG003|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879070|NCT04091360|12044904|FG004|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879071|NCT04091360|12044905|FG005|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||0
10879072|NCT04091360|12044906|FG006|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||2
10879073|NCT04091360|12044907|FG007|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||1
10879074|NCT04091360|12044908|FG008|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||1
10879075|NCT04091360|12044909|FG009|NOT COMPLETED|Part B (R, PC, XO) Twice Daily for 7 Day||2
10879076|NCT04089553|12044933|FG000|STARTED|Overall Study||29
10879077|NCT04089553|12044934|FG001|STARTED|Overall Study||30
10879078|NCT04089553|12044933|FG000|COMPLETED|Overall Study||4
10879079|NCT04089553|12044934|FG001|COMPLETED|Overall Study||12
10879080|NCT04089553|12044933|FG000|NOT COMPLETED|Overall Study||25
10879081|NCT04089553|12044934|FG001|NOT COMPLETED|Overall Study||18
10879082|NCT04086472|12044946|FG000|STARTED|Overall Study||16
10879083|NCT04086472|12044947|FG001|STARTED|Overall Study||16
10879084|NCT04086472|12044948|FG002|STARTED|Overall Study||16
10879085|NCT04086472|12044949|FG003|STARTED|Overall Study||16
10879086|NCT04086472|12044950|FG004|STARTED|Overall Study||16
10879087|NCT04086472|12044946|FG000|Received MK-1654 or Placebo|Overall Study||16
10879088|NCT04086472|12044947|FG001|Received MK-1654 or Placebo|Overall Study||16
10879089|NCT04086472|12044948|FG002|Received MK-1654 or Placebo|Overall Study||16
10879090|NCT04086472|12044949|FG003|Received MK-1654 or Placebo|Overall Study||16
10879091|NCT04086472|12044950|FG004|Received MK-1654 or Placebo|Overall Study||16
10879092|NCT04086472|12044946|FG000|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
10879093|NCT04086472|12044947|FG001|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
10879094|NCT04086472|12044948|FG002|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
10879095|NCT04086472|12044949|FG003|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||13
10879096|NCT04086472|12044950|FG004|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||15
10879097|NCT04086472|12044946|FG000|Not Inoculated|Overall Study||2
10879098|NCT04086472|12044947|FG001|Not Inoculated|Overall Study||2
10879099|NCT04086472|12044948|FG002|Not Inoculated|Overall Study||2
10879100|NCT04086472|12044949|FG003|Not Inoculated|Overall Study||3
10879101|NCT04086472|12044950|FG004|Not Inoculated|Overall Study||1
10879102|NCT04086472|12044946|FG000|COMPLETED|Overall Study||12
10879103|NCT04086472|12044947|FG001|COMPLETED|Overall Study||14
10879104|NCT04086472|12044948|FG002|COMPLETED|Overall Study||14
10879105|NCT04086472|12044949|FG003|COMPLETED|Overall Study||13
10879106|NCT04086472|12044950|FG004|COMPLETED|Overall Study||14
10879107|NCT04086472|12044946|FG000|NOT COMPLETED|Overall Study||4
10879108|NCT04086472|12044947|FG001|NOT COMPLETED|Overall Study||2
10879109|NCT04086472|12044948|FG002|NOT COMPLETED|Overall Study||2
10879110|NCT04086472|12044949|FG003|NOT COMPLETED|Overall Study||3
10879111|NCT04086472|12044950|FG004|NOT COMPLETED|Overall Study||2
10879112|NCT04081727|12044964|FG000|STARTED|Overall Study||2
10879113|NCT04081727|12044965|FG001|STARTED|Overall Study||0
10879114|NCT04081727|12044964|FG000|As-treated Analysis|Overall Study||1
10879115|NCT04081727|12044965|FG001|As-treated Analysis|Overall Study||1
10879116|NCT04081727|12044964|FG000|COMPLETED|Overall Study||2
10879117|NCT04081727|12044965|FG001|COMPLETED|Overall Study||0
10879118|NCT04081727|12044964|FG000|NOT COMPLETED|Overall Study||0
10879119|NCT04081727|12044965|FG001|NOT COMPLETED|Overall Study||0
10879120|NCT04080882|12044975|FG000|STARTED|Overall Study||20
10879121|NCT04080882|12044976|FG001|STARTED|Overall Study||60
10879122|NCT04080882|12044975|FG000|COMPLETED|Overall Study||18
10879123|NCT04080882|12044976|FG001|COMPLETED|Overall Study||58
10879124|NCT04080882|12044975|FG000|NOT COMPLETED|Overall Study||2
10879125|NCT04080882|12044976|FG001|NOT COMPLETED|Overall Study||2
10879126|NCT04076696|12044982|FG000|STARTED|Overall Study||38
10879127|NCT04076696|12044982|FG000|COMPLETED|Overall Study||38
10879128|NCT04076696|12044982|FG000|NOT COMPLETED|Overall Study||0
10879129|NCT04075604|12044989|FG000|STARTED|Overall Study||2
10879130|NCT04075604|12044990|FG001|STARTED|Overall Study||9
10879131|NCT04075604|12044991|FG002|STARTED|Overall Study||12
10879132|NCT04075604|12044989|FG000|COMPLETED|Overall Study||1
10879133|NCT04075604|12044990|FG001|COMPLETED|Overall Study||3
10879134|NCT04075604|12044991|FG002|COMPLETED|Overall Study||6
10879135|NCT04075604|12044989|FG000|NOT COMPLETED|Overall Study||1
10879136|NCT04075604|12044990|FG001|NOT COMPLETED|Overall Study||6
10879137|NCT04075604|12044991|FG002|NOT COMPLETED|Overall Study||6
10879138|NCT04073186|12044999|FG000|STARTED|First Wearing Cycle||86
10879139|NCT04073186|12044999|FG000|COMPLETED|First Wearing Cycle||80
10879140|NCT04073186|12044999|FG000|NOT COMPLETED|First Wearing Cycle||6
10879141|NCT04073186|12044999|FG000|STARTED|Second Wearing Cycle||80
10879142|NCT04073186|12044999|FG000|COMPLETED|Second Wearing Cycle||79
10879143|NCT04073186|12044999|FG000|NOT COMPLETED|Second Wearing Cycle||1
10879144|NCT04072445|12045004|FG000|STARTED|Overall Study||28
10879145|NCT04072445|12045004|FG000|COMPLETED|Overall Study||27
10879146|NCT04072445|12045004|FG000|NOT COMPLETED|Overall Study||1
10879147|NCT04070833|12045013|FG000|STARTED|Overall Study||66
10879148|NCT04070833|12045014|FG001|STARTED|Overall Study||75
10879149|NCT04070833|12045015|FG002|STARTED|Overall Study||82
10879150|NCT04070833|12045016|FG003|STARTED|Overall Study||67
10879151|NCT04070833|12045013|FG000|COMPLETED|Overall Study||58
10879152|NCT04070833|12045014|FG001|COMPLETED|Overall Study||69
10879153|NCT04070833|12045015|FG002|COMPLETED|Overall Study||71
10879154|NCT04070833|12045016|FG003|COMPLETED|Overall Study||60
10879155|NCT04070833|12045013|FG000|NOT COMPLETED|Overall Study||8
10879156|NCT04070833|12045014|FG001|NOT COMPLETED|Overall Study||6
10879157|NCT04070833|12045015|FG002|NOT COMPLETED|Overall Study||11
10879158|NCT04070833|12045016|FG003|NOT COMPLETED|Overall Study||7
10879159|NCT04069702|12045026|FG000|STARTED|Overall Study||20
10879160|NCT04069702|12045026|FG000|COMPLETED|Overall Study||20
10879161|NCT04069702|12045026|FG000|NOT COMPLETED|Overall Study||0
10879162|NCT04068181|12045034|FG000|STARTED|Overall Study||27
10879163|NCT04068181|12045035|FG001|STARTED|Overall Study||15
10879164|NCT04068181|12045036|FG002|STARTED|Overall Study||15
10879165|NCT04068181|12045037|FG003|STARTED|Overall Study||15
10879166|NCT04068181|12045034|FG000|Received Talimogene Laherparepvec|Overall Study||26
10879167|NCT04068181|12045035|FG001|Received Talimogene Laherparepvec|Overall Study||15
10879168|NCT04068181|12045036|FG002|Received Talimogene Laherparepvec|Overall Study||15
10879169|NCT04068181|12045037|FG003|Received Talimogene Laherparepvec|Overall Study||15
10879170|NCT04068181|12045034|FG000|Received Pembrolizumab|Overall Study||26
10879171|NCT04068181|12045035|FG001|Received Pembrolizumab|Overall Study||15
10879172|NCT04068181|12045036|FG002|Received Pembrolizumab|Overall Study||15
10879173|NCT04068181|12045037|FG003|Received Pembrolizumab|Overall Study||15
10879174|NCT04068181|12045034|FG000|COMPLETED|Overall Study||0
10879175|NCT04068181|12045035|FG001|COMPLETED|Overall Study||0
10879176|NCT04068181|12045036|FG002|COMPLETED|Overall Study||0
10879177|NCT04068181|12045037|FG003|COMPLETED|Overall Study||0
10879178|NCT04068181|12045034|FG000|NOT COMPLETED|Overall Study||27
10879179|NCT04068181|12045035|FG001|NOT COMPLETED|Overall Study||15
10879180|NCT04068181|12045036|FG002|NOT COMPLETED|Overall Study||15
10879181|NCT04068181|12045037|FG003|NOT COMPLETED|Overall Study||15
10879182|NCT04067518|12045049|FG000|STARTED|Overall Study||3
10879183|NCT04067518|12045050|FG001|STARTED|Overall Study||25
10879184|NCT04067518|12045049|FG000|Safety Analysis Set|Overall Study|SR/IR: 3 participants; HR: 0 participants|3
10879185|NCT04067518|12045050|FG001|Safety Analysis Set|Overall Study|SR/IR: 21 participants; HR: 1 participant; Missing: 1 participant|23
10879186|NCT04067518|12045049|FG000|Full Analysis Set|Overall Study||0
10879187|NCT04067518|12045050|FG001|Full Analysis Set|Overall Study||23
10879188|NCT04067518|12045049|FG000|Immunogenicity Analysis Set|Overall Study||3
10879189|NCT04067518|12045050|FG001|Immunogenicity Analysis Set|Overall Study||22
10879190|NCT04067518|12045049|FG000|Pharmacokinetic Analysis Set|Overall Study||3
10879191|NCT04067518|12045050|FG001|Pharmacokinetic Analysis Set|Overall Study||23
10879192|NCT04067518|12045049|FG000|COMPLETED|Overall Study||0
10879193|NCT04067518|12045050|FG001|COMPLETED|Overall Study||0
10879194|NCT04067518|12045049|FG000|NOT COMPLETED|Overall Study||3
10879195|NCT04067518|12045050|FG001|NOT COMPLETED|Overall Study||25
10879196|NCT04063761|12045057|FG000|STARTED|Overall Study||20
10879197|NCT04063761|12045057|FG000|COMPLETED|Overall Study||20
10879198|NCT04063761|12045057|FG000|NOT COMPLETED|Overall Study||0
10879199|NCT04058054|12045061|FG000|STARTED|Overall Study||22
10879200|NCT04058054|12045062|FG001|STARTED|Overall Study||22
10879201|NCT04058054|12045063|FG002|STARTED|Overall Study||22
10879202|NCT04058054|12045064|FG003|STARTED|Overall Study||22
10879203|NCT04058054|12045065|FG004|STARTED|Overall Study||22
10879204|NCT04058054|12045061|FG000|COMPLETED|Overall Study||22
10879205|NCT04058054|12045062|FG001|COMPLETED|Overall Study||22
10879206|NCT04058054|12045063|FG002|COMPLETED|Overall Study||22
10879207|NCT04058054|12045064|FG003|COMPLETED|Overall Study||22
10879208|NCT04058054|12045065|FG004|COMPLETED|Overall Study||22
10879209|NCT04058054|12045061|FG000|NOT COMPLETED|Overall Study||0
10879210|NCT04058054|12045062|FG001|NOT COMPLETED|Overall Study||0
10879211|NCT04058054|12045063|FG002|NOT COMPLETED|Overall Study||0
10879212|NCT04058054|12045064|FG003|NOT COMPLETED|Overall Study||0
10879213|NCT04058054|12045065|FG004|NOT COMPLETED|Overall Study||0
10879214|NCT04057573|12045079|FG000|STARTED|24-Week Double-Blind Period||229
10879215|NCT04057573|12045080|FG001|STARTED|24-Week Double-Blind Period||115
10879216|NCT04057573|12045081|FG002|STARTED|24-Week Double-Blind Period||0
10879217|NCT04057573|12045082|FG003|STARTED|24-Week Double-Blind Period||0
10879218|NCT04057573|12045079|FG000|ITT Population|24-Week Double-Blind Period||229
10879219|NCT04057573|12045080|FG001|ITT Population|24-Week Double-Blind Period||115
10879220|NCT04057573|12045081|FG002|ITT Population|24-Week Double-Blind Period||0
10879221|NCT04057573|12045082|FG003|ITT Population|24-Week Double-Blind Period||0
10879222|NCT04057573|12045079|FG000|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||222
10879223|NCT04057573|12045080|FG001|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||109
10879224|NCT04057573|12045081|FG002|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||0
10879225|NCT04057573|12045082|FG003|ITT Population, Excluding Non-compliant Site|24-Week Double-Blind Period||0
10879226|NCT04057573|12045079|FG000|COMPLETED|24-Week Double-Blind Period||199
10879227|NCT04057573|12045080|FG001|COMPLETED|24-Week Double-Blind Period||98
10879228|NCT04057573|12045081|FG002|COMPLETED|24-Week Double-Blind Period||0
10879229|NCT04057573|12045082|FG003|COMPLETED|24-Week Double-Blind Period||0
10879230|NCT04057573|12045079|FG000|NOT COMPLETED|24-Week Double-Blind Period||30
10879231|NCT04057573|12045080|FG001|NOT COMPLETED|24-Week Double-Blind Period||17
10879232|NCT04057573|12045081|FG002|NOT COMPLETED|24-Week Double-Blind Period||0
10879233|NCT04057573|12045082|FG003|NOT COMPLETED|24-Week Double-Blind Period||0
10879234|NCT04057573|12045079|FG000|STARTED|28-Week Treatment Extension Period||0
10879235|NCT04057573|12045080|FG001|STARTED|28-Week Treatment Extension Period||0
10879236|NCT04057573|12045081|FG002|STARTED|28-Week Treatment Extension Period|Treatment-Extension Evaluable Population: all participants who applied ruxolitinib cream at least once in the TE period|199
10879237|NCT04057573|12045082|FG003|STARTED|28-Week Treatment Extension Period||98
10879238|NCT04057573|12045079|FG000|COMPLETED|28-Week Treatment Extension Period||0
10879239|NCT04057573|12045080|FG001|COMPLETED|28-Week Treatment Extension Period||0
10879240|NCT04057573|12045081|FG002|COMPLETED|28-Week Treatment Extension Period||178
10879241|NCT04057573|12045082|FG003|COMPLETED|28-Week Treatment Extension Period||79
10879242|NCT04057573|12045079|FG000|NOT COMPLETED|28-Week Treatment Extension Period||0
10879243|NCT04057573|12045080|FG001|NOT COMPLETED|28-Week Treatment Extension Period||0
10879244|NCT04057573|12045081|FG002|NOT COMPLETED|28-Week Treatment Extension Period||21
10879245|NCT04057573|12045082|FG003|NOT COMPLETED|28-Week Treatment Extension Period||19
10879246|NCT04057196|12045093|FG000|STARTED|Overall Study||30
10879247|NCT04057196|12045093|FG000|COMPLETED|Overall Study||24
10879248|NCT04057196|12045093|FG000|NOT COMPLETED|Overall Study||6
10879252|NCT04052425|12045104|FG000|STARTED|24-Week Double-blind Period||221
10879253|NCT04052425|12045105|FG001|STARTED|24-Week Double-blind Period||109
10879254|NCT04052425|12045106|FG002|STARTED|24-Week Double-blind Period||0
10879255|NCT04052425|12045107|FG003|STARTED|24-Week Double-blind Period||0
10879256|NCT04052425|12045104|FG000|COMPLETED|24-Week Double-blind Period||193
10879257|NCT04052425|12045105|FG001|COMPLETED|24-Week Double-blind Period||90
10879258|NCT04052425|12045106|FG002|COMPLETED|24-Week Double-blind Period||0
10879259|NCT04052425|12045107|FG003|COMPLETED|24-Week Double-blind Period||0
10879260|NCT04052425|12045104|FG000|NOT COMPLETED|24-Week Double-blind Period||28
10879261|NCT04052425|12045105|FG001|NOT COMPLETED|24-Week Double-blind Period||19
10879262|NCT04052425|12045106|FG002|NOT COMPLETED|24-Week Double-blind Period||0
10879263|NCT04052425|12045107|FG003|NOT COMPLETED|24-Week Double-blind Period||0
10879264|NCT04052425|12045104|FG000|STARTED|28-Week Treatment-Extension Period||0
10879265|NCT04052425|12045105|FG001|STARTED|28-Week Treatment-Extension Period||0
10879266|NCT04052425|12045106|FG002|STARTED|28-Week Treatment-Extension Period|Treatment-Extension Evaluable Population: all participants who applied ruxolitinib cream at least once in the TE period|193
10879267|NCT04052425|12045107|FG003|STARTED|28-Week Treatment-Extension Period||90
10879268|NCT04052425|12045104|FG000|COMPLETED|28-Week Treatment-Extension Period||0
10879269|NCT04052425|12045105|FG001|COMPLETED|28-Week Treatment-Extension Period||0
10879270|NCT04052425|12045106|FG002|COMPLETED|28-Week Treatment-Extension Period||174
10879271|NCT04052425|12045107|FG003|COMPLETED|28-Week Treatment-Extension Period||80
10879272|NCT04052425|12045104|FG000|NOT COMPLETED|28-Week Treatment-Extension Period||0
10879273|NCT04052425|12045105|FG001|NOT COMPLETED|28-Week Treatment-Extension Period||0
10879274|NCT04052425|12045106|FG002|NOT COMPLETED|28-Week Treatment-Extension Period||19
10879275|NCT04052425|12045107|FG003|NOT COMPLETED|28-Week Treatment-Extension Period||10
10879276|NCT04051957|12045119|FG000|STARTED|Overall Study||7
10879277|NCT04051957|12045120|FG001|STARTED|Overall Study||2
10879278|NCT04051957|12045119|FG000|COMPLETED|Overall Study||5
10879279|NCT04051957|12045120|FG001|COMPLETED|Overall Study||2
10879280|NCT04051957|12045119|FG000|NOT COMPLETED|Overall Study||2
10879281|NCT04051957|12045120|FG001|NOT COMPLETED|Overall Study||0
10879282|NCT04049617|12045132|FG000|STARTED|Overall Study||3
10879283|NCT04049617|12045133|FG001|STARTED|Overall Study||3
10879284|NCT04049617|12045134|FG002|STARTED|Overall Study||6
10879285|NCT04049617|12045135|FG003|STARTED|Overall Study||3
10879286|NCT04049617|12045136|FG004|STARTED|Overall Study||2
10879287|NCT04049617|12045137|FG005|STARTED|Overall Study||1
10879288|NCT04049617|12045132|FG000|COMPLETED|Overall Study||3
10879289|NCT04049617|12045133|FG001|COMPLETED|Overall Study||3
10879290|NCT04049617|12045134|FG002|COMPLETED|Overall Study||5
10879291|NCT04049617|12045135|FG003|COMPLETED|Overall Study||1
10879292|NCT04049617|12045136|FG004|COMPLETED|Overall Study||2
10879293|NCT04049617|12045137|FG005|COMPLETED|Overall Study||0
10879294|NCT04049617|12045132|FG000|NOT COMPLETED|Overall Study||0
10879295|NCT04049617|12045133|FG001|NOT COMPLETED|Overall Study||0
10879296|NCT04049617|12045134|FG002|NOT COMPLETED|Overall Study||1
10879297|NCT04049617|12045135|FG003|NOT COMPLETED|Overall Study||2
10879298|NCT04049617|12045136|FG004|NOT COMPLETED|Overall Study||0
10879299|NCT04049617|12045137|FG005|NOT COMPLETED|Overall Study||1
10879300|NCT04048863|12045156|FG000|STARTED|Overall Study||43
10879301|NCT04048863|12045157|FG001|STARTED|Overall Study||0
10879302|NCT04048863|12045158|FG002|STARTED|Overall Study||0
10879303|NCT04048863|12045159|FG003|STARTED|Overall Study||0
10879304|NCT04048863|12045156|FG000|COMPLETED|Overall Study||43
10879305|NCT04048863|12045157|FG001|COMPLETED|Overall Study||0
10879306|NCT04048863|12045158|FG002|COMPLETED|Overall Study||0
10879307|NCT04048863|12045159|FG003|COMPLETED|Overall Study||0
10879308|NCT04048863|12045156|FG000|NOT COMPLETED|Overall Study||0
10879309|NCT04048863|12045157|FG001|NOT COMPLETED|Overall Study||0
10879310|NCT04048863|12045158|FG002|NOT COMPLETED|Overall Study||0
10879311|NCT04048863|12045159|FG003|NOT COMPLETED|Overall Study||0
10879312|NCT04047446|12045171|FG000|STARTED|Overall Study||56
10879313|NCT04047446|12045172|FG001|STARTED|Overall Study||56
10879314|NCT04047446|12045171|FG000|COMPLETED|Overall Study||55
10879315|NCT04047446|12045172|FG001|COMPLETED|Overall Study||56
10879316|NCT04047446|12045171|FG000|NOT COMPLETED|Overall Study||1
10879317|NCT04047446|12045172|FG001|NOT COMPLETED|Overall Study||0
10879318|NCT04046263|12045178|FG000|STARTED|Overall Study||17
10879319|NCT04046263|12045178|FG000|COMPLETED|Overall Study||12
10879320|NCT04046263|12045178|FG000|NOT COMPLETED|Overall Study||5
10879321|NCT04041869|12045182|FG000|STARTED|Overall Study||68
10879322|NCT04041869|12045182|FG000|COMPLETED|Overall Study||54
10879323|NCT04041869|12045182|FG000|NOT COMPLETED|Overall Study||14
10879324|NCT04040621|12045187|FG000|STARTED|Overall Study||4
10879325|NCT04040621|12045187|FG000|COMPLETED|Overall Study||4
10879326|NCT04040621|12045187|FG000|NOT COMPLETED|Overall Study||0
10879327|NCT04030598|12045194|FG000|STARTED|Overall Study||6
10879328|NCT04030598|12045195|FG001|STARTED|Overall Study||14
10879329|NCT04030598|12045196|FG002|STARTED|Overall Study||3
10879330|NCT04030598|12045194|FG000|COMPLETED|Overall Study||6
10879331|NCT04030598|12045195|FG001|COMPLETED|Overall Study||13
10879332|NCT04030598|12045196|FG002|COMPLETED|Overall Study||3
10879333|NCT04030598|12045194|FG000|NOT COMPLETED|Overall Study||0
10879334|NCT04030598|12045195|FG001|NOT COMPLETED|Overall Study||1
10879335|NCT04030598|12045196|FG002|NOT COMPLETED|Overall Study||0
10879336|NCT04027439|12045210|FG000|STARTED|Part A (R, PC, PG) Single Dose||6
10879337|NCT04027439|12045211|FG001|STARTED|Part A (R, PC, PG) Single Dose||6
10879338|NCT04027439|12045212|FG002|STARTED|Part A (R, PC, PG) Single Dose||7
10879339|NCT04027439|12045213|FG003|STARTED|Part A (R, PC, PG) Single Dose||6
10879340|NCT04027439|12045214|FG004|STARTED|Part A (R, PC, PG) Single Dose||6
10879341|NCT04027439|12045215|FG005|STARTED|Part A (R, PC, PG) Single Dose||6
10879342|NCT04027439|12045216|FG006|STARTED|Part A (R, PC, PG) Single Dose||0
10879343|NCT04027439|12045217|FG007|STARTED|Part A (R, PC, PG) Single Dose||0
10879344|NCT04027439|12045218|FG008|STARTED|Part A (R, PC, PG) Single Dose||0
10879345|NCT04027439|12045219|FG009|STARTED|Part A (R, PC, PG) Single Dose||0
10879346|NCT04027439|12045220|FG010|STARTED|Part A (R, PC, PG) Single Dose||0
10879347|NCT04027439|12045221|FG011|STARTED|Part A (R, PC, PG) Single Dose||0
10879348|NCT04027439|12045222|FG012|STARTED|Part A (R, PC, PG) Single Dose||0
10879349|NCT04027439|12045223|FG013|STARTED|Part A (R, PC, PG) Single Dose||0
10879350|NCT04027439|12045224|FG014|STARTED|Part A (R, PC, PG) Single Dose||0
10879351|NCT04027439|12045225|FG015|STARTED|Part A (R, PC, PG) Single Dose||0
10879352|NCT04027439|12045210|FG000|COMPLETED|Part A (R, PC, PG) Single Dose||6
10879353|NCT04027439|12045211|FG001|COMPLETED|Part A (R, PC, PG) Single Dose||6
10879354|NCT04027439|12045212|FG002|COMPLETED|Part A (R, PC, PG) Single Dose||7
10879355|NCT04027439|12045213|FG003|COMPLETED|Part A (R, PC, PG) Single Dose||6
10879356|NCT04027439|12045214|FG004|COMPLETED|Part A (R, PC, PG) Single Dose||6
10879357|NCT04027439|12045215|FG005|COMPLETED|Part A (R, PC, PG) Single Dose||6
10879358|NCT04027439|12045216|FG006|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879359|NCT04027439|12045217|FG007|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879360|NCT04027439|12045218|FG008|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879361|NCT04027439|12045219|FG009|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879362|NCT04027439|12045220|FG010|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879363|NCT04027439|12045221|FG011|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879364|NCT04027439|12045222|FG012|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879365|NCT04027439|12045223|FG013|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879366|NCT04027439|12045224|FG014|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879367|NCT04027439|12045225|FG015|COMPLETED|Part A (R, PC, PG) Single Dose||0
10879368|NCT04027439|12045210|FG000|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879369|NCT04027439|12045211|FG001|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879370|NCT04027439|12045212|FG002|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879371|NCT04027439|12045213|FG003|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879372|NCT04027439|12045214|FG004|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879373|NCT04027439|12045215|FG005|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879374|NCT04027439|12045216|FG006|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879375|NCT04027439|12045217|FG007|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879376|NCT04027439|12045218|FG008|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879377|NCT04027439|12045219|FG009|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879378|NCT04027439|12045220|FG010|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879379|NCT04027439|12045221|FG011|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879380|NCT04027439|12045222|FG012|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879381|NCT04027439|12045223|FG013|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879382|NCT04027439|12045224|FG014|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879383|NCT04027439|12045225|FG015|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
10879384|NCT04027439|12045210|FG000|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879385|NCT04027439|12045211|FG001|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879386|NCT04027439|12045212|FG002|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879387|NCT04027439|12045213|FG003|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879388|NCT04027439|12045214|FG004|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879389|NCT04027439|12045215|FG005|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879390|NCT04027439|12045216|FG006|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879391|NCT04027439|12045217|FG007|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879392|NCT04027439|12045218|FG008|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879393|NCT04027439|12045219|FG009|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879394|NCT04027439|12045220|FG010|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879395|NCT04027439|12045221|FG011|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879396|NCT04027439|12045222|FG012|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879397|NCT04027439|12045223|FG013|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879398|NCT04027439|12045224|FG014|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879399|NCT04027439|12045225|FG015|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879400|NCT04027439|12045210|FG000|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879401|NCT04027439|12045211|FG001|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879402|NCT04027439|12045212|FG002|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879403|NCT04027439|12045213|FG003|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879404|NCT04027439|12045214|FG004|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879405|NCT04027439|12045215|FG005|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879406|NCT04027439|12045216|FG006|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879407|NCT04027439|12045217|FG007|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day|1 patient discontinued in part b/period 2 and another in part b/period 3.|1
10879408|NCT04027439|12045218|FG008|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879409|NCT04027439|12045219|FG009|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879410|NCT04027439|12045220|FG010|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879411|NCT04027439|12045221|FG011|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879412|NCT04027439|12045222|FG012|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879413|NCT04027439|12045223|FG013|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879414|NCT04027439|12045224|FG014|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
10879415|NCT04027439|12045225|FG015|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
10879416|NCT04027439|12045210|FG000|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879417|NCT04027439|12045211|FG001|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879418|NCT04027439|12045212|FG002|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879419|NCT04027439|12045213|FG003|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879420|NCT04027439|12045214|FG004|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879421|NCT04027439|12045215|FG005|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879422|NCT04027439|12045216|FG006|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879423|NCT04027439|12045217|FG007|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||2
10879424|NCT04027439|12045218|FG008|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879425|NCT04027439|12045219|FG009|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879426|NCT04027439|12045220|FG010|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879427|NCT04027439|12045221|FG011|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879428|NCT04027439|12045222|FG012|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879429|NCT04027439|12045223|FG013|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879430|NCT04027439|12045224|FG014|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879431|NCT04027439|12045225|FG015|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
10879432|NCT04026568|12045251|FG000|STARTED|Overall Study||0
10879433|NCT04026568|12045252|FG001|STARTED|Overall Study||1
10879434|NCT04026568|12045251|FG000|COMPLETED|Overall Study||0
10879435|NCT04026568|12045252|FG001|COMPLETED|Overall Study||0
10879436|NCT04026568|12045251|FG000|NOT COMPLETED|Overall Study||0
10879437|NCT04026568|12045252|FG001|NOT COMPLETED|Overall Study||1
10879438|NCT04025632|12045260|FG000|STARTED|Overall Study||15
10879439|NCT04025632|12045261|FG001|STARTED|Overall Study||12
10879440|NCT04025632|12045260|FG000|Completed Main Portion|Overall Study||15
10879441|NCT04025632|12045261|FG001|Completed Main Portion|Overall Study||12
10879442|NCT04025632|12045260|FG000|Started Main Portion Safety Follow-up|Overall Study||2
10879443|NCT04025632|12045261|FG001|Started Main Portion Safety Follow-up|Overall Study||0
10879444|NCT04025632|12045260|FG000|Completed Main Portion Safety Follow-up|Overall Study||0
10879445|NCT04025632|12045261|FG001|Completed Main Portion Safety Follow-up|Overall Study||0
10879446|NCT04025632|12045260|FG000|Started Extension Portion|Overall Study||13
10879447|NCT04025632|12045261|FG001|Started Extension Portion|Overall Study||12
10879448|NCT04025632|12045260|FG000|COMPLETED|Overall Study||0
10879449|NCT04025632|12045261|FG001|COMPLETED|Overall Study||0
10879450|NCT04025632|12045260|FG000|NOT COMPLETED|Overall Study||15
10879451|NCT04025632|12045261|FG001|NOT COMPLETED|Overall Study||12
10879452|NCT04024891|12045272|FG000|STARTED|Overall Study||16
10879453|NCT04024891|12045273|FG001|STARTED|Overall Study||16
10879454|NCT04024891|12045272|FG000|COMPLETED|Overall Study||16
10879455|NCT04024891|12045273|FG001|COMPLETED|Overall Study||15
10879456|NCT04024891|12045272|FG000|NOT COMPLETED|Overall Study||0
10879457|NCT04024891|12045273|FG001|NOT COMPLETED|Overall Study||1
10879458|NCT04019561|12045282|FG000|STARTED|Overall Study||25
10879459|NCT04019561|12045283|FG001|STARTED|Overall Study||25
10879460|NCT04019561|12045284|FG002|STARTED|Overall Study||24
10879461|NCT04019561|12045282|FG000|COMPLETED|Overall Study||21
10879462|NCT04019561|12045283|FG001|COMPLETED|Overall Study||23
10879463|NCT04019561|12045284|FG002|COMPLETED|Overall Study||19
10879464|NCT04019561|12045282|FG000|NOT COMPLETED|Overall Study||4
10879465|NCT04019561|12045283|FG001|NOT COMPLETED|Overall Study||2
10879466|NCT04019561|12045284|FG002|NOT COMPLETED|Overall Study||5
10879467|NCT04015518|12045297|FG000|STARTED|Overall Study||43
10879468|NCT04015518|12045298|FG001|STARTED|Overall Study||22
10879469|NCT04015518|12045299|FG002|STARTED|Overall Study||21
10879470|NCT04015518|12045300|FG003|STARTED|Overall Study||22
10879471|NCT04015518|12045301|FG004|STARTED|Overall Study||44
10879472|NCT04015518|12045297|FG000|Full Analysis Set (FAS)|Overall Study||43
10879473|NCT04015518|12045298|FG001|Full Analysis Set (FAS)|Overall Study||22
10879474|NCT04015518|12045299|FG002|Full Analysis Set (FAS)|Overall Study||21
10879475|NCT04015518|12045300|FG003|Full Analysis Set (FAS)|Overall Study||22
10879476|NCT04015518|12045301|FG004|Full Analysis Set (FAS)|Overall Study||44
10879477|NCT04015518|12045297|FG000|COMPLETED|Overall Study||32
10879478|NCT04015518|12045298|FG001|COMPLETED|Overall Study||19
10879479|NCT04015518|12045299|FG002|COMPLETED|Overall Study||18
10879480|NCT04015518|12045300|FG003|COMPLETED|Overall Study||17
10879481|NCT04015518|12045301|FG004|COMPLETED|Overall Study||32
10879482|NCT04015518|12045297|FG000|NOT COMPLETED|Overall Study||11
10879483|NCT04015518|12045298|FG001|NOT COMPLETED|Overall Study||3
10879484|NCT04015518|12045299|FG002|NOT COMPLETED|Overall Study||3
10879485|NCT04015518|12045300|FG003|NOT COMPLETED|Overall Study||5
10879486|NCT04015518|12045301|FG004|NOT COMPLETED|Overall Study||12
10879487|NCT04014075|12045316|FG000|STARTED|Overall Study||79
10879488|NCT04014075|12045316|FG000|COMPLETED|Overall Study||23
10879489|NCT04014075|12045316|FG000|NOT COMPLETED|Overall Study||56
10879490|NCT04005859|12045322|FG000|STARTED|Overall Study||32
10879491|NCT04005859|12045323|FG001|STARTED|Overall Study||29
10879492|NCT04005859|12045322|FG000|COMPLETED|Overall Study||28
10879493|NCT04005859|12045323|FG001|COMPLETED|Overall Study||25
10879494|NCT04005859|12045322|FG000|NOT COMPLETED|Overall Study||4
10879495|NCT04005859|12045323|FG001|NOT COMPLETED|Overall Study||4
10879496|NCT04003155|12045332|FG000|STARTED|Double-Blind (DB) Period (12 Weeks)||175
10879497|NCT04003155|12045333|FG001|STARTED|Double-Blind (DB) Period (12 Weeks)||176
10879498|NCT04003155|12045334|FG002|STARTED|Double-Blind (DB) Period (12 Weeks)||176
10879499|NCT04003155|12045335|FG003|STARTED|Double-Blind (DB) Period (12 Weeks)||0
10879500|NCT04003155|12045336|FG004|STARTED|Double-Blind (DB) Period (12 Weeks)||0
10879501|NCT04003155|12045332|FG000|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||175
10879502|NCT04003155|12045333|FG001|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||173
10879576|NCT03976401|12045404|FG003|COMPLETED|Overall Study||19
10879503|NCT04003155|12045334|FG002|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||174
10879504|NCT04003155|12045335|FG003|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||0
10879505|NCT04003155|12045336|FG004|Full Analysis Set|Double-Blind (DB) Period (12 Weeks)||0
10879506|NCT04003155|12045332|FG000|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||175
10879507|NCT04003155|12045333|FG001|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)|1 participant who was randomized to fezolinetant 45 mg received fezolinetant 30 mg during the 12-week study period. This participant was included in the fezolinetant 30 mg group for the Safety Analysis Set|174
10879508|NCT04003155|12045334|FG002|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||173
10879509|NCT04003155|12045335|FG003|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||0
10879510|NCT04003155|12045336|FG004|Safety Analysis Set|Double-Blind (DB) Period (12 Weeks)||0
10879511|NCT04003155|12045332|FG000|Treated|Double-Blind (DB) Period (12 Weeks)||175
10879512|NCT04003155|12045333|FG001|Treated|Double-Blind (DB) Period (12 Weeks)||173
10879513|NCT04003155|12045334|FG002|Treated|Double-Blind (DB) Period (12 Weeks)|1 participant who was randomized in this arm actually received 30mg fezolinetant.|174
10879514|NCT04003155|12045335|FG003|Treated|Double-Blind (DB) Period (12 Weeks)||0
10879515|NCT04003155|12045336|FG004|Treated|Double-Blind (DB) Period (12 Weeks)||0
10879516|NCT04003155|12045332|FG000|COMPLETED|Double-Blind (DB) Period (12 Weeks)||152
10879517|NCT04003155|12045333|FG001|COMPLETED|Double-Blind (DB) Period (12 Weeks)||142
10879518|NCT04003155|12045334|FG002|COMPLETED|Double-Blind (DB) Period (12 Weeks)||161
10879519|NCT04003155|12045335|FG003|COMPLETED|Double-Blind (DB) Period (12 Weeks)||0
10879520|NCT04003155|12045336|FG004|COMPLETED|Double-Blind (DB) Period (12 Weeks)||0
10879521|NCT04003155|12045332|FG000|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||23
10879522|NCT04003155|12045333|FG001|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||34
10879523|NCT04003155|12045334|FG002|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||15
10879524|NCT04003155|12045335|FG003|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||0
10879525|NCT04003155|12045336|FG004|NOT COMPLETED|Double-Blind (DB) Period (12 Weeks)||0
10879526|NCT04003155|12045332|FG000|STARTED|Extension Period (EP) (40 Weeks)|Participants who received placebo in double-blind period were moved to fezolinetant 30/45 mg arms in extension treatment period|0
10879527|NCT04003155|12045333|FG001|STARTED|Extension Period (EP) (40 Weeks)|"1 participant who completed DB discontinued study before entering EP.~1 participant who was randomized to 45 mg but received 30 mg in DB, was then moved to 30mg in EP."|142
10879528|NCT04003155|12045334|FG002|STARTED|Extension Period (EP) (40 Weeks)|Two participants who completed double-blind period discontinued the study before entering the extension treatment period|158
10879529|NCT04003155|12045335|FG003|STARTED|Extension Period (EP) (40 Weeks)|Participants who received placebo in double-blind period were randomized to fezolinetant 30 mg arms|76
10879530|NCT04003155|12045336|FG004|STARTED|Extension Period (EP) (40 Weeks)|Participants who received placebo in double-blind period were randomized to fezolinetant 45 mg arms|76
10879531|NCT04003155|12045332|FG000|COMPLETED|Extension Period (EP) (40 Weeks)||0
10879532|NCT04003155|12045333|FG001|COMPLETED|Extension Period (EP) (40 Weeks)||124
10879533|NCT04003155|12045334|FG002|COMPLETED|Extension Period (EP) (40 Weeks)||143
10879534|NCT04003155|12045335|FG003|COMPLETED|Extension Period (EP) (40 Weeks)||62
10879535|NCT04003155|12045336|FG004|COMPLETED|Extension Period (EP) (40 Weeks)||67
10879536|NCT04003155|12045332|FG000|NOT COMPLETED|Extension Period (EP) (40 Weeks)||0
10879537|NCT04003155|12045333|FG001|NOT COMPLETED|Extension Period (EP) (40 Weeks)||18
10879538|NCT04003155|12045334|FG002|NOT COMPLETED|Extension Period (EP) (40 Weeks)||15
10879539|NCT04003155|12045335|FG003|NOT COMPLETED|Extension Period (EP) (40 Weeks)||14
10879540|NCT04003155|12045336|FG004|NOT COMPLETED|Extension Period (EP) (40 Weeks)||9
10879541|NCT04000399|12045356|FG000|STARTED|Overall Study||38
10879542|NCT04000399|12045357|FG001|STARTED|Overall Study||5
10879543|NCT04000399|12045356|FG000|COMPLETED|Overall Study||38
10879544|NCT04000399|12045357|FG001|COMPLETED|Overall Study||5
10879545|NCT04000399|12045356|FG000|NOT COMPLETED|Overall Study||0
10879546|NCT04000399|12045357|FG001|NOT COMPLETED|Overall Study||0
10879547|NCT03999892|12045366|FG000|STARTED|Overall Study||17
10879548|NCT03999892|12045366|FG000|COMPLETED|Overall Study||16
10879549|NCT03999892|12045366|FG000|NOT COMPLETED|Overall Study||1
10879550|NCT03988166|12045370|FG000|STARTED|Overall Study||150
10879551|NCT03988166|12045370|FG000|COMPLETED|Overall Study||147
10879552|NCT03988166|12045370|FG000|NOT COMPLETED|Overall Study||3
10879553|NCT03980808|12045379|FG000|STARTED|Overall Study||24
10879554|NCT03980808|12045380|FG001|STARTED|Overall Study||17
10879555|NCT03980808|12045379|FG000|Phase 2 - 30-day Follow-up|Overall Study||24
10879556|NCT03980808|12045380|FG001|Phase 2 - 30-day Follow-up|Overall Study||17
10879557|NCT03980808|12045379|FG000|COMPLETED|Overall Study||22
10879558|NCT03980808|12045380|FG001|COMPLETED|Overall Study||15
10879559|NCT03980808|12045379|FG000|NOT COMPLETED|Overall Study||2
10879560|NCT03980808|12045380|FG001|NOT COMPLETED|Overall Study||2
10879561|NCT03977454|12045388|FG000|STARTED|Overall Study||97
10879562|NCT03977454|12045389|FG001|STARTED|Overall Study||95
10879563|NCT03977454|12045388|FG000|COMPLETED|Overall Study||95
10879564|NCT03977454|12045389|FG001|COMPLETED|Overall Study||93
10879565|NCT03977454|12045388|FG000|NOT COMPLETED|Overall Study||2
10879566|NCT03977454|12045389|FG001|NOT COMPLETED|Overall Study||2
10879567|NCT03976401|12045401|FG000|STARTED|Overall Study||19
10879568|NCT03976401|12045402|FG001|STARTED|Overall Study||20
10879569|NCT03976401|12045403|FG002|STARTED|Overall Study||20
10879570|NCT03976401|12045404|FG003|STARTED|Overall Study||21
10879571|NCT03976401|12045405|FG004|STARTED|Overall Study||20
10879572|NCT03976401|12045406|FG005|STARTED|Overall Study||10
10879573|NCT03976401|12045401|FG000|COMPLETED|Overall Study||16
10879574|NCT03976401|12045402|FG001|COMPLETED|Overall Study||16
10879575|NCT03976401|12045403|FG002|COMPLETED|Overall Study||15
10879577|NCT03976401|12045405|FG004|COMPLETED|Overall Study||19
10879578|NCT03976401|12045406|FG005|COMPLETED|Overall Study||9
10879579|NCT03976401|12045401|FG000|NOT COMPLETED|Overall Study||3
10879580|NCT03976401|12045402|FG001|NOT COMPLETED|Overall Study||4
10879581|NCT03976401|12045403|FG002|NOT COMPLETED|Overall Study||5
10879582|NCT03976401|12045404|FG003|NOT COMPLETED|Overall Study||2
10879583|NCT03976401|12045405|FG004|NOT COMPLETED|Overall Study||1
10879584|NCT03976401|12045406|FG005|NOT COMPLETED|Overall Study||1
10879585|NCT03967444|12045422|FG000|STARTED|Overall Study||19
10879586|NCT03967444|12045423|FG001|STARTED|Overall Study||40
10879587|NCT03967444|12045422|FG000|COMPLETED|Overall Study||18
10879588|NCT03967444|12045423|FG001|COMPLETED|Overall Study||38
10879589|NCT03967444|12045422|FG000|NOT COMPLETED|Overall Study||1
10879590|NCT03967444|12045423|FG001|NOT COMPLETED|Overall Study||2
10879591|NCT03966885|12045431|FG000|STARTED|Overall Study||78
10879592|NCT03966885|12045432|FG001|STARTED|Overall Study||82
10879593|NCT03966885|12045431|FG000|COMPLETED|Overall Study||56
10879594|NCT03966885|12045432|FG001|COMPLETED|Overall Study||62
10879595|NCT03966885|12045431|FG000|NOT COMPLETED|Overall Study||22
10879596|NCT03966885|12045432|FG001|NOT COMPLETED|Overall Study||20
10879597|NCT03964974|12045441|FG000|STARTED|Overall Study||30
10879598|NCT03964974|12045442|FG001|STARTED|Overall Study||27
10879599|NCT03964974|12045441|FG000|Assigned and Received Intervention|Overall Study||26
10879600|NCT03964974|12045442|FG001|Assigned and Received Intervention|Overall Study||21
10879601|NCT03964974|12045441|FG000|8 Week Follow Up|Overall Study||26
10879602|NCT03964974|12045442|FG001|8 Week Follow Up|Overall Study||22
10879603|NCT03964974|12045441|FG000|16 Week Follow Up|Overall Study||27
10879604|NCT03964974|12045442|FG001|16 Week Follow Up|Overall Study||22
10879605|NCT03964974|12045441|FG000|COMPLETED|Overall Study||27
10879606|NCT03964974|12045442|FG001|COMPLETED|Overall Study||22
10879607|NCT03964974|12045441|FG000|NOT COMPLETED|Overall Study||3
10879608|NCT03964974|12045442|FG001|NOT COMPLETED|Overall Study||5
10879609|NCT03963232|12045450|FG000|STARTED|Overall Study||259
10879610|NCT03963232|12045451|FG001|STARTED|Overall Study||261
10879611|NCT03963232|12045450|FG000|Received at Least One Dose of Study Drug|Overall Study||259
10879612|NCT03963232|12045451|FG001|Received at Least One Dose of Study Drug|Overall Study||261
10879613|NCT03963232|12045450|FG000|COMPLETED|Overall Study||242
10879614|NCT03963232|12045451|FG001|COMPLETED|Overall Study||245
10879615|NCT03963232|12045450|FG000|NOT COMPLETED|Overall Study||17
10879616|NCT03963232|12045451|FG001|NOT COMPLETED|Overall Study||16
10879617|NCT03960957|12045460|FG000|STARTED|Overall Study||224
10879618|NCT03960957|12045461|FG001|STARTED|Overall Study||77
10879619|NCT03960957|12045460|FG000|COMPLETED|Overall Study||216
10879620|NCT03960957|12045461|FG001|COMPLETED|Overall Study||71
10879621|NCT03960957|12045460|FG000|NOT COMPLETED|Overall Study||8
10879622|NCT03960957|12045461|FG001|NOT COMPLETED|Overall Study||6
10879623|NCT03958331|12045470|FG000|STARTED|Overall Study||21
10879624|NCT03958331|12045471|FG001|STARTED|Overall Study||19
10879625|NCT03958331|12045472|FG002|STARTED|Overall Study||64
10879626|NCT03958331|12045470|FG000|COMPLETED|Overall Study||14
10879627|NCT03958331|12045471|FG001|COMPLETED|Overall Study||17
10879628|NCT03958331|12045472|FG002|COMPLETED|Overall Study||47
10879629|NCT03958331|12045470|FG000|NOT COMPLETED|Overall Study||7
10879630|NCT03958331|12045471|FG001|NOT COMPLETED|Overall Study||2
10879631|NCT03958331|12045472|FG002|NOT COMPLETED|Overall Study||17
10879632|NCT03955471|12045478|FG000|STARTED|Overall Study||41
10879633|NCT03955471|12045478|FG000|COMPLETED|Overall Study||1
10879634|NCT03955471|12045478|FG000|NOT COMPLETED|Overall Study||40
10879635|NCT03950674|12045484|FG000|STARTED|Overall Study||25
10879636|NCT03950674|12045485|FG001|STARTED|Overall Study||15
10879637|NCT03950674|12045484|FG000|Treated|Overall Study||25
10879638|NCT03950674|12045485|FG001|Treated|Overall Study||15
10879639|NCT03950674|12045484|FG000|Switched to Pembrolizumab|Overall Study||0
10879640|NCT03950674|12045485|FG001|Switched to Pembrolizumab|Overall Study||4
10879641|NCT03950674|12045484|FG000|COMPLETED|Overall Study||0
10879642|NCT03950674|12045485|FG001|COMPLETED|Overall Study||0
10879643|NCT03950674|12045484|FG000|NOT COMPLETED|Overall Study||25
10879644|NCT03950674|12045485|FG001|NOT COMPLETED|Overall Study||15
10879645|NCT03948698|12045492|FG000|STARTED|Overall Study||4749072
10879646|NCT03948698|12045492|FG000|COMPLETED|Overall Study||4749072
10879647|NCT03948698|12045492|FG000|NOT COMPLETED|Overall Study||0
10879648|NCT03948581|12045498|FG000|STARTED|Overall Study||51
10879649|NCT03948581|12045499|FG001|STARTED|Overall Study||51
10879650|NCT03948581|12045498|FG000|COMPLETED|Overall Study||51
10879651|NCT03948581|12045499|FG001|COMPLETED|Overall Study||50
10879652|NCT03948581|12045498|FG000|NOT COMPLETED|Overall Study||0
10879653|NCT03948581|12045499|FG001|NOT COMPLETED|Overall Study||1
10879654|NCT03943290|12045514|FG000|STARTED|Overall Study||7
10879655|NCT03943290|12045515|FG001|STARTED|Overall Study||1
10879656|NCT03943290|12045516|FG002|STARTED|Overall Study||13
10879657|NCT03943290|12045517|FG003|STARTED|Overall Study||6
10879658|NCT03943290|12045518|FG004|STARTED|Overall Study||7
10879659|NCT03943290|12045519|FG005|STARTED|Overall Study||6
10879660|NCT03943290|12045520|FG006|STARTED|Overall Study||6
10879661|NCT03943290|12045521|FG007|STARTED|Overall Study||8
10879662|NCT03943290|12045522|FG008|STARTED|Overall Study||8
10879663|NCT03943290|12045514|FG000|COMPLETED|Overall Study||0
10879664|NCT03943290|12045515|FG001|COMPLETED|Overall Study||0
10879665|NCT03943290|12045516|FG002|COMPLETED|Overall Study||0
10879666|NCT03943290|12045517|FG003|COMPLETED|Overall Study||0
10879667|NCT03943290|12045518|FG004|COMPLETED|Overall Study||0
10879668|NCT03943290|12045519|FG005|COMPLETED|Overall Study||0
10879669|NCT03943290|12045520|FG006|COMPLETED|Overall Study||0
10879670|NCT03943290|12045521|FG007|COMPLETED|Overall Study||0
10879671|NCT03943290|12045522|FG008|COMPLETED|Overall Study||0
10879672|NCT03943290|12045514|FG000|NOT COMPLETED|Overall Study||7
10879673|NCT03943290|12045515|FG001|NOT COMPLETED|Overall Study||1
10879674|NCT03943290|12045516|FG002|NOT COMPLETED|Overall Study||13
10879675|NCT03943290|12045517|FG003|NOT COMPLETED|Overall Study||6
10879676|NCT03943290|12045518|FG004|NOT COMPLETED|Overall Study||7
10879677|NCT03943290|12045519|FG005|NOT COMPLETED|Overall Study||6
10879678|NCT03943290|12045520|FG006|NOT COMPLETED|Overall Study||6
10879679|NCT03943290|12045521|FG007|NOT COMPLETED|Overall Study||8
10879680|NCT03943290|12045522|FG008|NOT COMPLETED|Overall Study||8
10879681|NCT03938545|12045559|FG000|STARTED|Overall Study||18
10879682|NCT03938545|12045560|FG001|STARTED|Overall Study||19
10879683|NCT03938545|12045561|FG002|STARTED|Overall Study||10
10879684|NCT03938545|12045562|FG003|STARTED|Overall Study||18
10879685|NCT03938545|12045559|FG000|COMPLETED|Overall Study||10
10879686|NCT03938545|12045560|FG001|COMPLETED|Overall Study||14
10879687|NCT03938545|12045561|FG002|COMPLETED|Overall Study||7
10879688|NCT03938545|12045562|FG003|COMPLETED|Overall Study||13
10879689|NCT03938545|12045559|FG000|NOT COMPLETED|Overall Study||8
10879690|NCT03938545|12045560|FG001|NOT COMPLETED|Overall Study||5
10879691|NCT03938545|12045561|FG002|NOT COMPLETED|Overall Study||3
10879692|NCT03938545|12045562|FG003|NOT COMPLETED|Overall Study||5
10879693|NCT03933449|12045574|FG000|STARTED|Overall Study||62
10879694|NCT03933449|12045575|FG001|STARTED|Overall Study||61
10879695|NCT03933449|12045574|FG000|Treated|Overall Study||62
10879696|NCT03933449|12045575|FG001|Treated|Overall Study||59
10879697|NCT03933449|12045574|FG000|COMPLETED|Overall Study||0
10879698|NCT03933449|12045575|FG001|COMPLETED|Overall Study||0
10879699|NCT03933449|12045574|FG000|NOT COMPLETED|Overall Study||62
10879700|NCT03933449|12045575|FG001|NOT COMPLETED|Overall Study||61
10879701|NCT03930771|12045581|FG000|STARTED|Overall Study||1
10879702|NCT03930771|12045581|FG000|COMPLETED|Overall Study||1
10879703|NCT03930771|12045581|FG000|NOT COMPLETED|Overall Study||0
10879704|NCT03929224|12045587|FG000|STARTED|Overall Study||8
10879705|NCT03929224|12045588|FG001|STARTED|Overall Study||9
10879706|NCT03929224|12045587|FG000|COMPLETED|Overall Study||8
10879707|NCT03929224|12045588|FG001|COMPLETED|Overall Study||9
10879708|NCT03929224|12045587|FG000|NOT COMPLETED|Overall Study||0
10879709|NCT03929224|12045588|FG001|NOT COMPLETED|Overall Study||0
10879710|NCT03927482|12045598|FG000|STARTED|Overall Study||118
10879711|NCT03927482|12045599|FG001|STARTED|Overall Study||121
10879712|NCT03927482|12045598|FG000|COMPLETED|Overall Study||110
10879713|NCT03927482|12045599|FG001|COMPLETED|Overall Study||115
10879714|NCT03927482|12045598|FG000|NOT COMPLETED|Overall Study||8
10879715|NCT03927482|12045599|FG001|NOT COMPLETED|Overall Study||6
10879716|NCT03926169|12045608|FG000|STARTED|Period A||82
10879717|NCT03926169|12045609|FG001|STARTED|Period A||80
10879718|NCT03926169|12045610|FG002|STARTED|Period A||81
10879719|NCT03926169|12045608|FG000|Never Received Study Drug|Period A||0
10879720|NCT03926169|12045609|FG001|Never Received Study Drug|Period A||0
10879721|NCT03926169|12045610|FG002|Never Received Study Drug|Period A||1
10879722|NCT03926169|12045608|FG000|COMPLETED|Period A||74
10879723|NCT03926169|12045609|FG001|COMPLETED|Period A||70
10879724|NCT03926169|12045610|FG002|COMPLETED|Period A||75
10879725|NCT03926169|12045608|FG000|NOT COMPLETED|Period A||8
10879726|NCT03926169|12045609|FG001|NOT COMPLETED|Period A||10
10879727|NCT03926169|12045610|FG002|NOT COMPLETED|Period A||6
10879728|NCT03926169|12045608|FG000|STARTED|Period B||74
10879729|NCT03926169|12045609|FG001|STARTED|Period B||70
10879730|NCT03926169|12045610|FG002|STARTED|Period B||75
10879731|NCT03926169|12045608|FG000|Entered Period B and Received Study Drug|Period B||74
10879732|NCT03926169|12045609|FG001|Entered Period B and Received Study Drug|Period B||70
10879733|NCT03926169|12045610|FG002|Entered Period B and Received Study Drug|Period B||74
10879734|NCT03926169|12045608|FG000|COMPLETED|Period B||4
10879735|NCT03926169|12045609|FG001|COMPLETED|Period B||7
10879736|NCT03926169|12045610|FG002|COMPLETED|Period B||4
10879737|NCT03926169|12045608|FG000|NOT COMPLETED|Period B||70
10879738|NCT03926169|12045609|FG001|NOT COMPLETED|Period B||63
10879739|NCT03926169|12045610|FG002|NOT COMPLETED|Period B||71
10879740|NCT03922945|12045624|FG000|STARTED|Overall Study||56
10879741|NCT03922945|12045625|FG001|STARTED|Overall Study||54
10879742|NCT03922945|12045626|FG002|STARTED|Overall Study||113
10879743|NCT03922945|12045624|FG000|COMPLETED|Overall Study||29
10879744|NCT03922945|12045625|FG001|COMPLETED|Overall Study||37
10879745|NCT03922945|12045626|FG002|COMPLETED|Overall Study||73
10879746|NCT03922945|12045624|FG000|NOT COMPLETED|Overall Study||27
10879747|NCT03922945|12045625|FG001|NOT COMPLETED|Overall Study||17
10879748|NCT03922945|12045626|FG002|NOT COMPLETED|Overall Study||40
10879749|NCT03920280|12045639|FG000|STARTED|Overall Study||41
10879750|NCT03920280|12045640|FG001|STARTED|Overall Study||78
10879751|NCT03920280|12045639|FG000|COMPLETED|Overall Study||38
10879752|NCT03920280|12045640|FG001|COMPLETED|Overall Study||72
10879753|NCT03920280|12045639|FG000|NOT COMPLETED|Overall Study||3
10879754|NCT03920280|12045640|FG001|NOT COMPLETED|Overall Study||6
10879755|NCT03917654|12045661|FG000|STARTED|Year 1||15
10879756|NCT03917654|12045662|FG001|STARTED|Year 1||15
10879757|NCT03917654|12045663|FG002|STARTED|Year 1||15
10879758|NCT03917654|12045664|FG003|STARTED|Year 1||15
10879759|NCT03917654|12045665|FG004|STARTED|Year 1||99
10879760|NCT03917654|12045666|FG005|STARTED|Year 1||87
10879761|NCT03917654|12045667|FG006|STARTED|Year 1||192
10879762|NCT03917654|12045668|FG007|STARTED|Year 1||177
10879763|NCT03917654|12045669|FG008|STARTED|Year 1||227
10879764|NCT03917654|12045670|FG009|STARTED|Year 1||267
10879765|NCT03917654|12045671|FG010|STARTED|Year 1||97
10879766|NCT03917654|12045672|FG011|STARTED|Year 1||95
10879767|NCT03917654|12045661|FG000|COMPLETED|Year 1||14
10879768|NCT03917654|12045662|FG001|COMPLETED|Year 1||13
10879769|NCT03917654|12045663|FG002|COMPLETED|Year 1||13
10879770|NCT03917654|12045664|FG003|COMPLETED|Year 1||15
10879771|NCT03917654|12045665|FG004|COMPLETED|Year 1||94
10879772|NCT03917654|12045666|FG005|COMPLETED|Year 1||82
10879773|NCT03917654|12045667|FG006|COMPLETED|Year 1||173
10879774|NCT03917654|12045668|FG007|COMPLETED|Year 1||162
10879775|NCT03917654|12045669|FG008|COMPLETED|Year 1||218
10879776|NCT03917654|12045670|FG009|COMPLETED|Year 1||257
10879777|NCT03917654|12045671|FG010|COMPLETED|Year 1||92
10879778|NCT03917654|12045672|FG011|COMPLETED|Year 1||87
10879779|NCT03917654|12045661|FG000|NOT COMPLETED|Year 1||1
10879780|NCT03917654|12045662|FG001|NOT COMPLETED|Year 1||2
10879781|NCT03917654|12045663|FG002|NOT COMPLETED|Year 1||2
10879782|NCT03917654|12045664|FG003|NOT COMPLETED|Year 1||0
10879783|NCT03917654|12045665|FG004|NOT COMPLETED|Year 1||5
10879784|NCT03917654|12045666|FG005|NOT COMPLETED|Year 1||5
10879785|NCT03917654|12045667|FG006|NOT COMPLETED|Year 1||19
10879786|NCT03917654|12045668|FG007|NOT COMPLETED|Year 1||15
10879787|NCT03917654|12045669|FG008|NOT COMPLETED|Year 1||9
10879788|NCT03917654|12045670|FG009|NOT COMPLETED|Year 1||10
10879789|NCT03917654|12045671|FG010|NOT COMPLETED|Year 1||5
10879790|NCT03917654|12045672|FG011|NOT COMPLETED|Year 1||8
10879791|NCT03917654|12045661|FG000|STARTED|Year 2||13
10879792|NCT03917654|12045662|FG001|STARTED|Year 2||10
10879793|NCT03917654|12045663|FG002|STARTED|Year 2||13
10879794|NCT03917654|12045664|FG003|STARTED|Year 2||14
10879795|NCT03917654|12045665|FG004|STARTED|Year 2||86
10879796|NCT03917654|12045666|FG005|STARTED|Year 2||77
10879797|NCT03917654|12045667|FG006|STARTED|Year 2||152
10879798|NCT03917654|12045668|FG007|STARTED|Year 2||147
10879799|NCT03917654|12045669|FG008|STARTED|Year 2||199
10879800|NCT03917654|12045670|FG009|STARTED|Year 2||238
10879801|NCT03917654|12045671|FG010|STARTED|Year 2||90
10879802|NCT03917654|12045672|FG011|STARTED|Year 2||87
10879803|NCT03917654|12045661|FG000|Did Not Rescreen|Year 2||1
10879804|NCT03917654|12045662|FG001|Did Not Rescreen|Year 2||3
10879805|NCT03917654|12045663|FG002|Did Not Rescreen|Year 2||0
10879806|NCT03917654|12045664|FG003|Did Not Rescreen|Year 2||1
10879807|NCT03917654|12045665|FG004|Did Not Rescreen|Year 2||8
10879808|NCT03917654|12045666|FG005|Did Not Rescreen|Year 2||5
10879809|NCT03917654|12045667|FG006|Did Not Rescreen|Year 2||21
10879810|NCT03917654|12045668|FG007|Did Not Rescreen|Year 2||15
10879811|NCT03917654|12045669|FG008|Did Not Rescreen|Year 2||19
10879812|NCT03917654|12045670|FG009|Did Not Rescreen|Year 2||19
10879813|NCT03917654|12045671|FG010|Did Not Rescreen|Year 2||2
10879814|NCT03917654|12045672|FG011|Did Not Rescreen|Year 2||0
10879815|NCT03917654|12045661|FG000|COMPLETED|Year 2||10
10879816|NCT03917654|12045662|FG001|COMPLETED|Year 2||9
10879817|NCT03917654|12045663|FG002|COMPLETED|Year 2||13
10879818|NCT03917654|12045664|FG003|COMPLETED|Year 2||14
10879819|NCT03917654|12045665|FG004|COMPLETED|Year 2||82
10879820|NCT03917654|12045666|FG005|COMPLETED|Year 2||75
10879821|NCT03917654|12045667|FG006|COMPLETED|Year 2||138
10879822|NCT03917654|12045668|FG007|COMPLETED|Year 2||139
10879823|NCT03917654|12045669|FG008|COMPLETED|Year 2||185
10879824|NCT03917654|12045670|FG009|COMPLETED|Year 2||226
10879825|NCT03917654|12045671|FG010|COMPLETED|Year 2||89
10879826|NCT03917654|12045672|FG011|COMPLETED|Year 2||83
10879827|NCT03917654|12045661|FG000|NOT COMPLETED|Year 2||3
10879828|NCT03917654|12045662|FG001|NOT COMPLETED|Year 2||1
10879829|NCT03917654|12045663|FG002|NOT COMPLETED|Year 2||0
10879830|NCT03917654|12045664|FG003|NOT COMPLETED|Year 2||0
10879831|NCT03917654|12045665|FG004|NOT COMPLETED|Year 2||4
10879832|NCT03917654|12045666|FG005|NOT COMPLETED|Year 2||2
10879833|NCT03917654|12045667|FG006|NOT COMPLETED|Year 2||14
10879834|NCT03917654|12045668|FG007|NOT COMPLETED|Year 2||8
10879835|NCT03917654|12045669|FG008|NOT COMPLETED|Year 2||14
10879836|NCT03917654|12045670|FG009|NOT COMPLETED|Year 2||12
10879837|NCT03917654|12045671|FG010|NOT COMPLETED|Year 2||1
10879838|NCT03917654|12045672|FG011|NOT COMPLETED|Year 2||4
10879839|NCT03917472|12045700|FG000|STARTED|Overall Study||346
10879840|NCT03917472|12045701|FG001|STARTED|Overall Study||171
10879841|NCT03917472|12045700|FG000|COMPLETED|Overall Study||311
10879842|NCT03917472|12045701|FG001|COMPLETED|Overall Study||156
10879843|NCT03917472|12045700|FG000|NOT COMPLETED|Overall Study||35
10879844|NCT03917472|12045701|FG001|NOT COMPLETED|Overall Study||15
10879845|NCT03912805|12045710|FG000|STARTED|Overall Study||19
10879846|NCT03912805|12045711|FG001|STARTED|Overall Study||19
10879847|NCT03912805|12045710|FG000|COMPLETED|Overall Study||19
10879848|NCT03912805|12045711|FG001|COMPLETED|Overall Study||19
10879849|NCT03912805|12045710|FG000|NOT COMPLETED|Overall Study||0
10879850|NCT03912805|12045711|FG001|NOT COMPLETED|Overall Study||0
10879851|NCT03912584|12045717|FG000|STARTED|Overall Study||10
10879852|NCT03912584|12045717|FG000|COMPLETED|Overall Study||10
10879853|NCT03912584|12045717|FG000|NOT COMPLETED|Overall Study||0
10879854|NCT03911154|12045724|FG000|STARTED|Overall Study||9
10879855|NCT03911154|12045724|FG000|Continuous Fixed Interval|Overall Study||9
10879856|NCT03911154|12045724|FG000|Block|Overall Study||9
10879857|NCT03911154|12045724|FG000|In-Phase Adjustable|Overall Study||9
10879858|NCT03911154|12045724|FG000|SHAM|Overall Study||9
10879859|NCT03911154|12045724|FG000|COMPLETED|Overall Study||8
10879860|NCT03911154|12045724|FG000|NOT COMPLETED|Overall Study||1
10879861|NCT03905694|12045731|FG000|STARTED|Primary Analysis Period||18
10879862|NCT03905694|12045731|FG000|COMPLETED|Primary Analysis Period||18
10879863|NCT03905694|12045731|FG000|NOT COMPLETED|Primary Analysis Period||0
10879864|NCT03905694|12045731|FG000|STARTED|Long-term Extension Period||18
10879865|NCT03905694|12045731|FG000|COMPLETED|Long-term Extension Period||0
10879866|NCT03905694|12045731|FG000|NOT COMPLETED|Long-term Extension Period||18
10879867|NCT03905135|12045737|FG000|STARTED|Dose Escalation||6
10879868|NCT03905135|12045738|FG001|STARTED|Dose Escalation||2
10879869|NCT03905135|12045737|FG000|COMPLETED|Dose Escalation||1
10879870|NCT03905135|12045738|FG001|COMPLETED|Dose Escalation||0
10879871|NCT03905135|12045737|FG000|NOT COMPLETED|Dose Escalation||5
10879872|NCT03905135|12045738|FG001|NOT COMPLETED|Dose Escalation||2
10879873|NCT03905135|12045737|FG000|STARTED|Dose Expansion||0
10879874|NCT03905135|12045738|FG001|STARTED|Dose Expansion||0
10879875|NCT03905135|12045737|FG000|COMPLETED|Dose Expansion||0
10879876|NCT03905135|12045738|FG001|COMPLETED|Dose Expansion||0
10879877|NCT03905135|12045737|FG000|NOT COMPLETED|Dose Expansion||0
10879878|NCT03905135|12045738|FG001|NOT COMPLETED|Dose Expansion||0
10879879|NCT03904446|12045748|FG000|STARTED|Overall Study||80
10879880|NCT03904446|12045749|FG001|STARTED|Overall Study||80
10879881|NCT03904446|12045748|FG000|COMPLETED|Overall Study||80
10879882|NCT03904446|12045749|FG001|COMPLETED|Overall Study||80
10879883|NCT03904446|12045748|FG000|NOT COMPLETED|Overall Study||0
10879884|NCT03904446|12045749|FG001|NOT COMPLETED|Overall Study||0
10879885|NCT03901300|12045757|FG000|STARTED|Overall Study|Children were enrolled study participants. Parents were not study participants.|35
10879886|NCT03901300|12045758|FG001|STARTED|Overall Study||37
10879887|NCT03901300|12045757|FG000|COMPLETED|Overall Study||32
10879888|NCT03901300|12045758|FG001|COMPLETED|Overall Study||37
10879889|NCT03901300|12045757|FG000|NOT COMPLETED|Overall Study||3
10879890|NCT03901300|12045758|FG001|NOT COMPLETED|Overall Study||0
10879891|NCT03900624|12045766|FG000|STARTED|Overall Study||61
10879892|NCT03900624|12045767|FG001|STARTED|Overall Study||31
10879893|NCT03900624|12045766|FG000|COMPLETED|Overall Study||61
10879894|NCT03900624|12045767|FG001|COMPLETED|Overall Study||31
10879895|NCT03900624|12045766|FG000|NOT COMPLETED|Overall Study||0
10879896|NCT03900624|12045767|FG001|NOT COMPLETED|Overall Study||0
10879897|NCT03895801|12045778|FG000|STARTED|Overall Study||18
10879898|NCT03895801|12045779|FG001|STARTED|Overall Study||24
10879899|NCT03895801|12045780|FG002|STARTED|Overall Study||15
10879900|NCT03895801|12045778|FG000|COMPLETED|Overall Study||16
10879901|NCT03895801|12045779|FG001|COMPLETED|Overall Study||22
10879902|NCT03895801|12045780|FG002|COMPLETED|Overall Study||13
10879903|NCT03895801|12045778|FG000|NOT COMPLETED|Overall Study||2
10879904|NCT03895801|12045779|FG001|NOT COMPLETED|Overall Study||2
10879905|NCT03895801|12045780|FG002|NOT COMPLETED|Overall Study||2
10879906|NCT03894540|12045794|FG000|STARTED|Overall Study||1
10879907|NCT03894540|12045795|FG001|STARTED|Overall Study||1
10879908|NCT03894540|12045796|FG002|STARTED|Overall Study||1
10879909|NCT03894540|12045797|FG003|STARTED|Overall Study||4
10879910|NCT03894540|12045798|FG004|STARTED|Overall Study||11
10879911|NCT03894540|12045799|FG005|STARTED|Overall Study||4
10879912|NCT03894540|12045794|FG000|COMPLETED|Overall Study||0
10879913|NCT03894540|12045795|FG001|COMPLETED|Overall Study||0
10879914|NCT03894540|12045796|FG002|COMPLETED|Overall Study||0
10879915|NCT03894540|12045797|FG003|COMPLETED|Overall Study||0
10879916|NCT03894540|12045798|FG004|COMPLETED|Overall Study||0
10879917|NCT03894540|12045799|FG005|COMPLETED|Overall Study||0
10879918|NCT03894540|12045794|FG000|NOT COMPLETED|Overall Study||1
10879919|NCT03894540|12045795|FG001|NOT COMPLETED|Overall Study||1
10879920|NCT03894540|12045796|FG002|NOT COMPLETED|Overall Study||1
10879921|NCT03894540|12045797|FG003|NOT COMPLETED|Overall Study||4
10879922|NCT03894540|12045798|FG004|NOT COMPLETED|Overall Study||11
10879923|NCT03894540|12045799|FG005|NOT COMPLETED|Overall Study||4
10879924|NCT03889886|12045821|FG000|STARTED|Overall Study||76
10879925|NCT03889886|12045822|FG001|STARTED|Overall Study||77
10879926|NCT03889886|12045823|FG002|STARTED|Overall Study||76
10879927|NCT03889886|12045824|FG003|STARTED|Overall Study||76
10879928|NCT03889886|12045821|FG000|COMPLETED|Overall Study||76
10879929|NCT03889886|12045822|FG001|COMPLETED|Overall Study||76
10879930|NCT03889886|12045823|FG002|COMPLETED|Overall Study||75
10879931|NCT03889886|12045824|FG003|COMPLETED|Overall Study||69
10879932|NCT03889886|12045821|FG000|NOT COMPLETED|Overall Study||0
10879933|NCT03889886|12045822|FG001|NOT COMPLETED|Overall Study||1
10879934|NCT03889886|12045823|FG002|NOT COMPLETED|Overall Study||1
10879935|NCT03889886|12045824|FG003|NOT COMPLETED|Overall Study||7
10879936|NCT03887533|12045836|FG000|STARTED|Overall Study||1
10879937|NCT03887533|12045837|FG001|STARTED|Overall Study||1
10879938|NCT03887533|12045836|FG000|COMPLETED|Overall Study||1
10879939|NCT03887533|12045837|FG001|COMPLETED|Overall Study||1
10879940|NCT03887533|12045836|FG000|NOT COMPLETED|Overall Study||0
10879941|NCT03887533|12045837|FG001|NOT COMPLETED|Overall Study||0
10879942|NCT03875664|12045845|FG000|STARTED|Overall Study||37
10879943|NCT03875664|12045846|FG001|STARTED|Overall Study||35
10879944|NCT03875664|12045845|FG000|COMPLETED|Overall Study|vaginal surgery n=18; vaginal + abdominal surgery n=19|37
10879945|NCT03875664|12045846|FG001|COMPLETED|Overall Study|Vaginal surgery n=18; vaginal + abdominal surgery n=17|35
10879946|NCT03875664|12045845|FG000|NOT COMPLETED|Overall Study||0
10879947|NCT03875664|12045846|FG001|NOT COMPLETED|Overall Study||0
10879948|NCT03875092|12045854|FG000|STARTED|Overall Study||65
10879949|NCT03875092|12045855|FG001|STARTED|Overall Study||60
10879950|NCT03875092|12045854|FG000|Treated|Overall Study||65
10879951|NCT03875092|12045855|FG001|Treated|Overall Study||60
10879952|NCT03875092|12045854|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
10880043|NCT03848832|12045981|FG001|STARTED|Overall Study||9
10879953|NCT03875092|12045855|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||38
10879954|NCT03875092|12045854|FG000|COMPLETED|Overall Study||0
10879955|NCT03875092|12045855|FG001|COMPLETED|Overall Study||0
10879956|NCT03875092|12045854|FG000|NOT COMPLETED|Overall Study||65
10879957|NCT03875092|12045855|FG001|NOT COMPLETED|Overall Study||60
10879958|NCT03874754|12045863|FG000|STARTED|Overall Study||22
10879959|NCT03874754|12045864|FG001|STARTED|Overall Study||12
10879960|NCT03874754|12045863|FG000|COMPLETED|Overall Study||14
10879961|NCT03874754|12045864|FG001|COMPLETED|Overall Study||6
10879962|NCT03874754|12045863|FG000|NOT COMPLETED|Overall Study||8
10879963|NCT03874754|12045864|FG001|NOT COMPLETED|Overall Study||6
10879964|NCT03873337|12045871|FG000|STARTED|Overall Study||34
10879965|NCT03873337|12045871|FG000|COMPLETED|Overall Study||22
10879966|NCT03873337|12045871|FG000|NOT COMPLETED|Overall Study||12
10879967|NCT03870048|12045875|FG000|STARTED|SHAM Effects on Pain and Fatigue||6
10879968|NCT03870048|12045875|FG000|COMPLETED|SHAM Effects on Pain and Fatigue||6
10879969|NCT03870048|12045875|FG000|NOT COMPLETED|SHAM Effects on Pain and Fatigue||0
10879970|NCT03870048|12045875|FG000|STARTED|tDCS Effects on Pain and Fatigue||6
10879971|NCT03870048|12045875|FG000|COMPLETED|tDCS Effects on Pain and Fatigue||6
10879972|NCT03870048|12045875|FG000|NOT COMPLETED|tDCS Effects on Pain and Fatigue||0
10879973|NCT03869450|12045884|FG000|STARTED|Overall Study||31
10879974|NCT03869450|12045885|FG001|STARTED|Overall Study||25
10879975|NCT03869450|12045886|FG002|STARTED|Overall Study||34
10879976|NCT03869450|12045884|FG000|COMPLETED|Overall Study||30
10879977|NCT03869450|12045885|FG001|COMPLETED|Overall Study||23
10879978|NCT03869450|12045886|FG002|COMPLETED|Overall Study||34
10879979|NCT03869450|12045884|FG000|NOT COMPLETED|Overall Study||1
10879980|NCT03869450|12045885|FG001|NOT COMPLETED|Overall Study||2
10879981|NCT03869450|12045886|FG002|NOT COMPLETED|Overall Study||0
10879982|NCT03866538|12045896|FG000|STARTED|Overall Study||0
10879983|NCT03866538|12045897|FG001|STARTED|Overall Study||1
10879984|NCT03866538|12045896|FG000|COMPLETED|Overall Study||0
10879985|NCT03866538|12045897|FG001|COMPLETED|Overall Study||1
10879986|NCT03866538|12045896|FG000|NOT COMPLETED|Overall Study||0
10879987|NCT03866538|12045897|FG001|NOT COMPLETED|Overall Study||0
10879988|NCT03866473|12045905|FG000|STARTED|Phase 1||69
10879989|NCT03866473|12045906|FG001|STARTED|Phase 1||66
10879990|NCT03866473|12045905|FG000|COMPLETED|Phase 1||68
10879991|NCT03866473|12045906|FG001|COMPLETED|Phase 1||66
10879992|NCT03866473|12045905|FG000|NOT COMPLETED|Phase 1||1
10879993|NCT03866473|12045906|FG001|NOT COMPLETED|Phase 1||0
10879994|NCT03866473|12045905|FG000|STARTED|Phase 2|Three participants completed the study by receiving alternate treatment for diabetic macular edema in phase 1 and 3 were dropped.|62
10879995|NCT03866473|12045906|FG001|STARTED|Phase 2||61
10879996|NCT03866473|12045905|FG000|COMPLETED|Phase 2||60
10879997|NCT03866473|12045906|FG001|COMPLETED|Phase 2|One participant completed the study by receiving alternate treatment for diabetic macular edema in Phase 1 and 4 participants were dropped.|58
10879998|NCT03866473|12045905|FG000|NOT COMPLETED|Phase 2||2
10879999|NCT03866473|12045906|FG001|NOT COMPLETED|Phase 2||3
10880000|NCT03865732|12045918|FG000|STARTED|Overall Study||11
10880001|NCT03865732|12045919|FG001|STARTED|Overall Study||10
10880002|NCT03865732|12045918|FG000|COMPLETED|Overall Study||11
10880003|NCT03865732|12045919|FG001|COMPLETED|Overall Study||9
10880004|NCT03865732|12045918|FG000|NOT COMPLETED|Overall Study||0
10880005|NCT03865732|12045919|FG001|NOT COMPLETED|Overall Study||1
10880006|NCT03865654|12045926|FG000|STARTED|Overall Study||45
10880007|NCT03865654|12045926|FG000|COMPLETED|Overall Study||40
10880008|NCT03865654|12045926|FG000|NOT COMPLETED|Overall Study||5
10880009|NCT03864341|12045930|FG000|STARTED|Overall Study||40
10880010|NCT03864341|12045930|FG000|COMPLETED|Overall Study||39
10880011|NCT03864341|12045930|FG000|NOT COMPLETED|Overall Study||1
10880012|NCT03863834|12045934|FG000|STARTED|Overall Study||12
10880013|NCT03863834|12045934|FG000|COMPLETED|Overall Study||9
10880014|NCT03863834|12045934|FG000|NOT COMPLETED|Overall Study||3
10880015|NCT03860974|12045940|FG000|STARTED|Overall Study||49
10880016|NCT03860974|12045941|FG001|STARTED|Overall Study||51
10880017|NCT03860974|12045940|FG000|COMPLETED|Overall Study||49
10880018|NCT03860974|12045941|FG001|COMPLETED|Overall Study||51
10880019|NCT03860974|12045940|FG000|NOT COMPLETED|Overall Study||0
10880020|NCT03860974|12045941|FG001|NOT COMPLETED|Overall Study||0
10880021|NCT03853148|12045951|FG000|STARTED|Overall Study||10
10880022|NCT03853148|12045952|FG001|STARTED|Overall Study||10
10880023|NCT03853148|12045953|FG002|STARTED|Overall Study||10
10880024|NCT03853148|12045954|FG003|STARTED|Overall Study||20
10880025|NCT03853148|12045951|FG000|COMPLETED|Overall Study||5
10880026|NCT03853148|12045952|FG001|COMPLETED|Overall Study||2
10880027|NCT03853148|12045953|FG002|COMPLETED|Overall Study||2
10880028|NCT03853148|12045954|FG003|COMPLETED|Overall Study||15
10880029|NCT03853148|12045951|FG000|NOT COMPLETED|Overall Study||5
10880030|NCT03853148|12045952|FG001|NOT COMPLETED|Overall Study||8
10880031|NCT03853148|12045953|FG002|NOT COMPLETED|Overall Study||8
10880032|NCT03853148|12045954|FG003|NOT COMPLETED|Overall Study||5
10880033|NCT03852901|12045964|FG000|STARTED|Overall Study||21
10880034|NCT03852901|12045964|FG000|COMPLETED|Overall Study||20
10880035|NCT03852901|12045964|FG000|NOT COMPLETED|Overall Study||1
10880036|NCT03850444|12045970|FG000|STARTED|Overall Study||128
10880037|NCT03850444|12045971|FG001|STARTED|Overall Study||134
10880038|NCT03850444|12045970|FG000|COMPLETED|Overall Study||0
10880039|NCT03850444|12045971|FG001|COMPLETED|Overall Study||0
10880040|NCT03850444|12045970|FG000|NOT COMPLETED|Overall Study||128
10880041|NCT03850444|12045971|FG001|NOT COMPLETED|Overall Study||134
10880042|NCT03848832|12045980|FG000|STARTED|Overall Study||10
10880044|NCT03848832|12045982|FG002|STARTED|Overall Study||10
10880045|NCT03848832|12045980|FG000|COMPLETED|Overall Study||7
10880046|NCT03848832|12045981|FG001|COMPLETED|Overall Study||6
10880047|NCT03848832|12045982|FG002|COMPLETED|Overall Study||4
10880048|NCT03848832|12045980|FG000|NOT COMPLETED|Overall Study||3
10880049|NCT03848832|12045981|FG001|NOT COMPLETED|Overall Study||3
10880050|NCT03848832|12045982|FG002|NOT COMPLETED|Overall Study||6
10880051|NCT03844386|12045996|FG000|STARTED|Overall Study||7
10880052|NCT03844386|12045997|FG001|STARTED|Overall Study||7
10880053|NCT03844386|12045998|FG002|STARTED|Overall Study||8
10880054|NCT03844386|12045999|FG003|STARTED|Overall Study||4
10880055|NCT03844386|12045996|FG000|Completed Day 28|Overall Study||7
10880056|NCT03844386|12045997|FG001|Completed Day 28|Overall Study||7
10880057|NCT03844386|12045998|FG002|Completed Day 28|Overall Study||8
10880058|NCT03844386|12045999|FG003|Completed Day 28|Overall Study||3
10880059|NCT03844386|12045996|FG000|COMPLETED|Overall Study||7
10880060|NCT03844386|12045997|FG001|COMPLETED|Overall Study||7
10880061|NCT03844386|12045998|FG002|COMPLETED|Overall Study||7
10880062|NCT03844386|12045999|FG003|COMPLETED|Overall Study||3
10880063|NCT03844386|12045996|FG000|NOT COMPLETED|Overall Study||0
10880064|NCT03844386|12045997|FG001|NOT COMPLETED|Overall Study||0
10880065|NCT03844386|12045998|FG002|NOT COMPLETED|Overall Study||1
10880066|NCT03844386|12045999|FG003|NOT COMPLETED|Overall Study||1
10880067|NCT03839940|12046011|FG000|STARTED|Overall Study||20
10880068|NCT03839940|12046012|FG001|STARTED|Overall Study||19
10880069|NCT03839940|12046011|FG000|COMPLETED|Overall Study||16
10880070|NCT03839940|12046012|FG001|COMPLETED|Overall Study||17
10880071|NCT03839940|12046011|FG000|NOT COMPLETED|Overall Study||4
10880072|NCT03839940|12046012|FG001|NOT COMPLETED|Overall Study||2
10880073|NCT03839693|12046023|FG000|STARTED|Overall Study||25
10880074|NCT03839693|12046024|FG001|STARTED|Overall Study||30
10880075|NCT03839693|12046025|FG002|STARTED|Overall Study||20
10880076|NCT03839693|12046023|FG000|COMPLETED|Overall Study||23
10880077|NCT03839693|12046024|FG001|COMPLETED|Overall Study||28
10880078|NCT03839693|12046025|FG002|COMPLETED|Overall Study||16
10880079|NCT03839693|12046023|FG000|NOT COMPLETED|Overall Study||2
10880080|NCT03839693|12046024|FG001|NOT COMPLETED|Overall Study||2
10880081|NCT03839693|12046025|FG002|NOT COMPLETED|Overall Study||4
10880082|NCT03837743|12046035|FG000|STARTED|Overall Study||25
10880083|NCT03837743|12046035|FG000|DUR-928 Topical Solution Lesion|Overall Study||25
10880084|NCT03837743|12046035|FG000|Vehicle Topical Solution Lesion|Overall Study||25
10880085|NCT03837743|12046035|FG000|COMPLETED|Overall Study||22
10880086|NCT03837743|12046035|FG000|NOT COMPLETED|Overall Study||3
10880087|NCT03837184|12046043|FG000|STARTED|Overall Study||2
10880088|NCT03837184|12046043|FG000|COMPLETED|Overall Study||2
10880089|NCT03837184|12046043|FG000|NOT COMPLETED|Overall Study||0
10880090|NCT03834623|12046049|FG000|STARTED|Overall Study||11
10880091|NCT03834623|12046050|FG001|STARTED|Overall Study||12
10880092|NCT03834623|12046049|FG000|COMPLETED|Overall Study||11
10880093|NCT03834623|12046050|FG001|COMPLETED|Overall Study||11
10880094|NCT03834623|12046049|FG000|NOT COMPLETED|Overall Study||0
10880095|NCT03834623|12046050|FG001|NOT COMPLETED|Overall Study||1
10880096|NCT03834168|12046058|FG000|STARTED|Overall Study||19
10880097|NCT03834168|12046059|FG001|STARTED|Overall Study||23
10880098|NCT03834168|12046058|FG000|Total Participant Screened for the Purpose of Eligibility|Overall Study||22
10880099|NCT03834168|12046059|FG001|Total Participant Screened for the Purpose of Eligibility|Overall Study||30
10880100|NCT03834168|12046058|FG000|Ineligible Participants|Overall Study||3
10880101|NCT03834168|12046059|FG001|Ineligible Participants|Overall Study||7
10880102|NCT03834168|12046058|FG000|Unable to Complete the Protocol|Overall Study||0
10880103|NCT03834168|12046059|FG001|Unable to Complete the Protocol|Overall Study||1
10880104|NCT03834168|12046058|FG000|Study Dropouts|Overall Study||1
10880105|NCT03834168|12046059|FG001|Study Dropouts|Overall Study||0
10880106|NCT03834168|12046058|FG000|Participants Received 5 Days of Standardized Meals|Overall Study||19
10880107|NCT03834168|12046059|FG001|Participants Received 5 Days of Standardized Meals|Overall Study||23
10880108|NCT03834168|12046058|FG000|Participants Returned for the 24-h Inpatient Protocol|Overall Study||18
10880109|NCT03834168|12046059|FG001|Participants Returned for the 24-h Inpatient Protocol|Overall Study||23
10880110|NCT03834168|12046058|FG000|COMPLETED|Overall Study||18
10880111|NCT03834168|12046059|FG001|COMPLETED|Overall Study||22
10880112|NCT03834168|12046058|FG000|NOT COMPLETED|Overall Study||1
10880113|NCT03834168|12046059|FG001|NOT COMPLETED|Overall Study||1
10880114|NCT03834142|12046067|FG000|STARTED|Overall Study||10
10880115|NCT03834142|12046068|FG001|STARTED|Overall Study||10
10880116|NCT03834142|12046067|FG000|COMPLETED|Overall Study||10
10880117|NCT03834142|12046068|FG001|COMPLETED|Overall Study||10
10880118|NCT03834142|12046067|FG000|NOT COMPLETED|Overall Study||0
10880119|NCT03834142|12046068|FG001|NOT COMPLETED|Overall Study||0
10880120|NCT03833817|12046079|FG000|STARTED|Overall Study||14
10880121|NCT03833817|12046080|FG001|STARTED|Overall Study||14
10880122|NCT03833817|12046079|FG000|COMPLETED|Overall Study|*Note: Whereas 8 patients completed the study, 1 additional patient was able to be included in the analysis of most patient outcome measures as they completed the applicable assessments for those measures prior to being lost to follow-up.|8
10880123|NCT03833817|12046080|FG001|COMPLETED|Overall Study||8
10880124|NCT03833817|12046079|FG000|NOT COMPLETED|Overall Study||6
10880125|NCT03833817|12046080|FG001|NOT COMPLETED|Overall Study||6
10880126|NCT03832114|12046088|FG000|STARTED|Run-in Phase||16
10880127|NCT03832114|12046089|FG001|STARTED|Run-in Phase||11
10880128|NCT03832114|12046090|FG002|STARTED|Run-in Phase||0
10880129|NCT03832114|12046091|FG003|STARTED|Run-in Phase||0
10880130|NCT03832114|12046088|FG000|COMPLETED|Run-in Phase||16
10880131|NCT03832114|12046089|FG001|COMPLETED|Run-in Phase||11
10880132|NCT03832114|12046090|FG002|COMPLETED|Run-in Phase||0
10880133|NCT03832114|12046091|FG003|COMPLETED|Run-in Phase||0
10880134|NCT03832114|12046088|FG000|NOT COMPLETED|Run-in Phase||0
10880135|NCT03832114|12046089|FG001|NOT COMPLETED|Run-in Phase||0
10880136|NCT03832114|12046090|FG002|NOT COMPLETED|Run-in Phase||0
10880137|NCT03832114|12046091|FG003|NOT COMPLETED|Run-in Phase||0
10880138|NCT03832114|12046088|FG000|STARTED|Dose Escalation/200mg b.i.d Treatment||0
10880139|NCT03832114|12046089|FG001|STARTED|Dose Escalation/200mg b.i.d Treatment||0
10880140|NCT03832114|12046090|FG002|STARTED|Dose Escalation/200mg b.i.d Treatment||16
10880141|NCT03832114|12046091|FG003|STARTED|Dose Escalation/200mg b.i.d Treatment||11
10880142|NCT03832114|12046088|FG000|COMPLETED|Dose Escalation/200mg b.i.d Treatment||0
10880143|NCT03832114|12046089|FG001|COMPLETED|Dose Escalation/200mg b.i.d Treatment||0
10880144|NCT03832114|12046090|FG002|COMPLETED|Dose Escalation/200mg b.i.d Treatment||16
10880145|NCT03832114|12046091|FG003|COMPLETED|Dose Escalation/200mg b.i.d Treatment||11
10880146|NCT03832114|12046088|FG000|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0
10880147|NCT03832114|12046089|FG001|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0
10880148|NCT03832114|12046090|FG002|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0
10880149|NCT03832114|12046091|FG003|NOT COMPLETED|Dose Escalation/200mg b.i.d Treatment||0
10880150|NCT03824405|12046104|FG000|STARTED|Overall Study||100
10880151|NCT03824405|12046105|FG001|STARTED|Overall Study||100
10880152|NCT03824405|12046104|FG000|COMPLETED|Overall Study||65
10880153|NCT03824405|12046105|FG001|COMPLETED|Overall Study||55
10880154|NCT03824405|12046104|FG000|NOT COMPLETED|Overall Study||35
10880155|NCT03824405|12046105|FG001|NOT COMPLETED|Overall Study||45
10880156|NCT03823703|12046114|FG000|STARTED|Overall Study||3
10880157|NCT03823703|12046115|FG001|STARTED|Overall Study||5
10880158|NCT03823703|12046116|FG002|STARTED|Overall Study||4
10880159|NCT03823703|12046114|FG000|Treated|Overall Study||3
10880160|NCT03823703|12046115|FG001|Treated|Overall Study||5
10880161|NCT03823703|12046116|FG002|Treated|Overall Study||4
10880162|NCT03823703|12046114|FG000|COMPLETED|Overall Study||0
10880163|NCT03823703|12046115|FG001|COMPLETED|Overall Study||0
10880164|NCT03823703|12046116|FG002|COMPLETED|Overall Study||0
10880165|NCT03823703|12046114|FG000|NOT COMPLETED|Overall Study||3
10880166|NCT03823703|12046115|FG001|NOT COMPLETED|Overall Study||5
10880167|NCT03823703|12046116|FG002|NOT COMPLETED|Overall Study||4
10880168|NCT03823300|12046126|FG000|STARTED|Overall Study||331
10880169|NCT03823300|12046127|FG001|STARTED|Overall Study||327
10880170|NCT03823300|12046126|FG000|Received at Least One Dose of Study Drug|Overall Study||331
10880171|NCT03823300|12046127|FG001|Received at Least One Dose of Study Drug|Overall Study||326
10880172|NCT03823300|12046126|FG000|Completed up to Week 48|Overall Study||321
10880173|NCT03823300|12046127|FG001|Completed up to Week 48|Overall Study||309
10880174|NCT03823300|12046126|FG000|COMPLETED|Overall Study||0
10880175|NCT03823300|12046127|FG001|COMPLETED|Overall Study||0
10880176|NCT03823300|12046126|FG000|NOT COMPLETED|Overall Study||331
10880177|NCT03823300|12046127|FG001|NOT COMPLETED|Overall Study||327
10880178|NCT03817853|12046133|FG000|STARTED|Induction Phase||113
10880179|NCT03817853|12046134|FG001|STARTED|Induction Phase||0
10880180|NCT03817853|12046135|FG002|STARTED|Induction Phase||0
10880181|NCT03817853|12046133|FG000|COMPLETED|Induction Phase||62
10880182|NCT03817853|12046134|FG001|COMPLETED|Induction Phase||0
10880183|NCT03817853|12046135|FG002|COMPLETED|Induction Phase||0
10880184|NCT03817853|12046133|FG000|NOT COMPLETED|Induction Phase||51
10880185|NCT03817853|12046134|FG001|NOT COMPLETED|Induction Phase||0
10880186|NCT03817853|12046135|FG002|NOT COMPLETED|Induction Phase||0
10880187|NCT03817853|12046133|FG000|STARTED|Maintenance/ Follow-up Phase||0
10880188|NCT03817853|12046134|FG001|STARTED|Maintenance/ Follow-up Phase||56
10880189|NCT03817853|12046135|FG002|STARTED|Maintenance/ Follow-up Phase||17
10880190|NCT03817853|12046133|FG000|COMPLETED|Maintenance/ Follow-up Phase||0
10880191|NCT03817853|12046134|FG001|COMPLETED|Maintenance/ Follow-up Phase||0
10880192|NCT03817853|12046135|FG002|COMPLETED|Maintenance/ Follow-up Phase||11
10880193|NCT03817853|12046133|FG000|NOT COMPLETED|Maintenance/ Follow-up Phase||0
10880194|NCT03817853|12046134|FG001|NOT COMPLETED|Maintenance/ Follow-up Phase||56
10880195|NCT03817853|12046135|FG002|NOT COMPLETED|Maintenance/ Follow-up Phase||6
10880196|NCT03814590|12046157|FG000|STARTED|Overall Study||12
10880197|NCT03814590|12046158|FG001|STARTED|Overall Study||12
10880198|NCT03814590|12046159|FG002|STARTED|Overall Study||12
10880199|NCT03814590|12046160|FG003|STARTED|Overall Study||12
10880200|NCT03814590|12046161|FG004|STARTED|Overall Study||101
10880201|NCT03814590|12046162|FG005|STARTED|Overall Study||97
10880202|NCT03814590|12046163|FG006|STARTED|Overall Study||100
10880203|NCT03814590|12046164|FG007|STARTED|Overall Study||101
10880204|NCT03814590|12046165|FG008|STARTED|Overall Study||101
10880205|NCT03814590|12046166|FG009|STARTED|Overall Study||100
10880206|NCT03814590|12046167|FG010|STARTED|Overall Study||103
10880207|NCT03814590|12046168|FG011|STARTED|Overall Study||100
10880208|NCT03814590|12046169|FG012|STARTED|Overall Study||101
10880209|NCT03814590|12046170|FG013|STARTED|Overall Study||101
10880210|NCT03814590|12046157|FG000|COMPLETED|Overall Study||12
10880211|NCT03814590|12046158|FG001|COMPLETED|Overall Study||10
10880212|NCT03814590|12046159|FG002|COMPLETED|Overall Study||11
10880213|NCT03814590|12046160|FG003|COMPLETED|Overall Study||12
10880214|NCT03814590|12046161|FG004|COMPLETED|Overall Study||100
10880215|NCT03814590|12046162|FG005|COMPLETED|Overall Study||92
10880216|NCT03814590|12046163|FG006|COMPLETED|Overall Study||97
10880217|NCT03814590|12046164|FG007|COMPLETED|Overall Study||95
10880218|NCT03814590|12046165|FG008|COMPLETED|Overall Study||101
10880219|NCT03814590|12046166|FG009|COMPLETED|Overall Study||95
10880220|NCT03814590|12046167|FG010|COMPLETED|Overall Study||100
10880221|NCT03814590|12046168|FG011|COMPLETED|Overall Study||100
10880222|NCT03814590|12046169|FG012|COMPLETED|Overall Study||97
10880223|NCT03814590|12046170|FG013|COMPLETED|Overall Study||98
10880224|NCT03814590|12046157|FG000|NOT COMPLETED|Overall Study||0
10880225|NCT03814590|12046158|FG001|NOT COMPLETED|Overall Study||2
10880226|NCT03814590|12046159|FG002|NOT COMPLETED|Overall Study||1
10880227|NCT03814590|12046160|FG003|NOT COMPLETED|Overall Study||0
10880228|NCT03814590|12046161|FG004|NOT COMPLETED|Overall Study||1
10880229|NCT03814590|12046162|FG005|NOT COMPLETED|Overall Study||5
10880230|NCT03814590|12046163|FG006|NOT COMPLETED|Overall Study||3
10880231|NCT03814590|12046164|FG007|NOT COMPLETED|Overall Study||6
10880232|NCT03814590|12046165|FG008|NOT COMPLETED|Overall Study||0
10880233|NCT03814590|12046166|FG009|NOT COMPLETED|Overall Study||5
10880234|NCT03814590|12046167|FG010|NOT COMPLETED|Overall Study||3
10880235|NCT03814590|12046168|FG011|NOT COMPLETED|Overall Study||0
10880236|NCT03814590|12046169|FG012|NOT COMPLETED|Overall Study||4
10880237|NCT03814590|12046170|FG013|NOT COMPLETED|Overall Study||3
10880238|NCT03813121|12046212|FG000|STARTED|Overall Study||4
10880239|NCT03813121|12046213|FG001|STARTED|Overall Study||6
10880240|NCT03813121|12046212|FG000|COMPLETED|Overall Study||4
10880241|NCT03813121|12046213|FG001|COMPLETED|Overall Study||6
10880242|NCT03813121|12046212|FG000|NOT COMPLETED|Overall Study||0
10880243|NCT03813121|12046213|FG001|NOT COMPLETED|Overall Study||0
10880244|NCT03812380|12046221|FG000|STARTED|Overall Study||22
10880245|NCT03812380|12046222|FG001|STARTED|Overall Study||22
10880246|NCT03812380|12046221|FG000|COMPLETED|Overall Study||0
10880247|NCT03812380|12046222|FG001|COMPLETED|Overall Study||1
10880248|NCT03812380|12046221|FG000|NOT COMPLETED|Overall Study||22
10880249|NCT03812380|12046222|FG001|NOT COMPLETED|Overall Study||21
10880250|NCT03812224|12046230|FG000|STARTED|Double-blind Treatment Period||131
10880251|NCT03812224|12046231|FG001|STARTED|Double-blind Treatment Period||130
10880252|NCT03812224|12046230|FG000|COMPLETED|Double-blind Treatment Period||127
10880253|NCT03812224|12046231|FG001|COMPLETED|Double-blind Treatment Period||127
10880254|NCT03812224|12046230|FG000|NOT COMPLETED|Double-blind Treatment Period||4
10880255|NCT03812224|12046231|FG001|NOT COMPLETED|Double-blind Treatment Period||3
10880256|NCT03812224|12046230|FG000|STARTED|Open-label Treatment Period||127
10880257|NCT03812224|12046231|FG001|STARTED|Open-label Treatment Period||127
10880258|NCT03812224|12046230|FG000|COMPLETED|Open-label Treatment Period||125
10880259|NCT03812224|12046231|FG001|COMPLETED|Open-label Treatment Period||124
10880260|NCT03812224|12046230|FG000|NOT COMPLETED|Open-label Treatment Period||2
10880261|NCT03812224|12046231|FG001|NOT COMPLETED|Open-label Treatment Period||3
10880262|NCT03811093|12046240|FG000|STARTED|Overall Study||20
10880263|NCT03811093|12046241|FG001|STARTED|Overall Study||19
10880264|NCT03811093|12046240|FG000|COMPLETED|Overall Study||18
10880265|NCT03811093|12046241|FG001|COMPLETED|Overall Study||15
10880266|NCT03811093|12046240|FG000|NOT COMPLETED|Overall Study||2
10880267|NCT03811093|12046241|FG001|NOT COMPLETED|Overall Study||4
10880268|NCT03810534|12046254|FG000|STARTED|Standard of Care (5-10 Months)||40
10880269|NCT03810534|12046255|FG001|STARTED|Standard of Care (5-10 Months)||46
10880270|NCT03810534|12046256|FG002|STARTED|Standard of Care (5-10 Months)||54
10880271|NCT03810534|12046257|FG003|STARTED|Standard of Care (5-10 Months)||62
10880272|NCT03810534|12046258|FG004|STARTED|Standard of Care (5-10 Months)||34
10880273|NCT03810534|12046259|FG005|STARTED|Standard of Care (5-10 Months)||88
10880274|NCT03810534|12046254|FG000|Patients Started|Standard of Care (5-10 Months)||20
10880275|NCT03810534|12046255|FG001|Patients Started|Standard of Care (5-10 Months)||23
10880276|NCT03810534|12046256|FG002|Patients Started|Standard of Care (5-10 Months)||27
10880277|NCT03810534|12046257|FG003|Patients Started|Standard of Care (5-10 Months)||31
10880278|NCT03810534|12046258|FG004|Patients Started|Standard of Care (5-10 Months)||17
10880279|NCT03810534|12046259|FG005|Patients Started|Standard of Care (5-10 Months)||44
10880280|NCT03810534|12046254|FG000|Caregivers Started|Standard of Care (5-10 Months)||20
10880281|NCT03810534|12046255|FG001|Caregivers Started|Standard of Care (5-10 Months)||23
10880282|NCT03810534|12046256|FG002|Caregivers Started|Standard of Care (5-10 Months)||27
10880283|NCT03810534|12046257|FG003|Caregivers Started|Standard of Care (5-10 Months)||31
10880284|NCT03810534|12046258|FG004|Caregivers Started|Standard of Care (5-10 Months)||17
10880285|NCT03810534|12046259|FG005|Caregivers Started|Standard of Care (5-10 Months)||44
10880286|NCT03810534|12046254|FG000|Completed 7-day (Patients)|Standard of Care (5-10 Months)||16
10880287|NCT03810534|12046255|FG001|Completed 7-day (Patients)|Standard of Care (5-10 Months)||20
10880288|NCT03810534|12046256|FG002|Completed 7-day (Patients)|Standard of Care (5-10 Months)||23
10880289|NCT03810534|12046257|FG003|Completed 7-day (Patients)|Standard of Care (5-10 Months)||29
10880290|NCT03810534|12046258|FG004|Completed 7-day (Patients)|Standard of Care (5-10 Months)||13
10880291|NCT03810534|12046259|FG005|Completed 7-day (Patients)|Standard of Care (5-10 Months)||40
10880292|NCT03810534|12046254|FG000|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||18
10880293|NCT03810534|12046255|FG001|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||21
10880294|NCT03810534|12046256|FG002|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||23
10880295|NCT03810534|12046257|FG003|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||29
10880296|NCT03810534|12046258|FG004|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||13
10880297|NCT03810534|12046259|FG005|Completed 7-Day (Caregivers)|Standard of Care (5-10 Months)||38
10880298|NCT03810534|12046254|FG000|Completed 30-day (Patients)|Standard of Care (5-10 Months)||14
10880299|NCT03810534|12046255|FG001|Completed 30-day (Patients)|Standard of Care (5-10 Months)||16
10880300|NCT03810534|12046256|FG002|Completed 30-day (Patients)|Standard of Care (5-10 Months)||21
10880301|NCT03810534|12046257|FG003|Completed 30-day (Patients)|Standard of Care (5-10 Months)||23
10880302|NCT03810534|12046258|FG004|Completed 30-day (Patients)|Standard of Care (5-10 Months)||12
10880303|NCT03810534|12046259|FG005|Completed 30-day (Patients)|Standard of Care (5-10 Months)||38
10880304|NCT03810534|12046254|FG000|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||14
10880305|NCT03810534|12046255|FG001|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||16
10880306|NCT03810534|12046256|FG002|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||21
10880307|NCT03810534|12046257|FG003|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||23
10880308|NCT03810534|12046258|FG004|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||10
10880309|NCT03810534|12046259|FG005|Completed 30-Day (Caregivers)|Standard of Care (5-10 Months)||32
10880310|NCT03810534|12046254|FG000|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||10
10880311|NCT03810534|12046255|FG001|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||16
10880312|NCT03810534|12046256|FG002|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||17
10880313|NCT03810534|12046257|FG003|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||20
10880314|NCT03810534|12046258|FG004|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||10
10880315|NCT03810534|12046259|FG005|Completed 60-Day (Patients)|Standard of Care (5-10 Months)||32
10880316|NCT03810534|12046254|FG000|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||10
10880317|NCT03810534|12046255|FG001|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||16
10880318|NCT03810534|12046256|FG002|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||15
10880319|NCT03810534|12046257|FG003|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||20
10880320|NCT03810534|12046258|FG004|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||9
10880321|NCT03810534|12046259|FG005|Completed 60-Day (Caregivers)|Standard of Care (5-10 Months)||31
10880322|NCT03810534|12046254|FG000|COMPLETED|Standard of Care (5-10 Months)||20
10880323|NCT03810534|12046255|FG001|COMPLETED|Standard of Care (5-10 Months)||32
10880324|NCT03810534|12046256|FG002|COMPLETED|Standard of Care (5-10 Months)||32
10880325|NCT03810534|12046257|FG003|COMPLETED|Standard of Care (5-10 Months)||40
10880326|NCT03810534|12046258|FG004|COMPLETED|Standard of Care (5-10 Months)||19
10880327|NCT03810534|12046259|FG005|COMPLETED|Standard of Care (5-10 Months)||63
10880328|NCT03810534|12046254|FG000|NOT COMPLETED|Standard of Care (5-10 Months)||20
10880329|NCT03810534|12046255|FG001|NOT COMPLETED|Standard of Care (5-10 Months)||14
10880330|NCT03810534|12046256|FG002|NOT COMPLETED|Standard of Care (5-10 Months)||22
10880331|NCT03810534|12046257|FG003|NOT COMPLETED|Standard of Care (5-10 Months)||22
10880332|NCT03810534|12046258|FG004|NOT COMPLETED|Standard of Care (5-10 Months)||15
10880333|NCT03810534|12046259|FG005|NOT COMPLETED|Standard of Care (5-10 Months)||25
10880334|NCT03810534|12046254|FG000|STARTED|Pre-Implementation Phase (2 Months)||0
10880335|NCT03810534|12046255|FG001|STARTED|Pre-Implementation Phase (2 Months)||0
10880336|NCT03810534|12046256|FG002|STARTED|Pre-Implementation Phase (2 Months)||0
10880337|NCT03810534|12046257|FG003|STARTED|Pre-Implementation Phase (2 Months)||0
10880338|NCT03810534|12046258|FG004|STARTED|Pre-Implementation Phase (2 Months)||0
10880339|NCT03810534|12046259|FG005|STARTED|Pre-Implementation Phase (2 Months)||0
10880340|NCT03810534|12046254|FG000|Patients Started|Pre-Implementation Phase (2 Months)||0
10880341|NCT03810534|12046255|FG001|Patients Started|Pre-Implementation Phase (2 Months)||0
10880342|NCT03810534|12046256|FG002|Patients Started|Pre-Implementation Phase (2 Months)||0
10880343|NCT03810534|12046257|FG003|Patients Started|Pre-Implementation Phase (2 Months)||0
10880344|NCT03810534|12046258|FG004|Patients Started|Pre-Implementation Phase (2 Months)||0
10880345|NCT03810534|12046259|FG005|Patients Started|Pre-Implementation Phase (2 Months)||0
10880346|NCT03810534|12046254|FG000|Caregivers Started|Pre-Implementation Phase (2 Months)||0
10880347|NCT03810534|12046255|FG001|Caregivers Started|Pre-Implementation Phase (2 Months)||0
10880348|NCT03810534|12046256|FG002|Caregivers Started|Pre-Implementation Phase (2 Months)||0
10880349|NCT03810534|12046257|FG003|Caregivers Started|Pre-Implementation Phase (2 Months)||0
10880350|NCT03810534|12046258|FG004|Caregivers Started|Pre-Implementation Phase (2 Months)||0
10880351|NCT03810534|12046259|FG005|Caregivers Started|Pre-Implementation Phase (2 Months)||0
10880352|NCT03810534|12046254|FG000|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880353|NCT03810534|12046255|FG001|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880354|NCT03810534|12046256|FG002|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880355|NCT03810534|12046257|FG003|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880356|NCT03810534|12046258|FG004|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880357|NCT03810534|12046259|FG005|Completed 7-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880358|NCT03810534|12046254|FG000|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880359|NCT03810534|12046255|FG001|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880360|NCT03810534|12046256|FG002|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880361|NCT03810534|12046257|FG003|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880362|NCT03810534|12046258|FG004|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880363|NCT03810534|12046259|FG005|Completed 7-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880364|NCT03810534|12046254|FG000|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880365|NCT03810534|12046255|FG001|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880366|NCT03810534|12046256|FG002|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880367|NCT03810534|12046257|FG003|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880368|NCT03810534|12046258|FG004|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880369|NCT03810534|12046259|FG005|Completed 30-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880370|NCT03810534|12046254|FG000|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880371|NCT03810534|12046255|FG001|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880372|NCT03810534|12046256|FG002|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880373|NCT03810534|12046257|FG003|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880374|NCT03810534|12046258|FG004|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880375|NCT03810534|12046259|FG005|Completed 30-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880376|NCT03810534|12046254|FG000|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880377|NCT03810534|12046255|FG001|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880378|NCT03810534|12046256|FG002|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880379|NCT03810534|12046257|FG003|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880380|NCT03810534|12046258|FG004|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880381|NCT03810534|12046259|FG005|Completed 60-Day (Patients)|Pre-Implementation Phase (2 Months)||0
10880382|NCT03810534|12046254|FG000|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880383|NCT03810534|12046255|FG001|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880384|NCT03810534|12046256|FG002|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880385|NCT03810534|12046257|FG003|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880386|NCT03810534|12046258|FG004|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880387|NCT03810534|12046259|FG005|Completed 60-Day (Caregivers)|Pre-Implementation Phase (2 Months)||0
10880388|NCT03810534|12046254|FG000|COMPLETED|Pre-Implementation Phase (2 Months)||0
10880389|NCT03810534|12046255|FG001|COMPLETED|Pre-Implementation Phase (2 Months)||0
10880390|NCT03810534|12046256|FG002|COMPLETED|Pre-Implementation Phase (2 Months)||0
10880391|NCT03810534|12046257|FG003|COMPLETED|Pre-Implementation Phase (2 Months)||0
10880392|NCT03810534|12046258|FG004|COMPLETED|Pre-Implementation Phase (2 Months)||0
10880393|NCT03810534|12046259|FG005|COMPLETED|Pre-Implementation Phase (2 Months)||0
10880394|NCT03810534|12046254|FG000|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0
10880395|NCT03810534|12046255|FG001|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0
10880396|NCT03810534|12046256|FG002|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0
10880397|NCT03810534|12046257|FG003|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0
10880398|NCT03810534|12046258|FG004|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0
10880399|NCT03810534|12046259|FG005|NOT COMPLETED|Pre-Implementation Phase (2 Months)||0
10880400|NCT03810534|12046254|FG000|STARTED|Connect-Home (5-10 Months)||82
10880401|NCT03810534|12046255|FG001|STARTED|Connect-Home (5-10 Months)||80
10880402|NCT03810534|12046256|FG002|STARTED|Connect-Home (5-10 Months)||66
10880403|NCT03810534|12046257|FG003|STARTED|Connect-Home (5-10 Months)||54
10880404|NCT03810534|12046258|FG004|STARTED|Connect-Home (5-10 Months)||10
10880405|NCT03810534|12046259|FG005|STARTED|Connect-Home (5-10 Months)||38
10880406|NCT03810534|12046254|FG000|Patients Started|Connect-Home (5-10 Months)||41
10880407|NCT03810534|12046255|FG001|Patients Started|Connect-Home (5-10 Months)||40
10880408|NCT03810534|12046256|FG002|Patients Started|Connect-Home (5-10 Months)||33
10880409|NCT03810534|12046257|FG003|Patients Started|Connect-Home (5-10 Months)||27
10880410|NCT03810534|12046258|FG004|Patients Started|Connect-Home (5-10 Months)||5
10880411|NCT03810534|12046259|FG005|Patients Started|Connect-Home (5-10 Months)||19
10880412|NCT03810534|12046254|FG000|Caregivers Started|Connect-Home (5-10 Months)||41
10880413|NCT03810534|12046255|FG001|Caregivers Started|Connect-Home (5-10 Months)||40
10880414|NCT03810534|12046256|FG002|Caregivers Started|Connect-Home (5-10 Months)||33
10880415|NCT03810534|12046257|FG003|Caregivers Started|Connect-Home (5-10 Months)||27
10880416|NCT03810534|12046258|FG004|Caregivers Started|Connect-Home (5-10 Months)||5
10880417|NCT03810534|12046259|FG005|Caregivers Started|Connect-Home (5-10 Months)||19
10880418|NCT03810534|12046254|FG000|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||38
10880419|NCT03810534|12046255|FG001|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||35
10880420|NCT03810534|12046256|FG002|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||27
10880421|NCT03810534|12046257|FG003|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||23
10880422|NCT03810534|12046258|FG004|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||4
10880423|NCT03810534|12046259|FG005|Completed 7-Day (Patients)|Connect-Home (5-10 Months)||14
10880424|NCT03810534|12046254|FG000|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||35
10880425|NCT03810534|12046255|FG001|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||34
10880426|NCT03810534|12046256|FG002|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||29
10880427|NCT03810534|12046257|FG003|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||24
10880428|NCT03810534|12046258|FG004|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||4
10880429|NCT03810534|12046259|FG005|Completed 7-Day (Caregivers)|Connect-Home (5-10 Months)||13
10880430|NCT03810534|12046254|FG000|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||35
10880431|NCT03810534|12046255|FG001|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||31
10880432|NCT03810534|12046256|FG002|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||25
10880433|NCT03810534|12046257|FG003|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||19
10880434|NCT03810534|12046258|FG004|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||3
10880435|NCT03810534|12046259|FG005|Completed 30-Day (Patients)|Connect-Home (5-10 Months)||12
10880436|NCT03810534|12046254|FG000|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||34
10880437|NCT03810534|12046255|FG001|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||30
10880438|NCT03810534|12046256|FG002|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||25
10880439|NCT03810534|12046257|FG003|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||21
10880440|NCT03810534|12046258|FG004|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||2
10880441|NCT03810534|12046259|FG005|Completed 30-Day (Caregivers)|Connect-Home (5-10 Months)||10
10880442|NCT03810534|12046254|FG000|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||30
10880443|NCT03810534|12046255|FG001|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||25
10880444|NCT03810534|12046256|FG002|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||23
10880445|NCT03810534|12046257|FG003|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||19
10880446|NCT03810534|12046258|FG004|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||2
10880447|NCT03810534|12046259|FG005|Completed 60-Day (Patients)|Connect-Home (5-10 Months)||10
10880448|NCT03810534|12046254|FG000|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||32
10880449|NCT03810534|12046255|FG001|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||27
10880450|NCT03810534|12046256|FG002|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||21
10880451|NCT03810534|12046257|FG003|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||19
10880452|NCT03810534|12046258|FG004|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||2
10880453|NCT03810534|12046259|FG005|Completed 60-Day (Caregivers)|Connect-Home (5-10 Months)||9
10880454|NCT03810534|12046254|FG000|COMPLETED|Connect-Home (5-10 Months)||62
10880455|NCT03810534|12046255|FG001|COMPLETED|Connect-Home (5-10 Months)||52
10880456|NCT03810534|12046256|FG002|COMPLETED|Connect-Home (5-10 Months)||44
10880457|NCT03810534|12046257|FG003|COMPLETED|Connect-Home (5-10 Months)||38
10880458|NCT03810534|12046258|FG004|COMPLETED|Connect-Home (5-10 Months)||4
10880459|NCT03810534|12046259|FG005|COMPLETED|Connect-Home (5-10 Months)||19
10880460|NCT03810534|12046254|FG000|NOT COMPLETED|Connect-Home (5-10 Months)||20
10880461|NCT03810534|12046255|FG001|NOT COMPLETED|Connect-Home (5-10 Months)||28
10880462|NCT03810534|12046256|FG002|NOT COMPLETED|Connect-Home (5-10 Months)||22
10880463|NCT03810534|12046257|FG003|NOT COMPLETED|Connect-Home (5-10 Months)||16
10880464|NCT03810534|12046258|FG004|NOT COMPLETED|Connect-Home (5-10 Months)||6
10880465|NCT03810534|12046259|FG005|NOT COMPLETED|Connect-Home (5-10 Months)||19
10880466|NCT03810495|12046268|FG000|STARTED|Overall Study||20
10880467|NCT03810495|12046268|FG000|COMPLETED|Overall Study||17
10880468|NCT03810495|12046268|FG000|NOT COMPLETED|Overall Study||3
10880469|NCT03810313|12046274|FG000|STARTED|Overall Study||247
10880470|NCT03810313|12046275|FG001|STARTED|Overall Study||246
10880471|NCT03810313|12046274|FG000|COMPLETED|Overall Study||66
10880472|NCT03810313|12046275|FG001|COMPLETED|Overall Study||70
10880473|NCT03810313|12046274|FG000|NOT COMPLETED|Overall Study||181
10880474|NCT03810313|12046275|FG001|NOT COMPLETED|Overall Study||176
10880475|NCT03807843|12046284|FG000|STARTED|Overall Study||21
10880476|NCT03807843|12046285|FG001|STARTED|Overall Study||20
10880477|NCT03807843|12046284|FG000|COMPLETED|Overall Study||20
10880478|NCT03807843|12046285|FG001|COMPLETED|Overall Study||20
10880479|NCT03807843|12046284|FG000|NOT COMPLETED|Overall Study||1
10880480|NCT03807843|12046285|FG001|NOT COMPLETED|Overall Study||0
10880481|NCT03804879|12046293|FG000|STARTED|Overall Study||41
10880482|NCT03804879|12046294|FG001|STARTED|Overall Study||42
10880483|NCT03804879|12046293|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||41
10880484|NCT03804879|12046294|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||0
10880485|NCT03804879|12046293|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study||41
10880486|NCT03804879|12046294|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study||41
10880487|NCT03804879|12046293|FG000|COMPLETED|Overall Study||25
10880488|NCT03804879|12046294|FG001|COMPLETED|Overall Study||29
10880489|NCT03804879|12046293|FG000|NOT COMPLETED|Overall Study||16
10880490|NCT03804879|12046294|FG001|NOT COMPLETED|Overall Study||13
10880491|NCT03802630|12046303|FG000|STARTED|Overall Study||226
10880492|NCT03802630|12046304|FG001|STARTED|Overall Study||224
10880493|NCT03802630|12046303|FG000|COMPLETED|Overall Study||73
10880494|NCT03802630|12046304|FG001|COMPLETED|Overall Study||76
10880495|NCT03802630|12046303|FG000|NOT COMPLETED|Overall Study||153
10880496|NCT03802630|12046304|FG001|NOT COMPLETED|Overall Study||148
10880497|NCT03794882|12046313|FG000|STARTED|Overall Study||8
10880498|NCT03794882|12046314|FG001|STARTED|Overall Study||6
10880499|NCT03794882|12046313|FG000|COMPLETED|Overall Study||8
10880500|NCT03794882|12046314|FG001|COMPLETED|Overall Study||6
10880501|NCT03794882|12046313|FG000|NOT COMPLETED|Overall Study||0
10880502|NCT03794882|12046314|FG001|NOT COMPLETED|Overall Study||0
10880503|NCT03794700|12046323|FG000|STARTED|Overall Study||43
10880504|NCT03794700|12046324|FG001|STARTED|Overall Study||88
10880505|NCT03794700|12046323|FG000|COMPLETED|Overall Study||43
10880506|NCT03794700|12046324|FG001|COMPLETED|Overall Study||88
10880507|NCT03794700|12046323|FG000|NOT COMPLETED|Overall Study||0
10880508|NCT03794700|12046324|FG001|NOT COMPLETED|Overall Study||0
10880509|NCT03789214|12046333|FG000|STARTED|Overall Study||12
10880510|NCT03789214|12046334|FG001|STARTED|Overall Study||14
10880511|NCT03789214|12046335|FG002|STARTED|Overall Study||12
10880512|NCT03789214|12046333|FG000|COMPLETED|Overall Study||8
10880513|NCT03789214|12046334|FG001|COMPLETED|Overall Study||9
10880514|NCT03789214|12046335|FG002|COMPLETED|Overall Study||9
10880515|NCT03789214|12046333|FG000|NOT COMPLETED|Overall Study||4
10880516|NCT03789214|12046334|FG001|NOT COMPLETED|Overall Study||5
10880517|NCT03789214|12046335|FG002|NOT COMPLETED|Overall Study||3
10880518|NCT03789110|12046344|FG000|STARTED|Overall Study||30
10880519|NCT03789110|12046344|FG000|COMPLETED|Overall Study||0
10880520|NCT03789110|12046344|FG000|NOT COMPLETED|Overall Study||30
10880521|NCT03783533|12046348|FG000|STARTED|Overall Study||11
10880522|NCT03783533|12046348|FG000|COMPLETED|Overall Study||7
10880523|NCT03783533|12046348|FG000|NOT COMPLETED|Overall Study||4
10880524|NCT03782064|12046352|FG000|STARTED|Overall Study||5
10880525|NCT03782064|12046352|FG000|Initiated Treatment|Overall Study||2
10880526|NCT03782064|12046352|FG000|COMPLETED|Overall Study||0
10880527|NCT03782064|12046352|FG000|NOT COMPLETED|Overall Study||5
10880528|NCT03777917|12046358|FG000|STARTED|Overall Study||43
10880529|NCT03777917|12046359|FG001|STARTED|Overall Study||23
10880530|NCT03777917|12046358|FG000|Safety Population|Overall Study||43
10880531|NCT03777917|12046359|FG001|Safety Population|Overall Study||22
10880532|NCT03777917|12046358|FG000|COMPLETED|Overall Study||34
10880533|NCT03777917|12046359|FG001|COMPLETED|Overall Study||21
10880534|NCT03777917|12046358|FG000|NOT COMPLETED|Overall Study||9
10880535|NCT03777917|12046359|FG001|NOT COMPLETED|Overall Study||2
10880536|NCT03774875|12046368|FG000|STARTED|Placebo-controlled Period (Week 1-16)||92
10880537|NCT03774875|12046369|FG001|STARTED|Placebo-controlled Period (Week 1-16)||185
10880538|NCT03774875|12046368|FG000|Received Study Drug|Placebo-controlled Period (Week 1-16)||91
10880539|NCT03774875|12046369|FG001|Received Study Drug|Placebo-controlled Period (Week 1-16)||185
10880540|NCT03774875|12046368|FG000|COMPLETED|Placebo-controlled Period (Week 1-16)||69
10880541|NCT03774875|12046369|FG001|COMPLETED|Placebo-controlled Period (Week 1-16)||152
10880542|NCT03774875|12046368|FG000|NOT COMPLETED|Placebo-controlled Period (Week 1-16)||23
10880543|NCT03774875|12046369|FG001|NOT COMPLETED|Placebo-controlled Period (Week 1-16)||33
10880544|NCT03774875|12046368|FG000|STARTED|Apremilast Extension Period (Week 16-52)||69
10880545|NCT03774875|12046369|FG001|STARTED|Apremilast Extension Period (Week 16-52)||152
10880546|NCT03774875|12046368|FG000|COMPLETED|Apremilast Extension Period (Week 16-52)||53
10880547|NCT03774875|12046369|FG001|COMPLETED|Apremilast Extension Period (Week 16-52)||105
10880548|NCT03774875|12046368|FG000|NOT COMPLETED|Apremilast Extension Period (Week 16-52)||16
10880549|NCT03774875|12046369|FG001|NOT COMPLETED|Apremilast Extension Period (Week 16-52)||47
10880550|NCT03774407|12046380|FG000|STARTED|Overall Study||21
10880551|NCT03774407|12046380|FG000|COMPLETED|Overall Study||12
10880552|NCT03774407|12046380|FG000|NOT COMPLETED|Overall Study||9
10880553|NCT03773484|12046386|FG000|STARTED|Pre-intervention||41
10880554|NCT03773484|12046386|FG000|COMPLETED|Pre-intervention||41
10880555|NCT03773484|12046386|FG000|NOT COMPLETED|Pre-intervention||0
10880556|NCT03773484|12046386|FG000|STARTED|Post-intervention||41
10880557|NCT03773484|12046386|FG000|COMPLETED|Post-intervention||36
10880558|NCT03773484|12046386|FG000|NOT COMPLETED|Post-intervention||5
10880559|NCT03773133|12046390|FG000|STARTED|Overall Study||8
10880560|NCT03773133|12046390|FG000|Received the Screening IIP|Overall Study||8
10880561|NCT03773133|12046390|FG000|Received the Therapeutic IRPP|Overall Study||0
10880562|NCT03773133|12046390|FG000|COMPLETED|Overall Study||0
10880563|NCT03773133|12046390|FG000|NOT COMPLETED|Overall Study||8
10880564|NCT03769753|12046395|FG000|STARTED|Overall Study||8
10880565|NCT03769753|12046395|FG000|COMPLETED|Overall Study||1
10880566|NCT03769753|12046395|FG000|NOT COMPLETED|Overall Study||7
10880567|NCT03769090|12046402|FG000|STARTED|Overall Study||1016
10880568|NCT03769090|12046403|FG001|STARTED|Overall Study||1057
10880569|NCT03769090|12046404|FG002|STARTED|Overall Study||1059
10880570|NCT03769090|12046402|FG000|COMPLETED|Overall Study||915
10880571|NCT03769090|12046403|FG001|COMPLETED|Overall Study||933
10880572|NCT03769090|12046404|FG002|COMPLETED|Overall Study||916
10880573|NCT03769090|12046402|FG000|NOT COMPLETED|Overall Study||101
10880574|NCT03769090|12046403|FG001|NOT COMPLETED|Overall Study||124
10880575|NCT03769090|12046404|FG002|NOT COMPLETED|Overall Study||143
10880576|NCT03764475|12046417|FG000|STARTED|Overall Study||230
10880577|NCT03764475|12046418|FG001|STARTED|Overall Study||102
10880578|NCT03764475|12046417|FG000|COMPLETED|Overall Study||164
10880579|NCT03764475|12046418|FG001|COMPLETED|Overall Study||80
10880580|NCT03764475|12046417|FG000|NOT COMPLETED|Overall Study||66
10880581|NCT03764475|12046418|FG001|NOT COMPLETED|Overall Study||22
10880582|NCT03762265|12046430|FG000|STARTED|BT Period: Weeks 1 to 37||66
10880583|NCT03762265|12046431|FG001|STARTED|BT Period: Weeks 1 to 37||65
10880584|NCT03762265|12046430|FG000|COMPLETED|BT Period: Weeks 1 to 37||51
10880585|NCT03762265|12046431|FG001|COMPLETED|BT Period: Weeks 1 to 37||62
10880586|NCT03762265|12046430|FG000|NOT COMPLETED|BT Period: Weeks 1 to 37||15
10880587|NCT03762265|12046431|FG001|NOT COMPLETED|BT Period: Weeks 1 to 37||3
10880588|NCT03762265|12046430|FG000|STARTED|OLE Period: Weeks 37 to 61||51
10880589|NCT03762265|12046431|FG001|STARTED|OLE Period: Weeks 37 to 61|One participant did not enter OLE Period.|61
10880590|NCT03762265|12046430|FG000|COMPLETED|OLE Period: Weeks 37 to 61||35
10880591|NCT03762265|12046431|FG001|COMPLETED|OLE Period: Weeks 37 to 61||45
10880592|NCT03762265|12046430|FG000|NOT COMPLETED|OLE Period: Weeks 37 to 61||16
10880593|NCT03762265|12046431|FG001|NOT COMPLETED|OLE Period: Weeks 37 to 61||16
10880594|NCT03762265|12046430|FG000|STARTED|LTE Period: Weeks 61 to 109||35
10880595|NCT03762265|12046431|FG001|STARTED|LTE Period: Weeks 61 to 109|11 participants did not enter LTE Period.|34
10880596|NCT03762265|12046430|FG000|COMPLETED|LTE Period: Weeks 61 to 109||6
10880597|NCT03762265|12046431|FG001|COMPLETED|LTE Period: Weeks 61 to 109||6
10880598|NCT03762265|12046430|FG000|NOT COMPLETED|LTE Period: Weeks 61 to 109||29
10880599|NCT03762265|12046431|FG001|NOT COMPLETED|LTE Period: Weeks 61 to 109||28
10880600|NCT03760666|12046456|FG000|STARTED|Overall Study||5
10880601|NCT03760666|12046457|FG001|STARTED|Overall Study||11
10880602|NCT03760666|12046458|FG002|STARTED|Overall Study||1
10880603|NCT03760666|12046456|FG000|COMPLETED|Overall Study||0
10880604|NCT03760666|12046457|FG001|COMPLETED|Overall Study||0
10880605|NCT03760666|12046458|FG002|COMPLETED|Overall Study||0
10880606|NCT03760666|12046456|FG000|NOT COMPLETED|Overall Study||5
10880607|NCT03760666|12046457|FG001|NOT COMPLETED|Overall Study||11
10880608|NCT03760666|12046458|FG002|NOT COMPLETED|Overall Study||1
10880609|NCT03759379|12046472|FG000|STARTED|Treatment Period||122
10880610|NCT03759379|12046473|FG001|STARTED|Treatment Period||42
10880611|NCT03759379|12046472|FG000|COMPLETED|Treatment Period||0
10880612|NCT03759379|12046473|FG001|COMPLETED|Treatment Period||0
10880613|NCT03759379|12046472|FG000|NOT COMPLETED|Treatment Period||122
10880614|NCT03759379|12046473|FG001|NOT COMPLETED|Treatment Period||42
10880615|NCT03759379|12046472|FG000|STARTED|Randomized Treatment Extension Period||0
10880616|NCT03759379|12046473|FG001|STARTED|Randomized Treatment Extension Period||0
10880617|NCT03759379|12046472|FG000|COMPLETED|Randomized Treatment Extension Period||0
10880618|NCT03759379|12046473|FG001|COMPLETED|Randomized Treatment Extension Period||0
10880619|NCT03759379|12046472|FG000|NOT COMPLETED|Randomized Treatment Extension Period||0
10880620|NCT03759379|12046473|FG001|NOT COMPLETED|Randomized Treatment Extension Period||0
10880621|NCT03759366|12046479|FG000|STARTED|Primary Evaluation Period (26 Weeks)||11
10880622|NCT03759366|12046479|FG000|COMPLETED|Primary Evaluation Period (26 Weeks)||10
10880623|NCT03759366|12046479|FG000|NOT COMPLETED|Primary Evaluation Period (26 Weeks)||1
10880624|NCT03759366|12046479|FG000|STARTED|Extension Period (Up to 208 Weeks)||10
10880625|NCT03759366|12046479|FG000|COMPLETED|Extension Period (Up to 208 Weeks)||0
10880626|NCT03759366|12046479|FG000|NOT COMPLETED|Extension Period (Up to 208 Weeks)||10
10880627|NCT03759041|12046486|FG000|STARTED|Overall Study||69
10880628|NCT03759041|12046487|FG001|STARTED|Overall Study||68
10880629|NCT03759041|12046488|FG002|STARTED|Overall Study||66
10880630|NCT03759041|12046486|FG000|COMPLETED|Overall Study||42
10880631|NCT03759041|12046487|FG001|COMPLETED|Overall Study||34
10880632|NCT03759041|12046488|FG002|COMPLETED|Overall Study||38
10880633|NCT03759041|12046486|FG000|NOT COMPLETED|Overall Study||27
10880634|NCT03759041|12046487|FG001|NOT COMPLETED|Overall Study||34
10880635|NCT03759041|12046488|FG002|NOT COMPLETED|Overall Study||28
10880636|NCT03757715|12046498|FG000|STARTED|Overall Study||21
10880637|NCT03757715|12046499|FG001|STARTED|Overall Study||25
10880638|NCT03757715|12046498|FG000|COMPLETED|Overall Study||16
10880639|NCT03757715|12046499|FG001|COMPLETED|Overall Study||15
10880640|NCT03757715|12046498|FG000|NOT COMPLETED|Overall Study||5
10880641|NCT03757715|12046499|FG001|NOT COMPLETED|Overall Study||10
10880642|NCT03753542|12046507|FG000|STARTED|Overall Study|Actual Calculated Sample size was 30 Sample, 100 was taken to restore lost to follow up|50
10880643|NCT03753542|12046508|FG001|STARTED|Overall Study|Actual Calculated Sample size was 30 Sample, 100 was taken to restore lost to follow up|50
10880644|NCT03753542|12046507|FG000|COMPLETED|Overall Study|In spite of having lost to follow up the power of study was not lost|41
10880645|NCT03753542|12046508|FG001|COMPLETED|Overall Study|In spite of having lost to follow up the power of study was not lost|36
10880646|NCT03753542|12046507|FG000|NOT COMPLETED|Overall Study||9
10880647|NCT03753542|12046508|FG001|NOT COMPLETED|Overall Study||14
10880648|NCT03750552|12046516|FG000|STARTED|Overall Study||98
10880649|NCT03750552|12046517|FG001|STARTED|Overall Study||97
10880650|NCT03750552|12046516|FG000|Safety Analysis Set|Overall Study||96
10880651|NCT03750552|12046517|FG001|Safety Analysis Set|Overall Study||90
10880652|NCT03750552|12046516|FG000|Full Analysis Set|Overall Study||94
10880653|NCT03750552|12046517|FG001|Full Analysis Set|Overall Study||90
10880654|NCT03750552|12046516|FG000|COMPLETED|Overall Study||90
10880655|NCT03750552|12046517|FG001|COMPLETED|Overall Study||95
10880656|NCT03750552|12046516|FG000|NOT COMPLETED|Overall Study||8
10880657|NCT03750552|12046517|FG001|NOT COMPLETED|Overall Study||2
10880658|NCT03750240|12046524|FG000|STARTED|Overall Study||2
10880659|NCT03750240|12046524|FG000|COMPLETED|Overall Study||0
10880660|NCT03750240|12046524|FG000|NOT COMPLETED|Overall Study||2
10880661|NCT03749109|12046530|FG000|STARTED|Overall Study||35
10880662|NCT03749109|12046531|FG001|STARTED|Overall Study||32
10880663|NCT03749109|12046530|FG000|COMPLETED|Overall Study||33
10880664|NCT03749109|12046531|FG001|COMPLETED|Overall Study||32
10880665|NCT03749109|12046530|FG000|NOT COMPLETED|Overall Study||2
10880666|NCT03749109|12046531|FG001|NOT COMPLETED|Overall Study||0
10880667|NCT03747302|12046540|FG000|STARTED|Overall Study||834
10880668|NCT03747302|12046541|FG001|STARTED|Overall Study||164
10880669|NCT03747302|12046540|FG000|COMPLETED|Overall Study||833
10880670|NCT03747302|12046541|FG001|COMPLETED|Overall Study||162
10880671|NCT03747302|12046540|FG000|NOT COMPLETED|Overall Study||1
10880672|NCT03747302|12046541|FG001|NOT COMPLETED|Overall Study||2
10880673|NCT03744598|12046549|FG000|STARTED|Overall Study||20
10880674|NCT03744598|12046549|FG000|COMPLETED|Overall Study||19
10880675|NCT03744598|12046549|FG000|NOT COMPLETED|Overall Study||1
10880676|NCT03739203|12046556|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||250
10880677|NCT03739203|12046557|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||250
10880678|NCT03739203|12046558|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||251
10880679|NCT03739203|12046556|FG000|Modified Intent-to Treat (mITT) Population|Double-blind Treatment Period (6 Weeks)||249
10880680|NCT03739203|12046557|FG001|Modified Intent-to Treat (mITT) Population|Double-blind Treatment Period (6 Weeks)||250
10880681|NCT03739203|12046558|FG002|Modified Intent-to Treat (mITT) Population|Double-blind Treatment Period (6 Weeks)||251
10880682|NCT03739203|12046556|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||235
10880683|NCT03739203|12046557|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||233
10880684|NCT03739203|12046558|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||226
10880685|NCT03739203|12046556|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||15
10880686|NCT03739203|12046557|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||17
10880687|NCT03739203|12046558|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||25
10880688|NCT03739203|12046556|FG000|STARTED|Safety Follow-Up Period (4 Weeks)||242
10880689|NCT03739203|12046557|FG001|STARTED|Safety Follow-Up Period (4 Weeks)||242
10880690|NCT03739203|12046558|FG002|STARTED|Safety Follow-Up Period (4 Weeks)||242
10880691|NCT03739203|12046556|FG000|COMPLETED|Safety Follow-Up Period (4 Weeks)||240
10880692|NCT03739203|12046557|FG001|COMPLETED|Safety Follow-Up Period (4 Weeks)||240
10880693|NCT03739203|12046558|FG002|COMPLETED|Safety Follow-Up Period (4 Weeks)||238
10880694|NCT03739203|12046556|FG000|NOT COMPLETED|Safety Follow-Up Period (4 Weeks)||2
10880695|NCT03739203|12046557|FG001|NOT COMPLETED|Safety Follow-Up Period (4 Weeks)||2
10880696|NCT03739203|12046558|FG002|NOT COMPLETED|Safety Follow-Up Period (4 Weeks)||4
10880697|NCT03736928|12046571|FG000|STARTED|Overall Study||80
10880698|NCT03736928|12046572|FG001|STARTED|Overall Study||80
10880699|NCT03736928|12046573|FG002|STARTED|Overall Study||80
10880700|NCT03736928|12046574|FG003|STARTED|Overall Study||81
10880701|NCT03736928|12046575|FG004|STARTED|Overall Study||78
10880702|NCT03736928|12046571|FG000|COMPLETED|Overall Study||73
10880703|NCT03736928|12046572|FG001|COMPLETED|Overall Study||78
10880704|NCT03736928|12046573|FG002|COMPLETED|Overall Study||75
10880705|NCT03736928|12046574|FG003|COMPLETED|Overall Study||76
10880706|NCT03736928|12046575|FG004|COMPLETED|Overall Study||67
10880707|NCT03736928|12046571|FG000|NOT COMPLETED|Overall Study||7
10880708|NCT03736928|12046572|FG001|NOT COMPLETED|Overall Study||2
10880709|NCT03736928|12046573|FG002|NOT COMPLETED|Overall Study||5
10880710|NCT03736928|12046574|FG003|NOT COMPLETED|Overall Study||5
10880711|NCT03736928|12046575|FG004|NOT COMPLETED|Overall Study||11
10880712|NCT03733444|12046590|FG000|STARTED|Overall Study||260
10880713|NCT03733444|12046591|FG001|STARTED|Overall Study||262
10880714|NCT03733444|12046592|FG002|STARTED|Overall Study||259
10880715|NCT03733444|12046590|FG000|Treated|Overall Study||259
10880716|NCT03733444|12046591|FG001|Treated|Overall Study||260
10880717|NCT03733444|12046592|FG002|Treated|Overall Study||258
10880718|NCT03733444|12046590|FG000|COMPLETED|Overall Study||0
10880719|NCT03733444|12046591|FG001|COMPLETED|Overall Study||0
10880720|NCT03733444|12046592|FG002|COMPLETED|Overall Study||0
10880721|NCT03733444|12046590|FG000|NOT COMPLETED|Overall Study||260
10880722|NCT03733444|12046591|FG001|NOT COMPLETED|Overall Study||262
10880723|NCT03733444|12046592|FG002|NOT COMPLETED|Overall Study||259
10880724|NCT03730012|12046612|FG000|STARTED|Overall Study||3
10880725|NCT03730012|12046613|FG001|STARTED|Overall Study||8
10880726|NCT03730012|12046612|FG000|COMPLETED|Overall Study||0
10880727|NCT03730012|12046613|FG001|COMPLETED|Overall Study||0
10880728|NCT03730012|12046612|FG000|NOT COMPLETED|Overall Study||3
10880729|NCT03730012|12046613|FG001|NOT COMPLETED|Overall Study||8
10880730|NCT03727841|12046624|FG000|STARTED|Overall Study||3
10880731|NCT03727841|12046625|FG001|STARTED|Overall Study||1
10880732|NCT03727841|12046624|FG000|COMPLETED|Overall Study||0
10880733|NCT03727841|12046625|FG001|COMPLETED|Overall Study||0
10880734|NCT03727841|12046624|FG000|NOT COMPLETED|Overall Study||3
10880735|NCT03727841|12046625|FG001|NOT COMPLETED|Overall Study||1
10880736|NCT03726879|12046633|FG000|STARTED|Overall Study||226
10880737|NCT03726879|12046634|FG001|STARTED|Overall Study||228
10880738|NCT03726879|12046633|FG000|COMPLETED|Overall Study||0
10880739|NCT03726879|12046634|FG001|COMPLETED|Overall Study||0
10880740|NCT03726879|12046633|FG000|NOT COMPLETED|Overall Study||226
10880741|NCT03726879|12046634|FG001|NOT COMPLETED|Overall Study||228
10880742|NCT03724487|12046642|FG000|STARTED|Overall Study||30
10880743|NCT03724487|12046643|FG001|STARTED|Overall Study||30
10880744|NCT03724487|12046642|FG000|COMPLETED|Overall Study||30
10880745|NCT03724487|12046643|FG001|COMPLETED|Overall Study||30
10880746|NCT03724487|12046642|FG000|NOT COMPLETED|Overall Study||0
10880747|NCT03724487|12046643|FG001|NOT COMPLETED|Overall Study||0
10880748|NCT03719287|12046653|FG000|STARTED|Overall Study||100
10880749|NCT03719287|12046654|FG001|STARTED|Overall Study||99
10880750|NCT03719287|12046655|FG002|STARTED|Overall Study||96
10880751|NCT03719287|12046653|FG000|COMPLETED|Overall Study||100
10880752|NCT03719287|12046654|FG001|COMPLETED|Overall Study||99
10880753|NCT03719287|12046655|FG002|COMPLETED|Overall Study||96
10880754|NCT03719287|12046653|FG000|NOT COMPLETED|Overall Study||0
10880755|NCT03719287|12046654|FG001|NOT COMPLETED|Overall Study||0
10880756|NCT03719287|12046655|FG002|NOT COMPLETED|Overall Study||0
10880757|NCT03714620|12046665|FG000|STARTED|Overall Study||49
10880758|NCT03714620|12046666|FG001|STARTED|Overall Study||49
10880759|NCT03714620|12046665|FG000|COMPLETED|Overall Study||49
10880760|NCT03714620|12046666|FG001|COMPLETED|Overall Study||49
10880761|NCT03714620|12046665|FG000|NOT COMPLETED|Overall Study||0
10880762|NCT03714620|12046666|FG001|NOT COMPLETED|Overall Study||0
10880763|NCT03714425|12046674|FG000|STARTED|Overall Study||62
10880764|NCT03714425|12046675|FG001|STARTED|Overall Study||57
10880765|NCT03714425|12046674|FG000|COMPLETED|Overall Study||55
10880766|NCT03714425|12046675|FG001|COMPLETED|Overall Study||46
10880767|NCT03714425|12046674|FG000|NOT COMPLETED|Overall Study||7
10880768|NCT03714425|12046675|FG001|NOT COMPLETED|Overall Study||11
10880769|NCT03712787|12046685|FG000|STARTED|Overall Study||87
10880770|NCT03712787|12046686|FG001|STARTED|Overall Study||97
10880771|NCT03712787|12046687|FG002|STARTED|Overall Study||88
10880772|NCT03712787|12046688|FG003|STARTED|Overall Study||91
10880773|NCT03712787|12046685|FG000|COMPLETED|Overall Study||0
10880774|NCT03712787|12046686|FG001|COMPLETED|Overall Study||0
10880775|NCT03712787|12046687|FG002|COMPLETED|Overall Study||0
10880776|NCT03712787|12046688|FG003|COMPLETED|Overall Study||0
10880777|NCT03712787|12046685|FG000|NOT COMPLETED|Overall Study||87
10880778|NCT03712787|12046686|FG001|NOT COMPLETED|Overall Study||97
10880779|NCT03712787|12046687|FG002|NOT COMPLETED|Overall Study||88
10880780|NCT03712787|12046688|FG003|NOT COMPLETED|Overall Study||91
10880781|NCT03711162|12046701|FG000|STARTED|Overall Study||175
10880782|NCT03711162|12046702|FG001|STARTED|Overall Study||175
10880783|NCT03711162|12046703|FG002|STARTED|Overall Study||175
10880784|NCT03711162|12046701|FG000|Treated|Overall Study||174
10880785|NCT03711162|12046702|FG001|Treated|Overall Study||175
10880786|NCT03711162|12046703|FG002|Treated|Overall Study||174
10880787|NCT03711162|12046701|FG000|COMPLETED|Overall Study||0
10880788|NCT03711162|12046702|FG001|COMPLETED|Overall Study||0
10880789|NCT03711162|12046703|FG002|COMPLETED|Overall Study||0
10880790|NCT03711162|12046701|FG000|NOT COMPLETED|Overall Study||175
10880791|NCT03711162|12046702|FG001|NOT COMPLETED|Overall Study||175
10880792|NCT03711162|12046703|FG002|NOT COMPLETED|Overall Study||175
10880793|NCT03706456|12046717|FG000|STARTED|Overall Study||22
10880794|NCT03706456|12046717|FG000|Started|Overall Study||22
10880795|NCT03706456|12046717|FG000|Completed|Overall Study||0
10880796|NCT03706456|12046717|FG000|COMPLETED|Overall Study||0
10880797|NCT03706456|12046717|FG000|NOT COMPLETED|Overall Study||22
10880798|NCT03705793|12046723|FG000|STARTED|Overall Study||27
10880799|NCT03705793|12046724|FG001|STARTED|Overall Study||26
10880800|NCT03705793|12046723|FG000|COMPLETED|Overall Study||22
10880801|NCT03705793|12046724|FG001|COMPLETED|Overall Study||21
10880802|NCT03705793|12046723|FG000|NOT COMPLETED|Overall Study||5
10880803|NCT03705793|12046724|FG001|NOT COMPLETED|Overall Study||5
10880804|NCT03703466|12046733|FG000|STARTED|Overall Study||24
10880805|NCT03703466|12046734|FG001|STARTED|Overall Study||24
10880806|NCT03703466|12046735|FG002|STARTED|Overall Study||24
10880807|NCT03703466|12046733|FG000|Received at Least One Dose of Study Drug|Overall Study||24
10880808|NCT03703466|12046734|FG001|Received at Least One Dose of Study Drug|Overall Study||23
10880809|NCT03703466|12046735|FG002|Received at Least One Dose of Study Drug|Overall Study||24
10880810|NCT03703466|12046733|FG000|COMPLETED|Overall Study||20
10880811|NCT03703466|12046734|FG001|COMPLETED|Overall Study||18
10880812|NCT03703466|12046735|FG002|COMPLETED|Overall Study||22
10880813|NCT03703466|12046733|FG000|NOT COMPLETED|Overall Study||4
10880814|NCT03703466|12046734|FG001|NOT COMPLETED|Overall Study||6
10880815|NCT03703466|12046735|FG002|NOT COMPLETED|Overall Study||2
10880816|NCT03700047|12046747|FG000|STARTED|Overall Study||142
10880817|NCT03700047|12046748|FG001|STARTED|Overall Study||60
10880818|NCT03700047|12046749|FG002|STARTED|Overall Study||68
10880819|NCT03700047|12046747|FG000|COMPLETED|Overall Study||126
10880820|NCT03700047|12046748|FG001|COMPLETED|Overall Study||50
10880821|NCT03700047|12046749|FG002|COMPLETED|Overall Study||58
10880822|NCT03700047|12046747|FG000|NOT COMPLETED|Overall Study||16
10880823|NCT03700047|12046748|FG001|NOT COMPLETED|Overall Study||10
10880824|NCT03700047|12046749|FG002|NOT COMPLETED|Overall Study||10
10880825|NCT03693612|12046764|FG000|STARTED|Overall Study||1
10880826|NCT03693612|12046765|FG001|STARTED|Overall Study||1
10880827|NCT03693612|12046766|FG002|STARTED|Overall Study||5
10880828|NCT03693612|12046767|FG003|STARTED|Overall Study||3
10880829|NCT03693612|12046768|FG004|STARTED|Overall Study||16
10880830|NCT03693612|12046769|FG005|STARTED|Overall Study||0
10880831|NCT03693612|12046770|FG006|STARTED|Overall Study||0
10880832|NCT03693612|12046764|FG000|COMPLETED|Overall Study||1
10880833|NCT03693612|12046765|FG001|COMPLETED|Overall Study||0
10880834|NCT03693612|12046766|FG002|COMPLETED|Overall Study||4
10880835|NCT03693612|12046767|FG003|COMPLETED|Overall Study||3
10880836|NCT03693612|12046768|FG004|COMPLETED|Overall Study||10
10880837|NCT03693612|12046769|FG005|COMPLETED|Overall Study||0
10880838|NCT03693612|12046770|FG006|COMPLETED|Overall Study||0
10880839|NCT03693612|12046764|FG000|NOT COMPLETED|Overall Study||0
10880840|NCT03693612|12046765|FG001|NOT COMPLETED|Overall Study||1
10880841|NCT03693612|12046766|FG002|NOT COMPLETED|Overall Study||1
10880842|NCT03693612|12046767|FG003|NOT COMPLETED|Overall Study||0
10880843|NCT03693612|12046768|FG004|NOT COMPLETED|Overall Study||6
10880844|NCT03693612|12046769|FG005|NOT COMPLETED|Overall Study||0
10880845|NCT03693612|12046770|FG006|NOT COMPLETED|Overall Study||0
10880846|NCT03693170|12046786|FG000|STARTED|Overall Study||95
10880847|NCT03693170|12046786|FG000|COMPLETED|Overall Study|Participants with study treatment ongoing at the time of cut off date (29JUN2020)|20
10880848|NCT03693170|12046786|FG000|NOT COMPLETED|Overall Study||75
10880849|NCT03692871|12046793|FG000|STARTED|Overall Study||1972
10880850|NCT03692871|12046794|FG001|STARTED|Overall Study||437
10880851|NCT03692871|12046793|FG000|COMPLETED|Overall Study||1847
10880852|NCT03692871|12046794|FG001|COMPLETED|Overall Study||400
10880853|NCT03692871|12046793|FG000|NOT COMPLETED|Overall Study||125
10880854|NCT03692871|12046794|FG001|NOT COMPLETED|Overall Study||37
10880855|NCT03689855|12046800|FG000|STARTED|Overall Study||21
10880856|NCT03689855|12046800|FG000|COMPLETED|Overall Study||17
10880857|NCT03689855|12046800|FG000|NOT COMPLETED|Overall Study||4
10880858|NCT03687736|12046804|FG000|STARTED|Overall Study||120
10880859|NCT03687736|12046804|FG000|COMPLETED|Overall Study||110
10880860|NCT03687736|12046804|FG000|NOT COMPLETED|Overall Study||10
10880861|NCT03684408|12046813|FG000|STARTED|Overall Study||10
10880862|NCT03684408|12046814|FG001|STARTED|Overall Study||16
10880863|NCT03684408|12046815|FG002|STARTED|Overall Study||12
10880864|NCT03684408|12046813|FG000|COMPLETED|Overall Study||9
10880865|NCT03684408|12046814|FG001|COMPLETED|Overall Study||15
10880866|NCT03684408|12046815|FG002|COMPLETED|Overall Study||12
10880867|NCT03684408|12046813|FG000|NOT COMPLETED|Overall Study||1
10880868|NCT03684408|12046814|FG001|NOT COMPLETED|Overall Study||1
10880869|NCT03684408|12046815|FG002|NOT COMPLETED|Overall Study||0
10880870|NCT03682848|12046823|FG000|STARTED|Overall Study||32
10880871|NCT03682848|12046823|FG000|COMPLETED|Overall Study||23
10880872|NCT03682848|12046823|FG000|NOT COMPLETED|Overall Study||9
10880873|NCT03682601|12046830|FG000|STARTED|Overall Study||12
10880874|NCT03682601|12046831|FG001|STARTED|Overall Study||7
10880875|NCT03682601|12046832|FG002|STARTED|Overall Study||13
10880876|NCT03682601|12046830|FG000|COMPLETED|Overall Study||12
10880877|NCT03682601|12046831|FG001|COMPLETED|Overall Study||7
10880878|NCT03682601|12046832|FG002|COMPLETED|Overall Study||13
10880879|NCT03682601|12046830|FG000|NOT COMPLETED|Overall Study||0
10880880|NCT03682601|12046831|FG001|NOT COMPLETED|Overall Study||0
10880881|NCT03682601|12046832|FG002|NOT COMPLETED|Overall Study||0
10880882|NCT03681691|12046845|FG000|STARTED|Overall Study||8
10880883|NCT03681691|12046846|FG001|STARTED|Overall Study||4
10880884|NCT03681691|12046845|FG000|COMPLETED|Overall Study||6
10880885|NCT03681691|12046846|FG001|COMPLETED|Overall Study||3
10880886|NCT03681691|12046845|FG000|NOT COMPLETED|Overall Study||2
10880887|NCT03681691|12046846|FG001|NOT COMPLETED|Overall Study||1
10880888|NCT03681470|12046854|FG000|STARTED|Overall Study||20
10880889|NCT03681470|12046854|FG000|COMPLETED|Overall Study||12
10880890|NCT03681470|12046854|FG000|NOT COMPLETED|Overall Study||8
10880891|NCT03681184|12046860|FG000|STARTED|6-Month Double-Blind Period||13
10880892|NCT03681184|12046861|FG001|STARTED|6-Month Double-Blind Period||26
10880893|NCT03681184|12046860|FG000|COMPLETED|6-Month Double-Blind Period||13
10880894|NCT03681184|12046861|FG001|COMPLETED|6-Month Double-Blind Period||25
10880895|NCT03681184|12046860|FG000|NOT COMPLETED|6-Month Double-Blind Period||0
10880896|NCT03681184|12046861|FG001|NOT COMPLETED|6-Month Double-Blind Period||1
10880897|NCT03681184|12046860|FG000|STARTED|3-Month Blinded Extension Period||13
10880898|NCT03681184|12046861|FG001|STARTED|3-Month Blinded Extension Period|1 participant discontinued study drug and entered safety follow up after the DB period.|24
10880899|NCT03681184|12046860|FG000|COMPLETED|3-Month Blinded Extension Period||1
10880900|NCT03681184|12046861|FG001|COMPLETED|3-Month Blinded Extension Period||1
10880901|NCT03681184|12046860|FG000|NOT COMPLETED|3-Month Blinded Extension Period||12
10880902|NCT03681184|12046861|FG001|NOT COMPLETED|3-Month Blinded Extension Period||23
10880903|NCT03681184|12046860|FG000|STARTED|Open-Label Extension Period||1
10880904|NCT03681184|12046861|FG001|STARTED|Open-Label Extension Period||1
10880905|NCT03681184|12046860|FG000|COMPLETED|Open-Label Extension Period||0
10880906|NCT03681184|12046861|FG001|COMPLETED|Open-Label Extension Period||0
10880907|NCT03681184|12046860|FG000|NOT COMPLETED|Open-Label Extension Period||1
10880908|NCT03681184|12046861|FG001|NOT COMPLETED|Open-Label Extension Period||1
10880909|NCT03679767|12046871|FG000|STARTED|Overall Study||35
10880910|NCT03679767|12046872|FG001|STARTED|Overall Study||23
10880911|NCT03679767|12046873|FG002|STARTED|Overall Study||29
10880912|NCT03679767|12046874|FG003|STARTED|Overall Study||34
10880913|NCT03679767|12046871|FG000|COMPLETED|Overall Study||0
10880914|NCT03679767|12046872|FG001|COMPLETED|Overall Study||0
10880915|NCT03679767|12046873|FG002|COMPLETED|Overall Study||0
10880916|NCT03679767|12046874|FG003|COMPLETED|Overall Study||0
10880917|NCT03679767|12046871|FG000|NOT COMPLETED|Overall Study||35
10880918|NCT03679767|12046872|FG001|NOT COMPLETED|Overall Study||23
10880919|NCT03679767|12046873|FG002|NOT COMPLETED|Overall Study||29
10880920|NCT03679767|12046874|FG003|NOT COMPLETED|Overall Study||34
10880921|NCT03678675|12046888|FG000|STARTED|Overall Study||74
10880922|NCT03678675|12046889|FG001|STARTED|Overall Study||74
10880923|NCT03678675|12046888|FG000|COMPLETED|Overall Study||74
10880924|NCT03678675|12046889|FG001|COMPLETED|Overall Study||74
10880925|NCT03678675|12046888|FG000|NOT COMPLETED|Overall Study||0
10880926|NCT03678675|12046889|FG001|NOT COMPLETED|Overall Study||0
10880927|NCT03677869|12046897|FG000|STARTED|Overall Study||35
10880928|NCT03677869|12046897|FG000|COMPLETED|Overall Study||34
10880929|NCT03677869|12046897|FG000|NOT COMPLETED|Overall Study||1
10880930|NCT03674112|12046903|FG000|STARTED|Overall Study||80
10880931|NCT03674112|12046904|FG001|STARTED|Overall Study||80
10880932|NCT03674112|12046903|FG000|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
10880933|NCT03674112|12046904|FG001|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
10880934|NCT03674112|12046903|FG000|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||34
10880935|NCT03674112|12046904|FG001|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||36
10880936|NCT03674112|12046903|FG000|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
10880937|NCT03674112|12046904|FG001|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
10880938|NCT03674112|12046903|FG000|COMPLETED|Overall Study||0
10880939|NCT03674112|12046904|FG001|COMPLETED|Overall Study||0
10880940|NCT03674112|12046903|FG000|NOT COMPLETED|Overall Study||80
10880941|NCT03674112|12046904|FG001|NOT COMPLETED|Overall Study||80
10880942|NCT03673865|12046932|FG000|STARTED|Overall Study||13
10880943|NCT03673865|12046933|FG001|STARTED|Overall Study||12
10880944|NCT03673865|12046932|FG000|COMPLETED|Overall Study||13
10880945|NCT03673865|12046933|FG001|COMPLETED|Overall Study||12
10880946|NCT03673865|12046932|FG000|NOT COMPLETED|Overall Study||0
10880947|NCT03673865|12046933|FG001|NOT COMPLETED|Overall Study||0
10880948|NCT03673046|12046941|FG000|STARTED|Overall Study||40
10880949|NCT03673046|12046942|FG001|STARTED|Overall Study||40
10880950|NCT03673046|12046941|FG000|COMPLETED|Overall Study||31
10880951|NCT03673046|12046942|FG001|COMPLETED|Overall Study||37
10880952|NCT03673046|12046941|FG000|NOT COMPLETED|Overall Study||9
10880953|NCT03673046|12046942|FG001|NOT COMPLETED|Overall Study||3
10880954|NCT03670810|12046954|FG000|STARTED|Main Study||485
10880955|NCT03670810|12046955|FG001|STARTED|Main Study||486
10880956|NCT03670810|12046956|FG002|STARTED|Main Study||249
10880957|NCT03670810|12046957|FG003|STARTED|Main Study||251
10880958|NCT03670810|12046958|FG004|STARTED|Main Study||55
10880959|NCT03670810|12046959|FG005|STARTED|Main Study||53
10880960|NCT03670810|12046960|FG006|STARTED|Main Study||28
10880961|NCT03670810|12046961|FG007|STARTED|Main Study||26
10880962|NCT03670810|12046962|FG008|STARTED|Main Study||0
10880963|NCT03670810|12046954|FG000|Treated at Least One Migraine Attack|Main Study||485
10880964|NCT03670810|12046955|FG001|Treated at Least One Migraine Attack|Main Study||486
10880965|NCT03670810|12046956|FG002|Treated at Least One Migraine Attack|Main Study||249
10880966|NCT03670810|12046957|FG003|Treated at Least One Migraine Attack|Main Study||251
10880967|NCT03670810|12046958|FG004|Treated at Least One Migraine Attack|Main Study||55
10880968|NCT03670810|12046959|FG005|Treated at Least One Migraine Attack|Main Study||53
10880969|NCT03670810|12046960|FG006|Treated at Least One Migraine Attack|Main Study||28
10880970|NCT03670810|12046961|FG007|Treated at Least One Migraine Attack|Main Study||26
10880971|NCT03670810|12046962|FG008|Treated at Least One Migraine Attack|Main Study||0
10880972|NCT03670810|12046954|FG000|COMPLETED|Main Study||403
10880973|NCT03670810|12046955|FG001|COMPLETED|Main Study||394
10880974|NCT03670810|12046956|FG002|COMPLETED|Main Study||219
10880975|NCT03670810|12046957|FG003|COMPLETED|Main Study||223
10880976|NCT03670810|12046958|FG004|COMPLETED|Main Study||45
10880977|NCT03670810|12046959|FG005|COMPLETED|Main Study||46
10880978|NCT03670810|12046960|FG006|COMPLETED|Main Study||26
10880979|NCT03670810|12046961|FG007|COMPLETED|Main Study||23
10880980|NCT03670810|12046962|FG008|COMPLETED|Main Study||0
10880981|NCT03670810|12046954|FG000|NOT COMPLETED|Main Study||82
10880982|NCT03670810|12046955|FG001|NOT COMPLETED|Main Study||92
10880983|NCT03670810|12046956|FG002|NOT COMPLETED|Main Study||30
10880984|NCT03670810|12046957|FG003|NOT COMPLETED|Main Study||28
10880985|NCT03670810|12046958|FG004|NOT COMPLETED|Main Study||10
10880986|NCT03670810|12046959|FG005|NOT COMPLETED|Main Study||7
10880987|NCT03670810|12046960|FG006|NOT COMPLETED|Main Study||2
10880988|NCT03670810|12046961|FG007|NOT COMPLETED|Main Study||3
10880989|NCT03670810|12046962|FG008|NOT COMPLETED|Main Study||0
10880990|NCT03670810|12046954|FG000|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880991|NCT03670810|12046955|FG001|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880992|NCT03670810|12046956|FG002|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880993|NCT03670810|12046957|FG003|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880994|NCT03670810|12046958|FG004|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880995|NCT03670810|12046959|FG005|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880996|NCT03670810|12046960|FG006|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880997|NCT03670810|12046961|FG007|STARTED|Open Label Extension|Reported are only those participants who were enrolled in the OLE.|0
10880998|NCT03670810|12046962|FG008|STARTED|Open Label Extension||477
10880999|NCT03670810|12046954|FG000|Treated at Least One Migraine Attack|Open Label Extension||0
10881000|NCT03670810|12046955|FG001|Treated at Least One Migraine Attack|Open Label Extension||0
10881001|NCT03670810|12046956|FG002|Treated at Least One Migraine Attack|Open Label Extension||0
10881002|NCT03670810|12046957|FG003|Treated at Least One Migraine Attack|Open Label Extension||0
10881003|NCT03670810|12046958|FG004|Treated at Least One Migraine Attack|Open Label Extension||0
10881004|NCT03670810|12046959|FG005|Treated at Least One Migraine Attack|Open Label Extension||0
10881005|NCT03670810|12046960|FG006|Treated at Least One Migraine Attack|Open Label Extension||0
10881006|NCT03670810|12046961|FG007|Treated at Least One Migraine Attack|Open Label Extension||0
10881007|NCT03670810|12046962|FG008|Treated at Least One Migraine Attack|Open Label Extension|One participant signed consent but decided against participating in the OLE period and was not dosed.|476
10881008|NCT03670810|12046954|FG000|COMPLETED|Open Label Extension||0
10881009|NCT03670810|12046955|FG001|COMPLETED|Open Label Extension||0
10881010|NCT03670810|12046956|FG002|COMPLETED|Open Label Extension||0
10881011|NCT03670810|12046957|FG003|COMPLETED|Open Label Extension||0
10881012|NCT03670810|12046958|FG004|COMPLETED|Open Label Extension||0
10881013|NCT03670810|12046959|FG005|COMPLETED|Open Label Extension||0
10881014|NCT03670810|12046960|FG006|COMPLETED|Open Label Extension||0
10881015|NCT03670810|12046961|FG007|COMPLETED|Open Label Extension||0
10881016|NCT03670810|12046962|FG008|COMPLETED|Open Label Extension||324
10881017|NCT03670810|12046954|FG000|NOT COMPLETED|Open Label Extension||0
10881018|NCT03670810|12046955|FG001|NOT COMPLETED|Open Label Extension||0
10881019|NCT03670810|12046956|FG002|NOT COMPLETED|Open Label Extension||0
10881020|NCT03670810|12046957|FG003|NOT COMPLETED|Open Label Extension||0
10881021|NCT03670810|12046958|FG004|NOT COMPLETED|Open Label Extension||0
10881022|NCT03670810|12046959|FG005|NOT COMPLETED|Open Label Extension||0
10881023|NCT03670810|12046960|FG006|NOT COMPLETED|Open Label Extension||0
10881024|NCT03670810|12046961|FG007|NOT COMPLETED|Open Label Extension||0
10881025|NCT03670810|12046962|FG008|NOT COMPLETED|Open Label Extension||153
10881026|NCT03665441|12046978|FG000|STARTED|Overall Study||255
10881027|NCT03665441|12046979|FG001|STARTED|Overall Study||257
10881028|NCT03665441|12046978|FG000|COMPLETED|Overall Study||216
10881029|NCT03665441|12046979|FG001|COMPLETED|Overall Study||240
10881030|NCT03665441|12046978|FG000|NOT COMPLETED|Overall Study||39
10881031|NCT03665441|12046979|FG001|NOT COMPLETED|Overall Study||17
10881032|NCT03665038|12046988|FG000|STARTED|Overall Study||8
10881033|NCT03665038|12046989|FG001|STARTED|Overall Study||8
10881034|NCT03665038|12046990|FG002|STARTED|Overall Study||12
10881035|NCT03665038|12046988|FG000|COMPLETED|Overall Study||8
10881036|NCT03665038|12046989|FG001|COMPLETED|Overall Study||8
10881037|NCT03665038|12046990|FG002|COMPLETED|Overall Study||11
10881038|NCT03665038|12046988|FG000|NOT COMPLETED|Overall Study||0
10881039|NCT03665038|12046989|FG001|NOT COMPLETED|Overall Study||0
10881040|NCT03665038|12046990|FG002|NOT COMPLETED|Overall Study||1
10881041|NCT03664726|12047004|FG000|STARTED|Overall Study||21
10881042|NCT03664726|12047005|FG001|STARTED|Overall Study||20
10881043|NCT03664726|12047006|FG002|STARTED|Overall Study||18
10881044|NCT03664726|12047007|FG003|STARTED|Overall Study||19
10881045|NCT03664726|12047004|FG000|COMPLETED|Overall Study||21
10881046|NCT03664726|12047005|FG001|COMPLETED|Overall Study||20
10881047|NCT03664726|12047006|FG002|COMPLETED|Overall Study||18
10881048|NCT03664726|12047007|FG003|COMPLETED|Overall Study||19
10881049|NCT03664726|12047004|FG000|NOT COMPLETED|Overall Study||0
10881050|NCT03664726|12047005|FG001|NOT COMPLETED|Overall Study||0
10881051|NCT03664726|12047006|FG002|NOT COMPLETED|Overall Study||0
10881052|NCT03664726|12047007|FG003|NOT COMPLETED|Overall Study||0
10881053|NCT03663179|12047025|FG000|STARTED|Overall Study||18
10881054|NCT03663179|12047026|FG001|STARTED|Overall Study||14
10881055|NCT03663179|12047025|FG000|COMPLETED|Overall Study||14
10881056|NCT03663179|12047026|FG001|COMPLETED|Overall Study||13
10881057|NCT03663179|12047025|FG000|NOT COMPLETED|Overall Study||4
10881058|NCT03663179|12047026|FG001|NOT COMPLETED|Overall Study||1
10881059|NCT03662659|12047034|FG000|STARTED|Pre-treatment||138
10881060|NCT03662659|12047035|FG001|STARTED|Pre-treatment||136
10881061|NCT03662659|12047034|FG000|COMPLETED|Pre-treatment||136
10881062|NCT03662659|12047035|FG001|COMPLETED|Pre-treatment||135
10881063|NCT03662659|12047034|FG000|NOT COMPLETED|Pre-treatment||2
10881064|NCT03662659|12047035|FG001|NOT COMPLETED|Pre-treatment||1
10881065|NCT03662659|12047034|FG000|STARTED|Treatment||136
10881066|NCT03662659|12047035|FG001|STARTED|Treatment||135
10881067|NCT03662659|12047034|FG000|COMPLETED|Treatment||21
10881068|NCT03662659|12047035|FG001|COMPLETED|Treatment||29
10881069|NCT03662659|12047034|FG000|NOT COMPLETED|Treatment||115
10881070|NCT03662659|12047035|FG001|NOT COMPLETED|Treatment||106
10881071|NCT03662074|12047041|FG000|STARTED|Overall Study||14
10881072|NCT03662074|12047041|FG000|COMPLETED|Overall Study||14
10881073|NCT03662074|12047041|FG000|NOT COMPLETED|Overall Study||0
10881074|NCT03655756|12047045|FG000|STARTED|Overall Study||7
10881075|NCT03655756|12047045|FG000|COMPLETED|Overall Study||6
10881076|NCT03655756|12047045|FG000|NOT COMPLETED|Overall Study||1
10881077|NCT03655717|12047051|FG000|STARTED|Overall Study||70
10881078|NCT03655717|12047052|FG001|STARTED|Overall Study||68
10881079|NCT03655717|12047053|FG002|STARTED|Overall Study||2
10881080|NCT03655717|12047054|FG003|STARTED|Overall Study||1
10881081|NCT03655717|12047055|FG004|STARTED|Overall Study||0
10881082|NCT03655717|12047056|FG005|STARTED|Overall Study||3
10881083|NCT03655717|12047057|FG006|STARTED|Overall Study||3
10881084|NCT03655717|12047058|FG007|STARTED|Overall Study||3
10881085|NCT03655717|12047059|FG008|STARTED|Overall Study||2
10881086|NCT03655717|12047060|FG009|STARTED|Overall Study||1
10881087|NCT03655717|12047061|FG010|STARTED|Overall Study||1
10881088|NCT03655717|12047062|FG011|STARTED|Overall Study||3
10881089|NCT03655717|12047063|FG012|STARTED|Overall Study||2
10881090|NCT03655717|12047064|FG013|STARTED|Overall Study||3
10881091|NCT03655717|12047065|FG014|STARTED|Overall Study||2
10881092|NCT03655717|12047066|FG015|STARTED|Overall Study||2
10881093|NCT03655717|12047067|FG016|STARTED|Overall Study||2
10881094|NCT03655717|12047068|FG017|STARTED|Overall Study||2
10881095|NCT03655717|12047069|FG018|STARTED|Overall Study||3
10881096|NCT03655717|12047070|FG019|STARTED|Overall Study||3
10881097|NCT03655717|12047071|FG020|STARTED|Overall Study||2
10881098|NCT03655717|12047072|FG021|STARTED|Overall Study||3
10881099|NCT03655717|12047073|FG022|STARTED|Overall Study||2
10881100|NCT03655717|12047074|FG023|STARTED|Overall Study||4
10881101|NCT03655717|12047075|FG024|STARTED|Overall Study||1
10881102|NCT03655717|12047076|FG025|STARTED|Overall Study||2
10881103|NCT03655717|12047051|FG000|COMPLETED|Overall Study||60
10881104|NCT03655717|12047052|FG001|COMPLETED|Overall Study||56
10881105|NCT03655717|12047053|FG002|COMPLETED|Overall Study||1
10881106|NCT03655717|12047054|FG003|COMPLETED|Overall Study||0
10881107|NCT03655717|12047055|FG004|COMPLETED|Overall Study||0
10881108|NCT03655717|12047056|FG005|COMPLETED|Overall Study||1
10881109|NCT03655717|12047057|FG006|COMPLETED|Overall Study||0
10881110|NCT03655717|12047058|FG007|COMPLETED|Overall Study||2
10881111|NCT03655717|12047059|FG008|COMPLETED|Overall Study||0
10881112|NCT03655717|12047060|FG009|COMPLETED|Overall Study||0
10881113|NCT03655717|12047061|FG010|COMPLETED|Overall Study||1
10881114|NCT03655717|12047062|FG011|COMPLETED|Overall Study||1
10881115|NCT03655717|12047063|FG012|COMPLETED|Overall Study||2
10881116|NCT03655717|12047064|FG013|COMPLETED|Overall Study||0
10881117|NCT03655717|12047065|FG014|COMPLETED|Overall Study||2
10881118|NCT03655717|12047066|FG015|COMPLETED|Overall Study||1
10881119|NCT03655717|12047067|FG016|COMPLETED|Overall Study||2
10881120|NCT03655717|12047068|FG017|COMPLETED|Overall Study||2
10881121|NCT03655717|12047069|FG018|COMPLETED|Overall Study||2
10881122|NCT03655717|12047070|FG019|COMPLETED|Overall Study||2
10881123|NCT03655717|12047071|FG020|COMPLETED|Overall Study||2
10881124|NCT03655717|12047072|FG021|COMPLETED|Overall Study||2
10881125|NCT03655717|12047073|FG022|COMPLETED|Overall Study||0
10881126|NCT03655717|12047074|FG023|COMPLETED|Overall Study||2
10881127|NCT03655717|12047075|FG024|COMPLETED|Overall Study||0
10881128|NCT03655717|12047076|FG025|COMPLETED|Overall Study||2
10881129|NCT03655717|12047051|FG000|NOT COMPLETED|Overall Study||10
10881130|NCT03655717|12047052|FG001|NOT COMPLETED|Overall Study||12
10881131|NCT03655717|12047053|FG002|NOT COMPLETED|Overall Study||1
10881132|NCT03655717|12047054|FG003|NOT COMPLETED|Overall Study||1
10881133|NCT03655717|12047055|FG004|NOT COMPLETED|Overall Study||0
10881134|NCT03655717|12047056|FG005|NOT COMPLETED|Overall Study||2
10881135|NCT03655717|12047057|FG006|NOT COMPLETED|Overall Study||3
10881136|NCT03655717|12047058|FG007|NOT COMPLETED|Overall Study||1
10881137|NCT03655717|12047059|FG008|NOT COMPLETED|Overall Study||2
10881138|NCT03655717|12047060|FG009|NOT COMPLETED|Overall Study||1
10881139|NCT03655717|12047061|FG010|NOT COMPLETED|Overall Study||0
10881140|NCT03655717|12047062|FG011|NOT COMPLETED|Overall Study||2
10881141|NCT03655717|12047063|FG012|NOT COMPLETED|Overall Study||0
10881142|NCT03655717|12047064|FG013|NOT COMPLETED|Overall Study||3
10881143|NCT03655717|12047065|FG014|NOT COMPLETED|Overall Study||0
10881144|NCT03655717|12047066|FG015|NOT COMPLETED|Overall Study||1
10881145|NCT03655717|12047067|FG016|NOT COMPLETED|Overall Study||0
10881146|NCT03655717|12047068|FG017|NOT COMPLETED|Overall Study||0
10881147|NCT03655717|12047069|FG018|NOT COMPLETED|Overall Study||1
10881148|NCT03655717|12047070|FG019|NOT COMPLETED|Overall Study||1
10881149|NCT03655717|12047071|FG020|NOT COMPLETED|Overall Study||0
10881150|NCT03655717|12047072|FG021|NOT COMPLETED|Overall Study||1
10881151|NCT03655717|12047073|FG022|NOT COMPLETED|Overall Study||2
10881152|NCT03655717|12047074|FG023|NOT COMPLETED|Overall Study||2
10881153|NCT03655717|12047075|FG024|NOT COMPLETED|Overall Study||1
10881154|NCT03655717|12047076|FG025|NOT COMPLETED|Overall Study||0
10881155|NCT03647267|12047092|FG000|STARTED|Overall Study||24
10881156|NCT03647267|12047093|FG001|STARTED|Overall Study||22
10881157|NCT03647267|12047092|FG000|COMPLETED|Overall Study||23
10881158|NCT03647267|12047093|FG001|COMPLETED|Overall Study||22
10881159|NCT03647267|12047092|FG000|NOT COMPLETED|Overall Study||1
10881160|NCT03647267|12047093|FG001|NOT COMPLETED|Overall Study||0
10881161|NCT03646188|12047106|FG000|STARTED|Overall Study||3
10881162|NCT03646188|12047107|FG001|STARTED|Overall Study||3
10881163|NCT03646188|12047108|FG002|STARTED|Overall Study||3
10881164|NCT03646188|12047109|FG003|STARTED|Overall Study||3
10881165|NCT03646188|12047110|FG004|STARTED|Overall Study||1
10881166|NCT03646188|12047106|FG000|COMPLETED|Overall Study||3
10881167|NCT03646188|12047107|FG001|COMPLETED|Overall Study||3
10881168|NCT03646188|12047108|FG002|COMPLETED|Overall Study||3
10881169|NCT03646188|12047109|FG003|COMPLETED|Overall Study||3
10881170|NCT03646188|12047110|FG004|COMPLETED|Overall Study||1
10881171|NCT03646188|12047106|FG000|NOT COMPLETED|Overall Study||0
10881172|NCT03646188|12047107|FG001|NOT COMPLETED|Overall Study||0
10881173|NCT03646188|12047108|FG002|NOT COMPLETED|Overall Study||0
10881174|NCT03646188|12047109|FG003|NOT COMPLETED|Overall Study||0
10881175|NCT03646188|12047110|FG004|NOT COMPLETED|Overall Study||0
10881176|NCT03645395|12047126|FG000|STARTED|Part 1 (Up to 6 Months)||3
10881177|NCT03645395|12047127|FG001|STARTED|Part 1 (Up to 6 Months)||3
10881178|NCT03645395|12047128|FG002|STARTED|Part 1 (Up to 6 Months)||3
10881179|NCT03645395|12047129|FG003|STARTED|Part 1 (Up to 6 Months)||0
10881180|NCT03645395|12047126|FG000|COMPLETED|Part 1 (Up to 6 Months)||1
10881181|NCT03645395|12047127|FG001|COMPLETED|Part 1 (Up to 6 Months)||0
10881182|NCT03645395|12047128|FG002|COMPLETED|Part 1 (Up to 6 Months)||0
10881183|NCT03645395|12047129|FG003|COMPLETED|Part 1 (Up to 6 Months)||0
10881184|NCT03645395|12047126|FG000|NOT COMPLETED|Part 1 (Up to 6 Months)||2
10881185|NCT03645395|12047127|FG001|NOT COMPLETED|Part 1 (Up to 6 Months)||3
10881186|NCT03645395|12047128|FG002|NOT COMPLETED|Part 1 (Up to 6 Months)||3
10881187|NCT03645395|12047129|FG003|NOT COMPLETED|Part 1 (Up to 6 Months)||0
10881188|NCT03645395|12047126|FG000|STARTED|Part 2 (Up to 6 Months)||0
10881189|NCT03645395|12047127|FG001|STARTED|Part 2 (Up to 6 Months)||0
10881190|NCT03645395|12047128|FG002|STARTED|Part 2 (Up to 6 Months)||0
10881191|NCT03645395|12047129|FG003|STARTED|Part 2 (Up to 6 Months)||0
10881192|NCT03645395|12047126|FG000|COMPLETED|Part 2 (Up to 6 Months)||0
10881193|NCT03645395|12047127|FG001|COMPLETED|Part 2 (Up to 6 Months)||0
10881194|NCT03645395|12047128|FG002|COMPLETED|Part 2 (Up to 6 Months)||0
10881195|NCT03645395|12047129|FG003|COMPLETED|Part 2 (Up to 6 Months)||0
10881196|NCT03645395|12047126|FG000|NOT COMPLETED|Part 2 (Up to 6 Months)||0
10881197|NCT03645395|12047127|FG001|NOT COMPLETED|Part 2 (Up to 6 Months)||0
10881198|NCT03645395|12047128|FG002|NOT COMPLETED|Part 2 (Up to 6 Months)||0
10881199|NCT03645395|12047129|FG003|NOT COMPLETED|Part 2 (Up to 6 Months)||0
10881200|NCT03641651|12047140|FG000|STARTED|Overall Study||15
10881201|NCT03641651|12047140|FG000|COMPLETED|Overall Study||14
10881202|NCT03641651|12047140|FG000|NOT COMPLETED|Overall Study||1
10881203|NCT03638258|12047147|FG000|STARTED|Overall Study||109
10881204|NCT03638258|12047148|FG001|STARTED|Overall Study||113
10881205|NCT03638258|12047149|FG002|STARTED|Overall Study||109
10881206|NCT03638258|12047147|FG000|COMPLETED|Overall Study||102
10881207|NCT03638258|12047148|FG001|COMPLETED|Overall Study||104
10881208|NCT03638258|12047149|FG002|COMPLETED|Overall Study||86
10881209|NCT03638258|12047147|FG000|NOT COMPLETED|Overall Study||7
10881210|NCT03638258|12047148|FG001|NOT COMPLETED|Overall Study||9
10881211|NCT03638258|12047149|FG002|NOT COMPLETED|Overall Study||23
10881212|NCT03637374|12047160|FG000|STARTED|Overall Study||2
10881213|NCT03637374|12047161|FG001|STARTED|Overall Study||0
10881214|NCT03637374|12047160|FG000|COMPLETED|Overall Study||0
10881215|NCT03637374|12047161|FG001|COMPLETED|Overall Study||0
10881216|NCT03637374|12047160|FG000|NOT COMPLETED|Overall Study||2
10881217|NCT03637374|12047161|FG001|NOT COMPLETED|Overall Study||0
10881218|NCT03636906|12047170|FG000|STARTED|Overall Study||65
10881219|NCT03636906|12047171|FG001|STARTED|Overall Study||71
10881220|NCT03636906|12047172|FG002|STARTED|Overall Study||65
10881221|NCT03636906|12047170|FG000|COMPLETED|Overall Study||61
10881222|NCT03636906|12047171|FG001|COMPLETED|Overall Study||71
10881223|NCT03636906|12047172|FG002|COMPLETED|Overall Study||60
10881224|NCT03636906|12047170|FG000|NOT COMPLETED|Overall Study||4
10881225|NCT03636906|12047171|FG001|NOT COMPLETED|Overall Study||0
10881226|NCT03636906|12047172|FG002|NOT COMPLETED|Overall Study||5
10881227|NCT03635099|12047194|FG000|STARTED|Period 1||20
10881228|NCT03635099|12047195|FG001|STARTED|Period 1||40
10881229|NCT03635099|12047196|FG002|STARTED|Period 1||39
10881230|NCT03635099|12047197|FG003|STARTED|Period 1||39
10881231|NCT03635099|12047198|FG004|STARTED|Period 1||40
10881232|NCT03635099|12047199|FG005|STARTED|Period 1||10
10881233|NCT03635099|12047200|FG006|STARTED|Period 1||44
10881234|NCT03635099|12047201|FG007|STARTED|Period 1||42
10881235|NCT03635099|12047194|FG000|Full Analysis Set (FAS)|Period 1||20
10881236|NCT03635099|12047195|FG001|Full Analysis Set (FAS)|Period 1||40
10881237|NCT03635099|12047196|FG002|Full Analysis Set (FAS)|Period 1||39
10881238|NCT03635099|12047197|FG003|Full Analysis Set (FAS)|Period 1||39
10881239|NCT03635099|12047198|FG004|Full Analysis Set (FAS)|Period 1||40
10881240|NCT03635099|12047199|FG005|Full Analysis Set (FAS)|Period 1||10
10881241|NCT03635099|12047200|FG006|Full Analysis Set (FAS)|Period 1||43
10881242|NCT03635099|12047201|FG007|Full Analysis Set (FAS)|Period 1||42
10881243|NCT03635099|12047194|FG000|COMPLETED|Period 1||16
10881244|NCT03635099|12047195|FG001|COMPLETED|Period 1||37
10881245|NCT03635099|12047196|FG002|COMPLETED|Period 1||31
10881246|NCT03635099|12047197|FG003|COMPLETED|Period 1||34
10881247|NCT03635099|12047198|FG004|COMPLETED|Period 1||37
10881248|NCT03635099|12047199|FG005|COMPLETED|Period 1||9
10881249|NCT03635099|12047200|FG006|COMPLETED|Period 1||40
10881250|NCT03635099|12047201|FG007|COMPLETED|Period 1||40
10881251|NCT03635099|12047194|FG000|NOT COMPLETED|Period 1||4
10881252|NCT03635099|12047195|FG001|NOT COMPLETED|Period 1||3
10881253|NCT03635099|12047196|FG002|NOT COMPLETED|Period 1||8
10881254|NCT03635099|12047197|FG003|NOT COMPLETED|Period 1||5
10881255|NCT03635099|12047198|FG004|NOT COMPLETED|Period 1||3
10881256|NCT03635099|12047199|FG005|NOT COMPLETED|Period 1||1
10881257|NCT03635099|12047200|FG006|NOT COMPLETED|Period 1||4
10881258|NCT03635099|12047201|FG007|NOT COMPLETED|Period 1||2
10881259|NCT03635099|12047194|FG000|STARTED|Not Eligible for Period 2||16
10881260|NCT03635099|12047195|FG001|STARTED|Not Eligible for Period 2||37
10881261|NCT03635099|12047196|FG002|STARTED|Not Eligible for Period 2||31
10881262|NCT03635099|12047197|FG003|STARTED|Not Eligible for Period 2||34
10881263|NCT03635099|12047198|FG004|STARTED|Not Eligible for Period 2||37
10881264|NCT03635099|12047199|FG005|STARTED|Not Eligible for Period 2||9
10881265|NCT03635099|12047200|FG006|STARTED|Not Eligible for Period 2||40
10881266|NCT03635099|12047201|FG007|STARTED|Not Eligible for Period 2||40
10881267|NCT03635099|12047194|FG000|COMPLETED|Not Eligible for Period 2||15
10881268|NCT03635099|12047195|FG001|COMPLETED|Not Eligible for Period 2||37
10881269|NCT03635099|12047196|FG002|COMPLETED|Not Eligible for Period 2||31
10881270|NCT03635099|12047197|FG003|COMPLETED|Not Eligible for Period 2||33
10881271|NCT03635099|12047198|FG004|COMPLETED|Not Eligible for Period 2||37
10881272|NCT03635099|12047199|FG005|COMPLETED|Not Eligible for Period 2||0
10881273|NCT03635099|12047200|FG006|COMPLETED|Not Eligible for Period 2||0
10881274|NCT03635099|12047201|FG007|COMPLETED|Not Eligible for Period 2||0
10881275|NCT03635099|12047194|FG000|NOT COMPLETED|Not Eligible for Period 2||1
10881276|NCT03635099|12047195|FG001|NOT COMPLETED|Not Eligible for Period 2||0
10881277|NCT03635099|12047196|FG002|NOT COMPLETED|Not Eligible for Period 2||0
10881278|NCT03635099|12047197|FG003|NOT COMPLETED|Not Eligible for Period 2||1
10881279|NCT03635099|12047198|FG004|NOT COMPLETED|Not Eligible for Period 2||0
10881280|NCT03635099|12047199|FG005|NOT COMPLETED|Not Eligible for Period 2||9
10881281|NCT03635099|12047200|FG006|NOT COMPLETED|Not Eligible for Period 2||40
10881282|NCT03635099|12047201|FG007|NOT COMPLETED|Not Eligible for Period 2||40
10881283|NCT03635099|12047194|FG000|STARTED|Eligible for Period 2||15
10881284|NCT03635099|12047195|FG001|STARTED|Eligible for Period 2||37
10881285|NCT03635099|12047196|FG002|STARTED|Eligible for Period 2||31
10881286|NCT03635099|12047197|FG003|STARTED|Eligible for Period 2||33
10881287|NCT03635099|12047198|FG004|STARTED|Eligible for Period 2||37
10881288|NCT03635099|12047199|FG005|STARTED|Eligible for Period 2||0
10881289|NCT03635099|12047200|FG006|STARTED|Eligible for Period 2||0
10881290|NCT03635099|12047201|FG007|STARTED|Eligible for Period 2||0
10881291|NCT03635099|12047194|FG000|Switching Patients|Eligible for Period 2|Switched to the 'BI 200 mg' dose group.|15
10881292|NCT03635099|12047195|FG001|Switching Patients|Eligible for Period 2|Switched to the 'BI 50 mg' dose group.|35
10881293|NCT03635099|12047196|FG002|Switching Patients|Eligible for Period 2|Switched to the 'BI 100 mg' dose group.|21
10881294|NCT03635099|12047197|FG003|Switching Patients|Eligible for Period 2|Switched to the 'BI 200 mg' dose group.|25
10881295|NCT03635099|12047198|FG004|Switching Patients|Eligible for Period 2||0
10881296|NCT03635099|12047199|FG005|Switching Patients|Eligible for Period 2||0
10881297|NCT03635099|12047200|FG006|Switching Patients|Eligible for Period 2||0
10881298|NCT03635099|12047201|FG007|Switching Patients|Eligible for Period 2||0
10881299|NCT03635099|12047194|FG000|Non Switching Patients|Eligible for Period 2||0
10881300|NCT03635099|12047195|FG001|Non Switching Patients|Eligible for Period 2||2
10881301|NCT03635099|12047196|FG002|Non Switching Patients|Eligible for Period 2||10
10881302|NCT03635099|12047197|FG003|Non Switching Patients|Eligible for Period 2||8
10881303|NCT03635099|12047198|FG004|Non Switching Patients|Eligible for Period 2||37
10881304|NCT03635099|12047199|FG005|Non Switching Patients|Eligible for Period 2||0
10881305|NCT03635099|12047200|FG006|Non Switching Patients|Eligible for Period 2||0
10881306|NCT03635099|12047201|FG007|Non Switching Patients|Eligible for Period 2||0
10881307|NCT03635099|12047194|FG000|COMPLETED|Eligible for Period 2||0
10881308|NCT03635099|12047195|FG001|COMPLETED|Eligible for Period 2||2
10881309|NCT03635099|12047196|FG002|COMPLETED|Eligible for Period 2||10
10881310|NCT03635099|12047197|FG003|COMPLETED|Eligible for Period 2||8
10881311|NCT03635099|12047198|FG004|COMPLETED|Eligible for Period 2||37
10881312|NCT03635099|12047199|FG005|COMPLETED|Eligible for Period 2||0
10881313|NCT03635099|12047200|FG006|COMPLETED|Eligible for Period 2||0
10881314|NCT03635099|12047201|FG007|COMPLETED|Eligible for Period 2||0
10881315|NCT03635099|12047194|FG000|NOT COMPLETED|Eligible for Period 2||15
10881316|NCT03635099|12047195|FG001|NOT COMPLETED|Eligible for Period 2||35
10881317|NCT03635099|12047196|FG002|NOT COMPLETED|Eligible for Period 2||21
10881318|NCT03635099|12047197|FG003|NOT COMPLETED|Eligible for Period 2||25
10881319|NCT03635099|12047198|FG004|NOT COMPLETED|Eligible for Period 2||0
10881320|NCT03635099|12047199|FG005|NOT COMPLETED|Eligible for Period 2||0
10881321|NCT03635099|12047200|FG006|NOT COMPLETED|Eligible for Period 2||0
10881322|NCT03635099|12047201|FG007|NOT COMPLETED|Eligible for Period 2||0
10881323|NCT03635099|12047194|FG000|STARTED|Period 2||0
10881324|NCT03635099|12047195|FG001|STARTED|Period 2||2
10881325|NCT03635099|12047196|FG002|STARTED|Period 2|"Combination of period 1 dose groups: BI 50 mg and switched patients from dose Group BI 25 mg"|45
10881326|NCT03635099|12047197|FG003|STARTED|Period 2|"Combination of period 1 dose groups: BI 100 mg and switched patients from dose Group BI 50 mg"|29
10881327|NCT03635099|12047198|FG004|STARTED|Period 2|"Combination of period 1: BI 200mg, switched patients from dose Group BI 100 mg and Placebo."|77
10881328|NCT03635099|12047199|FG005|STARTED|Period 2||0
10881329|NCT03635099|12047200|FG006|STARTED|Period 2||0
10881330|NCT03635099|12047201|FG007|STARTED|Period 2||0
10881331|NCT03635099|12047194|FG000|COMPLETED|Period 2||0
10881332|NCT03635099|12047195|FG001|COMPLETED|Period 2||2
10881333|NCT03635099|12047196|FG002|COMPLETED|Period 2||36
10881334|NCT03635099|12047197|FG003|COMPLETED|Period 2||25
10881335|NCT03635099|12047198|FG004|COMPLETED|Period 2||65
10881336|NCT03635099|12047199|FG005|COMPLETED|Period 2||0
10881337|NCT03635099|12047200|FG006|COMPLETED|Period 2||0
10881338|NCT03635099|12047201|FG007|COMPLETED|Period 2||0
10881339|NCT03635099|12047194|FG000|NOT COMPLETED|Period 2||0
10881340|NCT03635099|12047195|FG001|NOT COMPLETED|Period 2||0
10881341|NCT03635099|12047196|FG002|NOT COMPLETED|Period 2||9
10881342|NCT03635099|12047197|FG003|NOT COMPLETED|Period 2||4
10881343|NCT03635099|12047198|FG004|NOT COMPLETED|Period 2||12
10881344|NCT03635099|12047199|FG005|NOT COMPLETED|Period 2||0
10881345|NCT03635099|12047200|FG006|NOT COMPLETED|Period 2||0
10881346|NCT03635099|12047201|FG007|NOT COMPLETED|Period 2||0
10881347|NCT03633227|12047229|FG000|STARTED|Double Blind (DB), up to Week 48||12
10881348|NCT03633227|12047230|FG001|STARTED|Double Blind (DB), up to Week 48||10
10881349|NCT03633227|12047229|FG000|COMPLETED|Double Blind (DB), up to Week 48||4
10881350|NCT03633227|12047230|FG001|COMPLETED|Double Blind (DB), up to Week 48||6
10881351|NCT03633227|12047229|FG000|NOT COMPLETED|Double Blind (DB), up to Week 48||8
10881352|NCT03633227|12047230|FG001|NOT COMPLETED|Double Blind (DB), up to Week 48||4
10881353|NCT03633227|12047229|FG000|STARTED|DB Extension, Week 48 up to 3 Years||4
10881354|NCT03633227|12047230|FG001|STARTED|DB Extension, Week 48 up to 3 Years||6
10881355|NCT03633227|12047229|FG000|COMPLETED|DB Extension, Week 48 up to 3 Years||0
10881356|NCT03633227|12047230|FG001|COMPLETED|DB Extension, Week 48 up to 3 Years||0
10881357|NCT03633227|12047229|FG000|NOT COMPLETED|DB Extension, Week 48 up to 3 Years||4
10881358|NCT03633227|12047230|FG001|NOT COMPLETED|DB Extension, Week 48 up to 3 Years||6
10881359|NCT03631550|12047243|FG000|STARTED|Overall Study||94
10881360|NCT03631550|12047244|FG001|STARTED|Overall Study||93
10881361|NCT03631550|12047243|FG000|The ITT Analysis Set|Overall Study||67
10881362|NCT03631550|12047244|FG001|The ITT Analysis Set|Overall Study||64
10881363|NCT03631550|12047243|FG000|The mITT Analysis Set|Overall Study||50
10881364|NCT03631550|12047244|FG001|The mITT Analysis Set|Overall Study||59
10881365|NCT03631550|12047243|FG000|COMPLETED|Overall Study||67
10881366|NCT03631550|12047244|FG001|COMPLETED|Overall Study||64
10881367|NCT03631550|12047243|FG000|NOT COMPLETED|Overall Study||27
10881368|NCT03631550|12047244|FG001|NOT COMPLETED|Overall Study||29
10881375|NCT03624881|12047261|FG000|STARTED|Overall Study||283
10881376|NCT03624881|12047262|FG001|STARTED|Overall Study||50
10881377|NCT03624881|12047261|FG000|Safety Set|Overall Study||261
10881378|NCT03624881|12047262|FG001|Safety Set|Overall Study||49
10881379|NCT03624881|12047261|FG000|COMPLETED|Overall Study||237
10881380|NCT03624881|12047262|FG001|COMPLETED|Overall Study||44
10881381|NCT03624881|12047261|FG000|NOT COMPLETED|Overall Study||46
10881382|NCT03624881|12047262|FG001|NOT COMPLETED|Overall Study||6
10881383|NCT03622593|12047271|FG000|STARTED|Overall Study||317
10881384|NCT03622593|12047272|FG001|STARTED|Overall Study||319
10881385|NCT03622593|12047273|FG002|STARTED|Overall Study||315
10881386|NCT03622593|12047271|FG000|Received at Least One Dose of Study Drug|Overall Study||317
10881387|NCT03622593|12047272|FG001|Received at Least One Dose of Study Drug|Overall Study||319
10881388|NCT03622593|12047273|FG002|Received at Least One Dose of Study Drug|Overall Study||314
10881389|NCT03622593|12047271|FG000|Completed up to Week 56|Overall Study||298
10881390|NCT03622593|12047272|FG001|Completed up to Week 56|Overall Study||312
10881391|NCT03622593|12047273|FG002|Completed up to Week 56|Overall Study||299
10881392|NCT03622593|12047271|FG000|COMPLETED|Overall Study||275
10881393|NCT03622593|12047272|FG001|COMPLETED|Overall Study||288
10881394|NCT03622593|12047273|FG002|COMPLETED|Overall Study||267
10881395|NCT03622593|12047271|FG000|NOT COMPLETED|Overall Study||42
10881396|NCT03622593|12047272|FG001|NOT COMPLETED|Overall Study||31
10881397|NCT03622593|12047273|FG002|NOT COMPLETED|Overall Study||48
10881398|NCT03622580|12047285|FG000|STARTED|Overall Study||315
10881399|NCT03622580|12047286|FG001|STARTED|Overall Study||313
10881400|NCT03622580|12047287|FG002|STARTED|Overall Study||312
10881401|NCT03622580|12047285|FG000|Received at Least One Dose of Study Drug|Overall Study||313
10881402|NCT03622580|12047286|FG001|Received at Least One Dose of Study Drug|Overall Study||313
10881403|NCT03622580|12047287|FG002|Received at Least One Dose of Study Drug|Overall Study||311
10881404|NCT03622580|12047285|FG000|Completed up to Week 56|Overall Study||291
10881405|NCT03622580|12047286|FG001|Completed up to Week 56|Overall Study||289
10881406|NCT03622580|12047287|FG002|Completed up to Week 56|Overall Study||292
10881407|NCT03622580|12047285|FG000|COMPLETED|Overall Study||263
10881408|NCT03622580|12047286|FG001|COMPLETED|Overall Study||269
10881409|NCT03622580|12047287|FG002|COMPLETED|Overall Study||260
10881410|NCT03622580|12047285|FG000|NOT COMPLETED|Overall Study||52
10881411|NCT03622580|12047286|FG001|NOT COMPLETED|Overall Study||44
10881412|NCT03622580|12047287|FG002|NOT COMPLETED|Overall Study||52
10881413|NCT03619174|12047298|FG000|STARTED|Overall Study|First subject enrolled 8/8/2018. Last subject, last visit, 7/5/2019|66
10881414|NCT03619174|12047299|FG001|STARTED|Overall Study|First subject enrolled 8/8/2018. Last subject, last visit, 7/5/2019|33
10881415|NCT03619174|12047298|FG000|COMPLETED|Overall Study||57
10881416|NCT03619174|12047299|FG001|COMPLETED|Overall Study||29
10881417|NCT03619174|12047298|FG000|NOT COMPLETED|Overall Study||9
10881418|NCT03619174|12047299|FG001|NOT COMPLETED|Overall Study||4
10881419|NCT03618641|12047305|FG000|STARTED|Overall Study||34
10881420|NCT03618641|12047305|FG000|COMPLETED|Overall Study||34
10881421|NCT03618641|12047305|FG000|NOT COMPLETED|Overall Study||0
10881422|NCT03611101|12047313|FG000|STARTED|Overall Study||32
10881423|NCT03611101|12047314|FG001|STARTED|Overall Study||32
10881424|NCT03611101|12047315|FG002|STARTED|Overall Study||30
10881425|NCT03611101|12047316|FG003|STARTED|Overall Study||30
10881426|NCT03611101|12047313|FG000|COMPLETED|Overall Study||25
10881427|NCT03611101|12047314|FG001|COMPLETED|Overall Study||28
10881428|NCT03611101|12047315|FG002|COMPLETED|Overall Study||27
10881429|NCT03611101|12047316|FG003|COMPLETED|Overall Study||23
10881430|NCT03611101|12047313|FG000|NOT COMPLETED|Overall Study||7
10881431|NCT03611101|12047314|FG001|NOT COMPLETED|Overall Study||4
10881432|NCT03611101|12047315|FG002|NOT COMPLETED|Overall Study||3
10881433|NCT03611101|12047316|FG003|NOT COMPLETED|Overall Study||7
10881434|NCT03607487|12047358|FG000|STARTED|Overall Study||9
10881435|NCT03607487|12047359|FG001|STARTED|Overall Study||9
10881436|NCT03607487|12047360|FG002|STARTED|Overall Study||9
10881437|NCT03607487|12047361|FG003|STARTED|Overall Study||8
10881438|NCT03607487|12047358|FG000|COMPLETED|Overall Study||7
10881439|NCT03607487|12047359|FG001|COMPLETED|Overall Study||9
10881440|NCT03607487|12047360|FG002|COMPLETED|Overall Study||9
10881441|NCT03607487|12047361|FG003|COMPLETED|Overall Study||7
10881442|NCT03607487|12047358|FG000|NOT COMPLETED|Overall Study||2
10881443|NCT03607487|12047359|FG001|NOT COMPLETED|Overall Study||0
10881444|NCT03607487|12047360|FG002|NOT COMPLETED|Overall Study||0
10881445|NCT03607487|12047361|FG003|NOT COMPLETED|Overall Study||1
10881446|NCT03606109|12047375|FG000|STARTED|Overall Study||31
10881447|NCT03606109|12047376|FG001|STARTED|Overall Study||27
10881448|NCT03606109|12047375|FG000|COMPLETED|Overall Study||29
10881449|NCT03606109|12047376|FG001|COMPLETED|Overall Study||26
10881450|NCT03606109|12047375|FG000|NOT COMPLETED|Overall Study||2
10881451|NCT03606109|12047376|FG001|NOT COMPLETED|Overall Study||1
10881452|NCT03602560|12047385|FG000|STARTED|Overall Study||89
10881453|NCT03602560|12047386|FG001|STARTED|Overall Study||89
10881454|NCT03602560|12047387|FG002|STARTED|Overall Study||87
10881455|NCT03602560|12047385|FG000|COMPLETED|Overall Study||1
10881456|NCT03602560|12047386|FG001|COMPLETED|Overall Study||1
10881457|NCT03602560|12047387|FG002|COMPLETED|Overall Study||1
10881458|NCT03602560|12047385|FG000|NOT COMPLETED|Overall Study||88
10881459|NCT03602560|12047386|FG001|NOT COMPLETED|Overall Study||88
10881460|NCT03602560|12047387|FG002|NOT COMPLETED|Overall Study||86
10881461|NCT03595384|12047395|FG000|STARTED|Overall Study||41
10881462|NCT03595384|12047395|FG000|Completed Week 12 Assessment|Overall Study||37
10881463|NCT03595384|12047395|FG000|COMPLETED|Overall Study||25
10881464|NCT03595384|12047395|FG000|NOT COMPLETED|Overall Study||16
10881465|NCT03593629|12047403|FG000|STARTED|Overall Study||166
10881466|NCT03593629|12047404|FG001|STARTED|Overall Study||166
10881467|NCT03593629|12047405|FG002|STARTED|Overall Study||295
10881468|NCT03593629|12047406|FG003|STARTED|Overall Study||163
10881469|NCT03593629|12047403|FG000|COMPLETED|Overall Study||166
10881470|NCT03593629|12047404|FG001|COMPLETED|Overall Study||166
10881471|NCT03593629|12047405|FG002|COMPLETED|Overall Study||295
10881472|NCT03593629|12047406|FG003|COMPLETED|Overall Study||163
10881473|NCT03593629|12047403|FG000|NOT COMPLETED|Overall Study||0
10881474|NCT03593629|12047404|FG001|NOT COMPLETED|Overall Study||0
10881475|NCT03593629|12047405|FG002|NOT COMPLETED|Overall Study||0
10881476|NCT03593629|12047406|FG003|NOT COMPLETED|Overall Study||0
10881477|NCT03592277|12047417|FG000|STARTED|Overall Study||60
10881478|NCT03592277|12047418|FG001|STARTED|Overall Study||60
10881479|NCT03592277|12047417|FG000|Powered For|Overall Study||60
10881480|NCT03592277|12047418|FG001|Powered For|Overall Study||60
10881481|NCT03592277|12047417|FG000|COMPLETED|Overall Study||54
10881482|NCT03592277|12047418|FG001|COMPLETED|Overall Study||52
10881483|NCT03592277|12047417|FG000|NOT COMPLETED|Overall Study||6
10881484|NCT03592277|12047418|FG001|NOT COMPLETED|Overall Study||8
10881485|NCT03591354|12047427|FG000|STARTED|Overall Study||54
10881486|NCT03591354|12047428|FG001|STARTED|Overall Study||55
10881487|NCT03591354|12047429|FG002|STARTED|Overall Study||55
10881488|NCT03591354|12047427|FG000|COMPLETED|Overall Study||54
10881489|NCT03591354|12047428|FG001|COMPLETED|Overall Study||55
10881490|NCT03591354|12047429|FG002|COMPLETED|Overall Study||55
10881491|NCT03591354|12047427|FG000|NOT COMPLETED|Overall Study||0
10881492|NCT03591354|12047428|FG001|NOT COMPLETED|Overall Study||0
10881493|NCT03591354|12047429|FG002|NOT COMPLETED|Overall Study||0
10881494|NCT03590457|12047444|FG000|STARTED|Overall Study||18
10881495|NCT03590457|12047444|FG000|COMPLETED|Overall Study||18
10881496|NCT03590457|12047444|FG000|NOT COMPLETED|Overall Study||0
10881497|NCT03590366|12047450|FG000|STARTED|Overall Study||73
10881498|NCT03590366|12047451|FG001|STARTED|Overall Study||67
10881499|NCT03590366|12047450|FG000|COMPLETED|Overall Study||70
10881500|NCT03590366|12047451|FG001|COMPLETED|Overall Study||59
10881501|NCT03590366|12047450|FG000|NOT COMPLETED|Overall Study||3
10881502|NCT03590366|12047451|FG001|NOT COMPLETED|Overall Study||8
10881503|NCT03589469|12047457|FG000|STARTED|Overall Study||145
10881504|NCT03589469|12047457|FG000|Received Treatment|Overall Study||145
10881505|NCT03589469|12047457|FG000|COMPLETED|Overall Study||0
10881506|NCT03589469|12047457|FG000|NOT COMPLETED|Overall Study||145
10881507|NCT03587584|12047463|FG000|STARTED|Overall Study||37
10881508|NCT03587584|12047464|FG001|STARTED|Overall Study||42
10881509|NCT03587584|12047463|FG000|COMPLETED|Overall Study||33
10881510|NCT03587584|12047464|FG001|COMPLETED|Overall Study||33
10881511|NCT03587584|12047463|FG000|NOT COMPLETED|Overall Study||4
10881512|NCT03587584|12047464|FG001|NOT COMPLETED|Overall Study||9
10881513|NCT03586427|12047475|FG000|STARTED|Overall Study||48
10881514|NCT03586427|12047476|FG001|STARTED|Overall Study||50
10881515|NCT03586427|12047477|FG002|STARTED|Overall Study||52
10881516|NCT03586427|12047478|FG003|STARTED|Overall Study||50
10881517|NCT03586427|12047479|FG004|STARTED|Overall Study||51
10881518|NCT03586427|12047475|FG000|COMPLETED|Overall Study||48
10881519|NCT03586427|12047476|FG001|COMPLETED|Overall Study||46
10881520|NCT03586427|12047477|FG002|COMPLETED|Overall Study||46
10881521|NCT03586427|12047478|FG003|COMPLETED|Overall Study||46
10881522|NCT03586427|12047479|FG004|COMPLETED|Overall Study||46
10881523|NCT03586427|12047475|FG000|NOT COMPLETED|Overall Study||0
10881524|NCT03586427|12047476|FG001|NOT COMPLETED|Overall Study||4
10881525|NCT03586427|12047477|FG002|NOT COMPLETED|Overall Study||6
10881526|NCT03586427|12047478|FG003|NOT COMPLETED|Overall Study||4
10881527|NCT03586427|12047479|FG004|NOT COMPLETED|Overall Study||5
10881528|NCT03586050|12047496|FG000|STARTED|Overall Study||33
10881529|NCT03586050|12047496|FG000|COMPLETED|Overall Study||33
10881530|NCT03586050|12047496|FG000|NOT COMPLETED|Overall Study||0
10881531|NCT03584789|12047503|FG000|STARTED|Overall Study||1739
10881532|NCT03584789|12047504|FG001|STARTED|Overall Study||2297
10881533|NCT03584789|12047505|FG002|STARTED|Overall Study||1686
10881534|NCT03584789|12047503|FG000|COMPLETED|Overall Study||1720
10881535|NCT03584789|12047504|FG001|COMPLETED|Overall Study||2269
10881536|NCT03584789|12047505|FG002|COMPLETED|Overall Study||1660
10881537|NCT03584789|12047503|FG000|NOT COMPLETED|Overall Study||19
10881538|NCT03584789|12047504|FG001|NOT COMPLETED|Overall Study||28
10881539|NCT03584789|12047505|FG002|NOT COMPLETED|Overall Study||26
10881540|NCT03575468|12047515|FG000|STARTED|Overall Study||56
10881541|NCT03575468|12047516|FG001|STARTED|Overall Study||54
10881542|NCT03575468|12047515|FG000|COMPLETED|Overall Study||30
10881543|NCT03575468|12047516|FG001|COMPLETED|Overall Study||33
10881544|NCT03575468|12047515|FG000|NOT COMPLETED|Overall Study||26
10881545|NCT03575468|12047516|FG001|NOT COMPLETED|Overall Study||21
10881546|NCT03575325|12047522|FG000|STARTED|Overall Study||11
10881547|NCT03575325|12047522|FG000|COMPLETED|Overall Study||10
10881548|NCT03575325|12047522|FG000|NOT COMPLETED|Overall Study||1
10881549|NCT03575065|12047530|FG000|STARTED|Overall Study||62
10881550|NCT03575065|12047531|FG001|STARTED|Overall Study||26
10881551|NCT03575065|12047530|FG000|COMPLETED|Overall Study||0
10881552|NCT03575065|12047531|FG001|COMPLETED|Overall Study||0
10881553|NCT03575065|12047530|FG000|NOT COMPLETED|Overall Study||62
10881554|NCT03575065|12047531|FG001|NOT COMPLETED|Overall Study||26
10881555|NCT03571581|12047538|FG000|STARTED|Overall Study||33
10881556|NCT03571581|12047538|FG000|COMPLETED|Overall Study||29
10881557|NCT03571581|12047538|FG000|NOT COMPLETED|Overall Study||4
10881558|NCT03570918|12047553|FG000|STARTED|Period 1||1
10881559|NCT03570918|12047554|FG001|STARTED|Period 1||1
10881560|NCT03570918|12047555|FG002|STARTED|Period 1||4
10881561|NCT03570918|12047556|FG003|STARTED|Period 1||3
10881562|NCT03570918|12047557|FG004|STARTED|Period 1||3
10881563|NCT03570918|12047558|FG005|STARTED|Period 1||3
10881564|NCT03570918|12047559|FG006|STARTED|Period 1||3
10881565|NCT03570918|12047560|FG007|STARTED|Period 1||3
10881566|NCT03570918|12047561|FG008|STARTED|Period 1||0
10881567|NCT03570918|12047553|FG000|COMPLETED|Period 1||1
10881568|NCT03570918|12047554|FG001|COMPLETED|Period 1||1
10881569|NCT03570918|12047555|FG002|COMPLETED|Period 1||4
10881570|NCT03570918|12047556|FG003|COMPLETED|Period 1||3
10881571|NCT03570918|12047557|FG004|COMPLETED|Period 1||3
10881572|NCT03570918|12047558|FG005|COMPLETED|Period 1||3
10881573|NCT03570918|12047559|FG006|COMPLETED|Period 1||3
10881574|NCT03570918|12047560|FG007|COMPLETED|Period 1||3
10881575|NCT03570918|12047561|FG008|COMPLETED|Period 1||0
10881576|NCT03570918|12047553|FG000|NOT COMPLETED|Period 1||0
10881577|NCT03570918|12047554|FG001|NOT COMPLETED|Period 1||0
10881578|NCT03570918|12047555|FG002|NOT COMPLETED|Period 1||0
10881579|NCT03570918|12047556|FG003|NOT COMPLETED|Period 1||0
10881580|NCT03570918|12047557|FG004|NOT COMPLETED|Period 1||0
10881581|NCT03570918|12047558|FG005|NOT COMPLETED|Period 1||0
10881582|NCT03570918|12047559|FG006|NOT COMPLETED|Period 1||0
10881583|NCT03570918|12047560|FG007|NOT COMPLETED|Period 1||0
10881584|NCT03570918|12047561|FG008|NOT COMPLETED|Period 1||0
10881585|NCT03570918|12047553|FG000|STARTED|Period 2||0
10881586|NCT03570918|12047554|FG001|STARTED|Period 2||0
10881587|NCT03570918|12047555|FG002|STARTED|Period 2||0
10881588|NCT03570918|12047556|FG003|STARTED|Period 2||0
10881589|NCT03570918|12047557|FG004|STARTED|Period 2||0
10881590|NCT03570918|12047558|FG005|STARTED|Period 2||0
10881591|NCT03570918|12047559|FG006|STARTED|Period 2||0
10881592|NCT03570918|12047560|FG007|STARTED|Period 2||0
10881593|NCT03570918|12047561|FG008|STARTED|Period 2||3
10881594|NCT03570918|12047553|FG000|COMPLETED|Period 2||0
10881595|NCT03570918|12047554|FG001|COMPLETED|Period 2||0
10881596|NCT03570918|12047555|FG002|COMPLETED|Period 2||0
10881597|NCT03570918|12047556|FG003|COMPLETED|Period 2||0
10881598|NCT03570918|12047557|FG004|COMPLETED|Period 2||0
10881599|NCT03570918|12047558|FG005|COMPLETED|Period 2||0
10881600|NCT03570918|12047559|FG006|COMPLETED|Period 2||0
10881601|NCT03570918|12047560|FG007|COMPLETED|Period 2||0
10881602|NCT03570918|12047561|FG008|COMPLETED|Period 2||3
10881603|NCT03570918|12047553|FG000|NOT COMPLETED|Period 2||0
10881604|NCT03570918|12047554|FG001|NOT COMPLETED|Period 2||0
10881605|NCT03570918|12047555|FG002|NOT COMPLETED|Period 2||0
10881606|NCT03570918|12047556|FG003|NOT COMPLETED|Period 2||0
10881607|NCT03570918|12047557|FG004|NOT COMPLETED|Period 2||0
10881608|NCT03570918|12047558|FG005|NOT COMPLETED|Period 2||0
10881609|NCT03570918|12047559|FG006|NOT COMPLETED|Period 2||0
10881610|NCT03570918|12047560|FG007|NOT COMPLETED|Period 2||0
10881611|NCT03570918|12047561|FG008|NOT COMPLETED|Period 2||0
10881612|NCT03569371|12047590|FG000|STARTED|Overall Study||10
10881613|NCT03569371|12047590|FG000|COMPLETED|Overall Study||7
10881614|NCT03569371|12047590|FG000|NOT COMPLETED|Overall Study||3
10881615|NCT03568643|12047596|FG000|STARTED|Overall Study||161
10881616|NCT03568643|12047597|FG001|STARTED|Overall Study||140
10881617|NCT03568643|12047596|FG000|COMPLETED|Overall Study||161
10881618|NCT03568643|12047597|FG001|COMPLETED|Overall Study||140
10881619|NCT03568643|12047596|FG000|NOT COMPLETED|Overall Study||0
10881620|NCT03568643|12047597|FG001|NOT COMPLETED|Overall Study||0
10881621|NCT03568162|12047609|FG000|STARTED|Overall Study||76
10881622|NCT03568162|12047610|FG001|STARTED|Overall Study||80
10881623|NCT03568162|12047611|FG002|STARTED|Overall Study||77
10881624|NCT03568162|12047612|FG003|STARTED|Overall Study||80
10881625|NCT03568162|12047613|FG004|STARTED|Overall Study||75
10881626|NCT03568162|12047614|FG005|STARTED|Overall Study||74
10881627|NCT03568162|12047609|FG000|COMPLETED|Overall Study||54
10881628|NCT03568162|12047610|FG001|COMPLETED|Overall Study||57
10881629|NCT03568162|12047611|FG002|COMPLETED|Overall Study||42
10881630|NCT03568162|12047612|FG003|COMPLETED|Overall Study||50
10881631|NCT03568162|12047613|FG004|COMPLETED|Overall Study||61
10881632|NCT03568162|12047614|FG005|COMPLETED|Overall Study||60
10881633|NCT03568162|12047609|FG000|NOT COMPLETED|Overall Study||22
10881634|NCT03568162|12047610|FG001|NOT COMPLETED|Overall Study||23
10881635|NCT03568162|12047611|FG002|NOT COMPLETED|Overall Study||35
10881636|NCT03568162|12047612|FG003|NOT COMPLETED|Overall Study||30
10881637|NCT03568162|12047613|FG004|NOT COMPLETED|Overall Study||14
10881638|NCT03568162|12047614|FG005|NOT COMPLETED|Overall Study||14
10881639|NCT03567850|12047633|FG000|STARTED|Overall Study||25
10881640|NCT03567850|12047634|FG001|STARTED|Overall Study||25
10881641|NCT03567850|12047633|FG000|COMPLETED|Overall Study||25
10881642|NCT03567850|12047634|FG001|COMPLETED|Overall Study||25
10881643|NCT03567850|12047633|FG000|NOT COMPLETED|Overall Study||0
10881644|NCT03567850|12047634|FG001|NOT COMPLETED|Overall Study||0
10881645|NCT03565237|12047640|FG000|STARTED|Overall Study||25
10881646|NCT03565237|12047640|FG000|Safety Analysis Set (SAS)|Overall Study||25
10881647|NCT03565237|12047640|FG000|Effectiveness Full Analysis Set (EFAS)|Overall Study||25
10881648|NCT03565237|12047640|FG000|COMPLETED|Overall Study||23
10881649|NCT03565237|12047640|FG000|NOT COMPLETED|Overall Study||2
10881650|NCT03563716|12047646|FG000|STARTED|Overall Study||68
10881651|NCT03563716|12047647|FG001|STARTED|Overall Study||67
10881652|NCT03563716|12047646|FG000|COMPLETED|Overall Study||0
10881653|NCT03563716|12047647|FG001|COMPLETED|Overall Study|"One participant who died had as reason for discontinuation Withdrawal by Subject"|0
10881654|NCT03563716|12047646|FG000|NOT COMPLETED|Overall Study||68
10881655|NCT03563716|12047647|FG001|NOT COMPLETED|Overall Study||67
10881656|NCT03558503|12047653|FG000|STARTED|Overall Study||63
10881657|NCT03558503|12047653|FG000|COMPLETED|Overall Study||60
10881658|NCT03558503|12047653|FG000|NOT COMPLETED|Overall Study||3
10881659|NCT03557151|12047659|FG000|STARTED|Randomization to 3 Months||74
10881660|NCT03557151|12047660|FG001|STARTED|Randomization to 3 Months||134
10881661|NCT03557151|12047659|FG000|Adolescent Participants|Randomization to 3 Months||37
10881662|NCT03557151|12047660|FG001|Adolescent Participants|Randomization to 3 Months||67
10881663|NCT03557151|12047659|FG000|Caregiver Participants|Randomization to 3 Months||37
10881664|NCT03557151|12047660|FG001|Caregiver Participants|Randomization to 3 Months||67
10881665|NCT03557151|12047659|FG000|COMPLETED|Randomization to 3 Months||72
10881666|NCT03557151|12047660|FG001|COMPLETED|Randomization to 3 Months||132
10881667|NCT03557151|12047659|FG000|NOT COMPLETED|Randomization to 3 Months||2
10881668|NCT03557151|12047660|FG001|NOT COMPLETED|Randomization to 3 Months||2
10881669|NCT03557151|12047659|FG000|STARTED|3 to 6 Months||72
10881670|NCT03557151|12047660|FG001|STARTED|3 to 6 Months||132
10881671|NCT03557151|12047659|FG000|Adolescent Participants|3 to 6 Months||36
10881672|NCT03557151|12047660|FG001|Adolescent Participants|3 to 6 Months||66
10881673|NCT03557151|12047659|FG000|Caregiver Participants|3 to 6 Months||36
10881674|NCT03557151|12047660|FG001|Caregiver Participants|3 to 6 Months||66
10881675|NCT03557151|12047659|FG000|COMPLETED|3 to 6 Months||72
10881676|NCT03557151|12047660|FG001|COMPLETED|3 to 6 Months||132
10881677|NCT03557151|12047659|FG000|NOT COMPLETED|3 to 6 Months||0
10881678|NCT03557151|12047660|FG001|NOT COMPLETED|3 to 6 Months||0
10881679|NCT03557151|12047659|FG000|STARTED|6 to 9 Months||72
10881680|NCT03557151|12047660|FG001|STARTED|6 to 9 Months||132
10881681|NCT03557151|12047659|FG000|Adolescent Participants|6 to 9 Months||36
10881682|NCT03557151|12047660|FG001|Adolescent Participants|6 to 9 Months||66
10881683|NCT03557151|12047659|FG000|Caregiver Participants|6 to 9 Months||36
10881684|NCT03557151|12047660|FG001|Caregiver Participants|6 to 9 Months||66
10881685|NCT03557151|12047659|FG000|COMPLETED|6 to 9 Months||70
10881686|NCT03557151|12047660|FG001|COMPLETED|6 to 9 Months||132
10881687|NCT03557151|12047659|FG000|NOT COMPLETED|6 to 9 Months||2
10881688|NCT03557151|12047660|FG001|NOT COMPLETED|6 to 9 Months||0
10881689|NCT03557151|12047659|FG000|STARTED|9 to 12 Months (End of Study)||70
10881690|NCT03557151|12047660|FG001|STARTED|9 to 12 Months (End of Study)||132
10881691|NCT03557151|12047659|FG000|Adolescent Participants|9 to 12 Months (End of Study)||35
10881692|NCT03557151|12047660|FG001|Adolescent Participants|9 to 12 Months (End of Study)||66
10881693|NCT03557151|12047659|FG000|Caregiver Participants|9 to 12 Months (End of Study)||35
10881694|NCT03557151|12047660|FG001|Caregiver Participants|9 to 12 Months (End of Study)||66
10881695|NCT03557151|12047659|FG000|COMPLETED|9 to 12 Months (End of Study)||70
10881696|NCT03557151|12047660|FG001|COMPLETED|9 to 12 Months (End of Study)||130
10881697|NCT03557151|12047659|FG000|NOT COMPLETED|9 to 12 Months (End of Study)||0
10881698|NCT03557151|12047660|FG001|NOT COMPLETED|9 to 12 Months (End of Study)||2
10881699|NCT03552822|12047670|FG000|STARTED|Overall Study||112
10881700|NCT03552822|12047671|FG001|STARTED|Overall Study||429
10881701|NCT03552822|12047670|FG000|COMPLETED|Overall Study||112
10881702|NCT03552822|12047671|FG001|COMPLETED|Overall Study||429
10881703|NCT03552822|12047670|FG000|NOT COMPLETED|Overall Study||0
10881704|NCT03552822|12047671|FG001|NOT COMPLETED|Overall Study||0
10881705|NCT03551522|12047681|FG000|STARTED|DB Phase||53
10881706|NCT03551522|12047682|FG001|STARTED|DB Phase||51
10881707|NCT03551522|12047683|FG002|STARTED|DB Phase||50
10881708|NCT03551522|12047684|FG003|STARTED|DB Phase||27
10881709|NCT03551522|12047685|FG004|STARTED|DB Phase||0
10881710|NCT03551522|12047681|FG000|COMPLETED|DB Phase||27
10881711|NCT03551522|12047682|FG001|COMPLETED|DB Phase||34
10881712|NCT03551522|12047683|FG002|COMPLETED|DB Phase||32
10881713|NCT03551522|12047684|FG003|COMPLETED|DB Phase||17
10881714|NCT03551522|12047685|FG004|COMPLETED|DB Phase||0
10881715|NCT03551522|12047681|FG000|NOT COMPLETED|DB Phase||26
10881716|NCT03551522|12047682|FG001|NOT COMPLETED|DB Phase||17
10881717|NCT03551522|12047683|FG002|NOT COMPLETED|DB Phase||18
10881718|NCT03551522|12047684|FG003|NOT COMPLETED|DB Phase||10
10881719|NCT03551522|12047685|FG004|NOT COMPLETED|DB Phase||0
10881720|NCT03551522|12047681|FG000|STARTED|OLE Phase||0
10881721|NCT03551522|12047682|FG001|STARTED|OLE Phase||0
10881722|NCT03551522|12047683|FG002|STARTED|OLE Phase||0
10881723|NCT03551522|12047684|FG003|STARTED|OLE Phase||0
10881724|NCT03551522|12047685|FG004|STARTED|OLE Phase||12
10881725|NCT03551522|12047681|FG000|COMPLETED|OLE Phase||0
10881726|NCT03551522|12047682|FG001|COMPLETED|OLE Phase||0
10881727|NCT03551522|12047683|FG002|COMPLETED|OLE Phase||0
10881728|NCT03551522|12047684|FG003|COMPLETED|OLE Phase||0
10881729|NCT03551522|12047685|FG004|COMPLETED|OLE Phase||0
10881730|NCT03551522|12047681|FG000|NOT COMPLETED|OLE Phase||0
10881731|NCT03551522|12047682|FG001|NOT COMPLETED|OLE Phase||0
10881732|NCT03551522|12047683|FG002|NOT COMPLETED|OLE Phase||0
10881733|NCT03551522|12047684|FG003|NOT COMPLETED|OLE Phase||0
10881734|NCT03551522|12047685|FG004|NOT COMPLETED|OLE Phase||12
10881735|NCT03547622|12047697|FG000|STARTED|Overall Study||3
10881736|NCT03547622|12047698|FG001|STARTED|Overall Study||3
10881737|NCT03547622|12047697|FG000|COMPLETED|Overall Study||3
10881738|NCT03547622|12047698|FG001|COMPLETED|Overall Study||2
10881739|NCT03547622|12047697|FG000|NOT COMPLETED|Overall Study||0
10881740|NCT03547622|12047698|FG001|NOT COMPLETED|Overall Study||1
10881741|NCT03538951|12047706|FG000|STARTED|Overall Study||41
10881742|NCT03538951|12047707|FG001|STARTED|Overall Study||42
10881743|NCT03538951|12047706|FG000|COMPLETED|Overall Study||40
10881744|NCT03538951|12047707|FG001|COMPLETED|Overall Study||40
10881745|NCT03538951|12047706|FG000|NOT COMPLETED|Overall Study||1
10881746|NCT03538951|12047707|FG001|NOT COMPLETED|Overall Study||2
10881747|NCT03538054|12047713|FG000|STARTED|Baseline Phase (2 Weeks)||19
10881748|NCT03538054|12047713|FG000|COMPLETED|Baseline Phase (2 Weeks)||18
10881749|NCT03538054|12047713|FG000|NOT COMPLETED|Baseline Phase (2 Weeks)||1
10881750|NCT03538054|12047713|FG000|STARTED|Placebo Phase (5 Weeks)||18
10881751|NCT03538054|12047713|FG000|COMPLETED|Placebo Phase (5 Weeks)||16
10881752|NCT03538054|12047713|FG000|NOT COMPLETED|Placebo Phase (5 Weeks)||2
10881753|NCT03538054|12047713|FG000|STARTED|Dextromethorphan Phase (10 Weeks)||16
10881754|NCT03538054|12047713|FG000|COMPLETED|Dextromethorphan Phase (10 Weeks)||14
10881755|NCT03538054|12047713|FG000|NOT COMPLETED|Dextromethorphan Phase (10 Weeks)||2
10881756|NCT03538041|12047721|FG000|STARTED|12-Week Treatment Period||10
10881757|NCT03538041|12047722|FG001|STARTED|12-Week Treatment Period||15
10881758|NCT03538041|12047721|FG000|COMPLETED|12-Week Treatment Period||9
10881759|NCT03538041|12047722|FG001|COMPLETED|12-Week Treatment Period||13
10881760|NCT03538041|12047721|FG000|NOT COMPLETED|12-Week Treatment Period||1
10881761|NCT03538041|12047722|FG001|NOT COMPLETED|12-Week Treatment Period||2
10881762|NCT03538041|12047721|FG000|STARTED|Treatment Extension Period|These participants completed the 24-week Treatment Period and were eligible for an extension of treatment based on their clinical response.|7
10881763|NCT03538041|12047722|FG001|STARTED|Treatment Extension Period|These participants completed the 24-week Treatment Period and were eligible for an extension of treatment based on their clinical response.|10
10881764|NCT03538041|12047721|FG000|COMPLETED|Treatment Extension Period||0
10881765|NCT03538041|12047722|FG001|COMPLETED|Treatment Extension Period||0
10881766|NCT03538041|12047721|FG000|NOT COMPLETED|Treatment Extension Period||7
10881767|NCT03538041|12047722|FG001|NOT COMPLETED|Treatment Extension Period||10
10881768|NCT03525678|12047734|FG000|STARTED|Overall Study||97
10881769|NCT03525678|12047735|FG001|STARTED|Overall Study||99
10881770|NCT03525678|12047736|FG002|STARTED|Overall Study||25
10881771|NCT03525678|12047734|FG000|Received Study Treatment|Overall Study||95
10881772|NCT03525678|12047735|FG001|Received Study Treatment|Overall Study||99
10881773|NCT03525678|12047736|FG002|Received Study Treatment|Overall Study||24
10881774|NCT03525678|12047734|FG000|COMPLETED|Overall Study||0
10881775|NCT03525678|12047735|FG001|COMPLETED|Overall Study||0
10881776|NCT03525678|12047736|FG002|COMPLETED|Overall Study||0
10881777|NCT03525678|12047734|FG000|NOT COMPLETED|Overall Study||97
10881778|NCT03525678|12047735|FG001|NOT COMPLETED|Overall Study||99
10881779|NCT03525678|12047736|FG002|NOT COMPLETED|Overall Study||25
10881780|NCT03525119|12047747|FG000|STARTED|Overall Study||300
10881781|NCT03525119|12047748|FG001|STARTED|Overall Study||300
10881782|NCT03525119|12047749|FG002|STARTED|Overall Study||300
10881783|NCT03525119|12047747|FG000|Safety Population|Overall Study||299
10881784|NCT03525119|12047748|FG001|Safety Population|Overall Study||300
10881785|NCT03525119|12047749|FG002|Safety Population|Overall Study||298
10881786|NCT03525119|12047747|FG000|COMPLETED|Overall Study||260
10881787|NCT03525119|12047748|FG001|COMPLETED|Overall Study||261
10881788|NCT03525119|12047749|FG002|COMPLETED|Overall Study||257
10881789|NCT03525119|12047747|FG000|NOT COMPLETED|Overall Study||40
10881790|NCT03525119|12047748|FG001|NOT COMPLETED|Overall Study||39
10881791|NCT03525119|12047749|FG002|NOT COMPLETED|Overall Study||43
10881792|NCT03521193|12047759|FG000|STARTED|Overall Study|enrolled on the PFO closure hospitalization|78
10881793|NCT03521193|12047760|FG001|STARTED|Overall Study||12
10881794|NCT03521193|12047759|FG000|COMPLETED|Overall Study|8 pts refused to continue the study; 8 patients were non compliant to ASA treatment|62
10881795|NCT03521193|12047760|FG001|COMPLETED|Overall Study||12
10881796|NCT03521193|12047759|FG000|NOT COMPLETED|Overall Study||16
10881797|NCT03521193|12047760|FG001|NOT COMPLETED|Overall Study||0
10881798|NCT03518086|12047769|FG000|STARTED|Overall Study||322
10881799|NCT03518086|12047770|FG001|STARTED|Overall Study||959
10881800|NCT03518086|12047771|FG002|STARTED|Overall Study||0
10881801|NCT03518086|12047772|FG003|STARTED|Overall Study||0
10881802|NCT03518086|12047769|FG000|Received at Least One Dose of Study Drug|Overall Study||321
10881803|NCT03518086|12047770|FG001|Received at Least One Dose of Study Drug|Overall Study||958
10881804|NCT03518086|12047771|FG002|Received at Least One Dose of Study Drug|Overall Study||0
10881805|NCT03518086|12047772|FG003|Received at Least One Dose of Study Drug|Overall Study||0
10881806|NCT03518086|12047769|FG000|COMPLETED|Overall Study||285
10881807|NCT03518086|12047770|FG001|COMPLETED|Overall Study||920
10881808|NCT03518086|12047771|FG002|COMPLETED|Overall Study||0
10881809|NCT03518086|12047772|FG003|COMPLETED|Overall Study||0
10881810|NCT03518086|12047769|FG000|NOT COMPLETED|Overall Study||37
10881811|NCT03518086|12047770|FG001|NOT COMPLETED|Overall Study||39
10881812|NCT03518086|12047771|FG002|NOT COMPLETED|Overall Study||0
10881813|NCT03518086|12047772|FG003|NOT COMPLETED|Overall Study||0
10881814|NCT03518073|12047782|FG000|STARTED|Overall Study||118
10881815|NCT03518073|12047783|FG001|STARTED|Overall Study||126
10881816|NCT03518073|12047784|FG002|STARTED|Overall Study||116
10881817|NCT03518073|12047782|FG000|Received at Least One Dose of Study Drug|Overall Study||118
10881818|NCT03518073|12047783|FG001|Received at Least One Dose of Study Drug|Overall Study||126
10881819|NCT03518073|12047784|FG002|Received at Least One Dose of Study Drug|Overall Study||116
10881820|NCT03518073|12047782|FG000|COMPLETED|Overall Study||74
10881821|NCT03518073|12047783|FG001|COMPLETED|Overall Study||78
10881822|NCT03518073|12047784|FG002|COMPLETED|Overall Study||70
10881823|NCT03518073|12047782|FG000|NOT COMPLETED|Overall Study||44
10881824|NCT03518073|12047783|FG001|NOT COMPLETED|Overall Study||48
10881825|NCT03518073|12047784|FG002|NOT COMPLETED|Overall Study||46
10881826|NCT03514914|12047796|FG000|STARTED|Overall Study||1200
10881827|NCT03514914|12047797|FG001|STARTED|Overall Study||1202
10881828|NCT03514914|12047796|FG000|9 Month Follow-up|Overall Study||1091
10881829|NCT03514914|12047797|FG001|9 Month Follow-up|Overall Study||1114
10881830|NCT03514914|12047796|FG000|COMPLETED|Overall Study||1080
10881831|NCT03514914|12047797|FG001|COMPLETED|Overall Study||1110
10881832|NCT03514914|12047796|FG000|NOT COMPLETED|Overall Study||120
10881833|NCT03514914|12047797|FG001|NOT COMPLETED|Overall Study||92
10881834|NCT03514394|12047806|FG000|STARTED|Overall Study||17
10881835|NCT03514394|12047807|FG001|STARTED|Overall Study||16
10881836|NCT03514394|12047808|FG002|STARTED|Overall Study||11
10881837|NCT03514394|12047806|FG000|COMPLETED|Overall Study||17
10881838|NCT03514394|12047807|FG001|COMPLETED|Overall Study||16
10881839|NCT03514394|12047808|FG002|COMPLETED|Overall Study||10
10881840|NCT03514394|12047806|FG000|NOT COMPLETED|Overall Study||0
10881841|NCT03514394|12047807|FG001|NOT COMPLETED|Overall Study||0
10881842|NCT03514394|12047808|FG002|NOT COMPLETED|Overall Study||1
10881843|NCT03511664|12047818|FG000|STARTED|Overall Study||551
10881844|NCT03511664|12047819|FG001|STARTED|Overall Study||280
10881845|NCT03511664|12047818|FG000|FAS Safety Analysis Set|Overall Study||529
10881846|NCT03511664|12047819|FG001|FAS Safety Analysis Set|Overall Study||205
10881847|NCT03511664|12047818|FG000|Progression-Free Survival (PFS) Full Analysis Set (PFS-FAS)|Overall Study||385
10881848|NCT03511664|12047819|FG001|Progression-Free Survival (PFS) Full Analysis Set (PFS-FAS)|Overall Study||196
10881849|NCT03511664|12047818|FG000|Response Evaluable Analysis Set|Overall Study||319
10881850|NCT03511664|12047819|FG001|Response Evaluable Analysis Set|Overall Study||120
10881851|NCT03511664|12047818|FG000|COMPLETED|Overall Study||329
10881852|NCT03511664|12047819|FG001|COMPLETED|Overall Study||167
10881853|NCT03511664|12047818|FG000|NOT COMPLETED|Overall Study||222
10881854|NCT03511664|12047819|FG001|NOT COMPLETED|Overall Study||113
10881855|NCT03509857|12047827|FG000|STARTED|Overall Study||50
10881856|NCT03509857|12047828|FG001|STARTED|Overall Study||50
10881857|NCT03509857|12047827|FG000|COMPLETED|Overall Study||50
10881858|NCT03509857|12047828|FG001|COMPLETED|Overall Study||50
10881859|NCT03509857|12047827|FG000|NOT COMPLETED|Overall Study||0
10881860|NCT03509857|12047828|FG001|NOT COMPLETED|Overall Study||0
10881861|NCT03505099|12047836|FG000|STARTED|Overall Study||14
10881862|NCT03505099|12047837|FG001|STARTED|Overall Study||15
10881863|NCT03505099|12047836|FG000|Received AVXS-101|Overall Study||14
10881864|NCT03505099|12047837|FG001|Received AVXS-101|Overall Study||15
10881865|NCT03505099|12047836|FG000|COMPLETED|Overall Study||14
10881866|NCT03505099|12047837|FG001|COMPLETED|Overall Study||15
10881867|NCT03505099|12047836|FG000|NOT COMPLETED|Overall Study||0
10881868|NCT03505099|12047837|FG001|NOT COMPLETED|Overall Study||0
10881869|NCT03499821|12047843|FG000|STARTED|Overall Study||35
10881870|NCT03499821|12047843|FG000|COMPLETED|Overall Study||34
10881871|NCT03499821|12047843|FG000|NOT COMPLETED|Overall Study||1
10881872|NCT03498313|12047853|FG000|STARTED|Experimental Period 1||9
10881873|NCT03498313|12047854|FG001|STARTED|Experimental Period 1||8
10881874|NCT03498313|12047855|FG002|STARTED|Experimental Period 1||9
10881875|NCT03498313|12047856|FG003|STARTED|Experimental Period 1||5
10881876|NCT03498313|12047857|FG004|STARTED|Experimental Period 1||9
10881877|NCT03498313|12047858|FG005|STARTED|Experimental Period 1||6
10881878|NCT03498313|12047853|FG000|COMPLETED|Experimental Period 1||8
10881879|NCT03498313|12047854|FG001|COMPLETED|Experimental Period 1||7
10881880|NCT03498313|12047855|FG002|COMPLETED|Experimental Period 1||9
10881881|NCT03498313|12047856|FG003|COMPLETED|Experimental Period 1||4
10881882|NCT03498313|12047857|FG004|COMPLETED|Experimental Period 1||9
10881883|NCT03498313|12047858|FG005|COMPLETED|Experimental Period 1||6
10881884|NCT03498313|12047853|FG000|NOT COMPLETED|Experimental Period 1||1
10881885|NCT03498313|12047854|FG001|NOT COMPLETED|Experimental Period 1||1
10881886|NCT03498313|12047855|FG002|NOT COMPLETED|Experimental Period 1||0
10881887|NCT03498313|12047856|FG003|NOT COMPLETED|Experimental Period 1||1
10881888|NCT03498313|12047857|FG004|NOT COMPLETED|Experimental Period 1||0
10881889|NCT03498313|12047858|FG005|NOT COMPLETED|Experimental Period 1||0
10881890|NCT03498313|12047853|FG000|STARTED|Washout Period 1||8
10881891|NCT03498313|12047854|FG001|STARTED|Washout Period 1||7
10881892|NCT03498313|12047855|FG002|STARTED|Washout Period 1||9
10881893|NCT03498313|12047856|FG003|STARTED|Washout Period 1||4
10881894|NCT03498313|12047857|FG004|STARTED|Washout Period 1||9
10881895|NCT03498313|12047858|FG005|STARTED|Washout Period 1||6
10881896|NCT03498313|12047853|FG000|COMPLETED|Washout Period 1||7
10881897|NCT03498313|12047854|FG001|COMPLETED|Washout Period 1||4
10881898|NCT03498313|12047855|FG002|COMPLETED|Washout Period 1||9
10881899|NCT03498313|12047856|FG003|COMPLETED|Washout Period 1||3
10881900|NCT03498313|12047857|FG004|COMPLETED|Washout Period 1||9
10881901|NCT03498313|12047858|FG005|COMPLETED|Washout Period 1||5
10881902|NCT03498313|12047853|FG000|NOT COMPLETED|Washout Period 1||1
10881903|NCT03498313|12047854|FG001|NOT COMPLETED|Washout Period 1||3
10881904|NCT03498313|12047855|FG002|NOT COMPLETED|Washout Period 1||0
10881905|NCT03498313|12047856|FG003|NOT COMPLETED|Washout Period 1||1
10881906|NCT03498313|12047857|FG004|NOT COMPLETED|Washout Period 1||0
10881907|NCT03498313|12047858|FG005|NOT COMPLETED|Washout Period 1||1
10881908|NCT03498313|12047853|FG000|STARTED|Experimental Period 2||7
10881909|NCT03498313|12047854|FG001|STARTED|Experimental Period 2||4
10881910|NCT03498313|12047855|FG002|STARTED|Experimental Period 2||9
10881911|NCT03498313|12047856|FG003|STARTED|Experimental Period 2||3
10881912|NCT03498313|12047857|FG004|STARTED|Experimental Period 2||9
10881913|NCT03498313|12047858|FG005|STARTED|Experimental Period 2||5
10881914|NCT03498313|12047853|FG000|COMPLETED|Experimental Period 2||7
10881915|NCT03498313|12047854|FG001|COMPLETED|Experimental Period 2||4
10881916|NCT03498313|12047855|FG002|COMPLETED|Experimental Period 2||9
10881917|NCT03498313|12047856|FG003|COMPLETED|Experimental Period 2||3
10881918|NCT03498313|12047857|FG004|COMPLETED|Experimental Period 2||8
10881919|NCT03498313|12047858|FG005|COMPLETED|Experimental Period 2||3
10881920|NCT03498313|12047853|FG000|NOT COMPLETED|Experimental Period 2||0
10881921|NCT03498313|12047854|FG001|NOT COMPLETED|Experimental Period 2||0
10881922|NCT03498313|12047855|FG002|NOT COMPLETED|Experimental Period 2||0
10881923|NCT03498313|12047856|FG003|NOT COMPLETED|Experimental Period 2||0
10881924|NCT03498313|12047857|FG004|NOT COMPLETED|Experimental Period 2||1
10881925|NCT03498313|12047858|FG005|NOT COMPLETED|Experimental Period 2||2
10881926|NCT03498313|12047853|FG000|STARTED|Washout Period 2||7
10881927|NCT03498313|12047854|FG001|STARTED|Washout Period 2||4
10881928|NCT03498313|12047855|FG002|STARTED|Washout Period 2||9
10881929|NCT03498313|12047856|FG003|STARTED|Washout Period 2||3
10881930|NCT03498313|12047857|FG004|STARTED|Washout Period 2||8
10881931|NCT03498313|12047858|FG005|STARTED|Washout Period 2||3
10881932|NCT03498313|12047853|FG000|COMPLETED|Washout Period 2||3
10881933|NCT03498313|12047854|FG001|COMPLETED|Washout Period 2||2
10881934|NCT03498313|12047855|FG002|COMPLETED|Washout Period 2||9
10881935|NCT03498313|12047856|FG003|COMPLETED|Washout Period 2||2
10881936|NCT03498313|12047857|FG004|COMPLETED|Washout Period 2||6
10881937|NCT03498313|12047858|FG005|COMPLETED|Washout Period 2||1
10881938|NCT03498313|12047853|FG000|NOT COMPLETED|Washout Period 2||4
10881939|NCT03498313|12047854|FG001|NOT COMPLETED|Washout Period 2||2
10881940|NCT03498313|12047855|FG002|NOT COMPLETED|Washout Period 2||0
10881941|NCT03498313|12047856|FG003|NOT COMPLETED|Washout Period 2||1
10881942|NCT03498313|12047857|FG004|NOT COMPLETED|Washout Period 2||2
10881943|NCT03498313|12047858|FG005|NOT COMPLETED|Washout Period 2||2
10881944|NCT03498313|12047853|FG000|STARTED|Experimental Period 3||3
10881945|NCT03498313|12047854|FG001|STARTED|Experimental Period 3||2
10881946|NCT03498313|12047855|FG002|STARTED|Experimental Period 3||9
10881947|NCT03498313|12047856|FG003|STARTED|Experimental Period 3||2
10881948|NCT03498313|12047857|FG004|STARTED|Experimental Period 3||6
10881949|NCT03498313|12047858|FG005|STARTED|Experimental Period 3||1
10881950|NCT03498313|12047853|FG000|COMPLETED|Experimental Period 3||3
10881951|NCT03498313|12047854|FG001|COMPLETED|Experimental Period 3||2
10881952|NCT03498313|12047855|FG002|COMPLETED|Experimental Period 3||9
10881953|NCT03498313|12047856|FG003|COMPLETED|Experimental Period 3||2
10881954|NCT03498313|12047857|FG004|COMPLETED|Experimental Period 3||6
10881955|NCT03498313|12047858|FG005|COMPLETED|Experimental Period 3||1
10881956|NCT03498313|12047853|FG000|NOT COMPLETED|Experimental Period 3||0
10881957|NCT03498313|12047854|FG001|NOT COMPLETED|Experimental Period 3||0
10881958|NCT03498313|12047855|FG002|NOT COMPLETED|Experimental Period 3||0
10881959|NCT03498313|12047856|FG003|NOT COMPLETED|Experimental Period 3||0
10881960|NCT03498313|12047857|FG004|NOT COMPLETED|Experimental Period 3||0
10881961|NCT03498313|12047858|FG005|NOT COMPLETED|Experimental Period 3||0
10881962|NCT03497806|12047866|FG000|STARTED|Week 8||132
10881963|NCT03497806|12047866|FG000|COMPLETED|Week 8||123
10881964|NCT03497806|12047866|FG000|NOT COMPLETED|Week 8||9
10881965|NCT03497806|12047866|FG000|STARTED|Week 24||123
10881966|NCT03497806|12047866|FG000|COMPLETED|Week 24||112
10881967|NCT03497806|12047866|FG000|NOT COMPLETED|Week 24||11
10881968|NCT03496844|12047870|FG000|STARTED|Overall Study||15
10881969|NCT03496844|12047870|FG000|COMPLETED|Overall Study||15
10881970|NCT03496844|12047870|FG000|NOT COMPLETED|Overall Study||0
10881971|NCT03495453|12047876|FG000|STARTED|Overall Study||30
10881972|NCT03495453|12047877|FG001|STARTED|Overall Study||30
10881973|NCT03495453|12047876|FG000|COMPLETED|Overall Study||30
10881974|NCT03495453|12047877|FG001|COMPLETED|Overall Study||29
10881975|NCT03495453|12047876|FG000|NOT COMPLETED|Overall Study||0
10881976|NCT03495453|12047877|FG001|NOT COMPLETED|Overall Study||1
10881977|NCT03488251|12047887|FG000|STARTED|Part 1:Dose Escalation (Up to 168 Days)||8
10881978|NCT03488251|12047888|FG001|STARTED|Part 1:Dose Escalation (Up to 168 Days)||0
10881979|NCT03488251|12047889|FG002|STARTED|Part 1:Dose Escalation (Up to 168 Days)||0
10881980|NCT03488251|12047890|FG003|STARTED|Part 1:Dose Escalation (Up to 168 Days)||0
10881981|NCT03488251|12047887|FG000|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0
10881982|NCT03488251|12047888|FG001|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0
10881983|NCT03488251|12047889|FG002|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0
10881984|NCT03488251|12047890|FG003|COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0
10881985|NCT03488251|12047887|FG000|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||8
10881986|NCT03488251|12047888|FG001|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0
10881987|NCT03488251|12047889|FG002|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0
10881988|NCT03488251|12047890|FG003|NOT COMPLETED|Part 1:Dose Escalation (Up to 168 Days)||0
10881989|NCT03488251|12047887|FG000|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0
10881990|NCT03488251|12047888|FG001|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0
10881991|NCT03488251|12047889|FG002|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0
10881992|NCT03488251|12047890|FG003|STARTED|Part 2:Dose Expansion (Up to 168 Days)||0
10881993|NCT03488251|12047887|FG000|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10881994|NCT03488251|12047888|FG001|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10881995|NCT03488251|12047889|FG002|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10881996|NCT03488251|12047890|FG003|COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10881997|NCT03488251|12047887|FG000|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10881998|NCT03488251|12047888|FG001|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10881999|NCT03488251|12047889|FG002|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10882000|NCT03488251|12047890|FG003|NOT COMPLETED|Part 2:Dose Expansion (Up to 168 Days)||0
10882001|NCT03486899|12047905|FG000|STARTED|Overall Study||49
10882002|NCT03486899|12047906|FG001|STARTED|Overall Study||50
10882003|NCT03486899|12047907|FG002|STARTED|Overall Study||49
10882004|NCT03486899|12047908|FG003|STARTED|Overall Study||49
10882005|NCT03486899|12047905|FG000|COMPLETED|Overall Study||41
10882006|NCT03486899|12047906|FG001|COMPLETED|Overall Study||39
10882007|NCT03486899|12047907|FG002|COMPLETED|Overall Study||41
10882008|NCT03486899|12047908|FG003|COMPLETED|Overall Study||39
10882009|NCT03486899|12047905|FG000|NOT COMPLETED|Overall Study||8
10882010|NCT03486899|12047906|FG001|NOT COMPLETED|Overall Study||11
10882011|NCT03486899|12047907|FG002|NOT COMPLETED|Overall Study||8
10882012|NCT03486899|12047908|FG003|NOT COMPLETED|Overall Study||10
10882013|NCT03483077|12047925|FG000|STARTED|Overall Study||12
10882014|NCT03483077|12047926|FG001|STARTED|Overall Study||6
10882015|NCT03483077|12047927|FG002|STARTED|Overall Study||6
10882016|NCT03483077|12047928|FG003|STARTED|Overall Study||6
10882017|NCT03483077|12047929|FG004|STARTED|Overall Study||6
10882018|NCT03483077|12047930|FG005|STARTED|Overall Study||6
10882019|NCT03483077|12047931|FG006|STARTED|Overall Study||6
10882020|NCT03483077|12047925|FG000|COMPLETED|Overall Study||12
10882021|NCT03483077|12047926|FG001|COMPLETED|Overall Study||6
10882022|NCT03483077|12047927|FG002|COMPLETED|Overall Study||6
10882023|NCT03483077|12047928|FG003|COMPLETED|Overall Study||6
10882024|NCT03483077|12047929|FG004|COMPLETED|Overall Study||6
10882025|NCT03483077|12047930|FG005|COMPLETED|Overall Study||6
10882026|NCT03483077|12047931|FG006|COMPLETED|Overall Study||6
10882027|NCT03483077|12047925|FG000|NOT COMPLETED|Overall Study||0
10882028|NCT03483077|12047926|FG001|NOT COMPLETED|Overall Study||0
10882029|NCT03483077|12047927|FG002|NOT COMPLETED|Overall Study||0
10882030|NCT03483077|12047928|FG003|NOT COMPLETED|Overall Study||0
10882031|NCT03483077|12047929|FG004|NOT COMPLETED|Overall Study||0
10882032|NCT03483077|12047930|FG005|NOT COMPLETED|Overall Study||0
10882033|NCT03483077|12047931|FG006|NOT COMPLETED|Overall Study||0
10882034|NCT03475056|12047956|FG000|STARTED|Overall Study||20
10882035|NCT03475056|12047957|FG001|STARTED|Overall Study||20
10882036|NCT03475056|12047956|FG000|Received Product Administration|Overall Study||20
10882037|NCT03475056|12047957|FG001|Received Product Administration|Overall Study||20
10882038|NCT03475056|12047956|FG000|COMPLETED|Overall Study||20
10882039|NCT03475056|12047957|FG001|COMPLETED|Overall Study||17
10882040|NCT03475056|12047956|FG000|NOT COMPLETED|Overall Study||0
10882041|NCT03475056|12047957|FG001|NOT COMPLETED|Overall Study||3
10882042|NCT03474107|12047966|FG000|STARTED|Overall Study||301
10882043|NCT03474107|12047967|FG001|STARTED|Overall Study||307
10882044|NCT03474107|12047966|FG000|Treated|Overall Study||296
10882045|NCT03474107|12047967|FG001|Treated|Overall Study||291
10882046|NCT03474107|12047966|FG000|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|56
10882047|NCT03474107|12047967|FG001|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|22
10882048|NCT03474107|12047966|FG000|NOT COMPLETED|Overall Study||245
10882049|NCT03474107|12047967|FG001|NOT COMPLETED|Overall Study||285
10882050|NCT03473340|12047975|FG000|STARTED|Overall Study||13
10882051|NCT03473340|12047976|FG001|STARTED|Overall Study||11
10882052|NCT03473340|12047975|FG000|COMPLETED|Overall Study||8
10882053|NCT03473340|12047976|FG001|COMPLETED|Overall Study||9
10882054|NCT03473340|12047975|FG000|NOT COMPLETED|Overall Study||5
10882055|NCT03473340|12047976|FG001|NOT COMPLETED|Overall Study||2
10882056|NCT03472885|12047982|FG000|STARTED|Overall Study||12
10882057|NCT03472885|12047982|FG000|Safety Population: Received at Least 1 Dose of Study Drug|Overall Study||12
10882058|NCT03472885|12047982|FG000|Efficacy Population: Received Study Drug for at Least 4 Weeks|Overall Study||11
10882059|NCT03472885|12047982|FG000|COMPLETED|Overall Study||11
10882060|NCT03472885|12047982|FG000|NOT COMPLETED|Overall Study||1
10882061|NCT03467152|12047988|FG000|STARTED|Overall Study||100
10882062|NCT03467152|12047989|FG001|STARTED|Overall Study||100
10882063|NCT03467152|12047990|FG002|STARTED|Overall Study|The treatment arms to which these 6 participants were randomized is unknown.|6
10882064|NCT03467152|12047988|FG000|Treated|Overall Study||97
10882065|NCT03467152|12047989|FG001|Treated|Overall Study||99
10882066|NCT03467152|12047990|FG002|Treated|Overall Study||0
10882067|NCT03467152|12047988|FG000|COMPLETED|Overall Study||84
10882068|NCT03467152|12047989|FG001|COMPLETED|Overall Study||89
10882069|NCT03467152|12047990|FG002|COMPLETED|Overall Study||0
10882070|NCT03467152|12047988|FG000|NOT COMPLETED|Overall Study||16
10882071|NCT03467152|12047989|FG001|NOT COMPLETED|Overall Study||11
10882072|NCT03467152|12047990|FG002|NOT COMPLETED|Overall Study||6
10882073|NCT03466918|12047996|FG000|STARTED|Overall Study||58
10882074|NCT03466918|12047996|FG000|Analysis Population|Overall Study||50
10882075|NCT03466918|12047996|FG000|COMPLETED|Overall Study|All 58 patients completed the 30-day primary endpoint.|58
10882076|NCT03466918|12047996|FG000|NOT COMPLETED|Overall Study||0
10882077|NCT03462966|12048001|FG000|STARTED|Overall Study||4
10882078|NCT03462966|12048001|FG000|COMPLETED|Overall Study||4
10882079|NCT03462966|12048001|FG000|NOT COMPLETED|Overall Study||0
10882080|NCT03462719|12048008|FG000|STARTED|Overall Study||106
10882081|NCT03462719|12048009|FG001|STARTED|Overall Study||105
10882082|NCT03462719|12048008|FG000|COMPLETED|Overall Study||11
10882083|NCT03462719|12048009|FG001|COMPLETED|Overall Study||11
10882084|NCT03462719|12048008|FG000|NOT COMPLETED|Overall Study||95
10882085|NCT03462719|12048009|FG001|NOT COMPLETED|Overall Study||94
10882086|NCT03462641|12048017|FG000|STARTED|Visit 1||19
10882087|NCT03462641|12048018|FG001|STARTED|Visit 1||11
10882088|NCT03462641|12048017|FG000|Actually Received Drug or Placebo|Visit 1||18
10882089|NCT03462641|12048018|FG001|Actually Received Drug or Placebo|Visit 1||11
10882090|NCT03462641|12048017|FG000|COMPLETED|Visit 1||18
10882091|NCT03462641|12048018|FG001|COMPLETED|Visit 1||11
10882092|NCT03462641|12048017|FG000|NOT COMPLETED|Visit 1||1
10882093|NCT03462641|12048018|FG001|NOT COMPLETED|Visit 1||0
10882094|NCT03462641|12048017|FG000|STARTED|Visit 2||18
10882095|NCT03462641|12048018|FG001|STARTED|Visit 2||11
10882096|NCT03462641|12048017|FG000|Actually Received Drug or Placebo|Visit 2||18
10882097|NCT03462641|12048018|FG001|Actually Received Drug or Placebo|Visit 2||10
10882098|NCT03462641|12048017|FG000|COMPLETED|Visit 2||18
10882099|NCT03462641|12048018|FG001|COMPLETED|Visit 2||10
10882100|NCT03462641|12048017|FG000|NOT COMPLETED|Visit 2||0
10882101|NCT03462641|12048018|FG001|NOT COMPLETED|Visit 2||1
10882102|NCT03462563|12048028|FG000|STARTED|Overall Study||94
10882103|NCT03462563|12048029|FG001|STARTED|Overall Study||81
10882104|NCT03462563|12048028|FG000|COMPLETED|Overall Study||79
10882105|NCT03462563|12048029|FG001|COMPLETED|Overall Study||64
10882106|NCT03462563|12048028|FG000|NOT COMPLETED|Overall Study||15
10882107|NCT03462563|12048029|FG001|NOT COMPLETED|Overall Study||17
10882108|NCT03461289|12048035|FG000|STARTED|Overall Study||33
10882109|NCT03461289|12048035|FG000|COMPLETED|Overall Study||32
10882110|NCT03461289|12048035|FG000|NOT COMPLETED|Overall Study||1
10882111|NCT03461003|12048041|FG000|STARTED|Overall Study||23
10882112|NCT03461003|12048042|FG001|STARTED|Overall Study||26
10882113|NCT03461003|12048041|FG000|Received Intervention|Overall Study||21
10882114|NCT03461003|12048042|FG001|Received Intervention|Overall Study||22
10882115|NCT03461003|12048041|FG000|Completed 6-month Follow up|Overall Study||18
10882116|NCT03461003|12048042|FG001|Completed 6-month Follow up|Overall Study||23
10882117|NCT03461003|12048041|FG000|COMPLETED|Overall Study||18
10882118|NCT03461003|12048042|FG001|COMPLETED|Overall Study||23
10882119|NCT03461003|12048041|FG000|NOT COMPLETED|Overall Study||5
10882120|NCT03461003|12048042|FG001|NOT COMPLETED|Overall Study||3
10882121|NCT03459443|12048048|FG000|STARTED|Overall Study||22
10882122|NCT03459443|12048048|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
10882123|NCT03459443|12048048|FG000|COMPLETED|Overall Study||0
10882124|NCT03459443|12048048|FG000|NOT COMPLETED|Overall Study||22
10882125|NCT03457818|12048054|FG000|STARTED|Overall Study||4
10882126|NCT03457818|12048055|FG001|STARTED|Overall Study||4
10882127|NCT03457818|12048054|FG000|COMPLETED|Overall Study|Study terminated|0
10882128|NCT03457818|12048055|FG001|COMPLETED|Overall Study|study terminated|0
10882129|NCT03457818|12048054|FG000|NOT COMPLETED|Overall Study||4
10882130|NCT03457818|12048055|FG001|NOT COMPLETED|Overall Study||4
10882131|NCT03452540|12048061|FG000|STARTED|Overall Study||9
10882132|NCT03452540|12048061|FG000|COMPLETED|Overall Study||5
10882133|NCT03452540|12048061|FG000|NOT COMPLETED|Overall Study||4
10882134|NCT03449199|12048068|FG000|STARTED|Overall Study||42
10882135|NCT03449199|12048069|FG001|STARTED|Overall Study||44
10882136|NCT03449199|12048070|FG002|STARTED|Overall Study||44
10882137|NCT03449199|12048068|FG000|COMPLETED|Overall Study||41
10882138|NCT03449199|12048069|FG001|COMPLETED|Overall Study||43
10882139|NCT03449199|12048070|FG002|COMPLETED|Overall Study||42
10882140|NCT03449199|12048068|FG000|NOT COMPLETED|Overall Study||1
10882141|NCT03449199|12048069|FG001|NOT COMPLETED|Overall Study||1
10882142|NCT03449199|12048070|FG002|NOT COMPLETED|Overall Study||2
10882143|NCT03442985|12048084|FG000|STARTED|Overall Study||62
10882144|NCT03442985|12048085|FG001|STARTED|Overall Study||66
10882145|NCT03442985|12048086|FG002|STARTED|Overall Study||65
10882146|NCT03442985|12048084|FG000|COMPLETED|Overall Study||0
10882147|NCT03442985|12048085|FG001|COMPLETED|Overall Study||0
10882148|NCT03442985|12048086|FG002|COMPLETED|Overall Study||0
10882149|NCT03442985|12048084|FG000|NOT COMPLETED|Overall Study||62
10882150|NCT03442985|12048085|FG001|NOT COMPLETED|Overall Study||66
10882151|NCT03442985|12048086|FG002|NOT COMPLETED|Overall Study||65
10882152|NCT03442764|12048099|FG000|STARTED|Overall Study||19
10882153|NCT03442764|12048100|FG001|STARTED|Overall Study||21
10882154|NCT03442764|12048101|FG002|STARTED|Overall Study||19
10882155|NCT03442764|12048099|FG000|COMPLETED|Overall Study||18
10882156|NCT03442764|12048100|FG001|COMPLETED|Overall Study||21
10882157|NCT03442764|12048101|FG002|COMPLETED|Overall Study||19
10882158|NCT03442764|12048099|FG000|NOT COMPLETED|Overall Study||1
10882159|NCT03442764|12048100|FG001|NOT COMPLETED|Overall Study||0
10882160|NCT03442764|12048101|FG002|NOT COMPLETED|Overall Study||0
10882161|NCT03438396|12048110|FG000|STARTED|Overall Study||102
10882162|NCT03438396|12048110|FG000|Treated|Overall Study||101
10882163|NCT03438396|12048110|FG000|COMPLETED|Overall Study||0
10882164|NCT03438396|12048110|FG000|NOT COMPLETED|Overall Study||102
10882165|NCT03435835|12048114|FG000|STARTED|First Intervention||8
10882166|NCT03435835|12048115|FG001|STARTED|First Intervention||8
10882167|NCT03435835|12048114|FG000|COMPLETED|First Intervention||8
10882168|NCT03435835|12048115|FG001|COMPLETED|First Intervention||8
10882169|NCT03435835|12048114|FG000|NOT COMPLETED|First Intervention||0
10882170|NCT03435835|12048115|FG001|NOT COMPLETED|First Intervention||0
10882171|NCT03435835|12048114|FG000|STARTED|Washout||8
10882172|NCT03435835|12048115|FG001|STARTED|Washout||8
10882173|NCT03435835|12048114|FG000|COMPLETED|Washout||8
10882174|NCT03435835|12048115|FG001|COMPLETED|Washout||8
10882175|NCT03435835|12048114|FG000|NOT COMPLETED|Washout||0
10882176|NCT03435835|12048115|FG001|NOT COMPLETED|Washout||0
10882177|NCT03435835|12048114|FG000|STARTED|Second Intervention||8
10882178|NCT03435835|12048115|FG001|STARTED|Second Intervention||8
10882179|NCT03435835|12048114|FG000|COMPLETED|Second Intervention||8
10882180|NCT03435835|12048115|FG001|COMPLETED|Second Intervention||8
10882181|NCT03435835|12048114|FG000|NOT COMPLETED|Second Intervention||0
10882182|NCT03435835|12048115|FG001|NOT COMPLETED|Second Intervention||0
10882183|NCT03435081|12048124|FG000|STARTED|Week 0 to Week 16||147
10882184|NCT03435081|12048125|FG001|STARTED|Week 0 to Week 16||147
10882185|NCT03435081|12048126|FG002|STARTED|Week 0 to Week 16||146
10882186|NCT03435081|12048124|FG000|Received at Least One Dose of Study Drug|Week 0 to Week 16||147
10882187|NCT03435081|12048125|FG001|Received at Least One Dose of Study Drug|Week 0 to Week 16||147
10882188|NCT03435081|12048126|FG002|Received at Least One Dose of Study Drug|Week 0 to Week 16||146
10882189|NCT03435081|12048124|FG000|Completed Week 16 and Entered JAIX Study|Week 0 to Week 16||111
10882190|NCT03435081|12048125|FG001|Completed Week 16 and Entered JAIX Study|Week 0 to Week 16||112
10882191|NCT03435081|12048126|FG002|Completed Week 16 and Entered JAIX Study|Week 0 to Week 16||96
10882192|NCT03435081|12048124|FG000|COMPLETED|Week 0 to Week 16||126
10882193|NCT03435081|12048125|FG001|COMPLETED|Week 0 to Week 16||131
10882194|NCT03435081|12048126|FG002|COMPLETED|Week 0 to Week 16||127
10882195|NCT03435081|12048124|FG000|NOT COMPLETED|Week 0 to Week 16||21
10882196|NCT03435081|12048125|FG001|NOT COMPLETED|Week 0 to Week 16||16
10882197|NCT03435081|12048126|FG002|NOT COMPLETED|Week 0 to Week 16||19
10882198|NCT03435081|12048124|FG000|STARTED|Week 16 to Week 104|Participants who met IGA 0 or 1 and did not require rescue therapy before Week 16 were allowed to continue in the study beyond 16 weeks.|8
10882199|NCT03435081|12048125|FG001|STARTED|Week 16 to Week 104|Participants who met IGA 0 or 1 and did not require rescue therapy before Week 16 were allowed to continue in the study beyond 16 weeks.|19
10882200|NCT03435081|12048126|FG002|STARTED|Week 16 to Week 104|Participants who met IGA 0 or 1 and did not require rescue therapy before Week 16 were allowed to continue in the study beyond 16 weeks.|35
10882280|NCT03416374|12048200|FG001|STARTED|Treatment Period II||30
10882201|NCT03435081|12048124|FG000|Rolled Over Into the Open-Label Extension Study JAIX.|Week 16 to Week 104|Participants who completed Week 104 and participants who experienced a loss of benefit (IGA score of ≥3) after Week 16, if eligible, had the option to roll over into the Open-Label Extension study JAIX.|6
10882202|NCT03435081|12048125|FG001|Rolled Over Into the Open-Label Extension Study JAIX.|Week 16 to Week 104|Participants who completed Week 104 and participants who experienced a loss of benefit (IGA score of ≥3) after Week 16, if eligible, had the option to roll over into the Open-Label Extension study JAIX.|14
10882203|NCT03435081|12048126|FG002|Rolled Over Into the Open-Label Extension Study JAIX.|Week 16 to Week 104|Participants who completed Week 104 and participants who experienced a loss of benefit (IGA score of ≥3) after Week 16, if eligible, had the option to roll over into the Open-Label Extension study JAIX.|19
10882204|NCT03435081|12048124|FG000|COMPLETED|Week 16 to Week 104||5
10882205|NCT03435081|12048125|FG001|COMPLETED|Week 16 to Week 104||6
10882206|NCT03435081|12048126|FG002|COMPLETED|Week 16 to Week 104||16
10882207|NCT03435081|12048124|FG000|NOT COMPLETED|Week 16 to Week 104||3
10882208|NCT03435081|12048125|FG001|NOT COMPLETED|Week 16 to Week 104||13
10882209|NCT03435081|12048126|FG002|NOT COMPLETED|Week 16 to Week 104||19
10882210|NCT03434379|12048140|FG000|STARTED|Global Period||165
10882211|NCT03434379|12048141|FG001|STARTED|Global Period||336
10882212|NCT03434379|12048142|FG002|STARTED|Global Period||0
10882213|NCT03434379|12048143|FG003|STARTED|Global Period||0
10882214|NCT03434379|12048140|FG000|COMPLETED|Global Period||0
10882215|NCT03434379|12048141|FG001|COMPLETED|Global Period||0
10882216|NCT03434379|12048142|FG002|COMPLETED|Global Period||0
10882217|NCT03434379|12048143|FG003|COMPLETED|Global Period||0
10882218|NCT03434379|12048140|FG000|NOT COMPLETED|Global Period||165
10882219|NCT03434379|12048141|FG001|NOT COMPLETED|Global Period||336
10882220|NCT03434379|12048142|FG002|NOT COMPLETED|Global Period||0
10882221|NCT03434379|12048143|FG003|NOT COMPLETED|Global Period||0
10882222|NCT03434379|12048140|FG000|STARTED|China Extension Period||0
10882223|NCT03434379|12048141|FG001|STARTED|China Extension Period||0
10882224|NCT03434379|12048142|FG002|STARTED|China Extension Period|n=43 Chinese participants from the sorafenib Global population are included in the China population.|61
10882225|NCT03434379|12048143|FG003|STARTED|China Extension Period|n=94 Chinese participants from the Atezolizumab + Bevacizumab Global population are included in the China population.|133
10882226|NCT03434379|12048140|FG000|COMPLETED|China Extension Period||0
10882227|NCT03434379|12048141|FG001|COMPLETED|China Extension Period||0
10882228|NCT03434379|12048142|FG002|COMPLETED|China Extension Period||0
10882229|NCT03434379|12048143|FG003|COMPLETED|China Extension Period||0
10882230|NCT03434379|12048140|FG000|NOT COMPLETED|China Extension Period||0
10882231|NCT03434379|12048141|FG001|NOT COMPLETED|China Extension Period||0
10882232|NCT03434379|12048142|FG002|NOT COMPLETED|China Extension Period||61
10882233|NCT03434379|12048143|FG003|NOT COMPLETED|China Extension Period||133
10882234|NCT03432650|12048157|FG000|STARTED|Overall Study||48
10882235|NCT03432650|12048158|FG001|STARTED|Overall Study||48
10882236|NCT03432650|12048157|FG000|COMPLETED|Overall Study||48
10882237|NCT03432650|12048158|FG001|COMPLETED|Overall Study||48
10882238|NCT03432650|12048157|FG000|NOT COMPLETED|Overall Study||0
10882239|NCT03432650|12048158|FG001|NOT COMPLETED|Overall Study||0
10882240|NCT03431168|12048166|FG000|STARTED|Overall Study||155
10882241|NCT03431168|12048167|FG001|STARTED|Overall Study||153
10882242|NCT03431168|12048166|FG000|COMPLETED|Overall Study||132
10882243|NCT03431168|12048167|FG001|COMPLETED|Overall Study||129
10882244|NCT03431168|12048166|FG000|NOT COMPLETED|Overall Study||23
10882245|NCT03431168|12048167|FG001|NOT COMPLETED|Overall Study||24
10882246|NCT03419364|12048176|FG000|STARTED|Overall Study||11
10882247|NCT03419364|12048177|FG001|STARTED|Overall Study||6
10882248|NCT03419364|12048178|FG002|STARTED|Overall Study||6
10882249|NCT03419364|12048176|FG000|Signed Consent|Overall Study||11
10882250|NCT03419364|12048177|FG001|Signed Consent|Overall Study||6
10882251|NCT03419364|12048178|FG002|Signed Consent|Overall Study||6
10882252|NCT03419364|12048176|FG000|Received Intervention|Overall Study||9
10882253|NCT03419364|12048177|FG001|Received Intervention|Overall Study||6
10882254|NCT03419364|12048178|FG002|Received Intervention|Overall Study||6
10882255|NCT03419364|12048176|FG000|COMPLETED|Overall Study||9
10882256|NCT03419364|12048177|FG001|COMPLETED|Overall Study||6
10882257|NCT03419364|12048178|FG002|COMPLETED|Overall Study||6
10882258|NCT03419364|12048176|FG000|NOT COMPLETED|Overall Study||2
10882259|NCT03419364|12048177|FG001|NOT COMPLETED|Overall Study||0
10882260|NCT03419364|12048178|FG002|NOT COMPLETED|Overall Study||0
10882261|NCT03417570|12048188|FG000|STARTED|Overall Study||50
10882262|NCT03417570|12048189|FG001|STARTED|Overall Study||50
10882263|NCT03417570|12048188|FG000|COMPLETED|Overall Study||50
10882264|NCT03417570|12048189|FG001|COMPLETED|Overall Study||50
10882265|NCT03417570|12048188|FG000|NOT COMPLETED|Overall Study||0
10882266|NCT03417570|12048189|FG001|NOT COMPLETED|Overall Study||0
10882267|NCT03416374|12048199|FG000|STARTED|Treatment Period I||6
10882268|NCT03416374|12048200|FG001|STARTED|Treatment Period I||39
10882269|NCT03416374|12048199|FG000|COMPLETED|Treatment Period I||0
10882270|NCT03416374|12048200|FG001|COMPLETED|Treatment Period I||0
10882271|NCT03416374|12048199|FG000|NOT COMPLETED|Treatment Period I||6
10882272|NCT03416374|12048200|FG001|NOT COMPLETED|Treatment Period I||39
10882273|NCT03416374|12048199|FG000|STARTED|Between Treatment Period I and II||6
10882274|NCT03416374|12048200|FG001|STARTED|Between Treatment Period I and II||39
10882275|NCT03416374|12048199|FG000|COMPLETED|Between Treatment Period I and II||6
10882276|NCT03416374|12048200|FG001|COMPLETED|Between Treatment Period I and II||30
10882277|NCT03416374|12048199|FG000|NOT COMPLETED|Between Treatment Period I and II||0
10882278|NCT03416374|12048200|FG001|NOT COMPLETED|Between Treatment Period I and II||9
10882279|NCT03416374|12048199|FG000|STARTED|Treatment Period II||6
10882281|NCT03416374|12048199|FG000|COMPLETED|Treatment Period II||2
10882282|NCT03416374|12048200|FG001|COMPLETED|Treatment Period II||12
10882283|NCT03416374|12048199|FG000|NOT COMPLETED|Treatment Period II||4
10882284|NCT03416374|12048200|FG001|NOT COMPLETED|Treatment Period II||18
10882285|NCT03414047|12048213|FG000|STARTED|Overall Study||53
10882286|NCT03414047|12048214|FG001|STARTED|Overall Study||46
10882287|NCT03414047|12048215|FG002|STARTED|Overall Study||41
10882288|NCT03414047|12048216|FG003|STARTED|Overall Study||29
10882289|NCT03414047|12048213|FG000|Received at Least One Dose of Study Drug|Overall Study||53
10882290|NCT03414047|12048214|FG001|Received at Least One Dose of Study Drug|Overall Study||46
10882291|NCT03414047|12048215|FG002|Received at Least One Dose of Study Drug|Overall Study||41
10882292|NCT03414047|12048216|FG003|Received at Least One Dose of Study Drug|Overall Study||29
10882293|NCT03414047|12048213|FG000|COMPLETED|Overall Study||51
10882294|NCT03414047|12048214|FG001|COMPLETED|Overall Study||46
10882295|NCT03414047|12048215|FG002|COMPLETED|Overall Study||38
10882296|NCT03414047|12048216|FG003|COMPLETED|Overall Study||27
10882297|NCT03414047|12048213|FG000|NOT COMPLETED|Overall Study||2
10882298|NCT03414047|12048214|FG001|NOT COMPLETED|Overall Study||0
10882299|NCT03414047|12048215|FG002|NOT COMPLETED|Overall Study||3
10882300|NCT03414047|12048216|FG003|NOT COMPLETED|Overall Study||2
10882301|NCT03412630|12048227|FG000|STARTED|Overall Study||1
10882302|NCT03412630|12048227|FG000|COMPLETED|Overall Study||1
10882303|NCT03412630|12048227|FG000|NOT COMPLETED|Overall Study||0
10882304|NCT03412604|12048231|FG000|STARTED|Overall Study||5
10882305|NCT03412604|12048231|FG000|COMPLETED|Overall Study||4
10882306|NCT03412604|12048231|FG000|NOT COMPLETED|Overall Study||1
10882307|NCT03412565|12048239|FG000|STARTED|Overall Study||67
10882308|NCT03412565|12048240|FG001|STARTED|Overall Study||67
10882309|NCT03412565|12048241|FG002|STARTED|Overall Study||65
10882310|NCT03412565|12048242|FG003|STARTED|Overall Study||66
10882311|NCT03412565|12048239|FG000|COMPLETED|Overall Study||66
10882312|NCT03412565|12048240|FG001|COMPLETED|Overall Study||2
10882313|NCT03412565|12048241|FG002|COMPLETED|Overall Study||3
10882314|NCT03412565|12048242|FG003|COMPLETED|Overall Study||12
10882315|NCT03412565|12048239|FG000|NOT COMPLETED|Overall Study||1
10882316|NCT03412565|12048240|FG001|NOT COMPLETED|Overall Study||65
10882317|NCT03412565|12048241|FG002|NOT COMPLETED|Overall Study||62
10882318|NCT03412565|12048242|FG003|NOT COMPLETED|Overall Study||54
10882319|NCT03410693|12048259|FG000|STARTED|Overall Study||87
10882320|NCT03410693|12048260|FG001|STARTED|Overall Study||88
10882321|NCT03410693|12048259|FG000|Started Treatment|Overall Study||86
10882322|NCT03410693|12048260|FG001|Started Treatment|Overall Study||82
10882323|NCT03410693|12048259|FG000|Active Follow-up Performed|Overall Study||61
10882324|NCT03410693|12048260|FG001|Active Follow-up Performed|Overall Study||56
10882325|NCT03410693|12048259|FG000|Entered Long Term Follow-up|Overall Study||56
10882326|NCT03410693|12048260|FG001|Entered Long Term Follow-up|Overall Study||69
10882327|NCT03410693|12048259|FG000|COMPLETED|Overall Study|Completed treatment|0
10882328|NCT03410693|12048260|FG001|COMPLETED|Overall Study|Completed treatment|0
10882329|NCT03410693|12048259|FG000|NOT COMPLETED|Overall Study||87
10882330|NCT03410693|12048260|FG001|NOT COMPLETED|Overall Study||88
10882331|NCT03406702|12048272|FG000|STARTED|Overall Study||7
10882332|NCT03406702|12048272|FG000|COMPLETED|Overall Study||6
10882333|NCT03406702|12048272|FG000|NOT COMPLETED|Overall Study||1
10882334|NCT03406507|12048290|FG000|STARTED|Primary Evaluation Period||5
10882335|NCT03406507|12048291|FG001|STARTED|Primary Evaluation Period||8
10882336|NCT03406507|12048290|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||5
10882337|NCT03406507|12048291|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||8
10882338|NCT03406507|12048290|FG000|COMPLETED|Primary Evaluation Period||5
10882339|NCT03406507|12048291|FG001|COMPLETED|Primary Evaluation Period||8
10882340|NCT03406507|12048290|FG000|NOT COMPLETED|Primary Evaluation Period||0
10882341|NCT03406507|12048291|FG001|NOT COMPLETED|Primary Evaluation Period||0
10882342|NCT03406507|12048290|FG000|STARTED|Extension Period||5
10882343|NCT03406507|12048291|FG001|STARTED|Extension Period||8
10882344|NCT03406507|12048290|FG000|Received at Least 1 Dose of Study Drug|Extension Period||5
10882345|NCT03406507|12048291|FG001|Received at Least 1 Dose of Study Drug|Extension Period||8
10882346|NCT03406507|12048290|FG000|COMPLETED|Extension Period||0
10882347|NCT03406507|12048291|FG001|COMPLETED|Extension Period||2
10882348|NCT03406507|12048290|FG000|NOT COMPLETED|Extension Period||5
10882349|NCT03406507|12048291|FG001|NOT COMPLETED|Extension Period||6
10882350|NCT03402230|12048297|FG000|STARTED|Overall Study||25
10882351|NCT03402230|12048298|FG001|STARTED|Overall Study||24
10882352|NCT03402230|12048297|FG000|COMPLETED|Overall Study||25
10882353|NCT03402230|12048298|FG001|COMPLETED|Overall Study||23
10882354|NCT03402230|12048297|FG000|NOT COMPLETED|Overall Study||0
10882355|NCT03402230|12048298|FG001|NOT COMPLETED|Overall Study||1
10882356|NCT03394027|12048306|FG000|STARTED|Overall Study||10
10882357|NCT03394027|12048307|FG001|STARTED|Overall Study||6
10882358|NCT03394027|12048308|FG002|STARTED|Overall Study||14
10882359|NCT03394027|12048306|FG000|COMPLETED|Overall Study||7
10882360|NCT03394027|12048307|FG001|COMPLETED|Overall Study||5
10882361|NCT03394027|12048308|FG002|COMPLETED|Overall Study||10
10882362|NCT03394027|12048306|FG000|NOT COMPLETED|Overall Study||3
10882363|NCT03394027|12048307|FG001|NOT COMPLETED|Overall Study||1
10882364|NCT03394027|12048308|FG002|NOT COMPLETED|Overall Study||4
10882365|NCT03392974|12048334|FG000|STARTED|Overall Study||1
10882366|NCT03392974|12048334|FG000|COMPLETED|Overall Study||1
10882367|NCT03392974|12048334|FG000|NOT COMPLETED|Overall Study||0
10882368|NCT03392753|12048341|FG000|STARTED|Overall Study||83
10882369|NCT03392753|12048342|FG001|STARTED|Overall Study||84
10882370|NCT03392753|12048341|FG000|COMPLETED|Overall Study||47
10882371|NCT03392753|12048342|FG001|COMPLETED|Overall Study||50
10882372|NCT03392753|12048341|FG000|NOT COMPLETED|Overall Study||36
10882373|NCT03392753|12048342|FG001|NOT COMPLETED|Overall Study||34
10882374|NCT03392649|12048350|FG000|STARTED|Overall Study||40
10882375|NCT03392649|12048351|FG001|STARTED|Overall Study||41
10882376|NCT03392649|12048350|FG000|COMPLETED|Overall Study||40
10882377|NCT03392649|12048351|FG001|COMPLETED|Overall Study||41
10882378|NCT03392649|12048350|FG000|NOT COMPLETED|Overall Study||0
10882379|NCT03392649|12048351|FG001|NOT COMPLETED|Overall Study||0
10882380|NCT03392168|12048361|FG000|STARTED|Period 1: Cohort 1||8
10882381|NCT03392168|12048362|FG001|STARTED|Period 1: Cohort 1||0
10882382|NCT03392168|12048363|FG002|STARTED|Period 1: Cohort 1||0
10882383|NCT03392168|12048364|FG003|STARTED|Period 1: Cohort 1||0
10882384|NCT03392168|12048361|FG000|COMPLETED|Period 1: Cohort 1||8
10882385|NCT03392168|12048362|FG001|COMPLETED|Period 1: Cohort 1||0
10882386|NCT03392168|12048363|FG002|COMPLETED|Period 1: Cohort 1||0
10882387|NCT03392168|12048364|FG003|COMPLETED|Period 1: Cohort 1||0
10882388|NCT03392168|12048361|FG000|NOT COMPLETED|Period 1: Cohort 1||0
10882389|NCT03392168|12048362|FG001|NOT COMPLETED|Period 1: Cohort 1||0
10882390|NCT03392168|12048363|FG002|NOT COMPLETED|Period 1: Cohort 1||0
10882391|NCT03392168|12048364|FG003|NOT COMPLETED|Period 1: Cohort 1||0
10882392|NCT03392168|12048361|FG000|STARTED|Period 2: Cohort 2||0
10882393|NCT03392168|12048362|FG001|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|30
10882394|NCT03392168|12048363|FG002|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|28
10882395|NCT03392168|12048364|FG003|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|31
10882396|NCT03392168|12048361|FG000|COMPLETED|Period 2: Cohort 2||0
10882397|NCT03392168|12048362|FG001|COMPLETED|Period 2: Cohort 2||28
10882398|NCT03392168|12048363|FG002|COMPLETED|Period 2: Cohort 2||27
10882399|NCT03392168|12048364|FG003|COMPLETED|Period 2: Cohort 2||30
10882400|NCT03392168|12048361|FG000|NOT COMPLETED|Period 2: Cohort 2||0
10882401|NCT03392168|12048362|FG001|NOT COMPLETED|Period 2: Cohort 2||2
10882402|NCT03392168|12048363|FG002|NOT COMPLETED|Period 2: Cohort 2||1
10882403|NCT03392168|12048364|FG003|NOT COMPLETED|Period 2: Cohort 2||1
10882404|NCT03388008|12048375|FG000|STARTED|Overall Study||14
10882405|NCT03388008|12048376|FG001|STARTED|Overall Study||13
10882406|NCT03388008|12048375|FG000|COMPLETED|Overall Study||14
10882407|NCT03388008|12048376|FG001|COMPLETED|Overall Study||13
10882408|NCT03388008|12048375|FG000|NOT COMPLETED|Overall Study||0
10882409|NCT03388008|12048376|FG001|NOT COMPLETED|Overall Study||0
10882410|NCT03387735|12048384|FG000|STARTED|Overall Study||168
10882411|NCT03387735|12048385|FG001|STARTED|Overall Study||176
10882412|NCT03387735|12048384|FG000|COMPLETED|Overall Study||160
10882413|NCT03387735|12048385|FG001|COMPLETED|Overall Study||160
10882414|NCT03387735|12048384|FG000|NOT COMPLETED|Overall Study||8
10882415|NCT03387735|12048385|FG001|NOT COMPLETED|Overall Study||16
10882416|NCT03387579|12048394|FG000|STARTED|Overall Study||12
10882417|NCT03387579|12048395|FG001|STARTED|Overall Study||12
10882418|NCT03387579|12048396|FG002|STARTED|Overall Study||24
10882419|NCT03387579|12048394|FG000|COMPLETED|Overall Study||12
10882420|NCT03387579|12048395|FG001|COMPLETED|Overall Study||12
10882421|NCT03387579|12048396|FG002|COMPLETED|Overall Study||24
10882422|NCT03387579|12048394|FG000|NOT COMPLETED|Overall Study||0
10882423|NCT03387579|12048395|FG001|NOT COMPLETED|Overall Study||0
10882424|NCT03387579|12048396|FG002|NOT COMPLETED|Overall Study||0
10882425|NCT03386773|12048407|FG000|STARTED|Overall Study||150
10882426|NCT03386773|12048408|FG001|STARTED|Overall Study||150
10882427|NCT03386773|12048407|FG000|COMPLETED|Overall Study||123
10882428|NCT03386773|12048408|FG001|COMPLETED|Overall Study||115
10882429|NCT03386773|12048407|FG000|NOT COMPLETED|Overall Study||27
10882430|NCT03386773|12048408|FG001|NOT COMPLETED|Overall Study||35
10882431|NCT03374631|12048416|FG000|STARTED|First Intervention (20 Minutes)||20
10882432|NCT03374631|12048417|FG001|STARTED|First Intervention (20 Minutes)||20
10882433|NCT03374631|12048416|FG000|COMPLETED|First Intervention (20 Minutes)||20
10882434|NCT03374631|12048417|FG001|COMPLETED|First Intervention (20 Minutes)||20
10882435|NCT03374631|12048416|FG000|NOT COMPLETED|First Intervention (20 Minutes)||0
10882436|NCT03374631|12048417|FG001|NOT COMPLETED|First Intervention (20 Minutes)||0
10882437|NCT03374631|12048416|FG000|STARTED|Washout (1 Week)||20
10882438|NCT03374631|12048417|FG001|STARTED|Washout (1 Week)||20
10882439|NCT03374631|12048416|FG000|COMPLETED|Washout (1 Week)||20
10882440|NCT03374631|12048417|FG001|COMPLETED|Washout (1 Week)||20
10882441|NCT03374631|12048416|FG000|NOT COMPLETED|Washout (1 Week)||0
10882442|NCT03374631|12048417|FG001|NOT COMPLETED|Washout (1 Week)||0
10882443|NCT03374631|12048416|FG000|STARTED|Second Intervention (20 Minutes)||20
10882444|NCT03374631|12048417|FG001|STARTED|Second Intervention (20 Minutes)||20
10882445|NCT03374631|12048416|FG000|COMPLETED|Second Intervention (20 Minutes)||20
10882446|NCT03374631|12048417|FG001|COMPLETED|Second Intervention (20 Minutes)||20
10882447|NCT03374631|12048416|FG000|NOT COMPLETED|Second Intervention (20 Minutes)||0
10882448|NCT03374631|12048417|FG001|NOT COMPLETED|Second Intervention (20 Minutes)||0
10882449|NCT03372161|12048428|FG000|STARTED|Overall Study||202
10882450|NCT03372161|12048429|FG001|STARTED|Overall Study||199
10882451|NCT03372161|12048428|FG000|COMPLETED|Overall Study||193
10882452|NCT03372161|12048429|FG001|COMPLETED|Overall Study||192
10882453|NCT03372161|12048428|FG000|NOT COMPLETED|Overall Study||9
10882454|NCT03372161|12048429|FG001|NOT COMPLETED|Overall Study||7
10882455|NCT03370510|12048437|FG000|STARTED|Overall Study||3
10882456|NCT03370510|12048438|FG001|STARTED|Overall Study||2
10882457|NCT03370510|12048437|FG000|COMPLETED|Overall Study||1
10882458|NCT03370510|12048438|FG001|COMPLETED|Overall Study||2
10882459|NCT03370510|12048437|FG000|NOT COMPLETED|Overall Study||2
10882460|NCT03370510|12048438|FG001|NOT COMPLETED|Overall Study||0
10882461|NCT03370341|12048446|FG000|STARTED|Overall Study||21
10882462|NCT03370341|12048447|FG001|STARTED|Overall Study||20
10882463|NCT03370341|12048446|FG000|COMPLETED|Overall Study||21
10882464|NCT03370341|12048447|FG001|COMPLETED|Overall Study||19
10882465|NCT03370341|12048446|FG000|NOT COMPLETED|Overall Study||0
10882466|NCT03370341|12048447|FG001|NOT COMPLETED|Overall Study||1
10882467|NCT03368781|12048453|FG000|STARTED|Overall Study||128
10882468|NCT03368781|12048453|FG000|Treated Subjects|Overall Study|106 subjects underwent an ablation procedure|106
10882469|NCT03368781|12048453|FG000|COMPLETED|Overall Study||103
10882470|NCT03368781|12048453|FG000|NOT COMPLETED|Overall Study||25
10882471|NCT03368196|12048461|FG000|STARTED|Overall Study||12
10882472|NCT03368196|12048461|FG000|COMPLETED|Overall Study||12
10882473|NCT03368196|12048461|FG000|NOT COMPLETED|Overall Study||0
10882474|NCT03366298|12048465|FG000|STARTED|Overall Study||3
10882475|NCT03366298|12048466|FG001|STARTED|Overall Study||3
10882476|NCT03366298|12048467|FG002|STARTED|Overall Study||3
10882477|NCT03366298|12048468|FG003|STARTED|Overall Study||3
10882478|NCT03366298|12048465|FG000|COMPLETED|Overall Study||3
10882479|NCT03366298|12048466|FG001|COMPLETED|Overall Study||3
10882480|NCT03366298|12048467|FG002|COMPLETED|Overall Study||3
10882481|NCT03366298|12048468|FG003|COMPLETED|Overall Study||3
10882482|NCT03366298|12048465|FG000|NOT COMPLETED|Overall Study||0
10882483|NCT03366298|12048466|FG001|NOT COMPLETED|Overall Study||0
10882484|NCT03366298|12048467|FG002|NOT COMPLETED|Overall Study||0
10882485|NCT03366298|12048468|FG003|NOT COMPLETED|Overall Study||0
10882486|NCT03364270|12048476|FG000|STARTED|Overall Study|First patient to undergo PET-MRI: 10/10/2018|6
10882487|NCT03364270|12048476|FG000|COMPLETED|Overall Study|Last subject scanned: 1/9/2020|6
10882488|NCT03364270|12048476|FG000|NOT COMPLETED|Overall Study||0
10882489|NCT03364036|12048482|FG000|STARTED|Overall Study||270
10882490|NCT03364036|12048482|FG000|Full Analysis Set (FAS)|Overall Study||270
10882491|NCT03364036|12048482|FG000|COMPLETED|Overall Study||264
10882492|NCT03364036|12048482|FG000|NOT COMPLETED|Overall Study||6
10882493|NCT03361306|12048486|FG000|STARTED|Overall Study||15
10882494|NCT03361306|12048486|FG000|COMPLETED|Overall Study||0
10882495|NCT03361306|12048486|FG000|NOT COMPLETED|Overall Study||15
10882496|NCT03360396|12048492|FG000|STARTED|Overall Study||80
10882497|NCT03360396|12048493|FG001|STARTED|Overall Study||40
10882498|NCT03360396|12048492|FG000|COMPLETED|Overall Study||0
10882499|NCT03360396|12048493|FG001|COMPLETED|Overall Study||0
10882500|NCT03360396|12048492|FG000|NOT COMPLETED|Overall Study||80
10882501|NCT03360396|12048493|FG001|NOT COMPLETED|Overall Study||40
10882502|NCT03359356|12048501|FG000|STARTED|Overall Study||20
10882503|NCT03359356|12048502|FG001|STARTED|Overall Study||40
10882504|NCT03359356|12048501|FG000|COMPLETED|Overall Study||20
10882505|NCT03359356|12048502|FG001|COMPLETED|Overall Study||40
10882506|NCT03359356|12048501|FG000|NOT COMPLETED|Overall Study||0
10882507|NCT03359356|12048502|FG001|NOT COMPLETED|Overall Study||0
10882508|NCT03358472|12048515|FG000|STARTED|Overall Study||35
10882509|NCT03358472|12048516|FG001|STARTED|Overall Study||19
10882510|NCT03358472|12048517|FG002|STARTED|Overall Study||35
10882511|NCT03358472|12048515|FG000|Intention-to-Treat (ITT)|Overall Study||35
10882512|NCT03358472|12048516|FG001|Intention-to-Treat (ITT)|Overall Study||19
10882513|NCT03358472|12048517|FG002|Intention-to-Treat (ITT)|Overall Study||35
10882514|NCT03358472|12048515|FG000|All Participants as Treated (APaT)|Overall Study||34
10882515|NCT03358472|12048516|FG001|All Participants as Treated (APaT)|Overall Study||19
10882516|NCT03358472|12048517|FG002|All Participants as Treated (APaT)|Overall Study||34
10882517|NCT03358472|12048515|FG000|COMPLETED|Overall Study||20
10882518|NCT03358472|12048516|FG001|COMPLETED|Overall Study||9
10882519|NCT03358472|12048517|FG002|COMPLETED|Overall Study||19
10882520|NCT03358472|12048515|FG000|NOT COMPLETED|Overall Study||15
10882521|NCT03358472|12048516|FG001|NOT COMPLETED|Overall Study||10
10882522|NCT03358472|12048517|FG002|NOT COMPLETED|Overall Study||16
10882523|NCT03350750|12048527|FG000|STARTED|Overall Study||9
10882524|NCT03350750|12048528|FG001|STARTED|Overall Study||9
10882525|NCT03350750|12048527|FG000|4-month Follow-up (Randomized Evaluation)|Overall Study||8
10882526|NCT03350750|12048528|FG001|4-month Follow-up (Randomized Evaluation)|Overall Study||8
10882527|NCT03350750|12048527|FG000|12-Month Follow-up (Entire Study)|Overall Study||8
10882528|NCT03350750|12048528|FG001|12-Month Follow-up (Entire Study)|Overall Study||8
10882529|NCT03350750|12048527|FG000|COMPLETED|Overall Study||8
10882530|NCT03350750|12048528|FG001|COMPLETED|Overall Study||8
10882531|NCT03350750|12048527|FG000|NOT COMPLETED|Overall Study||1
10882532|NCT03350750|12048528|FG001|NOT COMPLETED|Overall Study||1
10882533|NCT03346434|12048542|FG000|STARTED|Overall Study||10
10882534|NCT03346434|12048543|FG001|STARTED|Overall Study||10
10882535|NCT03346434|12048544|FG002|STARTED|Overall Study||10
10882536|NCT03346434|12048545|FG003|STARTED|Overall Study||10
10882537|NCT03346434|12048546|FG004|STARTED|Overall Study||79
10882538|NCT03346434|12048547|FG005|STARTED|Overall Study||83
10882539|NCT03346434|12048542|FG000|Completed Part A|Overall Study||10
10882540|NCT03346434|12048543|FG001|Completed Part A|Overall Study||10
10882541|NCT03346434|12048544|FG002|Completed Part A|Overall Study||9
10882542|NCT03346434|12048545|FG003|Completed Part A|Overall Study||10
10882543|NCT03346434|12048546|FG004|Completed Part A|Overall Study||0
10882544|NCT03346434|12048547|FG005|Completed Part A|Overall Study||0
10882545|NCT03346434|12048542|FG000|Completed Part B (Week 16)|Overall Study||0
10882546|NCT03346434|12048543|FG001|Completed Part B (Week 16)|Overall Study||0
10882547|NCT03346434|12048544|FG002|Completed Part B (Week 16)|Overall Study||0
10882548|NCT03346434|12048545|FG003|Completed Part B (Week 16)|Overall Study||0
10882549|NCT03346434|12048546|FG004|Completed Part B (Week 16)|Overall Study||76
10882550|NCT03346434|12048547|FG005|Completed Part B (Week 16)|Overall Study||83
10882551|NCT03346434|12048542|FG000|Completed Part B (Week 28)|Overall Study||0
10882552|NCT03346434|12048543|FG001|Completed Part B (Week 28)|Overall Study||0
10882553|NCT03346434|12048544|FG002|Completed Part B (Week 28)|Overall Study||0
10882554|NCT03346434|12048545|FG003|Completed Part B (Week 28)|Overall Study||0
10882555|NCT03346434|12048546|FG004|Completed Part B (Week 28)|Overall Study||1
10882556|NCT03346434|12048547|FG005|Completed Part B (Week 28)|Overall Study||1
10882557|NCT03346434|12048542|FG000|COMPLETED|Overall Study||10
10882558|NCT03346434|12048543|FG001|COMPLETED|Overall Study||10
10882559|NCT03346434|12048544|FG002|COMPLETED|Overall Study||9
10882560|NCT03346434|12048545|FG003|COMPLETED|Overall Study||10
10882561|NCT03346434|12048546|FG004|COMPLETED|Overall Study||1
10882562|NCT03346434|12048547|FG005|COMPLETED|Overall Study||1
10882563|NCT03346434|12048542|FG000|NOT COMPLETED|Overall Study||0
10882564|NCT03346434|12048543|FG001|NOT COMPLETED|Overall Study||0
10882565|NCT03346434|12048544|FG002|NOT COMPLETED|Overall Study||1
10882566|NCT03346434|12048545|FG003|NOT COMPLETED|Overall Study||0
10882567|NCT03346434|12048546|FG004|NOT COMPLETED|Overall Study||78
10882568|NCT03346434|12048547|FG005|NOT COMPLETED|Overall Study||82
10882569|NCT03345836|12048568|FG000|STARTED|Period 1: DB and OL Induction (12 Weeks)||171
10882570|NCT03345836|12048569|FG001|STARTED|Period 1: DB and OL Induction (12 Weeks)||324
10882571|NCT03345836|12048570|FG002|STARTED|Period 1: DB and OL Induction (12 Weeks)||129
10882572|NCT03345836|12048571|FG003|STARTED|Period 1: DB and OL Induction (12 Weeks)||0
10882573|NCT03345836|12048572|FG004|STARTED|Period 1: DB and OL Induction (12 Weeks)||0
10882574|NCT03345836|12048573|FG005|STARTED|Period 1: DB and OL Induction (12 Weeks)||0
10882575|NCT03345836|12048568|FG000|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||149
10882576|NCT03345836|12048569|FG001|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||291
10882577|NCT03345836|12048570|FG002|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||123
10882578|NCT03345836|12048571|FG003|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0
10882579|NCT03345836|12048572|FG004|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0
10882580|NCT03345836|12048573|FG005|COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0
10882581|NCT03345836|12048568|FG000|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||22
10882582|NCT03345836|12048569|FG001|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||33
10882583|NCT03345836|12048570|FG002|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||6
10882584|NCT03345836|12048571|FG003|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0
10882585|NCT03345836|12048572|FG004|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0
10882586|NCT03345836|12048573|FG005|NOT COMPLETED|Period 1: DB and OL Induction (12 Weeks)||0
10882587|NCT03345836|12048568|FG000|STARTED|Period 2: 12-Week Extended Treatment||0
10882588|NCT03345836|12048569|FG001|STARTED|Period 2: 12-Week Extended Treatment||0
10882589|NCT03345836|12048570|FG002|STARTED|Period 2: 12-Week Extended Treatment||0
10882590|NCT03345836|12048571|FG003|STARTED|Period 2: 12-Week Extended Treatment||78
10882591|NCT03345836|12048572|FG004|STARTED|Period 2: 12-Week Extended Treatment||69
10882592|NCT03345836|12048573|FG005|STARTED|Period 2: 12-Week Extended Treatment||14
10882593|NCT03345836|12048568|FG000|COMPLETED|Period 2: 12-Week Extended Treatment||0
10882594|NCT03345836|12048569|FG001|COMPLETED|Period 2: 12-Week Extended Treatment||0
10882595|NCT03345836|12048570|FG002|COMPLETED|Period 2: 12-Week Extended Treatment||0
10882596|NCT03345836|12048571|FG003|COMPLETED|Period 2: 12-Week Extended Treatment||67
10882597|NCT03345836|12048572|FG004|COMPLETED|Period 2: 12-Week Extended Treatment||51
10882598|NCT03345836|12048573|FG005|COMPLETED|Period 2: 12-Week Extended Treatment||8
10882599|NCT03345836|12048568|FG000|NOT COMPLETED|Period 2: 12-Week Extended Treatment||0
10882600|NCT03345836|12048569|FG001|NOT COMPLETED|Period 2: 12-Week Extended Treatment||0
10882601|NCT03345836|12048570|FG002|NOT COMPLETED|Period 2: 12-Week Extended Treatment||0
10882602|NCT03345836|12048571|FG003|NOT COMPLETED|Period 2: 12-Week Extended Treatment||11
10882603|NCT03345836|12048572|FG004|NOT COMPLETED|Period 2: 12-Week Extended Treatment||18
10882604|NCT03345836|12048573|FG005|NOT COMPLETED|Period 2: 12-Week Extended Treatment||6
10882605|NCT03343054|12048592|FG000|STARTED|Dose Escalation Period (Up to 286 Days)||3
10882606|NCT03343054|12048593|FG001|STARTED|Dose Escalation Period (Up to 286 Days)||6
10882607|NCT03343054|12048594|FG002|STARTED|Dose Escalation Period (Up to 286 Days)|Dose escalation and Dose expansion were separate populations.|0
10882608|NCT03343054|12048592|FG000|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
10882609|NCT03343054|12048593|FG001|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
10882610|NCT03343054|12048594|FG002|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
10882611|NCT03343054|12048592|FG000|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||3
10882612|NCT03343054|12048593|FG001|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||6
10882613|NCT03343054|12048594|FG002|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||0
10882614|NCT03343054|12048592|FG000|STARTED|Dose Expansion Period (Up to 502 Days)||0
10882615|NCT03343054|12048593|FG001|STARTED|Dose Expansion Period (Up to 502 Days)||0
10882616|NCT03343054|12048594|FG002|STARTED|Dose Expansion Period (Up to 502 Days)|Dose escalation and Dose expansion were separate populations.|19
10882617|NCT03343054|12048592|FG000|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10882618|NCT03343054|12048593|FG001|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10882619|NCT03343054|12048594|FG002|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10882620|NCT03343054|12048592|FG000|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10882621|NCT03343054|12048593|FG001|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||0
10882622|NCT03343054|12048594|FG002|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||19
10882623|NCT03342404|12048605|FG000|STARTED|Overall Study||96
10882624|NCT03342404|12048606|FG001|STARTED|Overall Study||49
10882625|NCT03342404|12048605|FG000|COMPLETED|Overall Study||81
10882626|NCT03342404|12048606|FG001|COMPLETED|Overall Study||18
10882627|NCT03342404|12048605|FG000|NOT COMPLETED|Overall Study||15
10882628|NCT03342404|12048606|FG001|NOT COMPLETED|Overall Study||31
10882629|NCT03338998|12048614|FG000|STARTED|Treatment Period||16
10882630|NCT03338998|12048615|FG001|STARTED|Treatment Period||13
10882631|NCT03338998|12048614|FG000|COMPLETED|Treatment Period||8
10882632|NCT03338998|12048615|FG001|COMPLETED|Treatment Period||10
10882633|NCT03338998|12048614|FG000|NOT COMPLETED|Treatment Period||8
10882634|NCT03338998|12048615|FG001|NOT COMPLETED|Treatment Period||3
10882635|NCT03338998|12048614|FG000|STARTED|Safety Follow-Up Period||16
10882636|NCT03338998|12048615|FG001|STARTED|Safety Follow-Up Period||13
10882637|NCT03338998|12048614|FG000|COMPLETED|Safety Follow-Up Period||14
10882638|NCT03338998|12048615|FG001|COMPLETED|Safety Follow-Up Period||12
10882639|NCT03338998|12048614|FG000|NOT COMPLETED|Safety Follow-Up Period||2
10882640|NCT03338998|12048615|FG001|NOT COMPLETED|Safety Follow-Up Period||1
10882641|NCT03338972|12048626|FG000|STARTED|Overall Study||7
10882642|NCT03338972|12048627|FG001|STARTED|Overall Study||8
10882643|NCT03338972|12048628|FG002|STARTED|Overall Study||7
10882644|NCT03338972|12048629|FG003|STARTED|Overall Study||3
10882645|NCT03338972|12048626|FG000|COMPLETED|Overall Study||5
10882646|NCT03338972|12048627|FG001|COMPLETED|Overall Study||7
10882647|NCT03338972|12048628|FG002|COMPLETED|Overall Study||7
10882648|NCT03338972|12048629|FG003|COMPLETED|Overall Study||3
10882649|NCT03338972|12048626|FG000|NOT COMPLETED|Overall Study||2
10882650|NCT03338972|12048627|FG001|NOT COMPLETED|Overall Study||1
10882651|NCT03338972|12048628|FG002|NOT COMPLETED|Overall Study||0
10882652|NCT03338972|12048629|FG003|NOT COMPLETED|Overall Study||0
10882653|NCT03338790|12048643|FG000|STARTED|Overall Study||88
10882654|NCT03338790|12048644|FG001|STARTED|Overall Study||71
10882655|NCT03338790|12048645|FG002|STARTED|Overall Study||84
10882656|NCT03338790|12048646|FG003|STARTED|Overall Study||49
10882657|NCT03338790|12048643|FG000|COMPLETED|Overall Study||4
10882658|NCT03338790|12048644|FG001|COMPLETED|Overall Study||4
10882659|NCT03338790|12048645|FG002|COMPLETED|Overall Study||8
10882660|NCT03338790|12048646|FG003|COMPLETED|Overall Study||4
10882661|NCT03338790|12048643|FG000|NOT COMPLETED|Overall Study||84
10882662|NCT03338790|12048644|FG001|NOT COMPLETED|Overall Study||67
10882663|NCT03338790|12048645|FG002|NOT COMPLETED|Overall Study||76
10882664|NCT03338790|12048646|FG003|NOT COMPLETED|Overall Study||45
10882665|NCT03338244|12048658|FG000|STARTED|Overall Study||33173
10882666|NCT03338244|12048659|FG001|STARTED|Overall Study||33055
10882667|NCT03338244|12048658|FG000|COMPLETED|Overall Study||25995
10882668|NCT03338244|12048659|FG001|COMPLETED|Overall Study||25568
10882669|NCT03338244|12048658|FG000|NOT COMPLETED|Overall Study||7178
10882670|NCT03338244|12048659|FG001|NOT COMPLETED|Overall Study||7487
10882671|NCT03338036|12048669|FG000|STARTED|Overall Study||0
10882672|NCT03338036|12048670|FG001|STARTED|Overall Study||11
10882673|NCT03338036|12048671|FG002|STARTED|Overall Study||12
10882674|NCT03338036|12048672|FG003|STARTED|Overall Study||8
10882675|NCT03338036|12048669|FG000|COMPLETED|Overall Study||0
10882676|NCT03338036|12048670|FG001|COMPLETED|Overall Study||7
10882677|NCT03338036|12048671|FG002|COMPLETED|Overall Study||9
10882678|NCT03338036|12048672|FG003|COMPLETED|Overall Study||8
10882679|NCT03338036|12048669|FG000|NOT COMPLETED|Overall Study||0
10882680|NCT03338036|12048670|FG001|NOT COMPLETED|Overall Study||4
10882681|NCT03338036|12048671|FG002|NOT COMPLETED|Overall Study||3
10882682|NCT03338036|12048672|FG003|NOT COMPLETED|Overall Study||0
10882683|NCT03335774|12048682|FG000|STARTED|Overall Study||51
10882684|NCT03335774|12048683|FG001|STARTED|Overall Study||52
10882685|NCT03335774|12048682|FG000|COMPLETED|Overall Study||50
10882686|NCT03335774|12048683|FG001|COMPLETED|Overall Study||51
10882687|NCT03335774|12048682|FG000|NOT COMPLETED|Overall Study||1
10882688|NCT03335774|12048683|FG001|NOT COMPLETED|Overall Study||1
10882689|NCT03334344|12048691|FG000|STARTED|Overall Study||44
10882690|NCT03334344|12048692|FG001|STARTED|Overall Study||48
10882691|NCT03334344|12048691|FG000|COMPLETED|Overall Study||44
10882692|NCT03334344|12048692|FG001|COMPLETED|Overall Study||48
10882693|NCT03334344|12048691|FG000|NOT COMPLETED|Overall Study||0
10882694|NCT03334344|12048692|FG001|NOT COMPLETED|Overall Study||0
10882695|NCT03333837|12048703|FG000|STARTED|Overall Study||24
10882696|NCT03333837|12048704|FG001|STARTED|Overall Study||25
10882697|NCT03333837|12048705|FG002|STARTED|Overall Study||27
10882698|NCT03333837|12048706|FG003|STARTED|Overall Study||25
10882699|NCT03333837|12048707|FG004|STARTED|Overall Study||3
10882700|NCT03333837|12048703|FG000|COMPLETED|Overall Study||22
10882701|NCT03333837|12048704|FG001|COMPLETED|Overall Study||22
10882702|NCT03333837|12048705|FG002|COMPLETED|Overall Study||22
10882703|NCT03333837|12048706|FG003|COMPLETED|Overall Study||23
10882704|NCT03333837|12048707|FG004|COMPLETED|Overall Study||0
10882705|NCT03333837|12048703|FG000|NOT COMPLETED|Overall Study||2
10882706|NCT03333837|12048704|FG001|NOT COMPLETED|Overall Study||3
10882707|NCT03333837|12048705|FG002|NOT COMPLETED|Overall Study||5
10882708|NCT03333837|12048706|FG003|NOT COMPLETED|Overall Study||2
10882709|NCT03333837|12048707|FG004|NOT COMPLETED|Overall Study||3
10882710|NCT03333590|12048725|FG000|STARTED|Overall Study||1
10882711|NCT03333590|12048726|FG001|STARTED|Overall Study||1
10882712|NCT03333590|12048725|FG000|COMPLETED|Overall Study||1
10882713|NCT03333590|12048726|FG001|COMPLETED|Overall Study||1
10882714|NCT03333590|12048725|FG000|NOT COMPLETED|Overall Study||0
10882715|NCT03333590|12048726|FG001|NOT COMPLETED|Overall Study||0
10882716|NCT03332095|12048736|FG000|STARTED|Overall Study||10
10882717|NCT03332095|12048737|FG001|STARTED|Overall Study||45
10882718|NCT03332095|12048736|FG000|Received at Least One Dose of Study Treatment|Overall Study||9
10882719|NCT03332095|12048737|FG001|Received at Least One Dose of Study Treatment|Overall Study||45
10882720|NCT03332095|12048736|FG000|COMPLETED|Overall Study||9
10882721|NCT03332095|12048737|FG001|COMPLETED|Overall Study||44
10882722|NCT03332095|12048736|FG000|NOT COMPLETED|Overall Study||1
10882723|NCT03332095|12048737|FG001|NOT COMPLETED|Overall Study||1
10882724|NCT03330847|12048746|FG000|STARTED|Overall Study||114
10882725|NCT03330847|12048747|FG001|STARTED|Overall Study||112
10882726|NCT03330847|12048748|FG002|STARTED|Overall Study||47
10882727|NCT03330847|12048746|FG000|COMPLETED|Overall Study||52
10882728|NCT03330847|12048747|FG001|COMPLETED|Overall Study||47
10882729|NCT03330847|12048748|FG002|COMPLETED|Overall Study||32
10882730|NCT03330847|12048746|FG000|NOT COMPLETED|Overall Study||62
10882731|NCT03330847|12048747|FG001|NOT COMPLETED|Overall Study||65
10882732|NCT03330847|12048748|FG002|NOT COMPLETED|Overall Study||15
10882733|NCT03327649|12048760|FG000|STARTED|Overall Study||26
10882734|NCT03327649|12048761|FG001|STARTED|Overall Study||26
10882735|NCT03327649|12048760|FG000|COMPLETED|Overall Study||24
10882736|NCT03327649|12048761|FG001|COMPLETED|Overall Study||24
10882737|NCT03327649|12048760|FG000|NOT COMPLETED|Overall Study||2
10882738|NCT03327649|12048761|FG001|NOT COMPLETED|Overall Study||2
10882739|NCT03325712|12048775|FG000|STARTED|Overall Study||10
10882740|NCT03325712|12048776|FG001|STARTED|Overall Study||2
10882741|NCT03325712|12048777|FG002|STARTED|Overall Study||8
10882742|NCT03325712|12048778|FG003|STARTED|Overall Study||8
10882743|NCT03325712|12048779|FG004|STARTED|Overall Study||8
10882744|NCT03325712|12048780|FG005|STARTED|Overall Study||8
10882745|NCT03325712|12048781|FG006|STARTED|Overall Study||8
10882746|NCT03325712|12048782|FG007|STARTED|Overall Study||8
10882747|NCT03325712|12048775|FG000|COMPLETED|Overall Study||10
10882748|NCT03325712|12048776|FG001|COMPLETED|Overall Study||2
10882749|NCT03325712|12048777|FG002|COMPLETED|Overall Study||8
10882750|NCT03325712|12048778|FG003|COMPLETED|Overall Study||8
10882751|NCT03325712|12048779|FG004|COMPLETED|Overall Study||6
10882752|NCT03325712|12048780|FG005|COMPLETED|Overall Study||8
10882753|NCT03325712|12048781|FG006|COMPLETED|Overall Study||8
10882754|NCT03325712|12048782|FG007|COMPLETED|Overall Study||8
10882755|NCT03325712|12048775|FG000|NOT COMPLETED|Overall Study||0
10882756|NCT03325712|12048776|FG001|NOT COMPLETED|Overall Study||0
10882757|NCT03325712|12048777|FG002|NOT COMPLETED|Overall Study||0
10882758|NCT03325712|12048778|FG003|NOT COMPLETED|Overall Study||0
10882759|NCT03325712|12048779|FG004|NOT COMPLETED|Overall Study||2
10882760|NCT03325712|12048780|FG005|NOT COMPLETED|Overall Study||0
10882761|NCT03325712|12048781|FG006|NOT COMPLETED|Overall Study||0
10882762|NCT03325712|12048782|FG007|NOT COMPLETED|Overall Study||0
10882763|NCT03325166|12048810|FG000|STARTED|Overall Study||2
10882764|NCT03325166|12048810|FG000|COMPLETED|Overall Study||1
10882765|NCT03325166|12048810|FG000|NOT COMPLETED|Overall Study||1
10882766|NCT03323034|12048819|FG000|STARTED|Overall Study||6
10882767|NCT03323034|12048820|FG001|STARTED|Overall Study||6
10882768|NCT03323034|12048821|FG002|STARTED|Overall Study||6
10882769|NCT03323034|12048822|FG003|STARTED|Overall Study||6
10882770|NCT03323034|12048823|FG004|STARTED|Overall Study||6
10882771|NCT03323034|12048819|FG000|COMPLETED|Overall Study||0
10882772|NCT03323034|12048820|FG001|COMPLETED|Overall Study||0
10882773|NCT03323034|12048821|FG002|COMPLETED|Overall Study||0
10882774|NCT03323034|12048822|FG003|COMPLETED|Overall Study||0
10882775|NCT03323034|12048823|FG004|COMPLETED|Overall Study||0
10882776|NCT03323034|12048819|FG000|NOT COMPLETED|Overall Study||6
10882777|NCT03323034|12048820|FG001|NOT COMPLETED|Overall Study||6
10882778|NCT03323034|12048821|FG002|NOT COMPLETED|Overall Study||6
10882779|NCT03323034|12048822|FG003|NOT COMPLETED|Overall Study||6
10882780|NCT03323034|12048823|FG004|NOT COMPLETED|Overall Study||6
10882781|NCT03321526|12048838|FG000|STARTED|Double-blind Treatment Phase (24 Weeks)||54
10882782|NCT03321526|12048839|FG001|STARTED|Double-blind Treatment Phase (24 Weeks)||53
10882783|NCT03321526|12048838|FG000|COMPLETED|Double-blind Treatment Phase (24 Weeks)||30
10882784|NCT03321526|12048839|FG001|COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
10882785|NCT03321526|12048838|FG000|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||24
10882786|NCT03321526|12048839|FG001|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||26
10882787|NCT03321526|12048838|FG000|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind treatment phase were followed-up in follow-up phase.|54
10882788|NCT03321526|12048839|FG001|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind treatment phase were followed-up in follow-up phase except 1 participant as that participant did not received any treatment.|52
10882789|NCT03321526|12048838|FG000|COMPLETED|Follow-up Phase (2 Weeks)||30
10882790|NCT03321526|12048839|FG001|COMPLETED|Follow-up Phase (2 Weeks)||28
10882791|NCT03321526|12048838|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||24
10882792|NCT03321526|12048839|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||24
10882793|NCT03320824|12048853|FG000|STARTED|Overall Study||184
10882794|NCT03320824|12048854|FG001|STARTED|Overall Study||89
10882795|NCT03320824|12048853|FG000|COMPLETED|Overall Study||166
10882796|NCT03320824|12048854|FG001|COMPLETED|Overall Study||85
10882797|NCT03320824|12048853|FG000|NOT COMPLETED|Overall Study||18
10882798|NCT03320824|12048854|FG001|NOT COMPLETED|Overall Study||4
10882799|NCT03320512|12048863|FG000|STARTED|Overall Study||82
10882800|NCT03320512|12048864|FG001|STARTED|Overall Study||81
10882801|NCT03320512|12048865|FG002|STARTED|Overall Study||83
10882802|NCT03320512|12048863|FG000|Month 3 Survey Started|Overall Study||69
10882803|NCT03320512|12048864|FG001|Month 3 Survey Started|Overall Study||72
10882804|NCT03320512|12048865|FG002|Month 3 Survey Started|Overall Study||71
10882805|NCT03320512|12048863|FG000|Month 3 Survey Completed|Overall Study||69
10882806|NCT03320512|12048864|FG001|Month 3 Survey Completed|Overall Study||72
10882807|NCT03320512|12048865|FG002|Month 3 Survey Completed|Overall Study||68
10882808|NCT03320512|12048863|FG000|Month 3 Lab Sample Collected|Overall Study||51
10882809|NCT03320512|12048864|FG001|Month 3 Lab Sample Collected|Overall Study||54
10882810|NCT03320512|12048865|FG002|Month 3 Lab Sample Collected|Overall Study||51
10882811|NCT03320512|12048863|FG000|Month 6 Survey Started|Overall Study||67
10882812|NCT03320512|12048864|FG001|Month 6 Survey Started|Overall Study||72
10882813|NCT03320512|12048865|FG002|Month 6 Survey Started|Overall Study||69
10882814|NCT03320512|12048863|FG000|Month 6 Survey Completed|Overall Study||65
10882815|NCT03320512|12048864|FG001|Month 6 Survey Completed|Overall Study||71
10882816|NCT03320512|12048865|FG002|Month 6 Survey Completed|Overall Study||68
10882817|NCT03320512|12048863|FG000|Month 6 Lab Sample Collected|Overall Study||53
10882818|NCT03320512|12048864|FG001|Month 6 Lab Sample Collected|Overall Study||59
10882819|NCT03320512|12048865|FG002|Month 6 Lab Sample Collected|Overall Study||51
10882820|NCT03320512|12048863|FG000|COMPLETED|Overall Study||82
10882821|NCT03320512|12048864|FG001|COMPLETED|Overall Study||81
10882822|NCT03320512|12048865|FG002|COMPLETED|Overall Study||83
10882823|NCT03320512|12048863|FG000|NOT COMPLETED|Overall Study||0
10882824|NCT03320512|12048864|FG001|NOT COMPLETED|Overall Study||0
10882825|NCT03320512|12048865|FG002|NOT COMPLETED|Overall Study||0
10882826|NCT03319732|12048873|FG000|STARTED|Overall Study||323
10882827|NCT03319732|12048873|FG000|COMPLETED|Overall Study||218
10882828|NCT03319732|12048873|FG000|NOT COMPLETED|Overall Study||105
10882829|NCT03318861|12048883|FG000|STARTED|Overall Study||3
10882830|NCT03318861|12048884|FG001|STARTED|Overall Study||4
10882831|NCT03318861|12048885|FG002|STARTED|Overall Study||3
10882832|NCT03318861|12048886|FG003|STARTED|Overall Study||4
10882833|NCT03318861|12048887|FG004|STARTED|Overall Study||3
10882834|NCT03318861|12048883|FG000|COMPLETED|Overall Study||0
10882835|NCT03318861|12048884|FG001|COMPLETED|Overall Study||0
10882836|NCT03318861|12048885|FG002|COMPLETED|Overall Study||0
10882837|NCT03318861|12048886|FG003|COMPLETED|Overall Study||0
10882838|NCT03318861|12048887|FG004|COMPLETED|Overall Study||0
10882839|NCT03318861|12048883|FG000|NOT COMPLETED|Overall Study||3
10882840|NCT03318861|12048884|FG001|NOT COMPLETED|Overall Study||4
10882841|NCT03318861|12048885|FG002|NOT COMPLETED|Overall Study||3
10882842|NCT03318861|12048886|FG003|NOT COMPLETED|Overall Study||4
10882843|NCT03318861|12048887|FG004|NOT COMPLETED|Overall Study||3
10882844|NCT03316118|12048901|FG000|STARTED|Overall Study||2
10882845|NCT03316118|12048902|FG001|STARTED|Overall Study||0
10882846|NCT03316118|12048901|FG000|COMPLETED|Overall Study||2
10882847|NCT03316118|12048902|FG001|COMPLETED|Overall Study||0
10882848|NCT03316118|12048901|FG000|NOT COMPLETED|Overall Study||0
10882849|NCT03316118|12048902|FG001|NOT COMPLETED|Overall Study||0
10882850|NCT03315130|12048911|FG000|STARTED|Main Portion (12 Weeks)||15
10882851|NCT03315130|12048912|FG001|STARTED|Main Portion (12 Weeks)||15
10882852|NCT03315130|12048913|FG002|STARTED|Main Portion (12 Weeks)||15
10882853|NCT03315130|12048914|FG003|STARTED|Main Portion (12 Weeks)||0
10882854|NCT03315130|12048911|FG000|COMPLETED|Main Portion (12 Weeks)||15
10882855|NCT03315130|12048912|FG001|COMPLETED|Main Portion (12 Weeks)||13
10882856|NCT03315130|12048913|FG002|COMPLETED|Main Portion (12 Weeks)||15
10882857|NCT03315130|12048914|FG003|COMPLETED|Main Portion (12 Weeks)||0
10882858|NCT03315130|12048911|FG000|NOT COMPLETED|Main Portion (12 Weeks)||0
10882859|NCT03315130|12048912|FG001|NOT COMPLETED|Main Portion (12 Weeks)||2
10882860|NCT03315130|12048913|FG002|NOT COMPLETED|Main Portion (12 Weeks)||0
10882861|NCT03315130|12048914|FG003|NOT COMPLETED|Main Portion (12 Weeks)||0
10882862|NCT03315130|12048911|FG000|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)|(15 [who received RA101495 0.1 mg/kg] + 7 [crossover from placebo])|22
10882863|NCT03315130|12048912|FG001|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)|(14 [who received RA101495 0.3 mg/kg + 7 [crossover from placebo] + 1 [Subject who withdrew consent in Main Portion rejoined])|21
10882864|NCT03315130|12048913|FG002|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10882865|NCT03315130|12048914|FG003|STARTED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10882866|NCT03315130|12048911|FG000|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||21
10882867|NCT03315130|12048912|FG001|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||21
10882868|NCT03315130|12048913|FG002|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10882869|NCT03315130|12048914|FG003|COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10882870|NCT03315130|12048911|FG000|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||1
10882871|NCT03315130|12048912|FG001|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10882872|NCT03315130|12048913|FG002|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10882873|NCT03315130|12048914|FG003|NOT COMPLETED|EP:Before Switch to 0.3 mg/kg(Week13-48)||0
10882874|NCT03315130|12048911|FG000|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10882875|NCT03315130|12048912|FG001|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||21
10882876|NCT03315130|12048913|FG002|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10882877|NCT03315130|12048914|FG003|STARTED|EP:After Switch to 0.3 mg/kg(Week48-122)||21
10882878|NCT03315130|12048911|FG000|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10882879|NCT03315130|12048912|FG001|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||17
10882880|NCT03315130|12048913|FG002|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10882881|NCT03315130|12048914|FG003|COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||20
10882882|NCT03315130|12048911|FG000|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10882883|NCT03315130|12048912|FG001|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||4
10882884|NCT03315130|12048913|FG002|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||0
10882885|NCT03315130|12048914|FG003|NOT COMPLETED|EP:After Switch to 0.3 mg/kg(Week48-122)||1
10882886|NCT03314857|12048934|FG000|STARTED|Overall Study||67
10882887|NCT03314857|12048934|FG000|Analysis Population|Overall Study||61
10882888|NCT03314857|12048934|FG000|COMPLETED|Overall Study|62/67 patients completed the 30-day primary endpoint visit.|62
10882889|NCT03314857|12048934|FG000|NOT COMPLETED|Overall Study||5
10882890|NCT03308942|12048943|FG000|STARTED|Stage 1 (Up to a Maximum of 45 Months)||17
10882891|NCT03308942|12048944|FG001|STARTED|Stage 1 (Up to a Maximum of 45 Months)||21
10882892|NCT03308942|12048945|FG002|STARTED|Stage 1 (Up to a Maximum of 45 Months)||3
10882893|NCT03308942|12048946|FG003|STARTED|Stage 1 (Up to a Maximum of 45 Months)||0
10882894|NCT03308942|12048947|FG004|STARTED|Stage 1 (Up to a Maximum of 45 Months)||0
10882895|NCT03308942|12048943|FG000|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0
10882896|NCT03308942|12048944|FG001|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0
10882897|NCT03308942|12048945|FG002|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0
10882898|NCT03308942|12048946|FG003|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0
10882899|NCT03308942|12048947|FG004|COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0
10882900|NCT03308942|12048943|FG000|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||17
10882901|NCT03308942|12048944|FG001|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||21
10882902|NCT03308942|12048945|FG002|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||3
10882903|NCT03308942|12048946|FG003|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0
10882904|NCT03308942|12048947|FG004|NOT COMPLETED|Stage 1 (Up to a Maximum of 45 Months)||0
10882905|NCT03308942|12048943|FG000|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0
10882906|NCT03308942|12048944|FG001|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0
10882907|NCT03308942|12048945|FG002|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0
10882908|NCT03308942|12048946|FG003|STARTED|Stage 2 (Up to a Maximum of 29 Months)||12
10882909|NCT03308942|12048947|FG004|STARTED|Stage 2 (Up to a Maximum of 29 Months)||0
10882910|NCT03308942|12048943|FG000|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882911|NCT03308942|12048944|FG001|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882912|NCT03308942|12048945|FG002|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882913|NCT03308942|12048946|FG003|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882914|NCT03308942|12048947|FG004|COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882915|NCT03308942|12048943|FG000|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882916|NCT03308942|12048944|FG001|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882917|NCT03308942|12048945|FG002|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882918|NCT03308942|12048946|FG003|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||12
10882919|NCT03308942|12048947|FG004|NOT COMPLETED|Stage 2 (Up to a Maximum of 29 Months)||0
10882920|NCT03308786|12048960|FG000|STARTED|Overall Study||9
10882921|NCT03308786|12048960|FG000|COMPLETED|Overall Study||0
10882922|NCT03308786|12048960|FG000|NOT COMPLETED|Overall Study||9
10882923|NCT03307785|12048976|FG000|STARTED|Part A: Up to 28.5 Months||16
10882924|NCT03307785|12048977|FG001|STARTED|Part A: Up to 28.5 Months||6
10882925|NCT03307785|12048978|FG002|STARTED|Part A: Up to 28.5 Months||0
10882926|NCT03307785|12048979|FG003|STARTED|Part A: Up to 28.5 Months||0
10882927|NCT03307785|12048980|FG004|STARTED|Part A: Up to 28.5 Months||0
10882928|NCT03307785|12048981|FG005|STARTED|Part A: Up to 28.5 Months||0
10882929|NCT03307785|12048982|FG006|STARTED|Part A: Up to 28.5 Months||0
10882930|NCT03307785|12048983|FG007|STARTED|Part A: Up to 28.5 Months||0
10882931|NCT03307785|12048984|FG008|STARTED|Part A: Up to 28.5 Months||0
10882932|NCT03307785|12048985|FG009|STARTED|Part A: Up to 28.5 Months||0
10882933|NCT03307785|12048986|FG010|STARTED|Part A: Up to 28.5 Months||0
10882934|NCT03307785|12048976|FG000|COMPLETED|Part A: Up to 28.5 Months||0
10882935|NCT03307785|12048977|FG001|COMPLETED|Part A: Up to 28.5 Months||0
10882936|NCT03307785|12048978|FG002|COMPLETED|Part A: Up to 28.5 Months||0
10882937|NCT03307785|12048979|FG003|COMPLETED|Part A: Up to 28.5 Months||0
10882938|NCT03307785|12048980|FG004|COMPLETED|Part A: Up to 28.5 Months||0
10882939|NCT03307785|12048981|FG005|COMPLETED|Part A: Up to 28.5 Months||0
10882940|NCT03307785|12048982|FG006|COMPLETED|Part A: Up to 28.5 Months||0
10882941|NCT03307785|12048983|FG007|COMPLETED|Part A: Up to 28.5 Months||0
10882942|NCT03307785|12048984|FG008|COMPLETED|Part A: Up to 28.5 Months||0
10882943|NCT03307785|12048985|FG009|COMPLETED|Part A: Up to 28.5 Months||0
10882944|NCT03307785|12048986|FG010|COMPLETED|Part A: Up to 28.5 Months||0
10882945|NCT03307785|12048976|FG000|NOT COMPLETED|Part A: Up to 28.5 Months||16
10882946|NCT03307785|12048977|FG001|NOT COMPLETED|Part A: Up to 28.5 Months||6
10882947|NCT03307785|12048978|FG002|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882948|NCT03307785|12048979|FG003|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882949|NCT03307785|12048980|FG004|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882950|NCT03307785|12048981|FG005|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882951|NCT03307785|12048982|FG006|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882952|NCT03307785|12048983|FG007|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882953|NCT03307785|12048984|FG008|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882954|NCT03307785|12048985|FG009|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882955|NCT03307785|12048986|FG010|NOT COMPLETED|Part A: Up to 28.5 Months||0
10882956|NCT03307785|12048976|FG000|STARTED|Part B: Up to 28.5 Months||0
10882957|NCT03307785|12048977|FG001|STARTED|Part B: Up to 28.5 Months||0
10882958|NCT03307785|12048978|FG002|STARTED|Part B: Up to 28.5 Months||14
10882959|NCT03307785|12048979|FG003|STARTED|Part B: Up to 28.5 Months||0
10882960|NCT03307785|12048980|FG004|STARTED|Part B: Up to 28.5 Months||0
10882961|NCT03307785|12048981|FG005|STARTED|Part B: Up to 28.5 Months||0
10882962|NCT03307785|12048982|FG006|STARTED|Part B: Up to 28.5 Months||0
10882963|NCT03307785|12048983|FG007|STARTED|Part B: Up to 28.5 Months||0
10882964|NCT03307785|12048984|FG008|STARTED|Part B: Up to 28.5 Months||0
10882965|NCT03307785|12048985|FG009|STARTED|Part B: Up to 28.5 Months||0
10882966|NCT03307785|12048986|FG010|STARTED|Part B: Up to 28.5 Months||0
10882967|NCT03307785|12048976|FG000|COMPLETED|Part B: Up to 28.5 Months||0
10882968|NCT03307785|12048977|FG001|COMPLETED|Part B: Up to 28.5 Months||0
10882969|NCT03307785|12048978|FG002|COMPLETED|Part B: Up to 28.5 Months||0
10882970|NCT03307785|12048979|FG003|COMPLETED|Part B: Up to 28.5 Months||0
10882971|NCT03307785|12048980|FG004|COMPLETED|Part B: Up to 28.5 Months||0
10882972|NCT03307785|12048981|FG005|COMPLETED|Part B: Up to 28.5 Months||0
10882973|NCT03307785|12048982|FG006|COMPLETED|Part B: Up to 28.5 Months||0
10882974|NCT03307785|12048983|FG007|COMPLETED|Part B: Up to 28.5 Months||0
10882975|NCT03307785|12048984|FG008|COMPLETED|Part B: Up to 28.5 Months||0
10882976|NCT03307785|12048985|FG009|COMPLETED|Part B: Up to 28.5 Months||0
10882977|NCT03307785|12048986|FG010|COMPLETED|Part B: Up to 28.5 Months||0
10882978|NCT03307785|12048976|FG000|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882979|NCT03307785|12048977|FG001|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882980|NCT03307785|12048978|FG002|NOT COMPLETED|Part B: Up to 28.5 Months||14
10882981|NCT03307785|12048979|FG003|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882982|NCT03307785|12048980|FG004|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882983|NCT03307785|12048981|FG005|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882984|NCT03307785|12048982|FG006|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882985|NCT03307785|12048983|FG007|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882986|NCT03307785|12048984|FG008|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882987|NCT03307785|12048985|FG009|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882988|NCT03307785|12048986|FG010|NOT COMPLETED|Part B: Up to 28.5 Months||0
10882989|NCT03307785|12048976|FG000|STARTED|Part C: Up to 22.5 Months||0
10882990|NCT03307785|12048977|FG001|STARTED|Part C: Up to 22.5 Months||0
10882991|NCT03307785|12048978|FG002|STARTED|Part C: Up to 22.5 Months||0
10882992|NCT03307785|12048979|FG003|STARTED|Part C: Up to 22.5 Months||6
10882993|NCT03307785|12048980|FG004|STARTED|Part C: Up to 22.5 Months||7
10882994|NCT03307785|12048981|FG005|STARTED|Part C: Up to 22.5 Months||0
10882995|NCT03307785|12048982|FG006|STARTED|Part C: Up to 22.5 Months||0
10882996|NCT03307785|12048983|FG007|STARTED|Part C: Up to 22.5 Months||0
10882997|NCT03307785|12048984|FG008|STARTED|Part C: Up to 22.5 Months||0
10882998|NCT03307785|12048985|FG009|STARTED|Part C: Up to 22.5 Months||0
10882999|NCT03307785|12048986|FG010|STARTED|Part C: Up to 22.5 Months||0
10883000|NCT03307785|12048976|FG000|COMPLETED|Part C: Up to 22.5 Months||0
10883001|NCT03307785|12048977|FG001|COMPLETED|Part C: Up to 22.5 Months||0
10883002|NCT03307785|12048978|FG002|COMPLETED|Part C: Up to 22.5 Months||0
10883003|NCT03307785|12048979|FG003|COMPLETED|Part C: Up to 22.5 Months||0
10883004|NCT03307785|12048980|FG004|COMPLETED|Part C: Up to 22.5 Months||0
10883005|NCT03307785|12048981|FG005|COMPLETED|Part C: Up to 22.5 Months||0
10883006|NCT03307785|12048982|FG006|COMPLETED|Part C: Up to 22.5 Months||0
10883007|NCT03307785|12048983|FG007|COMPLETED|Part C: Up to 22.5 Months||0
10883008|NCT03307785|12048984|FG008|COMPLETED|Part C: Up to 22.5 Months||0
10883009|NCT03307785|12048985|FG009|COMPLETED|Part C: Up to 22.5 Months||0
10883010|NCT03307785|12048986|FG010|COMPLETED|Part C: Up to 22.5 Months||0
10883011|NCT03307785|12048976|FG000|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883012|NCT03307785|12048977|FG001|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883013|NCT03307785|12048978|FG002|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883014|NCT03307785|12048979|FG003|NOT COMPLETED|Part C: Up to 22.5 Months||6
10883015|NCT03307785|12048980|FG004|NOT COMPLETED|Part C: Up to 22.5 Months||7
10883016|NCT03307785|12048981|FG005|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883017|NCT03307785|12048982|FG006|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883018|NCT03307785|12048983|FG007|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883019|NCT03307785|12048984|FG008|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883020|NCT03307785|12048985|FG009|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883021|NCT03307785|12048986|FG010|NOT COMPLETED|Part C: Up to 22.5 Months||0
10883022|NCT03307785|12048976|FG000|STARTED|Part D: Up to 9.5 Months||0
10883023|NCT03307785|12048977|FG001|STARTED|Part D: Up to 9.5 Months||0
10883024|NCT03307785|12048978|FG002|STARTED|Part D: Up to 9.5 Months||0
10883025|NCT03307785|12048979|FG003|STARTED|Part D: Up to 9.5 Months||0
10883026|NCT03307785|12048980|FG004|STARTED|Part D: Up to 9.5 Months||0
10883027|NCT03307785|12048981|FG005|STARTED|Part D: Up to 9.5 Months||6
10883028|NCT03307785|12048982|FG006|STARTED|Part D: Up to 9.5 Months||0
10883029|NCT03307785|12048983|FG007|STARTED|Part D: Up to 9.5 Months||0
10883030|NCT03307785|12048984|FG008|STARTED|Part D: Up to 9.5 Months||0
10883031|NCT03307785|12048985|FG009|STARTED|Part D: Up to 9.5 Months||0
10883032|NCT03307785|12048986|FG010|STARTED|Part D: Up to 9.5 Months||0
10883033|NCT03307785|12048976|FG000|COMPLETED|Part D: Up to 9.5 Months||0
10883034|NCT03307785|12048977|FG001|COMPLETED|Part D: Up to 9.5 Months||0
10883035|NCT03307785|12048978|FG002|COMPLETED|Part D: Up to 9.5 Months||0
10883036|NCT03307785|12048979|FG003|COMPLETED|Part D: Up to 9.5 Months||0
10883037|NCT03307785|12048980|FG004|COMPLETED|Part D: Up to 9.5 Months||0
10883038|NCT03307785|12048981|FG005|COMPLETED|Part D: Up to 9.5 Months||3
10883039|NCT03307785|12048982|FG006|COMPLETED|Part D: Up to 9.5 Months||0
10883040|NCT03307785|12048983|FG007|COMPLETED|Part D: Up to 9.5 Months||0
10883041|NCT03307785|12048984|FG008|COMPLETED|Part D: Up to 9.5 Months||0
10883042|NCT03307785|12048985|FG009|COMPLETED|Part D: Up to 9.5 Months||0
10883043|NCT03307785|12048986|FG010|COMPLETED|Part D: Up to 9.5 Months||0
10883044|NCT03307785|12048976|FG000|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883045|NCT03307785|12048977|FG001|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883046|NCT03307785|12048978|FG002|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883047|NCT03307785|12048979|FG003|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883048|NCT03307785|12048980|FG004|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883049|NCT03307785|12048981|FG005|NOT COMPLETED|Part D: Up to 9.5 Months||3
10883050|NCT03307785|12048982|FG006|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883051|NCT03307785|12048983|FG007|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883052|NCT03307785|12048984|FG008|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883053|NCT03307785|12048985|FG009|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883054|NCT03307785|12048986|FG010|NOT COMPLETED|Part D: Up to 9.5 Months||0
10883055|NCT03307785|12048976|FG000|STARTED|Part E: Up to 4.4 Months||0
10883056|NCT03307785|12048977|FG001|STARTED|Part E: Up to 4.4 Months||0
10883057|NCT03307785|12048978|FG002|STARTED|Part E: Up to 4.4 Months||0
10883058|NCT03307785|12048979|FG003|STARTED|Part E: Up to 4.4 Months||0
10883059|NCT03307785|12048980|FG004|STARTED|Part E: Up to 4.4 Months||0
10883060|NCT03307785|12048981|FG005|STARTED|Part E: Up to 4.4 Months||0
10883061|NCT03307785|12048982|FG006|STARTED|Part E: Up to 4.4 Months||2
10883062|NCT03307785|12048983|FG007|STARTED|Part E: Up to 4.4 Months||0
10883063|NCT03307785|12048984|FG008|STARTED|Part E: Up to 4.4 Months||0
10883064|NCT03307785|12048985|FG009|STARTED|Part E: Up to 4.4 Months||0
10883065|NCT03307785|12048986|FG010|STARTED|Part E: Up to 4.4 Months||0
10883066|NCT03307785|12048976|FG000|COMPLETED|Part E: Up to 4.4 Months||0
10883067|NCT03307785|12048977|FG001|COMPLETED|Part E: Up to 4.4 Months||0
10883068|NCT03307785|12048978|FG002|COMPLETED|Part E: Up to 4.4 Months||0
10883069|NCT03307785|12048979|FG003|COMPLETED|Part E: Up to 4.4 Months||0
10883070|NCT03307785|12048980|FG004|COMPLETED|Part E: Up to 4.4 Months||0
10883071|NCT03307785|12048981|FG005|COMPLETED|Part E: Up to 4.4 Months||0
10883072|NCT03307785|12048982|FG006|COMPLETED|Part E: Up to 4.4 Months||0
10883073|NCT03307785|12048983|FG007|COMPLETED|Part E: Up to 4.4 Months||0
10883074|NCT03307785|12048984|FG008|COMPLETED|Part E: Up to 4.4 Months||0
10883075|NCT03307785|12048985|FG009|COMPLETED|Part E: Up to 4.4 Months||0
10883076|NCT03307785|12048986|FG010|COMPLETED|Part E: Up to 4.4 Months||0
10883077|NCT03307785|12048976|FG000|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883078|NCT03307785|12048977|FG001|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883079|NCT03307785|12048978|FG002|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883080|NCT03307785|12048979|FG003|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883081|NCT03307785|12048980|FG004|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883082|NCT03307785|12048981|FG005|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883083|NCT03307785|12048982|FG006|NOT COMPLETED|Part E: Up to 4.4 Months||2
10883084|NCT03307785|12048983|FG007|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883085|NCT03307785|12048984|FG008|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883086|NCT03307785|12048985|FG009|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883087|NCT03307785|12048986|FG010|NOT COMPLETED|Part E: Up to 4.4 Months||0
10883088|NCT03307785|12048976|FG000|STARTED|Part F: Up to 3.5 Months||0
10883089|NCT03307785|12048977|FG001|STARTED|Part F: Up to 3.5 Months||0
10883090|NCT03307785|12048978|FG002|STARTED|Part F: Up to 3.5 Months||0
10883091|NCT03307785|12048979|FG003|STARTED|Part F: Up to 3.5 Months||0
10883092|NCT03307785|12048980|FG004|STARTED|Part F: Up to 3.5 Months||0
10883093|NCT03307785|12048981|FG005|STARTED|Part F: Up to 3.5 Months||0
10883094|NCT03307785|12048982|FG006|STARTED|Part F: Up to 3.5 Months||0
10883095|NCT03307785|12048983|FG007|STARTED|Part F: Up to 3.5 Months||1
10883096|NCT03307785|12048984|FG008|STARTED|Part F: Up to 3.5 Months||0
10883097|NCT03307785|12048985|FG009|STARTED|Part F: Up to 3.5 Months||0
10883098|NCT03307785|12048986|FG010|STARTED|Part F: Up to 3.5 Months||0
10883099|NCT03307785|12048976|FG000|COMPLETED|Part F: Up to 3.5 Months||0
10883100|NCT03307785|12048977|FG001|COMPLETED|Part F: Up to 3.5 Months||0
10883101|NCT03307785|12048978|FG002|COMPLETED|Part F: Up to 3.5 Months||0
10883102|NCT03307785|12048979|FG003|COMPLETED|Part F: Up to 3.5 Months||0
10883103|NCT03307785|12048980|FG004|COMPLETED|Part F: Up to 3.5 Months||0
10883104|NCT03307785|12048981|FG005|COMPLETED|Part F: Up to 3.5 Months||0
10883105|NCT03307785|12048982|FG006|COMPLETED|Part F: Up to 3.5 Months||0
10883106|NCT03307785|12048983|FG007|COMPLETED|Part F: Up to 3.5 Months||0
10883107|NCT03307785|12048984|FG008|COMPLETED|Part F: Up to 3.5 Months||0
10883108|NCT03307785|12048985|FG009|COMPLETED|Part F: Up to 3.5 Months||0
10883109|NCT03307785|12048986|FG010|COMPLETED|Part F: Up to 3.5 Months||0
10883110|NCT03307785|12048976|FG000|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883111|NCT03307785|12048977|FG001|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883112|NCT03307785|12048978|FG002|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883113|NCT03307785|12048979|FG003|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883114|NCT03307785|12048980|FG004|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883115|NCT03307785|12048981|FG005|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883116|NCT03307785|12048982|FG006|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883117|NCT03307785|12048983|FG007|NOT COMPLETED|Part F: Up to 3.5 Months||1
10883118|NCT03307785|12048984|FG008|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883119|NCT03307785|12048985|FG009|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883120|NCT03307785|12048986|FG010|NOT COMPLETED|Part F: Up to 3.5 Months||0
10883121|NCT03307785|12048976|FG000|STARTED|Part G: Up to 24 Months||0
10883122|NCT03307785|12048977|FG001|STARTED|Part G: Up to 24 Months||0
10883123|NCT03307785|12048978|FG002|STARTED|Part G: Up to 24 Months||0
10883124|NCT03307785|12048979|FG003|STARTED|Part G: Up to 24 Months||0
10883125|NCT03307785|12048980|FG004|STARTED|Part G: Up to 24 Months||0
10883126|NCT03307785|12048981|FG005|STARTED|Part G: Up to 24 Months||0
10883127|NCT03307785|12048982|FG006|STARTED|Part G: Up to 24 Months||0
10883128|NCT03307785|12048983|FG007|STARTED|Part G: Up to 24 Months||0
10883129|NCT03307785|12048984|FG008|STARTED|Part G: Up to 24 Months||0
10883130|NCT03307785|12048985|FG009|STARTED|Part G: Up to 24 Months||0
10883131|NCT03307785|12048986|FG010|STARTED|Part G: Up to 24 Months||0
10883132|NCT03307785|12048976|FG000|COMPLETED|Part G: Up to 24 Months||0
10883133|NCT03307785|12048977|FG001|COMPLETED|Part G: Up to 24 Months||0
10883134|NCT03307785|12048978|FG002|COMPLETED|Part G: Up to 24 Months||0
10883135|NCT03307785|12048979|FG003|COMPLETED|Part G: Up to 24 Months||0
10883136|NCT03307785|12048980|FG004|COMPLETED|Part G: Up to 24 Months||0
10883137|NCT03307785|12048981|FG005|COMPLETED|Part G: Up to 24 Months||0
10883138|NCT03307785|12048982|FG006|COMPLETED|Part G: Up to 24 Months||0
10883139|NCT03307785|12048983|FG007|COMPLETED|Part G: Up to 24 Months||0
10883140|NCT03307785|12048984|FG008|COMPLETED|Part G: Up to 24 Months||0
10883141|NCT03307785|12048985|FG009|COMPLETED|Part G: Up to 24 Months||0
10883142|NCT03307785|12048986|FG010|COMPLETED|Part G: Up to 24 Months||0
10883143|NCT03307785|12048976|FG000|NOT COMPLETED|Part G: Up to 24 Months||0
10883144|NCT03307785|12048977|FG001|NOT COMPLETED|Part G: Up to 24 Months||0
10883145|NCT03307785|12048978|FG002|NOT COMPLETED|Part G: Up to 24 Months||0
10883146|NCT03307785|12048979|FG003|NOT COMPLETED|Part G: Up to 24 Months||0
10883147|NCT03307785|12048980|FG004|NOT COMPLETED|Part G: Up to 24 Months||0
10883148|NCT03307785|12048981|FG005|NOT COMPLETED|Part G: Up to 24 Months||0
10883149|NCT03307785|12048982|FG006|NOT COMPLETED|Part G: Up to 24 Months||0
10883150|NCT03307785|12048983|FG007|NOT COMPLETED|Part G: Up to 24 Months||0
10883151|NCT03307785|12048984|FG008|NOT COMPLETED|Part G: Up to 24 Months||0
10883152|NCT03307785|12048985|FG009|NOT COMPLETED|Part G: Up to 24 Months||0
10883153|NCT03307785|12048986|FG010|NOT COMPLETED|Part G: Up to 24 Months||0
10883154|NCT03307785|12048976|FG000|STARTED|Part H: Up to 24 Months||0
10883155|NCT03307785|12048977|FG001|STARTED|Part H: Up to 24 Months||0
10883156|NCT03307785|12048978|FG002|STARTED|Part H: Up to 24 Months||0
10883157|NCT03307785|12048979|FG003|STARTED|Part H: Up to 24 Months||0
10883158|NCT03307785|12048980|FG004|STARTED|Part H: Up to 24 Months||0
10883159|NCT03307785|12048981|FG005|STARTED|Part H: Up to 24 Months||0
10883160|NCT03307785|12048982|FG006|STARTED|Part H: Up to 24 Months||0
10883161|NCT03307785|12048983|FG007|STARTED|Part H: Up to 24 Months||0
10883162|NCT03307785|12048984|FG008|STARTED|Part H: Up to 24 Months||0
10883163|NCT03307785|12048985|FG009|STARTED|Part H: Up to 24 Months||0
10883164|NCT03307785|12048986|FG010|STARTED|Part H: Up to 24 Months||0
10883165|NCT03307785|12048976|FG000|COMPLETED|Part H: Up to 24 Months||0
10883166|NCT03307785|12048977|FG001|COMPLETED|Part H: Up to 24 Months||0
10883167|NCT03307785|12048978|FG002|COMPLETED|Part H: Up to 24 Months||0
10883168|NCT03307785|12048979|FG003|COMPLETED|Part H: Up to 24 Months||0
10883169|NCT03307785|12048980|FG004|COMPLETED|Part H: Up to 24 Months||0
10883170|NCT03307785|12048981|FG005|COMPLETED|Part H: Up to 24 Months||0
10883171|NCT03307785|12048982|FG006|COMPLETED|Part H: Up to 24 Months||0
10883172|NCT03307785|12048983|FG007|COMPLETED|Part H: Up to 24 Months||0
10883173|NCT03307785|12048984|FG008|COMPLETED|Part H: Up to 24 Months||0
10883174|NCT03307785|12048985|FG009|COMPLETED|Part H: Up to 24 Months||0
10883175|NCT03307785|12048986|FG010|COMPLETED|Part H: Up to 24 Months||0
10883176|NCT03307785|12048976|FG000|NOT COMPLETED|Part H: Up to 24 Months||0
10883177|NCT03307785|12048977|FG001|NOT COMPLETED|Part H: Up to 24 Months||0
10883178|NCT03307785|12048978|FG002|NOT COMPLETED|Part H: Up to 24 Months||0
10883179|NCT03307785|12048979|FG003|NOT COMPLETED|Part H: Up to 24 Months||0
10883180|NCT03307785|12048980|FG004|NOT COMPLETED|Part H: Up to 24 Months||0
10883181|NCT03307785|12048981|FG005|NOT COMPLETED|Part H: Up to 24 Months||0
10883182|NCT03307785|12048982|FG006|NOT COMPLETED|Part H: Up to 24 Months||0
10883183|NCT03307785|12048983|FG007|NOT COMPLETED|Part H: Up to 24 Months||0
10883184|NCT03307785|12048984|FG008|NOT COMPLETED|Part H: Up to 24 Months||0
10883185|NCT03307785|12048985|FG009|NOT COMPLETED|Part H: Up to 24 Months||0
10883186|NCT03307785|12048986|FG010|NOT COMPLETED|Part H: Up to 24 Months||0
10883187|NCT03307785|12048976|FG000|STARTED|Part I: Up to 24 Months||0
10883188|NCT03307785|12048977|FG001|STARTED|Part I: Up to 24 Months||0
10883189|NCT03307785|12048978|FG002|STARTED|Part I: Up to 24 Months||0
10883190|NCT03307785|12048979|FG003|STARTED|Part I: Up to 24 Months||0
10883191|NCT03307785|12048980|FG004|STARTED|Part I: Up to 24 Months||0
10883192|NCT03307785|12048981|FG005|STARTED|Part I: Up to 24 Months||0
10883193|NCT03307785|12048982|FG006|STARTED|Part I: Up to 24 Months||0
10883194|NCT03307785|12048983|FG007|STARTED|Part I: Up to 24 Months||0
10883195|NCT03307785|12048984|FG008|STARTED|Part I: Up to 24 Months||0
10883196|NCT03307785|12048985|FG009|STARTED|Part I: Up to 24 Months||0
10883197|NCT03307785|12048986|FG010|STARTED|Part I: Up to 24 Months||0
10883198|NCT03307785|12048976|FG000|COMPLETED|Part I: Up to 24 Months||0
10883199|NCT03307785|12048977|FG001|COMPLETED|Part I: Up to 24 Months||0
10883200|NCT03307785|12048978|FG002|COMPLETED|Part I: Up to 24 Months||0
10883201|NCT03307785|12048979|FG003|COMPLETED|Part I: Up to 24 Months||0
10883202|NCT03307785|12048980|FG004|COMPLETED|Part I: Up to 24 Months||0
10883203|NCT03307785|12048981|FG005|COMPLETED|Part I: Up to 24 Months||0
10883204|NCT03307785|12048982|FG006|COMPLETED|Part I: Up to 24 Months||0
10883205|NCT03307785|12048983|FG007|COMPLETED|Part I: Up to 24 Months||0
10883206|NCT03307785|12048984|FG008|COMPLETED|Part I: Up to 24 Months||0
10883207|NCT03307785|12048985|FG009|COMPLETED|Part I: Up to 24 Months||0
10883208|NCT03307785|12048986|FG010|COMPLETED|Part I: Up to 24 Months||0
10883209|NCT03307785|12048976|FG000|NOT COMPLETED|Part I: Up to 24 Months||0
10883210|NCT03307785|12048977|FG001|NOT COMPLETED|Part I: Up to 24 Months||0
10883211|NCT03307785|12048978|FG002|NOT COMPLETED|Part I: Up to 24 Months||0
10883212|NCT03307785|12048979|FG003|NOT COMPLETED|Part I: Up to 24 Months||0
10883213|NCT03307785|12048980|FG004|NOT COMPLETED|Part I: Up to 24 Months||0
10883214|NCT03307785|12048981|FG005|NOT COMPLETED|Part I: Up to 24 Months||0
10883215|NCT03307785|12048982|FG006|NOT COMPLETED|Part I: Up to 24 Months||0
10883216|NCT03307785|12048983|FG007|NOT COMPLETED|Part I: Up to 24 Months||0
10883217|NCT03307785|12048984|FG008|NOT COMPLETED|Part I: Up to 24 Months||0
10883218|NCT03307785|12048985|FG009|NOT COMPLETED|Part I: Up to 24 Months||0
10883219|NCT03307785|12048986|FG010|NOT COMPLETED|Part I: Up to 24 Months||0
10883220|NCT03306277|12049007|FG000|STARTED|Overall Study||22
10883221|NCT03306277|12049007|FG000|COMPLETED|Overall Study||19
10883222|NCT03306277|12049007|FG000|NOT COMPLETED|Overall Study||3
10883223|NCT03303391|12049013|FG000|STARTED|Overall Study||9
10883224|NCT03303391|12049014|FG001|STARTED|Overall Study||3
10883225|NCT03303391|12049013|FG000|COMPLETED|Overall Study||9
10883226|NCT03303391|12049014|FG001|COMPLETED|Overall Study||3
10883227|NCT03303391|12049013|FG000|NOT COMPLETED|Overall Study||0
10883228|NCT03303391|12049014|FG001|NOT COMPLETED|Overall Study||0
10883229|NCT03301636|12049023|FG000|STARTED|Overall Study||7
10883230|NCT03301636|12049024|FG001|STARTED|Overall Study||6
10883231|NCT03301636|12049025|FG002|STARTED|Overall Study||8
10883232|NCT03301636|12049023|FG000|COMPLETED|Overall Study||7
10883233|NCT03301636|12049024|FG001|COMPLETED|Overall Study||6
10883234|NCT03301636|12049025|FG002|COMPLETED|Overall Study||8
10883235|NCT03301636|12049023|FG000|NOT COMPLETED|Overall Study||0
10883236|NCT03301636|12049024|FG001|NOT COMPLETED|Overall Study||0
10883237|NCT03301636|12049025|FG002|NOT COMPLETED|Overall Study||0
10883238|NCT03300466|12049035|FG000|STARTED|Overall Study||10
10883239|NCT03300466|12049036|FG001|STARTED|Overall Study||10
10883240|NCT03300466|12049035|FG000|COMPLETED|Overall Study||9
10883241|NCT03300466|12049036|FG001|COMPLETED|Overall Study||10
10883242|NCT03300466|12049035|FG000|NOT COMPLETED|Overall Study||1
10883243|NCT03300466|12049036|FG001|NOT COMPLETED|Overall Study||0
10883244|NCT03299049|12049044|FG000|STARTED|Overall Study||522
10883245|NCT03299049|12049045|FG001|STARTED|Overall Study||523
10883246|NCT03299049|12049044|FG000|COMPLETED|Overall Study||0
10883247|NCT03299049|12049045|FG001|COMPLETED|Overall Study||0
10883248|NCT03299049|12049044|FG000|NOT COMPLETED|Overall Study||522
10883249|NCT03299049|12049045|FG001|NOT COMPLETED|Overall Study||523
10883250|NCT03293238|12049062|FG000|STARTED|Overall Study||19
10883251|NCT03293238|12049063|FG001|STARTED|Overall Study||16
10883252|NCT03293238|12049064|FG002|STARTED|Overall Study||14
10883253|NCT03293238|12049065|FG003|STARTED|Overall Study||14
10883254|NCT03293238|12049062|FG000|COMPLETED|Overall Study||19
10883255|NCT03293238|12049063|FG001|COMPLETED|Overall Study||16
10883256|NCT03293238|12049064|FG002|COMPLETED|Overall Study||14
10883257|NCT03293238|12049065|FG003|COMPLETED|Overall Study||14
10883258|NCT03293238|12049062|FG000|NOT COMPLETED|Overall Study||0
10883259|NCT03293238|12049063|FG001|NOT COMPLETED|Overall Study||0
10883260|NCT03293238|12049064|FG002|NOT COMPLETED|Overall Study||0
10883261|NCT03293238|12049065|FG003|NOT COMPLETED|Overall Study||0
10883262|NCT03292926|12049077|FG000|STARTED|Overall Study||39
10883263|NCT03292926|12049078|FG001|STARTED|Overall Study||39
10883264|NCT03292926|12049077|FG000|COMPLETED|Overall Study||39
10883265|NCT03292926|12049078|FG001|COMPLETED|Overall Study||39
10883266|NCT03292926|12049077|FG000|NOT COMPLETED|Overall Study||0
10883267|NCT03292926|12049078|FG001|NOT COMPLETED|Overall Study||0
10883268|NCT03292913|12049086|FG000|STARTED|Overall Study||397
10883269|NCT03292913|12049087|FG001|STARTED|Overall Study||402
10883270|NCT03292913|12049086|FG000|COMPLETED|Overall Study||315
10883271|NCT03292913|12049087|FG001|COMPLETED|Overall Study||314
10883272|NCT03292913|12049086|FG000|NOT COMPLETED|Overall Study||82
10883273|NCT03292913|12049087|FG001|NOT COMPLETED|Overall Study||88
10883274|NCT03291808|12049097|FG000|STARTED|Overall Study||43
10883275|NCT03291808|12049097|FG000|COMPLETED|Overall Study||33
10883276|NCT03291808|12049097|FG000|NOT COMPLETED|Overall Study||10
10883277|NCT03290326|12049101|FG000|STARTED|Overall Study||10
10883278|NCT03290326|12049101|FG000|COMPLETED|Overall Study||10
10883279|NCT03290326|12049101|FG000|NOT COMPLETED|Overall Study||0
10883280|NCT03290300|12049107|FG000|STARTED|Overall Study||39
10883281|NCT03290300|12049107|FG000|COMPLETED|Overall Study||36
10883282|NCT03290300|12049107|FG000|NOT COMPLETED|Overall Study||3
10883283|NCT03289052|12049121|FG000|STARTED|Overall Study||20
10883284|NCT03289052|12049122|FG001|STARTED|Overall Study||111
10883285|NCT03289052|12049123|FG002|STARTED|Overall Study||37
10883286|NCT03289052|12049121|FG000|COMPLETED|Overall Study||20
10883287|NCT03289052|12049122|FG001|COMPLETED|Overall Study||108
10883288|NCT03289052|12049123|FG002|COMPLETED|Overall Study||32
10883289|NCT03289052|12049121|FG000|NOT COMPLETED|Overall Study||0
10883290|NCT03289052|12049122|FG001|NOT COMPLETED|Overall Study||3
10883291|NCT03289052|12049123|FG002|NOT COMPLETED|Overall Study||5
10883292|NCT03287947|12049131|FG000|STARTED|Overall Study|Five subjects were enrolled to the study.|5
10883293|NCT03287947|12049131|FG000|COMPLETED|Overall Study|All subjects enrolled discontinued treatment and are now off study.|5
10883294|NCT03287947|12049131|FG000|NOT COMPLETED|Overall Study||0
10883295|NCT03287089|12049137|FG000|STARTED|Overall Study||82
10883296|NCT03287089|12049138|FG001|STARTED|Overall Study||82
10883297|NCT03287089|12049137|FG000|COMPLETED|Overall Study||82
10883298|NCT03287089|12049138|FG001|COMPLETED|Overall Study||76
10883299|NCT03287089|12049137|FG000|NOT COMPLETED|Overall Study||0
10883300|NCT03287089|12049138|FG001|NOT COMPLETED|Overall Study||6
10883301|NCT03286283|12049144|FG000|STARTED|Overall Study||55
10883302|NCT03286283|12049144|FG000|COMPLETED|Overall Study||55
10883303|NCT03286283|12049144|FG000|NOT COMPLETED|Overall Study||0
10883304|NCT03281304|12049150|FG000|STARTED|Overall Study||70
10883305|NCT03281304|12049151|FG001|STARTED|Overall Study||70
10883306|NCT03281304|12049150|FG000|COMPLETED|Overall Study||57
10883307|NCT03281304|12049151|FG001|COMPLETED|Overall Study||58
10883308|NCT03281304|12049150|FG000|NOT COMPLETED|Overall Study||13
10883309|NCT03281304|12049151|FG001|NOT COMPLETED|Overall Study||12
10883310|NCT03279250|12049159|FG000|STARTED|Overall Study||34
10883311|NCT03279250|12049160|FG001|STARTED|Overall Study||34
10883312|NCT03279250|12049159|FG000|COMPLETED|Overall Study||34
10883313|NCT03279250|12049160|FG001|COMPLETED|Overall Study||34
10883314|NCT03279250|12049159|FG000|NOT COMPLETED|Overall Study||0
10883315|NCT03279250|12049160|FG001|NOT COMPLETED|Overall Study||0
10883316|NCT03277105|12049168|FG000|STARTED|Overall Study||259
10883317|NCT03277105|12049169|FG001|STARTED|Overall Study||263
10883318|NCT03277105|12049168|FG000|Safety Analysis Set|Overall Study||258
10883319|NCT03277105|12049169|FG001|Safety Analysis Set|Overall Study||260
10883320|NCT03277105|12049168|FG000|COMPLETED|Overall Study||0
10883321|NCT03277105|12049169|FG001|COMPLETED|Overall Study||0
10883322|NCT03277105|12049168|FG000|NOT COMPLETED|Overall Study||259
10883323|NCT03277105|12049169|FG001|NOT COMPLETED|Overall Study||263
10883324|NCT03276728|12049183|FG000|STARTED|Overall Study||22
10883325|NCT03276728|12049184|FG001|STARTED|Overall Study||66
10883326|NCT03276728|12049185|FG002|STARTED|Overall Study||16
10883327|NCT03276728|12049186|FG003|STARTED|Overall Study||50
10883328|NCT03276728|12049187|FG004|STARTED|Overall Study||7
10883329|NCT03276728|12049188|FG005|STARTED|Overall Study||1
10883330|NCT03276728|12049189|FG006|STARTED|Overall Study||17
10883331|NCT03276728|12049190|FG007|STARTED|Overall Study||3
10883332|NCT03276728|12049183|FG000|Treated Participants|Overall Study||22
10883333|NCT03276728|12049184|FG001|Treated Participants|Overall Study||66
10883334|NCT03276728|12049185|FG002|Treated Participants|Overall Study||16
10883335|NCT03276728|12049186|FG003|Treated Participants|Overall Study||50
10883336|NCT03276728|12049187|FG004|Treated Participants|Overall Study||7
10883337|NCT03276728|12049188|FG005|Treated Participants|Overall Study||1
10883338|NCT03276728|12049189|FG006|Treated Participants|Overall Study||16
10883339|NCT03276728|12049190|FG007|Treated Participants|Overall Study||3
10883340|NCT03276728|12049183|FG000|COMPLETED|Overall Study||22
10883341|NCT03276728|12049184|FG001|COMPLETED|Overall Study||66
10883342|NCT03276728|12049185|FG002|COMPLETED|Overall Study||14
10883343|NCT03276728|12049186|FG003|COMPLETED|Overall Study||45
10883344|NCT03276728|12049187|FG004|COMPLETED|Overall Study||6
10883345|NCT03276728|12049188|FG005|COMPLETED|Overall Study||1
10883346|NCT03276728|12049189|FG006|COMPLETED|Overall Study||15
10883347|NCT03276728|12049190|FG007|COMPLETED|Overall Study||2
10883348|NCT03276728|12049183|FG000|NOT COMPLETED|Overall Study||0
10883349|NCT03276728|12049184|FG001|NOT COMPLETED|Overall Study||0
10883350|NCT03276728|12049185|FG002|NOT COMPLETED|Overall Study||2
10883351|NCT03276728|12049186|FG003|NOT COMPLETED|Overall Study||5
10883352|NCT03276728|12049187|FG004|NOT COMPLETED|Overall Study||1
10883353|NCT03276728|12049188|FG005|NOT COMPLETED|Overall Study||0
10883354|NCT03276728|12049189|FG006|NOT COMPLETED|Overall Study||2
10883355|NCT03276728|12049190|FG007|NOT COMPLETED|Overall Study||1
10883356|NCT03274466|12049212|FG000|STARTED|Overall Study||147
10883357|NCT03274466|12049213|FG001|STARTED|Overall Study||147
10883358|NCT03274466|12049212|FG000|COMPLETED|Overall Study||124
10883359|NCT03274466|12049213|FG001|COMPLETED|Overall Study||118
10883360|NCT03274466|12049212|FG000|NOT COMPLETED|Overall Study||23
10883361|NCT03274466|12049213|FG001|NOT COMPLETED|Overall Study||29
10883362|NCT03273907|12049219|FG000|STARTED|Overall Study||43
10883363|NCT03273907|12049219|FG000|COMPLETED|Overall Study||34
10883364|NCT03273907|12049219|FG000|NOT COMPLETED|Overall Study||9
10883365|NCT03273153|12049227|FG000|STARTED|Overall Study||224
10883366|NCT03273153|12049228|FG001|STARTED|Overall Study||222
10883367|NCT03273153|12049227|FG000|COMPLETED|Overall Study||0
10883368|NCT03273153|12049228|FG001|COMPLETED|Overall Study||0
10883369|NCT03273153|12049227|FG000|NOT COMPLETED|Overall Study||224
10883370|NCT03273153|12049228|FG001|NOT COMPLETED|Overall Study||222
10883371|NCT03268954|12049237|FG000|STARTED|Overall Study||227
10883372|NCT03268954|12049238|FG001|STARTED|Overall Study||227
10883373|NCT03268954|12049237|FG000|Safety Population|Overall Study||220
10883374|NCT03268954|12049238|FG001|Safety Population|Overall Study||223
10883375|NCT03268954|12049237|FG000|COMPLETED|Overall Study||0
10883376|NCT03268954|12049238|FG001|COMPLETED|Overall Study||0
10883377|NCT03268954|12049237|FG000|NOT COMPLETED|Overall Study||227
10883378|NCT03268954|12049238|FG001|NOT COMPLETED|Overall Study||227
10883395|NCT03255629|12049261|FG000|STARTED|Overall Study||8
10883396|NCT03255629|12049262|FG001|STARTED|Overall Study||8
10883475|NCT03253796|12049303|FG002|STARTED|Period 2: Open-Label Retreatment||0
10883476|NCT03253796|12049304|FG003|STARTED|Period 2: Open-Label Retreatment||0
10883397|NCT03255629|12049261|FG000|COMPLETED|Overall Study|"One participant developed intractable nausea and emesis after consuming the mixed meal, and was withdrawn.~Two participants were withdrawn due to not experiencing hypoglycemia during mixed meal testing."|5
10883398|NCT03255629|12049262|FG001|COMPLETED|Overall Study|One participant was withdrawn due to not experiencing hypoglycemia during mixed meal testing.|7
10883399|NCT03255629|12049261|FG000|NOT COMPLETED|Overall Study||3
10883400|NCT03255629|12049262|FG001|NOT COMPLETED|Overall Study||1
10883401|NCT03255187|12049271|FG000|STARTED|Periodfrom Enrollment to First Follow-up||35
10883402|NCT03255187|12049272|FG001|STARTED|Periodfrom Enrollment to First Follow-up||35
10883403|NCT03255187|12049271|FG000|COMPLETED|Periodfrom Enrollment to First Follow-up||34
10883404|NCT03255187|12049272|FG001|COMPLETED|Periodfrom Enrollment to First Follow-up||32
10883405|NCT03255187|12049271|FG000|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1
10883406|NCT03255187|12049272|FG001|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3
10883407|NCT03255187|12049271|FG000|STARTED|Period From First to Second Follow-up||34
10883408|NCT03255187|12049272|FG001|STARTED|Period From First to Second Follow-up||32
10883409|NCT03255187|12049271|FG000|COMPLETED|Period From First to Second Follow-up||34
10883410|NCT03255187|12049272|FG001|COMPLETED|Period From First to Second Follow-up||31
10883411|NCT03255187|12049271|FG000|NOT COMPLETED|Period From First to Second Follow-up||0
10883412|NCT03255187|12049272|FG001|NOT COMPLETED|Period From First to Second Follow-up||1
10883413|NCT03255187|12049271|FG000|STARTED|Period From Second to Third Follow-up||34
10883414|NCT03255187|12049272|FG001|STARTED|Period From Second to Third Follow-up||31
10883415|NCT03255187|12049271|FG000|COMPLETED|Period From Second to Third Follow-up||34
10883416|NCT03255187|12049272|FG001|COMPLETED|Period From Second to Third Follow-up||31
10883417|NCT03255187|12049271|FG000|NOT COMPLETED|Period From Second to Third Follow-up||0
10883418|NCT03255187|12049272|FG001|NOT COMPLETED|Period From Second to Third Follow-up||0
10883419|NCT03255187|12049271|FG000|STARTED|Period From Third to Fourth Follow-up||34
10883420|NCT03255187|12049272|FG001|STARTED|Period From Third to Fourth Follow-up||31
10883421|NCT03255187|12049271|FG000|COMPLETED|Period From Third to Fourth Follow-up||34
10883422|NCT03255187|12049272|FG001|COMPLETED|Period From Third to Fourth Follow-up||31
10883423|NCT03255187|12049271|FG000|NOT COMPLETED|Period From Third to Fourth Follow-up||0
10883424|NCT03255187|12049272|FG001|NOT COMPLETED|Period From Third to Fourth Follow-up||0
10883425|NCT03255187|12049271|FG000|STARTED|Period at Fourth Follow-up||34
10883426|NCT03255187|12049272|FG001|STARTED|Period at Fourth Follow-up||31
10883427|NCT03255187|12049271|FG000|COMPLETED|Period at Fourth Follow-up||34
10883428|NCT03255187|12049272|FG001|COMPLETED|Period at Fourth Follow-up||31
10883429|NCT03255187|12049271|FG000|NOT COMPLETED|Period at Fourth Follow-up||0
10883430|NCT03255187|12049272|FG001|NOT COMPLETED|Period at Fourth Follow-up||0
10883431|NCT03254485|12049282|FG000|STARTED|Overall Study||90
10883432|NCT03254485|12049283|FG001|STARTED|Overall Study||7
10883433|NCT03254485|12049284|FG002|STARTED|Overall Study||7
10883434|NCT03254485|12049285|FG003|STARTED|Overall Study||92
10883435|NCT03254485|12049282|FG000|COMPLETED|Overall Study||78
10883436|NCT03254485|12049283|FG001|COMPLETED|Overall Study||7
10883437|NCT03254485|12049284|FG002|COMPLETED|Overall Study||7
10883438|NCT03254485|12049285|FG003|COMPLETED|Overall Study||77
10883439|NCT03254485|12049282|FG000|NOT COMPLETED|Overall Study||12
10883440|NCT03254485|12049283|FG001|NOT COMPLETED|Overall Study||0
10883441|NCT03254485|12049284|FG002|NOT COMPLETED|Overall Study||0
10883442|NCT03254485|12049285|FG003|NOT COMPLETED|Overall Study||15
10883443|NCT03253796|12049301|FG000|STARTED|Period 1: Run-In||323
10883444|NCT03253796|12049302|FG001|STARTED|Period 1: Run-In||0
10883445|NCT03253796|12049303|FG002|STARTED|Period 1: Run-In||0
10883446|NCT03253796|12049304|FG003|STARTED|Period 1: Run-In||0
10883447|NCT03253796|12049305|FG004|STARTED|Period 1: Run-In||0
10883448|NCT03253796|12049301|FG000|COMPLETED|Period 1: Run-In||207
10883449|NCT03253796|12049302|FG001|COMPLETED|Period 1: Run-In||0
10883450|NCT03253796|12049303|FG002|COMPLETED|Period 1: Run-In||0
10883451|NCT03253796|12049304|FG003|COMPLETED|Period 1: Run-In||0
10883452|NCT03253796|12049305|FG004|COMPLETED|Period 1: Run-In||0
10883453|NCT03253796|12049301|FG000|NOT COMPLETED|Period 1: Run-In||116
10883454|NCT03253796|12049302|FG001|NOT COMPLETED|Period 1: Run-In||0
10883455|NCT03253796|12049303|FG002|NOT COMPLETED|Period 1: Run-In||0
10883456|NCT03253796|12049304|FG003|NOT COMPLETED|Period 1: Run-In||0
10883457|NCT03253796|12049305|FG004|NOT COMPLETED|Period 1: Run-In||0
10883458|NCT03253796|12049301|FG000|STARTED|Period 2: Withdrawal vs Continued Tx||0
10883459|NCT03253796|12049302|FG001|STARTED|Period 2: Withdrawal vs Continued Tx||63
10883460|NCT03253796|12049303|FG002|STARTED|Period 2: Withdrawal vs Continued Tx||64
10883461|NCT03253796|12049304|FG003|STARTED|Period 2: Withdrawal vs Continued Tx||62
10883462|NCT03253796|12049305|FG004|STARTED|Period 2: Withdrawal vs Continued Tx||0
10883463|NCT03253796|12049301|FG000|COMPLETED|Period 2: Withdrawal vs Continued Tx||0
10883464|NCT03253796|12049302|FG001|COMPLETED|Period 2: Withdrawal vs Continued Tx||53
10883465|NCT03253796|12049303|FG002|COMPLETED|Period 2: Withdrawal vs Continued Tx||43
10883466|NCT03253796|12049304|FG003|COMPLETED|Period 2: Withdrawal vs Continued Tx||21
10883467|NCT03253796|12049305|FG004|COMPLETED|Period 2: Withdrawal vs Continued Tx||0
10883468|NCT03253796|12049301|FG000|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||0
10883469|NCT03253796|12049302|FG001|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||10
10883470|NCT03253796|12049303|FG002|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||21
10883471|NCT03253796|12049304|FG003|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||41
10883472|NCT03253796|12049305|FG004|NOT COMPLETED|Period 2: Withdrawal vs Continued Tx||0
10883473|NCT03253796|12049301|FG000|STARTED|Period 2: Open-Label Retreatment||0
10883474|NCT03253796|12049302|FG001|STARTED|Period 2: Open-Label Retreatment||0
10883477|NCT03253796|12049305|FG004|STARTED|Period 2: Open-Label Retreatment||63
10883478|NCT03253796|12049301|FG000|COMPLETED|Period 2: Open-Label Retreatment||0
10883479|NCT03253796|12049302|FG001|COMPLETED|Period 2: Open-Label Retreatment||0
10883480|NCT03253796|12049303|FG002|COMPLETED|Period 2: Open-Label Retreatment||0
10883481|NCT03253796|12049304|FG003|COMPLETED|Period 2: Open-Label Retreatment||0
10883482|NCT03253796|12049305|FG004|COMPLETED|Period 2: Open-Label Retreatment||58
10883483|NCT03253796|12049301|FG000|NOT COMPLETED|Period 2: Open-Label Retreatment||0
10883484|NCT03253796|12049302|FG001|NOT COMPLETED|Period 2: Open-Label Retreatment||0
10883485|NCT03253796|12049303|FG002|NOT COMPLETED|Period 2: Open-Label Retreatment||0
10883486|NCT03253796|12049304|FG003|NOT COMPLETED|Period 2: Open-Label Retreatment||0
10883487|NCT03253796|12049305|FG004|NOT COMPLETED|Period 2: Open-Label Retreatment||5
10883488|NCT03252587|12049324|FG000|STARTED|Overall Study||90
10883489|NCT03252587|12049325|FG001|STARTED|Overall Study||91
10883490|NCT03252587|12049326|FG002|STARTED|Overall Study||93
10883491|NCT03252587|12049327|FG003|STARTED|Overall Study||89
10883492|NCT03252587|12049324|FG000|COMPLETED|Overall Study||66
10883493|NCT03252587|12049325|FG001|COMPLETED|Overall Study||71
10883494|NCT03252587|12049326|FG002|COMPLETED|Overall Study||76
10883495|NCT03252587|12049327|FG003|COMPLETED|Overall Study||62
10883496|NCT03252587|12049324|FG000|NOT COMPLETED|Overall Study||24
10883497|NCT03252587|12049325|FG001|NOT COMPLETED|Overall Study||20
10883498|NCT03252587|12049326|FG002|NOT COMPLETED|Overall Study||17
10883499|NCT03252587|12049327|FG003|NOT COMPLETED|Overall Study||27
10883500|NCT03250273|12049342|FG000|STARTED|Overall Study||13
10883501|NCT03250273|12049343|FG001|STARTED|Overall Study||30
10883502|NCT03250273|12049342|FG000|COMPLETED|Overall Study||11
10883503|NCT03250273|12049343|FG001|COMPLETED|Overall Study||18
10883504|NCT03250273|12049342|FG000|NOT COMPLETED|Overall Study||2
10883505|NCT03250273|12049343|FG001|NOT COMPLETED|Overall Study||12
10883506|NCT03249103|12049349|FG000|STARTED|Overall Study||22
10883507|NCT03249103|12049349|FG000|COMPLETED|Overall Study||20
10883508|NCT03249103|12049349|FG000|NOT COMPLETED|Overall Study||2
10883509|NCT03246061|12049355|FG000|STARTED|Overall Study||66
10883510|NCT03246061|12049356|FG001|STARTED|Overall Study||74
10883511|NCT03246061|12049355|FG000|Interim Analysis|Overall Study||51
10883512|NCT03246061|12049356|FG001|Interim Analysis|Overall Study||53
10883513|NCT03246061|12049355|FG000|COMPLETED|Overall Study||51
10883514|NCT03246061|12049356|FG001|COMPLETED|Overall Study||53
10883515|NCT03246061|12049355|FG000|NOT COMPLETED|Overall Study||15
10883516|NCT03246061|12049356|FG001|NOT COMPLETED|Overall Study||21
10883517|NCT03241173|12049375|FG000|STARTED|Overall Study||4
10883518|NCT03241173|12049376|FG001|STARTED|Overall Study||4
10883519|NCT03241173|12049377|FG002|STARTED|Overall Study||5
10883520|NCT03241173|12049378|FG003|STARTED|Overall Study||5
10883521|NCT03241173|12049379|FG004|STARTED|Overall Study||4
10883522|NCT03241173|12049380|FG005|STARTED|Overall Study||5
10883523|NCT03241173|12049381|FG006|STARTED|Overall Study||4
10883524|NCT03241173|12049382|FG007|STARTED|Overall Study||3
10883525|NCT03241173|12049383|FG008|STARTED|Overall Study|This treatment group did not open for enrollment.|0
10883526|NCT03241173|12049384|FG009|STARTED|Overall Study||6
10883527|NCT03241173|12049385|FG010|STARTED|Overall Study||6
10883528|NCT03241173|12049386|FG011|STARTED|Overall Study||6
10883529|NCT03241173|12049387|FG012|STARTED|Overall Study|This treatment group did not open for enrollment.|0
10883530|NCT03241173|12049388|FG013|STARTED|Overall Study|Phase 2 of the study did not open for enrollment.|0
10883531|NCT03241173|12049389|FG014|STARTED|Overall Study|Phase 2 of the study did not open for enrollment.|0
10883532|NCT03241173|12049375|FG000|COMPLETED|Overall Study||0
10883533|NCT03241173|12049376|FG001|COMPLETED|Overall Study||0
10883534|NCT03241173|12049377|FG002|COMPLETED|Overall Study||0
10883535|NCT03241173|12049378|FG003|COMPLETED|Overall Study||0
10883536|NCT03241173|12049379|FG004|COMPLETED|Overall Study||0
10883537|NCT03241173|12049380|FG005|COMPLETED|Overall Study||0
10883538|NCT03241173|12049381|FG006|COMPLETED|Overall Study||0
10883539|NCT03241173|12049382|FG007|COMPLETED|Overall Study||0
10883540|NCT03241173|12049383|FG008|COMPLETED|Overall Study||0
10883541|NCT03241173|12049384|FG009|COMPLETED|Overall Study||0
10883542|NCT03241173|12049385|FG010|COMPLETED|Overall Study||0
10883543|NCT03241173|12049386|FG011|COMPLETED|Overall Study||0
10883544|NCT03241173|12049387|FG012|COMPLETED|Overall Study||0
10883545|NCT03241173|12049388|FG013|COMPLETED|Overall Study||0
10883546|NCT03241173|12049389|FG014|COMPLETED|Overall Study||0
10883547|NCT03241173|12049375|FG000|NOT COMPLETED|Overall Study||4
10883548|NCT03241173|12049376|FG001|NOT COMPLETED|Overall Study||4
10883549|NCT03241173|12049377|FG002|NOT COMPLETED|Overall Study||5
10883550|NCT03241173|12049378|FG003|NOT COMPLETED|Overall Study||5
10883551|NCT03241173|12049379|FG004|NOT COMPLETED|Overall Study||4
10883552|NCT03241173|12049380|FG005|NOT COMPLETED|Overall Study||5
10883553|NCT03241173|12049381|FG006|NOT COMPLETED|Overall Study||4
10883554|NCT03241173|12049382|FG007|NOT COMPLETED|Overall Study||3
10883555|NCT03241173|12049383|FG008|NOT COMPLETED|Overall Study||0
10883556|NCT03241173|12049384|FG009|NOT COMPLETED|Overall Study||6
10883557|NCT03241173|12049385|FG010|NOT COMPLETED|Overall Study||6
10883558|NCT03241173|12049386|FG011|NOT COMPLETED|Overall Study||6
10883559|NCT03241173|12049387|FG012|NOT COMPLETED|Overall Study||0
10883560|NCT03241173|12049388|FG013|NOT COMPLETED|Overall Study||0
10883561|NCT03241173|12049389|FG014|NOT COMPLETED|Overall Study||0
10883562|NCT03237325|12049419|FG000|STARTED|Overall Study||127
10883563|NCT03237325|12049420|FG001|STARTED|Overall Study||139
10883564|NCT03237325|12049419|FG000|COMPLETED|Overall Study||112
10883565|NCT03237325|12049420|FG001|COMPLETED|Overall Study||114
10883566|NCT03237325|12049419|FG000|NOT COMPLETED|Overall Study||15
10883567|NCT03237325|12049420|FG001|NOT COMPLETED|Overall Study||25
10883568|NCT03234907|12049428|FG000|STARTED|Induction Phase (Week 0 to Week 10)||71
10883569|NCT03234907|12049429|FG001|STARTED|Induction Phase (Week 0 to Week 10)||144
10883570|NCT03234907|12049430|FG002|STARTED|Induction Phase (Week 0 to Week 10)||0
10883571|NCT03234907|12049431|FG003|STARTED|Induction Phase (Week 0 to Week 10)||0
10883572|NCT03234907|12049432|FG004|STARTED|Induction Phase (Week 0 to Week 10)||0
10883573|NCT03234907|12049433|FG005|STARTED|Induction Phase (Week 0 to Week 10)||0
10883574|NCT03234907|12049428|FG000|Treated|Induction Phase (Week 0 to Week 10)||70
10883575|NCT03234907|12049429|FG001|Treated|Induction Phase (Week 0 to Week 10)||144
10883576|NCT03234907|12049430|FG002|Treated|Induction Phase (Week 0 to Week 10)||0
10883577|NCT03234907|12049431|FG003|Treated|Induction Phase (Week 0 to Week 10)||0
10883578|NCT03234907|12049432|FG004|Treated|Induction Phase (Week 0 to Week 10)||0
10883579|NCT03234907|12049433|FG005|Treated|Induction Phase (Week 0 to Week 10)||0
10883580|NCT03234907|12049428|FG000|COMPLETED|Induction Phase (Week 0 to Week 10)||61
10883581|NCT03234907|12049429|FG001|COMPLETED|Induction Phase (Week 0 to Week 10)||138
10883582|NCT03234907|12049430|FG002|COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883583|NCT03234907|12049431|FG003|COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883584|NCT03234907|12049432|FG004|COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883585|NCT03234907|12049433|FG005|COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883586|NCT03234907|12049428|FG000|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||10
10883587|NCT03234907|12049429|FG001|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||6
10883588|NCT03234907|12049430|FG002|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883589|NCT03234907|12049431|FG003|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883590|NCT03234907|12049432|FG004|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883591|NCT03234907|12049433|FG005|NOT COMPLETED|Induction Phase (Week 0 to Week 10)||0
10883592|NCT03234907|12049428|FG000|STARTED|Maintenance Phase (Week 10 to Week 60)||0
10883593|NCT03234907|12049429|FG001|STARTED|Maintenance Phase (Week 10 to Week 60)||0
10883594|NCT03234907|12049430|FG002|STARTED|Maintenance Phase (Week 10 to Week 60)||18
10883595|NCT03234907|12049431|FG003|STARTED|Maintenance Phase (Week 10 to Week 60)||38
10883596|NCT03234907|12049432|FG004|STARTED|Maintenance Phase (Week 10 to Week 60)||46
10883597|NCT03234907|12049433|FG005|STARTED|Maintenance Phase (Week 10 to Week 60)||88
10883598|NCT03234907|12049428|FG000|COMPLETED|Maintenance Phase (Week 10 to Week 60)||0
10883599|NCT03234907|12049429|FG001|COMPLETED|Maintenance Phase (Week 10 to Week 60)||0
10883600|NCT03234907|12049430|FG002|COMPLETED|Maintenance Phase (Week 10 to Week 60)||17
10883601|NCT03234907|12049431|FG003|COMPLETED|Maintenance Phase (Week 10 to Week 60)||27
10883602|NCT03234907|12049432|FG004|COMPLETED|Maintenance Phase (Week 10 to Week 60)||36
10883603|NCT03234907|12049433|FG005|COMPLETED|Maintenance Phase (Week 10 to Week 60)||67
10883604|NCT03234907|12049428|FG000|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||0
10883605|NCT03234907|12049429|FG001|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||0
10883606|NCT03234907|12049430|FG002|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||1
10883607|NCT03234907|12049431|FG003|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||11
10883608|NCT03234907|12049432|FG004|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||10
10883609|NCT03234907|12049433|FG005|NOT COMPLETED|Maintenance Phase (Week 10 to Week 60)||21
10883610|NCT03230877|12049443|FG000|STARTED|Visit 1||23
10883611|NCT03230877|12049444|FG001|STARTED|Visit 1||15
10883612|NCT03230877|12049443|FG000|COMPLETED|Visit 1||23
10883613|NCT03230877|12049444|FG001|COMPLETED|Visit 1||15
10883614|NCT03230877|12049443|FG000|NOT COMPLETED|Visit 1||0
10883615|NCT03230877|12049444|FG001|NOT COMPLETED|Visit 1||0
10883616|NCT03230877|12049443|FG000|STARTED|Visit 2||23
10883617|NCT03230877|12049444|FG001|STARTED|Visit 2||15
10883618|NCT03230877|12049443|FG000|COMPLETED|Visit 2||23
10883619|NCT03230877|12049444|FG001|COMPLETED|Visit 2||15
10883620|NCT03230877|12049443|FG000|NOT COMPLETED|Visit 2||0
10883621|NCT03230877|12049444|FG001|NOT COMPLETED|Visit 2||0
10883622|NCT03221842|12049453|FG000|STARTED|Period 1 (Open-label)||63
10883623|NCT03221842|12049454|FG001|STARTED|Period 1 (Open-label)||0
10883624|NCT03221842|12049453|FG000|COMPLETED|Period 1 (Open-label)||53
10883625|NCT03221842|12049454|FG001|COMPLETED|Period 1 (Open-label)||0
10883626|NCT03221842|12049453|FG000|NOT COMPLETED|Period 1 (Open-label)||10
10883627|NCT03221842|12049454|FG001|NOT COMPLETED|Period 1 (Open-label)||0
10883628|NCT03221842|12049453|FG000|STARTED|Period 2 (Randomized, Blinded)||7
10883629|NCT03221842|12049454|FG001|STARTED|Period 2 (Randomized, Blinded)||6
10883630|NCT03221842|12049453|FG000|COMPLETED|Period 2 (Randomized, Blinded)||6
10883631|NCT03221842|12049454|FG001|COMPLETED|Period 2 (Randomized, Blinded)||5
10883632|NCT03221842|12049453|FG000|NOT COMPLETED|Period 2 (Randomized, Blinded)||1
10883633|NCT03221842|12049454|FG001|NOT COMPLETED|Period 2 (Randomized, Blinded)||1
10883634|NCT03217591|12049467|FG000|STARTED|Overall Study||54
10883635|NCT03217591|12049468|FG001|STARTED|Overall Study||50
10883636|NCT03217591|12049469|FG002|STARTED|Overall Study||52
10883637|NCT03217591|12049467|FG000|COMPLETED|Overall Study||51
10883638|NCT03217591|12049468|FG001|COMPLETED|Overall Study||47
10883639|NCT03217591|12049469|FG002|COMPLETED|Overall Study||42
10883640|NCT03217591|12049467|FG000|NOT COMPLETED|Overall Study||3
10883641|NCT03217591|12049468|FG001|NOT COMPLETED|Overall Study||3
10883642|NCT03217591|12049469|FG002|NOT COMPLETED|Overall Study||10
10883643|NCT03214250|12049485|FG000|STARTED|Overall Study||7
10883644|NCT03214250|12049486|FG001|STARTED|Overall Study||7
10883645|NCT03214250|12049487|FG002|STARTED|Overall Study||8
10883646|NCT03214250|12049488|FG003|STARTED|Overall Study||8
10883647|NCT03214250|12049489|FG004|STARTED|Overall Study||37
10883648|NCT03214250|12049490|FG005|STARTED|Overall Study||31
10883649|NCT03214250|12049491|FG006|STARTED|Overall Study||31
10883650|NCT03214250|12049485|FG000|COMPLETED|Overall Study||0
10883651|NCT03214250|12049486|FG001|COMPLETED|Overall Study||0
10883652|NCT03214250|12049487|FG002|COMPLETED|Overall Study||0
10883653|NCT03214250|12049488|FG003|COMPLETED|Overall Study||0
10883654|NCT03214250|12049489|FG004|COMPLETED|Overall Study||0
10883655|NCT03214250|12049490|FG005|COMPLETED|Overall Study||0
10883656|NCT03214250|12049491|FG006|COMPLETED|Overall Study||0
10883657|NCT03214250|12049485|FG000|NOT COMPLETED|Overall Study||7
10883658|NCT03214250|12049486|FG001|NOT COMPLETED|Overall Study||7
10883659|NCT03214250|12049487|FG002|NOT COMPLETED|Overall Study||8
10883660|NCT03214250|12049488|FG003|NOT COMPLETED|Overall Study||8
10883661|NCT03214250|12049489|FG004|NOT COMPLETED|Overall Study||37
10883662|NCT03214250|12049490|FG005|NOT COMPLETED|Overall Study||31
10883663|NCT03214250|12049491|FG006|NOT COMPLETED|Overall Study||31
10883664|NCT03213938|12049513|FG000|STARTED|Overall Study||220
10883665|NCT03213938|12049514|FG001|STARTED|Overall Study||220
10883666|NCT03213938|12049513|FG000|COMPLETED|Overall Study||206
10883667|NCT03213938|12049514|FG001|COMPLETED|Overall Study||208
10883668|NCT03213938|12049513|FG000|NOT COMPLETED|Overall Study||14
10883669|NCT03213938|12049514|FG001|NOT COMPLETED|Overall Study||12
10883670|NCT03208127|12049520|FG000|STARTED|Overall Study||24
10883671|NCT03208127|12049520|FG000|COMPLETED|Overall Study||23
10883672|NCT03208127|12049520|FG000|NOT COMPLETED|Overall Study||1
10883673|NCT03207451|12049528|FG000|STARTED|Overall Study||21
10883674|NCT03207451|12049529|FG001|STARTED|Overall Study||8
10883675|NCT03207451|12049530|FG002|STARTED|Overall Study||29
10883676|NCT03207451|12049531|FG003|STARTED|Overall Study||23
10883677|NCT03207451|12049528|FG000|COMPLETED|Overall Study|Scheduling conflict|20
10883678|NCT03207451|12049529|FG001|COMPLETED|Overall Study||8
10883679|NCT03207451|12049530|FG002|COMPLETED|Overall Study|Patients had scheduling issues|27
10883680|NCT03207451|12049531|FG003|COMPLETED|Overall Study|Minor bleeding and scheduling conflicts|20
10883681|NCT03207451|12049528|FG000|NOT COMPLETED|Overall Study||1
10883682|NCT03207451|12049529|FG001|NOT COMPLETED|Overall Study||0
10883683|NCT03207451|12049530|FG002|NOT COMPLETED|Overall Study||2
10883684|NCT03207451|12049531|FG003|NOT COMPLETED|Overall Study||3
10883685|NCT03201965|12049544|FG000|STARTED|Overall Study||28
10883686|NCT03201965|12049545|FG001|STARTED|Overall Study||193
10883687|NCT03201965|12049546|FG002|STARTED|Overall Study||195
10883688|NCT03201965|12049544|FG000|Treated|Overall Study||28
10883689|NCT03201965|12049545|FG001|Treated|Overall Study||188
10883690|NCT03201965|12049546|FG002|Treated|Overall Study||193
10883691|NCT03201965|12049544|FG000|COMPLETED|Overall Study||0
10883692|NCT03201965|12049545|FG001|COMPLETED|Overall Study||0
10883693|NCT03201965|12049546|FG002|COMPLETED|Overall Study||0
10883694|NCT03201965|12049544|FG000|NOT COMPLETED|Overall Study||28
10883695|NCT03201965|12049545|FG001|NOT COMPLETED|Overall Study||193
10883696|NCT03201965|12049546|FG002|NOT COMPLETED|Overall Study||195
10883697|NCT03201562|12049556|FG000|STARTED|Overall Study||18
10883698|NCT03201562|12049557|FG001|STARTED|Overall Study||20
10883699|NCT03201562|12049558|FG002|STARTED|Overall Study||20
10883700|NCT03201562|12049556|FG000|COMPLETED|Overall Study||18
10883701|NCT03201562|12049557|FG001|COMPLETED|Overall Study||19
10883702|NCT03201562|12049558|FG002|COMPLETED|Overall Study||16
10883703|NCT03201562|12049556|FG000|NOT COMPLETED|Overall Study||0
10883704|NCT03201562|12049557|FG001|NOT COMPLETED|Overall Study||1
10883705|NCT03201562|12049558|FG002|NOT COMPLETED|Overall Study||4
10883706|NCT03197935|12049568|FG000|STARTED|Overall Study||168
10883707|NCT03197935|12049569|FG001|STARTED|Overall Study||165
10883708|NCT03197935|12049568|FG000|COMPLETED|Overall Study||0
10883709|NCT03197935|12049569|FG001|COMPLETED|Overall Study||0
10883710|NCT03197935|12049568|FG000|NOT COMPLETED|Overall Study||168
10883711|NCT03197935|12049569|FG001|NOT COMPLETED|Overall Study||165
10883712|NCT03194646|12049580|FG000|STARTED|Overall Study||363
10883713|NCT03194646|12049581|FG001|STARTED|Overall Study||361
10883714|NCT03194646|12049582|FG002|STARTED|Overall Study||183
10883715|NCT03194646|12049583|FG003|STARTED|Overall Study||365
10883716|NCT03194646|12049580|FG000|Treated|Overall Study||349
10883717|NCT03194646|12049581|FG001|Treated|Overall Study||347
10883718|NCT03194646|12049582|FG002|Treated|Overall Study||177
10883719|NCT03194646|12049583|FG003|Treated|Overall Study||365
10883720|NCT03194646|12049580|FG000|COMPLETED|Overall Study||61
10883721|NCT03194646|12049581|FG001|COMPLETED|Overall Study||93
10883722|NCT03194646|12049582|FG002|COMPLETED|Overall Study||44
10883723|NCT03194646|12049583|FG003|COMPLETED|Overall Study||85
10883724|NCT03194646|12049580|FG000|NOT COMPLETED|Overall Study||302
10883725|NCT03194646|12049581|FG001|NOT COMPLETED|Overall Study||268
10883726|NCT03194646|12049582|FG002|NOT COMPLETED|Overall Study||139
10883727|NCT03194646|12049583|FG003|NOT COMPLETED|Overall Study||280
10883728|NCT03192358|12049600|FG000|STARTED|Overall Study||20
10883729|NCT03192358|12049601|FG001|STARTED|Overall Study||20
10883730|NCT03192358|12049600|FG000|COMPLETED|Overall Study||20
10883731|NCT03192358|12049601|FG001|COMPLETED|Overall Study||20
10883732|NCT03192358|12049600|FG000|NOT COMPLETED|Overall Study||0
10883733|NCT03192358|12049601|FG001|NOT COMPLETED|Overall Study||0
10883734|NCT03185949|12049621|FG000|STARTED|ITT Analysis||22
10883735|NCT03185949|12049622|FG001|STARTED|ITT Analysis||22
10883736|NCT03185949|12049621|FG000|COMPLETED|ITT Analysis||18
10883737|NCT03185949|12049622|FG001|COMPLETED|ITT Analysis||19
10883738|NCT03185949|12049621|FG000|NOT COMPLETED|ITT Analysis||4
10883739|NCT03185949|12049622|FG001|NOT COMPLETED|ITT Analysis||3
10883740|NCT03185949|12049621|FG000|STARTED|PP Analysis||18
10883741|NCT03185949|12049622|FG001|STARTED|PP Analysis||19
10883742|NCT03185949|12049621|FG000|COMPLETED|PP Analysis||16
10883743|NCT03185949|12049622|FG001|COMPLETED|PP Analysis||15
10883744|NCT03185949|12049621|FG000|NOT COMPLETED|PP Analysis||2
10883745|NCT03185949|12049622|FG001|NOT COMPLETED|PP Analysis||4
10883746|NCT03185949|12049621|FG000|STARTED|Cross-over at 6 Months||16
10883747|NCT03185949|12049622|FG001|STARTED|Cross-over at 6 Months||0
10883748|NCT03185949|12049621|FG000|COMPLETED|Cross-over at 6 Months||15
10883749|NCT03185949|12049622|FG001|COMPLETED|Cross-over at 6 Months||0
10883750|NCT03185949|12049621|FG000|NOT COMPLETED|Cross-over at 6 Months||1
10883751|NCT03185949|12049622|FG001|NOT COMPLETED|Cross-over at 6 Months||0
10883752|NCT03182686|12049632|FG000|STARTED|Overall Study||144
10883753|NCT03182686|12049633|FG001|STARTED|Overall Study||24
10883754|NCT03182686|12049632|FG000|COMPLETED|Overall Study||137
10883755|NCT03182686|12049633|FG001|COMPLETED|Overall Study||24
10883756|NCT03182686|12049632|FG000|NOT COMPLETED|Overall Study||7
10883757|NCT03182686|12049633|FG001|NOT COMPLETED|Overall Study||0
10883758|NCT03179995|12049641|FG000|STARTED|Overall Study||20
10883759|NCT03179995|12049642|FG001|STARTED|Overall Study||4
10883760|NCT03179995|12049641|FG000|COMPLETED|Overall Study||4
10883761|NCT03179995|12049642|FG001|COMPLETED|Overall Study||1
10883762|NCT03179995|12049641|FG000|NOT COMPLETED|Overall Study||16
10883763|NCT03179995|12049642|FG001|NOT COMPLETED|Overall Study||3
10883764|NCT03179202|12049648|FG000|STARTED|Overall Study||166
10883765|NCT03179202|12049648|FG000|Enrolled/Received Leads|Overall Study||99
10883766|NCT03179202|12049648|FG000|Protocol Population|Overall Study||91
10883767|NCT03179202|12049648|FG000|COMPLETED|Overall Study||75
10883768|NCT03179202|12049648|FG000|NOT COMPLETED|Overall Study||91
10883769|NCT03175549|12049656|FG000|STARTED|Overall Study||26
10883770|NCT03175549|12049657|FG001|STARTED|Overall Study||25
10883771|NCT03175549|12049656|FG000|COMPLETED|Overall Study||22
10883772|NCT03175549|12049657|FG001|COMPLETED|Overall Study||21
10883773|NCT03175549|12049656|FG000|NOT COMPLETED|Overall Study||4
10883774|NCT03175549|12049657|FG001|NOT COMPLETED|Overall Study||4
10883775|NCT03174132|12049665|FG000|STARTED|Overall Study||70
10883776|NCT03174132|12049665|FG000|COMPLETED|Overall Study||70
10883777|NCT03174132|12049665|FG000|NOT COMPLETED|Overall Study||0
10883778|NCT03170349|12049669|FG000|STARTED|At 30 Days Follow-up||124
10883779|NCT03170349|12049669|FG000|COMPLETED|At 30 Days Follow-up||123
10883780|NCT03170349|12049669|FG000|NOT COMPLETED|At 30 Days Follow-up||1
10883781|NCT03170349|12049669|FG000|STARTED|At 6 Months Follow-up||123
10883782|NCT03170349|12049669|FG000|COMPLETED|At 6 Months Follow-up||114
10883783|NCT03170349|12049669|FG000|NOT COMPLETED|At 6 Months Follow-up||9
10883784|NCT03170349|12049669|FG000|STARTED|At 1 Year Follow-up||114
10883785|NCT03170349|12049669|FG000|COMPLETED|At 1 Year Follow-up||106
10883786|NCT03170349|12049669|FG000|NOT COMPLETED|At 1 Year Follow-up||8
10883787|NCT03167619|12049675|FG000|STARTED|Overall Study||23
10883788|NCT03167619|12049676|FG001|STARTED|Overall Study||22
10883789|NCT03167619|12049675|FG000|COMPLETED|Overall Study||11
10883790|NCT03167619|12049676|FG001|COMPLETED|Overall Study||11
10883791|NCT03167619|12049675|FG000|NOT COMPLETED|Overall Study||12
10883792|NCT03167619|12049676|FG001|NOT COMPLETED|Overall Study||11
10883793|NCT03167099|12049684|FG000|STARTED|Overall Study||26
10883794|NCT03167099|12049685|FG001|STARTED|Overall Study||27
10883795|NCT03167099|12049684|FG000|COMPLETED|Overall Study||19
10883796|NCT03167099|12049685|FG001|COMPLETED|Overall Study||19
10883797|NCT03167099|12049684|FG000|NOT COMPLETED|Overall Study||7
10883798|NCT03167099|12049685|FG001|NOT COMPLETED|Overall Study||8
10883799|NCT03164772|12049693|FG000|STARTED|Overall Study||23
10883800|NCT03164772|12049694|FG001|STARTED|Overall Study||34
10883801|NCT03164772|12049693|FG000|COMPLETED|Overall Study||5
10883802|NCT03164772|12049694|FG001|COMPLETED|Overall Study||3
10883803|NCT03164772|12049693|FG000|NOT COMPLETED|Overall Study||18
10883804|NCT03164772|12049694|FG001|NOT COMPLETED|Overall Study||31
10883817|NCT03163992|12049718|FG000|STARTED|Overall Study||60
10883818|NCT03163992|12049718|FG000|COMPLETED|Overall Study||1
10883819|NCT03163992|12049718|FG000|NOT COMPLETED|Overall Study||59
10883820|NCT03163667|12049724|FG000|STARTED|Overall Study||23
10883821|NCT03163667|12049725|FG001|STARTED|Overall Study||46
10883822|NCT03163667|12049724|FG000|COMPLETED|Overall Study||0
10883823|NCT03163667|12049725|FG001|COMPLETED|Overall Study||0
10883824|NCT03163667|12049724|FG000|NOT COMPLETED|Overall Study||23
10883825|NCT03163667|12049725|FG001|NOT COMPLETED|Overall Study||46
10883826|NCT03162224|12049734|FG000|STARTED|Overall Study||15
10883827|NCT03162224|12049735|FG001|STARTED|Overall Study||9
10883828|NCT03162224|12049736|FG002|STARTED|Overall Study||11
10883829|NCT03162224|12049734|FG000|COMPLETED|Overall Study||4
10883830|NCT03162224|12049735|FG001|COMPLETED|Overall Study||1
10883831|NCT03162224|12049736|FG002|COMPLETED|Overall Study||1
10883832|NCT03162224|12049734|FG000|NOT COMPLETED|Overall Study||11
10883833|NCT03162224|12049735|FG001|NOT COMPLETED|Overall Study||8
10883834|NCT03162224|12049736|FG002|NOT COMPLETED|Overall Study||10
10883835|NCT03160716|12049744|FG000|STARTED|Overall Study||60
10883836|NCT03160716|12049744|FG000|COMPLETED|Overall Study||59
10883837|NCT03160716|12049744|FG000|NOT COMPLETED|Overall Study||1
10883838|NCT03158688|12049750|FG000|STARTED|Overall Study||154
10883839|NCT03158688|12049751|FG001|STARTED|Overall Study||312
10883840|NCT03158688|12049750|FG000|Treated|Overall Study||153
10883841|NCT03158688|12049751|FG001|Treated|Overall Study||308
10883842|NCT03158688|12049750|FG000|COMPLETED|Overall Study||0
10883843|NCT03158688|12049751|FG001|COMPLETED|Overall Study||0
10883844|NCT03158688|12049750|FG000|NOT COMPLETED|Overall Study||154
10883845|NCT03158688|12049751|FG001|NOT COMPLETED|Overall Study||312
10883846|NCT03153137|12049759|FG000|STARTED|Overall Study||69
10883847|NCT03153137|12049760|FG001|STARTED|Overall Study||68
10883848|NCT03153137|12049759|FG000|COMPLETED|Overall Study||66
10883849|NCT03153137|12049760|FG001|COMPLETED|Overall Study||64
10883850|NCT03153137|12049759|FG000|NOT COMPLETED|Overall Study||3
10883851|NCT03153137|12049760|FG001|NOT COMPLETED|Overall Study||4
10883852|NCT03151811|12049768|FG000|STARTED|Overall Study||246
10883853|NCT03151811|12049769|FG001|STARTED|Overall Study||249
10883854|NCT03151811|12049768|FG000|COMPLETED|Overall Study|At the time of data entry for primary outcome, there are still patients being treated with melflufen + dexamethasone in the study.|220
10883855|NCT03151811|12049769|FG001|COMPLETED|Overall Study|At the time of data entry for primary outcome, there are still patients being treated with pomalidomide + dexamethasone in the study.|231
10883856|NCT03151811|12049768|FG000|NOT COMPLETED|Overall Study||26
10883857|NCT03151811|12049769|FG001|NOT COMPLETED|Overall Study||18
10883858|NCT03150056|12049781|FG000|STARTED|Overall Study||10
10883859|NCT03150056|12049782|FG001|STARTED|Overall Study||6
10883860|NCT03150056|12049783|FG002|STARTED|Overall Study||4
10883861|NCT03150056|12049784|FG003|STARTED|Overall Study||10
10883862|NCT03150056|12049785|FG004|STARTED|Overall Study||22
10883863|NCT03150056|12049786|FG005|STARTED|Overall Study||21
10883864|NCT03150056|12049781|FG000|COMPLETED|Overall Study||0
10883865|NCT03150056|12049782|FG001|COMPLETED|Overall Study||1
10883866|NCT03150056|12049783|FG002|COMPLETED|Overall Study||1
10883867|NCT03150056|12049784|FG003|COMPLETED|Overall Study||2
10883868|NCT03150056|12049785|FG004|COMPLETED|Overall Study||9
10883869|NCT03150056|12049786|FG005|COMPLETED|Overall Study||3
10883870|NCT03150056|12049781|FG000|NOT COMPLETED|Overall Study||10
10883871|NCT03150056|12049782|FG001|NOT COMPLETED|Overall Study||5
10883872|NCT03150056|12049783|FG002|NOT COMPLETED|Overall Study||3
10883873|NCT03150056|12049784|FG003|NOT COMPLETED|Overall Study||8
10883874|NCT03150056|12049785|FG004|NOT COMPLETED|Overall Study||13
10883875|NCT03150056|12049786|FG005|NOT COMPLETED|Overall Study||18
10883876|NCT03148795|12049803|FG000|STARTED|Overall Study||128
10883877|NCT03148795|12049803|FG000|Treated|Overall Study||127
10883878|NCT03148795|12049803|FG000|COMPLETED|Overall Study||0
10883879|NCT03148795|12049803|FG000|NOT COMPLETED|Overall Study||128
10883880|NCT03144674|12049811|FG000|STARTED|Overall Study||4
10883881|NCT03144674|12049812|FG001|STARTED|Overall Study||6
10883882|NCT03144674|12049813|FG002|STARTED|Overall Study||28
10883883|NCT03144674|12049814|FG003|STARTED|Overall Study||72
10883884|NCT03144674|12049811|FG000|COMPLETED|Overall Study||0
10883885|NCT03144674|12049812|FG001|COMPLETED|Overall Study||0
10883886|NCT03144674|12049813|FG002|COMPLETED|Overall Study||0
10883887|NCT03144674|12049814|FG003|COMPLETED|Overall Study||0
10883888|NCT03144674|12049811|FG000|NOT COMPLETED|Overall Study||4
10883889|NCT03144674|12049812|FG001|NOT COMPLETED|Overall Study||6
10883890|NCT03144674|12049813|FG002|NOT COMPLETED|Overall Study||28
10883891|NCT03144674|12049814|FG003|NOT COMPLETED|Overall Study||72
10883892|NCT03141177|12049832|FG000|STARTED|Overall Study||323
10883893|NCT03141177|12049833|FG001|STARTED|Overall Study||50
10883894|NCT03141177|12049834|FG002|STARTED|Overall Study||328
10883895|NCT03141177|12049832|FG000|Treated|Overall Study||320
10883896|NCT03141177|12049833|FG001|Treated|Overall Study||50
10883897|NCT03141177|12049834|FG002|Treated|Overall Study||320
10883898|NCT03141177|12049832|FG000|COMPLETED|Overall Study||242
10883899|NCT03141177|12049833|FG001|COMPLETED|Overall Study||34
10883900|NCT03141177|12049834|FG002|COMPLETED|Overall Study||210
10883901|NCT03141177|12049832|FG000|NOT COMPLETED|Overall Study||81
10883902|NCT03141177|12049833|FG001|NOT COMPLETED|Overall Study||16
10883903|NCT03141177|12049834|FG002|NOT COMPLETED|Overall Study||118
10883904|NCT03132805|12049846|FG000|STARTED|Overall Study||1629
10883905|NCT03132805|12049847|FG001|STARTED|Overall Study||1792
10883906|NCT03132805|12049848|FG002|STARTED|Overall Study||1812
10883907|NCT03132805|12049846|FG000|Students|Overall Study||1527
10883908|NCT03132805|12049847|FG001|Students|Overall Study||1694
10883909|NCT03132805|12049848|FG002|Students|Overall Study||1702
10883910|NCT03132805|12049846|FG000|Teachers|Overall Study||102
10883911|NCT03132805|12049847|FG001|Teachers|Overall Study||98
10883912|NCT03132805|12049848|FG002|Teachers|Overall Study||110
10883913|NCT03132805|12049846|FG000|Baseline Data Collection (Students)|Overall Study||1442
10883914|NCT03132805|12049847|FG001|Baseline Data Collection (Students)|Overall Study||1603
10883915|NCT03132805|12049848|FG002|Baseline Data Collection (Students)|Overall Study||1617
10883916|NCT03132805|12049846|FG000|Post-test Data Collection (Students)|Overall Study||1395
10883917|NCT03132805|12049847|FG001|Post-test Data Collection (Students)|Overall Study||1564
10883918|NCT03132805|12049848|FG002|Post-test Data Collection (Students)|Overall Study||1609
10883919|NCT03132805|12049846|FG000|Baseline Data Collection (Teachers)|Overall Study||102
10883920|NCT03132805|12049847|FG001|Baseline Data Collection (Teachers)|Overall Study||91
10883921|NCT03132805|12049848|FG002|Baseline Data Collection (Teachers)|Overall Study||99
10883922|NCT03132805|12049846|FG000|Post-test Data Collection (Teachers)|Overall Study||92
10883923|NCT03132805|12049847|FG001|Post-test Data Collection (Teachers)|Overall Study||87
10883924|NCT03132805|12049848|FG002|Post-test Data Collection (Teachers)|Overall Study||90
10883925|NCT03132805|12049846|FG000|COMPLETED|Overall Study||1487
10883926|NCT03132805|12049847|FG001|COMPLETED|Overall Study||1651
10883927|NCT03132805|12049848|FG002|COMPLETED|Overall Study||1699
10883928|NCT03132805|12049846|FG000|NOT COMPLETED|Overall Study||142
10883929|NCT03132805|12049847|FG001|NOT COMPLETED|Overall Study||141
10883930|NCT03132805|12049848|FG002|NOT COMPLETED|Overall Study||113
10883931|NCT03132467|12049856|FG000|STARTED|Overall Study||8
10883932|NCT03132467|12049856|FG000|COMPLETED|Overall Study||4
10883933|NCT03132467|12049856|FG000|NOT COMPLETED|Overall Study||4
10883934|NCT03131219|12049863|FG000|STARTED|Initial Evaluation Period||21
10883935|NCT03131219|12049864|FG001|STARTED|Initial Evaluation Period||10
10883936|NCT03131219|12049863|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||21
10883937|NCT03131219|12049864|FG001|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||10
10883938|NCT03131219|12049863|FG000|COMPLETED|Initial Evaluation Period||17
10883939|NCT03131219|12049864|FG001|COMPLETED|Initial Evaluation Period||10
10883940|NCT03131219|12049863|FG000|NOT COMPLETED|Initial Evaluation Period||4
10883941|NCT03131219|12049864|FG001|NOT COMPLETED|Initial Evaluation Period||0
10883942|NCT03131219|12049863|FG000|STARTED|Extension Period||17
10883943|NCT03131219|12049864|FG001|STARTED|Extension Period||10
10883944|NCT03131219|12049863|FG000|Received At Least 1 Dose of Study Drug|Extension Period||17
10883945|NCT03131219|12049864|FG001|Received At Least 1 Dose of Study Drug|Extension Period||10
10883946|NCT03131219|12049863|FG000|Ongoing|Extension Period||16
10883947|NCT03131219|12049864|FG001|Ongoing|Extension Period||10
10883948|NCT03131219|12049863|FG000|COMPLETED|Extension Period||0
10883949|NCT03131219|12049864|FG001|COMPLETED|Extension Period||0
10883950|NCT03131219|12049863|FG000|NOT COMPLETED|Extension Period||17
10883951|NCT03131219|12049864|FG001|NOT COMPLETED|Extension Period||10
10883952|NCT03130959|12049880|FG000|STARTED|Overall Study||23
10883953|NCT03130959|12049881|FG001|STARTED|Overall Study||22
10883954|NCT03130959|12049882|FG002|STARTED|Overall Study||16
10883955|NCT03130959|12049883|FG003|STARTED|Overall Study||15
10883956|NCT03130959|12049884|FG004|STARTED|Overall Study||15
10883957|NCT03130959|12049885|FG005|STARTED|Overall Study||15
10883958|NCT03130959|12049886|FG006|STARTED|Overall Study||12
10883959|NCT03130959|12049887|FG007|STARTED|Overall Study||10
10883960|NCT03130959|12049888|FG008|STARTED|Overall Study||19
10883961|NCT03130959|12049889|FG009|STARTED|Overall Study||19
10883962|NCT03130959|12049880|FG000|COMPLETED|Overall Study||0
10883963|NCT03130959|12049881|FG001|COMPLETED|Overall Study||12
10883964|NCT03130959|12049882|FG002|COMPLETED|Overall Study||0
10883965|NCT03130959|12049883|FG003|COMPLETED|Overall Study||1
10883966|NCT03130959|12049884|FG004|COMPLETED|Overall Study||0
10883967|NCT03130959|12049885|FG005|COMPLETED|Overall Study||9
10883968|NCT03130959|12049886|FG006|COMPLETED|Overall Study||0
10883969|NCT03130959|12049887|FG007|COMPLETED|Overall Study||6
10883970|NCT03130959|12049888|FG008|COMPLETED|Overall Study||0
10883971|NCT03130959|12049889|FG009|COMPLETED|Overall Study||4
10883972|NCT03130959|12049880|FG000|NOT COMPLETED|Overall Study||23
10883973|NCT03130959|12049881|FG001|NOT COMPLETED|Overall Study||10
10883974|NCT03130959|12049882|FG002|NOT COMPLETED|Overall Study||16
10883975|NCT03130959|12049883|FG003|NOT COMPLETED|Overall Study||14
10883976|NCT03130959|12049884|FG004|NOT COMPLETED|Overall Study||15
10883977|NCT03130959|12049885|FG005|NOT COMPLETED|Overall Study||6
10883978|NCT03130959|12049886|FG006|NOT COMPLETED|Overall Study||12
10883979|NCT03130959|12049887|FG007|NOT COMPLETED|Overall Study||4
10883980|NCT03130959|12049888|FG008|NOT COMPLETED|Overall Study||19
10883981|NCT03130959|12049889|FG009|NOT COMPLETED|Overall Study||15
10883982|NCT03130439|12049924|FG000|STARTED|Overall Study||27
10883983|NCT03130439|12049924|FG000|COMPLETED|Overall Study||27
10883984|NCT03130439|12049924|FG000|NOT COMPLETED|Overall Study||0
10883985|NCT03128957|12049928|FG000|STARTED|Overall Study||10
10883986|NCT03128957|12049928|FG000|COMPLETED|Overall Study||10
10883987|NCT03128957|12049928|FG000|NOT COMPLETED|Overall Study||0
10883988|NCT03127384|12049932|FG000|STARTED|Overall Study||49
10883989|NCT03127384|12049932|FG000|Completed 3 Month Visit|Overall Study||47
10883990|NCT03127384|12049932|FG000|COMPLETED|Overall Study||43
10883991|NCT03127384|12049932|FG000|NOT COMPLETED|Overall Study||6
10883992|NCT03125902|12049940|FG000|STARTED|Overall Study||220
10883993|NCT03125902|12049941|FG001|STARTED|Overall Study||431
10883994|NCT03125902|12049940|FG000|COMPLETED|Overall Study||0
10883995|NCT03125902|12049941|FG001|COMPLETED|Overall Study||0
10883996|NCT03125902|12049940|FG000|NOT COMPLETED|Overall Study||220
10883997|NCT03125902|12049941|FG001|NOT COMPLETED|Overall Study||431
10883998|NCT03124459|12049954|FG000|STARTED|Part 1-Open Label Dose Escalation||6
10883999|NCT03124459|12049955|FG001|STARTED|Part 1-Open Label Dose Escalation||6
10884000|NCT03124459|12049956|FG002|STARTED|Part 1-Open Label Dose Escalation||6
10884001|NCT03124459|12049957|FG003|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
10884002|NCT03124459|12049958|FG004|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
10884054|NCT03122301|12049974|FG000|COMPLETED|Overall Study||1
10884055|NCT03122301|12049975|FG001|COMPLETED|Overall Study||1
10884056|NCT03122301|12049974|FG000|NOT COMPLETED|Overall Study||0
10884003|NCT03124459|12049959|FG005|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
10884004|NCT03124459|12049954|FG000|COMPLETED|Part 1-Open Label Dose Escalation||6
10884005|NCT03124459|12049955|FG001|COMPLETED|Part 1-Open Label Dose Escalation||6
10884006|NCT03124459|12049956|FG002|COMPLETED|Part 1-Open Label Dose Escalation||6
10884007|NCT03124459|12049957|FG003|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
10884008|NCT03124459|12049958|FG004|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
10884009|NCT03124459|12049959|FG005|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
10884010|NCT03124459|12049954|FG000|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10884011|NCT03124459|12049955|FG001|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10884012|NCT03124459|12049956|FG002|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10884013|NCT03124459|12049957|FG003|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10884014|NCT03124459|12049958|FG004|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10884015|NCT03124459|12049959|FG005|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
10884016|NCT03124459|12049954|FG000|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
10884017|NCT03124459|12049955|FG001|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
10884018|NCT03124459|12049956|FG002|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
10884019|NCT03124459|12049957|FG003|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|21
10884020|NCT03124459|12049958|FG004|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|24
10884021|NCT03124459|12049959|FG005|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
10884022|NCT03124459|12049954|FG000|COMPLETED|Phase 2- Randomized Doubled-blind||0
10884023|NCT03124459|12049955|FG001|COMPLETED|Phase 2- Randomized Doubled-blind||0
10884024|NCT03124459|12049956|FG002|COMPLETED|Phase 2- Randomized Doubled-blind||0
10884025|NCT03124459|12049957|FG003|COMPLETED|Phase 2- Randomized Doubled-blind||9
10884026|NCT03124459|12049958|FG004|COMPLETED|Phase 2- Randomized Doubled-blind||5
10884027|NCT03124459|12049959|FG005|COMPLETED|Phase 2- Randomized Doubled-blind||0
10884028|NCT03124459|12049954|FG000|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
10884029|NCT03124459|12049955|FG001|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
10884030|NCT03124459|12049956|FG002|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
10884031|NCT03124459|12049957|FG003|NOT COMPLETED|Phase 2- Randomized Doubled-blind||12
10884032|NCT03124459|12049958|FG004|NOT COMPLETED|Phase 2- Randomized Doubled-blind||19
10884033|NCT03124459|12049959|FG005|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
10884034|NCT03124459|12049954|FG000|STARTED|Part 2- Open Label ACE-083||0
10884035|NCT03124459|12049955|FG001|STARTED|Part 2- Open Label ACE-083||0
10884036|NCT03124459|12049956|FG002|STARTED|Part 2- Open Label ACE-083||0
10884037|NCT03124459|12049957|FG003|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
10884038|NCT03124459|12049958|FG004|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
10884039|NCT03124459|12049959|FG005|STARTED|Part 2- Open Label ACE-083|The open-label portion of Part 2 are the participants that were enrolled in and completed the double-blind placebo-controlled portion of Part 2.|40
10884040|NCT03124459|12049954|FG000|COMPLETED|Part 2- Open Label ACE-083||0
10884041|NCT03124459|12049955|FG001|COMPLETED|Part 2- Open Label ACE-083||0
10884042|NCT03124459|12049956|FG002|COMPLETED|Part 2- Open Label ACE-083||0
10884043|NCT03124459|12049957|FG003|COMPLETED|Part 2- Open Label ACE-083||0
10884044|NCT03124459|12049958|FG004|COMPLETED|Part 2- Open Label ACE-083||0
10884045|NCT03124459|12049959|FG005|COMPLETED|Part 2- Open Label ACE-083||17
10884046|NCT03124459|12049954|FG000|NOT COMPLETED|Part 2- Open Label ACE-083||0
10884047|NCT03124459|12049955|FG001|NOT COMPLETED|Part 2- Open Label ACE-083||0
10884048|NCT03124459|12049956|FG002|NOT COMPLETED|Part 2- Open Label ACE-083||0
10884049|NCT03124459|12049957|FG003|NOT COMPLETED|Part 2- Open Label ACE-083||0
10884050|NCT03124459|12049958|FG004|NOT COMPLETED|Part 2- Open Label ACE-083||0
10884051|NCT03124459|12049959|FG005|NOT COMPLETED|Part 2- Open Label ACE-083||23
10884052|NCT03122301|12049974|FG000|STARTED|Overall Study||1
10884053|NCT03122301|12049975|FG001|STARTED|Overall Study||1
10884057|NCT03122301|12049975|FG001|NOT COMPLETED|Overall Study||0
10884058|NCT03108924|12049985|FG000|STARTED|Overall Study||6
10884059|NCT03108924|12049986|FG001|STARTED|Overall Study||6
10884060|NCT03108924|12049987|FG002|STARTED|Overall Study||6
10884061|NCT03108924|12049988|FG003|STARTED|Overall Study||6
10884062|NCT03108924|12049985|FG000|COMPLETED|Overall Study||6
10884063|NCT03108924|12049986|FG001|COMPLETED|Overall Study||6
10884064|NCT03108924|12049987|FG002|COMPLETED|Overall Study||6
10884065|NCT03108924|12049988|FG003|COMPLETED|Overall Study||6
10884066|NCT03108924|12049985|FG000|NOT COMPLETED|Overall Study||0
10884067|NCT03108924|12049986|FG001|NOT COMPLETED|Overall Study||0
10884068|NCT03108924|12049987|FG002|NOT COMPLETED|Overall Study||0
10884069|NCT03108924|12049988|FG003|NOT COMPLETED|Overall Study||0
10884070|NCT03106779|12050009|FG000|STARTED|Overall Study||157
10884071|NCT03106779|12050010|FG001|STARTED|Overall Study||76
10884072|NCT03106779|12050009|FG000|Treated|Overall Study||156
10884073|NCT03106779|12050010|FG001|Treated|Overall Study||0
10884074|NCT03106779|12050009|FG000|Not Treated|Overall Study||1
10884075|NCT03106779|12050010|FG001|Not Treated|Overall Study||0
10884076|NCT03106779|12050009|FG000|COMPLETED|Overall Study||97
10884077|NCT03106779|12050010|FG001|COMPLETED|Overall Study||22
10884078|NCT03106779|12050009|FG000|NOT COMPLETED|Overall Study||60
10884079|NCT03106779|12050010|FG001|NOT COMPLETED|Overall Study||54
10884080|NCT03105518|12050016|FG000|STARTED|Overall Study||100
10884081|NCT03105518|12050016|FG000|COMPLETED|Overall Study||100
10884082|NCT03105518|12050016|FG000|NOT COMPLETED|Overall Study||0
10884083|NCT03101930|12050023|FG000|STARTED|Overall Study||46
10884084|NCT03101930|12050024|FG001|STARTED|Overall Study||23
10884085|NCT03101930|12050025|FG002|STARTED|Overall Study||24
10884086|NCT03101930|12050023|FG000|COMPLETED|Overall Study||44
10884087|NCT03101930|12050024|FG001|COMPLETED|Overall Study||22
10884088|NCT03101930|12050025|FG002|COMPLETED|Overall Study||22
10884089|NCT03101930|12050023|FG000|NOT COMPLETED|Overall Study||2
10884090|NCT03101930|12050024|FG001|NOT COMPLETED|Overall Study||1
10884091|NCT03101930|12050025|FG002|NOT COMPLETED|Overall Study||2
10884092|NCT03100149|12050036|FG000|STARTED|Overall Study||105
10884093|NCT03100149|12050037|FG001|STARTED|Overall Study||105
10884094|NCT03100149|12050038|FG002|STARTED|Overall Study||106
10884095|NCT03100149|12050036|FG000|COMPLETED|Overall Study||105
10884096|NCT03100149|12050037|FG001|COMPLETED|Overall Study||101
10884097|NCT03100149|12050038|FG002|COMPLETED|Overall Study||104
10884098|NCT03100149|12050036|FG000|NOT COMPLETED|Overall Study||0
10884099|NCT03100149|12050037|FG001|NOT COMPLETED|Overall Study||4
10884100|NCT03100149|12050038|FG002|NOT COMPLETED|Overall Study||2
10884101|NCT03097783|12050048|FG000|STARTED|Overall Study||132
10884102|NCT03097783|12050049|FG001|STARTED|Overall Study||37
10884103|NCT03097783|12050048|FG000|COMPLETED|Overall Study||123
10884104|NCT03097783|12050049|FG001|COMPLETED|Overall Study||31
10884105|NCT03097783|12050048|FG000|NOT COMPLETED|Overall Study||9
10884106|NCT03097783|12050049|FG001|NOT COMPLETED|Overall Study||6
10884107|NCT03095118|12050055|FG000|STARTED|Overall Study||12
10884108|NCT03095118|12050055|FG000|COMPLETED|Overall Study||10
10884109|NCT03095118|12050055|FG000|NOT COMPLETED|Overall Study||2
10884110|NCT03094637|12050061|FG000|STARTED|Overall Study||17
10884111|NCT03094637|12050062|FG001|STARTED|Overall Study||20
10884112|NCT03094637|12050061|FG000|COMPLETED|Overall Study||17
10884113|NCT03094637|12050062|FG001|COMPLETED|Overall Study||20
10884114|NCT03094637|12050061|FG000|NOT COMPLETED|Overall Study||0
10884115|NCT03094637|12050062|FG001|NOT COMPLETED|Overall Study||0
10884122|NCT03091192|12050080|FG000|STARTED|Overall Study||33
10884123|NCT03091192|12050081|FG001|STARTED|Overall Study||27
10884124|NCT03091192|12050080|FG000|COMPLETED|Overall Study||0
10884125|NCT03091192|12050081|FG001|COMPLETED|Overall Study||0
10884126|NCT03091192|12050080|FG000|NOT COMPLETED|Overall Study||33
10884127|NCT03091192|12050081|FG001|NOT COMPLETED|Overall Study||27
10884128|NCT03090152|12050090|FG000|STARTED|Overall Study||60
10884129|NCT03090152|12050091|FG001|STARTED|Overall Study||60
10884130|NCT03090152|12050092|FG002|STARTED|Overall Study||60
10884131|NCT03090152|12050090|FG000|COMPLETED|Overall Study||59
10884132|NCT03090152|12050091|FG001|COMPLETED|Overall Study||56
10884133|NCT03090152|12050092|FG002|COMPLETED|Overall Study||59
10884134|NCT03090152|12050090|FG000|NOT COMPLETED|Overall Study||1
10884135|NCT03090152|12050091|FG001|NOT COMPLETED|Overall Study||4
10884136|NCT03090152|12050092|FG002|NOT COMPLETED|Overall Study||1
10884137|NCT03087708|12050103|FG000|STARTED|Overall Study||17
10884138|NCT03087708|12050104|FG001|STARTED|Overall Study||16
10884139|NCT03087708|12050105|FG002|STARTED|Overall Study||17
10884140|NCT03087708|12050103|FG000|COMPLETED|Overall Study||15
10884141|NCT03087708|12050104|FG001|COMPLETED|Overall Study||15
10884142|NCT03087708|12050105|FG002|COMPLETED|Overall Study||13
10884143|NCT03087708|12050103|FG000|NOT COMPLETED|Overall Study||2
10884144|NCT03087708|12050104|FG001|NOT COMPLETED|Overall Study||1
10884145|NCT03087708|12050105|FG002|NOT COMPLETED|Overall Study||4
10884146|NCT03087058|12050125|FG000|STARTED|Overall Study||14
10884147|NCT03087058|12050126|FG001|STARTED|Overall Study||9
10884235|NCT03060083|12050252|FG001|Attended End of Baseline Study Visit|Overall Study||32
10884236|NCT03060083|12050251|FG000|COMPLETED|Overall Study||31
10884237|NCT03060083|12050252|FG001|COMPLETED|Overall Study||27
10884148|NCT03087058|12050127|FG002|STARTED|Overall Study|Vifor believes the 23 enrolled subjects in Cohort 1 and 2 are representative of patients with hyperkalaemia due to CKD 6 to <18 years of age and that data are sufficient to support assessment of the PD effects, safety, and tolerability of patiromer in this population. The trial was terminated by sponsor decision on the 13 July 2022. The PD and safety of patiromer in the population aged from 0 to <6 will be assessed in a new trial with the protocol number RLY5016-208p.|0
10884149|NCT03087058|12050125|FG000|COMPLETED|Overall Study||12
10884150|NCT03087058|12050126|FG001|COMPLETED|Overall Study||9
10884151|NCT03087058|12050127|FG002|COMPLETED|Overall Study||0
10884152|NCT03087058|12050125|FG000|NOT COMPLETED|Overall Study||2
10884153|NCT03087058|12050126|FG001|NOT COMPLETED|Overall Study||0
10884154|NCT03087058|12050127|FG002|NOT COMPLETED|Overall Study||0
10884155|NCT03087019|12050136|FG000|STARTED|Overall Study||11
10884156|NCT03087019|12050137|FG001|STARTED|Overall Study||10
10884157|NCT03087019|12050136|FG000|COMPLETED|Overall Study||10
10884158|NCT03087019|12050137|FG001|COMPLETED|Overall Study||10
10884159|NCT03087019|12050136|FG000|NOT COMPLETED|Overall Study||1
10884160|NCT03087019|12050137|FG001|NOT COMPLETED|Overall Study||0
10884161|NCT03085914|12050150|FG000|STARTED|Overall Study||9
10884162|NCT03085914|12050151|FG001|STARTED|Overall Study||9
10884163|NCT03085914|12050152|FG002|STARTED|Overall Study||11
10884164|NCT03085914|12050153|FG003|STARTED|Overall Study||9
10884165|NCT03085914|12050154|FG004|STARTED|Overall Study||13
10884166|NCT03085914|12050155|FG005|STARTED|Overall Study||8
10884167|NCT03085914|12050156|FG006|STARTED|Overall Study||11
10884168|NCT03085914|12050150|FG000|COMPLETED|Overall Study||0
10884169|NCT03085914|12050151|FG001|COMPLETED|Overall Study||0
10884170|NCT03085914|12050152|FG002|COMPLETED|Overall Study||0
10884171|NCT03085914|12050153|FG003|COMPLETED|Overall Study||0
10884172|NCT03085914|12050154|FG004|COMPLETED|Overall Study||0
10884173|NCT03085914|12050155|FG005|COMPLETED|Overall Study||0
10884174|NCT03085914|12050156|FG006|COMPLETED|Overall Study||0
10884175|NCT03085914|12050150|FG000|NOT COMPLETED|Overall Study||9
10884176|NCT03085914|12050151|FG001|NOT COMPLETED|Overall Study||9
10884177|NCT03085914|12050152|FG002|NOT COMPLETED|Overall Study||11
10884178|NCT03085914|12050153|FG003|NOT COMPLETED|Overall Study||9
10884179|NCT03085914|12050154|FG004|NOT COMPLETED|Overall Study||13
10884180|NCT03085914|12050155|FG005|NOT COMPLETED|Overall Study||8
10884181|NCT03085914|12050156|FG006|NOT COMPLETED|Overall Study||11
10884182|NCT03084471|12050173|FG000|STARTED|Overall Study||867
10884183|NCT03084471|12050173|FG000|COMPLETED|Overall Study||0
10884184|NCT03084471|12050173|FG000|NOT COMPLETED|Overall Study||867
10884185|NCT03082677|12050180|FG000|STARTED|Overall Study||20
10884186|NCT03082677|12050180|FG000|COMPLETED|Overall Study||18
10884187|NCT03082677|12050180|FG000|NOT COMPLETED|Overall Study||2
10884188|NCT03082664|12050186|FG000|STARTED|Overall Study||75
10884189|NCT03082664|12050187|FG001|STARTED|Overall Study||79
10884190|NCT03082664|12050186|FG000|COMPLETED|Overall Study||75
10884191|NCT03082664|12050187|FG001|COMPLETED|Overall Study||79
10884192|NCT03082664|12050186|FG000|NOT COMPLETED|Overall Study||0
10884193|NCT03082664|12050187|FG001|NOT COMPLETED|Overall Study||0
10884194|NCT03078582|12050195|FG000|STARTED|Overall Study||10
10884195|NCT03078582|12050196|FG001|STARTED|Overall Study||16
10884196|NCT03078582|12050195|FG000|COMPLETED|Overall Study||10
10884197|NCT03078582|12050196|FG001|COMPLETED|Overall Study||8
10884198|NCT03078582|12050195|FG000|NOT COMPLETED|Overall Study||0
10884199|NCT03078582|12050196|FG001|NOT COMPLETED|Overall Study||8
10884200|NCT03075527|12050202|FG000|STARTED|Overall Study||19
10884201|NCT03075527|12050202|FG000|COMPLETED|Overall Study||17
10884202|NCT03075527|12050202|FG000|NOT COMPLETED|Overall Study||2
10884203|NCT03070444|12050208|FG000|STARTED|Overall Study||52
10884204|NCT03070444|12050209|FG001|STARTED|Overall Study||52
10884205|NCT03070444|12050208|FG000|COMPLETED|Overall Study||39
10884206|NCT03070444|12050209|FG001|COMPLETED|Overall Study||35
10884207|NCT03070444|12050208|FG000|NOT COMPLETED|Overall Study||13
10884208|NCT03070444|12050209|FG001|NOT COMPLETED|Overall Study||17
10884209|NCT03070236|12050217|FG000|STARTED|Overall Study||912
10884210|NCT03070236|12050217|FG000|Guideline Concordant Care (GCC) Arm|Overall Study||538
10884211|NCT03070236|12050217|FG000|Active Surveillance (AS) Arm|Overall Study||374
10884212|NCT03070236|12050217|FG000|COMPLETED|Overall Study||912
10884213|NCT03070236|12050217|FG000|NOT COMPLETED|Overall Study||0
10884214|NCT03064126|12050226|FG000|STARTED|Overall Study||278
10884215|NCT03064126|12050227|FG001|STARTED|Overall Study||98
10884216|NCT03064126|12050228|FG002|STARTED|Overall Study||52
10884217|NCT03064126|12050229|FG003|STARTED|Overall Study||12
10884218|NCT03064126|12050226|FG000|COMPLETED|Overall Study||252
10884219|NCT03064126|12050227|FG001|COMPLETED|Overall Study||91
10884220|NCT03064126|12050228|FG002|COMPLETED|Overall Study||49
10884221|NCT03064126|12050229|FG003|COMPLETED|Overall Study||11
10884222|NCT03064126|12050226|FG000|NOT COMPLETED|Overall Study||26
10884223|NCT03064126|12050227|FG001|NOT COMPLETED|Overall Study||7
10884224|NCT03064126|12050228|FG002|NOT COMPLETED|Overall Study||3
10884225|NCT03064126|12050229|FG003|NOT COMPLETED|Overall Study||1
10884226|NCT03063632|12050242|FG000|STARTED|Overall Study||16
10884227|NCT03063632|12050243|FG001|STARTED|Overall Study||12
10884228|NCT03063632|12050242|FG000|COMPLETED|Overall Study||9
10884229|NCT03063632|12050243|FG001|COMPLETED|Overall Study||2
10884230|NCT03063632|12050242|FG000|NOT COMPLETED|Overall Study||7
10884231|NCT03063632|12050243|FG001|NOT COMPLETED|Overall Study||10
10884232|NCT03060083|12050251|FG000|STARTED|Overall Study||39
10884233|NCT03060083|12050252|FG001|STARTED|Overall Study||35
10884234|NCT03060083|12050251|FG000|Attended End of Baseline Study Visit|Overall Study||36
10884238|NCT03060083|12050251|FG000|NOT COMPLETED|Overall Study||8
10884239|NCT03060083|12050252|FG001|NOT COMPLETED|Overall Study||8
10884240|NCT03057600|12050262|FG000|STARTED|Overall Study||9
10884241|NCT03057600|12050263|FG001|STARTED|Overall Study||10
10884242|NCT03057600|12050264|FG002|STARTED|Overall Study||20
10884243|NCT03057600|12050265|FG003|STARTED|Overall Study||13
10884244|NCT03057600|12050262|FG000|COMPLETED|Overall Study||0
10884245|NCT03057600|12050263|FG001|COMPLETED|Overall Study||0
10884246|NCT03057600|12050264|FG002|COMPLETED|Overall Study||0
10884247|NCT03057600|12050265|FG003|COMPLETED|Overall Study||0
10884248|NCT03057600|12050262|FG000|NOT COMPLETED|Overall Study||9
10884249|NCT03057600|12050263|FG001|NOT COMPLETED|Overall Study||10
10884250|NCT03057600|12050264|FG002|NOT COMPLETED|Overall Study||20
10884251|NCT03057600|12050265|FG003|NOT COMPLETED|Overall Study||13
10884252|NCT03055858|12050276|FG000|STARTED|Overall Study||200
10884253|NCT03055858|12050276|FG000|IDE Cohort|Overall Study||50
10884254|NCT03055858|12050276|FG000|CAP Cohort|Overall Study||150
10884255|NCT03055858|12050276|FG000|COMPLETED|Overall Study||194
10884256|NCT03055858|12050276|FG000|NOT COMPLETED|Overall Study||6
10884257|NCT03043872|12050283|FG000|STARTED|Overall Study||329
10884258|NCT03043872|12050284|FG001|STARTED|Overall Study||328
10884259|NCT03043872|12050285|FG002|STARTED|Overall Study||330
10884260|NCT03043872|12050283|FG000|Randomized and Included in Global Cohort Analysis|Overall Study||268
10884261|NCT03043872|12050284|FG001|Randomized and Included in Global Cohort Analysis|Overall Study||268
10884262|NCT03043872|12050285|FG002|Randomized and Included in Global Cohort Analysis|Overall Study||269
10884263|NCT03043872|12050283|FG000|Received Treatment in Global Cohort|Overall Study||266
10884264|NCT03043872|12050284|FG001|Received Treatment in Global Cohort|Overall Study||265
10884265|NCT03043872|12050285|FG002|Received Treatment in Global Cohort|Overall Study||266
10884266|NCT03043872|12050283|FG000|Randomized and Included in China Cohort Analysis|Overall Study||65
10884267|NCT03043872|12050284|FG001|Randomized and Included in China Cohort Analysis|Overall Study||61
10884268|NCT03043872|12050285|FG002|Randomized and Included in China Cohort Analysis|Overall Study||62
10884269|NCT03043872|12050283|FG000|Received Treatment in China Cohort|Overall Study||65
10884270|NCT03043872|12050284|FG001|Received Treatment in China Cohort|Overall Study||61
10884271|NCT03043872|12050285|FG002|Received Treatment in China Cohort|Overall Study||62
10884272|NCT03043872|12050283|FG000|Included in Both Cohorts (Global + China)|Overall Study||4
10884273|NCT03043872|12050284|FG001|Included in Both Cohorts (Global + China)|Overall Study||1
10884274|NCT03043872|12050285|FG002|Included in Both Cohorts (Global + China)|Overall Study||1
10884275|NCT03043872|12050283|FG000|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||56
10884276|NCT03043872|12050284|FG001|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||56
10884277|NCT03043872|12050285|FG002|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||31
10884278|NCT03043872|12050283|FG000|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||16
10884279|NCT03043872|12050284|FG001|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||11
10884280|NCT03043872|12050285|FG002|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||7
10884281|NCT03043872|12050283|FG000|COMPLETED|Overall Study||51
10884282|NCT03043872|12050284|FG001|COMPLETED|Overall Study||52
10884283|NCT03043872|12050285|FG002|COMPLETED|Overall Study||18
10884284|NCT03043872|12050283|FG000|NOT COMPLETED|Overall Study||278
10884285|NCT03043872|12050284|FG001|NOT COMPLETED|Overall Study||276
10884286|NCT03043872|12050285|FG002|NOT COMPLETED|Overall Study||312
10884287|NCT03043664|12050303|FG000|STARTED|Overall Study||22
10884288|NCT03043664|12050303|FG000|COMPLETED|Overall Study||15
10884289|NCT03043664|12050303|FG000|NOT COMPLETED|Overall Study||7
10884290|NCT03043599|12050307|FG000|STARTED|Overall Study||21
10884291|NCT03043599|12050307|FG000|COMPLETED|Overall Study||21
10884292|NCT03043599|12050307|FG000|NOT COMPLETED|Overall Study||0
10884293|NCT03041467|12050313|FG000|STARTED|Overall Study||170
10884294|NCT03041467|12050314|FG001|STARTED|Overall Study||160
10884295|NCT03041467|12050313|FG000|30 Days|Overall Study||159
10884296|NCT03041467|12050314|FG001|30 Days|Overall Study||152
10884297|NCT03041467|12050313|FG000|3 Months|Overall Study||158
10884298|NCT03041467|12050314|FG001|3 Months|Overall Study||151
10884299|NCT03041467|12050313|FG000|6 Months|Overall Study||145
10884300|NCT03041467|12050314|FG001|6 Months|Overall Study||144
10884301|NCT03041467|12050313|FG000|9 Months|Overall Study||138
10884302|NCT03041467|12050314|FG001|9 Months|Overall Study||138
10884303|NCT03041467|12050313|FG000|12 Months|Overall Study||131
10884304|NCT03041467|12050314|FG001|12 Months|Overall Study||121
10884305|NCT03041467|12050313|FG000|18 Months|Overall Study||123
10884306|NCT03041467|12050314|FG001|18 Months|Overall Study||113
10884307|NCT03041467|12050313|FG000|24 Months|Overall Study||110
10884308|NCT03041467|12050314|FG001|24 Months|Overall Study||101
10884309|NCT03041467|12050313|FG000|36 Months|Overall Study||75
10884310|NCT03041467|12050314|FG001|36 Months|Overall Study||58
10884311|NCT03041467|12050313|FG000|COMPLETED|Overall Study||75
10884312|NCT03041467|12050314|FG001|COMPLETED|Overall Study||58
10884313|NCT03041467|12050313|FG000|NOT COMPLETED|Overall Study||95
10884314|NCT03041467|12050314|FG001|NOT COMPLETED|Overall Study||102
10884315|NCT03041415|12050324|FG000|STARTED|Overall Study||140
10884316|NCT03041415|12050325|FG001|STARTED|Overall Study||160
10884317|NCT03041415|12050324|FG000|COMPLETED|Overall Study||123
10884318|NCT03041415|12050325|FG001|COMPLETED|Overall Study||145
10884319|NCT03041415|12050324|FG000|NOT COMPLETED|Overall Study||17
10884320|NCT03041415|12050325|FG001|NOT COMPLETED|Overall Study||15
10884321|NCT03041324|12050334|FG000|STARTED|Overall Study||2
10884322|NCT03041324|12050335|FG001|STARTED|Overall Study||2
10884323|NCT03041324|12050336|FG002|STARTED|Overall Study||5
10884324|NCT03041324|12050334|FG000|COMPLETED|Overall Study||2
10884325|NCT03041324|12050335|FG001|COMPLETED|Overall Study||2
10884326|NCT03041324|12050336|FG002|COMPLETED|Overall Study||5
10884327|NCT03041324|12050334|FG000|NOT COMPLETED|Overall Study||0
10884328|NCT03041324|12050335|FG001|NOT COMPLETED|Overall Study||0
10884329|NCT03041324|12050336|FG002|NOT COMPLETED|Overall Study||0
10884330|NCT03035227|12050349|FG000|STARTED|Overall Study||1
10884331|NCT03035227|12050350|FG001|STARTED|Overall Study||1
10884332|NCT03035227|12050349|FG000|COMPLETED|Overall Study|study stopped due to PI leaving institution|0
10884333|NCT03035227|12050350|FG001|COMPLETED|Overall Study|study stopped due to PI leaving institution|0
10884334|NCT03035227|12050349|FG000|NOT COMPLETED|Overall Study||1
10884335|NCT03035227|12050350|FG001|NOT COMPLETED|Overall Study||1
10884336|NCT03032198|12050358|FG000|STARTED|Overall Study||37
10884337|NCT03032198|12050358|FG000|COMPLETED|Overall Study||36
10884338|NCT03032198|12050358|FG000|NOT COMPLETED|Overall Study||1
10884339|NCT03031847|12050366|FG000|STARTED|Overall Study||22
10884340|NCT03031847|12050367|FG001|STARTED|Overall Study||20
10884341|NCT03031847|12050368|FG002|STARTED|Overall Study||18
10884342|NCT03031847|12050369|FG003|STARTED|Overall Study||42
10884343|NCT03031847|12050366|FG000|COMPLETED|Overall Study||20
10884344|NCT03031847|12050367|FG001|COMPLETED|Overall Study||18
10884345|NCT03031847|12050368|FG002|COMPLETED|Overall Study||14
10884346|NCT03031847|12050369|FG003|COMPLETED|Overall Study||36
10884347|NCT03031847|12050366|FG000|NOT COMPLETED|Overall Study||2
10884348|NCT03031847|12050367|FG001|NOT COMPLETED|Overall Study||2
10884349|NCT03031847|12050368|FG002|NOT COMPLETED|Overall Study||4
10884350|NCT03031847|12050369|FG003|NOT COMPLETED|Overall Study||6
10884351|NCT03031782|12050379|FG000|STARTED|Treatment Period 1||86
10884352|NCT03031782|12050380|FG001|STARTED|Treatment Period 1||0
10884353|NCT03031782|12050381|FG002|STARTED|Treatment Period 1||0
10884354|NCT03031782|12050382|FG003|STARTED|Treatment Period 1||0
10884355|NCT03031782|12050383|FG004|STARTED|Treatment Period 1||0
10884356|NCT03031782|12050379|FG000|COMPLETED|Treatment Period 1||83
10884357|NCT03031782|12050380|FG001|COMPLETED|Treatment Period 1||0
10884358|NCT03031782|12050381|FG002|COMPLETED|Treatment Period 1||0
10884359|NCT03031782|12050382|FG003|COMPLETED|Treatment Period 1||0
10884360|NCT03031782|12050383|FG004|COMPLETED|Treatment Period 1||0
10884361|NCT03031782|12050379|FG000|NOT COMPLETED|Treatment Period 1||3
10884362|NCT03031782|12050380|FG001|NOT COMPLETED|Treatment Period 1||0
10884363|NCT03031782|12050381|FG002|NOT COMPLETED|Treatment Period 1||0
10884364|NCT03031782|12050382|FG003|NOT COMPLETED|Treatment Period 1||0
10884365|NCT03031782|12050383|FG004|NOT COMPLETED|Treatment Period 1||0
10884366|NCT03031782|12050379|FG000|STARTED|Treatment Period 2||0
10884367|NCT03031782|12050380|FG001|STARTED|Treatment Period 2||37
10884368|NCT03031782|12050381|FG002|STARTED|Treatment Period 2||38
10884369|NCT03031782|12050382|FG003|STARTED|Treatment Period 2||0
10884370|NCT03031782|12050383|FG004|STARTED|Treatment Period 2||21
10884371|NCT03031782|12050379|FG000|COMPLETED|Treatment Period 2||0
10884372|NCT03031782|12050380|FG001|COMPLETED|Treatment Period 2||31
10884373|NCT03031782|12050381|FG002|COMPLETED|Treatment Period 2||36
10884374|NCT03031782|12050382|FG003|COMPLETED|Treatment Period 2||0
10884375|NCT03031782|12050383|FG004|COMPLETED|Treatment Period 2||16
10884376|NCT03031782|12050379|FG000|NOT COMPLETED|Treatment Period 2||0
10884377|NCT03031782|12050380|FG001|NOT COMPLETED|Treatment Period 2||6
10884378|NCT03031782|12050381|FG002|NOT COMPLETED|Treatment Period 2||2
10884379|NCT03031782|12050382|FG003|NOT COMPLETED|Treatment Period 2||0
10884380|NCT03031782|12050383|FG004|NOT COMPLETED|Treatment Period 2||5
10884381|NCT03031782|12050379|FG000|STARTED|Treatment Period 3||0
10884382|NCT03031782|12050380|FG001|STARTED|Treatment Period 3||0
10884383|NCT03031782|12050381|FG002|STARTED|Treatment Period 3||0
10884384|NCT03031782|12050382|FG003|STARTED|Treatment Period 3||11
10884385|NCT03031782|12050383|FG004|STARTED|Treatment Period 3||0
10884386|NCT03031782|12050379|FG000|COMPLETED|Treatment Period 3||0
10884387|NCT03031782|12050380|FG001|COMPLETED|Treatment Period 3||0
10884388|NCT03031782|12050381|FG002|COMPLETED|Treatment Period 3||0
10884389|NCT03031782|12050382|FG003|COMPLETED|Treatment Period 3||10
10884390|NCT03031782|12050383|FG004|COMPLETED|Treatment Period 3||0
10884391|NCT03031782|12050379|FG000|NOT COMPLETED|Treatment Period 3||0
10884392|NCT03031782|12050380|FG001|NOT COMPLETED|Treatment Period 3||0
10884393|NCT03031782|12050381|FG002|NOT COMPLETED|Treatment Period 3||0
10884394|NCT03031782|12050382|FG003|NOT COMPLETED|Treatment Period 3||1
10884395|NCT03031782|12050383|FG004|NOT COMPLETED|Treatment Period 3||0
10884396|NCT03030183|12050397|FG000|STARTED|Overall Study||3
10884397|NCT03030183|12050397|FG000|COMPLETED|Overall Study||3
10884398|NCT03030183|12050397|FG000|NOT COMPLETED|Overall Study||0
10884399|NCT03025828|12050401|FG000|STARTED|Overall Study||5
10884400|NCT03025828|12050401|FG000|COMPLETED|Overall Study||4
10884401|NCT03025828|12050401|FG000|NOT COMPLETED|Overall Study||1
10884402|NCT03025542|12050407|FG000|STARTED|Overall Study||32
10884403|NCT03025542|12050408|FG001|STARTED|Overall Study||17
10884404|NCT03025542|12050407|FG000|COMPLETED|Overall Study||30
10884405|NCT03025542|12050408|FG001|COMPLETED|Overall Study||15
10884406|NCT03025542|12050407|FG000|NOT COMPLETED|Overall Study||2
10884407|NCT03025542|12050408|FG001|NOT COMPLETED|Overall Study||2
10884408|NCT03022578|12050418|FG000|STARTED|Overall Study||4
10884409|NCT03022578|12050418|FG000|COMPLETED|Overall Study||0
10884410|NCT03022578|12050418|FG000|NOT COMPLETED|Overall Study||4
10884411|NCT03021642|12050422|FG000|STARTED|Treatment Period 1 (Day 1)||12
10884412|NCT03021642|12050423|FG001|STARTED|Treatment Period 1 (Day 1)||12
10884413|NCT03021642|12050422|FG000|COMPLETED|Treatment Period 1 (Day 1)||12
10884414|NCT03021642|12050423|FG001|COMPLETED|Treatment Period 1 (Day 1)||12
10884415|NCT03021642|12050422|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10884416|NCT03021642|12050423|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
10884417|NCT03021642|12050422|FG000|STARTED|Washout Period (21 Days)||12
10884418|NCT03021642|12050423|FG001|STARTED|Washout Period (21 Days)||12
10884419|NCT03021642|12050422|FG000|COMPLETED|Washout Period (21 Days)||11
10884420|NCT03021642|12050423|FG001|COMPLETED|Washout Period (21 Days)||11
10884421|NCT03021642|12050422|FG000|NOT COMPLETED|Washout Period (21 Days)||1
10884422|NCT03021642|12050423|FG001|NOT COMPLETED|Washout Period (21 Days)||1
10884423|NCT03021642|12050422|FG000|STARTED|Treatment Period 2 (Day 22)||11
10884424|NCT03021642|12050423|FG001|STARTED|Treatment Period 2 (Day 22)||11
10884425|NCT03021642|12050422|FG000|COMPLETED|Treatment Period 2 (Day 22)||11
10884426|NCT03021642|12050423|FG001|COMPLETED|Treatment Period 2 (Day 22)||11
10884427|NCT03021642|12050422|FG000|NOT COMPLETED|Treatment Period 2 (Day 22)||0
10884428|NCT03021642|12050423|FG001|NOT COMPLETED|Treatment Period 2 (Day 22)||0
10884429|NCT03021486|12050432|FG000|STARTED|Overall Study||23
10884430|NCT03021486|12050433|FG001|STARTED|Overall Study||22
10884431|NCT03021486|12050434|FG002|STARTED|Overall Study||23
10884432|NCT03021486|12050432|FG000|COMPLETED|Overall Study||15
10884433|NCT03021486|12050433|FG001|COMPLETED|Overall Study||16
10884434|NCT03021486|12050434|FG002|COMPLETED|Overall Study||14
10884435|NCT03021486|12050432|FG000|NOT COMPLETED|Overall Study||8
10884436|NCT03021486|12050433|FG001|NOT COMPLETED|Overall Study||6
10884437|NCT03021486|12050434|FG002|NOT COMPLETED|Overall Study||9
10884438|NCT03020160|12050445|FG000|STARTED|Overall Study||7
10884439|NCT03020160|12050446|FG001|STARTED|Overall Study||41
10884440|NCT03020160|12050445|FG000|Completed 24 Weeks in the Study|Overall Study||7
10884441|NCT03020160|12050446|FG001|Completed 24 Weeks in the Study|Overall Study||41
10884442|NCT03020160|12050445|FG000|COMPLETED|Overall Study||0
10884443|NCT03020160|12050446|FG001|COMPLETED|Overall Study||0
10884444|NCT03020160|12050445|FG000|NOT COMPLETED|Overall Study||7
10884445|NCT03020160|12050446|FG001|NOT COMPLETED|Overall Study||41
10884446|NCT03020017|12050453|FG000|STARTED|NU-0129||8
10884447|NCT03020017|12050453|FG000|COMPLETED|NU-0129||8
10884448|NCT03020017|12050453|FG000|NOT COMPLETED|NU-0129||0
10884449|NCT03020017|12050453|FG000|STARTED|Standard of Care Resection||8
10884450|NCT03020017|12050453|FG000|COMPLETED|Standard of Care Resection||8
10884451|NCT03020017|12050453|FG000|NOT COMPLETED|Standard of Care Resection||0
10884452|NCT03018730|12050457|FG000|STARTED|Overall Study||22
10884453|NCT03018730|12050457|FG000|COMPLETED|Overall Study||20
10884454|NCT03018730|12050457|FG000|NOT COMPLETED|Overall Study||2
10884455|NCT03018392|12050464|FG000|STARTED|Overall Study||20
10884456|NCT03018392|12050464|FG000|COMPLETED|Overall Study||20
10884457|NCT03018392|12050464|FG000|NOT COMPLETED|Overall Study||0
10884458|NCT03016312|12050470|FG000|STARTED|Overall Study||391
10884459|NCT03016312|12050471|FG001|STARTED|Overall Study||380
10884460|NCT03016312|12050470|FG000|COMPLETED|Overall Study||150
10884461|NCT03016312|12050471|FG001|COMPLETED|Overall Study||162
10884462|NCT03016312|12050470|FG000|NOT COMPLETED|Overall Study||241
10884463|NCT03016312|12050471|FG001|NOT COMPLETED|Overall Study||218
10884464|NCT03015259|12050480|FG000|STARTED|Overall Study||613
10884465|NCT03015259|12050481|FG001|STARTED|Overall Study||622
10884466|NCT03015259|12050482|FG002|STARTED|Overall Study||204
10884467|NCT03015259|12050480|FG000|COMPLETED|Overall Study||598
10884468|NCT03015259|12050481|FG001|COMPLETED|Overall Study||604
10884469|NCT03015259|12050482|FG002|COMPLETED|Overall Study||199
10884470|NCT03015259|12050480|FG000|NOT COMPLETED|Overall Study||15
10884471|NCT03015259|12050481|FG001|NOT COMPLETED|Overall Study||18
10884472|NCT03015259|12050482|FG002|NOT COMPLETED|Overall Study||5
10884473|NCT03014362|12050492|FG000|STARTED|Overall Study||59
10884474|NCT03014362|12050493|FG001|STARTED|Overall Study||61
10884475|NCT03014362|12050492|FG000|COMPLETED|Overall Study||41
10884476|NCT03014362|12050493|FG001|COMPLETED|Overall Study||51
10884477|NCT03014362|12050492|FG000|NOT COMPLETED|Overall Study||18
10884478|NCT03014362|12050493|FG001|NOT COMPLETED|Overall Study||10
10884479|NCT03008005|12050502|FG000|STARTED|Overall Study||14
10884480|NCT03008005|12050503|FG001|STARTED|Overall Study||17
10884481|NCT03008005|12050504|FG002|STARTED|Overall Study||15
10884482|NCT03008005|12050502|FG000|COMPLETED|Overall Study||12
10884483|NCT03008005|12050503|FG001|COMPLETED|Overall Study||16
10884484|NCT03008005|12050504|FG002|COMPLETED|Overall Study||15
10884485|NCT03008005|12050502|FG000|NOT COMPLETED|Overall Study||2
10884486|NCT03008005|12050503|FG001|NOT COMPLETED|Overall Study||1
10884487|NCT03008005|12050504|FG002|NOT COMPLETED|Overall Study||0
10884488|NCT03006926|12050514|FG000|STARTED|Overall Study||6
10884489|NCT03006926|12050515|FG001|STARTED|Overall Study||98
10884490|NCT03006926|12050514|FG000|COMPLETED|Overall Study||6
10884491|NCT03006926|12050515|FG001|COMPLETED|Overall Study||0
10884492|NCT03006926|12050514|FG000|NOT COMPLETED|Overall Study||0
10884493|NCT03006926|12050515|FG001|NOT COMPLETED|Overall Study||98
10884494|NCT03006848|12050523|FG000|STARTED|Overall Study||18
10884495|NCT03006848|12050523|FG000|COMPLETED|Overall Study||0
10884496|NCT03006848|12050523|FG000|NOT COMPLETED|Overall Study||18
10884497|NCT03006185|12050534|FG000|STARTED|Overall Study|Since all participants had two test areas each, all participants received both interventions (18 test areas received CO2 and 18 test areas received microdermabrasion)|18
10884498|NCT03006185|12050534|FG000|Number of Test Areas Recieving AFL|Overall Study||18
10884499|NCT03006185|12050534|FG000|Number of Test Areas Receiving MD|Overall Study||18
10884500|NCT03006185|12050534|FG000|COMPLETED|Overall Study||18
10884501|NCT03006185|12050534|FG000|NOT COMPLETED|Overall Study||0
10884502|NCT03004976|12050542|FG000|STARTED|Overall Study||52
10884503|NCT03004976|12050543|FG001|STARTED|Overall Study||27
10884504|NCT03004976|12050542|FG000|COMPLETED|Overall Study||47
10884505|NCT03004976|12050543|FG001|COMPLETED|Overall Study||26
10884506|NCT03004976|12050542|FG000|NOT COMPLETED|Overall Study||5
10884507|NCT03004976|12050543|FG001|NOT COMPLETED|Overall Study||1
10884508|NCT03003520|12050551|FG000|STARTED|Induction||43
10884509|NCT03003520|12050552|FG001|STARTED|Induction||3
10884510|NCT03003520|12050551|FG000|Safety Population|Induction||43
10884511|NCT03003520|12050552|FG001|Safety Population|Induction||3
10884512|NCT03003520|12050551|FG000|Efficacy Evaluable Population|Induction||37
10884513|NCT03003520|12050552|FG001|Efficacy Evaluable Population|Induction||3
10884514|NCT03003520|12050551|FG000|COMPLETED|Induction||30
10884515|NCT03003520|12050552|FG001|COMPLETED|Induction||3
10884516|NCT03003520|12050551|FG000|NOT COMPLETED|Induction||13
10884517|NCT03003520|12050552|FG001|NOT COMPLETED|Induction||0
10884518|NCT03003520|12050551|FG000|STARTED|Consolidation||25
10884519|NCT03003520|12050552|FG001|STARTED|Consolidation||3
10884520|NCT03003520|12050551|FG000|COMPLETED|Consolidation||1
10884521|NCT03003520|12050552|FG001|COMPLETED|Consolidation||2
10884522|NCT03003520|12050551|FG000|NOT COMPLETED|Consolidation||24
10884523|NCT03003520|12050552|FG001|NOT COMPLETED|Consolidation||1
10884524|NCT03003520|12050551|FG000|STARTED|Follow-up||14
10884525|NCT03003520|12050552|FG001|STARTED|Follow-up||3
10884526|NCT03003520|12050551|FG000|COMPLETED|Follow-up||0
10884527|NCT03003520|12050552|FG001|COMPLETED|Follow-up||0
10884528|NCT03003520|12050551|FG000|NOT COMPLETED|Follow-up||14
10884529|NCT03003520|12050552|FG001|NOT COMPLETED|Follow-up||3
10884530|NCT03003130|12050568|FG000|STARTED|Overall Study||88
10884531|NCT03003130|12050569|FG001|STARTED|Overall Study||87
10884532|NCT03003130|12050568|FG000|COMPLETED|Overall Study||80
10884533|NCT03003130|12050569|FG001|COMPLETED|Overall Study||80
10884534|NCT03003130|12050568|FG000|NOT COMPLETED|Overall Study||8
10884535|NCT03003130|12050569|FG001|NOT COMPLETED|Overall Study||7
10884536|NCT02999984|12050575|FG000|STARTED|Overall Study||10
10884537|NCT02999984|12050575|FG000|COMPLETED|Overall Study||9
10884538|NCT02999984|12050575|FG000|NOT COMPLETED|Overall Study||1
10884539|NCT02998840|12050583|FG000|STARTED|Overall Study||33
10884540|NCT02998840|12050584|FG001|STARTED|Overall Study||33
10884541|NCT02998840|12050585|FG002|STARTED|Overall Study||33
10884542|NCT02998840|12050586|FG003|STARTED|Overall Study||33
10884543|NCT02998840|12050583|FG000|COMPLETED|Overall Study||29
10884544|NCT02998840|12050584|FG001|COMPLETED|Overall Study||30
10884545|NCT02998840|12050585|FG002|COMPLETED|Overall Study||31
10884546|NCT02998840|12050586|FG003|COMPLETED|Overall Study||28
10884547|NCT02998840|12050583|FG000|NOT COMPLETED|Overall Study||4
10884548|NCT02998840|12050584|FG001|NOT COMPLETED|Overall Study||3
10884549|NCT02998840|12050585|FG002|NOT COMPLETED|Overall Study||2
10884550|NCT02998840|12050586|FG003|NOT COMPLETED|Overall Study||5
10884551|NCT02998528|12050597|FG000|STARTED|Randomization Period||113
10884552|NCT02998528|12050598|FG001|STARTED|Randomization Period||213
10884553|NCT02998528|12050599|FG002|STARTED|Randomization Period||179
10884554|NCT02998528|12050597|FG000|All Concurrently Randomized Participants in Arms B and C|Randomization Period||0
10884555|NCT02998528|12050598|FG001|All Concurrently Randomized Participants in Arms B and C|Randomization Period||179
10884556|NCT02998528|12050599|FG002|All Concurrently Randomized Participants in Arms B and C|Randomization Period||179
10884557|NCT02998528|12050597|FG000|COMPLETED|Randomization Period||112
10884558|NCT02998528|12050598|FG001|COMPLETED|Randomization Period||207
10884559|NCT02998528|12050599|FG002|COMPLETED|Randomization Period||176
10884560|NCT02998528|12050597|FG000|NOT COMPLETED|Randomization Period||1
10884561|NCT02998528|12050598|FG001|NOT COMPLETED|Randomization Period||6
10884562|NCT02998528|12050599|FG002|NOT COMPLETED|Randomization Period||3
10884563|NCT02998528|12050597|FG000|STARTED|Neoadjuvant Treatment Period||111
10884564|NCT02998528|12050598|FG001|STARTED|Neoadjuvant Treatment Period||208
10884565|NCT02998528|12050599|FG002|STARTED|Neoadjuvant Treatment Period||176
10884566|NCT02998528|12050597|FG000|All Treated Participants From Concurrently Randomized Arms B and C|Neoadjuvant Treatment Period||0
10884567|NCT02998528|12050598|FG001|All Treated Participants From Concurrently Randomized Arms B and C|Neoadjuvant Treatment Period||176
10884568|NCT02998528|12050599|FG002|All Treated Participants From Concurrently Randomized Arms B and C|Neoadjuvant Treatment Period||176
10884569|NCT02998528|12050597|FG000|COMPLETED|Neoadjuvant Treatment Period||101
10884570|NCT02998528|12050598|FG001|COMPLETED|Neoadjuvant Treatment Period||177
10884571|NCT02998528|12050599|FG002|COMPLETED|Neoadjuvant Treatment Period||165
10884572|NCT02998528|12050597|FG000|NOT COMPLETED|Neoadjuvant Treatment Period||10
10884573|NCT02998528|12050598|FG001|NOT COMPLETED|Neoadjuvant Treatment Period||31
10884574|NCT02998528|12050599|FG002|NOT COMPLETED|Neoadjuvant Treatment Period||11
10884575|NCT02998528|12050597|FG000|STARTED|Systemic Adjuvant Treatment Period||37
10884576|NCT02998528|12050598|FG001|STARTED|Systemic Adjuvant Treatment Period||47
10884577|NCT02998528|12050599|FG002|STARTED|Systemic Adjuvant Treatment Period||26
10884578|NCT02998528|12050597|FG000|COMPLETED|Systemic Adjuvant Treatment Period||28
10884579|NCT02998528|12050598|FG001|COMPLETED|Systemic Adjuvant Treatment Period||41
10884580|NCT02998528|12050599|FG002|COMPLETED|Systemic Adjuvant Treatment Period||22
10884581|NCT02998528|12050597|FG000|NOT COMPLETED|Systemic Adjuvant Treatment Period||9
10884582|NCT02998528|12050598|FG001|NOT COMPLETED|Systemic Adjuvant Treatment Period||6
10884583|NCT02998528|12050599|FG002|NOT COMPLETED|Systemic Adjuvant Treatment Period||4
10884584|NCT02994927|12050608|FG000|STARTED|Overall Study||165
10884585|NCT02994927|12050609|FG001|STARTED|Overall Study||166
10884586|NCT02994927|12050608|FG000|COMPLETED|Overall Study||150
10884587|NCT02994927|12050609|FG001|COMPLETED|Overall Study||151
10884588|NCT02994927|12050608|FG000|NOT COMPLETED|Overall Study||15
10884589|NCT02994927|12050609|FG001|NOT COMPLETED|Overall Study||15
10884590|NCT02991482|12050617|FG000|STARTED|Overall Study||73
10884591|NCT02991482|12050618|FG001|STARTED|Overall Study||71
10884592|NCT02991482|12050617|FG000|Crossed-over to Pembrolizumab at Progression|Overall Study||0
10884593|NCT02991482|12050618|FG001|Crossed-over to Pembrolizumab at Progression|Overall Study||45
10884594|NCT02991482|12050617|FG000|COMPLETED|Overall Study||8
10884595|NCT02991482|12050618|FG001|COMPLETED|Overall Study||5
10884596|NCT02991482|12050617|FG000|NOT COMPLETED|Overall Study||65
10884597|NCT02991482|12050618|FG001|NOT COMPLETED|Overall Study||66
10884598|NCT02989194|12050627|FG000|STARTED|Overall Study||50
10884599|NCT02989194|12050628|FG001|STARTED|Overall Study||50
10884600|NCT02989194|12050629|FG002|STARTED|Overall Study||50
10884601|NCT02989194|12050627|FG000|COMPLETED|Overall Study||49
10884602|NCT02989194|12050628|FG001|COMPLETED|Overall Study||48
10884603|NCT02989194|12050629|FG002|COMPLETED|Overall Study||50
10884604|NCT02989194|12050627|FG000|NOT COMPLETED|Overall Study||1
10884605|NCT02989194|12050628|FG001|NOT COMPLETED|Overall Study||2
10884606|NCT02989194|12050629|FG002|NOT COMPLETED|Overall Study||0
10884607|NCT02987543|12050652|FG000|STARTED|Overall Study||162
10884608|NCT02987543|12050653|FG001|STARTED|Overall Study||83
10884609|NCT02987543|12050654|FG002|STARTED|Overall Study||94
10884610|NCT02987543|12050655|FG003|STARTED|Overall Study||48
10884611|NCT02987543|12050652|FG000|COMPLETED|Overall Study||0
10884612|NCT02987543|12050653|FG001|COMPLETED|Overall Study||0
10884613|NCT02987543|12050654|FG002|COMPLETED|Overall Study||0
10884614|NCT02987543|12050655|FG003|COMPLETED|Overall Study||0
10884615|NCT02987543|12050652|FG000|NOT COMPLETED|Overall Study||162
10884616|NCT02987543|12050653|FG001|NOT COMPLETED|Overall Study||83
10884617|NCT02987543|12050654|FG002|NOT COMPLETED|Overall Study||94
10884618|NCT02987543|12050655|FG003|NOT COMPLETED|Overall Study||48
10884619|NCT02984228|12050663|FG000|STARTED|Overall Study||34
10884620|NCT02984228|12050664|FG001|STARTED|Overall Study||36
10884621|NCT02984228|12050663|FG000|COMPLETED|Overall Study||34
10884622|NCT02984228|12050664|FG001|COMPLETED|Overall Study||35
10884623|NCT02984228|12050663|FG000|NOT COMPLETED|Overall Study||0
10884624|NCT02984228|12050664|FG001|NOT COMPLETED|Overall Study||1
10884625|NCT02979587|12050670|FG000|STARTED|Overall Study||50
10884626|NCT02979587|12050670|FG000|Catheterized|Overall Study||50
10884627|NCT02979587|12050670|FG000|Implanted|Overall Study||50
10884628|NCT02979587|12050670|FG000|Implanted > 24 Hours|Overall Study||48
10884629|NCT02979587|12050670|FG000|COMPLETED|Overall Study||48
10884630|NCT02979587|12050670|FG000|NOT COMPLETED|Overall Study||2
10884631|NCT02973425|12050680|FG000|STARTED|Overall Study||220
10884632|NCT02973425|12050681|FG001|STARTED|Overall Study||213
10884633|NCT02973425|12050680|FG000|COMPLETED|Overall Study||171
10884634|NCT02973425|12050681|FG001|COMPLETED|Overall Study||160
10884635|NCT02973425|12050680|FG000|NOT COMPLETED|Overall Study||49
10884636|NCT02973425|12050681|FG001|NOT COMPLETED|Overall Study||53
10884637|NCT02972424|12050690|FG000|STARTED|3 Month Endpoints- Blinded Portion||18
10884638|NCT02972424|12050691|FG001|STARTED|3 Month Endpoints- Blinded Portion||17
10884639|NCT02972424|12050690|FG000|COMPLETED|3 Month Endpoints- Blinded Portion||17
10884640|NCT02972424|12050691|FG001|COMPLETED|3 Month Endpoints- Blinded Portion||12
10884641|NCT02972424|12050690|FG000|NOT COMPLETED|3 Month Endpoints- Blinded Portion||1
10884642|NCT02972424|12050691|FG001|NOT COMPLETED|3 Month Endpoints- Blinded Portion||5
10884643|NCT02972424|12050690|FG000|STARTED|Open Label Extension 3 to 12 Months||17
10884644|NCT02972424|12050691|FG001|STARTED|Open Label Extension 3 to 12 Months||12
10884645|NCT02972424|12050690|FG000|COMPLETED|Open Label Extension 3 to 12 Months||12
10884646|NCT02972424|12050691|FG001|COMPLETED|Open Label Extension 3 to 12 Months||9
10884647|NCT02972424|12050690|FG000|NOT COMPLETED|Open Label Extension 3 to 12 Months||5
10884648|NCT02972424|12050691|FG001|NOT COMPLETED|Open Label Extension 3 to 12 Months||3
10884649|NCT02971683|12050700|FG000|STARTED|Overall Study||75
10884650|NCT02971683|12050701|FG001|STARTED|Overall Study||73
10884651|NCT02971683|12050700|FG000|COMPLETED|Overall Study||69
10884652|NCT02971683|12050701|FG001|COMPLETED|Overall Study||65
10884653|NCT02971683|12050700|FG000|NOT COMPLETED|Overall Study||6
10884654|NCT02971683|12050701|FG001|NOT COMPLETED|Overall Study||8
10884655|NCT02970981|12050707|FG000|STARTED|Overall Study||16
10884656|NCT02970981|12050707|FG000|COMPLETED|Overall Study||16
10884657|NCT02970981|12050707|FG000|NOT COMPLETED|Overall Study||0
10884658|NCT02969356|12050711|FG000|STARTED|Overall Study||157
10884659|NCT02969356|12050711|FG000|Intent-to-Treat (ITT) Population|Overall Study||153
10884660|NCT02969356|12050711|FG000|COMPLETED|Overall Study||134
10884661|NCT02969356|12050711|FG000|NOT COMPLETED|Overall Study||23
10884662|NCT02968004|12050717|FG000|STARTED|Overall Study||109
10884663|NCT02968004|12050718|FG001|STARTED|Overall Study||115
10884664|NCT02968004|12050717|FG000|COMPLETED|Overall Study||108
10884665|NCT02968004|12050718|FG001|COMPLETED|Overall Study||114
10884666|NCT02968004|12050717|FG000|NOT COMPLETED|Overall Study||1
10884667|NCT02968004|12050718|FG001|NOT COMPLETED|Overall Study||1
10884668|NCT02967133|12050726|FG000|STARTED|Overall Study||3
10884669|NCT02967133|12050727|FG001|STARTED|Overall Study||4
10884670|NCT02967133|12050726|FG000|COMPLETED|Overall Study||3
10884671|NCT02967133|12050727|FG001|COMPLETED|Overall Study||4
10884672|NCT02967133|12050726|FG000|NOT COMPLETED|Overall Study||0
10884673|NCT02967133|12050727|FG001|NOT COMPLETED|Overall Study||0
10884674|NCT02965729|12050736|FG000|STARTED|Overall Study||24
10884675|NCT02965729|12050737|FG001|STARTED|Overall Study||25
10884676|NCT02965729|12050738|FG002|STARTED|Overall Study||56
10884677|NCT02965729|12050736|FG000|COMPLETED|Overall Study||17
10884678|NCT02965729|12050737|FG001|COMPLETED|Overall Study||22
10884679|NCT02965729|12050738|FG002|COMPLETED|Overall Study||45
10884680|NCT02965729|12050736|FG000|NOT COMPLETED|Overall Study||7
10884681|NCT02965729|12050737|FG001|NOT COMPLETED|Overall Study||3
10884682|NCT02965729|12050738|FG002|NOT COMPLETED|Overall Study||11
10884683|NCT02964741|12050749|FG000|STARTED|Overall Study||15
10884684|NCT02964741|12050750|FG001|STARTED|Overall Study||13
10884685|NCT02964741|12050751|FG002|STARTED|Overall Study||12
10884686|NCT02964741|12050749|FG000|COMPLETED|Overall Study||13
10884687|NCT02964741|12050750|FG001|COMPLETED|Overall Study||12
10884688|NCT02964741|12050751|FG002|COMPLETED|Overall Study||12
10884689|NCT02964741|12050749|FG000|NOT COMPLETED|Overall Study||2
10884690|NCT02964741|12050750|FG001|NOT COMPLETED|Overall Study||1
10884691|NCT02964741|12050751|FG002|NOT COMPLETED|Overall Study||0
10884692|NCT02963506|12050762|FG000|STARTED|Double-Blind Period||60
10884693|NCT02963506|12050763|FG001|STARTED|Double-Blind Period||61
10884694|NCT02963506|12050764|FG002|STARTED|Double-Blind Period||61
10884695|NCT02963506|12050765|FG003|STARTED|Double-Blind Period||60
10884696|NCT02963506|12050766|FG004|STARTED|Double-Blind Period||61
10884697|NCT02963506|12050767|FG005|STARTED|Double-Blind Period||0
10884698|NCT02963506|12050768|FG006|STARTED|Double-Blind Period||0
10884699|NCT02963506|12050769|FG007|STARTED|Double-Blind Period||0
10884700|NCT02963506|12050770|FG008|STARTED|Double-Blind Period||0
10884701|NCT02963506|12050771|FG009|STARTED|Double-Blind Period||0
10884702|NCT02963506|12050772|FG010|STARTED|Double-Blind Period||0
10884703|NCT02963506|12050773|FG011|STARTED|Double-Blind Period||0
10884704|NCT02963506|12050774|FG012|STARTED|Double-Blind Period||0
10884705|NCT02963506|12050762|FG000|Completed Double-Blind Period|Double-Blind Period||60
10884706|NCT02963506|12050763|FG001|Completed Double-Blind Period|Double-Blind Period||59
10884707|NCT02963506|12050764|FG002|Completed Double-Blind Period|Double-Blind Period||59
10884708|NCT02963506|12050765|FG003|Completed Double-Blind Period|Double-Blind Period||58
10884709|NCT02963506|12050766|FG004|Completed Double-Blind Period|Double-Blind Period||61
10884710|NCT02963506|12050767|FG005|Completed Double-Blind Period|Double-Blind Period||0
10884711|NCT02963506|12050768|FG006|Completed Double-Blind Period|Double-Blind Period||0
10884712|NCT02963506|12050769|FG007|Completed Double-Blind Period|Double-Blind Period||0
10884713|NCT02963506|12050770|FG008|Completed Double-Blind Period|Double-Blind Period||0
10884714|NCT02963506|12050771|FG009|Completed Double-Blind Period|Double-Blind Period||0
10884715|NCT02963506|12050772|FG010|Completed Double-Blind Period|Double-Blind Period||0
10884716|NCT02963506|12050773|FG011|Completed Double-Blind Period|Double-Blind Period||0
10884717|NCT02963506|12050774|FG012|Completed Double-Blind Period|Double-Blind Period||0
10884718|NCT02963506|12050762|FG000|Completed Week 12 - Started Dose-Blind|Double-Blind Period||60
10884719|NCT02963506|12050763|FG001|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
10884720|NCT02963506|12050764|FG002|Completed Week 12 - Started Dose-Blind|Double-Blind Period||59
10884721|NCT02963506|12050765|FG003|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
10884722|NCT02963506|12050766|FG004|Completed Week 12 - Started Dose-Blind|Double-Blind Period||61
10884723|NCT02963506|12050767|FG005|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884724|NCT02963506|12050768|FG006|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884725|NCT02963506|12050769|FG007|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884726|NCT02963506|12050770|FG008|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884727|NCT02963506|12050771|FG009|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884728|NCT02963506|12050772|FG010|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884729|NCT02963506|12050773|FG011|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884730|NCT02963506|12050774|FG012|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
10884731|NCT02963506|12050762|FG000|COMPLETED|Double-Blind Period||60
10884732|NCT02963506|12050763|FG001|COMPLETED|Double-Blind Period||58
10884733|NCT02963506|12050764|FG002|COMPLETED|Double-Blind Period||59
10884734|NCT02963506|12050765|FG003|COMPLETED|Double-Blind Period||58
10884735|NCT02963506|12050766|FG004|COMPLETED|Double-Blind Period||61
10884736|NCT02963506|12050767|FG005|COMPLETED|Double-Blind Period||0
10884737|NCT02963506|12050768|FG006|COMPLETED|Double-Blind Period||0
10884738|NCT02963506|12050769|FG007|COMPLETED|Double-Blind Period||0
10884739|NCT02963506|12050770|FG008|COMPLETED|Double-Blind Period||0
10884740|NCT02963506|12050771|FG009|COMPLETED|Double-Blind Period||0
10884741|NCT02963506|12050772|FG010|COMPLETED|Double-Blind Period||0
10884742|NCT02963506|12050773|FG011|COMPLETED|Double-Blind Period||0
10884743|NCT02963506|12050774|FG012|COMPLETED|Double-Blind Period||0
10884744|NCT02963506|12050762|FG000|NOT COMPLETED|Double-Blind Period||0
10884745|NCT02963506|12050763|FG001|NOT COMPLETED|Double-Blind Period||3
10884746|NCT02963506|12050764|FG002|NOT COMPLETED|Double-Blind Period||2
10884747|NCT02963506|12050765|FG003|NOT COMPLETED|Double-Blind Period||2
10884748|NCT02963506|12050766|FG004|NOT COMPLETED|Double-Blind Period||0
10884749|NCT02963506|12050767|FG005|NOT COMPLETED|Double-Blind Period||0
10884750|NCT02963506|12050768|FG006|NOT COMPLETED|Double-Blind Period||0
10884751|NCT02963506|12050769|FG007|NOT COMPLETED|Double-Blind Period||0
10884752|NCT02963506|12050770|FG008|NOT COMPLETED|Double-Blind Period||0
10884753|NCT02963506|12050771|FG009|NOT COMPLETED|Double-Blind Period||0
10884754|NCT02963506|12050772|FG010|NOT COMPLETED|Double-Blind Period||0
10884755|NCT02963506|12050773|FG011|NOT COMPLETED|Double-Blind Period||0
10884756|NCT02963506|12050774|FG012|NOT COMPLETED|Double-Blind Period||0
10884757|NCT02963506|12050762|FG000|STARTED|Dose-Blind Period||0
10884758|NCT02963506|12050763|FG001|STARTED|Dose-Blind Period||0
10884759|NCT02963506|12050764|FG002|STARTED|Dose-Blind Period||0
10884760|NCT02963506|12050765|FG003|STARTED|Dose-Blind Period||0
10884761|NCT02963506|12050766|FG004|STARTED|Dose-Blind Period||0
10884762|NCT02963506|12050767|FG005|STARTED|Dose-Blind Period||24
10884763|NCT02963506|12050768|FG006|STARTED|Dose-Blind Period||36
10884764|NCT02963506|12050769|FG007|STARTED|Dose-Blind Period||31
10884765|NCT02963506|12050770|FG008|STARTED|Dose-Blind Period||27
10884766|NCT02963506|12050771|FG009|STARTED|Dose-Blind Period||34
10884767|NCT02963506|12050772|FG010|STARTED|Dose-Blind Period||25
10884768|NCT02963506|12050773|FG011|STARTED|Dose-Blind Period||58
10884769|NCT02963506|12050774|FG012|STARTED|Dose-Blind Period||61
10884770|NCT02963506|12050762|FG000|COMPLETED|Dose-Blind Period||0
10884771|NCT02963506|12050763|FG001|COMPLETED|Dose-Blind Period||0
10884772|NCT02963506|12050764|FG002|COMPLETED|Dose-Blind Period||0
10884773|NCT02963506|12050765|FG003|COMPLETED|Dose-Blind Period||0
10884774|NCT02963506|12050766|FG004|COMPLETED|Dose-Blind Period||0
10884775|NCT02963506|12050767|FG005|COMPLETED|Dose-Blind Period||20
10884776|NCT02963506|12050768|FG006|COMPLETED|Dose-Blind Period||31
10884777|NCT02963506|12050769|FG007|COMPLETED|Dose-Blind Period||26
10884778|NCT02963506|12050770|FG008|COMPLETED|Dose-Blind Period||24
10884779|NCT02963506|12050771|FG009|COMPLETED|Dose-Blind Period||30
10884780|NCT02963506|12050772|FG010|COMPLETED|Dose-Blind Period||24
10884781|NCT02963506|12050773|FG011|COMPLETED|Dose-Blind Period||56
10884782|NCT02963506|12050774|FG012|COMPLETED|Dose-Blind Period||54
10884783|NCT02963506|12050762|FG000|NOT COMPLETED|Dose-Blind Period||0
10884784|NCT02963506|12050763|FG001|NOT COMPLETED|Dose-Blind Period||0
10884785|NCT02963506|12050764|FG002|NOT COMPLETED|Dose-Blind Period||0
10884786|NCT02963506|12050765|FG003|NOT COMPLETED|Dose-Blind Period||0
10884787|NCT02963506|12050766|FG004|NOT COMPLETED|Dose-Blind Period||0
10884788|NCT02963506|12050767|FG005|NOT COMPLETED|Dose-Blind Period||4
10884789|NCT02963506|12050768|FG006|NOT COMPLETED|Dose-Blind Period||5
10884790|NCT02963506|12050769|FG007|NOT COMPLETED|Dose-Blind Period||5
10884791|NCT02963506|12050770|FG008|NOT COMPLETED|Dose-Blind Period||3
10884792|NCT02963506|12050771|FG009|NOT COMPLETED|Dose-Blind Period||4
10884793|NCT02963506|12050772|FG010|NOT COMPLETED|Dose-Blind Period||1
10884794|NCT02963506|12050773|FG011|NOT COMPLETED|Dose-Blind Period||2
10884795|NCT02963506|12050774|FG012|NOT COMPLETED|Dose-Blind Period||7
10884796|NCT02963090|12050794|FG000|STARTED|Overall Study||1
10884797|NCT02963090|12050795|FG001|STARTED|Overall Study||6
10884798|NCT02963090|12050796|FG002|STARTED|Overall Study||2
10884799|NCT02963090|12050794|FG000|COMPLETED|Overall Study||1
10884800|NCT02963090|12050795|FG001|COMPLETED|Overall Study||6
10884801|NCT02963090|12050796|FG002|COMPLETED|Overall Study||2
10884802|NCT02963090|12050794|FG000|NOT COMPLETED|Overall Study||0
10884803|NCT02963090|12050795|FG001|NOT COMPLETED|Overall Study||0
10884804|NCT02963090|12050796|FG002|NOT COMPLETED|Overall Study||0
10884805|NCT02954887|12050803|FG000|STARTED|Overall Study||9
10884806|NCT02954887|12050803|FG000|COMPLETED|Overall Study||2
10884807|NCT02954887|12050803|FG000|NOT COMPLETED|Overall Study||7
10884808|NCT02953548|12050807|FG000|STARTED|Overall Study||5
10884809|NCT02953548|12050808|FG001|STARTED|Overall Study||4
10884810|NCT02953548|12050807|FG000|COMPLETED|Overall Study||5
10884811|NCT02953548|12050808|FG001|COMPLETED|Overall Study||4
10884812|NCT02953548|12050807|FG000|NOT COMPLETED|Overall Study||0
10884813|NCT02953548|12050808|FG001|NOT COMPLETED|Overall Study||0
10884814|NCT02951767|12050815|FG000|STARTED|Overall Study||119
10884815|NCT02951767|12050815|FG000|COMPLETED|Overall Study||0
10884816|NCT02951767|12050815|FG000|NOT COMPLETED|Overall Study||119
10884817|NCT02950818|12050821|FG000|STARTED|Overall Study||228
10884818|NCT02950818|12050822|FG001|STARTED|Overall Study||225
10884819|NCT02950818|12050821|FG000|COMPLETED|Overall Study||161
10884820|NCT02950818|12050822|FG001|COMPLETED|Overall Study||201
10884821|NCT02950818|12050821|FG000|NOT COMPLETED|Overall Study||67
10884822|NCT02950818|12050822|FG001|NOT COMPLETED|Overall Study||24
10884823|NCT02949128|12050829|FG000|STARTED|Initial Evaluation Period||58
10884824|NCT02949128|12050829|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||58
10884825|NCT02949128|12050829|FG000|COMPLETED|Initial Evaluation Period||49
10884826|NCT02949128|12050829|FG000|NOT COMPLETED|Initial Evaluation Period||9
10884827|NCT02949128|12050829|FG000|STARTED|Extension Period||49
10884828|NCT02949128|12050829|FG000|Received At Least 1 Dose of Study Drug|Extension Period||47
10884829|NCT02949128|12050829|FG000|COMPLETED|Extension Period||0
10884830|NCT02949128|12050829|FG000|NOT COMPLETED|Extension Period||49
10884831|NCT02946931|12050833|FG000|STARTED|Overall Study||1402
10884832|NCT02946931|12050833|FG000|Case Report Forms (CRFs) Collected|Overall Study||814
10884833|NCT02946931|12050833|FG000|CRFs Valid|Overall Study||813
10884834|NCT02946931|12050833|FG000|COMPLETED|Overall Study||571
10884835|NCT02946931|12050833|FG000|NOT COMPLETED|Overall Study||831
10884836|NCT02946463|12050839|FG000|STARTED|Primary Evaluation Period||125
10884837|NCT02946463|12050840|FG001|STARTED|Primary Evaluation Period||121
10884838|NCT02946463|12050839|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125
10884839|NCT02946463|12050840|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121
10884840|NCT02946463|12050839|FG000|COMPLETED|Primary Evaluation Period||125
10884841|NCT02946463|12050840|FG001|COMPLETED|Primary Evaluation Period||119
10884842|NCT02946463|12050839|FG000|NOT COMPLETED|Primary Evaluation Period||0
10884843|NCT02946463|12050840|FG001|NOT COMPLETED|Primary Evaluation Period||2
10884844|NCT02946463|12050839|FG000|STARTED|Extension Period||124
10884845|NCT02946463|12050840|FG001|STARTED|Extension Period||119
10884846|NCT02946463|12050839|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||124
10884847|NCT02946463|12050840|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||119
10884848|NCT02946463|12050839|FG000|COMPLETED|Extension Period||0
10884849|NCT02946463|12050840|FG001|COMPLETED|Extension Period||0
10884850|NCT02946463|12050839|FG000|NOT COMPLETED|Extension Period||124
10884851|NCT02946463|12050840|FG001|NOT COMPLETED|Extension Period||119
10884852|NCT02944071|12050846|FG000|STARTED|Overall Study||123
10884853|NCT02944071|12050846|FG000|COMPLETED|Overall Study||113
10884854|NCT02944071|12050846|FG000|NOT COMPLETED|Overall Study||10
10884855|NCT02938520|12050852|FG000|STARTED|Overall Study||283
10884856|NCT02938520|12050853|FG001|STARTED|Overall Study||283
10884857|NCT02938520|12050852|FG000|COMPLETED|Overall Study||0
10884858|NCT02938520|12050853|FG001|COMPLETED|Overall Study||0
10884859|NCT02938520|12050852|FG000|NOT COMPLETED|Overall Study||283
10884860|NCT02938520|12050853|FG001|NOT COMPLETED|Overall Study||283
10884861|NCT02937818|12050866|FG000|STARTED|Overall Study||21
10884862|NCT02937818|12050867|FG001|STARTED|Overall Study||20
10884863|NCT02937818|12050868|FG002|STARTED|Overall Study||10
10884864|NCT02937818|12050869|FG003|STARTED|Overall Study||21
10884865|NCT02937818|12050866|FG000|COMPLETED|Overall Study||0
10884866|NCT02937818|12050867|FG001|COMPLETED|Overall Study||0
10884867|NCT02937818|12050868|FG002|COMPLETED|Overall Study||0
10884868|NCT02937818|12050869|FG003|COMPLETED|Overall Study||0
10884869|NCT02937818|12050866|FG000|NOT COMPLETED|Overall Study||21
10884870|NCT02937818|12050867|FG001|NOT COMPLETED|Overall Study||20
10884871|NCT02937818|12050868|FG002|NOT COMPLETED|Overall Study||10
10884872|NCT02937818|12050869|FG003|NOT COMPLETED|Overall Study||21
10884873|NCT02933489|12050884|FG000|STARTED|Overall Study||757
10884874|NCT02933489|12050885|FG001|STARTED|Overall Study||759
10884875|NCT02933489|12050884|FG000|DBTperformed|Overall Study||726
10884876|NCT02933489|12050885|FG001|DBTperformed|Overall Study||737
10884877|NCT02933489|12050884|FG000|AB MR Performed|Overall Study||713
10884878|NCT02933489|12050885|FG001|AB MR Performed|Overall Study||733
10884879|NCT02933489|12050884|FG000|COMPLETED|Overall Study||713
10884880|NCT02933489|12050885|FG001|COMPLETED|Overall Study||731
10884881|NCT02933489|12050884|FG000|NOT COMPLETED|Overall Study||44
10884882|NCT02933489|12050885|FG001|NOT COMPLETED|Overall Study||28
10884904|NCT02927080|12050941|FG000|STARTED|Overall Study||6
10884905|NCT02927080|12050942|FG001|STARTED|Overall Study||6
10884906|NCT02927080|12050943|FG002|STARTED|Overall Study||6
10884907|NCT02927080|12050944|FG003|STARTED|Overall Study||6
10884908|NCT02927080|12050945|FG004|STARTED|Overall Study||7
10884909|NCT02927080|12050946|FG005|STARTED|Overall Study||6
10884910|NCT02927080|12050947|FG006|STARTED|Overall Study||15
10884911|NCT02927080|12050948|FG007|STARTED|Overall Study||14
10884912|NCT02927080|12050949|FG008|STARTED|Overall Study||15
10884913|NCT02927080|12050950|FG009|STARTED|Overall Study||14
10884914|NCT02927080|12050941|FG000|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10884915|NCT02927080|12050942|FG001|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10884916|NCT02927080|12050943|FG002|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10884917|NCT02927080|12050944|FG003|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10884918|NCT02927080|12050945|FG004|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10884919|NCT02927080|12050946|FG005|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
10884920|NCT02927080|12050947|FG006|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
10884921|NCT02927080|12050948|FG007|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||13
10884922|NCT02927080|12050949|FG008|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
10884923|NCT02927080|12050950|FG009|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||12
10884924|NCT02927080|12050941|FG000|COMPLETED|Overall Study||6
10884925|NCT02927080|12050942|FG001|COMPLETED|Overall Study||5
10884926|NCT02927080|12050943|FG002|COMPLETED|Overall Study||6
10884927|NCT02927080|12050944|FG003|COMPLETED|Overall Study||6
10884928|NCT02927080|12050945|FG004|COMPLETED|Overall Study||6
10884929|NCT02927080|12050946|FG005|COMPLETED|Overall Study||6
10884930|NCT02927080|12050947|FG006|COMPLETED|Overall Study||7
10884931|NCT02927080|12050948|FG007|COMPLETED|Overall Study||5
10884932|NCT02927080|12050949|FG008|COMPLETED|Overall Study||12
10884933|NCT02927080|12050950|FG009|COMPLETED|Overall Study||7
10884934|NCT02927080|12050941|FG000|NOT COMPLETED|Overall Study||0
10884935|NCT02927080|12050942|FG001|NOT COMPLETED|Overall Study||1
10884936|NCT02927080|12050943|FG002|NOT COMPLETED|Overall Study||0
10884937|NCT02927080|12050944|FG003|NOT COMPLETED|Overall Study||0
10884938|NCT02927080|12050945|FG004|NOT COMPLETED|Overall Study||1
10884939|NCT02927080|12050946|FG005|NOT COMPLETED|Overall Study||0
10884940|NCT02927080|12050947|FG006|NOT COMPLETED|Overall Study||8
10884941|NCT02927080|12050948|FG007|NOT COMPLETED|Overall Study||9
10884942|NCT02927080|12050949|FG008|NOT COMPLETED|Overall Study||3
10884943|NCT02927080|12050950|FG009|NOT COMPLETED|Overall Study||7
10884944|NCT02923180|12050995|FG000|STARTED|Overall Study||32
10884945|NCT02923180|12050995|FG000|COMPLETED|Overall Study||6
10884946|NCT02923180|12050995|FG000|NOT COMPLETED|Overall Study||26
10884947|NCT02921919|12051001|FG000|STARTED|Overall Study||66
10884948|NCT02921919|12051002|FG001|STARTED|Overall Study||52
10884949|NCT02921919|12051001|FG000|Treated|Overall Study||66
10884950|NCT02921919|12051002|FG001|Treated|Overall Study||52
10884951|NCT02921919|12051001|FG000|COMPLETED|Overall Study||0
10884952|NCT02921919|12051002|FG001|COMPLETED|Overall Study||0
10884953|NCT02921919|12051001|FG000|NOT COMPLETED|Overall Study||66
10884954|NCT02921919|12051002|FG001|NOT COMPLETED|Overall Study||52
10884955|NCT02918721|12051008|FG000|STARTED|Overall Study||70
10884956|NCT02918721|12051008|FG000|COMPLETED|Overall Study||70
10884957|NCT02918721|12051008|FG000|NOT COMPLETED|Overall Study||0
10884958|NCT02918292|12051013|FG000|STARTED|Study Enrollment Prior to Transplant||32
10884959|NCT02918292|12051013|FG000|COMPLETED|Study Enrollment Prior to Transplant||31
10884960|NCT02918292|12051013|FG000|NOT COMPLETED|Study Enrollment Prior to Transplant||1
10884961|NCT02918292|12051013|FG000|STARTED|Study Follow up After Transplant||31
10884962|NCT02918292|12051013|FG000|COMPLETED|Study Follow up After Transplant||25
10884963|NCT02918292|12051013|FG000|NOT COMPLETED|Study Follow up After Transplant||6
10884964|NCT02908685|12051029|FG000|STARTED|Part 1 Exploratory||7
10884965|NCT02908685|12051030|FG001|STARTED|Part 1 Exploratory||7
10884966|NCT02908685|12051031|FG002|STARTED|Part 1 Exploratory||3
10884967|NCT02908685|12051032|FG003|STARTED|Part 1 Exploratory||3
10884968|NCT02908685|12051033|FG004|STARTED|Part 1 Exploratory||7
10884969|NCT02908685|12051034|FG005|STARTED|Part 1 Exploratory||7
10884970|NCT02908685|12051035|FG006|STARTED|Part 1 Exploratory||7
10884971|NCT02908685|12051036|FG007|STARTED|Part 1 Exploratory||3
10884972|NCT02908685|12051037|FG008|STARTED|Part 1 Exploratory||4
10884973|NCT02908685|12051038|FG009|STARTED|Part 1 Exploratory||3
10884974|NCT02908685|12051039|FG010|STARTED|Part 1 Exploratory||0
10884975|NCT02908685|12051040|FG011|STARTED|Part 1 Exploratory||0
10884976|NCT02908685|12051029|FG000|COMPLETED|Part 1 Exploratory||7
10884977|NCT02908685|12051030|FG001|COMPLETED|Part 1 Exploratory||6
10884978|NCT02908685|12051031|FG002|COMPLETED|Part 1 Exploratory||3
10884979|NCT02908685|12051032|FG003|COMPLETED|Part 1 Exploratory||3
10884980|NCT02908685|12051033|FG004|COMPLETED|Part 1 Exploratory||7
10884981|NCT02908685|12051034|FG005|COMPLETED|Part 1 Exploratory||7
10884982|NCT02908685|12051035|FG006|COMPLETED|Part 1 Exploratory||7
10884983|NCT02908685|12051036|FG007|COMPLETED|Part 1 Exploratory||3
10884984|NCT02908685|12051037|FG008|COMPLETED|Part 1 Exploratory||4
10884985|NCT02908685|12051038|FG009|COMPLETED|Part 1 Exploratory||3
10884986|NCT02908685|12051039|FG010|COMPLETED|Part 1 Exploratory||0
10884987|NCT02908685|12051040|FG011|COMPLETED|Part 1 Exploratory||0
10884988|NCT02908685|12051029|FG000|NOT COMPLETED|Part 1 Exploratory||0
10884989|NCT02908685|12051030|FG001|NOT COMPLETED|Part 1 Exploratory||1
10884990|NCT02908685|12051031|FG002|NOT COMPLETED|Part 1 Exploratory||0
10884991|NCT02908685|12051032|FG003|NOT COMPLETED|Part 1 Exploratory||0
10884992|NCT02908685|12051033|FG004|NOT COMPLETED|Part 1 Exploratory||0
10884993|NCT02908685|12051034|FG005|NOT COMPLETED|Part 1 Exploratory||0
10884994|NCT02908685|12051035|FG006|NOT COMPLETED|Part 1 Exploratory||0
10884995|NCT02908685|12051036|FG007|NOT COMPLETED|Part 1 Exploratory||0
10884996|NCT02908685|12051037|FG008|NOT COMPLETED|Part 1 Exploratory||0
10884997|NCT02908685|12051038|FG009|NOT COMPLETED|Part 1 Exploratory||0
10884998|NCT02908685|12051039|FG010|NOT COMPLETED|Part 1 Exploratory||0
10884999|NCT02908685|12051040|FG011|NOT COMPLETED|Part 1 Exploratory||0
10885000|NCT02908685|12051029|FG000|STARTED|Part 2 Confirmatory||0
10885001|NCT02908685|12051030|FG001|STARTED|Part 2 Confirmatory||0
10885002|NCT02908685|12051031|FG002|STARTED|Part 2 Confirmatory||0
10885003|NCT02908685|12051032|FG003|STARTED|Part 2 Confirmatory||0
10885004|NCT02908685|12051033|FG004|STARTED|Part 2 Confirmatory||0
10885005|NCT02908685|12051034|FG005|STARTED|Part 2 Confirmatory||0
10885006|NCT02908685|12051035|FG006|STARTED|Part 2 Confirmatory||0
10885007|NCT02908685|12051036|FG007|STARTED|Part 2 Confirmatory||0
10885008|NCT02908685|12051037|FG008|STARTED|Part 2 Confirmatory||0
10885009|NCT02908685|12051038|FG009|STARTED|Part 2 Confirmatory||0
10885010|NCT02908685|12051039|FG010|STARTED|Part 2 Confirmatory||120
10885011|NCT02908685|12051040|FG011|STARTED|Part 2 Confirmatory||60
10885012|NCT02908685|12051029|FG000|COMPLETED|Part 2 Confirmatory||0
10885013|NCT02908685|12051030|FG001|COMPLETED|Part 2 Confirmatory||0
10885014|NCT02908685|12051031|FG002|COMPLETED|Part 2 Confirmatory||0
10885015|NCT02908685|12051032|FG003|COMPLETED|Part 2 Confirmatory||0
10885016|NCT02908685|12051033|FG004|COMPLETED|Part 2 Confirmatory||0
10885017|NCT02908685|12051034|FG005|COMPLETED|Part 2 Confirmatory||0
10885018|NCT02908685|12051035|FG006|COMPLETED|Part 2 Confirmatory||0
10885019|NCT02908685|12051036|FG007|COMPLETED|Part 2 Confirmatory||0
10885020|NCT02908685|12051037|FG008|COMPLETED|Part 2 Confirmatory||0
10885021|NCT02908685|12051038|FG009|COMPLETED|Part 2 Confirmatory||0
10885022|NCT02908685|12051039|FG010|COMPLETED|Part 2 Confirmatory||117
10885023|NCT02908685|12051040|FG011|COMPLETED|Part 2 Confirmatory||59
10885024|NCT02908685|12051029|FG000|NOT COMPLETED|Part 2 Confirmatory||0
10885025|NCT02908685|12051030|FG001|NOT COMPLETED|Part 2 Confirmatory||0
10885026|NCT02908685|12051031|FG002|NOT COMPLETED|Part 2 Confirmatory||0
10885027|NCT02908685|12051032|FG003|NOT COMPLETED|Part 2 Confirmatory||0
10885028|NCT02908685|12051033|FG004|NOT COMPLETED|Part 2 Confirmatory||0
10885029|NCT02908685|12051034|FG005|NOT COMPLETED|Part 2 Confirmatory||0
10885030|NCT02908685|12051035|FG006|NOT COMPLETED|Part 2 Confirmatory||0
10885031|NCT02908685|12051036|FG007|NOT COMPLETED|Part 2 Confirmatory||0
10885032|NCT02908685|12051037|FG008|NOT COMPLETED|Part 2 Confirmatory||0
10885033|NCT02908685|12051038|FG009|NOT COMPLETED|Part 2 Confirmatory||0
10885034|NCT02908685|12051039|FG010|NOT COMPLETED|Part 2 Confirmatory||3
10885035|NCT02908685|12051040|FG011|NOT COMPLETED|Part 2 Confirmatory||1
10885036|NCT02908672|12051059|FG000|STARTED|Overall Study||258
10885037|NCT02908672|12051060|FG001|STARTED|Overall Study||256
10885038|NCT02908672|12051059|FG000|COMPLETED|Overall Study||0
10885039|NCT02908672|12051060|FG001|COMPLETED|Overall Study||0
10885040|NCT02908672|12051059|FG000|NOT COMPLETED|Overall Study||258
10885041|NCT02908672|12051060|FG001|NOT COMPLETED|Overall Study||256
10885042|NCT02903914|12051074|FG000|STARTED|Overall Study||8
10885043|NCT02903914|12051075|FG001|STARTED|Overall Study||7
10885044|NCT02903914|12051076|FG002|STARTED|Overall Study||85
10885045|NCT02903914|12051077|FG003|STARTED|Overall Study||7
10885046|NCT02903914|12051078|FG004|STARTED|Overall Study||10
10885047|NCT02903914|12051079|FG005|STARTED|Overall Study||14
10885048|NCT02903914|12051080|FG006|STARTED|Overall Study||123
10885049|NCT02903914|12051081|FG007|STARTED|Overall Study||6
10885050|NCT02903914|12051074|FG000|COMPLETED|Overall Study||0
10885051|NCT02903914|12051075|FG001|COMPLETED|Overall Study||0
10885052|NCT02903914|12051076|FG002|COMPLETED|Overall Study||0
10885053|NCT02903914|12051077|FG003|COMPLETED|Overall Study||0
10885054|NCT02903914|12051078|FG004|COMPLETED|Overall Study||0
10885055|NCT02903914|12051079|FG005|COMPLETED|Overall Study||0
10885056|NCT02903914|12051080|FG006|COMPLETED|Overall Study||6
10885057|NCT02903914|12051081|FG007|COMPLETED|Overall Study||1
10885058|NCT02903914|12051074|FG000|NOT COMPLETED|Overall Study||8
10885059|NCT02903914|12051075|FG001|NOT COMPLETED|Overall Study||7
10885060|NCT02903914|12051076|FG002|NOT COMPLETED|Overall Study||85
10885061|NCT02903914|12051077|FG003|NOT COMPLETED|Overall Study||7
10885062|NCT02903914|12051078|FG004|NOT COMPLETED|Overall Study||10
10885063|NCT02903914|12051079|FG005|NOT COMPLETED|Overall Study||14
10885064|NCT02903914|12051080|FG006|NOT COMPLETED|Overall Study||117
10885065|NCT02903914|12051081|FG007|NOT COMPLETED|Overall Study||5
10885066|NCT02901548|12051101|FG000|STARTED|Overall Study||17
10885067|NCT02901548|12051101|FG000|COMPLETED|Overall Study||13
10885068|NCT02901548|12051101|FG000|NOT COMPLETED|Overall Study||4
10885069|NCT02899299|12051107|FG000|STARTED|Pre-treatment||303
10885070|NCT02899299|12051108|FG001|STARTED|Pre-treatment||302
10885071|NCT02899299|12051107|FG000|COMPLETED|Pre-treatment||300
10885072|NCT02899299|12051108|FG001|COMPLETED|Pre-treatment||284
10885073|NCT02899299|12051107|FG000|NOT COMPLETED|Pre-treatment||3
10885074|NCT02899299|12051108|FG001|NOT COMPLETED|Pre-treatment||18
10885075|NCT02899299|12051107|FG000|STARTED|Treatment||300
10885076|NCT02899299|12051108|FG001|STARTED|Treatment||284
10885077|NCT02899299|12051107|FG000|COMPLETED|Treatment||5
10885078|NCT02899299|12051108|FG001|COMPLETED|Treatment||0
10885079|NCT02899299|12051107|FG000|NOT COMPLETED|Treatment||295
10885080|NCT02899299|12051108|FG001|NOT COMPLETED|Treatment||284
10885081|NCT02898259|12051119|FG000|STARTED|Overall Study||3
10885082|NCT02898259|12051120|FG001|STARTED|Overall Study||3
10885083|NCT02898259|12051121|FG002|STARTED|Overall Study||6
10885084|NCT02898259|12051122|FG003|STARTED|Overall Study||7
10885085|NCT02898259|12051123|FG004|STARTED|Overall Study||0
10885086|NCT02898259|12051119|FG000|COMPLETED|Overall Study||2
10885087|NCT02898259|12051120|FG001|COMPLETED|Overall Study||2
10885088|NCT02898259|12051121|FG002|COMPLETED|Overall Study||1
10885089|NCT02898259|12051122|FG003|COMPLETED|Overall Study||6
10885090|NCT02898259|12051123|FG004|COMPLETED|Overall Study||0
10885091|NCT02898259|12051119|FG000|NOT COMPLETED|Overall Study||1
10885092|NCT02898259|12051120|FG001|NOT COMPLETED|Overall Study||1
10885093|NCT02898259|12051121|FG002|NOT COMPLETED|Overall Study||5
10885094|NCT02898259|12051122|FG003|NOT COMPLETED|Overall Study||1
10885095|NCT02898259|12051123|FG004|NOT COMPLETED|Overall Study||0
10885096|NCT02893930|12051136|FG000|STARTED|Overall Study||13
10885097|NCT02893930|12051136|FG000|Eligible and Treated|Overall Study||12
10885098|NCT02893930|12051136|FG000|COMPLETED|Overall Study||0
10885099|NCT02893930|12051136|FG000|NOT COMPLETED|Overall Study||13
10885100|NCT02893423|12051143|FG000|STARTED|Overall Study||17
10885101|NCT02893423|12051144|FG001|STARTED|Overall Study||16
10885102|NCT02893423|12051145|FG002|STARTED|Overall Study||18
10885103|NCT02893423|12051143|FG000|COMPLETED|Overall Study||17
10885104|NCT02893423|12051144|FG001|COMPLETED|Overall Study||16
10885105|NCT02893423|12051145|FG002|COMPLETED|Overall Study||18
10885106|NCT02893423|12051143|FG000|NOT COMPLETED|Overall Study||0
10885107|NCT02893423|12051144|FG001|NOT COMPLETED|Overall Study||0
10885108|NCT02893423|12051145|FG002|NOT COMPLETED|Overall Study||0
10885109|NCT02891226|12051157|FG000|STARTED|Period 1 (Weeks 0 to 12)||64
10885110|NCT02891226|12051158|FG001|STARTED|Period 1 (Weeks 0 to 12)||31
10885111|NCT02891226|12051159|FG002|STARTED|Period 1 (Weeks 0 to 12)||32
10885112|NCT02891226|12051160|FG003|STARTED|Period 1 (Weeks 0 to 12)||64
10885113|NCT02891226|12051161|FG004|STARTED|Period 1 (Weeks 0 to 12)||0
10885114|NCT02891226|12051162|FG005|STARTED|Period 1 (Weeks 0 to 12)||0
10885115|NCT02891226|12051163|FG006|STARTED|Period 1 (Weeks 0 to 12)||0
10885116|NCT02891226|12051164|FG007|STARTED|Period 1 (Weeks 0 to 12)||0
10885117|NCT02891226|12051165|FG008|STARTED|Period 1 (Weeks 0 to 12)||0
10885118|NCT02891226|12051166|FG009|STARTED|Period 1 (Weeks 0 to 12)||0
10885119|NCT02891226|12051167|FG010|STARTED|Period 1 (Weeks 0 to 12)||0
10885120|NCT02891226|12051168|FG011|STARTED|Period 1 (Weeks 0 to 12)||0
10885121|NCT02891226|12051169|FG012|STARTED|Period 1 (Weeks 0 to 12)||0
10885122|NCT02891226|12051170|FG013|STARTED|Period 1 (Weeks 0 to 12)||0
10885123|NCT02891226|12051171|FG014|STARTED|Period 1 (Weeks 0 to 12)||0
10885124|NCT02891226|12051172|FG015|STARTED|Period 1 (Weeks 0 to 12)||0
10885125|NCT02891226|12051157|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64
10885126|NCT02891226|12051158|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||31
10885127|NCT02891226|12051159|FG002|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||32
10885128|NCT02891226|12051160|FG003|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64
10885129|NCT02891226|12051161|FG004|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885130|NCT02891226|12051162|FG005|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885131|NCT02891226|12051163|FG006|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885132|NCT02891226|12051164|FG007|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885133|NCT02891226|12051165|FG008|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885134|NCT02891226|12051166|FG009|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885135|NCT02891226|12051167|FG010|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885136|NCT02891226|12051168|FG011|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885137|NCT02891226|12051169|FG012|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885138|NCT02891226|12051170|FG013|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885139|NCT02891226|12051171|FG014|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885140|NCT02891226|12051172|FG015|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
10885141|NCT02891226|12051157|FG000|COMPLETED|Period 1 (Weeks 0 to 12)||59
10885142|NCT02891226|12051158|FG001|COMPLETED|Period 1 (Weeks 0 to 12)||29
10885143|NCT02891226|12051159|FG002|COMPLETED|Period 1 (Weeks 0 to 12)||28
10885144|NCT02891226|12051160|FG003|COMPLETED|Period 1 (Weeks 0 to 12)||60
10885145|NCT02891226|12051161|FG004|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885146|NCT02891226|12051162|FG005|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885147|NCT02891226|12051163|FG006|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885148|NCT02891226|12051164|FG007|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885149|NCT02891226|12051165|FG008|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885150|NCT02891226|12051166|FG009|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885151|NCT02891226|12051167|FG010|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885152|NCT02891226|12051168|FG011|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885153|NCT02891226|12051169|FG012|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885154|NCT02891226|12051170|FG013|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885155|NCT02891226|12051171|FG014|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885156|NCT02891226|12051172|FG015|COMPLETED|Period 1 (Weeks 0 to 12)||0
10885157|NCT02891226|12051157|FG000|NOT COMPLETED|Period 1 (Weeks 0 to 12)||5
10885158|NCT02891226|12051158|FG001|NOT COMPLETED|Period 1 (Weeks 0 to 12)||2
10885159|NCT02891226|12051159|FG002|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4
10885160|NCT02891226|12051160|FG003|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4
10885161|NCT02891226|12051161|FG004|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885162|NCT02891226|12051162|FG005|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885163|NCT02891226|12051163|FG006|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885164|NCT02891226|12051164|FG007|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885165|NCT02891226|12051165|FG008|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885166|NCT02891226|12051166|FG009|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885167|NCT02891226|12051167|FG010|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885168|NCT02891226|12051168|FG011|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885169|NCT02891226|12051169|FG012|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885170|NCT02891226|12051170|FG013|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885171|NCT02891226|12051171|FG014|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885172|NCT02891226|12051172|FG015|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
10885173|NCT02891226|12051157|FG000|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
10885174|NCT02891226|12051158|FG001|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
10885175|NCT02891226|12051159|FG002|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
10885176|NCT02891226|12051160|FG003|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
10885177|NCT02891226|12051161|FG004|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|9
10885178|NCT02891226|12051162|FG005|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|9
10885179|NCT02891226|12051163|FG006|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|23
10885180|NCT02891226|12051164|FG007|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|46
10885181|NCT02891226|12051165|FG008|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|30
10885182|NCT02891226|12051166|FG009|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|59
10885183|NCT02891226|12051167|FG010|STARTED|Period 2 (Weeks 12 to 52)||0
10885184|NCT02891226|12051168|FG011|STARTED|Period 2 (Weeks 12 to 52)||0
10885185|NCT02891226|12051169|FG012|STARTED|Period 2 (Weeks 12 to 52)||0
10885186|NCT02891226|12051170|FG013|STARTED|Period 2 (Weeks 12 to 52)||0
10885187|NCT02891226|12051171|FG014|STARTED|Period 2 (Weeks 12 to 52)||0
10885188|NCT02891226|12051172|FG015|STARTED|Period 2 (Weeks 12 to 52)||0
10885189|NCT02891226|12051157|FG000|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885190|NCT02891226|12051158|FG001|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885191|NCT02891226|12051159|FG002|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885192|NCT02891226|12051160|FG003|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885193|NCT02891226|12051161|FG004|COMPLETED|Period 2 (Weeks 12 to 52)||8
10885194|NCT02891226|12051162|FG005|COMPLETED|Period 2 (Weeks 12 to 52)||8
10885195|NCT02891226|12051163|FG006|COMPLETED|Period 2 (Weeks 12 to 52)||20
10885196|NCT02891226|12051164|FG007|COMPLETED|Period 2 (Weeks 12 to 52)||41
10885197|NCT02891226|12051165|FG008|COMPLETED|Period 2 (Weeks 12 to 52)||24
10885198|NCT02891226|12051166|FG009|COMPLETED|Period 2 (Weeks 12 to 52)||42
10885199|NCT02891226|12051167|FG010|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885200|NCT02891226|12051168|FG011|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885201|NCT02891226|12051169|FG012|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885202|NCT02891226|12051170|FG013|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885203|NCT02891226|12051171|FG014|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885204|NCT02891226|12051172|FG015|COMPLETED|Period 2 (Weeks 12 to 52)||0
10885205|NCT02891226|12051157|FG000|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885206|NCT02891226|12051158|FG001|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885207|NCT02891226|12051159|FG002|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885208|NCT02891226|12051160|FG003|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885209|NCT02891226|12051161|FG004|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1
10885210|NCT02891226|12051162|FG005|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1
10885211|NCT02891226|12051163|FG006|NOT COMPLETED|Period 2 (Weeks 12 to 52)||3
10885212|NCT02891226|12051164|FG007|NOT COMPLETED|Period 2 (Weeks 12 to 52)||5
10885213|NCT02891226|12051165|FG008|NOT COMPLETED|Period 2 (Weeks 12 to 52)||6
10885214|NCT02891226|12051166|FG009|NOT COMPLETED|Period 2 (Weeks 12 to 52)||17
10885215|NCT02891226|12051167|FG010|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885216|NCT02891226|12051168|FG011|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885217|NCT02891226|12051169|FG012|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885218|NCT02891226|12051170|FG013|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885219|NCT02891226|12051171|FG014|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885220|NCT02891226|12051172|FG015|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
10885221|NCT02891226|12051157|FG000|STARTED|Period 3 (Weeks 52 to 208)||0
10885222|NCT02891226|12051158|FG001|STARTED|Period 3 (Weeks 52 to 208)||0
10885223|NCT02891226|12051159|FG002|STARTED|Period 3 (Weeks 52 to 208)||0
10885224|NCT02891226|12051160|FG003|STARTED|Period 3 (Weeks 52 to 208)||0
10885225|NCT02891226|12051161|FG004|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10885226|NCT02891226|12051162|FG005|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10885227|NCT02891226|12051163|FG006|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10885228|NCT02891226|12051164|FG007|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10885229|NCT02891226|12051165|FG008|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10885230|NCT02891226|12051166|FG009|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
10885231|NCT02891226|12051167|FG010|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 3.|137
10885232|NCT02891226|12051168|FG011|STARTED|Period 3 (Weeks 52 to 208)||0
10885233|NCT02891226|12051169|FG012|STARTED|Period 3 (Weeks 52 to 208)||0
10885234|NCT02891226|12051170|FG013|STARTED|Period 3 (Weeks 52 to 208)||0
10885235|NCT02891226|12051171|FG014|STARTED|Period 3 (Weeks 52 to 208)||0
10885236|NCT02891226|12051172|FG015|STARTED|Period 3 (Weeks 52 to 208)||0
10885237|NCT02891226|12051157|FG000|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885238|NCT02891226|12051158|FG001|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885239|NCT02891226|12051159|FG002|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885240|NCT02891226|12051160|FG003|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885241|NCT02891226|12051161|FG004|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885242|NCT02891226|12051162|FG005|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885243|NCT02891226|12051163|FG006|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885244|NCT02891226|12051164|FG007|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885245|NCT02891226|12051165|FG008|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885246|NCT02891226|12051166|FG009|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885247|NCT02891226|12051167|FG010|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885248|NCT02891226|12051168|FG011|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885249|NCT02891226|12051169|FG012|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885250|NCT02891226|12051170|FG013|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885251|NCT02891226|12051171|FG014|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885252|NCT02891226|12051172|FG015|COMPLETED|Period 3 (Weeks 52 to 208)||0
10885253|NCT02891226|12051157|FG000|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885254|NCT02891226|12051158|FG001|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885255|NCT02891226|12051159|FG002|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885256|NCT02891226|12051160|FG003|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885257|NCT02891226|12051161|FG004|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885258|NCT02891226|12051162|FG005|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885259|NCT02891226|12051163|FG006|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885260|NCT02891226|12051164|FG007|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885261|NCT02891226|12051165|FG008|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885262|NCT02891226|12051166|FG009|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885263|NCT02891226|12051167|FG010|NOT COMPLETED|Period 3 (Weeks 52 to 208)||137
10885264|NCT02891226|12051168|FG011|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885265|NCT02891226|12051169|FG012|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885266|NCT02891226|12051170|FG013|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885267|NCT02891226|12051171|FG014|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885268|NCT02891226|12051172|FG015|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
10885269|NCT02891226|12051157|FG000|STARTED|Follow-up Period||0
10885270|NCT02891226|12051158|FG001|STARTED|Follow-up Period||0
10885271|NCT02891226|12051159|FG002|STARTED|Follow-up Period||0
10885272|NCT02891226|12051160|FG003|STARTED|Follow-up Period||0
10885273|NCT02891226|12051161|FG004|STARTED|Follow-up Period||0
10885274|NCT02891226|12051162|FG005|STARTED|Follow-up Period||0
10885275|NCT02891226|12051163|FG006|STARTED|Follow-up Period||0
10885276|NCT02891226|12051164|FG007|STARTED|Follow-up Period||0
10885277|NCT02891226|12051165|FG008|STARTED|Follow-up Period||0
10885278|NCT02891226|12051166|FG009|STARTED|Follow-up Period||0
10885279|NCT02891226|12051167|FG010|STARTED|Follow-up Period||0
10885280|NCT02891226|12051168|FG011|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
10885281|NCT02891226|12051169|FG012|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|2
10885282|NCT02891226|12051170|FG013|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
10885283|NCT02891226|12051171|FG014|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
10885284|NCT02891226|12051172|FG015|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|3
10885285|NCT02891226|12051157|FG000|COMPLETED|Follow-up Period||0
10885286|NCT02891226|12051158|FG001|COMPLETED|Follow-up Period||0
10885287|NCT02891226|12051159|FG002|COMPLETED|Follow-up Period||0
10885288|NCT02891226|12051160|FG003|COMPLETED|Follow-up Period||0
10885289|NCT02891226|12051161|FG004|COMPLETED|Follow-up Period||0
10885290|NCT02891226|12051162|FG005|COMPLETED|Follow-up Period||0
10885291|NCT02891226|12051163|FG006|COMPLETED|Follow-up Period||0
10885292|NCT02891226|12051164|FG007|COMPLETED|Follow-up Period||0
10885293|NCT02891226|12051165|FG008|COMPLETED|Follow-up Period||0
10885294|NCT02891226|12051166|FG009|COMPLETED|Follow-up Period||0
10885295|NCT02891226|12051167|FG010|COMPLETED|Follow-up Period||0
10885296|NCT02891226|12051168|FG011|COMPLETED|Follow-up Period||0
10885297|NCT02891226|12051169|FG012|COMPLETED|Follow-up Period||2
10885298|NCT02891226|12051170|FG013|COMPLETED|Follow-up Period||1
10885299|NCT02891226|12051171|FG014|COMPLETED|Follow-up Period||0
10885300|NCT02891226|12051172|FG015|COMPLETED|Follow-up Period||2
10885301|NCT02891226|12051157|FG000|NOT COMPLETED|Follow-up Period||0
10885302|NCT02891226|12051158|FG001|NOT COMPLETED|Follow-up Period||0
10885303|NCT02891226|12051159|FG002|NOT COMPLETED|Follow-up Period||0
10885304|NCT02891226|12051160|FG003|NOT COMPLETED|Follow-up Period||0
10885305|NCT02891226|12051161|FG004|NOT COMPLETED|Follow-up Period||0
10885306|NCT02891226|12051162|FG005|NOT COMPLETED|Follow-up Period||0
10885307|NCT02891226|12051163|FG006|NOT COMPLETED|Follow-up Period||0
10885308|NCT02891226|12051164|FG007|NOT COMPLETED|Follow-up Period||0
10885309|NCT02891226|12051165|FG008|NOT COMPLETED|Follow-up Period||0
10885310|NCT02891226|12051166|FG009|NOT COMPLETED|Follow-up Period||0
10885311|NCT02891226|12051167|FG010|NOT COMPLETED|Follow-up Period||0
10885312|NCT02891226|12051168|FG011|NOT COMPLETED|Follow-up Period||1
10885313|NCT02891226|12051169|FG012|NOT COMPLETED|Follow-up Period||0
10885314|NCT02891226|12051170|FG013|NOT COMPLETED|Follow-up Period||0
10885315|NCT02891226|12051171|FG014|NOT COMPLETED|Follow-up Period||1
10885316|NCT02891226|12051172|FG015|NOT COMPLETED|Follow-up Period||1
10885317|NCT02890355|12051198|FG000|STARTED|Overall Study||59
10885318|NCT02890355|12051199|FG001|STARTED|Overall Study||58
10885319|NCT02890355|12051198|FG000|Treated & Assessed for AEs|Overall Study||56
10885320|NCT02890355|12051199|FG001|Treated & Assessed for AEs|Overall Study||50
10885321|NCT02890355|12051198|FG000|COMPLETED|Overall Study||0
10885322|NCT02890355|12051199|FG001|COMPLETED|Overall Study||0
10885323|NCT02890355|12051198|FG000|NOT COMPLETED|Overall Study||59
10885324|NCT02890355|12051199|FG001|NOT COMPLETED|Overall Study||58
10885325|NCT02885324|12051207|FG000|STARTED|Overall Study||4
10885326|NCT02885324|12051207|FG000|COMPLETED|Overall Study||4
10885327|NCT02885324|12051207|FG000|NOT COMPLETED|Overall Study||0
10885328|NCT02883673|12051211|FG000|STARTED|Overall Study||107
10885329|NCT02883673|12051211|FG000|COMPLETED|Overall Study||107
10885330|NCT02883673|12051211|FG000|NOT COMPLETED|Overall Study||0
10885331|NCT02880956|12051220|FG000|STARTED|Overall Study||116
10885332|NCT02880956|12051221|FG001|STARTED|Overall Study||108
10885333|NCT02880956|12051222|FG002|STARTED|Overall Study||116
10885334|NCT02880956|12051223|FG003|STARTED|Overall Study||113
10885335|NCT02880956|12051220|FG000|COMPLETED|Overall Study||99
10885336|NCT02880956|12051221|FG001|COMPLETED|Overall Study||93
10885337|NCT02880956|12051222|FG002|COMPLETED|Overall Study||105
10885338|NCT02880956|12051223|FG003|COMPLETED|Overall Study||95
10885339|NCT02880956|12051220|FG000|NOT COMPLETED|Overall Study||17
10885340|NCT02880956|12051221|FG001|NOT COMPLETED|Overall Study||15
10885341|NCT02880956|12051222|FG002|NOT COMPLETED|Overall Study||11
10885342|NCT02880956|12051223|FG003|NOT COMPLETED|Overall Study||18
10885343|NCT02879318|12051238|FG000|STARTED|Overall Study||61
10885344|NCT02879318|12051239|FG001|STARTED|Overall Study||119
10885345|NCT02879318|12051238|FG000|COMPLETED|Overall Study||61
10885346|NCT02879318|12051239|FG001|COMPLETED|Overall Study||119
10885347|NCT02879318|12051238|FG000|NOT COMPLETED|Overall Study||0
10885348|NCT02879318|12051239|FG001|NOT COMPLETED|Overall Study||0
10885349|NCT02876328|12051269|FG000|STARTED|Overall Study||396
10885350|NCT02876328|12051270|FG001|STARTED|Overall Study||221
10885351|NCT02876328|12051271|FG002|STARTED|Overall Study||395
10885352|NCT02876328|12051272|FG003|STARTED|Overall Study||197
10885353|NCT02876328|12051273|FG004|STARTED|Overall Study||191
10885354|NCT02876328|12051274|FG005|STARTED|Overall Study||403
10885355|NCT02876328|12051275|FG006|STARTED|Overall Study||179
10885356|NCT02876328|12051276|FG007|STARTED|Overall Study||407
10885357|NCT02876328|12051277|FG008|STARTED|Overall Study||202
10885358|NCT02876328|12051278|FG009|STARTED|Overall Study||210
10885359|NCT02876328|12051279|FG010|STARTED|Overall Study||187
10885360|NCT02876328|12051280|FG011|STARTED|Overall Study||99
10885361|NCT02876328|12051281|FG012|STARTED|Overall Study||177
10885362|NCT02876328|12051282|FG013|STARTED|Overall Study||99
10885363|NCT02876328|12051283|FG014|STARTED|Overall Study||100
10885364|NCT02876328|12051284|FG015|STARTED|Overall Study||227
10885365|NCT02876328|12051285|FG016|STARTED|Overall Study||107
10885366|NCT02876328|12051286|FG017|STARTED|Overall Study||237
10885367|NCT02876328|12051287|FG018|STARTED|Overall Study||108
10885368|NCT02876328|12051288|FG019|STARTED|Overall Study||107
10885369|NCT02876328|12051289|FG020|STARTED|Overall Study||324
10885370|NCT02876328|12051290|FG021|STARTED|Overall Study||172
10885371|NCT02876328|12051291|FG022|STARTED|Overall Study||34
10885372|NCT02876328|12051292|FG023|STARTED|Overall Study||7
10885373|NCT02876328|12051269|FG000|COMPLETED|Overall Study||379
10885374|NCT02876328|12051270|FG001|COMPLETED|Overall Study||208
10885375|NCT02876328|12051271|FG002|COMPLETED|Overall Study||378
10885376|NCT02876328|12051272|FG003|COMPLETED|Overall Study||188
10885377|NCT02876328|12051273|FG004|COMPLETED|Overall Study||181
10885378|NCT02876328|12051274|FG005|COMPLETED|Overall Study||388
10885379|NCT02876328|12051275|FG006|COMPLETED|Overall Study||175
10885380|NCT02876328|12051276|FG007|COMPLETED|Overall Study||395
10885381|NCT02876328|12051277|FG008|COMPLETED|Overall Study||192
10885382|NCT02876328|12051278|FG009|COMPLETED|Overall Study||202
10885383|NCT02876328|12051279|FG010|COMPLETED|Overall Study||182
10885384|NCT02876328|12051280|FG011|COMPLETED|Overall Study||98
10885385|NCT02876328|12051281|FG012|COMPLETED|Overall Study||172
10885386|NCT02876328|12051282|FG013|COMPLETED|Overall Study||95
10885387|NCT02876328|12051283|FG014|COMPLETED|Overall Study||96
10885388|NCT02876328|12051284|FG015|COMPLETED|Overall Study||223
10885389|NCT02876328|12051285|FG016|COMPLETED|Overall Study||102
10885390|NCT02876328|12051286|FG017|COMPLETED|Overall Study||227
10885391|NCT02876328|12051287|FG018|COMPLETED|Overall Study||106
10885392|NCT02876328|12051288|FG019|COMPLETED|Overall Study||105
10885393|NCT02876328|12051289|FG020|COMPLETED|Overall Study||312
10885394|NCT02876328|12051290|FG021|COMPLETED|Overall Study||164
10885395|NCT02876328|12051291|FG022|COMPLETED|Overall Study||33
10885396|NCT02876328|12051292|FG023|COMPLETED|Overall Study||7
10885397|NCT02876328|12051269|FG000|NOT COMPLETED|Overall Study||17
10885398|NCT02876328|12051270|FG001|NOT COMPLETED|Overall Study||13
10885399|NCT02876328|12051271|FG002|NOT COMPLETED|Overall Study||17
10885400|NCT02876328|12051272|FG003|NOT COMPLETED|Overall Study||9
10885401|NCT02876328|12051273|FG004|NOT COMPLETED|Overall Study||10
10885402|NCT02876328|12051274|FG005|NOT COMPLETED|Overall Study||15
10885403|NCT02876328|12051275|FG006|NOT COMPLETED|Overall Study||4
10885404|NCT02876328|12051276|FG007|NOT COMPLETED|Overall Study||12
10885405|NCT02876328|12051277|FG008|NOT COMPLETED|Overall Study||10
10885406|NCT02876328|12051278|FG009|NOT COMPLETED|Overall Study||8
10885407|NCT02876328|12051279|FG010|NOT COMPLETED|Overall Study||5
10885408|NCT02876328|12051280|FG011|NOT COMPLETED|Overall Study||1
10885409|NCT02876328|12051281|FG012|NOT COMPLETED|Overall Study||5
10885410|NCT02876328|12051282|FG013|NOT COMPLETED|Overall Study||4
10885411|NCT02876328|12051283|FG014|NOT COMPLETED|Overall Study||4
10885412|NCT02876328|12051284|FG015|NOT COMPLETED|Overall Study||4
10885413|NCT02876328|12051285|FG016|NOT COMPLETED|Overall Study||5
10885414|NCT02876328|12051286|FG017|NOT COMPLETED|Overall Study||10
10885415|NCT02876328|12051287|FG018|NOT COMPLETED|Overall Study||2
10885416|NCT02876328|12051288|FG019|NOT COMPLETED|Overall Study||2
10885417|NCT02876328|12051289|FG020|NOT COMPLETED|Overall Study||12
10885418|NCT02876328|12051290|FG021|NOT COMPLETED|Overall Study||8
10885419|NCT02876328|12051291|FG022|NOT COMPLETED|Overall Study||1
10885420|NCT02876328|12051292|FG023|NOT COMPLETED|Overall Study||0
10885421|NCT02873975|12051321|FG000|STARTED|Overall Study||8
10885422|NCT02873975|12051322|FG001|STARTED|Overall Study||10
10885423|NCT02873975|12051323|FG002|STARTED|Overall Study||9
10885424|NCT02873975|12051321|FG000|COMPLETED|Overall Study||8
10885425|NCT02873975|12051322|FG001|COMPLETED|Overall Study||10
10885426|NCT02873975|12051323|FG002|COMPLETED|Overall Study||9
10885427|NCT02873975|12051321|FG000|NOT COMPLETED|Overall Study||0
10885428|NCT02873975|12051322|FG001|NOT COMPLETED|Overall Study||0
10885429|NCT02873975|12051323|FG002|NOT COMPLETED|Overall Study||0
10885430|NCT02872116|12051334|FG000|STARTED|Pre-Treatment||789
10885431|NCT02872116|12051335|FG001|STARTED|Pre-Treatment||833
10885432|NCT02872116|12051336|FG002|STARTED|Pre-Treatment||409
10885433|NCT02872116|12051334|FG000|COMPLETED|Pre-Treatment||782
10885434|NCT02872116|12051335|FG001|COMPLETED|Pre-Treatment||806
10885435|NCT02872116|12051336|FG002|COMPLETED|Pre-Treatment||403
10885436|NCT02872116|12051334|FG000|NOT COMPLETED|Pre-Treatment||7
10885437|NCT02872116|12051335|FG001|NOT COMPLETED|Pre-Treatment||27
10885438|NCT02872116|12051336|FG002|NOT COMPLETED|Pre-Treatment||6
10885439|NCT02872116|12051334|FG000|STARTED|Treatment||782
10885440|NCT02872116|12051335|FG001|STARTED|Treatment||806
10885441|NCT02872116|12051336|FG002|STARTED|Treatment||403
10885442|NCT02872116|12051334|FG000|COMPLETED|Treatment||623
10885443|NCT02872116|12051335|FG001|COMPLETED|Treatment||653
10885444|NCT02872116|12051336|FG002|COMPLETED|Treatment||319
10885445|NCT02872116|12051334|FG000|NOT COMPLETED|Treatment||159
10885446|NCT02872116|12051335|FG001|NOT COMPLETED|Treatment||153
10885447|NCT02872116|12051336|FG002|NOT COMPLETED|Treatment||84
10885448|NCT02871791|12051351|FG000|STARTED|Phase 1b||6
10885449|NCT02871791|12051352|FG001|STARTED|Phase 1b||3
10885450|NCT02871791|12051351|FG000|COMPLETED|Phase 1b||0
10885451|NCT02871791|12051352|FG001|COMPLETED|Phase 1b||0
10885452|NCT02871791|12051351|FG000|NOT COMPLETED|Phase 1b||6
10885453|NCT02871791|12051352|FG001|NOT COMPLETED|Phase 1b||3
10885454|NCT02871791|12051351|FG000|STARTED|Phase 2||32
10885455|NCT02871791|12051352|FG001|STARTED|Phase 2||0
10885456|NCT02871791|12051351|FG000|COMPLETED|Phase 2||29
10885457|NCT02871791|12051352|FG001|COMPLETED|Phase 2||0
10885458|NCT02871791|12051351|FG000|NOT COMPLETED|Phase 2||3
10885459|NCT02871791|12051352|FG001|NOT COMPLETED|Phase 2||0
10885460|NCT02867761|12051360|FG000|STARTED|Overall Study||261
10885461|NCT02867761|12051361|FG001|STARTED|Overall Study||274
10885462|NCT02867761|12051360|FG000|COMPLETED|Overall Study||233
10885463|NCT02867761|12051361|FG001|COMPLETED|Overall Study||248
10885464|NCT02867761|12051360|FG000|NOT COMPLETED|Overall Study||28
10885465|NCT02867761|12051361|FG001|NOT COMPLETED|Overall Study||26
10885466|NCT02865811|12051367|FG000|STARTED|Overall Study||26
10885467|NCT02865811|12051367|FG000|COMPLETED|Overall Study||26
10885468|NCT02865811|12051367|FG000|NOT COMPLETED|Overall Study||0
10885469|NCT02864394|12051374|FG000|STARTED|Overall Study||213
10885470|NCT02864394|12051375|FG001|STARTED|Overall Study||212
10885471|NCT02864394|12051374|FG000|Treated|Overall Study||213
10885472|NCT02864394|12051375|FG001|Treated|Overall Study||198
10885473|NCT02864394|12051374|FG000|COMPLETED|Overall Study||0
10885474|NCT02864394|12051375|FG001|COMPLETED|Overall Study||0
10885475|NCT02864394|12051374|FG000|NOT COMPLETED|Overall Study||213
10885476|NCT02864394|12051375|FG001|NOT COMPLETED|Overall Study||212
10885477|NCT02862457|12051388|FG000|STARTED|Overall Study||3
10885478|NCT02862457|12051389|FG001|STARTED|Overall Study||3
10885479|NCT02862457|12051390|FG002|STARTED|Overall Study||3
10885480|NCT02862457|12051391|FG003|STARTED|Overall Study||6
10885481|NCT02862457|12051392|FG004|STARTED|Overall Study||7
10885482|NCT02862457|12051393|FG005|STARTED|Overall Study||6
10885483|NCT02862457|12051394|FG006|STARTED|Overall Study||6
10885484|NCT02862457|12051388|FG000|COMPLETED|Overall Study||1
10885485|NCT02862457|12051389|FG001|COMPLETED|Overall Study||0
10885486|NCT02862457|12051390|FG002|COMPLETED|Overall Study||0
10885487|NCT02862457|12051391|FG003|COMPLETED|Overall Study||2
10885488|NCT02862457|12051392|FG004|COMPLETED|Overall Study||7
10885489|NCT02862457|12051393|FG005|COMPLETED|Overall Study||3
10885490|NCT02862457|12051394|FG006|COMPLETED|Overall Study||5
10885491|NCT02862457|12051388|FG000|NOT COMPLETED|Overall Study||2
10885492|NCT02862457|12051389|FG001|NOT COMPLETED|Overall Study||3
10885493|NCT02862457|12051390|FG002|NOT COMPLETED|Overall Study||3
10885494|NCT02862457|12051391|FG003|NOT COMPLETED|Overall Study||4
10885495|NCT02862457|12051392|FG004|NOT COMPLETED|Overall Study||0
10885496|NCT02862457|12051393|FG005|NOT COMPLETED|Overall Study||3
10885497|NCT02862457|12051394|FG006|NOT COMPLETED|Overall Study||1
10885498|NCT02856581|12051420|FG000|STARTED|Overall Study||12
10885499|NCT02856581|12051421|FG001|STARTED|Overall Study||11
10885500|NCT02856581|12051420|FG000|COMPLETED|Overall Study||12
10885501|NCT02856581|12051421|FG001|COMPLETED|Overall Study||11
10885502|NCT02856581|12051420|FG000|NOT COMPLETED|Overall Study||0
10885503|NCT02856581|12051421|FG001|NOT COMPLETED|Overall Study||0
10885504|NCT02854436|12051429|FG000|STARTED|Overall Study||289
10885505|NCT02854436|12051429|FG000|Intent to Treat Participants (Breast Cancer Gene [BRCA] and Non-BRCA Participants)|Overall Study|There were 142 BRCA participants and 81 non-BRCA participants.|223
10885506|NCT02854436|12051429|FG000|COMPLETED|Overall Study||0
10885507|NCT02854436|12051429|FG000|NOT COMPLETED|Overall Study||289
10885508|NCT02853344|12051435|FG000|STARTED|Overall Study||110
10885509|NCT02853344|12051436|FG001|STARTED|Overall Study||165
10885510|NCT02853344|12051435|FG000|COMPLETED|Overall Study||0
10885511|NCT02853344|12051436|FG001|COMPLETED|Overall Study||0
10885512|NCT02853344|12051435|FG000|NOT COMPLETED|Overall Study||110
10885513|NCT02853344|12051436|FG001|NOT COMPLETED|Overall Study||165
10885514|NCT02853331|12051446|FG000|STARTED|Overall Study||432
10885515|NCT02853331|12051447|FG001|STARTED|Overall Study||429
10885516|NCT02853331|12051446|FG000|Treated|Overall Study||429
10885517|NCT02853331|12051447|FG001|Treated|Overall Study||425
10885518|NCT02853331|12051446|FG000|COMPLETED|Overall Study||0
10885519|NCT02853331|12051447|FG001|COMPLETED|Overall Study||0
10885520|NCT02853331|12051446|FG000|NOT COMPLETED|Overall Study||432
10885521|NCT02853331|12051447|FG001|NOT COMPLETED|Overall Study||429
10885522|NCT02853305|12051456|FG000|STARTED|Overall Study||351
10885523|NCT02853305|12051457|FG001|STARTED|Overall Study||307
10885524|NCT02853305|12051458|FG002|STARTED|Overall Study||352
10885525|NCT02853305|12051456|FG000|Treated|Overall Study|Includes 2 participants randomized to Pembrolizumab alone|349
10885526|NCT02853305|12051457|FG001|Treated|Overall Study||302
10885527|NCT02853305|12051458|FG002|Treated|Overall Study||342
10885528|NCT02853305|12051456|FG000|COMPLETED|Overall Study||0
10885529|NCT02853305|12051457|FG001|COMPLETED|Overall Study||0
10885530|NCT02853305|12051458|FG002|COMPLETED|Overall Study||0
10885531|NCT02853305|12051456|FG000|NOT COMPLETED|Overall Study||351
10885532|NCT02853305|12051457|FG001|NOT COMPLETED|Overall Study||307
10885533|NCT02853305|12051458|FG002|NOT COMPLETED|Overall Study||352
10885534|NCT02852005|12051471|FG000|STARTED|Overall Study||4
10885535|NCT02852005|12051472|FG001|STARTED|Overall Study||4
10885536|NCT02852005|12051473|FG002|STARTED|Overall Study||6
10885537|NCT02852005|12051474|FG003|STARTED|Overall Study||6
10885538|NCT02852005|12051475|FG004|STARTED|Overall Study||7
10885539|NCT02852005|12051471|FG000|Month 0.5|Overall Study||3
10885540|NCT02852005|12051472|FG001|Month 0.5|Overall Study||4
10885541|NCT02852005|12051473|FG002|Month 0.5|Overall Study||6
10885542|NCT02852005|12051474|FG003|Month 0.5|Overall Study||6
10885543|NCT02852005|12051475|FG004|Month 0.5|Overall Study||7
10885544|NCT02852005|12051471|FG000|Month 4.5|Overall Study||3
10885545|NCT02852005|12051472|FG001|Month 4.5|Overall Study||4
10885546|NCT02852005|12051473|FG002|Month 4.5|Overall Study||6
10885547|NCT02852005|12051474|FG003|Month 4.5|Overall Study||6
10885548|NCT02852005|12051475|FG004|Month 4.5|Overall Study||7
10885549|NCT02852005|12051471|FG000|Month 10|Overall Study||3
10885550|NCT02852005|12051472|FG001|Month 10|Overall Study||3
10885551|NCT02852005|12051473|FG002|Month 10|Overall Study||6
10885552|NCT02852005|12051474|FG003|Month 10|Overall Study||5
10885553|NCT02852005|12051475|FG004|Month 10|Overall Study||7
10885554|NCT02852005|12051471|FG000|COMPLETED|Overall Study||3
10885555|NCT02852005|12051472|FG001|COMPLETED|Overall Study||4
10885556|NCT02852005|12051473|FG002|COMPLETED|Overall Study||6
10885557|NCT02852005|12051474|FG003|COMPLETED|Overall Study||6
10885558|NCT02852005|12051475|FG004|COMPLETED|Overall Study||6
10885559|NCT02852005|12051471|FG000|NOT COMPLETED|Overall Study||1
10885560|NCT02852005|12051472|FG001|NOT COMPLETED|Overall Study||0
10885561|NCT02852005|12051473|FG002|NOT COMPLETED|Overall Study||0
10885562|NCT02852005|12051474|FG003|NOT COMPLETED|Overall Study||0
10885563|NCT02852005|12051475|FG004|NOT COMPLETED|Overall Study||1
10885564|NCT02849639|12051491|FG000|STARTED|Overall Study||44
10885565|NCT02849639|12051492|FG001|STARTED|Overall Study||46
10885566|NCT02849639|12051491|FG000|COMPLETED|Overall Study||41
10885567|NCT02849639|12051492|FG001|COMPLETED|Overall Study||44
10885568|NCT02849639|12051491|FG000|NOT COMPLETED|Overall Study||3
10885569|NCT02849639|12051492|FG001|NOT COMPLETED|Overall Study||2
10885570|NCT02836249|12051500|FG000|STARTED|Overall Study||123
10885571|NCT02836249|12051501|FG001|STARTED|Overall Study||58
10885572|NCT02836249|12051500|FG000|COMPLETED|Overall Study||0
10885573|NCT02836249|12051501|FG001|COMPLETED|Overall Study||0
10885574|NCT02836249|12051500|FG000|NOT COMPLETED|Overall Study||123
10885575|NCT02836249|12051501|FG001|NOT COMPLETED|Overall Study||58
10885576|NCT02832063|12051509|FG000|STARTED|Overall Study||186
10885577|NCT02832063|12051510|FG001|STARTED|Overall Study||186
10885578|NCT02832063|12051509|FG000|COMPLETED|Overall Study||152
10885579|NCT02832063|12051510|FG001|COMPLETED|Overall Study||148
10885580|NCT02832063|12051509|FG000|NOT COMPLETED|Overall Study||34
10885581|NCT02832063|12051510|FG001|NOT COMPLETED|Overall Study||38
10885582|NCT02831764|12051518|FG000|STARTED|Overall Study||360
10885583|NCT02831764|12051519|FG001|STARTED|Overall Study||359
10885584|NCT02831764|12051518|FG000|COMPLETED|Overall Study||0
10885585|NCT02831764|12051519|FG001|COMPLETED|Overall Study||0
10885586|NCT02831764|12051518|FG000|NOT COMPLETED|Overall Study||360
10885587|NCT02831764|12051519|FG001|NOT COMPLETED|Overall Study||359
10885588|NCT02831673|12051527|FG000|STARTED|Overall Study||356
10885589|NCT02831673|12051528|FG001|STARTED|Overall Study||358
10885590|NCT02831673|12051527|FG000|COMPLETED|Overall Study||0
10885591|NCT02831673|12051528|FG001|COMPLETED|Overall Study||0
10885592|NCT02831673|12051527|FG000|NOT COMPLETED|Overall Study||356
10885593|NCT02831673|12051528|FG001|NOT COMPLETED|Overall Study||358
10885594|NCT02829918|12051534|FG000|STARTED|Overall Study||54
10885595|NCT02829918|12051534|FG000|COMPLETED|Overall Study||46
10885596|NCT02829918|12051534|FG000|NOT COMPLETED|Overall Study||8
10885597|NCT02826681|12051540|FG000|STARTED|Overall Study||35
10885598|NCT02826681|12051541|FG001|STARTED|Overall Study||35
10885599|NCT02826681|12051540|FG000|COMPLETED|Overall Study||12
10885600|NCT02826681|12051541|FG001|COMPLETED|Overall Study||13
10885601|NCT02826681|12051540|FG000|NOT COMPLETED|Overall Study||23
10885602|NCT02826681|12051541|FG001|NOT COMPLETED|Overall Study||22
10885603|NCT02824627|12051549|FG000|STARTED|Overall Study||28
10885604|NCT02824627|12051550|FG001|STARTED|Overall Study||30
10885605|NCT02824627|12051549|FG000|COMPLETED|Overall Study||25
10885606|NCT02824627|12051550|FG001|COMPLETED|Overall Study||27
10885607|NCT02824627|12051549|FG000|NOT COMPLETED|Overall Study||3
10885608|NCT02824627|12051550|FG001|NOT COMPLETED|Overall Study||3
10885609|NCT02821000|12051556|FG000|STARTED|Overall Study||103
10885610|NCT02821000|12051556|FG000|Treated|Overall Study||103
10885611|NCT02821000|12051556|FG000|COMPLETED|Overall Study||0
10885612|NCT02821000|12051556|FG000|NOT COMPLETED|Overall Study||103
10885613|NCT02818894|12051562|FG000|STARTED|Overall Study||67
10885614|NCT02818894|12051563|FG001|STARTED|Overall Study||68
10885615|NCT02818894|12051562|FG000|COMPLETED|Overall Study||11
10885616|NCT02818894|12051563|FG001|COMPLETED|Overall Study||12
10885617|NCT02818894|12051562|FG000|NOT COMPLETED|Overall Study||56
10885618|NCT02818894|12051563|FG001|NOT COMPLETED|Overall Study||56
10885619|NCT02816255|12051571|FG000|STARTED|Overall Study||6
10885620|NCT02816255|12051572|FG001|STARTED|Overall Study||5
10885621|NCT02816255|12051571|FG000|COMPLETED|Overall Study||6
10885622|NCT02816255|12051572|FG001|COMPLETED|Overall Study||5
10885623|NCT02816255|12051571|FG000|NOT COMPLETED|Overall Study||0
10885624|NCT02816255|12051572|FG001|NOT COMPLETED|Overall Study||0
10885625|NCT02815540|12051580|FG000|STARTED|Overall Study||2
10885626|NCT02815540|12051580|FG000|COMPLETED|Overall Study||0
10885627|NCT02815540|12051580|FG000|NOT COMPLETED|Overall Study||2
10885628|NCT02808871|12051586|FG000|STARTED|Overall Study||63
10885629|NCT02808871|12051587|FG001|STARTED|Overall Study||60
10885630|NCT02808871|12051586|FG000|COMPLETED|Overall Study||52
10885631|NCT02808871|12051587|FG001|COMPLETED|Overall Study||51
10885632|NCT02808871|12051586|FG000|NOT COMPLETED|Overall Study||11
10885633|NCT02808871|12051587|FG001|NOT COMPLETED|Overall Study||9
10885634|NCT02807493|12051597|FG000|STARTED|Overall Study||174
10885635|NCT02807493|12051598|FG001|STARTED|Overall Study||173
10885636|NCT02807493|12051597|FG000|COMPLETED|Overall Study||87
10885637|NCT02807493|12051598|FG001|COMPLETED|Overall Study||121
10885638|NCT02807493|12051597|FG000|NOT COMPLETED|Overall Study||87
10885639|NCT02807493|12051598|FG001|NOT COMPLETED|Overall Study||52
10885640|NCT02802293|12051607|FG000|STARTED|Overall Study||1
10885641|NCT02802293|12051608|FG001|STARTED|Overall Study||2
10885642|NCT02802293|12051609|FG002|STARTED|Overall Study||3
10885643|NCT02802293|12051607|FG000|COMPLETED|Overall Study||0
10885644|NCT02802293|12051608|FG001|COMPLETED|Overall Study||1
10885645|NCT02802293|12051609|FG002|COMPLETED|Overall Study||1
10885646|NCT02802293|12051607|FG000|NOT COMPLETED|Overall Study||1
10885647|NCT02802293|12051608|FG001|NOT COMPLETED|Overall Study||1
10885648|NCT02802293|12051609|FG002|NOT COMPLETED|Overall Study||2
10885649|NCT02798536|12051620|FG000|STARTED|Overall Study||3
10885650|NCT02798536|12051621|FG001|STARTED|Overall Study||7
10885651|NCT02798536|12051622|FG002|STARTED|Overall Study||11
10885652|NCT02798536|12051620|FG000|COMPLETED|Overall Study||3
10885653|NCT02798536|12051621|FG001|COMPLETED|Overall Study||7
10885654|NCT02798536|12051622|FG002|COMPLETED|Overall Study||11
10885655|NCT02798536|12051620|FG000|NOT COMPLETED|Overall Study||0
10885656|NCT02798536|12051621|FG001|NOT COMPLETED|Overall Study||0
10885657|NCT02798536|12051622|FG002|NOT COMPLETED|Overall Study||0
10885658|NCT02784535|12051636|FG000|STARTED|Overall Study||20
10885659|NCT02784535|12051637|FG001|STARTED|Overall Study||20
10885660|NCT02784535|12051636|FG000|COMPLETED|Overall Study|Randomized ,placebo controlled, crossover phase (days 0-64)|19
10885661|NCT02784535|12051637|FG001|COMPLETED|Overall Study||18
10885662|NCT02784535|12051636|FG000|NOT COMPLETED|Overall Study||1
10885663|NCT02784535|12051637|FG001|NOT COMPLETED|Overall Study||2
10885664|NCT02783950|12051648|FG000|STARTED|Overall Study||182
10885665|NCT02783950|12051649|FG001|STARTED|Overall Study||174
10885666|NCT02783950|12051648|FG000|COMPLETED|Overall Study||175
10885667|NCT02783950|12051649|FG001|COMPLETED|Overall Study||165
10885668|NCT02783950|12051648|FG000|NOT COMPLETED|Overall Study||7
10885669|NCT02783950|12051649|FG001|NOT COMPLETED|Overall Study||9
10885670|NCT02781506|12051655|FG000|STARTED|Overall Study||7
10885671|NCT02781506|12051655|FG000|COMPLETED|Overall Study||2
10885672|NCT02781506|12051655|FG000|NOT COMPLETED|Overall Study||5
10885673|NCT02775903|12051663|FG000|STARTED|Overall Study||42
10885674|NCT02775903|12051664|FG001|STARTED|Overall Study||42
10885675|NCT02775903|12051665|FG002|STARTED|Overall Study||64
10885676|NCT02775903|12051666|FG003|STARTED|Overall Study||65
10885677|NCT02775903|12051663|FG000|Received Study Treatment|Overall Study||38
10885678|NCT02775903|12051664|FG001|Received Study Treatment|Overall Study||41
10885679|NCT02775903|12051665|FG002|Received Study Treatment|Overall Study||64
10885680|NCT02775903|12051666|FG003|Received Study Treatment|Overall Study||62
10885681|NCT02775903|12051663|FG000|COMPLETED|Overall Study||0
10885682|NCT02775903|12051664|FG001|COMPLETED|Overall Study||1
10885683|NCT02775903|12051665|FG002|COMPLETED|Overall Study||0
10885684|NCT02775903|12051666|FG003|COMPLETED|Overall Study||0
10885685|NCT02775903|12051663|FG000|NOT COMPLETED|Overall Study||42
10885686|NCT02775903|12051664|FG001|NOT COMPLETED|Overall Study||41
10885687|NCT02775903|12051665|FG002|NOT COMPLETED|Overall Study||64
10885688|NCT02775903|12051666|FG003|NOT COMPLETED|Overall Study||65
10885689|NCT02775435|12051682|FG000|STARTED|Overall Study||278
10885690|NCT02775435|12051683|FG001|STARTED|Overall Study||281
10885691|NCT02775435|12051682|FG000|Treated|Overall Study||278
10885692|NCT02775435|12051683|FG001|Treated|Overall Study||280
10885693|NCT02775435|12051682|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
10885694|NCT02775435|12051683|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||75
10885695|NCT02775435|12051682|FG000|COMPLETED|Overall Study||0
10885696|NCT02775435|12051683|FG001|COMPLETED|Overall Study||0
10885697|NCT02775435|12051682|FG000|NOT COMPLETED|Overall Study||278
10885698|NCT02775435|12051683|FG001|NOT COMPLETED|Overall Study||281
10885699|NCT02775162|12051691|FG000|STARTED|Overall Study||136
10885700|NCT02775162|12051692|FG001|STARTED|Overall Study||131
10885701|NCT02775162|12051691|FG000|COMPLETED|Overall Study||122
10885702|NCT02775162|12051692|FG001|COMPLETED|Overall Study||121
10885703|NCT02775162|12051691|FG000|NOT COMPLETED|Overall Study||14
10885704|NCT02775162|12051692|FG001|NOT COMPLETED|Overall Study||10
10885705|NCT02773849|12051700|FG000|STARTED|Overall Study||157
10885706|NCT02773849|12051700|FG000|COMPLETED|Overall Study||63
10885707|NCT02773849|12051700|FG000|NOT COMPLETED|Overall Study||94
10885708|NCT02773732|12051710|FG000|STARTED|Ciprofloxacin Dose Level 0||3
10885709|NCT02773732|12051711|FG001|STARTED|Ciprofloxacin Dose Level 0||0
10885710|NCT02773732|12051710|FG000|COMPLETED|Ciprofloxacin Dose Level 0||3
10885711|NCT02773732|12051711|FG001|COMPLETED|Ciprofloxacin Dose Level 0||0
10885712|NCT02773732|12051710|FG000|NOT COMPLETED|Ciprofloxacin Dose Level 0||0
10885713|NCT02773732|12051711|FG001|NOT COMPLETED|Ciprofloxacin Dose Level 0||0
10885714|NCT02773732|12051710|FG000|STARTED|Ciprofloxacin Dose Level +1||0
10885715|NCT02773732|12051711|FG001|STARTED|Ciprofloxacin Dose Level +1||8
10885716|NCT02773732|12051710|FG000|COMPLETED|Ciprofloxacin Dose Level +1||0
10885717|NCT02773732|12051711|FG001|COMPLETED|Ciprofloxacin Dose Level +1||8
10885718|NCT02773732|12051710|FG000|NOT COMPLETED|Ciprofloxacin Dose Level +1||0
10885719|NCT02773732|12051711|FG001|NOT COMPLETED|Ciprofloxacin Dose Level +1||0
10885720|NCT02770716|12051724|FG000|STARTED|Overall Study||199
10885721|NCT02770716|12051725|FG001|STARTED|Overall Study||101
10885722|NCT02770716|12051724|FG000|Intent to Treat (ITT)|Overall Study||199
10885723|NCT02770716|12051725|FG001|Intent to Treat (ITT)|Overall Study||101
10885724|NCT02770716|12051724|FG000|Safety Analysis Set (SAS)|Overall Study|One placebo participant received terlipressin as well, so is included in the terlipressin SAS|200
10885725|NCT02770716|12051725|FG001|Safety Analysis Set (SAS)|Overall Study|One placebo participant did not receive any treatment, so was excluded from the SAS|99
10885726|NCT02770716|12051724|FG000|COMPLETED|Overall Study|ITT Completed Study through Follow-up / Day 90 Visit|87
10885727|NCT02770716|12051725|FG001|COMPLETED|Overall Study|ITT Completed Study through Follow-up / Day 90 Visit|52
10885728|NCT02770716|12051724|FG000|NOT COMPLETED|Overall Study||112
10885729|NCT02770716|12051725|FG001|NOT COMPLETED|Overall Study||49
10885730|NCT02768792|12051731|FG000|STARTED|Overall Study||38
10885731|NCT02768792|12051731|FG000|COMPLETED|Overall Study||37
10885732|NCT02768792|12051731|FG000|NOT COMPLETED|Overall Study||1
10885733|NCT02768701|12051735|FG000|STARTED|Overall Study||40
10885734|NCT02768701|12051735|FG000|COMPLETED|Overall Study||32
10885735|NCT02768701|12051735|FG000|NOT COMPLETED|Overall Study||8
10885736|NCT02766478|12051744|FG000|STARTED|Overall Study||6
10885737|NCT02766478|12051745|FG001|STARTED|Overall Study||4
10885738|NCT02766478|12051744|FG000|COMPLETED|Overall Study||5
10885739|NCT02766478|12051745|FG001|COMPLETED|Overall Study||3
10885740|NCT02766478|12051744|FG000|NOT COMPLETED|Overall Study||1
10885741|NCT02766478|12051745|FG001|NOT COMPLETED|Overall Study||1
10885742|NCT02763566|12051755|FG000|STARTED|Overall Study||207
10885743|NCT02763566|12051756|FG001|STARTED|Overall Study||99
10885744|NCT02763566|12051757|FG002|STARTED|Overall Study||104
10885745|NCT02763566|12051758|FG003|STARTED|Overall Study||53
10885746|NCT02763566|12051755|FG000|COMPLETED|Overall Study||89
10885747|NCT02763566|12051756|FG001|COMPLETED|Overall Study||60
10885748|NCT02763566|12051757|FG002|COMPLETED|Overall Study||50
10885749|NCT02763566|12051758|FG003|COMPLETED|Overall Study||39
10885750|NCT02763566|12051755|FG000|NOT COMPLETED|Overall Study||118
10885751|NCT02763566|12051756|FG001|NOT COMPLETED|Overall Study||39
10885752|NCT02763566|12051757|FG002|NOT COMPLETED|Overall Study||54
10885753|NCT02763566|12051758|FG003|NOT COMPLETED|Overall Study||14
10885754|NCT02761057|12051776|FG000|STARTED|Overall Study||46
10885755|NCT02761057|12051777|FG001|STARTED|Overall Study||44
10885756|NCT02761057|12051778|FG002|STARTED|Overall Study||28
10885757|NCT02761057|12051779|FG003|STARTED|Overall Study||29
10885758|NCT02761057|12051776|FG000|Received Protocol Treatment|Overall Study||45
10885759|NCT02761057|12051777|FG001|Received Protocol Treatment|Overall Study||43
10885760|NCT02761057|12051778|FG002|Received Protocol Treatment|Overall Study||27
10885761|NCT02761057|12051779|FG003|Received Protocol Treatment|Overall Study||28
10885762|NCT02761057|12051776|FG000|COMPLETED|Overall Study||0
10885763|NCT02761057|12051777|FG001|COMPLETED|Overall Study||0
10885764|NCT02761057|12051778|FG002|COMPLETED|Overall Study||0
10885765|NCT02761057|12051779|FG003|COMPLETED|Overall Study||0
10885766|NCT02761057|12051776|FG000|NOT COMPLETED|Overall Study||46
10885767|NCT02761057|12051777|FG001|NOT COMPLETED|Overall Study||44
10885768|NCT02761057|12051778|FG002|NOT COMPLETED|Overall Study||28
10885769|NCT02761057|12051779|FG003|NOT COMPLETED|Overall Study||29
10885770|NCT02759458|12051791|FG000|STARTED|Overall Study||20
10885771|NCT02759458|12051792|FG001|STARTED|Overall Study||20
10885772|NCT02759458|12051791|FG000|COMPLETED|Overall Study||20
10885773|NCT02759458|12051792|FG001|COMPLETED|Overall Study||20
10885774|NCT02759458|12051791|FG000|NOT COMPLETED|Overall Study||0
10885775|NCT02759458|12051792|FG001|NOT COMPLETED|Overall Study||0
10885776|NCT02747927|12051800|FG000|STARTED|Overall Study||6698
10885777|NCT02747927|12051801|FG001|STARTED|Overall Study||13401
10885778|NCT02747927|12051800|FG000|Treated: Safety Set|Overall Study||6687
10885779|NCT02747927|12051801|FG001|Treated: Safety Set|Overall Study||13380
10885780|NCT02747927|12051800|FG000|COMPLETED|Overall Study||6477
10885781|NCT02747927|12051801|FG001|COMPLETED|Overall Study||12943
10885782|NCT02747927|12051800|FG000|NOT COMPLETED|Overall Study||221
10885783|NCT02747927|12051801|FG001|NOT COMPLETED|Overall Study||458
10885784|NCT02747043|12051809|FG000|STARTED|Overall Study||128
10885785|NCT02747043|12051810|FG001|STARTED|Overall Study||128
10885786|NCT02747043|12051809|FG000|Treated|Overall Study||128
10885787|NCT02747043|12051810|FG001|Treated|Overall Study||126
10885788|NCT02747043|12051809|FG000|COMPLETED|Overall Study||118
10885789|NCT02747043|12051810|FG001|COMPLETED|Overall Study||123
10885790|NCT02747043|12051809|FG000|NOT COMPLETED|Overall Study||10
10885791|NCT02747043|12051810|FG001|NOT COMPLETED|Overall Study||5
10885792|NCT02747004|12051819|FG000|STARTED|Overall Study||78
10885793|NCT02747004|12051820|FG001|STARTED|Overall Study||79
10885794|NCT02747004|12051821|FG002|STARTED|Overall Study||77
10885795|NCT02747004|12051819|FG000|Received at Least One Dose of Study Drug|Overall Study||78
10885796|NCT02747004|12051820|FG001|Received at Least One Dose of Study Drug|Overall Study||79
10885797|NCT02747004|12051821|FG002|Received at Least One Dose of Study Drug|Overall Study||77
10885798|NCT02747004|12051819|FG000|COMPLETED|Overall Study||21
10885799|NCT02747004|12051820|FG001|COMPLETED|Overall Study||30
10885800|NCT02747004|12051821|FG002|COMPLETED|Overall Study||30
10885801|NCT02747004|12051819|FG000|NOT COMPLETED|Overall Study||57
10885802|NCT02747004|12051820|FG001|NOT COMPLETED|Overall Study||49
10885803|NCT02747004|12051821|FG002|NOT COMPLETED|Overall Study||47
10885804|NCT02743728|12051829|FG000|STARTED|Overall Study||20
10885805|NCT02743728|12051829|FG000|COMPLETED|Overall Study||20
10885806|NCT02743728|12051829|FG000|NOT COMPLETED|Overall Study||0
10885807|NCT02743494|12051835|FG000|STARTED|Pre-treatment Period||532
10885808|NCT02743494|12051836|FG001|STARTED|Pre-treatment Period||262
10885809|NCT02743494|12051835|FG000|COMPLETED|Pre-treatment Period||532
10885810|NCT02743494|12051836|FG001|COMPLETED|Pre-treatment Period||260
10885811|NCT02743494|12051835|FG000|NOT COMPLETED|Pre-treatment Period||0
10885812|NCT02743494|12051836|FG001|NOT COMPLETED|Pre-treatment Period||2
10885813|NCT02743494|12051835|FG000|STARTED|Treatment Period||532
10885814|NCT02743494|12051836|FG001|STARTED|Treatment Period||260
10885815|NCT02743494|12051835|FG000|COMPLETED|Treatment Period||31
10885816|NCT02743494|12051836|FG001|COMPLETED|Treatment Period||19
10885817|NCT02743494|12051835|FG000|NOT COMPLETED|Treatment Period||501
10885818|NCT02743494|12051836|FG001|NOT COMPLETED|Treatment Period||241
10885819|NCT02741570|12051844|FG000|STARTED|Pre-Treatment Period||472
10885820|NCT02741570|12051845|FG001|STARTED|Pre-Treatment Period||475
10885821|NCT02741570|12051844|FG000|COMPLETED|Pre-Treatment Period||468
10885822|NCT02741570|12051845|FG001|COMPLETED|Pre-Treatment Period||441
10885823|NCT02741570|12051844|FG000|NOT COMPLETED|Pre-Treatment Period||4
10885824|NCT02741570|12051845|FG001|NOT COMPLETED|Pre-Treatment Period||34
10885825|NCT02741570|12051844|FG000|STARTED|Treatment Period||468
10885826|NCT02741570|12051845|FG001|STARTED|Treatment Period||441
10885827|NCT02741570|12051844|FG000|COMPLETED|Treatment Period||0
10885828|NCT02741570|12051845|FG001|COMPLETED|Treatment Period||7
10885829|NCT02741570|12051844|FG000|NOT COMPLETED|Treatment Period||468
10885830|NCT02741570|12051845|FG001|NOT COMPLETED|Treatment Period||434
10885831|NCT02735421|12051851|FG000|STARTED|Part A (Randomized): up to 24 Weeks||67
10885832|NCT02735421|12051851|FG000|COMPLETED|Part A (Randomized): up to 24 Weeks||54
10885833|NCT02735421|12051851|FG000|NOT COMPLETED|Part A (Randomized): up to 24 Weeks||13
10885834|NCT02735421|12051851|FG000|STARTED|Part 2 (Open Label): up to 48 Weeks|Participants who continue treatment with A-BPO Forte gel for up to 24 additional weeks.|45
10885835|NCT02735421|12051851|FG000|COMPLETED|Part 2 (Open Label): up to 48 Weeks||41
10885836|NCT02735421|12051851|FG000|NOT COMPLETED|Part 2 (Open Label): up to 48 Weeks||4
10885837|NCT02730546|12051863|FG000|STARTED|Overall Study||31
10885838|NCT02730546|12051863|FG000|COMPLETED|Overall Study||31
10885839|NCT02730546|12051863|FG000|NOT COMPLETED|Overall Study||0
10885840|NCT02730169|12051871|FG000|STARTED|Overall Study||67
10885841|NCT02730169|12051872|FG001|STARTED|Overall Study||66
10885842|NCT02730169|12051873|FG002|STARTED|Overall Study||67
10885843|NCT02730169|12051874|FG003|STARTED|Overall Study||71
10885844|NCT02730169|12051871|FG000|COMPLETED|Overall Study||53
10885845|NCT02730169|12051872|FG001|COMPLETED|Overall Study||45
10885846|NCT02730169|12051873|FG002|COMPLETED|Overall Study||50
10885847|NCT02730169|12051874|FG003|COMPLETED|Overall Study||55
10885848|NCT02730169|12051871|FG000|NOT COMPLETED|Overall Study||14
10885849|NCT02730169|12051872|FG001|NOT COMPLETED|Overall Study||21
10885850|NCT02730169|12051873|FG002|NOT COMPLETED|Overall Study||17
10885851|NCT02730169|12051874|FG003|NOT COMPLETED|Overall Study||16
10885852|NCT02729025|12051886|FG000|STARTED|Overall Study||64
10885853|NCT02729025|12051887|FG001|STARTED|Overall Study||65
10885854|NCT02729025|12051886|FG000|COMPLETED|Overall Study||64
10885855|NCT02729025|12051887|FG001|COMPLETED|Overall Study||64
10885856|NCT02729025|12051886|FG000|NOT COMPLETED|Overall Study||0
10885857|NCT02729025|12051887|FG001|NOT COMPLETED|Overall Study||1
10885858|NCT02728102|12051896|FG000|STARTED|Overall Study||68
10885859|NCT02728102|12051897|FG001|STARTED|Overall Study||37
10885860|NCT02728102|12051898|FG002|STARTED|Overall Study||35
10885861|NCT02728102|12051896|FG000|COMPLETED|Overall Study||61
10885862|NCT02728102|12051897|FG001|COMPLETED|Overall Study||33
10885863|NCT02728102|12051898|FG002|COMPLETED|Overall Study||30
10885864|NCT02728102|12051896|FG000|NOT COMPLETED|Overall Study||7
10885865|NCT02728102|12051897|FG001|NOT COMPLETED|Overall Study||4
10885866|NCT02728102|12051898|FG002|NOT COMPLETED|Overall Study||5
10885867|NCT02726542|12051909|FG000|STARTED|Overall Study||13
10885868|NCT02726542|12051910|FG001|STARTED|Overall Study||11
10885869|NCT02726542|12051909|FG000|COMPLETED|Overall Study||10
10885870|NCT02726542|12051910|FG001|COMPLETED|Overall Study||10
10885871|NCT02726542|12051909|FG000|NOT COMPLETED|Overall Study||3
10885872|NCT02726542|12051910|FG001|NOT COMPLETED|Overall Study||1
10885873|NCT02723929|12051918|FG000|STARTED|Overall Study||30
10885874|NCT02723929|12051919|FG001|STARTED|Overall Study||34
10885875|NCT02723929|12051918|FG000|COMPLETED|Overall Study||24
10885876|NCT02723929|12051919|FG001|COMPLETED|Overall Study||24
10885877|NCT02723929|12051918|FG000|NOT COMPLETED|Overall Study||6
10885878|NCT02723929|12051919|FG001|NOT COMPLETED|Overall Study||10
10885879|NCT02723162|12051931|FG000|STARTED|Overall Study||18
10885880|NCT02723162|12051932|FG001|STARTED|Overall Study||15
10885881|NCT02723162|12051933|FG002|STARTED|Overall Study||17
10885882|NCT02723162|12051934|FG003|STARTED|Overall Study||17
10885883|NCT02723162|12051931|FG000|Day 10 fMRI Visit|Overall Study||15
10885884|NCT02723162|12051932|FG001|Day 10 fMRI Visit|Overall Study||11
10885885|NCT02723162|12051933|FG002|Day 10 fMRI Visit|Overall Study||14
10885886|NCT02723162|12051934|FG003|Day 10 fMRI Visit|Overall Study||15
10885887|NCT02723162|12051931|FG000|COMPLETED|Overall Study||12
10885888|NCT02723162|12051932|FG001|COMPLETED|Overall Study||10
10885889|NCT02723162|12051933|FG002|COMPLETED|Overall Study||13
10885890|NCT02723162|12051934|FG003|COMPLETED|Overall Study||12
10885891|NCT02723162|12051931|FG000|NOT COMPLETED|Overall Study||6
10885892|NCT02723162|12051932|FG001|NOT COMPLETED|Overall Study||5
10885893|NCT02723162|12051933|FG002|NOT COMPLETED|Overall Study||4
10885894|NCT02723162|12051934|FG003|NOT COMPLETED|Overall Study||5
10885895|NCT02718118|12051946|FG000|STARTED|Overall Study||30
10885896|NCT02718118|12051947|FG001|STARTED|Overall Study||30
10885897|NCT02718118|12051946|FG000|COMPLETED|Overall Study||28
10885898|NCT02718118|12051947|FG001|COMPLETED|Overall Study||29
10885899|NCT02718118|12051946|FG000|NOT COMPLETED|Overall Study||2
10885900|NCT02718118|12051947|FG001|NOT COMPLETED|Overall Study||1
10885901|NCT02718040|12051953|FG000|STARTED|Overall Study||30
10885902|NCT02718040|12051953|FG000|COMPLETED|Overall Study||30
10885903|NCT02718040|12051953|FG000|NOT COMPLETED|Overall Study||0
10885904|NCT02717611|12051957|FG000|STARTED|Overall Study||60
10885905|NCT02717611|12051957|FG000|COMPLETED|Overall Study||0
10885906|NCT02717611|12051957|FG000|NOT COMPLETED|Overall Study||60
10885907|NCT02716974|12051961|FG000|STARTED|Overall Study||26
10885908|NCT02716974|12051961|FG000|COMPLETED|Overall Study||26
10885909|NCT02716974|12051961|FG000|NOT COMPLETED|Overall Study||0
10885910|NCT02714062|12051968|FG000|STARTED|Overall Study||14
10885911|NCT02714062|12051969|FG001|STARTED|Overall Study||15
10885912|NCT02714062|12051970|FG002|STARTED|Overall Study||13
10885913|NCT02714062|12051968|FG000|COMPLETED|Overall Study||13
10885914|NCT02714062|12051969|FG001|COMPLETED|Overall Study||14
10885915|NCT02714062|12051970|FG002|COMPLETED|Overall Study||10
10885916|NCT02714062|12051968|FG000|NOT COMPLETED|Overall Study||1
10885917|NCT02714062|12051969|FG001|NOT COMPLETED|Overall Study||1
10885918|NCT02714062|12051970|FG002|NOT COMPLETED|Overall Study||3
10885919|NCT02713373|12051980|FG000|STARTED|Overall Study||44
10885920|NCT02713373|12051980|FG000|COMPLETED|Overall Study||44
10885921|NCT02713373|12051980|FG000|NOT COMPLETED|Overall Study||0
10885922|NCT02709655|12051984|FG000|STARTED|Single-Blind Phase (4 Weeks)||683
10885923|NCT02709655|12051985|FG001|STARTED|Single-Blind Phase (4 Weeks)||0
10885924|NCT02709655|12051986|FG002|STARTED|Single-Blind Phase (4 Weeks)||0
10885925|NCT02709655|12051987|FG003|STARTED|Single-Blind Phase (4 Weeks)||0
10885926|NCT02709655|12051988|FG004|STARTED|Single-Blind Phase (4 Weeks)||0
10885927|NCT02709655|12051984|FG000|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||677
10885928|NCT02709655|12051985|FG001|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0
10885929|NCT02709655|12051986|FG002|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0
10885930|NCT02709655|12051987|FG003|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0
10885931|NCT02709655|12051988|FG004|Received at Least 1 Dose of Study Drug|Single-Blind Phase (4 Weeks)||0
10885932|NCT02709655|12051984|FG000|COMPLETED|Single-Blind Phase (4 Weeks)||540
10885933|NCT02709655|12051985|FG001|COMPLETED|Single-Blind Phase (4 Weeks)||0
10885934|NCT02709655|12051986|FG002|COMPLETED|Single-Blind Phase (4 Weeks)||0
10885935|NCT02709655|12051987|FG003|COMPLETED|Single-Blind Phase (4 Weeks)||0
10885936|NCT02709655|12051988|FG004|COMPLETED|Single-Blind Phase (4 Weeks)||0
10885937|NCT02709655|12051984|FG000|NOT COMPLETED|Single-Blind Phase (4 Weeks)||143
10885938|NCT02709655|12051985|FG001|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0
10885939|NCT02709655|12051986|FG002|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0
10885940|NCT02709655|12051987|FG003|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0
10885941|NCT02709655|12051988|FG004|NOT COMPLETED|Single-Blind Phase (4 Weeks)||0
10885942|NCT02709655|12051984|FG000|STARTED|Double-Blind Phase (8 Weeks)||0
10885943|NCT02709655|12051985|FG001|STARTED|Double-Blind Phase (8 Weeks)||153
10885944|NCT02709655|12051986|FG002|STARTED|Double-Blind Phase (8 Weeks)||151
10885945|NCT02709655|12051987|FG003|STARTED|Double-Blind Phase (8 Weeks)||153
10885946|NCT02709655|12051988|FG004|STARTED|Double-Blind Phase (8 Weeks)||83
10885947|NCT02709655|12051984|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||0
10885948|NCT02709655|12051985|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||153
10885949|NCT02709655|12051986|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||151
10885950|NCT02709655|12051987|FG003|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||153
10885951|NCT02709655|12051988|FG004|Received at Least 1 Dose of Study Drug|Double-Blind Phase (8 Weeks)||83
10885952|NCT02709655|12051984|FG000|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||0
10885953|NCT02709655|12051985|FG001|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||153
10885954|NCT02709655|12051986|FG002|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||148
10885955|NCT02709655|12051987|FG003|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||148
10885956|NCT02709655|12051988|FG004|Full Analysis Set (FAS)|Double-Blind Phase (8 Weeks)||81
10885957|NCT02709655|12051984|FG000|COMPLETED|Double-Blind Phase (8 Weeks)||0
10885958|NCT02709655|12051985|FG001|COMPLETED|Double-Blind Phase (8 Weeks)||138
10885959|NCT02709655|12051986|FG002|COMPLETED|Double-Blind Phase (8 Weeks)||135
10885960|NCT02709655|12051987|FG003|COMPLETED|Double-Blind Phase (8 Weeks)||133
10885961|NCT02709655|12051988|FG004|COMPLETED|Double-Blind Phase (8 Weeks)||78
10885962|NCT02709655|12051984|FG000|NOT COMPLETED|Double-Blind Phase (8 Weeks)||0
10885963|NCT02709655|12051985|FG001|NOT COMPLETED|Double-Blind Phase (8 Weeks)||15
10885964|NCT02709655|12051986|FG002|NOT COMPLETED|Double-Blind Phase (8 Weeks)||16
10885965|NCT02709655|12051987|FG003|NOT COMPLETED|Double-Blind Phase (8 Weeks)||20
10885966|NCT02709655|12051988|FG004|NOT COMPLETED|Double-Blind Phase (8 Weeks)||5
10885967|NCT02707692|12052006|FG000|STARTED|Cycle 1 (30 Days)||9
10885968|NCT02707692|12052007|FG001|STARTED|Cycle 1 (30 Days)||9
10885969|NCT02707692|12052008|FG002|STARTED|Cycle 1 (30 Days)||9
10885970|NCT02707692|12052009|FG003|STARTED|Cycle 1 (30 Days)||9
10885971|NCT02707692|12052010|FG004|STARTED|Cycle 1 (30 Days)||9
10885972|NCT02707692|12052011|FG005|STARTED|Cycle 1 (30 Days)||9
10885973|NCT02707692|12052006|FG000|COMPLETED|Cycle 1 (30 Days)||8
10885974|NCT02707692|12052007|FG001|COMPLETED|Cycle 1 (30 Days)||6
10885975|NCT02707692|12052008|FG002|COMPLETED|Cycle 1 (30 Days)||8
10885976|NCT02707692|12052009|FG003|COMPLETED|Cycle 1 (30 Days)||9
10885977|NCT02707692|12052010|FG004|COMPLETED|Cycle 1 (30 Days)||8
10885978|NCT02707692|12052011|FG005|COMPLETED|Cycle 1 (30 Days)||8
10885979|NCT02707692|12052006|FG000|NOT COMPLETED|Cycle 1 (30 Days)||1
10885980|NCT02707692|12052007|FG001|NOT COMPLETED|Cycle 1 (30 Days)||3
10885981|NCT02707692|12052008|FG002|NOT COMPLETED|Cycle 1 (30 Days)||1
10885982|NCT02707692|12052009|FG003|NOT COMPLETED|Cycle 1 (30 Days)||0
10885983|NCT02707692|12052010|FG004|NOT COMPLETED|Cycle 1 (30 Days)||1
10885984|NCT02707692|12052011|FG005|NOT COMPLETED|Cycle 1 (30 Days)||1
10885985|NCT02707692|12052006|FG000|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||8
10885986|NCT02707692|12052007|FG001|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||6
10885987|NCT02707692|12052008|FG002|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||9
10885988|NCT02707692|12052009|FG003|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||9
10885989|NCT02707692|12052010|FG004|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||8
10885990|NCT02707692|12052011|FG005|STARTED|Washout Between Cycles 1 and 2 (>=6 Wks)||8
10885991|NCT02707692|12052006|FG000|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||7
10885992|NCT02707692|12052007|FG001|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||6
10885993|NCT02707692|12052008|FG002|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||9
10885994|NCT02707692|12052009|FG003|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||8
10885995|NCT02707692|12052010|FG004|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||7
10885996|NCT02707692|12052011|FG005|COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||8
10885997|NCT02707692|12052006|FG000|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||1
10885998|NCT02707692|12052007|FG001|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||0
10885999|NCT02707692|12052008|FG002|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||0
10886000|NCT02707692|12052009|FG003|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||1
10886001|NCT02707692|12052010|FG004|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||1
10886002|NCT02707692|12052011|FG005|NOT COMPLETED|Washout Between Cycles 1 and 2 (>=6 Wks)||0
10886003|NCT02707692|12052006|FG000|STARTED|Cycle 2 (30 Days)||7
10886004|NCT02707692|12052007|FG001|STARTED|Cycle 2 (30 Days)||6
10886005|NCT02707692|12052008|FG002|STARTED|Cycle 2 (30 Days)||9
10886006|NCT02707692|12052009|FG003|STARTED|Cycle 2 (30 Days)||8
10886007|NCT02707692|12052010|FG004|STARTED|Cycle 2 (30 Days)||7
10886008|NCT02707692|12052011|FG005|STARTED|Cycle 2 (30 Days)||8
10886009|NCT02707692|12052006|FG000|COMPLETED|Cycle 2 (30 Days)||6
10886010|NCT02707692|12052007|FG001|COMPLETED|Cycle 2 (30 Days)||6
10886011|NCT02707692|12052008|FG002|COMPLETED|Cycle 2 (30 Days)||9
10886012|NCT02707692|12052009|FG003|COMPLETED|Cycle 2 (30 Days)||7
10886013|NCT02707692|12052010|FG004|COMPLETED|Cycle 2 (30 Days)||4
10886014|NCT02707692|12052011|FG005|COMPLETED|Cycle 2 (30 Days)||7
10886015|NCT02707692|12052006|FG000|NOT COMPLETED|Cycle 2 (30 Days)||1
10886016|NCT02707692|12052007|FG001|NOT COMPLETED|Cycle 2 (30 Days)||0
10886017|NCT02707692|12052008|FG002|NOT COMPLETED|Cycle 2 (30 Days)||0
10886018|NCT02707692|12052009|FG003|NOT COMPLETED|Cycle 2 (30 Days)||1
10886019|NCT02707692|12052010|FG004|NOT COMPLETED|Cycle 2 (30 Days)||3
10886020|NCT02707692|12052011|FG005|NOT COMPLETED|Cycle 2 (30 Days)||1
10886021|NCT02707692|12052006|FG000|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||7
10886022|NCT02707692|12052007|FG001|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||6
10886023|NCT02707692|12052008|FG002|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||9
10886024|NCT02707692|12052009|FG003|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||7
10886025|NCT02707692|12052010|FG004|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||6
10886026|NCT02707692|12052011|FG005|STARTED|Washout Between Cycles 2 and 3 (>=6 Wks)||7
10886027|NCT02707692|12052006|FG000|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||7
10886028|NCT02707692|12052007|FG001|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||6
10886029|NCT02707692|12052008|FG002|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||9
10886030|NCT02707692|12052009|FG003|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||5
10886031|NCT02707692|12052010|FG004|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||6
10886032|NCT02707692|12052011|FG005|COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||6
10886033|NCT02707692|12052006|FG000|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0
10886034|NCT02707692|12052007|FG001|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0
10886035|NCT02707692|12052008|FG002|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0
10886036|NCT02707692|12052009|FG003|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||2
10886037|NCT02707692|12052010|FG004|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||0
10886038|NCT02707692|12052011|FG005|NOT COMPLETED|Washout Between Cycles 2 and 3 (>=6 Wks)||1
10886039|NCT02707692|12052006|FG000|STARTED|Cycle 3 (30 Days)||7
10886040|NCT02707692|12052007|FG001|STARTED|Cycle 3 (30 Days)||6
10886041|NCT02707692|12052008|FG002|STARTED|Cycle 3 (30 Days)||9
10886042|NCT02707692|12052009|FG003|STARTED|Cycle 3 (30 Days)||5
10886043|NCT02707692|12052010|FG004|STARTED|Cycle 3 (30 Days)||6
10886044|NCT02707692|12052011|FG005|STARTED|Cycle 3 (30 Days)||6
10886045|NCT02707692|12052006|FG000|COMPLETED|Cycle 3 (30 Days)||5
10886046|NCT02707692|12052007|FG001|COMPLETED|Cycle 3 (30 Days)||5
10886047|NCT02707692|12052008|FG002|COMPLETED|Cycle 3 (30 Days)||9
10886048|NCT02707692|12052009|FG003|COMPLETED|Cycle 3 (30 Days)||5
10886049|NCT02707692|12052010|FG004|COMPLETED|Cycle 3 (30 Days)||5
10886050|NCT02707692|12052011|FG005|COMPLETED|Cycle 3 (30 Days)||5
10886051|NCT02707692|12052006|FG000|NOT COMPLETED|Cycle 3 (30 Days)||2
10886052|NCT02707692|12052007|FG001|NOT COMPLETED|Cycle 3 (30 Days)||1
10886053|NCT02707692|12052008|FG002|NOT COMPLETED|Cycle 3 (30 Days)||0
10886054|NCT02707692|12052009|FG003|NOT COMPLETED|Cycle 3 (30 Days)||0
10886055|NCT02707692|12052010|FG004|NOT COMPLETED|Cycle 3 (30 Days)||1
10886056|NCT02707692|12052011|FG005|NOT COMPLETED|Cycle 3 (30 Days)||1
10886057|NCT02706951|12052022|FG000|STARTED|Overall Study||216
10886058|NCT02706951|12052023|FG001|STARTED|Overall Study||217
10886059|NCT02706951|12052024|FG002|STARTED|Overall Study||215
10886060|NCT02706951|12052022|FG000|COMPLETED|Overall Study||202
10886061|NCT02706951|12052023|FG001|COMPLETED|Overall Study||201
10886062|NCT02706951|12052024|FG002|COMPLETED|Overall Study||205
10886063|NCT02706951|12052022|FG000|NOT COMPLETED|Overall Study||14
10886064|NCT02706951|12052023|FG001|NOT COMPLETED|Overall Study||16
10886065|NCT02706951|12052024|FG002|NOT COMPLETED|Overall Study||10
10886066|NCT02706405|12052040|FG000|STARTED|Overall Study||5
10886067|NCT02706405|12052041|FG001|STARTED|Overall Study||3
10886068|NCT02706405|12052042|FG002|STARTED|Overall Study||3
10886069|NCT02706405|12052043|FG003|STARTED|Overall Study||1
10886070|NCT02706405|12052044|FG004|STARTED|Overall Study||1
10886071|NCT02706405|12052045|FG005|STARTED|Overall Study||3
10886072|NCT02706405|12052046|FG006|STARTED|Overall Study||6
10886073|NCT02706405|12052047|FG007|STARTED|Overall Study||7
10886074|NCT02706405|12052040|FG000|COMPLETED|Overall Study||1
10886075|NCT02706405|12052041|FG001|COMPLETED|Overall Study||1
10886076|NCT02706405|12052042|FG002|COMPLETED|Overall Study||3
10886077|NCT02706405|12052043|FG003|COMPLETED|Overall Study||0
10886078|NCT02706405|12052044|FG004|COMPLETED|Overall Study||1
10886079|NCT02706405|12052045|FG005|COMPLETED|Overall Study||2
10886080|NCT02706405|12052046|FG006|COMPLETED|Overall Study||3
10886081|NCT02706405|12052047|FG007|COMPLETED|Overall Study||1
10886082|NCT02706405|12052040|FG000|NOT COMPLETED|Overall Study||4
10886083|NCT02706405|12052041|FG001|NOT COMPLETED|Overall Study||2
10886084|NCT02706405|12052042|FG002|NOT COMPLETED|Overall Study||0
10886085|NCT02706405|12052043|FG003|NOT COMPLETED|Overall Study||1
10886086|NCT02706405|12052044|FG004|NOT COMPLETED|Overall Study||0
10886087|NCT02706405|12052045|FG005|NOT COMPLETED|Overall Study||1
10886088|NCT02706405|12052046|FG006|NOT COMPLETED|Overall Study||3
10886089|NCT02706405|12052047|FG007|NOT COMPLETED|Overall Study||6
10886090|NCT02706392|12052079|FG000|STARTED|Overall Study||2
10886091|NCT02706392|12052080|FG001|STARTED|Overall Study||1
10886092|NCT02706392|12052081|FG002|STARTED|Overall Study||2
10886093|NCT02706392|12052082|FG003|STARTED|Overall Study||3
10886094|NCT02706392|12052083|FG004|STARTED|Overall Study||11
10886095|NCT02706392|12052084|FG005|STARTED|Overall Study||2
10886096|NCT02706392|12052079|FG000|COMPLETED|Overall Study||1
10886097|NCT02706392|12052080|FG001|COMPLETED|Overall Study||1
10886098|NCT02706392|12052081|FG002|COMPLETED|Overall Study||0
10886099|NCT02706392|12052082|FG003|COMPLETED|Overall Study||1
10886100|NCT02706392|12052083|FG004|COMPLETED|Overall Study||6
10886101|NCT02706392|12052084|FG005|COMPLETED|Overall Study||0
10886102|NCT02706392|12052079|FG000|NOT COMPLETED|Overall Study||1
10886103|NCT02706392|12052080|FG001|NOT COMPLETED|Overall Study||0
10886104|NCT02706392|12052081|FG002|NOT COMPLETED|Overall Study||2
10886105|NCT02706392|12052082|FG003|NOT COMPLETED|Overall Study||2
10886106|NCT02706392|12052083|FG004|NOT COMPLETED|Overall Study||5
10886107|NCT02706392|12052084|FG005|NOT COMPLETED|Overall Study||2
10886108|NCT02705755|12052098|FG000|STARTED|Part A (6 Days)||34
10886109|NCT02705755|12052099|FG001|STARTED|Part A (6 Days)||0
10886110|NCT02705755|12052100|FG002|STARTED|Part A (6 Days)||0
10886111|NCT02705755|12052101|FG003|STARTED|Part A (6 Days)||0
10886112|NCT02705755|12052098|FG000|Participants Who Received Placebo|Part A (6 Days)||34
10886113|NCT02705755|12052099|FG001|Participants Who Received Placebo|Part A (6 Days)||0
10886114|NCT02705755|12052100|FG002|Participants Who Received Placebo|Part A (6 Days)||0
10886115|NCT02705755|12052101|FG003|Participants Who Received Placebo|Part A (6 Days)||0
10886116|NCT02705755|12052098|FG000|Participants Who Received 1 mg Study Drug|Part A (6 Days)||17
10886117|NCT02705755|12052099|FG001|Participants Who Received 1 mg Study Drug|Part A (6 Days)||0
10886118|NCT02705755|12052100|FG002|Participants Who Received 1 mg Study Drug|Part A (6 Days)||0
10886119|NCT02705755|12052101|FG003|Participants Who Received 1 mg Study Drug|Part A (6 Days)||0
10886120|NCT02705755|12052098|FG000|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||31
10886121|NCT02705755|12052099|FG001|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||0
10886122|NCT02705755|12052100|FG002|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||0
10886123|NCT02705755|12052101|FG003|Participants Who Received 2.5 mg Study Drug|Part A (6 Days)||0
10886124|NCT02705755|12052098|FG000|Participants Who Received 5 mg Study Drug|Part A (6 Days)||29
10886125|NCT02705755|12052099|FG001|Participants Who Received 5 mg Study Drug|Part A (6 Days)||0
10886126|NCT02705755|12052100|FG002|Participants Who Received 5 mg Study Drug|Part A (6 Days)||0
10886127|NCT02705755|12052101|FG003|Participants Who Received 5 mg Study Drug|Part A (6 Days)||0
10886128|NCT02705755|12052098|FG000|Participants Who Received 10 mg Study Drug|Part A (6 Days)||28
10886129|NCT02705755|12052099|FG001|Participants Who Received 10 mg Study Drug|Part A (6 Days)||0
10886130|NCT02705755|12052100|FG002|Participants Who Received 10 mg Study Drug|Part A (6 Days)||0
10886131|NCT02705755|12052101|FG003|Participants Who Received 10 mg Study Drug|Part A (6 Days)||0
10886132|NCT02705755|12052098|FG000|Participants Who Received 20 mg Study Drug|Part A (6 Days)||13
10886133|NCT02705755|12052099|FG001|Participants Who Received 20 mg Study Drug|Part A (6 Days)||0
10886134|NCT02705755|12052100|FG002|Participants Who Received 20 mg Study Drug|Part A (6 Days)||0
10886135|NCT02705755|12052101|FG003|Participants Who Received 20 mg Study Drug|Part A (6 Days)||0
10886136|NCT02705755|12052098|FG000|Participants Who Rolled to Part B|Part A (6 Days)||10
10886137|NCT02705755|12052099|FG001|Participants Who Rolled to Part B|Part A (6 Days)||0
10886138|NCT02705755|12052100|FG002|Participants Who Rolled to Part B|Part A (6 Days)||0
10886139|NCT02705755|12052101|FG003|Participants Who Rolled to Part B|Part A (6 Days)||0
10886140|NCT02705755|12052098|FG000|Participants Who Rolled to Part C|Part A (6 Days)||21
10886141|NCT02705755|12052099|FG001|Participants Who Rolled to Part C|Part A (6 Days)||0
10886142|NCT02705755|12052100|FG002|Participants Who Rolled to Part C|Part A (6 Days)||0
10886143|NCT02705755|12052101|FG003|Participants Who Rolled to Part C|Part A (6 Days)||0
10886144|NCT02705755|12052098|FG000|COMPLETED|Part A (6 Days)||29
10886145|NCT02705755|12052099|FG001|COMPLETED|Part A (6 Days)||0
10886146|NCT02705755|12052100|FG002|COMPLETED|Part A (6 Days)||0
10886147|NCT02705755|12052101|FG003|COMPLETED|Part A (6 Days)||0
10886148|NCT02705755|12052098|FG000|NOT COMPLETED|Part A (6 Days)||5
10886149|NCT02705755|12052099|FG001|NOT COMPLETED|Part A (6 Days)||0
10886150|NCT02705755|12052100|FG002|NOT COMPLETED|Part A (6 Days)||0
10886151|NCT02705755|12052101|FG003|NOT COMPLETED|Part A (6 Days)||0
10886152|NCT02705755|12052098|FG000|STARTED|Part B (1 Day)||0
10886153|NCT02705755|12052099|FG001|STARTED|Part B (1 Day)||5
10886154|NCT02705755|12052100|FG002|STARTED|Part B (1 Day)|Each participant received their individual maximum tolerated dose from Part A.|5
10886155|NCT02705755|12052101|FG003|STARTED|Part B (1 Day)||0
10886156|NCT02705755|12052098|FG000|Received Study Drug|Part B (1 Day)||0
10886157|NCT02705755|12052099|FG001|Received Study Drug|Part B (1 Day)||5
10886158|NCT02705755|12052100|FG002|Received Study Drug|Part B (1 Day)||5
10886159|NCT02705755|12052101|FG003|Received Study Drug|Part B (1 Day)||0
10886160|NCT02705755|12052098|FG000|COMPLETED|Part B (1 Day)||0
10886161|NCT02705755|12052099|FG001|COMPLETED|Part B (1 Day)||5
10886162|NCT02705755|12052100|FG002|COMPLETED|Part B (1 Day)||5
10886163|NCT02705755|12052101|FG003|COMPLETED|Part B (1 Day)||0
10886164|NCT02705755|12052098|FG000|NOT COMPLETED|Part B (1 Day)||0
10886165|NCT02705755|12052099|FG001|NOT COMPLETED|Part B (1 Day)||0
10886166|NCT02705755|12052100|FG002|NOT COMPLETED|Part B (1 Day)||0
10886167|NCT02705755|12052101|FG003|NOT COMPLETED|Part B (1 Day)||0
10886168|NCT02705755|12052098|FG000|STARTED|Part C (20 Weeks)||0
10886169|NCT02705755|12052099|FG001|STARTED|Part C (20 Weeks)||0
10886170|NCT02705755|12052100|FG002|STARTED|Part C (20 Weeks)||0
10886171|NCT02705755|12052101|FG003|STARTED|Part C (20 Weeks)||21
10886172|NCT02705755|12052098|FG000|Received Study Drug|Part C (20 Weeks)||0
10886173|NCT02705755|12052099|FG001|Received Study Drug|Part C (20 Weeks)||0
10886174|NCT02705755|12052100|FG002|Received Study Drug|Part C (20 Weeks)||0
10886175|NCT02705755|12052101|FG003|Received Study Drug|Part C (20 Weeks)||21
10886176|NCT02705755|12052098|FG000|COMPLETED|Part C (20 Weeks)||0
10886177|NCT02705755|12052099|FG001|COMPLETED|Part C (20 Weeks)||0
10886178|NCT02705755|12052100|FG002|COMPLETED|Part C (20 Weeks)||0
10886179|NCT02705755|12052101|FG003|COMPLETED|Part C (20 Weeks)||11
10886180|NCT02705755|12052098|FG000|NOT COMPLETED|Part C (20 Weeks)||0
10886181|NCT02705755|12052099|FG001|NOT COMPLETED|Part C (20 Weeks)||0
10886182|NCT02705755|12052100|FG002|NOT COMPLETED|Part C (20 Weeks)||0
10886183|NCT02705755|12052101|FG003|NOT COMPLETED|Part C (20 Weeks)||10
10886184|NCT02705105|12052136|FG000|STARTED|Treatment||4
10886185|NCT02705105|12052137|FG001|STARTED|Treatment||110
10886186|NCT02705105|12052136|FG000|Subjects Who Were Replaced|Treatment||1
10886187|NCT02705105|12052137|FG001|Subjects Who Were Replaced|Treatment||0
10886188|NCT02705105|12052136|FG000|D/C From Treatment Phase|Treatment||4
10886189|NCT02705105|12052137|FG001|D/C From Treatment Phase|Treatment||107
10886190|NCT02705105|12052136|FG000|D/C From Follow-Up|Treatment||4
10886191|NCT02705105|12052137|FG001|D/C From Follow-Up|Treatment||110
10886192|NCT02705105|12052136|FG000|COMPLETED|Treatment||0
10886193|NCT02705105|12052137|FG001|COMPLETED|Treatment||1
10886194|NCT02705105|12052136|FG000|NOT COMPLETED|Treatment||4
10886195|NCT02705105|12052137|FG001|NOT COMPLETED|Treatment||109
10886196|NCT02705105|12052136|FG000|STARTED|Follow-Up||4
10886197|NCT02705105|12052137|FG001|STARTED|Follow-Up||110
10886198|NCT02705105|12052136|FG000|COMPLETED|Follow-Up||0
10886199|NCT02705105|12052137|FG001|COMPLETED|Follow-Up||0
10886200|NCT02705105|12052136|FG000|NOT COMPLETED|Follow-Up||4
10886201|NCT02705105|12052137|FG001|NOT COMPLETED|Follow-Up||110
10886202|NCT02703948|12052155|FG000|STARTED|Overall Study||60
10886203|NCT02703948|12052155|FG000|COMPLETED|Overall Study||57
10886204|NCT02703948|12052155|FG000|NOT COMPLETED|Overall Study||3
10886205|NCT02698189|12052161|FG000|STARTED|Overall Study||3
10886206|NCT02698189|12052162|FG001|STARTED|Overall Study||6
10886207|NCT02698189|12052161|FG000|COMPLETED|Overall Study||0
10886208|NCT02698189|12052162|FG001|COMPLETED|Overall Study||0
10886209|NCT02698189|12052161|FG000|NOT COMPLETED|Overall Study||3
10886210|NCT02698189|12052162|FG001|NOT COMPLETED|Overall Study||6
10886211|NCT02697006|12052172|FG000|STARTED|Overall Study||34
10886212|NCT02697006|12052173|FG001|STARTED|Overall Study||13
10886213|NCT02697006|12052172|FG000|COMPLETED|Overall Study||31
10886214|NCT02697006|12052173|FG001|COMPLETED|Overall Study||9
10886215|NCT02697006|12052172|FG000|NOT COMPLETED|Overall Study||3
10886216|NCT02697006|12052173|FG001|NOT COMPLETED|Overall Study||4
10886217|NCT02696096|12052179|FG000|STARTED|Overall Study||21
10886218|NCT02696096|12052179|FG000|Opioid Abstinence During Study Period|Overall Study||11
10886219|NCT02696096|12052179|FG000|COMPLETED|Overall Study||19
10886220|NCT02696096|12052179|FG000|NOT COMPLETED|Overall Study||2
10886221|NCT02689284|12052189|FG000|STARTED|Overall Study||3
10886222|NCT02689284|12052190|FG001|STARTED|Overall Study||92
10886223|NCT02689284|12052189|FG000|COMPLETED|Overall Study||0
10886224|NCT02689284|12052190|FG001|COMPLETED|Overall Study||5
10886225|NCT02689284|12052189|FG000|NOT COMPLETED|Overall Study||3
10886226|NCT02689284|12052190|FG001|NOT COMPLETED|Overall Study||87
10886227|NCT02688647|12052199|FG000|STARTED|Initial Treatment Period (24 Weeks)||52
10886228|NCT02688647|12052200|FG001|STARTED|Initial Treatment Period (24 Weeks)||24
10886229|NCT02688647|12052199|FG000|Treated|Initial Treatment Period (24 Weeks)|1 subject was randomized but did not receive treatment.|51
10886230|NCT02688647|12052200|FG001|Treated|Initial Treatment Period (24 Weeks)||24
10886231|NCT02688647|12052199|FG000|COMPLETED|Initial Treatment Period (24 Weeks)||51
10886232|NCT02688647|12052200|FG001|COMPLETED|Initial Treatment Period (24 Weeks)||18
10886233|NCT02688647|12052199|FG000|NOT COMPLETED|Initial Treatment Period (24 Weeks)||1
10886234|NCT02688647|12052200|FG001|NOT COMPLETED|Initial Treatment Period (24 Weeks)||6
10886235|NCT02688647|12052199|FG000|STARTED|Post Switch Treatment Period (72 Weeks)|51 subjects originally randomized to treatment with belumosudil 400 mg PO QD continued receiving belumosudil 400 mg PO QD.|51
10886236|NCT02688647|12052200|FG001|STARTED|Post Switch Treatment Period (72 Weeks)|17 subjects randomized to treatment with BSC-R cross-overed to treatment with belumosudil 400 mg PO QD.|17
10886237|NCT02688647|12052199|FG000|COMPLETED|Post Switch Treatment Period (72 Weeks)||23
10886238|NCT02688647|12052200|FG001|COMPLETED|Post Switch Treatment Period (72 Weeks)||3
10886239|NCT02688647|12052199|FG000|NOT COMPLETED|Post Switch Treatment Period (72 Weeks)||28
10886240|NCT02688647|12052200|FG001|NOT COMPLETED|Post Switch Treatment Period (72 Weeks)||14
10886241|NCT02688556|12052220|FG000|STARTED|Overall Study||372
10886242|NCT02688556|12052221|FG001|STARTED|Overall Study||373
10886243|NCT02688556|12052220|FG000|COMPLETED|Overall Study||347
10886244|NCT02688556|12052221|FG001|COMPLETED|Overall Study||361
10886245|NCT02688556|12052220|FG000|NOT COMPLETED|Overall Study||25
10886246|NCT02688556|12052221|FG001|NOT COMPLETED|Overall Study||12
10886247|NCT02685826|12052230|FG000|STARTED|Overall Study||25
10886248|NCT02685826|12052231|FG001|STARTED|Overall Study||10
10886249|NCT02685826|12052232|FG002|STARTED|Overall Study||21
10886250|NCT02685826|12052230|FG000|COMPLETED|Overall Study||0
10886251|NCT02685826|12052231|FG001|COMPLETED|Overall Study||0
10886252|NCT02685826|12052232|FG002|COMPLETED|Overall Study||0
10886253|NCT02685826|12052230|FG000|NOT COMPLETED|Overall Study||25
10886254|NCT02685826|12052231|FG001|NOT COMPLETED|Overall Study||10
10886255|NCT02685826|12052232|FG002|NOT COMPLETED|Overall Study||21
10886256|NCT02680587|12052242|FG000|STARTED|Overall Study||18
10886257|NCT02680587|12052243|FG001|STARTED|Overall Study||36
10886258|NCT02680587|12052242|FG000|COMPLETED|Overall Study||17
10886259|NCT02680587|12052243|FG001|COMPLETED|Overall Study||36
10886260|NCT02680587|12052242|FG000|NOT COMPLETED|Overall Study||1
10886261|NCT02680587|12052243|FG001|NOT COMPLETED|Overall Study||0
10886262|NCT02680314|12052255|FG000|STARTED|Overall Study||120
10886263|NCT02680314|12052256|FG001|STARTED|Overall Study||123
10886264|NCT02680314|12052255|FG000|COMPLETED|Overall Study||120
10886265|NCT02680314|12052256|FG001|COMPLETED|Overall Study||123
10886266|NCT02680314|12052255|FG000|NOT COMPLETED|Overall Study||0
10886267|NCT02680314|12052256|FG001|NOT COMPLETED|Overall Study||0
10886268|NCT02679755|12052264|FG000|STARTED|Overall Study||100
10886269|NCT02679755|12052265|FG001|STARTED|Overall Study||152
10886270|NCT02679755|12052264|FG000|COMPLETED|Overall Study||66
10886271|NCT02679755|12052265|FG001|COMPLETED|Overall Study||47
10886272|NCT02679755|12052264|FG000|NOT COMPLETED|Overall Study||34
10886273|NCT02679755|12052265|FG001|NOT COMPLETED|Overall Study||105
10886274|NCT02677896|12052276|FG000|STARTED|Double Blind Period (up to 35 Months)||574
10886275|NCT02677896|12052277|FG001|STARTED|Double Blind Period (up to 35 Months)||576
10886276|NCT02677896|12052276|FG000|Treated|Double Blind Period (up to 35 Months)||572
10886277|NCT02677896|12052277|FG001|Treated|Double Blind Period (up to 35 Months)||574
10886278|NCT02677896|12052276|FG000|COMPLETED|Double Blind Period (up to 35 Months)||0
10886279|NCT02677896|12052277|FG001|COMPLETED|Double Blind Period (up to 35 Months)||0
10886280|NCT02677896|12052276|FG000|NOT COMPLETED|Double Blind Period (up to 35 Months)||574
10886281|NCT02677896|12052277|FG001|NOT COMPLETED|Double Blind Period (up to 35 Months)||576
10886282|NCT02677896|12052276|FG000|STARTED|Open-Label Extension (up to 25 Months)|Eligible participants who provided consent took part in open-label period|365
10886283|NCT02677896|12052277|FG001|STARTED|Open-Label Extension (up to 25 Months)|Eligible participants who provided consent took part in open-label period|180
10886284|NCT02677896|12052276|FG000|COMPLETED|Open-Label Extension (up to 25 Months)||0
10886285|NCT02677896|12052277|FG001|COMPLETED|Open-Label Extension (up to 25 Months)||0
10886286|NCT02677896|12052276|FG000|NOT COMPLETED|Open-Label Extension (up to 25 Months)||365
10886287|NCT02677896|12052277|FG001|NOT COMPLETED|Open-Label Extension (up to 25 Months)||180
10886288|NCT02675231|12052287|FG000|STARTED|Overall Study||79
10886289|NCT02675231|12052288|FG001|STARTED|Overall Study||79
10886290|NCT02675231|12052289|FG002|STARTED|Overall Study||79
10886291|NCT02675231|12052287|FG000|Received at Least One Dose of Drug|Overall Study||78
10886292|NCT02675231|12052288|FG001|Received at Least One Dose of Drug|Overall Study||77
10886293|NCT02675231|12052289|FG002|Received at Least One Dose of Drug|Overall Study||72
10886294|NCT02675231|12052287|FG000|COMPLETED|Overall Study||53
10886295|NCT02675231|12052288|FG001|COMPLETED|Overall Study||43
10886296|NCT02675231|12052289|FG002|COMPLETED|Overall Study||53
10886297|NCT02675231|12052287|FG000|NOT COMPLETED|Overall Study||26
10886298|NCT02675231|12052288|FG001|NOT COMPLETED|Overall Study||36
10886299|NCT02675231|12052289|FG002|NOT COMPLETED|Overall Study||26
10886300|NCT02673697|12052300|FG000|STARTED|Overall Study||453
10886301|NCT02673697|12052301|FG001|STARTED|Overall Study||457
10886302|NCT02673697|12052300|FG000|Implanted|Overall Study||450
10886303|NCT02673697|12052301|FG001|Implanted|Overall Study||446
10886304|NCT02673697|12052300|FG000|Per-Protocol Population|Overall Study||407
10886305|NCT02673697|12052301|FG001|Per-Protocol Population|Overall Study||412
10886306|NCT02673697|12052300|FG000|COMPLETED|Overall Study||0
10886307|NCT02673697|12052301|FG001|COMPLETED|Overall Study||0
10886308|NCT02673697|12052300|FG000|NOT COMPLETED|Overall Study||453
10886309|NCT02673697|12052301|FG001|NOT COMPLETED|Overall Study||457
10886310|NCT02673398|12052307|FG000|STARTED|Overall Study||25
10886311|NCT02673398|12052307|FG000|COMPLETED|Overall Study||25
10886312|NCT02673398|12052307|FG000|NOT COMPLETED|Overall Study||0
10886313|NCT02667587|12052313|FG000|STARTED|Pre-Treatment||358
10886314|NCT02667587|12052314|FG001|STARTED|Pre-Treatment||358
10886315|NCT02667587|12052313|FG000|COMPLETED|Pre-Treatment||354
10886316|NCT02667587|12052314|FG001|COMPLETED|Pre-Treatment||355
10886317|NCT02667587|12052313|FG000|NOT COMPLETED|Pre-Treatment||4
10886318|NCT02667587|12052314|FG001|NOT COMPLETED|Pre-Treatment||3
10886407|NCT02657343|12052421|FG001|NOT COMPLETED|Overall Study||2
10886408|NCT02657343|12052422|FG002|NOT COMPLETED|Overall Study||0
10886319|NCT02667587|12052313|FG000|STARTED|End of Treatment|1 participant was randomized to Radiotherapy, Temozolomide plus Placebo but received Radiotherapy, Temozolomide plus Nivolumab.|355
10886320|NCT02667587|12052314|FG001|STARTED|End of Treatment|1 participant was randomized to Radiotherapy, Temozolomide plus Placebo but received Radiotherapy, Temozolomide plus Nivolumab.|354
10886321|NCT02667587|12052313|FG000|COMPLETED|End of Treatment||37
10886322|NCT02667587|12052314|FG001|COMPLETED|End of Treatment||44
10886323|NCT02667587|12052313|FG000|NOT COMPLETED|End of Treatment||318
10886324|NCT02667587|12052314|FG001|NOT COMPLETED|End of Treatment||310
10886325|NCT02667119|12052322|FG000|STARTED|Overall Study||14
10886326|NCT02667119|12052323|FG001|STARTED|Overall Study||13
10886327|NCT02667119|12052322|FG000|COMPLETED|Overall Study||11
10886328|NCT02667119|12052323|FG001|COMPLETED|Overall Study||13
10886329|NCT02667119|12052322|FG000|NOT COMPLETED|Overall Study||3
10886330|NCT02667119|12052323|FG001|NOT COMPLETED|Overall Study||0
10886331|NCT02666742|12052331|FG000|STARTED|Overall Study||123
10886332|NCT02666742|12052332|FG001|STARTED|Overall Study||123
10886333|NCT02666742|12052331|FG000|COMPLETED|Overall Study||123
10886334|NCT02666742|12052332|FG001|COMPLETED|Overall Study||123
10886335|NCT02666742|12052331|FG000|NOT COMPLETED|Overall Study||0
10886336|NCT02666742|12052332|FG001|NOT COMPLETED|Overall Study||0
10886337|NCT02665481|12052344|FG000|STARTED|Overall Study||150
10886338|NCT02665481|12052345|FG001|STARTED|Overall Study||138
10886339|NCT02665481|12052346|FG002|STARTED|Overall Study||144
10886340|NCT02665481|12052347|FG003|STARTED|Overall Study||153
10886341|NCT02665481|12052344|FG000|COMPLETED|Overall Study||139
10886342|NCT02665481|12052345|FG001|COMPLETED|Overall Study||119
10886343|NCT02665481|12052346|FG002|COMPLETED|Overall Study||106
10886344|NCT02665481|12052347|FG003|COMPLETED|Overall Study||111
10886345|NCT02665481|12052344|FG000|NOT COMPLETED|Overall Study||11
10886346|NCT02665481|12052345|FG001|NOT COMPLETED|Overall Study||19
10886347|NCT02665481|12052346|FG002|NOT COMPLETED|Overall Study||38
10886348|NCT02665481|12052347|FG003|NOT COMPLETED|Overall Study||42
10886349|NCT02665338|12052359|FG000|STARTED|Overall Study||5
10886350|NCT02665338|12052360|FG001|STARTED|Overall Study||6
10886351|NCT02665338|12052359|FG000|COMPLETED|Overall Study||5
10886352|NCT02665338|12052360|FG001|COMPLETED|Overall Study||5
10886353|NCT02665338|12052359|FG000|NOT COMPLETED|Overall Study||0
10886354|NCT02665338|12052360|FG001|NOT COMPLETED|Overall Study||1
10886355|NCT02664181|12052368|FG000|STARTED|Overall Study||8
10886356|NCT02664181|12052369|FG001|STARTED|Overall Study||5
10886357|NCT02664181|12052368|FG000|COMPLETED|Overall Study||8
10886358|NCT02664181|12052369|FG001|COMPLETED|Overall Study||5
10886359|NCT02664181|12052368|FG000|NOT COMPLETED|Overall Study||0
10886360|NCT02664181|12052369|FG001|NOT COMPLETED|Overall Study||0
10886361|NCT02660359|12052378|FG000|STARTED|Overall Study||86
10886362|NCT02660359|12052379|FG001|STARTED|Overall Study||86
10886363|NCT02660359|12052380|FG002|STARTED|Overall Study||85
10886364|NCT02660359|12052378|FG000|Subjects Entered in the Dysport Cycles|Overall Study||56
10886365|NCT02660359|12052379|FG001|Subjects Entered in the Dysport Cycles|Overall Study||86
10886366|NCT02660359|12052380|FG002|Subjects Entered in the Dysport Cycles|Overall Study||85
10886367|NCT02660359|12052378|FG000|COMPLETED|Overall Study||0
10886368|NCT02660359|12052379|FG001|COMPLETED|Overall Study||0
10886369|NCT02660359|12052380|FG002|COMPLETED|Overall Study||1
10886370|NCT02660359|12052378|FG000|NOT COMPLETED|Overall Study||86
10886371|NCT02660359|12052379|FG001|NOT COMPLETED|Overall Study||86
10886372|NCT02660359|12052380|FG002|NOT COMPLETED|Overall Study||84
10886373|NCT02660138|12052391|FG000|STARTED|Overall Study||76
10886374|NCT02660138|12052392|FG001|STARTED|Overall Study||76
10886375|NCT02660138|12052393|FG002|STARTED|Overall Study||75
10886376|NCT02660138|12052391|FG000|Subjects Treated in DBPC Cycle|Overall Study||76
10886377|NCT02660138|12052392|FG001|Subjects Treated in DBPC Cycle|Overall Study||75
10886378|NCT02660138|12052393|FG002|Subjects Treated in DBPC Cycle|Overall Study||75
10886379|NCT02660138|12052391|FG000|Subjects Entered in the Dysport Cycles|Overall Study||49
10886380|NCT02660138|12052392|FG001|Subjects Entered in the Dysport Cycles|Overall Study||75
10886381|NCT02660138|12052393|FG002|Subjects Entered in the Dysport Cycles|Overall Study||75
10886382|NCT02660138|12052391|FG000|COMPLETED|Overall Study||6
10886383|NCT02660138|12052392|FG001|COMPLETED|Overall Study||2
10886384|NCT02660138|12052393|FG002|COMPLETED|Overall Study||3
10886385|NCT02660138|12052391|FG000|NOT COMPLETED|Overall Study||70
10886386|NCT02660138|12052392|FG001|NOT COMPLETED|Overall Study||74
10886387|NCT02660138|12052393|FG002|NOT COMPLETED|Overall Study||72
10886388|NCT02659059|12052406|FG000|STARTED|Overall Study||288
10886389|NCT02659059|12052407|FG001|STARTED|Overall Study||36
10886390|NCT02659059|12052406|FG000|COMPLETED|Overall Study||88
10886391|NCT02659059|12052407|FG001|COMPLETED|Overall Study||4
10886392|NCT02659059|12052406|FG000|NOT COMPLETED|Overall Study||200
10886393|NCT02659059|12052407|FG001|NOT COMPLETED|Overall Study||32
10886394|NCT02657343|12052420|FG000|STARTED|Overall Study||3
10886395|NCT02657343|12052421|FG001|STARTED|Overall Study||3
10886396|NCT02657343|12052422|FG002|STARTED|Overall Study||3
10886397|NCT02657343|12052423|FG003|STARTED|Overall Study||3
10886398|NCT02657343|12052424|FG004|STARTED|Overall Study||13
10886399|NCT02657343|12052425|FG005|STARTED|Overall Study||0
10886400|NCT02657343|12052420|FG000|COMPLETED|Overall Study||2
10886401|NCT02657343|12052421|FG001|COMPLETED|Overall Study||1
10886402|NCT02657343|12052422|FG002|COMPLETED|Overall Study||3
10886403|NCT02657343|12052423|FG003|COMPLETED|Overall Study||3
10886404|NCT02657343|12052424|FG004|COMPLETED|Overall Study||12
10886405|NCT02657343|12052425|FG005|COMPLETED|Overall Study||0
10886406|NCT02657343|12052420|FG000|NOT COMPLETED|Overall Study||1
10886409|NCT02657343|12052423|FG003|NOT COMPLETED|Overall Study||0
10886410|NCT02657343|12052424|FG004|NOT COMPLETED|Overall Study||1
10886411|NCT02657343|12052425|FG005|NOT COMPLETED|Overall Study||0
10886412|NCT02656017|12052441|FG000|STARTED|Overall Study||49
10886413|NCT02656017|12052442|FG001|STARTED|Overall Study||48
10886414|NCT02656017|12052441|FG000|COMPLETED|Overall Study||40
10886415|NCT02656017|12052442|FG001|COMPLETED|Overall Study||42
10886416|NCT02656017|12052441|FG000|NOT COMPLETED|Overall Study||9
10886417|NCT02656017|12052442|FG001|NOT COMPLETED|Overall Study||6
10886418|NCT02652767|12052448|FG000|STARTED|Overall Study||39
10886419|NCT02652767|12052448|FG000|Completed Week 48|Overall Study||38
10886420|NCT02652767|12052448|FG000|COMPLETED|Overall Study||35
10886421|NCT02652767|12052448|FG000|NOT COMPLETED|Overall Study||4
10886422|NCT02652260|12052456|FG000|STARTED|Overall Study||43
10886423|NCT02652260|12052457|FG001|STARTED|Overall Study||43
10886424|NCT02652260|12052456|FG000|COMPLETED|Overall Study||43
10886425|NCT02652260|12052457|FG001|COMPLETED|Overall Study||41
10886426|NCT02652260|12052456|FG000|NOT COMPLETED|Overall Study||0
10886427|NCT02652260|12052457|FG001|NOT COMPLETED|Overall Study||2
10886428|NCT02650921|12052466|FG000|STARTED|Overall Study||92
10886429|NCT02650921|12052466|FG000|COMPLETED|Overall Study||84
10886430|NCT02650921|12052466|FG000|NOT COMPLETED|Overall Study||8
10886431|NCT02644967|12052472|FG000|STARTED|Overall Study|All participants who received at least 1 dose of study treatment (8 mg Tilso/Ipi) including nine rollover participants from the Phase 1 study.|53
10886432|NCT02644967|12052472|FG000|COMPLETED|Overall Study||18
10886433|NCT02644967|12052472|FG000|NOT COMPLETED|Overall Study||35
10886434|NCT02642042|12052476|FG000|STARTED|Overall Study||54
10886435|NCT02642042|12052476|FG000|COMPLETED|Overall Study||0
10886436|NCT02642042|12052476|FG000|NOT COMPLETED|Overall Study||54
10886437|NCT02639546|12052488|FG000|STARTED|Overall Study||6
10886438|NCT02639546|12052489|FG001|STARTED|Overall Study||6
10886439|NCT02639546|12052490|FG002|STARTED|Overall Study||6
10886440|NCT02639546|12052491|FG003|STARTED|Overall Study||6
10886441|NCT02639546|12052492|FG004|STARTED|Overall Study||7
10886442|NCT02639546|12052493|FG005|STARTED|Overall Study||8
10886443|NCT02639546|12052494|FG006|STARTED|Overall Study||5
10886444|NCT02639546|12052495|FG007|STARTED|Overall Study||12
10886445|NCT02639546|12052488|FG000|Tumor Type - Neuroblastoma|Overall Study||0
10886446|NCT02639546|12052489|FG001|Tumor Type - Neuroblastoma|Overall Study||0
10886447|NCT02639546|12052490|FG002|Tumor Type - Neuroblastoma|Overall Study||1
10886448|NCT02639546|12052491|FG003|Tumor Type - Neuroblastoma|Overall Study||0
10886449|NCT02639546|12052492|FG004|Tumor Type - Neuroblastoma|Overall Study||0
10886450|NCT02639546|12052493|FG005|Tumor Type - Neuroblastoma|Overall Study||0
10886451|NCT02639546|12052494|FG006|Tumor Type - Neuroblastoma|Overall Study||0
10886452|NCT02639546|12052495|FG007|Tumor Type - Neuroblastoma|Overall Study||0
10886453|NCT02639546|12052488|FG000|Tumor Type - High-Grade Glioma|Overall Study||3
10886454|NCT02639546|12052489|FG001|Tumor Type - High-Grade Glioma|Overall Study||1
10886455|NCT02639546|12052490|FG002|Tumor Type - High-Grade Glioma|Overall Study||0
10886456|NCT02639546|12052491|FG003|Tumor Type - High-Grade Glioma|Overall Study||0
10886457|NCT02639546|12052492|FG004|Tumor Type - High-Grade Glioma|Overall Study||1
10886458|NCT02639546|12052493|FG005|Tumor Type - High-Grade Glioma|Overall Study||0
10886459|NCT02639546|12052494|FG006|Tumor Type - High-Grade Glioma|Overall Study||0
10886460|NCT02639546|12052495|FG007|Tumor Type - High-Grade Glioma|Overall Study||0
10886461|NCT02639546|12052488|FG000|Tumor Type - Low-Grade Glioma|Overall Study||1
10886462|NCT02639546|12052489|FG001|Tumor Type - Low-Grade Glioma|Overall Study||2
10886463|NCT02639546|12052490|FG002|Tumor Type - Low-Grade Glioma|Overall Study||4
10886464|NCT02639546|12052491|FG003|Tumor Type - Low-Grade Glioma|Overall Study||5
10886465|NCT02639546|12052492|FG004|Tumor Type - Low-Grade Glioma|Overall Study||3
10886466|NCT02639546|12052493|FG005|Tumor Type - Low-Grade Glioma|Overall Study||2
10886467|NCT02639546|12052494|FG006|Tumor Type - Low-Grade Glioma|Overall Study||3
10886468|NCT02639546|12052495|FG007|Tumor Type - Low-Grade Glioma|Overall Study||12
10886469|NCT02639546|12052488|FG000|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886470|NCT02639546|12052489|FG001|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886471|NCT02639546|12052490|FG002|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886472|NCT02639546|12052491|FG003|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886473|NCT02639546|12052492|FG004|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886474|NCT02639546|12052493|FG005|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886475|NCT02639546|12052494|FG006|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||1
10886476|NCT02639546|12052495|FG007|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886477|NCT02639546|12052488|FG000|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
10886478|NCT02639546|12052489|FG001|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
10886479|NCT02639546|12052490|FG002|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
10886480|NCT02639546|12052491|FG003|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
10886481|NCT02639546|12052492|FG004|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||1
10886482|NCT02639546|12052493|FG005|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||1
10886483|NCT02639546|12052494|FG006|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
10886484|NCT02639546|12052495|FG007|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
10886485|NCT02639546|12052488|FG000|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||1
10886486|NCT02639546|12052489|FG001|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886487|NCT02639546|12052490|FG002|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886488|NCT02639546|12052491|FG003|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886489|NCT02639546|12052492|FG004|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886490|NCT02639546|12052493|FG005|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886491|NCT02639546|12052494|FG006|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886492|NCT02639546|12052495|FG007|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
10886493|NCT02639546|12052488|FG000|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10886494|NCT02639546|12052489|FG001|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||1
10886495|NCT02639546|12052490|FG002|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10886496|NCT02639546|12052491|FG003|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10886497|NCT02639546|12052492|FG004|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10886498|NCT02639546|12052493|FG005|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10886499|NCT02639546|12052494|FG006|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10886500|NCT02639546|12052495|FG007|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
10886501|NCT02639546|12052488|FG000|Tumor Type - Plexiform Neurofibroma|Overall Study||1
10886502|NCT02639546|12052489|FG001|Tumor Type - Plexiform Neurofibroma|Overall Study||2
10886503|NCT02639546|12052490|FG002|Tumor Type - Plexiform Neurofibroma|Overall Study||1
10886504|NCT02639546|12052491|FG003|Tumor Type - Plexiform Neurofibroma|Overall Study||1
10886505|NCT02639546|12052492|FG004|Tumor Type - Plexiform Neurofibroma|Overall Study||2
10886506|NCT02639546|12052493|FG005|Tumor Type - Plexiform Neurofibroma|Overall Study||4
10886507|NCT02639546|12052494|FG006|Tumor Type - Plexiform Neurofibroma|Overall Study||1
10886508|NCT02639546|12052495|FG007|Tumor Type - Plexiform Neurofibroma|Overall Study||0
10886509|NCT02639546|12052488|FG000|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
10886510|NCT02639546|12052489|FG001|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
10886511|NCT02639546|12052490|FG002|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
10886512|NCT02639546|12052491|FG003|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
10886513|NCT02639546|12052492|FG004|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
10886514|NCT02639546|12052493|FG005|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||1
10886515|NCT02639546|12052494|FG006|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
10886516|NCT02639546|12052495|FG007|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
10886517|NCT02639546|12052488|FG000|COMPLETED|Overall Study||0
10886518|NCT02639546|12052489|FG001|COMPLETED|Overall Study||0
10886519|NCT02639546|12052490|FG002|COMPLETED|Overall Study||0
10886520|NCT02639546|12052491|FG003|COMPLETED|Overall Study||0
10886521|NCT02639546|12052492|FG004|COMPLETED|Overall Study||0
10886522|NCT02639546|12052493|FG005|COMPLETED|Overall Study||0
10886523|NCT02639546|12052494|FG006|COMPLETED|Overall Study||0
10886524|NCT02639546|12052495|FG007|COMPLETED|Overall Study||0
10886525|NCT02639546|12052488|FG000|NOT COMPLETED|Overall Study||6
10886526|NCT02639546|12052489|FG001|NOT COMPLETED|Overall Study||6
10886527|NCT02639546|12052490|FG002|NOT COMPLETED|Overall Study||6
10886528|NCT02639546|12052491|FG003|NOT COMPLETED|Overall Study||6
10886529|NCT02639546|12052492|FG004|NOT COMPLETED|Overall Study||7
10886530|NCT02639546|12052493|FG005|NOT COMPLETED|Overall Study||8
10886531|NCT02639546|12052494|FG006|NOT COMPLETED|Overall Study||5
10886532|NCT02639546|12052495|FG007|NOT COMPLETED|Overall Study||12
10886533|NCT02638883|12052527|FG000|STARTED|Overall Study||6
10886534|NCT02638883|12052527|FG000|COMPLETED|Overall Study||6
10886535|NCT02638883|12052527|FG000|NOT COMPLETED|Overall Study||0
10886536|NCT02634333|12052533|FG000|STARTED|Overall Study|Number of Eyes|200
10886537|NCT02634333|12052534|FG001|STARTED|Overall Study|Number of Eyes|199
10886538|NCT02634333|12052533|FG000|COMPLETED|Overall Study|Number of Eyes|160
10886539|NCT02634333|12052534|FG001|COMPLETED|Overall Study|Number of Eyes|167
10886540|NCT02634333|12052533|FG000|NOT COMPLETED|Overall Study||40
10886541|NCT02634333|12052534|FG001|NOT COMPLETED|Overall Study||32
10886542|NCT02633267|12052543|FG000|STARTED|Overall Study||120
10886543|NCT02633267|12052544|FG001|STARTED|Overall Study||130
10886544|NCT02633267|12052543|FG000|COMPLETED|Overall Study||89
10886545|NCT02633267|12052544|FG001|COMPLETED|Overall Study||91
10886546|NCT02633267|12052543|FG000|NOT COMPLETED|Overall Study||31
10886547|NCT02633267|12052544|FG001|NOT COMPLETED|Overall Study||39
10886548|NCT02630459|12052554|FG000|STARTED|Double-Blind Treatment Phase (DBTP)||136
10886549|NCT02630459|12052555|FG001|STARTED|Double-Blind Treatment Phase (DBTP)||67
10886550|NCT02630459|12052556|FG002|STARTED|Double-Blind Treatment Phase (DBTP)||135
10886551|NCT02630459|12052557|FG003|STARTED|Double-Blind Treatment Phase (DBTP)||137
10886552|NCT02630459|12052558|FG004|STARTED|Double-Blind Treatment Phase (DBTP)||0
10886553|NCT02630459|12052559|FG005|STARTED|Double-Blind Treatment Phase (DBTP)||0
10886554|NCT02630459|12052560|FG006|STARTED|Double-Blind Treatment Phase (DBTP)||0
10886555|NCT02630459|12052561|FG007|STARTED|Double-Blind Treatment Phase (DBTP)||0
10886556|NCT02630459|12052554|FG000|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||136
10886557|NCT02630459|12052555|FG001|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||66
10886558|NCT02630459|12052556|FG002|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||135
10886559|NCT02630459|12052557|FG003|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||137
10886560|NCT02630459|12052558|FG004|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
10886561|NCT02630459|12052559|FG005|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
10886562|NCT02630459|12052560|FG006|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
10886563|NCT02630459|12052561|FG007|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
10886564|NCT02630459|12052554|FG000|COMPLETED|Double-Blind Treatment Phase (DBTP)||133
10886565|NCT02630459|12052555|FG001|COMPLETED|Double-Blind Treatment Phase (DBTP)||65
10886566|NCT02630459|12052556|FG002|COMPLETED|Double-Blind Treatment Phase (DBTP)||130
10886567|NCT02630459|12052557|FG003|COMPLETED|Double-Blind Treatment Phase (DBTP)||134
10886568|NCT02630459|12052558|FG004|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886569|NCT02630459|12052559|FG005|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886570|NCT02630459|12052560|FG006|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886571|NCT02630459|12052561|FG007|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886572|NCT02630459|12052554|FG000|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
10886573|NCT02630459|12052555|FG001|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||2
10886574|NCT02630459|12052556|FG002|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||5
10886575|NCT02630459|12052557|FG003|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
10886576|NCT02630459|12052558|FG004|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886577|NCT02630459|12052559|FG005|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886578|NCT02630459|12052560|FG006|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886579|NCT02630459|12052561|FG007|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
10886580|NCT02630459|12052554|FG000|STARTED|Open-Label Treatment Phase (OLTP)||0
10886581|NCT02630459|12052555|FG001|STARTED|Open-Label Treatment Phase (OLTP)||0
10886582|NCT02630459|12052556|FG002|STARTED|Open-Label Treatment Phase (OLTP)||0
10886583|NCT02630459|12052557|FG003|STARTED|Open-Label Treatment Phase (OLTP)||0
10886584|NCT02630459|12052558|FG004|STARTED|Open-Label Treatment Phase (OLTP)||386
10886585|NCT02630459|12052559|FG005|STARTED|Open-Label Treatment Phase (OLTP)||73
10886586|NCT02630459|12052560|FG006|STARTED|Open-Label Treatment Phase (OLTP)||0
10886587|NCT02630459|12052561|FG007|STARTED|Open-Label Treatment Phase (OLTP)||0
10886588|NCT02630459|12052554|FG000|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886589|NCT02630459|12052555|FG001|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886590|NCT02630459|12052556|FG002|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886591|NCT02630459|12052557|FG003|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886592|NCT02630459|12052558|FG004|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||270
10886593|NCT02630459|12052559|FG005|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886594|NCT02630459|12052560|FG006|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886595|NCT02630459|12052561|FG007|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886596|NCT02630459|12052554|FG000|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886597|NCT02630459|12052555|FG001|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886598|NCT02630459|12052556|FG002|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886599|NCT02630459|12052557|FG003|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886600|NCT02630459|12052558|FG004|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886601|NCT02630459|12052559|FG005|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||73
10886602|NCT02630459|12052560|FG006|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886603|NCT02630459|12052561|FG007|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886604|NCT02630459|12052554|FG000|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886605|NCT02630459|12052555|FG001|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886606|NCT02630459|12052556|FG002|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886607|NCT02630459|12052557|FG003|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886608|NCT02630459|12052558|FG004|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||116
10886609|NCT02630459|12052559|FG005|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886610|NCT02630459|12052560|FG006|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886611|NCT02630459|12052561|FG007|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
10886612|NCT02630459|12052554|FG000|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886613|NCT02630459|12052555|FG001|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886614|NCT02630459|12052556|FG002|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886615|NCT02630459|12052557|FG003|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886616|NCT02630459|12052558|FG004|COMPLETED|Open-Label Treatment Phase (OLTP)||357
10886617|NCT02630459|12052559|FG005|COMPLETED|Open-Label Treatment Phase (OLTP)||69
10886618|NCT02630459|12052560|FG006|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886619|NCT02630459|12052561|FG007|COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886620|NCT02630459|12052554|FG000|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886621|NCT02630459|12052555|FG001|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886622|NCT02630459|12052556|FG002|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886623|NCT02630459|12052557|FG003|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886624|NCT02630459|12052558|FG004|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||29
10886625|NCT02630459|12052559|FG005|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||4
10886626|NCT02630459|12052560|FG006|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886627|NCT02630459|12052561|FG007|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
10886628|NCT02630459|12052554|FG000|STARTED|Optional CHU Sub-Study (During OLTP)||0
10886790|NCT02594111|12052715|FG001|STARTED|Overall Study||348
10886629|NCT02630459|12052555|FG001|STARTED|Optional CHU Sub-Study (During OLTP)||0
10886630|NCT02630459|12052556|FG002|STARTED|Optional CHU Sub-Study (During OLTP)||0
10886631|NCT02630459|12052557|FG003|STARTED|Optional CHU Sub-Study (During OLTP)||0
10886632|NCT02630459|12052558|FG004|STARTED|Optional CHU Sub-Study (During OLTP)||0
10886633|NCT02630459|12052559|FG005|STARTED|Optional CHU Sub-Study (During OLTP)||0
10886634|NCT02630459|12052560|FG006|STARTED|Optional CHU Sub-Study (During OLTP)||24
10886635|NCT02630459|12052561|FG007|STARTED|Optional CHU Sub-Study (During OLTP)||25
10886636|NCT02630459|12052554|FG000|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886637|NCT02630459|12052555|FG001|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886638|NCT02630459|12052556|FG002|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886639|NCT02630459|12052557|FG003|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886640|NCT02630459|12052558|FG004|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886641|NCT02630459|12052559|FG005|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886642|NCT02630459|12052560|FG006|COMPLETED|Optional CHU Sub-Study (During OLTP)||24
10886643|NCT02630459|12052561|FG007|COMPLETED|Optional CHU Sub-Study (During OLTP)||25
10886644|NCT02630459|12052554|FG000|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886645|NCT02630459|12052555|FG001|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886646|NCT02630459|12052556|FG002|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886647|NCT02630459|12052557|FG003|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886648|NCT02630459|12052558|FG004|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886649|NCT02630459|12052559|FG005|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886650|NCT02630459|12052560|FG006|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886651|NCT02630459|12052561|FG007|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
10886652|NCT02630316|12052588|FG000|STARTED|Overall Study||163
10886653|NCT02630316|12052589|FG001|STARTED|Overall Study||163
10886654|NCT02630316|12052588|FG000|COMPLETED|Overall Study||128
10886655|NCT02630316|12052589|FG001|COMPLETED|Overall Study||130
10886656|NCT02630316|12052588|FG000|NOT COMPLETED|Overall Study||35
10886657|NCT02630316|12052589|FG001|NOT COMPLETED|Overall Study||33
10886658|NCT02622386|12052595|FG000|STARTED|First Assignment||12
10886659|NCT02622386|12052596|FG001|STARTED|First Assignment||11
10886660|NCT02622386|12052595|FG000|COMPLETED|First Assignment||9
10886661|NCT02622386|12052596|FG001|COMPLETED|First Assignment||9
10886662|NCT02622386|12052595|FG000|NOT COMPLETED|First Assignment||3
10886663|NCT02622386|12052596|FG001|NOT COMPLETED|First Assignment||2
10886664|NCT02622386|12052595|FG000|STARTED|Washout||9
10886665|NCT02622386|12052596|FG001|STARTED|Washout||9
10886666|NCT02622386|12052595|FG000|COMPLETED|Washout||5
10886667|NCT02622386|12052596|FG001|COMPLETED|Washout||5
10886668|NCT02622386|12052595|FG000|NOT COMPLETED|Washout||4
10886669|NCT02622386|12052596|FG001|NOT COMPLETED|Washout||4
10886670|NCT02622386|12052595|FG000|STARTED|Second Assignment||5
10886671|NCT02622386|12052596|FG001|STARTED|Second Assignment||5
10886672|NCT02622386|12052595|FG000|COMPLETED|Second Assignment||5
10886673|NCT02622386|12052596|FG001|COMPLETED|Second Assignment||3
10886674|NCT02622386|12052595|FG000|NOT COMPLETED|Second Assignment||0
10886675|NCT02622386|12052596|FG001|NOT COMPLETED|Second Assignment||2
10886676|NCT02621606|12052605|FG000|STARTED|Overall Study||3
10886677|NCT02621606|12052606|FG001|STARTED|Overall Study||7
10886678|NCT02621606|12052607|FG002|STARTED|Overall Study||10
10886679|NCT02621606|12052605|FG000|Treated|Overall Study||3
10886680|NCT02621606|12052606|FG001|Treated|Overall Study||7
10886681|NCT02621606|12052607|FG002|Treated|Overall Study||10
10886682|NCT02621606|12052605|FG000|COMPLETED|Overall Study||3
10886683|NCT02621606|12052606|FG001|COMPLETED|Overall Study||6
10886684|NCT02621606|12052607|FG002|COMPLETED|Overall Study||10
10886685|NCT02621606|12052605|FG000|NOT COMPLETED|Overall Study||0
10886686|NCT02621606|12052606|FG001|NOT COMPLETED|Overall Study||1
10886687|NCT02621606|12052607|FG002|NOT COMPLETED|Overall Study||0
10886688|NCT02620761|12052617|FG000|STARTED|Overall Study||1
10886689|NCT02620761|12052618|FG001|STARTED|Overall Study||0
10886690|NCT02620761|12052617|FG000|COMPLETED|Overall Study||1
10886691|NCT02620761|12052618|FG001|COMPLETED|Overall Study||0
10886692|NCT02620761|12052617|FG000|NOT COMPLETED|Overall Study||0
10886693|NCT02620761|12052618|FG001|NOT COMPLETED|Overall Study||0
10886694|NCT02619682|12052624|FG000|STARTED|Overall Study||30
10886695|NCT02619682|12052624|FG000|COMPLETED|Overall Study||16
10886696|NCT02619682|12052624|FG000|NOT COMPLETED|Overall Study||14
10886697|NCT02614794|12052630|FG000|STARTED|Overall Study||410
10886698|NCT02614794|12052631|FG001|STARTED|Overall Study||202
10886699|NCT02614794|12052630|FG000|COMPLETED|Overall Study||0
10886700|NCT02614794|12052631|FG001|COMPLETED|Overall Study||0
10886701|NCT02614794|12052630|FG000|NOT COMPLETED|Overall Study||410
10886702|NCT02614794|12052631|FG001|NOT COMPLETED|Overall Study||202
10886703|NCT02614066|12052641|FG000|STARTED|Overall Study||6
10886704|NCT02614066|12052642|FG001|STARTED|Overall Study||28
10886705|NCT02614066|12052643|FG002|STARTED|Overall Study||20
10886706|NCT02614066|12052644|FG003|STARTED|Overall Study||71
10886707|NCT02614066|12052641|FG000|COMPLETED|Overall Study||0
10886708|NCT02614066|12052642|FG001|COMPLETED|Overall Study||0
10886709|NCT02614066|12052643|FG002|COMPLETED|Overall Study||0
10886710|NCT02614066|12052644|FG003|COMPLETED|Overall Study||0
10886711|NCT02614066|12052641|FG000|NOT COMPLETED|Overall Study||6
10886712|NCT02614066|12052642|FG001|NOT COMPLETED|Overall Study||28
10886713|NCT02614066|12052643|FG002|NOT COMPLETED|Overall Study||20
10886714|NCT02614066|12052644|FG003|NOT COMPLETED|Overall Study||71
10886715|NCT02610777|12052654|FG000|STARTED|Overall Study||62
10886716|NCT02610777|12052655|FG001|STARTED|Overall Study||58
10886717|NCT02610777|12052654|FG000|Response Evaluable Population (REP)|Overall Study||53
10886718|NCT02610777|12052655|FG001|Response Evaluable Population (REP)|Overall Study||55
10886719|NCT02610777|12052654|FG000|COMPLETED|Overall Study||0
10886720|NCT02610777|12052655|FG001|COMPLETED|Overall Study||0
10886721|NCT02610777|12052654|FG000|NOT COMPLETED|Overall Study||62
10886722|NCT02610777|12052655|FG001|NOT COMPLETED|Overall Study||58
10886723|NCT02604511|12052663|FG000|STARTED|Overall Study||31
10886724|NCT02604511|12052663|FG000|COMPLETED|Overall Study||19
10886725|NCT02604511|12052663|FG000|NOT COMPLETED|Overall Study||12
10886726|NCT02603432|12052670|FG000|STARTED|Overall Study||350
10886727|NCT02603432|12052671|FG001|STARTED|Overall Study||350
10886728|NCT02603432|12052670|FG000|COMPLETED|Overall Study||0
10886729|NCT02603432|12052671|FG001|COMPLETED|Overall Study||0
10886730|NCT02603432|12052670|FG000|NOT COMPLETED|Overall Study||350
10886731|NCT02603432|12052671|FG001|NOT COMPLETED|Overall Study||350
10886732|NCT02601209|12052684|FG000|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
10886733|NCT02601209|12052685|FG001|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
10886734|NCT02601209|12052686|FG002|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
10886735|NCT02601209|12052687|FG003|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
10886736|NCT02601209|12052688|FG004|STARTED|Initial Treatment (Up to 4 Months)|Randomized|13
10886737|NCT02601209|12052689|FG005|STARTED|Initial Treatment (Up to 4 Months)|Randomized|15
10886738|NCT02601209|12052690|FG006|STARTED|Initial Treatment (Up to 4 Months)|Randomized|56
10886739|NCT02601209|12052691|FG007|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
10886740|NCT02601209|12052692|FG008|STARTED|Initial Treatment (Up to 4 Months)|Randomized|43
10886741|NCT02601209|12052684|FG000|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
10886742|NCT02601209|12052685|FG001|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
10886743|NCT02601209|12052686|FG002|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
10886744|NCT02601209|12052687|FG003|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
10886745|NCT02601209|12052688|FG004|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|12
10886746|NCT02601209|12052689|FG005|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|13
10886747|NCT02601209|12052690|FG006|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|55
10886748|NCT02601209|12052691|FG007|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
10886749|NCT02601209|12052692|FG008|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|43
10886750|NCT02601209|12052684|FG000|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10886751|NCT02601209|12052685|FG001|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10886752|NCT02601209|12052686|FG002|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10886753|NCT02601209|12052687|FG003|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
10886754|NCT02601209|12052688|FG004|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10886755|NCT02601209|12052689|FG005|NOT COMPLETED|Initial Treatment (Up to 4 Months)||2
10886756|NCT02601209|12052690|FG006|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
10886757|NCT02601209|12052691|FG007|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
10886758|NCT02601209|12052692|FG008|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
10886759|NCT02601209|12052684|FG000|STARTED|Optional Crossover (Up to 2 Months)||0
10886760|NCT02601209|12052685|FG001|STARTED|Optional Crossover (Up to 2 Months)||0
10886761|NCT02601209|12052686|FG002|STARTED|Optional Crossover (Up to 2 Months)||0
10886762|NCT02601209|12052687|FG003|STARTED|Optional Crossover (Up to 2 Months)||0
10886763|NCT02601209|12052688|FG004|STARTED|Optional Crossover (Up to 2 Months)||0
10886764|NCT02601209|12052689|FG005|STARTED|Optional Crossover (Up to 2 Months)||0
10886765|NCT02601209|12052690|FG006|STARTED|Optional Crossover (Up to 2 Months)||0
10886766|NCT02601209|12052691|FG007|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|6
10886767|NCT02601209|12052692|FG008|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|43
10886768|NCT02601209|12052684|FG000|COMPLETED|Optional Crossover (Up to 2 Months)||0
10886769|NCT02601209|12052685|FG001|COMPLETED|Optional Crossover (Up to 2 Months)||0
10886770|NCT02601209|12052686|FG002|COMPLETED|Optional Crossover (Up to 2 Months)||0
10886771|NCT02601209|12052687|FG003|COMPLETED|Optional Crossover (Up to 2 Months)||0
10886772|NCT02601209|12052688|FG004|COMPLETED|Optional Crossover (Up to 2 Months)||0
10886773|NCT02601209|12052689|FG005|COMPLETED|Optional Crossover (Up to 2 Months)||0
10886774|NCT02601209|12052690|FG006|COMPLETED|Optional Crossover (Up to 2 Months)||0
10886775|NCT02601209|12052691|FG007|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|4
10886776|NCT02601209|12052692|FG008|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|26
10886777|NCT02601209|12052684|FG000|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10886778|NCT02601209|12052685|FG001|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10886779|NCT02601209|12052686|FG002|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10886780|NCT02601209|12052687|FG003|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10886781|NCT02601209|12052688|FG004|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10886782|NCT02601209|12052689|FG005|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10886783|NCT02601209|12052690|FG006|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
10886784|NCT02601209|12052691|FG007|NOT COMPLETED|Optional Crossover (Up to 2 Months)||2
10886785|NCT02601209|12052692|FG008|NOT COMPLETED|Optional Crossover (Up to 2 Months)||17
10886786|NCT02594735|12052706|FG000|STARTED|Overall Study||10
10886787|NCT02594735|12052706|FG000|COMPLETED|Overall Study|One patient did not receive Abatacept at week 24 due to worsening pre-existing ILD.|9
10886788|NCT02594735|12052706|FG000|NOT COMPLETED|Overall Study||1
10886789|NCT02594111|12052714|FG000|STARTED|Overall Study||366
10886791|NCT02594111|12052714|FG000|COMPLETED|Overall Study||366
10886792|NCT02594111|12052715|FG001|COMPLETED|Overall Study||348
10886793|NCT02594111|12052714|FG000|NOT COMPLETED|Overall Study||0
10886794|NCT02594111|12052715|FG001|NOT COMPLETED|Overall Study||0
10886795|NCT02584634|12052723|FG000|STARTED|Overall Study||12
10886796|NCT02584634|12052724|FG001|STARTED|Overall Study||31
10886797|NCT02584634|12052723|FG000|COMPLETED|Overall Study||0
10886798|NCT02584634|12052724|FG001|COMPLETED|Overall Study||0
10886799|NCT02584634|12052723|FG000|NOT COMPLETED|Overall Study||12
10886800|NCT02584634|12052724|FG001|NOT COMPLETED|Overall Study||31
10886801|NCT02581930|12052733|FG000|STARTED|Overall Study||18
10886802|NCT02581930|12052733|FG000|COMPLETED|Overall Study||16
10886803|NCT02581930|12052733|FG000|NOT COMPLETED|Overall Study||2
10886804|NCT02581137|12052737|FG000|STARTED|Overall Study||26
10886805|NCT02581137|12052737|FG000|COMPLETED|Overall Study||22
10886806|NCT02581137|12052737|FG000|NOT COMPLETED|Overall Study||4
10886807|NCT02580058|12052744|FG000|STARTED|Overall Study||188
10886808|NCT02580058|12052745|FG001|STARTED|Overall Study||188
10886809|NCT02580058|12052746|FG002|STARTED|Overall Study||190
10886810|NCT02580058|12052744|FG000|Treated|Overall Study||187
10886811|NCT02580058|12052745|FG001|Treated|Overall Study||182
10886812|NCT02580058|12052746|FG002|Treated|Overall Study||177
10886813|NCT02580058|12052744|FG000|COMPLETED|Overall Study||109
10886814|NCT02580058|12052745|FG001|COMPLETED|Overall Study||102
10886815|NCT02580058|12052746|FG002|COMPLETED|Overall Study||104
10886816|NCT02580058|12052744|FG000|NOT COMPLETED|Overall Study||79
10886817|NCT02580058|12052745|FG001|NOT COMPLETED|Overall Study||86
10886818|NCT02580058|12052746|FG002|NOT COMPLETED|Overall Study||86
10886819|NCT02579096|12052756|FG000|STARTED|Phase 1, Weeks 0 - 24||468
10886820|NCT02579096|12052757|FG001|STARTED|Phase 1, Weeks 0 - 24||472
10886821|NCT02579096|12052756|FG000|COMPLETED|Phase 1, Weeks 0 - 24||411
10886822|NCT02579096|12052757|FG001|COMPLETED|Phase 1, Weeks 0 - 24||422
10886823|NCT02579096|12052756|FG000|NOT COMPLETED|Phase 1, Weeks 0 - 24||57
10886824|NCT02579096|12052757|FG001|NOT COMPLETED|Phase 1, Weeks 0 - 24||50
10886825|NCT02579096|12052756|FG000|STARTED|Phase 2, Weeks 25 - 48||411
10886826|NCT02579096|12052757|FG001|STARTED|Phase 2, Weeks 25 - 48||422
10886827|NCT02579096|12052756|FG000|COMPLETED|Phase 2, Weeks 25 - 48||389
10886828|NCT02579096|12052757|FG001|COMPLETED|Phase 2, Weeks 25 - 48||391
10886829|NCT02579096|12052756|FG000|NOT COMPLETED|Phase 2, Weeks 25 - 48||22
10886830|NCT02579096|12052757|FG001|NOT COMPLETED|Phase 2, Weeks 25 - 48||31
10886831|NCT02579096|12052756|FG000|STARTED|Phase 3, Weeks 49 - 72||389
10886832|NCT02579096|12052757|FG001|STARTED|Phase 3, Weeks 49 - 72||391
10886833|NCT02579096|12052756|FG000|COMPLETED|Phase 3, Weeks 49 - 72||367
10886834|NCT02579096|12052757|FG001|COMPLETED|Phase 3, Weeks 49 - 72||373
10886835|NCT02579096|12052756|FG000|NOT COMPLETED|Phase 3, Weeks 49 - 72||22
10886836|NCT02579096|12052757|FG001|NOT COMPLETED|Phase 3, Weeks 49 - 72||18
10886837|NCT02578680|12052765|FG000|STARTED|Overall Study||410
10886838|NCT02578680|12052766|FG001|STARTED|Overall Study||206
10886839|NCT02578680|12052765|FG000|Treated|Overall Study||405
10886840|NCT02578680|12052766|FG001|Treated|Overall Study||202
10886841|NCT02578680|12052765|FG000|Switched to Pembrolizumab|Overall Study||0
10886842|NCT02578680|12052766|FG001|Switched to Pembrolizumab|Overall Study||67
10886843|NCT02578680|12052765|FG000|COMPLETED|Overall Study||0
10886844|NCT02578680|12052766|FG001|COMPLETED|Overall Study||0
10886845|NCT02578680|12052765|FG000|NOT COMPLETED|Overall Study||410
10886846|NCT02578680|12052766|FG001|NOT COMPLETED|Overall Study||206
10886847|NCT02577406|12052774|FG000|STARTED|Randomized Period||158
10886848|NCT02577406|12052775|FG001|STARTED|Randomized Period||161
10886849|NCT02577406|12052774|FG000|COMPLETED|Randomized Period||157
10886850|NCT02577406|12052775|FG001|COMPLETED|Randomized Period||141
10886851|NCT02577406|12052774|FG000|NOT COMPLETED|Randomized Period||1
10886852|NCT02577406|12052775|FG001|NOT COMPLETED|Randomized Period||20
10886853|NCT02577406|12052774|FG000|STARTED|Treatment Period||157
10886854|NCT02577406|12052775|FG001|STARTED|Treatment Period||141
10886855|NCT02577406|12052774|FG000|COMPLETED|Treatment Period||10
10886856|NCT02577406|12052775|FG001|COMPLETED|Treatment Period||4
10886857|NCT02577406|12052774|FG000|NOT COMPLETED|Treatment Period||147
10886858|NCT02577406|12052775|FG001|NOT COMPLETED|Treatment Period||137
10886859|NCT02576860|12052787|FG000|STARTED|Overall Study||136
10886860|NCT02576860|12052788|FG001|STARTED|Overall Study||127
10886861|NCT02576860|12052787|FG000|COMPLETED|Overall Study||111
10886862|NCT02576860|12052788|FG001|COMPLETED|Overall Study||103
10886863|NCT02576860|12052787|FG000|NOT COMPLETED|Overall Study||25
10886864|NCT02576860|12052788|FG001|NOT COMPLETED|Overall Study||24
10886865|NCT02576509|12052797|FG000|STARTED|Pre-Treatment Period||371
10886866|NCT02576509|12052798|FG001|STARTED|Pre-Treatment Period||372
10886867|NCT02576509|12052797|FG000|COMPLETED|Pre-Treatment Period||367
10886868|NCT02576509|12052798|FG001|COMPLETED|Pre-Treatment Period||363
10886869|NCT02576509|12052797|FG000|NOT COMPLETED|Pre-Treatment Period||4
10886870|NCT02576509|12052798|FG001|NOT COMPLETED|Pre-Treatment Period||9
10886871|NCT02576509|12052797|FG000|STARTED|Treatment Period||367
10886872|NCT02576509|12052798|FG001|STARTED|Treatment Period||363
10886873|NCT02576509|12052797|FG000|COMPLETED|Treatment Period||38
10886874|NCT02576509|12052798|FG001|COMPLETED|Treatment Period||8
10886875|NCT02576509|12052797|FG000|NOT COMPLETED|Treatment Period||329
10886876|NCT02576509|12052798|FG001|NOT COMPLETED|Treatment Period||355
10886877|NCT02576509|12052797|FG000|STARTED|Follow-up Period||367
10886878|NCT02576509|12052798|FG001|STARTED|Follow-up Period||363
10886879|NCT02576509|12052797|FG000|COMPLETED|Follow-up Period||318
10886880|NCT02576509|12052798|FG001|COMPLETED|Follow-up Period||311
10886881|NCT02576509|12052797|FG000|NOT COMPLETED|Follow-up Period||49
10886882|NCT02576509|12052798|FG001|NOT COMPLETED|Follow-up Period||52
10886895|NCT02572453|12052827|FG000|STARTED|Overall Study||1
10886896|NCT02572453|12052828|FG001|STARTED|Overall Study||4
10886897|NCT02572453|12052829|FG002|STARTED|Overall Study||20
10886898|NCT02572453|12052827|FG000|COMPLETED|Overall Study||1
10886899|NCT02572453|12052828|FG001|COMPLETED|Overall Study||4
10886900|NCT02572453|12052829|FG002|COMPLETED|Overall Study||20
10886901|NCT02572453|12052827|FG000|NOT COMPLETED|Overall Study||0
10886902|NCT02572453|12052828|FG001|NOT COMPLETED|Overall Study||0
10886903|NCT02572453|12052829|FG002|NOT COMPLETED|Overall Study||0
10886904|NCT02565784|12052837|FG000|STARTED|First Treatment||100
10886905|NCT02565784|12052837|FG000|6 Months Follow-up|First Treatment||99
10886906|NCT02565784|12052837|FG000|12 Months Follow-up|First Treatment||98
10886907|NCT02565784|12052837|FG000|COMPLETED|First Treatment||98
10886908|NCT02565784|12052837|FG000|NOT COMPLETED|First Treatment||2
10886909|NCT02565784|12052837|FG000|STARTED|Second Treatment||98
10886910|NCT02565784|12052837|FG000|6 Months Follow-up|Second Treatment||97
10886911|NCT02565784|12052837|FG000|12 Months Follow-up|Second Treatment||96
10886912|NCT02565784|12052837|FG000|COMPLETED|Second Treatment||96
10886913|NCT02565784|12052837|FG000|NOT COMPLETED|Second Treatment||2
10886914|NCT02565108|12052847|FG000|STARTED|Overall Study||16
10886915|NCT02565108|12052848|FG001|STARTED|Overall Study||4
10886916|NCT02565108|12052847|FG000|Safety Set|Overall Study||16
10886917|NCT02565108|12052848|FG001|Safety Set|Overall Study||4
10886918|NCT02565108|12052847|FG000|Pharmacokinetic (PK) Set|Overall Study||10
10886919|NCT02565108|12052848|FG001|Pharmacokinetic (PK) Set|Overall Study||3
10886920|NCT02565108|12052847|FG000|COMPLETED|Overall Study||14
10886921|NCT02565108|12052848|FG001|COMPLETED|Overall Study||4
10886922|NCT02565108|12052847|FG000|NOT COMPLETED|Overall Study||2
10886923|NCT02565108|12052848|FG001|NOT COMPLETED|Overall Study||0
10886924|NCT02564952|12052854|FG000|STARTED|Overall Study||18
10886925|NCT02564952|12052854|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
10886926|NCT02564952|12052854|FG000|Completed OLE Titration Period|Overall Study||16
10886927|NCT02564952|12052854|FG000|COMPLETED|Overall Study||7
10886928|NCT02564952|12052854|FG000|NOT COMPLETED|Overall Study||11
10886929|NCT02563925|12052858|FG000|STARTED|Overall Study||28
10886930|NCT02563925|12052858|FG000|COMPLETED|Overall Study||26
10886931|NCT02563925|12052858|FG000|NOT COMPLETED|Overall Study||2
10886932|NCT02563002|12052865|FG000|STARTED|Overall Study||153
10886933|NCT02563002|12052866|FG001|STARTED|Overall Study||154
10886934|NCT02563002|12052865|FG000|Treated|Overall Study||153
10886935|NCT02563002|12052866|FG001|Treated|Overall Study||143
10886936|NCT02563002|12052865|FG000|Received Second Course of Pembrolizumab|Overall Study||8
10886937|NCT02563002|12052866|FG001|Received Second Course of Pembrolizumab|Overall Study||4
10886938|NCT02563002|12052865|FG000|Switched Over to Pembrolizumab|Overall Study||0
10886939|NCT02563002|12052866|FG001|Switched Over to Pembrolizumab|Overall Study||56
10886940|NCT02563002|12052865|FG000|COMPLETED|Overall Study||0
10886941|NCT02563002|12052866|FG001|COMPLETED|Overall Study||0
10886942|NCT02563002|12052865|FG000|NOT COMPLETED|Overall Study||153
10886943|NCT02563002|12052866|FG001|NOT COMPLETED|Overall Study||154
10886944|NCT02562235|12052875|FG000|STARTED|Overall Study||24
10886945|NCT02562235|12052875|FG000|COMPLETED|Overall Study||21
10886946|NCT02562235|12052875|FG000|NOT COMPLETED|Overall Study||3
10886947|NCT02561221|12052886|FG000|STARTED|Overall Study||452
10886948|NCT02561221|12052887|FG001|STARTED|Overall Study||351
10886949|NCT02561221|12052886|FG000|Month 6|Overall Study||386
10886950|NCT02561221|12052887|FG001|Month 6|Overall Study||340
10886951|NCT02561221|12052886|FG000|Month 12|Overall Study||365
10886952|NCT02561221|12052887|FG001|Month 12|Overall Study||326
10886953|NCT02561221|12052886|FG000|Month 18|Overall Study||357
10886954|NCT02561221|12052887|FG001|Month 18|Overall Study||316
10886955|NCT02561221|12052886|FG000|COMPLETED|Overall Study||362
10886956|NCT02561221|12052887|FG001|COMPLETED|Overall Study||308
10886957|NCT02561221|12052886|FG000|NOT COMPLETED|Overall Study||90
10886958|NCT02561221|12052887|FG001|NOT COMPLETED|Overall Study||43
10886959|NCT02560623|12052897|FG000|STARTED|Overall Study||19
10886960|NCT02560623|12052898|FG001|STARTED|Overall Study||22
10886961|NCT02560623|12052899|FG002|STARTED|Overall Study||112
10886962|NCT02560623|12052900|FG003|STARTED|Overall Study||89
10886963|NCT02560623|12052897|FG000|COMPLETED|Overall Study||19
10886964|NCT02560623|12052898|FG001|COMPLETED|Overall Study||20
10886965|NCT02560623|12052899|FG002|COMPLETED|Overall Study||112
10886966|NCT02560623|12052900|FG003|COMPLETED|Overall Study||89
10886967|NCT02560623|12052897|FG000|NOT COMPLETED|Overall Study||0
10886968|NCT02560623|12052898|FG001|NOT COMPLETED|Overall Study||2
10886969|NCT02560623|12052899|FG002|NOT COMPLETED|Overall Study||0
10886970|NCT02560623|12052900|FG003|NOT COMPLETED|Overall Study||0
10886971|NCT02559687|12052910|FG000|STARTED|Overall Study||121
10886972|NCT02559687|12052910|FG000|Received First Course of Pembrolizumab|Overall Study||121
10886973|NCT02559687|12052910|FG000|Received Second Course of Pembrolizumab|Overall Study||1
10886974|NCT02559687|12052910|FG000|COMPLETED|Overall Study||0
10886975|NCT02559687|12052910|FG000|NOT COMPLETED|Overall Study||121
10886976|NCT02556710|12052917|FG000|STARTED|Overall Study||237
10886977|NCT02556710|12052918|FG001|STARTED|Overall Study||243
10886978|NCT02556710|12052917|FG000|COMPLETED|Overall Study||226
10886979|NCT02556710|12052918|FG001|COMPLETED|Overall Study||237
10886980|NCT02556710|12052917|FG000|NOT COMPLETED|Overall Study||11
10886981|NCT02556710|12052918|FG001|NOT COMPLETED|Overall Study||6
10886982|NCT02552212|12052928|FG000|STARTED|Double-Blind Period (Week 0 - 52)||158
10886983|NCT02552212|12052929|FG001|STARTED|Double-Blind Period (Week 0 - 52)||159
10886984|NCT02552212|12052930|FG002|STARTED|Double-Blind Period (Week 0 - 52)||0
10886985|NCT02552212|12052928|FG000|Received OL CZP|Double-Blind Period (Week 0 - 52)||96
10886986|NCT02552212|12052929|FG001|Received OL CZP|Double-Blind Period (Week 0 - 52)||20
10886987|NCT02552212|12052930|FG002|Received OL CZP|Double-Blind Period (Week 0 - 52)||0
10886988|NCT02552212|12052928|FG000|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||20
10886989|NCT02552212|12052929|FG001|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||22
10886990|NCT02552212|12052930|FG002|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||0
10886991|NCT02552212|12052928|FG000|COMPLETED|Double-Blind Period (Week 0 - 52)||143
10886992|NCT02552212|12052929|FG001|COMPLETED|Double-Blind Period (Week 0 - 52)||142
10886993|NCT02552212|12052930|FG002|COMPLETED|Double-Blind Period (Week 0 - 52)||0
10886994|NCT02552212|12052928|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||15
10886995|NCT02552212|12052929|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||17
10886996|NCT02552212|12052930|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||0
10886997|NCT02552212|12052928|FG000|STARTED|SFE Period (Week 52 - 156)||0
10886998|NCT02552212|12052929|FG001|STARTED|SFE Period (Week 52 - 156)||0
10886999|NCT02552212|12052930|FG002|STARTED|SFE Period (Week 52 - 156)|123 subjects from Placebo arm and 120 subjects from CZP 200 mg Q2W arm|243
10887000|NCT02552212|12052928|FG000|COMPLETED|SFE Period (Week 52 - 156)||0
10887001|NCT02552212|12052929|FG001|COMPLETED|SFE Period (Week 52 - 156)||0
10887002|NCT02552212|12052930|FG002|COMPLETED|SFE Period (Week 52 - 156)||206
10887003|NCT02552212|12052928|FG000|NOT COMPLETED|SFE Period (Week 52 - 156)||0
10887004|NCT02552212|12052929|FG001|NOT COMPLETED|SFE Period (Week 52 - 156)||0
10887005|NCT02552212|12052930|FG002|NOT COMPLETED|SFE Period (Week 52 - 156)||37
10887006|NCT02550652|12052948|FG000|STARTED|Overall Study||63
10887007|NCT02550652|12052949|FG001|STARTED|Overall Study||62
10887008|NCT02550652|12052948|FG000|COMPLETED|Overall Study||42
10887009|NCT02550652|12052949|FG001|COMPLETED|Overall Study||41
10887010|NCT02550652|12052948|FG000|NOT COMPLETED|Overall Study||21
10887011|NCT02550652|12052949|FG001|NOT COMPLETED|Overall Study||21
10887012|NCT02547441|12052957|FG000|STARTED|Double-Blind Study Period||235
10887013|NCT02547441|12052958|FG001|STARTED|Double-Blind Study Period||228
10887014|NCT02547441|12052957|FG000|COMPLETED|Double-Blind Study Period||211
10887015|NCT02547441|12052958|FG001|COMPLETED|Double-Blind Study Period||196
10887016|NCT02547441|12052957|FG000|NOT COMPLETED|Double-Blind Study Period||24
10887017|NCT02547441|12052958|FG001|NOT COMPLETED|Double-Blind Study Period||32
10887018|NCT02547441|12052957|FG000|STARTED|Open-Label Study Period||188
10887019|NCT02547441|12052958|FG001|STARTED|Open-Label Study Period||175
10887020|NCT02547441|12052957|FG000|COMPLETED|Open-Label Study Period||66
10887021|NCT02547441|12052958|FG001|COMPLETED|Open-Label Study Period||48
10887022|NCT02547441|12052957|FG000|NOT COMPLETED|Open-Label Study Period||122
10887023|NCT02547441|12052958|FG001|NOT COMPLETED|Open-Label Study Period||127
10887024|NCT02546986|12052967|FG000|STARTED|Treatment Period||51
10887025|NCT02546986|12052968|FG001|STARTED|Treatment Period||49
10887026|NCT02546986|12052967|FG000|COMPLETED|Treatment Period||0
10887027|NCT02546986|12052968|FG001|COMPLETED|Treatment Period||0
10887028|NCT02546986|12052967|FG000|NOT COMPLETED|Treatment Period||51
10887029|NCT02546986|12052968|FG001|NOT COMPLETED|Treatment Period||49
10887030|NCT02546986|12052967|FG000|STARTED|Survival Follow-Up Phase||36
10887031|NCT02546986|12052968|FG001|STARTED|Survival Follow-Up Phase||35
10887032|NCT02546986|12052967|FG000|COMPLETED|Survival Follow-Up Phase||0
10887033|NCT02546986|12052968|FG001|COMPLETED|Survival Follow-Up Phase||0
10887034|NCT02546986|12052967|FG000|NOT COMPLETED|Survival Follow-Up Phase||36
10887035|NCT02546986|12052968|FG001|NOT COMPLETED|Survival Follow-Up Phase||35
10887036|NCT02545608|12052976|FG000|STARTED|Overall Study||9
10887037|NCT02545608|12052977|FG001|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100
10887038|NCT02545608|12052976|FG000|COMPLETED|Overall Study||9
10887039|NCT02545608|12052977|FG001|COMPLETED|Overall Study||93
10887040|NCT02545608|12052976|FG000|NOT COMPLETED|Overall Study||0
10887041|NCT02545608|12052977|FG001|NOT COMPLETED|Overall Study||7
10887042|NCT02544763|12052987|FG000|STARTED|Overall Study||75
10887043|NCT02544763|12052988|FG001|STARTED|Overall Study||73
10887044|NCT02544763|12052989|FG002|STARTED|Overall Study||76
10887045|NCT02544763|12052987|FG000|COMPLETED|Overall Study||65
10887046|NCT02544763|12052988|FG001|COMPLETED|Overall Study||61
10887047|NCT02544763|12052989|FG002|COMPLETED|Overall Study||75
10887048|NCT02544763|12052987|FG000|NOT COMPLETED|Overall Study||10
10887049|NCT02544763|12052988|FG001|NOT COMPLETED|Overall Study||12
10887050|NCT02544763|12052989|FG002|NOT COMPLETED|Overall Study||1
10887051|NCT02544503|12052999|FG000|STARTED|Overall Study||66
10887052|NCT02544503|12053000|FG001|STARTED|Overall Study||34
10887053|NCT02544503|12052999|FG000|Completed First Study Assessment|Overall Study||42
10887054|NCT02544503|12053000|FG001|Completed First Study Assessment|Overall Study||31
10887055|NCT02544503|12052999|FG000|Stroke Patients Who Completed the 6 Month Post-stroke Assessment|Overall Study||32
10887056|NCT02544503|12053000|FG001|Stroke Patients Who Completed the 6 Month Post-stroke Assessment|Overall Study|Healthy control participants were not assessed at the 6 month time point.|0
10887057|NCT02544503|12052999|FG000|COMPLETED|Overall Study||32
10887058|NCT02544503|12053000|FG001|COMPLETED|Overall Study||31
10887059|NCT02544503|12052999|FG000|NOT COMPLETED|Overall Study||34
10887060|NCT02544503|12053000|FG001|NOT COMPLETED|Overall Study||3
10887061|NCT02544373|12053008|FG000|STARTED|Overall Study||71
10887062|NCT02544373|12053009|FG001|STARTED|Overall Study||40
10887063|NCT02544373|12053008|FG000|COMPLETED|Overall Study||58
10887064|NCT02544373|12053009|FG001|COMPLETED|Overall Study||35
10887065|NCT02544373|12053008|FG000|NOT COMPLETED|Overall Study||13
10887066|NCT02544373|12053009|FG001|NOT COMPLETED|Overall Study||5
10887067|NCT02543944|12053018|FG000|STARTED|Phase 1: GBN/BUP Induction and BUP Detox||60
10887068|NCT02543944|12053019|FG001|STARTED|Phase 1: GBN/BUP Induction and BUP Detox||57
10887069|NCT02543944|12053018|FG000|COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||41
10887070|NCT02543944|12053019|FG001|COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||34
10887071|NCT02543944|12053018|FG000|NOT COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||19
10887072|NCT02543944|12053019|FG001|NOT COMPLETED|Phase 1: GBN/BUP Induction and BUP Detox||23
10887073|NCT02543944|12053018|FG000|STARTED|Phase 2: Transition From BUP to XR-NTX||33
10887074|NCT02543944|12053019|FG001|STARTED|Phase 2: Transition From BUP to XR-NTX||29
10887075|NCT02543944|12053018|FG000|COMPLETED|Phase 2: Transition From BUP to XR-NTX||12
10887076|NCT02543944|12053019|FG001|COMPLETED|Phase 2: Transition From BUP to XR-NTX||12
10887077|NCT02543944|12053018|FG000|NOT COMPLETED|Phase 2: Transition From BUP to XR-NTX||21
10887078|NCT02543944|12053019|FG001|NOT COMPLETED|Phase 2: Transition From BUP to XR-NTX||17
10887079|NCT02543944|12053018|FG000|STARTED|Phase 3: XR-NTX Maintenance||12
10887080|NCT02543944|12053019|FG001|STARTED|Phase 3: XR-NTX Maintenance||12
10887081|NCT02543944|12053018|FG000|COMPLETED|Phase 3: XR-NTX Maintenance||7
10887082|NCT02543944|12053019|FG001|COMPLETED|Phase 3: XR-NTX Maintenance||3
10887083|NCT02543944|12053018|FG000|NOT COMPLETED|Phase 3: XR-NTX Maintenance||5
10887084|NCT02543944|12053019|FG001|NOT COMPLETED|Phase 3: XR-NTX Maintenance||9
10887085|NCT02542293|12053027|FG000|STARTED|Overall Study||474
10887086|NCT02542293|12053028|FG001|STARTED|Overall Study||479
10887087|NCT02542293|12053027|FG000|Randomized in Global Cohort|Overall Study||410
10887088|NCT02542293|12053028|FG001|Randomized in Global Cohort|Overall Study||413
10887089|NCT02542293|12053027|FG000|Received Treatment in Global Cohort|Overall Study||410
10887090|NCT02542293|12053028|FG001|Received Treatment in Global Cohort|Overall Study||399
10887091|NCT02542293|12053027|FG000|Randomized in China Cohort|Overall Study||78
10887092|NCT02542293|12053028|FG001|Randomized in China Cohort|Overall Study||82
10887093|NCT02542293|12053027|FG000|Received Treatment in China Cohort|Overall Study||77
10887094|NCT02542293|12053028|FG001|Received Treatment in China Cohort|Overall Study||78
10887095|NCT02542293|12053027|FG000|Included in Both Cohorts (Global and China)|Overall Study||14
10887096|NCT02542293|12053028|FG001|Included in Both Cohorts (Global and China)|Overall Study||16
10887097|NCT02542293|12053027|FG000|Ongoing in Study at DCO for Final Analysis in Global Cohort|Overall Study||75
10887098|NCT02542293|12053028|FG001|Ongoing in Study at DCO for Final Analysis in Global Cohort|Overall Study||67
10887099|NCT02542293|12053027|FG000|Ongoing in Study at DCO for Final Analysis in China Cohort|Overall Study||27
10887100|NCT02542293|12053028|FG001|Ongoing in Study at DCO for Final Analysis in China Cohort|Overall Study||18
10887101|NCT02542293|12053027|FG000|COMPLETED|Overall Study||99
10887102|NCT02542293|12053028|FG001|COMPLETED|Overall Study||83
10887103|NCT02542293|12053027|FG000|NOT COMPLETED|Overall Study||375
10887104|NCT02542293|12053028|FG001|NOT COMPLETED|Overall Study||396
10887105|NCT02539823|12053044|FG000|STARTED|Overall Study||15
10887106|NCT02539823|12053045|FG001|STARTED|Overall Study||14
10887107|NCT02539823|12053046|FG002|STARTED|Overall Study||13
10887108|NCT02539823|12053044|FG000|COMPLETED|Overall Study||15
10887109|NCT02539823|12053045|FG001|COMPLETED|Overall Study||14
10887110|NCT02539823|12053046|FG002|COMPLETED|Overall Study||13
10887111|NCT02539823|12053044|FG000|NOT COMPLETED|Overall Study||0
10887112|NCT02539823|12053045|FG001|NOT COMPLETED|Overall Study||0
10887113|NCT02539823|12053046|FG002|NOT COMPLETED|Overall Study||0
10887114|NCT02538510|12053056|FG000|STARTED|Overall Study||25
10887115|NCT02538510|12053057|FG001|STARTED|Overall Study||25
10887116|NCT02538510|12053056|FG000|COMPLETED|Overall Study||25
10887117|NCT02538510|12053057|FG001|COMPLETED|Overall Study||25
10887118|NCT02538510|12053056|FG000|NOT COMPLETED|Overall Study||0
10887119|NCT02538510|12053057|FG001|NOT COMPLETED|Overall Study||0
10887120|NCT02533180|12053069|FG000|STARTED|Overall Study||39
10887121|NCT02533180|12053070|FG001|STARTED|Overall Study||61
10887122|NCT02533180|12053069|FG000|COMPLETED|Overall Study||0
10887123|NCT02533180|12053070|FG001|COMPLETED|Overall Study||14
10887124|NCT02533180|12053069|FG000|NOT COMPLETED|Overall Study||39
10887125|NCT02533180|12053070|FG001|NOT COMPLETED|Overall Study||47
10887126|NCT02531308|12053075|FG000|STARTED|Overall Study||5
10887127|NCT02531308|12053075|FG000|COMPLETED|Overall Study||2
10887128|NCT02531308|12053075|FG000|NOT COMPLETED|Overall Study||3
10887129|NCT02527434|12053082|FG000|STARTED|Overall Study||32
10887130|NCT02527434|12053083|FG001|STARTED|Overall Study||12
10887131|NCT02527434|12053084|FG002|STARTED|Overall Study||20
10887132|NCT02527434|12053082|FG000|Started Retreatment Phase (COMBO)|Overall Study||7
10887133|NCT02527434|12053083|FG001|Started Retreatment Phase (COMBO)|Overall Study||5
10887134|NCT02527434|12053084|FG002|Started Retreatment Phase (COMBO)|Overall Study||4
10887135|NCT02527434|12053082|FG000|Started Retreatment Phase (MEDI)|Overall Study||4
10887136|NCT02527434|12053083|FG001|Started Retreatment Phase (MEDI)|Overall Study||0
10887137|NCT02527434|12053084|FG002|Started Retreatment Phase (MEDI)|Overall Study||1
10887138|NCT02527434|12053082|FG000|COMPLETED|Overall Study||4
10887139|NCT02527434|12053083|FG001|COMPLETED|Overall Study||1
10887140|NCT02527434|12053084|FG002|COMPLETED|Overall Study||0
10887141|NCT02527434|12053082|FG000|NOT COMPLETED|Overall Study||28
10887142|NCT02527434|12053083|FG001|NOT COMPLETED|Overall Study||11
10887143|NCT02527434|12053084|FG002|NOT COMPLETED|Overall Study||20
10887144|NCT02526498|12053102|FG000|STARTED|Overall Study||200
10887145|NCT02526498|12053102|FG000|COMPLETED|Overall Study||200
10887146|NCT02526498|12053102|FG000|NOT COMPLETED|Overall Study||0
10887147|NCT02524275|12053106|FG000|STARTED|Overall Study||14
10887148|NCT02524275|12053106|FG000|COMPLETED|Overall Study||9
10887149|NCT02524275|12053106|FG000|NOT COMPLETED|Overall Study||5
10887150|NCT02522845|12053112|FG000|STARTED|Overall Study||100
10887151|NCT02522845|12053113|FG001|STARTED|Overall Study||104
10887152|NCT02522845|12053112|FG000|COMPLETED|Overall Study||63
10887153|NCT02522845|12053113|FG001|COMPLETED|Overall Study||69
10887154|NCT02522845|12053112|FG000|NOT COMPLETED|Overall Study||37
10887155|NCT02522845|12053113|FG001|NOT COMPLETED|Overall Study||35
10887156|NCT02522494|12053121|FG000|STARTED|Overall Study||51
10887157|NCT02522494|12053122|FG001|STARTED|Overall Study||51
10887158|NCT02522494|12053121|FG000|Post-CVT Visit Interview|Overall Study||37
10887159|NCT02522494|12053122|FG001|Post-CVT Visit Interview|Overall Study||48
10887160|NCT02522494|12053121|FG000|4-Week Follow Up|Overall Study||37
10887161|NCT02522494|12053122|FG001|4-Week Follow Up|Overall Study||46
10887162|NCT02522494|12053121|FG000|COMPLETED|Overall Study||37
10887163|NCT02522494|12053122|FG001|COMPLETED|Overall Study||46
10887164|NCT02522494|12053121|FG000|NOT COMPLETED|Overall Study||14
10887165|NCT02522494|12053122|FG001|NOT COMPLETED|Overall Study||5
10887166|NCT02516670|12053130|FG000|STARTED|Overall Study||34
10887167|NCT02516670|12053131|FG001|STARTED|Overall Study||16
10887168|NCT02516670|12053130|FG000|COMPLETED|Overall Study||34
10887169|NCT02516670|12053131|FG001|COMPLETED|Overall Study||16
10887170|NCT02516670|12053130|FG000|NOT COMPLETED|Overall Study||0
10887171|NCT02516670|12053131|FG001|NOT COMPLETED|Overall Study||0
10887172|NCT02513784|12053139|FG000|STARTED|Overall Study||10
10887173|NCT02513784|12053140|FG001|STARTED|Overall Study||10
10887174|NCT02513784|12053139|FG000|COMPLETED|Overall Study||10
10887175|NCT02513784|12053140|FG001|COMPLETED|Overall Study||10
10887176|NCT02513784|12053139|FG000|NOT COMPLETED|Overall Study||0
10887177|NCT02513784|12053140|FG001|NOT COMPLETED|Overall Study||0
10887178|NCT02513485|12053148|FG000|STARTED|Overall Study||28
10887179|NCT02513485|12053149|FG001|STARTED|Overall Study||29
10887180|NCT02513485|12053148|FG000|COMPLETED|Overall Study||27
10887181|NCT02513485|12053149|FG001|COMPLETED|Overall Study||29
10887182|NCT02513485|12053148|FG000|NOT COMPLETED|Overall Study||1
10887183|NCT02513485|12053149|FG001|NOT COMPLETED|Overall Study||0
10887184|NCT02504151|12053157|FG000|STARTED|First Intervention (4 Weeks)||8
10887185|NCT02504151|12053158|FG001|STARTED|First Intervention (4 Weeks)||10
10887186|NCT02504151|12053157|FG000|COMPLETED|First Intervention (4 Weeks)||7
10887187|NCT02504151|12053158|FG001|COMPLETED|First Intervention (4 Weeks)||9
10887188|NCT02504151|12053157|FG000|NOT COMPLETED|First Intervention (4 Weeks)||1
10887189|NCT02504151|12053158|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
10887190|NCT02504151|12053157|FG000|STARTED|Washout (2 Weeks)||7
10887191|NCT02504151|12053158|FG001|STARTED|Washout (2 Weeks)||9
10887192|NCT02504151|12053157|FG000|COMPLETED|Washout (2 Weeks)||6
10887193|NCT02504151|12053158|FG001|COMPLETED|Washout (2 Weeks)||9
10887194|NCT02504151|12053157|FG000|NOT COMPLETED|Washout (2 Weeks)||1
10887195|NCT02504151|12053158|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10887196|NCT02504151|12053157|FG000|STARTED|Second Intervention (4 Weeks)||6
10887197|NCT02504151|12053158|FG001|STARTED|Second Intervention (4 Weeks)||9
10887198|NCT02504151|12053157|FG000|COMPLETED|Second Intervention (4 Weeks)||4
10887199|NCT02504151|12053158|FG001|COMPLETED|Second Intervention (4 Weeks)||7
10887200|NCT02504151|12053157|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||2
10887201|NCT02504151|12053158|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2
10887202|NCT02499328|12053183|FG000|STARTED|Overall Study||4
10887203|NCT02499328|12053184|FG001|STARTED|Overall Study||7
10887204|NCT02499328|12053185|FG002|STARTED|Overall Study||10
10887205|NCT02499328|12053186|FG003|STARTED|Overall Study||11
10887206|NCT02499328|12053187|FG004|STARTED|Overall Study||15
10887207|NCT02499328|12053188|FG005|STARTED|Overall Study||9
10887208|NCT02499328|12053189|FG006|STARTED|Overall Study||7
10887209|NCT02499328|12053190|FG007|STARTED|Overall Study||6
10887210|NCT02499328|12053191|FG008|STARTED|Overall Study||14
10887211|NCT02499328|12053192|FG009|STARTED|Overall Study||24
10887212|NCT02499328|12053193|FG010|STARTED|Overall Study||20
10887213|NCT02499328|12053194|FG011|STARTED|Overall Study||54
10887214|NCT02499328|12053195|FG012|STARTED|Overall Study||25
10887215|NCT02499328|12053196|FG013|STARTED|Overall Study||17
10887216|NCT02499328|12053197|FG014|STARTED|Overall Study||10
10887217|NCT02499328|12053198|FG015|STARTED|Overall Study||1
10887218|NCT02499328|12053199|FG016|STARTED|Overall Study||1
10887219|NCT02499328|12053200|FG017|STARTED|Overall Study||55
10887220|NCT02499328|12053201|FG018|STARTED|Overall Study||50
10887221|NCT02499328|12053183|FG000|COMPLETED|Overall Study||0
10887222|NCT02499328|12053184|FG001|COMPLETED|Overall Study||0
10887223|NCT02499328|12053185|FG002|COMPLETED|Overall Study||0
10887224|NCT02499328|12053186|FG003|COMPLETED|Overall Study||0
10887225|NCT02499328|12053187|FG004|COMPLETED|Overall Study||0
10887226|NCT02499328|12053188|FG005|COMPLETED|Overall Study||0
10887227|NCT02499328|12053189|FG006|COMPLETED|Overall Study||0
10887228|NCT02499328|12053190|FG007|COMPLETED|Overall Study||0
10887229|NCT02499328|12053191|FG008|COMPLETED|Overall Study||0
10887230|NCT02499328|12053192|FG009|COMPLETED|Overall Study||0
10887231|NCT02499328|12053193|FG010|COMPLETED|Overall Study||0
10887232|NCT02499328|12053194|FG011|COMPLETED|Overall Study||0
10887233|NCT02499328|12053195|FG012|COMPLETED|Overall Study||0
10887234|NCT02499328|12053196|FG013|COMPLETED|Overall Study||0
10887235|NCT02499328|12053197|FG014|COMPLETED|Overall Study||0
10887236|NCT02499328|12053198|FG015|COMPLETED|Overall Study||0
10887237|NCT02499328|12053199|FG016|COMPLETED|Overall Study||0
10887238|NCT02499328|12053200|FG017|COMPLETED|Overall Study||0
10887239|NCT02499328|12053201|FG018|COMPLETED|Overall Study||1
10887240|NCT02499328|12053183|FG000|NOT COMPLETED|Overall Study||4
10887241|NCT02499328|12053184|FG001|NOT COMPLETED|Overall Study||7
10887242|NCT02499328|12053185|FG002|NOT COMPLETED|Overall Study||10
10887243|NCT02499328|12053186|FG003|NOT COMPLETED|Overall Study||11
10887244|NCT02499328|12053187|FG004|NOT COMPLETED|Overall Study||15
10887245|NCT02499328|12053188|FG005|NOT COMPLETED|Overall Study||9
10887246|NCT02499328|12053189|FG006|NOT COMPLETED|Overall Study||7
10887247|NCT02499328|12053190|FG007|NOT COMPLETED|Overall Study||6
10887248|NCT02499328|12053191|FG008|NOT COMPLETED|Overall Study||14
10887249|NCT02499328|12053192|FG009|NOT COMPLETED|Overall Study||24
10887250|NCT02499328|12053193|FG010|NOT COMPLETED|Overall Study||20
10887251|NCT02499328|12053194|FG011|NOT COMPLETED|Overall Study||54
10887252|NCT02499328|12053195|FG012|NOT COMPLETED|Overall Study||25
10887253|NCT02499328|12053196|FG013|NOT COMPLETED|Overall Study||17
10887254|NCT02499328|12053197|FG014|NOT COMPLETED|Overall Study||10
10887255|NCT02499328|12053198|FG015|NOT COMPLETED|Overall Study||1
10887256|NCT02499328|12053199|FG016|NOT COMPLETED|Overall Study||1
10887257|NCT02499328|12053200|FG017|NOT COMPLETED|Overall Study||55
10887258|NCT02499328|12053201|FG018|NOT COMPLETED|Overall Study||49
10887259|NCT02498600|12053286|FG000|STARTED|Overall Study||49
10887260|NCT02498600|12053287|FG001|STARTED|Overall Study||51
10887261|NCT02498600|12053286|FG000|COMPLETED|Overall Study||49
10887262|NCT02498600|12053287|FG001|COMPLETED|Overall Study||51
10887263|NCT02498600|12053286|FG000|NOT COMPLETED|Overall Study||0
10887264|NCT02498600|12053287|FG001|NOT COMPLETED|Overall Study||0
10887265|NCT02495077|12053295|FG000|STARTED|Overall Study||113
10887266|NCT02495077|12053296|FG001|STARTED|Overall Study||112
10887267|NCT02495077|12053297|FG002|STARTED|Overall Study||17
10887268|NCT02495077|12053298|FG003|STARTED|Overall Study||48
10887269|NCT02495077|12053295|FG000|COMPLETED|Overall Study||93
10887270|NCT02495077|12053296|FG001|COMPLETED|Overall Study||91
10887271|NCT02495077|12053297|FG002|COMPLETED|Overall Study||0
10887272|NCT02495077|12053298|FG003|COMPLETED|Overall Study||0
10887273|NCT02495077|12053295|FG000|NOT COMPLETED|Overall Study||20
10887274|NCT02495077|12053296|FG001|NOT COMPLETED|Overall Study||21
10887275|NCT02495077|12053297|FG002|NOT COMPLETED|Overall Study||17
10887276|NCT02495077|12053298|FG003|NOT COMPLETED|Overall Study||48
10887277|NCT02494921|12053309|FG000|STARTED|Phase 1b, Dose Level I||5
10887278|NCT02494921|12053310|FG001|STARTED|Phase 1b, Dose Level I||0
10887279|NCT02494921|12053311|FG002|STARTED|Phase 1b, Dose Level I||0
10887280|NCT02494921|12053312|FG003|STARTED|Phase 1b, Dose Level I||0
10887281|NCT02494921|12053313|FG004|STARTED|Phase 1b, Dose Level I||0
10887282|NCT02494921|12053309|FG000|COMPLETED|Phase 1b, Dose Level I||3
10887283|NCT02494921|12053310|FG001|COMPLETED|Phase 1b, Dose Level I||0
10887284|NCT02494921|12053311|FG002|COMPLETED|Phase 1b, Dose Level I||0
10887285|NCT02494921|12053312|FG003|COMPLETED|Phase 1b, Dose Level I||0
10887286|NCT02494921|12053313|FG004|COMPLETED|Phase 1b, Dose Level I||0
10887287|NCT02494921|12053309|FG000|NOT COMPLETED|Phase 1b, Dose Level I||2
10887288|NCT02494921|12053310|FG001|NOT COMPLETED|Phase 1b, Dose Level I||0
10887289|NCT02494921|12053311|FG002|NOT COMPLETED|Phase 1b, Dose Level I||0
10887290|NCT02494921|12053312|FG003|NOT COMPLETED|Phase 1b, Dose Level I||0
10887291|NCT02494921|12053313|FG004|NOT COMPLETED|Phase 1b, Dose Level I||0
10887292|NCT02494921|12053309|FG000|STARTED|Phase 1b, Dose Level IA||0
10887293|NCT02494921|12053310|FG001|STARTED|Phase 1b, Dose Level IA||4
10887294|NCT02494921|12053311|FG002|STARTED|Phase 1b, Dose Level IA||0
10887295|NCT02494921|12053312|FG003|STARTED|Phase 1b, Dose Level IA||0
10887296|NCT02494921|12053313|FG004|STARTED|Phase 1b, Dose Level IA||0
10887297|NCT02494921|12053309|FG000|COMPLETED|Phase 1b, Dose Level IA||0
10887298|NCT02494921|12053310|FG001|COMPLETED|Phase 1b, Dose Level IA||3
10887299|NCT02494921|12053311|FG002|COMPLETED|Phase 1b, Dose Level IA||0
10887300|NCT02494921|12053312|FG003|COMPLETED|Phase 1b, Dose Level IA||0
10887301|NCT02494921|12053313|FG004|COMPLETED|Phase 1b, Dose Level IA||0
10887302|NCT02494921|12053309|FG000|NOT COMPLETED|Phase 1b, Dose Level IA||0
10887303|NCT02494921|12053310|FG001|NOT COMPLETED|Phase 1b, Dose Level IA||1
10887304|NCT02494921|12053311|FG002|NOT COMPLETED|Phase 1b, Dose Level IA||0
10887305|NCT02494921|12053312|FG003|NOT COMPLETED|Phase 1b, Dose Level IA||0
10887306|NCT02494921|12053313|FG004|NOT COMPLETED|Phase 1b, Dose Level IA||0
10887307|NCT02494921|12053309|FG000|STARTED|Phase 1b, Dose Level IIC||0
10887308|NCT02494921|12053310|FG001|STARTED|Phase 1b, Dose Level IIC||0
10887309|NCT02494921|12053311|FG002|STARTED|Phase 1b, Dose Level IIC||4
10887310|NCT02494921|12053312|FG003|STARTED|Phase 1b, Dose Level IIC||0
10887311|NCT02494921|12053313|FG004|STARTED|Phase 1b, Dose Level IIC||0
10887312|NCT02494921|12053309|FG000|COMPLETED|Phase 1b, Dose Level IIC||0
10887313|NCT02494921|12053310|FG001|COMPLETED|Phase 1b, Dose Level IIC||0
10887314|NCT02494921|12053311|FG002|COMPLETED|Phase 1b, Dose Level IIC||3
10887315|NCT02494921|12053312|FG003|COMPLETED|Phase 1b, Dose Level IIC||0
10887316|NCT02494921|12053313|FG004|COMPLETED|Phase 1b, Dose Level IIC||0
10887317|NCT02494921|12053309|FG000|NOT COMPLETED|Phase 1b, Dose Level IIC||0
10887318|NCT02494921|12053310|FG001|NOT COMPLETED|Phase 1b, Dose Level IIC||0
10887319|NCT02494921|12053311|FG002|NOT COMPLETED|Phase 1b, Dose Level IIC||1
10887320|NCT02494921|12053312|FG003|NOT COMPLETED|Phase 1b, Dose Level IIC||0
10887321|NCT02494921|12053313|FG004|NOT COMPLETED|Phase 1b, Dose Level IIC||0
10887322|NCT02494921|12053309|FG000|STARTED|Phase 1b, Dose Level IIIC, RP2D||0
10887323|NCT02494921|12053310|FG001|STARTED|Phase 1b, Dose Level IIIC, RP2D||0
10887324|NCT02494921|12053311|FG002|STARTED|Phase 1b, Dose Level IIIC, RP2D||0
10887325|NCT02494921|12053312|FG003|STARTED|Phase 1b, Dose Level IIIC, RP2D||6
10887326|NCT02494921|12053313|FG004|STARTED|Phase 1b, Dose Level IIIC, RP2D||0
10887327|NCT02494921|12053309|FG000|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887328|NCT02494921|12053310|FG001|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887329|NCT02494921|12053311|FG002|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887330|NCT02494921|12053312|FG003|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||6
10887331|NCT02494921|12053313|FG004|COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887332|NCT02494921|12053309|FG000|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887333|NCT02494921|12053310|FG001|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887334|NCT02494921|12053311|FG002|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887335|NCT02494921|12053312|FG003|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887336|NCT02494921|12053313|FG004|NOT COMPLETED|Phase 1b, Dose Level IIIC, RP2D||0
10887337|NCT02494921|12053309|FG000|STARTED|Phase 2, RP2D||0
10887338|NCT02494921|12053310|FG001|STARTED|Phase 2, RP2D||0
10887339|NCT02494921|12053311|FG002|STARTED|Phase 2, RP2D||0
10887340|NCT02494921|12053312|FG003|STARTED|Phase 2, RP2D||0
10887341|NCT02494921|12053313|FG004|STARTED|Phase 2, RP2D||24
10887342|NCT02494921|12053309|FG000|COMPLETED|Phase 2, RP2D||0
10887343|NCT02494921|12053310|FG001|COMPLETED|Phase 2, RP2D||0
10887344|NCT02494921|12053311|FG002|COMPLETED|Phase 2, RP2D||0
10887345|NCT02494921|12053312|FG003|COMPLETED|Phase 2, RP2D||0
10887346|NCT02494921|12053313|FG004|COMPLETED|Phase 2, RP2D||24
10887347|NCT02494921|12053309|FG000|NOT COMPLETED|Phase 2, RP2D||0
10887348|NCT02494921|12053310|FG001|NOT COMPLETED|Phase 2, RP2D||0
10887349|NCT02494921|12053311|FG002|NOT COMPLETED|Phase 2, RP2D||0
10887350|NCT02494921|12053312|FG003|NOT COMPLETED|Phase 2, RP2D||0
10887351|NCT02494921|12053313|FG004|NOT COMPLETED|Phase 2, RP2D||0
10887352|NCT02494583|12053334|FG000|STARTED|Overall Study||256
10887353|NCT02494583|12053335|FG001|STARTED|Overall Study||257
10887354|NCT02494583|12053336|FG002|STARTED|Overall Study||250
10887355|NCT02494583|12053334|FG000|Treated|Overall Study|1 participant randomized to the pembro combo arm received pembrolizumab monotherapy by mistake.|254
10887356|NCT02494583|12053335|FG001|Treated|Overall Study||250
10887357|NCT02494583|12053336|FG002|Treated|Overall Study||244
10887358|NCT02494583|12053334|FG000|COMPLETED|Overall Study||0
10887359|NCT02494583|12053335|FG001|COMPLETED|Overall Study||0
10887360|NCT02494583|12053336|FG002|COMPLETED|Overall Study||0
10887361|NCT02494583|12053334|FG000|NOT COMPLETED|Overall Study||256
10887362|NCT02494583|12053335|FG001|NOT COMPLETED|Overall Study||257
10887363|NCT02494583|12053336|FG002|NOT COMPLETED|Overall Study||250
10887364|NCT02493946|12053347|FG000|STARTED|DB Period||126
10887365|NCT02493946|12053348|FG001|STARTED|DB Period||64
10887366|NCT02493946|12053349|FG002|STARTED|DB Period||0
10887367|NCT02493946|12053347|FG000|COMPLETED|DB Period||118
10887368|NCT02493946|12053348|FG001|COMPLETED|DB Period||59
10887369|NCT02493946|12053349|FG002|COMPLETED|DB Period||0
10887370|NCT02493946|12053347|FG000|NOT COMPLETED|DB Period||8
10887371|NCT02493946|12053348|FG001|NOT COMPLETED|DB Period||5
10887372|NCT02493946|12053349|FG002|NOT COMPLETED|DB Period||0
10887373|NCT02493946|12053347|FG000|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
10887374|NCT02493946|12053348|FG001|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
10887375|NCT02493946|12053349|FG002|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595
10887376|NCT02493946|12053347|FG000|COMPLETED|Open Label Period||0
10887377|NCT02493946|12053348|FG001|COMPLETED|Open Label Period||0
10887378|NCT02493946|12053349|FG002|COMPLETED|Open Label Period||509
10887379|NCT02493946|12053347|FG000|NOT COMPLETED|Open Label Period||0
10887380|NCT02493946|12053348|FG001|NOT COMPLETED|Open Label Period||0
10887381|NCT02493946|12053349|FG002|NOT COMPLETED|Open Label Period||86
10887382|NCT02491632|12053359|FG000|STARTED|Overall Study||38
10887383|NCT02491632|12053360|FG001|STARTED|Overall Study||38
10887384|NCT02491632|12053359|FG000|COMPLETED|Overall Study||31
10887385|NCT02491632|12053360|FG001|COMPLETED|Overall Study||29
10887386|NCT02491632|12053359|FG000|NOT COMPLETED|Overall Study||7
10887387|NCT02491632|12053360|FG001|NOT COMPLETED|Overall Study||9
10887388|NCT02489318|12053368|FG000|STARTED|Randomized||527
10887389|NCT02489318|12053369|FG001|STARTED|Randomized||525
10887390|NCT02489318|12053368|FG000|COMPLETED|Randomized||527
10887391|NCT02489318|12053369|FG001|COMPLETED|Randomized||524
10887392|NCT02489318|12053368|FG000|NOT COMPLETED|Randomized||0
10887393|NCT02489318|12053369|FG001|NOT COMPLETED|Randomized||1
10887394|NCT02489318|12053368|FG000|STARTED|Treated||527
10887395|NCT02489318|12053369|FG001|STARTED|Treated||524
10887396|NCT02489318|12053368|FG000|COMPLETED|Treated|Participants crossed over from placebo to apalutamide after positive results at interim analysis.|208
10887397|NCT02489318|12053369|FG001|COMPLETED|Treated||0
10887398|NCT02489318|12053368|FG000|NOT COMPLETED|Treated||319
10887399|NCT02489318|12053369|FG001|NOT COMPLETED|Treated||524
10887400|NCT02488785|12053378|FG000|STARTED|Overall Study||47
10887401|NCT02488785|12053379|FG001|STARTED|Overall Study||49
10887402|NCT02488785|12053378|FG000|COMPLETED|Overall Study||41
10887403|NCT02488785|12053379|FG001|COMPLETED|Overall Study||38
10887404|NCT02488785|12053378|FG000|NOT COMPLETED|Overall Study||6
10887405|NCT02488785|12053379|FG001|NOT COMPLETED|Overall Study||11
10887406|NCT02488759|12053391|FG000|STARTED|Overall Study||113
10887407|NCT02488759|12053392|FG001|STARTED|Overall Study||195
10887408|NCT02488759|12053393|FG002|STARTED|Overall Study||133
10887409|NCT02488759|12053394|FG003|STARTED|Overall Study||8
10887410|NCT02488759|12053395|FG004|STARTED|Overall Study||6
10887411|NCT02488759|12053396|FG005|STARTED|Overall Study||123
10887412|NCT02488759|12053391|FG000|COMPLETED|Overall Study||2
10887413|NCT02488759|12053392|FG001|COMPLETED|Overall Study||0
10887414|NCT02488759|12053393|FG002|COMPLETED|Overall Study||2
10887415|NCT02488759|12053394|FG003|COMPLETED|Overall Study||0
10887416|NCT02488759|12053395|FG004|COMPLETED|Overall Study||0
10887417|NCT02488759|12053396|FG005|COMPLETED|Overall Study||0
10887418|NCT02488759|12053391|FG000|NOT COMPLETED|Overall Study||111
10887419|NCT02488759|12053392|FG001|NOT COMPLETED|Overall Study||195
10887420|NCT02488759|12053393|FG002|NOT COMPLETED|Overall Study||131
10887421|NCT02488759|12053394|FG003|NOT COMPLETED|Overall Study||8
10887422|NCT02488759|12053395|FG004|NOT COMPLETED|Overall Study||6
10887423|NCT02488759|12053396|FG005|NOT COMPLETED|Overall Study||123
10887424|NCT02488551|12053414|FG000|STARTED|Overall Study||86
10887425|NCT02488551|12053415|FG001|STARTED|Overall Study||49
10887426|NCT02488551|12053416|FG002|STARTED|Overall Study||17
10887427|NCT02488551|12053417|FG003|STARTED|Overall Study||15
10887428|NCT02488551|12053414|FG000|COMPLETED|Overall Study||81
10887429|NCT02488551|12053415|FG001|COMPLETED|Overall Study||41
10887430|NCT02488551|12053416|FG002|COMPLETED|Overall Study||17
10887431|NCT02488551|12053417|FG003|COMPLETED|Overall Study||15
10887432|NCT02488551|12053414|FG000|NOT COMPLETED|Overall Study||5
10887433|NCT02488551|12053415|FG001|NOT COMPLETED|Overall Study||8
10887434|NCT02488551|12053416|FG002|NOT COMPLETED|Overall Study||0
10887435|NCT02488551|12053417|FG003|NOT COMPLETED|Overall Study||0
10887436|NCT02487966|12053431|FG000|STARTED|Overall Study||29
10887437|NCT02487966|12053432|FG001|STARTED|Overall Study||28
10887438|NCT02487966|12053433|FG002|STARTED|Overall Study||28
10887439|NCT02487966|12053434|FG003|STARTED|Overall Study||27
10887440|NCT02487966|12053431|FG000|COMPLETED|Overall Study||28
10887441|NCT02487966|12053432|FG001|COMPLETED|Overall Study||24
10887442|NCT02487966|12053433|FG002|COMPLETED|Overall Study||26
10887443|NCT02487966|12053434|FG003|COMPLETED|Overall Study||25
10887444|NCT02487966|12053431|FG000|NOT COMPLETED|Overall Study||1
10887445|NCT02487966|12053432|FG001|NOT COMPLETED|Overall Study||4
10887446|NCT02487966|12053433|FG002|NOT COMPLETED|Overall Study||2
10887447|NCT02487966|12053434|FG003|NOT COMPLETED|Overall Study||2
10887448|NCT02487745|12053446|FG000|STARTED|Overall Study||47
10887449|NCT02487745|12053447|FG001|STARTED|Overall Study||44
10887450|NCT02487745|12053446|FG000|COMPLETED|Overall Study||47
10887451|NCT02487745|12053447|FG001|COMPLETED|Overall Study||44
10887452|NCT02487745|12053446|FG000|NOT COMPLETED|Overall Study||0
10887453|NCT02487745|12053447|FG001|NOT COMPLETED|Overall Study||0
10887454|NCT02485899|12053455|FG000|STARTED|Overall Study||24
10887455|NCT02485899|12053456|FG001|STARTED|Overall Study|The control group (NH comparator) used for determination of the primary efficacy outcomes of this study was comprised of data from 42 subjects with CLN2 disease from the DEM-CHILD database (NCT04613089).|42
10887456|NCT02485899|12053455|FG000|COMPLETED|Overall Study||17
10887457|NCT02485899|12053456|FG001|COMPLETED|Overall Study|The control group (NH comparator) used for determination of the primary efficacy outcomes of this study was comprised of data from 42 subjects with CLN2 disease from the DEM-CHILD database (NCT04613089).|42
10887458|NCT02485899|12053455|FG000|NOT COMPLETED|Overall Study||7
10887459|NCT02485899|12053456|FG001|NOT COMPLETED|Overall Study||0
10887460|NCT02484443|12053462|FG000|STARTED|Overall Study||41
10887461|NCT02484443|12053462|FG000|COMPLETED|Overall Study||9
10887462|NCT02484443|12053462|FG000|NOT COMPLETED|Overall Study||32
10887463|NCT02477774|12053468|FG000|STARTED|Overall Study||29
10887464|NCT02477774|12053469|FG001|STARTED|Overall Study||26
10887465|NCT02477774|12053468|FG000|COMPLETED|Overall Study||29
10887466|NCT02477774|12053469|FG001|COMPLETED|Overall Study||26
10887467|NCT02477774|12053468|FG000|NOT COMPLETED|Overall Study||0
10887468|NCT02477774|12053469|FG001|NOT COMPLETED|Overall Study||0
10887469|NCT02477696|12053477|FG000|STARTED|Overall Study|3 patients withdrew after being randomized but prior to receiving Acalabrutinib treatment.|268
10887470|NCT02477696|12053478|FG001|STARTED|Overall Study|1 patient withdrew after being randomized but prior to receiving Ibrutinib treatment.|265
10887471|NCT02477696|12053477|FG000|COMPLETED|Overall Study||127
10887472|NCT02477696|12053478|FG001|COMPLETED|Overall Study||110
10887473|NCT02477696|12053477|FG000|NOT COMPLETED|Overall Study||141
10887474|NCT02477696|12053478|FG001|NOT COMPLETED|Overall Study||155
10887475|NCT02476968|12053487|FG000|STARTED|Overall Study||145
10887476|NCT02476968|12053488|FG001|STARTED|Overall Study||33
10887477|NCT02476968|12053489|FG002|STARTED|Overall Study||3
10887478|NCT02476968|12053487|FG000|Received Treatment|Overall Study||143
10887479|NCT02476968|12053488|FG001|Received Treatment|Overall Study||32
10887480|NCT02476968|12053489|FG002|Received Treatment|Overall Study||2
10887481|NCT02476968|12053487|FG000|COMPLETED|Overall Study||50
10887482|NCT02476968|12053488|FG001|COMPLETED|Overall Study||15
10887483|NCT02476968|12053489|FG002|COMPLETED|Overall Study||0
10887484|NCT02476968|12053487|FG000|NOT COMPLETED|Overall Study||95
10887485|NCT02476968|12053488|FG001|NOT COMPLETED|Overall Study||18
10887486|NCT02476968|12053489|FG002|NOT COMPLETED|Overall Study||3
10887487|NCT02476916|12053501|FG000|STARTED|Core Period||27
10887488|NCT02476916|12053502|FG001|STARTED|Core Period||25
10887489|NCT02476916|12053501|FG000|COMPLETED|Core Period||21
10887490|NCT02476916|12053502|FG001|COMPLETED|Core Period||22
10887491|NCT02476916|12053501|FG000|NOT COMPLETED|Core Period||6
10887492|NCT02476916|12053502|FG001|NOT COMPLETED|Core Period||3
10887493|NCT02476916|12053501|FG000|STARTED|Extension Period||18
10887494|NCT02476916|12053502|FG001|STARTED|Extension Period||18
10887495|NCT02476916|12053501|FG000|COMPLETED|Extension Period||0
10887496|NCT02476916|12053502|FG001|COMPLETED|Extension Period||0
10887497|NCT02476916|12053501|FG000|NOT COMPLETED|Extension Period||18
10887498|NCT02476916|12053502|FG001|NOT COMPLETED|Extension Period||18
10887499|NCT02470377|12053512|FG000|STARTED|Overall Study||10
10887500|NCT02470377|12053513|FG001|STARTED|Overall Study||9
10887501|NCT02470377|12053514|FG002|STARTED|Overall Study||5
10887502|NCT02470377|12053512|FG000|COMPLETED|Overall Study||10
10887503|NCT02470377|12053513|FG001|COMPLETED|Overall Study||9
10887504|NCT02470377|12053514|FG002|COMPLETED|Overall Study||5
10887505|NCT02470377|12053512|FG000|NOT COMPLETED|Overall Study||0
10887506|NCT02470377|12053513|FG001|NOT COMPLETED|Overall Study||0
10887507|NCT02470377|12053514|FG002|NOT COMPLETED|Overall Study||0
10887508|NCT02466009|12053522|FG000|STARTED|Overall Study||27
10887509|NCT02466009|12053522|FG000|COMPLETED|Overall Study||27
10887510|NCT02466009|12053522|FG000|NOT COMPLETED|Overall Study||0
10887511|NCT02464410|12053528|FG000|STARTED|Overall Study||147
10887512|NCT02464410|12053529|FG001|STARTED|Overall Study||152
10887513|NCT02464410|12053528|FG000|3-month Follow-up|Overall Study||137
10887514|NCT02464410|12053529|FG001|3-month Follow-up|Overall Study||138
10887515|NCT02464410|12053528|FG000|6-month Follow-up|Overall Study||132
10887516|NCT02464410|12053529|FG001|6-month Follow-up|Overall Study||140
10887517|NCT02464410|12053528|FG000|12-month Follow-up|Overall Study||125
10887518|NCT02464410|12053529|FG001|12-month Follow-up|Overall Study||136
10887519|NCT02464410|12053528|FG000|COMPLETED|Overall Study||125
10887520|NCT02464410|12053529|FG001|COMPLETED|Overall Study||136
10887521|NCT02464410|12053528|FG000|NOT COMPLETED|Overall Study||22
10887522|NCT02464410|12053529|FG001|NOT COMPLETED|Overall Study||16
10887523|NCT02462421|12053539|FG000|STARTED|Overall Study||13
10887524|NCT02462421|12053540|FG001|STARTED|Overall Study||4
10887525|NCT02462421|12053541|FG002|STARTED|Overall Study||6
10887526|NCT02462421|12053542|FG003|STARTED|Overall Study||7
10887527|NCT02462421|12053539|FG000|COMPLETED|Overall Study||13
10887528|NCT02462421|12053540|FG001|COMPLETED|Overall Study||4
10887529|NCT02462421|12053541|FG002|COMPLETED|Overall Study||6
10887530|NCT02462421|12053542|FG003|COMPLETED|Overall Study||7
10887531|NCT02462421|12053539|FG000|NOT COMPLETED|Overall Study||0
10887532|NCT02462421|12053540|FG001|NOT COMPLETED|Overall Study||0
10887533|NCT02462421|12053541|FG002|NOT COMPLETED|Overall Study||0
10887534|NCT02462421|12053542|FG003|NOT COMPLETED|Overall Study||0
10887535|NCT02460874|12053554|FG000|STARTED|Overall Study||1
10887536|NCT02460874|12053555|FG001|STARTED|Overall Study||0
10887537|NCT02460874|12053554|FG000|COMPLETED|Overall Study||1
10887538|NCT02460874|12053555|FG001|COMPLETED|Overall Study||0
10887539|NCT02460874|12053554|FG000|NOT COMPLETED|Overall Study||0
10887540|NCT02460874|12053555|FG001|NOT COMPLETED|Overall Study||0
10887541|NCT02460198|12053563|FG000|STARTED|Overall Study||61
10887542|NCT02460198|12053564|FG001|STARTED|Overall Study||63
10887543|NCT02460198|12053563|FG000|COMPLETED|Overall Study||0
10887544|NCT02460198|12053564|FG001|COMPLETED|Overall Study||0
10887545|NCT02460198|12053563|FG000|NOT COMPLETED|Overall Study||61
10887546|NCT02460198|12053564|FG001|NOT COMPLETED|Overall Study||63
10887547|NCT02457910|12053578|FG000|STARTED|Overall Study||3
10887548|NCT02457910|12053579|FG001|STARTED|Overall Study|In dose escalation, two patients receiving the 4 mg dose of taselisib were removed for toxicities|5
10887549|NCT02457910|12053580|FG002|STARTED|Overall Study||3
10887550|NCT02457910|12053581|FG003|STARTED|Overall Study||2
10887551|NCT02457910|12053582|FG004|STARTED|Overall Study|3 participants crossed over to enzalutamide and taselisib|5
10887552|NCT02457910|12053583|FG005|STARTED|Overall Study||12
10887553|NCT02457910|12053578|FG000|COMPLETED|Overall Study||0
10887554|NCT02457910|12053579|FG001|COMPLETED|Overall Study||0
10887555|NCT02457910|12053580|FG002|COMPLETED|Overall Study||0
10887556|NCT02457910|12053581|FG003|COMPLETED|Overall Study||0
10887557|NCT02457910|12053582|FG004|COMPLETED|Overall Study||0
10887558|NCT02457910|12053583|FG005|COMPLETED|Overall Study||1
10887559|NCT02457910|12053578|FG000|NOT COMPLETED|Overall Study||3
10887560|NCT02457910|12053579|FG001|NOT COMPLETED|Overall Study||5
10887561|NCT02457910|12053580|FG002|NOT COMPLETED|Overall Study||3
10887562|NCT02457910|12053581|FG003|NOT COMPLETED|Overall Study||2
10887563|NCT02457910|12053582|FG004|NOT COMPLETED|Overall Study||5
10887564|NCT02457910|12053583|FG005|NOT COMPLETED|Overall Study||11
10887565|NCT02456740|12053603|FG000|STARTED|Double-blind Treatment Phase (24 Weeks)||319
10887566|NCT02456740|12053604|FG001|STARTED|Double-blind Treatment Phase (24 Weeks)||317
10887567|NCT02456740|12053605|FG002|STARTED|Double-blind Treatment Phase (24 Weeks)||319
10887568|NCT02456740|12053606|FG003|STARTED|Double-blind Treatment Phase (24 Weeks)||0
10887569|NCT02456740|12053607|FG004|STARTED|Double-blind Treatment Phase (24 Weeks)||0
10887570|NCT02456740|12053608|FG005|STARTED|Double-blind Treatment Phase (24 Weeks)||0
10887571|NCT02456740|12053609|FG006|STARTED|Double-blind Treatment Phase (24 Weeks)||0
10887572|NCT02456740|12053610|FG007|STARTED|Double-blind Treatment Phase (24 Weeks)||0
10887573|NCT02456740|12053611|FG008|STARTED|Double-blind Treatment Phase (24 Weeks)||0
10887574|NCT02456740|12053603|FG000|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
10887575|NCT02456740|12053604|FG001|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
10887576|NCT02456740|12053605|FG002|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
10887577|NCT02456740|12053606|FG003|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
10887578|NCT02456740|12053607|FG004|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
10887579|NCT02456740|12053608|FG005|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
10887580|NCT02456740|12053609|FG006|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
10887581|NCT02456740|12053610|FG007|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
10887582|NCT02456740|12053611|FG008|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
10887583|NCT02456740|12053603|FG000|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
10887584|NCT02456740|12053604|FG001|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
10887585|NCT02456740|12053605|FG002|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
10887586|NCT02456740|12053606|FG003|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887587|NCT02456740|12053607|FG004|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887588|NCT02456740|12053608|FG005|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887589|NCT02456740|12053609|FG006|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887590|NCT02456740|12053610|FG007|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887591|NCT02456740|12053611|FG008|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887592|NCT02456740|12053603|FG000|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
10887593|NCT02456740|12053604|FG001|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
10887594|NCT02456740|12053605|FG002|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
10887595|NCT02456740|12053606|FG003|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887596|NCT02456740|12053607|FG004|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887597|NCT02456740|12053608|FG005|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887598|NCT02456740|12053609|FG006|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887599|NCT02456740|12053610|FG007|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887600|NCT02456740|12053611|FG008|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
10887601|NCT02456740|12053603|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
10887602|NCT02456740|12053604|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
10887603|NCT02456740|12053605|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
10887604|NCT02456740|12053606|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
10887605|NCT02456740|12053607|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
10887606|NCT02456740|12053608|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
10887607|NCT02456740|12053609|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
10887608|NCT02456740|12053610|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
10887609|NCT02456740|12053611|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
10887610|NCT02456740|12053603|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10887611|NCT02456740|12053604|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10887612|NCT02456740|12053605|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10887613|NCT02456740|12053606|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
10887614|NCT02456740|12053607|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
10887615|NCT02456740|12053608|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
10887616|NCT02456740|12053609|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
10887617|NCT02456740|12053610|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
10887618|NCT02456740|12053611|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
10887619|NCT02456740|12053603|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10887620|NCT02456740|12053604|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10887621|NCT02456740|12053605|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
10887622|NCT02456740|12053606|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
10887623|NCT02456740|12053607|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
10887624|NCT02456740|12053608|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
10887625|NCT02456740|12053609|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
10887626|NCT02456740|12053610|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
10887627|NCT02456740|12053611|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
10887628|NCT02454933|12053623|FG000|STARTED|Overall Study||17
10887629|NCT02454933|12053624|FG001|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
10887630|NCT02454933|12053623|FG000|Treatment Group Randomised to|Overall Study||15
10887631|NCT02454933|12053624|FG001|Treatment Group Randomised to|Overall Study||14
10887632|NCT02454933|12053623|FG000|COMPLETED|Overall Study||9
10887633|NCT02454933|12053624|FG001|COMPLETED|Overall Study||4
10887634|NCT02454933|12053623|FG000|NOT COMPLETED|Overall Study||8
10887635|NCT02454933|12053624|FG001|NOT COMPLETED|Overall Study||8
10887636|NCT02453282|12053632|FG000|STARTED|Overall Study||374
10887637|NCT02453282|12053633|FG001|STARTED|Overall Study||372
10887638|NCT02453282|12053634|FG002|STARTED|Overall Study||372
10887639|NCT02453282|12053632|FG000|Received Treatment|Overall Study||369
10887640|NCT02453282|12053633|FG001|Received Treatment|Overall Study||371
10887641|NCT02453282|12053634|FG002|Received Treatment|Overall Study||352
10887642|NCT02453282|12053632|FG000|COMPLETED|Overall Study||0
10887643|NCT02453282|12053633|FG001|COMPLETED|Overall Study||0
10887644|NCT02453282|12053634|FG002|COMPLETED|Overall Study||0
10887645|NCT02453282|12053632|FG000|NOT COMPLETED|Overall Study||374
10887646|NCT02453282|12053633|FG001|NOT COMPLETED|Overall Study||372
10887647|NCT02453282|12053634|FG002|NOT COMPLETED|Overall Study||372
10887648|NCT02451176|12053646|FG000|STARTED|Overall Study||126
10887649|NCT02451176|12053647|FG001|STARTED|Overall Study||127
10887650|NCT02451176|12053646|FG000|COMPLETED|Overall Study||126
10887651|NCT02451176|12053647|FG001|COMPLETED|Overall Study||127
10887652|NCT02451176|12053646|FG000|NOT COMPLETED|Overall Study||0
10887653|NCT02451176|12053647|FG001|NOT COMPLETED|Overall Study||0
10887654|NCT02448225|12053653|FG000|STARTED|Overall Study||46
10887655|NCT02448225|12053653|FG000|COMPLETED|Overall Study||26
10887656|NCT02448225|12053653|FG000|NOT COMPLETED|Overall Study||20
10887657|NCT02446600|12053664|FG000|STARTED|Overall Study||187
10887658|NCT02446600|12053665|FG001|STARTED|Overall Study|Duplicate enrollment patient has been excluded from all analyses.|190
10887659|NCT02446600|12053666|FG002|STARTED|Overall Study||189
10887660|NCT02446600|12053667|FG003|STARTED|Overall Study||13
10887661|NCT02446600|12053664|FG000|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|147
10887662|NCT02446600|12053665|FG001|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|178
10887663|NCT02446600|12053666|FG002|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|162
10887664|NCT02446600|12053667|FG003|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|12
10887665|NCT02446600|12053664|FG000|NOT COMPLETED|Overall Study||40
10887666|NCT02446600|12053665|FG001|NOT COMPLETED|Overall Study||12
10887667|NCT02446600|12053666|FG002|NOT COMPLETED|Overall Study||27
10887668|NCT02446600|12053667|FG003|NOT COMPLETED|Overall Study||1
10887669|NCT02442778|12053680|FG000|STARTED|Overall Study||210
10887670|NCT02442778|12053681|FG001|STARTED|Overall Study||151
10887671|NCT02442778|12053682|FG002|STARTED|Overall Study||161
10887672|NCT02442778|12053680|FG000|Safety Population|Overall Study||210
10887673|NCT02442778|12053681|FG001|Safety Population|Overall Study||151
10887674|NCT02442778|12053682|FG002|Safety Population|Overall Study||160
10887675|NCT02442778|12053680|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||210
10887676|NCT02442778|12053681|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||150
10887677|NCT02442778|12053682|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||159
10887678|NCT02442778|12053680|FG000|COMPLETED|Overall Study||192
10887679|NCT02442778|12053681|FG001|COMPLETED|Overall Study||121
10887680|NCT02442778|12053682|FG002|COMPLETED|Overall Study||146
10887681|NCT02442778|12053680|FG000|NOT COMPLETED|Overall Study||18
10887682|NCT02442778|12053681|FG001|NOT COMPLETED|Overall Study||30
10887683|NCT02442778|12053682|FG002|NOT COMPLETED|Overall Study||15
10887684|NCT02439216|12053696|FG000|STARTED|PartA(7 Day Open-Label Treatment Period)||5
10887685|NCT02439216|12053697|FG001|STARTED|PartA(7 Day Open-Label Treatment Period)||6
10887686|NCT02439216|12053698|FG002|STARTED|PartA(7 Day Open-Label Treatment Period)||6
10887687|NCT02439216|12053699|FG003|STARTED|PartA(7 Day Open-Label Treatment Period)||0
10887688|NCT02439216|12053700|FG004|STARTED|PartA(7 Day Open-Label Treatment Period)||0
10887689|NCT02439216|12053701|FG005|STARTED|PartA(7 Day Open-Label Treatment Period)||0
10887690|NCT02439216|12053702|FG006|STARTED|PartA(7 Day Open-Label Treatment Period)||0
10887691|NCT02439216|12053703|FG007|STARTED|PartA(7 Day Open-Label Treatment Period)||0
10887692|NCT02439216|12053704|FG008|STARTED|PartA(7 Day Open-Label Treatment Period)||0
10887693|NCT02439216|12053696|FG000|COMPLETED|PartA(7 Day Open-Label Treatment Period)||4
10887694|NCT02439216|12053697|FG001|COMPLETED|PartA(7 Day Open-Label Treatment Period)||6
10887695|NCT02439216|12053698|FG002|COMPLETED|PartA(7 Day Open-Label Treatment Period)||6
10887696|NCT02439216|12053699|FG003|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887697|NCT02439216|12053700|FG004|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887698|NCT02439216|12053701|FG005|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887699|NCT02439216|12053702|FG006|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887700|NCT02439216|12053703|FG007|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887701|NCT02439216|12053704|FG008|COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887702|NCT02439216|12053696|FG000|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||1
10887703|NCT02439216|12053697|FG001|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887704|NCT02439216|12053698|FG002|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887705|NCT02439216|12053699|FG003|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887706|NCT02439216|12053700|FG004|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887707|NCT02439216|12053701|FG005|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887708|NCT02439216|12053702|FG006|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887709|NCT02439216|12053703|FG007|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887710|NCT02439216|12053704|FG008|NOT COMPLETED|PartA(7 Day Open-Label Treatment Period)||0
10887711|NCT02439216|12053696|FG000|STARTED|Part B (12-week Double Blind)||0
10887712|NCT02439216|12053697|FG001|STARTED|Part B (12-week Double Blind)||0
10887713|NCT02439216|12053698|FG002|STARTED|Part B (12-week Double Blind)||0
10887714|NCT02439216|12053699|FG003|STARTED|Part B (12-week Double Blind)|4 New subjects plus 6 subjects who completed Part A|10
10887715|NCT02439216|12053700|FG004|STARTED|Part B (12-week Double Blind)|4 New subjects plus 6 subjects who completed Part A|10
10887716|NCT02439216|12053701|FG005|STARTED|Part B (12-week Double Blind)|3 New subjects plus 2 subjects who completed Part A|5
10887717|NCT02439216|12053702|FG006|STARTED|Part B (12-week Double Blind)|4 New subjects plus 2 subjects who completed Part A|6
10887718|NCT02439216|12053703|FG007|STARTED|Part B (12-week Double Blind)||0
10887719|NCT02439216|12053704|FG008|STARTED|Part B (12-week Double Blind)||0
10887720|NCT02439216|12053696|FG000|COMPLETED|Part B (12-week Double Blind)||0
10887721|NCT02439216|12053697|FG001|COMPLETED|Part B (12-week Double Blind)||0
10887722|NCT02439216|12053698|FG002|COMPLETED|Part B (12-week Double Blind)||0
10887723|NCT02439216|12053699|FG003|COMPLETED|Part B (12-week Double Blind)||10
10887724|NCT02439216|12053700|FG004|COMPLETED|Part B (12-week Double Blind)||10
10887725|NCT02439216|12053701|FG005|COMPLETED|Part B (12-week Double Blind)||5
10887726|NCT02439216|12053702|FG006|COMPLETED|Part B (12-week Double Blind)||6
10887727|NCT02439216|12053703|FG007|COMPLETED|Part B (12-week Double Blind)||0
10887728|NCT02439216|12053704|FG008|COMPLETED|Part B (12-week Double Blind)||0
10887729|NCT02439216|12053696|FG000|NOT COMPLETED|Part B (12-week Double Blind)||0
10887730|NCT02439216|12053697|FG001|NOT COMPLETED|Part B (12-week Double Blind)||0
10887731|NCT02439216|12053698|FG002|NOT COMPLETED|Part B (12-week Double Blind)||0
10887732|NCT02439216|12053699|FG003|NOT COMPLETED|Part B (12-week Double Blind)||0
10887733|NCT02439216|12053700|FG004|NOT COMPLETED|Part B (12-week Double Blind)||0
10887734|NCT02439216|12053701|FG005|NOT COMPLETED|Part B (12-week Double Blind)||0
10887735|NCT02439216|12053702|FG006|NOT COMPLETED|Part B (12-week Double Blind)||0
10887736|NCT02439216|12053703|FG007|NOT COMPLETED|Part B (12-week Double Blind)||0
10887737|NCT02439216|12053704|FG008|NOT COMPLETED|Part B (12-week Double Blind)||0
10887738|NCT02439216|12053696|FG000|STARTED|Part C (138-week, Open-label Treatment)||0
10887739|NCT02439216|12053697|FG001|STARTED|Part C (138-week, Open-label Treatment)||0
10887740|NCT02439216|12053698|FG002|STARTED|Part C (138-week, Open-label Treatment)||0
10887741|NCT02439216|12053699|FG003|STARTED|Part C (138-week, Open-label Treatment)||0
10887742|NCT02439216|12053700|FG004|STARTED|Part C (138-week, Open-label Treatment)||0
10887743|NCT02439216|12053701|FG005|STARTED|Part C (138-week, Open-label Treatment)||0
10887744|NCT02439216|12053702|FG006|STARTED|Part C (138-week, Open-label Treatment)||0
10887745|NCT02439216|12053703|FG007|STARTED|Part C (138-week, Open-label Treatment)||15
10887746|NCT02439216|12053704|FG008|STARTED|Part C (138-week, Open-label Treatment)||16
10887747|NCT02439216|12053696|FG000|COMPLETED|Part C (138-week, Open-label Treatment)||0
10887748|NCT02439216|12053697|FG001|COMPLETED|Part C (138-week, Open-label Treatment)||0
10887749|NCT02439216|12053698|FG002|COMPLETED|Part C (138-week, Open-label Treatment)||0
10887750|NCT02439216|12053699|FG003|COMPLETED|Part C (138-week, Open-label Treatment)||0
10887751|NCT02439216|12053700|FG004|COMPLETED|Part C (138-week, Open-label Treatment)||0
10887752|NCT02439216|12053701|FG005|COMPLETED|Part C (138-week, Open-label Treatment)||0
10887753|NCT02439216|12053702|FG006|COMPLETED|Part C (138-week, Open-label Treatment)||0
10887754|NCT02439216|12053703|FG007|COMPLETED|Part C (138-week, Open-label Treatment)||8
10887755|NCT02439216|12053704|FG008|COMPLETED|Part C (138-week, Open-label Treatment)||5
10887756|NCT02439216|12053696|FG000|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0
10887757|NCT02439216|12053697|FG001|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0
10887758|NCT02439216|12053698|FG002|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0
10887759|NCT02439216|12053699|FG003|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0
10887760|NCT02439216|12053700|FG004|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0
10887761|NCT02439216|12053701|FG005|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0
10887762|NCT02439216|12053702|FG006|NOT COMPLETED|Part C (138-week, Open-label Treatment)||0
10887763|NCT02439216|12053703|FG007|NOT COMPLETED|Part C (138-week, Open-label Treatment)||7
10887764|NCT02439216|12053704|FG008|NOT COMPLETED|Part C (138-week, Open-label Treatment)||11
10887765|NCT02437318|12053730|FG000|STARTED|Overall Study||284
10887766|NCT02437318|12053731|FG001|STARTED|Overall Study||288
10887767|NCT02437318|12053730|FG000|End of Treatment (Didn't Complete)|Overall Study||229
10887768|NCT02437318|12053731|FG001|End of Treatment (Didn't Complete)|Overall Study||241
10887769|NCT02437318|12053730|FG000|Untreated (Protocol Deviation)|Overall Study||0
10887770|NCT02437318|12053731|FG001|Untreated (Protocol Deviation)|Overall Study||1
10887771|NCT02437318|12053730|FG000|COMPLETED|Overall Study||55
10887772|NCT02437318|12053731|FG001|COMPLETED|Overall Study||46
10887773|NCT02437318|12053730|FG000|NOT COMPLETED|Overall Study||229
10887774|NCT02437318|12053731|FG001|NOT COMPLETED|Overall Study||242
10887775|NCT02435173|12053740|FG000|STARTED|Overall Study||6
10887776|NCT02435173|12053741|FG001|STARTED|Overall Study||21
10887777|NCT02435173|12053742|FG002|STARTED|Overall Study||10
10887778|NCT02435173|12053740|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||6
10887779|NCT02435173|12053741|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||19
10887780|NCT02435173|12053742|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0
10887781|NCT02435173|12053740|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6
10887782|NCT02435173|12053741|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||19
10887783|NCT02435173|12053742|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||8
10887784|NCT02435173|12053740|FG000|COMPLETED|Overall Study||6
10887785|NCT02435173|12053741|FG001|COMPLETED|Overall Study||21
10887786|NCT02435173|12053742|FG002|COMPLETED|Overall Study||10
10887787|NCT02435173|12053740|FG000|NOT COMPLETED|Overall Study||0
10887788|NCT02435173|12053741|FG001|NOT COMPLETED|Overall Study||0
10887789|NCT02435173|12053742|FG002|NOT COMPLETED|Overall Study||0
10887790|NCT02434081|12053756|FG000|STARTED|Overall Study|Only patients enrolled after protocol amendments 1 (n=43) and 2 (n=36) were analysed (concurrent CRT+Nivo). Patients who received CRT and sequentially Nivo (enrolled under original protocol (n=12) or protocol amendment 1 (n=3)) were not included in the analysis population.|79
10887791|NCT02434081|12053756|FG000|COMPLETED|Overall Study||31
10887792|NCT02434081|12053756|FG000|NOT COMPLETED|Overall Study||48
10887793|NCT02433210|12053763|FG000|STARTED|Overall Study||5
10887794|NCT02433210|12053764|FG001|STARTED|Overall Study||3
10887795|NCT02433210|12053765|FG002|STARTED|Overall Study||3
10887796|NCT02433210|12053763|FG000|COMPLETED|Overall Study||4
10887797|NCT02433210|12053764|FG001|COMPLETED|Overall Study||3
10887798|NCT02433210|12053765|FG002|COMPLETED|Overall Study||3
10887799|NCT02433210|12053763|FG000|NOT COMPLETED|Overall Study||1
10887800|NCT02433210|12053764|FG001|NOT COMPLETED|Overall Study||0
10887801|NCT02433210|12053765|FG002|NOT COMPLETED|Overall Study||0
10887802|NCT02432846|12053857|FG000|STARTED|Overall Study (4 Arms/Strata)||17
10887803|NCT02432846|12053858|FG001|STARTED|Overall Study (4 Arms/Strata)||8
10887804|NCT02432846|12053859|FG002|STARTED|Overall Study (4 Arms/Strata)||41
10887805|NCT02432846|12053860|FG003|STARTED|Overall Study (4 Arms/Strata)||22
10887806|NCT02432846|12053861|FG004|STARTED|Overall Study (4 Arms/Strata)||0
10887807|NCT02432846|12053862|FG005|STARTED|Overall Study (4 Arms/Strata)||0
10887808|NCT02432846|12053857|FG000|COMPLETED|Overall Study (4 Arms/Strata)||2
10887809|NCT02432846|12053858|FG001|COMPLETED|Overall Study (4 Arms/Strata)||0
10887810|NCT02432846|12053859|FG002|COMPLETED|Overall Study (4 Arms/Strata)||17
10887811|NCT02432846|12053860|FG003|COMPLETED|Overall Study (4 Arms/Strata)||8
10887812|NCT02432846|12053861|FG004|COMPLETED|Overall Study (4 Arms/Strata)||0
10887813|NCT02432846|12053862|FG005|COMPLETED|Overall Study (4 Arms/Strata)||0
10887814|NCT02432846|12053857|FG000|NOT COMPLETED|Overall Study (4 Arms/Strata)||15
10887815|NCT02432846|12053858|FG001|NOT COMPLETED|Overall Study (4 Arms/Strata)||8
10887816|NCT02432846|12053859|FG002|NOT COMPLETED|Overall Study (4 Arms/Strata)||24
10887817|NCT02432846|12053860|FG003|NOT COMPLETED|Overall Study (4 Arms/Strata)||14
10887818|NCT02432846|12053861|FG004|NOT COMPLETED|Overall Study (4 Arms/Strata)||0
10887819|NCT02432846|12053862|FG005|NOT COMPLETED|Overall Study (4 Arms/Strata)||0
10887820|NCT02432846|12053857|FG000|STARTED|Overall Study (2 Total/Combined Groups)||0
10887821|NCT02432846|12053858|FG001|STARTED|Overall Study (2 Total/Combined Groups)||0
10887822|NCT02432846|12053859|FG002|STARTED|Overall Study (2 Total/Combined Groups)||0
10887823|NCT02432846|12053860|FG003|STARTED|Overall Study (2 Total/Combined Groups)||0
10887824|NCT02432846|12053861|FG004|STARTED|Overall Study (2 Total/Combined Groups)||58
10887825|NCT02432846|12053862|FG005|STARTED|Overall Study (2 Total/Combined Groups)||30
10887826|NCT02432846|12053857|FG000|COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887827|NCT02432846|12053858|FG001|COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887828|NCT02432846|12053859|FG002|COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887829|NCT02432846|12053860|FG003|COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887830|NCT02432846|12053861|FG004|COMPLETED|Overall Study (2 Total/Combined Groups)||19
10887831|NCT02432846|12053862|FG005|COMPLETED|Overall Study (2 Total/Combined Groups)||8
10887832|NCT02432846|12053857|FG000|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887833|NCT02432846|12053858|FG001|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887834|NCT02432846|12053859|FG002|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887835|NCT02432846|12053860|FG003|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||0
10887836|NCT02432846|12053861|FG004|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||39
10887837|NCT02432846|12053862|FG005|NOT COMPLETED|Overall Study (2 Total/Combined Groups)||22
10887838|NCT02432742|12053875|FG000|STARTED|Overall Study||100
10887839|NCT02432742|12053875|FG000|COMPLETED|Overall Study||95
10887840|NCT02432742|12053875|FG000|NOT COMPLETED|Overall Study||5
10887841|NCT02432690|12053880|FG000|STARTED|Overall Study||13
10887842|NCT02432690|12053880|FG000|COMPLETED|Overall Study||13
10887843|NCT02432690|12053880|FG000|NOT COMPLETED|Overall Study||0
10887844|NCT02432274|12053892|FG000|STARTED|Overall Study||3
10887845|NCT02432274|12053893|FG001|STARTED|Overall Study||9
10887846|NCT02432274|12053894|FG002|STARTED|Overall Study||11
10887847|NCT02432274|12053895|FG003|STARTED|Overall Study||1
10887848|NCT02432274|12053896|FG004|STARTED|Overall Study||31
10887849|NCT02432274|12053897|FG005|STARTED|Overall Study||7
10887850|NCT02432274|12053898|FG006|STARTED|Overall Study||15
10887851|NCT02432274|12053899|FG007|STARTED|Overall Study||20
10887852|NCT02432274|12053892|FG000|Underwent Run-in Period|Overall Study||1
10887853|NCT02432274|12053893|FG001|Underwent Run-in Period|Overall Study||1
10887854|NCT02432274|12053894|FG002|Underwent Run-in Period|Overall Study||0
10887855|NCT02432274|12053895|FG003|Underwent Run-in Period|Overall Study||0
10887856|NCT02432274|12053896|FG004|Underwent Run-in Period|Overall Study||0
10887857|NCT02432274|12053897|FG005|Underwent Run-in Period|Overall Study||0
10887858|NCT02432274|12053898|FG006|Underwent Run-in Period|Overall Study||0
10887859|NCT02432274|12053899|FG007|Underwent Run-in Period|Overall Study||0
10887860|NCT02432274|12053892|FG000|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|5
10887861|NCT02432274|12053893|FG001|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 14mg/m^2 (dose capped at 24 mg/day).|11
10887862|NCT02432274|12053894|FG002|Treated (Safety Population)|Overall Study||7
10887863|NCT02432274|12053895|FG003|Treated (Safety Population)|Overall Study||1
10887864|NCT02432274|12053896|FG004|Treated (Safety Population)|Overall Study||31
10887865|NCT02432274|12053897|FG005|Treated (Safety Population)|Overall Study|4 participants assigned to lenvatinib14mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|11
10887866|NCT02432274|12053898|FG006|Treated (Safety Population)|Overall Study||11
10887867|NCT02432274|12053899|FG007|Treated (Safety Population)|Overall Study||20
10887868|NCT02432274|12053892|FG000|COMPLETED|Overall Study||0
10887869|NCT02432274|12053893|FG001|COMPLETED|Overall Study||0
10887870|NCT02432274|12053894|FG002|COMPLETED|Overall Study||0
10887871|NCT02432274|12053895|FG003|COMPLETED|Overall Study||0
10887872|NCT02432274|12053896|FG004|COMPLETED|Overall Study||0
10887873|NCT02432274|12053897|FG005|COMPLETED|Overall Study||0
10887874|NCT02432274|12053898|FG006|COMPLETED|Overall Study||0
10887875|NCT02432274|12053899|FG007|COMPLETED|Overall Study||0
10887876|NCT02432274|12053892|FG000|NOT COMPLETED|Overall Study||3
10887877|NCT02432274|12053893|FG001|NOT COMPLETED|Overall Study||9
10887878|NCT02432274|12053894|FG002|NOT COMPLETED|Overall Study||11
10887879|NCT02432274|12053895|FG003|NOT COMPLETED|Overall Study||1
10887880|NCT02432274|12053896|FG004|NOT COMPLETED|Overall Study||31
10887881|NCT02432274|12053897|FG005|NOT COMPLETED|Overall Study||7
10887882|NCT02432274|12053898|FG006|NOT COMPLETED|Overall Study||15
10887883|NCT02432274|12053899|FG007|NOT COMPLETED|Overall Study||20
10887884|NCT02432196|12053929|FG000|STARTED|Overall Study||26
10887885|NCT02432196|12053929|FG000|Implanted With Device|Overall Study||25
10887886|NCT02432196|12053929|FG000|COMPLETED|Overall Study||0
10887887|NCT02432196|12053929|FG000|NOT COMPLETED|Overall Study||26
10887888|NCT02431247|12053935|FG000|STARTED|BL to EOE-Test and BL to Switch- Control||362
10887889|NCT02431247|12053936|FG001|STARTED|BL to EOE-Test and BL to Switch- Control||363
10887890|NCT02431247|12053937|FG002|STARTED|BL to EOE-Test and BL to Switch- Control||0
10887891|NCT02431247|12053935|FG000|COMPLETED|BL to EOE-Test and BL to Switch- Control||296
10887892|NCT02431247|12053936|FG001|COMPLETED|BL to EOE-Test and BL to Switch- Control||322
10887893|NCT02431247|12053937|FG002|COMPLETED|BL to EOE-Test and BL to Switch- Control||0
10887894|NCT02431247|12053935|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||66
10887895|NCT02431247|12053936|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||41
10887896|NCT02431247|12053937|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||0
10887897|NCT02431247|12053935|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0
10887898|NCT02431247|12053936|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|0
10887899|NCT02431247|12053937|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|322
10887900|NCT02431247|12053935|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10887901|NCT02431247|12053936|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10887902|NCT02431247|12053937|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||289
10887903|NCT02431247|12053935|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10887904|NCT02431247|12053936|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
10887905|NCT02431247|12053937|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||33
10887906|NCT02429830|12053949|FG000|STARTED|Overall Study||30
10887907|NCT02429830|12053949|FG000|COMPLETED|Overall Study||27
10887908|NCT02429830|12053949|FG000|NOT COMPLETED|Overall Study||3
10887909|NCT02427464|12053955|FG000|STARTED|Overall Study||338
10887910|NCT02427464|12053956|FG001|STARTED|Overall Study||169
10887911|NCT02427464|12053955|FG000|Intent-to-Treat Population|Overall Study||336
10887912|NCT02427464|12053956|FG001|Intent-to-Treat Population|Overall Study||164
10887913|NCT02427464|12053955|FG000|COMPLETED|Overall Study||288
10887914|NCT02427464|12053956|FG001|COMPLETED|Overall Study||145
10887915|NCT02427464|12053955|FG000|NOT COMPLETED|Overall Study||50
10887916|NCT02427464|12053956|FG001|NOT COMPLETED|Overall Study||24
10887917|NCT02426125|12053964|FG000|STARTED|Overall Study||263
10887918|NCT02426125|12053965|FG001|STARTED|Overall Study||267
10887919|NCT02426125|12053964|FG000|Received at Least One Dose of Study Drug|Overall Study||258
10887920|NCT02426125|12053965|FG001|Received at Least One Dose of Study Drug|Overall Study||265
10887921|NCT02426125|12053964|FG000|First Randomized Participants|Overall Study||216
10887922|NCT02426125|12053965|FG001|First Randomized Participants|Overall Study||221
10887923|NCT02426125|12053964|FG000|COMPLETED|Overall Study||234
10887924|NCT02426125|12053965|FG001|COMPLETED|Overall Study||241
10887925|NCT02426125|12053964|FG000|NOT COMPLETED|Overall Study||29
10887926|NCT02426125|12053965|FG001|NOT COMPLETED|Overall Study||26
10887927|NCT02422615|12053975|FG000|STARTED|Overall Study||484
10887928|NCT02422615|12053976|FG001|STARTED|Overall Study||242
10887929|NCT02422615|12053975|FG000|Untreated|Overall Study||1
10887930|NCT02422615|12053976|FG001|Untreated|Overall Study||1
10887931|NCT02422615|12053975|FG000|COMPLETED|Overall Study||204
10887932|NCT02422615|12053976|FG001|COMPLETED|Overall Study||76
10887933|NCT02422615|12053975|FG000|NOT COMPLETED|Overall Study||280
10887934|NCT02422615|12053976|FG001|NOT COMPLETED|Overall Study||166
10887935|NCT02421939|12053984|FG000|STARTED|Overall Study||247
10887936|NCT02421939|12053985|FG001|STARTED|Overall Study||124
10887937|NCT02421939|12053984|FG000|Treated|Overall Study||246
10887938|NCT02421939|12053985|FG001|Treated|Overall Study||109
10887939|NCT02421939|12053984|FG000|COMPLETED|Overall Study||38
10887940|NCT02421939|12053985|FG001|COMPLETED|Overall Study||0
10887941|NCT02421939|12053984|FG000|NOT COMPLETED|Overall Study||209
10887942|NCT02421939|12053985|FG001|NOT COMPLETED|Overall Study||124
10887943|NCT02420119|12053991|FG000|STARTED|Overall Study||53
10887944|NCT02420119|12053991|FG000|COMPLETED|Overall Study||48
10887945|NCT02420119|12053991|FG000|NOT COMPLETED|Overall Study||5
10887946|NCT02418195|12053999|FG000|STARTED|Overall Study|Number subjects screened in this group.|62
10887947|NCT02418195|12054000|FG001|STARTED|Overall Study|Number subjects screened in this group.|63
10887948|NCT02418195|12054001|FG002|STARTED|Overall Study|Number subjects screened in this group.|61
10887949|NCT02418195|12054002|FG003|STARTED|Overall Study|Number subjects screened in this group.|61
10887950|NCT02418195|12053999|FG000|COMPLETED|Overall Study|Number subjects screened in this group.|62
10887951|NCT02418195|12054000|FG001|COMPLETED|Overall Study|Number subjects screened in this group.|63
10887952|NCT02418195|12054001|FG002|COMPLETED|Overall Study|Number subjects screened in this group.|61
10887953|NCT02418195|12054002|FG003|COMPLETED|Overall Study|Number subjects screened in this group.|61
10887954|NCT02418195|12053999|FG000|NOT COMPLETED|Overall Study||0
10887955|NCT02418195|12054000|FG001|NOT COMPLETED|Overall Study||0
10887956|NCT02418195|12054001|FG002|NOT COMPLETED|Overall Study||0
10887957|NCT02418195|12054002|FG003|NOT COMPLETED|Overall Study||0
10887958|NCT02412878|12054014|FG000|STARTED|Overall Study||238
10887959|NCT02412878|12054015|FG001|STARTED|Overall Study||240
10887960|NCT02412878|12054014|FG000|Received Carfilzomib|Overall Study||235
10887961|NCT02412878|12054015|FG001|Received Carfilzomib|Overall Study||238
10887962|NCT02412878|12054014|FG000|COMPLETED|Overall Study||217
10887963|NCT02412878|12054015|FG001|COMPLETED|Overall Study||227
10887964|NCT02412878|12054014|FG000|NOT COMPLETED|Overall Study||21
10887965|NCT02412878|12054015|FG001|NOT COMPLETED|Overall Study||13
10887966|NCT02412670|12054023|FG000|STARTED|Overall Study||30
10887967|NCT02412670|12054024|FG001|STARTED|Overall Study||6
10887968|NCT02412670|12054023|FG000|Eligible and Treated|Overall Study||29
10887969|NCT02412670|12054024|FG001|Eligible and Treated|Overall Study||6
10887970|NCT02412670|12054023|FG000|COMPLETED|Overall Study||23
10887971|NCT02412670|12054024|FG001|COMPLETED|Overall Study||5
10887972|NCT02412670|12054023|FG000|NOT COMPLETED|Overall Study||7
10887973|NCT02412670|12054024|FG001|NOT COMPLETED|Overall Study||1
10887974|NCT02412306|12054035|FG000|STARTED|Overall Study||5
10887975|NCT02412306|12054036|FG001|STARTED|Overall Study||9
10887976|NCT02412306|12054037|FG002|STARTED|Overall Study||21
10887977|NCT02412306|12054038|FG003|STARTED|Overall Study||14
10887978|NCT02412306|12054039|FG004|STARTED|Overall Study||17
10887979|NCT02412306|12054035|FG000|COMPLETED|Overall Study||0
10887980|NCT02412306|12054036|FG001|COMPLETED|Overall Study||1
10887981|NCT02412306|12054037|FG002|COMPLETED|Overall Study||5
10887982|NCT02412306|12054038|FG003|COMPLETED|Overall Study||14
10887983|NCT02412306|12054039|FG004|COMPLETED|Overall Study||15
10887984|NCT02412306|12054035|FG000|NOT COMPLETED|Overall Study||5
10887985|NCT02412306|12054036|FG001|NOT COMPLETED|Overall Study||8
10887986|NCT02412306|12054037|FG002|NOT COMPLETED|Overall Study||16
10887987|NCT02412306|12054038|FG003|NOT COMPLETED|Overall Study||0
10887988|NCT02412306|12054039|FG004|NOT COMPLETED|Overall Study||2
10887989|NCT02408887|12054062|FG000|STARTED|Overall Study||8
10887990|NCT02408887|12054063|FG001|STARTED|Overall Study||6
10887991|NCT02408887|12054062|FG000|COMPLETED|Overall Study||7
10887992|NCT02408887|12054063|FG001|COMPLETED|Overall Study||5
10887993|NCT02408887|12054062|FG000|NOT COMPLETED|Overall Study||1
10887994|NCT02408887|12054063|FG001|NOT COMPLETED|Overall Study||1
10887995|NCT02407236|12054077|FG000|STARTED|Induction Study (8 Weeks)||319
10887996|NCT02407236|12054078|FG001|STARTED|Induction Study (8 Weeks)||320
10887997|NCT02407236|12054079|FG002|STARTED|Induction Study (8 Weeks)||322
10887998|NCT02407236|12054080|FG003|STARTED|Induction Study (8 Weeks)||0
10887999|NCT02407236|12054081|FG004|STARTED|Induction Study (8 Weeks)||0
10888000|NCT02407236|12054082|FG005|STARTED|Induction Study (8 Weeks)||0
10888001|NCT02407236|12054083|FG006|STARTED|Induction Study (8 Weeks)||0
10888002|NCT02407236|12054084|FG007|STARTED|Induction Study (8 Weeks)||0
10888003|NCT02407236|12054077|FG000|Clinical Response at IS Week 8|Induction Study (8 Weeks)||103
10888004|NCT02407236|12054078|FG001|Clinical Response at IS Week 8|Induction Study (8 Weeks)||172
10888005|NCT02407236|12054079|FG002|Clinical Response at IS Week 8|Induction Study (8 Weeks)||208
10888006|NCT02407236|12054080|FG003|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
10888007|NCT02407236|12054081|FG004|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
10888008|NCT02407236|12054082|FG005|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
10888009|NCT02407236|12054083|FG006|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
10888010|NCT02407236|12054084|FG007|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
10888011|NCT02407236|12054077|FG000|Clinical Response at IS Week 16|Induction Study (8 Weeks)||143
10888012|NCT02407236|12054078|FG001|Clinical Response at IS Week 16|Induction Study (8 Weeks)||90
10888013|NCT02407236|12054079|FG002|Clinical Response at IS Week 16|Induction Study (8 Weeks)||67
10888014|NCT02407236|12054080|FG003|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
10888015|NCT02407236|12054081|FG004|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
10888016|NCT02407236|12054082|FG005|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
10888017|NCT02407236|12054083|FG006|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
10888018|NCT02407236|12054084|FG007|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
10888019|NCT02407236|12054077|FG000|Completed Safety Follow-up|Induction Study (8 Weeks)|17 participants from Induction Week (IW)- 8 and 33 participants from IW- 16.|50
10888020|NCT02407236|12054078|FG001|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 37 from IW- 16.|47
10888021|NCT02407236|12054079|FG002|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 22 from IW- 16.|32
10888022|NCT02407236|12054080|FG003|Completed Safety Follow-up|Induction Study (8 Weeks)||0
10888023|NCT02407236|12054081|FG004|Completed Safety Follow-up|Induction Study (8 Weeks)||0
10888024|NCT02407236|12054082|FG005|Completed Safety Follow-up|Induction Study (8 Weeks)||0
10888025|NCT02407236|12054083|FG006|Completed Safety Follow-up|Induction Study (8 Weeks)||0
10888026|NCT02407236|12054084|FG007|Completed Safety Follow-up|Induction Study (8 Weeks)||0
10888027|NCT02407236|12054077|FG000|Safety Analysis Set|Induction Study (8 Weeks)||319
10888028|NCT02407236|12054078|FG001|Safety Analysis Set|Induction Study (8 Weeks)|1 participant of ustekinumab 130mg never had drug, 2 participants planned to 6 mg/kg but had 130mg.|321
10888029|NCT02407236|12054079|FG002|Safety Analysis Set|Induction Study (8 Weeks)||320
10888030|NCT02407236|12054080|FG003|Safety Analysis Set|Induction Study (8 Weeks)||0
10888031|NCT02407236|12054081|FG004|Safety Analysis Set|Induction Study (8 Weeks)||0
10888032|NCT02407236|12054082|FG005|Safety Analysis Set|Induction Study (8 Weeks)||0
10888033|NCT02407236|12054083|FG006|Safety Analysis Set|Induction Study (8 Weeks)||0
10888034|NCT02407236|12054084|FG007|Safety Analysis Set|Induction Study (8 Weeks)||0
10888035|NCT02407236|12054077|FG000|Non-responders at Week 8|Induction Study (8 Weeks)||184
10888036|NCT02407236|12054078|FG001|Non-responders at Week 8|Induction Study (8 Weeks)||132
10888037|NCT02407236|12054079|FG002|Non-responders at Week 8|Induction Study (8 Weeks)||101
10888038|NCT02407236|12054080|FG003|Non-responders at Week 8|Induction Study (8 Weeks)||0
10888039|NCT02407236|12054081|FG004|Non-responders at Week 8|Induction Study (8 Weeks)||0
10888040|NCT02407236|12054082|FG005|Non-responders at Week 8|Induction Study (8 Weeks)||0
10888041|NCT02407236|12054083|FG006|Non-responders at Week 8|Induction Study (8 Weeks)||0
10888042|NCT02407236|12054084|FG007|Non-responders at Week 8|Induction Study (8 Weeks)||0
10888043|NCT02407236|12054077|FG000|COMPLETED|Induction Study (8 Weeks)||296
10888044|NCT02407236|12054078|FG001|COMPLETED|Induction Study (8 Weeks)||309
10888045|NCT02407236|12054079|FG002|COMPLETED|Induction Study (8 Weeks)||307
10888046|NCT02407236|12054080|FG003|COMPLETED|Induction Study (8 Weeks)||0
10888047|NCT02407236|12054081|FG004|COMPLETED|Induction Study (8 Weeks)||0
10888048|NCT02407236|12054082|FG005|COMPLETED|Induction Study (8 Weeks)||0
10888049|NCT02407236|12054083|FG006|COMPLETED|Induction Study (8 Weeks)||0
10888050|NCT02407236|12054084|FG007|COMPLETED|Induction Study (8 Weeks)||0
10888051|NCT02407236|12054077|FG000|NOT COMPLETED|Induction Study (8 Weeks)||23
10888052|NCT02407236|12054078|FG001|NOT COMPLETED|Induction Study (8 Weeks)||11
10888053|NCT02407236|12054079|FG002|NOT COMPLETED|Induction Study (8 Weeks)||15
10888054|NCT02407236|12054080|FG003|NOT COMPLETED|Induction Study (8 Weeks)||0
10888055|NCT02407236|12054081|FG004|NOT COMPLETED|Induction Study (8 Weeks)||0
10888056|NCT02407236|12054082|FG005|NOT COMPLETED|Induction Study (8 Weeks)||0
10888057|NCT02407236|12054083|FG006|NOT COMPLETED|Induction Study (8 Weeks)||0
10888058|NCT02407236|12054084|FG007|NOT COMPLETED|Induction Study (8 Weeks)||0
10888059|NCT02407236|12054077|FG000|STARTED|Maintenance Study (44 Weeks)||0
10888060|NCT02407236|12054078|FG001|STARTED|Maintenance Study (44 Weeks)||0
10888061|NCT02407236|12054079|FG002|STARTED|Maintenance Study (44 Weeks)||0
10888062|NCT02407236|12054080|FG003|STARTED|Maintenance Study (44 Weeks)||175
10888063|NCT02407236|12054081|FG004|STARTED|Maintenance Study (44 Weeks)||172
10888064|NCT02407236|12054082|FG005|STARTED|Maintenance Study (44 Weeks)||176
10888065|NCT02407236|12054083|FG006|STARTED|Maintenance Study (44 Weeks)||103
10888066|NCT02407236|12054084|FG007|STARTED|Maintenance Study (44 Weeks)||157
10888067|NCT02407236|12054077|FG000|COMPLETED|Maintenance Study (44 Weeks)||0
10888068|NCT02407236|12054078|FG001|COMPLETED|Maintenance Study (44 Weeks)||0
10888069|NCT02407236|12054079|FG002|COMPLETED|Maintenance Study (44 Weeks)||0
10888070|NCT02407236|12054080|FG003|COMPLETED|Maintenance Study (44 Weeks)||165
10888071|NCT02407236|12054081|FG004|COMPLETED|Maintenance Study (44 Weeks)||161
10888072|NCT02407236|12054082|FG005|COMPLETED|Maintenance Study (44 Weeks)||168
10888073|NCT02407236|12054083|FG006|COMPLETED|Maintenance Study (44 Weeks)||94
10888074|NCT02407236|12054084|FG007|COMPLETED|Maintenance Study (44 Weeks)||149
10888075|NCT02407236|12054077|FG000|NOT COMPLETED|Maintenance Study (44 Weeks)||0
10888076|NCT02407236|12054078|FG001|NOT COMPLETED|Maintenance Study (44 Weeks)||0
10888077|NCT02407236|12054079|FG002|NOT COMPLETED|Maintenance Study (44 Weeks)||0
10888078|NCT02407236|12054080|FG003|NOT COMPLETED|Maintenance Study (44 Weeks)||10
10888079|NCT02407236|12054081|FG004|NOT COMPLETED|Maintenance Study (44 Weeks)||11
10888080|NCT02407236|12054082|FG005|NOT COMPLETED|Maintenance Study (44 Weeks)||8
10888081|NCT02407236|12054083|FG006|NOT COMPLETED|Maintenance Study (44 Weeks)||9
10888082|NCT02407236|12054084|FG007|NOT COMPLETED|Maintenance Study (44 Weeks)||8
10888083|NCT02404441|12054112|FG000|STARTED|Phase 1 Part||16
10888084|NCT02404441|12054113|FG001|STARTED|Phase 1 Part||15
10888085|NCT02404441|12054114|FG002|STARTED|Phase 1 Part||11
10888086|NCT02404441|12054115|FG003|STARTED|Phase 1 Part||6
10888087|NCT02404441|12054116|FG004|STARTED|Phase 1 Part||10
10888088|NCT02404441|12054117|FG005|STARTED|Phase 1 Part||0
10888089|NCT02404441|12054118|FG006|STARTED|Phase 1 Part||0
10888090|NCT02404441|12054119|FG007|STARTED|Phase 1 Part||0
10888091|NCT02404441|12054120|FG008|STARTED|Phase 1 Part||0
10888092|NCT02404441|12054121|FG009|STARTED|Phase 1 Part||0
10888093|NCT02404441|12054112|FG000|COMPLETED|Phase 1 Part||0
10888094|NCT02404441|12054113|FG001|COMPLETED|Phase 1 Part||0
10888095|NCT02404441|12054114|FG002|COMPLETED|Phase 1 Part||0
10888096|NCT02404441|12054115|FG003|COMPLETED|Phase 1 Part||0
10888097|NCT02404441|12054116|FG004|COMPLETED|Phase 1 Part||0
10888098|NCT02404441|12054117|FG005|COMPLETED|Phase 1 Part||0
10888099|NCT02404441|12054118|FG006|COMPLETED|Phase 1 Part||0
10888100|NCT02404441|12054119|FG007|COMPLETED|Phase 1 Part||0
10888101|NCT02404441|12054120|FG008|COMPLETED|Phase 1 Part||0
10888102|NCT02404441|12054121|FG009|COMPLETED|Phase 1 Part||0
10888103|NCT02404441|12054112|FG000|NOT COMPLETED|Phase 1 Part||16
10888104|NCT02404441|12054113|FG001|NOT COMPLETED|Phase 1 Part||15
10888105|NCT02404441|12054114|FG002|NOT COMPLETED|Phase 1 Part||11
10888106|NCT02404441|12054115|FG003|NOT COMPLETED|Phase 1 Part||6
10888107|NCT02404441|12054116|FG004|NOT COMPLETED|Phase 1 Part||10
10888108|NCT02404441|12054117|FG005|NOT COMPLETED|Phase 1 Part||0
10888109|NCT02404441|12054118|FG006|NOT COMPLETED|Phase 1 Part||0
10888110|NCT02404441|12054119|FG007|NOT COMPLETED|Phase 1 Part||0
10888111|NCT02404441|12054120|FG008|NOT COMPLETED|Phase 1 Part||0
10888112|NCT02404441|12054121|FG009|NOT COMPLETED|Phase 1 Part||0
10888113|NCT02404441|12054112|FG000|STARTED|Phase 2 Part||0
10888114|NCT02404441|12054113|FG001|STARTED|Phase 2 Part||0
10888115|NCT02404441|12054114|FG002|STARTED|Phase 2 Part||0
10888116|NCT02404441|12054115|FG003|STARTED|Phase 2 Part||0
10888117|NCT02404441|12054116|FG004|STARTED|Phase 2 Part||0
10888118|NCT02404441|12054117|FG005|STARTED|Phase 2 Part||59
10888119|NCT02404441|12054118|FG006|STARTED|Phase 2 Part||61
10888120|NCT02404441|12054119|FG007|STARTED|Phase 2 Part||40
10888121|NCT02404441|12054120|FG008|STARTED|Phase 2 Part||59
10888122|NCT02404441|12054121|FG009|STARTED|Phase 2 Part||42
10888123|NCT02404441|12054112|FG000|Entered Post-treatment Follow-up|Phase 2 Part||0
10888124|NCT02404441|12054113|FG001|Entered Post-treatment Follow-up|Phase 2 Part||0
10888125|NCT02404441|12054114|FG002|Entered Post-treatment Follow-up|Phase 2 Part||0
10888126|NCT02404441|12054115|FG003|Entered Post-treatment Follow-up|Phase 2 Part||0
10888127|NCT02404441|12054116|FG004|Entered Post-treatment Follow-up|Phase 2 Part||0
10888128|NCT02404441|12054117|FG005|Entered Post-treatment Follow-up|Phase 2 Part||2
10888129|NCT02404441|12054118|FG006|Entered Post-treatment Follow-up|Phase 2 Part||6
10888130|NCT02404441|12054119|FG007|Entered Post-treatment Follow-up|Phase 2 Part||1
10888298|NCT02376790|12054291|FG000|COMPLETED|Overall Study||224
10888131|NCT02404441|12054120|FG008|Entered Post-treatment Follow-up|Phase 2 Part||6
10888132|NCT02404441|12054121|FG009|Entered Post-treatment Follow-up|Phase 2 Part||1
10888133|NCT02404441|12054112|FG000|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10888134|NCT02404441|12054113|FG001|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10888135|NCT02404441|12054114|FG002|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10888136|NCT02404441|12054115|FG003|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10888137|NCT02404441|12054116|FG004|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
10888138|NCT02404441|12054117|FG005|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||2
10888139|NCT02404441|12054118|FG006|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6
10888140|NCT02404441|12054119|FG007|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1
10888141|NCT02404441|12054120|FG008|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6
10888142|NCT02404441|12054121|FG009|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1
10888143|NCT02404441|12054112|FG000|Entered Survival Follow-up|Phase 2 Part||0
10888144|NCT02404441|12054113|FG001|Entered Survival Follow-up|Phase 2 Part||0
10888145|NCT02404441|12054114|FG002|Entered Survival Follow-up|Phase 2 Part||0
10888146|NCT02404441|12054115|FG003|Entered Survival Follow-up|Phase 2 Part||0
10888147|NCT02404441|12054116|FG004|Entered Survival Follow-up|Phase 2 Part||0
10888148|NCT02404441|12054117|FG005|Entered Survival Follow-up|Phase 2 Part||38
10888149|NCT02404441|12054118|FG006|Entered Survival Follow-up|Phase 2 Part||34
10888150|NCT02404441|12054119|FG007|Entered Survival Follow-up|Phase 2 Part||26
10888151|NCT02404441|12054120|FG008|Entered Survival Follow-up|Phase 2 Part||35
10888152|NCT02404441|12054121|FG009|Entered Survival Follow-up|Phase 2 Part||25
10888153|NCT02404441|12054112|FG000|COMPLETED|Phase 2 Part||0
10888154|NCT02404441|12054113|FG001|COMPLETED|Phase 2 Part||0
10888155|NCT02404441|12054114|FG002|COMPLETED|Phase 2 Part||0
10888156|NCT02404441|12054115|FG003|COMPLETED|Phase 2 Part||0
10888157|NCT02404441|12054116|FG004|COMPLETED|Phase 2 Part||0
10888158|NCT02404441|12054117|FG005|COMPLETED|Phase 2 Part||0
10888159|NCT02404441|12054118|FG006|COMPLETED|Phase 2 Part||0
10888160|NCT02404441|12054119|FG007|COMPLETED|Phase 2 Part||0
10888161|NCT02404441|12054120|FG008|COMPLETED|Phase 2 Part||0
10888162|NCT02404441|12054121|FG009|COMPLETED|Phase 2 Part||0
10888163|NCT02404441|12054112|FG000|NOT COMPLETED|Phase 2 Part||0
10888164|NCT02404441|12054113|FG001|NOT COMPLETED|Phase 2 Part||0
10888165|NCT02404441|12054114|FG002|NOT COMPLETED|Phase 2 Part||0
10888166|NCT02404441|12054115|FG003|NOT COMPLETED|Phase 2 Part||0
10888167|NCT02404441|12054116|FG004|NOT COMPLETED|Phase 2 Part||0
10888168|NCT02404441|12054117|FG005|NOT COMPLETED|Phase 2 Part||59
10888169|NCT02404441|12054118|FG006|NOT COMPLETED|Phase 2 Part||61
10888170|NCT02404441|12054119|FG007|NOT COMPLETED|Phase 2 Part||40
10888171|NCT02404441|12054120|FG008|NOT COMPLETED|Phase 2 Part||59
10888172|NCT02404441|12054121|FG009|NOT COMPLETED|Phase 2 Part||42
10888173|NCT02403986|12054167|FG000|STARTED|Overall Study||26
10888174|NCT02403986|12054168|FG001|STARTED|Overall Study||27
10888175|NCT02403986|12054167|FG000|COMPLETED|Overall Study||21
10888176|NCT02403986|12054168|FG001|COMPLETED|Overall Study||23
10888177|NCT02403986|12054167|FG000|NOT COMPLETED|Overall Study||5
10888178|NCT02403986|12054168|FG001|NOT COMPLETED|Overall Study||4
10888179|NCT02403778|12054176|FG000|STARTED|Overall Study||6
10888180|NCT02403778|12054177|FG001|STARTED|Overall Study||4
10888181|NCT02403778|12054176|FG000|COMPLETED|Overall Study||6
10888182|NCT02403778|12054177|FG001|COMPLETED|Overall Study||4
10888183|NCT02403778|12054176|FG000|NOT COMPLETED|Overall Study||0
10888184|NCT02403778|12054177|FG001|NOT COMPLETED|Overall Study||0
10888185|NCT02403674|12054185|FG000|STARTED|Overall Study||368
10888186|NCT02403674|12054186|FG001|STARTED|Overall Study||366
10888187|NCT02403674|12054185|FG000|Treated|Overall Study||364
10888188|NCT02403674|12054186|FG001|Treated|Overall Study||364
10888189|NCT02403674|12054185|FG000|COMPLETED|Overall Study||313
10888190|NCT02403674|12054186|FG001|COMPLETED|Overall Study||303
10888191|NCT02403674|12054185|FG000|NOT COMPLETED|Overall Study||55
10888192|NCT02403674|12054186|FG001|NOT COMPLETED|Overall Study||63
10888193|NCT02399449|12054194|FG000|STARTED|Overall Study||25
10888194|NCT02399449|12054195|FG001|STARTED|Overall Study||32
10888195|NCT02399449|12054194|FG000|COMPLETED|Overall Study||22
10888196|NCT02399449|12054195|FG001|COMPLETED|Overall Study||22
10888197|NCT02399449|12054194|FG000|NOT COMPLETED|Overall Study||3
10888198|NCT02399449|12054195|FG001|NOT COMPLETED|Overall Study||10
10888199|NCT02397096|12054203|FG000|STARTED|Day 1 to Week 24||447
10888200|NCT02397096|12054204|FG001|STARTED|Day 1 to Week 24||223
10888201|NCT02397096|12054203|FG000|COMPLETED|Day 1 to Week 24||427
10888202|NCT02397096|12054204|FG001|COMPLETED|Day 1 to Week 24||209
10888203|NCT02397096|12054203|FG000|NOT COMPLETED|Day 1 to Week 24||20
10888204|NCT02397096|12054204|FG001|NOT COMPLETED|Day 1 to Week 24||14
10888205|NCT02397096|12054203|FG000|STARTED|Week 24 to Week 48||427
10888206|NCT02397096|12054204|FG001|STARTED|Week 24 to Week 48||209
10888207|NCT02397096|12054203|FG000|COMPLETED|Week 24 to Week 48||407
10888208|NCT02397096|12054204|FG001|COMPLETED|Week 24 to Week 48||202
10888209|NCT02397096|12054203|FG000|NOT COMPLETED|Week 24 to Week 48||20
10888210|NCT02397096|12054204|FG001|NOT COMPLETED|Week 24 to Week 48||7
10888211|NCT02397096|12054203|FG000|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399
10888212|NCT02397096|12054204|FG001|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202
10888213|NCT02397096|12054203|FG000|COMPLETED|Study Extensions|The extension study is ongoing.|0
10888299|NCT02376790|12054292|FG001|COMPLETED|Overall Study||237
10888214|NCT02397096|12054204|FG001|COMPLETED|Study Extensions|The extension study is ongoing.|0
10888215|NCT02397096|12054203|FG000|NOT COMPLETED|Study Extensions||399
10888216|NCT02397096|12054204|FG001|NOT COMPLETED|Study Extensions||202
10888217|NCT02396251|12054216|FG000|STARTED|Overall Study||36
10888218|NCT02396251|12054217|FG001|STARTED|Overall Study||12
10888219|NCT02396251|12054216|FG000|COMPLETED|Overall Study||23
10888220|NCT02396251|12054217|FG001|COMPLETED|Overall Study||7
10888221|NCT02396251|12054216|FG000|NOT COMPLETED|Overall Study||13
10888222|NCT02396251|12054217|FG001|NOT COMPLETED|Overall Study||5
10888223|NCT02394769|12054225|FG000|STARTED|Overall Study||60
10888224|NCT02394769|12054226|FG001|STARTED|Overall Study||60
10888225|NCT02394769|12054227|FG002|STARTED|Overall Study||60
10888226|NCT02394769|12054225|FG000|COMPLETED|Overall Study||58
10888227|NCT02394769|12054226|FG001|COMPLETED|Overall Study||57
10888228|NCT02394769|12054227|FG002|COMPLETED|Overall Study||54
10888229|NCT02394769|12054225|FG000|NOT COMPLETED|Overall Study||2
10888230|NCT02394769|12054226|FG001|NOT COMPLETED|Overall Study||3
10888231|NCT02394769|12054227|FG002|NOT COMPLETED|Overall Study||6
10888232|NCT02393859|12054237|FG000|STARTED|Overall Study||54
10888233|NCT02393859|12054238|FG001|STARTED|Overall Study||54
10888234|NCT02393859|12054237|FG000|COMPLETED|Overall Study||0
10888235|NCT02393859|12054238|FG001|COMPLETED|Overall Study||0
10888236|NCT02393859|12054237|FG000|NOT COMPLETED|Overall Study||54
10888237|NCT02393859|12054238|FG001|NOT COMPLETED|Overall Study||54
10888238|NCT02393690|12054247|FG000|STARTED|Overall Study||29
10888239|NCT02393690|12054248|FG001|STARTED|Overall Study||31
10888240|NCT02393690|12054247|FG000|COMPLETED|Overall Study||29
10888241|NCT02393690|12054248|FG001|COMPLETED|Overall Study||31
10888242|NCT02393690|12054247|FG000|NOT COMPLETED|Overall Study||0
10888243|NCT02393690|12054248|FG001|NOT COMPLETED|Overall Study||0
10888244|NCT02390323|12054254|FG000|STARTED|Overall Study||13
10888245|NCT02390323|12054254|FG000|COMPLETED|Overall Study||13
10888246|NCT02390323|12054254|FG000|NOT COMPLETED|Overall Study||0
10888247|NCT02390245|12054259|FG000|STARTED|Phase I. Telemedicine Screening||906
10888248|NCT02390245|12054260|FG001|STARTED|Phase I. Telemedicine Screening||0
10888249|NCT02390245|12054261|FG002|STARTED|Phase I. Telemedicine Screening||0
10888250|NCT02390245|12054259|FG000|COMPLETED|Phase I. Telemedicine Screening||906
10888251|NCT02390245|12054260|FG001|COMPLETED|Phase I. Telemedicine Screening||0
10888252|NCT02390245|12054261|FG002|COMPLETED|Phase I. Telemedicine Screening||0
10888253|NCT02390245|12054259|FG000|NOT COMPLETED|Phase I. Telemedicine Screening||0
10888254|NCT02390245|12054260|FG001|NOT COMPLETED|Phase I. Telemedicine Screening||0
10888255|NCT02390245|12054261|FG002|NOT COMPLETED|Phase I. Telemedicine Screening||0
10888256|NCT02390245|12054259|FG000|STARTED|Phase 2. Randomization Into 2 Groups|Remaining 355 participants from Phase I Telemedicine Screening had normal eye examinations requiring no further follow-up.|0
10888257|NCT02390245|12054260|FG001|STARTED|Phase 2. Randomization Into 2 Groups||275
10888258|NCT02390245|12054261|FG002|STARTED|Phase 2. Randomization Into 2 Groups||276
10888259|NCT02390245|12054259|FG000|COMPLETED|Phase 2. Randomization Into 2 Groups||0
10888260|NCT02390245|12054260|FG001|COMPLETED|Phase 2. Randomization Into 2 Groups||172
10888261|NCT02390245|12054261|FG002|COMPLETED|Phase 2. Randomization Into 2 Groups||172
10888262|NCT02390245|12054259|FG000|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||0
10888263|NCT02390245|12054260|FG001|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||103
10888264|NCT02390245|12054261|FG002|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||104
10888265|NCT02390245|12054259|FG000|STARTED|Phase 3. Ophthalmic Follow-up Adherence||0
10888266|NCT02390245|12054260|FG001|STARTED|Phase 3. Ophthalmic Follow-up Adherence||172
10888267|NCT02390245|12054261|FG002|STARTED|Phase 3. Ophthalmic Follow-up Adherence||172
10888268|NCT02390245|12054259|FG000|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||0
10888269|NCT02390245|12054260|FG001|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||77
10888270|NCT02390245|12054261|FG002|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||66
10888271|NCT02390245|12054259|FG000|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||0
10888272|NCT02390245|12054260|FG001|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||95
10888273|NCT02390245|12054261|FG002|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||106
10888274|NCT02389946|12054272|FG000|STARTED|Overall Study||884
10888275|NCT02389946|12054273|FG001|STARTED|Overall Study||450
10888276|NCT02389946|12054272|FG000|COMPLETED|Overall Study||860
10888277|NCT02389946|12054273|FG001|COMPLETED|Overall Study||435
10888278|NCT02389946|12054272|FG000|NOT COMPLETED|Overall Study||24
10888279|NCT02389946|12054273|FG001|NOT COMPLETED|Overall Study||15
10888280|NCT02388906|12054281|FG000|STARTED|Pre-Treatment Period||453
10888281|NCT02388906|12054282|FG001|STARTED|Pre-Treatment Period||453
10888282|NCT02388906|12054281|FG000|COMPLETED|Pre-Treatment Period||452
10888283|NCT02388906|12054282|FG001|COMPLETED|Pre-Treatment Period||453
10888284|NCT02388906|12054281|FG000|NOT COMPLETED|Pre-Treatment Period||1
10888285|NCT02388906|12054282|FG001|NOT COMPLETED|Pre-Treatment Period||0
10888286|NCT02388906|12054281|FG000|STARTED|Treatment Period||452
10888287|NCT02388906|12054282|FG001|STARTED|Treatment Period||453
10888288|NCT02388906|12054281|FG000|COMPLETED|Treatment Period||275
10888289|NCT02388906|12054282|FG001|COMPLETED|Treatment Period||122
10888290|NCT02388906|12054281|FG000|NOT COMPLETED|Treatment Period||177
10888291|NCT02388906|12054282|FG001|NOT COMPLETED|Treatment Period||331
10888292|NCT02376790|12054291|FG000|STARTED|Overall Study||284
10888293|NCT02376790|12054292|FG001|STARTED|Overall Study||284
10888294|NCT02376790|12054293|FG002|STARTED|Overall Study||283
10888295|NCT02376790|12054291|FG000|Received Treatment|Overall Study||282
10888296|NCT02376790|12054292|FG001|Received Treatment|Overall Study||284
10888297|NCT02376790|12054293|FG002|Received Treatment|Overall Study||282
10888300|NCT02376790|12054293|FG002|COMPLETED|Overall Study||230
10888301|NCT02376790|12054291|FG000|NOT COMPLETED|Overall Study||60
10888302|NCT02376790|12054292|FG001|NOT COMPLETED|Overall Study||47
10888303|NCT02376790|12054293|FG002|NOT COMPLETED|Overall Study||53
10888304|NCT02372877|12054301|FG000|STARTED|Overall Study||83
10888305|NCT02372877|12054301|FG000|COMPLETED|Overall Study||59
10888306|NCT02372877|12054301|FG000|NOT COMPLETED|Overall Study||24
10888307|NCT02370914|12054305|FG000|STARTED|Overall Study||84
10888308|NCT02370914|12054305|FG000|COMPLETED|Overall Study||82
10888309|NCT02370914|12054305|FG000|NOT COMPLETED|Overall Study||2
10888310|NCT02370238|12054311|FG000|STARTED|Overall Study||62
10888311|NCT02370238|12054312|FG001|STARTED|Overall Study||61
10888312|NCT02370238|12054311|FG000|ITT Population|Overall Study||62
10888313|NCT02370238|12054312|FG001|ITT Population|Overall Study||61
10888314|NCT02370238|12054311|FG000|Safety Population|Overall Study||61
10888315|NCT02370238|12054312|FG001|Safety Population|Overall Study||60
10888316|NCT02370238|12054311|FG000|Responsable-evaluable Population|Overall Study||57
10888317|NCT02370238|12054312|FG001|Responsable-evaluable Population|Overall Study||54
10888318|NCT02370238|12054311|FG000|COMPLETED|Overall Study||15
10888319|NCT02370238|12054312|FG001|COMPLETED|Overall Study||16
10888320|NCT02370238|12054311|FG000|NOT COMPLETED|Overall Study||47
10888321|NCT02370238|12054312|FG001|NOT COMPLETED|Overall Study||45
10888322|NCT02369484|12054322|FG000|STARTED|Overall Study||13
10888323|NCT02369484|12054322|FG000|COMPLETED|Overall Study||13
10888324|NCT02369484|12054322|FG000|NOT COMPLETED|Overall Study||0
10888333|NCT02362594|12054337|FG000|STARTED|Overall Study||514
10888334|NCT02362594|12054338|FG001|STARTED|Overall Study||505
10888335|NCT02362594|12054337|FG000|Treated|Overall Study||509
10888336|NCT02362594|12054338|FG001|Treated|Overall Study||502
10888337|NCT02362594|12054337|FG000|Continuing Part 1 Adjuvant Therapy|Overall Study||41
10888338|NCT02362594|12054338|FG001|Continuing Part 1 Adjuvant Therapy|Overall Study||21
10888339|NCT02362594|12054337|FG000|COMPLETED|Overall Study||264
10888340|NCT02362594|12054338|FG001|COMPLETED|Overall Study||280
10888341|NCT02362594|12054337|FG000|NOT COMPLETED|Overall Study||250
10888342|NCT02362594|12054338|FG001|NOT COMPLETED|Overall Study||225
10888343|NCT02362503|12054347|FG000|STARTED|Double-blind Period-Up to 8 Days||69
10888344|NCT02362503|12054348|FG001|STARTED|Double-blind Period-Up to 8 Days||203
10888345|NCT02362503|12054349|FG002|STARTED|Double-blind Period-Up to 8 Days||0
10888346|NCT02362503|12054347|FG000|COMPLETED|Double-blind Period-Up to 8 Days||68
10888347|NCT02362503|12054348|FG001|COMPLETED|Double-blind Period-Up to 8 Days||199
10888348|NCT02362503|12054349|FG002|COMPLETED|Double-blind Period-Up to 8 Days||0
10888349|NCT02362503|12054347|FG000|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
10888350|NCT02362503|12054348|FG001|NOT COMPLETED|Double-blind Period-Up to 8 Days||4
10888351|NCT02362503|12054349|FG002|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
10888352|NCT02362503|12054347|FG000|STARTED|Open Label Period-Up to 96 Weeks||68
10888353|NCT02362503|12054348|FG001|STARTED|Open Label Period-Up to 96 Weeks||199
10888354|NCT02362503|12054349|FG002|STARTED|Open Label Period-Up to 96 Weeks||99
10888355|NCT02362503|12054347|FG000|COMPLETED|Open Label Period-Up to 96 Weeks||0
10888356|NCT02362503|12054348|FG001|COMPLETED|Open Label Period-Up to 96 Weeks||0
10888357|NCT02362503|12054349|FG002|COMPLETED|Open Label Period-Up to 96 Weeks||0
10888358|NCT02362503|12054347|FG000|NOT COMPLETED|Open Label Period-Up to 96 Weeks||68
10888359|NCT02362503|12054348|FG001|NOT COMPLETED|Open Label Period-Up to 96 Weeks||199
10888360|NCT02362503|12054349|FG002|NOT COMPLETED|Open Label Period-Up to 96 Weeks||99
10888361|NCT02362464|12054360|FG000|STARTED|Overall Study||14
10888362|NCT02362464|12054360|FG000|COMPLETED|Overall Study||8
10888363|NCT02362464|12054360|FG000|NOT COMPLETED|Overall Study||6
10888364|NCT02361346|12054373|FG000|STARTED|Part 1 and 2 ( Up to Day 112)||3
10888365|NCT02361346|12054374|FG001|STARTED|Part 1 and 2 ( Up to Day 112)||3
10888366|NCT02361346|12054375|FG002|STARTED|Part 1 and 2 ( Up to Day 112)||3
10888367|NCT02361346|12054376|FG003|STARTED|Part 1 and 2 ( Up to Day 112)||4
10888368|NCT02361346|12054377|FG004|STARTED|Part 1 and 2 ( Up to Day 112)||2
10888369|NCT02361346|12054378|FG005|STARTED|Part 1 and 2 ( Up to Day 112)||6
10888370|NCT02361346|12054379|FG006|STARTED|Part 1 and 2 ( Up to Day 112)||6
10888371|NCT02361346|12054380|FG007|STARTED|Part 1 and 2 ( Up to Day 112)||0
10888372|NCT02361346|12054381|FG008|STARTED|Part 1 and 2 ( Up to Day 112)||0
10888373|NCT02361346|12054373|FG000|COMPLETED|Part 1 and 2 ( Up to Day 112)||3
10888374|NCT02361346|12054374|FG001|COMPLETED|Part 1 and 2 ( Up to Day 112)||3
10888375|NCT02361346|12054375|FG002|COMPLETED|Part 1 and 2 ( Up to Day 112)||3
10888376|NCT02361346|12054376|FG003|COMPLETED|Part 1 and 2 ( Up to Day 112)||3
10888377|NCT02361346|12054377|FG004|COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888378|NCT02361346|12054378|FG005|COMPLETED|Part 1 and 2 ( Up to Day 112)||6
10888379|NCT02361346|12054379|FG006|COMPLETED|Part 1 and 2 ( Up to Day 112)||6
10888380|NCT02361346|12054380|FG007|COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888381|NCT02361346|12054381|FG008|COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888382|NCT02361346|12054373|FG000|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888383|NCT02361346|12054374|FG001|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888384|NCT02361346|12054375|FG002|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888385|NCT02361346|12054376|FG003|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||1
10888386|NCT02361346|12054377|FG004|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||2
10888387|NCT02361346|12054378|FG005|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888388|NCT02361346|12054379|FG006|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888389|NCT02361346|12054380|FG007|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888390|NCT02361346|12054381|FG008|NOT COMPLETED|Part 1 and 2 ( Up to Day 112)||0
10888391|NCT02361346|12054373|FG000|STARTED|Part 3 (Up to Day 112)||0
10888392|NCT02361346|12054374|FG001|STARTED|Part 3 (Up to Day 112)||0
10888393|NCT02361346|12054375|FG002|STARTED|Part 3 (Up to Day 112)||0
10888394|NCT02361346|12054376|FG003|STARTED|Part 3 (Up to Day 112)||0
10888395|NCT02361346|12054377|FG004|STARTED|Part 3 (Up to Day 112)||0
10888396|NCT02361346|12054378|FG005|STARTED|Part 3 (Up to Day 112)||0
10888397|NCT02361346|12054379|FG006|STARTED|Part 3 (Up to Day 112)||0
10888398|NCT02361346|12054380|FG007|STARTED|Part 3 (Up to Day 112)||11
10888399|NCT02361346|12054381|FG008|STARTED|Part 3 (Up to Day 112)||0
10888400|NCT02361346|12054373|FG000|COMPLETED|Part 3 (Up to Day 112)||0
10888401|NCT02361346|12054374|FG001|COMPLETED|Part 3 (Up to Day 112)||0
10888402|NCT02361346|12054375|FG002|COMPLETED|Part 3 (Up to Day 112)||0
10888403|NCT02361346|12054376|FG003|COMPLETED|Part 3 (Up to Day 112)||0
10888404|NCT02361346|12054377|FG004|COMPLETED|Part 3 (Up to Day 112)||0
10888405|NCT02361346|12054378|FG005|COMPLETED|Part 3 (Up to Day 112)||0
10888406|NCT02361346|12054379|FG006|COMPLETED|Part 3 (Up to Day 112)||0
10888407|NCT02361346|12054380|FG007|COMPLETED|Part 3 (Up to Day 112)||0
10888408|NCT02361346|12054381|FG008|COMPLETED|Part 3 (Up to Day 112)||0
10888409|NCT02361346|12054373|FG000|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888410|NCT02361346|12054374|FG001|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888411|NCT02361346|12054375|FG002|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888412|NCT02361346|12054376|FG003|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888413|NCT02361346|12054377|FG004|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888414|NCT02361346|12054378|FG005|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888415|NCT02361346|12054379|FG006|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888416|NCT02361346|12054380|FG007|NOT COMPLETED|Part 3 (Up to Day 112)||11
10888417|NCT02361346|12054381|FG008|NOT COMPLETED|Part 3 (Up to Day 112)||0
10888418|NCT02361346|12054373|FG000|STARTED|Part 4 (Up to Day 112)||0
10888419|NCT02361346|12054374|FG001|STARTED|Part 4 (Up to Day 112)||0
10888420|NCT02361346|12054375|FG002|STARTED|Part 4 (Up to Day 112)||0
10888421|NCT02361346|12054376|FG003|STARTED|Part 4 (Up to Day 112)||0
10888422|NCT02361346|12054377|FG004|STARTED|Part 4 (Up to Day 112)||0
10888423|NCT02361346|12054378|FG005|STARTED|Part 4 (Up to Day 112)||0
10888424|NCT02361346|12054379|FG006|STARTED|Part 4 (Up to Day 112)||0
10888425|NCT02361346|12054380|FG007|STARTED|Part 4 (Up to Day 112)||0
10888426|NCT02361346|12054381|FG008|STARTED|Part 4 (Up to Day 112)||0
10888427|NCT02361346|12054373|FG000|COMPLETED|Part 4 (Up to Day 112)||0
10888428|NCT02361346|12054374|FG001|COMPLETED|Part 4 (Up to Day 112)||0
10888429|NCT02361346|12054375|FG002|COMPLETED|Part 4 (Up to Day 112)||0
10888430|NCT02361346|12054376|FG003|COMPLETED|Part 4 (Up to Day 112)||0
10888431|NCT02361346|12054377|FG004|COMPLETED|Part 4 (Up to Day 112)||0
10888432|NCT02361346|12054378|FG005|COMPLETED|Part 4 (Up to Day 112)||0
10888433|NCT02361346|12054379|FG006|COMPLETED|Part 4 (Up to Day 112)||0
10888434|NCT02361346|12054380|FG007|COMPLETED|Part 4 (Up to Day 112)||0
10888435|NCT02361346|12054381|FG008|COMPLETED|Part 4 (Up to Day 112)||0
10888436|NCT02361346|12054373|FG000|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888437|NCT02361346|12054374|FG001|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888438|NCT02361346|12054375|FG002|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888439|NCT02361346|12054376|FG003|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888440|NCT02361346|12054377|FG004|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888441|NCT02361346|12054378|FG005|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888442|NCT02361346|12054379|FG006|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888443|NCT02361346|12054380|FG007|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888444|NCT02361346|12054381|FG008|NOT COMPLETED|Part 4 (Up to Day 112)||0
10888445|NCT02358538|12054427|FG000|STARTED|Through Week 26||7
10888446|NCT02358538|12054428|FG001|STARTED|Through Week 26||2
10888447|NCT02358538|12054429|FG002|STARTED|Through Week 26||10
10888448|NCT02358538|12054430|FG003|STARTED|Through Week 26||11
10888449|NCT02358538|12054427|FG000|COMPLETED|Through Week 26||4
10888450|NCT02358538|12054428|FG001|COMPLETED|Through Week 26||0
10888451|NCT02358538|12054429|FG002|COMPLETED|Through Week 26||5
10888452|NCT02358538|12054430|FG003|COMPLETED|Through Week 26||6
10888453|NCT02358538|12054427|FG000|NOT COMPLETED|Through Week 26||3
10888454|NCT02358538|12054428|FG001|NOT COMPLETED|Through Week 26||2
10888455|NCT02358538|12054429|FG002|NOT COMPLETED|Through Week 26||5
10888456|NCT02358538|12054430|FG003|NOT COMPLETED|Through Week 26||5
10888457|NCT02358538|12054427|FG000|STARTED|52 Week Extension Period||4
10888458|NCT02358538|12054428|FG001|STARTED|52 Week Extension Period||0
10888459|NCT02358538|12054429|FG002|STARTED|52 Week Extension Period||4
10888460|NCT02358538|12054430|FG003|STARTED|52 Week Extension Period||6
10888461|NCT02358538|12054427|FG000|COMPLETED|52 Week Extension Period||4
10888462|NCT02358538|12054428|FG001|COMPLETED|52 Week Extension Period||0
10888463|NCT02358538|12054429|FG002|COMPLETED|52 Week Extension Period||2
10888464|NCT02358538|12054430|FG003|COMPLETED|52 Week Extension Period||2
10888465|NCT02358538|12054427|FG000|NOT COMPLETED|52 Week Extension Period||0
10888466|NCT02358538|12054428|FG001|NOT COMPLETED|52 Week Extension Period||0
10888467|NCT02358538|12054429|FG002|NOT COMPLETED|52 Week Extension Period||2
10888468|NCT02358538|12054430|FG003|NOT COMPLETED|52 Week Extension Period||4
10888469|NCT02358031|12054447|FG000|STARTED|Overall Study||301
10888470|NCT02358031|12054448|FG001|STARTED|Overall Study||281
10888471|NCT02358031|12054449|FG002|STARTED|Overall Study||300
10888472|NCT02358031|12054447|FG000|Treated|Overall Study||300
10888473|NCT02358031|12054448|FG001|Treated|Overall Study||276
10888474|NCT02358031|12054449|FG002|Treated|Overall Study||287
10888475|NCT02358031|12054447|FG000|Pembro Mono v Control Efficacy Analyses|Overall Study||301
10888476|NCT02358031|12054448|FG001|Pembro Mono v Control Efficacy Analyses|Overall Study||0
10888477|NCT02358031|12054449|FG002|Pembro Mono v Control Efficacy Analyses|Overall Study||300
10888478|NCT02358031|12054447|FG000|Pembro Combo v Control Efficacy Analyses|Overall Study||0
10888479|NCT02358031|12054448|FG001|Pembro Combo v Control Efficacy Analyses|Overall Study||281
10888480|NCT02358031|12054449|FG002|Pembro Combo v Control Efficacy Analyses|Overall Study||278
10888481|NCT02358031|12054447|FG000|COMPLETED|Overall Study||0
10888482|NCT02358031|12054448|FG001|COMPLETED|Overall Study||0
10888483|NCT02358031|12054449|FG002|COMPLETED|Overall Study||0
10888484|NCT02358031|12054447|FG000|NOT COMPLETED|Overall Study||301
10888485|NCT02358031|12054448|FG001|NOT COMPLETED|Overall Study||281
10888486|NCT02358031|12054449|FG002|NOT COMPLETED|Overall Study||300
10888487|NCT02354820|12054459|FG000|STARTED|Overall Study||9667
10888488|NCT02354820|12054460|FG001|STARTED|Overall Study||6597
10888489|NCT02354820|12054459|FG000|COMPLETED|Overall Study||9667
10888490|NCT02354820|12054460|FG001|COMPLETED|Overall Study||6597
10888491|NCT02354820|12054459|FG000|NOT COMPLETED|Overall Study||0
10888492|NCT02354820|12054460|FG001|NOT COMPLETED|Overall Study||0
10888493|NCT02354586|12054466|FG000|STARTED|Overall Study||463
10888494|NCT02354586|12054466|FG000|COMPLETED|Overall Study||0
10888495|NCT02354586|12054466|FG000|NOT COMPLETED|Overall Study||463
10888496|NCT02354118|12054472|FG000|STARTED|Overall Study||222
10888497|NCT02354118|12054473|FG001|STARTED|Overall Study||214
10888498|NCT02354118|12054472|FG000|COMPLETED|Overall Study||222
10888499|NCT02354118|12054473|FG001|COMPLETED|Overall Study||214
10888500|NCT02354118|12054472|FG000|NOT COMPLETED|Overall Study||0
10888501|NCT02354118|12054473|FG001|NOT COMPLETED|Overall Study||0
10888502|NCT02353871|12054481|FG000|STARTED|Overall Study|Randomised.|125
10888503|NCT02353871|12054482|FG001|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
10888504|NCT02353871|12054481|FG000|COMPLETED|Overall Study||122
10888505|NCT02353871|12054482|FG001|COMPLETED|Overall Study||51
10888506|NCT02353871|12054481|FG000|NOT COMPLETED|Overall Study||3
10888507|NCT02353871|12054482|FG001|NOT COMPLETED|Overall Study||9
10888508|NCT02352090|12054491|FG000|STARTED|Overall Study||20
10888509|NCT02352090|12054492|FG001|STARTED|Overall Study||20
10888510|NCT02352090|12054493|FG002|STARTED|Overall Study||19
10888511|NCT02352090|12054491|FG000|COMPLETED|Overall Study||19
10888512|NCT02352090|12054492|FG001|COMPLETED|Overall Study||20
10888513|NCT02352090|12054493|FG002|COMPLETED|Overall Study||17
10888514|NCT02352090|12054491|FG000|NOT COMPLETED|Overall Study||1
10888515|NCT02352090|12054492|FG001|NOT COMPLETED|Overall Study||0
10888516|NCT02352090|12054493|FG002|NOT COMPLETED|Overall Study||2
10888517|NCT02348008|12054503|FG000|STARTED|Overall Study||3
10888518|NCT02348008|12054504|FG001|STARTED|Overall Study||10
10888519|NCT02348008|12054505|FG002|STARTED|Overall Study||48
10888520|NCT02348008|12054503|FG000|COMPLETED|Overall Study||0
10888521|NCT02348008|12054504|FG001|COMPLETED|Overall Study||0
10888522|NCT02348008|12054505|FG002|COMPLETED|Overall Study||29
10888523|NCT02348008|12054503|FG000|NOT COMPLETED|Overall Study||3
10888524|NCT02348008|12054504|FG001|NOT COMPLETED|Overall Study||10
10888525|NCT02348008|12054505|FG002|NOT COMPLETED|Overall Study||19
10888526|NCT02347527|12054515|FG000|STARTED|Overall Study||25
10888527|NCT02347527|12054516|FG001|STARTED|Overall Study||22
10888528|NCT02347527|12054517|FG002|STARTED|Overall Study||23
10888529|NCT02347527|12054518|FG003|STARTED|Overall Study||22
10888530|NCT02347527|12054515|FG000|Completed Intervention|Overall Study||24
10888531|NCT02347527|12054516|FG001|Completed Intervention|Overall Study||21
10888532|NCT02347527|12054517|FG002|Completed Intervention|Overall Study||23
10888533|NCT02347527|12054518|FG003|Completed Intervention|Overall Study||22
10888534|NCT02347527|12054515|FG000|Included in Analyses|Overall Study||22
10888535|NCT02347527|12054516|FG001|Included in Analyses|Overall Study||19
10888536|NCT02347527|12054517|FG002|Included in Analyses|Overall Study||22
10888537|NCT02347527|12054518|FG003|Included in Analyses|Overall Study||20
10888538|NCT02347527|12054515|FG000|COMPLETED|Overall Study||22
10888539|NCT02347527|12054516|FG001|COMPLETED|Overall Study||19
10888540|NCT02347527|12054517|FG002|COMPLETED|Overall Study||22
10888541|NCT02347527|12054518|FG003|COMPLETED|Overall Study||20
10888542|NCT02347527|12054515|FG000|NOT COMPLETED|Overall Study||3
10888543|NCT02347527|12054516|FG001|NOT COMPLETED|Overall Study||3
10888544|NCT02347527|12054517|FG002|NOT COMPLETED|Overall Study||1
10888545|NCT02347527|12054518|FG003|NOT COMPLETED|Overall Study||2
10888546|NCT02341625|12054540|FG000|STARTED|Overall Study||2
10888547|NCT02341625|12054541|FG001|STARTED|Overall Study||2
10888548|NCT02341625|12054542|FG002|STARTED|Overall Study||3
10888549|NCT02341625|12054543|FG003|STARTED|Overall Study||8
10888550|NCT02341625|12054544|FG004|STARTED|Overall Study||8
10888551|NCT02341625|12054545|FG005|STARTED|Overall Study||10
10888552|NCT02341625|12054546|FG006|STARTED|Overall Study||51
10888553|NCT02341625|12054547|FG007|STARTED|Overall Study||8
10888554|NCT02341625|12054548|FG008|STARTED|Overall Study||4
10888555|NCT02341625|12054549|FG009|STARTED|Overall Study||30
10888556|NCT02341625|12054540|FG000|COMPLETED|Overall Study||0
10888557|NCT02341625|12054541|FG001|COMPLETED|Overall Study||0
10888558|NCT02341625|12054542|FG002|COMPLETED|Overall Study||0
10888559|NCT02341625|12054543|FG003|COMPLETED|Overall Study||0
10888560|NCT02341625|12054544|FG004|COMPLETED|Overall Study||0
10888561|NCT02341625|12054545|FG005|COMPLETED|Overall Study||0
10888562|NCT02341625|12054546|FG006|COMPLETED|Overall Study||0
10888563|NCT02341625|12054547|FG007|COMPLETED|Overall Study||0
10888564|NCT02341625|12054548|FG008|COMPLETED|Overall Study||0
10888565|NCT02341625|12054549|FG009|COMPLETED|Overall Study||0
10888566|NCT02341625|12054540|FG000|NOT COMPLETED|Overall Study||2
10888567|NCT02341625|12054541|FG001|NOT COMPLETED|Overall Study||2
10888568|NCT02341625|12054542|FG002|NOT COMPLETED|Overall Study||3
10888569|NCT02341625|12054543|FG003|NOT COMPLETED|Overall Study||8
10888570|NCT02341625|12054544|FG004|NOT COMPLETED|Overall Study||8
10888571|NCT02341625|12054545|FG005|NOT COMPLETED|Overall Study||10
10888572|NCT02341625|12054546|FG006|NOT COMPLETED|Overall Study||51
10888573|NCT02341625|12054547|FG007|NOT COMPLETED|Overall Study||8
10888574|NCT02341625|12054548|FG008|NOT COMPLETED|Overall Study||4
10888575|NCT02341625|12054549|FG009|NOT COMPLETED|Overall Study||30
10888576|NCT02335424|12054594|FG000|STARTED|Overall Study||374
10888577|NCT02335424|12054594|FG000|Treated|Overall Study||370
10888578|NCT02335424|12054594|FG000|COMPLETED|Overall Study||0
10888579|NCT02335424|12054594|FG000|NOT COMPLETED|Overall Study||374
10888580|NCT02335411|12054601|FG000|STARTED|Overall Study||259
10888581|NCT02335411|12054602|FG001|STARTED|Overall Study||25
10888582|NCT02335411|12054603|FG002|STARTED|Overall Study||31
10888583|NCT02335411|12054601|FG000|Second Course Pembrolizumab|Overall Study||3
10888584|NCT02335411|12054602|FG001|Second Course Pembrolizumab|Overall Study||1
10888585|NCT02335411|12054603|FG002|Second Course Pembrolizumab|Overall Study||2
10888586|NCT02335411|12054601|FG000|COMPLETED|Overall Study||0
10888587|NCT02335411|12054602|FG001|COMPLETED|Overall Study||0
10888588|NCT02335411|12054603|FG002|COMPLETED|Overall Study||0
10888589|NCT02335411|12054601|FG000|NOT COMPLETED|Overall Study||259
10888590|NCT02335411|12054602|FG001|NOT COMPLETED|Overall Study||25
10888591|NCT02335411|12054603|FG002|NOT COMPLETED|Overall Study||31
10888592|NCT02328105|12054614|FG000|STARTED|Overall Study||11
10888593|NCT02328105|12054614|FG000|COMPLETED|Overall Study||0
10888594|NCT02328105|12054614|FG000|NOT COMPLETED|Overall Study||11
10888595|NCT02323698|12054618|FG000|STARTED|Overall Study||2
10888596|NCT02323698|12054619|FG001|STARTED|Overall Study||2
10888597|NCT02323698|12054620|FG002|STARTED|Overall Study||2
10888598|NCT02323698|12054621|FG003|STARTED|Overall Study||2
10888599|NCT02323698|12054622|FG004|STARTED|Overall Study||2
10888600|NCT02323698|12054623|FG005|STARTED|Overall Study||2
10888601|NCT02323698|12054618|FG000|Completed First Intervention (5 Days)|Overall Study||2
10888602|NCT02323698|12054619|FG001|Completed First Intervention (5 Days)|Overall Study||2
10888603|NCT02323698|12054620|FG002|Completed First Intervention (5 Days)|Overall Study||2
10888604|NCT02323698|12054621|FG003|Completed First Intervention (5 Days)|Overall Study||2
10888605|NCT02323698|12054622|FG004|Completed First Intervention (5 Days)|Overall Study||2
10888606|NCT02323698|12054623|FG005|Completed First Intervention (5 Days)|Overall Study||2
10888607|NCT02323698|12054618|FG000|Completed Second Intervention (5 Days)|Overall Study||2
10888608|NCT02323698|12054619|FG001|Completed Second Intervention (5 Days)|Overall Study||2
10888609|NCT02323698|12054620|FG002|Completed Second Intervention (5 Days)|Overall Study||1
10888610|NCT02323698|12054621|FG003|Completed Second Intervention (5 Days)|Overall Study||2
10888611|NCT02323698|12054622|FG004|Completed Second Intervention (5 Days)|Overall Study||2
10888612|NCT02323698|12054623|FG005|Completed Second Intervention (5 Days)|Overall Study||2
10888613|NCT02323698|12054618|FG000|Completed Third Intervention (5 Days)|Overall Study||2
10888614|NCT02323698|12054619|FG001|Completed Third Intervention (5 Days)|Overall Study||2
10888615|NCT02323698|12054620|FG002|Completed Third Intervention (5 Days)|Overall Study||0
10888616|NCT02323698|12054621|FG003|Completed Third Intervention (5 Days)|Overall Study||2
10888617|NCT02323698|12054622|FG004|Completed Third Intervention (5 Days)|Overall Study||1
10888618|NCT02323698|12054623|FG005|Completed Third Intervention (5 Days)|Overall Study||2
10888619|NCT02323698|12054618|FG000|COMPLETED|Overall Study||2
10888620|NCT02323698|12054619|FG001|COMPLETED|Overall Study||2
10888621|NCT02323698|12054620|FG002|COMPLETED|Overall Study||0
10888622|NCT02323698|12054621|FG003|COMPLETED|Overall Study||2
10888623|NCT02323698|12054622|FG004|COMPLETED|Overall Study||1
10888624|NCT02323698|12054623|FG005|COMPLETED|Overall Study||2
10888625|NCT02323698|12054618|FG000|NOT COMPLETED|Overall Study||0
10888626|NCT02323698|12054619|FG001|NOT COMPLETED|Overall Study||0
10888627|NCT02323698|12054620|FG002|NOT COMPLETED|Overall Study||2
10888628|NCT02323698|12054621|FG003|NOT COMPLETED|Overall Study||0
10888629|NCT02323698|12054622|FG004|NOT COMPLETED|Overall Study||1
10888630|NCT02323698|12054623|FG005|NOT COMPLETED|Overall Study||0
10888631|NCT02321514|12054631|FG000|STARTED|Overall Study||191
10888632|NCT02321514|12054631|FG000|COMPLETED|Overall Study||166
10888633|NCT02321514|12054631|FG000|NOT COMPLETED|Overall Study||25
10888634|NCT02321436|12054637|FG000|STARTED|Overall Study||28
10888635|NCT02321436|12054638|FG001|STARTED|Overall Study||14
10888636|NCT02321436|12054637|FG000|COMPLETED|Overall Study||27
10888637|NCT02321436|12054638|FG001|COMPLETED|Overall Study||13
10888638|NCT02321436|12054637|FG000|NOT COMPLETED|Overall Study||1
10888639|NCT02321436|12054638|FG001|NOT COMPLETED|Overall Study||1
10888640|NCT02316171|12054647|FG000|STARTED|Overall Study||4
10888641|NCT02316171|12054648|FG001|STARTED|Overall Study||6
10888642|NCT02316171|12054649|FG002|STARTED|Overall Study||3
10888643|NCT02316171|12054650|FG003|STARTED|Overall Study||3
10888644|NCT02316171|12054647|FG000|COMPLETED|Overall Study||3
10888645|NCT02316171|12054648|FG001|COMPLETED|Overall Study||6
10888646|NCT02316171|12054649|FG002|COMPLETED|Overall Study||3
10888647|NCT02316171|12054650|FG003|COMPLETED|Overall Study||3
10888648|NCT02316171|12054647|FG000|NOT COMPLETED|Overall Study||1
10888649|NCT02316171|12054648|FG001|NOT COMPLETED|Overall Study||0
10888650|NCT02316171|12054649|FG002|NOT COMPLETED|Overall Study||0
10888651|NCT02316171|12054650|FG003|NOT COMPLETED|Overall Study||0
10888652|NCT02308488|12054656|FG000|STARTED|Overall Study||97
10888653|NCT02308488|12054656|FG000|COMPLETED|Overall Study||95
10888654|NCT02308488|12054656|FG000|NOT COMPLETED|Overall Study||2
10888655|NCT02307279|12054662|FG000|STARTED|Overall Study||223
10888656|NCT02307279|12054663|FG001|STARTED|Overall Study||213
10888657|NCT02307279|12054662|FG000|COMPLETED|Overall Study||172
10888658|NCT02307279|12054663|FG001|COMPLETED|Overall Study||152
10888659|NCT02307279|12054662|FG000|NOT COMPLETED|Overall Study||51
10888660|NCT02307279|12054663|FG001|NOT COMPLETED|Overall Study||61
10888661|NCT02306161|12054671|FG000|STARTED|Overall Study||157
10888662|NCT02306161|12054672|FG001|STARTED|Overall Study||155
10888663|NCT02306161|12054671|FG000|COMPLETED|Overall Study||93
10888664|NCT02306161|12054672|FG001|COMPLETED|Overall Study||86
10888665|NCT02306161|12054671|FG000|NOT COMPLETED|Overall Study||64
10888666|NCT02306161|12054672|FG001|NOT COMPLETED|Overall Study||69
10888667|NCT02302222|12054680|FG000|STARTED|Overall Study||34
10888668|NCT02302222|12054681|FG001|STARTED|Overall Study||37
10888669|NCT02302222|12054680|FG000|COMPLETED|Overall Study||33
10888670|NCT02302222|12054681|FG001|COMPLETED|Overall Study||31
10888671|NCT02302222|12054680|FG000|NOT COMPLETED|Overall Study||1
10888672|NCT02302222|12054681|FG001|NOT COMPLETED|Overall Study||6
10888673|NCT02297503|12054689|FG000|STARTED|Overall Study||30
10888674|NCT02297503|12054690|FG001|STARTED|Overall Study||31
10888675|NCT02297503|12054689|FG000|Initial Single Treatment|Overall Study||29
10888676|NCT02297503|12054690|FG001|Initial Single Treatment|Overall Study||31
10888677|NCT02297503|12054689|FG000|First Combined Treatment|Overall Study||28
10888678|NCT02297503|12054690|FG001|First Combined Treatment|Overall Study||28
10888679|NCT02297503|12054689|FG000|Second Combined Treatment|Overall Study||28
10888680|NCT02297503|12054690|FG001|Second Combined Treatment|Overall Study||28
10888681|NCT02297503|12054689|FG000|COMPLETED|Overall Study||28
10888682|NCT02297503|12054690|FG001|COMPLETED|Overall Study||27
10888683|NCT02297503|12054689|FG000|NOT COMPLETED|Overall Study||2
10888684|NCT02297503|12054690|FG001|NOT COMPLETED|Overall Study||4
10888685|NCT02296125|12054707|FG000|STARTED|Overall Study||279
10888686|NCT02296125|12054708|FG001|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
10888687|NCT02296125|12054709|FG002|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|71
10888688|NCT02296125|12054710|FG003|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65
10888689|NCT02296125|12054707|FG000|COMPLETED|Overall Study||61
10888690|NCT02296125|12054708|FG001|COMPLETED|Overall Study||13
10888691|NCT02296125|12054709|FG002|COMPLETED|Overall Study||15
10888692|NCT02296125|12054710|FG003|COMPLETED|Overall Study||3
10888693|NCT02296125|12054707|FG000|NOT COMPLETED|Overall Study||218
10888694|NCT02296125|12054708|FG001|NOT COMPLETED|Overall Study||264
10888695|NCT02296125|12054709|FG002|NOT COMPLETED|Overall Study||56
10888696|NCT02296125|12054710|FG003|NOT COMPLETED|Overall Study||62
10888697|NCT02294461|12054723|FG000|STARTED|Double-blind Period (up to 29.4 Months)||202
10888698|NCT02294461|12054724|FG001|STARTED|Double-blind Period (up to 29.4 Months)||193
10888699|NCT02294461|12054723|FG000|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||202
10888700|NCT02294461|12054724|FG001|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||193
10888701|NCT02294461|12054723|FG000|COMPLETED|Double-blind Period (up to 29.4 Months)||84
10888702|NCT02294461|12054724|FG001|COMPLETED|Double-blind Period (up to 29.4 Months)||1
10888703|NCT02294461|12054723|FG000|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||118
10888704|NCT02294461|12054724|FG001|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||192
10888705|NCT02294461|12054723|FG000|STARTED|Open-label Period (up to 54.3 Months)|Eligible participants who provided consent took part in open-label period.|85
10888706|NCT02294461|12054724|FG001|STARTED|Open-label Period (up to 54.3 Months)|Eligible participants who provided consent took part in open-label period.|51
10888707|NCT02294461|12054723|FG000|COMPLETED|Open-label Period (up to 54.3 Months)||0
10888708|NCT02294461|12054724|FG001|COMPLETED|Open-label Period (up to 54.3 Months)||0
10888709|NCT02294461|12054723|FG000|NOT COMPLETED|Open-label Period (up to 54.3 Months)||85
10888710|NCT02294461|12054724|FG001|NOT COMPLETED|Open-label Period (up to 54.3 Months)||51
10888711|NCT02287233|12054745|FG000|STARTED|Overall Study||8
10888712|NCT02287233|12054746|FG001|STARTED|Overall Study||10
10888713|NCT02287233|12054747|FG002|STARTED|Overall Study||76
10888714|NCT02287233|12054745|FG000|Treated|Overall Study||8
10888715|NCT02287233|12054746|FG001|Treated|Overall Study||10
10888716|NCT02287233|12054747|FG002|Treated|Overall Study||74
10888717|NCT02287233|12054745|FG000|COMPLETED|Overall Study||0
10888718|NCT02287233|12054746|FG001|COMPLETED|Overall Study||0
10888719|NCT02287233|12054747|FG002|COMPLETED|Overall Study||0
10888720|NCT02287233|12054745|FG000|NOT COMPLETED|Overall Study||8
10888721|NCT02287233|12054746|FG001|NOT COMPLETED|Overall Study||10
10888722|NCT02287233|12054747|FG002|NOT COMPLETED|Overall Study||76
10888723|NCT02285062|12054760|FG000|STARTED|Overall Study||285
10888724|NCT02285062|12054761|FG001|STARTED|Overall Study||285
10888725|NCT02285062|12054760|FG000|Received Study Treatment|Overall Study||283
10888726|NCT02285062|12054761|FG001|Received Study Treatment|Overall Study||284
10888727|NCT02285062|12054760|FG000|Ongoing Study Treatment|Overall Study||0
10888728|NCT02285062|12054761|FG001|Ongoing Study Treatment|Overall Study||0
10888729|NCT02285062|12054760|FG000|COMPLETED|Overall Study||207
10888730|NCT02285062|12054761|FG001|COMPLETED|Overall Study||201
10888731|NCT02285062|12054760|FG000|NOT COMPLETED|Overall Study||78
10888732|NCT02285062|12054761|FG001|NOT COMPLETED|Overall Study||84
10888733|NCT02281084|12054771|FG000|STARTED|Overall Study||32
10888734|NCT02281084|12054772|FG001|STARTED|Overall Study||22
10888735|NCT02281084|12054773|FG002|STARTED|Overall Study||6
10888736|NCT02281084|12054774|FG003|STARTED|Overall Study||5
10888737|NCT02281084|12054771|FG000|COMPLETED|Overall Study||10
10888738|NCT02281084|12054772|FG001|COMPLETED|Overall Study||4
10888739|NCT02281084|12054773|FG002|COMPLETED|Overall Study||2
10888740|NCT02281084|12054774|FG003|COMPLETED|Overall Study||0
10888741|NCT02281084|12054771|FG000|NOT COMPLETED|Overall Study||22
10888742|NCT02281084|12054772|FG001|NOT COMPLETED|Overall Study||18
10888743|NCT02281084|12054773|FG002|NOT COMPLETED|Overall Study||4
10888744|NCT02281084|12054774|FG003|NOT COMPLETED|Overall Study||5
10888745|NCT02278120|12054786|FG000|STARTED|Overall Study||335
10888746|NCT02278120|12054787|FG001|STARTED|Overall Study||337
10888747|NCT02278120|12054786|FG000|COMPLETED|Overall Study||174
10888748|NCT02278120|12054787|FG001|COMPLETED|Overall Study||121
10888749|NCT02278120|12054786|FG000|NOT COMPLETED|Overall Study||161
10888750|NCT02278120|12054787|FG001|NOT COMPLETED|Overall Study||216
10888751|NCT02277444|12054793|FG000|STARTED|Overall Study||130
10888752|NCT02277444|12054793|FG000|Treated|Overall Study||127
10888753|NCT02277444|12054793|FG000|COMPLETED|Overall Study||0
10888754|NCT02277444|12054793|FG000|NOT COMPLETED|Overall Study||130
10888755|NCT02275780|12054799|FG000|STARTED|Base Study: 96 Weeks||385
10888756|NCT02275780|12054800|FG001|STARTED|Base Study: 96 Weeks||384
10888757|NCT02275780|12054799|FG000|Treated|Base Study: 96 Weeks||383
10888758|NCT02275780|12054800|FG001|Treated|Base Study: 96 Weeks||383
10888759|NCT02275780|12054799|FG000|COMPLETED|Base Study: 96 Weeks||292
10888760|NCT02275780|12054800|FG001|COMPLETED|Base Study: 96 Weeks||273
10888761|NCT02275780|12054799|FG000|NOT COMPLETED|Base Study: 96 Weeks||93
10888762|NCT02275780|12054800|FG001|NOT COMPLETED|Base Study: 96 Weeks||111
10888763|NCT02275780|12054799|FG000|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
10888764|NCT02275780|12054800|FG001|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
10888765|NCT02275780|12054799|FG000|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
10888766|NCT02275780|12054800|FG001|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
10888767|NCT02275780|12054799|FG000|NOT COMPLETED|Extension Study: up to 192 Weeks||260
10888768|NCT02275780|12054800|FG001|NOT COMPLETED|Extension Study: up to 192 Weeks||233
10888769|NCT02272790|12054812|FG000|STARTED|Overall Study||9
10888770|NCT02272790|12054813|FG001|STARTED|Overall Study||39
10888771|NCT02272790|12054814|FG002|STARTED|Overall Study||23
10888772|NCT02272790|12054815|FG003|STARTED|Overall Study||12
10888773|NCT02272790|12054816|FG004|STARTED|Overall Study||6
10888774|NCT02272790|12054817|FG005|STARTED|Overall Study||6
10888775|NCT02272790|12054812|FG000|COMPLETED|Overall Study||9
10888776|NCT02272790|12054813|FG001|COMPLETED|Overall Study||38
10888777|NCT02272790|12054814|FG002|COMPLETED|Overall Study||23
10888778|NCT02272790|12054815|FG003|COMPLETED|Overall Study||12
10888779|NCT02272790|12054816|FG004|COMPLETED|Overall Study||6
10888780|NCT02272790|12054817|FG005|COMPLETED|Overall Study||6
10888781|NCT02272790|12054812|FG000|NOT COMPLETED|Overall Study||0
10888782|NCT02272790|12054813|FG001|NOT COMPLETED|Overall Study||1
10888783|NCT02272790|12054814|FG002|NOT COMPLETED|Overall Study||0
10888784|NCT02272790|12054815|FG003|NOT COMPLETED|Overall Study||0
10888785|NCT02272790|12054816|FG004|NOT COMPLETED|Overall Study||0
10888786|NCT02272790|12054817|FG005|NOT COMPLETED|Overall Study||0
10888787|NCT02268916|12054839|FG000|STARTED|Overall Study||52
10888788|NCT02268916|12054840|FG001|STARTED|Overall Study||52
10888789|NCT02268916|12054839|FG000|COMPLETED|Overall Study||35
10888790|NCT02268916|12054840|FG001|COMPLETED|Overall Study||42
10888791|NCT02268916|12054839|FG000|NOT COMPLETED|Overall Study||17
10888792|NCT02268916|12054840|FG001|NOT COMPLETED|Overall Study||10
10888793|NCT02268851|12054853|FG000|STARTED|Overall Study||3
10888794|NCT02268851|12054854|FG001|STARTED|Overall Study||3
10888795|NCT02268851|12054855|FG002|STARTED|Overall Study||4
10888796|NCT02268851|12054856|FG003|STARTED|Overall Study||3
10888797|NCT02268851|12054857|FG004|STARTED|Overall Study||15
10888798|NCT02268851|12054858|FG005|STARTED|Overall Study||15
10888799|NCT02268851|12054853|FG000|COMPLETED|Overall Study||2
10888800|NCT02268851|12054854|FG001|COMPLETED|Overall Study||0
10888801|NCT02268851|12054855|FG002|COMPLETED|Overall Study||3
10888802|NCT02268851|12054856|FG003|COMPLETED|Overall Study||0
10888803|NCT02268851|12054857|FG004|COMPLETED|Overall Study||8
10888804|NCT02268851|12054858|FG005|COMPLETED|Overall Study||4
10888805|NCT02268851|12054853|FG000|NOT COMPLETED|Overall Study||1
10888806|NCT02268851|12054854|FG001|NOT COMPLETED|Overall Study||3
10888807|NCT02268851|12054855|FG002|NOT COMPLETED|Overall Study||1
10888808|NCT02268851|12054856|FG003|NOT COMPLETED|Overall Study||3
10888809|NCT02268851|12054857|FG004|NOT COMPLETED|Overall Study||7
10888810|NCT02268851|12054858|FG005|NOT COMPLETED|Overall Study||11
10888811|NCT02268656|12054874|FG000|STARTED|Overall Study||20
10888812|NCT02268656|12054875|FG001|STARTED|Overall Study||20
10888813|NCT02268656|12054874|FG000|COMPLETED|Overall Study||20
10888814|NCT02268656|12054875|FG001|COMPLETED|Overall Study||20
10888815|NCT02268656|12054874|FG000|NOT COMPLETED|Overall Study||0
10888816|NCT02268656|12054875|FG001|NOT COMPLETED|Overall Study||0
10888817|NCT02264977|12054881|FG000|STARTED|Overall Study||9
10888818|NCT02264977|12054881|FG000|COMPLETED|Overall Study||4
10888819|NCT02264977|12054881|FG000|NOT COMPLETED|Overall Study||5
10888826|NCT02257736|12054898|FG000|STARTED|Overall Study||490
10888827|NCT02257736|12054899|FG001|STARTED|Overall Study||492
10888828|NCT02257736|12054898|FG000|COMPLETED|Overall Study||39
10888829|NCT02257736|12054899|FG001|COMPLETED|Overall Study||45
10888830|NCT02257736|12054898|FG000|NOT COMPLETED|Overall Study||451
10888831|NCT02257736|12054899|FG001|NOT COMPLETED|Overall Study||447
10888832|NCT02257528|12054905|FG000|STARTED|Overall Study||26
10888833|NCT02257528|12054905|FG000|COMPLETED|Overall Study||25
10888834|NCT02257528|12054905|FG000|NOT COMPLETED|Overall Study||1
10888835|NCT02257489|12054918|FG000|STARTED|Overall Study||6
10888836|NCT02257489|12054919|FG001|STARTED|Overall Study||6
10888837|NCT02257489|12054920|FG002|STARTED|Overall Study||6
10888838|NCT02257489|12054921|FG003|STARTED|Overall Study||6
10888839|NCT02257489|12054922|FG004|STARTED|Overall Study||6
10888840|NCT02257489|12054923|FG005|STARTED|Overall Study||6
10888841|NCT02257489|12054924|FG006|STARTED|Overall Study||6
10888842|NCT02257489|12054925|FG007|STARTED|Overall Study||10
10888843|NCT02257489|12054926|FG008|STARTED|Overall Study||6
10888844|NCT02257489|12054918|FG000|COMPLETED|Overall Study||6
10888845|NCT02257489|12054919|FG001|COMPLETED|Overall Study||6
10888846|NCT02257489|12054920|FG002|COMPLETED|Overall Study||6
10888847|NCT02257489|12054921|FG003|COMPLETED|Overall Study||5
10888848|NCT02257489|12054922|FG004|COMPLETED|Overall Study||6
10888849|NCT02257489|12054923|FG005|COMPLETED|Overall Study||6
10888850|NCT02257489|12054924|FG006|COMPLETED|Overall Study||6
10888851|NCT02257489|12054925|FG007|COMPLETED|Overall Study||10
10888852|NCT02257489|12054926|FG008|COMPLETED|Overall Study||6
10888853|NCT02257489|12054918|FG000|NOT COMPLETED|Overall Study||0
10888854|NCT02257489|12054919|FG001|NOT COMPLETED|Overall Study||0
10888855|NCT02257489|12054920|FG002|NOT COMPLETED|Overall Study||0
10888856|NCT02257489|12054921|FG003|NOT COMPLETED|Overall Study||1
10888857|NCT02257489|12054922|FG004|NOT COMPLETED|Overall Study||0
10888858|NCT02257489|12054923|FG005|NOT COMPLETED|Overall Study||0
10888859|NCT02257489|12054924|FG006|NOT COMPLETED|Overall Study||0
10888860|NCT02257489|12054925|FG007|NOT COMPLETED|Overall Study||0
10888861|NCT02257489|12054926|FG008|NOT COMPLETED|Overall Study||0
10888862|NCT02257138|12054951|FG000|STARTED|Overall Study||5
10888863|NCT02257138|12054952|FG001|STARTED|Overall Study||3
10888864|NCT02257138|12054953|FG002|STARTED|Overall Study||3
10888865|NCT02257138|12054954|FG003|STARTED|Overall Study||3
10888866|NCT02257138|12054955|FG004|STARTED|Overall Study||16
10888867|NCT02257138|12054951|FG000|COMPLETED|Overall Study||5
10888868|NCT02257138|12054952|FG001|COMPLETED|Overall Study||3
10888869|NCT02257138|12054953|FG002|COMPLETED|Overall Study||3
10888870|NCT02257138|12054954|FG003|COMPLETED|Overall Study||3
10888871|NCT02257138|12054955|FG004|COMPLETED|Overall Study||16
10888872|NCT02257138|12054951|FG000|NOT COMPLETED|Overall Study||0
10888873|NCT02257138|12054952|FG001|NOT COMPLETED|Overall Study||0
10888874|NCT02257138|12054953|FG002|NOT COMPLETED|Overall Study||0
10888875|NCT02257138|12054954|FG003|NOT COMPLETED|Overall Study||0
10888876|NCT02257138|12054955|FG004|NOT COMPLETED|Overall Study||0
10888877|NCT02254278|12054966|FG000|STARTED|Overall Study||158
10888878|NCT02254278|12054967|FG001|STARTED|Overall Study||150
10888879|NCT02254278|12054966|FG000|Eligible|Overall Study||157
10888880|NCT02254278|12054967|FG001|Eligible|Overall Study||149
10888881|NCT02254278|12054966|FG000|Started Study Treatment|Overall Study||152
10888882|NCT02254278|12054967|FG001|Started Study Treatment|Overall Study||147
10888883|NCT02254278|12054966|FG000|Negative Post-treatment PET|Overall Study||58
10888884|NCT02254278|12054967|FG001|Negative Post-treatment PET|Overall Study||57
10888885|NCT02254278|12054966|FG000|COMPLETED|Overall Study||157
10888886|NCT02254278|12054967|FG001|COMPLETED|Overall Study||149
10888887|NCT02254278|12054966|FG000|NOT COMPLETED|Overall Study||1
10888888|NCT02254278|12054967|FG001|NOT COMPLETED|Overall Study||1
10888889|NCT02254265|12054979|FG000|STARTED|Overall Study||151
10888890|NCT02254265|12054980|FG001|STARTED|Overall Study||152
10888891|NCT02254265|12054981|FG002|STARTED|Overall Study||152
10888892|NCT02254265|12054979|FG000|COMPLETED|Overall Study||142
10888893|NCT02254265|12054980|FG001|COMPLETED|Overall Study||140
10888894|NCT02254265|12054981|FG002|COMPLETED|Overall Study||144
10888895|NCT02254265|12054979|FG000|NOT COMPLETED|Overall Study||9
10888896|NCT02254265|12054980|FG001|NOT COMPLETED|Overall Study||12
10888897|NCT02254265|12054981|FG002|NOT COMPLETED|Overall Study||8
10888898|NCT02253316|12054989|FG000|STARTED|Consolidation||236
10888899|NCT02253316|12054990|FG001|STARTED|Consolidation||0
10888900|NCT02253316|12054991|FG002|STARTED|Consolidation||0
10888901|NCT02253316|12054989|FG000|COMPLETED|Consolidation||220
10888902|NCT02253316|12054990|FG001|COMPLETED|Consolidation||0
10888903|NCT02253316|12054991|FG002|COMPLETED|Consolidation||0
10888904|NCT02253316|12054989|FG000|NOT COMPLETED|Consolidation||16
10888905|NCT02253316|12054990|FG001|NOT COMPLETED|Consolidation||0
10888906|NCT02253316|12054991|FG002|NOT COMPLETED|Consolidation||0
10888907|NCT02253316|12054989|FG000|STARTED|Maintenance||0
10888908|NCT02253316|12054990|FG001|STARTED|Maintenance||99
10888909|NCT02253316|12054991|FG002|STARTED|Maintenance||116
10888910|NCT02253316|12054989|FG000|COMPLETED|Maintenance||0
10888911|NCT02253316|12054990|FG001|COMPLETED|Maintenance||54
10888912|NCT02253316|12054991|FG002|COMPLETED|Maintenance||50
10888913|NCT02253316|12054989|FG000|NOT COMPLETED|Maintenance||0
10888914|NCT02253316|12054990|FG001|NOT COMPLETED|Maintenance||45
10888915|NCT02253316|12054991|FG002|NOT COMPLETED|Maintenance||66
10888916|NCT02252172|12055001|FG000|STARTED|Overall Study||369
10888917|NCT02252172|12055002|FG001|STARTED|Overall Study||368
10888918|NCT02252172|12055001|FG000|Treated|Overall Study||365
10888919|NCT02252172|12055002|FG001|Treated|Overall Study||364
10888920|NCT02252172|12055001|FG000|COMPLETED|Overall Study||90
10888921|NCT02252172|12055002|FG001|COMPLETED|Overall Study||69
10888922|NCT02252172|12055001|FG000|NOT COMPLETED|Overall Study||279
10888923|NCT02252172|12055002|FG001|NOT COMPLETED|Overall Study||299
10888924|NCT02252042|12055010|FG000|STARTED|Overall Study||247
10888925|NCT02252042|12055011|FG001|STARTED|Overall Study||248
10888926|NCT02252042|12055010|FG000|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
10888927|NCT02252042|12055011|FG001|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
10888928|NCT02252042|12055010|FG000|COMPLETED|Overall Study||0
10888929|NCT02252042|12055011|FG001|COMPLETED|Overall Study||0
10888930|NCT02252042|12055010|FG000|NOT COMPLETED|Overall Study||247
10888931|NCT02252042|12055011|FG001|NOT COMPLETED|Overall Study||248
10888932|NCT02249104|12055017|FG000|STARTED|Overall Study||28
10888933|NCT02249104|12055017|FG000|COMPLETED|Overall Study||25
10888934|NCT02249104|12055017|FG000|NOT COMPLETED|Overall Study||3
10888935|NCT02249065|12055021|FG000|STARTED|Overall Study||205
10888936|NCT02249065|12055021|FG000|Treated|Overall Study||181
10888937|NCT02249065|12055021|FG000|COMPLETED|Overall Study||176
10888938|NCT02249065|12055021|FG000|NOT COMPLETED|Overall Study||29
10888939|NCT02246621|12055027|FG000|STARTED|Overall Study||328
10888940|NCT02246621|12055028|FG001|STARTED|Overall Study||165
10888941|NCT02246621|12055027|FG000|Received At Least One Dose of Study Drug|Overall Study||327
10888942|NCT02246621|12055028|FG001|Received At Least One Dose of Study Drug|Overall Study||161
10888943|NCT02246621|12055027|FG000|COMPLETED|Overall Study||63
10888944|NCT02246621|12055028|FG001|COMPLETED|Overall Study||30
10888945|NCT02246621|12055027|FG000|NOT COMPLETED|Overall Study||265
10888946|NCT02246621|12055028|FG001|NOT COMPLETED|Overall Study||135
10888947|NCT02243605|12055036|FG000|STARTED|Stage 1 - Interim Analysis Population||23
10888948|NCT02243605|12055037|FG001|STARTED|Stage 1 - Interim Analysis Population||22
10888949|NCT02243605|12055036|FG000|COMPLETED|Stage 1 - Interim Analysis Population||21
10888950|NCT02243605|12055037|FG001|COMPLETED|Stage 1 - Interim Analysis Population||21
10888951|NCT02243605|12055036|FG000|NOT COMPLETED|Stage 1 - Interim Analysis Population||2
10888952|NCT02243605|12055037|FG001|NOT COMPLETED|Stage 1 - Interim Analysis Population||1
10888953|NCT02243605|12055036|FG000|STARTED|Stage 2 - Final Analysis Population||45
10888954|NCT02243605|12055037|FG001|STARTED|Stage 2 - Final Analysis Population||45
10888955|NCT02243605|12055036|FG000|COMPLETED|Stage 2 - Final Analysis Population||39
10888956|NCT02243605|12055037|FG001|COMPLETED|Stage 2 - Final Analysis Population||42
10888957|NCT02243605|12055036|FG000|NOT COMPLETED|Stage 2 - Final Analysis Population||6
10888958|NCT02243605|12055037|FG001|NOT COMPLETED|Stage 2 - Final Analysis Population||3
10888959|NCT02243020|12055045|FG000|STARTED|Overall Study||8
10888960|NCT02243020|12055046|FG001|STARTED|Overall Study||9
10888961|NCT02243020|12055045|FG000|COMPLETED|Overall Study||8
10888962|NCT02243020|12055046|FG001|COMPLETED|Overall Study||9
10888963|NCT02243020|12055045|FG000|NOT COMPLETED|Overall Study||0
10888964|NCT02243020|12055046|FG001|NOT COMPLETED|Overall Study||0
10888965|NCT02242435|12055054|FG000|STARTED|Overall Study||172
10888966|NCT02242435|12055055|FG001|STARTED|Overall Study||170
10888967|NCT02242435|12055054|FG000|COMPLETED|Overall Study||152
10888968|NCT02242435|12055055|FG001|COMPLETED|Overall Study||154
10888969|NCT02242435|12055054|FG000|NOT COMPLETED|Overall Study||20
10888970|NCT02242435|12055055|FG001|NOT COMPLETED|Overall Study||16
10888971|NCT02230189|12055064|FG000|STARTED|Overall Study||22
10888972|NCT02230189|12055065|FG001|STARTED|Overall Study||2
10888973|NCT02230189|12055066|FG002|STARTED|Overall Study||4
10888974|NCT02230189|12055064|FG000|COMPLETED|Overall Study||17
10888975|NCT02230189|12055065|FG001|COMPLETED|Overall Study||2
10888976|NCT02230189|12055066|FG002|COMPLETED|Overall Study||3
10888977|NCT02230189|12055064|FG000|NOT COMPLETED|Overall Study||5
10888978|NCT02230189|12055065|FG001|NOT COMPLETED|Overall Study||0
10888979|NCT02230189|12055066|FG002|NOT COMPLETED|Overall Study||1
10888980|NCT02226159|12055077|FG000|STARTED|Overall Study||33
10888981|NCT02226159|12055078|FG001|STARTED|Overall Study||32
10888982|NCT02226159|12055077|FG000|COMPLETED|Overall Study||27
10888983|NCT02226159|12055078|FG001|COMPLETED|Overall Study||26
10888984|NCT02226159|12055077|FG000|NOT COMPLETED|Overall Study||6
10888985|NCT02226159|12055078|FG001|NOT COMPLETED|Overall Study||6
10888986|NCT02225275|12055084|FG000|STARTED|Overall Study||9
10888987|NCT02225275|12055084|FG000|COMPLETED|Overall Study||9
10888988|NCT02225275|12055084|FG000|NOT COMPLETED|Overall Study||0
10888989|NCT02224703|12055091|FG000|STARTED|Overall Study||67
10888990|NCT02224703|12055092|FG001|STARTED|Overall Study||67
10888991|NCT02224703|12055093|FG002|STARTED|Overall Study||65
10888992|NCT02224703|12055091|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66
10888993|NCT02224703|12055092|FG001|Received at Least 1 Dose of Study Drug|Overall Study||67
10888994|NCT02224703|12055093|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65
10888995|NCT02224703|12055091|FG000|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64
10888996|NCT02224703|12055092|FG001|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69
10888997|NCT02224703|12055093|FG002|Safety Analysis Set|Overall Study||65
10888998|NCT02224703|12055091|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||66
10888999|NCT02224703|12055092|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||67
10889000|NCT02224703|12055093|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||65
10889001|NCT02224703|12055091|FG000|COMPLETED|Overall Study||64
10889002|NCT02224703|12055092|FG001|COMPLETED|Overall Study||61
10889003|NCT02224703|12055093|FG002|COMPLETED|Overall Study||65
10889004|NCT02224703|12055091|FG000|NOT COMPLETED|Overall Study||3
10889005|NCT02224703|12055092|FG001|NOT COMPLETED|Overall Study||6
10889006|NCT02224703|12055093|FG002|NOT COMPLETED|Overall Study||0
10889007|NCT02224690|12055104|FG000|STARTED|Overall Study||86
10889008|NCT02224690|12055105|FG001|STARTED|Overall Study||85
10889009|NCT02224690|12055104|FG000|Safety Analysis Set|Overall Study||86
10889010|NCT02224690|12055105|FG001|Safety Analysis Set|Overall Study||85
10889011|NCT02224690|12055104|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||86
10889012|NCT02224690|12055105|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||85
10889013|NCT02224690|12055104|FG000|COMPLETED|Overall Study||72
10889014|NCT02224690|12055105|FG001|COMPLETED|Overall Study||84
10889015|NCT02224690|12055104|FG000|NOT COMPLETED|Overall Study||14
10889016|NCT02224690|12055105|FG001|NOT COMPLETED|Overall Study||1
10889017|NCT02224560|12055114|FG000|STARTED|Overall Study||76
10889018|NCT02224560|12055115|FG001|STARTED|Overall Study||73
10889019|NCT02224560|12055116|FG002|STARTED|Overall Study||76
10889020|NCT02224560|12055114|FG000|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
10889021|NCT02224560|12055115|FG001|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
10889022|NCT02224560|12055116|FG002|Safety Analysis Set|Overall Study||76
10889023|NCT02224560|12055114|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||76
10889024|NCT02224560|12055115|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||73
10889025|NCT02224560|12055116|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||76
10889026|NCT02224560|12055114|FG000|COMPLETED|Overall Study||67
10889027|NCT02224560|12055115|FG001|COMPLETED|Overall Study||71
10889028|NCT02224560|12055116|FG002|COMPLETED|Overall Study||74
10889029|NCT02224560|12055114|FG000|NOT COMPLETED|Overall Study||9
10889030|NCT02224560|12055115|FG001|NOT COMPLETED|Overall Study||2
10889031|NCT02224560|12055116|FG002|NOT COMPLETED|Overall Study||2
10889032|NCT02224391|12055126|FG000|STARTED|Overall Study||124
10889033|NCT02224391|12055127|FG001|STARTED|Overall Study||122
10889034|NCT02224391|12055126|FG000|COMPLETED|Overall Study||92
10889035|NCT02224391|12055127|FG001|COMPLETED|Overall Study||98
10889036|NCT02224391|12055126|FG000|NOT COMPLETED|Overall Study||32
10889037|NCT02224391|12055127|FG001|NOT COMPLETED|Overall Study||24
10889038|NCT02220894|12055135|FG000|STARTED|Overall Study|1 additional participant was randomized in error|637
10889039|NCT02220894|12055136|FG001|STARTED|Overall Study||637
10889040|NCT02220894|12055135|FG000|Treated|Overall Study||636
10889041|NCT02220894|12055136|FG001|Treated|Overall Study||615
10889042|NCT02220894|12055135|FG000|COMPLETED|Overall Study||0
10889043|NCT02220894|12055136|FG001|COMPLETED|Overall Study||0
10889044|NCT02220894|12055135|FG000|NOT COMPLETED|Overall Study||637
10889045|NCT02220894|12055136|FG001|NOT COMPLETED|Overall Study||637
10889046|NCT02216851|12055144|FG000|STARTED|Overall Study||98
10889047|NCT02216851|12055145|FG001|STARTED|Overall Study||33
10889048|NCT02216851|12055144|FG000|COMPLETED|Overall Study||96
10889049|NCT02216851|12055145|FG001|COMPLETED|Overall Study||32
10889050|NCT02216851|12055144|FG000|NOT COMPLETED|Overall Study||2
10889051|NCT02216851|12055145|FG001|NOT COMPLETED|Overall Study||1
10889052|NCT02209636|12055153|FG000|STARTED|Main/Parent Study||32
10889053|NCT02209636|12055154|FG001|STARTED|Main/Parent Study||29
10889054|NCT02209636|12055153|FG000|COMPLETED|Main/Parent Study||27
10889055|NCT02209636|12055154|FG001|COMPLETED|Main/Parent Study||27
10889056|NCT02209636|12055153|FG000|NOT COMPLETED|Main/Parent Study||5
10889057|NCT02209636|12055154|FG001|NOT COMPLETED|Main/Parent Study||2
10889058|NCT02209636|12055153|FG000|STARTED|Balance Sub-study||7
10889059|NCT02209636|12055154|FG001|STARTED|Balance Sub-study||8
10889060|NCT02209636|12055153|FG000|COMPLETED|Balance Sub-study||6
10889061|NCT02209636|12055154|FG001|COMPLETED|Balance Sub-study||8
10889062|NCT02209636|12055153|FG000|NOT COMPLETED|Balance Sub-study||1
10889063|NCT02209636|12055154|FG001|NOT COMPLETED|Balance Sub-study||0
10889064|NCT02203513|12055167|FG000|STARTED|Overall Study||22
10889065|NCT02203513|12055168|FG001|STARTED|Overall Study||29
10889066|NCT02203513|12055169|FG002|STARTED|Overall Study||9
10889067|NCT02203513|12055170|FG003|STARTED|Overall Study||2
10889068|NCT02203513|12055171|FG004|STARTED|Overall Study||49
10889069|NCT02203513|12055167|FG000|COMPLETED|Overall Study||16
10889070|NCT02203513|12055168|FG001|COMPLETED|Overall Study||21
10889071|NCT02203513|12055169|FG002|COMPLETED|Overall Study||6
10889072|NCT02203513|12055170|FG003|COMPLETED|Overall Study||1
10889073|NCT02203513|12055171|FG004|COMPLETED|Overall Study||43
10889074|NCT02203513|12055167|FG000|NOT COMPLETED|Overall Study||6
10889075|NCT02203513|12055168|FG001|NOT COMPLETED|Overall Study||8
10889076|NCT02203513|12055169|FG002|NOT COMPLETED|Overall Study||3
10889077|NCT02203513|12055170|FG003|NOT COMPLETED|Overall Study||1
10889078|NCT02203513|12055171|FG004|NOT COMPLETED|Overall Study||6
10889079|NCT02200445|12055188|FG000|STARTED|Overall Study||4
10889080|NCT02200445|12055189|FG001|STARTED|Overall Study||17
10889081|NCT02200445|12055190|FG002|STARTED|Overall Study||5
10889082|NCT02200445|12055188|FG000|COMPLETED|Overall Study||3
10889083|NCT02200445|12055189|FG001|COMPLETED|Overall Study||13
10889084|NCT02200445|12055190|FG002|COMPLETED|Overall Study||3
10889085|NCT02200445|12055188|FG000|NOT COMPLETED|Overall Study||1
10889086|NCT02200445|12055189|FG001|NOT COMPLETED|Overall Study||4
10889087|NCT02200445|12055190|FG002|NOT COMPLETED|Overall Study||2
10889088|NCT02197234|12055198|FG000|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
10889089|NCT02197234|12055198|FG000|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
10889090|NCT02197234|12055198|FG000|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
10889091|NCT02197234|12055198|FG000|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
10889092|NCT02197234|12055198|FG000|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
10889093|NCT02197234|12055198|FG000|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
10889094|NCT02197234|12055198|FG000|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
10889095|NCT02197234|12055198|FG000|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
10889096|NCT02197234|12055198|FG000|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
10889097|NCT02197234|12055198|FG000|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
10889098|NCT02197234|12055198|FG000|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
10889099|NCT02197234|12055198|FG000|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
10889100|NCT02195479|12055207|FG000|STARTED|Overall Study||356
10889101|NCT02195479|12055208|FG001|STARTED|Overall Study||350
10889102|NCT02195479|12055207|FG000|Treated|Overall Study||354
10889103|NCT02195479|12055208|FG001|Treated|Overall Study||346
10889104|NCT02195479|12055207|FG000|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
10889105|NCT02195479|12055208|FG001|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
10889106|NCT02195479|12055207|FG000|NOT COMPLETED|Overall Study||356
10889107|NCT02195479|12055208|FG001|NOT COMPLETED|Overall Study||350
10889108|NCT02186834|12055214|FG000|STARTED|Dose Escalation||6
10889109|NCT02186834|12055215|FG001|STARTED|Dose Escalation||3
10889110|NCT02186834|12055216|FG002|STARTED|Dose Escalation||0
10889111|NCT02186834|12055217|FG003|STARTED|Dose Escalation||7
10889112|NCT02186834|12055218|FG004|STARTED|Dose Escalation||4
10889113|NCT02186834|12055219|FG005|STARTED|Dose Escalation||0
10889114|NCT02186834|12055214|FG000|COMPLETED|Dose Escalation||6
10889115|NCT02186834|12055215|FG001|COMPLETED|Dose Escalation||3
10889116|NCT02186834|12055216|FG002|COMPLETED|Dose Escalation||0
10889117|NCT02186834|12055217|FG003|COMPLETED|Dose Escalation||6
10889118|NCT02186834|12055218|FG004|COMPLETED|Dose Escalation||4
10889119|NCT02186834|12055219|FG005|COMPLETED|Dose Escalation||0
10889120|NCT02186834|12055214|FG000|NOT COMPLETED|Dose Escalation||0
10889121|NCT02186834|12055215|FG001|NOT COMPLETED|Dose Escalation||0
10889122|NCT02186834|12055216|FG002|NOT COMPLETED|Dose Escalation||0
10889123|NCT02186834|12055217|FG003|NOT COMPLETED|Dose Escalation||1
10889124|NCT02186834|12055218|FG004|NOT COMPLETED|Dose Escalation||0
10889125|NCT02186834|12055219|FG005|NOT COMPLETED|Dose Escalation||0
10889126|NCT02186834|12055214|FG000|STARTED|Treatment at RP2D||0
10889127|NCT02186834|12055215|FG001|STARTED|Treatment at RP2D||0
10889128|NCT02186834|12055216|FG002|STARTED|Treatment at RP2D||0
10889129|NCT02186834|12055217|FG003|STARTED|Treatment at RP2D||0
10889130|NCT02186834|12055218|FG004|STARTED|Treatment at RP2D||0
10889131|NCT02186834|12055219|FG005|STARTED|Treatment at RP2D||14
10889132|NCT02186834|12055214|FG000|COMPLETED|Treatment at RP2D||0
10889133|NCT02186834|12055215|FG001|COMPLETED|Treatment at RP2D||0
10889134|NCT02186834|12055216|FG002|COMPLETED|Treatment at RP2D||0
10889135|NCT02186834|12055217|FG003|COMPLETED|Treatment at RP2D||0
10889136|NCT02186834|12055218|FG004|COMPLETED|Treatment at RP2D||0
10889137|NCT02186834|12055219|FG005|COMPLETED|Treatment at RP2D||13
10889138|NCT02186834|12055214|FG000|NOT COMPLETED|Treatment at RP2D||0
10889139|NCT02186834|12055215|FG001|NOT COMPLETED|Treatment at RP2D||0
10889140|NCT02186834|12055216|FG002|NOT COMPLETED|Treatment at RP2D||0
10889141|NCT02186834|12055217|FG003|NOT COMPLETED|Treatment at RP2D||0
10889142|NCT02186834|12055218|FG004|NOT COMPLETED|Treatment at RP2D||0
10889143|NCT02186834|12055219|FG005|NOT COMPLETED|Treatment at RP2D||1
10889144|NCT02184195|12055230|FG000|STARTED|Overall Study||92
10889145|NCT02184195|12055231|FG001|STARTED|Overall Study||62
10889146|NCT02184195|12055230|FG000|COMPLETED|Overall Study||73
10889147|NCT02184195|12055231|FG001|COMPLETED|Overall Study||55
10889148|NCT02184195|12055230|FG000|NOT COMPLETED|Overall Study||19
10889149|NCT02184195|12055231|FG001|NOT COMPLETED|Overall Study||7
10889150|NCT02180867|12055244|FG000|STARTED|Overall Study||10
10889151|NCT02180867|12055245|FG001|STARTED|Overall Study||11
10889152|NCT02180867|12055246|FG002|STARTED|Overall Study||10
10889153|NCT02180867|12055247|FG003|STARTED|Overall Study||49
10889154|NCT02180867|12055248|FG004|STARTED|Overall Study||48
10889155|NCT02180867|12055249|FG005|STARTED|Overall Study||6
10889156|NCT02180867|12055250|FG006|STARTED|Overall Study||6
10889157|NCT02180867|12055244|FG000|Pediatric Patients|Overall Study||6
10889158|NCT02180867|12055245|FG001|Pediatric Patients|Overall Study||4
10889159|NCT02180867|12055246|FG002|Pediatric Patients|Overall Study||3
10889160|NCT02180867|12055247|FG003|Pediatric Patients|Overall Study||18
10889161|NCT02180867|12055248|FG004|Pediatric Patients|Overall Study||19
10889162|NCT02180867|12055249|FG005|Pediatric Patients|Overall Study||1
10889163|NCT02180867|12055250|FG006|Pediatric Patients|Overall Study||0
10889164|NCT02180867|12055244|FG000|Adult Patients|Overall Study||4
10889165|NCT02180867|12055245|FG001|Adult Patients|Overall Study||7
10889166|NCT02180867|12055246|FG002|Adult Patients|Overall Study||7
10889167|NCT02180867|12055247|FG003|Adult Patients|Overall Study||31
10889168|NCT02180867|12055248|FG004|Adult Patients|Overall Study||29
10889169|NCT02180867|12055249|FG005|Adult Patients|Overall Study||5
10889170|NCT02180867|12055250|FG006|Adult Patients|Overall Study||6
10889171|NCT02180867|12055244|FG000|COMPLETED|Overall Study||4
10889172|NCT02180867|12055245|FG001|COMPLETED|Overall Study||0
10889173|NCT02180867|12055246|FG002|COMPLETED|Overall Study||6
10889174|NCT02180867|12055247|FG003|COMPLETED|Overall Study||23
10889175|NCT02180867|12055248|FG004|COMPLETED|Overall Study||21
10889176|NCT02180867|12055249|FG005|COMPLETED|Overall Study||3
10889177|NCT02180867|12055250|FG006|COMPLETED|Overall Study||1
10889178|NCT02180867|12055244|FG000|NOT COMPLETED|Overall Study||6
10889179|NCT02180867|12055245|FG001|NOT COMPLETED|Overall Study||11
10889180|NCT02180867|12055246|FG002|NOT COMPLETED|Overall Study||4
10889181|NCT02180867|12055247|FG003|NOT COMPLETED|Overall Study||26
10889182|NCT02180867|12055248|FG004|NOT COMPLETED|Overall Study||27
10889183|NCT02180867|12055249|FG005|NOT COMPLETED|Overall Study||3
10889184|NCT02180867|12055250|FG006|NOT COMPLETED|Overall Study||5
10889185|NCT02173379|12055280|FG000|STARTED|Overall Study||1296
10889186|NCT02173379|12055281|FG001|STARTED|Overall Study||1308
10889187|NCT02173379|12055280|FG000|COMPLETED|Overall Study||1205
10889188|NCT02173379|12055281|FG001|COMPLETED|Overall Study||1231
10889189|NCT02173379|12055280|FG000|NOT COMPLETED|Overall Study||91
10889190|NCT02173379|12055281|FG001|NOT COMPLETED|Overall Study||77
10889191|NCT02168686|12055291|FG000|STARTED|Overall Study||2
10889192|NCT02168686|12055292|FG001|STARTED|Overall Study||2
10889193|NCT02168686|12055293|FG002|STARTED|Overall Study||2
10889194|NCT02168686|12055291|FG000|COMPLETED|Overall Study||2
10889195|NCT02168686|12055292|FG001|COMPLETED|Overall Study||2
10889196|NCT02168686|12055293|FG002|COMPLETED|Overall Study||2
10889197|NCT02168686|12055291|FG000|NOT COMPLETED|Overall Study||0
10889198|NCT02168686|12055292|FG001|NOT COMPLETED|Overall Study||0
10889199|NCT02168686|12055293|FG002|NOT COMPLETED|Overall Study||0
10889200|NCT02163733|12055312|FG000|STARTED|Part A: Day 1-9 (1st Intervention)||18
10889201|NCT02163733|12055313|FG001|STARTED|Part A: Day 1-9 (1st Intervention)||20
10889202|NCT02163733|12055314|FG002|STARTED|Part A: Day 1-9 (1st Intervention)||0
10889203|NCT02163733|12055312|FG000|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
10889204|NCT02163733|12055313|FG001|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
10889205|NCT02163733|12055314|FG002|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
10889206|NCT02163733|12055312|FG000|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
10889207|NCT02163733|12055313|FG001|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
10889208|NCT02163733|12055314|FG002|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
10889209|NCT02163733|12055312|FG000|STARTED|Part A: Day 10-15 (2nd Intervention)||18
10889210|NCT02163733|12055313|FG001|STARTED|Part A: Day 10-15 (2nd Intervention)||20
10889211|NCT02163733|12055314|FG002|STARTED|Part A: Day 10-15 (2nd Intervention)||0
10889212|NCT02163733|12055312|FG000|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
10889213|NCT02163733|12055313|FG001|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
10889214|NCT02163733|12055314|FG002|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
10889215|NCT02163733|12055312|FG000|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
10889216|NCT02163733|12055313|FG001|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
10889217|NCT02163733|12055314|FG002|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
10889218|NCT02163733|12055312|FG000|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
10889219|NCT02163733|12055313|FG001|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
10889220|NCT02163733|12055314|FG002|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
10889221|NCT02163733|12055312|FG000|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
10889222|NCT02163733|12055313|FG001|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
10889223|NCT02163733|12055314|FG002|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
10889224|NCT02163733|12055312|FG000|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
10889225|NCT02163733|12055313|FG001|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
10889226|NCT02163733|12055314|FG002|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
10889227|NCT02162667|12055323|FG000|STARTED|Neoadjuvant Period||278
10889228|NCT02162667|12055324|FG001|STARTED|Neoadjuvant Period||284
10889229|NCT02162667|12055323|FG000|COMPLETED|Neoadjuvant Period||264
10889230|NCT02162667|12055324|FG001|COMPLETED|Neoadjuvant Period||267
10889231|NCT02162667|12055323|FG000|NOT COMPLETED|Neoadjuvant Period||14
10889232|NCT02162667|12055324|FG001|NOT COMPLETED|Neoadjuvant Period||17
10889233|NCT02162667|12055323|FG000|STARTED|Adjuvant Period||260
10889234|NCT02162667|12055324|FG001|STARTED|Adjuvant Period||268
10889235|NCT02162667|12055323|FG000|COMPLETED|Adjuvant Period||248
10889236|NCT02162667|12055324|FG001|COMPLETED|Adjuvant Period||255
10889237|NCT02162667|12055323|FG000|NOT COMPLETED|Adjuvant Period||12
10889238|NCT02162667|12055324|FG001|NOT COMPLETED|Adjuvant Period||13
10889239|NCT02157883|12055334|FG000|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
10889240|NCT02157883|12055334|FG000|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
10889241|NCT02157883|12055334|FG000|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
10889242|NCT02157883|12055334|FG000|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
10889243|NCT02157883|12055334|FG000|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
10889244|NCT02157883|12055334|FG000|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
10889245|NCT02157883|12055334|FG000|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
10889246|NCT02157883|12055334|FG000|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
10889247|NCT02157883|12055334|FG000|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
10889248|NCT02155946|12055345|FG000|STARTED|Overall Study||29
10889249|NCT02155946|12055346|FG001|STARTED|Overall Study||25
10889250|NCT02155946|12055347|FG002|STARTED|Overall Study||29
10889251|NCT02155946|12055348|FG003|STARTED|Overall Study||24
10889252|NCT02155946|12055345|FG000|COMPLETED|Overall Study|number completed at primary endpoint|29
10889253|NCT02155946|12055346|FG001|COMPLETED|Overall Study|number completed at primary endpoint|23
10889254|NCT02155946|12055347|FG002|COMPLETED|Overall Study|number completed at primary endpoint|29
10889255|NCT02155946|12055348|FG003|COMPLETED|Overall Study|number completed at primary endpoint|24
10889256|NCT02155946|12055345|FG000|NOT COMPLETED|Overall Study||0
10889257|NCT02155946|12055346|FG001|NOT COMPLETED|Overall Study||2
10889258|NCT02155946|12055347|FG002|NOT COMPLETED|Overall Study||0
10889259|NCT02155946|12055348|FG003|NOT COMPLETED|Overall Study||0
10889260|NCT02155712|12055362|FG000|STARTED|Primary Objective||319
10889261|NCT02155712|12055363|FG001|STARTED|Primary Objective|Cohort 2 isn't included in primary obj analysis|0
10889262|NCT02155712|12055362|FG000|COMPLETED|Primary Objective||259
10889263|NCT02155712|12055363|FG001|COMPLETED|Primary Objective||0
10889264|NCT02155712|12055362|FG000|NOT COMPLETED|Primary Objective||60
10889265|NCT02155712|12055363|FG001|NOT COMPLETED|Primary Objective||0
10889266|NCT02155712|12055362|FG000|STARTED|Secondary Objectives||319
10889267|NCT02155712|12055363|FG001|STARTED|Secondary Objectives|This period will be updated when posting secondary objective results.|134
10889268|NCT02155712|12055362|FG000|COMPLETED|Secondary Objectives||0
10889269|NCT02155712|12055363|FG001|COMPLETED|Secondary Objectives||0
10889270|NCT02155712|12055362|FG000|NOT COMPLETED|Secondary Objectives||319
10889271|NCT02155712|12055363|FG001|NOT COMPLETED|Secondary Objectives||134
10889272|NCT02152631|12055371|FG000|STARTED|Overall Study||270
10889273|NCT02152631|12055372|FG001|STARTED|Overall Study||183
10889274|NCT02152631|12055371|FG000|Received at Least One Dose of Study Drug|Overall Study||265
10889275|NCT02152631|12055372|FG001|Received at Least One Dose of Study Drug|Overall Study||175
10889276|NCT02152631|12055371|FG000|Off Treatment|Overall Study||246
10889277|NCT02152631|12055372|FG001|Off Treatment|Overall Study||172
10889278|NCT02152631|12055371|FG000|Death Due to Any Cause|Overall Study||30
10889279|NCT02152631|12055372|FG001|Death Due to Any Cause|Overall Study||20
10889280|NCT02152631|12055371|FG000|Progressive Disease|Overall Study||174
10889281|NCT02152631|12055372|FG001|Progressive Disease|Overall Study||137
10889282|NCT02152631|12055371|FG000|COMPLETED|Overall Study||204
10889283|NCT02152631|12055372|FG001|COMPLETED|Overall Study||157
10889284|NCT02152631|12055371|FG000|NOT COMPLETED|Overall Study||66
10889285|NCT02152631|12055372|FG001|NOT COMPLETED|Overall Study||26
10889292|NCT02136134|12055389|FG000|STARTED|Overall Study||247
10889293|NCT02136134|12055390|FG001|STARTED|Overall Study||251
10889294|NCT02136134|12055389|FG000|Treated|Overall Study||237
10889295|NCT02136134|12055390|FG001|Treated|Overall Study||243
10889296|NCT02136134|12055389|FG000|COMPLETED|Overall Study||0
10889297|NCT02136134|12055390|FG001|COMPLETED|Overall Study||0
10889298|NCT02136134|12055389|FG000|NOT COMPLETED|Overall Study||247
10889299|NCT02136134|12055390|FG001|NOT COMPLETED|Overall Study||251
10889300|NCT02134925|12055398|FG000|STARTED|Overall Study||54
10889301|NCT02134925|12055399|FG001|STARTED|Overall Study||56
10889302|NCT02134925|12055398|FG000|Received at Least One Dose of Treatment|Overall Study||53
10889303|NCT02134925|12055399|FG001|Received at Least One Dose of Treatment|Overall Study||50
10889304|NCT02134925|12055398|FG000|COMPLETED|Overall Study||52
10889305|NCT02134925|12055399|FG001|COMPLETED|Overall Study||50
10889306|NCT02134925|12055398|FG000|NOT COMPLETED|Overall Study||2
10889307|NCT02134925|12055399|FG001|NOT COMPLETED|Overall Study||6
10889308|NCT02130466|12055419|FG000|STARTED|Overall Study||7
10889309|NCT02130466|12055420|FG001|STARTED|Overall Study||3
10889310|NCT02130466|12055421|FG002|STARTED|Overall Study||2
10889311|NCT02130466|12055422|FG003|STARTED|Overall Study||8
10889312|NCT02130466|12055423|FG004|STARTED|Overall Study||2
10889313|NCT02130466|12055424|FG005|STARTED|Overall Study||60
10889314|NCT02130466|12055425|FG006|STARTED|Overall Study||60
10889315|NCT02130466|12055426|FG007|STARTED|Overall Study||3
10889316|NCT02130466|12055427|FG008|STARTED|Overall Study||4
10889317|NCT02130466|12055428|FG009|STARTED|Overall Study||5
10889318|NCT02130466|12055429|FG010|STARTED|Overall Study||6
10889319|NCT02130466|12055430|FG011|STARTED|Overall Study||3
10889320|NCT02130466|12055431|FG012|STARTED|Overall Study||12
10889321|NCT02130466|12055432|FG013|STARTED|Overall Study||9
10889322|NCT02130466|12055419|FG000|Treated|Overall Study||7
10889323|NCT02130466|12055420|FG001|Treated|Overall Study||3
10889324|NCT02130466|12055421|FG002|Treated|Overall Study||2
10889325|NCT02130466|12055422|FG003|Treated|Overall Study||8
10889326|NCT02130466|12055423|FG004|Treated|Overall Study||2
10889327|NCT02130466|12055424|FG005|Treated|Overall Study||60
10889328|NCT02130466|12055425|FG006|Treated|Overall Study||60
10889329|NCT02130466|12055426|FG007|Treated|Overall Study||3
10889330|NCT02130466|12055427|FG008|Treated|Overall Study||4
10889331|NCT02130466|12055428|FG009|Treated|Overall Study||5
10889332|NCT02130466|12055429|FG010|Treated|Overall Study||6
10889333|NCT02130466|12055430|FG011|Treated|Overall Study||3
10889334|NCT02130466|12055431|FG012|Treated|Overall Study||12
10889335|NCT02130466|12055432|FG013|Treated|Overall Study||9
10889336|NCT02130466|12055419|FG000|COMPLETED|Overall Study||0
10889337|NCT02130466|12055420|FG001|COMPLETED|Overall Study||0
10889338|NCT02130466|12055421|FG002|COMPLETED|Overall Study||0
10889339|NCT02130466|12055422|FG003|COMPLETED|Overall Study||0
10889340|NCT02130466|12055423|FG004|COMPLETED|Overall Study||0
10889341|NCT02130466|12055424|FG005|COMPLETED|Overall Study||0
10889342|NCT02130466|12055425|FG006|COMPLETED|Overall Study||0
10889343|NCT02130466|12055426|FG007|COMPLETED|Overall Study||0
10889344|NCT02130466|12055427|FG008|COMPLETED|Overall Study||0
10889345|NCT02130466|12055428|FG009|COMPLETED|Overall Study||0
10889346|NCT02130466|12055429|FG010|COMPLETED|Overall Study||0
10889347|NCT02130466|12055430|FG011|COMPLETED|Overall Study||0
10889348|NCT02130466|12055431|FG012|COMPLETED|Overall Study||0
10889349|NCT02130466|12055432|FG013|COMPLETED|Overall Study||0
10889350|NCT02130466|12055419|FG000|NOT COMPLETED|Overall Study||7
10889351|NCT02130466|12055420|FG001|NOT COMPLETED|Overall Study||3
10889352|NCT02130466|12055421|FG002|NOT COMPLETED|Overall Study||2
10889353|NCT02130466|12055422|FG003|NOT COMPLETED|Overall Study||8
10889354|NCT02130466|12055423|FG004|NOT COMPLETED|Overall Study||2
10889355|NCT02130466|12055424|FG005|NOT COMPLETED|Overall Study||60
10889356|NCT02130466|12055425|FG006|NOT COMPLETED|Overall Study||60
10889357|NCT02130466|12055426|FG007|NOT COMPLETED|Overall Study||3
10889358|NCT02130466|12055427|FG008|NOT COMPLETED|Overall Study||4
10889359|NCT02130466|12055428|FG009|NOT COMPLETED|Overall Study||5
10889360|NCT02130466|12055429|FG010|NOT COMPLETED|Overall Study||6
10889361|NCT02130466|12055430|FG011|NOT COMPLETED|Overall Study||3
10889362|NCT02130466|12055431|FG012|NOT COMPLETED|Overall Study||12
10889363|NCT02130466|12055432|FG013|NOT COMPLETED|Overall Study||9
10889364|NCT02127723|12055479|FG000|STARTED|Overall Study||20
10889365|NCT02127723|12055479|FG000|COMPLETED|Overall Study||19
10889366|NCT02127723|12055479|FG000|NOT COMPLETED|Overall Study||1
10889367|NCT02126969|12055485|FG000|STARTED|Overall Study||23
10889368|NCT02126969|12055486|FG001|STARTED|Overall Study||22
10889369|NCT02126969|12055485|FG000|COMPLETED|Overall Study||22
10889370|NCT02126969|12055486|FG001|COMPLETED|Overall Study||20
10889371|NCT02126969|12055485|FG000|NOT COMPLETED|Overall Study||1
10889372|NCT02126969|12055486|FG001|NOT COMPLETED|Overall Study||2
10889373|NCT02125461|12055494|FG000|STARTED|Overall Study||476
10889374|NCT02125461|12055495|FG001|STARTED|Overall Study||237
10889375|NCT02125461|12055494|FG000|Full Analysis Set (FAS)|Overall Study||476
10889376|NCT02125461|12055495|FG001|Full Analysis Set (FAS)|Overall Study||237
10889377|NCT02125461|12055494|FG000|Received Treatment|Overall Study||473
10889378|NCT02125461|12055495|FG001|Received Treatment|Overall Study||236
10889379|NCT02125461|12055494|FG000|Safety Analysis Set|Overall Study||475
10889380|NCT02125461|12055495|FG001|Safety Analysis Set|Overall Study||234
10889381|NCT02125461|12055494|FG000|Completed 12 Months of Treatment|Overall Study||232
10889382|NCT02125461|12055495|FG001|Completed 12 Months of Treatment|Overall Study||82
10889383|NCT02125461|12055494|FG000|COMPLETED|Overall Study||178
10889384|NCT02125461|12055495|FG001|COMPLETED|Overall Study||68
10889385|NCT02125461|12055494|FG000|NOT COMPLETED|Overall Study||298
10889386|NCT02125461|12055495|FG001|NOT COMPLETED|Overall Study||169
10889387|NCT02122952|12055503|FG000|STARTED|Overall Study||3
10889388|NCT02122952|12055504|FG001|STARTED|Overall Study||12
10889389|NCT02122952|12055503|FG000|COMPLETED|Overall Study||3
10889390|NCT02122952|12055504|FG001|COMPLETED|Overall Study||12
10889391|NCT02122952|12055503|FG000|NOT COMPLETED|Overall Study||0
10889392|NCT02122952|12055504|FG001|NOT COMPLETED|Overall Study||0
10889393|NCT02120352|12055510|FG000|STARTED|Induction Period (20 Weeks)||309
10889394|NCT02120352|12055511|FG001|STARTED|Induction Period (20 Weeks)||0
10889395|NCT02120352|12055512|FG002|STARTED|Induction Period (20 Weeks)||0
10889396|NCT02120352|12055513|FG003|STARTED|Induction Period (20 Weeks)||0
10889397|NCT02120352|12055510|FG000|COMPLETED|Induction Period (20 Weeks)||288
10889398|NCT02120352|12055511|FG001|COMPLETED|Induction Period (20 Weeks)||0
10889399|NCT02120352|12055512|FG002|COMPLETED|Induction Period (20 Weeks)||0
10889400|NCT02120352|12055513|FG003|COMPLETED|Induction Period (20 Weeks)||0
10889401|NCT02120352|12055510|FG000|NOT COMPLETED|Induction Period (20 Weeks)||21
10889402|NCT02120352|12055511|FG001|NOT COMPLETED|Induction Period (20 Weeks)||0
10889403|NCT02120352|12055512|FG002|NOT COMPLETED|Induction Period (20 Weeks)||0
10889404|NCT02120352|12055513|FG003|NOT COMPLETED|Induction Period (20 Weeks)||0
10889405|NCT02120352|12055510|FG000|STARTED|Maintenance Period (32 Weeks)||0
10889406|NCT02120352|12055511|FG001|STARTED|Maintenance Period (32 Weeks)||115
10889407|NCT02120352|12055512|FG002|STARTED|Maintenance Period (32 Weeks)||115
10889408|NCT02120352|12055513|FG003|STARTED|Maintenance Period (32 Weeks)||56
10889409|NCT02120352|12055510|FG000|COMPLETED|Maintenance Period (32 Weeks)||0
10889410|NCT02120352|12055511|FG001|COMPLETED|Maintenance Period (32 Weeks)||0
10889411|NCT02120352|12055512|FG002|COMPLETED|Maintenance Period (32 Weeks)||0
10889412|NCT02120352|12055513|FG003|COMPLETED|Maintenance Period (32 Weeks)||0
10889413|NCT02120352|12055510|FG000|NOT COMPLETED|Maintenance Period (32 Weeks)||0
10889414|NCT02120352|12055511|FG001|NOT COMPLETED|Maintenance Period (32 Weeks)||115
10889415|NCT02120352|12055512|FG002|NOT COMPLETED|Maintenance Period (32 Weeks)||115
10889416|NCT02120352|12055513|FG003|NOT COMPLETED|Maintenance Period (32 Weeks)||56
10889417|NCT02119416|12055530|FG000|STARTED|Overall Study||32
10889418|NCT02119416|12055531|FG001|STARTED|Overall Study||36
10889419|NCT02119416|12055532|FG002|STARTED|Overall Study||33
10889420|NCT02119416|12055530|FG000|COMPLETED|Overall Study||30
10889421|NCT02119416|12055531|FG001|COMPLETED|Overall Study||35
10889422|NCT02119416|12055532|FG002|COMPLETED|Overall Study||31
10889423|NCT02119416|12055530|FG000|NOT COMPLETED|Overall Study||2
10889424|NCT02119416|12055531|FG001|NOT COMPLETED|Overall Study||1
10889425|NCT02119416|12055532|FG002|NOT COMPLETED|Overall Study||2
10889426|NCT02115373|12055546|FG000|STARTED|Overall Study||4
10889427|NCT02115373|12055547|FG001|STARTED|Overall Study||13
10889428|NCT02115373|12055548|FG002|STARTED|Overall Study||49
10889429|NCT02115373|12055546|FG000|COMPLETED|Overall Study||4
10889430|NCT02115373|12055547|FG001|COMPLETED|Overall Study||13
10889431|NCT02115373|12055548|FG002|COMPLETED|Overall Study||49
10889432|NCT02115373|12055546|FG000|NOT COMPLETED|Overall Study||0
10889433|NCT02115373|12055547|FG001|NOT COMPLETED|Overall Study||0
10889434|NCT02115373|12055548|FG002|NOT COMPLETED|Overall Study||0
10889435|NCT02112526|12055565|FG000|STARTED|Overall Study||11
10889436|NCT02112526|12055566|FG001|STARTED|Overall Study||10
10889437|NCT02112526|12055565|FG000|Enrolled|Overall Study||11
10889438|NCT02112526|12055566|FG001|Enrolled|Overall Study||10
10889439|NCT02112526|12055565|FG000|Received Study Medication|Overall Study||11
10889440|NCT02112526|12055566|FG001|Received Study Medication|Overall Study||10
10889441|NCT02112526|12055565|FG000|Discontinued Study|Overall Study||11
10889442|NCT02112526|12055566|FG001|Discontinued Study|Overall Study||9
10889443|NCT02112526|12055565|FG000|Subjects Continuing Study Medication|Overall Study||0
10889444|NCT02112526|12055566|FG001|Subjects Continuing Study Medication|Overall Study||1
10889445|NCT02112526|12055565|FG000|COMPLETED|Overall Study||0
10889446|NCT02112526|12055566|FG001|COMPLETED|Overall Study||1
10889447|NCT02112526|12055565|FG000|NOT COMPLETED|Overall Study||11
10889448|NCT02112526|12055566|FG001|NOT COMPLETED|Overall Study||9
10889449|NCT02108652|12055572|FG000|STARTED|Overall Study||310
10889450|NCT02108652|12055572|FG000|COMPLETED|Overall Study||0
10889451|NCT02108652|12055572|FG000|NOT COMPLETED|Overall Study||310
10889452|NCT02106351|12055579|FG000|STARTED|Treatment Cycle 1||71
10889453|NCT02106351|12055580|FG001|STARTED|Treatment Cycle 1||70
10889454|NCT02106351|12055581|FG002|STARTED|Treatment Cycle 1||71
10889455|NCT02106351|12055579|FG000|Received Treatment in TC 1|Treatment Cycle 1||70
10889456|NCT02106351|12055580|FG001|Received Treatment in TC 1|Treatment Cycle 1||70
10889457|NCT02106351|12055581|FG002|Received Treatment in TC 1|Treatment Cycle 1||70
10889458|NCT02106351|12055579|FG000|COMPLETED|Treatment Cycle 1||66
10889459|NCT02106351|12055580|FG001|COMPLETED|Treatment Cycle 1||67
10889460|NCT02106351|12055581|FG002|COMPLETED|Treatment Cycle 1||67
10889461|NCT02106351|12055579|FG000|NOT COMPLETED|Treatment Cycle 1||5
10889462|NCT02106351|12055580|FG001|NOT COMPLETED|Treatment Cycle 1||3
10889463|NCT02106351|12055581|FG002|NOT COMPLETED|Treatment Cycle 1||4
10889464|NCT02106351|12055579|FG000|STARTED|Treatment Cycle 2|Subjects who received Dysport 2 U/kg in TC 1 were randomised to receive 8 or 16 U/kg in TCs 2-4.|0
10889465|NCT02106351|12055580|FG001|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|88
10889466|NCT02106351|12055581|FG002|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|90
10889467|NCT02106351|12055579|FG000|COMPLETED|Treatment Cycle 2||0
10889468|NCT02106351|12055580|FG001|COMPLETED|Treatment Cycle 2||83
10889469|NCT02106351|12055581|FG002|COMPLETED|Treatment Cycle 2||87
10889470|NCT02106351|12055579|FG000|NOT COMPLETED|Treatment Cycle 2||0
10889471|NCT02106351|12055580|FG001|NOT COMPLETED|Treatment Cycle 2||5
10889472|NCT02106351|12055581|FG002|NOT COMPLETED|Treatment Cycle 2||3
10889473|NCT02106351|12055579|FG000|STARTED|Treatment Cycle 3||0
10889474|NCT02106351|12055580|FG001|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|49
10889475|NCT02106351|12055581|FG002|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|58
10889476|NCT02106351|12055579|FG000|COMPLETED|Treatment Cycle 3||0
10889477|NCT02106351|12055580|FG001|COMPLETED|Treatment Cycle 3||45
10889478|NCT02106351|12055581|FG002|COMPLETED|Treatment Cycle 3||53
10889479|NCT02106351|12055579|FG000|NOT COMPLETED|Treatment Cycle 3||0
10889480|NCT02106351|12055580|FG001|NOT COMPLETED|Treatment Cycle 3||4
10889481|NCT02106351|12055581|FG002|NOT COMPLETED|Treatment Cycle 3||5
10889482|NCT02106351|12055579|FG000|STARTED|Treatment Cycle 4||0
10889483|NCT02106351|12055580|FG001|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|22
10889484|NCT02106351|12055581|FG002|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|33
10889485|NCT02106351|12055579|FG000|COMPLETED|Treatment Cycle 4||0
10889486|NCT02106351|12055580|FG001|COMPLETED|Treatment Cycle 4||21
10889487|NCT02106351|12055581|FG002|COMPLETED|Treatment Cycle 4||31
10889488|NCT02106351|12055579|FG000|NOT COMPLETED|Treatment Cycle 4||0
10889489|NCT02106351|12055580|FG001|NOT COMPLETED|Treatment Cycle 4||1
10889490|NCT02106351|12055581|FG002|NOT COMPLETED|Treatment Cycle 4||2
10889491|NCT02099864|12055595|FG000|STARTED|Overall Study||36
10889492|NCT02099864|12055595|FG000|COMPLETED|Overall Study||36
10889493|NCT02099864|12055595|FG000|NOT COMPLETED|Overall Study||0
10889494|NCT02098876|12055605|FG000|STARTED|Overall Study||45
10889495|NCT02098876|12055606|FG001|STARTED|Overall Study||41
10889496|NCT02098876|12055605|FG000|COMPLETED|Overall Study||40
10889497|NCT02098876|12055606|FG001|COMPLETED|Overall Study||36
10889498|NCT02098876|12055605|FG000|NOT COMPLETED|Overall Study||5
10889499|NCT02098876|12055606|FG001|NOT COMPLETED|Overall Study||5
10889500|NCT02098343|12055617|FG000|STARTED|Overall Study||9
10889501|NCT02098343|12055618|FG001|STARTED|Overall Study||6
10889502|NCT02098343|12055619|FG002|STARTED|Overall Study||21
10889503|NCT02098343|12055620|FG003|STARTED|Overall Study||105
10889504|NCT02098343|12055621|FG004|STARTED|Overall Study||106
10889505|NCT02098343|12055617|FG000|COMPLETED|Overall Study||9
10889506|NCT02098343|12055618|FG001|COMPLETED|Overall Study||6
10889507|NCT02098343|12055619|FG002|COMPLETED|Overall Study||20
10889508|NCT02098343|12055620|FG003|COMPLETED|Overall Study||105
10889509|NCT02098343|12055621|FG004|COMPLETED|Overall Study||106
10889510|NCT02098343|12055617|FG000|NOT COMPLETED|Overall Study||0
10889511|NCT02098343|12055618|FG001|NOT COMPLETED|Overall Study||0
10889512|NCT02098343|12055619|FG002|NOT COMPLETED|Overall Study||1
10889513|NCT02098343|12055620|FG003|NOT COMPLETED|Overall Study||0
10889514|NCT02098343|12055621|FG004|NOT COMPLETED|Overall Study||0
10889515|NCT02094261|12055634|FG000|STARTED|Overall Study||210
10889516|NCT02094261|12055634|FG000|COMPLETED|Overall Study||0
10889517|NCT02094261|12055634|FG000|NOT COMPLETED|Overall Study||210
10889518|NCT02091960|12055638|FG000|STARTED|Overall Study||103
10889519|NCT02091960|12055638|FG000|Received Treatment|Overall Study||103
10889520|NCT02091960|12055638|FG000|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
10889521|NCT02091960|12055638|FG000|NOT COMPLETED|Overall Study||51
10889522|NCT02091375|12055644|FG000|STARTED|Overall Study||61
10889523|NCT02091375|12055645|FG001|STARTED|Overall Study||59
10889524|NCT02091375|12055644|FG000|Safety Analysis Set|Overall Study||61
10889525|NCT02091375|12055645|FG001|Safety Analysis Set|Overall Study||59
10889526|NCT02091375|12055644|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||61
10889527|NCT02091375|12055645|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||59
10889528|NCT02091375|12055644|FG000|COMPLETED|Overall Study||52
10889529|NCT02091375|12055645|FG001|COMPLETED|Overall Study||56
10889530|NCT02091375|12055644|FG000|NOT COMPLETED|Overall Study||9
10889531|NCT02091375|12055645|FG001|NOT COMPLETED|Overall Study||3
10889532|NCT02091206|12055655|FG000|STARTED|Treatment Period||10
10889533|NCT02091206|12055656|FG001|STARTED|Treatment Period||8
10889534|NCT02091206|12055657|FG002|STARTED|Treatment Period||9
10889535|NCT02091206|12055658|FG003|STARTED|Treatment Period||7
10889536|NCT02091206|12055655|FG000|Safety Analysis Set|Treatment Period||10
10889537|NCT02091206|12055656|FG001|Safety Analysis Set|Treatment Period||8
10889538|NCT02091206|12055657|FG002|Safety Analysis Set|Treatment Period||9
10889539|NCT02091206|12055658|FG003|Safety Analysis Set|Treatment Period||7
10889540|NCT02091206|12055655|FG000|COMPLETED|Treatment Period||10
10889541|NCT02091206|12055656|FG001|COMPLETED|Treatment Period||7
10889542|NCT02091206|12055657|FG002|COMPLETED|Treatment Period||8
10889543|NCT02091206|12055658|FG003|COMPLETED|Treatment Period||7
10889544|NCT02091206|12055655|FG000|NOT COMPLETED|Treatment Period||0
10889545|NCT02091206|12055656|FG001|NOT COMPLETED|Treatment Period||1
10889546|NCT02091206|12055657|FG002|NOT COMPLETED|Treatment Period||1
10889547|NCT02091206|12055658|FG003|NOT COMPLETED|Treatment Period||0
10889548|NCT02091206|12055655|FG000|STARTED|Taper Period||10
10889549|NCT02091206|12055656|FG001|STARTED|Taper Period||7
10889550|NCT02091206|12055657|FG002|STARTED|Taper Period||8
10889551|NCT02091206|12055658|FG003|STARTED|Taper Period||7
10889552|NCT02091206|12055655|FG000|COMPLETED|Taper Period||9
10889553|NCT02091206|12055656|FG001|COMPLETED|Taper Period||7
10889554|NCT02091206|12055657|FG002|COMPLETED|Taper Period||8
10889555|NCT02091206|12055658|FG003|COMPLETED|Taper Period||5
10889556|NCT02091206|12055655|FG000|NOT COMPLETED|Taper Period||1
10889557|NCT02091206|12055656|FG001|NOT COMPLETED|Taper Period||0
10889558|NCT02091206|12055657|FG002|NOT COMPLETED|Taper Period||0
10889559|NCT02091206|12055658|FG003|NOT COMPLETED|Taper Period||2
10889560|NCT02089685|12055674|FG000|STARTED|Overall Study||23
10889561|NCT02089685|12055675|FG001|STARTED|Overall Study||14
10889562|NCT02089685|12055676|FG002|STARTED|Overall Study||3
10889563|NCT02089685|12055677|FG003|STARTED|Overall Study||153
10889564|NCT02089685|12055678|FG004|STARTED|Overall Study||51
10889565|NCT02089685|12055679|FG005|STARTED|Overall Study||51
10889566|NCT02089685|12055674|FG000|Treated|Overall Study||22
10889567|NCT02089685|12055675|FG001|Treated|Overall Study||14
10889568|NCT02089685|12055676|FG002|Treated|Overall Study||3
10889569|NCT02089685|12055677|FG003|Treated|Overall Study||153
10889570|NCT02089685|12055678|FG004|Treated|Overall Study||51
10889571|NCT02089685|12055679|FG005|Treated|Overall Study||51
10889572|NCT02089685|12055674|FG000|COMPLETED|Overall Study||0
10889573|NCT02089685|12055675|FG001|COMPLETED|Overall Study||0
10889574|NCT02089685|12055676|FG002|COMPLETED|Overall Study||0
10889575|NCT02089685|12055677|FG003|COMPLETED|Overall Study||0
10889576|NCT02089685|12055678|FG004|COMPLETED|Overall Study||0
10889577|NCT02089685|12055679|FG005|COMPLETED|Overall Study||0
10889578|NCT02089685|12055674|FG000|NOT COMPLETED|Overall Study||23
10889579|NCT02089685|12055675|FG001|NOT COMPLETED|Overall Study||14
10889580|NCT02089685|12055676|FG002|NOT COMPLETED|Overall Study||3
10889581|NCT02089685|12055677|FG003|NOT COMPLETED|Overall Study||153
10889582|NCT02089685|12055678|FG004|NOT COMPLETED|Overall Study||51
10889583|NCT02089685|12055679|FG005|NOT COMPLETED|Overall Study||51
10889584|NCT02085941|12055705|FG000|STARTED|Overall Study||25
10889585|NCT02085941|12055706|FG001|STARTED|Overall Study||5
10889586|NCT02085941|12055705|FG000|COMPLETED|Overall Study||17
10889587|NCT02085941|12055706|FG001|COMPLETED|Overall Study||2
10889588|NCT02085941|12055705|FG000|NOT COMPLETED|Overall Study||8
10889589|NCT02085941|12055706|FG001|NOT COMPLETED|Overall Study||3
10889590|NCT02080403|12055714|FG000|STARTED|Overall Study||146
10889591|NCT02080403|12055715|FG001|STARTED|Overall Study||144
10889592|NCT02080403|12055714|FG000|COMPLETED|Overall Study||131
10889593|NCT02080403|12055715|FG001|COMPLETED|Overall Study||132
10889594|NCT02080403|12055714|FG000|NOT COMPLETED|Overall Study||15
10889595|NCT02080403|12055715|FG001|NOT COMPLETED|Overall Study||12
10889596|NCT02080221|12055721|FG000|STARTED|Overall Study||50
10889597|NCT02080221|12055721|FG000|COMPLETED|Overall Study||48
10889598|NCT02080221|12055721|FG000|NOT COMPLETED|Overall Study||2
10889599|NCT02076113|12055727|FG000|STARTED|Overall Study||63
10889600|NCT02076113|12055728|FG001|STARTED|Overall Study||100
10889601|NCT02076113|12055727|FG000|Surgery as Randomized|Overall Study|1 patient underwent dorsal fusion surgery|62
10889602|NCT02076113|12055728|FG001|Surgery as Randomized|Overall Study|4 patients underwent ventral fusion surgery|96
10889603|NCT02076113|12055727|FG000|3-Month Follow-up|Overall Study|5 missed follow-up visit; 2 lost to follow-up|56
10889604|NCT02076113|12055728|FG001|3-Month Follow-up|Overall Study|9 missed follow-up appointment; 1 lost to follow-up|90
10889605|NCT02076113|12055727|FG000|6-Month Follow-up|Overall Study|7 missed follow-up visit; 3 lost to follow-up|53
10889606|NCT02076113|12055728|FG001|6-Month Follow-up|Overall Study|7 missed follow-up visit; 1 lost to follow-up; 1 deceased|91
10889607|NCT02076113|12055727|FG000|1-Year Follow-up|Overall Study|3 lost to follow-up|60
10889608|NCT02076113|12055728|FG001|1-Year Follow-up|Overall Study|2 missed follow-up visit; 1 lost to follow-up; 2 deceased|95
10889609|NCT02076113|12055727|FG000|2-Year Follow-up|Overall Study|5 missed follow-up visit; 4 lost to follow-up; 2 withdrew consent; 1 deceased|51
10889610|NCT02076113|12055728|FG001|2-Year Follow-up|Overall Study|14 missed follow-up visit; 1 lost to follow-up; 3 withdrew consent; 3 deceased|79
10889611|NCT02076113|12055727|FG000|COMPLETED|Overall Study||56
10889612|NCT02076113|12055728|FG001|COMPLETED|Overall Study||93
10889613|NCT02076113|12055727|FG000|NOT COMPLETED|Overall Study||7
10889614|NCT02076113|12055728|FG001|NOT COMPLETED|Overall Study||7
10889615|NCT02076009|12055739|FG000|STARTED|Overall Study||283
10889616|NCT02076009|12055740|FG001|STARTED|Overall Study||286
10889617|NCT02076009|12055739|FG000|Treated|Overall Study||281
10889618|NCT02076009|12055740|FG001|Treated|Overall Study||283
10889619|NCT02076009|12055739|FG000|COMPLETED|Overall Study||0
10889620|NCT02076009|12055740|FG001|COMPLETED|Overall Study||0
10889621|NCT02076009|12055739|FG000|NOT COMPLETED|Overall Study||283
10889622|NCT02076009|12055740|FG001|NOT COMPLETED|Overall Study||286
10889623|NCT02075840|12055748|FG000|STARTED|Overall Study||152
10889624|NCT02075840|12055749|FG001|STARTED|Overall Study||151
10889625|NCT02075840|12055748|FG000|COMPLETED|Overall Study||0
10889626|NCT02075840|12055749|FG001|COMPLETED|Overall Study||0
10889627|NCT02075840|12055748|FG000|NOT COMPLETED|Overall Study||152
10889628|NCT02075840|12055749|FG001|NOT COMPLETED|Overall Study||151
10889629|NCT02069366|12055761|FG000|STARTED|Overall Study||13
10889630|NCT02069366|12055762|FG001|STARTED|Overall Study||10
10889631|NCT02069366|12055763|FG002|STARTED|Overall Study||18
10889632|NCT02069366|12055764|FG003|STARTED|Overall Study||17
10889633|NCT02069366|12055765|FG004|STARTED|Overall Study||14
10889634|NCT02069366|12055766|FG005|STARTED|Overall Study||14
10889635|NCT02069366|12055761|FG000|COMPLETED|Overall Study||12
10889636|NCT02069366|12055762|FG001|COMPLETED|Overall Study||10
10889637|NCT02069366|12055763|FG002|COMPLETED|Overall Study||15
10889638|NCT02069366|12055764|FG003|COMPLETED|Overall Study||15
10889639|NCT02069366|12055765|FG004|COMPLETED|Overall Study||14
10889640|NCT02069366|12055766|FG005|COMPLETED|Overall Study||12
10889641|NCT02069366|12055761|FG000|NOT COMPLETED|Overall Study||1
10889642|NCT02069366|12055762|FG001|NOT COMPLETED|Overall Study||0
10889643|NCT02069366|12055763|FG002|NOT COMPLETED|Overall Study||3
10889644|NCT02069366|12055764|FG003|NOT COMPLETED|Overall Study||2
10889645|NCT02069366|12055765|FG004|NOT COMPLETED|Overall Study||0
10889646|NCT02069366|12055766|FG005|NOT COMPLETED|Overall Study||2
10889647|NCT02066415|12055784|FG000|STARTED|Overall Study||286
10889648|NCT02066415|12055785|FG001|STARTED|Overall Study||191
10889649|NCT02066415|12055786|FG002|STARTED|Overall Study||190
10889650|NCT02066415|12055784|FG000|Received Study Drug|Overall Study||282
10889651|NCT02066415|12055785|FG001|Received Study Drug|Overall Study||190
10889652|NCT02066415|12055786|FG002|Received Study Drug|Overall Study||188
10889653|NCT02066415|12055784|FG000|COMPLETED|Overall Study||265
10889654|NCT02066415|12055785|FG001|COMPLETED|Overall Study||184
10889655|NCT02066415|12055786|FG002|COMPLETED|Overall Study||182
10889656|NCT02066415|12055784|FG000|NOT COMPLETED|Overall Study||21
10889657|NCT02066415|12055785|FG001|NOT COMPLETED|Overall Study||7
10889658|NCT02066415|12055786|FG002|NOT COMPLETED|Overall Study||8
10889659|NCT02064296|12055797|FG000|STARTED|Eligibility to Baseline Data Collection||27
10889660|NCT02064296|12055798|FG001|STARTED|Eligibility to Baseline Data Collection||39
10889661|NCT02064296|12055799|FG002|STARTED|Eligibility to Baseline Data Collection||40
10889662|NCT02064296|12055797|FG000|COMPLETED|Eligibility to Baseline Data Collection||26
10889663|NCT02064296|12055798|FG001|COMPLETED|Eligibility to Baseline Data Collection||39
10889664|NCT02064296|12055799|FG002|COMPLETED|Eligibility to Baseline Data Collection||40
10889665|NCT02064296|12055797|FG000|NOT COMPLETED|Eligibility to Baseline Data Collection||1
10889666|NCT02064296|12055798|FG001|NOT COMPLETED|Eligibility to Baseline Data Collection||0
10889667|NCT02064296|12055799|FG002|NOT COMPLETED|Eligibility to Baseline Data Collection||0
10889668|NCT02064296|12055797|FG000|STARTED|Baseline Data Collection|No healthy volunteers were given any treatment as they were used for baseline comparison purposes.|26
10889669|NCT02064296|12055798|FG001|STARTED|Baseline Data Collection||39
10889670|NCT02064296|12055799|FG002|STARTED|Baseline Data Collection||40
10889671|NCT02064296|12055797|FG000|COMPLETED|Baseline Data Collection||26
10889672|NCT02064296|12055798|FG001|COMPLETED|Baseline Data Collection||39
10889673|NCT02064296|12055799|FG002|COMPLETED|Baseline Data Collection||40
10889674|NCT02064296|12055797|FG000|NOT COMPLETED|Baseline Data Collection||0
10889675|NCT02064296|12055798|FG001|NOT COMPLETED|Baseline Data Collection||0
10889676|NCT02064296|12055799|FG002|NOT COMPLETED|Baseline Data Collection||0
10889677|NCT02064296|12055797|FG000|STARTED|Intervention|Healthy controls were never intended to have interventions.|0
10889678|NCT02064296|12055798|FG001|STARTED|Intervention||39
10889679|NCT02064296|12055799|FG002|STARTED|Intervention||40
10889680|NCT02064296|12055797|FG000|COMPLETED|Intervention||0
10889681|NCT02064296|12055798|FG001|COMPLETED|Intervention||38
10889682|NCT02064296|12055799|FG002|COMPLETED|Intervention||38
10889683|NCT02064296|12055797|FG000|NOT COMPLETED|Intervention||0
10889684|NCT02064296|12055798|FG001|NOT COMPLETED|Intervention||1
10889685|NCT02064296|12055799|FG002|NOT COMPLETED|Intervention||2
10889686|NCT02063724|12055809|FG000|STARTED|Overall Study||15
10889687|NCT02063724|12055809|FG000|COMPLETED|Overall Study||14
10889688|NCT02063724|12055809|FG000|NOT COMPLETED|Overall Study||1
10889689|NCT02061358|12055822|FG000|STARTED|Overall Study||6
10889690|NCT02061358|12055823|FG001|STARTED|Overall Study||6
10889691|NCT02061358|12055824|FG002|STARTED|Overall Study||6
10889692|NCT02061358|12055825|FG003|STARTED|Overall Study||6
10889693|NCT02061358|12055826|FG004|STARTED|Overall Study||6
10889694|NCT02061358|12055827|FG005|STARTED|Overall Study||6
10889695|NCT02061358|12055828|FG006|STARTED|Overall Study||6
10889696|NCT02061358|12055829|FG007|STARTED|Overall Study||6
10889697|NCT02061358|12055830|FG008|STARTED|Overall Study||16
10889698|NCT02061358|12055822|FG000|COMPLETED|Overall Study||6
10889699|NCT02061358|12055823|FG001|COMPLETED|Overall Study||6
10889700|NCT02061358|12055824|FG002|COMPLETED|Overall Study||6
10889701|NCT02061358|12055825|FG003|COMPLETED|Overall Study||6
10889702|NCT02061358|12055826|FG004|COMPLETED|Overall Study||6
10889703|NCT02061358|12055827|FG005|COMPLETED|Overall Study||6
10889704|NCT02061358|12055828|FG006|COMPLETED|Overall Study||6
10889705|NCT02061358|12055829|FG007|COMPLETED|Overall Study||6
10889706|NCT02061358|12055830|FG008|COMPLETED|Overall Study||16
10889707|NCT02061358|12055822|FG000|NOT COMPLETED|Overall Study||0
10889708|NCT02061358|12055823|FG001|NOT COMPLETED|Overall Study||0
10889709|NCT02061358|12055824|FG002|NOT COMPLETED|Overall Study||0
10889710|NCT02061358|12055825|FG003|NOT COMPLETED|Overall Study||0
10889711|NCT02061358|12055826|FG004|NOT COMPLETED|Overall Study||0
10889712|NCT02061358|12055827|FG005|NOT COMPLETED|Overall Study||0
10889713|NCT02061358|12055828|FG006|NOT COMPLETED|Overall Study||0
10889714|NCT02061358|12055829|FG007|NOT COMPLETED|Overall Study||0
10889715|NCT02061358|12055830|FG008|NOT COMPLETED|Overall Study||0
10889716|NCT02059265|12055850|FG000|STARTED|Overall Study||32
10889717|NCT02059265|12055850|FG000|COMPLETED|Overall Study||28
10889718|NCT02059265|12055850|FG000|NOT COMPLETED|Overall Study||4
10889719|NCT02053909|12055856|FG000|STARTED|Overall Study||123
10889720|NCT02053909|12055857|FG001|STARTED|Overall Study||127
10889721|NCT02053909|12055856|FG000|COMPLETED|Overall Study||123
10889722|NCT02053909|12055857|FG001|COMPLETED|Overall Study||127
10889723|NCT02053909|12055856|FG000|NOT COMPLETED|Overall Study||0
10889724|NCT02053909|12055857|FG001|NOT COMPLETED|Overall Study||0
10889725|NCT02043678|12055865|FG000|STARTED|Overall Study||401
10889726|NCT02043678|12055866|FG001|STARTED|Overall Study||405
10889727|NCT02043678|12055865|FG000|Treated|Overall Study||390
10889728|NCT02043678|12055866|FG001|Treated|Overall Study||396
10889729|NCT02043678|12055865|FG000|COMPLETED|Overall Study||0
10889730|NCT02043678|12055866|FG001|COMPLETED|Overall Study||0
10889731|NCT02043678|12055865|FG000|NOT COMPLETED|Overall Study||401
10889732|NCT02043678|12055866|FG001|NOT COMPLETED|Overall Study||405
10889733|NCT02032823|12055874|FG000|STARTED|Overall Study||921
10889734|NCT02032823|12055875|FG001|STARTED|Overall Study||915
10889735|NCT02032823|12055874|FG000|COMPLETED|Overall Study||0
10889736|NCT02032823|12055875|FG001|COMPLETED|Overall Study||0
10889737|NCT02032823|12055874|FG000|NOT COMPLETED|Overall Study||921
10889738|NCT02032823|12055875|FG001|NOT COMPLETED|Overall Study||915
10889739|NCT02029443|12055886|FG000|STARTED|Overall Study||134
10889740|NCT02029443|12055887|FG001|STARTED|Overall Study||99
10889741|NCT02029443|12055888|FG002|STARTED|Overall Study||33
10889742|NCT02029443|12055889|FG003|STARTED|Overall Study||29
10889743|NCT02029443|12055890|FG004|STARTED|Overall Study||6
10889744|NCT02029443|12055886|FG000|COMPLETED|Overall Study||41
10889745|NCT02029443|12055887|FG001|COMPLETED|Overall Study||70
10889746|NCT02029443|12055888|FG002|COMPLETED|Overall Study||6
10889747|NCT02029443|12055889|FG003|COMPLETED|Overall Study||3
10889748|NCT02029443|12055890|FG004|COMPLETED|Overall Study||0
10889749|NCT02029443|12055886|FG000|NOT COMPLETED|Overall Study||93
10889750|NCT02029443|12055887|FG001|NOT COMPLETED|Overall Study||29
10889751|NCT02029443|12055888|FG002|NOT COMPLETED|Overall Study||27
10889752|NCT02029443|12055889|FG003|NOT COMPLETED|Overall Study||26
10889753|NCT02029443|12055890|FG004|NOT COMPLETED|Overall Study||6
10889754|NCT02024529|12055926|FG000|STARTED|Overall Study||269
10889755|NCT02024529|12055927|FG001|STARTED|Overall Study||269
10889756|NCT02024529|12055926|FG000|COMPLETED|Overall Study||256
10889757|NCT02024529|12055927|FG001|COMPLETED|Overall Study||244
10889758|NCT02024529|12055926|FG000|NOT COMPLETED|Overall Study||13
10889759|NCT02024529|12055927|FG001|NOT COMPLETED|Overall Study||25
10889760|NCT02024087|12055937|FG000|STARTED|Overall Study||5
10889761|NCT02024087|12055938|FG001|STARTED|Overall Study|Dose change to 0.4 mg/kg and cohort expanded to 16 participants in total at this dose level|16
10889762|NCT02024087|12055937|FG000|COMPLETED|Overall Study||5
10889763|NCT02024087|12055938|FG001|COMPLETED|Overall Study||16
10889764|NCT02024087|12055937|FG000|NOT COMPLETED|Overall Study||0
10889765|NCT02024087|12055938|FG001|NOT COMPLETED|Overall Study||0
10889766|NCT02021812|12055945|FG000|STARTED|Overall Study||31
10889767|NCT02021812|12055945|FG000|COMPLETED|Overall Study||16
10889768|NCT02021812|12055945|FG000|NOT COMPLETED|Overall Study||15
10889769|NCT02016781|12055951|FG000|STARTED|Interim Look for Primary Analysis||260
10889770|NCT02016781|12055952|FG001|STARTED|Interim Look for Primary Analysis||124
10889771|NCT02016781|12055951|FG000|COMPLETED|Interim Look for Primary Analysis||187
10889772|NCT02016781|12055952|FG001|COMPLETED|Interim Look for Primary Analysis||100
10889773|NCT02016781|12055951|FG000|NOT COMPLETED|Interim Look for Primary Analysis||73
10889774|NCT02016781|12055952|FG001|NOT COMPLETED|Interim Look for Primary Analysis||24
10889775|NCT02016781|12055951|FG000|STARTED|Final Database Lock||261
10889776|NCT02016781|12055952|FG001|STARTED|Final Database Lock||123
10889777|NCT02016781|12055951|FG000|COMPLETED|Final Database Lock||248
10889778|NCT02016781|12055952|FG001|COMPLETED|Final Database Lock||115
10889779|NCT02016781|12055951|FG000|NOT COMPLETED|Final Database Lock||13
10889780|NCT02016781|12055952|FG001|NOT COMPLETED|Final Database Lock||8
10889781|NCT02006628|12055960|FG000|STARTED|Overall Study||43
10889782|NCT02006628|12055961|FG001|STARTED|Overall Study||45
10889783|NCT02006628|12055960|FG000|Received at Least 1 Dose of Study Drug|Overall Study||43
10889784|NCT02006628|12055961|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45
10889785|NCT02006628|12055960|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||42
10889786|NCT02006628|12055961|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||44
10889787|NCT02006628|12055960|FG000|COMPLETED|Overall Study||40
10889788|NCT02006628|12055961|FG001|COMPLETED|Overall Study||43
10889789|NCT02006628|12055960|FG000|NOT COMPLETED|Overall Study||3
10889790|NCT02006628|12055961|FG001|NOT COMPLETED|Overall Study||2
10889791|NCT02003144|12055969|FG000|STARTED|Blind Induction Phase||41
10889792|NCT02003144|12055970|FG001|STARTED|Blind Induction Phase||78
10889793|NCT02003144|12055969|FG000|Received at Least 1 Dose of Study Drug|Blind Induction Phase||41
10889794|NCT02003144|12055970|FG001|Received at Least 1 Dose of Study Drug|Blind Induction Phase||78
10889795|NCT02003144|12055969|FG000|COMPLETED|Blind Induction Phase||41
10889796|NCT02003144|12055970|FG001|COMPLETED|Blind Induction Phase||78
10889797|NCT02003144|12055969|FG000|NOT COMPLETED|Blind Induction Phase||0
10889798|NCT02003144|12055970|FG001|NOT COMPLETED|Blind Induction Phase||0
10889799|NCT02003144|12055969|FG000|STARTED|Open Label Maintenance Phase||41
10889800|NCT02003144|12055970|FG001|STARTED|Open Label Maintenance Phase||78
10889801|NCT02003144|12055969|FG000|Received at Least 1 Dose of Study Drug|Open Label Maintenance Phase||41
10889802|NCT02003144|12055970|FG001|Received at Least 1 Dose of Study Drug|Open Label Maintenance Phase||78
10889803|NCT02003144|12055969|FG000|COMPLETED|Open Label Maintenance Phase||32
10889804|NCT02003144|12055970|FG001|COMPLETED|Open Label Maintenance Phase||64
10889805|NCT02003144|12055969|FG000|NOT COMPLETED|Open Label Maintenance Phase||9
10889806|NCT02003144|12055970|FG001|NOT COMPLETED|Open Label Maintenance Phase||14
10889807|NCT02002182|12055979|FG000|STARTED|Overall Study||9
10889808|NCT02002182|12055980|FG001|STARTED|Overall Study||6
10889809|NCT02002182|12055979|FG000|COMPLETED|Overall Study||4
10889810|NCT02002182|12055980|FG001|COMPLETED|Overall Study||5
10889811|NCT02002182|12055979|FG000|NOT COMPLETED|Overall Study||5
10889812|NCT02002182|12055980|FG001|NOT COMPLETED|Overall Study||1
10889813|NCT02000427|12055986|FG000|STARTED|Overall Study||45
10889814|NCT02000427|12055986|FG000|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
10889815|NCT02000427|12055986|FG000|NOT COMPLETED|Overall Study||22
10889816|NCT01992393|12055992|FG000|STARTED|Baseline||22
10889817|NCT01992393|12055993|FG001|STARTED|Baseline||22
10889818|NCT01992393|12055992|FG000|COMPLETED|Baseline||21
10889819|NCT01992393|12055993|FG001|COMPLETED|Baseline||22
10889820|NCT01992393|12055992|FG000|NOT COMPLETED|Baseline||1
10889821|NCT01992393|12055993|FG001|NOT COMPLETED|Baseline||0
10889822|NCT01992393|12055992|FG000|STARTED|Week 12 (3 Months)||21
10889823|NCT01992393|12055993|FG001|STARTED|Week 12 (3 Months)||22
10889824|NCT01992393|12055992|FG000|COMPLETED|Week 12 (3 Months)||19
10889825|NCT01992393|12055993|FG001|COMPLETED|Week 12 (3 Months)||18
10889826|NCT01992393|12055992|FG000|NOT COMPLETED|Week 12 (3 Months)||2
10889827|NCT01992393|12055993|FG001|NOT COMPLETED|Week 12 (3 Months)||4
10889828|NCT01992393|12055992|FG000|STARTED|Week 16 (4 Months)||19
10889829|NCT01992393|12055993|FG001|STARTED|Week 16 (4 Months)||18
10889830|NCT01992393|12055992|FG000|COMPLETED|Week 16 (4 Months)||19
10889831|NCT01992393|12055993|FG001|COMPLETED|Week 16 (4 Months)||16
10889832|NCT01992393|12055992|FG000|NOT COMPLETED|Week 16 (4 Months)||0
10889833|NCT01992393|12055993|FG001|NOT COMPLETED|Week 16 (4 Months)||2
10889834|NCT01991457|12055999|FG000|STARTED|Overall Study||19
10889835|NCT01991457|12055999|FG000|COMPLETED|Overall Study||19
10889836|NCT01991457|12055999|FG000|NOT COMPLETED|Overall Study||0
10889837|NCT01988493|12056008|FG000|STARTED|Overall Study||7
10889838|NCT01988493|12056009|FG001|STARTED|Overall Study||14
10889839|NCT01988493|12056010|FG002|STARTED|Overall Study||6
10889840|NCT01988493|12056011|FG003|STARTED|Overall Study||45
10889841|NCT01988493|12056012|FG004|STARTED|Overall Study||45
10889842|NCT01988493|12056008|FG000|Treated|Overall Study||7
10889843|NCT01988493|12056009|FG001|Treated|Overall Study||14
10889844|NCT01988493|12056010|FG002|Treated|Overall Study||6
10889845|NCT01988493|12056011|FG003|Treated|Overall Study||45
10889846|NCT01988493|12056012|FG004|Treated|Overall Study||44
10889847|NCT01988493|12056008|FG000|Safety Population|Overall Study||7
10889848|NCT01988493|12056009|FG001|Safety Population|Overall Study||14
10889849|NCT01988493|12056010|FG002|Safety Population|Overall Study||6
10889850|NCT01988493|12056011|FG003|Safety Population|Overall Study||45
10889851|NCT01988493|12056012|FG004|Safety Population|Overall Study||44
10889852|NCT01988493|12056008|FG000|COMPLETED|Overall Study||7
10889853|NCT01988493|12056009|FG001|COMPLETED|Overall Study||14
10889854|NCT01988493|12056010|FG002|COMPLETED|Overall Study||6
10889855|NCT01988493|12056011|FG003|COMPLETED|Overall Study||45
10889856|NCT01988493|12056012|FG004|COMPLETED|Overall Study||44
10889857|NCT01988493|12056008|FG000|NOT COMPLETED|Overall Study||0
10889858|NCT01988493|12056009|FG001|NOT COMPLETED|Overall Study||0
10889859|NCT01988493|12056010|FG002|NOT COMPLETED|Overall Study||0
10889860|NCT01988493|12056011|FG003|NOT COMPLETED|Overall Study||0
10889861|NCT01988493|12056012|FG004|NOT COMPLETED|Overall Study||1
10889862|NCT01988233|12056026|FG000|STARTED|Overall Study||167
10889863|NCT01988233|12056027|FG001|STARTED|Overall Study||166
10889864|NCT01988233|12056026|FG000|COMPLETED|Overall Study||103
10889865|NCT01988233|12056027|FG001|COMPLETED|Overall Study||115
10889866|NCT01988233|12056026|FG000|NOT COMPLETED|Overall Study||64
10889867|NCT01988233|12056027|FG001|NOT COMPLETED|Overall Study||51
10889868|NCT01986881|12056036|FG000|STARTED|Overall Study||2752
10889869|NCT01986881|12056037|FG001|STARTED|Overall Study||2747
10889870|NCT01986881|12056038|FG002|STARTED|Overall Study||2747
10889871|NCT01986881|12056036|FG000|Treated|Overall Study||2746
10889872|NCT01986881|12056037|FG001|Treated|Overall Study||2747
10889873|NCT01986881|12056038|FG002|Treated|Overall Study||2745
10889874|NCT01986881|12056036|FG000|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||348
10889875|NCT01986881|12056037|FG001|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||370
10889876|NCT01986881|12056038|FG002|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||347
10889877|NCT01986881|12056036|FG000|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||55
10889878|NCT01986881|12056037|FG001|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||54
10889879|NCT01986881|12056038|FG002|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||48
10889880|NCT01986881|12056036|FG000|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||100
10889881|NCT01986881|12056037|FG001|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||113
10889882|NCT01986881|12056038|FG002|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||117
10889883|NCT01986881|12056036|FG000|COMPLETED|Overall Study||2422
10889884|NCT01986881|12056037|FG001|COMPLETED|Overall Study||2401
10889885|NCT01986881|12056038|FG002|COMPLETED|Overall Study||2389
10889886|NCT01986881|12056036|FG000|NOT COMPLETED|Overall Study||330
10889887|NCT01986881|12056037|FG001|NOT COMPLETED|Overall Study||346
10889888|NCT01986881|12056038|FG002|NOT COMPLETED|Overall Study||358
10889889|NCT01982955|12056074|FG000|STARTED|Overall Study||6
10889890|NCT01982955|12056075|FG001|STARTED|Overall Study||12
10889891|NCT01982955|12056076|FG002|STARTED|Overall Study||31
10889892|NCT01982955|12056077|FG003|STARTED|Overall Study||24
10889893|NCT01982955|12056078|FG004|STARTED|Overall Study||15
10889894|NCT01982955|12056074|FG000|Treated|Overall Study||6
10889895|NCT01982955|12056075|FG001|Treated|Overall Study||12
10889896|NCT01982955|12056076|FG002|Treated|Overall Study||31
10889897|NCT01982955|12056077|FG003|Treated|Overall Study||23
10889898|NCT01982955|12056078|FG004|Treated|Overall Study||15
10889899|NCT01982955|12056074|FG000|COMPLETED|Overall Study||6
10889900|NCT01982955|12056075|FG001|COMPLETED|Overall Study||12
10889901|NCT01982955|12056076|FG002|COMPLETED|Overall Study||27
10889902|NCT01982955|12056077|FG003|COMPLETED|Overall Study||23
10889903|NCT01982955|12056078|FG004|COMPLETED|Overall Study||15
10889904|NCT01982955|12056074|FG000|NOT COMPLETED|Overall Study||0
10889905|NCT01982955|12056075|FG001|NOT COMPLETED|Overall Study||0
10889906|NCT01982955|12056076|FG002|NOT COMPLETED|Overall Study||4
10889907|NCT01982955|12056077|FG003|NOT COMPLETED|Overall Study||1
10889908|NCT01982955|12056078|FG004|NOT COMPLETED|Overall Study||0
10889909|NCT01981044|12056091|FG000|STARTED|Overall Study||1
10889910|NCT01981044|12056091|FG000|COMPLETED|Overall Study||1
10889911|NCT01981044|12056091|FG000|NOT COMPLETED|Overall Study||0
10889912|NCT01979536|12056097|FG000|STARTED|Overall Study||68
10889913|NCT01979536|12056098|FG001|STARTED|Overall Study||69
10889914|NCT01979536|12056097|FG000|COMPLETED|Overall Study||66
10889915|NCT01979536|12056098|FG001|COMPLETED|Overall Study||61
10889916|NCT01979536|12056097|FG000|NOT COMPLETED|Overall Study||2
10889917|NCT01979536|12056098|FG001|NOT COMPLETED|Overall Study||8
10889918|NCT01976091|12056111|FG000|STARTED|Overall Study||1
10889919|NCT01976091|12056112|FG001|STARTED|Overall Study||3
10889920|NCT01976091|12056113|FG002|STARTED|Overall Study||2
10889921|NCT01976091|12056111|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
10889922|NCT01976091|12056112|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10889923|NCT01976091|12056113|FG002|Received at Least 1 Dose of Study Drug|Overall Study||2
10889924|NCT01976091|12056111|FG000|COMPLETED|Overall Study||1
10889925|NCT01976091|12056112|FG001|COMPLETED|Overall Study||3
10889926|NCT01976091|12056113|FG002|COMPLETED|Overall Study||2
10889927|NCT01976091|12056111|FG000|NOT COMPLETED|Overall Study||0
10889928|NCT01976091|12056112|FG001|NOT COMPLETED|Overall Study||0
10889929|NCT01976091|12056113|FG002|NOT COMPLETED|Overall Study||0
10889930|NCT01975272|12056124|FG000|STARTED|Overall Study||9
10889931|NCT01975272|12056125|FG001|STARTED|Overall Study||10
10889932|NCT01975272|12056126|FG002|STARTED|Overall Study||8
10889933|NCT01975272|12056124|FG000|COMPLETED|Overall Study||8
10889934|NCT01975272|12056125|FG001|COMPLETED|Overall Study||9
10889935|NCT01975272|12056126|FG002|COMPLETED|Overall Study||6
10889936|NCT01975272|12056124|FG000|NOT COMPLETED|Overall Study||1
10889937|NCT01975272|12056125|FG001|NOT COMPLETED|Overall Study||1
10889938|NCT01975272|12056126|FG002|NOT COMPLETED|Overall Study||2
10889939|NCT01972308|12056136|FG000|STARTED|Overall Study||156
10889940|NCT01972308|12056137|FG001|STARTED|Overall Study||156
10889941|NCT01972308|12056136|FG000|COMPLETED|Overall Study||148
10889942|NCT01972308|12056137|FG001|COMPLETED|Overall Study||148
10889943|NCT01972308|12056136|FG000|NOT COMPLETED|Overall Study||8
10889944|NCT01972308|12056137|FG001|NOT COMPLETED|Overall Study||8
10889945|NCT01970501|12056147|FG000|STARTED|Overall Study||134
10889946|NCT01970501|12056148|FG001|STARTED|Overall Study||133
10889947|NCT01970501|12056147|FG000|Randomization (Visit 2)|Overall Study||134
10889948|NCT01970501|12056148|FG001|Randomization (Visit 2)|Overall Study||133
10889949|NCT01970501|12056147|FG000|Initial Dose Level 1|Overall Study||35
10889950|NCT01970501|12056148|FG001|Initial Dose Level 1|Overall Study||45
10889951|NCT01970501|12056147|FG000|Initial Dose Level 2|Overall Study||45
10889952|NCT01970501|12056148|FG001|Initial Dose Level 2|Overall Study||38
10889953|NCT01970501|12056147|FG000|Initial Dose Level 3|Overall Study||51
10889954|NCT01970501|12056148|FG001|Initial Dose Level 3|Overall Study||45
10889955|NCT01970501|12056147|FG000|Initial Dose Level 4|Overall Study||3
10889956|NCT01970501|12056148|FG001|Initial Dose Level 4|Overall Study||5
10889957|NCT01970501|12056147|FG000|Drug Lead-in Period|Overall Study||134
10889958|NCT01970501|12056148|FG001|Drug Lead-in Period|Overall Study||133
10889959|NCT01970501|12056147|FG000|Attained Target Dose|Overall Study||112
10889960|NCT01970501|12056148|FG001|Attained Target Dose|Overall Study||96
10889961|NCT01970501|12056147|FG000|24-Week Follow Up Period|Overall Study||132
10889962|NCT01970501|12056148|FG001|24-Week Follow Up Period|Overall Study||126
10889963|NCT01970501|12056147|FG000|Treatment Extension Period|Overall Study||77
10889964|NCT01970501|12056148|FG001|Treatment Extension Period|Overall Study||64
10889965|NCT01970501|12056147|FG000|COMPLETED|Overall Study||107
10889966|NCT01970501|12056148|FG001|COMPLETED|Overall Study||105
10889967|NCT01970501|12056147|FG000|NOT COMPLETED|Overall Study||27
10889968|NCT01970501|12056148|FG001|NOT COMPLETED|Overall Study||28
10889969|NCT01958021|12056156|FG000|STARTED|Overall Study||334
10889970|NCT01958021|12056157|FG001|STARTED|Overall Study||334
10889971|NCT01958021|12056156|FG000|Patients Untreated|Overall Study||0
10889972|NCT01958021|12056157|FG001|Patients Untreated|Overall Study||4
10889973|NCT01958021|12056156|FG000|Patients Treated|Overall Study||334
10889974|NCT01958021|12056157|FG001|Patients Treated|Overall Study||330
10889975|NCT01958021|12056156|FG000|COMPLETED|Overall Study|Completed = Treatment ongoing|195
10889976|NCT01958021|12056157|FG001|COMPLETED|Overall Study|Completed = Treatment ongoing|154
10889977|NCT01958021|12056156|FG000|NOT COMPLETED|Overall Study||139
10889978|NCT01958021|12056157|FG001|NOT COMPLETED|Overall Study||180
10889979|NCT01952574|12056167|FG000|STARTED|Double-blind Treatment Phase||160
10889980|NCT01952574|12056168|FG001|STARTED|Double-blind Treatment Phase||108
10889981|NCT01952574|12056169|FG002|STARTED|Double-blind Treatment Phase||108
10889982|NCT01952574|12056170|FG003|STARTED|Double-blind Treatment Phase||107
10889983|NCT01952574|12056171|FG004|STARTED|Double-blind Treatment Phase||0
10889984|NCT01952574|12056172|FG005|STARTED|Double-blind Treatment Phase||0
10889985|NCT01952574|12056173|FG006|STARTED|Double-blind Treatment Phase||0
10889986|NCT01952574|12056167|FG000|Received Study Drug|Double-blind Treatment Phase||153
10889987|NCT01952574|12056168|FG001|Received Study Drug|Double-blind Treatment Phase||108
10889988|NCT01952574|12056169|FG002|Received Study Drug|Double-blind Treatment Phase||105
10889989|NCT01952574|12056170|FG003|Received Study Drug|Double-blind Treatment Phase||106
10889990|NCT01952574|12056171|FG004|Received Study Drug|Double-blind Treatment Phase||0
10889991|NCT01952574|12056172|FG005|Received Study Drug|Double-blind Treatment Phase||0
10889992|NCT01952574|12056173|FG006|Received Study Drug|Double-blind Treatment Phase||0
10889993|NCT01952574|12056167|FG000|COMPLETED|Double-blind Treatment Phase||143
10889994|NCT01952574|12056168|FG001|COMPLETED|Double-blind Treatment Phase||105
10889995|NCT01952574|12056169|FG002|COMPLETED|Double-blind Treatment Phase||99
10889996|NCT01952574|12056170|FG003|COMPLETED|Double-blind Treatment Phase||101
10889997|NCT01952574|12056171|FG004|COMPLETED|Double-blind Treatment Phase||0
10889998|NCT01952574|12056172|FG005|COMPLETED|Double-blind Treatment Phase||0
10889999|NCT01952574|12056173|FG006|COMPLETED|Double-blind Treatment Phase||0
10890000|NCT01952574|12056167|FG000|NOT COMPLETED|Double-blind Treatment Phase||17
10890001|NCT01952574|12056168|FG001|NOT COMPLETED|Double-blind Treatment Phase||3
10890002|NCT01952574|12056169|FG002|NOT COMPLETED|Double-blind Treatment Phase||9
10890003|NCT01952574|12056170|FG003|NOT COMPLETED|Double-blind Treatment Phase||6
10890004|NCT01952574|12056171|FG004|NOT COMPLETED|Double-blind Treatment Phase||0
10890005|NCT01952574|12056172|FG005|NOT COMPLETED|Double-blind Treatment Phase||0
10890006|NCT01952574|12056173|FG006|NOT COMPLETED|Double-blind Treatment Phase||0
10890007|NCT01952574|12056167|FG000|STARTED|Open-label Treatment Phase||0
10890008|NCT01952574|12056168|FG001|STARTED|Open-label Treatment Phase||0
10890009|NCT01952574|12056169|FG002|STARTED|Open-label Treatment Phase||0
10890010|NCT01952574|12056170|FG003|STARTED|Open-label Treatment Phase||0
10890011|NCT01952574|12056171|FG004|STARTED|Open-label Treatment Phase||383
10890012|NCT01952574|12056172|FG005|STARTED|Open-label Treatment Phase||0
10890013|NCT01952574|12056173|FG006|STARTED|Open-label Treatment Phase||0
10890014|NCT01952574|12056167|FG000|Received 70 mg Erenumab|Open-label Treatment Phase||0
10890015|NCT01952574|12056168|FG001|Received 70 mg Erenumab|Open-label Treatment Phase||0
10890016|NCT01952574|12056169|FG002|Received 70 mg Erenumab|Open-label Treatment Phase||0
10890017|NCT01952574|12056170|FG003|Received 70 mg Erenumab|Open-label Treatment Phase||0
10890018|NCT01952574|12056171|FG004|Received 70 mg Erenumab|Open-label Treatment Phase||383
10890019|NCT01952574|12056172|FG005|Received 70 mg Erenumab|Open-label Treatment Phase||0
10890020|NCT01952574|12056173|FG006|Received 70 mg Erenumab|Open-label Treatment Phase||0
10890021|NCT01952574|12056167|FG000|Received 140 mg Erenumab|Open-label Treatment Phase||0
10890022|NCT01952574|12056168|FG001|Received 140 mg Erenumab|Open-label Treatment Phase||0
10890023|NCT01952574|12056169|FG002|Received 140 mg Erenumab|Open-label Treatment Phase||0
10890024|NCT01952574|12056170|FG003|Received 140 mg Erenumab|Open-label Treatment Phase||0
10890025|NCT01952574|12056171|FG004|Received 140 mg Erenumab|Open-label Treatment Phase||250
10890026|NCT01952574|12056172|FG005|Received 140 mg Erenumab|Open-label Treatment Phase||0
10890027|NCT01952574|12056173|FG006|Received 140 mg Erenumab|Open-label Treatment Phase||0
10890028|NCT01952574|12056167|FG000|COMPLETED|Open-label Treatment Phase||0
10890029|NCT01952574|12056168|FG001|COMPLETED|Open-label Treatment Phase||0
10890030|NCT01952574|12056169|FG002|COMPLETED|Open-label Treatment Phase||0
10890031|NCT01952574|12056170|FG003|COMPLETED|Open-label Treatment Phase||0
10890032|NCT01952574|12056171|FG004|COMPLETED|Open-label Treatment Phase||221
10890033|NCT01952574|12056172|FG005|COMPLETED|Open-label Treatment Phase||0
10890034|NCT01952574|12056173|FG006|COMPLETED|Open-label Treatment Phase||0
10890035|NCT01952574|12056167|FG000|NOT COMPLETED|Open-label Treatment Phase||0
10890036|NCT01952574|12056168|FG001|NOT COMPLETED|Open-label Treatment Phase||0
10890037|NCT01952574|12056169|FG002|NOT COMPLETED|Open-label Treatment Phase||0
10890038|NCT01952574|12056170|FG003|NOT COMPLETED|Open-label Treatment Phase||0
10890039|NCT01952574|12056171|FG004|NOT COMPLETED|Open-label Treatment Phase||162
10890040|NCT01952574|12056172|FG005|NOT COMPLETED|Open-label Treatment Phase||0
10890041|NCT01952574|12056173|FG006|NOT COMPLETED|Open-label Treatment Phase||0
10890042|NCT01952574|12056167|FG000|STARTED|Clinical Home Use Substudy||0
10890043|NCT01952574|12056168|FG001|STARTED|Clinical Home Use Substudy||0
10890044|NCT01952574|12056169|FG002|STARTED|Clinical Home Use Substudy||0
10890045|NCT01952574|12056170|FG003|STARTED|Clinical Home Use Substudy||0
10890046|NCT01952574|12056171|FG004|STARTED|Clinical Home Use Substudy||0
10890047|NCT01952574|12056172|FG005|STARTED|Clinical Home Use Substudy||42
10890048|NCT01952574|12056173|FG006|STARTED|Clinical Home Use Substudy||41
10890049|NCT01952574|12056167|FG000|COMPLETED|Clinical Home Use Substudy||0
10890050|NCT01952574|12056168|FG001|COMPLETED|Clinical Home Use Substudy||0
10890051|NCT01952574|12056169|FG002|COMPLETED|Clinical Home Use Substudy||0
10890052|NCT01952574|12056170|FG003|COMPLETED|Clinical Home Use Substudy||0
10890053|NCT01952574|12056171|FG004|COMPLETED|Clinical Home Use Substudy||0
10890054|NCT01952574|12056172|FG005|COMPLETED|Clinical Home Use Substudy||39
10890055|NCT01952574|12056173|FG006|COMPLETED|Clinical Home Use Substudy||40
10890056|NCT01952574|12056167|FG000|NOT COMPLETED|Clinical Home Use Substudy||0
10890057|NCT01952574|12056168|FG001|NOT COMPLETED|Clinical Home Use Substudy||0
10890058|NCT01952574|12056169|FG002|NOT COMPLETED|Clinical Home Use Substudy||0
10890059|NCT01952574|12056170|FG003|NOT COMPLETED|Clinical Home Use Substudy||0
10890060|NCT01952574|12056171|FG004|NOT COMPLETED|Clinical Home Use Substudy||0
10890061|NCT01952574|12056172|FG005|NOT COMPLETED|Clinical Home Use Substudy||3
10890062|NCT01952574|12056173|FG006|NOT COMPLETED|Clinical Home Use Substudy||1
10890063|NCT01951417|12056198|FG000|STARTED|Overall Study||81
10890064|NCT01951417|12056198|FG000|COMPLETED|Overall Study||72
10890065|NCT01951417|12056198|FG000|NOT COMPLETED|Overall Study||9
10890066|NCT01949662|12056208|FG000|STARTED|Overall Study||47
10890067|NCT01949662|12056209|FG001|STARTED|Overall Study||43
10890068|NCT01949662|12056208|FG000|COMPLETED|Overall Study||29
10890069|NCT01949662|12056209|FG001|COMPLETED|Overall Study||29
10890070|NCT01949662|12056208|FG000|NOT COMPLETED|Overall Study||18
10890071|NCT01949662|12056209|FG001|NOT COMPLETED|Overall Study||14
10890072|NCT01949337|12056217|FG000|STARTED|Overall Study||657
10890073|NCT01949337|12056218|FG001|STARTED|Overall Study||654
10890074|NCT01949337|12056217|FG000|COMPLETED|Overall Study||657
10890075|NCT01949337|12056218|FG001|COMPLETED|Overall Study||654
10890076|NCT01949337|12056217|FG000|NOT COMPLETED|Overall Study||0
10890077|NCT01949337|12056218|FG001|NOT COMPLETED|Overall Study||0
10890078|NCT01946529|12056227|FG000|STARTED|End of Window Therapy (2 Courses)||1
10890079|NCT01946529|12056228|FG001|STARTED|End of Window Therapy (2 Courses)||17
10890080|NCT01946529|12056229|FG002|STARTED|End of Window Therapy (2 Courses)||6
10890081|NCT01946529|12056227|FG000|COMPLETED|End of Window Therapy (2 Courses)||1
10890082|NCT01946529|12056228|FG001|COMPLETED|End of Window Therapy (2 Courses)||16
10890083|NCT01946529|12056229|FG002|COMPLETED|End of Window Therapy (2 Courses)||6
10890084|NCT01946529|12056227|FG000|NOT COMPLETED|End of Window Therapy (2 Courses)||0
10890085|NCT01946529|12056228|FG001|NOT COMPLETED|End of Window Therapy (2 Courses)||1
10890086|NCT01946529|12056229|FG002|NOT COMPLETED|End of Window Therapy (2 Courses)||0
10890087|NCT01946529|12056227|FG000|STARTED|Completion of All Therapy||1
10890088|NCT01946529|12056228|FG001|STARTED|Completion of All Therapy||16
10890089|NCT01946529|12056229|FG002|STARTED|Completion of All Therapy||6
10890090|NCT01946529|12056227|FG000|COMPLETED|Completion of All Therapy||0
10890091|NCT01946529|12056228|FG001|COMPLETED|Completion of All Therapy||0
10890092|NCT01946529|12056229|FG002|COMPLETED|Completion of All Therapy||0
10890093|NCT01946529|12056227|FG000|NOT COMPLETED|Completion of All Therapy||1
10890094|NCT01946529|12056228|FG001|NOT COMPLETED|Completion of All Therapy||16
10890095|NCT01946529|12056229|FG002|NOT COMPLETED|Completion of All Therapy||6
10890096|NCT01946204|12056238|FG000|STARTED|Overall Study||401
10890097|NCT01946204|12056239|FG001|STARTED|Overall Study||806
10890098|NCT01946204|12056238|FG000|Treated|Overall Study||398
10890099|NCT01946204|12056239|FG001|Treated|Overall Study||803
10890100|NCT01946204|12056238|FG000|COMPLETED|Overall Study||0
10890101|NCT01946204|12056239|FG001|COMPLETED|Overall Study||0
10890102|NCT01946204|12056238|FG000|NOT COMPLETED|Overall Study||401
10890103|NCT01946204|12056239|FG001|NOT COMPLETED|Overall Study||806
10890104|NCT01942694|12056247|FG000|STARTED|Overall Study||1212
10890105|NCT01942694|12056248|FG001|STARTED|Overall Study||1211
10890106|NCT01942694|12056247|FG000|COMPLETED|Overall Study||1211
10890107|NCT01942694|12056248|FG001|COMPLETED|Overall Study||1211
10890108|NCT01942694|12056247|FG000|NOT COMPLETED|Overall Study||1
10890109|NCT01942694|12056248|FG001|NOT COMPLETED|Overall Study||0
10890110|NCT01942135|12056256|FG000|STARTED|Overall Study||347
10890111|NCT01942135|12056257|FG001|STARTED|Overall Study||174
10890112|NCT01942135|12056256|FG000|COMPLETED|Overall Study||0
10890113|NCT01942135|12056257|FG001|COMPLETED|Overall Study||0
10890114|NCT01942135|12056256|FG000|NOT COMPLETED|Overall Study||347
10890115|NCT01942135|12056257|FG001|NOT COMPLETED|Overall Study||174
10890116|NCT01940471|12056265|FG000|STARTED|Double-Blind Phase||582
10890117|NCT01940471|12056266|FG001|STARTED|Double-Blind Phase||293
10890118|NCT01940471|12056265|FG000|COMPLETED|Double-Blind Phase||14
10890119|NCT01940471|12056266|FG001|COMPLETED|Double-Blind Phase||8
10890120|NCT01940471|12056265|FG000|NOT COMPLETED|Double-Blind Phase||568
10890121|NCT01940471|12056266|FG001|NOT COMPLETED|Double-Blind Phase||285
10890122|NCT01940471|12056265|FG000|STARTED|Open-Label Extension||14
10890123|NCT01940471|12056266|FG001|STARTED|Open-Label Extension||8
10890124|NCT01940471|12056265|FG000|COMPLETED|Open-Label Extension||0
10890125|NCT01940471|12056266|FG001|COMPLETED|Open-Label Extension||0
10890126|NCT01940471|12056265|FG000|NOT COMPLETED|Open-Label Extension||14
10890127|NCT01940471|12056266|FG001|NOT COMPLETED|Open-Label Extension||8
10890128|NCT01935934|12056275|FG000|STARTED|Overall Study||70
10890129|NCT01935934|12056276|FG001|STARTED|Overall Study||32
10890130|NCT01935934|12056275|FG000|COMPLETED|Overall Study||70
10890131|NCT01935934|12056276|FG001|COMPLETED|Overall Study||32
10890132|NCT01935934|12056275|FG000|NOT COMPLETED|Overall Study||0
10890133|NCT01935934|12056276|FG001|NOT COMPLETED|Overall Study||0
10890134|NCT01933932|12056287|FG000|STARTED|Overall Study||254
10890135|NCT01933932|12056288|FG001|STARTED|Overall Study||256
10890136|NCT01933932|12056287|FG000|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
10890137|NCT01933932|12056288|FG001|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
10890138|NCT01933932|12056287|FG000|NOT COMPLETED|Overall Study||184
10890139|NCT01933932|12056288|FG001|NOT COMPLETED|Overall Study||178
10890140|NCT01930123|12056296|FG000|STARTED|Overall Study||81
10890141|NCT01930123|12056297|FG001|STARTED|Overall Study||37
10890142|NCT01930123|12056296|FG000|COMPLETED|Overall Study||58
10890143|NCT01930123|12056297|FG001|COMPLETED|Overall Study||29
10890144|NCT01930123|12056296|FG000|NOT COMPLETED|Overall Study||23
10890145|NCT01930123|12056297|FG001|NOT COMPLETED|Overall Study||8
10890146|NCT01924533|12056305|FG000|STARTED|Overall Study||263
10890147|NCT01924533|12056306|FG001|STARTED|Overall Study||262
10890148|NCT01924533|12056305|FG000|COMPLETED|Overall Study||74
10890149|NCT01924533|12056306|FG001|COMPLETED|Overall Study||57
10890150|NCT01924533|12056305|FG000|NOT COMPLETED|Overall Study||189
10890151|NCT01924533|12056306|FG001|NOT COMPLETED|Overall Study||205
10890152|NCT01920932|12056312|FG000|STARTED|Overall Study||77
10890153|NCT01920932|12056312|FG000|COMPLETED|Overall Study||75
10890154|NCT01920932|12056312|FG000|NOT COMPLETED|Overall Study||2
10890155|NCT01920061|12056353|FG000|STARTED|Overall Study||4
10890156|NCT01920061|12056354|FG001|STARTED|Overall Study||5
10890157|NCT01920061|12056355|FG002|STARTED|Overall Study||3
10890158|NCT01920061|12056356|FG003|STARTED|Overall Study||4
10890159|NCT01920061|12056357|FG004|STARTED|Overall Study||5
10890160|NCT01920061|12056358|FG005|STARTED|Overall Study||4
10890161|NCT01920061|12056359|FG006|STARTED|Overall Study||3
10890162|NCT01920061|12056360|FG007|STARTED|Overall Study||3
10890163|NCT01920061|12056361|FG008|STARTED|Overall Study||3
10890164|NCT01920061|12056362|FG009|STARTED|Overall Study||3
10890165|NCT01920061|12056363|FG010|STARTED|Overall Study||10
10890166|NCT01920061|12056364|FG011|STARTED|Overall Study||5
10890167|NCT01920061|12056365|FG012|STARTED|Overall Study||3
10890168|NCT01920061|12056366|FG013|STARTED|Overall Study||16
10890169|NCT01920061|12056367|FG014|STARTED|Overall Study||4
10890170|NCT01920061|12056368|FG015|STARTED|Overall Study||7
10890171|NCT01920061|12056369|FG016|STARTED|Overall Study||3
10890172|NCT01920061|12056370|FG017|STARTED|Overall Study||3
10890173|NCT01920061|12056371|FG018|STARTED|Overall Study||10
10890174|NCT01920061|12056372|FG019|STARTED|Overall Study||12
10890175|NCT01920061|12056353|FG000|Received Treatment|Overall Study||4
10890176|NCT01920061|12056354|FG001|Received Treatment|Overall Study||5
10890177|NCT01920061|12056355|FG002|Received Treatment|Overall Study||3
10890178|NCT01920061|12056356|FG003|Received Treatment|Overall Study||3
10890179|NCT01920061|12056357|FG004|Received Treatment|Overall Study||5
10890180|NCT01920061|12056358|FG005|Received Treatment|Overall Study||4
10890181|NCT01920061|12056359|FG006|Received Treatment|Overall Study||3
10890182|NCT01920061|12056360|FG007|Received Treatment|Overall Study||3
10890183|NCT01920061|12056361|FG008|Received Treatment|Overall Study||3
10890184|NCT01920061|12056362|FG009|Received Treatment|Overall Study||3
10890185|NCT01920061|12056363|FG010|Received Treatment|Overall Study||10
10890186|NCT01920061|12056364|FG011|Received Treatment|Overall Study||5
10890187|NCT01920061|12056365|FG012|Received Treatment|Overall Study||2
10890188|NCT01920061|12056366|FG013|Received Treatment|Overall Study||15
10890189|NCT01920061|12056367|FG014|Received Treatment|Overall Study||4
10890190|NCT01920061|12056368|FG015|Received Treatment|Overall Study||7
10890191|NCT01920061|12056369|FG016|Received Treatment|Overall Study||3
10890192|NCT01920061|12056370|FG017|Received Treatment|Overall Study||3
10890193|NCT01920061|12056371|FG018|Received Treatment|Overall Study||10
10890194|NCT01920061|12056372|FG019|Received Treatment|Overall Study||12
10890195|NCT01920061|12056353|FG000|COMPLETED|Overall Study||2
10890196|NCT01920061|12056354|FG001|COMPLETED|Overall Study||1
10890197|NCT01920061|12056355|FG002|COMPLETED|Overall Study||1
10890198|NCT01920061|12056356|FG003|COMPLETED|Overall Study||2
10890199|NCT01920061|12056357|FG004|COMPLETED|Overall Study||3
10890200|NCT01920061|12056358|FG005|COMPLETED|Overall Study||2
10890201|NCT01920061|12056359|FG006|COMPLETED|Overall Study||2
10890202|NCT01920061|12056360|FG007|COMPLETED|Overall Study||2
10890203|NCT01920061|12056361|FG008|COMPLETED|Overall Study||2
10890204|NCT01920061|12056362|FG009|COMPLETED|Overall Study||1
10890205|NCT01920061|12056363|FG010|COMPLETED|Overall Study||5
10890206|NCT01920061|12056364|FG011|COMPLETED|Overall Study||2
10890207|NCT01920061|12056365|FG012|COMPLETED|Overall Study||1
10890208|NCT01920061|12056366|FG013|COMPLETED|Overall Study||10
10890209|NCT01920061|12056367|FG014|COMPLETED|Overall Study||3
10890210|NCT01920061|12056368|FG015|COMPLETED|Overall Study||4
10890211|NCT01920061|12056369|FG016|COMPLETED|Overall Study||1
10890212|NCT01920061|12056370|FG017|COMPLETED|Overall Study||1
10890213|NCT01920061|12056371|FG018|COMPLETED|Overall Study||4
10890214|NCT01920061|12056372|FG019|COMPLETED|Overall Study||8
10890215|NCT01920061|12056353|FG000|NOT COMPLETED|Overall Study||2
10890216|NCT01920061|12056354|FG001|NOT COMPLETED|Overall Study||4
10890217|NCT01920061|12056355|FG002|NOT COMPLETED|Overall Study||2
10890218|NCT01920061|12056356|FG003|NOT COMPLETED|Overall Study||2
10890219|NCT01920061|12056357|FG004|NOT COMPLETED|Overall Study||2
10890220|NCT01920061|12056358|FG005|NOT COMPLETED|Overall Study||2
10890221|NCT01920061|12056359|FG006|NOT COMPLETED|Overall Study||1
10890222|NCT01920061|12056360|FG007|NOT COMPLETED|Overall Study||1
10890223|NCT01920061|12056361|FG008|NOT COMPLETED|Overall Study||1
10890224|NCT01920061|12056362|FG009|NOT COMPLETED|Overall Study||2
10890225|NCT01920061|12056363|FG010|NOT COMPLETED|Overall Study||5
10890226|NCT01920061|12056364|FG011|NOT COMPLETED|Overall Study||3
10890227|NCT01920061|12056365|FG012|NOT COMPLETED|Overall Study||2
10890228|NCT01920061|12056366|FG013|NOT COMPLETED|Overall Study||6
10890229|NCT01920061|12056367|FG014|NOT COMPLETED|Overall Study||1
10890230|NCT01920061|12056368|FG015|NOT COMPLETED|Overall Study||3
10890231|NCT01920061|12056369|FG016|NOT COMPLETED|Overall Study||2
10890232|NCT01920061|12056370|FG017|NOT COMPLETED|Overall Study||2
10890233|NCT01920061|12056371|FG018|NOT COMPLETED|Overall Study||6
10890234|NCT01920061|12056372|FG019|NOT COMPLETED|Overall Study||4
10890247|NCT01909713|12056446|FG000|STARTED|Overall Study||35
10890248|NCT01909713|12056446|FG000|COMPLETED|Overall Study||35
10890249|NCT01909713|12056446|FG000|NOT COMPLETED|Overall Study||0
10890250|NCT01909479|12056473|FG000|STARTED|From Baseline to Week 26||135
10890251|NCT01909479|12056474|FG001|STARTED|From Baseline to Week 26||67
10890252|NCT01909479|12056473|FG000|COMPLETED|From Baseline to Week 26||129
10890253|NCT01909479|12056474|FG001|COMPLETED|From Baseline to Week 26||58
10890254|NCT01909479|12056473|FG000|NOT COMPLETED|From Baseline to Week 26||6
10890255|NCT01909479|12056474|FG001|NOT COMPLETED|From Baseline to Week 26||9
10890256|NCT01909479|12056473|FG000|STARTED|26 - 52 Weeks||128
10890257|NCT01909479|12056474|FG001|STARTED|26 - 52 Weeks||58
10890258|NCT01909479|12056473|FG000|COMPLETED|26 - 52 Weeks||125
10890259|NCT01909479|12056474|FG001|COMPLETED|26 - 52 Weeks||56
10890260|NCT01909479|12056473|FG000|NOT COMPLETED|26 - 52 Weeks||3
10890261|NCT01909479|12056474|FG001|NOT COMPLETED|26 - 52 Weeks||2
10890262|NCT01909479|12056473|FG000|STARTED|52 Weeks to End of Study|Not all of the participants that completed the previous period continued on in the study|111
10890263|NCT01909479|12056474|FG001|STARTED|52 Weeks to End of Study|Not all of the participants that completed the previous period continued on in the study|50
10890264|NCT01909479|12056473|FG000|COMPLETED|52 Weeks to End of Study||83
10890265|NCT01909479|12056474|FG001|COMPLETED|52 Weeks to End of Study||35
10890266|NCT01909479|12056473|FG000|NOT COMPLETED|52 Weeks to End of Study||28
10890267|NCT01909479|12056474|FG001|NOT COMPLETED|52 Weeks to End of Study||15
10890268|NCT01909453|12056489|FG000|STARTED|Overall Study||192
10890269|NCT01909453|12056490|FG001|STARTED|Overall Study||194
10890270|NCT01909453|12056491|FG002|STARTED|Overall Study||191
10890271|NCT01909453|12056492|FG003|STARTED|Overall Study||258
10890272|NCT01909453|12056493|FG004|STARTED|Overall Study||86
10890273|NCT01909453|12056489|FG000|COMPLETED|Overall Study||0
10890274|NCT01909453|12056490|FG001|COMPLETED|Overall Study||0
10890275|NCT01909453|12056491|FG002|COMPLETED|Overall Study||0
10890276|NCT01909453|12056492|FG003|COMPLETED|Overall Study||0
10890277|NCT01909453|12056493|FG004|COMPLETED|Overall Study||0
10890278|NCT01909453|12056489|FG000|NOT COMPLETED|Overall Study||192
10890279|NCT01909453|12056490|FG001|NOT COMPLETED|Overall Study||194
10890280|NCT01909453|12056491|FG002|NOT COMPLETED|Overall Study||191
10890281|NCT01909453|12056492|FG003|NOT COMPLETED|Overall Study||258
10890282|NCT01909453|12056493|FG004|NOT COMPLETED|Overall Study||86
10890283|NCT01907191|12056513|FG000|STARTED|Overall Study||13
10890284|NCT01907191|12056514|FG001|STARTED|Overall Study||10
10890285|NCT01907191|12056513|FG000|COMPLETED|Overall Study||13
10890286|NCT01907191|12056514|FG001|COMPLETED|Overall Study||10
10890287|NCT01907191|12056513|FG000|NOT COMPLETED|Overall Study||0
10890288|NCT01907191|12056514|FG001|NOT COMPLETED|Overall Study||0
10890289|NCT01902290|12056524|FG000|STARTED|Overall Study||210
10890290|NCT01902290|12056525|FG001|STARTED|Overall Study||211
10890291|NCT01902290|12056524|FG000|Received Study Drug|Overall Study||207
10890292|NCT01902290|12056525|FG001|Received Study Drug|Overall Study||208
10890293|NCT01902290|12056524|FG000|COMPLETED|Overall Study||162
10890294|NCT01902290|12056525|FG001|COMPLETED|Overall Study||158
10890295|NCT01902290|12056524|FG000|NOT COMPLETED|Overall Study||48
10890296|NCT01902290|12056525|FG001|NOT COMPLETED|Overall Study||53
10890297|NCT01902173|12056538|FG000|STARTED|Phase 1 Doublet Regimen Cohort 1||3
10890298|NCT01902173|12056539|FG001|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10890299|NCT01902173|12056540|FG002|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10890300|NCT01902173|12056541|FG003|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10890301|NCT01902173|12056542|FG004|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10890302|NCT01902173|12056543|FG005|STARTED|Phase 1 Doublet Regimen Cohort 1||0
10890303|NCT01902173|12056538|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890304|NCT01902173|12056539|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890305|NCT01902173|12056540|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890306|NCT01902173|12056541|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890307|NCT01902173|12056542|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890308|NCT01902173|12056543|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890309|NCT01902173|12056538|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||3
10890310|NCT01902173|12056539|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890311|NCT01902173|12056540|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890312|NCT01902173|12056541|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890313|NCT01902173|12056542|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890314|NCT01902173|12056543|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
10890315|NCT01902173|12056538|FG000|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10890316|NCT01902173|12056539|FG001|STARTED|Phase 1 Doublet Regimen Cohort 2||9
10890317|NCT01902173|12056540|FG002|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10890318|NCT01902173|12056541|FG003|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10890319|NCT01902173|12056542|FG004|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10890320|NCT01902173|12056543|FG005|STARTED|Phase 1 Doublet Regimen Cohort 2||0
10890321|NCT01902173|12056538|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890322|NCT01902173|12056539|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890323|NCT01902173|12056540|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890324|NCT01902173|12056541|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890325|NCT01902173|12056542|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890326|NCT01902173|12056543|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890327|NCT01902173|12056538|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890328|NCT01902173|12056539|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||9
10890329|NCT01902173|12056540|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890330|NCT01902173|12056541|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890331|NCT01902173|12056542|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890332|NCT01902173|12056543|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
10890333|NCT01902173|12056538|FG000|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10890334|NCT01902173|12056539|FG001|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10890335|NCT01902173|12056540|FG002|STARTED|Phase 1 Triplet Regimen Cohort 1||4
10890336|NCT01902173|12056541|FG003|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10890337|NCT01902173|12056542|FG004|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10890338|NCT01902173|12056543|FG005|STARTED|Phase 1 Triplet Regimen Cohort 1||0
10890339|NCT01902173|12056538|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890340|NCT01902173|12056539|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890341|NCT01902173|12056540|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890342|NCT01902173|12056541|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890343|NCT01902173|12056542|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890344|NCT01902173|12056543|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890345|NCT01902173|12056538|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890346|NCT01902173|12056539|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890347|NCT01902173|12056540|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||4
10890348|NCT01902173|12056541|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890349|NCT01902173|12056542|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890350|NCT01902173|12056543|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
10890351|NCT01902173|12056538|FG000|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10890352|NCT01902173|12056539|FG001|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10890353|NCT01902173|12056540|FG002|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10890354|NCT01902173|12056541|FG003|STARTED|Phase 1 Triplet Regimen Cohort 2||3
10890355|NCT01902173|12056542|FG004|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10890356|NCT01902173|12056543|FG005|STARTED|Phase 1 Triplet Regimen Cohort 2||0
10890357|NCT01902173|12056538|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890358|NCT01902173|12056539|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890359|NCT01902173|12056540|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890360|NCT01902173|12056541|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890361|NCT01902173|12056542|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890362|NCT01902173|12056543|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890363|NCT01902173|12056538|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890364|NCT01902173|12056539|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890365|NCT01902173|12056540|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890366|NCT01902173|12056541|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||3
10890367|NCT01902173|12056542|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890368|NCT01902173|12056543|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
10890369|NCT01902173|12056538|FG000|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10890370|NCT01902173|12056539|FG001|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10890371|NCT01902173|12056540|FG002|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10890372|NCT01902173|12056541|FG003|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10890373|NCT01902173|12056542|FG004|STARTED|Phase 1 Triplet Regimen Cohort 3||3
10890374|NCT01902173|12056543|FG005|STARTED|Phase 1 Triplet Regimen Cohort 3||0
10890375|NCT01902173|12056538|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890376|NCT01902173|12056539|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890377|NCT01902173|12056540|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890378|NCT01902173|12056541|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890379|NCT01902173|12056542|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890380|NCT01902173|12056543|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890381|NCT01902173|12056538|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890382|NCT01902173|12056539|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890383|NCT01902173|12056540|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890384|NCT01902173|12056541|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890385|NCT01902173|12056542|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||3
10890386|NCT01902173|12056543|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
10890387|NCT01902173|12056538|FG000|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10890388|NCT01902173|12056539|FG001|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10890389|NCT01902173|12056540|FG002|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10890390|NCT01902173|12056541|FG003|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10890391|NCT01902173|12056542|FG004|STARTED|Phase 1 Triplet Regimen Cohort 4||0
10890392|NCT01902173|12056543|FG005|STARTED|Phase 1 Triplet Regimen Cohort 4||5
10890393|NCT01902173|12056538|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890394|NCT01902173|12056539|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890395|NCT01902173|12056540|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890396|NCT01902173|12056541|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890397|NCT01902173|12056542|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890398|NCT01902173|12056543|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890399|NCT01902173|12056538|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890400|NCT01902173|12056539|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890401|NCT01902173|12056540|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890402|NCT01902173|12056541|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890403|NCT01902173|12056542|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
10890404|NCT01902173|12056543|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||5
10890405|NCT01902173|12056538|FG000|STARTED|Phase II||0
10890406|NCT01902173|12056539|FG001|STARTED|Phase II||0
10890407|NCT01902173|12056540|FG002|STARTED|Phase II||0
10890408|NCT01902173|12056541|FG003|STARTED|Phase II||0
10890409|NCT01902173|12056542|FG004|STARTED|Phase II||0
10890410|NCT01902173|12056543|FG005|STARTED|Phase II||0
10890411|NCT01902173|12056538|FG000|COMPLETED|Phase II||0
10890412|NCT01902173|12056539|FG001|COMPLETED|Phase II||0
10890413|NCT01902173|12056540|FG002|COMPLETED|Phase II||0
10890414|NCT01902173|12056541|FG003|COMPLETED|Phase II||0
10890415|NCT01902173|12056542|FG004|COMPLETED|Phase II||0
10890416|NCT01902173|12056543|FG005|COMPLETED|Phase II||0
10890417|NCT01902173|12056538|FG000|NOT COMPLETED|Phase II||0
10890418|NCT01902173|12056539|FG001|NOT COMPLETED|Phase II||0
10890419|NCT01902173|12056540|FG002|NOT COMPLETED|Phase II||0
10890420|NCT01902173|12056541|FG003|NOT COMPLETED|Phase II||0
10890421|NCT01902173|12056542|FG004|NOT COMPLETED|Phase II||0
10890422|NCT01902173|12056543|FG005|NOT COMPLETED|Phase II||0
10890423|NCT01900691|12056560|FG000|STARTED|Overall Study||130
10890424|NCT01900691|12056560|FG000|COMPLETED|Overall Study||111
10890425|NCT01900691|12056560|FG000|NOT COMPLETED|Overall Study||19
10890426|NCT01898494|12056569|FG000|STARTED|Step 1 (Arm S - Transoral Surgery)||49
10890427|NCT01898494|12056570|FG001|STARTED|Step 1 (Arm S - Transoral Surgery)||126
10890428|NCT01898494|12056571|FG002|STARTED|Step 1 (Arm S - Transoral Surgery)||132
10890429|NCT01898494|12056572|FG003|STARTED|Step 1 (Arm S - Transoral Surgery)||138
10890430|NCT01898494|12056573|FG004|STARTED|Step 1 (Arm S - Transoral Surgery)||74
10890431|NCT01898494|12056569|FG000|COMPLETED|Step 1 (Arm S - Transoral Surgery)||49
10890432|NCT01898494|12056570|FG001|COMPLETED|Step 1 (Arm S - Transoral Surgery)||126
10890433|NCT01898494|12056571|FG002|COMPLETED|Step 1 (Arm S - Transoral Surgery)||132
10890434|NCT01898494|12056572|FG003|COMPLETED|Step 1 (Arm S - Transoral Surgery)||138
10890435|NCT01898494|12056573|FG004|COMPLETED|Step 1 (Arm S - Transoral Surgery)||50
10890436|NCT01898494|12056569|FG000|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0
10890437|NCT01898494|12056570|FG001|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0
10890438|NCT01898494|12056571|FG002|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0
10890439|NCT01898494|12056572|FG003|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||0
10890440|NCT01898494|12056573|FG004|NOT COMPLETED|Step 1 (Arm S - Transoral Surgery)||24
10890441|NCT01898494|12056569|FG000|STARTED|Step 2 (Adjuvant Treatment)||49
10890442|NCT01898494|12056570|FG001|STARTED|Step 2 (Adjuvant Treatment)||126
10890443|NCT01898494|12056571|FG002|STARTED|Step 2 (Adjuvant Treatment)||132
10890444|NCT01898494|12056572|FG003|STARTED|Step 2 (Adjuvant Treatment)||138
10890445|NCT01898494|12056573|FG004|STARTED|Step 2 (Adjuvant Treatment)|This group of patients did not proceed to adjuvant treatment on this study. They either received surgery but did not proceed to adjuvant treatment or did not receive surgery in Step 1.|0
10890446|NCT01898494|12056569|FG000|Treated|Step 2 (Adjuvant Treatment)||49
10890447|NCT01898494|12056570|FG001|Treated|Step 2 (Adjuvant Treatment)||120
10890448|NCT01898494|12056571|FG002|Treated|Step 2 (Adjuvant Treatment)||127
10890449|NCT01898494|12056572|FG003|Treated|Step 2 (Adjuvant Treatment)||134
10890450|NCT01898494|12056573|FG004|Treated|Step 2 (Adjuvant Treatment)||0
10890451|NCT01898494|12056569|FG000|Eligible and Treated|Step 2 (Adjuvant Treatment)||38
10890452|NCT01898494|12056570|FG001|Eligible and Treated|Step 2 (Adjuvant Treatment)||100
10890453|NCT01898494|12056571|FG002|Eligible and Treated|Step 2 (Adjuvant Treatment)||108
10890454|NCT01898494|12056572|FG003|Eligible and Treated|Step 2 (Adjuvant Treatment)||113
10890455|NCT01898494|12056573|FG004|Eligible and Treated|Step 2 (Adjuvant Treatment)||0
10890456|NCT01898494|12056569|FG000|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||35
10890457|NCT01898494|12056570|FG001|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||91
10890458|NCT01898494|12056571|FG002|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||99
10890459|NCT01898494|12056572|FG003|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||102
10890460|NCT01898494|12056573|FG004|Eligible and Treated Patients With Baseline MDADI Assessed|Step 2 (Adjuvant Treatment)||0
10890461|NCT01898494|12056569|FG000|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||31
10890462|NCT01898494|12056570|FG001|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||83
10890463|NCT01898494|12056571|FG002|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||88
10890464|NCT01898494|12056572|FG003|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||94
10890465|NCT01898494|12056573|FG004|Eligible and Treated Patients With Post-surgery MDADI Assessed|Step 2 (Adjuvant Treatment)||0
10890466|NCT01898494|12056569|FG000|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||21
10890467|NCT01898494|12056570|FG001|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||75
10890468|NCT01898494|12056571|FG002|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||80
10890469|NCT01898494|12056572|FG003|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||77
10890470|NCT01898494|12056573|FG004|Eligible and Treated Patients With FACT-H&N Assessed at 6 Months|Step 2 (Adjuvant Treatment)||0
10890471|NCT01898494|12056569|FG000|COMPLETED|Step 2 (Adjuvant Treatment)||49
10890472|NCT01898494|12056570|FG001|COMPLETED|Step 2 (Adjuvant Treatment)||119
10890473|NCT01898494|12056571|FG002|COMPLETED|Step 2 (Adjuvant Treatment)||118
10890474|NCT01898494|12056572|FG003|COMPLETED|Step 2 (Adjuvant Treatment)||127
10890475|NCT01898494|12056573|FG004|COMPLETED|Step 2 (Adjuvant Treatment)||0
10890476|NCT01898494|12056569|FG000|NOT COMPLETED|Step 2 (Adjuvant Treatment)||0
10890477|NCT01898494|12056570|FG001|NOT COMPLETED|Step 2 (Adjuvant Treatment)||7
10890478|NCT01898494|12056571|FG002|NOT COMPLETED|Step 2 (Adjuvant Treatment)||14
10890479|NCT01898494|12056572|FG003|NOT COMPLETED|Step 2 (Adjuvant Treatment)||11
10890480|NCT01898494|12056573|FG004|NOT COMPLETED|Step 2 (Adjuvant Treatment)||0
10890481|NCT01893567|12056585|FG000|STARTED|Overall Study||28
10890482|NCT01893567|12056585|FG000|COMPLETED|Overall Study||28
10890483|NCT01893567|12056585|FG000|NOT COMPLETED|Overall Study||0
10890484|NCT01892722|12056591|FG000|STARTED|Overall Study||107
10890485|NCT01892722|12056592|FG001|STARTED|Overall Study||108
10890486|NCT01892722|12056591|FG000|Full Analysis Set|Overall Study||107
10890487|NCT01892722|12056592|FG001|Full Analysis Set|Overall Study||107
10890488|NCT01892722|12056591|FG000|COMPLETED|Overall Study||100
10890489|NCT01892722|12056592|FG001|COMPLETED|Overall Study||88
10890490|NCT01892722|12056591|FG000|NOT COMPLETED|Overall Study||7
10890491|NCT01892722|12056592|FG001|NOT COMPLETED|Overall Study||20
10890492|NCT01892657|12056598|FG000|STARTED|Overall Study||128
10890493|NCT01892657|12056598|FG000|COMPLETED|Overall Study||110
10890494|NCT01892657|12056598|FG000|NOT COMPLETED|Overall Study||18
10890495|NCT01890954|12056616|FG000|STARTED|Overall Study||9
10890496|NCT01890954|12056617|FG001|STARTED|Overall Study||8
10890497|NCT01890954|12056616|FG000|COMPLETED|Overall Study||8
10890498|NCT01890954|12056617|FG001|COMPLETED|Overall Study||8
10890499|NCT01890954|12056616|FG000|NOT COMPLETED|Overall Study||1
10890500|NCT01890954|12056617|FG001|NOT COMPLETED|Overall Study||0
10890501|NCT01886872|12056626|FG000|STARTED|Overall Study||183
10890502|NCT01886872|12056627|FG001|STARTED|Overall Study||182
10890503|NCT01886872|12056628|FG002|STARTED|Overall Study||182
10890504|NCT01886872|12056626|FG000|Evaluable for Secondary Endpoints|Overall Study||183
10890505|NCT01886872|12056627|FG001|Evaluable for Secondary Endpoints|Overall Study||182
10890506|NCT01886872|12056628|FG002|Evaluable for Secondary Endpoints|Overall Study||182
10890507|NCT01886872|12056626|FG000|Evaluable for Adverse Events|Overall Study||176
10890508|NCT01886872|12056627|FG001|Evaluable for Adverse Events|Overall Study||180
10890509|NCT01886872|12056628|FG002|Evaluable for Adverse Events|Overall Study||181
10890510|NCT01886872|12056626|FG000|Crossover Cohort|Overall Study||30
10890511|NCT01886872|12056627|FG001|Crossover Cohort|Overall Study||0
10890512|NCT01886872|12056628|FG002|Crossover Cohort|Overall Study||0
10890513|NCT01886872|12056626|FG000|COMPLETED|Overall Study||176
10890514|NCT01886872|12056627|FG001|COMPLETED|Overall Study||178
10890515|NCT01886872|12056628|FG002|COMPLETED|Overall Study||170
10890516|NCT01886872|12056626|FG000|NOT COMPLETED|Overall Study||7
10890517|NCT01886872|12056627|FG001|NOT COMPLETED|Overall Study||4
10890518|NCT01886872|12056628|FG002|NOT COMPLETED|Overall Study||12
10890519|NCT01884740|12056637|FG000|STARTED|Overall Study||13
10890520|NCT01884740|12056637|FG000|COMPLETED|Overall Study||13
10890521|NCT01884740|12056637|FG000|NOT COMPLETED|Overall Study||0
10890522|NCT01879085|12056644|FG000|STARTED|Phase 1b||6
10890523|NCT01879085|12056645|FG001|STARTED|Phase 1b||6
10890524|NCT01879085|12056646|FG002|STARTED|Phase 1b||0
10890525|NCT01879085|12056644|FG000|COMPLETED|Phase 1b||6
10890526|NCT01879085|12056645|FG001|COMPLETED|Phase 1b||6
10890527|NCT01879085|12056646|FG002|COMPLETED|Phase 1b||0
10890528|NCT01879085|12056644|FG000|NOT COMPLETED|Phase 1b||0
10890529|NCT01879085|12056645|FG001|NOT COMPLETED|Phase 1b||0
10890530|NCT01879085|12056646|FG002|NOT COMPLETED|Phase 1b||0
10890531|NCT01879085|12056644|FG000|STARTED|Phase 2||6
10890532|NCT01879085|12056645|FG001|STARTED|Phase 2||0
10890533|NCT01879085|12056646|FG002|STARTED|Phase 2||25
10890534|NCT01879085|12056644|FG000|COMPLETED|Phase 2||6
10890535|NCT01879085|12056645|FG001|COMPLETED|Phase 2||0
10890536|NCT01879085|12056646|FG002|COMPLETED|Phase 2||25
10890537|NCT01879085|12056644|FG000|NOT COMPLETED|Phase 2||0
10890538|NCT01879085|12056645|FG001|NOT COMPLETED|Phase 2||0
10890539|NCT01879085|12056646|FG002|NOT COMPLETED|Phase 2||0
10890540|NCT01872715|12056653|FG000|STARTED|Overall Study||24
10890541|NCT01872715|12056653|FG000|COMPLETED|Overall Study||20
10890542|NCT01872715|12056653|FG000|NOT COMPLETED|Overall Study||4
10890543|NCT01867580|12056669|FG000|STARTED|Overall Study||93
10890544|NCT01867580|12056670|FG001|STARTED|Overall Study||88
10890545|NCT01867580|12056669|FG000|COMPLETED|Overall Study||65
10890546|NCT01867580|12056670|FG001|COMPLETED|Overall Study||64
10890547|NCT01867580|12056669|FG000|NOT COMPLETED|Overall Study||28
10890548|NCT01867580|12056670|FG001|NOT COMPLETED|Overall Study||24
10890549|NCT01865812|12056676|FG000|STARTED|Primary Treatment Phase||27
10890550|NCT01865812|12056677|FG001|STARTED|Primary Treatment Phase||0
10890551|NCT01865812|12056676|FG000|Received at Least 1 Dose of Study Drug|Primary Treatment Phase||27
10890552|NCT01865812|12056677|FG001|Received at Least 1 Dose of Study Drug|Primary Treatment Phase||0
10890553|NCT01865812|12056676|FG000|COMPLETED|Primary Treatment Phase||25
10890554|NCT01865812|12056677|FG001|COMPLETED|Primary Treatment Phase||0
10890555|NCT01865812|12056676|FG000|NOT COMPLETED|Primary Treatment Phase||2
10890556|NCT01865812|12056677|FG001|NOT COMPLETED|Primary Treatment Phase||0
10890557|NCT01865812|12056676|FG000|STARTED|Long-term Safety Extension Phase|Only eligible participants who completed the PTP phase enrolled in the LTSE phase.|0
10890558|NCT01865812|12056677|FG001|STARTED|Long-term Safety Extension Phase|Only eligible participants who completed the PTP phase enrolled in the LTSE phase.|21
10890559|NCT01865812|12056676|FG000|Received at Least 1 Dose of Study Drug|Long-term Safety Extension Phase||0
10890560|NCT01865812|12056677|FG001|Received at Least 1 Dose of Study Drug|Long-term Safety Extension Phase||21
10890561|NCT01865812|12056676|FG000|COMPLETED|Long-term Safety Extension Phase||0
10890562|NCT01865812|12056677|FG001|COMPLETED|Long-term Safety Extension Phase||15
10890563|NCT01865812|12056676|FG000|NOT COMPLETED|Long-term Safety Extension Phase||0
10890564|NCT01865812|12056677|FG001|NOT COMPLETED|Long-term Safety Extension Phase||6
10890565|NCT01864018|12056686|FG000|STARTED|Overall Study||51
10890566|NCT01864018|12056687|FG001|STARTED|Overall Study||36
10890567|NCT01864018|12056686|FG000|Accrued During Phase I|Overall Study||10
10890568|NCT01864018|12056687|FG001|Accrued During Phase I|Overall Study||0
10890569|NCT01864018|12056686|FG000|Accrued During Phase II|Overall Study||41
10890570|NCT01864018|12056687|FG001|Accrued During Phase II|Overall Study||36
10890571|NCT01864018|12056686|FG000|COMPLETED|Overall Study||48
10890572|NCT01864018|12056687|FG001|COMPLETED|Overall Study||35
10890573|NCT01864018|12056686|FG000|NOT COMPLETED|Overall Study||3
10890574|NCT01864018|12056687|FG001|NOT COMPLETED|Overall Study||1
10890575|NCT01856192|12056700|FG000|STARTED|Overall Study||173
10890576|NCT01856192|12056701|FG001|STARTED|Overall Study||176
10890577|NCT01856192|12056700|FG000|Treated Patients|Overall Study||166
10890578|NCT01856192|12056701|FG001|Treated Patients|Overall Study||171
10890579|NCT01856192|12056700|FG000|Evaluable Patients (Eligible and Treated)|Overall Study||145
10890580|NCT01856192|12056701|FG001|Evaluable Patients (Eligible and Treated)|Overall Study||135
10890581|NCT01856192|12056700|FG000|COMPLETED|Overall Study||124
10890582|NCT01856192|12056701|FG001|COMPLETED|Overall Study||116
10890583|NCT01856192|12056700|FG000|NOT COMPLETED|Overall Study||49
10890584|NCT01856192|12056701|FG001|NOT COMPLETED|Overall Study||60
10890585|NCT01853163|12056711|FG000|STARTED|Overall Study||45
10890586|NCT01853163|12056712|FG001|STARTED|Overall Study||29
10890587|NCT01853163|12056713|FG002|STARTED|Overall Study||7
10890588|NCT01853163|12056714|FG003|STARTED|Overall Study||11
10890589|NCT01853163|12056711|FG000|COMPLETED|Overall Study||45
10890590|NCT01853163|12056712|FG001|COMPLETED|Overall Study||29
10890591|NCT01853163|12056713|FG002|COMPLETED|Overall Study||7
10890592|NCT01853163|12056714|FG003|COMPLETED|Overall Study||11
10890593|NCT01853163|12056711|FG000|NOT COMPLETED|Overall Study||0
10890594|NCT01853163|12056712|FG001|NOT COMPLETED|Overall Study||0
10890595|NCT01853163|12056713|FG002|NOT COMPLETED|Overall Study||0
10890596|NCT01853163|12056714|FG003|NOT COMPLETED|Overall Study||0
10890597|NCT01852071|12056728|FG000|STARTED|Overall Study||20
10890598|NCT01852071|12056729|FG001|STARTED|Overall Study||26
10890599|NCT01852071|12056728|FG000|COMPLETED|Overall Study||20
10890600|NCT01852071|12056729|FG001|COMPLETED|Overall Study||26
10890601|NCT01852071|12056728|FG000|NOT COMPLETED|Overall Study||0
10890602|NCT01852071|12056729|FG001|NOT COMPLETED|Overall Study||0
10890603|NCT01850524|12056743|FG000|STARTED|Overall Study||354
10890604|NCT01850524|12056744|FG001|STARTED|Overall Study||351
10890605|NCT01850524|12056743|FG000|Intent-to-Treat (ITT) Population|Overall Study||354
10890606|NCT01850524|12056744|FG001|Intent-to-Treat (ITT) Population|Overall Study||351
10890607|NCT01850524|12056743|FG000|Safety Population|Overall Study|1 participant in this arm who withdrew from the study was not included in the safety population.|349
10890608|NCT01850524|12056744|FG001|Safety Population|Overall Study|Included 4 participants from placebo who received ixazomib; 1 participant who withdrew was excluded.|354
10890609|NCT01850524|12056743|FG000|Participants Completed Study Treatment Per Protocol|Overall Study||270
10890610|NCT01850524|12056744|FG001|Participants Completed Study Treatment Per Protocol|Overall Study||264
10890611|NCT01850524|12056743|FG000|Per Protocol (PP) Population|Overall Study||295
10890612|NCT01850524|12056744|FG001|Per Protocol (PP) Population|Overall Study||298
10890613|NCT01850524|12056743|FG000|Participants With Exposure of ≥ 19 Cycles|Overall Study||189
10890614|NCT01850524|12056744|FG001|Participants With Exposure of ≥ 19 Cycles|Overall Study||191
10890615|NCT01850524|12056743|FG000|COMPLETED|Overall Study||0
10890616|NCT01850524|12056744|FG001|COMPLETED|Overall Study||0
10890617|NCT01850524|12056743|FG000|NOT COMPLETED|Overall Study||354
10890618|NCT01850524|12056744|FG001|NOT COMPLETED|Overall Study||351
10890619|NCT01849575|12056754|FG000|STARTED|Overall Study||1749
10890620|NCT01849575|12056755|FG001|STARTED|Overall Study||1783
10890621|NCT01849575|12056754|FG000|COMPLETED|Overall Study||1599
10890622|NCT01849575|12056755|FG001|COMPLETED|Overall Study||1576
10890623|NCT01849575|12056754|FG000|NOT COMPLETED|Overall Study||150
10890624|NCT01849575|12056755|FG001|NOT COMPLETED|Overall Study||207
10890625|NCT01849263|12056763|FG000|STARTED|Overall Study||40
10890626|NCT01849263|12056763|FG000|COMPLETED|Overall Study||40
10890627|NCT01849263|12056763|FG000|NOT COMPLETED|Overall Study||0
10890628|NCT01844986|12056769|FG000|STARTED|Overall Study||260
10890629|NCT01844986|12056770|FG001|STARTED|Overall Study||131
10890630|NCT01844986|12056769|FG000|COMPLETED|Overall Study||183
10890631|NCT01844986|12056770|FG001|COMPLETED|Overall Study||91
10890632|NCT01844986|12056769|FG000|NOT COMPLETED|Overall Study||77
10890633|NCT01844986|12056770|FG001|NOT COMPLETED|Overall Study||40
10890634|NCT01844518|12056778|FG000|STARTED|Overall Study||173
10890635|NCT01844518|12056779|FG001|STARTED|Overall Study||46
10890636|NCT01844518|12056778|FG000|COMPLETED|Overall Study||132
10890637|NCT01844518|12056779|FG001|COMPLETED|Overall Study||39
10890638|NCT01844518|12056778|FG000|NOT COMPLETED|Overall Study||41
10890639|NCT01844518|12056779|FG001|NOT COMPLETED|Overall Study||7
10890640|NCT01843374|12056790|FG000|STARTED|Overall Study||189
10890641|NCT01843374|12056791|FG001|STARTED|Overall Study||382
10890642|NCT01843374|12056790|FG000|RANDOMIZED|Overall Study||189
10890643|NCT01843374|12056791|FG001|RANDOMIZED|Overall Study||382
10890644|NCT01843374|12056790|FG000|COMPLETED|Overall Study||0
10890645|NCT01843374|12056791|FG001|COMPLETED|Overall Study||3
10890646|NCT01843374|12056790|FG000|NOT COMPLETED|Overall Study||189
10890647|NCT01843374|12056791|FG001|NOT COMPLETED|Overall Study||379
10890648|NCT01841736|12056802|FG000|STARTED|Overall Study||97
10890649|NCT01841736|12056803|FG001|STARTED|Overall Study||74
10890650|NCT01841736|12056802|FG000|Crossover|Overall Study||0
10890651|NCT01841736|12056803|FG001|Crossover|Overall Study||49
10890652|NCT01841736|12056802|FG000|COMPLETED|Overall Study||97
10890653|NCT01841736|12056803|FG001|COMPLETED|Overall Study||74
10890654|NCT01841736|12056802|FG000|NOT COMPLETED|Overall Study||0
10890655|NCT01841736|12056803|FG001|NOT COMPLETED|Overall Study||0
10890656|NCT01839396|12056812|FG000|STARTED|Overall Study||121
10890657|NCT01839396|12056813|FG001|STARTED|Overall Study||39
10890658|NCT01839396|12056812|FG000|COMPLETED|Overall Study||121
10890659|NCT01839396|12056813|FG001|COMPLETED|Overall Study||39
10890660|NCT01839396|12056812|FG000|NOT COMPLETED|Overall Study||0
10890661|NCT01839396|12056813|FG001|NOT COMPLETED|Overall Study||0
10890662|NCT01836445|12056821|FG000|STARTED|Intervention Modules||445
10890663|NCT01836445|12056822|FG001|STARTED|Intervention Modules||456
10890664|NCT01836445|12056821|FG000|COMPLETED|Intervention Modules||375
10890665|NCT01836445|12056822|FG001|COMPLETED|Intervention Modules||434
10890666|NCT01836445|12056821|FG000|NOT COMPLETED|Intervention Modules||70
10890667|NCT01836445|12056822|FG001|NOT COMPLETED|Intervention Modules||22
10890668|NCT01836445|12056821|FG000|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
10890669|NCT01836445|12056822|FG001|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
10890670|NCT01836445|12056821|FG000|COMPLETED|3 Month Follow-up Assessment||348
10890671|NCT01836445|12056822|FG001|COMPLETED|3 Month Follow-up Assessment||409
10890672|NCT01836445|12056821|FG000|NOT COMPLETED|3 Month Follow-up Assessment||97
10890673|NCT01836445|12056822|FG001|NOT COMPLETED|3 Month Follow-up Assessment||47
10890674|NCT01836445|12056821|FG000|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
10890675|NCT01836445|12056822|FG001|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
10890676|NCT01836445|12056821|FG000|COMPLETED|6 Month Follow-up Assessment||342
10890677|NCT01836445|12056822|FG001|COMPLETED|6 Month Follow-up Assessment||380
10890678|NCT01836445|12056821|FG000|NOT COMPLETED|6 Month Follow-up Assessment||103
10890679|NCT01836445|12056822|FG001|NOT COMPLETED|6 Month Follow-up Assessment||75
10890680|NCT01836445|12056821|FG000|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
10890681|NCT01836445|12056822|FG001|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
10890682|NCT01836445|12056821|FG000|COMPLETED|12 Month Follow-up Assessment||370
10890683|NCT01836445|12056822|FG001|COMPLETED|12 Month Follow-up Assessment||391
10890684|NCT01836445|12056821|FG000|NOT COMPLETED|12 Month Follow-up Assessment||75
10890685|NCT01836445|12056822|FG001|NOT COMPLETED|12 Month Follow-up Assessment||64
10890686|NCT01836445|12056821|FG000|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
10890687|NCT01836445|12056822|FG001|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
10890688|NCT01836445|12056821|FG000|COMPLETED|12 Month STI Testing||365
10890689|NCT01836445|12056822|FG001|COMPLETED|12 Month STI Testing||378
10890690|NCT01836445|12056821|FG000|NOT COMPLETED|12 Month STI Testing||80
10890691|NCT01836445|12056822|FG001|NOT COMPLETED|12 Month STI Testing||77
10890692|NCT01835145|12056830|FG000|STARTED|Overall Study||32
10890693|NCT01835145|12056831|FG001|STARTED|Overall Study||15
10890694|NCT01835145|12056830|FG000|COMPLETED|Overall Study||31
10890695|NCT01835145|12056831|FG001|COMPLETED|Overall Study||15
10890696|NCT01835145|12056830|FG000|NOT COMPLETED|Overall Study||1
10890697|NCT01835145|12056831|FG001|NOT COMPLETED|Overall Study||0
10890698|NCT01831596|12056839|FG000|STARTED|Overall Study||59
10890699|NCT01831596|12056839|FG000|COMPLETED|Overall Study||51
10890700|NCT01831596|12056839|FG000|NOT COMPLETED|Overall Study||8
10890721|NCT01818739|12056852|FG000|STARTED|Overall Study||204
10890722|NCT01818739|12056852|FG000|COMPLETED|Overall Study||204
10890723|NCT01818739|12056852|FG000|NOT COMPLETED|Overall Study||0
10890724|NCT01816971|12056857|FG000|STARTED|Overall Study||76
10890725|NCT01816971|12056857|FG000|COMPLETED|Overall Study||64
10890726|NCT01816971|12056857|FG000|NOT COMPLETED|Overall Study||12
10890727|NCT01809691|12056863|FG000|STARTED|Overall Study||638
10890728|NCT01809691|12056864|FG001|STARTED|Overall Study||641
10890729|NCT01809691|12056863|FG000|COMPLETED|Overall Study||0
10890730|NCT01809691|12056864|FG001|COMPLETED|Overall Study||0
10890731|NCT01809691|12056863|FG000|NOT COMPLETED|Overall Study||638
10890732|NCT01809691|12056864|FG001|NOT COMPLETED|Overall Study||641
10890733|NCT01807455|12056870|FG000|STARTED|Overall Study||12
10890734|NCT01807455|12056870|FG000|COMPLETED|Overall Study||12
10890735|NCT01807455|12056870|FG000|NOT COMPLETED|Overall Study||0
10890736|NCT01802632|12056880|FG000|STARTED|Overall Study||201
10890737|NCT01802632|12056881|FG001|STARTED|Overall Study||31
10890738|NCT01802632|12056882|FG002|STARTED|Overall Study||271
10890739|NCT01802632|12056883|FG003|STARTED|Overall Study||60
10890740|NCT01802632|12056884|FG004|STARTED|Overall Study||12
10890741|NCT01802632|12056885|FG005|STARTED|Overall Study||28
10890742|NCT01802632|12056880|FG000|COMPLETED|Overall Study||0
10890743|NCT01802632|12056881|FG001|COMPLETED|Overall Study||0
10890744|NCT01802632|12056882|FG002|COMPLETED|Overall Study||0
10890745|NCT01802632|12056883|FG003|COMPLETED|Overall Study||0
10890746|NCT01802632|12056884|FG004|COMPLETED|Overall Study||0
10890747|NCT01802632|12056885|FG005|COMPLETED|Overall Study||0
10890748|NCT01802632|12056880|FG000|NOT COMPLETED|Overall Study||201
10890749|NCT01802632|12056881|FG001|NOT COMPLETED|Overall Study||31
10890750|NCT01802632|12056882|FG002|NOT COMPLETED|Overall Study||271
10890751|NCT01802632|12056883|FG003|NOT COMPLETED|Overall Study||60
10890752|NCT01802632|12056884|FG004|NOT COMPLETED|Overall Study||12
10890753|NCT01802632|12056885|FG005|NOT COMPLETED|Overall Study||28
10890754|NCT01802281|12056899|FG000|STARTED|Overall Study||93
10890755|NCT01802281|12056900|FG001|STARTED|Overall Study||90
10890756|NCT01802281|12056899|FG000|Eligible and Received Randomized Treatment|Overall Study||88
10890757|NCT01802281|12056900|FG001|Eligible and Received Randomized Treatment|Overall Study||87
10890758|NCT01802281|12056899|FG000|Completed Year 1 Follow-up|Overall Study||88
10890759|NCT01802281|12056900|FG001|Completed Year 1 Follow-up|Overall Study||86
10890760|NCT01802281|12056899|FG000|Completed Year 2 Follow-up|Overall Study||87
10890761|NCT01802281|12056900|FG001|Completed Year 2 Follow-up|Overall Study||84
10890762|NCT01802281|12056899|FG000|COMPLETED|Overall Study||85
10890763|NCT01802281|12056900|FG001|COMPLETED|Overall Study||84
10890764|NCT01802281|12056899|FG000|NOT COMPLETED|Overall Study||8
10890765|NCT01802281|12056900|FG001|NOT COMPLETED|Overall Study||6
10890766|NCT01797458|12056909|FG000|STARTED|Overall Study||52
10890767|NCT01797458|12056910|FG001|STARTED|Overall Study||52
10890768|NCT01797458|12056911|FG002|STARTED|Overall Study||65
10890769|NCT01797458|12056909|FG000|COMPLETED|Overall Study||40
10890770|NCT01797458|12056910|FG001|COMPLETED|Overall Study||43
10890771|NCT01797458|12056911|FG002|COMPLETED|Overall Study||58
10890772|NCT01797458|12056909|FG000|NOT COMPLETED|Overall Study||12
10890773|NCT01797458|12056910|FG001|NOT COMPLETED|Overall Study||9
10890774|NCT01797458|12056911|FG002|NOT COMPLETED|Overall Study||7
10890775|NCT01794338|12056930|FG000|STARTED|Overall Study||8
10890776|NCT01794338|12056931|FG001|STARTED|Overall Study||9
10890777|NCT01794338|12056930|FG000|Screen Failure|Overall Study||3
10890778|NCT01794338|12056931|FG001|Screen Failure|Overall Study||3
10890779|NCT01794338|12056930|FG000|1 Month Follow Up|Overall Study||6
10890780|NCT01794338|12056931|FG001|1 Month Follow Up|Overall Study||9
10890781|NCT01794338|12056930|FG000|6 Month Follow Up|Overall Study||0
10890782|NCT01794338|12056931|FG001|6 Month Follow Up|Overall Study||0
10890783|NCT01794338|12056930|FG000|12 Month Follow Up|Overall Study||0
10890784|NCT01794338|12056931|FG001|12 Month Follow Up|Overall Study||0
10890785|NCT01794338|12056930|FG000|24 Month Follow Up|Overall Study||0
10890786|NCT01794338|12056931|FG001|24 Month Follow Up|Overall Study||0
10890787|NCT01794338|12056930|FG000|36 Month Follow Up|Overall Study||0
10890788|NCT01794338|12056931|FG001|36 Month Follow Up|Overall Study||0
10890789|NCT01794338|12056930|FG000|COMPLETED|Overall Study||0
10890790|NCT01794338|12056931|FG001|COMPLETED|Overall Study||0
10890791|NCT01794338|12056930|FG000|NOT COMPLETED|Overall Study||8
10890792|NCT01794338|12056931|FG001|NOT COMPLETED|Overall Study||9
10890793|NCT01791985|12056937|FG000|STARTED|Overall Study||52
10890794|NCT01791985|12056937|FG000|COMPLETED|Overall Study|Eight patients (8) discontinued study treatment prior to 12 weeks or disease disease progression|44
10890795|NCT01791985|12056937|FG000|NOT COMPLETED|Overall Study||8
10890796|NCT01783223|12056942|FG000|STARTED|Overall Study||668
10890797|NCT01783223|12056942|FG000|COMPLETED|Overall Study||668
10890798|NCT01783223|12056942|FG000|NOT COMPLETED|Overall Study||0
10890799|NCT01783041|12056948|FG000|STARTED|First 2 Weeks of Life||72
10890800|NCT01783041|12056949|FG001|STARTED|First 2 Weeks of Life||72
10890801|NCT01783041|12056948|FG000|COMPLETED|First 2 Weeks of Life||69
10890802|NCT01783041|12056949|FG001|COMPLETED|First 2 Weeks of Life||71
10890803|NCT01783041|12056948|FG000|NOT COMPLETED|First 2 Weeks of Life||3
10890804|NCT01783041|12056949|FG001|NOT COMPLETED|First 2 Weeks of Life||1
10890805|NCT01783041|12056948|FG000|STARTED|NNNS Examination at Term Equivalent Age||69
10890806|NCT01783041|12056949|FG001|STARTED|NNNS Examination at Term Equivalent Age||71
10890807|NCT01783041|12056948|FG000|COMPLETED|NNNS Examination at Term Equivalent Age||60
10890808|NCT01783041|12056949|FG001|COMPLETED|NNNS Examination at Term Equivalent Age||59
10890809|NCT01783041|12056948|FG000|NOT COMPLETED|NNNS Examination at Term Equivalent Age||9
10890810|NCT01783041|12056949|FG001|NOT COMPLETED|NNNS Examination at Term Equivalent Age||12
10890811|NCT01782352|12056959|FG000|STARTED|Overall Study||6463
10890812|NCT01782352|12056960|FG001|STARTED|Overall Study||6464
10890813|NCT01782352|12056961|FG002|STARTED|Overall Study||6470
10890814|NCT01782352|12056962|FG003|STARTED|Overall Study||6474
10890815|NCT01782352|12056959|FG000|COMPLETED|Overall Study||6463
10890816|NCT01782352|12056960|FG001|COMPLETED|Overall Study||6464
10890817|NCT01782352|12056961|FG002|COMPLETED|Overall Study||6470
10890818|NCT01782352|12056962|FG003|COMPLETED|Overall Study||6474
10890819|NCT01782352|12056959|FG000|NOT COMPLETED|Overall Study||0
10890820|NCT01782352|12056960|FG001|NOT COMPLETED|Overall Study||0
10890821|NCT01782352|12056961|FG002|NOT COMPLETED|Overall Study||0
10890822|NCT01782352|12056962|FG003|NOT COMPLETED|Overall Study||0
10890823|NCT01776840|12056974|FG000|STARTED|Overall Study||261
10890824|NCT01776840|12056975|FG001|STARTED|Overall Study||262
10890825|NCT01776840|12056974|FG000|COMPLETED|Overall Study||103
10890826|NCT01776840|12056975|FG001|COMPLETED|Overall Study||107
10890827|NCT01776840|12056974|FG000|NOT COMPLETED|Overall Study||158
10890828|NCT01776840|12056975|FG001|NOT COMPLETED|Overall Study||155
10890829|NCT01776723|12056986|FG000|STARTED|Overall Study||6
10890830|NCT01776723|12056987|FG001|STARTED|Overall Study||4
10890831|NCT01776723|12056988|FG002|STARTED|Overall Study||5
10890832|NCT01776723|12056989|FG003|STARTED|Overall Study||5
10890833|NCT01776723|12056990|FG004|STARTED|Overall Study||30
10890834|NCT01776723|12056986|FG000|COMPLETED|Overall Study||6
10890835|NCT01776723|12056987|FG001|COMPLETED|Overall Study||4
10890836|NCT01776723|12056988|FG002|COMPLETED|Overall Study||5
10890837|NCT01776723|12056989|FG003|COMPLETED|Overall Study||5
10890838|NCT01776723|12056990|FG004|COMPLETED|Overall Study||30
10890839|NCT01776723|12056986|FG000|NOT COMPLETED|Overall Study||0
10890840|NCT01776723|12056987|FG001|NOT COMPLETED|Overall Study||0
10890841|NCT01776723|12056988|FG002|NOT COMPLETED|Overall Study||0
10890842|NCT01776723|12056989|FG003|NOT COMPLETED|Overall Study||0
10890843|NCT01776723|12056990|FG004|NOT COMPLETED|Overall Study||0
10890844|NCT01772472|12057008|FG000|STARTED|Overall Study||743
10890845|NCT01772472|12057009|FG001|STARTED|Overall Study||743
10890846|NCT01772472|12057008|FG000|COMPLETED|Overall Study||0
10890847|NCT01772472|12057009|FG001|COMPLETED|Overall Study||0
10890848|NCT01772472|12057008|FG000|NOT COMPLETED|Overall Study||743
10890849|NCT01772472|12057009|FG001|NOT COMPLETED|Overall Study||743
10890850|NCT01767194|12057017|FG000|STARTED|Overall Study||19
10890851|NCT01767194|12057018|FG001|STARTED|Overall Study||54
10890852|NCT01767194|12057017|FG000|COMPLETED|Overall Study||1
10890853|NCT01767194|12057018|FG001|COMPLETED|Overall Study||11
10890854|NCT01767194|12057017|FG000|NOT COMPLETED|Overall Study||18
10890855|NCT01767194|12057018|FG001|NOT COMPLETED|Overall Study||43
10890856|NCT01760447|12057029|FG000|STARTED|Weeks 0-20|The first randomization for the participant who withdrew and re-randomized is not counted in the 62.|62
10890857|NCT01760447|12057030|FG001|STARTED|Weeks 0-20||62
10890858|NCT01760447|12057031|FG002|STARTED|Weeks 0-20||47
10890859|NCT01760447|12057032|FG003|STARTED|Weeks 0-20||51
10890860|NCT01760447|12057029|FG000|Treated|Weeks 0-20||62
10890861|NCT01760447|12057030|FG001|Treated|Weeks 0-20||62
10890862|NCT01760447|12057031|FG002|Treated|Weeks 0-20||45
10890863|NCT01760447|12057032|FG003|Treated|Weeks 0-20||51
10890864|NCT01760447|12057029|FG000|COMPLETED|Weeks 0-20||59
10890865|NCT01760447|12057030|FG001|COMPLETED|Weeks 0-20||62
10890866|NCT01760447|12057031|FG002|COMPLETED|Weeks 0-20||42
10890867|NCT01760447|12057032|FG003|COMPLETED|Weeks 0-20||47
10890868|NCT01760447|12057029|FG000|NOT COMPLETED|Weeks 0-20||3
10890869|NCT01760447|12057030|FG001|NOT COMPLETED|Weeks 0-20||0
10890870|NCT01760447|12057031|FG002|NOT COMPLETED|Weeks 0-20||5
10890871|NCT01760447|12057032|FG003|NOT COMPLETED|Weeks 0-20||4
10890963|NCT01730118|12057113|FG006|NOT COMPLETED|Dose Expansion||0
10890872|NCT01760447|12057029|FG000|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|28
10890873|NCT01760447|12057030|FG001|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|30
10890874|NCT01760447|12057031|FG002|STARTED|Weeks 20-54||42
10890875|NCT01760447|12057032|FG003|STARTED|Weeks 20-54||47
10890876|NCT01760447|12057029|FG000|COMPLETED|Weeks 20-54||25
10890877|NCT01760447|12057030|FG001|COMPLETED|Weeks 20-54||28
10890878|NCT01760447|12057031|FG002|COMPLETED|Weeks 20-54||39
10890879|NCT01760447|12057032|FG003|COMPLETED|Weeks 20-54||43
10890880|NCT01760447|12057029|FG000|NOT COMPLETED|Weeks 20-54||3
10890881|NCT01760447|12057030|FG001|NOT COMPLETED|Weeks 20-54||2
10890882|NCT01760447|12057031|FG002|NOT COMPLETED|Weeks 20-54||3
10890883|NCT01760447|12057032|FG003|NOT COMPLETED|Weeks 20-54||4
10890884|NCT01757535|12057050|FG000|STARTED|Overall Study||238
10890885|NCT01757535|12057051|FG001|STARTED|Overall Study||234
10890886|NCT01757535|12057050|FG000|Received Treatment|Overall Study||236
10890887|NCT01757535|12057051|FG001|Received Treatment|Overall Study||233
10890888|NCT01757535|12057050|FG000|COMPLETED|Overall Study||45
10890889|NCT01757535|12057051|FG001|COMPLETED|Overall Study||26
10890890|NCT01757535|12057050|FG000|NOT COMPLETED|Overall Study||193
10890891|NCT01757535|12057051|FG001|NOT COMPLETED|Overall Study||208
10890892|NCT01753830|12057059|FG000|STARTED|Overall Study||37
10890893|NCT01753830|12057060|FG001|STARTED|Overall Study||38
10890894|NCT01753830|12057059|FG000|COMPLETED|Overall Study||30
10890895|NCT01753830|12057060|FG001|COMPLETED|Overall Study||35
10890896|NCT01753830|12057059|FG000|NOT COMPLETED|Overall Study||7
10890897|NCT01753830|12057060|FG001|NOT COMPLETED|Overall Study||3
10890898|NCT01750281|12057069|FG000|STARTED|Overall Study||43
10890899|NCT01750281|12057070|FG001|STARTED|Overall Study||85
10890900|NCT01750281|12057071|FG002|STARTED|Overall Study||84
10890901|NCT01750281|12057069|FG000|Received Treatment|Overall Study||43
10890902|NCT01750281|12057070|FG001|Received Treatment|Overall Study||84
10890903|NCT01750281|12057071|FG002|Received Treatment|Overall Study||84
10890904|NCT01750281|12057069|FG000|Did Not Receive Treatment|Overall Study||0
10890905|NCT01750281|12057070|FG001|Did Not Receive Treatment|Overall Study||1
10890906|NCT01750281|12057071|FG002|Did Not Receive Treatment|Overall Study||0
10890907|NCT01750281|12057069|FG000|COMPLETED|Overall Study||0
10890908|NCT01750281|12057070|FG001|COMPLETED|Overall Study||0
10890909|NCT01750281|12057071|FG002|COMPLETED|Overall Study||0
10890910|NCT01750281|12057069|FG000|NOT COMPLETED|Overall Study||43
10890911|NCT01750281|12057070|FG001|NOT COMPLETED|Overall Study||85
10890912|NCT01750281|12057071|FG002|NOT COMPLETED|Overall Study||84
10890913|NCT01743872|12057079|FG000|STARTED|Overall Study||23
10890914|NCT01743872|12057079|FG000|COMPLETED|Overall Study||23
10890915|NCT01743872|12057079|FG000|NOT COMPLETED|Overall Study||0
10890916|NCT01740427|12057093|FG000|STARTED|Overall Study||444
10890917|NCT01740427|12057094|FG001|STARTED|Overall Study||222
10890918|NCT01740427|12057093|FG000|COMPLETED|Overall Study||0
10890919|NCT01740427|12057094|FG001|COMPLETED|Overall Study||0
10890920|NCT01740427|12057093|FG000|NOT COMPLETED|Overall Study||444
10890921|NCT01740427|12057094|FG001|NOT COMPLETED|Overall Study||222
10890922|NCT01730118|12057107|FG000|STARTED|Dose Escalation||6
10890923|NCT01730118|12057108|FG001|STARTED|Dose Escalation||7
10890924|NCT01730118|12057109|FG002|STARTED|Dose Escalation||6
10890925|NCT01730118|12057110|FG003|STARTED|Dose Escalation||6
10890926|NCT01730118|12057111|FG004|STARTED|Dose Escalation||0
10890927|NCT01730118|12057112|FG005|STARTED|Dose Escalation||0
10890928|NCT01730118|12057113|FG006|STARTED|Dose Escalation||2
10890929|NCT01730118|12057107|FG000|COMPLETED|Dose Escalation||0
10890930|NCT01730118|12057108|FG001|COMPLETED|Dose Escalation||0
10890931|NCT01730118|12057109|FG002|COMPLETED|Dose Escalation||3
10890932|NCT01730118|12057110|FG003|COMPLETED|Dose Escalation||0
10890933|NCT01730118|12057111|FG004|COMPLETED|Dose Escalation||0
10890934|NCT01730118|12057112|FG005|COMPLETED|Dose Escalation||0
10890935|NCT01730118|12057113|FG006|COMPLETED|Dose Escalation||0
10890936|NCT01730118|12057107|FG000|NOT COMPLETED|Dose Escalation||6
10890937|NCT01730118|12057108|FG001|NOT COMPLETED|Dose Escalation||7
10890938|NCT01730118|12057109|FG002|NOT COMPLETED|Dose Escalation||3
10890939|NCT01730118|12057110|FG003|NOT COMPLETED|Dose Escalation||6
10890940|NCT01730118|12057111|FG004|NOT COMPLETED|Dose Escalation||0
10890941|NCT01730118|12057112|FG005|NOT COMPLETED|Dose Escalation||0
10890942|NCT01730118|12057113|FG006|NOT COMPLETED|Dose Escalation||2
10890943|NCT01730118|12057107|FG000|STARTED|Dose Expansion||0
10890944|NCT01730118|12057108|FG001|STARTED|Dose Expansion||0
10890945|NCT01730118|12057109|FG002|STARTED|Dose Expansion||0
10890946|NCT01730118|12057110|FG003|STARTED|Dose Expansion||0
10890947|NCT01730118|12057111|FG004|STARTED|Dose Expansion||3
10890948|NCT01730118|12057112|FG005|STARTED|Dose Expansion||3
10890949|NCT01730118|12057113|FG006|STARTED|Dose Expansion||0
10890950|NCT01730118|12057107|FG000|COMPLETED|Dose Expansion||0
10890951|NCT01730118|12057108|FG001|COMPLETED|Dose Expansion||0
10890952|NCT01730118|12057109|FG002|COMPLETED|Dose Expansion||0
10890953|NCT01730118|12057110|FG003|COMPLETED|Dose Expansion||0
10890954|NCT01730118|12057111|FG004|COMPLETED|Dose Expansion||0
10890955|NCT01730118|12057112|FG005|COMPLETED|Dose Expansion||0
10890956|NCT01730118|12057113|FG006|COMPLETED|Dose Expansion||0
10890957|NCT01730118|12057107|FG000|NOT COMPLETED|Dose Expansion||0
10890958|NCT01730118|12057108|FG001|NOT COMPLETED|Dose Expansion||0
10890959|NCT01730118|12057109|FG002|NOT COMPLETED|Dose Expansion||0
10890960|NCT01730118|12057110|FG003|NOT COMPLETED|Dose Expansion||0
10890961|NCT01730118|12057111|FG004|NOT COMPLETED|Dose Expansion||3
10890962|NCT01730118|12057112|FG005|NOT COMPLETED|Dose Expansion||3
10890964|NCT01728805|12057132|FG000|STARTED|Randomization Period||186
10890965|NCT01728805|12057133|FG001|STARTED|Randomization Period||186
10890966|NCT01728805|12057134|FG002|STARTED|Randomization Period||0
10890967|NCT01728805|12057132|FG000|COMPLETED|Randomization Period||186
10890968|NCT01728805|12057133|FG001|COMPLETED|Randomization Period||186
10890969|NCT01728805|12057134|FG002|COMPLETED|Randomization Period||0
10890970|NCT01728805|12057132|FG000|NOT COMPLETED|Randomization Period||0
10890971|NCT01728805|12057133|FG001|NOT COMPLETED|Randomization Period||0
10890972|NCT01728805|12057134|FG002|NOT COMPLETED|Randomization Period||0
10890973|NCT01728805|12057132|FG000|STARTED|Crossover Period||0
10890974|NCT01728805|12057133|FG001|STARTED|Crossover Period||0
10890975|NCT01728805|12057134|FG002|STARTED|Crossover Period||136
10890976|NCT01728805|12057132|FG000|COMPLETED|Crossover Period||0
10890977|NCT01728805|12057133|FG001|COMPLETED|Crossover Period||0
10890978|NCT01728805|12057134|FG002|COMPLETED|Crossover Period||136
10890979|NCT01728805|12057132|FG000|NOT COMPLETED|Crossover Period||0
10890980|NCT01728805|12057133|FG001|NOT COMPLETED|Crossover Period||0
10890981|NCT01728805|12057134|FG002|NOT COMPLETED|Crossover Period||0
10890982|NCT01723774|12057144|FG000|STARTED|Neoadjuvant||34
10890983|NCT01723774|12057145|FG001|STARTED|Neoadjuvant||16
10890984|NCT01723774|12057146|FG002|STARTED|Neoadjuvant||34
10890985|NCT01723774|12057147|FG003|STARTED|Neoadjuvant||0
10890986|NCT01723774|12057144|FG000|COMPLETED|Neoadjuvant||27
10890987|NCT01723774|12057145|FG001|COMPLETED|Neoadjuvant||12
10890988|NCT01723774|12057146|FG002|COMPLETED|Neoadjuvant||21
10890989|NCT01723774|12057147|FG003|COMPLETED|Neoadjuvant||0
10890990|NCT01723774|12057144|FG000|NOT COMPLETED|Neoadjuvant||7
10890991|NCT01723774|12057145|FG001|NOT COMPLETED|Neoadjuvant||4
10890992|NCT01723774|12057146|FG002|NOT COMPLETED|Neoadjuvant||13
10890993|NCT01723774|12057147|FG003|NOT COMPLETED|Neoadjuvant||0
10890994|NCT01723774|12057144|FG000|STARTED|Adjuvant||0
10890995|NCT01723774|12057145|FG001|STARTED|Adjuvant||0
10890996|NCT01723774|12057146|FG002|STARTED|Adjuvant||0
10890997|NCT01723774|12057147|FG003|STARTED|Adjuvant||7
10890998|NCT01723774|12057144|FG000|COMPLETED|Adjuvant||0
10890999|NCT01723774|12057145|FG001|COMPLETED|Adjuvant||0
10891000|NCT01723774|12057146|FG002|COMPLETED|Adjuvant||0
10891001|NCT01723774|12057147|FG003|COMPLETED|Adjuvant||6
10891002|NCT01723774|12057144|FG000|NOT COMPLETED|Adjuvant||0
10891003|NCT01723774|12057145|FG001|NOT COMPLETED|Adjuvant||0
10891004|NCT01723774|12057146|FG002|NOT COMPLETED|Adjuvant||0
10891005|NCT01723774|12057147|FG003|NOT COMPLETED|Adjuvant||1
10891006|NCT01719237|12057158|FG000|STARTED|Overall Study||30
10891007|NCT01719237|12057159|FG001|STARTED|Overall Study||30
10891008|NCT01719237|12057158|FG000|COMPLETED|Overall Study||30
10891009|NCT01719237|12057159|FG001|COMPLETED|Overall Study||29
10891010|NCT01719237|12057158|FG000|NOT COMPLETED|Overall Study||0
10891011|NCT01719237|12057159|FG001|NOT COMPLETED|Overall Study||1
10891012|NCT01711541|12057170|FG000|STARTED|Overall Study||4
10891013|NCT01711541|12057171|FG001|STARTED|Overall Study||4
10891014|NCT01711541|12057172|FG002|STARTED|Overall Study||3
10891015|NCT01711541|12057173|FG003|STARTED|Overall Study||6
10891016|NCT01711541|12057174|FG004|STARTED|Overall Study||7
10891017|NCT01711541|12057170|FG000|COMPLETED|Overall Study||4
10891018|NCT01711541|12057171|FG001|COMPLETED|Overall Study||3
10891019|NCT01711541|12057172|FG002|COMPLETED|Overall Study||3
10891020|NCT01711541|12057173|FG003|COMPLETED|Overall Study||5
10891021|NCT01711541|12057174|FG004|COMPLETED|Overall Study||7
10891022|NCT01711541|12057170|FG000|NOT COMPLETED|Overall Study||0
10891023|NCT01711541|12057171|FG001|NOT COMPLETED|Overall Study||1
10891024|NCT01711541|12057172|FG002|NOT COMPLETED|Overall Study||0
10891025|NCT01711541|12057173|FG003|NOT COMPLETED|Overall Study||1
10891026|NCT01711541|12057174|FG004|NOT COMPLETED|Overall Study||0
10891027|NCT01708954|12057194|FG000|STARTED|Step 1||42
10891028|NCT01708954|12057195|FG001|STARTED|Step 1||40
10891029|NCT01708954|12057196|FG002|STARTED|Step 1||43
10891030|NCT01708954|12057194|FG000|Started Protocol Therapy|Step 1||40
10891031|NCT01708954|12057195|FG001|Started Protocol Therapy|Step 1||40
10891032|NCT01708954|12057196|FG002|Started Protocol Therapy|Step 1||39
10891033|NCT01708954|12057194|FG000|Eligible and Treated|Step 1||38
10891034|NCT01708954|12057195|FG001|Eligible and Treated|Step 1||38
10891035|NCT01708954|12057196|FG002|Eligible and Treated|Step 1||35
10891036|NCT01708954|12057194|FG000|Patients With MET Status Data Available|Step 1||30
10891037|NCT01708954|12057195|FG001|Patients With MET Status Data Available|Step 1||32
10891038|NCT01708954|12057196|FG002|Patients With MET Status Data Available|Step 1||24
10891039|NCT01708954|12057194|FG000|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
10891040|NCT01708954|12057195|FG001|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
10891041|NCT01708954|12057196|FG002|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
10891042|NCT01708954|12057194|FG000|NOT COMPLETED|Step 1||42
10891043|NCT01708954|12057195|FG001|NOT COMPLETED|Step 1||40
10891044|NCT01708954|12057196|FG002|NOT COMPLETED|Step 1||43
10891045|NCT01708954|12057194|FG000|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
10891046|NCT01708954|12057195|FG001|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
10891047|NCT01708954|12057196|FG002|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
10891048|NCT01708954|12057194|FG000|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
10891049|NCT01708954|12057195|FG001|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
10891050|NCT01708954|12057196|FG002|COMPLETED|Step 2||0
10891051|NCT01708954|12057194|FG000|NOT COMPLETED|Step 2||13
10891052|NCT01708954|12057195|FG001|NOT COMPLETED|Step 2||7
10891053|NCT01708954|12057196|FG002|NOT COMPLETED|Step 2||0
10891054|NCT01708941|12057209|FG000|STARTED|Overall Study||21
10891055|NCT01708941|12057210|FG001|STARTED|Overall Study||23
10891056|NCT01708941|12057211|FG002|STARTED|Overall Study||22
10891057|NCT01708941|12057212|FG003|STARTED|Overall Study||22
10891058|NCT01708941|12057209|FG000|Eligible and Started Treatment|Overall Study||18
10891059|NCT01708941|12057210|FG001|Eligible and Started Treatment|Overall Study||22
10891060|NCT01708941|12057211|FG002|Eligible and Started Treatment|Overall Study||19
10891061|NCT01708941|12057212|FG003|Eligible and Started Treatment|Overall Study||22
10891062|NCT01708941|12057209|FG000|COMPLETED|Overall Study||3
10891063|NCT01708941|12057210|FG001|COMPLETED|Overall Study||5
10891064|NCT01708941|12057211|FG002|COMPLETED|Overall Study||3
10891065|NCT01708941|12057212|FG003|COMPLETED|Overall Study||4
10891066|NCT01708941|12057209|FG000|NOT COMPLETED|Overall Study||18
10891067|NCT01708941|12057210|FG001|NOT COMPLETED|Overall Study||18
10891068|NCT01708941|12057211|FG002|NOT COMPLETED|Overall Study||19
10891069|NCT01708941|12057212|FG003|NOT COMPLETED|Overall Study||18
10891070|NCT01706939|12057224|FG000|STARTED|Pre Randomization||23
10891071|NCT01706939|12057225|FG001|STARTED|Pre Randomization||0
10891072|NCT01706939|12057226|FG002|STARTED|Pre Randomization||0
10891073|NCT01706939|12057224|FG000|COMPLETED|Pre Randomization||20
10891074|NCT01706939|12057225|FG001|COMPLETED|Pre Randomization||0
10891075|NCT01706939|12057226|FG002|COMPLETED|Pre Randomization||0
10891076|NCT01706939|12057224|FG000|NOT COMPLETED|Pre Randomization||3
10891077|NCT01706939|12057225|FG001|NOT COMPLETED|Pre Randomization||0
10891078|NCT01706939|12057226|FG002|NOT COMPLETED|Pre Randomization||0
10891079|NCT01706939|12057224|FG000|STARTED|Randomization||0
10891080|NCT01706939|12057225|FG001|STARTED|Randomization||12
10891081|NCT01706939|12057226|FG002|STARTED|Randomization||8
10891082|NCT01706939|12057224|FG000|COMPLETED|Randomization||0
10891083|NCT01706939|12057225|FG001|COMPLETED|Randomization||9
10891084|NCT01706939|12057226|FG002|COMPLETED|Randomization||6
10891085|NCT01706939|12057224|FG000|NOT COMPLETED|Randomization||0
10891086|NCT01706939|12057225|FG001|NOT COMPLETED|Randomization||3
10891087|NCT01706939|12057226|FG002|NOT COMPLETED|Randomization||2
10891088|NCT01700946|12057235|FG000|STARTED|Overall Study||18
10891089|NCT01700946|12057236|FG001|STARTED|Overall Study||24
10891090|NCT01700946|12057235|FG000|COMPLETED|Overall Study||7
10891091|NCT01700946|12057236|FG001|COMPLETED|Overall Study||7
10891092|NCT01700946|12057235|FG000|NOT COMPLETED|Overall Study||11
10891093|NCT01700946|12057236|FG001|NOT COMPLETED|Overall Study||17
10891094|NCT01696994|12057248|FG000|STARTED|Overall Study||39111
10891095|NCT01696994|12057249|FG001|STARTED|Overall Study||39105
10891096|NCT01696994|12057248|FG000|COMPLETED|Overall Study||33919
10891097|NCT01696994|12057249|FG001|COMPLETED|Overall Study||30668
10891098|NCT01696994|12057248|FG000|NOT COMPLETED|Overall Study||5192
10891099|NCT01696994|12057249|FG001|NOT COMPLETED|Overall Study||8437
10891100|NCT01696968|12057259|FG000|STARTED|Overall Study||77456
10891101|NCT01696968|12057260|FG001|STARTED|Overall Study||77445
10891102|NCT01696968|12057259|FG000|COMPLETED|Overall Study||76255
10891103|NCT01696968|12057260|FG001|COMPLETED|Overall Study||70633
10891104|NCT01696968|12057259|FG000|NOT COMPLETED|Overall Study||1201
10891105|NCT01696968|12057260|FG001|NOT COMPLETED|Overall Study||6812
10891106|NCT01682226|12057267|FG000|STARTED|Overall Study||84
10891107|NCT01682226|12057267|FG000|COMPLETED|Overall Study||78
10891108|NCT01682226|12057267|FG000|NOT COMPLETED|Overall Study||6
10891109|NCT01682148|12057273|FG000|STARTED|Overall Study||44
10891110|NCT01682148|12057274|FG001|STARTED|Overall Study||44
10891111|NCT01682148|12057273|FG000|COMPLETED|Overall Study||40
10891112|NCT01682148|12057274|FG001|COMPLETED|Overall Study||41
10891113|NCT01682148|12057273|FG000|NOT COMPLETED|Overall Study||4
10891114|NCT01682148|12057274|FG001|NOT COMPLETED|Overall Study||3
10891115|NCT01682083|12057287|FG000|STARTED|Overall Study||438
10891116|NCT01682083|12057288|FG001|STARTED|Overall Study||432
10891117|NCT01682083|12057287|FG000|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
10891118|NCT01682083|12057288|FG001|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
10891119|NCT01682083|12057287|FG000|NOT COMPLETED|Overall Study||107
10891120|NCT01682083|12057288|FG001|NOT COMPLETED|Overall Study||155
10891121|NCT01678131|12057297|FG000|STARTED|Overall Study||10
10891122|NCT01678131|12057298|FG001|STARTED|Overall Study||10
10891123|NCT01678131|12057299|FG002|STARTED|Overall Study||11
10891124|NCT01678131|12057297|FG000|COMPLETED|Overall Study||10
10891125|NCT01678131|12057298|FG001|COMPLETED|Overall Study||9
10891126|NCT01678131|12057299|FG002|COMPLETED|Overall Study||9
10891127|NCT01678131|12057297|FG000|NOT COMPLETED|Overall Study||0
10891128|NCT01678131|12057298|FG001|NOT COMPLETED|Overall Study||1
10891129|NCT01678131|12057299|FG002|NOT COMPLETED|Overall Study||2
10891130|NCT01677858|12057312|FG000|STARTED|Overall Study||3
10891131|NCT01677858|12057313|FG001|STARTED|Overall Study||3
10891132|NCT01677858|12057314|FG002|STARTED|Overall Study||15
10891133|NCT01677858|12057315|FG003|STARTED|Overall Study||6
10891134|NCT01677858|12057316|FG004|STARTED|Overall Study||89
10891135|NCT01677858|12057312|FG000|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
10891136|NCT01677858|12057313|FG001|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
10891137|NCT01677858|12057314|FG002|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
10891138|NCT01677858|12057315|FG003|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
10891139|NCT01677858|12057316|FG004|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
10891140|NCT01677858|12057312|FG000|NOT COMPLETED|Overall Study||3
10891141|NCT01677858|12057313|FG001|NOT COMPLETED|Overall Study||2
10891142|NCT01677858|12057314|FG002|NOT COMPLETED|Overall Study||14
10891143|NCT01677858|12057315|FG003|NOT COMPLETED|Overall Study||6
10891144|NCT01677858|12057316|FG004|NOT COMPLETED|Overall Study||85
10891145|NCT01670006|12057333|FG000|STARTED|Overall Study||10
10891146|NCT01670006|12057333|FG000|COMPLETED|Overall Study||10
10891147|NCT01670006|12057333|FG000|NOT COMPLETED|Overall Study||0
10891148|NCT01668784|12057339|FG000|STARTED|Randomized (Pre-treatment)||410
10891149|NCT01668784|12057340|FG001|STARTED|Randomized (Pre-treatment)||411
10891150|NCT01668784|12057339|FG000|COMPLETED|Randomized (Pre-treatment)||406
10891151|NCT01668784|12057340|FG001|COMPLETED|Randomized (Pre-treatment)||397
10891152|NCT01668784|12057339|FG000|NOT COMPLETED|Randomized (Pre-treatment)||4
10891153|NCT01668784|12057340|FG001|NOT COMPLETED|Randomized (Pre-treatment)||14
10891154|NCT01668784|12057339|FG000|STARTED|Treatment Period||406
10891155|NCT01668784|12057340|FG001|STARTED|Treatment Period||397
10891156|NCT01668784|12057339|FG000|COMPLETED|Treatment Period||0
10891157|NCT01668784|12057340|FG001|COMPLETED|Treatment Period||0
10891158|NCT01668784|12057339|FG000|NOT COMPLETED|Treatment Period||406
10891159|NCT01668784|12057340|FG001|NOT COMPLETED|Treatment Period||397
10891160|NCT01665144|12057348|FG000|STARTED|Overall Study||1105
10891161|NCT01665144|12057349|FG001|STARTED|Overall Study||546
10891162|NCT01665144|12057348|FG000|Safety Set|Overall Study||1099
10891163|NCT01665144|12057349|FG001|Safety Set|Overall Study||546
10891164|NCT01665144|12057348|FG000|Full Analysis Set|Overall Study||1099
10891165|NCT01665144|12057349|FG001|Full Analysis Set|Overall Study||546
10891166|NCT01665144|12057348|FG000|COMPLETED|Overall Study||903
10891167|NCT01665144|12057349|FG001|COMPLETED|Overall Study||424
10891168|NCT01665144|12057348|FG000|NOT COMPLETED|Overall Study||202
10891169|NCT01665144|12057349|FG001|NOT COMPLETED|Overall Study||122
10891170|NCT01660451|12057358|FG000|STARTED|Overall Study||33
10891171|NCT01660451|12057359|FG001|STARTED|Overall Study||51
10891172|NCT01660451|12057360|FG002|STARTED|Overall Study||142
10891173|NCT01660451|12057358|FG000|COMPLETED|Overall Study||16
10891174|NCT01660451|12057359|FG001|COMPLETED|Overall Study||34
10891175|NCT01660451|12057360|FG002|COMPLETED|Overall Study||37
10891176|NCT01660451|12057358|FG000|NOT COMPLETED|Overall Study||17
10891177|NCT01660451|12057359|FG001|NOT COMPLETED|Overall Study||17
10891178|NCT01660451|12057360|FG002|NOT COMPLETED|Overall Study||105
10891179|NCT01659853|12057369|FG000|STARTED|Treatment Period 1||35
10891180|NCT01659853|12057370|FG001|STARTED|Treatment Period 1||35
10891181|NCT01659853|12057369|FG000|COMPLETED|Treatment Period 1||35
10891182|NCT01659853|12057370|FG001|COMPLETED|Treatment Period 1||35
10891183|NCT01659853|12057369|FG000|NOT COMPLETED|Treatment Period 1||0
10891184|NCT01659853|12057370|FG001|NOT COMPLETED|Treatment Period 1||0
10891185|NCT01659853|12057369|FG000|STARTED|Washout , 3 to 7 Days||35
10891186|NCT01659853|12057370|FG001|STARTED|Washout , 3 to 7 Days||35
10891187|NCT01659853|12057369|FG000|COMPLETED|Washout , 3 to 7 Days||33
10891188|NCT01659853|12057370|FG001|COMPLETED|Washout , 3 to 7 Days||35
10891189|NCT01659853|12057369|FG000|NOT COMPLETED|Washout , 3 to 7 Days||2
10891190|NCT01659853|12057370|FG001|NOT COMPLETED|Washout , 3 to 7 Days||0
10891191|NCT01659853|12057369|FG000|STARTED|Treatment Period 2||33
10891192|NCT01659853|12057370|FG001|STARTED|Treatment Period 2||35
10891193|NCT01659853|12057369|FG000|COMPLETED|Treatment Period 2||33
10891194|NCT01659853|12057370|FG001|COMPLETED|Treatment Period 2||35
10891195|NCT01659853|12057369|FG000|NOT COMPLETED|Treatment Period 2||0
10891196|NCT01659853|12057370|FG001|NOT COMPLETED|Treatment Period 2||0
10891197|NCT01659541|12057378|FG000|STARTED|Overall Study||12
10891198|NCT01659541|12057378|FG000|COMPLETED|Overall Study||11
10891199|NCT01659541|12057378|FG000|NOT COMPLETED|Overall Study||1
10891200|NCT01652872|12057395|FG000|STARTED|Overall Study||377
10891201|NCT01652872|12057396|FG001|STARTED|Overall Study||379
10891202|NCT01652872|12057395|FG000|Received Investigational Product|Overall Study||377
10891203|NCT01652872|12057396|FG001|Received Investigational Product|Overall Study||377
10891204|NCT01652872|12057395|FG000|COMPLETED|Overall Study||232
10891205|NCT01652872|12057396|FG001|COMPLETED|Overall Study||226
10891206|NCT01652872|12057395|FG000|NOT COMPLETED|Overall Study||145
10891207|NCT01652872|12057396|FG001|NOT COMPLETED|Overall Study||153
10891208|NCT01652469|12057404|FG000|STARTED|Overall Study||38
10891209|NCT01652469|12057405|FG001|STARTED|Overall Study||42
10891210|NCT01652469|12057404|FG000|COMPLETED|Overall Study||37
10891211|NCT01652469|12057405|FG001|COMPLETED|Overall Study||36
10891212|NCT01652469|12057404|FG000|NOT COMPLETED|Overall Study||1
10891213|NCT01652469|12057405|FG001|NOT COMPLETED|Overall Study||6
10891214|NCT01650558|12057414|FG000|STARTED|Overall Study||500
10891215|NCT01650558|12057415|FG001|STARTED|Overall Study||500
10891216|NCT01650558|12057416|FG002|STARTED|Overall Study||499
10891217|NCT01650558|12057414|FG000|COMPLETED|Overall Study||417
10891218|NCT01650558|12057415|FG001|COMPLETED|Overall Study||408
10891219|NCT01650558|12057416|FG002|COMPLETED|Overall Study||424
10891220|NCT01650558|12057414|FG000|NOT COMPLETED|Overall Study||83
10891221|NCT01650558|12057415|FG001|NOT COMPLETED|Overall Study||92
10891222|NCT01650558|12057416|FG002|NOT COMPLETED|Overall Study||75
10891223|NCT01639131|12057425|FG000|STARTED|Overall Study||6
10891224|NCT01639131|12057425|FG000|COMPLETED|Overall Study||0
10891225|NCT01639131|12057425|FG000|NOT COMPLETED|Overall Study||6
10891226|NCT01626079|12057432|FG000|STARTED|Overall Study||302
10891227|NCT01626079|12057433|FG001|STARTED|Overall Study||312
10891228|NCT01626079|12057434|FG002|STARTED|Overall Study||162
10891229|NCT01626079|12057432|FG000|COMPLETED|Overall Study||152
10891230|NCT01626079|12057433|FG001|COMPLETED|Overall Study||111
10891231|NCT01626079|12057434|FG002|COMPLETED|Overall Study||110
10891232|NCT01626079|12057432|FG000|NOT COMPLETED|Overall Study||150
10891233|NCT01626079|12057433|FG001|NOT COMPLETED|Overall Study||201
10891234|NCT01626079|12057434|FG002|NOT COMPLETED|Overall Study||52
10891235|NCT01625611|12057447|FG000|STARTED|Overall Study||55
10891236|NCT01625611|12057448|FG001|STARTED|Overall Study||4
10891237|NCT01625611|12057447|FG000|PET Scan 1|Overall Study||49
10891238|NCT01625611|12057448|FG001|PET Scan 1|Overall Study||4
10891239|NCT01625611|12057447|FG000|Lab 2|Overall Study||48
10891240|NCT01625611|12057448|FG001|Lab 2|Overall Study||0
10891241|NCT01625611|12057447|FG000|PET Scan 2|Overall Study||47
10891242|NCT01625611|12057448|FG001|PET Scan 2|Overall Study||0
10891243|NCT01625611|12057447|FG000|COMPLETED|Overall Study||47
10891244|NCT01625611|12057448|FG001|COMPLETED|Overall Study||4
10891245|NCT01625611|12057447|FG000|NOT COMPLETED|Overall Study||8
10891246|NCT01625611|12057448|FG001|NOT COMPLETED|Overall Study||0
10891247|NCT01625286|12057462|FG000|STARTED|Overall Study||12
10891248|NCT01625286|12057463|FG001|STARTED|Overall Study||8
10891249|NCT01625286|12057464|FG002|STARTED|Overall Study||5
10891250|NCT01625286|12057465|FG003|STARTED|Overall Study||7
10891251|NCT01625286|12057466|FG004|STARTED|Overall Study||6
10891252|NCT01625286|12057467|FG005|STARTED|Overall Study||54
10891253|NCT01625286|12057468|FG006|STARTED|Overall Study||56
10891254|NCT01625286|12057462|FG000|Received AZD5363/Placebo Treatment|Overall Study||12
10891255|NCT01625286|12057463|FG001|Received AZD5363/Placebo Treatment|Overall Study||8
10891256|NCT01625286|12057464|FG002|Received AZD5363/Placebo Treatment|Overall Study||5
10891257|NCT01625286|12057465|FG003|Received AZD5363/Placebo Treatment|Overall Study||7
10891258|NCT01625286|12057466|FG004|Received AZD5363/Placebo Treatment|Overall Study||6
10891259|NCT01625286|12057467|FG005|Received AZD5363/Placebo Treatment|Overall Study||54
10891260|NCT01625286|12057468|FG006|Received AZD5363/Placebo Treatment|Overall Study||55
10891261|NCT01625286|12057462|FG000|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
10891262|NCT01625286|12057463|FG001|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
10891263|NCT01625286|12057464|FG002|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
10891264|NCT01625286|12057465|FG003|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
10891265|NCT01625286|12057466|FG004|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
10891266|NCT01625286|12057467|FG005|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
10891267|NCT01625286|12057468|FG006|Did Not Receive AZD5363/Placebo Trt|Overall Study||1
10891268|NCT01625286|12057462|FG000|COMPLETED|Overall Study||0
10891269|NCT01625286|12057463|FG001|COMPLETED|Overall Study||0
10891270|NCT01625286|12057464|FG002|COMPLETED|Overall Study||0
10891271|NCT01625286|12057465|FG003|COMPLETED|Overall Study||0
10891272|NCT01625286|12057466|FG004|COMPLETED|Overall Study||0
10891273|NCT01625286|12057467|FG005|COMPLETED|Overall Study||0
10891274|NCT01625286|12057468|FG006|COMPLETED|Overall Study||0
10891275|NCT01625286|12057462|FG000|NOT COMPLETED|Overall Study||12
10891276|NCT01625286|12057463|FG001|NOT COMPLETED|Overall Study||8
10891277|NCT01625286|12057464|FG002|NOT COMPLETED|Overall Study||5
10891278|NCT01625286|12057465|FG003|NOT COMPLETED|Overall Study||7
10891279|NCT01625286|12057466|FG004|NOT COMPLETED|Overall Study||6
10891280|NCT01625286|12057467|FG005|NOT COMPLETED|Overall Study||54
10891281|NCT01625286|12057468|FG006|NOT COMPLETED|Overall Study||56
10891282|NCT01621906|12057486|FG000|STARTED|Overall Study||12
10891283|NCT01621906|12057487|FG001|STARTED|Overall Study||5
10891284|NCT01621906|12057486|FG000|COMPLETED|Overall Study||12
10891285|NCT01621906|12057487|FG001|COMPLETED|Overall Study||5
10891286|NCT01621906|12057486|FG000|NOT COMPLETED|Overall Study||0
10891287|NCT01621906|12057487|FG001|NOT COMPLETED|Overall Study||0
10891288|NCT01615887|12057496|FG000|STARTED|Overall Study||41
10891289|NCT01615887|12057497|FG001|STARTED|Overall Study||22
10891290|NCT01615887|12057496|FG000|COMPLETED|Overall Study||29
10891291|NCT01615887|12057497|FG001|COMPLETED|Overall Study||19
10891292|NCT01615887|12057496|FG000|NOT COMPLETED|Overall Study||12
10891293|NCT01615887|12057497|FG001|NOT COMPLETED|Overall Study||3
10891294|NCT01615029|12057508|FG000|STARTED|Overall Study||3
10891295|NCT01615029|12057509|FG001|STARTED|Overall Study||3
10891296|NCT01615029|12057510|FG002|STARTED|Overall Study||4
10891297|NCT01615029|12057511|FG003|STARTED|Overall Study||3
10891298|NCT01615029|12057512|FG004|STARTED|Overall Study||32
10891299|NCT01615029|12057508|FG000|COMPLETED|Overall Study||0
10891300|NCT01615029|12057509|FG001|COMPLETED|Overall Study||0
10891301|NCT01615029|12057510|FG002|COMPLETED|Overall Study||0
10891302|NCT01615029|12057511|FG003|COMPLETED|Overall Study||0
10891303|NCT01615029|12057512|FG004|COMPLETED|Overall Study||0
10891304|NCT01615029|12057508|FG000|NOT COMPLETED|Overall Study||3
10891305|NCT01615029|12057509|FG001|NOT COMPLETED|Overall Study||3
10891306|NCT01615029|12057510|FG002|NOT COMPLETED|Overall Study||4
10891307|NCT01615029|12057511|FG003|NOT COMPLETED|Overall Study||3
10891308|NCT01615029|12057512|FG004|NOT COMPLETED|Overall Study||32
10891309|NCT01613118|12057528|FG000|STARTED|Double-blind||13
10891310|NCT01613118|12057529|FG001|STARTED|Double-blind||26
10891311|NCT01613118|12057530|FG002|STARTED|Double-blind||34
10891312|NCT01613118|12057531|FG003|STARTED|Double-blind||36
10891313|NCT01613118|12057528|FG000|COMPLETED|Double-blind||13
10891314|NCT01613118|12057529|FG001|COMPLETED|Double-blind||23
10891315|NCT01613118|12057530|FG002|COMPLETED|Double-blind||32
10891316|NCT01613118|12057531|FG003|COMPLETED|Double-blind||35
10891317|NCT01613118|12057528|FG000|NOT COMPLETED|Double-blind||0
10891318|NCT01613118|12057529|FG001|NOT COMPLETED|Double-blind||3
10891319|NCT01613118|12057530|FG002|NOT COMPLETED|Double-blind||2
10891320|NCT01613118|12057531|FG003|NOT COMPLETED|Double-blind||1
10891321|NCT01613118|12057528|FG000|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|21
10891322|NCT01613118|12057529|FG001|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|42
10891323|NCT01613118|12057530|FG002|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|40
10891324|NCT01613118|12057531|FG003|STARTED|Open-label Extension||0
10891325|NCT01613118|12057528|FG000|COMPLETED|Open-label Extension|OLE ongoing|0
10891326|NCT01613118|12057529|FG001|COMPLETED|Open-label Extension|OLE ongoing|0
10891327|NCT01613118|12057530|FG002|COMPLETED|Open-label Extension|OLE ongoing|0
10891328|NCT01613118|12057531|FG003|COMPLETED|Open-label Extension||0
10891329|NCT01613118|12057528|FG000|NOT COMPLETED|Open-label Extension||21
10891330|NCT01613118|12057529|FG001|NOT COMPLETED|Open-label Extension||42
10891331|NCT01613118|12057530|FG002|NOT COMPLETED|Open-label Extension||40
10891332|NCT01613118|12057531|FG003|NOT COMPLETED|Open-label Extension||0
10891333|NCT01603407|12057545|FG000|STARTED|Overall Study||65
10891334|NCT01603407|12057546|FG001|STARTED|Overall Study||65
10891335|NCT01603407|12057547|FG002|STARTED|Overall Study||66
10891336|NCT01603407|12057545|FG000|COMPLETED|Overall Study||54
10891337|NCT01603407|12057546|FG001|COMPLETED|Overall Study||54
10891338|NCT01603407|12057547|FG002|COMPLETED|Overall Study||56
10891339|NCT01603407|12057545|FG000|NOT COMPLETED|Overall Study||11
10891340|NCT01603407|12057546|FG001|NOT COMPLETED|Overall Study||11
10891341|NCT01603407|12057547|FG002|NOT COMPLETED|Overall Study||10
10891342|NCT01602380|12057557|FG000|STARTED|Overall Study||230
10891343|NCT01602380|12057558|FG001|STARTED|Overall Study||232
10891344|NCT01602380|12057557|FG000|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
10891345|NCT01602380|12057558|FG001|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
10891346|NCT01602380|12057557|FG000|NOT COMPLETED|Overall Study||93
10891347|NCT01602380|12057558|FG001|NOT COMPLETED|Overall Study||101
10891348|NCT01598311|12057566|FG000|STARTED|Overall Study||303
10891349|NCT01598311|12057567|FG001|STARTED|Overall Study||305
10891350|NCT01598311|12057566|FG000|Treated|Overall Study||294
10891351|NCT01598311|12057567|FG001|Treated|Overall Study||301
10891352|NCT01598311|12057566|FG000|Treated and Confirmed CDAD|Overall Study||285
10891353|NCT01598311|12057567|FG001|Treated and Confirmed CDAD|Overall Study||292
10891354|NCT01598311|12057566|FG000|COMPLETED|Overall Study||256
10891355|NCT01598311|12057567|FG001|COMPLETED|Overall Study||244
10891356|NCT01598311|12057566|FG000|NOT COMPLETED|Overall Study||47
10891357|NCT01598311|12057567|FG001|NOT COMPLETED|Overall Study||61
10891358|NCT01597388|12057582|FG000|STARTED|Overall Study||6
10891359|NCT01597388|12057583|FG001|STARTED|Overall Study||13
10891360|NCT01597388|12057584|FG002|STARTED|Overall Study||14
10891361|NCT01597388|12057585|FG003|STARTED|Overall Study||10
10891362|NCT01597388|12057586|FG004|STARTED|Overall Study||37
10891363|NCT01597388|12057587|FG005|STARTED|Overall Study||4
10891364|NCT01597388|12057588|FG006|STARTED|Overall Study||8
10891365|NCT01597388|12057589|FG007|STARTED|Overall Study||5
10891366|NCT01597388|12057590|FG008|STARTED|Overall Study||2
10891367|NCT01597388|12057582|FG000|COMPLETED|Overall Study||6
10891368|NCT01597388|12057583|FG001|COMPLETED|Overall Study||13
10891369|NCT01597388|12057584|FG002|COMPLETED|Overall Study||14
10891370|NCT01597388|12057585|FG003|COMPLETED|Overall Study||10
10891371|NCT01597388|12057586|FG004|COMPLETED|Overall Study||37
10891372|NCT01597388|12057587|FG005|COMPLETED|Overall Study||4
10891373|NCT01597388|12057588|FG006|COMPLETED|Overall Study||8
10891374|NCT01597388|12057589|FG007|COMPLETED|Overall Study||5
10891375|NCT01597388|12057590|FG008|COMPLETED|Overall Study||2
10891376|NCT01597388|12057582|FG000|NOT COMPLETED|Overall Study||0
10891377|NCT01597388|12057583|FG001|NOT COMPLETED|Overall Study||0
10891378|NCT01597388|12057584|FG002|NOT COMPLETED|Overall Study||0
10891379|NCT01597388|12057585|FG003|NOT COMPLETED|Overall Study||0
10891380|NCT01597388|12057586|FG004|NOT COMPLETED|Overall Study||0
10891381|NCT01597388|12057587|FG005|NOT COMPLETED|Overall Study||0
10891382|NCT01597388|12057588|FG006|NOT COMPLETED|Overall Study||0
10891383|NCT01597388|12057589|FG007|NOT COMPLETED|Overall Study||0
10891384|NCT01597388|12057590|FG008|NOT COMPLETED|Overall Study||0
10891385|NCT01593761|12057627|FG000|STARTED|Overall Study||20
10891386|NCT01593761|12057627|FG000|COMPLETED|Overall Study||12
10891387|NCT01593761|12057627|FG000|NOT COMPLETED|Overall Study||8
10891402|NCT01592721|12057647|FG000|STARTED|Treatment Period||6
10891403|NCT01592721|12057647|FG000|COMPLETED|Treatment Period||6
10891404|NCT01592721|12057647|FG000|NOT COMPLETED|Treatment Period||0
10891405|NCT01592721|12057647|FG000|STARTED|Long-term Follow-up||6
10891406|NCT01592721|12057647|FG000|COMPLETED|Long-term Follow-up||5
10891407|NCT01592721|12057647|FG000|NOT COMPLETED|Long-term Follow-up||1
10891408|NCT01592370|12057658|FG000|STARTED|Overall Study||105
10891409|NCT01592370|12057659|FG001|STARTED|Overall Study||65
10891410|NCT01592370|12057660|FG002|STARTED|Overall Study||72
10891411|NCT01592370|12057661|FG003|STARTED|Overall Study||6
10891412|NCT01592370|12057662|FG004|STARTED|Overall Study||5
10891413|NCT01592370|12057663|FG005|STARTED|Overall Study||41
10891414|NCT01592370|12057664|FG006|STARTED|Overall Study||22
10891415|NCT01592370|12057658|FG000|COMPLETED|Overall Study||1
10891416|NCT01592370|12057659|FG001|COMPLETED|Overall Study||40
10891417|NCT01592370|12057660|FG002|COMPLETED|Overall Study||0
10891418|NCT01592370|12057661|FG003|COMPLETED|Overall Study||1
10891419|NCT01592370|12057662|FG004|COMPLETED|Overall Study||1
10891420|NCT01592370|12057663|FG005|COMPLETED|Overall Study||7
10891421|NCT01592370|12057664|FG006|COMPLETED|Overall Study||6
10891422|NCT01592370|12057658|FG000|NOT COMPLETED|Overall Study||104
10891423|NCT01592370|12057659|FG001|NOT COMPLETED|Overall Study||25
10891424|NCT01592370|12057660|FG002|NOT COMPLETED|Overall Study||72
10891425|NCT01592370|12057661|FG003|NOT COMPLETED|Overall Study||5
10891426|NCT01592370|12057662|FG004|NOT COMPLETED|Overall Study||4
10891427|NCT01592370|12057663|FG005|NOT COMPLETED|Overall Study||34
10891428|NCT01592370|12057664|FG006|NOT COMPLETED|Overall Study||16
10891429|NCT01590017|12057684|FG000|STARTED|Overall Study||41
10891430|NCT01590017|12057684|FG000|COMPLETED|Overall Study||37
10891431|NCT01590017|12057684|FG000|NOT COMPLETED|Overall Study||4
10891432|NCT01582009|12057688|FG000|STARTED|Overall Study||26
10891433|NCT01582009|12057688|FG000|COMPLETED|Overall Study||24
10891434|NCT01582009|12057688|FG000|NOT COMPLETED|Overall Study||2
10891435|NCT01575834|12057694|FG000|STARTED|Overall Study||3591
10891436|NCT01575834|12057695|FG001|STARTED|Overall Study||3589
10891437|NCT01575834|12057694|FG000|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
10891438|NCT01575834|12057695|FG001|Received Double-blind Treatment|Overall Study||3575
10891439|NCT01575834|12057694|FG000|Completed Double-blind Period|Overall Study||3205
10891440|NCT01575834|12057695|FG001|Completed Double-blind Period|Overall Study||3185
10891441|NCT01575834|12057694|FG000|Completed 24-month Study Period|Overall Study||3032
10891442|NCT01575834|12057695|FG001|Completed 24-month Study Period|Overall Study||2994
10891443|NCT01575834|12057694|FG000|COMPLETED|Overall Study|Completed 36-month study period|2892
10891444|NCT01575834|12057695|FG001|COMPLETED|Overall Study|Completed 36-month study period|2851
10891445|NCT01575834|12057694|FG000|NOT COMPLETED|Overall Study||699
10891446|NCT01575834|12057695|FG001|NOT COMPLETED|Overall Study||738
10891461|NCT01572480|12057714|FG000|STARTED|Participants Enrolled||55
10891462|NCT01572480|12057714|FG000|COMPLETED|Participants Enrolled||54
10891463|NCT01572480|12057714|FG000|NOT COMPLETED|Participants Enrolled||1
10891464|NCT01572480|12057714|FG000|STARTED|Drug Administration||54
10891465|NCT01572480|12057714|FG000|COMPLETED|Drug Administration|2 participants discontinued drug administration early because of adverse events, thus 1 was taken off study and 1 proceeded to maintenance.|53
10891466|NCT01572480|12057714|FG000|NOT COMPLETED|Drug Administration||1
10891467|NCT01572480|12057714|FG000|STARTED|Initiated Maintenance Therapy||53
10891468|NCT01572480|12057714|FG000|COMPLETED|Initiated Maintenance Therapy||50
10891469|NCT01572480|12057714|FG000|NOT COMPLETED|Initiated Maintenance Therapy||3
10891470|NCT01572480|12057714|FG000|STARTED|Completed Maintenance Therapy||50
10891471|NCT01572480|12057714|FG000|COMPLETED|Completed Maintenance Therapy||30
10891472|NCT01572480|12057714|FG000|NOT COMPLETED|Completed Maintenance Therapy||20
10891473|NCT01568866|12057720|FG000|STARTED|Overall Study||465
10891474|NCT01568866|12057721|FG001|STARTED|Overall Study||464
10891475|NCT01568866|12057720|FG000|Received Treatment|Overall Study||456
10891476|NCT01568866|12057721|FG001|Received Treatment|Overall Study||463
10891477|NCT01568866|12057720|FG000|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
10891478|NCT01568866|12057721|FG001|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
10891479|NCT01568866|12057720|FG000|NOT COMPLETED|Overall Study||438
10891480|NCT01568866|12057721|FG001|NOT COMPLETED|Overall Study||416
10891481|NCT01566695|12057729|FG000|STARTED|Overall Study||107
10891482|NCT01566695|12057730|FG001|STARTED|Overall Study||109
10891483|NCT01566695|12057729|FG000|COMPLETED|Overall Study||12
10891484|NCT01566695|12057730|FG001|COMPLETED|Overall Study||10
10891485|NCT01566695|12057729|FG000|NOT COMPLETED|Overall Study||95
10891486|NCT01566695|12057730|FG001|NOT COMPLETED|Overall Study||99
10891487|NCT01565382|12057736|FG000|STARTED|Overall Study||40
10891488|NCT01565382|12057736|FG000|COMPLETED|Overall Study||40
10891489|NCT01565382|12057736|FG000|NOT COMPLETED|Overall Study||0
10891490|NCT01562028|12057743|FG000|STARTED|Overall Study||37
10891491|NCT01562028|12057744|FG001|STARTED|Overall Study||72
10891492|NCT01562028|12057743|FG000|COMPLETED|Overall Study||34
10891493|NCT01562028|12057744|FG001|COMPLETED|Overall Study||70
10891494|NCT01562028|12057743|FG000|NOT COMPLETED|Overall Study||3
10891495|NCT01562028|12057744|FG001|NOT COMPLETED|Overall Study||2
10891496|NCT01555697|12057758|FG000|STARTED|Overall Study||10
10891497|NCT01555697|12057759|FG001|STARTED|Overall Study||10
10891498|NCT01555697|12057760|FG002|STARTED|Overall Study||10
10891499|NCT01555697|12057761|FG003|STARTED|Overall Study||10
10891500|NCT01555697|12057762|FG004|STARTED|Overall Study||10
10891501|NCT01555697|12057763|FG005|STARTED|Overall Study||10
10891502|NCT01555697|12057764|FG006|STARTED|Overall Study||10
10891503|NCT01555697|12057765|FG007|STARTED|Overall Study||10
10891504|NCT01555697|12057758|FG000|6 Hours Lab Testing Day 1|Overall Study||10
10891505|NCT01555697|12057759|FG001|6 Hours Lab Testing Day 1|Overall Study||10
10891506|NCT01555697|12057760|FG002|6 Hours Lab Testing Day 1|Overall Study||10
10891507|NCT01555697|12057761|FG003|6 Hours Lab Testing Day 1|Overall Study||10
10891508|NCT01555697|12057762|FG004|6 Hours Lab Testing Day 1|Overall Study||10
10891509|NCT01555697|12057763|FG005|6 Hours Lab Testing Day 1|Overall Study||10
10891510|NCT01555697|12057764|FG006|6 Hours Lab Testing Day 1|Overall Study||10
10891511|NCT01555697|12057765|FG007|6 Hours Lab Testing Day 1|Overall Study||10
10891512|NCT01555697|12057758|FG000|Approx 7 Day Washout|Overall Study||10
10891513|NCT01555697|12057759|FG001|Approx 7 Day Washout|Overall Study||10
10891514|NCT01555697|12057760|FG002|Approx 7 Day Washout|Overall Study||10
10891515|NCT01555697|12057761|FG003|Approx 7 Day Washout|Overall Study||10
10891516|NCT01555697|12057762|FG004|Approx 7 Day Washout|Overall Study||10
10891517|NCT01555697|12057763|FG005|Approx 7 Day Washout|Overall Study||10
10891518|NCT01555697|12057764|FG006|Approx 7 Day Washout|Overall Study||10
10891519|NCT01555697|12057765|FG007|Approx 7 Day Washout|Overall Study||10
10891520|NCT01555697|12057758|FG000|6 Hours Lab Testing Day 2|Overall Study||10
10891521|NCT01555697|12057759|FG001|6 Hours Lab Testing Day 2|Overall Study||10
10891522|NCT01555697|12057760|FG002|6 Hours Lab Testing Day 2|Overall Study||10
10891523|NCT01555697|12057761|FG003|6 Hours Lab Testing Day 2|Overall Study||10
10891524|NCT01555697|12057762|FG004|6 Hours Lab Testing Day 2|Overall Study||10
10891525|NCT01555697|12057763|FG005|6 Hours Lab Testing Day 2|Overall Study||10
10891526|NCT01555697|12057764|FG006|6 Hours Lab Testing Day 2|Overall Study||10
10891527|NCT01555697|12057765|FG007|6 Hours Lab Testing Day 2|Overall Study||10
10891528|NCT01555697|12057758|FG000|COMPLETED|Overall Study||10
10891529|NCT01555697|12057759|FG001|COMPLETED|Overall Study||10
10891530|NCT01555697|12057760|FG002|COMPLETED|Overall Study||10
10891531|NCT01555697|12057761|FG003|COMPLETED|Overall Study||10
10891532|NCT01555697|12057762|FG004|COMPLETED|Overall Study||10
10891533|NCT01555697|12057763|FG005|COMPLETED|Overall Study||10
10891534|NCT01555697|12057764|FG006|COMPLETED|Overall Study||10
10891535|NCT01555697|12057765|FG007|COMPLETED|Overall Study||10
10891536|NCT01555697|12057758|FG000|NOT COMPLETED|Overall Study||0
10891537|NCT01555697|12057759|FG001|NOT COMPLETED|Overall Study||0
10891538|NCT01555697|12057760|FG002|NOT COMPLETED|Overall Study||0
10891539|NCT01555697|12057761|FG003|NOT COMPLETED|Overall Study||0
10891540|NCT01555697|12057762|FG004|NOT COMPLETED|Overall Study||0
10891541|NCT01555697|12057763|FG005|NOT COMPLETED|Overall Study||0
10891542|NCT01555697|12057764|FG006|NOT COMPLETED|Overall Study||0
10891543|NCT01555697|12057765|FG007|NOT COMPLETED|Overall Study||0
10891544|NCT01553149|12057779|FG000|STARTED|Overall Study||37
10891545|NCT01553149|12057780|FG001|STARTED|Overall Study||38
10891546|NCT01553149|12057779|FG000|COMPLETED|Overall Study||32
10891547|NCT01553149|12057780|FG001|COMPLETED|Overall Study||18
10891548|NCT01553149|12057779|FG000|NOT COMPLETED|Overall Study||5
10891549|NCT01553149|12057780|FG001|NOT COMPLETED|Overall Study||20
10891550|NCT01535053|12057788|FG000|STARTED|Overall Study||29
10891551|NCT01535053|12057789|FG001|STARTED|Overall Study||28
10891552|NCT01535053|12057788|FG000|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28
10891553|NCT01535053|12057789|FG001|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26
10891554|NCT01535053|12057788|FG000|NOT COMPLETED|Overall Study||1
10891555|NCT01535053|12057789|FG001|NOT COMPLETED|Overall Study||2
10891556|NCT01522976|12057798|FG000|STARTED|Overall Study||97
10891557|NCT01522976|12057799|FG001|STARTED|Overall Study||92
10891558|NCT01522976|12057800|FG002|STARTED|Overall Study||93
10891559|NCT01522976|12057798|FG000|COMPLETED|Overall Study||0
10891560|NCT01522976|12057799|FG001|COMPLETED|Overall Study||0
10891561|NCT01522976|12057800|FG002|COMPLETED|Overall Study||0
10891562|NCT01522976|12057798|FG000|NOT COMPLETED|Overall Study||97
10891563|NCT01522976|12057799|FG001|NOT COMPLETED|Overall Study||92
10891564|NCT01522976|12057800|FG002|NOT COMPLETED|Overall Study||93
10891565|NCT01522456|12057811|FG000|STARTED|Overall Study||73
10891566|NCT01522456|12057811|FG000|COMPLETED|Overall Study||65
10891567|NCT01522456|12057811|FG000|NOT COMPLETED|Overall Study||8
10891568|NCT01522365|12057824|FG000|STARTED|Overall Study||20
10891569|NCT01522365|12057825|FG001|STARTED|Overall Study||20
10891570|NCT01522365|12057824|FG000|Intention-to-Treat|Overall Study||19
10891571|NCT01522365|12057825|FG001|Intention-to-Treat|Overall Study||19
10891572|NCT01522365|12057824|FG000|COMPLETED|Overall Study||18
10891573|NCT01522365|12057825|FG001|COMPLETED|Overall Study||18
10891574|NCT01522365|12057824|FG000|NOT COMPLETED|Overall Study||2
10891575|NCT01522365|12057825|FG001|NOT COMPLETED|Overall Study||2
10891576|NCT01517711|12057834|FG000|STARTED|Overall Study||22
10891577|NCT01517711|12057835|FG001|STARTED|Overall Study||18
10891578|NCT01517711|12057834|FG000|COMPLETED|Overall Study||20
10891579|NCT01517711|12057835|FG001|COMPLETED|Overall Study||15
10891580|NCT01517711|12057834|FG000|NOT COMPLETED|Overall Study||2
10891581|NCT01517711|12057835|FG001|NOT COMPLETED|Overall Study||3
10891582|NCT01496976|12057845|FG000|STARTED|Overall Study||45
10891583|NCT01496976|12057845|FG000|COMPLETED|Overall Study||44
10891584|NCT01496976|12057845|FG000|NOT COMPLETED|Overall Study||1
10891585|NCT01490502|12057851|FG000|STARTED|Overall Study||83
10891586|NCT01490502|12057852|FG001|STARTED|Overall Study||89
10891587|NCT01490502|12057851|FG000|Received Allocated Intervention|Overall Study||83
10891588|NCT01490502|12057852|FG001|Received Allocated Intervention|Overall Study||88
10891589|NCT01490502|12057851|FG000|Attended at Least 1 Follow-up Visit|Overall Study||82
10891590|NCT01490502|12057852|FG001|Attended at Least 1 Follow-up Visit|Overall Study||83
10891591|NCT01490502|12057851|FG000|COMPLETED|Overall Study||68
10891592|NCT01490502|12057852|FG001|COMPLETED|Overall Study||72
10891593|NCT01490502|12057851|FG000|NOT COMPLETED|Overall Study||15
10891594|NCT01490502|12057852|FG001|NOT COMPLETED|Overall Study||17
10891595|NCT01485614|12057862|FG000|STARTED|Randomization||96
10891596|NCT01485614|12057863|FG001|STARTED|Randomization||90
10891597|NCT01485614|12057864|FG002|STARTED|Randomization||9
10891598|NCT01485614|12057865|FG003|STARTED|Randomization||5
10891599|NCT01485614|12057862|FG000|COMPLETED|Randomization||95
10891600|NCT01485614|12057863|FG001|COMPLETED|Randomization||90
10891601|NCT01485614|12057864|FG002|COMPLETED|Randomization||9
10891602|NCT01485614|12057865|FG003|COMPLETED|Randomization||5
10891603|NCT01485614|12057862|FG000|NOT COMPLETED|Randomization||1
10891604|NCT01485614|12057863|FG001|NOT COMPLETED|Randomization||0
10891605|NCT01485614|12057864|FG002|NOT COMPLETED|Randomization||0
10891606|NCT01485614|12057865|FG003|NOT COMPLETED|Randomization||0
10891607|NCT01485614|12057862|FG000|STARTED|Weeks 0-20||95
10891608|NCT01485614|12057863|FG001|STARTED|Weeks 0-20||90
10891609|NCT01485614|12057864|FG002|STARTED|Weeks 0-20||9
10891610|NCT01485614|12057865|FG003|STARTED|Weeks 0-20||5
10891611|NCT01485614|12057862|FG000|Treated|Weeks 0-20||95
10891612|NCT01485614|12057863|FG001|Treated|Weeks 0-20||90
10891613|NCT01485614|12057864|FG002|Treated|Weeks 0-20||9
10891614|NCT01485614|12057865|FG003|Treated|Weeks 0-20||5
10891615|NCT01485614|12057862|FG000|COMPLETED|Weeks 0-20||85
10891616|NCT01485614|12057863|FG001|COMPLETED|Weeks 0-20||86
10891617|NCT01485614|12057864|FG002|COMPLETED|Weeks 0-20||8
10891618|NCT01485614|12057865|FG003|COMPLETED|Weeks 0-20||5
10891619|NCT01485614|12057862|FG000|NOT COMPLETED|Weeks 0-20||10
10891620|NCT01485614|12057863|FG001|NOT COMPLETED|Weeks 0-20||4
10891621|NCT01485614|12057864|FG002|NOT COMPLETED|Weeks 0-20||1
10891622|NCT01485614|12057865|FG003|NOT COMPLETED|Weeks 0-20||0
10891623|NCT01485614|12057862|FG000|STARTED|Weeks 20-54||85
10891624|NCT01485614|12057863|FG001|STARTED|Weeks 20-54||86
10891625|NCT01485614|12057864|FG002|STARTED|Weeks 20-54||8
10891626|NCT01485614|12057865|FG003|STARTED|Weeks 20-54||5
10891627|NCT01485614|12057862|FG000|COMPLETED|Weeks 20-54||74
10891628|NCT01485614|12057863|FG001|COMPLETED|Weeks 20-54||78
10891629|NCT01485614|12057864|FG002|COMPLETED|Weeks 20-54||6
10891630|NCT01485614|12057865|FG003|COMPLETED|Weeks 20-54||5
10891631|NCT01485614|12057862|FG000|NOT COMPLETED|Weeks 20-54||11
10891632|NCT01485614|12057863|FG001|NOT COMPLETED|Weeks 20-54||8
10891633|NCT01485614|12057864|FG002|NOT COMPLETED|Weeks 20-54||2
10891634|NCT01485614|12057865|FG003|NOT COMPLETED|Weeks 20-54||0
10891635|NCT01471522|12057883|FG000|STARTED|Overall Study||2588
10891636|NCT01471522|12057884|FG001|STARTED|Overall Study||2591
10891637|NCT01471522|12057883|FG000|COMPLETED|Overall Study||2524
10891638|NCT01471522|12057884|FG001|COMPLETED|Overall Study||2543
10891639|NCT01471522|12057883|FG000|NOT COMPLETED|Overall Study||64
10891640|NCT01471522|12057884|FG001|NOT COMPLETED|Overall Study||48
10891641|NCT01462630|12057891|FG000|STARTED|Overall Study||29
10891642|NCT01462630|12057891|FG000|COMPLETED|Overall Study||22
10891643|NCT01462630|12057891|FG000|NOT COMPLETED|Overall Study||7
10891644|NCT01458366|12057900|FG000|STARTED|Period 1: 70mg/m^2||5
10891645|NCT01458366|12057901|FG001|STARTED|Period 1: 70mg/m^2||0
10891646|NCT01458366|12057902|FG002|STARTED|Period 1: 70mg/m^2||0
10891647|NCT01458366|12057903|FG003|STARTED|Period 1: 70mg/m^2||0
10891648|NCT01458366|12057904|FG004|STARTED|Period 1: 70mg/m^2||0
10891649|NCT01458366|12057900|FG000|COMPLETED|Period 1: 70mg/m^2||3
10891650|NCT01458366|12057901|FG001|COMPLETED|Period 1: 70mg/m^2||0
10891651|NCT01458366|12057902|FG002|COMPLETED|Period 1: 70mg/m^2||0
10891652|NCT01458366|12057903|FG003|COMPLETED|Period 1: 70mg/m^2||0
10891653|NCT01458366|12057904|FG004|COMPLETED|Period 1: 70mg/m^2||0
10891654|NCT01458366|12057900|FG000|NOT COMPLETED|Period 1: 70mg/m^2||2
10891655|NCT01458366|12057901|FG001|NOT COMPLETED|Period 1: 70mg/m^2||0
10891656|NCT01458366|12057902|FG002|NOT COMPLETED|Period 1: 70mg/m^2||0
10891657|NCT01458366|12057903|FG003|NOT COMPLETED|Period 1: 70mg/m^2||0
10891658|NCT01458366|12057904|FG004|NOT COMPLETED|Period 1: 70mg/m^2||0
10891659|NCT01458366|12057900|FG000|STARTED|Period 2: 50mg/m^2||0
10891660|NCT01458366|12057901|FG001|STARTED|Period 2: 50mg/m^2||0
10891661|NCT01458366|12057902|FG002|STARTED|Period 2: 50mg/m^2||0
10891662|NCT01458366|12057903|FG003|STARTED|Period 2: 50mg/m^2||0
10891663|NCT01458366|12057904|FG004|STARTED|Period 2: 50mg/m^2||0
10891664|NCT01458366|12057900|FG000|COMPLETED|Period 2: 50mg/m^2||0
10891665|NCT01458366|12057901|FG001|COMPLETED|Period 2: 50mg/m^2||0
10891666|NCT01458366|12057902|FG002|COMPLETED|Period 2: 50mg/m^2||0
10891667|NCT01458366|12057903|FG003|COMPLETED|Period 2: 50mg/m^2||0
10891668|NCT01458366|12057904|FG004|COMPLETED|Period 2: 50mg/m^2||0
10891669|NCT01458366|12057900|FG000|NOT COMPLETED|Period 2: 50mg/m^2||0
10891670|NCT01458366|12057901|FG001|NOT COMPLETED|Period 2: 50mg/m^2||0
10891671|NCT01458366|12057902|FG002|NOT COMPLETED|Period 2: 50mg/m^2||0
10891672|NCT01458366|12057903|FG003|NOT COMPLETED|Period 2: 50mg/m^2||0
10891673|NCT01458366|12057904|FG004|NOT COMPLETED|Period 2: 50mg/m^2||0
10891674|NCT01458366|12057900|FG000|STARTED|Period 3: 90mg/m^2||0
10891675|NCT01458366|12057901|FG001|STARTED|Period 3: 90mg/m^2||0
10891676|NCT01458366|12057902|FG002|STARTED|Period 3: 90mg/m^2||3
10891677|NCT01458366|12057903|FG003|STARTED|Period 3: 90mg/m^2||0
10891678|NCT01458366|12057904|FG004|STARTED|Period 3: 90mg/m^2||0
10891679|NCT01458366|12057900|FG000|COMPLETED|Period 3: 90mg/m^2||0
10891680|NCT01458366|12057901|FG001|COMPLETED|Period 3: 90mg/m^2||0
10891681|NCT01458366|12057902|FG002|COMPLETED|Period 3: 90mg/m^2||3
10891682|NCT01458366|12057903|FG003|COMPLETED|Period 3: 90mg/m^2||0
10891683|NCT01458366|12057904|FG004|COMPLETED|Period 3: 90mg/m^2||0
10891684|NCT01458366|12057900|FG000|NOT COMPLETED|Period 3: 90mg/m^2||0
10891685|NCT01458366|12057901|FG001|NOT COMPLETED|Period 3: 90mg/m^2||0
10891686|NCT01458366|12057902|FG002|NOT COMPLETED|Period 3: 90mg/m^2||0
10891687|NCT01458366|12057903|FG003|NOT COMPLETED|Period 3: 90mg/m^2||0
10891688|NCT01458366|12057904|FG004|NOT COMPLETED|Period 3: 90mg/m^2||0
10891689|NCT01458366|12057900|FG000|STARTED|Period 4: 120mg/m^2||0
10891690|NCT01458366|12057901|FG001|STARTED|Period 4: 120mg/m^2||0
10891691|NCT01458366|12057902|FG002|STARTED|Period 4: 120mg/m^2||0
10891692|NCT01458366|12057903|FG003|STARTED|Period 4: 120mg/m^2||3
10891693|NCT01458366|12057904|FG004|STARTED|Period 4: 120mg/m^2||0
10891694|NCT01458366|12057900|FG000|COMPLETED|Period 4: 120mg/m^2||0
10891695|NCT01458366|12057901|FG001|COMPLETED|Period 4: 120mg/m^2||0
10891696|NCT01458366|12057902|FG002|COMPLETED|Period 4: 120mg/m^2||0
10891697|NCT01458366|12057903|FG003|COMPLETED|Period 4: 120mg/m^2||3
10891698|NCT01458366|12057904|FG004|COMPLETED|Period 4: 120mg/m^2||0
10891699|NCT01458366|12057900|FG000|NOT COMPLETED|Period 4: 120mg/m^2||0
10891700|NCT01458366|12057901|FG001|NOT COMPLETED|Period 4: 120mg/m^2||0
10891701|NCT01458366|12057902|FG002|NOT COMPLETED|Period 4: 120mg/m^2||0
10891702|NCT01458366|12057903|FG003|NOT COMPLETED|Period 4: 120mg/m^2||0
10891703|NCT01458366|12057904|FG004|NOT COMPLETED|Period 4: 120mg/m^2||0
10891704|NCT01458366|12057900|FG000|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
10891705|NCT01458366|12057901|FG001|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
10891706|NCT01458366|12057902|FG002|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
10891707|NCT01458366|12057903|FG003|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
10891708|NCT01458366|12057904|FG004|STARTED|Period 5: Maximum Tolerated Dose (MTD)||27
10891709|NCT01458366|12057900|FG000|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891710|NCT01458366|12057901|FG001|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891711|NCT01458366|12057902|FG002|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891712|NCT01458366|12057903|FG003|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891713|NCT01458366|12057904|FG004|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||26
10891714|NCT01458366|12057900|FG000|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891715|NCT01458366|12057901|FG001|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891716|NCT01458366|12057902|FG002|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891717|NCT01458366|12057903|FG003|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
10891718|NCT01458366|12057904|FG004|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||1
10891719|NCT01452919|12057912|FG000|STARTED|Open-Label Treatment|During the open label treatment, all patients received LY2140023 monotherapy (first column); no patients were randomized yet (thus, 0 patients listed in column 2 and 3)|123
10891720|NCT01452919|12057913|FG001|STARTED|Open-Label Treatment||0
10891721|NCT01452919|12057914|FG002|STARTED|Open-Label Treatment||0
10891722|NCT01452919|12057912|FG000|Received at Least 1 Dose of Study Drug|Open-Label Treatment||123
10891723|NCT01452919|12057913|FG001|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0
10891724|NCT01452919|12057914|FG002|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0
10891725|NCT01452919|12057912|FG000|COMPLETED|Open-Label Treatment||103
10891726|NCT01452919|12057913|FG001|COMPLETED|Open-Label Treatment||0
10891727|NCT01452919|12057914|FG002|COMPLETED|Open-Label Treatment||0
10891728|NCT01452919|12057912|FG000|NOT COMPLETED|Open-Label Treatment||20
10891729|NCT01452919|12057913|FG001|NOT COMPLETED|Open-Label Treatment||0
10891730|NCT01452919|12057914|FG002|NOT COMPLETED|Open-Label Treatment||0
10891731|NCT01452919|12057912|FG000|STARTED|Randomization Treatment||0
10891732|NCT01452919|12057913|FG001|STARTED|Randomization Treatment|For randomization treatment, the 103 completers of the open label period above were assigned to placebo (50 patients; column 2) and LY2140023 (randomization) (53 patients) (column 3)|50
10891733|NCT01452919|12057914|FG002|STARTED|Randomization Treatment|For randomization treatment, the 103 completers of the open label period above were assigned to placebo (50 patients; column 2) and LY2140023 (randomization) (53 patients) (column 3)|53
10891734|NCT01452919|12057912|FG000|Received at Least 1 Dose of Study Drug|Randomization Treatment||0
10891735|NCT01452919|12057913|FG001|Received at Least 1 Dose of Study Drug|Randomization Treatment||50
10891736|NCT01452919|12057914|FG002|Received at Least 1 Dose of Study Drug|Randomization Treatment||53
10891737|NCT01452919|12057912|FG000|COMPLETED|Randomization Treatment||0
10891738|NCT01452919|12057913|FG001|COMPLETED|Randomization Treatment||47
10891739|NCT01452919|12057914|FG002|COMPLETED|Randomization Treatment||51
10891740|NCT01452919|12057912|FG000|NOT COMPLETED|Randomization Treatment||0
10891741|NCT01452919|12057913|FG001|NOT COMPLETED|Randomization Treatment||3
10891742|NCT01452919|12057914|FG002|NOT COMPLETED|Randomization Treatment||2
10891743|NCT01450631|12057926|FG000|STARTED|Overall Study||46
10891744|NCT01450631|12057927|FG001|STARTED|Overall Study||46
10891745|NCT01450631|12057926|FG000|COMPLETED|Overall Study||43
10891746|NCT01450631|12057927|FG001|COMPLETED|Overall Study||42
10891747|NCT01450631|12057926|FG000|NOT COMPLETED|Overall Study||3
10891748|NCT01450631|12057927|FG001|NOT COMPLETED|Overall Study||4
10891749|NCT01439880|12057935|FG000|STARTED|SOC-controlled Period (Year 1)||442
10891750|NCT01439880|12057936|FG001|STARTED|SOC-controlled Period (Year 1)||882
10891751|NCT01439880|12057935|FG000|Received Evolocumab|SOC-controlled Period (Year 1)||0
10891752|NCT01439880|12057936|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||881
10891753|NCT01439880|12057935|FG000|COMPLETED|SOC-controlled Period (Year 1)||398
10891754|NCT01439880|12057936|FG001|COMPLETED|SOC-controlled Period (Year 1)||822
10891755|NCT01439880|12057935|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||44
10891756|NCT01439880|12057936|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||60
10891757|NCT01439880|12057935|FG000|STARTED|All-IP Period (Years 2 to 5)||398
10891758|NCT01439880|12057936|FG001|STARTED|All-IP Period (Years 2 to 5)||822
10891759|NCT01439880|12057935|FG000|Received Evolocumab|All-IP Period (Years 2 to 5)||374
10891760|NCT01439880|12057936|FG001|Received Evolocumab|All-IP Period (Years 2 to 5)||777
10891761|NCT01439880|12057935|FG000|COMPLETED|All-IP Period (Years 2 to 5)||328
10891762|NCT01439880|12057936|FG001|COMPLETED|All-IP Period (Years 2 to 5)||682
10891763|NCT01439880|12057935|FG000|NOT COMPLETED|All-IP Period (Years 2 to 5)||70
10891764|NCT01439880|12057936|FG001|NOT COMPLETED|All-IP Period (Years 2 to 5)||140
10891765|NCT01431755|12057953|FG000|STARTED|Overall Study||54
10891766|NCT01431755|12057953|FG000|COMPLETED|Overall Study||49
10891767|NCT01431755|12057953|FG000|NOT COMPLETED|Overall Study||5
10891768|NCT01428024|12057961|FG000|STARTED|Overall Study||30
10891769|NCT01428024|12057962|FG001|STARTED|Overall Study||30
10891770|NCT01428024|12057961|FG000|COMPLETED|Overall Study||29
10891771|NCT01428024|12057962|FG001|COMPLETED|Overall Study||29
10891772|NCT01428024|12057961|FG000|NOT COMPLETED|Overall Study||1
10891773|NCT01428024|12057962|FG001|NOT COMPLETED|Overall Study||1
10891774|NCT01426269|12057979|FG000|STARTED|Period 1: 12 Weeks||235
10891775|NCT01426269|12057980|FG001|STARTED|Period 1: 12 Weeks||0
10891776|NCT01426269|12057981|FG002|STARTED|Period 1: 12 Weeks||0
10891777|NCT01426269|12057979|FG000|COMPLETED|Period 1: 12 Weeks||180
10891778|NCT01426269|12057980|FG001|COMPLETED|Period 1: 12 Weeks||0
10891779|NCT01426269|12057981|FG002|COMPLETED|Period 1: 12 Weeks||0
10891780|NCT01426269|12057979|FG000|NOT COMPLETED|Period 1: 12 Weeks||55
10891781|NCT01426269|12057980|FG001|NOT COMPLETED|Period 1: 12 Weeks||0
10891782|NCT01426269|12057981|FG002|NOT COMPLETED|Period 1: 12 Weeks||0
10891783|NCT01426269|12057979|FG000|STARTED|Eligibility for Period 2, Randomization||180
10891784|NCT01426269|12057980|FG001|STARTED|Eligibility for Period 2, Randomization||0
10891785|NCT01426269|12057981|FG002|STARTED|Eligibility for Period 2, Randomization||0
10891786|NCT01426269|12057979|FG000|COMPLETED|Eligibility for Period 2, Randomization||130
10891787|NCT01426269|12057980|FG001|COMPLETED|Eligibility for Period 2, Randomization||0
10891788|NCT01426269|12057981|FG002|COMPLETED|Eligibility for Period 2, Randomization||0
10891789|NCT01426269|12057979|FG000|NOT COMPLETED|Eligibility for Period 2, Randomization||50
10891790|NCT01426269|12057980|FG001|NOT COMPLETED|Eligibility for Period 2, Randomization||0
10891791|NCT01426269|12057981|FG002|NOT COMPLETED|Eligibility for Period 2, Randomization||0
10891792|NCT01426269|12057979|FG000|STARTED|Period 2: 40 Weeks||0
10891793|NCT01426269|12057980|FG001|STARTED|Period 2: 40 Weeks||65
10891794|NCT01426269|12057981|FG002|STARTED|Period 2: 40 Weeks||65
10891795|NCT01426269|12057979|FG000|COMPLETED|Period 2: 40 Weeks||0
10891796|NCT01426269|12057980|FG001|COMPLETED|Period 2: 40 Weeks||27
10891797|NCT01426269|12057981|FG002|COMPLETED|Period 2: 40 Weeks||18
10891798|NCT01426269|12057979|FG000|NOT COMPLETED|Period 2: 40 Weeks||0
10891799|NCT01426269|12057980|FG001|NOT COMPLETED|Period 2: 40 Weeks||38
10891800|NCT01426269|12057981|FG002|NOT COMPLETED|Period 2: 40 Weeks||47
10891801|NCT01420926|12057994|FG000|STARTED|Overall Study||82
10891802|NCT01420926|12057995|FG001|STARTED|Overall Study||81
10891803|NCT01420926|12057994|FG000|COMPLETED|Overall Study||22
10891804|NCT01420926|12057995|FG001|COMPLETED|Overall Study||16
10891805|NCT01420926|12057994|FG000|NOT COMPLETED|Overall Study||60
10891806|NCT01420926|12057995|FG001|NOT COMPLETED|Overall Study||65
10891807|NCT01417234|12058001|FG000|STARTED|Overall Study||30
10891808|NCT01417234|12058001|FG000|COMPLETED|Overall Study||27
10891809|NCT01417234|12058001|FG000|NOT COMPLETED|Overall Study||3
10891810|NCT01415440|12058008|FG000|STARTED|Overall Study||41
10891811|NCT01415440|12058009|FG001|STARTED|Overall Study||29
10891812|NCT01415440|12058010|FG002|STARTED|Overall Study||29
10891813|NCT01415440|12058008|FG000|COMPLETED|Overall Study||37
10891814|NCT01415440|12058009|FG001|COMPLETED|Overall Study||28
10891815|NCT01415440|12058010|FG002|COMPLETED|Overall Study||27
10891816|NCT01415440|12058008|FG000|NOT COMPLETED|Overall Study||4
10891817|NCT01415440|12058009|FG001|NOT COMPLETED|Overall Study||1
10891818|NCT01415440|12058010|FG002|NOT COMPLETED|Overall Study||2
10891819|NCT01393522|12058019|FG000|STARTED|Overall Study||19
10891820|NCT01393522|12058020|FG001|STARTED|Overall Study||18
10891821|NCT01393522|12058019|FG000|COMPLETED|Overall Study||12
10891822|NCT01393522|12058020|FG001|COMPLETED|Overall Study||14
10891823|NCT01393522|12058019|FG000|NOT COMPLETED|Overall Study||7
10891824|NCT01393522|12058020|FG001|NOT COMPLETED|Overall Study||4
10891825|NCT01393314|12058028|FG000|STARTED|Overall Study||54
10891826|NCT01393314|12058029|FG001|STARTED|Overall Study||45
10891827|NCT01393314|12058028|FG000|COMPLETED|Overall Study||54
10891828|NCT01393314|12058029|FG001|COMPLETED|Overall Study||45
10891829|NCT01393314|12058028|FG000|NOT COMPLETED|Overall Study||0
10891830|NCT01393314|12058029|FG001|NOT COMPLETED|Overall Study||0
10891831|NCT01386385|12058041|FG000|STARTED|Phase I 40mg: Concurrent CRT||8
10891832|NCT01386385|12058042|FG001|STARTED|Phase I 40mg: Concurrent CRT||0
10891833|NCT01386385|12058043|FG002|STARTED|Phase I 40mg: Concurrent CRT||0
10891834|NCT01386385|12058044|FG003|STARTED|Phase I 40mg: Concurrent CRT||0
10891835|NCT01386385|12058045|FG004|STARTED|Phase I 40mg: Concurrent CRT||0
10891836|NCT01386385|12058046|FG005|STARTED|Phase I 40mg: Concurrent CRT||0
10891837|NCT01386385|12058047|FG006|STARTED|Phase I 40mg: Concurrent CRT||0
10891838|NCT01386385|12058048|FG007|STARTED|Phase I 40mg: Concurrent CRT||0
10891839|NCT01386385|12058041|FG000|COMPLETED|Phase I 40mg: Concurrent CRT||6
10891840|NCT01386385|12058042|FG001|COMPLETED|Phase I 40mg: Concurrent CRT||0
10891841|NCT01386385|12058043|FG002|COMPLETED|Phase I 40mg: Concurrent CRT||0
10891842|NCT01386385|12058044|FG003|COMPLETED|Phase I 40mg: Concurrent CRT||0
10891843|NCT01386385|12058045|FG004|COMPLETED|Phase I 40mg: Concurrent CRT||0
10891844|NCT01386385|12058046|FG005|COMPLETED|Phase I 40mg: Concurrent CRT||0
10891845|NCT01386385|12058047|FG006|COMPLETED|Phase I 40mg: Concurrent CRT||0
10891846|NCT01386385|12058048|FG007|COMPLETED|Phase I 40mg: Concurrent CRT||0
10891847|NCT01386385|12058041|FG000|NOT COMPLETED|Phase I 40mg: Concurrent CRT||2
10891848|NCT01386385|12058042|FG001|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10891849|NCT01386385|12058043|FG002|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10891850|NCT01386385|12058044|FG003|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10891851|NCT01386385|12058045|FG004|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10891852|NCT01386385|12058046|FG005|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10891853|NCT01386385|12058047|FG006|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10891854|NCT01386385|12058048|FG007|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
10891855|NCT01386385|12058041|FG000|STARTED|Phase I 40mg: Consolidation Therapy||0
10891856|NCT01386385|12058042|FG001|STARTED|Phase I 40mg: Consolidation Therapy||4
10891857|NCT01386385|12058043|FG002|STARTED|Phase I 40mg: Consolidation Therapy||0
10891858|NCT01386385|12058044|FG003|STARTED|Phase I 40mg: Consolidation Therapy||0
10891859|NCT01386385|12058045|FG004|STARTED|Phase I 40mg: Consolidation Therapy||0
10891860|NCT01386385|12058046|FG005|STARTED|Phase I 40mg: Consolidation Therapy||0
10891861|NCT01386385|12058047|FG006|STARTED|Phase I 40mg: Consolidation Therapy||0
10891862|NCT01386385|12058048|FG007|STARTED|Phase I 40mg: Consolidation Therapy||0
10891863|NCT01386385|12058041|FG000|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891864|NCT01386385|12058042|FG001|COMPLETED|Phase I 40mg: Consolidation Therapy||4
10891865|NCT01386385|12058043|FG002|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891866|NCT01386385|12058044|FG003|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891867|NCT01386385|12058045|FG004|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891868|NCT01386385|12058046|FG005|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891869|NCT01386385|12058047|FG006|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891870|NCT01386385|12058048|FG007|COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891871|NCT01386385|12058041|FG000|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891872|NCT01386385|12058042|FG001|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891873|NCT01386385|12058043|FG002|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891874|NCT01386385|12058044|FG003|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891875|NCT01386385|12058045|FG004|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891876|NCT01386385|12058046|FG005|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891877|NCT01386385|12058047|FG006|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891878|NCT01386385|12058048|FG007|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
10891879|NCT01386385|12058041|FG000|STARTED|Phase I 80mg: Concurrent CRT||0
10891880|NCT01386385|12058042|FG001|STARTED|Phase I 80mg: Concurrent CRT||0
10891881|NCT01386385|12058043|FG002|STARTED|Phase I 80mg: Concurrent CRT||7
10891882|NCT01386385|12058044|FG003|STARTED|Phase I 80mg: Concurrent CRT||0
10891883|NCT01386385|12058045|FG004|STARTED|Phase I 80mg: Concurrent CRT||0
10891884|NCT01386385|12058046|FG005|STARTED|Phase I 80mg: Concurrent CRT||0
10891885|NCT01386385|12058047|FG006|STARTED|Phase I 80mg: Concurrent CRT||0
10891886|NCT01386385|12058048|FG007|STARTED|Phase I 80mg: Concurrent CRT||0
10891887|NCT01386385|12058041|FG000|COMPLETED|Phase I 80mg: Concurrent CRT||0
10891888|NCT01386385|12058042|FG001|COMPLETED|Phase I 80mg: Concurrent CRT||0
10891889|NCT01386385|12058043|FG002|COMPLETED|Phase I 80mg: Concurrent CRT||5
10891890|NCT01386385|12058044|FG003|COMPLETED|Phase I 80mg: Concurrent CRT||0
10891891|NCT01386385|12058045|FG004|COMPLETED|Phase I 80mg: Concurrent CRT||0
10891892|NCT01386385|12058046|FG005|COMPLETED|Phase I 80mg: Concurrent CRT||0
10891893|NCT01386385|12058047|FG006|COMPLETED|Phase I 80mg: Concurrent CRT||0
10891894|NCT01386385|12058048|FG007|COMPLETED|Phase I 80mg: Concurrent CRT||0
10891895|NCT01386385|12058041|FG000|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10891896|NCT01386385|12058042|FG001|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10891897|NCT01386385|12058043|FG002|NOT COMPLETED|Phase I 80mg: Concurrent CRT||2
10891898|NCT01386385|12058044|FG003|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10891899|NCT01386385|12058045|FG004|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10891900|NCT01386385|12058046|FG005|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10891901|NCT01386385|12058047|FG006|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10891902|NCT01386385|12058048|FG007|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
10891903|NCT01386385|12058041|FG000|STARTED|Phase I 80mg: Consolidation Therapy||0
10891904|NCT01386385|12058042|FG001|STARTED|Phase I 80mg: Consolidation Therapy||0
10891905|NCT01386385|12058043|FG002|STARTED|Phase I 80mg: Consolidation Therapy||0
10891906|NCT01386385|12058044|FG003|STARTED|Phase I 80mg: Consolidation Therapy||5
10891907|NCT01386385|12058045|FG004|STARTED|Phase I 80mg: Consolidation Therapy||0
10891908|NCT01386385|12058046|FG005|STARTED|Phase I 80mg: Consolidation Therapy||0
10891909|NCT01386385|12058047|FG006|STARTED|Phase I 80mg: Consolidation Therapy||0
10891910|NCT01386385|12058048|FG007|STARTED|Phase I 80mg: Consolidation Therapy||0
10891911|NCT01386385|12058041|FG000|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891912|NCT01386385|12058042|FG001|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891913|NCT01386385|12058043|FG002|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891914|NCT01386385|12058044|FG003|COMPLETED|Phase I 80mg: Consolidation Therapy||5
10891915|NCT01386385|12058045|FG004|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891916|NCT01386385|12058046|FG005|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891917|NCT01386385|12058047|FG006|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891918|NCT01386385|12058048|FG007|COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891919|NCT01386385|12058041|FG000|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891920|NCT01386385|12058042|FG001|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891921|NCT01386385|12058043|FG002|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891922|NCT01386385|12058044|FG003|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891923|NCT01386385|12058045|FG004|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891924|NCT01386385|12058046|FG005|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891925|NCT01386385|12058047|FG006|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891926|NCT01386385|12058048|FG007|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
10891927|NCT01386385|12058041|FG000|STARTED|Phase I 120mg: Concurrent CRT||0
10891928|NCT01386385|12058042|FG001|STARTED|Phase I 120mg: Concurrent CRT||0
10891929|NCT01386385|12058043|FG002|STARTED|Phase I 120mg: Concurrent CRT||0
10891930|NCT01386385|12058044|FG003|STARTED|Phase I 120mg: Concurrent CRT||0
10891931|NCT01386385|12058045|FG004|STARTED|Phase I 120mg: Concurrent CRT||6
10891932|NCT01386385|12058046|FG005|STARTED|Phase I 120mg: Concurrent CRT||0
10891933|NCT01386385|12058047|FG006|STARTED|Phase I 120mg: Concurrent CRT||0
10891934|NCT01386385|12058048|FG007|STARTED|Phase I 120mg: Concurrent CRT||0
10891935|NCT01386385|12058041|FG000|COMPLETED|Phase I 120mg: Concurrent CRT||0
10891936|NCT01386385|12058042|FG001|COMPLETED|Phase I 120mg: Concurrent CRT||0
10891937|NCT01386385|12058043|FG002|COMPLETED|Phase I 120mg: Concurrent CRT||0
10891938|NCT01386385|12058044|FG003|COMPLETED|Phase I 120mg: Concurrent CRT||0
10891939|NCT01386385|12058045|FG004|COMPLETED|Phase I 120mg: Concurrent CRT||5
10891940|NCT01386385|12058046|FG005|COMPLETED|Phase I 120mg: Concurrent CRT||0
10891941|NCT01386385|12058047|FG006|COMPLETED|Phase I 120mg: Concurrent CRT||0
10891942|NCT01386385|12058048|FG007|COMPLETED|Phase I 120mg: Concurrent CRT||0
10891943|NCT01386385|12058041|FG000|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10891944|NCT01386385|12058042|FG001|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10891945|NCT01386385|12058043|FG002|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10891946|NCT01386385|12058044|FG003|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10891947|NCT01386385|12058045|FG004|NOT COMPLETED|Phase I 120mg: Concurrent CRT||1
10891948|NCT01386385|12058046|FG005|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10891949|NCT01386385|12058047|FG006|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10891950|NCT01386385|12058048|FG007|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
10891951|NCT01386385|12058041|FG000|STARTED|Phase I 120mg: Consolidation Therapy||0
10891952|NCT01386385|12058042|FG001|STARTED|Phase I 120mg: Consolidation Therapy||0
10891953|NCT01386385|12058043|FG002|STARTED|Phase I 120mg: Consolidation Therapy||0
10891954|NCT01386385|12058044|FG003|STARTED|Phase I 120mg: Consolidation Therapy||0
10891955|NCT01386385|12058045|FG004|STARTED|Phase I 120mg: Consolidation Therapy||0
10891956|NCT01386385|12058046|FG005|STARTED|Phase I 120mg: Consolidation Therapy||5
10891957|NCT01386385|12058047|FG006|STARTED|Phase I 120mg: Consolidation Therapy||0
10891958|NCT01386385|12058048|FG007|STARTED|Phase I 120mg: Consolidation Therapy||0
10891959|NCT01386385|12058041|FG000|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891960|NCT01386385|12058042|FG001|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891961|NCT01386385|12058043|FG002|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891962|NCT01386385|12058044|FG003|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891963|NCT01386385|12058045|FG004|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891964|NCT01386385|12058046|FG005|COMPLETED|Phase I 120mg: Consolidation Therapy||5
10891965|NCT01386385|12058047|FG006|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891966|NCT01386385|12058048|FG007|COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891967|NCT01386385|12058041|FG000|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891968|NCT01386385|12058042|FG001|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891969|NCT01386385|12058043|FG002|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891970|NCT01386385|12058044|FG003|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891971|NCT01386385|12058045|FG004|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891972|NCT01386385|12058046|FG005|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891973|NCT01386385|12058047|FG006|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891974|NCT01386385|12058048|FG007|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
10891975|NCT01386385|12058041|FG000|STARTED|Phase II Concurrent CRT||0
10891976|NCT01386385|12058042|FG001|STARTED|Phase II Concurrent CRT||0
10891977|NCT01386385|12058043|FG002|STARTED|Phase II Concurrent CRT||0
10891978|NCT01386385|12058044|FG003|STARTED|Phase II Concurrent CRT||0
10891979|NCT01386385|12058045|FG004|STARTED|Phase II Concurrent CRT||0
10891980|NCT01386385|12058046|FG005|STARTED|Phase II Concurrent CRT||0
10891981|NCT01386385|12058047|FG006|STARTED|Phase II Concurrent CRT||18
10891982|NCT01386385|12058048|FG007|STARTED|Phase II Concurrent CRT||13
10891983|NCT01386385|12058041|FG000|COMPLETED|Phase II Concurrent CRT||0
10891984|NCT01386385|12058042|FG001|COMPLETED|Phase II Concurrent CRT||0
10891985|NCT01386385|12058043|FG002|COMPLETED|Phase II Concurrent CRT||0
10891986|NCT01386385|12058044|FG003|COMPLETED|Phase II Concurrent CRT||0
10891987|NCT01386385|12058045|FG004|COMPLETED|Phase II Concurrent CRT||0
10891988|NCT01386385|12058046|FG005|COMPLETED|Phase II Concurrent CRT||0
10891989|NCT01386385|12058047|FG006|COMPLETED|Phase II Concurrent CRT||12
10891990|NCT01386385|12058048|FG007|COMPLETED|Phase II Concurrent CRT||10
10891991|NCT01386385|12058041|FG000|NOT COMPLETED|Phase II Concurrent CRT||0
10891992|NCT01386385|12058042|FG001|NOT COMPLETED|Phase II Concurrent CRT||0
10891993|NCT01386385|12058043|FG002|NOT COMPLETED|Phase II Concurrent CRT||0
10891994|NCT01386385|12058044|FG003|NOT COMPLETED|Phase II Concurrent CRT||0
10891995|NCT01386385|12058045|FG004|NOT COMPLETED|Phase II Concurrent CRT||0
10891996|NCT01386385|12058046|FG005|NOT COMPLETED|Phase II Concurrent CRT||0
10891997|NCT01386385|12058047|FG006|NOT COMPLETED|Phase II Concurrent CRT||6
10891998|NCT01386385|12058048|FG007|NOT COMPLETED|Phase II Concurrent CRT||3
10891999|NCT01386385|12058041|FG000|STARTED|Phase II: Consolidation Therapy||0
10892000|NCT01386385|12058042|FG001|STARTED|Phase II: Consolidation Therapy||0
10892001|NCT01386385|12058043|FG002|STARTED|Phase II: Consolidation Therapy||0
10892002|NCT01386385|12058044|FG003|STARTED|Phase II: Consolidation Therapy||0
10892003|NCT01386385|12058045|FG004|STARTED|Phase II: Consolidation Therapy||0
10892004|NCT01386385|12058046|FG005|STARTED|Phase II: Consolidation Therapy||0
10892005|NCT01386385|12058047|FG006|STARTED|Phase II: Consolidation Therapy||13
10892006|NCT01386385|12058048|FG007|STARTED|Phase II: Consolidation Therapy||10
10892007|NCT01386385|12058041|FG000|COMPLETED|Phase II: Consolidation Therapy||0
10892008|NCT01386385|12058042|FG001|COMPLETED|Phase II: Consolidation Therapy||0
10892009|NCT01386385|12058043|FG002|COMPLETED|Phase II: Consolidation Therapy||0
10892010|NCT01386385|12058044|FG003|COMPLETED|Phase II: Consolidation Therapy||0
10892011|NCT01386385|12058045|FG004|COMPLETED|Phase II: Consolidation Therapy||0
10892012|NCT01386385|12058046|FG005|COMPLETED|Phase II: Consolidation Therapy||0
10892013|NCT01386385|12058047|FG006|COMPLETED|Phase II: Consolidation Therapy||8
10892014|NCT01386385|12058048|FG007|COMPLETED|Phase II: Consolidation Therapy||8
10892015|NCT01386385|12058041|FG000|NOT COMPLETED|Phase II: Consolidation Therapy||0
10892016|NCT01386385|12058042|FG001|NOT COMPLETED|Phase II: Consolidation Therapy||0
10892017|NCT01386385|12058043|FG002|NOT COMPLETED|Phase II: Consolidation Therapy||0
10892018|NCT01386385|12058044|FG003|NOT COMPLETED|Phase II: Consolidation Therapy||0
10892019|NCT01386385|12058045|FG004|NOT COMPLETED|Phase II: Consolidation Therapy||0
10892020|NCT01386385|12058046|FG005|NOT COMPLETED|Phase II: Consolidation Therapy||0
10892021|NCT01386385|12058047|FG006|NOT COMPLETED|Phase II: Consolidation Therapy||5
10892022|NCT01386385|12058048|FG007|NOT COMPLETED|Phase II: Consolidation Therapy||2
10892023|NCT01385176|12058071|FG000|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|63
10892024|NCT01385176|12058072|FG001|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|32
10892025|NCT01385176|12058071|FG000|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|62
10892026|NCT01385176|12058072|FG001|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|30
10892027|NCT01385176|12058071|FG000|NOT COMPLETED|Randomization Phase||1
10892028|NCT01385176|12058072|FG001|NOT COMPLETED|Randomization Phase||2
10892029|NCT01385176|12058071|FG000|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|62
10892030|NCT01385176|12058072|FG001|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|30
10892031|NCT01385176|12058071|FG000|COMPLETED|6-18 Month All VNS Active||58
10892032|NCT01385176|12058072|FG001|COMPLETED|6-18 Month All VNS Active||27
10892033|NCT01385176|12058071|FG000|NOT COMPLETED|6-18 Month All VNS Active||4
10892034|NCT01385176|12058072|FG001|NOT COMPLETED|6-18 Month All VNS Active||3
10892035|NCT01372774|12058085|FG000|STARTED|Overall Study||96
10892036|NCT01372774|12058086|FG001|STARTED|Overall Study||98
10892037|NCT01372774|12058085|FG000|COMPLETED|Overall Study||92
10892038|NCT01372774|12058086|FG001|COMPLETED|Overall Study||93
10892039|NCT01372774|12058085|FG000|NOT COMPLETED|Overall Study||4
10892040|NCT01372774|12058086|FG001|NOT COMPLETED|Overall Study||5
10892041|NCT01371981|12058100|FG000|STARTED|Overall Study||580
10892042|NCT01371981|12058101|FG001|STARTED|Overall Study||591
10892043|NCT01371981|12058102|FG002|STARTED|Overall Study||12
10892044|NCT01371981|12058103|FG003|STARTED|Overall Study||33
10892045|NCT01371981|12058104|FG004|STARTED|Overall Study||47
10892046|NCT01371981|12058105|FG005|STARTED|Overall Study||382
10892047|NCT01371981|12058100|FG000|COMPLETED|Overall Study||396
10892048|NCT01371981|12058101|FG001|COMPLETED|Overall Study||399
10892049|NCT01371981|12058102|FG002|COMPLETED|Overall Study||6
10892050|NCT01371981|12058103|FG003|COMPLETED|Overall Study||12
10892051|NCT01371981|12058104|FG004|COMPLETED|Overall Study||15
10892052|NCT01371981|12058105|FG005|COMPLETED|Overall Study||368
10892053|NCT01371981|12058100|FG000|NOT COMPLETED|Overall Study||184
10892054|NCT01371981|12058101|FG001|NOT COMPLETED|Overall Study||192
10892055|NCT01371981|12058102|FG002|NOT COMPLETED|Overall Study||6
10892056|NCT01371981|12058103|FG003|NOT COMPLETED|Overall Study||21
10892057|NCT01371981|12058104|FG004|NOT COMPLETED|Overall Study||32
10892058|NCT01371981|12058105|FG005|NOT COMPLETED|Overall Study||14
10892059|NCT01364597|12058128|FG000|STARTED|Overall Study||36
10892060|NCT01364597|12058129|FG001|STARTED|Overall Study||15
10892061|NCT01364597|12058130|FG002|STARTED|Overall Study||141
10892062|NCT01364597|12058131|FG003|STARTED|Overall Study||65
10892063|NCT01364597|12058128|FG000|Directly Enrolled (DE) Participants|Overall Study||0
10892064|NCT01364597|12058129|FG001|Directly Enrolled (DE) Participants|Overall Study||0
10892065|NCT01364597|12058130|FG002|Directly Enrolled (DE) Participants|Overall Study||85
10892066|NCT01364597|12058131|FG003|Directly Enrolled (DE) Participants|Overall Study||35
10892067|NCT01364597|12058128|FG000|Long-term Follow-up (LTFU) Participants|Overall Study||36
10892068|NCT01364597|12058129|FG001|Long-term Follow-up (LTFU) Participants|Overall Study||15
10892069|NCT01364597|12058130|FG002|Long-term Follow-up (LTFU) Participants|Overall Study||56
10892070|NCT01364597|12058131|FG003|Long-term Follow-up (LTFU) Participants|Overall Study||30
10892071|NCT01364597|12058128|FG000|COMPLETED|Overall Study||18
10892072|NCT01364597|12058129|FG001|COMPLETED|Overall Study||4
10892073|NCT01364597|12058130|FG002|COMPLETED|Overall Study||65
10892074|NCT01364597|12058131|FG003|COMPLETED|Overall Study||37
10892075|NCT01364597|12058128|FG000|NOT COMPLETED|Overall Study||18
10892076|NCT01364597|12058129|FG001|NOT COMPLETED|Overall Study||11
10892077|NCT01364597|12058130|FG002|NOT COMPLETED|Overall Study||76
10892078|NCT01364597|12058131|FG003|NOT COMPLETED|Overall Study||28
10892079|NCT01359592|12058144|FG000|STARTED|Initial Registration||158
10892080|NCT01359592|12058145|FG001|STARTED|Initial Registration||1
10892081|NCT01359592|12058146|FG002|STARTED|Initial Registration||0
10892082|NCT01359592|12058147|FG003|STARTED|Initial Registration||0
10892083|NCT01359592|12058144|FG000|Eligible and Evaluable|Initial Registration||132
10892084|NCT01359592|12058145|FG001|Eligible and Evaluable|Initial Registration||1
10892085|NCT01359592|12058146|FG002|Eligible and Evaluable|Initial Registration||0
10892086|NCT01359592|12058147|FG003|Eligible and Evaluable|Initial Registration||0
10892087|NCT01359592|12058144|FG000|COMPLETED|Initial Registration||129
10892088|NCT01359592|12058145|FG001|COMPLETED|Initial Registration||1
10892089|NCT01359592|12058146|FG002|COMPLETED|Initial Registration||0
10892090|NCT01359592|12058147|FG003|COMPLETED|Initial Registration||0
10892091|NCT01359592|12058144|FG000|NOT COMPLETED|Initial Registration||29
10892092|NCT01359592|12058145|FG001|NOT COMPLETED|Initial Registration||0
10892093|NCT01359592|12058146|FG002|NOT COMPLETED|Initial Registration||0
10892094|NCT01359592|12058147|FG003|NOT COMPLETED|Initial Registration||0
10892095|NCT01359592|12058144|FG000|STARTED|PET-Directed Therapy||0
10892096|NCT01359592|12058145|FG001|STARTED|PET-Directed Therapy||0
10892097|NCT01359592|12058146|FG002|STARTED|PET-Directed Therapy||137
10892098|NCT01359592|12058147|FG003|STARTED|PET-Directed Therapy||12
10892099|NCT01359592|12058144|FG000|Eligible and Evaluable|PET-Directed Therapy||0
10892100|NCT01359592|12058145|FG001|Eligible and Evaluable|PET-Directed Therapy||0
10892101|NCT01359592|12058146|FG002|Eligible and Evaluable|PET-Directed Therapy||113
10892102|NCT01359592|12058147|FG003|Eligible and Evaluable|PET-Directed Therapy||12
10892103|NCT01359592|12058144|FG000|COMPLETED|PET-Directed Therapy||0
10892104|NCT01359592|12058145|FG001|COMPLETED|PET-Directed Therapy||0
10892105|NCT01359592|12058146|FG002|COMPLETED|PET-Directed Therapy||111
10892106|NCT01359592|12058147|FG003|COMPLETED|PET-Directed Therapy||12
10892107|NCT01359592|12058144|FG000|NOT COMPLETED|PET-Directed Therapy||0
10892108|NCT01359592|12058145|FG001|NOT COMPLETED|PET-Directed Therapy||0
10892109|NCT01359592|12058146|FG002|NOT COMPLETED|PET-Directed Therapy||26
10892110|NCT01359592|12058147|FG003|NOT COMPLETED|PET-Directed Therapy||0
10892111|NCT01357980|12058166|FG000|STARTED|Overall Study||16
10892112|NCT01357980|12058167|FG001|STARTED|Overall Study||7
10892113|NCT01357980|12058168|FG002|STARTED|Overall Study||17
10892114|NCT01357980|12058169|FG003|STARTED|Overall Study||7
10892115|NCT01357980|12058166|FG000|COMPLETED|Overall Study||16
10892116|NCT01357980|12058167|FG001|COMPLETED|Overall Study||6
10892117|NCT01357980|12058168|FG002|COMPLETED|Overall Study||16
10892118|NCT01357980|12058169|FG003|COMPLETED|Overall Study||7
10892119|NCT01357980|12058166|FG000|NOT COMPLETED|Overall Study||0
10892120|NCT01357980|12058167|FG001|NOT COMPLETED|Overall Study||1
10892121|NCT01357980|12058168|FG002|NOT COMPLETED|Overall Study||1
10892122|NCT01357980|12058169|FG003|NOT COMPLETED|Overall Study||0
10892123|NCT01354353|12058185|FG000|STARTED|Overall Study||16
10892124|NCT01354353|12058186|FG001|STARTED|Overall Study|Included in this arm are six participants who erroneously received oral 80 mg LY2140023 BID.|12
10892125|NCT01354353|12058187|FG002|STARTED|Overall Study||11
10892126|NCT01354353|12058188|FG003|STARTED|Overall Study||12
10892127|NCT01354353|12058189|FG004|STARTED|Overall Study||12
10892128|NCT01354353|12058190|FG005|STARTED|Overall Study||12
10892129|NCT01354353|12058185|FG000|Received at Least One Dose of Study Drug|Overall Study||16
10892130|NCT01354353|12058186|FG001|Received at Least One Dose of Study Drug|Overall Study||11
10892131|NCT01354353|12058187|FG002|Received at Least One Dose of Study Drug|Overall Study||10
10892132|NCT01354353|12058188|FG003|Received at Least One Dose of Study Drug|Overall Study||11
10892133|NCT01354353|12058189|FG004|Received at Least One Dose of Study Drug|Overall Study||11
10892134|NCT01354353|12058190|FG005|Received at Least One Dose of Study Drug|Overall Study||11
10892135|NCT01354353|12058185|FG000|COMPLETED|Overall Study||13
10892136|NCT01354353|12058186|FG001|COMPLETED|Overall Study||11
10892137|NCT01354353|12058187|FG002|COMPLETED|Overall Study||9
10892138|NCT01354353|12058188|FG003|COMPLETED|Overall Study||7
10892139|NCT01354353|12058189|FG004|COMPLETED|Overall Study||11
10892140|NCT01354353|12058190|FG005|COMPLETED|Overall Study||6
10892141|NCT01354353|12058185|FG000|NOT COMPLETED|Overall Study||3
10892142|NCT01354353|12058186|FG001|NOT COMPLETED|Overall Study||1
10892143|NCT01354353|12058187|FG002|NOT COMPLETED|Overall Study||2
10892144|NCT01354353|12058188|FG003|NOT COMPLETED|Overall Study||5
10892145|NCT01354353|12058189|FG004|NOT COMPLETED|Overall Study||1
10892146|NCT01354353|12058190|FG005|NOT COMPLETED|Overall Study||6
10892147|NCT01353313|12058213|FG000|STARTED|Overall Study||398
10892148|NCT01353313|12058214|FG001|STARTED|Overall Study||402
10892149|NCT01353313|12058213|FG000|Completed Assessment for Neurodevelopmental Impairment|Overall Study||321
10892150|NCT01353313|12058214|FG001|Completed Assessment for Neurodevelopmental Impairment|Overall Study||318
10892151|NCT01353313|12058213|FG000|Died After Discharge|Overall Study||8
10892152|NCT01353313|12058214|FG001|Died After Discharge|Overall Study||6
10892153|NCT01353313|12058213|FG000|Died Before Discharge|Overall Study||35
10892154|NCT01353313|12058214|FG001|Died Before Discharge|Overall Study||40
10892155|NCT01353313|12058213|FG000|Survived to Discharge|Overall Study||363
10892156|NCT01353313|12058214|FG001|Survived to Discharge|Overall Study||362
10892157|NCT01353313|12058213|FG000|COMPLETED|Overall Study||364
10892158|NCT01353313|12058214|FG001|COMPLETED|Overall Study||364
10892159|NCT01353313|12058213|FG000|NOT COMPLETED|Overall Study||34
10892160|NCT01353313|12058214|FG001|NOT COMPLETED|Overall Study||38
10892161|NCT01351805|12058224|FG000|STARTED|Overall Study||6463
10892162|NCT01351805|12058225|FG001|STARTED|Overall Study||6464
10892163|NCT01351805|12058226|FG002|STARTED|Overall Study||6470
10892164|NCT01351805|12058227|FG003|STARTED|Overall Study||6474
10892165|NCT01351805|12058224|FG000|COMPLETED|Overall Study||6463
10892166|NCT01351805|12058225|FG001|COMPLETED|Overall Study||6464
10892167|NCT01351805|12058226|FG002|COMPLETED|Overall Study||6470
10892168|NCT01351805|12058227|FG003|COMPLETED|Overall Study||6474
10892169|NCT01351805|12058224|FG000|NOT COMPLETED|Overall Study||0
10892170|NCT01351805|12058225|FG001|NOT COMPLETED|Overall Study||0
10892171|NCT01351805|12058226|FG002|NOT COMPLETED|Overall Study||0
10892172|NCT01351805|12058227|FG003|NOT COMPLETED|Overall Study||0
10892173|NCT01341444|12058243|FG000|STARTED|Overall Study||31
10892174|NCT01341444|12058244|FG001|STARTED|Overall Study||32
10892175|NCT01341444|12058243|FG000|COMPLETED|Overall Study||26
10892176|NCT01341444|12058244|FG001|COMPLETED|Overall Study||29
10892177|NCT01341444|12058243|FG000|NOT COMPLETED|Overall Study||5
10892178|NCT01341444|12058244|FG001|NOT COMPLETED|Overall Study||3
10892179|NCT01333397|12058255|FG000|STARTED|Overall Study||35
10892180|NCT01333397|12058256|FG001|STARTED|Overall Study||36
10892181|NCT01333397|12058257|FG002|STARTED|Overall Study||35
10892182|NCT01333397|12058258|FG003|STARTED|Overall Study||35
10892183|NCT01333397|12058259|FG004|STARTED|Overall Study||35
10892184|NCT01333397|12058255|FG000|COMPLETED|Overall Study||34
10892185|NCT01333397|12058256|FG001|COMPLETED|Overall Study||36
10892186|NCT01333397|12058257|FG002|COMPLETED|Overall Study||35
10892187|NCT01333397|12058258|FG003|COMPLETED|Overall Study||34
10892188|NCT01333397|12058259|FG004|COMPLETED|Overall Study||35
10892189|NCT01333397|12058255|FG000|NOT COMPLETED|Overall Study||1
10892190|NCT01333397|12058256|FG001|NOT COMPLETED|Overall Study||0
10892191|NCT01333397|12058257|FG002|NOT COMPLETED|Overall Study||0
10892192|NCT01333397|12058258|FG003|NOT COMPLETED|Overall Study||1
10892193|NCT01333397|12058259|FG004|NOT COMPLETED|Overall Study||0
10892194|NCT01332968|12058282|FG000|STARTED|Induction Period||699
10892195|NCT01332968|12058283|FG001|STARTED|Induction Period||702
10892196|NCT01332968|12058284|FG002|STARTED|Induction Period||0
10892197|NCT01332968|12058285|FG003|STARTED|Induction Period||0
10892198|NCT01332968|12058286|FG004|STARTED|Induction Period||0
10892199|NCT01332968|12058287|FG005|STARTED|Induction Period||0
10892200|NCT01332968|12058288|FG006|STARTED|Induction Period||0
10892201|NCT01332968|12058289|FG007|STARTED|Induction Period||0
10892202|NCT01332968|12058282|FG000|COMPLETED|Induction Period||641
10892203|NCT01332968|12058283|FG001|COMPLETED|Induction Period||646
10892204|NCT01332968|12058284|FG002|COMPLETED|Induction Period||0
10892205|NCT01332968|12058285|FG003|COMPLETED|Induction Period||0
10892206|NCT01332968|12058286|FG004|COMPLETED|Induction Period||0
10892207|NCT01332968|12058287|FG005|COMPLETED|Induction Period||0
10892208|NCT01332968|12058288|FG006|COMPLETED|Induction Period||0
10892209|NCT01332968|12058289|FG007|COMPLETED|Induction Period||0
10892210|NCT01332968|12058282|FG000|NOT COMPLETED|Induction Period||58
10892211|NCT01332968|12058283|FG001|NOT COMPLETED|Induction Period||56
10892212|NCT01332968|12058284|FG002|NOT COMPLETED|Induction Period||0
10892213|NCT01332968|12058285|FG003|NOT COMPLETED|Induction Period||0
10892214|NCT01332968|12058286|FG004|NOT COMPLETED|Induction Period||0
10892215|NCT01332968|12058287|FG005|NOT COMPLETED|Induction Period||0
10892216|NCT01332968|12058288|FG006|NOT COMPLETED|Induction Period||0
10892217|NCT01332968|12058289|FG007|NOT COMPLETED|Induction Period||0
10892218|NCT01332968|12058282|FG000|STARTED|Maintenance/Observation Period||0
10892219|NCT01332968|12058283|FG001|STARTED|Maintenance/Observation Period||0
10892220|NCT01332968|12058284|FG002|STARTED|Maintenance/Observation Period||612
10892221|NCT01332968|12058285|FG003|STARTED|Maintenance/Observation Period||624
10892222|NCT01332968|12058286|FG004|STARTED|Maintenance/Observation Period||12
10892223|NCT01332968|12058287|FG005|STARTED|Maintenance/Observation Period||11
10892224|NCT01332968|12058288|FG006|STARTED|Maintenance/Observation Period||0
10892225|NCT01332968|12058289|FG007|STARTED|Maintenance/Observation Period||0
10892226|NCT01332968|12058282|FG000|COMPLETED|Maintenance/Observation Period||0
10892227|NCT01332968|12058283|FG001|COMPLETED|Maintenance/Observation Period||0
10892228|NCT01332968|12058284|FG002|COMPLETED|Maintenance/Observation Period||451
10892229|NCT01332968|12058285|FG003|COMPLETED|Maintenance/Observation Period||475
10892230|NCT01332968|12058286|FG004|COMPLETED|Maintenance/Observation Period||12
10892231|NCT01332968|12058287|FG005|COMPLETED|Maintenance/Observation Period||10
10892232|NCT01332968|12058288|FG006|COMPLETED|Maintenance/Observation Period||0
10892233|NCT01332968|12058289|FG007|COMPLETED|Maintenance/Observation Period||0
10892234|NCT01332968|12058282|FG000|NOT COMPLETED|Maintenance/Observation Period||0
10892235|NCT01332968|12058283|FG001|NOT COMPLETED|Maintenance/Observation Period||0
10892236|NCT01332968|12058284|FG002|NOT COMPLETED|Maintenance/Observation Period||161
10892237|NCT01332968|12058285|FG003|NOT COMPLETED|Maintenance/Observation Period||149
10892238|NCT01332968|12058286|FG004|NOT COMPLETED|Maintenance/Observation Period||0
10892239|NCT01332968|12058287|FG005|NOT COMPLETED|Maintenance/Observation Period||1
10892240|NCT01332968|12058288|FG006|NOT COMPLETED|Maintenance/Observation Period||0
10892241|NCT01332968|12058289|FG007|NOT COMPLETED|Maintenance/Observation Period||0
10892242|NCT01332968|12058282|FG000|STARTED|Follow-Up Period||0
10892243|NCT01332968|12058283|FG001|STARTED|Follow-Up Period||0
10892244|NCT01332968|12058284|FG002|STARTED|Follow-Up Period||0
10892245|NCT01332968|12058285|FG003|STARTED|Follow-Up Period||0
10892246|NCT01332968|12058286|FG004|STARTED|Follow-Up Period||0
10892247|NCT01332968|12058287|FG005|STARTED|Follow-Up Period||0
10892248|NCT01332968|12058288|FG006|STARTED|Follow-Up Period||554
10892249|NCT01332968|12058289|FG007|STARTED|Follow-Up Period||602
10892250|NCT01332968|12058282|FG000|COMPLETED|Follow-Up Period||0
10892251|NCT01332968|12058283|FG001|COMPLETED|Follow-Up Period||0
10892252|NCT01332968|12058284|FG002|COMPLETED|Follow-Up Period||0
10892253|NCT01332968|12058285|FG003|COMPLETED|Follow-Up Period||0
10892254|NCT01332968|12058286|FG004|COMPLETED|Follow-Up Period||0
10892255|NCT01332968|12058287|FG005|COMPLETED|Follow-Up Period||0
10892256|NCT01332968|12058288|FG006|COMPLETED|Follow-Up Period||324
10892257|NCT01332968|12058289|FG007|COMPLETED|Follow-Up Period||367
10892258|NCT01332968|12058282|FG000|NOT COMPLETED|Follow-Up Period||0
10892259|NCT01332968|12058283|FG001|NOT COMPLETED|Follow-Up Period||0
10892260|NCT01332968|12058284|FG002|NOT COMPLETED|Follow-Up Period||0
10892261|NCT01332968|12058285|FG003|NOT COMPLETED|Follow-Up Period||0
10892262|NCT01332968|12058286|FG004|NOT COMPLETED|Follow-Up Period||0
10892263|NCT01332968|12058287|FG005|NOT COMPLETED|Follow-Up Period||0
10892264|NCT01332968|12058288|FG006|NOT COMPLETED|Follow-Up Period||230
10892265|NCT01332968|12058289|FG007|NOT COMPLETED|Follow-Up Period||235
10892266|NCT01331408|12058297|FG000|STARTED|Overall Study||61
10892267|NCT01331408|12058297|FG000|COMPLETED|Overall Study||50
10892268|NCT01331408|12058297|FG000|NOT COMPLETED|Overall Study||11
10892269|NCT01331148|12058303|FG000|STARTED|Overall Study||23
10892270|NCT01331148|12058304|FG001|STARTED|Overall Study||23
10892271|NCT01331148|12058303|FG000|COMPLETED|Overall Study||20
10892272|NCT01331148|12058304|FG001|COMPLETED|Overall Study||19
10892273|NCT01331148|12058303|FG000|NOT COMPLETED|Overall Study||3
10892274|NCT01331148|12058304|FG001|NOT COMPLETED|Overall Study||4
10892275|NCT01328093|12058312|FG000|STARTED|Double-Blind Phase||516
10892276|NCT01328093|12058313|FG001|STARTED|Double-Blind Phase||162
10892277|NCT01328093|12058312|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Phase||514
10892278|NCT01328093|12058313|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Phase||161
10892279|NCT01328093|12058312|FG000|Modified Intent-To-Treat (mITT)|Double-Blind Phase||511
10892280|NCT01328093|12058313|FG001|Modified Intent-To-Treat (mITT)|Double-Blind Phase||161
10892281|NCT01328093|12058312|FG000|COMPLETED|Double-Blind Phase|Not all participants entered Open-Label Treatment Phase.|231
10892282|NCT01328093|12058313|FG001|COMPLETED|Double-Blind Phase|Not all participants entered Open-Label Treatment Phase.|84
10892283|NCT01328093|12058312|FG000|NOT COMPLETED|Double-Blind Phase||285
10892284|NCT01328093|12058313|FG001|NOT COMPLETED|Double-Blind Phase||78
10892285|NCT01328093|12058312|FG000|STARTED|Open-Label Phase||200
10892286|NCT01328093|12058313|FG001|STARTED|Open-Label Phase||73
10892287|NCT01328093|12058312|FG000|Received at Least 1 Dose of Study Drug|Open-Label Phase||198
10892288|NCT01328093|12058313|FG001|Received at Least 1 Dose of Study Drug|Open-Label Phase||73
10892289|NCT01328093|12058312|FG000|Modified Intent-To-Treat (mITT)|Open-Label Phase||197
10892290|NCT01328093|12058313|FG001|Modified Intent-To-Treat (mITT)|Open-Label Phase||73
10892291|NCT01328093|12058312|FG000|COMPLETED|Open-Label Phase||60
10892292|NCT01328093|12058313|FG001|COMPLETED|Open-Label Phase||23
10892293|NCT01328093|12058312|FG000|NOT COMPLETED|Open-Label Phase||140
10892294|NCT01328093|12058313|FG001|NOT COMPLETED|Open-Label Phase||50
10892295|NCT01327651|12058329|FG000|STARTED|Self-administered Dosing Period||60
10892296|NCT01327651|12058330|FG001|STARTED|Self-administered Dosing Period||59
10892297|NCT01327651|12058331|FG002|STARTED|Self-administered Dosing Period||60
10892298|NCT01327651|12058332|FG003|STARTED|Self-administered Dosing Period||60
10892299|NCT01327651|12058333|FG004|STARTED|Self-administered Dosing Period||59
10892300|NCT01327651|12058334|FG005|STARTED|Self-administered Dosing Period||59
10892301|NCT01327651|12058335|FG006|STARTED|Self-administered Dosing Period||59
10892302|NCT01327651|12058336|FG007|STARTED|Self-administered Dosing Period||60
10892303|NCT01327651|12058337|FG008|STARTED|Self-administered Dosing Period||60
10892304|NCT01327651|12058329|FG000|Week 10|Self-administered Dosing Period||59
10892305|NCT01327651|12058330|FG001|Week 10|Self-administered Dosing Period||58
10892306|NCT01327651|12058331|FG002|Week 10|Self-administered Dosing Period||60
10892307|NCT01327651|12058332|FG003|Week 10|Self-administered Dosing Period||60
10892308|NCT01327651|12058333|FG004|Week 10|Self-administered Dosing Period||59
10892309|NCT01327651|12058334|FG005|Week 10|Self-administered Dosing Period||59
10892310|NCT01327651|12058335|FG006|Week 10|Self-administered Dosing Period||57
10892311|NCT01327651|12058336|FG007|Week 10|Self-administered Dosing Period||57
10892312|NCT01327651|12058337|FG008|Week 10|Self-administered Dosing Period||56
10892313|NCT01327651|12058329|FG000|Week 14|Self-administered Dosing Period||59
10892314|NCT01327651|12058330|FG001|Week 14|Self-administered Dosing Period||55
10892315|NCT01327651|12058331|FG002|Week 14|Self-administered Dosing Period||57
10892316|NCT01327651|12058332|FG003|Week 14|Self-administered Dosing Period||60
10892317|NCT01327651|12058333|FG004|Week 14|Self-administered Dosing Period||58
10892318|NCT01327651|12058334|FG005|Week 14|Self-administered Dosing Period||59
10892319|NCT01327651|12058335|FG006|Week 14|Self-administered Dosing Period||54
10892320|NCT01327651|12058336|FG007|Week 14|Self-administered Dosing Period||51
10892321|NCT01327651|12058337|FG008|Week 14|Self-administered Dosing Period||54
10892322|NCT01327651|12058329|FG000|Week 18|Self-administered Dosing Period||57
10892323|NCT01327651|12058330|FG001|Week 18|Self-administered Dosing Period||56
10892324|NCT01327651|12058331|FG002|Week 18|Self-administered Dosing Period||56
10892325|NCT01327651|12058332|FG003|Week 18|Self-administered Dosing Period||60
10892326|NCT01327651|12058333|FG004|Week 18|Self-administered Dosing Period||57
10892327|NCT01327651|12058334|FG005|Week 18|Self-administered Dosing Period||59
10892328|NCT01327651|12058335|FG006|Week 18|Self-administered Dosing Period||53
10892329|NCT01327651|12058336|FG007|Week 18|Self-administered Dosing Period||49
10892330|NCT01327651|12058337|FG008|Week 18|Self-administered Dosing Period||53
10892331|NCT01327651|12058329|FG000|Week 22|Self-administered Dosing Period||59
10892332|NCT01327651|12058330|FG001|Week 22|Self-administered Dosing Period||56
10892333|NCT01327651|12058331|FG002|Week 22|Self-administered Dosing Period||55
10892334|NCT01327651|12058332|FG003|Week 22|Self-administered Dosing Period||58
10892335|NCT01327651|12058333|FG004|Week 22|Self-administered Dosing Period||56
10892336|NCT01327651|12058334|FG005|Week 22|Self-administered Dosing Period||59
10892337|NCT01327651|12058335|FG006|Week 22|Self-administered Dosing Period||50
10892338|NCT01327651|12058336|FG007|Week 22|Self-administered Dosing Period||50
10892339|NCT01327651|12058337|FG008|Week 22|Self-administered Dosing Period||51
10892340|NCT01327651|12058329|FG000|Week 26|Self-administered Dosing Period||58
10892341|NCT01327651|12058330|FG001|Week 26|Self-administered Dosing Period||56
10892342|NCT01327651|12058331|FG002|Week 26|Self-administered Dosing Period||53
10892343|NCT01327651|12058332|FG003|Week 26|Self-administered Dosing Period||57
10892344|NCT01327651|12058333|FG004|Week 26|Self-administered Dosing Period||56
10892345|NCT01327651|12058334|FG005|Week 26|Self-administered Dosing Period||58
10892346|NCT01327651|12058335|FG006|Week 26|Self-administered Dosing Period||50
10892347|NCT01327651|12058336|FG007|Week 26|Self-administered Dosing Period||51
10892348|NCT01327651|12058337|FG008|Week 26|Self-administered Dosing Period||49
10892349|NCT01327651|12058329|FG000|COMPLETED|Self-administered Dosing Period||56
10892350|NCT01327651|12058330|FG001|COMPLETED|Self-administered Dosing Period||56
10892351|NCT01327651|12058331|FG002|COMPLETED|Self-administered Dosing Period||56
10892352|NCT01327651|12058332|FG003|COMPLETED|Self-administered Dosing Period||57
10892353|NCT01327651|12058333|FG004|COMPLETED|Self-administered Dosing Period||56
10892354|NCT01327651|12058334|FG005|COMPLETED|Self-administered Dosing Period||59
10892355|NCT01327651|12058335|FG006|COMPLETED|Self-administered Dosing Period||49
10892356|NCT01327651|12058336|FG007|COMPLETED|Self-administered Dosing Period||50
10892357|NCT01327651|12058337|FG008|COMPLETED|Self-administered Dosing Period||49
10892358|NCT01327651|12058329|FG000|NOT COMPLETED|Self-administered Dosing Period||4
10892359|NCT01327651|12058330|FG001|NOT COMPLETED|Self-administered Dosing Period||3
10892360|NCT01327651|12058331|FG002|NOT COMPLETED|Self-administered Dosing Period||4
10892361|NCT01327651|12058332|FG003|NOT COMPLETED|Self-administered Dosing Period||3
10892362|NCT01327651|12058333|FG004|NOT COMPLETED|Self-administered Dosing Period||3
10892363|NCT01327651|12058334|FG005|NOT COMPLETED|Self-administered Dosing Period||0
10892364|NCT01327651|12058335|FG006|NOT COMPLETED|Self-administered Dosing Period||10
10892365|NCT01327651|12058336|FG007|NOT COMPLETED|Self-administered Dosing Period||10
10892366|NCT01327651|12058337|FG008|NOT COMPLETED|Self-administered Dosing Period||11
10892367|NCT01327651|12058329|FG000|STARTED|Post Study Follow-up||56
10892368|NCT01327651|12058330|FG001|STARTED|Post Study Follow-up||56
10892369|NCT01327651|12058331|FG002|STARTED|Post Study Follow-up||56
10892370|NCT01327651|12058332|FG003|STARTED|Post Study Follow-up||57
10892371|NCT01327651|12058333|FG004|STARTED|Post Study Follow-up||56
10892372|NCT01327651|12058334|FG005|STARTED|Post Study Follow-up||59
10892373|NCT01327651|12058335|FG006|STARTED|Post Study Follow-up||49
10892374|NCT01327651|12058336|FG007|STARTED|Post Study Follow-up||50
10892375|NCT01327651|12058337|FG008|STARTED|Post Study Follow-up||49
10892376|NCT01327651|12058329|FG000|COMPLETED|Post Study Follow-up||56
10892377|NCT01327651|12058330|FG001|COMPLETED|Post Study Follow-up||55
10892378|NCT01327651|12058331|FG002|COMPLETED|Post Study Follow-up||55
10892379|NCT01327651|12058332|FG003|COMPLETED|Post Study Follow-up||57
10892380|NCT01327651|12058333|FG004|COMPLETED|Post Study Follow-up||56
10892381|NCT01327651|12058334|FG005|COMPLETED|Post Study Follow-up||59
10892382|NCT01327651|12058335|FG006|COMPLETED|Post Study Follow-up||45
10892383|NCT01327651|12058336|FG007|COMPLETED|Post Study Follow-up||49
10892384|NCT01327651|12058337|FG008|COMPLETED|Post Study Follow-up||47
10892385|NCT01327651|12058329|FG000|NOT COMPLETED|Post Study Follow-up||0
10892386|NCT01327651|12058330|FG001|NOT COMPLETED|Post Study Follow-up||1
10892387|NCT01327651|12058331|FG002|NOT COMPLETED|Post Study Follow-up||1
10892388|NCT01327651|12058332|FG003|NOT COMPLETED|Post Study Follow-up||0
10892389|NCT01327651|12058333|FG004|NOT COMPLETED|Post Study Follow-up||0
10892390|NCT01327651|12058334|FG005|NOT COMPLETED|Post Study Follow-up||0
10892391|NCT01327651|12058335|FG006|NOT COMPLETED|Post Study Follow-up||4
10892392|NCT01327651|12058336|FG007|NOT COMPLETED|Post Study Follow-up||1
10892393|NCT01327651|12058337|FG008|NOT COMPLETED|Post Study Follow-up||2
10892394|NCT01326455|12058379|FG000|STARTED|Overall Study||25
10892395|NCT01326455|12058380|FG001|STARTED|Overall Study||25
10892396|NCT01326455|12058381|FG002|STARTED|Overall Study||25
10892397|NCT01326455|12058379|FG000|COMPLETED|Overall Study||15
10892398|NCT01326455|12058380|FG001|COMPLETED|Overall Study||20
10892399|NCT01326455|12058381|FG002|COMPLETED|Overall Study||18
10892400|NCT01326455|12058379|FG000|NOT COMPLETED|Overall Study||10
10892401|NCT01326455|12058380|FG001|NOT COMPLETED|Overall Study||5
10892402|NCT01326455|12058381|FG002|NOT COMPLETED|Overall Study||7
10892403|NCT01319981|12058393|FG000|STARTED|Overall Study||15
10892404|NCT01319981|12058394|FG001|STARTED|Overall Study||16
10892405|NCT01319981|12058393|FG000|COMPLETED|Overall Study||15
10892406|NCT01319981|12058394|FG001|COMPLETED|Overall Study||16
10892407|NCT01319981|12058393|FG000|NOT COMPLETED|Overall Study||0
10892408|NCT01319981|12058394|FG001|NOT COMPLETED|Overall Study||0
10892409|NCT01314313|12058404|FG000|STARTED|Overall Study||1011
10892410|NCT01314313|12058405|FG001|STARTED|Overall Study||1021
10892411|NCT01314313|12058404|FG000|As Treated|Overall Study||994
10892412|NCT01314313|12058405|FG001|As Treated|Overall Study||944
10892413|NCT01314313|12058404|FG000|Valve Implanted|Overall Study||974
10892414|NCT01314313|12058405|FG001|Valve Implanted|Overall Study||936
10892415|NCT01314313|12058404|FG000|COMPLETED|Overall Study||784
10892416|NCT01314313|12058405|FG001|COMPLETED|Overall Study||710
10892417|NCT01314313|12058404|FG000|NOT COMPLETED|Overall Study||227
10892418|NCT01314313|12058405|FG001|NOT COMPLETED|Overall Study||311
10892419|NCT01314118|12058413|FG000|STARTED|Overall Study||131
10892420|NCT01314118|12058413|FG000|COMPLETED|Overall Study||0
10892421|NCT01314118|12058413|FG000|NOT COMPLETED|Overall Study||131
10892422|NCT01313312|12058417|FG000|STARTED|Overall Study||258
10892423|NCT01313312|12058417|FG000|Cycle 1|Overall Study||254
10892424|NCT01313312|12058417|FG000|Cycle 2|Overall Study||229
10892425|NCT01313312|12058417|FG000|Cycle 3|Overall Study||175
10892426|NCT01313312|12058417|FG000|Cycle 4|Overall Study||81
10892427|NCT01313312|12058417|FG000|Cycle 5|Overall Study||11
10892428|NCT01313312|12058417|FG000|COMPLETED|Overall Study||222
10892429|NCT01313312|12058417|FG000|NOT COMPLETED|Overall Study||36
10892430|NCT01313299|12058424|FG000|STARTED|Overall Study||81
10892431|NCT01313299|12058425|FG001|STARTED|Overall Study||81
10892432|NCT01313299|12058426|FG002|STARTED|Overall Study||81
10892433|NCT01313299|12058424|FG000|COMPLETED|Overall Study||74
10892434|NCT01313299|12058425|FG001|COMPLETED|Overall Study||78
10892435|NCT01313299|12058426|FG002|COMPLETED|Overall Study||77
10892436|NCT01313299|12058424|FG000|NOT COMPLETED|Overall Study||7
10892437|NCT01313299|12058425|FG001|NOT COMPLETED|Overall Study||3
10892438|NCT01313299|12058426|FG002|NOT COMPLETED|Overall Study||4
10892439|NCT01311115|12058436|FG000|STARTED|Overall Study||132
10892440|NCT01311115|12058437|FG001|STARTED|Overall Study||69
10892441|NCT01311115|12058436|FG000|COMPLETED|Overall Study||132
10892442|NCT01311115|12058437|FG001|COMPLETED|Overall Study||69
10892443|NCT01311115|12058436|FG000|NOT COMPLETED|Overall Study||0
10892444|NCT01311115|12058437|FG001|NOT COMPLETED|Overall Study||0
10892445|NCT01308853|12058443|FG000|STARTED|Overall Study||24
10892446|NCT01308853|12058443|FG000|COMPLETED|Overall Study||20
10892447|NCT01308853|12058443|FG000|NOT COMPLETED|Overall Study||4
10892448|NCT01308619|12058449|FG000|STARTED|Overall Study||84
10892449|NCT01308619|12058450|FG001|STARTED|Overall Study||86
10892450|NCT01308619|12058449|FG000|COMPLETED|Overall Study||77
10892451|NCT01308619|12058450|FG001|COMPLETED|Overall Study||83
10892452|NCT01308619|12058449|FG000|NOT COMPLETED|Overall Study||7
10892453|NCT01308619|12058450|FG001|NOT COMPLETED|Overall Study||3
10892454|NCT01288911|12058460|FG000|STARTED|Double-blind Period||184
10892455|NCT01288911|12058461|FG001|STARTED|Double-blind Period||191
10892456|NCT01288911|12058460|FG000|Received Treatment|Double-blind Period||183
10892457|NCT01288911|12058461|FG001|Received Treatment|Double-blind Period||189
10892458|NCT01288911|12058460|FG000|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
10892459|NCT01288911|12058461|FG001|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
10892460|NCT01288911|12058460|FG000|NOT COMPLETED|Double-blind Period||142
10892461|NCT01288911|12058461|FG001|NOT COMPLETED|Double-blind Period||182
10892462|NCT01288911|12058460|FG000|STARTED|Open-label Period (All Enzalutamide)||42
10892463|NCT01288911|12058461|FG001|STARTED|Open-label Period (All Enzalutamide)||9
10892464|NCT01288911|12058460|FG000|Received Treatment|Open-label Period (All Enzalutamide)||42
10892465|NCT01288911|12058461|FG001|Received Treatment|Open-label Period (All Enzalutamide)||9
10892466|NCT01288911|12058460|FG000|COMPLETED|Open-label Period (All Enzalutamide)||0
10892467|NCT01288911|12058461|FG001|COMPLETED|Open-label Period (All Enzalutamide)||0
10892468|NCT01288911|12058460|FG000|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
10892469|NCT01288911|12058461|FG001|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
10892470|NCT01286272|12058472|FG000|STARTED|Overall Study||67
10892471|NCT01286272|12058473|FG001|STARTED|Overall Study||65
10892472|NCT01286272|12058472|FG000|COMPLETED|Overall Study||66
10892473|NCT01286272|12058473|FG001|COMPLETED|Overall Study||62
10892474|NCT01286272|12058472|FG000|NOT COMPLETED|Overall Study||1
10892475|NCT01286272|12058473|FG001|NOT COMPLETED|Overall Study||3
10892476|NCT01275677|12058481|FG000|STARTED|Overall Study||1630
10892477|NCT01275677|12058482|FG001|STARTED|Overall Study||1640
10892478|NCT01275677|12058481|FG000|COMPLETED|Overall Study||1602
10892479|NCT01275677|12058482|FG001|COMPLETED|Overall Study||1598
10892480|NCT01275677|12058481|FG000|NOT COMPLETED|Overall Study||28
10892481|NCT01275677|12058482|FG001|NOT COMPLETED|Overall Study||42
10892482|NCT01273610|12058490|FG000|STARTED|Overall Study||30
10892483|NCT01273610|12058491|FG001|STARTED|Overall Study||10
10892484|NCT01273610|12058490|FG000|COMPLETED|Overall Study||30
10892485|NCT01273610|12058491|FG001|COMPLETED|Overall Study||10
10892486|NCT01273610|12058490|FG000|NOT COMPLETED|Overall Study||0
10892487|NCT01273610|12058491|FG001|NOT COMPLETED|Overall Study||0
10892488|NCT01267955|12058498|FG000|STARTED|Stage 1 (6 Months)||20
10892489|NCT01267955|12058498|FG000|COMPLETED|Stage 1 (6 Months)||17
10892490|NCT01267955|12058498|FG000|NOT COMPLETED|Stage 1 (6 Months)||3
10892491|NCT01267955|12058498|FG000|STARTED|Stage 2 (6 Months)||45
10892492|NCT01267955|12058498|FG000|COMPLETED|Stage 2 (6 Months)||39
10892493|NCT01267955|12058498|FG000|NOT COMPLETED|Stage 2 (6 Months)||6
10892494|NCT01265849|12058505|FG000|STARTED|Overall Study||396
10892495|NCT01265849|12058506|FG001|STARTED|Overall Study||398
10892496|NCT01265849|12058507|FG002|STARTED|Overall Study||134
10892497|NCT01265849|12058505|FG000|COMPLETED|Overall Study||350
10892498|NCT01265849|12058506|FG001|COMPLETED|Overall Study||337
10892499|NCT01265849|12058507|FG002|COMPLETED|Overall Study||115
10892500|NCT01265849|12058505|FG000|NOT COMPLETED|Overall Study||46
10892501|NCT01265849|12058506|FG001|NOT COMPLETED|Overall Study||61
10892502|NCT01265849|12058507|FG002|NOT COMPLETED|Overall Study||19
10892503|NCT01265459|12058522|FG000|STARTED|Overall Study||23
10892504|NCT01265459|12058523|FG001|STARTED|Overall Study||23
10892505|NCT01265459|12058524|FG002|STARTED|Overall Study||22
10892506|NCT01265459|12058522|FG000|COMPLETED|Overall Study||23
10892507|NCT01265459|12058523|FG001|COMPLETED|Overall Study||23
10892508|NCT01265459|12058524|FG002|COMPLETED|Overall Study||20
10892509|NCT01265459|12058522|FG000|NOT COMPLETED|Overall Study||0
10892510|NCT01265459|12058523|FG001|NOT COMPLETED|Overall Study||0
10892511|NCT01265459|12058524|FG002|NOT COMPLETED|Overall Study||2
10892512|NCT01263769|12058544|FG000|STARTED|Overall Study||25
10892513|NCT01263769|12058544|FG000|COMPLETED|Overall Study||24
10892514|NCT01263769|12058544|FG000|NOT COMPLETED|Overall Study||1
10892515|NCT01261611|12058551|FG000|STARTED|Treatment Cycle 1||156
10892516|NCT01261611|12058552|FG001|STARTED|Treatment Cycle 1||159
10892517|NCT01261611|12058553|FG002|STARTED|Treatment Cycle 1||54
10892518|NCT01261611|12058551|FG000|COMPLETED|Treatment Cycle 1||152
10892519|NCT01261611|12058552|FG001|COMPLETED|Treatment Cycle 1||156
10892520|NCT01261611|12058553|FG002|COMPLETED|Treatment Cycle 1||52
10892521|NCT01261611|12058551|FG000|NOT COMPLETED|Treatment Cycle 1||4
10892522|NCT01261611|12058552|FG001|NOT COMPLETED|Treatment Cycle 1||3
10892523|NCT01261611|12058553|FG002|NOT COMPLETED|Treatment Cycle 1||2
10892524|NCT01261611|12058551|FG000|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359
10892525|NCT01261611|12058552|FG001|STARTED|Treatment Cycle 2||0
10892526|NCT01261611|12058553|FG002|STARTED|Treatment Cycle 2||0
10892527|NCT01261611|12058551|FG000|COMPLETED|Treatment Cycle 2||346
10892528|NCT01261611|12058552|FG001|COMPLETED|Treatment Cycle 2||0
10892529|NCT01261611|12058553|FG002|COMPLETED|Treatment Cycle 2||0
10892530|NCT01261611|12058551|FG000|NOT COMPLETED|Treatment Cycle 2||13
10892531|NCT01261611|12058552|FG001|NOT COMPLETED|Treatment Cycle 2||0
10892532|NCT01261611|12058553|FG002|NOT COMPLETED|Treatment Cycle 2||0
10892533|NCT01261611|12058551|FG000|STARTED|Treatment Cycle 3||346
10892534|NCT01261611|12058552|FG001|STARTED|Treatment Cycle 3||0
10892535|NCT01261611|12058553|FG002|STARTED|Treatment Cycle 3||0
10892536|NCT01261611|12058551|FG000|COMPLETED|Treatment Cycle 3||316
10892537|NCT01261611|12058552|FG001|COMPLETED|Treatment Cycle 3||0
10892538|NCT01261611|12058553|FG002|COMPLETED|Treatment Cycle 3||0
10892539|NCT01261611|12058551|FG000|NOT COMPLETED|Treatment Cycle 3||30
10892540|NCT01261611|12058552|FG001|NOT COMPLETED|Treatment Cycle 3||0
10892541|NCT01261611|12058553|FG002|NOT COMPLETED|Treatment Cycle 3||0
10892542|NCT01261611|12058551|FG000|STARTED|Treatment Cycle 4||316
10892543|NCT01261611|12058552|FG001|STARTED|Treatment Cycle 4||0
10892544|NCT01261611|12058553|FG002|STARTED|Treatment Cycle 4||0
10892545|NCT01261611|12058551|FG000|COMPLETED|Treatment Cycle 4||220
10892546|NCT01261611|12058552|FG001|COMPLETED|Treatment Cycle 4||0
10892547|NCT01261611|12058553|FG002|COMPLETED|Treatment Cycle 4||0
10892548|NCT01261611|12058551|FG000|NOT COMPLETED|Treatment Cycle 4||96
10892549|NCT01261611|12058552|FG001|NOT COMPLETED|Treatment Cycle 4||0
10892550|NCT01261611|12058553|FG002|NOT COMPLETED|Treatment Cycle 4||0
10892551|NCT01261611|12058551|FG000|STARTED|Treatment Cycle 5||220
10892552|NCT01261611|12058552|FG001|STARTED|Treatment Cycle 5||0
10892553|NCT01261611|12058553|FG002|STARTED|Treatment Cycle 5||0
10892554|NCT01261611|12058551|FG000|COMPLETED|Treatment Cycle 5||217
10892555|NCT01261611|12058552|FG001|COMPLETED|Treatment Cycle 5||0
10892556|NCT01261611|12058553|FG002|COMPLETED|Treatment Cycle 5||0
10892557|NCT01261611|12058551|FG000|NOT COMPLETED|Treatment Cycle 5||3
10892558|NCT01261611|12058552|FG001|NOT COMPLETED|Treatment Cycle 5||0
10892559|NCT01261611|12058553|FG002|NOT COMPLETED|Treatment Cycle 5||0
10892560|NCT01256398|12058565|FG000|STARTED|Overall Study||66
10892561|NCT01256398|12058565|FG000|COMPLETED|Overall Study||65
10892562|NCT01256398|12058565|FG000|NOT COMPLETED|Overall Study||1
10892563|NCT01253070|12058569|FG000|STARTED|Overall Study||54
10892564|NCT01253070|12058569|FG000|COMPLETED|Overall Study||54
10892565|NCT01253070|12058569|FG000|NOT COMPLETED|Overall Study||0
10892566|NCT01252719|12058576|FG000|STARTED|Overall Study|Participants Randomized|483
10892567|NCT01252719|12058577|FG001|STARTED|Overall Study|Participants Randomized|485
10892568|NCT01252719|12058576|FG000|Modified Intent to Treat Population|Overall Study||475
10892569|NCT01252719|12058577|FG001|Modified Intent to Treat Population|Overall Study||479
10892570|NCT01252719|12058576|FG000|COMPLETED|Overall Study||433
10892571|NCT01252719|12058577|FG001|COMPLETED|Overall Study||423
10892572|NCT01252719|12058576|FG000|NOT COMPLETED|Overall Study||50
10892573|NCT01252719|12058577|FG001|NOT COMPLETED|Overall Study||62
10892574|NCT01251861|12058585|FG000|STARTED|Overall Study||54
10892575|NCT01251861|12058586|FG001|STARTED|Overall Study||54
10892576|NCT01251861|12058585|FG000|Pts Who Received Protocol Therapy|Overall Study||50
10892577|NCT01251861|12058586|FG001|Pts Who Received Protocol Therapy|Overall Study||53
10892578|NCT01251861|12058585|FG000|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49
10892579|NCT01251861|12058586|FG001|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47
10892580|NCT01251861|12058585|FG000|Pts With PSA Response|Overall Study||44
10892581|NCT01251861|12058586|FG001|Pts With PSA Response|Overall Study||36
10892582|NCT01251861|12058585|FG000|COMPLETED|Overall Study||36
10892583|NCT01251861|12058586|FG001|COMPLETED|Overall Study||26
10892584|NCT01251861|12058585|FG000|NOT COMPLETED|Overall Study||18
10892585|NCT01251861|12058586|FG001|NOT COMPLETED|Overall Study||28
10892586|NCT01251380|12058592|FG000|STARTED|Overall Study|Safety population.|216
10892587|NCT01251380|12058592|FG000|Cycle 1|Overall Study||207
10892588|NCT01251380|12058592|FG000|Cycle 2|Overall Study||175
10892589|NCT01251380|12058592|FG000|Cycle 3|Overall Study||86
10892590|NCT01251380|12058592|FG000|Cycle 4|Overall Study||11
10892591|NCT01251380|12058592|FG000|COMPLETED|Overall Study||194
10892592|NCT01251380|12058592|FG000|NOT COMPLETED|Overall Study||22
10892593|NCT01251367|12058601|FG000|STARTED|Overall Study||345
10892594|NCT01251367|12058601|FG000|Cycle 1|Overall Study||345
10892595|NCT01251367|12058601|FG000|Cycle 2|Overall Study||297
10892596|NCT01251367|12058601|FG000|Cycle 3|Overall Study||224
10892597|NCT01251367|12058601|FG000|Cycle 4|Overall Study||139
10892598|NCT01251367|12058601|FG000|COMPLETED|Overall Study||269
10892599|NCT01251367|12058601|FG000|NOT COMPLETED|Overall Study||76
10892600|NCT01251276|12058607|FG000|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
10892601|NCT01251276|12058608|FG001|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
10892602|NCT01251276|12058607|FG000|Vaccinated|Overall Study||96
10892603|NCT01251276|12058608|FG001|Vaccinated|Overall Study||108
10892604|NCT01251276|12058607|FG000|COMPLETED|Overall Study||95
10892605|NCT01251276|12058608|FG001|COMPLETED|Overall Study||107
10892606|NCT01251276|12058607|FG000|NOT COMPLETED|Overall Study||1
10892607|NCT01251276|12058608|FG001|NOT COMPLETED|Overall Study||1
10892608|NCT01249417|12058617|FG000|STARTED|Randomised Population||80
10892609|NCT01249417|12058618|FG001|STARTED|Randomised Population||80
10892610|NCT01249417|12058619|FG002|STARTED|Randomised Population||81
10892611|NCT01249417|12058617|FG000|Treated|Randomised Population||80
10892612|NCT01249417|12058618|FG001|Treated|Randomised Population||80
10892613|NCT01249417|12058619|FG002|Treated|Randomised Population||79
10892614|NCT01249417|12058617|FG000|COMPLETED|Randomised Population||79
10892615|NCT01249417|12058618|FG001|COMPLETED|Randomised Population||79
10892616|NCT01249417|12058619|FG002|COMPLETED|Randomised Population||77
10892617|NCT01249417|12058617|FG000|NOT COMPLETED|Randomised Population||1
10892618|NCT01249417|12058618|FG001|NOT COMPLETED|Randomised Population||1
10892619|NCT01249417|12058619|FG002|NOT COMPLETED|Randomised Population||4
10892620|NCT01249417|12058617|FG000|STARTED|Treatment Phase - ITT Population||79
10892621|NCT01249417|12058618|FG001|STARTED|Treatment Phase - ITT Population||79
10892622|NCT01249417|12058619|FG002|STARTED|Treatment Phase - ITT Population||77
10892623|NCT01249417|12058617|FG000|COMPLETED|Treatment Phase - ITT Population||78
10892624|NCT01249417|12058618|FG001|COMPLETED|Treatment Phase - ITT Population||75
10892625|NCT01249417|12058619|FG002|COMPLETED|Treatment Phase - ITT Population||73
10892626|NCT01249417|12058617|FG000|NOT COMPLETED|Treatment Phase - ITT Population||1
10892627|NCT01249417|12058618|FG001|NOT COMPLETED|Treatment Phase - ITT Population||4
10892628|NCT01249417|12058619|FG002|NOT COMPLETED|Treatment Phase - ITT Population||4
10892629|NCT01249404|12058630|FG000|STARTED|Overall Study||127
10892630|NCT01249404|12058631|FG001|STARTED|Overall Study||129
10892631|NCT01249404|12058632|FG002|STARTED|Overall Study||132
10892632|NCT01249404|12058630|FG000|COMPLETED|Overall Study||120
10892633|NCT01249404|12058631|FG001|COMPLETED|Overall Study||121
10892634|NCT01249404|12058632|FG002|COMPLETED|Overall Study||125
10892635|NCT01249404|12058630|FG000|NOT COMPLETED|Overall Study||7
10892636|NCT01249404|12058631|FG001|NOT COMPLETED|Overall Study||8
10892637|NCT01249404|12058632|FG002|NOT COMPLETED|Overall Study||7
10892638|NCT01238211|12058640|FG000|STARTED|Overall Study||61
10892639|NCT01238211|12058640|FG000|COMPLETED|Overall Study||3
10892640|NCT01238211|12058640|FG000|NOT COMPLETED|Overall Study||58
10892641|NCT01236560|12058650|FG000|STARTED|Overall Study||6
10892642|NCT01236560|12058651|FG001|STARTED|Overall Study||32
10892643|NCT01236560|12058652|FG002|STARTED|Overall Study||31
10892644|NCT01236560|12058653|FG003|STARTED|Overall Study||32
10892645|NCT01236560|12058654|FG004|STARTED|Overall Study||0
10892646|NCT01236560|12058655|FG005|STARTED|Overall Study||0
10892647|NCT01236560|12058650|FG000|COMPLETED|Overall Study||1
10892648|NCT01236560|12058651|FG001|COMPLETED|Overall Study||8
10892649|NCT01236560|12058652|FG002|COMPLETED|Overall Study||11
10892650|NCT01236560|12058653|FG003|COMPLETED|Overall Study||10
10892651|NCT01236560|12058654|FG004|COMPLETED|Overall Study||0
10892652|NCT01236560|12058655|FG005|COMPLETED|Overall Study||0
10892653|NCT01236560|12058650|FG000|NOT COMPLETED|Overall Study||5
10892654|NCT01236560|12058651|FG001|NOT COMPLETED|Overall Study||24
10892655|NCT01236560|12058652|FG002|NOT COMPLETED|Overall Study||20
10892656|NCT01236560|12058653|FG003|NOT COMPLETED|Overall Study||22
10892657|NCT01236560|12058654|FG004|NOT COMPLETED|Overall Study||0
10892658|NCT01236560|12058655|FG005|NOT COMPLETED|Overall Study||0
10892659|NCT01230411|12058667|FG000|STARTED|Overall Study||21
10892660|NCT01230411|12058668|FG001|STARTED|Overall Study||23
10892661|NCT01230411|12058667|FG000|COMPLETED|Overall Study||21
10892662|NCT01230411|12058668|FG001|COMPLETED|Overall Study||23
10892663|NCT01230411|12058667|FG000|NOT COMPLETED|Overall Study||0
10892664|NCT01230411|12058668|FG001|NOT COMPLETED|Overall Study||0
10892665|NCT01229943|12058676|FG000|STARTED|Overall Study||75
10892666|NCT01229943|12058677|FG001|STARTED|Overall Study||75
10892667|NCT01229943|12058676|FG000|COMPLETED|Overall Study||57
10892668|NCT01229943|12058677|FG001|COMPLETED|Overall Study||58
10892669|NCT01229943|12058676|FG000|NOT COMPLETED|Overall Study||18
10892670|NCT01229943|12058677|FG001|NOT COMPLETED|Overall Study||17
10892671|NCT01223963|12058685|FG000|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
10892672|NCT01223963|12058685|FG000|COMPLETED|Overall Study||93
10892673|NCT01223963|12058685|FG000|NOT COMPLETED|Overall Study||0
10892674|NCT01212822|12058690|FG000|STARTED|Overall Study||20
10892675|NCT01212822|12058690|FG000|COMPLETED|Overall Study||20
10892676|NCT01212822|12058690|FG000|NOT COMPLETED|Overall Study||0
10892677|NCT01209949|12058694|FG000|STARTED|Overall Study||30
10892678|NCT01209949|12058694|FG000|COMPLETED|Overall Study||27
10892679|NCT01209949|12058694|FG000|NOT COMPLETED|Overall Study||3
10892680|NCT01207492|12058698|FG000|STARTED|Overall Study||17
10892681|NCT01207492|12058698|FG000|COMPLETED|Overall Study||2
10892682|NCT01207492|12058698|FG000|NOT COMPLETED|Overall Study||15
10892683|NCT01197950|12058705|FG000|STARTED|Overall Study||99
10892684|NCT01197950|12058706|FG001|STARTED|Overall Study||103
10892685|NCT01197950|12058707|FG002|STARTED|Overall Study||101
10892686|NCT01197950|12058705|FG000|COMPLETED|Overall Study|women's request (9), high workload (3), returned home (1), partus in one hour (1), other (2)|83
10892687|NCT01197950|12058706|FG001|COMPLETED|Overall Study|women's request (11) high workload (4) returned to home (1)|87
10892688|NCT01197950|12058707|FG002|COMPLETED|Overall Study|woman's request (11) high workload (1) returned to home (2) other (4)|83
10892689|NCT01197950|12058705|FG000|NOT COMPLETED|Overall Study||16
10892690|NCT01197950|12058706|FG001|NOT COMPLETED|Overall Study||16
10892691|NCT01197950|12058707|FG002|NOT COMPLETED|Overall Study||18
10892692|NCT01196390|12058717|FG000|STARTED|Overall Study||102
10892693|NCT01196390|12058718|FG001|STARTED|Overall Study||101
10892694|NCT01196390|12058717|FG000|Eligible|Overall Study||98
10892695|NCT01196390|12058718|FG001|Eligible|Overall Study||96
10892696|NCT01196390|12058717|FG000|Eligible and Started Study Treatment|Overall Study||95
10892697|NCT01196390|12058718|FG001|Eligible and Started Study Treatment|Overall Study||96
10892698|NCT01196390|12058717|FG000|Eligible and Had Surgery|Overall Study||82
10892699|NCT01196390|12058718|FG001|Eligible and Had Surgery|Overall Study||78
10892700|NCT01196390|12058717|FG000|COMPLETED|Overall Study||98
10892701|NCT01196390|12058718|FG001|COMPLETED|Overall Study||96
10892702|NCT01196390|12058717|FG000|NOT COMPLETED|Overall Study||4
10892703|NCT01196390|12058718|FG001|NOT COMPLETED|Overall Study||5
10892704|NCT01171898|12058730|FG000|STARTED|Overall Study||30
10892705|NCT01171898|12058731|FG001|STARTED|Overall Study||51
10892706|NCT01171898|12058732|FG002|STARTED|Overall Study||25
10892707|NCT01171898|12058733|FG003|STARTED|Overall Study||21
10892708|NCT01171898|12058730|FG000|COMPLETED|Overall Study||26
10892709|NCT01171898|12058731|FG001|COMPLETED|Overall Study||32
10892710|NCT01171898|12058732|FG002|COMPLETED|Overall Study||13
10892711|NCT01171898|12058733|FG003|COMPLETED|Overall Study||15
10892712|NCT01171898|12058730|FG000|NOT COMPLETED|Overall Study||4
10892713|NCT01171898|12058731|FG001|NOT COMPLETED|Overall Study||19
10892714|NCT01171898|12058732|FG002|NOT COMPLETED|Overall Study||12
10892715|NCT01171898|12058733|FG003|NOT COMPLETED|Overall Study||6
10892716|NCT01168219|12058746|FG000|STARTED|Overall Study||68
10892717|NCT01168219|12058746|FG000|COMPLETED|Overall Study||63
10892718|NCT01168219|12058746|FG000|NOT COMPLETED|Overall Study||5
10892719|NCT01167712|12058752|FG000|STARTED|Overall Study||346
10892720|NCT01167712|12058753|FG001|STARTED|Overall Study||346
10892721|NCT01167712|12058752|FG000|COMPLETED|Overall Study||346
10892722|NCT01167712|12058753|FG001|COMPLETED|Overall Study||346
10892723|NCT01167712|12058752|FG000|NOT COMPLETED|Overall Study||0
10892724|NCT01167712|12058753|FG001|NOT COMPLETED|Overall Study||0
10892725|NCT01146275|12058759|FG000|STARTED|Overall Study||6
10892726|NCT01146275|12058759|FG000|COMPLETED|Overall Study||6
10892727|NCT01146275|12058759|FG000|NOT COMPLETED|Overall Study||0
10892728|NCT01145495|12058764|FG000|STARTED|Overall Study||63
10892729|NCT01145495|12058764|FG000|COMPLETED|Overall Study||51
10892730|NCT01145495|12058764|FG000|NOT COMPLETED|Overall Study||12
10892731|NCT01145209|12058770|FG000|STARTED|Overall Study||13
10892732|NCT01145209|12058771|FG001|STARTED|Overall Study||19
10892733|NCT01145209|12058770|FG000|COMPLETED|Overall Study||10
10892734|NCT01145209|12058771|FG001|COMPLETED|Overall Study||18
10892735|NCT01145209|12058770|FG000|NOT COMPLETED|Overall Study||3
10892736|NCT01145209|12058771|FG001|NOT COMPLETED|Overall Study||1
10892737|NCT01143038|12058785|FG000|STARTED|Overall Study||75
10892738|NCT01143038|12058785|FG000|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
10892739|NCT01143038|12058785|FG000|NOT COMPLETED|Overall Study||16
10892740|NCT01142388|12058791|FG000|STARTED|Overall Study||47
10892741|NCT01142388|12058792|FG001|STARTED|Overall Study||47
10892742|NCT01142388|12058791|FG000|Eligible|Overall Study||43
10892743|NCT01142388|12058792|FG001|Eligible|Overall Study||44
10892744|NCT01142388|12058791|FG000|Treated|Overall Study||40
10892745|NCT01142388|12058792|FG001|Treated|Overall Study||44
10892746|NCT01142388|12058791|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
10892747|NCT01142388|12058792|FG001|COMPLETED|Overall Study||0
10892748|NCT01142388|12058791|FG000|NOT COMPLETED|Overall Study||47
10892749|NCT01142388|12058792|FG001|NOT COMPLETED|Overall Study||47
10892750|NCT01139047|12058798|FG000|STARTED|Overall Study||77
10892751|NCT01139047|12058798|FG000|COMPLETED|Overall Study||76
10892752|NCT01139047|12058798|FG000|NOT COMPLETED|Overall Study||1
10892753|NCT01139008|12058805|FG000|STARTED|Overall Study||80
10892754|NCT01139008|12058805|FG000|COMPLETED|Overall Study||74
10892755|NCT01139008|12058805|FG000|NOT COMPLETED|Overall Study||6
10892756|NCT01134614|12058814|FG000|STARTED|Overall Study||123
10892757|NCT01134614|12058815|FG001|STARTED|Overall Study||122
10892758|NCT01134614|12058814|FG000|Treated|Overall Study||119
10892759|NCT01134614|12058815|FG001|Treated|Overall Study||121
10892760|NCT01134614|12058814|FG000|Treated and Toxicity Assessed|Overall Study||118
10892761|NCT01134614|12058815|FG001|Treated and Toxicity Assessed|Overall Study||120
10892762|NCT01134614|12058814|FG000|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
10892763|NCT01134614|12058815|FG001|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
10892764|NCT01134614|12058814|FG000|NOT COMPLETED|Overall Study||123
10892765|NCT01134614|12058815|FG001|NOT COMPLETED|Overall Study||122
10892766|NCT01131182|12058823|FG000|STARTED|Overall Study||529
10892767|NCT01131182|12058824|FG001|STARTED|Overall Study||537
10892768|NCT01131182|12058823|FG000|COMPLETED|Overall Study||513
10892769|NCT01131182|12058824|FG001|COMPLETED|Overall Study||521
10892770|NCT01131182|12058823|FG000|NOT COMPLETED|Overall Study||16
10892771|NCT01131182|12058824|FG001|NOT COMPLETED|Overall Study||16
10892772|NCT01126736|12058835|FG000|STARTED|Overall Study||4
10892773|NCT01126736|12058836|FG001|STARTED|Overall Study||6
10892774|NCT01126736|12058837|FG002|STARTED|Overall Study||5
10892775|NCT01126736|12058838|FG003|STARTED|Overall Study||42
10892776|NCT01126736|12058839|FG004|STARTED|Overall Study||41
10892777|NCT01126736|12058835|FG000|Safety Population|Overall Study||4
10892778|NCT01126736|12058836|FG001|Safety Population|Overall Study||6
10892779|NCT01126736|12058837|FG002|Safety Population|Overall Study||5
10892780|NCT01126736|12058838|FG003|Safety Population|Overall Study||41
10892781|NCT01126736|12058839|FG004|Safety Population|Overall Study||39
10892782|NCT01126736|12058835|FG000|Modified Intent-to-treat (MITT)|Overall Study||4
10892783|NCT01126736|12058836|FG001|Modified Intent-to-treat (MITT)|Overall Study||6
10892784|NCT01126736|12058837|FG002|Modified Intent-to-treat (MITT)|Overall Study||5
10892785|NCT01126736|12058838|FG003|Modified Intent-to-treat (MITT)|Overall Study||39
10892786|NCT01126736|12058839|FG004|Modified Intent-to-treat (MITT)|Overall Study||39
10892787|NCT01126736|12058835|FG000|COMPLETED|Overall Study||0
10892788|NCT01126736|12058836|FG001|COMPLETED|Overall Study||0
10892789|NCT01126736|12058837|FG002|COMPLETED|Overall Study||0
10892790|NCT01126736|12058838|FG003|COMPLETED|Overall Study||0
10892791|NCT01126736|12058839|FG004|COMPLETED|Overall Study||0
10892792|NCT01126736|12058835|FG000|NOT COMPLETED|Overall Study||4
10892793|NCT01126736|12058836|FG001|NOT COMPLETED|Overall Study||6
10892794|NCT01126736|12058837|FG002|NOT COMPLETED|Overall Study||5
10892795|NCT01126736|12058838|FG003|NOT COMPLETED|Overall Study||42
10892796|NCT01126736|12058839|FG004|NOT COMPLETED|Overall Study||41
10892797|NCT01125436|12058853|FG000|STARTED|Overall Study||31
10892798|NCT01125436|12058854|FG001|STARTED|Overall Study||33
10892799|NCT01125436|12058853|FG000|COMPLETED|Overall Study||19
10892800|NCT01125436|12058854|FG001|COMPLETED|Overall Study||21
10892801|NCT01125436|12058853|FG000|NOT COMPLETED|Overall Study||12
10892802|NCT01125436|12058854|FG001|NOT COMPLETED|Overall Study||12
10892803|NCT01120964|12058862|FG000|STARTED|Overall Study||11
10892804|NCT01120964|12058863|FG001|STARTED|Overall Study||11
10892805|NCT01120964|12058862|FG000|COMPLETED|Overall Study||10
10892806|NCT01120964|12058863|FG001|COMPLETED|Overall Study||11
10892807|NCT01120964|12058862|FG000|NOT COMPLETED|Overall Study||1
10892808|NCT01120964|12058863|FG001|NOT COMPLETED|Overall Study||0
10892809|NCT01119066|12058873|FG000|STARTED|Overall Study||132
10892810|NCT01119066|12058874|FG001|STARTED|Overall Study||227
10892811|NCT01119066|12058875|FG002|STARTED|Overall Study||52
10892812|NCT01119066|12058876|FG003|STARTED|Overall Study||11
10892813|NCT01119066|12058873|FG000|COMPLETED|Overall Study||125
10892814|NCT01119066|12058874|FG001|COMPLETED|Overall Study||213
10892815|NCT01119066|12058875|FG002|COMPLETED|Overall Study||52
10892816|NCT01119066|12058876|FG003|COMPLETED|Overall Study||11
10892817|NCT01119066|12058873|FG000|NOT COMPLETED|Overall Study||7
10892818|NCT01119066|12058874|FG001|NOT COMPLETED|Overall Study||14
10892819|NCT01119066|12058875|FG002|NOT COMPLETED|Overall Study||0
10892820|NCT01119066|12058876|FG003|NOT COMPLETED|Overall Study||0
10892821|NCT01112306|12058886|FG000|STARTED|Overall Study||709
10892822|NCT01112306|12058886|FG000|COMPLETED|Overall Study||424
10892823|NCT01112306|12058886|FG000|NOT COMPLETED|Overall Study||285
10892824|NCT01110681|12058890|FG000|STARTED|Overall Study||115
10892825|NCT01110681|12058890|FG000|COMPLETED|Overall Study||83
10892826|NCT01110681|12058890|FG000|NOT COMPLETED|Overall Study||32
10892827|NCT01081678|12058898|FG000|STARTED|Overall Study||89
10892828|NCT01081678|12058899|FG001|STARTED|Overall Study||60
10892829|NCT01081678|12058900|FG002|STARTED|Overall Study||93
10892830|NCT01081678|12058901|FG003|STARTED|Overall Study||90
10892831|NCT01081678|12058898|FG000|Received Study Drug|Overall Study||87
10892832|NCT01081678|12058899|FG001|Received Study Drug|Overall Study||60
10892833|NCT01081678|12058900|FG002|Received Study Drug|Overall Study||89
10892834|NCT01081678|12058901|FG003|Received Study Drug|Overall Study||89
10892835|NCT01081678|12058898|FG000|Completed 24 Weeks of Study|Overall Study||73
10892836|NCT01081678|12058899|FG001|Completed 24 Weeks of Study|Overall Study||50
10892837|NCT01081678|12058900|FG002|Completed 24 Weeks of Study|Overall Study||72
10892838|NCT01081678|12058901|FG003|Completed 24 Weeks of Study|Overall Study||68
10892839|NCT01081678|12058898|FG000|COMPLETED|Overall Study||62
10892840|NCT01081678|12058899|FG001|COMPLETED|Overall Study||44
10892841|NCT01081678|12058900|FG002|COMPLETED|Overall Study||62
10892842|NCT01081678|12058901|FG003|COMPLETED|Overall Study||61
10892843|NCT01081678|12058898|FG000|NOT COMPLETED|Overall Study||27
10892844|NCT01081678|12058899|FG001|NOT COMPLETED|Overall Study||16
10892845|NCT01081678|12058900|FG002|NOT COMPLETED|Overall Study||31
10892846|NCT01081678|12058901|FG003|NOT COMPLETED|Overall Study||29
10892847|NCT01081262|12058915|FG000|STARTED|Overall Study||13
10892848|NCT01081262|12058916|FG001|STARTED|Overall Study||13
10892849|NCT01081262|12058917|FG002|STARTED|Overall Study||13
10892850|NCT01081262|12058918|FG003|STARTED|Overall Study||11
10892851|NCT01081262|12058915|FG000|COMPLETED|Overall Study||13
10892852|NCT01081262|12058916|FG001|COMPLETED|Overall Study||13
10892853|NCT01081262|12058917|FG002|COMPLETED|Overall Study||13
10892854|NCT01081262|12058918|FG003|COMPLETED|Overall Study||11
10892855|NCT01081262|12058915|FG000|NOT COMPLETED|Overall Study||0
10892856|NCT01081262|12058916|FG001|NOT COMPLETED|Overall Study||0
10892857|NCT01081262|12058917|FG002|NOT COMPLETED|Overall Study||0
10892858|NCT01081262|12058918|FG003|NOT COMPLETED|Overall Study||0
10892859|NCT01080391|12058930|FG000|STARTED|Overall Study||396
10892860|NCT01080391|12058931|FG001|STARTED|Overall Study||396
10892861|NCT01080391|12058930|FG000|Treated|Overall Study||389
10892862|NCT01080391|12058931|FG001|Treated|Overall Study||392
10892863|NCT01080391|12058930|FG000|COMPLETED|Overall Study||389
10892864|NCT01080391|12058931|FG001|COMPLETED|Overall Study||392
10892865|NCT01080391|12058930|FG000|NOT COMPLETED|Overall Study||7
10892866|NCT01080391|12058931|FG001|NOT COMPLETED|Overall Study||4
10892867|NCT01077856|12058940|FG000|STARTED|Overall Study||22199
10892868|NCT01077856|12058941|FG001|STARTED|Overall Study||16604
10892869|NCT01077856|12058942|FG002|STARTED|Overall Study||15713
10892870|NCT01077856|12058940|FG000|COMPLETED|Overall Study||22199
10892871|NCT01077856|12058941|FG001|COMPLETED|Overall Study||16604
10892872|NCT01077856|12058942|FG002|COMPLETED|Overall Study||15713
10892873|NCT01077856|12058940|FG000|NOT COMPLETED|Overall Study||0
10892874|NCT01077856|12058941|FG001|NOT COMPLETED|Overall Study||0
10892875|NCT01077856|12058942|FG002|NOT COMPLETED|Overall Study||0
10892876|NCT01065454|12058986|FG000|STARTED|Treatment||67
10892877|NCT01065454|12058987|FG001|STARTED|Treatment||33
10892878|NCT01065454|12058988|FG002|STARTED|Treatment||32
10892879|NCT01065454|12058989|FG003|STARTED|Treatment||69
10892880|NCT01065454|12058986|FG000|COMPLETED|Treatment||54
10892881|NCT01065454|12058987|FG001|COMPLETED|Treatment||28
10892882|NCT01065454|12058988|FG002|COMPLETED|Treatment||23
10892883|NCT01065454|12058989|FG003|COMPLETED|Treatment||57
10892884|NCT01065454|12058986|FG000|NOT COMPLETED|Treatment||13
10892885|NCT01065454|12058987|FG001|NOT COMPLETED|Treatment||5
10892886|NCT01065454|12058988|FG002|NOT COMPLETED|Treatment||9
10892887|NCT01065454|12058989|FG003|NOT COMPLETED|Treatment||12
10892888|NCT01065454|12058986|FG000|STARTED|Follow up||54
10892889|NCT01065454|12058987|FG001|STARTED|Follow up||28
10892890|NCT01065454|12058988|FG002|STARTED|Follow up||23
10892891|NCT01065454|12058989|FG003|STARTED|Follow up||57
10892892|NCT01065454|12058986|FG000|Entering Follow-up|Follow up||49
10892893|NCT01065454|12058987|FG001|Entering Follow-up|Follow up||27
10892894|NCT01065454|12058988|FG002|Entering Follow-up|Follow up||23
10892895|NCT01065454|12058989|FG003|Entering Follow-up|Follow up||51
10892896|NCT01065454|12058986|FG000|COMPLETED|Follow up||15
10892897|NCT01065454|12058987|FG001|COMPLETED|Follow up||4
10892898|NCT01065454|12058988|FG002|COMPLETED|Follow up||6
10892899|NCT01065454|12058989|FG003|COMPLETED|Follow up||13
10892900|NCT01065454|12058986|FG000|NOT COMPLETED|Follow up||39
10892901|NCT01065454|12058987|FG001|NOT COMPLETED|Follow up||24
10892902|NCT01065454|12058988|FG002|NOT COMPLETED|Follow up||17
10892903|NCT01065454|12058989|FG003|NOT COMPLETED|Follow up||44
10892904|NCT01064648|12059002|FG000|STARTED|Phase I Cohort1: Dose Level 1||7
10892905|NCT01064648|12059003|FG001|STARTED|Phase I Cohort1: Dose Level 1||0
10892906|NCT01064648|12059004|FG002|STARTED|Phase I Cohort1: Dose Level 1||0
10892907|NCT01064648|12059005|FG003|STARTED|Phase I Cohort1: Dose Level 1||0
10892908|NCT01064648|12059002|FG000|COMPLETED|Phase I Cohort1: Dose Level 1||0
10892909|NCT01064648|12059003|FG001|COMPLETED|Phase I Cohort1: Dose Level 1||0
10892910|NCT01064648|12059004|FG002|COMPLETED|Phase I Cohort1: Dose Level 1||0
10892911|NCT01064648|12059005|FG003|COMPLETED|Phase I Cohort1: Dose Level 1||0
10892912|NCT01064648|12059002|FG000|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7
10892913|NCT01064648|12059003|FG001|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
10892914|NCT01064648|12059004|FG002|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
10892915|NCT01064648|12059005|FG003|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
10892916|NCT01064648|12059002|FG000|STARTED|Phase I Cohort 2: Dose Level 2||0
10892917|NCT01064648|12059003|FG001|STARTED|Phase I Cohort 2: Dose Level 2||13
10892918|NCT01064648|12059004|FG002|STARTED|Phase I Cohort 2: Dose Level 2||0
10892919|NCT01064648|12059005|FG003|STARTED|Phase I Cohort 2: Dose Level 2||0
10892920|NCT01064648|12059002|FG000|COMPLETED|Phase I Cohort 2: Dose Level 2||0
10892921|NCT01064648|12059003|FG001|COMPLETED|Phase I Cohort 2: Dose Level 2||0
10892922|NCT01064648|12059004|FG002|COMPLETED|Phase I Cohort 2: Dose Level 2||0
10892923|NCT01064648|12059005|FG003|COMPLETED|Phase I Cohort 2: Dose Level 2||0
10892924|NCT01064648|12059002|FG000|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
10892925|NCT01064648|12059003|FG001|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13
10892926|NCT01064648|12059004|FG002|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
10892927|NCT01064648|12059005|FG003|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
10892928|NCT01064648|12059002|FG000|STARTED|Phase II||0
10892929|NCT01064648|12059003|FG001|STARTED|Phase II||0
10892930|NCT01064648|12059004|FG002|STARTED|Phase II||49
10892931|NCT01064648|12059005|FG003|STARTED|Phase II||48
10892932|NCT01064648|12059002|FG000|COMPLETED|Phase II||0
10892933|NCT01064648|12059003|FG001|COMPLETED|Phase II||0
10892934|NCT01064648|12059004|FG002|COMPLETED|Phase II||0
10892935|NCT01064648|12059005|FG003|COMPLETED|Phase II||0
10892936|NCT01064648|12059002|FG000|NOT COMPLETED|Phase II||0
10892937|NCT01064648|12059003|FG001|NOT COMPLETED|Phase II||0
10892938|NCT01064648|12059004|FG002|NOT COMPLETED|Phase II||49
10892939|NCT01064648|12059005|FG003|NOT COMPLETED|Phase II||48
10892940|NCT01064479|12059020|FG000|STARTED|Overall Study||60
10892941|NCT01064479|12059021|FG001|STARTED|Overall Study||59
10892942|NCT01064479|12059020|FG000|COMPLETED|Overall Study||45
10892943|NCT01064479|12059021|FG001|COMPLETED|Overall Study||42
10892944|NCT01064479|12059020|FG000|NOT COMPLETED|Overall Study||15
10892945|NCT01064479|12059021|FG001|NOT COMPLETED|Overall Study||17
10892946|NCT01063517|12059029|FG000|STARTED|Overall Study||62
10892947|NCT01063517|12059030|FG001|STARTED|Overall Study||62
10892948|NCT01063517|12059029|FG000|Received Randomised Treatment|Overall Study||61
10892949|NCT01063517|12059030|FG001|Received Randomised Treatment|Overall Study||62
10892950|NCT01063517|12059029|FG000|COMPLETED|Overall Study||4
10892951|NCT01063517|12059030|FG001|COMPLETED|Overall Study||2
10892952|NCT01063517|12059029|FG000|NOT COMPLETED|Overall Study||58
10892953|NCT01063517|12059030|FG001|NOT COMPLETED|Overall Study||60
10892954|NCT01052103|12059038|FG000|STARTED|Overall Study||84
10892955|NCT01052103|12059039|FG001|STARTED|Overall Study||83
10892956|NCT01052103|12059038|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
10892957|NCT01052103|12059039|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82
10892958|NCT01052103|12059038|FG000|COMPLETED|Overall Study||50
10892959|NCT01052103|12059039|FG001|COMPLETED|Overall Study||60
10892960|NCT01052103|12059038|FG000|NOT COMPLETED|Overall Study||34
10892961|NCT01052103|12059039|FG001|NOT COMPLETED|Overall Study||23
10892962|NCT01046565|12059046|FG000|STARTED|Overall Study||75
10892963|NCT01046565|12059046|FG000|COMPLETED|Overall Study||66
10892964|NCT01046565|12059046|FG000|NOT COMPLETED|Overall Study||9
10892965|NCT01046396|12059055|FG000|STARTED|Overall Study||69
10892966|NCT01046396|12059055|FG000|COMPLETED|Overall Study||64
10892967|NCT01046396|12059055|FG000|NOT COMPLETED|Overall Study||5
10892971|NCT01026012|12059066|FG000|STARTED|Overall Study||40
10892972|NCT01026012|12059066|FG000|COMPLETED|Overall Study||40
10892973|NCT01026012|12059066|FG000|NOT COMPLETED|Overall Study||0
10892974|NCT01016353|12059072|FG000|STARTED|Overall Study||180
10892975|NCT01016353|12059073|FG001|STARTED|Overall Study||103
10892976|NCT01016353|12059072|FG000|COMPLETED|Overall Study||178
10892977|NCT01016353|12059073|FG001|COMPLETED|Overall Study||102
10892978|NCT01016353|12059072|FG000|NOT COMPLETED|Overall Study||2
10892979|NCT01016353|12059073|FG001|NOT COMPLETED|Overall Study||1
10892980|NCT01015833|12059081|FG000|STARTED|Overall Study||180
10892981|NCT01015833|12059082|FG001|STARTED|Overall Study||176
10892982|NCT01015833|12059081|FG000|COMPLETED|Overall Study||167
10892983|NCT01015833|12059082|FG001|COMPLETED|Overall Study||171
10892984|NCT01015833|12059081|FG000|NOT COMPLETED|Overall Study||13
10892985|NCT01015833|12059082|FG001|NOT COMPLETED|Overall Study||5
10892986|NCT01014936|12059091|FG000|STARTED|Overall Study||42
10892987|NCT01014936|12059092|FG001|STARTED|Overall Study||45
10892988|NCT01014936|12059093|FG002|STARTED|Overall Study||62
10892989|NCT01014936|12059091|FG000|COMPLETED|Overall Study||42
10892990|NCT01014936|12059092|FG001|COMPLETED|Overall Study||45
10892991|NCT01014936|12059093|FG002|COMPLETED|Overall Study||62
10892992|NCT01014936|12059091|FG000|NOT COMPLETED|Overall Study||0
10892993|NCT01014936|12059092|FG001|NOT COMPLETED|Overall Study||0
10892994|NCT01014936|12059093|FG002|NOT COMPLETED|Overall Study||0
10892995|NCT01005745|12059159|FG000|STARTED|Overall Study||19
10892996|NCT01005745|12059159|FG000|COMPLETED|Overall Study||13
10892997|NCT01005745|12059159|FG000|NOT COMPLETED|Overall Study||6
10892998|NCT01002820|12059163|FG000|STARTED|Overall Study||11
10892999|NCT01002820|12059163|FG000|COMPLETED|Overall Study||7
10893000|NCT01002820|12059163|FG000|NOT COMPLETED|Overall Study||4
10893001|NCT01001377|12059169|FG000|STARTED|Overall Study||504
10893002|NCT01001377|12059170|FG001|STARTED|Overall Study||506
10893003|NCT01001377|12059169|FG000|Received Treatment|Overall Study||500
10893004|NCT01001377|12059170|FG001|Received Treatment|Overall Study||499
10893005|NCT01001377|12059169|FG000|COMPLETED|Overall Study|Indicates participants continuing in study|78
10893006|NCT01001377|12059170|FG001|COMPLETED|Overall Study|Indicates participants continuing in study|85
10893007|NCT01001377|12059169|FG000|NOT COMPLETED|Overall Study||426
10893008|NCT01001377|12059170|FG001|NOT COMPLETED|Overall Study||421
10893009|NCT00994162|12059178|FG000|STARTED|Overall Study||153
10893010|NCT00994162|12059178|FG000|Participants Receiving Treatment|Overall Study||152
10893011|NCT00994162|12059178|FG000|COMPLETED|Overall Study||125
10893012|NCT00994162|12059178|FG000|NOT COMPLETED|Overall Study||28
10893013|NCT00988637|12059185|FG000|STARTED|Overall Study||70
10893014|NCT00988637|12059186|FG001|STARTED|Overall Study||68
10893015|NCT00988637|12059185|FG000|COMPLETED|Overall Study||67
10893016|NCT00988637|12059186|FG001|COMPLETED|Overall Study||65
10893017|NCT00988637|12059185|FG000|NOT COMPLETED|Overall Study||3
10893018|NCT00988637|12059186|FG001|NOT COMPLETED|Overall Study||3
10893019|NCT00980538|12059192|FG000|STARTED|Overall Study||180
10893020|NCT00980538|12059192|FG000|COMPLETED|Overall Study||0
10893021|NCT00980538|12059192|FG000|NOT COMPLETED|Overall Study||180
10893022|NCT00980460|12059201|FG000|STARTED|Overall Study||8
10893023|NCT00980460|12059202|FG001|STARTED|Overall Study||51
10893024|NCT00980460|12059203|FG002|STARTED|Overall Study||105
10893025|NCT00980460|12059204|FG003|STARTED|Overall Study||32
10893026|NCT00980460|12059205|FG004|STARTED|Overall Study||40
10893027|NCT00980460|12059201|FG000|COMPLETED|Overall Study||8
10893028|NCT00980460|12059202|FG001|COMPLETED|Overall Study||47
10893029|NCT00980460|12059203|FG002|COMPLETED|Overall Study||70
10893030|NCT00980460|12059204|FG003|COMPLETED|Overall Study||14
10893031|NCT00980460|12059205|FG004|COMPLETED|Overall Study||24
10893032|NCT00980460|12059201|FG000|NOT COMPLETED|Overall Study||0
10893033|NCT00980460|12059202|FG001|NOT COMPLETED|Overall Study||4
10893034|NCT00980460|12059203|FG002|NOT COMPLETED|Overall Study||35
10893035|NCT00980460|12059204|FG003|NOT COMPLETED|Overall Study||18
10893036|NCT00980460|12059205|FG004|NOT COMPLETED|Overall Study||16
10893037|NCT00978562|12059224|FG000|STARTED|Overall Study||14
10893038|NCT00978562|12059224|FG000|COMPLETED|Overall Study||12
10893039|NCT00978562|12059224|FG000|NOT COMPLETED|Overall Study||2
10893040|NCT00977574|12059233|FG000|STARTED|Overall Study||116
10893041|NCT00977574|12059234|FG001|STARTED|Overall Study||115
10893042|NCT00977574|12059235|FG002|STARTED|Overall Study||118
10893043|NCT00977574|12059233|FG000|COMPLETED|Overall Study||112
10893044|NCT00977574|12059234|FG001|COMPLETED|Overall Study||113
10893045|NCT00977574|12059235|FG002|COMPLETED|Overall Study||114
10893046|NCT00977574|12059233|FG000|NOT COMPLETED|Overall Study||4
10893047|NCT00977574|12059234|FG001|NOT COMPLETED|Overall Study||2
10893048|NCT00977574|12059235|FG002|NOT COMPLETED|Overall Study||4
10893049|NCT00972478|12059245|FG000|STARTED|Overall Study||11
10893050|NCT00972478|12059246|FG001|STARTED|Overall Study||72
10893051|NCT00972478|12059245|FG000|Eligible and Began Protocol Therapy|Overall Study||9
10893052|NCT00972478|12059246|FG001|Eligible and Began Protocol Therapy|Overall Study||63
10893053|NCT00972478|12059245|FG000|COMPLETED|Overall Study||4
10893054|NCT00972478|12059246|FG001|COMPLETED|Overall Study||34
10893055|NCT00972478|12059245|FG000|NOT COMPLETED|Overall Study||7
10893056|NCT00972478|12059246|FG001|NOT COMPLETED|Overall Study||38
10893057|NCT00972179|12059260|FG000|STARTED|Overall Study||6
10893058|NCT00972179|12059261|FG001|STARTED|Overall Study||6
10893059|NCT00972179|12059262|FG002|STARTED|Overall Study||6
10893060|NCT00972179|12059263|FG003|STARTED|Overall Study||6
10893061|NCT00972179|12059264|FG004|STARTED|Overall Study||7
10893062|NCT00972179|12059265|FG005|STARTED|Overall Study||6
10893063|NCT00972179|12059266|FG006|STARTED|Overall Study||12
10893064|NCT00972179|12059260|FG000|COMPLETED|Overall Study||5
10893065|NCT00972179|12059261|FG001|COMPLETED|Overall Study||3
10893066|NCT00972179|12059262|FG002|COMPLETED|Overall Study||5
10893067|NCT00972179|12059263|FG003|COMPLETED|Overall Study||5
10893068|NCT00972179|12059264|FG004|COMPLETED|Overall Study||5
10893069|NCT00972179|12059265|FG005|COMPLETED|Overall Study||3
10893070|NCT00972179|12059266|FG006|COMPLETED|Overall Study||8
10893071|NCT00972179|12059260|FG000|NOT COMPLETED|Overall Study||1
10893072|NCT00972179|12059261|FG001|NOT COMPLETED|Overall Study||3
10893073|NCT00972179|12059262|FG002|NOT COMPLETED|Overall Study||1
10893074|NCT00972179|12059263|FG003|NOT COMPLETED|Overall Study||1
10893075|NCT00972179|12059264|FG004|NOT COMPLETED|Overall Study||2
10893076|NCT00972179|12059265|FG005|NOT COMPLETED|Overall Study||3
10893077|NCT00972179|12059266|FG006|NOT COMPLETED|Overall Study||4
10893078|NCT00970684|12059286|FG000|STARTED|Overall Study||13
10893079|NCT00970684|12059286|FG000|COMPLETED|Overall Study||3
10893080|NCT00970684|12059286|FG000|NOT COMPLETED|Overall Study||10
10893081|NCT00961064|12059290|FG000|STARTED|Initial Treatment (Weeks 1 - 20)||30
10893082|NCT00961064|12059290|FG000|COMPLETED|Initial Treatment (Weeks 1 - 20)||14
10893083|NCT00961064|12059290|FG000|NOT COMPLETED|Initial Treatment (Weeks 1 - 20)||16
10893084|NCT00961064|12059290|FG000|STARTED|Extended Access: Week 20 to Up to Year 5||14
10893085|NCT00961064|12059290|FG000|COMPLETED|Extended Access: Week 20 to Up to Year 5||7
10893086|NCT00961064|12059290|FG000|NOT COMPLETED|Extended Access: Week 20 to Up to Year 5||7
10893087|NCT00951080|12059296|FG000|STARTED|Overall Study||64
10893088|NCT00951080|12059297|FG001|STARTED|Overall Study||68
10893089|NCT00951080|12059296|FG000|COMPLETED|Overall Study||38
10893090|NCT00951080|12059297|FG001|COMPLETED|Overall Study||41
10893091|NCT00951080|12059296|FG000|NOT COMPLETED|Overall Study||26
10893092|NCT00951080|12059297|FG001|NOT COMPLETED|Overall Study||27
10893093|NCT00942331|12059305|FG000|STARTED|Overall Study||252
10893094|NCT00942331|12059306|FG001|STARTED|Overall Study||254
10893095|NCT00942331|12059305|FG000|COMPLETED|Overall Study||237
10893096|NCT00942331|12059306|FG001|COMPLETED|Overall Study||232
10893097|NCT00942331|12059305|FG000|NOT COMPLETED|Overall Study||15
10893098|NCT00942331|12059306|FG001|NOT COMPLETED|Overall Study||22
10893099|NCT00937937|12059312|FG000|STARTED|Overall Study||72
10893100|NCT00937937|12059312|FG000|COMPLETED|Overall Study||0
10893101|NCT00937937|12059312|FG000|NOT COMPLETED|Overall Study||72
10893102|NCT00931268|12059317|FG000|STARTED|Overall Study||10
10893103|NCT00931268|12059317|FG000|COMPLETED|Overall Study||4
10893104|NCT00931268|12059317|FG000|NOT COMPLETED|Overall Study||6
10893105|NCT00907478|12059324|FG000|STARTED|Overall Study||50
10893106|NCT00907478|12059325|FG001|STARTED|Overall Study||50
10893107|NCT00907478|12059326|FG002|STARTED|Overall Study||69
10893108|NCT00907478|12059324|FG000|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
10893109|NCT00907478|12059325|FG001|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
10893110|NCT00907478|12059326|FG002|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
10893111|NCT00907478|12059324|FG000|NOT COMPLETED|Overall Study||27
10893112|NCT00907478|12059325|FG001|NOT COMPLETED|Overall Study||17
10893113|NCT00907478|12059326|FG002|NOT COMPLETED|Overall Study||22
10893114|NCT00907296|12059346|FG000|STARTED|Overall Study||103
10893115|NCT00907296|12059347|FG001|STARTED|Overall Study||34
10893116|NCT00907296|12059348|FG002|STARTED|Overall Study||34
10893117|NCT00907296|12059349|FG003|STARTED|Overall Study||33
10893118|NCT00907296|12059350|FG004|STARTED|Overall Study||33
10893119|NCT00907296|12059351|FG005|STARTED|Overall Study||33
10893120|NCT00907296|12059352|FG006|STARTED|Overall Study||33
10893121|NCT00907296|12059353|FG007|STARTED|Overall Study||33
10893122|NCT00907296|12059354|FG008|STARTED|Overall Study||31
10893123|NCT00907296|12059355|FG009|STARTED|Overall Study||35
10893124|NCT00907296|12059346|FG000|Received Treatment|Overall Study||100
10893125|NCT00907296|12059347|FG001|Received Treatment|Overall Study||34
10893126|NCT00907296|12059348|FG002|Received Treatment|Overall Study||34
10893127|NCT00907296|12059349|FG003|Received Treatment|Overall Study||32
10893128|NCT00907296|12059350|FG004|Received Treatment|Overall Study||33
10893129|NCT00907296|12059351|FG005|Received Treatment|Overall Study||32
10893130|NCT00907296|12059352|FG006|Received Treatment|Overall Study||31
10893131|NCT00907296|12059353|FG007|Received Treatment|Overall Study||32
10893132|NCT00907296|12059354|FG008|Received Treatment|Overall Study||30
10893133|NCT00907296|12059355|FG009|Received Treatment|Overall Study||35
10893134|NCT00907296|12059346|FG000|COMPLETED|Overall Study||83
10893135|NCT00907296|12059347|FG001|COMPLETED|Overall Study||29
10893136|NCT00907296|12059348|FG002|COMPLETED|Overall Study||32
10893137|NCT00907296|12059349|FG003|COMPLETED|Overall Study||29
10893138|NCT00907296|12059350|FG004|COMPLETED|Overall Study||32
10893139|NCT00907296|12059351|FG005|COMPLETED|Overall Study||24
10893140|NCT00907296|12059352|FG006|COMPLETED|Overall Study||27
10893141|NCT00907296|12059353|FG007|COMPLETED|Overall Study||26
10893142|NCT00907296|12059354|FG008|COMPLETED|Overall Study||27
10893143|NCT00907296|12059355|FG009|COMPLETED|Overall Study||28
10893144|NCT00907296|12059346|FG000|NOT COMPLETED|Overall Study||20
10893145|NCT00907296|12059347|FG001|NOT COMPLETED|Overall Study||5
10893146|NCT00907296|12059348|FG002|NOT COMPLETED|Overall Study||2
10893147|NCT00907296|12059349|FG003|NOT COMPLETED|Overall Study||4
10893148|NCT00907296|12059350|FG004|NOT COMPLETED|Overall Study||1
10893149|NCT00907296|12059351|FG005|NOT COMPLETED|Overall Study||9
10893150|NCT00907296|12059352|FG006|NOT COMPLETED|Overall Study||6
10893151|NCT00907296|12059353|FG007|NOT COMPLETED|Overall Study||7
10893152|NCT00907296|12059354|FG008|NOT COMPLETED|Overall Study||4
10893153|NCT00907296|12059355|FG009|NOT COMPLETED|Overall Study||7
10893154|NCT00907101|12059377|FG000|STARTED|Overall Study||30
10893155|NCT00907101|12059377|FG000|COMPLETED|Overall Study||30
10893156|NCT00907101|12059377|FG000|NOT COMPLETED|Overall Study||0
10893157|NCT00896532|12059389|FG000|STARTED|Months 1-24: Romosozumab Treatment Phase||52
10893158|NCT00896532|12059390|FG001|STARTED|Months 1-24: Romosozumab Treatment Phase||51
10893159|NCT00896532|12059391|FG002|STARTED|Months 1-24: Romosozumab Treatment Phase||55
10893160|NCT00896532|12059392|FG003|STARTED|Months 1-24: Romosozumab Treatment Phase||51
10893161|NCT00896532|12059393|FG004|STARTED|Months 1-24: Romosozumab Treatment Phase||54
10893162|NCT00896532|12059394|FG005|STARTED|Months 1-24: Romosozumab Treatment Phase||51
10893163|NCT00896532|12059395|FG006|STARTED|Months 1-24: Romosozumab Treatment Phase||53
10893164|NCT00896532|12059396|FG007|STARTED|Months 1-24: Romosozumab Treatment Phase||52
10893165|NCT00896532|12059397|FG008|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893166|NCT00896532|12059398|FG009|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893167|NCT00896532|12059399|FG010|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893168|NCT00896532|12059400|FG011|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893169|NCT00896532|12059401|FG012|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893170|NCT00896532|12059402|FG013|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893171|NCT00896532|12059403|FG014|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893172|NCT00896532|12059404|FG015|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893173|NCT00896532|12059405|FG016|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893174|NCT00896532|12059406|FG017|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893175|NCT00896532|12059407|FG018|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893176|NCT00896532|12059408|FG019|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893177|NCT00896532|12059409|FG020|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893178|NCT00896532|12059410|FG021|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893179|NCT00896532|12059411|FG022|STARTED|Months 1-24: Romosozumab Treatment Phase||0
10893180|NCT00896532|12059389|FG000|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
10893181|NCT00896532|12059390|FG001|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
10893182|NCT00896532|12059391|FG002|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
10893183|NCT00896532|12059392|FG003|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
10893184|NCT00896532|12059393|FG004|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
10893185|NCT00896532|12059394|FG005|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
10893186|NCT00896532|12059395|FG006|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
10893187|NCT00896532|12059396|FG007|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
10893188|NCT00896532|12059397|FG008|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893189|NCT00896532|12059398|FG009|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893190|NCT00896532|12059399|FG010|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893191|NCT00896532|12059400|FG011|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893192|NCT00896532|12059401|FG012|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893193|NCT00896532|12059402|FG013|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893194|NCT00896532|12059403|FG014|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893195|NCT00896532|12059404|FG015|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893196|NCT00896532|12059405|FG016|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893197|NCT00896532|12059406|FG017|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893198|NCT00896532|12059407|FG018|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893199|NCT00896532|12059408|FG019|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893200|NCT00896532|12059409|FG020|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893201|NCT00896532|12059410|FG021|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893202|NCT00896532|12059411|FG022|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
10893203|NCT00896532|12059389|FG000|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
10893204|NCT00896532|12059390|FG001|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
10893205|NCT00896532|12059391|FG002|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
10893206|NCT00896532|12059392|FG003|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
10893207|NCT00896532|12059393|FG004|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
10893208|NCT00896532|12059394|FG005|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
10893209|NCT00896532|12059395|FG006|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
10893210|NCT00896532|12059396|FG007|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
10893211|NCT00896532|12059397|FG008|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893212|NCT00896532|12059398|FG009|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893213|NCT00896532|12059399|FG010|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893214|NCT00896532|12059400|FG011|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893215|NCT00896532|12059401|FG012|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893216|NCT00896532|12059402|FG013|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893217|NCT00896532|12059403|FG014|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893218|NCT00896532|12059404|FG015|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893219|NCT00896532|12059405|FG016|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893220|NCT00896532|12059406|FG017|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893221|NCT00896532|12059407|FG018|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893222|NCT00896532|12059408|FG019|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893223|NCT00896532|12059409|FG020|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893224|NCT00896532|12059410|FG021|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893225|NCT00896532|12059411|FG022|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
10893226|NCT00896532|12059389|FG000|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
10893227|NCT00896532|12059390|FG001|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
10893228|NCT00896532|12059391|FG002|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
10893229|NCT00896532|12059392|FG003|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
10893230|NCT00896532|12059393|FG004|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
10893231|NCT00896532|12059394|FG005|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
10893232|NCT00896532|12059395|FG006|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
10893233|NCT00896532|12059396|FG007|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
10893234|NCT00896532|12059397|FG008|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893235|NCT00896532|12059398|FG009|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893236|NCT00896532|12059399|FG010|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893237|NCT00896532|12059400|FG011|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893238|NCT00896532|12059401|FG012|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893239|NCT00896532|12059402|FG013|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893240|NCT00896532|12059403|FG014|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893241|NCT00896532|12059404|FG015|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893242|NCT00896532|12059405|FG016|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893243|NCT00896532|12059406|FG017|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893244|NCT00896532|12059407|FG018|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893245|NCT00896532|12059408|FG019|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893246|NCT00896532|12059409|FG020|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893247|NCT00896532|12059410|FG021|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893248|NCT00896532|12059411|FG022|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893249|NCT00896532|12059389|FG000|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
10893250|NCT00896532|12059390|FG001|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
10893251|NCT00896532|12059391|FG002|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
10893252|NCT00896532|12059392|FG003|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
10893253|NCT00896532|12059393|FG004|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
10893254|NCT00896532|12059394|FG005|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
10893255|NCT00896532|12059395|FG006|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
10893256|NCT00896532|12059396|FG007|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
10893257|NCT00896532|12059397|FG008|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893258|NCT00896532|12059398|FG009|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893259|NCT00896532|12059399|FG010|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893260|NCT00896532|12059400|FG011|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893261|NCT00896532|12059401|FG012|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893262|NCT00896532|12059402|FG013|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893263|NCT00896532|12059403|FG014|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893264|NCT00896532|12059404|FG015|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893265|NCT00896532|12059405|FG016|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893266|NCT00896532|12059406|FG017|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893267|NCT00896532|12059407|FG018|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893268|NCT00896532|12059408|FG019|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893269|NCT00896532|12059409|FG020|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893270|NCT00896532|12059410|FG021|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893271|NCT00896532|12059411|FG022|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
10893272|NCT00896532|12059389|FG000|STARTED|Months 24-36: Denosumab Extension Phase||0
10893273|NCT00896532|12059390|FG001|STARTED|Months 24-36: Denosumab Extension Phase||0
10893274|NCT00896532|12059391|FG002|STARTED|Months 24-36: Denosumab Extension Phase||0
10893275|NCT00896532|12059392|FG003|STARTED|Months 24-36: Denosumab Extension Phase||0
10893276|NCT00896532|12059393|FG004|STARTED|Months 24-36: Denosumab Extension Phase||0
10893277|NCT00896532|12059394|FG005|STARTED|Months 24-36: Denosumab Extension Phase||0
10893278|NCT00896532|12059395|FG006|STARTED|Months 24-36: Denosumab Extension Phase||0
10893279|NCT00896532|12059396|FG007|STARTED|Months 24-36: Denosumab Extension Phase||0
10893280|NCT00896532|12059397|FG008|STARTED|Months 24-36: Denosumab Extension Phase||18
10893281|NCT00896532|12059398|FG009|STARTED|Months 24-36: Denosumab Extension Phase||18
10893282|NCT00896532|12059399|FG010|STARTED|Months 24-36: Denosumab Extension Phase||20
10893283|NCT00896532|12059400|FG011|STARTED|Months 24-36: Denosumab Extension Phase||21
10893284|NCT00896532|12059401|FG012|STARTED|Months 24-36: Denosumab Extension Phase||93
10893285|NCT00896532|12059402|FG013|STARTED|Months 24-36: Denosumab Extension Phase||90
10893286|NCT00896532|12059403|FG014|STARTED|Months 24-36: Denosumab Extension Phase||0
10893287|NCT00896532|12059404|FG015|STARTED|Months 24-36: Denosumab Extension Phase||0
10893288|NCT00896532|12059405|FG016|STARTED|Months 24-36: Denosumab Extension Phase||0
10893289|NCT00896532|12059406|FG017|STARTED|Months 24-36: Denosumab Extension Phase||0
10893290|NCT00896532|12059407|FG018|STARTED|Months 24-36: Denosumab Extension Phase||0
10893291|NCT00896532|12059408|FG019|STARTED|Months 24-36: Denosumab Extension Phase||0
10893292|NCT00896532|12059409|FG020|STARTED|Months 24-36: Denosumab Extension Phase||0
10893293|NCT00896532|12059410|FG021|STARTED|Months 24-36: Denosumab Extension Phase||0
10893294|NCT00896532|12059411|FG022|STARTED|Months 24-36: Denosumab Extension Phase||0
10893295|NCT00896532|12059389|FG000|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893296|NCT00896532|12059390|FG001|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893297|NCT00896532|12059391|FG002|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893298|NCT00896532|12059392|FG003|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893299|NCT00896532|12059393|FG004|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893300|NCT00896532|12059394|FG005|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893301|NCT00896532|12059395|FG006|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893302|NCT00896532|12059396|FG007|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893303|NCT00896532|12059397|FG008|Received Treatment|Months 24-36: Denosumab Extension Phase||18
10893304|NCT00896532|12059398|FG009|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
10893305|NCT00896532|12059399|FG010|Received Treatment|Months 24-36: Denosumab Extension Phase||19
10893306|NCT00896532|12059400|FG011|Received Treatment|Months 24-36: Denosumab Extension Phase||19
10893307|NCT00896532|12059401|FG012|Received Treatment|Months 24-36: Denosumab Extension Phase||90
10893308|NCT00896532|12059402|FG013|Received Treatment|Months 24-36: Denosumab Extension Phase||88
10893309|NCT00896532|12059403|FG014|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893310|NCT00896532|12059404|FG015|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893311|NCT00896532|12059405|FG016|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893312|NCT00896532|12059406|FG017|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893313|NCT00896532|12059407|FG018|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893314|NCT00896532|12059408|FG019|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893315|NCT00896532|12059409|FG020|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893316|NCT00896532|12059410|FG021|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893317|NCT00896532|12059411|FG022|Received Treatment|Months 24-36: Denosumab Extension Phase||0
10893318|NCT00896532|12059389|FG000|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893319|NCT00896532|12059390|FG001|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893320|NCT00896532|12059391|FG002|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893321|NCT00896532|12059392|FG003|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893322|NCT00896532|12059393|FG004|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893323|NCT00896532|12059394|FG005|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893324|NCT00896532|12059395|FG006|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893325|NCT00896532|12059396|FG007|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893326|NCT00896532|12059397|FG008|COMPLETED|Months 24-36: Denosumab Extension Phase||17
10893327|NCT00896532|12059398|FG009|COMPLETED|Months 24-36: Denosumab Extension Phase||18
10893328|NCT00896532|12059399|FG010|COMPLETED|Months 24-36: Denosumab Extension Phase||18
10893329|NCT00896532|12059400|FG011|COMPLETED|Months 24-36: Denosumab Extension Phase||19
10893330|NCT00896532|12059401|FG012|COMPLETED|Months 24-36: Denosumab Extension Phase||88
10893331|NCT00896532|12059402|FG013|COMPLETED|Months 24-36: Denosumab Extension Phase||88
10893332|NCT00896532|12059403|FG014|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893333|NCT00896532|12059404|FG015|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893334|NCT00896532|12059405|FG016|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893335|NCT00896532|12059406|FG017|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893336|NCT00896532|12059407|FG018|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893337|NCT00896532|12059408|FG019|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893338|NCT00896532|12059409|FG020|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893339|NCT00896532|12059410|FG021|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893340|NCT00896532|12059411|FG022|COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893341|NCT00896532|12059389|FG000|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893342|NCT00896532|12059390|FG001|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893343|NCT00896532|12059391|FG002|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893344|NCT00896532|12059392|FG003|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893345|NCT00896532|12059393|FG004|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893346|NCT00896532|12059394|FG005|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893347|NCT00896532|12059395|FG006|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893348|NCT00896532|12059396|FG007|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893349|NCT00896532|12059397|FG008|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
10893350|NCT00896532|12059398|FG009|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893351|NCT00896532|12059399|FG010|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
10893352|NCT00896532|12059400|FG011|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
10893353|NCT00896532|12059401|FG012|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
10893354|NCT00896532|12059402|FG013|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
10893355|NCT00896532|12059403|FG014|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893356|NCT00896532|12059404|FG015|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893357|NCT00896532|12059405|FG016|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893358|NCT00896532|12059406|FG017|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893359|NCT00896532|12059407|FG018|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893360|NCT00896532|12059408|FG019|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893361|NCT00896532|12059409|FG020|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893362|NCT00896532|12059410|FG021|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893363|NCT00896532|12059411|FG022|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
10893364|NCT00896532|12059389|FG000|STARTED|Months 36-48: Romosozumab Retreatment||0
10893365|NCT00896532|12059390|FG001|STARTED|Months 36-48: Romosozumab Retreatment||0
10893366|NCT00896532|12059391|FG002|STARTED|Months 36-48: Romosozumab Retreatment||0
10893367|NCT00896532|12059392|FG003|STARTED|Months 36-48: Romosozumab Retreatment||0
10893368|NCT00896532|12059393|FG004|STARTED|Months 36-48: Romosozumab Retreatment||0
10893369|NCT00896532|12059394|FG005|STARTED|Months 36-48: Romosozumab Retreatment||0
10893370|NCT00896532|12059395|FG006|STARTED|Months 36-48: Romosozumab Retreatment||0
10893371|NCT00896532|12059396|FG007|STARTED|Months 36-48: Romosozumab Retreatment||0
10893372|NCT00896532|12059397|FG008|STARTED|Months 36-48: Romosozumab Retreatment||0
10893373|NCT00896532|12059398|FG009|STARTED|Months 36-48: Romosozumab Retreatment||0
10893374|NCT00896532|12059399|FG010|STARTED|Months 36-48: Romosozumab Retreatment||0
10893375|NCT00896532|12059400|FG011|STARTED|Months 36-48: Romosozumab Retreatment||0
10893376|NCT00896532|12059401|FG012|STARTED|Months 36-48: Romosozumab Retreatment||0
10893377|NCT00896532|12059402|FG013|STARTED|Months 36-48: Romosozumab Retreatment||0
10893378|NCT00896532|12059403|FG014|STARTED|Months 36-48: Romosozumab Retreatment||12
10893379|NCT00896532|12059404|FG015|STARTED|Months 36-48: Romosozumab Retreatment||16
10893380|NCT00896532|12059405|FG016|STARTED|Months 36-48: Romosozumab Retreatment||72
10893381|NCT00896532|12059406|FG017|STARTED|Months 36-48: Romosozumab Retreatment||67
10893382|NCT00896532|12059407|FG018|STARTED|Months 36-48: Romosozumab Retreatment||0
10893383|NCT00896532|12059408|FG019|STARTED|Months 36-48: Romosozumab Retreatment||0
10893384|NCT00896532|12059409|FG020|STARTED|Months 36-48: Romosozumab Retreatment||0
10893385|NCT00896532|12059410|FG021|STARTED|Months 36-48: Romosozumab Retreatment||0
10893386|NCT00896532|12059411|FG022|STARTED|Months 36-48: Romosozumab Retreatment||0
10893387|NCT00896532|12059389|FG000|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893388|NCT00896532|12059390|FG001|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893389|NCT00896532|12059391|FG002|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893390|NCT00896532|12059392|FG003|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893391|NCT00896532|12059393|FG004|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893392|NCT00896532|12059394|FG005|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893393|NCT00896532|12059395|FG006|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893394|NCT00896532|12059396|FG007|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893395|NCT00896532|12059397|FG008|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893396|NCT00896532|12059398|FG009|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893397|NCT00896532|12059399|FG010|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893398|NCT00896532|12059400|FG011|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893399|NCT00896532|12059401|FG012|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893400|NCT00896532|12059402|FG013|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893401|NCT00896532|12059403|FG014|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
10893402|NCT00896532|12059404|FG015|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
10893403|NCT00896532|12059405|FG016|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
10893404|NCT00896532|12059406|FG017|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
10893405|NCT00896532|12059407|FG018|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893406|NCT00896532|12059408|FG019|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893407|NCT00896532|12059409|FG020|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893561|NCT00881868|12059484|FG001|STARTED|Overall Study||40
10893408|NCT00896532|12059410|FG021|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893409|NCT00896532|12059411|FG022|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
10893410|NCT00896532|12059389|FG000|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893411|NCT00896532|12059390|FG001|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893412|NCT00896532|12059391|FG002|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893413|NCT00896532|12059392|FG003|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893414|NCT00896532|12059393|FG004|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893415|NCT00896532|12059394|FG005|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893416|NCT00896532|12059395|FG006|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893417|NCT00896532|12059396|FG007|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893418|NCT00896532|12059397|FG008|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893419|NCT00896532|12059398|FG009|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893420|NCT00896532|12059399|FG010|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893421|NCT00896532|12059400|FG011|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893422|NCT00896532|12059401|FG012|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893423|NCT00896532|12059402|FG013|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893424|NCT00896532|12059403|FG014|COMPLETED|Months 36-48: Romosozumab Retreatment||12
10893425|NCT00896532|12059404|FG015|COMPLETED|Months 36-48: Romosozumab Retreatment||14
10893426|NCT00896532|12059405|FG016|COMPLETED|Months 36-48: Romosozumab Retreatment||65
10893427|NCT00896532|12059406|FG017|COMPLETED|Months 36-48: Romosozumab Retreatment||64
10893428|NCT00896532|12059407|FG018|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893429|NCT00896532|12059408|FG019|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893430|NCT00896532|12059409|FG020|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893431|NCT00896532|12059410|FG021|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893432|NCT00896532|12059411|FG022|COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893433|NCT00896532|12059389|FG000|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893434|NCT00896532|12059390|FG001|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893435|NCT00896532|12059391|FG002|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893436|NCT00896532|12059392|FG003|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893437|NCT00896532|12059393|FG004|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893438|NCT00896532|12059394|FG005|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893439|NCT00896532|12059395|FG006|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893440|NCT00896532|12059396|FG007|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893441|NCT00896532|12059397|FG008|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893442|NCT00896532|12059398|FG009|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893443|NCT00896532|12059399|FG010|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893444|NCT00896532|12059400|FG011|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893445|NCT00896532|12059401|FG012|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893446|NCT00896532|12059402|FG013|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893447|NCT00896532|12059403|FG014|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893448|NCT00896532|12059404|FG015|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
10893449|NCT00896532|12059405|FG016|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
10893450|NCT00896532|12059406|FG017|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
10893451|NCT00896532|12059407|FG018|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893452|NCT00896532|12059408|FG019|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893453|NCT00896532|12059409|FG020|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893454|NCT00896532|12059410|FG021|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893455|NCT00896532|12059411|FG022|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
10893456|NCT00896532|12059389|FG000|STARTED|Months 48-72: Follow-on Phase||0
10893457|NCT00896532|12059390|FG001|STARTED|Months 48-72: Follow-on Phase||0
10893458|NCT00896532|12059391|FG002|STARTED|Months 48-72: Follow-on Phase||0
10893459|NCT00896532|12059392|FG003|STARTED|Months 48-72: Follow-on Phase||0
10893460|NCT00896532|12059393|FG004|STARTED|Months 48-72: Follow-on Phase||0
10893461|NCT00896532|12059394|FG005|STARTED|Months 48-72: Follow-on Phase||0
10893462|NCT00896532|12059395|FG006|STARTED|Months 48-72: Follow-on Phase||0
10893463|NCT00896532|12059396|FG007|STARTED|Months 48-72: Follow-on Phase||0
10893464|NCT00896532|12059397|FG008|STARTED|Months 48-72: Follow-on Phase||0
10893465|NCT00896532|12059398|FG009|STARTED|Months 48-72: Follow-on Phase||0
10893466|NCT00896532|12059399|FG010|STARTED|Months 48-72: Follow-on Phase||0
10893467|NCT00896532|12059400|FG011|STARTED|Months 48-72: Follow-on Phase||0
10893468|NCT00896532|12059401|FG012|STARTED|Months 48-72: Follow-on Phase||0
10893469|NCT00896532|12059402|FG013|STARTED|Months 48-72: Follow-on Phase||0
10893470|NCT00896532|12059403|FG014|STARTED|Months 48-72: Follow-on Phase||0
10893471|NCT00896532|12059404|FG015|STARTED|Months 48-72: Follow-on Phase||0
10893472|NCT00896532|12059405|FG016|STARTED|Months 48-72: Follow-on Phase||0
10893473|NCT00896532|12059406|FG017|STARTED|Months 48-72: Follow-on Phase||0
10893474|NCT00896532|12059407|FG018|STARTED|Months 48-72: Follow-on Phase||51
10893475|NCT00896532|12059408|FG019|STARTED|Months 48-72: Follow-on Phase||11
10893476|NCT00896532|12059409|FG020|STARTED|Months 48-72: Follow-on Phase||12
10893477|NCT00896532|12059410|FG021|STARTED|Months 48-72: Follow-on Phase||59
10893478|NCT00896532|12059411|FG022|STARTED|Months 48-72: Follow-on Phase||8
10893479|NCT00896532|12059389|FG000|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893480|NCT00896532|12059390|FG001|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893481|NCT00896532|12059391|FG002|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893482|NCT00896532|12059392|FG003|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893483|NCT00896532|12059393|FG004|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893484|NCT00896532|12059394|FG005|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893485|NCT00896532|12059395|FG006|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893486|NCT00896532|12059396|FG007|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893487|NCT00896532|12059397|FG008|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893488|NCT00896532|12059398|FG009|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893489|NCT00896532|12059399|FG010|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893490|NCT00896532|12059400|FG011|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893491|NCT00896532|12059401|FG012|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893492|NCT00896532|12059402|FG013|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893493|NCT00896532|12059403|FG014|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893494|NCT00896532|12059404|FG015|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893495|NCT00896532|12059405|FG016|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893496|NCT00896532|12059406|FG017|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893497|NCT00896532|12059407|FG018|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
10893498|NCT00896532|12059408|FG019|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
10893499|NCT00896532|12059409|FG020|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
10893500|NCT00896532|12059410|FG021|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
10893501|NCT00896532|12059411|FG022|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
10893502|NCT00896532|12059389|FG000|COMPLETED|Months 48-72: Follow-on Phase||0
10893503|NCT00896532|12059390|FG001|COMPLETED|Months 48-72: Follow-on Phase||0
10893504|NCT00896532|12059391|FG002|COMPLETED|Months 48-72: Follow-on Phase||0
10893505|NCT00896532|12059392|FG003|COMPLETED|Months 48-72: Follow-on Phase||0
10893506|NCT00896532|12059393|FG004|COMPLETED|Months 48-72: Follow-on Phase||0
10893507|NCT00896532|12059394|FG005|COMPLETED|Months 48-72: Follow-on Phase||0
10893508|NCT00896532|12059395|FG006|COMPLETED|Months 48-72: Follow-on Phase||0
10893509|NCT00896532|12059396|FG007|COMPLETED|Months 48-72: Follow-on Phase||0
10893510|NCT00896532|12059397|FG008|COMPLETED|Months 48-72: Follow-on Phase||0
10893511|NCT00896532|12059398|FG009|COMPLETED|Months 48-72: Follow-on Phase||0
10893512|NCT00896532|12059399|FG010|COMPLETED|Months 48-72: Follow-on Phase||0
10893513|NCT00896532|12059400|FG011|COMPLETED|Months 48-72: Follow-on Phase||0
10893514|NCT00896532|12059401|FG012|COMPLETED|Months 48-72: Follow-on Phase||0
10893515|NCT00896532|12059402|FG013|COMPLETED|Months 48-72: Follow-on Phase||0
10893516|NCT00896532|12059403|FG014|COMPLETED|Months 48-72: Follow-on Phase||0
10893517|NCT00896532|12059404|FG015|COMPLETED|Months 48-72: Follow-on Phase||0
10893518|NCT00896532|12059405|FG016|COMPLETED|Months 48-72: Follow-on Phase||0
10893519|NCT00896532|12059406|FG017|COMPLETED|Months 48-72: Follow-on Phase||0
10893520|NCT00896532|12059407|FG018|COMPLETED|Months 48-72: Follow-on Phase||50
10893521|NCT00896532|12059408|FG019|COMPLETED|Months 48-72: Follow-on Phase||11
10893522|NCT00896532|12059409|FG020|COMPLETED|Months 48-72: Follow-on Phase||12
10893523|NCT00896532|12059410|FG021|COMPLETED|Months 48-72: Follow-on Phase||57
10893524|NCT00896532|12059411|FG022|COMPLETED|Months 48-72: Follow-on Phase||8
10893525|NCT00896532|12059389|FG000|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893526|NCT00896532|12059390|FG001|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893527|NCT00896532|12059391|FG002|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893528|NCT00896532|12059392|FG003|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893529|NCT00896532|12059393|FG004|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893530|NCT00896532|12059394|FG005|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893531|NCT00896532|12059395|FG006|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893532|NCT00896532|12059396|FG007|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893533|NCT00896532|12059397|FG008|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893534|NCT00896532|12059398|FG009|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893535|NCT00896532|12059399|FG010|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893536|NCT00896532|12059400|FG011|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893537|NCT00896532|12059401|FG012|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893538|NCT00896532|12059402|FG013|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893539|NCT00896532|12059403|FG014|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893540|NCT00896532|12059404|FG015|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893541|NCT00896532|12059405|FG016|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893542|NCT00896532|12059406|FG017|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893543|NCT00896532|12059407|FG018|NOT COMPLETED|Months 48-72: Follow-on Phase||1
10893544|NCT00896532|12059408|FG019|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893545|NCT00896532|12059409|FG020|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893546|NCT00896532|12059410|FG021|NOT COMPLETED|Months 48-72: Follow-on Phase||2
10893547|NCT00896532|12059411|FG022|NOT COMPLETED|Months 48-72: Follow-on Phase||0
10893548|NCT00892281|12059460|FG000|STARTED|Overall Study||1197
10893549|NCT00892281|12059461|FG001|STARTED|Overall Study||224
10893550|NCT00892281|12059460|FG000|COMPLETED|Overall Study||930
10893551|NCT00892281|12059461|FG001|COMPLETED|Overall Study||187
10893552|NCT00892281|12059460|FG000|NOT COMPLETED|Overall Study||267
10893553|NCT00892281|12059461|FG001|NOT COMPLETED|Overall Study||37
10893554|NCT00888290|12059467|FG000|STARTED|Overall Study||20
10893555|NCT00888290|12059467|FG000|COMPLETED|Overall Study||20
10893556|NCT00888290|12059467|FG000|NOT COMPLETED|Overall Study||0
10893557|NCT00885664|12059475|FG000|STARTED|Overall Study||60
10893558|NCT00885664|12059475|FG000|COMPLETED|Overall Study||48
10893559|NCT00885664|12059475|FG000|NOT COMPLETED|Overall Study||12
10893560|NCT00881868|12059483|FG000|STARTED|Overall Study||41
10893562|NCT00881868|12059483|FG000|COMPLETED|Overall Study||33
10893563|NCT00881868|12059484|FG001|COMPLETED|Overall Study||38
10893564|NCT00881868|12059483|FG000|NOT COMPLETED|Overall Study||8
10893565|NCT00881868|12059484|FG001|NOT COMPLETED|Overall Study||2
10893566|NCT00866840|12059490|FG000|STARTED|Overall Study||13
10893567|NCT00866840|12059490|FG000|COMPLETED|Overall Study||13
10893568|NCT00866840|12059490|FG000|NOT COMPLETED|Overall Study||0
10893569|NCT00861705|12059498|FG000|STARTED|Overall Study||115
10893570|NCT00861705|12059499|FG001|STARTED|Overall Study||113
10893571|NCT00861705|12059500|FG002|STARTED|Overall Study||113
10893572|NCT00861705|12059501|FG003|STARTED|Overall Study||113
10893573|NCT00861705|12059498|FG000|COMPLETED|Overall Study||108
10893574|NCT00861705|12059499|FG001|COMPLETED|Overall Study||110
10893575|NCT00861705|12059500|FG002|COMPLETED|Overall Study||113
10893576|NCT00861705|12059501|FG003|COMPLETED|Overall Study||112
10893577|NCT00861705|12059498|FG000|NOT COMPLETED|Overall Study||7
10893578|NCT00861705|12059499|FG001|NOT COMPLETED|Overall Study||3
10893579|NCT00861705|12059500|FG002|NOT COMPLETED|Overall Study||0
10893580|NCT00861705|12059501|FG003|NOT COMPLETED|Overall Study||1
10893581|NCT00847730|12059519|FG000|STARTED|Overall Study||33
10893582|NCT00847730|12059519|FG000|COMPLETED|Overall Study||25
10893583|NCT00847730|12059519|FG000|NOT COMPLETED|Overall Study||8
10893584|NCT00846742|12059523|FG000|STARTED|Overall Study||85
10893585|NCT00846742|12059523|FG000|With Radiation Therapy (RT)|Overall Study||17
10893586|NCT00846742|12059523|FG000|Without Radiation Therapy (RT)|Overall Study||68
10893587|NCT00846742|12059523|FG000|COMPLETED|Overall Study||84
10893588|NCT00846742|12059523|FG000|NOT COMPLETED|Overall Study||1
10893589|NCT00845026|12059530|FG000|STARTED|Study Period III||130
10893590|NCT00845026|12059531|FG001|STARTED|Study Period III||131
10893591|NCT00845026|12059530|FG000|COMPLETED|Study Period III|7 completed, left study; 28 completed, entered Study Phase IV.|35
10893592|NCT00845026|12059531|FG001|COMPLETED|Study Period III|9 completed, left study; 50 completed, entered Study Phase IV.|59
10893593|NCT00845026|12059530|FG000|NOT COMPLETED|Study Period III||95
10893594|NCT00845026|12059531|FG001|NOT COMPLETED|Study Period III||72
10893595|NCT00845026|12059530|FG000|STARTED|Study Period IV|7 completed period III but left study; 28 completed period III AND entered period IV.|28
10893596|NCT00845026|12059531|FG001|STARTED|Study Period IV|9 completed period III, left study; 50 completed period III AND entered period IV.|50
10893597|NCT00845026|12059530|FG000|COMPLETED|Study Period IV||12
10893598|NCT00845026|12059531|FG001|COMPLETED|Study Period IV||46
10893599|NCT00845026|12059530|FG000|NOT COMPLETED|Study Period IV||16
10893600|NCT00845026|12059531|FG001|NOT COMPLETED|Study Period IV||4
10893601|NCT00843882|12059542|FG000|STARTED|Step 1||38
10893602|NCT00843882|12059543|FG001|STARTED|Step 1||103
10893603|NCT00843882|12059544|FG002|STARTED|Step 1||106
10893604|NCT00843882|12059542|FG000|Treated Patients|Step 1||36
10893605|NCT00843882|12059543|FG001|Treated Patients|Step 1||103
10893606|NCT00843882|12059544|FG002|Treated Patients|Step 1||106
10893607|NCT00843882|12059542|FG000|Evaluable Patients Included in Primary Analysis|Step 1||0
10893608|NCT00843882|12059543|FG001|Evaluable Patients Included in Primary Analysis|Step 1||96
10893609|NCT00843882|12059544|FG002|Evaluable Patients Included in Primary Analysis|Step 1||99
10893610|NCT00843882|12059542|FG000|Patients With Cytogenetic Response Data Available|Step 1||0
10893611|NCT00843882|12059543|FG001|Patients With Cytogenetic Response Data Available|Step 1||55
10893612|NCT00843882|12059544|FG002|Patients With Cytogenetic Response Data Available|Step 1||51
10893613|NCT00843882|12059542|FG000|COMPLETED|Step 1||6
10893614|NCT00843882|12059543|FG001|COMPLETED|Step 1||48
10893615|NCT00843882|12059544|FG002|COMPLETED|Step 1||41
10893616|NCT00843882|12059542|FG000|NOT COMPLETED|Step 1||32
10893617|NCT00843882|12059543|FG001|NOT COMPLETED|Step 1||55
10893618|NCT00843882|12059544|FG002|NOT COMPLETED|Step 1||65
10893619|NCT00843882|12059542|FG000|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|7
10893620|NCT00843882|12059543|FG001|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|46
10893621|NCT00843882|12059544|FG002|STARTED|Step 2 (Cross-over to Arm B)|Only patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|0
10893622|NCT00843882|12059542|FG000|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||7
10893623|NCT00843882|12059543|FG001|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||37
10893624|NCT00843882|12059544|FG002|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||0
10893625|NCT00843882|12059542|FG000|COMPLETED|Step 2 (Cross-over to Arm B)||3
10893626|NCT00843882|12059543|FG001|COMPLETED|Step 2 (Cross-over to Arm B)||20
10893627|NCT00843882|12059544|FG002|COMPLETED|Step 2 (Cross-over to Arm B)||0
10893628|NCT00843882|12059542|FG000|NOT COMPLETED|Step 2 (Cross-over to Arm B)||4
10893629|NCT00843882|12059543|FG001|NOT COMPLETED|Step 2 (Cross-over to Arm B)||26
10893630|NCT00843882|12059544|FG002|NOT COMPLETED|Step 2 (Cross-over to Arm B)||0
10893631|NCT00838383|12059560|FG000|STARTED|Overall Study||9
10893632|NCT00838383|12059561|FG001|STARTED|Overall Study||10
10893633|NCT00838383|12059562|FG002|STARTED|Overall Study||10
10893634|NCT00838383|12059560|FG000|COMPLETED|Overall Study||9
10893635|NCT00838383|12059561|FG001|COMPLETED|Overall Study||10
10893636|NCT00838383|12059562|FG002|COMPLETED|Overall Study||10
10893637|NCT00838383|12059560|FG000|NOT COMPLETED|Overall Study||0
10893638|NCT00838383|12059561|FG001|NOT COMPLETED|Overall Study||0
10893639|NCT00838383|12059562|FG002|NOT COMPLETED|Overall Study||0
10893640|NCT00837096|12059572|FG000|STARTED|Overall Study||10
10893641|NCT00837096|12059573|FG001|STARTED|Overall Study||9
10893642|NCT00837096|12059572|FG000|COMPLETED|Overall Study||0
10893643|NCT00837096|12059573|FG001|COMPLETED|Overall Study||0
10893644|NCT00837096|12059572|FG000|NOT COMPLETED|Overall Study||10
10893645|NCT00837096|12059573|FG001|NOT COMPLETED|Overall Study||9
10893646|NCT00836810|12059581|FG000|STARTED|Overall Study||5
10893647|NCT00836810|12059582|FG001|STARTED|Overall Study||6
10893648|NCT00836810|12059581|FG000|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
10893649|NCT00836810|12059582|FG001|COMPLETED|Overall Study||6
10893650|NCT00836810|12059581|FG000|NOT COMPLETED|Overall Study||1
10893651|NCT00836810|12059582|FG001|NOT COMPLETED|Overall Study||0
10893652|NCT00822120|12059590|FG000|STARTED|Initial Registration||358
10893653|NCT00822120|12059591|FG001|STARTED|Initial Registration||13
10893654|NCT00822120|12059592|FG002|STARTED|Initial Registration||0
10893655|NCT00822120|12059593|FG003|STARTED|Initial Registration||0
10893656|NCT00822120|12059594|FG004|STARTED|Initial Registration||0
10893657|NCT00822120|12059595|FG005|STARTED|Initial Registration||0
10893658|NCT00822120|12059590|FG000|Eligible and Evaluable Patients|Initial Registration||336
10893659|NCT00822120|12059591|FG001|Eligible and Evaluable Patients|Initial Registration||12
10893660|NCT00822120|12059592|FG002|Eligible and Evaluable Patients|Initial Registration||0
10893661|NCT00822120|12059593|FG003|Eligible and Evaluable Patients|Initial Registration||0
10893662|NCT00822120|12059594|FG004|Eligible and Evaluable Patients|Initial Registration||0
10893663|NCT00822120|12059595|FG005|Eligible and Evaluable Patients|Initial Registration||0
10893664|NCT00822120|12059590|FG000|COMPLETED|Initial Registration||332
10893665|NCT00822120|12059591|FG001|COMPLETED|Initial Registration||12
10893666|NCT00822120|12059592|FG002|COMPLETED|Initial Registration||0
10893667|NCT00822120|12059593|FG003|COMPLETED|Initial Registration||0
10893668|NCT00822120|12059594|FG004|COMPLETED|Initial Registration||0
10893669|NCT00822120|12059595|FG005|COMPLETED|Initial Registration||0
10893670|NCT00822120|12059590|FG000|NOT COMPLETED|Initial Registration||26
10893671|NCT00822120|12059591|FG001|NOT COMPLETED|Initial Registration||1
10893672|NCT00822120|12059592|FG002|NOT COMPLETED|Initial Registration||0
10893673|NCT00822120|12059593|FG003|NOT COMPLETED|Initial Registration||0
10893674|NCT00822120|12059594|FG004|NOT COMPLETED|Initial Registration||0
10893675|NCT00822120|12059595|FG005|NOT COMPLETED|Initial Registration||0
10893676|NCT00822120|12059590|FG000|STARTED|PET-directed Therapy||0
10893677|NCT00822120|12059591|FG001|STARTED|PET-directed Therapy||0
10893678|NCT00822120|12059592|FG002|STARTED|PET-directed Therapy||270
10893679|NCT00822120|12059593|FG003|STARTED|PET-directed Therapy||55
10893680|NCT00822120|12059594|FG004|STARTED|PET-directed Therapy||10
10893681|NCT00822120|12059595|FG005|STARTED|PET-directed Therapy||1
10893682|NCT00822120|12059590|FG000|Eligibile and Evaluable Patients|PET-directed Therapy||0
10893683|NCT00822120|12059591|FG001|Eligibile and Evaluable Patients|PET-directed Therapy||0
10893684|NCT00822120|12059592|FG002|Eligibile and Evaluable Patients|PET-directed Therapy||270
10893685|NCT00822120|12059593|FG003|Eligibile and Evaluable Patients|PET-directed Therapy||55
10893686|NCT00822120|12059594|FG004|Eligibile and Evaluable Patients|PET-directed Therapy||10
10893687|NCT00822120|12059595|FG005|Eligibile and Evaluable Patients|PET-directed Therapy||1
10893688|NCT00822120|12059590|FG000|COMPLETED|PET-directed Therapy||0
10893689|NCT00822120|12059591|FG001|COMPLETED|PET-directed Therapy||0
10893690|NCT00822120|12059592|FG002|COMPLETED|PET-directed Therapy||270
10893691|NCT00822120|12059593|FG003|COMPLETED|PET-directed Therapy||45
10893692|NCT00822120|12059594|FG004|COMPLETED|PET-directed Therapy||10
10893693|NCT00822120|12059595|FG005|COMPLETED|PET-directed Therapy||1
10893694|NCT00822120|12059590|FG000|NOT COMPLETED|PET-directed Therapy||0
10893695|NCT00822120|12059591|FG001|NOT COMPLETED|PET-directed Therapy||0
10893696|NCT00822120|12059592|FG002|NOT COMPLETED|PET-directed Therapy||0
10893697|NCT00822120|12059593|FG003|NOT COMPLETED|PET-directed Therapy||10
10893698|NCT00822120|12059594|FG004|NOT COMPLETED|PET-directed Therapy||0
10893699|NCT00822120|12059595|FG005|NOT COMPLETED|PET-directed Therapy||0
10893700|NCT00819780|12059618|FG000|STARTED|Overall Study||142
10893701|NCT00819780|12059619|FG001|STARTED|Overall Study||143
10893702|NCT00819780|12059618|FG000|Received Study Treatment|Overall Study||139
10893703|NCT00819780|12059619|FG001|Received Study Treatment|Overall Study||139
10893704|NCT00819780|12059618|FG000|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
10893705|NCT00819780|12059619|FG001|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
10893706|NCT00819780|12059618|FG000|NOT COMPLETED|Overall Study||28
10893707|NCT00819780|12059619|FG001|NOT COMPLETED|Overall Study||21
10893708|NCT00792948|12059625|FG000|STARTED|Overall Study|Patients registered to induction/consolidation step|97
10893709|NCT00792948|12059625|FG000|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
10893710|NCT00792948|12059625|FG000|NOT COMPLETED|Overall Study||28
10893711|NCT00789399|12059634|FG000|STARTED|Overall Study||41
10893712|NCT00789399|12059635|FG001|STARTED|Overall Study||37
10893713|NCT00789399|12059634|FG000|COMPLETED|Overall Study||39
10893714|NCT00789399|12059635|FG001|COMPLETED|Overall Study||37
10893715|NCT00789399|12059634|FG000|NOT COMPLETED|Overall Study||2
10893716|NCT00789399|12059635|FG001|NOT COMPLETED|Overall Study||0
10893717|NCT00785291|12059644|FG000|STARTED|Overall Study||283
10893718|NCT00785291|12059645|FG001|STARTED|Overall Study||271
10893719|NCT00785291|12059646|FG002|STARTED|Overall Study||245
10893720|NCT00785291|12059644|FG000|COMPLETED|Overall Study||147
10893721|NCT00785291|12059645|FG001|COMPLETED|Overall Study||122
10893722|NCT00785291|12059646|FG002|COMPLETED|Overall Study||139
10893723|NCT00785291|12059644|FG000|NOT COMPLETED|Overall Study||136
10893724|NCT00785291|12059645|FG001|NOT COMPLETED|Overall Study||149
10893725|NCT00785291|12059646|FG002|NOT COMPLETED|Overall Study||106
10893726|NCT00784823|12059658|FG000|STARTED|Overall Study||6
10893727|NCT00784823|12059659|FG001|STARTED|Overall Study||3
10893728|NCT00784823|12059660|FG002|STARTED|Overall Study||3
10893729|NCT00784823|12059661|FG003|STARTED|Overall Study||20
10893730|NCT00784823|12059658|FG000|COMPLETED|Overall Study||6
10893731|NCT00784823|12059659|FG001|COMPLETED|Overall Study||3
10893732|NCT00784823|12059660|FG002|COMPLETED|Overall Study||3
10893733|NCT00784823|12059661|FG003|COMPLETED|Overall Study||20
10893734|NCT00784823|12059658|FG000|NOT COMPLETED|Overall Study||0
10893735|NCT00784823|12059659|FG001|NOT COMPLETED|Overall Study||0
10893736|NCT00784823|12059660|FG002|NOT COMPLETED|Overall Study||0
10893737|NCT00784823|12059661|FG003|NOT COMPLETED|Overall Study||0
10893738|NCT00773357|12059668|FG000|STARTED|Overall Study||50
10893739|NCT00773357|12059669|FG001|STARTED|Overall Study||50
10893740|NCT00773357|12059668|FG000|COMPLETED|Overall Study||50
10893741|NCT00773357|12059669|FG001|COMPLETED|Overall Study||50
10893742|NCT00773357|12059668|FG000|NOT COMPLETED|Overall Study||0
10893743|NCT00773357|12059669|FG001|NOT COMPLETED|Overall Study||0
10893744|NCT00770809|12059678|FG000|STARTED|Overall Study||118
10893745|NCT00770809|12059679|FG001|STARTED|Overall Study||120
10893746|NCT00770809|12059680|FG002|STARTED|Overall Study||67
10893747|NCT00770809|12059678|FG000|COMPLETED|Overall Study||101
10893748|NCT00770809|12059679|FG001|COMPLETED|Overall Study||110
10893749|NCT00770809|12059680|FG002|COMPLETED|Overall Study||44
10893750|NCT00770809|12059678|FG000|NOT COMPLETED|Overall Study||17
10893751|NCT00770809|12059679|FG001|NOT COMPLETED|Overall Study||10
10893752|NCT00770809|12059680|FG002|NOT COMPLETED|Overall Study||23
10893753|NCT00769379|12059690|FG000|STARTED|Overall Study||1008
10893754|NCT00769379|12059691|FG001|STARTED|Overall Study||1006
10893755|NCT00769379|12059690|FG000|COMPLETED|Overall Study||1005
10893756|NCT00769379|12059691|FG001|COMPLETED|Overall Study||993
10893757|NCT00769379|12059690|FG000|NOT COMPLETED|Overall Study||3
10893758|NCT00769379|12059691|FG001|NOT COMPLETED|Overall Study||13
10893759|NCT00763555|12059699|FG000|STARTED|Overall Study||44
10893760|NCT00763555|12059700|FG001|STARTED|Overall Study||44
10893761|NCT00763555|12059699|FG000|COMPLETED|Overall Study||40
10893762|NCT00763555|12059700|FG001|COMPLETED|Overall Study||34
10893763|NCT00763555|12059699|FG000|NOT COMPLETED|Overall Study||4
10893764|NCT00763555|12059700|FG001|NOT COMPLETED|Overall Study||10
10893765|NCT00757042|12059717|FG000|STARTED|Overall Study||6
10893766|NCT00757042|12059718|FG001|STARTED|Overall Study||6
10893767|NCT00757042|12059719|FG002|STARTED|Overall Study||6
10893768|NCT00757042|12059720|FG003|STARTED|Overall Study||6
10893769|NCT00757042|12059721|FG004|STARTED|Overall Study||6
10893770|NCT00757042|12059722|FG005|STARTED|Overall Study||6
10893771|NCT00757042|12059723|FG006|STARTED|Overall Study||6
10893772|NCT00757042|12059724|FG007|STARTED|Overall Study||6
10893773|NCT00757042|12059725|FG008|STARTED|Overall Study||16
10893774|NCT00757042|12059726|FG009|STARTED|Overall Study||10
10893775|NCT00757042|12059727|FG010|STARTED|Overall Study||4
10893776|NCT00757042|12059717|FG000|Received Study Drug|Overall Study||6
10893777|NCT00757042|12059718|FG001|Received Study Drug|Overall Study||6
10893778|NCT00757042|12059719|FG002|Received Study Drug|Overall Study||6
10893779|NCT00757042|12059720|FG003|Received Study Drug|Overall Study||6
10893780|NCT00757042|12059721|FG004|Received Study Drug|Overall Study||6
10893781|NCT00757042|12059722|FG005|Received Study Drug|Overall Study||6
10893782|NCT00757042|12059723|FG006|Received Study Drug|Overall Study||6
10893783|NCT00757042|12059724|FG007|Received Study Drug|Overall Study||6
10893784|NCT00757042|12059725|FG008|Received Study Drug|Overall Study||16
10893785|NCT00757042|12059726|FG009|Received Study Drug|Overall Study||9
10893786|NCT00757042|12059727|FG010|Received Study Drug|Overall Study||3
10893787|NCT00757042|12059717|FG000|COMPLETED|Overall Study||6
10893788|NCT00757042|12059718|FG001|COMPLETED|Overall Study||6
10893789|NCT00757042|12059719|FG002|COMPLETED|Overall Study||6
10893790|NCT00757042|12059720|FG003|COMPLETED|Overall Study||6
10893791|NCT00757042|12059721|FG004|COMPLETED|Overall Study||6
10893792|NCT00757042|12059722|FG005|COMPLETED|Overall Study||6
10893793|NCT00757042|12059723|FG006|COMPLETED|Overall Study||6
10893794|NCT00757042|12059724|FG007|COMPLETED|Overall Study||6
10893795|NCT00757042|12059725|FG008|COMPLETED|Overall Study||15
10893796|NCT00757042|12059726|FG009|COMPLETED|Overall Study||9
10893797|NCT00757042|12059727|FG010|COMPLETED|Overall Study||3
10893798|NCT00757042|12059717|FG000|NOT COMPLETED|Overall Study||0
10893799|NCT00757042|12059718|FG001|NOT COMPLETED|Overall Study||0
10893800|NCT00757042|12059719|FG002|NOT COMPLETED|Overall Study||0
10893801|NCT00757042|12059720|FG003|NOT COMPLETED|Overall Study||0
10893802|NCT00757042|12059721|FG004|NOT COMPLETED|Overall Study||0
10893803|NCT00757042|12059722|FG005|NOT COMPLETED|Overall Study||0
10893804|NCT00757042|12059723|FG006|NOT COMPLETED|Overall Study||0
10893805|NCT00757042|12059724|FG007|NOT COMPLETED|Overall Study||0
10893806|NCT00757042|12059725|FG008|NOT COMPLETED|Overall Study||1
10893807|NCT00757042|12059726|FG009|NOT COMPLETED|Overall Study||1
10893808|NCT00757042|12059727|FG010|NOT COMPLETED|Overall Study||1
10893809|NCT00738920|12059761|FG000|STARTED|Baseline to 2-Week Follow-Up||145
10893810|NCT00738920|12059762|FG001|STARTED|Baseline to 2-Week Follow-Up||146
10893811|NCT00738920|12059763|FG002|STARTED|Baseline to 2-Week Follow-Up||145
10893812|NCT00738920|12059761|FG000|COMPLETED|Baseline to 2-Week Follow-Up||129
10893813|NCT00738920|12059762|FG001|COMPLETED|Baseline to 2-Week Follow-Up||123
10893814|NCT00738920|12059763|FG002|COMPLETED|Baseline to 2-Week Follow-Up||130
10893815|NCT00738920|12059761|FG000|NOT COMPLETED|Baseline to 2-Week Follow-Up||16
10893816|NCT00738920|12059762|FG001|NOT COMPLETED|Baseline to 2-Week Follow-Up||23
10893896|NCT00725049|12059813|FG001|COMPLETED|Overall Study||20
10893817|NCT00738920|12059763|FG002|NOT COMPLETED|Baseline to 2-Week Follow-Up||15
10893818|NCT00738920|12059761|FG000|STARTED|2-Week Follow-Up to 3-Month Follow-Up||129
10893819|NCT00738920|12059762|FG001|STARTED|2-Week Follow-Up to 3-Month Follow-Up||123
10893820|NCT00738920|12059763|FG002|STARTED|2-Week Follow-Up to 3-Month Follow-Up||130
10893821|NCT00738920|12059761|FG000|COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||121
10893822|NCT00738920|12059762|FG001|COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||111
10893823|NCT00738920|12059763|FG002|COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||118
10893824|NCT00738920|12059761|FG000|NOT COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||8
10893825|NCT00738920|12059762|FG001|NOT COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||12
10893826|NCT00738920|12059763|FG002|NOT COMPLETED|2-Week Follow-Up to 3-Month Follow-Up||12
10893827|NCT00738920|12059761|FG000|STARTED|3-Month Follow-Up to 6-Month Follow-Up||121
10893828|NCT00738920|12059762|FG001|STARTED|3-Month Follow-Up to 6-Month Follow-Up||111
10893829|NCT00738920|12059763|FG002|STARTED|3-Month Follow-Up to 6-Month Follow-Up||118
10893830|NCT00738920|12059761|FG000|COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||117
10893831|NCT00738920|12059762|FG001|COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||111
10893832|NCT00738920|12059763|FG002|COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||115
10893833|NCT00738920|12059761|FG000|NOT COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||4
10893834|NCT00738920|12059762|FG001|NOT COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||0
10893835|NCT00738920|12059763|FG002|NOT COMPLETED|3-Month Follow-Up to 6-Month Follow-Up||3
10893836|NCT00738920|12059761|FG000|STARTED|6-Month Follow-Up to 9-Month Follow-Up||117
10893837|NCT00738920|12059762|FG001|STARTED|6-Month Follow-Up to 9-Month Follow-Up||111
10893838|NCT00738920|12059763|FG002|STARTED|6-Month Follow-Up to 9-Month Follow-Up||115
10893839|NCT00738920|12059761|FG000|COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||113
10893840|NCT00738920|12059762|FG001|COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||104
10893841|NCT00738920|12059763|FG002|COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||103
10893842|NCT00738920|12059761|FG000|NOT COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||4
10893843|NCT00738920|12059762|FG001|NOT COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||7
10893844|NCT00738920|12059763|FG002|NOT COMPLETED|6-Month Follow-Up to 9-Month Follow-Up||12
10893845|NCT00738920|12059761|FG000|STARTED|9-Month Follow-Up to 12-Month Follow-Up||113
10893846|NCT00738920|12059762|FG001|STARTED|9-Month Follow-Up to 12-Month Follow-Up||104
10893847|NCT00738920|12059763|FG002|STARTED|9-Month Follow-Up to 12-Month Follow-Up||103
10893848|NCT00738920|12059761|FG000|COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||112
10893849|NCT00738920|12059762|FG001|COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||103
10893850|NCT00738920|12059763|FG002|COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||102
10893851|NCT00738920|12059761|FG000|NOT COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||1
10893852|NCT00738920|12059762|FG001|NOT COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||1
10893853|NCT00738920|12059763|FG002|NOT COMPLETED|9-Month Follow-Up to 12-Month Follow-Up||1
10893854|NCT00738582|12059771|FG000|STARTED|Combination Therapy||89
10893855|NCT00738582|12059772|FG001|STARTED|Combination Therapy||0
10893856|NCT00738582|12059771|FG000|COMPLETED|Combination Therapy||56
10893857|NCT00738582|12059772|FG001|COMPLETED|Combination Therapy||0
10893858|NCT00738582|12059771|FG000|NOT COMPLETED|Combination Therapy||33
10893859|NCT00738582|12059772|FG001|NOT COMPLETED|Combination Therapy||0
10893860|NCT00738582|12059771|FG000|STARTED|Maintenance Therapy|This arm ended once all participants entered into the Maintenance Therapy phase of the study.|0
10893861|NCT00738582|12059772|FG001|STARTED|Maintenance Therapy|Only eligible participants entered into this phase of the study.|56
10893862|NCT00738582|12059771|FG000|COMPLETED|Maintenance Therapy||0
10893863|NCT00738582|12059772|FG001|COMPLETED|Maintenance Therapy||0
10893864|NCT00738582|12059771|FG000|NOT COMPLETED|Maintenance Therapy||0
10893865|NCT00738582|12059772|FG001|NOT COMPLETED|Maintenance Therapy||56
10893866|NCT00733954|12059781|FG000|STARTED|Overall Study||124
10893867|NCT00733954|12059782|FG001|STARTED|Overall Study||125
10893868|NCT00733954|12059781|FG000|COMPLETED|Overall Study||116
10893869|NCT00733954|12059782|FG001|COMPLETED|Overall Study||123
10893870|NCT00733954|12059781|FG000|NOT COMPLETED|Overall Study||8
10893871|NCT00733954|12059782|FG001|NOT COMPLETED|Overall Study||2
10893872|NCT00731731|12059791|FG000|STARTED|Overall Study||12
10893873|NCT00731731|12059792|FG001|STARTED|Overall Study||3
10893874|NCT00731731|12059793|FG002|STARTED|Overall Study||110
10893875|NCT00731731|12059791|FG000|COMPLETED|Overall Study||12
10893876|NCT00731731|12059792|FG001|COMPLETED|Overall Study||3
10893877|NCT00731731|12059793|FG002|COMPLETED|Overall Study||107
10893878|NCT00731731|12059791|FG000|NOT COMPLETED|Overall Study||0
10893879|NCT00731731|12059792|FG001|NOT COMPLETED|Overall Study||0
10893880|NCT00731731|12059793|FG002|NOT COMPLETED|Overall Study||3
10893881|NCT00728884|12059806|FG000|STARTED|Implant Placement Surgery||162
10893882|NCT00728884|12059806|FG000|COMPLETED|Implant Placement Surgery||162
10893883|NCT00728884|12059806|FG000|NOT COMPLETED|Implant Placement Surgery||0
10893884|NCT00728884|12059806|FG000|STARTED|Permanent Prosthesis Placement||162
10893885|NCT00728884|12059806|FG000|COMPLETED|Permanent Prosthesis Placement||149
10893886|NCT00728884|12059806|FG000|NOT COMPLETED|Permanent Prosthesis Placement||13
10893887|NCT00728884|12059806|FG000|STARTED|One Year Post Placement Follow-up||149
10893888|NCT00728884|12059806|FG000|COMPLETED|One Year Post Placement Follow-up||145
10893889|NCT00728884|12059806|FG000|NOT COMPLETED|One Year Post Placement Follow-up||4
10893890|NCT00728884|12059806|FG000|STARTED|Two Year Post Placement Follow-up||145
10893891|NCT00728884|12059806|FG000|COMPLETED|Two Year Post Placement Follow-up||145
10893892|NCT00728884|12059806|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
10893893|NCT00725049|12059812|FG000|STARTED|Overall Study||17
10893894|NCT00725049|12059813|FG001|STARTED|Overall Study||20
10893895|NCT00725049|12059812|FG000|COMPLETED|Overall Study||17
10893897|NCT00725049|12059812|FG000|NOT COMPLETED|Overall Study||0
10893898|NCT00725049|12059813|FG001|NOT COMPLETED|Overall Study||0
10893899|NCT00716443|12059819|FG000|STARTED|Overall Study||51
10893900|NCT00716443|12059819|FG000|COMPLETED|Overall Study||51
10893901|NCT00716443|12059819|FG000|NOT COMPLETED|Overall Study||0
10893902|NCT00680992|12059827|FG000|STARTED|Overall Study||268
10893903|NCT00680992|12059828|FG001|STARTED|Overall Study||252
10893904|NCT00680992|12059829|FG002|STARTED|Overall Study||12
10893905|NCT00680992|12059827|FG000|Safety Analysis Set|Overall Study||265
10893906|NCT00680992|12059828|FG001|Safety Analysis Set|Overall Study||249
10893907|NCT00680992|12059829|FG002|Safety Analysis Set|Overall Study||12
10893908|NCT00680992|12059827|FG000|Efficacy Analysis Set|Overall Study||260
10893909|NCT00680992|12059828|FG001|Efficacy Analysis Set|Overall Study||242
10893910|NCT00680992|12059829|FG002|Efficacy Analysis Set|Overall Study||11
10893911|NCT00680992|12059827|FG000|COMPLETED|Overall Study||0
10893912|NCT00680992|12059828|FG001|COMPLETED|Overall Study||0
10893913|NCT00680992|12059829|FG002|COMPLETED|Overall Study||0
10893914|NCT00680992|12059827|FG000|NOT COMPLETED|Overall Study||268
10893915|NCT00680992|12059828|FG001|NOT COMPLETED|Overall Study||252
10893916|NCT00680992|12059829|FG002|NOT COMPLETED|Overall Study||12
10893917|NCT00679783|12059845|FG000|STARTED|Overall Study|Gave Informed consent and passed screening|4
10893918|NCT00679783|12059846|FG001|STARTED|Overall Study|Gave Informed consent and passed screening|13
10893919|NCT00679783|12059847|FG002|STARTED|Overall Study|Gave Informed consent and passed screening|3
10893920|NCT00679783|12059848|FG003|STARTED|Overall Study|Gave Informed consent and passed screening|45
10893921|NCT00679783|12059849|FG004|STARTED|Overall Study|Gave Informed consent and passed screening|5
10893922|NCT00679783|12059850|FG005|STARTED|Overall Study|Gave Informed consent and passed screening|5
10893923|NCT00679783|12059851|FG006|STARTED|Overall Study|Gave Informed consent and passed screening|16
10893924|NCT00679783|12059845|FG000|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
10893925|NCT00679783|12059846|FG001|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
10893926|NCT00679783|12059847|FG002|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
10893927|NCT00679783|12059848|FG003|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
10893928|NCT00679783|12059849|FG004|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
10893929|NCT00679783|12059850|FG005|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
10893930|NCT00679783|12059851|FG006|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
10893931|NCT00679783|12059845|FG000|NOT COMPLETED|Overall Study||2
10893932|NCT00679783|12059846|FG001|NOT COMPLETED|Overall Study||3
10893933|NCT00679783|12059847|FG002|NOT COMPLETED|Overall Study||1
10893934|NCT00679783|12059848|FG003|NOT COMPLETED|Overall Study||20
10893935|NCT00679783|12059849|FG004|NOT COMPLETED|Overall Study||1
10893936|NCT00679783|12059850|FG005|NOT COMPLETED|Overall Study||0
10893937|NCT00679783|12059851|FG006|NOT COMPLETED|Overall Study||1
10893938|NCT00679042|12059867|FG000|STARTED|Transplant + 1 Year Follow Up||21
10893939|NCT00679042|12059867|FG000|COMPLETED|Transplant + 1 Year Follow Up||19
10893940|NCT00679042|12059867|FG000|NOT COMPLETED|Transplant + 1 Year Follow Up||2
10893941|NCT00679042|12059867|FG000|STARTED|5-Year Follow Up||19
10893942|NCT00679042|12059867|FG000|COMPLETED|5-Year Follow Up||5
10893943|NCT00679042|12059867|FG000|NOT COMPLETED|5-Year Follow Up||14
10893944|NCT00679042|12059867|FG000|STARTED|10-Year Follow Up||5
10893945|NCT00679042|12059867|FG000|COMPLETED|10-Year Follow Up||0
10893946|NCT00679042|12059867|FG000|NOT COMPLETED|10-Year Follow Up||5
10893947|NCT00671749|12059871|FG000|STARTED|Overall Study||100
10893948|NCT00671749|12059871|FG000|COMPLETED|Overall Study||92
10893949|NCT00671749|12059871|FG000|NOT COMPLETED|Overall Study||8
10893950|NCT00669071|12059875|FG000|STARTED|Overall Study||56
10893951|NCT00669071|12059875|FG000|COMPLETED|Overall Study||52
10893952|NCT00669071|12059875|FG000|NOT COMPLETED|Overall Study||4
10893953|NCT00667251|12059883|FG000|STARTED|Overall Study||326
10893954|NCT00667251|12059884|FG001|STARTED|Overall Study||326
10893955|NCT00667251|12059883|FG000|Combination Rx|Overall Study||322
10893956|NCT00667251|12059884|FG001|Combination Rx|Overall Study||325
10893957|NCT00667251|12059883|FG000|Monotherapy|Overall Study||225
10893958|NCT00667251|12059884|FG001|Monotherapy|Overall Study||232
10893959|NCT00667251|12059883|FG000|Not Started|Overall Study||4
10893960|NCT00667251|12059884|FG001|Not Started|Overall Study||1
10893961|NCT00667251|12059883|FG000|COMPLETED|Overall Study||256
10893962|NCT00667251|12059884|FG001|COMPLETED|Overall Study||231
10893963|NCT00667251|12059883|FG000|NOT COMPLETED|Overall Study||70
10893964|NCT00667251|12059884|FG001|NOT COMPLETED|Overall Study||95
10893965|NCT00658814|12059892|FG000|STARTED|Remission Induction Chemotherapy||83
10893966|NCT00658814|12059893|FG001|STARTED|Remission Induction Chemotherapy||59
10893967|NCT00658814|12059892|FG000|Eligible|Remission Induction Chemotherapy||82
10893968|NCT00658814|12059893|FG001|Eligible|Remission Induction Chemotherapy||57
10893969|NCT00658814|12059892|FG000|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
10893970|NCT00658814|12059893|FG001|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
10893971|NCT00658814|12059892|FG000|COMPLETED|Remission Induction Chemotherapy||75
10893972|NCT00658814|12059893|FG001|COMPLETED|Remission Induction Chemotherapy||41
10893973|NCT00658814|12059892|FG000|NOT COMPLETED|Remission Induction Chemotherapy||8
10893974|NCT00658814|12059893|FG001|NOT COMPLETED|Remission Induction Chemotherapy||18
10893975|NCT00658814|12059892|FG000|STARTED|Consolidation Therapy||24
10893976|NCT00658814|12059893|FG001|STARTED|Consolidation Therapy||13
10893977|NCT00658814|12059892|FG000|Eligible|Consolidation Therapy||22
10893978|NCT00658814|12059893|FG001|Eligible|Consolidation Therapy||11
10893979|NCT00658814|12059892|FG000|COMPLETED|Consolidation Therapy||22
10893980|NCT00658814|12059893|FG001|COMPLETED|Consolidation Therapy||10
10893981|NCT00658814|12059892|FG000|NOT COMPLETED|Consolidation Therapy||2
10893982|NCT00658814|12059893|FG001|NOT COMPLETED|Consolidation Therapy||3
10893983|NCT00658814|12059892|FG000|STARTED|Maintenance Therapy||20
10893984|NCT00658814|12059893|FG001|STARTED|Maintenance Therapy||8
10893985|NCT00658814|12059892|FG000|Eligible|Maintenance Therapy||19
10893986|NCT00658814|12059893|FG001|Eligible|Maintenance Therapy||8
10893987|NCT00658814|12059892|FG000|COMPLETED|Maintenance Therapy||17
10893988|NCT00658814|12059893|FG001|COMPLETED|Maintenance Therapy||7
10893989|NCT00658814|12059892|FG000|NOT COMPLETED|Maintenance Therapy||3
10893990|NCT00658814|12059893|FG001|NOT COMPLETED|Maintenance Therapy||1
10893991|NCT00658788|12059903|FG000|STARTED|Overall Study||305
10893992|NCT00658788|12059903|FG000|COMPLETED|Overall Study||231
10893993|NCT00658788|12059903|FG000|NOT COMPLETED|Overall Study||74
10893994|NCT00647556|12059918|FG000|STARTED|Overall Study||15
10893995|NCT00647556|12059919|FG001|STARTED|Overall Study||15
10893996|NCT00647556|12059918|FG000|COMPLETED|Overall Study||12
10893997|NCT00647556|12059919|FG001|COMPLETED|Overall Study||13
10893998|NCT00647556|12059918|FG000|NOT COMPLETED|Overall Study||3
10893999|NCT00647556|12059919|FG001|NOT COMPLETED|Overall Study||2
10894000|NCT00644280|12059927|FG000|STARTED|Overall Study||6
10894001|NCT00644280|12059928|FG001|STARTED|Overall Study||5
10894002|NCT00644280|12059927|FG000|COMPLETED|Overall Study||6
10894003|NCT00644280|12059928|FG001|COMPLETED|Overall Study||5
10894004|NCT00644280|12059927|FG000|NOT COMPLETED|Overall Study||0
10894005|NCT00644280|12059928|FG001|NOT COMPLETED|Overall Study||0
10894006|NCT00641186|12059934|FG000|STARTED|Overall Study||30
10894007|NCT00641186|12059934|FG000|COMPLETED|Overall Study||27
10894008|NCT00641186|12059934|FG000|NOT COMPLETED|Overall Study||3
10894009|NCT00635700|12059940|FG000|STARTED|Overall Study||24
10894010|NCT00635700|12059941|FG001|STARTED|Overall Study||27
10894011|NCT00635700|12059940|FG000|COMPLETED|Overall Study||9
10894012|NCT00635700|12059941|FG001|COMPLETED|Overall Study||13
10894013|NCT00635700|12059940|FG000|NOT COMPLETED|Overall Study||15
10894014|NCT00635700|12059941|FG001|NOT COMPLETED|Overall Study||14
10894015|NCT00625378|12059949|FG000|STARTED|Overall Study||205
10894016|NCT00625378|12059950|FG001|STARTED|Overall Study||1
10894017|NCT00625378|12059949|FG000|Treated in STEP|Overall Study||203
10894018|NCT00625378|12059950|FG001|Treated in STEP|Overall Study||1
10894019|NCT00625378|12059949|FG000|COMPLETED|Overall Study||0
10894020|NCT00625378|12059950|FG001|COMPLETED|Overall Study||0
10894021|NCT00625378|12059949|FG000|NOT COMPLETED|Overall Study||205
10894022|NCT00625378|12059950|FG001|NOT COMPLETED|Overall Study||1
10894023|NCT00609791|12059956|FG000|STARTED|Overall Study||40
10894024|NCT00609791|12059956|FG000|COMPLETED|Overall Study||39
10894025|NCT00609791|12059956|FG000|NOT COMPLETED|Overall Study||1
10894026|NCT00605189|12059963|FG000|STARTED|Overall Study||20
10894027|NCT00605189|12059964|FG001|STARTED|Overall Study||21
10894028|NCT00605189|12059965|FG002|STARTED|Overall Study||9
10894029|NCT00605189|12059963|FG000|COMPLETED|Overall Study||17
10894030|NCT00605189|12059964|FG001|COMPLETED|Overall Study||19
10894031|NCT00605189|12059965|FG002|COMPLETED|Overall Study||9
10894032|NCT00605189|12059963|FG000|NOT COMPLETED|Overall Study||3
10894033|NCT00605189|12059964|FG001|NOT COMPLETED|Overall Study||2
10894034|NCT00605189|12059965|FG002|NOT COMPLETED|Overall Study||0
10894035|NCT00602641|12059975|FG000|STARTED|Overall Study||154
10894036|NCT00602641|12059976|FG001|STARTED|Overall Study||152
10894037|NCT00602641|12059975|FG000|Started Protocol Therapy|Overall Study||148
10894038|NCT00602641|12059976|FG001|Started Protocol Therapy|Overall Study||150
10894039|NCT00602641|12059975|FG000|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
10894040|NCT00602641|12059976|FG001|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
10894041|NCT00602641|12059975|FG000|NOT COMPLETED|Overall Study||154
10894042|NCT00602641|12059976|FG001|NOT COMPLETED|Overall Study||152
10894043|NCT00602459|12059986|FG000|STARTED|Initial Registration/Randomization||138
10894044|NCT00602459|12059987|FG001|STARTED|Initial Registration/Randomization||140
10894045|NCT00602459|12059988|FG002|STARTED|Initial Registration/Randomization||140
10894046|NCT00602459|12059989|FG003|STARTED|Initial Registration/Randomization||0
10894047|NCT00602459|12059986|FG000|COMPLETED|Initial Registration/Randomization||133
10894048|NCT00602459|12059987|FG001|COMPLETED|Initial Registration/Randomization||130
10894049|NCT00602459|12059988|FG002|COMPLETED|Initial Registration/Randomization||137
10894050|NCT00602459|12059989|FG003|COMPLETED|Initial Registration/Randomization||0
10894051|NCT00602459|12059986|FG000|NOT COMPLETED|Initial Registration/Randomization||5
10894052|NCT00602459|12059987|FG001|NOT COMPLETED|Initial Registration/Randomization||10
10894053|NCT00602459|12059988|FG002|NOT COMPLETED|Initial Registration/Randomization||3
10894054|NCT00602459|12059989|FG003|NOT COMPLETED|Initial Registration/Randomization||0
10894055|NCT00602459|12059986|FG000|STARTED|Re-assignment After Del(11q22.3) Testing||123
10894056|NCT00602459|12059987|FG001|STARTED|Re-assignment After Del(11q22.3) Testing||109
10894057|NCT00602459|12059988|FG002|STARTED|Re-assignment After Del(11q22.3) Testing||137
10894058|NCT00602459|12059989|FG003|STARTED|Re-assignment After Del(11q22.3) Testing||31
10894059|NCT00602459|12059986|FG000|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
10894060|NCT00602459|12059987|FG001|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
10894061|NCT00602459|12059988|FG002|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
10894062|NCT00602459|12059989|FG003|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
10894063|NCT00602459|12059986|FG000|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
10894064|NCT00602459|12059987|FG001|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
10894065|NCT00602459|12059988|FG002|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
10894066|NCT00602459|12059989|FG003|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
10894067|NCT00602030|12060009|FG000|STARTED|Lead-in Phase||3
10894068|NCT00602030|12060010|FG001|STARTED|Lead-in Phase||6
10894069|NCT00602030|12060011|FG002|STARTED|Lead-in Phase||0
10894070|NCT00602030|12060012|FG003|STARTED|Lead-in Phase||0
10894071|NCT00602030|12060013|FG004|STARTED|Lead-in Phase||0
10894072|NCT00602030|12060009|FG000|COMPLETED|Lead-in Phase||1
10894073|NCT00602030|12060010|FG001|COMPLETED|Lead-in Phase||1
10894074|NCT00602030|12060011|FG002|COMPLETED|Lead-in Phase||0
10894075|NCT00602030|12060012|FG003|COMPLETED|Lead-in Phase||0
10894076|NCT00602030|12060013|FG004|COMPLETED|Lead-in Phase||0
10894077|NCT00602030|12060009|FG000|NOT COMPLETED|Lead-in Phase||2
10894078|NCT00602030|12060010|FG001|NOT COMPLETED|Lead-in Phase||5
10894079|NCT00602030|12060011|FG002|NOT COMPLETED|Lead-in Phase||0
10894080|NCT00602030|12060012|FG003|NOT COMPLETED|Lead-in Phase||0
10894081|NCT00602030|12060013|FG004|NOT COMPLETED|Lead-in Phase||0
10894082|NCT00602030|12060009|FG000|STARTED|Double-blind Phase||0
10894083|NCT00602030|12060010|FG001|STARTED|Double-blind Phase||0
10894084|NCT00602030|12060011|FG002|STARTED|Double-blind Phase||65
10894085|NCT00602030|12060012|FG003|STARTED|Double-blind Phase||67
10894086|NCT00602030|12060013|FG004|STARTED|Double-blind Phase||0
10894087|NCT00602030|12060009|FG000|Received Treatment|Double-blind Phase||0
10894088|NCT00602030|12060010|FG001|Received Treatment|Double-blind Phase||0
10894089|NCT00602030|12060011|FG002|Received Treatment|Double-blind Phase||63
10894090|NCT00602030|12060012|FG003|Received Treatment|Double-blind Phase||65
10894091|NCT00602030|12060013|FG004|Received Treatment|Double-blind Phase||0
10894092|NCT00602030|12060009|FG000|COMPLETED|Double-blind Phase||0
10894093|NCT00602030|12060010|FG001|COMPLETED|Double-blind Phase||0
10894094|NCT00602030|12060011|FG002|COMPLETED|Double-blind Phase||11
10894095|NCT00602030|12060012|FG003|COMPLETED|Double-blind Phase||8
10894096|NCT00602030|12060013|FG004|COMPLETED|Double-blind Phase||0
10894097|NCT00602030|12060009|FG000|NOT COMPLETED|Double-blind Phase||0
10894098|NCT00602030|12060010|FG001|NOT COMPLETED|Double-blind Phase||0
10894099|NCT00602030|12060011|FG002|NOT COMPLETED|Double-blind Phase||54
10894100|NCT00602030|12060012|FG003|NOT COMPLETED|Double-blind Phase||59
10894101|NCT00602030|12060013|FG004|NOT COMPLETED|Double-blind Phase||0
10894102|NCT00602030|12060009|FG000|STARTED|Crossover Phase||0
10894103|NCT00602030|12060010|FG001|STARTED|Crossover Phase||0
10894104|NCT00602030|12060011|FG002|STARTED|Crossover Phase||0
10894105|NCT00602030|12060012|FG003|STARTED|Crossover Phase||0
10894106|NCT00602030|12060013|FG004|STARTED|Crossover Phase||16
10894107|NCT00602030|12060009|FG000|COMPLETED|Crossover Phase||0
10894108|NCT00602030|12060010|FG001|COMPLETED|Crossover Phase||0
10894109|NCT00602030|12060011|FG002|COMPLETED|Crossover Phase||0
10894110|NCT00602030|12060012|FG003|COMPLETED|Crossover Phase||0
10894111|NCT00602030|12060013|FG004|COMPLETED|Crossover Phase||0
10894112|NCT00602030|12060009|FG000|NOT COMPLETED|Crossover Phase||0
10894113|NCT00602030|12060010|FG001|NOT COMPLETED|Crossover Phase||0
10894114|NCT00602030|12060011|FG002|NOT COMPLETED|Crossover Phase||0
10894115|NCT00602030|12060012|FG003|NOT COMPLETED|Crossover Phase||0
10894116|NCT00602030|12060013|FG004|NOT COMPLETED|Crossover Phase||16
10894117|NCT00601900|12060027|FG000|STARTED|Overall Study||195
10894118|NCT00601900|12060028|FG001|STARTED|Overall Study||199
10894119|NCT00601900|12060027|FG000|COMPLETED|Overall Study||195
10894120|NCT00601900|12060028|FG001|COMPLETED|Overall Study||196
10894121|NCT00601900|12060027|FG000|NOT COMPLETED|Overall Study||0
10894122|NCT00601900|12060028|FG001|NOT COMPLETED|Overall Study||3
10894123|NCT00597012|12060036|FG000|STARTED|Overall Study||174
10894124|NCT00597012|12060037|FG001|STARTED|Overall Study||177
10894125|NCT00597012|12060036|FG000|COMPLETED|Overall Study||161
10894126|NCT00597012|12060037|FG001|COMPLETED|Overall Study||169
10894127|NCT00597012|12060036|FG000|NOT COMPLETED|Overall Study||13
10894128|NCT00597012|12060037|FG001|NOT COMPLETED|Overall Study||8
10894129|NCT00588770|12060047|FG000|STARTED|Overall Study||200
10894130|NCT00588770|12060048|FG001|STARTED|Overall Study||203
10894131|NCT00588770|12060047|FG000|Eligible|Overall Study||188
10894132|NCT00588770|12060048|FG001|Eligible|Overall Study||183
10894133|NCT00588770|12060047|FG000|Start Protocol Therapy|Overall Study||200
10894134|NCT00588770|12060048|FG001|Start Protocol Therapy|Overall Study||194
10894135|NCT00588770|12060047|FG000|COMPLETED|Overall Study||41
10894136|NCT00588770|12060048|FG001|COMPLETED|Overall Study||3
10894137|NCT00588770|12060047|FG000|NOT COMPLETED|Overall Study||159
10894138|NCT00588770|12060048|FG001|NOT COMPLETED|Overall Study||200
10894139|NCT00580489|12060056|FG000|STARTED|Overall Study||104
10894140|NCT00580489|12060057|FG001|STARTED|Overall Study||100
10894141|NCT00580489|12060056|FG000|COMPLETED|Overall Study||104
10894142|NCT00580489|12060057|FG001|COMPLETED|Overall Study||100
10894143|NCT00580489|12060056|FG000|NOT COMPLETED|Overall Study||0
10894144|NCT00580489|12060057|FG001|NOT COMPLETED|Overall Study||0
10894145|NCT00569127|12060067|FG000|STARTED|Overall Study||214
10894146|NCT00569127|12060068|FG001|STARTED|Overall Study||213
10894147|NCT00569127|12060067|FG000|Eligible|Overall Study||200
10894148|NCT00569127|12060068|FG001|Eligible|Overall Study||202
10894149|NCT00569127|12060067|FG000|COMPLETED|Overall Study||0
10894150|NCT00569127|12060068|FG001|COMPLETED|Overall Study||0
10894151|NCT00569127|12060067|FG000|NOT COMPLETED|Overall Study||214
10894152|NCT00569127|12060068|FG001|NOT COMPLETED|Overall Study||213
10894153|NCT00565851|12060082|FG000|STARTED|Surgical Assignment||316
10894154|NCT00565851|12060083|FG001|STARTED|Surgical Assignment||456
10894155|NCT00565851|12060084|FG002|STARTED|Surgical Assignment||33
10894156|NCT00565851|12060085|FG003|STARTED|Surgical Assignment||165
10894157|NCT00565851|12060086|FG004|STARTED|Surgical Assignment||6
10894158|NCT00565851|12060087|FG005|STARTED|Surgical Assignment||34
10894159|NCT00565851|12060088|FG006|STARTED|Surgical Assignment||5
10894160|NCT00565851|12060089|FG007|STARTED|Surgical Assignment||37
10894161|NCT00565851|12060082|FG000|Randomized - Yes Surgery|Surgical Assignment||0
10894162|NCT00565851|12060083|FG001|Randomized - Yes Surgery|Surgical Assignment||0
10894163|NCT00565851|12060084|FG002|Randomized - Yes Surgery|Surgical Assignment||33
10894164|NCT00565851|12060085|FG003|Randomized - Yes Surgery|Surgical Assignment||165
10894165|NCT00565851|12060086|FG004|Randomized - Yes Surgery|Surgical Assignment||0
10894166|NCT00565851|12060087|FG005|Randomized - Yes Surgery|Surgical Assignment||0
10894167|NCT00565851|12060088|FG006|Randomized - Yes Surgery|Surgical Assignment||5
10894168|NCT00565851|12060089|FG007|Randomized - Yes Surgery|Surgical Assignment||37
10894169|NCT00565851|12060082|FG000|Randomized - no Surgery|Surgical Assignment||33
10894170|NCT00565851|12060083|FG001|Randomized - no Surgery|Surgical Assignment||172
10894171|NCT00565851|12060084|FG002|Randomized - no Surgery|Surgical Assignment||0
10894172|NCT00565851|12060085|FG003|Randomized - no Surgery|Surgical Assignment||0
10894173|NCT00565851|12060086|FG004|Randomized - no Surgery|Surgical Assignment||6
10894174|NCT00565851|12060087|FG005|Randomized - no Surgery|Surgical Assignment||34
10894175|NCT00565851|12060088|FG006|Randomized - no Surgery|Surgical Assignment||0
10894176|NCT00565851|12060089|FG007|Randomized - no Surgery|Surgical Assignment||0
10894177|NCT00565851|12060082|FG000|Not Surgical Candidate|Surgical Assignment||283
10894178|NCT00565851|12060083|FG001|Not Surgical Candidate|Surgical Assignment||284
10894179|NCT00565851|12060084|FG002|Not Surgical Candidate|Surgical Assignment||0
10894180|NCT00565851|12060085|FG003|Not Surgical Candidate|Surgical Assignment||0
10894181|NCT00565851|12060086|FG004|Not Surgical Candidate|Surgical Assignment||0
10894182|NCT00565851|12060087|FG005|Not Surgical Candidate|Surgical Assignment||0
10894183|NCT00565851|12060088|FG006|Not Surgical Candidate|Surgical Assignment||0
10894184|NCT00565851|12060089|FG007|Not Surgical Candidate|Surgical Assignment||0
10894185|NCT00565851|12060082|FG000|COMPLETED|Surgical Assignment||313
10894186|NCT00565851|12060083|FG001|COMPLETED|Surgical Assignment||454
10894187|NCT00565851|12060084|FG002|COMPLETED|Surgical Assignment||31
10894188|NCT00565851|12060085|FG003|COMPLETED|Surgical Assignment||154
10894189|NCT00565851|12060086|FG004|COMPLETED|Surgical Assignment||6
10894190|NCT00565851|12060087|FG005|COMPLETED|Surgical Assignment||34
10894191|NCT00565851|12060088|FG006|COMPLETED|Surgical Assignment||5
10894192|NCT00565851|12060089|FG007|COMPLETED|Surgical Assignment||35
10894193|NCT00565851|12060082|FG000|NOT COMPLETED|Surgical Assignment||3
10894194|NCT00565851|12060083|FG001|NOT COMPLETED|Surgical Assignment||2
10894195|NCT00565851|12060084|FG002|NOT COMPLETED|Surgical Assignment||2
10894196|NCT00565851|12060085|FG003|NOT COMPLETED|Surgical Assignment||11
10894197|NCT00565851|12060086|FG004|NOT COMPLETED|Surgical Assignment||0
10894198|NCT00565851|12060087|FG005|NOT COMPLETED|Surgical Assignment||0
10894199|NCT00565851|12060088|FG006|NOT COMPLETED|Surgical Assignment||0
10894200|NCT00565851|12060089|FG007|NOT COMPLETED|Surgical Assignment||2
10894201|NCT00565851|12060082|FG000|STARTED|Chemotherapy Assignment||316
10894202|NCT00565851|12060083|FG001|STARTED|Chemotherapy Assignment||456
10894203|NCT00565851|12060084|FG002|STARTED|Chemotherapy Assignment||33
10894204|NCT00565851|12060085|FG003|STARTED|Chemotherapy Assignment||165
10894205|NCT00565851|12060086|FG004|STARTED|Chemotherapy Assignment||6
10894206|NCT00565851|12060087|FG005|STARTED|Chemotherapy Assignment||34
10894207|NCT00565851|12060088|FG006|STARTED|Chemotherapy Assignment||5
10894208|NCT00565851|12060089|FG007|STARTED|Chemotherapy Assignment||37
10894209|NCT00565851|12060082|FG000|Randomized to Chemo|Chemotherapy Assignment||310
10894210|NCT00565851|12060083|FG001|Randomized to Chemo|Chemotherapy Assignment||311
10894211|NCT00565851|12060084|FG002|Randomized to Chemo|Chemotherapy Assignment||27
10894212|NCT00565851|12060085|FG003|Randomized to Chemo|Chemotherapy Assignment||26
10894213|NCT00565851|12060086|FG004|Randomized to Chemo|Chemotherapy Assignment||0
10894214|NCT00565851|12060087|FG005|Randomized to Chemo|Chemotherapy Assignment||0
10894215|NCT00565851|12060088|FG006|Randomized to Chemo|Chemotherapy Assignment||0
10894216|NCT00565851|12060089|FG007|Randomized to Chemo|Chemotherapy Assignment||0
10894217|NCT00565851|12060082|FG000|Pre-specified Chemo|Chemotherapy Assignment||6
10894218|NCT00565851|12060083|FG001|Pre-specified Chemo|Chemotherapy Assignment||145
10894219|NCT00565851|12060084|FG002|Pre-specified Chemo|Chemotherapy Assignment||6
10894220|NCT00565851|12060085|FG003|Pre-specified Chemo|Chemotherapy Assignment||139
10894221|NCT00565851|12060086|FG004|Pre-specified Chemo|Chemotherapy Assignment||6
10894222|NCT00565851|12060087|FG005|Pre-specified Chemo|Chemotherapy Assignment||34
10894223|NCT00565851|12060088|FG006|Pre-specified Chemo|Chemotherapy Assignment||5
10894224|NCT00565851|12060089|FG007|Pre-specified Chemo|Chemotherapy Assignment||37
10894225|NCT00565851|12060082|FG000|COMPLETED|Chemotherapy Assignment||307
10894226|NCT00565851|12060083|FG001|COMPLETED|Chemotherapy Assignment||433
10894227|NCT00565851|12060084|FG002|COMPLETED|Chemotherapy Assignment||30
10894228|NCT00565851|12060085|FG003|COMPLETED|Chemotherapy Assignment||129
10894229|NCT00565851|12060086|FG004|COMPLETED|Chemotherapy Assignment||6
10894230|NCT00565851|12060087|FG005|COMPLETED|Chemotherapy Assignment||31
10894231|NCT00565851|12060088|FG006|COMPLETED|Chemotherapy Assignment||5
10894232|NCT00565851|12060089|FG007|COMPLETED|Chemotherapy Assignment||34
10894233|NCT00565851|12060082|FG000|NOT COMPLETED|Chemotherapy Assignment||9
10894234|NCT00565851|12060083|FG001|NOT COMPLETED|Chemotherapy Assignment||23
10894235|NCT00565851|12060084|FG002|NOT COMPLETED|Chemotherapy Assignment||3
10894236|NCT00565851|12060085|FG003|NOT COMPLETED|Chemotherapy Assignment||36
10894237|NCT00565851|12060086|FG004|NOT COMPLETED|Chemotherapy Assignment||0
10894238|NCT00565851|12060087|FG005|NOT COMPLETED|Chemotherapy Assignment||3
10894239|NCT00565851|12060088|FG006|NOT COMPLETED|Chemotherapy Assignment||0
10894240|NCT00565851|12060089|FG007|NOT COMPLETED|Chemotherapy Assignment||3
10894241|NCT00557193|12060111|FG000|STARTED|Induction||218
10894242|NCT00557193|12060112|FG001|STARTED|Induction||0
10894243|NCT00557193|12060113|FG002|STARTED|Induction||0
10894244|NCT00557193|12060114|FG003|STARTED|Induction||0
10894245|NCT00557193|12060115|FG004|STARTED|Induction||0
10894246|NCT00557193|12060116|FG005|STARTED|Induction||0
10894247|NCT00557193|12060111|FG000|COMPLETED|Induction||192
10894248|NCT00557193|12060112|FG001|COMPLETED|Induction||0
10894249|NCT00557193|12060113|FG002|COMPLETED|Induction||0
10894250|NCT00557193|12060114|FG003|COMPLETED|Induction||0
10894251|NCT00557193|12060115|FG004|COMPLETED|Induction||0
10894252|NCT00557193|12060116|FG005|COMPLETED|Induction||0
10894253|NCT00557193|12060111|FG000|NOT COMPLETED|Induction||26
10894254|NCT00557193|12060112|FG001|NOT COMPLETED|Induction||0
10894255|NCT00557193|12060113|FG002|NOT COMPLETED|Induction||0
10894256|NCT00557193|12060114|FG003|NOT COMPLETED|Induction||0
10894257|NCT00557193|12060115|FG004|NOT COMPLETED|Induction||0
10894258|NCT00557193|12060116|FG005|NOT COMPLETED|Induction||0
10894259|NCT00557193|12060111|FG000|STARTED|Post Induction Therapy by Tx Assignment||0
10894260|NCT00557193|12060112|FG001|STARTED|Post Induction Therapy by Tx Assignment||60
10894261|NCT00557193|12060113|FG002|STARTED|Post Induction Therapy by Tx Assignment||54
10894262|NCT00557193|12060114|FG003|STARTED|Post Induction Therapy by Tx Assignment||11
10894263|NCT00557193|12060115|FG004|STARTED|Post Induction Therapy by Tx Assignment||11
10894264|NCT00557193|12060116|FG005|STARTED|Post Induction Therapy by Tx Assignment||56
10894265|NCT00557193|12060111|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0
10894266|NCT00557193|12060112|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||50
10894267|NCT00557193|12060113|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||22
10894268|NCT00557193|12060114|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||4
10894269|NCT00557193|12060115|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||4
10894270|NCT00557193|12060116|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||19
10894271|NCT00557193|12060111|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
10894272|NCT00557193|12060112|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
10894273|NCT00557193|12060113|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
10894274|NCT00557193|12060114|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
10894275|NCT00557193|12060115|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
10894276|NCT00557193|12060116|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
10894277|NCT00556374|12060143|FG000|STARTED|Overall Study||1709
10894278|NCT00556374|12060144|FG001|STARTED|Overall Study||1711
10894279|NCT00556374|12060143|FG000|Received Study Drug|Overall Study||1699
10894280|NCT00556374|12060144|FG001|Received Study Drug|Overall Study||1700
10894281|NCT00556374|12060143|FG000|COMPLETED|Overall Study|Indicates participants continuing study|1462
10894282|NCT00556374|12060144|FG001|COMPLETED|Overall Study|Indicates participants continuing study|1491
10894283|NCT00556374|12060143|FG000|NOT COMPLETED|Overall Study||247
10894284|NCT00556374|12060144|FG001|NOT COMPLETED|Overall Study||220
10894285|NCT00549848|12060153|FG000|STARTED|Overall Study||206
10894286|NCT00549848|12060154|FG001|STARTED|Overall Study||208
10894287|NCT00549848|12060155|FG002|STARTED|Overall Study||184
10894288|NCT00549848|12060153|FG000|COMPLETED|Overall Study||194
10894289|NCT00549848|12060154|FG001|COMPLETED|Overall Study||188
10894290|NCT00549848|12060155|FG002|COMPLETED|Overall Study||133
10894291|NCT00549848|12060153|FG000|NOT COMPLETED|Overall Study||12
10894292|NCT00549848|12060154|FG001|NOT COMPLETED|Overall Study||20
10894293|NCT00549848|12060155|FG002|NOT COMPLETED|Overall Study||51
10894294|NCT00530062|12060171|FG000|STARTED|Overall Study||49
10894295|NCT00530062|12060171|FG000|Received at Least 1 Dose of Study Drug|Overall Study||49
10894296|NCT00530062|12060171|FG000|COMPLETED|Overall Study||49
10894297|NCT00530062|12060171|FG000|NOT COMPLETED|Overall Study||0
10894298|NCT00523341|12060179|FG000|STARTED|Overall Study||2207
10894299|NCT00523341|12060180|FG001|STARTED|Overall Study||2343
10894300|NCT00523341|12060179|FG000|Received Treatment|Overall Study||2206
10894301|NCT00523341|12060180|FG001|Received Treatment|Overall Study||2343
10894302|NCT00523341|12060179|FG000|COMPLETED|Overall Study||1283
10894303|NCT00523341|12060180|FG001|COMPLETED|Overall Study||1343
10894304|NCT00523341|12060179|FG000|NOT COMPLETED|Overall Study||924
10894305|NCT00523341|12060180|FG001|NOT COMPLETED|Overall Study||1000
10894306|NCT00520767|12060186|FG000|STARTED|Overall Study||35
10894307|NCT00520767|12060186|FG000|COMPLETED|Overall Study||33
10894308|NCT00520767|12060186|FG000|NOT COMPLETED|Overall Study||2
10894309|NCT00508820|12060192|FG000|STARTED|Overall Study||168
10894310|NCT00508820|12060193|FG001|STARTED|Overall Study||239
10894311|NCT00508820|12060192|FG000|COMPLETED|Overall Study||113
10894312|NCT00508820|12060193|FG001|COMPLETED|Overall Study||175
10894313|NCT00508820|12060192|FG000|NOT COMPLETED|Overall Study||55
10894314|NCT00508820|12060193|FG001|NOT COMPLETED|Overall Study||64
10894315|NCT00493467|12060199|FG000|STARTED|Overall Study||31
10894316|NCT00493467|12060199|FG000|COMPLETED|Overall Study||30
10894317|NCT00493467|12060199|FG000|NOT COMPLETED|Overall Study||1
10894318|NCT00486889|12060203|FG000|STARTED|Overall Study||12
10894319|NCT00486889|12060203|FG000|COMPLETED|Overall Study||1
10894320|NCT00486889|12060203|FG000|NOT COMPLETED|Overall Study||11
10894321|NCT00472212|12060209|FG000|STARTED|Overall Study||31
10894322|NCT00472212|12060210|FG001|STARTED|Overall Study||27
10894323|NCT00472212|12060209|FG000|COMPLETED|Overall Study||25
10894324|NCT00472212|12060210|FG001|COMPLETED|Overall Study||23
10894325|NCT00472212|12060209|FG000|NOT COMPLETED|Overall Study||6
10894326|NCT00472212|12060210|FG001|NOT COMPLETED|Overall Study||4
10894327|NCT00470704|12060218|FG000|STARTED|Overall Study||41
10894328|NCT00470704|12060219|FG001|STARTED|Overall Study||46
10894329|NCT00470704|12060218|FG000|Safety Population|Overall Study||41
10894330|NCT00470704|12060219|FG001|Safety Population|Overall Study||45
10894331|NCT00470704|12060218|FG000|Treated|Overall Study||40
10894332|NCT00470704|12060219|FG001|Treated|Overall Study||45
10894333|NCT00470704|12060218|FG000|COMPLETED|Overall Study||0
10894334|NCT00470704|12060219|FG001|COMPLETED|Overall Study||0
10894335|NCT00470704|12060218|FG000|NOT COMPLETED|Overall Study||41
10894336|NCT00470704|12060219|FG001|NOT COMPLETED|Overall Study||46
10894337|NCT00468715|12060225|FG000|STARTED|Overall Study||28
10894338|NCT00468715|12060225|FG000|COMPLETED|Overall Study||28
10894339|NCT00468715|12060225|FG000|NOT COMPLETED|Overall Study||0
10894340|NCT00436566|12060229|FG000|STARTED|Overall Study||112
10894341|NCT00436566|12060229|FG000|COMPLETED|Overall Study||109
10894342|NCT00436566|12060229|FG000|NOT COMPLETED|Overall Study||3
10894343|NCT00433511|12060236|FG000|STARTED|Step 1||1000
10894344|NCT00433511|12060237|FG001|STARTED|Step 1||1986
10894345|NCT00433511|12060238|FG002|STARTED|Step 1||2008
10894346|NCT00433511|12060236|FG000|Patients Who Received Treatment|Step 1||972
10894347|NCT00433511|12060237|FG001|Patients Who Received Treatment|Step 1||1922
10894348|NCT00433511|12060238|FG002|Patients Who Received Treatment|Step 1||1942
10894349|NCT00433511|12060236|FG000|Patients in Genetic Ancestry Analysis|Step 1||575
10894350|NCT00433511|12060237|FG001|Patients in Genetic Ancestry Analysis|Step 1||1126
10894351|NCT00433511|12060238|FG002|Patients in Genetic Ancestry Analysis|Step 1||1158
10894352|NCT00433511|12060236|FG000|COMPLETED|Step 1||864
10894353|NCT00433511|12060237|FG001|COMPLETED|Step 1||1601
10894354|NCT00433511|12060238|FG002|COMPLETED|Step 1||1618
10894355|NCT00433511|12060236|FG000|NOT COMPLETED|Step 1||136
10894356|NCT00433511|12060237|FG001|NOT COMPLETED|Step 1||385
10894357|NCT00433511|12060238|FG002|NOT COMPLETED|Step 1||390
10894358|NCT00433511|12060236|FG000|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
10894359|NCT00433511|12060237|FG001|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
10894360|NCT00433511|12060238|FG002|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316
10894361|NCT00433511|12060236|FG000|Patients Who Received Treatment|Step 2 (Arm D)||0
10894362|NCT00433511|12060237|FG001|Patients Who Received Treatment|Step 2 (Arm D)||0
10894363|NCT00433511|12060238|FG002|Patients Who Received Treatment|Step 2 (Arm D)||1168
10894364|NCT00433511|12060236|FG000|COMPLETED|Step 2 (Arm D)||0
10894365|NCT00433511|12060237|FG001|COMPLETED|Step 2 (Arm D)||0
10894366|NCT00433511|12060238|FG002|COMPLETED|Step 2 (Arm D)||825
10894367|NCT00433511|12060236|FG000|NOT COMPLETED|Step 2 (Arm D)||0
10894368|NCT00433511|12060237|FG001|NOT COMPLETED|Step 2 (Arm D)||0
10894369|NCT00433511|12060238|FG002|NOT COMPLETED|Step 2 (Arm D)||491
10894370|NCT00432965|12060251|FG000|STARTED|Overall Study||169
10894371|NCT00432965|12060252|FG001|STARTED|Overall Study||166
10894372|NCT00432965|12060251|FG000|COMPLETED|Overall Study||75
10894373|NCT00432965|12060252|FG001|COMPLETED|Overall Study||80
10894374|NCT00432965|12060251|FG000|NOT COMPLETED|Overall Study||94
10894375|NCT00432965|12060252|FG001|NOT COMPLETED|Overall Study||86
10894376|NCT00415532|12060260|FG000|STARTED|Treatment Period||77
10894377|NCT00415532|12060261|FG001|STARTED|Treatment Period||157
10894378|NCT00415532|12060260|FG000|Received Treatment|Treatment Period||75
10894379|NCT00415532|12060261|FG001|Received Treatment|Treatment Period||154
10894380|NCT00415532|12060260|FG000|Switched to Romiplostim Group|Treatment Period||2
10894381|NCT00415532|12060261|FG001|Switched to Romiplostim Group|Treatment Period||0
10894382|NCT00415532|12060260|FG000|COMPLETED|Treatment Period||60
10894383|NCT00415532|12060261|FG001|COMPLETED|Treatment Period||142
10894384|NCT00415532|12060260|FG000|NOT COMPLETED|Treatment Period||17
10894385|NCT00415532|12060261|FG001|NOT COMPLETED|Treatment Period||15
10894386|NCT00415532|12060260|FG000|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
10894387|NCT00415532|12060261|FG001|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
10894388|NCT00415532|12060260|FG000|COMPLETED|Safety Follow Up Period||34
10894389|NCT00415532|12060261|FG001|COMPLETED|Safety Follow Up Period||18
10894390|NCT00415532|12060260|FG000|NOT COMPLETED|Safety Follow Up Period||9
10894391|NCT00415532|12060261|FG001|NOT COMPLETED|Safety Follow Up Period||12
10894392|NCT00408005|12060269|FG000|STARTED|Induction||1596
10894393|NCT00408005|12060270|FG001|STARTED|Induction||299
10894394|NCT00408005|12060271|FG002|STARTED|Induction||0
10894395|NCT00408005|12060272|FG003|STARTED|Induction||0
10894396|NCT00408005|12060273|FG004|STARTED|Induction||0
10894397|NCT00408005|12060274|FG005|STARTED|Induction||0
10894398|NCT00408005|12060275|FG006|STARTED|Induction||0
10894399|NCT00408005|12060276|FG007|STARTED|Induction||0
10894400|NCT00408005|12060269|FG000|COMPLETED|Induction||1189
10894401|NCT00408005|12060270|FG001|COMPLETED|Induction||205
10894402|NCT00408005|12060271|FG002|COMPLETED|Induction||0
10894403|NCT00408005|12060272|FG003|COMPLETED|Induction||0
10894404|NCT00408005|12060273|FG004|COMPLETED|Induction||0
10894405|NCT00408005|12060274|FG005|COMPLETED|Induction||0
10894406|NCT00408005|12060275|FG006|COMPLETED|Induction||0
10894407|NCT00408005|12060276|FG007|COMPLETED|Induction||0
10894408|NCT00408005|12060269|FG000|NOT COMPLETED|Induction||407
10894409|NCT00408005|12060270|FG001|NOT COMPLETED|Induction||94
10894410|NCT00408005|12060271|FG002|NOT COMPLETED|Induction||0
10894411|NCT00408005|12060272|FG003|NOT COMPLETED|Induction||0
10894412|NCT00408005|12060273|FG004|NOT COMPLETED|Induction||0
10894413|NCT00408005|12060274|FG005|NOT COMPLETED|Induction||0
10894414|NCT00408005|12060275|FG006|NOT COMPLETED|Induction||0
10894415|NCT00408005|12060276|FG007|NOT COMPLETED|Induction||0
10894416|NCT00408005|12060269|FG000|STARTED|Post Induction Therapy by Tx Assignment||0
10894417|NCT00408005|12060270|FG001|STARTED|Post Induction Therapy by Tx Assignment||0
10894418|NCT00408005|12060271|FG002|STARTED|Post Induction Therapy by Tx Assignment||372
10894419|NCT00408005|12060272|FG003|STARTED|Post Induction Therapy by Tx Assignment||147
10894420|NCT00408005|12060273|FG004|STARTED|Post Induction Therapy by Tx Assignment||451
10894421|NCT00408005|12060274|FG005|STARTED|Post Induction Therapy by Tx Assignment||219
10894422|NCT00408005|12060275|FG006|STARTED|Post Induction Therapy by Tx Assignment||143
10894423|NCT00408005|12060276|FG007|STARTED|Post Induction Therapy by Tx Assignment||62
10894424|NCT00408005|12060269|FG000|Low Risk|Post Induction Therapy by Tx Assignment||0
10894425|NCT00408005|12060270|FG001|Low Risk|Post Induction Therapy by Tx Assignment||0
10894426|NCT00408005|12060271|FG002|Low Risk|Post Induction Therapy by Tx Assignment||217
10894427|NCT00408005|12060272|FG003|Low Risk|Post Induction Therapy by Tx Assignment||0
10894428|NCT00408005|12060273|FG004|Low Risk|Post Induction Therapy by Tx Assignment||55
10894429|NCT00408005|12060274|FG005|Low Risk|Post Induction Therapy by Tx Assignment||0
10894430|NCT00408005|12060275|FG006|Low Risk|Post Induction Therapy by Tx Assignment||0
10894431|NCT00408005|12060276|FG007|Low Risk|Post Induction Therapy by Tx Assignment||0
10894432|NCT00408005|12060269|FG000|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
10894433|NCT00408005|12060270|FG001|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
10894434|NCT00408005|12060271|FG002|Intermediate Risk|Post Induction Therapy by Tx Assignment||99
10894435|NCT00408005|12060272|FG003|Intermediate Risk|Post Induction Therapy by Tx Assignment||95
10894436|NCT00408005|12060273|FG004|Intermediate Risk|Post Induction Therapy by Tx Assignment||257
10894437|NCT00408005|12060274|FG005|Intermediate Risk|Post Induction Therapy by Tx Assignment||93
10894438|NCT00408005|12060275|FG006|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
10894439|NCT00408005|12060276|FG007|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
10894440|NCT00408005|12060269|FG000|High Risk|Post Induction Therapy by Tx Assignment||0
10894441|NCT00408005|12060270|FG001|High Risk|Post Induction Therapy by Tx Assignment||0
10894442|NCT00408005|12060271|FG002|High Risk|Post Induction Therapy by Tx Assignment||56
10894443|NCT00408005|12060272|FG003|High Risk|Post Induction Therapy by Tx Assignment||52
10894444|NCT00408005|12060273|FG004|High Risk|Post Induction Therapy by Tx Assignment||55
10894445|NCT00408005|12060274|FG005|High Risk|Post Induction Therapy by Tx Assignment||52
10894446|NCT00408005|12060275|FG006|High Risk|Post Induction Therapy by Tx Assignment||0
10894447|NCT00408005|12060276|FG007|High Risk|Post Induction Therapy by Tx Assignment||0
10894448|NCT00408005|12060269|FG000|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10894449|NCT00408005|12060270|FG001|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10894450|NCT00408005|12060271|FG002|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10894451|NCT00408005|12060272|FG003|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10894452|NCT00408005|12060273|FG004|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84
10894453|NCT00408005|12060274|FG005|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31
10894454|NCT00408005|12060275|FG006|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10894455|NCT00408005|12060276|FG007|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
10894456|NCT00408005|12060269|FG000|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10894457|NCT00408005|12060270|FG001|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10894458|NCT00408005|12060271|FG002|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10894459|NCT00408005|12060272|FG003|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10894460|NCT00408005|12060273|FG004|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10894461|NCT00408005|12060274|FG005|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43
10894462|NCT00408005|12060275|FG006|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10894463|NCT00408005|12060276|FG007|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
10894464|NCT00408005|12060269|FG000|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10894465|NCT00408005|12060270|FG001|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10894466|NCT00408005|12060271|FG002|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10894467|NCT00408005|12060272|FG003|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10894468|NCT00408005|12060273|FG004|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10894469|NCT00408005|12060274|FG005|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10894470|NCT00408005|12060275|FG006|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82
10894471|NCT00408005|12060276|FG007|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
10894472|NCT00408005|12060269|FG000|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10894473|NCT00408005|12060270|FG001|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10894474|NCT00408005|12060271|FG002|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10894475|NCT00408005|12060272|FG003|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10894476|NCT00408005|12060273|FG004|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10894477|NCT00408005|12060274|FG005|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
10894478|NCT00408005|12060275|FG006|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61
10894479|NCT00408005|12060276|FG007|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60
10894480|NCT00408005|12060269|FG000|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10894481|NCT00408005|12060270|FG001|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10894482|NCT00408005|12060271|FG002|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10894483|NCT00408005|12060272|FG003|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10894484|NCT00408005|12060273|FG004|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10894485|NCT00408005|12060274|FG005|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10894486|NCT00408005|12060275|FG006|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
10894487|NCT00408005|12060276|FG007|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2
10894488|NCT00408005|12060269|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0
10894489|NCT00408005|12060270|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||0
10894490|NCT00408005|12060271|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||287
10894491|NCT00408005|12060272|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||103
10894492|NCT00408005|12060273|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||319
10894493|NCT00408005|12060274|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||118
10894494|NCT00408005|12060275|FG006|COMPLETED|Post Induction Therapy by Tx Assignment||115
10894495|NCT00408005|12060276|FG007|COMPLETED|Post Induction Therapy by Tx Assignment||48
10894496|NCT00408005|12060269|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
10894497|NCT00408005|12060270|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
10894498|NCT00408005|12060271|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85
10894499|NCT00408005|12060272|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44
10894500|NCT00408005|12060273|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132
10894501|NCT00408005|12060274|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101
10894502|NCT00408005|12060275|FG006|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28
10894503|NCT00408005|12060276|FG007|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14
10894504|NCT00394147|12060296|FG000|STARTED|Overall Study||17
10894505|NCT00394147|12060296|FG000|COMPLETED|Overall Study||17
10894506|NCT00394147|12060296|FG000|NOT COMPLETED|Overall Study||0
10894507|NCT00389610|12060302|FG000|STARTED|Overall Study||11
10894508|NCT00389610|12060303|FG001|STARTED|Overall Study||45
10894509|NCT00389610|12060302|FG000|COMPLETED|Overall Study||11
10894510|NCT00389610|12060303|FG001|COMPLETED|Overall Study|milestone period is defined as receiving at least one booster vaccine|23
10894511|NCT00389610|12060302|FG000|NOT COMPLETED|Overall Study||0
10894512|NCT00389610|12060303|FG001|NOT COMPLETED|Overall Study||22
10894513|NCT00383708|12060309|FG000|STARTED|Enrolment Through Start Treatment||125
10894514|NCT00383708|12060309|FG000|COMPLETED|Enrolment Through Start Treatment||92
10894515|NCT00383708|12060309|FG000|NOT COMPLETED|Enrolment Through Start Treatment||33
10894516|NCT00383708|12060309|FG000|STARTED|Run-in Period||92
10894517|NCT00383708|12060309|FG000|COMPLETED|Run-in Period||85
10894518|NCT00383708|12060309|FG000|NOT COMPLETED|Run-in Period||7
10894519|NCT00383708|12060309|FG000|STARTED|Co-administration Period||57
10894520|NCT00383708|12060309|FG000|COMPLETED|Co-administration Period||52
10894521|NCT00383708|12060309|FG000|NOT COMPLETED|Co-administration Period||5
10894522|NCT00377156|12060316|FG000|STARTED|Overall Study||111
10894523|NCT00377156|12060317|FG001|STARTED|Overall Study||102
10894524|NCT00377156|12060316|FG000|COMPLETED|Overall Study||63
10894525|NCT00377156|12060317|FG001|COMPLETED|Overall Study||48
10894526|NCT00377156|12060316|FG000|NOT COMPLETED|Overall Study||48
10894527|NCT00377156|12060317|FG001|NOT COMPLETED|Overall Study||54
10894528|NCT00373217|12060327|FG000|STARTED|Overall Study||3
10894529|NCT00373217|12060328|FG001|STARTED|Overall Study||3
10894530|NCT00373217|12060327|FG000|COMPLETED|Overall Study||2
10894531|NCT00373217|12060328|FG001|COMPLETED|Overall Study||3
10894532|NCT00373217|12060327|FG000|NOT COMPLETED|Overall Study||1
10894533|NCT00373217|12060328|FG001|NOT COMPLETED|Overall Study||0
10894534|NCT00364013|12060336|FG000|STARTED|Overall Study||593
10894535|NCT00364013|12060337|FG001|STARTED|Overall Study||590
10894536|NCT00364013|12060336|FG000|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
10894537|NCT00364013|12060337|FG001|Received Study Drug|Overall Study||583
10894538|NCT00364013|12060336|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
10894539|NCT00364013|12060337|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
10894540|NCT00364013|12060336|FG000|NOT COMPLETED|Overall Study||101
10894541|NCT00364013|12060337|FG001|NOT COMPLETED|Overall Study||95
10894542|NCT00345839|12060349|FG000|STARTED|Overall Study|Randomized to cinacalcet|1948
10894543|NCT00345839|12060350|FG001|STARTED|Overall Study|Randomized to placebo|1935
10894544|NCT00345839|12060349|FG000|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
10894545|NCT00345839|12060350|FG001|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
10894546|NCT00345839|12060349|FG000|NOT COMPLETED|Overall Study||149
10894547|NCT00345839|12060350|FG001|NOT COMPLETED|Overall Study||159
10894548|NCT00339183|12060358|FG000|STARTED|Overall Study||591
10894549|NCT00339183|12060359|FG001|STARTED|Overall Study||595
10894550|NCT00339183|12060358|FG000|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
10894551|NCT00339183|12060359|FG001|Received Study Drug|Overall Study||593
10894552|NCT00339183|12060358|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
10894638|NCT00278915|12060448|FG000|COMPLETED|Overall Study||29
10894553|NCT00339183|12060359|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
10894554|NCT00339183|12060358|FG000|NOT COMPLETED|Overall Study||121
10894555|NCT00339183|12060359|FG001|NOT COMPLETED|Overall Study||105
10894556|NCT00332605|12060372|FG000|STARTED|Overall Study||14
10894557|NCT00332605|12060373|FG001|STARTED|Overall Study||14
10894558|NCT00332605|12060374|FG002|STARTED|Overall Study||17
10894559|NCT00332605|12060372|FG000|COMPLETED|Overall Study||12
10894560|NCT00332605|12060373|FG001|COMPLETED|Overall Study||12
10894561|NCT00332605|12060374|FG002|COMPLETED|Overall Study||9
10894562|NCT00332605|12060372|FG000|NOT COMPLETED|Overall Study||2
10894563|NCT00332605|12060373|FG001|NOT COMPLETED|Overall Study||2
10894564|NCT00332605|12060374|FG002|NOT COMPLETED|Overall Study||8
10894565|NCT00326625|12060384|FG000|STARTED|Overall Study||184
10894566|NCT00326625|12060385|FG001|STARTED|Overall Study||182
10894567|NCT00326625|12060384|FG000|COMPLETED|Overall Study||130
10894568|NCT00326625|12060385|FG001|COMPLETED|Overall Study||144
10894569|NCT00326625|12060384|FG000|NOT COMPLETED|Overall Study||54
10894570|NCT00326625|12060385|FG001|NOT COMPLETED|Overall Study||38
10894571|NCT00324805|12060393|FG000|STARTED|Overall Study||749
10894572|NCT00324805|12060394|FG001|STARTED|Overall Study||752
10894573|NCT00324805|12060393|FG000|Started Assigned Therapy|Overall Study||737
10894574|NCT00324805|12060394|FG001|Started Assigned Therapy|Overall Study||735
10894575|NCT00324805|12060393|FG000|COMPLETED|Overall Study||599
10894576|NCT00324805|12060394|FG001|COMPLETED|Overall Study||269
10894577|NCT00324805|12060393|FG000|NOT COMPLETED|Overall Study||150
10894578|NCT00324805|12060394|FG001|NOT COMPLETED|Overall Study||483
10894579|NCT00323063|12060402|FG000|STARTED|Overall Study||26
10894580|NCT00323063|12060403|FG001|STARTED|Overall Study||23
10894581|NCT00323063|12060402|FG000|COMPLETED|Overall Study||24
10894582|NCT00323063|12060403|FG001|COMPLETED|Overall Study||23
10894583|NCT00323063|12060402|FG000|NOT COMPLETED|Overall Study||2
10894584|NCT00323063|12060403|FG001|NOT COMPLETED|Overall Study||0
10894585|NCT00310180|12060413|FG000|STARTED|Overall Study||1629
10894586|NCT00310180|12060414|FG001|STARTED|Overall Study||3458
10894587|NCT00310180|12060415|FG002|STARTED|Overall Study||3449
10894588|NCT00310180|12060416|FG003|STARTED|Overall Study||1737
10894589|NCT00310180|12060413|FG000|No On-study Data|Overall Study||0
10894590|NCT00310180|12060414|FG001|No On-study Data|Overall Study||2
10894591|NCT00310180|12060415|FG002|No On-study Data|Overall Study||10
10894592|NCT00310180|12060416|FG003|No On-study Data|Overall Study||172
10894593|NCT00310180|12060413|FG000|Ineligible|Overall Study||3
10894594|NCT00310180|12060414|FG001|Ineligible|Overall Study||4
10894595|NCT00310180|12060415|FG002|Ineligible|Overall Study||6
10894596|NCT00310180|12060416|FG003|Ineligible|Overall Study||7
10894597|NCT00310180|12060413|FG000|No Follow-up Data|Overall Study||7
10894598|NCT00310180|12060414|FG001|No Follow-up Data|Overall Study||55
10894599|NCT00310180|12060415|FG002|No Follow-up Data|Overall Study||131
10894600|NCT00310180|12060416|FG003|No Follow-up Data|Overall Study||245
10894601|NCT00310180|12060413|FG000|COMPLETED|Overall Study||1619
10894602|NCT00310180|12060414|FG001|COMPLETED|Overall Study||3399
10894603|NCT00310180|12060415|FG002|COMPLETED|Overall Study||3312
10894604|NCT00310180|12060416|FG003|COMPLETED|Overall Study||1389
10894605|NCT00310180|12060413|FG000|NOT COMPLETED|Overall Study||10
10894606|NCT00310180|12060414|FG001|NOT COMPLETED|Overall Study||59
10894607|NCT00310180|12060415|FG002|NOT COMPLETED|Overall Study||137
10894608|NCT00310180|12060416|FG003|NOT COMPLETED|Overall Study||348
10894609|NCT00302952|12060428|FG000|STARTED|Overall Study||34
10894610|NCT00302952|12060429|FG001|STARTED|Overall Study||30
10894611|NCT00302952|12060428|FG000|Started Intent-to-Treat (ITT)|Overall Study||34
10894612|NCT00302952|12060429|FG001|Started Intent-to-Treat (ITT)|Overall Study||30
10894613|NCT00302952|12060428|FG000|Completed Intent-to-Treat (ITT)|Overall Study||34
10894614|NCT00302952|12060429|FG001|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
10894615|NCT00302952|12060428|FG000|COMPLETED|Overall Study||31
10894616|NCT00302952|12060429|FG001|COMPLETED|Overall Study||25
10894617|NCT00302952|12060428|FG000|NOT COMPLETED|Overall Study||3
10894618|NCT00302952|12060429|FG001|NOT COMPLETED|Overall Study||5
10894619|NCT00289094|12060437|FG000|STARTED|Overall Study||50
10894620|NCT00289094|12060438|FG001|STARTED|Overall Study||49
10894621|NCT00289094|12060437|FG000|COMPLETED|Overall Study||3
10894622|NCT00289094|12060438|FG001|COMPLETED|Overall Study||2
10894623|NCT00289094|12060437|FG000|NOT COMPLETED|Overall Study||47
10894624|NCT00289094|12060438|FG001|NOT COMPLETED|Overall Study||47
10894625|NCT00288509|12060444|FG000|STARTED|Treatment Cycle 1||108
10894626|NCT00288509|12060444|FG000|COMPLETED|Treatment Cycle 1||102
10894627|NCT00288509|12060444|FG000|NOT COMPLETED|Treatment Cycle 1||6
10894628|NCT00288509|12060444|FG000|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
10894629|NCT00288509|12060444|FG000|COMPLETED|Treatment Cycle 2||97
10894630|NCT00288509|12060444|FG000|NOT COMPLETED|Treatment Cycle 2||3
10894631|NCT00288509|12060444|FG000|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
10894632|NCT00288509|12060444|FG000|COMPLETED|Treatment Cycle 3||91
10894633|NCT00288509|12060444|FG000|NOT COMPLETED|Treatment Cycle 3||5
10894634|NCT00288509|12060444|FG000|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
10894635|NCT00288509|12060444|FG000|COMPLETED|Treatment Cycle 4||80
10894636|NCT00288509|12060444|FG000|NOT COMPLETED|Treatment Cycle 4||8
10894637|NCT00278915|12060448|FG000|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
10894639|NCT00278915|12060448|FG000|NOT COMPLETED|Overall Study||1
10894640|NCT00257660|12060454|FG000|STARTED|Overall Study||55
10894641|NCT00257660|12060455|FG001|STARTED|Overall Study||61
10894642|NCT00257660|12060454|FG000|COMPLETED|Overall Study||45
10894643|NCT00257660|12060455|FG001|COMPLETED|Overall Study||38
10894644|NCT00257660|12060454|FG000|NOT COMPLETED|Overall Study||10
10894645|NCT00257660|12060455|FG001|NOT COMPLETED|Overall Study||23
10894646|NCT00136695|12060463|FG000|STARTED|Overall Study||45
10894647|NCT00136695|12060464|FG001|STARTED|Overall Study||43
10894648|NCT00136695|12060463|FG000|COMPLETED|Overall Study||34
10894649|NCT00136695|12060464|FG001|COMPLETED|Overall Study||35
10894650|NCT00136695|12060463|FG000|NOT COMPLETED|Overall Study||11
10894651|NCT00136695|12060464|FG001|NOT COMPLETED|Overall Study||8
10894652|NCT00127127|12060474|FG000|STARTED|Overall Study||3
10894653|NCT00127127|12060475|FG001|STARTED|Overall Study||6
10894654|NCT00127127|12060476|FG002|STARTED|Overall Study||3
10894655|NCT00127127|12060477|FG003|STARTED|Overall Study||6
10894656|NCT00127127|12060474|FG000|COMPLETED|Overall Study||2
10894657|NCT00127127|12060475|FG001|COMPLETED|Overall Study||1
10894658|NCT00127127|12060476|FG002|COMPLETED|Overall Study||3
10894659|NCT00127127|12060477|FG003|COMPLETED|Overall Study||3
10894660|NCT00127127|12060474|FG000|NOT COMPLETED|Overall Study||1
10894661|NCT00127127|12060475|FG001|NOT COMPLETED|Overall Study||5
10894662|NCT00127127|12060476|FG002|NOT COMPLETED|Overall Study||0
10894663|NCT00127127|12060477|FG003|NOT COMPLETED|Overall Study||3
10894664|NCT00119366|12060519|FG000|STARTED|Overall Study||1
10894665|NCT00119366|12060520|FG001|STARTED|Overall Study||2
10894666|NCT00119366|12060521|FG002|STARTED|Overall Study||3
10894667|NCT00119366|12060522|FG003|STARTED|Overall Study||2
10894668|NCT00119366|12060523|FG004|STARTED|Overall Study||8
10894669|NCT00119366|12060519|FG000|COMPLETED|Overall Study||1
10894670|NCT00119366|12060520|FG001|COMPLETED|Overall Study||2
10894671|NCT00119366|12060521|FG002|COMPLETED|Overall Study||3
10894672|NCT00119366|12060522|FG003|COMPLETED|Overall Study||2
10894673|NCT00119366|12060523|FG004|COMPLETED|Overall Study||8
10894674|NCT00119366|12060519|FG000|NOT COMPLETED|Overall Study||0
10894675|NCT00119366|12060520|FG001|NOT COMPLETED|Overall Study||0
10894676|NCT00119366|12060521|FG002|NOT COMPLETED|Overall Study||0
10894677|NCT00119366|12060522|FG003|NOT COMPLETED|Overall Study||0
10894678|NCT00119366|12060523|FG004|NOT COMPLETED|Overall Study||0
10894679|NCT00114101|12060545|FG000|STARTED|Overall Study||231
10894680|NCT00114101|12060546|FG001|STARTED|Overall Study||229
10894681|NCT00114101|12060545|FG000|COMPLETED|Overall Study||231
10894682|NCT00114101|12060546|FG001|COMPLETED|Overall Study||229
10894683|NCT00114101|12060545|FG000|NOT COMPLETED|Overall Study||0
10894684|NCT00114101|12060546|FG001|NOT COMPLETED|Overall Study||0
10894685|NCT00113763|12060556|FG000|STARTED|Overall Study||231
10894686|NCT00113763|12060557|FG001|STARTED|Overall Study||232
10894687|NCT00113763|12060556|FG000|Received Study Drug|Overall Study||229
10894688|NCT00113763|12060557|FG001|Received Study Drug|Overall Study||0
10894689|NCT00113763|12060556|FG000|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
10894690|NCT00113763|12060557|FG001|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
10894691|NCT00113763|12060556|FG000|NOT COMPLETED|Overall Study||73
10894692|NCT00113763|12060557|FG001|NOT COMPLETED|Overall Study||26
10894693|NCT00101101|12060564|FG000|STARTED|Overall Study||43
10894694|NCT00101101|12060564|FG000|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
10894695|NCT00101101|12060564|FG000|NOT COMPLETED|Overall Study||20
10894696|NCT00099437|12060570|FG000|STARTED|Overall Study|randomised patients|374
10894697|NCT00099437|12060571|FG001|STARTED|Overall Study|randomised patients|362
10894698|NCT00099437|12060570|FG000|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
10894699|NCT00099437|12060571|FG001|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
10894700|NCT00099437|12060570|FG000|NOT COMPLETED|Overall Study||366
10894701|NCT00099437|12060571|FG001|NOT COMPLETED|Overall Study||349
10894702|NCT00098475|12060579|FG000|STARTED|Step 1||223
10894703|NCT00098475|12060580|FG001|STARTED|Step 1||222
10894704|NCT00098475|12060581|FG002|STARTED|Step 1||4
10894705|NCT00098475|12060582|FG003|STARTED|Step 1||3
10894706|NCT00098475|12060579|FG000|Treated|Step 1||223
10894707|NCT00098475|12060580|FG001|Treated|Step 1||220
10894708|NCT00098475|12060581|FG002|Treated|Step 1||4
10894709|NCT00098475|12060582|FG003|Treated|Step 1||3
10894710|NCT00098475|12060579|FG000|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
10894711|NCT00098475|12060580|FG001|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
10894712|NCT00098475|12060581|FG002|Eligible|Step 1||4
10894713|NCT00098475|12060582|FG003|Eligible|Step 1||3
10894714|NCT00098475|12060579|FG000|COMPLETED|Step 1||52
10894715|NCT00098475|12060580|FG001|COMPLETED|Step 1||49
10894716|NCT00098475|12060581|FG002|COMPLETED|Step 1||0
10894717|NCT00098475|12060582|FG003|COMPLETED|Step 1||0
10894718|NCT00098475|12060579|FG000|NOT COMPLETED|Step 1||171
10894719|NCT00098475|12060580|FG001|NOT COMPLETED|Step 1||173
10894720|NCT00098475|12060581|FG002|NOT COMPLETED|Step 1||4
10894721|NCT00098475|12060582|FG003|NOT COMPLETED|Step 1||3
10894722|NCT00098475|12060579|FG000|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
10894723|NCT00098475|12060580|FG001|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
10894724|NCT00098475|12060581|FG002|STARTED|Step 2||0
10894725|NCT00098475|12060582|FG003|STARTED|Step 2||0
10894726|NCT00098475|12060579|FG000|Treated|Step 2||4
10894727|NCT00098475|12060580|FG001|Treated|Step 2||14
10894728|NCT00098475|12060581|FG002|Treated|Step 2||0
10894729|NCT00098475|12060582|FG003|Treated|Step 2||0
10894730|NCT00098475|12060579|FG000|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
10894731|NCT00098475|12060580|FG001|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
10894732|NCT00098475|12060581|FG002|Eligible|Step 2||0
10894733|NCT00098475|12060582|FG003|Eligible|Step 2||0
10894734|NCT00098475|12060579|FG000|COMPLETED|Step 2||0
10894735|NCT00098475|12060580|FG001|COMPLETED|Step 2||5
10894736|NCT00098475|12060581|FG002|COMPLETED|Step 2||0
10894737|NCT00098475|12060582|FG003|COMPLETED|Step 2||0
10894738|NCT00098475|12060579|FG000|NOT COMPLETED|Step 2||5
10894739|NCT00098475|12060580|FG001|NOT COMPLETED|Step 2||10
10894740|NCT00098475|12060581|FG002|NOT COMPLETED|Step 2||0
10894741|NCT00098475|12060582|FG003|NOT COMPLETED|Step 2||0
10894742|NCT00093015|12060594|FG000|STARTED|Overall Study||2026
10894743|NCT00093015|12060595|FG001|STARTED|Overall Study||2012
10894744|NCT00093015|12060594|FG000|Received Study Medication|Overall Study||2019
10894745|NCT00093015|12060595|FG001|Received Study Medication|Overall Study||2004
10894746|NCT00093015|12060594|FG000|COMPLETED|Overall Study||1361
10894747|NCT00093015|12060595|FG001|COMPLETED|Overall Study||1348
10894748|NCT00093015|12060594|FG000|NOT COMPLETED|Overall Study||665
10894749|NCT00093015|12060595|FG001|NOT COMPLETED|Overall Study||664
10894750|NCT00092534|12060603|FG000|STARTED|Base Study Vaccination Period||6087
10894751|NCT00092534|12060604|FG001|STARTED|Base Study Vaccination Period||6080
10894752|NCT00092534|12060605|FG002|STARTED|Base Study Vaccination Period||0
10894753|NCT00092534|12060606|FG003|STARTED|Base Study Vaccination Period||0
10894754|NCT00092534|12060607|FG004|STARTED|Base Study Vaccination Period||0
10894755|NCT00092534|12060603|FG000|COMPLETED|Base Study Vaccination Period||5916
10894756|NCT00092534|12060604|FG001|COMPLETED|Base Study Vaccination Period||5954
10894757|NCT00092534|12060605|FG002|COMPLETED|Base Study Vaccination Period||0
10894758|NCT00092534|12060606|FG003|COMPLETED|Base Study Vaccination Period||0
10894759|NCT00092534|12060607|FG004|COMPLETED|Base Study Vaccination Period||0
10894760|NCT00092534|12060603|FG000|NOT COMPLETED|Base Study Vaccination Period||171
10894761|NCT00092534|12060604|FG001|NOT COMPLETED|Base Study Vaccination Period||126
10894762|NCT00092534|12060605|FG002|NOT COMPLETED|Base Study Vaccination Period||0
10894763|NCT00092534|12060606|FG003|NOT COMPLETED|Base Study Vaccination Period||0
10894764|NCT00092534|12060607|FG004|NOT COMPLETED|Base Study Vaccination Period||0
10894765|NCT00092534|12060603|FG000|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
10894766|NCT00092534|12060604|FG001|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
10894767|NCT00092534|12060605|FG002|STARTED|Base Study Follow-Up Period||0
10894768|NCT00092534|12060606|FG003|STARTED|Base Study Follow-Up Period||0
10894769|NCT00092534|12060607|FG004|STARTED|Base Study Follow-Up Period||0
10894770|NCT00092534|12060603|FG000|COMPLETED|Base Study Follow-Up Period||5626
10894771|NCT00092534|12060604|FG001|COMPLETED|Base Study Follow-Up Period||5277
10894772|NCT00092534|12060605|FG002|COMPLETED|Base Study Follow-Up Period||0
10894773|NCT00092534|12060606|FG003|COMPLETED|Base Study Follow-Up Period||0
10894774|NCT00092534|12060607|FG004|COMPLETED|Base Study Follow-Up Period||0
10894775|NCT00092534|12060603|FG000|NOT COMPLETED|Base Study Follow-Up Period||316
10894776|NCT00092534|12060604|FG001|NOT COMPLETED|Base Study Follow-Up Period||694
10894777|NCT00092534|12060605|FG002|NOT COMPLETED|Base Study Follow-Up Period||0
10894778|NCT00092534|12060606|FG003|NOT COMPLETED|Base Study Follow-Up Period||0
10894779|NCT00092534|12060607|FG004|NOT COMPLETED|Base Study Follow-Up Period||0
10894780|NCT00092534|12060603|FG000|STARTED|Base Study EXT||0
10894781|NCT00092534|12060604|FG001|STARTED|Base Study EXT||0
10894782|NCT00092534|12060605|FG002|STARTED|Base Study EXT||594
10894783|NCT00092534|12060606|FG003|STARTED|Base Study EXT||0
10894784|NCT00092534|12060607|FG004|STARTED|Base Study EXT||0
10894785|NCT00092534|12060603|FG000|COMPLETED|Base Study EXT||0
10894786|NCT00092534|12060604|FG001|COMPLETED|Base Study EXT||0
10894787|NCT00092534|12060605|FG002|COMPLETED|Base Study EXT||449
10894788|NCT00092534|12060606|FG003|COMPLETED|Base Study EXT||0
10894789|NCT00092534|12060607|FG004|COMPLETED|Base Study EXT||0
10894790|NCT00092534|12060603|FG000|NOT COMPLETED|Base Study EXT||0
10894791|NCT00092534|12060604|FG001|NOT COMPLETED|Base Study EXT||0
10894792|NCT00092534|12060605|FG002|NOT COMPLETED|Base Study EXT||145
10894793|NCT00092534|12060606|FG003|NOT COMPLETED|Base Study EXT||0
10894794|NCT00092534|12060607|FG004|NOT COMPLETED|Base Study EXT||0
10894795|NCT00092534|12060603|FG000|STARTED|Long-Term Follow-Up (LTFU) Study||0
10894796|NCT00092534|12060604|FG001|STARTED|Long-Term Follow-Up (LTFU) Study||0
10894797|NCT00092534|12060605|FG002|STARTED|Long-Term Follow-Up (LTFU) Study||0
10894798|NCT00092534|12060606|FG003|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2750
10894799|NCT00092534|12060607|FG004|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2097
10894800|NCT00092534|12060603|FG000|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
10894801|NCT00092534|12060604|FG001|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
10894802|NCT00092534|12060605|FG002|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
10894803|NCT00092534|12060606|FG003|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650
10894804|NCT00092534|12060607|FG004|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050
10894805|NCT00092534|12060603|FG000|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
10894806|NCT00092534|12060604|FG001|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
10894807|NCT00092534|12060605|FG002|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
10894808|NCT00092534|12060606|FG003|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385
10894809|NCT00092534|12060607|FG004|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849
10894810|NCT00092534|12060603|FG000|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
10894811|NCT00092534|12060604|FG001|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
10894812|NCT00092534|12060605|FG002|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
10894813|NCT00092534|12060606|FG003|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448
10894814|NCT00092534|12060607|FG004|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888
10894815|NCT00092534|12060603|FG000|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
10894816|NCT00092534|12060604|FG001|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
10894817|NCT00092534|12060605|FG002|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
10894818|NCT00092534|12060606|FG003|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749
10894819|NCT00092534|12060607|FG004|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097
10894820|NCT00092534|12060603|FG000|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
10894821|NCT00092534|12060604|FG001|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
10894822|NCT00092534|12060605|FG002|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
10894823|NCT00092534|12060606|FG003|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1
10894824|NCT00092534|12060607|FG004|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
10894825|NCT00089791|12060619|FG000|STARTED|Overall Study||3906
10894826|NCT00089791|12060620|FG001|STARTED|Overall Study||3902
10894827|NCT00089791|12060619|FG000|Received Study Medication|Overall Study||3883
10894828|NCT00089791|12060620|FG001|Received Study Medication|Overall Study||3879
10894829|NCT00089791|12060619|FG000|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
10894830|NCT00089791|12060620|FG001|Safety Analysis Set|Overall Study||3886
10894831|NCT00089791|12060619|FG000|COMPLETED|Overall Study||3206
10894832|NCT00089791|12060620|FG001|COMPLETED|Overall Study||3272
10894833|NCT00089791|12060619|FG000|NOT COMPLETED|Overall Study||700
10894834|NCT00089791|12060620|FG001|NOT COMPLETED|Overall Study||630
10894835|NCT00087178|12060628|FG000|STARTED|Overall Study||1361
10894836|NCT00087178|12060629|FG001|STARTED|Overall Study||1361
10894837|NCT00087178|12060628|FG000|COMPLETED|Overall Study||1355
10894838|NCT00087178|12060629|FG001|COMPLETED|Overall Study||1343
10894839|NCT00087178|12060628|FG000|NOT COMPLETED|Overall Study||6
10894840|NCT00087178|12060629|FG001|NOT COMPLETED|Overall Study||18
10894841|NCT00074412|12060637|FG000|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
10894842|NCT00074412|12060638|FG001|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
10894843|NCT00074412|12060637|FG000|Week 8 Visit|Overall Study||759
10894844|NCT00074412|12060638|FG001|Week 8 Visit|Overall Study||759
10894845|NCT00074412|12060637|FG000|Month 3 Visit|Overall Study||759
10894846|NCT00074412|12060638|FG001|Month 3 Visit|Overall Study||755
10894847|NCT00074412|12060637|FG000|Month 4 Visit|Overall Study||758
10894848|NCT00074412|12060638|FG001|Month 4 Visit|Overall Study||752
10894849|NCT00074412|12060637|FG000|Month 5 Visit|Overall Study||756
10894850|NCT00074412|12060638|FG001|Month 5 Visit|Overall Study||750
10894851|NCT00074412|12060637|FG000|Month 6 Visit|Overall Study||748
10894852|NCT00074412|12060638|FG001|Month 6 Visit|Overall Study||748
10894853|NCT00074412|12060637|FG000|Month 9 Visit|Overall Study||741
10894854|NCT00074412|12060638|FG001|Month 9 Visit|Overall Study||741
10894855|NCT00074412|12060637|FG000|Month 12 Visit|Overall Study||733
10894856|NCT00074412|12060638|FG001|Month 12 Visit|Overall Study||735
10894857|NCT00074412|12060637|FG000|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
10894858|NCT00074412|12060638|FG001|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
10894859|NCT00074412|12060637|FG000|NOT COMPLETED|Overall Study||82
10894860|NCT00074412|12060638|FG001|NOT COMPLETED|Overall Study||84
10894861|NCT00070499|12060649|FG000|STARTED|Overall Study||75
10894862|NCT00070499|12060650|FG001|STARTED|Overall Study||78
10894863|NCT00070499|12060651|FG002|STARTED|Overall Study||126
10894864|NCT00070499|12060652|FG003|STARTED|Overall Study||127
10894865|NCT00070499|12060649|FG000|Eligible|Overall Study||73
10894866|NCT00070499|12060650|FG001|Eligible|Overall Study||73
10894867|NCT00070499|12060651|FG002|Eligible|Overall Study||123
10894868|NCT00070499|12060652|FG003|Eligible|Overall Study||125
10894869|NCT00070499|12060649|FG000|Eligible and Treated|Overall Study||72
10894870|NCT00070499|12060650|FG001|Eligible and Treated|Overall Study||73
10894871|NCT00070499|12060651|FG002|Eligible and Treated|Overall Study||123
10894872|NCT00070499|12060652|FG003|Eligible and Treated|Overall Study||123
10894873|NCT00070499|12060649|FG000|COMPLETED|Overall Study||37
10894874|NCT00070499|12060650|FG001|COMPLETED|Overall Study||52
10894875|NCT00070499|12060651|FG002|COMPLETED|Overall Study||6
10894876|NCT00070499|12060652|FG003|COMPLETED|Overall Study||17
10894877|NCT00070499|12060649|FG000|NOT COMPLETED|Overall Study||38
10894878|NCT00070499|12060650|FG001|NOT COMPLETED|Overall Study||26
10894879|NCT00070499|12060651|FG002|NOT COMPLETED|Overall Study||120
10894880|NCT00070499|12060652|FG003|NOT COMPLETED|Overall Study||110
10894881|NCT00026312|12060672|FG000|STARTED|Overall Study||116
10894882|NCT00026312|12060673|FG001|STARTED|Overall Study||1333
10894883|NCT00026312|12060672|FG000|COMPLETED|Overall Study||82
10894884|NCT00026312|12060673|FG001|COMPLETED|Overall Study||1064
10894885|NCT00026312|12060672|FG000|NOT COMPLETED|Overall Study||34
10894886|NCT00026312|12060673|FG001|NOT COMPLETED|Overall Study||269
10894887|NCT00006721|12060686|FG000|STARTED|Overall Study||17
10894888|NCT00006721|12060687|FG001|STARTED|Overall Study||279
10894889|NCT00006721|12060688|FG002|STARTED|Overall Study||275
10894890|NCT00006721|12060686|FG000|Eligible|Overall Study||15
10894891|NCT00006721|12060687|FG001|Eligible|Overall Study||267
10894892|NCT00006721|12060688|FG002|Eligible|Overall Study||265
10894893|NCT00006721|12060686|FG000|Eligible and Began Protocol Therapy|Overall Study||14
10894894|NCT00006721|12060687|FG001|Eligible and Began Protocol Therapy|Overall Study||267
10894895|NCT00006721|12060688|FG002|Eligible and Began Protocol Therapy|Overall Study||265
10894896|NCT00006721|12060686|FG000|COMPLETED|Overall Study||13
10894897|NCT00006721|12060687|FG001|COMPLETED|Overall Study||254
10894898|NCT00006721|12060688|FG002|COMPLETED|Overall Study||242
10894899|NCT00006721|12060686|FG000|NOT COMPLETED|Overall Study||4
10894900|NCT00006721|12060687|FG001|NOT COMPLETED|Overall Study||25
10894901|NCT00006721|12060688|FG002|NOT COMPLETED|Overall Study||33
10894902|NCT00006436|12060698|FG000|STARTED|Overall Study||68
10894903|NCT00006436|12060698|FG000|COMPLETED|Overall Study||65
10894904|NCT00006436|12060698|FG000|NOT COMPLETED|Overall Study||3
10894905|NCT00002540|12060707|FG000|STARTED|Overall Study||38345
10894906|NCT00002540|12060708|FG001|STARTED|Overall Study||38340
10894907|NCT00002540|12060707|FG000|COMPLETED|Overall Study||37544
10894908|NCT00002540|12060708|FG001|COMPLETED|Overall Study||35876
10894909|NCT00002540|12060707|FG000|NOT COMPLETED|Overall Study||801
10894910|NCT00002540|12060708|FG001|NOT COMPLETED|Overall Study||2464
10894911|NCT04780919|12060716|FG000|STARTED|Overall Study||9
10894912|NCT04780919|12060717|FG001|STARTED|Overall Study||9
10894913|NCT04780919|12060716|FG000|COMPLETED|Overall Study||9
10894914|NCT04780919|12060717|FG001|COMPLETED|Overall Study||9
10894915|NCT04780919|12060716|FG000|NOT COMPLETED|Overall Study||0
10894916|NCT04780919|12060717|FG001|NOT COMPLETED|Overall Study||0
10894917|NCT04779606|12060727|FG000|STARTED|First Phase: Tolerability and Safety||16
10894918|NCT04779606|12060728|FG001|STARTED|First Phase: Tolerability and Safety||4
10894919|NCT04779606|12060727|FG000|COMPLETED|First Phase: Tolerability and Safety||16
10894920|NCT04779606|12060728|FG001|COMPLETED|First Phase: Tolerability and Safety||4
10894921|NCT04779606|12060727|FG000|NOT COMPLETED|First Phase: Tolerability and Safety||0
10894922|NCT04779606|12060728|FG001|NOT COMPLETED|First Phase: Tolerability and Safety||0
10894923|NCT04779606|12060727|FG000|STARTED|Second Phase: Efficacy||68
10894924|NCT04779606|12060728|FG001|STARTED|Second Phase: Efficacy||17
10894925|NCT04779606|12060727|FG000|COMPLETED|Second Phase: Efficacy||68
10894926|NCT04779606|12060728|FG001|COMPLETED|Second Phase: Efficacy||17
10894927|NCT04779606|12060727|FG000|NOT COMPLETED|Second Phase: Efficacy||0
10894928|NCT04779606|12060728|FG001|NOT COMPLETED|Second Phase: Efficacy||0
10894929|NCT04773028|12060736|FG000|STARTED|Overall Study||24
10894930|NCT04773028|12060737|FG001|STARTED|Overall Study||24
10894931|NCT04773028|12060736|FG000|COMPLETED|Overall Study||24
10894932|NCT04773028|12060737|FG001|COMPLETED|Overall Study||24
10894933|NCT04773028|12060736|FG000|NOT COMPLETED|Overall Study||0
10894934|NCT04773028|12060737|FG001|NOT COMPLETED|Overall Study||0
10894935|NCT04755595|12060743|FG000|STARTED|Overall Study||20
10894936|NCT04755595|12060743|FG000|COMPLETED|Overall Study||19
10894937|NCT04755595|12060743|FG000|NOT COMPLETED|Overall Study||1
10894938|NCT04749745|12060748|FG000|STARTED|Overall Study||5
10894939|NCT04749745|12060749|FG001|STARTED|Overall Study||6
10894940|NCT04749745|12060748|FG000|First Intervention|Overall Study||4
10894941|NCT04749745|12060749|FG001|First Intervention|Overall Study||6
10894942|NCT04749745|12060748|FG000|Washout|Overall Study||4
10894943|NCT04749745|12060749|FG001|Washout|Overall Study||6
10894944|NCT04749745|12060748|FG000|Second Intervention|Overall Study||4
10894945|NCT04749745|12060749|FG001|Second Intervention|Overall Study||6
10894946|NCT04749745|12060748|FG000|COMPLETED|Overall Study||4
10894947|NCT04749745|12060749|FG001|COMPLETED|Overall Study||6
10894948|NCT04749745|12060748|FG000|NOT COMPLETED|Overall Study||1
10894949|NCT04749745|12060749|FG001|NOT COMPLETED|Overall Study||0
10894950|NCT04748341|12060757|FG000|STARTED|Overall Study||31
10894951|NCT04748341|12060758|FG001|STARTED|Overall Study||31
10894952|NCT04748341|12060757|FG000|COMPLETED|Overall Study||30
10894953|NCT04748341|12060758|FG001|COMPLETED|Overall Study||30
10894954|NCT04748341|12060757|FG000|NOT COMPLETED|Overall Study||1
10894955|NCT04748341|12060758|FG001|NOT COMPLETED|Overall Study||1
10894956|NCT04737278|12060766|FG000|STARTED|Overall Study||28
10894957|NCT04737278|12060767|FG001|STARTED|Overall Study||28
10894958|NCT04737278|12060766|FG000|COMPLETED|Overall Study||24
10894959|NCT04737278|12060767|FG001|COMPLETED|Overall Study||25
10894960|NCT04737278|12060766|FG000|NOT COMPLETED|Overall Study||4
10894961|NCT04737278|12060767|FG001|NOT COMPLETED|Overall Study||3
10894962|NCT04736069|12060775|FG000|STARTED|Overall Study||30
10894963|NCT04736069|12060776|FG001|STARTED|Overall Study||30
10894964|NCT04736069|12060775|FG000|COMPLETED|Overall Study||30
10894965|NCT04736069|12060776|FG001|COMPLETED|Overall Study||22
10894966|NCT04736069|12060775|FG000|NOT COMPLETED|Overall Study||0
10894967|NCT04736069|12060776|FG001|NOT COMPLETED|Overall Study||8
10894968|NCT04600375|12060790|FG000|STARTED|Overall Study||12
10894969|NCT04600375|12060791|FG001|STARTED|Overall Study||10
10894970|NCT04600375|12060790|FG000|COMPLETED|Overall Study||12
10894971|NCT04600375|12060791|FG001|COMPLETED|Overall Study||10
10894972|NCT04600375|12060790|FG000|NOT COMPLETED|Overall Study||0
10894973|NCT04600375|12060791|FG001|NOT COMPLETED|Overall Study||0
10894974|NCT04334460|12060799|FG000|STARTED|Full Enrollment||81
10894975|NCT04334460|12060800|FG001|STARTED|Full Enrollment||39
10894976|NCT04334460|12060799|FG000|COMPLETED|Full Enrollment||81
10894977|NCT04334460|12060800|FG001|COMPLETED|Full Enrollment||39
10894978|NCT04334460|12060799|FG000|NOT COMPLETED|Full Enrollment||0
10894979|NCT04334460|12060800|FG001|NOT COMPLETED|Full Enrollment||0
10894980|NCT04334460|12060799|FG000|STARTED|Full Analysis Set (FAS)||81
10894981|NCT04334460|12060800|FG001|STARTED|Full Analysis Set (FAS)||39
10894982|NCT04334460|12060799|FG000|COMPLETED|Full Analysis Set (FAS)||77
10894983|NCT04334460|12060800|FG001|COMPLETED|Full Analysis Set (FAS)||38
10894984|NCT04334460|12060799|FG000|NOT COMPLETED|Full Analysis Set (FAS)||4
10894985|NCT04334460|12060800|FG001|NOT COMPLETED|Full Analysis Set (FAS)||1
10894986|NCT04334460|12060799|FG000|STARTED|Safety Analysis Population||81
10894987|NCT04334460|12060800|FG001|STARTED|Safety Analysis Population||39
10894988|NCT04334460|12060799|FG000|COMPLETED|Safety Analysis Population||77
10894989|NCT04334460|12060800|FG001|COMPLETED|Safety Analysis Population||38
10894990|NCT04334460|12060799|FG000|NOT COMPLETED|Safety Analysis Population||4
10894991|NCT04334460|12060800|FG001|NOT COMPLETED|Safety Analysis Population||1
10894992|NCT04247828|12060807|FG000|STARTED|Overall Study||30
10894993|NCT04247828|12060807|FG000|Started - Controls|Overall Study||19
10894994|NCT04247828|12060807|FG000|Started - Participants With SPI|Overall Study||11
10894995|NCT04247828|12060807|FG000|COMPLETED|Overall Study|16 controls and 5 participants with SPI completed the study|21
10894996|NCT04247828|12060807|FG000|NOT COMPLETED|Overall Study||9
10894997|NCT04084769|12060815|FG000|STARTED|Overall Study||191
10894998|NCT04084769|12060816|FG001|STARTED|Overall Study||190
10894999|NCT04084769|12060817|FG002|STARTED|Overall Study||95
10895000|NCT04084769|12060818|FG003|STARTED|Overall Study||94
10895001|NCT04084769|12060815|FG000|Safety Analysis Set (SAfAS)|Overall Study||186
10895002|NCT04084769|12060816|FG001|Safety Analysis Set (SAfAS)|Overall Study||184
10895003|NCT04084769|12060817|FG002|Safety Analysis Set (SAfAS)|Overall Study||93
10895004|NCT04084769|12060818|FG003|Safety Analysis Set (SAfAS)|Overall Study||92
10895005|NCT04084769|12060815|FG000|Full Analysis Set|Overall Study||191
10895006|NCT04084769|12060816|FG001|Full Analysis Set|Overall Study||190
10895007|NCT04084769|12060817|FG002|Full Analysis Set|Overall Study||95
10895008|NCT04084769|12060818|FG003|Full Analysis Set|Overall Study||94
10895009|NCT04084769|12060815|FG000|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||46
10895010|NCT04084769|12060816|FG001|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||45
10895011|NCT04084769|12060817|FG002|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
10895012|NCT04084769|12060818|FG003|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
10895013|NCT04084769|12060815|FG000|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||174
10895014|NCT04084769|12060816|FG001|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||176
10895015|NCT04084769|12060817|FG002|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||90
10895016|NCT04084769|12060818|FG003|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||89
10895017|NCT04084769|12060815|FG000|COMPLETED|Overall Study||187
10895018|NCT04084769|12060816|FG001|COMPLETED|Overall Study||186
10895019|NCT04084769|12060817|FG002|COMPLETED|Overall Study||95
10895020|NCT04084769|12060818|FG003|COMPLETED|Overall Study||92
10895021|NCT04084769|12060815|FG000|NOT COMPLETED|Overall Study||4
10895022|NCT04084769|12060816|FG001|NOT COMPLETED|Overall Study||4
10895023|NCT04084769|12060817|FG002|NOT COMPLETED|Overall Study||0
10895024|NCT04084769|12060818|FG003|NOT COMPLETED|Overall Study||2
10895025|NCT04024228|12060835|FG000|STARTED|Overall Study||774
10895026|NCT04024228|12060836|FG001|STARTED|Overall Study||765
10895027|NCT04024228|12060835|FG000|Vaccinated|Overall Study||772
10895028|NCT04024228|12060836|FG001|Vaccinated|Overall Study||761
10895029|NCT04024228|12060835|FG000|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 392 participants (>=65 years).|769
10895030|NCT04024228|12060836|FG001|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 381 participants (>=65 years).|758
10895031|NCT04024228|12060835|FG000|COMPLETED|Overall Study||770
10895032|NCT04024228|12060836|FG001|COMPLETED|Overall Study||759
10895033|NCT04024228|12060835|FG000|NOT COMPLETED|Overall Study||4
10895034|NCT04024228|12060836|FG001|NOT COMPLETED|Overall Study||6
10895035|NCT03996148|12060847|FG000|STARTED|Overall Study||7
10895036|NCT03996148|12060848|FG001|STARTED|Overall Study||7
10895037|NCT03996148|12060849|FG002|STARTED|Overall Study||7
10895038|NCT03996148|12060847|FG000|COMPLETED|Overall Study||7
10895039|NCT03996148|12060848|FG001|COMPLETED|Overall Study||6
10895040|NCT03996148|12060849|FG002|COMPLETED|Overall Study||7
10895041|NCT03996148|12060847|FG000|NOT COMPLETED|Overall Study||0
10895042|NCT03996148|12060848|FG001|NOT COMPLETED|Overall Study||1
10895043|NCT03996148|12060849|FG002|NOT COMPLETED|Overall Study||0
10895044|NCT03980938|12060859|FG000|STARTED|Treatment Period 1||7
10895045|NCT03980938|12060860|FG001|STARTED|Treatment Period 1||8
10895046|NCT03980938|12060859|FG000|COMPLETED|Treatment Period 1||6
10895047|NCT03980938|12060860|FG001|COMPLETED|Treatment Period 1||7
10895048|NCT03980938|12060859|FG000|NOT COMPLETED|Treatment Period 1||1
10895049|NCT03980938|12060860|FG001|NOT COMPLETED|Treatment Period 1||1
10895050|NCT03980938|12060859|FG000|STARTED|Treatment Period 2||3
10895051|NCT03980938|12060860|FG001|STARTED|Treatment Period 2||2
10895052|NCT03980938|12060859|FG000|COMPLETED|Treatment Period 2|One participant completed the study remotely. On-site visits were no longer permitted due to COVID-19 pandemic. Visits were conducted remotely for Weeks 8 and 10 of Treatment Period 2, and the follow-up visit.|1
10895053|NCT03980938|12060860|FG001|COMPLETED|Treatment Period 2||0
10895054|NCT03980938|12060859|FG000|NOT COMPLETED|Treatment Period 2||2
10895055|NCT03980938|12060860|FG001|NOT COMPLETED|Treatment Period 2||2
10895056|NCT03863353|12060868|FG000|STARTED|Overall Study||282
10895057|NCT03863353|12060869|FG001|STARTED|Overall Study||221
10895058|NCT03863353|12060868|FG000|COMPLETED|Overall Study||258
10895059|NCT03863353|12060869|FG001|COMPLETED|Overall Study||201
10895060|NCT03863353|12060868|FG000|NOT COMPLETED|Overall Study||24
10895061|NCT03863353|12060869|FG001|NOT COMPLETED|Overall Study||20
10895062|NCT03572634|12060877|FG000|STARTED|Overall Study||1
10895063|NCT03572634|12060878|FG001|STARTED|Overall Study||2
10895064|NCT03572634|12060877|FG000|COMPLETED|Overall Study||1
10895065|NCT03572634|12060878|FG001|COMPLETED|Overall Study||2
10895066|NCT03572634|12060877|FG000|NOT COMPLETED|Overall Study||0
10895067|NCT03572634|12060878|FG001|NOT COMPLETED|Overall Study||0
10895068|NCT03562156|12060887|FG000|STARTED|Overall Study||217
10895069|NCT03562156|12060888|FG001|STARTED|Overall Study||109
10895070|NCT03562156|12060887|FG000|COMPLETED|Overall Study||182
10895071|NCT03562156|12060888|FG001|COMPLETED|Overall Study||91
10895072|NCT03562156|12060887|FG000|NOT COMPLETED|Overall Study||35
10895073|NCT03562156|12060888|FG001|NOT COMPLETED|Overall Study||18
10895074|NCT03476135|12060896|FG000|STARTED|Overall Study||42
10895075|NCT03476135|12060897|FG001|STARTED|Overall Study||49
10895076|NCT03476135|12060896|FG000|COMPLETED|Overall Study||42
10895077|NCT03476135|12060897|FG001|COMPLETED|Overall Study||49
10895078|NCT03476135|12060896|FG000|NOT COMPLETED|Overall Study||0
10895079|NCT03476135|12060897|FG001|NOT COMPLETED|Overall Study||0
10895080|NCT03333928|12060906|FG000|STARTED|Initial Dosing Period (Period 1)||16
10895081|NCT03333928|12060907|FG001|STARTED|Initial Dosing Period (Period 1)||25
10895082|NCT03333928|12060908|FG002|STARTED|Initial Dosing Period (Period 1)||18
10895083|NCT03333928|12060906|FG000|COMPLETED|Initial Dosing Period (Period 1)||15
10895084|NCT03333928|12060907|FG001|COMPLETED|Initial Dosing Period (Period 1)||21
10895085|NCT03333928|12060908|FG002|COMPLETED|Initial Dosing Period (Period 1)||14
10895086|NCT03333928|12060906|FG000|NOT COMPLETED|Initial Dosing Period (Period 1)||1
10895087|NCT03333928|12060907|FG001|NOT COMPLETED|Initial Dosing Period (Period 1)||4
10895088|NCT03333928|12060908|FG002|NOT COMPLETED|Initial Dosing Period (Period 1)||4
10895089|NCT03333928|12060906|FG000|STARTED|Dose-controlled Extension (Period 2)||22
10895090|NCT03333928|12060907|FG001|STARTED|Dose-controlled Extension (Period 2)||29
10895091|NCT03333928|12060908|FG002|STARTED|Dose-controlled Extension (Period 2)||0
10895092|NCT03333928|12060906|FG000|COMPLETED|Dose-controlled Extension (Period 2)||19
10895093|NCT03333928|12060907|FG001|COMPLETED|Dose-controlled Extension (Period 2)||28
10895094|NCT03333928|12060908|FG002|COMPLETED|Dose-controlled Extension (Period 2)||0
10895095|NCT03333928|12060906|FG000|NOT COMPLETED|Dose-controlled Extension (Period 2)||3
10895096|NCT03333928|12060907|FG001|NOT COMPLETED|Dose-controlled Extension (Period 2)||1
10895097|NCT03333928|12060908|FG002|NOT COMPLETED|Dose-controlled Extension (Period 2)||0
10895098|NCT03333928|12060906|FG000|STARTED|Randomized Withdrawal (Period 3)||10
10895099|NCT03333928|12060907|FG001|STARTED|Randomized Withdrawal (Period 3)||14
10895100|NCT03333928|12060908|FG002|STARTED|Randomized Withdrawal (Period 3)||26
10895101|NCT03333928|12060906|FG000|COMPLETED|Randomized Withdrawal (Period 3)||8
10895102|NCT03333928|12060907|FG001|COMPLETED|Randomized Withdrawal (Period 3)||14
10895103|NCT03333928|12060908|FG002|COMPLETED|Randomized Withdrawal (Period 3)||25
10895104|NCT03333928|12060906|FG000|NOT COMPLETED|Randomized Withdrawal (Period 3)||2
10895105|NCT03333928|12060907|FG001|NOT COMPLETED|Randomized Withdrawal (Period 3)||0
10895106|NCT03333928|12060908|FG002|NOT COMPLETED|Randomized Withdrawal (Period 3)||1
10895107|NCT03298984|12060928|FG000|STARTED|Overall Study||3
10895108|NCT03298984|12060929|FG001|STARTED|Overall Study||3
10895109|NCT03298984|12060930|FG002|STARTED|Overall Study||3
10895110|NCT03298984|12060931|FG003|STARTED|Overall Study||23
10895111|NCT03298984|12060928|FG000|COMPLETED|Overall Study||2
10895112|NCT03298984|12060929|FG001|COMPLETED|Overall Study||2
10895113|NCT03298984|12060930|FG002|COMPLETED|Overall Study||1
10895114|NCT03298984|12060931|FG003|COMPLETED|Overall Study||8
10895115|NCT03298984|12060928|FG000|NOT COMPLETED|Overall Study||1
10895116|NCT03298984|12060929|FG001|NOT COMPLETED|Overall Study||1
10895117|NCT03298984|12060930|FG002|NOT COMPLETED|Overall Study||2
10895118|NCT03298984|12060931|FG003|NOT COMPLETED|Overall Study||15
10895119|NCT03175198|12060942|FG000|STARTED|Overall Study||5565
10895120|NCT03175198|12060942|FG000|Safety Set 1|Overall Study||5436
10895121|NCT03175198|12060942|FG000|COMPLETED|Overall Study||3238
10895122|NCT03175198|12060942|FG000|NOT COMPLETED|Overall Study||2327
10895123|NCT03158727|12060948|FG000|STARTED|Overall Study||42
10895124|NCT03158727|12060949|FG001|STARTED|Overall Study||42
10895125|NCT03158727|12060948|FG000|Enrolled, Not Treated|Overall Study||1
10895126|NCT03158727|12060949|FG001|Enrolled, Not Treated|Overall Study||0
10895127|NCT03158727|12060948|FG000|COMPLETED|Overall Study||25
10895128|NCT03158727|12060949|FG001|COMPLETED|Overall Study||23
10895129|NCT03158727|12060948|FG000|NOT COMPLETED|Overall Study||17
10895130|NCT03158727|12060949|FG001|NOT COMPLETED|Overall Study||19
10895131|NCT03075826|12060955|FG000|STARTED|Overall Study||22
10895132|NCT03075826|12060955|FG000|COMPLETED|Overall Study||16
10895133|NCT03075826|12060955|FG000|NOT COMPLETED|Overall Study||6
10895134|NCT02993731|12060961|FG000|STARTED|Overall Study||565
10895135|NCT02993731|12060962|FG001|STARTED|Overall Study||569
10895136|NCT02993731|12060961|FG000|COMPLETED|Overall Study||464
10895137|NCT02993731|12060962|FG001|COMPLETED|Overall Study||464
10895138|NCT02993731|12060961|FG000|NOT COMPLETED|Overall Study||101
10895139|NCT02993731|12060962|FG001|NOT COMPLETED|Overall Study||105
10895140|NCT02826161|12060980|FG000|STARTED|Overall Study||1
10895141|NCT02826161|12060981|FG001|STARTED|Overall Study||3
10895142|NCT02826161|12060980|FG000|Discontinued Due to Treatment Related AE|Overall Study||1
10895143|NCT02826161|12060981|FG001|Discontinued Due to Treatment Related AE|Overall Study||0
10895144|NCT02826161|12060980|FG000|Discontinued Due to Death|Overall Study||0
10895145|NCT02826161|12060981|FG001|Discontinued Due to Death|Overall Study||1
10895146|NCT02826161|12060980|FG000|Discontinued Due to Patient Withdrawal|Overall Study||0
10895147|NCT02826161|12060981|FG001|Discontinued Due to Patient Withdrawal|Overall Study||1
10895148|NCT02826161|12060980|FG000|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
10895149|NCT02826161|12060981|FG001|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
10895150|NCT02826161|12060980|FG000|COMPLETED|Overall Study||1
10895151|NCT02826161|12060981|FG001|COMPLETED|Overall Study||3
10895152|NCT02826161|12060980|FG000|NOT COMPLETED|Overall Study||0
10895153|NCT02826161|12060981|FG001|NOT COMPLETED|Overall Study||0
10895154|NCT02520011|12060989|FG000|STARTED|Overall Study||11
10895155|NCT02520011|12060990|FG001|STARTED|Overall Study||79
10895156|NCT02520011|12060991|FG002|STARTED|Overall Study||14
10895157|NCT02520011|12060989|FG000|Stage 1|Overall Study||0
10895158|NCT02520011|12060990|FG001|Stage 1|Overall Study||32
10895159|NCT02520011|12060991|FG002|Stage 1|Overall Study||10
10895160|NCT02520011|12060989|FG000|Stage 2|Overall Study||11
10895161|NCT02520011|12060990|FG001|Stage 2|Overall Study||47
10895162|NCT02520011|12060991|FG002|Stage 2|Overall Study||4
10895163|NCT02520011|12060989|FG000|COMPLETED|Overall Study||6
10895164|NCT02520011|12060990|FG001|COMPLETED|Overall Study||33
10895165|NCT02520011|12060991|FG002|COMPLETED|Overall Study||5
10895166|NCT02520011|12060989|FG000|NOT COMPLETED|Overall Study||5
10895167|NCT02520011|12060990|FG001|NOT COMPLETED|Overall Study||46
10895168|NCT02520011|12060991|FG002|NOT COMPLETED|Overall Study||9
10895169|NCT02315534|12061006|FG000|STARTED|Overall Study||4
10895170|NCT02315534|12061007|FG001|STARTED|Overall Study||30
10895171|NCT02315534|12061006|FG000|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0
10895172|NCT02315534|12061007|FG001|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0
10895173|NCT02315534|12061006|FG000|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||2
10895174|NCT02315534|12061007|FG001|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||20
10895175|NCT02315534|12061006|FG000|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||1
10895176|NCT02315534|12061007|FG001|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||7
10895177|NCT02315534|12061006|FG000|Off Treatment Due to Patient Request|Overall Study||1
10895178|NCT02315534|12061007|FG001|Off Treatment Due to Patient Request|Overall Study||2
10895179|NCT02315534|12061006|FG000|Off Treatment Due to Clinical PD|Overall Study||0
10895180|NCT02315534|12061007|FG001|Off Treatment Due to Clinical PD|Overall Study||1
10895181|NCT02315534|12061006|FG000|COMPLETED|Overall Study||4
10895182|NCT02315534|12061007|FG001|COMPLETED|Overall Study||30
10895183|NCT02315534|12061006|FG000|NOT COMPLETED|Overall Study||0
10895184|NCT02315534|12061007|FG001|NOT COMPLETED|Overall Study||0
10895185|NCT02279719|12061028|FG000|STARTED|Overall Study||5
10895186|NCT02279719|12061029|FG001|STARTED|Overall Study||10
10895187|NCT02279719|12061030|FG002|STARTED|Overall Study||4
10895188|NCT02279719|12061031|FG003|STARTED|Overall Study||9
10895189|NCT02279719|12061032|FG004|STARTED|Overall Study||28
10895190|NCT02279719|12061033|FG005|STARTED|Overall Study||10
10895191|NCT02279719|12061034|FG006|STARTED|Overall Study||31
10895192|NCT02279719|12061028|FG000|COMPLETED|Overall Study||5
10895193|NCT02279719|12061029|FG001|COMPLETED|Overall Study||10
10895194|NCT02279719|12061030|FG002|COMPLETED|Overall Study||4
10895195|NCT02279719|12061031|FG003|COMPLETED|Overall Study||9
10895196|NCT02279719|12061032|FG004|COMPLETED|Overall Study||25
10895197|NCT02279719|12061033|FG005|COMPLETED|Overall Study||10
10895198|NCT02279719|12061034|FG006|COMPLETED|Overall Study||28
10895199|NCT02279719|12061028|FG000|NOT COMPLETED|Overall Study||0
10895200|NCT02279719|12061029|FG001|NOT COMPLETED|Overall Study||0
10895201|NCT02279719|12061030|FG002|NOT COMPLETED|Overall Study||0
10895202|NCT02279719|12061031|FG003|NOT COMPLETED|Overall Study||0
10895203|NCT02279719|12061032|FG004|NOT COMPLETED|Overall Study||3
10895204|NCT02279719|12061033|FG005|NOT COMPLETED|Overall Study||0
10895205|NCT02279719|12061034|FG006|NOT COMPLETED|Overall Study||3
10895206|NCT02178956|12061069|FG000|STARTED|Overall Study||357
10895207|NCT02178956|12061070|FG001|STARTED|Overall Study||357
10895208|NCT02178956|12061069|FG000|COMPLETED|Overall Study||286
10895209|NCT02178956|12061070|FG001|COMPLETED|Overall Study||279
10895210|NCT02178956|12061069|FG000|NOT COMPLETED|Overall Study||71
10895211|NCT02178956|12061070|FG001|NOT COMPLETED|Overall Study||78
10895212|NCT02097420|12061080|FG000|STARTED|Overall Study||20
10895213|NCT02097420|12061080|FG000|COMPLETED|Overall Study||6
10895214|NCT02097420|12061080|FG000|NOT COMPLETED|Overall Study||14
10895215|NCT02024607|12061091|FG000|STARTED|Overall Study||115
10895216|NCT02024607|12061092|FG001|STARTED|Overall Study||41
10895217|NCT02024607|12061093|FG002|STARTED|Overall Study||87
10895218|NCT02024607|12061094|FG003|STARTED|Overall Study||156
10895219|NCT02024607|12061095|FG004|STARTED|Overall Study||40
10895220|NCT02024607|12061096|FG005|STARTED|Overall Study||54
10895221|NCT02024607|12061097|FG006|STARTED|Overall Study||2
10895222|NCT02024607|12061091|FG000|COMPLETED|Overall Study||115
10895223|NCT02024607|12061092|FG001|COMPLETED|Overall Study||41
10895224|NCT02024607|12061093|FG002|COMPLETED|Overall Study||87
10895225|NCT02024607|12061094|FG003|COMPLETED|Overall Study||156
10895226|NCT02024607|12061095|FG004|COMPLETED|Overall Study||40
10895227|NCT02024607|12061096|FG005|COMPLETED|Overall Study||54
10895228|NCT02024607|12061097|FG006|COMPLETED|Overall Study||2
10895229|NCT02024607|12061091|FG000|NOT COMPLETED|Overall Study||0
10895230|NCT02024607|12061092|FG001|NOT COMPLETED|Overall Study||0
10895231|NCT02024607|12061093|FG002|NOT COMPLETED|Overall Study||0
10895232|NCT02024607|12061094|FG003|NOT COMPLETED|Overall Study||0
10895233|NCT02024607|12061095|FG004|NOT COMPLETED|Overall Study||0
10895234|NCT02024607|12061096|FG005|NOT COMPLETED|Overall Study||0
10895235|NCT02024607|12061097|FG006|NOT COMPLETED|Overall Study||0
10895236|NCT01925131|12061137|FG000|STARTED|Overall Study||5
10895237|NCT01925131|12061138|FG001|STARTED|Overall Study||4
10895238|NCT01925131|12061139|FG002|STARTED|Overall Study||10
10895239|NCT01925131|12061140|FG003|STARTED|Overall Study||5
10895240|NCT01925131|12061141|FG004|STARTED|Overall Study||11
10895241|NCT01925131|12061142|FG005|STARTED|Overall Study||13
10895242|NCT01925131|12061137|FG000|COMPLETED|Overall Study||0
10895243|NCT01925131|12061138|FG001|COMPLETED|Overall Study||2
10895244|NCT01925131|12061139|FG002|COMPLETED|Overall Study||1
10895245|NCT01925131|12061140|FG003|COMPLETED|Overall Study||0
10895246|NCT01925131|12061141|FG004|COMPLETED|Overall Study||0
10895247|NCT01925131|12061142|FG005|COMPLETED|Overall Study||3
10895248|NCT01925131|12061137|FG000|NOT COMPLETED|Overall Study||5
10895249|NCT01925131|12061138|FG001|NOT COMPLETED|Overall Study||2
10895250|NCT01925131|12061139|FG002|NOT COMPLETED|Overall Study||9
10895251|NCT01925131|12061140|FG003|NOT COMPLETED|Overall Study||5
10895252|NCT01925131|12061141|FG004|NOT COMPLETED|Overall Study||11
10895253|NCT01925131|12061142|FG005|NOT COMPLETED|Overall Study||10
10895254|NCT01776307|12061161|FG000|STARTED|Overall Study||49
10895255|NCT01776307|12061162|FG001|STARTED|Overall Study||75
10895256|NCT01776307|12061163|FG002|STARTED|Overall Study||76
10895257|NCT01776307|12061161|FG000|COMPLETED|Overall Study||49
10895258|NCT01776307|12061162|FG001|COMPLETED|Overall Study||75
10895259|NCT01776307|12061163|FG002|COMPLETED|Overall Study||75
10895260|NCT01776307|12061161|FG000|NOT COMPLETED|Overall Study||0
10895261|NCT01776307|12061162|FG001|NOT COMPLETED|Overall Study||0
10895262|NCT01776307|12061163|FG002|NOT COMPLETED|Overall Study||1
10895263|NCT01623167|12061195|FG000|STARTED|Overall Study||30
10895264|NCT01623167|12061196|FG001|STARTED|Overall Study||31
10895265|NCT01623167|12061197|FG002|STARTED|Overall Study||31
10895266|NCT01623167|12061195|FG000|COMPLETED|Overall Study||13
10895267|NCT01623167|12061196|FG001|COMPLETED|Overall Study||17
10895268|NCT01623167|12061197|FG002|COMPLETED|Overall Study||18
10895269|NCT01623167|12061195|FG000|NOT COMPLETED|Overall Study||17
10895270|NCT01623167|12061196|FG001|NOT COMPLETED|Overall Study||14
10895271|NCT01623167|12061197|FG002|NOT COMPLETED|Overall Study||13
10895272|NCT01535274|12061207|FG000|STARTED|Overall Study||28
10895273|NCT01535274|12061208|FG001|STARTED|Overall Study|"29 participants were initially randomized to receive desflurane treatment. One participant initially randomized to the desflurane arm was misallocated to the propofol arm and received propofol treatment, as shown in the reason not completed section below."|29
10895274|NCT01535274|12061207|FG000|Received Propofol|Overall Study||28
10895275|NCT01535274|12061208|FG001|Received Propofol|Overall Study|"Of the 29 participants initially randomized to receive desflurane treatment, one was misallocated to the propofol arm and received propofol treatment, as shown in the reason not completed section below. That participant is included in the baseline characteristics, outcome measures, and adverse events with the propofol arm."|1
10895276|NCT01535274|12061207|FG000|Received Desflurane|Overall Study||0
10895277|NCT01535274|12061208|FG001|Received Desflurane|Overall Study||28
10895278|NCT01535274|12061207|FG000|COMPLETED|Overall Study||28
10895279|NCT01535274|12061208|FG001|COMPLETED|Overall Study||27
10895280|NCT01535274|12061207|FG000|NOT COMPLETED|Overall Study||0
10895281|NCT01535274|12061208|FG001|NOT COMPLETED|Overall Study||2
10895282|NCT00544830|12061216|FG000|STARTED|Overall Study||29
10895283|NCT00544830|12061216|FG000|COMPLETED|Overall Study||29
10895284|NCT00544830|12061216|FG000|NOT COMPLETED|Overall Study||0
10895285|NCT00539981|12061222|FG000|STARTED|Overall Study||2344
10895286|NCT00539981|12061223|FG001|STARTED|Overall Study||2304
10895287|NCT00539981|12061222|FG000|COMPLETED|Overall Study||2049
10895288|NCT00539981|12061223|FG001|COMPLETED|Overall Study||2022
10895289|NCT00539981|12061222|FG000|NOT COMPLETED|Overall Study||295
10895290|NCT00539981|12061223|FG001|NOT COMPLETED|Overall Study||282
10895291|NCT04732819|12061234|FG000|STARTED|Overall Study||12582
10895292|NCT04732819|12061235|FG001|STARTED|Overall Study||11186
10895293|NCT04732819|12061234|FG000|COMPLETED|Overall Study||12582
10895294|NCT04732819|12061235|FG001|COMPLETED|Overall Study||11186
10895295|NCT04732819|12061234|FG000|NOT COMPLETED|Overall Study||0
10895296|NCT04732819|12061235|FG001|NOT COMPLETED|Overall Study||0
10895297|NCT04732338|12061243|FG000|STARTED|Overall Study||13
10895298|NCT04732338|12061244|FG001|STARTED|Overall Study||13
10895299|NCT04732338|12061243|FG000|COMPLETED|Overall Study||10
10895300|NCT04732338|12061244|FG001|COMPLETED|Overall Study||10
10895301|NCT04732338|12061243|FG000|NOT COMPLETED|Overall Study||3
10895302|NCT04732338|12061244|FG001|NOT COMPLETED|Overall Study||3
10895303|NCT04728802|12061252|FG000|STARTED|Overall Study||317
10895304|NCT04728802|12061253|FG001|STARTED|Overall Study||328
10895305|NCT04728802|12061252|FG000|COMPLETED|Overall Study||288
10895306|NCT04728802|12061253|FG001|COMPLETED|Overall Study||292
10895307|NCT04728802|12061252|FG000|NOT COMPLETED|Overall Study||29
10895308|NCT04728802|12061253|FG001|NOT COMPLETED|Overall Study||36
10895309|NCT04728594|12061262|FG000|STARTED|Overall Study|The number of participants who were sent a follow up email (delayed, three days after the other two arms) was used to see how many started.|3178
10895310|NCT04728594|12061263|FG001|STARTED|Overall Study||3198
10895311|NCT04728594|12061264|FG002|STARTED|Overall Study||3190
10895312|NCT04728594|12061262|FG000|COMPLETED|Overall Study||3178
10895313|NCT04728594|12061263|FG001|COMPLETED|Overall Study||3198
10895314|NCT04728594|12061264|FG002|COMPLETED|Overall Study||3190
10895315|NCT04728594|12061262|FG000|NOT COMPLETED|Overall Study||0
10895316|NCT04728594|12061263|FG001|NOT COMPLETED|Overall Study||0
10895317|NCT04728594|12061264|FG002|NOT COMPLETED|Overall Study||0
10895318|NCT04725500|12061274|FG000|STARTED|Screening||42
10895319|NCT04725500|12061274|FG000|COMPLETED|Screening||15
10895320|NCT04725500|12061274|FG000|NOT COMPLETED|Screening||27
10895321|NCT04725500|12061274|FG000|STARTED|Overnight Polysomnography (PSG)||15
10895322|NCT04725500|12061274|FG000|COMPLETED|Overnight Polysomnography (PSG)||15
10895404|NCT04646291|12061378|FG002|STARTED|Overall Study||8
10895323|NCT04725500|12061274|FG000|NOT COMPLETED|Overnight Polysomnography (PSG)||0
10895324|NCT04725500|12061274|FG000|STARTED|2 Week Take Home||15
10895325|NCT04725500|12061274|FG000|COMPLETED|2 Week Take Home||10
10895326|NCT04725500|12061274|FG000|NOT COMPLETED|2 Week Take Home||5
10895327|NCT04724538|12061280|FG000|STARTED|Overall Study||11
10895328|NCT04724538|12061281|FG001|STARTED|Overall Study||14
10895329|NCT04724538|12061280|FG000|COMPLETED|Overall Study||11
10895330|NCT04724538|12061281|FG001|COMPLETED|Overall Study||14
10895331|NCT04724538|12061280|FG000|NOT COMPLETED|Overall Study||0
10895332|NCT04724538|12061281|FG001|NOT COMPLETED|Overall Study||0
10895333|NCT04716426|12061289|FG000|STARTED|Overall Study||50
10895334|NCT04716426|12061290|FG001|STARTED|Overall Study||50
10895335|NCT04716426|12061289|FG000|COMPLETED|Overall Study||48
10895336|NCT04716426|12061290|FG001|COMPLETED|Overall Study||49
10895337|NCT04716426|12061289|FG000|NOT COMPLETED|Overall Study||2
10895338|NCT04716426|12061290|FG001|NOT COMPLETED|Overall Study||1
10895339|NCT04709068|12061296|FG000|STARTED|Overall Study||8
10895340|NCT04709068|12061296|FG000|COMPLETED|Overall Study||8
10895341|NCT04709068|12061296|FG000|NOT COMPLETED|Overall Study||0
10895342|NCT04704713|12061302|FG000|STARTED|Overall Study||15
10895343|NCT04704713|12061303|FG001|STARTED|Overall Study||16
10895344|NCT04704713|12061302|FG000|COMPLETED|Overall Study||11
10895345|NCT04704713|12061303|FG001|COMPLETED|Overall Study||12
10895346|NCT04704713|12061302|FG000|NOT COMPLETED|Overall Study||4
10895347|NCT04704713|12061303|FG001|NOT COMPLETED|Overall Study||4
10895348|NCT04698993|12061311|FG000|STARTED|Overall Study||275
10895349|NCT04698993|12061312|FG001|STARTED|Overall Study||113
10895350|NCT04698993|12061311|FG000|COMPLETED|Overall Study||272
10895351|NCT04698993|12061312|FG001|COMPLETED|Overall Study||106
10895352|NCT04698993|12061311|FG000|NOT COMPLETED|Overall Study||3
10895353|NCT04698993|12061312|FG001|NOT COMPLETED|Overall Study||7
10895354|NCT04697888|12061318|FG000|STARTED|Overall Study||2
10895355|NCT04697888|12061318|FG000|COMPLETED|Overall Study||2
10895356|NCT04697888|12061318|FG000|NOT COMPLETED|Overall Study||0
10895357|NCT04693078|12061322|FG000|STARTED|Overall Study||100
10895358|NCT04693078|12061322|FG000|COMPLETED|Overall Study||100
10895359|NCT04693078|12061322|FG000|NOT COMPLETED|Overall Study||0
10895360|NCT04688346|12061328|FG000|STARTED|Overall Study||6
10895361|NCT04688346|12061329|FG001|STARTED|Overall Study||7
10895362|NCT04688346|12061328|FG000|First Intervention|Overall Study||6
10895363|NCT04688346|12061329|FG001|First Intervention|Overall Study||7
10895364|NCT04688346|12061328|FG000|Second Intervention|Overall Study||6
10895365|NCT04688346|12061329|FG001|Second Intervention|Overall Study||7
10895366|NCT04688346|12061328|FG000|COMPLETED|Overall Study||6
10895367|NCT04688346|12061329|FG001|COMPLETED|Overall Study||7
10895368|NCT04688346|12061328|FG000|NOT COMPLETED|Overall Study||0
10895369|NCT04688346|12061329|FG001|NOT COMPLETED|Overall Study||0
10895370|NCT04684992|12061335|FG000|STARTED|Overall Study||36
10895371|NCT04684992|12061335|FG000|COMPLETED|Overall Study||34
10895372|NCT04684992|12061335|FG000|NOT COMPLETED|Overall Study||2
10895373|NCT04674644|12061339|FG000|STARTED|Overall Study||850
10895374|NCT04674644|12061339|FG000|COMPLETED|Overall Study||813
10895375|NCT04674644|12061339|FG000|NOT COMPLETED|Overall Study||37
10895376|NCT04673214|12061346|FG000|STARTED|Overall Study||67
10895377|NCT04673214|12061347|FG001|STARTED|Overall Study||47
10895378|NCT04673214|12061346|FG000|Lost to Follow up|Overall Study|These patients were discontinued, given in the first days of their follow-up by video call, they presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; Following the protocol's follow-up criteria, patients were informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patients is searched, registering their death.|2
10895379|NCT04673214|12061347|FG001|Lost to Follow up|Overall Study|This patient was stopped being followed up in the first days of his follow-up by video call. He presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; With the follow-up criteria of the protocol, the patient was informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patient is searched, registering death.|1
10895380|NCT04673214|12061346|FG000|COMPLETED|Overall Study||65
10895381|NCT04673214|12061347|FG001|COMPLETED|Overall Study||46
10895382|NCT04673214|12061346|FG000|NOT COMPLETED|Overall Study||2
10895383|NCT04673214|12061347|FG001|NOT COMPLETED|Overall Study||1
10895384|NCT04668989|12061357|FG000|STARTED|First Intervention||36
10895385|NCT04668989|12061358|FG001|STARTED|First Intervention||30
10895386|NCT04668989|12061357|FG000|COMPLETED|First Intervention||36
10895387|NCT04668989|12061358|FG001|COMPLETED|First Intervention||29
10895388|NCT04668989|12061357|FG000|NOT COMPLETED|First Intervention||0
10895389|NCT04668989|12061358|FG001|NOT COMPLETED|First Intervention||1
10895390|NCT04668989|12061357|FG000|STARTED|Second Intervention||36
10895391|NCT04668989|12061358|FG001|STARTED|Second Intervention||29
10895392|NCT04668989|12061357|FG000|COMPLETED|Second Intervention||36
10895393|NCT04668989|12061358|FG001|COMPLETED|Second Intervention||28
10895394|NCT04668989|12061357|FG000|NOT COMPLETED|Second Intervention||0
10895395|NCT04668989|12061358|FG001|NOT COMPLETED|Second Intervention||1
10895396|NCT04668352|12061366|FG000|STARTED|Overall Study||511
10895397|NCT04668352|12061367|FG001|STARTED|Overall Study||513
10895398|NCT04668352|12061366|FG000|COMPLETED|Overall Study||510
10895399|NCT04668352|12061367|FG001|COMPLETED|Overall Study||511
10895400|NCT04668352|12061366|FG000|NOT COMPLETED|Overall Study||1
10895401|NCT04668352|12061367|FG001|NOT COMPLETED|Overall Study||2
10895402|NCT04646291|12061376|FG000|STARTED|Overall Study||272
10895403|NCT04646291|12061377|FG001|STARTED|Overall Study||70
10895405|NCT04646291|12061376|FG000|COMPLETED|Overall Study||272
10895406|NCT04646291|12061377|FG001|COMPLETED|Overall Study||70
10895407|NCT04646291|12061378|FG002|COMPLETED|Overall Study||8
10895408|NCT04646291|12061376|FG000|NOT COMPLETED|Overall Study||0
10895409|NCT04646291|12061377|FG001|NOT COMPLETED|Overall Study||0
10895410|NCT04646291|12061378|FG002|NOT COMPLETED|Overall Study||0
10895411|NCT04646109|12061394|FG000|STARTED|Overall Study||30
10895412|NCT04646109|12061395|FG001|STARTED|Overall Study||36
10895413|NCT04646109|12061394|FG000|COMPLETED|Overall Study||30
10895414|NCT04646109|12061395|FG001|COMPLETED|Overall Study||30
10895415|NCT04646109|12061394|FG000|NOT COMPLETED|Overall Study||0
10895416|NCT04646109|12061395|FG001|NOT COMPLETED|Overall Study||6
10895417|NCT04637997|12061404|FG000|STARTED|Overall Study||9
10895418|NCT04637997|12061405|FG001|STARTED|Overall Study||9
10895419|NCT04637997|12061404|FG000|COMPLETED|Overall Study||9
10895420|NCT04637997|12061405|FG001|COMPLETED|Overall Study||9
10895421|NCT04637997|12061404|FG000|NOT COMPLETED|Overall Study||0
10895422|NCT04637997|12061405|FG001|NOT COMPLETED|Overall Study||0
10895423|NCT04634903|12061418|FG000|STARTED|Overall Study||818
10895424|NCT04634903|12061419|FG001|STARTED|Overall Study||821
10895425|NCT04634903|12061420|FG002|STARTED|Overall Study||813
10895426|NCT04634903|12061418|FG000|COMPLETED|Overall Study||669
10895427|NCT04634903|12061419|FG001|COMPLETED|Overall Study||732
10895428|NCT04634903|12061420|FG002|COMPLETED|Overall Study||653
10895429|NCT04634903|12061418|FG000|NOT COMPLETED|Overall Study||149
10895430|NCT04634903|12061419|FG001|NOT COMPLETED|Overall Study||89
10895431|NCT04634903|12061420|FG002|NOT COMPLETED|Overall Study||160
10895432|NCT04633642|12061430|FG000|STARTED|Overall Study|27 participants|27
10895433|NCT04633642|12061431|FG001|STARTED|Overall Study|24 participants|24
10895434|NCT04633642|12061430|FG000|COMPLETED|Overall Study|26 participants|26
10895435|NCT04633642|12061431|FG001|COMPLETED|Overall Study|22 participants|22
10895436|NCT04633642|12061430|FG000|NOT COMPLETED|Overall Study||1
10895437|NCT04633642|12061431|FG001|NOT COMPLETED|Overall Study||2
10895438|NCT04633174|12061437|FG000|STARTED|Overall Study||1
10895439|NCT04633174|12061437|FG000|COMPLETED|Overall Study||1
10895440|NCT04633174|12061437|FG000|NOT COMPLETED|Overall Study||0
10895441|NCT04628221|12061442|FG000|STARTED|Overall Study||40
10895442|NCT04628221|12061442|FG000|COMPLETED|Overall Study||40
10895443|NCT04628221|12061442|FG000|NOT COMPLETED|Overall Study||0
10895444|NCT04625426|12061449|FG000|STARTED|Overall Study||23
10895445|NCT04625426|12061450|FG001|STARTED|Overall Study||37
10895446|NCT04625426|12061451|FG002|STARTED|Overall Study||24
10895447|NCT04625426|12061449|FG000|COMPLETED|Overall Study||9
10895448|NCT04625426|12061450|FG001|COMPLETED|Overall Study||12
10895449|NCT04625426|12061451|FG002|COMPLETED|Overall Study||12
10895450|NCT04625426|12061449|FG000|NOT COMPLETED|Overall Study||14
10895451|NCT04625426|12061450|FG001|NOT COMPLETED|Overall Study||25
10895452|NCT04625426|12061451|FG002|NOT COMPLETED|Overall Study||12
10895453|NCT04617509|12061459|FG000|STARTED|Period 1: Part 1 Formulation A||14
10895454|NCT04617509|12061460|FG001|STARTED|Period 1: Part 1 Formulation A||0
10895455|NCT04617509|12061461|FG002|STARTED|Period 1: Part 1 Formulation A|Subjects were expected to participate in both Part I and Part II, seven visits in total. Subject 112 was prematurely withdrawn from the study due to self-reported Covid-19-like symptoms via phone after Visit 5, i.e. after receiving both GS-248 formulations but prior to the food interaction part. This means subject 112 was withdrawn after Part I Formulation B but before Part II which cannot be visualized in the Period section. The correct number of subjects started Part II is thus 13.|0
10895456|NCT04617509|12061459|FG000|COMPLETED|Period 1: Part 1 Formulation A||14
10895457|NCT04617509|12061460|FG001|COMPLETED|Period 1: Part 1 Formulation A||0
10895458|NCT04617509|12061461|FG002|COMPLETED|Period 1: Part 1 Formulation A||0
10895459|NCT04617509|12061459|FG000|NOT COMPLETED|Period 1: Part 1 Formulation A||0
10895460|NCT04617509|12061460|FG001|NOT COMPLETED|Period 1: Part 1 Formulation A||0
10895461|NCT04617509|12061461|FG002|NOT COMPLETED|Period 1: Part 1 Formulation A||0
10895462|NCT04617509|12061459|FG000|STARTED|Period 2: Part 1 Formulation B||0
10895463|NCT04617509|12061460|FG001|STARTED|Period 2: Part 1 Formulation B||14
10895464|NCT04617509|12061461|FG002|STARTED|Period 2: Part 1 Formulation B||0
10895465|NCT04617509|12061459|FG000|COMPLETED|Period 2: Part 1 Formulation B||0
10895466|NCT04617509|12061460|FG001|COMPLETED|Period 2: Part 1 Formulation B||14
10895467|NCT04617509|12061461|FG002|COMPLETED|Period 2: Part 1 Formulation B||0
10895468|NCT04617509|12061459|FG000|NOT COMPLETED|Period 2: Part 1 Formulation B||0
10895469|NCT04617509|12061460|FG001|NOT COMPLETED|Period 2: Part 1 Formulation B||0
10895470|NCT04617509|12061461|FG002|NOT COMPLETED|Period 2: Part 1 Formulation B||0
10895471|NCT04617509|12061459|FG000|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
10895472|NCT04617509|12061460|FG001|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
10895473|NCT04617509|12061461|FG002|STARTED|Period 3: Part 2 Formulation A Fed Cond.||14
10895474|NCT04617509|12061459|FG000|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
10895475|NCT04617509|12061460|FG001|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
10895476|NCT04617509|12061461|FG002|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||13
10895477|NCT04617509|12061459|FG000|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
10895478|NCT04617509|12061460|FG001|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
10895479|NCT04617509|12061461|FG002|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||1
10895480|NCT04616430|12061474|FG000|STARTED|Overall Study||30
10895481|NCT04616430|12061475|FG001|STARTED|Overall Study||30
10895482|NCT04616430|12061476|FG002|STARTED|Overall Study||30
10895483|NCT04616430|12061474|FG000|COMPLETED|Overall Study||23
10895484|NCT04616430|12061475|FG001|COMPLETED|Overall Study||2
10895485|NCT04616430|12061476|FG002|COMPLETED|Overall Study||0
10895486|NCT04616430|12061474|FG000|NOT COMPLETED|Overall Study||7
10895487|NCT04616430|12061475|FG001|NOT COMPLETED|Overall Study||28
10895488|NCT04616430|12061476|FG002|NOT COMPLETED|Overall Study||30
10895489|NCT04615507|12061486|FG000|STARTED|Period 1||34
10895490|NCT04615507|12061487|FG001|STARTED|Period 1||34
10895491|NCT04615507|12061486|FG000|COMPLETED|Period 1||32
10895492|NCT04615507|12061487|FG001|COMPLETED|Period 1||33
10895493|NCT04615507|12061486|FG000|NOT COMPLETED|Period 1||2
10895494|NCT04615507|12061487|FG001|NOT COMPLETED|Period 1||1
10895495|NCT04615507|12061486|FG000|STARTED|Period 2||32
10895496|NCT04615507|12061487|FG001|STARTED|Period 2||33
10895497|NCT04615507|12061486|FG000|COMPLETED|Period 2||30
10895498|NCT04615507|12061487|FG001|COMPLETED|Period 2||31
10895499|NCT04615507|12061486|FG000|NOT COMPLETED|Period 2||2
10895500|NCT04615507|12061487|FG001|NOT COMPLETED|Period 2||2
10895501|NCT04615507|12061486|FG000|STARTED|Period 3||30
10895502|NCT04615507|12061487|FG001|STARTED|Period 3||31
10895503|NCT04615507|12061486|FG000|COMPLETED|Period 3||30
10895504|NCT04615507|12061487|FG001|COMPLETED|Period 3||30
10895505|NCT04615507|12061486|FG000|NOT COMPLETED|Period 3||0
10895506|NCT04615507|12061487|FG001|NOT COMPLETED|Period 3||1
10895507|NCT04610489|12061493|FG000|STARTED|Overall Study||117
10895508|NCT04610489|12061493|FG000|COMPLETED|Overall Study||117
10895509|NCT04610489|12061493|FG000|NOT COMPLETED|Overall Study||0
10895510|NCT04608500|12061500|FG000|STARTED|Overall Study||514
10895511|NCT04608500|12061501|FG001|STARTED|Overall Study||257
10895512|NCT04608500|12061500|FG000|COMPLETED|Overall Study||479
10895513|NCT04608500|12061501|FG001|COMPLETED|Overall Study||239
10895514|NCT04608500|12061500|FG000|NOT COMPLETED|Overall Study||35
10895515|NCT04608500|12061501|FG001|NOT COMPLETED|Overall Study||18
10895516|NCT04607291|12061507|FG000|STARTED|Overall Study||183
10895517|NCT04607291|12061507|FG000|COMPLETED|Overall Study||183
10895518|NCT04607291|12061507|FG000|NOT COMPLETED|Overall Study||0
10895519|NCT04605588|12061513|FG000|STARTED|Overall Study||2
10895520|NCT04605588|12061514|FG001|STARTED|Overall Study||5
10895521|NCT04605588|12061513|FG000|COMPLETED|Overall Study||1
10895522|NCT04605588|12061514|FG001|COMPLETED|Overall Study||5
10895523|NCT04605588|12061513|FG000|NOT COMPLETED|Overall Study||1
10895524|NCT04605588|12061514|FG001|NOT COMPLETED|Overall Study||0
10895525|NCT04599959|12061520|FG000|STARTED|Overall Study||151
10895526|NCT04599959|12061520|FG000|COMPLETED|Overall Study||151
10895527|NCT04599959|12061520|FG000|NOT COMPLETED|Overall Study||0
10895528|NCT04596085|12061528|FG000|STARTED|Overall Study||59
10895529|NCT04596085|12061529|FG001|STARTED|Overall Study||59
10895530|NCT04596085|12061528|FG000|COMPLETED|Overall Study||59
10895531|NCT04596085|12061529|FG001|COMPLETED|Overall Study||59
10895532|NCT04596085|12061528|FG000|NOT COMPLETED|Overall Study||0
10895533|NCT04596085|12061529|FG001|NOT COMPLETED|Overall Study||0
10895534|NCT04590027|12061539|FG000|STARTED|Overall Study||47
10895535|NCT04590027|12061540|FG001|STARTED|Overall Study||39
10895536|NCT04590027|12061539|FG000|COMPLETED|Overall Study||30
10895537|NCT04590027|12061540|FG001|COMPLETED|Overall Study||22
10895538|NCT04590027|12061539|FG000|NOT COMPLETED|Overall Study||17
10895539|NCT04590027|12061540|FG001|NOT COMPLETED|Overall Study||17
10895540|NCT04578457|12061550|FG000|STARTED|Hearing Aid Without NR Enabled (0)||19
10895541|NCT04578457|12061550|FG000|COMPLETED|Hearing Aid Without NR Enabled (0)||17
10895542|NCT04578457|12061550|FG000|NOT COMPLETED|Hearing Aid Without NR Enabled (0)||2
10895543|NCT04578457|12061550|FG000|STARTED|Hearing Aid With NR (1)||19
10895544|NCT04578457|12061550|FG000|COMPLETED|Hearing Aid With NR (1)||17
10895545|NCT04578457|12061550|FG000|NOT COMPLETED|Hearing Aid With NR (1)||2
10895546|NCT04578457|12061550|FG000|STARTED|Hearing Aid With NR (2)||19
10895547|NCT04578457|12061550|FG000|COMPLETED|Hearing Aid With NR (2)||17
10895548|NCT04578457|12061550|FG000|NOT COMPLETED|Hearing Aid With NR (2)||2
10895549|NCT04578457|12061550|FG000|STARTED|Hearing Aid With NR (4)||19
10895550|NCT04578457|12061550|FG000|COMPLETED|Hearing Aid With NR (4)||17
10895551|NCT04578457|12061550|FG000|NOT COMPLETED|Hearing Aid With NR (4)||2
10895552|NCT04578496|12061558|FG000|STARTED|Overall Study||16
10895553|NCT04578496|12061558|FG000|COMPLETED|Overall Study||12
10895554|NCT04578496|12061558|FG000|NOT COMPLETED|Overall Study||4
10895555|NCT04577183|12061562|FG000|STARTED|Overall Study||13
10895556|NCT04577183|12061562|FG000|COMPLETED|Overall Study||7
10895557|NCT04577183|12061562|FG000|NOT COMPLETED|Overall Study||6
10895558|NCT04574999|12061568|FG000|STARTED|Overall Study||114
10895559|NCT04574999|12061569|FG001|STARTED|Overall Study||53
10895560|NCT04574999|12061568|FG000|COMPLETED|Overall Study||105
10895561|NCT04574999|12061569|FG001|COMPLETED|Overall Study||48
10895562|NCT04574999|12061568|FG000|NOT COMPLETED|Overall Study||9
10895563|NCT04574999|12061569|FG001|NOT COMPLETED|Overall Study||5
10895564|NCT04572997|12061575|FG000|STARTED|Overall Study||21
10895565|NCT04572997|12061575|FG000|COMPLETED|Overall Study||20
10895566|NCT04572997|12061575|FG000|NOT COMPLETED|Overall Study||1
10895567|NCT04563767|12061583|FG000|STARTED|Overall Study||4
10895568|NCT04563767|12061583|FG000|COMPLETED|Overall Study||4
10895569|NCT04563767|12061583|FG000|NOT COMPLETED|Overall Study||0
10895570|NCT04560374|12061589|FG000|STARTED|Overall Study||50
10895571|NCT04560374|12061590|FG001|STARTED|Overall Study||50
10895572|NCT04560374|12061589|FG000|COMPLETED|Overall Study||50
10895573|NCT04560374|12061590|FG001|COMPLETED|Overall Study||50
10895574|NCT04560374|12061589|FG000|NOT COMPLETED|Overall Study||0
10895575|NCT04560374|12061590|FG001|NOT COMPLETED|Overall Study||0
10895576|NCT04555525|12061600|FG000|STARTED|Overall Study||75
10895577|NCT04555525|12061601|FG001|STARTED|Overall Study||25
10895578|NCT04555525|12061600|FG000|COMPLETED|Overall Study||72
10895579|NCT04555525|12061601|FG001|COMPLETED|Overall Study||25
10895580|NCT04555525|12061600|FG000|NOT COMPLETED|Overall Study||3
10895581|NCT04555525|12061601|FG001|NOT COMPLETED|Overall Study||0
10895582|NCT04553497|12061609|FG000|STARTED|Overall Study||17
10895583|NCT04553497|12061610|FG001|STARTED|Overall Study||18
10895584|NCT04553497|12061609|FG000|COMPLETED|Overall Study||15
10895585|NCT04553497|12061610|FG001|COMPLETED|Overall Study||17
10895586|NCT04553497|12061609|FG000|NOT COMPLETED|Overall Study||2
10895587|NCT04553497|12061610|FG001|NOT COMPLETED|Overall Study||1
10895588|NCT04548622|12061619|FG000|STARTED|Overall Study||15
10895589|NCT04548622|12061619|FG000|COMPLETED|Overall Study||15
10895590|NCT04548622|12061619|FG000|NOT COMPLETED|Overall Study||0
10895591|NCT04547036|12061623|FG000|STARTED|Overall Study||129
10895592|NCT04547036|12061623|FG000|COMPLETED|Overall Study||129
10895593|NCT04547036|12061623|FG000|NOT COMPLETED|Overall Study||0
10895594|NCT04544566|12061633|FG000|STARTED|Overall Study||2
10895595|NCT04544566|12061634|FG001|STARTED|Overall Study||2
10895596|NCT04544566|12061635|FG002|STARTED|Overall Study||2
10895597|NCT04544566|12061636|FG003|STARTED|Overall Study||2
10895598|NCT04544566|12061637|FG004|STARTED|Overall Study||2
10895599|NCT04544566|12061638|FG005|STARTED|Overall Study||2
10895600|NCT04544566|12061633|FG000|COMPLETED|Overall Study||2
10895601|NCT04544566|12061634|FG001|COMPLETED|Overall Study||2
10895602|NCT04544566|12061635|FG002|COMPLETED|Overall Study||2
10895603|NCT04544566|12061636|FG003|COMPLETED|Overall Study||2
10895604|NCT04544566|12061637|FG004|COMPLETED|Overall Study||2
10895605|NCT04544566|12061638|FG005|COMPLETED|Overall Study||2
10895606|NCT04544566|12061633|FG000|NOT COMPLETED|Overall Study||0
10895607|NCT04544566|12061634|FG001|NOT COMPLETED|Overall Study||0
10895608|NCT04544566|12061635|FG002|NOT COMPLETED|Overall Study||0
10895609|NCT04544566|12061636|FG003|NOT COMPLETED|Overall Study||0
10895610|NCT04544566|12061637|FG004|NOT COMPLETED|Overall Study||0
10895611|NCT04544566|12061638|FG005|NOT COMPLETED|Overall Study||0
10895612|NCT04542694|12061654|FG000|STARTED|Overall Study||100
10895613|NCT04542694|12061655|FG001|STARTED|Overall Study||100
10895614|NCT04542694|12061654|FG000|COMPLETED|Overall Study||96
10895615|NCT04542694|12061655|FG001|COMPLETED|Overall Study||100
10895616|NCT04542694|12061654|FG000|NOT COMPLETED|Overall Study||4
10895617|NCT04542694|12061655|FG001|NOT COMPLETED|Overall Study||0
10895618|NCT04542226|12061661|FG000|STARTED|Overall Study||81
10895619|NCT04542226|12061661|FG000|COMPLETED|Overall Study||81
10895620|NCT04542226|12061661|FG000|NOT COMPLETED|Overall Study||0
10895621|NCT04540627|12061668|FG000|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the double-blind period.|6
10895622|NCT04540627|12061669|FG001|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0
10895623|NCT04540627|12061670|FG002|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0
10895624|NCT04540627|12061668|FG000|COMPLETED|Open-label Treatment: PK Sentinel||6
10895625|NCT04540627|12061669|FG001|COMPLETED|Open-label Treatment: PK Sentinel||0
10895626|NCT04540627|12061670|FG002|COMPLETED|Open-label Treatment: PK Sentinel||0
10895627|NCT04540627|12061668|FG000|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
10895628|NCT04540627|12061669|FG001|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
10895629|NCT04540627|12061670|FG002|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
10895630|NCT04540627|12061668|FG000|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the double-blind period.|0
10895631|NCT04540627|12061669|FG001|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25
10895632|NCT04540627|12061670|FG002|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25
10895633|NCT04540627|12061668|FG000|COMPLETED|Double-blind Treatment: Viral Challenge||0
10895634|NCT04540627|12061669|FG001|COMPLETED|Double-blind Treatment: Viral Challenge||25
10895635|NCT04540627|12061670|FG002|COMPLETED|Double-blind Treatment: Viral Challenge||25
10895636|NCT04540627|12061668|FG000|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
10895637|NCT04540627|12061669|FG001|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
10895638|NCT04540627|12061670|FG002|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
10895639|NCT04540510|12061683|FG000|STARTED|Overall Study||5
10895640|NCT04540510|12061684|FG001|STARTED|Overall Study||6
10895641|NCT04540510|12061683|FG000|COMPLETED|Overall Study||5
10895642|NCT04540510|12061684|FG001|COMPLETED|Overall Study||6
10895643|NCT04540510|12061683|FG000|NOT COMPLETED|Overall Study||0
10895644|NCT04540510|12061684|FG001|NOT COMPLETED|Overall Study||0
10895645|NCT04534764|12061690|FG000|STARTED|Period 1||18
10895646|NCT04534764|12061691|FG001|STARTED|Period 1||17
10895647|NCT04534764|12061690|FG000|COMPLETED|Period 1||18
10895648|NCT04534764|12061691|FG001|COMPLETED|Period 1||17
10895649|NCT04534764|12061690|FG000|NOT COMPLETED|Period 1||0
10895650|NCT04534764|12061691|FG001|NOT COMPLETED|Period 1||0
10895651|NCT04534764|12061690|FG000|STARTED|Period 2||18
10895652|NCT04534764|12061691|FG001|STARTED|Period 2||17
10895653|NCT04534764|12061690|FG000|COMPLETED|Period 2||18
10895654|NCT04534764|12061691|FG001|COMPLETED|Period 2||17
10895655|NCT04534764|12061690|FG000|NOT COMPLETED|Period 2||0
10895656|NCT04534764|12061691|FG001|NOT COMPLETED|Period 2||0
10895657|NCT04534491|12061697|FG000|STARTED|Overall Study||855
10895658|NCT04534491|12061697|FG000|Treated|Overall Study||727
10895659|NCT04534491|12061697|FG000|COMPLETED|Overall Study||703
10895660|NCT04534491|12061697|FG000|NOT COMPLETED|Overall Study||152
10895661|NCT04534465|12061701|FG000|STARTED|Overall Study||10
10895662|NCT04534465|12061702|FG001|STARTED|Overall Study||10
10895663|NCT04534465|12061703|FG002|STARTED|Overall Study||10
10895664|NCT04534465|12061704|FG003|STARTED|Overall Study||10
10895665|NCT04534465|12061705|FG004|STARTED|Overall Study||10
10895666|NCT04534465|12061701|FG000|COMPLETED|Overall Study||10
10895667|NCT04534465|12061702|FG001|COMPLETED|Overall Study||10
10895668|NCT04534465|12061703|FG002|COMPLETED|Overall Study||10
10895669|NCT04534465|12061704|FG003|COMPLETED|Overall Study||10
10895670|NCT04534465|12061705|FG004|COMPLETED|Overall Study||10
10895671|NCT04534465|12061701|FG000|NOT COMPLETED|Overall Study||0
10895672|NCT04534465|12061702|FG001|NOT COMPLETED|Overall Study||0
10895673|NCT04534465|12061703|FG002|NOT COMPLETED|Overall Study||0
10895674|NCT04534465|12061704|FG003|NOT COMPLETED|Overall Study||0
10895675|NCT04534465|12061705|FG004|NOT COMPLETED|Overall Study||0
10895676|NCT04533204|12061719|FG000|STARTED|Overall Study||29
10895677|NCT04533204|12061720|FG001|STARTED|Overall Study||30
10895678|NCT04533204|12061719|FG000|COMPLETED|Overall Study||28
10895679|NCT04533204|12061720|FG001|COMPLETED|Overall Study||29
10895680|NCT04533204|12061719|FG000|NOT COMPLETED|Overall Study||1
10895681|NCT04533204|12061720|FG001|NOT COMPLETED|Overall Study||1
10895682|NCT04532164|12061726|FG000|STARTED|Overall Study||137
10895683|NCT04532164|12061726|FG000|Treated|Overall Study||132
10895684|NCT04532164|12061726|FG000|COMPLETED|Overall Study||113
10895685|NCT04532164|12061726|FG000|NOT COMPLETED|Overall Study||24
10895686|NCT04531813|12061731|FG000|STARTED|Overall Study||32
10895687|NCT04531813|12061731|FG000|Treated|Overall Study||31
10895688|NCT04531813|12061731|FG000|COMPLETED|Overall Study||30
10895689|NCT04531813|12061731|FG000|NOT COMPLETED|Overall Study||2
10895690|NCT04531527|12061735|FG000|STARTED|Overall Study||32
10895691|NCT04531527|12061735|FG000|Treated|Overall Study||29
10895692|NCT04531527|12061735|FG000|COMPLETED|Overall Study||29
10895693|NCT04531527|12061735|FG000|NOT COMPLETED|Overall Study||3
10895694|NCT04531540|12061739|FG000|STARTED|Overall Study||225
10895695|NCT04531540|12061739|FG000|Treated|Overall Study||222
10895696|NCT04531540|12061739|FG000|COMPLETED|Overall Study||216
10895697|NCT04531540|12061739|FG000|NOT COMPLETED|Overall Study||9
10895698|NCT04530591|12061743|FG000|STARTED|Overall Study||97
10895699|NCT04530591|12061743|FG000|COMPLETED|Overall Study||97
10895700|NCT04530591|12061743|FG000|NOT COMPLETED|Overall Study||0
10895701|NCT04615832|12061747|FG000|STARTED|Overall Study||44
10895702|NCT04615832|12061747|FG000|COMPLETED|Overall Study||44
10895703|NCT04615832|12061747|FG000|NOT COMPLETED|Overall Study||0
10895704|NCT04093258|12061751|FG000|STARTED|Period 1||21
10895705|NCT04093258|12061752|FG001|STARTED|Period 1||20
10895706|NCT04093258|12061751|FG000|COMPLETED|Period 1||21
10895707|NCT04093258|12061752|FG001|COMPLETED|Period 1||20
10895708|NCT04093258|12061751|FG000|NOT COMPLETED|Period 1||0
10895709|NCT04093258|12061752|FG001|NOT COMPLETED|Period 1||0
10895710|NCT04093258|12061751|FG000|STARTED|Period 2||21
10895711|NCT04093258|12061752|FG001|STARTED|Period 2||20
10895712|NCT04093258|12061751|FG000|COMPLETED|Period 2||20
10895713|NCT04093258|12061752|FG001|COMPLETED|Period 2||20
10895714|NCT04093258|12061751|FG000|NOT COMPLETED|Period 2||1
10895715|NCT04093258|12061752|FG001|NOT COMPLETED|Period 2||0
10895716|NCT04011826|12061758|FG000|STARTED|Overall Study||45
10895717|NCT04011826|12061758|FG000|COMPLETED|Overall Study||45
10895718|NCT04011826|12061758|FG000|NOT COMPLETED|Overall Study||0
10895719|NCT03993379|12061766|FG000|STARTED|Overall Study||0
10895720|NCT03993379|12061767|FG001|STARTED|Overall Study||3
10895721|NCT03993379|12061768|FG002|STARTED|Overall Study||0
10895722|NCT03993379|12061769|FG003|STARTED|Overall Study||0
10895723|NCT03993379|12061766|FG000|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
10895724|NCT03993379|12061767|FG001|COMPLETED|Overall Study|Subjects did not complete due to early termination of the study due to business reasons.|0
10895725|NCT03993379|12061768|FG002|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
10895726|NCT03993379|12061769|FG003|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
10895727|NCT03993379|12061766|FG000|NOT COMPLETED|Overall Study||0
10895728|NCT03993379|12061767|FG001|NOT COMPLETED|Overall Study||3
10895729|NCT03993379|12061768|FG002|NOT COMPLETED|Overall Study||0
10895730|NCT03993379|12061769|FG003|NOT COMPLETED|Overall Study||0
10895731|NCT03956615|12061779|FG000|STARTED|Overall Study||10
10895732|NCT03956615|12061779|FG000|COMPLETED|Overall Study||3
10895733|NCT03956615|12061779|FG000|NOT COMPLETED|Overall Study||7
10895734|NCT03803059|12061783|FG000|STARTED|Overall Study||35
10895735|NCT03803059|12061783|FG000|COMPLETED|Overall Study||32
10895736|NCT03803059|12061783|FG000|NOT COMPLETED|Overall Study||3
10895737|NCT03723590|12061788|FG000|STARTED|Overall Study||5
10895738|NCT03723590|12061788|FG000|COMPLETED|Overall Study||2
10895739|NCT03723590|12061788|FG000|NOT COMPLETED|Overall Study||3
10895740|NCT03720392|12061794|FG000|STARTED|Overall Study||3
10895741|NCT03720392|12061795|FG001|STARTED|Overall Study||3
10895742|NCT03720392|12061794|FG000|COMPLETED|Overall Study||3
10895743|NCT03720392|12061795|FG001|COMPLETED|Overall Study||3
10895744|NCT03720392|12061794|FG000|NOT COMPLETED|Overall Study||0
10895745|NCT03720392|12061795|FG001|NOT COMPLETED|Overall Study||0
10895746|NCT03430895|12061801|FG000|STARTED|Overall Study||15
10895747|NCT03430895|12061801|FG000|COMPLETED|Overall Study||13
10895748|NCT03430895|12061801|FG000|NOT COMPLETED|Overall Study||2
10895749|NCT03321617|12061809|FG000|STARTED|Overall Study||3
10895750|NCT03321617|12061810|FG001|STARTED|Overall Study||3
10895751|NCT03321617|12061811|FG002|STARTED|Overall Study||2
10895752|NCT03321617|12061812|FG003|STARTED|Overall Study||3
10895753|NCT03321617|12061809|FG000|COMPLETED|Overall Study||2
10895754|NCT03321617|12061810|FG001|COMPLETED|Overall Study||3
10895755|NCT03321617|12061811|FG002|COMPLETED|Overall Study||2
10895756|NCT03321617|12061812|FG003|COMPLETED|Overall Study||2
10895757|NCT03321617|12061809|FG000|NOT COMPLETED|Overall Study||1
10895758|NCT03321617|12061810|FG001|NOT COMPLETED|Overall Study||0
10895759|NCT03321617|12061811|FG002|NOT COMPLETED|Overall Study||0
10895760|NCT03321617|12061812|FG003|NOT COMPLETED|Overall Study||1
10895761|NCT03230838|12061824|FG000|STARTED|Overall Study||101
10895762|NCT03230838|12061825|FG001|STARTED|Overall Study||33
10895763|NCT03230838|12061824|FG000|Treated|Overall Study||100
10895764|NCT03230838|12061825|FG001|Treated|Overall Study||33
10895765|NCT03230838|12061824|FG000|COMPLETED|Overall Study||97
10895766|NCT03230838|12061825|FG001|COMPLETED|Overall Study||33
10895767|NCT03230838|12061824|FG000|NOT COMPLETED|Overall Study||4
10895768|NCT03230838|12061825|FG001|NOT COMPLETED|Overall Study||0
10895769|NCT03183778|12061831|FG000|STARTED|Overall Study||3
10895770|NCT03183778|12061831|FG000|COMPLETED|Overall Study||2
10895771|NCT03183778|12061831|FG000|NOT COMPLETED|Overall Study||1
10895772|NCT03113955|12061835|FG000|STARTED|Overall Study||109
10895773|NCT03113955|12061835|FG000|COMPLETED|Overall Study||92
10895774|NCT03113955|12061835|FG000|NOT COMPLETED|Overall Study||17
10895775|NCT02995694|12061842|FG000|STARTED|Overall Study||215
10895776|NCT02995694|12061843|FG001|STARTED|Overall Study||211
10895777|NCT02995694|12061844|FG002|STARTED|Overall Study||109
10895778|NCT02995694|12061842|FG000|COMPLETED|Overall Study||181
10895779|NCT02995694|12061843|FG001|COMPLETED|Overall Study||183
10895780|NCT02995694|12061844|FG002|COMPLETED|Overall Study||94
10895781|NCT02995694|12061842|FG000|NOT COMPLETED|Overall Study||34
10895782|NCT02995694|12061843|FG001|NOT COMPLETED|Overall Study||28
10895783|NCT02995694|12061844|FG002|NOT COMPLETED|Overall Study||15
10895784|NCT02700698|12061857|FG000|STARTED|Overall Study||17
10895785|NCT02700698|12061858|FG001|STARTED|Overall Study||18
10895786|NCT02700698|12061857|FG000|COMPLETED|Overall Study||16
10895787|NCT02700698|12061858|FG001|COMPLETED|Overall Study||18
10895788|NCT02700698|12061857|FG000|NOT COMPLETED|Overall Study||1
10895789|NCT02700698|12061858|FG001|NOT COMPLETED|Overall Study||0
10895790|NCT02699086|12061864|FG000|STARTED|Overall Study||0
10895791|NCT02699086|12061865|FG001|STARTED|Overall Study||6
10895792|NCT02699086|12061864|FG000|COMPLETED|Overall Study||0
10895793|NCT02699086|12061865|FG001|COMPLETED|Overall Study||6
10895794|NCT02699086|12061864|FG000|NOT COMPLETED|Overall Study||0
10895795|NCT02699086|12061865|FG001|NOT COMPLETED|Overall Study||0
10895796|NCT02698865|12061875|FG000|STARTED|Overall Study||140
10895797|NCT02698865|12061876|FG001|STARTED|Overall Study||80
10895798|NCT02698865|12061875|FG000|Treated|Overall Study||140
10895799|NCT02698865|12061876|FG001|Treated|Overall Study||80
10895800|NCT02698865|12061875|FG000|COMPLETED|Overall Study||105
10895801|NCT02698865|12061876|FG001|COMPLETED|Overall Study||47
10895802|NCT02698865|12061875|FG000|NOT COMPLETED|Overall Study||35
10895803|NCT02698865|12061876|FG001|NOT COMPLETED|Overall Study||33
10895804|NCT02660086|12061884|FG000|STARTED|Overall Study- 12-month||299
10895805|NCT02660086|12061885|FG001|STARTED|Overall Study- 12-month||303
10895806|NCT02660086|12061884|FG000|COMPLETED|Overall Study- 12-month||273
10895807|NCT02660086|12061885|FG001|COMPLETED|Overall Study- 12-month||274
10895808|NCT02660086|12061884|FG000|NOT COMPLETED|Overall Study- 12-month||26
10895809|NCT02660086|12061885|FG001|NOT COMPLETED|Overall Study- 12-month||29
10895810|NCT02660086|12061884|FG000|STARTED|Overall Study: 24-month Follow-up||281
10895811|NCT02660086|12061885|FG001|STARTED|Overall Study: 24-month Follow-up||278
10895812|NCT02660086|12061884|FG000|COMPLETED|Overall Study: 24-month Follow-up||255
10895813|NCT02660086|12061885|FG001|COMPLETED|Overall Study: 24-month Follow-up||254
10895814|NCT02660086|12061884|FG000|NOT COMPLETED|Overall Study: 24-month Follow-up||26
10895815|NCT02660086|12061885|FG001|NOT COMPLETED|Overall Study: 24-month Follow-up||24
10895816|NCT02335749|12061891|FG000|STARTED|Overall Study||40
10895817|NCT02335749|12061891|FG000|COMPLETED|Overall Study||40
10895818|NCT02335749|12061891|FG000|NOT COMPLETED|Overall Study||0
10895819|NCT02129647|12061895|FG000|STARTED|Overall Study||13
10895820|NCT02129647|12061895|FG000|COMPLETED|Overall Study||10
10895821|NCT02129647|12061895|FG000|NOT COMPLETED|Overall Study||3
10895822|NCT02071901|12061899|FG000|STARTED|Overall Study||31
10895823|NCT02071901|12061899|FG000|COMPLETED|Overall Study||31
10895824|NCT02071901|12061899|FG000|NOT COMPLETED|Overall Study||0
10895825|NCT01959139|12061907|FG000|STARTED|Phase I: Cohort 1||5
10895826|NCT01959139|12061908|FG001|STARTED|Phase I: Cohort 1||0
10895827|NCT01959139|12061909|FG002|STARTED|Phase I: Cohort 1||0
10895828|NCT01959139|12061910|FG003|STARTED|Phase I: Cohort 1||0
10895829|NCT01959139|12061907|FG000|COMPLETED|Phase I: Cohort 1||5
10895830|NCT01959139|12061908|FG001|COMPLETED|Phase I: Cohort 1||0
10895831|NCT01959139|12061909|FG002|COMPLETED|Phase I: Cohort 1||0
10895832|NCT01959139|12061910|FG003|COMPLETED|Phase I: Cohort 1||0
10895833|NCT01959139|12061907|FG000|NOT COMPLETED|Phase I: Cohort 1||0
10895834|NCT01959139|12061908|FG001|NOT COMPLETED|Phase I: Cohort 1||0
10895835|NCT01959139|12061909|FG002|NOT COMPLETED|Phase I: Cohort 1||0
10895836|NCT01959139|12061910|FG003|NOT COMPLETED|Phase I: Cohort 1||0
10895837|NCT01959139|12061907|FG000|STARTED|Phase I: Cohort 2||0
10895838|NCT01959139|12061908|FG001|STARTED|Phase I: Cohort 2||6
10895839|NCT01959139|12061909|FG002|STARTED|Phase I: Cohort 2||0
10895840|NCT01959139|12061910|FG003|STARTED|Phase I: Cohort 2||0
10895841|NCT01959139|12061907|FG000|COMPLETED|Phase I: Cohort 2||0
10895842|NCT01959139|12061908|FG001|COMPLETED|Phase I: Cohort 2||6
10895843|NCT01959139|12061909|FG002|COMPLETED|Phase I: Cohort 2||0
10895844|NCT01959139|12061910|FG003|COMPLETED|Phase I: Cohort 2||0
10895845|NCT01959139|12061907|FG000|NOT COMPLETED|Phase I: Cohort 2||0
10895846|NCT01959139|12061908|FG001|NOT COMPLETED|Phase I: Cohort 2||0
10895847|NCT01959139|12061909|FG002|NOT COMPLETED|Phase I: Cohort 2||0
10895848|NCT01959139|12061910|FG003|NOT COMPLETED|Phase I: Cohort 2||0
10895849|NCT01959139|12061907|FG000|STARTED|Phase II||0
10895850|NCT01959139|12061908|FG001|STARTED|Phase II||0
10895851|NCT01959139|12061909|FG002|STARTED|Phase II||56
10895852|NCT01959139|12061910|FG003|STARTED|Phase II||55
10895853|NCT01959139|12061907|FG000|Assessed for AEs|Phase II||0
10895854|NCT01959139|12061908|FG001|Assessed for AEs|Phase II||0
10895855|NCT01959139|12061909|FG002|Assessed for AEs|Phase II||54
10895856|NCT01959139|12061910|FG003|Assessed for AEs|Phase II||51
10895857|NCT01959139|12061907|FG000|COMPLETED|Phase II||0
10895858|NCT01959139|12061908|FG001|COMPLETED|Phase II||0
10895859|NCT01959139|12061909|FG002|COMPLETED|Phase II||0
10895860|NCT01959139|12061910|FG003|COMPLETED|Phase II||0
10895861|NCT01959139|12061907|FG000|NOT COMPLETED|Phase II||0
10895862|NCT01959139|12061908|FG001|NOT COMPLETED|Phase II||0
10895863|NCT01959139|12061909|FG002|NOT COMPLETED|Phase II||56
10895864|NCT01959139|12061910|FG003|NOT COMPLETED|Phase II||55
10895865|NCT01597778|12061927|FG000|STARTED|Overall Study||186
10895866|NCT01597778|12061928|FG001|STARTED|Overall Study||182
10895867|NCT01597778|12061927|FG000|COMPLETED|Overall Study||172
10895868|NCT01597778|12061928|FG001|COMPLETED|Overall Study||153
10895869|NCT01597778|12061927|FG000|NOT COMPLETED|Overall Study||14
10895870|NCT01597778|12061928|FG001|NOT COMPLETED|Overall Study||29
10895871|NCT01134601|12061934|FG000|STARTED|Overall Study||1
10895872|NCT01134601|12061934|FG000|COMPLETED|Overall Study||1
10895873|NCT01134601|12061934|FG000|NOT COMPLETED|Overall Study||0
10895874|NCT01118026|12061938|FG000|STARTED|Overall Study||101
10895875|NCT01118026|12061938|FG000|COMPLETED|Overall Study||101
10895876|NCT01118026|12061938|FG000|NOT COMPLETED|Overall Study||0
10895877|NCT00879086|12061945|FG000|STARTED|Overall Study||52
10895878|NCT00879086|12061946|FG001|STARTED|Overall Study||52
10895879|NCT00879086|12061945|FG000|Safety Analysis Set (SAS)|Overall Study||51
10895880|NCT00879086|12061946|FG001|Safety Analysis Set (SAS)|Overall Study||50
10895881|NCT00879086|12061945|FG000|COMPLETED|Overall Study||0
10895882|NCT00879086|12061946|FG001|COMPLETED|Overall Study||0
10895883|NCT00879086|12061945|FG000|NOT COMPLETED|Overall Study||52
10895884|NCT00879086|12061946|FG001|NOT COMPLETED|Overall Study||52
10895885|NCT00864227|12061952|FG000|STARTED|Overall Study||54
10895886|NCT00864227|12061952|FG000|COMPLETED|Overall Study||50
10895887|NCT00864227|12061952|FG000|NOT COMPLETED|Overall Study||4
10895888|NCT00685360|12061959|FG000|STARTED|Overall Study||161
10895889|NCT00685360|12061960|FG001|STARTED|Overall Study||160
10895890|NCT00685360|12061961|FG002|STARTED|Overall Study||160
10895891|NCT00685360|12061959|FG000|Modified Intent-to-Treat (MITT)|Overall Study||141
10895892|NCT00685360|12061960|FG001|Modified Intent-to-Treat (MITT)|Overall Study||136
10895893|NCT00685360|12061961|FG002|Modified Intent-to-Treat (MITT)|Overall Study||125
10895894|NCT00685360|12061959|FG000|MITT (Solid Culture)|Overall Study||119
10895895|NCT00685360|12061960|FG001|MITT (Solid Culture)|Overall Study||115
10895896|NCT00685360|12061961|FG002|MITT (Solid Culture)|Overall Study||113
10895897|NCT00685360|12061959|FG000|COMPLETED|Overall Study||143
10895898|NCT00685360|12061960|FG001|COMPLETED|Overall Study||146
10895899|NCT00685360|12061961|FG002|COMPLETED|Overall Study||145
10895900|NCT00685360|12061959|FG000|NOT COMPLETED|Overall Study||18
10895901|NCT00685360|12061960|FG001|NOT COMPLETED|Overall Study||14
10895902|NCT00685360|12061961|FG002|NOT COMPLETED|Overall Study||15
10895903|NCT00299728|12061971|FG000|STARTED|Overall Study||11
10895904|NCT00299728|12061972|FG001|STARTED|Overall Study||11
10895905|NCT00299728|12061971|FG000|COMPLETED|Overall Study||11
10895906|NCT00299728|12061972|FG001|COMPLETED|Overall Study||8
10895907|NCT00299728|12061971|FG000|NOT COMPLETED|Overall Study||0
10895908|NCT00299728|12061972|FG001|NOT COMPLETED|Overall Study||3
10895909|NCT04450823|12061978|FG000|STARTED|Overall Study||61
10895910|NCT04450823|12061978|FG000|COMPLETED|Overall Study||58
10895911|NCT04450823|12061978|FG000|NOT COMPLETED|Overall Study||3
10895912|NCT04446247|12061982|FG000|STARTED|Overall Study||14
10895913|NCT04446247|12061982|FG000|COMPLETED|Overall Study||14
10895914|NCT04446247|12061982|FG000|NOT COMPLETED|Overall Study||0
10895915|NCT04386785|12061988|FG000|STARTED|Overall Study||27
10895916|NCT04386785|12061988|FG000|COMPLETED|Overall Study||27
10895917|NCT04386785|12061988|FG000|NOT COMPLETED|Overall Study||0
10895918|NCT04347564|12061992|FG000|STARTED|Overall Study||45
10895919|NCT04347564|12061992|FG000|COMPLETED|Overall Study||45
10895920|NCT04347564|12061992|FG000|NOT COMPLETED|Overall Study||0
10895921|NCT04330157|12061999|FG000|STARTED|Overall Study||50
10895922|NCT04330157|12061999|FG000|COMPLETED|Overall Study||43
10895923|NCT04330157|12061999|FG000|NOT COMPLETED|Overall Study||7
10895924|NCT04317690|12062013|FG000|STARTED|Overall Study||100
10895925|NCT04317690|12062014|FG001|STARTED|Overall Study||100
10895926|NCT04317690|12062015|FG002|STARTED|Overall Study||140
10895927|NCT04317690|12062016|FG003|STARTED|Overall Study||100
10895928|NCT04317690|12062017|FG004|STARTED|Overall Study||99
10895929|NCT04317690|12062013|FG000|COMPLETED|Overall Study||100
10895930|NCT04317690|12062014|FG001|COMPLETED|Overall Study||96
10895931|NCT04317690|12062015|FG002|COMPLETED|Overall Study||140
10895932|NCT04317690|12062016|FG003|COMPLETED|Overall Study||98
10895933|NCT04317690|12062017|FG004|COMPLETED|Overall Study||99
10895934|NCT04317690|12062013|FG000|NOT COMPLETED|Overall Study||0
10895935|NCT04317690|12062014|FG001|NOT COMPLETED|Overall Study||4
10895936|NCT04317690|12062015|FG002|NOT COMPLETED|Overall Study||0
10895937|NCT04317690|12062016|FG003|NOT COMPLETED|Overall Study||2
10895938|NCT04317690|12062017|FG004|NOT COMPLETED|Overall Study||0
10895939|NCT04274556|12062029|FG000|STARTED|Overall Study||86
10895940|NCT04274556|12062029|FG000|COMPLETED|Overall Study||86
10895941|NCT04274556|12062029|FG000|NOT COMPLETED|Overall Study||0
10895942|NCT04270292|12062033|FG000|STARTED|Overall Study||164
10895943|NCT04270292|12062033|FG000|COMPLETED|Overall Study||164
10895944|NCT04270292|12062033|FG000|NOT COMPLETED|Overall Study||0
10895945|NCT04182217|12062037|FG000|STARTED|Overall Study||91
10895946|NCT04182217|12062037|FG000|COMPLETED|Overall Study||91
10895947|NCT04182217|12062037|FG000|NOT COMPLETED|Overall Study||0
10895948|NCT04160988|12062041|FG000|STARTED|Overall Study||703
10895949|NCT04160988|12062041|FG000|COMPLETED|Overall Study||675
10895950|NCT04160988|12062041|FG000|NOT COMPLETED|Overall Study||28
10895951|NCT04083404|12062046|FG000|STARTED|Overall Study||202
10895952|NCT04083404|12062046|FG000|COMPLETED|Overall Study||202
10895953|NCT04083404|12062046|FG000|NOT COMPLETED|Overall Study||0
10895954|NCT04079114|12062050|FG000|STARTED|Overall Study||166
10895955|NCT04079114|12062050|FG000|COMPLETED|Overall Study|Study prematurely terminated.|0
10895956|NCT04079114|12062050|FG000|NOT COMPLETED|Overall Study||166
10895957|NCT04075279|12062054|FG000|STARTED|Overall Study||19
10895958|NCT04075279|12062054|FG000|COMPLETED|Overall Study||19
10895959|NCT04075279|12062054|FG000|NOT COMPLETED|Overall Study||0
10895960|NCT04066686|12062060|FG000|STARTED|Overall Study||14
10895961|NCT04066686|12062061|FG001|STARTED|Overall Study||13
10895962|NCT04066686|12062060|FG000|COMPLETED|Overall Study||12
10895963|NCT04066686|12062061|FG001|COMPLETED|Overall Study||13
10895964|NCT04066686|12062060|FG000|NOT COMPLETED|Overall Study||2
10895965|NCT04066686|12062061|FG001|NOT COMPLETED|Overall Study||0
10895966|NCT04058626|12062067|FG000|STARTED|Overall Study||305
10895967|NCT04058626|12062067|FG000|COMPLETED|Overall Study||305
10895968|NCT04058626|12062067|FG000|NOT COMPLETED|Overall Study||0
10895969|NCT04057235|12062071|FG000|STARTED|Overall Study||129
10895970|NCT04057235|12062071|FG000|Had Radiographic Data|Overall Study||58
10895971|NCT04057235|12062071|FG000|Had ODI Data|Overall Study||43
10895972|NCT04057235|12062071|FG000|Had VAS Back Data|Overall Study||45
10895973|NCT04057235|12062071|FG000|Had VAS Leg Data|Overall Study||45
10895974|NCT04057235|12062071|FG000|COMPLETED|Overall Study|All 129 participants had data for at least one of the primary/secondary outcomes or adverse events|129
10895975|NCT04057235|12062071|FG000|NOT COMPLETED|Overall Study||0
10895976|NCT04041037|12062075|FG000|STARTED|Overall Study||2
10895977|NCT04041037|12062075|FG000|COMPLETED|Overall Study||2
10895978|NCT04041037|12062075|FG000|NOT COMPLETED|Overall Study||0
10895979|NCT04034043|12062079|FG000|STARTED|Overall Study||68
10895980|NCT04034043|12062079|FG000|COMPLETED|Overall Study||68
10895981|NCT04034043|12062079|FG000|NOT COMPLETED|Overall Study||0
10895982|NCT03977818|12062083|FG000|STARTED|Overall Study||2165
10895983|NCT03977818|12062083|FG000|COMPLETED|Overall Study||2165
10895984|NCT03977818|12062083|FG000|NOT COMPLETED|Overall Study||0
10895985|NCT03976531|12062087|FG000|STARTED|Overall Study||42
10895986|NCT03976531|12062087|FG000|COMPLETED|Overall Study||42
10895987|NCT03976531|12062087|FG000|NOT COMPLETED|Overall Study||0
10895988|NCT03964649|12062101|FG000|STARTED|Overall Study||349
10895989|NCT03964649|12062102|FG001|STARTED|Overall Study||304
10895990|NCT03964649|12062103|FG002|STARTED|Overall Study||2728
10895991|NCT03964649|12062104|FG003|STARTED|Overall Study||192
10895992|NCT03964649|12062105|FG004|STARTED|Overall Study||1948
10895993|NCT03964649|12062106|FG005|STARTED|Overall Study||349
10895994|NCT03964649|12062107|FG006|STARTED|Overall Study||376
10895995|NCT03964649|12062108|FG007|STARTED|Overall Study||325
10895996|NCT03964649|12062109|FG008|STARTED|Overall Study||204
10895997|NCT03964649|12062110|FG009|STARTED|Overall Study||533
10895998|NCT03964649|12062101|FG000|COMPLETED|Overall Study||349
10895999|NCT03964649|12062102|FG001|COMPLETED|Overall Study||304
10896000|NCT03964649|12062103|FG002|COMPLETED|Overall Study||2728
10896001|NCT03964649|12062104|FG003|COMPLETED|Overall Study||192
10896002|NCT03964649|12062105|FG004|COMPLETED|Overall Study||1948
10896003|NCT03964649|12062106|FG005|COMPLETED|Overall Study||349
10896004|NCT03964649|12062107|FG006|COMPLETED|Overall Study||376
10896005|NCT03964649|12062108|FG007|COMPLETED|Overall Study||325
10896006|NCT03964649|12062109|FG008|COMPLETED|Overall Study||204
10896007|NCT03964649|12062110|FG009|COMPLETED|Overall Study||533
10896008|NCT03964649|12062101|FG000|NOT COMPLETED|Overall Study||0
10896009|NCT03964649|12062102|FG001|NOT COMPLETED|Overall Study||0
10896010|NCT03964649|12062103|FG002|NOT COMPLETED|Overall Study||0
10896011|NCT03964649|12062104|FG003|NOT COMPLETED|Overall Study||0
10896012|NCT03964649|12062105|FG004|NOT COMPLETED|Overall Study||0
10896013|NCT03964649|12062106|FG005|NOT COMPLETED|Overall Study||0
10896014|NCT03964649|12062107|FG006|NOT COMPLETED|Overall Study||0
10896015|NCT03964649|12062108|FG007|NOT COMPLETED|Overall Study||0
10896016|NCT03964649|12062109|FG008|NOT COMPLETED|Overall Study||0
10896017|NCT03964649|12062110|FG009|NOT COMPLETED|Overall Study||0
10896018|NCT03941015|12062134|FG000|STARTED|Overall Study||38
10896019|NCT03941015|12062135|FG001|STARTED|Overall Study||207
10896020|NCT03941015|12062134|FG000|COMPLETED|Overall Study||38
10896021|NCT03941015|12062135|FG001|COMPLETED|Overall Study||204
10896022|NCT03941015|12062134|FG000|NOT COMPLETED|Overall Study||0
10896023|NCT03941015|12062135|FG001|NOT COMPLETED|Overall Study||3
10896024|NCT03889028|12062144|FG000|STARTED|Overall Study||144
10896025|NCT03889028|12062145|FG001|STARTED|Overall Study||422
10896026|NCT03889028|12062146|FG002|STARTED|Overall Study||312
10896027|NCT03889028|12062144|FG000|COMPLETED|Overall Study||144
10896028|NCT03889028|12062145|FG001|COMPLETED|Overall Study||422
10896029|NCT03889028|12062146|FG002|COMPLETED|Overall Study||312
10896030|NCT03889028|12062144|FG000|NOT COMPLETED|Overall Study||0
10896031|NCT03889028|12062145|FG001|NOT COMPLETED|Overall Study||0
10896032|NCT03889028|12062146|FG002|NOT COMPLETED|Overall Study||0
10896033|NCT03842683|12062153|FG000|STARTED|Overall Study||472
10896034|NCT03842683|12062153|FG000|COMPLETED|Overall Study||472
10896035|NCT03842683|12062153|FG000|NOT COMPLETED|Overall Study||0
10896036|NCT03839511|12062158|FG000|STARTED|Overall Study||4
10896037|NCT03839511|12062158|FG000|COMPLETED|Overall Study||4
10896038|NCT03839511|12062158|FG000|NOT COMPLETED|Overall Study||0
10896039|NCT03835546|12062165|FG000|STARTED|Overall Study||15
10896040|NCT03835546|12062166|FG001|STARTED|Overall Study||15
10896041|NCT03835546|12062167|FG002|STARTED|Overall Study||15
10896042|NCT03835546|12062165|FG000|COMPLETED|Overall Study||12
10896043|NCT03835546|12062166|FG001|COMPLETED|Overall Study||15
10896044|NCT03835546|12062167|FG002|COMPLETED|Overall Study||15
10896045|NCT03835546|12062165|FG000|NOT COMPLETED|Overall Study||3
10896046|NCT03835546|12062166|FG001|NOT COMPLETED|Overall Study||0
10896047|NCT03835546|12062167|FG002|NOT COMPLETED|Overall Study||0
10896048|NCT04461795|12062175|FG000|STARTED|Overall Study||40
10896049|NCT04461795|12062175|FG000|COMPLETED|Overall Study||35
10896050|NCT04461795|12062175|FG000|NOT COMPLETED|Overall Study||5
10896051|NCT04405999|12062182|FG000|STARTED|Overall Study||25
10896052|NCT04405999|12062183|FG001|STARTED|Overall Study||25
10896053|NCT04405999|12062182|FG000|COMPLETED|Overall Study||25
10896054|NCT04405999|12062183|FG001|COMPLETED|Overall Study||25
10896055|NCT04405999|12062182|FG000|NOT COMPLETED|Overall Study||0
10896056|NCT04405999|12062183|FG001|NOT COMPLETED|Overall Study||0
10896057|NCT04383587|12062189|FG000|STARTED|Overall Study||300
10896058|NCT04383587|12062189|FG000|COMPLETED|Overall Study||292
10896059|NCT04383587|12062189|FG000|NOT COMPLETED|Overall Study||8
10896060|NCT04035473|12062196|FG000|STARTED|Screening/Baseline||20
10896061|NCT04035473|12062197|FG001|STARTED|Screening/Baseline||22
10896062|NCT04035473|12062196|FG000|COMPLETED|Screening/Baseline||20
10896063|NCT04035473|12062197|FG001|COMPLETED|Screening/Baseline||20
10896064|NCT04035473|12062196|FG000|NOT COMPLETED|Screening/Baseline||0
10896065|NCT04035473|12062197|FG001|NOT COMPLETED|Screening/Baseline||2
10896066|NCT04035473|12062196|FG000|STARTED|Treatment Period 1||20
10896067|NCT04035473|12062197|FG001|STARTED|Treatment Period 1||20
10896068|NCT04035473|12062196|FG000|COMPLETED|Treatment Period 1||20
10896069|NCT04035473|12062197|FG001|COMPLETED|Treatment Period 1||20
10896070|NCT04035473|12062196|FG000|NOT COMPLETED|Treatment Period 1||0
10896071|NCT04035473|12062197|FG001|NOT COMPLETED|Treatment Period 1||0
10896072|NCT04035473|12062196|FG000|STARTED|Treatment Period 2|2 subjects withdrew before starting treatment period 2 due to diease progression and withdrawal from study treatment and procedure.|18
10896073|NCT04035473|12062197|FG001|STARTED|Treatment Period 2|1 subject withdrew before starting treatment period 2 due to SAE and investigator's decision.|19
10896074|NCT04035473|12062196|FG000|COMPLETED|Treatment Period 2||18
10896075|NCT04035473|12062197|FG001|COMPLETED|Treatment Period 2||19
10896076|NCT04035473|12062196|FG000|NOT COMPLETED|Treatment Period 2||0
10896077|NCT04035473|12062197|FG001|NOT COMPLETED|Treatment Period 2||0
10896078|NCT04035473|12062196|FG000|STARTED|Follow-up Period||18
10896079|NCT04035473|12062197|FG001|STARTED|Follow-up Period||19
10896080|NCT04035473|12062196|FG000|COMPLETED|Follow-up Period||16
10896081|NCT04035473|12062197|FG001|COMPLETED|Follow-up Period||19
10896082|NCT04035473|12062196|FG000|NOT COMPLETED|Follow-up Period||2
10896083|NCT04035473|12062197|FG001|NOT COMPLETED|Follow-up Period||0
10896084|NCT03796676|12062206|FG000|STARTED|Overall Study||96
10896085|NCT03796676|12062207|FG001|STARTED|Overall Study||95
10896086|NCT03796676|12062208|FG002|STARTED|Overall Study||94
10896087|NCT03796676|12062206|FG000|COMPLETED|Overall Study||90
10896088|NCT03796676|12062207|FG001|COMPLETED|Overall Study||92
10896089|NCT03796676|12062208|FG002|COMPLETED|Overall Study||91
10896090|NCT03796676|12062206|FG000|NOT COMPLETED|Overall Study||6
10896091|NCT03796676|12062207|FG001|NOT COMPLETED|Overall Study||3
10896092|NCT03796676|12062208|FG002|NOT COMPLETED|Overall Study||3
10896093|NCT03366220|12062221|FG000|STARTED|Overall Study||4
10896094|NCT03366220|12062222|FG001|STARTED|Overall Study||4
10896095|NCT03366220|12062221|FG000|COMPLETED|Overall Study||4
10896096|NCT03366220|12062222|FG001|COMPLETED|Overall Study||4
10896097|NCT03366220|12062221|FG000|NOT COMPLETED|Overall Study||0
10896098|NCT03366220|12062222|FG001|NOT COMPLETED|Overall Study||0
10896099|NCT02989857|12062230|FG000|STARTED|Randomization Phase||126
10896100|NCT02989857|12062231|FG001|STARTED|Randomization Phase||61
10896101|NCT02989857|12062232|FG002|STARTED|Randomization Phase||0
10896102|NCT02989857|12062230|FG000|COMPLETED|Randomization Phase|Completed implies the participants who completed the study treatment.|0
10896103|NCT02989857|12062231|FG001|COMPLETED|Randomization Phase|Completed implies the participants who completed the study treatment.|0
10896104|NCT02989857|12062232|FG002|COMPLETED|Randomization Phase||0
10896105|NCT02989857|12062230|FG000|NOT COMPLETED|Randomization Phase||126
10896106|NCT02989857|12062231|FG001|NOT COMPLETED|Randomization Phase||61
10896107|NCT02989857|12062232|FG002|NOT COMPLETED|Randomization Phase||0
10896108|NCT02989857|12062230|FG000|STARTED|Cross Over Phase||0
10896109|NCT02989857|12062231|FG001|STARTED|Cross Over Phase||0
10896110|NCT02989857|12062232|FG002|STARTED|Cross Over Phase|Participants who had experienced disease progression and received placebo were allowed to cross over to receive AG-120.|43
10896111|NCT02989857|12062230|FG000|COMPLETED|Cross Over Phase||0
10896112|NCT02989857|12062231|FG001|COMPLETED|Cross Over Phase||0
10896113|NCT02989857|12062232|FG002|COMPLETED|Cross Over Phase|Completed implies the participants who completed the study treatment.|0
10896114|NCT02989857|12062230|FG000|NOT COMPLETED|Cross Over Phase||0
10896115|NCT02989857|12062231|FG001|NOT COMPLETED|Cross Over Phase||0
10896116|NCT02989857|12062232|FG002|NOT COMPLETED|Cross Over Phase||43
10896117|NCT02983799|12062244|FG000|STARTED|Overall Study||75
10896118|NCT02983799|12062245|FG001|STARTED|Overall Study||26
10896119|NCT02983799|12062246|FG002|STARTED|Overall Study||68
10896120|NCT02983799|12062247|FG003|STARTED|Overall Study||90
10896121|NCT02983799|12062248|FG004|STARTED|Overall Study||13
10896122|NCT02983799|12062244|FG000|COMPLETED|Overall Study||25
10896123|NCT02983799|12062245|FG001|COMPLETED|Overall Study||8
10896124|NCT02983799|12062246|FG002|COMPLETED|Overall Study||18
10896125|NCT02983799|12062247|FG003|COMPLETED|Overall Study||14
10896126|NCT02983799|12062248|FG004|COMPLETED|Overall Study||3
10896127|NCT02983799|12062244|FG000|NOT COMPLETED|Overall Study||50
10896128|NCT02983799|12062245|FG001|NOT COMPLETED|Overall Study||18
10896129|NCT02983799|12062246|FG002|NOT COMPLETED|Overall Study||50
10896130|NCT02983799|12062247|FG003|NOT COMPLETED|Overall Study||76
10896131|NCT02983799|12062248|FG004|NOT COMPLETED|Overall Study||10
10896132|NCT02682992|12062264|FG000|STARTED|Overall Study||47
10896133|NCT02682992|12062264|FG000|COMPLETED|Overall Study||47
10896134|NCT02682992|12062264|FG000|NOT COMPLETED|Overall Study||0
10896135|NCT02631577|12062270|FG000|STARTED|Overall Study||4
10896136|NCT02631577|12062271|FG001|STARTED|Overall Study||34
10896137|NCT02631577|12062270|FG000|COMPLETED|Overall Study||3
10896138|NCT02631577|12062271|FG001|COMPLETED|Overall Study||24
10896139|NCT02631577|12062270|FG000|NOT COMPLETED|Overall Study||1
10896140|NCT02631577|12062271|FG001|NOT COMPLETED|Overall Study||10
10896141|NCT02573779|12062279|FG000|STARTED|Overall Study||74
10896142|NCT02573779|12062280|FG001|STARTED|Overall Study||43
10896143|NCT02573779|12062279|FG000|COMPLETED|Overall Study||74
10896144|NCT02573779|12062280|FG001|COMPLETED|Overall Study||43
10896145|NCT02573779|12062279|FG000|NOT COMPLETED|Overall Study||0
10896146|NCT02573779|12062280|FG001|NOT COMPLETED|Overall Study||0
10896147|NCT02408315|12062288|FG000|STARTED|Overall Study||148
10896148|NCT02408315|12062289|FG001|STARTED|Overall Study||152
10896149|NCT02408315|12062288|FG000|COMPLETED|Overall Study||148
10896150|NCT02408315|12062289|FG001|COMPLETED|Overall Study||152
10896151|NCT02408315|12062288|FG000|NOT COMPLETED|Overall Study||0
10896152|NCT02408315|12062289|FG001|NOT COMPLETED|Overall Study||0
10896153|NCT02300233|12062298|FG000|STARTED|Overall Study||38
10896154|NCT02300233|12062299|FG001|STARTED|Overall Study||25
10896155|NCT02300233|12062300|FG002|STARTED|Overall Study||50
10896156|NCT02300233|12062298|FG000|COMPLETED|Overall Study||34
10896157|NCT02300233|12062299|FG001|COMPLETED|Overall Study||24
10896158|NCT02300233|12062300|FG002|COMPLETED|Overall Study||27
10896159|NCT02300233|12062298|FG000|NOT COMPLETED|Overall Study||4
10896160|NCT02300233|12062299|FG001|NOT COMPLETED|Overall Study||1
10896161|NCT02300233|12062300|FG002|NOT COMPLETED|Overall Study||23
10896162|NCT02211209|12062311|FG000|STARTED|Overall Study||34
10896163|NCT02211209|12062312|FG001|STARTED|Overall Study||33
10896164|NCT02211209|12062311|FG000|Dosed|Overall Study||33
10896165|NCT02211209|12062312|FG001|Dosed|Overall Study||33
10896166|NCT02211209|12062311|FG000|COMPLETED|Overall Study||32
10896167|NCT02211209|12062312|FG001|COMPLETED|Overall Study||19
10896168|NCT02211209|12062311|FG000|NOT COMPLETED|Overall Study||2
10896169|NCT02211209|12062312|FG001|NOT COMPLETED|Overall Study||14
10896170|NCT02000115|12062321|FG000|STARTED|Overall Study||381
10896171|NCT02000115|12062322|FG001|STARTED|Overall Study||369
10896172|NCT02000115|12062323|FG002|STARTED|Overall Study||100
10896173|NCT02000115|12062324|FG003|STARTED|Overall Study||53
10896174|NCT02000115|12062321|FG000|COMPLETED|Overall Study|6 subjects missed the One-year follow-up visit|302
10896175|NCT02000115|12062322|FG001|COMPLETED|Overall Study|8 subjects missed the One-year follow-up visit|301
10896176|NCT02000115|12062323|FG002|COMPLETED|Overall Study|1 subject missed the 30 day follow-up visit|99
10896177|NCT02000115|12062324|FG003|COMPLETED|Overall Study||0
10896178|NCT02000115|12062321|FG000|NOT COMPLETED|Overall Study||79
10896179|NCT02000115|12062322|FG001|NOT COMPLETED|Overall Study||68
10896180|NCT02000115|12062323|FG002|NOT COMPLETED|Overall Study||1
10896181|NCT02000115|12062324|FG003|NOT COMPLETED|Overall Study||53
10896182|NCT01888653|12062335|FG000|STARTED|Overall Study||24
10896183|NCT01888653|12062336|FG001|STARTED|Overall Study||26
10896184|NCT01888653|12062335|FG000|COMPLETED|Overall Study||24
10896185|NCT01888653|12062336|FG001|COMPLETED|Overall Study||26
10896186|NCT01888653|12062335|FG000|NOT COMPLETED|Overall Study||0
10896187|NCT01888653|12062336|FG001|NOT COMPLETED|Overall Study||0
10896188|NCT01813227|12062342|FG000|STARTED|Overall Study||7
10896189|NCT01813227|12062342|FG000|COMPLETED|Overall Study||7
10896190|NCT01813227|12062342|FG000|NOT COMPLETED|Overall Study||0
10896191|NCT01695317|12062348|FG000|STARTED|Period 1 in the Cross-over Design||36
10896192|NCT01695317|12062349|FG001|STARTED|Period 1 in the Cross-over Design||36
10896193|NCT01695317|12062348|FG000|COMPLETED|Period 1 in the Cross-over Design||34
10896194|NCT01695317|12062349|FG001|COMPLETED|Period 1 in the Cross-over Design||35
10896195|NCT01695317|12062348|FG000|NOT COMPLETED|Period 1 in the Cross-over Design||2
10896196|NCT01695317|12062349|FG001|NOT COMPLETED|Period 1 in the Cross-over Design||1
10896197|NCT01695317|12062348|FG000|STARTED|Cross-over to Period 2||34
10896198|NCT01695317|12062349|FG001|STARTED|Cross-over to Period 2||35
10896199|NCT01695317|12062348|FG000|COMPLETED|Cross-over to Period 2||30
10896200|NCT01695317|12062349|FG001|COMPLETED|Cross-over to Period 2||1
10896201|NCT01695317|12062348|FG000|NOT COMPLETED|Cross-over to Period 2||4
10896202|NCT01695317|12062349|FG001|NOT COMPLETED|Cross-over to Period 2||34
10896203|NCT01683825|12062358|FG000|STARTED|Overall Study||10
10896204|NCT01683825|12062359|FG001|STARTED|Overall Study||6
10896205|NCT01683825|12062360|FG002|STARTED|Overall Study||7
10896206|NCT01683825|12062358|FG000|COMPLETED|Overall Study||10
10896207|NCT01683825|12062359|FG001|COMPLETED|Overall Study||6
10896208|NCT01683825|12062360|FG002|COMPLETED|Overall Study||7
10896209|NCT01683825|12062358|FG000|NOT COMPLETED|Overall Study||0
10896210|NCT01683825|12062359|FG001|NOT COMPLETED|Overall Study||0
10896211|NCT01683825|12062360|FG002|NOT COMPLETED|Overall Study||0
10896212|NCT01196936|12062371|FG000|STARTED|Overall Study||34
10896213|NCT01196936|12062372|FG001|STARTED|Overall Study||38
10896214|NCT01196936|12062371|FG000|Year One Post Treatment|Overall Study||27
10896215|NCT01196936|12062372|FG001|Year One Post Treatment|Overall Study||28
10896216|NCT01196936|12062371|FG000|COMPLETED|Overall Study||23
10896217|NCT01196936|12062372|FG001|COMPLETED|Overall Study||21
10896218|NCT01196936|12062371|FG000|NOT COMPLETED|Overall Study||11
10896219|NCT01196936|12062372|FG001|NOT COMPLETED|Overall Study||17
10896220|NCT01127451|12062380|FG000|STARTED|Overall Study||43
10896221|NCT01127451|12062381|FG001|STARTED|Overall Study||32
10896222|NCT01127451|12062380|FG000|Safety Analysis Set|Overall Study||43
10896223|NCT01127451|12062381|FG001|Safety Analysis Set|Overall Study||32
10896224|NCT01127451|12062380|FG000|Modified Intent-to-Treat (MITT)|Overall Study||42
10896225|NCT01127451|12062381|FG001|Modified Intent-to-Treat (MITT)|Overall Study||32
10896226|NCT01127451|12062380|FG000|COMPLETED|Overall Study||0
10896227|NCT01127451|12062381|FG001|COMPLETED|Overall Study||0
10896228|NCT01127451|12062380|FG000|NOT COMPLETED|Overall Study||43
10896229|NCT01127451|12062381|FG001|NOT COMPLETED|Overall Study||32
10896230|NCT01004874|12062387|FG000|STARTED|Overall Study||80
10896231|NCT01004874|12062387|FG000|COMPLETED|Overall Study||80
10896232|NCT01004874|12062387|FG000|NOT COMPLETED|Overall Study||0
10896233|NCT04748120|12062393|FG000|STARTED|Overall Study||1
10896234|NCT04748120|12062394|FG001|STARTED|Overall Study||1
10896235|NCT04748120|12062393|FG000|COMPLETED|Overall Study||1
10896236|NCT04748120|12062394|FG001|COMPLETED|Overall Study||1
10896237|NCT04748120|12062393|FG000|NOT COMPLETED|Overall Study||0
10896238|NCT04748120|12062394|FG001|NOT COMPLETED|Overall Study||0
10896239|NCT04559698|12062404|FG000|STARTED|Overall Study||61
10896240|NCT04559698|12062405|FG001|STARTED|Overall Study||60
10896241|NCT04559698|12062404|FG000|Four-month Pre-intervention|Overall Study|Participants in this arm started training immediately after randomization, and therefore, did not have a four-month waiting period prior to receiving the training.|0
10896242|NCT04559698|12062405|FG001|Four-month Pre-intervention|Overall Study||60
10896243|NCT04559698|12062404|FG000|Immediate Pre-intervention|Overall Study||61
10896244|NCT04559698|12062405|FG001|Immediate Pre-intervention|Overall Study||55
10896245|NCT04559698|12062404|FG000|Immediate Post-intervention|Overall Study||52
10896246|NCT04559698|12062405|FG001|Immediate Post-intervention|Overall Study||44
10896247|NCT04559698|12062404|FG000|Four-month Post-intervention|Overall Study||47
10896248|NCT04559698|12062405|FG001|Four-month Post-intervention|Overall Study|Participants in this arm started training four months after randomization (waitlist) and therefore, were not assessed at the four-month follow-up time point due to completion of the study.|0
10896249|NCT04559698|12062404|FG000|COMPLETED|Overall Study||47
10896250|NCT04559698|12062405|FG001|COMPLETED|Overall Study||44
10896251|NCT04559698|12062404|FG000|NOT COMPLETED|Overall Study||14
10896252|NCT04559698|12062405|FG001|NOT COMPLETED|Overall Study||16
10896253|NCT04492475|12062413|FG000|STARTED|Overall Study||487
10896254|NCT04492475|12062414|FG001|STARTED|Overall Study||482
10896255|NCT04492475|12062413|FG000|ITT and Modified ITT Population|Overall Study||487
10896256|NCT04492475|12062414|FG001|ITT and Modified ITT Population|Overall Study||482
10896257|NCT04492475|12062413|FG000|As Treated Population|Overall Study||477
10896258|NCT04492475|12062414|FG001|As Treated Population|Overall Study||468
10896259|NCT04492475|12062413|FG000|COMPLETED|Overall Study||473
10896260|NCT04492475|12062414|FG001|COMPLETED|Overall Study||474
10896261|NCT04492475|12062413|FG000|NOT COMPLETED|Overall Study||14
10896262|NCT04492475|12062414|FG001|NOT COMPLETED|Overall Study||8
10896263|NCT04401579|12062429|FG000|STARTED|Overall Study||515
10896264|NCT04401579|12062430|FG001|STARTED|Overall Study||518
10896265|NCT04401579|12062429|FG000|Treated|Overall Study||507
10896266|NCT04401579|12062430|FG001|Treated|Overall Study||509
10896267|NCT04401579|12062429|FG000|COMPLETED|Overall Study||431
10896268|NCT04401579|12062430|FG001|COMPLETED|Overall Study||408
10896269|NCT04401579|12062429|FG000|NOT COMPLETED|Overall Study||84
10896270|NCT04401579|12062430|FG001|NOT COMPLETED|Overall Study||110
10896271|NCT04321460|12062438|FG000|STARTED|Overall Study||260
10896272|NCT04321460|12062439|FG001|STARTED|Overall Study||260
10896273|NCT04321460|12062438|FG000|Intention to Treat (ITT) Population|Overall Study||260
10896274|NCT04321460|12062439|FG001|Intention to Treat (ITT) Population|Overall Study||260
10896275|NCT04321460|12062438|FG000|Per-protocol (PP) Population|Overall Study||252
10896276|NCT04321460|12062439|FG001|Per-protocol (PP) Population|Overall Study||248
10896277|NCT04321460|12062438|FG000|COMPLETED|Overall Study||259
10896278|NCT04321460|12062439|FG001|COMPLETED|Overall Study||259
10896279|NCT04321460|12062438|FG000|NOT COMPLETED|Overall Study||1
10896280|NCT04321460|12062439|FG001|NOT COMPLETED|Overall Study||1
10896281|NCT04280705|12062447|FG000|STARTED|Overall Study||521
10896282|NCT04280705|12062448|FG001|STARTED|Overall Study||541
10896283|NCT04280705|12062447|FG000|Received Treatment|Overall Study||517
10896284|NCT04280705|12062448|FG001|Received Treatment|Overall Study||531
10896285|NCT04280705|12062447|FG000|COMPLETED|Overall Study||508
10896286|NCT04280705|12062448|FG001|COMPLETED|Overall Study||517
10896287|NCT04280705|12062447|FG000|NOT COMPLETED|Overall Study||13
10896288|NCT04280705|12062448|FG001|NOT COMPLETED|Overall Study||24
10896289|NCT04208750|12062456|FG000|STARTED|Overall Study||58
10896290|NCT04208750|12062457|FG001|STARTED|Overall Study||61
10896291|NCT04208750|12062456|FG000|Visit 2|Overall Study||58
10896292|NCT04208750|12062457|FG001|Visit 2|Overall Study||61
10896293|NCT04208750|12062456|FG000|Visit 3|Overall Study||58
10896294|NCT04208750|12062457|FG001|Visit 3|Overall Study||53
10896295|NCT04208750|12062456|FG000|Visit 4|Overall Study||43
10896296|NCT04208750|12062457|FG001|Visit 4|Overall Study||47
10896297|NCT04208750|12062456|FG000|COMPLETED|Overall Study||42
10896298|NCT04208750|12062457|FG001|COMPLETED|Overall Study||46
10896299|NCT04208750|12062456|FG000|NOT COMPLETED|Overall Study||16
10896300|NCT04208750|12062457|FG001|NOT COMPLETED|Overall Study||15
10896301|NCT03713281|12062463|FG000|STARTED|Overall Study||28
10896302|NCT03713281|12062463|FG000|COMPLETED|Overall Study||25
10896303|NCT03713281|12062463|FG000|NOT COMPLETED|Overall Study||3
10896304|NCT03608254|12062467|FG000|STARTED|Overall Study||11
10896305|NCT03608254|12062467|FG000|COMPLETED|Overall Study||8
10896306|NCT03608254|12062467|FG000|NOT COMPLETED|Overall Study||3
10896307|NCT03512275|12062473|FG000|STARTED|Overall Study||24
10896308|NCT03512275|12062474|FG001|STARTED|Overall Study||18
10896309|NCT03512275|12062473|FG000|COMPLETED|Overall Study||22
10896310|NCT03512275|12062474|FG001|COMPLETED|Overall Study||11
10896311|NCT03512275|12062473|FG000|NOT COMPLETED|Overall Study||2
10896312|NCT03512275|12062474|FG001|NOT COMPLETED|Overall Study||7
10896313|NCT03414983|12062482|FG000|STARTED|Pre-Treatment||127
10896314|NCT03414983|12062483|FG001|STARTED|Pre-Treatment||68
10896315|NCT03414983|12062482|FG000|COMPLETED|Pre-Treatment||123
10896316|NCT03414983|12062483|FG001|COMPLETED|Pre-Treatment||62
10896317|NCT03414983|12062482|FG000|NOT COMPLETED|Pre-Treatment||4
10896318|NCT03414983|12062483|FG001|NOT COMPLETED|Pre-Treatment||6
10896319|NCT03414983|12062482|FG000|STARTED|Treatment||123
10896320|NCT03414983|12062483|FG001|STARTED|Treatment||62
10896321|NCT03414983|12062482|FG000|COMPLETED|Treatment||4
10896322|NCT03414983|12062483|FG001|COMPLETED|Treatment||2
10896323|NCT03414983|12062482|FG000|NOT COMPLETED|Treatment||119
10896324|NCT03414983|12062483|FG001|NOT COMPLETED|Treatment||60
10896325|NCT03383692|12062491|FG000|STARTED|Overall Study||17
10896326|NCT03383692|12062492|FG001|STARTED|Overall Study||23
10896327|NCT03383692|12062491|FG000|COMPLETED|Overall Study||11
10896328|NCT03383692|12062492|FG001|COMPLETED|Overall Study||19
10896329|NCT03383692|12062491|FG000|NOT COMPLETED|Overall Study||6
10896330|NCT03383692|12062492|FG001|NOT COMPLETED|Overall Study||4
10896331|NCT03371251|12062506|FG000|STARTED|Overall Study||7
10896332|NCT03371251|12062507|FG001|STARTED|Overall Study||5
10896333|NCT03371251|12062508|FG002|STARTED|Overall Study||9
10896334|NCT03371251|12062509|FG003|STARTED|Overall Study||9
10896335|NCT03371251|12062510|FG004|STARTED|Overall Study||37
10896336|NCT03371251|12062511|FG005|STARTED|Overall Study||76
10896337|NCT03371251|12062506|FG000|COMPLETED|Overall Study||5
10896338|NCT03371251|12062507|FG001|COMPLETED|Overall Study||5
10896339|NCT03371251|12062508|FG002|COMPLETED|Overall Study||8
10896340|NCT03371251|12062509|FG003|COMPLETED|Overall Study||9
10896341|NCT03371251|12062510|FG004|COMPLETED|Overall Study||30
10896342|NCT03371251|12062511|FG005|COMPLETED|Overall Study||71
10896343|NCT03371251|12062506|FG000|NOT COMPLETED|Overall Study||2
10896344|NCT03371251|12062507|FG001|NOT COMPLETED|Overall Study||0
10896345|NCT03371251|12062508|FG002|NOT COMPLETED|Overall Study||1
10896346|NCT03371251|12062509|FG003|NOT COMPLETED|Overall Study||0
10896347|NCT03371251|12062510|FG004|NOT COMPLETED|Overall Study||7
10896348|NCT03371251|12062511|FG005|NOT COMPLETED|Overall Study||5
10896349|NCT03349268|12062531|FG000|STARTED|Overall Study||9117
10896350|NCT03349268|12062532|FG001|STARTED|Overall Study||10296
10896351|NCT03349268|12062533|FG002|STARTED|Overall Study||6319
10896352|NCT03349268|12062531|FG000|COMPLETED|Overall Study||9117
10896353|NCT03349268|12062532|FG001|COMPLETED|Overall Study||10296
10896354|NCT03349268|12062533|FG002|COMPLETED|Overall Study||6319
10896355|NCT03349268|12062531|FG000|NOT COMPLETED|Overall Study||0
10896356|NCT03349268|12062532|FG001|NOT COMPLETED|Overall Study||0
10896357|NCT03349268|12062533|FG002|NOT COMPLETED|Overall Study||0
10896358|NCT03088826|12062542|FG000|STARTED|Overall Study||40
10896359|NCT03088826|12062543|FG001|STARTED|Overall Study||40
10896360|NCT03088826|12062542|FG000|COMPLETED|Overall Study||40
10896361|NCT03088826|12062543|FG001|COMPLETED|Overall Study||40
10896362|NCT03088826|12062542|FG000|NOT COMPLETED|Overall Study||0
10896363|NCT03088826|12062543|FG001|NOT COMPLETED|Overall Study||0
10896364|NCT03034018|12062551|FG000|STARTED|Overall Study||30
10896365|NCT03034018|12062552|FG001|STARTED|Overall Study||30
10896366|NCT03034018|12062551|FG000|Initiated Assigned Treatment|Overall Study||27
10896367|NCT03034018|12062552|FG001|Initiated Assigned Treatment|Overall Study||29
10896368|NCT03034018|12062551|FG000|COMPLETED|Overall Study||25
10896369|NCT03034018|12062552|FG001|COMPLETED|Overall Study||28
10896370|NCT03034018|12062551|FG000|NOT COMPLETED|Overall Study||5
10896371|NCT03034018|12062552|FG001|NOT COMPLETED|Overall Study||2
10896372|NCT02750215|12062558|FG000|STARTED|Overall Study||20
10896373|NCT02750215|12062558|FG000|COMPLETED|Overall Study||20
10896374|NCT02750215|12062558|FG000|NOT COMPLETED|Overall Study||0
10896375|NCT02673333|12062562|FG000|STARTED|Overall Study||39
10896376|NCT02673333|12062562|FG000|COMPLETED|Overall Study||39
10896377|NCT02673333|12062562|FG000|NOT COMPLETED|Overall Study||0
10896378|NCT01353118|12062568|FG000|STARTED|Overall Study||21
10896379|NCT01353118|12062569|FG001|STARTED|Overall Study||20
10896380|NCT01353118|12062568|FG000|COMPLETED|Overall Study||21
10896381|NCT01353118|12062569|FG001|COMPLETED|Overall Study||20
10896382|NCT01353118|12062568|FG000|NOT COMPLETED|Overall Study||0
10896383|NCT01353118|12062569|FG001|NOT COMPLETED|Overall Study||0
10896384|NCT01252953|12062577|FG000|STARTED|Overall Study||15225
10896385|NCT01252953|12062578|FG001|STARTED|Overall Study||15224
10896386|NCT01252953|12062577|FG000|COMPLETED|Overall Study||15187
10896387|NCT01252953|12062578|FG001|COMPLETED|Overall Study||15186
10896388|NCT01252953|12062577|FG000|NOT COMPLETED|Overall Study||38
10896389|NCT01252953|12062578|FG001|NOT COMPLETED|Overall Study||38
10896390|NCT01012609|12062587|FG000|STARTED|Overall Study||21
10896391|NCT01012609|12062588|FG001|STARTED|Overall Study||26
10896392|NCT01012609|12062587|FG000|COMPLETED|Overall Study||20
10896393|NCT01012609|12062588|FG001|COMPLETED|Overall Study||25
10896394|NCT01012609|12062587|FG000|NOT COMPLETED|Overall Study||1
10896395|NCT01012609|12062588|FG001|NOT COMPLETED|Overall Study||1
10896396|NCT00458835|12062601|FG000|STARTED|Overall Study||5
10896397|NCT00458835|12062602|FG001|STARTED|Overall Study||5
10896398|NCT00458835|12062603|FG002|STARTED|Overall Study||5
10896399|NCT00458835|12062604|FG003|STARTED|Overall Study||5
10896400|NCT00458835|12062605|FG004|STARTED|Overall Study||5
10896401|NCT00458835|12062606|FG005|STARTED|Overall Study||5
10896402|NCT00458835|12062601|FG000|COMPLETED|Overall Study||5
10896403|NCT00458835|12062602|FG001|COMPLETED|Overall Study||5
10896404|NCT00458835|12062603|FG002|COMPLETED|Overall Study||5
10896405|NCT00458835|12062604|FG003|COMPLETED|Overall Study||5
10896406|NCT00458835|12062605|FG004|COMPLETED|Overall Study||5
10896407|NCT00458835|12062606|FG005|COMPLETED|Overall Study||4
10896408|NCT00458835|12062601|FG000|NOT COMPLETED|Overall Study||0
10896409|NCT00458835|12062602|FG001|NOT COMPLETED|Overall Study||0
10896410|NCT00458835|12062603|FG002|NOT COMPLETED|Overall Study||0
10896411|NCT00458835|12062604|FG003|NOT COMPLETED|Overall Study||0
10896412|NCT00458835|12062605|FG004|NOT COMPLETED|Overall Study||0
10896413|NCT00458835|12062606|FG005|NOT COMPLETED|Overall Study||1
10896414|NCT00403559|12062616|FG000|STARTED|Overall Study||56
10896415|NCT00403559|12062617|FG001|STARTED|Overall Study||56
10896416|NCT00403559|12062616|FG000|COMPLETED|Overall Study||52
10896417|NCT00403559|12062617|FG001|COMPLETED|Overall Study||52
10896418|NCT00403559|12062616|FG000|NOT COMPLETED|Overall Study||4
10896419|NCT00403559|12062617|FG001|NOT COMPLETED|Overall Study||4
10896420|NCT00176436|12062627|FG000|STARTED|Overall Study||20
10896421|NCT00176436|12062628|FG001|STARTED|Overall Study||17
10896422|NCT00176436|12062627|FG000|COMPLETED|Overall Study||14
10896423|NCT00176436|12062628|FG001|COMPLETED|Overall Study||12
10896424|NCT00176436|12062627|FG000|NOT COMPLETED|Overall Study||6
10896425|NCT00176436|12062628|FG001|NOT COMPLETED|Overall Study||5
10896426|NCT04749459|12062634|FG000|STARTED|Overall Study||14
10896427|NCT04749459|12062634|FG000|CSM Classic|Overall Study||12
10896428|NCT04749459|12062634|FG000|CSM Strawberry Flavor|Overall Study||10
10896429|NCT04749459|12062634|FG000|P2 Control Standard|Overall Study||14
10896430|NCT04749459|12062634|FG000|COMPLETED|Overall Study||14
10896431|NCT04749459|12062634|FG000|NOT COMPLETED|Overall Study||0
10896432|NCT04702984|12062645|FG000|STARTED|Overall Study||39
10896433|NCT04702984|12062645|FG000|COMPLETED|Overall Study||38
10896434|NCT04702984|12062645|FG000|NOT COMPLETED|Overall Study||1
10896435|NCT04633564|12062653|FG000|STARTED|Period 1||335
10896436|NCT04633564|12062654|FG001|STARTED|Period 1||329
10896437|NCT04633564|12062653|FG000|COMPLETED|Period 1||227
10896438|NCT04633564|12062654|FG001|COMPLETED|Period 1||220
10896439|NCT04633564|12062653|FG000|NOT COMPLETED|Period 1||108
10896440|NCT04633564|12062654|FG001|NOT COMPLETED|Period 1||109
10896441|NCT04633564|12062653|FG000|STARTED|Period 2||200
10896442|NCT04633564|12062654|FG001|STARTED|Period 2||199
10896443|NCT04633564|12062653|FG000|COMPLETED|Period 2||107
10896444|NCT04633564|12062654|FG001|COMPLETED|Period 2||102
10896445|NCT04633564|12062653|FG000|NOT COMPLETED|Period 2||93
10896446|NCT04633564|12062654|FG001|NOT COMPLETED|Period 2||97
10896447|NCT04195958|12062660|FG000|STARTED|Overall Study||3
10896448|NCT04195958|12062660|FG000|COMPLETED|Overall Study||1
10896449|NCT04195958|12062660|FG000|NOT COMPLETED|Overall Study||2
10896450|NCT04191148|12062666|FG000|STARTED|Overall Study||24
10896451|NCT04191148|12062667|FG001|STARTED|Overall Study||12
10896452|NCT04191148|12062666|FG000|COMPLETED|Overall Study||22
10896453|NCT04191148|12062667|FG001|COMPLETED|Overall Study||12
10896454|NCT04191148|12062666|FG000|NOT COMPLETED|Overall Study||2
10896455|NCT04191148|12062667|FG001|NOT COMPLETED|Overall Study||0
10896456|NCT04130802|12062678|FG000|STARTED|Overall Study||51
10896457|NCT04130802|12062679|FG001|STARTED|Overall Study||51
10896458|NCT04130802|12062680|FG002|STARTED|Overall Study||51
10896459|NCT04130802|12062678|FG000|COMPLETED|Overall Study||50
10896460|NCT04130802|12062679|FG001|COMPLETED|Overall Study||50
10896461|NCT04130802|12062680|FG002|COMPLETED|Overall Study||48
10896462|NCT04130802|12062678|FG000|NOT COMPLETED|Overall Study||1
10896463|NCT04130802|12062679|FG001|NOT COMPLETED|Overall Study||1
10896464|NCT04130802|12062680|FG002|NOT COMPLETED|Overall Study||3
10896465|NCT04105738|12062691|FG000|STARTED|Overall Study||13
10896466|NCT04105738|12062692|FG001|STARTED|Overall Study||0
10896467|NCT04105738|12062691|FG000|COMPLETED|Overall Study||13
10896468|NCT04105738|12062692|FG001|COMPLETED|Overall Study||0
10896469|NCT04105738|12062691|FG000|NOT COMPLETED|Overall Study||0
10896470|NCT04105738|12062692|FG001|NOT COMPLETED|Overall Study||0
10896471|NCT04022733|12062700|FG000|STARTED|Overall Study||67
10896472|NCT04022733|12062701|FG001|STARTED|Overall Study||67
10896473|NCT04022733|12062700|FG000|COMPLETED|Overall Study||64
10896474|NCT04022733|12062701|FG001|COMPLETED|Overall Study||64
10896475|NCT04022733|12062700|FG000|NOT COMPLETED|Overall Study||3
10896476|NCT04022733|12062701|FG001|NOT COMPLETED|Overall Study||3
10896477|NCT04021524|12062709|FG000|STARTED|Overall Study||25
10896478|NCT04021524|12062710|FG001|STARTED|Overall Study||25
10896479|NCT04021524|12062709|FG000|COMPLETED|Overall Study||25
10896480|NCT04021524|12062710|FG001|COMPLETED|Overall Study||24
10896481|NCT04021524|12062709|FG000|NOT COMPLETED|Overall Study||0
10896482|NCT04021524|12062710|FG001|NOT COMPLETED|Overall Study||1
10896483|NCT03830359|12062716|FG000|STARTED|Overall Study||62
10896484|NCT03830359|12062716|FG000|COMPLETED|Overall Study||62
10896485|NCT03830359|12062716|FG000|NOT COMPLETED|Overall Study||0
10896486|NCT03675516|12062722|FG000|STARTED|Overall Study||6591
10896487|NCT03675516|12062723|FG001|STARTED|Overall Study||6591
10896488|NCT03675516|12062722|FG000|COMPLETED|Overall Study||6591
10896489|NCT03675516|12062723|FG001|COMPLETED|Overall Study||6591
10896490|NCT03675516|12062722|FG000|NOT COMPLETED|Overall Study||0
10896491|NCT03675516|12062723|FG001|NOT COMPLETED|Overall Study||0
10896492|NCT03605680|12062734|FG000|STARTED|SB Placebo Run-in Period (1 Week)||604
10896493|NCT03605680|12062735|FG001|STARTED|SB Placebo Run-in Period (1 Week)||0
10896494|NCT03605680|12062736|FG002|STARTED|SB Placebo Run-in Period (1 Week)||0
10896495|NCT03605680|12062737|FG003|STARTED|SB Placebo Run-in Period (1 Week)||0
10896496|NCT03605680|12062734|FG000|Treated|SB Placebo Run-in Period (1 Week)||584
10896497|NCT03605680|12062735|FG001|Treated|SB Placebo Run-in Period (1 Week)||0
10896498|NCT03605680|12062736|FG002|Treated|SB Placebo Run-in Period (1 Week)||0
10896499|NCT03605680|12062737|FG003|Treated|SB Placebo Run-in Period (1 Week)||0
10896500|NCT03605680|12062734|FG000|COMPLETED|SB Placebo Run-in Period (1 Week)||466
10896501|NCT03605680|12062735|FG001|COMPLETED|SB Placebo Run-in Period (1 Week)||0
10896502|NCT03605680|12062736|FG002|COMPLETED|SB Placebo Run-in Period (1 Week)||0
10896503|NCT03605680|12062737|FG003|COMPLETED|SB Placebo Run-in Period (1 Week)||0
10896504|NCT03605680|12062734|FG000|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||138
10896505|NCT03605680|12062735|FG001|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
10896506|NCT03605680|12062736|FG002|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
10896507|NCT03605680|12062737|FG003|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
10896508|NCT03605680|12062734|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||0
10896509|NCT03605680|12062735|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||154
10896510|NCT03605680|12062736|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||156
10896511|NCT03605680|12062737|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||156
10896512|NCT03605680|12062734|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||0
10896513|NCT03605680|12062735|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||110
10896514|NCT03605680|12062736|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||117
10896515|NCT03605680|12062737|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||121
10896516|NCT03605680|12062734|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||0
10896517|NCT03605680|12062735|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||44
10896518|NCT03605680|12062736|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||39
10896519|NCT03605680|12062737|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||35
10896520|NCT03485950|12062748|FG000|STARTED|Overall Study||50
10896521|NCT03485950|12062749|FG001|STARTED|Overall Study||50
10896522|NCT03485950|12062748|FG000|COMPLETED|Overall Study||43
10896523|NCT03485950|12062749|FG001|COMPLETED|Overall Study||48
10896524|NCT03485950|12062748|FG000|NOT COMPLETED|Overall Study||7
10896525|NCT03485950|12062749|FG001|NOT COMPLETED|Overall Study||2
10896526|NCT03404518|12062757|FG000|STARTED|Overall Study||97
10896527|NCT03404518|12062758|FG001|STARTED|Overall Study||88
10896528|NCT03404518|12062757|FG000|COMPLETED|Overall Study||56
10896529|NCT03404518|12062758|FG001|COMPLETED|Overall Study||52
10896530|NCT03404518|12062757|FG000|NOT COMPLETED|Overall Study||41
10896531|NCT03404518|12062758|FG001|NOT COMPLETED|Overall Study||36
10896532|NCT03370757|12062766|FG000|STARTED|Overall Study||20
10896533|NCT03370757|12062767|FG001|STARTED|Overall Study||28
10896534|NCT03370757|12062766|FG000|COMPLETED|Overall Study||20
10896535|NCT03370757|12062767|FG001|COMPLETED|Overall Study||26
10896536|NCT03370757|12062766|FG000|NOT COMPLETED|Overall Study||0
10896537|NCT03370757|12062767|FG001|NOT COMPLETED|Overall Study||2
10896538|NCT03303989|12062777|FG000|STARTED|Overall Study||24
10896539|NCT03303989|12062778|FG001|STARTED|Overall Study||11
10896540|NCT03303989|12062777|FG000|COMPLETED|Overall Study||22
10896541|NCT03303989|12062778|FG001|COMPLETED|Overall Study||10
10896542|NCT03303989|12062777|FG000|NOT COMPLETED|Overall Study||2
10896543|NCT03303989|12062778|FG001|NOT COMPLETED|Overall Study||1
10896544|NCT03289143|12062788|FG000|STARTED|Overall Study||135
10896545|NCT03289143|12062789|FG001|STARTED|Overall Study||94
10896546|NCT03289143|12062790|FG002|STARTED|Overall Study||136
10896547|NCT03289143|12062791|FG003|STARTED|Overall Study||92
10896548|NCT03289143|12062788|FG000|COMPLETED|Overall Study||1
10896549|NCT03289143|12062789|FG001|COMPLETED|Overall Study||0
10896550|NCT03289143|12062790|FG002|COMPLETED|Overall Study||2
10896551|NCT03289143|12062791|FG003|COMPLETED|Overall Study||0
10896552|NCT03289143|12062788|FG000|NOT COMPLETED|Overall Study||134
10896553|NCT03289143|12062789|FG001|NOT COMPLETED|Overall Study||94
10896554|NCT03289143|12062790|FG002|NOT COMPLETED|Overall Study||134
10896555|NCT03289143|12062791|FG003|NOT COMPLETED|Overall Study||92
10896556|NCT03156504|12062806|FG000|STARTED|Overall Study||75
10896557|NCT03156504|12062806|FG000|COMPLETED|Overall Study||74
10896558|NCT03156504|12062806|FG000|NOT COMPLETED|Overall Study||1
10896559|NCT02993926|12062810|FG000|STARTED|Enantone Treatment Phase||108
10896560|NCT02993926|12062811|FG001|STARTED|Enantone Treatment Phase||0
10896561|NCT02993926|12062812|FG002|STARTED|Enantone Treatment Phase||0
10896562|NCT02993926|12062810|FG000|COMPLETED|Enantone Treatment Phase||76
10896563|NCT02993926|12062811|FG001|COMPLETED|Enantone Treatment Phase||0
10896564|NCT02993926|12062812|FG002|COMPLETED|Enantone Treatment Phase||0
10896565|NCT02993926|12062810|FG000|NOT COMPLETED|Enantone Treatment Phase||32
10896566|NCT02993926|12062811|FG001|NOT COMPLETED|Enantone Treatment Phase||0
10896567|NCT02993926|12062812|FG002|NOT COMPLETED|Enantone Treatment Phase||0
10896568|NCT02993926|12062810|FG000|STARTED|Follow-Up Phase||0
10896569|NCT02993926|12062811|FG001|STARTED|Follow-Up Phase||44
10896570|NCT02993926|12062812|FG002|STARTED|Follow-Up Phase||26
10896571|NCT02993926|12062810|FG000|COMPLETED|Follow-Up Phase||0
10896572|NCT02993926|12062811|FG001|COMPLETED|Follow-Up Phase||44
10896573|NCT02993926|12062812|FG002|COMPLETED|Follow-Up Phase||26
10896574|NCT02993926|12062810|FG000|NOT COMPLETED|Follow-Up Phase||0
10896575|NCT02993926|12062811|FG001|NOT COMPLETED|Follow-Up Phase||0
10896576|NCT02993926|12062812|FG002|NOT COMPLETED|Follow-Up Phase||0
10896577|NCT02932579|12062824|FG000|STARTED|Overall Study||33
10896578|NCT02932579|12062825|FG001|STARTED|Overall Study||26
10896579|NCT02932579|12062824|FG000|COMPLETED|Overall Study||29
10896580|NCT02932579|12062825|FG001|COMPLETED|Overall Study||25
10896581|NCT02932579|12062824|FG000|NOT COMPLETED|Overall Study||4
10896582|NCT02932579|12062825|FG001|NOT COMPLETED|Overall Study||1
10896583|NCT02858154|12062831|FG000|STARTED|HFNC 3-4 Hours||9
10896584|NCT02858154|12062831|FG000|COMPLETED|HFNC 3-4 Hours||9
10896585|NCT02858154|12062831|FG000|NOT COMPLETED|HFNC 3-4 Hours||0
10896586|NCT02858154|12062831|FG000|STARTED|Clinically Ordered PSG/Low Flow Oxygen||9
10896587|NCT02858154|12062831|FG000|COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||9
10896588|NCT02858154|12062831|FG000|NOT COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||0
10896589|NCT02852967|12062841|FG000|STARTED|Overall Study||23
10896590|NCT02852967|12062842|FG001|STARTED|Overall Study||22
10896591|NCT02852967|12062843|FG002|STARTED|Overall Study||21
10896592|NCT02852967|12062844|FG003|STARTED|Overall Study||26
10896593|NCT02852967|12062845|FG004|STARTED|Overall Study||18
10896594|NCT02852967|12062841|FG000|Completed Period 1: Double-blind|Overall Study||14
10896595|NCT02852967|12062842|FG001|Completed Period 1: Double-blind|Overall Study||15
10896596|NCT02852967|12062843|FG002|Completed Period 1: Double-blind|Overall Study||17
10896597|NCT02852967|12062844|FG003|Completed Period 1: Double-blind|Overall Study||16
10896598|NCT02852967|12062845|FG004|Completed Period 1: Double-blind|Overall Study||10
10896599|NCT02852967|12062841|FG000|Completed Period 2: Open-label|Overall Study||11
10896600|NCT02852967|12062842|FG001|Completed Period 2: Open-label|Overall Study||8
10896601|NCT02852967|12062843|FG002|Completed Period 2: Open-label|Overall Study||13
10896602|NCT02852967|12062844|FG003|Completed Period 2: Open-label|Overall Study||11
10896603|NCT02852967|12062845|FG004|Completed Period 2: Open-label|Overall Study||14
10896604|NCT02852967|12062841|FG000|COMPLETED|Overall Study||9
10896605|NCT02852967|12062842|FG001|COMPLETED|Overall Study||6
10896606|NCT02852967|12062843|FG002|COMPLETED|Overall Study||9
10896607|NCT02852967|12062844|FG003|COMPLETED|Overall Study||4
10896608|NCT02852967|12062845|FG004|COMPLETED|Overall Study||2
10896609|NCT02852967|12062841|FG000|NOT COMPLETED|Overall Study||14
10896610|NCT02852967|12062842|FG001|NOT COMPLETED|Overall Study||16
10896611|NCT02852967|12062843|FG002|NOT COMPLETED|Overall Study||12
10896612|NCT02852967|12062844|FG003|NOT COMPLETED|Overall Study||22
10896613|NCT02852967|12062845|FG004|NOT COMPLETED|Overall Study||16
10896614|NCT02810418|12062872|FG000|STARTED|Arm A Dose Escalation||6
10896615|NCT02810418|12062873|FG001|STARTED|Arm A Dose Escalation||8
10896616|NCT02810418|12062874|FG002|STARTED|Arm A Dose Escalation||0
10896617|NCT02810418|12062875|FG003|STARTED|Arm A Dose Escalation||0
10896618|NCT02810418|12062876|FG004|STARTED|Arm A Dose Escalation||0
10896619|NCT02810418|12062877|FG005|STARTED|Arm A Dose Escalation||0
10896620|NCT02810418|12062878|FG006|STARTED|Arm A Dose Escalation||0
10896621|NCT02810418|12062872|FG000|COMPLETED|Arm A Dose Escalation||4
10896622|NCT02810418|12062873|FG001|COMPLETED|Arm A Dose Escalation||7
10896623|NCT02810418|12062874|FG002|COMPLETED|Arm A Dose Escalation||0
10896624|NCT02810418|12062875|FG003|COMPLETED|Arm A Dose Escalation||0
10896625|NCT02810418|12062876|FG004|COMPLETED|Arm A Dose Escalation||0
10896626|NCT02810418|12062877|FG005|COMPLETED|Arm A Dose Escalation||0
10896627|NCT02810418|12062878|FG006|COMPLETED|Arm A Dose Escalation||0
10896628|NCT02810418|12062872|FG000|NOT COMPLETED|Arm A Dose Escalation||2
10896629|NCT02810418|12062873|FG001|NOT COMPLETED|Arm A Dose Escalation||1
10896630|NCT02810418|12062874|FG002|NOT COMPLETED|Arm A Dose Escalation||0
10896631|NCT02810418|12062875|FG003|NOT COMPLETED|Arm A Dose Escalation||0
10896632|NCT02810418|12062876|FG004|NOT COMPLETED|Arm A Dose Escalation||0
10896633|NCT02810418|12062877|FG005|NOT COMPLETED|Arm A Dose Escalation||0
10896634|NCT02810418|12062878|FG006|NOT COMPLETED|Arm A Dose Escalation||0
10896635|NCT02810418|12062872|FG000|STARTED|Dose Expansion||0
10896636|NCT02810418|12062873|FG001|STARTED|Dose Expansion||8
10896637|NCT02810418|12062874|FG002|STARTED|Dose Expansion||6
10896638|NCT02810418|12062875|FG003|STARTED|Dose Expansion||0
10896639|NCT02810418|12062876|FG004|STARTED|Dose Expansion||0
10896640|NCT02810418|12062877|FG005|STARTED|Dose Expansion||0
10896641|NCT02810418|12062878|FG006|STARTED|Dose Expansion||0
10896642|NCT02810418|12062872|FG000|COMPLETED|Dose Expansion||0
10896643|NCT02810418|12062873|FG001|COMPLETED|Dose Expansion||7
10896644|NCT02810418|12062874|FG002|COMPLETED|Dose Expansion||3
10896645|NCT02810418|12062875|FG003|COMPLETED|Dose Expansion||0
10896646|NCT02810418|12062876|FG004|COMPLETED|Dose Expansion||0
10896647|NCT02810418|12062877|FG005|COMPLETED|Dose Expansion||0
10896648|NCT02810418|12062878|FG006|COMPLETED|Dose Expansion||0
10896649|NCT02810418|12062872|FG000|NOT COMPLETED|Dose Expansion||0
10896650|NCT02810418|12062873|FG001|NOT COMPLETED|Dose Expansion||1
10896651|NCT02810418|12062874|FG002|NOT COMPLETED|Dose Expansion||3
10896652|NCT02810418|12062875|FG003|NOT COMPLETED|Dose Expansion||0
10896653|NCT02810418|12062876|FG004|NOT COMPLETED|Dose Expansion||0
10896654|NCT02810418|12062877|FG005|NOT COMPLETED|Dose Expansion||0
10896655|NCT02810418|12062878|FG006|NOT COMPLETED|Dose Expansion||0
10896656|NCT02810418|12062872|FG000|STARTED|Arm B Dose Escalation||0
10896657|NCT02810418|12062873|FG001|STARTED|Arm B Dose Escalation||0
10896658|NCT02810418|12062874|FG002|STARTED|Arm B Dose Escalation||0
10896659|NCT02810418|12062875|FG003|STARTED|Arm B Dose Escalation||6
10896660|NCT02810418|12062876|FG004|STARTED|Arm B Dose Escalation||3
10896661|NCT02810418|12062877|FG005|STARTED|Arm B Dose Escalation||6
10896662|NCT02810418|12062878|FG006|STARTED|Arm B Dose Escalation||0
10896663|NCT02810418|12062872|FG000|COMPLETED|Arm B Dose Escalation||0
10896664|NCT02810418|12062873|FG001|COMPLETED|Arm B Dose Escalation||0
10896665|NCT02810418|12062874|FG002|COMPLETED|Arm B Dose Escalation||0
10896666|NCT02810418|12062875|FG003|COMPLETED|Arm B Dose Escalation||6
10896667|NCT02810418|12062876|FG004|COMPLETED|Arm B Dose Escalation||2
10896668|NCT02810418|12062877|FG005|COMPLETED|Arm B Dose Escalation||4
10896669|NCT02810418|12062878|FG006|COMPLETED|Arm B Dose Escalation||0
10896670|NCT02810418|12062872|FG000|NOT COMPLETED|Arm B Dose Escalation||0
10896671|NCT02810418|12062873|FG001|NOT COMPLETED|Arm B Dose Escalation||0
10896672|NCT02810418|12062874|FG002|NOT COMPLETED|Arm B Dose Escalation||0
10896673|NCT02810418|12062875|FG003|NOT COMPLETED|Arm B Dose Escalation||0
10896674|NCT02810418|12062876|FG004|NOT COMPLETED|Arm B Dose Escalation||1
10896675|NCT02810418|12062877|FG005|NOT COMPLETED|Arm B Dose Escalation||2
10896676|NCT02810418|12062878|FG006|NOT COMPLETED|Arm B Dose Escalation||0
10896677|NCT02810418|12062872|FG000|STARTED|Arm B Combination Therapy||0
10896678|NCT02810418|12062873|FG001|STARTED|Arm B Combination Therapy||0
10896679|NCT02810418|12062874|FG002|STARTED|Arm B Combination Therapy||0
10896680|NCT02810418|12062875|FG003|STARTED|Arm B Combination Therapy||0
10896681|NCT02810418|12062876|FG004|STARTED|Arm B Combination Therapy||0
10896682|NCT02810418|12062877|FG005|STARTED|Arm B Combination Therapy||0
10896683|NCT02810418|12062878|FG006|STARTED|Arm B Combination Therapy||5
10896684|NCT02810418|12062872|FG000|COMPLETED|Arm B Combination Therapy||0
10896685|NCT02810418|12062873|FG001|COMPLETED|Arm B Combination Therapy||0
10896686|NCT02810418|12062874|FG002|COMPLETED|Arm B Combination Therapy||0
10896687|NCT02810418|12062875|FG003|COMPLETED|Arm B Combination Therapy||0
10896688|NCT02810418|12062876|FG004|COMPLETED|Arm B Combination Therapy||0
10896689|NCT02810418|12062877|FG005|COMPLETED|Arm B Combination Therapy||0
10896690|NCT02810418|12062878|FG006|COMPLETED|Arm B Combination Therapy||5
10896691|NCT02810418|12062872|FG000|NOT COMPLETED|Arm B Combination Therapy||0
10896692|NCT02810418|12062873|FG001|NOT COMPLETED|Arm B Combination Therapy||0
10896693|NCT02810418|12062874|FG002|NOT COMPLETED|Arm B Combination Therapy||0
10896694|NCT02810418|12062875|FG003|NOT COMPLETED|Arm B Combination Therapy||0
10896695|NCT02810418|12062876|FG004|NOT COMPLETED|Arm B Combination Therapy||0
10896696|NCT02810418|12062877|FG005|NOT COMPLETED|Arm B Combination Therapy||0
10896697|NCT02810418|12062878|FG006|NOT COMPLETED|Arm B Combination Therapy||0
10896698|NCT02785991|12062941|FG000|STARTED|Overall Study||1742
10896699|NCT02785991|12062941|FG000|COMPLETED|Overall Study||1741
10896700|NCT02785991|12062941|FG000|NOT COMPLETED|Overall Study||1
10896701|NCT02781584|12062959|FG000|STARTED|Pre-treatment Phase||0
10896702|NCT02781584|12062960|FG001|STARTED|Pre-treatment Phase||0
10896703|NCT02781584|12062961|FG002|STARTED|Pre-treatment Phase||0
10896704|NCT02781584|12062962|FG003|STARTED|Pre-treatment Phase||0
10896705|NCT02781584|12062963|FG004|STARTED|Pre-treatment Phase||0
10896706|NCT02781584|12062964|FG005|STARTED|Pre-treatment Phase||0
10896707|NCT02781584|12062965|FG006|STARTED|Pre-treatment Phase||0
10896708|NCT02781584|12062966|FG007|STARTED|Pre-treatment Phase||0
10896709|NCT02781584|12062967|FG008|STARTED|Pre-treatment Phase||0
10896710|NCT02781584|12062968|FG009|STARTED|Pre-treatment Phase||15
10896711|NCT02781584|12062969|FG010|STARTED|Pre-treatment Phase||16
10896712|NCT02781584|12062970|FG011|STARTED|Pre-treatment Phase||33
10896713|NCT02781584|12062971|FG012|STARTED|Pre-treatment Phase||33
10896714|NCT02781584|12062959|FG000|COMPLETED|Pre-treatment Phase||0
10896715|NCT02781584|12062960|FG001|COMPLETED|Pre-treatment Phase||0
10896716|NCT02781584|12062961|FG002|COMPLETED|Pre-treatment Phase||0
10896717|NCT02781584|12062962|FG003|COMPLETED|Pre-treatment Phase||0
10896718|NCT02781584|12062963|FG004|COMPLETED|Pre-treatment Phase||0
10896719|NCT02781584|12062964|FG005|COMPLETED|Pre-treatment Phase||0
10896720|NCT02781584|12062965|FG006|COMPLETED|Pre-treatment Phase||0
10896721|NCT02781584|12062966|FG007|COMPLETED|Pre-treatment Phase||0
10896722|NCT02781584|12062967|FG008|COMPLETED|Pre-treatment Phase||0
10896723|NCT02781584|12062968|FG009|COMPLETED|Pre-treatment Phase||15
10896724|NCT02781584|12062969|FG010|COMPLETED|Pre-treatment Phase||16
10896725|NCT02781584|12062970|FG011|COMPLETED|Pre-treatment Phase||30
10896726|NCT02781584|12062971|FG012|COMPLETED|Pre-treatment Phase||32
10896727|NCT02781584|12062959|FG000|NOT COMPLETED|Pre-treatment Phase||0
10896728|NCT02781584|12062960|FG001|NOT COMPLETED|Pre-treatment Phase||0
10896729|NCT02781584|12062961|FG002|NOT COMPLETED|Pre-treatment Phase||0
10896730|NCT02781584|12062962|FG003|NOT COMPLETED|Pre-treatment Phase||0
10896731|NCT02781584|12062963|FG004|NOT COMPLETED|Pre-treatment Phase||0
10896732|NCT02781584|12062964|FG005|NOT COMPLETED|Pre-treatment Phase||0
10896733|NCT02781584|12062965|FG006|NOT COMPLETED|Pre-treatment Phase||0
10896734|NCT02781584|12062966|FG007|NOT COMPLETED|Pre-treatment Phase||0
10896735|NCT02781584|12062967|FG008|NOT COMPLETED|Pre-treatment Phase||0
10896736|NCT02781584|12062968|FG009|NOT COMPLETED|Pre-treatment Phase||0
10896737|NCT02781584|12062969|FG010|NOT COMPLETED|Pre-treatment Phase||0
10896738|NCT02781584|12062970|FG011|NOT COMPLETED|Pre-treatment Phase||3
10896739|NCT02781584|12062971|FG012|NOT COMPLETED|Pre-treatment Phase||1
10896906|NCT02316002|12063142|FG000|COMPLETED|Overall Study||45
10896740|NCT02781584|12062959|FG000|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
10896741|NCT02781584|12062960|FG001|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
10896742|NCT02781584|12062961|FG002|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
10896743|NCT02781584|12062962|FG003|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
10896744|NCT02781584|12062963|FG004|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
10896745|NCT02781584|12062964|FG005|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
10896746|NCT02781584|12062965|FG006|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
10896747|NCT02781584|12062966|FG007|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
10896748|NCT02781584|12062967|FG008|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|13
10896749|NCT02781584|12062968|FG009|STARTED|Treatment Phase||15
10896750|NCT02781584|12062969|FG010|STARTED|Treatment Phase||16
10896751|NCT02781584|12062970|FG011|STARTED|Treatment Phase||30
10896752|NCT02781584|12062971|FG012|STARTED|Treatment Phase||32
10896753|NCT02781584|12062959|FG000|COMPLETED|Treatment Phase||10
10896754|NCT02781584|12062960|FG001|COMPLETED|Treatment Phase||10
10896755|NCT02781584|12062961|FG002|COMPLETED|Treatment Phase||10
10896756|NCT02781584|12062962|FG003|COMPLETED|Treatment Phase||20
10896757|NCT02781584|12062963|FG004|COMPLETED|Treatment Phase||20
10896758|NCT02781584|12062964|FG005|COMPLETED|Treatment Phase||19
10896759|NCT02781584|12062965|FG006|COMPLETED|Treatment Phase||10
10896760|NCT02781584|12062966|FG007|COMPLETED|Treatment Phase||9
10896761|NCT02781584|12062967|FG008|COMPLETED|Treatment Phase||13
10896762|NCT02781584|12062968|FG009|COMPLETED|Treatment Phase||15
10896763|NCT02781584|12062969|FG010|COMPLETED|Treatment Phase||15
10896764|NCT02781584|12062970|FG011|COMPLETED|Treatment Phase||28
10896765|NCT02781584|12062971|FG012|COMPLETED|Treatment Phase||32
10896766|NCT02781584|12062959|FG000|NOT COMPLETED|Treatment Phase||0
10896767|NCT02781584|12062960|FG001|NOT COMPLETED|Treatment Phase||0
10896768|NCT02781584|12062961|FG002|NOT COMPLETED|Treatment Phase||0
10896769|NCT02781584|12062962|FG003|NOT COMPLETED|Treatment Phase||0
10896770|NCT02781584|12062963|FG004|NOT COMPLETED|Treatment Phase||0
10896771|NCT02781584|12062964|FG005|NOT COMPLETED|Treatment Phase||1
10896772|NCT02781584|12062965|FG006|NOT COMPLETED|Treatment Phase||0
10896773|NCT02781584|12062966|FG007|NOT COMPLETED|Treatment Phase||1
10896774|NCT02781584|12062967|FG008|NOT COMPLETED|Treatment Phase||0
10896775|NCT02781584|12062968|FG009|NOT COMPLETED|Treatment Phase||0
10896776|NCT02781584|12062969|FG010|NOT COMPLETED|Treatment Phase||1
10896777|NCT02781584|12062970|FG011|NOT COMPLETED|Treatment Phase||2
10896778|NCT02781584|12062971|FG012|NOT COMPLETED|Treatment Phase||0
10896779|NCT02730130|12062999|FG000|STARTED|Overall Study||17
10896780|NCT02730130|12062999|FG000|COMPLETED|Overall Study||17
10896781|NCT02730130|12062999|FG000|NOT COMPLETED|Overall Study||0
10896782|NCT02707055|12063005|FG000|STARTED|Phase 1||18
10896783|NCT02707055|12063006|FG001|STARTED|Phase 1||19
10896784|NCT02707055|12063005|FG000|COMPLETED|Phase 1||17
10896785|NCT02707055|12063006|FG001|COMPLETED|Phase 1||16
10896786|NCT02707055|12063005|FG000|NOT COMPLETED|Phase 1||1
10896787|NCT02707055|12063006|FG001|NOT COMPLETED|Phase 1||3
10896788|NCT02707055|12063005|FG000|STARTED|Washout Period||17
10896789|NCT02707055|12063006|FG001|STARTED|Washout Period||16
10896790|NCT02707055|12063005|FG000|COMPLETED|Washout Period||17
10896791|NCT02707055|12063006|FG001|COMPLETED|Washout Period||16
10896792|NCT02707055|12063005|FG000|NOT COMPLETED|Washout Period||0
10896793|NCT02707055|12063006|FG001|NOT COMPLETED|Washout Period||0
10896794|NCT02707055|12063005|FG000|STARTED|Phase 2||17
10896795|NCT02707055|12063006|FG001|STARTED|Phase 2||16
10896796|NCT02707055|12063005|FG000|COMPLETED|Phase 2||16
10896797|NCT02707055|12063006|FG001|COMPLETED|Phase 2||14
10896798|NCT02707055|12063005|FG000|NOT COMPLETED|Phase 2||1
10896799|NCT02707055|12063006|FG001|NOT COMPLETED|Phase 2||2
10896800|NCT02696759|12063012|FG000|STARTED|Overall Study||15
10896801|NCT02696759|12063012|FG000|COMPLETED|Overall Study||15
10896802|NCT02696759|12063012|FG000|NOT COMPLETED|Overall Study||0
10896803|NCT02656290|12063016|FG000|STARTED|Overall Study||26
10896804|NCT02656290|12063016|FG000|1 Year|Overall Study|One subject missed the 1 year follow-up visit.|25
10896805|NCT02656290|12063016|FG000|2 Year|Overall Study||17
10896806|NCT02656290|12063016|FG000|3 Year|Overall Study||6
10896807|NCT02656290|12063016|FG000|COMPLETED|Overall Study||0
10896808|NCT02656290|12063016|FG000|NOT COMPLETED|Overall Study||26
10896809|NCT02652130|12063020|FG000|STARTED|Overall Study||32
10896810|NCT02652130|12063020|FG000|COMPLETED|Overall Study||31
10896811|NCT02652130|12063020|FG000|NOT COMPLETED|Overall Study||1
10896812|NCT02616393|12063027|FG000|STARTED|Overall Study||13
10896813|NCT02616393|12063028|FG001|STARTED|Overall Study||20
10896814|NCT02616393|12063029|FG002|STARTED|Overall Study||3
10896815|NCT02616393|12063027|FG000|COMPLETED|Overall Study||0
10896816|NCT02616393|12063028|FG001|COMPLETED|Overall Study||0
10896817|NCT02616393|12063029|FG002|COMPLETED|Overall Study||0
10896818|NCT02616393|12063027|FG000|NOT COMPLETED|Overall Study||13
10896819|NCT02616393|12063028|FG001|NOT COMPLETED|Overall Study||20
10896820|NCT02616393|12063029|FG002|NOT COMPLETED|Overall Study||3
10896821|NCT02602288|12063055|FG000|STARTED|End of Treatment/3 Month Follow-up||199
10896822|NCT02602288|12063056|FG001|STARTED|End of Treatment/3 Month Follow-up||197
10896823|NCT02602288|12063055|FG000|COMPLETED|End of Treatment/3 Month Follow-up||174
10896824|NCT02602288|12063056|FG001|COMPLETED|End of Treatment/3 Month Follow-up||179
10896825|NCT02602288|12063055|FG000|NOT COMPLETED|End of Treatment/3 Month Follow-up||25
10896826|NCT02602288|12063056|FG001|NOT COMPLETED|End of Treatment/3 Month Follow-up||18
10896827|NCT02602288|12063055|FG000|STARTED|12 Month Follow-up||174
10896828|NCT02602288|12063056|FG001|STARTED|12 Month Follow-up||179
10896829|NCT02602288|12063055|FG000|COMPLETED|12 Month Follow-up||172
10896830|NCT02602288|12063056|FG001|COMPLETED|12 Month Follow-up||175
10896831|NCT02602288|12063055|FG000|NOT COMPLETED|12 Month Follow-up||2
10896832|NCT02602288|12063056|FG001|NOT COMPLETED|12 Month Follow-up||4
10896833|NCT02577523|12063064|FG000|STARTED|Overall Study||19
10896834|NCT02577523|12063065|FG001|STARTED|Overall Study||19
10896835|NCT02577523|12063064|FG000|COMPLETED|Overall Study||16
10896836|NCT02577523|12063065|FG001|COMPLETED|Overall Study||17
10896837|NCT02577523|12063064|FG000|NOT COMPLETED|Overall Study||3
10896838|NCT02577523|12063065|FG001|NOT COMPLETED|Overall Study||2
10896839|NCT02461225|12063073|FG000|STARTED|Overall Study||19
10896840|NCT02461225|12063074|FG001|STARTED|Overall Study||11
10896841|NCT02461225|12063073|FG000|COMPLETED|Overall Study||19
10896842|NCT02461225|12063074|FG001|COMPLETED|Overall Study||11
10896843|NCT02461225|12063073|FG000|NOT COMPLETED|Overall Study||0
10896844|NCT02461225|12063074|FG001|NOT COMPLETED|Overall Study||0
10896845|NCT02427958|12063080|FG000|STARTED|Overall Study||307
10896846|NCT02427958|12063080|FG000|COMPLETED|Overall Study||283
10896847|NCT02427958|12063080|FG000|NOT COMPLETED|Overall Study||24
10896848|NCT02425826|12063086|FG000|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
10896849|NCT02425826|12063087|FG001|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
10896850|NCT02425826|12063088|FG002|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
10896851|NCT02425826|12063086|FG000|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
10896852|NCT02425826|12063087|FG001|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
10896853|NCT02425826|12063088|FG002|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
10896854|NCT02425826|12063086|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
10896855|NCT02425826|12063087|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
10896856|NCT02425826|12063088|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
10896857|NCT02425826|12063086|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
10896858|NCT02425826|12063087|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
10896859|NCT02425826|12063088|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
10896860|NCT02425826|12063086|FG000|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
10896861|NCT02425826|12063087|FG001|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
10896862|NCT02425826|12063088|FG002|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
10896863|NCT02425826|12063086|FG000|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
10896864|NCT02425826|12063087|FG001|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
10896865|NCT02425826|12063088|FG002|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
10896866|NCT02425826|12063086|FG000|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
10896867|NCT02425826|12063087|FG001|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
10896868|NCT02425826|12063088|FG002|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
10896869|NCT02425826|12063086|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
10896870|NCT02425826|12063087|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
10896871|NCT02425826|12063088|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
10896872|NCT02425826|12063086|FG000|STARTED|Post-Treatment Observational Follow-Up||81
10896873|NCT02425826|12063087|FG001|STARTED|Post-Treatment Observational Follow-Up||0
10896874|NCT02425826|12063088|FG002|STARTED|Post-Treatment Observational Follow-Up||49
10896875|NCT02425826|12063086|FG000|COMPLETED|Post-Treatment Observational Follow-Up||80
10896876|NCT02425826|12063087|FG001|COMPLETED|Post-Treatment Observational Follow-Up||0
10896877|NCT02425826|12063088|FG002|COMPLETED|Post-Treatment Observational Follow-Up||49
10896878|NCT02425826|12063086|FG000|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
10896879|NCT02425826|12063087|FG001|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
10896880|NCT02425826|12063088|FG002|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
10896881|NCT02384239|12063100|FG000|STARTED|Overall Study||36
10896882|NCT02384239|12063101|FG001|STARTED|Overall Study||34
10896883|NCT02384239|12063100|FG000|COMPLETED|Overall Study||36
10896884|NCT02384239|12063101|FG001|COMPLETED|Overall Study||34
10896885|NCT02384239|12063100|FG000|NOT COMPLETED|Overall Study||0
10896886|NCT02384239|12063101|FG001|NOT COMPLETED|Overall Study||0
10896887|NCT02356705|12063111|FG000|STARTED|Overall Study||14
10896888|NCT02356705|12063112|FG001|STARTED|Overall Study||14
10896889|NCT02356705|12063113|FG002|STARTED|Overall Study||14
10896890|NCT02356705|12063111|FG000|COMPLETED|Overall Study||14
10896891|NCT02356705|12063112|FG001|COMPLETED|Overall Study||14
10896892|NCT02356705|12063113|FG002|COMPLETED|Overall Study||14
10896893|NCT02356705|12063111|FG000|NOT COMPLETED|Overall Study||0
10896894|NCT02356705|12063112|FG001|NOT COMPLETED|Overall Study||0
10896895|NCT02356705|12063113|FG002|NOT COMPLETED|Overall Study||0
10896896|NCT02353247|12063126|FG000|STARTED|Overall Study||30
10896897|NCT02353247|12063127|FG001|STARTED|Overall Study||23
10896898|NCT02353247|12063128|FG002|STARTED|Overall Study||35
10896899|NCT02353247|12063126|FG000|COMPLETED|Overall Study||21
10896900|NCT02353247|12063127|FG001|COMPLETED|Overall Study||18
10896901|NCT02353247|12063128|FG002|COMPLETED|Overall Study||0
10896902|NCT02353247|12063126|FG000|NOT COMPLETED|Overall Study||9
10896903|NCT02353247|12063127|FG001|NOT COMPLETED|Overall Study||5
10896904|NCT02353247|12063128|FG002|NOT COMPLETED|Overall Study||35
10896905|NCT02316002|12063142|FG000|STARTED|Overall Study||51
10896907|NCT02316002|12063142|FG000|NOT COMPLETED|Overall Study||6
10896908|NCT02021071|12063148|FG000|STARTED|Overall Study||12
10896909|NCT02021071|12063149|FG001|STARTED|Overall Study||12
10896910|NCT02021071|12063148|FG000|COMPLETED|Overall Study||12
10896911|NCT02021071|12063149|FG001|COMPLETED|Overall Study||12
10896912|NCT02021071|12063148|FG000|NOT COMPLETED|Overall Study||0
10896913|NCT02021071|12063149|FG001|NOT COMPLETED|Overall Study||0
10896914|NCT01927068|12063158|FG000|STARTED|Overall Study||370
10896915|NCT01927068|12063159|FG001|STARTED|Overall Study||129
10896916|NCT01927068|12063158|FG000|COMPLETED|Overall Study||262
10896917|NCT01927068|12063159|FG001|COMPLETED|Overall Study||121
10896918|NCT01927068|12063158|FG000|NOT COMPLETED|Overall Study||108
10896919|NCT01927068|12063159|FG001|NOT COMPLETED|Overall Study||8
10896920|NCT01883817|12063168|FG000|STARTED|Overall Study||14
10896921|NCT01883817|12063169|FG001|STARTED|Overall Study||16
10896922|NCT01883817|12063168|FG000|COMPLETED|Overall Study||10
10896923|NCT01883817|12063169|FG001|COMPLETED|Overall Study||9
10896924|NCT01883817|12063168|FG000|NOT COMPLETED|Overall Study||4
10896925|NCT01883817|12063169|FG001|NOT COMPLETED|Overall Study||7
10896926|NCT01813435|12063177|FG000|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980
10896927|NCT01813435|12063178|FG001|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988
10896928|NCT01813435|12063177|FG000|COMPLETED|Overall Study||5810
10896929|NCT01813435|12063178|FG001|COMPLETED|Overall Study||6981
10896930|NCT01813435|12063177|FG000|NOT COMPLETED|Overall Study||2170
10896931|NCT01813435|12063178|FG001|NOT COMPLETED|Overall Study||1007
10896932|NCT01700439|12063184|FG000|STARTED|Overall Study||889
10896933|NCT01700439|12063184|FG000|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
10896934|NCT01700439|12063184|FG000|Discharge|Overall Study||831
10896935|NCT01700439|12063184|FG000|3 Month|Overall Study||778
10896936|NCT01700439|12063184|FG000|1 Year|Overall Study||573
10896937|NCT01700439|12063184|FG000|2 Year|Overall Study||215
10896938|NCT01700439|12063184|FG000|COMPLETED|Overall Study||0
10896939|NCT01700439|12063184|FG000|NOT COMPLETED|Overall Study||889
10896940|NCT01690299|12063192|FG000|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
10896941|NCT01690299|12063193|FG001|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
10896942|NCT01690299|12063194|FG002|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
10896943|NCT01690299|12063195|FG003|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
10896944|NCT01690299|12063196|FG004|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
10896945|NCT01690299|12063197|FG005|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
10896946|NCT01690299|12063192|FG000|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
10896947|NCT01690299|12063193|FG001|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
10896948|NCT01690299|12063194|FG002|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
10896949|NCT01690299|12063195|FG003|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
10896950|NCT01690299|12063196|FG004|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
10896951|NCT01690299|12063197|FG005|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
10896952|NCT01690299|12063192|FG000|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
10896953|NCT01690299|12063193|FG001|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
10896954|NCT01690299|12063194|FG002|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
10896955|NCT01690299|12063195|FG003|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
10896956|NCT01690299|12063196|FG004|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
10896957|NCT01690299|12063197|FG005|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
10896958|NCT01690299|12063192|FG000|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
10896959|NCT01690299|12063193|FG001|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
10896960|NCT01690299|12063194|FG002|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
10896961|NCT01690299|12063195|FG003|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
10896962|NCT01690299|12063196|FG004|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
10896963|NCT01690299|12063197|FG005|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
10896964|NCT01690299|12063192|FG000|STARTED|Apremilast Extension Phase (Weeks16-104)||0
10896965|NCT01690299|12063193|FG001|STARTED|Apremilast Extension Phase (Weeks16-104)||0
10896966|NCT01690299|12063194|FG002|STARTED|Apremilast Extension Phase (Weeks16-104)||0
10896967|NCT01690299|12063195|FG003|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
10896968|NCT01690299|12063196|FG004|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
10896969|NCT01690299|12063197|FG005|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
10896970|NCT01690299|12063192|FG000|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
10896971|NCT01690299|12063193|FG001|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
10896972|NCT01690299|12063194|FG002|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
10896973|NCT01690299|12063195|FG003|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
10896974|NCT01690299|12063196|FG004|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
10896975|NCT01690299|12063197|FG005|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
10896976|NCT01690299|12063192|FG000|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
10896977|NCT01690299|12063193|FG001|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
10896978|NCT01690299|12063194|FG002|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
10896979|NCT01690299|12063195|FG003|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
10896980|NCT01690299|12063196|FG004|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
10896981|NCT01690299|12063197|FG005|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
10896982|NCT01690299|12063192|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
10896983|NCT01690299|12063193|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
10896984|NCT01690299|12063194|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
10896985|NCT01690299|12063195|FG003|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
10896986|NCT01690299|12063196|FG004|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
10896987|NCT01690299|12063197|FG005|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
10896988|NCT01525329|12063220|FG000|STARTED|Overall Study||4
10896989|NCT01525329|12063221|FG001|STARTED|Overall Study||14
10896990|NCT01525329|12063220|FG000|COMPLETED|Overall Study||4
10896991|NCT01525329|12063221|FG001|COMPLETED|Overall Study||14
10896992|NCT01525329|12063220|FG000|NOT COMPLETED|Overall Study||0
10896993|NCT01525329|12063221|FG001|NOT COMPLETED|Overall Study||0
10896994|NCT01482286|12063235|FG000|STARTED|Overall Study||7
10896995|NCT01482286|12063236|FG001|STARTED|Overall Study||7
10896996|NCT01482286|12063237|FG002|STARTED|Overall Study||8
10896997|NCT01482286|12063238|FG003|STARTED|Overall Study||10
10896998|NCT01482286|12063235|FG000|COMPLETED|Overall Study||4
10896999|NCT01482286|12063236|FG001|COMPLETED|Overall Study||4
10897000|NCT01482286|12063237|FG002|COMPLETED|Overall Study||4
10897001|NCT01482286|12063238|FG003|COMPLETED|Overall Study||5
10897002|NCT01482286|12063235|FG000|NOT COMPLETED|Overall Study||3
10897003|NCT01482286|12063236|FG001|NOT COMPLETED|Overall Study||3
10897004|NCT01482286|12063237|FG002|NOT COMPLETED|Overall Study||4
10897005|NCT01482286|12063238|FG003|NOT COMPLETED|Overall Study||5
10897006|NCT01452152|12063251|FG000|STARTED|Overall Study||5
10897007|NCT01452152|12063252|FG001|STARTED|Overall Study||0
10897008|NCT01452152|12063253|FG002|STARTED|Overall Study||4
10897009|NCT01452152|12063251|FG000|COMPLETED|Overall Study||0
10897010|NCT01452152|12063252|FG001|COMPLETED|Overall Study||0
10897011|NCT01452152|12063253|FG002|COMPLETED|Overall Study||0
10897012|NCT01452152|12063251|FG000|NOT COMPLETED|Overall Study||5
10897013|NCT01452152|12063252|FG001|NOT COMPLETED|Overall Study||0
10897014|NCT01452152|12063253|FG002|NOT COMPLETED|Overall Study||4
10897015|NCT01313351|12063261|FG000|STARTED|Overall Study||206
10897016|NCT01313351|12063261|FG000|COMPLETED|Overall Study||206
10897017|NCT01313351|12063261|FG000|NOT COMPLETED|Overall Study||0
10897018|NCT01232283|12063268|FG000|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
10897019|NCT01232283|12063269|FG001|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
10897020|NCT01232283|12063270|FG002|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10897021|NCT01232283|12063271|FG003|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10897022|NCT01232283|12063272|FG004|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10897023|NCT01232283|12063273|FG005|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10897024|NCT01232283|12063274|FG006|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10897025|NCT01232283|12063275|FG007|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10897026|NCT01232283|12063276|FG008|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10897027|NCT01232283|12063277|FG009|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
10897028|NCT01232283|12063268|FG000|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
10897029|NCT01232283|12063269|FG001|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
10897030|NCT01232283|12063270|FG002|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10897031|NCT01232283|12063271|FG003|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10897032|NCT01232283|12063272|FG004|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10897033|NCT01232283|12063273|FG005|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10897034|NCT01232283|12063274|FG006|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10897035|NCT01232283|12063275|FG007|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10897036|NCT01232283|12063276|FG008|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10897037|NCT01232283|12063277|FG009|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
10897038|NCT01232283|12063268|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
10897039|NCT01232283|12063269|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
10897040|NCT01232283|12063270|FG002|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897041|NCT01232283|12063271|FG003|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897042|NCT01232283|12063272|FG004|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897043|NCT01232283|12063273|FG005|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897044|NCT01232283|12063274|FG006|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897045|NCT01232283|12063275|FG007|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897046|NCT01232283|12063276|FG008|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897047|NCT01232283|12063277|FG009|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897048|NCT01232283|12063268|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
10897049|NCT01232283|12063269|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
10897050|NCT01232283|12063270|FG002|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897051|NCT01232283|12063271|FG003|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897052|NCT01232283|12063272|FG004|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897053|NCT01232283|12063273|FG005|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897054|NCT01232283|12063274|FG006|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897055|NCT01232283|12063275|FG007|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897056|NCT01232283|12063276|FG008|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897057|NCT01232283|12063277|FG009|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
10897058|NCT01232283|12063268|FG000|STARTED|Maintenance Phase (Weeks16-32)||0
10897059|NCT01232283|12063269|FG001|STARTED|Maintenance Phase (Weeks16-32)||0
10897060|NCT01232283|12063270|FG002|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
10897061|NCT01232283|12063271|FG003|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
10897062|NCT01232283|12063272|FG004|STARTED|Maintenance Phase (Weeks16-32)||0
10897063|NCT01232283|12063273|FG005|STARTED|Maintenance Phase (Weeks16-32)||0
10897064|NCT01232283|12063274|FG006|STARTED|Maintenance Phase (Weeks16-32)||0
10897065|NCT01232283|12063275|FG007|STARTED|Maintenance Phase (Weeks16-32)||0
10897066|NCT01232283|12063276|FG008|STARTED|Maintenance Phase (Weeks16-32)||0
10897067|NCT01232283|12063277|FG009|STARTED|Maintenance Phase (Weeks16-32)||0
10897068|NCT01232283|12063268|FG000|COMPLETED|Maintenance Phase (Weeks16-32)||0
10897069|NCT01232283|12063269|FG001|COMPLETED|Maintenance Phase (Weeks16-32)||0
10897070|NCT01232283|12063270|FG002|COMPLETED|Maintenance Phase (Weeks16-32)||194
10897071|NCT01232283|12063271|FG003|COMPLETED|Maintenance Phase (Weeks16-32)||100
10897072|NCT01232283|12063272|FG004|COMPLETED|Maintenance Phase (Weeks16-32)||0
10897073|NCT01232283|12063273|FG005|COMPLETED|Maintenance Phase (Weeks16-32)||0
10897074|NCT01232283|12063274|FG006|COMPLETED|Maintenance Phase (Weeks16-32)||0
10897075|NCT01232283|12063275|FG007|COMPLETED|Maintenance Phase (Weeks16-32)||0
10897076|NCT01232283|12063276|FG008|COMPLETED|Maintenance Phase (Weeks16-32)||0
10897077|NCT01232283|12063277|FG009|COMPLETED|Maintenance Phase (Weeks16-32)||0
10897078|NCT01232283|12063268|FG000|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10897079|NCT01232283|12063269|FG001|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10897080|NCT01232283|12063270|FG002|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
10897081|NCT01232283|12063271|FG003|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
10897082|NCT01232283|12063272|FG004|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10897083|NCT01232283|12063273|FG005|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10897084|NCT01232283|12063274|FG006|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10897085|NCT01232283|12063275|FG007|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10897086|NCT01232283|12063276|FG008|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10897087|NCT01232283|12063277|FG009|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
10897088|NCT01232283|12063268|FG000|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897089|NCT01232283|12063269|FG001|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897090|NCT01232283|12063270|FG002|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897091|NCT01232283|12063271|FG003|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897092|NCT01232283|12063272|FG004|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
10897093|NCT01232283|12063273|FG005|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
10897094|NCT01232283|12063274|FG006|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
10897095|NCT01232283|12063275|FG007|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
10897096|NCT01232283|12063276|FG008|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897097|NCT01232283|12063277|FG009|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897098|NCT01232283|12063268|FG000|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10897099|NCT01232283|12063269|FG001|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10897100|NCT01232283|12063270|FG002|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10897101|NCT01232283|12063271|FG003|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10897102|NCT01232283|12063272|FG004|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10897103|NCT01232283|12063273|FG005|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10897104|NCT01232283|12063274|FG006|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
10897105|NCT01232283|12063275|FG007|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
10897106|NCT01232283|12063276|FG008|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10897107|NCT01232283|12063277|FG009|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
10897108|NCT01232283|12063268|FG000|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897109|NCT01232283|12063269|FG001|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897110|NCT01232283|12063270|FG002|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897111|NCT01232283|12063271|FG003|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897112|NCT01232283|12063272|FG004|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
10897113|NCT01232283|12063273|FG005|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
10897114|NCT01232283|12063274|FG006|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
10897115|NCT01232283|12063275|FG007|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
10897116|NCT01232283|12063276|FG008|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897117|NCT01232283|12063277|FG009|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897118|NCT01232283|12063268|FG000|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897119|NCT01232283|12063269|FG001|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897120|NCT01232283|12063270|FG002|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897121|NCT01232283|12063271|FG003|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897122|NCT01232283|12063272|FG004|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
10897123|NCT01232283|12063273|FG005|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
10897124|NCT01232283|12063274|FG006|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
10897125|NCT01232283|12063275|FG007|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
10897126|NCT01232283|12063276|FG008|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897127|NCT01232283|12063277|FG009|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
10897128|NCT01232283|12063268|FG000|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10897129|NCT01232283|12063269|FG001|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10897130|NCT01232283|12063270|FG002|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10897131|NCT01232283|12063271|FG003|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10897132|NCT01232283|12063272|FG004|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10897133|NCT01232283|12063273|FG005|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10897134|NCT01232283|12063274|FG006|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10897135|NCT01232283|12063275|FG007|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
10897136|NCT01232283|12063276|FG008|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
10897137|NCT01232283|12063277|FG009|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
10897138|NCT01232283|12063268|FG000|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897139|NCT01232283|12063269|FG001|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897140|NCT01232283|12063270|FG002|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897141|NCT01232283|12063271|FG003|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897142|NCT01232283|12063272|FG004|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897143|NCT01232283|12063273|FG005|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897144|NCT01232283|12063274|FG006|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897145|NCT01232283|12063275|FG007|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897146|NCT01232283|12063276|FG008|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
10897147|NCT01232283|12063277|FG009|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
10897148|NCT01232283|12063268|FG000|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897149|NCT01232283|12063269|FG001|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897150|NCT01232283|12063270|FG002|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897151|NCT01232283|12063271|FG003|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897152|NCT01232283|12063272|FG004|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897153|NCT01232283|12063273|FG005|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897154|NCT01232283|12063274|FG006|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897155|NCT01232283|12063275|FG007|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
10897156|NCT01232283|12063276|FG008|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
10897157|NCT01232283|12063277|FG009|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
10897158|NCT01231516|12063301|FG000|STARTED|Double-blind Phase (Up to Week [Wk] 48)||360
10897159|NCT01231516|12063302|FG001|STARTED|Double-blind Phase (Up to Week [Wk] 48)||364
10897160|NCT01231516|12063301|FG000|ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||357
10897161|NCT01231516|12063302|FG001|ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||362
10897162|NCT01231516|12063301|FG000|Modified (m)ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||354
10897163|NCT01231516|12063302|FG001|Modified (m)ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||361
10897164|NCT01231516|12063301|FG000|COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||299
10897165|NCT01231516|12063302|FG001|COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||283
10897166|NCT01231516|12063301|FG000|NOT COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||61
10897167|NCT01231516|12063302|FG001|NOT COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||81
10897168|NCT01231516|12063301|FG000|STARTED|Open-label Phase:From Wk 48 up to Wk 480|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
10897169|NCT01231516|12063302|FG001|STARTED|Open-label Phase:From Wk 48 up to Wk 480|157 participants completed the Double-blind Phase but did not enter the Open-label Phase.|126
10897170|NCT01231516|12063301|FG000|COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||227
10897171|NCT01231516|12063302|FG001|COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||109
10897172|NCT01231516|12063301|FG000|NOT COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||68
10897173|NCT01231516|12063302|FG001|NOT COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||17
10897174|NCT01194219|12063310|FG000|STARTED|Placebo-Controlled Phase Weeks 0-16||562
10897175|NCT01194219|12063311|FG001|STARTED|Placebo-Controlled Phase Weeks 0-16||282
10897176|NCT01194219|12063312|FG002|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10897177|NCT01194219|12063313|FG003|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10897178|NCT01194219|12063314|FG004|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10897179|NCT01194219|12063315|FG005|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10897180|NCT01194219|12063316|FG006|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10897181|NCT01194219|12063317|FG007|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10897182|NCT01194219|12063318|FG008|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10897183|NCT01194219|12063319|FG009|STARTED|Placebo-Controlled Phase Weeks 0-16||0
10897184|NCT01194219|12063310|FG000|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
10897185|NCT01194219|12063311|FG001|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
10897186|NCT01194219|12063312|FG002|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10897187|NCT01194219|12063313|FG003|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10897188|NCT01194219|12063314|FG004|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10897189|NCT01194219|12063315|FG005|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10897190|NCT01194219|12063316|FG006|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10897191|NCT01194219|12063317|FG007|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10897192|NCT01194219|12063318|FG008|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10897193|NCT01194219|12063319|FG009|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
10897194|NCT01194219|12063310|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
10897195|NCT01194219|12063311|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
10897196|NCT01194219|12063312|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897197|NCT01194219|12063313|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897198|NCT01194219|12063314|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897199|NCT01194219|12063315|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897200|NCT01194219|12063316|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897201|NCT01194219|12063317|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897202|NCT01194219|12063318|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897203|NCT01194219|12063319|FG009|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897204|NCT01194219|12063310|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
10897205|NCT01194219|12063311|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
10897206|NCT01194219|12063312|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897207|NCT01194219|12063313|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897208|NCT01194219|12063314|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897209|NCT01194219|12063315|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897210|NCT01194219|12063316|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897211|NCT01194219|12063317|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897212|NCT01194219|12063318|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897213|NCT01194219|12063319|FG009|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
10897214|NCT01194219|12063310|FG000|STARTED|Maintenance Phase Weeks16-32||0
10897215|NCT01194219|12063311|FG001|STARTED|Maintenance Phase Weeks16-32||0
10897216|NCT01194219|12063312|FG002|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
10897217|NCT01194219|12063313|FG003|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
10897218|NCT01194219|12063314|FG004|STARTED|Maintenance Phase Weeks16-32||0
10897219|NCT01194219|12063315|FG005|STARTED|Maintenance Phase Weeks16-32||0
10897220|NCT01194219|12063316|FG006|STARTED|Maintenance Phase Weeks16-32||0
10897221|NCT01194219|12063317|FG007|STARTED|Maintenance Phase Weeks16-32||0
10897222|NCT01194219|12063318|FG008|STARTED|Maintenance Phase Weeks16-32||0
10897223|NCT01194219|12063319|FG009|STARTED|Maintenance Phase Weeks16-32||0
10897224|NCT01194219|12063310|FG000|Received Apremilast|Maintenance Phase Weeks16-32||0
10897225|NCT01194219|12063311|FG001|Received Apremilast|Maintenance Phase Weeks16-32||0
10897226|NCT01194219|12063312|FG002|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
10897227|NCT01194219|12063313|FG003|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
10897228|NCT01194219|12063314|FG004|Received Apremilast|Maintenance Phase Weeks16-32||0
10897229|NCT01194219|12063315|FG005|Received Apremilast|Maintenance Phase Weeks16-32||0
10897230|NCT01194219|12063316|FG006|Received Apremilast|Maintenance Phase Weeks16-32||0
10897231|NCT01194219|12063317|FG007|Received Apremilast|Maintenance Phase Weeks16-32||0
10897232|NCT01194219|12063318|FG008|Received Apremilast|Maintenance Phase Weeks16-32||0
10897233|NCT01194219|12063319|FG009|Received Apremilast|Maintenance Phase Weeks16-32||0
10897234|NCT01194219|12063310|FG000|COMPLETED|Maintenance Phase Weeks16-32||0
10897235|NCT01194219|12063311|FG001|COMPLETED|Maintenance Phase Weeks16-32||0
10897236|NCT01194219|12063312|FG002|COMPLETED|Maintenance Phase Weeks16-32||424
10897237|NCT01194219|12063313|FG003|COMPLETED|Maintenance Phase Weeks16-32||215
10897238|NCT01194219|12063314|FG004|COMPLETED|Maintenance Phase Weeks16-32||0
10897239|NCT01194219|12063315|FG005|COMPLETED|Maintenance Phase Weeks16-32||0
10897240|NCT01194219|12063316|FG006|COMPLETED|Maintenance Phase Weeks16-32||0
10897241|NCT01194219|12063317|FG007|COMPLETED|Maintenance Phase Weeks16-32||0
10897242|NCT01194219|12063318|FG008|COMPLETED|Maintenance Phase Weeks16-32||0
10897243|NCT01194219|12063319|FG009|COMPLETED|Maintenance Phase Weeks16-32||0
10897244|NCT01194219|12063310|FG000|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10897245|NCT01194219|12063311|FG001|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10897246|NCT01194219|12063312|FG002|NOT COMPLETED|Maintenance Phase Weeks16-32||70
10897247|NCT01194219|12063313|FG003|NOT COMPLETED|Maintenance Phase Weeks16-32||30
10897248|NCT01194219|12063314|FG004|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10897249|NCT01194219|12063315|FG005|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10897250|NCT01194219|12063316|FG006|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10897251|NCT01194219|12063317|FG007|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10897252|NCT01194219|12063318|FG008|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10897253|NCT01194219|12063319|FG009|NOT COMPLETED|Maintenance Phase Weeks16-32||0
10897254|NCT01194219|12063310|FG000|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
10897255|NCT01194219|12063311|FG001|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
10897256|NCT01194219|12063312|FG002|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
10897257|NCT01194219|12063313|FG003|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
10897258|NCT01194219|12063314|FG004|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
10897259|NCT01194219|12063315|FG005|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
10897260|NCT01194219|12063316|FG006|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
10897261|NCT01194219|12063317|FG007|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
10897262|NCT01194219|12063318|FG008|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
10897263|NCT01194219|12063319|FG009|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
10897264|NCT01194219|12063310|FG000|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10897265|NCT01194219|12063311|FG001|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10897266|NCT01194219|12063312|FG002|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10897267|NCT01194219|12063313|FG003|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10897268|NCT01194219|12063314|FG004|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10897269|NCT01194219|12063315|FG005|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10897270|NCT01194219|12063316|FG006|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
10897271|NCT01194219|12063317|FG007|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
10897272|NCT01194219|12063318|FG008|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10897273|NCT01194219|12063319|FG009|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
10897274|NCT01194219|12063310|FG000|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10897275|NCT01194219|12063311|FG001|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10897276|NCT01194219|12063312|FG002|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10897277|NCT01194219|12063313|FG003|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10897278|NCT01194219|12063314|FG004|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
10897279|NCT01194219|12063315|FG005|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
10897280|NCT01194219|12063316|FG006|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
10897281|NCT01194219|12063317|FG007|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
10897282|NCT01194219|12063318|FG008|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10897283|NCT01194219|12063319|FG009|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10897284|NCT01194219|12063310|FG000|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10897285|NCT01194219|12063311|FG001|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10897286|NCT01194219|12063312|FG002|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10897287|NCT01194219|12063313|FG003|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10897288|NCT01194219|12063314|FG004|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
10897289|NCT01194219|12063315|FG005|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
10897290|NCT01194219|12063316|FG006|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
10897291|NCT01194219|12063317|FG007|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
10897292|NCT01194219|12063318|FG008|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10897293|NCT01194219|12063319|FG009|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
10897294|NCT01194219|12063310|FG000|STARTED|Long-Term Extension Weeks 52 to 260||0
10897295|NCT01194219|12063311|FG001|STARTED|Long-Term Extension Weeks 52 to 260||0
10897296|NCT01194219|12063312|FG002|STARTED|Long-Term Extension Weeks 52 to 260||0
10897297|NCT01194219|12063313|FG003|STARTED|Long-Term Extension Weeks 52 to 260||0
10897298|NCT01194219|12063314|FG004|STARTED|Long-Term Extension Weeks 52 to 260||0
10897299|NCT01194219|12063315|FG005|STARTED|Long-Term Extension Weeks 52 to 260||0
10897300|NCT01194219|12063316|FG006|STARTED|Long-Term Extension Weeks 52 to 260||0
10897301|NCT01194219|12063317|FG007|STARTED|Long-Term Extension Weeks 52 to 260||0
10897302|NCT01194219|12063318|FG008|STARTED|Long-Term Extension Weeks 52 to 260||306
10897303|NCT01194219|12063319|FG009|STARTED|Long-Term Extension Weeks 52 to 260||153
10897304|NCT01194219|12063310|FG000|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10897305|NCT01194219|12063311|FG001|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10897306|NCT01194219|12063312|FG002|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10897307|NCT01194219|12063313|FG003|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10897308|NCT01194219|12063314|FG004|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10897309|NCT01194219|12063315|FG005|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10897310|NCT01194219|12063316|FG006|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10897311|NCT01194219|12063317|FG007|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
10897312|NCT01194219|12063318|FG008|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
10897313|NCT01194219|12063319|FG009|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
10897314|NCT01194219|12063310|FG000|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897315|NCT01194219|12063311|FG001|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897316|NCT01194219|12063312|FG002|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897317|NCT01194219|12063313|FG003|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897318|NCT01194219|12063314|FG004|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897319|NCT01194219|12063315|FG005|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897320|NCT01194219|12063316|FG006|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897321|NCT01194219|12063317|FG007|COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897322|NCT01194219|12063318|FG008|COMPLETED|Long-Term Extension Weeks 52 to 260||86
10897323|NCT01194219|12063319|FG009|COMPLETED|Long-Term Extension Weeks 52 to 260||41
10897324|NCT01194219|12063310|FG000|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897325|NCT01194219|12063311|FG001|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897326|NCT01194219|12063312|FG002|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897327|NCT01194219|12063313|FG003|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897328|NCT01194219|12063314|FG004|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897329|NCT01194219|12063315|FG005|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897330|NCT01194219|12063316|FG006|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897409|NCT00855803|12063368|FG000|STARTED|Overall Study||35
10897331|NCT01194219|12063317|FG007|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
10897332|NCT01194219|12063318|FG008|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
10897333|NCT01194219|12063319|FG009|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
10897334|NCT01193842|12063347|FG000|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
10897335|NCT01193842|12063348|FG001|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10897336|NCT01193842|12063349|FG002|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10897337|NCT01193842|12063350|FG003|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10897338|NCT01193842|12063351|FG004|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10897339|NCT01193842|12063347|FG000|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
10897340|NCT01193842|12063348|FG001|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10897341|NCT01193842|12063349|FG002|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10897342|NCT01193842|12063350|FG003|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10897343|NCT01193842|12063351|FG004|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10897344|NCT01193842|12063347|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10897345|NCT01193842|12063348|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10897346|NCT01193842|12063349|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10897347|NCT01193842|12063350|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10897348|NCT01193842|12063351|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
10897349|NCT01193842|12063347|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
10897350|NCT01193842|12063348|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
10897351|NCT01193842|12063349|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
10897352|NCT01193842|12063350|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
10897353|NCT01193842|12063351|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
10897354|NCT01193842|12063347|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10897355|NCT01193842|12063348|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
10897356|NCT01193842|12063349|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10897357|NCT01193842|12063350|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10897358|NCT01193842|12063351|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10897359|NCT01193842|12063347|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10897360|NCT01193842|12063348|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
10897361|NCT01193842|12063349|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10897362|NCT01193842|12063350|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10897363|NCT01193842|12063351|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
10897364|NCT01193842|12063347|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
10897365|NCT01193842|12063348|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10897366|NCT01193842|12063349|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10897367|NCT01193842|12063350|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10897368|NCT01193842|12063351|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10897369|NCT01193842|12063347|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
10897370|NCT01193842|12063348|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10897371|NCT01193842|12063349|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10897372|NCT01193842|12063350|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10897373|NCT01193842|12063351|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10897374|NCT01193842|12063347|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
10897375|NCT01193842|12063348|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10897376|NCT01193842|12063349|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10897377|NCT01193842|12063350|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10897378|NCT01193842|12063351|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
10897379|NCT01193842|12063347|FG000|STARTED|Phase I: VR-CHOP, DL 1||0
10897380|NCT01193842|12063348|FG001|STARTED|Phase I: VR-CHOP, DL 1||0
10897381|NCT01193842|12063349|FG002|STARTED|Phase I: VR-CHOP, DL 1||2
10897382|NCT01193842|12063350|FG003|STARTED|Phase I: VR-CHOP, DL 1||0
10897383|NCT01193842|12063351|FG004|STARTED|Phase I: VR-CHOP, DL 1||0
10897384|NCT01193842|12063347|FG000|COMPLETED|Phase I: VR-CHOP, DL 1||0
10897385|NCT01193842|12063348|FG001|COMPLETED|Phase I: VR-CHOP, DL 1||0
10897386|NCT01193842|12063349|FG002|COMPLETED|Phase I: VR-CHOP, DL 1||1
10897387|NCT01193842|12063350|FG003|COMPLETED|Phase I: VR-CHOP, DL 1||0
10897388|NCT01193842|12063351|FG004|COMPLETED|Phase I: VR-CHOP, DL 1||0
10897389|NCT01193842|12063347|FG000|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
10897390|NCT01193842|12063348|FG001|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
10897391|NCT01193842|12063349|FG002|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
10897392|NCT01193842|12063350|FG003|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
10897393|NCT01193842|12063351|FG004|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
10897394|NCT01193842|12063347|FG000|STARTED|Phase II: Randomized Groups||0
10897395|NCT01193842|12063348|FG001|STARTED|Phase II: Randomized Groups||0
10897396|NCT01193842|12063349|FG002|STARTED|Phase II: Randomized Groups||0
10897397|NCT01193842|12063350|FG003|STARTED|Phase II: Randomized Groups||45
10897398|NCT01193842|12063351|FG004|STARTED|Phase II: Randomized Groups||46
10897399|NCT01193842|12063347|FG000|COMPLETED|Phase II: Randomized Groups||0
10897400|NCT01193842|12063348|FG001|COMPLETED|Phase II: Randomized Groups||0
10897401|NCT01193842|12063349|FG002|COMPLETED|Phase II: Randomized Groups||0
10897402|NCT01193842|12063350|FG003|COMPLETED|Phase II: Randomized Groups||33
10897403|NCT01193842|12063351|FG004|COMPLETED|Phase II: Randomized Groups||36
10897404|NCT01193842|12063347|FG000|NOT COMPLETED|Phase II: Randomized Groups||0
10897405|NCT01193842|12063348|FG001|NOT COMPLETED|Phase II: Randomized Groups||0
10897406|NCT01193842|12063349|FG002|NOT COMPLETED|Phase II: Randomized Groups||0
10897407|NCT01193842|12063350|FG003|NOT COMPLETED|Phase II: Randomized Groups||12
10897408|NCT01193842|12063351|FG004|NOT COMPLETED|Phase II: Randomized Groups||10
10897410|NCT00855803|12063368|FG000|COMPLETED|Overall Study||21
10897411|NCT00855803|12063368|FG000|NOT COMPLETED|Overall Study||14
10897412|NCT00790803|12063372|FG000|STARTED|Overall Study||5
10897413|NCT00790803|12063372|FG000|COMPLETED|Overall Study||5
10897414|NCT00790803|12063372|FG000|NOT COMPLETED|Overall Study||0
10897415|NCT00740116|12063378|FG000|STARTED|Overall Study||50
10897416|NCT00740116|12063379|FG001|STARTED|Overall Study||50
10897417|NCT00740116|12063378|FG000|COMPLETED|Overall Study||48
10897418|NCT00740116|12063379|FG001|COMPLETED|Overall Study||45
10897419|NCT00740116|12063378|FG000|NOT COMPLETED|Overall Study||2
10897420|NCT00740116|12063379|FG001|NOT COMPLETED|Overall Study||5
10897421|NCT00565617|12063387|FG000|STARTED|Overall Study||6
10897422|NCT00565617|12063387|FG000|COMPLETED|Overall Study||5
10897423|NCT00565617|12063387|FG000|NOT COMPLETED|Overall Study||1
10897424|NCT00427193|12063393|FG000|STARTED|Overall Study||143
10897425|NCT00427193|12063394|FG001|STARTED|Overall Study||75
10897426|NCT00427193|12063393|FG000|COMPLETED|Overall Study||117
10897427|NCT00427193|12063394|FG001|COMPLETED|Overall Study||71
10897428|NCT00427193|12063393|FG000|NOT COMPLETED|Overall Study||26
10897429|NCT00427193|12063394|FG001|NOT COMPLETED|Overall Study||4
10897430|NCT00148733|12063404|FG000|STARTED|Overall Study||1314
10897431|NCT00148733|12063405|FG001|STARTED|Overall Study||1314
10897432|NCT00148733|12063404|FG000|COMPLETED|Overall Study||1300
10897433|NCT00148733|12063405|FG001|COMPLETED|Overall Study||1299
10897434|NCT00148733|12063404|FG000|NOT COMPLETED|Overall Study||14
10897435|NCT00148733|12063405|FG001|NOT COMPLETED|Overall Study||15
10897436|NCT00142584|12063413|FG000|STARTED|Overall Study||252
10897437|NCT00142584|12063414|FG001|STARTED|Overall Study||84
10897438|NCT00142584|12063413|FG000|COMPLETED|Overall Study||108
10897439|NCT00142584|12063414|FG001|COMPLETED|Overall Study||28
10897440|NCT00142584|12063413|FG000|NOT COMPLETED|Overall Study||144
10897441|NCT00142584|12063414|FG001|NOT COMPLETED|Overall Study||56
10897442|NCT04753710|12063424|FG000|STARTED|Overall||67
10897443|NCT04753710|12063425|FG001|STARTED|Overall||29
10897444|NCT04753710|12063424|FG000|COMPLETED|Overall||67
10897445|NCT04753710|12063425|FG001|COMPLETED|Overall||29
10897446|NCT04753710|12063424|FG000|NOT COMPLETED|Overall||0
10897447|NCT04753710|12063425|FG001|NOT COMPLETED|Overall||0
10897448|NCT04753710|12063424|FG000|STARTED|First Phase||27
10897449|NCT04753710|12063425|FG001|STARTED|First Phase||9
10897450|NCT04753710|12063424|FG000|COMPLETED|First Phase||27
10897451|NCT04753710|12063425|FG001|COMPLETED|First Phase||9
10897452|NCT04753710|12063424|FG000|NOT COMPLETED|First Phase||0
10897453|NCT04753710|12063425|FG001|NOT COMPLETED|First Phase||0
10897454|NCT04753710|12063424|FG000|STARTED|Second Phase||40
10897455|NCT04753710|12063425|FG001|STARTED|Second Phase||20
10897456|NCT04753710|12063424|FG000|COMPLETED|Second Phase||40
10897457|NCT04753710|12063425|FG001|COMPLETED|Second Phase||20
10897458|NCT04753710|12063424|FG000|NOT COMPLETED|Second Phase||0
10897459|NCT04753710|12063425|FG001|NOT COMPLETED|Second Phase||0
10897460|NCT04570605|12063433|FG000|STARTED|Overall Study||15
10897461|NCT04570605|12063434|FG001|STARTED|Overall Study||15
10897462|NCT04570605|12063433|FG000|COMPLETED|Overall Study||11
10897463|NCT04570605|12063434|FG001|COMPLETED|Overall Study||13
10897464|NCT04570605|12063433|FG000|NOT COMPLETED|Overall Study||4
10897465|NCT04570605|12063434|FG001|NOT COMPLETED|Overall Study||2
10897466|NCT04551898|12063444|FG000|STARTED|Overall Study||47
10897467|NCT04551898|12063445|FG001|STARTED|Overall Study||45
10897468|NCT04551898|12063446|FG002|STARTED|Overall Study||43
10897469|NCT04551898|12063447|FG003|STARTED|Overall Study||46
10897470|NCT04551898|12063444|FG000|COMPLETED|Overall Study||39
10897471|NCT04551898|12063445|FG001|COMPLETED|Overall Study||42
10897472|NCT04551898|12063446|FG002|COMPLETED|Overall Study||35
10897473|NCT04551898|12063447|FG003|COMPLETED|Overall Study||41
10897474|NCT04551898|12063444|FG000|NOT COMPLETED|Overall Study||8
10897475|NCT04551898|12063445|FG001|NOT COMPLETED|Overall Study||3
10897476|NCT04551898|12063446|FG002|NOT COMPLETED|Overall Study||8
10897477|NCT04551898|12063447|FG003|NOT COMPLETED|Overall Study||5
10897478|NCT04402866|12063469|FG000|STARTED|Overall Study||6
10897479|NCT04402866|12063470|FG001|STARTED|Overall Study||6
10897480|NCT04402866|12063471|FG002|STARTED|Overall Study||7
10897481|NCT04402866|12063472|FG003|STARTED|Overall Study||6
10897482|NCT04402866|12063473|FG004|STARTED|Overall Study||104
10897483|NCT04402866|12063474|FG005|STARTED|Overall Study||106
10897484|NCT04402866|12063469|FG000|Randomized and Treated With Study Drug|Overall Study||6
10897485|NCT04402866|12063470|FG001|Randomized and Treated With Study Drug|Overall Study||6
10897486|NCT04402866|12063471|FG002|Randomized and Treated With Study Drug|Overall Study||7
10897487|NCT04402866|12063472|FG003|Randomized and Treated With Study Drug|Overall Study||6
10897488|NCT04402866|12063473|FG004|Randomized and Treated With Study Drug|Overall Study||102
10897489|NCT04402866|12063474|FG005|Randomized and Treated With Study Drug|Overall Study||103
10897490|NCT04402866|12063469|FG000|COMPLETED|Overall Study||4
10897491|NCT04402866|12063470|FG001|COMPLETED|Overall Study||5
10897492|NCT04402866|12063471|FG002|COMPLETED|Overall Study||6
10897493|NCT04402866|12063472|FG003|COMPLETED|Overall Study||6
10897494|NCT04402866|12063473|FG004|COMPLETED|Overall Study||89
10897495|NCT04402866|12063474|FG005|COMPLETED|Overall Study||92
10897496|NCT04402866|12063469|FG000|NOT COMPLETED|Overall Study||2
10897497|NCT04402866|12063470|FG001|NOT COMPLETED|Overall Study||1
10897498|NCT04402866|12063471|FG002|NOT COMPLETED|Overall Study||1
10897499|NCT04402866|12063472|FG003|NOT COMPLETED|Overall Study||0
10897500|NCT04402866|12063473|FG004|NOT COMPLETED|Overall Study||15
10897501|NCT04402866|12063474|FG005|NOT COMPLETED|Overall Study||14
10897502|NCT04327388|12063487|FG000|STARTED|Overall Study||161
10897503|NCT04327388|12063488|FG001|STARTED|Overall Study||173
10897504|NCT04327388|12063489|FG002|STARTED|Overall Study||86
10897505|NCT04327388|12063487|FG000|Treated|Overall Study||159
10897506|NCT04327388|12063488|FG001|Treated|Overall Study||173
10897507|NCT04327388|12063489|FG002|Treated|Overall Study||84
10897508|NCT04327388|12063487|FG000|Participants Who Received Second Dose|Overall Study||13
10897509|NCT04327388|12063488|FG001|Participants Who Received Second Dose|Overall Study||11
10897510|NCT04327388|12063489|FG002|Participants Who Received Second Dose|Overall Study||5
10897511|NCT04327388|12063487|FG000|COMPLETED|Overall Study||141
10897512|NCT04327388|12063488|FG001|COMPLETED|Overall Study||153
10897513|NCT04327388|12063489|FG002|COMPLETED|Overall Study||75
10897514|NCT04327388|12063487|FG000|NOT COMPLETED|Overall Study||20
10897515|NCT04327388|12063488|FG001|NOT COMPLETED|Overall Study||20
10897516|NCT04327388|12063489|FG002|NOT COMPLETED|Overall Study||11
10897517|NCT03860259|12063499|FG000|STARTED|Overall Study||25
10897518|NCT03860259|12063500|FG001|STARTED|Overall Study||25
10897519|NCT03860259|12063499|FG000|COMPLETED|Overall Study||19
10897520|NCT03860259|12063500|FG001|COMPLETED|Overall Study||20
10897521|NCT03860259|12063499|FG000|NOT COMPLETED|Overall Study||6
10897522|NCT03860259|12063500|FG001|NOT COMPLETED|Overall Study||5
10897523|NCT03767634|12063509|FG000|STARTED|Overall Study||62145
10897524|NCT03767634|12063510|FG001|STARTED|Overall Study|8,146 neonates were included in the matched propensity score analysis|19080
10897525|NCT03767634|12063511|FG002|STARTED|Overall Study|8,146 neonates were included in the matched propensity score analysis|16282
10897526|NCT03767634|12063509|FG000|COMPLETED|Overall Study||62145
10897527|NCT03767634|12063510|FG001|COMPLETED|Overall Study|8,146 neonates were included in the matched propensity score analysis|19080
10897528|NCT03767634|12063511|FG002|COMPLETED|Overall Study|8,146 neonates were included in the matched propensity score analysis|16282
10897529|NCT03767634|12063509|FG000|NOT COMPLETED|Overall Study||0
10897530|NCT03767634|12063510|FG001|NOT COMPLETED|Overall Study||0
10897531|NCT03767634|12063511|FG002|NOT COMPLETED|Overall Study||0
10897532|NCT03388138|12063522|FG000|STARTED|Overall Study||94
10897533|NCT03388138|12063523|FG001|STARTED|Overall Study||47
10897534|NCT03388138|12063522|FG000|COMPLETED|Overall Study||93
10897535|NCT03388138|12063523|FG001|COMPLETED|Overall Study||47
10897536|NCT03388138|12063522|FG000|NOT COMPLETED|Overall Study||1
10897537|NCT03388138|12063523|FG001|NOT COMPLETED|Overall Study||0
10897538|NCT03067610|12063529|FG000|STARTED|Overall Study||72
10897539|NCT03067610|12063529|FG000|COMPLETED|Overall Study||72
10897540|NCT03067610|12063529|FG000|NOT COMPLETED|Overall Study||0
10897541|NCT03027609|12063539|FG000|STARTED|Overall Study|Safety and ITT population|79
10897542|NCT03027609|12063540|FG001|STARTED|Overall Study|Safety and ITT population|79
10897543|NCT03027609|12063539|FG000|COMPLETED|Overall Study|Safety and ITT population|49
10897544|NCT03027609|12063540|FG001|COMPLETED|Overall Study|Safety and ITT population|62
10897545|NCT03027609|12063539|FG000|NOT COMPLETED|Overall Study||30
10897546|NCT03027609|12063540|FG001|NOT COMPLETED|Overall Study||17
10897547|NCT02993107|12063556|FG000|STARTED|Overall Study||113
10897548|NCT02993107|12063557|FG001|STARTED|Overall Study||120
10897549|NCT02993107|12063558|FG002|STARTED|Overall Study||50
10897550|NCT02993107|12063559|FG003|STARTED|Overall Study||35
10897551|NCT02993107|12063560|FG004|STARTED|Overall Study||34
10897552|NCT02993107|12063561|FG005|STARTED|Overall Study||36
10897553|NCT02993107|12063556|FG000|Adverse Event|Overall Study||12
10897554|NCT02993107|12063557|FG001|Adverse Event|Overall Study||4
10897555|NCT02993107|12063558|FG002|Adverse Event|Overall Study||1
10897556|NCT02993107|12063559|FG003|Adverse Event|Overall Study||1
10897557|NCT02993107|12063560|FG004|Adverse Event|Overall Study||3
10897558|NCT02993107|12063561|FG005|Adverse Event|Overall Study||5
10897559|NCT02993107|12063556|FG000|Physician Decision|Overall Study||1
10897560|NCT02993107|12063557|FG001|Physician Decision|Overall Study||0
10897561|NCT02993107|12063558|FG002|Physician Decision|Overall Study||1
10897562|NCT02993107|12063559|FG003|Physician Decision|Overall Study||0
10897563|NCT02993107|12063560|FG004|Physician Decision|Overall Study||0
10897564|NCT02993107|12063561|FG005|Physician Decision|Overall Study||0
10897565|NCT02993107|12063556|FG000|Withdrawal by Subject|Overall Study||32
10897566|NCT02993107|12063557|FG001|Withdrawal by Subject|Overall Study||7
10897567|NCT02993107|12063558|FG002|Withdrawal by Subject|Overall Study||7
10897568|NCT02993107|12063559|FG003|Withdrawal by Subject|Overall Study||3
10897569|NCT02993107|12063560|FG004|Withdrawal by Subject|Overall Study||6
10897570|NCT02993107|12063561|FG005|Withdrawal by Subject|Overall Study||2
10897571|NCT02993107|12063556|FG000|Lost to Follow-up|Overall Study||0
10897572|NCT02993107|12063557|FG001|Lost to Follow-up|Overall Study||1
10897573|NCT02993107|12063558|FG002|Lost to Follow-up|Overall Study||0
10897574|NCT02993107|12063559|FG003|Lost to Follow-up|Overall Study||0
10897575|NCT02993107|12063560|FG004|Lost to Follow-up|Overall Study||0
10897576|NCT02993107|12063561|FG005|Lost to Follow-up|Overall Study||1
10897577|NCT02993107|12063556|FG000|Sponsor Decision|Overall Study||4
10897578|NCT02993107|12063557|FG001|Sponsor Decision|Overall Study||0
10897579|NCT02993107|12063558|FG002|Sponsor Decision|Overall Study||1
10897580|NCT02993107|12063559|FG003|Sponsor Decision|Overall Study||1
10897581|NCT02993107|12063560|FG004|Sponsor Decision|Overall Study||0
10897582|NCT02993107|12063561|FG005|Sponsor Decision|Overall Study||4
10897583|NCT02993107|12063556|FG000|Protocol Deviation|Overall Study||0
10897584|NCT02993107|12063557|FG001|Protocol Deviation|Overall Study||0
10897585|NCT02993107|12063558|FG002|Protocol Deviation|Overall Study||0
10897586|NCT02993107|12063559|FG003|Protocol Deviation|Overall Study||0
10897587|NCT02993107|12063560|FG004|Protocol Deviation|Overall Study||1
10897588|NCT02993107|12063561|FG005|Protocol Deviation|Overall Study||0
10897589|NCT02993107|12063556|FG000|Other Reasons|Overall Study||2
10897590|NCT02993107|12063557|FG001|Other Reasons|Overall Study||1
10897591|NCT02993107|12063558|FG002|Other Reasons|Overall Study||1
10897592|NCT02993107|12063559|FG003|Other Reasons|Overall Study||1
10897593|NCT02993107|12063560|FG004|Other Reasons|Overall Study||2
10897594|NCT02993107|12063561|FG005|Other Reasons|Overall Study||3
10897595|NCT02993107|12063556|FG000|COMPLETED|Overall Study||62
10897596|NCT02993107|12063557|FG001|COMPLETED|Overall Study||107
10897597|NCT02993107|12063558|FG002|COMPLETED|Overall Study||39
10897598|NCT02993107|12063559|FG003|COMPLETED|Overall Study||29
10897599|NCT02993107|12063560|FG004|COMPLETED|Overall Study||22
10897600|NCT02993107|12063561|FG005|COMPLETED|Overall Study||21
10897601|NCT02993107|12063556|FG000|NOT COMPLETED|Overall Study||51
10897602|NCT02993107|12063557|FG001|NOT COMPLETED|Overall Study||13
10897603|NCT02993107|12063558|FG002|NOT COMPLETED|Overall Study||11
10897604|NCT02993107|12063559|FG003|NOT COMPLETED|Overall Study||6
10897605|NCT02993107|12063560|FG004|NOT COMPLETED|Overall Study||12
10897606|NCT02993107|12063561|FG005|NOT COMPLETED|Overall Study||15
10897607|NCT02981082|12063589|FG000|STARTED|Overall Study||4
10897608|NCT02981082|12063590|FG001|STARTED|Overall Study||2
10897609|NCT02981082|12063589|FG000|COMPLETED|Overall Study||1
10897610|NCT02981082|12063590|FG001|COMPLETED|Overall Study||1
10897611|NCT02981082|12063589|FG000|NOT COMPLETED|Overall Study||3
10897612|NCT02981082|12063590|FG001|NOT COMPLETED|Overall Study||1
10897619|NCT02741700|12063607|FG000|STARTED|Overall Study||152
10897620|NCT02741700|12063608|FG001|STARTED|Overall Study||154
10897621|NCT02741700|12063607|FG000|COMPLETED|Overall Study||126
10897622|NCT02741700|12063608|FG001|COMPLETED|Overall Study||135
10897623|NCT02741700|12063607|FG000|NOT COMPLETED|Overall Study||26
10897624|NCT02741700|12063608|FG001|NOT COMPLETED|Overall Study||19
10897625|NCT02635776|12063616|FG000|STARTED|Overall Study||416
10897626|NCT02635776|12063617|FG001|STARTED|Overall Study||139
10897627|NCT02635776|12063616|FG000|COMPLETED|Overall Study||314
10897628|NCT02635776|12063617|FG001|COMPLETED|Overall Study||128
10897629|NCT02635776|12063616|FG000|NOT COMPLETED|Overall Study||102
10897630|NCT02635776|12063617|FG001|NOT COMPLETED|Overall Study||11
10897631|NCT02609724|12063628|FG000|STARTED|Overall Study||65
10897632|NCT02609724|12063629|FG001|STARTED|Overall Study||64
10897633|NCT02609724|12063630|FG002|STARTED|Overall Study||65
10897634|NCT02609724|12063628|FG000|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||63
10897635|NCT02609724|12063629|FG001|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||63
10897636|NCT02609724|12063630|FG002|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||64
10897637|NCT02609724|12063628|FG000|COMPLETED|Overall Study|post follow-up phase|60
10897638|NCT02609724|12063629|FG001|COMPLETED|Overall Study|post follow-up phase|61
10897639|NCT02609724|12063630|FG002|COMPLETED|Overall Study|post follow-up phase|61
10897640|NCT02609724|12063628|FG000|NOT COMPLETED|Overall Study||5
10897641|NCT02609724|12063629|FG001|NOT COMPLETED|Overall Study||3
10897642|NCT02609724|12063630|FG002|NOT COMPLETED|Overall Study||4
10897643|NCT02359994|12063640|FG000|STARTED|Overall Population Study||161
10897644|NCT02359994|12063641|FG001|STARTED|Overall Population Study||163
10897645|NCT02359994|12063640|FG000|Treated|Overall Population Study||160
10897646|NCT02359994|12063641|FG001|Treated|Overall Population Study||162
10897647|NCT02359994|12063640|FG000|COMPLETED|Overall Population Study||156
10897648|NCT02359994|12063641|FG001|COMPLETED|Overall Population Study||155
10897649|NCT02359994|12063640|FG000|NOT COMPLETED|Overall Population Study||5
10897650|NCT02359994|12063641|FG001|NOT COMPLETED|Overall Population Study||8
10897651|NCT02359994|12063640|FG000|STARTED|Extended Oncology 24-Month Survival|Oncology subjects in the PerClot group who completed either the 6 week or 3 month visit in the Overall Population Study.|85
10897652|NCT02359994|12063641|FG001|STARTED|Extended Oncology 24-Month Survival|Oncology subjects in the Arista group who completed either the 6 week or 3 month visit in the Overall Population Study.|93
10897653|NCT02359994|12063640|FG000|COMPLETED|Extended Oncology 24-Month Survival||65
10897654|NCT02359994|12063641|FG001|COMPLETED|Extended Oncology 24-Month Survival||72
10897655|NCT02359994|12063640|FG000|NOT COMPLETED|Extended Oncology 24-Month Survival||20
10897656|NCT02359994|12063641|FG001|NOT COMPLETED|Extended Oncology 24-Month Survival||21
10897657|NCT02336230|12063647|FG000|STARTED|Overall Study||55
10897658|NCT02336230|12063647|FG000|Full Analysis Set (FAS)|Overall Study||55
10897659|NCT02336230|12063647|FG000|Safety Analysis Population|Overall Study||54
10897660|NCT02336230|12063647|FG000|COMPLETED|Overall Study||42
10897661|NCT02336230|12063647|FG000|NOT COMPLETED|Overall Study||13
10897662|NCT01557751|12063651|FG000|STARTED|Overall Study||156
10897663|NCT01557751|12063651|FG000|COMPLETED|Overall Study||153
10897664|NCT01557751|12063651|FG000|NOT COMPLETED|Overall Study||3
10897665|NCT01363401|12063657|FG000|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
10897666|NCT01363401|12063658|FG001|STARTED|Overall Study||31
10897667|NCT01363401|12063657|FG000|COMPLETED|Overall Study||39
10897668|NCT01363401|12063658|FG001|COMPLETED|Overall Study||27
10897669|NCT01363401|12063657|FG000|NOT COMPLETED|Overall Study||2
10897670|NCT01363401|12063658|FG001|NOT COMPLETED|Overall Study||4
10897671|NCT03825393|12063666|FG000|STARTED|Overall Study||100
10897672|NCT03825393|12063667|FG001|STARTED|Overall Study||100
10897673|NCT03825393|12063666|FG000|COMPLETED|Overall Study||100
10897674|NCT03825393|12063667|FG001|COMPLETED|Overall Study||100
10897675|NCT03825393|12063666|FG000|NOT COMPLETED|Overall Study||0
10897676|NCT03825393|12063667|FG001|NOT COMPLETED|Overall Study||0
10897677|NCT03813719|12063675|FG000|STARTED|Overall Study||250
10897678|NCT03813719|12063675|FG000|COMPLETED|Overall Study||250
10897679|NCT03813719|12063675|FG000|NOT COMPLETED|Overall Study||0
10897680|NCT03798756|12063681|FG000|STARTED|Overall Study||9274
10897681|NCT03798756|12063681|FG000|COMPLETED|Overall Study||9274
10897682|NCT03798756|12063681|FG000|NOT COMPLETED|Overall Study||0
10897683|NCT03790917|12063686|FG000|STARTED|Overall Study||201
10897684|NCT03790917|12063686|FG000|COMPLETED|Overall Study||200
10897685|NCT03790917|12063686|FG000|NOT COMPLETED|Overall Study||1
10897686|NCT03790306|12063691|FG000|STARTED|Overall Study||207
10897687|NCT03790306|12063691|FG000|COMPLETED|Overall Study||207
10897688|NCT03790306|12063691|FG000|NOT COMPLETED|Overall Study||0
10897689|NCT03727373|12063696|FG000|STARTED|Overall Study||8
10897690|NCT03727373|12063696|FG000|COMPLETED|Overall Study||8
10897691|NCT03727373|12063696|FG000|NOT COMPLETED|Overall Study||0
10897692|NCT05017493|12063702|FG000|STARTED|Overall Study||483
10897693|NCT05017493|12063703|FG001|STARTED|Overall Study||178
10897694|NCT05017493|12063702|FG000|Treatment & Care|Overall Study||483
10897695|NCT05017493|12063703|FG001|Treatment & Care|Overall Study||178
10897696|NCT05017493|12063702|FG000|Follow up|Overall Study||483
10897697|NCT05017493|12063703|FG001|Follow up|Overall Study||178
10897698|NCT05017493|12063702|FG000|Mortality Check|Overall Study||483
10897699|NCT05017493|12063703|FG001|Mortality Check|Overall Study||178
10897700|NCT05017493|12063702|FG000|COMPLETED|Overall Study||361
10897701|NCT05017493|12063703|FG001|COMPLETED|Overall Study||178
10897702|NCT05017493|12063702|FG000|NOT COMPLETED|Overall Study||122
10897703|NCT05017493|12063703|FG001|NOT COMPLETED|Overall Study||0
10897704|NCT04870138|12063712|FG000|STARTED|Overall Study||5
10897705|NCT04870138|12063713|FG001|STARTED|Overall Study||5
10897706|NCT04870138|12063714|FG002|STARTED|Overall Study||6
10897707|NCT04870138|12063712|FG000|COMPLETED|Overall Study||5
10897708|NCT04870138|12063713|FG001|COMPLETED|Overall Study||5
10897709|NCT04870138|12063714|FG002|COMPLETED|Overall Study||6
10897710|NCT04870138|12063712|FG000|NOT COMPLETED|Overall Study||0
10897711|NCT04870138|12063713|FG001|NOT COMPLETED|Overall Study||0
10897712|NCT04870138|12063714|FG002|NOT COMPLETED|Overall Study||0
10897713|NCT04374149|12063727|FG000|STARTED|Overall Study||10
10897714|NCT04374149|12063728|FG001|STARTED|Overall Study||10
10897715|NCT04374149|12063727|FG000|COMPLETED|Overall Study||10
10897716|NCT04374149|12063728|FG001|COMPLETED|Overall Study||10
10897717|NCT04374149|12063727|FG000|NOT COMPLETED|Overall Study||0
10897718|NCT04374149|12063728|FG001|NOT COMPLETED|Overall Study||0
10897719|NCT04348500|12063736|FG000|STARTED|Overall Study||8
10897720|NCT04348500|12063737|FG001|STARTED|Overall Study||9
10897721|NCT04348500|12063736|FG000|Treated|Overall Study||8
10897722|NCT04348500|12063737|FG001|Treated|Overall Study||8
10897723|NCT04348500|12063736|FG000|COMPLETED|Overall Study||6
10897724|NCT04348500|12063737|FG001|COMPLETED|Overall Study||6
10897725|NCT04348500|12063736|FG000|NOT COMPLETED|Overall Study||2
10897726|NCT04348500|12063737|FG001|NOT COMPLETED|Overall Study||3
10897727|NCT04347941|12063745|FG000|STARTED|Overall Study||12
10897728|NCT04347941|12063746|FG001|STARTED|Overall Study||12
10897729|NCT04347941|12063745|FG000|COMPLETED|Overall Study||12
10897730|NCT04347941|12063746|FG001|COMPLETED|Overall Study||12
10897731|NCT04347941|12063745|FG000|NOT COMPLETED|Overall Study||0
10897732|NCT04347941|12063746|FG001|NOT COMPLETED|Overall Study||0
10897733|NCT04308694|12063755|FG000|STARTED|Overall Study||20
10897734|NCT04308694|12063755|FG000|COMPLETED|Overall Study||16
10897735|NCT04308694|12063755|FG000|NOT COMPLETED|Overall Study||4
10897736|NCT03999411|12063762|FG000|STARTED|Overall Study||13
10897737|NCT03999411|12063763|FG001|STARTED|Overall Study||13
10897738|NCT03999411|12063764|FG002|STARTED|Overall Study||13
10897739|NCT03999411|12063762|FG000|COMPLETED|Overall Study||12
10897740|NCT03999411|12063763|FG001|COMPLETED|Overall Study||11
10897741|NCT03999411|12063764|FG002|COMPLETED|Overall Study||13
10897742|NCT03999411|12063762|FG000|NOT COMPLETED|Overall Study||1
10897743|NCT03999411|12063763|FG001|NOT COMPLETED|Overall Study||2
10897744|NCT03999411|12063764|FG002|NOT COMPLETED|Overall Study||0
10897745|NCT03803605|12063773|FG000|STARTED|Overall Study||15
10897746|NCT03803605|12063773|FG000|Step 1: Participants With an RCI Measurement > 0.30 Per Million Cells|Overall Study||8
10897747|NCT03803605|12063773|FG000|Steps 2-4: Participants Receiving Study Intervention|Overall Study||8
10897748|NCT03803605|12063773|FG000|COMPLETED|Overall Study||8
10897749|NCT03803605|12063773|FG000|NOT COMPLETED|Overall Study||7
10897750|NCT03799198|12063780|FG000|STARTED|Overall Study||100
10897751|NCT03799198|12063781|FG001|STARTED|Overall Study||100
10897752|NCT03799198|12063780|FG000|Full Analysis Set (FAS)|Overall Study||100
10897753|NCT03799198|12063781|FG001|Full Analysis Set (FAS)|Overall Study||100
10897754|NCT03799198|12063780|FG000|COMPLETED|Overall Study||96
10897755|NCT03799198|12063781|FG001|COMPLETED|Overall Study||91
10897756|NCT03799198|12063780|FG000|NOT COMPLETED|Overall Study||4
10897757|NCT03799198|12063781|FG001|NOT COMPLETED|Overall Study||9
10897758|NCT03770728|12063791|FG000|STARTED|Overall Study||79
10897759|NCT03770728|12063792|FG001|STARTED|Overall Study||78
10897760|NCT03770728|12063793|FG002|STARTED|Overall Study||77
10897761|NCT03770728|12063794|FG003|STARTED|Overall Study||78
10897762|NCT03770728|12063791|FG000|Safety Population|Overall Study||79
10897763|NCT03770728|12063792|FG001|Safety Population|Overall Study||78
10897842|NCT03713684|12063850|FG000|Completed 30-Week Core Treatment Period|Overall Study||50
10897764|NCT03770728|12063793|FG002|Safety Population|Overall Study|For safety analysis, participants were included in the treatment group that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg group for safety analysis.|80
10897765|NCT03770728|12063794|FG003|Safety Population|Overall Study||75
10897766|NCT03770728|12063791|FG000|COMPLETED|Overall Study||41
10897767|NCT03770728|12063792|FG001|COMPLETED|Overall Study||47
10897768|NCT03770728|12063793|FG002|COMPLETED|Overall Study||45
10897769|NCT03770728|12063794|FG003|COMPLETED|Overall Study||43
10897770|NCT03770728|12063791|FG000|NOT COMPLETED|Overall Study||38
10897771|NCT03770728|12063792|FG001|NOT COMPLETED|Overall Study||31
10897772|NCT03770728|12063793|FG002|NOT COMPLETED|Overall Study||32
10897773|NCT03770728|12063794|FG003|NOT COMPLETED|Overall Study||35
10897774|NCT03760146|12063812|FG000|STARTED|Overall Study||1514
10897775|NCT03760146|12063813|FG001|STARTED|Overall Study||1495
10897776|NCT03760146|12063814|FG002|STARTED|Overall Study||334
10897777|NCT03760146|12063815|FG003|STARTED|Overall Study||111
10897778|NCT03760146|12063816|FG004|STARTED|Overall Study||336
10897779|NCT03760146|12063817|FG005|STARTED|Overall Study||112
10897780|NCT03760146|12063812|FG000|Evaluable 13-Matched Immunogenicity Population|Overall Study||1435
10897781|NCT03760146|12063813|FG001|Evaluable 13-Matched Immunogenicity Population|Overall Study||1420
10897782|NCT03760146|12063814|FG002|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
10897783|NCT03760146|12063815|FG003|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
10897784|NCT03760146|12063816|FG004|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
10897785|NCT03760146|12063817|FG005|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
10897786|NCT03760146|12063812|FG000|Evaluable 7-Additional Immunogenicity Population|Overall Study||1433
10897787|NCT03760146|12063813|FG001|Evaluable 7-Additional Immunogenicity Population|Overall Study||1383
10897788|NCT03760146|12063814|FG002|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
10897789|NCT03760146|12063815|FG003|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
10897790|NCT03760146|12063816|FG004|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
10897791|NCT03760146|12063817|FG005|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
10897792|NCT03760146|12063812|FG000|Vaccination 1|Overall Study||1507
10897793|NCT03760146|12063813|FG001|Vaccination 1|Overall Study||1490
10897794|NCT03760146|12063814|FG002|Vaccination 1|Overall Study||334
10897795|NCT03760146|12063815|FG003|Vaccination 1|Overall Study||111
10897796|NCT03760146|12063816|FG004|Vaccination 1|Overall Study||335
10897797|NCT03760146|12063817|FG005|Vaccination 1|Overall Study||112
10897798|NCT03760146|12063812|FG000|Vaccination 2|Overall Study||1461
10897799|NCT03760146|12063813|FG001|Vaccination 2|Overall Study||1446
10897800|NCT03760146|12063814|FG002|Vaccination 2|Overall Study||0
10897801|NCT03760146|12063815|FG003|Vaccination 2|Overall Study||0
10897802|NCT03760146|12063816|FG004|Vaccination 2|Overall Study||0
10897803|NCT03760146|12063817|FG005|Vaccination 2|Overall Study||0
10897804|NCT03760146|12063812|FG000|Safety Population|Overall Study||1507
10897805|NCT03760146|12063813|FG001|Safety Population|Overall Study||1490
10897806|NCT03760146|12063814|FG002|Safety Population|Overall Study||334
10897807|NCT03760146|12063815|FG003|Safety Population|Overall Study||111
10897808|NCT03760146|12063816|FG004|Safety Population|Overall Study||335
10897809|NCT03760146|12063817|FG005|Safety Population|Overall Study||112
10897810|NCT03760146|12063812|FG000|Evaluable-20 Immunogenicity Population|Overall Study|Only for 60-64 years of age.|946
10897811|NCT03760146|12063813|FG001|Evaluable-20 Immunogenicity Population|Overall Study||0
10897812|NCT03760146|12063814|FG002|Evaluable-20 Immunogenicity Population|Overall Study||321
10897813|NCT03760146|12063815|FG003|Evaluable-20 Immunogenicity Population|Overall Study||0
10897814|NCT03760146|12063816|FG004|Evaluable-20 Immunogenicity Population|Overall Study||317
10897815|NCT03760146|12063817|FG005|Evaluable-20 Immunogenicity Population|Overall Study||0
10897816|NCT03760146|12063812|FG000|COMPLETED|Overall Study||1418
10897817|NCT03760146|12063813|FG001|COMPLETED|Overall Study||1417
10897818|NCT03760146|12063814|FG002|COMPLETED|Overall Study||323
10897819|NCT03760146|12063815|FG003|COMPLETED|Overall Study||109
10897820|NCT03760146|12063816|FG004|COMPLETED|Overall Study||319
10897821|NCT03760146|12063817|FG005|COMPLETED|Overall Study||104
10897822|NCT03760146|12063812|FG000|NOT COMPLETED|Overall Study||96
10897823|NCT03760146|12063813|FG001|NOT COMPLETED|Overall Study||78
10897824|NCT03760146|12063814|FG002|NOT COMPLETED|Overall Study||11
10897825|NCT03760146|12063815|FG003|NOT COMPLETED|Overall Study||2
10897826|NCT03760146|12063816|FG004|NOT COMPLETED|Overall Study||17
10897827|NCT03760146|12063817|FG005|NOT COMPLETED|Overall Study||8
10897828|NCT03760081|12063837|FG000|STARTED|Overall Study||6
10897829|NCT03760081|12063838|FG001|STARTED|Overall Study||13
10897830|NCT03760081|12063837|FG000|COMPLETED|Overall Study||0
10897831|NCT03760081|12063838|FG001|COMPLETED|Overall Study||1
10897832|NCT03760081|12063837|FG000|NOT COMPLETED|Overall Study||6
10897833|NCT03760081|12063838|FG001|NOT COMPLETED|Overall Study||12
10897834|NCT03713684|12063850|FG000|STARTED|Overall Study||92
10897835|NCT03713684|12063851|FG001|STARTED|Overall Study||92
10897836|NCT03713684|12063852|FG002|STARTED|Overall Study||93
10897837|NCT03713684|12063853|FG003|STARTED|Overall Study||93
10897838|NCT03713684|12063850|FG000|Safety Population|Overall Study||92
10897839|NCT03713684|12063851|FG001|Safety Population|Overall Study||92
10897840|NCT03713684|12063852|FG002|Safety Population|Overall Study|For safety analysis participants were included in the treatment arm that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg arm received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg arm for safety analysis.|96
10897841|NCT03713684|12063853|FG003|Safety Population|Overall Study||90
10897843|NCT03713684|12063851|FG001|Completed 30-Week Core Treatment Period|Overall Study||52
10897844|NCT03713684|12063852|FG002|Completed 30-Week Core Treatment Period|Overall Study||51
10897845|NCT03713684|12063853|FG003|Completed 30-Week Core Treatment Period|Overall Study||49
10897846|NCT03713684|12063850|FG000|COMPLETED|Overall Study||6
10897847|NCT03713684|12063851|FG001|COMPLETED|Overall Study||5
10897848|NCT03713684|12063852|FG002|COMPLETED|Overall Study||5
10897849|NCT03713684|12063853|FG003|COMPLETED|Overall Study||6
10897850|NCT03713684|12063850|FG000|NOT COMPLETED|Overall Study||86
10897851|NCT03713684|12063851|FG001|NOT COMPLETED|Overall Study||87
10897852|NCT03713684|12063852|FG002|NOT COMPLETED|Overall Study||88
10897853|NCT03713684|12063853|FG003|NOT COMPLETED|Overall Study||87
10897854|NCT03644550|12063863|FG000|STARTED|Overall Study||18
10897855|NCT03644550|12063863|FG000|COMPLETED|Overall Study||0
10897856|NCT03644550|12063863|FG000|NOT COMPLETED|Overall Study||18
10897857|NCT03557970|12063870|FG000|STARTED|Overall Study||1
10897858|NCT03557970|12063871|FG001|STARTED|Overall Study||2
10897859|NCT03557970|12063870|FG000|COMPLETED|Overall Study||0
10897860|NCT03557970|12063871|FG001|COMPLETED|Overall Study||0
10897861|NCT03557970|12063870|FG000|NOT COMPLETED|Overall Study||1
10897862|NCT03557970|12063871|FG001|NOT COMPLETED|Overall Study||2
10897863|NCT03369197|12063879|FG000|STARTED|Overall Study||53
10897864|NCT03369197|12063880|FG001|STARTED|Overall Study||57
10897865|NCT03369197|12063879|FG000|COMPLETED|Overall Study||53
10897866|NCT03369197|12063880|FG001|COMPLETED|Overall Study||57
10897867|NCT03369197|12063879|FG000|NOT COMPLETED|Overall Study||0
10897868|NCT03369197|12063880|FG001|NOT COMPLETED|Overall Study||0
10897869|NCT02964039|12063889|FG000|STARTED|Overall Study||18
10897870|NCT02964039|12063890|FG001|STARTED|Overall Study||18
10897871|NCT02964039|12063891|FG002|STARTED|Overall Study||18
10897872|NCT02964039|12063889|FG000|Received Allocated Intervention|Overall Study||15
10897873|NCT02964039|12063890|FG001|Received Allocated Intervention|Overall Study||17
10897874|NCT02964039|12063891|FG002|Received Allocated Intervention|Overall Study||14
10897875|NCT02964039|12063889|FG000|COMPLETED|Overall Study||14
10897876|NCT02964039|12063890|FG001|COMPLETED|Overall Study||17
10897877|NCT02964039|12063891|FG002|COMPLETED|Overall Study||13
10897878|NCT02964039|12063889|FG000|NOT COMPLETED|Overall Study||4
10897879|NCT02964039|12063890|FG001|NOT COMPLETED|Overall Study||1
10897880|NCT02964039|12063891|FG002|NOT COMPLETED|Overall Study||5
10897881|NCT02930889|12063899|FG000|STARTED|Overall Study||21
10897882|NCT02930889|12063899|FG000|COMPLETED|Overall Study||5
10897883|NCT02930889|12063899|FG000|NOT COMPLETED|Overall Study||16
10897884|NCT02919618|12063903|FG000|STARTED|Overall Study||19
10897885|NCT02919618|12063903|FG000|Primary Safety Endpoint (</=90 Days)|Overall Study||19
10897886|NCT02919618|12063903|FG000|Primary Efficacy Endpoint (6 Months)|Overall Study||18
10897887|NCT02919618|12063903|FG000|COMPLETED|Overall Study||18
10897888|NCT02919618|12063903|FG000|NOT COMPLETED|Overall Study||1
10897889|NCT02844946|12063920|FG000|STARTED|Overall Study||27
10897890|NCT02844946|12063921|FG001|STARTED|Overall Study||12
10897891|NCT02844946|12063920|FG000|COMPLETED|Overall Study||20
10897892|NCT02844946|12063921|FG001|COMPLETED|Overall Study||12
10897893|NCT02844946|12063920|FG000|NOT COMPLETED|Overall Study||7
10897894|NCT02844946|12063921|FG001|NOT COMPLETED|Overall Study||0
10897895|NCT02675114|12063929|FG000|STARTED|Overall Study||497
10897896|NCT02675114|12063930|FG001|STARTED|Overall Study||503
10897897|NCT02675114|12063929|FG000|As Treated|Overall Study||454
10897898|NCT02675114|12063930|FG001|As Treated|Overall Study||496
10897899|NCT02675114|12063929|FG000|Valve Implant|Overall Study||453
10897900|NCT02675114|12063930|FG001|Valve Implant|Overall Study||495
10897901|NCT02675114|12063929|FG000|COMPLETED|Overall Study||424
10897902|NCT02675114|12063930|FG001|COMPLETED|Overall Study||490
10897903|NCT02675114|12063929|FG000|NOT COMPLETED|Overall Study||73
10897904|NCT02675114|12063930|FG001|NOT COMPLETED|Overall Study||13
10897905|NCT02564796|12063938|FG000|STARTED|Overall Study||2
10897906|NCT02564796|12063939|FG001|STARTED|Overall Study||2
10897907|NCT02564796|12063938|FG000|COMPLETED|Overall Study||0
10897908|NCT02564796|12063939|FG001|COMPLETED|Overall Study||0
10897909|NCT02564796|12063938|FG000|NOT COMPLETED|Overall Study||2
10897910|NCT02564796|12063939|FG001|NOT COMPLETED|Overall Study||2
10897911|NCT02562716|12063947|FG000|STARTED|Overall Study||55
10897912|NCT02562716|12063948|FG001|STARTED|Overall Study||47
10897913|NCT02562716|12063947|FG000|Participants Assessed for AEs|Overall Study||53
10897914|NCT02562716|12063948|FG001|Participants Assessed for AEs|Overall Study||45
10897915|NCT02562716|12063947|FG000|COMPLETED|Overall Study||27
10897916|NCT02562716|12063948|FG001|COMPLETED|Overall Study||19
10897917|NCT02562716|12063947|FG000|NOT COMPLETED|Overall Study||28
10897918|NCT02562716|12063948|FG001|NOT COMPLETED|Overall Study||28
10897919|NCT01803854|12063956|FG000|STARTED|Overall Study||1275
10897920|NCT01803854|12063956|FG000|COMPLETED|Overall Study||1275
10897921|NCT01803854|12063956|FG000|NOT COMPLETED|Overall Study||0
10897922|NCT01472081|12063967|FG000|STARTED|Overall Study||7
10897923|NCT01472081|12063968|FG001|STARTED|Overall Study||26
10897924|NCT01472081|12063969|FG002|STARTED|Overall Study||20
10897925|NCT01472081|12063970|FG003|STARTED|Overall Study||47
10897926|NCT01472081|12063971|FG004|STARTED|Overall Study||47
10897927|NCT01472081|12063972|FG005|STARTED|Overall Study||6
10897928|NCT01472081|12063967|FG000|COMPLETED|Overall Study||0
10897929|NCT01472081|12063968|FG001|COMPLETED|Overall Study||0
10897930|NCT01472081|12063969|FG002|COMPLETED|Overall Study||0
10897931|NCT01472081|12063970|FG003|COMPLETED|Overall Study||1
10897932|NCT01472081|12063971|FG004|COMPLETED|Overall Study||0
10897933|NCT01472081|12063972|FG005|COMPLETED|Overall Study||0
10897934|NCT01472081|12063967|FG000|NOT COMPLETED|Overall Study||7
10897935|NCT01472081|12063968|FG001|NOT COMPLETED|Overall Study||26
10897936|NCT01472081|12063969|FG002|NOT COMPLETED|Overall Study||20
10897937|NCT01472081|12063970|FG003|NOT COMPLETED|Overall Study||46
10897938|NCT01472081|12063971|FG004|NOT COMPLETED|Overall Study||47
10897939|NCT01472081|12063972|FG005|NOT COMPLETED|Overall Study||6
10897940|NCT01309672|12063985|FG000|STARTED|Overall Study||41
10897941|NCT01309672|12063985|FG000|Received Protocol Treatment|Overall Study||40
10897942|NCT01309672|12063985|FG000|COMPLETED|Overall Study||4
10897943|NCT01309672|12063985|FG000|NOT COMPLETED|Overall Study||37
10897944|NCT01131169|12063992|FG000|STARTED|Overall Study||47
10897945|NCT01131169|12063993|FG001|STARTED|Overall Study||19
10897946|NCT01131169|12063992|FG000|COMPLETED|Overall Study||47
10897947|NCT01131169|12063993|FG001|COMPLETED|Overall Study||19
10897948|NCT01131169|12063992|FG000|NOT COMPLETED|Overall Study||0
10897949|NCT01131169|12063993|FG001|NOT COMPLETED|Overall Study||0
10897950|NCT00774345|12064002|FG000|STARTED|Pre-treatment||160
10897951|NCT00774345|12064003|FG001|STARTED|Pre-treatment||157
10897952|NCT00774345|12064002|FG000|COMPLETED|Pre-treatment||158
10897953|NCT00774345|12064003|FG001|COMPLETED|Pre-treatment||157
10897954|NCT00774345|12064002|FG000|NOT COMPLETED|Pre-treatment||2
10897955|NCT00774345|12064003|FG001|NOT COMPLETED|Pre-treatment||0
10897956|NCT00774345|12064002|FG000|STARTED|Treatment||158
10897957|NCT00774345|12064003|FG001|STARTED|Treatment||157
10897958|NCT00774345|12064002|FG000|Participants Escalated to 5mg|Treatment||129
10897959|NCT00774345|12064003|FG001|Participants Escalated to 5mg|Treatment||149
10897960|NCT00774345|12064002|FG000|Participants Escalated to 10mg|Treatment||68
10897961|NCT00774345|12064003|FG001|Participants Escalated to 10mg|Treatment||88
10897962|NCT00774345|12064002|FG000|COMPLETED|Treatment||0
10897963|NCT00774345|12064003|FG001|COMPLETED|Treatment||0
10897964|NCT00774345|12064002|FG000|NOT COMPLETED|Treatment||158
10897965|NCT00774345|12064003|FG001|NOT COMPLETED|Treatment||157
10897966|NCT00457951|12064012|FG000|STARTED|Overall Study||13
10897967|NCT00457951|12064013|FG001|STARTED|Overall Study||66
10897968|NCT00457951|12064014|FG002|STARTED|Overall Study||72
10897969|NCT00457951|12064012|FG000|COMPLETED|Overall Study||13
10897970|NCT00457951|12064013|FG001|COMPLETED|Overall Study||50
10897971|NCT00457951|12064014|FG002|COMPLETED|Overall Study||60
10897972|NCT00457951|12064012|FG000|NOT COMPLETED|Overall Study||0
10897973|NCT00457951|12064013|FG001|NOT COMPLETED|Overall Study||16
10897974|NCT00457951|12064014|FG002|NOT COMPLETED|Overall Study||12
10897975|NCT00345943|12064023|FG000|STARTED|Overall Study||38
10897976|NCT00345943|12064024|FG001|STARTED|Overall Study||33
10897977|NCT00345943|12064023|FG000|COMPLETED|Overall Study||33
10897978|NCT00345943|12064024|FG001|COMPLETED|Overall Study||28
10897979|NCT00345943|12064023|FG000|NOT COMPLETED|Overall Study||5
10897980|NCT00345943|12064024|FG001|NOT COMPLETED|Overall Study||5
10897981|NCT00258427|12064034|FG000|STARTED|Overall Study||3
10897982|NCT00258427|12064035|FG001|STARTED|Overall Study||8
10897983|NCT00258427|12064036|FG002|STARTED|Overall Study||2
10897984|NCT00258427|12064037|FG003|STARTED|Overall Study||1
10897985|NCT00258427|12064034|FG000|COMPLETED|Overall Study||3
10897986|NCT00258427|12064035|FG001|COMPLETED|Overall Study||8
10897987|NCT00258427|12064036|FG002|COMPLETED|Overall Study||2
10897988|NCT00258427|12064037|FG003|COMPLETED|Overall Study||1
10897989|NCT00258427|12064034|FG000|NOT COMPLETED|Overall Study||0
10897990|NCT00258427|12064035|FG001|NOT COMPLETED|Overall Study||0
10897991|NCT00258427|12064036|FG002|NOT COMPLETED|Overall Study||0
10897992|NCT00258427|12064037|FG003|NOT COMPLETED|Overall Study||0
10897993|NCT03722810|12064049|FG000|STARTED|Overall Study||157
10897994|NCT03722810|12064050|FG001|STARTED|Overall Study||160
10897995|NCT03722810|12064049|FG000|COMPLETED|Overall Study||150
10897996|NCT03722810|12064050|FG001|COMPLETED|Overall Study||156
10897997|NCT03722810|12064049|FG000|NOT COMPLETED|Overall Study||7
10897998|NCT03722810|12064050|FG001|NOT COMPLETED|Overall Study||4
10897999|NCT00000125|12064065|FG000|STARTED|Overall Study||819
10898000|NCT00000125|12064066|FG001|STARTED|Overall Study||817
10898001|NCT00000125|12064065|FG000|Completed OHTS Phase I, June 2002|Overall Study||706
10898002|NCT00000125|12064066|FG001|Completed OHTS Phase I, June 2002|Overall Study||702
10898003|NCT00000125|12064065|FG000|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
10898004|NCT00000125|12064066|FG001|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
10898005|NCT00000125|12064065|FG000|NOT COMPLETED|Overall Study||239
10898006|NCT00000125|12064066|FG001|NOT COMPLETED|Overall Study||238
10898007|NCT00000134|12064075|FG000|STARTED|Overall Study||89
10898008|NCT00000134|12064076|FG001|STARTED|Overall Study||94
10898009|NCT00000134|12064077|FG002|STARTED|Overall Study||96
10898010|NCT00000134|12064075|FG000|COMPLETED|Overall Study||89
10898011|NCT00000134|12064076|FG001|COMPLETED|Overall Study||94
10898012|NCT00000134|12064077|FG002|COMPLETED|Overall Study||96
10898013|NCT00000134|12064075|FG000|NOT COMPLETED|Overall Study||0
10898014|NCT00000134|12064076|FG001|NOT COMPLETED|Overall Study||0
10898015|NCT00000134|12064077|FG002|NOT COMPLETED|Overall Study||0
10898016|NCT00000135|12064087|FG000|STARTED|Overall Study||104
10898017|NCT00000135|12064088|FG001|STARTED|Overall Study||105
10898018|NCT00000135|12064087|FG000|COMPLETED|Overall Study||77
10898019|NCT00000135|12064088|FG001|COMPLETED|Overall Study||91
10898020|NCT00000135|12064087|FG000|NOT COMPLETED|Overall Study||27
10898021|NCT00000135|12064088|FG001|NOT COMPLETED|Overall Study||14
10898022|NCT00000136|12064096|FG000|STARTED|Overall Study||107
10898023|NCT00000136|12064097|FG001|STARTED|Overall Study||127
10898024|NCT00000136|12064096|FG000|COMPLETED|Overall Study||107
10898025|NCT00000136|12064097|FG001|COMPLETED|Overall Study||127
10898026|NCT00000136|12064096|FG000|NOT COMPLETED|Overall Study||0
10898027|NCT00000136|12064097|FG001|NOT COMPLETED|Overall Study||0
10898028|NCT00000142|12064106|FG000|STARTED|Overall Study||26
10898029|NCT00000142|12064107|FG001|STARTED|Overall Study||26
10898030|NCT00000142|12064108|FG002|STARTED|Overall Study||12
10898031|NCT00000142|12064106|FG000|COMPLETED|Overall Study||26
10898032|NCT00000142|12064107|FG001|COMPLETED|Overall Study||26
10898033|NCT00000142|12064108|FG002|COMPLETED|Overall Study||12
10898034|NCT00000142|12064106|FG000|NOT COMPLETED|Overall Study||0
10898035|NCT00000142|12064107|FG001|NOT COMPLETED|Overall Study||0
10898036|NCT00000142|12064108|FG002|NOT COMPLETED|Overall Study||0
10898037|NCT00000143|12064118|FG000|STARTED|Overall Study||31
10898038|NCT00000143|12064119|FG001|STARTED|Overall Study||30
10898039|NCT00000143|12064118|FG000|COMPLETED|Overall Study||31
10898040|NCT00000143|12064119|FG001|COMPLETED|Overall Study||30
10898041|NCT00000143|12064118|FG000|NOT COMPLETED|Overall Study||0
10898042|NCT00000143|12064119|FG001|NOT COMPLETED|Overall Study||0
10898043|NCT00000371|12064127|FG000|STARTED|Overall Study||27
10898044|NCT00000371|12064128|FG001|STARTED|Overall Study||28
10898045|NCT00000371|12064127|FG000|COMPLETED|Overall Study||14
10898046|NCT00000371|12064128|FG001|COMPLETED|Overall Study||12
10898047|NCT00000371|12064127|FG000|NOT COMPLETED|Overall Study||13
10898048|NCT00000371|12064128|FG001|NOT COMPLETED|Overall Study||16
10898049|NCT00000378|12064136|FG000|STARTED|Overall Study||58
10898050|NCT00000378|12064137|FG001|STARTED|Overall Study||52
10898051|NCT00000378|12064136|FG000|COMPLETED|Overall Study||42
10898052|NCT00000378|12064137|FG001|COMPLETED|Overall Study||38
10898053|NCT00000378|12064136|FG000|NOT COMPLETED|Overall Study||16
10898054|NCT00000378|12064137|FG001|NOT COMPLETED|Overall Study||14
10898055|NCT00000392|12064145|FG000|STARTED|Overall Study||106
10898056|NCT00000392|12064146|FG001|STARTED|Overall Study||109
10898057|NCT00000392|12064145|FG000|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
10898058|NCT00000392|12064146|FG001|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
10898059|NCT00000392|12064145|FG000|NOT COMPLETED|Overall Study||40
10898060|NCT00000392|12064146|FG001|NOT COMPLETED|Overall Study||32
10898061|NCT00000479|12064156|FG000|STARTED|Overall Study||9968
10898062|NCT00000479|12064157|FG001|STARTED|Overall Study||9971
10898063|NCT00000479|12064158|FG002|STARTED|Overall Study||9966
10898064|NCT00000479|12064159|FG003|STARTED|Overall Study||9971
10898065|NCT00000479|12064156|FG000|COMPLETED|Overall Study||9968
10898066|NCT00000479|12064157|FG001|COMPLETED|Overall Study||9971
10898067|NCT00000479|12064158|FG002|COMPLETED|Overall Study||9966
10898068|NCT00000479|12064159|FG003|COMPLETED|Overall Study||9971
10898069|NCT00000479|12064156|FG000|NOT COMPLETED|Overall Study||0
10898070|NCT00000479|12064157|FG001|NOT COMPLETED|Overall Study||0
10898071|NCT00000479|12064158|FG002|NOT COMPLETED|Overall Study||0
10898072|NCT00000479|12064159|FG003|NOT COMPLETED|Overall Study||0
10898073|NCT00000575|12064172|FG000|STARTED|Overall Study||311
10898074|NCT00000575|12064173|FG001|STARTED|Overall Study||312
10898075|NCT00000575|12064174|FG002|STARTED|Overall Study||418
10898076|NCT00000575|12064172|FG000|COMPLETED|Overall Study||311
10898077|NCT00000575|12064173|FG001|COMPLETED|Overall Study||312
10898078|NCT00000575|12064174|FG002|COMPLETED|Overall Study||418
10898079|NCT00000575|12064172|FG000|NOT COMPLETED|Overall Study||0
10898080|NCT00000575|12064173|FG001|NOT COMPLETED|Overall Study||0
10898081|NCT00000575|12064174|FG002|NOT COMPLETED|Overall Study||0
10898082|NCT00000620|12064184|FG000|STARTED|Overall Study||1178
10898083|NCT00000620|12064185|FG001|STARTED|Overall Study||1193
10898084|NCT00000620|12064186|FG002|STARTED|Overall Study||1374
10898085|NCT00000620|12064187|FG003|STARTED|Overall Study||1383
10898086|NCT00000620|12064188|FG004|STARTED|Overall Study||1184
10898087|NCT00000620|12064189|FG005|STARTED|Overall Study||1178
10898088|NCT00000620|12064190|FG006|STARTED|Overall Study||1391
10898089|NCT00000620|12064191|FG007|STARTED|Overall Study||1370
10898090|NCT00000620|12064184|FG000|COMPLETED|Overall Study||1016
10898091|NCT00000620|12064185|FG001|COMPLETED|Overall Study||1057
10898092|NCT00000620|12064186|FG002|COMPLETED|Overall Study||1204
10898093|NCT00000620|12064187|FG003|COMPLETED|Overall Study||1205
10898094|NCT00000620|12064188|FG004|COMPLETED|Overall Study||1049
10898095|NCT00000620|12064189|FG005|COMPLETED|Overall Study||1026
10898096|NCT00000620|12064190|FG006|COMPLETED|Overall Study||1242
10898097|NCT00000620|12064191|FG007|COMPLETED|Overall Study||1224
10898098|NCT00000620|12064184|FG000|NOT COMPLETED|Overall Study||162
10898099|NCT00000620|12064185|FG001|NOT COMPLETED|Overall Study||136
10898100|NCT00000620|12064186|FG002|NOT COMPLETED|Overall Study||170
10898101|NCT00000620|12064187|FG003|NOT COMPLETED|Overall Study||178
10898102|NCT00000620|12064188|FG004|NOT COMPLETED|Overall Study||135
10898103|NCT00000620|12064189|FG005|NOT COMPLETED|Overall Study||152
10898104|NCT00000620|12064190|FG006|NOT COMPLETED|Overall Study||149
10898105|NCT00000620|12064191|FG007|NOT COMPLETED|Overall Study||146
10898106|NCT00001151|12064203|FG000|STARTED|Overall Study||6
10898107|NCT00001151|12064203|FG000|COMPLETED|Overall Study||1
10898108|NCT00001151|12064203|FG000|NOT COMPLETED|Overall Study||5
10898109|NCT00001213|12064207|FG000|STARTED|Overall Study||328
10898110|NCT00001213|12064207|FG000|COMPLETED|Overall Study||310
10898111|NCT00001213|12064207|FG000|NOT COMPLETED|Overall Study||18
10898112|NCT00001262|12064214|FG000|STARTED|Overall Study||35
10898113|NCT00001262|12064215|FG001|STARTED|Overall Study||22
10898114|NCT00001262|12064216|FG002|STARTED|Overall Study||3
10898115|NCT00001262|12064214|FG000|COMPLETED|Overall Study||25
10898116|NCT00001262|12064215|FG001|COMPLETED|Overall Study||8
10898117|NCT00001262|12064216|FG002|COMPLETED|Overall Study||3
10898118|NCT00001262|12064214|FG000|NOT COMPLETED|Overall Study||10
10898119|NCT00001262|12064215|FG001|NOT COMPLETED|Overall Study||14
10898120|NCT00001262|12064216|FG002|NOT COMPLETED|Overall Study||0
10898121|NCT00001304|12064226|FG000|STARTED|Overall Study||13
10898122|NCT00001304|12064227|FG001|STARTED|Overall Study||14
10898123|NCT00001304|12064226|FG000|COMPLETED|Overall Study||13
10898124|NCT00001304|12064227|FG001|COMPLETED|Overall Study||14
10898125|NCT00001304|12064226|FG000|NOT COMPLETED|Overall Study||0
10898126|NCT00001304|12064227|FG001|NOT COMPLETED|Overall Study||0
10898127|NCT00001305|12064233|FG000|STARTED|Overall Study||42
10898128|NCT00001305|12064233|FG000|COMPLETED|Overall Study||42
10898129|NCT00001305|12064233|FG000|NOT COMPLETED|Overall Study||0
10898130|NCT00001566|12064237|FG000|STARTED|Overall Study||42
10898131|NCT00001566|12064237|FG000|Completed Immunotherapy|Overall Study||23
10898132|NCT00001566|12064237|FG000|COMPLETED|Overall Study||23
10898133|NCT00001566|12064237|FG000|NOT COMPLETED|Overall Study||19
10898134|NCT00001575|12064241|FG000|STARTED|Overall Study||87
10898135|NCT00001575|12064241|FG000|Treated|Overall Study||65
10898136|NCT00001575|12064241|FG000|COMPLETED|Overall Study||42
10898137|NCT00001575|12064241|FG000|NOT COMPLETED|Overall Study||45
10898138|NCT00001586|12064247|FG000|STARTED|Overall Study||49
10898139|NCT00001586|12064248|FG001|STARTED|Overall Study||56
10898140|NCT00001586|12064247|FG000|COMPLETED|Overall Study||49
10898141|NCT00001586|12064248|FG001|COMPLETED|Overall Study||56
10898142|NCT00001586|12064247|FG000|NOT COMPLETED|Overall Study||0
10898143|NCT00001586|12064248|FG001|NOT COMPLETED|Overall Study||0
10898144|NCT00001596|12064256|FG000|STARTED|Overall Study||23
10898145|NCT00001596|12064257|FG001|STARTED|Overall Study||12
10898146|NCT00001596|12064256|FG000|COMPLETED|Overall Study||6
10898147|NCT00001596|12064257|FG001|COMPLETED|Overall Study||2
10898148|NCT00001596|12064256|FG000|NOT COMPLETED|Overall Study||17
10898149|NCT00001596|12064257|FG001|NOT COMPLETED|Overall Study||10
10898150|NCT00001656|12064265|FG000|STARTED|Overall Study||13
10898151|NCT00001656|12064266|FG001|STARTED|Overall Study||12
10898152|NCT00001656|12064265|FG000|COMPLETED|Overall Study||12
10898153|NCT00001656|12064266|FG001|COMPLETED|Overall Study||12
10898154|NCT00001656|12064265|FG000|NOT COMPLETED|Overall Study||1
10898155|NCT00001656|12064266|FG001|NOT COMPLETED|Overall Study||0
10898156|NCT00001703|12064272|FG000|STARTED|Overall Study||6
10898157|NCT00001703|12064272|FG000|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
10898158|NCT00001703|12064272|FG000|COMPLETED|Overall Study||1
10898159|NCT00001703|12064272|FG000|NOT COMPLETED|Overall Study||5
10898160|NCT00001723|12064278|FG000|STARTED|Overall Study||100
10898161|NCT00001723|12064279|FG001|STARTED|Overall Study||100
10898162|NCT00001723|12064278|FG000|COMPLETED|Overall Study||87
10898163|NCT00001723|12064279|FG001|COMPLETED|Overall Study||84
10898164|NCT00001723|12064278|FG000|NOT COMPLETED|Overall Study||13
10898165|NCT00001723|12064279|FG001|NOT COMPLETED|Overall Study||16
10898166|NCT00001832|12064303|FG000|STARTED|Apheresis Period||170
10898167|NCT00001832|12064304|FG001|STARTED|Apheresis Period||0
10898168|NCT00001832|12064305|FG002|STARTED|Apheresis Period||0
10898169|NCT00001832|12064306|FG003|STARTED|Apheresis Period||0
10898170|NCT00001832|12064307|FG004|STARTED|Apheresis Period||0
10898171|NCT00001832|12064308|FG005|STARTED|Apheresis Period||0
10898172|NCT00001832|12064309|FG006|STARTED|Apheresis Period||0
10898173|NCT00001832|12064310|FG007|STARTED|Apheresis Period||0
10898174|NCT00001832|12064311|FG008|STARTED|Apheresis Period||0
10898175|NCT00001832|12064312|FG009|STARTED|Apheresis Period||0
10898176|NCT00001832|12064313|FG010|STARTED|Apheresis Period||0
10898177|NCT00001832|12064314|FG011|STARTED|Apheresis Period||0
10898178|NCT00001832|12064315|FG012|STARTED|Apheresis Period||0
10898179|NCT00001832|12064316|FG013|STARTED|Apheresis Period||0
10898180|NCT00001832|12064317|FG014|STARTED|Apheresis Period||0
10898181|NCT00001832|12064303|FG000|COMPLETED|Apheresis Period||110
10898182|NCT00001832|12064304|FG001|COMPLETED|Apheresis Period||0
10898183|NCT00001832|12064305|FG002|COMPLETED|Apheresis Period||0
10898184|NCT00001832|12064306|FG003|COMPLETED|Apheresis Period||0
10898185|NCT00001832|12064307|FG004|COMPLETED|Apheresis Period||0
10898186|NCT00001832|12064308|FG005|COMPLETED|Apheresis Period||0
10898187|NCT00001832|12064309|FG006|COMPLETED|Apheresis Period||0
10898188|NCT00001832|12064310|FG007|COMPLETED|Apheresis Period||0
10898189|NCT00001832|12064311|FG008|COMPLETED|Apheresis Period||0
10898190|NCT00001832|12064312|FG009|COMPLETED|Apheresis Period||0
10898191|NCT00001832|12064313|FG010|COMPLETED|Apheresis Period||0
10898192|NCT00001832|12064314|FG011|COMPLETED|Apheresis Period||0
10898193|NCT00001832|12064315|FG012|COMPLETED|Apheresis Period||0
10898194|NCT00001832|12064316|FG013|COMPLETED|Apheresis Period||0
10898195|NCT00001832|12064317|FG014|COMPLETED|Apheresis Period||0
10898196|NCT00001832|12064303|FG000|NOT COMPLETED|Apheresis Period||60
10898197|NCT00001832|12064304|FG001|NOT COMPLETED|Apheresis Period||0
10898198|NCT00001832|12064305|FG002|NOT COMPLETED|Apheresis Period||0
10898199|NCT00001832|12064306|FG003|NOT COMPLETED|Apheresis Period||0
10898200|NCT00001832|12064307|FG004|NOT COMPLETED|Apheresis Period||0
10898201|NCT00001832|12064308|FG005|NOT COMPLETED|Apheresis Period||0
10898202|NCT00001832|12064309|FG006|NOT COMPLETED|Apheresis Period||0
10898203|NCT00001832|12064310|FG007|NOT COMPLETED|Apheresis Period||0
10898204|NCT00001832|12064311|FG008|NOT COMPLETED|Apheresis Period||0
10898205|NCT00001832|12064312|FG009|NOT COMPLETED|Apheresis Period||0
10898206|NCT00001832|12064313|FG010|NOT COMPLETED|Apheresis Period||0
10898207|NCT00001832|12064314|FG011|NOT COMPLETED|Apheresis Period||0
10898208|NCT00001832|12064315|FG012|NOT COMPLETED|Apheresis Period||0
10898209|NCT00001832|12064316|FG013|NOT COMPLETED|Apheresis Period||0
10898210|NCT00001832|12064317|FG014|NOT COMPLETED|Apheresis Period||0
10898211|NCT00001832|12064303|FG000|STARTED|Treatment Period||0
10898212|NCT00001832|12064304|FG001|STARTED|Treatment Period||3
10898213|NCT00001832|12064305|FG002|STARTED|Treatment Period||3
10898214|NCT00001832|12064306|FG003|STARTED|Treatment Period||3
10898215|NCT00001832|12064307|FG004|STARTED|Treatment Period||6
10898216|NCT00001832|12064308|FG005|STARTED|Treatment Period||51
10898217|NCT00001832|12064309|FG006|STARTED|Treatment Period||4
10898218|NCT00001832|12064310|FG007|STARTED|Treatment Period||7
10898219|NCT00001832|12064311|FG008|STARTED|Treatment Period||8
10898220|NCT00001832|12064312|FG009|STARTED|Treatment Period||6
10898221|NCT00001832|12064313|FG010|STARTED|Treatment Period||1
10898222|NCT00001832|12064314|FG011|STARTED|Treatment Period||7
10898223|NCT00001832|12064315|FG012|STARTED|Treatment Period||6
10898224|NCT00001832|12064316|FG013|STARTED|Treatment Period||3
10898225|NCT00001832|12064317|FG014|STARTED|Treatment Period||2
10898226|NCT00001832|12064303|FG000|COMPLETED|Treatment Period||0
10898227|NCT00001832|12064304|FG001|COMPLETED|Treatment Period||3
10898228|NCT00001832|12064305|FG002|COMPLETED|Treatment Period||3
10898229|NCT00001832|12064306|FG003|COMPLETED|Treatment Period||3
10898230|NCT00001832|12064307|FG004|COMPLETED|Treatment Period||6
10898231|NCT00001832|12064308|FG005|COMPLETED|Treatment Period||50
10898232|NCT00001832|12064309|FG006|COMPLETED|Treatment Period||4
10898233|NCT00001832|12064310|FG007|COMPLETED|Treatment Period||6
10898234|NCT00001832|12064311|FG008|COMPLETED|Treatment Period||8
10898235|NCT00001832|12064312|FG009|COMPLETED|Treatment Period||6
10898236|NCT00001832|12064313|FG010|COMPLETED|Treatment Period||1
10898237|NCT00001832|12064314|FG011|COMPLETED|Treatment Period||7
10898238|NCT00001832|12064315|FG012|COMPLETED|Treatment Period||6
10898239|NCT00001832|12064316|FG013|COMPLETED|Treatment Period||3
10898240|NCT00001832|12064317|FG014|COMPLETED|Treatment Period||2
10898241|NCT00001832|12064303|FG000|NOT COMPLETED|Treatment Period||0
10898242|NCT00001832|12064304|FG001|NOT COMPLETED|Treatment Period||0
10898243|NCT00001832|12064305|FG002|NOT COMPLETED|Treatment Period||0
10898244|NCT00001832|12064306|FG003|NOT COMPLETED|Treatment Period||0
10898245|NCT00001832|12064307|FG004|NOT COMPLETED|Treatment Period||0
10898246|NCT00001832|12064308|FG005|NOT COMPLETED|Treatment Period||1
10898247|NCT00001832|12064309|FG006|NOT COMPLETED|Treatment Period||0
10898248|NCT00001832|12064310|FG007|NOT COMPLETED|Treatment Period||1
10898249|NCT00001832|12064311|FG008|NOT COMPLETED|Treatment Period||0
10898250|NCT00001832|12064312|FG009|NOT COMPLETED|Treatment Period||0
10898251|NCT00001832|12064313|FG010|NOT COMPLETED|Treatment Period||0
10898252|NCT00001832|12064314|FG011|NOT COMPLETED|Treatment Period||0
10898253|NCT00001832|12064315|FG012|NOT COMPLETED|Treatment Period||0
10898254|NCT00001832|12064316|FG013|NOT COMPLETED|Treatment Period||0
10898255|NCT00001832|12064317|FG014|NOT COMPLETED|Treatment Period||0
10898256|NCT00001849|12064347|FG000|STARTED|Overall Study||68
10898257|NCT00001849|12064347|FG000|COMPLETED|Overall Study|Patients completed when an ectopic ACTH-secreting tumor was identified|54
10898258|NCT00001849|12064347|FG000|NOT COMPLETED|Overall Study||14
10898259|NCT00001880|12064360|FG000|STARTED|Overall Study||42
10898260|NCT00001880|12064360|FG000|COMPLETED|Overall Study||28
10898261|NCT00001880|12064360|FG000|NOT COMPLETED|Overall Study||14
10898262|NCT00001941|12064364|FG000|STARTED|Overall Study||3
10898263|NCT00001941|12064365|FG001|STARTED|Overall Study||5
10898264|NCT00001941|12064366|FG002|STARTED|Overall Study||3
10898265|NCT00001941|12064367|FG003|STARTED|Overall Study||3
10898266|NCT00001941|12064368|FG004|STARTED|Overall Study||20
10898267|NCT00001941|12064364|FG000|COMPLETED|Overall Study||3
10898268|NCT00001941|12064365|FG001|COMPLETED|Overall Study||5
10898269|NCT00001941|12064366|FG002|COMPLETED|Overall Study||3
10898270|NCT00001941|12064367|FG003|COMPLETED|Overall Study||3
10898271|NCT00001941|12064368|FG004|COMPLETED|Overall Study||19
10898272|NCT00001941|12064364|FG000|NOT COMPLETED|Overall Study||0
10898273|NCT00001941|12064365|FG001|NOT COMPLETED|Overall Study||0
10898274|NCT00001941|12064366|FG002|NOT COMPLETED|Overall Study||0
10898275|NCT00001941|12064367|FG003|NOT COMPLETED|Overall Study||0
10898276|NCT00001941|12064368|FG004|NOT COMPLETED|Overall Study||1
10898277|NCT00001959|12064373|FG000|STARTED|Overall Study||21
10898278|NCT00001959|12064373|FG000|COMPLETED|Overall Study||18
10898279|NCT00001959|12064373|FG000|NOT COMPLETED|Overall Study||3
10898280|NCT00001962|12064377|FG000|STARTED|Overall Study||100
10898281|NCT00001962|12064377|FG000|COMPLETED|Overall Study||72
10898282|NCT00001962|12064377|FG000|NOT COMPLETED|Overall Study||28
10898283|NCT00001984|12064381|FG000|STARTED|Overall Study||5
10898284|NCT00001984|12064381|FG000|COMPLETED|Overall Study||5
10898285|NCT00001984|12064381|FG000|NOT COMPLETED|Overall Study||0
10898286|NCT00002525|12064387|FG000|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
10898287|NCT00002525|12064388|FG001|STARTED|Overall Study||428
10898288|NCT00002525|12064387|FG000|Treated|Overall Study||419
10898289|NCT00002525|12064388|FG001|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
10898290|NCT00002525|12064387|FG000|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
10898291|NCT00002525|12064388|FG001|Dukes' B3 or C Stage|Overall Study||158
10898292|NCT00002525|12064387|FG000|Dukes' B2 Stage|Overall Study||150
10898293|NCT00002525|12064388|FG001|Dukes' B2 Stage|Overall Study||139
10898294|NCT00002525|12064387|FG000|COMPLETED|Overall Study||241
10898295|NCT00002525|12064388|FG001|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
10898296|NCT00002525|12064387|FG000|NOT COMPLETED|Overall Study||186
10898297|NCT00002525|12064388|FG001|NOT COMPLETED|Overall Study||0
10898298|NCT00002558|12064398|FG000|STARTED|Overall Study||92
10898299|NCT00002558|12064399|FG001|STARTED|Overall Study||16
10898300|NCT00002558|12064398|FG000|COMPLETED|Overall Study||92
10898301|NCT00002558|12064399|FG001|COMPLETED|Overall Study||15
10898302|NCT00002558|12064398|FG000|NOT COMPLETED|Overall Study||0
10898303|NCT00002558|12064399|FG001|NOT COMPLETED|Overall Study||1
10898304|NCT00002597|12064407|FG000|STARTED|Overall Study||1013
10898305|NCT00002597|12064408|FG001|STARTED|Overall Study||1015
10898306|NCT00002597|12064407|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
10898307|NCT00002597|12064408|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
10898308|NCT00002597|12064407|FG000|NOT COMPLETED|Overall Study||26
10898309|NCT00002597|12064408|FG001|NOT COMPLETED|Overall Study||23
10898310|NCT00002601|12064414|FG000|STARTED|Overall Study||13
10898311|NCT00002601|12064414|FG000|COMPLETED|Overall Study||13
10898312|NCT00002601|12064414|FG000|NOT COMPLETED|Overall Study||0
10898313|NCT00002651|12064422|FG000|STARTED|Induction||3040
10898314|NCT00002651|12064423|FG001|STARTED|Induction||0
10898315|NCT00002651|12064424|FG002|STARTED|Induction||0
10898316|NCT00002651|12064422|FG000|Eligible|Induction||2950
10898317|NCT00002651|12064423|FG001|Eligible|Induction||0
10898318|NCT00002651|12064424|FG002|Eligible|Induction||0
10898319|NCT00002651|12064422|FG000|Eligible and Began Protocol Therapy|Induction||2950
10898320|NCT00002651|12064423|FG001|Eligible and Began Protocol Therapy|Induction||0
10898321|NCT00002651|12064424|FG002|Eligible and Began Protocol Therapy|Induction||0
10898322|NCT00002651|12064422|FG000|COMPLETED|Induction||1697
10898323|NCT00002651|12064423|FG001|COMPLETED|Induction||0
10898324|NCT00002651|12064424|FG002|COMPLETED|Induction||0
10898325|NCT00002651|12064422|FG000|NOT COMPLETED|Induction||1343
10898326|NCT00002651|12064423|FG001|NOT COMPLETED|Induction||0
10898327|NCT00002651|12064424|FG002|NOT COMPLETED|Induction||0
10898328|NCT00002651|12064422|FG000|STARTED|Consolidation and Randomization||0
10898329|NCT00002651|12064423|FG001|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
10898330|NCT00002651|12064424|FG002|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
10898331|NCT00002651|12064422|FG000|Eligible|Consolidation and Randomization||0
10898332|NCT00002651|12064423|FG001|Eligible|Consolidation and Randomization||765
10898333|NCT00002651|12064424|FG002|Eligible|Consolidation and Randomization||770
10898334|NCT00002651|12064422|FG000|Assessable for Toxicity|Consolidation and Randomization||0
10898335|NCT00002651|12064423|FG001|Assessable for Toxicity|Consolidation and Randomization||732
10898336|NCT00002651|12064424|FG002|Assessable for Toxicity|Consolidation and Randomization||702
10898337|NCT00002651|12064422|FG000|COMPLETED|Consolidation and Randomization||0
10898338|NCT00002651|12064423|FG001|COMPLETED|Consolidation and Randomization||29
10898339|NCT00002651|12064424|FG002|COMPLETED|Consolidation and Randomization||22
10898340|NCT00002651|12064422|FG000|NOT COMPLETED|Consolidation and Randomization||0
10898341|NCT00002651|12064423|FG001|NOT COMPLETED|Consolidation and Randomization||838
10898342|NCT00002651|12064424|FG002|NOT COMPLETED|Consolidation and Randomization||860
10898343|NCT00002766|12064434|FG000|STARTED|Overall Study||81
10898344|NCT00002766|12064435|FG001|STARTED|Overall Study||89
10898345|NCT00002766|12064434|FG000|COMPLETED|Overall Study||78
10898346|NCT00002766|12064435|FG001|COMPLETED|Overall Study||85
10898347|NCT00002766|12064434|FG000|NOT COMPLETED|Overall Study||3
10898348|NCT00002766|12064435|FG001|NOT COMPLETED|Overall Study||4
10898349|NCT00002842|12064441|FG000|STARTED|Overall Study||49
10898350|NCT00002842|12064441|FG000|COMPLETED|Overall Study||22
10898351|NCT00002842|12064441|FG000|NOT COMPLETED|Overall Study||27
10898352|NCT00002850|12064448|FG000|STARTED|Overall Study||69
10898353|NCT00002850|12064449|FG001|STARTED|Overall Study||76
10898354|NCT00002850|12064450|FG002|STARTED|Overall Study||67
10898355|NCT00002850|12064448|FG000|COMPLETED|Overall Study||64
10898356|NCT00002850|12064449|FG001|COMPLETED|Overall Study||74
10898357|NCT00002850|12064450|FG002|COMPLETED|Overall Study||63
10898358|NCT00002850|12064448|FG000|NOT COMPLETED|Overall Study||5
10898359|NCT00002850|12064449|FG001|NOT COMPLETED|Overall Study||2
10898360|NCT00002850|12064450|FG002|NOT COMPLETED|Overall Study||4
10898361|NCT03666988|12064464|FG000|STARTED|Part 1 (Up to 28 Months)||3
10898362|NCT03666988|12064465|FG001|STARTED|Part 1 (Up to 28 Months)||16
10898363|NCT03666988|12064466|FG002|STARTED|Part 1 (Up to 28 Months)||12
10898364|NCT03666988|12064467|FG003|STARTED|Part 1 (Up to 28 Months)||0
10898365|NCT03666988|12064468|FG004|STARTED|Part 1 (Up to 28 Months)||0
10898366|NCT03666988|12064469|FG005|STARTED|Part 1 (Up to 28 Months)||0
10898367|NCT03666988|12064464|FG000|COMPLETED|Part 1 (Up to 28 Months)||0
10898368|NCT03666988|12064465|FG001|COMPLETED|Part 1 (Up to 28 Months)||0
10898369|NCT03666988|12064466|FG002|COMPLETED|Part 1 (Up to 28 Months)||0
10898370|NCT03666988|12064467|FG003|COMPLETED|Part 1 (Up to 28 Months)||0
10898371|NCT03666988|12064468|FG004|COMPLETED|Part 1 (Up to 28 Months)||0
10898372|NCT03666988|12064469|FG005|COMPLETED|Part 1 (Up to 28 Months)||0
10898373|NCT03666988|12064464|FG000|NOT COMPLETED|Part 1 (Up to 28 Months)||3
10898374|NCT03666988|12064465|FG001|NOT COMPLETED|Part 1 (Up to 28 Months)||16
10898375|NCT03666988|12064466|FG002|NOT COMPLETED|Part 1 (Up to 28 Months)||12
10898376|NCT03666988|12064467|FG003|NOT COMPLETED|Part 1 (Up to 28 Months)||0
10898377|NCT03666988|12064468|FG004|NOT COMPLETED|Part 1 (Up to 28 Months)||0
10898378|NCT03666988|12064469|FG005|NOT COMPLETED|Part 1 (Up to 28 Months)||0
10898379|NCT03666988|12064464|FG000|STARTED|Part 2 (Up to 48 Months)||0
10898380|NCT03666988|12064465|FG001|STARTED|Part 2 (Up to 48 Months)||0
10898381|NCT03666988|12064466|FG002|STARTED|Part 2 (Up to 48 Months)||0
10898382|NCT03666988|12064467|FG003|STARTED|Part 2 (Up to 48 Months)||0
10898383|NCT03666988|12064468|FG004|STARTED|Part 2 (Up to 48 Months)||0
10898384|NCT03666988|12064469|FG005|STARTED|Part 2 (Up to 48 Months)||0
10898385|NCT03666988|12064464|FG000|COMPLETED|Part 2 (Up to 48 Months)||0
10898386|NCT03666988|12064465|FG001|COMPLETED|Part 2 (Up to 48 Months)||0
10898387|NCT03666988|12064466|FG002|COMPLETED|Part 2 (Up to 48 Months)||0
10898388|NCT03666988|12064467|FG003|COMPLETED|Part 2 (Up to 48 Months)||0
10898389|NCT03666988|12064468|FG004|COMPLETED|Part 2 (Up to 48 Months)||0
10898390|NCT03666988|12064469|FG005|COMPLETED|Part 2 (Up to 48 Months)||0
10898391|NCT03666988|12064464|FG000|NOT COMPLETED|Part 2 (Up to 48 Months)||0
10898392|NCT03666988|12064465|FG001|NOT COMPLETED|Part 2 (Up to 48 Months)||0
10898393|NCT03666988|12064466|FG002|NOT COMPLETED|Part 2 (Up to 48 Months)||0
10898394|NCT03666988|12064467|FG003|NOT COMPLETED|Part 2 (Up to 48 Months)||0
10898395|NCT03666988|12064468|FG004|NOT COMPLETED|Part 2 (Up to 48 Months)||0
10898396|NCT03666988|12064469|FG005|NOT COMPLETED|Part 2 (Up to 48 Months)||0
10898397|NCT03552029|12064489|FG000|STARTED|Overall Study||4
10898398|NCT03552029|12064490|FG001|STARTED|Overall Study||6
10898399|NCT03552029|12064489|FG000|COMPLETED|Overall Study||0
10898400|NCT03552029|12064490|FG001|COMPLETED|Overall Study||0
10898401|NCT03552029|12064489|FG000|NOT COMPLETED|Overall Study||4
10898402|NCT03552029|12064490|FG001|NOT COMPLETED|Overall Study||6
10898403|NCT03549104|12064498|FG000|STARTED|Overall Study||26
10898404|NCT03549104|12064499|FG001|STARTED|Overall Study||25
10898405|NCT03549104|12064498|FG000|COMPLETED|Overall Study||18
10898406|NCT03549104|12064499|FG001|COMPLETED|Overall Study||21
10898407|NCT03549104|12064498|FG000|NOT COMPLETED|Overall Study||8
10898408|NCT03549104|12064499|FG001|NOT COMPLETED|Overall Study||4
10898409|NCT03332589|12064508|FG000|STARTED|Overall Study||4
10898410|NCT03332589|12064509|FG001|STARTED|Overall Study||0
10898411|NCT03332589|12064510|FG002|STARTED|Overall Study||0
10898412|NCT03332589|12064508|FG000|COMPLETED|Overall Study||0
10898413|NCT03332589|12064509|FG001|COMPLETED|Overall Study||0
10898414|NCT03332589|12064510|FG002|COMPLETED|Overall Study||0
10898415|NCT03332589|12064508|FG000|NOT COMPLETED|Overall Study||4
10898416|NCT03332589|12064509|FG001|NOT COMPLETED|Overall Study||0
10898417|NCT03332589|12064510|FG002|NOT COMPLETED|Overall Study||0
10898418|NCT02301156|12064520|FG000|STARTED|Overall Study||64
10898419|NCT02301156|12064521|FG001|STARTED|Overall Study||62
10898420|NCT02301156|12064520|FG000|Intent to Treat (ITT) Population|Overall Study||64
10898421|NCT02301156|12064521|FG001|Intent to Treat (ITT) Population|Overall Study||62
10898422|NCT02301156|12064520|FG000|Safety Population|Overall Study||59
10898423|NCT02301156|12064521|FG001|Safety Population|Overall Study||58
10898424|NCT02301156|12064520|FG000|COMPLETED|Overall Study||11
10898425|NCT02301156|12064521|FG001|COMPLETED|Overall Study||10
10898426|NCT02301156|12064520|FG000|NOT COMPLETED|Overall Study||53
10898427|NCT02301156|12064521|FG001|NOT COMPLETED|Overall Study||52
10898428|NCT01612351|12064527|FG000|STARTED|Chemotherapy||40
10898429|NCT01612351|12064527|FG000|COMPLETED|Chemotherapy||40
10898430|NCT01612351|12064527|FG000|NOT COMPLETED|Chemotherapy||0
10898431|NCT01612351|12064527|FG000|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
10898432|NCT01612351|12064527|FG000|COMPLETED|Transoral Surgery||39
10898433|NCT01612351|12064527|FG000|NOT COMPLETED|Transoral Surgery||0
10898434|NCT01612351|12064527|FG000|STARTED|Post-Operative Treatment||39
10898435|NCT01612351|12064527|FG000|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
10898436|NCT01612351|12064527|FG000|NOT COMPLETED|Post-Operative Treatment||0
10898437|NCT01590628|12064538|FG000|STARTED|Overall Study||13
10898438|NCT01590628|12064539|FG001|STARTED|Overall Study||3
10898439|NCT01590628|12064538|FG000|COMPLETED|Overall Study||11
10898440|NCT01590628|12064539|FG001|COMPLETED|Overall Study||3
10898441|NCT01590628|12064538|FG000|NOT COMPLETED|Overall Study||2
10898442|NCT01590628|12064539|FG001|NOT COMPLETED|Overall Study||0
10898443|NCT01533714|12064555|FG000|STARTED|Overall Study||10
10898444|NCT01533714|12064556|FG001|STARTED|Overall Study||15
10898445|NCT01533714|12064557|FG002|STARTED|Overall Study||11
10898446|NCT01533714|12064558|FG003|STARTED|Overall Study||15
10898447|NCT01533714|12064559|FG004|STARTED|Overall Study||28
10898448|NCT01533714|12064560|FG005|STARTED|Overall Study||24
10898449|NCT01533714|12064555|FG000|COMPLETED|Overall Study||10
10898450|NCT01533714|12064556|FG001|COMPLETED|Overall Study||12
10898451|NCT01533714|12064557|FG002|COMPLETED|Overall Study||7
10898452|NCT01533714|12064558|FG003|COMPLETED|Overall Study||11
10898453|NCT01533714|12064559|FG004|COMPLETED|Overall Study||21
10898454|NCT01533714|12064560|FG005|COMPLETED|Overall Study||21
10898455|NCT01533714|12064555|FG000|NOT COMPLETED|Overall Study||0
10898456|NCT01533714|12064556|FG001|NOT COMPLETED|Overall Study||3
10898457|NCT01533714|12064557|FG002|NOT COMPLETED|Overall Study||4
10898458|NCT01533714|12064558|FG003|NOT COMPLETED|Overall Study||4
10898459|NCT01533714|12064559|FG004|NOT COMPLETED|Overall Study||7
10898460|NCT01533714|12064560|FG005|NOT COMPLETED|Overall Study||3
10898461|NCT00002931|12064574|FG000|STARTED|Overall Study||48
10898462|NCT00002931|12064574|FG000|COMPLETED|Overall Study||46
10898463|NCT00002931|12064574|FG000|NOT COMPLETED|Overall Study||2
10898464|NCT00003138|12064580|FG000|STARTED|Step 1||61
10898465|NCT00003138|12064581|FG001|STARTED|Step 1||57
10898466|NCT00003138|12064580|FG000|Patients With Complete Data|Step 1||57
10898467|NCT00003138|12064581|FG001|Patients With Complete Data|Step 1||53
10898468|NCT00003138|12064580|FG000|Treated|Step 1||56
10898469|NCT00003138|12064581|FG001|Treated|Step 1||53
10898470|NCT00003138|12064580|FG000|Eligible and Treated|Step 1||52
10898471|NCT00003138|12064581|FG001|Eligible and Treated|Step 1||50
10898472|NCT00003138|12064580|FG000|Patients With QOL Data at 4 Months|Step 1||42
10898473|NCT00003138|12064581|FG001|Patients With QOL Data at 4 Months|Step 1||42
10898474|NCT00003138|12064580|FG000|Patients With Transfusion Data|Step 1||37
10898475|NCT00003138|12064581|FG001|Patients With Transfusion Data|Step 1||42
10898476|NCT00003138|12064580|FG000|COMPLETED|Step 1||0
10898477|NCT00003138|12064581|FG001|COMPLETED|Step 1||0
10898478|NCT00003138|12064580|FG000|NOT COMPLETED|Step 1||61
10898479|NCT00003138|12064581|FG001|NOT COMPLETED|Step 1||57
10898480|NCT00003138|12064580|FG000|STARTED|Step 2 (Cross Over)||26
10898481|NCT00003138|12064581|FG001|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
10898482|NCT00003138|12064580|FG000|COMPLETED|Step 2 (Cross Over)||0
10898483|NCT00003138|12064581|FG001|COMPLETED|Step 2 (Cross Over)||0
10898484|NCT00003138|12064580|FG000|NOT COMPLETED|Step 2 (Cross Over)||26
10898485|NCT00003138|12064581|FG001|NOT COMPLETED|Step 2 (Cross Over)||0
10898486|NCT00003138|12064580|FG000|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
10898487|NCT00003138|12064581|FG001|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
10898488|NCT00003138|12064580|FG000|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
10898489|NCT00003138|12064581|FG001|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
10898490|NCT00003138|12064580|FG000|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
10898491|NCT00003138|12064581|FG001|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
10898492|NCT00003138|12064580|FG000|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
10898493|NCT00003138|12064581|FG001|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
10898494|NCT00003138|12064580|FG000|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
10898495|NCT00003138|12064581|FG001|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
10898496|NCT00003138|12064580|FG000|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
10898497|NCT00003138|12064581|FG001|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
10898498|NCT00003138|12064580|FG000|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
10898499|NCT00003138|12064581|FG001|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
10898500|NCT00003199|12064590|FG000|STARTED|Overall Study||50
10898501|NCT00003199|12064590|FG000|COMPLETED|Overall Study||28
10898502|NCT00003199|12064590|FG000|NOT COMPLETED|Overall Study||22
10898503|NCT00003222|12064596|FG000|STARTED|Overall Study||13
10898504|NCT00003222|12064597|FG001|STARTED|Overall Study||28
10898505|NCT00003222|12064596|FG000|COMPLETED|Overall Study||13
10898506|NCT00003222|12064597|FG001|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
10898507|NCT00003222|12064596|FG000|NOT COMPLETED|Overall Study||0
10898508|NCT00003222|12064597|FG001|NOT COMPLETED|Overall Study||1
10898509|NCT00003224|12064609|FG000|STARTED|Overall Study||4
10898510|NCT00003224|12064610|FG001|STARTED|Overall Study||5
10898511|NCT00003224|12064611|FG002|STARTED|Overall Study||4
10898512|NCT00003224|12064612|FG003|STARTED|Overall Study||2
10898513|NCT00003224|12064613|FG004|STARTED|Overall Study||4
10898514|NCT00003224|12064614|FG005|STARTED|Overall Study||3
10898515|NCT00003224|12064609|FG000|COMPLETED|Overall Study||4
10898516|NCT00003224|12064610|FG001|COMPLETED|Overall Study||5
10898517|NCT00003224|12064611|FG002|COMPLETED|Overall Study||4
10898518|NCT00003224|12064612|FG003|COMPLETED|Overall Study||2
10898519|NCT00003224|12064613|FG004|COMPLETED|Overall Study||4
10898520|NCT00003224|12064614|FG005|COMPLETED|Overall Study||3
10898521|NCT00003224|12064609|FG000|NOT COMPLETED|Overall Study||0
10898522|NCT00003224|12064610|FG001|NOT COMPLETED|Overall Study||0
10898523|NCT00003224|12064611|FG002|NOT COMPLETED|Overall Study||0
10898524|NCT00003224|12064612|FG003|NOT COMPLETED|Overall Study||0
10898525|NCT00003224|12064613|FG004|NOT COMPLETED|Overall Study||0
10898526|NCT00003224|12064614|FG005|NOT COMPLETED|Overall Study||0
10898527|NCT00003270|12064626|FG000|STARTED|Overall Study||20
10898528|NCT00003270|12064626|FG000|COMPLETED|Overall Study||20
10898529|NCT00003270|12064626|FG000|NOT COMPLETED|Overall Study||0
10898530|NCT04848662|12064632|FG000|STARTED|Period 1 (First Treatment Intervention)||6
10898531|NCT04848662|12064633|FG001|STARTED|Period 1 (First Treatment Intervention)||6
10898532|NCT04848662|12064632|FG000|COMPLETED|Period 1 (First Treatment Intervention)||6
10898533|NCT04848662|12064633|FG001|COMPLETED|Period 1 (First Treatment Intervention)||6
10898534|NCT04848662|12064632|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
10898535|NCT04848662|12064633|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
10898536|NCT04848662|12064632|FG000|STARTED|Period 2 (Second Treatment Intervention)||6
10898537|NCT04848662|12064633|FG001|STARTED|Period 2 (Second Treatment Intervention)||6
10898538|NCT04848662|12064632|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||5
10898539|NCT04848662|12064633|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||6
10898540|NCT04848662|12064632|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1
10898541|NCT04848662|12064633|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0
10898542|NCT04697693|12064639|FG000|STARTED|Overall Study||1
10898543|NCT04697693|12064639|FG000|COMPLETED|Overall Study||1
10898544|NCT04697693|12064639|FG000|NOT COMPLETED|Overall Study||0
10898545|NCT03969719|12064646|FG000|STARTED|Overall Study||54
10898546|NCT03969719|12064647|FG001|STARTED|Overall Study||55
10898547|NCT03969719|12064648|FG002|STARTED|Overall Study||55
10898548|NCT03969719|12064646|FG000|COMPLETED|Overall Study||50
10898549|NCT03969719|12064647|FG001|COMPLETED|Overall Study||46
10898550|NCT03969719|12064648|FG002|COMPLETED|Overall Study||50
10898551|NCT03969719|12064646|FG000|NOT COMPLETED|Overall Study||4
10898552|NCT03969719|12064647|FG001|NOT COMPLETED|Overall Study||9
10898553|NCT03969719|12064648|FG002|NOT COMPLETED|Overall Study||5
10898554|NCT03883477|12064658|FG000|STARTED|Overall Study||13
10898555|NCT03883477|12064659|FG001|STARTED|Overall Study||13
10898556|NCT03883477|12064658|FG000|COMPLETED|Overall Study||12
10898557|NCT03883477|12064659|FG001|COMPLETED|Overall Study||12
10898558|NCT03883477|12064658|FG000|NOT COMPLETED|Overall Study||1
10898559|NCT03883477|12064659|FG001|NOT COMPLETED|Overall Study||1
10898560|NCT03813108|12064671|FG000|STARTED|Overall Study||10
10898561|NCT03813108|12064672|FG001|STARTED|Overall Study||10
10898562|NCT03813108|12064673|FG002|STARTED|Overall Study||20
10898563|NCT03813108|12064674|FG003|STARTED|Overall Study||3
10898564|NCT03813108|12064675|FG004|STARTED|Overall Study||0
10898565|NCT03813108|12064676|FG005|STARTED|Overall Study||0
10898566|NCT03813108|12064671|FG000|COMPLETED|Overall Study||8
10898567|NCT03813108|12064672|FG001|COMPLETED|Overall Study||9
10898568|NCT03813108|12064673|FG002|COMPLETED|Overall Study||0
10898569|NCT03813108|12064674|FG003|COMPLETED|Overall Study||3
10898570|NCT03813108|12064675|FG004|COMPLETED|Overall Study||0
10898571|NCT03813108|12064676|FG005|COMPLETED|Overall Study||0
10898572|NCT03813108|12064671|FG000|NOT COMPLETED|Overall Study||2
10898573|NCT03813108|12064672|FG001|NOT COMPLETED|Overall Study||1
10898574|NCT03813108|12064673|FG002|NOT COMPLETED|Overall Study||20
10898575|NCT03813108|12064674|FG003|NOT COMPLETED|Overall Study||0
10898576|NCT03813108|12064675|FG004|NOT COMPLETED|Overall Study||0
10898577|NCT03813108|12064676|FG005|NOT COMPLETED|Overall Study||0
10898578|NCT03809611|12064688|FG000|STARTED|Overall Study||62
10898579|NCT03809611|12064689|FG001|STARTED|Overall Study||62
10898580|NCT03809611|12064688|FG000|COMPLETED|Overall Study||61
10898581|NCT03809611|12064689|FG001|COMPLETED|Overall Study||61
10898582|NCT03809611|12064688|FG000|NOT COMPLETED|Overall Study||1
10898583|NCT03809611|12064689|FG001|NOT COMPLETED|Overall Study||1
10898584|NCT03721705|12064698|FG000|STARTED|Overall Study||95
10898585|NCT03721705|12064699|FG001|STARTED|Overall Study||95
10898586|NCT03721705|12064698|FG000|COMPLETED|Overall Study||85
10898587|NCT03721705|12064699|FG001|COMPLETED|Overall Study||77
10898588|NCT03721705|12064698|FG000|NOT COMPLETED|Overall Study||10
10898589|NCT03721705|12064699|FG001|NOT COMPLETED|Overall Study||18
10898590|NCT03505021|12064707|FG000|STARTED|Overall Study||329
10898591|NCT03505021|12064708|FG001|STARTED|Overall Study||167
10898592|NCT03505021|12064707|FG000|COMPLETED|Overall Study||217
10898593|NCT03505021|12064708|FG001|COMPLETED|Overall Study||112
10898594|NCT03505021|12064707|FG000|NOT COMPLETED|Overall Study||112
10898595|NCT03505021|12064708|FG001|NOT COMPLETED|Overall Study||55
10898596|NCT03405714|12064718|FG000|STARTED|Overall Study||12
10898597|NCT03405714|12064719|FG001|STARTED|Overall Study||12
10898598|NCT03405714|12064720|FG002|STARTED|Overall Study||13
10898599|NCT03405714|12064721|FG003|STARTED|Overall Study||13
10898600|NCT03405714|12064718|FG000|COMPLETED|Overall Study||12
10898601|NCT03405714|12064719|FG001|COMPLETED|Overall Study||12
10898602|NCT03405714|12064720|FG002|COMPLETED|Overall Study||13
10898603|NCT03405714|12064721|FG003|COMPLETED|Overall Study||13
10898604|NCT03405714|12064718|FG000|NOT COMPLETED|Overall Study||0
10898605|NCT03405714|12064719|FG001|NOT COMPLETED|Overall Study||0
10898606|NCT03405714|12064720|FG002|NOT COMPLETED|Overall Study||0
10898607|NCT03405714|12064721|FG003|NOT COMPLETED|Overall Study||0
10898608|NCT03366194|12064737|FG000|STARTED|Overall Study||36
10898609|NCT03366194|12064737|FG000|COMPLETED|Overall Study||34
10898610|NCT03366194|12064737|FG000|NOT COMPLETED|Overall Study||2
10898611|NCT03272139|12064744|FG000|STARTED|Overall Study||63
10898612|NCT03272139|12064745|FG001|STARTED|Overall Study||63
10898613|NCT03272139|12064744|FG000|COMPLETED|Overall Study||63
10898614|NCT03272139|12064745|FG001|COMPLETED|Overall Study||63
10898615|NCT03272139|12064744|FG000|NOT COMPLETED|Overall Study||0
10898616|NCT03272139|12064745|FG001|NOT COMPLETED|Overall Study||0
10898617|NCT03203473|12064751|FG000|STARTED|Induction Phase||85
10898618|NCT03203473|12064752|FG001|STARTED|Induction Phase||0
10898619|NCT03203473|12064753|FG002|STARTED|Induction Phase||0
10898620|NCT03203473|12064751|FG000|COMPLETED|Induction Phase||69
10898621|NCT03203473|12064752|FG001|COMPLETED|Induction Phase||0
10898622|NCT03203473|12064753|FG002|COMPLETED|Induction Phase||0
10898623|NCT03203473|12064751|FG000|NOT COMPLETED|Induction Phase||16
10898624|NCT03203473|12064752|FG001|NOT COMPLETED|Induction Phase||0
10898625|NCT03203473|12064753|FG002|NOT COMPLETED|Induction Phase||0
10898626|NCT03203473|12064751|FG000|STARTED|Arm Allocation Phase||0
10898627|NCT03203473|12064752|FG001|STARTED|Arm Allocation Phase||12
10898628|NCT03203473|12064753|FG002|STARTED|Arm Allocation Phase||57
10898629|NCT03203473|12064751|FG000|COMPLETED|Arm Allocation Phase||0
10898630|NCT03203473|12064752|FG001|COMPLETED|Arm Allocation Phase||0
10898631|NCT03203473|12064753|FG002|COMPLETED|Arm Allocation Phase||0
10898632|NCT03203473|12064751|FG000|NOT COMPLETED|Arm Allocation Phase||0
10898633|NCT03203473|12064752|FG001|NOT COMPLETED|Arm Allocation Phase||12
10898634|NCT03203473|12064753|FG002|NOT COMPLETED|Arm Allocation Phase||57
10898635|NCT03180736|12064766|FG000|STARTED|Overall Study||151
10898636|NCT03180736|12064767|FG001|STARTED|Overall Study||153
10898637|NCT03180736|12064766|FG000|Treated|Overall Study||149
10898638|NCT03180736|12064767|FG001|Treated|Overall Study||150
10898639|NCT03180736|12064766|FG000|COMPLETED|Overall Study||60
10898640|NCT03180736|12064767|FG001|COMPLETED|Overall Study||33
10898641|NCT03180736|12064766|FG000|NOT COMPLETED|Overall Study||91
10898642|NCT03180736|12064767|FG001|NOT COMPLETED|Overall Study||120
10898643|NCT03051659|12064780|FG000|STARTED|Treatment Period||44
10898644|NCT03051659|12064781|FG001|STARTED|Treatment Period||46
10898645|NCT03051659|12064780|FG000|COMPLETED|Treatment Period||44
10898646|NCT03051659|12064781|FG001|COMPLETED|Treatment Period||44
10898647|NCT03051659|12064780|FG000|NOT COMPLETED|Treatment Period||0
10898648|NCT03051659|12064781|FG001|NOT COMPLETED|Treatment Period||2
10898649|NCT03051659|12064780|FG000|STARTED|Survival Follow-up||44
10898650|NCT03051659|12064781|FG001|STARTED|Survival Follow-up||44
10898651|NCT03051659|12064780|FG000|COMPLETED|Survival Follow-up||21
10898652|NCT03051659|12064781|FG001|COMPLETED|Survival Follow-up||22
10898653|NCT03051659|12064780|FG000|NOT COMPLETED|Survival Follow-up||23
10898654|NCT03051659|12064781|FG001|NOT COMPLETED|Survival Follow-up||22
10898655|NCT03048552|12064791|FG000|STARTED|Overall Study||4
10898656|NCT03048552|12064792|FG001|STARTED|Overall Study||18
10898657|NCT03048552|12064793|FG002|STARTED|Overall Study||4
10898658|NCT03048552|12064794|FG003|STARTED|Overall Study|Fewer caregivers were enrolled in Family CONNECT arm than youth as 2 caregivers had multiple children in the Family CONNECT arm: one caregiver had n=2 children and 1 caregiver had n=3 children.|15
10898659|NCT03048552|12064791|FG000|COMPLETED|Overall Study||4
10898660|NCT03048552|12064792|FG001|COMPLETED|Overall Study||18
10898661|NCT03048552|12064793|FG002|COMPLETED|Overall Study||4
10898662|NCT03048552|12064794|FG003|COMPLETED|Overall Study||15
10898663|NCT03048552|12064791|FG000|NOT COMPLETED|Overall Study||0
10898664|NCT03048552|12064792|FG001|NOT COMPLETED|Overall Study||0
10898665|NCT03048552|12064793|FG002|NOT COMPLETED|Overall Study||0
10898666|NCT03048552|12064794|FG003|NOT COMPLETED|Overall Study||0
10898667|NCT02886884|12064808|FG000|STARTED|Treatment||3
10898668|NCT02886884|12064809|FG001|STARTED|Treatment||3
10898669|NCT02886884|12064810|FG002|STARTED|Treatment||5
10898670|NCT02886884|12064811|FG003|STARTED|Treatment||5
10898671|NCT02886884|12064808|FG000|COMPLETED|Treatment||3
10898672|NCT02886884|12064809|FG001|COMPLETED|Treatment||3
10898673|NCT02886884|12064810|FG002|COMPLETED|Treatment||5
10898674|NCT02886884|12064811|FG003|COMPLETED|Treatment||5
10898675|NCT02886884|12064808|FG000|NOT COMPLETED|Treatment||0
10898676|NCT02886884|12064809|FG001|NOT COMPLETED|Treatment||0
10898677|NCT02886884|12064810|FG002|NOT COMPLETED|Treatment||0
10898678|NCT02886884|12064811|FG003|NOT COMPLETED|Treatment||0
10898679|NCT02886884|12064808|FG000|STARTED|Follow-up||3
10898680|NCT02886884|12064809|FG001|STARTED|Follow-up||3
10898681|NCT02886884|12064810|FG002|STARTED|Follow-up||5
10898682|NCT02886884|12064811|FG003|STARTED|Follow-up||5
10898683|NCT02886884|12064808|FG000|COMPLETED|Follow-up||3
10898684|NCT02886884|12064809|FG001|COMPLETED|Follow-up||3
10898685|NCT02886884|12064810|FG002|COMPLETED|Follow-up||5
10898686|NCT02886884|12064811|FG003|COMPLETED|Follow-up||4
10898687|NCT02886884|12064808|FG000|NOT COMPLETED|Follow-up||0
10898688|NCT02886884|12064809|FG001|NOT COMPLETED|Follow-up||0
10898689|NCT02886884|12064810|FG002|NOT COMPLETED|Follow-up||0
10898690|NCT02886884|12064811|FG003|NOT COMPLETED|Follow-up||1
10898691|NCT02845453|12064823|FG000|STARTED|Overall Study||13
10898692|NCT02845453|12064824|FG001|STARTED|Overall Study||11
10898693|NCT02845453|12064823|FG000|Took One Dose of Study Medication|Overall Study||11
10898694|NCT02845453|12064824|FG001|Took One Dose of Study Medication|Overall Study||10
10898695|NCT02845453|12064823|FG000|Took One Week of Study Medication|Overall Study||10
10898696|NCT02845453|12064824|FG001|Took One Week of Study Medication|Overall Study||9
10898697|NCT02845453|12064823|FG000|COMPLETED|Overall Study||7
10898698|NCT02845453|12064824|FG001|COMPLETED|Overall Study||6
10898699|NCT02845453|12064823|FG000|NOT COMPLETED|Overall Study||6
10898700|NCT02845453|12064824|FG001|NOT COMPLETED|Overall Study||5
10898701|NCT02739542|12064832|FG000|STARTED|Overall Study||44
10898702|NCT02739542|12064833|FG001|STARTED|Overall Study||43
10898703|NCT02739542|12064832|FG000|COMPLETED|Overall Study||30
10898704|NCT02739542|12064833|FG001|COMPLETED|Overall Study||29
10898705|NCT02739542|12064832|FG000|NOT COMPLETED|Overall Study||14
10898706|NCT02739542|12064833|FG001|NOT COMPLETED|Overall Study||14
10898707|NCT02717832|12064839|FG000|STARTED|Overall Study||20
10898708|NCT02717832|12064839|FG000|COMPLETED|Overall Study||17
10898709|NCT02717832|12064839|FG000|NOT COMPLETED|Overall Study||3
10898710|NCT02677324|12064844|FG000|STARTED|Overall Study||33
10898711|NCT02677324|12064844|FG000|COMPLETED|Overall Study||21
10898712|NCT02677324|12064844|FG000|NOT COMPLETED|Overall Study||12
10898713|NCT02563028|12064850|FG000|STARTED|Overall Study||20
10898714|NCT02563028|12064850|FG000|COMPLETED|Overall Study||18
10898715|NCT02563028|12064850|FG000|NOT COMPLETED|Overall Study||2
10898716|NCT02439749|12064856|FG000|STARTED|Overall Study||182
10898717|NCT02439749|12064857|FG001|STARTED|Overall Study||184
10898718|NCT02439749|12064856|FG000|COMPLETED|Overall Study||153
10898719|NCT02439749|12064857|FG001|COMPLETED|Overall Study||147
10898720|NCT02439749|12064856|FG000|NOT COMPLETED|Overall Study||29
10898721|NCT02439749|12064857|FG001|NOT COMPLETED|Overall Study||37
10898722|NCT02435511|12064865|FG000|STARTED|Overall Study|Defined as enrolled and completed baseline|202
10898723|NCT02435511|12064866|FG001|STARTED|Overall Study|Defined as enrolled and completed baseline|209
10898724|NCT02435511|12064865|FG000|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158
10898725|NCT02435511|12064866|FG001|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174
10898726|NCT02435511|12064865|FG000|NOT COMPLETED|Overall Study||44
10898727|NCT02435511|12064866|FG001|NOT COMPLETED|Overall Study||35
10898728|NCT02411448|12064875|FG000|STARTED|Overall Study||14
10898729|NCT02411448|12064876|FG001|STARTED|Overall Study||224
10898730|NCT02411448|12064877|FG002|STARTED|Overall Study||225
10898731|NCT02411448|12064875|FG000|Received at Least One Dose of Study Drug|Overall Study||14
10898732|NCT02411448|12064876|FG001|Received at Least One Dose of Study Drug|Overall Study||221
10898733|NCT02411448|12064877|FG002|Received at Least One Dose of Study Drug|Overall Study||225
10898734|NCT02411448|12064875|FG000|COMPLETED|Overall Study||10
10898735|NCT02411448|12064876|FG001|COMPLETED|Overall Study||141
10898736|NCT02411448|12064877|FG002|COMPLETED|Overall Study||173
10898737|NCT02411448|12064875|FG000|NOT COMPLETED|Overall Study||4
10898738|NCT02411448|12064876|FG001|NOT COMPLETED|Overall Study||83
10898739|NCT02411448|12064877|FG002|NOT COMPLETED|Overall Study||52
10898740|NCT02371369|12064891|FG000|STARTED|Part 1||61
10898741|NCT02371369|12064892|FG001|STARTED|Part 1||59
10898742|NCT02371369|12064891|FG000|COMPLETED|Part 1||52
10898743|NCT02371369|12064892|FG001|COMPLETED|Part 1||48
10898744|NCT02371369|12064891|FG000|NOT COMPLETED|Part 1||9
10898745|NCT02371369|12064892|FG001|NOT COMPLETED|Part 1||11
10898746|NCT02371369|12064891|FG000|STARTED|Part 2|N=48; Only participants who were eligible to receive treatment in Part 2.|48
10898747|NCT02371369|12064892|FG001|STARTED|Part 2|N=30; Only participants who were eligible to receive treatment in Part 2.|30
10898748|NCT02371369|12064891|FG000|COMPLETED|Part 2||0
10898749|NCT02371369|12064892|FG001|COMPLETED|Part 2||0
10898750|NCT02371369|12064891|FG000|NOT COMPLETED|Part 2||48
10898751|NCT02371369|12064892|FG001|NOT COMPLETED|Part 2||30
10898752|NCT02282917|12064914|FG000|STARTED|Overall Study||7
10898753|NCT02282917|12064914|FG000|COMPLETED|Overall Study||5
10898754|NCT02282917|12064914|FG000|NOT COMPLETED|Overall Study||2
10898755|NCT01849783|12064918|FG000|STARTED|Overall Study||41
10898756|NCT01849783|12064918|FG000|COMPLETED|Overall Study||19
10898757|NCT01849783|12064918|FG000|NOT COMPLETED|Overall Study||22
10898758|NCT01741480|12064930|FG000|STARTED|Overall Study||285
10898759|NCT01741480|12064931|FG001|STARTED|Overall Study||286
10898760|NCT01741480|12064930|FG000|COMPLETED|Overall Study||285
10898761|NCT01741480|12064931|FG001|COMPLETED|Overall Study||286
10898762|NCT01741480|12064930|FG000|NOT COMPLETED|Overall Study||0
10898763|NCT01741480|12064931|FG001|NOT COMPLETED|Overall Study||0
10898764|NCT01737021|12064939|FG000|STARTED|Overall Study||22
10898765|NCT01737021|12064940|FG001|STARTED|Overall Study||9
10898766|NCT01737021|12064939|FG000|COMPLETED|Overall Study||17
10898767|NCT01737021|12064940|FG001|COMPLETED|Overall Study||6
10898768|NCT01737021|12064939|FG000|NOT COMPLETED|Overall Study||5
10898769|NCT01737021|12064940|FG001|NOT COMPLETED|Overall Study||3
10898770|NCT01505465|12064948|FG000|STARTED|Overall Study||25
10898771|NCT01505465|12064949|FG001|STARTED|Overall Study||25
10898772|NCT01505465|12064948|FG000|COMPLETED|Overall Study||19
10898773|NCT01505465|12064949|FG001|COMPLETED|Overall Study||18
10898774|NCT01505465|12064948|FG000|NOT COMPLETED|Overall Study||6
10898775|NCT01505465|12064949|FG001|NOT COMPLETED|Overall Study||7
10898776|NCT01333943|12064957|FG000|STARTED|Overall Study||47
10898777|NCT01333943|12064958|FG001|STARTED|Overall Study||47
10898778|NCT01333943|12064957|FG000|COMPLETED|Overall Study||46
10898779|NCT01333943|12064958|FG001|COMPLETED|Overall Study||47
10898780|NCT01333943|12064957|FG000|NOT COMPLETED|Overall Study||1
10898781|NCT01333943|12064958|FG001|NOT COMPLETED|Overall Study||0
10898782|NCT01322646|12064966|FG000|STARTED|Overall Study||86
10898783|NCT01322646|12064967|FG001|STARTED|Overall Study||86
10898784|NCT01322646|12064966|FG000|COMPLETED|Overall Study||83
10898785|NCT01322646|12064967|FG001|COMPLETED|Overall Study||84
10898786|NCT01322646|12064966|FG000|NOT COMPLETED|Overall Study||3
10898787|NCT01322646|12064967|FG001|NOT COMPLETED|Overall Study||2
10898788|NCT01090024|12064973|FG000|STARTED|Period 1||6
10898789|NCT01090024|12064974|FG001|STARTED|Period 1||6
10898790|NCT01090024|12064975|FG002|STARTED|Period 1||6
10898791|NCT01090024|12064976|FG003|STARTED|Period 1||6
10898792|NCT01090024|12064977|FG004|STARTED|Period 1||6
10898793|NCT01090024|12064978|FG005|STARTED|Period 1||6
10898794|NCT01090024|12064979|FG006|STARTED|Period 1||6
10898795|NCT01090024|12064980|FG007|STARTED|Period 1||6
10898796|NCT01090024|12064981|FG008|STARTED|Period 1||6
10898797|NCT01090024|12064982|FG009|STARTED|Period 1||6
10898798|NCT01090024|12064983|FG010|STARTED|Period 1||6
10898799|NCT01090024|12064984|FG011|STARTED|Period 1||6
10898800|NCT01090024|12064985|FG012|STARTED|Period 1||6
10898801|NCT01090024|12064986|FG013|STARTED|Period 1||6
10898802|NCT01090024|12064987|FG014|STARTED|Period 1||6
10898803|NCT01090024|12064988|FG015|STARTED|Period 1||6
10898804|NCT01090024|12064989|FG016|STARTED|Period 1||6
10898805|NCT01090024|12064990|FG017|STARTED|Period 1||6
10898806|NCT01090024|12064973|FG000|COMPLETED|Period 1||6
10898807|NCT01090024|12064974|FG001|COMPLETED|Period 1||5
10898808|NCT01090024|12064975|FG002|COMPLETED|Period 1||6
10898809|NCT01090024|12064976|FG003|COMPLETED|Period 1||5
10898810|NCT01090024|12064977|FG004|COMPLETED|Period 1||6
10898811|NCT01090024|12064978|FG005|COMPLETED|Period 1||6
10898812|NCT01090024|12064979|FG006|COMPLETED|Period 1||6
10898813|NCT01090024|12064980|FG007|COMPLETED|Period 1||6
10898814|NCT01090024|12064981|FG008|COMPLETED|Period 1||6
10898815|NCT01090024|12064982|FG009|COMPLETED|Period 1||5
10898816|NCT01090024|12064983|FG010|COMPLETED|Period 1||6
10898817|NCT01090024|12064984|FG011|COMPLETED|Period 1||5
10898818|NCT01090024|12064985|FG012|COMPLETED|Period 1||6
10898819|NCT01090024|12064986|FG013|COMPLETED|Period 1||6
10898820|NCT01090024|12064987|FG014|COMPLETED|Period 1||5
10898821|NCT01090024|12064988|FG015|COMPLETED|Period 1||6
10898822|NCT01090024|12064989|FG016|COMPLETED|Period 1||6
10898823|NCT01090024|12064990|FG017|COMPLETED|Period 1||5
10898824|NCT01090024|12064973|FG000|NOT COMPLETED|Period 1||0
10898825|NCT01090024|12064974|FG001|NOT COMPLETED|Period 1||1
10898826|NCT01090024|12064975|FG002|NOT COMPLETED|Period 1||0
10898827|NCT01090024|12064976|FG003|NOT COMPLETED|Period 1||1
10898828|NCT01090024|12064977|FG004|NOT COMPLETED|Period 1||0
10898829|NCT01090024|12064978|FG005|NOT COMPLETED|Period 1||0
10898830|NCT01090024|12064979|FG006|NOT COMPLETED|Period 1||0
10898831|NCT01090024|12064980|FG007|NOT COMPLETED|Period 1||0
10898832|NCT01090024|12064981|FG008|NOT COMPLETED|Period 1||0
10898833|NCT01090024|12064982|FG009|NOT COMPLETED|Period 1||1
10898834|NCT01090024|12064983|FG010|NOT COMPLETED|Period 1||0
10898835|NCT01090024|12064984|FG011|NOT COMPLETED|Period 1||1
10898836|NCT01090024|12064985|FG012|NOT COMPLETED|Period 1||0
10898837|NCT01090024|12064986|FG013|NOT COMPLETED|Period 1||0
10898838|NCT01090024|12064987|FG014|NOT COMPLETED|Period 1||1
10898839|NCT01090024|12064988|FG015|NOT COMPLETED|Period 1||0
10898840|NCT01090024|12064989|FG016|NOT COMPLETED|Period 1||0
10898841|NCT01090024|12064990|FG017|NOT COMPLETED|Period 1||1
10898842|NCT01090024|12064973|FG000|STARTED|Period 2||6
10898843|NCT01090024|12064974|FG001|STARTED|Period 2||5
10898844|NCT01090024|12064975|FG002|STARTED|Period 2||6
10898845|NCT01090024|12064976|FG003|STARTED|Period 2||5
10898846|NCT01090024|12064977|FG004|STARTED|Period 2||6
10898847|NCT01090024|12064978|FG005|STARTED|Period 2||6
10898848|NCT01090024|12064979|FG006|STARTED|Period 2||6
10898849|NCT01090024|12064980|FG007|STARTED|Period 2||6
10898850|NCT01090024|12064981|FG008|STARTED|Period 2||6
10898851|NCT01090024|12064982|FG009|STARTED|Period 2||5
10898852|NCT01090024|12064983|FG010|STARTED|Period 2||6
10898853|NCT01090024|12064984|FG011|STARTED|Period 2||5
10898854|NCT01090024|12064985|FG012|STARTED|Period 2||6
10898855|NCT01090024|12064986|FG013|STARTED|Period 2||6
10898856|NCT01090024|12064987|FG014|STARTED|Period 2||5
10898857|NCT01090024|12064988|FG015|STARTED|Period 2||6
10898858|NCT01090024|12064989|FG016|STARTED|Period 2||6
10898859|NCT01090024|12064990|FG017|STARTED|Period 2||5
10898860|NCT01090024|12064973|FG000|COMPLETED|Period 2||5
10898861|NCT01090024|12064974|FG001|COMPLETED|Period 2||5
10898862|NCT01090024|12064975|FG002|COMPLETED|Period 2||6
10898863|NCT01090024|12064976|FG003|COMPLETED|Period 2||4
10898864|NCT01090024|12064977|FG004|COMPLETED|Period 2||6
10898865|NCT01090024|12064978|FG005|COMPLETED|Period 2||6
10898866|NCT01090024|12064979|FG006|COMPLETED|Period 2||6
10898867|NCT01090024|12064980|FG007|COMPLETED|Period 2||6
10898868|NCT01090024|12064981|FG008|COMPLETED|Period 2||6
10898869|NCT01090024|12064982|FG009|COMPLETED|Period 2||5
10898870|NCT01090024|12064983|FG010|COMPLETED|Period 2||6
10898871|NCT01090024|12064984|FG011|COMPLETED|Period 2||5
10898872|NCT01090024|12064985|FG012|COMPLETED|Period 2||6
10898873|NCT01090024|12064986|FG013|COMPLETED|Period 2||6
10898874|NCT01090024|12064987|FG014|COMPLETED|Period 2||5
10898875|NCT01090024|12064988|FG015|COMPLETED|Period 2||6
10898876|NCT01090024|12064989|FG016|COMPLETED|Period 2||6
10898877|NCT01090024|12064990|FG017|COMPLETED|Period 2||5
10898878|NCT01090024|12064973|FG000|NOT COMPLETED|Period 2||1
10898879|NCT01090024|12064974|FG001|NOT COMPLETED|Period 2||0
10898880|NCT01090024|12064975|FG002|NOT COMPLETED|Period 2||0
10898881|NCT01090024|12064976|FG003|NOT COMPLETED|Period 2||1
10898882|NCT01090024|12064977|FG004|NOT COMPLETED|Period 2||0
10898883|NCT01090024|12064978|FG005|NOT COMPLETED|Period 2||0
10898884|NCT01090024|12064979|FG006|NOT COMPLETED|Period 2||0
10898885|NCT01090024|12064980|FG007|NOT COMPLETED|Period 2||0
10898886|NCT01090024|12064981|FG008|NOT COMPLETED|Period 2||0
10898887|NCT01090024|12064982|FG009|NOT COMPLETED|Period 2||0
10898888|NCT01090024|12064983|FG010|NOT COMPLETED|Period 2||0
10898889|NCT01090024|12064984|FG011|NOT COMPLETED|Period 2||0
10898890|NCT01090024|12064985|FG012|NOT COMPLETED|Period 2||0
10898891|NCT01090024|12064986|FG013|NOT COMPLETED|Period 2||0
10898892|NCT01090024|12064987|FG014|NOT COMPLETED|Period 2||0
10898893|NCT01090024|12064988|FG015|NOT COMPLETED|Period 2||0
10898894|NCT01090024|12064989|FG016|NOT COMPLETED|Period 2||0
10898895|NCT01090024|12064990|FG017|NOT COMPLETED|Period 2||0
10898896|NCT01090024|12064973|FG000|STARTED|Period 3||5
10898897|NCT01090024|12064974|FG001|STARTED|Period 3||5
10898898|NCT01090024|12064975|FG002|STARTED|Period 3||6
10898899|NCT01090024|12064976|FG003|STARTED|Period 3||4
10898900|NCT01090024|12064977|FG004|STARTED|Period 3||6
10898901|NCT01090024|12064978|FG005|STARTED|Period 3||6
10898902|NCT01090024|12064979|FG006|STARTED|Period 3||6
10898903|NCT01090024|12064980|FG007|STARTED|Period 3||6
10898904|NCT01090024|12064981|FG008|STARTED|Period 3||6
10898905|NCT01090024|12064982|FG009|STARTED|Period 3||5
10898906|NCT01090024|12064983|FG010|STARTED|Period 3||6
10898907|NCT01090024|12064984|FG011|STARTED|Period 3||5
10898908|NCT01090024|12064985|FG012|STARTED|Period 3||6
10898909|NCT01090024|12064986|FG013|STARTED|Period 3||6
10898910|NCT01090024|12064987|FG014|STARTED|Period 3||5
10898911|NCT01090024|12064988|FG015|STARTED|Period 3||6
10898912|NCT01090024|12064989|FG016|STARTED|Period 3||6
10898913|NCT01090024|12064990|FG017|STARTED|Period 3||5
10898914|NCT01090024|12064973|FG000|Treated|Period 3||5
10898915|NCT01090024|12064974|FG001|Treated|Period 3||5
10898916|NCT01090024|12064975|FG002|Treated|Period 3||6
10898917|NCT01090024|12064976|FG003|Treated|Period 3||4
10898918|NCT01090024|12064977|FG004|Treated|Period 3||6
10898919|NCT01090024|12064978|FG005|Treated|Period 3||6
10898920|NCT01090024|12064979|FG006|Treated|Period 3||6
10898921|NCT01090024|12064980|FG007|Treated|Period 3||6
10898922|NCT01090024|12064981|FG008|Treated|Period 3||6
10898923|NCT01090024|12064982|FG009|Treated|Period 3||5
10898924|NCT01090024|12064983|FG010|Treated|Period 3||6
10898925|NCT01090024|12064984|FG011|Treated|Period 3||5
10898926|NCT01090024|12064985|FG012|Treated|Period 3||6
10898927|NCT01090024|12064986|FG013|Treated|Period 3||6
10898928|NCT01090024|12064987|FG014|Treated|Period 3||5
10898929|NCT01090024|12064988|FG015|Treated|Period 3||5
10898930|NCT01090024|12064989|FG016|Treated|Period 3||6
10898931|NCT01090024|12064990|FG017|Treated|Period 3||5
10898932|NCT01090024|12064973|FG000|COMPLETED|Period 3||5
10898933|NCT01090024|12064974|FG001|COMPLETED|Period 3||5
10898934|NCT01090024|12064975|FG002|COMPLETED|Period 3||6
10898935|NCT01090024|12064976|FG003|COMPLETED|Period 3||4
10898936|NCT01090024|12064977|FG004|COMPLETED|Period 3||6
10898937|NCT01090024|12064978|FG005|COMPLETED|Period 3||5
10898938|NCT01090024|12064979|FG006|COMPLETED|Period 3||6
10898939|NCT01090024|12064980|FG007|COMPLETED|Period 3||6
10898940|NCT01090024|12064981|FG008|COMPLETED|Period 3||5
10898941|NCT01090024|12064982|FG009|COMPLETED|Period 3||5
10898942|NCT01090024|12064983|FG010|COMPLETED|Period 3||6
10898943|NCT01090024|12064984|FG011|COMPLETED|Period 3||5
10898944|NCT01090024|12064985|FG012|COMPLETED|Period 3||6
10898945|NCT01090024|12064986|FG013|COMPLETED|Period 3||6
10898946|NCT01090024|12064987|FG014|COMPLETED|Period 3||5
10898947|NCT01090024|12064988|FG015|COMPLETED|Period 3||5
10898948|NCT01090024|12064989|FG016|COMPLETED|Period 3||6
10898949|NCT01090024|12064990|FG017|COMPLETED|Period 3||5
10898950|NCT01090024|12064973|FG000|NOT COMPLETED|Period 3||0
10898951|NCT01090024|12064974|FG001|NOT COMPLETED|Period 3||0
10898952|NCT01090024|12064975|FG002|NOT COMPLETED|Period 3||0
10898953|NCT01090024|12064976|FG003|NOT COMPLETED|Period 3||0
10898954|NCT01090024|12064977|FG004|NOT COMPLETED|Period 3||0
10898955|NCT01090024|12064978|FG005|NOT COMPLETED|Period 3||1
10898956|NCT01090024|12064979|FG006|NOT COMPLETED|Period 3||0
10898957|NCT01090024|12064980|FG007|NOT COMPLETED|Period 3||0
10898958|NCT01090024|12064981|FG008|NOT COMPLETED|Period 3||1
10898959|NCT01090024|12064982|FG009|NOT COMPLETED|Period 3||0
10898960|NCT01090024|12064983|FG010|NOT COMPLETED|Period 3||0
10898961|NCT01090024|12064984|FG011|NOT COMPLETED|Period 3||0
10898962|NCT01090024|12064985|FG012|NOT COMPLETED|Period 3||0
10898963|NCT01090024|12064986|FG013|NOT COMPLETED|Period 3||0
10898964|NCT01090024|12064987|FG014|NOT COMPLETED|Period 3||0
10898965|NCT01090024|12064988|FG015|NOT COMPLETED|Period 3||1
10898966|NCT01090024|12064989|FG016|NOT COMPLETED|Period 3||0
10898967|NCT01090024|12064990|FG017|NOT COMPLETED|Period 3||0
10898968|NCT00943722|12065005|FG000|STARTED|Base Study||648
10898969|NCT00943722|12065006|FG001|STARTED|Base Study||643
10898970|NCT00943722|12065007|FG002|STARTED|Base Study||644
10898971|NCT00943722|12065008|FG003|STARTED|Base Study||669
10898972|NCT00943722|12065009|FG004|STARTED|Base Study||470
10898973|NCT00943722|12065010|FG005|STARTED|Base Study||0
10898974|NCT00943722|12065011|FG006|STARTED|Base Study||0
10898975|NCT00943722|12065005|FG000|Vaccination 1|Base Study||646
10898976|NCT00943722|12065006|FG001|Vaccination 1|Base Study||642
10898977|NCT00943722|12065007|FG002|Vaccination 1|Base Study||644
10898978|NCT00943722|12065008|FG003|Vaccination 1|Base Study||666
10898979|NCT00943722|12065009|FG004|Vaccination 1|Base Study||468
10898980|NCT00943722|12065010|FG005|Vaccination 1|Base Study||0
10898981|NCT00943722|12065011|FG006|Vaccination 1|Base Study||0
10898982|NCT00943722|12065005|FG000|Vaccination 2|Base Study||637
10898983|NCT00943722|12065006|FG001|Vaccination 2|Base Study||633
10898984|NCT00943722|12065007|FG002|Vaccination 2|Base Study||638
10898985|NCT00943722|12065008|FG003|Vaccination 2|Base Study||658
10898986|NCT00943722|12065009|FG004|Vaccination 2|Base Study||462
10898987|NCT00943722|12065010|FG005|Vaccination 2|Base Study||0
10898988|NCT00943722|12065011|FG006|Vaccination 2|Base Study||0
10898989|NCT00943722|12065005|FG000|Vaccination 3|Base Study||635
10898990|NCT00943722|12065006|FG001|Vaccination 3|Base Study||627
10898991|NCT00943722|12065007|FG002|Vaccination 3|Base Study||637
10898992|NCT00943722|12065008|FG003|Vaccination 3|Base Study||653
10898993|NCT00943722|12065009|FG004|Vaccination 3|Base Study||455
10898994|NCT00943722|12065010|FG005|Vaccination 3|Base Study||0
10898995|NCT00943722|12065011|FG006|Vaccination 3|Base Study||0
10898996|NCT00943722|12065005|FG000|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||643
10898997|NCT00943722|12065006|FG001|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||639
10898998|NCT00943722|12065007|FG002|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||641
10898999|NCT00943722|12065008|FG003|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||662
10899000|NCT00943722|12065009|FG004|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||466
10899001|NCT00943722|12065010|FG005|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||0
10899002|NCT00943722|12065011|FG006|At Least One Dose With Protocol-specified Safety Follow-up|Base Study||0
10899003|NCT00943722|12065005|FG000|COMPLETED|Base Study||623
10899004|NCT00943722|12065006|FG001|COMPLETED|Base Study||621
10899005|NCT00943722|12065007|FG002|COMPLETED|Base Study||631
10899006|NCT00943722|12065008|FG003|COMPLETED|Base Study||647
10899007|NCT00943722|12065009|FG004|COMPLETED|Base Study||444
10899008|NCT00943722|12065010|FG005|COMPLETED|Base Study||0
10899009|NCT00943722|12065011|FG006|COMPLETED|Base Study||0
10899010|NCT00943722|12065005|FG000|NOT COMPLETED|Base Study||25
10899011|NCT00943722|12065006|FG001|NOT COMPLETED|Base Study||22
10899012|NCT00943722|12065007|FG002|NOT COMPLETED|Base Study||13
10899013|NCT00943722|12065008|FG003|NOT COMPLETED|Base Study||22
10899014|NCT00943722|12065009|FG004|NOT COMPLETED|Base Study||26
10899015|NCT00943722|12065010|FG005|NOT COMPLETED|Base Study||0
10899016|NCT00943722|12065011|FG006|NOT COMPLETED|Base Study||0
10899017|NCT00943722|12065005|FG000|STARTED|First Extension Study: EXT 1||0
10899018|NCT00943722|12065006|FG001|STARTED|First Extension Study: EXT 1||0
10899019|NCT00943722|12065007|FG002|STARTED|First Extension Study: EXT 1||0
10899020|NCT00943722|12065008|FG003|STARTED|First Extension Study: EXT 1||0
10899021|NCT00943722|12065009|FG004|STARTED|First Extension Study: EXT 1||0
10899022|NCT00943722|12065010|FG005|STARTED|First Extension Study: EXT 1||1604
10899023|NCT00943722|12065011|FG006|STARTED|First Extension Study: EXT 1||568
10899024|NCT00943722|12065005|FG000|COMPLETED|First Extension Study: EXT 1||0
10899025|NCT00943722|12065006|FG001|COMPLETED|First Extension Study: EXT 1||0
10899026|NCT00943722|12065007|FG002|COMPLETED|First Extension Study: EXT 1||0
10899027|NCT00943722|12065008|FG003|COMPLETED|First Extension Study: EXT 1||0
10899028|NCT00943722|12065009|FG004|COMPLETED|First Extension Study: EXT 1||0
10899029|NCT00943722|12065010|FG005|COMPLETED|First Extension Study: EXT 1||1489
10899030|NCT00943722|12065011|FG006|COMPLETED|First Extension Study: EXT 1||527
10899031|NCT00943722|12065005|FG000|NOT COMPLETED|First Extension Study: EXT 1||0
10899032|NCT00943722|12065006|FG001|NOT COMPLETED|First Extension Study: EXT 1||0
10899033|NCT00943722|12065007|FG002|NOT COMPLETED|First Extension Study: EXT 1||0
10899034|NCT00943722|12065008|FG003|NOT COMPLETED|First Extension Study: EXT 1||0
10899035|NCT00943722|12065009|FG004|NOT COMPLETED|First Extension Study: EXT 1||0
10899036|NCT00943722|12065010|FG005|NOT COMPLETED|First Extension Study: EXT 1||115
10899037|NCT00943722|12065011|FG006|NOT COMPLETED|First Extension Study: EXT 1||41
10899038|NCT00943722|12065005|FG000|STARTED|Second Extension Study: EXT 2||0
10899039|NCT00943722|12065006|FG001|STARTED|Second Extension Study: EXT 2||0
10899040|NCT00943722|12065007|FG002|STARTED|Second Extension Study: EXT 2||0
10899041|NCT00943722|12065008|FG003|STARTED|Second Extension Study: EXT 2||0
10899042|NCT00943722|12065009|FG004|STARTED|Second Extension Study: EXT 2||0
10899043|NCT00943722|12065010|FG005|STARTED|Second Extension Study: EXT 2||971
10899044|NCT00943722|12065011|FG006|STARTED|Second Extension Study: EXT 2||301
10899045|NCT00943722|12065005|FG000|COMPLETED|Second Extension Study: EXT 2||0
10899046|NCT00943722|12065006|FG001|COMPLETED|Second Extension Study: EXT 2||0
10899047|NCT00943722|12065007|FG002|COMPLETED|Second Extension Study: EXT 2||0
10899048|NCT00943722|12065008|FG003|COMPLETED|Second Extension Study: EXT 2||0
10899049|NCT00943722|12065009|FG004|COMPLETED|Second Extension Study: EXT 2||0
10899050|NCT00943722|12065010|FG005|COMPLETED|Second Extension Study: EXT 2||720
10899051|NCT00943722|12065011|FG006|COMPLETED|Second Extension Study: EXT 2||202
10899052|NCT00943722|12065005|FG000|NOT COMPLETED|Second Extension Study: EXT 2||0
10899053|NCT00943722|12065006|FG001|NOT COMPLETED|Second Extension Study: EXT 2||0
10899054|NCT00943722|12065007|FG002|NOT COMPLETED|Second Extension Study: EXT 2||0
10899055|NCT00943722|12065008|FG003|NOT COMPLETED|Second Extension Study: EXT 2||0
10899056|NCT00943722|12065009|FG004|NOT COMPLETED|Second Extension Study: EXT 2||0
10899057|NCT00943722|12065010|FG005|NOT COMPLETED|Second Extension Study: EXT 2||251
10899058|NCT00943722|12065011|FG006|NOT COMPLETED|Second Extension Study: EXT 2||99
10899059|NCT00676663|12065036|FG000|STARTED|Overall Study||66
10899060|NCT00676663|12065037|FG001|STARTED|Overall Study||64
10899061|NCT00676663|12065036|FG000|COMPLETED|Overall Study||21
10899062|NCT00676663|12065037|FG001|COMPLETED|Overall Study||26
10899063|NCT00676663|12065036|FG000|NOT COMPLETED|Overall Study||45
10899064|NCT00676663|12065037|FG001|NOT COMPLETED|Overall Study||38
10899065|NCT00391365|12065047|FG000|STARTED|Overall Study||103
10899066|NCT00391365|12065048|FG001|STARTED|Overall Study||170
10899067|NCT00391365|12065047|FG000|COMPLETED|Overall Study||78
10899068|NCT00391365|12065048|FG001|COMPLETED|Overall Study||151
10899069|NCT00391365|12065047|FG000|NOT COMPLETED|Overall Study||25
10899070|NCT00391365|12065048|FG001|NOT COMPLETED|Overall Study||19
10899071|NCT04617860|12065058|FG000|STARTED|Overall Study||8
10899072|NCT04617860|12065059|FG001|STARTED|Overall Study||10
10899073|NCT04617860|12065060|FG002|STARTED|Overall Study||18
10899074|NCT04617860|12065058|FG000|Dose Modified to 8 mg|Overall Study||8
10899075|NCT04617860|12065059|FG001|Dose Modified to 8 mg|Overall Study||1
10899076|NCT04617860|12065060|FG002|Dose Modified to 8 mg|Overall Study||0
10899077|NCT04617860|12065058|FG000|Dose Modified to 16 mg|Overall Study||8
10899078|NCT04617860|12065059|FG001|Dose Modified to 16 mg|Overall Study||9
10899079|NCT04617860|12065060|FG002|Dose Modified to 16 mg|Overall Study||8
10899080|NCT04617860|12065058|FG000|Dose Modified to 32 mg|Overall Study||2
10899081|NCT04617860|12065059|FG001|Dose Modified to 32 mg|Overall Study||4
10899082|NCT04617860|12065060|FG002|Dose Modified to 32 mg|Overall Study||11
10899083|NCT04617860|12065058|FG000|COMPLETED|Overall Study||0
10899084|NCT04617860|12065059|FG001|COMPLETED|Overall Study||0
10899085|NCT04617860|12065060|FG002|COMPLETED|Overall Study||0
10899086|NCT04617860|12065058|FG000|NOT COMPLETED|Overall Study||8
10899087|NCT04617860|12065059|FG001|NOT COMPLETED|Overall Study||10
10899088|NCT04617860|12065060|FG002|NOT COMPLETED|Overall Study||18
10899089|NCT04617847|12065072|FG000|STARTED|Overall Study||3
10899090|NCT04617847|12065073|FG001|STARTED|Overall Study||24
10899091|NCT04617847|12065072|FG000|Dose Modified to 16 mg WVE-120101|Overall Study||3
10899092|NCT04617847|12065073|FG001|Dose Modified to 16 mg WVE-120101|Overall Study||1
10899093|NCT04617847|12065072|FG000|Dose Modified to 32 mg WVE-120101|Overall Study||0
10899094|NCT04617847|12065073|FG001|Dose Modified to 32 mg WVE-120101|Overall Study||5
10899095|NCT04617847|12065072|FG000|COMPLETED|Overall Study||0
10899096|NCT04617847|12065073|FG001|COMPLETED|Overall Study||0
10899097|NCT04617847|12065072|FG000|NOT COMPLETED|Overall Study||3
10899098|NCT04617847|12065073|FG001|NOT COMPLETED|Overall Study||24
10899099|NCT04426318|12065083|FG000|STARTED|Overall Study||346
10899100|NCT04426318|12065084|FG001|STARTED|Overall Study||320
10899101|NCT04426318|12065083|FG000|Failed Attention Checks|Overall Study||4
10899102|NCT04426318|12065084|FG001|Failed Attention Checks|Overall Study||6
10899103|NCT04426318|12065083|FG000|Downloaded HMP App|Overall Study||329
10899104|NCT04426318|12065084|FG001|Downloaded HMP App|Overall Study||0
10899105|NCT04426318|12065083|FG000|Completed T2 Assessment|Overall Study||281
10899106|NCT04426318|12065084|FG001|Completed T2 Assessment|Overall Study||280
10899107|NCT04426318|12065083|FG000|Completed T3 Assessment|Overall Study||261
10899108|NCT04426318|12065084|FG001|Completed T3 Assessment|Overall Study||274
10899109|NCT04426318|12065083|FG000|Completed T4 Assessment|Overall Study||261
10899110|NCT04426318|12065084|FG001|Completed T4 Assessment|Overall Study||275
10899111|NCT04426318|12065083|FG000|Completed T5 Assessment|Overall Study||284
10899112|NCT04426318|12065084|FG001|Completed T5 Assessment|Overall Study||293
10899113|NCT04426318|12065083|FG000|Completed T6 Assessment|Overall Study||286
10899114|NCT04426318|12065084|FG001|Completed T6 Assessment|Overall Study||293
10899115|NCT04426318|12065083|FG000|Final Intent to Treat Sample|Overall Study||344
10899116|NCT04426318|12065084|FG001|Final Intent to Treat Sample|Overall Study||318
10899117|NCT04426318|12065083|FG000|COMPLETED|Overall Study||344
10899118|NCT04426318|12065084|FG001|COMPLETED|Overall Study||318
10899119|NCT04426318|12065083|FG000|NOT COMPLETED|Overall Study||2
10899120|NCT04426318|12065084|FG001|NOT COMPLETED|Overall Study||2
10899121|NCT04063657|12065092|FG000|STARTED|Overall Study||1
10899122|NCT04063657|12065093|FG001|STARTED|Overall Study||0
10899123|NCT04063657|12065092|FG000|COMPLETED|Overall Study||0
10899124|NCT04063657|12065093|FG001|COMPLETED|Overall Study||0
10899125|NCT04063657|12065092|FG000|NOT COMPLETED|Overall Study||1
10899126|NCT04063657|12065093|FG001|NOT COMPLETED|Overall Study||0
10899127|NCT04042623|12065099|FG000|STARTED|Overall Study||1
10899128|NCT04042623|12065099|FG000|COMPLETED|Overall Study||0
10899129|NCT04042623|12065099|FG000|NOT COMPLETED|Overall Study||1
10899130|NCT03882047|12065106|FG000|STARTED|Overall Study||104
10899131|NCT03882047|12065107|FG001|STARTED|Overall Study||105
10899132|NCT03882047|12065108|FG002|STARTED|Overall Study||104
10899133|NCT03882047|12065106|FG000|Treated|Overall Study||104
10899134|NCT03882047|12065107|FG001|Treated|Overall Study||104
10899135|NCT03882047|12065108|FG002|Treated|Overall Study||103
10899136|NCT03882047|12065106|FG000|COMPLETED|Overall Study||98
10899137|NCT03882047|12065107|FG001|COMPLETED|Overall Study||95
10899138|NCT03882047|12065108|FG002|COMPLETED|Overall Study||88
10899139|NCT03882047|12065106|FG000|NOT COMPLETED|Overall Study||6
10899140|NCT03882047|12065107|FG001|NOT COMPLETED|Overall Study||10
10899141|NCT03882047|12065108|FG002|NOT COMPLETED|Overall Study||16
10899142|NCT03879772|12065121|FG000|STARTED|Overall Study||137
10899143|NCT03879772|12065122|FG001|STARTED|Overall Study||135
10899144|NCT03879772|12065123|FG002|STARTED|Overall Study||133
10899145|NCT03879772|12065124|FG003|STARTED|Overall Study||138
10899146|NCT03879772|12065125|FG004|STARTED|Overall Study||136
10899147|NCT03879772|12065121|FG000|COMPLETED|Overall Study||133
10899148|NCT03879772|12065122|FG001|COMPLETED|Overall Study||132
10899149|NCT03879772|12065123|FG002|COMPLETED|Overall Study||123
10899150|NCT03879772|12065124|FG003|COMPLETED|Overall Study||130
10899151|NCT03879772|12065125|FG004|COMPLETED|Overall Study||128
10899152|NCT03879772|12065121|FG000|NOT COMPLETED|Overall Study||4
10899153|NCT03879772|12065122|FG001|NOT COMPLETED|Overall Study||3
10899154|NCT03879772|12065123|FG002|NOT COMPLETED|Overall Study||10
10899155|NCT03879772|12065124|FG003|NOT COMPLETED|Overall Study||8
10899156|NCT03879772|12065125|FG004|NOT COMPLETED|Overall Study||8
10899157|NCT03861559|12065139|FG000|STARTED|Overall Study||101
10899158|NCT03861559|12065140|FG001|STARTED|Overall Study||100
10899159|NCT03861559|12065139|FG000|COMPLETED|Overall Study||99
10899160|NCT03861559|12065140|FG001|COMPLETED|Overall Study||95
10899161|NCT03861559|12065139|FG000|NOT COMPLETED|Overall Study||2
10899162|NCT03861559|12065140|FG001|NOT COMPLETED|Overall Study||5
10899163|NCT03855228|12065150|FG000|STARTED|Overall Study||169
10899164|NCT03855228|12065151|FG001|STARTED|Overall Study||176
10899165|NCT03855228|12065152|FG002|STARTED|Overall Study||182
10899166|NCT03855228|12065153|FG003|STARTED|Overall Study||177
10899167|NCT03855228|12065150|FG000|Treated|Overall Study||169
10899168|NCT03855228|12065151|FG001|Treated|Overall Study||176
10899169|NCT03855228|12065152|FG002|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181
10899170|NCT03855228|12065153|FG003|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176
10899171|NCT03855228|12065150|FG000|COMPLETED|Overall Study||166
10899172|NCT03855228|12065151|FG001|COMPLETED|Overall Study||167
10899173|NCT03855228|12065152|FG002|COMPLETED|Overall Study||174
10899174|NCT03855228|12065153|FG003|COMPLETED|Overall Study||158
10899175|NCT03855228|12065150|FG000|NOT COMPLETED|Overall Study||3
10899176|NCT03855228|12065151|FG001|NOT COMPLETED|Overall Study||9
10899177|NCT03855228|12065152|FG002|NOT COMPLETED|Overall Study||8
10899178|NCT03855228|12065153|FG003|NOT COMPLETED|Overall Study||19
10899179|NCT03855189|12065166|FG000|STARTED|Overall Study||113
10899180|NCT03855189|12065167|FG001|STARTED|Overall Study||116
10899181|NCT03855189|12065168|FG002|STARTED|Overall Study||116
10899182|NCT03855189|12065166|FG000|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112
10899183|NCT03855189|12065167|FG001|Treated|Overall Study||116
10899184|NCT03855189|12065168|FG002|Treated|Overall Study||116
10899185|NCT03855189|12065166|FG000|COMPLETED|Overall Study||103
10899186|NCT03855189|12065167|FG001|COMPLETED|Overall Study||109
10899187|NCT03855189|12065168|FG002|COMPLETED|Overall Study||110
10899188|NCT03855189|12065166|FG000|NOT COMPLETED|Overall Study||10
10899189|NCT03855189|12065167|FG001|NOT COMPLETED|Overall Study||7
10899190|NCT03855189|12065168|FG002|NOT COMPLETED|Overall Study||6
10899191|NCT03764631|12065178|FG000|STARTED|Overall Study||751
10899192|NCT03764631|12065179|FG001|STARTED|Overall Study||751
10899193|NCT03764631|12065178|FG000|COMPLETED|Overall Study||710
10899194|NCT03764631|12065179|FG001|COMPLETED|Overall Study||698
10899195|NCT03764631|12065178|FG000|NOT COMPLETED|Overall Study||41
10899196|NCT03764631|12065179|FG001|NOT COMPLETED|Overall Study||53
10899197|NCT03764072|12065191|FG000|STARTED|Overall Study||46
10899198|NCT03764072|12065192|FG001|STARTED|Overall Study||42
10899199|NCT03764072|12065193|FG002|STARTED|Overall Study||44
10899200|NCT03764072|12065194|FG003|STARTED|Overall Study||45
10899201|NCT03764072|12065195|FG004|STARTED|Overall Study||46
10899202|NCT03764072|12065196|FG005|STARTED|Overall Study||27
10899203|NCT03764072|12065191|FG000|COMPLETED|Overall Study||46
10899204|NCT03764072|12065192|FG001|COMPLETED|Overall Study||42
10899205|NCT03764072|12065193|FG002|COMPLETED|Overall Study||43
10899206|NCT03764072|12065194|FG003|COMPLETED|Overall Study||45
10899207|NCT03764072|12065195|FG004|COMPLETED|Overall Study||45
10899208|NCT03764072|12065196|FG005|COMPLETED|Overall Study||26
10899209|NCT03764072|12065191|FG000|NOT COMPLETED|Overall Study||0
10899210|NCT03764072|12065192|FG001|NOT COMPLETED|Overall Study||0
10899211|NCT03764072|12065193|FG002|NOT COMPLETED|Overall Study||1
10899212|NCT03764072|12065194|FG003|NOT COMPLETED|Overall Study||0
10899213|NCT03764072|12065195|FG004|NOT COMPLETED|Overall Study||1
10899214|NCT03764072|12065196|FG005|NOT COMPLETED|Overall Study||1
10899215|NCT03645408|12065217|FG000|STARTED|Overall Study||1
10899216|NCT03645408|12065218|FG001|STARTED|Overall Study||2
10899217|NCT03645408|12065217|FG000|COMPLETED|Overall Study||1
10899218|NCT03645408|12065218|FG001|COMPLETED|Overall Study||2
10899219|NCT03645408|12065217|FG000|NOT COMPLETED|Overall Study||0
10899220|NCT03645408|12065218|FG001|NOT COMPLETED|Overall Study||0
10899221|NCT03578809|12065228|FG000|STARTED|Overall Study||94
10899222|NCT03578809|12065229|FG001|STARTED|Overall Study||185
10899223|NCT03578809|12065230|FG002|STARTED|Overall Study||112
10899224|NCT03578809|12065231|FG003|STARTED|Overall Study||202
10899225|NCT03578809|12065228|FG000|Treated|Overall Study||90
10899226|NCT03578809|12065229|FG001|Treated|Overall Study||179
10899227|NCT03578809|12065230|FG002|Treated|Overall Study||111
10899228|NCT03578809|12065231|FG003|Treated|Overall Study||195
10899229|NCT03578809|12065228|FG000|COMPLETED|Overall Study||88
10899230|NCT03578809|12065229|FG001|COMPLETED|Overall Study||171
10899231|NCT03578809|12065230|FG002|COMPLETED|Overall Study||108
10899232|NCT03578809|12065231|FG003|COMPLETED|Overall Study||193
10899233|NCT03578809|12065228|FG000|NOT COMPLETED|Overall Study||6
10899234|NCT03578809|12065229|FG001|NOT COMPLETED|Overall Study||14
10899235|NCT03578809|12065230|FG002|NOT COMPLETED|Overall Study||4
10899236|NCT03578809|12065231|FG003|NOT COMPLETED|Overall Study||9
10899237|NCT03571204|12065247|FG000|STARTED|Overall Study||8
10899238|NCT03571204|12065248|FG001|STARTED|Overall Study||8
10899239|NCT03571204|12065249|FG002|STARTED|Overall Study||5
10899240|NCT03571204|12065247|FG000|COMPLETED|Overall Study||7
10899241|NCT03571204|12065248|FG001|COMPLETED|Overall Study||6
10899242|NCT03571204|12065249|FG002|COMPLETED|Overall Study||5
10899243|NCT03571204|12065247|FG000|NOT COMPLETED|Overall Study||1
10899244|NCT03571204|12065248|FG001|NOT COMPLETED|Overall Study||2
10899245|NCT03571204|12065249|FG002|NOT COMPLETED|Overall Study||0
10899246|NCT03523091|12065260|FG000|STARTED|Overall Study||1
10899247|NCT03523091|12065261|FG001|STARTED|Overall Study||5
10899248|NCT03523091|12065260|FG000|COMPLETED|Overall Study||0
10899249|NCT03523091|12065261|FG001|COMPLETED|Overall Study||1
10899250|NCT03523091|12065260|FG000|NOT COMPLETED|Overall Study||1
10899251|NCT03523091|12065261|FG001|NOT COMPLETED|Overall Study||4
10899252|NCT03503474|12065269|FG000|STARTED|Overall Study|The number of participant with a diarrhoeal sample that returned a positive test result at the coordinating laboratory. There is no intervention as this is an observational study only.|103
10899253|NCT03503474|12065270|FG001|STARTED|Overall Study|The number of participant with a diarrhoeal sample that returned a negative test result at the coordinating laboratory. There is no intervention as this is an observational study only.|3050
10899254|NCT03503474|12065269|FG000|COMPLETED|Overall Study||103
10899255|NCT03503474|12065270|FG001|COMPLETED|Overall Study||3050
10899256|NCT03503474|12065269|FG000|NOT COMPLETED|Overall Study||0
10899257|NCT03503474|12065270|FG001|NOT COMPLETED|Overall Study||0
10899258|NCT03476317|12065279|FG000|STARTED|Overall Study|Group 1 study was not completed|0
10899259|NCT03476317|12065280|FG001|STARTED|Overall Study|Group 1 study was not completed|0
10899260|NCT03476317|12065281|FG002|STARTED|Overall Study||10
10899261|NCT03476317|12065279|FG000|COMPLETED|Overall Study|Group 1 study was not completed|0
10899262|NCT03476317|12065280|FG001|COMPLETED|Overall Study|Group 1 study was not completed|0
10899263|NCT03476317|12065281|FG002|COMPLETED|Overall Study||10
10899264|NCT03476317|12065279|FG000|NOT COMPLETED|Overall Study||0
10899265|NCT03476317|12065280|FG001|NOT COMPLETED|Overall Study||0
10899266|NCT03476317|12065281|FG002|NOT COMPLETED|Overall Study||0
10899267|NCT03391960|12065289|FG000|STARTED|Overall Study|Units were not assessed for this Arm/Group. Data was collected from the health care worker surveys for the retrospective study to monitor compliance with the scrub-the-hub protocol (signed informed consent and were enrolled)|165
10899268|NCT03391960|12065290|FG001|STARTED|Overall Study|No individual patient was recruited into the study. Data was collected from the compliance audits to monitor compliance with the disinfecting barrier cap protocol.|
10899269|NCT03391960|12065289|FG000|COMPLETED|Overall Study||165
10899270|NCT03391960|12065290|FG001|COMPLETED|Overall Study|No individual patient was recruited into the study. Data was collected from the compliance audits to monitor compliance with the disinfecting barrier cap protocol.|
10899271|NCT03391960|12065289|FG000|NOT COMPLETED|Overall Study||0
10899272|NCT03391960|12065290|FG001|NOT COMPLETED|Overall Study||
10899273|NCT03362190|12065309|FG000|STARTED|Overall Study||10
10899274|NCT03362190|12065310|FG001|STARTED|Overall Study||10
10899275|NCT03362190|12065311|FG002|STARTED|Overall Study||22
10899276|NCT03362190|12065312|FG003|STARTED|Overall Study||22
10899277|NCT03362190|12065309|FG000|COMPLETED|Overall Study||10
10899278|NCT03362190|12065310|FG001|COMPLETED|Overall Study||10
10899279|NCT03362190|12065311|FG002|COMPLETED|Overall Study||22
10899280|NCT03362190|12065312|FG003|COMPLETED|Overall Study||20
10899281|NCT03362190|12065309|FG000|NOT COMPLETED|Overall Study||0
10899282|NCT03362190|12065310|FG001|NOT COMPLETED|Overall Study||0
10899283|NCT03362190|12065311|FG002|NOT COMPLETED|Overall Study||0
10899284|NCT03362190|12065312|FG003|NOT COMPLETED|Overall Study||2
10899285|NCT03252522|12065327|FG000|STARTED|Overall Study||78
10899286|NCT03252522|12065328|FG001|STARTED|Overall Study||57
10899287|NCT03252522|12065329|FG002|STARTED|Overall Study||0
10899288|NCT03252522|12065327|FG000|COMPLETED|Overall Study||69
10899289|NCT03252522|12065328|FG001|COMPLETED|Overall Study||54
10899290|NCT03252522|12065329|FG002|COMPLETED|Overall Study||0
10899291|NCT03252522|12065327|FG000|NOT COMPLETED|Overall Study||9
10899292|NCT03252522|12065328|FG001|NOT COMPLETED|Overall Study||3
10899293|NCT03252522|12065329|FG002|NOT COMPLETED|Overall Study||0
10899294|NCT03225833|12065346|FG000|STARTED|Overall Study||16
10899295|NCT03225833|12065347|FG001|STARTED|Overall Study||9
10899296|NCT03225833|12065348|FG002|STARTED|Overall Study||9
10899297|NCT03225833|12065349|FG003|STARTED|Overall Study||9
10899298|NCT03225833|12065350|FG004|STARTED|Overall Study||8
10899299|NCT03225833|12065351|FG005|STARTED|Overall Study||10
10899300|NCT03225833|12065346|FG000|Single Dose Period Only|Overall Study||1
10899301|NCT03225833|12065347|FG001|Single Dose Period Only|Overall Study||1
10899302|NCT03225833|12065348|FG002|Single Dose Period Only|Overall Study||2
10899303|NCT03225833|12065349|FG003|Single Dose Period Only|Overall Study||0
10899304|NCT03225833|12065350|FG004|Single Dose Period Only|Overall Study||0
10899305|NCT03225833|12065351|FG005|Single Dose Period Only|Overall Study||4
10899306|NCT03225833|12065346|FG000|Multiple Dose Period Only|Overall Study||0
10899307|NCT03225833|12065347|FG001|Multiple Dose Period Only|Overall Study||0
10899308|NCT03225833|12065348|FG002|Multiple Dose Period Only|Overall Study||0
10899309|NCT03225833|12065349|FG003|Multiple Dose Period Only|Overall Study||0
10899310|NCT03225833|12065350|FG004|Multiple Dose Period Only|Overall Study||0
10899311|NCT03225833|12065351|FG005|Multiple Dose Period Only|Overall Study||1
10899312|NCT03225833|12065346|FG000|Single Dose and Multiple Dose Periods|Overall Study||15
10899313|NCT03225833|12065347|FG001|Single Dose and Multiple Dose Periods|Overall Study||8
10899314|NCT03225833|12065348|FG002|Single Dose and Multiple Dose Periods|Overall Study||7
10899315|NCT03225833|12065349|FG003|Single Dose and Multiple Dose Periods|Overall Study||9
10899316|NCT03225833|12065350|FG004|Single Dose and Multiple Dose Periods|Overall Study||8
10899317|NCT03225833|12065351|FG005|Single Dose and Multiple Dose Periods|Overall Study||5
10899318|NCT03225833|12065346|FG000|COMPLETED|Overall Study||11
10899319|NCT03225833|12065347|FG001|COMPLETED|Overall Study||8
10899320|NCT03225833|12065348|FG002|COMPLETED|Overall Study||7
10899321|NCT03225833|12065349|FG003|COMPLETED|Overall Study||9
10899322|NCT03225833|12065350|FG004|COMPLETED|Overall Study||7
10899323|NCT03225833|12065351|FG005|COMPLETED|Overall Study||0
10899324|NCT03225833|12065346|FG000|NOT COMPLETED|Overall Study||5
10899325|NCT03225833|12065347|FG001|NOT COMPLETED|Overall Study||1
10899326|NCT03225833|12065348|FG002|NOT COMPLETED|Overall Study||2
10899327|NCT03225833|12065349|FG003|NOT COMPLETED|Overall Study||0
10899328|NCT03225833|12065350|FG004|NOT COMPLETED|Overall Study||1
10899329|NCT03225833|12065351|FG005|NOT COMPLETED|Overall Study||10
10899330|NCT03167242|12065382|FG000|STARTED|Overall Study||12
10899331|NCT03167242|12065383|FG001|STARTED|Overall Study||51
10899332|NCT03167242|12065384|FG002|STARTED|Overall Study||51
10899333|NCT03167242|12065385|FG003|STARTED|Overall Study||51
10899334|NCT03167242|12065386|FG004|STARTED|Overall Study||54
10899335|NCT03167242|12065387|FG005|STARTED|Overall Study||51
10899336|NCT03167242|12065388|FG006|STARTED|Overall Study||52
10899337|NCT03167242|12065389|FG007|STARTED|Overall Study||27
10899338|NCT03167242|12065390|FG008|STARTED|Overall Study||53
10899339|NCT03167242|12065391|FG009|STARTED|Overall Study||53
10899340|NCT03167242|12065392|FG010|STARTED|Overall Study||45
10899341|NCT03167242|12065393|FG011|STARTED|Overall Study||24
10899342|NCT03167242|12065382|FG000|Full Analysis Set (FAS)|Overall Study||12
10899343|NCT03167242|12065383|FG001|Full Analysis Set (FAS)|Overall Study||51
10899344|NCT03167242|12065384|FG002|Full Analysis Set (FAS)|Overall Study||51
10899345|NCT03167242|12065385|FG003|Full Analysis Set (FAS)|Overall Study||51
10899346|NCT03167242|12065386|FG004|Full Analysis Set (FAS)|Overall Study||54
10899347|NCT03167242|12065387|FG005|Full Analysis Set (FAS)|Overall Study||51
10899348|NCT03167242|12065388|FG006|Full Analysis Set (FAS)|Overall Study||52
10899349|NCT03167242|12065389|FG007|Full Analysis Set (FAS)|Overall Study||27
10899350|NCT03167242|12065390|FG008|Full Analysis Set (FAS)|Overall Study||52
10899351|NCT03167242|12065391|FG009|Full Analysis Set (FAS)|Overall Study||53
10899352|NCT03167242|12065392|FG010|Full Analysis Set (FAS)|Overall Study||45
10899353|NCT03167242|12065393|FG011|Full Analysis Set (FAS)|Overall Study||24
10899354|NCT03167242|12065382|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||12
10899355|NCT03167242|12065383|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||47
10899356|NCT03167242|12065384|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||51
10899357|NCT03167242|12065385|FG003|Pharmacokinetics (PK) Analysis Set|Overall Study||46
10899358|NCT03167242|12065386|FG004|Pharmacokinetics (PK) Analysis Set|Overall Study||48
10899359|NCT03167242|12065387|FG005|Pharmacokinetics (PK) Analysis Set|Overall Study||46
10899360|NCT03167242|12065388|FG006|Pharmacokinetics (PK) Analysis Set|Overall Study||45
10899361|NCT03167242|12065389|FG007|Pharmacokinetics (PK) Analysis Set|Overall Study||24
10899362|NCT03167242|12065390|FG008|Pharmacokinetics (PK) Analysis Set|Overall Study||48
10899363|NCT03167242|12065391|FG009|Pharmacokinetics (PK) Analysis Set|Overall Study||46
10899364|NCT03167242|12065392|FG010|Pharmacokinetics (PK) Analysis Set|Overall Study||41
10899365|NCT03167242|12065393|FG011|Pharmacokinetics (PK) Analysis Set|Overall Study||24
10899366|NCT03167242|12065382|FG000|Per-Protocol Set (PPS)|Overall Study||12
10899367|NCT03167242|12065383|FG001|Per-Protocol Set (PPS)|Overall Study||50
10899368|NCT03167242|12065384|FG002|Per-Protocol Set (PPS)|Overall Study||48
10899369|NCT03167242|12065385|FG003|Per-Protocol Set (PPS)|Overall Study||48
10899370|NCT03167242|12065386|FG004|Per-Protocol Set (PPS)|Overall Study||47
10899371|NCT03167242|12065387|FG005|Per-Protocol Set (PPS)|Overall Study||44
10899372|NCT03167242|12065388|FG006|Per-Protocol Set (PPS)|Overall Study||43
10899373|NCT03167242|12065389|FG007|Per-Protocol Set (PPS)|Overall Study||25
10899374|NCT03167242|12065390|FG008|Per-Protocol Set (PPS)|Overall Study||48
10899375|NCT03167242|12065391|FG009|Per-Protocol Set (PPS)|Overall Study||46
10899376|NCT03167242|12065392|FG010|Per-Protocol Set (PPS)|Overall Study||40
10899377|NCT03167242|12065393|FG011|Per-Protocol Set (PPS)|Overall Study||22
10899378|NCT03167242|12065382|FG000|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12
10899379|NCT03167242|12065383|FG001|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5
10899380|NCT03167242|12065384|FG002|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
10899381|NCT03167242|12065385|FG003|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
10899382|NCT03167242|12065386|FG004|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
10899383|NCT03167242|12065387|FG005|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12
10899384|NCT03167242|12065388|FG006|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5
10899385|NCT03167242|12065389|FG007|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
10899386|NCT03167242|12065390|FG008|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
10899387|NCT03167242|12065391|FG009|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
10899388|NCT03167242|12065392|FG010|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
10899389|NCT03167242|12065393|FG011|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
10899390|NCT03167242|12065382|FG000|COMPLETED|Overall Study||12
10899391|NCT03167242|12065383|FG001|COMPLETED|Overall Study||50
10899392|NCT03167242|12065384|FG002|COMPLETED|Overall Study||48
10899393|NCT03167242|12065385|FG003|COMPLETED|Overall Study||50
10899394|NCT03167242|12065386|FG004|COMPLETED|Overall Study||53
10899395|NCT03167242|12065387|FG005|COMPLETED|Overall Study||49
10899396|NCT03167242|12065388|FG006|COMPLETED|Overall Study||50
10899397|NCT03167242|12065389|FG007|COMPLETED|Overall Study||26
10899398|NCT03167242|12065390|FG008|COMPLETED|Overall Study||52
10899399|NCT03167242|12065391|FG009|COMPLETED|Overall Study||53
10899400|NCT03167242|12065392|FG010|COMPLETED|Overall Study||43
10899401|NCT03167242|12065393|FG011|COMPLETED|Overall Study||23
10899402|NCT03167242|12065382|FG000|NOT COMPLETED|Overall Study||0
10899403|NCT03167242|12065383|FG001|NOT COMPLETED|Overall Study||1
10899404|NCT03167242|12065384|FG002|NOT COMPLETED|Overall Study||3
10899405|NCT03167242|12065385|FG003|NOT COMPLETED|Overall Study||1
10899406|NCT03167242|12065386|FG004|NOT COMPLETED|Overall Study||1
10899407|NCT03167242|12065387|FG005|NOT COMPLETED|Overall Study||2
10899408|NCT03167242|12065388|FG006|NOT COMPLETED|Overall Study||2
10899409|NCT03167242|12065389|FG007|NOT COMPLETED|Overall Study||1
10899410|NCT03167242|12065390|FG008|NOT COMPLETED|Overall Study||1
10899411|NCT03167242|12065391|FG009|NOT COMPLETED|Overall Study||0
10899412|NCT03167242|12065392|FG010|NOT COMPLETED|Overall Study||2
10899413|NCT03167242|12065393|FG011|NOT COMPLETED|Overall Study||1
10899414|NCT03137537|12065431|FG000|STARTED|Overall Study||12
10899415|NCT03137537|12065432|FG001|STARTED|Overall Study||11
10899416|NCT03137537|12065431|FG000|COMPLETED|Overall Study||12
10899417|NCT03137537|12065432|FG001|COMPLETED|Overall Study||10
10899418|NCT03137537|12065431|FG000|NOT COMPLETED|Overall Study||0
10899419|NCT03137537|12065432|FG001|NOT COMPLETED|Overall Study||1
10899420|NCT03113383|12065438|FG000|STARTED|Overall Study||4
10899421|NCT03113383|12065439|FG001|STARTED|Overall Study||0
10899422|NCT03113383|12065438|FG000|COMPLETED|Overall Study||0
10899423|NCT03113383|12065439|FG001|COMPLETED|Overall Study||0
10899424|NCT03113383|12065438|FG000|NOT COMPLETED|Overall Study||4
10899425|NCT03113383|12065439|FG001|NOT COMPLETED|Overall Study||0
10899426|NCT03028896|12065447|FG000|STARTED|Overall Study||66
10899427|NCT03028896|12065448|FG001|STARTED|Overall Study||66
10899428|NCT03028896|12065447|FG000|COMPLETED|Overall Study||63
10899429|NCT03028896|12065448|FG001|COMPLETED|Overall Study||66
10899430|NCT03028896|12065447|FG000|NOT COMPLETED|Overall Study||3
10899431|NCT03028896|12065448|FG001|NOT COMPLETED|Overall Study||0
10899432|NCT03008369|12065454|FG000|STARTED|Overall Study||3
10899433|NCT03008369|12065454|FG000|COMPLETED|Overall Study||3
10899434|NCT03008369|12065454|FG000|NOT COMPLETED|Overall Study||0
10899435|NCT02978326|12065461|FG000|STARTED|Part A (Up to 75 Days)||1
10899436|NCT02978326|12065462|FG001|STARTED|Part A (Up to 75 Days)||0
10899437|NCT02978326|12065463|FG002|STARTED|Part A (Up to 75 Days)||0
10899438|NCT02978326|12065461|FG000|COMPLETED|Part A (Up to 75 Days)||1
10899439|NCT02978326|12065462|FG001|COMPLETED|Part A (Up to 75 Days)||0
10899440|NCT02978326|12065463|FG002|COMPLETED|Part A (Up to 75 Days)||0
10899441|NCT02978326|12065461|FG000|NOT COMPLETED|Part A (Up to 75 Days)||0
10899442|NCT02978326|12065462|FG001|NOT COMPLETED|Part A (Up to 75 Days)||0
10899443|NCT02978326|12065463|FG002|NOT COMPLETED|Part A (Up to 75 Days)||0
10899444|NCT02978326|12065461|FG000|STARTED|Part B (Up to 45 Days)||0
10899445|NCT02978326|12065462|FG001|STARTED|Part B (Up to 45 Days)||76
10899446|NCT02978326|12065463|FG002|STARTED|Part B (Up to 45 Days)||77
10899447|NCT02978326|12065461|FG000|Received Study Drug|Part B (Up to 45 Days)||0
10899448|NCT02978326|12065462|FG001|Received Study Drug|Part B (Up to 45 Days)||73
10899534|NCT02553265|12065583|FG000|STARTED|Enrollment||9
10899535|NCT02553265|12065584|FG001|STARTED|Enrollment||7
10899449|NCT02978326|12065463|FG002|Received Study Drug|Part B (Up to 45 Days)|Two participants were randomized to placebo but received at least 1 dose of SAGE-217 in error and were included in the SAGE-217 group for 'Received Study Drug' and for 'Safety Analysis'.|78
10899450|NCT02978326|12065461|FG000|Safety Set (Part B)|Part B (Up to 45 Days)||0
10899451|NCT02978326|12065462|FG001|Safety Set (Part B)|Part B (Up to 45 Days)||73
10899452|NCT02978326|12065463|FG002|Safety Set (Part B)|Part B (Up to 45 Days)||78
10899453|NCT02978326|12065461|FG000|Efficacy Set (Part B)|Part B (Up to 45 Days)||0
10899454|NCT02978326|12065462|FG001|Efficacy Set (Part B)|Part B (Up to 45 Days)||74
10899455|NCT02978326|12065463|FG002|Efficacy Set (Part B)|Part B (Up to 45 Days)||76
10899456|NCT02978326|12065461|FG000|COMPLETED|Part B (Up to 45 Days)||0
10899457|NCT02978326|12065462|FG001|COMPLETED|Part B (Up to 45 Days)||69
10899458|NCT02978326|12065463|FG002|COMPLETED|Part B (Up to 45 Days)||73
10899459|NCT02978326|12065461|FG000|NOT COMPLETED|Part B (Up to 45 Days)||0
10899460|NCT02978326|12065462|FG001|NOT COMPLETED|Part B (Up to 45 Days)||7
10899461|NCT02978326|12065463|FG002|NOT COMPLETED|Part B (Up to 45 Days)||4
10899462|NCT02970929|12065473|FG000|STARTED|Overall Study||157
10899463|NCT02970929|12065473|FG000|Subjects Who Received Study Medication|Overall Study||156
10899464|NCT02970929|12065473|FG000|COMPLETED|Overall Study||105
10899465|NCT02970929|12065473|FG000|NOT COMPLETED|Overall Study||52
10899466|NCT02963493|12065479|FG000|STARTED|Overall Study||157
10899467|NCT02963493|12065479|FG000|COMPLETED|Overall Study||157
10899468|NCT02963493|12065479|FG000|NOT COMPLETED|Overall Study||0
10899469|NCT02899078|12065490|FG000|STARTED|Overall Study||31
10899470|NCT02899078|12065490|FG000|COMPLETED|Overall Study||28
10899471|NCT02899078|12065490|FG000|NOT COMPLETED|Overall Study||3
10899472|NCT02797951|12065494|FG000|STARTED|Overall Study||165
10899473|NCT02797951|12065494|FG000|Received at Least One Dose of Study Drug|Overall Study||164
10899474|NCT02797951|12065494|FG000|COMPLETED|Overall Study||116
10899475|NCT02797951|12065494|FG000|NOT COMPLETED|Overall Study||49
10899476|NCT02753751|12065500|FG000|STARTED|Overall Study||2971
10899477|NCT02753751|12065501|FG001|STARTED|Overall Study||3059
10899478|NCT02753751|12065500|FG000|COMPLETED|Overall Study||2971
10899479|NCT02753751|12065501|FG001|COMPLETED|Overall Study||3059
10899480|NCT02753751|12065500|FG000|NOT COMPLETED|Overall Study||0
10899481|NCT02753751|12065501|FG001|NOT COMPLETED|Overall Study||0
10899482|NCT02748057|12065509|FG000|STARTED|Overall Study||114
10899483|NCT02748057|12065510|FG001|STARTED|Overall Study||21
10899484|NCT02748057|12065509|FG000|COMPLETED|Overall Study||109
10899485|NCT02748057|12065510|FG001|COMPLETED|Overall Study||19
10899486|NCT02748057|12065509|FG000|NOT COMPLETED|Overall Study||5
10899487|NCT02748057|12065510|FG001|NOT COMPLETED|Overall Study||2
10899488|NCT02741271|12065518|FG000|STARTED|Overall Study||91
10899489|NCT02741271|12065519|FG001|STARTED|Overall Study||90
10899490|NCT02741271|12065518|FG000|COMPLETED|Overall Study||89
10899491|NCT02741271|12065519|FG001|COMPLETED|Overall Study||88
10899492|NCT02741271|12065518|FG000|NOT COMPLETED|Overall Study||2
10899493|NCT02741271|12065519|FG001|NOT COMPLETED|Overall Study||2
10899494|NCT02741245|12065532|FG000|STARTED|Overall Study||35
10899495|NCT02741245|12065533|FG001|STARTED|Overall Study||72
10899496|NCT02741245|12065534|FG002|STARTED|Overall Study||71
10899497|NCT02741245|12065535|FG003|STARTED|Overall Study||71
10899498|NCT02741245|12065536|FG004|STARTED|Overall Study||72
10899499|NCT02741245|12065532|FG000|COMPLETED|Overall Study||35
10899500|NCT02741245|12065533|FG001|COMPLETED|Overall Study||71
10899501|NCT02741245|12065534|FG002|COMPLETED|Overall Study||71
10899502|NCT02741245|12065535|FG003|COMPLETED|Overall Study||67
10899503|NCT02741245|12065536|FG004|COMPLETED|Overall Study||70
10899504|NCT02741245|12065532|FG000|NOT COMPLETED|Overall Study||0
10899505|NCT02741245|12065533|FG001|NOT COMPLETED|Overall Study||1
10899506|NCT02741245|12065534|FG002|NOT COMPLETED|Overall Study||0
10899507|NCT02741245|12065535|FG003|NOT COMPLETED|Overall Study||4
10899508|NCT02741245|12065536|FG004|NOT COMPLETED|Overall Study||2
10899509|NCT02688608|12065548|FG000|STARTED|Overall Study||6
10899510|NCT02688608|12065548|FG000|COMPLETED|Overall Study||5
10899511|NCT02688608|12065548|FG000|NOT COMPLETED|Overall Study||1
10899512|NCT02634268|12065554|FG000|STARTED|Overall Study||346
10899513|NCT02634268|12065555|FG001|STARTED|Overall Study||338
10899514|NCT02634268|12065554|FG000|COMPLETED|Overall Study|In-person visit completion = 267 for both groups. Some participants completed only surveys because of Covid-19 restrictions.|287
10899515|NCT02634268|12065555|FG001|COMPLETED|Overall Study|In-person visit completion = 267 for both groups. Some participants completed only surveys because of Covid-19 restrictions.|291
10899516|NCT02634268|12065554|FG000|NOT COMPLETED|Overall Study||59
10899517|NCT02634268|12065555|FG001|NOT COMPLETED|Overall Study||47
10899518|NCT02605967|12065563|FG000|STARTED|Overall Study||82
10899519|NCT02605967|12065564|FG001|STARTED|Overall Study||40
10899520|NCT02605967|12065563|FG000|Safety Set|Overall Study||82
10899521|NCT02605967|12065564|FG001|Safety Set|Overall Study||39
10899522|NCT02605967|12065563|FG000|Crossover to Spartalizumab|Overall Study||0
10899523|NCT02605967|12065564|FG001|Crossover to Spartalizumab|Overall Study||27
10899524|NCT02605967|12065563|FG000|COMPLETED|Overall Study||0
10899525|NCT02605967|12065564|FG001|COMPLETED|Overall Study||0
10899526|NCT02605967|12065563|FG000|NOT COMPLETED|Overall Study||82
10899527|NCT02605967|12065564|FG001|NOT COMPLETED|Overall Study||40
10899528|NCT02570503|12065576|FG000|STARTED|Overall Study||34
10899529|NCT02570503|12065577|FG001|STARTED|Overall Study||30
10899530|NCT02570503|12065576|FG000|COMPLETED|Overall Study||34
10899531|NCT02570503|12065577|FG001|COMPLETED|Overall Study||30
10899532|NCT02570503|12065576|FG000|NOT COMPLETED|Overall Study||0
10899533|NCT02570503|12065577|FG001|NOT COMPLETED|Overall Study||0
10899536|NCT02553265|12065585|FG002|STARTED|Enrollment||6
10899537|NCT02553265|12065583|FG000|COMPLETED|Enrollment||9
10899538|NCT02553265|12065584|FG001|COMPLETED|Enrollment||7
10899539|NCT02553265|12065585|FG002|COMPLETED|Enrollment||5
10899540|NCT02553265|12065583|FG000|NOT COMPLETED|Enrollment||0
10899541|NCT02553265|12065584|FG001|NOT COMPLETED|Enrollment||0
10899542|NCT02553265|12065585|FG002|NOT COMPLETED|Enrollment||1
10899543|NCT02553265|12065583|FG000|STARTED|First Intervention (28 Days)||9
10899544|NCT02553265|12065584|FG001|STARTED|First Intervention (28 Days)||7
10899545|NCT02553265|12065585|FG002|STARTED|First Intervention (28 Days)||5
10899546|NCT02553265|12065583|FG000|COMPLETED|First Intervention (28 Days)||8
10899547|NCT02553265|12065584|FG001|COMPLETED|First Intervention (28 Days)||7
10899548|NCT02553265|12065585|FG002|COMPLETED|First Intervention (28 Days)||4
10899549|NCT02553265|12065583|FG000|NOT COMPLETED|First Intervention (28 Days)||1
10899550|NCT02553265|12065584|FG001|NOT COMPLETED|First Intervention (28 Days)||0
10899551|NCT02553265|12065585|FG002|NOT COMPLETED|First Intervention (28 Days)||1
10899552|NCT02553265|12065583|FG000|STARTED|Second Intervention (28 Days)||8
10899553|NCT02553265|12065584|FG001|STARTED|Second Intervention (28 Days)||7
10899554|NCT02553265|12065585|FG002|STARTED|Second Intervention (28 Days)||4
10899555|NCT02553265|12065583|FG000|COMPLETED|Second Intervention (28 Days)||7
10899556|NCT02553265|12065584|FG001|COMPLETED|Second Intervention (28 Days)||7
10899557|NCT02553265|12065585|FG002|COMPLETED|Second Intervention (28 Days)||4
10899558|NCT02553265|12065583|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
10899559|NCT02553265|12065584|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
10899560|NCT02553265|12065585|FG002|NOT COMPLETED|Second Intervention (28 Days)||0
10899561|NCT02553265|12065583|FG000|STARTED|Third Intervention (28 Days)||7
10899562|NCT02553265|12065584|FG001|STARTED|Third Intervention (28 Days)||7
10899563|NCT02553265|12065585|FG002|STARTED|Third Intervention (28 Days)||4
10899564|NCT02553265|12065583|FG000|COMPLETED|Third Intervention (28 Days)||6
10899565|NCT02553265|12065584|FG001|COMPLETED|Third Intervention (28 Days)||7
10899566|NCT02553265|12065585|FG002|COMPLETED|Third Intervention (28 Days)||3
10899567|NCT02553265|12065583|FG000|NOT COMPLETED|Third Intervention (28 Days)||1
10899568|NCT02553265|12065584|FG001|NOT COMPLETED|Third Intervention (28 Days)||0
10899569|NCT02553265|12065585|FG002|NOT COMPLETED|Third Intervention (28 Days)||1
10899570|NCT02550288|12065601|FG000|STARTED|Overall Study||35
10899571|NCT02550288|12065602|FG001|STARTED|Overall Study||68
10899572|NCT02550288|12065603|FG002|STARTED|Overall Study||69
10899573|NCT02550288|12065604|FG003|STARTED|Overall Study||68
10899574|NCT02550288|12065605|FG004|STARTED|Overall Study||69
10899575|NCT02550288|12065601|FG000|COMPLETED|Overall Study||33
10899576|NCT02550288|12065602|FG001|COMPLETED|Overall Study||65
10899577|NCT02550288|12065603|FG002|COMPLETED|Overall Study||68
10899578|NCT02550288|12065604|FG003|COMPLETED|Overall Study||65
10899579|NCT02550288|12065605|FG004|COMPLETED|Overall Study||66
10899580|NCT02550288|12065601|FG000|NOT COMPLETED|Overall Study||2
10899581|NCT02550288|12065602|FG001|NOT COMPLETED|Overall Study||3
10899582|NCT02550288|12065603|FG002|NOT COMPLETED|Overall Study||1
10899583|NCT02550288|12065604|FG003|NOT COMPLETED|Overall Study||3
10899584|NCT02550288|12065605|FG004|NOT COMPLETED|Overall Study||3
10899585|NCT02510040|12065620|FG000|STARTED|Overall Study||81
10899586|NCT02510040|12065621|FG001|STARTED|Overall Study||114
10899587|NCT02510040|12065622|FG002|STARTED|Overall Study||22
10899588|NCT02510040|12065620|FG000|COMPLETED|Overall Study||63
10899589|NCT02510040|12065621|FG001|COMPLETED|Overall Study||111
10899590|NCT02510040|12065622|FG002|COMPLETED|Overall Study||21
10899591|NCT02510040|12065620|FG000|NOT COMPLETED|Overall Study||18
10899592|NCT02510040|12065621|FG001|NOT COMPLETED|Overall Study||3
10899593|NCT02510040|12065622|FG002|NOT COMPLETED|Overall Study||1
10899594|NCT02463981|12065633|FG000|STARTED|Overall Study||21
10899595|NCT02463981|12065634|FG001|STARTED|Overall Study||16
10899596|NCT02463981|12065633|FG000|COMPLETED|Overall Study||18
10899597|NCT02463981|12065634|FG001|COMPLETED|Overall Study||14
10899598|NCT02463981|12065633|FG000|NOT COMPLETED|Overall Study||3
10899599|NCT02463981|12065634|FG001|NOT COMPLETED|Overall Study||2
10899600|NCT02460224|12065669|FG000|STARTED|Overall Study||17
10899601|NCT02460224|12065670|FG001|STARTED|Overall Study||12
10899602|NCT02460224|12065671|FG002|STARTED|Overall Study||6
10899603|NCT02460224|12065672|FG003|STARTED|Overall Study||6
10899604|NCT02460224|12065673|FG004|STARTED|Overall Study||6
10899605|NCT02460224|12065674|FG005|STARTED|Overall Study||30
10899606|NCT02460224|12065675|FG006|STARTED|Overall Study||30
10899607|NCT02460224|12065676|FG007|STARTED|Overall Study||5
10899608|NCT02460224|12065677|FG008|STARTED|Overall Study||6
10899609|NCT02460224|12065678|FG009|STARTED|Overall Study||11
10899610|NCT02460224|12065679|FG010|STARTED|Overall Study||5
10899611|NCT02460224|12065680|FG011|STARTED|Overall Study||6
10899612|NCT02460224|12065681|FG012|STARTED|Overall Study||6
10899613|NCT02460224|12065682|FG013|STARTED|Overall Study||6
10899614|NCT02460224|12065683|FG014|STARTED|Overall Study||5
10899615|NCT02460224|12065684|FG015|STARTED|Overall Study||6
10899616|NCT02460224|12065685|FG016|STARTED|Overall Study||20
10899617|NCT02460224|12065686|FG017|STARTED|Overall Study||6
10899618|NCT02460224|12065687|FG018|STARTED|Overall Study||12
10899619|NCT02460224|12065688|FG019|STARTED|Overall Study||7
10899620|NCT02460224|12065689|FG020|STARTED|Overall Study||6
10899621|NCT02460224|12065690|FG021|STARTED|Overall Study||12
10899622|NCT02460224|12065691|FG022|STARTED|Overall Study||6
10899623|NCT02460224|12065692|FG023|STARTED|Overall Study||11
10899624|NCT02460224|12065693|FG024|STARTED|Overall Study||6
10899625|NCT02460224|12065694|FG025|STARTED|Overall Study||6
10899626|NCT02460224|12065695|FG026|STARTED|Overall Study||121
10899627|NCT02460224|12065696|FG027|STARTED|Overall Study||21
10899628|NCT02460224|12065697|FG028|STARTED|Overall Study||93
10899629|NCT02460224|12065669|FG000|Rest of the World Patients in the Dose Escalation Part|Overall Study||13
10899630|NCT02460224|12065670|FG001|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
10899631|NCT02460224|12065671|FG002|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10899632|NCT02460224|12065672|FG003|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10899633|NCT02460224|12065673|FG004|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10899634|NCT02460224|12065674|FG005|Rest of the World Patients in the Dose Escalation Part|Overall Study||25
10899635|NCT02460224|12065675|FG006|Rest of the World Patients in the Dose Escalation Part|Overall Study||24
10899636|NCT02460224|12065676|FG007|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
10899637|NCT02460224|12065677|FG008|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10899638|NCT02460224|12065678|FG009|Rest of the World Patients in the Dose Escalation Part|Overall Study||11
10899639|NCT02460224|12065679|FG010|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
10899640|NCT02460224|12065680|FG011|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10899641|NCT02460224|12065681|FG012|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10899642|NCT02460224|12065682|FG013|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10899643|NCT02460224|12065683|FG014|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
10899644|NCT02460224|12065684|FG015|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10899645|NCT02460224|12065685|FG016|Rest of the World Patients in the Dose Escalation Part|Overall Study||20
10899646|NCT02460224|12065686|FG017|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10899647|NCT02460224|12065687|FG018|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
10899648|NCT02460224|12065688|FG019|Rest of the World Patients in the Dose Escalation Part|Overall Study||7
10899649|NCT02460224|12065689|FG020|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10899650|NCT02460224|12065690|FG021|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
10899651|NCT02460224|12065691|FG022|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10899652|NCT02460224|12065692|FG023|Rest of the World Patients in the Dose Escalation Part|Overall Study||11
10899653|NCT02460224|12065693|FG024|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10899654|NCT02460224|12065694|FG025|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
10899655|NCT02460224|12065695|FG026|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
10899656|NCT02460224|12065696|FG027|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
10899657|NCT02460224|12065697|FG028|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
10899658|NCT02460224|12065669|FG000|Japanese Patients in the Dose Escalation Part|Overall Study||4
10899659|NCT02460224|12065670|FG001|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899660|NCT02460224|12065671|FG002|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899661|NCT02460224|12065672|FG003|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899662|NCT02460224|12065673|FG004|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899663|NCT02460224|12065674|FG005|Japanese Patients in the Dose Escalation Part|Overall Study||5
10899664|NCT02460224|12065675|FG006|Japanese Patients in the Dose Escalation Part|Overall Study||6
10899665|NCT02460224|12065676|FG007|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899666|NCT02460224|12065677|FG008|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899667|NCT02460224|12065678|FG009|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899668|NCT02460224|12065679|FG010|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899669|NCT02460224|12065680|FG011|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899670|NCT02460224|12065681|FG012|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899671|NCT02460224|12065682|FG013|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899672|NCT02460224|12065683|FG014|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899673|NCT02460224|12065684|FG015|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899674|NCT02460224|12065685|FG016|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899675|NCT02460224|12065686|FG017|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899676|NCT02460224|12065687|FG018|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899677|NCT02460224|12065688|FG019|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899678|NCT02460224|12065689|FG020|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899679|NCT02460224|12065690|FG021|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899680|NCT02460224|12065691|FG022|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899681|NCT02460224|12065692|FG023|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899682|NCT02460224|12065693|FG024|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899683|NCT02460224|12065694|FG025|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899684|NCT02460224|12065695|FG026|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899685|NCT02460224|12065696|FG027|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899686|NCT02460224|12065697|FG028|Japanese Patients in the Dose Escalation Part|Overall Study||0
10899687|NCT02460224|12065669|FG000|COMPLETED|Overall Study||0
10899688|NCT02460224|12065670|FG001|COMPLETED|Overall Study||0
10899689|NCT02460224|12065671|FG002|COMPLETED|Overall Study||0
10899690|NCT02460224|12065672|FG003|COMPLETED|Overall Study||0
10899691|NCT02460224|12065673|FG004|COMPLETED|Overall Study||0
10899692|NCT02460224|12065674|FG005|COMPLETED|Overall Study||0
10899693|NCT02460224|12065675|FG006|COMPLETED|Overall Study||0
10899694|NCT02460224|12065676|FG007|COMPLETED|Overall Study||0
10899695|NCT02460224|12065677|FG008|COMPLETED|Overall Study||0
10899696|NCT02460224|12065678|FG009|COMPLETED|Overall Study||0
10899697|NCT02460224|12065679|FG010|COMPLETED|Overall Study||0
10899698|NCT02460224|12065680|FG011|COMPLETED|Overall Study||0
10899699|NCT02460224|12065681|FG012|COMPLETED|Overall Study||0
10899700|NCT02460224|12065682|FG013|COMPLETED|Overall Study||0
10899701|NCT02460224|12065683|FG014|COMPLETED|Overall Study||0
10899702|NCT02460224|12065684|FG015|COMPLETED|Overall Study||0
10899703|NCT02460224|12065685|FG016|COMPLETED|Overall Study||0
10899704|NCT02460224|12065686|FG017|COMPLETED|Overall Study||0
10899705|NCT02460224|12065687|FG018|COMPLETED|Overall Study||0
10899706|NCT02460224|12065688|FG019|COMPLETED|Overall Study||0
10899707|NCT02460224|12065689|FG020|COMPLETED|Overall Study||0
10899708|NCT02460224|12065690|FG021|COMPLETED|Overall Study||0
10899709|NCT02460224|12065691|FG022|COMPLETED|Overall Study||0
10899710|NCT02460224|12065692|FG023|COMPLETED|Overall Study||0
10899711|NCT02460224|12065693|FG024|COMPLETED|Overall Study||0
10899712|NCT02460224|12065694|FG025|COMPLETED|Overall Study||0
10899713|NCT02460224|12065695|FG026|COMPLETED|Overall Study||0
10899714|NCT02460224|12065696|FG027|COMPLETED|Overall Study||0
10899715|NCT02460224|12065697|FG028|COMPLETED|Overall Study||0
10899716|NCT02460224|12065669|FG000|NOT COMPLETED|Overall Study||17
10899717|NCT02460224|12065670|FG001|NOT COMPLETED|Overall Study||12
10899718|NCT02460224|12065671|FG002|NOT COMPLETED|Overall Study||6
10899719|NCT02460224|12065672|FG003|NOT COMPLETED|Overall Study||6
10899720|NCT02460224|12065673|FG004|NOT COMPLETED|Overall Study||6
10899721|NCT02460224|12065674|FG005|NOT COMPLETED|Overall Study||30
10899722|NCT02460224|12065675|FG006|NOT COMPLETED|Overall Study||30
10899723|NCT02460224|12065676|FG007|NOT COMPLETED|Overall Study||5
10899724|NCT02460224|12065677|FG008|NOT COMPLETED|Overall Study||6
10899725|NCT02460224|12065678|FG009|NOT COMPLETED|Overall Study||11
10899726|NCT02460224|12065679|FG010|NOT COMPLETED|Overall Study||5
10899727|NCT02460224|12065680|FG011|NOT COMPLETED|Overall Study||6
10899728|NCT02460224|12065681|FG012|NOT COMPLETED|Overall Study||6
10899729|NCT02460224|12065682|FG013|NOT COMPLETED|Overall Study||6
10899730|NCT02460224|12065683|FG014|NOT COMPLETED|Overall Study||5
10899731|NCT02460224|12065684|FG015|NOT COMPLETED|Overall Study||6
10899732|NCT02460224|12065685|FG016|NOT COMPLETED|Overall Study||20
10899733|NCT02460224|12065686|FG017|NOT COMPLETED|Overall Study||6
10899734|NCT02460224|12065687|FG018|NOT COMPLETED|Overall Study||12
10899735|NCT02460224|12065688|FG019|NOT COMPLETED|Overall Study||7
10899736|NCT02460224|12065689|FG020|NOT COMPLETED|Overall Study||6
10899737|NCT02460224|12065690|FG021|NOT COMPLETED|Overall Study||12
10899738|NCT02460224|12065691|FG022|NOT COMPLETED|Overall Study||6
10899739|NCT02460224|12065692|FG023|NOT COMPLETED|Overall Study||11
10899740|NCT02460224|12065693|FG024|NOT COMPLETED|Overall Study||6
10899741|NCT02460224|12065694|FG025|NOT COMPLETED|Overall Study||6
10899742|NCT02460224|12065695|FG026|NOT COMPLETED|Overall Study||121
10899743|NCT02460224|12065696|FG027|NOT COMPLETED|Overall Study||21
10899744|NCT02460224|12065697|FG028|NOT COMPLETED|Overall Study||93
10899745|NCT02460159|12065771|FG000|STARTED|Overall Study||117
10899746|NCT02460159|12065772|FG001|STARTED|Overall Study||18
10899747|NCT02460159|12065771|FG000|COMPLETED|Overall Study||111
10899748|NCT02460159|12065772|FG001|COMPLETED|Overall Study||17
10899749|NCT02460159|12065771|FG000|NOT COMPLETED|Overall Study||6
10899750|NCT02460159|12065772|FG001|NOT COMPLETED|Overall Study||1
10899751|NCT02320396|12065780|FG000|STARTED|Overall Study||224
10899752|NCT02320396|12065781|FG001|STARTED|Overall Study||225
10899753|NCT02320396|12065780|FG000|Treated (Full Analysis Set)|Overall Study||223
10899754|NCT02320396|12065781|FG001|Treated (Full Analysis Set)|Overall Study||225
10899755|NCT02320396|12065780|FG000|COMPLETED|Overall Study||220
10899756|NCT02320396|12065781|FG001|COMPLETED|Overall Study||221
10899757|NCT02320396|12065780|FG000|NOT COMPLETED|Overall Study||4
10899758|NCT02320396|12065781|FG001|NOT COMPLETED|Overall Study||4
10899759|NCT02230410|12065787|FG000|STARTED|Overall Study||18
10899760|NCT02230410|12065787|FG000|COMPLETED|Overall Study||15
10899761|NCT02230410|12065787|FG000|NOT COMPLETED|Overall Study||3
10899762|NCT02053246|12065791|FG000|STARTED|Overall Study||11
10899763|NCT02053246|12065791|FG000|COMPLETED|Overall Study||7
10899764|NCT02053246|12065791|FG000|NOT COMPLETED|Overall Study||4
10899765|NCT01980940|12065803|FG000|STARTED|Overall Study||5
10899766|NCT01980940|12065804|FG001|STARTED|Overall Study||5
10899767|NCT01980940|12065805|FG002|STARTED|Overall Study||5
10899768|NCT01980940|12065806|FG003|STARTED|Overall Study||3
10899769|NCT01980940|12065807|FG004|STARTED|Overall Study||2
10899770|NCT01980940|12065808|FG005|STARTED|Overall Study||2
10899771|NCT01980940|12065809|FG006|STARTED|Overall Study||24
10899772|NCT01980940|12065810|FG007|STARTED|Overall Study||24
10899773|NCT01980940|12065803|FG000|Treated|Overall Study||5
10899774|NCT01980940|12065804|FG001|Treated|Overall Study||5
10899775|NCT01980940|12065805|FG002|Treated|Overall Study||5
10899776|NCT01980940|12065806|FG003|Treated|Overall Study||3
10899777|NCT01980940|12065807|FG004|Treated|Overall Study||2
10899778|NCT01980940|12065808|FG005|Treated|Overall Study||2
10899779|NCT01980940|12065809|FG006|Treated|Overall Study||24
10899780|NCT01980940|12065810|FG007|Treated|Overall Study||24
10899781|NCT01980940|12065803|FG000|COMPLETED|Overall Study||5
10899782|NCT01980940|12065804|FG001|COMPLETED|Overall Study||5
10899783|NCT01980940|12065805|FG002|COMPLETED|Overall Study||5
10899784|NCT01980940|12065806|FG003|COMPLETED|Overall Study||3
10899785|NCT01980940|12065807|FG004|COMPLETED|Overall Study||2
10899786|NCT01980940|12065808|FG005|COMPLETED|Overall Study||0
10899787|NCT01980940|12065809|FG006|COMPLETED|Overall Study||24
10899788|NCT01980940|12065810|FG007|COMPLETED|Overall Study||24
10899789|NCT01980940|12065803|FG000|NOT COMPLETED|Overall Study||0
10899790|NCT01980940|12065804|FG001|NOT COMPLETED|Overall Study||0
10899791|NCT01980940|12065805|FG002|NOT COMPLETED|Overall Study||0
10899792|NCT01980940|12065806|FG003|NOT COMPLETED|Overall Study||0
10899793|NCT01980940|12065807|FG004|NOT COMPLETED|Overall Study||0
10899794|NCT01980940|12065808|FG005|NOT COMPLETED|Overall Study||2
10899795|NCT01980940|12065809|FG006|NOT COMPLETED|Overall Study||0
10899796|NCT01980940|12065810|FG007|NOT COMPLETED|Overall Study||0
10899797|NCT01923298|12065834|FG000|STARTED|Overall Study||14
10899798|NCT01923298|12065834|FG000|COMPLETED|Overall Study||14
10899799|NCT01923298|12065834|FG000|NOT COMPLETED|Overall Study||0
10899800|NCT01918033|12065841|FG000|STARTED|Overall Study||203
10899801|NCT01918033|12065842|FG001|STARTED|Overall Study||203
10899802|NCT01918033|12065843|FG002|STARTED|Overall Study||202
10899803|NCT01918033|12065841|FG000|Treated|Overall Study|One randomized participant did not receive study drug.|202
10899804|NCT01918033|12065842|FG001|Treated|Overall Study||203
10899805|NCT01918033|12065843|FG002|Treated|Overall Study|One randomized participant did not receive study drug.|201
10899806|NCT01918033|12065841|FG000|COMPLETED|Overall Study||198
10899807|NCT01918033|12065842|FG001|COMPLETED|Overall Study||201
10899808|NCT01918033|12065843|FG002|COMPLETED|Overall Study||199
10899809|NCT01918033|12065841|FG000|NOT COMPLETED|Overall Study||5
10899810|NCT01918033|12065842|FG001|NOT COMPLETED|Overall Study||2
10899811|NCT01918033|12065843|FG002|NOT COMPLETED|Overall Study||3
10899812|NCT01916980|12065853|FG000|STARTED|Overall Study||65
10899813|NCT01916980|12065854|FG001|STARTED|Overall Study||29
10899814|NCT01916980|12065853|FG000|COMPLETED|Overall Study||58
10899815|NCT01916980|12065854|FG001|COMPLETED|Overall Study||25
10899816|NCT01916980|12065853|FG000|NOT COMPLETED|Overall Study||7
10899817|NCT01916980|12065854|FG001|NOT COMPLETED|Overall Study||4
10899818|NCT01916967|12065863|FG000|STARTED|Overall Study||80
10899819|NCT01916967|12065864|FG001|STARTED|Overall Study||79
10899820|NCT01916967|12065865|FG002|STARTED|Overall Study||80
10899821|NCT01916967|12065863|FG000|COMPLETED|Overall Study||80
10899822|NCT01916967|12065864|FG001|COMPLETED|Overall Study||78
10899823|NCT01916967|12065865|FG002|COMPLETED|Overall Study||71
10899824|NCT01916967|12065863|FG000|NOT COMPLETED|Overall Study||0
10899825|NCT01916967|12065864|FG001|NOT COMPLETED|Overall Study||1
10899826|NCT01916967|12065865|FG002|NOT COMPLETED|Overall Study||9
10899827|NCT01893320|12065877|FG000|STARTED|Overall Study||7
10899828|NCT01893320|12065878|FG001|STARTED|Overall Study||59
10899829|NCT01893320|12065877|FG000|COMPLETED|Overall Study||7
10899830|NCT01893320|12065878|FG001|COMPLETED|Overall Study||59
10899831|NCT01893320|12065877|FG000|NOT COMPLETED|Overall Study||0
10899832|NCT01893320|12065878|FG001|NOT COMPLETED|Overall Study||0
10899833|NCT01870401|12065886|FG000|STARTED|Overall Study||287
10899834|NCT01870401|12065887|FG001|STARTED|Overall Study||155
10899835|NCT01870401|12065886|FG000|COMPLETED|Overall Study||137
10899836|NCT01870401|12065887|FG001|COMPLETED|Overall Study||59
10899837|NCT01870401|12065886|FG000|NOT COMPLETED|Overall Study||150
10899838|NCT01870401|12065887|FG001|NOT COMPLETED|Overall Study||96
10899839|NCT01867606|12065897|FG000|STARTED|Overall Study||26
10899840|NCT01867606|12065898|FG001|STARTED|Overall Study||32
10899841|NCT01867606|12065897|FG000|COMPLETED|Overall Study||16
10899842|NCT01867606|12065898|FG001|COMPLETED|Overall Study||17
10899843|NCT01867606|12065897|FG000|NOT COMPLETED|Overall Study||10
10899844|NCT01867606|12065898|FG001|NOT COMPLETED|Overall Study||15
10899845|NCT01857063|12065912|FG000|STARTED|Period 1 (7 Days)||110
10899846|NCT01857063|12065913|FG001|STARTED|Period 1 (7 Days)||110
10899847|NCT01857063|12065912|FG000|COMPLETED|Period 1 (7 Days)||108
10899848|NCT01857063|12065913|FG001|COMPLETED|Period 1 (7 Days)||106
10899849|NCT01857063|12065912|FG000|NOT COMPLETED|Period 1 (7 Days)||2
10899850|NCT01857063|12065913|FG001|NOT COMPLETED|Period 1 (7 Days)||4
10899851|NCT01857063|12065912|FG000|STARTED|Period 2 (7 Days)||108
10899852|NCT01857063|12065913|FG001|STARTED|Period 2 (7 Days)||106
10899853|NCT01857063|12065912|FG000|COMPLETED|Period 2 (7 Days)||104
10899854|NCT01857063|12065913|FG001|COMPLETED|Period 2 (7 Days)||104
10899855|NCT01857063|12065912|FG000|NOT COMPLETED|Period 2 (7 Days)||4
10899856|NCT01857063|12065913|FG001|NOT COMPLETED|Period 2 (7 Days)||2
10899857|NCT01854268|12065919|FG000|STARTED|Overall Study||25
10899858|NCT01854268|12065919|FG000|COMPLETED|Overall Study||25
10899859|NCT01854268|12065919|FG000|NOT COMPLETED|Overall Study||0
10899860|NCT01852812|12065926|FG000|STARTED|Overall Study||51
10899861|NCT01852812|12065927|FG001|STARTED|Overall Study||18
10899862|NCT01852812|12065928|FG002|STARTED|Overall Study||18
10899863|NCT01852812|12065926|FG000|COMPLETED|Overall Study||51
10899864|NCT01852812|12065927|FG001|COMPLETED|Overall Study||17
10899865|NCT01852812|12065928|FG002|COMPLETED|Overall Study||17
10899866|NCT01852812|12065926|FG000|NOT COMPLETED|Overall Study||0
10899867|NCT01852812|12065927|FG001|NOT COMPLETED|Overall Study||1
10899868|NCT01852812|12065928|FG002|NOT COMPLETED|Overall Study||1
10899869|NCT01828021|12065936|FG000|STARTED|Overall Study||25
10899870|NCT01828021|12065936|FG000|COMPLETED|Overall Study||0
10899871|NCT01828021|12065936|FG000|NOT COMPLETED|Overall Study||25
10899872|NCT01709318|12065947|FG000|STARTED|Overall Study||82
10899873|NCT01709318|12065948|FG001|STARTED|Overall Study||85
10899874|NCT01709318|12065949|FG002|STARTED|Overall Study||77
10899875|NCT01709318|12065950|FG003|STARTED|Overall Study||78
10899876|NCT01709318|12065951|FG004|STARTED|Overall Study||78
10899877|NCT01709318|12065952|FG005|STARTED|Overall Study||84
10899878|NCT01709318|12065953|FG006|STARTED|Overall Study||182
10899879|NCT01709318|12065947|FG000|Treated|Overall Study||79
10899880|NCT01709318|12065948|FG001|Treated|Overall Study||85
10899881|NCT01709318|12065949|FG002|Treated|Overall Study||78
10899882|NCT01709318|12065950|FG003|Treated|Overall Study||77
10899883|NCT01709318|12065951|FG004|Treated|Overall Study||77
10899884|NCT01709318|12065952|FG005|Treated|Overall Study||86
10899885|NCT01709318|12065953|FG006|Treated|Overall Study||178
10899886|NCT01709318|12065947|FG000|COMPLETED|Overall Study||73
10899887|NCT01709318|12065948|FG001|COMPLETED|Overall Study||78
10899888|NCT01709318|12065949|FG002|COMPLETED|Overall Study||71
10899889|NCT01709318|12065950|FG003|COMPLETED|Overall Study||72
10899890|NCT01709318|12065951|FG004|COMPLETED|Overall Study||74
10899891|NCT01709318|12065952|FG005|COMPLETED|Overall Study||80
10899892|NCT01709318|12065953|FG006|COMPLETED|Overall Study||171
10899893|NCT01709318|12065947|FG000|NOT COMPLETED|Overall Study||9
10899894|NCT01709318|12065948|FG001|NOT COMPLETED|Overall Study||7
10899895|NCT01709318|12065949|FG002|NOT COMPLETED|Overall Study||6
10899896|NCT01709318|12065950|FG003|NOT COMPLETED|Overall Study||6
10899897|NCT01709318|12065951|FG004|NOT COMPLETED|Overall Study||4
10899898|NCT01709318|12065952|FG005|NOT COMPLETED|Overall Study||4
10899899|NCT01709318|12065953|FG006|NOT COMPLETED|Overall Study||11
10899900|NCT01698918|12065969|FG000|STARTED|First Line Treatment (Core+Extension)||202
10899901|NCT01698918|12065969|FG000|Dexamethasone Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||11
10899902|NCT01698918|12065969|FG000|Standard of Care Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||13
10899903|NCT01698918|12065969|FG000|COMPLETED|First Line Treatment (Core+Extension)||29
10899904|NCT01698918|12065969|FG000|NOT COMPLETED|First Line Treatment (Core+Extension)||173
10899905|NCT01698918|12065969|FG000|STARTED|Second Line Treatment (Core+Extension)||53
10899906|NCT01698918|12065969|FG000|COMPLETED|Second Line Treatment (Core+Extension)||7
10899907|NCT01698918|12065969|FG000|NOT COMPLETED|Second Line Treatment (Core+Extension)||46
10899908|NCT01673620|12065983|FG000|STARTED|Overall Study||47
10899909|NCT01673620|12065984|FG001|STARTED|Overall Study||22
10899910|NCT01673620|12065983|FG000|COMPLETED|Overall Study||46
10899911|NCT01673620|12065984|FG001|COMPLETED|Overall Study||22
10899912|NCT01673620|12065983|FG000|NOT COMPLETED|Overall Study||1
10899913|NCT01673620|12065984|FG001|NOT COMPLETED|Overall Study||0
10899914|NCT01660243|12065994|FG000|STARTED|Overall Study||10
10899915|NCT01660243|12065995|FG001|STARTED|Overall Study||13
10899916|NCT01660243|12065996|FG002|STARTED|Overall Study||11
10899917|NCT01660243|12065997|FG003|STARTED|Overall Study||11
10899918|NCT01660243|12065994|FG000|COMPLETED|Overall Study||8
10899919|NCT01660243|12065995|FG001|COMPLETED|Overall Study||13
10899920|NCT01660243|12065996|FG002|COMPLETED|Overall Study||9
10899921|NCT01660243|12065997|FG003|COMPLETED|Overall Study||10
10899922|NCT01660243|12065994|FG000|NOT COMPLETED|Overall Study||2
10899923|NCT01660243|12065995|FG001|NOT COMPLETED|Overall Study||0
10899924|NCT01660243|12065996|FG002|NOT COMPLETED|Overall Study||2
10899925|NCT01660243|12065997|FG003|NOT COMPLETED|Overall Study||1
10899926|NCT01617187|12066011|FG000|STARTED|Randomization Through Start Treatment|Randomized|98
10899927|NCT01617187|12066012|FG001|STARTED|Randomization Through Start Treatment|Randomized|113
10899928|NCT01617187|12066013|FG002|STARTED|Randomization Through Start Treatment|Randomized|46
10899929|NCT01617187|12066014|FG003|STARTED|Randomization Through Start Treatment|Randomized|103
10899930|NCT01617187|12066011|FG000|COMPLETED|Randomization Through Start Treatment||97
10899931|NCT01617187|12066012|FG001|COMPLETED|Randomization Through Start Treatment||113
10899932|NCT01617187|12066013|FG002|COMPLETED|Randomization Through Start Treatment||46
10899933|NCT01617187|12066014|FG003|COMPLETED|Randomization Through Start Treatment||101
10899934|NCT01617187|12066011|FG000|NOT COMPLETED|Randomization Through Start Treatment||1
10899935|NCT01617187|12066012|FG001|NOT COMPLETED|Randomization Through Start Treatment||0
10899936|NCT01617187|12066013|FG002|NOT COMPLETED|Randomization Through Start Treatment||0
10899937|NCT01617187|12066014|FG003|NOT COMPLETED|Randomization Through Start Treatment||2
10899938|NCT01617187|12066011|FG000|STARTED|Treatment Through Study Completion|Treated|97
10899939|NCT01617187|12066012|FG001|STARTED|Treatment Through Study Completion|Treated|113
10899940|NCT01617187|12066013|FG002|STARTED|Treatment Through Study Completion|Treated|46
10899941|NCT01617187|12066014|FG003|STARTED|Treatment Through Study Completion|Treated|101
10899942|NCT01617187|12066011|FG000|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
10899943|NCT01617187|12066012|FG001|COMPLETED|Treatment Through Study Completion||102
10899944|NCT01617187|12066013|FG002|COMPLETED|Treatment Through Study Completion||41
10899945|NCT01617187|12066014|FG003|COMPLETED|Treatment Through Study Completion||91
10899946|NCT01617187|12066011|FG000|NOT COMPLETED|Treatment Through Study Completion||11
10899947|NCT01617187|12066012|FG001|NOT COMPLETED|Treatment Through Study Completion||11
10899948|NCT01617187|12066013|FG002|NOT COMPLETED|Treatment Through Study Completion||5
10899949|NCT01617187|12066014|FG003|NOT COMPLETED|Treatment Through Study Completion||10
10899950|NCT01611883|12066026|FG000|STARTED|Overall Study||75
10899951|NCT01611883|12066027|FG001|STARTED|Overall Study||77
10899952|NCT01611883|12066026|FG000|COMPLETED|Overall Study||74
10899953|NCT01611883|12066027|FG001|COMPLETED|Overall Study||76
10899954|NCT01611883|12066026|FG000|NOT COMPLETED|Overall Study||1
10899955|NCT01611883|12066027|FG001|NOT COMPLETED|Overall Study||1
10899956|NCT01572675|12066035|FG000|STARTED|Overall Study||268
10899957|NCT01572675|12066036|FG001|STARTED|Overall Study||279
10899958|NCT01572675|12066035|FG000|COMPLETED|Overall Study||31
10899959|NCT01572675|12066036|FG001|COMPLETED|Overall Study||56
10899960|NCT01572675|12066035|FG000|NOT COMPLETED|Overall Study||237
10899961|NCT01572675|12066036|FG001|NOT COMPLETED|Overall Study||223
10899962|NCT01554163|12066057|FG000|STARTED|Overall Study||120
10899963|NCT01554163|12066058|FG001|STARTED|Overall Study||119
10899964|NCT01554163|12066057|FG000|Number Treated|Overall Study||119
10899965|NCT01554163|12066058|FG001|Number Treated|Overall Study||119
10899966|NCT01554163|12066057|FG000|COMPLETED|Overall Study||112
10899967|NCT01554163|12066058|FG001|COMPLETED|Overall Study||109
10899968|NCT01554163|12066057|FG000|NOT COMPLETED|Overall Study||8
10899969|NCT01554163|12066058|FG001|NOT COMPLETED|Overall Study||10
10899970|NCT01502371|12066069|FG000|STARTED|Overall Study||120
10899971|NCT01502371|12066070|FG001|STARTED|Overall Study||113
10899972|NCT01502371|12066071|FG002|STARTED|Overall Study||108
10899973|NCT01502371|12066072|FG003|STARTED|Overall Study||125
10899974|NCT01502371|12066073|FG004|STARTED|Overall Study||112
10899975|NCT01502371|12066069|FG000|COMPLETED|Overall Study||79
10899976|NCT01502371|12066070|FG001|COMPLETED|Overall Study||81
10899977|NCT01502371|12066071|FG002|COMPLETED|Overall Study||83
10899978|NCT01502371|12066072|FG003|COMPLETED|Overall Study||88
10899979|NCT01502371|12066073|FG004|COMPLETED|Overall Study||60
10899980|NCT01502371|12066069|FG000|NOT COMPLETED|Overall Study||41
10899981|NCT01502371|12066070|FG001|NOT COMPLETED|Overall Study||32
10899982|NCT01502371|12066071|FG002|NOT COMPLETED|Overall Study||25
10899983|NCT01502371|12066072|FG003|NOT COMPLETED|Overall Study||37
10899984|NCT01502371|12066073|FG004|NOT COMPLETED|Overall Study||52
10899985|NCT01490190|12066086|FG000|STARTED|Overall Study||252
10899986|NCT01490190|12066086|FG000|COMPLETED|Overall Study||204
10899987|NCT01490190|12066086|FG000|NOT COMPLETED|Overall Study||48
10899988|NCT01471340|12066092|FG000|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
10899989|NCT01471340|12066093|FG001|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
10899990|NCT01471340|12066092|FG000|COMPLETED|Overall Study||5862
10899991|NCT01471340|12066093|FG001|COMPLETED|Overall Study||5855
10899992|NCT01471340|12066092|FG000|NOT COMPLETED|Overall Study||6
10899993|NCT01471340|12066093|FG001|NOT COMPLETED|Overall Study||6
10899994|NCT01462370|12066099|FG000|STARTED|Overall Study||69
10899995|NCT01462370|12066100|FG001|STARTED|Overall Study||70
10899996|NCT01462370|12066099|FG000|COMPLETED|Overall Study||68
10899997|NCT01462370|12066100|FG001|COMPLETED|Overall Study||65
10899998|NCT01462370|12066099|FG000|NOT COMPLETED|Overall Study||1
10899999|NCT01462370|12066100|FG001|NOT COMPLETED|Overall Study||5
10900000|NCT01436253|12066106|FG000|STARTED|Overall Study||2196
10900001|NCT01436253|12066106|FG000|COMPLETED|Overall Study||1897
10900002|NCT01436253|12066106|FG000|NOT COMPLETED|Overall Study||299
10900003|NCT01414192|12066114|FG000|STARTED|Overall Study||490
10900004|NCT01414192|12066115|FG001|STARTED|Overall Study||575
10900005|NCT01414192|12066116|FG002|STARTED|Overall Study||424
10900006|NCT01414192|12066117|FG003|STARTED|Overall Study||1726
10900007|NCT01414192|12066114|FG000|COMPLETED|Overall Study||490
10900008|NCT01414192|12066115|FG001|COMPLETED|Overall Study||575
10900009|NCT01414192|12066116|FG002|COMPLETED|Overall Study||424
10900010|NCT01414192|12066117|FG003|COMPLETED|Overall Study||1726
10900011|NCT01414192|12066114|FG000|NOT COMPLETED|Overall Study||0
10900012|NCT01414192|12066115|FG001|NOT COMPLETED|Overall Study||0
10900013|NCT01414192|12066116|FG002|NOT COMPLETED|Overall Study||0
10900014|NCT01414192|12066117|FG003|NOT COMPLETED|Overall Study||0
10900015|NCT01390415|12066133|FG000|STARTED|Overall Study||99
10900016|NCT01390415|12066134|FG001|STARTED|Overall Study||37
10900017|NCT01390415|12066133|FG000|COMPLETED|Overall Study||99
10900018|NCT01390415|12066134|FG001|COMPLETED|Overall Study||37
10900019|NCT01390415|12066133|FG000|NOT COMPLETED|Overall Study||0
10900020|NCT01390415|12066134|FG001|NOT COMPLETED|Overall Study||0
10900021|NCT01381679|12066140|FG000|STARTED|Overall Study||1682
10900022|NCT01381679|12066140|FG000|COMPLETED|Overall Study||794
10900023|NCT01381679|12066140|FG000|NOT COMPLETED|Overall Study||888
10900024|NCT01370603|12066146|FG000|STARTED|Period 1||164
10900025|NCT01370603|12066147|FG001|STARTED|Period 1||164
10900026|NCT01370603|12066146|FG000|COMPLETED|Period 1||150
10900027|NCT01370603|12066147|FG001|COMPLETED|Period 1||154
10900028|NCT01370603|12066146|FG000|NOT COMPLETED|Period 1||14
10900029|NCT01370603|12066147|FG001|NOT COMPLETED|Period 1||10
10900030|NCT01370603|12066146|FG000|STARTED|Crossover Washout||150
10900031|NCT01370603|12066147|FG001|STARTED|Crossover Washout||154
10900032|NCT01370603|12066146|FG000|COMPLETED|Crossover Washout||141
10900033|NCT01370603|12066147|FG001|COMPLETED|Crossover Washout||150
10900034|NCT01370603|12066146|FG000|NOT COMPLETED|Crossover Washout||9
10900035|NCT01370603|12066147|FG001|NOT COMPLETED|Crossover Washout||4
10900036|NCT01370603|12066146|FG000|STARTED|Period 2||141
10900037|NCT01370603|12066147|FG001|STARTED|Period 2||150
10900038|NCT01370603|12066146|FG000|COMPLETED|Period 2||138
10900039|NCT01370603|12066147|FG001|COMPLETED|Period 2||146
10900040|NCT01370603|12066146|FG000|NOT COMPLETED|Period 2||3
10900041|NCT01370603|12066147|FG001|NOT COMPLETED|Period 2||4
10900042|NCT01370590|12066155|FG000|STARTED|Period 1||203
10900043|NCT01370590|12066156|FG001|STARTED|Period 1||203
10900044|NCT01370590|12066155|FG000|COMPLETED|Period 1||187
10900045|NCT01370590|12066156|FG001|COMPLETED|Period 1||192
10900046|NCT01370590|12066155|FG000|NOT COMPLETED|Period 1||16
10900047|NCT01370590|12066156|FG001|NOT COMPLETED|Period 1||11
10900048|NCT01370590|12066155|FG000|STARTED|Crossover Washout Period||187
10900049|NCT01370590|12066156|FG001|STARTED|Crossover Washout Period||192
10900050|NCT01370590|12066155|FG000|COMPLETED|Crossover Washout Period||181
10900051|NCT01370590|12066156|FG001|COMPLETED|Crossover Washout Period||186
10900052|NCT01370590|12066155|FG000|NOT COMPLETED|Crossover Washout Period||6
10900053|NCT01370590|12066156|FG001|NOT COMPLETED|Crossover Washout Period||6
10900054|NCT01370590|12066155|FG000|STARTED|Period 2||181
10900055|NCT01370590|12066156|FG001|STARTED|Period 2||186
10900056|NCT01370590|12066155|FG000|COMPLETED|Period 2||180
10900057|NCT01370590|12066156|FG001|COMPLETED|Period 2||184
10900058|NCT01370590|12066155|FG000|NOT COMPLETED|Period 2||1
10900059|NCT01370590|12066156|FG001|NOT COMPLETED|Period 2||2
10900060|NCT01368185|12066162|FG000|STARTED|Overall Study||1705
10900061|NCT01368185|12066162|FG000|COMPLETED|Overall Study||1705
10900062|NCT01368185|12066162|FG000|NOT COMPLETED|Overall Study||0
10900063|NCT01349907|12066168|FG000|STARTED|Overall Study|Enrolled and Treated|241
10900064|NCT01349907|12066169|FG001|STARTED|Overall Study|Enrolled and Treated|81
10900065|NCT01349907|12066168|FG000|COMPLETED|Overall Study||102
10900066|NCT01349907|12066169|FG001|COMPLETED|Overall Study||38
10900067|NCT01349907|12066168|FG000|NOT COMPLETED|Overall Study||139
10900068|NCT01349907|12066169|FG001|NOT COMPLETED|Overall Study||43
10900069|NCT01345786|12066179|FG000|STARTED|Overall Study|Number randomized|41
10900070|NCT01345786|12066180|FG001|STARTED|Overall Study|Number randomized|41
10900071|NCT01345786|12066181|FG002|STARTED|Overall Study|Number randomized|38
10900072|NCT01345786|12066182|FG003|STARTED|Overall Study|Number randomized|38
10900073|NCT01345786|12066179|FG000|Treated|Overall Study||41
10900074|NCT01345786|12066180|FG001|Treated|Overall Study||41
10900075|NCT01345786|12066181|FG002|Treated|Overall Study||37
10900076|NCT01345786|12066182|FG003|Treated|Overall Study||37
10900077|NCT01345786|12066179|FG000|COMPLETED|Overall Study||35
10900078|NCT01345786|12066180|FG001|COMPLETED|Overall Study||33
10900079|NCT01345786|12066181|FG002|COMPLETED|Overall Study||33
10900080|NCT01345786|12066182|FG003|COMPLETED|Overall Study||35
10900081|NCT01345786|12066179|FG000|NOT COMPLETED|Overall Study||6
10900082|NCT01345786|12066180|FG001|NOT COMPLETED|Overall Study||8
10900083|NCT01345786|12066181|FG002|NOT COMPLETED|Overall Study||5
10900084|NCT01345786|12066182|FG003|NOT COMPLETED|Overall Study||3
10900085|NCT01306929|12066192|FG000|STARTED|Overall Study||134
10900086|NCT01306929|12066192|FG000|COMPLETED|Overall Study||40
10900087|NCT01306929|12066192|FG000|NOT COMPLETED|Overall Study||94
10900088|NCT01294696|12066198|FG000|STARTED|Overall Study||1261
10900089|NCT01294696|12066198|FG000|COMPLETED|Overall Study||1187
10900090|NCT01294696|12066198|FG000|NOT COMPLETED|Overall Study||74
10900091|NCT01277822|12066205|FG000|STARTED|Overall Study||168
10900092|NCT01277822|12066206|FG001|STARTED|Overall Study||166
10900093|NCT01277822|12066205|FG000|COMPLETED|Overall Study||153
10900094|NCT01277822|12066206|FG001|COMPLETED|Overall Study||155
10900095|NCT01277822|12066205|FG000|NOT COMPLETED|Overall Study||15
10900096|NCT01277822|12066206|FG001|NOT COMPLETED|Overall Study||11
10900097|NCT01244763|12066218|FG000|STARTED|Overall Study||24
10900098|NCT01244763|12066219|FG001|STARTED|Overall Study||24
10900099|NCT01244763|12066220|FG002|STARTED|Overall Study||24
10900100|NCT01244763|12066221|FG003|STARTED|Overall Study||24
10900101|NCT01244763|12066222|FG004|STARTED|Overall Study||24
10900102|NCT01244763|12066223|FG005|STARTED|Overall Study||25
10900103|NCT01244763|12066218|FG000|Safety Population|Overall Study||24
10900104|NCT01244763|12066219|FG001|Safety Population|Overall Study||24
10900105|NCT01244763|12066220|FG002|Safety Population|Overall Study||24
10900106|NCT01244763|12066221|FG003|Safety Population|Overall Study||24
10900107|NCT01244763|12066222|FG004|Safety Population|Overall Study||24
10900108|NCT01244763|12066223|FG005|Safety Population|Overall Study||25
10900109|NCT01244763|12066218|FG000|Efficacy Evaluable (EE) Population|Overall Study||23
10900110|NCT01244763|12066219|FG001|Efficacy Evaluable (EE) Population|Overall Study||24
10900111|NCT01244763|12066220|FG002|Efficacy Evaluable (EE) Population|Overall Study||23
10900112|NCT01244763|12066221|FG003|Efficacy Evaluable (EE) Population|Overall Study||24
10900113|NCT01244763|12066222|FG004|Efficacy Evaluable (EE) Population|Overall Study||24
10900114|NCT01244763|12066223|FG005|Efficacy Evaluable (EE) Population|Overall Study||25
10900115|NCT01244763|12066218|FG000|COMPLETED|Overall Study||21
10900116|NCT01244763|12066219|FG001|COMPLETED|Overall Study||21
10900117|NCT01244763|12066220|FG002|COMPLETED|Overall Study||22
10900118|NCT01244763|12066221|FG003|COMPLETED|Overall Study||23
10900119|NCT01244763|12066222|FG004|COMPLETED|Overall Study||21
10900120|NCT01244763|12066223|FG005|COMPLETED|Overall Study||21
10900121|NCT01244763|12066218|FG000|NOT COMPLETED|Overall Study||3
10900122|NCT01244763|12066219|FG001|NOT COMPLETED|Overall Study||3
10900123|NCT01244763|12066220|FG002|NOT COMPLETED|Overall Study||2
10900124|NCT01244763|12066221|FG003|NOT COMPLETED|Overall Study||1
10900125|NCT01244763|12066222|FG004|NOT COMPLETED|Overall Study||3
10900126|NCT01244763|12066223|FG005|NOT COMPLETED|Overall Study||4
10900127|NCT01208207|12066240|FG000|STARTED|Part I||702
10900128|NCT01208207|12066241|FG001|STARTED|Part I||156
10900129|NCT01208207|12066242|FG002|STARTED|Part I||157
10900130|NCT01208207|12066243|FG003|STARTED|Part I||0
10900131|NCT01208207|12066244|FG004|STARTED|Part I||0
10900132|NCT01208207|12066245|FG005|STARTED|Part I||0
10900133|NCT01208207|12066246|FG006|STARTED|Part I||0
10900134|NCT01208207|12066240|FG000|COMPLETED|Part I||632
10900135|NCT01208207|12066241|FG001|COMPLETED|Part I||145
10900136|NCT01208207|12066242|FG002|COMPLETED|Part I||142
10900137|NCT01208207|12066243|FG003|COMPLETED|Part I||0
10900138|NCT01208207|12066244|FG004|COMPLETED|Part I||0
10900139|NCT01208207|12066245|FG005|COMPLETED|Part I||0
10900140|NCT01208207|12066246|FG006|COMPLETED|Part I||0
10900141|NCT01208207|12066240|FG000|NOT COMPLETED|Part I||70
10900142|NCT01208207|12066241|FG001|NOT COMPLETED|Part I||11
10900143|NCT01208207|12066242|FG002|NOT COMPLETED|Part I||15
10900144|NCT01208207|12066243|FG003|NOT COMPLETED|Part I||0
10900145|NCT01208207|12066244|FG004|NOT COMPLETED|Part I||0
10900146|NCT01208207|12066245|FG005|NOT COMPLETED|Part I||0
10900147|NCT01208207|12066246|FG006|NOT COMPLETED|Part I||0
10900148|NCT01208207|12066240|FG000|STARTED|Part II||0
10900149|NCT01208207|12066241|FG001|STARTED|Part II||0
10900150|NCT01208207|12066242|FG002|STARTED|Part II||0
10900151|NCT01208207|12066243|FG003|STARTED|Part II||314
10900152|NCT01208207|12066244|FG004|STARTED|Part II||318
10900153|NCT01208207|12066245|FG005|STARTED|Part II||145
10900154|NCT01208207|12066246|FG006|STARTED|Part II||142
10900155|NCT01208207|12066240|FG000|COMPLETED|Part II||0
10900156|NCT01208207|12066241|FG001|COMPLETED|Part II||0
10900157|NCT01208207|12066242|FG002|COMPLETED|Part II||0
10900158|NCT01208207|12066243|FG003|COMPLETED|Part II||282
10900159|NCT01208207|12066244|FG004|COMPLETED|Part II||295
10900160|NCT01208207|12066245|FG005|COMPLETED|Part II||129
10900161|NCT01208207|12066246|FG006|COMPLETED|Part II||131
10900162|NCT01208207|12066240|FG000|NOT COMPLETED|Part II||0
10900163|NCT01208207|12066241|FG001|NOT COMPLETED|Part II||0
10900164|NCT01208207|12066242|FG002|NOT COMPLETED|Part II||0
10900165|NCT01208207|12066243|FG003|NOT COMPLETED|Part II||32
10900166|NCT01208207|12066244|FG004|NOT COMPLETED|Part II||23
10900167|NCT01208207|12066245|FG005|NOT COMPLETED|Part II||16
10900168|NCT01208207|12066246|FG006|NOT COMPLETED|Part II||11
10900169|NCT01208181|12066271|FG000|STARTED|Part 1||818
10900170|NCT01208181|12066272|FG001|STARTED|Part 1||468
10900171|NCT01208181|12066273|FG002|STARTED|Part 1||0
10900172|NCT01208181|12066274|FG003|STARTED|Part 1||0
10900173|NCT01208181|12066275|FG004|STARTED|Part 1||118
10900174|NCT01208181|12066271|FG000|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
10900175|NCT01208181|12066272|FG001|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
10900176|NCT01208181|12066273|FG002|COMPLETED|Part 1||0
10900177|NCT01208181|12066274|FG003|COMPLETED|Part 1||0
10900178|NCT01208181|12066275|FG004|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
10900179|NCT01208181|12066271|FG000|NOT COMPLETED|Part 1||99
10900180|NCT01208181|12066272|FG001|NOT COMPLETED|Part 1||55
10900181|NCT01208181|12066273|FG002|NOT COMPLETED|Part 1||0
10900182|NCT01208181|12066274|FG003|NOT COMPLETED|Part 1||0
10900183|NCT01208181|12066275|FG004|NOT COMPLETED|Part 1||22
10900184|NCT01208181|12066271|FG000|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
10900185|NCT01208181|12066272|FG001|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
10900186|NCT01208181|12066273|FG002|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
10900187|NCT01208181|12066274|FG003|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
10900188|NCT01208181|12066275|FG004|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
10900189|NCT01208181|12066271|FG000|COMPLETED|Part 2||0
10900190|NCT01208181|12066272|FG001|COMPLETED|Part 2||0
10900191|NCT01208181|12066273|FG002|COMPLETED|Part 2||334
10900192|NCT01208181|12066274|FG003|COMPLETED|Part 2||343
10900193|NCT01208181|12066275|FG004|COMPLETED|Part 2||0
10900194|NCT01208181|12066271|FG000|NOT COMPLETED|Part 2||0
10900195|NCT01208181|12066272|FG001|NOT COMPLETED|Part 2||0
10900196|NCT01208181|12066273|FG002|NOT COMPLETED|Part 2||16
10900197|NCT01208181|12066274|FG003|NOT COMPLETED|Part 2||20
10900198|NCT01208181|12066275|FG004|NOT COMPLETED|Part 2||0
10900199|NCT01206517|12066298|FG000|STARTED|Overall Study||6
10900200|NCT01206517|12066299|FG001|STARTED|Overall Study||6
10900201|NCT01206517|12066300|FG002|STARTED|Overall Study||6
10900202|NCT01206517|12066301|FG003|STARTED|Overall Study||4
10900203|NCT01206517|12066302|FG004|STARTED|Overall Study||4
10900204|NCT01206517|12066303|FG005|STARTED|Overall Study||4
10900205|NCT01206517|12066298|FG000|COMPLETED|Overall Study||6
10900206|NCT01206517|12066299|FG001|COMPLETED|Overall Study||6
10900207|NCT01206517|12066300|FG002|COMPLETED|Overall Study||4
10900208|NCT01206517|12066301|FG003|COMPLETED|Overall Study||4
10900209|NCT01206517|12066302|FG004|COMPLETED|Overall Study||3
10900210|NCT01206517|12066303|FG005|COMPLETED|Overall Study||4
10900211|NCT01206517|12066298|FG000|NOT COMPLETED|Overall Study||0
10900212|NCT01206517|12066299|FG001|NOT COMPLETED|Overall Study||0
10900213|NCT01206517|12066300|FG002|NOT COMPLETED|Overall Study||2
10900214|NCT01206517|12066301|FG003|NOT COMPLETED|Overall Study||0
10900215|NCT01206517|12066302|FG004|NOT COMPLETED|Overall Study||1
10900216|NCT01206517|12066303|FG005|NOT COMPLETED|Overall Study||0
10900217|NCT01190267|12066316|FG000|STARTED|Overall Study||196
10900218|NCT01190267|12066317|FG001|STARTED|Overall Study||8
10900219|NCT01190267|12066316|FG000|COMPLETED|Overall Study||155
10900220|NCT01190267|12066317|FG001|COMPLETED|Overall Study||4
10900221|NCT01190267|12066316|FG000|NOT COMPLETED|Overall Study||41
10900222|NCT01190267|12066317|FG001|NOT COMPLETED|Overall Study||4
10900223|NCT01190254|12066326|FG000|STARTED|Overall Study||102
10900224|NCT01190254|12066327|FG001|STARTED|Overall Study||98
10900225|NCT01190254|12066328|FG002|STARTED|Overall Study||106
10900226|NCT01190254|12066326|FG000|Treated|Overall Study||102
10900227|NCT01190254|12066327|FG001|Treated|Overall Study||98
10900228|NCT01190254|12066328|FG002|Treated|Overall Study||106
10900229|NCT01190254|12066326|FG000|COMPLETED|Overall Study||81
10900230|NCT01190254|12066327|FG001|COMPLETED|Overall Study||81
10900231|NCT01190254|12066328|FG002|COMPLETED|Overall Study||84
10900232|NCT01190254|12066326|FG000|NOT COMPLETED|Overall Study||21
10900233|NCT01190254|12066327|FG001|NOT COMPLETED|Overall Study||17
10900234|NCT01190254|12066328|FG002|NOT COMPLETED|Overall Study||22
10900235|NCT01154036|12066339|FG000|STARTED|Phase I||120
10900236|NCT01154036|12066340|FG001|STARTED|Phase I||483
10900237|NCT01154036|12066341|FG002|STARTED|Phase I||944
10900238|NCT01154036|12066342|FG003|STARTED|Phase I||0
10900239|NCT01154036|12066343|FG004|STARTED|Phase I||0
10900240|NCT01154036|12066344|FG005|STARTED|Phase I||0
10900241|NCT01154036|12066345|FG006|STARTED|Phase I||0
10900242|NCT01154036|12066346|FG007|STARTED|Phase I||0
10900243|NCT01154036|12066339|FG000|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
10900244|NCT01154036|12066340|FG001|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
10900245|NCT01154036|12066341|FG002|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
10900246|NCT01154036|12066342|FG003|COMPLETED|Phase I||0
10900247|NCT01154036|12066343|FG004|COMPLETED|Phase I||0
10900248|NCT01154036|12066344|FG005|COMPLETED|Phase I||0
10900249|NCT01154036|12066345|FG006|COMPLETED|Phase I||0
10900250|NCT01154036|12066346|FG007|COMPLETED|Phase I||0
10900251|NCT01154036|12066339|FG000|NOT COMPLETED|Phase I||3
10900252|NCT01154036|12066340|FG001|NOT COMPLETED|Phase I||28
10900253|NCT01154036|12066341|FG002|NOT COMPLETED|Phase I||56
10900254|NCT01154036|12066342|FG003|NOT COMPLETED|Phase I||0
10900255|NCT01154036|12066343|FG004|NOT COMPLETED|Phase I||0
10900256|NCT01154036|12066344|FG005|NOT COMPLETED|Phase I||0
10900257|NCT01154036|12066345|FG006|NOT COMPLETED|Phase I||0
10900258|NCT01154036|12066346|FG007|NOT COMPLETED|Phase I||0
10900259|NCT01154036|12066339|FG000|STARTED|Phase II||0
10900260|NCT01154036|12066340|FG001|STARTED|Phase II||0
10900261|NCT01154036|12066341|FG002|STARTED|Phase II||0
10900262|NCT01154036|12066342|FG003|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
10900263|NCT01154036|12066343|FG004|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
10900264|NCT01154036|12066344|FG005|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
10900265|NCT01154036|12066345|FG006|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
10900266|NCT01154036|12066346|FG007|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
10900267|NCT01154036|12066339|FG000|COMPLETED|Phase II||0
10900268|NCT01154036|12066340|FG001|COMPLETED|Phase II||0
10900269|NCT01154036|12066341|FG002|COMPLETED|Phase II||0
10900270|NCT01154036|12066342|FG003|COMPLETED|Phase II||27
10900271|NCT01154036|12066343|FG004|COMPLETED|Phase II||116
10900272|NCT01154036|12066344|FG005|COMPLETED|Phase II||121
10900273|NCT01154036|12066345|FG006|COMPLETED|Phase II||225
10900274|NCT01154036|12066346|FG007|COMPLETED|Phase II||200
10900275|NCT01154036|12066339|FG000|NOT COMPLETED|Phase II||0
10900276|NCT01154036|12066340|FG001|NOT COMPLETED|Phase II||0
10900277|NCT01154036|12066341|FG002|NOT COMPLETED|Phase II||0
10900278|NCT01154036|12066342|FG003|NOT COMPLETED|Phase II||1
10900279|NCT01154036|12066343|FG004|NOT COMPLETED|Phase II||8
10900280|NCT01154036|12066344|FG005|NOT COMPLETED|Phase II||5
10900281|NCT01154036|12066345|FG006|NOT COMPLETED|Phase II||9
10900282|NCT01154036|12066346|FG007|NOT COMPLETED|Phase II||6
10900283|NCT01101464|12066368|FG000|STARTED|Day 1 Through AM Dose of Day 5||4
10900284|NCT01101464|12066369|FG001|STARTED|Day 1 Through AM Dose of Day 5||4
10900285|NCT01101464|12066368|FG000|COMPLETED|Day 1 Through AM Dose of Day 5||4
10900286|NCT01101464|12066369|FG001|COMPLETED|Day 1 Through AM Dose of Day 5||4
10900287|NCT01101464|12066368|FG000|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
10900288|NCT01101464|12066369|FG001|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
10900289|NCT01101464|12066368|FG000|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
10900290|NCT01101464|12066369|FG001|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
10900291|NCT01101464|12066368|FG000|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
10900292|NCT01101464|12066369|FG001|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
10900293|NCT01101464|12066368|FG000|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
10900294|NCT01101464|12066369|FG001|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
10900295|NCT01098071|12066377|FG000|STARTED|Overall Study||34
10900296|NCT01098071|12066377|FG000|COMPLETED|Overall Study||19
10900297|NCT01098071|12066377|FG000|NOT COMPLETED|Overall Study||15
10900298|NCT01077830|12066383|FG000|STARTED|Overall Study||677
10900299|NCT01077830|12066384|FG001|STARTED|Overall Study||682
10900300|NCT01077830|12066383|FG000|COMPLETED|Overall Study||677
10900301|NCT01077830|12066384|FG001|COMPLETED|Overall Study||682
10900302|NCT01077830|12066383|FG000|NOT COMPLETED|Overall Study||0
10900303|NCT01077830|12066384|FG001|NOT COMPLETED|Overall Study||0
10900304|NCT01070966|12066390|FG000|STARTED|Participants for Safety Evaluation||2089
10900305|NCT01070966|12066390|FG000|COMPLETED|Participants for Safety Evaluation||2011
10900306|NCT01070966|12066390|FG000|NOT COMPLETED|Participants for Safety Evaluation||78
10900307|NCT01070966|12066390|FG000|STARTED|Participants for Efficacy Evaluation||2011
10900308|NCT01070966|12066390|FG000|COMPLETED|Participants for Efficacy Evaluation||1929
10900309|NCT01070966|12066390|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||82
10900310|NCT01070953|12066401|FG000|STARTED|Participants for Safety Evaluation||4467
10900311|NCT01070953|12066401|FG000|COMPLETED|Participants for Safety Evaluation||3536
10900312|NCT01070953|12066401|FG000|NOT COMPLETED|Participants for Safety Evaluation||931
10900313|NCT01070953|12066401|FG000|STARTED|Participants for Efficacy Evaluation||3536
10900314|NCT01070953|12066401|FG000|COMPLETED|Participants for Efficacy Evaluation||3309
10900315|NCT01070953|12066401|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||227
10900316|NCT01030341|12066411|FG000|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
10900317|NCT01030341|12066411|FG000|COMPLETED|Overall Study|42 participants completed the study|42
10900318|NCT01030341|12066411|FG000|NOT COMPLETED|Overall Study||3
10900319|NCT00979901|12066419|FG000|STARTED|Overall Study||352
10900320|NCT00979901|12066420|FG001|STARTED|Overall Study||348
10900321|NCT00979901|12066421|FG002|STARTED|Overall Study||602
10900322|NCT00979901|12066422|FG003|STARTED|Overall Study||275
10900323|NCT00979901|12066419|FG000|COMPLETED|Overall Study||334
10900324|NCT00979901|12066420|FG001|COMPLETED|Overall Study||336
10900325|NCT00979901|12066421|FG002|COMPLETED|Overall Study||573
10900326|NCT00979901|12066422|FG003|COMPLETED|Overall Study||159
10900327|NCT00979901|12066419|FG000|NOT COMPLETED|Overall Study||18
10900328|NCT00979901|12066420|FG001|NOT COMPLETED|Overall Study||12
10900329|NCT00979901|12066421|FG002|NOT COMPLETED|Overall Study||29
10900330|NCT00979901|12066422|FG003|NOT COMPLETED|Overall Study||116
10900331|NCT00963599|12066435|FG000|STARTED|Overall Study||149
10900332|NCT00963599|12066436|FG001|STARTED|Overall Study||155
10900333|NCT00963599|12066437|FG002|STARTED|Overall Study||301
10900334|NCT00963599|12066438|FG003|STARTED|Overall Study||302
10900335|NCT00963599|12066435|FG000|COMPLETED|Overall Study||143
10900336|NCT00963599|12066436|FG001|COMPLETED|Overall Study||149
10900337|NCT00963599|12066437|FG002|COMPLETED|Overall Study||292
10900338|NCT00963599|12066438|FG003|COMPLETED|Overall Study||288
10900339|NCT00963599|12066435|FG000|NOT COMPLETED|Overall Study||6
10900340|NCT00963599|12066436|FG001|NOT COMPLETED|Overall Study||6
10900341|NCT00963599|12066437|FG002|NOT COMPLETED|Overall Study||9
10900342|NCT00963599|12066438|FG003|NOT COMPLETED|Overall Study||14
10900343|NCT00954915|12066448|FG000|STARTED|Overall Study||1
10900344|NCT00954915|12066448|FG000|COMPLETED|Overall Study||1
10900345|NCT00954915|12066448|FG000|NOT COMPLETED|Overall Study||0
10900346|NCT00953680|12066453|FG000|STARTED|Period 1||38
10900347|NCT00953680|12066454|FG001|STARTED|Period 1||39
10900348|NCT00953680|12066453|FG000|COMPLETED|Period 1||38
10900349|NCT00953680|12066454|FG001|COMPLETED|Period 1||38
10900350|NCT00953680|12066453|FG000|NOT COMPLETED|Period 1||0
10900351|NCT00953680|12066454|FG001|NOT COMPLETED|Period 1||1
10900352|NCT00953680|12066453|FG000|STARTED|Period 2||38
10900353|NCT00953680|12066454|FG001|STARTED|Period 2||38
10900354|NCT00953680|12066453|FG000|COMPLETED|Period 2||38
10900355|NCT00953680|12066454|FG001|COMPLETED|Period 2||38
10900356|NCT00953680|12066453|FG000|NOT COMPLETED|Period 2||0
10900357|NCT00953680|12066454|FG001|NOT COMPLETED|Period 2||0
10900358|NCT00945035|12066460|FG000|STARTED|Period 1||18
10900359|NCT00945035|12066461|FG001|STARTED|Period 1||18
10900360|NCT00945035|12066460|FG000|COMPLETED|Period 1||18
10900361|NCT00945035|12066461|FG001|COMPLETED|Period 1||18
10900362|NCT00945035|12066460|FG000|NOT COMPLETED|Period 1||0
10900363|NCT00945035|12066461|FG001|NOT COMPLETED|Period 1||0
10900364|NCT00945035|12066460|FG000|STARTED|Period 2||18
10900365|NCT00945035|12066461|FG001|STARTED|Period 2||18
10900366|NCT00945035|12066460|FG000|COMPLETED|Period 2||18
10900367|NCT00945035|12066461|FG001|COMPLETED|Period 2||18
10900368|NCT00945035|12066460|FG000|NOT COMPLETED|Period 2||0
10900369|NCT00945035|12066461|FG001|NOT COMPLETED|Period 2||0
10900370|NCT00943852|12066467|FG000|STARTED|First Period of Treatment Intervention||2
10900371|NCT00943852|12066468|FG001|STARTED|First Period of Treatment Intervention||1
10900372|NCT00943852|12066469|FG002|STARTED|First Period of Treatment Intervention||1
10900373|NCT00943852|12066470|FG003|STARTED|First Period of Treatment Intervention||2
10900374|NCT00943852|12066471|FG004|STARTED|First Period of Treatment Intervention||1
10900375|NCT00943852|12066472|FG005|STARTED|First Period of Treatment Intervention||1
10900376|NCT00943852|12066473|FG006|STARTED|First Period of Treatment Intervention||2
10900377|NCT00943852|12066474|FG007|STARTED|First Period of Treatment Intervention||1
10900378|NCT00943852|12066475|FG008|STARTED|First Period of Treatment Intervention||1
10900379|NCT00943852|12066476|FG009|STARTED|First Period of Treatment Intervention||1
10900380|NCT00943852|12066467|FG000|COMPLETED|First Period of Treatment Intervention||2
10900381|NCT00943852|12066468|FG001|COMPLETED|First Period of Treatment Intervention||1
10900382|NCT00943852|12066469|FG002|COMPLETED|First Period of Treatment Intervention||1
10900383|NCT00943852|12066470|FG003|COMPLETED|First Period of Treatment Intervention||2
10900384|NCT00943852|12066471|FG004|COMPLETED|First Period of Treatment Intervention||1
10900385|NCT00943852|12066472|FG005|COMPLETED|First Period of Treatment Intervention||1
10900386|NCT00943852|12066473|FG006|COMPLETED|First Period of Treatment Intervention||2
10900387|NCT00943852|12066474|FG007|COMPLETED|First Period of Treatment Intervention||1
10900388|NCT00943852|12066475|FG008|COMPLETED|First Period of Treatment Intervention||1
10900389|NCT00943852|12066476|FG009|COMPLETED|First Period of Treatment Intervention||1
10900390|NCT00943852|12066467|FG000|NOT COMPLETED|First Period of Treatment Intervention||0
10900391|NCT00943852|12066468|FG001|NOT COMPLETED|First Period of Treatment Intervention||0
10900392|NCT00943852|12066469|FG002|NOT COMPLETED|First Period of Treatment Intervention||0
10900393|NCT00943852|12066470|FG003|NOT COMPLETED|First Period of Treatment Intervention||0
10900394|NCT00943852|12066471|FG004|NOT COMPLETED|First Period of Treatment Intervention||0
10900395|NCT00943852|12066472|FG005|NOT COMPLETED|First Period of Treatment Intervention||0
10900396|NCT00943852|12066473|FG006|NOT COMPLETED|First Period of Treatment Intervention||0
10900397|NCT00943852|12066474|FG007|NOT COMPLETED|First Period of Treatment Intervention||0
10900398|NCT00943852|12066475|FG008|NOT COMPLETED|First Period of Treatment Intervention||0
10900399|NCT00943852|12066476|FG009|NOT COMPLETED|First Period of Treatment Intervention||0
10900400|NCT00943852|12066467|FG000|STARTED|Washout Period After Period 1 Treatment||2
10900401|NCT00943852|12066468|FG001|STARTED|Washout Period After Period 1 Treatment||1
10900402|NCT00943852|12066469|FG002|STARTED|Washout Period After Period 1 Treatment||1
10900403|NCT00943852|12066470|FG003|STARTED|Washout Period After Period 1 Treatment||2
10900404|NCT00943852|12066471|FG004|STARTED|Washout Period After Period 1 Treatment||1
10900405|NCT00943852|12066472|FG005|STARTED|Washout Period After Period 1 Treatment||1
10900406|NCT00943852|12066473|FG006|STARTED|Washout Period After Period 1 Treatment||2
10900407|NCT00943852|12066474|FG007|STARTED|Washout Period After Period 1 Treatment||1
10900408|NCT00943852|12066475|FG008|STARTED|Washout Period After Period 1 Treatment||1
10900409|NCT00943852|12066476|FG009|STARTED|Washout Period After Period 1 Treatment||1
10900410|NCT00943852|12066467|FG000|COMPLETED|Washout Period After Period 1 Treatment||2
10900411|NCT00943852|12066468|FG001|COMPLETED|Washout Period After Period 1 Treatment||1
10900412|NCT00943852|12066469|FG002|COMPLETED|Washout Period After Period 1 Treatment||1
10900413|NCT00943852|12066470|FG003|COMPLETED|Washout Period After Period 1 Treatment||1
10900414|NCT00943852|12066471|FG004|COMPLETED|Washout Period After Period 1 Treatment||1
10900415|NCT00943852|12066472|FG005|COMPLETED|Washout Period After Period 1 Treatment||1
10900416|NCT00943852|12066473|FG006|COMPLETED|Washout Period After Period 1 Treatment||2
10900417|NCT00943852|12066474|FG007|COMPLETED|Washout Period After Period 1 Treatment||1
10900418|NCT00943852|12066475|FG008|COMPLETED|Washout Period After Period 1 Treatment||1
10900419|NCT00943852|12066476|FG009|COMPLETED|Washout Period After Period 1 Treatment||1
10900420|NCT00943852|12066467|FG000|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10900421|NCT00943852|12066468|FG001|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10900422|NCT00943852|12066469|FG002|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10900423|NCT00943852|12066470|FG003|NOT COMPLETED|Washout Period After Period 1 Treatment||1
10900424|NCT00943852|12066471|FG004|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10900425|NCT00943852|12066472|FG005|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10900426|NCT00943852|12066473|FG006|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10900427|NCT00943852|12066474|FG007|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10900428|NCT00943852|12066475|FG008|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10900429|NCT00943852|12066476|FG009|NOT COMPLETED|Washout Period After Period 1 Treatment||0
10900430|NCT00943852|12066467|FG000|STARTED|Second Period of Treatment Intervention||2
10900431|NCT00943852|12066468|FG001|STARTED|Second Period of Treatment Intervention||1
10900432|NCT00943852|12066469|FG002|STARTED|Second Period of Treatment Intervention||1
10900433|NCT00943852|12066470|FG003|STARTED|Second Period of Treatment Intervention||1
10900434|NCT00943852|12066471|FG004|STARTED|Second Period of Treatment Intervention||1
10900435|NCT00943852|12066472|FG005|STARTED|Second Period of Treatment Intervention||1
10900436|NCT00943852|12066473|FG006|STARTED|Second Period of Treatment Intervention||2
10900437|NCT00943852|12066474|FG007|STARTED|Second Period of Treatment Intervention||1
10900438|NCT00943852|12066475|FG008|STARTED|Second Period of Treatment Intervention||1
10900439|NCT00943852|12066476|FG009|STARTED|Second Period of Treatment Intervention||1
10900440|NCT00943852|12066467|FG000|COMPLETED|Second Period of Treatment Intervention||2
10900441|NCT00943852|12066468|FG001|COMPLETED|Second Period of Treatment Intervention||1
10900442|NCT00943852|12066469|FG002|COMPLETED|Second Period of Treatment Intervention||1
10900443|NCT00943852|12066470|FG003|COMPLETED|Second Period of Treatment Intervention||1
10900444|NCT00943852|12066471|FG004|COMPLETED|Second Period of Treatment Intervention||1
10900445|NCT00943852|12066472|FG005|COMPLETED|Second Period of Treatment Intervention||1
10900446|NCT00943852|12066473|FG006|COMPLETED|Second Period of Treatment Intervention||2
10900447|NCT00943852|12066474|FG007|COMPLETED|Second Period of Treatment Intervention||1
10900448|NCT00943852|12066475|FG008|COMPLETED|Second Period of Treatment Intervention||1
10900449|NCT00943852|12066476|FG009|COMPLETED|Second Period of Treatment Intervention||1
10900450|NCT00943852|12066467|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0
10900451|NCT00943852|12066468|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0
10900452|NCT00943852|12066469|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0
10900453|NCT00943852|12066470|FG003|NOT COMPLETED|Second Period of Treatment Intervention||0
10900454|NCT00943852|12066471|FG004|NOT COMPLETED|Second Period of Treatment Intervention||0
10900455|NCT00943852|12066472|FG005|NOT COMPLETED|Second Period of Treatment Intervention||0
10900456|NCT00943852|12066473|FG006|NOT COMPLETED|Second Period of Treatment Intervention||0
10900457|NCT00943852|12066474|FG007|NOT COMPLETED|Second Period of Treatment Intervention||0
10900458|NCT00943852|12066475|FG008|NOT COMPLETED|Second Period of Treatment Intervention||0
10900459|NCT00943852|12066476|FG009|NOT COMPLETED|Second Period of Treatment Intervention||0
10900460|NCT00943852|12066467|FG000|STARTED|Washout Period After Period 2 Treatment||2
10900461|NCT00943852|12066468|FG001|STARTED|Washout Period After Period 2 Treatment||1
10900462|NCT00943852|12066469|FG002|STARTED|Washout Period After Period 2 Treatment||1
10900463|NCT00943852|12066470|FG003|STARTED|Washout Period After Period 2 Treatment||1
10900464|NCT00943852|12066471|FG004|STARTED|Washout Period After Period 2 Treatment||1
10900465|NCT00943852|12066472|FG005|STARTED|Washout Period After Period 2 Treatment||1
10900466|NCT00943852|12066473|FG006|STARTED|Washout Period After Period 2 Treatment||2
10900467|NCT00943852|12066474|FG007|STARTED|Washout Period After Period 2 Treatment||1
10900468|NCT00943852|12066475|FG008|STARTED|Washout Period After Period 2 Treatment||1
10900469|NCT00943852|12066476|FG009|STARTED|Washout Period After Period 2 Treatment||1
10900470|NCT00943852|12066467|FG000|COMPLETED|Washout Period After Period 2 Treatment||2
10900471|NCT00943852|12066468|FG001|COMPLETED|Washout Period After Period 2 Treatment||1
10900472|NCT00943852|12066469|FG002|COMPLETED|Washout Period After Period 2 Treatment||1
10900473|NCT00943852|12066470|FG003|COMPLETED|Washout Period After Period 2 Treatment||1
10900474|NCT00943852|12066471|FG004|COMPLETED|Washout Period After Period 2 Treatment||1
10900475|NCT00943852|12066472|FG005|COMPLETED|Washout Period After Period 2 Treatment||0
10900476|NCT00943852|12066473|FG006|COMPLETED|Washout Period After Period 2 Treatment||2
10900477|NCT00943852|12066474|FG007|COMPLETED|Washout Period After Period 2 Treatment||1
10900478|NCT00943852|12066475|FG008|COMPLETED|Washout Period After Period 2 Treatment||1
10900479|NCT00943852|12066476|FG009|COMPLETED|Washout Period After Period 2 Treatment||1
10900480|NCT00943852|12066467|FG000|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10900481|NCT00943852|12066468|FG001|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10900482|NCT00943852|12066469|FG002|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10900483|NCT00943852|12066470|FG003|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10900484|NCT00943852|12066471|FG004|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10900485|NCT00943852|12066472|FG005|NOT COMPLETED|Washout Period After Period 2 Treatment||1
10900486|NCT00943852|12066473|FG006|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10900487|NCT00943852|12066474|FG007|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10900488|NCT00943852|12066475|FG008|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10900489|NCT00943852|12066476|FG009|NOT COMPLETED|Washout Period After Period 2 Treatment||0
10900490|NCT00943852|12066467|FG000|STARTED|Third Period of Treatment Intervention||2
10900491|NCT00943852|12066468|FG001|STARTED|Third Period of Treatment Intervention||1
10900492|NCT00943852|12066469|FG002|STARTED|Third Period of Treatment Intervention||1
10900493|NCT00943852|12066470|FG003|STARTED|Third Period of Treatment Intervention||1
10900494|NCT00943852|12066471|FG004|STARTED|Third Period of Treatment Intervention||1
10900495|NCT00943852|12066472|FG005|STARTED|Third Period of Treatment Intervention||0
10900496|NCT00943852|12066473|FG006|STARTED|Third Period of Treatment Intervention||2
10900497|NCT00943852|12066474|FG007|STARTED|Third Period of Treatment Intervention||1
10900498|NCT00943852|12066475|FG008|STARTED|Third Period of Treatment Intervention||1
10900499|NCT00943852|12066476|FG009|STARTED|Third Period of Treatment Intervention||1
10900500|NCT00943852|12066467|FG000|COMPLETED|Third Period of Treatment Intervention||2
10900501|NCT00943852|12066468|FG001|COMPLETED|Third Period of Treatment Intervention||1
10900502|NCT00943852|12066469|FG002|COMPLETED|Third Period of Treatment Intervention||1
10900503|NCT00943852|12066470|FG003|COMPLETED|Third Period of Treatment Intervention||1
10900504|NCT00943852|12066471|FG004|COMPLETED|Third Period of Treatment Intervention||1
10900505|NCT00943852|12066472|FG005|COMPLETED|Third Period of Treatment Intervention||0
10900506|NCT00943852|12066473|FG006|COMPLETED|Third Period of Treatment Intervention||2
10900507|NCT00943852|12066474|FG007|COMPLETED|Third Period of Treatment Intervention||1
10900508|NCT00943852|12066475|FG008|COMPLETED|Third Period of Treatment Intervention||1
10900509|NCT00943852|12066476|FG009|COMPLETED|Third Period of Treatment Intervention||1
10900510|NCT00943852|12066467|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0
10900511|NCT00943852|12066468|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0
10900512|NCT00943852|12066469|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0
10900513|NCT00943852|12066470|FG003|NOT COMPLETED|Third Period of Treatment Intervention||0
10900514|NCT00943852|12066471|FG004|NOT COMPLETED|Third Period of Treatment Intervention||0
10900515|NCT00943852|12066472|FG005|NOT COMPLETED|Third Period of Treatment Intervention||0
10900516|NCT00943852|12066473|FG006|NOT COMPLETED|Third Period of Treatment Intervention||0
10900517|NCT00943852|12066474|FG007|NOT COMPLETED|Third Period of Treatment Intervention||0
10900518|NCT00943852|12066475|FG008|NOT COMPLETED|Third Period of Treatment Intervention||0
10900519|NCT00943852|12066476|FG009|NOT COMPLETED|Third Period of Treatment Intervention||0
10900520|NCT00943852|12066467|FG000|STARTED|Washout Period After Period 3 Treatment||2
10900521|NCT00943852|12066468|FG001|STARTED|Washout Period After Period 3 Treatment||1
10900522|NCT00943852|12066469|FG002|STARTED|Washout Period After Period 3 Treatment||1
10900523|NCT00943852|12066470|FG003|STARTED|Washout Period After Period 3 Treatment||1
10900524|NCT00943852|12066471|FG004|STARTED|Washout Period After Period 3 Treatment||1
10900525|NCT00943852|12066472|FG005|STARTED|Washout Period After Period 3 Treatment||0
10900526|NCT00943852|12066473|FG006|STARTED|Washout Period After Period 3 Treatment||2
10900527|NCT00943852|12066474|FG007|STARTED|Washout Period After Period 3 Treatment||1
10900528|NCT00943852|12066475|FG008|STARTED|Washout Period After Period 3 Treatment||1
10900529|NCT00943852|12066476|FG009|STARTED|Washout Period After Period 3 Treatment||1
10900530|NCT00943852|12066467|FG000|COMPLETED|Washout Period After Period 3 Treatment||2
10900531|NCT00943852|12066468|FG001|COMPLETED|Washout Period After Period 3 Treatment||1
10900532|NCT00943852|12066469|FG002|COMPLETED|Washout Period After Period 3 Treatment||1
10900533|NCT00943852|12066470|FG003|COMPLETED|Washout Period After Period 3 Treatment||1
10900534|NCT00943852|12066471|FG004|COMPLETED|Washout Period After Period 3 Treatment||1
10900535|NCT00943852|12066472|FG005|COMPLETED|Washout Period After Period 3 Treatment||0
10900536|NCT00943852|12066473|FG006|COMPLETED|Washout Period After Period 3 Treatment||1
10900537|NCT00943852|12066474|FG007|COMPLETED|Washout Period After Period 3 Treatment||1
10900538|NCT00943852|12066475|FG008|COMPLETED|Washout Period After Period 3 Treatment||1
10900539|NCT00943852|12066476|FG009|COMPLETED|Washout Period After Period 3 Treatment||1
10900540|NCT00943852|12066467|FG000|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10900541|NCT00943852|12066468|FG001|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10900542|NCT00943852|12066469|FG002|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10900543|NCT00943852|12066470|FG003|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10900544|NCT00943852|12066471|FG004|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10900545|NCT00943852|12066472|FG005|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10900546|NCT00943852|12066473|FG006|NOT COMPLETED|Washout Period After Period 3 Treatment||1
10900547|NCT00943852|12066474|FG007|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10900548|NCT00943852|12066475|FG008|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10900549|NCT00943852|12066476|FG009|NOT COMPLETED|Washout Period After Period 3 Treatment||0
10900550|NCT00943852|12066467|FG000|STARTED|Fourth Period of Treatment Intervention||2
10900551|NCT00943852|12066468|FG001|STARTED|Fourth Period of Treatment Intervention||1
10900552|NCT00943852|12066469|FG002|STARTED|Fourth Period of Treatment Intervention||1
10900553|NCT00943852|12066470|FG003|STARTED|Fourth Period of Treatment Intervention||1
10900554|NCT00943852|12066471|FG004|STARTED|Fourth Period of Treatment Intervention||1
10900555|NCT00943852|12066472|FG005|STARTED|Fourth Period of Treatment Intervention||0
10900556|NCT00943852|12066473|FG006|STARTED|Fourth Period of Treatment Intervention||1
10900557|NCT00943852|12066474|FG007|STARTED|Fourth Period of Treatment Intervention||1
10900558|NCT00943852|12066475|FG008|STARTED|Fourth Period of Treatment Intervention||1
10900559|NCT00943852|12066476|FG009|STARTED|Fourth Period of Treatment Intervention||1
10900560|NCT00943852|12066467|FG000|COMPLETED|Fourth Period of Treatment Intervention||2
10900561|NCT00943852|12066468|FG001|COMPLETED|Fourth Period of Treatment Intervention||1
10900562|NCT00943852|12066469|FG002|COMPLETED|Fourth Period of Treatment Intervention||1
10900563|NCT00943852|12066470|FG003|COMPLETED|Fourth Period of Treatment Intervention||1
10900564|NCT00943852|12066471|FG004|COMPLETED|Fourth Period of Treatment Intervention||1
10900565|NCT00943852|12066472|FG005|COMPLETED|Fourth Period of Treatment Intervention||0
10900566|NCT00943852|12066473|FG006|COMPLETED|Fourth Period of Treatment Intervention||1
10900567|NCT00943852|12066474|FG007|COMPLETED|Fourth Period of Treatment Intervention||1
10900568|NCT00943852|12066475|FG008|COMPLETED|Fourth Period of Treatment Intervention||1
10900569|NCT00943852|12066476|FG009|COMPLETED|Fourth Period of Treatment Intervention||1
10900570|NCT00943852|12066467|FG000|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10900571|NCT00943852|12066468|FG001|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10900572|NCT00943852|12066469|FG002|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10900573|NCT00943852|12066470|FG003|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10900574|NCT00943852|12066471|FG004|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10900575|NCT00943852|12066472|FG005|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10900576|NCT00943852|12066473|FG006|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10900577|NCT00943852|12066474|FG007|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10900578|NCT00943852|12066475|FG008|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10900579|NCT00943852|12066476|FG009|NOT COMPLETED|Fourth Period of Treatment Intervention||0
10900580|NCT00943852|12066467|FG000|STARTED|Washout Period After Period 4 Treatment||2
10900581|NCT00943852|12066468|FG001|STARTED|Washout Period After Period 4 Treatment||1
10900582|NCT00943852|12066469|FG002|STARTED|Washout Period After Period 4 Treatment||1
10900583|NCT00943852|12066470|FG003|STARTED|Washout Period After Period 4 Treatment||1
10900584|NCT00943852|12066471|FG004|STARTED|Washout Period After Period 4 Treatment||1
10900585|NCT00943852|12066472|FG005|STARTED|Washout Period After Period 4 Treatment||0
10900586|NCT00943852|12066473|FG006|STARTED|Washout Period After Period 4 Treatment||1
10900587|NCT00943852|12066474|FG007|STARTED|Washout Period After Period 4 Treatment||1
10900588|NCT00943852|12066475|FG008|STARTED|Washout Period After Period 4 Treatment||1
10900589|NCT00943852|12066476|FG009|STARTED|Washout Period After Period 4 Treatment||1
10900590|NCT00943852|12066467|FG000|COMPLETED|Washout Period After Period 4 Treatment||1
10900591|NCT00943852|12066468|FG001|COMPLETED|Washout Period After Period 4 Treatment||1
10900592|NCT00943852|12066469|FG002|COMPLETED|Washout Period After Period 4 Treatment||0
10900593|NCT00943852|12066470|FG003|COMPLETED|Washout Period After Period 4 Treatment||0
10900594|NCT00943852|12066471|FG004|COMPLETED|Washout Period After Period 4 Treatment||1
10900595|NCT00943852|12066472|FG005|COMPLETED|Washout Period After Period 4 Treatment||0
10900596|NCT00943852|12066473|FG006|COMPLETED|Washout Period After Period 4 Treatment||0
10900597|NCT00943852|12066474|FG007|COMPLETED|Washout Period After Period 4 Treatment||0
10900598|NCT00943852|12066475|FG008|COMPLETED|Washout Period After Period 4 Treatment||1
10900599|NCT00943852|12066476|FG009|COMPLETED|Washout Period After Period 4 Treatment||1
10900600|NCT00943852|12066467|FG000|NOT COMPLETED|Washout Period After Period 4 Treatment||1
10900601|NCT00943852|12066468|FG001|NOT COMPLETED|Washout Period After Period 4 Treatment||0
10900602|NCT00943852|12066469|FG002|NOT COMPLETED|Washout Period After Period 4 Treatment||1
10900603|NCT00943852|12066470|FG003|NOT COMPLETED|Washout Period After Period 4 Treatment||1
10900604|NCT00943852|12066471|FG004|NOT COMPLETED|Washout Period After Period 4 Treatment||0
10900605|NCT00943852|12066472|FG005|NOT COMPLETED|Washout Period After Period 4 Treatment||0
10900606|NCT00943852|12066473|FG006|NOT COMPLETED|Washout Period After Period 4 Treatment||1
10900607|NCT00943852|12066474|FG007|NOT COMPLETED|Washout Period After Period 4 Treatment||1
10900608|NCT00943852|12066475|FG008|NOT COMPLETED|Washout Period After Period 4 Treatment||0
10900609|NCT00943852|12066476|FG009|NOT COMPLETED|Washout Period After Period 4 Treatment||0
10900610|NCT00943852|12066467|FG000|STARTED|Fifth Period of Treatment Intervention||1
10900611|NCT00943852|12066468|FG001|STARTED|Fifth Period of Treatment Intervention||1
10900612|NCT00943852|12066469|FG002|STARTED|Fifth Period of Treatment Intervention||0
10900613|NCT00943852|12066470|FG003|STARTED|Fifth Period of Treatment Intervention||0
10900614|NCT00943852|12066471|FG004|STARTED|Fifth Period of Treatment Intervention||1
10900615|NCT00943852|12066472|FG005|STARTED|Fifth Period of Treatment Intervention||0
10900616|NCT00943852|12066473|FG006|STARTED|Fifth Period of Treatment Intervention||0
10900617|NCT00943852|12066474|FG007|STARTED|Fifth Period of Treatment Intervention||0
10900618|NCT00943852|12066475|FG008|STARTED|Fifth Period of Treatment Intervention||1
10900619|NCT00943852|12066476|FG009|STARTED|Fifth Period of Treatment Intervention||1
10900620|NCT00943852|12066467|FG000|COMPLETED|Fifth Period of Treatment Intervention||1
10900621|NCT00943852|12066468|FG001|COMPLETED|Fifth Period of Treatment Intervention||1
10900622|NCT00943852|12066469|FG002|COMPLETED|Fifth Period of Treatment Intervention||0
10900623|NCT00943852|12066470|FG003|COMPLETED|Fifth Period of Treatment Intervention||0
10900624|NCT00943852|12066471|FG004|COMPLETED|Fifth Period of Treatment Intervention||1
10900625|NCT00943852|12066472|FG005|COMPLETED|Fifth Period of Treatment Intervention||0
10900626|NCT00943852|12066473|FG006|COMPLETED|Fifth Period of Treatment Intervention||0
10900627|NCT00943852|12066474|FG007|COMPLETED|Fifth Period of Treatment Intervention||0
10900628|NCT00943852|12066475|FG008|COMPLETED|Fifth Period of Treatment Intervention||1
10900629|NCT00943852|12066476|FG009|COMPLETED|Fifth Period of Treatment Intervention||1
10900630|NCT00943852|12066467|FG000|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10900631|NCT00943852|12066468|FG001|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10900632|NCT00943852|12066469|FG002|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10900633|NCT00943852|12066470|FG003|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10900634|NCT00943852|12066471|FG004|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10900635|NCT00943852|12066472|FG005|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10900636|NCT00943852|12066473|FG006|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10900637|NCT00943852|12066474|FG007|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10900638|NCT00943852|12066475|FG008|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10900639|NCT00943852|12066476|FG009|NOT COMPLETED|Fifth Period of Treatment Intervention||0
10900640|NCT00927953|12066488|FG000|STARTED|Overall Study||6
10900641|NCT00927953|12066489|FG001|STARTED|Overall Study||7
10900642|NCT00927953|12066488|FG000|COMPLETED|Overall Study||4
10900643|NCT00927953|12066489|FG001|COMPLETED|Overall Study||6
10900644|NCT00927953|12066488|FG000|NOT COMPLETED|Overall Study||2
10900645|NCT00927953|12066489|FG001|NOT COMPLETED|Overall Study||1
10900646|NCT00909389|12066496|FG000|STARTED|Overall Study||4748
10900647|NCT00909389|12066496|FG000|COMPLETED|Overall Study||4615
10900648|NCT00909389|12066496|FG000|NOT COMPLETED|Overall Study||133
10900649|NCT00820027|12066504|FG000|STARTED|Overall Study||224
10900650|NCT00820027|12066505|FG001|STARTED|Overall Study||230
10900651|NCT00820027|12066506|FG002|STARTED|Overall Study||224
10900652|NCT00820027|12066507|FG003|STARTED|Overall Study||98
10900653|NCT00820027|12066504|FG000|COMPLETED|Overall Study||198
10900654|NCT00820027|12066505|FG001|COMPLETED|Overall Study||216
10900655|NCT00820027|12066506|FG002|COMPLETED|Overall Study||203
10900656|NCT00820027|12066507|FG003|COMPLETED|Overall Study||85
10900657|NCT00820027|12066504|FG000|NOT COMPLETED|Overall Study||26
10900658|NCT00820027|12066505|FG001|NOT COMPLETED|Overall Study||14
10900659|NCT00820027|12066506|FG002|NOT COMPLETED|Overall Study||21
10900660|NCT00820027|12066507|FG003|NOT COMPLETED|Overall Study||13
10900661|NCT00788710|12066521|FG000|STARTED|Overall Study||144
10900662|NCT00788710|12066522|FG001|STARTED|Overall Study||142
10900663|NCT00788710|12066523|FG002|STARTED|Overall Study||144
10900664|NCT00788710|12066521|FG000|COMPLETED|Overall Study||139
10900665|NCT00788710|12066522|FG001|COMPLETED|Overall Study||134
10900666|NCT00788710|12066523|FG002|COMPLETED|Overall Study||138
10900667|NCT00788710|12066521|FG000|NOT COMPLETED|Overall Study||5
10900668|NCT00788710|12066522|FG001|NOT COMPLETED|Overall Study||8
10900669|NCT00788710|12066523|FG002|NOT COMPLETED|Overall Study||6
10900670|NCT00783224|12066535|FG000|STARTED|Overall Study||32
10900671|NCT00783224|12066536|FG001|STARTED|Overall Study||34
10900672|NCT00783224|12066537|FG002|STARTED|Overall Study||143
10900673|NCT00783224|12066538|FG003|STARTED|Overall Study||142
10900674|NCT00783224|12066535|FG000|COMPLETED|Overall Study||32
10900675|NCT00783224|12066536|FG001|COMPLETED|Overall Study||34
10900676|NCT00783224|12066537|FG002|COMPLETED|Overall Study||142
10900677|NCT00783224|12066538|FG003|COMPLETED|Overall Study||140
10900678|NCT00783224|12066535|FG000|NOT COMPLETED|Overall Study||0
10900679|NCT00783224|12066536|FG001|NOT COMPLETED|Overall Study||0
10900680|NCT00783224|12066537|FG002|NOT COMPLETED|Overall Study||1
10900681|NCT00783224|12066538|FG003|NOT COMPLETED|Overall Study||2
10900682|NCT00780403|12066547|FG000|STARTED|First Intervention||109
10900683|NCT00780403|12066548|FG001|STARTED|First Intervention||111
10900684|NCT00780403|12066547|FG000|COMPLETED|First Intervention||109
10900685|NCT00780403|12066548|FG001|COMPLETED|First Intervention||111
10900686|NCT00780403|12066547|FG000|NOT COMPLETED|First Intervention||0
10900687|NCT00780403|12066548|FG001|NOT COMPLETED|First Intervention||0
10900688|NCT00780403|12066547|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109
10900689|NCT00780403|12066548|FG001|STARTED|Interval Between Doses (8-10 Minutes)||111
10900690|NCT00780403|12066547|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109
10900691|NCT00780403|12066548|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||111
10900692|NCT00780403|12066547|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
10900693|NCT00780403|12066548|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
10900694|NCT00780403|12066547|FG000|STARTED|Second Intervention||109
10900695|NCT00780403|12066548|FG001|STARTED|Second Intervention||111
10900696|NCT00780403|12066547|FG000|COMPLETED|Second Intervention||109
10900697|NCT00780403|12066548|FG001|COMPLETED|Second Intervention||111
10900698|NCT00780403|12066547|FG000|NOT COMPLETED|Second Intervention||0
10900699|NCT00780403|12066548|FG001|NOT COMPLETED|Second Intervention||0
10900700|NCT00779116|12066555|FG000|STARTED|First Intervention||109
10900701|NCT00779116|12066556|FG001|STARTED|First Intervention||108
10900702|NCT00779116|12066555|FG000|COMPLETED|First Intervention||109
10900703|NCT00779116|12066556|FG001|COMPLETED|First Intervention||108
10900704|NCT00779116|12066555|FG000|NOT COMPLETED|First Intervention||0
10900705|NCT00779116|12066556|FG001|NOT COMPLETED|First Intervention||0
10900706|NCT00779116|12066555|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109
10900707|NCT00779116|12066556|FG001|STARTED|Interval Between Doses (8-10 Minutes)||108
10900708|NCT00779116|12066555|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109
10900709|NCT00779116|12066556|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||108
10900710|NCT00779116|12066555|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
10900711|NCT00779116|12066556|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
10900712|NCT00779116|12066555|FG000|STARTED|Second Intervention||109
10900713|NCT00779116|12066556|FG001|STARTED|Second Intervention||108
10900714|NCT00779116|12066555|FG000|COMPLETED|Second Intervention||109
10900715|NCT00779116|12066556|FG001|COMPLETED|Second Intervention||108
10900716|NCT00779116|12066555|FG000|NOT COMPLETED|Second Intervention||0
10900717|NCT00779116|12066556|FG001|NOT COMPLETED|Second Intervention||0
10900718|NCT00778700|12066567|FG000|STARTED|Overall Study||50
10900719|NCT00778700|12066568|FG001|STARTED|Overall Study||51
10900720|NCT00778700|12066569|FG002|STARTED|Overall Study||49
10900721|NCT00778700|12066570|FG003|STARTED|Overall Study||49
10900722|NCT00778700|12066567|FG000|COMPLETED|Overall Study||32
10900723|NCT00778700|12066568|FG001|COMPLETED|Overall Study||44
10900724|NCT00778700|12066569|FG002|COMPLETED|Overall Study||43
10900725|NCT00778700|12066570|FG003|COMPLETED|Overall Study||36
10900726|NCT00778700|12066567|FG000|NOT COMPLETED|Overall Study||18
10900727|NCT00778700|12066568|FG001|NOT COMPLETED|Overall Study||7
10900728|NCT00778700|12066569|FG002|NOT COMPLETED|Overall Study||6
10900729|NCT00778700|12066570|FG003|NOT COMPLETED|Overall Study||13
10900730|NCT00764478|12066587|FG000|STARTED|Overall Study||122
10900731|NCT00764478|12066588|FG001|STARTED|Overall Study||119
10900732|NCT00764478|12066589|FG002|STARTED|Overall Study||126
10900733|NCT00764478|12066587|FG000|COMPLETED|Overall Study||107
10900734|NCT00764478|12066588|FG001|COMPLETED|Overall Study||97
10900735|NCT00764478|12066589|FG002|COMPLETED|Overall Study||118
10900736|NCT00764478|12066587|FG000|NOT COMPLETED|Overall Study||15
10900737|NCT00764478|12066588|FG001|NOT COMPLETED|Overall Study||22
10900738|NCT00764478|12066589|FG002|NOT COMPLETED|Overall Study||8
10900739|NCT00761527|12066597|FG000|STARTED|Overall Study||2980
10900740|NCT00761527|12066597|FG000|Received One Dose of Study Medication|Overall Study||2978
10900741|NCT00761527|12066597|FG000|COMPLETED|Overall Study||2958
10900742|NCT00761527|12066597|FG000|NOT COMPLETED|Overall Study||22
10900743|NCT00757627|12066601|FG000|STARTED|Overall Study||500
10900744|NCT00757627|12066601|FG000|COMPLETED|Overall Study||419
10900745|NCT00757627|12066601|FG000|NOT COMPLETED|Overall Study||81
10900746|NCT00756938|12066613|FG000|STARTED|12-week Base Study||33
10900747|NCT00756938|12066614|FG001|STARTED|12-week Base Study||34
10900748|NCT00756938|12066615|FG002|STARTED|12-week Base Study||34
10900749|NCT00756938|12066616|FG003|STARTED|12-week Base Study||0
10900750|NCT00756938|12066613|FG000|COMPLETED|12-week Base Study||31
10900751|NCT00756938|12066614|FG001|COMPLETED|12-week Base Study||34
10900752|NCT00756938|12066615|FG002|COMPLETED|12-week Base Study||32
10900753|NCT00756938|12066616|FG003|COMPLETED|12-week Base Study||0
10900754|NCT00756938|12066613|FG000|NOT COMPLETED|12-week Base Study||2
10900755|NCT00756938|12066614|FG001|NOT COMPLETED|12-week Base Study||0
10900756|NCT00756938|12066615|FG002|NOT COMPLETED|12-week Base Study||2
10900757|NCT00756938|12066616|FG003|NOT COMPLETED|12-week Base Study||0
10900758|NCT00756938|12066613|FG000|STARTED|Optional Extension||0
10900759|NCT00756938|12066614|FG001|STARTED|Optional Extension||0
10900760|NCT00756938|12066615|FG002|STARTED|Optional Extension||0
10900761|NCT00756938|12066616|FG003|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
10900762|NCT00756938|12066613|FG000|COMPLETED|Optional Extension||0
10900763|NCT00756938|12066614|FG001|COMPLETED|Optional Extension||0
10900764|NCT00756938|12066615|FG002|COMPLETED|Optional Extension||0
10900765|NCT00756938|12066616|FG003|COMPLETED|Optional Extension||53
10900766|NCT00756938|12066613|FG000|NOT COMPLETED|Optional Extension||0
10900767|NCT00756938|12066614|FG001|NOT COMPLETED|Optional Extension||0
10900768|NCT00756938|12066615|FG002|NOT COMPLETED|Optional Extension||0
10900769|NCT00756938|12066616|FG003|NOT COMPLETED|Optional Extension||37
10900770|NCT00730132|12066634|FG000|STARTED|Overall Study||712
10900771|NCT00730132|12066634|FG000|COMPLETED|Overall Study||557
10900772|NCT00730132|12066634|FG000|NOT COMPLETED|Overall Study||155
10900773|NCT00728416|12066643|FG000|STARTED|Overall Study||168
10900774|NCT00728416|12066644|FG001|STARTED|Overall Study||165
10900775|NCT00728416|12066643|FG000|COMPLETED|Overall Study||166
10900776|NCT00728416|12066644|FG001|COMPLETED|Overall Study||163
10900777|NCT00728416|12066643|FG000|NOT COMPLETED|Overall Study||2
10900778|NCT00728416|12066644|FG001|NOT COMPLETED|Overall Study||2
10900779|NCT00724477|12066650|FG000|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
10900780|NCT00724477|12066650|FG000|COMPLETED|Overall Study||1663
10900781|NCT00724477|12066650|FG000|NOT COMPLETED|Overall Study||0
10900782|NCT00723736|12066654|FG000|STARTED|Overall Study||100
10900783|NCT00723736|12066654|FG000|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
10900784|NCT00723736|12066654|FG000|NOT COMPLETED|Overall Study||1
10900785|NCT00705081|12066660|FG000|STARTED|Overall Study||255
10900786|NCT00705081|12066661|FG001|STARTED|Overall Study||198
10900787|NCT00705081|12066660|FG000|COMPLETED|Overall Study||255
10900788|NCT00705081|12066661|FG001|COMPLETED|Overall Study||198
10900789|NCT00705081|12066660|FG000|NOT COMPLETED|Overall Study||0
10900790|NCT00705081|12066661|FG001|NOT COMPLETED|Overall Study||0
10900791|NCT00704769|12066667|FG000|STARTED|Overall Study||591
10900792|NCT00704769|12066667|FG000|COMPLETED|Overall Study||591
10900793|NCT00704769|12066667|FG000|NOT COMPLETED|Overall Study||0
10900794|NCT00704535|12066671|FG000|STARTED|Overall Study||4105
10900795|NCT00704535|12066671|FG000|COMPLETED|Overall Study||3959
10900796|NCT00704535|12066671|FG000|NOT COMPLETED|Overall Study||146
10900797|NCT00694369|12066680|FG000|STARTED|Overall Study||46
10900798|NCT00694369|12066681|FG001|STARTED|Overall Study||191
10900799|NCT00694369|12066682|FG002|STARTED|Overall Study||97
10900800|NCT00694369|12066683|FG003|STARTED|Overall Study||192
10900801|NCT00694369|12066684|FG004|STARTED|Overall Study||62
10900802|NCT00694369|12066680|FG000|COMPLETED|Overall Study||45
10900803|NCT00694369|12066681|FG001|COMPLETED|Overall Study||188
10900804|NCT00694369|12066682|FG002|COMPLETED|Overall Study||95
10900805|NCT00694369|12066683|FG003|COMPLETED|Overall Study||189
10900806|NCT00694369|12066684|FG004|COMPLETED|Overall Study||56
10900807|NCT00694369|12066680|FG000|NOT COMPLETED|Overall Study||1
10900808|NCT00694369|12066681|FG001|NOT COMPLETED|Overall Study||3
10900809|NCT00694369|12066682|FG002|NOT COMPLETED|Overall Study||2
10900810|NCT00694369|12066683|FG003|NOT COMPLETED|Overall Study||3
10900811|NCT00694369|12066684|FG004|NOT COMPLETED|Overall Study||6
10900812|NCT00671528|12066699|FG000|STARTED|Overall Study||1
10900813|NCT00671528|12066700|FG001|STARTED|Overall Study||1
10900814|NCT00671528|12066701|FG002|STARTED|Overall Study||1
10900815|NCT00671528|12066699|FG000|COMPLETED|Overall Study||1
10900816|NCT00671528|12066700|FG001|COMPLETED|Overall Study||1
10900817|NCT00671528|12066701|FG002|COMPLETED|Overall Study||1
10900818|NCT00671528|12066699|FG000|NOT COMPLETED|Overall Study||0
10900819|NCT00671528|12066700|FG001|NOT COMPLETED|Overall Study||0
10900820|NCT00671528|12066701|FG002|NOT COMPLETED|Overall Study||0
10900821|NCT00667823|12066709|FG000|STARTED|Overall Study||550
10900822|NCT00667823|12066709|FG000|COMPLETED|Overall Study||334
10900823|NCT00667823|12066709|FG000|NOT COMPLETED|Overall Study||216
10900824|NCT00652327|12066715|FG000|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
10900825|NCT00652327|12066716|FG001|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
10900826|NCT00652327|12066715|FG000|COMPLETED|Overall Study||42
10900827|NCT00652327|12066716|FG001|COMPLETED|Overall Study||36
10900828|NCT00652327|12066715|FG000|NOT COMPLETED|Overall Study||0
10900829|NCT00652327|12066716|FG001|NOT COMPLETED|Overall Study||5
10900830|NCT00604500|12066722|FG000|STARTED|Overall Study||272
10900831|NCT00604500|12066722|FG000|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
10900832|NCT00604500|12066722|FG000|NOT COMPLETED|Overall Study||11
10900833|NCT00568178|12066728|FG000|STARTED|Double Blind Base Study||122
10900834|NCT00568178|12066729|FG001|STARTED|Double Blind Base Study||124
10900835|NCT00568178|12066730|FG002|STARTED|Double Blind Base Study||30
10900836|NCT00568178|12066731|FG003|STARTED|Double Blind Base Study||30
10900837|NCT00568178|12066732|FG004|STARTED|Double Blind Base Study||0
10900838|NCT00568178|12066733|FG005|STARTED|Double Blind Base Study||0
10900839|NCT00568178|12066728|FG000|COMPLETED|Double Blind Base Study||116
10900840|NCT00568178|12066729|FG001|COMPLETED|Double Blind Base Study||118
10900841|NCT00568178|12066730|FG002|COMPLETED|Double Blind Base Study||29
10900842|NCT00568178|12066731|FG003|COMPLETED|Double Blind Base Study||25
10900843|NCT00568178|12066732|FG004|COMPLETED|Double Blind Base Study||0
10900844|NCT00568178|12066733|FG005|COMPLETED|Double Blind Base Study||0
10900845|NCT00568178|12066728|FG000|NOT COMPLETED|Double Blind Base Study||6
10900846|NCT00568178|12066729|FG001|NOT COMPLETED|Double Blind Base Study||6
10900847|NCT00568178|12066730|FG002|NOT COMPLETED|Double Blind Base Study||1
10900848|NCT00568178|12066731|FG003|NOT COMPLETED|Double Blind Base Study||5
10900849|NCT00568178|12066732|FG004|NOT COMPLETED|Double Blind Base Study||0
10900850|NCT00568178|12066733|FG005|NOT COMPLETED|Double Blind Base Study||0
10900851|NCT00568178|12066728|FG000|STARTED|Open Label Extension||0
10900852|NCT00568178|12066729|FG001|STARTED|Open Label Extension||0
10900853|NCT00568178|12066730|FG002|STARTED|Open Label Extension||0
10900854|NCT00568178|12066731|FG003|STARTED|Open Label Extension||0
10900855|NCT00568178|12066732|FG004|STARTED|Open Label Extension||134
10900856|NCT00568178|12066733|FG005|STARTED|Open Label Extension||134
10900857|NCT00568178|12066728|FG000|COMPLETED|Open Label Extension||0
10900858|NCT00568178|12066729|FG001|COMPLETED|Open Label Extension||0
10900859|NCT00568178|12066730|FG002|COMPLETED|Open Label Extension||0
10900860|NCT00568178|12066731|FG003|COMPLETED|Open Label Extension||0
10900861|NCT00568178|12066732|FG004|COMPLETED|Open Label Extension||55
10900862|NCT00568178|12066733|FG005|COMPLETED|Open Label Extension||54
10900863|NCT00568178|12066728|FG000|NOT COMPLETED|Open Label Extension||0
10900864|NCT00568178|12066729|FG001|NOT COMPLETED|Open Label Extension||0
10900865|NCT00568178|12066730|FG002|NOT COMPLETED|Open Label Extension||0
10900866|NCT00568178|12066731|FG003|NOT COMPLETED|Open Label Extension||0
10900867|NCT00568178|12066732|FG004|NOT COMPLETED|Open Label Extension||79
10900868|NCT00568178|12066733|FG005|NOT COMPLETED|Open Label Extension||80
10900869|NCT00545844|12066747|FG000|STARTED|Overall Study||313
10900870|NCT00545844|12066747|FG000|COMPLETED|Overall Study||301
10900871|NCT00545844|12066747|FG000|NOT COMPLETED|Overall Study||12
10900872|NCT00511433|12066755|FG000|STARTED|Overall Study||32
10900873|NCT00511433|12066756|FG001|STARTED|Overall Study||16
10900874|NCT00511433|12066755|FG000|COMPLETED|Overall Study||26
10900875|NCT00511433|12066756|FG001|COMPLETED|Overall Study||15
10900876|NCT00511433|12066755|FG000|NOT COMPLETED|Overall Study||6
10900877|NCT00511433|12066756|FG001|NOT COMPLETED|Overall Study||1
10900878|NCT00511355|12066766|FG000|STARTED|Overall Study||60
10900879|NCT00511355|12066767|FG001|STARTED|Overall Study||61
10900880|NCT00511355|12066766|FG000|COMPLETED|Overall Study||53
10900881|NCT00511355|12066767|FG001|COMPLETED|Overall Study||52
10900882|NCT00511355|12066766|FG000|NOT COMPLETED|Overall Study||7
10900883|NCT00511355|12066767|FG001|NOT COMPLETED|Overall Study||9
10900884|NCT00511342|12066777|FG000|STARTED|Overall Study||56
10900885|NCT00511342|12066778|FG001|STARTED|Overall Study||54
10900886|NCT00511342|12066777|FG000|COMPLETED|Overall Study||43
10900887|NCT00511342|12066778|FG001|COMPLETED|Overall Study||32
10900888|NCT00511342|12066777|FG000|NOT COMPLETED|Overall Study||13
10900889|NCT00511342|12066778|FG001|NOT COMPLETED|Overall Study||22
10900890|NCT00511199|12066786|FG000|STARTED|Overall Study||1591
10900891|NCT00511199|12066787|FG001|STARTED|Overall Study||535
10900892|NCT00511199|12066786|FG000|COMPLETED|Overall Study||1142
10900893|NCT00511199|12066787|FG001|COMPLETED|Overall Study||410
10900894|NCT00511199|12066786|FG000|NOT COMPLETED|Overall Study||449
10900895|NCT00511199|12066787|FG001|NOT COMPLETED|Overall Study||125
10900896|NCT00491504|12066799|FG000|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
10900897|NCT00491504|12066800|FG001|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
10900898|NCT00491504|12066801|FG002|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
10900899|NCT00491504|12066802|FG003|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
10900900|NCT00491504|12066799|FG000|COMPLETED|Overall Study||77
10900901|NCT00491504|12066800|FG001|COMPLETED|Overall Study||77
10900902|NCT00491504|12066801|FG002|COMPLETED|Overall Study||74
10900903|NCT00491504|12066802|FG003|COMPLETED|Overall Study||73
10900904|NCT00491504|12066799|FG000|NOT COMPLETED|Overall Study||0
10900905|NCT00491504|12066800|FG001|NOT COMPLETED|Overall Study||1
10900906|NCT00491504|12066801|FG002|NOT COMPLETED|Overall Study||4
10900907|NCT00491504|12066802|FG003|NOT COMPLETED|Overall Study||4
10900908|NCT00468312|12066812|FG000|STARTED|Overall Study||220
10900909|NCT00468312|12066813|FG001|STARTED|Overall Study||209
10900910|NCT00468312|12066812|FG000|COMPLETED|Overall Study||216
10900911|NCT00468312|12066813|FG001|COMPLETED|Overall Study||204
10900912|NCT00468312|12066812|FG000|NOT COMPLETED|Overall Study||4
10900913|NCT00468312|12066813|FG001|NOT COMPLETED|Overall Study||5
10900914|NCT00453063|12066821|FG000|STARTED|Overall Study||211
10900915|NCT00453063|12066822|FG001|STARTED|Overall Study||215
10900916|NCT00453063|12066821|FG000|COMPLETED|Overall Study||208
10900917|NCT00453063|12066822|FG001|COMPLETED|Overall Study||212
10900918|NCT00453063|12066821|FG000|NOT COMPLETED|Overall Study||3
10900919|NCT00453063|12066822|FG001|NOT COMPLETED|Overall Study||3
10900920|NCT00447603|12066828|FG000|STARTED|Screening||40
10900921|NCT00447603|12066829|FG001|STARTED|Screening||0
10900922|NCT00447603|12066830|FG002|STARTED|Screening||0
10900923|NCT00447603|12066828|FG000|COMPLETED|Screening||19
10900924|NCT00447603|12066829|FG001|COMPLETED|Screening||0
10900925|NCT00447603|12066830|FG002|COMPLETED|Screening||0
10900926|NCT00447603|12066828|FG000|NOT COMPLETED|Screening||21
10900927|NCT00447603|12066829|FG001|NOT COMPLETED|Screening||0
10900928|NCT00447603|12066830|FG002|NOT COMPLETED|Screening||0
10900929|NCT00447603|12066828|FG000|STARTED|Filter Period||0
10900930|NCT00447603|12066829|FG001|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
10900931|NCT00447603|12066830|FG002|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
10900932|NCT00447603|12066828|FG000|COMPLETED|Filter Period||0
10900933|NCT00447603|12066829|FG001|COMPLETED|Filter Period||0
10900934|NCT00447603|12066830|FG002|COMPLETED|Filter Period||0
10900935|NCT00447603|12066828|FG000|NOT COMPLETED|Filter Period||0
10900936|NCT00447603|12066829|FG001|NOT COMPLETED|Filter Period||4
10900937|NCT00447603|12066830|FG002|NOT COMPLETED|Filter Period||15
10900938|NCT00442351|12066840|FG000|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
10900939|NCT00442351|12066841|FG001|STARTED|Overall Study||9
10900940|NCT00442351|12066840|FG000|COMPLETED|Overall Study||10
10900941|NCT00442351|12066841|FG001|COMPLETED|Overall Study||3
10900942|NCT00442351|12066840|FG000|NOT COMPLETED|Overall Study||7
10900943|NCT00442351|12066841|FG001|NOT COMPLETED|Overall Study||6
10900944|NCT00423488|12066849|FG000|STARTED|Overall Study||42
10900945|NCT00423488|12066850|FG001|STARTED|Overall Study||51
10900946|NCT00423488|12066849|FG000|COMPLETED|Overall Study||37
10900947|NCT00423488|12066850|FG001|COMPLETED|Overall Study||50
10900948|NCT00423488|12066849|FG000|NOT COMPLETED|Overall Study||5
10900949|NCT00423488|12066850|FG001|NOT COMPLETED|Overall Study||1
10900950|NCT00413972|12066860|FG000|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
10900951|NCT00413972|12066861|FG001|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
10900952|NCT00413972|12066862|FG002|STARTED|Overall Study||98
10900953|NCT00413972|12066863|FG003|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
10900954|NCT00413972|12066860|FG000|COMPLETED|Overall Study||91
10900955|NCT00413972|12066861|FG001|COMPLETED|Overall Study||90
10900956|NCT00413972|12066862|FG002|COMPLETED|Overall Study||88
10900957|NCT00413972|12066863|FG003|COMPLETED|Overall Study||95
10900958|NCT00413972|12066860|FG000|NOT COMPLETED|Overall Study||7
10900959|NCT00413972|12066861|FG001|NOT COMPLETED|Overall Study||8
10900960|NCT00413972|12066862|FG002|NOT COMPLETED|Overall Study||10
10900961|NCT00413972|12066863|FG003|NOT COMPLETED|Overall Study||3
10900962|NCT00413062|12066875|FG000|STARTED|Overall Study||1666
10900963|NCT00413062|12066876|FG001|STARTED|Overall Study||554
10900964|NCT00413062|12066875|FG000|COMPLETED|Overall Study||988
10900965|NCT00413062|12066876|FG001|COMPLETED|Overall Study||344
10900966|NCT00413062|12066875|FG000|NOT COMPLETED|Overall Study||678
10900967|NCT00413062|12066876|FG001|NOT COMPLETED|Overall Study||210
10900968|NCT00391170|12066886|FG000|STARTED|Overall Study||27
10900969|NCT00391170|12066887|FG001|STARTED|Overall Study||27
10900970|NCT00391170|12066886|FG000|COMPLETED|Overall Study||21
10900971|NCT00391170|12066887|FG001|COMPLETED|Overall Study||23
10900972|NCT00391170|12066886|FG000|NOT COMPLETED|Overall Study||6
10900973|NCT00391170|12066887|FG001|NOT COMPLETED|Overall Study||4
10900974|NCT00359138|12066896|FG000|STARTED|Overall Study||12
10900975|NCT00359138|12066897|FG001|STARTED|Overall Study||12
10900976|NCT00359138|12066898|FG002|STARTED|Overall Study||12
10900977|NCT00359138|12066896|FG000|COMPLETED|Overall Study||12
10900978|NCT00359138|12066897|FG001|COMPLETED|Overall Study||12
10900979|NCT00359138|12066898|FG002|COMPLETED|Overall Study||12
10900980|NCT00359138|12066896|FG000|NOT COMPLETED|Overall Study||0
10900981|NCT00359138|12066897|FG001|NOT COMPLETED|Overall Study||0
10900982|NCT00359138|12066898|FG002|NOT COMPLETED|Overall Study||0
10900983|NCT00350701|12066909|FG000|STARTED|Overall Study||17
10900984|NCT00350701|12066910|FG001|STARTED|Overall Study||17
10900985|NCT00350701|12066911|FG002|STARTED|Overall Study||15
10900986|NCT00350701|12066909|FG000|COMPLETED|Overall Study||17
10900987|NCT00350701|12066910|FG001|COMPLETED|Overall Study||17
10900988|NCT00350701|12066911|FG002|COMPLETED|Overall Study||15
10900989|NCT00350701|12066909|FG000|NOT COMPLETED|Overall Study||0
10900990|NCT00350701|12066910|FG001|NOT COMPLETED|Overall Study||0
10900991|NCT00350701|12066911|FG002|NOT COMPLETED|Overall Study||0
10900992|NCT00319449|12066921|FG000|STARTED|Overall Study||10
10900993|NCT00319449|12066922|FG001|STARTED|Overall Study||12
10900994|NCT00319449|12066921|FG000|COMPLETED|Overall Study||8
10900995|NCT00319449|12066922|FG001|COMPLETED|Overall Study||12
10900996|NCT00319449|12066921|FG000|NOT COMPLETED|Overall Study||2
10900997|NCT00319449|12066922|FG001|NOT COMPLETED|Overall Study||0
10900998|NCT00305344|12066928|FG000|STARTED|Overall Study||23
10900999|NCT00305344|12066928|FG000|COMPLETED|Overall Study||23
10901000|NCT00305344|12066928|FG000|NOT COMPLETED|Overall Study||0
10901001|NCT00289887|12066934|FG000|STARTED|Overall Study||127
10901002|NCT00289887|12066935|FG001|STARTED|Overall Study||134
10901003|NCT00289887|12066934|FG000|COMPLETED|Overall Study||105
10901004|NCT00289887|12066935|FG001|COMPLETED|Overall Study||105
10901005|NCT00289887|12066934|FG000|NOT COMPLETED|Overall Study||22
10901006|NCT00289887|12066935|FG001|NOT COMPLETED|Overall Study||29
10901007|NCT00281320|12066943|FG000|STARTED|Overall Study||61
10901008|NCT00281320|12066944|FG001|STARTED|Overall Study||61
10901009|NCT00281320|12066943|FG000|COMPLETED|Overall Study||36
10901010|NCT00281320|12066944|FG001|COMPLETED|Overall Study||40
10901011|NCT00281320|12066943|FG000|NOT COMPLETED|Overall Study||25
10901012|NCT00281320|12066944|FG001|NOT COMPLETED|Overall Study||21
10901013|NCT00276016|12066962|FG000|STARTED|Intervention 1||7
10901014|NCT00276016|12066963|FG001|STARTED|Intervention 1||7
10901015|NCT00276016|12066964|FG002|STARTED|Intervention 1||7
10901016|NCT00276016|12066965|FG003|STARTED|Intervention 1||6
10901017|NCT00276016|12066966|FG004|STARTED|Intervention 1||6
10901018|NCT00276016|12066967|FG005|STARTED|Intervention 1||6
10901019|NCT00276016|12066962|FG000|COMPLETED|Intervention 1||7
10901020|NCT00276016|12066963|FG001|COMPLETED|Intervention 1||6
10901021|NCT00276016|12066964|FG002|COMPLETED|Intervention 1||7
10901022|NCT00276016|12066965|FG003|COMPLETED|Intervention 1||6
10901023|NCT00276016|12066966|FG004|COMPLETED|Intervention 1||6
10901024|NCT00276016|12066967|FG005|COMPLETED|Intervention 1||6
10901025|NCT00276016|12066962|FG000|NOT COMPLETED|Intervention 1||0
10901026|NCT00276016|12066963|FG001|NOT COMPLETED|Intervention 1||1
10901027|NCT00276016|12066964|FG002|NOT COMPLETED|Intervention 1||0
10901028|NCT00276016|12066965|FG003|NOT COMPLETED|Intervention 1||0
10901029|NCT00276016|12066966|FG004|NOT COMPLETED|Intervention 1||0
10901030|NCT00276016|12066967|FG005|NOT COMPLETED|Intervention 1||0
10901031|NCT00276016|12066962|FG000|STARTED|Wash Out 1||7
10901032|NCT00276016|12066963|FG001|STARTED|Wash Out 1||6
10901033|NCT00276016|12066964|FG002|STARTED|Wash Out 1||7
10901034|NCT00276016|12066965|FG003|STARTED|Wash Out 1||6
10901035|NCT00276016|12066966|FG004|STARTED|Wash Out 1||6
10901036|NCT00276016|12066967|FG005|STARTED|Wash Out 1||6
10901037|NCT00276016|12066962|FG000|COMPLETED|Wash Out 1||7
10901038|NCT00276016|12066963|FG001|COMPLETED|Wash Out 1||6
10901039|NCT00276016|12066964|FG002|COMPLETED|Wash Out 1||7
10901040|NCT00276016|12066965|FG003|COMPLETED|Wash Out 1||6
10901041|NCT00276016|12066966|FG004|COMPLETED|Wash Out 1||6
10901042|NCT00276016|12066967|FG005|COMPLETED|Wash Out 1||6
10901043|NCT00276016|12066962|FG000|NOT COMPLETED|Wash Out 1||0
10901044|NCT00276016|12066963|FG001|NOT COMPLETED|Wash Out 1||0
10901045|NCT00276016|12066964|FG002|NOT COMPLETED|Wash Out 1||0
10901046|NCT00276016|12066965|FG003|NOT COMPLETED|Wash Out 1||0
10901047|NCT00276016|12066966|FG004|NOT COMPLETED|Wash Out 1||0
10901048|NCT00276016|12066967|FG005|NOT COMPLETED|Wash Out 1||0
10901049|NCT00276016|12066962|FG000|STARTED|Intervention 2||7
10901050|NCT00276016|12066963|FG001|STARTED|Intervention 2||6
10901051|NCT00276016|12066964|FG002|STARTED|Intervention 2||7
10901052|NCT00276016|12066965|FG003|STARTED|Intervention 2||6
10901053|NCT00276016|12066966|FG004|STARTED|Intervention 2||6
10901054|NCT00276016|12066967|FG005|STARTED|Intervention 2||6
10901055|NCT00276016|12066962|FG000|COMPLETED|Intervention 2||7
10901056|NCT00276016|12066963|FG001|COMPLETED|Intervention 2||6
10901057|NCT00276016|12066964|FG002|COMPLETED|Intervention 2||7
10901058|NCT00276016|12066965|FG003|COMPLETED|Intervention 2||6
10901059|NCT00276016|12066966|FG004|COMPLETED|Intervention 2||6
10901060|NCT00276016|12066967|FG005|COMPLETED|Intervention 2||6
10901061|NCT00276016|12066962|FG000|NOT COMPLETED|Intervention 2||0
10901062|NCT00276016|12066963|FG001|NOT COMPLETED|Intervention 2||0
10901063|NCT00276016|12066964|FG002|NOT COMPLETED|Intervention 2||0
10901064|NCT00276016|12066965|FG003|NOT COMPLETED|Intervention 2||0
10901065|NCT00276016|12066966|FG004|NOT COMPLETED|Intervention 2||0
10901066|NCT00276016|12066967|FG005|NOT COMPLETED|Intervention 2||0
10901067|NCT00276016|12066962|FG000|STARTED|Wash Out 2||7
10901068|NCT00276016|12066963|FG001|STARTED|Wash Out 2||6
10901069|NCT00276016|12066964|FG002|STARTED|Wash Out 2||7
10901070|NCT00276016|12066965|FG003|STARTED|Wash Out 2||6
10901071|NCT00276016|12066966|FG004|STARTED|Wash Out 2||6
10901072|NCT00276016|12066967|FG005|STARTED|Wash Out 2||6
10901073|NCT00276016|12066962|FG000|COMPLETED|Wash Out 2||7
10901074|NCT00276016|12066963|FG001|COMPLETED|Wash Out 2||6
10901075|NCT00276016|12066964|FG002|COMPLETED|Wash Out 2||7
10901076|NCT00276016|12066965|FG003|COMPLETED|Wash Out 2||6
10901077|NCT00276016|12066966|FG004|COMPLETED|Wash Out 2||6
10901078|NCT00276016|12066967|FG005|COMPLETED|Wash Out 2||6
10901079|NCT00276016|12066962|FG000|NOT COMPLETED|Wash Out 2||0
10901080|NCT00276016|12066963|FG001|NOT COMPLETED|Wash Out 2||0
10901081|NCT00276016|12066964|FG002|NOT COMPLETED|Wash Out 2||0
10901082|NCT00276016|12066965|FG003|NOT COMPLETED|Wash Out 2||0
10901083|NCT00276016|12066966|FG004|NOT COMPLETED|Wash Out 2||0
10901084|NCT00276016|12066967|FG005|NOT COMPLETED|Wash Out 2||0
10901085|NCT00276016|12066962|FG000|STARTED|Intervention 3||7
10901086|NCT00276016|12066963|FG001|STARTED|Intervention 3||6
10901087|NCT00276016|12066964|FG002|STARTED|Intervention 3||7
10901088|NCT00276016|12066965|FG003|STARTED|Intervention 3||6
10901089|NCT00276016|12066966|FG004|STARTED|Intervention 3||6
10901090|NCT00276016|12066967|FG005|STARTED|Intervention 3||6
10901091|NCT00276016|12066962|FG000|COMPLETED|Intervention 3||7
10901092|NCT00276016|12066963|FG001|COMPLETED|Intervention 3||6
10901093|NCT00276016|12066964|FG002|COMPLETED|Intervention 3||7
10901094|NCT00276016|12066965|FG003|COMPLETED|Intervention 3||6
10901095|NCT00276016|12066966|FG004|COMPLETED|Intervention 3||6
10901096|NCT00276016|12066967|FG005|COMPLETED|Intervention 3||6
10901097|NCT00276016|12066962|FG000|NOT COMPLETED|Intervention 3||0
10901098|NCT00276016|12066963|FG001|NOT COMPLETED|Intervention 3||0
10901099|NCT00276016|12066964|FG002|NOT COMPLETED|Intervention 3||0
10901100|NCT00276016|12066965|FG003|NOT COMPLETED|Intervention 3||0
10901101|NCT00276016|12066966|FG004|NOT COMPLETED|Intervention 3||0
10901102|NCT00276016|12066967|FG005|NOT COMPLETED|Intervention 3||0
10901103|NCT00265343|12066978|FG000|STARTED|Overall Study||134
10901104|NCT00265343|12066979|FG001|STARTED|Overall Study||172
10901105|NCT00265343|12066978|FG000|COMPLETED|Overall Study||113
10901106|NCT00265343|12066979|FG001|COMPLETED|Overall Study||153
10901107|NCT00265343|12066978|FG000|NOT COMPLETED|Overall Study||21
10901108|NCT00265343|12066979|FG001|NOT COMPLETED|Overall Study||19
10901109|NCT00264147|12066990|FG000|STARTED|Treatment I Period||161
10901110|NCT00264147|12066991|FG001|STARTED|Treatment I Period||154
10901111|NCT00264147|12066992|FG002|STARTED|Treatment I Period||151
10901112|NCT00264147|12066993|FG003|STARTED|Treatment I Period||140
10901113|NCT00264147|12066994|FG004|STARTED|Treatment I Period||155
10901114|NCT00264147|12066995|FG005|STARTED|Treatment I Period||0
10901115|NCT00264147|12066990|FG000|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
10901116|NCT00264147|12066991|FG001|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
10901117|NCT00264147|12066992|FG002|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
10901118|NCT00264147|12066993|FG003|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
10901119|NCT00264147|12066994|FG004|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
10901120|NCT00264147|12066995|FG005|COMPLETED|Treatment I Period||0
10901121|NCT00264147|12066990|FG000|NOT COMPLETED|Treatment I Period||98
10901122|NCT00264147|12066991|FG001|NOT COMPLETED|Treatment I Period||83
10901123|NCT00264147|12066992|FG002|NOT COMPLETED|Treatment I Period||77
10901124|NCT00264147|12066993|FG003|NOT COMPLETED|Treatment I Period||72
10901125|NCT00264147|12066994|FG004|NOT COMPLETED|Treatment I Period||56
10901126|NCT00264147|12066995|FG005|NOT COMPLETED|Treatment I Period||0
10901127|NCT00264147|12066990|FG000|STARTED|Treatment II Period||0
10901128|NCT00264147|12066991|FG001|STARTED|Treatment II Period||0
10901129|NCT00264147|12066992|FG002|STARTED|Treatment II Period||0
10901130|NCT00264147|12066993|FG003|STARTED|Treatment II Period||0
10901131|NCT00264147|12066994|FG004|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
10901132|NCT00264147|12066995|FG005|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
10901133|NCT00264147|12066990|FG000|COMPLETED|Treatment II Period||0
10901134|NCT00264147|12066991|FG001|COMPLETED|Treatment II Period||0
10901135|NCT00264147|12066992|FG002|COMPLETED|Treatment II Period||0
10901136|NCT00264147|12066993|FG003|COMPLETED|Treatment II Period||0
10901137|NCT00264147|12066994|FG004|COMPLETED|Treatment II Period||147
10901138|NCT00264147|12066995|FG005|COMPLETED|Treatment II Period||116
10901139|NCT00264147|12066990|FG000|NOT COMPLETED|Treatment II Period||0
10901140|NCT00264147|12066991|FG001|NOT COMPLETED|Treatment II Period||0
10901141|NCT00264147|12066992|FG002|NOT COMPLETED|Treatment II Period||0
10901142|NCT00264147|12066993|FG003|NOT COMPLETED|Treatment II Period||0
10901143|NCT00264147|12066994|FG004|NOT COMPLETED|Treatment II Period||33
10901144|NCT00264147|12066995|FG005|NOT COMPLETED|Treatment II Period||33
10901145|NCT00202878|12067011|FG000|STARTED|Overall Study||9067
10901146|NCT00202878|12067012|FG001|STARTED|Overall Study||9077
10901147|NCT00202878|12067011|FG000|COMPLETED|Overall Study||6868
10901148|NCT00202878|12067012|FG001|COMPLETED|Overall Study||6860
10901149|NCT00202878|12067011|FG000|NOT COMPLETED|Overall Study||2199
10901150|NCT00202878|12067012|FG001|NOT COMPLETED|Overall Study||2217
10901233|NCT00003404|12067095|FG000|STARTED|Overall Study||46
10901151|NCT00174265|12067020|FG000|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
10901152|NCT00174265|12067021|FG001|STARTED|Overall Study||110
10901153|NCT00174265|12067020|FG000|COMPLETED|Overall Study||57
10901154|NCT00174265|12067021|FG001|COMPLETED|Overall Study||89
10901155|NCT00174265|12067020|FG000|NOT COMPLETED|Overall Study||29
10901156|NCT00174265|12067021|FG001|NOT COMPLETED|Overall Study||21
10901157|NCT00159783|12067030|FG000|STARTED|Overall Study||32
10901158|NCT00159783|12067031|FG001|STARTED|Overall Study||79
10901159|NCT00159783|12067032|FG002|STARTED|Overall Study||107
10901160|NCT00159783|12067030|FG000|COMPLETED|Overall Study||13
10901161|NCT00159783|12067031|FG001|COMPLETED|Overall Study||52
10901162|NCT00159783|12067032|FG002|COMPLETED|Overall Study||68
10901163|NCT00159783|12067030|FG000|NOT COMPLETED|Overall Study||19
10901164|NCT00159783|12067031|FG001|NOT COMPLETED|Overall Study||27
10901165|NCT00159783|12067032|FG002|NOT COMPLETED|Overall Study||39
10901166|NCT00092677|12067043|FG000|STARTED|Overall Study||944
10901167|NCT00092677|12067044|FG001|STARTED|Overall Study||929
10901168|NCT00092677|12067043|FG000|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
10901169|NCT00092677|12067044|FG001|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
10901170|NCT00092677|12067043|FG000|NOT COMPLETED|Overall Study||5
10901171|NCT00092677|12067044|FG001|NOT COMPLETED|Overall Study||11
10901172|NCT00090259|12067052|FG000|STARTED|Overall Study||1913
10901173|NCT00090259|12067053|FG001|STARTED|Overall Study||1921
10901174|NCT00090259|12067052|FG000|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
10901175|NCT00090259|12067053|FG001|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
10901176|NCT00090259|12067052|FG000|NOT COMPLETED|Overall Study||62
10901177|NCT00090259|12067053|FG001|NOT COMPLETED|Overall Study||48
10901178|NCT00003298|12067059|FG000|STARTED|Step 1 (Neoadjuvant Therapy)||39
10901179|NCT00003298|12067059|FG000|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
10901180|NCT00003298|12067059|FG000|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
10901181|NCT00003298|12067059|FG000|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
10901182|NCT00003298|12067059|FG000|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
10901183|NCT00003298|12067059|FG000|STARTED|Surgery||35
10901184|NCT00003298|12067059|FG000|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
10901185|NCT00003298|12067059|FG000|NOT COMPLETED|Surgery||7
10901186|NCT00003298|12067059|FG000|STARTED|Re-register to Step 2 After Surgery||28
10901187|NCT00003298|12067059|FG000|COMPLETED|Re-register to Step 2 After Surgery||10
10901188|NCT00003298|12067059|FG000|NOT COMPLETED|Re-register to Step 2 After Surgery||18
10901189|NCT00003298|12067059|FG000|STARTED|Step 2 (Adjuvant Therapy)||10
10901190|NCT00003298|12067059|FG000|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
10901191|NCT00003298|12067059|FG000|COMPLETED|Step 2 (Adjuvant Therapy)||4
10901192|NCT00003298|12067059|FG000|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
10901193|NCT00003377|12067069|FG000|STARTED|Period I||3
10901194|NCT00003377|12067070|FG001|STARTED|Period I||3
10901195|NCT00003377|12067071|FG002|STARTED|Period I||3
10901196|NCT00003377|12067072|FG003|STARTED|Period I||3
10901197|NCT00003377|12067073|FG004|STARTED|Period I||0
10901198|NCT00003377|12067069|FG000|COMPLETED|Period I||3
10901199|NCT00003377|12067070|FG001|COMPLETED|Period I||3
10901200|NCT00003377|12067071|FG002|COMPLETED|Period I||2
10901201|NCT00003377|12067072|FG003|COMPLETED|Period I||2
10901202|NCT00003377|12067073|FG004|COMPLETED|Period I||0
10901203|NCT00003377|12067069|FG000|NOT COMPLETED|Period I||0
10901204|NCT00003377|12067070|FG001|NOT COMPLETED|Period I||0
10901205|NCT00003377|12067071|FG002|NOT COMPLETED|Period I||1
10901206|NCT00003377|12067072|FG003|NOT COMPLETED|Period I||1
10901207|NCT00003377|12067073|FG004|NOT COMPLETED|Period I||0
10901208|NCT00003377|12067069|FG000|STARTED|Period II|Patients participated at this dose level only in Period I.|0
10901209|NCT00003377|12067070|FG001|STARTED|Period II|Patients participated at this dose level only in Period I.|0
10901210|NCT00003377|12067071|FG002|STARTED|Period II|Patients participated at this dose level only in Period I.|0
10901211|NCT00003377|12067072|FG003|STARTED|Period II|Patients participated at this dose level only in Period I.|0
10901212|NCT00003377|12067073|FG004|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
10901213|NCT00003377|12067069|FG000|COMPLETED|Period II||0
10901214|NCT00003377|12067070|FG001|COMPLETED|Period II||0
10901215|NCT00003377|12067071|FG002|COMPLETED|Period II||0
10901216|NCT00003377|12067072|FG003|COMPLETED|Period II||0
10901217|NCT00003377|12067073|FG004|COMPLETED|Period II||16
10901218|NCT00003377|12067069|FG000|NOT COMPLETED|Period II||0
10901219|NCT00003377|12067070|FG001|NOT COMPLETED|Period II||0
10901220|NCT00003377|12067071|FG002|NOT COMPLETED|Period II||0
10901221|NCT00003377|12067072|FG003|NOT COMPLETED|Period II||0
10901222|NCT00003377|12067073|FG004|NOT COMPLETED|Period II||1
10901223|NCT00003389|12067088|FG000|STARTED|Overall Study||428
10901224|NCT00003389|12067089|FG001|STARTED|Overall Study||426
10901225|NCT00003389|12067088|FG000|Treated Pts w/ Toxicity Data Available|Overall Study||414
10901226|NCT00003389|12067089|FG001|Treated Pts w/ Toxicity Data Available|Overall Study||422
10901227|NCT00003389|12067088|FG000|Eligible Patients|Overall Study||395
10901228|NCT00003389|12067089|FG001|Eligible Patients|Overall Study||399
10901229|NCT00003389|12067088|FG000|COMPLETED|Overall Study||330
10901230|NCT00003389|12067089|FG001|COMPLETED|Overall Study||366
10901231|NCT00003389|12067088|FG000|NOT COMPLETED|Overall Study||98
10901232|NCT00003389|12067089|FG001|NOT COMPLETED|Overall Study||60
10901234|NCT00003404|12067095|FG000|COMPLETED|Overall Study||46
10901235|NCT00003404|12067095|FG000|NOT COMPLETED|Overall Study||0
10901236|NCT00003453|12067100|FG000|STARTED|Overall Study||6
10901237|NCT00003453|12067100|FG000|COMPLETED|Overall Study|One patient was not evaluable|5
10901238|NCT00003453|12067100|FG000|NOT COMPLETED|Overall Study||1
10901239|NCT00003456|12067104|FG000|STARTED|Overall Study||40
10901240|NCT00003456|12067104|FG000|COMPLETED|Overall Study||32
10901241|NCT00003456|12067104|FG000|NOT COMPLETED|Overall Study||8
10901242|NCT00003457|12067108|FG000|STARTED|Overall Study||40
10901243|NCT00003457|12067108|FG000|COMPLETED|Overall Study||31
10901244|NCT00003457|12067108|FG000|NOT COMPLETED|Overall Study||9
10901245|NCT00003459|12067112|FG000|STARTED|Overall Study||40
10901246|NCT00003459|12067112|FG000|COMPLETED|Overall Study|Nine patients were not evaluable.|31
10901247|NCT00003459|12067112|FG000|NOT COMPLETED|Overall Study||9
10901248|NCT00003460|12067116|FG000|STARTED|Overall Study||13
10901249|NCT00003460|12067116|FG000|COMPLETED|Overall Study|One patient was not evaluable.|12
10901250|NCT00003460|12067116|FG000|NOT COMPLETED|Overall Study||1
10901251|NCT00003468|12067120|FG000|STARTED|Overall Study||11
10901252|NCT00003468|12067120|FG000|COMPLETED|Overall Study|Two patients were not evaluable.|9
10901253|NCT00003468|12067120|FG000|NOT COMPLETED|Overall Study||2
10901254|NCT00003469|12067124|FG000|STARTED|Overall Study||4
10901255|NCT00003469|12067124|FG000|COMPLETED|Overall Study||4
10901256|NCT00003469|12067124|FG000|NOT COMPLETED|Overall Study||0
10901257|NCT00003470|12067128|FG000|STARTED|Overall Study||27
10901258|NCT00003470|12067128|FG000|COMPLETED|Overall Study||21
10901259|NCT00003470|12067128|FG000|NOT COMPLETED|Overall Study||6
10901260|NCT00003471|12067132|FG000|STARTED|Overall Study||7
10901261|NCT00003471|12067132|FG000|COMPLETED|Overall Study||3
10901262|NCT00003471|12067132|FG000|NOT COMPLETED|Overall Study||4
10901263|NCT00003472|12067136|FG000|STARTED|Overall Study||13
10901264|NCT00003472|12067136|FG000|COMPLETED|Overall Study||10
10901265|NCT00003472|12067136|FG000|NOT COMPLETED|Overall Study||3
10901266|NCT00003473|12067140|FG000|STARTED|Overall Study||20
10901267|NCT00003473|12067140|FG000|COMPLETED|Overall Study||17
10901268|NCT00003473|12067140|FG000|NOT COMPLETED|Overall Study||3
10901269|NCT00003474|12067144|FG000|STARTED|Overall Study||40
10901270|NCT00003474|12067144|FG000|COMPLETED|Overall Study||26
10901271|NCT00003474|12067144|FG000|NOT COMPLETED|Overall Study||14
10901272|NCT00003475|12067148|FG000|STARTED|Overall Study||40
10901273|NCT00003475|12067148|FG000|COMPLETED|Overall Study||27
10901274|NCT00003475|12067148|FG000|NOT COMPLETED|Overall Study||13
10901275|NCT00003476|12067153|FG000|STARTED|Overall Study||8
10901276|NCT00003476|12067153|FG000|COMPLETED|Overall Study||7
10901277|NCT00003476|12067153|FG000|NOT COMPLETED|Overall Study||1
10901278|NCT00003477|12067157|FG000|STARTED|Overall Study||12
10901279|NCT00003477|12067157|FG000|COMPLETED|Overall Study||8
10901280|NCT00003477|12067157|FG000|NOT COMPLETED|Overall Study||4
10901281|NCT00003483|12067161|FG000|STARTED|Overall Study||3
10901282|NCT00003483|12067161|FG000|COMPLETED|Overall Study||2
10901283|NCT00003483|12067161|FG000|NOT COMPLETED|Overall Study||1
10901284|NCT00003487|12067165|FG000|STARTED|Overall Study||8
10901285|NCT00003487|12067165|FG000|COMPLETED|Overall Study||6
10901286|NCT00003487|12067165|FG000|NOT COMPLETED|Overall Study||2
10901287|NCT00003492|12067169|FG000|STARTED|Overall Study||9
10901288|NCT00003492|12067169|FG000|COMPLETED|Overall Study||3
10901289|NCT00003492|12067169|FG000|NOT COMPLETED|Overall Study||6
10901290|NCT00003498|12067173|FG000|STARTED|Overall Study||5
10901291|NCT00003498|12067173|FG000|COMPLETED|Overall Study||1
10901292|NCT00003498|12067173|FG000|NOT COMPLETED|Overall Study||4
10901293|NCT00003499|12067177|FG000|STARTED|Overall Study||31
10901294|NCT00003499|12067177|FG000|COMPLETED|Overall Study||23
10901295|NCT00003499|12067177|FG000|NOT COMPLETED|Overall Study||8
10901296|NCT00003508|12067181|FG000|STARTED|Overall Study||8
10901297|NCT00003508|12067181|FG000|COMPLETED|Overall Study||3
10901298|NCT00003508|12067181|FG000|NOT COMPLETED|Overall Study||5
10901299|NCT00003509|12067185|FG000|STARTED|Overall Study||13
10901300|NCT00003509|12067185|FG000|COMPLETED|Overall Study||8
10901301|NCT00003509|12067185|FG000|NOT COMPLETED|Overall Study||5
10901302|NCT00003511|12067189|FG000|STARTED|Overall Study||5
10901303|NCT00003511|12067189|FG000|COMPLETED|Overall Study||1
10901304|NCT00003511|12067189|FG000|NOT COMPLETED|Overall Study||4
10901305|NCT00003526|12067193|FG000|STARTED|Overall Study||8
10901306|NCT00003526|12067193|FG000|COMPLETED|Overall Study||2
10901307|NCT00003526|12067193|FG000|NOT COMPLETED|Overall Study||6
10901308|NCT00003531|12067197|FG000|STARTED|Overall Study||15
10901309|NCT00003531|12067197|FG000|COMPLETED|Overall Study||5
10901310|NCT00003531|12067197|FG000|NOT COMPLETED|Overall Study||10
10901311|NCT00003535|12067201|FG000|STARTED|Overall Study||9
10901312|NCT00003535|12067201|FG000|COMPLETED|Overall Study||4
10901313|NCT00003535|12067201|FG000|NOT COMPLETED|Overall Study||5
10901314|NCT00003537|12067205|FG000|STARTED|Overall Study||19
10901315|NCT00003537|12067205|FG000|COMPLETED|Overall Study||18
10901316|NCT00003537|12067205|FG000|NOT COMPLETED|Overall Study||1
10901317|NCT00003590|12067209|FG000|STARTED|Overall Study||29
10901318|NCT00003590|12067209|FG000|Eligible|Overall Study||28
10901319|NCT00003590|12067209|FG000|Eligible and Began Protocol Therapy|Overall Study||28
10901320|NCT00003590|12067209|FG000|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
10901321|NCT00003590|12067209|FG000|NOT COMPLETED|Overall Study||22
10901322|NCT00003631|12067216|FG000|STARTED|Overall Study||50
10901323|NCT00003631|12067217|FG001|STARTED|Overall Study||44
10901324|NCT00003631|12067218|FG002|STARTED|Overall Study||24
10901325|NCT00003631|12067216|FG000|COMPLETED|Overall Study||47
10901326|NCT00003631|12067217|FG001|COMPLETED|Overall Study||43
10901327|NCT00003631|12067218|FG002|COMPLETED|Overall Study||15
10901328|NCT00003631|12067216|FG000|NOT COMPLETED|Overall Study||3
10901329|NCT00003631|12067217|FG001|NOT COMPLETED|Overall Study||1
10901330|NCT00003631|12067218|FG002|NOT COMPLETED|Overall Study||9
10901331|NCT00003644|12067228|FG000|STARTED|Overall Study||289
10901332|NCT00003644|12067229|FG001|STARTED|Overall Study||282
10901333|NCT00003644|12067228|FG000|COMPLETED|Overall Study||274
10901334|NCT00003644|12067229|FG001|COMPLETED|Overall Study||268
10901335|NCT00003644|12067228|FG000|NOT COMPLETED|Overall Study||15
10901336|NCT00003644|12067229|FG001|NOT COMPLETED|Overall Study||14
10901337|NCT00003645|12067239|FG000|STARTED|Overall Study||30
10901338|NCT00003645|12067240|FG001|STARTED|Overall Study||34
10901339|NCT00003645|12067239|FG000|COMPLETED|Overall Study||18
10901340|NCT00003645|12067240|FG001|COMPLETED|Overall Study||22
10901341|NCT00003645|12067239|FG000|NOT COMPLETED|Overall Study||12
10901342|NCT00003645|12067240|FG001|NOT COMPLETED|Overall Study||12
10901343|NCT00003659|12067248|FG000|STARTED|Overall Study||39
10901344|NCT00003659|12067248|FG000|COMPLETED|Overall Study||36
10901345|NCT00003659|12067248|FG000|NOT COMPLETED|Overall Study||3
10901346|NCT00003702|12067254|FG000|STARTED|Overall Study||120
10901347|NCT00003702|12067255|FG001|STARTED|Overall Study||120
10901348|NCT00003702|12067254|FG000|COMPLETED|Overall Study||107
10901349|NCT00003702|12067255|FG001|COMPLETED|Overall Study||109
10901350|NCT00003702|12067254|FG000|NOT COMPLETED|Overall Study||13
10901351|NCT00003702|12067255|FG001|NOT COMPLETED|Overall Study||11
10901352|NCT00003782|12067265|FG000|STARTED|Overall Study||1783
10901353|NCT00003782|12067266|FG001|STARTED|Overall Study||1784
10901354|NCT00003782|12067267|FG002|STARTED|Overall Study||1784
10901355|NCT00003782|12067265|FG000|COMPLETED|Overall Study||1753
10901356|NCT00003782|12067266|FG001|COMPLETED|Overall Study||1753
10901357|NCT00003782|12067267|FG002|COMPLETED|Overall Study||1758
10901358|NCT00003782|12067265|FG000|NOT COMPLETED|Overall Study||30
10901359|NCT00003782|12067266|FG001|NOT COMPLETED|Overall Study||31
10901360|NCT00003782|12067267|FG002|NOT COMPLETED|Overall Study||26
10901361|NCT00003816|12067280|FG000|STARTED|Overall Study||55
10901362|NCT00003816|12067281|FG001|STARTED|Overall Study||69
10901363|NCT00003816|12067282|FG002|STARTED|Overall Study||199
10901364|NCT00003816|12067283|FG003|STARTED|Overall Study||23
10901365|NCT00003816|12067284|FG004|STARTED|Overall Study||15
10901366|NCT00003816|12067280|FG000|COMPLETED|Overall Study||55
10901367|NCT00003816|12067281|FG001|COMPLETED|Overall Study||69
10901368|NCT00003816|12067282|FG002|COMPLETED|Overall Study||199
10901369|NCT00003816|12067283|FG003|COMPLETED|Overall Study||23
10901370|NCT00003816|12067284|FG004|COMPLETED|Overall Study||15
10901371|NCT00003816|12067280|FG000|NOT COMPLETED|Overall Study||0
10901372|NCT00003816|12067281|FG001|NOT COMPLETED|Overall Study||0
10901373|NCT00003816|12067282|FG002|NOT COMPLETED|Overall Study||0
10901374|NCT00003816|12067283|FG003|NOT COMPLETED|Overall Study||0
10901375|NCT00003816|12067284|FG004|NOT COMPLETED|Overall Study||0
10901376|NCT00003820|12067296|FG000|STARTED|Cycle 1 (Initial Treatment)||23
10901377|NCT00003820|12067297|FG001|STARTED|Cycle 1 (Initial Treatment)||16
10901378|NCT00003820|12067296|FG000|COMPLETED|Cycle 1 (Initial Treatment)||23
10901379|NCT00003820|12067297|FG001|COMPLETED|Cycle 1 (Initial Treatment)||16
10901380|NCT00003820|12067296|FG000|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
10901381|NCT00003820|12067297|FG001|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
10901382|NCT00003820|12067296|FG000|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
10901383|NCT00003820|12067297|FG001|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
10901384|NCT00003820|12067296|FG000|COMPLETED|Cycle 2 (Maintenance Treatment)||0
10901385|NCT00003820|12067297|FG001|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
10901386|NCT00003820|12067296|FG000|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
10901387|NCT00003820|12067297|FG001|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
10901388|NCT00003820|12067296|FG000|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
10901389|NCT00003820|12067297|FG001|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
10901390|NCT00003820|12067296|FG000|COMPLETED|Cycle 3 (Maintenance Treatment)||0
10901391|NCT00003820|12067297|FG001|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
10901392|NCT00003820|12067296|FG000|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
10901393|NCT00003820|12067297|FG001|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
10901394|NCT00003820|12067296|FG000|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
10901395|NCT00003820|12067297|FG001|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
10901396|NCT00003820|12067296|FG000|COMPLETED|Cycle 4 (Maintenance Treatment)||0
10901397|NCT00003820|12067297|FG001|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
10901398|NCT00003820|12067296|FG000|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
10901399|NCT00003820|12067297|FG001|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
10901400|NCT00003830|12067305|FG000|STARTED|Overall Study||2807
10901401|NCT00003830|12067306|FG001|STARTED|Overall Study||2804
10901402|NCT00003830|12067305|FG000|COMPLETED|Overall Study||1975
10901403|NCT00003830|12067306|FG001|COMPLETED|Overall Study||2011
10901404|NCT00003830|12067305|FG000|NOT COMPLETED|Overall Study||832
10901405|NCT00003830|12067306|FG001|NOT COMPLETED|Overall Study||793
10901406|NCT00003869|12067316|FG000|STARTED|Overall Study||94
10901407|NCT00003869|12067317|FG001|STARTED|Overall Study||92
10901408|NCT00003869|12067316|FG000|COMPLETED|Overall Study||53
10901409|NCT00003869|12067317|FG001|COMPLETED|Overall Study||80
10901410|NCT00003869|12067316|FG000|NOT COMPLETED|Overall Study||41
10901411|NCT00003869|12067317|FG001|NOT COMPLETED|Overall Study||12
10901412|NCT00003875|12067323|FG000|STARTED|Overall Study||30
10901413|NCT00003875|12067323|FG000|COMPLETED|Overall Study||29
10901414|NCT00003875|12067323|FG000|NOT COMPLETED|Overall Study||1
10901415|NCT00003895|12067329|FG000|STARTED|Overall Study||18
10901416|NCT00003895|12067330|FG001|STARTED|Overall Study||18
10901417|NCT00003895|12067329|FG000|COMPLETED|Overall Study||11
10901418|NCT00003895|12067330|FG001|COMPLETED|Overall Study||14
10901419|NCT00003895|12067329|FG000|NOT COMPLETED|Overall Study||7
10901420|NCT00003895|12067330|FG001|NOT COMPLETED|Overall Study||4
10901421|NCT00003896|12067336|FG000|STARTED|Overall Study||68
10901422|NCT00003896|12067336|FG000|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
10901423|NCT00003896|12067336|FG000|COMPLETED|Overall Study||39
10901424|NCT00003896|12067336|FG000|NOT COMPLETED|Overall Study||29
10901425|NCT00003901|12067341|FG000|STARTED|Overall Study||1047
10901426|NCT00003901|12067341|FG000|COMPLETED|Overall Study||1030
10901427|NCT00003901|12067341|FG000|NOT COMPLETED|Overall Study||17
10901428|NCT00003907|12067350|FG000|STARTED|Overall Study||19
10901429|NCT00003907|12067351|FG001|STARTED|Overall Study||31
10901430|NCT00003907|12067350|FG000|Eligible|Overall Study||18
10901431|NCT00003907|12067351|FG001|Eligible|Overall Study||29
10901432|NCT00003907|12067350|FG000|Received Protocol Therapy (Treated)|Overall Study||18
10901433|NCT00003907|12067351|FG001|Received Protocol Therapy (Treated)|Overall Study||31
10901434|NCT00003907|12067350|FG000|Eligible and Treated|Overall Study||17
10901435|NCT00003907|12067351|FG001|Eligible and Treated|Overall Study||29
10901436|NCT00003907|12067350|FG000|COMPLETED|Overall Study||6
10901437|NCT00003907|12067351|FG001|COMPLETED|Overall Study||8
10901438|NCT00003907|12067350|FG000|NOT COMPLETED|Overall Study||13
10901439|NCT00003907|12067351|FG001|NOT COMPLETED|Overall Study||23
10901440|NCT00003910|12067357|FG000|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
10901441|NCT00003910|12067358|FG001|STARTED|Step 1||0
10901442|NCT00003910|12067357|FG000|COMPLETED|Step 1||55
10901443|NCT00003910|12067358|FG001|COMPLETED|Step 1||0
10901444|NCT00003910|12067357|FG000|NOT COMPLETED|Step 1||0
10901445|NCT00003910|12067358|FG001|NOT COMPLETED|Step 1||0
10901446|NCT00003910|12067357|FG000|STARTED|Step 2||0
10901447|NCT00003910|12067358|FG001|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
10901448|NCT00003910|12067357|FG000|COMPLETED|Step 2||0
10901449|NCT00003910|12067358|FG001|COMPLETED|Step 2||16
10901450|NCT00003910|12067357|FG000|NOT COMPLETED|Step 2||0
10901451|NCT00003910|12067358|FG001|NOT COMPLETED|Step 2||0
10901452|NCT00004031|12067366|FG000|STARTED|Overall Study||128
10901453|NCT00004031|12067367|FG001|STARTED|Overall Study||125
10901454|NCT00004031|12067366|FG000|Assessed for Adverse Events|Overall Study||123
10901455|NCT00004031|12067367|FG001|Assessed for Adverse Events|Overall Study||113
10901456|NCT00004031|12067366|FG000|COMPLETED|Overall Study||103
10901457|NCT00004031|12067367|FG001|COMPLETED|Overall Study||104
10901458|NCT00004031|12067366|FG000|NOT COMPLETED|Overall Study||25
10901459|NCT00004031|12067367|FG001|NOT COMPLETED|Overall Study||21
10901460|NCT00004054|12067377|FG000|STARTED|Overall Study||197
10901461|NCT00004054|12067378|FG001|STARTED|Overall Study||200
10901462|NCT00004054|12067377|FG000|COMPLETED|Overall Study||197
10901463|NCT00004054|12067378|FG001|COMPLETED|Overall Study||200
10901464|NCT00004054|12067377|FG000|NOT COMPLETED|Overall Study||0
10901465|NCT00004054|12067378|FG001|NOT COMPLETED|Overall Study||0
10901466|NCT00004088|12067384|FG000|STARTED|Overall Study||77
10901467|NCT00004088|12067384|FG000|COMPLETED|Overall Study||68
10901468|NCT00004088|12067384|FG000|NOT COMPLETED|Overall Study||9
10901469|NCT00004092|12067390|FG000|STARTED|Overall Study||21
10901470|NCT00004092|12067391|FG001|STARTED|Overall Study||51
10901471|NCT00004092|12067390|FG000|COMPLETED|Overall Study||21
10901472|NCT00004092|12067391|FG001|COMPLETED|Overall Study||51
10901473|NCT00004092|12067390|FG000|NOT COMPLETED|Overall Study||0
10901474|NCT00004092|12067391|FG001|NOT COMPLETED|Overall Study||0
10901475|NCT00004124|12067399|FG000|STARTED|Overall Study||481
10901476|NCT00004124|12067400|FG001|STARTED|Overall Study||480
10901477|NCT00004124|12067399|FG000|COMPLETED|Overall Study||469
10901478|NCT00004124|12067400|FG001|COMPLETED|Overall Study||460
10901479|NCT00004124|12067399|FG000|NOT COMPLETED|Overall Study||12
10901480|NCT00004124|12067400|FG001|NOT COMPLETED|Overall Study||20
10901481|NCT00004143|12067406|FG000|STARTED|Overall Study||2
10901482|NCT00004143|12067406|FG000|COMPLETED|Overall Study||2
10901483|NCT00004143|12067406|FG000|NOT COMPLETED|Overall Study||0
10901484|NCT00004146|12067410|FG000|STARTED|Overall Study||55
10901485|NCT00004146|12067410|FG000|COMPLETED|Overall Study||55
10901486|NCT00004146|12067410|FG000|NOT COMPLETED|Overall Study||0
10901487|NCT00004228|12067423|FG000|STARTED|Overall Study||60
10901488|NCT00004228|12067424|FG001|STARTED|Overall Study||66
10901489|NCT00004228|12067425|FG002|STARTED|Overall Study||65
10901490|NCT00004228|12067426|FG003|STARTED|Overall Study||13
10901491|NCT00004228|12067427|FG004|STARTED|Overall Study||67
10901492|NCT00004228|12067428|FG005|STARTED|Overall Study||65
10901493|NCT00004228|12067429|FG006|STARTED|Overall Study||57
10901494|NCT00004228|12067423|FG000|COMPLETED|Overall Study||51
10901495|NCT00004228|12067424|FG001|COMPLETED|Overall Study||51
10901496|NCT00004228|12067425|FG002|COMPLETED|Overall Study||46
10901497|NCT00004228|12067426|FG003|COMPLETED|Overall Study||6
10901498|NCT00004228|12067427|FG004|COMPLETED|Overall Study||51
10901499|NCT00004228|12067428|FG005|COMPLETED|Overall Study||51
10901500|NCT00004228|12067429|FG006|COMPLETED|Overall Study||45
10901501|NCT00004228|12067423|FG000|NOT COMPLETED|Overall Study||9
10901502|NCT00004228|12067424|FG001|NOT COMPLETED|Overall Study||15
10901503|NCT00004228|12067425|FG002|NOT COMPLETED|Overall Study||19
10901504|NCT00004228|12067426|FG003|NOT COMPLETED|Overall Study||7
10901505|NCT00004228|12067427|FG004|NOT COMPLETED|Overall Study||16
10901506|NCT00004228|12067428|FG005|NOT COMPLETED|Overall Study||14
10901507|NCT00004228|12067429|FG006|NOT COMPLETED|Overall Study||12
10901508|NCT00004259|12067450|FG000|STARTED|Overall Study||98
10901509|NCT00004259|12067451|FG001|STARTED|Overall Study||103
10901510|NCT00004259|12067452|FG002|STARTED|Overall Study||15
10901511|NCT00004259|12067453|FG003|STARTED|Overall Study||14
10901512|NCT00004259|12067450|FG000|COMPLETED|Overall Study||97
10901513|NCT00004259|12067451|FG001|COMPLETED|Overall Study||99
10901514|NCT00004259|12067452|FG002|COMPLETED|Overall Study||15
10901515|NCT00004259|12067453|FG003|COMPLETED|Overall Study||14
10901516|NCT00004259|12067450|FG000|NOT COMPLETED|Overall Study||1
10901517|NCT00004259|12067451|FG001|NOT COMPLETED|Overall Study||4
10901518|NCT00004259|12067452|FG002|NOT COMPLETED|Overall Study||0
10901519|NCT00004259|12067453|FG003|NOT COMPLETED|Overall Study||0
10901520|NCT00004412|12067469|FG000|STARTED|Randomized Period||11
10901521|NCT00004412|12067470|FG001|STARTED|Randomized Period||12
10901522|NCT00004412|12067471|FG002|STARTED|Randomized Period||0
10901523|NCT00004412|12067469|FG000|COMPLETED|Randomized Period||8
10901524|NCT00004412|12067470|FG001|COMPLETED|Randomized Period||12
10901525|NCT00004412|12067471|FG002|COMPLETED|Randomized Period||0
10901526|NCT00004412|12067469|FG000|NOT COMPLETED|Randomized Period||3
10901527|NCT00004412|12067470|FG001|NOT COMPLETED|Randomized Period||0
10901528|NCT00004412|12067471|FG002|NOT COMPLETED|Randomized Period||0
10901529|NCT00004412|12067469|FG000|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
10901530|NCT00004412|12067470|FG001|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
10901531|NCT00004412|12067471|FG002|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
10901532|NCT00004412|12067469|FG000|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
10901533|NCT00004412|12067470|FG001|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
10901534|NCT00004412|12067471|FG002|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
10901535|NCT00004412|12067469|FG000|NOT COMPLETED|Crossover Period||0
10901536|NCT00004412|12067470|FG001|NOT COMPLETED|Crossover Period||0
10901537|NCT00004412|12067471|FG002|NOT COMPLETED|Crossover Period||0
10901538|NCT00004418|12067477|FG000|STARTED|Overall Study||126
10901539|NCT00004418|12067477|FG000|COMPLETED|Overall Study|The definition of completed is until the subject wished to stop taking the oil.|126
10901540|NCT00004418|12067477|FG000|NOT COMPLETED|Overall Study||0
10901541|NCT00004445|12067481|FG000|STARTED|Overall Study||18
10901542|NCT00004445|12067481|FG000|COMPLETED|Overall Study||15
10901543|NCT00004445|12067481|FG000|NOT COMPLETED|Overall Study||3
10901544|NCT00004500|12067487|FG000|STARTED|Overall Study||38
10901545|NCT00004500|12067488|FG001|STARTED|Overall Study||31
10901546|NCT00004500|12067487|FG000|1 Year Follow-Up|Overall Study||24
10901547|NCT00004500|12067488|FG001|1 Year Follow-Up|Overall Study||24
10901548|NCT00004500|12067487|FG000|COMPLETED|Overall Study||38
10901549|NCT00004500|12067488|FG001|COMPLETED|Overall Study||31
10901550|NCT00004500|12067487|FG000|NOT COMPLETED|Overall Study||0
10901551|NCT00004500|12067488|FG001|NOT COMPLETED|Overall Study||0
10901552|NCT00004547|12067497|FG000|STARTED|Overall Study||83
10901553|NCT00004547|12067498|FG001|STARTED|Overall Study||48
10901554|NCT00004547|12067499|FG002|STARTED|Overall Study||57
10901555|NCT00004547|12067497|FG000|Not Evaluable|Overall Study||21
10901556|NCT00004547|12067498|FG001|Not Evaluable|Overall Study||9
10901557|NCT00004547|12067499|FG002|Not Evaluable|Overall Study||23
10901558|NCT00004547|12067497|FG000|COMPLETED|Overall Study||61
10901559|NCT00004547|12067498|FG001|COMPLETED|Overall Study||39
10901560|NCT00004547|12067499|FG002|COMPLETED|Overall Study||35
10901561|NCT00004547|12067497|FG000|NOT COMPLETED|Overall Study||22
10901562|NCT00004547|12067498|FG001|NOT COMPLETED|Overall Study||9
10901563|NCT00004547|12067499|FG002|NOT COMPLETED|Overall Study||22
10901564|NCT00004562|12067510|FG000|STARTED|Overall Study||1101
10901565|NCT00004562|12067511|FG001|STARTED|Overall Study||1100
10901566|NCT00004562|12067510|FG000|COMPLETED|Overall Study||999
10901567|NCT00004562|12067511|FG001|COMPLETED|Overall Study||1009
10901568|NCT00004562|12067510|FG000|NOT COMPLETED|Overall Study||102
10901569|NCT00004562|12067511|FG001|NOT COMPLETED|Overall Study||91
10901570|NCT00004563|12067519|FG000|STARTED|Overall Study||79
10901571|NCT00004563|12067520|FG001|STARTED|Overall Study||79
10901572|NCT00004563|12067519|FG000|COMPLETED|Overall Study||54
10901573|NCT00004563|12067520|FG001|COMPLETED|Overall Study||55
10901574|NCT00004563|12067519|FG000|NOT COMPLETED|Overall Study||25
10901575|NCT00004563|12067520|FG001|NOT COMPLETED|Overall Study||24
10901576|NCT00004635|12067528|FG000|STARTED|Period One||79
10901577|NCT00004635|12067529|FG001|STARTED|Period One||80
10901578|NCT00004635|12067528|FG000|Received Treatment|Period One||73
10901579|NCT00004635|12067529|FG001|Received Treatment|Period One||75
10901580|NCT00004635|12067528|FG000|COMPLETED|Period One||73
10901581|NCT00004635|12067529|FG001|COMPLETED|Period One||74
10901582|NCT00004635|12067528|FG000|NOT COMPLETED|Period One||6
10901583|NCT00004635|12067529|FG001|NOT COMPLETED|Period One||6
10901584|NCT00004635|12067528|FG000|STARTED|Period Two||44
10901585|NCT00004635|12067529|FG001|STARTED|Period Two||59
10901586|NCT00004635|12067528|FG000|COMPLETED|Period Two||38
10901587|NCT00004635|12067529|FG001|COMPLETED|Period Two||50
10901588|NCT00004635|12067528|FG000|NOT COMPLETED|Period Two||6
10901589|NCT00004635|12067529|FG001|NOT COMPLETED|Period Two||9
10901590|NCT00004732|12067540|FG000|STARTED|Overall Study||1262
10901591|NCT00004732|12067541|FG001|STARTED|Overall Study||1240
10901592|NCT00004732|12067540|FG000|COMPLETED|Overall Study||1193
10901593|NCT00004732|12067541|FG001|COMPLETED|Overall Study||1129
10901594|NCT00004732|12067540|FG000|NOT COMPLETED|Overall Study||69
10901595|NCT00004732|12067541|FG001|NOT COMPLETED|Overall Study||111
10901596|NCT00004859|12067551|FG000|STARTED|Overall Study||295
10901597|NCT00004859|12067552|FG001|STARTED|Overall Study||294
10901598|NCT00004859|12067551|FG000|Eligible|Overall Study||275
10901599|NCT00004859|12067552|FG001|Eligible|Overall Study||271
10901600|NCT00004859|12067551|FG000|Treated|Overall Study||289
10901601|NCT00004859|12067552|FG001|Treated|Overall Study||289
10901602|NCT00004859|12067551|FG000|Treated and Having Toxicity Data|Overall Study||289
10901603|NCT00004859|12067552|FG001|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
10901604|NCT00004859|12067551|FG000|COMPLETED|Overall Study||177
10901605|NCT00004859|12067552|FG001|COMPLETED|Overall Study||12
10901606|NCT00004859|12067551|FG000|NOT COMPLETED|Overall Study||118
10901607|NCT00004859|12067552|FG001|NOT COMPLETED|Overall Study||282
10901608|NCT00004888|12067562|FG000|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
10901609|NCT00004888|12067563|FG001|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
10901610|NCT00004888|12067562|FG000|COMPLETED|Overall Study||27
10901611|NCT00004888|12067563|FG001|COMPLETED|Overall Study||22
10901612|NCT00004888|12067562|FG000|NOT COMPLETED|Overall Study||11
10901613|NCT00004888|12067563|FG001|NOT COMPLETED|Overall Study||24
10901614|NCT00004978|12067571|FG000|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
10901615|NCT00004978|12067572|FG001|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
10901616|NCT00004978|12067571|FG000|COMPLETED|Overall Study||1846
10901617|NCT00004978|12067572|FG001|COMPLETED|Overall Study||1790
10901618|NCT00004978|12067571|FG000|NOT COMPLETED|Overall Study||244
10901619|NCT00004978|12067572|FG001|NOT COMPLETED|Overall Study||270
10901620|NCT00004980|12067580|FG000|STARTED|Overall Study||27
10901621|NCT00004980|12067581|FG001|STARTED|Overall Study||23
10901622|NCT00004980|12067580|FG000|COMPLETED|Overall Study||25
10901623|NCT00004980|12067581|FG001|COMPLETED|Overall Study||21
10901624|NCT00004980|12067580|FG000|NOT COMPLETED|Overall Study||2
10901625|NCT00004980|12067581|FG001|NOT COMPLETED|Overall Study||2
10901626|NCT00005047|12067591|FG000|STARTED|Overall Study||58
10901627|NCT00005047|12067592|FG001|STARTED|Overall Study||56
10901628|NCT00005047|12067593|FG002|STARTED|Overall Study||227
10901629|NCT00005047|12067594|FG003|STARTED|Overall Study||158
10901630|NCT00005047|12067591|FG000|COMPLETED|Overall Study||39
10901631|NCT00005047|12067592|FG001|COMPLETED|Overall Study||56
10901632|NCT00005047|12067593|FG002|COMPLETED|Overall Study||227
10901633|NCT00005047|12067594|FG003|COMPLETED|Overall Study||158
10901634|NCT00005047|12067591|FG000|NOT COMPLETED|Overall Study||19
10901635|NCT00005047|12067592|FG001|NOT COMPLETED|Overall Study||0
10901636|NCT00005047|12067593|FG002|NOT COMPLETED|Overall Study||0
10901637|NCT00005047|12067594|FG003|NOT COMPLETED|Overall Study||0
10901638|NCT00005669|12067606|FG000|STARTED|Overall Study||53
10901639|NCT00005669|12067607|FG001|STARTED|Overall Study||47
10901640|NCT00005669|12067606|FG000|COMPLETED|Overall Study||45
10901641|NCT00005669|12067607|FG001|COMPLETED|Overall Study||40
10901642|NCT00005669|12067606|FG000|NOT COMPLETED|Overall Study||8
10901643|NCT00005669|12067607|FG001|NOT COMPLETED|Overall Study||7
10901644|NCT00005803|12067613|FG000|STARTED|Overall Study||76
10901645|NCT00005803|12067613|FG000|COMPLETED|Overall Study||54
10901646|NCT00005803|12067613|FG000|NOT COMPLETED|Overall Study||22
10901647|NCT00005879|12067622|FG000|STARTED|Overall Study||101
10901648|NCT00005879|12067623|FG001|STARTED|Overall Study||98
10901649|NCT00005879|12067622|FG000|COMPLETED|Overall Study||93
10901650|NCT00005879|12067623|FG001|COMPLETED|Overall Study||88
10901651|NCT00005879|12067622|FG000|NOT COMPLETED|Overall Study||8
10901652|NCT00005879|12067623|FG001|NOT COMPLETED|Overall Study||10
10901653|NCT00005901|12067631|FG000|STARTED|Overall Study||19
10901654|NCT00005901|12067632|FG001|STARTED|Overall Study||15
10901655|NCT00005901|12067631|FG000|COMPLETED|Overall Study||19
10901656|NCT00005901|12067632|FG001|COMPLETED|Overall Study||15
10901657|NCT00005901|12067631|FG000|NOT COMPLETED|Overall Study||0
10901658|NCT00005901|12067632|FG001|NOT COMPLETED|Overall Study||0
10901659|NCT00005906|12067638|FG000|STARTED|Overall Study||4
10901660|NCT00005906|12067638|FG000|COMPLETED|Overall Study||1
10901661|NCT00005906|12067638|FG000|NOT COMPLETED|Overall Study||3
10901662|NCT00005908|12067642|FG000|STARTED|Overall Study||10
10901663|NCT00005908|12067643|FG001|STARTED|Overall Study||20
10901664|NCT00005908|12067642|FG000|COMPLETED|Overall Study||9
10901665|NCT00005908|12067643|FG001|COMPLETED|Overall Study||20
10901666|NCT00005908|12067642|FG000|NOT COMPLETED|Overall Study||1
10901667|NCT00005908|12067643|FG001|NOT COMPLETED|Overall Study||0
10901668|NCT00005937|12067652|FG000|STARTED|Overall Study||42
10901669|NCT00005937|12067652|FG000|COMPLETED|Overall Study||37
10901670|NCT00005937|12067652|FG000|NOT COMPLETED|Overall Study||5
10901671|NCT00005947|12067658|FG000|STARTED|Overall Study||82
10901672|NCT00005947|12067659|FG001|STARTED|Overall Study||45
10901673|NCT00005947|12067658|FG000|COMPLETED|Overall Study||25
10901674|NCT00005947|12067659|FG001|COMPLETED|Overall Study||4
10901675|NCT00005947|12067658|FG000|NOT COMPLETED|Overall Study||57
10901676|NCT00005947|12067659|FG001|NOT COMPLETED|Overall Study||41
10901677|NCT00005957|12067669|FG000|STARTED|Overall Study||916
10901678|NCT00005957|12067670|FG001|STARTED|Overall Study||916
10901679|NCT00005957|12067669|FG000|COMPLETED|Overall Study||908
10901680|NCT00005957|12067670|FG001|COMPLETED|Overall Study||888
10901681|NCT00005957|12067669|FG000|NOT COMPLETED|Overall Study||8
10901682|NCT00005957|12067670|FG001|NOT COMPLETED|Overall Study||28
10901683|NCT00006011|12067679|FG000|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
10901684|NCT00006011|12067680|FG001|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
10901685|NCT00006011|12067681|FG002|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
10901686|NCT00006011|12067679|FG000|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
10901687|NCT00006011|12067680|FG001|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
10901688|NCT00006011|12067681|FG002|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
10901689|NCT00006011|12067679|FG000|NOT COMPLETED|Overall Study||65
10901690|NCT00006011|12067680|FG001|NOT COMPLETED|Overall Study||77
10901691|NCT00006011|12067681|FG002|NOT COMPLETED|Overall Study||73
10901692|NCT00006046|12067692|FG000|STARTED|Overall Study||7
10901693|NCT00006046|12067693|FG001|STARTED|Overall Study||0
10901694|NCT00006046|12067694|FG002|STARTED|Overall Study||0
10901695|NCT00006046|12067695|FG003|STARTED|Overall Study||0
10901696|NCT00006046|12067696|FG004|STARTED|Overall Study||0
10901697|NCT00006046|12067692|FG000|COMPLETED|Overall Study||2
10901698|NCT00006046|12067693|FG001|COMPLETED|Overall Study||0
10901699|NCT00006046|12067694|FG002|COMPLETED|Overall Study||0
10901700|NCT00006046|12067695|FG003|COMPLETED|Overall Study||0
10901701|NCT00006046|12067696|FG004|COMPLETED|Overall Study||0
10901702|NCT00006046|12067692|FG000|NOT COMPLETED|Overall Study||5
10901703|NCT00006046|12067693|FG001|NOT COMPLETED|Overall Study||0
10901704|NCT00006046|12067694|FG002|NOT COMPLETED|Overall Study||0
10901705|NCT00006046|12067695|FG003|NOT COMPLETED|Overall Study||0
10901706|NCT00006046|12067696|FG004|NOT COMPLETED|Overall Study||0
10901707|NCT00006099|12067710|FG000|STARTED|Overall Study||1
10901708|NCT00006099|12067711|FG001|STARTED|Overall Study||0
10901709|NCT00006099|12067710|FG000|COMPLETED|Overall Study||1
10901710|NCT00006099|12067711|FG001|COMPLETED|Overall Study||0
10901711|NCT00006099|12067710|FG000|NOT COMPLETED|Overall Study||0
10901712|NCT00006099|12067711|FG001|NOT COMPLETED|Overall Study||0
10901713|NCT00006101|12067719|FG000|STARTED|Overall Study||38
10901714|NCT00006101|12067720|FG001|STARTED|Overall Study||38
10901715|NCT00006101|12067719|FG000|COMPLETED|Overall Study||33
10901716|NCT00006101|12067720|FG001|COMPLETED|Overall Study||33
10901717|NCT00006101|12067719|FG000|NOT COMPLETED|Overall Study||5
10901718|NCT00006101|12067720|FG001|NOT COMPLETED|Overall Study||5
10901719|NCT00006110|12067728|FG000|STARTED|Overall Study||52
10901720|NCT00006110|12067729|FG001|STARTED|Overall Study||30
10901721|NCT00006110|12067728|FG000|COMPLETED|Overall Study||52
10901722|NCT00006110|12067729|FG001|COMPLETED|Overall Study||30
10901723|NCT00006110|12067728|FG000|NOT COMPLETED|Overall Study||0
10901724|NCT00006110|12067729|FG001|NOT COMPLETED|Overall Study||0
10901725|NCT00006151|12067743|FG000|STARTED|Overall Study||30
10901726|NCT00006151|12067744|FG001|STARTED|Overall Study||30
10901727|NCT00006151|12067743|FG000|COMPLETED|Overall Study||17
10901728|NCT00006151|12067744|FG001|COMPLETED|Overall Study||16
10901729|NCT00006151|12067743|FG000|NOT COMPLETED|Overall Study||13
10901730|NCT00006151|12067744|FG001|NOT COMPLETED|Overall Study||14
10901731|NCT00006156|12067752|FG000|STARTED|Overall Study||42
10901732|NCT00006156|12067753|FG001|STARTED|Overall Study||7
10901733|NCT00006156|12067752|FG000|COMPLETED|Overall Study||42
10901734|NCT00006156|12067753|FG001|COMPLETED|Overall Study||7
10901735|NCT00006156|12067752|FG000|NOT COMPLETED|Overall Study||0
10901736|NCT00006156|12067753|FG001|NOT COMPLETED|Overall Study||0
10901737|NCT00006164|12067760|FG000|STARTED|Overall Study||517
10901738|NCT00006164|12067761|FG001|STARTED|Overall Study||533
10901739|NCT00006164|12067760|FG000|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
10901740|NCT00006164|12067761|FG001|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
10901741|NCT00006164|12067760|FG000|NOT COMPLETED|Overall Study||70
10901742|NCT00006164|12067761|FG001|NOT COMPLETED|Overall Study||81
10901743|NCT00006170|12067771|FG000|STARTED|Overall Study||106
10901744|NCT00006170|12067772|FG001|STARTED|Overall Study||87
10901745|NCT00006170|12067773|FG002|STARTED|Overall Study||89
10901746|NCT00006170|12067774|FG003|STARTED|Overall Study||67
10901747|NCT00006170|12067771|FG000|COMPLETED|Overall Study||57
10901748|NCT00006170|12067772|FG001|COMPLETED|Overall Study||37
10901749|NCT00006170|12067773|FG002|COMPLETED|Overall Study||46
10901750|NCT00006170|12067774|FG003|COMPLETED|Overall Study||28
10901751|NCT00006170|12067771|FG000|NOT COMPLETED|Overall Study||49
10901752|NCT00006170|12067772|FG001|NOT COMPLETED|Overall Study||50
10901753|NCT00006170|12067773|FG002|NOT COMPLETED|Overall Study||43
10901754|NCT00006170|12067774|FG003|NOT COMPLETED|Overall Study||39
10901755|NCT04323800|12067786|FG000|STARTED|Overall Study||87
10901756|NCT04323800|12067787|FG001|STARTED|Overall Study||93
10901757|NCT04323800|12067786|FG000|COMPLETED|Overall Study||81
10901758|NCT04323800|12067787|FG001|COMPLETED|Overall Study||87
10901759|NCT04323800|12067786|FG000|NOT COMPLETED|Overall Study||6
10901760|NCT04323800|12067787|FG001|NOT COMPLETED|Overall Study||6
10901761|NCT04279925|12067795|FG000|STARTED|Overall Study||4
10901762|NCT04279925|12067796|FG001|STARTED|Overall Study||5
10901763|NCT04279925|12067795|FG000|COMPLETED|Overall Study||4
10901764|NCT04279925|12067796|FG001|COMPLETED|Overall Study||5
10901765|NCT04279925|12067795|FG000|NOT COMPLETED|Overall Study||0
10901766|NCT04279925|12067796|FG001|NOT COMPLETED|Overall Study||0
10901767|NCT04110145|12067807|FG000|STARTED|Double-Blind Treatment Period (4 Weeks)||7
10901768|NCT04110145|12067808|FG001|STARTED|Double-Blind Treatment Period (4 Weeks)||7
10901769|NCT04110145|12067809|FG002|STARTED|Double-Blind Treatment Period (4 Weeks)||6
10901770|NCT04110145|12067810|FG003|STARTED|Double-Blind Treatment Period (4 Weeks)||7
10901771|NCT04110145|12067811|FG004|STARTED|Double-Blind Treatment Period (4 Weeks)||8
10901772|NCT04110145|12067807|FG000|COMPLETED|Double-Blind Treatment Period (4 Weeks)||7
10901773|NCT04110145|12067808|FG001|COMPLETED|Double-Blind Treatment Period (4 Weeks)||7
10901774|NCT04110145|12067809|FG002|COMPLETED|Double-Blind Treatment Period (4 Weeks)||6
10901775|NCT04110145|12067810|FG003|COMPLETED|Double-Blind Treatment Period (4 Weeks)||6
10901776|NCT04110145|12067811|FG004|COMPLETED|Double-Blind Treatment Period (4 Weeks)||8
10901777|NCT04110145|12067807|FG000|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
10901778|NCT04110145|12067808|FG001|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
10901779|NCT04110145|12067809|FG002|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
10901780|NCT04110145|12067810|FG003|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||1
10901781|NCT04110145|12067811|FG004|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
10901782|NCT04110145|12067807|FG000|STARTED|Post-Treatment Period (1 Week)||7
10901783|NCT04110145|12067808|FG001|STARTED|Post-Treatment Period (1 Week)||7
10901784|NCT04110145|12067809|FG002|STARTED|Post-Treatment Period (1 Week)||5
10901785|NCT04110145|12067810|FG003|STARTED|Post-Treatment Period (1 Week)||6
10901786|NCT04110145|12067811|FG004|STARTED|Post-Treatment Period (1 Week)||8
10901787|NCT04110145|12067807|FG000|COMPLETED|Post-Treatment Period (1 Week)||7
10901788|NCT04110145|12067808|FG001|COMPLETED|Post-Treatment Period (1 Week)||7
10901789|NCT04110145|12067809|FG002|COMPLETED|Post-Treatment Period (1 Week)||5
10901790|NCT04110145|12067810|FG003|COMPLETED|Post-Treatment Period (1 Week)||6
10901791|NCT04110145|12067811|FG004|COMPLETED|Post-Treatment Period (1 Week)||8
10901792|NCT04110145|12067807|FG000|NOT COMPLETED|Post-Treatment Period (1 Week)||0
10901793|NCT04110145|12067808|FG001|NOT COMPLETED|Post-Treatment Period (1 Week)||0
10901794|NCT04110145|12067809|FG002|NOT COMPLETED|Post-Treatment Period (1 Week)||0
10901795|NCT04110145|12067810|FG003|NOT COMPLETED|Post-Treatment Period (1 Week)||0
10901796|NCT04110145|12067811|FG004|NOT COMPLETED|Post-Treatment Period (1 Week)||0
10901797|NCT03986866|12067825|FG000|STARTED|Overall Study||55
10901798|NCT03986866|12067826|FG001|STARTED|Overall Study||55
10901799|NCT03986866|12067825|FG000|COMPLETED|Overall Study||53
10901800|NCT03986866|12067826|FG001|COMPLETED|Overall Study||50
10901801|NCT03986866|12067825|FG000|NOT COMPLETED|Overall Study||2
10901802|NCT03986866|12067826|FG001|NOT COMPLETED|Overall Study||5
10901803|NCT03636269|12067834|FG000|STARTED|Period 1: Double-blind Phase||235
10901804|NCT03636269|12067835|FG001|STARTED|Period 1: Double-blind Phase||236
10901805|NCT03636269|12067836|FG002|STARTED|Period 1: Double-blind Phase||0
10901806|NCT03636269|12067834|FG000|COMPLETED|Period 1: Double-blind Phase||206
10901807|NCT03636269|12067835|FG001|COMPLETED|Period 1: Double-blind Phase||223
10901808|NCT03636269|12067836|FG002|COMPLETED|Period 1: Double-blind Phase||0
10901809|NCT03636269|12067834|FG000|NOT COMPLETED|Period 1: Double-blind Phase||29
10901810|NCT03636269|12067835|FG001|NOT COMPLETED|Period 1: Double-blind Phase||13
10901811|NCT03636269|12067836|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0
10901812|NCT03636269|12067834|FG000|STARTED|Period 2: Open-label Phase||0
10901813|NCT03636269|12067835|FG001|STARTED|Period 2: Open-label Phase||0
10901814|NCT03636269|12067836|FG002|STARTED|Period 2: Open-label Phase||399
10901815|NCT03636269|12067834|FG000|COMPLETED|Period 2: Open-label Phase||0
10901816|NCT03636269|12067835|FG001|COMPLETED|Period 2: Open-label Phase||0
10901817|NCT03636269|12067836|FG002|COMPLETED|Period 2: Open-label Phase||5
10901818|NCT03636269|12067834|FG000|NOT COMPLETED|Period 2: Open-label Phase||0
10901819|NCT03636269|12067835|FG001|NOT COMPLETED|Period 2: Open-label Phase||0
10901820|NCT03636269|12067836|FG002|NOT COMPLETED|Period 2: Open-label Phase||394
10901821|NCT03527264|12067849|FG000|STARTED|Overall Study||3
10901822|NCT03527264|12067850|FG001|STARTED|Overall Study||1
10901823|NCT03527264|12067851|FG002|STARTED|Overall Study||0
10901824|NCT03527264|12067852|FG003|STARTED|Overall Study||0
10901825|NCT03527264|12067849|FG000|COMPLETED|Overall Study||3
10901826|NCT03527264|12067850|FG001|COMPLETED|Overall Study||1
10901827|NCT03527264|12067851|FG002|COMPLETED|Overall Study||0
10901828|NCT03527264|12067852|FG003|COMPLETED|Overall Study||0
10901829|NCT03527264|12067849|FG000|NOT COMPLETED|Overall Study||0
10901830|NCT03527264|12067850|FG001|NOT COMPLETED|Overall Study||0
10901831|NCT03527264|12067851|FG002|NOT COMPLETED|Overall Study||0
10901832|NCT03527264|12067852|FG003|NOT COMPLETED|Overall Study||0
10901833|NCT03447314|12067876|FG000|STARTED|Part 1 (Up to 27 Months)||9
10901834|NCT03447314|12067877|FG001|STARTED|Part 1 (Up to 27 Months)||6
10901835|NCT03447314|12067878|FG002|STARTED|Part 1 (Up to 27 Months)||9
10901836|NCT03447314|12067879|FG003|STARTED|Part 1 (Up to 27 Months)||4
10901837|NCT03447314|12067880|FG004|STARTED|Part 1 (Up to 27 Months)||2
10901838|NCT03447314|12067881|FG005|STARTED|Part 1 (Up to 27 Months)||6
10901839|NCT03447314|12067882|FG006|STARTED|Part 1 (Up to 27 Months)||5
10901840|NCT03447314|12067883|FG007|STARTED|Part 1 (Up to 27 Months)||0
10901841|NCT03447314|12067884|FG008|STARTED|Part 1 (Up to 27 Months)||0
10901842|NCT03447314|12067885|FG009|STARTED|Part 1 (Up to 27 Months)||0
10901843|NCT03447314|12067886|FG010|STARTED|Part 1 (Up to 27 Months)||7
10901844|NCT03447314|12067887|FG011|STARTED|Part 1 (Up to 27 Months)||6
10901845|NCT03447314|12067888|FG012|STARTED|Part 1 (Up to 27 Months)||0
10901846|NCT03447314|12067889|FG013|STARTED|Part 1 (Up to 27 Months)||0
10901847|NCT03447314|12067890|FG014|STARTED|Part 1 (Up to 27 Months)||0
10901848|NCT03447314|12067891|FG015|STARTED|Part 1 (Up to 27 Months)||0
10901849|NCT03447314|12067892|FG016|STARTED|Part 1 (Up to 27 Months)||0
10901850|NCT03447314|12067893|FG017|STARTED|Part 1 (Up to 27 Months)||0
10901851|NCT03447314|12067876|FG000|COMPLETED|Part 1 (Up to 27 Months)||0
10901852|NCT03447314|12067877|FG001|COMPLETED|Part 1 (Up to 27 Months)||0
10901853|NCT03447314|12067878|FG002|COMPLETED|Part 1 (Up to 27 Months)||0
10901854|NCT03447314|12067879|FG003|COMPLETED|Part 1 (Up to 27 Months)||0
10901855|NCT03447314|12067880|FG004|COMPLETED|Part 1 (Up to 27 Months)||0
10901856|NCT03447314|12067881|FG005|COMPLETED|Part 1 (Up to 27 Months)||0
10901857|NCT03447314|12067882|FG006|COMPLETED|Part 1 (Up to 27 Months)||0
10901858|NCT03447314|12067883|FG007|COMPLETED|Part 1 (Up to 27 Months)||0
10901859|NCT03447314|12067884|FG008|COMPLETED|Part 1 (Up to 27 Months)||0
10901860|NCT03447314|12067885|FG009|COMPLETED|Part 1 (Up to 27 Months)||0
10901861|NCT03447314|12067886|FG010|COMPLETED|Part 1 (Up to 27 Months)||0
10901862|NCT03447314|12067887|FG011|COMPLETED|Part 1 (Up to 27 Months)||0
10901863|NCT03447314|12067888|FG012|COMPLETED|Part 1 (Up to 27 Months)||0
10901864|NCT03447314|12067889|FG013|COMPLETED|Part 1 (Up to 27 Months)||0
10901865|NCT03447314|12067890|FG014|COMPLETED|Part 1 (Up to 27 Months)||0
10901866|NCT03447314|12067891|FG015|COMPLETED|Part 1 (Up to 27 Months)||0
10901867|NCT03447314|12067892|FG016|COMPLETED|Part 1 (Up to 27 Months)||0
10901868|NCT03447314|12067893|FG017|COMPLETED|Part 1 (Up to 27 Months)||0
10901869|NCT03447314|12067876|FG000|NOT COMPLETED|Part 1 (Up to 27 Months)||9
10901870|NCT03447314|12067877|FG001|NOT COMPLETED|Part 1 (Up to 27 Months)||6
10901871|NCT03447314|12067878|FG002|NOT COMPLETED|Part 1 (Up to 27 Months)||9
10901872|NCT03447314|12067879|FG003|NOT COMPLETED|Part 1 (Up to 27 Months)||4
10901873|NCT03447314|12067880|FG004|NOT COMPLETED|Part 1 (Up to 27 Months)||2
10901874|NCT03447314|12067881|FG005|NOT COMPLETED|Part 1 (Up to 27 Months)||6
10901875|NCT03447314|12067882|FG006|NOT COMPLETED|Part 1 (Up to 27 Months)||5
10901876|NCT03447314|12067883|FG007|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10901877|NCT03447314|12067884|FG008|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10901878|NCT03447314|12067885|FG009|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10901879|NCT03447314|12067886|FG010|NOT COMPLETED|Part 1 (Up to 27 Months)||7
10901880|NCT03447314|12067887|FG011|NOT COMPLETED|Part 1 (Up to 27 Months)||6
10901881|NCT03447314|12067888|FG012|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10901882|NCT03447314|12067889|FG013|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10901883|NCT03447314|12067890|FG014|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10901884|NCT03447314|12067891|FG015|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10901885|NCT03447314|12067892|FG016|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10901886|NCT03447314|12067893|FG017|NOT COMPLETED|Part 1 (Up to 27 Months)||0
10901887|NCT03447314|12067876|FG000|STARTED|Part 2 (Up to 27 Months)||0
10901888|NCT03447314|12067877|FG001|STARTED|Part 2 (Up to 27 Months)||0
10901889|NCT03447314|12067878|FG002|STARTED|Part 2 (Up to 27 Months)||0
10901890|NCT03447314|12067879|FG003|STARTED|Part 2 (Up to 27 Months)||0
10901891|NCT03447314|12067880|FG004|STARTED|Part 2 (Up to 27 Months)||0
10901892|NCT03447314|12067881|FG005|STARTED|Part 2 (Up to 27 Months)||0
10901893|NCT03447314|12067882|FG006|STARTED|Part 2 (Up to 27 Months)||0
10901894|NCT03447314|12067883|FG007|STARTED|Part 2 (Up to 27 Months)||0
10901895|NCT03447314|12067884|FG008|STARTED|Part 2 (Up to 27 Months)||0
10901896|NCT03447314|12067885|FG009|STARTED|Part 2 (Up to 27 Months)||0
10901897|NCT03447314|12067886|FG010|STARTED|Part 2 (Up to 27 Months)||0
10901898|NCT03447314|12067887|FG011|STARTED|Part 2 (Up to 27 Months)||0
10901899|NCT03447314|12067888|FG012|STARTED|Part 2 (Up to 27 Months)||0
10901900|NCT03447314|12067889|FG013|STARTED|Part 2 (Up to 27 Months)||0
10901901|NCT03447314|12067890|FG014|STARTED|Part 2 (Up to 27 Months)||0
10901902|NCT03447314|12067891|FG015|STARTED|Part 2 (Up to 27 Months)||0
10901903|NCT03447314|12067892|FG016|STARTED|Part 2 (Up to 27 Months)||0
10901904|NCT03447314|12067893|FG017|STARTED|Part 2 (Up to 27 Months)||0
10901905|NCT03447314|12067876|FG000|COMPLETED|Part 2 (Up to 27 Months)||0
10901906|NCT03447314|12067877|FG001|COMPLETED|Part 2 (Up to 27 Months)||0
10901907|NCT03447314|12067878|FG002|COMPLETED|Part 2 (Up to 27 Months)||0
10901908|NCT03447314|12067879|FG003|COMPLETED|Part 2 (Up to 27 Months)||0
10901909|NCT03447314|12067880|FG004|COMPLETED|Part 2 (Up to 27 Months)||0
10901910|NCT03447314|12067881|FG005|COMPLETED|Part 2 (Up to 27 Months)||0
10901911|NCT03447314|12067882|FG006|COMPLETED|Part 2 (Up to 27 Months)||0
10901912|NCT03447314|12067883|FG007|COMPLETED|Part 2 (Up to 27 Months)||0
10901913|NCT03447314|12067884|FG008|COMPLETED|Part 2 (Up to 27 Months)||0
10901914|NCT03447314|12067885|FG009|COMPLETED|Part 2 (Up to 27 Months)||0
10901915|NCT03447314|12067886|FG010|COMPLETED|Part 2 (Up to 27 Months)||0
10901916|NCT03447314|12067887|FG011|COMPLETED|Part 2 (Up to 27 Months)||0
10901917|NCT03447314|12067888|FG012|COMPLETED|Part 2 (Up to 27 Months)||0
10901918|NCT03447314|12067889|FG013|COMPLETED|Part 2 (Up to 27 Months)||0
10901919|NCT03447314|12067890|FG014|COMPLETED|Part 2 (Up to 27 Months)||0
10901920|NCT03447314|12067891|FG015|COMPLETED|Part 2 (Up to 27 Months)||0
10901921|NCT03447314|12067892|FG016|COMPLETED|Part 2 (Up to 27 Months)||0
10901922|NCT03447314|12067893|FG017|COMPLETED|Part 2 (Up to 27 Months)||0
10901923|NCT03447314|12067876|FG000|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901924|NCT03447314|12067877|FG001|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901925|NCT03447314|12067878|FG002|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901926|NCT03447314|12067879|FG003|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901927|NCT03447314|12067880|FG004|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901928|NCT03447314|12067881|FG005|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901929|NCT03447314|12067882|FG006|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901930|NCT03447314|12067883|FG007|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901931|NCT03447314|12067884|FG008|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901932|NCT03447314|12067885|FG009|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901933|NCT03447314|12067886|FG010|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901934|NCT03447314|12067887|FG011|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901935|NCT03447314|12067888|FG012|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901936|NCT03447314|12067889|FG013|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901937|NCT03447314|12067890|FG014|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901938|NCT03447314|12067891|FG015|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901939|NCT03447314|12067892|FG016|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901940|NCT03447314|12067893|FG017|NOT COMPLETED|Part 2 (Up to 27 Months)||0
10901941|NCT03422653|12067936|FG000|STARTED|Period 1: Double-blind Phase||189
10901942|NCT03422653|12067937|FG001|STARTED|Period 1: Double-blind Phase||189
10901943|NCT03422653|12067938|FG002|STARTED|Period 1: Double-blind Phase||0
10901944|NCT03422653|12067936|FG000|COMPLETED|Period 1: Double-blind Phase||162
10901945|NCT03422653|12067937|FG001|COMPLETED|Period 1: Double-blind Phase||170
10901946|NCT03422653|12067938|FG002|COMPLETED|Period 1: Double-blind Phase||0
10901947|NCT03422653|12067936|FG000|NOT COMPLETED|Period 1: Double-blind Phase||27
10901948|NCT03422653|12067937|FG001|NOT COMPLETED|Period 1: Double-blind Phase||19
10901949|NCT03422653|12067938|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0
10901950|NCT03422653|12067936|FG000|STARTED|Period 2: Open-label Phase||0
10901951|NCT03422653|12067937|FG001|STARTED|Period 2: Open-label Phase||0
10901952|NCT03422653|12067938|FG002|STARTED|Period 2: Open-label Phase||313
10901953|NCT03422653|12067936|FG000|COMPLETED|Period 2: Open-label Phase||0
10901954|NCT03422653|12067937|FG001|COMPLETED|Period 2: Open-label Phase||0
10901955|NCT03422653|12067938|FG002|COMPLETED|Period 2: Open-label Phase||189
10901956|NCT03422653|12067936|FG000|NOT COMPLETED|Period 2: Open-label Phase||0
10901957|NCT03422653|12067937|FG001|NOT COMPLETED|Period 2: Open-label Phase||0
10901958|NCT03422653|12067938|FG002|NOT COMPLETED|Period 2: Open-label Phase||124
10901959|NCT03320330|12067950|FG000|STARTED|Overall Study||6
10901960|NCT03320330|12067951|FG001|STARTED|Overall Study||6
10901961|NCT03320330|12067952|FG002|STARTED|Overall Study||14
10901962|NCT03320330|12067950|FG000|COMPLETED|Overall Study||0
10901963|NCT03320330|12067951|FG001|COMPLETED|Overall Study||1
10901964|NCT03320330|12067952|FG002|COMPLETED|Overall Study||0
10901965|NCT03320330|12067950|FG000|NOT COMPLETED|Overall Study||6
10901966|NCT03320330|12067951|FG001|NOT COMPLETED|Overall Study||5
10901967|NCT03320330|12067952|FG002|NOT COMPLETED|Overall Study||14
10901968|NCT03271151|12067963|FG000|STARTED|Overall Study||80
10901969|NCT03271151|12067964|FG001|STARTED|Overall Study||80
10901970|NCT03271151|12067963|FG000|COMPLETED|Overall Study||78
10901971|NCT03271151|12067964|FG001|COMPLETED|Overall Study||77
10901972|NCT03271151|12067963|FG000|NOT COMPLETED|Overall Study||2
10901973|NCT03271151|12067964|FG001|NOT COMPLETED|Overall Study||3
10901974|NCT03023813|12067973|FG000|STARTED|Overall Study||39
10901975|NCT03023813|12067974|FG001|STARTED|Overall Study||34
10901976|NCT03023813|12067975|FG002|STARTED|Overall Study||31
10901977|NCT03023813|12067973|FG000|COMPLETED|Overall Study||38
10901978|NCT03023813|12067974|FG001|COMPLETED|Overall Study||32
10901979|NCT03023813|12067975|FG002|COMPLETED|Overall Study||31
10901980|NCT03023813|12067973|FG000|NOT COMPLETED|Overall Study||1
10901981|NCT03023813|12067974|FG001|NOT COMPLETED|Overall Study||2
10901982|NCT03023813|12067975|FG002|NOT COMPLETED|Overall Study||0
10901983|NCT02993822|12067988|FG000|STARTED|Overall Study||79
10901984|NCT02993822|12067989|FG001|STARTED|Overall Study||78
10901985|NCT02993822|12067990|FG002|STARTED|Overall Study||79
10901986|NCT02993822|12067991|FG003|STARTED|Overall Study||79
10901987|NCT02993822|12067988|FG000|COMPLETED|Overall Study||69
10901988|NCT02993822|12067989|FG001|COMPLETED|Overall Study||74
10901989|NCT02993822|12067990|FG002|COMPLETED|Overall Study||69
10901990|NCT02993822|12067991|FG003|COMPLETED|Overall Study||75
10901991|NCT02993822|12067988|FG000|NOT COMPLETED|Overall Study||10
10901992|NCT02993822|12067989|FG001|NOT COMPLETED|Overall Study||4
10901993|NCT02993822|12067990|FG002|NOT COMPLETED|Overall Study||10
10901994|NCT02993822|12067991|FG003|NOT COMPLETED|Overall Study||4
10901995|NCT02924324|12068003|FG000|STARTED|Overall Study||28
10901996|NCT02924324|12068004|FG001|STARTED|Overall Study||28
10901997|NCT02924324|12068003|FG000|COMPLETED|Overall Study||28
10901998|NCT02924324|12068004|FG001|COMPLETED|Overall Study||28
10901999|NCT02924324|12068003|FG000|NOT COMPLETED|Overall Study||0
10902000|NCT02924324|12068004|FG001|NOT COMPLETED|Overall Study||0
10902001|NCT02828917|12068010|FG000|STARTED|Overall Study||104
10902002|NCT02828917|12068010|FG000|COMPLETED|Overall Study||104
10902003|NCT02828917|12068010|FG000|NOT COMPLETED|Overall Study||0
10902004|NCT02753127|12068016|FG000|STARTED|Overall Study||624
10902005|NCT02753127|12068017|FG001|STARTED|Overall Study||629
10902006|NCT02753127|12068016|FG000|Discontinued Due to Death|Overall Study||507
10902007|NCT02753127|12068017|FG001|Discontinued Due to Death|Overall Study||499
10902008|NCT02753127|12068016|FG000|Completion of Survival Follow-Up Due to Study Completion|Overall Study||64
10902009|NCT02753127|12068017|FG001|Completion of Survival Follow-Up Due to Study Completion|Overall Study||62
10902010|NCT02753127|12068016|FG000|COMPLETED|Overall Study||571
10902011|NCT02753127|12068017|FG001|COMPLETED|Overall Study||561
10902012|NCT02753127|12068016|FG000|NOT COMPLETED|Overall Study||53
10902013|NCT02753127|12068017|FG001|NOT COMPLETED|Overall Study||68
10902014|NCT02744430|12068033|FG000|STARTED|Overall Study||17
10902015|NCT02744430|12068034|FG001|STARTED|Overall Study||16
10902016|NCT02744430|12068033|FG000|COMPLETED|Overall Study||17
10902017|NCT02744430|12068034|FG001|COMPLETED|Overall Study||16
10902018|NCT02744430|12068033|FG000|NOT COMPLETED|Overall Study||0
10902019|NCT02744430|12068034|FG001|NOT COMPLETED|Overall Study||0
10902020|NCT02260869|12068042|FG000|STARTED|Overall Study||38
10902021|NCT02260869|12068043|FG001|STARTED|Overall Study||37
10902022|NCT02260869|12068042|FG000|COMPLETED|Overall Study||31
10902023|NCT02260869|12068043|FG001|COMPLETED|Overall Study||29
10902024|NCT02260869|12068042|FG000|NOT COMPLETED|Overall Study||7
10902025|NCT02260869|12068043|FG001|NOT COMPLETED|Overall Study||8
10902026|NCT02255838|12068049|FG000|STARTED|Overall Study||6
10902027|NCT02255838|12068050|FG001|STARTED|Overall Study||6
10902028|NCT02255838|12068049|FG000|COMPLETED|Overall Study||6
10902029|NCT02255838|12068050|FG001|COMPLETED|Overall Study||6
10902030|NCT02255838|12068049|FG000|NOT COMPLETED|Overall Study||0
10902031|NCT02255838|12068050|FG001|NOT COMPLETED|Overall Study||0
10902032|NCT02151526|12068060|FG000|STARTED|Overall Study||3
10902033|NCT02151526|12068061|FG001|STARTED|Overall Study||4
10902034|NCT02151526|12068060|FG000|COMPLETED|Overall Study||3
10902035|NCT02151526|12068061|FG001|COMPLETED|Overall Study||4
10902036|NCT02151526|12068060|FG000|NOT COMPLETED|Overall Study||0
10902037|NCT02151526|12068061|FG001|NOT COMPLETED|Overall Study||0
10902038|NCT02119468|12068071|FG000|STARTED|Overall Study||7
10902039|NCT02119468|12068072|FG001|STARTED|Overall Study||25
10902040|NCT02119468|12068071|FG000|COMPLETED|Overall Study||7
10902041|NCT02119468|12068072|FG001|COMPLETED|Overall Study||25
10902042|NCT02119468|12068071|FG000|NOT COMPLETED|Overall Study||0
10902043|NCT02119468|12068072|FG001|NOT COMPLETED|Overall Study||0
10902044|NCT01960530|12068079|FG000|STARTED|Overall Study||14
10902045|NCT01960530|12068079|FG000|COMPLETED|Overall Study||14
10902046|NCT01960530|12068079|FG000|NOT COMPLETED|Overall Study||0
10902047|NCT01516216|12068096|FG000|STARTED|Overall Study||70
10902048|NCT01516216|12068097|FG001|STARTED|Overall Study||69
10902049|NCT01516216|12068096|FG000|AE Evaluable|Overall Study||67
10902050|NCT01516216|12068097|FG001|AE Evaluable|Overall Study||68
10902051|NCT01516216|12068096|FG000|Response Evaluable|Overall Study||62
10902052|NCT01516216|12068097|FG001|Response Evaluable|Overall Study||66
10902053|NCT01516216|12068096|FG000|COMPLETED|Overall Study||0
10902054|NCT01516216|12068097|FG001|COMPLETED|Overall Study||0
10902055|NCT01516216|12068096|FG000|NOT COMPLETED|Overall Study||70
10902056|NCT01516216|12068097|FG001|NOT COMPLETED|Overall Study||69
10902057|NCT00519818|12068105|FG000|STARTED|Overall Study||14
10902058|NCT00519818|12068105|FG000|COMPLETED|Overall Study||14
10902059|NCT00519818|12068105|FG000|NOT COMPLETED|Overall Study||0
10902060|NCT00006178|12068111|FG000|STARTED|Overall Study||12
10902061|NCT00006178|12068111|FG000|COMPLETED|Overall Study||12
10902062|NCT00006178|12068111|FG000|NOT COMPLETED|Overall Study||0
10902063|NCT00006184|12068117|FG000|STARTED|Overall Study||10
10902064|NCT00006184|12068118|FG001|STARTED|Overall Study||10
10902065|NCT00006184|12068117|FG000|COMPLETED|Overall Study||9
10902066|NCT00006184|12068118|FG001|COMPLETED|Overall Study||10
10902067|NCT00006184|12068117|FG000|NOT COMPLETED|Overall Study||1
10902068|NCT00006184|12068118|FG001|NOT COMPLETED|Overall Study||0
10902069|NCT00006227|12068124|FG000|STARTED|Overall Study||31
10902070|NCT00006227|12068124|FG000|COMPLETED|Overall Study||31
10902071|NCT00006227|12068124|FG000|NOT COMPLETED|Overall Study||0
10902072|NCT00006237|12068130|FG000|STARTED|Overall Study||212
10902073|NCT00006237|12068131|FG001|STARTED|Overall Study||220
10902074|NCT00006237|12068130|FG000|Eligible|Overall Study||203
10902075|NCT00006237|12068131|FG001|Eligible|Overall Study||200
10902076|NCT00006237|12068130|FG000|Eligible and Treated|Overall Study||203
10902077|NCT00006237|12068131|FG001|Eligible and Treated|Overall Study||199
10902078|NCT00006237|12068130|FG000|COMPLETED|Overall Study||87
10902079|NCT00006237|12068131|FG001|COMPLETED|Overall Study||159
10902080|NCT00006237|12068130|FG000|NOT COMPLETED|Overall Study||125
10902081|NCT00006237|12068131|FG001|NOT COMPLETED|Overall Study||61
10902082|NCT00006244|12068140|FG000|STARTED|Overall Study||36
10902083|NCT00006244|12068140|FG000|COMPLETED|Overall Study||36
10902084|NCT00006244|12068140|FG000|NOT COMPLETED|Overall Study||0
10902085|NCT00006289|12068146|FG000|STARTED|First Intervention (5 Weeks)||11
10902086|NCT00006289|12068147|FG001|STARTED|First Intervention (5 Weeks)||10
10902087|NCT00006289|12068146|FG000|COMPLETED|First Intervention (5 Weeks)||10
10902088|NCT00006289|12068147|FG001|COMPLETED|First Intervention (5 Weeks)||10
10902089|NCT00006289|12068146|FG000|NOT COMPLETED|First Intervention (5 Weeks)||1
10902090|NCT00006289|12068147|FG001|NOT COMPLETED|First Intervention (5 Weeks)||0
10902091|NCT00006289|12068146|FG000|STARTED|Washout (>= 1 Week)||10
10902092|NCT00006289|12068147|FG001|STARTED|Washout (>= 1 Week)||10
10902093|NCT00006289|12068146|FG000|COMPLETED|Washout (>= 1 Week)||10
10902094|NCT00006289|12068147|FG001|COMPLETED|Washout (>= 1 Week)||10
10902095|NCT00006289|12068146|FG000|NOT COMPLETED|Washout (>= 1 Week)||0
10902096|NCT00006289|12068147|FG001|NOT COMPLETED|Washout (>= 1 Week)||0
10902097|NCT00006289|12068146|FG000|STARTED|Second Intervention (5 Weeks)||10
10902098|NCT00006289|12068147|FG001|STARTED|Second Intervention (5 Weeks)||10
10902099|NCT00006289|12068146|FG000|COMPLETED|Second Intervention (5 Weeks)||9
10902100|NCT00006289|12068147|FG001|COMPLETED|Second Intervention (5 Weeks)||9
10902101|NCT00006289|12068146|FG000|NOT COMPLETED|Second Intervention (5 Weeks)||1
10902102|NCT00006289|12068147|FG001|NOT COMPLETED|Second Intervention (5 Weeks)||1
10902103|NCT00006305|12068167|FG000|STARTED|Overall Study||592
10902104|NCT00006305|12068168|FG001|STARTED|Overall Study||584
10902105|NCT00006305|12068169|FG002|STARTED|Overall Study||593
10902106|NCT00006305|12068170|FG003|STARTED|Overall Study||599
10902107|NCT00006305|12068167|FG000|COMPLETED|Overall Study||575
10902108|NCT00006305|12068168|FG001|COMPLETED|Overall Study||574
10902109|NCT00006305|12068169|FG002|COMPLETED|Overall Study||578
10902110|NCT00006305|12068170|FG003|COMPLETED|Overall Study||585
10902111|NCT00006305|12068167|FG000|NOT COMPLETED|Overall Study||17
10902112|NCT00006305|12068168|FG001|NOT COMPLETED|Overall Study||10
10902113|NCT00006305|12068169|FG002|NOT COMPLETED|Overall Study||15
10902114|NCT00006305|12068170|FG003|NOT COMPLETED|Overall Study||14
10902115|NCT00006389|12068180|FG000|STARTED|Overall Study||12
10902116|NCT00006389|12068180|FG000|COMPLETED|Overall Study||11
10902117|NCT00006389|12068180|FG000|NOT COMPLETED|Overall Study||1
10902118|NCT00006392|12068189|FG000|STARTED|Overall Study||8904
10902119|NCT00006392|12068190|FG001|STARTED|Overall Study||8910
10902120|NCT00006392|12068191|FG002|STARTED|Overall Study||8863
10902121|NCT00006392|12068192|FG003|STARTED|Overall Study||8856
10902122|NCT00006392|12068189|FG000|COMPLETED|Overall Study||8737
10902123|NCT00006392|12068190|FG001|COMPLETED|Overall Study||8752
10902124|NCT00006392|12068191|FG002|COMPLETED|Overall Study||8703
10902125|NCT00006392|12068192|FG003|COMPLETED|Overall Study||8696
10902126|NCT00006392|12068189|FG000|NOT COMPLETED|Overall Study||167
10902127|NCT00006392|12068190|FG001|NOT COMPLETED|Overall Study||158
10902128|NCT00006392|12068191|FG002|NOT COMPLETED|Overall Study||160
10902129|NCT00006392|12068192|FG003|NOT COMPLETED|Overall Study||160
10902130|NCT00006400|12068204|FG000|STARTED|Overall Study||96
10902131|NCT00006400|12068205|FG001|STARTED|Overall Study||97
10902132|NCT00006400|12068204|FG000|COMPLETED|Overall Study||83
10902133|NCT00006400|12068205|FG001|COMPLETED|Overall Study||84
10902134|NCT00006400|12068204|FG000|NOT COMPLETED|Overall Study||13
10902135|NCT00006400|12068205|FG001|NOT COMPLETED|Overall Study||13
10902136|NCT00006409|12068217|FG000|STARTED|Baseline||865
10902137|NCT00006409|12068218|FG001|STARTED|Baseline||856
10902138|NCT00006409|12068219|FG002|STARTED|Baseline||0
10902139|NCT00006409|12068220|FG003|STARTED|Baseline||0
10902140|NCT00006409|12068221|FG004|STARTED|Baseline||0
10902141|NCT00006409|12068222|FG005|STARTED|Baseline||0
10902142|NCT00006409|12068217|FG000|COMPLETED|Baseline||817
10902143|NCT00006409|12068218|FG001|COMPLETED|Baseline||786
10902144|NCT00006409|12068219|FG002|COMPLETED|Baseline||0
10902145|NCT00006409|12068220|FG003|COMPLETED|Baseline||0
10902146|NCT00006409|12068221|FG004|COMPLETED|Baseline||0
10902147|NCT00006409|12068222|FG005|COMPLETED|Baseline||0
10902148|NCT00006409|12068217|FG000|NOT COMPLETED|Baseline||48
10902149|NCT00006409|12068218|FG001|NOT COMPLETED|Baseline||70
10902150|NCT00006409|12068219|FG002|NOT COMPLETED|Baseline||0
10902151|NCT00006409|12068220|FG003|NOT COMPLETED|Baseline||0
10902152|NCT00006409|12068221|FG004|NOT COMPLETED|Baseline||0
10902153|NCT00006409|12068222|FG005|NOT COMPLETED|Baseline||0
10902154|NCT00006409|12068217|FG000|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
10902155|NCT00006409|12068218|FG001|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
10902156|NCT00006409|12068219|FG002|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
10902157|NCT00006409|12068220|FG003|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
10902158|NCT00006409|12068221|FG004|STARTED|Post-2 Year Intervention||0
10902159|NCT00006409|12068222|FG005|STARTED|Post-2 Year Intervention||0
10902160|NCT00006409|12068217|FG000|COMPLETED|Post-2 Year Intervention||0
10902161|NCT00006409|12068218|FG001|COMPLETED|Post-2 Year Intervention||0
10902162|NCT00006409|12068219|FG002|COMPLETED|Post-2 Year Intervention||1540
10902163|NCT00006409|12068220|FG003|COMPLETED|Post-2 Year Intervention||1545
10902164|NCT00006409|12068221|FG004|COMPLETED|Post-2 Year Intervention||0
10902165|NCT00006409|12068222|FG005|COMPLETED|Post-2 Year Intervention||0
10902166|NCT00006409|12068217|FG000|NOT COMPLETED|Post-2 Year Intervention||0
10902167|NCT00006409|12068218|FG001|NOT COMPLETED|Post-2 Year Intervention||0
10902168|NCT00006409|12068219|FG002|NOT COMPLETED|Post-2 Year Intervention||251
10902169|NCT00006409|12068220|FG003|NOT COMPLETED|Post-2 Year Intervention||168
10902170|NCT00006409|12068221|FG004|NOT COMPLETED|Post-2 Year Intervention||0
10902171|NCT00006409|12068222|FG005|NOT COMPLETED|Post-2 Year Intervention||0
10902172|NCT00006409|12068217|FG000|STARTED|Post-3 Year Intervention||0
10902173|NCT00006409|12068218|FG001|STARTED|Post-3 Year Intervention||0
10902174|NCT00006409|12068219|FG002|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
10902175|NCT00006409|12068220|FG003|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
10902176|NCT00006409|12068221|FG004|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
10902177|NCT00006409|12068222|FG005|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
10902178|NCT00006409|12068217|FG000|COMPLETED|Post-3 Year Intervention||0
10902179|NCT00006409|12068218|FG001|COMPLETED|Post-3 Year Intervention||0
10902180|NCT00006409|12068219|FG002|COMPLETED|Post-3 Year Intervention||0
10902181|NCT00006409|12068220|FG003|COMPLETED|Post-3 Year Intervention||0
10902182|NCT00006409|12068221|FG004|COMPLETED|Post-3 Year Intervention||1664
10902183|NCT00006409|12068222|FG005|COMPLETED|Post-3 Year Intervention||1714
10902184|NCT00006409|12068217|FG000|NOT COMPLETED|Post-3 Year Intervention||0
10902185|NCT00006409|12068218|FG001|NOT COMPLETED|Post-3 Year Intervention||0
10902186|NCT00006409|12068219|FG002|NOT COMPLETED|Post-3 Year Intervention||0
10902187|NCT00006409|12068220|FG003|NOT COMPLETED|Post-3 Year Intervention||0
10902188|NCT00006409|12068221|FG004|NOT COMPLETED|Post-3 Year Intervention||62
10902189|NCT00006409|12068222|FG005|NOT COMPLETED|Post-3 Year Intervention||62
10902190|NCT00006411|12068238|FG000|STARTED|Overall Study||707
10902191|NCT00006411|12068239|FG001|STARTED|Overall Study||383
10902192|NCT00006411|12068238|FG000|COMPLETED|Overall Study||707
10902193|NCT00006411|12068239|FG001|COMPLETED|Overall Study||383
10902194|NCT00006411|12068238|FG000|NOT COMPLETED|Overall Study||0
10902195|NCT00006411|12068239|FG001|NOT COMPLETED|Overall Study||0
10902196|NCT00006489|12068249|FG000|STARTED|Overall Study||42
10902197|NCT00006489|12068250|FG001|STARTED|Overall Study||40
10902198|NCT00006489|12068251|FG002|STARTED|Overall Study||40
10902199|NCT00006489|12068252|FG003|STARTED|Overall Study||43
10902200|NCT00006489|12068249|FG000|COMPLETED|Overall Study||29
10902201|NCT00006489|12068250|FG001|COMPLETED|Overall Study||26
10902202|NCT00006489|12068251|FG002|COMPLETED|Overall Study||25
10902203|NCT00006489|12068252|FG003|COMPLETED|Overall Study||32
10902204|NCT00006489|12068249|FG000|NOT COMPLETED|Overall Study||13
10902205|NCT00006489|12068250|FG001|NOT COMPLETED|Overall Study||14
10902206|NCT00006489|12068251|FG002|NOT COMPLETED|Overall Study||15
10902207|NCT00006489|12068252|FG003|NOT COMPLETED|Overall Study||11
10902208|NCT00006604|12068269|FG000|STARTED|Overall Study||6
10902209|NCT00006604|12068270|FG001|STARTED|Overall Study||2
10902210|NCT00006604|12068271|FG002|STARTED|Overall Study||5
10902211|NCT00006604|12068272|FG003|STARTED|Overall Study||6
10902212|NCT00006604|12068273|FG004|STARTED|Overall Study||5
10902213|NCT00006604|12068274|FG005|STARTED|Overall Study||5
10902214|NCT00006604|12068275|FG006|STARTED|Overall Study||21
10902215|NCT00006604|12068276|FG007|STARTED|Overall Study||5
10902216|NCT00006604|12068277|FG008|STARTED|Overall Study||5
10902217|NCT00006604|12068278|FG009|STARTED|Overall Study||25
10902218|NCT00006604|12068279|FG010|STARTED|Overall Study||21
10902219|NCT00006604|12068280|FG011|STARTED|Overall Study||12
10902220|NCT00006604|12068281|FG012|STARTED|Overall Study||26
10902221|NCT00006604|12068282|FG013|STARTED|Overall Study||6
10902222|NCT00006604|12068283|FG014|STARTED|Overall Study||24
10902223|NCT00006604|12068284|FG015|STARTED|Overall Study||6
10902224|NCT00006604|12068285|FG016|STARTED|Overall Study||15
10902225|NCT00006604|12068269|FG000|COMPLETED|Overall Study||4
10902226|NCT00006604|12068270|FG001|COMPLETED|Overall Study||2
10902227|NCT00006604|12068271|FG002|COMPLETED|Overall Study||1
10902228|NCT00006604|12068272|FG003|COMPLETED|Overall Study||1
10902229|NCT00006604|12068273|FG004|COMPLETED|Overall Study||3
10902230|NCT00006604|12068274|FG005|COMPLETED|Overall Study||2
10902231|NCT00006604|12068275|FG006|COMPLETED|Overall Study||12
10902232|NCT00006604|12068276|FG007|COMPLETED|Overall Study||2
10902233|NCT00006604|12068277|FG008|COMPLETED|Overall Study||4
10902234|NCT00006604|12068278|FG009|COMPLETED|Overall Study||6
10902235|NCT00006604|12068279|FG010|COMPLETED|Overall Study||13
10902236|NCT00006604|12068280|FG011|COMPLETED|Overall Study||6
10902237|NCT00006604|12068281|FG012|COMPLETED|Overall Study||22
10902238|NCT00006604|12068282|FG013|COMPLETED|Overall Study||0
10902239|NCT00006604|12068283|FG014|COMPLETED|Overall Study||14
10902240|NCT00006604|12068284|FG015|COMPLETED|Overall Study||1
10902241|NCT00006604|12068285|FG016|COMPLETED|Overall Study||6
10902242|NCT00006604|12068269|FG000|NOT COMPLETED|Overall Study||2
10902243|NCT00006604|12068270|FG001|NOT COMPLETED|Overall Study||0
10902244|NCT00006604|12068271|FG002|NOT COMPLETED|Overall Study||4
10902245|NCT00006604|12068272|FG003|NOT COMPLETED|Overall Study||5
10902246|NCT00006604|12068273|FG004|NOT COMPLETED|Overall Study||2
10902247|NCT00006604|12068274|FG005|NOT COMPLETED|Overall Study||3
10902248|NCT00006604|12068275|FG006|NOT COMPLETED|Overall Study||9
10902249|NCT00006604|12068276|FG007|NOT COMPLETED|Overall Study||3
10902250|NCT00006604|12068277|FG008|NOT COMPLETED|Overall Study||1
10902251|NCT00006604|12068278|FG009|NOT COMPLETED|Overall Study||19
10902252|NCT00006604|12068279|FG010|NOT COMPLETED|Overall Study||8
10902253|NCT00006604|12068280|FG011|NOT COMPLETED|Overall Study||6
10902254|NCT00006604|12068281|FG012|NOT COMPLETED|Overall Study||4
10902255|NCT00006604|12068282|FG013|NOT COMPLETED|Overall Study||6
10902256|NCT00006604|12068283|FG014|NOT COMPLETED|Overall Study||10
10902257|NCT00006604|12068284|FG015|NOT COMPLETED|Overall Study||5
10902258|NCT00006604|12068285|FG016|NOT COMPLETED|Overall Study||9
10902259|NCT00006903|12068310|FG000|STARTED|Overall Study||10
10902260|NCT00006903|12068311|FG001|STARTED|Overall Study||24
10902261|NCT00006903|12068312|FG002|STARTED|Overall Study||33
10902262|NCT00006903|12068310|FG000|COMPLETED|Overall Study||0
10902263|NCT00006903|12068311|FG001|COMPLETED|Overall Study||20
10902264|NCT00006903|12068312|FG002|COMPLETED|Overall Study||27
10902265|NCT00006903|12068310|FG000|NOT COMPLETED|Overall Study||10
10902266|NCT00006903|12068311|FG001|NOT COMPLETED|Overall Study||4
10902267|NCT00006903|12068312|FG002|NOT COMPLETED|Overall Study||6
10902268|NCT00007020|12068320|FG000|STARTED|Overall Study||85
10902269|NCT00007020|12068320|FG000|COMPLETED|Overall Study||41
10902270|NCT00007020|12068320|FG000|NOT COMPLETED|Overall Study||44
10902271|NCT00007345|12068328|FG000|STARTED|Overall Study||47
10902272|NCT00007345|12068329|FG001|STARTED|Overall Study||84
10902273|NCT00007345|12068328|FG000|COMPLETED|Overall Study||45
10902274|NCT00007345|12068329|FG001|COMPLETED|Overall Study||73
10902275|NCT00007345|12068328|FG000|NOT COMPLETED|Overall Study||2
10902276|NCT00007345|12068329|FG001|NOT COMPLETED|Overall Study||11
10902277|NCT00007475|12068338|FG000|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
10902278|NCT00007475|12068339|FG001|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
10902279|NCT00007475|12068340|FG002|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
10902280|NCT00007475|12068341|FG003|STARTED|Overall Study||0
10902281|NCT00007475|12068338|FG000|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
10902282|NCT00007475|12068339|FG001|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
10902283|NCT00007475|12068340|FG002|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
10902284|NCT00007475|12068341|FG003|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
10902285|NCT00007475|12068338|FG000|Initial Transplant|Overall Study||12
10902286|NCT00007475|12068339|FG001|Initial Transplant|Overall Study||1
10902287|NCT00007475|12068340|FG002|Initial Transplant|Overall Study||2
10902288|NCT00007475|12068341|FG003|Initial Transplant|Overall Study||0
10902289|NCT00007475|12068338|FG000|Post-initial Transplant Proteinuria|Overall Study||12
10902290|NCT00007475|12068339|FG001|Post-initial Transplant Proteinuria|Overall Study||1
10902291|NCT00007475|12068340|FG002|Post-initial Transplant Proteinuria|Overall Study||2
10902292|NCT00007475|12068341|FG003|Post-initial Transplant Proteinuria|Overall Study||0
10902293|NCT00007475|12068338|FG000|Initial Plasma Exchange|Overall Study||12
10902294|NCT00007475|12068339|FG001|Initial Plasma Exchange|Overall Study||1
10902295|NCT00007475|12068340|FG002|Initial Plasma Exchange|Overall Study||2
10902296|NCT00007475|12068341|FG003|Initial Plasma Exchange|Overall Study||0
10902297|NCT00007475|12068338|FG000|Initiate Cyclophosphamide|Overall Study||12
10902298|NCT00007475|12068339|FG001|Initiate Cyclophosphamide|Overall Study||1
10902299|NCT00007475|12068340|FG002|Initiate Cyclophosphamide|Overall Study||2
10902300|NCT00007475|12068341|FG003|Initiate Cyclophosphamide|Overall Study||0
10902301|NCT00007475|12068338|FG000|COMPLETED|Overall Study||8
10902302|NCT00007475|12068339|FG001|COMPLETED|Overall Study||1
10902303|NCT00007475|12068340|FG002|COMPLETED|Overall Study||2
10902304|NCT00007475|12068341|FG003|COMPLETED|Overall Study||0
10902305|NCT00007475|12068338|FG000|NOT COMPLETED|Overall Study||4
10902306|NCT00007475|12068339|FG001|NOT COMPLETED|Overall Study||0
10902307|NCT00007475|12068340|FG002|NOT COMPLETED|Overall Study||0
10902308|NCT00007475|12068341|FG003|NOT COMPLETED|Overall Study||0
10902309|NCT00007644|12068353|FG000|STARTED|Overall Study||364
10902310|NCT00007644|12068354|FG001|STARTED|Overall Study||367
10902311|NCT00007644|12068353|FG000|COMPLETED|Overall Study||364
10902312|NCT00007644|12068354|FG001|COMPLETED|Overall Study||367
10902313|NCT00007644|12068353|FG000|NOT COMPLETED|Overall Study||0
10902314|NCT00007644|12068354|FG001|NOT COMPLETED|Overall Study||0
10902315|NCT00008138|12068360|FG000|STARTED|Neoadjuvant Chemotherapy||58
10902316|NCT00008138|12068360|FG000|Eligible|Neoadjuvant Chemotherapy||58
10902317|NCT00008138|12068360|FG000|COMPLETED|Neoadjuvant Chemotherapy||38
10902318|NCT00008138|12068360|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||20
10902319|NCT00008138|12068360|FG000|STARTED|Interval Debulking||38
10902320|NCT00008138|12068360|FG000|Received Protocol Surgery|Interval Debulking||36
10902321|NCT00008138|12068360|FG000|COMPLETED|Interval Debulking||36
10902322|NCT00008138|12068360|FG000|NOT COMPLETED|Interval Debulking||2
10902323|NCT00008138|12068360|FG000|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
10902324|NCT00008138|12068360|FG000|COMPLETED|Post-Cytoreduction Chemotherapy||18
10902325|NCT00008138|12068360|FG000|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
10902326|NCT00008385|12068367|FG000|STARTED|Overall Study||521
10902327|NCT00008385|12068368|FG001|STARTED|Overall Study||1040
10902328|NCT00008385|12068367|FG000|Treated|Overall Study||477
10902329|NCT00008385|12068368|FG001|Treated|Overall Study||865
10902330|NCT00008385|12068367|FG000|Off Treatment Reasons Reported|Overall Study||398
10902331|NCT00008385|12068368|FG001|Off Treatment Reasons Reported|Overall Study||795
10902332|NCT00008385|12068367|FG000|COMPLETED|Overall Study||134
10902333|NCT00008385|12068368|FG001|COMPLETED|Overall Study||238
10902334|NCT00008385|12068367|FG000|NOT COMPLETED|Overall Study||387
10902335|NCT00008385|12068368|FG001|NOT COMPLETED|Overall Study||802
10902336|NCT00009737|12068376|FG000|STARTED|Overall Study||1004
10902337|NCT00009737|12068377|FG001|STARTED|Overall Study||983
10902338|NCT00009737|12068376|FG000|COMPLETED|Overall Study||834
10902339|NCT00009737|12068377|FG001|COMPLETED|Overall Study||860
10902340|NCT00009737|12068376|FG000|NOT COMPLETED|Overall Study||170
10902341|NCT00009737|12068377|FG001|NOT COMPLETED|Overall Study||123
10902342|NCT00009945|12068385|FG000|STARTED|Overall Study||1662
10902343|NCT00009945|12068386|FG001|STARTED|Overall Study||1661
10902344|NCT00009945|12068385|FG000|COMPLETED|Overall Study||1655
10902345|NCT00009945|12068386|FG001|COMPLETED|Overall Study||1656
10902346|NCT00009945|12068385|FG000|NOT COMPLETED|Overall Study||7
10902347|NCT00009945|12068386|FG001|NOT COMPLETED|Overall Study||5
10902348|NCT00010257|12068394|FG000|STARTED|Overall Study||25
10902349|NCT00010257|12068395|FG001|STARTED|Overall Study||21
10902350|NCT00010257|12068394|FG000|COMPLETED|Overall Study||24
10902351|NCT00010257|12068395|FG001|COMPLETED|Overall Study||21
10902352|NCT00010257|12068394|FG000|NOT COMPLETED|Overall Study||1
10902353|NCT00010257|12068395|FG001|NOT COMPLETED|Overall Study||0
10902354|NCT00010374|12068401|FG000|STARTED|Overall Study||54
10902355|NCT00010374|12068401|FG000|COMPLETED|Overall Study|One compassionate use participant was withheld from analysis per FDA instructions|53
10902356|NCT00010374|12068401|FG000|NOT COMPLETED|Overall Study||1
10902357|NCT00010439|12068406|FG000|STARTED|Overall Study||10
10902358|NCT00010439|12068406|FG000|6 Months|Overall Study||10
10902359|NCT00010439|12068406|FG000|COMPLETED|Overall Study||10
10902360|NCT00010439|12068406|FG000|NOT COMPLETED|Overall Study||0
10902361|NCT00010803|12068412|FG000|STARTED|Overall Study|Randomized|1545
10902362|NCT00010803|12068413|FG001|STARTED|Overall Study|Randomized|1524
10902363|NCT00010803|12068412|FG000|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
10902364|NCT00010803|12068413|FG001|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
10902365|NCT00010803|12068412|FG000|NOT COMPLETED|Overall Study||97
10902366|NCT00010803|12068413|FG001|NOT COMPLETED|Overall Study||98
10902367|NCT00011986|12068424|FG000|STARTED|Overall Study||864
10902368|NCT00011986|12068425|FG001|STARTED|Overall Study||864
10902369|NCT00011986|12068426|FG002|STARTED|Overall Study||862
10902370|NCT00011986|12068427|FG003|STARTED|Overall Study||861
10902371|NCT00011986|12068428|FG004|STARTED|Overall Study||861
10902372|NCT00011986|12068424|FG000|Initiated Treatment|Overall Study||862
10902373|NCT00011986|12068425|FG001|Initiated Treatment|Overall Study||860
10902374|NCT00011986|12068426|FG002|Initiated Treatment|Overall Study||854
10902375|NCT00011986|12068427|FG003|Initiated Treatment|Overall Study||846
10902376|NCT00011986|12068428|FG004|Initiated Treatment|Overall Study||851
10902377|NCT00011986|12068424|FG000|COMPLETED|Overall Study||864
10902378|NCT00011986|12068425|FG001|COMPLETED|Overall Study||864
10902379|NCT00011986|12068426|FG002|COMPLETED|Overall Study||862
10902380|NCT00011986|12068427|FG003|COMPLETED|Overall Study||861
10902381|NCT00011986|12068428|FG004|COMPLETED|Overall Study||861
10902382|NCT00011986|12068424|FG000|NOT COMPLETED|Overall Study||0
10902383|NCT00011986|12068425|FG001|NOT COMPLETED|Overall Study||0
10902384|NCT00011986|12068426|FG002|NOT COMPLETED|Overall Study||0
10902385|NCT00011986|12068427|FG003|NOT COMPLETED|Overall Study||0
10902386|NCT00011986|12068428|FG004|NOT COMPLETED|Overall Study||0
10902387|NCT00012012|12068447|FG000|STARTED|Overall Study||27
10902388|NCT00012012|12068448|FG001|STARTED|Overall Study||18
10902389|NCT00012012|12068447|FG000|COMPLETED|Overall Study||26
10902390|NCT00012012|12068448|FG001|COMPLETED|Overall Study||15
10902391|NCT00012012|12068447|FG000|NOT COMPLETED|Overall Study||1
10902392|NCT00012012|12068448|FG001|NOT COMPLETED|Overall Study||3
10902393|NCT00012298|12068461|FG000|STARTED|Overall Study||11
10902394|NCT00012298|12068462|FG001|STARTED|Overall Study||7
10902395|NCT00012298|12068463|FG002|STARTED|Overall Study||9
10902396|NCT00012298|12068464|FG003|STARTED|Overall Study||4
10902397|NCT00012298|12068465|FG004|STARTED|Overall Study||5
10902398|NCT00012298|12068466|FG005|STARTED|Overall Study||6
10902399|NCT00012298|12068467|FG006|STARTED|Overall Study||39
10902400|NCT00012298|12068461|FG000|COMPLETED|Overall Study||11
10902401|NCT00012298|12068462|FG001|COMPLETED|Overall Study||7
10902402|NCT00012298|12068463|FG002|COMPLETED|Overall Study||9
10902403|NCT00012298|12068464|FG003|COMPLETED|Overall Study||4
10902404|NCT00012298|12068465|FG004|COMPLETED|Overall Study||5
10902405|NCT00012298|12068466|FG005|COMPLETED|Overall Study||6
10902406|NCT00012298|12068467|FG006|COMPLETED|Overall Study||39
10902407|NCT00012298|12068461|FG000|NOT COMPLETED|Overall Study||0
10902408|NCT00012298|12068462|FG001|NOT COMPLETED|Overall Study||0
10902409|NCT00012298|12068463|FG002|NOT COMPLETED|Overall Study||0
10902410|NCT00012298|12068464|FG003|NOT COMPLETED|Overall Study||0
10902411|NCT00012298|12068465|FG004|NOT COMPLETED|Overall Study||0
10902412|NCT00012298|12068466|FG005|NOT COMPLETED|Overall Study||0
10902413|NCT00012298|12068467|FG006|NOT COMPLETED|Overall Study||0
10902414|NCT00013611|12068487|FG000|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
10902415|NCT00013611|12068488|FG001|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
10902416|NCT00013611|12068487|FG000|COMPLETED|Overall Study||758
10902417|NCT00013611|12068488|FG001|COMPLETED|Overall Study||746
10902418|NCT00013611|12068487|FG000|NOT COMPLETED|Overall Study||91
10902419|NCT00013611|12068488|FG001|NOT COMPLETED|Overall Study||100
10902420|NCT00014222|12068497|FG000|STARTED|Overall Study||701
10902421|NCT00014222|12068498|FG001|STARTED|Overall Study||701
10902422|NCT00014222|12068499|FG002|STARTED|Overall Study||702
10902423|NCT00014222|12068497|FG000|COMPLETED|Overall Study||680
10902424|NCT00014222|12068498|FG001|COMPLETED|Overall Study||688
10902425|NCT00014222|12068499|FG002|COMPLETED|Overall Study||675
10902426|NCT00014222|12068497|FG000|NOT COMPLETED|Overall Study||21
10902427|NCT00014222|12068498|FG001|NOT COMPLETED|Overall Study||13
10902428|NCT00014222|12068499|FG002|NOT COMPLETED|Overall Study||27
10902429|NCT00014495|12068511|FG000|STARTED|Overall Study||3
10902430|NCT00014495|12068512|FG001|STARTED|Overall Study||3
10902431|NCT00014495|12068513|FG002|STARTED|Overall Study||20
10902432|NCT00014495|12068514|FG003|STARTED|Overall Study||6
10902433|NCT00014495|12068511|FG000|COMPLETED|Overall Study||3
10902434|NCT00014495|12068512|FG001|COMPLETED|Overall Study||3
10902435|NCT00014495|12068513|FG002|COMPLETED|Overall Study||19
10902436|NCT00014495|12068514|FG003|COMPLETED|Overall Study||5
10902437|NCT00014495|12068511|FG000|NOT COMPLETED|Overall Study||0
10902438|NCT00014495|12068512|FG001|NOT COMPLETED|Overall Study||0
10902439|NCT00014495|12068513|FG002|NOT COMPLETED|Overall Study||1
10902440|NCT00014495|12068514|FG003|NOT COMPLETED|Overall Study||1
10902441|NCT00014911|12068521|FG000|STARTED|Overall Study||36
10902442|NCT00014911|12068521|FG000|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
10902443|NCT00014911|12068521|FG000|NOT COMPLETED|Overall Study||11
10902444|NCT00015457|12068525|FG000|STARTED|First Intervention||8
10902445|NCT00015457|12068526|FG001|STARTED|First Intervention||8
10902446|NCT00015457|12068525|FG000|COMPLETED|First Intervention||8
10902447|NCT00015457|12068526|FG001|COMPLETED|First Intervention||5
10902448|NCT00015457|12068525|FG000|NOT COMPLETED|First Intervention||0
10902449|NCT00015457|12068526|FG001|NOT COMPLETED|First Intervention||3
10902450|NCT00015457|12068525|FG000|STARTED|Second Intervention||8
10902451|NCT00015457|12068526|FG001|STARTED|Second Intervention||5
10902452|NCT00015457|12068525|FG000|COMPLETED|Second Intervention||7
10902453|NCT00015457|12068526|FG001|COMPLETED|Second Intervention||5
10902454|NCT00015457|12068525|FG000|NOT COMPLETED|Second Intervention||1
10902455|NCT00015457|12068526|FG001|NOT COMPLETED|Second Intervention||0
10902456|NCT00015847|12068532|FG000|STARTED|Overall Study||25
10902457|NCT00015847|12068532|FG000|COMPLETED|Overall Study||25
10902458|NCT00015847|12068532|FG000|NOT COMPLETED|Overall Study||0
10902459|NCT00016354|12068536|FG000|STARTED|Overall Study||1
10902460|NCT00016354|12068537|FG001|STARTED|Overall Study||1
10902461|NCT00016354|12068538|FG002|STARTED|Overall Study||1
10902462|NCT00016354|12068539|FG003|STARTED|Overall Study||1
10902463|NCT00016354|12068540|FG004|STARTED|Overall Study||1
10902464|NCT00016354|12068541|FG005|STARTED|Overall Study||1
10902465|NCT00016354|12068542|FG006|STARTED|Overall Study||6
10902466|NCT00016354|12068543|FG007|STARTED|Overall Study||7
10902467|NCT00016354|12068536|FG000|COMPLETED|Overall Study||1
10902468|NCT00016354|12068537|FG001|COMPLETED|Overall Study||1
10902469|NCT00016354|12068538|FG002|COMPLETED|Overall Study||1
10902470|NCT00016354|12068539|FG003|COMPLETED|Overall Study||1
10902471|NCT00016354|12068540|FG004|COMPLETED|Overall Study||1
10902472|NCT00016354|12068541|FG005|COMPLETED|Overall Study||1
10902473|NCT00016354|12068542|FG006|COMPLETED|Overall Study||6
10902474|NCT00016354|12068543|FG007|COMPLETED|Overall Study||6
10902475|NCT00016354|12068536|FG000|NOT COMPLETED|Overall Study||0
10902476|NCT00016354|12068537|FG001|NOT COMPLETED|Overall Study||0
10902477|NCT00016354|12068538|FG002|NOT COMPLETED|Overall Study||0
10902478|NCT00016354|12068539|FG003|NOT COMPLETED|Overall Study||0
10902479|NCT00016354|12068540|FG004|NOT COMPLETED|Overall Study||0
10902480|NCT00016354|12068541|FG005|NOT COMPLETED|Overall Study||0
10902481|NCT00016354|12068542|FG006|NOT COMPLETED|Overall Study||0
10902482|NCT00016354|12068543|FG007|NOT COMPLETED|Overall Study||1
10902483|NCT00016718|12068550|FG000|STARTED|Overall Study||6
10902484|NCT00016718|12068551|FG001|STARTED|Overall Study||21
10902485|NCT00016718|12068552|FG002|STARTED|Overall Study||16
10902486|NCT00016718|12068550|FG000|COMPLETED|Overall Study||6
10902487|NCT00016718|12068551|FG001|COMPLETED|Overall Study||21
10902488|NCT00016718|12068552|FG002|COMPLETED|Overall Study||16
10902489|NCT00016718|12068550|FG000|NOT COMPLETED|Overall Study||0
10902490|NCT00016718|12068551|FG001|NOT COMPLETED|Overall Study||0
10902491|NCT00016718|12068552|FG002|NOT COMPLETED|Overall Study||0
10902492|NCT00016913|12068560|FG000|STARTED|Overall Study||27
10902493|NCT00016913|12068560|FG000|COMPLETED|Overall Study||27
10902494|NCT00016913|12068560|FG000|NOT COMPLETED|Overall Study||0
10902495|NCT00017563|12068564|FG000|STARTED|Overall Study||57
10902496|NCT00017563|12068564|FG000|COMPLETED|Overall Study||56
10902497|NCT00017563|12068564|FG000|NOT COMPLETED|Overall Study||1
10902498|NCT00018031|12068568|FG000|STARTED|Overall Study||36
10902499|NCT00018031|12068568|FG000|COMPLETED|Overall Study||36
10902500|NCT00018031|12068568|FG000|NOT COMPLETED|Overall Study||0
10902501|NCT00019604|12068572|FG000|STARTED|Overall Study||44
10902502|NCT00019604|12068572|FG000|COMPLETED|Overall Study||5
10902503|NCT00019604|12068572|FG000|NOT COMPLETED|Overall Study||39
10902504|NCT00019682|12068578|FG000|STARTED|Overall Study||94
10902505|NCT00019682|12068579|FG001|STARTED|Overall Study||91
10902506|NCT00019682|12068578|FG000|COMPLETED|Overall Study||93
10902507|NCT00019682|12068579|FG001|COMPLETED|Overall Study||85
10902508|NCT00019682|12068578|FG000|NOT COMPLETED|Overall Study||1
10902509|NCT00019682|12068579|FG001|NOT COMPLETED|Overall Study||6
10902510|NCT00021229|12068588|FG000|STARTED|Overall Study||36
10902511|NCT00021229|12068589|FG001|STARTED|Overall Study||33
10902512|NCT00021229|12068590|FG002|STARTED|Overall Study||16
10902513|NCT00021229|12068588|FG000|Enrolled in Phase I|Overall Study||35
10902514|NCT00021229|12068589|FG001|Enrolled in Phase I|Overall Study||33
10902515|NCT00021229|12068590|FG002|Enrolled in Phase I|Overall Study||16
10902516|NCT00021229|12068588|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
10902517|NCT00021229|12068589|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
10902518|NCT00021229|12068590|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
10902519|NCT00021229|12068588|FG000|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
10902520|NCT00021229|12068589|FG001|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
10902521|NCT00021229|12068590|FG002|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
10902522|NCT00021229|12068588|FG000|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
10902523|NCT00021229|12068589|FG001|COMPLETED|Overall Study||0
10902524|NCT00021229|12068590|FG002|COMPLETED|Overall Study||0
10902525|NCT00021229|12068588|FG000|NOT COMPLETED|Overall Study||35
10902526|NCT00021229|12068589|FG001|NOT COMPLETED|Overall Study||33
10902527|NCT00021229|12068590|FG002|NOT COMPLETED|Overall Study||16
10902528|NCT00021255|12068603|FG000|STARTED|Overall Study|Randomized|1073
10902529|NCT00021255|12068604|FG001|STARTED|Overall Study|Randomized|1074
10902530|NCT00021255|12068605|FG002|STARTED|Overall Study|Randomized|1075
10902531|NCT00021255|12068603|FG000|Treated|Overall Study||1045
10902532|NCT00021255|12068604|FG001|Treated|Overall Study||1072
10902533|NCT00021255|12068605|FG002|Treated|Overall Study||1057
10902534|NCT00021255|12068603|FG000|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
10902535|NCT00021255|12068604|FG001|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
10902536|NCT00021255|12068605|FG002|Safety Population|Overall Study|1056 participants received TCH.|1056
10902537|NCT00021255|12068603|FG000|COMPLETED|Overall Study||952
10902538|NCT00021255|12068604|FG001|COMPLETED|Overall Study||804
10902539|NCT00021255|12068605|FG002|COMPLETED|Overall Study||926
10902540|NCT00021255|12068603|FG000|NOT COMPLETED|Overall Study||121
10902541|NCT00021255|12068604|FG001|NOT COMPLETED|Overall Study||270
10902542|NCT00021255|12068605|FG002|NOT COMPLETED|Overall Study||149
10902543|NCT00021541|12068615|FG000|STARTED|Period 1-First Treatment||31
10902544|NCT00021541|12068616|FG001|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
10902545|NCT00021541|12068615|FG000|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
10902546|NCT00021541|12068616|FG001|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
10902547|NCT00021541|12068615|FG000|Ineligible Patients|Period 1-First Treatment||0
10902548|NCT00021541|12068616|FG001|Ineligible Patients|Period 1-First Treatment||2
10902549|NCT00021541|12068615|FG000|COMPLETED|Period 1-First Treatment||20
10902550|NCT00021541|12068616|FG001|COMPLETED|Period 1-First Treatment||23
10902551|NCT00021541|12068615|FG000|NOT COMPLETED|Period 1-First Treatment||11
10902552|NCT00021541|12068616|FG001|NOT COMPLETED|Period 1-First Treatment||8
10902553|NCT00021541|12068615|FG000|STARTED|Period 2-crossover||20
10902554|NCT00021541|12068616|FG001|STARTED|Period 2-crossover||23
10902555|NCT00021541|12068615|FG000|COMPLETED|Period 2-crossover||10
10902556|NCT00021541|12068616|FG001|COMPLETED|Period 2-crossover||12
10902557|NCT00021541|12068615|FG000|NOT COMPLETED|Period 2-crossover||10
10902558|NCT00021541|12068616|FG001|NOT COMPLETED|Period 2-crossover||11
10902559|NCT00022490|12068624|FG000|STARTED|Overall Study||24
10902560|NCT00022490|12068624|FG000|COMPLETED|Overall Study||24
10902561|NCT00022490|12068624|FG000|NOT COMPLETED|Overall Study||0
10902562|NCT00022516|12068630|FG000|STARTED|Overall Study||542
10902563|NCT00022516|12068631|FG001|STARTED|Overall Study||544
10902564|NCT00022516|12068630|FG000|COMPLETED|Overall Study||539
10902565|NCT00022516|12068631|FG001|COMPLETED|Overall Study||314
10902566|NCT00022516|12068630|FG000|NOT COMPLETED|Overall Study||3
10902567|NCT00022516|12068631|FG001|NOT COMPLETED|Overall Study||230
10902568|NCT00022633|12068639|FG000|STARTED|Overall Study||55
10902569|NCT00022633|12068640|FG001|STARTED|Overall Study||10
10902570|NCT00022633|12068639|FG000|Eligible|Overall Study||51
10902571|NCT00022633|12068640|FG001|Eligible|Overall Study||10
10902572|NCT00022633|12068639|FG000|COMPLETED|Overall Study||23
10902573|NCT00022633|12068640|FG001|COMPLETED|Overall Study||5
10902574|NCT00022633|12068639|FG000|NOT COMPLETED|Overall Study||32
10902575|NCT00022633|12068640|FG001|NOT COMPLETED|Overall Study||5
10902576|NCT00022659|12068645|FG000|STARTED|Overall Study||64
10902577|NCT00022659|12068645|FG000|COMPLETED|Overall Study|Eligible and treated patients.|62
10902578|NCT00022659|12068645|FG000|NOT COMPLETED|Overall Study||2
10902579|NCT00022672|12068655|FG000|STARTED|Main Phase: 24 Months||103
10902580|NCT00022672|12068656|FG001|STARTED|Main Phase: 24 Months||104
10902581|NCT00022672|12068655|FG000|Safety Set: Received Study Drug|Main Phase: 24 Months||103
10902582|NCT00022672|12068656|FG001|Safety Set: Received Study Drug|Main Phase: 24 Months||104
10902583|NCT00022672|12068655|FG000|COMPLETED|Main Phase: 24 Months||16
10902584|NCT00022672|12068656|FG001|COMPLETED|Main Phase: 24 Months||4
10902585|NCT00022672|12068655|FG000|NOT COMPLETED|Main Phase: 24 Months||87
10902586|NCT00022672|12068656|FG001|NOT COMPLETED|Main Phase: 24 Months||100
10902587|NCT00022672|12068655|FG000|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
10902588|NCT00022672|12068656|FG001|STARTED|Extension Phase||58
10902589|NCT00022672|12068655|FG000|Safety Set: Received Study Drug|Extension Phase||14
10902590|NCT00022672|12068656|FG001|Safety Set: Received Study Drug|Extension Phase||58
10902591|NCT00022672|12068655|FG000|COMPLETED|Extension Phase||11
10902592|NCT00022672|12068656|FG001|COMPLETED|Extension Phase||7
10902593|NCT00022672|12068655|FG000|NOT COMPLETED|Extension Phase||3
10902594|NCT00022672|12068656|FG001|NOT COMPLETED|Extension Phase||51
10902595|NCT00022698|12068665|FG000|STARTED|Overall Study||15
10902596|NCT00022698|12068666|FG001|STARTED|Overall Study||52
10902597|NCT00022698|12068665|FG000|COMPLETED|Overall Study||7
10902598|NCT00022698|12068666|FG001|COMPLETED|Overall Study||17
10902599|NCT00022698|12068665|FG000|NOT COMPLETED|Overall Study||8
10902600|NCT00022698|12068666|FG001|NOT COMPLETED|Overall Study||35
10902601|NCT00022763|12068676|FG000|STARTED|Overall Study||24
10902602|NCT00022763|12068677|FG001|STARTED|Overall Study||28
10902603|NCT00022763|12068676|FG000|COMPLETED|Overall Study||15
10902604|NCT00022763|12068677|FG001|COMPLETED|Overall Study||11
10902605|NCT00022763|12068676|FG000|NOT COMPLETED|Overall Study||9
10902606|NCT00022763|12068677|FG001|NOT COMPLETED|Overall Study||17
10902607|NCT00023309|12068684|FG000|STARTED|Overall Study||22
10902608|NCT00023309|12068685|FG001|STARTED|Overall Study||19
10902609|NCT00023309|12068684|FG000|COMPLETED|Overall Study||22
10902610|NCT00023309|12068685|FG001|COMPLETED|Overall Study||19
10902611|NCT00023309|12068684|FG000|NOT COMPLETED|Overall Study||0
10902612|NCT00023309|12068685|FG001|NOT COMPLETED|Overall Study||0
10902613|NCT00023322|12068691|FG000|STARTED|Overall Study||13
10902614|NCT00023322|12068691|FG000|COMPLETED|Overall Study||12
10902615|NCT00023322|12068691|FG000|NOT COMPLETED|Overall Study||1
10902616|NCT00023452|12068697|FG000|STARTED|Overall Study||3908
10902617|NCT00023452|12068698|FG001|STARTED|Overall Study||4145
10902618|NCT00023452|12068697|FG000|Randomized|Overall Study||3190
10902619|NCT00023452|12068698|FG001|Randomized|Overall Study||3174
10902620|NCT00023452|12068697|FG000|Enrolled as Part of a Cluster|Overall Study||718
10902621|NCT00023452|12068698|FG001|Enrolled as Part of a Cluster|Overall Study||971
10902622|NCT00023452|12068697|FG000|Completed Treatment|Overall Study||2585
10902623|NCT00023452|12068698|FG001|Completed Treatment|Overall Study||3273
10902624|NCT00023452|12068697|FG000|Not Treated|Overall Study||149
10902625|NCT00023452|12068698|FG001|Not Treated|Overall Study||105
10902626|NCT00023452|12068697|FG000|Completed Study|Overall Study||3174
10902627|NCT00023452|12068698|FG001|Completed Study|Overall Study||3475
10902628|NCT00023452|12068697|FG000|COMPLETED|Overall Study||2585
10902629|NCT00023452|12068698|FG001|COMPLETED|Overall Study||3273
10902630|NCT00023452|12068697|FG000|NOT COMPLETED|Overall Study||1323
10902631|NCT00023452|12068698|FG001|NOT COMPLETED|Overall Study||872
10902632|NCT00023595|12068713|FG000|STARTED|5 Year Follow up||602
10902633|NCT00023595|12068714|FG001|STARTED|5 Year Follow up||534
10902634|NCT00023595|12068715|FG002|STARTED|5 Year Follow up||76
10902635|NCT00023595|12068716|FG003|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
10902636|NCT00023595|12068717|FG004|STARTED|5 Year Follow up||501
10902637|NCT00023595|12068713|FG000|COMPLETED|5 Year Follow up||600
10902638|NCT00023595|12068714|FG001|COMPLETED|5 Year Follow up||532
10902639|NCT00023595|12068715|FG002|COMPLETED|5 Year Follow up||75
10902640|NCT00023595|12068716|FG003|COMPLETED|5 Year Follow up||416
10902641|NCT00023595|12068717|FG004|COMPLETED|5 Year Follow up||498
10902642|NCT00023595|12068713|FG000|NOT COMPLETED|5 Year Follow up||2
10902643|NCT00023595|12068714|FG001|NOT COMPLETED|5 Year Follow up||2
10902644|NCT00023595|12068715|FG002|NOT COMPLETED|5 Year Follow up||1
10902645|NCT00023595|12068716|FG003|NOT COMPLETED|5 Year Follow up||7
10902646|NCT00023595|12068717|FG004|NOT COMPLETED|5 Year Follow up||3
10902647|NCT00023595|12068713|FG000|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
10902648|NCT00023595|12068714|FG001|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
10902649|NCT00023595|12068715|FG002|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
10902650|NCT00023595|12068716|FG003|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
10902651|NCT00023595|12068717|FG004|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
10902652|NCT00023595|12068713|FG000|COMPLETED|10 Year Follow up||590
10902653|NCT00023595|12068714|FG001|COMPLETED|10 Year Follow up||524
10902654|NCT00023595|12068715|FG002|COMPLETED|10 Year Follow up||73
10902655|NCT00023595|12068716|FG003|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
10902656|NCT00023595|12068717|FG004|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
10902657|NCT00023595|12068713|FG000|NOT COMPLETED|10 Year Follow up||12
10902658|NCT00023595|12068714|FG001|NOT COMPLETED|10 Year Follow up||10
10902659|NCT00023595|12068715|FG002|NOT COMPLETED|10 Year Follow up||3
10902660|NCT00023595|12068716|FG003|NOT COMPLETED|10 Year Follow up||0
10902661|NCT00023595|12068717|FG004|NOT COMPLETED|10 Year Follow up||0
10902662|NCT00023673|12068743|FG000|STARTED|Overall Study||8
10902663|NCT00023673|12068744|FG001|STARTED|Overall Study||9
10902664|NCT00023673|12068745|FG002|STARTED|Overall Study||0
10902665|NCT00023673|12068746|FG003|STARTED|Overall Study||46
10902666|NCT00023673|12068743|FG000|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
10902667|NCT00023673|12068744|FG001|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
10902668|NCT00023673|12068745|FG002|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
10902669|NCT00023673|12068746|FG003|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
10902670|NCT00023673|12068743|FG000|NOT COMPLETED|Overall Study||0
10902671|NCT00023673|12068744|FG001|NOT COMPLETED|Overall Study||0
10902672|NCT00023673|12068745|FG002|NOT COMPLETED|Overall Study||0
10902673|NCT00023673|12068746|FG003|NOT COMPLETED|Overall Study||2
10902674|NCT00023712|12068758|FG000|STARTED|Overall Study|total number of participants enrolled on study|28
10902675|NCT00023712|12068759|FG001|STARTED|Overall Study|total number of participants enrolled on study|30
10902676|NCT00023712|12068758|FG000|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
10902677|NCT00023712|12068759|FG001|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
10902678|NCT00023712|12068758|FG000|NOT COMPLETED|Overall Study||2
10902679|NCT00023712|12068759|FG001|NOT COMPLETED|Overall Study||1
10902680|NCT00023764|12068775|FG000|STARTED|Overall Study||103
10902681|NCT00023764|12068775|FG000|COMPLETED|Overall Study||89
10902682|NCT00023764|12068775|FG000|NOT COMPLETED|Overall Study||14
10902683|NCT00024102|12068782|FG000|STARTED|Overall Study||326
10902684|NCT00024102|12068783|FG001|STARTED|Overall Study||307
10902685|NCT00024102|12068782|FG000|COMPLETED|Overall Study||326
10902686|NCT00024102|12068783|FG001|COMPLETED|Overall Study||307
10902687|NCT00024102|12068782|FG000|NOT COMPLETED|Overall Study||0
10902688|NCT00024102|12068783|FG001|NOT COMPLETED|Overall Study||0
10902689|NCT00024167|12068796|FG000|STARTED|Overall Study||65
10902690|NCT00024167|12068797|FG001|STARTED|Overall Study||62
10902691|NCT00024167|12068796|FG000|Induction Treatment Option 1 Completed|Overall Study||22
10902692|NCT00024167|12068797|FG001|Induction Treatment Option 1 Completed|Overall Study||21
10902693|NCT00024167|12068796|FG000|Induction Treatment Option 2 Completed|Overall Study||43
10902694|NCT00024167|12068797|FG001|Induction Treatment Option 2 Completed|Overall Study||41
10902695|NCT00024167|12068796|FG000|COMPLETED|Overall Study||12
10902696|NCT00024167|12068797|FG001|COMPLETED|Overall Study||15
10902697|NCT00024167|12068796|FG000|NOT COMPLETED|Overall Study||53
10902698|NCT00024167|12068797|FG001|NOT COMPLETED|Overall Study||47
10902699|NCT00024258|12068804|FG000|STARTED|Overall Study||22
10902700|NCT00024258|12068804|FG000|COMPLETED|Overall Study||13
10902701|NCT00024258|12068804|FG000|NOT COMPLETED|Overall Study||9
10902702|NCT00025155|12068808|FG000|STARTED|Overall Study||51
10902703|NCT00025155|12068808|FG000|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
10902704|NCT00025155|12068808|FG000|NOT COMPLETED|Overall Study||2
10902705|NCT00025233|12068817|FG000|STARTED|Overall Study||50
10902706|NCT00025233|12068817|FG000|COMPLETED|Overall Study||46
10902707|NCT00025233|12068817|FG000|NOT COMPLETED|Overall Study||4
10902708|NCT00025259|12068834|FG000|STARTED|Overall Study||52
10902709|NCT00025259|12068835|FG001|STARTED|Overall Study||381
10902710|NCT00025259|12068836|FG002|STARTED|Overall Study||382
10902711|NCT00025259|12068837|FG003|STARTED|Overall Study||571
10902712|NCT00025259|12068838|FG004|STARTED|Overall Study||42
10902713|NCT00025259|12068839|FG005|STARTED|Overall Study||153
10902714|NCT00025259|12068840|FG006|STARTED|Overall Study||153
10902715|NCT00025259|12068834|FG000|COMPLETED|Overall Study||7
10902716|NCT00025259|12068835|FG001|COMPLETED|Overall Study||292
10902717|NCT00025259|12068836|FG002|COMPLETED|Overall Study||301
10902718|NCT00025259|12068837|FG003|COMPLETED|Overall Study||457
10902719|NCT00025259|12068838|FG004|COMPLETED|Overall Study||6
10902720|NCT00025259|12068839|FG005|COMPLETED|Overall Study||101
10902721|NCT00025259|12068840|FG006|COMPLETED|Overall Study||102
10902722|NCT00025259|12068834|FG000|NOT COMPLETED|Overall Study||45
10902723|NCT00025259|12068835|FG001|NOT COMPLETED|Overall Study||89
10902724|NCT00025259|12068836|FG002|NOT COMPLETED|Overall Study||81
10902725|NCT00025259|12068837|FG003|NOT COMPLETED|Overall Study||114
10902726|NCT00025259|12068838|FG004|NOT COMPLETED|Overall Study||36
10902727|NCT00025259|12068839|FG005|NOT COMPLETED|Overall Study||52
10902728|NCT00025259|12068840|FG006|NOT COMPLETED|Overall Study||51
10902729|NCT00025506|12068859|FG000|STARTED|Overall Study||55
10902730|NCT00025506|12068859|FG000|COMPLETED|Overall Study|Eligible and treated patients.|45
10902731|NCT00025506|12068859|FG000|NOT COMPLETED|Overall Study||10
10902732|NCT00025662|12068868|FG000|STARTED|Overall Study||25
10902733|NCT00025662|12068868|FG000|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
10902734|NCT00025662|12068868|FG000|NOT COMPLETED|Overall Study||3
10902735|NCT00025883|12068874|FG000|STARTED|Overall Study||103
10902736|NCT00025883|12068874|FG000|Generalized Lipodystrophy|Overall Study||63
10902737|NCT00025883|12068874|FG000|Partial Lipodystrophy|Overall Study||40
10902738|NCT00025883|12068874|FG000|COMPLETED|Overall Study||86
10902739|NCT00025883|12068874|FG000|NOT COMPLETED|Overall Study||17
10902740|NCT00026208|12068881|FG000|STARTED|Overall Study||72
10902741|NCT00026208|12068882|FG001|STARTED|Overall Study||4
10902742|NCT00026208|12068881|FG000|COMPLETED|Overall Study||71
10902743|NCT00026208|12068882|FG001|COMPLETED|Overall Study||4
10902744|NCT00026208|12068881|FG000|NOT COMPLETED|Overall Study||1
10902745|NCT00026208|12068882|FG001|NOT COMPLETED|Overall Study||0
10902746|NCT00026221|12068891|FG000|STARTED|Overall Study||16
10902747|NCT00026221|12068892|FG001|STARTED|Overall Study||16
10902748|NCT00026221|12068893|FG002|STARTED|Overall Study||25
10902749|NCT00026221|12068891|FG000|COMPLETED|Overall Study||16
10902750|NCT00026221|12068892|FG001|COMPLETED|Overall Study||16
10902751|NCT00026221|12068893|FG002|COMPLETED|Overall Study||25
10902752|NCT00026221|12068891|FG000|NOT COMPLETED|Overall Study||0
10902753|NCT00026221|12068892|FG001|NOT COMPLETED|Overall Study||0
10902754|NCT00026221|12068893|FG002|NOT COMPLETED|Overall Study||0
10902755|NCT00026494|12068905|FG000|STARTED|Overall Study||7
10902756|NCT00026494|12068906|FG001|STARTED|Overall Study||4
10902757|NCT00026494|12068907|FG002|STARTED|Overall Study||22
10902758|NCT00026494|12068908|FG003|STARTED|Overall Study||16
10902759|NCT00026494|12068905|FG000|COMPLETED|Overall Study||5
10902760|NCT00026494|12068906|FG001|COMPLETED|Overall Study||4
10902761|NCT00026494|12068907|FG002|COMPLETED|Overall Study||16
10902762|NCT00026494|12068908|FG003|COMPLETED|Overall Study||16
10902763|NCT00026494|12068905|FG000|NOT COMPLETED|Overall Study||2
10902764|NCT00026494|12068906|FG001|NOT COMPLETED|Overall Study||0
10902765|NCT00026494|12068907|FG002|NOT COMPLETED|Overall Study||6
10902766|NCT00026494|12068908|FG003|NOT COMPLETED|Overall Study||0
10902767|NCT00026793|12068918|FG000|STARTED|Overall Study||29
10902768|NCT00026793|12068918|FG000|COMPLETED|Overall Study||21
10902769|NCT00026793|12068918|FG000|NOT COMPLETED|Overall Study||8
10902770|NCT00027027|12068927|FG000|STARTED|Overall Study||3
10902771|NCT00027027|12068928|FG001|STARTED|Overall Study||3
10902772|NCT00027027|12068929|FG002|STARTED|Overall Study||4
10902773|NCT00027027|12068930|FG003|STARTED|Overall Study||3
10902774|NCT00027027|12068931|FG004|STARTED|Overall Study||8
10902775|NCT00027027|12068927|FG000|Discontinued Before 2 Treatment Cycles|Overall Study||0
10902776|NCT00027027|12068928|FG001|Discontinued Before 2 Treatment Cycles|Overall Study||0
10902777|NCT00027027|12068929|FG002|Discontinued Before 2 Treatment Cycles|Overall Study||1
10902778|NCT00027027|12068930|FG003|Discontinued Before 2 Treatment Cycles|Overall Study||0
10902779|NCT00027027|12068931|FG004|Discontinued Before 2 Treatment Cycles|Overall Study||1
10902780|NCT00027027|12068927|FG000|Completed 2 Cycles of Treatment|Overall Study||3
10902781|NCT00027027|12068928|FG001|Completed 2 Cycles of Treatment|Overall Study||3
10902782|NCT00027027|12068929|FG002|Completed 2 Cycles of Treatment|Overall Study||3
10902783|NCT00027027|12068930|FG003|Completed 2 Cycles of Treatment|Overall Study||3
10902784|NCT00027027|12068931|FG004|Completed 2 Cycles of Treatment|Overall Study||7
10902785|NCT00027027|12068927|FG000|Discontinued at Cycle 2|Overall Study||2
10902786|NCT00027027|12068928|FG001|Discontinued at Cycle 2|Overall Study||2
10902787|NCT00027027|12068929|FG002|Discontinued at Cycle 2|Overall Study||1
10902788|NCT00027027|12068930|FG003|Discontinued at Cycle 2|Overall Study||1
10902789|NCT00027027|12068931|FG004|Discontinued at Cycle 2|Overall Study||3
10902790|NCT00027027|12068927|FG000|Treated Beyond Cycle 2|Overall Study||1
10902791|NCT00027027|12068928|FG001|Treated Beyond Cycle 2|Overall Study||1
10902792|NCT00027027|12068929|FG002|Treated Beyond Cycle 2|Overall Study||2
10902793|NCT00027027|12068930|FG003|Treated Beyond Cycle 2|Overall Study||2
10902794|NCT00027027|12068931|FG004|Treated Beyond Cycle 2|Overall Study||4
10902795|NCT00027027|12068927|FG000|COMPLETED|Overall Study||0
10902796|NCT00027027|12068928|FG001|COMPLETED|Overall Study||0
10902797|NCT00027027|12068929|FG002|COMPLETED|Overall Study||0
10902798|NCT00027027|12068930|FG003|COMPLETED|Overall Study||0
10902799|NCT00027027|12068931|FG004|COMPLETED|Overall Study||0
10902800|NCT00027027|12068927|FG000|NOT COMPLETED|Overall Study||3
10902801|NCT00027027|12068928|FG001|NOT COMPLETED|Overall Study||3
10902802|NCT00027027|12068929|FG002|NOT COMPLETED|Overall Study||4
10902803|NCT00027027|12068930|FG003|NOT COMPLETED|Overall Study||3
10902804|NCT00027027|12068931|FG004|NOT COMPLETED|Overall Study||8
10902805|NCT00027378|12068949|FG000|STARTED|Overall Study||24
10902806|NCT00027378|12068950|FG001|STARTED|Overall Study||26
10902807|NCT00027378|12068949|FG000|COMPLETED|Overall Study||24
10902808|NCT00027378|12068950|FG001|COMPLETED|Overall Study||23
10902809|NCT00027378|12068949|FG000|NOT COMPLETED|Overall Study||0
10902810|NCT00027378|12068950|FG001|NOT COMPLETED|Overall Study||3
10902811|NCT00027560|12068956|FG000|STARTED|Overall Study||51
10902812|NCT00027560|12068956|FG000|COMPLETED|Overall Study||50
10902813|NCT00027560|12068956|FG000|NOT COMPLETED|Overall Study||1
10902814|NCT00027846|12068965|FG000|STARTED|Overall Study||13
10902815|NCT00027846|12068966|FG001|STARTED|Overall Study||287
10902816|NCT00027846|12068967|FG002|STARTED|Overall Study||78
10902817|NCT00027846|12068965|FG000|COMPLETED|Overall Study||11
10902818|NCT00027846|12068966|FG001|COMPLETED|Overall Study||219
10902819|NCT00027846|12068967|FG002|COMPLETED|Overall Study||41
10902820|NCT00027846|12068965|FG000|NOT COMPLETED|Overall Study||2
10902821|NCT00027846|12068966|FG001|NOT COMPLETED|Overall Study||68
10902822|NCT00027846|12068967|FG002|NOT COMPLETED|Overall Study||37
10902823|NCT00028002|12068977|FG000|STARTED|Overall Study||63
10902824|NCT00028002|12068977|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
10902825|NCT00028002|12068977|FG000|NOT COMPLETED|Overall Study||11
10902826|NCT00028093|12068984|FG000|STARTED|Overall Study||25
10902827|NCT00028093|12068985|FG001|STARTED|Overall Study||25
10902828|NCT00028093|12068984|FG000|COMPLETED|Overall Study||25
10902829|NCT00028093|12068985|FG001|COMPLETED|Overall Study||25
10902830|NCT00028093|12068984|FG000|NOT COMPLETED|Overall Study||0
10902831|NCT00028093|12068985|FG001|NOT COMPLETED|Overall Study||0
10902832|NCT00028262|12068991|FG000|STARTED|Overall Study||10
10902833|NCT00028262|12068991|FG000|COMPLETED|Overall Study||9
10902834|NCT00028262|12068991|FG000|NOT COMPLETED|Overall Study||1
10902835|NCT00028769|12068995|FG000|STARTED|Overall Study||41
10902836|NCT00028769|12068995|FG000|Eligible|Overall Study||36
10902837|NCT00028769|12068995|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
10902838|NCT00028769|12068995|FG000|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
10902839|NCT00028769|12068995|FG000|NOT COMPLETED|Overall Study||41
10902840|NCT00029107|12069001|FG000|STARTED|Overall Study||12
10902841|NCT00029107|12069002|FG001|STARTED|Overall Study||12
10902842|NCT00029107|12069001|FG000|COMPLETED|Overall Study||12
10902843|NCT00029107|12069002|FG001|COMPLETED|Overall Study||12
10902844|NCT00029107|12069001|FG000|NOT COMPLETED|Overall Study||0
10902845|NCT00029107|12069002|FG001|NOT COMPLETED|Overall Study||0
10902846|NCT00029146|12069010|FG000|STARTED|Overall Study||97
10902847|NCT00029146|12069011|FG001|STARTED|Overall Study||98
10902848|NCT00029146|12069010|FG000|COMPLETED|Overall Study||95
10902849|NCT00029146|12069011|FG001|COMPLETED|Overall Study||97
10902850|NCT00029146|12069010|FG000|NOT COMPLETED|Overall Study||2
10902851|NCT00029146|12069011|FG001|NOT COMPLETED|Overall Study||1
10902852|NCT00029172|12069017|FG000|STARTED|Overall Study||188
10902853|NCT00029172|12069017|FG000|COMPLETED|Overall Study||182
10902854|NCT00029172|12069017|FG000|NOT COMPLETED|Overall Study||6
10902855|NCT00029536|12069025|FG000|STARTED|Overall Study||85
10902856|NCT00029536|12069026|FG001|STARTED|Overall Study||45
10902857|NCT00029536|12069027|FG002|STARTED|Overall Study||105
10902858|NCT00029536|12069028|FG003|STARTED|Overall Study||59
10902859|NCT00029536|12069025|FG000|COMPLETED|Overall Study||85
10902860|NCT00029536|12069026|FG001|COMPLETED|Overall Study||45
10902861|NCT00029536|12069027|FG002|COMPLETED|Overall Study||105
10902862|NCT00029536|12069028|FG003|COMPLETED|Overall Study||59
10902863|NCT00029536|12069025|FG000|NOT COMPLETED|Overall Study||0
10902864|NCT00029536|12069026|FG001|NOT COMPLETED|Overall Study||0
10902865|NCT00029536|12069027|FG002|NOT COMPLETED|Overall Study||0
10902866|NCT00029536|12069028|FG003|NOT COMPLETED|Overall Study||0
10902867|NCT00030147|12069044|FG000|STARTED|Overall Study||17
10902868|NCT00030147|12069045|FG001|STARTED|Overall Study||19
10902869|NCT00030147|12069046|FG002|STARTED|Overall Study||16
10902870|NCT00030147|12069047|FG003|STARTED|Overall Study||11
10902871|NCT00030147|12069044|FG000|COMPLETED|Overall Study||17
10902872|NCT00030147|12069045|FG001|COMPLETED|Overall Study||18
10902873|NCT00030147|12069046|FG002|COMPLETED|Overall Study||16
10902874|NCT00030147|12069047|FG003|COMPLETED|Overall Study||11
10902875|NCT00030147|12069044|FG000|NOT COMPLETED|Overall Study||0
10902876|NCT00030147|12069045|FG001|NOT COMPLETED|Overall Study||1
10902877|NCT00030147|12069046|FG002|NOT COMPLETED|Overall Study||0
10902878|NCT00030147|12069047|FG003|NOT COMPLETED|Overall Study||0
10902879|NCT00030264|12069057|FG000|STARTED|Overall Study||23
10902880|NCT00030264|12069057|FG000|COMPLETED|Overall Study||23
10902881|NCT00030264|12069057|FG000|NOT COMPLETED|Overall Study||0
10902882|NCT00030823|12069061|FG000|STARTED|Overall Study||14
10902883|NCT00030823|12069061|FG000|COMPLETED|Overall Study||13
10902884|NCT00030823|12069061|FG000|NOT COMPLETED|Overall Study||1
10902885|NCT00030901|12069067|FG000|STARTED|Initial Registration||619
10902886|NCT00030901|12069068|FG001|STARTED|Initial Registration||0
10902887|NCT00030901|12069069|FG002|STARTED|Initial Registration||0
10902888|NCT00030901|12069067|FG000|COMPLETED|Initial Registration||452
10902889|NCT00030901|12069068|FG001|COMPLETED|Initial Registration||0
10902890|NCT00030901|12069069|FG002|COMPLETED|Initial Registration||0
10902891|NCT00030901|12069067|FG000|NOT COMPLETED|Initial Registration||167
10902892|NCT00030901|12069068|FG001|NOT COMPLETED|Initial Registration||0
10902893|NCT00030901|12069069|FG002|NOT COMPLETED|Initial Registration||0
10902894|NCT00030901|12069067|FG000|STARTED|Randomization||0
10902895|NCT00030901|12069068|FG001|STARTED|Randomization||227
10902896|NCT00030901|12069069|FG002|STARTED|Randomization||225
10902897|NCT00030901|12069067|FG000|Eligible|Randomization||0
10902898|NCT00030901|12069068|FG001|Eligible|Randomization||212
10902899|NCT00030901|12069069|FG002|Eligible|Randomization||211
10902900|NCT00030901|12069067|FG000|COMPLETED|Randomization||0
10902901|NCT00030901|12069068|FG001|COMPLETED|Randomization||126
10902902|NCT00030901|12069069|FG002|COMPLETED|Randomization||137
10902903|NCT00030901|12069067|FG000|NOT COMPLETED|Randomization||0
10902904|NCT00030901|12069068|FG001|NOT COMPLETED|Randomization||101
10902905|NCT00030901|12069069|FG002|NOT COMPLETED|Randomization||88
10902906|NCT00030992|12069075|FG000|STARTED|Overall Study||102
10902907|NCT00030992|12069075|FG000|COMPLETED|Overall Study||102
10902908|NCT00030992|12069075|FG000|NOT COMPLETED|Overall Study||0
10902909|NCT00031447|12069081|FG000|STARTED|Overall Study||14
10902910|NCT00031447|12069082|FG001|STARTED|Overall Study||15
10902911|NCT00031447|12069081|FG000|COMPLETED|Overall Study||4
10902912|NCT00031447|12069082|FG001|COMPLETED|Overall Study||8
10902913|NCT00031447|12069081|FG000|NOT COMPLETED|Overall Study||10
10902914|NCT00031447|12069082|FG001|NOT COMPLETED|Overall Study||7
10902915|NCT00031460|12069090|FG000|STARTED|Overall Study||24
10902916|NCT00031460|12069091|FG001|STARTED|Overall Study||22
10902917|NCT00031460|12069090|FG000|COMPLETED|Overall Study||15
10902918|NCT00031460|12069091|FG001|COMPLETED|Overall Study||8
10902919|NCT00031460|12069090|FG000|NOT COMPLETED|Overall Study||9
10902920|NCT00031460|12069091|FG001|NOT COMPLETED|Overall Study||14
10902921|NCT00031486|12069099|FG000|STARTED|Overall Study||40
10902922|NCT00031486|12069100|FG001|STARTED|Overall Study||47
10902923|NCT00031486|12069099|FG000|COMPLETED|Overall Study||33
10902924|NCT00031486|12069100|FG001|COMPLETED|Overall Study||35
10902925|NCT00031486|12069099|FG000|NOT COMPLETED|Overall Study||7
10902926|NCT00031486|12069100|FG001|NOT COMPLETED|Overall Study||12
10902927|NCT00031551|12069110|FG000|STARTED|Overall Study||2
10902928|NCT00031551|12069111|FG001|STARTED|Overall Study||25
10902929|NCT00031551|12069110|FG000|COMPLETED|Overall Study||0
10902930|NCT00031551|12069111|FG001|COMPLETED|Overall Study||25
10902931|NCT00031551|12069110|FG000|NOT COMPLETED|Overall Study||2
10902932|NCT00031551|12069111|FG001|NOT COMPLETED|Overall Study||0
10902933|NCT00031590|12069121|FG000|STARTED|Overall Study||28
10902934|NCT00031590|12069121|FG000|COMPLETED|Overall Study||25
10902935|NCT00031590|12069121|FG000|NOT COMPLETED|Overall Study||3
10902936|NCT00031694|12069126|FG000|STARTED|Overall Study||19
10902937|NCT00031694|12069126|FG000|COMPLETED|Overall Study||0
10902938|NCT00031694|12069126|FG000|NOT COMPLETED|Overall Study||19
10902939|NCT00032487|12069133|FG000|STARTED|Overall Study||899
10902940|NCT00032487|12069134|FG001|STARTED|Overall Study||892
10902941|NCT00032487|12069133|FG000|COMPLETED|Overall Study||760
10902942|NCT00032487|12069134|FG001|COMPLETED|Overall Study||772
10902943|NCT00032487|12069133|FG000|NOT COMPLETED|Overall Study||139
10902944|NCT00032487|12069134|FG001|NOT COMPLETED|Overall Study||120
10902945|NCT00032591|12069142|FG000|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
10902946|NCT00032591|12069143|FG001|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
10902947|NCT00032591|12069142|FG000|COMPLETED|Screening|823 were excluded from the study|1465
10902948|NCT00032591|12069143|FG001|COMPLETED|Screening||1457
10902949|NCT00032591|12069142|FG000|NOT COMPLETED|Screening||408
10902950|NCT00032591|12069143|FG001|NOT COMPLETED|Screening||415
10902951|NCT00032591|12069142|FG000|STARTED|Randomization|2922 underwent randomization|1465
10902952|NCT00032591|12069143|FG001|STARTED|Randomization||1457
10902953|NCT00032591|12069142|FG000|COMPLETED|Randomization|1465 were assigned to self-testing|1465
10902954|NCT00032591|12069143|FG001|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
10902955|NCT00032591|12069142|FG000|NOT COMPLETED|Randomization||0
10902956|NCT00032591|12069143|FG001|NOT COMPLETED|Randomization||0
10902957|NCT00032591|12069142|FG000|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
10902958|NCT00032591|12069143|FG001|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
10902959|NCT00032591|12069142|FG000|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
10902960|NCT00032591|12069143|FG001|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
10902961|NCT00032591|12069142|FG000|NOT COMPLETED|Follow-up||2
10902962|NCT00032591|12069143|FG001|NOT COMPLETED|Follow-up||5
10902963|NCT00032630|12069151|FG000|STARTED|Overall Study||1099
10902964|NCT00032630|12069152|FG001|STARTED|Overall Study||1104
10902965|NCT00032630|12069151|FG000|COMPLETED|Overall Study||1050
10902966|NCT00032630|12069152|FG001|COMPLETED|Overall Study||1061
10902967|NCT00032630|12069151|FG000|NOT COMPLETED|Overall Study||49
10902968|NCT00032630|12069152|FG001|NOT COMPLETED|Overall Study||43
10902969|NCT00033371|12069160|FG000|STARTED|Overall Study||55
10902970|NCT00033371|12069161|FG001|STARTED|Overall Study||57
10902971|NCT00033371|12069160|FG000|COMPLETED|Overall Study||49
10902972|NCT00033371|12069161|FG001|COMPLETED|Overall Study||47
10902973|NCT00033371|12069160|FG000|NOT COMPLETED|Overall Study||6
10902974|NCT00033371|12069161|FG001|NOT COMPLETED|Overall Study||10
10902975|NCT00033514|12069173|FG000|STARTED|Overall Study||16
10902976|NCT00033514|12069174|FG001|STARTED|Overall Study||11
10902977|NCT00033514|12069173|FG000|COMPLETED|Overall Study||15
10902978|NCT00033514|12069174|FG001|COMPLETED|Overall Study||7
10902979|NCT00033514|12069173|FG000|NOT COMPLETED|Overall Study||1
10902980|NCT00033514|12069174|FG001|NOT COMPLETED|Overall Study||4
10902981|NCT00033540|12069181|FG000|STARTED|Overall Study||57
10902982|NCT00033540|12069181|FG000|Eligible|Overall Study||54
10902983|NCT00033540|12069181|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
10902984|NCT00033540|12069181|FG000|COMPLETED|Overall Study||0
10902985|NCT00033540|12069181|FG000|NOT COMPLETED|Overall Study||57
10902986|NCT00033657|12069188|FG000|STARTED|Neoadjuvant Chemotherapy||50
10902987|NCT00033657|12069189|FG001|STARTED|Neoadjuvant Chemotherapy||47
10902988|NCT00033657|12069188|FG000|Eligible|Neoadjuvant Chemotherapy||42
10902989|NCT00033657|12069189|FG001|Eligible|Neoadjuvant Chemotherapy||43
10902990|NCT00033657|12069188|FG000|Eligible and Treated|Neoadjuvant Chemotherapy||39
10902991|NCT00033657|12069189|FG001|Eligible and Treated|Neoadjuvant Chemotherapy||42
10902992|NCT00033657|12069188|FG000|COMPLETED|Neoadjuvant Chemotherapy||36
10902993|NCT00033657|12069189|FG001|COMPLETED|Neoadjuvant Chemotherapy||36
10902994|NCT00033657|12069188|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||14
10902995|NCT00033657|12069189|FG001|NOT COMPLETED|Neoadjuvant Chemotherapy||11
10902996|NCT00033657|12069188|FG000|STARTED|Surgical Resection||36
10902997|NCT00033657|12069189|FG001|STARTED|Surgical Resection||36
10902998|NCT00033657|12069188|FG000|COMPLETED|Surgical Resection||36
10902999|NCT00033657|12069189|FG001|COMPLETED|Surgical Resection||33
10903000|NCT00033657|12069188|FG000|NOT COMPLETED|Surgical Resection||0
10903001|NCT00033657|12069189|FG001|NOT COMPLETED|Surgical Resection||3
10903002|NCT00033657|12069188|FG000|STARTED|Adjuvant Chemotherapy||36
10903003|NCT00033657|12069189|FG001|STARTED|Adjuvant Chemotherapy||33
10903004|NCT00033657|12069188|FG000|COMPLETED|Adjuvant Chemotherapy||18
10903005|NCT00033657|12069189|FG001|COMPLETED|Adjuvant Chemotherapy||16
10903006|NCT00033657|12069188|FG000|NOT COMPLETED|Adjuvant Chemotherapy||18
10903007|NCT00033657|12069189|FG001|NOT COMPLETED|Adjuvant Chemotherapy||17
10903008|NCT00033917|12069199|FG000|STARTED|Overall Study||209
10903009|NCT00033917|12069200|FG001|STARTED|Overall Study||222
10903010|NCT00033917|12069199|FG000|COMPLETED|Overall Study||209
10903011|NCT00033917|12069200|FG001|COMPLETED|Overall Study||222
10903012|NCT00033917|12069199|FG000|NOT COMPLETED|Overall Study||0
10903013|NCT00033917|12069200|FG001|NOT COMPLETED|Overall Study||0
10903014|NCT00035555|12069213|FG000|STARTED|Overall Study|Randomized patients|74
10903015|NCT00035555|12069214|FG001|STARTED|Overall Study|Randomized patients|71
10903016|NCT00035555|12069215|FG002|STARTED|Overall Study|Randomized patients|73
10903017|NCT00035555|12069213|FG000|Number Who Had Undergone Transplantation|Overall Study||74
10903018|NCT00035555|12069214|FG001|Number Who Had Undergone Transplantation|Overall Study||71
10903019|NCT00035555|12069215|FG002|Number Who Had Undergone Transplantation|Overall Study||73
10903020|NCT00035555|12069213|FG000|Number Who Received Study Drug|Overall Study||74
10903021|NCT00035555|12069214|FG001|Number Who Received Study Drug|Overall Study||71
10903022|NCT00035555|12069215|FG002|Number Who Received Study Drug|Overall Study||71
10903023|NCT00035555|12069213|FG000|COMPLETED|Overall Study||58
10903024|NCT00035555|12069214|FG001|COMPLETED|Overall Study||55
10903025|NCT00035555|12069215|FG002|COMPLETED|Overall Study||51
10903026|NCT00035555|12069213|FG000|NOT COMPLETED|Overall Study||16
10903027|NCT00035555|12069214|FG001|NOT COMPLETED|Overall Study||16
10903028|NCT00035555|12069215|FG002|NOT COMPLETED|Overall Study||22
10903029|NCT00035815|12069226|FG000|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
10903030|NCT00035815|12069227|FG001|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
10903031|NCT00035815|12069226|FG000|COMPLETED|Overall Study||150
10903032|NCT00035815|12069227|FG001|COMPLETED|Overall Study||152
10903033|NCT00035815|12069226|FG000|NOT COMPLETED|Overall Study||17
10903034|NCT00035815|12069227|FG001|NOT COMPLETED|Overall Study||11
10903035|NCT00035932|12069236|FG000|STARTED|Overall Study|120 randomized, 119 treated|119
10903036|NCT00035932|12069237|FG001|STARTED|Overall Study|115 randomized, 110 treated|110
10903037|NCT00035932|12069238|FG002|STARTED|Overall Study|123 randomized, 118 treated|118
10903038|NCT00035932|12069236|FG000|Discontinued Prior to Week 48 Visit|Overall Study||26
10903039|NCT00035932|12069237|FG001|Discontinued Prior to Week 48 Visit|Overall Study||29
10903040|NCT00035932|12069238|FG002|Discontinued Prior to Week 48 Visit|Overall Study||13
10903041|NCT00035932|12069236|FG000|Discontinued Between Weeks 48 and 96|Overall Study||26
10903042|NCT00035932|12069237|FG001|Discontinued Between Weeks 48 and 96|Overall Study||27
10903043|NCT00035932|12069238|FG002|Discontinued Between Weeks 48 and 96|Overall Study||30
10903044|NCT00035932|12069236|FG000|Discontinued on or After Week 96|Overall Study||4
10903045|NCT00035932|12069237|FG001|Discontinued on or After Week 96|Overall Study||4
10903046|NCT00035932|12069238|FG002|Discontinued on or After Week 96|Overall Study||6
10903047|NCT00035932|12069236|FG000|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
10903048|NCT00035932|12069237|FG001|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
10903049|NCT00035932|12069238|FG002|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
10903050|NCT00035932|12069236|FG000|NOT COMPLETED|Overall Study||56
10903051|NCT00035932|12069237|FG001|NOT COMPLETED|Overall Study||60
10903052|NCT00035932|12069238|FG002|NOT COMPLETED|Overall Study||49
10903053|NCT00036270|12069253|FG000|STARTED|Randomized to Study Treatment||4904
10903054|NCT00036270|12069254|FG001|STARTED|Randomized to Study Treatment||4875
10903055|NCT00036270|12069253|FG000|COMPLETED|Randomized to Study Treatment||4898
10903056|NCT00036270|12069254|FG001|COMPLETED|Randomized to Study Treatment||4868
10903057|NCT00036270|12069253|FG000|NOT COMPLETED|Randomized to Study Treatment||6
10903058|NCT00036270|12069254|FG001|NOT COMPLETED|Randomized to Study Treatment||7
10903059|NCT00036270|12069253|FG000|STARTED|Study Treatment to 5 Year Report||4898
10903060|NCT00036270|12069254|FG001|STARTED|Study Treatment to 5 Year Report||4868
10903061|NCT00036270|12069253|FG000|Treated|Study Treatment to 5 Year Report||4852
10903062|NCT00036270|12069254|FG001|Treated|Study Treatment to 5 Year Report||4814
10903063|NCT00036270|12069253|FG000|COMPLETED|Study Treatment to 5 Year Report||2333
10903064|NCT00036270|12069254|FG001|COMPLETED|Study Treatment to 5 Year Report||1380
10903065|NCT00036270|12069253|FG000|NOT COMPLETED|Study Treatment to 5 Year Report||2565
10903066|NCT00036270|12069254|FG001|NOT COMPLETED|Study Treatment to 5 Year Report||3488
10903067|NCT00036569|12069260|FG000|STARTED|Overall Study||32
10903068|NCT00036569|12069260|FG000|COMPLETED|Overall Study||32
10903069|NCT00036569|12069260|FG000|NOT COMPLETED|Overall Study||0
10903070|NCT00036738|12069266|FG000|STARTED|Overall Study||28
10903071|NCT00036738|12069266|FG000|COMPLETED|Overall Study||28
10903072|NCT00036738|12069266|FG000|NOT COMPLETED|Overall Study||0
10903073|NCT00037830|12069273|FG000|STARTED|Overall Study||39
10903074|NCT00037830|12069274|FG001|STARTED|Overall Study||38
10903075|NCT00037830|12069275|FG002|STARTED|Overall Study||17
10903076|NCT00037830|12069273|FG000|COMPLETED|Overall Study||29
10903077|NCT00037830|12069274|FG001|COMPLETED|Overall Study||31
10903078|NCT00037830|12069275|FG002|COMPLETED|Overall Study||16
10903079|NCT00037830|12069273|FG000|NOT COMPLETED|Overall Study||10
10903080|NCT00037830|12069274|FG001|NOT COMPLETED|Overall Study||7
10903081|NCT00037830|12069275|FG002|NOT COMPLETED|Overall Study||1
10903082|NCT00038103|12069285|FG000|STARTED|Overall Study||55
10903083|NCT00038103|12069286|FG001|STARTED|Overall Study||56
10903084|NCT00038103|12069285|FG000|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
10903085|NCT00038103|12069286|FG001|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
10903086|NCT00038103|12069285|FG000|COMPLETED|Overall Study||0
10903087|NCT00038103|12069286|FG001|COMPLETED|Overall Study||0
10903088|NCT00038103|12069285|FG000|NOT COMPLETED|Overall Study||55
10903089|NCT00038103|12069286|FG001|NOT COMPLETED|Overall Study||56
10903090|NCT00038467|12069294|FG000|STARTED|Overall Study||2352
10903091|NCT00038467|12069295|FG001|STARTED|Overall Study||2372
10903092|NCT00038467|12069294|FG000|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
10903093|NCT00038467|12069295|FG001|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
10903094|NCT00038467|12069294|FG000|COMPLETED|Overall Study||1810
10903095|NCT00038467|12069295|FG001|COMPLETED|Overall Study||1830
10903096|NCT00038467|12069294|FG000|NOT COMPLETED|Overall Study||542
10903097|NCT00038467|12069295|FG001|NOT COMPLETED|Overall Study||542
10903098|NCT00038610|12069301|FG000|STARTED|Overall Study||54
10903099|NCT00038610|12069301|FG000|COMPLETED|Overall Study||54
10903100|NCT00038610|12069301|FG000|NOT COMPLETED|Overall Study||0
10903101|NCT00038649|12069305|FG000|STARTED|Overall Study||114
10903102|NCT00038649|12069305|FG000|COMPLETED|Overall Study||105
10903103|NCT00038649|12069305|FG000|NOT COMPLETED|Overall Study||9
10903104|NCT00038857|12069309|FG000|STARTED|Overall Study||29
10903105|NCT00038857|12069309|FG000|COMPLETED|Overall Study||28
10903106|NCT00038857|12069309|FG000|NOT COMPLETED|Overall Study||1
10903107|NCT00038948|12069315|FG000|STARTED|Overall Study||555
10903108|NCT00038948|12069316|FG001|STARTED|Overall Study||275
10903109|NCT00038948|12069315|FG000|COMPLETED|Overall Study||386
10903110|NCT00038948|12069316|FG001|COMPLETED|Overall Study||198
10903111|NCT00038948|12069315|FG000|NOT COMPLETED|Overall Study||169
10903112|NCT00038948|12069316|FG001|NOT COMPLETED|Overall Study||77
10903113|NCT00039130|12069328|FG000|STARTED|Overall Study||105
10903114|NCT00039130|12069328|FG000|COMPLETED|Overall Study||75
10903115|NCT00039130|12069328|FG000|NOT COMPLETED|Overall Study||30
10903116|NCT00039195|12069332|FG000|STARTED|Overall Study||98
10903117|NCT00039195|12069332|FG000|COMPLETED|Overall Study||98
10903118|NCT00039195|12069332|FG000|NOT COMPLETED|Overall Study||0
10903119|NCT00039377|12069336|FG000|STARTED|Initial Registration||57
10903120|NCT00039377|12069337|FG001|STARTED|Initial Registration||0
10903121|NCT00039377|12069338|FG002|STARTED|Initial Registration||0
10903122|NCT00039377|12069339|FG003|STARTED|Initial Registration||0
10903123|NCT00039377|12069336|FG000|COMPLETED|Initial Registration||35
10903124|NCT00039377|12069337|FG001|COMPLETED|Initial Registration||0
10903125|NCT00039377|12069338|FG002|COMPLETED|Initial Registration||0
10903126|NCT00039377|12069339|FG003|COMPLETED|Initial Registration||0
10903127|NCT00039377|12069336|FG000|NOT COMPLETED|Initial Registration||22
10903128|NCT00039377|12069337|FG001|NOT COMPLETED|Initial Registration||0
10903129|NCT00039377|12069338|FG002|NOT COMPLETED|Initial Registration||0
10903130|NCT00039377|12069339|FG003|NOT COMPLETED|Initial Registration||0
10903131|NCT00039377|12069336|FG000|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
10903132|NCT00039377|12069337|FG001|STARTED|Course 5 (Transplant Assignments)||15
10903133|NCT00039377|12069338|FG002|STARTED|Course 5 (Transplant Assignments)||19
10903134|NCT00039377|12069339|FG003|STARTED|Course 5 (Transplant Assignments)||1
10903135|NCT00039377|12069336|FG000|COMPLETED|Course 5 (Transplant Assignments)||0
10903136|NCT00039377|12069337|FG001|COMPLETED|Course 5 (Transplant Assignments)||15
10903137|NCT00039377|12069338|FG002|COMPLETED|Course 5 (Transplant Assignments)||19
10903138|NCT00039377|12069339|FG003|COMPLETED|Course 5 (Transplant Assignments)||1
10903139|NCT00039377|12069336|FG000|NOT COMPLETED|Course 5 (Transplant Assignments)||0
10903140|NCT00039377|12069337|FG001|NOT COMPLETED|Course 5 (Transplant Assignments)||0
10903141|NCT00039377|12069338|FG002|NOT COMPLETED|Course 5 (Transplant Assignments)||0
10903142|NCT00039377|12069339|FG003|NOT COMPLETED|Course 5 (Transplant Assignments)||0
10903143|NCT00039741|12069351|FG000|STARTED|Overall Study||66
10903144|NCT00039741|12069352|FG001|STARTED|Overall Study||68
10903145|NCT00039741|12069353|FG002|STARTED|Overall Study||65
10903146|NCT00039741|12069354|FG003|STARTED|Overall Study||64
10903147|NCT00039741|12069351|FG000|Death|Overall Study||0
10903148|NCT00039741|12069352|FG001|Death|Overall Study||1
10903149|NCT00039741|12069353|FG002|Death|Overall Study||0
10903150|NCT00039741|12069354|FG003|Death|Overall Study||0
10903151|NCT00039741|12069351|FG000|COMPLETED|Overall Study||51
10903152|NCT00039741|12069352|FG001|COMPLETED|Overall Study||56
10903153|NCT00039741|12069353|FG002|COMPLETED|Overall Study||54
10903154|NCT00039741|12069354|FG003|COMPLETED|Overall Study||50
10903155|NCT00039741|12069351|FG000|NOT COMPLETED|Overall Study||15
10903156|NCT00039741|12069352|FG001|NOT COMPLETED|Overall Study||12
10903157|NCT00039741|12069353|FG002|NOT COMPLETED|Overall Study||11
10903158|NCT00039741|12069354|FG003|NOT COMPLETED|Overall Study||14
10903159|NCT00039871|12069364|FG000|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
10903160|NCT00039871|12069364|FG000|COMPLETED|Overall Study||928
10903161|NCT00039871|12069364|FG000|NOT COMPLETED|Overall Study||1384
10903162|NCT00040365|12069368|FG000|STARTED|Overall Study||30
10903163|NCT00040365|12069368|FG000|Completed Follow Up Phase|Overall Study||19
10903164|NCT00040365|12069368|FG000|COMPLETED|Overall Study||19
10903165|NCT00040365|12069368|FG000|NOT COMPLETED|Overall Study||11
10903166|NCT00040443|12069374|FG000|STARTED|Overall Study||84
10903167|NCT00040443|12069375|FG001|STARTED|Overall Study||91
10903168|NCT00040443|12069374|FG000|COMPLETED|Overall Study||84
10903169|NCT00040443|12069375|FG001|COMPLETED|Overall Study||91
10903170|NCT00040443|12069374|FG000|NOT COMPLETED|Overall Study||0
10903171|NCT00040443|12069375|FG001|NOT COMPLETED|Overall Study||0
10903172|NCT00040664|12069381|FG000|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
10903173|NCT00040664|12069382|FG001|STARTED|Overall Study||17
10903174|NCT00040664|12069383|FG002|STARTED|Overall Study||17
10903175|NCT00040664|12069384|FG003|STARTED|Overall Study||35
10903176|NCT00040664|12069381|FG000|COMPLETED|Overall Study||16
10903177|NCT00040664|12069382|FG001|COMPLETED|Overall Study||4
10903178|NCT00040664|12069383|FG002|COMPLETED|Overall Study||4
10903179|NCT00040664|12069384|FG003|COMPLETED|Overall Study||8
10903180|NCT00040664|12069381|FG000|NOT COMPLETED|Overall Study||53
10903181|NCT00040664|12069382|FG001|NOT COMPLETED|Overall Study||13
10903182|NCT00040664|12069383|FG002|NOT COMPLETED|Overall Study||13
10903183|NCT00040664|12069384|FG003|NOT COMPLETED|Overall Study||27
10903184|NCT00040742|12069406|FG000|STARTED|Overall Study||188
10903185|NCT00040742|12069407|FG001|STARTED|Overall Study||183
10903186|NCT00040742|12069408|FG002|STARTED|Overall Study||187
10903187|NCT00040742|12069409|FG003|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
10903188|NCT00040742|12069406|FG000|COMPLETED|Overall Study||149
10903189|NCT00040742|12069407|FG001|COMPLETED|Overall Study||134
10903190|NCT00040742|12069408|FG002|COMPLETED|Overall Study||141
10903191|NCT00040742|12069409|FG003|COMPLETED|Overall Study||152
10903192|NCT00040742|12069406|FG000|NOT COMPLETED|Overall Study||39
10903193|NCT00040742|12069407|FG001|NOT COMPLETED|Overall Study||49
10903194|NCT00040742|12069408|FG002|NOT COMPLETED|Overall Study||46
10903195|NCT00040742|12069409|FG003|NOT COMPLETED|Overall Study||34
10903196|NCT00040846|12069425|FG000|STARTED|Overall Study||60
10903197|NCT00040846|12069426|FG001|STARTED|Overall Study||0
10903198|NCT00040846|12069427|FG002|STARTED|Overall Study||0
10903199|NCT00040846|12069428|FG003|STARTED|Overall Study||0
10903200|NCT00040846|12069429|FG004|STARTED|Overall Study||0
10903201|NCT00040846|12069430|FG005|STARTED|Overall Study||0
10903202|NCT00040846|12069425|FG000|COMPLETED|Overall Study||60
10903203|NCT00040846|12069426|FG001|COMPLETED|Overall Study||0
10903204|NCT00040846|12069427|FG002|COMPLETED|Overall Study||0
10903205|NCT00040846|12069428|FG003|COMPLETED|Overall Study||0
10903206|NCT00040846|12069429|FG004|COMPLETED|Overall Study||0
10903207|NCT00040846|12069430|FG005|COMPLETED|Overall Study||0
10903208|NCT00040846|12069425|FG000|NOT COMPLETED|Overall Study||0
10903209|NCT00040846|12069426|FG001|NOT COMPLETED|Overall Study||0
10903210|NCT00040846|12069427|FG002|NOT COMPLETED|Overall Study||0
10903211|NCT00040846|12069428|FG003|NOT COMPLETED|Overall Study||0
10903212|NCT00040846|12069429|FG004|NOT COMPLETED|Overall Study||0
10903213|NCT00040846|12069430|FG005|NOT COMPLETED|Overall Study||0
10903214|NCT00040937|12069444|FG000|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
10903215|NCT00040937|12069444|FG000|COMPLETED|Induction/PBSC Mobilization||110
10903216|NCT00040937|12069444|FG000|NOT COMPLETED|Induction/PBSC Mobilization||37
10903217|NCT00040937|12069444|FG000|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
10903218|NCT00040937|12069444|FG000|COMPLETED|Autologous PBSCT||77
10903219|NCT00040937|12069444|FG000|NOT COMPLETED|Autologous PBSCT||31
10903220|NCT00040937|12069444|FG000|STARTED|Maintenance||76
10903221|NCT00040937|12069444|FG000|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
10903222|NCT00040937|12069444|FG000|NOT COMPLETED|Maintenance||0
10903223|NCT00041067|12069451|FG000|STARTED|Overall Study||76
10903224|NCT00041067|12069451|FG000|Eligible|Overall Study||74
10903225|NCT00041067|12069451|FG000|COMPLETED|Overall Study||0
10903226|NCT00041067|12069451|FG000|NOT COMPLETED|Overall Study||76
10903227|NCT00041080|12069458|FG000|STARTED|Overall Study|number patients enrolled on study|69
10903228|NCT00041080|12069459|FG001|STARTED|Overall Study|number patients enrolled on study|70
10903229|NCT00041080|12069458|FG000|COMPLETED|Overall Study||39
10903230|NCT00041080|12069459|FG001|COMPLETED|Overall Study||60
10903231|NCT00041080|12069458|FG000|NOT COMPLETED|Overall Study||30
10903232|NCT00041080|12069459|FG001|NOT COMPLETED|Overall Study||10
10903233|NCT00041119|12069469|FG000|STARTED|Overall Study||1142
10903234|NCT00041119|12069470|FG001|STARTED|Overall Study||789
10903235|NCT00041119|12069471|FG002|STARTED|Overall Study||1151
10903236|NCT00041119|12069472|FG003|STARTED|Overall Study||789
10903237|NCT00041119|12069469|FG000|COMPLETED|Overall Study||1142
10903238|NCT00041119|12069470|FG001|COMPLETED|Overall Study||789
10903239|NCT00041119|12069471|FG002|COMPLETED|Overall Study||1151
10903240|NCT00041119|12069472|FG003|COMPLETED|Overall Study||789
10903241|NCT00041119|12069469|FG000|NOT COMPLETED|Overall Study||0
10903242|NCT00041119|12069470|FG001|NOT COMPLETED|Overall Study||0
10903243|NCT00041119|12069471|FG002|NOT COMPLETED|Overall Study||0
10903244|NCT00041119|12069472|FG003|NOT COMPLETED|Overall Study||0
10903245|NCT00041132|12069486|FG000|STARTED|Overall Study||56
10903246|NCT00041132|12069486|FG000|Eligible|Overall Study||49
10903247|NCT00041132|12069486|FG000|Eligible and Began Protocol Therapy|Overall Study||49
10903248|NCT00041132|12069486|FG000|COMPLETED|Overall Study||26
10903249|NCT00041132|12069486|FG000|NOT COMPLETED|Overall Study||30
10903250|NCT00041470|12069490|FG000|STARTED|Overall Study||38
10903251|NCT00041470|12069490|FG000|COMPLETED|Overall Study||0
10903252|NCT00041470|12069490|FG000|NOT COMPLETED|Overall Study||38
10903253|NCT00041717|12069496|FG000|STARTED|Overall Study||114
10903254|NCT00041717|12069497|FG001|STARTED|Overall Study||98
10903255|NCT00041717|12069496|FG000|COMPLETED|Overall Study||81
10903256|NCT00041717|12069497|FG001|COMPLETED|Overall Study||86
10903257|NCT00041717|12069496|FG000|NOT COMPLETED|Overall Study||33
10903258|NCT00041717|12069497|FG001|NOT COMPLETED|Overall Study||12
10903259|NCT00041756|12069508|FG000|STARTED|Overall Study||77
10903260|NCT00041756|12069509|FG001|STARTED|Overall Study||80
10903261|NCT00041756|12069510|FG002|STARTED|Overall Study||79
10903262|NCT00041756|12069511|FG003|STARTED|Overall Study||80
10903263|NCT00041756|12069512|FG004|STARTED|Overall Study||79
10903264|NCT00041756|12069508|FG000|COMPLETED|Overall Study||69
10903265|NCT00041756|12069509|FG001|COMPLETED|Overall Study||65
10903266|NCT00041756|12069510|FG002|COMPLETED|Overall Study||66
10903267|NCT00041756|12069511|FG003|COMPLETED|Overall Study||64
10903268|NCT00041756|12069512|FG004|COMPLETED|Overall Study||19
10903269|NCT00041756|12069508|FG000|NOT COMPLETED|Overall Study||8
10903270|NCT00041756|12069509|FG001|NOT COMPLETED|Overall Study||15
10903271|NCT00041756|12069510|FG002|NOT COMPLETED|Overall Study||13
10903272|NCT00041756|12069511|FG003|NOT COMPLETED|Overall Study||16
10903273|NCT00041756|12069512|FG004|NOT COMPLETED|Overall Study||60
10903274|NCT00041938|12069526|FG000|STARTED|Overall Study||1163
10903275|NCT00041938|12069527|FG001|STARTED|Overall Study||1142
10903276|NCT00041938|12069526|FG000|Completed Follow-up|Overall Study||761
10903277|NCT00041938|12069527|FG001|Completed Follow-up|Overall Study||745
10903278|NCT00041938|12069526|FG000|Primary Endpoint|Overall Study||320
10903279|NCT00041938|12069527|FG001|Primary Endpoint|Overall Study||302
10903280|NCT00041938|12069526|FG000|Only Vital Status Known|Overall Study||44
10903281|NCT00041938|12069527|FG001|Only Vital Status Known|Overall Study||46
10903282|NCT00041938|12069526|FG000|Lost to Follow-up|Overall Study||18
10903283|NCT00041938|12069527|FG001|Lost to Follow-up|Overall Study||17
10903284|NCT00041938|12069526|FG000|Withdrew Consent|Overall Study||20
10903285|NCT00041938|12069527|FG001|Withdrew Consent|Overall Study||14
10903286|NCT00041938|12069526|FG000|COMPLETED|Overall Study||1125
10903287|NCT00041938|12069527|FG001|COMPLETED|Overall Study||1111
10903288|NCT00041938|12069526|FG000|NOT COMPLETED|Overall Study||38
10903289|NCT00041938|12069527|FG001|NOT COMPLETED|Overall Study||31
10903290|NCT00042224|12069535|FG000|STARTED|Overall Study||20
10903291|NCT00042224|12069536|FG001|STARTED|Overall Study||19
10903292|NCT00042224|12069535|FG000|COMPLETED|Overall Study||17
10903293|NCT00042224|12069536|FG001|COMPLETED|Overall Study||16
10903294|NCT00042224|12069535|FG000|NOT COMPLETED|Overall Study||3
10903295|NCT00042224|12069536|FG001|NOT COMPLETED|Overall Study||3
10903296|NCT00042432|12069544|FG000|STARTED|Overall Study||27
10903297|NCT00042432|12069545|FG001|STARTED|Overall Study||27
10903298|NCT00042432|12069544|FG000|COMPLETED|Overall Study||18
10903299|NCT00042432|12069545|FG001|COMPLETED|Overall Study||20
10903300|NCT00042432|12069544|FG000|NOT COMPLETED|Overall Study||9
10903301|NCT00042432|12069545|FG001|NOT COMPLETED|Overall Study||7
10903302|NCT00042666|12069551|FG000|STARTED|Overall Study||55
10903303|NCT00042666|12069551|FG000|Received at Least 1 Dose of Study Drug|Overall Study||55
10903304|NCT00042666|12069551|FG000|Completed at Least 1 Cycle of Study Drug|Overall Study||42
10903305|NCT00042666|12069551|FG000|COMPLETED|Overall Study||1
10903306|NCT00042666|12069551|FG000|NOT COMPLETED|Overall Study||54
10903307|NCT00042939|12069558|FG000|STARTED|Overall Study||48
10903308|NCT00042939|12069559|FG001|STARTED|Overall Study||46
10903309|NCT00042939|12069558|FG000|Treated|Overall Study||46
10903310|NCT00042939|12069559|FG001|Treated|Overall Study||45
10903311|NCT00042939|12069558|FG000|Eligible and Began Protocol Therapy|Overall Study||44
10903312|NCT00042939|12069559|FG001|Eligible and Began Protocol Therapy|Overall Study||43
10903313|NCT00042939|12069558|FG000|Patients With EGFR Results Available|Overall Study||30
10903314|NCT00042939|12069559|FG001|Patients With EGFR Results Available|Overall Study||31
10903315|NCT00042939|12069558|FG000|COMPLETED|Overall Study||24
10903316|NCT00042939|12069559|FG001|COMPLETED|Overall Study||25
10903317|NCT00042939|12069558|FG000|NOT COMPLETED|Overall Study||24
10903318|NCT00042939|12069559|FG001|NOT COMPLETED|Overall Study||21
10903319|NCT00042991|12069572|FG000|STARTED|Overall Study||6
10903320|NCT00042991|12069573|FG001|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
10903321|NCT00042991|12069574|FG002|STARTED|Overall Study||7
10903322|NCT00042991|12069575|FG003|STARTED|Overall Study||2
10903323|NCT00042991|12069576|FG004|STARTED|Overall Study||3
10903324|NCT00042991|12069577|FG005|STARTED|Overall Study||5
10903325|NCT00042991|12069578|FG006|STARTED|Overall Study||3
10903326|NCT00042991|12069572|FG000|Phase-I Trial|Overall Study||6
10903327|NCT00042991|12069573|FG001|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
10903328|NCT00042991|12069574|FG002|Phase-I Trial|Overall Study||7
10903329|NCT00042991|12069575|FG003|Phase-I Trial|Overall Study||2
10903330|NCT00042991|12069576|FG004|Phase-I Trial|Overall Study||3
10903331|NCT00042991|12069577|FG005|Phase-I Trial|Overall Study||5
10903332|NCT00042991|12069578|FG006|Phase-I Trial|Overall Study||3
10903333|NCT00042991|12069572|FG000|Phase-II Trial|Overall Study||0
10903334|NCT00042991|12069573|FG001|Phase-II Trial|Overall Study||36
10903335|NCT00042991|12069574|FG002|Phase-II Trial|Overall Study||0
10903336|NCT00042991|12069575|FG003|Phase-II Trial|Overall Study||0
10903337|NCT00042991|12069576|FG004|Phase-II Trial|Overall Study||0
10903338|NCT00042991|12069577|FG005|Phase-II Trial|Overall Study||0
10903339|NCT00042991|12069578|FG006|Phase-II Trial|Overall Study||0
10903340|NCT00042991|12069572|FG000|COMPLETED|Overall Study||0
10903341|NCT00042991|12069573|FG001|COMPLETED|Overall Study||3
10903342|NCT00042991|12069574|FG002|COMPLETED|Overall Study||1
10903343|NCT00042991|12069575|FG003|COMPLETED|Overall Study||0
10903344|NCT00042991|12069576|FG004|COMPLETED|Overall Study||0
10903345|NCT00042991|12069577|FG005|COMPLETED|Overall Study||0
10903346|NCT00042991|12069578|FG006|COMPLETED|Overall Study||1
10903347|NCT00042991|12069572|FG000|NOT COMPLETED|Overall Study||6
10903348|NCT00042991|12069573|FG001|NOT COMPLETED|Overall Study||40
10903349|NCT00042991|12069574|FG002|NOT COMPLETED|Overall Study||6
10903350|NCT00042991|12069575|FG003|NOT COMPLETED|Overall Study||2
10903351|NCT00042991|12069576|FG004|NOT COMPLETED|Overall Study||3
10903352|NCT00042991|12069577|FG005|NOT COMPLETED|Overall Study||5
10903353|NCT00042991|12069578|FG006|NOT COMPLETED|Overall Study||2
10903354|NCT00043186|12069605|FG000|STARTED|Overall Study||46
10903355|NCT00043186|12069606|FG001|STARTED|Overall Study||44
10903356|NCT00043186|12069607|FG002|STARTED|Overall Study||44
10903357|NCT00043186|12069608|FG003|STARTED|Overall Study||41
10903358|NCT00043186|12069609|FG004|STARTED|Overall Study||54
10903359|NCT00043186|12069610|FG005|STARTED|Overall Study||47
10903360|NCT00043186|12069611|FG006|STARTED|Overall Study||42
10903361|NCT00043186|12069612|FG007|STARTED|Overall Study||47
10903362|NCT00043186|12069613|FG008|STARTED|Overall Study||47
10903363|NCT00043186|12069605|FG000|COMPLETED|Overall Study||29
10903364|NCT00043186|12069606|FG001|COMPLETED|Overall Study||29
10903365|NCT00043186|12069607|FG002|COMPLETED|Overall Study||24
10903366|NCT00043186|12069608|FG003|COMPLETED|Overall Study||19
10903367|NCT00043186|12069609|FG004|COMPLETED|Overall Study||36
10903368|NCT00043186|12069610|FG005|COMPLETED|Overall Study||39
10903369|NCT00043186|12069611|FG006|COMPLETED|Overall Study||25
10903370|NCT00043186|12069612|FG007|COMPLETED|Overall Study||31
10903371|NCT00043186|12069613|FG008|COMPLETED|Overall Study||30
10903372|NCT00043186|12069605|FG000|NOT COMPLETED|Overall Study||17
10903373|NCT00043186|12069606|FG001|NOT COMPLETED|Overall Study||15
10903374|NCT00043186|12069607|FG002|NOT COMPLETED|Overall Study||20
10903375|NCT00043186|12069608|FG003|NOT COMPLETED|Overall Study||22
10903376|NCT00043186|12069609|FG004|NOT COMPLETED|Overall Study||18
10903377|NCT00043186|12069610|FG005|NOT COMPLETED|Overall Study||8
10903378|NCT00043186|12069611|FG006|NOT COMPLETED|Overall Study||17
10903379|NCT00043186|12069612|FG007|NOT COMPLETED|Overall Study||16
10903380|NCT00043186|12069613|FG008|NOT COMPLETED|Overall Study||17
10903381|NCT00043550|12069637|FG000|STARTED|Overall Study||55
10903382|NCT00043550|12069638|FG001|STARTED|Overall Study||51
10903383|NCT00043550|12069639|FG002|STARTED|Overall Study||50
10903384|NCT00043550|12069637|FG000|Week 8 Completed|Overall Study||35
10903385|NCT00043550|12069638|FG001|Week 8 Completed|Overall Study||40
10903386|NCT00043550|12069639|FG002|Week 8 Completed|Overall Study||35
10903387|NCT00043550|12069637|FG000|COMPLETED|Overall Study||33
10903388|NCT00043550|12069638|FG001|COMPLETED|Overall Study||39
10903389|NCT00043550|12069639|FG002|COMPLETED|Overall Study||30
10903390|NCT00043550|12069637|FG000|NOT COMPLETED|Overall Study||22
10903391|NCT00043550|12069638|FG001|NOT COMPLETED|Overall Study||12
10903392|NCT00043550|12069639|FG002|NOT COMPLETED|Overall Study||20
10903393|NCT00043979|12069649|FG000|STARTED|Period 1||30
10903394|NCT00043979|12069650|FG001|STARTED|Period 1||17
10903395|NCT00043979|12069651|FG002|STARTED|Period 1||13
10903396|NCT00043979|12069649|FG000|COMPLETED|Period 1||23
10903397|NCT00043979|12069650|FG001|COMPLETED|Period 1||13
10903398|NCT00043979|12069651|FG002|COMPLETED|Period 1||10
10903399|NCT00043979|12069649|FG000|NOT COMPLETED|Period 1||7
10903400|NCT00043979|12069650|FG001|NOT COMPLETED|Period 1||4
10903401|NCT00043979|12069651|FG002|NOT COMPLETED|Period 1||3
10903402|NCT00043979|12069649|FG000|STARTED|Period 2||0
10903403|NCT00043979|12069650|FG001|STARTED|Period 2||13
10903404|NCT00043979|12069651|FG002|STARTED|Period 2||10
10903405|NCT00043979|12069649|FG000|COMPLETED|Period 2||0
10903406|NCT00043979|12069650|FG001|COMPLETED|Period 2||13
10903407|NCT00043979|12069651|FG002|COMPLETED|Period 2||10
10903408|NCT00043979|12069649|FG000|NOT COMPLETED|Period 2||0
10903409|NCT00043979|12069650|FG001|NOT COMPLETED|Period 2||0
10903410|NCT00043979|12069651|FG002|NOT COMPLETED|Period 2||0
10903411|NCT00044005|12069660|FG000|STARTED|Overall Study||32
10903412|NCT00044005|12069661|FG001|STARTED|Overall Study||33
10903413|NCT00044005|12069662|FG002|STARTED|Overall Study||33
10903414|NCT00044005|12069660|FG000|COMPLETED|Overall Study||13
10903415|NCT00044005|12069661|FG001|COMPLETED|Overall Study||19
10903416|NCT00044005|12069662|FG002|COMPLETED|Overall Study||11
10903417|NCT00044005|12069660|FG000|NOT COMPLETED|Overall Study||19
10903418|NCT00044005|12069661|FG001|NOT COMPLETED|Overall Study||14
10903419|NCT00044005|12069662|FG002|NOT COMPLETED|Overall Study||22
10903420|NCT00044044|12069675|FG000|STARTED|Overall Study||71
10903421|NCT00044044|12069676|FG001|STARTED|Overall Study||69
10903422|NCT00044044|12069677|FG002|STARTED|Overall Study||71
10903423|NCT00044044|12069678|FG003|STARTED|Overall Study||73
10903424|NCT00044044|12069679|FG004|STARTED|Overall Study||72
10903425|NCT00044044|12069675|FG000|COMPLETED|Overall Study||27
10903426|NCT00044044|12069676|FG001|COMPLETED|Overall Study||28
10903427|NCT00044044|12069677|FG002|COMPLETED|Overall Study||31
10903428|NCT00044044|12069678|FG003|COMPLETED|Overall Study||29
10903429|NCT00044044|12069679|FG004|COMPLETED|Overall Study||36
10903430|NCT00044044|12069675|FG000|NOT COMPLETED|Overall Study||44
10903431|NCT00044044|12069676|FG001|NOT COMPLETED|Overall Study||41
10903432|NCT00044044|12069677|FG002|NOT COMPLETED|Overall Study||40
10903433|NCT00044044|12069678|FG003|NOT COMPLETED|Overall Study||44
10903434|NCT00044044|12069679|FG004|NOT COMPLETED|Overall Study||36
10903435|NCT00044083|12069693|FG000|STARTED|First Intervention (One Week)- HV's||74
10903436|NCT00044083|12069694|FG001|STARTED|First Intervention (One Week)- HV's||73
10903437|NCT00044083|12069693|FG000|COMPLETED|First Intervention (One Week)- HV's||64
10903438|NCT00044083|12069694|FG001|COMPLETED|First Intervention (One Week)- HV's||66
10903439|NCT00044083|12069693|FG000|NOT COMPLETED|First Intervention (One Week)- HV's||10
10903440|NCT00044083|12069694|FG001|NOT COMPLETED|First Intervention (One Week)- HV's||7
10903441|NCT00044083|12069693|FG000|STARTED|Second Intervention (One Week) HV's||64
10903442|NCT00044083|12069694|FG001|STARTED|Second Intervention (One Week) HV's||66
10903443|NCT00044083|12069693|FG000|COMPLETED|Second Intervention (One Week) HV's||64
10903444|NCT00044083|12069694|FG001|COMPLETED|Second Intervention (One Week) HV's||66
10903445|NCT00044083|12069693|FG000|NOT COMPLETED|Second Intervention (One Week) HV's||0
10903446|NCT00044083|12069694|FG001|NOT COMPLETED|Second Intervention (One Week) HV's||0
10903447|NCT00044083|12069693|FG000|STARTED|First Intervention (One Week) Patients||31
10903448|NCT00044083|12069694|FG001|STARTED|First Intervention (One Week) Patients||32
10903449|NCT00044083|12069693|FG000|COMPLETED|First Intervention (One Week) Patients||30
10903450|NCT00044083|12069694|FG001|COMPLETED|First Intervention (One Week) Patients||30
10903451|NCT00044083|12069693|FG000|NOT COMPLETED|First Intervention (One Week) Patients||1
10903452|NCT00044083|12069694|FG001|NOT COMPLETED|First Intervention (One Week) Patients||2
10903453|NCT00044083|12069693|FG000|STARTED|Second Intervention (One Week) Patients||30
10903454|NCT00044083|12069694|FG001|STARTED|Second Intervention (One Week) Patients||30
10903455|NCT00044083|12069693|FG000|COMPLETED|Second Intervention (One Week) Patients||30
10903456|NCT00044083|12069694|FG001|COMPLETED|Second Intervention (One Week) Patients||29
10903457|NCT00044083|12069693|FG000|NOT COMPLETED|Second Intervention (One Week) Patients||0
10903458|NCT00044083|12069694|FG001|NOT COMPLETED|Second Intervention (One Week) Patients||1
10903459|NCT00044213|12069731|FG000|STARTED|Overall Study||421
10903460|NCT00044213|12069732|FG001|STARTED|Overall Study||418
10903461|NCT00044213|12069733|FG002|STARTED|Overall Study||432
10903462|NCT00044213|12069734|FG003|STARTED|Overall Study||437
10903463|NCT00044213|12069731|FG000|COMPLETED|Overall Study||321
10903464|NCT00044213|12069732|FG001|COMPLETED|Overall Study||306
10903465|NCT00044213|12069733|FG002|COMPLETED|Overall Study||294
10903466|NCT00044213|12069734|FG003|COMPLETED|Overall Study||301
10903467|NCT00044213|12069731|FG000|NOT COMPLETED|Overall Study||100
10903468|NCT00044213|12069732|FG001|NOT COMPLETED|Overall Study||112
10903469|NCT00044213|12069733|FG002|NOT COMPLETED|Overall Study||138
10903470|NCT00044213|12069734|FG003|NOT COMPLETED|Overall Study||136
10903471|NCT00044512|12069744|FG000|STARTED|Treatment||137
10903472|NCT00044512|12069744|FG000|COMPLETED|Treatment||137
10903473|NCT00044512|12069744|FG000|NOT COMPLETED|Treatment||0
10903474|NCT00044512|12069744|FG000|STARTED|Follow Up||137
10903475|NCT00044512|12069744|FG000|COMPLETED|Follow Up||135
10903476|NCT00044512|12069744|FG000|NOT COMPLETED|Follow Up||2
10903477|NCT00044655|12069750|FG000|STARTED|Overall Study||102
10903478|NCT00044655|12069751|FG001|STARTED|Overall Study||117
10903479|NCT00044655|12069750|FG000|COMPLETED|Overall Study||82
10903480|NCT00044655|12069751|FG001|COMPLETED|Overall Study||79
10903481|NCT00044655|12069750|FG000|NOT COMPLETED|Overall Study||20
10903482|NCT00044655|12069751|FG001|NOT COMPLETED|Overall Study||38
10903483|NCT00045032|12069760|FG000|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
10903484|NCT00045032|12069761|FG001|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
10903485|NCT00045032|12069762|FG002|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
10903486|NCT00045032|12069760|FG000|Crossover to Adjuvant Herceptin|Overall Study||888
10903487|NCT00045032|12069761|FG001|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
10903488|NCT00045032|12069762|FG002|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
10903489|NCT00045032|12069760|FG000|COMPLETED|Overall Study||834
10903490|NCT00045032|12069761|FG001|COMPLETED|Overall Study||994
10903491|NCT00045032|12069762|FG002|COMPLETED|Overall Study||974
10903492|NCT00045032|12069760|FG000|NOT COMPLETED|Overall Study||863
10903493|NCT00045032|12069761|FG001|NOT COMPLETED|Overall Study||708
10903494|NCT00045032|12069762|FG002|NOT COMPLETED|Overall Study||726
10903495|NCT00045110|12069775|FG000|STARTED|100mg Phase 1 Dose Escalalation||6
10903496|NCT00045110|12069776|FG001|STARTED|100mg Phase 1 Dose Escalalation||59
10903497|NCT00045110|12069777|FG002|STARTED|100mg Phase 1 Dose Escalalation||45
10903498|NCT00045110|12069775|FG000|COMPLETED|100mg Phase 1 Dose Escalalation||6
10903499|NCT00045110|12069776|FG001|COMPLETED|100mg Phase 1 Dose Escalalation||53
10903500|NCT00045110|12069777|FG002|COMPLETED|100mg Phase 1 Dose Escalalation||43
10903501|NCT00045110|12069775|FG000|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
10903502|NCT00045110|12069776|FG001|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
10903503|NCT00045110|12069777|FG002|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
10903504|NCT00045110|12069775|FG000|STARTED|200mg Phase 1 Dose Escalation||4
10903505|NCT00045110|12069776|FG001|STARTED|200mg Phase 1 Dose Escalation||0
10903506|NCT00045110|12069777|FG002|STARTED|200mg Phase 1 Dose Escalation||0
10903507|NCT00045110|12069775|FG000|COMPLETED|200mg Phase 1 Dose Escalation||4
10903508|NCT00045110|12069776|FG001|COMPLETED|200mg Phase 1 Dose Escalation||0
10903509|NCT00045110|12069777|FG002|COMPLETED|200mg Phase 1 Dose Escalation||0
10903510|NCT00045110|12069775|FG000|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
10903511|NCT00045110|12069776|FG001|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
10903512|NCT00045110|12069777|FG002|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
10903513|NCT00045110|12069775|FG000|STARTED|275mg Phase 1 Dose Escalation||3
10903514|NCT00045110|12069776|FG001|STARTED|275mg Phase 1 Dose Escalation||0
10903515|NCT00045110|12069777|FG002|STARTED|275mg Phase 1 Dose Escalation||0
10903516|NCT00045110|12069775|FG000|COMPLETED|275mg Phase 1 Dose Escalation||3
10903517|NCT00045110|12069776|FG001|COMPLETED|275mg Phase 1 Dose Escalation||0
10903518|NCT00045110|12069777|FG002|COMPLETED|275mg Phase 1 Dose Escalation||0
10903519|NCT00045110|12069775|FG000|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
10903520|NCT00045110|12069776|FG001|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
10903521|NCT00045110|12069777|FG002|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
10903522|NCT00045110|12069775|FG000|STARTED|400mg Phase 1 Dose Escalation||3
10903523|NCT00045110|12069776|FG001|STARTED|400mg Phase 1 Dose Escalation||0
10903524|NCT00045110|12069777|FG002|STARTED|400mg Phase 1 Dose Escalation||0
10903525|NCT00045110|12069775|FG000|COMPLETED|400mg Phase 1 Dose Escalation||3
10903526|NCT00045110|12069776|FG001|COMPLETED|400mg Phase 1 Dose Escalation||0
10903527|NCT00045110|12069777|FG002|COMPLETED|400mg Phase 1 Dose Escalation||0
10903528|NCT00045110|12069775|FG000|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
10903529|NCT00045110|12069776|FG001|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
10903530|NCT00045110|12069777|FG002|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
10903531|NCT00045110|12069775|FG000|STARTED|525mg Phase 1 Dose Escalation||3
10903532|NCT00045110|12069776|FG001|STARTED|525mg Phase 1 Dose Escalation||0
10903533|NCT00045110|12069777|FG002|STARTED|525mg Phase 1 Dose Escalation||0
10903534|NCT00045110|12069775|FG000|COMPLETED|525mg Phase 1 Dose Escalation||3
10903535|NCT00045110|12069776|FG001|COMPLETED|525mg Phase 1 Dose Escalation||0
10903536|NCT00045110|12069777|FG002|COMPLETED|525mg Phase 1 Dose Escalation||0
10903537|NCT00045110|12069775|FG000|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
10903538|NCT00045110|12069776|FG001|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
10903539|NCT00045110|12069777|FG002|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
10903540|NCT00045110|12069775|FG000|STARTED|650mg Phase 1 Dose Escalation||6
10903541|NCT00045110|12069776|FG001|STARTED|650mg Phase 1 Dose Escalation||0
10903542|NCT00045110|12069777|FG002|STARTED|650mg Phase 1 Dose Escalation||0
10903543|NCT00045110|12069775|FG000|COMPLETED|650mg Phase 1 Dose Escalation||6
10903544|NCT00045110|12069776|FG001|COMPLETED|650mg Phase 1 Dose Escalation||0
10903545|NCT00045110|12069777|FG002|COMPLETED|650mg Phase 1 Dose Escalation||0
10903546|NCT00045110|12069775|FG000|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
10903547|NCT00045110|12069776|FG001|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
10903548|NCT00045110|12069777|FG002|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
10903549|NCT00045110|12069775|FG000|STARTED|775mg Dose Escalation||7
10903550|NCT00045110|12069776|FG001|STARTED|775mg Dose Escalation||0
10903551|NCT00045110|12069777|FG002|STARTED|775mg Dose Escalation||0
10903552|NCT00045110|12069775|FG000|COMPLETED|775mg Dose Escalation||7
10903553|NCT00045110|12069776|FG001|COMPLETED|775mg Dose Escalation||0
10903554|NCT00045110|12069777|FG002|COMPLETED|775mg Dose Escalation||0
10903555|NCT00045110|12069775|FG000|NOT COMPLETED|775mg Dose Escalation||0
10903556|NCT00045110|12069776|FG001|NOT COMPLETED|775mg Dose Escalation||0
10903557|NCT00045110|12069777|FG002|NOT COMPLETED|775mg Dose Escalation||0
10903558|NCT00045162|12069796|FG000|STARTED|Overall Study||336
10903559|NCT00045162|12069797|FG001|STARTED|Overall Study||335
10903560|NCT00045162|12069796|FG000|COMPLETED|Overall Study||194
10903561|NCT00045162|12069797|FG001|COMPLETED|Overall Study||217
10903562|NCT00045162|12069796|FG000|NOT COMPLETED|Overall Study||142
10903563|NCT00045162|12069797|FG001|NOT COMPLETED|Overall Study||118
10903564|NCT00045305|12069803|FG000|STARTED|Overall Study||17
10903565|NCT00045305|12069803|FG000|Eligible and Treated|Overall Study||17
10903566|NCT00045305|12069803|FG000|COMPLETED|Overall Study||3
10903567|NCT00045305|12069803|FG000|NOT COMPLETED|Overall Study||14
10903568|NCT00045435|12069807|FG000|STARTED|Overall Study||17
10903569|NCT00045435|12069807|FG000|COMPLETED|Overall Study||17
10903570|NCT00045435|12069807|FG000|NOT COMPLETED|Overall Study||0
10903571|NCT00045487|12069811|FG000|STARTED|Overall Study||41
10903572|NCT00045487|12069811|FG000|COMPLETED|Overall Study||30
10903573|NCT00045487|12069811|FG000|NOT COMPLETED|Overall Study||11
10903574|NCT00045630|12069815|FG000|STARTED|Overall Study||77
10903575|NCT00045630|12069815|FG000|Eligible|Overall Study||75
10903576|NCT00045630|12069815|FG000|Eligible and Began Protocol Therapy|Overall Study||74
10903577|NCT00045630|12069815|FG000|COMPLETED|Overall Study||71
10903578|NCT00045630|12069815|FG000|NOT COMPLETED|Overall Study||6
10903579|NCT00045708|12069822|FG000|STARTED|Phase 1||21
10903580|NCT00045708|12069823|FG001|STARTED|Phase 1||17
10903581|NCT00045708|12069824|FG002|STARTED|Phase 1||0
10903582|NCT00045708|12069822|FG000|COMPLETED|Phase 1||21
10903583|NCT00045708|12069823|FG001|COMPLETED|Phase 1||16
10903584|NCT00045708|12069824|FG002|COMPLETED|Phase 1||0
10903585|NCT00045708|12069822|FG000|NOT COMPLETED|Phase 1||0
10903586|NCT00045708|12069823|FG001|NOT COMPLETED|Phase 1||1
10903587|NCT00045708|12069824|FG002|NOT COMPLETED|Phase 1||0
10903588|NCT00045708|12069822|FG000|STARTED|Phase 2||0
10903589|NCT00045708|12069823|FG001|STARTED|Phase 2||0
10903590|NCT00045708|12069824|FG002|STARTED|Phase 2||19
10903591|NCT00045708|12069822|FG000|COMPLETED|Phase 2||0
10903592|NCT00045708|12069823|FG001|COMPLETED|Phase 2||0
10903593|NCT00045708|12069824|FG002|COMPLETED|Phase 2||19
10903594|NCT00045708|12069822|FG000|NOT COMPLETED|Phase 2||0
10903595|NCT00045708|12069823|FG001|NOT COMPLETED|Phase 2||0
10903596|NCT00045708|12069824|FG002|NOT COMPLETED|Phase 2||0
10903597|NCT00045734|12069841|FG000|STARTED|Overall Study||23
10903598|NCT00045734|12069841|FG000|COMPLETED|Overall Study||22
10903599|NCT00045734|12069841|FG000|NOT COMPLETED|Overall Study||1
10903600|NCT00045942|12069854|FG000|STARTED|PKC412A2104 (Core)||20
10903601|NCT00045942|12069855|FG001|STARTED|PKC412A2104 (Core)||0
10903602|NCT00045942|12069856|FG002|STARTED|PKC412A2104 (Core)||0
10903603|NCT00045942|12069857|FG003|STARTED|PKC412A2104 (Core)||0
10903604|NCT00045942|12069858|FG004|STARTED|PKC412A2104 (Core)||0
10903605|NCT00045942|12069859|FG005|STARTED|PKC412A2104 (Core)||0
10903606|NCT00045942|12069860|FG006|STARTED|PKC412A2104 (Core)||0
10903607|NCT00045942|12069861|FG007|STARTED|PKC412A2104 (Core)||0
10903608|NCT00045942|12069862|FG008|STARTED|PKC412A2104 (Core)||0
10903609|NCT00045942|12069854|FG000|Core Primary Efficacy|PKC412A2104 (Core)||20
10903610|NCT00045942|12069855|FG001|Core Primary Efficacy|PKC412A2104 (Core)||0
10903611|NCT00045942|12069856|FG002|Core Primary Efficacy|PKC412A2104 (Core)||0
10903612|NCT00045942|12069857|FG003|Core Primary Efficacy|PKC412A2104 (Core)||0
10903613|NCT00045942|12069858|FG004|Core Primary Efficacy|PKC412A2104 (Core)||0
10903614|NCT00045942|12069859|FG005|Core Primary Efficacy|PKC412A2104 (Core)||0
10903615|NCT00045942|12069860|FG006|Core Primary Efficacy|PKC412A2104 (Core)||0
10903616|NCT00045942|12069861|FG007|Core Primary Efficacy|PKC412A2104 (Core)||0
10903617|NCT00045942|12069862|FG008|Core Primary Efficacy|PKC412A2104 (Core)||0
10903618|NCT00045942|12069854|FG000|COMPLETED|PKC412A2104 (Core)||0
10903619|NCT00045942|12069855|FG001|COMPLETED|PKC412A2104 (Core)||0
10903620|NCT00045942|12069856|FG002|COMPLETED|PKC412A2104 (Core)||0
10903621|NCT00045942|12069857|FG003|COMPLETED|PKC412A2104 (Core)||0
10903622|NCT00045942|12069858|FG004|COMPLETED|PKC412A2104 (Core)||0
10903623|NCT00045942|12069859|FG005|COMPLETED|PKC412A2104 (Core)||0
10903624|NCT00045942|12069860|FG006|COMPLETED|PKC412A2104 (Core)||0
10903625|NCT00045942|12069861|FG007|COMPLETED|PKC412A2104 (Core)||0
10903626|NCT00045942|12069862|FG008|COMPLETED|PKC412A2104 (Core)||0
10903627|NCT00045942|12069854|FG000|NOT COMPLETED|PKC412A2104 (Core)||20
10903628|NCT00045942|12069855|FG001|NOT COMPLETED|PKC412A2104 (Core)||0
10903629|NCT00045942|12069856|FG002|NOT COMPLETED|PKC412A2104 (Core)||0
10903630|NCT00045942|12069857|FG003|NOT COMPLETED|PKC412A2104 (Core)||0
10903631|NCT00045942|12069858|FG004|NOT COMPLETED|PKC412A2104 (Core)||0
10903632|NCT00045942|12069859|FG005|NOT COMPLETED|PKC412A2104 (Core)||0
10903633|NCT00045942|12069860|FG006|NOT COMPLETED|PKC412A2104 (Core)||0
10903634|NCT00045942|12069861|FG007|NOT COMPLETED|PKC412A2104 (Core)||0
10903635|NCT00045942|12069862|FG008|NOT COMPLETED|PKC412A2104 (Core)||0
10903636|NCT00045942|12069854|FG000|STARTED|PKC412A2104E1||0
10903637|NCT00045942|12069855|FG001|STARTED|PKC412A2104E1||18
10903638|NCT00045942|12069856|FG002|STARTED|PKC412A2104E1||17
10903639|NCT00045942|12069857|FG003|STARTED|PKC412A2104E1||33
10903640|NCT00045942|12069858|FG004|STARTED|PKC412A2104E1||27
10903641|NCT00045942|12069859|FG005|STARTED|PKC412A2104E1||0
10903642|NCT00045942|12069860|FG006|STARTED|PKC412A2104E1||0
10903643|NCT00045942|12069861|FG007|STARTED|PKC412A2104E1||0
10903644|NCT00045942|12069862|FG008|STARTED|PKC412A2104E1||0
10903645|NCT00045942|12069854|FG000|Primary Efficacy|PKC412A2104E1||0
10903646|NCT00045942|12069855|FG001|Primary Efficacy|PKC412A2104E1||18
10903647|NCT00045942|12069856|FG002|Primary Efficacy|PKC412A2104E1||17
10903648|NCT00045942|12069857|FG003|Primary Efficacy|PKC412A2104E1||32
10903649|NCT00045942|12069858|FG004|Primary Efficacy|PKC412A2104E1||25
10903650|NCT00045942|12069859|FG005|Primary Efficacy|PKC412A2104E1||0
10903651|NCT00045942|12069860|FG006|Primary Efficacy|PKC412A2104E1||0
10903652|NCT00045942|12069861|FG007|Primary Efficacy|PKC412A2104E1||0
10903653|NCT00045942|12069862|FG008|Primary Efficacy|PKC412A2104E1||0
10903654|NCT00045942|12069854|FG000|COMPLETED|PKC412A2104E1||0
10903655|NCT00045942|12069855|FG001|COMPLETED|PKC412A2104E1||0
10903656|NCT00045942|12069856|FG002|COMPLETED|PKC412A2104E1||0
10903657|NCT00045942|12069857|FG003|COMPLETED|PKC412A2104E1||0
10903658|NCT00045942|12069858|FG004|COMPLETED|PKC412A2104E1||0
10903659|NCT00045942|12069859|FG005|COMPLETED|PKC412A2104E1||0
10903660|NCT00045942|12069860|FG006|COMPLETED|PKC412A2104E1||0
10903661|NCT00045942|12069861|FG007|COMPLETED|PKC412A2104E1||0
10903662|NCT00045942|12069862|FG008|COMPLETED|PKC412A2104E1||0
10903663|NCT00045942|12069854|FG000|NOT COMPLETED|PKC412A2104E1||0
10903664|NCT00045942|12069855|FG001|NOT COMPLETED|PKC412A2104E1||18
10903665|NCT00045942|12069856|FG002|NOT COMPLETED|PKC412A2104E1||17
10903666|NCT00045942|12069857|FG003|NOT COMPLETED|PKC412A2104E1||33
10903667|NCT00045942|12069858|FG004|NOT COMPLETED|PKC412A2104E1||27
10903668|NCT00045942|12069859|FG005|NOT COMPLETED|PKC412A2104E1||0
10903669|NCT00045942|12069860|FG006|NOT COMPLETED|PKC412A2104E1||0
10903670|NCT00045942|12069861|FG007|NOT COMPLETED|PKC412A2104E1||0
10903671|NCT00045942|12069862|FG008|NOT COMPLETED|PKC412A2104E1||0
10903672|NCT00045942|12069854|FG000|STARTED|PKC412A2104E2||0
10903673|NCT00045942|12069855|FG001|STARTED|PKC412A2104E2||0
10903674|NCT00045942|12069856|FG002|STARTED|PKC412A2104E2||0
10903675|NCT00045942|12069857|FG003|STARTED|PKC412A2104E2||0
10903676|NCT00045942|12069858|FG004|STARTED|PKC412A2104E2||0
10903677|NCT00045942|12069859|FG005|STARTED|PKC412A2104E2||9
10903678|NCT00045942|12069860|FG006|STARTED|PKC412A2104E2||7
10903679|NCT00045942|12069861|FG007|STARTED|PKC412A2104E2||7
10903680|NCT00045942|12069862|FG008|STARTED|PKC412A2104E2||6
10903681|NCT00045942|12069854|FG000|Primary Efficacy|PKC412A2104E2||0
10903682|NCT00045942|12069855|FG001|Primary Efficacy|PKC412A2104E2||0
10903683|NCT00045942|12069856|FG002|Primary Efficacy|PKC412A2104E2||0
10903684|NCT00045942|12069857|FG003|Primary Efficacy|PKC412A2104E2||0
10903685|NCT00045942|12069858|FG004|Primary Efficacy|PKC412A2104E2||0
10903686|NCT00045942|12069859|FG005|Primary Efficacy|PKC412A2104E2||9
10903687|NCT00045942|12069860|FG006|Primary Efficacy|PKC412A2104E2||7
10903688|NCT00045942|12069861|FG007|Primary Efficacy|PKC412A2104E2||7
10903689|NCT00045942|12069862|FG008|Primary Efficacy|PKC412A2104E2||6
10903690|NCT00045942|12069854|FG000|COMPLETED|PKC412A2104E2||0
10903691|NCT00045942|12069855|FG001|COMPLETED|PKC412A2104E2||0
10903692|NCT00045942|12069856|FG002|COMPLETED|PKC412A2104E2||0
10903693|NCT00045942|12069857|FG003|COMPLETED|PKC412A2104E2||0
10903694|NCT00045942|12069858|FG004|COMPLETED|PKC412A2104E2||0
10903695|NCT00045942|12069859|FG005|COMPLETED|PKC412A2104E2||0
10903696|NCT00045942|12069860|FG006|COMPLETED|PKC412A2104E2||0
10903697|NCT00045942|12069861|FG007|COMPLETED|PKC412A2104E2||0
10903698|NCT00045942|12069862|FG008|COMPLETED|PKC412A2104E2||0
10903699|NCT00045942|12069854|FG000|NOT COMPLETED|PKC412A2104E2||0
10903700|NCT00045942|12069855|FG001|NOT COMPLETED|PKC412A2104E2||0
10903701|NCT00045942|12069856|FG002|NOT COMPLETED|PKC412A2104E2||0
10903702|NCT00045942|12069857|FG003|NOT COMPLETED|PKC412A2104E2||0
10903703|NCT00045942|12069858|FG004|NOT COMPLETED|PKC412A2104E2||0
10903704|NCT00045942|12069859|FG005|NOT COMPLETED|PKC412A2104E2||9
10903705|NCT00045942|12069860|FG006|NOT COMPLETED|PKC412A2104E2||7
10903706|NCT00045942|12069861|FG007|NOT COMPLETED|PKC412A2104E2||7
10903707|NCT00045942|12069862|FG008|NOT COMPLETED|PKC412A2104E2||6
10903708|NCT00046228|12069889|FG000|STARTED|90 Days||806
10903709|NCT00046228|12069890|FG001|STARTED|90 Days||818
10903710|NCT00046228|12069891|FG002|STARTED|90 Days||828
10903711|NCT00046228|12069889|FG000|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
10903712|NCT00046228|12069890|FG001|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
10903713|NCT00046228|12069891|FG002|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
10903714|NCT00046228|12069889|FG000|NOT COMPLETED|90 Days||13
10903715|NCT00046228|12069890|FG001|NOT COMPLETED|90 Days||8
10903716|NCT00046228|12069891|FG002|NOT COMPLETED|90 Days||15
10903717|NCT00046228|12069889|FG000|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
10903718|NCT00046228|12069890|FG001|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
10903719|NCT00046228|12069891|FG002|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
10903720|NCT00046228|12069889|FG000|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
10903721|NCT00046228|12069890|FG001|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
10903722|NCT00046228|12069891|FG002|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
10903723|NCT00046228|12069889|FG000|NOT COMPLETED|1 Year||19
10903724|NCT00046228|12069890|FG001|NOT COMPLETED|1 Year||14
10903725|NCT00046228|12069891|FG002|NOT COMPLETED|1 Year||12
10903726|NCT00046475|12069901|FG000|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
10903727|NCT00046475|12069902|FG001|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
10903728|NCT00046475|12069903|FG002|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
10903729|NCT00046475|12069901|FG000|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
10903730|NCT00046475|12069902|FG001|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
10903731|NCT00046475|12069903|FG002|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
10903732|NCT00046475|12069901|FG000|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
10903733|NCT00046475|12069902|FG001|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
10903734|NCT00046475|12069903|FG002|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
10903735|NCT00046475|12069901|FG000|STARTED|Titration (1 Week)||136
10903736|NCT00046475|12069902|FG001|STARTED|Titration (1 Week)||0
10903737|NCT00046475|12069903|FG002|STARTED|Titration (1 Week)||0
10903738|NCT00046475|12069901|FG000|COMPLETED|Titration (1 Week)||136
10903739|NCT00046475|12069902|FG001|COMPLETED|Titration (1 Week)||0
10903740|NCT00046475|12069903|FG002|COMPLETED|Titration (1 Week)||0
10903741|NCT00046475|12069901|FG000|NOT COMPLETED|Titration (1 Week)||0
10903742|NCT00046475|12069902|FG001|NOT COMPLETED|Titration (1 Week)||0
10903743|NCT00046475|12069903|FG002|NOT COMPLETED|Titration (1 Week)||0
10903744|NCT00046475|12069901|FG000|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
10903745|NCT00046475|12069902|FG001|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
10903746|NCT00046475|12069903|FG002|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
10903747|NCT00046475|12069901|FG000|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
10903748|NCT00046475|12069902|FG001|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
10903749|NCT00046475|12069903|FG002|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
10903750|NCT00046475|12069901|FG000|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
10903751|NCT00046475|12069902|FG001|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
10903752|NCT00046475|12069903|FG002|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
10903753|NCT00046475|12069901|FG000|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
10903754|NCT00046475|12069902|FG001|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
10903755|NCT00046475|12069903|FG002|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
10903756|NCT00046475|12069901|FG000|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
10903757|NCT00046475|12069902|FG001|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
10903758|NCT00046475|12069903|FG002|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
10903759|NCT00046475|12069901|FG000|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
10903760|NCT00046475|12069902|FG001|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
10903761|NCT00046475|12069903|FG002|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
10903762|NCT00046566|12069916|FG000|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
10903763|NCT00046566|12069917|FG001|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
10903764|NCT00046566|12069918|FG002|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
10903765|NCT00046566|12069916|FG000|COMPLETED|Intervention 1 (8 Weeks)||101
10903766|NCT00046566|12069917|FG001|COMPLETED|Intervention 1 (8 Weeks)||104
10903767|NCT00046566|12069918|FG002|COMPLETED|Intervention 1 (8 Weeks)||101
10903768|NCT00046566|12069916|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16
10903769|NCT00046566|12069917|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13
10903770|NCT00046566|12069918|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17
10903771|NCT00046566|12069916|FG000|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
10903772|NCT00046566|12069917|FG001|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
10903773|NCT00046566|12069918|FG002|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
10903774|NCT00046566|12069916|FG000|COMPLETED|Intervention 2 (8 Weeks)||93
10903775|NCT00046566|12069917|FG001|COMPLETED|Intervention 2 (8 Weeks)||92
10903776|NCT00046566|12069918|FG002|COMPLETED|Intervention 2 (8 Weeks)||88
10903777|NCT00046566|12069916|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8
10903778|NCT00046566|12069917|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12
10903779|NCT00046566|12069918|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13
10903780|NCT00046566|12069916|FG000|STARTED|Intervention 3 (8 Weeks)||93
10903781|NCT00046566|12069917|FG001|STARTED|Intervention 3 (8 Weeks)||92
10903782|NCT00046566|12069918|FG002|STARTED|Intervention 3 (8 Weeks)||88
10903783|NCT00046566|12069916|FG000|COMPLETED|Intervention 3 (8 Weeks)||93
10903784|NCT00046566|12069917|FG001|COMPLETED|Intervention 3 (8 Weeks)||92
10903785|NCT00046566|12069918|FG002|COMPLETED|Intervention 3 (8 Weeks)||88
10903786|NCT00046566|12069916|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0
10903787|NCT00046566|12069917|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0
10903788|NCT00046566|12069918|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0
10903789|NCT00046839|12069929|FG000|STARTED|Overall Study||8
10903790|NCT00046839|12069930|FG001|STARTED|Overall Study||13
10903791|NCT00046839|12069929|FG000|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
10903792|NCT00046839|12069930|FG001|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
10903793|NCT00046839|12069929|FG000|NOT COMPLETED|Overall Study||1
10903794|NCT00046839|12069930|FG001|NOT COMPLETED|Overall Study||2
10903795|NCT00046891|12069939|FG000|STARTED|Overall Study||113
10903796|NCT00046891|12069940|FG001|STARTED|Overall Study||113
10903797|NCT00046891|12069939|FG000|COMPLETED|Overall Study||84
10903798|NCT00046891|12069940|FG001|COMPLETED|Overall Study||83
10903799|NCT00046891|12069939|FG000|NOT COMPLETED|Overall Study||29
10903800|NCT00046891|12069940|FG001|NOT COMPLETED|Overall Study||30
10903801|NCT00046930|12069956|FG000|STARTED|Overall Study||224
10903802|NCT00046930|12069957|FG001|STARTED|Overall Study||225
10903803|NCT00046930|12069956|FG000|COMPLETED|Overall Study||212
10903804|NCT00046930|12069957|FG001|COMPLETED|Overall Study||221
10903805|NCT00046930|12069956|FG000|NOT COMPLETED|Overall Study||12
10903806|NCT00046930|12069957|FG001|NOT COMPLETED|Overall Study||4
10903807|NCT00047060|12069966|FG000|STARTED|Overall Study||5
10903808|NCT00047060|12069966|FG000|COMPLETED|Overall Study||3
10903809|NCT00047060|12069966|FG000|NOT COMPLETED|Overall Study||2
10903810|NCT00047320|12069970|FG000|STARTED|Overall Study||104
10903811|NCT00047320|12069970|FG000|COMPLETED|Overall Study||76
10903812|NCT00047320|12069970|FG000|NOT COMPLETED|Overall Study||28
10903813|NCT00047385|12069976|FG000|STARTED|Overall Study||26722
10903814|NCT00047385|12069977|FG001|STARTED|Overall Study||26732
10903815|NCT00047385|12069976|FG000|COMPLETED|Overall Study|Had at least one screening exam.|26455
10903816|NCT00047385|12069977|FG001|COMPLETED|Overall Study||26232
10903817|NCT00047385|12069976|FG000|NOT COMPLETED|Overall Study||267
10903818|NCT00047385|12069977|FG001|NOT COMPLETED|Overall Study||500
10903819|NCT00047463|12069985|FG000|STARTED|Overall Study||13
10903820|NCT00047463|12069986|FG001|STARTED|Overall Study||22
10903821|NCT00047463|12069985|FG000|COMPLETED|Overall Study||13
10903822|NCT00047463|12069986|FG001|COMPLETED|Overall Study||19
10903823|NCT00047463|12069985|FG000|NOT COMPLETED|Overall Study||0
10903824|NCT00047463|12069986|FG001|NOT COMPLETED|Overall Study||3
10903825|NCT00047619|12069997|FG000|STARTED|Overall Study||14
10903826|NCT00047619|12069998|FG001|STARTED|Overall Study||14
10903827|NCT00047619|12069997|FG000|COMPLETED|Overall Study||14
10903828|NCT00047619|12069998|FG001|COMPLETED|Overall Study||14
10903829|NCT00047619|12069997|FG000|NOT COMPLETED|Overall Study||0
10903830|NCT00047619|12069998|FG001|NOT COMPLETED|Overall Study||0
10903831|NCT00047697|12070006|FG000|STARTED|Overall Study||18
10903832|NCT00047697|12070007|FG001|STARTED|Overall Study||16
10903833|NCT00047697|12070006|FG000|COMPLETED|Overall Study||18
10903834|NCT00047697|12070007|FG001|COMPLETED|Overall Study||14
10903835|NCT00047697|12070006|FG000|NOT COMPLETED|Overall Study||0
10903836|NCT00047697|12070007|FG001|NOT COMPLETED|Overall Study||2
10903837|NCT00047879|12070016|FG000|STARTED|Overall Study||4
10903838|NCT00047879|12070017|FG001|STARTED|Overall Study||3
10903839|NCT00047879|12070016|FG000|COMPLETED|Overall Study||0
10903840|NCT00047879|12070017|FG001|COMPLETED|Overall Study||0
10903841|NCT00047879|12070016|FG000|NOT COMPLETED|Overall Study||4
10903842|NCT00047879|12070017|FG001|NOT COMPLETED|Overall Study||3
10903843|NCT00048035|12070029|FG000|STARTED|Core Period||15
10903844|NCT00048035|12070030|FG001|STARTED|Core Period||15
10903845|NCT00048035|12070031|FG002|STARTED|Core Period||15
10903846|NCT00048035|12070032|FG003|STARTED|Core Period||15
10903847|NCT00048035|12070033|FG004|STARTED|Core Period||16
10903848|NCT00048035|12070034|FG005|STARTED|Core Period||15
10903849|NCT00048035|12070035|FG006|STARTED|Core Period||0
10903850|NCT00048035|12070036|FG007|STARTED|Core Period||0
10903851|NCT00048035|12070029|FG000|COMPLETED|Core Period||11
10903852|NCT00048035|12070030|FG001|COMPLETED|Core Period||13
10903853|NCT00048035|12070031|FG002|COMPLETED|Core Period||14
10903854|NCT00048035|12070032|FG003|COMPLETED|Core Period||14
10903855|NCT00048035|12070033|FG004|COMPLETED|Core Period||15
10903856|NCT00048035|12070034|FG005|COMPLETED|Core Period||14
10903857|NCT00048035|12070035|FG006|COMPLETED|Core Period||0
10903858|NCT00048035|12070036|FG007|COMPLETED|Core Period||0
10903859|NCT00048035|12070029|FG000|NOT COMPLETED|Core Period||4
10903860|NCT00048035|12070030|FG001|NOT COMPLETED|Core Period||2
10903861|NCT00048035|12070031|FG002|NOT COMPLETED|Core Period||1
10903862|NCT00048035|12070032|FG003|NOT COMPLETED|Core Period||1
10903863|NCT00048035|12070033|FG004|NOT COMPLETED|Core Period||1
10903864|NCT00048035|12070034|FG005|NOT COMPLETED|Core Period||1
10903865|NCT00048035|12070035|FG006|NOT COMPLETED|Core Period||0
10903866|NCT00048035|12070036|FG007|NOT COMPLETED|Core Period||0
10903867|NCT00048035|12070029|FG000|STARTED|Extension Year 1||0
10903868|NCT00048035|12070030|FG001|STARTED|Extension Year 1||0
10903869|NCT00048035|12070031|FG002|STARTED|Extension Year 1||0
10903870|NCT00048035|12070032|FG003|STARTED|Extension Year 1||0
10903871|NCT00048035|12070033|FG004|STARTED|Extension Year 1||0
10903872|NCT00048035|12070034|FG005|STARTED|Extension Year 1||0
10903873|NCT00048035|12070035|FG006|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
10903874|NCT00048035|12070036|FG007|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
10903875|NCT00048035|12070029|FG000|COMPLETED|Extension Year 1||0
10903876|NCT00048035|12070030|FG001|COMPLETED|Extension Year 1||0
10903877|NCT00048035|12070031|FG002|COMPLETED|Extension Year 1||0
10903878|NCT00048035|12070032|FG003|COMPLETED|Extension Year 1||0
10903879|NCT00048035|12070033|FG004|COMPLETED|Extension Year 1||0
10903880|NCT00048035|12070034|FG005|COMPLETED|Extension Year 1||0
10903881|NCT00048035|12070035|FG006|COMPLETED|Extension Year 1||16
10903882|NCT00048035|12070036|FG007|COMPLETED|Extension Year 1||15
10903883|NCT00048035|12070029|FG000|NOT COMPLETED|Extension Year 1||0
10903884|NCT00048035|12070030|FG001|NOT COMPLETED|Extension Year 1||0
10903885|NCT00048035|12070031|FG002|NOT COMPLETED|Extension Year 1||0
10903886|NCT00048035|12070032|FG003|NOT COMPLETED|Extension Year 1||0
10903887|NCT00048035|12070033|FG004|NOT COMPLETED|Extension Year 1||0
10903888|NCT00048035|12070034|FG005|NOT COMPLETED|Extension Year 1||0
10903889|NCT00048035|12070035|FG006|NOT COMPLETED|Extension Year 1||11
10903890|NCT00048035|12070036|FG007|NOT COMPLETED|Extension Year 1||11
10903891|NCT00048035|12070029|FG000|STARTED|Extension Year 2||0
10903892|NCT00048035|12070030|FG001|STARTED|Extension Year 2||0
10903893|NCT00048035|12070031|FG002|STARTED|Extension Year 2||0
10903894|NCT00048035|12070032|FG003|STARTED|Extension Year 2||0
10903895|NCT00048035|12070033|FG004|STARTED|Extension Year 2||0
10903896|NCT00048035|12070034|FG005|STARTED|Extension Year 2||0
10903897|NCT00048035|12070035|FG006|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
10903898|NCT00048035|12070036|FG007|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
10903899|NCT00048035|12070029|FG000|COMPLETED|Extension Year 2||0
10903900|NCT00048035|12070030|FG001|COMPLETED|Extension Year 2||0
10903901|NCT00048035|12070031|FG002|COMPLETED|Extension Year 2||0
10903902|NCT00048035|12070032|FG003|COMPLETED|Extension Year 2||0
10903903|NCT00048035|12070033|FG004|COMPLETED|Extension Year 2||0
10903904|NCT00048035|12070034|FG005|COMPLETED|Extension Year 2||0
10903905|NCT00048035|12070035|FG006|COMPLETED|Extension Year 2||11
10903906|NCT00048035|12070036|FG007|COMPLETED|Extension Year 2||10
10903907|NCT00048035|12070029|FG000|NOT COMPLETED|Extension Year 2||0
10903908|NCT00048035|12070030|FG001|NOT COMPLETED|Extension Year 2||0
10903909|NCT00048035|12070031|FG002|NOT COMPLETED|Extension Year 2||0
10903910|NCT00048035|12070032|FG003|NOT COMPLETED|Extension Year 2||0
10903911|NCT00048035|12070033|FG004|NOT COMPLETED|Extension Year 2||0
10903912|NCT00048035|12070034|FG005|NOT COMPLETED|Extension Year 2||0
10903913|NCT00048035|12070035|FG006|NOT COMPLETED|Extension Year 2||3
10903914|NCT00048035|12070036|FG007|NOT COMPLETED|Extension Year 2||3
10903915|NCT00048048|12070060|FG000|STARTED|Core Treatment||6
10903916|NCT00048048|12070061|FG001|STARTED|Core Treatment||6
10903917|NCT00048048|12070062|FG002|STARTED|Core Treatment||10
10903918|NCT00048048|12070063|FG003|STARTED|Core Treatment||6
10903919|NCT00048048|12070064|FG004|STARTED|Core Treatment||6
10903920|NCT00048048|12070065|FG005|STARTED|Core Treatment||9
10903921|NCT00048048|12070066|FG006|STARTED|Core Treatment||6
10903922|NCT00048048|12070067|FG007|STARTED|Core Treatment||6
10903923|NCT00048048|12070068|FG008|STARTED|Core Treatment||10
10903924|NCT00048048|12070069|FG009|STARTED|Core Treatment||0
10903925|NCT00048048|12070070|FG010|STARTED|Core Treatment||0
10903926|NCT00048048|12070071|FG011|STARTED|Core Treatment||0
10903927|NCT00048048|12070060|FG000|COMPLETED|Core Treatment||6
10903928|NCT00048048|12070061|FG001|COMPLETED|Core Treatment||6
10903929|NCT00048048|12070062|FG002|COMPLETED|Core Treatment||9
10903930|NCT00048048|12070063|FG003|COMPLETED|Core Treatment||6
10903931|NCT00048048|12070064|FG004|COMPLETED|Core Treatment||6
10903932|NCT00048048|12070065|FG005|COMPLETED|Core Treatment||9
10903933|NCT00048048|12070066|FG006|COMPLETED|Core Treatment||6
10903934|NCT00048048|12070067|FG007|COMPLETED|Core Treatment||5
10903935|NCT00048048|12070068|FG008|COMPLETED|Core Treatment||10
10903936|NCT00048048|12070069|FG009|COMPLETED|Core Treatment||0
10903937|NCT00048048|12070070|FG010|COMPLETED|Core Treatment||0
10903938|NCT00048048|12070071|FG011|COMPLETED|Core Treatment||0
10903939|NCT00048048|12070060|FG000|NOT COMPLETED|Core Treatment||0
10903940|NCT00048048|12070061|FG001|NOT COMPLETED|Core Treatment||0
10903941|NCT00048048|12070062|FG002|NOT COMPLETED|Core Treatment||1
10903942|NCT00048048|12070063|FG003|NOT COMPLETED|Core Treatment||0
10903943|NCT00048048|12070064|FG004|NOT COMPLETED|Core Treatment||0
10903944|NCT00048048|12070065|FG005|NOT COMPLETED|Core Treatment||0
10903945|NCT00048048|12070066|FG006|NOT COMPLETED|Core Treatment||0
10903946|NCT00048048|12070067|FG007|NOT COMPLETED|Core Treatment||1
10903947|NCT00048048|12070068|FG008|NOT COMPLETED|Core Treatment||0
10903948|NCT00048048|12070069|FG009|NOT COMPLETED|Core Treatment||0
10903949|NCT00048048|12070070|FG010|NOT COMPLETED|Core Treatment||0
10903950|NCT00048048|12070071|FG011|NOT COMPLETED|Core Treatment||0
10903951|NCT00048048|12070060|FG000|STARTED|Extension Year 1||0
10903952|NCT00048048|12070061|FG001|STARTED|Extension Year 1||0
10903953|NCT00048048|12070062|FG002|STARTED|Extension Year 1||0
10903954|NCT00048048|12070063|FG003|STARTED|Extension Year 1||0
10903955|NCT00048048|12070064|FG004|STARTED|Extension Year 1||0
10903956|NCT00048048|12070065|FG005|STARTED|Extension Year 1||0
10903957|NCT00048048|12070066|FG006|STARTED|Extension Year 1||0
10903958|NCT00048048|12070067|FG007|STARTED|Extension Year 1||0
10903959|NCT00048048|12070068|FG008|STARTED|Extension Year 1||0
10903960|NCT00048048|12070069|FG009|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
10903961|NCT00048048|12070070|FG010|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
10903962|NCT00048048|12070071|FG011|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
10903963|NCT00048048|12070060|FG000|COMPLETED|Extension Year 1||0
10903964|NCT00048048|12070061|FG001|COMPLETED|Extension Year 1||0
10903965|NCT00048048|12070062|FG002|COMPLETED|Extension Year 1||0
10903966|NCT00048048|12070063|FG003|COMPLETED|Extension Year 1||0
10903967|NCT00048048|12070064|FG004|COMPLETED|Extension Year 1||0
10903968|NCT00048048|12070065|FG005|COMPLETED|Extension Year 1||0
10903969|NCT00048048|12070066|FG006|COMPLETED|Extension Year 1||0
10903970|NCT00048048|12070067|FG007|COMPLETED|Extension Year 1||0
10903971|NCT00048048|12070068|FG008|COMPLETED|Extension Year 1||0
10903972|NCT00048048|12070069|FG009|COMPLETED|Extension Year 1||14
10903973|NCT00048048|12070070|FG010|COMPLETED|Extension Year 1||14
10903974|NCT00048048|12070071|FG011|COMPLETED|Extension Year 1||15
10903975|NCT00048048|12070060|FG000|NOT COMPLETED|Extension Year 1||0
10903976|NCT00048048|12070061|FG001|NOT COMPLETED|Extension Year 1||0
10903977|NCT00048048|12070062|FG002|NOT COMPLETED|Extension Year 1||0
10903978|NCT00048048|12070063|FG003|NOT COMPLETED|Extension Year 1||0
10903979|NCT00048048|12070064|FG004|NOT COMPLETED|Extension Year 1||0
10903980|NCT00048048|12070065|FG005|NOT COMPLETED|Extension Year 1||0
10903981|NCT00048048|12070066|FG006|NOT COMPLETED|Extension Year 1||0
10903982|NCT00048048|12070067|FG007|NOT COMPLETED|Extension Year 1||0
10903983|NCT00048048|12070068|FG008|NOT COMPLETED|Extension Year 1||0
10903984|NCT00048048|12070069|FG009|NOT COMPLETED|Extension Year 1||2
10903985|NCT00048048|12070070|FG010|NOT COMPLETED|Extension Year 1||2
10903986|NCT00048048|12070071|FG011|NOT COMPLETED|Extension Year 1||4
10903987|NCT00048048|12070060|FG000|STARTED|Extension Year 2||0
10903988|NCT00048048|12070061|FG001|STARTED|Extension Year 2||0
10903989|NCT00048048|12070062|FG002|STARTED|Extension Year 2||0
10903990|NCT00048048|12070063|FG003|STARTED|Extension Year 2||0
10903991|NCT00048048|12070064|FG004|STARTED|Extension Year 2||0
10903992|NCT00048048|12070065|FG005|STARTED|Extension Year 2||0
10903993|NCT00048048|12070066|FG006|STARTED|Extension Year 2||0
10903994|NCT00048048|12070067|FG007|STARTED|Extension Year 2||0
10903995|NCT00048048|12070068|FG008|STARTED|Extension Year 2||0
10903996|NCT00048048|12070069|FG009|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
10903997|NCT00048048|12070070|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
10903998|NCT00048048|12070071|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
10903999|NCT00048048|12070060|FG000|COMPLETED|Extension Year 2||0
10904000|NCT00048048|12070061|FG001|COMPLETED|Extension Year 2||0
10904001|NCT00048048|12070062|FG002|COMPLETED|Extension Year 2||0
10904002|NCT00048048|12070063|FG003|COMPLETED|Extension Year 2||0
10904003|NCT00048048|12070064|FG004|COMPLETED|Extension Year 2||0
10904004|NCT00048048|12070065|FG005|COMPLETED|Extension Year 2||0
10904005|NCT00048048|12070066|FG006|COMPLETED|Extension Year 2||0
10904006|NCT00048048|12070067|FG007|COMPLETED|Extension Year 2||0
10904007|NCT00048048|12070068|FG008|COMPLETED|Extension Year 2||0
10904008|NCT00048048|12070069|FG009|COMPLETED|Extension Year 2||2
10904009|NCT00048048|12070070|FG010|COMPLETED|Extension Year 2||19
10904010|NCT00048048|12070071|FG011|COMPLETED|Extension Year 2||13
10904011|NCT00048048|12070060|FG000|NOT COMPLETED|Extension Year 2||0
10904012|NCT00048048|12070061|FG001|NOT COMPLETED|Extension Year 2||0
10904013|NCT00048048|12070062|FG002|NOT COMPLETED|Extension Year 2||0
10904014|NCT00048048|12070063|FG003|NOT COMPLETED|Extension Year 2||0
10904015|NCT00048048|12070064|FG004|NOT COMPLETED|Extension Year 2||0
10904016|NCT00048048|12070065|FG005|NOT COMPLETED|Extension Year 2||0
10904017|NCT00048048|12070066|FG006|NOT COMPLETED|Extension Year 2||0
10904018|NCT00048048|12070067|FG007|NOT COMPLETED|Extension Year 2||0
10904019|NCT00048048|12070068|FG008|NOT COMPLETED|Extension Year 2||0
10904020|NCT00048048|12070069|FG009|NOT COMPLETED|Extension Year 2||0
10904021|NCT00048048|12070070|FG010|NOT COMPLETED|Extension Year 2||4
10904022|NCT00048048|12070071|FG011|NOT COMPLETED|Extension Year 2||2
10904023|NCT00048061|12070102|FG000|STARTED|Overall Study||400
10904024|NCT00048061|12070103|FG001|STARTED|Overall Study||401
10904025|NCT00048061|12070104|FG002|STARTED|Overall Study||400
10904026|NCT00048061|12070105|FG003|STARTED|Overall Study||401
10904027|NCT00048061|12070102|FG000|COMPLETED|Overall Study||325
10904028|NCT00048061|12070103|FG001|COMPLETED|Overall Study||328
10904029|NCT00048061|12070104|FG002|COMPLETED|Overall Study||316
10904030|NCT00048061|12070105|FG003|COMPLETED|Overall Study||322
10904031|NCT00048061|12070102|FG000|NOT COMPLETED|Overall Study||75
10904032|NCT00048061|12070103|FG001|NOT COMPLETED|Overall Study||73
10904033|NCT00048061|12070104|FG002|NOT COMPLETED|Overall Study||84
10904034|NCT00048061|12070105|FG003|NOT COMPLETED|Overall Study||79
10904035|NCT00048074|12070118|FG000|STARTED|Overall Study||465
10904036|NCT00048074|12070119|FG001|STARTED|Overall Study||448
10904037|NCT00048074|12070120|FG002|STARTED|Overall Study||469
10904038|NCT00048074|12070118|FG000|COMPLETED|Overall Study||384
10904039|NCT00048074|12070119|FG001|COMPLETED|Overall Study||361
10904040|NCT00048074|12070120|FG002|COMPLETED|Overall Study||372
10904041|NCT00048074|12070118|FG000|NOT COMPLETED|Overall Study||81
10904042|NCT00048074|12070119|FG001|NOT COMPLETED|Overall Study||87
10904043|NCT00048074|12070120|FG002|NOT COMPLETED|Overall Study||97
10904044|NCT00048165|12070130|FG000|STARTED|Completed 6 Months Study||216
10904045|NCT00048165|12070131|FG001|STARTED|Completed 6 Months Study||218
10904046|NCT00048165|12070130|FG000|COMPLETED|Completed 6 Months Study||165
10904047|NCT00048165|12070131|FG001|COMPLETED|Completed 6 Months Study||170
10904048|NCT00048165|12070130|FG000|NOT COMPLETED|Completed 6 Months Study||51
10904049|NCT00048165|12070131|FG001|NOT COMPLETED|Completed 6 Months Study||48
10904050|NCT00048165|12070130|FG000|STARTED|Completed 12 Months Study||165
10904051|NCT00048165|12070131|FG001|STARTED|Completed 12 Months Study||170
10904052|NCT00048165|12070130|FG000|COMPLETED|Completed 12 Months Study||162
10904053|NCT00048165|12070131|FG001|COMPLETED|Completed 12 Months Study||167
10904054|NCT00048165|12070130|FG000|NOT COMPLETED|Completed 12 Months Study||3
10904055|NCT00048165|12070131|FG001|NOT COMPLETED|Completed 12 Months Study||3
10904056|NCT00048347|12070139|FG000|STARTED|Overall Study||18
10904057|NCT00048347|12070139|FG000|COMPLETED|Overall Study||16
10904058|NCT00048347|12070139|FG000|NOT COMPLETED|Overall Study||2
10904059|NCT00048542|12070147|FG000|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
10904060|NCT00048542|12070148|FG001|STARTED|Double-Blind Phase||37
10904061|NCT00048542|12070149|FG002|STARTED|Double-Blind Phase||30
10904062|NCT00048542|12070150|FG003|STARTED|Double-Blind Phase||28
10904063|NCT00048542|12070151|FG004|STARTED|Double-Blind Phase||0
10904064|NCT00048542|12070152|FG005|STARTED|Double-Blind Phase||0
10904065|NCT00048542|12070153|FG006|STARTED|Double-Blind Phase||0
10904066|NCT00048542|12070154|FG007|STARTED|Double-Blind Phase||0
10904067|NCT00048542|12070147|FG000|COMPLETED|Double-Blind Phase||35
10904068|NCT00048542|12070148|FG001|COMPLETED|Double-Blind Phase||36
10904069|NCT00048542|12070149|FG002|COMPLETED|Double-Blind Phase||29
10904070|NCT00048542|12070150|FG003|COMPLETED|Double-Blind Phase||28
10904071|NCT00048542|12070151|FG004|COMPLETED|Double-Blind Phase||0
10904072|NCT00048542|12070152|FG005|COMPLETED|Double-Blind Phase||0
10904073|NCT00048542|12070153|FG006|COMPLETED|Double-Blind Phase||0
10904074|NCT00048542|12070154|FG007|COMPLETED|Double-Blind Phase||0
10904075|NCT00048542|12070147|FG000|NOT COMPLETED|Double-Blind Phase||3
10904076|NCT00048542|12070148|FG001|NOT COMPLETED|Double-Blind Phase||1
10904077|NCT00048542|12070149|FG002|NOT COMPLETED|Double-Blind Phase||1
10904078|NCT00048542|12070150|FG003|NOT COMPLETED|Double-Blind Phase||0
10904079|NCT00048542|12070151|FG004|NOT COMPLETED|Double-Blind Phase||0
10904080|NCT00048542|12070152|FG005|NOT COMPLETED|Double-Blind Phase||0
10904081|NCT00048542|12070153|FG006|NOT COMPLETED|Double-Blind Phase||0
10904082|NCT00048542|12070154|FG007|NOT COMPLETED|Double-Blind Phase||0
10904083|NCT00048542|12070147|FG000|STARTED|Open-Label Extension BSA Phase||0
10904084|NCT00048542|12070148|FG001|STARTED|Open-Label Extension BSA Phase||0
10904085|NCT00048542|12070149|FG002|STARTED|Open-Label Extension BSA Phase||0
10904086|NCT00048542|12070150|FG003|STARTED|Open-Label Extension BSA Phase||0
10904087|NCT00048542|12070151|FG004|STARTED|Open-Label Extension BSA Phase||71
10904088|NCT00048542|12070152|FG005|STARTED|Open-Label Extension BSA Phase||57
10904089|NCT00048542|12070153|FG006|STARTED|Open-Label Extension BSA Phase||0
10904090|NCT00048542|12070154|FG007|STARTED|Open-Label Extension BSA Phase||0
10904091|NCT00048542|12070147|FG000|COMPLETED|Open-Label Extension BSA Phase||0
10904092|NCT00048542|12070148|FG001|COMPLETED|Open-Label Extension BSA Phase||0
10904093|NCT00048542|12070149|FG002|COMPLETED|Open-Label Extension BSA Phase||0
10904094|NCT00048542|12070150|FG003|COMPLETED|Open-Label Extension BSA Phase||0
10904095|NCT00048542|12070151|FG004|COMPLETED|Open-Label Extension BSA Phase||59
10904096|NCT00048542|12070152|FG005|COMPLETED|Open-Label Extension BSA Phase||47
10904097|NCT00048542|12070153|FG006|COMPLETED|Open-Label Extension BSA Phase||0
10904098|NCT00048542|12070154|FG007|COMPLETED|Open-Label Extension BSA Phase||0
10904099|NCT00048542|12070147|FG000|NOT COMPLETED|Open-Label Extension BSA Phase||0
10904100|NCT00048542|12070148|FG001|NOT COMPLETED|Open-Label Extension BSA Phase||0
10904101|NCT00048542|12070149|FG002|NOT COMPLETED|Open-Label Extension BSA Phase||0
10904102|NCT00048542|12070150|FG003|NOT COMPLETED|Open-Label Extension BSA Phase||0
10904103|NCT00048542|12070151|FG004|NOT COMPLETED|Open-Label Extension BSA Phase||12
10904104|NCT00048542|12070152|FG005|NOT COMPLETED|Open-Label Extension BSA Phase||10
10904105|NCT00048542|12070153|FG006|NOT COMPLETED|Open-Label Extension BSA Phase||0
10904106|NCT00048542|12070154|FG007|NOT COMPLETED|Open-Label Extension BSA Phase||0
10904107|NCT00048542|12070147|FG000|STARTED|Open-Label Extension Fixed Dose Phase||0
10904108|NCT00048542|12070148|FG001|STARTED|Open-Label Extension Fixed Dose Phase||0
10904109|NCT00048542|12070149|FG002|STARTED|Open-Label Extension Fixed Dose Phase||0
10904110|NCT00048542|12070150|FG003|STARTED|Open-Label Extension Fixed Dose Phase||0
10904111|NCT00048542|12070151|FG004|STARTED|Open-Label Extension Fixed Dose Phase||0
10904112|NCT00048542|12070152|FG005|STARTED|Open-Label Extension Fixed Dose Phase||0
10904113|NCT00048542|12070153|FG006|STARTED|Open-Label Extension Fixed Dose Phase||59
10904114|NCT00048542|12070154|FG007|STARTED|Open-Label Extension Fixed Dose Phase||47
10904115|NCT00048542|12070147|FG000|COMPLETED|Open-Label Extension Fixed Dose Phase||0
10904116|NCT00048542|12070148|FG001|COMPLETED|Open-Label Extension Fixed Dose Phase||0
10904117|NCT00048542|12070149|FG002|COMPLETED|Open-Label Extension Fixed Dose Phase||0
10904118|NCT00048542|12070150|FG003|COMPLETED|Open-Label Extension Fixed Dose Phase||0
10904119|NCT00048542|12070151|FG004|COMPLETED|Open-Label Extension Fixed Dose Phase||0
10904120|NCT00048542|12070152|FG005|COMPLETED|Open-Label Extension Fixed Dose Phase||0
10904121|NCT00048542|12070153|FG006|COMPLETED|Open-Label Extension Fixed Dose Phase||37
10904122|NCT00048542|12070154|FG007|COMPLETED|Open-Label Extension Fixed Dose Phase||25
10904123|NCT00048542|12070147|FG000|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
10904124|NCT00048542|12070148|FG001|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
10904125|NCT00048542|12070149|FG002|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
10904126|NCT00048542|12070150|FG003|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
10904127|NCT00048542|12070151|FG004|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
10904128|NCT00048542|12070152|FG005|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
10904129|NCT00048542|12070153|FG006|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
10904130|NCT00048542|12070154|FG007|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
10904131|NCT00048568|12070185|FG000|STARTED|Double-Blind Period Days 1 to 169||433
10904132|NCT00048568|12070186|FG001|STARTED|Double-Blind Period Days 1 to 169||219
10904133|NCT00048568|12070187|FG002|STARTED|Double-Blind Period Days 1 to 169||0
10904134|NCT00048568|12070185|FG000|COMPLETED|Double-Blind Period Days 1 to 169||401
10904135|NCT00048568|12070186|FG001|COMPLETED|Double-Blind Period Days 1 to 169||174
10904136|NCT00048568|12070187|FG002|COMPLETED|Double-Blind Period Days 1 to 169||0
10904137|NCT00048568|12070185|FG000|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
10904138|NCT00048568|12070186|FG001|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
10904139|NCT00048568|12070187|FG002|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
10904140|NCT00048568|12070185|FG000|STARTED|Double-Blind Period Days 170 to 365||401
10904141|NCT00048568|12070186|FG001|STARTED|Double-Blind Period Days 170 to 365||174
10904142|NCT00048568|12070187|FG002|STARTED|Double-Blind Period Days 170 to 365||0
10904143|NCT00048568|12070185|FG000|COMPLETED|Double-Blind Period Days 170 to 365||385
10904144|NCT00048568|12070186|FG001|COMPLETED|Double-Blind Period Days 170 to 365||162
10904145|NCT00048568|12070187|FG002|COMPLETED|Double-Blind Period Days 170 to 365||0
10904146|NCT00048568|12070185|FG000|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
10904147|NCT00048568|12070186|FG001|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
10904148|NCT00048568|12070187|FG002|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
10904149|NCT00048568|12070185|FG000|STARTED|Open-Label Period||0
10904150|NCT00048568|12070186|FG001|STARTED|Open-Label Period||0
10904151|NCT00048568|12070187|FG002|STARTED|Open-Label Period||539
10904152|NCT00048568|12070185|FG000|COMPLETED|Open-Label Period||0
10904153|NCT00048568|12070186|FG001|COMPLETED|Open-Label Period||0
10904154|NCT00048568|12070187|FG002|COMPLETED|Open-Label Period||379
10904155|NCT00048568|12070185|FG000|NOT COMPLETED|Open-Label Period||0
10904156|NCT00048568|12070186|FG001|NOT COMPLETED|Open-Label Period||0
10904157|NCT00048568|12070187|FG002|NOT COMPLETED|Open-Label Period||160
10904158|NCT00048581|12070210|FG000|STARTED|Double-Blind Period||258
10904159|NCT00048581|12070211|FG001|STARTED|Double-Blind Period||133
10904160|NCT00048581|12070212|FG002|STARTED|Double-Blind Period||0
10904161|NCT00048581|12070210|FG000|COMPLETED|Double-Blind Period||223
10904162|NCT00048581|12070211|FG001|COMPLETED|Double-Blind Period||99
10904163|NCT00048581|12070212|FG002|COMPLETED|Double-Blind Period||0
10904164|NCT00048581|12070210|FG000|NOT COMPLETED|Double-Blind Period||35
10904165|NCT00048581|12070211|FG001|NOT COMPLETED|Double-Blind Period||34
10904166|NCT00048581|12070212|FG002|NOT COMPLETED|Double-Blind Period||0
10904167|NCT00048581|12070210|FG000|STARTED|Open-Label Period||0
10904168|NCT00048581|12070211|FG001|STARTED|Open-Label Period||0
10904169|NCT00048581|12070212|FG002|STARTED|Open-Label Period||317
10904170|NCT00048581|12070210|FG000|COMPLETED|Open-Label Period||0
10904171|NCT00048581|12070211|FG001|COMPLETED|Open-Label Period||0
10904172|NCT00048581|12070212|FG002|COMPLETED|Open-Label Period||150
10904173|NCT00048581|12070210|FG000|NOT COMPLETED|Open-Label Period||0
10904174|NCT00048581|12070211|FG001|NOT COMPLETED|Open-Label Period||0
10904175|NCT00048581|12070212|FG002|NOT COMPLETED|Open-Label Period||167
10904176|NCT00048724|12070227|FG000|STARTED|Overall Study||311
10904177|NCT00048724|12070228|FG001|STARTED|Overall Study||315
10904178|NCT00048724|12070227|FG000|COMPLETED|Overall Study||195
10904179|NCT00048724|12070228|FG001|COMPLETED|Overall Study||197
10904180|NCT00048724|12070227|FG000|NOT COMPLETED|Overall Study||116
10904181|NCT00048724|12070228|FG001|NOT COMPLETED|Overall Study||118
10904182|NCT00048737|12070234|FG000|STARTED|Overall Study||70
10904183|NCT00048737|12070234|FG000|COMPLETED|Overall Study||70
10904184|NCT00048737|12070234|FG000|NOT COMPLETED|Overall Study||0
10904185|NCT00048815|12070241|FG000|STARTED|Overall Study||24
10904186|NCT00048815|12070242|FG001|STARTED|Overall Study||26
10904187|NCT00048815|12070243|FG002|STARTED|Overall Study||23
10904188|NCT00048815|12070241|FG000|COMPLETED|Overall Study||18
10904189|NCT00048815|12070242|FG001|COMPLETED|Overall Study||22
10904190|NCT00048815|12070243|FG002|COMPLETED|Overall Study||19
10904191|NCT00048815|12070241|FG000|NOT COMPLETED|Overall Study||6
10904192|NCT00048815|12070242|FG001|NOT COMPLETED|Overall Study||4
10904193|NCT00048815|12070243|FG002|NOT COMPLETED|Overall Study||4
10904194|NCT00048893|12070251|FG000|STARTED|Overall Study||37
10904195|NCT00048893|12070251|FG000|COMPLETED|Overall Study||37
10904196|NCT00048893|12070251|FG000|NOT COMPLETED|Overall Study||0
10904197|NCT00048932|12070257|FG000|STARTED|Double Blind Period (DB)|Number Treated|959
10904198|NCT00048932|12070258|FG001|STARTED|Double Blind Period (DB)|Number Treated|482
10904199|NCT00048932|12070259|FG002|STARTED|Double Blind Period (DB)||0
10904200|NCT00048932|12070257|FG000|COMPLETED|Double Blind Period (DB)||836
10904201|NCT00048932|12070258|FG001|COMPLETED|Double Blind Period (DB)||395
10904202|NCT00048932|12070259|FG002|COMPLETED|Double Blind Period (DB)||0
10904203|NCT00048932|12070257|FG000|NOT COMPLETED|Double Blind Period (DB)||123
10904204|NCT00048932|12070258|FG001|NOT COMPLETED|Double Blind Period (DB)||87
10904205|NCT00048932|12070259|FG002|NOT COMPLETED|Double Blind Period (DB)||0
10904206|NCT00048932|12070257|FG000|STARTED|Open Label Period (OL)||0
10904207|NCT00048932|12070258|FG001|STARTED|Open Label Period (OL)||0
10904208|NCT00048932|12070259|FG002|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
10904209|NCT00048932|12070257|FG000|COMPLETED|Open Label Period (OL)||0
10904210|NCT00048932|12070258|FG001|COMPLETED|Open Label Period (OL)||0
10904211|NCT00048932|12070259|FG002|COMPLETED|Open Label Period (OL)||743
10904212|NCT00048932|12070257|FG000|NOT COMPLETED|Open Label Period (OL)||0
10904213|NCT00048932|12070258|FG001|NOT COMPLETED|Open Label Period (OL)||0
10904214|NCT00048932|12070259|FG002|NOT COMPLETED|Open Label Period (OL)||441
10904215|NCT00048997|12070270|FG000|STARTED|Overall Study||176
10904216|NCT00048997|12070271|FG001|STARTED|Overall Study||180
10904217|NCT00048997|12070270|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
10904218|NCT00048997|12070271|FG001|COMPLETED|Overall Study||177
10904219|NCT00048997|12070270|FG000|NOT COMPLETED|Overall Study||13
10904220|NCT00048997|12070271|FG001|NOT COMPLETED|Overall Study||3
10904221|NCT00049036|12070278|FG000|STARTED|Overall Study||51
10904222|NCT00049036|12070279|FG001|STARTED|Overall Study||55
10904223|NCT00049036|12070278|FG000|COMPLETED|Overall Study||51
10904224|NCT00049036|12070279|FG001|COMPLETED|Overall Study||55
10904225|NCT00049036|12070278|FG000|NOT COMPLETED|Overall Study||0
10904226|NCT00049036|12070279|FG001|NOT COMPLETED|Overall Study||0
10904227|NCT00049127|12070290|FG000|STARTED|Overall Study||12
10904228|NCT00049127|12070291|FG001|STARTED|Overall Study||0
10904229|NCT00049127|12070292|FG002|STARTED|Overall Study||40
10904230|NCT00049127|12070293|FG003|STARTED|Overall Study||0
10904231|NCT00049127|12070294|FG004|STARTED|Overall Study||12
10904232|NCT00049127|12070290|FG000|COMPLETED|Overall Study||12
10904233|NCT00049127|12070291|FG001|COMPLETED|Overall Study||0
10904234|NCT00049127|12070292|FG002|COMPLETED|Overall Study||39
10904235|NCT00049127|12070293|FG003|COMPLETED|Overall Study||0
10904236|NCT00049127|12070294|FG004|COMPLETED|Overall Study||12
10904237|NCT00049127|12070290|FG000|NOT COMPLETED|Overall Study||0
10904238|NCT00049127|12070291|FG001|NOT COMPLETED|Overall Study||0
10904239|NCT00049127|12070292|FG002|NOT COMPLETED|Overall Study||1
10904240|NCT00049127|12070293|FG003|NOT COMPLETED|Overall Study||0
10904241|NCT00049127|12070294|FG004|NOT COMPLETED|Overall Study||0
10904242|NCT00049257|12070306|FG000|STARTED|Carboplatin, Paclitaxel||58
10904243|NCT00049257|12070306|FG000|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
10904244|NCT00049257|12070306|FG000|NOT COMPLETED|Carboplatin, Paclitaxel||13
10904245|NCT00049257|12070306|FG000|STARTED|Follow-up Period for Survival Status||45
10904246|NCT00049257|12070306|FG000|COMPLETED|Follow-up Period for Survival Status||41
10904247|NCT00049257|12070306|FG000|NOT COMPLETED|Follow-up Period for Survival Status||4
10904248|NCT00049322|12070312|FG000|STARTED|Overall Study||15
10904249|NCT00049322|12070313|FG001|STARTED|Overall Study||15
10904250|NCT00049322|12070312|FG000|COMPLETED|Overall Study||14
10904251|NCT00049322|12070313|FG001|COMPLETED|Overall Study||9
10904252|NCT00049322|12070312|FG000|NOT COMPLETED|Overall Study||1
10904253|NCT00049322|12070313|FG001|NOT COMPLETED|Overall Study||6
10904254|NCT00049504|12070321|FG000|STARTED|Overall Study||55
10904255|NCT00049504|12070321|FG000|COMPLETED|Overall Study||55
10904256|NCT00049504|12070321|FG000|NOT COMPLETED|Overall Study||0
10904257|NCT00049517|12070327|FG000|STARTED|Induction||79
10904258|NCT00049517|12070328|FG001|STARTED|Induction||90
10904259|NCT00049517|12070329|FG002|STARTED|Induction||63
10904260|NCT00049517|12070330|FG003|STARTED|Induction||75
10904261|NCT00049517|12070331|FG004|STARTED|Induction||188
10904262|NCT00049517|12070332|FG005|STARTED|Induction||162
10904263|NCT00049517|12070327|FG000|Treated|Induction||79
10904264|NCT00049517|12070328|FG001|Treated|Induction||90
10904265|NCT00049517|12070329|FG002|Treated|Induction||63
10904266|NCT00049517|12070330|FG003|Treated|Induction||75
10904267|NCT00049517|12070331|FG004|Treated|Induction||186
10904268|NCT00049517|12070332|FG005|Treated|Induction||160
10904269|NCT00049517|12070327|FG000|COMPLETED|Induction||79
10904270|NCT00049517|12070328|FG001|COMPLETED|Induction||90
10904271|NCT00049517|12070329|FG002|COMPLETED|Induction||63
10904272|NCT00049517|12070330|FG003|COMPLETED|Induction||75
10904273|NCT00049517|12070331|FG004|COMPLETED|Induction||128
10904274|NCT00049517|12070332|FG005|COMPLETED|Induction||108
10904275|NCT00049517|12070327|FG000|NOT COMPLETED|Induction||0
10904276|NCT00049517|12070328|FG001|NOT COMPLETED|Induction||0
10904277|NCT00049517|12070329|FG002|NOT COMPLETED|Induction||0
10904278|NCT00049517|12070330|FG003|NOT COMPLETED|Induction||0
10904279|NCT00049517|12070331|FG004|NOT COMPLETED|Induction||60
10904280|NCT00049517|12070332|FG005|NOT COMPLETED|Induction||54
10904281|NCT00049517|12070327|FG000|STARTED|Conditioning/Transplant||79
10904282|NCT00049517|12070328|FG001|STARTED|Conditioning/Transplant||90
10904283|NCT00049517|12070329|FG002|STARTED|Conditioning/Transplant||63
10904284|NCT00049517|12070330|FG003|STARTED|Conditioning/Transplant||75
10904285|NCT00049517|12070331|FG004|STARTED|Conditioning/Transplant||21
10904286|NCT00049517|12070332|FG005|STARTED|Conditioning/Transplant||24
10904287|NCT00049517|12070327|FG000|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
10904288|NCT00049517|12070328|FG001|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
10904289|NCT00049517|12070329|FG002|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
10904290|NCT00049517|12070330|FG003|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
10904291|NCT00049517|12070331|FG004|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
10904292|NCT00049517|12070332|FG005|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
10904293|NCT00049517|12070327|FG000|COMPLETED|Conditioning/Transplant||27
10904294|NCT00049517|12070328|FG001|COMPLETED|Conditioning/Transplant||40
10904295|NCT00049517|12070329|FG002|COMPLETED|Conditioning/Transplant||25
10904296|NCT00049517|12070330|FG003|COMPLETED|Conditioning/Transplant||32
10904297|NCT00049517|12070331|FG004|COMPLETED|Conditioning/Transplant||15
10904298|NCT00049517|12070332|FG005|COMPLETED|Conditioning/Transplant||18
10904299|NCT00049517|12070327|FG000|NOT COMPLETED|Conditioning/Transplant||52
10904300|NCT00049517|12070328|FG001|NOT COMPLETED|Conditioning/Transplant||50
10904301|NCT00049517|12070329|FG002|NOT COMPLETED|Conditioning/Transplant||38
10904302|NCT00049517|12070330|FG003|NOT COMPLETED|Conditioning/Transplant||43
10904303|NCT00049517|12070331|FG004|NOT COMPLETED|Conditioning/Transplant||6
10904304|NCT00049517|12070332|FG005|NOT COMPLETED|Conditioning/Transplant||6
10904305|NCT00049530|12070340|FG000|STARTED|Overall Study||32
10904306|NCT00049530|12070340|FG000|Eligible and Treated|Overall Study||29
10904307|NCT00049530|12070340|FG000|COMPLETED|Overall Study||0
10904308|NCT00049530|12070340|FG000|NOT COMPLETED|Overall Study||32
10904309|NCT00049543|12070346|FG000|STARTED|Overall Study||251
10904310|NCT00049543|12070347|FG001|STARTED|Overall Study||252
10904311|NCT00049543|12070346|FG000|COMPLETED|Overall Study||249
10904312|NCT00049543|12070347|FG001|COMPLETED|Overall Study||243
10904313|NCT00049543|12070346|FG000|NOT COMPLETED|Overall Study||2
10904314|NCT00049543|12070347|FG001|NOT COMPLETED|Overall Study||9
10904315|NCT00049673|12070355|FG000|STARTED|Overall Study||166
10904316|NCT00049673|12070356|FG001|STARTED|Overall Study||166
10904317|NCT00049673|12070355|FG000|COMPLETED|Overall Study||165
10904318|NCT00049673|12070356|FG001|COMPLETED|Overall Study||163
10904319|NCT00049673|12070355|FG000|NOT COMPLETED|Overall Study||1
10904320|NCT00049673|12070356|FG001|NOT COMPLETED|Overall Study||3
10904321|NCT00049842|12070364|FG000|STARTED|Treatment Phase||270
10904322|NCT00049842|12070365|FG001|STARTED|Treatment Phase||270
10904323|NCT00049842|12070364|FG000|COMPLETED|Treatment Phase||177
10904324|NCT00049842|12070365|FG001|COMPLETED|Treatment Phase||192
10904325|NCT00049842|12070364|FG000|NOT COMPLETED|Treatment Phase||93
10904326|NCT00049842|12070365|FG001|NOT COMPLETED|Treatment Phase||78
10904327|NCT00049842|12070364|FG000|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
10904328|NCT00049842|12070365|FG001|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
10904329|NCT00049842|12070364|FG000|COMPLETED|Follow-up Phase||211
10904330|NCT00049842|12070365|FG001|COMPLETED|Follow-up Phase||189
10904331|NCT00049842|12070364|FG000|NOT COMPLETED|Follow-up Phase||7
10904332|NCT00049842|12070365|FG001|NOT COMPLETED|Follow-up Phase||5
10904333|NCT00050011|12070373|FG000|STARTED|Overall Study||301
10904334|NCT00050011|12070374|FG001|STARTED|Overall Study||301
10904335|NCT00050011|12070373|FG000|Intent-to-treat Population|Overall Study||300
10904336|NCT00050011|12070374|FG001|Intent-to-treat Population|Overall Study||300
10904337|NCT00050011|12070373|FG000|COMPLETED|Overall Study||180
10904338|NCT00050011|12070374|FG001|COMPLETED|Overall Study||175
10904339|NCT00050011|12070373|FG000|NOT COMPLETED|Overall Study||121
10904340|NCT00050011|12070374|FG001|NOT COMPLETED|Overall Study||126
10904341|NCT00050089|12070385|FG000|STARTED|Overall Study||106
10904342|NCT00050089|12070386|FG001|STARTED|Overall Study||98
10904343|NCT00050089|12070387|FG002|STARTED|Overall Study||86
10904344|NCT00050089|12070388|FG003|STARTED|Overall Study||78
10904345|NCT00050089|12070385|FG000|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
10904346|NCT00050089|12070386|FG001|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
10904347|NCT00050089|12070387|FG002|Baseline|Overall Study||86
10904348|NCT00050089|12070388|FG003|Baseline|Overall Study||78
10904349|NCT00050089|12070385|FG000|COMPLETED|Overall Study|For primary outcome assessment|106
10904350|NCT00050089|12070386|FG001|COMPLETED|Overall Study|For primary outcome assessment|98
10904351|NCT00050089|12070387|FG002|COMPLETED|Overall Study|For primary outcome assessment|86
10904352|NCT00050089|12070388|FG003|COMPLETED|Overall Study|For primary outcome assessment|78
10904353|NCT00050089|12070385|FG000|NOT COMPLETED|Overall Study||0
10904354|NCT00050089|12070386|FG001|NOT COMPLETED|Overall Study||0
10904355|NCT00050089|12070387|FG002|NOT COMPLETED|Overall Study||0
10904356|NCT00050089|12070388|FG003|NOT COMPLETED|Overall Study||0
10904357|NCT00050167|12070404|FG000|STARTED|Overall Study||302
10904358|NCT00050167|12070405|FG001|STARTED|Overall Study||301
10904359|NCT00050167|12070404|FG000|COMPLETED|Overall Study||301
10904360|NCT00050167|12070405|FG001|COMPLETED|Overall Study||300
10904361|NCT00050167|12070404|FG000|NOT COMPLETED|Overall Study||1
10904362|NCT00050167|12070405|FG001|NOT COMPLETED|Overall Study||1
10904363|NCT00050622|12070411|FG000|STARTED|Overall Study||154
10904364|NCT00050622|12070411|FG000|COMPLETED|Overall Study||153
10904365|NCT00050622|12070411|FG000|NOT COMPLETED|Overall Study||1
10904366|NCT00050778|12070438|FG000|STARTED|Overall Study|Randomized.|111
10904367|NCT00050778|12070439|FG001|STARTED|Overall Study||113
10904368|NCT00050778|12070440|FG002|STARTED|Overall Study||110
10904369|NCT00050778|12070438|FG000|Treated|Overall Study||107
10904370|NCT00050778|12070439|FG001|Treated|Overall Study||108
10904371|NCT00050778|12070440|FG002|Treated|Overall Study||108
10904372|NCT00050778|12070438|FG000|COMPLETED|Overall Study||66
10904373|NCT00050778|12070439|FG001|COMPLETED|Overall Study||92
10904374|NCT00050778|12070440|FG002|COMPLETED|Overall Study||92
10904375|NCT00050778|12070438|FG000|NOT COMPLETED|Overall Study||45
10904376|NCT00050778|12070439|FG001|NOT COMPLETED|Overall Study||21
10904377|NCT00050778|12070440|FG002|NOT COMPLETED|Overall Study||18
10904378|NCT00050960|12070452|FG000|STARTED|Overall Study||306
10904379|NCT00050960|12070453|FG001|STARTED|Overall Study||306
10904380|NCT00050960|12070452|FG000|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
10904381|NCT00050960|12070453|FG001|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
10904382|NCT00050960|12070452|FG000|NOT COMPLETED|Overall Study||302
10904383|NCT00050960|12070453|FG001|NOT COMPLETED|Overall Study||304
10904384|NCT00050986|12070459|FG000|STARTED|Overall Study||55
10904385|NCT00050986|12070459|FG000|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
10904386|NCT00050986|12070459|FG000|NOT COMPLETED|Overall Study||2
10904387|NCT00051025|12070465|FG000|STARTED|Overall Study||5
10904388|NCT00051025|12070466|FG001|STARTED|Overall Study||4
10904389|NCT00051025|12070465|FG000|COMPLETED|Overall Study||3
10904390|NCT00051025|12070466|FG001|COMPLETED|Overall Study||0
10904391|NCT00051025|12070465|FG000|NOT COMPLETED|Overall Study||2
10904392|NCT00051025|12070466|FG001|NOT COMPLETED|Overall Study||4
10904393|NCT00051168|12070472|FG000|STARTED|Overall Study||502
10904394|NCT00051168|12070472|FG000|COMPLETED|Overall Study||367
10904395|NCT00051168|12070472|FG000|NOT COMPLETED|Overall Study||135
10904396|NCT00051311|12070478|FG000|STARTED|Overall Study||31
10904397|NCT00051311|12070479|FG001|STARTED|Overall Study||31
10904398|NCT00051311|12070478|FG000|COMPLETED|Overall Study||19
10904399|NCT00051311|12070479|FG001|COMPLETED|Overall Study||17
10904400|NCT00051311|12070478|FG000|NOT COMPLETED|Overall Study||12
10904401|NCT00051311|12070479|FG001|NOT COMPLETED|Overall Study||14
10904402|NCT00051363|12070485|FG000|STARTED|Overall Study||558
10904403|NCT00051363|12070486|FG001|STARTED|Overall Study||547
10904404|NCT00051363|12070485|FG000|Randomized & Analyzed|Overall Study||556
10904405|NCT00051363|12070486|FG001|Randomized & Analyzed|Overall Study||542
10904406|NCT00051363|12070485|FG000|Completed 2M Visit On-Treatment|Overall Study||456
10904407|NCT00051363|12070486|FG001|Completed 2M Visit On-Treatment|Overall Study||417
10904408|NCT00051363|12070485|FG000|Completed 2M Visit On-Study|Overall Study||468
10904409|NCT00051363|12070486|FG001|Completed 2M Visit On-Study|Overall Study||432
10904410|NCT00051363|12070485|FG000|Completed 6M Visit On-Treatment|Overall Study||427
10904411|NCT00051363|12070486|FG001|Completed 6M Visit On-Treatment|Overall Study||372
10904412|NCT00051363|12070485|FG000|Completed 6M Vist On-Study|Overall Study||443
10904413|NCT00051363|12070486|FG001|Completed 6M Vist On-Study|Overall Study||403
10904414|NCT00051363|12070485|FG000|COMPLETED|Overall Study||443
10904415|NCT00051363|12070486|FG001|COMPLETED|Overall Study||403
10904416|NCT00051363|12070485|FG000|NOT COMPLETED|Overall Study||115
10904417|NCT00051363|12070486|FG001|NOT COMPLETED|Overall Study||144
10904418|NCT00051558|12070494|FG000|STARTED|Overall Study||214
10904419|NCT00051558|12070495|FG001|STARTED|Overall Study||214
10904420|NCT00051558|12070494|FG000|COMPLETED|Overall Study||123
10904421|NCT00051558|12070495|FG001|COMPLETED|Overall Study||118
10904422|NCT00051558|12070494|FG000|NOT COMPLETED|Overall Study||91
10904423|NCT00051558|12070495|FG001|NOT COMPLETED|Overall Study||96
10904424|NCT00051636|12070503|FG000|STARTED|Period 1 - Core||90
10904425|NCT00051636|12070504|FG001|STARTED|Period 1 - Core||82
10904426|NCT00051636|12070503|FG000|COMPLETED|Period 1 - Core||86
10904427|NCT00051636|12070504|FG001|COMPLETED|Period 1 - Core||76
10904428|NCT00051636|12070503|FG000|NOT COMPLETED|Period 1 - Core||4
10904429|NCT00051636|12070504|FG001|NOT COMPLETED|Period 1 - Core||6
10904430|NCT00051636|12070503|FG000|STARTED|Period 2- Extended Observation Period||75
10904431|NCT00051636|12070504|FG001|STARTED|Period 2- Extended Observation Period||52
10904432|NCT00051636|12070503|FG000|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
10904433|NCT00051636|12070504|FG001|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
10904434|NCT00051636|12070503|FG000|NOT COMPLETED|Period 2- Extended Observation Period||70
10904435|NCT00051636|12070504|FG001|NOT COMPLETED|Period 2- Extended Observation Period||30
10904436|NCT00052078|12070514|FG000|STARTED|Overall Study||133
10904437|NCT00052078|12070515|FG001|STARTED|Overall Study||139
10904438|NCT00052078|12070516|FG002|STARTED|Overall Study||140
10904439|NCT00052078|12070517|FG003|STARTED|Overall Study||76
10904440|NCT00052078|12070514|FG000|COMPLETED|Overall Study||110
10904441|NCT00052078|12070515|FG001|COMPLETED|Overall Study||133
10904442|NCT00052078|12070516|FG002|COMPLETED|Overall Study||127
10904443|NCT00052078|12070517|FG003|COMPLETED|Overall Study||61
10904444|NCT00052078|12070514|FG000|NOT COMPLETED|Overall Study||23
10904445|NCT00052078|12070515|FG001|NOT COMPLETED|Overall Study||6
10904446|NCT00052078|12070516|FG002|NOT COMPLETED|Overall Study||13
10904447|NCT00052078|12070517|FG003|NOT COMPLETED|Overall Study||15
10904448|NCT00052429|12070527|FG000|STARTED|Overall Study||25
10904449|NCT00052429|12070527|FG000|COMPLETED|Overall Study||25
10904450|NCT00052429|12070527|FG000|NOT COMPLETED|Overall Study||0
10904451|NCT00052442|12070536|FG000|STARTED|Overall Study||16
10904452|NCT00052442|12070537|FG001|STARTED|Overall Study||3
10904453|NCT00052442|12070538|FG002|STARTED|Overall Study||27
10904454|NCT00052442|12070539|FG003|STARTED|Overall Study||11
10904455|NCT00052442|12070540|FG004|STARTED|Overall Study||15
10904456|NCT00052442|12070536|FG000|COMPLETED|Overall Study||16
10904457|NCT00052442|12070537|FG001|COMPLETED|Overall Study||3
10904458|NCT00052442|12070538|FG002|COMPLETED|Overall Study||27
10904459|NCT00052442|12070539|FG003|COMPLETED|Overall Study||11
10904460|NCT00052442|12070540|FG004|COMPLETED|Overall Study||15
10904461|NCT00052442|12070536|FG000|NOT COMPLETED|Overall Study||0
10904462|NCT00052442|12070537|FG001|NOT COMPLETED|Overall Study||0
10904463|NCT00052442|12070538|FG002|NOT COMPLETED|Overall Study||0
10904464|NCT00052442|12070539|FG003|NOT COMPLETED|Overall Study||0
10904465|NCT00052442|12070540|FG004|NOT COMPLETED|Overall Study||0
10904466|NCT00052715|12070552|FG000|STARTED|Overall Study||31
10904467|NCT00052715|12070552|FG000|COMPLETED|Overall Study||30
10904468|NCT00052715|12070552|FG000|NOT COMPLETED|Overall Study||1
10904469|NCT00052910|12070558|FG000|STARTED|Overall Study||280
10904470|NCT00052910|12070559|FG001|STARTED|Overall Study||266
10904471|NCT00052910|12070558|FG000|COMPLETED|Overall Study||280
10904472|NCT00052910|12070559|FG001|COMPLETED|Overall Study||266
10904473|NCT00052910|12070558|FG000|NOT COMPLETED|Overall Study||0
10904474|NCT00052910|12070559|FG001|NOT COMPLETED|Overall Study||0
10904475|NCT00052962|12070567|FG000|STARTED|Overall Study||13
10904476|NCT00052962|12070568|FG001|STARTED|Overall Study||17
10904477|NCT00052962|12070567|FG000|COMPLETED|Overall Study||12
10904478|NCT00052962|12070568|FG001|COMPLETED|Overall Study||15
10904479|NCT00052962|12070567|FG000|NOT COMPLETED|Overall Study||1
10904480|NCT00052962|12070568|FG001|NOT COMPLETED|Overall Study||2
10904481|NCT00053014|12070574|FG000|STARTED|Overall Study||5
10904482|NCT00053014|12070574|FG000|COMPLETED|Overall Study||5
10904483|NCT00053014|12070574|FG000|NOT COMPLETED|Overall Study||0
10904484|NCT00053352|12070580|FG000|STARTED|Overall Study||190
10904485|NCT00053352|12070581|FG001|STARTED|Overall Study||112
10904486|NCT00053352|12070580|FG000|COMPLETED|Overall Study||169
10904487|NCT00053352|12070581|FG001|COMPLETED|Overall Study||102
10904488|NCT00053352|12070580|FG000|NOT COMPLETED|Overall Study||21
10904489|NCT00053352|12070581|FG001|NOT COMPLETED|Overall Study||10
10904490|NCT00053365|12070588|FG000|STARTED|Overall Study||61
10904491|NCT00053365|12070588|FG000|COMPLETED|Overall Study||55
10904492|NCT00053365|12070588|FG000|NOT COMPLETED|Overall Study||6
10904493|NCT00053417|12070598|FG000|STARTED|Overall Study||47
10904494|NCT00053417|12070599|FG001|STARTED|Overall Study||52
10904495|NCT00053417|12070600|FG002|STARTED|Overall Study||50
10904496|NCT00053417|12070601|FG003|STARTED|Overall Study||57
10904497|NCT00053417|12070598|FG000|COMPLETED|Overall Study||45
10904498|NCT00053417|12070599|FG001|COMPLETED|Overall Study||50
10904499|NCT00053417|12070600|FG002|COMPLETED|Overall Study||49
10904500|NCT00053417|12070601|FG003|COMPLETED|Overall Study||51
10904501|NCT00053417|12070598|FG000|NOT COMPLETED|Overall Study||2
10904502|NCT00053417|12070599|FG001|NOT COMPLETED|Overall Study||2
10904503|NCT00053417|12070600|FG002|NOT COMPLETED|Overall Study||1
10904504|NCT00053417|12070601|FG003|NOT COMPLETED|Overall Study||6
10904505|NCT00053482|12070616|FG000|STARTED|Overall Study||51
10904506|NCT00053482|12070617|FG001|STARTED|Overall Study||102
10904507|NCT00053482|12070618|FG002|STARTED|Overall Study||102
10904508|NCT00053482|12070619|FG003|STARTED|Overall Study||50
10904509|NCT00053482|12070620|FG004|STARTED|Overall Study||52
10904510|NCT00053482|12070616|FG000|COMPLETED|Overall Study||51
10904511|NCT00053482|12070617|FG001|COMPLETED|Overall Study||102
10904512|NCT00053482|12070618|FG002|COMPLETED|Overall Study||102
10904513|NCT00053482|12070619|FG003|COMPLETED|Overall Study||50
10904514|NCT00053482|12070620|FG004|COMPLETED|Overall Study||52
10904515|NCT00053482|12070616|FG000|NOT COMPLETED|Overall Study||0
10904516|NCT00053482|12070617|FG001|NOT COMPLETED|Overall Study||0
10904517|NCT00053482|12070618|FG002|NOT COMPLETED|Overall Study||0
10904518|NCT00053482|12070619|FG003|NOT COMPLETED|Overall Study||0
10904519|NCT00053482|12070620|FG004|NOT COMPLETED|Overall Study||0
10904520|NCT00041392|12070634|FG000|STARTED|Overall Study||198
10904521|NCT00041392|12070635|FG001|STARTED|Overall Study||191
10904522|NCT00041392|12070634|FG000|COMPLETED|Overall Study||198
10904523|NCT00041392|12070635|FG001|COMPLETED|Overall Study||191
10904524|NCT00041392|12070634|FG000|NOT COMPLETED|Overall Study||0
10904525|NCT00041392|12070635|FG001|NOT COMPLETED|Overall Study||0
10904526|NCT00053495|12070646|FG000|STARTED|Overall Study||51
10904527|NCT00053495|12070647|FG001|STARTED|Overall Study||101
10904528|NCT00053495|12070648|FG002|STARTED|Overall Study||101
10904529|NCT00053495|12070649|FG003|STARTED|Overall Study||51
10904530|NCT00053495|12070650|FG004|STARTED|Overall Study||49
10904531|NCT00053495|12070646|FG000|COMPLETED|Overall Study||51
10904532|NCT00053495|12070647|FG001|COMPLETED|Overall Study||101
10904533|NCT00053495|12070648|FG002|COMPLETED|Overall Study||101
10904534|NCT00053495|12070649|FG003|COMPLETED|Overall Study||51
10904535|NCT00053495|12070650|FG004|COMPLETED|Overall Study||49
10904536|NCT00053495|12070646|FG000|NOT COMPLETED|Overall Study||0
10904537|NCT00053495|12070647|FG001|NOT COMPLETED|Overall Study||0
10904538|NCT00053495|12070648|FG002|NOT COMPLETED|Overall Study||0
10904539|NCT00053495|12070649|FG003|NOT COMPLETED|Overall Study||0
10904540|NCT00053495|12070650|FG004|NOT COMPLETED|Overall Study||0
10904541|NCT00053677|12070664|FG000|STARTED|Overall Study||58
10904542|NCT00053677|12070665|FG001|STARTED|Overall Study||19
10904543|NCT00053677|12070664|FG000|COMPLETED|Overall Study||36
10904544|NCT00053677|12070665|FG001|COMPLETED|Overall Study||13
10904545|NCT00053677|12070664|FG000|NOT COMPLETED|Overall Study||22
10904546|NCT00053677|12070665|FG001|NOT COMPLETED|Overall Study||6
10904547|NCT00053703|12070674|FG000|STARTED|Overall Study||35
10904548|NCT00053703|12070675|FG001|STARTED|Overall Study||41
10904549|NCT00053703|12070676|FG002|STARTED|Overall Study||40
10904550|NCT00053703|12070674|FG000|COMPLETED|Overall Study||17
10904551|NCT00053703|12070675|FG001|COMPLETED|Overall Study||28
10904552|NCT00053703|12070676|FG002|COMPLETED|Overall Study||25
10904553|NCT00053703|12070674|FG000|NOT COMPLETED|Overall Study||18
10904554|NCT00053703|12070675|FG001|NOT COMPLETED|Overall Study||13
10904555|NCT00053703|12070676|FG002|NOT COMPLETED|Overall Study||15
10904556|NCT00053846|12070686|FG000|STARTED|Overall Study||213
10904557|NCT00053846|12070687|FG001|STARTED|Overall Study||219
10904558|NCT00053846|12070686|FG000|COMPLETED|Overall Study||187
10904559|NCT00053846|12070687|FG001|COMPLETED|Overall Study||192
10904560|NCT00053846|12070686|FG000|NOT COMPLETED|Overall Study||26
10904561|NCT00053846|12070687|FG001|NOT COMPLETED|Overall Study||27
10904562|NCT00053898|12070695|FG000|STARTED|Overall Study||1552
10904563|NCT00053898|12070696|FG001|STARTED|Overall Study||1552
10904564|NCT00053898|12070695|FG000|COMPLETED|Overall Study||1538
10904565|NCT00053898|12070696|FG001|COMPLETED|Overall Study||1539
10904566|NCT00053898|12070695|FG000|NOT COMPLETED|Overall Study||14
10904567|NCT00053898|12070696|FG001|NOT COMPLETED|Overall Study||13
10904568|NCT00053989|12070702|FG000|STARTED|Overall Study||41
10904569|NCT00053989|12070702|FG000|COMPLETED|Overall Study||41
10904570|NCT00053989|12070702|FG000|NOT COMPLETED|Overall Study||0
10904571|NCT00054028|12070708|FG000|STARTED|Overall Study||31
10904572|NCT00054028|12070708|FG000|Phase I|Overall Study||9
10904573|NCT00054028|12070708|FG000|Phase II|Overall Study||22
10904574|NCT00054028|12070708|FG000|COMPLETED|Overall Study||31
10904575|NCT00054028|12070708|FG000|NOT COMPLETED|Overall Study||0
10904576|NCT00054132|12070713|FG000|STARTED|Overall Study||38
10904577|NCT00054132|12070713|FG000|COMPLETED|Overall Study||37
10904578|NCT00054132|12070713|FG000|NOT COMPLETED|Overall Study||1
10904579|NCT00054275|12070718|FG000|STARTED|Overall Study||39
10904580|NCT00054275|12070718|FG000|COMPLETED|Overall Study||28
10904581|NCT00054275|12070718|FG000|NOT COMPLETED|Overall Study||11
10904582|NCT00054327|12070728|FG000|STARTED|Overall Study||11
10904583|NCT00054327|12070729|FG001|STARTED|Overall Study||4
10904584|NCT00054327|12070730|FG002|STARTED|Overall Study||3
10904585|NCT00054327|12070731|FG003|STARTED|Overall Study||4
10904586|NCT00054327|12070732|FG004|STARTED|Overall Study||10
10904587|NCT00054327|12070733|FG005|STARTED|Overall Study||2
10904588|NCT00054327|12070728|FG000|COMPLETED|Overall Study||10
10904589|NCT00054327|12070729|FG001|COMPLETED|Overall Study||4
10904590|NCT00054327|12070730|FG002|COMPLETED|Overall Study||3
10904591|NCT00054327|12070731|FG003|COMPLETED|Overall Study||4
10904592|NCT00054327|12070732|FG004|COMPLETED|Overall Study||10
10904593|NCT00054327|12070733|FG005|COMPLETED|Overall Study||2
10904594|NCT00054327|12070728|FG000|NOT COMPLETED|Overall Study||1
10904595|NCT00054327|12070729|FG001|NOT COMPLETED|Overall Study||0
10904596|NCT00054327|12070730|FG002|NOT COMPLETED|Overall Study||0
10904597|NCT00054327|12070731|FG003|NOT COMPLETED|Overall Study||0
10904598|NCT00054327|12070732|FG004|NOT COMPLETED|Overall Study||0
10904599|NCT00054327|12070733|FG005|NOT COMPLETED|Overall Study||0
10904600|NCT00054353|12070749|FG000|STARTED|Overall Study||12
10904601|NCT00054353|12070750|FG001|STARTED|Overall Study||4
10904602|NCT00054353|12070749|FG000|COMPLETED|Overall Study||12
10904603|NCT00054353|12070750|FG001|COMPLETED|Overall Study||4
10904604|NCT00054353|12070749|FG000|NOT COMPLETED|Overall Study||0
10904605|NCT00054353|12070750|FG001|NOT COMPLETED|Overall Study||0
10904606|NCT00054639|12070760|FG000|STARTED|Overall Study||48
10904607|NCT00054639|12070760|FG000|COMPLETED|Overall Study||46
10904608|NCT00054639|12070760|FG000|NOT COMPLETED|Overall Study||2
10904609|NCT00054665|12070764|FG000|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
10904610|NCT00054665|12070765|FG001|STARTED|Part A||0
10904611|NCT00054665|12070764|FG000|COMPLETED|Part A||23
10904612|NCT00054665|12070765|FG001|COMPLETED|Part A||0
10904613|NCT00054665|12070764|FG000|NOT COMPLETED|Part A||0
10904614|NCT00054665|12070765|FG001|NOT COMPLETED|Part A||0
10904615|NCT00054665|12070764|FG000|STARTED|Part B||0
10904616|NCT00054665|12070765|FG001|STARTED|Part B|26 participants received only Part B|44
10904617|NCT00054665|12070764|FG000|COMPLETED|Part B||0
10904618|NCT00054665|12070765|FG001|COMPLETED|Part B||44
10904619|NCT00054665|12070764|FG000|NOT COMPLETED|Part B||0
10904620|NCT00054665|12070765|FG001|NOT COMPLETED|Part B||0
10904621|NCT00054691|12070773|FG000|STARTED|Overall Study||40
10904622|NCT00054691|12070773|FG000|COMPLETED|Overall Study||37
10904623|NCT00054691|12070773|FG000|NOT COMPLETED|Overall Study||3
10904624|NCT00054704|12070779|FG000|STARTED|Overall Study||8
10904625|NCT00054704|12070780|FG001|STARTED|Overall Study||11
10904626|NCT00054704|12070779|FG000|COMPLETED|Overall Study||3
10904627|NCT00054704|12070780|FG001|COMPLETED|Overall Study||6
10904628|NCT00054704|12070779|FG000|NOT COMPLETED|Overall Study||5
10904629|NCT00054704|12070780|FG001|NOT COMPLETED|Overall Study||5
10904630|NCT00054717|12070788|FG000|STARTED|Overall Study||313
10904631|NCT00054717|12070789|FG001|STARTED|Overall Study||317
10904632|NCT00054717|12070788|FG000|COMPLETED|Overall Study||51
10904633|NCT00054717|12070789|FG001|COMPLETED|Overall Study||18
10904634|NCT00054717|12070788|FG000|NOT COMPLETED|Overall Study||262
10904635|NCT00054717|12070789|FG001|NOT COMPLETED|Overall Study||299
10904636|NCT00054756|12070795|FG000|STARTED|Overall Study||96
10904637|NCT00054756|12070795|FG000|COMPLETED|Overall Study||94
10904638|NCT00054756|12070795|FG000|NOT COMPLETED|Overall Study||2
10904639|NCT00054847|12070801|FG000|STARTED|Overall Study||367
10904640|NCT00054847|12070802|FG001|STARTED|Overall Study||366
10904641|NCT00054847|12070801|FG000|COMPLETED|Overall Study||269
10904642|NCT00054847|12070802|FG001|COMPLETED|Overall Study||266
10904643|NCT00054847|12070801|FG000|NOT COMPLETED|Overall Study||98
10904644|NCT00054847|12070802|FG001|NOT COMPLETED|Overall Study||100
10904645|NCT00055237|12070814|FG000|STARTED|Overall Study||17
10904646|NCT00055237|12070815|FG001|STARTED|Overall Study||2
10904647|NCT00055237|12070814|FG000|COMPLETED|Overall Study||17
10904648|NCT00055237|12070815|FG001|COMPLETED|Overall Study||2
10904649|NCT00055237|12070814|FG000|NOT COMPLETED|Overall Study||0
10904650|NCT00055237|12070815|FG001|NOT COMPLETED|Overall Study||0
10904651|NCT00055471|12070823|FG000|STARTED|Period 1: Dose Escalation Period||3
10904652|NCT00055471|12070824|FG001|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
10904653|NCT00055471|12070825|FG002|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
10904654|NCT00055471|12070823|FG000|COMPLETED|Period 1: Dose Escalation Period||3
10904655|NCT00055471|12070824|FG001|COMPLETED|Period 1: Dose Escalation Period||8
10904656|NCT00055471|12070825|FG002|COMPLETED|Period 1: Dose Escalation Period||0
10904657|NCT00055471|12070823|FG000|NOT COMPLETED|Period 1: Dose Escalation Period||0
10904658|NCT00055471|12070824|FG001|NOT COMPLETED|Period 1: Dose Escalation Period||2
10904659|NCT00055471|12070825|FG002|NOT COMPLETED|Period 1: Dose Escalation Period||3
10904660|NCT00055471|12070823|FG000|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
10904661|NCT00055471|12070824|FG001|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
10904662|NCT00055471|12070825|FG002|STARTED|Period 2: Extension Period||0
10904663|NCT00055471|12070823|FG000|COMPLETED|Period 2: Extension Period||3
10904664|NCT00055471|12070824|FG001|COMPLETED|Period 2: Extension Period||6
10904665|NCT00055471|12070825|FG002|COMPLETED|Period 2: Extension Period||0
10904666|NCT00055471|12070823|FG000|NOT COMPLETED|Period 2: Extension Period||0
10904667|NCT00055471|12070824|FG001|NOT COMPLETED|Period 2: Extension Period||0
10904668|NCT00055471|12070825|FG002|NOT COMPLETED|Period 2: Extension Period||0
10904669|NCT00055497|12070837|FG000|STARTED|Overall Study||18
10904670|NCT00055497|12070838|FG001|STARTED|Overall Study||19
10904671|NCT00055497|12070839|FG002|STARTED|Overall Study||18
10904672|NCT00055497|12070840|FG003|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
10904673|NCT00055497|12070837|FG000|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
10904674|NCT00055497|12070838|FG001|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
10904675|NCT00055497|12070839|FG002|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
10904676|NCT00055497|12070840|FG003|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
10904677|NCT00055497|12070837|FG000|NOT COMPLETED|Overall Study||5
10904678|NCT00055497|12070838|FG001|NOT COMPLETED|Overall Study||3
10904679|NCT00055497|12070839|FG002|NOT COMPLETED|Overall Study||2
10904680|NCT00055497|12070840|FG003|NOT COMPLETED|Overall Study||90
10904681|NCT00055601|12070857|FG000|STARTED|Overall Study||48
10904682|NCT00055601|12070858|FG001|STARTED|Overall Study||49
10904683|NCT00055601|12070857|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
10904684|NCT00055601|12070858|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
10904685|NCT00055601|12070857|FG000|NOT COMPLETED|Overall Study||2
10904686|NCT00055601|12070858|FG001|NOT COMPLETED|Overall Study||2
10904687|NCT00055692|12070864|FG000|STARTED|Overall Study||46
10904688|NCT00055692|12070864|FG000|COMPLETED|Overall Study||46
10904689|NCT00055692|12070864|FG000|NOT COMPLETED|Overall Study||0
10904690|NCT00056160|12070872|FG000|STARTED|Up to Unblinding (07 Jun 2005)||177
10904691|NCT00056160|12070873|FG001|STARTED|Up to Unblinding (07 Jun 2005)||176
10904692|NCT00056160|12070872|FG000|COMPLETED|Up to Unblinding (07 Jun 2005)||64
10904693|NCT00056160|12070873|FG001|COMPLETED|Up to Unblinding (07 Jun 2005)||13
10904694|NCT00056160|12070872|FG000|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
10904695|NCT00056160|12070873|FG001|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
10904696|NCT00056160|12070872|FG000|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
10904697|NCT00056160|12070873|FG001|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
10904698|NCT00056160|12070872|FG000|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
10904699|NCT00056160|12070873|FG001|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
10904700|NCT00056160|12070872|FG000|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
10904701|NCT00056160|12070873|FG001|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
10904702|NCT00056160|12070872|FG000|STARTED|Final Follow-up||6
10904703|NCT00056160|12070873|FG001|STARTED|Final Follow-up||0
10904704|NCT00056160|12070872|FG000|COMPLETED|Final Follow-up||0
10904705|NCT00056160|12070873|FG001|COMPLETED|Final Follow-up||0
10904706|NCT00056160|12070872|FG000|NOT COMPLETED|Final Follow-up||6
10904707|NCT00056160|12070873|FG001|NOT COMPLETED|Final Follow-up||0
10904708|NCT00056316|12070881|FG000|STARTED|Overall Study||33
10904709|NCT00056316|12070882|FG001|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
10904710|NCT00056316|12070881|FG000|COMPLETED|Overall Study||30
10904711|NCT00056316|12070882|FG001|COMPLETED|Overall Study||38
10904712|NCT00056316|12070881|FG000|NOT COMPLETED|Overall Study||3
10904713|NCT00056316|12070882|FG001|NOT COMPLETED|Overall Study||3
10904714|NCT00056407|12070890|FG000|STARTED|Overall Study||4126
10904715|NCT00056407|12070891|FG001|STARTED|Overall Study||4105
10904716|NCT00056407|12070890|FG000|COMPLETED|Overall Study||2915
10904717|NCT00056407|12070891|FG001|COMPLETED|Overall Study||2912
10904718|NCT00056407|12070890|FG000|NOT COMPLETED|Overall Study||1211
10904719|NCT00056407|12070891|FG001|NOT COMPLETED|Overall Study||1193
10904720|NCT00056472|12070899|FG000|STARTED|Overall Study||129
10904721|NCT00056472|12070900|FG001|STARTED|Overall Study||130
10904722|NCT00056472|12070899|FG000|COMPLETED|Overall Study||81
10904723|NCT00056472|12070900|FG001|COMPLETED|Overall Study||61
10904724|NCT00056472|12070899|FG000|NOT COMPLETED|Overall Study||48
10904725|NCT00056472|12070900|FG001|NOT COMPLETED|Overall Study||69
10904726|NCT00056498|12070908|FG000|STARTED|Overall Study||30
10904727|NCT00056498|12070909|FG001|STARTED|Overall Study||35
10904728|NCT00056498|12070908|FG000|COMPLETED|Overall Study||25
10904729|NCT00056498|12070909|FG001|COMPLETED|Overall Study||28
10904730|NCT00056498|12070908|FG000|NOT COMPLETED|Overall Study||5
10904731|NCT00056498|12070909|FG001|NOT COMPLETED|Overall Study||7
10904732|NCT00056550|12070915|FG000|STARTED|Overall Study||14
10904733|NCT00056550|12070915|FG000|COMPLETED|Overall Study||14
10904734|NCT00056550|12070915|FG000|NOT COMPLETED|Overall Study||0
10904735|NCT00056563|12070922|FG000|STARTED|Overall Study||121
10904736|NCT00056563|12070923|FG001|STARTED|Overall Study||134
10904737|NCT00056563|12070922|FG000|COMPLETED|Overall Study||121
10904738|NCT00056563|12070923|FG001|COMPLETED|Overall Study||134
10904739|NCT00056563|12070922|FG000|NOT COMPLETED|Overall Study||0
10904740|NCT00056563|12070923|FG001|NOT COMPLETED|Overall Study||0
10904741|NCT00056862|12070931|FG000|STARTED|Overall Study||31
10904742|NCT00056862|12070932|FG001|STARTED|Overall Study||27
10904743|NCT00056862|12070931|FG000|COMPLETED|Overall Study||30
10904744|NCT00056862|12070932|FG001|COMPLETED|Overall Study||27
10904745|NCT00056862|12070931|FG000|NOT COMPLETED|Overall Study||1
10904746|NCT00056862|12070932|FG001|NOT COMPLETED|Overall Study||0
10904747|NCT00057330|12070940|FG000|STARTED|Overall Study||4577
10904748|NCT00057330|12070941|FG001|STARTED|Overall Study||3746
10904749|NCT00057330|12070940|FG000|COMPLETED|Overall Study||3445
10904750|NCT00057330|12070941|FG001|COMPLETED|Overall Study||2826
10904751|NCT00057330|12070940|FG000|NOT COMPLETED|Overall Study||1132
10904752|NCT00057330|12070941|FG001|NOT COMPLETED|Overall Study||920
10904753|NCT00057551|12070950|FG000|STARTED|Overall Study||200
10904754|NCT00057551|12070951|FG001|STARTED|Overall Study||195
10904755|NCT00057551|12070952|FG002|STARTED|Overall Study||96
10904756|NCT00057551|12070950|FG000|COMPLETED|Overall Study||175
10904757|NCT00057551|12070951|FG001|COMPLETED|Overall Study||168
10904758|NCT00057551|12070952|FG002|COMPLETED|Overall Study||80
10904759|NCT00057551|12070950|FG000|NOT COMPLETED|Overall Study||25
10904760|NCT00057551|12070951|FG001|NOT COMPLETED|Overall Study||27
10904761|NCT00057551|12070952|FG002|NOT COMPLETED|Overall Study||16
10904762|NCT00057577|12070962|FG000|STARTED|Overall Study||227
10904763|NCT00057577|12070963|FG001|STARTED|Overall Study||225
10904764|NCT00057577|12070962|FG000|COMPLETED|Overall Study||227
10904765|NCT00057577|12070963|FG001|COMPLETED|Overall Study||225
10904766|NCT00057577|12070962|FG000|NOT COMPLETED|Overall Study||0
10904767|NCT00057577|12070963|FG001|NOT COMPLETED|Overall Study||0
10904768|NCT00057681|12070977|FG000|STARTED|Overall Study||137
10904769|NCT00057681|12070978|FG001|STARTED|Overall Study||139
10904770|NCT00057681|12070979|FG002|STARTED|Overall Study||103
10904771|NCT00057681|12070977|FG000|COMPLETED|Overall Study||72
10904772|NCT00057681|12070978|FG001|COMPLETED|Overall Study||67
10904773|NCT00057681|12070979|FG002|COMPLETED|Overall Study||69
10904774|NCT00057681|12070977|FG000|NOT COMPLETED|Overall Study||65
10904775|NCT00057681|12070978|FG001|NOT COMPLETED|Overall Study||72
10904776|NCT00057681|12070979|FG002|NOT COMPLETED|Overall Study||34
10904777|NCT00057746|12070990|FG000|STARTED|Overall Study||131
10904778|NCT00057746|12070991|FG001|STARTED|Overall Study||67
10904779|NCT00057746|12070992|FG002|STARTED|Overall Study||67
10904780|NCT00057746|12070990|FG000|COMPLETED|Overall Study||131
10904781|NCT00057746|12070991|FG001|COMPLETED|Overall Study||67
10904782|NCT00057746|12070992|FG002|COMPLETED|Overall Study||66
10904783|NCT00057746|12070990|FG000|NOT COMPLETED|Overall Study||0
10904784|NCT00057746|12070991|FG001|NOT COMPLETED|Overall Study||0
10904785|NCT00057746|12070992|FG002|NOT COMPLETED|Overall Study||1
10904786|NCT00057785|12071000|FG000|STARTED|Overall Study||68
10904787|NCT00057785|12071000|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
10904788|NCT00057785|12071000|FG000|NOT COMPLETED|Overall Study||0
10904789|NCT00057811|12071006|FG000|STARTED|Overall Study||51
10904790|NCT00057811|12071007|FG001|STARTED|Overall Study||46
10904791|NCT00057811|12071006|FG000|COMPLETED|Overall Study||41
10904792|NCT00057811|12071007|FG001|COMPLETED|Overall Study||34
10904793|NCT00057811|12071006|FG000|NOT COMPLETED|Overall Study||10
10904794|NCT00057811|12071007|FG001|NOT COMPLETED|Overall Study||12
10904795|NCT00057837|12071015|FG000|STARTED|Overall Study||70
10904796|NCT00057837|12071016|FG001|STARTED|Overall Study||70
10904797|NCT00057837|12071015|FG000|Treated|Overall Study||69
10904798|NCT00057837|12071016|FG001|Treated|Overall Study||68
10904799|NCT00057837|12071015|FG000|Eligible and Treated|Overall Study||66
10904800|NCT00057837|12071016|FG001|Eligible and Treated|Overall Study||66
10904801|NCT00057837|12071015|FG000|Patients With Response|Overall Study||46
10904802|NCT00057837|12071016|FG001|Patients With Response|Overall Study||38
10904803|NCT00057837|12071015|FG000|COMPLETED|Overall Study||39
10904804|NCT00057837|12071016|FG001|COMPLETED|Overall Study||31
10904805|NCT00057837|12071015|FG000|NOT COMPLETED|Overall Study||31
10904806|NCT00057837|12071016|FG001|NOT COMPLETED|Overall Study||39
10904807|NCT00057863|12071022|FG000|STARTED|Overall Study||35
10904808|NCT00057863|12071022|FG000|COMPLETED|Overall Study||32
10904809|NCT00057863|12071022|FG000|NOT COMPLETED|Overall Study||3
10904810|NCT00057876|12071028|FG000|STARTED|Overall Study||38
10904811|NCT00057876|12071029|FG001|STARTED|Overall Study||36
10904812|NCT00057876|12071028|FG000|Eligible|Overall Study||37
10904813|NCT00057876|12071029|FG001|Eligible|Overall Study||34
10904814|NCT00057876|12071028|FG000|Began Protocol Therapy|Overall Study||35
10904815|NCT00057876|12071029|FG001|Began Protocol Therapy|Overall Study||34
10904816|NCT00057876|12071028|FG000|Eligible and Treated|Overall Study||34
10904817|NCT00057876|12071029|FG001|Eligible and Treated|Overall Study||34
10904818|NCT00057876|12071028|FG000|COMPLETED|Overall Study||9
10904819|NCT00057876|12071029|FG001|COMPLETED|Overall Study||9
10904820|NCT00057876|12071028|FG000|NOT COMPLETED|Overall Study||29
10904821|NCT00057876|12071029|FG001|NOT COMPLETED|Overall Study||27
10904822|NCT00057941|12071037|FG000|STARTED|Overall Study||74
10904823|NCT00057941|12071038|FG001|STARTED|Overall Study||74
10904824|NCT00057941|12071037|FG000|Treated|Overall Study||74
10904825|NCT00057941|12071038|FG001|Treated|Overall Study||74
10904826|NCT00057941|12071037|FG000|Eligible|Overall Study||72
10904827|NCT00057941|12071038|FG001|Eligible|Overall Study||69
10904828|NCT00057941|12071037|FG000|COMPLETED|Overall Study||0
10904829|NCT00057941|12071038|FG001|COMPLETED|Overall Study||0
10904830|NCT00057941|12071037|FG000|NOT COMPLETED|Overall Study||74
10904831|NCT00057941|12071038|FG001|NOT COMPLETED|Overall Study||74
10904832|NCT00057954|12071044|FG000|STARTED|Overall Study||6
10904833|NCT00057954|12071044|FG000|COMPLETED|Overall Study||4
10904834|NCT00057954|12071044|FG000|NOT COMPLETED|Overall Study||2
10904835|NCT00058019|12071050|FG000|STARTED|Overall Study||39
10904836|NCT00058019|12071051|FG001|STARTED|Overall Study||12
10904837|NCT00058019|12071050|FG000|COMPLETED|Overall Study||39
10904838|NCT00058019|12071051|FG001|COMPLETED|Overall Study||12
10904839|NCT00058019|12071050|FG000|NOT COMPLETED|Overall Study||0
10904840|NCT00058019|12071051|FG001|NOT COMPLETED|Overall Study||0
10904841|NCT00058058|12071056|FG000|STARTED|Overall Study||1007
10904842|NCT00058058|12071056|FG000|COMPLETED|Overall Study||969
10904843|NCT00058058|12071056|FG000|NOT COMPLETED|Overall Study||38
10904844|NCT00058123|12071061|FG000|STARTED|Overall Study||55
10904845|NCT00058123|12071061|FG000|COMPLETED|Overall Study||45
10904846|NCT00058123|12071061|FG000|NOT COMPLETED|Overall Study||10
10904847|NCT00058214|12071066|FG000|STARTED|Overall Study||25
10904848|NCT00058214|12071066|FG000|COMPLETED|Overall Study||24
10904849|NCT00058214|12071066|FG000|NOT COMPLETED|Overall Study||1
10904850|NCT00058240|12071074|FG000|STARTED|First Dose Level||20
10904851|NCT00058240|12071075|FG001|STARTED|First Dose Level||3
10904852|NCT00058240|12071076|FG002|STARTED|First Dose Level||17
10904853|NCT00058240|12071077|FG003|STARTED|First Dose Level||12
10904854|NCT00058240|12071074|FG000|Treated|First Dose Level||20
10904855|NCT00058240|12071075|FG001|Treated|First Dose Level||3
10904856|NCT00058240|12071076|FG002|Treated|First Dose Level||17
10904857|NCT00058240|12071077|FG003|Treated|First Dose Level||12
10904858|NCT00058240|12071074|FG000|COMPLETED|First Dose Level||20
10904859|NCT00058240|12071075|FG001|COMPLETED|First Dose Level||3
10904860|NCT00058240|12071076|FG002|COMPLETED|First Dose Level||17
10904861|NCT00058240|12071077|FG003|COMPLETED|First Dose Level||12
10904862|NCT00058240|12071074|FG000|NOT COMPLETED|First Dose Level||0
10904863|NCT00058240|12071075|FG001|NOT COMPLETED|First Dose Level||0
10904864|NCT00058240|12071076|FG002|NOT COMPLETED|First Dose Level||0
10904865|NCT00058240|12071077|FG003|NOT COMPLETED|First Dose Level||0
10904866|NCT00058240|12071074|FG000|STARTED|Second Dose Level||0
10904867|NCT00058240|12071075|FG001|STARTED|Second Dose Level||0
10904868|NCT00058240|12071076|FG002|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
10904869|NCT00058240|12071077|FG003|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
10904870|NCT00058240|12071074|FG000|COMPLETED|Second Dose Level||0
10904871|NCT00058240|12071075|FG001|COMPLETED|Second Dose Level||0
10904872|NCT00058240|12071076|FG002|COMPLETED|Second Dose Level||2
10904873|NCT00058240|12071077|FG003|COMPLETED|Second Dose Level||4
10904874|NCT00058240|12071074|FG000|NOT COMPLETED|Second Dose Level||0
10904875|NCT00058240|12071075|FG001|NOT COMPLETED|Second Dose Level||0
10904876|NCT00058240|12071076|FG002|NOT COMPLETED|Second Dose Level||0
10904877|NCT00058240|12071077|FG003|NOT COMPLETED|Second Dose Level||0
10904878|NCT00058370|12071087|FG000|STARTED|Overall Study||6
10904879|NCT00058370|12071087|FG000|COMPLETED|Overall Study||6
10904880|NCT00058370|12071087|FG000|NOT COMPLETED|Overall Study||0
10904881|NCT00058422|12071091|FG000|STARTED|Overall Study||65
10904882|NCT00058422|12071091|FG000|COMPLETED|Overall Study||63
10904883|NCT00058422|12071091|FG000|NOT COMPLETED|Overall Study||2
10904884|NCT00058539|12071095|FG000|STARTED|Overall Study||42
10904885|NCT00058539|12071095|FG000|COMPLETED|Overall Study||0
10904886|NCT00058539|12071095|FG000|NOT COMPLETED|Overall Study||42
10904887|NCT00058552|12071101|FG000|STARTED|Overall Study||65
10904888|NCT00058552|12071102|FG001|STARTED|Overall Study||64
10904889|NCT00058552|12071101|FG000|COMPLETED|Overall Study||0
10904890|NCT00058552|12071102|FG001|COMPLETED|Overall Study||2
10904891|NCT00058552|12071101|FG000|NOT COMPLETED|Overall Study||65
10904892|NCT00058552|12071102|FG001|NOT COMPLETED|Overall Study||62
10904893|NCT00058825|12071110|FG000|STARTED|Overall Study||27
10904894|NCT00058825|12071110|FG000|COMPLETED|Overall Study||5
10904895|NCT00058825|12071110|FG000|NOT COMPLETED|Overall Study||22
10904896|NCT00059202|12071118|FG000|STARTED|Overall Study||76
10904897|NCT00059202|12071119|FG001|STARTED|Overall Study||74
10904898|NCT00059202|12071118|FG000|COMPLETED|Overall Study||70
10904899|NCT00059202|12071119|FG001|COMPLETED|Overall Study||59
10904900|NCT00059202|12071118|FG000|NOT COMPLETED|Overall Study||6
10904901|NCT00059202|12071119|FG001|NOT COMPLETED|Overall Study||15
10904902|NCT00059215|12071132|FG000|STARTED|Overall Study||200
10904903|NCT00059215|12071133|FG001|STARTED|Overall Study||200
10904904|NCT00059215|12071134|FG002|STARTED|Overall Study||251
10904905|NCT00059215|12071135|FG003|STARTED|Overall Study||254
10904906|NCT00059215|12071132|FG000|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
10904907|NCT00059215|12071133|FG001|COMPLETED|Overall Study||186
10904908|NCT00059215|12071134|FG002|COMPLETED|Overall Study||236
10904909|NCT00059215|12071135|FG003|COMPLETED|Overall Study||239
10904910|NCT00059215|12071132|FG000|NOT COMPLETED|Overall Study||13
10904911|NCT00059215|12071133|FG001|NOT COMPLETED|Overall Study||14
10904912|NCT00059215|12071134|FG002|NOT COMPLETED|Overall Study||15
10904913|NCT00059215|12071135|FG003|NOT COMPLETED|Overall Study||15
10904914|NCT00059228|12071148|FG000|STARTED|Overall Study||6
10904915|NCT00059228|12071149|FG001|STARTED|Overall Study||6
10904916|NCT00059228|12071148|FG000|COMPLETED|Overall Study||6
10904917|NCT00059228|12071149|FG001|COMPLETED|Overall Study||5
10904918|NCT00059228|12071148|FG000|NOT COMPLETED|Overall Study||0
10904919|NCT00059228|12071149|FG001|NOT COMPLETED|Overall Study||1
10904920|NCT00059332|12071157|FG000|STARTED|Overall Study||843
10904921|NCT00059332|12071158|FG001|STARTED|Overall Study||857
10904922|NCT00059332|12071157|FG000|COMPLETED|Overall Study||840
10904923|NCT00059332|12071158|FG001|COMPLETED|Overall Study||855
10904924|NCT00059332|12071157|FG000|NOT COMPLETED|Overall Study||3
10904925|NCT00059332|12071158|FG001|NOT COMPLETED|Overall Study||2
10904926|NCT00059475|12071172|FG000|STARTED|Overall Study||33
10904927|NCT00059475|12071173|FG001|STARTED|Overall Study||2
10904928|NCT00059475|12071174|FG002|STARTED|Overall Study||24
10904929|NCT00059475|12071175|FG003|STARTED|Overall Study||3
10904930|NCT00059475|12071176|FG004|STARTED|Overall Study||33
10904931|NCT00059475|12071177|FG005|STARTED|Overall Study||2
10904932|NCT00059475|12071178|FG006|STARTED|Overall Study||34
10904933|NCT00059475|12071179|FG007|STARTED|Overall Study||7
10904934|NCT00059475|12071172|FG000|COMPLETED|Overall Study||33
10904935|NCT00059475|12071173|FG001|COMPLETED|Overall Study||2
10904936|NCT00059475|12071174|FG002|COMPLETED|Overall Study||24
10904937|NCT00059475|12071175|FG003|COMPLETED|Overall Study||3
10904938|NCT00059475|12071176|FG004|COMPLETED|Overall Study||33
10904939|NCT00059475|12071177|FG005|COMPLETED|Overall Study||2
10904940|NCT00059475|12071178|FG006|COMPLETED|Overall Study||34
10904941|NCT00059475|12071179|FG007|COMPLETED|Overall Study||7
10904942|NCT00059475|12071172|FG000|NOT COMPLETED|Overall Study||0
10904943|NCT00059475|12071173|FG001|NOT COMPLETED|Overall Study||0
10904944|NCT00059475|12071174|FG002|NOT COMPLETED|Overall Study||0
10904945|NCT00059475|12071175|FG003|NOT COMPLETED|Overall Study||0
10904946|NCT00059475|12071176|FG004|NOT COMPLETED|Overall Study||0
10904947|NCT00059475|12071177|FG005|NOT COMPLETED|Overall Study||0
10904948|NCT00059475|12071178|FG006|NOT COMPLETED|Overall Study||0
10904949|NCT00059475|12071179|FG007|NOT COMPLETED|Overall Study||0
10904950|NCT00059787|12071204|FG000|STARTED|Overall Study||56
10904951|NCT00059787|12071204|FG000|COMPLETED|Overall Study||36
10904952|NCT00059787|12071204|FG000|NOT COMPLETED|Overall Study||20
10904953|NCT00059839|12071211|FG000|STARTED|Overall Study||65
10904954|NCT00059839|12071212|FG001|STARTED|Overall Study||64
10904955|NCT00059839|12071211|FG000|COMPLETED|Overall Study||53
10904956|NCT00059839|12071212|FG001|COMPLETED|Overall Study||47
10904957|NCT00059839|12071211|FG000|NOT COMPLETED|Overall Study||12
10904958|NCT00059839|12071212|FG001|NOT COMPLETED|Overall Study||17
10904959|NCT00060008|12071218|FG000|STARTED|Overall Study||18
10904960|NCT00060008|12071218|FG000|COMPLETED|Overall Study||18
10904961|NCT00060008|12071218|FG000|NOT COMPLETED|Overall Study||0
10904962|NCT00060333|12071223|FG000|STARTED|Overall Study||20
10904963|NCT00060333|12071223|FG000|COMPLETED|Overall Study||20
10904964|NCT00060333|12071223|FG000|NOT COMPLETED|Overall Study||0
10904965|NCT00060346|12071230|FG000|STARTED|Overall Study||16
10904966|NCT00060346|12071230|FG000|Eligible and Treated|Overall Study||16
10904967|NCT00060346|12071230|FG000|COMPLETED|Overall Study||16
10904968|NCT00060346|12071230|FG000|NOT COMPLETED|Overall Study||0
10904969|NCT00060424|12071234|FG000|STARTED|Overall Study||21
10904970|NCT00060424|12071234|FG000|COMPLETED|Overall Study||21
10904971|NCT00060424|12071234|FG000|NOT COMPLETED|Overall Study||0
10904972|NCT00060528|12071238|FG000|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
10904973|NCT00060528|12071239|FG001|STARTED|Overall Study||9
10904974|NCT00060528|12071240|FG002|STARTED|Overall Study||7
10904975|NCT00060528|12071241|FG003|STARTED|Overall Study||8
10904976|NCT00060528|12071238|FG000|COMPLETED|Overall Study||8
10904977|NCT00060528|12071239|FG001|COMPLETED|Overall Study||9
10904978|NCT00060528|12071240|FG002|COMPLETED|Overall Study||7
10904979|NCT00060528|12071241|FG003|COMPLETED|Overall Study||8
10904980|NCT00060528|12071238|FG000|NOT COMPLETED|Overall Study||0
10904981|NCT00060528|12071239|FG001|NOT COMPLETED|Overall Study||0
10904982|NCT00060528|12071240|FG002|NOT COMPLETED|Overall Study||0
10904983|NCT00060528|12071241|FG003|NOT COMPLETED|Overall Study||0
10904984|NCT00060606|12071256|FG000|STARTED|Overall Study||91
10904985|NCT00060606|12071257|FG001|STARTED|Overall Study||92
10904986|NCT00060606|12071256|FG000|First Primary Outcome - Shunt at 12 Mont|Overall Study||91
10904987|NCT00060606|12071257|FG001|First Primary Outcome - Shunt at 12 Mont|Overall Study||92
10904988|NCT00060606|12071256|FG000|COMPLETED|Overall Study||91
10904989|NCT00060606|12071257|FG001|COMPLETED|Overall Study||91
10904990|NCT00060606|12071256|FG000|NOT COMPLETED|Overall Study||0
10904991|NCT00060606|12071257|FG001|NOT COMPLETED|Overall Study||1
10904992|NCT00060840|12071265|FG000|STARTED|Overall Study||73
10904993|NCT00060840|12071266|FG001|STARTED|Overall Study||77
10904994|NCT00060840|12071265|FG000|COMPLETED|Overall Study||69
10904995|NCT00060840|12071266|FG001|COMPLETED|Overall Study||68
10904996|NCT00060840|12071265|FG000|NOT COMPLETED|Overall Study||4
10904997|NCT00060840|12071266|FG001|NOT COMPLETED|Overall Study||9
10904998|NCT00060944|12071274|FG000|STARTED|Overall Study||136
10904999|NCT00060944|12071275|FG001|STARTED|Overall Study||134
10905000|NCT00060944|12071274|FG000|Treated|Overall Study||130
10905001|NCT00060944|12071275|FG001|Treated|Overall Study||130
10905002|NCT00060944|12071274|FG000|COMPLETED|Overall Study||0
10905003|NCT00060944|12071275|FG001|COMPLETED|Overall Study||0
10905004|NCT00060944|12071274|FG000|NOT COMPLETED|Overall Study||136
10905005|NCT00060944|12071275|FG001|NOT COMPLETED|Overall Study||134
10905006|NCT00061048|12071281|FG000|STARTED|Overall Study||29
10905007|NCT00061048|12071281|FG000|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
10905008|NCT00061048|12071281|FG000|NOT COMPLETED|Overall Study||22
10905009|NCT00061373|12071287|FG000|STARTED|Overall Study||15
10905010|NCT00061373|12071288|FG001|STARTED|Overall Study||3
10905011|NCT00061373|12071287|FG000|Aspirin and Tinzaparin|Overall Study||15
10905012|NCT00061373|12071288|FG001|Aspirin and Tinzaparin|Overall Study||3
10905013|NCT00061373|12071287|FG000|COMPLETED|Overall Study||15
10905014|NCT00061373|12071288|FG001|COMPLETED|Overall Study||3
10905015|NCT00061373|12071287|FG000|NOT COMPLETED|Overall Study||0
10905016|NCT00061373|12071288|FG001|NOT COMPLETED|Overall Study||0
10905017|NCT00061633|12071296|FG000|STARTED|Overall Study||84
10905018|NCT00061633|12071297|FG001|STARTED|Overall Study||85
10905019|NCT00061633|12071296|FG000|COMPLETED|Overall Study||79
10905020|NCT00061633|12071297|FG001|COMPLETED|Overall Study||74
10905021|NCT00061633|12071296|FG000|NOT COMPLETED|Overall Study||5
10905022|NCT00061633|12071297|FG001|NOT COMPLETED|Overall Study||11
10905023|NCT00061893|12071303|FG000|STARTED|Overall Study||38
10905024|NCT00061893|12071303|FG000|COMPLETED|Overall Study||20
10905025|NCT00061893|12071303|FG000|NOT COMPLETED|Overall Study||18
10905026|NCT00061932|12071309|FG000|STARTED|Overall Study||29
10905027|NCT00061932|12071310|FG001|STARTED|Overall Study||12
10905028|NCT00061932|12071309|FG000|COMPLETED|Overall Study||16
10905029|NCT00061932|12071310|FG001|COMPLETED|Overall Study||8
10905030|NCT00061932|12071309|FG000|NOT COMPLETED|Overall Study||13
10905031|NCT00061932|12071310|FG001|NOT COMPLETED|Overall Study||4
10905032|NCT00062010|12071317|FG000|STARTED|Overall Study||37
10905033|NCT00062010|12071317|FG000|Eligible and Treated|Overall Study||34
10905034|NCT00062010|12071317|FG000|COMPLETED|Overall Study||34
10905035|NCT00062010|12071317|FG000|NOT COMPLETED|Overall Study||3
10905036|NCT00062166|12071321|FG000|STARTED|Overall Study||340
10905037|NCT00062166|12071321|FG000|COMPLETED|Overall Study||334
10905038|NCT00062166|12071321|FG000|NOT COMPLETED|Overall Study||6
10905039|NCT00062374|12071326|FG000|STARTED|Overall Study||55
10905040|NCT00062374|12071326|FG000|COMPLETED|Overall Study||43
10905041|NCT00062374|12071326|FG000|NOT COMPLETED|Overall Study||12
10905042|NCT00062439|12071330|FG000|STARTED|Induction Chemotherapy + Radiotherapy||46
10905043|NCT00062439|12071330|FG000|COMPLETED|Induction Chemotherapy + Radiotherapy||38
10905137|NCT00062868|12071391|FG002|STARTED|Dose Level 2||0
10905044|NCT00062439|12071330|FG000|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
10905045|NCT00062439|12071330|FG000|STARTED|Post Chemoradiation Assessment||38
10905046|NCT00062439|12071330|FG000|COMPLETED|Post Chemoradiation Assessment||29
10905047|NCT00062439|12071330|FG000|NOT COMPLETED|Post Chemoradiation Assessment||9
10905048|NCT00062439|12071330|FG000|STARTED|Surgery||29
10905049|NCT00062439|12071330|FG000|COMPLETED|Surgery||22
10905050|NCT00062439|12071330|FG000|NOT COMPLETED|Surgery||7
10905051|NCT00062439|12071330|FG000|STARTED|Consolidation Chemotherapy||22
10905052|NCT00062439|12071330|FG000|COMPLETED|Consolidation Chemotherapy||20
10905053|NCT00062439|12071330|FG000|NOT COMPLETED|Consolidation Chemotherapy||2
10905054|NCT00062647|12071341|FG000|STARTED|Overall Study||30
10905055|NCT00062647|12071342|FG001|STARTED|Overall Study||30
10905056|NCT00062647|12071341|FG000|COMPLETED|Overall Study||14
10905057|NCT00062647|12071342|FG001|COMPLETED|Overall Study||17
10905058|NCT00062647|12071341|FG000|NOT COMPLETED|Overall Study||16
10905059|NCT00062647|12071342|FG001|NOT COMPLETED|Overall Study||13
10905060|NCT00062738|12071351|FG000|STARTED|Overall Study||17
10905061|NCT00062738|12071352|FG001|STARTED|Overall Study||18
10905062|NCT00062738|12071353|FG002|STARTED|Overall Study||17
10905063|NCT00062738|12071351|FG000|COMPLETED|Overall Study||17
10905064|NCT00062738|12071352|FG001|COMPLETED|Overall Study||18
10905065|NCT00062738|12071353|FG002|COMPLETED|Overall Study||17
10905066|NCT00062738|12071351|FG000|NOT COMPLETED|Overall Study||0
10905067|NCT00062738|12071352|FG001|NOT COMPLETED|Overall Study||0
10905068|NCT00062738|12071353|FG002|NOT COMPLETED|Overall Study||0
10905069|NCT00062764|12071364|FG000|STARTED|Overall Study||18
10905070|NCT00062764|12071364|FG000|COMPLETED|Overall Study||18
10905071|NCT00062764|12071364|FG000|NOT COMPLETED|Overall Study||0
10905072|NCT00062868|12071389|FG000|STARTED|Dose Level 1||3
10905073|NCT00062868|12071390|FG001|STARTED|Dose Level 1||0
10905074|NCT00062868|12071391|FG002|STARTED|Dose Level 1||0
10905075|NCT00062868|12071392|FG003|STARTED|Dose Level 1||3
10905076|NCT00062868|12071393|FG004|STARTED|Dose Level 1||0
10905077|NCT00062868|12071394|FG005|STARTED|Dose Level 1||0
10905078|NCT00062868|12071395|FG006|STARTED|Dose Level 1||4
10905079|NCT00062868|12071396|FG007|STARTED|Dose Level 1||0
10905080|NCT00062868|12071397|FG008|STARTED|Dose Level 1||0
10905081|NCT00062868|12071398|FG009|STARTED|Dose Level 1||3
10905082|NCT00062868|12071399|FG010|STARTED|Dose Level 1||0
10905083|NCT00062868|12071400|FG011|STARTED|Dose Level 1||0
10905084|NCT00062868|12071401|FG012|STARTED|Dose Level 1||3
10905085|NCT00062868|12071402|FG013|STARTED|Dose Level 1||0
10905086|NCT00062868|12071403|FG014|STARTED|Dose Level 1||0
10905087|NCT00062868|12071404|FG015|STARTED|Dose Level 1||3
10905088|NCT00062868|12071405|FG016|STARTED|Dose Level 1||0
10905089|NCT00062868|12071406|FG017|STARTED|Dose Level 1||0
10905090|NCT00062868|12071407|FG018|STARTED|Dose Level 1||16
10905091|NCT00062868|12071408|FG019|STARTED|Dose Level 1||2
10905092|NCT00062868|12071409|FG020|STARTED|Dose Level 1||3
10905093|NCT00062868|12071389|FG000|COMPLETED|Dose Level 1||1
10905094|NCT00062868|12071390|FG001|COMPLETED|Dose Level 1||0
10905095|NCT00062868|12071391|FG002|COMPLETED|Dose Level 1||0
10905096|NCT00062868|12071392|FG003|COMPLETED|Dose Level 1||1
10905097|NCT00062868|12071393|FG004|COMPLETED|Dose Level 1||0
10905098|NCT00062868|12071394|FG005|COMPLETED|Dose Level 1||0
10905099|NCT00062868|12071395|FG006|COMPLETED|Dose Level 1||1
10905100|NCT00062868|12071396|FG007|COMPLETED|Dose Level 1||0
10905101|NCT00062868|12071397|FG008|COMPLETED|Dose Level 1||0
10905102|NCT00062868|12071398|FG009|COMPLETED|Dose Level 1||3
10905103|NCT00062868|12071399|FG010|COMPLETED|Dose Level 1||0
10905104|NCT00062868|12071400|FG011|COMPLETED|Dose Level 1||0
10905105|NCT00062868|12071401|FG012|COMPLETED|Dose Level 1||2
10905106|NCT00062868|12071402|FG013|COMPLETED|Dose Level 1||0
10905107|NCT00062868|12071403|FG014|COMPLETED|Dose Level 1||0
10905108|NCT00062868|12071404|FG015|COMPLETED|Dose Level 1||3
10905109|NCT00062868|12071405|FG016|COMPLETED|Dose Level 1||0
10905110|NCT00062868|12071406|FG017|COMPLETED|Dose Level 1||0
10905111|NCT00062868|12071407|FG018|COMPLETED|Dose Level 1||7
10905112|NCT00062868|12071408|FG019|COMPLETED|Dose Level 1||2
10905113|NCT00062868|12071409|FG020|COMPLETED|Dose Level 1||1
10905114|NCT00062868|12071389|FG000|NOT COMPLETED|Dose Level 1||2
10905115|NCT00062868|12071390|FG001|NOT COMPLETED|Dose Level 1||0
10905116|NCT00062868|12071391|FG002|NOT COMPLETED|Dose Level 1||0
10905117|NCT00062868|12071392|FG003|NOT COMPLETED|Dose Level 1||2
10905118|NCT00062868|12071393|FG004|NOT COMPLETED|Dose Level 1||0
10905119|NCT00062868|12071394|FG005|NOT COMPLETED|Dose Level 1||0
10905120|NCT00062868|12071395|FG006|NOT COMPLETED|Dose Level 1||3
10905121|NCT00062868|12071396|FG007|NOT COMPLETED|Dose Level 1||0
10905122|NCT00062868|12071397|FG008|NOT COMPLETED|Dose Level 1||0
10905123|NCT00062868|12071398|FG009|NOT COMPLETED|Dose Level 1||0
10905124|NCT00062868|12071399|FG010|NOT COMPLETED|Dose Level 1||0
10905125|NCT00062868|12071400|FG011|NOT COMPLETED|Dose Level 1||0
10905126|NCT00062868|12071401|FG012|NOT COMPLETED|Dose Level 1||1
10905127|NCT00062868|12071402|FG013|NOT COMPLETED|Dose Level 1||0
10905128|NCT00062868|12071403|FG014|NOT COMPLETED|Dose Level 1||0
10905129|NCT00062868|12071404|FG015|NOT COMPLETED|Dose Level 1||0
10905130|NCT00062868|12071405|FG016|NOT COMPLETED|Dose Level 1||0
10905131|NCT00062868|12071406|FG017|NOT COMPLETED|Dose Level 1||0
10905132|NCT00062868|12071407|FG018|NOT COMPLETED|Dose Level 1||9
10905133|NCT00062868|12071408|FG019|NOT COMPLETED|Dose Level 1||0
10905134|NCT00062868|12071409|FG020|NOT COMPLETED|Dose Level 1||2
10905135|NCT00062868|12071389|FG000|STARTED|Dose Level 2||0
10905136|NCT00062868|12071390|FG001|STARTED|Dose Level 2||6
10905138|NCT00062868|12071392|FG003|STARTED|Dose Level 2||0
10905139|NCT00062868|12071393|FG004|STARTED|Dose Level 2||3
10905140|NCT00062868|12071394|FG005|STARTED|Dose Level 2||0
10905141|NCT00062868|12071395|FG006|STARTED|Dose Level 2||0
10905142|NCT00062868|12071396|FG007|STARTED|Dose Level 2||0
10905143|NCT00062868|12071397|FG008|STARTED|Dose Level 2||0
10905144|NCT00062868|12071398|FG009|STARTED|Dose Level 2||0
10905145|NCT00062868|12071399|FG010|STARTED|Dose Level 2||4
10905146|NCT00062868|12071400|FG011|STARTED|Dose Level 2||0
10905147|NCT00062868|12071401|FG012|STARTED|Dose Level 2||0
10905148|NCT00062868|12071402|FG013|STARTED|Dose Level 2||3
10905149|NCT00062868|12071403|FG014|STARTED|Dose Level 2||0
10905150|NCT00062868|12071404|FG015|STARTED|Dose Level 2||0
10905151|NCT00062868|12071405|FG016|STARTED|Dose Level 2||3
10905152|NCT00062868|12071406|FG017|STARTED|Dose Level 2||0
10905153|NCT00062868|12071407|FG018|STARTED|Dose Level 2||0
10905154|NCT00062868|12071408|FG019|STARTED|Dose Level 2||0
10905155|NCT00062868|12071409|FG020|STARTED|Dose Level 2||0
10905156|NCT00062868|12071389|FG000|COMPLETED|Dose Level 2||0
10905157|NCT00062868|12071390|FG001|COMPLETED|Dose Level 2||3
10905158|NCT00062868|12071391|FG002|COMPLETED|Dose Level 2||0
10905159|NCT00062868|12071392|FG003|COMPLETED|Dose Level 2||0
10905160|NCT00062868|12071393|FG004|COMPLETED|Dose Level 2||1
10905161|NCT00062868|12071394|FG005|COMPLETED|Dose Level 2||0
10905162|NCT00062868|12071395|FG006|COMPLETED|Dose Level 2||0
10905163|NCT00062868|12071396|FG007|COMPLETED|Dose Level 2||0
10905164|NCT00062868|12071397|FG008|COMPLETED|Dose Level 2||0
10905165|NCT00062868|12071398|FG009|COMPLETED|Dose Level 2||0
10905166|NCT00062868|12071399|FG010|COMPLETED|Dose Level 2||3
10905167|NCT00062868|12071400|FG011|COMPLETED|Dose Level 2||0
10905168|NCT00062868|12071401|FG012|COMPLETED|Dose Level 2||0
10905169|NCT00062868|12071402|FG013|COMPLETED|Dose Level 2||2
10905170|NCT00062868|12071403|FG014|COMPLETED|Dose Level 2||0
10905171|NCT00062868|12071404|FG015|COMPLETED|Dose Level 2||0
10905172|NCT00062868|12071405|FG016|COMPLETED|Dose Level 2||0
10905173|NCT00062868|12071406|FG017|COMPLETED|Dose Level 2||0
10905174|NCT00062868|12071407|FG018|COMPLETED|Dose Level 2||0
10905175|NCT00062868|12071408|FG019|COMPLETED|Dose Level 2||0
10905176|NCT00062868|12071409|FG020|COMPLETED|Dose Level 2||0
10905177|NCT00062868|12071389|FG000|NOT COMPLETED|Dose Level 2||0
10905178|NCT00062868|12071390|FG001|NOT COMPLETED|Dose Level 2||3
10905179|NCT00062868|12071391|FG002|NOT COMPLETED|Dose Level 2||0
10905180|NCT00062868|12071392|FG003|NOT COMPLETED|Dose Level 2||0
10905181|NCT00062868|12071393|FG004|NOT COMPLETED|Dose Level 2||2
10905182|NCT00062868|12071394|FG005|NOT COMPLETED|Dose Level 2||0
10905183|NCT00062868|12071395|FG006|NOT COMPLETED|Dose Level 2||0
10905184|NCT00062868|12071396|FG007|NOT COMPLETED|Dose Level 2||0
10905185|NCT00062868|12071397|FG008|NOT COMPLETED|Dose Level 2||0
10905186|NCT00062868|12071398|FG009|NOT COMPLETED|Dose Level 2||0
10905187|NCT00062868|12071399|FG010|NOT COMPLETED|Dose Level 2||1
10905188|NCT00062868|12071400|FG011|NOT COMPLETED|Dose Level 2||0
10905189|NCT00062868|12071401|FG012|NOT COMPLETED|Dose Level 2||0
10905190|NCT00062868|12071402|FG013|NOT COMPLETED|Dose Level 2||1
10905191|NCT00062868|12071403|FG014|NOT COMPLETED|Dose Level 2||0
10905192|NCT00062868|12071404|FG015|NOT COMPLETED|Dose Level 2||0
10905193|NCT00062868|12071405|FG016|NOT COMPLETED|Dose Level 2||3
10905194|NCT00062868|12071406|FG017|NOT COMPLETED|Dose Level 2||0
10905195|NCT00062868|12071407|FG018|NOT COMPLETED|Dose Level 2||0
10905196|NCT00062868|12071408|FG019|NOT COMPLETED|Dose Level 2||0
10905197|NCT00062868|12071409|FG020|NOT COMPLETED|Dose Level 2||0
10905198|NCT00062868|12071389|FG000|STARTED|Dose Level 3||0
10905199|NCT00062868|12071390|FG001|STARTED|Dose Level 3||0
10905200|NCT00062868|12071391|FG002|STARTED|Dose Level 3||3
10905201|NCT00062868|12071392|FG003|STARTED|Dose Level 3||0
10905202|NCT00062868|12071393|FG004|STARTED|Dose Level 3||0
10905203|NCT00062868|12071394|FG005|STARTED|Dose Level 3||0
10905204|NCT00062868|12071395|FG006|STARTED|Dose Level 3||0
10905205|NCT00062868|12071396|FG007|STARTED|Dose Level 3||0
10905206|NCT00062868|12071397|FG008|STARTED|Dose Level 3||0
10905207|NCT00062868|12071398|FG009|STARTED|Dose Level 3||0
10905208|NCT00062868|12071399|FG010|STARTED|Dose Level 3||0
10905209|NCT00062868|12071400|FG011|STARTED|Dose Level 3||5
10905210|NCT00062868|12071401|FG012|STARTED|Dose Level 3||0
10905211|NCT00062868|12071402|FG013|STARTED|Dose Level 3||0
10905212|NCT00062868|12071403|FG014|STARTED|Dose Level 3||3
10905213|NCT00062868|12071404|FG015|STARTED|Dose Level 3||0
10905214|NCT00062868|12071405|FG016|STARTED|Dose Level 3||0
10905215|NCT00062868|12071406|FG017|STARTED|Dose Level 3||4
10905216|NCT00062868|12071407|FG018|STARTED|Dose Level 3||0
10905217|NCT00062868|12071408|FG019|STARTED|Dose Level 3||0
10905218|NCT00062868|12071409|FG020|STARTED|Dose Level 3||0
10905219|NCT00062868|12071389|FG000|COMPLETED|Dose Level 3||0
10905220|NCT00062868|12071390|FG001|COMPLETED|Dose Level 3||0
10905221|NCT00062868|12071391|FG002|COMPLETED|Dose Level 3||1
10905222|NCT00062868|12071392|FG003|COMPLETED|Dose Level 3||0
10905223|NCT00062868|12071393|FG004|COMPLETED|Dose Level 3||0
10905224|NCT00062868|12071394|FG005|COMPLETED|Dose Level 3||0
10905225|NCT00062868|12071395|FG006|COMPLETED|Dose Level 3||0
10905226|NCT00062868|12071396|FG007|COMPLETED|Dose Level 3||0
10905227|NCT00062868|12071397|FG008|COMPLETED|Dose Level 3||0
10905228|NCT00062868|12071398|FG009|COMPLETED|Dose Level 3||0
10905229|NCT00062868|12071399|FG010|COMPLETED|Dose Level 3||0
10905230|NCT00062868|12071400|FG011|COMPLETED|Dose Level 3||4
10905231|NCT00062868|12071401|FG012|COMPLETED|Dose Level 3||0
10905232|NCT00062868|12071402|FG013|COMPLETED|Dose Level 3||0
10905233|NCT00062868|12071403|FG014|COMPLETED|Dose Level 3||2
10905234|NCT00062868|12071404|FG015|COMPLETED|Dose Level 3||0
10905235|NCT00062868|12071405|FG016|COMPLETED|Dose Level 3||0
10905236|NCT00062868|12071406|FG017|COMPLETED|Dose Level 3||3
10905237|NCT00062868|12071407|FG018|COMPLETED|Dose Level 3||0
10905238|NCT00062868|12071408|FG019|COMPLETED|Dose Level 3||0
10905239|NCT00062868|12071409|FG020|COMPLETED|Dose Level 3||0
10905240|NCT00062868|12071389|FG000|NOT COMPLETED|Dose Level 3||0
10905241|NCT00062868|12071390|FG001|NOT COMPLETED|Dose Level 3||0
10905242|NCT00062868|12071391|FG002|NOT COMPLETED|Dose Level 3||2
10905243|NCT00062868|12071392|FG003|NOT COMPLETED|Dose Level 3||0
10905244|NCT00062868|12071393|FG004|NOT COMPLETED|Dose Level 3||0
10905245|NCT00062868|12071394|FG005|NOT COMPLETED|Dose Level 3||0
10905246|NCT00062868|12071395|FG006|NOT COMPLETED|Dose Level 3||0
10905247|NCT00062868|12071396|FG007|NOT COMPLETED|Dose Level 3||0
10905248|NCT00062868|12071397|FG008|NOT COMPLETED|Dose Level 3||0
10905249|NCT00062868|12071398|FG009|NOT COMPLETED|Dose Level 3||0
10905250|NCT00062868|12071399|FG010|NOT COMPLETED|Dose Level 3||0
10905251|NCT00062868|12071400|FG011|NOT COMPLETED|Dose Level 3||1
10905252|NCT00062868|12071401|FG012|NOT COMPLETED|Dose Level 3||0
10905253|NCT00062868|12071402|FG013|NOT COMPLETED|Dose Level 3||0
10905254|NCT00062868|12071403|FG014|NOT COMPLETED|Dose Level 3||1
10905255|NCT00062868|12071404|FG015|NOT COMPLETED|Dose Level 3||0
10905256|NCT00062868|12071405|FG016|NOT COMPLETED|Dose Level 3||0
10905257|NCT00062868|12071406|FG017|NOT COMPLETED|Dose Level 3||1
10905258|NCT00062868|12071407|FG018|NOT COMPLETED|Dose Level 3||0
10905259|NCT00062868|12071408|FG019|NOT COMPLETED|Dose Level 3||0
10905260|NCT00062868|12071409|FG020|NOT COMPLETED|Dose Level 3||0
10905261|NCT00063154|12071453|FG000|STARTED|Overall Study||51
10905262|NCT00063154|12071453|FG000|COMPLETED|Overall Study||0
10905263|NCT00063154|12071453|FG000|NOT COMPLETED|Overall Study||51
10905264|NCT00063232|12071457|FG000|STARTED|Overall Study||26
10905265|NCT00063232|12071457|FG000|COMPLETED|Overall Study||26
10905266|NCT00063232|12071457|FG000|NOT COMPLETED|Overall Study||0
10905267|NCT00063258|12071463|FG000|STARTED|Overall Study||5
10905268|NCT00063258|12071464|FG001|STARTED|Overall Study||0
10905269|NCT00063258|12071463|FG000|COMPLETED|Overall Study||1
10905270|NCT00063258|12071464|FG001|COMPLETED|Overall Study||0
10905271|NCT00063258|12071463|FG000|NOT COMPLETED|Overall Study||4
10905272|NCT00063258|12071464|FG001|NOT COMPLETED|Overall Study||0
10905273|NCT00063362|12071472|FG000|STARTED|Overall Study||23
10905274|NCT00063362|12071473|FG001|STARTED|Overall Study||26
10905275|NCT00063362|12071472|FG000|COMPLETED|Overall Study||19
10905276|NCT00063362|12071473|FG001|COMPLETED|Overall Study||22
10905277|NCT00063362|12071472|FG000|NOT COMPLETED|Overall Study||4
10905278|NCT00063362|12071473|FG001|NOT COMPLETED|Overall Study||4
10905279|NCT00063570|12071481|FG000|STARTED|Overall Study||52
10905280|NCT00063570|12071482|FG001|STARTED|Overall Study||21
10905281|NCT00063570|12071481|FG000|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
10905282|NCT00063570|12071482|FG001|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
10905283|NCT00063570|12071481|FG000|NOT COMPLETED|Overall Study||0
10905284|NCT00063570|12071482|FG001|NOT COMPLETED|Overall Study||0
10905285|NCT00063622|12071491|FG000|STARTED|Overall Study||80
10905286|NCT00063622|12071492|FG001|STARTED|Overall Study||84
10905287|NCT00063622|12071493|FG002|STARTED|Overall Study||83
10905288|NCT00063622|12071491|FG000|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
10905289|NCT00063622|12071492|FG001|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
10905290|NCT00063622|12071493|FG002|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
10905291|NCT00063622|12071491|FG000|NOT COMPLETED|Overall Study||10
10905292|NCT00063622|12071492|FG001|NOT COMPLETED|Overall Study||4
10905293|NCT00063622|12071493|FG002|NOT COMPLETED|Overall Study||11
10905294|NCT00063635|12071504|FG000|STARTED|Overall Study||57
10905295|NCT00063635|12071505|FG001|STARTED|Overall Study||58
10905296|NCT00063635|12071506|FG002|STARTED|Overall Study||58
10905297|NCT00063635|12071504|FG000|COMPLETED|Overall Study||51
10905298|NCT00063635|12071505|FG001|COMPLETED|Overall Study||50
10905299|NCT00063635|12071506|FG002|COMPLETED|Overall Study||49
10905300|NCT00063635|12071504|FG000|NOT COMPLETED|Overall Study||6
10905301|NCT00063635|12071505|FG001|NOT COMPLETED|Overall Study||8
10905302|NCT00063635|12071506|FG002|NOT COMPLETED|Overall Study||9
10905303|NCT00063882|12071516|FG000|STARTED|Overall Study||292
10905304|NCT00063882|12071517|FG001|STARTED|Overall Study||296
10905305|NCT00063882|12071516|FG000|Has Acute Adverse Event Data|Overall Study||282
10905306|NCT00063882|12071517|FG001|Has Acute Adverse Event Data|Overall Study||288
10905307|NCT00063882|12071516|FG000|Has Late Adverse Event Data|Overall Study||282
10905308|NCT00063882|12071517|FG001|Has Late Adverse Event Data|Overall Study||287
10905309|NCT00063882|12071516|FG000|Has Baseline/4-month EPIC Data|Overall Study||222
10905310|NCT00063882|12071517|FG001|Has Baseline/4-month EPIC Data|Overall Study||241
10905311|NCT00063882|12071516|FG000|Has Baseline/24-month EPIC Data|Overall Study||201
10905312|NCT00063882|12071517|FG001|Has Baseline/24-month EPIC Data|Overall Study||219
10905313|NCT00063882|12071516|FG000|Eligible Patients|Overall Study||287
10905314|NCT00063882|12071517|FG001|Eligible Patients|Overall Study||292
10905315|NCT00063882|12071516|FG000|COMPLETED|Overall Study||287
10905316|NCT00063882|12071517|FG001|COMPLETED|Overall Study||292
10905317|NCT00063882|12071516|FG000|NOT COMPLETED|Overall Study||5
10905318|NCT00063882|12071517|FG001|NOT COMPLETED|Overall Study||4
10905319|NCT00063934|12071523|FG000|STARTED|Overall Study||31
10905320|NCT00063934|12071523|FG000|COMPLETED|Overall Study||30
10905321|NCT00063934|12071523|FG000|NOT COMPLETED|Overall Study||1
10905322|NCT00063986|12071527|FG000|STARTED|Overall Study||110
10905323|NCT00063986|12071527|FG000|Treated|Overall Study||105
10905324|NCT00063986|12071527|FG000|Eligible and Treated|Overall Study||104
10905325|NCT00063986|12071527|FG000|COMPLETED|Overall Study||104
10905326|NCT00063986|12071527|FG000|NOT COMPLETED|Overall Study||6
10905327|NCT00063999|12071533|FG000|STARTED|Overall Study||692
10905328|NCT00063999|12071534|FG001|STARTED|Overall Study||689
10905329|NCT00063999|12071533|FG000|COMPLETED|Overall Study||647
10905330|NCT00063999|12071534|FG001|COMPLETED|Overall Study||665
10905331|NCT00063999|12071533|FG000|NOT COMPLETED|Overall Study||45
10905332|NCT00063999|12071534|FG001|NOT COMPLETED|Overall Study||24
10905333|NCT00064025|12071547|FG000|STARTED|Overall Study||75
10905334|NCT00064025|12071547|FG000|COMPLETED|Overall Study||68
10905335|NCT00064025|12071547|FG000|NOT COMPLETED|Overall Study||7
10905336|NCT00064038|12071555|FG000|STARTED|Initial Randomization||100
10905337|NCT00064038|12071556|FG001|STARTED|Initial Randomization||98
10905338|NCT00064038|12071557|FG002|STARTED|Initial Randomization||0
10905339|NCT00064038|12071555|FG000|Eligible and Analyzable|Initial Randomization||97
10905340|NCT00064038|12071556|FG001|Eligible and Analyzable|Initial Randomization||95
10905341|NCT00064038|12071557|FG002|Eligible and Analyzable|Initial Randomization||0
10905342|NCT00064038|12071555|FG000|Safety Population|Initial Randomization||96
10905343|NCT00064038|12071556|FG001|Safety Population|Initial Randomization||94
10905344|NCT00064038|12071557|FG002|Safety Population|Initial Randomization||0
10905345|NCT00064038|12071555|FG000|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
10905346|NCT00064038|12071556|FG001|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
10905347|NCT00064038|12071557|FG002|COMPLETED|Initial Randomization||0
10905348|NCT00064038|12071555|FG000|NOT COMPLETED|Initial Randomization||100
10905349|NCT00064038|12071556|FG001|NOT COMPLETED|Initial Randomization||98
10905350|NCT00064038|12071557|FG002|NOT COMPLETED|Initial Randomization||0
10905351|NCT00064038|12071555|FG000|STARTED|Crossover to Lenalidomide+Dexamethasone||0
10905352|NCT00064038|12071556|FG001|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
10905353|NCT00064038|12071557|FG002|STARTED|Crossover to Lenalidomide+Dexamethasone||42
10905354|NCT00064038|12071555|FG000|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
10905355|NCT00064038|12071556|FG001|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
10905356|NCT00064038|12071557|FG002|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
10905357|NCT00064038|12071555|FG000|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
10905358|NCT00064038|12071556|FG001|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
10905359|NCT00064038|12071557|FG002|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
10905360|NCT00064038|12071555|FG000|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
10905361|NCT00064038|12071556|FG001|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
10905362|NCT00064038|12071557|FG002|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
10905363|NCT00064038|12071555|FG000|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
10905364|NCT00064038|12071556|FG001|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
10905365|NCT00064038|12071557|FG002|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
10905366|NCT00064077|12071570|FG000|STARTED|Overall Study||118
10905367|NCT00064077|12071571|FG001|STARTED|Overall Study||117
10905368|NCT00064077|12071572|FG002|STARTED|Overall Study||119
10905369|NCT00064077|12071573|FG003|STARTED|Overall Study||118
10905370|NCT00064077|12071570|FG000|COMPLETED|Overall Study|Evaluable (treatment)|103
10905371|NCT00064077|12071571|FG001|COMPLETED|Overall Study|Evaluable (treatment)|108
10905372|NCT00064077|12071572|FG002|COMPLETED|Overall Study|Evaluable (treatment)|112
10905373|NCT00064077|12071573|FG003|COMPLETED|Overall Study|Evaluable (treatment)|111
10905374|NCT00064077|12071570|FG000|NOT COMPLETED|Overall Study||15
10905375|NCT00064077|12071571|FG001|NOT COMPLETED|Overall Study||9
10905376|NCT00064077|12071572|FG002|NOT COMPLETED|Overall Study||7
10905377|NCT00064077|12071573|FG003|NOT COMPLETED|Overall Study||7
10905378|NCT00064259|12071583|FG000|STARTED|Overall Study||4
10905379|NCT00064259|12071584|FG001|STARTED|Overall Study||4
10905380|NCT00064259|12071585|FG002|STARTED|Overall Study||6
10905381|NCT00064259|12071586|FG003|STARTED|Overall Study||1
10905382|NCT00064259|12071583|FG000|COMPLETED|Overall Study||3
10905383|NCT00064259|12071584|FG001|COMPLETED|Overall Study||4
10905384|NCT00064259|12071585|FG002|COMPLETED|Overall Study||6
10905385|NCT00064259|12071586|FG003|COMPLETED|Overall Study||0
10905386|NCT00064259|12071583|FG000|NOT COMPLETED|Overall Study||1
10905387|NCT00064259|12071584|FG001|NOT COMPLETED|Overall Study||0
10905388|NCT00064259|12071585|FG002|NOT COMPLETED|Overall Study||0
10905389|NCT00064259|12071586|FG003|NOT COMPLETED|Overall Study||1
10905390|NCT00064298|12071593|FG000|STARTED|Overall Study||72
10905391|NCT00064298|12071594|FG001|STARTED|Overall Study||62
10905392|NCT00064298|12071593|FG000|COMPLETED|Overall Study||66
10905393|NCT00064298|12071594|FG001|COMPLETED|Overall Study||57
10905394|NCT00064298|12071593|FG000|NOT COMPLETED|Overall Study||6
10905395|NCT00064298|12071594|FG001|NOT COMPLETED|Overall Study||5
10905396|NCT00064337|12071600|FG000|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
10905397|NCT00064337|12071600|FG000|COMPLETED|PBSCC or Induction/PBSCC||73
10905398|NCT00064337|12071600|FG000|NOT COMPLETED|PBSCC or Induction/PBSCC||20
10905399|NCT00064337|12071600|FG000|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
10905400|NCT00064337|12071600|FG000|COMPLETED|Transplant||46
10905401|NCT00064337|12071600|FG000|NOT COMPLETED|Transplant||21
10905402|NCT00064337|12071600|FG000|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
10905403|NCT00064337|12071600|FG000|COMPLETED|Maintenance||3
10905404|NCT00064337|12071600|FG000|NOT COMPLETED|Maintenance||10
10905405|NCT00064350|12071610|FG000|STARTED|Induction Treatment||59
10905406|NCT00064350|12071611|FG001|STARTED|Induction Treatment||46
10905407|NCT00064350|12071612|FG002|STARTED|Induction Treatment||237
10905408|NCT00064350|12071610|FG000|Treated|Induction Treatment||59
10905409|NCT00064350|12071611|FG001|Treated|Induction Treatment||46
10905410|NCT00064350|12071612|FG002|Treated|Induction Treatment||228
10905411|NCT00064350|12071610|FG000|Eligible and Treated|Induction Treatment||59
10905412|NCT00064350|12071611|FG001|Eligible and Treated|Induction Treatment||46
10905413|NCT00064350|12071612|FG002|Eligible and Treated|Induction Treatment||194
10905414|NCT00064350|12071610|FG000|COMPLETED|Induction Treatment||51
10905415|NCT00064350|12071611|FG001|COMPLETED|Induction Treatment||37
10905416|NCT00064350|12071612|FG002|COMPLETED|Induction Treatment||1
10905417|NCT00064350|12071610|FG000|NOT COMPLETED|Induction Treatment||8
10905418|NCT00064350|12071611|FG001|NOT COMPLETED|Induction Treatment||9
10905419|NCT00064350|12071612|FG002|NOT COMPLETED|Induction Treatment||236
10905420|NCT00064350|12071610|FG000|STARTED|Randomization||59
10905421|NCT00064350|12071611|FG001|STARTED|Randomization||46
10905422|NCT00064350|12071612|FG002|STARTED|Randomization||0
10905423|NCT00064350|12071610|FG000|Treated|Randomization||55
10905424|NCT00064350|12071611|FG001|Treated|Randomization||40
10905425|NCT00064350|12071612|FG002|Treated|Randomization||0
10905426|NCT00064350|12071610|FG000|Eligible and Treated|Randomization||50
10905427|NCT00064350|12071611|FG001|Eligible and Treated|Randomization||31
10905428|NCT00064350|12071612|FG002|Eligible and Treated|Randomization||0
10905429|NCT00064350|12071610|FG000|COMPLETED|Randomization||33
10905430|NCT00064350|12071611|FG001|COMPLETED|Randomization||28
10905431|NCT00064350|12071612|FG002|COMPLETED|Randomization||0
10905432|NCT00064350|12071610|FG000|NOT COMPLETED|Randomization||26
10905433|NCT00064350|12071611|FG001|NOT COMPLETED|Randomization||18
10905434|NCT00064350|12071612|FG002|NOT COMPLETED|Randomization||0
10905435|NCT00064350|12071610|FG000|STARTED|Cross-Over||10
10905436|NCT00064350|12071611|FG001|STARTED|Cross-Over||27
10905437|NCT00064350|12071612|FG002|STARTED|Cross-Over||0
10905438|NCT00064350|12071610|FG000|Treated|Cross-Over||9
10905439|NCT00064350|12071611|FG001|Treated|Cross-Over||26
10905440|NCT00064350|12071612|FG002|Treated|Cross-Over||0
10905441|NCT00064350|12071610|FG000|Eligible and Treated|Cross-Over||7
10905442|NCT00064350|12071611|FG001|Eligible and Treated|Cross-Over||21
10905443|NCT00064350|12071612|FG002|Eligible and Treated|Cross-Over||0
10905444|NCT00064350|12071610|FG000|COMPLETED|Cross-Over||4
10905445|NCT00064350|12071611|FG001|COMPLETED|Cross-Over||13
10905446|NCT00064350|12071612|FG002|COMPLETED|Cross-Over||0
10905447|NCT00064350|12071610|FG000|NOT COMPLETED|Cross-Over||6
10905448|NCT00064350|12071611|FG001|NOT COMPLETED|Cross-Over||14
10905449|NCT00064350|12071612|FG002|NOT COMPLETED|Cross-Over||0
10905450|NCT00064662|12071623|FG000|STARTED|Overall Study||329
10905451|NCT00064662|12071624|FG001|STARTED|Overall Study||326
10905452|NCT00064662|12071623|FG000|COMPLETED|Overall Study||255
10905453|NCT00064662|12071624|FG001|COMPLETED|Overall Study||265
10905454|NCT00064662|12071623|FG000|NOT COMPLETED|Overall Study||74
10905455|NCT00064662|12071624|FG001|NOT COMPLETED|Overall Study||61
10905456|NCT00064701|12071633|FG000|STARTED|One Year Post-transplant||219
10905457|NCT00064701|12071634|FG001|STARTED|One Year Post-transplant||226
10905458|NCT00064701|12071635|FG002|STARTED|One Year Post-transplant||223
10905459|NCT00064701|12071633|FG000|Received Study Drug|One Year Post-transplant||212
10905460|NCT00064701|12071634|FG001|Received Study Drug|One Year Post-transplant||214
10905461|NCT00064701|12071635|FG002|Received Study Drug|One Year Post-transplant||212
10905462|NCT00064701|12071633|FG000|COMPLETED|One Year Post-transplant||179
10905463|NCT00064701|12071634|FG001|COMPLETED|One Year Post-transplant||183
10905464|NCT00064701|12071635|FG002|COMPLETED|One Year Post-transplant||151
10905465|NCT00064701|12071633|FG000|NOT COMPLETED|One Year Post-transplant||40
10905466|NCT00064701|12071634|FG001|NOT COMPLETED|One Year Post-transplant||43
10905467|NCT00064701|12071635|FG002|NOT COMPLETED|One Year Post-transplant||72
10905468|NCT00064701|12071633|FG000|STARTED|Clinical Continuation Phase||179
10905469|NCT00064701|12071634|FG001|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
10905470|NCT00064701|12071635|FG002|STARTED|Clinical Continuation Phase||151
10905471|NCT00064701|12071633|FG000|COMPLETED|Clinical Continuation Phase||9
10905472|NCT00064701|12071634|FG001|COMPLETED|Clinical Continuation Phase||4
10905473|NCT00064701|12071635|FG002|COMPLETED|Clinical Continuation Phase||11
10905474|NCT00064701|12071633|FG000|NOT COMPLETED|Clinical Continuation Phase||170
10905475|NCT00064701|12071634|FG001|NOT COMPLETED|Clinical Continuation Phase||178
10905476|NCT00064701|12071635|FG002|NOT COMPLETED|Clinical Continuation Phase||140
10905477|NCT00064753|12071645|FG000|STARTED|Overall Study||2056
10905478|NCT00064753|12071646|FG001|STARTED|Overall Study||2054
10905479|NCT00064753|12071645|FG000|COMPLETED|Overall Study||1382
10905480|NCT00064753|12071646|FG001|COMPLETED|Overall Study||1406
10905481|NCT00064753|12071645|FG000|NOT COMPLETED|Overall Study||674
10905482|NCT00064753|12071646|FG001|NOT COMPLETED|Overall Study||648
10905483|NCT00064792|12071654|FG000|STARTED|Overall Study||13
10905484|NCT00064792|12071655|FG001|STARTED|Overall Study||10
10905485|NCT00064792|12071654|FG000|COMPLETED|Overall Study||8
10905486|NCT00064792|12071655|FG001|COMPLETED|Overall Study||10
10905487|NCT00064792|12071654|FG000|NOT COMPLETED|Overall Study||5
10905488|NCT00064792|12071655|FG001|NOT COMPLETED|Overall Study||0
10905489|NCT00064844|12071663|FG000|STARTED|Overall Study||45
10905490|NCT00064844|12071664|FG001|STARTED|Overall Study||51
10905491|NCT00064844|12071663|FG000|2 Week Follow-up|Overall Study||45
10905492|NCT00064844|12071664|FG001|2 Week Follow-up|Overall Study||51
10905493|NCT00064844|12071663|FG000|3 Month Follow-up|Overall Study||40
10905494|NCT00064844|12071664|FG001|3 Month Follow-up|Overall Study||47
10905495|NCT00064844|12071663|FG000|6 Month Follow-up|Overall Study||39
10905496|NCT00064844|12071664|FG001|6 Month Follow-up|Overall Study||40
10905497|NCT00064844|12071663|FG000|12 Month Follow-up|Overall Study||37
10905498|NCT00064844|12071664|FG001|12 Month Follow-up|Overall Study||32
10905499|NCT00064844|12071663|FG000|COMPLETED|Overall Study||37
10905500|NCT00064844|12071664|FG001|COMPLETED|Overall Study||32
10905501|NCT00064844|12071663|FG000|NOT COMPLETED|Overall Study||8
10905502|NCT00064844|12071664|FG001|NOT COMPLETED|Overall Study||19
10905503|NCT00064987|12071672|FG000|STARTED|Overall Study||10
10905504|NCT00064987|12071673|FG001|STARTED|Overall Study||6
10905505|NCT00064987|12071672|FG000|COMPLETED|Overall Study||7
10905506|NCT00064987|12071673|FG001|COMPLETED|Overall Study||6
10905507|NCT00064987|12071672|FG000|NOT COMPLETED|Overall Study||3
10905508|NCT00064987|12071673|FG001|NOT COMPLETED|Overall Study||0
10905509|NCT00065065|12071681|FG000|STARTED|Overall Study||52
10905510|NCT00065065|12071682|FG001|STARTED|Overall Study||53
10905511|NCT00065065|12071681|FG000|COMPLETED|Overall Study||42
10905512|NCT00065065|12071682|FG001|COMPLETED|Overall Study||33
10905513|NCT00065065|12071681|FG000|NOT COMPLETED|Overall Study||10
10905514|NCT00065065|12071682|FG001|NOT COMPLETED|Overall Study||20
10905515|NCT00065156|12071690|FG000|STARTED|Overall Study||148
10905516|NCT00065156|12071690|FG000|Modified Intent to Treat Population|Overall Study||94
10905517|NCT00065156|12071690|FG000|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
10905518|NCT00065156|12071690|FG000|NOT COMPLETED|Overall Study||124
10905519|NCT00065182|12071696|FG000|STARTED|Overall Study||202
10905520|NCT00065182|12071697|FG001|STARTED|Overall Study||197
10905521|NCT00065182|12071696|FG000|COMPLETED|Overall Study||154
10905522|NCT00065182|12071697|FG001|COMPLETED|Overall Study||160
10905523|NCT00065182|12071696|FG000|NOT COMPLETED|Overall Study||48
10905524|NCT00065182|12071697|FG001|NOT COMPLETED|Overall Study||37
10905525|NCT00065260|12071705|FG000|STARTED|Overall Study||27
10905526|NCT00065260|12071706|FG001|STARTED|Overall Study||27
10905527|NCT00065260|12071705|FG000|COMPLETED|Overall Study||27
10905528|NCT00065260|12071706|FG001|COMPLETED|Overall Study||26
10905529|NCT00065260|12071705|FG000|NOT COMPLETED|Overall Study||0
10905530|NCT00065260|12071706|FG001|NOT COMPLETED|Overall Study||1
10905531|NCT00065429|12071719|FG000|STARTED|Phase I - May 2001 - Oct 2002||4
10905532|NCT00065429|12071720|FG001|STARTED|Phase I - May 2001 - Oct 2002||3
10905533|NCT00065429|12071721|FG002|STARTED|Phase I - May 2001 - Oct 2002||4
10905534|NCT00065429|12071722|FG003|STARTED|Phase I - May 2001 - Oct 2002||4
10905535|NCT00065429|12071723|FG004|STARTED|Phase I - May 2001 - Oct 2002||9
10905536|NCT00065429|12071724|FG005|STARTED|Phase I - May 2001 - Oct 2002||4
10905537|NCT00065429|12071725|FG006|STARTED|Phase I - May 2001 - Oct 2002||4
10905538|NCT00065429|12071719|FG000|COMPLETED|Phase I - May 2001 - Oct 2002||3
10905539|NCT00065429|12071720|FG001|COMPLETED|Phase I - May 2001 - Oct 2002||3
10905540|NCT00065429|12071721|FG002|COMPLETED|Phase I - May 2001 - Oct 2002||3
10905541|NCT00065429|12071722|FG003|COMPLETED|Phase I - May 2001 - Oct 2002||3
10905542|NCT00065429|12071723|FG004|COMPLETED|Phase I - May 2001 - Oct 2002||8
10905543|NCT00065429|12071724|FG005|COMPLETED|Phase I - May 2001 - Oct 2002||2
10905544|NCT00065429|12071725|FG006|COMPLETED|Phase I - May 2001 - Oct 2002||2
10905545|NCT00065429|12071719|FG000|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
10905546|NCT00065429|12071720|FG001|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
10905547|NCT00065429|12071721|FG002|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
10905548|NCT00065429|12071722|FG003|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
10905549|NCT00065429|12071723|FG004|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
10905550|NCT00065429|12071724|FG005|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
10905551|NCT00065429|12071725|FG006|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
10905552|NCT00065429|12071719|FG000|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
10905553|NCT00065429|12071720|FG001|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
10905554|NCT00065429|12071721|FG002|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
10905555|NCT00065429|12071722|FG003|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
10905556|NCT00065429|12071723|FG004|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
10905557|NCT00065429|12071724|FG005|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
10905558|NCT00065429|12071725|FG006|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
10905559|NCT00065429|12071719|FG000|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10905560|NCT00065429|12071720|FG001|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10905561|NCT00065429|12071721|FG002|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10905562|NCT00065429|12071722|FG003|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10905563|NCT00065429|12071723|FG004|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
10905564|NCT00065429|12071724|FG005|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10905565|NCT00065429|12071725|FG006|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10905566|NCT00065429|12071719|FG000|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10905567|NCT00065429|12071720|FG001|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10905568|NCT00065429|12071721|FG002|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10905569|NCT00065429|12071722|FG003|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10905570|NCT00065429|12071723|FG004|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
10905571|NCT00065429|12071724|FG005|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10905572|NCT00065429|12071725|FG006|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
10905573|NCT00065442|12071738|FG000|STARTED|Overall Study||171
10905574|NCT00065442|12071739|FG001|STARTED|Overall Study||341
10905575|NCT00065442|12071738|FG000|COMPLETED|Overall Study||46
10905576|NCT00065442|12071739|FG001|COMPLETED|Overall Study||121
10905577|NCT00065442|12071738|FG000|NOT COMPLETED|Overall Study||125
10905578|NCT00065442|12071739|FG001|NOT COMPLETED|Overall Study||220
10905579|NCT00065468|12071748|FG000|STARTED|Overall Study||207
10905580|NCT00065468|12071749|FG001|STARTED|Overall Study||209
10905581|NCT00065468|12071750|FG002|STARTED|Overall Study||210
10905582|NCT00065468|12071748|FG000|Received Treatment|Overall Study||200
10905583|NCT00065468|12071749|FG001|Received Treatment|Overall Study||208
10905584|NCT00065468|12071750|FG002|Received Treatment|Overall Study||208
10905585|NCT00065468|12071748|FG000|COMPLETED|Overall Study||0
10905586|NCT00065468|12071749|FG001|COMPLETED|Overall Study||0
10905587|NCT00065468|12071750|FG002|COMPLETED|Overall Study||0
10905588|NCT00065468|12071748|FG000|NOT COMPLETED|Overall Study||207
10905589|NCT00065468|12071749|FG001|NOT COMPLETED|Overall Study||209
10905590|NCT00065468|12071750|FG002|NOT COMPLETED|Overall Study||210
10905591|NCT00065507|12071760|FG000|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
10905592|NCT00065507|12071761|FG001|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
10905593|NCT00065507|12071760|FG000|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
10905594|NCT00065507|12071761|FG001|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
10905595|NCT00065507|12071760|FG000|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
10905596|NCT00065507|12071761|FG001|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
10905597|NCT00065507|12071760|FG000|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
10905598|NCT00065507|12071761|FG001|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
10905599|NCT00065507|12071760|FG000|Treated, 24-Week Follow-Up Population|Overall Study||25
10905600|NCT00065507|12071761|FG001|Treated, 24-Week Follow-Up Population|Overall Study||28
10905601|NCT00065507|12071760|FG000|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
10905602|NCT00065507|12071761|FG001|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
10905603|NCT00065507|12071760|FG000|NOT COMPLETED|Overall Study||29
10905604|NCT00065507|12071761|FG001|NOT COMPLETED|Overall Study||29
10905605|NCT00065611|12071773|FG000|STARTED|Overall Study||4
10905606|NCT00065611|12071774|FG001|STARTED|Overall Study||4
10905607|NCT00065611|12071773|FG000|COMPLETED|Overall Study||4
10905608|NCT00065611|12071774|FG001|COMPLETED|Overall Study||3
10905609|NCT00065611|12071773|FG000|NOT COMPLETED|Overall Study||0
10905610|NCT00065611|12071774|FG001|NOT COMPLETED|Overall Study||1
10905611|NCT00065806|12071782|FG000|STARTED|Overall Study||113
10905612|NCT00065806|12071783|FG001|STARTED|Overall Study||108
10905613|NCT00065806|12071782|FG000|COMPLETED|Overall Study||93
10905614|NCT00065806|12071783|FG001|COMPLETED|Overall Study||89
10905615|NCT00065806|12071782|FG000|NOT COMPLETED|Overall Study||20
10905616|NCT00065806|12071783|FG001|NOT COMPLETED|Overall Study||19
10905617|NCT00066066|12071792|FG000|STARTED|Overall Study||27
10905618|NCT00066066|12071793|FG001|STARTED|Overall Study||22
10905619|NCT00066066|12071794|FG002|STARTED|Overall Study||30
10905620|NCT00066066|12071795|FG003|STARTED|Overall Study||20
10905621|NCT00066066|12071796|FG004|STARTED|Overall Study||27
10905622|NCT00066066|12071797|FG005|STARTED|Overall Study||20
10905623|NCT00066066|12071792|FG000|Baseline|Overall Study||27
10905624|NCT00066066|12071793|FG001|Baseline|Overall Study||22
10905625|NCT00066066|12071794|FG002|Baseline|Overall Study||30
10905626|NCT00066066|12071795|FG003|Baseline|Overall Study||20
10905627|NCT00066066|12071796|FG004|Baseline|Overall Study||27
10905628|NCT00066066|12071797|FG005|Baseline|Overall Study||20
10905629|NCT00066066|12071792|FG000|3 Month|Overall Study||21
10905630|NCT00066066|12071793|FG001|3 Month|Overall Study||17
10905631|NCT00066066|12071794|FG002|3 Month|Overall Study||23
10905632|NCT00066066|12071795|FG003|3 Month|Overall Study||16
10905633|NCT00066066|12071796|FG004|3 Month|Overall Study||22
10905634|NCT00066066|12071797|FG005|3 Month|Overall Study||15
10905635|NCT00066066|12071792|FG000|6 Month|Overall Study||19
10905636|NCT00066066|12071793|FG001|6 Month|Overall Study||13
10905637|NCT00066066|12071794|FG002|6 Month|Overall Study||23
10905638|NCT00066066|12071795|FG003|6 Month|Overall Study||13
10905639|NCT00066066|12071796|FG004|6 Month|Overall Study||21
10905640|NCT00066066|12071797|FG005|6 Month|Overall Study||14
10905641|NCT00066066|12071792|FG000|12 Month|Overall Study||18
10905642|NCT00066066|12071793|FG001|12 Month|Overall Study||11
10905643|NCT00066066|12071794|FG002|12 Month|Overall Study||21
10905644|NCT00066066|12071795|FG003|12 Month|Overall Study||11
10905645|NCT00066066|12071796|FG004|12 Month|Overall Study||19
10905646|NCT00066066|12071797|FG005|12 Month|Overall Study||9
10905647|NCT00066066|12071792|FG000|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
10905648|NCT00066066|12071793|FG001|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
10905649|NCT00066066|12071794|FG002|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
10905650|NCT00066066|12071795|FG003|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
10905651|NCT00066066|12071796|FG004|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
10905652|NCT00066066|12071797|FG005|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
10905653|NCT00066066|12071792|FG000|NOT COMPLETED|Overall Study||6
10905654|NCT00066066|12071793|FG001|NOT COMPLETED|Overall Study||4
10905655|NCT00066066|12071794|FG002|NOT COMPLETED|Overall Study||7
10905656|NCT00066066|12071795|FG003|NOT COMPLETED|Overall Study||4
10905657|NCT00066066|12071796|FG004|NOT COMPLETED|Overall Study||3
10905658|NCT00066066|12071797|FG005|NOT COMPLETED|Overall Study||5
10905659|NCT00066170|12071815|FG000|STARTED|Overall Study||56
10905660|NCT00066170|12071816|FG001|STARTED|Overall Study||55
10905661|NCT00066170|12071817|FG002|STARTED|Overall Study||63
10905662|NCT00066170|12071818|FG003|STARTED|Overall Study||57
10905663|NCT00066170|12071815|FG000|Intent to Treat|Overall Study||55
10905664|NCT00066170|12071816|FG001|Intent to Treat|Overall Study||50
10905665|NCT00066170|12071817|FG002|Intent to Treat|Overall Study||63
10905666|NCT00066170|12071818|FG003|Intent to Treat|Overall Study||54
10905667|NCT00066170|12071815|FG000|COMPLETED|Overall Study||49
10905668|NCT00066170|12071816|FG001|COMPLETED|Overall Study||45
10905669|NCT00066170|12071817|FG002|COMPLETED|Overall Study||59
10905670|NCT00066170|12071818|FG003|COMPLETED|Overall Study||48
10905671|NCT00066170|12071815|FG000|NOT COMPLETED|Overall Study||7
10905672|NCT00066170|12071816|FG001|NOT COMPLETED|Overall Study||10
10905673|NCT00066170|12071817|FG002|NOT COMPLETED|Overall Study||4
10905674|NCT00066170|12071818|FG003|NOT COMPLETED|Overall Study||9
10905675|NCT00066222|12071828|FG000|STARTED|Overall Study||72
10905676|NCT00066222|12071828|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
10905677|NCT00066222|12071828|FG000|NOT COMPLETED|Overall Study||1
10905678|NCT00066365|12071834|FG000|STARTED|Overall Study||31
10905679|NCT00066365|12071835|FG001|STARTED|Overall Study||18
10905680|NCT00066365|12071834|FG000|COMPLETED|Overall Study||8
10905681|NCT00066365|12071835|FG001|COMPLETED|Overall Study||4
10905682|NCT00066365|12071834|FG000|NOT COMPLETED|Overall Study||23
10905683|NCT00066365|12071835|FG001|NOT COMPLETED|Overall Study||14
10905684|NCT00066469|12071843|FG000|STARTED|Overall Study||55
10905685|NCT00066469|12071843|FG000|COMPLETED|Overall Study||39
10905686|NCT00066469|12071843|FG000|NOT COMPLETED|Overall Study||16
10905687|NCT00066573|12071849|FG000|STARTED|Overall Study||3789
10905688|NCT00066573|12071850|FG001|STARTED|Overall Study||3787
10905689|NCT00066573|12071849|FG000|COMPLETED|Overall Study||3761
10905690|NCT00066573|12071850|FG001|COMPLETED|Overall Study||3759
10905691|NCT00066573|12071849|FG000|NOT COMPLETED|Overall Study||28
10905692|NCT00066573|12071850|FG001|NOT COMPLETED|Overall Study||28
10905693|NCT00066677|12071858|FG000|STARTED|Overall Study||16
10905694|NCT00066677|12071859|FG001|STARTED|Overall Study||16
10905695|NCT00066677|12071858|FG000|COMPLETED|Overall Study||16
10905696|NCT00066677|12071859|FG001|COMPLETED|Overall Study||16
10905697|NCT00066677|12071858|FG000|NOT COMPLETED|Overall Study||0
10905698|NCT00066677|12071859|FG001|NOT COMPLETED|Overall Study||0
10905699|NCT00066690|12071868|FG000|STARTED|Overall Study||1021
10905700|NCT00066690|12071869|FG001|STARTED|Overall Study||1024
10905701|NCT00066690|12071870|FG002|STARTED|Overall Study||1021
10905702|NCT00066690|12071868|FG000|COMPLETED|Overall Study||423
10905703|NCT00066690|12071869|FG001|COMPLETED|Overall Study||502
10905704|NCT00066690|12071870|FG002|COMPLETED|Overall Study||457
10905705|NCT00066690|12071868|FG000|NOT COMPLETED|Overall Study||598
10905706|NCT00066690|12071869|FG001|NOT COMPLETED|Overall Study||522
10905707|NCT00066690|12071870|FG002|NOT COMPLETED|Overall Study||564
10905708|NCT00066703|12071883|FG000|STARTED|Overall Study||1334
10905709|NCT00066703|12071884|FG001|STARTED|Overall Study||1338
10905710|NCT00066703|12071883|FG000|COMPLETED|Overall Study||722
10905711|NCT00066703|12071884|FG001|COMPLETED|Overall Study||756
10905712|NCT00066703|12071883|FG000|NOT COMPLETED|Overall Study||612
10905713|NCT00066703|12071884|FG001|NOT COMPLETED|Overall Study||582
10905714|NCT00066729|12071890|FG000|STARTED|Overall Study||9
10905715|NCT00066729|12071890|FG000|COMPLETED|Overall Study||7
10905716|NCT00066729|12071890|FG000|NOT COMPLETED|Overall Study||2
10905717|NCT00066742|12071894|FG000|STARTED|Induction Chemoradiotherapy||72
10905718|NCT00066742|12071894|FG000|Eligible|Induction Chemoradiotherapy||69
10905719|NCT00066742|12071894|FG000|Began Protocol Treatment|Induction Chemoradiotherapy||68
10905720|NCT00066742|12071894|FG000|COMPLETED|Induction Chemoradiotherapy||43
10905721|NCT00066742|12071894|FG000|NOT COMPLETED|Induction Chemoradiotherapy||29
10905722|NCT00066742|12071894|FG000|STARTED|Consolidation Chemotherapy||42
10905723|NCT00066742|12071894|FG000|Eligible|Consolidation Chemotherapy||40
10905724|NCT00066742|12071894|FG000|COMPLETED|Consolidation Chemotherapy||39
10905725|NCT00066742|12071894|FG000|NOT COMPLETED|Consolidation Chemotherapy||3
10905726|NCT00066781|12071902|FG000|STARTED|Overall Study||14
10905727|NCT00066781|12071903|FG001|STARTED|Overall Study||17
10905728|NCT00066781|12071902|FG000|COMPLETED|Overall Study||14
10905729|NCT00066781|12071903|FG001|COMPLETED|Overall Study||17
10905730|NCT00066781|12071902|FG000|NOT COMPLETED|Overall Study||0
10905731|NCT00066781|12071903|FG001|NOT COMPLETED|Overall Study||0
10905732|NCT00066937|12071913|FG000|STARTED|Treatment Phase||41
10905733|NCT00066937|12071914|FG001|STARTED|Treatment Phase||38
10905734|NCT00066937|12071915|FG002|STARTED|Treatment Phase||37
10905735|NCT00066937|12071916|FG003|STARTED|Treatment Phase||24
10905736|NCT00066937|12071913|FG000|COMPLETED|Treatment Phase||38
10905737|NCT00066937|12071914|FG001|COMPLETED|Treatment Phase||33
10905738|NCT00066937|12071915|FG002|COMPLETED|Treatment Phase||26
10905739|NCT00066937|12071916|FG003|COMPLETED|Treatment Phase||19
10905740|NCT00066937|12071913|FG000|NOT COMPLETED|Treatment Phase||3
10905741|NCT00066937|12071914|FG001|NOT COMPLETED|Treatment Phase||5
10905742|NCT00066937|12071915|FG002|NOT COMPLETED|Treatment Phase||11
10905743|NCT00066937|12071916|FG003|NOT COMPLETED|Treatment Phase||5
10905744|NCT00066937|12071913|FG000|STARTED|3 Month Follow-up||38
10905745|NCT00066937|12071914|FG001|STARTED|3 Month Follow-up||33
10905746|NCT00066937|12071915|FG002|STARTED|3 Month Follow-up||26
10905747|NCT00066937|12071916|FG003|STARTED|3 Month Follow-up||19
10905748|NCT00066937|12071913|FG000|COMPLETED|3 Month Follow-up||33
10905749|NCT00066937|12071914|FG001|COMPLETED|3 Month Follow-up||32
10905750|NCT00066937|12071915|FG002|COMPLETED|3 Month Follow-up||25
10905751|NCT00066937|12071916|FG003|COMPLETED|3 Month Follow-up||15
10905752|NCT00066937|12071913|FG000|NOT COMPLETED|3 Month Follow-up||5
10905753|NCT00066937|12071914|FG001|NOT COMPLETED|3 Month Follow-up||1
10905754|NCT00066937|12071915|FG002|NOT COMPLETED|3 Month Follow-up||1
10905755|NCT00066937|12071916|FG003|NOT COMPLETED|3 Month Follow-up||4
10905756|NCT00066937|12071913|FG000|STARTED|6 Month Follow-up||33
10905757|NCT00066937|12071914|FG001|STARTED|6 Month Follow-up||32
10905758|NCT00066937|12071915|FG002|STARTED|6 Month Follow-up||25
10905759|NCT00066937|12071916|FG003|STARTED|6 Month Follow-up||15
10905760|NCT00066937|12071913|FG000|COMPLETED|6 Month Follow-up||26
10905761|NCT00066937|12071914|FG001|COMPLETED|6 Month Follow-up||29
10905762|NCT00066937|12071915|FG002|COMPLETED|6 Month Follow-up||22
10905763|NCT00066937|12071916|FG003|COMPLETED|6 Month Follow-up||14
10905764|NCT00066937|12071913|FG000|NOT COMPLETED|6 Month Follow-up||7
10905765|NCT00066937|12071914|FG001|NOT COMPLETED|6 Month Follow-up||3
10905766|NCT00066937|12071915|FG002|NOT COMPLETED|6 Month Follow-up||3
10905767|NCT00066937|12071916|FG003|NOT COMPLETED|6 Month Follow-up||1
10905768|NCT00067002|12071928|FG000|STARTED|Overall Study||52
10905769|NCT00067002|12071929|FG001|STARTED|Overall Study||53
10905770|NCT00067002|12071928|FG000|COMPLETED|Overall Study||45
10905771|NCT00067002|12071929|FG001|COMPLETED|Overall Study||44
10905772|NCT00067002|12071928|FG000|NOT COMPLETED|Overall Study||7
10905773|NCT00067002|12071929|FG001|NOT COMPLETED|Overall Study||9
10905774|NCT00067028|12071938|FG000|STARTED|Overall Study||17
10905775|NCT00067028|12071939|FG001|STARTED|Overall Study||36
10905776|NCT00067028|12071940|FG002|STARTED|Overall Study||63
10905777|NCT00067028|12071938|FG000|COMPLETED|Overall Study||17
10905778|NCT00067028|12071939|FG001|COMPLETED|Overall Study||36
10905779|NCT00067028|12071940|FG002|COMPLETED|Overall Study||63
10905780|NCT00067028|12071938|FG000|NOT COMPLETED|Overall Study||0
10905781|NCT00067028|12071939|FG001|NOT COMPLETED|Overall Study||0
10905782|NCT00067028|12071940|FG002|NOT COMPLETED|Overall Study||0
10905783|NCT00067236|12071952|FG000|STARTED|Overall Study||128
10905784|NCT00067236|12071953|FG001|STARTED|Overall Study||125
10905785|NCT00067236|12071952|FG000|COMPLETED|Overall Study||108
10905786|NCT00067236|12071953|FG001|COMPLETED|Overall Study||99
10905787|NCT00067236|12071952|FG000|NOT COMPLETED|Overall Study||20
10905788|NCT00067236|12071953|FG001|NOT COMPLETED|Overall Study||26
10905789|NCT00067470|12071961|FG000|STARTED|Overall Study||19
10905790|NCT00067470|12071962|FG001|STARTED|Overall Study||20
10905791|NCT00067470|12071961|FG000|COMPLETED|Overall Study||19
10905792|NCT00067470|12071962|FG001|COMPLETED|Overall Study||19
10905793|NCT00067470|12071961|FG000|NOT COMPLETED|Overall Study||0
10905794|NCT00067470|12071962|FG001|NOT COMPLETED|Overall Study||1
10905795|NCT00067808|12071971|FG000|STARTED|Overall Study||17
10905796|NCT00067808|12071972|FG001|STARTED|Overall Study||93
10905797|NCT00067808|12071973|FG002|STARTED|Overall Study||14
10905798|NCT00067808|12071971|FG000|COMPLETED|Overall Study||17
10905799|NCT00067808|12071972|FG001|COMPLETED|Overall Study||93
10905800|NCT00067808|12071973|FG002|COMPLETED|Overall Study||14
10905801|NCT00067808|12071971|FG000|NOT COMPLETED|Overall Study||0
10905802|NCT00067808|12071972|FG001|NOT COMPLETED|Overall Study||0
10905803|NCT00067808|12071973|FG002|NOT COMPLETED|Overall Study||0
10905804|NCT00067990|12071983|FG000|STARTED|Overall Study||77
10905805|NCT00067990|12071984|FG001|STARTED|Overall Study||76
10905806|NCT00067990|12071983|FG000|COMPLETED|Overall Study||67
10905807|NCT00067990|12071984|FG001|COMPLETED|Overall Study||54
10905808|NCT00067990|12071983|FG000|NOT COMPLETED|Overall Study||10
10905809|NCT00067990|12071984|FG001|NOT COMPLETED|Overall Study||22
10905810|NCT00068107|12071990|FG000|STARTED|Overall Study||12
10905811|NCT00068107|12071990|FG000|COMPLETED|Overall Study||3
10905812|NCT00068107|12071990|FG000|NOT COMPLETED|Overall Study||9
10905813|NCT00068237|12071997|FG000|STARTED|Overall Study||49
10905814|NCT00068237|12071997|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
10905815|NCT00068237|12071997|FG000|NOT COMPLETED|Overall Study||5
10905816|NCT00068250|12072004|FG000|STARTED|Phase I: Dose Level 1||6
10905817|NCT00068250|12072005|FG001|STARTED|Phase I: Dose Level 1||0
10905818|NCT00068250|12072006|FG002|STARTED|Phase I: Dose Level 1||0
10905819|NCT00068250|12072007|FG003|STARTED|Phase I: Dose Level 1||0
10905820|NCT00068250|12072004|FG000|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
10905821|NCT00068250|12072005|FG001|COMPLETED|Phase I: Dose Level 1||0
10905822|NCT00068250|12072006|FG002|COMPLETED|Phase I: Dose Level 1||0
10905823|NCT00068250|12072007|FG003|COMPLETED|Phase I: Dose Level 1||0
10905824|NCT00068250|12072004|FG000|NOT COMPLETED|Phase I: Dose Level 1||0
10905825|NCT00068250|12072005|FG001|NOT COMPLETED|Phase I: Dose Level 1||0
10905826|NCT00068250|12072006|FG002|NOT COMPLETED|Phase I: Dose Level 1||0
10905827|NCT00068250|12072007|FG003|NOT COMPLETED|Phase I: Dose Level 1||0
10905828|NCT00068250|12072004|FG000|STARTED|Phase I: Dose Level 2||0
10905829|NCT00068250|12072005|FG001|STARTED|Phase I: Dose Level 2||7
10905830|NCT00068250|12072006|FG002|STARTED|Phase I: Dose Level 2||0
10905831|NCT00068250|12072007|FG003|STARTED|Phase I: Dose Level 2||0
10905832|NCT00068250|12072004|FG000|COMPLETED|Phase I: Dose Level 2||0
10905833|NCT00068250|12072005|FG001|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
10905834|NCT00068250|12072006|FG002|COMPLETED|Phase I: Dose Level 2||0
10905835|NCT00068250|12072007|FG003|COMPLETED|Phase I: Dose Level 2||0
10905836|NCT00068250|12072004|FG000|NOT COMPLETED|Phase I: Dose Level 2||0
10905837|NCT00068250|12072005|FG001|NOT COMPLETED|Phase I: Dose Level 2||1
10905838|NCT00068250|12072006|FG002|NOT COMPLETED|Phase I: Dose Level 2||0
10905839|NCT00068250|12072007|FG003|NOT COMPLETED|Phase I: Dose Level 2||0
10905840|NCT00068250|12072004|FG000|STARTED|Phase II: Dose Level 2||0
10905841|NCT00068250|12072005|FG001|STARTED|Phase II: Dose Level 2||0
10905842|NCT00068250|12072006|FG002|STARTED|Phase II: Dose Level 2||0
10905843|NCT00068250|12072007|FG003|STARTED|Phase II: Dose Level 2||47
10905844|NCT00068250|12072004|FG000|COMPLETED|Phase II: Dose Level 2||0
10905845|NCT00068250|12072005|FG001|COMPLETED|Phase II: Dose Level 2||0
10905846|NCT00068250|12072006|FG002|COMPLETED|Phase II: Dose Level 2||0
10905847|NCT00068250|12072007|FG003|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
10905848|NCT00068250|12072004|FG000|NOT COMPLETED|Phase II: Dose Level 2||0
10905849|NCT00068250|12072005|FG001|NOT COMPLETED|Phase II: Dose Level 2||0
10905850|NCT00068250|12072006|FG002|NOT COMPLETED|Phase II: Dose Level 2||0
10905851|NCT00068250|12072007|FG003|NOT COMPLETED|Phase II: Dose Level 2||0
10905852|NCT00068341|12072018|FG000|STARTED|Overall Study||15
10905853|NCT00068341|12072019|FG001|STARTED|Overall Study||15
10905854|NCT00068341|12072020|FG002|STARTED|Overall Study||44
10905855|NCT00068341|12072018|FG000|COMPLETED|Overall Study||15
10905856|NCT00068341|12072019|FG001|COMPLETED|Overall Study||15
10905857|NCT00068341|12072020|FG002|COMPLETED|Overall Study||44
10905858|NCT00068341|12072018|FG000|NOT COMPLETED|Overall Study||0
10905859|NCT00068341|12072019|FG001|NOT COMPLETED|Overall Study||0
10905860|NCT00068341|12072020|FG002|NOT COMPLETED|Overall Study||0
10905861|NCT00068367|12072041|FG000|STARTED|Overall Study||20
10905862|NCT00068367|12072041|FG000|COMPLETED|Overall Study||20
10905863|NCT00068367|12072041|FG000|NOT COMPLETED|Overall Study||0
10905864|NCT00068380|12072045|FG000|STARTED|Overall Study||17
10905865|NCT00068380|12072045|FG000|COMPLETED|Overall Study||12
10905866|NCT00068380|12072045|FG000|NOT COMPLETED|Overall Study||5
10905867|NCT00068393|12072049|FG000|STARTED|Overall Study||39
10905868|NCT00068393|12072049|FG000|Eligible and Treated|Overall Study||38
10905869|NCT00068393|12072049|FG000|COMPLETED|Overall Study||29
10905870|NCT00068393|12072049|FG000|NOT COMPLETED|Overall Study||10
10905871|NCT00068406|12072053|FG000|STARTED|Overall Study||61
10905872|NCT00068406|12072053|FG000|COMPLETED|Overall Study||58
10905873|NCT00068406|12072053|FG000|NOT COMPLETED|Overall Study||3
10905874|NCT00068419|12072057|FG000|STARTED|Overall Study||70
10905875|NCT00068419|12072057|FG000|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
10905876|NCT00068419|12072057|FG000|NOT COMPLETED|Overall Study||60
10905877|NCT00068445|12072063|FG000|STARTED|Randomization||65
10905878|NCT00068445|12072064|FG001|STARTED|Randomization||66
10905879|NCT00068445|12072063|FG000|COMPLETED|Randomization||63
10905880|NCT00068445|12072064|FG001|COMPLETED|Randomization||62
10905881|NCT00068445|12072063|FG000|NOT COMPLETED|Randomization||2
10905882|NCT00068445|12072064|FG001|NOT COMPLETED|Randomization||4
10905883|NCT00068445|12072063|FG000|STARTED|Treatment||63
10905884|NCT00068445|12072064|FG001|STARTED|Treatment||62
10905885|NCT00068445|12072063|FG000|COMPLETED|Treatment||34
10905886|NCT00068445|12072064|FG001|COMPLETED|Treatment||46
10905887|NCT00068445|12072063|FG000|NOT COMPLETED|Treatment||29
10905888|NCT00068445|12072064|FG001|NOT COMPLETED|Treatment||16
10905889|NCT00068575|12072070|FG000|STARTED|Overall Study||28
10905890|NCT00068575|12072070|FG000|COMPLETED|Overall Study||28
10905891|NCT00068575|12072070|FG000|NOT COMPLETED|Overall Study||0
10905892|NCT00068588|12072077|FG000|STARTED|Overall Study||0
10905893|NCT00068588|12072078|FG001|STARTED|Overall Study||3
10905894|NCT00068588|12072079|FG002|STARTED|Overall Study||21
10905895|NCT00068588|12072077|FG000|COMPLETED|Overall Study||0
10905896|NCT00068588|12072078|FG001|COMPLETED|Overall Study||3
10905897|NCT00068588|12072079|FG002|COMPLETED|Overall Study||17
10905898|NCT00068588|12072077|FG000|NOT COMPLETED|Overall Study||0
10905899|NCT00068588|12072078|FG001|NOT COMPLETED|Overall Study||0
10905900|NCT00068588|12072079|FG002|NOT COMPLETED|Overall Study||4
10905901|NCT00068601|12072088|FG000|STARTED|Overall Study||131
10905902|NCT00068601|12072089|FG001|STARTED|Overall Study||126
10905903|NCT00068601|12072088|FG000|COMPLETED|Overall Study||69
10905904|NCT00068601|12072089|FG001|COMPLETED|Overall Study||66
10905905|NCT00068601|12072088|FG000|NOT COMPLETED|Overall Study||62
10905906|NCT00068601|12072089|FG001|NOT COMPLETED|Overall Study||60
10905907|NCT00068692|12072098|FG000|STARTED|Step 1: Registration||128
10905908|NCT00068692|12072099|FG001|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
10905909|NCT00068692|12072100|FG002|STARTED|Step 1: Registration||0
10905910|NCT00068692|12072101|FG003|STARTED|Step 1: Registration||0
10905911|NCT00068692|12072102|FG004|STARTED|Step 1: Registration||0
10905912|NCT00068692|12072103|FG005|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
10905913|NCT00068692|12072104|FG006|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
10905914|NCT00068692|12072105|FG007|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
10905915|NCT00068692|12072098|FG000|Started Concurrent Chemo/Radiation|Step 1: Registration||125
10905916|NCT00068692|12072099|FG001|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
10905917|NCT00068692|12072100|FG002|Started Concurrent Chemo/Radiation|Step 1: Registration||0
10905918|NCT00068692|12072101|FG003|Started Concurrent Chemo/Radiation|Step 1: Registration||0
10905919|NCT00068692|12072102|FG004|Started Concurrent Chemo/Radiation|Step 1: Registration||0
10905920|NCT00068692|12072103|FG005|Started Concurrent Chemo/Radiation|Step 1: Registration||0
10905921|NCT00068692|12072104|FG006|Started Concurrent Chemo/Radiation|Step 1: Registration||0
10905922|NCT00068692|12072105|FG007|Started Concurrent Chemo/Radiation|Step 1: Registration||0
10905923|NCT00068692|12072098|FG000|Reported AE Data|Step 1: Registration||123
10905924|NCT00068692|12072099|FG001|Reported AE Data|Step 1: Registration||0
10905925|NCT00068692|12072100|FG002|Reported AE Data|Step 1: Registration||0
10905926|NCT00068692|12072101|FG003|Reported AE Data|Step 1: Registration||0
10905927|NCT00068692|12072102|FG004|Reported AE Data|Step 1: Registration||0
10905928|NCT00068692|12072103|FG005|Reported AE Data|Step 1: Registration||0
10905929|NCT00068692|12072104|FG006|Reported AE Data|Step 1: Registration||0
10905930|NCT00068692|12072105|FG007|Reported AE Data|Step 1: Registration||0
10905931|NCT00068692|12072098|FG000|COMPLETED|Step 1: Registration||88
10905932|NCT00068692|12072099|FG001|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
10905933|NCT00068692|12072100|FG002|COMPLETED|Step 1: Registration||0
10905934|NCT00068692|12072101|FG003|COMPLETED|Step 1: Registration||0
10905935|NCT00068692|12072102|FG004|COMPLETED|Step 1: Registration||0
10905936|NCT00068692|12072103|FG005|COMPLETED|Step 1: Registration||0
10905937|NCT00068692|12072104|FG006|COMPLETED|Step 1: Registration||0
10905938|NCT00068692|12072105|FG007|COMPLETED|Step 1: Registration||0
10905939|NCT00068692|12072098|FG000|NOT COMPLETED|Step 1: Registration||40
10905940|NCT00068692|12072099|FG001|NOT COMPLETED|Step 1: Registration||1
10905941|NCT00068692|12072100|FG002|NOT COMPLETED|Step 1: Registration||0
10905942|NCT00068692|12072101|FG003|NOT COMPLETED|Step 1: Registration||0
10905943|NCT00068692|12072102|FG004|NOT COMPLETED|Step 1: Registration||0
10905944|NCT00068692|12072103|FG005|NOT COMPLETED|Step 1: Registration||0
10905945|NCT00068692|12072104|FG006|NOT COMPLETED|Step 1: Registration||0
10905946|NCT00068692|12072105|FG007|NOT COMPLETED|Step 1: Registration||0
10905947|NCT00068692|12072098|FG000|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
10905948|NCT00068692|12072099|FG001|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
10905949|NCT00068692|12072100|FG002|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
10905950|NCT00068692|12072101|FG003|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
10905951|NCT00068692|12072102|FG004|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
10905952|NCT00068692|12072103|FG005|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
10905953|NCT00068692|12072104|FG006|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
10905954|NCT00068692|12072105|FG007|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
10905955|NCT00068692|12072098|FG000|Treated|Step 2: Randomization||0
10905956|NCT00068692|12072099|FG001|Treated|Step 2: Randomization||0
10905957|NCT00068692|12072100|FG002|Treated|Step 2: Randomization||27
10905958|NCT00068692|12072101|FG003|Treated|Step 2: Randomization||25
10905959|NCT00068692|12072102|FG004|Treated|Step 2: Randomization||29
10905960|NCT00068692|12072103|FG005|Treated|Step 2: Randomization||31
10905961|NCT00068692|12072104|FG006|Treated|Step 2: Randomization||33
10905962|NCT00068692|12072105|FG007|Treated|Step 2: Randomization||32
10905963|NCT00068692|12072098|FG000|Had Sphincter Preservation|Step 2: Randomization||0
10905964|NCT00068692|12072099|FG001|Had Sphincter Preservation|Step 2: Randomization||0
10905965|NCT00068692|12072100|FG002|Had Sphincter Preservation|Step 2: Randomization||28
10905966|NCT00068692|12072101|FG003|Had Sphincter Preservation|Step 2: Randomization||25
10905967|NCT00068692|12072102|FG004|Had Sphincter Preservation|Step 2: Randomization||28
10905968|NCT00068692|12072103|FG005|Had Sphincter Preservation|Step 2: Randomization||31
10905969|NCT00068692|12072104|FG006|Had Sphincter Preservation|Step 2: Randomization||33
10905970|NCT00068692|12072105|FG007|Had Sphincter Preservation|Step 2: Randomization||30
10905971|NCT00068692|12072098|FG000|Reported AE Data|Step 2: Randomization||0
10905972|NCT00068692|12072099|FG001|Reported AE Data|Step 2: Randomization||0
10905973|NCT00068692|12072100|FG002|Reported AE Data|Step 2: Randomization||27
10905974|NCT00068692|12072101|FG003|Reported AE Data|Step 2: Randomization||22
10905975|NCT00068692|12072102|FG004|Reported AE Data|Step 2: Randomization||28
10905976|NCT00068692|12072103|FG005|Reported AE Data|Step 2: Randomization||31
10905977|NCT00068692|12072104|FG006|Reported AE Data|Step 2: Randomization||33
10905978|NCT00068692|12072105|FG007|Reported AE Data|Step 2: Randomization||32
10905979|NCT00068692|12072098|FG000|COMPLETED|Step 2: Randomization||0
10905980|NCT00068692|12072099|FG001|COMPLETED|Step 2: Randomization||0
10905981|NCT00068692|12072100|FG002|COMPLETED|Step 2: Randomization||18
10905982|NCT00068692|12072101|FG003|COMPLETED|Step 2: Randomization||13
10905983|NCT00068692|12072102|FG004|COMPLETED|Step 2: Randomization||21
10905984|NCT00068692|12072103|FG005|COMPLETED|Step 2: Randomization||25
10905985|NCT00068692|12072104|FG006|COMPLETED|Step 2: Randomization||29
10905986|NCT00068692|12072105|FG007|COMPLETED|Step 2: Randomization||24
10905987|NCT00068692|12072098|FG000|NOT COMPLETED|Step 2: Randomization||0
10905988|NCT00068692|12072099|FG001|NOT COMPLETED|Step 2: Randomization||0
10905989|NCT00068692|12072100|FG002|NOT COMPLETED|Step 2: Randomization||10
10905990|NCT00068692|12072101|FG003|NOT COMPLETED|Step 2: Randomization||12
10905991|NCT00068692|12072102|FG004|NOT COMPLETED|Step 2: Randomization||9
10905992|NCT00068692|12072103|FG005|NOT COMPLETED|Step 2: Randomization||6
10905993|NCT00068692|12072104|FG006|NOT COMPLETED|Step 2: Randomization||4
10905994|NCT00068692|12072105|FG007|NOT COMPLETED|Step 2: Randomization||8
10905995|NCT00068718|12072118|FG000|STARTED|Overall Study||35
10905996|NCT00068718|12072118|FG000|COMPLETED|Overall Study||35
10905997|NCT00068718|12072118|FG000|NOT COMPLETED|Overall Study||0
10905998|NCT00068770|12072124|FG000|STARTED|Overall Study||13
10905999|NCT00068770|12072125|FG001|STARTED|Overall Study||22
10906000|NCT00068770|12072124|FG000|COMPLETED|Overall Study||13
10906001|NCT00068770|12072125|FG001|COMPLETED|Overall Study||22
10906002|NCT00068770|12072124|FG000|NOT COMPLETED|Overall Study||0
10906003|NCT00068770|12072125|FG001|NOT COMPLETED|Overall Study||0
10906004|NCT00068822|12072135|FG000|STARTED|First Randomized Intervention||68
10906005|NCT00068822|12072136|FG001|STARTED|First Randomized Intervention||63
10906006|NCT00068822|12072135|FG000|COMPLETED|First Randomized Intervention||67
10906007|NCT00068822|12072136|FG001|COMPLETED|First Randomized Intervention||61
10906008|NCT00068822|12072135|FG000|NOT COMPLETED|First Randomized Intervention||1
10906009|NCT00068822|12072136|FG001|NOT COMPLETED|First Randomized Intervention||2
10906010|NCT00068822|12072135|FG000|STARTED|Optional Crossover Intervention||9
10906011|NCT00068822|12072136|FG001|STARTED|Optional Crossover Intervention||29
10906012|NCT00068822|12072135|FG000|Crossover at Month 1|Optional Crossover Intervention||1
10906013|NCT00068822|12072136|FG001|Crossover at Month 1|Optional Crossover Intervention||2
10906014|NCT00068822|12072135|FG000|Crossover at Month 3|Optional Crossover Intervention||8
10906015|NCT00068822|12072136|FG001|Crossover at Month 3|Optional Crossover Intervention||27
10906016|NCT00068822|12072135|FG000|COMPLETED|Optional Crossover Intervention||9
10906017|NCT00068822|12072136|FG001|COMPLETED|Optional Crossover Intervention||29
10906018|NCT00068822|12072135|FG000|NOT COMPLETED|Optional Crossover Intervention||0
10906019|NCT00068822|12072136|FG001|NOT COMPLETED|Optional Crossover Intervention||0
10906020|NCT00069095|12072148|FG000|STARTED|Primary Treatment Phase||317
10906021|NCT00069095|12072149|FG001|STARTED|Primary Treatment Phase||317
10906022|NCT00069095|12072150|FG002|STARTED|Primary Treatment Phase||350
10906023|NCT00069095|12072151|FG003|STARTED|Primary Treatment Phase||351
10906024|NCT00069095|12072152|FG004|STARTED|Primary Treatment Phase||350
10906025|NCT00069095|12072153|FG005|STARTED|Primary Treatment Phase||349
10906026|NCT00069095|12072148|FG000|COMPLETED|Primary Treatment Phase||22
10906027|NCT00069095|12072149|FG001|COMPLETED|Primary Treatment Phase||15
10906028|NCT00069095|12072150|FG002|COMPLETED|Primary Treatment Phase||36
10906029|NCT00069095|12072151|FG003|COMPLETED|Primary Treatment Phase||31
10906030|NCT00069095|12072152|FG004|COMPLETED|Primary Treatment Phase||48
10906031|NCT00069095|12072153|FG005|COMPLETED|Primary Treatment Phase||48
10906032|NCT00069095|12072148|FG000|NOT COMPLETED|Primary Treatment Phase||295
10906033|NCT00069095|12072149|FG001|NOT COMPLETED|Primary Treatment Phase||302
10906034|NCT00069095|12072150|FG002|NOT COMPLETED|Primary Treatment Phase||314
10906035|NCT00069095|12072151|FG003|NOT COMPLETED|Primary Treatment Phase||320
10906036|NCT00069095|12072152|FG004|NOT COMPLETED|Primary Treatment Phase||302
10906037|NCT00069095|12072153|FG005|NOT COMPLETED|Primary Treatment Phase||301
10906038|NCT00069095|12072148|FG000|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
10906039|NCT00069095|12072149|FG001|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
10906040|NCT00069095|12072150|FG002|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
10906041|NCT00069095|12072151|FG003|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
10906042|NCT00069095|12072152|FG004|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
10906043|NCT00069095|12072153|FG005|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
10906044|NCT00069095|12072148|FG000|COMPLETED|Post-study Treatment Phase||0
10906045|NCT00069095|12072149|FG001|COMPLETED|Post-study Treatment Phase||0
10906046|NCT00069095|12072150|FG002|COMPLETED|Post-study Treatment Phase||0
10906047|NCT00069095|12072151|FG003|COMPLETED|Post-study Treatment Phase||0
10906048|NCT00069095|12072152|FG004|COMPLETED|Post-study Treatment Phase||0
10906049|NCT00069095|12072153|FG005|COMPLETED|Post-study Treatment Phase||0
10906050|NCT00069095|12072148|FG000|NOT COMPLETED|Post-study Treatment Phase||8
10906051|NCT00069095|12072149|FG001|NOT COMPLETED|Post-study Treatment Phase||13
10906052|NCT00069095|12072150|FG002|NOT COMPLETED|Post-study Treatment Phase||21
10906053|NCT00069095|12072151|FG003|NOT COMPLETED|Post-study Treatment Phase||17
10906054|NCT00069095|12072152|FG004|NOT COMPLETED|Post-study Treatment Phase||36
10906055|NCT00069095|12072153|FG005|NOT COMPLETED|Post-study Treatment Phase||29
10906056|NCT00069095|12072148|FG000|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
10906057|NCT00069095|12072149|FG001|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
10906058|NCT00069095|12072150|FG002|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
10906059|NCT00069095|12072151|FG003|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
10906060|NCT00069095|12072152|FG004|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
10906061|NCT00069095|12072153|FG005|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
10906062|NCT00069095|12072148|FG000|COMPLETED|Follow-up Phase||110
10906063|NCT00069095|12072149|FG001|COMPLETED|Follow-up Phase||93
10906064|NCT00069095|12072150|FG002|COMPLETED|Follow-up Phase||178
10906065|NCT00069095|12072151|FG003|COMPLETED|Follow-up Phase||187
10906066|NCT00069095|12072152|FG004|COMPLETED|Follow-up Phase||186
10906067|NCT00069095|12072153|FG005|COMPLETED|Follow-up Phase||171
10906068|NCT00069095|12072148|FG000|NOT COMPLETED|Follow-up Phase||174
10906069|NCT00069095|12072149|FG001|NOT COMPLETED|Follow-up Phase||206
10906070|NCT00069095|12072150|FG002|NOT COMPLETED|Follow-up Phase||120
10906071|NCT00069095|12072151|FG003|NOT COMPLETED|Follow-up Phase||112
10906072|NCT00069095|12072152|FG004|NOT COMPLETED|Follow-up Phase||92
10906073|NCT00069095|12072153|FG005|NOT COMPLETED|Follow-up Phase||101
10906074|NCT00069108|12072167|FG000|STARTED|Overall Study||313
10906075|NCT00069108|12072168|FG001|STARTED|Overall Study||314
10906076|NCT00069108|12072167|FG000|COMPLETED|Overall Study||100
10906077|NCT00069108|12072168|FG001|COMPLETED|Overall Study||95
10906078|NCT00069108|12072167|FG000|NOT COMPLETED|Overall Study||213
10906079|NCT00069108|12072168|FG001|NOT COMPLETED|Overall Study||219
10906080|NCT00069121|12072177|FG000|STARTED|Overall Study||942
10906081|NCT00069121|12072178|FG001|STARTED|Overall Study||944
10906082|NCT00069121|12072177|FG000|Received Treatment|Overall Study|Safety Population|926
10906083|NCT00069121|12072178|FG001|Received Treatment|Overall Study|Safety Population|938
10906084|NCT00069121|12072177|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|575
10906085|NCT00069121|12072178|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|619
10906086|NCT00069121|12072177|FG000|NOT COMPLETED|Overall Study||367
10906087|NCT00069121|12072178|FG001|NOT COMPLETED|Overall Study||325
10906088|NCT00069160|12072190|FG000|STARTED|Overall Study||23
10906089|NCT00069160|12072191|FG001|STARTED|Overall Study||25
10906090|NCT00069160|12072190|FG000|COMPLETED|Overall Study||23
10906091|NCT00069160|12072191|FG001|COMPLETED|Overall Study||25
10906092|NCT00069160|12072190|FG000|NOT COMPLETED|Overall Study||0
10906093|NCT00069160|12072191|FG001|NOT COMPLETED|Overall Study||0
10906094|NCT00069264|12072200|FG000|STARTED|Overall Study||32
10906095|NCT00069264|12072200|FG000|COMPLETED|Overall Study||0
10906096|NCT00069264|12072200|FG000|NOT COMPLETED|Overall Study||32
10906097|NCT00069277|12072204|FG000|STARTED|Overall Study||21
10906098|NCT00069277|12072204|FG000|COMPLETED|Overall Study||0
10906099|NCT00069277|12072204|FG000|NOT COMPLETED|Overall Study||21
10906100|NCT00069329|12072208|FG000|STARTED|Overall Study||43
10906101|NCT00069329|12072208|FG000|COMPLETED|Overall Study||41
10906102|NCT00069329|12072208|FG000|NOT COMPLETED|Overall Study||2
10906103|NCT00069576|12072214|FG000|STARTED|Original Trial||485
10906104|NCT00069576|12072215|FG001|STARTED|Original Trial||473
10906105|NCT00069576|12072214|FG000|COMPLETED|Original Trial||460
10906106|NCT00069576|12072215|FG001|COMPLETED|Original Trial||440
10906107|NCT00069576|12072214|FG000|NOT COMPLETED|Original Trial||25
10906108|NCT00069576|12072215|FG001|NOT COMPLETED|Original Trial||33
10906109|NCT00069576|12072214|FG000|STARTED|Follow-up Study at 5-10 Years||460
10906110|NCT00069576|12072215|FG001|STARTED|Follow-up Study at 5-10 Years||440
10906111|NCT00069576|12072214|FG000|COMPLETED|Follow-up Study at 5-10 Years||264
10906112|NCT00069576|12072215|FG001|COMPLETED|Follow-up Study at 5-10 Years||236
10906113|NCT00069576|12072214|FG000|NOT COMPLETED|Follow-up Study at 5-10 Years||196
10906114|NCT00069576|12072215|FG001|NOT COMPLETED|Follow-up Study at 5-10 Years||204
10906115|NCT00069641|12072224|FG000|STARTED|Overall Study||32
10906116|NCT00069641|12072225|FG001|STARTED|Overall Study||32
10906117|NCT00069641|12072226|FG002|STARTED|Overall Study||32
10906118|NCT00069641|12072224|FG000|COMPLETED|Overall Study||31
10906119|NCT00069641|12072225|FG001|COMPLETED|Overall Study||32
10906120|NCT00069641|12072226|FG002|COMPLETED|Overall Study||31
10906121|NCT00069641|12072224|FG000|NOT COMPLETED|Overall Study||1
10906122|NCT00069641|12072225|FG001|NOT COMPLETED|Overall Study||0
10906123|NCT00069641|12072226|FG002|NOT COMPLETED|Overall Study||1
10906124|NCT00069784|12072237|FG000|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
10906125|NCT00069784|12072238|FG001|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
10906126|NCT00069784|12072237|FG000|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
10906127|NCT00069784|12072238|FG001|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
10906128|NCT00069784|12072237|FG000|COMPLETED|Overall Study|completed study treatment|5052
10906129|NCT00069784|12072238|FG001|COMPLETED|Overall Study|not applicable (no treatment)|6273
10906130|NCT00069784|12072237|FG000|NOT COMPLETED|Overall Study||1212
10906131|NCT00069784|12072238|FG001|NOT COMPLETED|Overall Study||0
10906132|NCT00069823|12072246|FG000|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
10906133|NCT00069823|12072247|FG001|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
10906134|NCT00069823|12072246|FG000|COMPLETED|Overall Study||193
10906135|NCT00069823|12072247|FG001|COMPLETED|Overall Study||200
10906136|NCT00069823|12072246|FG000|NOT COMPLETED|Overall Study||6
10906137|NCT00069823|12072247|FG001|NOT COMPLETED|Overall Study||3
10906138|NCT00069953|12072253|FG000|STARTED|Overall Study||43
10906139|NCT00069953|12072253|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
10906140|NCT00069953|12072253|FG000|NOT COMPLETED|Overall Study||2
10906141|NCT00070070|12072261|FG000|STARTED|Overall Study||1
10906142|NCT00070070|12072262|FG001|STARTED|Overall Study||0
10906143|NCT00070070|12072263|FG002|STARTED|Overall Study||0
10906144|NCT00070070|12072264|FG003|STARTED|Overall Study||5
10906145|NCT00070070|12072261|FG000|COMPLETED|Overall Study||1
10906146|NCT00070070|12072262|FG001|COMPLETED|Overall Study||0
10906147|NCT00070070|12072263|FG002|COMPLETED|Overall Study||0
10906148|NCT00070070|12072264|FG003|COMPLETED|Overall Study||5
10906149|NCT00070070|12072261|FG000|NOT COMPLETED|Overall Study||0
10906150|NCT00070070|12072262|FG001|NOT COMPLETED|Overall Study||0
10906151|NCT00070070|12072263|FG002|NOT COMPLETED|Overall Study||0
10906152|NCT00070070|12072264|FG003|NOT COMPLETED|Overall Study||0
10906153|NCT00070109|12072279|FG000|STARTED|Overall Study||8
10906154|NCT00070109|12072280|FG001|STARTED|Overall Study||6
10906155|NCT00070109|12072281|FG002|STARTED|Overall Study||8
10906156|NCT00070109|12072282|FG003|STARTED|Overall Study||20
10906157|NCT00070109|12072283|FG004|STARTED|Overall Study||8
10906158|NCT00070109|12072279|FG000|COMPLETED|Overall Study||0
10906159|NCT00070109|12072280|FG001|COMPLETED|Overall Study||0
10906160|NCT00070109|12072281|FG002|COMPLETED|Overall Study||0
10906161|NCT00070109|12072282|FG003|COMPLETED|Overall Study||0
10906162|NCT00070109|12072283|FG004|COMPLETED|Overall Study||0
10906163|NCT00070109|12072279|FG000|NOT COMPLETED|Overall Study||8
10906164|NCT00070109|12072280|FG001|NOT COMPLETED|Overall Study||6
10906165|NCT00070109|12072281|FG002|NOT COMPLETED|Overall Study||8
10906166|NCT00070109|12072282|FG003|NOT COMPLETED|Overall Study||20
10906167|NCT00070109|12072283|FG004|NOT COMPLETED|Overall Study||8
10906168|NCT00070135|12072302|FG000|STARTED|Overall Study||114
10906169|NCT00070135|12072302|FG000|COMPLETED|Overall Study||114
10906170|NCT00070135|12072302|FG000|NOT COMPLETED|Overall Study||0
10906171|NCT00070291|12072306|FG000|STARTED|Step 1||4
10906172|NCT00070291|12072306|FG000|Treated|Step 1||3
10906173|NCT00070291|12072306|FG000|COMPLETED|Step 1||2
10906174|NCT00070291|12072306|FG000|NOT COMPLETED|Step 1||2
10906175|NCT00070291|12072306|FG000|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
10906176|NCT00070291|12072306|FG000|COMPLETED|Step 2||0
10906177|NCT00070291|12072306|FG000|NOT COMPLETED|Step 2||1
10906178|NCT00070317|12072310|FG000|STARTED|Overall Study||102
10906179|NCT00070317|12072310|FG000|COMPLETED|Overall Study||89
10906180|NCT00070317|12072310|FG000|NOT COMPLETED|Overall Study||13
10906181|NCT00070941|12072317|FG000|STARTED|Overall Study||12
10906182|NCT00070941|12072318|FG001|STARTED|Overall Study||11
10906183|NCT00070941|12072319|FG002|STARTED|Overall Study||6
10906184|NCT00070941|12072317|FG000|COMPLETED|Overall Study||2
10906185|NCT00070941|12072318|FG001|COMPLETED|Overall Study||3
10906186|NCT00070941|12072319|FG002|COMPLETED|Overall Study||2
10906187|NCT00070941|12072317|FG000|NOT COMPLETED|Overall Study||10
10906188|NCT00070941|12072318|FG001|NOT COMPLETED|Overall Study||8
10906189|NCT00070941|12072319|FG002|NOT COMPLETED|Overall Study||4
10906190|NCT00071006|12072327|FG000|STARTED|Overall Study||12
10906191|NCT00071006|12072327|FG000|COMPLETED|Overall Study||0
10906192|NCT00071006|12072327|FG000|NOT COMPLETED|Overall Study||12
10906193|NCT00071032|12072333|FG000|STARTED|Overall Study||1007
10906194|NCT00071032|12072334|FG001|STARTED|Overall Study||1009
10906195|NCT00071032|12072333|FG000|COMPLETED|Overall Study||998
10906196|NCT00071032|12072334|FG001|COMPLETED|Overall Study||1001
10906197|NCT00071032|12072333|FG000|NOT COMPLETED|Overall Study||9
10906198|NCT00071032|12072334|FG001|NOT COMPLETED|Overall Study||8
10906199|NCT00071058|12072341|FG000|STARTED|Overall Study||50
10906200|NCT00071058|12072341|FG000|COMPLETED|Overall Study||49
10906201|NCT00071058|12072341|FG000|NOT COMPLETED|Overall Study||1
10906202|NCT00071110|12072348|FG000|STARTED|Overall Study||28
10906203|NCT00071110|12072349|FG001|STARTED|Overall Study||29
10906204|NCT00071110|12072348|FG000|COMPLETED|Overall Study||28
10906205|NCT00071110|12072349|FG001|COMPLETED|Overall Study||25
10906206|NCT00071110|12072348|FG000|NOT COMPLETED|Overall Study||0
10906207|NCT00071110|12072349|FG001|NOT COMPLETED|Overall Study||4
10906208|NCT00071396|12072355|FG000|STARTED|Overall Study||44
10906209|NCT00071396|12072355|FG000|COMPLETED|Overall Study|Evaluable for response.|41
10906210|NCT00071396|12072355|FG000|NOT COMPLETED|Overall Study||3
10906211|NCT00071487|12072363|FG000|STARTED|52-Week Double-Blind Period||113
10906212|NCT00071487|12072364|FG001|STARTED|52-Week Double-Blind Period||114
10906213|NCT00071487|12072365|FG002|STARTED|52-Week Double-Blind Period||111
10906214|NCT00071487|12072366|FG003|STARTED|52-Week Double-Blind Period||111
10906215|NCT00071487|12072363|FG000|COMPLETED|52-Week Double-Blind Period||93
10906216|NCT00071487|12072364|FG001|COMPLETED|52-Week Double-Blind Period||87
10906217|NCT00071487|12072365|FG002|COMPLETED|52-Week Double-Blind Period||94
10906218|NCT00071487|12072366|FG003|COMPLETED|52-Week Double-Blind Period||90
10906219|NCT00071487|12072363|FG000|NOT COMPLETED|52-Week Double-Blind Period||20
10906220|NCT00071487|12072364|FG001|NOT COMPLETED|52-Week Double-Blind Period||27
10906221|NCT00071487|12072365|FG002|NOT COMPLETED|52-Week Double-Blind Period||17
10906222|NCT00071487|12072366|FG003|NOT COMPLETED|52-Week Double-Blind Period||21
10906223|NCT00071487|12072363|FG000|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
10906297|NCT00071981|12072455|FG000|Eligible|Overall Study||43
10906224|NCT00071487|12072364|FG001|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
10906225|NCT00071487|12072365|FG002|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
10906226|NCT00071487|12072366|FG003|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
10906227|NCT00071487|12072363|FG000|COMPLETED|24-Week Open-Label Extension Period||0
10906228|NCT00071487|12072364|FG001|COMPLETED|24-Week Open-Label Extension Period||19
10906229|NCT00071487|12072365|FG002|COMPLETED|24-Week Open-Label Extension Period||23
10906230|NCT00071487|12072366|FG003|COMPLETED|24-Week Open-Label Extension Period||279
10906231|NCT00071487|12072363|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0
10906232|NCT00071487|12072364|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0
10906233|NCT00071487|12072365|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1
10906234|NCT00071487|12072366|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||23
10906235|NCT00071513|12072380|FG000|STARTED|Intervention Component||241
10906236|NCT00071513|12072381|FG001|STARTED|Intervention Component||256
10906237|NCT00071513|12072380|FG000|COMPLETED|Intervention Component||239
10906238|NCT00071513|12072381|FG001|COMPLETED|Intervention Component||253
10906239|NCT00071513|12072380|FG000|NOT COMPLETED|Intervention Component||2
10906240|NCT00071513|12072381|FG001|NOT COMPLETED|Intervention Component||3
10906241|NCT00071513|12072380|FG000|STARTED|Follow-up Assessment||239
10906242|NCT00071513|12072381|FG001|STARTED|Follow-up Assessment||253
10906243|NCT00071513|12072380|FG000|COMPLETED|Follow-up Assessment||233
10906244|NCT00071513|12072381|FG001|COMPLETED|Follow-up Assessment||247
10906245|NCT00071513|12072380|FG000|NOT COMPLETED|Follow-up Assessment||6
10906246|NCT00071513|12072381|FG001|NOT COMPLETED|Follow-up Assessment||6
10906247|NCT00071721|12072391|FG000|STARTED|Overall Study||153
10906248|NCT00071721|12072392|FG001|STARTED|Overall Study||160
10906249|NCT00071721|12072391|FG000|COMPLETED|Overall Study||81
10906250|NCT00071721|12072392|FG001|COMPLETED|Overall Study||69
10906251|NCT00071721|12072391|FG000|NOT COMPLETED|Overall Study||72
10906252|NCT00071721|12072392|FG001|NOT COMPLETED|Overall Study||91
10906253|NCT00071760|12072398|FG000|STARTED|Overall Study||54
10906254|NCT00071760|12072398|FG000|Ongoing|Overall Study||25
10906255|NCT00071760|12072398|FG000|COMPLETED|Overall Study||0
10906256|NCT00071760|12072398|FG000|NOT COMPLETED|Overall Study||54
10906257|NCT00071799|12072410|FG000|STARTED|Overall Study||179
10906258|NCT00071799|12072411|FG001|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
10906259|NCT00071799|12072410|FG000|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
10906260|NCT00071799|12072411|FG001|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
10906261|NCT00071799|12072410|FG000|NOT COMPLETED|Overall Study||70
10906262|NCT00071799|12072411|FG001|NOT COMPLETED|Overall Study||98
10906263|NCT00071812|12072427|FG000|STARTED|24-Week Double-Blind Period||69
10906264|NCT00071812|12072428|FG001|STARTED|24-Week Double-Blind Period||72
10906265|NCT00071812|12072429|FG002|STARTED|24-Week Double-Blind Period||71
10906266|NCT00071812|12072430|FG003|STARTED|24-Week Double-Blind Period||71
10906267|NCT00071812|12072427|FG000|COMPLETED|24-Week Double-Blind Period||59
10906268|NCT00071812|12072428|FG001|COMPLETED|24-Week Double-Blind Period||66
10906269|NCT00071812|12072429|FG002|COMPLETED|24-Week Double-Blind Period||63
10906270|NCT00071812|12072430|FG003|COMPLETED|24-Week Double-Blind Period||60
10906271|NCT00071812|12072427|FG000|NOT COMPLETED|24-Week Double-Blind Period||10
10906272|NCT00071812|12072428|FG001|NOT COMPLETED|24-Week Double-Blind Period||6
10906273|NCT00071812|12072429|FG002|NOT COMPLETED|24-Week Double-Blind Period||8
10906274|NCT00071812|12072430|FG003|NOT COMPLETED|24-Week Double-Blind Period||11
10906275|NCT00071812|12072427|FG000|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
10906276|NCT00071812|12072428|FG001|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
10906277|NCT00071812|12072429|FG002|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
10906278|NCT00071812|12072430|FG003|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
10906279|NCT00071812|12072427|FG000|COMPLETED|24-Week Open-Label Extension Period||0
10906280|NCT00071812|12072428|FG001|COMPLETED|24-Week Open-Label Extension Period||11
10906281|NCT00071812|12072429|FG002|COMPLETED|24-Week Open-Label Extension Period||7
10906282|NCT00071812|12072430|FG003|COMPLETED|24-Week Open-Label Extension Period||178
10906283|NCT00071812|12072427|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0
10906284|NCT00071812|12072428|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0
10906285|NCT00071812|12072429|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1
10906286|NCT00071812|12072430|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||40
10906287|NCT00071890|12072444|FG000|STARTED|Overall Study|3 patients did not received Interleukin-2|81
10906288|NCT00071890|12072445|FG001|STARTED|Overall Study|1 patients stopped HAART at week 0|67
10906289|NCT00071890|12072444|FG000|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
10906290|NCT00071890|12072445|FG001|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
10906291|NCT00071890|12072444|FG000|NOT COMPLETED|Overall Study||0
10906292|NCT00071890|12072445|FG001|NOT COMPLETED|Overall Study||0
10906293|NCT00071981|12072455|FG000|STARTED|Overall Study||47
10906294|NCT00071981|12072456|FG001|STARTED|Overall Study||43
10906295|NCT00071981|12072457|FG002|STARTED|Overall Study||37
10906296|NCT00071981|12072458|FG003|STARTED|Overall Study||48
10906298|NCT00071981|12072456|FG001|Eligible|Overall Study||36
10906299|NCT00071981|12072457|FG002|Eligible|Overall Study||33
10906300|NCT00071981|12072458|FG003|Eligible|Overall Study||42
10906301|NCT00071981|12072455|FG000|Treated|Overall Study||45
10906302|NCT00071981|12072456|FG001|Treated|Overall Study||38
10906303|NCT00071981|12072457|FG002|Treated|Overall Study||36
10906304|NCT00071981|12072458|FG003|Treated|Overall Study||48
10906305|NCT00071981|12072455|FG000|Eligible and Treated|Overall Study||41
10906306|NCT00071981|12072456|FG001|Eligible and Treated|Overall Study||33
10906307|NCT00071981|12072457|FG002|Eligible and Treated|Overall Study||32
10906308|NCT00071981|12072458|FG003|Eligible and Treated|Overall Study||42
10906309|NCT00071981|12072455|FG000|Have CTL Response Data|Overall Study||40
10906310|NCT00071981|12072456|FG001|Have CTL Response Data|Overall Study||30
10906311|NCT00071981|12072457|FG002|Have CTL Response Data|Overall Study||29
10906312|NCT00071981|12072458|FG003|Have CTL Response Data|Overall Study||41
10906313|NCT00071981|12072455|FG000|Have Helper T Cell Response Data|Overall Study||37
10906314|NCT00071981|12072456|FG001|Have Helper T Cell Response Data|Overall Study||27
10906315|NCT00071981|12072457|FG002|Have Helper T Cell Response Data|Overall Study||25
10906316|NCT00071981|12072458|FG003|Have Helper T Cell Response Data|Overall Study||39
10906317|NCT00071981|12072455|FG000|COMPLETED|Overall Study||1
10906318|NCT00071981|12072456|FG001|COMPLETED|Overall Study||2
10906319|NCT00071981|12072457|FG002|COMPLETED|Overall Study||0
10906320|NCT00071981|12072458|FG003|COMPLETED|Overall Study||3
10906321|NCT00071981|12072455|FG000|NOT COMPLETED|Overall Study||46
10906322|NCT00071981|12072456|FG001|NOT COMPLETED|Overall Study||41
10906323|NCT00071981|12072457|FG002|NOT COMPLETED|Overall Study||37
10906324|NCT00071981|12072458|FG003|NOT COMPLETED|Overall Study||45
10906325|NCT00072176|12072470|FG000|STARTED|Overall Study||34
10906326|NCT00072176|12072471|FG001|STARTED|Overall Study||28
10906327|NCT00072176|12072470|FG000|COMPLETED|Overall Study||33
10906328|NCT00072176|12072471|FG001|COMPLETED|Overall Study||27
10906329|NCT00072176|12072470|FG000|NOT COMPLETED|Overall Study||1
10906330|NCT00072176|12072471|FG001|NOT COMPLETED|Overall Study||1
10906331|NCT00072189|12072477|FG000|STARTED|Overall Study||17
10906332|NCT00072189|12072477|FG000|COMPLETED|Overall Study||16
10906333|NCT00072189|12072477|FG000|NOT COMPLETED|Overall Study||1
10906334|NCT00072280|12072483|FG000|STARTED|Treatment||3
10906335|NCT00072280|12072484|FG001|STARTED|Treatment||4
10906336|NCT00072280|12072483|FG000|COMPLETED|Treatment||2
10906337|NCT00072280|12072484|FG001|COMPLETED|Treatment||2
10906338|NCT00072280|12072483|FG000|NOT COMPLETED|Treatment||1
10906339|NCT00072280|12072484|FG001|NOT COMPLETED|Treatment||2
10906340|NCT00072280|12072483|FG000|STARTED|Follow-up||2
10906341|NCT00072280|12072484|FG001|STARTED|Follow-up||2
10906342|NCT00072280|12072483|FG000|COMPLETED|Follow-up||0
10906343|NCT00072280|12072484|FG001|COMPLETED|Follow-up||0
10906344|NCT00072280|12072483|FG000|NOT COMPLETED|Follow-up||2
10906345|NCT00072280|12072484|FG001|NOT COMPLETED|Follow-up||2
10906346|NCT00072293|12072491|FG000|STARTED|Overall Study||465
10906347|NCT00072293|12072492|FG001|STARTED|Overall Study||469
10906348|NCT00072293|12072491|FG000|COMPLETED|Overall Study||464
10906349|NCT00072293|12072492|FG001|COMPLETED|Overall Study||467
10906350|NCT00072293|12072491|FG000|NOT COMPLETED|Overall Study||1
10906351|NCT00072293|12072492|FG001|NOT COMPLETED|Overall Study||2
10906352|NCT00072384|12072498|FG000|STARTED|Overall Study||30
10906353|NCT00072384|12072498|FG000|COMPLETED|Overall Study||21
10906354|NCT00072384|12072498|FG000|NOT COMPLETED|Overall Study||9
10906355|NCT00072449|12072504|FG000|STARTED|Overall Study||12
10906356|NCT00072449|12072504|FG000|COMPLETED|Overall Study||12
10906357|NCT00072449|12072504|FG000|NOT COMPLETED|Overall Study||0
10906358|NCT00072475|12072508|FG000|STARTED|Overall Study||142
10906359|NCT00072475|12072508|FG000|COMPLETED|Overall Study||45
10906360|NCT00072475|12072508|FG000|NOT COMPLETED|Overall Study||97
10906361|NCT00072514|12072512|FG000|STARTED|Overall Study||55
10906362|NCT00072514|12072512|FG000|COMPLETED|Overall Study||51
10906363|NCT00072514|12072512|FG000|NOT COMPLETED|Overall Study||4
10906364|NCT00072566|12072516|FG000|STARTED|Overall Study||70
10906365|NCT00072566|12072516|FG000|COMPLETED|Overall Study||70
10906366|NCT00072566|12072516|FG000|NOT COMPLETED|Overall Study||0
10906367|NCT00072761|12072522|FG000|STARTED|Overall Study||99
10906368|NCT00072761|12072523|FG001|STARTED|Overall Study||97
10906369|NCT00072761|12072522|FG000|COMPLETED|Overall Study||90
10906370|NCT00072761|12072523|FG001|COMPLETED|Overall Study||95
10906371|NCT00072761|12072522|FG000|NOT COMPLETED|Overall Study||9
10906372|NCT00072761|12072523|FG001|NOT COMPLETED|Overall Study||2
10906373|NCT00073008|12072531|FG000|STARTED|Overall Study||65
10906374|NCT00073008|12072532|FG001|STARTED|Overall Study||66
10906375|NCT00073008|12072531|FG000|COMPLETED|Overall Study||3
10906376|NCT00073008|12072532|FG001|COMPLETED|Overall Study||3
10906377|NCT00073008|12072531|FG000|NOT COMPLETED|Overall Study||62
10906378|NCT00073008|12072532|FG001|NOT COMPLETED|Overall Study||63
10906379|NCT00073021|12072540|FG000|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
10906380|NCT00073021|12072541|FG001|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
10906381|NCT00073021|12072540|FG000|COMPLETED|Overall Study||113
10906382|NCT00073021|12072541|FG001|COMPLETED|Overall Study||113
10906383|NCT00073021|12072540|FG000|NOT COMPLETED|Overall Study||26
10906384|NCT00073021|12072541|FG001|NOT COMPLETED|Overall Study||16
10906385|NCT00073073|12072547|FG000|STARTED|Overall Study||46
10906386|NCT00073073|12072547|FG000|COMPLETED|Overall Study||42
10906387|NCT00073073|12072547|FG000|NOT COMPLETED|Overall Study||4
10906388|NCT00073307|12072553|FG000|STARTED|Double-Blind (DB, as of ~31May2005)||451
10906389|NCT00073307|12072554|FG001|STARTED|Double-Blind (DB, as of ~31May2005)||452
10906390|NCT00073307|12072555|FG002|STARTED|Double-Blind (DB, as of ~31May2005)||0
10906391|NCT00073307|12072553|FG000|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
10906392|NCT00073307|12072554|FG001|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
10906393|NCT00073307|12072555|FG002|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
10906394|NCT00073307|12072553|FG000|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
10906395|NCT00073307|12072554|FG001|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
10906396|NCT00073307|12072555|FG002|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
10906397|NCT00073307|12072553|FG000|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
10906398|NCT00073307|12072554|FG001|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
10906399|NCT00073307|12072555|FG002|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
10906400|NCT00073307|12072553|FG000|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
10906401|NCT00073307|12072554|FG001|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
10906402|NCT00073307|12072555|FG002|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
10906403|NCT00073307|12072553|FG000|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
10906404|NCT00073307|12072554|FG001|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
10906405|NCT00073307|12072555|FG002|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
10906406|NCT00073307|12072553|FG000|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
10906407|NCT00073307|12072554|FG001|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
10906408|NCT00073307|12072555|FG002|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
10906409|NCT00073307|12072553|FG000|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
10906410|NCT00073307|12072554|FG001|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
10906411|NCT00073307|12072555|FG002|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
10906412|NCT00073333|12072567|FG000|STARTED|Overall Study||46
10906413|NCT00073333|12072568|FG001|STARTED|Overall Study||41
10906414|NCT00073333|12072569|FG002|STARTED|Overall Study||19
10906415|NCT00073333|12072567|FG000|COMPLETED|Overall Study||32
10906416|NCT00073333|12072568|FG001|COMPLETED|Overall Study||27
10906417|NCT00073333|12072569|FG002|COMPLETED|Overall Study||19
10906418|NCT00073333|12072567|FG000|NOT COMPLETED|Overall Study||14
10906419|NCT00073333|12072568|FG001|NOT COMPLETED|Overall Study||14
10906420|NCT00073333|12072569|FG002|NOT COMPLETED|Overall Study||0
10906421|NCT00073528|12072579|FG000|STARTED|Overall Study||644
10906422|NCT00073528|12072580|FG001|STARTED|Overall Study||642
10906423|NCT00073528|12072579|FG000|COMPLETED|Overall Study||14
10906424|NCT00073528|12072580|FG001|COMPLETED|Overall Study||14
10906425|NCT00073528|12072579|FG000|NOT COMPLETED|Overall Study||630
10906426|NCT00073528|12072580|FG001|NOT COMPLETED|Overall Study||628
10906427|NCT00073749|12072593|FG000|STARTED|Overall Study||2
10906428|NCT00073749|12072594|FG001|STARTED|Overall Study||5
10906429|NCT00073749|12072595|FG002|STARTED|Overall Study||11
10906430|NCT00073749|12072596|FG003|STARTED|Overall Study||6
10906431|NCT00073749|12072597|FG004|STARTED|Overall Study||6
10906432|NCT00073749|12072598|FG005|STARTED|Overall Study||6
10906433|NCT00073749|12072599|FG006|STARTED|Overall Study||43
10906434|NCT00073749|12072593|FG000|COMPLETED|Overall Study||0
10906435|NCT00073749|12072594|FG001|COMPLETED|Overall Study||0
10906436|NCT00073749|12072595|FG002|COMPLETED|Overall Study||0
10906437|NCT00073749|12072596|FG003|COMPLETED|Overall Study||0
10906438|NCT00073749|12072597|FG004|COMPLETED|Overall Study||0
10906439|NCT00073749|12072598|FG005|COMPLETED|Overall Study||0
10906440|NCT00073749|12072599|FG006|COMPLETED|Overall Study||3
10906441|NCT00073749|12072593|FG000|NOT COMPLETED|Overall Study||2
10906442|NCT00073749|12072594|FG001|NOT COMPLETED|Overall Study||5
10906443|NCT00073749|12072595|FG002|NOT COMPLETED|Overall Study||11
10906444|NCT00073749|12072596|FG003|NOT COMPLETED|Overall Study||6
10906445|NCT00073749|12072597|FG004|NOT COMPLETED|Overall Study||6
10906446|NCT00073749|12072598|FG005|NOT COMPLETED|Overall Study||6
10906447|NCT00073749|12072599|FG006|NOT COMPLETED|Overall Study||40
10906448|NCT00073918|12072618|FG000|STARTED|Overall Study||111
10906449|NCT00073918|12072618|FG000|COMPLETED|Overall Study||107
10906450|NCT00073918|12072618|FG000|NOT COMPLETED|Overall Study||4
10906451|NCT00073957|12072622|FG000|STARTED|Overall Study||25
10906452|NCT00073957|12072622|FG000|COMPLETED|Overall Study||25
10906453|NCT00073957|12072622|FG000|NOT COMPLETED|Overall Study||0
10906454|NCT00073983|12072628|FG000|STARTED|Overall Study||54
10906455|NCT00073983|12072628|FG000|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
10906456|NCT00073983|12072628|FG000|NOT COMPLETED|Overall Study||1
10906457|NCT00074035|12072634|FG000|STARTED|Overall Study||38
10906458|NCT00074035|12072634|FG000|COMPLETED|Overall Study||38
10906459|NCT00074035|12072634|FG000|NOT COMPLETED|Overall Study||0
10906460|NCT00074152|12072640|FG000|STARTED|Overall Study||77
10906461|NCT00074152|12072641|FG001|STARTED|Overall Study||85
10906462|NCT00074152|12072640|FG000|COMPLETED|Overall Study||22
10906463|NCT00074152|12072641|FG001|COMPLETED|Overall Study||52
10906464|NCT00074152|12072640|FG000|NOT COMPLETED|Overall Study||55
10906465|NCT00074152|12072641|FG001|NOT COMPLETED|Overall Study||33
10906466|NCT00074165|12072648|FG000|STARTED|Overall Study||17
10906467|NCT00074165|12072648|FG000|COMPLETED|Overall Study||17
10906468|NCT00074165|12072648|FG000|NOT COMPLETED|Overall Study||0
10906469|NCT00074269|12072652|FG000|STARTED|Overall Study||5
10906470|NCT00074269|12072652|FG000|COMPLETED|Overall Study||5
10906471|NCT00074269|12072652|FG000|NOT COMPLETED|Overall Study||0
10906472|NCT00074282|12072660|FG000|STARTED|Step 1||102
10906473|NCT00074282|12072661|FG001|STARTED|Step 1||0
10906474|NCT00074282|12072662|FG002|STARTED|Step 1||0
10906475|NCT00074282|12072660|FG000|Eligible|Step 1||98
10906476|NCT00074282|12072661|FG001|Eligible|Step 1||0
10906477|NCT00074282|12072662|FG002|Eligible|Step 1||0
10906478|NCT00074282|12072660|FG000|Started Treatment|Step 1||96
10906479|NCT00074282|12072661|FG001|Started Treatment|Step 1||0
10906480|NCT00074282|12072662|FG002|Started Treatment|Step 1||0
10906481|NCT00074282|12072660|FG000|COMPLETED|Step 1||44
10906482|NCT00074282|12072661|FG001|COMPLETED|Step 1||0
10906483|NCT00074282|12072662|FG002|COMPLETED|Step 1||0
10906484|NCT00074282|12072660|FG000|NOT COMPLETED|Step 1||58
10906485|NCT00074282|12072661|FG001|NOT COMPLETED|Step 1||0
10906486|NCT00074282|12072662|FG002|NOT COMPLETED|Step 1||0
10906487|NCT00074282|12072660|FG000|STARTED|Step 2||0
10906488|NCT00074282|12072661|FG001|STARTED|Step 2||9
10906489|NCT00074282|12072662|FG002|STARTED|Step 2||31
10906490|NCT00074282|12072660|FG000|COMPLETED|Step 2||0
10906491|NCT00074282|12072661|FG001|COMPLETED|Step 2||7
10906492|NCT00074282|12072662|FG002|COMPLETED|Step 2||7
10906493|NCT00074282|12072660|FG000|NOT COMPLETED|Step 2||0
10906494|NCT00074282|12072661|FG001|NOT COMPLETED|Step 2||2
10906495|NCT00074282|12072662|FG002|NOT COMPLETED|Step 2||24
10906496|NCT00074308|12072672|FG000|STARTED|Overall Study||3
10906497|NCT00074308|12072673|FG001|STARTED|Overall Study||3
10906498|NCT00074308|12072674|FG002|STARTED|Overall Study||3
10906499|NCT00074308|12072675|FG003|STARTED|Overall Study||8
10906500|NCT00074308|12072676|FG004|STARTED|Overall Study||23
10906501|NCT00074308|12072672|FG000|COMPLETED|Overall Study||3
10906502|NCT00074308|12072673|FG001|COMPLETED|Overall Study||3
10906503|NCT00074308|12072674|FG002|COMPLETED|Overall Study||3
10906504|NCT00074308|12072675|FG003|COMPLETED|Overall Study||8
10906505|NCT00074308|12072676|FG004|COMPLETED|Overall Study||23
10906506|NCT00074308|12072672|FG000|NOT COMPLETED|Overall Study||0
10906507|NCT00074308|12072673|FG001|NOT COMPLETED|Overall Study||0
10906508|NCT00074308|12072674|FG002|NOT COMPLETED|Overall Study||0
10906509|NCT00074308|12072675|FG003|NOT COMPLETED|Overall Study||0
10906510|NCT00074308|12072676|FG004|NOT COMPLETED|Overall Study||0
10906511|NCT00074490|12072691|FG000|STARTED|Overall Study||1
10906512|NCT00074490|12072692|FG001|STARTED|Overall Study||34
10906513|NCT00074490|12072693|FG002|STARTED|Overall Study||40
10906514|NCT00074490|12072694|FG003|STARTED|Overall Study||44
10906515|NCT00074490|12072695|FG004|STARTED|Overall Study||45
10906516|NCT00074490|12072696|FG005|STARTED|Overall Study||221
10906517|NCT00074490|12072691|FG000|COMPLETED|Overall Study||1
10906518|NCT00074490|12072692|FG001|COMPLETED|Overall Study||27
10906519|NCT00074490|12072693|FG002|COMPLETED|Overall Study||40
10906520|NCT00074490|12072694|FG003|COMPLETED|Overall Study||44
10906521|NCT00074490|12072695|FG004|COMPLETED|Overall Study||42
10906522|NCT00074490|12072696|FG005|COMPLETED|Overall Study||221
10906523|NCT00074490|12072691|FG000|NOT COMPLETED|Overall Study||0
10906524|NCT00074490|12072692|FG001|NOT COMPLETED|Overall Study||7
10906525|NCT00074490|12072693|FG002|NOT COMPLETED|Overall Study||0
10906526|NCT00074490|12072694|FG003|NOT COMPLETED|Overall Study||0
10906527|NCT00074490|12072695|FG004|NOT COMPLETED|Overall Study||3
10906528|NCT00074490|12072696|FG005|NOT COMPLETED|Overall Study||0
10906529|NCT00074581|12072711|FG000|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
10906530|NCT00074581|12072712|FG001|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
10906531|NCT00074581|12072711|FG000|COMPLETED|Overall Study||1545
10906532|NCT00074581|12072712|FG001|COMPLETED|Overall Study||1541
10906533|NCT00074581|12072711|FG000|NOT COMPLETED|Overall Study||244
10906534|NCT00074581|12072712|FG001|NOT COMPLETED|Overall Study||226
10906535|NCT00074711|12072720|FG000|STARTED|Overall Study||120
10906536|NCT00074711|12072721|FG001|STARTED|Overall Study||121
10906537|NCT00074711|12072720|FG000|COMPLETED|Overall Study||105
10906538|NCT00074711|12072721|FG001|COMPLETED|Overall Study||106
10906539|NCT00074711|12072720|FG000|NOT COMPLETED|Overall Study||15
10906540|NCT00074711|12072721|FG001|NOT COMPLETED|Overall Study||15
10906541|NCT00074802|12072729|FG000|STARTED|Overall Study||29
10906542|NCT00074802|12072730|FG001|STARTED|Overall Study||32
10906543|NCT00074802|12072729|FG000|COMPLETED|Overall Study||20
10906544|NCT00074802|12072730|FG001|COMPLETED|Overall Study||25
10906545|NCT00074802|12072729|FG000|NOT COMPLETED|Overall Study||9
10906546|NCT00074802|12072730|FG001|NOT COMPLETED|Overall Study||7
10906547|NCT00074815|12072739|FG000|STARTED|Overall Study||42
10906548|NCT00074815|12072740|FG001|STARTED|Overall Study||40
10906549|NCT00074815|12072741|FG002|STARTED|Overall Study||42
10906550|NCT00074815|12072739|FG000|COMPLETED|Overall Study||37
10906551|NCT00074815|12072740|FG001|COMPLETED|Overall Study||34
10906552|NCT00074815|12072741|FG002|COMPLETED|Overall Study||30
10906553|NCT00074815|12072739|FG000|NOT COMPLETED|Overall Study||5
10906554|NCT00074815|12072740|FG001|NOT COMPLETED|Overall Study||6
10906555|NCT00074815|12072741|FG002|NOT COMPLETED|Overall Study||12
10906556|NCT00074958|12072749|FG000|STARTED|Overall Study||16
10906557|NCT00074958|12072749|FG000|COMPLETED|Overall Study||15
10906558|NCT00074958|12072749|FG000|NOT COMPLETED|Overall Study||1
10906559|NCT00074984|12072755|FG000|STARTED|Overall Study||31
10906560|NCT00074984|12072756|FG001|STARTED|Overall Study||51
10906561|NCT00074984|12072755|FG000|COMPLETED|Overall Study||28
10906562|NCT00074984|12072756|FG001|COMPLETED|Overall Study||43
10906563|NCT00074984|12072755|FG000|NOT COMPLETED|Overall Study||3
10906564|NCT00074984|12072756|FG001|NOT COMPLETED|Overall Study||8
10906565|NCT00075023|12072765|FG000|STARTED|Pilot Study||5
10906566|NCT00075023|12072766|FG001|STARTED|Pilot Study||5
10906567|NCT00075023|12072765|FG000|COMPLETED|Pilot Study||3
10906568|NCT00075023|12072766|FG001|COMPLETED|Pilot Study||3
10906569|NCT00075023|12072765|FG000|NOT COMPLETED|Pilot Study||2
10906570|NCT00075023|12072766|FG001|NOT COMPLETED|Pilot Study||2
10906571|NCT00075023|12072765|FG000|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
10906572|NCT00075023|12072766|FG001|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
10906573|NCT00075023|12072765|FG000|COMPLETED|Part Two||0
10906574|NCT00075023|12072766|FG001|COMPLETED|Part Two||0
10906575|NCT00075023|12072765|FG000|NOT COMPLETED|Part Two||0
10906576|NCT00075023|12072766|FG001|NOT COMPLETED|Part Two||0
10906577|NCT00075088|12072775|FG000|STARTED|Overall Study||403
10906578|NCT00075088|12072776|FG001|STARTED|Overall Study||391
10906579|NCT00075088|12072775|FG000|COMPLETED|Overall Study||403
10906580|NCT00075088|12072776|FG001|COMPLETED|Overall Study||391
10906581|NCT00075088|12072775|FG000|NOT COMPLETED|Overall Study||0
10906582|NCT00075088|12072776|FG001|NOT COMPLETED|Overall Study||0
10906583|NCT00075218|12072785|FG000|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
10906584|NCT00075218|12072786|FG001|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
10906585|NCT00075218|12072787|FG002|STARTED|Double-Blind Treatment||0
10906586|NCT00075218|12072785|FG000|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
10906587|NCT00075218|12072786|FG001|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
10906588|NCT00075218|12072787|FG002|Received Double-Blind Treatment|Double-Blind Treatment||0
10906589|NCT00075218|12072785|FG000|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
10906590|NCT00075218|12072786|FG001|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
10906591|NCT00075218|12072787|FG002|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
10906592|NCT00075218|12072785|FG000|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
10906593|NCT00075218|12072786|FG001|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
10906594|NCT00075218|12072787|FG002|COMPLETED|Double-Blind Treatment||0
10906595|NCT00075218|12072785|FG000|NOT COMPLETED|Double-Blind Treatment||91
10906596|NCT00075218|12072786|FG001|NOT COMPLETED|Double-Blind Treatment||15
10906597|NCT00075218|12072787|FG002|NOT COMPLETED|Double-Blind Treatment||0
10906598|NCT00075218|12072785|FG000|STARTED|Open-Label Treatment||0
10906599|NCT00075218|12072786|FG001|STARTED|Open-Label Treatment||0
10906600|NCT00075218|12072787|FG002|STARTED|Open-Label Treatment||255
10906601|NCT00075218|12072785|FG000|COMPLETED|Open-Label Treatment||0
10906602|NCT00075218|12072786|FG001|COMPLETED|Open-Label Treatment||0
10906603|NCT00075218|12072787|FG002|COMPLETED|Open-Label Treatment||0
10906604|NCT00075218|12072785|FG000|NOT COMPLETED|Open-Label Treatment||0
10906605|NCT00075218|12072786|FG001|NOT COMPLETED|Open-Label Treatment||0
10906606|NCT00075218|12072787|FG002|NOT COMPLETED|Open-Label Treatment||255
10906607|NCT00075270|12072796|FG000|STARTED|Overall Study||291
10906608|NCT00075270|12072797|FG001|STARTED|Overall Study||288
10906609|NCT00075270|12072796|FG000|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
10906610|NCT00075270|12072797|FG001|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
10906611|NCT00075270|12072796|FG000|COMPLETED|Overall Study||5
10906612|NCT00075270|12072797|FG001|COMPLETED|Overall Study||4
10906613|NCT00075270|12072796|FG000|NOT COMPLETED|Overall Study||286
10906614|NCT00075270|12072797|FG001|NOT COMPLETED|Overall Study||284
10906615|NCT00075335|12072804|FG000|STARTED|Overall Study||8
10906616|NCT00075335|12072804|FG000|COMPLETED|Overall Study||8
10906617|NCT00075335|12072804|FG000|NOT COMPLETED|Overall Study||0
10906618|NCT00075400|12072808|FG000|STARTED|Overall Study||26
10906619|NCT00075400|12072808|FG000|COMPLETED|Overall Study|Eligible and treated patients.|23
10906620|NCT00075400|12072808|FG000|NOT COMPLETED|Overall Study||3
10906621|NCT00075478|12072819|FG000|STARTED|Overall Study||42
10906622|NCT00075478|12072820|FG001|STARTED|Overall Study||45
10906623|NCT00075478|12072819|FG000|COMPLETED|Overall Study||41
10906624|NCT00075478|12072820|FG001|COMPLETED|Overall Study||44
10906625|NCT00075478|12072819|FG000|NOT COMPLETED|Overall Study||1
10906626|NCT00075478|12072820|FG001|NOT COMPLETED|Overall Study||1
10906627|NCT00075504|12072828|FG000|STARTED|Overall Study||23
10906628|NCT00075504|12072829|FG001|STARTED|Overall Study||10
10906629|NCT00075504|12072828|FG000|COMPLETED|Overall Study||14
10906630|NCT00075504|12072829|FG001|COMPLETED|Overall Study||3
10906631|NCT00075504|12072828|FG000|NOT COMPLETED|Overall Study||9
10906632|NCT00075504|12072829|FG001|NOT COMPLETED|Overall Study||7
10906633|NCT00075582|12072837|FG000|STARTED|Overall Study||305
10906634|NCT00075582|12072838|FG001|STARTED|Overall Study||85
10906635|NCT00075582|12072837|FG000|COMPLETED|Overall Study||255
10906636|NCT00075582|12072838|FG001|COMPLETED|Overall Study||50
10906637|NCT00075582|12072837|FG000|NOT COMPLETED|Overall Study||50
10906638|NCT00075582|12072838|FG001|NOT COMPLETED|Overall Study||35
10906639|NCT00075725|12072860|FG000|STARTED|Overall Study||246
10906640|NCT00075725|12072861|FG001|STARTED|Overall Study||106
10906641|NCT00075725|12072862|FG002|STARTED|Overall Study||296
10906642|NCT00075725|12072863|FG003|STARTED|Overall Study||246
10906643|NCT00075725|12072864|FG004|STARTED|Overall Study||232
10906644|NCT00075725|12072865|FG005|STARTED|Overall Study||710
10906645|NCT00075725|12072866|FG006|STARTED|Overall Study||246
10906646|NCT00075725|12072867|FG007|STARTED|Overall Study||696
10906647|NCT00075725|12072868|FG008|STARTED|Overall Study||302
10906648|NCT00075725|12072869|FG009|STARTED|Overall Study||34
10906649|NCT00075725|12072870|FG010|STARTED|Overall Study||12
10906650|NCT00075725|12072871|FG011|STARTED|Overall Study||28
10906651|NCT00075725|12072860|FG000|COMPLETED|Overall Study||172
10906652|NCT00075725|12072861|FG001|COMPLETED|Overall Study||57
10906653|NCT00075725|12072862|FG002|COMPLETED|Overall Study||175
10906654|NCT00075725|12072863|FG003|COMPLETED|Overall Study||168
10906655|NCT00075725|12072864|FG004|COMPLETED|Overall Study||166
10906656|NCT00075725|12072865|FG005|COMPLETED|Overall Study||397
10906657|NCT00075725|12072866|FG006|COMPLETED|Overall Study||171
10906658|NCT00075725|12072867|FG007|COMPLETED|Overall Study||401
10906659|NCT00075725|12072868|FG008|COMPLETED|Overall Study||185
10906660|NCT00075725|12072869|FG009|COMPLETED|Overall Study||16
10906661|NCT00075725|12072870|FG010|COMPLETED|Overall Study||3
10906662|NCT00075725|12072871|FG011|COMPLETED|Overall Study||10
10906663|NCT00075725|12072860|FG000|NOT COMPLETED|Overall Study||74
10906664|NCT00075725|12072861|FG001|NOT COMPLETED|Overall Study||49
10906665|NCT00075725|12072862|FG002|NOT COMPLETED|Overall Study||121
10906666|NCT00075725|12072863|FG003|NOT COMPLETED|Overall Study||78
10906667|NCT00075725|12072864|FG004|NOT COMPLETED|Overall Study||66
10906668|NCT00075725|12072865|FG005|NOT COMPLETED|Overall Study||313
10906669|NCT00075725|12072866|FG006|NOT COMPLETED|Overall Study||75
10906670|NCT00075725|12072867|FG007|NOT COMPLETED|Overall Study||295
10906671|NCT00075725|12072868|FG008|NOT COMPLETED|Overall Study||117
10906672|NCT00075725|12072869|FG009|NOT COMPLETED|Overall Study||18
10906673|NCT00075725|12072870|FG010|NOT COMPLETED|Overall Study||9
10906674|NCT00075725|12072871|FG011|NOT COMPLETED|Overall Study||18
10906675|NCT00075764|12072904|FG000|STARTED|Overall Study||345
10906676|NCT00075764|12072905|FG001|STARTED|Overall Study||349
10906677|NCT00075764|12072904|FG000|COMPLETED|Overall Study||0
10906678|NCT00075764|12072905|FG001|COMPLETED|Overall Study||0
10906679|NCT00075764|12072904|FG000|NOT COMPLETED|Overall Study||345
10906680|NCT00075764|12072905|FG001|NOT COMPLETED|Overall Study||349
10906681|NCT00075803|12072915|FG000|STARTED|Overall Study||295
10906682|NCT00075803|12072916|FG001|STARTED|Overall Study||305
10906683|NCT00075803|12072915|FG000|COMPLETED|Overall Study||295
10906684|NCT00075803|12072916|FG001|COMPLETED|Overall Study||305
10906685|NCT00075803|12072915|FG000|NOT COMPLETED|Overall Study||0
10906686|NCT00075803|12072916|FG001|NOT COMPLETED|Overall Study||0
10906687|NCT00075816|12072924|FG000|STARTED|Overall Study||278
10906688|NCT00075816|12072925|FG001|STARTED|Overall Study||273
10906689|NCT00075816|12072924|FG000|COMPLETED|Overall Study||264
10906690|NCT00075816|12072925|FG001|COMPLETED|Overall Study||262
10906691|NCT00075816|12072924|FG000|NOT COMPLETED|Overall Study||14
10906692|NCT00075816|12072925|FG001|NOT COMPLETED|Overall Study||11
10906693|NCT00075829|12072937|FG000|STARTED|Overall Study||436
10906694|NCT00075829|12072938|FG001|STARTED|Overall Study||189
10906695|NCT00075829|12072939|FG002|STARTED|Overall Study||48
10906696|NCT00075829|12072940|FG003|STARTED|Overall Study||37
10906697|NCT00075829|12072937|FG000|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
10906698|NCT00075829|12072938|FG001|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
10906699|NCT00075829|12072939|FG002|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
10906700|NCT00075829|12072940|FG003|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
10906701|NCT00075829|12072937|FG000|NOT COMPLETED|Overall Study||258
10906702|NCT00075829|12072938|FG001|NOT COMPLETED|Overall Study||118
10906703|NCT00075829|12072939|FG002|NOT COMPLETED|Overall Study||34
10906704|NCT00075829|12072940|FG003|NOT COMPLETED|Overall Study||24
10906705|NCT00075881|12072953|FG000|STARTED|Overall Study||44
10906706|NCT00075881|12072953|FG000|Eligible|Overall Study||43
10906707|NCT00075881|12072953|FG000|Treated|Overall Study||42
10906708|NCT00075881|12072953|FG000|Induction Treatment|Overall Study||42
10906709|NCT00075881|12072953|FG000|Maintenance Treatment|Overall Study||15
10906710|NCT00075881|12072953|FG000|Reinduction Treatment|Overall Study||7
10906711|NCT00075881|12072953|FG000|COMPLETED|Overall Study||1
10906712|NCT00075881|12072953|FG000|NOT COMPLETED|Overall Study||43
10906713|NCT00076011|12072959|FG000|STARTED|Overall Study||52
10906714|NCT00076011|12072959|FG000|COMPLETED|Overall Study||0
10906715|NCT00076011|12072959|FG000|NOT COMPLETED|Overall Study||52
10906716|NCT00076024|12072966|FG000|STARTED|Phase 1, Lead-in||6
10906717|NCT00076024|12072967|FG001|STARTED|Phase 1, Lead-in||0
10906718|NCT00076024|12072968|FG002|STARTED|Phase 1, Lead-in||0
10906719|NCT00076024|12072969|FG003|STARTED|Phase 1, Lead-in||0
10906720|NCT00076024|12072966|FG000|COMPLETED|Phase 1, Lead-in||0
10906721|NCT00076024|12072967|FG001|COMPLETED|Phase 1, Lead-in||0
10906722|NCT00076024|12072968|FG002|COMPLETED|Phase 1, Lead-in||0
10906723|NCT00076024|12072969|FG003|COMPLETED|Phase 1, Lead-in||0
10906724|NCT00076024|12072966|FG000|NOT COMPLETED|Phase 1, Lead-in||6
10906725|NCT00076024|12072967|FG001|NOT COMPLETED|Phase 1, Lead-in||0
10906726|NCT00076024|12072968|FG002|NOT COMPLETED|Phase 1, Lead-in||0
10906727|NCT00076024|12072969|FG003|NOT COMPLETED|Phase 1, Lead-in||0
10906728|NCT00076024|12072966|FG000|STARTED|Phase 2, Double-blind||0
10906729|NCT00076024|12072967|FG001|STARTED|Phase 2, Double-blind||112
10906730|NCT00076024|12072968|FG002|STARTED|Phase 2, Double-blind||56
10906731|NCT00076024|12072969|FG003|STARTED|Phase 2, Double-blind||0
10906732|NCT00076024|12072966|FG000|Treated|Phase 2, Double-blind||0
10906733|NCT00076024|12072967|FG001|Treated|Phase 2, Double-blind||111
10906734|NCT00076024|12072968|FG002|Treated|Phase 2, Double-blind||56
10906735|NCT00076024|12072969|FG003|Treated|Phase 2, Double-blind||0
10906736|NCT00076024|12072966|FG000|COMPLETED|Phase 2, Double-blind||0
10906737|NCT00076024|12072967|FG001|COMPLETED|Phase 2, Double-blind||0
10906738|NCT00076024|12072968|FG002|COMPLETED|Phase 2, Double-blind||0
10906739|NCT00076024|12072969|FG003|COMPLETED|Phase 2, Double-blind||0
10906740|NCT00076024|12072966|FG000|NOT COMPLETED|Phase 2, Double-blind||0
10906741|NCT00076024|12072967|FG001|NOT COMPLETED|Phase 2, Double-blind||112
10906742|NCT00076024|12072968|FG002|NOT COMPLETED|Phase 2, Double-blind||56
10906743|NCT00076024|12072969|FG003|NOT COMPLETED|Phase 2, Double-blind||0
10906744|NCT00076024|12072966|FG000|STARTED|Phase 2, Open-label||0
10906745|NCT00076024|12072967|FG001|STARTED|Phase 2, Open-label||0
10906746|NCT00076024|12072968|FG002|STARTED|Phase 2, Open-label||0
10906747|NCT00076024|12072969|FG003|STARTED|Phase 2, Open-label||16
10906748|NCT00076024|12072966|FG000|COMPLETED|Phase 2, Open-label||0
10906749|NCT00076024|12072967|FG001|COMPLETED|Phase 2, Open-label||0
10906750|NCT00076024|12072968|FG002|COMPLETED|Phase 2, Open-label||0
10906751|NCT00076024|12072969|FG003|COMPLETED|Phase 2, Open-label||0
10906752|NCT00076024|12072966|FG000|NOT COMPLETED|Phase 2, Open-label||0
10906753|NCT00076024|12072967|FG001|NOT COMPLETED|Phase 2, Open-label||0
10906754|NCT00076024|12072968|FG002|NOT COMPLETED|Phase 2, Open-label||0
10906755|NCT00076024|12072969|FG003|NOT COMPLETED|Phase 2, Open-label||16
10906756|NCT00076050|12072980|FG000|STARTED|Overall Study||122
10906757|NCT00076050|12072981|FG001|STARTED|Overall Study||126
10906758|NCT00076050|12072980|FG000|COMPLETED|Overall Study||99
10906759|NCT00076050|12072981|FG001|COMPLETED|Overall Study||83
10906760|NCT00076050|12072980|FG000|NOT COMPLETED|Overall Study||23
10906761|NCT00076050|12072981|FG001|NOT COMPLETED|Overall Study||43
10906762|NCT00076102|12072987|FG000|STARTED|Overall Study||36
10906763|NCT00076102|12072987|FG000|COMPLETED|Overall Study||31
10906764|NCT00076102|12072987|FG000|NOT COMPLETED|Overall Study||5
10906765|NCT00076219|12072995|FG000|STARTED|Overall Study||563
10906766|NCT00076219|12072996|FG001|STARTED|Overall Study||561
10906767|NCT00076219|12072995|FG000|COMPLETED|Overall Study||545
10906768|NCT00076219|12072996|FG001|COMPLETED|Overall Study||550
10906769|NCT00076219|12072995|FG000|NOT COMPLETED|Overall Study||18
10906770|NCT00076219|12072996|FG001|NOT COMPLETED|Overall Study||11
10906771|NCT00076245|12073006|FG000|STARTED|Overall Study||16
10906772|NCT00076245|12073007|FG001|STARTED|Overall Study||15
10906773|NCT00076245|12073008|FG002|STARTED|Overall Study||15
10906774|NCT00076245|12073009|FG003|STARTED|Overall Study||15
10906775|NCT00076245|12073006|FG000|COMPLETED|Overall Study||16
10906776|NCT00076245|12073007|FG001|COMPLETED|Overall Study||15
10906777|NCT00076245|12073008|FG002|COMPLETED|Overall Study||15
10906778|NCT00076245|12073009|FG003|COMPLETED|Overall Study||14
10906779|NCT00076245|12073006|FG000|NOT COMPLETED|Overall Study||0
10906780|NCT00076245|12073007|FG001|NOT COMPLETED|Overall Study||0
10906781|NCT00076245|12073008|FG002|NOT COMPLETED|Overall Study||0
10906782|NCT00076245|12073009|FG003|NOT COMPLETED|Overall Study||1
10906783|NCT00076258|12073021|FG000|STARTED|Overall Study||62
10906784|NCT00076258|12073022|FG001|STARTED|Overall Study||64
10906785|NCT00076258|12073021|FG000|COMPLETED|Overall Study||61
10906786|NCT00076258|12073022|FG001|COMPLETED|Overall Study||61
10906787|NCT00076258|12073021|FG000|NOT COMPLETED|Overall Study||1
10906788|NCT00076258|12073022|FG001|NOT COMPLETED|Overall Study||3
10906789|NCT00076336|12073030|FG000|STARTED|Overall Study||116
10906790|NCT00076336|12073031|FG001|STARTED|Overall Study||116
10906791|NCT00076336|12073030|FG000|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
10906792|NCT00076336|12073031|FG001|Safety Population|Overall Study||116
10906793|NCT00076336|12073030|FG000|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
10906794|NCT00076336|12073031|FG001|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
10906795|NCT00076336|12073030|FG000|Completed Week 52|Overall Study||97
10906796|NCT00076336|12073031|FG001|Completed Week 52|Overall Study||94
10906797|NCT00076336|12073030|FG000|Completed Week 104|Overall Study||70
10906798|NCT00076336|12073031|FG001|Completed Week 104|Overall Study||62
10906799|NCT00076336|12073030|FG000|COMPLETED|Overall Study||64
10906800|NCT00076336|12073031|FG001|COMPLETED|Overall Study||60
10906801|NCT00076336|12073030|FG000|NOT COMPLETED|Overall Study||52
10906802|NCT00076336|12073031|FG001|NOT COMPLETED|Overall Study||56
10906803|NCT00076570|12073039|FG000|STARTED|Overall Study||15
10906804|NCT00076570|12073040|FG001|STARTED|Overall Study||16
10906805|NCT00076570|12073039|FG000|COMPLETED|Overall Study||7
10906806|NCT00076570|12073040|FG001|COMPLETED|Overall Study||8
10906807|NCT00076570|12073039|FG000|NOT COMPLETED|Overall Study||8
10906808|NCT00076570|12073040|FG001|NOT COMPLETED|Overall Study||8
10906809|NCT00076622|12073050|FG000|STARTED|Overall Study||23
10906810|NCT00076622|12073051|FG001|STARTED|Overall Study||13
10906811|NCT00076622|12073052|FG002|STARTED|Overall Study||40
10906812|NCT00076622|12073053|FG003|STARTED|Overall Study||18
10906813|NCT00076622|12073050|FG000|COMPLETED|Overall Study||23
10906814|NCT00076622|12073051|FG001|COMPLETED|Overall Study||13
10906815|NCT00076622|12073052|FG002|COMPLETED|Overall Study||40
10906816|NCT00076622|12073053|FG003|COMPLETED|Overall Study||18
10906817|NCT00076622|12073050|FG000|NOT COMPLETED|Overall Study||0
10906818|NCT00076622|12073051|FG001|NOT COMPLETED|Overall Study||0
10906819|NCT00076622|12073052|FG002|NOT COMPLETED|Overall Study||0
10906820|NCT00076622|12073053|FG003|NOT COMPLETED|Overall Study||0
10906821|NCT00076687|12073070|FG000|STARTED|Overall Study||48
10906822|NCT00076687|12073071|FG001|STARTED|Overall Study||52
10906823|NCT00076687|12073072|FG002|STARTED|Overall Study||55
10906824|NCT00076687|12073070|FG000|COMPLETED|Overall Study||42
10906825|NCT00076687|12073071|FG001|COMPLETED|Overall Study||47
10906826|NCT00076687|12073072|FG002|COMPLETED|Overall Study||51
10906827|NCT00076687|12073070|FG000|NOT COMPLETED|Overall Study||6
10906828|NCT00076687|12073071|FG001|NOT COMPLETED|Overall Study||5
10906829|NCT00076687|12073072|FG002|NOT COMPLETED|Overall Study||4
10906830|NCT00076752|12073080|FG000|STARTED|Overall Study||9
10906831|NCT00076752|12073080|FG000|COMPLETED|Overall Study||6
10906832|NCT00076752|12073080|FG000|NOT COMPLETED|Overall Study||3
10906833|NCT00076804|12073087|FG000|STARTED|Overall Study||137
10906834|NCT00076804|12073088|FG001|STARTED|Overall Study||137
10906835|NCT00076804|12073087|FG000|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
10906836|NCT00076804|12073088|FG001|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
10906837|NCT00076804|12073087|FG000|NOT COMPLETED|Overall Study||60
10906838|NCT00076804|12073088|FG001|NOT COMPLETED|Overall Study||69
10906839|NCT00076999|12073098|FG000|STARTED|Overall Study||25
10906840|NCT00076999|12073099|FG001|STARTED|Overall Study||31
10906841|NCT00076999|12073100|FG002|STARTED|Overall Study||19
10906842|NCT00076999|12073101|FG003|STARTED|Overall Study||6
10906843|NCT00076999|12073102|FG004|STARTED|Overall Study||34
10906844|NCT00076999|12073098|FG000|COMPLETED|Overall Study||13
10906845|NCT00076999|12073099|FG001|COMPLETED|Overall Study||7
10906846|NCT00076999|12073100|FG002|COMPLETED|Overall Study||2
10906847|NCT00076999|12073101|FG003|COMPLETED|Overall Study||5
10906848|NCT00076999|12073102|FG004|COMPLETED|Overall Study||9
10906849|NCT00076999|12073098|FG000|NOT COMPLETED|Overall Study||12
10906850|NCT00076999|12073099|FG001|NOT COMPLETED|Overall Study||24
10906851|NCT00076999|12073100|FG002|NOT COMPLETED|Overall Study||17
10906852|NCT00076999|12073101|FG003|NOT COMPLETED|Overall Study||1
10906853|NCT00076999|12073102|FG004|NOT COMPLETED|Overall Study||25
10906854|NCT00077064|12073117|FG000|STARTED|Overall Study||17
10906855|NCT00077064|12073118|FG001|STARTED|Overall Study||16
10906856|NCT00077064|12073117|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
10906857|NCT00077064|12073118|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
10906858|NCT00077064|12073117|FG000|NOT COMPLETED|Overall Study||0
10906859|NCT00077064|12073118|FG001|NOT COMPLETED|Overall Study||6
10906860|NCT00077207|12073125|FG000|STARTED|Overall Study||66
10906861|NCT00077207|12073125|FG000|COMPLETED|Overall Study||36
10906862|NCT00077207|12073125|FG000|NOT COMPLETED|Overall Study||30
10906863|NCT00077376|12073130|FG000|STARTED|Overall Study||61
10906864|NCT00077376|12073130|FG000|Treated|Overall Study||59
10906865|NCT00077376|12073130|FG000|HER2+ in Central Testing|Overall Study||39
10906866|NCT00077376|12073130|FG000|COMPLETED|Overall Study||39
10906867|NCT00077376|12073130|FG000|NOT COMPLETED|Overall Study||22
10906868|NCT00077610|12073137|FG000|STARTED|Overall Study||223
10906869|NCT00077610|12073138|FG001|STARTED|Overall Study||224
10906870|NCT00077610|12073139|FG002|STARTED|Overall Study||226
10906871|NCT00077610|12073137|FG000|Started Treatment|Overall Study||221
10906872|NCT00077610|12073138|FG001|Started Treatment|Overall Study||220
10906873|NCT00077610|12073139|FG002|Started Treatment|Overall Study||225
10906874|NCT00077610|12073137|FG000|COMPLETED|Overall Study||169
10906875|NCT00077610|12073138|FG001|COMPLETED|Overall Study||168
10906876|NCT00077610|12073139|FG002|COMPLETED|Overall Study||180
10906877|NCT00077610|12073137|FG000|NOT COMPLETED|Overall Study||54
10906878|NCT00077610|12073138|FG001|NOT COMPLETED|Overall Study||56
10906879|NCT00077610|12073139|FG002|NOT COMPLETED|Overall Study||46
10906880|NCT00077623|12073155|FG000|STARTED|Overall Study||190
10906881|NCT00077623|12073156|FG001|STARTED|Overall Study||191
10906882|NCT00077623|12073157|FG002|STARTED|Overall Study||191
10906883|NCT00077623|12073155|FG000|COMPLETED|Overall Study||154
10906884|NCT00077623|12073156|FG001|COMPLETED|Overall Study||148
10906885|NCT00077623|12073157|FG002|COMPLETED|Overall Study||159
10906886|NCT00077623|12073155|FG000|NOT COMPLETED|Overall Study||36
10906887|NCT00077623|12073156|FG001|NOT COMPLETED|Overall Study||43
10906888|NCT00077623|12073157|FG002|NOT COMPLETED|Overall Study||32
10906889|NCT00077636|12073167|FG000|STARTED|Overall Study||736
10906890|NCT00077636|12073168|FG001|STARTED|Overall Study||733
10906891|NCT00077636|12073167|FG000|COMPLETED|Overall Study||692
10906892|NCT00077636|12073168|FG001|COMPLETED|Overall Study||641
10906893|NCT00077636|12073167|FG000|NOT COMPLETED|Overall Study||44
10906894|NCT00077636|12073168|FG001|NOT COMPLETED|Overall Study||92
10906895|NCT00077649|12073179|FG000|STARTED|Overall Study||47
10906896|NCT00077649|12073180|FG001|STARTED|Overall Study||47
10906897|NCT00077649|12073181|FG002|STARTED|Overall Study||47
10906898|NCT00077649|12073182|FG003|STARTED|Overall Study||47
10906899|NCT00077649|12073179|FG000|Completed 24 Weeks of Follow-up|Overall Study||36
10906900|NCT00077649|12073180|FG001|Completed 24 Weeks of Follow-up|Overall Study||40
10906901|NCT00077649|12073181|FG002|Completed 24 Weeks of Follow-up|Overall Study||36
10906902|NCT00077649|12073182|FG003|Completed 24 Weeks of Follow-up|Overall Study||31
10906903|NCT00077649|12073179|FG000|COMPLETED|Overall Study||33
10906904|NCT00077649|12073180|FG001|COMPLETED|Overall Study||38
10906905|NCT00077649|12073181|FG002|COMPLETED|Overall Study||32
10906906|NCT00077649|12073182|FG003|COMPLETED|Overall Study||30
10906907|NCT00077649|12073179|FG000|NOT COMPLETED|Overall Study||14
10906908|NCT00077649|12073180|FG001|NOT COMPLETED|Overall Study||9
10906909|NCT00077649|12073181|FG002|NOT COMPLETED|Overall Study||15
10906910|NCT00077649|12073182|FG003|NOT COMPLETED|Overall Study||17
10906911|NCT00077675|12073198|FG000|STARTED|Overall Study||103
10906912|NCT00077675|12073199|FG001|STARTED|Overall Study||98
10906913|NCT00077675|12073198|FG000|COMPLETED|Overall Study||92
10906914|NCT00077675|12073199|FG001|COMPLETED|Overall Study||89
10906915|NCT00077675|12073198|FG000|NOT COMPLETED|Overall Study||11
10906916|NCT00077675|12073199|FG001|NOT COMPLETED|Overall Study||9
10906917|NCT00077766|12073207|FG000|STARTED|Overall Study||157
10906918|NCT00077766|12073208|FG001|STARTED|Overall Study||156
10906919|NCT00077766|12073207|FG000|COMPLETED|Overall Study||118
10906920|NCT00077766|12073208|FG001|COMPLETED|Overall Study||131
10906921|NCT00077766|12073207|FG000|NOT COMPLETED|Overall Study||39
10906922|NCT00077766|12073208|FG001|NOT COMPLETED|Overall Study||25
10906923|NCT00077857|12073217|FG000|STARTED|Overall Study||235
10906924|NCT00077857|12073218|FG001|STARTED|Overall Study||235
10906925|NCT00077857|12073217|FG000|Received Study Drug|Overall Study||231
10906926|NCT00077857|12073218|FG001|Received Study Drug|Overall Study||234
10906927|NCT00077857|12073217|FG000|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
10906928|NCT00077857|12073218|FG001|Safety Population: Actual Dose Received|Overall Study||248
10906929|NCT00077857|12073217|FG000|COMPLETED|Overall Study||34
10906930|NCT00077857|12073218|FG001|COMPLETED|Overall Study||31
10906931|NCT00077857|12073217|FG000|NOT COMPLETED|Overall Study||201
10906932|NCT00077857|12073218|FG001|NOT COMPLETED|Overall Study||204
10906933|NCT00077922|12073224|FG000|STARTED|Overall Study||15
10906934|NCT00077922|12073224|FG000|COMPLETED|Overall Study||15
10906935|NCT00077922|12073224|FG000|NOT COMPLETED|Overall Study||0
10906936|NCT00077974|12073228|FG000|STARTED|Overall Study||106
10906937|NCT00077974|12073228|FG000|COMPLETED|Overall Study||2
10906938|NCT00077974|12073228|FG000|NOT COMPLETED|Overall Study||104
10906939|NCT00078286|12073234|FG000|STARTED|Overall Study||234
10906940|NCT00078286|12073235|FG001|STARTED|Overall Study||235
10906941|NCT00078286|12073234|FG000|COMPLETED|Overall Study||138
10906942|NCT00078286|12073235|FG001|COMPLETED|Overall Study||152
10906943|NCT00078286|12073234|FG000|NOT COMPLETED|Overall Study||96
10906944|NCT00078286|12073235|FG001|NOT COMPLETED|Overall Study||83
10906945|NCT00078312|12073241|FG000|STARTED|Overall Study||328
10906946|NCT00078312|12073241|FG000|COMPLETED|Overall Study||151
10906947|NCT00078312|12073241|FG000|NOT COMPLETED|Overall Study||177
10906948|NCT00078325|12073248|FG000|STARTED|Overall Study||131
10906949|NCT00078325|12073249|FG001|STARTED|Overall Study||133
10906950|NCT00078325|12073250|FG002|STARTED|Overall Study||131
10906951|NCT00078325|12073248|FG000|COMPLETED|Overall Study||110
10906952|NCT00078325|12073249|FG001|COMPLETED|Overall Study||114
10906953|NCT00078325|12073250|FG002|COMPLETED|Overall Study||120
10906954|NCT00078325|12073248|FG000|NOT COMPLETED|Overall Study||21
10906955|NCT00078325|12073249|FG001|NOT COMPLETED|Overall Study||19
10906956|NCT00078325|12073250|FG002|NOT COMPLETED|Overall Study||11
10906957|NCT00078338|12073260|FG000|STARTED|Overall Study||386
10906958|NCT00078338|12073261|FG001|STARTED|Overall Study||378
10906959|NCT00078338|12073260|FG000|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
10906960|NCT00078338|12073261|FG001|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
10906961|NCT00078338|12073260|FG000|COMPLETED|Overall Study||301
10906962|NCT00078338|12073261|FG001|COMPLETED|Overall Study||324
10906963|NCT00078338|12073260|FG000|NOT COMPLETED|Overall Study||85
10906964|NCT00078338|12073261|FG001|NOT COMPLETED|Overall Study||54
10906965|NCT00078377|12073270|FG000|STARTED|Overall Study||67
10906966|NCT00078377|12073271|FG001|STARTED|Overall Study||65
10906967|NCT00078377|12073272|FG002|STARTED|Overall Study||64
10906968|NCT00078377|12073270|FG000|COMPLETED|Overall Study||56
10906969|NCT00078377|12073271|FG001|COMPLETED|Overall Study||49
10906970|NCT00078377|12073272|FG002|COMPLETED|Overall Study||55
10906971|NCT00078377|12073270|FG000|NOT COMPLETED|Overall Study||11
10906972|NCT00078377|12073271|FG001|NOT COMPLETED|Overall Study||16
10906973|NCT00078377|12073272|FG002|NOT COMPLETED|Overall Study||9
10906974|NCT00078403|12073284|FG000|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
10906975|NCT00078403|12073285|FG001|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
10906976|NCT00078403|12073286|FG002|STARTED|Overall Study||169
10906977|NCT00078403|12073284|FG000|COMPLETED|Overall Study||26
10906978|NCT00078403|12073285|FG001|COMPLETED|Overall Study||26
10906979|NCT00078403|12073286|FG002|COMPLETED|Overall Study||141
10906980|NCT00078403|12073284|FG000|NOT COMPLETED|Overall Study||18
10906981|NCT00078403|12073285|FG001|NOT COMPLETED|Overall Study||16
10906982|NCT00078403|12073286|FG002|NOT COMPLETED|Overall Study||28
10906983|NCT00078559|12073295|FG000|STARTED|Overall Study||10
10906984|NCT00078559|12073295|FG000|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
10906985|NCT00078559|12073295|FG000|NOT COMPLETED|Overall Study||0
10906986|NCT00078715|12073302|FG000|STARTED|First Intervention||2
10906987|NCT00078715|12073303|FG001|STARTED|First Intervention||4
10906988|NCT00078715|12073302|FG000|COMPLETED|First Intervention||2
10906989|NCT00078715|12073303|FG001|COMPLETED|First Intervention||4
10906990|NCT00078715|12073302|FG000|NOT COMPLETED|First Intervention||0
10906991|NCT00078715|12073303|FG001|NOT COMPLETED|First Intervention||0
10906992|NCT00078715|12073302|FG000|STARTED|Second Intervention||2
10906993|NCT00078715|12073303|FG001|STARTED|Second Intervention||4
10906994|NCT00078715|12073302|FG000|COMPLETED|Second Intervention||2
10906995|NCT00078715|12073303|FG001|COMPLETED|Second Intervention||4
10906996|NCT00078715|12073302|FG000|NOT COMPLETED|Second Intervention||0
10906997|NCT00078715|12073303|FG001|NOT COMPLETED|Second Intervention||0
10906998|NCT00078728|12073311|FG000|STARTED|Overall Study||20
10906999|NCT00078728|12073312|FG001|STARTED|Overall Study||20
10907000|NCT00078728|12073311|FG000|COMPLETED|Overall Study||16
10907001|NCT00078728|12073312|FG001|COMPLETED|Overall Study||17
10907002|NCT00078728|12073311|FG000|NOT COMPLETED|Overall Study||4
10907003|NCT00078728|12073312|FG001|NOT COMPLETED|Overall Study||3
10907004|NCT00078754|12073322|FG000|STARTED|Overall Study||29
10907005|NCT00078754|12073323|FG001|STARTED|Overall Study||30
10907006|NCT00078754|12073324|FG002|STARTED|Overall Study||31
10907007|NCT00078754|12073322|FG000|COMPLETED|Overall Study||14
10907008|NCT00078754|12073323|FG001|COMPLETED|Overall Study||11
10907009|NCT00078754|12073324|FG002|COMPLETED|Overall Study||16
10907010|NCT00078754|12073322|FG000|NOT COMPLETED|Overall Study||15
10907011|NCT00078754|12073323|FG001|NOT COMPLETED|Overall Study||19
10907012|NCT00078754|12073324|FG002|NOT COMPLETED|Overall Study||15
10907013|NCT00078767|12073337|FG000|STARTED|Overall Study||12
10907014|NCT00078767|12073338|FG001|STARTED|Overall Study||12
10907015|NCT00078767|12073337|FG000|COMPLETED|Overall Study||11
10907016|NCT00078767|12073338|FG001|COMPLETED|Overall Study||11
10907017|NCT00078767|12073337|FG000|NOT COMPLETED|Overall Study||1
10907018|NCT00078767|12073338|FG001|NOT COMPLETED|Overall Study||1
10907019|NCT00078819|12073346|FG000|STARTED|Double-blind Treatment Period: Week 1-12||105
10907020|NCT00078819|12073347|FG001|STARTED|Double-blind Treatment Period: Week 1-12||106
10907021|NCT00078819|12073348|FG002|STARTED|Double-blind Treatment Period: Week 1-12||0
10907022|NCT00078819|12073349|FG003|STARTED|Double-blind Treatment Period: Week 1-12||0
10907023|NCT00078819|12073346|FG000|Entered Escape|Double-blind Treatment Period: Week 1-12||27
10907024|NCT00078819|12073347|FG001|Entered Escape|Double-blind Treatment Period: Week 1-12||5
10907025|NCT00078819|12073348|FG002|Entered Escape|Double-blind Treatment Period: Week 1-12||0
10907026|NCT00078819|12073349|FG003|Entered Escape|Double-blind Treatment Period: Week 1-12||0
10907027|NCT00078819|12073346|FG000|COMPLETED|Double-blind Treatment Period: Week 1-12||104
10907028|NCT00078819|12073347|FG001|COMPLETED|Double-blind Treatment Period: Week 1-12||105
10907029|NCT00078819|12073348|FG002|COMPLETED|Double-blind Treatment Period: Week 1-12||0
10907030|NCT00078819|12073349|FG003|COMPLETED|Double-blind Treatment Period: Week 1-12||0
10907031|NCT00078819|12073346|FG000|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
10907032|NCT00078819|12073347|FG001|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
10907033|NCT00078819|12073348|FG002|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
10907034|NCT00078819|12073349|FG003|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
10907035|NCT00078819|12073346|FG000|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103
10907036|NCT00078819|12073347|FG001|STARTED|Open-label Treatment Period: Weeks 13-36||105
10907037|NCT00078819|12073348|FG002|STARTED|Open-label Treatment Period: Weeks 13-36||0
10907038|NCT00078819|12073349|FG003|STARTED|Open-label Treatment Period: Weeks 13-36||0
10907039|NCT00078819|12073346|FG000|COMPLETED|Open-label Treatment Period: Weeks 13-36||63
10907040|NCT00078819|12073347|FG001|COMPLETED|Open-label Treatment Period: Weeks 13-36||75
10907041|NCT00078819|12073348|FG002|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
10907042|NCT00078819|12073349|FG003|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
10907043|NCT00078819|12073346|FG000|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40
10907044|NCT00078819|12073347|FG001|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30
10907045|NCT00078819|12073348|FG002|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
10907046|NCT00078819|12073349|FG003|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
10907047|NCT00078819|12073346|FG000|STARTED|Withdrawal Period: Weeks 37-48||0
10907048|NCT00078819|12073347|FG001|STARTED|Withdrawal Period: Weeks 37-48||0
10907049|NCT00078819|12073348|FG002|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
10907050|NCT00078819|12073349|FG003|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
10907051|NCT00078819|12073346|FG000|Received Study Drug|Withdrawal Period: Weeks 37-48||0
10907052|NCT00078819|12073347|FG001|Received Study Drug|Withdrawal Period: Weeks 37-48||0
10907053|NCT00078819|12073348|FG002|Received Study Drug|Withdrawal Period: Weeks 37-48||69
10907054|NCT00078819|12073349|FG003|Received Study Drug|Withdrawal Period: Weeks 37-48||68
10907055|NCT00078819|12073346|FG000|COMPLETED|Withdrawal Period: Weeks 37-48||0
10907056|NCT00078819|12073347|FG001|COMPLETED|Withdrawal Period: Weeks 37-48||0
10907057|NCT00078819|12073348|FG002|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40
10907058|NCT00078819|12073349|FG003|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55
10907059|NCT00078819|12073346|FG000|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
10907060|NCT00078819|12073347|FG001|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
10907061|NCT00078819|12073348|FG002|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29
10907062|NCT00078819|12073349|FG003|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14
10907063|NCT00078819|12073346|FG000|STARTED|Re-treatment Period||0
10907064|NCT00078819|12073347|FG001|STARTED|Re-treatment Period||0
10907065|NCT00078819|12073348|FG002|STARTED|Re-treatment Period||29
10907066|NCT00078819|12073349|FG003|STARTED|Re-treatment Period||13
10907067|NCT00078819|12073346|FG000|Received Study Drug|Re-treatment Period||0
10907068|NCT00078819|12073347|FG001|Received Study Drug|Re-treatment Period||0
10907069|NCT00078819|12073348|FG002|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30
10907070|NCT00078819|12073349|FG003|Received Study Drug|Re-treatment Period||12
10907071|NCT00078819|12073346|FG000|COMPLETED|Re-treatment Period||0
10907072|NCT00078819|12073347|FG001|COMPLETED|Re-treatment Period||0
10907073|NCT00078819|12073348|FG002|COMPLETED|Re-treatment Period||29
10907074|NCT00078819|12073349|FG003|COMPLETED|Re-treatment Period||13
10907075|NCT00078819|12073346|FG000|NOT COMPLETED|Re-treatment Period||0
10907076|NCT00078819|12073347|FG001|NOT COMPLETED|Re-treatment Period||0
10907077|NCT00078819|12073348|FG002|NOT COMPLETED|Re-treatment Period||0
10907078|NCT00078819|12073349|FG003|NOT COMPLETED|Re-treatment Period||0
10907079|NCT00078897|12073368|FG000|STARTED|Overall Study||809
10907080|NCT00078897|12073369|FG001|STARTED|Overall Study||812
10907081|NCT00078897|12073368|FG000|COMPLETED|Overall Study||685
10907082|NCT00078897|12073369|FG001|COMPLETED|Overall Study||689
10907083|NCT00078897|12073368|FG000|NOT COMPLETED|Overall Study||124
10907084|NCT00078897|12073369|FG001|NOT COMPLETED|Overall Study||123
10907085|NCT00078949|12073379|FG000|STARTED|Overall Study||310
10907086|NCT00078949|12073380|FG001|STARTED|Overall Study||309
10907087|NCT00078949|12073381|FG002|STARTED|Overall Study||115
10907088|NCT00078949|12073382|FG003|STARTED|Overall Study||115
10907089|NCT00078949|12073379|FG000|COMPLETED|Overall Study||306
10907090|NCT00078949|12073380|FG001|COMPLETED|Overall Study||304
10907091|NCT00078949|12073381|FG002|COMPLETED|Overall Study||112
10907092|NCT00078949|12073382|FG003|COMPLETED|Overall Study||112
10907093|NCT00078949|12073379|FG000|NOT COMPLETED|Overall Study||4
10907094|NCT00078949|12073380|FG001|NOT COMPLETED|Overall Study||5
10907095|NCT00078949|12073381|FG002|NOT COMPLETED|Overall Study||3
10907096|NCT00078949|12073382|FG003|NOT COMPLETED|Overall Study||3
10907097|NCT00079001|12073396|FG000|STARTED|Overall Study||323
10907098|NCT00079001|12073397|FG001|STARTED|Overall Study||322
10907099|NCT00079001|12073396|FG000|COMPLETED|Overall Study||323
10907100|NCT00079001|12073397|FG001|COMPLETED|Overall Study||322
10907101|NCT00079001|12073396|FG000|NOT COMPLETED|Overall Study||0
10907102|NCT00079001|12073397|FG001|NOT COMPLETED|Overall Study||0
10907103|NCT00079040|12073403|FG000|STARTED|Overall Study||65
10907104|NCT00079040|12073403|FG000|COMPLETED|Overall Study||63
10907105|NCT00079040|12073403|FG000|NOT COMPLETED|Overall Study||2
10907106|NCT00079183|12073407|FG000|STARTED|Overall Study||44
10907107|NCT00079183|12073407|FG000|Drop Outs|Overall Study||7
10907108|NCT00079183|12073407|FG000|COMPLETED|Overall Study||37
10907109|NCT00079183|12073407|FG000|NOT COMPLETED|Overall Study||7
10907110|NCT00079274|12073419|FG000|STARTED|Overall Study||1402
10907111|NCT00079274|12073420|FG001|STARTED|Overall Study||111
10907112|NCT00079274|12073421|FG002|STARTED|Overall Study||111
10907113|NCT00079274|12073422|FG003|STARTED|Overall Study||1350
10907114|NCT00079274|12073423|FG004|STARTED|Overall Study||45
10907115|NCT00079274|12073424|FG005|STARTED|Overall Study||46
10907116|NCT00079274|12073425|FG006|STARTED|Overall Study||332
10907117|NCT00079274|12073419|FG000|COMPLETED|Overall Study||1081
10907118|NCT00079274|12073420|FG001|COMPLETED|Overall Study||84
10907119|NCT00079274|12073421|FG002|COMPLETED|Overall Study||84
10907120|NCT00079274|12073422|FG003|COMPLETED|Overall Study||906
10907121|NCT00079274|12073423|FG004|COMPLETED|Overall Study||30
10907122|NCT00079274|12073424|FG005|COMPLETED|Overall Study||26
10907123|NCT00079274|12073425|FG006|COMPLETED|Overall Study||332
10907124|NCT00079274|12073419|FG000|NOT COMPLETED|Overall Study||321
10907125|NCT00079274|12073420|FG001|NOT COMPLETED|Overall Study||27
10907126|NCT00079274|12073421|FG002|NOT COMPLETED|Overall Study||27
10907127|NCT00079274|12073422|FG003|NOT COMPLETED|Overall Study||444
10907128|NCT00079274|12073423|FG004|NOT COMPLETED|Overall Study||15
10907129|NCT00079274|12073424|FG005|NOT COMPLETED|Overall Study||20
10907130|NCT00079274|12073425|FG006|NOT COMPLETED|Overall Study||0
10907131|NCT00079326|12073440|FG000|STARTED|Overall Study||15
10907132|NCT00079326|12073441|FG001|STARTED|Overall Study||24
10907133|NCT00079326|12073440|FG000|COMPLETED|Overall Study||15
10907134|NCT00079326|12073441|FG001|COMPLETED|Overall Study||24
10907135|NCT00079326|12073440|FG000|NOT COMPLETED|Overall Study||0
10907136|NCT00079326|12073441|FG001|NOT COMPLETED|Overall Study||0
10907137|NCT00079339|12073449|FG000|STARTED|Overall Study||5
10907138|NCT00079339|12073450|FG001|STARTED|Overall Study||40
10907139|NCT00079339|12073451|FG002|STARTED|Overall Study||6
10907140|NCT00079339|12073449|FG000|Enrolled in Phase I|Overall Study||5
10907141|NCT00079339|12073450|FG001|Enrolled in Phase I|Overall Study||6
10907142|NCT00079339|12073451|FG002|Enrolled in Phase I|Overall Study||6
10907143|NCT00079339|12073449|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
10907144|NCT00079339|12073450|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
10907145|NCT00079339|12073451|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
10907146|NCT00079339|12073449|FG000|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
10907147|NCT00079339|12073450|FG001|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
10907148|NCT00079339|12073451|FG002|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
10907149|NCT00079339|12073449|FG000|COMPLETED|Overall Study||0
10907150|NCT00079339|12073450|FG001|COMPLETED|Overall Study||1
10907151|NCT00079339|12073451|FG002|COMPLETED|Overall Study||0
10907152|NCT00079339|12073449|FG000|NOT COMPLETED|Overall Study||5
10907153|NCT00079339|12073450|FG001|NOT COMPLETED|Overall Study||39
10907154|NCT00079339|12073451|FG002|NOT COMPLETED|Overall Study||6
10907155|NCT00079391|12073464|FG000|STARTED|Overall Study|1 of these withdrew after consent.|50
10907156|NCT00079391|12073464|FG000|COMPLETED|Overall Study||49
10907157|NCT00079391|12073464|FG000|NOT COMPLETED|Overall Study||1
10907158|NCT00079417|12073470|FG000|STARTED|Overall Study||28
10907159|NCT00079417|12073470|FG000|COMPLETED|Overall Study||19
10907160|NCT00079417|12073470|FG000|NOT COMPLETED|Overall Study||9
10907161|NCT00079677|12073476|FG000|STARTED|Overall Study||131
10907162|NCT00079677|12073477|FG001|STARTED|Overall Study||132
10907163|NCT00079677|12073476|FG000|COMPLETED|Overall Study||111
10907164|NCT00079677|12073477|FG001|COMPLETED|Overall Study||118
10907165|NCT00079677|12073476|FG000|NOT COMPLETED|Overall Study||20
10907166|NCT00079677|12073477|FG001|NOT COMPLETED|Overall Study||14
10907167|NCT00079781|12073486|FG000|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
10907168|NCT00079781|12073487|FG001|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
10907169|NCT00079781|12073488|FG002|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
10907170|NCT00079781|12073486|FG000|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
10907171|NCT00079781|12073487|FG001|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
10907172|NCT00079781|12073488|FG002|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
10907173|NCT00079781|12073486|FG000|NOT COMPLETED|Pre-implant Period||3
10907174|NCT00079781|12073487|FG001|NOT COMPLETED|Pre-implant Period||1
10907175|NCT00079781|12073488|FG002|NOT COMPLETED|Pre-implant Period||1
10907176|NCT00079781|12073486|FG000|STARTED|Evaluation Period||42
10907177|NCT00079781|12073487|FG001|STARTED|Evaluation Period||9
10907178|NCT00079781|12073488|FG002|STARTED|Evaluation Period||14
10907179|NCT00079781|12073486|FG000|COMPLETED|Evaluation Period||42
10907180|NCT00079781|12073487|FG001|COMPLETED|Evaluation Period||9
10907181|NCT00079781|12073488|FG002|COMPLETED|Evaluation Period||14
10907182|NCT00079781|12073486|FG000|NOT COMPLETED|Evaluation Period||0
10907183|NCT00079781|12073487|FG001|NOT COMPLETED|Evaluation Period||0
10907184|NCT00079781|12073488|FG002|NOT COMPLETED|Evaluation Period||0
10907185|NCT00079781|12073486|FG000|STARTED|Follow-up Period||42
10907186|NCT00079781|12073487|FG001|STARTED|Follow-up Period||9
10907187|NCT00079781|12073488|FG002|STARTED|Follow-up Period||14
10907188|NCT00079781|12073486|FG000|COMPLETED|Follow-up Period||38
10907189|NCT00079781|12073487|FG001|COMPLETED|Follow-up Period||9
10907190|NCT00079781|12073488|FG002|COMPLETED|Follow-up Period||12
10907191|NCT00079781|12073486|FG000|NOT COMPLETED|Follow-up Period||4
10907192|NCT00079781|12073487|FG001|NOT COMPLETED|Follow-up Period||0
10907193|NCT00079781|12073488|FG002|NOT COMPLETED|Follow-up Period||2
10907194|NCT00079937|12073496|FG000|STARTED|Overall Study||421
10907195|NCT00079937|12073497|FG001|STARTED|Overall Study||207
10907196|NCT00079937|12073496|FG000|COMPLETED|Overall Study||352
10907197|NCT00079937|12073497|FG001|COMPLETED|Overall Study||175
10907198|NCT00079937|12073496|FG000|NOT COMPLETED|Overall Study||69
10907199|NCT00079937|12073497|FG001|NOT COMPLETED|Overall Study||32
10907200|NCT00080119|12073507|FG000|STARTED|Overall Study||403
10907201|NCT00080119|12073508|FG001|STARTED|Overall Study||401
10907202|NCT00080119|12073509|FG002|STARTED|Overall Study||273
10907203|NCT00080119|12073510|FG003|STARTED|Overall Study||274
10907204|NCT00080119|12073507|FG000|COMPLETED|Overall Study||347
10907205|NCT00080119|12073508|FG001|COMPLETED|Overall Study||339
10907206|NCT00080119|12073509|FG002|COMPLETED|Overall Study||108
10907207|NCT00080119|12073510|FG003|COMPLETED|Overall Study||111
10907208|NCT00080119|12073507|FG000|NOT COMPLETED|Overall Study||56
10907209|NCT00080119|12073508|FG001|NOT COMPLETED|Overall Study||62
10907210|NCT00080119|12073509|FG002|NOT COMPLETED|Overall Study||165
10907211|NCT00080119|12073510|FG003|NOT COMPLETED|Overall Study||163
10907212|NCT00080223|12073522|FG000|STARTED|Overall Study||83
10907213|NCT00080223|12073522|FG000|COMPLETED|Overall Study||7
10907214|NCT00080223|12073522|FG000|NOT COMPLETED|Overall Study||76
10907215|NCT00080288|12073528|FG000|STARTED|Overall Study||127
10907216|NCT00080288|12073529|FG001|STARTED|Overall Study||127
10907217|NCT00080288|12073528|FG000|COMPLETED|Overall Study||97
10907218|NCT00080288|12073529|FG001|COMPLETED|Overall Study||89
10907219|NCT00080288|12073528|FG000|NOT COMPLETED|Overall Study||30
10907220|NCT00080288|12073529|FG001|NOT COMPLETED|Overall Study||38
10907221|NCT00080301|12073537|FG000|STARTED|Overall Study||375
10907222|NCT00080301|12073538|FG001|STARTED|Overall Study||377
10907223|NCT00080301|12073537|FG000|Never Treated|Overall Study||5
10907224|NCT00080301|12073538|FG001|Never Treated|Overall Study||10
10907225|NCT00080301|12073537|FG000|Still on Treatment|Overall Study||0
10907226|NCT00080301|12073538|FG001|Still on Treatment|Overall Study||1
10907227|NCT00080301|12073537|FG000|COMPLETED|Overall Study|Participants who are off treatment|370
10907228|NCT00080301|12073538|FG001|COMPLETED|Overall Study|Participants who are off treatment|366
10907229|NCT00080301|12073537|FG000|NOT COMPLETED|Overall Study||5
10907230|NCT00080301|12073538|FG001|NOT COMPLETED|Overall Study||11
10907231|NCT00080470|12073547|FG000|STARTED|Overall Study||45
10907232|NCT00080470|12073548|FG001|STARTED|Overall Study||42
10907233|NCT00080470|12073547|FG000|COMPLETED|Overall Study||11
10907234|NCT00080470|12073548|FG001|COMPLETED|Overall Study||14
10907235|NCT00080470|12073547|FG000|NOT COMPLETED|Overall Study||34
10907236|NCT00080470|12073548|FG001|NOT COMPLETED|Overall Study||28
10907237|NCT00080483|12073558|FG000|STARTED|Overall Study||17
10907238|NCT00080483|12073559|FG001|STARTED|Overall Study||18
10907239|NCT00080483|12073558|FG000|COMPLETED|Overall Study||15
10907240|NCT00080483|12073559|FG001|COMPLETED|Overall Study||16
10907241|NCT00080483|12073558|FG000|NOT COMPLETED|Overall Study||2
10907242|NCT00080483|12073559|FG001|NOT COMPLETED|Overall Study||2
10907243|NCT00080535|12073565|FG000|STARTED|Overall Study||10
10907244|NCT00080535|12073565|FG000|COMPLETED|Overall Study||10
10907245|NCT00080535|12073565|FG000|NOT COMPLETED|Overall Study||0
10907246|NCT00080899|12073569|FG000|STARTED|Overall Study||23
10907247|NCT00080899|12073569|FG000|COMPLETED|Overall Study||22
10907248|NCT00080899|12073569|FG000|NOT COMPLETED|Overall Study||1
10907249|NCT00080912|12073575|FG000|STARTED|Overall Study||425
10907250|NCT00080912|12073576|FG001|STARTED|Overall Study||425
10907251|NCT00080912|12073575|FG000|COMPLETED|Overall Study||425
10907252|NCT00080912|12073576|FG001|COMPLETED|Overall Study||425
10907253|NCT00080912|12073575|FG000|NOT COMPLETED|Overall Study||0
10907254|NCT00080912|12073576|FG001|NOT COMPLETED|Overall Study||0
10907255|NCT00080938|12073582|FG000|STARTED|Overall Study||26
10907256|NCT00080938|12073582|FG000|Began Protocol Therapy|Overall Study||25
10907257|NCT00080938|12073582|FG000|Eligible and Treated|Overall Study||21
10907258|NCT00080938|12073582|FG000|COMPLETED|Overall Study||2
10907259|NCT00080938|12073582|FG000|NOT COMPLETED|Overall Study||24
10907260|NCT00081159|12073588|FG000|STARTED|Overall Study||39
10907261|NCT00081159|12073589|FG001|STARTED|Overall Study||40
10907262|NCT00081159|12073588|FG000|COMPLETED|Overall Study||37
10907263|NCT00081159|12073589|FG001|COMPLETED|Overall Study||35
10907264|NCT00081159|12073588|FG000|NOT COMPLETED|Overall Study||2
10907265|NCT00081159|12073589|FG001|NOT COMPLETED|Overall Study||5
10907266|NCT00081263|12073597|FG000|STARTED|Overall Study||67
10907267|NCT00081263|12073598|FG001|STARTED|Overall Study||63
10907268|NCT00081263|12073597|FG000|COMPLETED|Overall Study||50
10907269|NCT00081263|12073598|FG001|COMPLETED|Overall Study||41
10907270|NCT00081263|12073597|FG000|NOT COMPLETED|Overall Study||17
10907271|NCT00081263|12073598|FG001|NOT COMPLETED|Overall Study||22
10907272|NCT00081289|12073606|FG000|STARTED|Overall Study||73
10907273|NCT00081289|12073607|FG001|STARTED|Overall Study||73
10907274|NCT00081289|12073606|FG000|Primary Endpoint Population|Overall Study||48
10907275|NCT00081289|12073607|FG001|Primary Endpoint Population|Overall Study||48
10907276|NCT00081289|12073606|FG000|General Analysis Population|Overall Study||52
10907277|NCT00081289|12073607|FG001|General Analysis Population|Overall Study||52
10907278|NCT00081289|12073606|FG000|Full AE Population|Overall Study||70
10907279|NCT00081289|12073607|FG001|Full AE Population|Overall Study||68
10907280|NCT00081289|12073606|FG000|Surgery|Overall Study||47
10907281|NCT00081289|12073607|FG001|Surgery|Overall Study||51
10907282|NCT00081289|12073606|FG000|Global Health Status Score at End of CR|Overall Study|European Organization for Research & Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ]|34
10907283|NCT00081289|12073607|FG001|Global Health Status Score at End of CR|Overall Study||32
10907284|NCT00081289|12073606|FG000|GHS at End of Post-op CT|Overall Study||20
10907285|NCT00081289|12073607|FG001|GHS at End of Post-op CT|Overall Study||28
10907286|NCT00081289|12073606|FG000|GHS at Two Years|Overall Study||21
10907287|NCT00081289|12073607|FG001|GHS at Two Years|Overall Study||20
10907288|NCT00081289|12073606|FG000|GI Symptom Score at End of CR|Overall Study||34
10907289|NCT00081289|12073607|FG001|GI Symptom Score at End of CR|Overall Study||33
10907290|NCT00081289|12073606|FG000|GI Symptom Score at End of Post-op CT|Overall Study||22
10907291|NCT00081289|12073607|FG001|GI Symptom Score at End of Post-op CT|Overall Study||27
10907292|NCT00081289|12073606|FG000|GI Symptom Score at Two Years|Overall Study||21
10907293|NCT00081289|12073607|FG001|GI Symptom Score at Two Years|Overall Study||20
10907294|NCT00081289|12073606|FG000|Defecation Symptom Score at End of CR|Overall Study||32
10907295|NCT00081289|12073607|FG001|Defecation Symptom Score at End of CR|Overall Study||32
10907296|NCT00081289|12073606|FG000|DS Score at End of Post-op CT|Overall Study||12
10907297|NCT00081289|12073607|FG001|DS Score at End of Post-op CT|Overall Study||14
10907298|NCT00081289|12073606|FG000|Defecation Symptom Score at Two Years|Overall Study||13
10907299|NCT00081289|12073607|FG001|Defecation Symptom Score at Two Years|Overall Study||15
10907300|NCT00081289|12073606|FG000|COMPLETED|Overall Study||52
10907301|NCT00081289|12073607|FG001|COMPLETED|Overall Study||52
10907302|NCT00081289|12073606|FG000|NOT COMPLETED|Overall Study||21
10907303|NCT00081289|12073607|FG001|NOT COMPLETED|Overall Study||21
10907304|NCT00081328|12073617|FG000|STARTED|Overall Study||232
10907305|NCT00081328|12073618|FG001|STARTED|Overall Study||233
10907306|NCT00081328|12073619|FG002|STARTED|Overall Study||234
10907307|NCT00081328|12073617|FG000|COMPLETED|Overall Study||232
10907308|NCT00081328|12073618|FG001|COMPLETED|Overall Study||233
10907309|NCT00081328|12073619|FG002|COMPLETED|Overall Study||234
10907310|NCT00081328|12073617|FG000|NOT COMPLETED|Overall Study||0
10907311|NCT00081328|12073618|FG001|NOT COMPLETED|Overall Study||0
10907312|NCT00081328|12073619|FG002|NOT COMPLETED|Overall Study||0
10907313|NCT00081458|12073631|FG000|STARTED|Overall Study||16
10907314|NCT00081458|12073632|FG001|STARTED|Overall Study||35
10907315|NCT00081458|12073633|FG002|STARTED|Overall Study||33
10907316|NCT00081458|12073631|FG000|Received Treatment|Overall Study||16
10907317|NCT00081458|12073632|FG001|Received Treatment|Overall Study||35
10907318|NCT00081458|12073633|FG002|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
10907319|NCT00081458|12073631|FG000|COMPLETED|Overall Study||15
10907320|NCT00081458|12073632|FG001|COMPLETED|Overall Study||27
10907321|NCT00081458|12073633|FG002|COMPLETED|Overall Study||29
10907322|NCT00081458|12073631|FG000|NOT COMPLETED|Overall Study||1
10907323|NCT00081458|12073632|FG001|NOT COMPLETED|Overall Study||8
10907324|NCT00081458|12073633|FG002|NOT COMPLETED|Overall Study||4
10907325|NCT00081497|12073644|FG000|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
10907326|NCT00081497|12073645|FG001|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
10907327|NCT00081497|12073644|FG000|COMPLETED|Overall Study||25
10907328|NCT00081497|12073645|FG001|COMPLETED|Overall Study||37
10907329|NCT00081497|12073644|FG000|NOT COMPLETED|Overall Study||3
10907330|NCT00081497|12073645|FG001|NOT COMPLETED|Overall Study||2
10907331|NCT00081653|12073659|FG000|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
10907332|NCT00081653|12073660|FG001|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
10907333|NCT00081653|12073659|FG000|COMPLETED|Overall Study|Completed 3 years of treatment|311
10907334|NCT00081653|12073660|FG001|COMPLETED|Overall Study|Completed 3 years of treatment|324
10907335|NCT00081653|12073659|FG000|NOT COMPLETED|Overall Study||47
10907336|NCT00081653|12073660|FG001|NOT COMPLETED|Overall Study||37
10907337|NCT00081731|12073669|FG000|STARTED|Overall Study||480
10907338|NCT00081731|12073670|FG001|STARTED|Overall Study||467
10907339|NCT00081731|12073669|FG000|COMPLETED|Overall Study||472
10907340|NCT00081731|12073670|FG001|COMPLETED|Overall Study||459
10907341|NCT00081731|12073669|FG000|NOT COMPLETED|Overall Study||8
10907342|NCT00081731|12073670|FG001|NOT COMPLETED|Overall Study||8
10907343|NCT00081770|12073679|FG000|STARTED|Overall Study||1019
10907344|NCT00081770|12073680|FG001|STARTED|Overall Study||1016
10907345|NCT00081770|12073681|FG002|STARTED|Overall Study||1035
10907346|NCT00081770|12073679|FG000|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
10907347|NCT00081770|12073680|FG001|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
10907348|NCT00081770|12073681|FG002|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
10907349|NCT00081770|12073679|FG000|NOT COMPLETED|Overall Study||502
10907350|NCT00081770|12073680|FG001|NOT COMPLETED|Overall Study||546
10907351|NCT00081770|12073681|FG002|NOT COMPLETED|Overall Study||456
10907352|NCT00081861|12073689|FG000|STARTED|Overall Study||13
10907353|NCT00081861|12073689|FG000|COMPLETED|Overall Study||13
10907354|NCT00081861|12073689|FG000|NOT COMPLETED|Overall Study||0
10907355|NCT00081939|12073693|FG000|STARTED|Overall Study||303
10907356|NCT00081939|12073693|FG000|COMPLETED|Overall Study||303
10907357|NCT00081939|12073693|FG000|NOT COMPLETED|Overall Study||0
10907358|NCT00082017|12073697|FG000|STARTED|Overall Study||11
10907359|NCT00082017|12073698|FG001|STARTED|Overall Study||9
10907360|NCT00082017|12073697|FG000|COMPLETED|Overall Study||11
10907361|NCT00082017|12073698|FG001|COMPLETED|Overall Study||9
10907362|NCT00082017|12073697|FG000|NOT COMPLETED|Overall Study||0
10907363|NCT00082017|12073698|FG001|NOT COMPLETED|Overall Study||0
10907364|NCT00082173|12073706|FG000|STARTED|Overall Study||74
10907365|NCT00082173|12073707|FG001|STARTED|Overall Study||72
10907366|NCT00082173|12073706|FG000|COMPLETED|Overall Study||64
10907367|NCT00082173|12073707|FG001|COMPLETED|Overall Study||61
10907368|NCT00082173|12073706|FG000|NOT COMPLETED|Overall Study||10
10907369|NCT00082173|12073707|FG001|NOT COMPLETED|Overall Study||11
10907370|NCT00082329|12073713|FG000|STARTED|Overall Study||9
10907371|NCT00082329|12073713|FG000|COMPLETED|Overall Study||9
10907372|NCT00082329|12073713|FG000|NOT COMPLETED|Overall Study||0
10907373|NCT00082342|12073719|FG000|STARTED|Overall Study||13
10907374|NCT00082342|12073720|FG001|STARTED|Overall Study||12
10907375|NCT00082342|12073719|FG000|COMPLETED|Overall Study||13
10907376|NCT00082342|12073720|FG001|COMPLETED|Overall Study||12
10907377|NCT00082342|12073719|FG000|NOT COMPLETED|Overall Study||0
10907378|NCT00082342|12073720|FG001|NOT COMPLETED|Overall Study||0
10907379|NCT00082355|12073740|FG000|STARTED|Initial Results of Thrombolytic Therapy||30
10907380|NCT00082355|12073740|FG000|COMPLETED|Initial Results of Thrombolytic Therapy||28
10907381|NCT00082355|12073740|FG000|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
10907382|NCT00082355|12073740|FG000|STARTED|5 Year Recurrent Thromboembolism Rate||28
10907383|NCT00082355|12073740|FG000|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
10907384|NCT00082355|12073740|FG000|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
10907385|NCT00082368|12073744|FG000|STARTED|Overall Study||12
10907386|NCT00082368|12073744|FG000|COMPLETED|Overall Study||11
10907387|NCT00082368|12073744|FG000|NOT COMPLETED|Overall Study||1
10907388|NCT00082381|12073750|FG000|STARTED|Overall Study||283
10907389|NCT00082381|12073751|FG001|STARTED|Overall Study||268
10907390|NCT00082381|12073750|FG000|Received Treatment (Intent to Treat)|Overall Study||282
10907391|NCT00082381|12073751|FG001|Received Treatment (Intent to Treat)|Overall Study||267
10907392|NCT00082381|12073750|FG000|COMPLETED|Overall Study||228
10907393|NCT00082381|12073751|FG001|COMPLETED|Overall Study||242
10907394|NCT00082381|12073750|FG000|NOT COMPLETED|Overall Study||55
10907395|NCT00082381|12073751|FG001|NOT COMPLETED|Overall Study||26
10907396|NCT00082407|12073759|FG000|STARTED|Overall Study||255
10907397|NCT00082407|12073760|FG001|STARTED|Overall Study||250
10907398|NCT00082407|12073759|FG000|Received Treatment (Intent to Treat)|Overall Study||253
10907399|NCT00082407|12073760|FG001|Received Treatment (Intent to Treat)|Overall Study||248
10907400|NCT00082407|12073759|FG000|COMPLETED|Overall Study||199
10907401|NCT00082407|12073760|FG001|COMPLETED|Overall Study||223
10907402|NCT00082407|12073759|FG000|NOT COMPLETED|Overall Study||56
10907403|NCT00082407|12073760|FG001|NOT COMPLETED|Overall Study||27
10907404|NCT00082433|12073768|FG000|STARTED|Overall Study||609
10907405|NCT00082433|12073769|FG001|STARTED|Overall Study||612
10907406|NCT00082433|12073768|FG000|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
10907407|NCT00082433|12073769|FG001|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
10907408|NCT00082433|12073768|FG000|NOT COMPLETED|Overall Study||594
10907409|NCT00082433|12073769|FG001|NOT COMPLETED|Overall Study||597
10907410|NCT00082628|12073777|FG000|STARTED|Treatment Period I (Week 1 to Week 12)||81
10907411|NCT00082628|12073778|FG001|STARTED|Treatment Period I (Week 1 to Week 12)||245
10907412|NCT00082628|12073779|FG002|STARTED|Treatment Period I (Week 1 to Week 12)||0
10907413|NCT00082628|12073780|FG003|STARTED|Treatment Period I (Week 1 to Week 12)||0
10907414|NCT00082628|12073781|FG004|STARTED|Treatment Period I (Week 1 to Week 12)||0
10907415|NCT00082628|12073777|FG000|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
10907416|NCT00082628|12073778|FG001|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
10907417|NCT00082628|12073779|FG002|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
10907418|NCT00082628|12073780|FG003|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
10907419|NCT00082628|12073781|FG004|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
10907420|NCT00082628|12073777|FG000|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
10907421|NCT00082628|12073778|FG001|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
10907422|NCT00082628|12073779|FG002|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
10907423|NCT00082628|12073780|FG003|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
10907424|NCT00082628|12073781|FG004|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
10907425|NCT00082628|12073777|FG000|STARTED|Treatment Period II: Week 12 to Week 36||0
10907426|NCT00082628|12073778|FG001|STARTED|Treatment Period II: Week 12 to Week 36||0
10907427|NCT00082628|12073779|FG002|STARTED|Treatment Period II: Week 12 to Week 36||93
10907428|NCT00082628|12073780|FG003|STARTED|Treatment Period II: Week 12 to Week 36||92
10907429|NCT00082628|12073781|FG004|STARTED|Treatment Period II: Week 12 to Week 36||73
10907430|NCT00082628|12073777|FG000|COMPLETED|Treatment Period II: Week 12 to Week 36||0
10907431|NCT00082628|12073778|FG001|COMPLETED|Treatment Period II: Week 12 to Week 36||0
10907432|NCT00082628|12073779|FG002|COMPLETED|Treatment Period II: Week 12 to Week 36||78
10907433|NCT00082628|12073780|FG003|COMPLETED|Treatment Period II: Week 12 to Week 36||76
10907434|NCT00082628|12073781|FG004|COMPLETED|Treatment Period II: Week 12 to Week 36||55
10907435|NCT00082628|12073777|FG000|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
10907436|NCT00082628|12073778|FG001|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
10907437|NCT00082628|12073779|FG002|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
10907438|NCT00082628|12073780|FG003|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
10907439|NCT00082628|12073781|FG004|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
10907440|NCT00082641|12073795|FG000|STARTED|Overall Study||11
10907441|NCT00082641|12073796|FG001|STARTED|Overall Study||12
10907442|NCT00082641|12073795|FG000|COMPLETED|Overall Study||11
10907443|NCT00082641|12073796|FG001|COMPLETED|Overall Study||12
10907444|NCT00082641|12073795|FG000|NOT COMPLETED|Overall Study||0
10907445|NCT00082641|12073796|FG001|NOT COMPLETED|Overall Study||0
10907446|NCT00082758|12073806|FG000|STARTED|Overall Study||15
10907447|NCT00082758|12073807|FG001|STARTED|Overall Study||24
10907448|NCT00082758|12073808|FG002|STARTED|Overall Study||0
10907449|NCT00082758|12073806|FG000|COMPLETED|Overall Study||0
10907450|NCT00082758|12073807|FG001|COMPLETED|Overall Study||7
10907451|NCT00082758|12073808|FG002|COMPLETED|Overall Study||0
10907452|NCT00082758|12073806|FG000|NOT COMPLETED|Overall Study||15
10907453|NCT00082758|12073807|FG001|NOT COMPLETED|Overall Study||17
10907454|NCT00082758|12073808|FG002|NOT COMPLETED|Overall Study||0
10907455|NCT00082810|12073816|FG000|STARTED|Overall Study||33
10907456|NCT00082810|12073816|FG000|COMPLETED|Overall Study||2
10907457|NCT00082810|12073816|FG000|NOT COMPLETED|Overall Study||31
10907458|NCT00082888|12073824|FG000|STARTED|Overall Study||42
10907459|NCT00082888|12073825|FG001|STARTED|Overall Study||15
10907460|NCT00082888|12073826|FG002|STARTED|Overall Study||36
10907461|NCT00082888|12073824|FG000|COMPLETED|Overall Study||41
10907462|NCT00082888|12073825|FG001|COMPLETED|Overall Study||15
10907463|NCT00082888|12073826|FG002|COMPLETED|Overall Study||36
10907464|NCT00082888|12073824|FG000|NOT COMPLETED|Overall Study||1
10907465|NCT00082888|12073825|FG001|NOT COMPLETED|Overall Study||0
10907466|NCT00082888|12073826|FG002|NOT COMPLETED|Overall Study||0
10907467|NCT00083122|12073837|FG000|STARTED|Overall Study||40
10907468|NCT00083122|12073838|FG001|STARTED|Overall Study||5
10907469|NCT00083122|12073837|FG000|COMPLETED|Overall Study||40
10907470|NCT00083122|12073838|FG001|COMPLETED|Overall Study||5
10907471|NCT00083122|12073837|FG000|NOT COMPLETED|Overall Study||0
10907472|NCT00083122|12073838|FG001|NOT COMPLETED|Overall Study||0
10907473|NCT00083174|12073846|FG000|STARTED|Randomization Period||2285
10907474|NCT00083174|12073847|FG001|STARTED|Randomization Period||2275
10907475|NCT00083174|12073848|FG002|STARTED|Randomization Period||0
10907476|NCT00083174|12073846|FG000|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
10907477|NCT00083174|12073847|FG001|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
10907478|NCT00083174|12073848|FG002|COMPLETED|Randomization Period||0
10907479|NCT00083174|12073846|FG000|NOT COMPLETED|Randomization Period||0
10907480|NCT00083174|12073847|FG001|NOT COMPLETED|Randomization Period||0
10907481|NCT00083174|12073848|FG002|NOT COMPLETED|Randomization Period||0
10907482|NCT00083174|12073846|FG000|STARTED|Open-label Extension||0
10907483|NCT00083174|12073847|FG001|STARTED|Open-label Extension||0
10907484|NCT00083174|12073848|FG002|STARTED|Open-label Extension||2831
10907485|NCT00083174|12073846|FG000|COMPLETED|Open-label Extension||0
10907486|NCT00083174|12073847|FG001|COMPLETED|Open-label Extension||0
10907487|NCT00083174|12073848|FG002|COMPLETED|Open-label Extension||2831
10907488|NCT00083174|12073846|FG000|NOT COMPLETED|Open-label Extension||0
10907489|NCT00083174|12073847|FG001|NOT COMPLETED|Open-label Extension||0
10907490|NCT00083174|12073848|FG002|NOT COMPLETED|Open-label Extension||0
10907491|NCT00083226|12073858|FG000|STARTED|Overall Study||42
10907492|NCT00083226|12073858|FG000|COMPLETED|Overall Study||0
10907493|NCT00083226|12073858|FG000|NOT COMPLETED|Overall Study||42
10907494|NCT00083382|12073862|FG000|STARTED|Overall Study||83
10907495|NCT00083382|12073862|FG000|COMPLETED|Overall Study||83
10907496|NCT00083382|12073862|FG000|NOT COMPLETED|Overall Study||0
10907497|NCT00083551|12073868|FG000|STARTED|Overall Study||323
10907498|NCT00083551|12073869|FG001|STARTED|Overall Study||345
10907499|NCT00083551|12073868|FG000|COMPLETED|Overall Study||323
10907500|NCT00083551|12073869|FG001|COMPLETED|Overall Study||345
10907501|NCT00083551|12073868|FG000|NOT COMPLETED|Overall Study||0
10907502|NCT00083551|12073869|FG001|NOT COMPLETED|Overall Study||0
10907503|NCT00083616|12073875|FG000|STARTED|Overall Study||185
10907504|NCT00083616|12073875|FG000|Received Study Medication|Overall Study||182
10907505|NCT00083616|12073875|FG000|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
10907506|NCT00083616|12073875|FG000|NOT COMPLETED|Overall Study||31
10907507|NCT00083720|12073879|FG000|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
10907508|NCT00083720|12073879|FG000|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
10907509|NCT00083720|12073879|FG000|NOT COMPLETED|Overall Study||0
10907510|NCT00083889|12073885|FG000|STARTED|Overall Study||375
10907511|NCT00083889|12073886|FG001|STARTED|Overall Study||375
10907512|NCT00083889|12073885|FG000|Received Treatment|Overall Study||375
10907513|NCT00083889|12073886|FG001|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
10907514|NCT00083889|12073885|FG000|COMPLETED|Overall Study||0
10907515|NCT00083889|12073886|FG001|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
10907516|NCT00083889|12073885|FG000|NOT COMPLETED|Overall Study||375
10907517|NCT00083889|12073886|FG001|NOT COMPLETED|Overall Study||375
10907518|NCT00084084|12073895|FG000|STARTED|Phase 1 (Treatment With Replagal RB)||17
10907519|NCT00084084|12073895|FG000|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
10907520|NCT00084084|12073895|FG000|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
10907521|NCT00084084|12073895|FG000|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
10907522|NCT00084084|12073895|FG000|COMPLETED|Phase 2 (Transition to Replagal AF)||10
10907523|NCT00084084|12073895|FG000|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
10907524|NCT00084136|12073903|FG000|STARTED|PI Comparison||519
10907525|NCT00084136|12073904|FG001|STARTED|PI Comparison||526
10907526|NCT00084136|12073905|FG002|STARTED|PI Comparison||0
10907527|NCT00084136|12073903|FG000|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
10907528|NCT00084136|12073904|FG001|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
10907529|NCT00084136|12073905|FG002|COMPLETED|PI Comparison||0
10907530|NCT00084136|12073903|FG000|NOT COMPLETED|PI Comparison||55
10907531|NCT00084136|12073904|FG001|NOT COMPLETED|PI Comparison||47
10907532|NCT00084136|12073905|FG002|NOT COMPLETED|PI Comparison||0
10907533|NCT00084136|12073903|FG000|STARTED|NRTI Comparison||519
10907534|NCT00084136|12073904|FG001|STARTED|NRTI Comparison||0
10907535|NCT00084136|12073905|FG002|STARTED|NRTI Comparison||526
10907536|NCT00084136|12073903|FG000|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
10907537|NCT00084136|12073904|FG001|COMPLETED|NRTI Comparison||0
10907538|NCT00084136|12073905|FG002|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
10907539|NCT00084136|12073903|FG000|NOT COMPLETED|NRTI Comparison||101
10907540|NCT00084136|12073904|FG001|NOT COMPLETED|NRTI Comparison||0
10907541|NCT00084136|12073905|FG002|NOT COMPLETED|NRTI Comparison||82
10907542|NCT00084149|12073916|FG000|STARTED|Overall Study||36
10907543|NCT00084149|12073917|FG001|STARTED|Overall Study||18
10907544|NCT00084149|12073916|FG000|COMPLETED|Overall Study||28
10907545|NCT00084149|12073917|FG001|COMPLETED|Overall Study||13
10907546|NCT00084149|12073916|FG000|NOT COMPLETED|Overall Study||8
10907547|NCT00084149|12073917|FG001|NOT COMPLETED|Overall Study||5
10907548|NCT00084266|12073929|FG000|STARTED|Overall Study||618
10907549|NCT00084266|12073930|FG001|STARTED|Overall Study||607
10907550|NCT00084266|12073929|FG000|Treated|Overall Study||597
10907551|NCT00084266|12073930|FG001|Treated|Overall Study||587
10907552|NCT00084266|12073929|FG000|COMPLETED|Overall Study||177
10907553|NCT00084266|12073930|FG001|COMPLETED|Overall Study||184
10907554|NCT00084266|12073929|FG000|NOT COMPLETED|Overall Study||441
10907555|NCT00084266|12073930|FG001|NOT COMPLETED|Overall Study||423
10907556|NCT00084318|12073938|FG000|STARTED|Overall Study||119
10907557|NCT00084318|12073939|FG001|STARTED|Overall Study||119
10907558|NCT00084318|12073938|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
10907559|NCT00084318|12073939|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
10907560|NCT00084318|12073938|FG000|NOT COMPLETED|Overall Study||22
10907561|NCT00084318|12073939|FG001|NOT COMPLETED|Overall Study||13
10907562|NCT00084383|12073947|FG000|STARTED|Overall Study||60
10907563|NCT00084383|12073947|FG000|COMPLETED|Overall Study||13
10907564|NCT00084383|12073947|FG000|NOT COMPLETED|Overall Study||47
10907565|NCT00084409|12073953|FG000|STARTED|Overall Study|40 Current, 35 former|75
10907566|NCT00084409|12073954|FG001|STARTED|Overall Study|41 current, 36 former|77
10907567|NCT00084409|12073953|FG000|COMPLETED|Overall Study|9 current, 6 former|60
10907568|NCT00084409|12073954|FG001|COMPLETED|Overall Study|4 Current, 8 former|65
10907569|NCT00084409|12073953|FG000|NOT COMPLETED|Overall Study||15
10907570|NCT00084409|12073954|FG001|NOT COMPLETED|Overall Study||12
10907571|NCT00084487|12073962|FG000|STARTED|Overall Study||21
10907572|NCT00084487|12073962|FG000|COMPLETED|Overall Study||20
10907573|NCT00084487|12073962|FG000|NOT COMPLETED|Overall Study||1
10907574|NCT00084552|12073968|FG000|STARTED|Overall Study||54
10907575|NCT00084552|12073969|FG001|STARTED|Overall Study||62
10907576|NCT00084552|12073968|FG000|COMPLETED|Overall Study||54
10907577|NCT00084552|12073969|FG001|COMPLETED|Overall Study||62
10907578|NCT00084552|12073968|FG000|NOT COMPLETED|Overall Study||0
10907579|NCT00084552|12073969|FG001|NOT COMPLETED|Overall Study||0
10907580|NCT00084617|12073975|FG000|STARTED|Overall Study||39
10907581|NCT00084617|12073975|FG000|COMPLETED|Overall Study||30
10907582|NCT00084617|12073975|FG000|NOT COMPLETED|Overall Study||9
10907583|NCT00084682|12073979|FG000|STARTED|Overall Study||14
10907584|NCT00084682|12073979|FG000|COMPLETED|Overall Study||13
10907585|NCT00084682|12073979|FG000|NOT COMPLETED|Overall Study||1
10907586|NCT00084747|12073984|FG000|STARTED|Overall Study||30
10907587|NCT00084747|12073984|FG000|COMPLETED|Overall Study||17
10907588|NCT00084747|12073984|FG000|NOT COMPLETED|Overall Study||13
10907589|NCT00084838|12073989|FG000|STARTED|Overall Study||25
10907590|NCT00084838|12073989|FG000|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
10907591|NCT00084838|12073989|FG000|COMPLETED|Overall Study||12
10907592|NCT00084838|12073989|FG000|NOT COMPLETED|Overall Study||13
10907593|NCT00084864|12073999|FG000|STARTED|Overall Study||10
10907594|NCT00084864|12074000|FG001|STARTED|Overall Study||7
10907595|NCT00084864|12074001|FG002|STARTED|Overall Study||4
10907596|NCT00084864|12074002|FG003|STARTED|Overall Study||4
10907597|NCT00084864|12073999|FG000|COMPLETED|Overall Study||9
10907598|NCT00084864|12074000|FG001|COMPLETED|Overall Study||7
10907599|NCT00084864|12074001|FG002|COMPLETED|Overall Study||4
10907600|NCT00084864|12074002|FG003|COMPLETED|Overall Study||4
10907601|NCT00084864|12073999|FG000|NOT COMPLETED|Overall Study||1
10907602|NCT00084864|12074000|FG001|NOT COMPLETED|Overall Study||0
10907603|NCT00084864|12074001|FG002|NOT COMPLETED|Overall Study||0
10907604|NCT00084864|12074002|FG003|NOT COMPLETED|Overall Study||0
10907605|NCT00084929|12074012|FG000|STARTED|Overall Study||2600
10907606|NCT00084929|12074012|FG000|COMPLETED|Overall Study||2531
10907607|NCT00084929|12074012|FG000|NOT COMPLETED|Overall Study||69
10907608|NCT00085098|12074022|FG000|STARTED|Overall Study||11
10907609|NCT00085098|12074023|FG001|STARTED|Overall Study||13
10907610|NCT00085098|12074022|FG000|COMPLETED|Overall Study||10
10907611|NCT00085098|12074023|FG001|COMPLETED|Overall Study||11
10907612|NCT00085098|12074022|FG000|NOT COMPLETED|Overall Study||1
10907613|NCT00085098|12074023|FG001|NOT COMPLETED|Overall Study||2
10907614|NCT00085254|12074035|FG000|STARTED|Overall Study||18
10907615|NCT00085254|12074036|FG001|STARTED|Overall Study||46
10907616|NCT00085254|12074037|FG002|STARTED|Overall Study||48
10907617|NCT00085254|12074035|FG000|COMPLETED|Overall Study||18
10907618|NCT00085254|12074036|FG001|COMPLETED|Overall Study||46
10907619|NCT00085254|12074037|FG002|COMPLETED|Overall Study||48
10907620|NCT00085254|12074035|FG000|NOT COMPLETED|Overall Study||0
10907621|NCT00085254|12074036|FG001|NOT COMPLETED|Overall Study||0
10907622|NCT00085254|12074037|FG002|NOT COMPLETED|Overall Study||0
10907623|NCT00085293|12074051|FG000|STARTED|Overall Study||12
10907624|NCT00085293|12074051|FG000|COMPLETED|Overall Study||12
10907625|NCT00085293|12074051|FG000|NOT COMPLETED|Overall Study||0
10907626|NCT00085410|12074055|FG000|STARTED|Overall Study||20
10907627|NCT00085410|12074055|FG000|COMPLETED|Overall Study||20
10907628|NCT00085410|12074055|FG000|NOT COMPLETED|Overall Study||0
10907629|NCT00085423|12074060|FG000|STARTED|Overall Study||20
10907630|NCT00085423|12074060|FG000|COMPLETED|Overall Study||18
10907631|NCT00085423|12074060|FG000|NOT COMPLETED|Overall Study||2
10907632|NCT00085436|12074064|FG000|STARTED|Overall Study||18
10907633|NCT00085436|12074064|FG000|COMPLETED|Overall Study||18
10907634|NCT00085436|12074064|FG000|NOT COMPLETED|Overall Study||0
10907635|NCT00085540|12074071|FG000|STARTED|Overall Study||8
10907636|NCT00085540|12074072|FG001|STARTED|Overall Study||42
10907637|NCT00085540|12074071|FG000|COMPLETED|Overall Study||8
10907638|NCT00085540|12074072|FG001|COMPLETED|Overall Study||40
10907639|NCT00085540|12074071|FG000|NOT COMPLETED|Overall Study||0
10907640|NCT00085540|12074072|FG001|NOT COMPLETED|Overall Study||2
10907641|NCT00085566|12074081|FG000|STARTED|Overall Study||3
10907642|NCT00085566|12074082|FG001|STARTED|Overall Study||3
10907643|NCT00085566|12074083|FG002|STARTED|Overall Study||57
10907644|NCT00085566|12074081|FG000|COMPLETED|Overall Study||3
10907645|NCT00085566|12074082|FG001|COMPLETED|Overall Study||3
10907646|NCT00085566|12074083|FG002|COMPLETED|Overall Study||43
10907647|NCT00085566|12074081|FG000|NOT COMPLETED|Overall Study||0
10907648|NCT00085566|12074082|FG001|NOT COMPLETED|Overall Study||0
10907649|NCT00085566|12074083|FG002|NOT COMPLETED|Overall Study||14
10907650|NCT00085644|12074093|FG000|STARTED|Double-Blind Period||208
10907651|NCT00085644|12074094|FG001|STARTED|Double-Blind Period||107
10907652|NCT00085644|12074095|FG002|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
10907653|NCT00085644|12074093|FG000|COMPLETED|Double-Blind Period||195
10907654|NCT00085644|12074094|FG001|COMPLETED|Double-Blind Period||101
10907655|NCT00085644|12074095|FG002|COMPLETED|Double-Blind Period||0
10907656|NCT00085644|12074093|FG000|NOT COMPLETED|Double-Blind Period||13
10907657|NCT00085644|12074094|FG001|NOT COMPLETED|Double-Blind Period||6
10907658|NCT00085644|12074095|FG002|NOT COMPLETED|Double-Blind Period||0
10907659|NCT00085644|12074093|FG000|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
10907660|NCT00085644|12074094|FG001|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
10907661|NCT00085644|12074095|FG002|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
10907662|NCT00085644|12074093|FG000|COMPLETED|Open-Label Period||0
10907663|NCT00085644|12074094|FG001|COMPLETED|Open-Label Period||0
10907664|NCT00085644|12074095|FG002|COMPLETED|Open-Label Period||202
10907665|NCT00085644|12074093|FG000|NOT COMPLETED|Open-Label Period||0
10907666|NCT00085644|12074094|FG001|NOT COMPLETED|Open-Label Period||0
10907667|NCT00085644|12074095|FG002|NOT COMPLETED|Open-Label Period||109
10907668|NCT00085709|12074104|FG000|STARTED|Overall Study||317
10907669|NCT00085709|12074105|FG001|STARTED|Overall Study||320
10907670|NCT00085709|12074104|FG000|Eligible|Overall Study||298
10907671|NCT00085709|12074105|FG001|Eligible|Overall Study||301
10907672|NCT00085709|12074104|FG000|Eligible and Did Not Withdraw Consent|Overall Study||296
10907673|NCT00085709|12074105|FG001|Eligible and Did Not Withdraw Consent|Overall Study||300
10907674|NCT00085709|12074104|FG000|COMPLETED|Overall Study||264
10907675|NCT00085709|12074105|FG001|COMPLETED|Overall Study||270
10907676|NCT00085709|12074104|FG000|NOT COMPLETED|Overall Study||53
10907677|NCT00085709|12074105|FG001|NOT COMPLETED|Overall Study||50
10907678|NCT00085839|12074121|FG000|STARTED|Overall Study||52
10907679|NCT00085839|12074122|FG001|STARTED|Overall Study||51
10907680|NCT00085839|12074121|FG000|COMPLETED|Overall Study||52
10907681|NCT00085839|12074122|FG001|COMPLETED|Overall Study||51
10907682|NCT00085839|12074121|FG000|NOT COMPLETED|Overall Study||0
10907683|NCT00085839|12074122|FG001|NOT COMPLETED|Overall Study||0
10907684|NCT00085917|12074130|FG000|STARTED|Overall Study||15
10907685|NCT00085917|12074131|FG001|STARTED|Overall Study||14
10907686|NCT00085917|12074130|FG000|COMPLETED|Overall Study||11
10907687|NCT00085917|12074131|FG001|COMPLETED|Overall Study||11
10907688|NCT00085917|12074130|FG000|NOT COMPLETED|Overall Study||4
10907689|NCT00085917|12074131|FG001|NOT COMPLETED|Overall Study||3
10907690|NCT00086047|12074139|FG000|STARTED|Overall Study||57
10907691|NCT00086047|12074140|FG001|STARTED|Overall Study||57
10907692|NCT00086047|12074139|FG000|COMPLETED|Overall Study||50
10907693|NCT00086047|12074140|FG001|COMPLETED|Overall Study||50
10907694|NCT00086047|12074139|FG000|NOT COMPLETED|Overall Study||7
10907695|NCT00086047|12074140|FG001|NOT COMPLETED|Overall Study||7
10907696|NCT00086138|12074148|FG000|STARTED|Overall Study||64
10907697|NCT00086138|12074149|FG001|STARTED|Overall Study||67
10907698|NCT00086138|12074148|FG000|COMPLETED|Overall Study||60
10907699|NCT00086138|12074149|FG001|COMPLETED|Overall Study||64
10907700|NCT00086138|12074148|FG000|NOT COMPLETED|Overall Study||4
10907701|NCT00086138|12074149|FG001|NOT COMPLETED|Overall Study||3
10907702|NCT00086190|12074158|FG000|STARTED|Overall Study||42
10907703|NCT00086190|12074159|FG001|STARTED|Overall Study||34
10907704|NCT00086190|12074160|FG002|STARTED|Overall Study||39
10907705|NCT00086190|12074158|FG000|COMPLETED|Overall Study||34
10907706|NCT00086190|12074159|FG001|COMPLETED|Overall Study||30
10907707|NCT00086190|12074160|FG002|COMPLETED|Overall Study||33
10907708|NCT00086190|12074158|FG000|NOT COMPLETED|Overall Study||8
10907709|NCT00086190|12074159|FG001|NOT COMPLETED|Overall Study||4
10907710|NCT00086190|12074160|FG002|NOT COMPLETED|Overall Study||6
10907711|NCT00086281|12074183|FG000|STARTED|Phase 1||11
10907712|NCT00086281|12074184|FG001|STARTED|Phase 1||12
10907713|NCT00086281|12074185|FG002|STARTED|Phase 1||8
10907714|NCT00086281|12074186|FG003|STARTED|Phase 1||11
10907715|NCT00086281|12074187|FG004|STARTED|Phase 1||1
10907716|NCT00086281|12074188|FG005|STARTED|Phase 1||3
10907717|NCT00086281|12074189|FG006|STARTED|Phase 1||1
10907718|NCT00086281|12074190|FG007|STARTED|Phase 1||1
10907719|NCT00086281|12074191|FG008|STARTED|Phase 1||2
10907720|NCT00086281|12074192|FG009|STARTED|Phase 1||1
10907721|NCT00086281|12074193|FG010|STARTED|Phase 1||3
10907722|NCT00086281|12074194|FG011|STARTED|Phase 1||1
10907723|NCT00086281|12074195|FG012|STARTED|Phase 1||1
10907724|NCT00086281|12074196|FG013|STARTED|Phase 1||1
10907725|NCT00086281|12074197|FG014|STARTED|Phase 1||3
10907726|NCT00086281|12074183|FG000|COMPLETED|Phase 1||11
10907727|NCT00086281|12074184|FG001|COMPLETED|Phase 1||12
10907728|NCT00086281|12074185|FG002|COMPLETED|Phase 1||8
10907729|NCT00086281|12074186|FG003|COMPLETED|Phase 1||11
10907730|NCT00086281|12074187|FG004|COMPLETED|Phase 1||1
10907731|NCT00086281|12074188|FG005|COMPLETED|Phase 1||3
10907732|NCT00086281|12074189|FG006|COMPLETED|Phase 1||1
10907733|NCT00086281|12074190|FG007|COMPLETED|Phase 1||1
10907734|NCT00086281|12074191|FG008|COMPLETED|Phase 1||2
10907735|NCT00086281|12074192|FG009|COMPLETED|Phase 1||0
10907736|NCT00086281|12074193|FG010|COMPLETED|Phase 1||0
10907737|NCT00086281|12074194|FG011|COMPLETED|Phase 1||0
10907738|NCT00086281|12074195|FG012|COMPLETED|Phase 1||0
10907739|NCT00086281|12074196|FG013|COMPLETED|Phase 1||0
10907740|NCT00086281|12074197|FG014|COMPLETED|Phase 1||0
10907741|NCT00086281|12074183|FG000|NOT COMPLETED|Phase 1||0
10907742|NCT00086281|12074184|FG001|NOT COMPLETED|Phase 1||0
10907743|NCT00086281|12074185|FG002|NOT COMPLETED|Phase 1||0
10907744|NCT00086281|12074186|FG003|NOT COMPLETED|Phase 1||0
10907745|NCT00086281|12074187|FG004|NOT COMPLETED|Phase 1||0
10907746|NCT00086281|12074188|FG005|NOT COMPLETED|Phase 1||0
10907747|NCT00086281|12074189|FG006|NOT COMPLETED|Phase 1||0
10907748|NCT00086281|12074190|FG007|NOT COMPLETED|Phase 1||0
10907749|NCT00086281|12074191|FG008|NOT COMPLETED|Phase 1||0
10907750|NCT00086281|12074192|FG009|NOT COMPLETED|Phase 1||1
10907751|NCT00086281|12074193|FG010|NOT COMPLETED|Phase 1||3
10907752|NCT00086281|12074194|FG011|NOT COMPLETED|Phase 1||1
10907753|NCT00086281|12074195|FG012|NOT COMPLETED|Phase 1||1
10907754|NCT00086281|12074196|FG013|NOT COMPLETED|Phase 1||1
10907755|NCT00086281|12074197|FG014|NOT COMPLETED|Phase 1||3
10907756|NCT00086281|12074183|FG000|STARTED|Phase 2||0
10907757|NCT00086281|12074184|FG001|STARTED|Phase 2||0
10907758|NCT00086281|12074185|FG002|STARTED|Phase 2||0
10907759|NCT00086281|12074186|FG003|STARTED|Phase 2||0
10907760|NCT00086281|12074187|FG004|STARTED|Phase 2||0
10907761|NCT00086281|12074188|FG005|STARTED|Phase 2||0
10907762|NCT00086281|12074189|FG006|STARTED|Phase 2||0
10907763|NCT00086281|12074190|FG007|STARTED|Phase 2||0
10907764|NCT00086281|12074191|FG008|STARTED|Phase 2||0
10907765|NCT00086281|12074192|FG009|STARTED|Phase 2||0
10907766|NCT00086281|12074193|FG010|STARTED|Phase 2||0
10907767|NCT00086281|12074194|FG011|STARTED|Phase 2||0
10907768|NCT00086281|12074195|FG012|STARTED|Phase 2||23
10907769|NCT00086281|12074196|FG013|STARTED|Phase 2||27
10907770|NCT00086281|12074197|FG014|STARTED|Phase 2||0
10907771|NCT00086281|12074183|FG000|COMPLETED|Phase 2||0
10907772|NCT00086281|12074184|FG001|COMPLETED|Phase 2||0
10907773|NCT00086281|12074185|FG002|COMPLETED|Phase 2||0
10907774|NCT00086281|12074186|FG003|COMPLETED|Phase 2||0
10907775|NCT00086281|12074187|FG004|COMPLETED|Phase 2||0
10907776|NCT00086281|12074188|FG005|COMPLETED|Phase 2||0
10907777|NCT00086281|12074189|FG006|COMPLETED|Phase 2||0
10907778|NCT00086281|12074190|FG007|COMPLETED|Phase 2||0
10907779|NCT00086281|12074191|FG008|COMPLETED|Phase 2||0
10907780|NCT00086281|12074192|FG009|COMPLETED|Phase 2||0
10907781|NCT00086281|12074193|FG010|COMPLETED|Phase 2||0
10907782|NCT00086281|12074194|FG011|COMPLETED|Phase 2||0
10907783|NCT00086281|12074195|FG012|COMPLETED|Phase 2||22
10907784|NCT00086281|12074196|FG013|COMPLETED|Phase 2||26
10907785|NCT00086281|12074197|FG014|COMPLETED|Phase 2||0
10907786|NCT00086281|12074183|FG000|NOT COMPLETED|Phase 2||0
10907787|NCT00086281|12074184|FG001|NOT COMPLETED|Phase 2||0
10907788|NCT00086281|12074185|FG002|NOT COMPLETED|Phase 2||0
10907789|NCT00086281|12074186|FG003|NOT COMPLETED|Phase 2||0
10907790|NCT00086281|12074187|FG004|NOT COMPLETED|Phase 2||0
10907791|NCT00086281|12074188|FG005|NOT COMPLETED|Phase 2||0
10907792|NCT00086281|12074189|FG006|NOT COMPLETED|Phase 2||0
10907793|NCT00086281|12074190|FG007|NOT COMPLETED|Phase 2||0
10907794|NCT00086281|12074191|FG008|NOT COMPLETED|Phase 2||0
10907795|NCT00086281|12074192|FG009|NOT COMPLETED|Phase 2||0
10907796|NCT00086281|12074193|FG010|NOT COMPLETED|Phase 2||0
10907797|NCT00086281|12074194|FG011|NOT COMPLETED|Phase 2||0
10907798|NCT00086281|12074195|FG012|NOT COMPLETED|Phase 2||1
10907799|NCT00086281|12074196|FG013|NOT COMPLETED|Phase 2||1
10907800|NCT00086281|12074197|FG014|NOT COMPLETED|Phase 2||0
10907801|NCT00086307|12074210|FG000|STARTED|Overall Study||13
10907802|NCT00086307|12074211|FG001|STARTED|Overall Study||13
10907803|NCT00086307|12074212|FG002|STARTED|Overall Study||13
10907804|NCT00086307|12074210|FG000|COMPLETED|Overall Study||11
10907805|NCT00086307|12074211|FG001|COMPLETED|Overall Study||12
10907806|NCT00086307|12074212|FG002|COMPLETED|Overall Study||5
10907807|NCT00086307|12074210|FG000|NOT COMPLETED|Overall Study||2
10907808|NCT00086307|12074211|FG001|NOT COMPLETED|Overall Study||1
10907809|NCT00086307|12074212|FG002|NOT COMPLETED|Overall Study||8
10907810|NCT00086346|12074222|FG000|STARTED|Randomization||393
10907811|NCT00086346|12074223|FG001|STARTED|Randomization||214
10907812|NCT00086346|12074222|FG000|COMPLETED|Randomization||389
10907813|NCT00086346|12074223|FG001|COMPLETED|Randomization||210
10907814|NCT00086346|12074222|FG000|NOT COMPLETED|Randomization||4
10907815|NCT00086346|12074223|FG001|NOT COMPLETED|Randomization||4
10907816|NCT00086346|12074222|FG000|STARTED|Patients Dosed With Test Article||389
10907817|NCT00086346|12074223|FG001|STARTED|Patients Dosed With Test Article||210
10907818|NCT00086346|12074222|FG000|COMPLETED|Patients Dosed With Test Article||249
10907819|NCT00086346|12074223|FG001|COMPLETED|Patients Dosed With Test Article||187
10907820|NCT00086346|12074222|FG000|NOT COMPLETED|Patients Dosed With Test Article||140
10907821|NCT00086346|12074223|FG001|NOT COMPLETED|Patients Dosed With Test Article||23
10907822|NCT00086385|12074233|FG000|STARTED|Overall Study||100
10907823|NCT00086385|12074234|FG001|STARTED|Overall Study||99
10907824|NCT00086385|12074235|FG002|STARTED|Overall Study||104
10907825|NCT00086385|12074236|FG003|STARTED|Overall Study||99
10907826|NCT00086385|12074233|FG000|COMPLETED|Overall Study||98
10907827|NCT00086385|12074234|FG001|COMPLETED|Overall Study||97
10907828|NCT00086385|12074235|FG002|COMPLETED|Overall Study||103
10907829|NCT00086385|12074236|FG003|COMPLETED|Overall Study||98
10907830|NCT00086385|12074233|FG000|NOT COMPLETED|Overall Study||2
10907831|NCT00086385|12074234|FG001|NOT COMPLETED|Overall Study||2
10907832|NCT00086385|12074235|FG002|NOT COMPLETED|Overall Study||1
10907833|NCT00086385|12074236|FG003|NOT COMPLETED|Overall Study||1
10907834|NCT00086411|12074250|FG000|STARTED|Overall Study||70
10907835|NCT00086411|12074251|FG001|STARTED|Overall Study||63
10907836|NCT00086411|12074252|FG002|STARTED|Overall Study||62
10907837|NCT00086411|12074253|FG003|STARTED|Overall Study||65
10907838|NCT00086411|12074250|FG000|COMPLETED|Overall Study||59
10907839|NCT00086411|12074251|FG001|COMPLETED|Overall Study||52
10907840|NCT00086411|12074252|FG002|COMPLETED|Overall Study||49
10907841|NCT00086411|12074253|FG003|COMPLETED|Overall Study||53
10907842|NCT00086411|12074250|FG000|NOT COMPLETED|Overall Study||11
10907843|NCT00086411|12074251|FG001|NOT COMPLETED|Overall Study||11
10907844|NCT00086411|12074252|FG002|NOT COMPLETED|Overall Study||13
10907845|NCT00086411|12074253|FG003|NOT COMPLETED|Overall Study||12
10907846|NCT00086450|12074266|FG000|STARTED|Overall Study||953
10907847|NCT00086450|12074267|FG001|STARTED|Overall Study||947
10907848|NCT00086450|12074266|FG000|COMPLETED|Overall Study||953
10907849|NCT00086450|12074267|FG001|COMPLETED|Overall Study||947
10907850|NCT00086450|12074266|FG000|NOT COMPLETED|Overall Study||0
10907851|NCT00086450|12074267|FG001|NOT COMPLETED|Overall Study||0
10907852|NCT00086502|12074275|FG000|STARTED|Overall Study||175
10907853|NCT00086502|12074276|FG001|STARTED|Overall Study||178
10907854|NCT00086502|12074275|FG000|COMPLETED|Overall Study||149
10907855|NCT00086502|12074276|FG001|COMPLETED|Overall Study||158
10907856|NCT00086502|12074275|FG000|NOT COMPLETED|Overall Study||26
10907857|NCT00086502|12074276|FG001|NOT COMPLETED|Overall Study||20
10907858|NCT00086515|12074284|FG000|STARTED|Phase A (Weeks 0-24)||464
10907859|NCT00086515|12074285|FG001|STARTED|Phase A (Weeks 0-24)||237
10907860|NCT00086515|12074284|FG000|COMPLETED|Phase A (Weeks 0-24)||415
10907861|NCT00086515|12074285|FG001|COMPLETED|Phase A (Weeks 0-24)||192
10907862|NCT00086515|12074284|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||49
10907863|NCT00086515|12074285|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||45
10907864|NCT00086515|12074284|FG000|STARTED|Phase A to Phase B Transition Period||415
10907865|NCT00086515|12074285|FG001|STARTED|Phase A to Phase B Transition Period||192
10907866|NCT00086515|12074284|FG000|COMPLETED|Phase A to Phase B Transition Period||391
10907867|NCT00086515|12074285|FG001|COMPLETED|Phase A to Phase B Transition Period||164
10907868|NCT00086515|12074284|FG000|NOT COMPLETED|Phase A to Phase B Transition Period||24
10907869|NCT00086515|12074285|FG001|NOT COMPLETED|Phase A to Phase B Transition Period||28
10907870|NCT00086515|12074284|FG000|STARTED|Phase B (Weeks 24-104)||391
10907871|NCT00086515|12074285|FG001|STARTED|Phase B (Weeks 24-104)||164
10907872|NCT00086515|12074284|FG000|COMPLETED|Phase B (Weeks 24-104)||201
10907873|NCT00086515|12074285|FG001|COMPLETED|Phase B (Weeks 24-104)||109
10907874|NCT00086515|12074284|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||190
10907875|NCT00086515|12074285|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||55
10907876|NCT00086580|12074293|FG000|STARTED|Treatment Period||168
10907877|NCT00086580|12074294|FG001|STARTED|Treatment Period||167
10907878|NCT00086580|12074293|FG000|Safety Population|Treatment Period|Four participants did not receive treatment|164
10907879|NCT00086580|12074294|FG001|Safety Population|Treatment Period|Two participants did not receive treatment|165
10907880|NCT00086580|12074293|FG000|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
10907881|NCT00086580|12074294|FG001|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
10907882|NCT00086580|12074293|FG000|NOT COMPLETED|Treatment Period||65
10907883|NCT00086580|12074294|FG001|NOT COMPLETED|Treatment Period||60
10907884|NCT00086580|12074293|FG000|STARTED|Follow-up Period||141
10907885|NCT00086580|12074294|FG001|STARTED|Follow-up Period||137
10907886|NCT00086580|12074293|FG000|COMPLETED|Follow-up Period||37
10907887|NCT00086580|12074294|FG001|COMPLETED|Follow-up Period||18
10907888|NCT00086580|12074293|FG000|NOT COMPLETED|Follow-up Period||104
10907889|NCT00086580|12074294|FG001|NOT COMPLETED|Follow-up Period||119
10907890|NCT00086580|12074293|FG000|STARTED|Observation Period||95
10907891|NCT00086580|12074294|FG001|STARTED|Observation Period||121
10907892|NCT00086580|12074293|FG000|COMPLETED|Observation Period||49
10907893|NCT00086580|12074294|FG001|COMPLETED|Observation Period||56
10907894|NCT00086580|12074293|FG000|NOT COMPLETED|Observation Period||46
10907895|NCT00086580|12074294|FG001|NOT COMPLETED|Observation Period||65
10907896|NCT00086619|12074302|FG000|STARTED|Overall Study||40
10907897|NCT00086619|12074303|FG001|STARTED|Overall Study||40
10907898|NCT00086619|12074302|FG000|Completed Baseline Visit|Overall Study||34
10907899|NCT00086619|12074303|FG001|Completed Baseline Visit|Overall Study||36
10907900|NCT00086619|12074302|FG000|Completed 12 Month Visit|Overall Study||26
10907901|NCT00086619|12074303|FG001|Completed 12 Month Visit|Overall Study||26
10907902|NCT00086619|12074302|FG000|COMPLETED|Overall Study||25
10907903|NCT00086619|12074303|FG001|COMPLETED|Overall Study||23
10907904|NCT00086619|12074302|FG000|NOT COMPLETED|Overall Study||15
10907905|NCT00086619|12074303|FG001|NOT COMPLETED|Overall Study||17
10907906|NCT00086684|12074312|FG000|STARTED|Overall Study||118
10907907|NCT00086684|12074313|FG001|STARTED|Overall Study||129
10907908|NCT00086684|12074314|FG002|STARTED|Overall Study||122
10907909|NCT00086684|12074312|FG000|COMPLETED|Overall Study||63
10907910|NCT00086684|12074313|FG001|COMPLETED|Overall Study||74
10907911|NCT00086684|12074314|FG002|COMPLETED|Overall Study||69
10907912|NCT00086684|12074312|FG000|NOT COMPLETED|Overall Study||55
10907913|NCT00086684|12074313|FG001|NOT COMPLETED|Overall Study||55
10907914|NCT00086684|12074314|FG002|NOT COMPLETED|Overall Study||53
10907915|NCT00086957|12074322|FG000|STARTED|Overall Study||2
10907916|NCT00086957|12074323|FG001|STARTED|Overall Study||7
10907917|NCT00086957|12074324|FG002|STARTED|Overall Study||22
10907918|NCT00086957|12074322|FG000|COMPLETED|Overall Study||2
10907919|NCT00086957|12074323|FG001|COMPLETED|Overall Study||7
10907920|NCT00086957|12074324|FG002|COMPLETED|Overall Study||22
10907921|NCT00086957|12074322|FG000|NOT COMPLETED|Overall Study||0
10907922|NCT00086957|12074323|FG001|NOT COMPLETED|Overall Study||0
10907923|NCT00086957|12074324|FG002|NOT COMPLETED|Overall Study||0
10907924|NCT00086996|12074333|FG000|STARTED|Overall Study||98
10907925|NCT00086996|12074333|FG000|Eligible|Overall Study||93
10907926|NCT00086996|12074333|FG000|Eligible and Began Protocol Therapy|Overall Study||93
10907927|NCT00086996|12074333|FG000|COMPLETED|Overall Study||34
10907928|NCT00086996|12074333|FG000|NOT COMPLETED|Overall Study||64
10907929|NCT00087022|12074339|FG000|STARTED|Overall Study||433
10907930|NCT00087022|12074340|FG001|STARTED|Overall Study||431
10907931|NCT00087022|12074339|FG000|Treated (Safety Population)|Overall Study||431
10907932|NCT00087022|12074340|FG001|Treated (Safety Population)|Overall Study||424
10907933|NCT00087022|12074339|FG000|COMPLETED|Overall Study||379
10907934|NCT00087022|12074340|FG001|COMPLETED|Overall Study||376
10907935|NCT00087022|12074339|FG000|NOT COMPLETED|Overall Study||54
10907936|NCT00087022|12074340|FG001|NOT COMPLETED|Overall Study||55
10907937|NCT00087126|12074346|FG000|STARTED|Overall Study||27
10907938|NCT00087126|12074346|FG000|COMPLETED|Overall Study||25
10907939|NCT00087126|12074346|FG000|NOT COMPLETED|Overall Study||2
10907940|NCT00087139|12074358|FG000|STARTED|Overall Study||39
10907941|NCT00087139|12074359|FG001|STARTED|Overall Study||49
10907942|NCT00087139|12074360|FG002|STARTED|Overall Study||36
10907943|NCT00087139|12074358|FG000|Treated|Overall Study||39
10907944|NCT00087139|12074359|FG001|Treated|Overall Study||48
10907945|NCT00087139|12074360|FG002|Treated|Overall Study||36
10907946|NCT00087139|12074358|FG000|Eligible and Treated|Overall Study||35
10907947|NCT00087139|12074359|FG001|Eligible and Treated|Overall Study||42
10907948|NCT00087139|12074360|FG002|Eligible and Treated|Overall Study||32
10907949|NCT00087139|12074358|FG000|Patients for the Analysis of PSA Respons|Overall Study||30
10907950|NCT00087139|12074359|FG001|Patients for the Analysis of PSA Respons|Overall Study||34
10907951|NCT00087139|12074360|FG002|Patients for the Analysis of PSA Respons|Overall Study||22
10907952|NCT00087139|12074358|FG000|Patients With Measurable Disease|Overall Study||22
10907953|NCT00087139|12074359|FG001|Patients With Measurable Disease|Overall Study||25
10907954|NCT00087139|12074360|FG002|Patients With Measurable Disease|Overall Study||24
10907955|NCT00087139|12074358|FG000|Patients With PSA Response|Overall Study||10
10907956|NCT00087139|12074359|FG001|Patients With PSA Response|Overall Study||8
10907957|NCT00087139|12074360|FG002|Patients With PSA Response|Overall Study||4
10907958|NCT00087139|12074358|FG000|Patients w/ Measurable Disease Response|Overall Study||5
10907959|NCT00087139|12074359|FG001|Patients w/ Measurable Disease Response|Overall Study||2
10907960|NCT00087139|12074360|FG002|Patients w/ Measurable Disease Response|Overall Study||0
10907961|NCT00087139|12074358|FG000|COMPLETED|Overall Study||0
10907962|NCT00087139|12074359|FG001|COMPLETED|Overall Study||0
10907963|NCT00087139|12074360|FG002|COMPLETED|Overall Study||0
10907964|NCT00087139|12074358|FG000|NOT COMPLETED|Overall Study||39
10907965|NCT00087139|12074359|FG001|NOT COMPLETED|Overall Study||49
10907966|NCT00087139|12074360|FG002|NOT COMPLETED|Overall Study||36
10907967|NCT00087152|12074366|FG000|STARTED|Overall Study||27
10907968|NCT00087152|12074366|FG000|COMPLETED|Overall Study||21
10907969|NCT00087152|12074366|FG000|NOT COMPLETED|Overall Study||6
10907970|NCT00087438|12074371|FG000|STARTED|Overall Study||59
10907971|NCT00087438|12074371|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
10907972|NCT00087438|12074371|FG000|NOT COMPLETED|Overall Study||4
10907973|NCT00087490|12074379|FG000|STARTED|Overall Study||544
10907974|NCT00087490|12074380|FG001|STARTED|Overall Study||533
10907975|NCT00087490|12074379|FG000|Treated|Overall Study||537
10907976|NCT00087490|12074380|FG001|Treated|Overall Study||515
10907977|NCT00087490|12074379|FG000|COMPLETED|Overall Study||286
10907978|NCT00087490|12074380|FG001|COMPLETED|Overall Study||264
10907979|NCT00087490|12074379|FG000|NOT COMPLETED|Overall Study||258
10907980|NCT00087490|12074380|FG001|NOT COMPLETED|Overall Study||269
10907981|NCT00087516|12074389|FG000|STARTED|Overall Study||238
10907982|NCT00087516|12074390|FG001|STARTED|Overall Study||250
10907983|NCT00087516|12074391|FG002|STARTED|Overall Study||130
10907984|NCT00087516|12074392|FG003|STARTED|Overall Study||123
10907985|NCT00087516|12074389|FG000|COMPLETED|Overall Study||77
10907986|NCT00087516|12074390|FG001|COMPLETED|Overall Study||81
10907987|NCT00087516|12074391|FG002|COMPLETED|Overall Study||33
10907988|NCT00087516|12074392|FG003|COMPLETED|Overall Study||38
10907989|NCT00087516|12074389|FG000|NOT COMPLETED|Overall Study||161
10907990|NCT00087516|12074390|FG001|NOT COMPLETED|Overall Study||169
10907991|NCT00087516|12074391|FG002|NOT COMPLETED|Overall Study||97
10907992|NCT00087516|12074392|FG003|NOT COMPLETED|Overall Study||85
10907993|NCT00087529|12074408|FG000|STARTED|Overall Study||147
10907994|NCT00087529|12074409|FG001|STARTED|Overall Study||292
10907995|NCT00087529|12074408|FG000|COMPLETED|Overall Study||116
10907996|NCT00087529|12074409|FG001|COMPLETED|Overall Study||224
10907997|NCT00087529|12074408|FG000|NOT COMPLETED|Overall Study||31
10907998|NCT00087529|12074409|FG001|NOT COMPLETED|Overall Study||68
10907999|NCT00087555|12074418|FG000|STARTED|Overall Study||66
10908000|NCT00087555|12074419|FG001|STARTED|Overall Study||62
10908001|NCT00087555|12074420|FG002|STARTED|Overall Study||67
10908002|NCT00087555|12074418|FG000|Treated|Overall Study||65
10908003|NCT00087555|12074419|FG001|Treated|Overall Study||60
10908004|NCT00087555|12074420|FG002|Treated|Overall Study||67
10908005|NCT00087555|12074418|FG000|COMPLETED|Overall Study||54
10908006|NCT00087555|12074419|FG001|COMPLETED|Overall Study||51
10908007|NCT00087555|12074420|FG002|COMPLETED|Overall Study||46
10908008|NCT00087555|12074418|FG000|NOT COMPLETED|Overall Study||12
10908009|NCT00087555|12074419|FG001|NOT COMPLETED|Overall Study||11
10908010|NCT00087555|12074420|FG002|NOT COMPLETED|Overall Study||21
10908011|NCT00087568|12074430|FG000|STARTED|Overall Study||32
10908012|NCT00087568|12074431|FG001|STARTED|Overall Study||25
10908013|NCT00087568|12074430|FG000|COMPLETED|Overall Study||2
10908014|NCT00087568|12074431|FG001|COMPLETED|Overall Study||23
10908015|NCT00087568|12074430|FG000|NOT COMPLETED|Overall Study||30
10908016|NCT00087568|12074431|FG001|NOT COMPLETED|Overall Study||2
10908017|NCT00087594|12074439|FG000|STARTED|Overall Study||24
10908018|NCT00087594|12074440|FG001|STARTED|Overall Study||24
10908019|NCT00087594|12074439|FG000|COMPLETED|Overall Study||16
10908020|NCT00087594|12074440|FG001|COMPLETED|Overall Study||12
10908021|NCT00087594|12074439|FG000|NOT COMPLETED|Overall Study||8
10908022|NCT00087594|12074440|FG001|NOT COMPLETED|Overall Study||12
10908023|NCT00087607|12074448|FG000|STARTED|Overall Study||192
10908024|NCT00087607|12074449|FG001|STARTED|Overall Study||193
10908025|NCT00087607|12074448|FG000|COMPLETED|Overall Study||70
10908026|NCT00087607|12074449|FG001|COMPLETED|Overall Study||71
10908027|NCT00087607|12074448|FG000|NOT COMPLETED|Overall Study||122
10908028|NCT00087607|12074449|FG001|NOT COMPLETED|Overall Study||122
10908029|NCT00087633|12074461|FG000|STARTED|Overall Study|Randomized|55
10908030|NCT00087633|12074462|FG001|STARTED|Overall Study|Randomized|60
10908031|NCT00087633|12074461|FG000|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
10908032|NCT00087633|12074462|FG001|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
10908033|NCT00087633|12074461|FG000|NOT COMPLETED|Overall Study||24
10908034|NCT00087633|12074462|FG001|NOT COMPLETED|Overall Study||17
10908035|NCT00087646|12074472|FG000|STARTED|Overall Study||317
10908036|NCT00087646|12074473|FG001|STARTED|Overall Study||156
10908037|NCT00087646|12074474|FG002|STARTED|Overall Study||156
10908038|NCT00087646|12074475|FG003|STARTED|Overall Study||313
10908039|NCT00087646|12074472|FG000|COMPLETED|Overall Study||182
10908040|NCT00087646|12074473|FG001|COMPLETED|Overall Study||114
10908041|NCT00087646|12074474|FG002|COMPLETED|Overall Study||91
10908042|NCT00087646|12074475|FG003|COMPLETED|Overall Study||229
10908043|NCT00087646|12074472|FG000|NOT COMPLETED|Overall Study||135
10908044|NCT00087646|12074473|FG001|NOT COMPLETED|Overall Study||42
10908045|NCT00087646|12074474|FG002|NOT COMPLETED|Overall Study||65
10908046|NCT00087646|12074475|FG003|NOT COMPLETED|Overall Study||84
10908047|NCT00087672|12074490|FG000|STARTED|Overall Study||41
10908048|NCT00087672|12074490|FG000|COMPLETED|Overall Study||41
10908049|NCT00087672|12074490|FG000|NOT COMPLETED|Overall Study||0
10908050|NCT00087685|12074494|FG000|STARTED|Overall Study||35
10908051|NCT00087685|12074494|FG000|COMPLETED|Overall Study||21
10908052|NCT00087685|12074494|FG000|NOT COMPLETED|Overall Study||14
10908053|NCT00087698|12074498|FG000|STARTED|Overall Study||77
10908054|NCT00087698|12074498|FG000|COMPLETED|Overall Study||41
10908055|NCT00087698|12074498|FG000|NOT COMPLETED|Overall Study||36
10908056|NCT00088153|12074504|FG000|STARTED|Overall Study||55
10908057|NCT00088153|12074505|FG001|STARTED|Overall Study||55
10908058|NCT00088153|12074504|FG000|COMPLETED|Overall Study||31
10908059|NCT00088153|12074505|FG001|COMPLETED|Overall Study||30
10908060|NCT00088153|12074504|FG000|NOT COMPLETED|Overall Study||24
10908061|NCT00088153|12074505|FG001|NOT COMPLETED|Overall Study||25
10908062|NCT00088166|12074513|FG000|STARTED|Overall Study||100
10908063|NCT00088166|12074514|FG001|STARTED|Overall Study||100
10908064|NCT00088166|12074513|FG000|COMPLETED|Overall Study||47
10908065|NCT00088166|12074514|FG001|COMPLETED|Overall Study||39
10908066|NCT00088166|12074513|FG000|NOT COMPLETED|Overall Study||53
10908067|NCT00088166|12074514|FG001|NOT COMPLETED|Overall Study||61
10908068|NCT00088205|12074520|FG000|STARTED|Overall Study||60
10908069|NCT00088205|12074520|FG000|Received at Least 1 Dose of Study Drug|Overall Study||60
10908070|NCT00088205|12074520|FG000|Efficacy Population|Overall Study|Participants with diagnosis of relapsed mantle cell lymphoma.|59
10908071|NCT00088205|12074520|FG000|COMPLETED|Overall Study||0
10908072|NCT00088205|12074520|FG000|NOT COMPLETED|Overall Study||60
10908073|NCT00088218|12074526|FG000|STARTED|Overall Study||16
10908074|NCT00088218|12074527|FG001|STARTED|Overall Study||79
10908075|NCT00088218|12074526|FG000|COMPLETED|Overall Study||16
10908076|NCT00088218|12074527|FG001|COMPLETED|Overall Study||79
10908077|NCT00088218|12074526|FG000|NOT COMPLETED|Overall Study||0
10908078|NCT00088218|12074527|FG001|NOT COMPLETED|Overall Study||0
10908079|NCT00088374|12074533|FG000|STARTED|Overall Study||9
10908080|NCT00088374|12074533|FG000|COMPLETED|Overall Study||7
10908081|NCT00088374|12074533|FG000|NOT COMPLETED|Overall Study||2
10908082|NCT00088413|12074541|FG000|STARTED|Overall Study||10
10908083|NCT00088413|12074542|FG001|STARTED|Overall Study||15
10908084|NCT00088413|12074543|FG002|STARTED|Overall Study||12
10908085|NCT00088413|12074544|FG003|STARTED|Overall Study||14
10908086|NCT00088413|12074541|FG000|COMPLETED|Overall Study||0
10908087|NCT00088413|12074542|FG001|COMPLETED|Overall Study||0
10908088|NCT00088413|12074543|FG002|COMPLETED|Overall Study||0
10908089|NCT00088413|12074544|FG003|COMPLETED|Overall Study||0
10908090|NCT00088413|12074541|FG000|NOT COMPLETED|Overall Study||10
10908091|NCT00088413|12074542|FG001|NOT COMPLETED|Overall Study||15
10908092|NCT00088413|12074543|FG002|NOT COMPLETED|Overall Study||12
10908093|NCT00088413|12074544|FG003|NOT COMPLETED|Overall Study||14
10908094|NCT00088452|12074559|FG000|STARTED|Overall Study||156
10908095|NCT00088452|12074560|FG001|STARTED|Overall Study||149
10908096|NCT00088452|12074561|FG002|STARTED|Overall Study||148
10908097|NCT00088452|12074559|FG000|COMPLETED|Overall Study||155
10908098|NCT00088452|12074560|FG001|COMPLETED|Overall Study||149
10908099|NCT00088452|12074561|FG002|COMPLETED|Overall Study||147
10908100|NCT00088452|12074559|FG000|NOT COMPLETED|Overall Study||1
10908101|NCT00088452|12074560|FG001|NOT COMPLETED|Overall Study||0
10908102|NCT00088452|12074561|FG002|NOT COMPLETED|Overall Study||1
10908103|NCT00088465|12074569|FG000|STARTED|Overall Study||931
10908104|NCT00088465|12074569|FG000|COMPLETED|Overall Study||370
10908105|NCT00088465|12074569|FG000|NOT COMPLETED|Overall Study||561
10908106|NCT00088530|12074575|FG000|STARTED|Overall Study||70
10908107|NCT00088530|12074576|FG001|STARTED|Overall Study||70
10908108|NCT00088530|12074575|FG000|COMPLETED|Overall Study||20
10908109|NCT00088530|12074576|FG001|COMPLETED|Overall Study||16
10908110|NCT00088530|12074575|FG000|NOT COMPLETED|Overall Study||50
10908111|NCT00088530|12074576|FG001|NOT COMPLETED|Overall Study||54
10908112|NCT00088595|12074582|FG000|STARTED|Overall Study||45
10908113|NCT00088595|12074582|FG000|COMPLETED|Overall Study||17
10908114|NCT00088595|12074582|FG000|NOT COMPLETED|Overall Study||28
10908115|NCT00088621|12074596|FG000|STARTED|Overall Study||61
10908116|NCT00088621|12074596|FG000|COMPLETED|Overall Study||7
10908117|NCT00088621|12074596|FG000|NOT COMPLETED|Overall Study||54
10908118|NCT00088634|12074602|FG000|STARTED|Overall Study||90
10908119|NCT00088634|12074603|FG001|STARTED|Overall Study||90
10908120|NCT00088634|12074602|FG000|COMPLETED|Overall Study||52
10908121|NCT00088634|12074603|FG001|COMPLETED|Overall Study||47
10908122|NCT00088634|12074602|FG000|NOT COMPLETED|Overall Study||38
10908123|NCT00088634|12074603|FG001|NOT COMPLETED|Overall Study||43
10908124|NCT00088699|12074611|FG000|STARTED|Infusion 1||23
10908125|NCT00088699|12074612|FG001|STARTED|Infusion 1||19
10908126|NCT00088699|12074613|FG002|STARTED|Infusion 1||13
10908127|NCT00088699|12074614|FG003|STARTED|Infusion 1||12
10908128|NCT00088699|12074611|FG000|COMPLETED|Infusion 1||22
10908129|NCT00088699|12074612|FG001|COMPLETED|Infusion 1||19
10908130|NCT00088699|12074613|FG002|COMPLETED|Infusion 1||12
10908131|NCT00088699|12074614|FG003|COMPLETED|Infusion 1||10
10908132|NCT00088699|12074611|FG000|NOT COMPLETED|Infusion 1||1
10908133|NCT00088699|12074612|FG001|NOT COMPLETED|Infusion 1||0
10908134|NCT00088699|12074613|FG002|NOT COMPLETED|Infusion 1||1
10908135|NCT00088699|12074614|FG003|NOT COMPLETED|Infusion 1||2
10908136|NCT00088699|12074611|FG000|STARTED|Infusion 2||19
10908137|NCT00088699|12074612|FG001|STARTED|Infusion 2||18
10908138|NCT00088699|12074613|FG002|STARTED|Infusion 2||11
10908139|NCT00088699|12074614|FG003|STARTED|Infusion 2||11
10908140|NCT00088699|12074611|FG000|COMPLETED|Infusion 2||19
10908141|NCT00088699|12074612|FG001|COMPLETED|Infusion 2||18
10908142|NCT00088699|12074613|FG002|COMPLETED|Infusion 2||11
10908143|NCT00088699|12074614|FG003|COMPLETED|Infusion 2||10
10908144|NCT00088699|12074611|FG000|NOT COMPLETED|Infusion 2||0
10908145|NCT00088699|12074612|FG001|NOT COMPLETED|Infusion 2||0
10908146|NCT00088699|12074613|FG002|NOT COMPLETED|Infusion 2||0
10908147|NCT00088699|12074614|FG003|NOT COMPLETED|Infusion 2||1
10908148|NCT00088881|12074624|FG000|STARTED|Step 1 - R-CHOP||62
10908149|NCT00088881|12074624|FG000|Eligible and Treated|Step 1 - R-CHOP||53
10908150|NCT00088881|12074624|FG000|COMPLETED|Step 1 - R-CHOP||48
10908151|NCT00088881|12074624|FG000|NOT COMPLETED|Step 1 - R-CHOP||14
10908152|NCT00088881|12074624|FG000|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
10908153|NCT00088881|12074624|FG000|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
10908154|NCT00088881|12074624|FG000|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
10908155|NCT00088881|12074624|FG000|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
10908156|NCT00088881|12074624|FG000|STARTED|Step 3 - Radiation Therapy||1
10908157|NCT00088881|12074624|FG000|COMPLETED|Step 3 - Radiation Therapy||1
10908158|NCT00088881|12074624|FG000|NOT COMPLETED|Step 3 - Radiation Therapy||0
10908159|NCT00088907|12074632|FG000|STARTED|Randomized Study (Step 1)||136
10908160|NCT00088907|12074633|FG001|STARTED|Randomized Study (Step 1)||134
10908161|NCT00088907|12074632|FG000|Treated|Randomized Study (Step 1)||129
10908162|NCT00088907|12074633|FG001|Treated|Randomized Study (Step 1)||124
10908163|NCT00088907|12074632|FG000|Eligible|Randomized Study (Step 1)||117
10908164|NCT00088907|12074633|FG001|Eligible|Randomized Study (Step 1)||122
10908165|NCT00088907|12074632|FG000|Eligible and Treated|Randomized Study (Step 1)||117
10908166|NCT00088907|12074633|FG001|Eligible and Treated|Randomized Study (Step 1)||122
10908167|NCT00088907|12074632|FG000|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
10908168|NCT00088907|12074633|FG001|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
10908169|NCT00088907|12074632|FG000|NOT COMPLETED|Randomized Study (Step 1)||136
10908170|NCT00088907|12074633|FG001|NOT COMPLETED|Randomized Study (Step 1)||134
10908171|NCT00088907|12074632|FG000|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
10908172|NCT00088907|12074633|FG001|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
10908173|NCT00088907|12074632|FG000|Treated|Single Gefitinib Treatment (Step 2)||19
10908174|NCT00088907|12074633|FG001|Treated|Single Gefitinib Treatment (Step 2)||0
10908175|NCT00088907|12074632|FG000|COMPLETED|Single Gefitinib Treatment (Step 2)||0
10908176|NCT00088907|12074633|FG001|COMPLETED|Single Gefitinib Treatment (Step 2)||0
10908177|NCT00088907|12074632|FG000|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
10908178|NCT00088907|12074633|FG001|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
10908179|NCT00088985|12074640|FG000|STARTED|Overall Study||7
10908180|NCT00088985|12074640|FG000|COMPLETED|Overall Study||4
10908181|NCT00088985|12074640|FG000|NOT COMPLETED|Overall Study||3
10908182|NCT00089011|12074646|FG000|STARTED|Overall Study||100
10908183|NCT00089011|12074647|FG001|STARTED|Overall Study||50
10908184|NCT00089011|12074646|FG000|COMPLETED|Overall Study||100
10908185|NCT00089011|12074647|FG001|COMPLETED|Overall Study||50
10908186|NCT00089011|12074646|FG000|NOT COMPLETED|Overall Study||0
10908187|NCT00089011|12074647|FG001|NOT COMPLETED|Overall Study||0
10908188|NCT00089024|12074653|FG000|STARTED|Overall Study||29
10908189|NCT00089024|12074653|FG000|Treated Subjects|Overall Study||29
10908190|NCT00089024|12074653|FG000|COMPLETED|Overall Study||24
10908191|NCT00089024|12074653|FG000|NOT COMPLETED|Overall Study||5
10908192|NCT00089076|12074657|FG000|STARTED|Overall Study||18
10908193|NCT00089076|12074657|FG000|COMPLETED|Overall Study||8
10908194|NCT00089076|12074657|FG000|NOT COMPLETED|Overall Study||10
10908195|NCT00089102|12074661|FG000|STARTED|Overall Study||9
10908196|NCT00089102|12074661|FG000|COMPLETED|Overall Study||9
10908197|NCT00089102|12074661|FG000|NOT COMPLETED|Overall Study||0
10908198|NCT00089284|12074670|FG000|STARTED|Overall Study||7
10908199|NCT00089284|12074671|FG001|STARTED|Overall Study||3
10908200|NCT00089284|12074672|FG002|STARTED|Overall Study||6
10908201|NCT00089284|12074673|FG003|STARTED|Overall Study||6
10908202|NCT00089284|12074674|FG004|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
10908203|NCT00089284|12074675|FG005|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
10908204|NCT00089284|12074676|FG006|STARTED|Overall Study||8
10908205|NCT00089284|12074670|FG000|COMPLETED|Overall Study||7
10908206|NCT00089284|12074671|FG001|COMPLETED|Overall Study||3
10908207|NCT00089284|12074672|FG002|COMPLETED|Overall Study||6
10908208|NCT00089284|12074673|FG003|COMPLETED|Overall Study||6
10908209|NCT00089284|12074674|FG004|COMPLETED|Overall Study||0
10908210|NCT00089284|12074675|FG005|COMPLETED|Overall Study||0
10908211|NCT00089284|12074676|FG006|COMPLETED|Overall Study||7
10908212|NCT00089284|12074670|FG000|NOT COMPLETED|Overall Study||0
10908213|NCT00089284|12074671|FG001|NOT COMPLETED|Overall Study||0
10908214|NCT00089284|12074672|FG002|NOT COMPLETED|Overall Study||0
10908215|NCT00089284|12074673|FG003|NOT COMPLETED|Overall Study||0
10908216|NCT00089284|12074674|FG004|NOT COMPLETED|Overall Study||0
10908217|NCT00089284|12074675|FG005|NOT COMPLETED|Overall Study||0
10908218|NCT00089284|12074676|FG006|NOT COMPLETED|Overall Study||1
10908219|NCT00089297|12074698|FG000|STARTED|Overall Study||74
10908220|NCT00089297|12074698|FG000|Treated|Overall Study||70
10908221|NCT00089297|12074698|FG000|Eligible|Overall Study||63
10908222|NCT00089297|12074698|FG000|COMPLETED|Overall Study||36
10908223|NCT00089297|12074698|FG000|NOT COMPLETED|Overall Study||38
10908224|NCT00089479|12074704|FG000|STARTED|Overall Study||1304
10908225|NCT00089479|12074705|FG001|STARTED|Overall Study||1307
10908226|NCT00089479|12074704|FG000|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
10908227|NCT00089479|12074705|FG001|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
10908228|NCT00089479|12074704|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
10908229|NCT00089479|12074705|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
10908230|NCT00089479|12074704|FG000|NOT COMPLETED|Overall Study||331
10908231|NCT00089479|12074705|FG001|NOT COMPLETED|Overall Study||289
10908232|NCT00089505|12074715|FG000|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
10908233|NCT00089505|12074716|FG001|STARTED|Overall Study||120
10908234|NCT00089505|12074717|FG002|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
10908235|NCT00089505|12074718|FG003|STARTED|Overall Study||251
10908236|NCT00089505|12074715|FG000|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
10908237|NCT00089505|12074716|FG001|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
10908238|NCT00089505|12074717|FG002|COMPLETED|Overall Study||228
10908239|NCT00089505|12074718|FG003|COMPLETED|Overall Study||230
10908240|NCT00089505|12074715|FG000|NOT COMPLETED|Overall Study||9
10908241|NCT00089505|12074716|FG001|NOT COMPLETED|Overall Study||2
10908242|NCT00089505|12074717|FG002|NOT COMPLETED|Overall Study||21
10908243|NCT00089505|12074718|FG003|NOT COMPLETED|Overall Study||21
10908244|NCT00089544|12074730|FG000|STARTED|Overall Study||16
10908245|NCT00089544|12074731|FG001|STARTED|Overall Study||7
10908246|NCT00089544|12074730|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
10908247|NCT00089544|12074731|FG001|COMPLETED|Overall Study||7
10908248|NCT00089544|12074730|FG000|NOT COMPLETED|Overall Study||1
10908249|NCT00089544|12074731|FG001|NOT COMPLETED|Overall Study||0
10908250|NCT00089583|12074739|FG000|STARTED|Overall Study||20
10908251|NCT00089583|12074740|FG001|STARTED|Overall Study||89
10908252|NCT00089583|12074739|FG000|COMPLETED|Overall Study||13
10908253|NCT00089583|12074740|FG001|COMPLETED|Overall Study||51
10908254|NCT00089583|12074739|FG000|NOT COMPLETED|Overall Study||7
10908255|NCT00089583|12074740|FG001|NOT COMPLETED|Overall Study||38
10908256|NCT00089609|12074754|FG000|STARTED|Overall Study||60
10908257|NCT00089609|12074755|FG001|STARTED|Overall Study||13
10908258|NCT00089609|12074754|FG000|COMPLETED|Overall Study||57
10908259|NCT00089609|12074755|FG001|COMPLETED|Overall Study||12
10908260|NCT00089609|12074754|FG000|NOT COMPLETED|Overall Study||3
10908261|NCT00089609|12074755|FG001|NOT COMPLETED|Overall Study||1
10908262|NCT00089635|12074764|FG000|STARTED|Overall Study||203
10908263|NCT00089635|12074764|FG000|COMPLETED|Overall Study||160
10908264|NCT00089635|12074764|FG000|NOT COMPLETED|Overall Study||43
10908265|NCT00089648|12074768|FG000|STARTED|Overall Study||61
10908266|NCT00089648|12074768|FG000|COMPLETED|Overall Study||20
10908267|NCT00089648|12074768|FG000|NOT COMPLETED|Overall Study||41
10908268|NCT00089661|12074774|FG000|STARTED|Overall Study||127
10908269|NCT00089661|12074775|FG001|STARTED|Overall Study||125
10908270|NCT00089661|12074774|FG000|COMPLETED|Overall Study||106
10908271|NCT00089661|12074775|FG001|COMPLETED|Overall Study||99
10908272|NCT00089661|12074774|FG000|NOT COMPLETED|Overall Study||21
10908273|NCT00089661|12074775|FG001|NOT COMPLETED|Overall Study||26
10908274|NCT00089674|12074783|FG000|STARTED|Overall Study||734
10908275|NCT00089674|12074784|FG001|STARTED|Overall Study||734
10908276|NCT00089674|12074783|FG000|Received Study Drug|Overall Study||730
10908277|NCT00089674|12074784|FG001|Received Study Drug|Overall Study||726
10908278|NCT00089674|12074783|FG000|COMPLETED|Overall Study||445
10908279|NCT00089674|12074784|FG001|COMPLETED|Overall Study||467
10908280|NCT00089674|12074783|FG000|NOT COMPLETED|Overall Study||289
10908281|NCT00089674|12074784|FG001|NOT COMPLETED|Overall Study||267
10908282|NCT00089752|12074792|FG000|STARTED|Overall Study||141
10908283|NCT00089752|12074793|FG001|STARTED|Overall Study||140
10908284|NCT00089752|12074792|FG000|COMPLETED|Overall Study||121
10908285|NCT00089752|12074793|FG001|COMPLETED|Overall Study||118
10908286|NCT00089752|12074792|FG000|NOT COMPLETED|Overall Study||20
10908287|NCT00089752|12074793|FG001|NOT COMPLETED|Overall Study||22
10908288|NCT00089778|12074804|FG000|STARTED|Overall Study||2
10908289|NCT00089778|12074805|FG001|STARTED|Overall Study||1
10908290|NCT00089778|12074806|FG002|STARTED|Overall Study||8
10908291|NCT00089778|12074804|FG000|COMPLETED|Overall Study||2
10908292|NCT00089778|12074805|FG001|COMPLETED|Overall Study||1
10908293|NCT00089778|12074806|FG002|COMPLETED|Overall Study||7
10908294|NCT00089778|12074804|FG000|NOT COMPLETED|Overall Study||0
10908295|NCT00089778|12074805|FG001|NOT COMPLETED|Overall Study||0
10908296|NCT00089778|12074806|FG002|NOT COMPLETED|Overall Study||1
10908297|NCT00089843|12074820|FG000|STARTED|Overall Study||19
10908298|NCT00089843|12074821|FG001|STARTED|Overall Study||20
10908299|NCT00089843|12074822|FG002|STARTED|Overall Study||20
10908300|NCT00089843|12074823|FG003|STARTED|Overall Study||18
10908301|NCT00089843|12074820|FG000|COMPLETED|Overall Study||17
10908302|NCT00089843|12074821|FG001|COMPLETED|Overall Study||16
10908303|NCT00089843|12074822|FG002|COMPLETED|Overall Study||15
10908304|NCT00089843|12074823|FG003|COMPLETED|Overall Study||11
10908305|NCT00089843|12074820|FG000|NOT COMPLETED|Overall Study||2
10908306|NCT00089843|12074821|FG001|NOT COMPLETED|Overall Study||4
10908307|NCT00089843|12074822|FG002|NOT COMPLETED|Overall Study||5
10908308|NCT00089843|12074823|FG003|NOT COMPLETED|Overall Study||7
10908309|NCT00089973|12074833|FG000|STARTED|Overall Study||50
10908310|NCT00089973|12074833|FG000|COMPLETED|Overall Study||0
10908311|NCT00089973|12074833|FG000|NOT COMPLETED|Overall Study||50
10908312|NCT00089986|12074840|FG000|STARTED|Overall Study||599
10908313|NCT00089986|12074841|FG001|STARTED|Overall Study||598
10908314|NCT00089986|12074842|FG002|STARTED|Overall Study||182
10908315|NCT00089986|12074840|FG000|COMPLETED|Overall Study||584
10908316|NCT00089986|12074841|FG001|COMPLETED|Overall Study||574
10908317|NCT00089986|12074842|FG002|COMPLETED|Overall Study||172
10908318|NCT00089986|12074840|FG000|NOT COMPLETED|Overall Study||15
10908319|NCT00089986|12074841|FG001|NOT COMPLETED|Overall Study||24
10908320|NCT00089986|12074842|FG002|NOT COMPLETED|Overall Study||10
10908321|NCT00089999|12074852|FG000|STARTED|Overall Study||69
10908322|NCT00089999|12074853|FG001|STARTED|Overall Study||69
10908323|NCT00089999|12074852|FG000|COMPLETED|Overall Study||0
10908324|NCT00089999|12074853|FG001|COMPLETED|Overall Study||0
10908325|NCT00089999|12074852|FG000|NOT COMPLETED|Overall Study||69
10908326|NCT00089999|12074853|FG001|NOT COMPLETED|Overall Study||69
10908327|NCT00090051|12074862|FG000|STARTED|Overall Study||276
10908328|NCT00090051|12074863|FG001|STARTED|Overall Study||276
10908329|NCT00090051|12074862|FG000|Safety Population; Received Study Drug|Overall Study||272
10908330|NCT00090051|12074863|FG001|Safety Population; Received Study Drug|Overall Study||274
10908331|NCT00090051|12074862|FG000|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
10908332|NCT00090051|12074863|FG001|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
10908333|NCT00090051|12074862|FG000|NOT COMPLETED|Overall Study||109
10908334|NCT00090051|12074863|FG001|NOT COMPLETED|Overall Study||95
10908335|NCT00090103|12074872|FG000|STARTED|Four-Year Double-Blind Treatment Period||1610
10908336|NCT00090103|12074873|FG001|STARTED|Four-Year Double-Blind Treatment Period||1623
10908337|NCT00090103|12074874|FG002|STARTED|Four-Year Double-Blind Treatment Period||1611
10908338|NCT00090103|12074872|FG000|COMPLETED|Four-Year Double-Blind Treatment Period||1113
10908339|NCT00090103|12074873|FG001|COMPLETED|Four-Year Double-Blind Treatment Period||1093
10908340|NCT00090103|12074874|FG002|COMPLETED|Four-Year Double-Blind Treatment Period||989
10908341|NCT00090103|12074872|FG000|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
10908342|NCT00090103|12074873|FG001|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
10908343|NCT00090103|12074874|FG002|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
10908344|NCT00090103|12074872|FG000|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
10908345|NCT00090103|12074873|FG001|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
10908346|NCT00090103|12074874|FG002|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
10908347|NCT00090103|12074872|FG000|COMPLETED|16-Week Safety Follow-up Period||1224
10908348|NCT00090103|12074873|FG001|COMPLETED|16-Week Safety Follow-up Period||1205
10908349|NCT00090103|12074874|FG002|COMPLETED|16-Week Safety Follow-up Period||1143
10908350|NCT00090103|12074872|FG000|NOT COMPLETED|16-Week Safety Follow-up Period||374
10908351|NCT00090103|12074873|FG001|NOT COMPLETED|16-Week Safety Follow-up Period||410
10908352|NCT00090103|12074874|FG002|NOT COMPLETED|16-Week Safety Follow-up Period||457
10908353|NCT00090220|12074884|FG000|STARTED|Base Study Vaccination Period||1911
10908354|NCT00090220|12074885|FG001|STARTED|Base Study Vaccination Period||1908
10908355|NCT00090220|12074886|FG002|STARTED|Base Study Vaccination Period||0
10908356|NCT00090220|12074887|FG003|STARTED|Base Study Vaccination Period||0
10908357|NCT00090220|12074888|FG004|STARTED|Base Study Vaccination Period||0
10908358|NCT00090220|12074889|FG005|STARTED|Base Study Vaccination Period||0
10908359|NCT00090220|12074884|FG000|Vaccinated|Base Study Vaccination Period||1910
10908360|NCT00090220|12074885|FG001|Vaccinated|Base Study Vaccination Period||1907
10908361|NCT00090220|12074886|FG002|Vaccinated|Base Study Vaccination Period||0
10908362|NCT00090220|12074887|FG003|Vaccinated|Base Study Vaccination Period||0
10908363|NCT00090220|12074888|FG004|Vaccinated|Base Study Vaccination Period||0
10908364|NCT00090220|12074889|FG005|Vaccinated|Base Study Vaccination Period||0
10908365|NCT00090220|12074884|FG000|COMPLETED|Base Study Vaccination Period||1847
10908366|NCT00090220|12074885|FG001|COMPLETED|Base Study Vaccination Period||1845
10908367|NCT00090220|12074886|FG002|COMPLETED|Base Study Vaccination Period||0
10908368|NCT00090220|12074887|FG003|COMPLETED|Base Study Vaccination Period||0
10908369|NCT00090220|12074888|FG004|COMPLETED|Base Study Vaccination Period||0
10908370|NCT00090220|12074889|FG005|COMPLETED|Base Study Vaccination Period||0
10908371|NCT00090220|12074884|FG000|NOT COMPLETED|Base Study Vaccination Period||64
10908372|NCT00090220|12074885|FG001|NOT COMPLETED|Base Study Vaccination Period||63
10908373|NCT00090220|12074886|FG002|NOT COMPLETED|Base Study Vaccination Period||0
10908374|NCT00090220|12074887|FG003|NOT COMPLETED|Base Study Vaccination Period||0
10908375|NCT00090220|12074888|FG004|NOT COMPLETED|Base Study Vaccination Period||0
10908376|NCT00090220|12074889|FG005|NOT COMPLETED|Base Study Vaccination Period||0
10908377|NCT00090220|12074884|FG000|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
10908378|NCT00090220|12074885|FG001|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
10908379|NCT00090220|12074886|FG002|STARTED|Base Study Follow-up Period||0
10908380|NCT00090220|12074887|FG003|STARTED|Base Study Follow-up Period||0
10908381|NCT00090220|12074888|FG004|STARTED|Base Study Follow-up Period||0
10908382|NCT00090220|12074889|FG005|STARTED|Base Study Follow-up Period||0
10908383|NCT00090220|12074884|FG000|COMPLETED|Base Study Follow-up Period||1695
10908384|NCT00090220|12074885|FG001|COMPLETED|Base Study Follow-up Period||1687
10908385|NCT00090220|12074886|FG002|COMPLETED|Base Study Follow-up Period||0
10908386|NCT00090220|12074887|FG003|COMPLETED|Base Study Follow-up Period||0
10908387|NCT00090220|12074888|FG004|COMPLETED|Base Study Follow-up Period||0
10908388|NCT00090220|12074889|FG005|COMPLETED|Base Study Follow-up Period||0
10908389|NCT00090220|12074884|FG000|NOT COMPLETED|Base Study Follow-up Period||160
10908390|NCT00090220|12074885|FG001|NOT COMPLETED|Base Study Follow-up Period||164
10908391|NCT00090220|12074886|FG002|NOT COMPLETED|Base Study Follow-up Period||0
10908392|NCT00090220|12074887|FG003|NOT COMPLETED|Base Study Follow-up Period||0
10908393|NCT00090220|12074888|FG004|NOT COMPLETED|Base Study Follow-up Period||0
10908394|NCT00090220|12074889|FG005|NOT COMPLETED|Base Study Follow-up Period||0
10908395|NCT00090220|12074884|FG000|STARTED|Extension 1 (EXT1)||0
10908396|NCT00090220|12074885|FG001|STARTED|Extension 1 (EXT1)||0
10908397|NCT00090220|12074886|FG002|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
10908398|NCT00090220|12074887|FG003|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
10908399|NCT00090220|12074888|FG004|STARTED|Extension 1 (EXT1)||0
10908400|NCT00090220|12074889|FG005|STARTED|Extension 1 (EXT1)||0
10908401|NCT00090220|12074884|FG000|Vaccinated|Extension 1 (EXT1)||0
10908402|NCT00090220|12074885|FG001|Vaccinated|Extension 1 (EXT1)||0
10908403|NCT00090220|12074886|FG002|Vaccinated|Extension 1 (EXT1)||1321
10908404|NCT00090220|12074887|FG003|Vaccinated|Extension 1 (EXT1)||7
10908405|NCT00090220|12074888|FG004|Vaccinated|Extension 1 (EXT1)||0
10908406|NCT00090220|12074889|FG005|Vaccinated|Extension 1 (EXT1)||0
10908407|NCT00090220|12074884|FG000|COMPLETED|Extension 1 (EXT1)||0
10908408|NCT00090220|12074885|FG001|COMPLETED|Extension 1 (EXT1)||0
10908409|NCT00090220|12074886|FG002|COMPLETED|Extension 1 (EXT1)||1267
10908410|NCT00090220|12074887|FG003|COMPLETED|Extension 1 (EXT1)||5
10908411|NCT00090220|12074888|FG004|COMPLETED|Extension 1 (EXT1)||0
10908412|NCT00090220|12074889|FG005|COMPLETED|Extension 1 (EXT1)||0
10908413|NCT00090220|12074884|FG000|NOT COMPLETED|Extension 1 (EXT1)||0
10908414|NCT00090220|12074885|FG001|NOT COMPLETED|Extension 1 (EXT1)||0
10908415|NCT00090220|12074886|FG002|NOT COMPLETED|Extension 1 (EXT1)||55
10908416|NCT00090220|12074887|FG003|NOT COMPLETED|Extension 1 (EXT1)||2
10908417|NCT00090220|12074888|FG004|NOT COMPLETED|Extension 1 (EXT1)||0
10908418|NCT00090220|12074889|FG005|NOT COMPLETED|Extension 1 (EXT1)||0
10908419|NCT00090220|12074884|FG000|STARTED|Long-term Follow-up (EXT2)||0
10908420|NCT00090220|12074885|FG001|STARTED|Long-term Follow-up (EXT2)||0
10908421|NCT00090220|12074886|FG002|STARTED|Long-term Follow-up (EXT2)||0
10908422|NCT00090220|12074887|FG003|STARTED|Long-term Follow-up (EXT2)||0
10908423|NCT00090220|12074888|FG004|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
10908424|NCT00090220|12074889|FG005|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
10908425|NCT00090220|12074884|FG000|COMPLETED|Long-term Follow-up (EXT2)||0
10908426|NCT00090220|12074885|FG001|COMPLETED|Long-term Follow-up (EXT2)||0
10908427|NCT00090220|12074886|FG002|COMPLETED|Long-term Follow-up (EXT2)||0
10908428|NCT00090220|12074887|FG003|COMPLETED|Long-term Follow-up (EXT2)||0
10908429|NCT00090220|12074888|FG004|COMPLETED|Long-term Follow-up (EXT2)||641
10908430|NCT00090220|12074889|FG005|COMPLETED|Long-term Follow-up (EXT2)||623
10908431|NCT00090220|12074884|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10908432|NCT00090220|12074885|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10908433|NCT00090220|12074886|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10908434|NCT00090220|12074887|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10908435|NCT00090220|12074888|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||44
10908436|NCT00090220|12074889|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||28
10908437|NCT00090233|12074908|FG000|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
10908438|NCT00090233|12074909|FG001|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
10908439|NCT00090233|12074908|FG000|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
10908440|NCT00090233|12074909|FG001|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
10908441|NCT00090233|12074908|FG000|Vaccinated at Visit 2|Overall Study||31052
10908442|NCT00090233|12074909|FG001|Vaccinated at Visit 2|Overall Study||31066
10908443|NCT00090233|12074908|FG000|Vaccinated at Visit 3|Overall Study||29667
10908444|NCT00090233|12074909|FG001|Vaccinated at Visit 3|Overall Study||29598
10908445|NCT00090233|12074908|FG000|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
10908446|NCT00090233|12074909|FG001|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
10908447|NCT00090233|12074908|FG000|NOT COMPLETED|Overall Study||4999
10908448|NCT00090233|12074909|FG001|NOT COMPLETED|Overall Study||5065
10908449|NCT00090285|12074921|FG000|STARTED|Base Study Vaccination Period||2032
10908450|NCT00090285|12074922|FG001|STARTED|Base Study Vaccination Period||2033
10908451|NCT00090285|12074923|FG002|STARTED|Base Study Vaccination Period||0
10908452|NCT00090285|12074924|FG003|STARTED|Base Study Vaccination Period||0
10908453|NCT00090285|12074925|FG004|STARTED|Base Study Vaccination Period||0
10908454|NCT00090285|12074926|FG005|STARTED|Base Study Vaccination Period||0
10908455|NCT00090285|12074921|FG000|Vaccinated|Base Study Vaccination Period||2025
10908456|NCT00090285|12074922|FG001|Vaccinated|Base Study Vaccination Period||2030
10908457|NCT00090285|12074923|FG002|Vaccinated|Base Study Vaccination Period||0
10908458|NCT00090285|12074924|FG003|Vaccinated|Base Study Vaccination Period||0
10908459|NCT00090285|12074925|FG004|Vaccinated|Base Study Vaccination Period||0
10908460|NCT00090285|12074926|FG005|Vaccinated|Base Study Vaccination Period||0
10908461|NCT00090285|12074921|FG000|COMPLETED|Base Study Vaccination Period||1818
10908462|NCT00090285|12074922|FG001|COMPLETED|Base Study Vaccination Period||1814
10908463|NCT00090285|12074923|FG002|COMPLETED|Base Study Vaccination Period||0
10908464|NCT00090285|12074924|FG003|COMPLETED|Base Study Vaccination Period||0
10908465|NCT00090285|12074925|FG004|COMPLETED|Base Study Vaccination Period||0
10908466|NCT00090285|12074926|FG005|COMPLETED|Base Study Vaccination Period||0
10908467|NCT00090285|12074921|FG000|NOT COMPLETED|Base Study Vaccination Period||214
10908468|NCT00090285|12074922|FG001|NOT COMPLETED|Base Study Vaccination Period||219
10908469|NCT00090285|12074923|FG002|NOT COMPLETED|Base Study Vaccination Period||0
10908470|NCT00090285|12074924|FG003|NOT COMPLETED|Base Study Vaccination Period||0
10908471|NCT00090285|12074925|FG004|NOT COMPLETED|Base Study Vaccination Period||0
10908472|NCT00090285|12074926|FG005|NOT COMPLETED|Base Study Vaccination Period||0
10908473|NCT00090285|12074921|FG000|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
10908474|NCT00090285|12074922|FG001|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
10908475|NCT00090285|12074923|FG002|STARTED|Base Study Follow-up Period||0
10908476|NCT00090285|12074924|FG003|STARTED|Base Study Follow-up Period||0
10908477|NCT00090285|12074925|FG004|STARTED|Base Study Follow-up Period||0
10908478|NCT00090285|12074926|FG005|STARTED|Base Study Follow-up Period||0
10908479|NCT00090285|12074921|FG000|COMPLETED|Base Study Follow-up Period||1487
10908480|NCT00090285|12074922|FG001|COMPLETED|Base Study Follow-up Period||1479
10908481|NCT00090285|12074923|FG002|COMPLETED|Base Study Follow-up Period||0
10908482|NCT00090285|12074924|FG003|COMPLETED|Base Study Follow-up Period||0
10908483|NCT00090285|12074925|FG004|COMPLETED|Base Study Follow-up Period||0
10908484|NCT00090285|12074926|FG005|COMPLETED|Base Study Follow-up Period||0
10908485|NCT00090285|12074921|FG000|NOT COMPLETED|Base Study Follow-up Period||335
10908486|NCT00090285|12074922|FG001|NOT COMPLETED|Base Study Follow-up Period||342
10908487|NCT00090285|12074923|FG002|NOT COMPLETED|Base Study Follow-up Period||0
10908488|NCT00090285|12074924|FG003|NOT COMPLETED|Base Study Follow-up Period||0
10908489|NCT00090285|12074925|FG004|NOT COMPLETED|Base Study Follow-up Period||0
10908490|NCT00090285|12074926|FG005|NOT COMPLETED|Base Study Follow-up Period||0
10908491|NCT00090285|12074921|FG000|STARTED|Extension 1||0
10908492|NCT00090285|12074922|FG001|STARTED|Extension 1||0
10908493|NCT00090285|12074923|FG002|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
10908494|NCT00090285|12074924|FG003|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
10908495|NCT00090285|12074925|FG004|STARTED|Extension 1||0
10908496|NCT00090285|12074926|FG005|STARTED|Extension 1||0
10908497|NCT00090285|12074921|FG000|COMPLETED|Extension 1||0
10908498|NCT00090285|12074922|FG001|COMPLETED|Extension 1||0
10908499|NCT00090285|12074923|FG002|COMPLETED|Extension 1||1041
10908500|NCT00090285|12074924|FG003|COMPLETED|Extension 1||15
10908501|NCT00090285|12074925|FG004|COMPLETED|Extension 1||0
10908502|NCT00090285|12074926|FG005|COMPLETED|Extension 1||0
10908503|NCT00090285|12074921|FG000|NOT COMPLETED|Extension 1||0
10908504|NCT00090285|12074922|FG001|NOT COMPLETED|Extension 1||0
10908505|NCT00090285|12074923|FG002|NOT COMPLETED|Extension 1||57
10908506|NCT00090285|12074924|FG003|NOT COMPLETED|Extension 1||1
10908507|NCT00090285|12074925|FG004|NOT COMPLETED|Extension 1||0
10908508|NCT00090285|12074926|FG005|NOT COMPLETED|Extension 1||0
10908509|NCT00090285|12074921|FG000|STARTED|Long-term Follow-up (EXT2)||0
10908510|NCT00090285|12074922|FG001|STARTED|Long-term Follow-up (EXT2)||0
10908511|NCT00090285|12074923|FG002|STARTED|Long-term Follow-up (EXT2)||0
10908512|NCT00090285|12074924|FG003|STARTED|Long-term Follow-up (EXT2)||0
10908513|NCT00090285|12074925|FG004|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
10908514|NCT00090285|12074926|FG005|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
10908515|NCT00090285|12074921|FG000|COMPLETED|Long-term Follow-up (EXT2)||0
10908516|NCT00090285|12074922|FG001|COMPLETED|Long-term Follow-up (EXT2)||0
10908517|NCT00090285|12074923|FG002|COMPLETED|Long-term Follow-up (EXT2)||0
10908518|NCT00090285|12074924|FG003|COMPLETED|Long-term Follow-up (EXT2)||0
10908519|NCT00090285|12074925|FG004|COMPLETED|Long-term Follow-up (EXT2)||709
10908520|NCT00090285|12074926|FG005|COMPLETED|Long-term Follow-up (EXT2)||664
10908521|NCT00090285|12074921|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10908522|NCT00090285|12074922|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10908523|NCT00090285|12074923|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10908524|NCT00090285|12074924|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0
10908525|NCT00090285|12074925|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||227
10908526|NCT00090285|12074926|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||203
10908527|NCT00090363|12074944|FG000|STARTED|Overall Study||107
10908528|NCT00090363|12074945|FG001|STARTED|Overall Study||107
10908529|NCT00090363|12074946|FG002|STARTED|Overall Study||98
10908530|NCT00090363|12074944|FG000|Received Study Treatment.|Overall Study||107
10908531|NCT00090363|12074945|FG001|Received Study Treatment.|Overall Study||107
10908532|NCT00090363|12074946|FG002|Received Study Treatment.|Overall Study||98
10908533|NCT00090363|12074944|FG000|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
10908534|NCT00090363|12074945|FG001|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
10908535|NCT00090363|12074946|FG002|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
10908536|NCT00090363|12074944|FG000|NOT COMPLETED|Overall Study||106
10908537|NCT00090363|12074945|FG001|NOT COMPLETED|Overall Study||107
10908538|NCT00090363|12074946|FG002|NOT COMPLETED|Overall Study||96
10908539|NCT00090402|12074957|FG000|STARTED|Overall Study||13
10908540|NCT00090402|12074958|FG001|STARTED|Overall Study||13
10908541|NCT00090402|12074959|FG002|STARTED|Overall Study||13
10908542|NCT00090402|12074957|FG000|COMPLETED|Overall Study||11
10908543|NCT00090402|12074958|FG001|COMPLETED|Overall Study||11
10908544|NCT00090402|12074959|FG002|COMPLETED|Overall Study||12
10908545|NCT00090402|12074957|FG000|NOT COMPLETED|Overall Study||2
10908546|NCT00090402|12074958|FG001|NOT COMPLETED|Overall Study||2
10908547|NCT00090402|12074959|FG002|NOT COMPLETED|Overall Study||1
10908548|NCT00090493|12074970|FG000|STARTED|Overall Study||4
10908549|NCT00090493|12074970|FG000|COMPLETED|Overall Study||2
10908550|NCT00090493|12074970|FG000|NOT COMPLETED|Overall Study||2
10908551|NCT00090519|12074976|FG000|STARTED|Overall Study||371
10908552|NCT00090519|12074977|FG001|STARTED|Overall Study||360
10908553|NCT00090519|12074976|FG000|COMPLETED|Overall Study||298
10908554|NCT00090519|12074977|FG001|COMPLETED|Overall Study||285
10908555|NCT00090519|12074976|FG000|NOT COMPLETED|Overall Study||73
10908556|NCT00090519|12074977|FG001|NOT COMPLETED|Overall Study||75
10908557|NCT00090545|12074985|FG000|STARTED|Overall Study||22
10908558|NCT00090545|12074986|FG001|STARTED|Overall Study||24
10908559|NCT00090545|12074985|FG000|COMPLETED|Overall Study||0
10908560|NCT00090545|12074986|FG001|COMPLETED|Overall Study||0
10908561|NCT00090545|12074985|FG000|NOT COMPLETED|Overall Study||22
10908562|NCT00090545|12074986|FG001|NOT COMPLETED|Overall Study||24
10908563|NCT00090584|12074996|FG000|STARTED|Baseline to 10 Weeks||154
10908564|NCT00090584|12074997|FG001|STARTED|Baseline to 10 Weeks||153
10908565|NCT00090584|12074996|FG000|COMPLETED|Baseline to 10 Weeks||139
10908566|NCT00090584|12074997|FG001|COMPLETED|Baseline to 10 Weeks||141
10908567|NCT00090584|12074996|FG000|NOT COMPLETED|Baseline to 10 Weeks||15
10908568|NCT00090584|12074997|FG001|NOT COMPLETED|Baseline to 10 Weeks||12
10908569|NCT00090584|12074996|FG000|STARTED|Baseline to 8 Months||154
10908570|NCT00090584|12074997|FG001|STARTED|Baseline to 8 Months||153
10908571|NCT00090584|12074996|FG000|COMPLETED|Baseline to 8 Months||110
10908572|NCT00090584|12074997|FG001|COMPLETED|Baseline to 8 Months||112
10908573|NCT00090584|12074996|FG000|NOT COMPLETED|Baseline to 8 Months||44
10908574|NCT00090584|12074997|FG001|NOT COMPLETED|Baseline to 8 Months||41
10908575|NCT00090610|12075013|FG000|STARTED|Overall Study||75
10908576|NCT00090610|12075014|FG001|STARTED|Overall Study||75
10908577|NCT00090610|12075013|FG000|COMPLETED|Overall Study||74
10908578|NCT00090610|12075014|FG001|COMPLETED|Overall Study||74
10908579|NCT00090610|12075013|FG000|NOT COMPLETED|Overall Study||1
10908580|NCT00090610|12075014|FG001|NOT COMPLETED|Overall Study||1
10908581|NCT00090753|12075022|FG000|STARTED|First Treatment Period||748
10908582|NCT00090753|12075023|FG001|STARTED|First Treatment Period||480
10908583|NCT00090753|12075022|FG000|COMPLETED|First Treatment Period||492
10908584|NCT00090753|12075023|FG001|COMPLETED|First Treatment Period||302
10908585|NCT00090753|12075022|FG000|NOT COMPLETED|First Treatment Period||256
10908586|NCT00090753|12075023|FG001|NOT COMPLETED|First Treatment Period||178
10908587|NCT00090753|12075022|FG000|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
10908588|NCT00090753|12075023|FG001|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
10908589|NCT00090753|12075022|FG000|COMPLETED|Extended Treatment Period||94
10908590|NCT00090753|12075023|FG001|COMPLETED|Extended Treatment Period||59
10908591|NCT00090753|12075022|FG000|NOT COMPLETED|Extended Treatment Period||359
10908592|NCT00090753|12075023|FG001|NOT COMPLETED|Extended Treatment Period||191
10908593|NCT00090766|12075032|FG000|STARTED|Overall Study||17
10908594|NCT00090766|12075033|FG001|STARTED|Overall Study||21
10908595|NCT00090766|12075034|FG002|STARTED|Overall Study||25
10908596|NCT00090766|12075032|FG000|COMPLETED|Overall Study||14
10908597|NCT00090766|12075033|FG001|COMPLETED|Overall Study||19
10908598|NCT00090766|12075034|FG002|COMPLETED|Overall Study||22
10908599|NCT00090766|12075032|FG000|NOT COMPLETED|Overall Study||3
10908600|NCT00090766|12075033|FG001|NOT COMPLETED|Overall Study||2
10908601|NCT00090766|12075034|FG002|NOT COMPLETED|Overall Study||3
10908602|NCT00090779|12075046|FG000|STARTED|Step 1||66
10908603|NCT00090779|12075047|FG001|STARTED|Step 1||64
10908604|NCT00090779|12075046|FG000|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
10908605|NCT00090779|12075047|FG001|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
10908606|NCT00090779|12075046|FG000|NOT COMPLETED|Step 1||11
10908607|NCT00090779|12075047|FG001|NOT COMPLETED|Step 1||15
10908608|NCT00090779|12075046|FG000|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
10908609|NCT00090779|12075047|FG001|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
10908610|NCT00090779|12075046|FG000|COMPLETED|Step 2||0
10908611|NCT00090779|12075047|FG001|COMPLETED|Step 2||1
10908612|NCT00090779|12075046|FG000|NOT COMPLETED|Step 2||6
10908613|NCT00090779|12075047|FG001|NOT COMPLETED|Step 2||18
10908614|NCT00090779|12075046|FG000|STARTED|Step 3||7
10908615|NCT00090779|12075047|FG001|STARTED|Step 3||5
10908616|NCT00090779|12075046|FG000|COMPLETED|Step 3||0
10908617|NCT00090779|12075047|FG001|COMPLETED|Step 3||0
10908618|NCT00090779|12075046|FG000|NOT COMPLETED|Step 3||7
10908619|NCT00090779|12075047|FG001|NOT COMPLETED|Step 3||5
10908620|NCT00090844|12075055|FG000|STARTED|Overall Study||27
10908621|NCT00090844|12075056|FG001|STARTED|Overall Study||22
10908622|NCT00090844|12075055|FG000|COMPLETED|Overall Study||26
10908623|NCT00090844|12075056|FG001|COMPLETED|Overall Study||21
10908624|NCT00090844|12075055|FG000|NOT COMPLETED|Overall Study||1
10908625|NCT00090844|12075056|FG001|NOT COMPLETED|Overall Study||1
10908626|NCT00090857|12075065|FG000|STARTED|Overall Study||33
10908627|NCT00090857|12075066|FG001|STARTED|Overall Study||16
10908628|NCT00090857|12075065|FG000|COMPLETED|Overall Study||29
10908629|NCT00090857|12075066|FG001|COMPLETED|Overall Study||13
10908630|NCT00090857|12075065|FG000|NOT COMPLETED|Overall Study||4
10908631|NCT00090857|12075066|FG001|NOT COMPLETED|Overall Study||3
10908632|NCT00090987|12075072|FG000|STARTED|Overall Study||30
10908633|NCT00090987|12075072|FG000|COMPLETED|Overall Study||9
10908634|NCT00090987|12075072|FG000|NOT COMPLETED|Overall Study||21
10908635|NCT00091026|12075078|FG000|STARTED|Overall Study||72
10908636|NCT00091026|12075079|FG001|STARTED|Overall Study||71
10908637|NCT00091026|12075078|FG000|COMPLETED|Overall Study||71
10908638|NCT00091026|12075079|FG001|COMPLETED|Overall Study||68
10908639|NCT00091026|12075078|FG000|NOT COMPLETED|Overall Study||1
10908640|NCT00091026|12075079|FG001|NOT COMPLETED|Overall Study||3
10908641|NCT00091169|12075087|FG000|STARTED|Overall Study||189
10908642|NCT00091169|12075088|FG001|STARTED|Overall Study||187
10908643|NCT00091169|12075087|FG000|Treated|Overall Study||163
10908644|NCT00091169|12075088|FG001|Treated|Overall Study||170
10908645|NCT00091169|12075087|FG000|COMPLETED|Overall Study||132
10908646|NCT00091169|12075088|FG001|COMPLETED|Overall Study||134
10908647|NCT00091169|12075087|FG000|NOT COMPLETED|Overall Study||57
10908648|NCT00091169|12075088|FG001|NOT COMPLETED|Overall Study||53
10908649|NCT00091260|12075096|FG000|STARTED|Overall Study||82
10908650|NCT00091260|12075096|FG000|COMPLETED|Overall Study||82
10908651|NCT00091260|12075096|FG000|NOT COMPLETED|Overall Study||0
10908652|NCT00091273|12075101|FG000|STARTED|Overall Study||9
10908653|NCT00091273|12075101|FG000|COMPLETED|Overall Study||9
10908654|NCT00091273|12075101|FG000|NOT COMPLETED|Overall Study||0
10908655|NCT00091390|12075105|FG000|STARTED|Overall Study||129
10908656|NCT00091390|12075105|FG000|Eligible and Started Study Treatment|Overall Study||125
10908657|NCT00091390|12075105|FG000|Eligible, Started Treatment, Has AE Data|Overall Study||115
10908658|NCT00091390|12075105|FG000|COMPLETED|Overall Study|Subjects contributing data to results are considered to have completed the study.|125
10908659|NCT00091390|12075105|FG000|NOT COMPLETED|Overall Study||4
10908660|NCT00091442|12075111|FG000|STARTED|Overall Study||373
10908661|NCT00091442|12075112|FG001|STARTED|Overall Study||378
10908662|NCT00091442|12075111|FG000|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
10908663|NCT00091442|12075112|FG001|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
10908664|NCT00091442|12075111|FG000|NOT COMPLETED|Overall Study||369
10908665|NCT00091442|12075112|FG001|NOT COMPLETED|Overall Study||373
10908666|NCT00091507|12075120|FG000|STARTED|Overall Study||432
10908667|NCT00091507|12075121|FG001|STARTED|Overall Study||479
10908668|NCT00091507|12075120|FG000|COMPLETED|Overall Study||411
10908669|NCT00091507|12075121|FG001|COMPLETED|Overall Study||460
10908670|NCT00091507|12075120|FG000|NOT COMPLETED|Overall Study||21
10908671|NCT00091507|12075121|FG001|NOT COMPLETED|Overall Study||19
10908672|NCT00091572|12075129|FG000|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
10908673|NCT00091572|12075130|FG001|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
10908674|NCT00091572|12075129|FG000|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
10908675|NCT00091572|12075130|FG001|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
10908676|NCT00091572|12075129|FG000|NOT COMPLETED|Overall Study||95
10908677|NCT00091572|12075130|FG001|NOT COMPLETED|Overall Study||82
10908678|NCT00091793|12075138|FG000|STARTED|Overall Study||166
10908679|NCT00091793|12075139|FG001|STARTED|Overall Study||166
10908680|NCT00091793|12075138|FG000|COMPLETED|Overall Study||142
10908681|NCT00091793|12075139|FG001|COMPLETED|Overall Study||144
10908682|NCT00091793|12075138|FG000|NOT COMPLETED|Overall Study||24
10908683|NCT00091793|12075139|FG001|NOT COMPLETED|Overall Study||22
10908684|NCT00091819|12075147|FG000|STARTED|Overall Study||429
10908685|NCT00091819|12075148|FG001|STARTED|Overall Study||433
10908686|NCT00091819|12075147|FG000|COMPLETED|Overall Study||387
10908687|NCT00091819|12075148|FG001|COMPLETED|Overall Study||387
10908688|NCT00091819|12075147|FG000|NOT COMPLETED|Overall Study||42
10908689|NCT00091819|12075148|FG001|NOT COMPLETED|Overall Study||46
10908690|NCT00091832|12075160|FG000|STARTED|Overall Study||43
10908691|NCT00091832|12075161|FG001|STARTED|Overall Study||42
10908692|NCT00091832|12075162|FG002|STARTED|Overall Study||42
10908693|NCT00091832|12075163|FG003|STARTED|Overall Study||43
10908694|NCT00091832|12075164|FG004|STARTED|Overall Study||42
10908695|NCT00091832|12075165|FG005|STARTED|Overall Study||43
10908696|NCT00091832|12075160|FG000|Received Study Medication|Overall Study||43
10908697|NCT00091832|12075161|FG001|Received Study Medication|Overall Study||42
10908698|NCT00091832|12075162|FG002|Received Study Medication|Overall Study||41
10908699|NCT00091832|12075163|FG003|Received Study Medication|Overall Study||43
10908700|NCT00091832|12075164|FG004|Received Study Medication|Overall Study||42
10908701|NCT00091832|12075165|FG005|Received Study Medication|Overall Study||43
10908702|NCT00091832|12075160|FG000|COMPLETED|Overall Study||29
10908703|NCT00091832|12075161|FG001|COMPLETED|Overall Study||31
10908704|NCT00091832|12075162|FG002|COMPLETED|Overall Study||30
10908705|NCT00091832|12075163|FG003|COMPLETED|Overall Study||29
10908706|NCT00091832|12075164|FG004|COMPLETED|Overall Study||27
10908707|NCT00091832|12075165|FG005|COMPLETED|Overall Study||32
10908708|NCT00091832|12075160|FG000|NOT COMPLETED|Overall Study||14
10908709|NCT00091832|12075161|FG001|NOT COMPLETED|Overall Study||11
10908710|NCT00091832|12075162|FG002|NOT COMPLETED|Overall Study||12
10908711|NCT00091832|12075163|FG003|NOT COMPLETED|Overall Study||14
10908712|NCT00091832|12075164|FG004|NOT COMPLETED|Overall Study||15
10908713|NCT00091832|12075165|FG005|NOT COMPLETED|Overall Study||11
10908714|NCT00091949|12075181|FG000|STARTED|Overall Study||1939
10908715|NCT00091949|12075182|FG001|STARTED|Overall Study||1937
10908716|NCT00091949|12075181|FG000|COMPLETED|Overall Study||1764
10908717|NCT00091949|12075182|FG001|COMPLETED|Overall Study||1786
10908718|NCT00091949|12075181|FG000|NOT COMPLETED|Overall Study||175
10908719|NCT00091949|12075182|FG001|NOT COMPLETED|Overall Study||151
10908720|NCT00091962|12075191|FG000|STARTED|Overall Study||150
10908721|NCT00091962|12075192|FG001|STARTED|Overall Study||152
10908722|NCT00091962|12075193|FG002|STARTED|Overall Study||151
10908723|NCT00091962|12075191|FG000|COMPLETED|Overall Study||150
10908724|NCT00091962|12075192|FG001|COMPLETED|Overall Study||152
10908725|NCT00091962|12075193|FG002|COMPLETED|Overall Study||151
10908726|NCT00091962|12075191|FG000|NOT COMPLETED|Overall Study||0
10908727|NCT00091962|12075192|FG001|NOT COMPLETED|Overall Study||0
10908728|NCT00091962|12075193|FG002|NOT COMPLETED|Overall Study||0
10908729|NCT00092417|12075206|FG000|STARTED|Overall Study|Started Period Group 1|464
10908730|NCT00092417|12075207|FG001|STARTED|Overall Study|Started Period Group 2|234
10908731|NCT00092417|12075206|FG000|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
10908732|NCT00092417|12075207|FG001|Vaccinated|Overall Study||234
10908733|NCT00092417|12075206|FG000|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
10908734|NCT00092417|12075207|FG001|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
10908735|NCT00092417|12075206|FG000|NOT COMPLETED|Overall Study||5
10908736|NCT00092417|12075207|FG001|NOT COMPLETED|Overall Study||1
10908737|NCT00092443|12075215|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
10908738|NCT00092443|12075216|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
10908739|NCT00092443|12075215|FG000|Vaccinated at Visit 1|Overall Study||650
10908740|NCT00092443|12075216|FG001|Vaccinated at Visit 1|Overall Study||660
10908741|NCT00092443|12075215|FG000|Vaccinated at Visit 2|Overall Study||618
10908742|NCT00092443|12075216|FG001|Vaccinated at Visit 2|Overall Study||627
10908743|NCT00092443|12075215|FG000|Vaccinated at Visit 3|Overall Study||593
10908744|NCT00092443|12075216|FG001|Vaccinated at Visit 3|Overall Study||608
10908745|NCT00092443|12075215|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
10908746|NCT00092443|12075216|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
10908747|NCT00092443|12075215|FG000|NOT COMPLETED|Overall Study||58
10908748|NCT00092443|12075216|FG001|NOT COMPLETED|Overall Study||54
10908749|NCT00092456|12075236|FG000|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
10908750|NCT00092456|12075237|FG001|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
10908751|NCT00092456|12075238|FG002|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
10908752|NCT00092456|12075239|FG003|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
10908753|NCT00092456|12075236|FG000|Vaccinated at Visit 1|Overall Study||226
10908754|NCT00092456|12075237|FG001|Vaccinated at Visit 1|Overall Study||225
10908755|NCT00092456|12075238|FG002|Vaccinated at Visit 1|Overall Study||229
10908756|NCT00092456|12075239|FG003|Vaccinated at Visit 1|Overall Study||113
10908757|NCT00092456|12075236|FG000|Vaccinated at Visit 2|Overall Study||208
10908758|NCT00092456|12075237|FG001|Vaccinated at Visit 2|Overall Study||217
10908759|NCT00092456|12075238|FG002|Vaccinated at Visit 2|Overall Study||210
10908760|NCT00092456|12075239|FG003|Vaccinated at Visit 2|Overall Study||104
10908761|NCT00092456|12075236|FG000|Vaccinated at Visit 3|Overall Study||202
10908762|NCT00092456|12075237|FG001|Vaccinated at Visit 3|Overall Study||210
10908763|NCT00092456|12075238|FG002|Vaccinated at Visit 3|Overall Study||200
10908764|NCT00092456|12075239|FG003|Vaccinated at Visit 3|Overall Study||98
10908765|NCT00092456|12075236|FG000|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
10908766|NCT00092456|12075237|FG001|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
10908767|NCT00092456|12075238|FG002|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
10908768|NCT00092456|12075239|FG003|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
10908769|NCT00092456|12075236|FG000|NOT COMPLETED|Overall Study||25
10908770|NCT00092456|12075237|FG001|NOT COMPLETED|Overall Study||17
10908771|NCT00092456|12075238|FG002|NOT COMPLETED|Overall Study||29
10908772|NCT00092456|12075239|FG003|NOT COMPLETED|Overall Study||16
10908773|NCT00092495|12075253|FG000|STARTED|Base Study Vaccination Period||504
10908774|NCT00092495|12075254|FG001|STARTED|Base Study Vaccination Period||514
10908775|NCT00092495|12075255|FG002|STARTED|Base Study Vaccination Period||508
10908776|NCT00092495|12075256|FG003|STARTED|Base Study Vaccination Period||1529
10908777|NCT00092495|12075257|FG004|STARTED|Base Study Vaccination Period||0
10908778|NCT00092495|12075253|FG000|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
10908779|NCT00092495|12075254|FG001|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
10908780|NCT00092495|12075255|FG002|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
10908781|NCT00092495|12075256|FG003|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
10908782|NCT00092495|12075257|FG004|With Long-term Follow-up *|Base Study Vaccination Period||0
10908783|NCT00092495|12075253|FG000|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
10908784|NCT00092495|12075254|FG001|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
10908785|NCT00092495|12075255|FG002|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
10908786|NCT00092495|12075256|FG003|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
10908787|NCT00092495|12075257|FG004|Without Long-term Follow-up|Base Study Vaccination Period||0
10908788|NCT00092495|12075253|FG000|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
10908789|NCT00092495|12075254|FG001|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
10908790|NCT00092495|12075255|FG002|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
10908791|NCT00092495|12075256|FG003|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
10908792|NCT00092495|12075257|FG004|COMPLETED|Base Study Vaccination Period||0
10908793|NCT00092495|12075253|FG000|NOT COMPLETED|Base Study Vaccination Period||37
10908794|NCT00092495|12075254|FG001|NOT COMPLETED|Base Study Vaccination Period||22
10908795|NCT00092495|12075255|FG002|NOT COMPLETED|Base Study Vaccination Period||34
10908796|NCT00092495|12075256|FG003|NOT COMPLETED|Base Study Vaccination Period||88
10908797|NCT00092495|12075257|FG004|NOT COMPLETED|Base Study Vaccination Period||0
10908798|NCT00092495|12075253|FG000|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
10908799|NCT00092495|12075254|FG001|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
10908800|NCT00092495|12075255|FG002|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
10908801|NCT00092495|12075256|FG003|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
10908802|NCT00092495|12075257|FG004|STARTED|Base Study Follow-up Period||0
10908803|NCT00092495|12075253|FG000|COMPLETED|Base Study Follow-up Period||112
10908804|NCT00092495|12075254|FG001|COMPLETED|Base Study Follow-up Period||122
10908805|NCT00092495|12075255|FG002|COMPLETED|Base Study Follow-up Period||126
10908806|NCT00092495|12075256|FG003|COMPLETED|Base Study Follow-up Period||446
10908807|NCT00092495|12075257|FG004|COMPLETED|Base Study Follow-up Period||0
10908808|NCT00092495|12075253|FG000|NOT COMPLETED|Base Study Follow-up Period||3
10908809|NCT00092495|12075254|FG001|NOT COMPLETED|Base Study Follow-up Period||3
10908810|NCT00092495|12075255|FG002|NOT COMPLETED|Base Study Follow-up Period||4
10908811|NCT00092495|12075256|FG003|NOT COMPLETED|Base Study Follow-up Period||14
10908812|NCT00092495|12075257|FG004|NOT COMPLETED|Base Study Follow-up Period||0
10908813|NCT00092495|12075253|FG000|STARTED|Extension Study||0
10908814|NCT00092495|12075254|FG001|STARTED|Extension Study||0
10908815|NCT00092495|12075255|FG002|STARTED|Extension Study||0
10908816|NCT00092495|12075256|FG003|STARTED|Extension Study||0
10908817|NCT00092495|12075257|FG004|STARTED|Extension Study||12
10908818|NCT00092495|12075253|FG000|COMPLETED|Extension Study||0
10908819|NCT00092495|12075254|FG001|COMPLETED|Extension Study||0
10908820|NCT00092495|12075255|FG002|COMPLETED|Extension Study||0
10908821|NCT00092495|12075256|FG003|COMPLETED|Extension Study||0
10908822|NCT00092495|12075257|FG004|COMPLETED|Extension Study||12
10908823|NCT00092495|12075253|FG000|NOT COMPLETED|Extension Study||0
10908824|NCT00092495|12075254|FG001|NOT COMPLETED|Extension Study||0
10908825|NCT00092495|12075255|FG002|NOT COMPLETED|Extension Study||0
10908826|NCT00092495|12075256|FG003|NOT COMPLETED|Extension Study||0
10908827|NCT00092495|12075257|FG004|NOT COMPLETED|Extension Study||0
10908828|NCT00092521|12075273|FG000|STARTED|Vaccination (Day 1 Through Month 7)||2723
10908829|NCT00092521|12075274|FG001|STARTED|Vaccination (Day 1 Through Month 7)||304
10908830|NCT00092521|12075275|FG002|STARTED|Vaccination (Day 1 Through Month 7)||2732
10908831|NCT00092521|12075276|FG003|STARTED|Vaccination (Day 1 Through Month 7)||0
10908832|NCT00092521|12075273|FG000|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
10908833|NCT00092521|12075274|FG001|COMPLETED|Vaccination (Day 1 Through Month 7)||290
10908834|NCT00092521|12075275|FG002|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
10908835|NCT00092521|12075276|FG003|COMPLETED|Vaccination (Day 1 Through Month 7)||0
10908836|NCT00092521|12075273|FG000|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
10908837|NCT00092521|12075274|FG001|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
10908838|NCT00092521|12075275|FG002|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
10908839|NCT00092521|12075276|FG003|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
10908840|NCT00092521|12075273|FG000|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
10908841|NCT00092521|12075274|FG001|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
10908842|NCT00092521|12075275|FG002|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
10908843|NCT00092521|12075276|FG003|STARTED|Follow-Up (After Month 7)||0
10908844|NCT00092521|12075273|FG000|COMPLETED|Follow-Up (After Month 7)||2353
10908845|NCT00092521|12075274|FG001|COMPLETED|Follow-Up (After Month 7)||155
10908846|NCT00092521|12075275|FG002|COMPLETED|Follow-Up (After Month 7)||1959
10908847|NCT00092521|12075276|FG003|COMPLETED|Follow-Up (After Month 7)||0
10908848|NCT00092521|12075273|FG000|NOT COMPLETED|Follow-Up (After Month 7)||246
10908849|NCT00092521|12075274|FG001|NOT COMPLETED|Follow-Up (After Month 7)||136
10908850|NCT00092521|12075275|FG002|NOT COMPLETED|Follow-Up (After Month 7)||648
10908851|NCT00092521|12075276|FG003|NOT COMPLETED|Follow-Up (After Month 7)||0
10908852|NCT00092521|12075273|FG000|STARTED|Extension Study (Group 4)||0
10908853|NCT00092521|12075274|FG001|STARTED|Extension Study (Group 4)||0
10908854|NCT00092521|12075275|FG002|STARTED|Extension Study (Group 4)||0
10908855|NCT00092521|12075276|FG003|STARTED|Extension Study (Group 4)||844
10908856|NCT00092521|12075273|FG000|Initiated Extension Study|Extension Study (Group 4)||0
10908857|NCT00092521|12075274|FG001|Initiated Extension Study|Extension Study (Group 4)||0
10908858|NCT00092521|12075275|FG002|Initiated Extension Study|Extension Study (Group 4)||0
10908859|NCT00092521|12075276|FG003|Initiated Extension Study|Extension Study (Group 4)||829
10908860|NCT00092521|12075273|FG000|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
10908861|NCT00092521|12075274|FG001|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
10908862|NCT00092521|12075275|FG002|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
10908863|NCT00092521|12075276|FG003|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
10908864|NCT00092521|12075273|FG000|COMPLETED|Extension Study (Group 4)||0
10908865|NCT00092521|12075274|FG001|COMPLETED|Extension Study (Group 4)||0
10908866|NCT00092521|12075275|FG002|COMPLETED|Extension Study (Group 4)||0
10908867|NCT00092521|12075276|FG003|COMPLETED|Extension Study (Group 4)||635
10908868|NCT00092521|12075273|FG000|NOT COMPLETED|Extension Study (Group 4)||0
10908869|NCT00092521|12075274|FG001|NOT COMPLETED|Extension Study (Group 4)||0
10908870|NCT00092521|12075275|FG002|NOT COMPLETED|Extension Study (Group 4)||0
10908871|NCT00092521|12075276|FG003|NOT COMPLETED|Extension Study (Group 4)||209
10908872|NCT00092547|12075286|FG000|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
10908873|NCT00092547|12075287|FG001|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
10908874|NCT00092547|12075288|FG002|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
10908875|NCT00092547|12075286|FG000|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
10908876|NCT00092547|12075287|FG001|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
10908877|NCT00092547|12075288|FG002|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
10908878|NCT00092547|12075286|FG000|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
10908879|NCT00092547|12075287|FG001|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
10908880|NCT00092547|12075288|FG002|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
10908881|NCT00092547|12075286|FG000|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
10908882|NCT00092547|12075287|FG001|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
10908883|NCT00092547|12075288|FG002|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
10908884|NCT00092547|12075286|FG000|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
10908885|NCT00092547|12075287|FG001|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
10908886|NCT00092547|12075288|FG002|STARTED|Base Follow-up Phase (Month 7 to 18)||0
10908887|NCT00092547|12075286|FG000|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
10908888|NCT00092547|12075287|FG001|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
10908889|NCT00092547|12075288|FG002|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
10908890|NCT00092547|12075286|FG000|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
10908891|NCT00092547|12075287|FG001|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
10908892|NCT00092547|12075288|FG002|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
10908893|NCT00092547|12075286|FG000|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
10908894|NCT00092547|12075287|FG001|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
10908895|NCT00092547|12075288|FG002|STARTED|Base Follow-up Phase (Month 18 to 30)||0
10908896|NCT00092547|12075286|FG000|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
10908897|NCT00092547|12075287|FG001|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
10908898|NCT00092547|12075288|FG002|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
10908899|NCT00092547|12075286|FG000|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
10908900|NCT00092547|12075287|FG001|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
10908901|NCT00092547|12075288|FG002|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
10908902|NCT00092547|12075286|FG000|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
10908903|NCT00092547|12075287|FG001|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
10908904|NCT00092547|12075288|FG002|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
10908905|NCT00092547|12075286|FG000|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
10908906|NCT00092547|12075287|FG001|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
10908978|NCT00093470|12075335|FG001|Treated|Overall Study||71
10908907|NCT00092547|12075288|FG002|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
10908908|NCT00092547|12075286|FG000|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
10908909|NCT00092547|12075287|FG001|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
10908910|NCT00092547|12075288|FG002|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
10908911|NCT00092547|12075286|FG000|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
10908912|NCT00092547|12075287|FG001|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
10908913|NCT00092547|12075288|FG002|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
10908914|NCT00092547|12075286|FG000|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
10908915|NCT00092547|12075287|FG001|STARTED|Long-term Follow-up (Month 42 Visit)||0
10908916|NCT00092547|12075288|FG002|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
10908917|NCT00092547|12075286|FG000|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
10908918|NCT00092547|12075287|FG001|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
10908919|NCT00092547|12075288|FG002|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
10908920|NCT00092547|12075286|FG000|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
10908921|NCT00092547|12075287|FG001|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
10908922|NCT00092547|12075288|FG002|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
10908923|NCT00092547|12075286|FG000|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
10908924|NCT00092547|12075287|FG001|STARTED|Long-term Follow-up (Month 72 Visit)||0
10908925|NCT00092547|12075288|FG002|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
10908926|NCT00092547|12075286|FG000|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
10908927|NCT00092547|12075287|FG001|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
10908928|NCT00092547|12075288|FG002|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
10908929|NCT00092547|12075286|FG000|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
10908930|NCT00092547|12075287|FG001|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
10908931|NCT00092547|12075288|FG002|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
10908932|NCT00092547|12075286|FG000|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
10908933|NCT00092547|12075287|FG001|STARTED|Long-term Follow-up (Month 96 Visit)||0
10908934|NCT00092547|12075288|FG002|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
10908935|NCT00092547|12075286|FG000|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
10908936|NCT00092547|12075287|FG001|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
10908937|NCT00092547|12075288|FG002|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
10908938|NCT00092547|12075286|FG000|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
10908939|NCT00092547|12075287|FG001|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
10908940|NCT00092547|12075288|FG002|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
10908941|NCT00092547|12075286|FG000|STARTED|Long-term Follow-up (Month 126 Visit)||454
10908942|NCT00092547|12075287|FG001|STARTED|Long-term Follow-up (Month 126 Visit)||0
10908943|NCT00092547|12075288|FG002|STARTED|Long-term Follow-up (Month 126 Visit)||211
10908944|NCT00092547|12075286|FG000|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
10908945|NCT00092547|12075287|FG001|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
10908946|NCT00092547|12075288|FG002|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
10908947|NCT00092547|12075286|FG000|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
10908948|NCT00092547|12075287|FG001|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
10908949|NCT00092547|12075288|FG002|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
10908950|NCT00093041|12075305|FG000|STARTED|Overall Study||4
10908951|NCT00093041|12075306|FG001|STARTED|Overall Study||4
10908952|NCT00093041|12075307|FG002|STARTED|Overall Study||5
10908953|NCT00093041|12075308|FG003|STARTED|Overall Study||4
10908954|NCT00093041|12075309|FG004|STARTED|Overall Study||4
10908955|NCT00093041|12075310|FG005|STARTED|Overall Study||7
10908956|NCT00093041|12075305|FG000|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
10908957|NCT00093041|12075306|FG001|COMPLETED|Overall Study|Three discontinued during single dose period|1
10908958|NCT00093041|12075307|FG002|COMPLETED|Overall Study|Two discontinued during single dose period|3
10908959|NCT00093041|12075308|FG003|COMPLETED|Overall Study|One discontinued during single dose period|3
10908960|NCT00093041|12075309|FG004|COMPLETED|Overall Study|One discontinued during multiple dose period|3
10908961|NCT00093041|12075310|FG005|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
10908962|NCT00093041|12075305|FG000|NOT COMPLETED|Overall Study||2
10908963|NCT00093041|12075306|FG001|NOT COMPLETED|Overall Study||3
10908964|NCT00093041|12075307|FG002|NOT COMPLETED|Overall Study||2
10908965|NCT00093041|12075308|FG003|NOT COMPLETED|Overall Study||1
10908966|NCT00093041|12075309|FG004|NOT COMPLETED|Overall Study||1
10908967|NCT00093041|12075310|FG005|NOT COMPLETED|Overall Study||3
10908968|NCT00093145|12075324|FG000|STARTED|Overall Study||32
10908969|NCT00093145|12075324|FG000|At Least One Response Assessment|Overall Study||31
10908970|NCT00093145|12075324|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
10908971|NCT00093145|12075324|FG000|NOT COMPLETED|Overall Study||17
10908972|NCT00093379|12075328|FG000|STARTED|Overall Study||20
10908973|NCT00093379|12075328|FG000|COMPLETED|Overall Study||20
10908974|NCT00093379|12075328|FG000|NOT COMPLETED|Overall Study||0
10908975|NCT00093470|12075334|FG000|STARTED|Overall Study||73
10908976|NCT00093470|12075335|FG001|STARTED|Overall Study||71
10908977|NCT00093470|12075334|FG000|Treated|Overall Study||72
10908979|NCT00093470|12075334|FG000|Patients With Toxicity Assessment|Overall Study||72
10908980|NCT00093470|12075335|FG001|Patients With Toxicity Assessment|Overall Study||69
10908981|NCT00093470|12075334|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
10908982|NCT00093470|12075335|FG001|COMPLETED|Overall Study|Patients underwent observation only.|71
10908983|NCT00093470|12075334|FG000|NOT COMPLETED|Overall Study||73
10908984|NCT00093470|12075335|FG001|NOT COMPLETED|Overall Study||0
10908985|NCT00093496|12075343|FG000|STARTED|Overall Study||15
10908986|NCT00093496|12075344|FG001|STARTED|Overall Study||14
10908987|NCT00093496|12075343|FG000|COMPLETED|Overall Study||14
10908988|NCT00093496|12075344|FG001|COMPLETED|Overall Study||11
10908989|NCT00093496|12075343|FG000|NOT COMPLETED|Overall Study||1
10908990|NCT00093496|12075344|FG001|NOT COMPLETED|Overall Study||3
10908991|NCT00093756|12075351|FG000|STARTED|Overall Study||27
10908992|NCT00093756|12075352|FG001|STARTED|Overall Study||21
10908993|NCT00093756|12075351|FG000|COMPLETED|Overall Study||27
10908994|NCT00093756|12075352|FG001|COMPLETED|Overall Study||21
10908995|NCT00093756|12075351|FG000|NOT COMPLETED|Overall Study||0
10908996|NCT00093756|12075352|FG001|NOT COMPLETED|Overall Study||0
10908997|NCT00093782|12075360|FG000|STARTED|Overall Study||36
10908998|NCT00093782|12075360|FG000|COMPLETED|Overall Study||36
10908999|NCT00093782|12075360|FG000|NOT COMPLETED|Overall Study||0
10909000|NCT00093795|12075367|FG000|STARTED|Overall Study||1630
10909001|NCT00093795|12075368|FG001|STARTED|Overall Study||1634
10909002|NCT00093795|12075369|FG002|STARTED|Overall Study||1630
10909003|NCT00093795|12075367|FG000|COMPLETED|Overall Study||1610
10909004|NCT00093795|12075368|FG001|COMPLETED|Overall Study||1618
10909005|NCT00093795|12075369|FG002|COMPLETED|Overall Study||1613
10909006|NCT00093795|12075367|FG000|NOT COMPLETED|Overall Study||20
10909007|NCT00093795|12075368|FG001|NOT COMPLETED|Overall Study||16
10909008|NCT00093795|12075369|FG002|NOT COMPLETED|Overall Study||17
10909009|NCT00093808|12075377|FG000|STARTED|Overall Study||47
10909010|NCT00093808|12075377|FG000|COMPLETED|Overall Study||45
10909011|NCT00093808|12075377|FG000|NOT COMPLETED|Overall Study||2
10909012|NCT00093847|12075383|FG000|STARTED|Overall Study||39
10909013|NCT00093847|12075384|FG001|STARTED|Overall Study||34
10909014|NCT00093847|12075383|FG000|COMPLETED|Overall Study||31
10909015|NCT00093847|12075384|FG001|COMPLETED|Overall Study||24
10909016|NCT00093847|12075383|FG000|NOT COMPLETED|Overall Study||8
10909017|NCT00093847|12075384|FG001|NOT COMPLETED|Overall Study||10
10909018|NCT00093964|12075392|FG000|STARTED|Overall Study||41
10909019|NCT00093964|12075393|FG001|STARTED|Overall Study||40
10909020|NCT00093964|12075392|FG000|COMPLETED|Overall Study||41
10909021|NCT00093964|12075393|FG001|COMPLETED|Overall Study||40
10909022|NCT00093964|12075392|FG000|NOT COMPLETED|Overall Study||0
10909023|NCT00093964|12075393|FG001|NOT COMPLETED|Overall Study||0
10909024|NCT00094055|12075401|FG000|STARTED|Overall Study||60
10909025|NCT00094055|12075401|FG000|COMPLETED|Overall Study||0
10909026|NCT00094055|12075401|FG000|NOT COMPLETED|Overall Study||60
10909027|NCT00094094|12075405|FG000|STARTED|Overall Study||32
10909028|NCT00094094|12075405|FG000|COMPLETED|Overall Study||0
10909029|NCT00094094|12075405|FG000|NOT COMPLETED|Overall Study||32
10909030|NCT00094107|12075409|FG000|STARTED|Overall Study||32
10909031|NCT00094107|12075409|FG000|COMPLETED|Overall Study||0
10909032|NCT00094107|12075409|FG000|NOT COMPLETED|Overall Study||32
10909033|NCT00094172|12075415|FG000|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
10909034|NCT00094172|12075416|FG001|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
10909035|NCT00094172|12075415|FG000|COMPLETED|Overall Study||36
10909036|NCT00094172|12075416|FG001|COMPLETED|Overall Study||25
10909037|NCT00094172|12075415|FG000|NOT COMPLETED|Overall Study||14
10909038|NCT00094172|12075416|FG001|NOT COMPLETED|Overall Study||7
10909039|NCT00094211|12075426|FG000|STARTED|Overall Study||221
10909040|NCT00094211|12075427|FG001|STARTED|Overall Study||259
10909041|NCT00094211|12075428|FG002|STARTED|Overall Study||230
10909042|NCT00094211|12075429|FG003|STARTED|Overall Study||186
10909043|NCT00094211|12075426|FG000|COMPLETED|Overall Study||212
10909044|NCT00094211|12075427|FG001|COMPLETED|Overall Study||251
10909045|NCT00094211|12075428|FG002|COMPLETED|Overall Study||220
10909046|NCT00094211|12075429|FG003|COMPLETED|Overall Study||179
10909047|NCT00094211|12075426|FG000|NOT COMPLETED|Overall Study||9
10909048|NCT00094211|12075427|FG001|NOT COMPLETED|Overall Study||8
10909049|NCT00094211|12075428|FG002|NOT COMPLETED|Overall Study||10
10909050|NCT00094211|12075429|FG003|NOT COMPLETED|Overall Study||7
10909051|NCT00094302|12075445|FG000|STARTED|Overall Study||1723
10909052|NCT00094302|12075446|FG001|STARTED|Overall Study||1722
10909053|NCT00094302|12075445|FG000|COMPLETED|Overall Study||1306
10909054|NCT00094302|12075446|FG001|COMPLETED|Overall Study||1316
10909055|NCT00094302|12075445|FG000|NOT COMPLETED|Overall Study||417
10909056|NCT00094302|12075446|FG001|NOT COMPLETED|Overall Study||406
10909057|NCT00094328|12075452|FG000|STARTED|Overall Study|Received treatment|14
10909058|NCT00094328|12075452|FG000|COMPLETED|Overall Study|Completed 12 months on treatment|13
10909059|NCT00094328|12075452|FG000|NOT COMPLETED|Overall Study||1
10909060|NCT00094445|12075456|FG000|STARTED|Overall Study||50
10909061|NCT00094445|12075456|FG000|COMPLETED|Overall Study||44
10909062|NCT00094445|12075456|FG000|NOT COMPLETED|Overall Study||6
10909063|NCT00094458|12075463|FG000|STARTED|Main Study: Through Week 30||170
10909064|NCT00094458|12075464|FG001|STARTED|Main Study: Through Week 30||169
10909065|NCT00094458|12075465|FG002|STARTED|Main Study: Through Week 30||169
10909066|NCT00094458|12075466|FG003|STARTED|Main Study: Through Week 30||0
10909067|NCT00094458|12075467|FG004|STARTED|Main Study: Through Week 30||0
10909068|NCT00094458|12075468|FG005|STARTED|Main Study: Through Week 30||0
10909069|NCT00094458|12075463|FG000|COMPLETED|Main Study: Through Week 30||86
10909070|NCT00094458|12075464|FG001|COMPLETED|Main Study: Through Week 30||111
10909071|NCT00094458|12075465|FG002|COMPLETED|Main Study: Through Week 30||121
10909072|NCT00094458|12075466|FG003|COMPLETED|Main Study: Through Week 30||0
10909073|NCT00094458|12075467|FG004|COMPLETED|Main Study: Through Week 30||0
10909074|NCT00094458|12075468|FG005|COMPLETED|Main Study: Through Week 30||0
10909075|NCT00094458|12075463|FG000|NOT COMPLETED|Main Study: Through Week 30||84
10909076|NCT00094458|12075464|FG001|NOT COMPLETED|Main Study: Through Week 30||58
10909077|NCT00094458|12075465|FG002|NOT COMPLETED|Main Study: Through Week 30||48
10909078|NCT00094458|12075466|FG003|NOT COMPLETED|Main Study: Through Week 30||0
10909079|NCT00094458|12075467|FG004|NOT COMPLETED|Main Study: Through Week 30||0
10909080|NCT00094458|12075468|FG005|NOT COMPLETED|Main Study: Through Week 30||0
10909081|NCT00094458|12075463|FG000|STARTED|Study Extension: Week 30 Through Week 50||75
10909082|NCT00094458|12075464|FG001|STARTED|Study Extension: Week 30 Through Week 50||97
10909083|NCT00094458|12075465|FG002|STARTED|Study Extension: Week 30 Through Week 50||108
10909084|NCT00094458|12075466|FG003|STARTED|Study Extension: Week 30 Through Week 50||0
10909085|NCT00094458|12075467|FG004|STARTED|Study Extension: Week 30 Through Week 50||0
10909086|NCT00094458|12075468|FG005|STARTED|Study Extension: Week 30 Through Week 50||0
10909087|NCT00094458|12075463|FG000|COMPLETED|Study Extension: Week 30 Through Week 50||67
10909088|NCT00094458|12075464|FG001|COMPLETED|Study Extension: Week 30 Through Week 50||85
10909089|NCT00094458|12075465|FG002|COMPLETED|Study Extension: Week 30 Through Week 50||90
10909090|NCT00094458|12075466|FG003|COMPLETED|Study Extension: Week 30 Through Week 50||0
10909091|NCT00094458|12075467|FG004|COMPLETED|Study Extension: Week 30 Through Week 50||0
10909092|NCT00094458|12075468|FG005|COMPLETED|Study Extension: Week 30 Through Week 50||0
10909093|NCT00094458|12075463|FG000|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
10909094|NCT00094458|12075464|FG001|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
10909095|NCT00094458|12075465|FG002|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
10909096|NCT00094458|12075466|FG003|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
10909097|NCT00094458|12075467|FG004|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
10909098|NCT00094458|12075468|FG005|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
10909099|NCT00094458|12075463|FG000|STARTED|OLE: Open-Label Extension||0
10909100|NCT00094458|12075464|FG001|STARTED|OLE: Open-Label Extension||0
10909101|NCT00094458|12075465|FG002|STARTED|OLE: Open-Label Extension||0
10909102|NCT00094458|12075466|FG003|STARTED|OLE: Open-Label Extension||8
10909103|NCT00094458|12075467|FG004|STARTED|OLE: Open-Label Extension||18
10909104|NCT00094458|12075468|FG005|STARTED|OLE: Open-Label Extension||17
10909105|NCT00094458|12075463|FG000|COMPLETED|OLE: Open-Label Extension||0
10909106|NCT00094458|12075464|FG001|COMPLETED|OLE: Open-Label Extension||0
10909107|NCT00094458|12075465|FG002|COMPLETED|OLE: Open-Label Extension||0
10909108|NCT00094458|12075466|FG003|COMPLETED|OLE: Open-Label Extension||7
10909109|NCT00094458|12075467|FG004|COMPLETED|OLE: Open-Label Extension||13
10909110|NCT00094458|12075468|FG005|COMPLETED|OLE: Open-Label Extension||13
10909111|NCT00094458|12075463|FG000|NOT COMPLETED|OLE: Open-Label Extension||0
10909112|NCT00094458|12075464|FG001|NOT COMPLETED|OLE: Open-Label Extension||0
10909113|NCT00094458|12075465|FG002|NOT COMPLETED|OLE: Open-Label Extension||0
10909114|NCT00094458|12075466|FG003|NOT COMPLETED|OLE: Open-Label Extension||1
10909115|NCT00094458|12075467|FG004|NOT COMPLETED|OLE: Open-Label Extension||5
10909116|NCT00094458|12075468|FG005|NOT COMPLETED|OLE: Open-Label Extension||4
10909117|NCT00094497|12075484|FG000|STARTED|Overall Study||151
10909118|NCT00094497|12075485|FG001|STARTED|Overall Study||153
10909119|NCT00094497|12075484|FG000|Treated|Overall Study||148
10909120|NCT00094497|12075485|FG001|Treated|Overall Study||149
10909121|NCT00094497|12075484|FG000|Received Second Line Therapy|Overall Study||84
10909122|NCT00094497|12075485|FG001|Received Second Line Therapy|Overall Study||101
10909123|NCT00094497|12075484|FG000|COMPLETED|Overall Study||151
10909124|NCT00094497|12075485|FG001|COMPLETED|Overall Study||153
10909125|NCT00094497|12075484|FG000|NOT COMPLETED|Overall Study||0
10909126|NCT00094497|12075485|FG001|NOT COMPLETED|Overall Study||0
10909127|NCT00094536|12075491|FG000|STARTED|Inclusion Exclusion Evaluation||106
10909128|NCT00094536|12075491|FG000|COMPLETED|Inclusion Exclusion Evaluation||82
10909129|NCT00094536|12075491|FG000|NOT COMPLETED|Inclusion Exclusion Evaluation||24
10909130|NCT00094536|12075491|FG000|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
10909131|NCT00094536|12075491|FG000|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
10909132|NCT00094536|12075491|FG000|24 Month Follow-up|Treatment and Follow-up||53
10909133|NCT00094536|12075491|FG000|36 Month Follow-up|Treatment and Follow-up||51
10909134|NCT00094536|12075491|FG000|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
10909135|NCT00094536|12075491|FG000|NOT COMPLETED|Treatment and Follow-up||31
10909136|NCT00094575|12075497|FG000|STARTED|Overall Study||444
10909137|NCT00094575|12075498|FG001|STARTED|Overall Study||437
10909138|NCT00094575|12075497|FG000|COMPLETED|Overall Study||298
10909139|NCT00094575|12075498|FG001|COMPLETED|Overall Study||291
10909140|NCT00094575|12075497|FG000|NOT COMPLETED|Overall Study||146
10909141|NCT00094575|12075498|FG001|NOT COMPLETED|Overall Study||146
10909142|NCT00094653|12075509|FG000|STARTED|Overall Study||403
10909143|NCT00094653|12075510|FG001|STARTED|Overall Study||137
10909144|NCT00094653|12075511|FG002|STARTED|Overall Study||136
10909145|NCT00094653|12075509|FG000|Treated|Overall Study||381
10909146|NCT00094653|12075510|FG001|Treated|Overall Study||131
10909147|NCT00094653|12075511|FG002|Treated|Overall Study||131
10909148|NCT00094653|12075509|FG000|COMPLETED|Overall Study||82
10909149|NCT00094653|12075510|FG001|COMPLETED|Overall Study||31
10909150|NCT00094653|12075511|FG002|COMPLETED|Overall Study||10
10909151|NCT00094653|12075509|FG000|NOT COMPLETED|Overall Study||321
10909152|NCT00094653|12075510|FG001|NOT COMPLETED|Overall Study||106
10909153|NCT00094653|12075511|FG002|NOT COMPLETED|Overall Study||126
10909154|NCT00094757|12075523|FG000|STARTED|Overall Study||205
10909155|NCT00094757|12075524|FG001|STARTED|Overall Study||206
10909156|NCT00094757|12075525|FG002|STARTED|Overall Study||110
10909157|NCT00094757|12075523|FG000|COMPLETED|Overall Study||152
10909158|NCT00094757|12075524|FG001|COMPLETED|Overall Study||144
10909159|NCT00094757|12075525|FG002|COMPLETED|Overall Study||80
10909160|NCT00094757|12075523|FG000|NOT COMPLETED|Overall Study||53
10909161|NCT00094757|12075524|FG001|NOT COMPLETED|Overall Study||62
10909162|NCT00094757|12075525|FG002|NOT COMPLETED|Overall Study||30
10909163|NCT00094770|12075535|FG000|STARTED|Year 1 ( Week 0 to Week 52)||588
10909164|NCT00094770|12075536|FG001|STARTED|Year 1 ( Week 0 to Week 52)||584
10909165|NCT00094770|12075535|FG000|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
10909166|NCT00094770|12075536|FG001|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
10909167|NCT00094770|12075535|FG000|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
10909168|NCT00094770|12075536|FG001|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
10909169|NCT00094770|12075535|FG000|STARTED|Year 2 (Week 0 to Week 104)||588
10909170|NCT00094770|12075536|FG001|STARTED|Year 2 (Week 0 to Week 104)||584
10909171|NCT00094770|12075535|FG000|COMPLETED|Year 2 (Week 0 to Week 104)||255
10909172|NCT00094770|12075536|FG001|COMPLETED|Year 2 (Week 0 to Week 104)||264
10909173|NCT00094770|12075535|FG000|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
10909174|NCT00094770|12075536|FG001|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
10909175|NCT00094809|12075544|FG000|STARTED|Overall Study||126
10909176|NCT00094809|12075545|FG001|STARTED|Overall Study||126
10909177|NCT00094809|12075544|FG000|Received Study Drug|Overall Study||124
10909178|NCT00094809|12075545|FG001|Received Study Drug|Overall Study||118
10909179|NCT00094809|12075544|FG000|Properly Consented; Received Study Drug|Overall Study||123
10909180|NCT00094809|12075545|FG001|Properly Consented; Received Study Drug|Overall Study||118
10909181|NCT00094809|12075544|FG000|Completed All 4 Cycles of Treatment|Overall Study||98
10909182|NCT00094809|12075545|FG001|Completed All 4 Cycles of Treatment|Overall Study||90
10909183|NCT00094809|12075544|FG000|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
10909184|NCT00094809|12075545|FG001|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
10909185|NCT00094809|12075544|FG000|NOT COMPLETED|Overall Study||52
10909186|NCT00094809|12075545|FG001|NOT COMPLETED|Overall Study||65
10909187|NCT00094835|12075558|FG000|STARTED|Overall Study||9
10909188|NCT00094835|12075559|FG001|STARTED|Overall Study||11
10909189|NCT00094835|12075560|FG002|STARTED|Overall Study||7
10909190|NCT00094835|12075561|FG003|STARTED|Overall Study||5
10909191|NCT00094835|12075562|FG004|STARTED|Overall Study||7
10909192|NCT00094835|12075563|FG005|STARTED|Overall Study||6
10909193|NCT00094835|12075564|FG006|STARTED|Overall Study||6
10909194|NCT00094835|12075558|FG000|Treated With Motesanib|Overall Study||6
10909195|NCT00094835|12075559|FG001|Treated With Motesanib|Overall Study||11
10909196|NCT00094835|12075560|FG002|Treated With Motesanib|Overall Study||6
10909197|NCT00094835|12075561|FG003|Treated With Motesanib|Overall Study||4
10909198|NCT00094835|12075562|FG004|Treated With Motesanib|Overall Study||7
10909199|NCT00094835|12075563|FG005|Treated With Motesanib|Overall Study||5
10909200|NCT00094835|12075564|FG006|Treated With Motesanib|Overall Study||6
10909201|NCT00094835|12075558|FG000|COMPLETED|Overall Study||5
10909202|NCT00094835|12075559|FG001|COMPLETED|Overall Study||8
10909203|NCT00094835|12075560|FG002|COMPLETED|Overall Study||4
10909204|NCT00094835|12075561|FG003|COMPLETED|Overall Study||4
10909205|NCT00094835|12075562|FG004|COMPLETED|Overall Study||3
10909206|NCT00094835|12075563|FG005|COMPLETED|Overall Study||3
10909207|NCT00094835|12075564|FG006|COMPLETED|Overall Study||4
10909208|NCT00094835|12075558|FG000|NOT COMPLETED|Overall Study||4
10909209|NCT00094835|12075559|FG001|NOT COMPLETED|Overall Study||3
10909210|NCT00094835|12075560|FG002|NOT COMPLETED|Overall Study||3
10909211|NCT00094835|12075561|FG003|NOT COMPLETED|Overall Study||1
10909212|NCT00094835|12075562|FG004|NOT COMPLETED|Overall Study||4
10909213|NCT00094835|12075563|FG005|NOT COMPLETED|Overall Study||3
10909214|NCT00094835|12075564|FG006|NOT COMPLETED|Overall Study||2
10909215|NCT00094861|12075587|FG000|STARTED|Overall Study||46
10909216|NCT00094861|12075588|FG001|STARTED|Overall Study||49
10909217|NCT00094861|12075587|FG000|Participants Treated|Overall Study||46
10909218|NCT00094861|12075588|FG001|Participants Treated|Overall Study||48
10909219|NCT00094861|12075587|FG000|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
10909220|NCT00094861|12075588|FG001|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
10909221|NCT00094861|12075587|FG000|NOT COMPLETED|Overall Study||18
10909222|NCT00094861|12075588|FG001|NOT COMPLETED|Overall Study||9
10909223|NCT00094887|12075596|FG000|STARTED|Overall Study||75
10909224|NCT00094887|12075597|FG001|STARTED|Overall Study||75
10909225|NCT00094887|12075596|FG000|Safety Population|Overall Study||75
10909226|NCT00094887|12075597|FG001|Safety Population|Overall Study||75
10909227|NCT00094887|12075596|FG000|Intent to Treat Population|Overall Study||75
10909228|NCT00094887|12075597|FG001|Intent to Treat Population|Overall Study||75
10909229|NCT00094887|12075596|FG000|Per Protocol Analysis Set|Overall Study||71
10909230|NCT00094887|12075597|FG001|Per Protocol Analysis Set|Overall Study||71
10909231|NCT00094887|12075596|FG000|Primary Efficacy Population|Overall Study||65
10909232|NCT00094887|12075597|FG001|Primary Efficacy Population|Overall Study||64
10909233|NCT00094887|12075596|FG000|COMPLETED|Overall Study||71
10909234|NCT00094887|12075597|FG001|COMPLETED|Overall Study||71
10909235|NCT00094887|12075596|FG000|NOT COMPLETED|Overall Study||4
10909236|NCT00094887|12075597|FG001|NOT COMPLETED|Overall Study||4
10909237|NCT00094900|12075603|FG000|STARTED|Overall Study||11
10909238|NCT00094900|12075603|FG000|COMPLETED|Overall Study||10
10909239|NCT00094900|12075603|FG000|NOT COMPLETED|Overall Study||1
10909240|NCT00095056|12075609|FG000|STARTED|Phase A (Weeks 0-12)||65
10909241|NCT00095056|12075610|FG001|STARTED|Phase A (Weeks 0-12)||26
10909242|NCT00095056|12075609|FG000|COMPLETED|Phase A (Weeks 0-12)||58
10909243|NCT00095056|12075610|FG001|COMPLETED|Phase A (Weeks 0-12)||25
10909244|NCT00095056|12075609|FG000|NOT COMPLETED|Phase A (Weeks 0-12)||7
10909245|NCT00095056|12075610|FG001|NOT COMPLETED|Phase A (Weeks 0-12)||1
10909246|NCT00095056|12075609|FG000|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
10909247|NCT00095056|12075610|FG001|STARTED|Phase B (Weeks 12-54)||25
10909248|NCT00095056|12075609|FG000|COMPLETED|Phase B (Weeks 12-54)||46
10909249|NCT00095056|12075610|FG001|COMPLETED|Phase B (Weeks 12-54)||20
10909250|NCT00095056|12075609|FG000|NOT COMPLETED|Phase B (Weeks 12-54)||10
10909251|NCT00095056|12075610|FG001|NOT COMPLETED|Phase B (Weeks 12-54)||5
10909252|NCT00095121|12075618|FG000|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
10909253|NCT00095121|12075619|FG001|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
10909254|NCT00095121|12075618|FG000|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
10909255|NCT00095121|12075619|FG001|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
10909256|NCT00095121|12075618|FG000|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
10909257|NCT00095121|12075619|FG001|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
10909258|NCT00095121|12075618|FG000|STARTED|Open-Label (Study Weeks 49 Through 240)||108
10909259|NCT00095121|12075619|FG001|STARTED|Open-Label (Study Weeks 49 Through 240)||54
10909260|NCT00095121|12075618|FG000|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
10909261|NCT00095121|12075619|FG001|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
10909262|NCT00095121|12075618|FG000|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
10909263|NCT00095121|12075619|FG001|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
10909264|NCT00095121|12075618|FG000|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
10909265|NCT00095121|12075619|FG001|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
10909266|NCT00095147|12075638|FG000|STARTED|Double-blind Period 1 (Days 1-197)||156
10909267|NCT00095147|12075639|FG001|STARTED|Double-blind Period 1 (Days 1-197)||165
10909268|NCT00095147|12075640|FG002|STARTED|Double-blind Period 1 (Days 1-197)||110
10909269|NCT00095147|12075641|FG003|STARTED|Double-blind Period 1 (Days 1-197)||0
10909270|NCT00095147|12075642|FG004|STARTED|Double-blind Period 1 (Days 1-197)||0
10909271|NCT00095147|12075638|FG000|COMPLETED|Double-blind Period 1 (Days 1-197)||147
10909272|NCT00095147|12075639|FG001|COMPLETED|Double-blind Period 1 (Days 1-197)||152
10909273|NCT00095147|12075640|FG002|COMPLETED|Double-blind Period 1 (Days 1-197)||107
10909274|NCT00095147|12075641|FG003|COMPLETED|Double-blind Period 1 (Days 1-197)||0
10909275|NCT00095147|12075642|FG004|COMPLETED|Double-blind Period 1 (Days 1-197)||0
10909276|NCT00095147|12075638|FG000|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
10909277|NCT00095147|12075639|FG001|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
10909278|NCT00095147|12075640|FG002|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
10909279|NCT00095147|12075641|FG003|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
10909280|NCT00095147|12075642|FG004|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
10909281|NCT00095147|12075638|FG000|STARTED|Double-blind Period 2 (Days 198-365)||147
10909282|NCT00095147|12075639|FG001|STARTED|Double-blind Period 2 (Days 198-365)||152
10909283|NCT00095147|12075640|FG002|STARTED|Double-blind Period 2 (Days 198-365)||0
10909284|NCT00095147|12075641|FG003|STARTED|Double-blind Period 2 (Days 198-365)||107
10909285|NCT00095147|12075642|FG004|STARTED|Double-blind Period 2 (Days 198-365)||0
10909286|NCT00095147|12075638|FG000|COMPLETED|Double-blind Period 2 (Days 198-365)||139
10909287|NCT00095147|12075639|FG001|COMPLETED|Double-blind Period 2 (Days 198-365)||141
10909288|NCT00095147|12075640|FG002|COMPLETED|Double-blind Period 2 (Days 198-365)||0
10909289|NCT00095147|12075641|FG003|COMPLETED|Double-blind Period 2 (Days 198-365)||104
10909290|NCT00095147|12075642|FG004|COMPLETED|Double-blind Period 2 (Days 198-365)||0
10909291|NCT00095147|12075638|FG000|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
10909292|NCT00095147|12075639|FG001|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
10909293|NCT00095147|12075640|FG002|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
10909294|NCT00095147|12075641|FG003|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
10909295|NCT00095147|12075642|FG004|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
10909296|NCT00095147|12075638|FG000|STARTED|Long-term Extension Period||0
10909297|NCT00095147|12075639|FG001|STARTED|Long-term Extension Period||0
10909298|NCT00095147|12075640|FG002|STARTED|Long-term Extension Period||0
10909299|NCT00095147|12075641|FG003|STARTED|Long-term Extension Period||0
10909300|NCT00095147|12075642|FG004|STARTED|Long-term Extension Period||372
10909301|NCT00095147|12075638|FG000|COMPLETED|Long-term Extension Period||0
10909302|NCT00095147|12075639|FG001|COMPLETED|Long-term Extension Period||0
10909303|NCT00095147|12075640|FG002|COMPLETED|Long-term Extension Period||0
10909304|NCT00095147|12075641|FG003|COMPLETED|Long-term Extension Period||0
10909305|NCT00095147|12075642|FG004|COMPLETED|Long-term Extension Period||327
10909306|NCT00095147|12075638|FG000|NOT COMPLETED|Long-term Extension Period||0
10909307|NCT00095147|12075639|FG001|NOT COMPLETED|Long-term Extension Period||0
10909308|NCT00095147|12075640|FG002|NOT COMPLETED|Long-term Extension Period||0
10909309|NCT00095147|12075641|FG003|NOT COMPLETED|Long-term Extension Period||0
10909310|NCT00095147|12075642|FG004|NOT COMPLETED|Long-term Extension Period||45
10909311|NCT00095173|12075660|FG000|STARTED|Open-Label Lead-In Phase (Period A)||190
10909312|NCT00095173|12075661|FG001|STARTED|Open-Label Lead-In Phase (Period A)||0
10909313|NCT00095173|12075662|FG002|STARTED|Open-Label Lead-In Phase (Period A)||0
10909314|NCT00095173|12075663|FG003|STARTED|Open-Label Lead-In Phase (Period A)||0
10909315|NCT00095173|12075664|FG004|STARTED|Open-Label Lead-In Phase (Period A)||0
10909316|NCT00095173|12075665|FG005|STARTED|Open-Label Lead-In Phase (Period A)||0
10909317|NCT00095173|12075660|FG000|COMPLETED|Open-Label Lead-In Phase (Period A)||170
10909318|NCT00095173|12075661|FG001|COMPLETED|Open-Label Lead-In Phase (Period A)||0
10909319|NCT00095173|12075662|FG002|COMPLETED|Open-Label Lead-In Phase (Period A)||0
10909320|NCT00095173|12075663|FG003|COMPLETED|Open-Label Lead-In Phase (Period A)||0
10909321|NCT00095173|12075664|FG004|COMPLETED|Open-Label Lead-In Phase (Period A)||0
10909322|NCT00095173|12075665|FG005|COMPLETED|Open-Label Lead-In Phase (Period A)||0
10909323|NCT00095173|12075660|FG000|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
10909324|NCT00095173|12075661|FG001|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
10909325|NCT00095173|12075662|FG002|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
10909326|NCT00095173|12075663|FG003|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
10909327|NCT00095173|12075664|FG004|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
10909328|NCT00095173|12075665|FG005|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
10909329|NCT00095173|12075660|FG000|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
10909330|NCT00095173|12075661|FG001|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
10909331|NCT00095173|12075662|FG002|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
10909332|NCT00095173|12075663|FG003|STARTED|Double-Blind Phase (Period B)||0
10909333|NCT00095173|12075664|FG004|STARTED|Double-Blind Phase (Period B)||0
10909334|NCT00095173|12075665|FG005|STARTED|Double-Blind Phase (Period B)||0
10909335|NCT00095173|12075660|FG000|COMPLETED|Double-Blind Phase (Period B)||0
10909336|NCT00095173|12075661|FG001|COMPLETED|Double-Blind Phase (Period B)||49
10909337|NCT00095173|12075662|FG002|COMPLETED|Double-Blind Phase (Period B)||31
10909338|NCT00095173|12075663|FG003|COMPLETED|Double-Blind Phase (Period B)||0
10909339|NCT00095173|12075664|FG004|COMPLETED|Double-Blind Phase (Period B)||0
10909340|NCT00095173|12075665|FG005|COMPLETED|Double-Blind Phase (Period B)||0
10909341|NCT00095173|12075660|FG000|NOT COMPLETED|Double-Blind Phase (Period B)||0
10909342|NCT00095173|12075661|FG001|NOT COMPLETED|Double-Blind Phase (Period B)||11
10909343|NCT00095173|12075662|FG002|NOT COMPLETED|Double-Blind Phase (Period B)||31
10909344|NCT00095173|12075663|FG003|NOT COMPLETED|Double-Blind Phase (Period B)||0
10909345|NCT00095173|12075664|FG004|NOT COMPLETED|Double-Blind Phase (Period B)||0
10909346|NCT00095173|12075665|FG005|NOT COMPLETED|Double-Blind Phase (Period B)||0
10909347|NCT00095173|12075660|FG000|STARTED|Open-Label Extension Phase (Period C)||0
10909348|NCT00095173|12075661|FG001|STARTED|Open-Label Extension Phase (Period C)||0
10909349|NCT00095173|12075662|FG002|STARTED|Open-Label Extension Phase (Period C)||0
10909350|NCT00095173|12075663|FG003|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
10909351|NCT00095173|12075664|FG004|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
10909352|NCT00095173|12075665|FG005|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
10909353|NCT00095173|12075660|FG000|COMPLETED|Open-Label Extension Phase (Period C)||0
10909354|NCT00095173|12075661|FG001|COMPLETED|Open-Label Extension Phase (Period C)||0
10909355|NCT00095173|12075662|FG002|COMPLETED|Open-Label Extension Phase (Period C)||0
10909356|NCT00095173|12075663|FG003|COMPLETED|Open-Label Extension Phase (Period C)||13
10909357|NCT00095173|12075664|FG004|COMPLETED|Open-Label Extension Phase (Period C)||29
10909358|NCT00095173|12075665|FG005|COMPLETED|Open-Label Extension Phase (Period C)||27
10909359|NCT00095173|12075660|FG000|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
10909360|NCT00095173|12075661|FG001|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
10909361|NCT00095173|12075662|FG002|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
10909362|NCT00095173|12075663|FG003|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
10909363|NCT00095173|12075664|FG004|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
10909364|NCT00095173|12075665|FG005|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
10909365|NCT00095199|12075683|FG000|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
10909366|NCT00095199|12075684|FG001|STARTED|Overall Study||304
10909367|NCT00095199|12075685|FG002|STARTED|Overall Study||167
10909368|NCT00095199|12075686|FG003|STARTED|Overall Study||166
10909369|NCT00095199|12075683|FG000|COMPLETED|Overall Study||6
10909370|NCT00095199|12075684|FG001|COMPLETED|Overall Study||62
10909371|NCT00095199|12075685|FG002|COMPLETED|Overall Study||7
10909372|NCT00095199|12075686|FG003|COMPLETED|Overall Study||23
10909373|NCT00095199|12075683|FG000|NOT COMPLETED|Overall Study||296
10909374|NCT00095199|12075684|FG001|NOT COMPLETED|Overall Study||242
10909375|NCT00095199|12075685|FG002|NOT COMPLETED|Overall Study||160
10909376|NCT00095199|12075686|FG003|NOT COMPLETED|Overall Study||143
10909377|NCT00095212|12075703|FG000|STARTED|Overall Study||13
10909378|NCT00095212|12075704|FG001|STARTED|Overall Study||12
10909379|NCT00095212|12075703|FG000|COMPLETED|Overall Study||12
10909380|NCT00095212|12075704|FG001|COMPLETED|Overall Study||9
10909381|NCT00095212|12075703|FG000|NOT COMPLETED|Overall Study||1
10909382|NCT00095212|12075704|FG001|NOT COMPLETED|Overall Study||3
10909383|NCT00095238|12075712|FG000|STARTED|Overall Study|number randomized|2067
10909384|NCT00095238|12075713|FG001|STARTED|Overall Study|number randomized|2061
10909385|NCT00095238|12075712|FG000|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
10909386|NCT00095238|12075713|FG001|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
10909387|NCT00095238|12075712|FG000|COMPLETED|Overall Study|completed double-blind therapy|1210
10909388|NCT00095238|12075713|FG001|COMPLETED|Overall Study|completed double-blind therapy|1209
10909389|NCT00095238|12075712|FG000|NOT COMPLETED|Overall Study||857
10909390|NCT00095238|12075713|FG001|NOT COMPLETED|Overall Study||852
10909391|NCT00095303|12075753|FG000|STARTED|Main Study||245
10909392|NCT00095303|12075754|FG001|STARTED|Main Study||235
10909393|NCT00095303|12075753|FG000|COMPLETED|Main Study||154
10909394|NCT00095303|12075754|FG001|COMPLETED|Main Study||148
10909395|NCT00095303|12075753|FG000|NOT COMPLETED|Main Study||91
10909396|NCT00095303|12075754|FG001|NOT COMPLETED|Main Study||87
10909397|NCT00095303|12075753|FG000|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
10909398|NCT00095303|12075754|FG001|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
10909399|NCT00095303|12075753|FG000|COMPLETED|Follow Up Study||140
10909400|NCT00095303|12075754|FG001|COMPLETED|Follow Up Study||121
10909401|NCT00095303|12075753|FG000|NOT COMPLETED|Follow Up Study||59
10909402|NCT00095303|12075754|FG001|NOT COMPLETED|Follow Up Study||58
10909403|NCT00095498|12075763|FG000|STARTED|Overall Study||76
10909404|NCT00095498|12075764|FG001|STARTED|Overall Study||73
10909405|NCT00095498|12075765|FG002|STARTED|Overall Study||78
10909406|NCT00095498|12075763|FG000|Received Investigational Product|Overall Study||72
10909407|NCT00095498|12075764|FG001|Received Investigational Product|Overall Study||71
10909408|NCT00095498|12075765|FG002|Received Investigational Product|Overall Study||75
10909409|NCT00095498|12075763|FG000|COMPLETED|Overall Study||39
10909410|NCT00095498|12075764|FG001|COMPLETED|Overall Study||38
10909411|NCT00095498|12075765|FG002|COMPLETED|Overall Study||39
10909412|NCT00095498|12075763|FG000|NOT COMPLETED|Overall Study||37
10909413|NCT00095498|12075764|FG001|NOT COMPLETED|Overall Study||35
10909414|NCT00095498|12075765|FG002|NOT COMPLETED|Overall Study||39
10909415|NCT00095563|12075773|FG000|STARTED|Overall Study||39
10909416|NCT00095563|12075773|FG000|COMPLETED|Overall Study||39
10909417|NCT00095563|12075773|FG000|NOT COMPLETED|Overall Study||0
10909418|NCT00095576|12075779|FG000|STARTED|Overall Study||1484
10909419|NCT00095576|12075780|FG001|STARTED|Overall Study||1495
10909420|NCT00095576|12075779|FG000|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
10909421|NCT00095576|12075780|FG001|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
10909422|NCT00095576|12075779|FG000|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
10909423|NCT00095576|12075780|FG001|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
10909424|NCT00095576|12075779|FG000|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
10909425|NCT00095576|12075780|FG001|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
10909426|NCT00095576|12075779|FG000|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
10909427|NCT00095576|12075780|FG001|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
10909428|NCT00095576|12075779|FG000|NOT COMPLETED|Overall Study||1475
10909429|NCT00095576|12075780|FG001|NOT COMPLETED|Overall Study||1481
10909430|NCT00095628|12075786|FG000|STARTED|Overall Study||21
10909431|NCT00095628|12075786|FG000|COMPLETED|Overall Study||20
10909432|NCT00095628|12075786|FG000|NOT COMPLETED|Overall Study||1
10909433|NCT00095836|12075790|FG000|STARTED|Overall Study||27
10909434|NCT00095836|12075790|FG000|COMPLETED|Overall Study||23
10909435|NCT00095836|12075790|FG000|NOT COMPLETED|Overall Study||4
10909436|NCT00095875|12075796|FG000|STARTED|Overall Study||70
10909437|NCT00095875|12075797|FG001|STARTED|Overall Study||75
10909438|NCT00095875|12075796|FG000|COMPLETED|Overall Study||56
10909439|NCT00095875|12075797|FG001|COMPLETED|Overall Study||66
10909440|NCT00095875|12075796|FG000|NOT COMPLETED|Overall Study||14
10909441|NCT00095875|12075797|FG001|NOT COMPLETED|Overall Study||9
10909442|NCT00095940|12075810|FG000|STARTED|Molecular Biology Phase||2
10909443|NCT00095940|12075811|FG001|STARTED|Molecular Biology Phase||2
10909444|NCT00095940|12075812|FG002|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
10909445|NCT00095940|12075813|FG003|STARTED|Molecular Biology Phase||0
10909446|NCT00095940|12075814|FG004|STARTED|Molecular Biology Phase||0
10909447|NCT00095940|12075815|FG005|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
10909448|NCT00095940|12075816|FG006|STARTED|Molecular Biology Phase||2
10909449|NCT00095940|12075817|FG007|STARTED|Molecular Biology Phase||2
10909450|NCT00095940|12075818|FG008|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
10909451|NCT00095940|12075810|FG000|COMPLETED|Molecular Biology Phase||2
10909452|NCT00095940|12075811|FG001|COMPLETED|Molecular Biology Phase||2
10909453|NCT00095940|12075812|FG002|COMPLETED|Molecular Biology Phase||0
10909454|NCT00095940|12075813|FG003|COMPLETED|Molecular Biology Phase||0
10909455|NCT00095940|12075814|FG004|COMPLETED|Molecular Biology Phase||0
10909456|NCT00095940|12075815|FG005|COMPLETED|Molecular Biology Phase||0
10909457|NCT00095940|12075816|FG006|COMPLETED|Molecular Biology Phase||2
10909458|NCT00095940|12075817|FG007|COMPLETED|Molecular Biology Phase||2
10909459|NCT00095940|12075818|FG008|COMPLETED|Molecular Biology Phase||0
10909460|NCT00095940|12075810|FG000|NOT COMPLETED|Molecular Biology Phase||0
10909461|NCT00095940|12075811|FG001|NOT COMPLETED|Molecular Biology Phase||0
10909462|NCT00095940|12075812|FG002|NOT COMPLETED|Molecular Biology Phase||0
10909463|NCT00095940|12075813|FG003|NOT COMPLETED|Molecular Biology Phase||0
10909464|NCT00095940|12075814|FG004|NOT COMPLETED|Molecular Biology Phase||0
10909465|NCT00095940|12075815|FG005|NOT COMPLETED|Molecular Biology Phase||0
10909466|NCT00095940|12075816|FG006|NOT COMPLETED|Molecular Biology Phase||0
10909467|NCT00095940|12075817|FG007|NOT COMPLETED|Molecular Biology Phase||0
10909468|NCT00095940|12075818|FG008|NOT COMPLETED|Molecular Biology Phase||0
10909469|NCT00095940|12075810|FG000|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
10909470|NCT00095940|12075811|FG001|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
10909471|NCT00095940|12075812|FG002|STARTED|Lapatinib Continuation/Phase II||17
10909472|NCT00095940|12075813|FG003|STARTED|Lapatinib Continuation/Phase II||0
10909473|NCT00095940|12075814|FG004|STARTED|Lapatinib Continuation/Phase II||0
10909474|NCT00095940|12075815|FG005|STARTED|Lapatinib Continuation/Phase II||13
10909475|NCT00095940|12075816|FG006|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
10909476|NCT00095940|12075817|FG007|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
10909477|NCT00095940|12075818|FG008|STARTED|Lapatinib Continuation/Phase II||14
10909478|NCT00095940|12075810|FG000|COMPLETED|Lapatinib Continuation/Phase II||0
10909479|NCT00095940|12075811|FG001|COMPLETED|Lapatinib Continuation/Phase II||0
10909480|NCT00095940|12075812|FG002|COMPLETED|Lapatinib Continuation/Phase II||1
10909481|NCT00095940|12075813|FG003|COMPLETED|Lapatinib Continuation/Phase II||0
10909482|NCT00095940|12075814|FG004|COMPLETED|Lapatinib Continuation/Phase II||0
10909483|NCT00095940|12075815|FG005|COMPLETED|Lapatinib Continuation/Phase II||0
10909484|NCT00095940|12075816|FG006|COMPLETED|Lapatinib Continuation/Phase II||0
10909485|NCT00095940|12075817|FG007|COMPLETED|Lapatinib Continuation/Phase II||0
10909486|NCT00095940|12075818|FG008|COMPLETED|Lapatinib Continuation/Phase II||1
10909487|NCT00095940|12075810|FG000|NOT COMPLETED|Lapatinib Continuation/Phase II||2
10909488|NCT00095940|12075811|FG001|NOT COMPLETED|Lapatinib Continuation/Phase II||2
10909489|NCT00095940|12075812|FG002|NOT COMPLETED|Lapatinib Continuation/Phase II||16
10909490|NCT00095940|12075813|FG003|NOT COMPLETED|Lapatinib Continuation/Phase II||0
10909491|NCT00095940|12075814|FG004|NOT COMPLETED|Lapatinib Continuation/Phase II||0
10909492|NCT00095940|12075815|FG005|NOT COMPLETED|Lapatinib Continuation/Phase II||13
10909493|NCT00095940|12075816|FG006|NOT COMPLETED|Lapatinib Continuation/Phase II||2
10909494|NCT00095940|12075817|FG007|NOT COMPLETED|Lapatinib Continuation/Phase II||2
10909495|NCT00095940|12075818|FG008|NOT COMPLETED|Lapatinib Continuation/Phase II||13
10909496|NCT00095979|12075836|FG000|STARTED|Overall Study||52
10909497|NCT00095979|12075836|FG000|COMPLETED|Overall Study||50
10909498|NCT00095979|12075836|FG000|NOT COMPLETED|Overall Study||2
10909499|NCT00096018|12075847|FG000|STARTED|Overall Study||13
10909500|NCT00096018|12075848|FG001|STARTED|Overall Study||30
10909501|NCT00096018|12075847|FG000|Treated With Study Therapy|Overall Study||13
10909502|NCT00096018|12075848|FG001|Treated With Study Therapy|Overall Study||25
10909503|NCT00096018|12075847|FG000|COMPLETED|Overall Study||11
10909504|NCT00096018|12075848|FG001|COMPLETED|Overall Study||16
10909505|NCT00096018|12075847|FG000|NOT COMPLETED|Overall Study||2
10909506|NCT00096018|12075848|FG001|NOT COMPLETED|Overall Study||14
10909507|NCT00096031|12075854|FG000|STARTED|Overall Study||63
10909508|NCT00096031|12075854|FG000|Eligible|Overall Study||57
10909509|NCT00096031|12075854|FG000|Eligible and Began Protocol Therapy|Overall Study||55
10909510|NCT00096031|12075854|FG000|COMPLETED|Overall Study||0
10909511|NCT00096031|12075854|FG000|NOT COMPLETED|Overall Study||63
10909512|NCT00096044|12075858|FG000|STARTED|Overall Study||45
10909513|NCT00096044|12075858|FG000|COMPLETED|Overall Study||11
10909514|NCT00096044|12075858|FG000|NOT COMPLETED|Overall Study||34
10909515|NCT00096109|12075862|FG000|STARTED|Overall Study||11
10909516|NCT00096109|12075862|FG000|COMPLETED|Overall Study||11
10909517|NCT00096109|12075862|FG000|NOT COMPLETED|Overall Study||0
10909518|NCT00096122|12075866|FG000|STARTED|Overall Study||95
10909519|NCT00096122|12075866|FG000|COMPLETED|Overall Study||95
10909520|NCT00096122|12075866|FG000|NOT COMPLETED|Overall Study||0
10909521|NCT00096135|12075872|FG000|STARTED|Overall Study||126
10909522|NCT00096135|12075873|FG001|STARTED|Overall Study||42
10909523|NCT00096135|12075872|FG000|COMPLETED|Overall Study||63
10909524|NCT00096135|12075873|FG001|COMPLETED|Overall Study||27
10909525|NCT00096135|12075872|FG000|NOT COMPLETED|Overall Study||63
10909526|NCT00096135|12075873|FG001|NOT COMPLETED|Overall Study||15
10909527|NCT00096161|12075883|FG000|STARTED|Overall Study||20
10909528|NCT00096161|12075884|FG001|STARTED|Overall Study||10
10909529|NCT00096161|12075885|FG002|STARTED|Overall Study||6
10909530|NCT00096161|12075886|FG003|STARTED|Overall Study||0
10909531|NCT00096161|12075883|FG000|COMPLETED|Overall Study||20
10909532|NCT00096161|12075884|FG001|COMPLETED|Overall Study||10
10909533|NCT00096161|12075885|FG002|COMPLETED|Overall Study||6
10909534|NCT00096161|12075886|FG003|COMPLETED|Overall Study||0
10909535|NCT00096161|12075883|FG000|NOT COMPLETED|Overall Study||0
10909536|NCT00096161|12075884|FG001|NOT COMPLETED|Overall Study||0
10909537|NCT00096161|12075885|FG002|NOT COMPLETED|Overall Study||0
10909538|NCT00096161|12075886|FG003|NOT COMPLETED|Overall Study||0
10909539|NCT00096174|12075896|FG000|STARTED|Overall Study||69
10909540|NCT00096174|12075896|FG000|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
10909541|NCT00096174|12075896|FG000|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
10909542|NCT00096174|12075896|FG000|COMPLETED|Overall Study||7
10909543|NCT00096174|12075896|FG000|NOT COMPLETED|Overall Study||62
10909544|NCT00096226|12075900|FG000|STARTED|Overall Study||60
10909545|NCT00096226|12075900|FG000|Eligible|Overall Study||57
10909546|NCT00096226|12075900|FG000|Eligible and Underwent Surgery|Overall Study||37
10909547|NCT00096226|12075900|FG000|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57
10909548|NCT00096226|12075900|FG000|NOT COMPLETED|Overall Study||3
10909549|NCT00096265|12075907|FG000|STARTED|Overall Study||45
10909550|NCT00096265|12075908|FG001|STARTED|Overall Study||40
10909551|NCT00096265|12075909|FG002|STARTED|Overall Study||41
10909552|NCT00096265|12075907|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
10909553|NCT00096265|12075908|FG001|COMPLETED|Overall Study||40
10909554|NCT00096265|12075909|FG002|COMPLETED|Overall Study||41
10909555|NCT00096265|12075907|FG000|NOT COMPLETED|Overall Study||1
10909556|NCT00096265|12075908|FG001|NOT COMPLETED|Overall Study||0
10909557|NCT00096265|12075909|FG002|NOT COMPLETED|Overall Study||0
10909558|NCT00096278|12075920|FG000|STARTED|Overall Study||1356
10909559|NCT00096278|12075921|FG001|STARTED|Overall Study||1354
10909560|NCT00096278|12075920|FG000|COMPLETED|Overall Study||1338
10909561|NCT00096278|12075921|FG001|COMPLETED|Overall Study||1334
10909562|NCT00096278|12075920|FG000|NOT COMPLETED|Overall Study||18
10909563|NCT00096278|12075921|FG001|NOT COMPLETED|Overall Study||20
10909564|NCT00096356|12075931|FG000|STARTED|Overall Study||122
10909565|NCT00096356|12075932|FG001|STARTED|Overall Study||114
10909566|NCT00096356|12075931|FG000|COMPLETED|Overall Study||78
10909567|NCT00096356|12075932|FG001|COMPLETED|Overall Study||61
10909568|NCT00096356|12075931|FG000|NOT COMPLETED|Overall Study||44
10909569|NCT00096356|12075932|FG001|NOT COMPLETED|Overall Study||53
10909570|NCT00096382|12075941|FG000|STARTED|Overall Study||23
10909571|NCT00096382|12075942|FG001|STARTED|Overall Study||3
10909572|NCT00096382|12075941|FG000|COMPLETED|Overall Study||21
10909573|NCT00096382|12075942|FG001|COMPLETED|Overall Study||3
10909574|NCT00096382|12075941|FG000|NOT COMPLETED|Overall Study||2
10909575|NCT00096382|12075942|FG001|NOT COMPLETED|Overall Study||0
10909576|NCT00096447|12075948|FG000|STARTED|Overall Study||31
10909577|NCT00096447|12075948|FG000|COMPLETED|Overall Study|Eligible and treated patients.|30
10909578|NCT00096447|12075948|FG000|NOT COMPLETED|Overall Study||1
10909579|NCT00096460|12075959|FG000|STARTED|Overall Study||22
10909580|NCT00096460|12075960|FG001|STARTED|Overall Study||8
10909581|NCT00096460|12075959|FG000|COMPLETED|Overall Study||15
10909582|NCT00096460|12075960|FG001|COMPLETED|Overall Study||7
10909583|NCT00096460|12075959|FG000|NOT COMPLETED|Overall Study||7
10909584|NCT00096460|12075960|FG001|NOT COMPLETED|Overall Study||1
10909585|NCT00096486|12075970|FG000|STARTED|Overall Study||4
10909586|NCT00096486|12075971|FG001|STARTED|Overall Study||6
10909587|NCT00096486|12075972|FG002|STARTED|Overall Study||26
10909588|NCT00096486|12075973|FG003|STARTED|Overall Study||38
10909589|NCT00096486|12075970|FG000|COMPLETED|Overall Study||4
10909590|NCT00096486|12075971|FG001|COMPLETED|Overall Study||6
10909591|NCT00096486|12075972|FG002|COMPLETED|Overall Study||24
10909592|NCT00096486|12075973|FG003|COMPLETED|Overall Study||36
10909593|NCT00096486|12075970|FG000|NOT COMPLETED|Overall Study||0
10909594|NCT00096486|12075971|FG001|NOT COMPLETED|Overall Study||0
10909595|NCT00096486|12075972|FG002|NOT COMPLETED|Overall Study||2
10909596|NCT00096486|12075973|FG003|NOT COMPLETED|Overall Study||2
10909597|NCT00096538|12075983|FG000|STARTED|Overall Study||6
10909598|NCT00096538|12075983|FG000|COMPLETED|Overall Study||5
10909599|NCT00096538|12075983|FG000|NOT COMPLETED|Overall Study||1
10909600|NCT00096681|12075987|FG000|STARTED|Overall Study||762
10909601|NCT00096681|12075987|FG000|COMPLETED|Overall Study||762
10909602|NCT00096681|12075987|FG000|NOT COMPLETED|Overall Study||0
10909603|NCT00096785|12075993|FG000|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
10909604|NCT00096785|12075994|FG001|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
10909605|NCT00096785|12075993|FG000|As-Randomized Population|Overall Study||35
10909606|NCT00096785|12075994|FG001|As-Randomized Population|Overall Study||34
10909607|NCT00096785|12075993|FG000|As-Treated Population|Overall Study||36
10909608|NCT00096785|12075994|FG001|As-Treated Population|Overall Study||33
10909609|NCT00096785|12075993|FG000|COMPLETED|Overall Study|As randomized cohort|33
10909610|NCT00096785|12075994|FG001|COMPLETED|Overall Study|As randomized cohort|33
10909611|NCT00096785|12075993|FG000|NOT COMPLETED|Overall Study||2
10909612|NCT00096785|12075994|FG001|NOT COMPLETED|Overall Study||1
10909613|NCT00096941|12076000|FG000|STARTED|Overall Study||3
10909614|NCT00096941|12076000|FG000|COMPLETED|Overall Study||0
10909615|NCT00096941|12076000|FG000|NOT COMPLETED|Overall Study||3
10909616|NCT00096954|12076006|FG000|STARTED|Overall Study||159
10909617|NCT00096954|12076007|FG001|STARTED|Overall Study||174
10909618|NCT00096954|12076006|FG000|Received Study Drug|Overall Study||157
10909619|NCT00096954|12076007|FG001|Received Study Drug|Overall Study||171
10909620|NCT00096954|12076006|FG000|COMPLETED|Overall Study||135
10909621|NCT00096954|12076007|FG001|COMPLETED|Overall Study||154
10909622|NCT00096954|12076006|FG000|NOT COMPLETED|Overall Study||24
10909623|NCT00096954|12076007|FG001|NOT COMPLETED|Overall Study||20
10909624|NCT00096993|12076015|FG000|STARTED|Overall Study||66
10909625|NCT00096993|12076016|FG001|STARTED|Overall Study||65
10909626|NCT00096993|12076015|FG000|COMPLETED|Overall Study||1
10909627|NCT00096993|12076016|FG001|COMPLETED|Overall Study||0
10909628|NCT00096993|12076015|FG000|NOT COMPLETED|Overall Study||65
10909629|NCT00096993|12076016|FG001|NOT COMPLETED|Overall Study||65
10909630|NCT00097253|12076022|FG000|STARTED|Lavender||56
10909631|NCT00097253|12076022|FG000|COMPLETED|Lavender||56
10909632|NCT00097253|12076022|FG000|NOT COMPLETED|Lavender||0
10909633|NCT00097253|12076022|FG000|STARTED|Lemon||56
10909634|NCT00097253|12076022|FG000|COMPLETED|Lemon||56
10909635|NCT00097253|12076022|FG000|NOT COMPLETED|Lemon||0
10909636|NCT00097253|12076022|FG000|STARTED|Water (Control)||56
10909637|NCT00097253|12076022|FG000|COMPLETED|Water (Control)||56
10909638|NCT00097253|12076022|FG000|NOT COMPLETED|Water (Control)||0
10909639|NCT00097370|12076030|FG000|STARTED|Stage 1|Participants entered from study MHE100185.|37
10909640|NCT00097370|12076030|FG000|COMPLETED|Stage 1||31
10909641|NCT00097370|12076030|FG000|NOT COMPLETED|Stage 1||6
10909642|NCT00097370|12076030|FG000|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
10909643|NCT00097370|12076030|FG000|COMPLETED|Stage 2||59
10909644|NCT00097370|12076030|FG000|NOT COMPLETED|Stage 2||13
10909645|NCT00097370|12076030|FG000|STARTED|Stage 3|Participants continued from Stage 2.|59
10909646|NCT00097370|12076030|FG000|COMPLETED|Stage 3||0
10909647|NCT00097370|12076030|FG000|NOT COMPLETED|Stage 3||59
10909648|NCT00097448|12076036|FG000|STARTED|Overall Study||125
10909649|NCT00097448|12076037|FG001|STARTED|Overall Study||130
10909650|NCT00097448|12076036|FG000|COMPLETED|Overall Study||121
10909651|NCT00097448|12076037|FG001|COMPLETED|Overall Study||129
10909652|NCT00097448|12076036|FG000|NOT COMPLETED|Overall Study||4
10909653|NCT00097448|12076037|FG001|NOT COMPLETED|Overall Study||1
10909654|NCT00097500|12076045|FG000|STARTED|On-drug Period (Week 0 to Week 52)||36
10909655|NCT00097500|12076046|FG001|STARTED|On-drug Period (Week 0 to Week 52)||33
10909656|NCT00097500|12076045|FG000|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
10909657|NCT00097500|12076046|FG001|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
10909658|NCT00097500|12076045|FG000|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
10909659|NCT00097500|12076046|FG001|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
10909660|NCT00097500|12076045|FG000|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
10909661|NCT00097500|12076046|FG001|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
10909662|NCT00097500|12076045|FG000|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
10909663|NCT00097500|12076046|FG001|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
10909664|NCT00097500|12076045|FG000|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
10909665|NCT00097500|12076046|FG001|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
10909666|NCT00097539|12076059|FG000|STARTED|Overall Study||27286
10909667|NCT00097539|12076060|FG001|STARTED|Overall Study||9356
10909668|NCT00097539|12076061|FG002|STARTED|Overall Study||12519
10909669|NCT00097539|12076062|FG003|STARTED|Overall Study||5651
10909670|NCT00097539|12076063|FG004|STARTED|Overall Study||2144
10909671|NCT00097539|12076064|FG005|STARTED|Overall Study||8010
10909672|NCT00097539|12076065|FG006|STARTED|Overall Study||239
10909673|NCT00097539|12076059|FG000|COMPLETED|Overall Study||8220
10909674|NCT00097539|12076060|FG001|COMPLETED|Overall Study||2825
10909675|NCT00097539|12076061|FG002|COMPLETED|Overall Study||3411
10909676|NCT00097539|12076062|FG003|COMPLETED|Overall Study||2066
10909677|NCT00097539|12076063|FG004|COMPLETED|Overall Study||386
10909678|NCT00097539|12076064|FG005|COMPLETED|Overall Study||2118
10909679|NCT00097539|12076065|FG006|COMPLETED|Overall Study||68
10909680|NCT00097539|12076059|FG000|NOT COMPLETED|Overall Study||19066
10909681|NCT00097539|12076060|FG001|NOT COMPLETED|Overall Study||6531
10909682|NCT00097539|12076061|FG002|NOT COMPLETED|Overall Study||9108
10909683|NCT00097539|12076062|FG003|NOT COMPLETED|Overall Study||3585
10909684|NCT00097539|12076063|FG004|NOT COMPLETED|Overall Study||1758
10909685|NCT00097539|12076064|FG005|NOT COMPLETED|Overall Study||5892
10909686|NCT00097539|12076065|FG006|NOT COMPLETED|Overall Study||171
10909687|NCT00097591|12076083|FG000|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
10909688|NCT00097591|12076084|FG001|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
10909689|NCT00097591|12076083|FG000|COMPLETED|Overall Study||6403
10909690|NCT00097591|12076084|FG001|COMPLETED|Overall Study||6401
10909691|NCT00097591|12076083|FG000|NOT COMPLETED|Overall Study||410
10909692|NCT00097591|12076084|FG001|NOT COMPLETED|Overall Study||394
10909693|NCT00097669|12076092|FG000|STARTED|Overall Study||4089
10909694|NCT00097669|12076093|FG001|STARTED|Overall Study||4075
10909695|NCT00097669|12076092|FG000|COMPLETED|Overall Study||4089
10909696|NCT00097669|12076093|FG001|COMPLETED|Overall Study||4075
10909697|NCT00097669|12076092|FG000|NOT COMPLETED|Overall Study||0
10909698|NCT00097669|12076093|FG001|NOT COMPLETED|Overall Study||0
10909699|NCT00097695|12076103|FG000|STARTED|The Controlled Phase||27
10909700|NCT00097695|12076104|FG001|STARTED|The Controlled Phase||29
10909701|NCT00097695|12076105|FG002|STARTED|The Controlled Phase||8
10909702|NCT00097695|12076106|FG003|STARTED|The Controlled Phase||20
10909703|NCT00097695|12076103|FG000|COMPLETED|The Controlled Phase||23
10909704|NCT00097695|12076104|FG001|COMPLETED|The Controlled Phase||26
10909705|NCT00097695|12076105|FG002|COMPLETED|The Controlled Phase||3
10909706|NCT00097695|12076106|FG003|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
10909707|NCT00097695|12076103|FG000|NOT COMPLETED|The Controlled Phase||4
10909708|NCT00097695|12076104|FG001|NOT COMPLETED|The Controlled Phase||3
10909709|NCT00097695|12076105|FG002|NOT COMPLETED|The Controlled Phase||5
10909710|NCT00097695|12076106|FG003|NOT COMPLETED|The Controlled Phase||20
10909711|NCT00097695|12076103|FG000|STARTED|The Open Label Extension (OLE) Phase||23
10909712|NCT00097695|12076104|FG001|STARTED|The Open Label Extension (OLE) Phase||26
10909713|NCT00097695|12076105|FG002|STARTED|The Open Label Extension (OLE) Phase||3
10909714|NCT00097695|12076106|FG003|STARTED|The Open Label Extension (OLE) Phase||20
10909715|NCT00097695|12076103|FG000|COMPLETED|The Open Label Extension (OLE) Phase||10
10909716|NCT00097695|12076104|FG001|COMPLETED|The Open Label Extension (OLE) Phase||11
10909717|NCT00097695|12076105|FG002|COMPLETED|The Open Label Extension (OLE) Phase||1
10909718|NCT00097695|12076106|FG003|COMPLETED|The Open Label Extension (OLE) Phase||15
10909719|NCT00097695|12076103|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
10909720|NCT00097695|12076104|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
10909721|NCT00097695|12076105|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
10909722|NCT00097695|12076106|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
10909723|NCT00097708|12076121|FG000|STARTED|Overall Study||173
10909724|NCT00097708|12076122|FG001|STARTED|Overall Study||176
10909725|NCT00097708|12076123|FG002|STARTED|Overall Study||162
10909726|NCT00097708|12076121|FG000|Intent-to-Treat (ITT)|Overall Study||165
10909727|NCT00097708|12076122|FG001|Intent-to-Treat (ITT)|Overall Study||169
10909728|NCT00097708|12076123|FG002|Intent-to-Treat (ITT)|Overall Study||149
10909729|NCT00097708|12076121|FG000|Treated|Overall Study||171
10909730|NCT00097708|12076122|FG001|Treated|Overall Study||176
10909731|NCT00097708|12076123|FG002|Treated|Overall Study||160
10909732|NCT00097708|12076121|FG000|COMPLETED|Overall Study||109
10909733|NCT00097708|12076122|FG001|COMPLETED|Overall Study||120
10909734|NCT00097708|12076123|FG002|COMPLETED|Overall Study||97
10909735|NCT00097708|12076121|FG000|NOT COMPLETED|Overall Study||64
10909736|NCT00097708|12076122|FG001|NOT COMPLETED|Overall Study||56
10909737|NCT00097708|12076123|FG002|NOT COMPLETED|Overall Study||65
10909738|NCT00097721|12076133|FG000|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
10909739|NCT00097721|12076134|FG001|STARTED|Overall Study||33
10909740|NCT00097721|12076133|FG000|COMPLETED|Overall Study||0
10909741|NCT00097721|12076134|FG001|COMPLETED|Overall Study||0
10909742|NCT00097721|12076133|FG000|NOT COMPLETED|Overall Study||71
10909743|NCT00097721|12076134|FG001|NOT COMPLETED|Overall Study||33
10909744|NCT00097773|12076144|FG000|STARTED|Overall Study||76
10909745|NCT00097773|12076145|FG001|STARTED|Overall Study||76
10909746|NCT00097773|12076146|FG002|STARTED|Overall Study||76
10909747|NCT00097773|12076147|FG003|STARTED|Overall Study||76
10909748|NCT00097773|12076144|FG000|COMPLETED|Overall Study||68
10909749|NCT00097773|12076145|FG001|COMPLETED|Overall Study||68
10909750|NCT00097773|12076146|FG002|COMPLETED|Overall Study||68
10909751|NCT00097773|12076147|FG003|COMPLETED|Overall Study||73
10909752|NCT00097773|12076144|FG000|NOT COMPLETED|Overall Study||8
10909753|NCT00097773|12076145|FG001|NOT COMPLETED|Overall Study||8
10909754|NCT00097773|12076146|FG002|NOT COMPLETED|Overall Study||8
10909755|NCT00097773|12076147|FG003|NOT COMPLETED|Overall Study||3
10909756|NCT00097786|12076166|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
10909757|NCT00097786|12076167|FG001|STARTED|Overall Study||2315
10909758|NCT00097786|12076168|FG002|STARTED|Overall Study||2329
10909759|NCT00097786|12076169|FG003|STARTED|Overall Study||2346
10909760|NCT00097786|12076166|FG000|Complete FU for Progression to Diabetes|Overall Study||1709
10909761|NCT00097786|12076167|FG001|Complete FU for Progression to Diabetes|Overall Study||1712
10909762|NCT00097786|12076168|FG002|Complete FU for Progression to Diabetes|Overall Study||1734
10909763|NCT00097786|12076169|FG003|Complete FU for Progression to Diabetes|Overall Study||1762
10909764|NCT00097786|12076166|FG000|Complete Follow-up for Extended CV EPs|Overall Study||1969
10909765|NCT00097786|12076167|FG001|Complete Follow-up for Extended CV EPs|Overall Study||1985
10909766|NCT00097786|12076168|FG002|Complete Follow-up for Extended CV EPs|Overall Study||1987
10909767|NCT00097786|12076169|FG003|Complete Follow-up for Extended CV EPs|Overall Study||2015
10909768|NCT00097786|12076166|FG000|Complete Follow-up for Core CV EPs|Overall Study||1948
10909769|NCT00097786|12076167|FG001|Complete Follow-up for Core CV EPs|Overall Study||1963
10909770|NCT00097786|12076168|FG002|Complete Follow-up for Core CV EPs|Overall Study||1966
10909771|NCT00097786|12076169|FG003|Complete Follow-up for Core CV EPs|Overall Study||1988
10909772|NCT00097786|12076166|FG000|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
10909773|NCT00097786|12076167|FG001|COMPLETED|Overall Study||2023
10909774|NCT00097786|12076168|FG002|COMPLETED|Overall Study||2016
10909775|NCT00097786|12076169|FG003|COMPLETED|Overall Study||2036
10909776|NCT00097786|12076166|FG000|NOT COMPLETED|Overall Study||296
10909777|NCT00097786|12076167|FG001|NOT COMPLETED|Overall Study||292
10909778|NCT00097786|12076168|FG002|NOT COMPLETED|Overall Study||313
10909779|NCT00097786|12076169|FG003|NOT COMPLETED|Overall Study||310
10909780|NCT00097981|12076181|FG000|STARTED|Overall Study|Enrollment at randomization|113
10909781|NCT00097981|12076182|FG001|STARTED|Overall Study|Enrollment at randomization|112
10909782|NCT00097981|12076181|FG000|Received Study Medication|Overall Study||110
10909783|NCT00097981|12076182|FG001|Received Study Medication|Overall Study||106
10909784|NCT00097981|12076181|FG000|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
10909785|NCT00097981|12076182|FG001|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
10909786|NCT00097981|12076181|FG000|NOT COMPLETED|Overall Study||106
10909787|NCT00097981|12076182|FG001|NOT COMPLETED|Overall Study||100
10909788|NCT00098020|12076188|FG000|STARTED|Overall Study||12
10909789|NCT00098020|12076188|FG000|Started Isotretinoin|Overall Study||8
10909790|NCT00098020|12076188|FG000|COMPLETED|Overall Study||6
10909791|NCT00098020|12076188|FG000|NOT COMPLETED|Overall Study||6
10909792|NCT00098059|12076194|FG000|STARTED|Overall Study||27
10909793|NCT00098059|12076195|FG001|STARTED|Overall Study||47
10909794|NCT00098059|12076194|FG000|COMPLETED|Overall Study||27
10909795|NCT00098059|12076195|FG001|COMPLETED|Overall Study||46
10909796|NCT00098059|12076194|FG000|NOT COMPLETED|Overall Study||0
10909797|NCT00098059|12076195|FG001|NOT COMPLETED|Overall Study||1
10909798|NCT00098254|12076206|FG000|STARTED|Overall Study||37
10909799|NCT00098254|12076206|FG000|COMPLETED|Overall Study||34
10909800|NCT00098254|12076206|FG000|NOT COMPLETED|Overall Study||3
10909801|NCT00098293|12076213|FG000|STARTED|Double-blind (DB) Phase||177
10909802|NCT00098293|12076214|FG001|STARTED|Double-blind (DB) Phase||368
10909803|NCT00098293|12076215|FG002|STARTED|Double-blind (DB) Phase||372
10909804|NCT00098293|12076216|FG003|STARTED|Double-blind (DB) Phase||0
10909805|NCT00098293|12076217|FG004|STARTED|Double-blind (DB) Phase||0
10909806|NCT00098293|12076213|FG000|Treated|Double-blind (DB) Phase||174
10909807|NCT00098293|12076214|FG001|Treated|Double-blind (DB) Phase||360
10909808|NCT00098293|12076215|FG002|Treated|Double-blind (DB) Phase||361
10909809|NCT00098293|12076216|FG003|Treated|Double-blind (DB) Phase||0
10909810|NCT00098293|12076217|FG004|Treated|Double-blind (DB) Phase||0
10909811|NCT00098293|12076213|FG000|COMPLETED|Double-blind (DB) Phase||0
10909812|NCT00098293|12076214|FG001|COMPLETED|Double-blind (DB) Phase||202
10909813|NCT00098293|12076215|FG002|COMPLETED|Double-blind (DB) Phase||202
10909814|NCT00098293|12076216|FG003|COMPLETED|Double-blind (DB) Phase||0
10909815|NCT00098293|12076217|FG004|COMPLETED|Double-blind (DB) Phase||0
10909816|NCT00098293|12076213|FG000|NOT COMPLETED|Double-blind (DB) Phase||177
10909817|NCT00098293|12076214|FG001|NOT COMPLETED|Double-blind (DB) Phase||166
10909818|NCT00098293|12076215|FG002|NOT COMPLETED|Double-blind (DB) Phase||170
10909819|NCT00098293|12076216|FG003|NOT COMPLETED|Double-blind (DB) Phase||0
10909820|NCT00098293|12076217|FG004|NOT COMPLETED|Double-blind (DB) Phase||0
10909821|NCT00098293|12076213|FG000|STARTED|Between DB and OL Phase||0
10909822|NCT00098293|12076214|FG001|STARTED|Between DB and OL Phase||202
10909823|NCT00098293|12076215|FG002|STARTED|Between DB and OL Phase||202
10909824|NCT00098293|12076216|FG003|STARTED|Between DB and OL Phase||0
10909825|NCT00098293|12076217|FG004|STARTED|Between DB and OL Phase||0
10909826|NCT00098293|12076213|FG000|COMPLETED|Between DB and OL Phase||0
10909827|NCT00098293|12076214|FG001|COMPLETED|Between DB and OL Phase||202
10909828|NCT00098293|12076215|FG002|COMPLETED|Between DB and OL Phase||199
10909829|NCT00098293|12076216|FG003|COMPLETED|Between DB and OL Phase||0
10909830|NCT00098293|12076217|FG004|COMPLETED|Between DB and OL Phase||0
10909831|NCT00098293|12076213|FG000|NOT COMPLETED|Between DB and OL Phase||0
10909832|NCT00098293|12076214|FG001|NOT COMPLETED|Between DB and OL Phase||0
10909833|NCT00098293|12076215|FG002|NOT COMPLETED|Between DB and OL Phase||3
10909834|NCT00098293|12076216|FG003|NOT COMPLETED|Between DB and OL Phase||0
10909835|NCT00098293|12076217|FG004|NOT COMPLETED|Between DB and OL Phase||0
10909836|NCT00098293|12076213|FG000|STARTED|Open-label (OL) Phase||0
10909837|NCT00098293|12076214|FG001|STARTED|Open-label (OL) Phase||202
10909838|NCT00098293|12076215|FG002|STARTED|Open-label (OL) Phase||199
10909839|NCT00098293|12076216|FG003|STARTED|Open-label (OL) Phase||130
10909840|NCT00098293|12076217|FG004|STARTED|Open-label (OL) Phase||0
10909841|NCT00098293|12076213|FG000|COMPLETED|Open-label (OL) Phase||0
10909842|NCT00098293|12076214|FG001|COMPLETED|Open-label (OL) Phase||177
10909843|NCT00098293|12076215|FG002|COMPLETED|Open-label (OL) Phase||158
10909844|NCT00098293|12076216|FG003|COMPLETED|Open-label (OL) Phase||65
10909845|NCT00098293|12076217|FG004|COMPLETED|Open-label (OL) Phase||0
10909846|NCT00098293|12076213|FG000|NOT COMPLETED|Open-label (OL) Phase||0
10909847|NCT00098293|12076214|FG001|NOT COMPLETED|Open-label (OL) Phase||25
10909848|NCT00098293|12076215|FG002|NOT COMPLETED|Open-label (OL) Phase||41
10909849|NCT00098293|12076216|FG003|NOT COMPLETED|Open-label (OL) Phase||65
10909850|NCT00098293|12076217|FG004|NOT COMPLETED|Open-label (OL) Phase||0
10909851|NCT00098293|12076213|FG000|STARTED|Supplemental Phase (SP)||0
10909852|NCT00098293|12076214|FG001|STARTED|Supplemental Phase (SP)||0
10909853|NCT00098293|12076215|FG002|STARTED|Supplemental Phase (SP)||0
10909854|NCT00098293|12076216|FG003|STARTED|Supplemental Phase (SP)||0
10909855|NCT00098293|12076217|FG004|STARTED|Supplemental Phase (SP)||127
10909856|NCT00098293|12076213|FG000|COMPLETED|Supplemental Phase (SP)||0
10909857|NCT00098293|12076214|FG001|COMPLETED|Supplemental Phase (SP)||0
10909858|NCT00098293|12076215|FG002|COMPLETED|Supplemental Phase (SP)||0
10909859|NCT00098293|12076216|FG003|COMPLETED|Supplemental Phase (SP)||0
10909860|NCT00098293|12076217|FG004|COMPLETED|Supplemental Phase (SP)||94
10909861|NCT00098293|12076213|FG000|NOT COMPLETED|Supplemental Phase (SP)||0
10909862|NCT00098293|12076214|FG001|NOT COMPLETED|Supplemental Phase (SP)||0
10909863|NCT00098293|12076215|FG002|NOT COMPLETED|Supplemental Phase (SP)||0
10909864|NCT00098293|12076216|FG003|NOT COMPLETED|Supplemental Phase (SP)||0
10909865|NCT00098293|12076217|FG004|NOT COMPLETED|Supplemental Phase (SP)||33
10909866|NCT00098306|12076231|FG000|STARTED|Double Blind||241
10909867|NCT00098306|12076232|FG001|STARTED|Double Blind||240
10909868|NCT00098306|12076233|FG002|STARTED|Double Blind||120
10909869|NCT00098306|12076234|FG003|STARTED|Double Blind||0
10909870|NCT00098306|12076235|FG004|STARTED|Double Blind||0
10909871|NCT00098306|12076236|FG005|STARTED|Double Blind||0
10909872|NCT00098306|12076237|FG006|STARTED|Double Blind||0
10909873|NCT00098306|12076231|FG000|Treated|Double Blind||232
10909874|NCT00098306|12076232|FG001|Treated|Double Blind||235
10909875|NCT00098306|12076233|FG002|Treated|Double Blind||118
10909876|NCT00098306|12076234|FG003|Treated|Double Blind||0
10909877|NCT00098306|12076235|FG004|Treated|Double Blind||0
10909878|NCT00098306|12076236|FG005|Treated|Double Blind||0
10909879|NCT00098306|12076237|FG006|Treated|Double Blind||0
10909880|NCT00098306|12076231|FG000|COMPLETED|Double Blind||0
10909881|NCT00098306|12076232|FG001|COMPLETED|Double Blind||0
10909882|NCT00098306|12076233|FG002|COMPLETED|Double Blind||0
10909883|NCT00098306|12076234|FG003|COMPLETED|Double Blind||0
10909884|NCT00098306|12076235|FG004|COMPLETED|Double Blind||0
10909885|NCT00098306|12076236|FG005|COMPLETED|Double Blind||0
10909886|NCT00098306|12076237|FG006|COMPLETED|Double Blind||0
10909887|NCT00098306|12076231|FG000|NOT COMPLETED|Double Blind||241
10909888|NCT00098306|12076232|FG001|NOT COMPLETED|Double Blind||240
10909889|NCT00098306|12076233|FG002|NOT COMPLETED|Double Blind||120
10909890|NCT00098306|12076234|FG003|NOT COMPLETED|Double Blind||0
10909891|NCT00098306|12076235|FG004|NOT COMPLETED|Double Blind||0
10909892|NCT00098306|12076236|FG005|NOT COMPLETED|Double Blind||0
10909893|NCT00098306|12076237|FG006|NOT COMPLETED|Double Blind||0
10909894|NCT00098306|12076231|FG000|STARTED|Open Label||0
10909895|NCT00098306|12076232|FG001|STARTED|Open Label||0
10909896|NCT00098306|12076233|FG002|STARTED|Open Label||0
10909897|NCT00098306|12076234|FG003|STARTED|Open Label||327
10909898|NCT00098306|12076235|FG004|STARTED|Open Label||62
10909899|NCT00098306|12076236|FG005|STARTED|Open Label||0
10909900|NCT00098306|12076237|FG006|STARTED|Open Label||0
10909901|NCT00098306|12076231|FG000|COMPLETED|Open Label||0
10909902|NCT00098306|12076232|FG001|COMPLETED|Open Label||0
10909903|NCT00098306|12076233|FG002|COMPLETED|Open Label||0
10909904|NCT00098306|12076234|FG003|COMPLETED|Open Label||0
10909905|NCT00098306|12076235|FG004|COMPLETED|Open Label||0
10909906|NCT00098306|12076236|FG005|COMPLETED|Open Label||0
10909907|NCT00098306|12076237|FG006|COMPLETED|Open Label||0
10909908|NCT00098306|12076231|FG000|NOT COMPLETED|Open Label||0
10909909|NCT00098306|12076232|FG001|NOT COMPLETED|Open Label||0
10909910|NCT00098306|12076233|FG002|NOT COMPLETED|Open Label||0
10909911|NCT00098306|12076234|FG003|NOT COMPLETED|Open Label||327
10909912|NCT00098306|12076235|FG004|NOT COMPLETED|Open Label||62
10909913|NCT00098306|12076236|FG005|NOT COMPLETED|Open Label||0
10909914|NCT00098306|12076237|FG006|NOT COMPLETED|Open Label||0
10909915|NCT00098306|12076231|FG000|STARTED|Observational Phase||0
10909916|NCT00098306|12076232|FG001|STARTED|Observational Phase||0
10909917|NCT00098306|12076233|FG002|STARTED|Observational Phase||0
10909918|NCT00098306|12076234|FG003|STARTED|Observational Phase||0
10909919|NCT00098306|12076235|FG004|STARTED|Observational Phase||0
10909920|NCT00098306|12076236|FG005|STARTED|Observational Phase||250
10909921|NCT00098306|12076237|FG006|STARTED|Observational Phase||81
10909922|NCT00098306|12076231|FG000|COMPLETED|Observational Phase||0
10909923|NCT00098306|12076232|FG001|COMPLETED|Observational Phase||0
10909924|NCT00098306|12076233|FG002|COMPLETED|Observational Phase||0
10909925|NCT00098306|12076234|FG003|COMPLETED|Observational Phase||0
10909926|NCT00098306|12076235|FG004|COMPLETED|Observational Phase||0
10909927|NCT00098306|12076236|FG005|COMPLETED|Observational Phase||204
10909928|NCT00098306|12076237|FG006|COMPLETED|Observational Phase||55
10909929|NCT00098306|12076231|FG000|NOT COMPLETED|Observational Phase||0
10909930|NCT00098306|12076232|FG001|NOT COMPLETED|Observational Phase||0
10909931|NCT00098306|12076233|FG002|NOT COMPLETED|Observational Phase||0
10909932|NCT00098306|12076234|FG003|NOT COMPLETED|Observational Phase||0
10909933|NCT00098306|12076235|FG004|NOT COMPLETED|Observational Phase||0
10909934|NCT00098306|12076236|FG005|NOT COMPLETED|Observational Phase||46
10909935|NCT00098306|12076237|FG006|NOT COMPLETED|Observational Phase||26
10909936|NCT00098345|12076250|FG000|STARTED|Overall Study||30
10909937|NCT00098345|12076250|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
10909938|NCT00098345|12076250|FG000|NOT COMPLETED|Overall Study||13
10909939|NCT00098371|12076254|FG000|STARTED|Overall Study||64
10909940|NCT00098371|12076254|FG000|COMPLETED|Overall Study||64
10909941|NCT00098371|12076254|FG000|NOT COMPLETED|Overall Study||0
10909942|NCT00098670|12076269|FG000|STARTED|Overall Study||102
10909943|NCT00098670|12076269|FG000|COMPLETED|Overall Study||102
10909944|NCT00098670|12076269|FG000|NOT COMPLETED|Overall Study||0
10909945|NCT00098722|12076277|FG000|STARTED|Double Blind Phase||186
10909946|NCT00098722|12076278|FG001|STARTED|Double Blind Phase||194
10909947|NCT00098722|12076279|FG002|STARTED|Double Blind Phase||94
10909948|NCT00098722|12076280|FG003|STARTED|Double Blind Phase||0
10909949|NCT00098722|12076281|FG004|STARTED|Double Blind Phase||0
10909950|NCT00098722|12076282|FG005|STARTED|Double Blind Phase||0
10909951|NCT00098722|12076283|FG006|STARTED|Double Blind Phase||0
10909952|NCT00098722|12076277|FG000|Treated|Double Blind Phase||182
10909953|NCT00098722|12076278|FG001|Treated|Double Blind Phase||191
10909954|NCT00098722|12076279|FG002|Treated|Double Blind Phase||91
10909955|NCT00098722|12076280|FG003|Treated|Double Blind Phase||0
10909956|NCT00098722|12076281|FG004|Treated|Double Blind Phase||0
10909957|NCT00098722|12076282|FG005|Treated|Double Blind Phase||0
10909958|NCT00098722|12076283|FG006|Treated|Double Blind Phase||0
10909959|NCT00098722|12076277|FG000|COMPLETED|Double Blind Phase||0
10909960|NCT00098722|12076278|FG001|COMPLETED|Double Blind Phase||0
10909961|NCT00098722|12076279|FG002|COMPLETED|Double Blind Phase||0
10909962|NCT00098722|12076280|FG003|COMPLETED|Double Blind Phase||0
10909963|NCT00098722|12076281|FG004|COMPLETED|Double Blind Phase||0
10909964|NCT00098722|12076282|FG005|COMPLETED|Double Blind Phase||0
10909965|NCT00098722|12076283|FG006|COMPLETED|Double Blind Phase||0
10909966|NCT00098722|12076277|FG000|NOT COMPLETED|Double Blind Phase||186
10909967|NCT00098722|12076278|FG001|NOT COMPLETED|Double Blind Phase||194
10909968|NCT00098722|12076279|FG002|NOT COMPLETED|Double Blind Phase||94
10909969|NCT00098722|12076280|FG003|NOT COMPLETED|Double Blind Phase||0
10909970|NCT00098722|12076281|FG004|NOT COMPLETED|Double Blind Phase||0
10909971|NCT00098722|12076282|FG005|NOT COMPLETED|Double Blind Phase||0
10909972|NCT00098722|12076283|FG006|NOT COMPLETED|Double Blind Phase||0
10909973|NCT00098722|12076277|FG000|STARTED|Open Label Phase||0
10909974|NCT00098722|12076278|FG001|STARTED|Open Label Phase||0
10909975|NCT00098722|12076279|FG002|STARTED|Open Label Phase||0
10909976|NCT00098722|12076280|FG003|STARTED|Open Label Phase||272
10909977|NCT00098722|12076281|FG004|STARTED|Open Label Phase||50
10909978|NCT00098722|12076282|FG005|STARTED|Open Label Phase||0
10909979|NCT00098722|12076283|FG006|STARTED|Open Label Phase||0
10909980|NCT00098722|12076277|FG000|COMPLETED|Open Label Phase||0
10909981|NCT00098722|12076278|FG001|COMPLETED|Open Label Phase||0
10909982|NCT00098722|12076279|FG002|COMPLETED|Open Label Phase||0
10909983|NCT00098722|12076280|FG003|COMPLETED|Open Label Phase||0
10909984|NCT00098722|12076281|FG004|COMPLETED|Open Label Phase||0
10909985|NCT00098722|12076282|FG005|COMPLETED|Open Label Phase||0
10909986|NCT00098722|12076283|FG006|COMPLETED|Open Label Phase||0
10909987|NCT00098722|12076277|FG000|NOT COMPLETED|Open Label Phase||0
10909988|NCT00098722|12076278|FG001|NOT COMPLETED|Open Label Phase||0
10909989|NCT00098722|12076279|FG002|NOT COMPLETED|Open Label Phase||0
10909990|NCT00098722|12076280|FG003|NOT COMPLETED|Open Label Phase||272
10909991|NCT00098722|12076281|FG004|NOT COMPLETED|Open Label Phase||50
10909992|NCT00098722|12076282|FG005|NOT COMPLETED|Open Label Phase||0
10909993|NCT00098722|12076283|FG006|NOT COMPLETED|Open Label Phase||0
10909994|NCT00098722|12076277|FG000|STARTED|Observation Phase||0
10909995|NCT00098722|12076278|FG001|STARTED|Observation Phase||0
10909996|NCT00098722|12076279|FG002|STARTED|Observation Phase||0
10909997|NCT00098722|12076280|FG003|STARTED|Observation Phase||0
10909998|NCT00098722|12076281|FG004|STARTED|Observation Phase||0
10909999|NCT00098722|12076282|FG005|STARTED|Observation Phase||205
10910000|NCT00098722|12076283|FG006|STARTED|Observation Phase||65
10910001|NCT00098722|12076277|FG000|COMPLETED|Observation Phase||0
10910002|NCT00098722|12076278|FG001|COMPLETED|Observation Phase||0
10910003|NCT00098722|12076279|FG002|COMPLETED|Observation Phase||0
10910004|NCT00098722|12076280|FG003|COMPLETED|Observation Phase||0
10910005|NCT00098722|12076281|FG004|COMPLETED|Observation Phase||0
10910006|NCT00098722|12076282|FG005|COMPLETED|Observation Phase||160
10910007|NCT00098722|12076283|FG006|COMPLETED|Observation Phase||48
10910008|NCT00098722|12076277|FG000|NOT COMPLETED|Observation Phase||0
10910009|NCT00098722|12076278|FG001|NOT COMPLETED|Observation Phase||0
10910010|NCT00098722|12076279|FG002|NOT COMPLETED|Observation Phase||0
10910011|NCT00098722|12076280|FG003|NOT COMPLETED|Observation Phase||0
10910012|NCT00098722|12076281|FG004|NOT COMPLETED|Observation Phase||0
10910013|NCT00098722|12076282|FG005|NOT COMPLETED|Observation Phase||45
10910014|NCT00098722|12076283|FG006|NOT COMPLETED|Observation Phase||17
10910015|NCT00098748|12076298|FG000|STARTED|Assigned to Study Treatment||63
10910016|NCT00098748|12076299|FG001|STARTED|Assigned to Study Treatment||63
10910017|NCT00098748|12076300|FG002|STARTED|Assigned to Study Treatment||64
10910018|NCT00098748|12076298|FG000|COMPLETED|Assigned to Study Treatment||63
10910019|NCT00098748|12076299|FG001|COMPLETED|Assigned to Study Treatment||61
10910020|NCT00098748|12076300|FG002|COMPLETED|Assigned to Study Treatment||62
10910021|NCT00098748|12076298|FG000|NOT COMPLETED|Assigned to Study Treatment||0
10910022|NCT00098748|12076299|FG001|NOT COMPLETED|Assigned to Study Treatment||2
10910023|NCT00098748|12076300|FG002|NOT COMPLETED|Assigned to Study Treatment||2
10910024|NCT00098748|12076298|FG000|STARTED|Received Study Treatment||63
10910025|NCT00098748|12076299|FG001|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
10910026|NCT00098748|12076300|FG002|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
10910027|NCT00098748|12076298|FG000|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
10910028|NCT00098748|12076299|FG001|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
10910029|NCT00098748|12076300|FG002|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
10910030|NCT00098748|12076298|FG000|COMPLETED|Received Study Treatment||15
10910031|NCT00098748|12076299|FG001|COMPLETED|Received Study Treatment||25
10910032|NCT00098748|12076300|FG002|COMPLETED|Received Study Treatment||18
10910033|NCT00098748|12076298|FG000|NOT COMPLETED|Received Study Treatment||48
10910034|NCT00098748|12076299|FG001|NOT COMPLETED|Received Study Treatment||36
10910035|NCT00098748|12076300|FG002|NOT COMPLETED|Received Study Treatment||44
10910036|NCT00098748|12076298|FG000|STARTED|Continued on Open-Label Treatment||15
10910037|NCT00098748|12076299|FG001|STARTED|Continued on Open-Label Treatment||25
10910038|NCT00098748|12076300|FG002|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
10910039|NCT00098748|12076298|FG000|COMPLETED|Continued on Open-Label Treatment||7
10910040|NCT00098748|12076299|FG001|COMPLETED|Continued on Open-Label Treatment||10
10910041|NCT00098748|12076300|FG002|COMPLETED|Continued on Open-Label Treatment||0
10910042|NCT00098748|12076298|FG000|NOT COMPLETED|Continued on Open-Label Treatment||8
10910043|NCT00098748|12076299|FG001|NOT COMPLETED|Continued on Open-Label Treatment||15
10910044|NCT00098748|12076300|FG002|NOT COMPLETED|Continued on Open-Label Treatment||0
10910045|NCT00098774|12076308|FG000|STARTED|Overall Study||44
10910046|NCT00098774|12076308|FG000|COMPLETED|Overall Study||26
10910047|NCT00098774|12076308|FG000|NOT COMPLETED|Overall Study||18
10910048|NCT00098787|12076315|FG000|STARTED|Overall Study||73
10910049|NCT00098787|12076316|FG001|STARTED|Overall Study||75
10910050|NCT00098787|12076317|FG002|STARTED|Overall Study||63
10910051|NCT00098787|12076315|FG000|Treated|Overall Study||70
10910052|NCT00098787|12076316|FG001|Treated|Overall Study||73
10910053|NCT00098787|12076317|FG002|Treated|Overall Study||62
10910054|NCT00098787|12076315|FG000|Eligible and Treated|Overall Study||61
10910055|NCT00098787|12076316|FG001|Eligible and Treated|Overall Study||66
10910056|NCT00098787|12076317|FG002|Eligible and Treated|Overall Study||59
10910057|NCT00098787|12076315|FG000|COMPLETED|Overall Study||0
10910058|NCT00098787|12076316|FG001|COMPLETED|Overall Study||0
10910059|NCT00098787|12076317|FG002|COMPLETED|Overall Study||0
10910060|NCT00098787|12076315|FG000|NOT COMPLETED|Overall Study||73
10910061|NCT00098787|12076316|FG001|NOT COMPLETED|Overall Study||75
10910062|NCT00098787|12076317|FG002|NOT COMPLETED|Overall Study||63
10910063|NCT00098813|12076325|FG000|STARTED|Overall Study||20
10910064|NCT00098813|12076325|FG000|COMPLETED|Overall Study||1
10910065|NCT00098813|12076325|FG000|NOT COMPLETED|Overall Study||19
10910066|NCT00098839|12076331|FG000|STARTED|Overall Study||56
10910067|NCT00098839|12076332|FG001|STARTED|Overall Study||60
10910068|NCT00098839|12076331|FG000|COMPLETED|Overall Study||24
10910069|NCT00098839|12076332|FG001|COMPLETED|Overall Study||27
10910070|NCT00098839|12076331|FG000|NOT COMPLETED|Overall Study||32
10910071|NCT00098839|12076332|FG001|NOT COMPLETED|Overall Study||33
10910072|NCT00098865|12076339|FG000|STARTED|Overall Study||15
10910073|NCT00098865|12076339|FG000|COMPLETED|Overall Study||6
10910074|NCT00098865|12076339|FG000|NOT COMPLETED|Overall Study||9
10910075|NCT00098956|12076343|FG000|STARTED|Overall Study||19
10910076|NCT00098956|12076343|FG000|COMPLETED|Overall Study||19
10910077|NCT00098956|12076343|FG000|NOT COMPLETED|Overall Study||0
10910078|NCT00099021|12076347|FG000|STARTED|Overall Study||21
10910079|NCT00099021|12076347|FG000|COMPLETED|Overall Study||21
10910080|NCT00099021|12076347|FG000|NOT COMPLETED|Overall Study||0
10910081|NCT00099047|12076353|FG000|STARTED|Overall Study||11
10910082|NCT00099047|12076354|FG001|STARTED|Overall Study||12
10910083|NCT00099047|12076353|FG000|COMPLETED|Overall Study||11
10910084|NCT00099047|12076354|FG001|COMPLETED|Overall Study||12
10910085|NCT00099047|12076353|FG000|NOT COMPLETED|Overall Study||0
10910086|NCT00099047|12076354|FG001|NOT COMPLETED|Overall Study||0
10910087|NCT00099268|12076362|FG000|STARTED|Overall Study||374
10910088|NCT00099268|12076363|FG001|STARTED|Overall Study||373
10910089|NCT00099268|12076362|FG000|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
10910090|NCT00099268|12076363|FG001|Intent-to-Treat|Overall Study||372
10910091|NCT00099268|12076362|FG000|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
10910092|NCT00099268|12076363|FG001|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
10910093|NCT00099268|12076362|FG000|NOT COMPLETED|Overall Study||92
10910094|NCT00099268|12076363|FG001|NOT COMPLETED|Overall Study||82
10910095|NCT00099359|12076372|FG000|STARTED|Overall Study||581
10910096|NCT00099359|12076373|FG001|STARTED|Overall Study||580
10910097|NCT00099359|12076374|FG002|STARTED|Overall Study||574
10910098|NCT00099359|12076372|FG000|COMPLETED|Overall Study||527
10910099|NCT00099359|12076373|FG001|COMPLETED|Overall Study||515
10910100|NCT00099359|12076374|FG002|COMPLETED|Overall Study||506
10910101|NCT00099359|12076372|FG000|NOT COMPLETED|Overall Study||54
10910102|NCT00099359|12076373|FG001|NOT COMPLETED|Overall Study||65
10910103|NCT00099359|12076374|FG002|NOT COMPLETED|Overall Study||68
10910104|NCT00099372|12076394|FG000|STARTED|Enrolled in Extended CARE Trial||104
10910105|NCT00099372|12076395|FG001|STARTED|Enrolled in Extended CARE Trial||111
10910106|NCT00099372|12076394|FG000|COMPLETED|Enrolled in Extended CARE Trial||104
10910107|NCT00099372|12076395|FG001|COMPLETED|Enrolled in Extended CARE Trial||111
10910108|NCT00099372|12076394|FG000|NOT COMPLETED|Enrolled in Extended CARE Trial||0
10910109|NCT00099372|12076395|FG001|NOT COMPLETED|Enrolled in Extended CARE Trial||0
10910110|NCT00099372|12076394|FG000|STARTED|Followed up 5 Years After Index Surgery||104
10910111|NCT00099372|12076395|FG001|STARTED|Followed up 5 Years After Index Surgery||111
10910112|NCT00099372|12076394|FG000|COMPLETED|Followed up 5 Years After Index Surgery||89
10910113|NCT00099372|12076395|FG001|COMPLETED|Followed up 5 Years After Index Surgery||92
10910114|NCT00099372|12076394|FG000|NOT COMPLETED|Followed up 5 Years After Index Surgery||15
10910115|NCT00099372|12076395|FG001|NOT COMPLETED|Followed up 5 Years After Index Surgery||19
10910116|NCT00099372|12076394|FG000|STARTED|Followed up 7 Years After Index Surgery||89
10910117|NCT00099372|12076395|FG001|STARTED|Followed up 7 Years After Index Surgery||92
10910118|NCT00099372|12076394|FG000|COMPLETED|Followed up 7 Years After Index Surgery||66
10910119|NCT00099372|12076395|FG001|COMPLETED|Followed up 7 Years After Index Surgery||60
10910120|NCT00099372|12076394|FG000|NOT COMPLETED|Followed up 7 Years After Index Surgery||23
10910121|NCT00099372|12076395|FG001|NOT COMPLETED|Followed up 7 Years After Index Surgery||32
10910122|NCT00099632|12076409|FG000|STARTED|Overall Study||73
10910123|NCT00099632|12076410|FG001|STARTED|Overall Study||68
10910124|NCT00099632|12076411|FG002|STARTED|Overall Study||75
10910125|NCT00099632|12076412|FG003|STARTED|Overall Study||67
10910126|NCT00099632|12076413|FG004|STARTED|Overall Study||71
10910127|NCT00099632|12076414|FG005|STARTED|Overall Study||68
10910128|NCT00099632|12076409|FG000|COMPLETED|Overall Study||72
10910129|NCT00099632|12076410|FG001|COMPLETED|Overall Study||67
10910130|NCT00099632|12076411|FG002|COMPLETED|Overall Study||72
10910131|NCT00099632|12076412|FG003|COMPLETED|Overall Study||66
10910132|NCT00099632|12076413|FG004|COMPLETED|Overall Study||70
10910133|NCT00099632|12076414|FG005|COMPLETED|Overall Study||66
10910134|NCT00099632|12076409|FG000|NOT COMPLETED|Overall Study||1
10910135|NCT00099632|12076410|FG001|NOT COMPLETED|Overall Study||1
10910136|NCT00099632|12076411|FG002|NOT COMPLETED|Overall Study||3
10910137|NCT00099632|12076412|FG003|NOT COMPLETED|Overall Study||1
10910138|NCT00099632|12076413|FG004|NOT COMPLETED|Overall Study||1
10910139|NCT00099632|12076414|FG005|NOT COMPLETED|Overall Study||2
10910140|NCT00099983|12076430|FG000|STARTED|Overall Study||147
10910141|NCT00099983|12076431|FG001|STARTED|Overall Study||149
10910142|NCT00099983|12076430|FG000|COMPLETED|Overall Study||123
10910143|NCT00099983|12076431|FG001|COMPLETED|Overall Study||124
10910144|NCT00099983|12076430|FG000|NOT COMPLETED|Overall Study||24
10910145|NCT00099983|12076431|FG001|NOT COMPLETED|Overall Study||25
10910146|NCT00100048|12076442|FG000|STARTED|Cohort I-Monotherapy Phase 10 Days||7
10910147|NCT00100048|12076443|FG001|STARTED|Cohort I-Monotherapy Phase 10 Days||7
10910148|NCT00100048|12076444|FG002|STARTED|Cohort I-Monotherapy Phase 10 Days||6
10910149|NCT00100048|12076445|FG003|STARTED|Cohort I-Monotherapy Phase 10 Days||8
10910150|NCT00100048|12076446|FG004|STARTED|Cohort I-Monotherapy Phase 10 Days||7
10910151|NCT00100048|12076447|FG005|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
10910152|NCT00100048|12076442|FG000|Treated|Cohort I-Monotherapy Phase 10 Days||7
10910153|NCT00100048|12076443|FG001|Treated|Cohort I-Monotherapy Phase 10 Days||7
10910154|NCT00100048|12076444|FG002|Treated|Cohort I-Monotherapy Phase 10 Days||6
10910155|NCT00100048|12076445|FG003|Treated|Cohort I-Monotherapy Phase 10 Days||8
10910156|NCT00100048|12076446|FG004|Treated|Cohort I-Monotherapy Phase 10 Days||7
10910157|NCT00100048|12076447|FG005|Treated|Cohort I-Monotherapy Phase 10 Days||0
10910158|NCT00100048|12076442|FG000|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
10910159|NCT00100048|12076443|FG001|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
10910160|NCT00100048|12076444|FG002|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
10910161|NCT00100048|12076445|FG003|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
10910162|NCT00100048|12076446|FG004|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
10910163|NCT00100048|12076447|FG005|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10910164|NCT00100048|12076442|FG000|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10910165|NCT00100048|12076443|FG001|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10910166|NCT00100048|12076444|FG002|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10910167|NCT00100048|12076445|FG003|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10910168|NCT00100048|12076446|FG004|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10910169|NCT00100048|12076447|FG005|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
10910170|NCT00100048|12076442|FG000|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
10910171|NCT00100048|12076443|FG001|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
10910172|NCT00100048|12076444|FG002|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
10910173|NCT00100048|12076445|FG003|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
10910174|NCT00100048|12076446|FG004|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
10910175|NCT00100048|12076447|FG005|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
10910176|NCT00100048|12076442|FG000|Treated|Cohort I & II-Combination Therapy Phase||39
10910177|NCT00100048|12076443|FG001|Treated|Cohort I & II-Combination Therapy Phase||40
10910178|NCT00100048|12076444|FG002|Treated|Cohort I & II-Combination Therapy Phase||41
10910179|NCT00100048|12076445|FG003|Treated|Cohort I & II-Combination Therapy Phase||40
10910180|NCT00100048|12076446|FG004|Treated|Cohort I & II-Combination Therapy Phase||0
10910181|NCT00100048|12076447|FG005|Treated|Cohort I & II-Combination Therapy Phase||38
10910182|NCT00100048|12076442|FG000|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
10910183|NCT00100048|12076443|FG001|Never Treated|Cohort I & II-Combination Therapy Phase||0
10910184|NCT00100048|12076444|FG002|Never Treated|Cohort I & II-Combination Therapy Phase||0
10910185|NCT00100048|12076445|FG003|Never Treated|Cohort I & II-Combination Therapy Phase||0
10910186|NCT00100048|12076446|FG004|Never Treated|Cohort I & II-Combination Therapy Phase||0
10910187|NCT00100048|12076447|FG005|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
10910188|NCT00100048|12076442|FG000|COMPLETED|Cohort I & II-Combination Therapy Phase||27
10910189|NCT00100048|12076443|FG001|COMPLETED|Cohort I & II-Combination Therapy Phase||31
10910190|NCT00100048|12076444|FG002|COMPLETED|Cohort I & II-Combination Therapy Phase||28
10910191|NCT00100048|12076445|FG003|COMPLETED|Cohort I & II-Combination Therapy Phase||30
10910192|NCT00100048|12076446|FG004|COMPLETED|Cohort I & II-Combination Therapy Phase||0
10910193|NCT00100048|12076447|FG005|COMPLETED|Cohort I & II-Combination Therapy Phase||26
10910194|NCT00100048|12076442|FG000|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
10910195|NCT00100048|12076443|FG001|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
10910196|NCT00100048|12076444|FG002|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
10910197|NCT00100048|12076445|FG003|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
10910198|NCT00100048|12076446|FG004|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
10910199|NCT00100048|12076447|FG005|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
10910200|NCT00100165|12076475|FG000|STARTED|Baseline||10
10910201|NCT00100165|12076476|FG001|STARTED|Baseline||10
10910202|NCT00100165|12076477|FG002|STARTED|Baseline||9
10910203|NCT00100165|12076475|FG000|COMPLETED|Baseline||10
10910204|NCT00100165|12076476|FG001|COMPLETED|Baseline||10
10910205|NCT00100165|12076477|FG002|COMPLETED|Baseline||9
10910206|NCT00100165|12076475|FG000|NOT COMPLETED|Baseline||0
10910207|NCT00100165|12076476|FG001|NOT COMPLETED|Baseline||0
10910208|NCT00100165|12076477|FG002|NOT COMPLETED|Baseline||0
10910209|NCT00100165|12076475|FG000|STARTED|First Intervention (4 Weeks)||10
10910210|NCT00100165|12076476|FG001|STARTED|First Intervention (4 Weeks)||10
10910211|NCT00100165|12076477|FG002|STARTED|First Intervention (4 Weeks)||9
10910212|NCT00100165|12076475|FG000|COMPLETED|First Intervention (4 Weeks)||10
10910213|NCT00100165|12076476|FG001|COMPLETED|First Intervention (4 Weeks)||10
10910214|NCT00100165|12076477|FG002|COMPLETED|First Intervention (4 Weeks)||9
10910215|NCT00100165|12076475|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
10910216|NCT00100165|12076476|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
10910217|NCT00100165|12076477|FG002|NOT COMPLETED|First Intervention (4 Weeks)||0
10910218|NCT00100165|12076475|FG000|STARTED|Washout (1 Week)||10
10910219|NCT00100165|12076476|FG001|STARTED|Washout (1 Week)||10
10910220|NCT00100165|12076477|FG002|STARTED|Washout (1 Week)||9
10910221|NCT00100165|12076475|FG000|COMPLETED|Washout (1 Week)||10
10910222|NCT00100165|12076476|FG001|COMPLETED|Washout (1 Week)||10
10910223|NCT00100165|12076477|FG002|COMPLETED|Washout (1 Week)||9
10910224|NCT00100165|12076475|FG000|NOT COMPLETED|Washout (1 Week)||0
10910225|NCT00100165|12076476|FG001|NOT COMPLETED|Washout (1 Week)||0
10910226|NCT00100165|12076477|FG002|NOT COMPLETED|Washout (1 Week)||0
10910227|NCT00100165|12076475|FG000|STARTED|Second Intervention (4 Weeks)||10
10910228|NCT00100165|12076476|FG001|STARTED|Second Intervention (4 Weeks)||10
10910229|NCT00100165|12076477|FG002|STARTED|Second Intervention (4 Weeks)||9
10910230|NCT00100165|12076475|FG000|COMPLETED|Second Intervention (4 Weeks)||10
10910231|NCT00100165|12076476|FG001|COMPLETED|Second Intervention (4 Weeks)||10
10910232|NCT00100165|12076477|FG002|COMPLETED|Second Intervention (4 Weeks)||9
10910233|NCT00100165|12076475|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10910234|NCT00100165|12076476|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
10910235|NCT00100165|12076477|FG002|NOT COMPLETED|Second Intervention (4 Weeks)||0
10910236|NCT00100165|12076475|FG000|STARTED|Washout (1 Week)||10
10910237|NCT00100165|12076476|FG001|STARTED|Washout (1 Week)||10
10910238|NCT00100165|12076477|FG002|STARTED|Washout (1 Week)||9
10910239|NCT00100165|12076475|FG000|COMPLETED|Washout (1 Week)||10
10910240|NCT00100165|12076476|FG001|COMPLETED|Washout (1 Week)||10
10910241|NCT00100165|12076477|FG002|COMPLETED|Washout (1 Week)||9
10910242|NCT00100165|12076475|FG000|NOT COMPLETED|Washout (1 Week)||0
10910243|NCT00100165|12076476|FG001|NOT COMPLETED|Washout (1 Week)||0
10910244|NCT00100165|12076477|FG002|NOT COMPLETED|Washout (1 Week)||0
10910245|NCT00100165|12076475|FG000|STARTED|Third Intervention (4 Weeks)||10
10910246|NCT00100165|12076476|FG001|STARTED|Third Intervention (4 Weeks)||10
10910247|NCT00100165|12076477|FG002|STARTED|Third Intervention (4 Weeks)||9
10910248|NCT00100165|12076475|FG000|COMPLETED|Third Intervention (4 Weeks)||10
10910249|NCT00100165|12076476|FG001|COMPLETED|Third Intervention (4 Weeks)||10
10910250|NCT00100165|12076477|FG002|COMPLETED|Third Intervention (4 Weeks)||9
10910251|NCT00100165|12076475|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0
10910252|NCT00100165|12076476|FG001|NOT COMPLETED|Third Intervention (4 Weeks)||0
10910253|NCT00100165|12076477|FG002|NOT COMPLETED|Third Intervention (4 Weeks)||0
10910254|NCT00100178|12076491|FG000|STARTED|Overall Study||41
10910255|NCT00100178|12076492|FG001|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
10910256|NCT00100178|12076493|FG002|STARTED|Overall Study||42
10910257|NCT00100178|12076491|FG000|COMPLETED|Overall Study||32
10910258|NCT00100178|12076492|FG001|COMPLETED|Overall Study||21
10910259|NCT00100178|12076493|FG002|COMPLETED|Overall Study||32
10910260|NCT00100178|12076491|FG000|NOT COMPLETED|Overall Study||9
10910261|NCT00100178|12076492|FG001|NOT COMPLETED|Overall Study||10
10910262|NCT00100178|12076493|FG002|NOT COMPLETED|Overall Study||10
10910263|NCT00100230|12076503|FG000|STARTED|Overall Study||41
10910264|NCT00100230|12076504|FG001|STARTED|Overall Study||37
10910265|NCT00100230|12076503|FG000|COMPLETED|Overall Study||29
10910266|NCT00100230|12076504|FG001|COMPLETED|Overall Study||22
10910267|NCT00100230|12076503|FG000|NOT COMPLETED|Overall Study||12
10910268|NCT00100230|12076504|FG001|NOT COMPLETED|Overall Study||15
10910269|NCT00100659|12076514|FG000|STARTED|Overall Study||55
10910270|NCT00100659|12076515|FG001|STARTED|Overall Study||59
10910271|NCT00100659|12076514|FG000|COMPLETED|Overall Study||52
10910272|NCT00100659|12076515|FG001|COMPLETED|Overall Study||57
10910273|NCT00100659|12076514|FG000|NOT COMPLETED|Overall Study||3
10910274|NCT00100659|12076515|FG001|NOT COMPLETED|Overall Study||2
10910275|NCT00100698|12076525|FG000|STARTED|Overall Study||27
10910276|NCT00100698|12076526|FG001|STARTED|Overall Study||29
10910277|NCT00100698|12076525|FG000|COMPLETED|Overall Study||21
10910278|NCT00100698|12076526|FG001|COMPLETED|Overall Study||27
10910279|NCT00100698|12076525|FG000|NOT COMPLETED|Overall Study||6
10910280|NCT00100698|12076526|FG001|NOT COMPLETED|Overall Study||2
10910281|NCT00100789|12076532|FG000|STARTED|Overall Study||67
10910282|NCT00100789|12076532|FG000|Eligible|Overall Study||64
10910283|NCT00100789|12076532|FG000|Eligible and Began Protocol Therapy|Overall Study||63
10910284|NCT00100789|12076532|FG000|COMPLETED|Overall Study||3
10910285|NCT00100789|12076532|FG000|NOT COMPLETED|Overall Study||64
10910286|NCT00100802|12076537|FG000|STARTED|Overall Study||118
10910287|NCT00100802|12076537|FG000|COMPLETED|Overall Study||38
10910288|NCT00100802|12076537|FG000|NOT COMPLETED|Overall Study||80
10910289|NCT00100815|12076541|FG000|STARTED|Overall Study||50
10910290|NCT00100815|12076541|FG000|COMPLETED|Overall Study||1
10910291|NCT00100815|12076541|FG000|NOT COMPLETED|Overall Study||49
10910292|NCT00100841|12076545|FG000|STARTED|Overall Study||66
10910293|NCT00100841|12076545|FG000|COMPLETED|Overall Study||66
10910294|NCT00100841|12076545|FG000|NOT COMPLETED|Overall Study||0
10910295|NCT00100932|12076551|FG000|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
10910296|NCT00100932|12076552|FG001|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
10910297|NCT00100932|12076551|FG000|COMPLETED|Overall Study||5
10910298|NCT00100932|12076552|FG001|COMPLETED|Overall Study||1
10910299|NCT00100932|12076551|FG000|NOT COMPLETED|Overall Study||73
10910300|NCT00100932|12076552|FG001|NOT COMPLETED|Overall Study||27
10910301|NCT00101010|12076558|FG000|STARTED|Overall Study||80
10910302|NCT00101010|12076558|FG000|COMPLETED|Overall Study||79
10910303|NCT00101010|12076558|FG000|NOT COMPLETED|Overall Study||1
10910304|NCT00101036|12076564|FG000|STARTED|Overall Study||17
10910305|NCT00101036|12076565|FG001|STARTED|Overall Study||40
10910306|NCT00101036|12076564|FG000|COMPLETED|Overall Study||17
10910307|NCT00101036|12076565|FG001|COMPLETED|Overall Study||40
10910308|NCT00101036|12076564|FG000|NOT COMPLETED|Overall Study||0
10910309|NCT00101036|12076565|FG001|NOT COMPLETED|Overall Study||0
10910310|NCT00101166|12076571|FG000|STARTED|Overall Study||28
10910311|NCT00101166|12076571|FG000|COMPLETED|Overall Study||18
10910312|NCT00101166|12076571|FG000|NOT COMPLETED|Overall Study||10
10910313|NCT00101192|12076575|FG000|STARTED|Overall Study||76
10910314|NCT00101192|12076575|FG000|COMPLETED|Overall Study||69
10910315|NCT00101192|12076575|FG000|NOT COMPLETED|Overall Study||7
10910316|NCT00101283|12076581|FG000|STARTED|Overall Study||16
10910317|NCT00101283|12076582|FG001|STARTED|Overall Study||16
10910318|NCT00101283|12076581|FG000|Began Treatment|Overall Study||16
10910319|NCT00101283|12076582|FG001|Began Treatment|Overall Study||13
10910320|NCT00101283|12076581|FG000|COMPLETED|Overall Study||16
10910321|NCT00101283|12076582|FG001|COMPLETED|Overall Study||13
10910322|NCT00101283|12076581|FG000|NOT COMPLETED|Overall Study||0
10910323|NCT00101283|12076582|FG001|NOT COMPLETED|Overall Study||3
10910324|NCT00101361|12076590|FG000|STARTED|Overall Study||108
10910325|NCT00101361|12076591|FG001|STARTED|Overall Study||104
10910326|NCT00101361|12076590|FG000|COMPLETED|Overall Study||108
10910327|NCT00101361|12076591|FG001|COMPLETED|Overall Study||104
10910328|NCT00101361|12076590|FG000|NOT COMPLETED|Overall Study||0
10910329|NCT00101361|12076591|FG001|NOT COMPLETED|Overall Study||0
10910330|NCT00101400|12076597|FG000|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
10910331|NCT00101400|12076597|FG000|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
10910332|NCT00101400|12076597|FG000|NOT COMPLETED|Treatment||0
10910333|NCT00101400|12076597|FG000|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
10910334|NCT00101400|12076597|FG000|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
10910335|NCT00101400|12076597|FG000|NOT COMPLETED|Survival Follow-Up||7
10910336|NCT00101413|12076601|FG000|STARTED|Overall Study||52
10910337|NCT00101413|12076601|FG000|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
10910338|NCT00101413|12076601|FG000|NOT COMPLETED|Overall Study||0
10910339|NCT00101452|12076608|FG000|STARTED|Overall Study||65
10910340|NCT00101452|12076609|FG001|STARTED|Overall Study||69
10910341|NCT00101452|12076610|FG002|STARTED|Overall Study||65
10910342|NCT00101452|12076608|FG000|COMPLETED|Overall Study||21
10910343|NCT00101452|12076609|FG001|COMPLETED|Overall Study||26
10910344|NCT00101452|12076610|FG002|COMPLETED|Overall Study||22
10910345|NCT00101452|12076608|FG000|NOT COMPLETED|Overall Study||44
10910346|NCT00101452|12076609|FG001|NOT COMPLETED|Overall Study||43
10910347|NCT00101452|12076610|FG002|NOT COMPLETED|Overall Study||43
10910348|NCT00101582|12076624|FG000|STARTED|Overall Study||94
10910349|NCT00101582|12076625|FG001|STARTED|Overall Study||94
10910350|NCT00101582|12076624|FG000|Received Study Drug|Overall Study||91
10910351|NCT00101582|12076625|FG001|Received Study Drug|Overall Study||94
10910352|NCT00101582|12076624|FG000|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
10910353|NCT00101582|12076625|FG001|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
10910354|NCT00101582|12076624|FG000|NOT COMPLETED|Overall Study||11
10910355|NCT00101582|12076625|FG001|NOT COMPLETED|Overall Study||15
10910356|NCT00101647|12076633|FG000|STARTED|Overall Study|Randomized|13
10910357|NCT00101647|12076634|FG001|STARTED|Overall Study|Randomized|161
10910358|NCT00101647|12076633|FG000|COMPLETED|Overall Study||13
10910359|NCT00101647|12076634|FG001|COMPLETED|Overall Study||161
10910360|NCT00101647|12076633|FG000|NOT COMPLETED|Overall Study||0
10910361|NCT00101647|12076634|FG001|NOT COMPLETED|Overall Study||0
10910362|NCT00101660|12076652|FG000|STARTED|Overall Study||99
10910363|NCT00101660|12076653|FG001|STARTED|Overall Study||288
10910364|NCT00101660|12076652|FG000|COMPLETED|Overall Study||99
10910365|NCT00101660|12076653|FG001|COMPLETED|Overall Study||288
10910366|NCT00101660|12076652|FG000|NOT COMPLETED|Overall Study||0
10910367|NCT00101660|12076653|FG001|NOT COMPLETED|Overall Study||0
10910368|NCT00101686|12076675|FG000|STARTED|Overall Study||71
10910369|NCT00101686|12076676|FG001|STARTED|Overall Study||73
10910370|NCT00101686|12076677|FG002|STARTED|Overall Study||69
10910371|NCT00101686|12076678|FG003|STARTED|Overall Study||72
10910372|NCT00101686|12076679|FG004|STARTED|Overall Study||73
10910373|NCT00101686|12076680|FG005|STARTED|Overall Study||72
10910374|NCT00101686|12076681|FG006|STARTED|Overall Study||27
10910375|NCT00101686|12076682|FG007|STARTED|Overall Study||30
10910376|NCT00101686|12076683|FG008|STARTED|Overall Study||30
10910377|NCT00101686|12076684|FG009|STARTED|Overall Study||30
10910378|NCT00101686|12076675|FG000|Received Treatment|Overall Study||70
10910379|NCT00101686|12076676|FG001|Received Treatment|Overall Study||67
10910380|NCT00101686|12076677|FG002|Received Treatment|Overall Study||67
10910381|NCT00101686|12076678|FG003|Received Treatment|Overall Study||70
10910382|NCT00101686|12076679|FG004|Received Treatment|Overall Study||71
10910383|NCT00101686|12076680|FG005|Received Treatment|Overall Study||70
10910384|NCT00101686|12076681|FG006|Received Treatment|Overall Study||27
10910385|NCT00101686|12076682|FG007|Received Treatment|Overall Study||29
10910386|NCT00101686|12076683|FG008|Received Treatment|Overall Study||30
10910387|NCT00101686|12076684|FG009|Received Treatment|Overall Study||29
10910388|NCT00101686|12076675|FG000|COMPLETED|Overall Study|Patients treated until disease progression.|0
10910389|NCT00101686|12076676|FG001|COMPLETED|Overall Study|Patients treated until disease progression.|0
10910390|NCT00101686|12076677|FG002|COMPLETED|Overall Study|Patients treated until disease progression.|0
10910391|NCT00101686|12076678|FG003|COMPLETED|Overall Study|Patients treated until disease progression.|0
10910392|NCT00101686|12076679|FG004|COMPLETED|Overall Study|Patients treated until disease progression.|0
10910393|NCT00101686|12076680|FG005|COMPLETED|Overall Study|Patients treated until disease progression.|0
10910394|NCT00101686|12076681|FG006|COMPLETED|Overall Study|Patients treated until disease progression.|0
10910395|NCT00101686|12076682|FG007|COMPLETED|Overall Study|Patients treated until disease progression.|0
10910396|NCT00101686|12076683|FG008|COMPLETED|Overall Study|Patients treated until disease progression.|0
10910397|NCT00101686|12076684|FG009|COMPLETED|Overall Study|Patients treated until disease progression.|0
10910398|NCT00101686|12076675|FG000|NOT COMPLETED|Overall Study||71
10910399|NCT00101686|12076676|FG001|NOT COMPLETED|Overall Study||73
10910400|NCT00101686|12076677|FG002|NOT COMPLETED|Overall Study||69
10910401|NCT00101686|12076678|FG003|NOT COMPLETED|Overall Study||72
10910402|NCT00101686|12076679|FG004|NOT COMPLETED|Overall Study||73
10910403|NCT00101686|12076680|FG005|NOT COMPLETED|Overall Study||72
10910404|NCT00101686|12076681|FG006|NOT COMPLETED|Overall Study||27
10910405|NCT00101686|12076682|FG007|NOT COMPLETED|Overall Study||30
10910406|NCT00101686|12076683|FG008|NOT COMPLETED|Overall Study||30
10910407|NCT00101686|12076684|FG009|NOT COMPLETED|Overall Study||30
10910408|NCT00101816|12076703|FG000|STARTED|Overall Study||10
10910409|NCT00101816|12076704|FG001|STARTED|Overall Study||99
10910410|NCT00101816|12076703|FG000|COMPLETED|Overall Study||10
10910411|NCT00101816|12076704|FG001|COMPLETED|Overall Study||99
10910412|NCT00101816|12076703|FG000|NOT COMPLETED|Overall Study||0
10910413|NCT00101816|12076704|FG001|NOT COMPLETED|Overall Study||0
10910414|NCT00101868|12076720|FG000|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
10910415|NCT00101868|12076721|FG001|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
10910416|NCT00101868|12076720|FG000|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
10910417|NCT00101868|12076721|FG001|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
10910418|NCT00101868|12076720|FG000|NOT COMPLETED|Overall Study||29
10910419|NCT00101868|12076721|FG001|NOT COMPLETED|Overall Study||32
10910420|NCT00101907|12076735|FG000|STARTED|Overall Study||8
10910421|NCT00101907|12076736|FG001|STARTED|Overall Study||8
10910422|NCT00101907|12076737|FG002|STARTED|Overall Study||6
10910423|NCT00101907|12076738|FG003|STARTED|Overall Study||6
10910424|NCT00101907|12076739|FG004|STARTED|Overall Study||11
10910425|NCT00101907|12076740|FG005|STARTED|Overall Study||2
10910426|NCT00101907|12076735|FG000|COMPLETED|Overall Study||6
10910427|NCT00101907|12076736|FG001|COMPLETED|Overall Study||7
10910428|NCT00101907|12076737|FG002|COMPLETED|Overall Study||5
10910429|NCT00101907|12076738|FG003|COMPLETED|Overall Study||5
10910430|NCT00101907|12076739|FG004|COMPLETED|Overall Study||6
10910431|NCT00101907|12076740|FG005|COMPLETED|Overall Study||2
10910432|NCT00101907|12076735|FG000|NOT COMPLETED|Overall Study||2
10910433|NCT00101907|12076736|FG001|NOT COMPLETED|Overall Study||1
10910434|NCT00101907|12076737|FG002|NOT COMPLETED|Overall Study||1
10910435|NCT00101907|12076738|FG003|NOT COMPLETED|Overall Study||1
10910436|NCT00101907|12076739|FG004|NOT COMPLETED|Overall Study||5
10910437|NCT00101907|12076740|FG005|NOT COMPLETED|Overall Study||0
10910438|NCT00101933|12076763|FG000|STARTED|Overall Study||54
10910439|NCT00101933|12076764|FG001|STARTED|Overall Study||55
10910440|NCT00101933|12076763|FG000|COMPLETED|Overall Study||54
10910441|NCT00101933|12076764|FG001|COMPLETED|Overall Study||55
10910442|NCT00101933|12076763|FG000|NOT COMPLETED|Overall Study||0
10910443|NCT00101933|12076764|FG001|NOT COMPLETED|Overall Study||0
10910444|NCT00102063|12076774|FG000|STARTED|Overall Study||100
10910445|NCT00102063|12076775|FG001|STARTED|Overall Study||102
10910446|NCT00102063|12076776|FG002|STARTED|Overall Study||100
10910447|NCT00102063|12076774|FG000|COMPLETED|Overall Study||84
10910448|NCT00102063|12076775|FG001|COMPLETED|Overall Study||84
10910449|NCT00102063|12076776|FG002|COMPLETED|Overall Study||90
10910450|NCT00102063|12076774|FG000|NOT COMPLETED|Overall Study||16
10910451|NCT00102063|12076775|FG001|NOT COMPLETED|Overall Study||18
10910452|NCT00102063|12076776|FG002|NOT COMPLETED|Overall Study||10
10910453|NCT00102440|12076787|FG000|STARTED|Overall Study||256
10910454|NCT00102440|12076788|FG001|STARTED|Overall Study||251
10910455|NCT00102440|12076789|FG002|STARTED|Overall Study||253
10910456|NCT00102440|12076787|FG000|COMPLETED|Overall Study||168
10910457|NCT00102440|12076788|FG001|COMPLETED|Overall Study||153
10910458|NCT00102440|12076789|FG002|COMPLETED|Overall Study||187
10910459|NCT00102440|12076787|FG000|NOT COMPLETED|Overall Study||88
10910460|NCT00102440|12076788|FG001|NOT COMPLETED|Overall Study||98
10910461|NCT00102440|12076789|FG002|NOT COMPLETED|Overall Study||66
10910462|NCT00102518|12076797|FG000|STARTED|Overall Study||325
10910463|NCT00102518|12076797|FG000|COMPLETED|Overall Study||238
10910464|NCT00102518|12076797|FG000|NOT COMPLETED|Overall Study||87
10910465|NCT00102531|12076803|FG000|STARTED|Overall Study||7
10910466|NCT00102531|12076804|FG001|STARTED|Overall Study||12
10910467|NCT00102531|12076803|FG000|COMPLETED|Overall Study||2
10910468|NCT00102531|12076804|FG001|COMPLETED|Overall Study||1
10910469|NCT00102531|12076803|FG000|NOT COMPLETED|Overall Study||5
10910470|NCT00102531|12076804|FG001|NOT COMPLETED|Overall Study||11
10910471|NCT00102596|12076810|FG000|STARTED|Part A||11
10910472|NCT00102596|12076811|FG001|STARTED|Part A||0
10910473|NCT00102596|12076810|FG000|Participants Assigned Treatment|Part A||5
10910474|NCT00102596|12076811|FG001|Participants Assigned Treatment|Part A||0
10910475|NCT00102596|12076810|FG000|COMPLETED|Part A||4
10910476|NCT00102596|12076811|FG001|COMPLETED|Part A||0
10910477|NCT00102596|12076810|FG000|NOT COMPLETED|Part A||7
10910478|NCT00102596|12076811|FG001|NOT COMPLETED|Part A||0
10910479|NCT00102596|12076810|FG000|STARTED|Part B|Participants from Part A did not continue to Part B|0
10910480|NCT00102596|12076811|FG001|STARTED|Part B||10
10910481|NCT00102596|12076810|FG000|COMPLETED|Part B||0
10910482|NCT00102596|12076811|FG001|COMPLETED|Part B||10
10910483|NCT00102596|12076810|FG000|NOT COMPLETED|Part B||0
10910484|NCT00102596|12076811|FG001|NOT COMPLETED|Part B||0
10910485|NCT00102596|12076810|FG000|STARTED|Part C||0
10910486|NCT00102596|12076811|FG001|STARTED|Part C|Only 2 patients participated in Part C|2
10910487|NCT00102596|12076810|FG000|COMPLETED|Part C||0
10910488|NCT00102596|12076811|FG001|COMPLETED|Part C||2
10910489|NCT00102596|12076810|FG000|NOT COMPLETED|Part C||0
10910490|NCT00102596|12076811|FG001|NOT COMPLETED|Part C||0
10910491|NCT00102687|12076821|FG000|STARTED|Initial Period||50
10910492|NCT00102687|12076822|FG001|STARTED|Initial Period||50
10910493|NCT00102687|12076823|FG002|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
10910494|NCT00102687|12076824|FG003|STARTED|Initial Period||0
10910495|NCT00102687|12076825|FG004|STARTED|Initial Period||0
10910496|NCT00102687|12076821|FG000|COMPLETED|Initial Period||32
10910497|NCT00102687|12076822|FG001|COMPLETED|Initial Period||22
10910498|NCT00102687|12076823|FG002|COMPLETED|Initial Period||25
10910499|NCT00102687|12076824|FG003|COMPLETED|Initial Period||0
10910500|NCT00102687|12076825|FG004|COMPLETED|Initial Period||0
10910501|NCT00102687|12076821|FG000|NOT COMPLETED|Initial Period||18
10910502|NCT00102687|12076822|FG001|NOT COMPLETED|Initial Period||28
10910503|NCT00102687|12076823|FG002|NOT COMPLETED|Initial Period||26
10910504|NCT00102687|12076824|FG003|NOT COMPLETED|Initial Period||0
10910505|NCT00102687|12076825|FG004|NOT COMPLETED|Initial Period||0
10910506|NCT00102687|12076821|FG000|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
10910507|NCT00102687|12076822|FG001|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
10910508|NCT00102687|12076823|FG002|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
10910509|NCT00102687|12076824|FG003|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
10910510|NCT00102687|12076825|FG004|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
10910511|NCT00102687|12076821|FG000|COMPLETED|Maintenance Period||6
10910512|NCT00102687|12076822|FG001|COMPLETED|Maintenance Period||2
10910513|NCT00102687|12076823|FG002|COMPLETED|Maintenance Period||2
10910514|NCT00102687|12076824|FG003|COMPLETED|Maintenance Period||12
10910515|NCT00102687|12076825|FG004|COMPLETED|Maintenance Period||8
10910516|NCT00102687|12076821|FG000|NOT COMPLETED|Maintenance Period||7
10910517|NCT00102687|12076822|FG001|NOT COMPLETED|Maintenance Period||4
10910518|NCT00102687|12076823|FG002|NOT COMPLETED|Maintenance Period||6
10910519|NCT00102687|12076824|FG003|NOT COMPLETED|Maintenance Period||10
10910520|NCT00102687|12076825|FG004|NOT COMPLETED|Maintenance Period||13
10910521|NCT00102804|12076843|FG000|STARTED|Overall Study||441
10910522|NCT00102804|12076844|FG001|STARTED|Overall Study||222
10910523|NCT00102804|12076843|FG000|Received at Least 1 Dose of Study Drug|Overall Study||434
10910524|NCT00102804|12076844|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
10910525|NCT00102804|12076843|FG000|COMPLETED|Overall Study||0
10910526|NCT00102804|12076844|FG001|COMPLETED|Overall Study||0
10910527|NCT00102804|12076843|FG000|NOT COMPLETED|Overall Study||441
10910528|NCT00102804|12076844|FG001|NOT COMPLETED|Overall Study||222
10910529|NCT00102960|12076853|FG000|STARTED|Overall Study||125
10910530|NCT00102960|12076854|FG001|STARTED|Overall Study||126
10910531|NCT00102960|12076855|FG002|STARTED|Overall Study||126
10910532|NCT00102960|12076853|FG000|COMPLETED|Overall Study||95
10910533|NCT00102960|12076854|FG001|COMPLETED|Overall Study||103
10910534|NCT00102960|12076855|FG002|COMPLETED|Overall Study||98
10910535|NCT00102960|12076853|FG000|NOT COMPLETED|Overall Study||30
10910536|NCT00102960|12076854|FG001|NOT COMPLETED|Overall Study||23
10910537|NCT00102960|12076855|FG002|NOT COMPLETED|Overall Study||28
10910538|NCT00103012|12076870|FG000|STARTED|Overall Study||17
10910539|NCT00103012|12076871|FG001|STARTED|Overall Study||14
10910540|NCT00103012|12076872|FG002|STARTED|Overall Study||16
10910541|NCT00103012|12076870|FG000|COMPLETED|Overall Study||14
10910542|NCT00103012|12076871|FG001|COMPLETED|Overall Study||13
10910543|NCT00103012|12076872|FG002|COMPLETED|Overall Study||12
10910544|NCT00103012|12076870|FG000|NOT COMPLETED|Overall Study||3
10910545|NCT00103012|12076871|FG001|NOT COMPLETED|Overall Study||1
10910546|NCT00103012|12076872|FG002|NOT COMPLETED|Overall Study||4
10910547|NCT00103116|12076880|FG000|STARTED|Overall Study||32
10910548|NCT00103116|12076880|FG000|COMPLETED|Overall Study||32
10910549|NCT00103116|12076880|FG000|NOT COMPLETED|Overall Study||0
10910550|NCT00103142|12076886|FG000|STARTED|Overall Study||36
10910551|NCT00103142|12076887|FG001|STARTED|Overall Study||37
10910552|NCT00103142|12076886|FG000|COMPLETED|Overall Study||33
10910553|NCT00103142|12076887|FG001|COMPLETED|Overall Study||36
10910554|NCT00103142|12076886|FG000|NOT COMPLETED|Overall Study||3
10910555|NCT00103142|12076887|FG001|NOT COMPLETED|Overall Study||1
10910556|NCT00103194|12076895|FG000|STARTED|Overall Study||49
10910557|NCT00103194|12076895|FG000|Treated|Overall Study||49
10910558|NCT00103194|12076895|FG000|Eligible|Overall Study||35
10910559|NCT00103194|12076895|FG000|Eligible and Treated|Overall Study||35
10910560|NCT00103194|12076895|FG000|COMPLETED|Overall Study||18
10910561|NCT00103194|12076895|FG000|NOT COMPLETED|Overall Study||31
10910562|NCT00103207|12076899|FG000|STARTED|Overall Study||72
10910563|NCT00103207|12076899|FG000|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
10910564|NCT00103207|12076899|FG000|Eligible Patients w/ Smoking Status Data|Overall Study||37
10910565|NCT00103207|12076899|FG000|COMPLETED|Overall Study||34
10910566|NCT00103207|12076899|FG000|NOT COMPLETED|Overall Study||38
10910567|NCT00103259|12076907|FG000|STARTED|Overall Study||27
10910568|NCT00103259|12076908|FG001|STARTED|Overall Study||44
10910569|NCT00103259|12076907|FG000|Eligible|Overall Study||27
10910570|NCT00103259|12076908|FG001|Eligible|Overall Study||41
10910571|NCT00103259|12076907|FG000|Treated|Overall Study||23
10910572|NCT00103259|12076908|FG001|Treated|Overall Study||41
10910573|NCT00103259|12076907|FG000|Eligible and Treated|Overall Study||23
10910574|NCT00103259|12076908|FG001|Eligible and Treated|Overall Study||38
10910575|NCT00103259|12076907|FG000|Cross Over to the Other Arm|Overall Study||0
10910576|NCT00103259|12076908|FG001|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
10910577|NCT00103259|12076907|FG000|Eligible Patients Who Cross Over|Overall Study||0
10910578|NCT00103259|12076908|FG001|Eligible Patients Who Cross Over|Overall Study||10
10910579|NCT00103259|12076907|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
10910580|NCT00103259|12076908|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
10910581|NCT00103259|12076907|FG000|NOT COMPLETED|Overall Study||12
10910582|NCT00103259|12076908|FG001|NOT COMPLETED|Overall Study||12
10910583|NCT00103285|12076916|FG000|STARTED|Induction||5377
10910584|NCT00103285|12076917|FG001|STARTED|Induction||0
10910585|NCT00103285|12076918|FG002|STARTED|Induction||0
10910586|NCT00103285|12076919|FG003|STARTED|Induction||0
10910587|NCT00103285|12076920|FG004|STARTED|Induction||0
10910588|NCT00103285|12076921|FG005|STARTED|Induction||0
10910589|NCT00103285|12076922|FG006|STARTED|Induction||0
10910590|NCT00103285|12076923|FG007|STARTED|Induction||0
10910591|NCT00103285|12076916|FG000|COMPLETED|Induction||4028
10910592|NCT00103285|12076917|FG001|COMPLETED|Induction||0
10910593|NCT00103285|12076918|FG002|COMPLETED|Induction||0
10910594|NCT00103285|12076919|FG003|COMPLETED|Induction||0
10910595|NCT00103285|12076920|FG004|COMPLETED|Induction||0
10910596|NCT00103285|12076921|FG005|COMPLETED|Induction||0
10910597|NCT00103285|12076922|FG006|COMPLETED|Induction||0
10910598|NCT00103285|12076923|FG007|COMPLETED|Induction||0
10910599|NCT00103285|12076916|FG000|NOT COMPLETED|Induction||1349
10910600|NCT00103285|12076917|FG001|NOT COMPLETED|Induction||0
10910601|NCT00103285|12076918|FG002|NOT COMPLETED|Induction||0
10910602|NCT00103285|12076919|FG003|NOT COMPLETED|Induction||0
10910603|NCT00103285|12076920|FG004|NOT COMPLETED|Induction||0
10910604|NCT00103285|12076921|FG005|NOT COMPLETED|Induction||0
10910605|NCT00103285|12076922|FG006|NOT COMPLETED|Induction||0
10910606|NCT00103285|12076923|FG007|NOT COMPLETED|Induction||0
10910607|NCT00103285|12076916|FG000|STARTED|Response Assignment||0
10910608|NCT00103285|12076917|FG001|STARTED|Response Assignment||939
10910609|NCT00103285|12076918|FG002|STARTED|Response Assignment||937
10910610|NCT00103285|12076919|FG003|STARTED|Response Assignment||503
10910611|NCT00103285|12076920|FG004|STARTED|Response Assignment||509
10910612|NCT00103285|12076921|FG005|STARTED|Response Assignment||249
10910613|NCT00103285|12076922|FG006|STARTED|Response Assignment||248
10910614|NCT00103285|12076923|FG007|STARTED|Response Assignment||643
10910615|NCT00103285|12076916|FG000|COMPLETED|Response Assignment||0
10910616|NCT00103285|12076917|FG001|COMPLETED|Response Assignment||807
10910617|NCT00103285|12076918|FG002|COMPLETED|Response Assignment||853
10910618|NCT00103285|12076919|FG003|COMPLETED|Response Assignment||441
10910619|NCT00103285|12076920|FG004|COMPLETED|Response Assignment||425
10910620|NCT00103285|12076921|FG005|COMPLETED|Response Assignment||201
10910621|NCT00103285|12076922|FG006|COMPLETED|Response Assignment||199
10910622|NCT00103285|12076923|FG007|COMPLETED|Response Assignment||523
10910623|NCT00103285|12076916|FG000|NOT COMPLETED|Response Assignment||0
10910624|NCT00103285|12076917|FG001|NOT COMPLETED|Response Assignment||132
10910625|NCT00103285|12076918|FG002|NOT COMPLETED|Response Assignment||84
10910626|NCT00103285|12076919|FG003|NOT COMPLETED|Response Assignment||62
10910627|NCT00103285|12076920|FG004|NOT COMPLETED|Response Assignment||84
10910628|NCT00103285|12076921|FG005|NOT COMPLETED|Response Assignment||48
10910629|NCT00103285|12076922|FG006|NOT COMPLETED|Response Assignment||49
10910630|NCT00103285|12076923|FG007|NOT COMPLETED|Response Assignment||120
10910631|NCT00103311|12076950|FG000|STARTED|Overall Study||33
10910632|NCT00103311|12076951|FG001|STARTED|Overall Study||31
10910633|NCT00103311|12076950|FG000|COMPLETED|Overall Study||29
10910634|NCT00103311|12076951|FG001|COMPLETED|Overall Study||30
10910635|NCT00103311|12076950|FG000|NOT COMPLETED|Overall Study||4
10910636|NCT00103311|12076951|FG001|NOT COMPLETED|Overall Study||1
10910637|NCT00103376|12076960|FG000|STARTED|Overall Study||8
10910638|NCT00103376|12076961|FG001|STARTED|Overall Study||7
10910639|NCT00103376|12076962|FG002|STARTED|Overall Study||8
10910640|NCT00103376|12076960|FG000|COMPLETED|Overall Study||8
10910641|NCT00103376|12076961|FG001|COMPLETED|Overall Study||7
10910642|NCT00103376|12076962|FG002|COMPLETED|Overall Study||8
10910643|NCT00103376|12076960|FG000|NOT COMPLETED|Overall Study||0
10910644|NCT00103376|12076961|FG001|NOT COMPLETED|Overall Study||0
10910645|NCT00103376|12076962|FG002|NOT COMPLETED|Overall Study||0
10910646|NCT00103402|12076978|FG000|STARTED|Overall Study||138
10910647|NCT00103402|12076979|FG001|STARTED|Overall Study||134
10910648|NCT00103402|12076978|FG000|COMPLETED|Overall Study||116
10910649|NCT00103402|12076979|FG001|COMPLETED|Overall Study||117
10910650|NCT00103402|12076978|FG000|NOT COMPLETED|Overall Study||22
10910651|NCT00103402|12076979|FG001|NOT COMPLETED|Overall Study||17
10910652|NCT00103506|12076987|FG000|STARTED|Overall Study||322
10910653|NCT00103506|12076988|FG001|STARTED|Overall Study||324
10910654|NCT00103506|12076987|FG000|COMPLETED|Overall Study||0
10910655|NCT00103506|12076988|FG001|COMPLETED|Overall Study||0
10910656|NCT00103506|12076987|FG000|NOT COMPLETED|Overall Study||322
10910657|NCT00103506|12076988|FG001|NOT COMPLETED|Overall Study||324
10910658|NCT00103610|12076996|FG000|STARTED|Overall Study||150
10910659|NCT00103610|12076997|FG001|STARTED|Overall Study||148
10910660|NCT00103610|12076996|FG000|COMPLETED|Overall Study||112
10910661|NCT00103610|12076997|FG001|COMPLETED|Overall Study||68
10910662|NCT00103610|12076996|FG000|NOT COMPLETED|Overall Study||38
10910663|NCT00103610|12076997|FG001|NOT COMPLETED|Overall Study||80
10910664|NCT00103662|12077006|FG000|STARTED|Overall Study||148
10910665|NCT00103662|12077007|FG001|STARTED|Overall Study||154
10910666|NCT00103662|12077006|FG000|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
10910667|NCT00103662|12077007|FG001|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
10910668|NCT00103662|12077006|FG000|NOT COMPLETED|Overall Study||19
10910669|NCT00103662|12077007|FG001|NOT COMPLETED|Overall Study||33
10910670|NCT00103740|12077015|FG000|STARTED|Period 1 - Core||92
10910671|NCT00103740|12077016|FG001|STARTED|Period 1 - Core||93
10910672|NCT00103740|12077015|FG000|COMPLETED|Period 1 - Core||85
10910673|NCT00103740|12077016|FG001|COMPLETED|Period 1 - Core||89
10910674|NCT00103740|12077015|FG000|NOT COMPLETED|Period 1 - Core||7
10910675|NCT00103740|12077016|FG001|NOT COMPLETED|Period 1 - Core||4
10910676|NCT00103740|12077015|FG000|STARTED|Period 2 - Extended Observation Period||78
10910677|NCT00103740|12077016|FG001|STARTED|Period 2 - Extended Observation Period||63
10910678|NCT00103740|12077015|FG000|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
10910679|NCT00103740|12077016|FG001|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
10910680|NCT00103740|12077015|FG000|NOT COMPLETED|Period 2 - Extended Observation Period||69
10910681|NCT00103740|12077016|FG001|NOT COMPLETED|Period 2 - Extended Observation Period||36
10910682|NCT00103844|12077024|FG000|STARTED|Overall Study||101
10910683|NCT00103844|12077025|FG001|STARTED|Overall Study||49
10910684|NCT00103844|12077024|FG000|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
10910685|NCT00103844|12077025|FG001|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
10910686|NCT00103844|12077024|FG000|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
10910687|NCT00103844|12077025|FG001|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
10910688|NCT00103844|12077024|FG000|NOT COMPLETED|Overall Study||0
10910689|NCT00103844|12077025|FG001|NOT COMPLETED|Overall Study||0
10910690|NCT00103857|12077038|FG000|STARTED|54-Week Base Study||179
10910691|NCT00103857|12077039|FG001|STARTED|54-Week Base Study||182
10910692|NCT00103857|12077040|FG002|STARTED|54-Week Base Study||182
10910693|NCT00103857|12077041|FG003|STARTED|54-Week Base Study||190
10910694|NCT00103857|12077042|FG004|STARTED|54-Week Base Study||182
10910695|NCT00103857|12077043|FG005|STARTED|54-Week Base Study||176
10910696|NCT00103857|12077044|FG006|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
10910697|NCT00103857|12077038|FG000|COMPLETED|54-Week Base Study||122
10910698|NCT00103857|12077039|FG001|COMPLETED|54-Week Base Study||126
10910699|NCT00103857|12077040|FG002|COMPLETED|54-Week Base Study||135
10910700|NCT00103857|12077041|FG003|COMPLETED|54-Week Base Study||148
10910701|NCT00103857|12077042|FG004|COMPLETED|54-Week Base Study||141
10910702|NCT00103857|12077043|FG005|COMPLETED|54-Week Base Study||115
10910703|NCT00103857|12077044|FG006|COMPLETED|54-Week Base Study||79
10910704|NCT00103857|12077038|FG000|NOT COMPLETED|54-Week Base Study||57
10910705|NCT00103857|12077039|FG001|NOT COMPLETED|54-Week Base Study||56
10910706|NCT00103857|12077040|FG002|NOT COMPLETED|54-Week Base Study||47
10910707|NCT00103857|12077041|FG003|NOT COMPLETED|54-Week Base Study||42
10910708|NCT00103857|12077042|FG004|NOT COMPLETED|54-Week Base Study||41
10910709|NCT00103857|12077043|FG005|NOT COMPLETED|54-Week Base Study||61
10910710|NCT00103857|12077044|FG006|NOT COMPLETED|54-Week Base Study||38
10910711|NCT00103857|12077038|FG000|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
10910712|NCT00103857|12077039|FG001|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
10910713|NCT00103857|12077040|FG002|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
10910714|NCT00103857|12077041|FG003|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
10910715|NCT00103857|12077042|FG004|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
10910716|NCT00103857|12077043|FG005|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
10910717|NCT00103857|12077044|FG006|STARTED|50-Week Extension Study||0
10910718|NCT00103857|12077038|FG000|COMPLETED|50-Week Extension Study||65
10910719|NCT00103857|12077039|FG001|COMPLETED|50-Week Extension Study||80
10910720|NCT00103857|12077040|FG002|COMPLETED|50-Week Extension Study||95
10910721|NCT00103857|12077041|FG003|COMPLETED|50-Week Extension Study||98
10910722|NCT00103857|12077042|FG004|COMPLETED|50-Week Extension Study||101
10910723|NCT00103857|12077043|FG005|COMPLETED|50-Week Extension Study||78
10910724|NCT00103857|12077044|FG006|COMPLETED|50-Week Extension Study||0
10910725|NCT00103857|12077038|FG000|NOT COMPLETED|50-Week Extension Study||38
10910726|NCT00103857|12077039|FG001|NOT COMPLETED|50-Week Extension Study||27
10910727|NCT00103857|12077040|FG002|NOT COMPLETED|50-Week Extension Study||26
10910728|NCT00103857|12077041|FG003|NOT COMPLETED|50-Week Extension Study||36
10910729|NCT00103857|12077042|FG004|NOT COMPLETED|50-Week Extension Study||21
10910730|NCT00103857|12077043|FG005|NOT COMPLETED|50-Week Extension Study||20
10910731|NCT00103857|12077044|FG006|NOT COMPLETED|50-Week Extension Study||0
10910732|NCT00104052|12077059|FG000|STARTED|Overall Study||107
10910733|NCT00104052|12077059|FG000|COMPLETED|Overall Study||78
10910734|NCT00104052|12077059|FG000|NOT COMPLETED|Overall Study||29
10910735|NCT00104104|12077065|FG000|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
10910736|NCT00104104|12077066|FG001|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
10910737|NCT00104104|12077065|FG000|Safety Population (Including Site 74)|Overall Study||88
10910738|NCT00104104|12077066|FG001|Safety Population (Including Site 74)|Overall Study||88
10910739|NCT00104104|12077065|FG000|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
10910740|NCT00104104|12077066|FG001|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
10910741|NCT00104104|12077065|FG000|COMPLETED|Overall Study||15
10910742|NCT00104104|12077066|FG001|COMPLETED|Overall Study||17
10910743|NCT00104104|12077065|FG000|NOT COMPLETED|Overall Study||75
10910744|NCT00104104|12077066|FG001|NOT COMPLETED|Overall Study||72
10910745|NCT00104234|12077074|FG000|STARTED|Overall Study||19
10910746|NCT00104234|12077075|FG001|STARTED|Overall Study||20
10910747|NCT00104234|12077074|FG000|COMPLETED|Overall Study||19
10910748|NCT00104234|12077075|FG001|COMPLETED|Overall Study||19
10910749|NCT00104234|12077074|FG000|NOT COMPLETED|Overall Study||0
10910750|NCT00104234|12077075|FG001|NOT COMPLETED|Overall Study||1
10910751|NCT00104247|12077083|FG000|STARTED|Overall Study||42
10910752|NCT00104247|12077084|FG001|STARTED|Overall Study||47
10910753|NCT00104247|12077083|FG000|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
10910754|NCT00104247|12077084|FG001|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
10910755|NCT00104247|12077083|FG000|NOT COMPLETED|Overall Study||1
10910756|NCT00104247|12077084|FG001|NOT COMPLETED|Overall Study||1
10910757|NCT00104299|12077092|FG000|STARTED|Overall Study||99
10910758|NCT00104299|12077093|FG001|STARTED|Overall Study||98
10910759|NCT00104299|12077092|FG000|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
10910760|NCT00104299|12077093|FG001|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
10910761|NCT00104299|12077092|FG000|NOT COMPLETED|Overall Study||9
10910762|NCT00104299|12077093|FG001|NOT COMPLETED|Overall Study||10
10910763|NCT00104416|12077101|FG000|STARTED|Double-Blind Phase||77
10910764|NCT00104416|12077102|FG001|STARTED|Double-Blind Phase||76
10910765|NCT00104416|12077103|FG002|STARTED|Double-Blind Phase||0
10910766|NCT00104416|12077104|FG003|STARTED|Double-Blind Phase||0
10910767|NCT00104416|12077105|FG004|STARTED|Double-Blind Phase||0
10910768|NCT00104416|12077101|FG000|COMPLETED|Double-Blind Phase||69
10910769|NCT00104416|12077102|FG001|COMPLETED|Double-Blind Phase||66
10910770|NCT00104416|12077103|FG002|COMPLETED|Double-Blind Phase||0
10910771|NCT00104416|12077104|FG003|COMPLETED|Double-Blind Phase||0
10910772|NCT00104416|12077105|FG004|COMPLETED|Double-Blind Phase||0
10910773|NCT00104416|12077101|FG000|NOT COMPLETED|Double-Blind Phase||8
10910774|NCT00104416|12077102|FG001|NOT COMPLETED|Double-Blind Phase||10
10910775|NCT00104416|12077103|FG002|NOT COMPLETED|Double-Blind Phase||0
10910776|NCT00104416|12077104|FG003|NOT COMPLETED|Double-Blind Phase||0
10910777|NCT00104416|12077105|FG004|NOT COMPLETED|Double-Blind Phase||0
10910778|NCT00104416|12077101|FG000|STARTED|Continuation Phase||0
10910779|NCT00104416|12077102|FG001|STARTED|Continuation Phase||0
10910780|NCT00104416|12077103|FG002|STARTED|Continuation Phase||69
10910781|NCT00104416|12077104|FG003|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
10910782|NCT00104416|12077105|FG004|STARTED|Continuation Phase||32
10910783|NCT00104416|12077101|FG000|COMPLETED|Continuation Phase||0
10910784|NCT00104416|12077102|FG001|COMPLETED|Continuation Phase||0
10910785|NCT00104416|12077103|FG002|COMPLETED|Continuation Phase||63
10910786|NCT00104416|12077104|FG003|COMPLETED|Continuation Phase||65
10910787|NCT00104416|12077105|FG004|COMPLETED|Continuation Phase||27
10910788|NCT00104416|12077101|FG000|NOT COMPLETED|Continuation Phase||0
10910789|NCT00104416|12077102|FG001|NOT COMPLETED|Continuation Phase||0
10910790|NCT00104416|12077103|FG002|NOT COMPLETED|Continuation Phase||6
10910791|NCT00104416|12077104|FG003|NOT COMPLETED|Continuation Phase||2
10910792|NCT00104416|12077105|FG004|NOT COMPLETED|Continuation Phase||5
10910793|NCT00104520|12077119|FG000|STARTED|Overall Study||76
10910794|NCT00104520|12077120|FG001|STARTED|Overall Study||135
10910795|NCT00104520|12077119|FG000|COMPLETED|Overall Study||26
10910796|NCT00104520|12077120|FG001|COMPLETED|Overall Study||64
10910797|NCT00104520|12077119|FG000|NOT COMPLETED|Overall Study||50
10910798|NCT00104520|12077120|FG001|NOT COMPLETED|Overall Study||71
10910799|NCT00104572|12077129|FG000|STARTED|Overall Study|These are the analysed subjects|13
10910800|NCT00104572|12077130|FG001|STARTED|Overall Study|These are the analysed subjects|13
10910801|NCT00104572|12077131|FG002|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
10910802|NCT00104572|12077129|FG000|COMPLETED|Overall Study||10
10910803|NCT00104572|12077130|FG001|COMPLETED|Overall Study||10
10910804|NCT00104572|12077131|FG002|COMPLETED|Overall Study||9
10910805|NCT00104572|12077129|FG000|NOT COMPLETED|Overall Study||3
10910806|NCT00104572|12077130|FG001|NOT COMPLETED|Overall Study||3
10910807|NCT00104572|12077131|FG002|NOT COMPLETED|Overall Study||0
10910808|NCT00104637|12077139|FG000|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
10910809|NCT00104637|12077140|FG001|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
10910810|NCT00104637|12077139|FG000|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
10910811|NCT00104637|12077140|FG001|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
10910812|NCT00104637|12077139|FG000|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
10910813|NCT00104637|12077140|FG001|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
10910814|NCT00104637|12077139|FG000|STARTED|Period 2 (WASHOUT: 1 Week)||5
10910815|NCT00104637|12077140|FG001|STARTED|Period 2 (WASHOUT: 1 Week)||4
10910816|NCT00104637|12077139|FG000|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
10910817|NCT00104637|12077140|FG001|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
10910818|NCT00104637|12077139|FG000|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
10910819|NCT00104637|12077140|FG001|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
10910820|NCT00104637|12077139|FG000|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
10910821|NCT00104637|12077140|FG001|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
10910822|NCT00104637|12077139|FG000|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
10910823|NCT00104637|12077140|FG001|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
10910824|NCT00104637|12077139|FG000|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
10910825|NCT00104637|12077140|FG001|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
10910826|NCT00104650|12077152|FG000|STARTED|Treatment Period (25 Weeks)||37
10910827|NCT00104650|12077153|FG001|STARTED|Treatment Period (25 Weeks)||36
10910828|NCT00104650|12077154|FG002|STARTED|Treatment Period (25 Weeks)||38
10910829|NCT00104650|12077152|FG000|Received Investigational Product|Treatment Period (25 Weeks)||35
10910830|NCT00104650|12077153|FG001|Received Investigational Product|Treatment Period (25 Weeks)||35
10910831|NCT00104650|12077154|FG002|Received Investigational Product|Treatment Period (25 Weeks)||38
10910832|NCT00104650|12077152|FG000|COMPLETED|Treatment Period (25 Weeks)||25
10910833|NCT00104650|12077153|FG001|COMPLETED|Treatment Period (25 Weeks)||25
10910834|NCT00104650|12077154|FG002|COMPLETED|Treatment Period (25 Weeks)||28
10910835|NCT00104650|12077152|FG000|NOT COMPLETED|Treatment Period (25 Weeks)||12
10910836|NCT00104650|12077153|FG001|NOT COMPLETED|Treatment Period (25 Weeks)||11
10910837|NCT00104650|12077154|FG002|NOT COMPLETED|Treatment Period (25 Weeks)||10
10910838|NCT00104650|12077152|FG000|STARTED|Follow-up Period||25
10910839|NCT00104650|12077153|FG001|STARTED|Follow-up Period||25
10910840|NCT00104650|12077154|FG002|STARTED|Follow-up Period||28
10910841|NCT00104650|12077152|FG000|COMPLETED|Follow-up Period||14
10910842|NCT00104650|12077153|FG001|COMPLETED|Follow-up Period||12
10910843|NCT00104650|12077154|FG002|COMPLETED|Follow-up Period||18
10910844|NCT00104650|12077152|FG000|NOT COMPLETED|Follow-up Period||11
10910845|NCT00104650|12077153|FG001|NOT COMPLETED|Follow-up Period||13
10910846|NCT00104650|12077154|FG002|NOT COMPLETED|Follow-up Period||10
10910847|NCT00104858|12077162|FG000|STARTED|Overall Study||52
10910848|NCT00104858|12077162|FG000|COMPLETED|Overall Study||52
10910849|NCT00104858|12077162|FG000|NOT COMPLETED|Overall Study||0
10910850|NCT00104871|12077168|FG000|STARTED|Overall Study||22
10910851|NCT00104871|12077168|FG000|COMPLETED|Overall Study||21
10910852|NCT00104871|12077168|FG000|NOT COMPLETED|Overall Study||1
10910853|NCT00104884|12077172|FG000|STARTED|Overall Study||4
10910854|NCT00104884|12077172|FG000|COMPLETED|Overall Study||0
10910855|NCT00104884|12077172|FG000|NOT COMPLETED|Overall Study||4
10910856|NCT00105001|12077179|FG000|STARTED|Overall Study||70
10910857|NCT00105001|12077180|FG001|STARTED|Overall Study||71
10910858|NCT00105001|12077181|FG002|STARTED|Overall Study||69
10910859|NCT00105001|12077179|FG000|COMPLETED|Overall Study||70
10910860|NCT00105001|12077180|FG001|COMPLETED|Overall Study||71
10910861|NCT00105001|12077181|FG002|COMPLETED|Overall Study||69
10910862|NCT00105001|12077179|FG000|NOT COMPLETED|Overall Study||0
10910863|NCT00105001|12077180|FG001|NOT COMPLETED|Overall Study||0
10910864|NCT00105001|12077181|FG002|NOT COMPLETED|Overall Study||0
10910865|NCT00105027|12077195|FG000|STARTED|Overall Study||88
10910866|NCT00105027|12077196|FG001|STARTED|Overall Study||92
10910867|NCT00105027|12077197|FG002|STARTED|Overall Study||91
10910868|NCT00105027|12077198|FG003|STARTED|Overall Study||137
10910869|NCT00105027|12077199|FG004|STARTED|Overall Study||136
10910870|NCT00105027|12077200|FG005|STARTED|Overall Study||138
10910871|NCT00105027|12077195|FG000|COMPLETED|Overall Study||73
10910872|NCT00105027|12077196|FG001|COMPLETED|Overall Study||83
10910873|NCT00105027|12077197|FG002|COMPLETED|Overall Study||82
10910874|NCT00105027|12077198|FG003|COMPLETED|Overall Study||121
10910875|NCT00105027|12077199|FG004|COMPLETED|Overall Study||121
10910876|NCT00105027|12077200|FG005|COMPLETED|Overall Study||125
10910877|NCT00105027|12077195|FG000|NOT COMPLETED|Overall Study||15
10910878|NCT00105027|12077196|FG001|NOT COMPLETED|Overall Study||9
10910879|NCT00105027|12077197|FG002|NOT COMPLETED|Overall Study||9
10910880|NCT00105027|12077198|FG003|NOT COMPLETED|Overall Study||16
10910881|NCT00105027|12077199|FG004|NOT COMPLETED|Overall Study||15
10910882|NCT00105027|12077200|FG005|NOT COMPLETED|Overall Study||13
10910883|NCT00105066|12077216|FG000|STARTED|Overall Study||27
10910884|NCT00105066|12077217|FG001|STARTED|Overall Study||50
10910885|NCT00105066|12077216|FG000|COMPLETED|Overall Study||25
10910886|NCT00105066|12077217|FG001|COMPLETED|Overall Study||45
10910887|NCT00105066|12077216|FG000|NOT COMPLETED|Overall Study||2
10910888|NCT00105066|12077217|FG001|NOT COMPLETED|Overall Study||5
10910889|NCT00105079|12077225|FG000|STARTED|Overall Study||167
10910890|NCT00105079|12077226|FG001|STARTED|Overall Study||170
10910891|NCT00105079|12077225|FG000|Safety Population|Overall Study||163
10910892|NCT00105079|12077226|FG001|Safety Population|Overall Study||168
10910893|NCT00105079|12077225|FG000|COMPLETED|Overall Study||128
10910894|NCT00105079|12077226|FG001|COMPLETED|Overall Study||135
10910895|NCT00105079|12077225|FG000|NOT COMPLETED|Overall Study||39
10910896|NCT00105079|12077226|FG001|NOT COMPLETED|Overall Study||35
10910897|NCT00105157|12077236|FG000|STARTED|Double-Blind (DB)||44
10910898|NCT00105157|12077237|FG001|STARTED|Double-Blind (DB)||45
10910899|NCT00105157|12077238|FG002|STARTED|Double-Blind (DB)||45
10910900|NCT00105157|12077239|FG003|STARTED|Double-Blind (DB)||45
10910901|NCT00105157|12077236|FG000|Treated|Double-Blind (DB)||43
10910902|NCT00105157|12077237|FG001|Treated|Double-Blind (DB)||45
10910903|NCT00105157|12077238|FG002|Treated|Double-Blind (DB)||45
10910904|NCT00105157|12077239|FG003|Treated|Double-Blind (DB)||45
10910905|NCT00105157|12077236|FG000|COMPLETED|Double-Blind (DB)||30
10910906|NCT00105157|12077237|FG001|COMPLETED|Double-Blind (DB)||31
10910907|NCT00105157|12077238|FG002|COMPLETED|Double-Blind (DB)||33
10910908|NCT00105157|12077239|FG003|COMPLETED|Double-Blind (DB)||6
10910909|NCT00105157|12077236|FG000|NOT COMPLETED|Double-Blind (DB)||14
10910910|NCT00105157|12077237|FG001|NOT COMPLETED|Double-Blind (DB)||14
10910911|NCT00105157|12077238|FG002|NOT COMPLETED|Double-Blind (DB)||12
10910912|NCT00105157|12077239|FG003|NOT COMPLETED|Double-Blind (DB)||39
10910913|NCT00105157|12077236|FG000|STARTED|Open-Label Continuation of DB||30
10910914|NCT00105157|12077237|FG001|STARTED|Open-Label Continuation of DB||31
10910915|NCT00105157|12077238|FG002|STARTED|Open-Label Continuation of DB||33
10910916|NCT00105157|12077239|FG003|STARTED|Open-Label Continuation of DB||6
10910917|NCT00105157|12077236|FG000|COMPLETED|Open-Label Continuation of DB||23
10910918|NCT00105157|12077237|FG001|COMPLETED|Open-Label Continuation of DB||21
10910919|NCT00105157|12077238|FG002|COMPLETED|Open-Label Continuation of DB||24
10910920|NCT00105157|12077239|FG003|COMPLETED|Open-Label Continuation of DB||5
10910921|NCT00105157|12077236|FG000|NOT COMPLETED|Open-Label Continuation of DB||7
10910922|NCT00105157|12077237|FG001|NOT COMPLETED|Open-Label Continuation of DB||10
10910923|NCT00105157|12077238|FG002|NOT COMPLETED|Open-Label Continuation of DB||9
10910924|NCT00105157|12077239|FG003|NOT COMPLETED|Open-Label Continuation of DB||1
10910925|NCT00105157|12077236|FG000|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
10910926|NCT00105157|12077237|FG001|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
10910927|NCT00105157|12077238|FG002|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
10910928|NCT00105157|12077239|FG003|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
10910929|NCT00105157|12077236|FG000|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
10910930|NCT00105157|12077237|FG001|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
10910931|NCT00105157|12077238|FG002|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
10910932|NCT00105157|12077239|FG003|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
10910933|NCT00105157|12077236|FG000|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
10910934|NCT00105157|12077237|FG001|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
10910935|NCT00105157|12077238|FG002|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
10910936|NCT00105157|12077239|FG003|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
10910937|NCT00105183|12077250|FG000|STARTED|Overall Study|Randomized|82
10910938|NCT00105183|12077251|FG001|STARTED|Overall Study|Randomized|79
10910939|NCT00105183|12077252|FG002|STARTED|Overall Study|Randomized|62
10910940|NCT00105183|12077250|FG000|COMPLETED|Overall Study|Completed at least 12 months follow up|60
10910941|NCT00105183|12077251|FG001|COMPLETED|Overall Study|Completed at least 12 months follow up|60
10910942|NCT00105183|12077252|FG002|COMPLETED|Overall Study|Completed at least 12 months follow up|39
10910943|NCT00105183|12077250|FG000|NOT COMPLETED|Overall Study||22
10910944|NCT00105183|12077251|FG001|NOT COMPLETED|Overall Study||19
10910945|NCT00105183|12077252|FG002|NOT COMPLETED|Overall Study||23
10910946|NCT00105196|12077262|FG000|STARTED|Overall Study||177
10910947|NCT00105196|12077263|FG001|STARTED|Overall Study||172
10910948|NCT00105196|12077262|FG000|COMPLETED|Overall Study||147
10910949|NCT00105196|12077263|FG001|COMPLETED|Overall Study||149
10910950|NCT00105196|12077262|FG000|NOT COMPLETED|Overall Study||30
10910951|NCT00105196|12077263|FG001|NOT COMPLETED|Overall Study||23
10910952|NCT00105235|12077269|FG000|STARTED|Overall Study||27
10910953|NCT00105235|12077269|FG000|COMPLETED|Overall Study||20
10910954|NCT00105235|12077269|FG000|NOT COMPLETED|Overall Study||7
10910955|NCT00105443|12077279|FG000|STARTED|Double-Blind Treatment||242
10910956|NCT00105443|12077280|FG001|STARTED|Double-Blind Treatment||57
10910957|NCT00105443|12077281|FG002|STARTED|Double-Blind Treatment||256
10910958|NCT00105443|12077282|FG003|STARTED|Double-Blind Treatment||47
10910959|NCT00105443|12077279|FG000|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
10910960|NCT00105443|12077280|FG001|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
10910961|NCT00105443|12077281|FG002|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
10910962|NCT00105443|12077282|FG003|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
10910963|NCT00105443|12077279|FG000|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
10910964|NCT00105443|12077280|FG001|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
10910965|NCT00105443|12077281|FG002|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
10910966|NCT00105443|12077282|FG003|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
10910967|NCT00105443|12077279|FG000|NOT COMPLETED|Double-Blind Treatment||14
10910968|NCT00105443|12077280|FG001|NOT COMPLETED|Double-Blind Treatment||0
10910969|NCT00105443|12077281|FG002|NOT COMPLETED|Double-Blind Treatment||11
10910970|NCT00105443|12077282|FG003|NOT COMPLETED|Double-Blind Treatment||0
10910971|NCT00105443|12077279|FG000|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
10910972|NCT00105443|12077280|FG001|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
10910973|NCT00105443|12077281|FG002|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
10910974|NCT00105443|12077282|FG003|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
10910975|NCT00105443|12077279|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
10910976|NCT00105443|12077280|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
10910977|NCT00105443|12077281|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
10910978|NCT00105443|12077282|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
10910979|NCT00105443|12077279|FG000|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
10910980|NCT00105443|12077280|FG001|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
10910981|NCT00105443|12077281|FG002|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
10910982|NCT00105443|12077282|FG003|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
10910983|NCT00105443|12077279|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
10910984|NCT00105443|12077280|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
10910985|NCT00105443|12077281|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
10910986|NCT00105443|12077282|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
10910987|NCT00105443|12077279|FG000|COMPLETED|Follow-up and/or Open Label Nexavar||0
10910988|NCT00105443|12077280|FG001|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
10910989|NCT00105443|12077281|FG002|COMPLETED|Follow-up and/or Open Label Nexavar||0
10910990|NCT00105443|12077282|FG003|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
10910991|NCT00105443|12077279|FG000|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
10910992|NCT00105443|12077280|FG001|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
10910993|NCT00105443|12077281|FG002|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
10910994|NCT00105443|12077282|FG003|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
10910995|NCT00105469|12077293|FG000|STARTED|Overall Study||365
10910996|NCT00105469|12077294|FG001|STARTED|Overall Study||378
10910997|NCT00105469|12077293|FG000|COMPLETED|Overall Study||343
10910998|NCT00105469|12077294|FG001|COMPLETED|Overall Study||367
10910999|NCT00105469|12077293|FG000|NOT COMPLETED|Overall Study||22
10911000|NCT00105469|12077294|FG001|NOT COMPLETED|Overall Study||11
10911001|NCT00105482|12077302|FG000|STARTED|Overall Study||87
10911002|NCT00105482|12077303|FG001|STARTED|Overall Study||85
10911003|NCT00105482|12077302|FG000|COMPLETED|Overall Study||28
10911004|NCT00105482|12077303|FG001|COMPLETED|Overall Study||30
10911005|NCT00105482|12077302|FG000|NOT COMPLETED|Overall Study||59
10911006|NCT00105482|12077303|FG001|NOT COMPLETED|Overall Study||55
10911007|NCT00105508|12077311|FG000|STARTED|Overall Study||253
10911008|NCT00105508|12077312|FG001|STARTED|Overall Study||253
10911009|NCT00105508|12077311|FG000|COMPLETED|Overall Study||213
10911010|NCT00105508|12077312|FG001|COMPLETED|Overall Study||217
10911011|NCT00105508|12077311|FG000|NOT COMPLETED|Overall Study||40
10911012|NCT00105508|12077312|FG001|NOT COMPLETED|Overall Study||36
10911013|NCT00105521|12077322|FG000|STARTED|Overall Study||98
10911014|NCT00105521|12077323|FG001|STARTED|Overall Study||101
10911015|NCT00105521|12077324|FG002|STARTED|Overall Study||97
10911016|NCT00105521|12077325|FG003|STARTED|Overall Study||102
10911017|NCT00105521|12077322|FG000|COMPLETED|Overall Study||83
10911018|NCT00105521|12077323|FG001|COMPLETED|Overall Study||90
10911019|NCT00105521|12077324|FG002|COMPLETED|Overall Study||80
10911020|NCT00105521|12077325|FG003|COMPLETED|Overall Study||85
10911021|NCT00105521|12077322|FG000|NOT COMPLETED|Overall Study||15
10911022|NCT00105521|12077323|FG001|NOT COMPLETED|Overall Study||11
10911023|NCT00105521|12077324|FG002|NOT COMPLETED|Overall Study||17
10911024|NCT00105521|12077325|FG003|NOT COMPLETED|Overall Study||17
10911025|NCT00105534|12077337|FG000|STARTED|Overall Study||335
10911026|NCT00105534|12077338|FG001|STARTED|Overall Study||350
10911027|NCT00105534|12077337|FG000|COMPLETED|Overall Study||313
10911028|NCT00105534|12077338|FG001|COMPLETED|Overall Study||317
10911029|NCT00105534|12077337|FG000|NOT COMPLETED|Overall Study||22
10911030|NCT00105534|12077338|FG001|NOT COMPLETED|Overall Study||33
10911031|NCT00105586|12077346|FG000|STARTED|Overall Study||92
10911032|NCT00105586|12077347|FG001|STARTED|Overall Study||85
10911033|NCT00105586|12077346|FG000|COMPLETED|Overall Study||75
10911034|NCT00105586|12077347|FG001|COMPLETED|Overall Study||69
10911035|NCT00105586|12077346|FG000|NOT COMPLETED|Overall Study||17
10911036|NCT00105586|12077347|FG001|NOT COMPLETED|Overall Study||16
10911037|NCT00105989|12077355|FG000|STARTED|Acute - Open Label: Week 0-10||514
10911038|NCT00105989|12077356|FG001|STARTED|Acute - Open Label: Week 0-10||0
10911039|NCT00105989|12077355|FG000|COMPLETED|Acute - Open Label: Week 0-10||413
10911040|NCT00105989|12077356|FG001|COMPLETED|Acute - Open Label: Week 0-10||0
10911041|NCT00105989|12077355|FG000|NOT COMPLETED|Acute - Open Label: Week 0-10||101
10911042|NCT00105989|12077356|FG001|NOT COMPLETED|Acute - Open Label: Week 0-10||0
10911043|NCT00105989|12077355|FG000|STARTED|Continuation - Open Label:Week 10-34||413
10911044|NCT00105989|12077356|FG001|STARTED|Continuation - Open Label:Week 10-34||0
10911045|NCT00105989|12077355|FG000|COMPLETED|Continuation - Open Label:Week 10-34||288
10911046|NCT00105989|12077356|FG001|COMPLETED|Continuation - Open Label:Week 10-34||0
10911047|NCT00105989|12077355|FG000|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
10911048|NCT00105989|12077356|FG001|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
10911049|NCT00105989|12077355|FG000|STARTED|Maintenance - Double-Blind:Week 34-86||146
10911050|NCT00105989|12077356|FG001|STARTED|Maintenance - Double-Blind:Week 34-86||142
10911051|NCT00105989|12077355|FG000|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
10911052|NCT00105989|12077356|FG001|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
10911053|NCT00105989|12077355|FG000|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
10911054|NCT00105989|12077356|FG001|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
10911055|NCT00106002|12077372|FG000|STARTED|Overall Study||37
10911056|NCT00106002|12077372|FG000|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
10911057|NCT00106002|12077372|FG000|NOT COMPLETED|Overall Study||2
10911058|NCT00106028|12077378|FG000|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
10911059|NCT00106028|12077379|FG001|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
10911060|NCT00106028|12077378|FG000|Month 12 Completed/Started Open Label|Overall Study||49
10911061|NCT00106028|12077379|FG001|Month 12 Completed/Started Open Label|Overall Study||87
10911062|NCT00106028|12077378|FG000|COMPLETED|Overall Study|Completed Month 36|43
10911063|NCT00106028|12077379|FG001|COMPLETED|Overall Study|Completed Month 36|82
10911064|NCT00106028|12077378|FG000|NOT COMPLETED|Overall Study||6
10911065|NCT00106028|12077379|FG001|NOT COMPLETED|Overall Study||12
10911066|NCT00106080|12077389|FG000|STARTED|Overall Study||194
10911067|NCT00106080|12077390|FG001|STARTED|Overall Study||182
10911068|NCT00106080|12077389|FG000|COMPLETED|Overall Study||151
10911069|NCT00106080|12077390|FG001|COMPLETED|Overall Study||155
10911070|NCT00106080|12077389|FG000|NOT COMPLETED|Overall Study||43
10911071|NCT00106080|12077390|FG001|NOT COMPLETED|Overall Study||27
10911072|NCT00106106|12077398|FG000|STARTED|Overall Study||26
10911073|NCT00106106|12077399|FG001|STARTED|Overall Study||23
10911074|NCT00106106|12077398|FG000|Completed Both MRS Scans|Overall Study||18
10911075|NCT00106106|12077399|FG001|Completed Both MRS Scans|Overall Study||15
10911076|NCT00106106|12077398|FG000|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
10911077|NCT00106106|12077399|FG001|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
10911078|NCT00106106|12077398|FG000|NOT COMPLETED|Overall Study||4
10911079|NCT00106106|12077399|FG001|NOT COMPLETED|Overall Study||4
10911080|NCT00106119|12077405|FG000|STARTED|First Intervention||7
10911081|NCT00106119|12077406|FG001|STARTED|First Intervention||7
10911082|NCT00106119|12077405|FG000|COMPLETED|First Intervention||7
10911083|NCT00106119|12077406|FG001|COMPLETED|First Intervention||7
10911084|NCT00106119|12077405|FG000|NOT COMPLETED|First Intervention||0
10911085|NCT00106119|12077406|FG001|NOT COMPLETED|First Intervention||0
10911086|NCT00106119|12077405|FG000|STARTED|Washout Period of 30 Days||7
10911087|NCT00106119|12077406|FG001|STARTED|Washout Period of 30 Days||7
10911088|NCT00106119|12077405|FG000|COMPLETED|Washout Period of 30 Days||7
10911089|NCT00106119|12077406|FG001|COMPLETED|Washout Period of 30 Days||7
10911090|NCT00106119|12077405|FG000|NOT COMPLETED|Washout Period of 30 Days||0
10911091|NCT00106119|12077406|FG001|NOT COMPLETED|Washout Period of 30 Days||0
10911092|NCT00106119|12077405|FG000|STARTED|Second Intervention||7
10911093|NCT00106119|12077406|FG001|STARTED|Second Intervention||7
10911094|NCT00106119|12077405|FG000|COMPLETED|Second Intervention||7
10911095|NCT00106119|12077406|FG001|COMPLETED|Second Intervention||7
10911096|NCT00106119|12077405|FG000|NOT COMPLETED|Second Intervention||0
10911097|NCT00106119|12077406|FG001|NOT COMPLETED|Second Intervention||0
10911098|NCT00106184|12077414|FG000|STARTED|Overall Study||96
10911099|NCT00106184|12077415|FG001|STARTED|Overall Study||104
10911100|NCT00106184|12077414|FG000|Treated|Overall Study|96 subjects were randomized.|93
10911101|NCT00106184|12077415|FG001|Treated|Overall Study|104 subjects were randomized.|102
10911102|NCT00106184|12077414|FG000|COMPLETED|Overall Study||93
10911103|NCT00106184|12077415|FG001|COMPLETED|Overall Study||102
10911104|NCT00106184|12077414|FG000|NOT COMPLETED|Overall Study||3
10911105|NCT00106184|12077415|FG001|NOT COMPLETED|Overall Study||2
10911106|NCT00106249|12077425|FG000|STARTED|Overall Study||14
10911107|NCT00106249|12077426|FG001|STARTED|Overall Study||13
10911108|NCT00106249|12077425|FG000|COMPLETED|Overall Study||11
10911109|NCT00106249|12077426|FG001|COMPLETED|Overall Study||11
10911110|NCT00106249|12077425|FG000|NOT COMPLETED|Overall Study||3
10911111|NCT00106249|12077426|FG001|NOT COMPLETED|Overall Study||2
10911112|NCT00106353|12077434|FG000|STARTED|Part 1||4
10911113|NCT00106353|12077435|FG001|STARTED|Part 1||5
10911114|NCT00106353|12077436|FG002|STARTED|Part 1||3
10911115|NCT00106353|12077437|FG003|STARTED|Part 1||7
10911116|NCT00106353|12077438|FG004|STARTED|Part 1||0
10911117|NCT00106353|12077439|FG005|STARTED|Part 1||0
10911118|NCT00106353|12077440|FG006|STARTED|Part 1||0
10911119|NCT00106353|12077434|FG000|COMPLETED|Part 1||0
10911120|NCT00106353|12077435|FG001|COMPLETED|Part 1||0
10911121|NCT00106353|12077436|FG002|COMPLETED|Part 1||0
10911122|NCT00106353|12077437|FG003|COMPLETED|Part 1||0
10911123|NCT00106353|12077438|FG004|COMPLETED|Part 1||0
10911124|NCT00106353|12077439|FG005|COMPLETED|Part 1||0
10911125|NCT00106353|12077440|FG006|COMPLETED|Part 1||0
10911126|NCT00106353|12077434|FG000|NOT COMPLETED|Part 1||4
10911127|NCT00106353|12077435|FG001|NOT COMPLETED|Part 1||5
10911128|NCT00106353|12077436|FG002|NOT COMPLETED|Part 1||3
10911129|NCT00106353|12077437|FG003|NOT COMPLETED|Part 1||7
10911130|NCT00106353|12077438|FG004|NOT COMPLETED|Part 1||0
10911131|NCT00106353|12077439|FG005|NOT COMPLETED|Part 1||0
10911132|NCT00106353|12077440|FG006|NOT COMPLETED|Part 1||0
10911133|NCT00106353|12077434|FG000|STARTED|Part 2||0
10911134|NCT00106353|12077435|FG001|STARTED|Part 2||0
10911135|NCT00106353|12077436|FG002|STARTED|Part 2||0
10911136|NCT00106353|12077437|FG003|STARTED|Part 2||0
10911137|NCT00106353|12077438|FG004|STARTED|Part 2||17
10911138|NCT00106353|12077439|FG005|STARTED|Part 2||19
10911139|NCT00106353|12077440|FG006|STARTED|Part 2||16
10911140|NCT00106353|12077434|FG000|COMPLETED|Part 2||0
10911141|NCT00106353|12077435|FG001|COMPLETED|Part 2||0
10911142|NCT00106353|12077436|FG002|COMPLETED|Part 2||0
10911143|NCT00106353|12077437|FG003|COMPLETED|Part 2||0
10911144|NCT00106353|12077438|FG004|COMPLETED|Part 2||1
10911145|NCT00106353|12077439|FG005|COMPLETED|Part 2||1
10911146|NCT00106353|12077440|FG006|COMPLETED|Part 2||0
10911147|NCT00106353|12077434|FG000|NOT COMPLETED|Part 2||0
10911148|NCT00106353|12077435|FG001|NOT COMPLETED|Part 2||0
10911149|NCT00106353|12077436|FG002|NOT COMPLETED|Part 2||0
10911150|NCT00106353|12077437|FG003|NOT COMPLETED|Part 2||0
10911151|NCT00106353|12077438|FG004|NOT COMPLETED|Part 2||16
10911152|NCT00106353|12077439|FG005|NOT COMPLETED|Part 2||18
10911153|NCT00106353|12077440|FG006|NOT COMPLETED|Part 2||16
10911154|NCT00106392|12077463|FG000|STARTED|Overall Study||62
10911155|NCT00106392|12077464|FG001|STARTED|Overall Study||69
10911156|NCT00106392|12077463|FG000|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
10911157|NCT00106392|12077464|FG001|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
10911158|NCT00106392|12077463|FG000|Full Analysis Set (FAS)|Overall Study||53
10911159|NCT00106392|12077464|FG001|Full Analysis Set (FAS)|Overall Study||61
10911160|NCT00106392|12077463|FG000|COMPLETED|Overall Study||36
10911161|NCT00106392|12077464|FG001|COMPLETED|Overall Study||42
10911162|NCT00106392|12077463|FG000|NOT COMPLETED|Overall Study||26
10911163|NCT00106392|12077464|FG001|NOT COMPLETED|Overall Study||27
10911164|NCT00106431|12077470|FG000|STARTED|Overall Study||102
10911165|NCT00106431|12077470|FG000|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
10911166|NCT00106431|12077470|FG000|NOT COMPLETED|Overall Study||65
10911167|NCT00106535|12077477|FG000|STARTED|2-year Placebo Controlled Period||394
10911168|NCT00106535|12077478|FG001|STARTED|2-year Placebo Controlled Period||401
10911169|NCT00106535|12077479|FG002|STARTED|2-year Placebo Controlled Period||401
10911170|NCT00106535|12077480|FG003|STARTED|2-year Placebo Controlled Period||0
10911171|NCT00106535|12077477|FG000|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
10911172|NCT00106535|12077478|FG001|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
10911173|NCT00106535|12077479|FG002|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
10911174|NCT00106535|12077480|FG003|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
10911175|NCT00106535|12077477|FG000|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
10911176|NCT00106535|12077478|FG001|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
10911177|NCT00106535|12077479|FG002|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
10911178|NCT00106535|12077480|FG003|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
10911179|NCT00106535|12077477|FG000|Completed Week 24|2-year Placebo Controlled Period||356
10911180|NCT00106535|12077478|FG001|Completed Week 24|2-year Placebo Controlled Period||373
10911181|NCT00106535|12077479|FG002|Completed Week 24|2-year Placebo Controlled Period||366
10911182|NCT00106535|12077480|FG003|Completed Week 24|2-year Placebo Controlled Period||0
10911183|NCT00106535|12077477|FG000|Completed Week 52|2-year Placebo Controlled Period||326
10911184|NCT00106535|12077478|FG001|Completed Week 52|2-year Placebo Controlled Period||342
10911185|NCT00106535|12077479|FG002|Completed Week 52|2-year Placebo Controlled Period||338
10911186|NCT00106535|12077480|FG003|Completed Week 52|2-year Placebo Controlled Period||0
10911187|NCT00106535|12077477|FG000|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
10911188|NCT00106535|12077478|FG001|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
10911189|NCT00106535|12077479|FG002|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
10911190|NCT00106535|12077480|FG003|COMPLETED|2-year Placebo Controlled Period||0
10911191|NCT00106535|12077477|FG000|NOT COMPLETED|2-year Placebo Controlled Period||107
10911192|NCT00106535|12077478|FG001|NOT COMPLETED|2-year Placebo Controlled Period||92
10911193|NCT00106535|12077479|FG002|NOT COMPLETED|2-year Placebo Controlled Period||91
10911194|NCT00106535|12077480|FG003|NOT COMPLETED|2-year Placebo Controlled Period||0
10911195|NCT00106535|12077477|FG000|STARTED|Long-term Extension Period (Year 3 to 5)||0
10911196|NCT00106535|12077478|FG001|STARTED|Long-term Extension Period (Year 3 to 5)||0
10911197|NCT00106535|12077479|FG002|STARTED|Long-term Extension Period (Year 3 to 5)||0
10911198|NCT00106535|12077480|FG003|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
10911199|NCT00106535|12077477|FG000|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
10911200|NCT00106535|12077478|FG001|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
10911201|NCT00106535|12077479|FG002|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
10911202|NCT00106535|12077480|FG003|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
10911203|NCT00106535|12077477|FG000|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
10911204|NCT00106535|12077478|FG001|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
10911205|NCT00106535|12077479|FG002|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
10911206|NCT00106535|12077480|FG003|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
10911207|NCT00106639|12077495|FG000|STARTED|Overall Study||20
10911208|NCT00106639|12077496|FG001|STARTED|Overall Study||20
10911209|NCT00106639|12077497|FG002|STARTED|Overall Study||21
10911210|NCT00106639|12077495|FG000|COMPLETED|Overall Study||17
10911211|NCT00106639|12077496|FG001|COMPLETED|Overall Study||13
10911212|NCT00106639|12077497|FG002|COMPLETED|Overall Study||19
10911213|NCT00106639|12077495|FG000|NOT COMPLETED|Overall Study||3
10911214|NCT00106639|12077496|FG001|NOT COMPLETED|Overall Study||7
10911215|NCT00106639|12077497|FG002|NOT COMPLETED|Overall Study||2
10911216|NCT00106704|12077508|FG000|STARTED|Overall Study||222
10911217|NCT00106704|12077509|FG001|STARTED|Overall Study||219
10911218|NCT00106704|12077508|FG000|COMPLETED|Overall Study||91
10911219|NCT00106704|12077509|FG001|COMPLETED|Overall Study||68
10911220|NCT00106704|12077508|FG000|NOT COMPLETED|Overall Study||131
10911221|NCT00106704|12077509|FG001|NOT COMPLETED|Overall Study||151
10911222|NCT00106938|12077517|FG000|STARTED|Overall Study||1089
10911223|NCT00106938|12077518|FG001|STARTED|Overall Study||364
10911224|NCT00106938|12077517|FG000|COMPLETED|Overall Study||913
10911225|NCT00106938|12077518|FG001|COMPLETED|Overall Study||293
10911226|NCT00106938|12077517|FG000|NOT COMPLETED|Overall Study||176
10911227|NCT00106938|12077518|FG001|NOT COMPLETED|Overall Study||71
10911228|NCT00106964|12077527|FG000|STARTED|Overall Study||118
10911229|NCT00106964|12077528|FG001|STARTED|Overall Study||126
10911230|NCT00106964|12077529|FG002|STARTED|Overall Study||127
10911231|NCT00106964|12077527|FG000|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
10911232|NCT00106964|12077528|FG001|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
10911233|NCT00106964|12077529|FG002|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
10911234|NCT00106964|12077527|FG000|NOT COMPLETED|Overall Study||13
10911235|NCT00106964|12077528|FG001|NOT COMPLETED|Overall Study||15
10911236|NCT00106964|12077529|FG002|NOT COMPLETED|Overall Study||7
10911237|NCT00107042|12077548|FG000|STARTED|Overall Study||60
10911238|NCT00107042|12077549|FG001|STARTED|Overall Study||63
10911239|NCT00107042|12077548|FG000|COMPLETED|Overall Study||38
10911240|NCT00107042|12077549|FG001|COMPLETED|Overall Study||47
10911241|NCT00107042|12077548|FG000|NOT COMPLETED|Overall Study||22
10911242|NCT00107042|12077549|FG001|NOT COMPLETED|Overall Study||16
10911243|NCT00107120|12077599|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
10911244|NCT00107120|12077600|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
10911245|NCT00107120|12077599|FG000|COMPLETED|Overall Study||126
10911246|NCT00107120|12077600|FG001|COMPLETED|Overall Study||133
10911247|NCT00107120|12077599|FG000|NOT COMPLETED|Overall Study||29
10911248|NCT00107120|12077600|FG001|NOT COMPLETED|Overall Study||24
10911249|NCT00107172|12077608|FG000|STARTED|Overall Study||114
10911250|NCT00107172|12077609|FG001|STARTED|Overall Study||108
10911251|NCT00107172|12077608|FG000|COMPLETED|Overall Study||109
10911252|NCT00107172|12077609|FG001|COMPLETED|Overall Study||103
10911253|NCT00107172|12077608|FG000|NOT COMPLETED|Overall Study||5
10911254|NCT00107172|12077609|FG001|NOT COMPLETED|Overall Study||5
10911255|NCT00107276|12077615|FG000|STARTED|Overall Study||112
10911256|NCT00107276|12077615|FG000|Eligible|Overall Study||96
10911257|NCT00107276|12077615|FG000|COMPLETED|Overall Study||40
10911258|NCT00107276|12077615|FG000|NOT COMPLETED|Overall Study||72
10911259|NCT00107380|12077620|FG000|STARTED|Overall Study||86
10911260|NCT00107380|12077620|FG000|Eligible|Overall Study||84
10911261|NCT00107380|12077620|FG000|COMPLETED|Overall Study||56
10911262|NCT00107380|12077620|FG000|NOT COMPLETED|Overall Study||30
10911263|NCT00107536|12077625|FG000|STARTED|Overall Study||26
10911264|NCT00107536|12077625|FG000|COMPLETED|Overall Study||26
10911265|NCT00107536|12077625|FG000|NOT COMPLETED|Overall Study||0
10911266|NCT00107575|12077631|FG000|STARTED|Overall Study||119
10911267|NCT00107575|12077632|FG001|STARTED|Overall Study||117
10911268|NCT00107575|12077631|FG000|COMPLETED|Overall Study||108
10911269|NCT00107575|12077632|FG001|COMPLETED|Overall Study||107
10911270|NCT00107575|12077631|FG000|NOT COMPLETED|Overall Study||11
10911271|NCT00107575|12077632|FG001|NOT COMPLETED|Overall Study||10
10911272|NCT00107653|12077640|FG000|STARTED|Overall Study||269
10911273|NCT00107653|12077641|FG001|STARTED|Overall Study||300
10911274|NCT00107653|12077640|FG000|COMPLETED|Overall Study||190
10911275|NCT00107653|12077641|FG001|COMPLETED|Overall Study||224
10911276|NCT00107653|12077640|FG000|NOT COMPLETED|Overall Study||79
10911277|NCT00107653|12077641|FG001|NOT COMPLETED|Overall Study||76
10911278|NCT00107744|12077650|FG000|STARTED|Intervention 1 (8 Weeks)||117
10911279|NCT00107744|12077651|FG001|STARTED|Intervention 1 (8 Weeks)||117
10911280|NCT00107744|12077652|FG002|STARTED|Intervention 1 (8 Weeks)||118
10911281|NCT00107744|12077650|FG000|COMPLETED|Intervention 1 (8 Weeks)||101
10911282|NCT00107744|12077651|FG001|COMPLETED|Intervention 1 (8 Weeks)||104
10911283|NCT00107744|12077652|FG002|COMPLETED|Intervention 1 (8 Weeks)||101
10911284|NCT00107744|12077650|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16
10911285|NCT00107744|12077651|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13
10911286|NCT00107744|12077652|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17
10911287|NCT00107744|12077650|FG000|STARTED|Intervention 2 (8 Weeks)||101
10911288|NCT00107744|12077651|FG001|STARTED|Intervention 2 (8 Weeks)||104
10911289|NCT00107744|12077652|FG002|STARTED|Intervention 2 (8 Weeks)||101
10911290|NCT00107744|12077650|FG000|COMPLETED|Intervention 2 (8 Weeks)||93
10911291|NCT00107744|12077651|FG001|COMPLETED|Intervention 2 (8 Weeks)||92
10911292|NCT00107744|12077652|FG002|COMPLETED|Intervention 2 (8 Weeks)||88
10911293|NCT00107744|12077650|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8
10911294|NCT00107744|12077651|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12
10911295|NCT00107744|12077652|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13
10911296|NCT00107744|12077650|FG000|STARTED|Intervention 3 (8 Weeks)||93
10911297|NCT00107744|12077651|FG001|STARTED|Intervention 3 (8 Weeks)||92
10911298|NCT00107744|12077652|FG002|STARTED|Intervention 3 (8 Weeks)||88
10911299|NCT00107744|12077650|FG000|COMPLETED|Intervention 3 (8 Weeks)||93
10911300|NCT00107744|12077651|FG001|COMPLETED|Intervention 3 (8 Weeks)||92
10911301|NCT00107744|12077652|FG002|COMPLETED|Intervention 3 (8 Weeks)||88
10911302|NCT00107744|12077650|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0
10911303|NCT00107744|12077651|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0
10911304|NCT00107744|12077652|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0
10911305|NCT00107783|12077662|FG000|STARTED|Overall Study||20
10911306|NCT00107783|12077663|FG001|STARTED|Overall Study||20
10911307|NCT00107783|12077662|FG000|COMPLETED|Overall Study||17
10911308|NCT00107783|12077663|FG001|COMPLETED|Overall Study||16
10911309|NCT00107783|12077662|FG000|NOT COMPLETED|Overall Study||3
10911310|NCT00107783|12077663|FG001|NOT COMPLETED|Overall Study||4
10911311|NCT00107900|12077675|FG000|STARTED|Overall Study||85
10911312|NCT00107900|12077676|FG001|STARTED|Overall Study||75
10911313|NCT00107900|12077677|FG002|STARTED|Overall Study||129
10911314|NCT00107900|12077678|FG003|STARTED|Overall Study||99
10911315|NCT00107900|12077679|FG004|STARTED|Overall Study||115
10911316|NCT00107900|12077680|FG005|STARTED|Overall Study||103
10911317|NCT00107900|12077675|FG000|COMPLETED|Overall Study||75
10911318|NCT00107900|12077676|FG001|COMPLETED|Overall Study||72
10911319|NCT00107900|12077677|FG002|COMPLETED|Overall Study||104
10911320|NCT00107900|12077678|FG003|COMPLETED|Overall Study||87
10911321|NCT00107900|12077679|FG004|COMPLETED|Overall Study||94
10911322|NCT00107900|12077680|FG005|COMPLETED|Overall Study||94
10911323|NCT00107900|12077675|FG000|NOT COMPLETED|Overall Study||10
10911324|NCT00107900|12077676|FG001|NOT COMPLETED|Overall Study||3
10911325|NCT00107900|12077677|FG002|NOT COMPLETED|Overall Study||25
10911326|NCT00107900|12077678|FG003|NOT COMPLETED|Overall Study||12
10911327|NCT00107900|12077679|FG004|NOT COMPLETED|Overall Study||21
10911328|NCT00107900|12077680|FG005|NOT COMPLETED|Overall Study||9
10911329|NCT00107952|12077696|FG000|STARTED|Overall Study||381
10911330|NCT00107952|12077697|FG001|STARTED|Overall Study||380
10911331|NCT00107952|12077696|FG000|COMPLETED|Overall Study||286
10911332|NCT00107952|12077697|FG001|COMPLETED|Overall Study||299
10911333|NCT00107952|12077696|FG000|NOT COMPLETED|Overall Study||95
10911334|NCT00107952|12077697|FG001|NOT COMPLETED|Overall Study||81
10911335|NCT00107978|12077705|FG000|STARTED|Overall Study||458
10911336|NCT00107978|12077706|FG001|STARTED|Overall Study||481
10911337|NCT00107978|12077705|FG000|COMPLETED|Overall Study||425
10911338|NCT00107978|12077706|FG001|COMPLETED|Overall Study||431
10911339|NCT00107978|12077705|FG000|NOT COMPLETED|Overall Study||33
10911340|NCT00107978|12077706|FG001|NOT COMPLETED|Overall Study||50
10911341|NCT00107991|12077712|FG000|STARTED|Eligibility Assessment||38
10911342|NCT00107991|12077712|FG000|COMPLETED|Eligibility Assessment||15
10911343|NCT00107991|12077712|FG000|NOT COMPLETED|Eligibility Assessment||23
10911344|NCT00107991|12077712|FG000|STARTED|12 Week Treatment Period||15
10911345|NCT00107991|12077712|FG000|COMPLETED|12 Week Treatment Period||10
10911346|NCT00107991|12077712|FG000|NOT COMPLETED|12 Week Treatment Period||5
10911347|NCT00107991|12077712|FG000|STARTED|18-Week Post Treatment Assessment||10
10911348|NCT00107991|12077712|FG000|COMPLETED|18-Week Post Treatment Assessment||8
10911349|NCT00107991|12077712|FG000|NOT COMPLETED|18-Week Post Treatment Assessment||2
10911350|NCT00108069|12077718|FG000|STARTED|Overall Study||30
10911351|NCT00108069|12077719|FG001|STARTED|Overall Study||13
10911352|NCT00108069|12077718|FG000|COMPLETED|Overall Study||0
10911353|NCT00108069|12077719|FG001|COMPLETED|Overall Study||0
10911354|NCT00108069|12077718|FG000|NOT COMPLETED|Overall Study||30
10911355|NCT00108069|12077719|FG001|NOT COMPLETED|Overall Study||13
10911356|NCT00108082|12077734|FG000|STARTED|Overall Study||91
10911357|NCT00108082|12077735|FG001|STARTED|Overall Study||100
10911358|NCT00108082|12077736|FG002|STARTED|Overall Study||96
10911359|NCT00108082|12077734|FG000|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
10911360|NCT00108082|12077735|FG001|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
10911361|NCT00108082|12077736|FG002|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
10911362|NCT00108082|12077734|FG000|NOT COMPLETED|Overall Study||38
10911363|NCT00108082|12077735|FG001|NOT COMPLETED|Overall Study||32
10911364|NCT00108082|12077736|FG002|NOT COMPLETED|Overall Study||43
10911365|NCT00108160|12077746|FG000|STARTED|Overall Study||83
10911366|NCT00108160|12077747|FG001|STARTED|Overall Study||63
10911367|NCT00108160|12077746|FG000|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
10911368|NCT00108160|12077747|FG001|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
10911369|NCT00108160|12077746|FG000|Completed Visit 1 (2 Wks)|Overall Study||72
10911370|NCT00108160|12077747|FG001|Completed Visit 1 (2 Wks)|Overall Study||54
10911371|NCT00108160|12077746|FG000|Completed Visit 2 (3 mo)|Overall Study||54
10911372|NCT00108160|12077747|FG001|Completed Visit 2 (3 mo)|Overall Study||46
10911373|NCT00108160|12077746|FG000|Completed Visit 3 (6 mo)|Overall Study||44
10911374|NCT00108160|12077747|FG001|Completed Visit 3 (6 mo)|Overall Study||38
10911375|NCT00108160|12077746|FG000|Completed Visit 4 (9 mo)|Overall Study||38
10911376|NCT00108160|12077747|FG001|Completed Visit 4 (9 mo)|Overall Study||37
10911377|NCT00108160|12077746|FG000|Completed Visit 5 (12 mo)|Overall Study||37
10911378|NCT00108160|12077747|FG001|Completed Visit 5 (12 mo)|Overall Study||37
10911379|NCT00108160|12077746|FG000|Completed Visit 6 (15 mo)|Overall Study||36
10911380|NCT00108160|12077747|FG001|Completed Visit 6 (15 mo)|Overall Study||33
10911381|NCT00108160|12077746|FG000|Completed Visit 7 (18 mo)|Overall Study||34
10911382|NCT00108160|12077747|FG001|Completed Visit 7 (18 mo)|Overall Study||31
10911383|NCT00108160|12077746|FG000|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
10911384|NCT00108160|12077747|FG001|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
10911385|NCT00108160|12077746|FG000|NOT COMPLETED|Overall Study||39
10911386|NCT00108160|12077747|FG001|NOT COMPLETED|Overall Study||21
10911387|NCT00108277|12077758|FG000|STARTED|Overall Study||29
10911388|NCT00108277|12077759|FG001|STARTED|Overall Study||28
10911389|NCT00108277|12077760|FG002|STARTED|Overall Study||35
10911390|NCT00108277|12077758|FG000|COMPLETED|Overall Study||19
10911391|NCT00108277|12077759|FG001|COMPLETED|Overall Study||16
10911392|NCT00108277|12077760|FG002|COMPLETED|Overall Study||19
10911393|NCT00108277|12077758|FG000|NOT COMPLETED|Overall Study||10
10911394|NCT00108277|12077759|FG001|NOT COMPLETED|Overall Study||12
10911395|NCT00108277|12077760|FG002|NOT COMPLETED|Overall Study||16
10911396|NCT00108303|12077771|FG000|STARTED|Overall Study||179
10911397|NCT00108303|12077772|FG001|STARTED|Overall Study||179
10911398|NCT00108303|12077773|FG002|STARTED|Overall Study||180
10911399|NCT00108303|12077771|FG000|COMPLETED|Overall Study||179
10911400|NCT00108303|12077772|FG001|COMPLETED|Overall Study||179
10911401|NCT00108303|12077773|FG002|COMPLETED|Overall Study||180
10911402|NCT00108303|12077771|FG000|NOT COMPLETED|Overall Study||0
10911403|NCT00108303|12077772|FG001|NOT COMPLETED|Overall Study||0
10911404|NCT00108303|12077773|FG002|NOT COMPLETED|Overall Study||0
10911405|NCT00108355|12077787|FG000|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
10911406|NCT00108355|12077788|FG001|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
10911407|NCT00108355|12077787|FG000|COMPLETED|Overall Study||13
10911408|NCT00108355|12077788|FG001|COMPLETED|Overall Study||12
10911409|NCT00108355|12077787|FG000|NOT COMPLETED|Overall Study||2
10911410|NCT00108355|12077788|FG001|NOT COMPLETED|Overall Study||2
10911411|NCT00108485|12077796|FG000|STARTED|Overall Study||5
10911412|NCT00108485|12077797|FG001|STARTED|Overall Study||4
10911413|NCT00108485|12077796|FG000|COMPLETED|Overall Study||2
10911414|NCT00108485|12077797|FG001|COMPLETED|Overall Study||2
10911415|NCT00108485|12077796|FG000|NOT COMPLETED|Overall Study||3
10911416|NCT00108485|12077797|FG001|NOT COMPLETED|Overall Study||2
10911417|NCT00108524|12077805|FG000|STARTED|Overall Study||81
10911418|NCT00108524|12077806|FG001|STARTED|Overall Study||79
10911419|NCT00108524|12077805|FG000|COMPLETED|Overall Study||52
10911420|NCT00108524|12077806|FG001|COMPLETED|Overall Study||61
10911421|NCT00108524|12077805|FG000|NOT COMPLETED|Overall Study||29
10911422|NCT00108524|12077806|FG001|NOT COMPLETED|Overall Study||18
10911423|NCT00108550|12077814|FG000|STARTED|Overall Study||55
10911424|NCT00108550|12077815|FG001|STARTED|Overall Study||53
10911425|NCT00108550|12077814|FG000|COMPLETED|Overall Study||39
10911426|NCT00108550|12077815|FG001|COMPLETED|Overall Study||37
10911427|NCT00108550|12077814|FG000|NOT COMPLETED|Overall Study||16
10911428|NCT00108550|12077815|FG001|NOT COMPLETED|Overall Study||16
10911429|NCT00108628|12077823|FG000|STARTED|Overall Study||61
10911430|NCT00108628|12077824|FG001|STARTED|Overall Study||63
10911431|NCT00108628|12077823|FG000|Received One or More Sessions|Overall Study||53
10911432|NCT00108628|12077824|FG001|Received One or More Sessions|Overall Study||58
10911433|NCT00108628|12077823|FG000|Completed Treatment|Overall Study||42
10911434|NCT00108628|12077824|FG001|Completed Treatment|Overall Study||57
10911435|NCT00108628|12077823|FG000|COMPLETED|Overall Study||41
10911436|NCT00108628|12077824|FG001|COMPLETED|Overall Study||53
10911437|NCT00108628|12077823|FG000|NOT COMPLETED|Overall Study||20
10911438|NCT00108628|12077824|FG001|NOT COMPLETED|Overall Study||10
10911439|NCT00108732|12077830|FG000|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
10911440|NCT00108732|12077830|FG000|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
10911441|NCT00108732|12077830|FG000|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
10911442|NCT00108732|12077830|FG000|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
10911443|NCT00108732|12077830|FG000|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
10911444|NCT00108732|12077830|FG000|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
10911445|NCT00108732|12077830|FG000|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
10911446|NCT00108745|12077837|FG000|STARTED|Overall Study||387
10911447|NCT00108745|12077838|FG001|STARTED|Overall Study||384
10911448|NCT00108745|12077839|FG002|STARTED|Overall Study||386
10911449|NCT00108745|12077837|FG000|COMPLETED|Overall Study||353
10911450|NCT00108745|12077838|FG001|COMPLETED|Overall Study||349
10911451|NCT00108745|12077839|FG002|COMPLETED|Overall Study||349
10911452|NCT00108745|12077837|FG000|NOT COMPLETED|Overall Study||34
10911453|NCT00108745|12077838|FG001|NOT COMPLETED|Overall Study||35
10911454|NCT00108745|12077839|FG002|NOT COMPLETED|Overall Study||37
10911455|NCT00108862|12077849|FG000|STARTED|Overall Study||405
10911456|NCT00108862|12077850|FG001|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
10911457|NCT00108862|12077849|FG000|COMPLETED|Overall Study||337
10911458|NCT00108862|12077850|FG001|COMPLETED|Overall Study||339
10911459|NCT00108862|12077849|FG000|NOT COMPLETED|Overall Study||68
10911460|NCT00108862|12077850|FG001|NOT COMPLETED|Overall Study||62
10911461|NCT00108953|12077858|FG000|STARTED|Treatment Period|ITT population|47
10911462|NCT00108953|12077859|FG001|STARTED|Treatment Period|ITT population|49
10911463|NCT00108953|12077858|FG000|COMPLETED|Treatment Period|No patient under study medication anymore|47
10911464|NCT00108953|12077859|FG001|COMPLETED|Treatment Period|No patient under study medication anymore|49
10911465|NCT00108953|12077858|FG000|NOT COMPLETED|Treatment Period||0
10911466|NCT00108953|12077859|FG001|NOT COMPLETED|Treatment Period||0
10911467|NCT00108953|12077858|FG000|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
10911468|NCT00108953|12077859|FG001|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
10911469|NCT00108953|12077858|FG000|COMPLETED|Follow-up||11
10911470|NCT00108953|12077859|FG001|COMPLETED|Follow-up||12
10911471|NCT00108953|12077858|FG000|NOT COMPLETED|Follow-up||29
10911472|NCT00108953|12077859|FG001|NOT COMPLETED|Follow-up||33
10911473|NCT00109005|12077869|FG000|STARTED|Overall Study||8
10911474|NCT00109005|12077870|FG001|STARTED|Overall Study||9
10911475|NCT00109005|12077869|FG000|COMPLETED|Overall Study||8
10911476|NCT00109005|12077870|FG001|COMPLETED|Overall Study||9
10911477|NCT00109005|12077869|FG000|NOT COMPLETED|Overall Study||0
10911478|NCT00109005|12077870|FG001|NOT COMPLETED|Overall Study||0
10911479|NCT00109031|12077881|FG000|STARTED|Overall Study||11
10911480|NCT00109031|12077882|FG001|STARTED|Overall Study||10
10911481|NCT00109031|12077883|FG002|STARTED|Overall Study||14
10911482|NCT00109031|12077884|FG003|STARTED|Overall Study||12
10911483|NCT00109031|12077881|FG000|COMPLETED|Overall Study||11
10911484|NCT00109031|12077882|FG001|COMPLETED|Overall Study||8
10911485|NCT00109031|12077883|FG002|COMPLETED|Overall Study||12
10911486|NCT00109031|12077884|FG003|COMPLETED|Overall Study||12
10911487|NCT00109031|12077881|FG000|NOT COMPLETED|Overall Study||0
10911488|NCT00109031|12077882|FG001|NOT COMPLETED|Overall Study||2
10911489|NCT00109031|12077883|FG002|NOT COMPLETED|Overall Study||2
10911490|NCT00109031|12077884|FG003|NOT COMPLETED|Overall Study||0
10911491|NCT00109343|12077897|FG000|STARTED|Overall Study||510
10911492|NCT00109343|12077898|FG001|STARTED|Overall Study||258
10911493|NCT00109343|12077899|FG002|STARTED|Overall Study||259
10911494|NCT00109343|12077897|FG000|Vaccinated at Visit 1|Overall Study||510
10911495|NCT00109343|12077898|FG001|Vaccinated at Visit 1|Overall Study||258
10911496|NCT00109343|12077899|FG002|Vaccinated at Visit 1|Overall Study||259
10911497|NCT00109343|12077897|FG000|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
10911498|NCT00109343|12077898|FG001|Vaccinated at Visit 2|Overall Study||246
10911499|NCT00109343|12077899|FG002|Vaccinated at Visit 2|Overall Study||246
10911500|NCT00109343|12077897|FG000|Vaccinated at Visit 4|Overall Study||466
10911501|NCT00109343|12077898|FG001|Vaccinated at Visit 4|Overall Study||235
10911502|NCT00109343|12077899|FG002|Vaccinated at Visit 4|Overall Study||240
10911503|NCT00109343|12077897|FG000|COMPLETED|Overall Study||446
10911504|NCT00109343|12077898|FG001|COMPLETED|Overall Study||221
10911505|NCT00109343|12077899|FG002|COMPLETED|Overall Study||229
10911506|NCT00109343|12077897|FG000|NOT COMPLETED|Overall Study||64
10911507|NCT00109343|12077898|FG001|NOT COMPLETED|Overall Study||37
10911508|NCT00109343|12077899|FG002|NOT COMPLETED|Overall Study||30
10911509|NCT00109473|12077909|FG000|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
10911510|NCT00109473|12077910|FG001|STARTED|Baseline (0 Through 12 Weeks)||10
10911511|NCT00109473|12077909|FG000|Analyzed|Baseline (0 Through 12 Weeks)||10
10911512|NCT00109473|12077910|FG001|Analyzed|Baseline (0 Through 12 Weeks)||10
10911513|NCT00109473|12077909|FG000|COMPLETED|Baseline (0 Through 12 Weeks)||10
10911514|NCT00109473|12077910|FG001|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
10911515|NCT00109473|12077909|FG000|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
10911516|NCT00109473|12077910|FG001|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
10911517|NCT00109473|12077909|FG000|STARTED|Week 12 to Week 24||10
10911518|NCT00109473|12077910|FG001|STARTED|Week 12 to Week 24||9
10911519|NCT00109473|12077909|FG000|Analyzed|Week 12 to Week 24||9
10911520|NCT00109473|12077910|FG001|Analyzed|Week 12 to Week 24||9
10911521|NCT00109473|12077909|FG000|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
10911522|NCT00109473|12077910|FG001|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
10911523|NCT00109473|12077909|FG000|NOT COMPLETED|Week 12 to Week 24||1
10911524|NCT00109473|12077910|FG001|NOT COMPLETED|Week 12 to Week 24||0
10911525|NCT00109473|12077909|FG000|STARTED|52 Week Extension Phase||9
10911526|NCT00109473|12077910|FG001|STARTED|52 Week Extension Phase||8
10911527|NCT00109473|12077909|FG000|Analyzed|52 Week Extension Phase||9
10911528|NCT00109473|12077910|FG001|Analyzed|52 Week Extension Phase||8
10911611|NCT00110019|12078023|FG001|Eligible|Overall Study||398
10911529|NCT00109473|12077909|FG000|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
10911530|NCT00109473|12077910|FG001|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
10911531|NCT00109473|12077909|FG000|NOT COMPLETED|52 Week Extension Phase||4
10911532|NCT00109473|12077910|FG001|NOT COMPLETED|52 Week Extension Phase||5
10911533|NCT00109577|12077921|FG000|STARTED|Overall Study||20
10911534|NCT00109577|12077922|FG001|STARTED|Overall Study||20
10911535|NCT00109577|12077921|FG000|COMPLETED|Overall Study||17
10911536|NCT00109577|12077922|FG001|COMPLETED|Overall Study||17
10911537|NCT00109577|12077921|FG000|NOT COMPLETED|Overall Study||3
10911538|NCT00109577|12077922|FG001|NOT COMPLETED|Overall Study||3
10911539|NCT00109590|12077931|FG000|STARTED|Overall Study||57
10911540|NCT00109590|12077932|FG001|STARTED|Overall Study||58
10911541|NCT00109590|12077933|FG002|STARTED|Overall Study||60
10911542|NCT00109590|12077931|FG000|RECEIVED TREATMENT|Overall Study||56
10911543|NCT00109590|12077932|FG001|RECEIVED TREATMENT|Overall Study||56
10911544|NCT00109590|12077933|FG002|RECEIVED TREATMENT|Overall Study||57
10911545|NCT00109590|12077931|FG000|COMPLETED|Overall Study||55
10911546|NCT00109590|12077932|FG001|COMPLETED|Overall Study||56
10911547|NCT00109590|12077933|FG002|COMPLETED|Overall Study||56
10911548|NCT00109590|12077931|FG000|NOT COMPLETED|Overall Study||2
10911549|NCT00109590|12077932|FG001|NOT COMPLETED|Overall Study||2
10911550|NCT00109590|12077933|FG002|NOT COMPLETED|Overall Study||4
10911551|NCT00109707|12077958|FG000|STARTED|Overall Study||321
10911552|NCT00109707|12077959|FG001|STARTED|Overall Study||137
10911553|NCT00109707|12077960|FG002|STARTED|Overall Study||49
10911554|NCT00109707|12077958|FG000|Entered Extension Study|Overall Study||106
10911555|NCT00109707|12077959|FG001|Entered Extension Study|Overall Study||15
10911556|NCT00109707|12077960|FG002|Entered Extension Study|Overall Study||15
10911557|NCT00109707|12077958|FG000|COMPLETED|Overall Study||67
10911558|NCT00109707|12077959|FG001|COMPLETED|Overall Study||8
10911559|NCT00109707|12077960|FG002|COMPLETED|Overall Study||8
10911560|NCT00109707|12077958|FG000|NOT COMPLETED|Overall Study||254
10911561|NCT00109707|12077959|FG001|NOT COMPLETED|Overall Study||129
10911562|NCT00109707|12077960|FG002|NOT COMPLETED|Overall Study||41
10911563|NCT00109733|12077974|FG000|STARTED|Overall Study||15
10911564|NCT00109733|12077975|FG001|STARTED|Overall Study||16
10911565|NCT00109733|12077974|FG000|COMPLETED|Overall Study||13
10911566|NCT00109733|12077975|FG001|COMPLETED|Overall Study||12
10911567|NCT00109733|12077974|FG000|NOT COMPLETED|Overall Study||2
10911568|NCT00109733|12077975|FG001|NOT COMPLETED|Overall Study||4
10911569|NCT00109772|12077983|FG000|STARTED|Double-blind Treatment||90
10911570|NCT00109772|12077984|FG001|STARTED|Double-blind Treatment||94
10911571|NCT00109772|12077983|FG000|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
10911572|NCT00109772|12077984|FG001|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
10911573|NCT00109772|12077983|FG000|COMPLETED|Double-blind Treatment||68
10911574|NCT00109772|12077984|FG001|COMPLETED|Double-blind Treatment||79
10911575|NCT00109772|12077983|FG000|NOT COMPLETED|Double-blind Treatment||22
10911576|NCT00109772|12077984|FG001|NOT COMPLETED|Double-blind Treatment||15
10911577|NCT00109772|12077983|FG000|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
10911578|NCT00109772|12077984|FG001|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
10911579|NCT00109772|12077983|FG000|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
10911580|NCT00109772|12077984|FG001|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
10911581|NCT00109772|12077983|FG000|NOT COMPLETED|Open-label Extension||45
10911582|NCT00109772|12077984|FG001|NOT COMPLETED|Open-label Extension||49
10911583|NCT00109837|12077990|FG000|STARTED|Overall Study||79
10911584|NCT00109837|12077990|FG000|Eligible|Overall Study||78
10911585|NCT00109837|12077990|FG000|Eligible and Ph-|Overall Study||61
10911586|NCT00109837|12077990|FG000|Eligible and Ph- and Treated|Overall Study||60
10911587|NCT00109837|12077990|FG000|COMPLETED|Overall Study||56
10911588|NCT00109837|12077990|FG000|NOT COMPLETED|Overall Study||23
10911589|NCT00109850|12077998|FG000|STARTED|Overall Study||22
10911590|NCT00109850|12077998|FG000|Eligible|Overall Study||21
10911591|NCT00109850|12077998|FG000|Eligible and Began Protocol Therapy|Overall Study||21
10911592|NCT00109850|12077998|FG000|COMPLETED|Overall Study||18
10911593|NCT00109850|12077998|FG000|NOT COMPLETED|Overall Study||4
10911594|NCT00109876|12078002|FG000|STARTED|Overall Study||51
10911595|NCT00109876|12078002|FG000|COMPLETED|Overall Study||51
10911596|NCT00109876|12078002|FG000|NOT COMPLETED|Overall Study||0
10911597|NCT00109928|12078006|FG000|STARTED|Overall Study||34
10911598|NCT00109928|12078006|FG000|Eligible|Overall Study||33
10911599|NCT00109928|12078006|FG000|Eligible and Began Protocol Therapy|Overall Study||33
10911600|NCT00109928|12078006|FG000|COMPLETED|Overall Study||21
10911601|NCT00109928|12078006|FG000|NOT COMPLETED|Overall Study||13
10911602|NCT00109967|12078013|FG000|STARTED|Overall Study||50
10911603|NCT00109967|12078014|FG001|STARTED|Overall Study||21
10911604|NCT00109967|12078013|FG000|COMPLETED|Overall Study||30
10911605|NCT00109967|12078014|FG001|COMPLETED|Overall Study||15
10911606|NCT00109967|12078013|FG000|NOT COMPLETED|Overall Study||20
10911607|NCT00109967|12078014|FG001|NOT COMPLETED|Overall Study||6
10911608|NCT00110019|12078022|FG000|STARTED|Overall Study||410
10911609|NCT00110019|12078023|FG001|STARTED|Overall Study||413
10911610|NCT00110019|12078022|FG000|Eligible|Overall Study||395
10911612|NCT00110019|12078022|FG000|Treated|Overall Study||393
10911613|NCT00110019|12078023|FG001|Treated|Overall Study||397
10911614|NCT00110019|12078022|FG000|COMPLETED|Overall Study||4
10911615|NCT00110019|12078023|FG001|COMPLETED|Overall Study||0
10911616|NCT00110019|12078022|FG000|NOT COMPLETED|Overall Study||406
10911617|NCT00110019|12078023|FG001|NOT COMPLETED|Overall Study||413
10911618|NCT00110084|12078029|FG000|STARTED|Overall Study||50
10911619|NCT00110084|12078029|FG000|COMPLETED|Overall Study||22
10911620|NCT00110084|12078029|FG000|NOT COMPLETED|Overall Study||28
10911621|NCT00110136|12078033|FG000|STARTED|Overall Study||9
10911622|NCT00110136|12078033|FG000|COMPLETED|Overall Study||9
10911623|NCT00110136|12078033|FG000|NOT COMPLETED|Overall Study||0
10911624|NCT00110149|12078038|FG000|STARTED|Overall Study|total number that signed consent to be screened.|12
10911625|NCT00110149|12078038|FG000|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
10911626|NCT00110149|12078038|FG000|COMPLETED|Overall Study||9
10911627|NCT00110149|12078038|FG000|NOT COMPLETED|Overall Study||3
10911628|NCT00110214|12078045|FG000|STARTED|Overall Study||526
10911629|NCT00110214|12078046|FG001|STARTED|Overall Study||524
10911630|NCT00110214|12078045|FG000|COMPLETED|Overall Study||17
10911631|NCT00110214|12078046|FG001|COMPLETED|Overall Study||21
10911632|NCT00110214|12078045|FG000|NOT COMPLETED|Overall Study||509
10911633|NCT00110214|12078046|FG001|NOT COMPLETED|Overall Study||503
10911634|NCT00110266|12078052|FG000|STARTED|Overall Study||173
10911635|NCT00110266|12078052|FG000|COMPLETED|Overall Study||95
10911636|NCT00110266|12078052|FG000|NOT COMPLETED|Overall Study||78
10911637|NCT00110305|12078061|FG000|STARTED|Overall Study||279
10911638|NCT00110305|12078062|FG001|STARTED|Overall Study||89
10911639|NCT00110305|12078061|FG000|COMPLETED|Overall Study||165
10911640|NCT00110305|12078062|FG001|COMPLETED|Overall Study||57
10911641|NCT00110305|12078061|FG000|NOT COMPLETED|Overall Study||114
10911642|NCT00110305|12078062|FG001|NOT COMPLETED|Overall Study||32
10911643|NCT00110357|12078081|FG000|STARTED|Overall Study||27
10911644|NCT00110357|12078082|FG001|STARTED|Overall Study||19
10911645|NCT00110357|12078081|FG000|COMPLETED|Overall Study|Number Still on Study|0
10911646|NCT00110357|12078082|FG001|COMPLETED|Overall Study|Number Still on Study|0
10911647|NCT00110357|12078081|FG000|NOT COMPLETED|Overall Study||27
10911648|NCT00110357|12078082|FG001|NOT COMPLETED|Overall Study||19
10911649|NCT00110396|12078115|FG000|STARTED|Overall Study||260
10911650|NCT00110396|12078115|FG000|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
10911651|NCT00110396|12078115|FG000|NOT COMPLETED|Overall Study||36
10911652|NCT00110461|12078122|FG000|STARTED|30-Week, Double-blind Treatment Phase||98
10911653|NCT00110461|12078123|FG001|STARTED|30-Week, Double-blind Treatment Phase||99
10911654|NCT00110461|12078124|FG002|STARTED|30-Week, Double-blind Treatment Phase||99
10911655|NCT00110461|12078122|FG000|COMPLETED|30-Week, Double-blind Treatment Phase||34
10911656|NCT00110461|12078123|FG001|COMPLETED|30-Week, Double-blind Treatment Phase||22
10911657|NCT00110461|12078124|FG002|COMPLETED|30-Week, Double-blind Treatment Phase||12
10911658|NCT00110461|12078122|FG000|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
10911659|NCT00110461|12078123|FG001|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
10911660|NCT00110461|12078124|FG002|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
10911661|NCT00110461|12078122|FG000|STARTED|Acute Phase||98
10911662|NCT00110461|12078123|FG001|STARTED|Acute Phase||99
10911663|NCT00110461|12078124|FG002|STARTED|Acute Phase||99
10911664|NCT00110461|12078122|FG000|COMPLETED|Acute Phase||84
10911665|NCT00110461|12078123|FG001|COMPLETED|Acute Phase||77
10911666|NCT00110461|12078124|FG002|COMPLETED|Acute Phase||76
10911667|NCT00110461|12078122|FG000|NOT COMPLETED|Acute Phase||14
10911668|NCT00110461|12078123|FG001|NOT COMPLETED|Acute Phase||22
10911669|NCT00110461|12078124|FG002|NOT COMPLETED|Acute Phase||23
10911670|NCT00110513|12078132|FG000|STARTED|Overall Study||18
10911671|NCT00110513|12078132|FG000|COMPLETED|Overall Study||18
10911672|NCT00110513|12078132|FG000|NOT COMPLETED|Overall Study||0
10911673|NCT00110617|12078138|FG000|STARTED|Overall Study||135
10911674|NCT00110617|12078139|FG001|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
10911675|NCT00110617|12078138|FG000|Safety Set 1; Received Study Drug|Overall Study||135
10911676|NCT00110617|12078139|FG001|Safety Set 1; Received Study Drug|Overall Study||56
10911677|NCT00110617|12078138|FG000|Full Analysis 2; Received ICL670|Overall Study||135
10911678|NCT00110617|12078139|FG001|Full Analysis 2; Received ICL670|Overall Study||53
10911679|NCT00110617|12078138|FG000|On Going at Week 24|Overall Study||126
10911680|NCT00110617|12078139|FG001|On Going at Week 24|Overall Study||53
10911681|NCT00110617|12078138|FG000|COMPLETED|Overall Study||96
10911682|NCT00110617|12078139|FG001|COMPLETED|Overall Study||39
10911683|NCT00110617|12078138|FG000|NOT COMPLETED|Overall Study||39
10911684|NCT00110617|12078139|FG001|NOT COMPLETED|Overall Study||29
10911685|NCT00110812|12078150|FG000|STARTED|Main Study||91
10911686|NCT00110812|12078151|FG001|STARTED|Main Study||89
10911687|NCT00110812|12078152|FG002|STARTED|Main Study||87
10911688|NCT00110812|12078150|FG000|COMPLETED|Main Study||83
10911689|NCT00110812|12078151|FG001|COMPLETED|Main Study||78
10911690|NCT00110812|12078152|FG002|COMPLETED|Main Study||74
10911691|NCT00110812|12078150|FG000|NOT COMPLETED|Main Study||8
10911692|NCT00110812|12078151|FG001|NOT COMPLETED|Main Study||11
10911693|NCT00110812|12078152|FG002|NOT COMPLETED|Main Study||13
10911694|NCT00110812|12078150|FG000|STARTED|Extended Follow-up||80
10911695|NCT00110812|12078151|FG001|STARTED|Extended Follow-up||69
10911696|NCT00110812|12078152|FG002|STARTED|Extended Follow-up||73
10911697|NCT00110812|12078150|FG000|COMPLETED|Extended Follow-up||78
10911698|NCT00110812|12078151|FG001|COMPLETED|Extended Follow-up||65
10911699|NCT00110812|12078152|FG002|COMPLETED|Extended Follow-up||69
10911700|NCT00110812|12078150|FG000|NOT COMPLETED|Extended Follow-up||2
10911701|NCT00110812|12078151|FG001|NOT COMPLETED|Extended Follow-up||4
10911702|NCT00110812|12078152|FG002|NOT COMPLETED|Extended Follow-up||4
10911703|NCT00110890|12078167|FG000|STARTED|Overall Study||368
10911704|NCT00110890|12078168|FG001|STARTED|Overall Study||184
10911705|NCT00110890|12078167|FG000|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
10911706|NCT00110890|12078168|FG001|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
10911707|NCT00110890|12078167|FG000|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
10911708|NCT00110890|12078168|FG001|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
10911709|NCT00110890|12078167|FG000|COMPLETED|Overall Study|Follow-up Phase|7
10911710|NCT00110890|12078168|FG001|COMPLETED|Overall Study|Follow-up Phase|5
10911711|NCT00110890|12078167|FG000|NOT COMPLETED|Overall Study||361
10911712|NCT00110890|12078168|FG001|NOT COMPLETED|Overall Study||179
10911713|NCT00110994|12078176|FG000|STARTED|Double-blind (DB) Treatment|ITT population|51
10911714|NCT00110994|12078177|FG001|STARTED|Double-blind (DB) Treatment|ITT population|50
10911715|NCT00110994|12078176|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|51
10911716|NCT00110994|12078177|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|50
10911717|NCT00110994|12078176|FG000|COMPLETED|Double-blind (DB) Treatment||9
10911718|NCT00110994|12078177|FG001|COMPLETED|Double-blind (DB) Treatment||3
10911719|NCT00110994|12078176|FG000|NOT COMPLETED|Double-blind (DB) Treatment||42
10911720|NCT00110994|12078177|FG001|NOT COMPLETED|Double-blind (DB) Treatment||47
10911721|NCT00110994|12078176|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
10911722|NCT00110994|12078177|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
10911723|NCT00110994|12078176|FG000|COMPLETED|Active Follow-up||0
10911724|NCT00110994|12078177|FG001|COMPLETED|Active Follow-up||0
10911725|NCT00110994|12078176|FG000|NOT COMPLETED|Active Follow-up||1
10911726|NCT00110994|12078177|FG001|NOT COMPLETED|Active Follow-up||2
10911727|NCT00110994|12078176|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
10911728|NCT00110994|12078177|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
10911729|NCT00110994|12078176|FG000|COMPLETED|Long Term Follow-up||22
10911730|NCT00110994|12078177|FG001|COMPLETED|Long Term Follow-up||30
10911731|NCT00110994|12078176|FG000|NOT COMPLETED|Long Term Follow-up||19
10911732|NCT00110994|12078177|FG001|NOT COMPLETED|Long Term Follow-up||17
10911733|NCT00111007|12078185|FG000|STARTED|Double-blind (DB) Treatment|ITT population|135
10911734|NCT00111007|12078186|FG001|STARTED|Double-blind (DB) Treatment|ITT population|135
10911735|NCT00111007|12078185|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|134
10911736|NCT00111007|12078186|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|134
10911737|NCT00111007|12078185|FG000|COMPLETED|Double-blind (DB) Treatment||27
10911738|NCT00111007|12078186|FG001|COMPLETED|Double-blind (DB) Treatment||24
10911739|NCT00111007|12078185|FG000|NOT COMPLETED|Double-blind (DB) Treatment||108
10911740|NCT00111007|12078186|FG001|NOT COMPLETED|Double-blind (DB) Treatment||111
10911741|NCT00111007|12078185|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
10911742|NCT00111007|12078186|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
10911743|NCT00111007|12078185|FG000|COMPLETED|Active Follow-up||0
10911744|NCT00111007|12078186|FG001|COMPLETED|Active Follow-up||2
10911745|NCT00111007|12078185|FG000|NOT COMPLETED|Active Follow-up||6
10911746|NCT00111007|12078186|FG001|NOT COMPLETED|Active Follow-up||2
10911747|NCT00111007|12078185|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
10911748|NCT00111007|12078186|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
10911749|NCT00111007|12078185|FG000|COMPLETED|Long Term Follow-up||54
10911750|NCT00111007|12078186|FG001|COMPLETED|Long Term Follow-up||62
10911751|NCT00111007|12078185|FG000|NOT COMPLETED|Long Term Follow-up||47
10911752|NCT00111007|12078186|FG001|NOT COMPLETED|Long Term Follow-up||45
10911753|NCT00111228|12078195|FG000|STARTED|Overall Study||54
10911754|NCT00111228|12078196|FG001|STARTED|Overall Study||54
10911755|NCT00111228|12078197|FG002|STARTED|Overall Study||54
10911756|NCT00111228|12078195|FG000|COMPLETED|Overall Study||49
10911757|NCT00111228|12078196|FG001|COMPLETED|Overall Study||53
10911758|NCT00111228|12078197|FG002|COMPLETED|Overall Study||54
10911759|NCT00111228|12078195|FG000|NOT COMPLETED|Overall Study||5
10911760|NCT00111228|12078196|FG001|NOT COMPLETED|Overall Study||1
10911761|NCT00111228|12078197|FG002|NOT COMPLETED|Overall Study||0
10911762|NCT00111241|12078207|FG000|STARTED|Overall Study||45
10911763|NCT00111241|12078208|FG001|STARTED|Overall Study||70
10911764|NCT00111241|12078207|FG000|COMPLETED|Overall Study||30
10911765|NCT00111241|12078208|FG001|COMPLETED|Overall Study||62
10911766|NCT00111241|12078207|FG000|NOT COMPLETED|Overall Study||15
10911767|NCT00111241|12078208|FG001|NOT COMPLETED|Overall Study||8
10911768|NCT00111475|12078226|FG000|STARTED|Overall Study||4
10911769|NCT00111475|12078227|FG001|STARTED|Overall Study||4
10911770|NCT00111475|12078228|FG002|STARTED|Overall Study||4
10911771|NCT00111475|12078229|FG003|STARTED|Overall Study||4
10911772|NCT00111475|12078230|FG004|STARTED|Overall Study||4
10911773|NCT00111475|12078231|FG005|STARTED|Overall Study||4
10911774|NCT00111475|12078232|FG006|STARTED|Overall Study||4
10911775|NCT00111475|12078233|FG007|STARTED|Overall Study||8
10911776|NCT00111475|12078234|FG008|STARTED|Overall Study||8
10911777|NCT00111475|12078235|FG009|STARTED|Overall Study||1
10911778|NCT00111475|12078226|FG000|COMPLETED|Overall Study||4
10911779|NCT00111475|12078227|FG001|COMPLETED|Overall Study||4
10911780|NCT00111475|12078228|FG002|COMPLETED|Overall Study||4
10911781|NCT00111475|12078229|FG003|COMPLETED|Overall Study||4
10911782|NCT00111475|12078230|FG004|COMPLETED|Overall Study||4
10911783|NCT00111475|12078231|FG005|COMPLETED|Overall Study||3
10911784|NCT00111475|12078232|FG006|COMPLETED|Overall Study||4
10911785|NCT00111475|12078233|FG007|COMPLETED|Overall Study||8
10911786|NCT00111475|12078234|FG008|COMPLETED|Overall Study||8
10911787|NCT00111475|12078235|FG009|COMPLETED|Overall Study||1
10911788|NCT00111475|12078226|FG000|NOT COMPLETED|Overall Study||0
10911789|NCT00111475|12078227|FG001|NOT COMPLETED|Overall Study||0
10911790|NCT00111475|12078228|FG002|NOT COMPLETED|Overall Study||0
10911791|NCT00111475|12078229|FG003|NOT COMPLETED|Overall Study||0
10911792|NCT00111475|12078230|FG004|NOT COMPLETED|Overall Study||0
10911793|NCT00111475|12078231|FG005|NOT COMPLETED|Overall Study||1
10911794|NCT00111475|12078232|FG006|NOT COMPLETED|Overall Study||0
10911795|NCT00111475|12078233|FG007|NOT COMPLETED|Overall Study||0
10911796|NCT00111475|12078234|FG008|NOT COMPLETED|Overall Study||0
10911797|NCT00111475|12078235|FG009|NOT COMPLETED|Overall Study||0
10911798|NCT00111657|12078262|FG000|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
10911799|NCT00111657|12078262|FG000|COMPLETED|Overall Study|Completed all intended doses.|21
10911800|NCT00111657|12078262|FG000|NOT COMPLETED|Overall Study||16
10911801|NCT00111761|12078270|FG000|STARTED|Part 1|This treatment group was not initiated until Part 2|0
10911802|NCT00111761|12078271|FG001|STARTED|Part 1||19
10911803|NCT00111761|12078270|FG000|COMPLETED|Part 1||0
10911804|NCT00111761|12078271|FG001|COMPLETED|Part 1|Completed through safety followup|14
10911805|NCT00111761|12078270|FG000|NOT COMPLETED|Part 1||0
10911806|NCT00111761|12078271|FG001|NOT COMPLETED|Part 1||5
10911807|NCT00111761|12078270|FG000|STARTED|Part 2||24
10911808|NCT00111761|12078271|FG001|STARTED|Part 2|This treatment group was used in Part 1 only|0
10911809|NCT00111761|12078270|FG000|COMPLETED|Part 2||16
10911810|NCT00111761|12078271|FG001|COMPLETED|Part 2||0
10911811|NCT00111761|12078270|FG000|NOT COMPLETED|Part 2||8
10911812|NCT00111761|12078271|FG001|NOT COMPLETED|Part 2||0
10911813|NCT00111800|12078283|FG000|STARTED|Period 1: Main Phase (12 Weeks)||64
10911814|NCT00111800|12078284|FG001|STARTED|Period 1: Main Phase (12 Weeks)||61
10911815|NCT00111800|12078285|FG002|STARTED|Period 1: Main Phase (12 Weeks)||63
10911816|NCT00111800|12078286|FG003|STARTED|Period 1: Main Phase (12 Weeks)||66
10911817|NCT00111800|12078287|FG004|STARTED|Period 1: Main Phase (12 Weeks)||60
10911818|NCT00111800|12078288|FG005|STARTED|Period 1: Main Phase (12 Weeks)||61
10911819|NCT00111800|12078283|FG000|COMPLETED|Period 1: Main Phase (12 Weeks)||49
10911820|NCT00111800|12078284|FG001|COMPLETED|Period 1: Main Phase (12 Weeks)||47
10911821|NCT00111800|12078285|FG002|COMPLETED|Period 1: Main Phase (12 Weeks)||54
10911822|NCT00111800|12078286|FG003|COMPLETED|Period 1: Main Phase (12 Weeks)||60
10911823|NCT00111800|12078287|FG004|COMPLETED|Period 1: Main Phase (12 Weeks)||55
10911824|NCT00111800|12078288|FG005|COMPLETED|Period 1: Main Phase (12 Weeks)||56
10911825|NCT00111800|12078283|FG000|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
10911826|NCT00111800|12078284|FG001|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
10911827|NCT00111800|12078285|FG002|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
10911828|NCT00111800|12078286|FG003|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
10911829|NCT00111800|12078287|FG004|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
10911830|NCT00111800|12078288|FG005|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
10911831|NCT00111800|12078283|FG000|STARTED|Period 2: Extension Phase (12 Weeks)||48
10911832|NCT00111800|12078284|FG001|STARTED|Period 2: Extension Phase (12 Weeks)||47
10911833|NCT00111800|12078285|FG002|STARTED|Period 2: Extension Phase (12 Weeks)||54
10911834|NCT00111800|12078286|FG003|STARTED|Period 2: Extension Phase (12 Weeks)||59
10911835|NCT00111800|12078287|FG004|STARTED|Period 2: Extension Phase (12 Weeks)||55
10911836|NCT00111800|12078288|FG005|STARTED|Period 2: Extension Phase (12 Weeks)||55
10911837|NCT00111800|12078283|FG000|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
10911838|NCT00111800|12078284|FG001|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
10911839|NCT00111800|12078285|FG002|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
10911840|NCT00111800|12078286|FG003|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
10911841|NCT00111800|12078287|FG004|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
10911842|NCT00111800|12078288|FG005|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
10911843|NCT00111800|12078283|FG000|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
10911844|NCT00111800|12078284|FG001|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
10911845|NCT00111800|12078285|FG002|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
10911846|NCT00111800|12078286|FG003|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
10911847|NCT00111800|12078287|FG004|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
10911848|NCT00111800|12078288|FG005|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
10911849|NCT00111813|12078311|FG000|STARTED|Overall Study||3
10911850|NCT00111813|12078312|FG001|STARTED|Overall Study||3
10911851|NCT00111813|12078313|FG002|STARTED|Overall Study||10
10911852|NCT00111813|12078314|FG003|STARTED|Overall Study||6
10911853|NCT00111813|12078315|FG004|STARTED|Overall Study||6
10911854|NCT00111813|12078316|FG005|STARTED|Overall Study||6
10911855|NCT00111813|12078311|FG000|COMPLETED|Overall Study||0
10911856|NCT00111813|12078312|FG001|COMPLETED|Overall Study||0
10911857|NCT00111813|12078313|FG002|COMPLETED|Overall Study||0
10911858|NCT00111813|12078314|FG003|COMPLETED|Overall Study||1
10911859|NCT00111813|12078315|FG004|COMPLETED|Overall Study||0
10911860|NCT00111813|12078316|FG005|COMPLETED|Overall Study||0
10911861|NCT00111813|12078311|FG000|NOT COMPLETED|Overall Study||3
10911862|NCT00111813|12078312|FG001|NOT COMPLETED|Overall Study||3
10911863|NCT00111813|12078313|FG002|NOT COMPLETED|Overall Study||10
10911864|NCT00111813|12078314|FG003|NOT COMPLETED|Overall Study||5
10911865|NCT00111813|12078315|FG004|NOT COMPLETED|Overall Study||6
10911866|NCT00111813|12078316|FG005|NOT COMPLETED|Overall Study||6
10911867|NCT00111839|12078334|FG000|STARTED|Overall Study||50
10911868|NCT00111839|12078335|FG001|STARTED|Overall Study||51
10911869|NCT00111839|12078336|FG002|STARTED|Overall Study||49
10911870|NCT00111839|12078334|FG000|Treated|Overall Study||50
10911871|NCT00111839|12078335|FG001|Treated|Overall Study||51
10911872|NCT00111839|12078336|FG002|Treated|Overall Study||47
10911873|NCT00111839|12078334|FG000|COMPLETED|Overall Study||2
10911874|NCT00111839|12078335|FG001|COMPLETED|Overall Study||5
10911875|NCT00111839|12078336|FG002|COMPLETED|Overall Study||0
10911876|NCT00111839|12078334|FG000|NOT COMPLETED|Overall Study||48
10911877|NCT00111839|12078335|FG001|NOT COMPLETED|Overall Study||46
10911878|NCT00111839|12078336|FG002|NOT COMPLETED|Overall Study||49
10911879|NCT00111917|12078346|FG000|STARTED|Overall Study||9
10911880|NCT00111917|12078347|FG001|STARTED|Overall Study||4
10911881|NCT00111917|12078346|FG000|COMPLETED|Overall Study||8
10911882|NCT00111917|12078347|FG001|COMPLETED|Overall Study||3
10911883|NCT00111917|12078346|FG000|NOT COMPLETED|Overall Study||1
10911884|NCT00111917|12078347|FG001|NOT COMPLETED|Overall Study||1
10911885|NCT00112047|12078359|FG000|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
10911886|NCT00112047|12078360|FG001|STARTED|Randomized Phase|ITT analysis population|254
10911887|NCT00112047|12078359|FG000|COMPLETED|Randomized Phase||187
10911888|NCT00112047|12078360|FG001|COMPLETED|Randomized Phase||166
10911889|NCT00112047|12078359|FG000|NOT COMPLETED|Randomized Phase||70
10911890|NCT00112047|12078360|FG001|NOT COMPLETED|Randomized Phase||88
10911891|NCT00112047|12078359|FG000|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
10911892|NCT00112047|12078360|FG001|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
10911893|NCT00112047|12078359|FG000|COMPLETED|Atripla Phase||142
10911894|NCT00112047|12078360|FG001|COMPLETED|Atripla Phase||106
10911895|NCT00112047|12078359|FG000|NOT COMPLETED|Atripla Phase||18
10911896|NCT00112047|12078360|FG001|NOT COMPLETED|Atripla Phase||20
10911897|NCT00112112|12078373|FG000|STARTED|Overall Study||10
10911898|NCT00112112|12078374|FG001|STARTED|Overall Study||10
10911899|NCT00112112|12078373|FG000|COMPLETED|Overall Study||10
10911900|NCT00112112|12078374|FG001|COMPLETED|Overall Study||10
10911901|NCT00112112|12078373|FG000|NOT COMPLETED|Overall Study||0
10911902|NCT00112112|12078374|FG001|NOT COMPLETED|Overall Study||0
10911903|NCT00112125|12078382|FG000|STARTED|Overall Study||213
10911904|NCT00112125|12078383|FG001|STARTED|Overall Study||215
10911905|NCT00112125|12078382|FG000|COMPLETED|Overall Study||189
10911906|NCT00112125|12078383|FG001|COMPLETED|Overall Study||193
10911907|NCT00112125|12078382|FG000|NOT COMPLETED|Overall Study||24
10911908|NCT00112125|12078383|FG001|NOT COMPLETED|Overall Study||22
10911909|NCT00112151|12078395|FG000|STARTED|Overall Study||28
10911910|NCT00112151|12078396|FG001|STARTED|Overall Study||28
10911911|NCT00112151|12078397|FG002|STARTED|Overall Study||28
10911912|NCT00112151|12078398|FG003|STARTED|Overall Study||27
10911913|NCT00112151|12078399|FG004|STARTED|Overall Study||28
10911914|NCT00112151|12078400|FG005|STARTED|Overall Study||28
10911915|NCT00112151|12078395|FG000|COMPLETED|Overall Study||24
10911916|NCT00112151|12078396|FG001|COMPLETED|Overall Study||23
10911917|NCT00112151|12078397|FG002|COMPLETED|Overall Study||25
10911918|NCT00112151|12078398|FG003|COMPLETED|Overall Study||24
10911919|NCT00112151|12078399|FG004|COMPLETED|Overall Study||22
10911920|NCT00112151|12078400|FG005|COMPLETED|Overall Study||25
10911921|NCT00112151|12078395|FG000|NOT COMPLETED|Overall Study||4
10911922|NCT00112151|12078396|FG001|NOT COMPLETED|Overall Study||5
10911923|NCT00112151|12078397|FG002|NOT COMPLETED|Overall Study||3
10911924|NCT00112151|12078398|FG003|NOT COMPLETED|Overall Study||3
10911925|NCT00112151|12078399|FG004|NOT COMPLETED|Overall Study||6
10911926|NCT00112151|12078400|FG005|NOT COMPLETED|Overall Study||3
10911927|NCT00112242|12078416|FG000|STARTED|Overall Study||10
10911928|NCT00112242|12078417|FG001|STARTED|Overall Study||5
10911929|NCT00112242|12078418|FG002|STARTED|Overall Study||5
10911930|NCT00112242|12078419|FG003|STARTED|Overall Study||10
10911931|NCT00112242|12078420|FG004|STARTED|Overall Study|One patient received only 1 vaccine however this minimum dose allowed the safety evaluation|9
10911932|NCT00112242|12078416|FG000|Cycle 1 Completed|Overall Study||10
10911933|NCT00112242|12078417|FG001|Cycle 1 Completed|Overall Study||5
10911934|NCT00112242|12078418|FG002|Cycle 1 Completed|Overall Study||5
10911935|NCT00112242|12078419|FG003|Cycle 1 Completed|Overall Study||9
10911936|NCT00112242|12078420|FG004|Cycle 1 Completed|Overall Study||7
10911937|NCT00112242|12078416|FG000|Cycle 2 Completed|Overall Study||8
10911938|NCT00112242|12078417|FG001|Cycle 2 Completed|Overall Study||3
10911939|NCT00112242|12078418|FG002|Cycle 2 Completed|Overall Study||4
10911940|NCT00112242|12078419|FG003|Cycle 2 Completed|Overall Study||8
10911941|NCT00112242|12078420|FG004|Cycle 2 Completed|Overall Study||4
10911942|NCT00112242|12078416|FG000|Cycle 3 Completed|Overall Study||5
10911943|NCT00112242|12078417|FG001|Cycle 3 Completed|Overall Study||3
10911944|NCT00112242|12078418|FG002|Cycle 3 Completed|Overall Study||4
10911945|NCT00112242|12078419|FG003|Cycle 3 Completed|Overall Study||4
10911946|NCT00112242|12078420|FG004|Cycle 3 Completed|Overall Study||2
10911947|NCT00112242|12078416|FG000|COMPLETED|Overall Study||5
10911948|NCT00112242|12078417|FG001|COMPLETED|Overall Study||3
10911949|NCT00112242|12078418|FG002|COMPLETED|Overall Study||4
10911950|NCT00112242|12078419|FG003|COMPLETED|Overall Study||4
10911951|NCT00112242|12078420|FG004|COMPLETED|Overall Study||2
10911952|NCT00112242|12078416|FG000|NOT COMPLETED|Overall Study||5
10911953|NCT00112242|12078417|FG001|NOT COMPLETED|Overall Study||2
10911954|NCT00112242|12078418|FG002|NOT COMPLETED|Overall Study||1
10911955|NCT00112242|12078419|FG003|NOT COMPLETED|Overall Study||6
10911956|NCT00112242|12078420|FG004|NOT COMPLETED|Overall Study||7
10911957|NCT00112294|12078442|FG000|STARTED|Overall Study|338 randomized and 325 treated.|325
10911958|NCT00112294|12078443|FG001|STARTED|Overall Study|338 randomized and 320 treated.|320
10911959|NCT00112294|12078442|FG000|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
10911960|NCT00112294|12078443|FG001|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
10911961|NCT00112294|12078442|FG000|COMPLETED|Overall Study|Off all study therapies.|320
10911962|NCT00112294|12078443|FG001|COMPLETED|Overall Study|Off all study therapies.|320
10911963|NCT00112294|12078442|FG000|NOT COMPLETED|Overall Study||5
10911964|NCT00112294|12078443|FG001|NOT COMPLETED|Overall Study||0
10911965|NCT00112359|12078451|FG000|STARTED|Overall Study||84
10911966|NCT00112359|12078452|FG001|STARTED|Overall Study||80
10911967|NCT00112359|12078451|FG000|COMPLETED|Overall Study||57
10911968|NCT00112359|12078452|FG001|COMPLETED|Overall Study||67
10911969|NCT00112359|12078451|FG000|NOT COMPLETED|Overall Study||27
10911970|NCT00112359|12078452|FG001|NOT COMPLETED|Overall Study||13
10911971|NCT00112385|12078460|FG000|STARTED|Overall Study||11
10911972|NCT00112385|12078461|FG001|STARTED|Overall Study||5
10911973|NCT00112385|12078460|FG000|COMPLETED|Overall Study||10
10911974|NCT00112385|12078461|FG001|COMPLETED|Overall Study||4
10911975|NCT00112385|12078460|FG000|NOT COMPLETED|Overall Study||1
10911976|NCT00112385|12078461|FG001|NOT COMPLETED|Overall Study||1
10911977|NCT00112437|12078472|FG000|STARTED|Year 1 (12-Month Base Study)||83
10911978|NCT00112437|12078473|FG001|STARTED|Year 1 (12-Month Base Study)||82
10911979|NCT00112437|12078474|FG002|STARTED|Year 1 (12-Month Base Study)||77
10911980|NCT00112437|12078475|FG003|STARTED|Year 1 (12-Month Base Study)||79
10911981|NCT00112437|12078476|FG004|STARTED|Year 1 (12-Month Base Study)||78
10911982|NCT00112437|12078477|FG005|STARTED|Year 1 (12-Month Base Study)||0
10911983|NCT00112437|12078478|FG006|STARTED|Year 1 (12-Month Base Study)||0
10911984|NCT00112437|12078479|FG007|STARTED|Year 1 (12-Month Base Study)||0
10911985|NCT00112437|12078480|FG008|STARTED|Year 1 (12-Month Base Study)||0
10911986|NCT00112437|12078481|FG009|STARTED|Year 1 (12-Month Base Study)||0
10911987|NCT00112437|12078482|FG010|STARTED|Year 1 (12-Month Base Study)||0
10911988|NCT00112437|12078483|FG011|STARTED|Year 1 (12-Month Base Study)||0
10911989|NCT00112437|12078484|FG012|STARTED|Year 1 (12-Month Base Study)||0
10911990|NCT00112437|12078485|FG013|STARTED|Year 1 (12-Month Base Study)||0
10911991|NCT00112437|12078486|FG014|STARTED|Year 1 (12-Month Base Study)||0
10911992|NCT00112437|12078487|FG015|STARTED|Year 1 (12-Month Base Study)||0
10911993|NCT00112437|12078488|FG016|STARTED|Year 1 (12-Month Base Study)||0
10911994|NCT00112437|12078489|FG017|STARTED|Year 1 (12-Month Base Study)||0
10911995|NCT00112437|12078490|FG018|STARTED|Year 1 (12-Month Base Study)||0
10911996|NCT00112437|12078491|FG019|STARTED|Year 1 (12-Month Base Study)||0
10911997|NCT00112437|12078492|FG020|STARTED|Year 1 (12-Month Base Study)||0
10911998|NCT00112437|12078493|FG021|STARTED|Year 1 (12-Month Base Study)||0
10911999|NCT00112437|12078494|FG022|STARTED|Year 1 (12-Month Base Study)||0
10912000|NCT00112437|12078495|FG023|STARTED|Year 1 (12-Month Base Study)||0
10912001|NCT00112437|12078496|FG024|STARTED|Year 1 (12-Month Base Study)||0
10912002|NCT00112437|12078497|FG025|STARTED|Year 1 (12-Month Base Study)||0
10912003|NCT00112437|12078472|FG000|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
10912004|NCT00112437|12078473|FG001|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
10912005|NCT00112437|12078474|FG002|COMPLETED|Year 1 (12-Month Base Study)||65
10912006|NCT00112437|12078475|FG003|COMPLETED|Year 1 (12-Month Base Study)||71
10912007|NCT00112437|12078476|FG004|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
10912008|NCT00112437|12078477|FG005|COMPLETED|Year 1 (12-Month Base Study)||0
10912009|NCT00112437|12078478|FG006|COMPLETED|Year 1 (12-Month Base Study)||0
10912010|NCT00112437|12078479|FG007|COMPLETED|Year 1 (12-Month Base Study)||0
10912011|NCT00112437|12078480|FG008|COMPLETED|Year 1 (12-Month Base Study)||0
10912012|NCT00112437|12078481|FG009|COMPLETED|Year 1 (12-Month Base Study)||0
10912013|NCT00112437|12078482|FG010|COMPLETED|Year 1 (12-Month Base Study)||0
10912014|NCT00112437|12078483|FG011|COMPLETED|Year 1 (12-Month Base Study)||0
10912015|NCT00112437|12078484|FG012|COMPLETED|Year 1 (12-Month Base Study)||0
10912016|NCT00112437|12078485|FG013|COMPLETED|Year 1 (12-Month Base Study)||0
10912017|NCT00112437|12078486|FG014|COMPLETED|Year 1 (12-Month Base Study)||0
10912018|NCT00112437|12078487|FG015|COMPLETED|Year 1 (12-Month Base Study)||0
10912019|NCT00112437|12078488|FG016|COMPLETED|Year 1 (12-Month Base Study)||0
10912020|NCT00112437|12078489|FG017|COMPLETED|Year 1 (12-Month Base Study)||0
10912021|NCT00112437|12078490|FG018|COMPLETED|Year 1 (12-Month Base Study)||0
10912022|NCT00112437|12078491|FG019|COMPLETED|Year 1 (12-Month Base Study)||0
10912023|NCT00112437|12078492|FG020|COMPLETED|Year 1 (12-Month Base Study)||0
10912024|NCT00112437|12078493|FG021|COMPLETED|Year 1 (12-Month Base Study)||0
10912025|NCT00112437|12078494|FG022|COMPLETED|Year 1 (12-Month Base Study)||0
10912026|NCT00112437|12078495|FG023|COMPLETED|Year 1 (12-Month Base Study)||0
10912027|NCT00112437|12078496|FG024|COMPLETED|Year 1 (12-Month Base Study)||0
10912028|NCT00112437|12078497|FG025|COMPLETED|Year 1 (12-Month Base Study)||0
10912029|NCT00112437|12078472|FG000|NOT COMPLETED|Year 1 (12-Month Base Study)||15
10912030|NCT00112437|12078473|FG001|NOT COMPLETED|Year 1 (12-Month Base Study)||18
10912031|NCT00112437|12078474|FG002|NOT COMPLETED|Year 1 (12-Month Base Study)||12
10912032|NCT00112437|12078475|FG003|NOT COMPLETED|Year 1 (12-Month Base Study)||8
10912033|NCT00112437|12078476|FG004|NOT COMPLETED|Year 1 (12-Month Base Study)||12
10912034|NCT00112437|12078477|FG005|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912035|NCT00112437|12078478|FG006|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912036|NCT00112437|12078479|FG007|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912037|NCT00112437|12078480|FG008|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912038|NCT00112437|12078481|FG009|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912039|NCT00112437|12078482|FG010|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912040|NCT00112437|12078483|FG011|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912041|NCT00112437|12078484|FG012|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912042|NCT00112437|12078485|FG013|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912043|NCT00112437|12078486|FG014|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912044|NCT00112437|12078487|FG015|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912045|NCT00112437|12078488|FG016|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912046|NCT00112437|12078489|FG017|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912047|NCT00112437|12078490|FG018|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912048|NCT00112437|12078491|FG019|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912049|NCT00112437|12078492|FG020|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912050|NCT00112437|12078493|FG021|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912051|NCT00112437|12078494|FG022|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912052|NCT00112437|12078495|FG023|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912053|NCT00112437|12078496|FG024|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912054|NCT00112437|12078497|FG025|NOT COMPLETED|Year 1 (12-Month Base Study)||0
10912055|NCT00112437|12078472|FG000|STARTED|Year 2 (12-Month Extension)||0
10912056|NCT00112437|12078473|FG001|STARTED|Year 2 (12-Month Extension)||0
10912057|NCT00112437|12078474|FG002|STARTED|Year 2 (12-Month Extension)||0
10912058|NCT00112437|12078475|FG003|STARTED|Year 2 (12-Month Extension)||0
10912059|NCT00112437|12078476|FG004|STARTED|Year 2 (12-Month Extension)||0
10912060|NCT00112437|12078477|FG005|STARTED|Year 2 (12-Month Extension)||63
10912061|NCT00112437|12078478|FG006|STARTED|Year 2 (12-Month Extension)||62
10912062|NCT00112437|12078479|FG007|STARTED|Year 2 (12-Month Extension)||63
10912063|NCT00112437|12078480|FG008|STARTED|Year 2 (12-Month Extension)||69
10912064|NCT00112437|12078481|FG009|STARTED|Year 2 (12-Month Extension)||63
10912065|NCT00112437|12078482|FG010|STARTED|Year 2 (12-Month Extension)||0
10912066|NCT00112437|12078483|FG011|STARTED|Year 2 (12-Month Extension)||0
10912067|NCT00112437|12078484|FG012|STARTED|Year 2 (12-Month Extension)||0
10912068|NCT00112437|12078485|FG013|STARTED|Year 2 (12-Month Extension)||0
10912069|NCT00112437|12078486|FG014|STARTED|Year 2 (12-Month Extension)||0
10912070|NCT00112437|12078487|FG015|STARTED|Year 2 (12-Month Extension)||0
10912071|NCT00112437|12078488|FG016|STARTED|Year 2 (12-Month Extension)||0
10912072|NCT00112437|12078489|FG017|STARTED|Year 2 (12-Month Extension)||0
10912073|NCT00112437|12078490|FG018|STARTED|Year 2 (12-Month Extension)||0
10912074|NCT00112437|12078491|FG019|STARTED|Year 2 (12-Month Extension)||0
10912075|NCT00112437|12078492|FG020|STARTED|Year 2 (12-Month Extension)||0
10912076|NCT00112437|12078493|FG021|STARTED|Year 2 (12-Month Extension)||0
10912077|NCT00112437|12078494|FG022|STARTED|Year 2 (12-Month Extension)||0
10912078|NCT00112437|12078495|FG023|STARTED|Year 2 (12-Month Extension)||0
10912079|NCT00112437|12078496|FG024|STARTED|Year 2 (12-Month Extension)||0
10912080|NCT00112437|12078497|FG025|STARTED|Year 2 (12-Month Extension)||0
10912081|NCT00112437|12078472|FG000|COMPLETED|Year 2 (12-Month Extension)||0
10912082|NCT00112437|12078473|FG001|COMPLETED|Year 2 (12-Month Extension)||0
10912083|NCT00112437|12078474|FG002|COMPLETED|Year 2 (12-Month Extension)||0
10912084|NCT00112437|12078475|FG003|COMPLETED|Year 2 (12-Month Extension)||0
10912085|NCT00112437|12078476|FG004|COMPLETED|Year 2 (12-Month Extension)||0
10912086|NCT00112437|12078477|FG005|COMPLETED|Year 2 (12-Month Extension)||60
10912087|NCT00112437|12078478|FG006|COMPLETED|Year 2 (12-Month Extension)||53
10912088|NCT00112437|12078479|FG007|COMPLETED|Year 2 (12-Month Extension)||55
10912089|NCT00112437|12078480|FG008|COMPLETED|Year 2 (12-Month Extension)||62
10912090|NCT00112437|12078481|FG009|COMPLETED|Year 2 (12-Month Extension)||50
10912091|NCT00112437|12078482|FG010|COMPLETED|Year 2 (12-Month Extension)||0
10912092|NCT00112437|12078483|FG011|COMPLETED|Year 2 (12-Month Extension)||0
10912093|NCT00112437|12078484|FG012|COMPLETED|Year 2 (12-Month Extension)||0
10912094|NCT00112437|12078485|FG013|COMPLETED|Year 2 (12-Month Extension)||0
10912095|NCT00112437|12078486|FG014|COMPLETED|Year 2 (12-Month Extension)||0
10912096|NCT00112437|12078487|FG015|COMPLETED|Year 2 (12-Month Extension)||0
10912097|NCT00112437|12078488|FG016|COMPLETED|Year 2 (12-Month Extension)||0
10912098|NCT00112437|12078489|FG017|COMPLETED|Year 2 (12-Month Extension)||0
10912099|NCT00112437|12078490|FG018|COMPLETED|Year 2 (12-Month Extension)||0
10912100|NCT00112437|12078491|FG019|COMPLETED|Year 2 (12-Month Extension)||0
10912101|NCT00112437|12078492|FG020|COMPLETED|Year 2 (12-Month Extension)||0
10912102|NCT00112437|12078493|FG021|COMPLETED|Year 2 (12-Month Extension)||0
10912103|NCT00112437|12078494|FG022|COMPLETED|Year 2 (12-Month Extension)||0
10912104|NCT00112437|12078495|FG023|COMPLETED|Year 2 (12-Month Extension)||0
10912105|NCT00112437|12078496|FG024|COMPLETED|Year 2 (12-Month Extension)||0
10912106|NCT00112437|12078497|FG025|COMPLETED|Year 2 (12-Month Extension)||0
10912107|NCT00112437|12078472|FG000|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912108|NCT00112437|12078473|FG001|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912109|NCT00112437|12078474|FG002|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912110|NCT00112437|12078475|FG003|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912111|NCT00112437|12078476|FG004|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912112|NCT00112437|12078477|FG005|NOT COMPLETED|Year 2 (12-Month Extension)||3
10912113|NCT00112437|12078478|FG006|NOT COMPLETED|Year 2 (12-Month Extension)||9
10912114|NCT00112437|12078479|FG007|NOT COMPLETED|Year 2 (12-Month Extension)||8
10912115|NCT00112437|12078480|FG008|NOT COMPLETED|Year 2 (12-Month Extension)||7
10912116|NCT00112437|12078481|FG009|NOT COMPLETED|Year 2 (12-Month Extension)||13
10912117|NCT00112437|12078482|FG010|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912118|NCT00112437|12078483|FG011|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912119|NCT00112437|12078484|FG012|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912120|NCT00112437|12078485|FG013|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912121|NCT00112437|12078486|FG014|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912122|NCT00112437|12078487|FG015|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912123|NCT00112437|12078488|FG016|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912124|NCT00112437|12078489|FG017|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912125|NCT00112437|12078490|FG018|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912126|NCT00112437|12078491|FG019|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912127|NCT00112437|12078492|FG020|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912128|NCT00112437|12078493|FG021|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912129|NCT00112437|12078494|FG022|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912130|NCT00112437|12078495|FG023|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912131|NCT00112437|12078496|FG024|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912132|NCT00112437|12078497|FG025|NOT COMPLETED|Year 2 (12-Month Extension)||0
10912133|NCT00112437|12078472|FG000|STARTED|Year 3 (12-Month Extension)||0
10912134|NCT00112437|12078473|FG001|STARTED|Year 3 (12-Month Extension)||0
10912135|NCT00112437|12078474|FG002|STARTED|Year 3 (12-Month Extension)||0
10912136|NCT00112437|12078475|FG003|STARTED|Year 3 (12-Month Extension)||0
10912137|NCT00112437|12078476|FG004|STARTED|Year 3 (12-Month Extension)||0
10912138|NCT00112437|12078477|FG005|STARTED|Year 3 (12-Month Extension)||0
10912139|NCT00112437|12078478|FG006|STARTED|Year 3 (12-Month Extension)||0
10912140|NCT00112437|12078479|FG007|STARTED|Year 3 (12-Month Extension)||0
10912141|NCT00112437|12078480|FG008|STARTED|Year 3 (12-Month Extension)||0
10912142|NCT00112437|12078481|FG009|STARTED|Year 3 (12-Month Extension)||0
10912143|NCT00112437|12078482|FG010|STARTED|Year 3 (12-Month Extension)||19
10912144|NCT00112437|12078483|FG011|STARTED|Year 3 (12-Month Extension)||22
10912145|NCT00112437|12078484|FG012|STARTED|Year 3 (12-Month Extension)||18
10912146|NCT00112437|12078485|FG013|STARTED|Year 3 (12-Month Extension)||17
10912147|NCT00112437|12078486|FG014|STARTED|Year 3 (12-Month Extension)||18
10912148|NCT00112437|12078487|FG015|STARTED|Year 3 (12-Month Extension)||17
10912149|NCT00112437|12078488|FG016|STARTED|Year 3 (12-Month Extension)||19
10912150|NCT00112437|12078489|FG017|STARTED|Year 3 (12-Month Extension)||21
10912151|NCT00112437|12078490|FG018|STARTED|Year 3 (12-Month Extension)||18
10912152|NCT00112437|12078491|FG019|STARTED|Year 3 (12-Month Extension)||20
10912153|NCT00112437|12078492|FG020|STARTED|Year 3 (12-Month Extension)||0
10912154|NCT00112437|12078493|FG021|STARTED|Year 3 (12-Month Extension)||0
10912155|NCT00112437|12078494|FG022|STARTED|Year 3 (12-Month Extension)||0
10912156|NCT00112437|12078495|FG023|STARTED|Year 3 (12-Month Extension)||0
10912157|NCT00112437|12078496|FG024|STARTED|Year 3 (12-Month Extension)||0
10912158|NCT00112437|12078497|FG025|STARTED|Year 3 (12-Month Extension)||0
10912159|NCT00112437|12078472|FG000|COMPLETED|Year 3 (12-Month Extension)||0
10912160|NCT00112437|12078473|FG001|COMPLETED|Year 3 (12-Month Extension)||0
10912161|NCT00112437|12078474|FG002|COMPLETED|Year 3 (12-Month Extension)||0
10912162|NCT00112437|12078475|FG003|COMPLETED|Year 3 (12-Month Extension)||0
10912163|NCT00112437|12078476|FG004|COMPLETED|Year 3 (12-Month Extension)||0
10912164|NCT00112437|12078477|FG005|COMPLETED|Year 3 (12-Month Extension)||0
10912165|NCT00112437|12078478|FG006|COMPLETED|Year 3 (12-Month Extension)||0
10912166|NCT00112437|12078479|FG007|COMPLETED|Year 3 (12-Month Extension)||0
10912167|NCT00112437|12078480|FG008|COMPLETED|Year 3 (12-Month Extension)||0
10912168|NCT00112437|12078481|FG009|COMPLETED|Year 3 (12-Month Extension)||0
10912169|NCT00112437|12078482|FG010|COMPLETED|Year 3 (12-Month Extension)||17
10912170|NCT00112437|12078483|FG011|COMPLETED|Year 3 (12-Month Extension)||17
10912171|NCT00112437|12078484|FG012|COMPLETED|Year 3 (12-Month Extension)||18
10912172|NCT00112437|12078485|FG013|COMPLETED|Year 3 (12-Month Extension)||16
10912173|NCT00112437|12078486|FG014|COMPLETED|Year 3 (12-Month Extension)||17
10912174|NCT00112437|12078487|FG015|COMPLETED|Year 3 (12-Month Extension)||13
10912175|NCT00112437|12078488|FG016|COMPLETED|Year 3 (12-Month Extension)||16
10912176|NCT00112437|12078489|FG017|COMPLETED|Year 3 (12-Month Extension)||20
10912177|NCT00112437|12078490|FG018|COMPLETED|Year 3 (12-Month Extension)||16
10912178|NCT00112437|12078491|FG019|COMPLETED|Year 3 (12-Month Extension)||19
10912179|NCT00112437|12078492|FG020|COMPLETED|Year 3 (12-Month Extension)||0
10912180|NCT00112437|12078493|FG021|COMPLETED|Year 3 (12-Month Extension)||0
10912181|NCT00112437|12078494|FG022|COMPLETED|Year 3 (12-Month Extension)||0
10912182|NCT00112437|12078495|FG023|COMPLETED|Year 3 (12-Month Extension)||0
10912183|NCT00112437|12078496|FG024|COMPLETED|Year 3 (12-Month Extension)||0
10912184|NCT00112437|12078497|FG025|COMPLETED|Year 3 (12-Month Extension)||0
10912185|NCT00112437|12078472|FG000|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912186|NCT00112437|12078473|FG001|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912187|NCT00112437|12078474|FG002|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912188|NCT00112437|12078475|FG003|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912189|NCT00112437|12078476|FG004|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912190|NCT00112437|12078477|FG005|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912191|NCT00112437|12078478|FG006|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912192|NCT00112437|12078479|FG007|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912193|NCT00112437|12078480|FG008|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912194|NCT00112437|12078481|FG009|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912195|NCT00112437|12078482|FG010|NOT COMPLETED|Year 3 (12-Month Extension)||2
10912196|NCT00112437|12078483|FG011|NOT COMPLETED|Year 3 (12-Month Extension)||5
10912197|NCT00112437|12078484|FG012|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912198|NCT00112437|12078485|FG013|NOT COMPLETED|Year 3 (12-Month Extension)||1
10912199|NCT00112437|12078486|FG014|NOT COMPLETED|Year 3 (12-Month Extension)||1
10912200|NCT00112437|12078487|FG015|NOT COMPLETED|Year 3 (12-Month Extension)||4
10912201|NCT00112437|12078488|FG016|NOT COMPLETED|Year 3 (12-Month Extension)||3
10912202|NCT00112437|12078489|FG017|NOT COMPLETED|Year 3 (12-Month Extension)||1
10912203|NCT00112437|12078490|FG018|NOT COMPLETED|Year 3 (12-Month Extension)||2
10912204|NCT00112437|12078491|FG019|NOT COMPLETED|Year 3 (12-Month Extension)||1
10912205|NCT00112437|12078492|FG020|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912206|NCT00112437|12078493|FG021|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912207|NCT00112437|12078494|FG022|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912208|NCT00112437|12078495|FG023|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912209|NCT00112437|12078496|FG024|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912210|NCT00112437|12078497|FG025|NOT COMPLETED|Year 3 (12-Month Extension)||0
10912211|NCT00112437|12078472|FG000|STARTED|Years 4-5 (24-Month Extension)||0
10912212|NCT00112437|12078473|FG001|STARTED|Years 4-5 (24-Month Extension)||0
10912213|NCT00112437|12078474|FG002|STARTED|Years 4-5 (24-Month Extension)||0
10912214|NCT00112437|12078475|FG003|STARTED|Years 4-5 (24-Month Extension)||0
10912215|NCT00112437|12078476|FG004|STARTED|Years 4-5 (24-Month Extension)||0
10912216|NCT00112437|12078477|FG005|STARTED|Years 4-5 (24-Month Extension)||0
10912217|NCT00112437|12078478|FG006|STARTED|Years 4-5 (24-Month Extension)||0
10912218|NCT00112437|12078479|FG007|STARTED|Years 4-5 (24-Month Extension)||0
10912219|NCT00112437|12078480|FG008|STARTED|Years 4-5 (24-Month Extension)||0
10912220|NCT00112437|12078481|FG009|STARTED|Years 4-5 (24-Month Extension)||0
10912221|NCT00112437|12078482|FG010|STARTED|Years 4-5 (24-Month Extension)||0
10912222|NCT00112437|12078483|FG011|STARTED|Years 4-5 (24-Month Extension)||0
10912223|NCT00112437|12078484|FG012|STARTED|Years 4-5 (24-Month Extension)||0
10912224|NCT00112437|12078485|FG013|STARTED|Years 4-5 (24-Month Extension)||0
10912225|NCT00112437|12078486|FG014|STARTED|Years 4-5 (24-Month Extension)||0
10912226|NCT00112437|12078487|FG015|STARTED|Years 4-5 (24-Month Extension)||0
10912227|NCT00112437|12078488|FG016|STARTED|Years 4-5 (24-Month Extension)||0
10912228|NCT00112437|12078489|FG017|STARTED|Years 4-5 (24-Month Extension)||0
10912229|NCT00112437|12078490|FG018|STARTED|Years 4-5 (24-Month Extension)||0
10912230|NCT00112437|12078491|FG019|STARTED|Years 4-5 (24-Month Extension)||0
10912231|NCT00112437|12078492|FG020|STARTED|Years 4-5 (24-Month Extension)||41
10912232|NCT00112437|12078493|FG021|STARTED|Years 4-5 (24-Month Extension)||100
10912233|NCT00112437|12078494|FG022|STARTED|Years 4-5 (24-Month Extension)||0
10912234|NCT00112437|12078495|FG023|STARTED|Years 4-5 (24-Month Extension)||0
10912235|NCT00112437|12078496|FG024|STARTED|Years 4-5 (24-Month Extension)||0
10912236|NCT00112437|12078497|FG025|STARTED|Years 4-5 (24-Month Extension)||0
10912237|NCT00112437|12078472|FG000|COMPLETED|Years 4-5 (24-Month Extension)||0
10912238|NCT00112437|12078473|FG001|COMPLETED|Years 4-5 (24-Month Extension)||0
10912239|NCT00112437|12078474|FG002|COMPLETED|Years 4-5 (24-Month Extension)||0
10912240|NCT00112437|12078475|FG003|COMPLETED|Years 4-5 (24-Month Extension)||0
10912241|NCT00112437|12078476|FG004|COMPLETED|Years 4-5 (24-Month Extension)||0
10912242|NCT00112437|12078477|FG005|COMPLETED|Years 4-5 (24-Month Extension)||0
10912243|NCT00112437|12078478|FG006|COMPLETED|Years 4-5 (24-Month Extension)||0
10912244|NCT00112437|12078479|FG007|COMPLETED|Years 4-5 (24-Month Extension)||0
10912245|NCT00112437|12078480|FG008|COMPLETED|Years 4-5 (24-Month Extension)||0
10912246|NCT00112437|12078481|FG009|COMPLETED|Years 4-5 (24-Month Extension)||0
10912247|NCT00112437|12078482|FG010|COMPLETED|Years 4-5 (24-Month Extension)||0
10912248|NCT00112437|12078483|FG011|COMPLETED|Years 4-5 (24-Month Extension)||0
10912249|NCT00112437|12078484|FG012|COMPLETED|Years 4-5 (24-Month Extension)||0
10912250|NCT00112437|12078485|FG013|COMPLETED|Years 4-5 (24-Month Extension)||0
10912251|NCT00112437|12078486|FG014|COMPLETED|Years 4-5 (24-Month Extension)||0
10912252|NCT00112437|12078487|FG015|COMPLETED|Years 4-5 (24-Month Extension)||0
10912253|NCT00112437|12078488|FG016|COMPLETED|Years 4-5 (24-Month Extension)||0
10912254|NCT00112437|12078489|FG017|COMPLETED|Years 4-5 (24-Month Extension)||0
10912255|NCT00112437|12078490|FG018|COMPLETED|Years 4-5 (24-Month Extension)||0
10912256|NCT00112437|12078491|FG019|COMPLETED|Years 4-5 (24-Month Extension)||0
10912257|NCT00112437|12078492|FG020|COMPLETED|Years 4-5 (24-Month Extension)||37
10912258|NCT00112437|12078493|FG021|COMPLETED|Years 4-5 (24-Month Extension)||92
10912259|NCT00112437|12078494|FG022|COMPLETED|Years 4-5 (24-Month Extension)||0
10912260|NCT00112437|12078495|FG023|COMPLETED|Years 4-5 (24-Month Extension)||0
10912261|NCT00112437|12078496|FG024|COMPLETED|Years 4-5 (24-Month Extension)||0
10912262|NCT00112437|12078497|FG025|COMPLETED|Years 4-5 (24-Month Extension)||0
10912263|NCT00112437|12078472|FG000|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912264|NCT00112437|12078473|FG001|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912265|NCT00112437|12078474|FG002|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912266|NCT00112437|12078475|FG003|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912267|NCT00112437|12078476|FG004|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912268|NCT00112437|12078477|FG005|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912269|NCT00112437|12078478|FG006|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912270|NCT00112437|12078479|FG007|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912271|NCT00112437|12078480|FG008|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912272|NCT00112437|12078481|FG009|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912273|NCT00112437|12078482|FG010|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912274|NCT00112437|12078483|FG011|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912275|NCT00112437|12078484|FG012|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912276|NCT00112437|12078485|FG013|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912277|NCT00112437|12078486|FG014|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912278|NCT00112437|12078487|FG015|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912279|NCT00112437|12078488|FG016|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912280|NCT00112437|12078489|FG017|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912281|NCT00112437|12078490|FG018|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912282|NCT00112437|12078491|FG019|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912283|NCT00112437|12078492|FG020|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
10912284|NCT00112437|12078493|FG021|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
10912285|NCT00112437|12078494|FG022|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912286|NCT00112437|12078495|FG023|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912287|NCT00112437|12078496|FG024|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912288|NCT00112437|12078497|FG025|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
10912289|NCT00112437|12078472|FG000|STARTED|Years 6-10 (60-Month Extension)||0
10912290|NCT00112437|12078473|FG001|STARTED|Years 6-10 (60-Month Extension)||0
10912291|NCT00112437|12078474|FG002|STARTED|Years 6-10 (60-Month Extension)||0
10912292|NCT00112437|12078475|FG003|STARTED|Years 6-10 (60-Month Extension)||0
10912293|NCT00112437|12078476|FG004|STARTED|Years 6-10 (60-Month Extension)||0
10912294|NCT00112437|12078477|FG005|STARTED|Years 6-10 (60-Month Extension)||0
10912295|NCT00112437|12078478|FG006|STARTED|Years 6-10 (60-Month Extension)||0
10912296|NCT00112437|12078479|FG007|STARTED|Years 6-10 (60-Month Extension)||0
10912297|NCT00112437|12078480|FG008|STARTED|Years 6-10 (60-Month Extension)||0
10912298|NCT00112437|12078481|FG009|STARTED|Years 6-10 (60-Month Extension)||0
10912299|NCT00112437|12078482|FG010|STARTED|Years 6-10 (60-Month Extension)||0
10912300|NCT00112437|12078483|FG011|STARTED|Years 6-10 (60-Month Extension)||0
10912301|NCT00112437|12078484|FG012|STARTED|Years 6-10 (60-Month Extension)||0
10912302|NCT00112437|12078485|FG013|STARTED|Years 6-10 (60-Month Extension)||0
10912303|NCT00112437|12078486|FG014|STARTED|Years 6-10 (60-Month Extension)||0
10912304|NCT00112437|12078487|FG015|STARTED|Years 6-10 (60-Month Extension)||0
10912305|NCT00112437|12078488|FG016|STARTED|Years 6-10 (60-Month Extension)||0
10912306|NCT00112437|12078489|FG017|STARTED|Years 6-10 (60-Month Extension)||0
10912307|NCT00112437|12078490|FG018|STARTED|Years 6-10 (60-Month Extension)||0
10912308|NCT00112437|12078491|FG019|STARTED|Years 6-10 (60-Month Extension)||0
10912309|NCT00112437|12078492|FG020|STARTED|Years 6-10 (60-Month Extension)||0
10912310|NCT00112437|12078493|FG021|STARTED|Years 6-10 (60-Month Extension)||0
10912311|NCT00112437|12078494|FG022|STARTED|Years 6-10 (60-Month Extension)||28
10912312|NCT00112437|12078495|FG023|STARTED|Years 6-10 (60-Month Extension)||34
10912313|NCT00112437|12078496|FG024|STARTED|Years 6-10 (60-Month Extension)||23
10912314|NCT00112437|12078497|FG025|STARTED|Years 6-10 (60-Month Extension)||32
10912315|NCT00112437|12078472|FG000|COMPLETED|Years 6-10 (60-Month Extension)||0
10912316|NCT00112437|12078473|FG001|COMPLETED|Years 6-10 (60-Month Extension)||0
10912317|NCT00112437|12078474|FG002|COMPLETED|Years 6-10 (60-Month Extension)||0
10912318|NCT00112437|12078475|FG003|COMPLETED|Years 6-10 (60-Month Extension)||0
10912319|NCT00112437|12078476|FG004|COMPLETED|Years 6-10 (60-Month Extension)||0
10912320|NCT00112437|12078477|FG005|COMPLETED|Years 6-10 (60-Month Extension)||0
10912321|NCT00112437|12078478|FG006|COMPLETED|Years 6-10 (60-Month Extension)||0
10912322|NCT00112437|12078479|FG007|COMPLETED|Years 6-10 (60-Month Extension)||0
10912323|NCT00112437|12078480|FG008|COMPLETED|Years 6-10 (60-Month Extension)||0
10912324|NCT00112437|12078481|FG009|COMPLETED|Years 6-10 (60-Month Extension)||0
10912325|NCT00112437|12078482|FG010|COMPLETED|Years 6-10 (60-Month Extension)||0
10912326|NCT00112437|12078483|FG011|COMPLETED|Years 6-10 (60-Month Extension)||0
10912327|NCT00112437|12078484|FG012|COMPLETED|Years 6-10 (60-Month Extension)||0
10912328|NCT00112437|12078485|FG013|COMPLETED|Years 6-10 (60-Month Extension)||0
10912329|NCT00112437|12078486|FG014|COMPLETED|Years 6-10 (60-Month Extension)||0
10912330|NCT00112437|12078487|FG015|COMPLETED|Years 6-10 (60-Month Extension)||0
10912331|NCT00112437|12078488|FG016|COMPLETED|Years 6-10 (60-Month Extension)||0
10912332|NCT00112437|12078489|FG017|COMPLETED|Years 6-10 (60-Month Extension)||0
10912333|NCT00112437|12078490|FG018|COMPLETED|Years 6-10 (60-Month Extension)||0
10912334|NCT00112437|12078491|FG019|COMPLETED|Years 6-10 (60-Month Extension)||0
10912335|NCT00112437|12078492|FG020|COMPLETED|Years 6-10 (60-Month Extension)||0
10912336|NCT00112437|12078493|FG021|COMPLETED|Years 6-10 (60-Month Extension)||0
10912337|NCT00112437|12078494|FG022|COMPLETED|Years 6-10 (60-Month Extension)||23
10912338|NCT00112437|12078495|FG023|COMPLETED|Years 6-10 (60-Month Extension)||22
10912339|NCT00112437|12078496|FG024|COMPLETED|Years 6-10 (60-Month Extension)||22
10912340|NCT00112437|12078497|FG025|COMPLETED|Years 6-10 (60-Month Extension)||27
10912341|NCT00112437|12078472|FG000|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912342|NCT00112437|12078473|FG001|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912343|NCT00112437|12078474|FG002|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912344|NCT00112437|12078475|FG003|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912345|NCT00112437|12078476|FG004|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912346|NCT00112437|12078477|FG005|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912347|NCT00112437|12078478|FG006|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912348|NCT00112437|12078479|FG007|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912349|NCT00112437|12078480|FG008|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912350|NCT00112437|12078481|FG009|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912351|NCT00112437|12078482|FG010|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912352|NCT00112437|12078483|FG011|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912353|NCT00112437|12078484|FG012|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912354|NCT00112437|12078485|FG013|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912355|NCT00112437|12078486|FG014|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912356|NCT00112437|12078487|FG015|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912357|NCT00112437|12078488|FG016|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912358|NCT00112437|12078489|FG017|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912359|NCT00112437|12078490|FG018|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912360|NCT00112437|12078491|FG019|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912361|NCT00112437|12078492|FG020|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912362|NCT00112437|12078493|FG021|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
10912363|NCT00112437|12078494|FG022|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
10912364|NCT00112437|12078495|FG023|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
10912365|NCT00112437|12078496|FG024|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
10912366|NCT00112437|12078497|FG025|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
10912367|NCT00112463|12078551|FG000|STARTED|Overall Study||40
10912368|NCT00112463|12078551|FG000|COMPLETED|Overall Study||1
10912369|NCT00112463|12078551|FG000|NOT COMPLETED|Overall Study||39
10912370|NCT00112489|12078556|FG000|STARTED|Overall Study|All patients enrolled on study|55
10912371|NCT00112489|12078556|FG000|COMPLETED|Overall Study|Completed regimen due to progression|15
10912372|NCT00112489|12078556|FG000|NOT COMPLETED|Overall Study||40
10912373|NCT00112502|12078574|FG000|STARTED|Overall Study||22
10912374|NCT00112502|12078575|FG001|STARTED|Overall Study||22
10912375|NCT00112502|12078576|FG002|STARTED|Overall Study||22
10912376|NCT00112502|12078577|FG003|STARTED|Overall Study||22
10912377|NCT00112502|12078578|FG004|STARTED|Overall Study||23
10912378|NCT00112502|12078579|FG005|STARTED|Overall Study||22
10912379|NCT00112502|12078580|FG006|STARTED|Overall Study||23
10912380|NCT00112502|12078581|FG007|STARTED|Overall Study||22
10912381|NCT00112502|12078574|FG000|COMPLETED|Overall Study||22
10912382|NCT00112502|12078575|FG001|COMPLETED|Overall Study||21
10912383|NCT00112502|12078576|FG002|COMPLETED|Overall Study||21
10912384|NCT00112502|12078577|FG003|COMPLETED|Overall Study||18
10912385|NCT00112502|12078578|FG004|COMPLETED|Overall Study||21
10912386|NCT00112502|12078579|FG005|COMPLETED|Overall Study||17
10912387|NCT00112502|12078580|FG006|COMPLETED|Overall Study||20
10912388|NCT00112502|12078581|FG007|COMPLETED|Overall Study||15
10912389|NCT00112502|12078574|FG000|NOT COMPLETED|Overall Study||0
10912390|NCT00112502|12078575|FG001|NOT COMPLETED|Overall Study||1
10912391|NCT00112502|12078576|FG002|NOT COMPLETED|Overall Study||1
10912392|NCT00112502|12078577|FG003|NOT COMPLETED|Overall Study||4
10912393|NCT00112502|12078578|FG004|NOT COMPLETED|Overall Study||2
10912394|NCT00112502|12078579|FG005|NOT COMPLETED|Overall Study||5
10912395|NCT00112502|12078580|FG006|NOT COMPLETED|Overall Study||3
10912396|NCT00112502|12078581|FG007|NOT COMPLETED|Overall Study||7
10912397|NCT00112580|12078611|FG000|STARTED|Overall Study||8
10912398|NCT00112580|12078612|FG001|STARTED|Overall Study||19
10912399|NCT00112580|12078611|FG000|COMPLETED|Overall Study||0
10912400|NCT00112580|12078612|FG001|COMPLETED|Overall Study||0
10912401|NCT00112580|12078611|FG000|NOT COMPLETED|Overall Study||8
10912402|NCT00112580|12078612|FG001|NOT COMPLETED|Overall Study||19
10912403|NCT00112593|12078617|FG000|STARTED|Overall Study||5
10912404|NCT00112593|12078617|FG000|COMPLETED|Overall Study||5
10912405|NCT00112593|12078617|FG000|NOT COMPLETED|Overall Study||0
10912406|NCT00112671|12078621|FG000|STARTED|Overall Study||17
10912407|NCT00112671|12078621|FG000|COMPLETED|Overall Study||17
10912408|NCT00112671|12078621|FG000|NOT COMPLETED|Overall Study||0
10912409|NCT00112723|12078625|FG000|STARTED|Overall Study||13
10912410|NCT00112723|12078626|FG001|STARTED|Overall Study||19
10912411|NCT00112723|12078627|FG002|STARTED|Overall Study||14
10912412|NCT00112723|12078625|FG000|Patients Evaluable for Toxicity|Overall Study||11
10912413|NCT00112723|12078626|FG001|Patients Evaluable for Toxicity|Overall Study||12
10912414|NCT00112723|12078627|FG002|Patients Evaluable for Toxicity|Overall Study||12
10912415|NCT00112723|12078625|FG000|COMPLETED|Overall Study||11
10912416|NCT00112723|12078626|FG001|COMPLETED|Overall Study||12
10912417|NCT00112723|12078627|FG002|COMPLETED|Overall Study||12
10912418|NCT00112723|12078625|FG000|NOT COMPLETED|Overall Study||2
10912419|NCT00112723|12078626|FG001|NOT COMPLETED|Overall Study||7
10912420|NCT00112723|12078627|FG002|NOT COMPLETED|Overall Study||2
10912421|NCT00112736|12078651|FG000|STARTED|Overall Study||22
10912422|NCT00112736|12078652|FG001|STARTED|Overall Study||47
10912423|NCT00112736|12078651|FG000|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
10912424|NCT00112736|12078652|FG001|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
10912425|NCT00112736|12078651|FG000|NOT COMPLETED|Overall Study||1
10912426|NCT00112736|12078652|FG001|NOT COMPLETED|Overall Study||0
10912427|NCT00112827|12078669|FG000|STARTED|Overall Study||3
10912428|NCT00112827|12078670|FG001|STARTED|Overall Study||4
10912429|NCT00112827|12078671|FG002|STARTED|Overall Study||4
10912430|NCT00112827|12078672|FG003|STARTED|Overall Study||36
10912431|NCT00112827|12078673|FG004|STARTED|Overall Study||7
10912432|NCT00112827|12078669|FG000|COMPLETED|Overall Study||3
10912433|NCT00112827|12078670|FG001|COMPLETED|Overall Study||4
10912434|NCT00112827|12078671|FG002|COMPLETED|Overall Study||4
10912435|NCT00112827|12078672|FG003|COMPLETED|Overall Study||36
10912436|NCT00112827|12078673|FG004|COMPLETED|Overall Study||7
10912437|NCT00112827|12078669|FG000|NOT COMPLETED|Overall Study||0
10912438|NCT00112827|12078670|FG001|NOT COMPLETED|Overall Study||0
10912439|NCT00112827|12078671|FG002|NOT COMPLETED|Overall Study||0
10912440|NCT00112827|12078672|FG003|NOT COMPLETED|Overall Study||0
10912441|NCT00112827|12078673|FG004|NOT COMPLETED|Overall Study||0
10912442|NCT00112866|12078688|FG000|STARTED|Overall Study||15
10912443|NCT00112866|12078689|FG001|STARTED|Overall Study||15
10912444|NCT00112866|12078688|FG000|COMPLETED|Overall Study||13
10912445|NCT00112866|12078689|FG001|COMPLETED|Overall Study||13
10912446|NCT00112866|12078688|FG000|NOT COMPLETED|Overall Study||2
10912447|NCT00112866|12078689|FG001|NOT COMPLETED|Overall Study||2
10912448|NCT00112905|12078703|FG000|STARTED|Overall Study||27
10912449|NCT00112905|12078703|FG000|Eligible and Treated|Overall Study||22
10912450|NCT00112905|12078703|FG000|COMPLETED|Overall Study||15
10912451|NCT00112905|12078703|FG000|NOT COMPLETED|Overall Study||12
10912452|NCT00112918|12078710|FG000|STARTED|Overall Study||1151
10912453|NCT00112918|12078711|FG001|STARTED|Overall Study||1155
10912454|NCT00112918|12078712|FG002|STARTED|Overall Study||1145
10912455|NCT00112918|12078710|FG000|Received Treatment|Overall Study||1126
10912456|NCT00112918|12078711|FG001|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
10912457|NCT00112918|12078712|FG002|Received Treatment|Overall Study||1135
10912458|NCT00112918|12078710|FG000|Stage III Disease Population|Overall Study||955
10912459|NCT00112918|12078711|FG001|Stage III Disease Population|Overall Study||960
10912460|NCT00112918|12078712|FG002|Stage III Disease Population|Overall Study||952
10912461|NCT00112918|12078710|FG000|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
10912462|NCT00112918|12078711|FG001|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
10912463|NCT00112918|12078712|FG002|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
10912464|NCT00112918|12078710|FG000|NOT COMPLETED|Overall Study||297
10912465|NCT00112918|12078711|FG001|NOT COMPLETED|Overall Study||345
10912466|NCT00112918|12078712|FG002|NOT COMPLETED|Overall Study||299
10912467|NCT00112957|12078720|FG000|STARTED|Overall Study||23
10912468|NCT00112957|12078720|FG000|COMPLETED|Overall Study||4
10912469|NCT00112957|12078720|FG000|NOT COMPLETED|Overall Study||19
10912470|NCT00113022|12078726|FG000|STARTED|Overall Study||5
10912471|NCT00113022|12078727|FG001|STARTED|Overall Study||4
10912472|NCT00113022|12078726|FG000|COMPLETED|Overall Study||2
10912473|NCT00113022|12078727|FG001|COMPLETED|Overall Study||2
10912474|NCT00113022|12078726|FG000|NOT COMPLETED|Overall Study||3
10912475|NCT00113022|12078727|FG001|NOT COMPLETED|Overall Study||2
10912476|NCT00113087|12078735|FG000|STARTED|Overall Study||115
10912477|NCT00113087|12078736|FG001|STARTED|Overall Study||115
10912478|NCT00113087|12078735|FG000|COMPLETED|Overall Study||91
10912479|NCT00113087|12078736|FG001|COMPLETED|Overall Study||94
10912480|NCT00113087|12078735|FG000|NOT COMPLETED|Overall Study||24
10912481|NCT00113087|12078736|FG001|NOT COMPLETED|Overall Study||21
10912482|NCT00113217|12078742|FG000|STARTED|Overall Study||50
10912483|NCT00113217|12078742|FG000|COMPLETED|Overall Study||50
10912484|NCT00113217|12078742|FG000|NOT COMPLETED|Overall Study||0
10912485|NCT00113230|12078746|FG000|STARTED|Overall Study||25
10912486|NCT00113230|12078746|FG000|COMPLETED|Overall Study||25
10912487|NCT00113230|12078746|FG000|NOT COMPLETED|Overall Study||0
10912488|NCT00113269|12078754|FG000|STARTED|Overall Study||76
10912489|NCT00113269|12078755|FG001|STARTED|Overall Study||70
10912490|NCT00113269|12078756|FG002|STARTED|Overall Study||175
10912491|NCT00113269|12078757|FG003|STARTED|Overall Study||180
10912492|NCT00113269|12078754|FG000|Received Treatment|Overall Study||70
10912493|NCT00113269|12078755|FG001|Received Treatment|Overall Study||69
10912494|NCT00113269|12078756|FG002|Received Treatment|Overall Study||164
10912495|NCT00113269|12078757|FG003|Received Treatment|Overall Study||171
10912496|NCT00113269|12078754|FG000|COMPLETED|Overall Study||51
10912497|NCT00113269|12078755|FG001|COMPLETED|Overall Study||48
10912498|NCT00113269|12078756|FG002|COMPLETED|Overall Study||134
10912499|NCT00113269|12078757|FG003|COMPLETED|Overall Study||140
10912500|NCT00113269|12078754|FG000|NOT COMPLETED|Overall Study||25
10912501|NCT00113269|12078755|FG001|NOT COMPLETED|Overall Study||22
10912502|NCT00113269|12078756|FG002|NOT COMPLETED|Overall Study||41
10912503|NCT00113269|12078757|FG003|NOT COMPLETED|Overall Study||40
10912504|NCT00113295|12078769|FG000|STARTED|Overall Study||11
10912505|NCT00113295|12078770|FG001|STARTED|Overall Study||11
10912506|NCT00113295|12078769|FG000|COMPLETED|Overall Study||6
10912507|NCT00113295|12078770|FG001|COMPLETED|Overall Study||10
10912508|NCT00113295|12078769|FG000|NOT COMPLETED|Overall Study||5
10912509|NCT00113295|12078770|FG001|NOT COMPLETED|Overall Study||1
10912510|NCT00113321|12078778|FG000|STARTED|Overall Study||16
10912511|NCT00113321|12078778|FG000|COMPLETED|Overall Study||16
10912512|NCT00113321|12078778|FG000|NOT COMPLETED|Overall Study||0
10912513|NCT00113334|12078782|FG000|STARTED|Overall Study||6
10912514|NCT00113334|12078782|FG000|COMPLETED|Overall Study||6
10912515|NCT00113334|12078782|FG000|NOT COMPLETED|Overall Study||0
10912516|NCT00113360|12078786|FG000|STARTED|Overall Study|67 participants were enrolled for screening.|67
10912517|NCT00113360|12078786|FG000|COMPLETED|Overall Study||60
10912518|NCT00113360|12078786|FG000|NOT COMPLETED|Overall Study||7
10912519|NCT00113373|12078790|FG000|STARTED|Overall Study||28
10912520|NCT00113373|12078790|FG000|COMPLETED|Overall Study|Eligible and treated patients.|25
10912521|NCT00113373|12078790|FG000|NOT COMPLETED|Overall Study||3
10912522|NCT00113425|12078799|FG000|STARTED|Overall Study||44
10912523|NCT00113425|12078799|FG000|COMPLETED|Overall Study||29
10912524|NCT00113425|12078799|FG000|NOT COMPLETED|Overall Study||15
10912525|NCT00113490|12078806|FG000|STARTED|Overall Study||66
10912526|NCT00113490|12078807|FG001|STARTED|Overall Study||70
10912527|NCT00113490|12078806|FG000|COMPLETED|Overall Study||64
10912528|NCT00113490|12078807|FG001|COMPLETED|Overall Study||67
10912529|NCT00113490|12078806|FG000|NOT COMPLETED|Overall Study||2
10912530|NCT00113490|12078807|FG001|NOT COMPLETED|Overall Study||3
10912531|NCT00113516|12078813|FG000|STARTED|Part 1||84
10912532|NCT00113516|12078814|FG001|STARTED|Part 1||0
10912533|NCT00113516|12078813|FG000|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
10912534|NCT00113516|12078814|FG001|COMPLETED|Part 1||0
10912535|NCT00113516|12078813|FG000|NOT COMPLETED|Part 1||84
10912536|NCT00113516|12078814|FG001|NOT COMPLETED|Part 1||0
10912537|NCT00113516|12078813|FG000|STARTED|Part 2||0
10912538|NCT00113516|12078814|FG001|STARTED|Part 2||66
10912539|NCT00113516|12078813|FG000|COMPLETED|Part 2||0
10912540|NCT00113516|12078814|FG001|COMPLETED|Part 2||0
10912541|NCT00113516|12078813|FG000|NOT COMPLETED|Part 2||0
10912542|NCT00113516|12078814|FG001|NOT COMPLETED|Part 2||66
10912543|NCT00113529|12078820|FG000|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
10912544|NCT00113529|12078820|FG000|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
10912545|NCT00113529|12078820|FG000|NOT COMPLETED|Overall Study||34
10912546|NCT00113555|12078824|FG000|STARTED|Overall Study||221
10912547|NCT00113555|12078824|FG000|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
10912548|NCT00113555|12078824|FG000|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
10912549|NCT00113555|12078824|FG000|NOT COMPLETED|Overall Study||79
10912550|NCT00113568|12078829|FG000|STARTED|Overall Study||784
10912551|NCT00113568|12078829|FG000|Intent to Treat Population|Overall Study||723
10912552|NCT00113568|12078829|FG000|COMPLETED|Overall Study||239
10912553|NCT00113568|12078829|FG000|NOT COMPLETED|Overall Study||545
10912554|NCT00113607|12078835|FG000|STARTED|Overall Study|Number of randomized participants|335
10912555|NCT00113607|12078836|FG001|STARTED|Overall Study|Number of randomized participants|337
10912556|NCT00113607|12078835|FG000|COMPLETED|Overall Study||0
10912557|NCT00113607|12078836|FG001|COMPLETED|Overall Study||0
10912558|NCT00113607|12078835|FG000|NOT COMPLETED|Overall Study||335
10912559|NCT00113607|12078836|FG001|NOT COMPLETED|Overall Study||337
10912560|NCT00113841|12078845|FG000|STARTED|Overall Study||16
10912561|NCT00113841|12078846|FG001|STARTED|Overall Study||17
10912562|NCT00113841|12078845|FG000|COMPLETED|Overall Study||15
10912563|NCT00113841|12078846|FG001|COMPLETED|Overall Study||15
10912564|NCT00113841|12078845|FG000|NOT COMPLETED|Overall Study||1
10912565|NCT00113841|12078846|FG001|NOT COMPLETED|Overall Study||2
10912566|NCT00113880|12078855|FG000|STARTED|Overall Study||63061
10912567|NCT00113880|12078856|FG001|STARTED|Overall Study||71949
10912568|NCT00113880|12078857|FG002|STARTED|Overall Study||62492
10912569|NCT00113880|12078855|FG000|COMPLETED|Overall Study||63061
10912570|NCT00113880|12078856|FG001|COMPLETED|Overall Study||71949
10912571|NCT00113880|12078857|FG002|COMPLETED|Overall Study||62492
10912572|NCT00113880|12078855|FG000|NOT COMPLETED|Overall Study||0
10912573|NCT00113880|12078856|FG001|NOT COMPLETED|Overall Study||0
10912574|NCT00113880|12078857|FG002|NOT COMPLETED|Overall Study||0
10912575|NCT00114114|12078878|FG000|STARTED|Overall Study||26
10912576|NCT00114114|12078879|FG001|STARTED|Overall Study||25
10912577|NCT00114114|12078880|FG002|STARTED|Overall Study||31
10912578|NCT00114114|12078881|FG003|STARTED|Overall Study||35
10912579|NCT00114114|12078882|FG004|STARTED|Overall Study||29
10912580|NCT00114114|12078883|FG005|STARTED|Overall Study||31
10912581|NCT00114114|12078878|FG000|COMPLETED|Overall Study||21
10912582|NCT00114114|12078879|FG001|COMPLETED|Overall Study||24
10912583|NCT00114114|12078880|FG002|COMPLETED|Overall Study||30
10912584|NCT00114114|12078881|FG003|COMPLETED|Overall Study||31
10912585|NCT00114114|12078882|FG004|COMPLETED|Overall Study||27
10912586|NCT00114114|12078883|FG005|COMPLETED|Overall Study||30
10912587|NCT00114114|12078878|FG000|NOT COMPLETED|Overall Study||5
10912588|NCT00114114|12078879|FG001|NOT COMPLETED|Overall Study||1
10912589|NCT00114114|12078880|FG002|NOT COMPLETED|Overall Study||1
10912590|NCT00114114|12078881|FG003|NOT COMPLETED|Overall Study||4
10912591|NCT00114114|12078882|FG004|NOT COMPLETED|Overall Study||2
10912592|NCT00114114|12078883|FG005|NOT COMPLETED|Overall Study||1
10912593|NCT00114127|12078901|FG000|STARTED|Overall Study||13
10912594|NCT00114127|12078902|FG001|STARTED|Overall Study||15
10912595|NCT00114127|12078901|FG000|COMPLETED|Overall Study||9
10912596|NCT00114127|12078902|FG001|COMPLETED|Overall Study||11
10912597|NCT00114127|12078901|FG000|NOT COMPLETED|Overall Study||4
10912598|NCT00114127|12078902|FG001|NOT COMPLETED|Overall Study||4
10912599|NCT00114166|12078910|FG000|STARTED|Overall Study||15
10912600|NCT00114166|12078911|FG001|STARTED|Overall Study||66
10912601|NCT00114166|12078910|FG000|COMPLETED|Overall Study||15
10912602|NCT00114166|12078911|FG001|COMPLETED|Overall Study||65
10912603|NCT00114166|12078910|FG000|NOT COMPLETED|Overall Study||0
10912604|NCT00114166|12078911|FG001|NOT COMPLETED|Overall Study||1
10912605|NCT00114218|12078919|FG000|STARTED|Overall Study||28
10912606|NCT00114218|12078919|FG000|COMPLETED|Overall Study||24
10912607|NCT00114218|12078919|FG000|NOT COMPLETED|Overall Study||4
10912608|NCT00114231|12078925|FG000|STARTED|Overall Study||62
10912609|NCT00114231|12078926|FG001|STARTED|Overall Study||28
10912610|NCT00114231|12078925|FG000|COMPLETED|Overall Study||53
10912611|NCT00114231|12078926|FG001|COMPLETED|Overall Study||26
10912612|NCT00114231|12078925|FG000|NOT COMPLETED|Overall Study||9
10912613|NCT00114231|12078926|FG001|NOT COMPLETED|Overall Study||2
10912614|NCT00114244|12078933|FG000|STARTED|Overall Study||15
10912615|NCT00114244|12078934|FG001|STARTED|Overall Study||37
10912616|NCT00114244|12078933|FG000|COMPLETED|Overall Study||13
10912617|NCT00114244|12078934|FG001|COMPLETED|Overall Study||30
10912618|NCT00114244|12078933|FG000|NOT COMPLETED|Overall Study||2
10912619|NCT00114244|12078934|FG001|NOT COMPLETED|Overall Study||7
10912620|NCT00114504|12078942|FG000|STARTED|Overall Study||21
10912621|NCT00114504|12078943|FG001|STARTED|Overall Study||22
10912622|NCT00114504|12078942|FG000|COMPLETED|Overall Study||21
10912623|NCT00114504|12078943|FG001|COMPLETED|Overall Study||22
10912624|NCT00114504|12078942|FG000|NOT COMPLETED|Overall Study||0
10912625|NCT00114504|12078943|FG001|NOT COMPLETED|Overall Study||0
10912626|NCT00114517|12078957|FG000|STARTED|Overall Study||137
10912627|NCT00114517|12078958|FG001|STARTED|Overall Study||134
10912628|NCT00114517|12078959|FG002|STARTED|Overall Study||186
10912629|NCT00114517|12078960|FG003|STARTED|Overall Study||186
10912630|NCT00114517|12078957|FG000|COMPLETED|Overall Study||125
10912631|NCT00114517|12078958|FG001|COMPLETED|Overall Study||123
10912632|NCT00114517|12078959|FG002|COMPLETED|Overall Study||172
10912633|NCT00114517|12078960|FG003|COMPLETED|Overall Study||176
10912634|NCT00114517|12078957|FG000|NOT COMPLETED|Overall Study||12
10912635|NCT00114517|12078958|FG001|NOT COMPLETED|Overall Study||11
10912636|NCT00114517|12078959|FG002|NOT COMPLETED|Overall Study||14
10912637|NCT00114517|12078960|FG003|NOT COMPLETED|Overall Study||10
10912638|NCT00114530|12078968|FG000|STARTED|Overall Study||36
10912639|NCT00114530|12078969|FG001|STARTED|Overall Study||39
10912640|NCT00114530|12078968|FG000|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|27
10912641|NCT00114530|12078969|FG001|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|19
10912642|NCT00114530|12078968|FG000|NOT COMPLETED|Overall Study||9
10912643|NCT00114530|12078969|FG001|NOT COMPLETED|Overall Study||20
10912644|NCT00114634|12078979|FG000|STARTED|Overall Study||13
10912645|NCT00114634|12078979|FG000|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
10912646|NCT00114634|12078979|FG000|NOT COMPLETED|Overall Study||3
10912647|NCT00114738|12078985|FG000|STARTED|Bortezomib Then Bortezomib + Induction||53
10912648|NCT00114738|12078986|FG001|STARTED|Bortezomib Then Bortezomib + Induction||0
10912649|NCT00114738|12078987|FG002|STARTED|Bortezomib Then Bortezomib + Induction||0
10912650|NCT00114738|12078985|FG000|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
10912651|NCT00114738|12078986|FG001|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
10912652|NCT00114738|12078987|FG002|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
10912653|NCT00114738|12078985|FG000|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
10912654|NCT00114738|12078986|FG001|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
10912655|NCT00114738|12078987|FG002|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
10912656|NCT00114738|12078985|FG000|COMPLETED|Bortezomib Then Bortezomib + Induction||51
10912657|NCT00114738|12078986|FG001|COMPLETED|Bortezomib Then Bortezomib + Induction||0
10912658|NCT00114738|12078987|FG002|COMPLETED|Bortezomib Then Bortezomib + Induction||0
10912659|NCT00114738|12078985|FG000|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
10912660|NCT00114738|12078986|FG001|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
10912661|NCT00114738|12078987|FG002|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
10912662|NCT00114738|12078985|FG000|STARTED|Screening for Randomization||51
10912663|NCT00114738|12078986|FG001|STARTED|Screening for Randomization||0
10912664|NCT00114738|12078987|FG002|STARTED|Screening for Randomization||0
10912665|NCT00114738|12078985|FG000|COMPLETED|Screening for Randomization||30
10912666|NCT00114738|12078986|FG001|COMPLETED|Screening for Randomization||0
10912667|NCT00114738|12078987|FG002|COMPLETED|Screening for Randomization||0
10912668|NCT00114738|12078985|FG000|NOT COMPLETED|Screening for Randomization||21
10912669|NCT00114738|12078986|FG001|NOT COMPLETED|Screening for Randomization||0
10912670|NCT00114738|12078987|FG002|NOT COMPLETED|Screening for Randomization||0
10912671|NCT00114738|12078985|FG000|STARTED|Randomization||0
10912672|NCT00114738|12078986|FG001|STARTED|Randomization||14
10912673|NCT00114738|12078987|FG002|STARTED|Randomization||16
10912674|NCT00114738|12078985|FG000|COMPLETED|Randomization||0
10912675|NCT00114738|12078986|FG001|COMPLETED|Randomization||14
10912676|NCT00114738|12078987|FG002|COMPLETED|Randomization||16
10912677|NCT00114738|12078985|FG000|NOT COMPLETED|Randomization||0
10912678|NCT00114738|12078986|FG001|NOT COMPLETED|Randomization||0
10912679|NCT00114738|12078987|FG002|NOT COMPLETED|Randomization||0
10912680|NCT00114777|12078997|FG000|STARTED|Randomization to Month 36||184
10912681|NCT00114777|12078998|FG001|STARTED|Randomization to Month 36||175
10912682|NCT00114777|12078999|FG002|STARTED|Randomization to Month 36||184
10912683|NCT00114777|12078997|FG000|COMPLETED|Randomization to Month 36||109
10912684|NCT00114777|12078998|FG001|COMPLETED|Randomization to Month 36||114
10912685|NCT00114777|12078999|FG002|COMPLETED|Randomization to Month 36||100
10912686|NCT00114777|12078997|FG000|NOT COMPLETED|Randomization to Month 36||75
10912687|NCT00114777|12078998|FG001|NOT COMPLETED|Randomization to Month 36||61
10912688|NCT00114777|12078999|FG002|NOT COMPLETED|Randomization to Month 36||84
10912689|NCT00114777|12078997|FG000|STARTED|Long-Term Extension to Month 84||104
10912690|NCT00114777|12078998|FG001|STARTED|Long-Term Extension to Month 84||113
10912691|NCT00114777|12078999|FG002|STARTED|Long-Term Extension to Month 84||87
10912692|NCT00114777|12078997|FG000|COMPLETED|Long-Term Extension to Month 84||74
10912693|NCT00114777|12078998|FG001|COMPLETED|Long-Term Extension to Month 84||84
10912694|NCT00114777|12078999|FG002|COMPLETED|Long-Term Extension to Month 84||57
10912695|NCT00114777|12078997|FG000|NOT COMPLETED|Long-Term Extension to Month 84||30
10912696|NCT00114777|12078998|FG001|NOT COMPLETED|Long-Term Extension to Month 84||29
10912697|NCT00114777|12078999|FG002|NOT COMPLETED|Long-Term Extension to Month 84||30
10912698|NCT00114959|12079008|FG000|STARTED|Overall Study||15
10912699|NCT00114959|12079008|FG000|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
10912700|NCT00114959|12079008|FG000|NOT COMPLETED|Overall Study||8
10912701|NCT00114972|12079014|FG000|STARTED|Overall Study||897
10912702|NCT00114972|12079015|FG001|STARTED|Overall Study||903
10912703|NCT00114972|12079014|FG000|COMPLETED|Overall Study||849
10912704|NCT00114972|12079015|FG001|COMPLETED|Overall Study||891
10912705|NCT00114972|12079014|FG000|NOT COMPLETED|Overall Study||48
10912706|NCT00114972|12079015|FG001|NOT COMPLETED|Overall Study||12
10912707|NCT00115037|12079023|FG000|STARTED|Phase1||152
10912708|NCT00115037|12079024|FG001|STARTED|Phase1||150
10912709|NCT00115037|12079025|FG002|STARTED|Phase1||0
10912710|NCT00115037|12079026|FG003|STARTED|Phase1||0
10912711|NCT00115037|12079027|FG004|STARTED|Phase1||0
10912712|NCT00115037|12079028|FG005|STARTED|Phase1||0
10912713|NCT00115037|12079023|FG000|COMPLETED|Phase1||127
10912714|NCT00115037|12079024|FG001|COMPLETED|Phase1||123
10912715|NCT00115037|12079025|FG002|COMPLETED|Phase1||0
10912716|NCT00115037|12079026|FG003|COMPLETED|Phase1||0
10912717|NCT00115037|12079027|FG004|COMPLETED|Phase1||0
10912718|NCT00115037|12079028|FG005|COMPLETED|Phase1||0
10912719|NCT00115037|12079023|FG000|NOT COMPLETED|Phase1||25
10912720|NCT00115037|12079024|FG001|NOT COMPLETED|Phase1||27
10912721|NCT00115037|12079025|FG002|NOT COMPLETED|Phase1||0
10912722|NCT00115037|12079026|FG003|NOT COMPLETED|Phase1||0
10912723|NCT00115037|12079027|FG004|NOT COMPLETED|Phase1||0
10912724|NCT00115037|12079028|FG005|NOT COMPLETED|Phase1||0
10912725|NCT00115037|12079023|FG000|STARTED|Phase2||0
10912726|NCT00115037|12079024|FG001|STARTED|Phase2||0
10912727|NCT00115037|12079025|FG002|STARTED|Phase2||91
10912728|NCT00115037|12079026|FG003|STARTED|Phase2||92
10912729|NCT00115037|12079027|FG004|STARTED|Phase2||34
10912730|NCT00115037|12079028|FG005|STARTED|Phase2||33
10912731|NCT00115037|12079023|FG000|COMPLETED|Phase2||0
10912732|NCT00115037|12079024|FG001|COMPLETED|Phase2||0
10912733|NCT00115037|12079025|FG002|COMPLETED|Phase2||76
10912734|NCT00115037|12079026|FG003|COMPLETED|Phase2||77
10912735|NCT00115037|12079027|FG004|COMPLETED|Phase2||28
10912736|NCT00115037|12079028|FG005|COMPLETED|Phase2||21
10912737|NCT00115037|12079023|FG000|NOT COMPLETED|Phase2||0
10912738|NCT00115037|12079024|FG001|NOT COMPLETED|Phase2||0
10912739|NCT00115037|12079025|FG002|NOT COMPLETED|Phase2||15
10912740|NCT00115037|12079026|FG003|NOT COMPLETED|Phase2||15
10912741|NCT00115037|12079027|FG004|NOT COMPLETED|Phase2||6
10912742|NCT00115037|12079028|FG005|NOT COMPLETED|Phase2||12
10912743|NCT00115063|12079044|FG000|STARTED|Overall Study||200
10912744|NCT00115063|12079045|FG001|STARTED|Overall Study||190
10912745|NCT00115063|12079044|FG000|COMPLETED|Overall Study||101
10912746|NCT00115063|12079045|FG001|COMPLETED|Overall Study||86
10912747|NCT00115063|12079044|FG000|NOT COMPLETED|Overall Study||99
10912748|NCT00115063|12079045|FG001|NOT COMPLETED|Overall Study||104
10912749|NCT00115076|12079051|FG000|STARTED|Overall Study||30
10912750|NCT00115076|12079051|FG000|COMPLETED|Overall Study||30
10912751|NCT00115076|12079051|FG000|NOT COMPLETED|Overall Study||0
10912752|NCT00115297|12079057|FG000|STARTED|Overall Study||30
10912753|NCT00115297|12079058|FG001|STARTED|Overall Study||32
10912754|NCT00115297|12079057|FG000|COMPLETED|Overall Study||30
10912755|NCT00115297|12079058|FG001|COMPLETED|Overall Study||32
10912756|NCT00115297|12079057|FG000|NOT COMPLETED|Overall Study||0
10912757|NCT00115297|12079058|FG001|NOT COMPLETED|Overall Study||0
10912758|NCT00115336|12079069|FG000|STARTED|Overall Study||6
10912759|NCT00115336|12079070|FG001|STARTED|Overall Study||4
10912760|NCT00115336|12079069|FG000|COMPLETED|Overall Study||6
10912761|NCT00115336|12079070|FG001|COMPLETED|Overall Study||3
10912762|NCT00115336|12079069|FG000|NOT COMPLETED|Overall Study||0
10912763|NCT00115336|12079070|FG001|NOT COMPLETED|Overall Study||1
10912764|NCT00115349|12079080|FG000|STARTED|Overall Study|Target was 43 subjects in this arm.|11
10912765|NCT00115349|12079081|FG001|STARTED|Overall Study|Target was 43 subjects in this arm.|9
10912766|NCT00115349|12079080|FG000|COMPLETED|Overall Study|Study closed due to low enrollment.|0
10912767|NCT00115349|12079081|FG001|COMPLETED|Overall Study|study closed due to low enrollment.|0
10912768|NCT00115349|12079080|FG000|NOT COMPLETED|Overall Study||11
10912769|NCT00115349|12079081|FG001|NOT COMPLETED|Overall Study||9
10912770|NCT00115739|12079087|FG000|STARTED|Overall Study||11
10912771|NCT00115739|12079087|FG000|COMPLETED|Overall Study||8
10912772|NCT00115739|12079087|FG000|NOT COMPLETED|Overall Study||3
10912773|NCT00115765|12079097|FG000|STARTED|Overall Study||115
10912774|NCT00115765|12079098|FG001|STARTED|Overall Study||413
10912775|NCT00115765|12079099|FG002|STARTED|Overall Study||410
10912776|NCT00115765|12079100|FG003|STARTED|Overall Study||115
10912777|NCT00115765|12079097|FG000|COMPLETED|Overall Study|Participants who were on study at closure or died|80
10912778|NCT00115765|12079098|FG001|COMPLETED|Overall Study|Participants who were on study at closure or died|313
10912779|NCT00115765|12079099|FG002|COMPLETED|Overall Study|Participants who were on study at closure or died|289
10912780|NCT00115765|12079100|FG003|COMPLETED|Overall Study|Participants who were on study at closure or died|84
10912781|NCT00115765|12079097|FG000|NOT COMPLETED|Overall Study||35
10912782|NCT00115765|12079098|FG001|NOT COMPLETED|Overall Study||100
10912783|NCT00115765|12079099|FG002|NOT COMPLETED|Overall Study||121
10912784|NCT00115765|12079100|FG003|NOT COMPLETED|Overall Study||31
10912785|NCT00115778|12079108|FG000|STARTED|Overall Study||6
10912786|NCT00115778|12079109|FG001|STARTED|Overall Study||5
10912787|NCT00115778|12079108|FG000|COMPLETED|Overall Study||6
10912788|NCT00115778|12079109|FG001|COMPLETED|Overall Study||4
10912789|NCT00115778|12079108|FG000|NOT COMPLETED|Overall Study||0
10912790|NCT00115778|12079109|FG001|NOT COMPLETED|Overall Study||1
10912791|NCT00115804|12079115|FG000|STARTED|Overall Study||6
10912792|NCT00115804|12079115|FG000|COMPLETED|Overall Study||4
10912793|NCT00115804|12079115|FG000|NOT COMPLETED|Overall Study||2
10912794|NCT00115869|12079123|FG000|STARTED|Overall Study||4211
10912795|NCT00115869|12079124|FG001|STARTED|Overall Study||4177
10912796|NCT00115869|12079123|FG000|Completed Data Collection at 12th Grade|Overall Study||3876
10912797|NCT00115869|12079124|FG001|Completed Data Collection at 12th Grade|Overall Study||3847
10912798|NCT00115869|12079123|FG000|COMPLETED|Overall Study||3894
10912799|NCT00115869|12079124|FG001|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
10912800|NCT00115869|12079123|FG000|NOT COMPLETED|Overall Study||317
10912801|NCT00115869|12079124|FG001|NOT COMPLETED|Overall Study||296
10912802|NCT00115934|12079134|FG000|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
10912803|NCT00115934|12079135|FG001|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
10912804|NCT00115934|12079134|FG000|COMPLETED|Overall Study||275
10912805|NCT00115934|12079135|FG001|COMPLETED|Overall Study||274
10912806|NCT00115934|12079134|FG000|NOT COMPLETED|Overall Study||4
10912807|NCT00115934|12079135|FG001|NOT COMPLETED|Overall Study||2
10912808|NCT00116168|12079145|FG000|STARTED|Overall Study||6
10912809|NCT00116168|12079146|FG001|STARTED|Overall Study||11
10912810|NCT00116168|12079147|FG002|STARTED|Overall Study||6
10912811|NCT00116168|12079148|FG003|STARTED|Overall Study||6
10912812|NCT00116168|12079145|FG000|COMPLETED|Overall Study||0
10912813|NCT00116168|12079146|FG001|COMPLETED|Overall Study||6
10912814|NCT00116168|12079147|FG002|COMPLETED|Overall Study||6
10912815|NCT00116168|12079148|FG003|COMPLETED|Overall Study||6
10912816|NCT00116168|12079145|FG000|NOT COMPLETED|Overall Study||6
10912817|NCT00116168|12079146|FG001|NOT COMPLETED|Overall Study||5
10912818|NCT00116168|12079147|FG002|NOT COMPLETED|Overall Study||0
10912819|NCT00116168|12079148|FG003|NOT COMPLETED|Overall Study||0
10912820|NCT00116207|12079160|FG000|STARTED|Overall Study||22
10912821|NCT00116207|12079161|FG001|STARTED|Overall Study||22
10912822|NCT00116207|12079160|FG000|COMPLETED|Overall Study||13
10912823|NCT00116207|12079161|FG001|COMPLETED|Overall Study||18
10912824|NCT00116207|12079160|FG000|NOT COMPLETED|Overall Study||9
10912825|NCT00116207|12079161|FG001|NOT COMPLETED|Overall Study||4
10912826|NCT00116272|12079169|FG000|STARTED|Overall Study||370
10912827|NCT00116272|12079170|FG001|STARTED|Overall Study||164
10912828|NCT00116272|12079169|FG000|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
10912829|NCT00116272|12079170|FG001|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
10912830|NCT00116272|12079169|FG000|NOT COMPLETED|Overall Study||11
10912831|NCT00116272|12079170|FG001|NOT COMPLETED|Overall Study||6
10912832|NCT00116337|12079178|FG000|STARTED|Overall Study||17
10912833|NCT00116337|12079178|FG000|COMPLETED|Overall Study||17
10912834|NCT00116337|12079178|FG000|NOT COMPLETED|Overall Study||0
10912835|NCT00116428|12079191|FG000|STARTED|Overall Study||106
10912836|NCT00116428|12079192|FG001|STARTED|Overall Study||61
10912837|NCT00116428|12079191|FG000|Underwent Study Ablation Procedure|Overall Study||103
10912838|NCT00116428|12079192|FG001|Underwent Study Ablation Procedure|Overall Study||36
10912839|NCT00116428|12079191|FG000|COMPLETED|Overall Study||103
10912840|NCT00116428|12079192|FG001|COMPLETED|Overall Study||56
10912841|NCT00116428|12079191|FG000|NOT COMPLETED|Overall Study||3
10912842|NCT00116428|12079192|FG001|NOT COMPLETED|Overall Study||5
10912843|NCT00116558|12079204|FG000|STARTED|Overall Study||80
10912844|NCT00116558|12079205|FG001|STARTED|Overall Study||26
10912845|NCT00116558|12079206|FG002|STARTED|Overall Study||47
10912846|NCT00116558|12079204|FG000|COMPLETED|Overall Study||49
10912847|NCT00116558|12079205|FG001|COMPLETED|Overall Study||11
10912848|NCT00116558|12079206|FG002|COMPLETED|Overall Study||14
10912849|NCT00116558|12079204|FG000|NOT COMPLETED|Overall Study||31
10912850|NCT00116558|12079205|FG001|NOT COMPLETED|Overall Study||15
10912851|NCT00116558|12079206|FG002|NOT COMPLETED|Overall Study||33
10912852|NCT00116584|12079215|FG000|STARTED|Overall Study||36
10912853|NCT00116584|12079216|FG001|STARTED|Overall Study||36
10912854|NCT00116584|12079215|FG000|COMPLETED|Overall Study||34
10912855|NCT00116584|12079216|FG001|COMPLETED|Overall Study||35
10912856|NCT00116584|12079215|FG000|NOT COMPLETED|Overall Study||2
10912857|NCT00116584|12079216|FG001|NOT COMPLETED|Overall Study||1
10912858|NCT00116649|12079222|FG000|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
10912859|NCT00116649|12079222|FG000|COMPLETED|Overall Study||396
10912860|NCT00116649|12079222|FG000|NOT COMPLETED|Overall Study||155
10912861|NCT00116688|12079228|FG000|STARTED|Overall Study||292
10912862|NCT00116688|12079229|FG001|STARTED|Overall Study||21
10912863|NCT00116688|12079228|FG000|Received Study Medication|Overall Study||291
10912864|NCT00116688|12079229|FG001|Received Study Medication|Overall Study||20
10912865|NCT00116688|12079228|FG000|COMPLETED|Overall Study||200
10912866|NCT00116688|12079229|FG001|COMPLETED|Overall Study||17
10912867|NCT00116688|12079228|FG000|NOT COMPLETED|Overall Study||92
10912868|NCT00116688|12079229|FG001|NOT COMPLETED|Overall Study||4
10912869|NCT00116753|12079238|FG000|STARTED|Overall Study|Randomised.|153
10912870|NCT00116753|12079239|FG001|STARTED|Overall Study||155
10912871|NCT00116753|12079240|FG002|STARTED|Overall Study||152
10912872|NCT00116753|12079238|FG000|ITT Population|Overall Study||150
10912873|NCT00116753|12079239|FG001|ITT Population|Overall Study||150
10912874|NCT00116753|12079240|FG002|ITT Population|Overall Study||147
10912875|NCT00116753|12079238|FG000|COMPLETED|Overall Study||121
10912876|NCT00116753|12079239|FG001|COMPLETED|Overall Study||125
10912877|NCT00116753|12079240|FG002|COMPLETED|Overall Study||128
10912878|NCT00116753|12079238|FG000|NOT COMPLETED|Overall Study||32
10912879|NCT00116753|12079239|FG001|NOT COMPLETED|Overall Study||30
10912880|NCT00116753|12079240|FG002|NOT COMPLETED|Overall Study||24
10912881|NCT00116779|12079250|FG000|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
10912882|NCT00116779|12079251|FG001|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
10912883|NCT00116779|12079250|FG000|COMPLETED|Overall Study||42
10912884|NCT00116779|12079251|FG001|COMPLETED|Overall Study||45
10912885|NCT00116779|12079250|FG000|NOT COMPLETED|Overall Study||21
10912886|NCT00116779|12079251|FG001|NOT COMPLETED|Overall Study||19
10912887|NCT00116805|12079259|FG000|STARTED|Double-blind Period Through Week 48||176
10912888|NCT00116805|12079260|FG001|STARTED|Double-blind Period Through Week 48||90
10912889|NCT00116805|12079259|FG000|COMPLETED|Double-blind Period Through Week 48||165
10912890|NCT00116805|12079260|FG001|COMPLETED|Double-blind Period Through Week 48||85
10912891|NCT00116805|12079259|FG000|NOT COMPLETED|Double-blind Period Through Week 48||11
10912892|NCT00116805|12079260|FG001|NOT COMPLETED|Double-blind Period Through Week 48||5
10912893|NCT00116805|12079259|FG000|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
10912894|NCT00116805|12079260|FG001|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
10912895|NCT00116805|12079259|FG000|COMPLETED|Open-label Period Weeks 49 - 96||144
10912896|NCT00116805|12079260|FG001|COMPLETED|Open-label Period Weeks 49 - 96||83
10912897|NCT00116805|12079259|FG000|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
10912898|NCT00116805|12079260|FG001|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
10912899|NCT00116805|12079259|FG000|STARTED|Open-label Period Weeks 97 - 144||144
10912900|NCT00116805|12079260|FG001|STARTED|Open-label Period Weeks 97 - 144||83
10912901|NCT00116805|12079259|FG000|COMPLETED|Open-label Period Weeks 97 - 144||133
10912902|NCT00116805|12079260|FG001|COMPLETED|Open-label Period Weeks 97 - 144||74
10912903|NCT00116805|12079259|FG000|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
10912904|NCT00116805|12079260|FG001|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
10912905|NCT00116805|12079259|FG000|STARTED|Open-label Period Weeks 145 - 192||133
10912906|NCT00116805|12079260|FG001|STARTED|Open-label Period Weeks 145 - 192||74
10912907|NCT00116805|12079259|FG000|COMPLETED|Open-label Period Weeks 145 - 192||123
10912908|NCT00116805|12079260|FG001|COMPLETED|Open-label Period Weeks 145 - 192||68
10912909|NCT00116805|12079259|FG000|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
10912910|NCT00116805|12079260|FG001|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
10912911|NCT00116805|12079259|FG000|STARTED|Open-label Period Weeks 193 - 240||123
10912912|NCT00116805|12079260|FG001|STARTED|Open-label Period Weeks 193 - 240||68
10912913|NCT00116805|12079259|FG000|COMPLETED|Open-label Period Weeks 193 - 240||110
10912914|NCT00116805|12079260|FG001|COMPLETED|Open-label Period Weeks 193 - 240||64
10912915|NCT00116805|12079259|FG000|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
10912916|NCT00116805|12079260|FG001|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
10912917|NCT00116805|12079259|FG000|STARTED|Open-label Period Weeks 241 - 288||110
10912918|NCT00116805|12079260|FG001|STARTED|Open-label Period Weeks 241 - 288||64
10912919|NCT00116805|12079259|FG000|COMPLETED|Open-label Period Weeks 241 - 288||104
10912920|NCT00116805|12079260|FG001|COMPLETED|Open-label Period Weeks 241 - 288||64
10912921|NCT00116805|12079259|FG000|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
10912922|NCT00116805|12079260|FG001|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
10912923|NCT00116805|12079259|FG000|STARTED|Open-label Period Weeks 289 - 336||104
10912924|NCT00116805|12079260|FG001|STARTED|Open-label Period Weeks 289 - 336||64
10912925|NCT00116805|12079259|FG000|COMPLETED|Open-label Period Weeks 289 - 336||98
10912926|NCT00116805|12079260|FG001|COMPLETED|Open-label Period Weeks 289 - 336||57
10912927|NCT00116805|12079259|FG000|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
10912928|NCT00116805|12079260|FG001|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
10912929|NCT00116805|12079259|FG000|STARTED|Open-label Period Weeks 337 - 384||98
10912930|NCT00116805|12079260|FG001|STARTED|Open-label Period Weeks 337 - 384||57
10912931|NCT00116805|12079259|FG000|COMPLETED|Open-label Period Weeks 337 - 384||90
10912932|NCT00116805|12079260|FG001|COMPLETED|Open-label Period Weeks 337 - 384||56
10912933|NCT00116805|12079259|FG000|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
10912934|NCT00116805|12079260|FG001|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
10912935|NCT00116805|12079259|FG000|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
10912936|NCT00116805|12079260|FG001|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
10912937|NCT00116805|12079259|FG000|COMPLETED|Open-label Period Weeks 385 - 432||57
10912938|NCT00116805|12079260|FG001|COMPLETED|Open-label Period Weeks 385 - 432||30
10912939|NCT00116805|12079259|FG000|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
10912940|NCT00116805|12079260|FG001|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
10912941|NCT00116805|12079259|FG000|STARTED|Open-label Period Weeks 433 - 480||57
10912942|NCT00116805|12079260|FG001|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
10912943|NCT00116805|12079259|FG000|COMPLETED|Open-label Period Weeks 433 - 480||53
10912944|NCT00116805|12079260|FG001|COMPLETED|Open-label Period Weeks 433 - 480||29
10912945|NCT00116805|12079259|FG000|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
10912946|NCT00116805|12079260|FG001|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
10912947|NCT00116831|12079277|FG000|STARTED|Overall Study||337
10912948|NCT00116831|12079278|FG001|STARTED|Overall Study||331
10912949|NCT00116831|12079277|FG000|COMPLETED|Overall Study||264
10912950|NCT00116831|12079278|FG001|COMPLETED|Overall Study||259
10912951|NCT00116831|12079277|FG000|NOT COMPLETED|Overall Study||73
10912952|NCT00116831|12079278|FG001|NOT COMPLETED|Overall Study||72
10912953|NCT00116844|12079286|FG000|STARTED|Period 1: Treatment Period 1 (60 Days)||35
10912954|NCT00116844|12079287|FG001|STARTED|Period 1: Treatment Period 1 (60 Days)||36
10912955|NCT00116844|12079286|FG000|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
10912956|NCT00116844|12079287|FG001|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
10912957|NCT00116844|12079286|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
10912958|NCT00116844|12079287|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
10912959|NCT00116844|12079286|FG000|STARTED|Period 2: Washout Period (7 Days)||28
10912960|NCT00116844|12079287|FG001|STARTED|Period 2: Washout Period (7 Days)||33
10912961|NCT00116844|12079286|FG000|COMPLETED|Period 2: Washout Period (7 Days)||28
10912962|NCT00116844|12079287|FG001|COMPLETED|Period 2: Washout Period (7 Days)||33
10912963|NCT00116844|12079286|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
10912964|NCT00116844|12079287|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
10912965|NCT00116844|12079286|FG000|STARTED|Period 1: Treatment Period 2 (60 Days)||28
10912966|NCT00116844|12079287|FG001|STARTED|Period 1: Treatment Period 2 (60 Days)||33
10912967|NCT00116844|12079286|FG000|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
10912968|NCT00116844|12079287|FG001|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
10912969|NCT00116844|12079286|FG000|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
10912970|NCT00116844|12079287|FG001|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
10912971|NCT00116857|12079295|FG000|STARTED|Overall Study||62
10912972|NCT00116857|12079296|FG001|STARTED|Overall Study||60
10912973|NCT00116857|12079295|FG000|COMPLETED|Overall Study||59
10912974|NCT00116857|12079296|FG001|COMPLETED|Overall Study||56
10912975|NCT00116857|12079295|FG000|NOT COMPLETED|Overall Study||3
10912976|NCT00116857|12079296|FG001|NOT COMPLETED|Overall Study||4
10912977|NCT00117143|12079306|FG000|STARTED|Overall Study||4
10912978|NCT00117143|12079307|FG001|STARTED|Overall Study||4
10912979|NCT00117143|12079308|FG002|STARTED|Overall Study||7
10912980|NCT00117143|12079309|FG003|STARTED|Overall Study||1
10912981|NCT00117143|12079306|FG000|Received First Dose|Overall Study||4
10912982|NCT00117143|12079307|FG001|Received First Dose|Overall Study||4
10912983|NCT00117143|12079308|FG002|Received First Dose|Overall Study||7
10912984|NCT00117143|12079309|FG003|Received First Dose|Overall Study||1
10912985|NCT00117143|12079306|FG000|Received Second Dose|Overall Study||4
10912986|NCT00117143|12079307|FG001|Received Second Dose|Overall Study||4
10912987|NCT00117143|12079308|FG002|Received Second Dose|Overall Study||6
10912988|NCT00117143|12079309|FG003|Received Second Dose|Overall Study||0
10912989|NCT00117143|12079306|FG000|COMPLETED|Overall Study||4
10912990|NCT00117143|12079307|FG001|COMPLETED|Overall Study||4
10912991|NCT00117143|12079308|FG002|COMPLETED|Overall Study||7
10912992|NCT00117143|12079309|FG003|COMPLETED|Overall Study||1
10912993|NCT00117143|12079306|FG000|NOT COMPLETED|Overall Study||0
10912994|NCT00117143|12079307|FG001|NOT COMPLETED|Overall Study||0
10912995|NCT00117143|12079308|FG002|NOT COMPLETED|Overall Study||0
10912996|NCT00117143|12079309|FG003|NOT COMPLETED|Overall Study||0
10912997|NCT00117156|12079319|FG000|STARTED|Overall Study||26
10912998|NCT00117156|12079319|FG000|COMPLETED|Overall Study||15
10912999|NCT00117156|12079319|FG000|NOT COMPLETED|Overall Study||11
10913000|NCT00117286|12079325|FG000|STARTED|Overall Study|Safety analysis set|30
10913001|NCT00117286|12079326|FG001|STARTED|Overall Study||27
10913002|NCT00117286|12079325|FG000|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
10913003|NCT00117286|12079326|FG001|Switched to Higher Dose|Overall Study||17
10913004|NCT00117286|12079325|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
10913005|NCT00117286|12079326|FG001|COMPLETED|Overall Study||6
10913006|NCT00117286|12079325|FG000|NOT COMPLETED|Overall Study||28
10913007|NCT00117286|12079326|FG001|NOT COMPLETED|Overall Study||21
10913008|NCT00117312|12079336|FG000|STARTED|Overall Study||10
10913009|NCT00117312|12079337|FG001|STARTED|Overall Study||24
10913010|NCT00117312|12079338|FG002|STARTED|Overall Study||24
10913011|NCT00117312|12079339|FG003|STARTED|Overall Study||24
10913012|NCT00117312|12079336|FG000|Started FE200486 CS06A|Overall Study||1
10913013|NCT00117312|12079337|FG001|Started FE200486 CS06A|Overall Study||11
10913014|NCT00117312|12079338|FG002|Started FE200486 CS06A|Overall Study||16
10913015|NCT00117312|12079339|FG003|Started FE200486 CS06A|Overall Study||9
10913016|NCT00117312|12079336|FG000|COMPLETED|Overall Study||0
10913017|NCT00117312|12079337|FG001|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
10913018|NCT00117312|12079338|FG002|COMPLETED|Overall Study||0
10913019|NCT00117312|12079339|FG003|COMPLETED|Overall Study||3
10913020|NCT00117312|12079336|FG000|NOT COMPLETED|Overall Study||10
10913021|NCT00117312|12079337|FG001|NOT COMPLETED|Overall Study||20
10913022|NCT00117312|12079338|FG002|NOT COMPLETED|Overall Study||24
10913023|NCT00117312|12079339|FG003|NOT COMPLETED|Overall Study||21
10913024|NCT00117325|12079351|FG000|STARTED|Overall Study||173
10913025|NCT00117325|12079352|FG001|STARTED|Overall Study||179
10913026|NCT00117325|12079351|FG000|COMPLETED|Overall Study||160
10913027|NCT00117325|12079352|FG001|COMPLETED|Overall Study||167
10913028|NCT00117325|12079351|FG000|NOT COMPLETED|Overall Study||13
10913029|NCT00117325|12079352|FG001|NOT COMPLETED|Overall Study||12
10913030|NCT00117507|12079359|FG000|STARTED|Overall Study||24
10913031|NCT00117507|12079359|FG000|COMPLETED|Overall Study||9
10913032|NCT00117507|12079359|FG000|NOT COMPLETED|Overall Study||15
10913033|NCT00117559|12079366|FG000|STARTED|Overall Study||9
10913034|NCT00117559|12079367|FG001|STARTED|Overall Study||10
10913035|NCT00117559|12079366|FG000|COMPLETED|Overall Study||8
10913036|NCT00117559|12079367|FG001|COMPLETED|Overall Study||9
10913037|NCT00117559|12079366|FG000|NOT COMPLETED|Overall Study||1
10913038|NCT00117559|12079367|FG001|NOT COMPLETED|Overall Study||1
10913039|NCT00117572|12079375|FG000|STARTED|Overall Study||144
10913040|NCT00117572|12079376|FG001|STARTED|Overall Study||141
10913041|NCT00117572|12079375|FG000|COMPLETED|Overall Study||138
10913042|NCT00117572|12079376|FG001|COMPLETED|Overall Study||135
10913043|NCT00117572|12079375|FG000|NOT COMPLETED|Overall Study||6
10913044|NCT00117572|12079376|FG001|NOT COMPLETED|Overall Study||6
10913045|NCT00117585|12079382|FG000|STARTED|Overall Study||341
10913046|NCT00117585|12079382|FG000|COMPLETED|Overall Study||341
10913047|NCT00117585|12079382|FG000|NOT COMPLETED|Overall Study||0
10913048|NCT00117598|12079389|FG000|STARTED|Prior to Treatment Cross Over||57
10913049|NCT00117598|12079390|FG001|STARTED|Prior to Treatment Cross Over||56
10913050|NCT00117598|12079391|FG002|STARTED|Prior to Treatment Cross Over||56
10913051|NCT00117598|12079392|FG003|STARTED|Prior to Treatment Cross Over||0
10913052|NCT00117598|12079393|FG004|STARTED|Prior to Treatment Cross Over||0
10913053|NCT00117598|12079389|FG000|COMPLETED|Prior to Treatment Cross Over||0
10913054|NCT00117598|12079390|FG001|COMPLETED|Prior to Treatment Cross Over||3
10913055|NCT00117598|12079391|FG002|COMPLETED|Prior to Treatment Cross Over||4
10913056|NCT00117598|12079392|FG003|COMPLETED|Prior to Treatment Cross Over||0
10913057|NCT00117598|12079393|FG004|COMPLETED|Prior to Treatment Cross Over||0
10913058|NCT00117598|12079389|FG000|NOT COMPLETED|Prior to Treatment Cross Over||57
10913059|NCT00117598|12079390|FG001|NOT COMPLETED|Prior to Treatment Cross Over||53
10913060|NCT00117598|12079391|FG002|NOT COMPLETED|Prior to Treatment Cross Over||52
10913061|NCT00117598|12079392|FG003|NOT COMPLETED|Prior to Treatment Cross Over||0
10913062|NCT00117598|12079393|FG004|NOT COMPLETED|Prior to Treatment Cross Over||0
10913063|NCT00117598|12079389|FG000|STARTED|After Treament Cross Over||0
10913064|NCT00117598|12079390|FG001|STARTED|After Treament Cross Over||0
10913065|NCT00117598|12079391|FG002|STARTED|After Treament Cross Over||0
10913066|NCT00117598|12079392|FG003|STARTED|After Treament Cross Over||3
10913067|NCT00117598|12079393|FG004|STARTED|After Treament Cross Over||4
10913068|NCT00117598|12079389|FG000|COMPLETED|After Treament Cross Over||0
10913069|NCT00117598|12079390|FG001|COMPLETED|After Treament Cross Over||0
10913070|NCT00117598|12079391|FG002|COMPLETED|After Treament Cross Over||0
10913071|NCT00117598|12079392|FG003|COMPLETED|After Treament Cross Over||0
10913072|NCT00117598|12079393|FG004|COMPLETED|After Treament Cross Over||0
10913073|NCT00117598|12079389|FG000|NOT COMPLETED|After Treament Cross Over||0
10913074|NCT00117598|12079390|FG001|NOT COMPLETED|After Treament Cross Over||0
10913075|NCT00117598|12079391|FG002|NOT COMPLETED|After Treament Cross Over||0
10913076|NCT00117598|12079392|FG003|NOT COMPLETED|After Treament Cross Over||3
10913077|NCT00117598|12079393|FG004|NOT COMPLETED|After Treament Cross Over||4
10913078|NCT00117637|12079405|FG000|STARTED|First Intervention (Period 1)||97
10913079|NCT00117637|12079406|FG001|STARTED|First Intervention (Period 1)||92
10913080|NCT00117637|12079405|FG000|Subjects Received Treatment|First Intervention (Period 1)||97
10913081|NCT00117637|12079406|FG001|Subjects Received Treatment|First Intervention (Period 1)||90
10913082|NCT00117637|12079405|FG000|COMPLETED|First Intervention (Period 1)||79
10913083|NCT00117637|12079406|FG001|COMPLETED|First Intervention (Period 1)||67
10913084|NCT00117637|12079405|FG000|NOT COMPLETED|First Intervention (Period 1)||18
10913085|NCT00117637|12079406|FG001|NOT COMPLETED|First Intervention (Period 1)||25
10913086|NCT00117637|12079405|FG000|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
10913087|NCT00117637|12079406|FG001|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
10913088|NCT00117637|12079405|FG000|Subjects Received Treatment|Second Intervention (Period 2)||49
10913089|NCT00117637|12079406|FG001|Subjects Received Treatment|Second Intervention (Period 2)||61
10913090|NCT00117637|12079405|FG000|COMPLETED|Second Intervention (Period 2)||39
10913091|NCT00117637|12079406|FG001|COMPLETED|Second Intervention (Period 2)||39
10913092|NCT00117637|12079405|FG000|NOT COMPLETED|Second Intervention (Period 2)||10
10913093|NCT00117637|12079406|FG001|NOT COMPLETED|Second Intervention (Period 2)||22
10913094|NCT00117676|12079421|FG000|STARTED|Double-blind Period Through Week 48||254
10913095|NCT00117676|12079422|FG001|STARTED|Double-blind Period Through Week 48||128
10913096|NCT00117676|12079421|FG000|COMPLETED|Double-blind Period Through Week 48||244
10913097|NCT00117676|12079422|FG001|COMPLETED|Double-blind Period Through Week 48||121
10913098|NCT00117676|12079421|FG000|NOT COMPLETED|Double-blind Period Through Week 48||10
10913099|NCT00117676|12079422|FG001|NOT COMPLETED|Double-blind Period Through Week 48||7
10913100|NCT00117676|12079421|FG000|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
10913101|NCT00117676|12079422|FG001|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
10913102|NCT00117676|12079421|FG000|COMPLETED|Open-label Period: Weeks 49 - 96||225
10913103|NCT00117676|12079422|FG001|COMPLETED|Open-label Period: Weeks 49 - 96||110
10913104|NCT00117676|12079421|FG000|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
10913105|NCT00117676|12079422|FG001|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
10913106|NCT00117676|12079421|FG000|STARTED|Open-label Period: Weeks 97 - 144||225
10913107|NCT00117676|12079422|FG001|STARTED|Open-label Period: Weeks 97 - 144||110
10913108|NCT00117676|12079421|FG000|COMPLETED|Open-label Period: Weeks 97 - 144||219
10913109|NCT00117676|12079422|FG001|COMPLETED|Open-label Period: Weeks 97 - 144||109
10913110|NCT00117676|12079421|FG000|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
10913111|NCT00117676|12079422|FG001|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
10913112|NCT00117676|12079421|FG000|STARTED|Open-label Period: Weeks 145 - 192||219
10913113|NCT00117676|12079422|FG001|STARTED|Open-label Period: Weeks 145 - 192||109
10913114|NCT00117676|12079421|FG000|COMPLETED|Open-label Period: Weeks 145 - 192||209
10913115|NCT00117676|12079422|FG001|COMPLETED|Open-label Period: Weeks 145 - 192||106
10913116|NCT00117676|12079421|FG000|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
10913117|NCT00117676|12079422|FG001|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
10913118|NCT00117676|12079421|FG000|STARTED|Open-label Period: Weeks 193 - 240||209
10913119|NCT00117676|12079422|FG001|STARTED|Open-label Period: Weeks 193 - 240||106
10913120|NCT00117676|12079421|FG000|COMPLETED|Open-label Period: Weeks 193 - 240||202
10913121|NCT00117676|12079422|FG001|COMPLETED|Open-label Period: Weeks 193 - 240||103
10913122|NCT00117676|12079421|FG000|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
10913123|NCT00117676|12079422|FG001|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
10913124|NCT00117676|12079421|FG000|STARTED|Open-label Period: Weeks 241 - 288||202
10913125|NCT00117676|12079422|FG001|STARTED|Open-label Period: Weeks 241 - 288||103
10913126|NCT00117676|12079421|FG000|COMPLETED|Open-label Period: Weeks 241 - 288||192
10913127|NCT00117676|12079422|FG001|COMPLETED|Open-label Period: Weeks 241 - 288||100
10913128|NCT00117676|12079421|FG000|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
10913129|NCT00117676|12079422|FG001|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
10913130|NCT00117676|12079421|FG000|STARTED|Open-label Period: Weeks 289 - 336||192
10913131|NCT00117676|12079422|FG001|STARTED|Open-label Period: Weeks 289 - 336||100
10913132|NCT00117676|12079421|FG000|COMPLETED|Open-label Period: Weeks 289 - 336||183
10913133|NCT00117676|12079422|FG001|COMPLETED|Open-label Period: Weeks 289 - 336||93
10913134|NCT00117676|12079421|FG000|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
10913135|NCT00117676|12079422|FG001|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
10913136|NCT00117676|12079421|FG000|STARTED|Open-label Period: Weeks 337 - 384||183
10913137|NCT00117676|12079422|FG001|STARTED|Open-label Period: Weeks 337 - 384||93
10913138|NCT00117676|12079421|FG000|COMPLETED|Open-label Period: Weeks 337 - 384||176
10913139|NCT00117676|12079422|FG001|COMPLETED|Open-label Period: Weeks 337 - 384||90
10913140|NCT00117676|12079421|FG000|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
10913141|NCT00117676|12079422|FG001|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
10913142|NCT00117676|12079421|FG000|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
10913143|NCT00117676|12079422|FG001|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
10913144|NCT00117676|12079421|FG000|COMPLETED|Open-label Period: Weeks 385 - 432||82
10913145|NCT00117676|12079422|FG001|COMPLETED|Open-label Period: Weeks 385 - 432||44
10913146|NCT00117676|12079421|FG000|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
10913147|NCT00117676|12079422|FG001|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
10913148|NCT00117676|12079421|FG000|STARTED|Open-label Period: Weeks 433 - 480||82
10913149|NCT00117676|12079422|FG001|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
10913150|NCT00117676|12079421|FG000|COMPLETED|Open-label Period: Weeks 433 - 480||80
10913151|NCT00117676|12079422|FG001|COMPLETED|Open-label Period: Weeks 433 - 480||41
10913152|NCT00117676|12079421|FG000|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
10913153|NCT00117676|12079422|FG001|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
10913154|NCT00117715|12079433|FG000|STARTED|Overall Study||121
10913155|NCT00117715|12079433|FG000|1 Year|Overall Study||88
10913156|NCT00117715|12079433|FG000|1.5 Year|Overall Study||85
10913157|NCT00117715|12079433|FG000|2 Year|Overall Study||76
10913158|NCT00117715|12079433|FG000|2.5 Year|Overall Study||70
10913159|NCT00117715|12079433|FG000|3 Year|Overall Study||61
10913160|NCT00117715|12079433|FG000|3.5 Year|Overall Study||60
10913161|NCT00117715|12079433|FG000|4 Year|Overall Study||58
10913162|NCT00117715|12079433|FG000|4.5 Year|Overall Study||55
10913163|NCT00117715|12079433|FG000|5 Year|Overall Study||49
10913164|NCT00117715|12079433|FG000|COMPLETED|Overall Study||49
10913165|NCT00117715|12079433|FG000|NOT COMPLETED|Overall Study||72
10913166|NCT00117793|12079437|FG000|STARTED|Overall Study||17
10913167|NCT00117793|12079437|FG000|COMPLETED|Overall Study||5
10913168|NCT00117793|12079437|FG000|NOT COMPLETED|Overall Study||12
10913169|NCT00117806|12079444|FG000|STARTED|Overall Study||81
10913170|NCT00117806|12079445|FG001|STARTED|Overall Study||76
10913171|NCT00117806|12079444|FG000|COMPLETED|Overall Study||43
10913172|NCT00117806|12079445|FG001|COMPLETED|Overall Study||60
10913173|NCT00117806|12079444|FG000|NOT COMPLETED|Overall Study||38
10913174|NCT00117806|12079445|FG001|NOT COMPLETED|Overall Study||16
10913175|NCT00117845|12079454|FG000|STARTED|Overall Study||17
10913176|NCT00117845|12079454|FG000|COMPLETED|Overall Study||16
10913177|NCT00117845|12079454|FG000|NOT COMPLETED|Overall Study||1
10913178|NCT00117949|12079462|FG000|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
10913179|NCT00117949|12079463|FG001|STARTED|Overall Study||24
10913180|NCT00117949|12079464|FG002|STARTED|Overall Study||24
10913181|NCT00117949|12079465|FG003|STARTED|Overall Study||24
10913182|NCT00117949|12079462|FG000|COMPLETED|Overall Study||0
10913183|NCT00117949|12079463|FG001|COMPLETED|Overall Study||0
10913184|NCT00117949|12079464|FG002|COMPLETED|Overall Study||0
10913185|NCT00117949|12079465|FG003|COMPLETED|Overall Study||0
10913186|NCT00117949|12079462|FG000|NOT COMPLETED|Overall Study||10
10913187|NCT00117949|12079463|FG001|NOT COMPLETED|Overall Study||24
10913188|NCT00117949|12079464|FG002|NOT COMPLETED|Overall Study||24
10913189|NCT00117949|12079465|FG003|NOT COMPLETED|Overall Study||24
10913190|NCT00117962|12079477|FG000|STARTED|Overall Study||48
10913191|NCT00117962|12079478|FG001|STARTED|Overall Study||53
10913192|NCT00117962|12079477|FG000|COMPLETED|Overall Study||26
10913193|NCT00117962|12079478|FG001|COMPLETED|Overall Study||28
10913194|NCT00117962|12079477|FG000|NOT COMPLETED|Overall Study||22
10913195|NCT00117962|12079478|FG001|NOT COMPLETED|Overall Study||25
10913196|NCT00117988|12079484|FG000|STARTED|Overall Study||22
10913197|NCT00117988|12079484|FG000|COMPLETED|Overall Study||18
10913198|NCT00117988|12079484|FG000|NOT COMPLETED|Overall Study||4
10913199|NCT00118040|12079491|FG000|STARTED|Overall Study||20
10913200|NCT00118040|12079492|FG001|STARTED|Overall Study||20
10913201|NCT00118040|12079493|FG002|STARTED|Overall Study||20
10913202|NCT00118040|12079491|FG000|COMPLETED|Overall Study||19
10913203|NCT00118040|12079492|FG001|COMPLETED|Overall Study||18
10913204|NCT00118040|12079493|FG002|COMPLETED|Overall Study||14
10913205|NCT00118040|12079491|FG000|NOT COMPLETED|Overall Study||1
10913206|NCT00118040|12079492|FG001|NOT COMPLETED|Overall Study||2
10913207|NCT00118040|12079493|FG002|NOT COMPLETED|Overall Study||6
10913208|NCT00118092|12079506|FG000|STARTED|Overall Study||17
10913209|NCT00118092|12079506|FG000|COMPLETED|Overall Study||15
10913210|NCT00118092|12079506|FG000|NOT COMPLETED|Overall Study||2
10913211|NCT00118131|12079511|FG000|STARTED|Overall Study||49
10913212|NCT00118131|12079511|FG000|COMPLETED|Overall Study||49
10913213|NCT00118131|12079511|FG000|NOT COMPLETED|Overall Study||0
10913214|NCT00118144|12079515|FG000|STARTED|Overall Study||42
10913215|NCT00118144|12079515|FG000|COMPLETED|Overall Study||41
10913216|NCT00118144|12079515|FG000|NOT COMPLETED|Overall Study||1
10913217|NCT00118157|12079520|FG000|STARTED|Overall Study||19
10913218|NCT00118157|12079520|FG000|COMPLETED|Overall Study||7
10913219|NCT00118157|12079520|FG000|NOT COMPLETED|Overall Study||12
10913220|NCT00118209|12079527|FG000|STARTED|Overall Study||262
10913221|NCT00118209|12079528|FG001|STARTED|Overall Study||262
10913222|NCT00118209|12079527|FG000|Evaluable for Primary Endpoint|Overall Study||250
10913223|NCT00118209|12079528|FG001|Evaluable for Primary Endpoint|Overall Study||241
10913224|NCT00118209|12079527|FG000|Evaluable for Safety Analysis|Overall Study||243
10913225|NCT00118209|12079528|FG001|Evaluable for Safety Analysis|Overall Study||237
10913226|NCT00118209|12079527|FG000|COMPLETED|Overall Study||250
10913227|NCT00118209|12079528|FG001|COMPLETED|Overall Study||241
10913228|NCT00118209|12079527|FG000|NOT COMPLETED|Overall Study||12
10913229|NCT00118209|12079528|FG001|NOT COMPLETED|Overall Study||21
10913230|NCT00118248|12079536|FG000|STARTED|Overall Study||17
10913231|NCT00118248|12079537|FG001|STARTED|Overall Study||24
10913232|NCT00118248|12079536|FG000|COMPLETED|Overall Study||17
10913233|NCT00118248|12079537|FG001|COMPLETED|Overall Study||24
10913234|NCT00118248|12079536|FG000|NOT COMPLETED|Overall Study||0
10913235|NCT00118248|12079537|FG001|NOT COMPLETED|Overall Study||0
10913236|NCT00118274|12079546|FG000|STARTED|Overall Study||41
10913237|NCT00118274|12079547|FG001|STARTED|Overall Study||43
10913238|NCT00118274|12079548|FG002|STARTED|Overall Study||42
10913239|NCT00118274|12079549|FG003|STARTED|Overall Study||44
10913240|NCT00118274|12079546|FG000|COMPLETED|Overall Study||21
10913241|NCT00118274|12079547|FG001|COMPLETED|Overall Study||21
10913242|NCT00118274|12079548|FG002|COMPLETED|Overall Study||25
10913243|NCT00118274|12079549|FG003|COMPLETED|Overall Study||29
10913244|NCT00118274|12079546|FG000|NOT COMPLETED|Overall Study||20
10913245|NCT00118274|12079547|FG001|NOT COMPLETED|Overall Study||22
10913246|NCT00118274|12079548|FG002|NOT COMPLETED|Overall Study||17
10913247|NCT00118274|12079549|FG003|NOT COMPLETED|Overall Study||15
10913248|NCT00118287|12079559|FG000|STARTED|Overall Study||32
10913249|NCT00118287|12079559|FG000|COMPLETED|Overall Study||30
10913250|NCT00118287|12079559|FG000|NOT COMPLETED|Overall Study||2
10913251|NCT00118352|12079566|FG000|STARTED|Overall Study||12
10913252|NCT00118352|12079567|FG001|STARTED|Overall Study||0
10913253|NCT00118352|12079568|FG002|STARTED|Overall Study||0
10913254|NCT00118352|12079566|FG000|COMPLETED|Overall Study||12
10913255|NCT00118352|12079567|FG001|COMPLETED|Overall Study||0
10913256|NCT00118352|12079568|FG002|COMPLETED|Overall Study||0
10913257|NCT00118352|12079566|FG000|NOT COMPLETED|Overall Study||0
10913258|NCT00118352|12079567|FG001|NOT COMPLETED|Overall Study||0
10913259|NCT00118352|12079568|FG002|NOT COMPLETED|Overall Study||0
10913260|NCT00118365|12079578|FG000|STARTED|Overall Study||191
10913261|NCT00118365|12079579|FG001|STARTED|Overall Study||184
10913262|NCT00118365|12079578|FG000|COMPLETED|Overall Study||132
10913263|NCT00118365|12079579|FG001|COMPLETED|Overall Study||124
10913264|NCT00118365|12079578|FG000|NOT COMPLETED|Overall Study||59
10913265|NCT00118365|12079579|FG001|NOT COMPLETED|Overall Study||60
10913266|NCT00118378|12079617|FG000|STARTED|Overall Study||62
10913267|NCT00118378|12079618|FG001|STARTED|Overall Study||53
10913268|NCT00118378|12079617|FG000|COMPLETED|Overall Study||60
10913269|NCT00118378|12079618|FG001|COMPLETED|Overall Study||45
10913270|NCT00118378|12079617|FG000|NOT COMPLETED|Overall Study||2
10913271|NCT00118378|12079618|FG001|NOT COMPLETED|Overall Study||8
10913272|NCT00118404|12079629|FG000|STARTED|Overall Study||86
10913273|NCT00118404|12079630|FG001|STARTED|Overall Study||86
10913274|NCT00118404|12079631|FG002|STARTED|Overall Study||69
10913275|NCT00118404|12079629|FG000|COMPLETED|Overall Study||62
10913276|NCT00118404|12079630|FG001|COMPLETED|Overall Study||70
10913277|NCT00118404|12079631|FG002|COMPLETED|Overall Study||49
10913278|NCT00118404|12079629|FG000|NOT COMPLETED|Overall Study||24
10913279|NCT00118404|12079630|FG001|NOT COMPLETED|Overall Study||16
10913280|NCT00118404|12079631|FG002|NOT COMPLETED|Overall Study||20
10913281|NCT00118417|12079639|FG000|STARTED|Phase I (Weeks 0 to 6)||39
10913531|NCT00121186|12079926|FG000|COMPLETED|Overall Study||1
10913282|NCT00118417|12079640|FG001|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
10913283|NCT00118417|12079639|FG000|COMPLETED|Phase I (Weeks 0 to 6)||21
10913284|NCT00118417|12079640|FG001|COMPLETED|Phase I (Weeks 0 to 6)||0
10913285|NCT00118417|12079639|FG000|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
10913286|NCT00118417|12079640|FG001|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
10913287|NCT00118417|12079639|FG000|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
10913288|NCT00118417|12079640|FG001|STARTED|Phase II (Weeks 6 to 12)||13
10913289|NCT00118417|12079639|FG000|COMPLETED|Phase II (Weeks 6 to 12)||9
10913290|NCT00118417|12079640|FG001|COMPLETED|Phase II (Weeks 6 to 12)||10
10913291|NCT00118417|12079639|FG000|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
10913292|NCT00118417|12079640|FG001|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
10913293|NCT00118417|12079639|FG000|STARTED|Phase III (Weeks 12 to 24)||9
10913294|NCT00118417|12079640|FG001|STARTED|Phase III (Weeks 12 to 24)||10
10913295|NCT00118417|12079639|FG000|COMPLETED|Phase III (Weeks 12 to 24)||8
10913296|NCT00118417|12079640|FG001|COMPLETED|Phase III (Weeks 12 to 24)||9
10913297|NCT00118417|12079639|FG000|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
10913298|NCT00118417|12079640|FG001|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
10913299|NCT00118430|12079653|FG000|STARTED|Overall Study||123
10913300|NCT00118430|12079654|FG001|STARTED|Overall Study||127
10913301|NCT00118430|12079655|FG002|STARTED|Overall Study||250
10913302|NCT00118430|12079653|FG000|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
10913303|NCT00118430|12079654|FG001|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
10913304|NCT00118430|12079655|FG002|COMPLETED|Overall Study||222
10913305|NCT00118430|12079653|FG000|NOT COMPLETED|Overall Study||21
10913306|NCT00118430|12079654|FG001|NOT COMPLETED|Overall Study||24
10913307|NCT00118430|12079655|FG002|NOT COMPLETED|Overall Study||28
10913308|NCT00118482|12079664|FG000|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
10913309|NCT00118482|12079665|FG001|STARTED|Overall Study||105
10913310|NCT00118482|12079664|FG000|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
10913311|NCT00118482|12079665|FG001|COMPLETED|Overall Study||76
10913312|NCT00118482|12079664|FG000|NOT COMPLETED|Overall Study||30
10913313|NCT00118482|12079665|FG001|NOT COMPLETED|Overall Study||29
10913314|NCT00118534|12079673|FG000|STARTED|Overall Study||472
10913315|NCT00118534|12079674|FG001|STARTED|Overall Study||471
10913316|NCT00118534|12079673|FG000|COMPLETED|Overall Study||472
10913317|NCT00118534|12079674|FG001|COMPLETED|Overall Study||471
10913318|NCT00118534|12079673|FG000|NOT COMPLETED|Overall Study||0
10913319|NCT00118534|12079674|FG001|NOT COMPLETED|Overall Study||0
10913320|NCT00118703|12079683|FG000|STARTED|Overall Study||173
10913321|NCT00118703|12079684|FG001|STARTED|Overall Study||174
10913322|NCT00118703|12079683|FG000|COMPLETED|Overall Study||168
10913323|NCT00118703|12079684|FG001|COMPLETED|Overall Study||165
10913324|NCT00118703|12079683|FG000|NOT COMPLETED|Overall Study||5
10913325|NCT00118703|12079684|FG001|NOT COMPLETED|Overall Study||9
10913326|NCT00118716|12079692|FG000|STARTED|Overall Study||124
10913327|NCT00118716|12079693|FG001|STARTED|Overall Study||124
10913328|NCT00118716|12079692|FG000|COMPLETED|Overall Study||111
10913329|NCT00118716|12079693|FG001|COMPLETED|Overall Study||102
10913330|NCT00118716|12079692|FG000|NOT COMPLETED|Overall Study||13
10913331|NCT00118716|12079693|FG001|NOT COMPLETED|Overall Study||22
10913332|NCT00118742|12079701|FG000|STARTED|Overall Study||145
10913333|NCT00118742|12079702|FG001|STARTED|Overall Study||148
10913334|NCT00118742|12079701|FG000|COMPLETED|Overall Study||96
10913335|NCT00118742|12079702|FG001|COMPLETED|Overall Study||82
10913336|NCT00118742|12079701|FG000|NOT COMPLETED|Overall Study||49
10913337|NCT00118742|12079702|FG001|NOT COMPLETED|Overall Study||66
10913338|NCT00118755|12079710|FG000|STARTED|Overall Study||217
10913339|NCT00118755|12079711|FG001|STARTED|Overall Study||218
10913340|NCT00118755|12079710|FG000|Safety Population|Overall Study||208
10913341|NCT00118755|12079711|FG001|Safety Population|Overall Study||211
10913342|NCT00118755|12079710|FG000|COMPLETED|Overall Study||7
10913343|NCT00118755|12079711|FG001|COMPLETED|Overall Study||3
10913344|NCT00118755|12079710|FG000|NOT COMPLETED|Overall Study||210
10913345|NCT00118755|12079711|FG001|NOT COMPLETED|Overall Study||215
10913346|NCT00118898|12079721|FG000|STARTED|Overall Study||464
10913347|NCT00118898|12079722|FG001|STARTED|Overall Study||465
10913348|NCT00118898|12079723|FG002|STARTED|Overall Study||465
10913349|NCT00118898|12079724|FG003|STARTED|Overall Study||463
10913350|NCT00118898|12079721|FG000|Initiated Treatment|Overall Study||461
10913351|NCT00118898|12079722|FG001|Initiated Treatment|Overall Study||461
10913352|NCT00118898|12079723|FG002|Initiated Treatment|Overall Study||464
10913353|NCT00118898|12079724|FG003|Initiated Treatment|Overall Study||462
10913354|NCT00118898|12079721|FG000|COMPLETED|Overall Study||343
10913355|NCT00118898|12079722|FG001|COMPLETED|Overall Study||324
10913356|NCT00118898|12079723|FG002|COMPLETED|Overall Study||342
10913357|NCT00118898|12079724|FG003|COMPLETED|Overall Study||322
10913358|NCT00118898|12079721|FG000|NOT COMPLETED|Overall Study||121
10913359|NCT00118898|12079722|FG001|NOT COMPLETED|Overall Study||141
10913360|NCT00118898|12079723|FG002|NOT COMPLETED|Overall Study||123
10913361|NCT00118898|12079724|FG003|NOT COMPLETED|Overall Study||141
10913362|NCT00118911|12079736|FG000|STARTED|Overall Study||43
10913363|NCT00118911|12079737|FG001|STARTED|Overall Study||43
10913364|NCT00118911|12079736|FG000|Received Intervention as Assigned|Overall Study||41
10913365|NCT00118911|12079737|FG001|Received Intervention as Assigned|Overall Study||38
10913366|NCT00118911|12079736|FG000|Completed Post-Treatment Assessment|Overall Study||41
10913367|NCT00118911|12079737|FG001|Completed Post-Treatment Assessment|Overall Study||37
10913368|NCT00118911|12079736|FG000|6 Month Follow-up|Overall Study||37
10913369|NCT00118911|12079737|FG001|6 Month Follow-up|Overall Study||30
10913370|NCT00118911|12079736|FG000|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
10913371|NCT00118911|12079737|FG001|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
10913372|NCT00118911|12079736|FG000|COMPLETED|Overall Study||41
10913373|NCT00118911|12079737|FG001|COMPLETED|Overall Study||38
10913374|NCT00118911|12079736|FG000|NOT COMPLETED|Overall Study||2
10913375|NCT00118911|12079737|FG001|NOT COMPLETED|Overall Study||5
10913376|NCT00119015|12079745|FG000|STARTED|Open-Label Phase (2 Weeks)||102
10913377|NCT00119015|12079746|FG001|STARTED|Open-Label Phase (2 Weeks)||0
10913378|NCT00119015|12079747|FG002|STARTED|Open-Label Phase (2 Weeks)||0
10913379|NCT00119015|12079745|FG000|COMPLETED|Open-Label Phase (2 Weeks)||54
10913380|NCT00119015|12079746|FG001|COMPLETED|Open-Label Phase (2 Weeks)||0
10913381|NCT00119015|12079747|FG002|COMPLETED|Open-Label Phase (2 Weeks)||0
10913382|NCT00119015|12079745|FG000|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
10913383|NCT00119015|12079746|FG001|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
10913384|NCT00119015|12079747|FG002|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
10913385|NCT00119015|12079745|FG000|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
10913386|NCT00119015|12079746|FG001|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
10913387|NCT00119015|12079747|FG002|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
10913388|NCT00119015|12079745|FG000|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
10913389|NCT00119015|12079746|FG001|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
10913390|NCT00119015|12079747|FG002|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
10913391|NCT00119015|12079745|FG000|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
10913392|NCT00119015|12079746|FG001|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
10913393|NCT00119015|12079747|FG002|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
10913394|NCT00119041|12079756|FG000|STARTED|Overall Study||199
10913395|NCT00119041|12079757|FG001|STARTED|Overall Study||83
10913396|NCT00119041|12079758|FG002|STARTED|Overall Study||22
10913397|NCT00119041|12079756|FG000|COMPLETED|Overall Study||199
10913398|NCT00119041|12079757|FG001|COMPLETED|Overall Study||83
10913399|NCT00119041|12079758|FG002|COMPLETED|Overall Study||22
10913400|NCT00119041|12079756|FG000|NOT COMPLETED|Overall Study||0
10913401|NCT00119041|12079757|FG001|NOT COMPLETED|Overall Study||0
10913402|NCT00119041|12079758|FG002|NOT COMPLETED|Overall Study||0
10913403|NCT00119106|12079769|FG000|STARTED|Overall Study||1204
10913404|NCT00119106|12079770|FG001|STARTED|Overall Study|2 participants later found to be HIV infected at baseline. Therefore 1207 in mITT analysis|1209
10913405|NCT00119106|12079769|FG000|COMPLETED|Overall Study||1025
10913406|NCT00119106|12079770|FG001|COMPLETED|Overall Study||1031
10913407|NCT00119106|12079769|FG000|NOT COMPLETED|Overall Study||179
10913408|NCT00119106|12079770|FG001|NOT COMPLETED|Overall Study||178
10913409|NCT00119158|12079786|FG000|STARTED|Active Treatment|patients are self controls|45
10913410|NCT00119158|12079787|FG001|STARTED|Active Treatment||45
10913411|NCT00119158|12079786|FG000|COMPLETED|Active Treatment||45
10913412|NCT00119158|12079787|FG001|COMPLETED|Active Treatment||45
10913413|NCT00119158|12079786|FG000|NOT COMPLETED|Active Treatment||0
10913414|NCT00119158|12079787|FG001|NOT COMPLETED|Active Treatment||0
10913415|NCT00119158|12079786|FG000|STARTED|Placebo Treatment||45
10913416|NCT00119158|12079787|FG001|STARTED|Placebo Treatment||45
10913417|NCT00119158|12079786|FG000|COMPLETED|Placebo Treatment||45
10913418|NCT00119158|12079787|FG001|COMPLETED|Placebo Treatment||45
10913419|NCT00119158|12079786|FG000|NOT COMPLETED|Placebo Treatment||0
10913420|NCT00119158|12079787|FG001|NOT COMPLETED|Placebo Treatment||0
10913421|NCT00119262|12079795|FG000|STARTED|Overall Study||104
10913422|NCT00119262|12079796|FG001|STARTED|Overall Study||122
10913423|NCT00119262|12079795|FG000|Eligible|Overall Study||103
10913424|NCT00119262|12079796|FG001|Eligible|Overall Study||120
10913425|NCT00119262|12079795|FG000|Treated|Overall Study||103
10913426|NCT00119262|12079796|FG001|Treated|Overall Study||120
10913427|NCT00119262|12079795|FG000|Eligible and Treated|Overall Study||102
10913428|NCT00119262|12079796|FG001|Eligible and Treated|Overall Study||119
10913429|NCT00119262|12079795|FG000|COMPLETED|Overall Study||58
10913430|NCT00119262|12079796|FG001|COMPLETED|Overall Study||64
10913431|NCT00119262|12079795|FG000|NOT COMPLETED|Overall Study||46
10913432|NCT00119262|12079796|FG001|NOT COMPLETED|Overall Study||58
10913433|NCT00119379|12079804|FG000|STARTED|Overall Study||26
10913434|NCT00119379|12079805|FG001|STARTED|Overall Study||24
10913435|NCT00119379|12079804|FG000|COMPLETED|Overall Study||22
10913436|NCT00119379|12079805|FG001|COMPLETED|Overall Study||23
10913437|NCT00119379|12079804|FG000|NOT COMPLETED|Overall Study||4
10913438|NCT00119379|12079805|FG001|NOT COMPLETED|Overall Study||1
10913439|NCT00119392|12079811|FG000|STARTED|Overall Study||45
10913440|NCT00119392|12079811|FG000|COMPLETED|Overall Study||40
10913441|NCT00119392|12079811|FG000|NOT COMPLETED|Overall Study||5
10913442|NCT00119405|12079815|FG000|STARTED|Overall Study||18
10913443|NCT00119405|12079815|FG000|COMPLETED|Overall Study||17
10913444|NCT00119405|12079815|FG000|NOT COMPLETED|Overall Study||1
10913445|NCT00119678|12079821|FG000|STARTED|Double-blind Treatment Period||122
10913446|NCT00119678|12079822|FG001|STARTED|Double-blind Treatment Period||61
10913447|NCT00119678|12079821|FG000|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
10913448|NCT00119678|12079822|FG001|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
10913449|NCT00119678|12079821|FG000|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
10913450|NCT00119678|12079822|FG001|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
10913451|NCT00119678|12079821|FG000|COMPLETED|Double-blind Treatment Period||81
10913452|NCT00119678|12079822|FG001|COMPLETED|Double-blind Treatment Period||35
10913453|NCT00119678|12079821|FG000|NOT COMPLETED|Double-blind Treatment Period||41
10913454|NCT00119678|12079822|FG001|NOT COMPLETED|Double-blind Treatment Period||26
10913455|NCT00119678|12079821|FG000|STARTED|Open-label Treatment Period|Number of participants treated|110
10913456|NCT00119678|12079822|FG001|STARTED|Open-label Treatment Period||0
10913457|NCT00119678|12079821|FG000|COMPLETED|Open-label Treatment Period||0
10913458|NCT00119678|12079822|FG001|COMPLETED|Open-label Treatment Period||0
10913459|NCT00119678|12079821|FG000|NOT COMPLETED|Open-label Treatment Period||110
10913460|NCT00119678|12079822|FG001|NOT COMPLETED|Open-label Treatment Period||0
10913461|NCT00120250|12079830|FG000|STARTED|Overall Study||13
10913462|NCT00120250|12079831|FG001|STARTED|Overall Study||14
10913463|NCT00120250|12079830|FG000|COMPLETED|Overall Study||12
10913464|NCT00120250|12079831|FG001|COMPLETED|Overall Study||12
10913465|NCT00120250|12079830|FG000|NOT COMPLETED|Overall Study||1
10913466|NCT00120250|12079831|FG001|NOT COMPLETED|Overall Study||2
10913467|NCT00120289|12079840|FG000|STARTED|Overall Study||1718
10913468|NCT00120289|12079841|FG001|STARTED|Overall Study||1696
10913469|NCT00120289|12079840|FG000|COMPLETED|Overall Study||1597
10913470|NCT00120289|12079841|FG001|COMPLETED|Overall Study||1587
10913471|NCT00120289|12079840|FG000|NOT COMPLETED|Overall Study||121
10913472|NCT00120289|12079841|FG001|NOT COMPLETED|Overall Study||109
10913473|NCT00120406|12079849|FG000|STARTED|Overall Study||236
10913474|NCT00120406|12079850|FG001|STARTED|Overall Study||238
10913475|NCT00120406|12079849|FG000|COMPLETED|Overall Study||217
10913476|NCT00120406|12079850|FG001|COMPLETED|Overall Study||222
10913477|NCT00120406|12079849|FG000|NOT COMPLETED|Overall Study||19
10913478|NCT00120406|12079850|FG001|NOT COMPLETED|Overall Study||16
10913479|NCT00120523|12079858|FG000|STARTED|Treatment Period||1205
10913480|NCT00120523|12079859|FG001|STARTED|Treatment Period||1213
10913481|NCT00120523|12079858|FG000|COMPLETED|Treatment Period||836
10913482|NCT00120523|12079859|FG001|COMPLETED|Treatment Period||874
10913483|NCT00120523|12079858|FG000|NOT COMPLETED|Treatment Period||369
10913484|NCT00120523|12079859|FG001|NOT COMPLETED|Treatment Period||339
10913485|NCT00120523|12079858|FG000|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
10913486|NCT00120523|12079859|FG001|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
10913487|NCT00120523|12079858|FG000|COMPLETED|Follow-Up Period||90
10913488|NCT00120523|12079859|FG001|COMPLETED|Follow-Up Period||46
10913489|NCT00120523|12079858|FG000|NOT COMPLETED|Follow-Up Period||30
10913490|NCT00120523|12079859|FG001|NOT COMPLETED|Follow-Up Period||24
10913491|NCT00120627|12079868|FG000|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
10913492|NCT00120627|12079869|FG001|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
10913493|NCT00120627|12079868|FG000|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
10913494|NCT00120627|12079869|FG001|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
10913495|NCT00120627|12079868|FG000|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
10913496|NCT00120627|12079869|FG001|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
10913497|NCT00120627|12079868|FG000|COMPLETED|Overall Study||66
10913498|NCT00120627|12079869|FG001|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
10913499|NCT00120627|12079868|FG000|NOT COMPLETED|Overall Study||5
10913500|NCT00120627|12079869|FG001|NOT COMPLETED|Overall Study||5
10913501|NCT00120874|12079886|FG000|STARTED|Overall Study||10
10913502|NCT00120874|12079887|FG001|STARTED|Overall Study||10
10913503|NCT00120874|12079886|FG000|Completed Study; Started Extension Study|Overall Study||10
10913504|NCT00120874|12079887|FG001|Completed Study; Started Extension Study|Overall Study||10
10913505|NCT00120874|12079886|FG000|COMPLETED|Overall Study||10
10913506|NCT00120874|12079887|FG001|COMPLETED|Overall Study||9
10913507|NCT00120874|12079886|FG000|NOT COMPLETED|Overall Study||0
10913508|NCT00120874|12079887|FG001|NOT COMPLETED|Overall Study||1
10913509|NCT00121134|12079897|FG000|STARTED|Overall Study||40
10913510|NCT00121134|12079898|FG001|STARTED|Overall Study||41
10913511|NCT00121134|12079899|FG002|STARTED|Overall Study||41
10913512|NCT00121134|12079900|FG003|STARTED|Overall Study||40
10913513|NCT00121134|12079897|FG000|COMPLETED|Overall Study||24
10913514|NCT00121134|12079898|FG001|COMPLETED|Overall Study||26
10913515|NCT00121134|12079899|FG002|COMPLETED|Overall Study||20
10913516|NCT00121134|12079900|FG003|COMPLETED|Overall Study||31
10913517|NCT00121134|12079897|FG000|NOT COMPLETED|Overall Study||16
10913518|NCT00121134|12079898|FG001|NOT COMPLETED|Overall Study||15
10913519|NCT00121134|12079899|FG002|NOT COMPLETED|Overall Study||21
10913520|NCT00121134|12079900|FG003|NOT COMPLETED|Overall Study||9
10913521|NCT00121173|12079913|FG000|STARTED|Overall Study||4
10913522|NCT00121173|12079914|FG001|STARTED|Overall Study||3
10913523|NCT00121173|12079915|FG002|STARTED|Overall Study||9
10913524|NCT00121173|12079913|FG000|COMPLETED|Overall Study||3
10913525|NCT00121173|12079914|FG001|COMPLETED|Overall Study||3
10913526|NCT00121173|12079915|FG002|COMPLETED|Overall Study||9
10913527|NCT00121173|12079913|FG000|NOT COMPLETED|Overall Study||1
10913528|NCT00121173|12079914|FG001|NOT COMPLETED|Overall Study||0
10913529|NCT00121173|12079915|FG002|NOT COMPLETED|Overall Study||0
10913530|NCT00121186|12079926|FG000|STARTED|Overall Study||1
10913532|NCT00121186|12079926|FG000|NOT COMPLETED|Overall Study||0
10913533|NCT00121199|12079930|FG000|STARTED|Overall Study||73
10913534|NCT00121199|12079930|FG000|Eligible|Overall Study||64
10913535|NCT00121199|12079930|FG000|Eligible and Began Protocol Therapy|Overall Study||64
10913536|NCT00121199|12079930|FG000|COMPLETED|Overall Study||45
10913537|NCT00121199|12079930|FG000|NOT COMPLETED|Overall Study||28
10913538|NCT00121225|12079934|FG000|STARTED|Overall Study||32
10913539|NCT00121225|12079934|FG000|COMPLETED|Overall Study||32
10913540|NCT00121225|12079934|FG000|NOT COMPLETED|Overall Study||0
10913541|NCT00121238|12079939|FG000|STARTED|Overall Study||16
10913542|NCT00121238|12079939|FG000|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
10913543|NCT00121238|12079939|FG000|NOT COMPLETED|Overall Study||3
10913544|NCT00121251|12079943|FG000|STARTED|Overall Study||17
10913545|NCT00121251|12079943|FG000|COMPLETED|Overall Study||17
10913546|NCT00121251|12079943|FG000|NOT COMPLETED|Overall Study||0
10913547|NCT00121641|12079951|FG000|STARTED|24-week Short-term Treatment Period||102
10913548|NCT00121641|12079952|FG001|STARTED|24-week Short-term Treatment Period||106
10913549|NCT00121641|12079953|FG002|STARTED|24-week Short-term Treatment Period||98
10913550|NCT00121641|12079954|FG003|STARTED|24-week Short-term Treatment Period||95
10913551|NCT00121641|12079955|FG004|STARTED|24-week Short-term Treatment Period||66
10913552|NCT00121641|12079951|FG000|COMPLETED|24-week Short-term Treatment Period||73
10913553|NCT00121641|12079952|FG001|COMPLETED|24-week Short-term Treatment Period||68
10913554|NCT00121641|12079953|FG002|COMPLETED|24-week Short-term Treatment Period||69
10913555|NCT00121641|12079954|FG003|COMPLETED|24-week Short-term Treatment Period||55
10913556|NCT00121641|12079955|FG004|COMPLETED|24-week Short-term Treatment Period||25
10913557|NCT00121641|12079951|FG000|NOT COMPLETED|24-week Short-term Treatment Period||29
10913558|NCT00121641|12079952|FG001|NOT COMPLETED|24-week Short-term Treatment Period||38
10913559|NCT00121641|12079953|FG002|NOT COMPLETED|24-week Short-term Treatment Period||29
10913560|NCT00121641|12079954|FG003|NOT COMPLETED|24-week Short-term Treatment Period||40
10913561|NCT00121641|12079955|FG004|NOT COMPLETED|24-week Short-term Treatment Period||41
10913562|NCT00121641|12079951|FG000|STARTED|48-month Short Term + Long Term Period||102
10913563|NCT00121641|12079952|FG001|STARTED|48-month Short Term + Long Term Period||106
10913564|NCT00121641|12079953|FG002|STARTED|48-month Short Term + Long Term Period||98
10913565|NCT00121641|12079954|FG003|STARTED|48-month Short Term + Long Term Period||95
10913566|NCT00121641|12079955|FG004|STARTED|48-month Short Term + Long Term Period||66
10913567|NCT00121641|12079951|FG000|COMPLETED|48-month Short Term + Long Term Period||23
10913568|NCT00121641|12079952|FG001|COMPLETED|48-month Short Term + Long Term Period||24
10913569|NCT00121641|12079953|FG002|COMPLETED|48-month Short Term + Long Term Period||28
10913570|NCT00121641|12079954|FG003|COMPLETED|48-month Short Term + Long Term Period||24
10913571|NCT00121641|12079955|FG004|COMPLETED|48-month Short Term + Long Term Period||8
10913572|NCT00121641|12079951|FG000|NOT COMPLETED|48-month Short Term + Long Term Period||79
10913573|NCT00121641|12079952|FG001|NOT COMPLETED|48-month Short Term + Long Term Period||82
10913574|NCT00121641|12079953|FG002|NOT COMPLETED|48-month Short Term + Long Term Period||70
10913575|NCT00121641|12079954|FG003|NOT COMPLETED|48-month Short Term + Long Term Period||71
10913576|NCT00121641|12079955|FG004|NOT COMPLETED|48-month Short Term + Long Term Period||58
10913577|NCT00121667|12079973|FG000|STARTED|Short Term (ST) Period||192
10913578|NCT00121667|12079974|FG001|STARTED|Short Term (ST) Period||191
10913579|NCT00121667|12079975|FG002|STARTED|Short Term (ST) Period||181
10913580|NCT00121667|12079976|FG003|STARTED|Short Term (ST) Period||179
10913581|NCT00121667|12079973|FG000|COMPLETED|Short Term (ST) Period||148
10913582|NCT00121667|12079974|FG001|COMPLETED|Short Term (ST) Period||143
10913583|NCT00121667|12079975|FG002|COMPLETED|Short Term (ST) Period||140
10913584|NCT00121667|12079976|FG003|COMPLETED|Short Term (ST) Period||112
10913585|NCT00121667|12079973|FG000|NOT COMPLETED|Short Term (ST) Period||44
10913586|NCT00121667|12079974|FG001|NOT COMPLETED|Short Term (ST) Period||48
10913587|NCT00121667|12079975|FG002|NOT COMPLETED|Short Term (ST) Period||41
10913588|NCT00121667|12079976|FG003|NOT COMPLETED|Short Term (ST) Period||67
10913589|NCT00121667|12079973|FG000|STARTED|Short Term (ST) + Long Term (LT) Period||192
10913590|NCT00121667|12079974|FG001|STARTED|Short Term (ST) + Long Term (LT) Period||191
10913591|NCT00121667|12079975|FG002|STARTED|Short Term (ST) + Long Term (LT) Period||181
10913592|NCT00121667|12079976|FG003|STARTED|Short Term (ST) + Long Term (LT) Period||179
10913593|NCT00121667|12079973|FG000|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
10913594|NCT00121667|12079974|FG001|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
10913595|NCT00121667|12079975|FG002|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
10913596|NCT00121667|12079976|FG003|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
10913597|NCT00121667|12079973|FG000|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
10913598|NCT00121667|12079974|FG001|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
10913599|NCT00121667|12079975|FG002|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
10913600|NCT00121667|12079976|FG003|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
10913601|NCT00121667|12079973|FG000|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
10913602|NCT00121667|12079974|FG001|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
10913603|NCT00121667|12079975|FG002|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
10913604|NCT00121667|12079976|FG003|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
10913605|NCT00121719|12079998|FG000|STARTED|Dose Escalation (4 Weeks)||4
10913606|NCT00121719|12079999|FG001|STARTED|Dose Escalation (4 Weeks)||4
10913607|NCT00121719|12080000|FG002|STARTED|Dose Escalation (4 Weeks)||4
10913608|NCT00121719|12080001|FG003|STARTED|Dose Escalation (4 Weeks)||3
10913609|NCT00121719|12080002|FG004|STARTED|Dose Escalation (4 Weeks)||3
10913610|NCT00121719|12080003|FG005|STARTED|Dose Escalation (4 Weeks)||3
10913611|NCT00121719|12080004|FG006|STARTED|Dose Escalation (4 Weeks)||12
10913612|NCT00121719|12080005|FG007|STARTED|Dose Escalation (4 Weeks)||9
10913613|NCT00121719|12080006|FG008|STARTED|Dose Escalation (4 Weeks)||6
10913614|NCT00121719|12080007|FG009|STARTED|Dose Escalation (4 Weeks)||3
10913615|NCT00121719|12080008|FG010|STARTED|Dose Escalation (4 Weeks)||0
10913616|NCT00121719|12080009|FG011|STARTED|Dose Escalation (4 Weeks)||0
10913617|NCT00121719|12080010|FG012|STARTED|Dose Escalation (4 Weeks)||24
10913618|NCT00121719|12080011|FG013|STARTED|Dose Escalation (4 Weeks)||7
10913619|NCT00121719|12079998|FG000|COMPLETED|Dose Escalation (4 Weeks)||4
10913620|NCT00121719|12079999|FG001|COMPLETED|Dose Escalation (4 Weeks)||4
10913621|NCT00121719|12080000|FG002|COMPLETED|Dose Escalation (4 Weeks)||4
10913622|NCT00121719|12080001|FG003|COMPLETED|Dose Escalation (4 Weeks)||3
10913623|NCT00121719|12080002|FG004|COMPLETED|Dose Escalation (4 Weeks)||3
10913624|NCT00121719|12080003|FG005|COMPLETED|Dose Escalation (4 Weeks)||3
10913625|NCT00121719|12080004|FG006|COMPLETED|Dose Escalation (4 Weeks)||12
10913626|NCT00121719|12080005|FG007|COMPLETED|Dose Escalation (4 Weeks)||9
10913627|NCT00121719|12080006|FG008|COMPLETED|Dose Escalation (4 Weeks)||6
10913628|NCT00121719|12080007|FG009|COMPLETED|Dose Escalation (4 Weeks)||3
10913629|NCT00121719|12080008|FG010|COMPLETED|Dose Escalation (4 Weeks)||0
10913630|NCT00121719|12080009|FG011|COMPLETED|Dose Escalation (4 Weeks)||0
10913631|NCT00121719|12080010|FG012|COMPLETED|Dose Escalation (4 Weeks)||24
10913632|NCT00121719|12080011|FG013|COMPLETED|Dose Escalation (4 Weeks)||7
10913633|NCT00121719|12079998|FG000|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10913634|NCT00121719|12079999|FG001|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10913635|NCT00121719|12080000|FG002|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10913636|NCT00121719|12080001|FG003|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10913637|NCT00121719|12080002|FG004|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10913638|NCT00121719|12080003|FG005|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10913639|NCT00121719|12080004|FG006|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10913640|NCT00121719|12080005|FG007|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10913641|NCT00121719|12080006|FG008|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10913642|NCT00121719|12080007|FG009|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10913643|NCT00121719|12080008|FG010|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10913644|NCT00121719|12080009|FG011|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10913645|NCT00121719|12080010|FG012|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10913646|NCT00121719|12080011|FG013|NOT COMPLETED|Dose Escalation (4 Weeks)||0
10913647|NCT00121719|12079998|FG000|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10913648|NCT00121719|12079999|FG001|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10913649|NCT00121719|12080000|FG002|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10913650|NCT00121719|12080001|FG003|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10913651|NCT00121719|12080002|FG004|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10913652|NCT00121719|12080003|FG005|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10913653|NCT00121719|12080004|FG006|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10913654|NCT00121719|12080005|FG007|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10913655|NCT00121719|12080006|FG008|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10913656|NCT00121719|12080007|FG009|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10913657|NCT00121719|12080008|FG010|STARTED|Food-Effect Pilot Study (4 Weeks)||6
10913658|NCT00121719|12080009|FG011|STARTED|Food-Effect Pilot Study (4 Weeks)||5
10913659|NCT00121719|12080010|FG012|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10913660|NCT00121719|12080011|FG013|STARTED|Food-Effect Pilot Study (4 Weeks)||0
10913661|NCT00121719|12079998|FG000|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913662|NCT00121719|12079999|FG001|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913663|NCT00121719|12080000|FG002|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913664|NCT00121719|12080001|FG003|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913665|NCT00121719|12080002|FG004|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913666|NCT00121719|12080003|FG005|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913667|NCT00121719|12080004|FG006|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913668|NCT00121719|12080005|FG007|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913669|NCT00121719|12080006|FG008|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913670|NCT00121719|12080007|FG009|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913671|NCT00121719|12080008|FG010|COMPLETED|Food-Effect Pilot Study (4 Weeks)||6
10913672|NCT00121719|12080009|FG011|COMPLETED|Food-Effect Pilot Study (4 Weeks)||5
10913673|NCT00121719|12080010|FG012|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913674|NCT00121719|12080011|FG013|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913675|NCT00121719|12079998|FG000|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913676|NCT00121719|12079999|FG001|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913677|NCT00121719|12080000|FG002|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913678|NCT00121719|12080001|FG003|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913679|NCT00121719|12080002|FG004|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913680|NCT00121719|12080003|FG005|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913681|NCT00121719|12080004|FG006|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913682|NCT00121719|12080005|FG007|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913683|NCT00121719|12080006|FG008|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913684|NCT00121719|12080007|FG009|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913685|NCT00121719|12080008|FG010|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913686|NCT00121719|12080009|FG011|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913687|NCT00121719|12080010|FG012|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913688|NCT00121719|12080011|FG013|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
10913689|NCT00121810|12080055|FG000|STARTED|Overall Study||151
10913690|NCT00121810|12080056|FG001|STARTED|Overall Study||154
10913691|NCT00121810|12080055|FG000|Safety Population|Overall Study||148
10913692|NCT00121810|12080056|FG001|Safety Population|Overall Study||153
10913693|NCT00121810|12080055|FG000|Intent-to-Treat (ITT) Population|Overall Study||148
10913694|NCT00121810|12080056|FG001|Intent-to-Treat (ITT) Population|Overall Study||151
10913695|NCT00121810|12080055|FG000|COMPLETED|Overall Study||121
10913696|NCT00121810|12080056|FG001|COMPLETED|Overall Study||115
10913697|NCT00121810|12080055|FG000|NOT COMPLETED|Overall Study||30
10913698|NCT00121810|12080056|FG001|NOT COMPLETED|Overall Study||39
10913699|NCT00121836|12080062|FG000|STARTED|Overall Study||109
10913700|NCT00121836|12080062|FG000|COMPLETED|Overall Study||54
10913701|NCT00121836|12080062|FG000|NOT COMPLETED|Overall Study||55
10913702|NCT00121992|12080069|FG000|STARTED|Overall Study||521
10913703|NCT00121992|12080070|FG001|STARTED|Overall Study||539
10913704|NCT00121992|12080069|FG000|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||28
10913705|NCT00121992|12080070|FG001|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||30
10913706|NCT00121992|12080069|FG000|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||24
10913707|NCT00121992|12080070|FG001|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||22
10913708|NCT00121992|12080069|FG000|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||209
10913709|NCT00121992|12080070|FG001|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||220
10913710|NCT00121992|12080069|FG000|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||92
10913711|NCT00121992|12080070|FG001|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||103
10913712|NCT00121992|12080069|FG000|COMPLETED|Overall Study||519
10913713|NCT00121992|12080070|FG001|COMPLETED|Overall Study||528
10913714|NCT00121992|12080069|FG000|NOT COMPLETED|Overall Study||2
10913715|NCT00121992|12080070|FG001|NOT COMPLETED|Overall Study||11
10913716|NCT00122109|12080078|FG000|STARTED|Overall Study|ITT|61
10913717|NCT00122109|12080079|FG001|STARTED|Overall Study|ITT|64
10913718|NCT00122109|12080078|FG000|COMPLETED|Overall Study||55
10913719|NCT00122109|12080079|FG001|COMPLETED|Overall Study||57
10913720|NCT00122109|12080078|FG000|NOT COMPLETED|Overall Study||6
10913721|NCT00122109|12080079|FG001|NOT COMPLETED|Overall Study||7
10913722|NCT00122135|12080090|FG000|STARTED|Overall Study||60
10913723|NCT00122135|12080091|FG001|STARTED|Overall Study||60
10913724|NCT00122135|12080090|FG000|COMPLETED|Overall Study||57
10913725|NCT00122135|12080091|FG001|COMPLETED|Overall Study||60
10913726|NCT00122135|12080090|FG000|NOT COMPLETED|Overall Study||3
10913727|NCT00122135|12080091|FG001|NOT COMPLETED|Overall Study||0
10913728|NCT00122187|12080099|FG000|STARTED|Overall Study||4
10913729|NCT00122187|12080100|FG001|STARTED|Overall Study||4
10913730|NCT00122187|12080099|FG000|Matched by Colonoscopy Volume|Overall Study||4
10913731|NCT00122187|12080100|FG001|Matched by Colonoscopy Volume|Overall Study||4
10913732|NCT00122187|12080099|FG000|Randomized to Intervention or Usual Care|Overall Study||4
10913733|NCT00122187|12080100|FG001|Randomized to Intervention or Usual Care|Overall Study||4
10913734|NCT00122187|12080099|FG000|Intervention Implemented|Overall Study||3
10913735|NCT00122187|12080100|FG001|Intervention Implemented|Overall Study||4
10913736|NCT00122187|12080099|FG000|Post-intervention Data Collection|Overall Study||2
10913737|NCT00122187|12080100|FG001|Post-intervention Data Collection|Overall Study||2
10913738|NCT00122187|12080099|FG000|COMPLETED|Overall Study||2
10913739|NCT00122187|12080100|FG001|COMPLETED|Overall Study||2
10913740|NCT00122187|12080099|FG000|NOT COMPLETED|Overall Study||2
10913741|NCT00122187|12080100|FG001|NOT COMPLETED|Overall Study||2
10913742|NCT00122278|12080110|FG000|STARTED|Overall Study||106
10913743|NCT00122278|12080111|FG001|STARTED|Overall Study||99
10913744|NCT00122278|12080110|FG000|COMPLETED|Overall Study||104
10913745|NCT00122278|12080111|FG001|COMPLETED|Overall Study||99
10913746|NCT00122278|12080110|FG000|NOT COMPLETED|Overall Study||2
10913747|NCT00122278|12080111|FG001|NOT COMPLETED|Overall Study||0
10913748|NCT00122317|12080117|FG000|STARTED|Overall Study||187
10913749|NCT00122317|12080117|FG000|COMPLETED|Overall Study||176
10913750|NCT00122317|12080117|FG000|NOT COMPLETED|Overall Study||11
10913751|NCT00122369|12080124|FG000|STARTED|Overall Study||76
10913752|NCT00122369|12080125|FG001|STARTED|Overall Study||82
10913753|NCT00122369|12080126|FG002|STARTED|Overall Study||78
10913754|NCT00122369|12080124|FG000|COMPLETED|Overall Study||76
10913755|NCT00122369|12080125|FG001|COMPLETED|Overall Study||82
10913756|NCT00122369|12080126|FG002|COMPLETED|Overall Study||78
10913757|NCT00122369|12080124|FG000|NOT COMPLETED|Overall Study||0
10913758|NCT00122369|12080125|FG001|NOT COMPLETED|Overall Study||0
10913759|NCT00122369|12080126|FG002|NOT COMPLETED|Overall Study||0
10913760|NCT00122382|12080139|FG000|STARTED|Double-Blind Study|participants randomized|256
10913761|NCT00122382|12080140|FG001|STARTED|Double-Blind Study|participants randomized|255
10913762|NCT00122382|12080141|FG002|STARTED|Double-Blind Study||0
10913763|NCT00122382|12080139|FG000|Treated|Double-Blind Study||256
10913764|NCT00122382|12080140|FG001|Treated|Double-Blind Study||253
10913765|NCT00122382|12080141|FG002|Treated|Double-Blind Study||0
10913766|NCT00122382|12080139|FG000|COMPLETED|Double-Blind Study||232
10913767|NCT00122382|12080140|FG001|COMPLETED|Double-Blind Study||227
10913768|NCT00122382|12080141|FG002|COMPLETED|Double-Blind Study||0
10913769|NCT00122382|12080139|FG000|NOT COMPLETED|Double-Blind Study||24
10913770|NCT00122382|12080140|FG001|NOT COMPLETED|Double-Blind Study||28
10913771|NCT00122382|12080141|FG002|NOT COMPLETED|Double-Blind Study||0
10913772|NCT00122382|12080139|FG000|STARTED|Open-Label Study||0
10913773|NCT00122382|12080140|FG001|STARTED|Open-Label Study||0
10913774|NCT00122382|12080141|FG002|STARTED|Open-Label Study||459
10913775|NCT00122382|12080139|FG000|COMPLETED|Open-Label Study||0
10913776|NCT00122382|12080140|FG001|COMPLETED|Open-Label Study||0
10913777|NCT00122382|12080141|FG002|COMPLETED|Open-Label Study||433
10913778|NCT00122382|12080139|FG000|NOT COMPLETED|Open-Label Study||0
10913779|NCT00122382|12080140|FG001|NOT COMPLETED|Open-Label Study||0
10913780|NCT00122382|12080141|FG002|NOT COMPLETED|Open-Label Study||26
10913781|NCT00122447|12080163|FG000|STARTED|Overall Study||18
10913782|NCT00122447|12080164|FG001|STARTED|Overall Study||18
10913783|NCT00122447|12080165|FG002|STARTED|Overall Study||17
10913784|NCT00122447|12080166|FG003|STARTED|Overall Study||17
10913785|NCT00122447|12080163|FG000|COMPLETED|Overall Study||17
10913786|NCT00122447|12080164|FG001|COMPLETED|Overall Study||13
10913787|NCT00122447|12080165|FG002|COMPLETED|Overall Study||16
10913788|NCT00122447|12080166|FG003|COMPLETED|Overall Study||14
10913789|NCT00122447|12080163|FG000|NOT COMPLETED|Overall Study||1
10913790|NCT00122447|12080164|FG001|NOT COMPLETED|Overall Study||5
10913791|NCT00122447|12080165|FG002|NOT COMPLETED|Overall Study||1
10913792|NCT00122447|12080166|FG003|NOT COMPLETED|Overall Study||3
10913793|NCT00122460|12080182|FG000|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
10913794|NCT00122460|12080183|FG001|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
10913795|NCT00122460|12080182|FG000|COMPLETED|Overall Study||215
10913796|NCT00122460|12080183|FG001|COMPLETED|Overall Study||219
10913797|NCT00122460|12080182|FG000|NOT COMPLETED|Overall Study||7
10913798|NCT00122460|12080183|FG001|NOT COMPLETED|Overall Study||1
10913799|NCT00122681|12080191|FG000|STARTED|Overall Study||9325
10913800|NCT00122681|12080192|FG001|STARTED|Overall Study||9319
10913801|NCT00122681|12080191|FG000|COMPLETED|Overall Study||7811
10913802|NCT00122681|12080192|FG001|COMPLETED|Overall Study||7798
10913803|NCT00122681|12080191|FG000|NOT COMPLETED|Overall Study||1514
10913804|NCT00122681|12080192|FG001|NOT COMPLETED|Overall Study||1521
10913805|NCT00122954|12080208|FG000|STARTED|Overall Study||18
10913806|NCT00122954|12080209|FG001|STARTED|Overall Study||21
10913807|NCT00122954|12080208|FG000|COMPLETED|Overall Study||16
10913808|NCT00122954|12080209|FG001|COMPLETED|Overall Study||18
10913809|NCT00122954|12080208|FG000|NOT COMPLETED|Overall Study||2
10913810|NCT00122954|12080209|FG001|NOT COMPLETED|Overall Study||3
10913811|NCT00122980|12080217|FG000|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
10913812|NCT00122980|12080218|FG001|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
10913813|NCT00122980|12080217|FG000|COMPLETED|Overall Study|Study terminated early|24
10913814|NCT00122980|12080218|FG001|COMPLETED|Overall Study|Study terminated early|26
10913815|NCT00122980|12080217|FG000|NOT COMPLETED|Overall Study||43
10913816|NCT00122980|12080218|FG001|NOT COMPLETED|Overall Study||40
10913817|NCT00123110|12080227|FG000|STARTED|Overall Study||12
10913818|NCT00123110|12080228|FG001|STARTED|Overall Study||12
10913819|NCT00123110|12080229|FG002|STARTED|Overall Study||11
10913820|NCT00123110|12080227|FG000|COMPLETED|Overall Study||12
10913821|NCT00123110|12080228|FG001|COMPLETED|Overall Study||12
10913822|NCT00123110|12080229|FG002|COMPLETED|Overall Study||11
10913823|NCT00123110|12080227|FG000|NOT COMPLETED|Overall Study||0
10913824|NCT00123110|12080228|FG001|NOT COMPLETED|Overall Study||0
10913825|NCT00123110|12080229|FG002|NOT COMPLETED|Overall Study||0
10913826|NCT00123123|12080240|FG000|STARTED|Overall Study||59
10913827|NCT00123123|12080241|FG001|STARTED|Overall Study||58
10913828|NCT00123123|12080242|FG002|STARTED|Overall Study||58
10913829|NCT00123123|12080240|FG000|COMPLETED|Overall Study||59
10913830|NCT00123123|12080241|FG001|COMPLETED|Overall Study||58
10913831|NCT00123123|12080242|FG002|COMPLETED|Overall Study||58
10913832|NCT00123123|12080240|FG000|NOT COMPLETED|Overall Study||0
10913833|NCT00123123|12080241|FG001|NOT COMPLETED|Overall Study||0
10913834|NCT00123123|12080242|FG002|NOT COMPLETED|Overall Study||0
10913835|NCT00123162|12080252|FG000|STARTED|Overall Study||13
10913836|NCT00123162|12080253|FG001|STARTED|Overall Study||12
10913837|NCT00123162|12080252|FG000|COMPLETED|Overall Study||13
10913838|NCT00123162|12080253|FG001|COMPLETED|Overall Study||12
10913839|NCT00123162|12080252|FG000|NOT COMPLETED|Overall Study||0
10913840|NCT00123162|12080253|FG001|NOT COMPLETED|Overall Study||0
10913841|NCT00123409|12080261|FG000|STARTED|Overall Study||72
10913842|NCT00123409|12080262|FG001|STARTED|Overall Study||74
10913843|NCT00123409|12080261|FG000|COMPLETED|Overall Study||68
10913844|NCT00123409|12080262|FG001|COMPLETED|Overall Study||71
10913845|NCT00123409|12080261|FG000|NOT COMPLETED|Overall Study||4
10913846|NCT00123409|12080262|FG001|NOT COMPLETED|Overall Study||3
10913847|NCT00123422|12080273|FG000|STARTED|Overall Study||35
10913848|NCT00123422|12080274|FG001|STARTED|Overall Study||33
10913849|NCT00123422|12080275|FG002|STARTED|Overall Study||35
10913850|NCT00123422|12080273|FG000|8-week Testing|Overall Study||32
10913851|NCT00123422|12080274|FG001|8-week Testing|Overall Study||30
10913852|NCT00123422|12080275|FG002|8-week Testing|Overall Study||27
10913853|NCT00123422|12080273|FG000|COMPLETED|Overall Study||31
10913854|NCT00123422|12080274|FG001|COMPLETED|Overall Study||27
10913855|NCT00123422|12080275|FG002|COMPLETED|Overall Study||25
10913856|NCT00123422|12080273|FG000|NOT COMPLETED|Overall Study||4
10913857|NCT00123422|12080274|FG001|NOT COMPLETED|Overall Study||6
10913858|NCT00123422|12080275|FG002|NOT COMPLETED|Overall Study||10
10913859|NCT00123474|12080287|FG000|STARTED|Randomized to Treatment||167
10913860|NCT00123474|12080288|FG001|STARTED|Randomized to Treatment||167
10913861|NCT00123474|12080289|FG002|STARTED|Randomized to Treatment||168
10913862|NCT00123474|12080290|FG003|STARTED|Randomized to Treatment||168
10913863|NCT00123474|12080287|FG000|COMPLETED|Randomized to Treatment||166
10913864|NCT00123474|12080288|FG001|COMPLETED|Randomized to Treatment||163
10913865|NCT00123474|12080289|FG002|COMPLETED|Randomized to Treatment||166
10913866|NCT00123474|12080290|FG003|COMPLETED|Randomized to Treatment||167
10913867|NCT00123474|12080287|FG000|NOT COMPLETED|Randomized to Treatment||1
10913868|NCT00123474|12080288|FG001|NOT COMPLETED|Randomized to Treatment||4
10913869|NCT00123474|12080289|FG002|NOT COMPLETED|Randomized to Treatment||2
10913870|NCT00123474|12080290|FG003|NOT COMPLETED|Randomized to Treatment||1
10913871|NCT00123474|12080287|FG000|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
10913872|NCT00123474|12080288|FG001|STARTED|As Treated at Study Closure||163
10913873|NCT00123474|12080289|FG002|STARTED|As Treated at Study Closure||167
10913874|NCT00123474|12080290|FG003|STARTED|As Treated at Study Closure||167
10913875|NCT00123474|12080287|FG000|COMPLETED|As Treated at Study Closure||0
10913876|NCT00123474|12080288|FG001|COMPLETED|As Treated at Study Closure||0
10913877|NCT00123474|12080289|FG002|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
10913878|NCT00123474|12080290|FG003|COMPLETED|As Treated at Study Closure||0
10913879|NCT00123474|12080287|FG000|NOT COMPLETED|As Treated at Study Closure||165
10913880|NCT00123474|12080288|FG001|NOT COMPLETED|As Treated at Study Closure||163
10913881|NCT00123474|12080289|FG002|NOT COMPLETED|As Treated at Study Closure||167
10913882|NCT00123474|12080290|FG003|NOT COMPLETED|As Treated at Study Closure||167
10913883|NCT00123487|12080323|FG000|STARTED|Randomized||306
10913884|NCT00123487|12080324|FG001|STARTED|Randomized||305
10913885|NCT00123487|12080323|FG000|COMPLETED|Randomized||305
10913886|NCT00123487|12080324|FG001|COMPLETED|Randomized||304
10913887|NCT00123487|12080323|FG000|NOT COMPLETED|Randomized||1
10913888|NCT00123487|12080324|FG001|NOT COMPLETED|Randomized||1
10913889|NCT00123487|12080323|FG000|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
10913890|NCT00123487|12080324|FG001|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
10913891|NCT00123487|12080323|FG000|COMPLETED|Treated With Study Drug||0
10913892|NCT00123487|12080324|FG001|COMPLETED|Treated With Study Drug||0
10913893|NCT00123487|12080323|FG000|NOT COMPLETED|Treated With Study Drug||304
10913894|NCT00123487|12080324|FG001|NOT COMPLETED|Treated With Study Drug||305
10913895|NCT00123604|12080333|FG000|STARTED|Overall Study||19
10913896|NCT00123604|12080334|FG001|STARTED|Overall Study||17
10913897|NCT00123604|12080333|FG000|COMPLETED|Overall Study||18
10913898|NCT00123604|12080334|FG001|COMPLETED|Overall Study||16
10913899|NCT00123604|12080333|FG000|NOT COMPLETED|Overall Study||1
10913900|NCT00123604|12080334|FG001|NOT COMPLETED|Overall Study||1
10913901|NCT00123630|12080342|FG000|STARTED|Overall Study||15
10913902|NCT00123630|12080343|FG001|STARTED|Overall Study||15
10913903|NCT00123630|12080342|FG000|COMPLETED|Overall Study||15
10913904|NCT00123630|12080343|FG001|COMPLETED|Overall Study||15
10913905|NCT00123630|12080342|FG000|NOT COMPLETED|Overall Study||0
10913906|NCT00123630|12080343|FG001|NOT COMPLETED|Overall Study||0
10913907|NCT00123643|12080351|FG000|STARTED|Overall Study||20
10913908|NCT00123643|12080352|FG001|STARTED|Overall Study||16
10913909|NCT00123643|12080351|FG000|COMPLETED|Overall Study||20
10913910|NCT00123643|12080352|FG001|COMPLETED|Overall Study||16
10913911|NCT00123643|12080351|FG000|NOT COMPLETED|Overall Study||0
10913912|NCT00123643|12080352|FG001|NOT COMPLETED|Overall Study||0
10913913|NCT00123682|12080362|FG000|STARTED|Overall Study||1069
10913914|NCT00123682|12080363|FG001|STARTED|Overall Study||934
10913915|NCT00123682|12080364|FG002|STARTED|Overall Study||592
10913916|NCT00123682|12080365|FG003|STARTED|Overall Study||525
10913917|NCT00123682|12080362|FG000|COMPLETED|Overall Study||749
10913918|NCT00123682|12080363|FG001|COMPLETED|Overall Study||731
10913919|NCT00123682|12080364|FG002|COMPLETED|Overall Study||438
10913920|NCT00123682|12080365|FG003|COMPLETED|Overall Study||430
10913921|NCT00123682|12080362|FG000|NOT COMPLETED|Overall Study||320
10913922|NCT00123682|12080363|FG001|NOT COMPLETED|Overall Study||203
10913923|NCT00123682|12080364|FG002|NOT COMPLETED|Overall Study||154
10913924|NCT00123682|12080365|FG003|NOT COMPLETED|Overall Study||95
10913925|NCT00123734|12080379|FG000|STARTED|Overall Study||82
10913926|NCT00123734|12080379|FG000|COMPLETED|Overall Study||74
10913927|NCT00123734|12080379|FG000|NOT COMPLETED|Overall Study||8
10913928|NCT00123955|12080388|FG000|STARTED|Overall Study||42
10913929|NCT00123955|12080389|FG001|STARTED|Overall Study||38
10913930|NCT00123955|12080388|FG000|COMPLETED|Overall Study||37
10913931|NCT00123955|12080389|FG001|COMPLETED|Overall Study||34
10913932|NCT00123955|12080388|FG000|NOT COMPLETED|Overall Study||5
10913933|NCT00123955|12080389|FG001|NOT COMPLETED|Overall Study||4
10913934|NCT00124020|12080397|FG000|STARTED|Overall Study||377
10913935|NCT00124020|12080398|FG001|STARTED|Overall Study||380
10913936|NCT00124020|12080397|FG000|COMPLETED|Overall Study||289
10913937|NCT00124020|12080398|FG001|COMPLETED|Overall Study||289
10913938|NCT00124020|12080397|FG000|NOT COMPLETED|Overall Study||88
10913939|NCT00124020|12080398|FG001|NOT COMPLETED|Overall Study||91
10913940|NCT00124072|12080408|FG000|STARTED|Overall Study||3017
10913941|NCT00124072|12080409|FG001|STARTED|Overall Study||3016
10913942|NCT00124072|12080410|FG002|STARTED|Overall Study||3016
10913943|NCT00124072|12080411|FG003|STARTED|Overall Study||3015
10913944|NCT00124072|12080408|FG000|COMPLETED|Overall Study||2503
10913945|NCT00124072|12080409|FG001|COMPLETED|Overall Study||2504
10913946|NCT00124072|12080410|FG002|COMPLETED|Overall Study||2524
10913947|NCT00124072|12080411|FG003|COMPLETED|Overall Study||2515
10913948|NCT00124072|12080408|FG000|NOT COMPLETED|Overall Study||514
10913949|NCT00124072|12080409|FG001|NOT COMPLETED|Overall Study||512
10913950|NCT00124072|12080410|FG002|NOT COMPLETED|Overall Study||492
10913951|NCT00124072|12080411|FG003|NOT COMPLETED|Overall Study||500
10913952|NCT00124176|12080423|FG000|STARTED|Overall Study||40
10913953|NCT00124176|12080424|FG001|STARTED|Overall Study||41
10913954|NCT00124176|12080423|FG000|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
10913955|NCT00124176|12080424|FG001|Received Study Drug|Overall Study||41
10913956|NCT00124176|12080423|FG000|COMPLETED|Overall Study||40
10913957|NCT00124176|12080424|FG001|COMPLETED|Overall Study||41
10913958|NCT00124176|12080423|FG000|NOT COMPLETED|Overall Study||0
10913959|NCT00124176|12080424|FG001|NOT COMPLETED|Overall Study||0
10913960|NCT00124449|12080432|FG000|STARTED|6-month Double-Blind Treatment Period||28
10913961|NCT00124449|12080433|FG001|STARTED|6-month Double-Blind Treatment Period||28
10913962|NCT00124449|12080432|FG000|COMPLETED|6-month Double-Blind Treatment Period||22
10913963|NCT00124449|12080433|FG001|COMPLETED|6-month Double-Blind Treatment Period||17
10913964|NCT00124449|12080432|FG000|NOT COMPLETED|6-month Double-Blind Treatment Period||6
10913965|NCT00124449|12080433|FG001|NOT COMPLETED|6-month Double-Blind Treatment Period||11
10913966|NCT00124449|12080432|FG000|STARTED|18-Month Untreated Observation Period||22
10913967|NCT00124449|12080433|FG001|STARTED|18-Month Untreated Observation Period||17
10913968|NCT00124449|12080432|FG000|Completed Year 1 of Study|18-Month Untreated Observation Period||14
10913969|NCT00124449|12080433|FG001|Completed Year 1 of Study|18-Month Untreated Observation Period||9
10913970|NCT00124449|12080432|FG000|COMPLETED|18-Month Untreated Observation Period||7
10913971|NCT00124449|12080433|FG001|COMPLETED|18-Month Untreated Observation Period||4
10913972|NCT00124449|12080432|FG000|NOT COMPLETED|18-Month Untreated Observation Period||15
10913973|NCT00124449|12080433|FG001|NOT COMPLETED|18-Month Untreated Observation Period||13
10913974|NCT00124462|12080442|FG000|STARTED|Overall Study||40
10913975|NCT00124462|12080443|FG001|STARTED|Overall Study||40
10913976|NCT00124462|12080442|FG000|COMPLETED|Overall Study||29
10913977|NCT00124462|12080443|FG001|COMPLETED|Overall Study||27
10913978|NCT00124462|12080442|FG000|NOT COMPLETED|Overall Study||11
10913979|NCT00124462|12080443|FG001|NOT COMPLETED|Overall Study||13
10913980|NCT00124514|12080454|FG000|STARTED|Overall Study||6
10913981|NCT00124514|12080455|FG001|STARTED|Overall Study||9
10913982|NCT00124514|12080456|FG002|STARTED|Overall Study||8
10913983|NCT00124514|12080457|FG003|STARTED|Overall Study||6
10913984|NCT00124514|12080458|FG004|STARTED|Overall Study||2
10913985|NCT00124514|12080454|FG000|COMPLETED|Overall Study||2
10913986|NCT00124514|12080455|FG001|COMPLETED|Overall Study||7
10913987|NCT00124514|12080456|FG002|COMPLETED|Overall Study||7
10913988|NCT00124514|12080457|FG003|COMPLETED|Overall Study||5
10913989|NCT00124514|12080458|FG004|COMPLETED|Overall Study||1
10913990|NCT00124514|12080454|FG000|NOT COMPLETED|Overall Study||4
10913991|NCT00124514|12080455|FG001|NOT COMPLETED|Overall Study||2
10913992|NCT00124514|12080456|FG002|NOT COMPLETED|Overall Study||1
10913993|NCT00124514|12080457|FG003|NOT COMPLETED|Overall Study||1
10913994|NCT00124514|12080458|FG004|NOT COMPLETED|Overall Study||1
10913995|NCT00124579|12080465|FG000|STARTED|Induction||7
10913996|NCT00124579|12080465|FG000|COMPLETED|Induction||2
10913997|NCT00124579|12080465|FG000|NOT COMPLETED|Induction||5
10913998|NCT00124579|12080465|FG000|STARTED|Maintenance||2
10913999|NCT00124579|12080465|FG000|COMPLETED|Maintenance||0
10914000|NCT00124579|12080465|FG000|NOT COMPLETED|Maintenance||2
10914001|NCT00124618|12080470|FG000|STARTED|Overall Study||58
10914002|NCT00124618|12080470|FG000|COMPLETED|Overall Study||57
10914003|NCT00124618|12080470|FG000|NOT COMPLETED|Overall Study||1
10914004|NCT00124657|12080477|FG000|STARTED|Overall Study||18
10914005|NCT00124657|12080478|FG001|STARTED|Overall Study||5
10914006|NCT00124657|12080479|FG002|STARTED|Overall Study||39
10914007|NCT00124657|12080477|FG000|COMPLETED|Overall Study||2
10914008|NCT00124657|12080478|FG001|COMPLETED|Overall Study||0
10914009|NCT00124657|12080479|FG002|COMPLETED|Overall Study||7
10914010|NCT00124657|12080477|FG000|NOT COMPLETED|Overall Study||16
10914011|NCT00124657|12080478|FG001|NOT COMPLETED|Overall Study||5
10914012|NCT00124657|12080479|FG002|NOT COMPLETED|Overall Study||32
10914013|NCT00124709|12080502|FG000|STARTED|Overall Study||546
10914014|NCT00124709|12080503|FG001|STARTED|Overall Study||545
10914015|NCT00124709|12080502|FG000|Patients Who Received Study Medication|Overall Study||543
10914016|NCT00124709|12080503|FG001|Patients Who Received Study Medication|Overall Study||544
10914017|NCT00124709|12080502|FG000|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
10914018|NCT00124709|12080503|FG001|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
10914019|NCT00124709|12080502|FG000|NOT COMPLETED|Overall Study||255
10914020|NCT00124709|12080503|FG001|NOT COMPLETED|Overall Study||272
10914021|NCT00124735|12080519|FG000|STARTED|Overall Study||5
10914022|NCT00124735|12080520|FG001|STARTED|Overall Study||8
10914023|NCT00124735|12080521|FG002|STARTED|Overall Study||18
10914024|NCT00124735|12080522|FG003|STARTED|Overall Study||21
10914025|NCT00124735|12080523|FG004|STARTED|Overall Study||19
10914026|NCT00124735|12080524|FG005|STARTED|Overall Study||7
10914027|NCT00124735|12080525|FG006|STARTED|Overall Study||6
10914028|NCT00124735|12080526|FG007|STARTED|Overall Study||20
10914029|NCT00124735|12080527|FG008|STARTED|Overall Study||25
10914030|NCT00124735|12080528|FG009|STARTED|Overall Study||20
10914031|NCT00124735|12080519|FG000|COMPLETED|Overall Study||4
10914032|NCT00124735|12080520|FG001|COMPLETED|Overall Study||6
10914033|NCT00124735|12080521|FG002|COMPLETED|Overall Study||18
10914034|NCT00124735|12080522|FG003|COMPLETED|Overall Study||18
10914035|NCT00124735|12080523|FG004|COMPLETED|Overall Study||17
10914036|NCT00124735|12080524|FG005|COMPLETED|Overall Study||5
10914037|NCT00124735|12080525|FG006|COMPLETED|Overall Study||6
10914038|NCT00124735|12080526|FG007|COMPLETED|Overall Study||19
10914039|NCT00124735|12080527|FG008|COMPLETED|Overall Study||22
10914040|NCT00124735|12080528|FG009|COMPLETED|Overall Study||18
10914041|NCT00124735|12080519|FG000|NOT COMPLETED|Overall Study||1
10914042|NCT00124735|12080520|FG001|NOT COMPLETED|Overall Study||2
10914043|NCT00124735|12080521|FG002|NOT COMPLETED|Overall Study||0
10914044|NCT00124735|12080522|FG003|NOT COMPLETED|Overall Study||3
10914045|NCT00124735|12080523|FG004|NOT COMPLETED|Overall Study||2
10914046|NCT00124735|12080524|FG005|NOT COMPLETED|Overall Study||2
10914047|NCT00124735|12080525|FG006|NOT COMPLETED|Overall Study||0
10914048|NCT00124735|12080526|FG007|NOT COMPLETED|Overall Study||1
10914049|NCT00124735|12080527|FG008|NOT COMPLETED|Overall Study||3
10914050|NCT00124735|12080528|FG009|NOT COMPLETED|Overall Study||2
10914051|NCT00124748|12080544|FG000|STARTED|Overall Study||157
10914052|NCT00124748|12080545|FG001|STARTED|Overall Study||319
10914053|NCT00124748|12080544|FG000|Safety Population|Overall Study||157
10914054|NCT00124748|12080545|FG001|Safety Population|Overall Study||316
10914055|NCT00124748|12080544|FG000|COMPLETED|Overall Study||14
10914056|NCT00124748|12080545|FG001|COMPLETED|Overall Study||35
10914057|NCT00124748|12080544|FG000|NOT COMPLETED|Overall Study||143
10914058|NCT00124748|12080545|FG001|NOT COMPLETED|Overall Study||284
10914059|NCT00124917|12080551|FG000|STARTED|Overall Study||6
10914060|NCT00124917|12080551|FG000|COMPLETED|Overall Study||3
10914061|NCT00124917|12080551|FG000|NOT COMPLETED|Overall Study||3
10914062|NCT00124943|12080560|FG000|STARTED|Phase I||3
10914063|NCT00124943|12080561|FG001|STARTED|Phase I||3
10914064|NCT00124943|12080562|FG002|STARTED|Phase I||3
10914065|NCT00124943|12080563|FG003|STARTED|Phase I||3
10914066|NCT00124943|12080560|FG000|COMPLETED|Phase I||3
10914067|NCT00124943|12080561|FG001|COMPLETED|Phase I||3
10914068|NCT00124943|12080562|FG002|COMPLETED|Phase I||3
10914069|NCT00124943|12080563|FG003|COMPLETED|Phase I||3
10914070|NCT00124943|12080560|FG000|NOT COMPLETED|Phase I||0
10914071|NCT00124943|12080561|FG001|NOT COMPLETED|Phase I||0
10914072|NCT00124943|12080562|FG002|NOT COMPLETED|Phase I||0
10914073|NCT00124943|12080563|FG003|NOT COMPLETED|Phase I||0
10914074|NCT00124943|12080560|FG000|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
10914075|NCT00124943|12080561|FG001|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
10914076|NCT00124943|12080562|FG002|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
10914077|NCT00124943|12080563|FG003|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
10914078|NCT00124943|12080560|FG000|COMPLETED|Phase II||3
10914079|NCT00124943|12080561|FG001|COMPLETED|Phase II||49
10914080|NCT00124943|12080562|FG002|COMPLETED|Phase II||3
10914081|NCT00124943|12080563|FG003|COMPLETED|Phase II||50
10914082|NCT00124943|12080560|FG000|NOT COMPLETED|Phase II||0
10914083|NCT00124943|12080561|FG001|NOT COMPLETED|Phase II||2
10914084|NCT00124943|12080562|FG002|NOT COMPLETED|Phase II||0
10914085|NCT00124943|12080563|FG003|NOT COMPLETED|Phase II||5
10914086|NCT00124982|12080575|FG000|STARTED|Short-term Period||449
10914087|NCT00124982|12080576|FG001|STARTED|Short-term Period||597
10914088|NCT00124982|12080577|FG002|STARTED|Short-term Period||0
10914089|NCT00124982|12080575|FG000|COMPLETED|Short-term Period||377
10914090|NCT00124982|12080576|FG001|COMPLETED|Short-term Period||483
10914091|NCT00124982|12080577|FG002|COMPLETED|Short-term Period||0
10914092|NCT00124982|12080575|FG000|NOT COMPLETED|Short-term Period||72
10914093|NCT00124982|12080576|FG001|NOT COMPLETED|Short-term Period||114
10914094|NCT00124982|12080577|FG002|NOT COMPLETED|Short-term Period||0
10914095|NCT00124982|12080575|FG000|STARTED|Long-term Period||0
10914096|NCT00124982|12080576|FG001|STARTED|Long-term Period||0
10914097|NCT00124982|12080577|FG002|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
10914098|NCT00124982|12080575|FG000|COMPLETED|Long-term Period||0
10914099|NCT00124982|12080576|FG001|COMPLETED|Long-term Period||0
10914100|NCT00124982|12080577|FG002|COMPLETED|Long-term Period||441
10914101|NCT00124982|12080575|FG000|NOT COMPLETED|Long-term Period||0
10914102|NCT00124982|12080576|FG001|NOT COMPLETED|Long-term Period||0
10914103|NCT00124982|12080577|FG002|NOT COMPLETED|Long-term Period||89
10914104|NCT00125034|12080588|FG000|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
10914105|NCT00125034|12080589|FG001|STARTED|Overall Study|Randomized & treated|168
10914106|NCT00125034|12080588|FG000|COMPLETED|Overall Study||170
10914107|NCT00125034|12080589|FG001|COMPLETED|Overall Study||168
10914108|NCT00125034|12080588|FG000|NOT COMPLETED|Overall Study||0
10914109|NCT00125034|12080589|FG001|NOT COMPLETED|Overall Study||0
10914110|NCT00125138|12080599|FG000|STARTED|Overall Study||15
10914111|NCT00125138|12080600|FG001|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
10914112|NCT00125138|12080601|FG002|STARTED|Overall Study||25
10914113|NCT00125138|12080602|FG003|STARTED|Overall Study||30
10914114|NCT00125138|12080599|FG000|COMPLETED|Overall Study||12
10914115|NCT00125138|12080600|FG001|COMPLETED|Overall Study||17
10914116|NCT00125138|12080601|FG002|COMPLETED|Overall Study||21
10914117|NCT00125138|12080602|FG003|COMPLETED|Overall Study||25
10914118|NCT00125138|12080599|FG000|NOT COMPLETED|Overall Study||3
10914119|NCT00125138|12080600|FG001|NOT COMPLETED|Overall Study||3
10914120|NCT00125138|12080601|FG002|NOT COMPLETED|Overall Study||4
10914121|NCT00125138|12080602|FG003|NOT COMPLETED|Overall Study||5
10914122|NCT00125164|12080616|FG000|STARTED|Overall Study||25
10914123|NCT00125164|12080617|FG001|STARTED|Overall Study||16
10914124|NCT00125164|12080618|FG002|STARTED|Overall Study||44
10914125|NCT00125164|12080619|FG003|STARTED|Overall Study||51
10914126|NCT00125164|12080616|FG000|COMPLETED|Overall Study||23
10914127|NCT00125164|12080617|FG001|COMPLETED|Overall Study||16
10914128|NCT00125164|12080618|FG002|COMPLETED|Overall Study||40
10914129|NCT00125164|12080619|FG003|COMPLETED|Overall Study||45
10914130|NCT00125164|12080616|FG000|NOT COMPLETED|Overall Study||2
10914131|NCT00125164|12080617|FG001|NOT COMPLETED|Overall Study||0
10914132|NCT00125164|12080618|FG002|NOT COMPLETED|Overall Study||4
10914133|NCT00125164|12080619|FG003|NOT COMPLETED|Overall Study||6
10914134|NCT00125190|12080629|FG000|STARTED|Overall Study||45
10914135|NCT00125190|12080629|FG000|Completed 34 Weeks of Study|Overall Study||43
10914136|NCT00125190|12080629|FG000|COMPLETED|Overall Study||30
10914137|NCT00125190|12080629|FG000|NOT COMPLETED|Overall Study||15
10914138|NCT00125242|12080636|FG000|STARTED|Overall Study||94
10914139|NCT00125242|12080637|FG001|STARTED|Overall Study||16
10914140|NCT00125242|12080636|FG000|COMPLETED|Overall Study||87
10914141|NCT00125242|12080637|FG001|COMPLETED|Overall Study||14
10914142|NCT00125242|12080636|FG000|NOT COMPLETED|Overall Study||7
10914143|NCT00125242|12080637|FG001|NOT COMPLETED|Overall Study||2
10914144|NCT00125359|12080642|FG000|STARTED|Overall Study||42
10914145|NCT00125359|12080642|FG000|COMPLETED|Overall Study||19
10914146|NCT00125359|12080642|FG000|NOT COMPLETED|Overall Study||23
10914147|NCT00125372|12080646|FG000|STARTED|Overall Study||12
10914148|NCT00125372|12080646|FG000|COMPLETED|Overall Study||10
10914149|NCT00125372|12080646|FG000|NOT COMPLETED|Overall Study||2
10914150|NCT00125515|12080653|FG000|STARTED|Overall Study||27
10914151|NCT00125515|12080654|FG001|STARTED|Overall Study||27
10914152|NCT00125515|12080655|FG002|STARTED|Overall Study||27
10914153|NCT00125515|12080653|FG000|COMPLETED|Overall Study||7
10914154|NCT00125515|12080654|FG001|COMPLETED|Overall Study||7
10914155|NCT00125515|12080655|FG002|COMPLETED|Overall Study||6
10914156|NCT00125515|12080653|FG000|NOT COMPLETED|Overall Study||20
10914157|NCT00125515|12080654|FG001|NOT COMPLETED|Overall Study||20
10914158|NCT00125515|12080655|FG002|NOT COMPLETED|Overall Study||21
10914159|NCT00125528|12080665|FG000|STARTED|Overall Study||20
10914160|NCT00125528|12080666|FG001|STARTED|Overall Study||21
10914161|NCT00125528|12080665|FG000|COMPLETED|Overall Study||18
10914162|NCT00125528|12080666|FG001|COMPLETED|Overall Study||20
10914163|NCT00125528|12080665|FG000|NOT COMPLETED|Overall Study||2
10914164|NCT00125528|12080666|FG001|NOT COMPLETED|Overall Study||1
10914165|NCT00125593|12080674|FG000|STARTED|Overall Study||4650
10914166|NCT00125593|12080675|FG001|STARTED|Overall Study||4620
10914167|NCT00125593|12080674|FG000|COMPLETED|Overall Study||4549
10914168|NCT00125593|12080675|FG001|COMPLETED|Overall Study||4517
10914169|NCT00125593|12080674|FG000|NOT COMPLETED|Overall Study||101
10914170|NCT00125593|12080675|FG001|NOT COMPLETED|Overall Study||103
10914171|NCT00125619|12080683|FG000|STARTED|Overall Study||8
10914172|NCT00125619|12080684|FG001|STARTED|Overall Study||8
10914173|NCT00125619|12080683|FG000|COMPLETED|Overall Study||8
10914174|NCT00125619|12080684|FG001|COMPLETED|Overall Study||8
10914175|NCT00125619|12080683|FG000|NOT COMPLETED|Overall Study||0
10914176|NCT00125619|12080684|FG001|NOT COMPLETED|Overall Study||0
10914177|NCT00125658|12080693|FG000|STARTED|Overall Study||8
10914178|NCT00125658|12080694|FG001|STARTED|Overall Study||6
10914179|NCT00125658|12080693|FG000|COMPLETED|Overall Study||8
10914180|NCT00125658|12080694|FG001|COMPLETED|Overall Study||6
10914181|NCT00125658|12080693|FG000|NOT COMPLETED|Overall Study||0
10914182|NCT00125658|12080694|FG001|NOT COMPLETED|Overall Study||0
10914183|NCT00125762|12080702|FG000|STARTED|Overall Study||907
10914184|NCT00125762|12080702|FG000|COMPLETED|Overall Study||748
10914185|NCT00125762|12080702|FG000|NOT COMPLETED|Overall Study||159
10914186|NCT00125788|12080708|FG000|STARTED|Overall Study||37
10914187|NCT00125788|12080709|FG001|STARTED|Overall Study||33
10914188|NCT00125788|12080708|FG000|COMPLETED|Overall Study||33
10914189|NCT00125788|12080709|FG001|COMPLETED|Overall Study||29
10914190|NCT00125788|12080708|FG000|NOT COMPLETED|Overall Study||4
10914191|NCT00125788|12080709|FG001|NOT COMPLETED|Overall Study||4
10914192|NCT00125853|12080715|FG000|STARTED|Wash-out (4 Weeks)||27
10914193|NCT00125853|12080716|FG001|STARTED|Wash-out (4 Weeks)||27
10914194|NCT00125853|12080715|FG000|COMPLETED|Wash-out (4 Weeks)||27
10914195|NCT00125853|12080716|FG001|COMPLETED|Wash-out (4 Weeks)||27
10914196|NCT00125853|12080715|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
10914197|NCT00125853|12080716|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
10914198|NCT00125853|12080715|FG000|STARTED|First Intervention (8 Weeks)||27
10914199|NCT00125853|12080716|FG001|STARTED|First Intervention (8 Weeks)||27
10914200|NCT00125853|12080715|FG000|COMPLETED|First Intervention (8 Weeks)||27
10914201|NCT00125853|12080716|FG001|COMPLETED|First Intervention (8 Weeks)||27
10914202|NCT00125853|12080715|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
10914203|NCT00125853|12080716|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
10914204|NCT00125853|12080715|FG000|STARTED|Wash-out (4 Weeks)||27
10914205|NCT00125853|12080716|FG001|STARTED|Wash-out (4 Weeks)||27
10914206|NCT00125853|12080715|FG000|COMPLETED|Wash-out (4 Weeks)||24
10914207|NCT00125853|12080716|FG001|COMPLETED|Wash-out (4 Weeks)||20
10914208|NCT00125853|12080715|FG000|NOT COMPLETED|Wash-out (4 Weeks)||3
10914209|NCT00125853|12080716|FG001|NOT COMPLETED|Wash-out (4 Weeks)||7
10914210|NCT00125853|12080715|FG000|STARTED|Second Intervention (8 Weeks)||24
10914211|NCT00125853|12080716|FG001|STARTED|Second Intervention (8 Weeks)||20
10914212|NCT00125853|12080715|FG000|COMPLETED|Second Intervention (8 Weeks)||24
10914213|NCT00125853|12080716|FG001|COMPLETED|Second Intervention (8 Weeks)||20
10914214|NCT00125853|12080715|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
10914215|NCT00125853|12080716|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
10914216|NCT00125931|12080722|FG000|STARTED|Overall Study||10
10914217|NCT00125931|12080722|FG000|COMPLETED|Overall Study||10
10914218|NCT00125931|12080722|FG000|NOT COMPLETED|Overall Study||0
10914219|NCT00125957|12080728|FG000|STARTED|First Intervention (3 Weeks)||15
10914220|NCT00125957|12080729|FG001|STARTED|First Intervention (3 Weeks)||17
10914221|NCT00125957|12080728|FG000|COMPLETED|First Intervention (3 Weeks)||15
10914222|NCT00125957|12080729|FG001|COMPLETED|First Intervention (3 Weeks)||17
10914223|NCT00125957|12080728|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
10914224|NCT00125957|12080729|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
10914225|NCT00125957|12080728|FG000|STARTED|Second Intervention (3 Weeks)||15
10914226|NCT00125957|12080729|FG001|STARTED|Second Intervention (3 Weeks)||17
10914227|NCT00125957|12080728|FG000|COMPLETED|Second Intervention (3 Weeks)||15
10914228|NCT00125957|12080729|FG001|COMPLETED|Second Intervention (3 Weeks)||17
10914229|NCT00125957|12080728|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
10914230|NCT00125957|12080729|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
10914231|NCT00126113|12080737|FG000|STARTED|Overall Study||37
10914232|NCT00126113|12080738|FG001|STARTED|Overall Study||37
10914233|NCT00126113|12080737|FG000|COMPLETED|Overall Study||34
10914234|NCT00126113|12080738|FG001|COMPLETED|Overall Study||35
10914235|NCT00126113|12080737|FG000|NOT COMPLETED|Overall Study||3
10914236|NCT00126113|12080738|FG001|NOT COMPLETED|Overall Study||2
10914237|NCT00126126|12080746|FG000|STARTED|Overall Study||9
10914238|NCT00126126|12080747|FG001|STARTED|Overall Study||9
10914239|NCT00126126|12080746|FG000|COMPLETED|Overall Study||9
10914240|NCT00126126|12080747|FG001|COMPLETED|Overall Study||7
10914241|NCT00126126|12080746|FG000|NOT COMPLETED|Overall Study||0
10914242|NCT00126126|12080747|FG001|NOT COMPLETED|Overall Study||2
10914243|NCT00126191|12080755|FG000|STARTED|Overall Study||2
10914244|NCT00126191|12080756|FG001|STARTED|Overall Study||8
10914245|NCT00126191|12080755|FG000|COMPLETED|Overall Study||2
10914246|NCT00126191|12080756|FG001|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
10914247|NCT00126191|12080755|FG000|NOT COMPLETED|Overall Study||0
10914248|NCT00126191|12080756|FG001|NOT COMPLETED|Overall Study||2
10914249|NCT00126425|12080764|FG000|STARTED|Overall Study||539
10914250|NCT00126425|12080765|FG001|STARTED|Overall Study||48
10914251|NCT00126425|12080764|FG000|COMPLETED|Overall Study||498
10914252|NCT00126425|12080765|FG001|COMPLETED|Overall Study||37
10914253|NCT00126425|12080764|FG000|NOT COMPLETED|Overall Study||41
10914254|NCT00126425|12080765|FG001|NOT COMPLETED|Overall Study||11
10914255|NCT00126438|12080773|FG000|STARTED|Overall Study||453
10914256|NCT00126438|12080774|FG001|STARTED|Overall Study||62
10914257|NCT00126438|12080773|FG000|COMPLETED|Overall Study||419
10914258|NCT00126438|12080774|FG001|COMPLETED|Overall Study||52
10914259|NCT00126438|12080773|FG000|NOT COMPLETED|Overall Study||34
10914260|NCT00126438|12080774|FG001|NOT COMPLETED|Overall Study||10
10914261|NCT00126490|12080780|FG000|STARTED|Overall Study||19
10914262|NCT00126490|12080780|FG000|COMPLETED|Overall Study||18
10914263|NCT00126490|12080780|FG000|NOT COMPLETED|Overall Study||1
10914264|NCT00126503|12080786|FG000|STARTED|Overall Study||48
10914265|NCT00126503|12080787|FG001|STARTED|Overall Study||21
10914266|NCT00126503|12080786|FG000|COMPLETED|Overall Study||1
10914267|NCT00126503|12080787|FG001|COMPLETED|Overall Study||0
10914268|NCT00126503|12080786|FG000|NOT COMPLETED|Overall Study||47
10914269|NCT00126503|12080787|FG001|NOT COMPLETED|Overall Study||21
10914270|NCT00126555|12080797|FG000|STARTED|Overall Study||23
10914271|NCT00126555|12080797|FG000|Stratum 1- Resectable|Overall Study|1 participant did not participate|18
10914272|NCT00126555|12080797|FG000|Stratum 2- Unresectable|Overall Study||4
10914273|NCT00126555|12080797|FG000|COMPLETED|Overall Study||17
10914274|NCT00126555|12080797|FG000|NOT COMPLETED|Overall Study||6
10914275|NCT00126568|12080813|FG000|STARTED|Overall Study||20
10914276|NCT00126568|12080813|FG000|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
10914277|NCT00126568|12080813|FG000|NOT COMPLETED|Overall Study||2
10914278|NCT00126581|12080820|FG000|STARTED|Overall Study||81
10914279|NCT00126581|12080821|FG001|STARTED|Overall Study||100
10914280|NCT00126581|12080820|FG000|COMPLETED|Overall Study||68
10914281|NCT00126581|12080821|FG001|COMPLETED|Overall Study||80
10914282|NCT00126581|12080820|FG000|NOT COMPLETED|Overall Study||13
10914283|NCT00126581|12080821|FG001|NOT COMPLETED|Overall Study||20
10914284|NCT00126594|12080831|FG000|STARTED|Overall Study||40
10914285|NCT00126594|12080832|FG001|STARTED|Overall Study||40
10914286|NCT00126594|12080831|FG000|COMPLETED|Overall Study||1
10914287|NCT00126594|12080832|FG001|COMPLETED|Overall Study||3
10914288|NCT00126594|12080831|FG000|NOT COMPLETED|Overall Study||39
10914289|NCT00126594|12080832|FG001|NOT COMPLETED|Overall Study||37
10914290|NCT00126737|12080843|FG000|STARTED|Overall Study||28
10914291|NCT00126737|12080844|FG001|STARTED|Overall Study||27
10914292|NCT00126737|12080845|FG002|STARTED|Overall Study||30
10914293|NCT00126737|12080846|FG003|STARTED|Overall Study||25
10914294|NCT00126737|12080843|FG000|COMPLETED|Overall Study||22
10914295|NCT00126737|12080844|FG001|COMPLETED|Overall Study||24
10914296|NCT00126737|12080845|FG002|COMPLETED|Overall Study||24
10914297|NCT00126737|12080846|FG003|COMPLETED|Overall Study||18
10914298|NCT00126737|12080843|FG000|NOT COMPLETED|Overall Study||6
10914299|NCT00126737|12080844|FG001|NOT COMPLETED|Overall Study||3
10914300|NCT00126737|12080845|FG002|NOT COMPLETED|Overall Study||6
10914301|NCT00126737|12080846|FG003|NOT COMPLETED|Overall Study||7
10914302|NCT00126750|12080861|FG000|STARTED|Overall Study|Number of providers from 84 clinics|385
10914303|NCT00126750|12080862|FG001|STARTED|Overall Study|Number of providers from 84 clinics|462
10914304|NCT00126750|12080861|FG000|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
10914305|NCT00126750|12080862|FG001|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
10914306|NCT00126750|12080861|FG000|NOT COMPLETED|Overall Study||180
10914307|NCT00126750|12080862|FG001|NOT COMPLETED|Overall Study||266
10914308|NCT00127036|12080870|FG000|STARTED|Overall Study||34
10914309|NCT00127036|12080871|FG001|STARTED|Overall Study||31
10914310|NCT00127036|12080870|FG000|COMPLETED|Overall Study|26 Participants were evaluable.|26
10914311|NCT00127036|12080871|FG001|COMPLETED|Overall Study|20 Participants were evaluable.|20
10914312|NCT00127036|12080870|FG000|NOT COMPLETED|Overall Study||8
10914313|NCT00127036|12080871|FG001|NOT COMPLETED|Overall Study||11
10914314|NCT00127062|12080879|FG000|STARTED|First intervention_Oxford Street||31
10914315|NCT00127062|12080880|FG001|STARTED|First intervention_Oxford Street||29
10914316|NCT00127062|12080879|FG000|COMPLETED|First intervention_Oxford Street||31
10914317|NCT00127062|12080880|FG001|COMPLETED|First intervention_Oxford Street||29
10914318|NCT00127062|12080879|FG000|NOT COMPLETED|First intervention_Oxford Street||0
10914319|NCT00127062|12080880|FG001|NOT COMPLETED|First intervention_Oxford Street||0
10914320|NCT00127062|12080879|FG000|STARTED|Second intervention_Hyde Park||31
10914321|NCT00127062|12080880|FG001|STARTED|Second intervention_Hyde Park||29
10914322|NCT00127062|12080879|FG000|COMPLETED|Second intervention_Hyde Park||31
10914323|NCT00127062|12080880|FG001|COMPLETED|Second intervention_Hyde Park||29
10914324|NCT00127062|12080879|FG000|NOT COMPLETED|Second intervention_Hyde Park||0
10914325|NCT00127062|12080880|FG001|NOT COMPLETED|Second intervention_Hyde Park||0
10914326|NCT00127101|12080896|FG000|STARTED|Base Protocol||3
10914327|NCT00127101|12080897|FG001|STARTED|Base Protocol||5
10914328|NCT00127101|12080898|FG002|STARTED|Base Protocol||3
10914329|NCT00127101|12080899|FG003|STARTED|Base Protocol||3
10914330|NCT00127101|12080900|FG004|STARTED|Base Protocol||5
10914331|NCT00127101|12080901|FG005|STARTED|Base Protocol||4
10914332|NCT00127101|12080896|FG000|COMPLETED|Base Protocol||1
10914333|NCT00127101|12080897|FG001|COMPLETED|Base Protocol||1
10914334|NCT00127101|12080898|FG002|COMPLETED|Base Protocol||1
10914335|NCT00127101|12080899|FG003|COMPLETED|Base Protocol||3
10914336|NCT00127101|12080900|FG004|COMPLETED|Base Protocol||3
10914337|NCT00127101|12080901|FG005|COMPLETED|Base Protocol||3
10914338|NCT00127101|12080896|FG000|NOT COMPLETED|Base Protocol||2
10914339|NCT00127101|12080897|FG001|NOT COMPLETED|Base Protocol||4
10914340|NCT00127101|12080898|FG002|NOT COMPLETED|Base Protocol||2
10914341|NCT00127101|12080899|FG003|NOT COMPLETED|Base Protocol||0
10914342|NCT00127101|12080900|FG004|NOT COMPLETED|Base Protocol||2
10914343|NCT00127101|12080901|FG005|NOT COMPLETED|Base Protocol||1
10914344|NCT00127101|12080896|FG000|STARTED|Continuation Phase||0
10914345|NCT00127101|12080897|FG001|STARTED|Continuation Phase||0
10914346|NCT00127101|12080898|FG002|STARTED|Continuation Phase||1
10914347|NCT00127101|12080899|FG003|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
10914348|NCT00127101|12080900|FG004|STARTED|Continuation Phase||3
10914349|NCT00127101|12080901|FG005|STARTED|Continuation Phase||3
10914350|NCT00127101|12080896|FG000|COMPLETED|Continuation Phase||0
10914351|NCT00127101|12080897|FG001|COMPLETED|Continuation Phase||0
10914352|NCT00127101|12080898|FG002|COMPLETED|Continuation Phase||0
10914353|NCT00127101|12080899|FG003|COMPLETED|Continuation Phase||0
10914354|NCT00127101|12080900|FG004|COMPLETED|Continuation Phase||0
10914355|NCT00127101|12080901|FG005|COMPLETED|Continuation Phase||0
10914356|NCT00127101|12080896|FG000|NOT COMPLETED|Continuation Phase||0
10914357|NCT00127101|12080897|FG001|NOT COMPLETED|Continuation Phase||0
10914358|NCT00127101|12080898|FG002|NOT COMPLETED|Continuation Phase||1
10914359|NCT00127101|12080899|FG003|NOT COMPLETED|Continuation Phase||0
10914360|NCT00127101|12080900|FG004|NOT COMPLETED|Continuation Phase||3
10914361|NCT00127101|12080901|FG005|NOT COMPLETED|Continuation Phase||3
10914362|NCT00127166|12080917|FG000|STARTED|Period I||78
10914363|NCT00127166|12080918|FG001|STARTED|Period I||76
10914364|NCT00127166|12080917|FG000|COMPLETED|Period I||75
10914365|NCT00127166|12080918|FG001|COMPLETED|Period I||74
10914366|NCT00127166|12080917|FG000|NOT COMPLETED|Period I||3
10914367|NCT00127166|12080918|FG001|NOT COMPLETED|Period I||2
10914368|NCT00127166|12080917|FG000|STARTED|Washout Period||75
10914369|NCT00127166|12080918|FG001|STARTED|Washout Period||74
10914370|NCT00127166|12080917|FG000|COMPLETED|Washout Period||75
10914371|NCT00127166|12080918|FG001|COMPLETED|Washout Period||73
10914372|NCT00127166|12080917|FG000|NOT COMPLETED|Washout Period||0
10914373|NCT00127166|12080918|FG001|NOT COMPLETED|Washout Period||1
10914374|NCT00127166|12080917|FG000|STARTED|Period II||75
10914375|NCT00127166|12080918|FG001|STARTED|Period II||73
10914376|NCT00127166|12080917|FG000|COMPLETED|Period II||72
10914377|NCT00127166|12080918|FG001|COMPLETED|Period II||73
10914378|NCT00127166|12080917|FG000|NOT COMPLETED|Period II||3
10914379|NCT00127166|12080918|FG001|NOT COMPLETED|Period II||0
10914380|NCT00127192|12080929|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
10914381|NCT00127192|12080930|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
10914382|NCT00127192|12080931|FG002|STARTED|Overall Study|Study enrolled as per the target of N=70|70
10914383|NCT00127192|12080932|FG003|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
10914384|NCT00127192|12080933|FG004|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
10914385|NCT00127192|12080929|FG000|COMPLETED|Overall Study||77
10914386|NCT00127192|12080930|FG001|COMPLETED|Overall Study||71
10914387|NCT00127192|12080931|FG002|COMPLETED|Overall Study||68
10914388|NCT00127192|12080932|FG003|COMPLETED|Overall Study||67
10914389|NCT00127192|12080933|FG004|COMPLETED|Overall Study||68
10914390|NCT00127192|12080929|FG000|NOT COMPLETED|Overall Study||3
10914391|NCT00127192|12080930|FG001|NOT COMPLETED|Overall Study||1
10914392|NCT00127192|12080931|FG002|NOT COMPLETED|Overall Study||2
10914393|NCT00127192|12080932|FG003|NOT COMPLETED|Overall Study||1
10914394|NCT00127192|12080933|FG004|NOT COMPLETED|Overall Study||5
10914395|NCT00127205|12080948|FG000|STARTED|Overall Study||2262
10914396|NCT00127205|12080949|FG001|STARTED|Overall Study||2268
10914397|NCT00127205|12080950|FG002|STARTED|Overall Study||1567
10914398|NCT00127205|12080948|FG000|COMPLETED|Overall Study||1433
10914399|NCT00127205|12080949|FG001|COMPLETED|Overall Study||1295
10914400|NCT00127205|12080950|FG002|COMPLETED|Overall Study||955
10914401|NCT00127205|12080948|FG000|NOT COMPLETED|Overall Study||829
10914402|NCT00127205|12080949|FG001|NOT COMPLETED|Overall Study||973
10914403|NCT00127205|12080950|FG002|NOT COMPLETED|Overall Study||612
10914404|NCT00127218|12080962|FG000|STARTED|Overall Study||72
10914405|NCT00127218|12080963|FG001|STARTED|Overall Study||73
10914406|NCT00127218|12080962|FG000|COMPLETED|Overall Study||59
10914407|NCT00127218|12080963|FG001|COMPLETED|Overall Study||58
10914408|NCT00127218|12080962|FG000|NOT COMPLETED|Overall Study||13
10914409|NCT00127218|12080963|FG001|NOT COMPLETED|Overall Study||15
10914410|NCT00127231|12080973|FG000|STARTED|Overall Study||74
10914411|NCT00127231|12080974|FG001|STARTED|Overall Study||74
10914412|NCT00127231|12080973|FG000|COMPLETED|Overall Study||68
10914413|NCT00127231|12080974|FG001|COMPLETED|Overall Study||68
10914414|NCT00127231|12080973|FG000|NOT COMPLETED|Overall Study||6
10914415|NCT00127231|12080974|FG001|NOT COMPLETED|Overall Study||6
10914416|NCT00127413|12080984|FG000|STARTED|Overall Study||12
10914417|NCT00127413|12080985|FG001|STARTED|Overall Study||10
10914418|NCT00127413|12080986|FG002|STARTED|Overall Study||13
10914419|NCT00127413|12080987|FG003|STARTED|Overall Study||7
10914420|NCT00127413|12080984|FG000|COMPLETED|Overall Study||6
10914421|NCT00127413|12080985|FG001|COMPLETED|Overall Study||6
10914422|NCT00127413|12080986|FG002|COMPLETED|Overall Study||5
10914423|NCT00127413|12080987|FG003|COMPLETED|Overall Study||5
10914424|NCT00127413|12080984|FG000|NOT COMPLETED|Overall Study||6
10914425|NCT00127413|12080985|FG001|NOT COMPLETED|Overall Study||4
10914426|NCT00127413|12080986|FG002|NOT COMPLETED|Overall Study||8
10914427|NCT00127413|12080987|FG003|NOT COMPLETED|Overall Study||2
10914428|NCT00127439|12080999|FG000|STARTED|Overall Study||9
10914429|NCT00127439|12081000|FG001|STARTED|Overall Study||10
10914430|NCT00127439|12080999|FG000|COMPLETED|Overall Study||9
10914431|NCT00127439|12081000|FG001|COMPLETED|Overall Study||10
10914432|NCT00127439|12080999|FG000|NOT COMPLETED|Overall Study||0
10914433|NCT00127439|12081000|FG001|NOT COMPLETED|Overall Study||0
10914434|NCT00127530|12081011|FG000|STARTED|Overall Study||72
10914435|NCT00127530|12081012|FG001|STARTED|Overall Study||228
10914436|NCT00127530|12081011|FG000|COMPLETED|Overall Study||71
10914437|NCT00127530|12081012|FG001|COMPLETED|Overall Study||207
10914438|NCT00127530|12081011|FG000|NOT COMPLETED|Overall Study||1
10914439|NCT00127530|12081012|FG001|NOT COMPLETED|Overall Study||21
10914440|NCT00127608|12081018|FG000|STARTED|Overall Study||36
10914441|NCT00127608|12081018|FG000|COMPLETED|Overall Study||35
10914442|NCT00127608|12081018|FG000|NOT COMPLETED|Overall Study||1
10914443|NCT00127660|12081026|FG000|STARTED|Overall Study||153
10914444|NCT00127660|12081027|FG001|STARTED|Overall Study||154
10914445|NCT00127660|12081028|FG002|STARTED|Overall Study||148
10914446|NCT00127660|12081029|FG003|STARTED|Overall Study||150
10914447|NCT00127660|12081026|FG000|COMPLETED|Overall Study||150
10914448|NCT00127660|12081027|FG001|COMPLETED|Overall Study||151
10914449|NCT00127660|12081028|FG002|COMPLETED|Overall Study||143
10914450|NCT00127660|12081029|FG003|COMPLETED|Overall Study||150
10914451|NCT00127660|12081026|FG000|NOT COMPLETED|Overall Study||3
10914452|NCT00127660|12081027|FG001|NOT COMPLETED|Overall Study||3
10914453|NCT00127660|12081028|FG002|NOT COMPLETED|Overall Study||5
10914454|NCT00127660|12081029|FG003|NOT COMPLETED|Overall Study||0
10914455|NCT00127712|12081041|FG000|STARTED|Overall Study||65
10914456|NCT00127712|12081042|FG001|STARTED|Overall Study||65
10914457|NCT00127712|12081041|FG000|COMPLETED|Overall Study||60
10914458|NCT00127712|12081042|FG001|COMPLETED|Overall Study||65
10914459|NCT00127712|12081041|FG000|NOT COMPLETED|Overall Study||5
10914460|NCT00127712|12081042|FG001|NOT COMPLETED|Overall Study||0
10914461|NCT00127790|12081052|FG000|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
10914462|NCT00127790|12081053|FG001|STARTED|Pre-Treatment||5
10914463|NCT00127790|12081054|FG002|STARTED|Pre-Treatment||6
10914464|NCT00127790|12081055|FG003|STARTED|Pre-Treatment||4
10914465|NCT00127790|12081052|FG000|COMPLETED|Pre-Treatment||6
10914466|NCT00127790|12081053|FG001|COMPLETED|Pre-Treatment||5
10914467|NCT00127790|12081054|FG002|COMPLETED|Pre-Treatment||6
10914468|NCT00127790|12081055|FG003|COMPLETED|Pre-Treatment||4
10914469|NCT00127790|12081052|FG000|NOT COMPLETED|Pre-Treatment||0
10914470|NCT00127790|12081053|FG001|NOT COMPLETED|Pre-Treatment||0
10914471|NCT00127790|12081054|FG002|NOT COMPLETED|Pre-Treatment||0
10914472|NCT00127790|12081055|FG003|NOT COMPLETED|Pre-Treatment||0
10914473|NCT00127790|12081052|FG000|STARTED|Post-Treatment||6
10914474|NCT00127790|12081053|FG001|STARTED|Post-Treatment||5
10914475|NCT00127790|12081054|FG002|STARTED|Post-Treatment||6
10914476|NCT00127790|12081055|FG003|STARTED|Post-Treatment||4
10914477|NCT00127790|12081052|FG000|COMPLETED|Post-Treatment||6
10914478|NCT00127790|12081053|FG001|COMPLETED|Post-Treatment||5
10914479|NCT00127790|12081054|FG002|COMPLETED|Post-Treatment||6
10914480|NCT00127790|12081055|FG003|COMPLETED|Post-Treatment||4
10914481|NCT00127790|12081052|FG000|NOT COMPLETED|Post-Treatment||0
10914482|NCT00127790|12081053|FG001|NOT COMPLETED|Post-Treatment||0
10914483|NCT00127790|12081054|FG002|NOT COMPLETED|Post-Treatment||0
10914484|NCT00127790|12081055|FG003|NOT COMPLETED|Post-Treatment||0
10914485|NCT00127803|12081069|FG000|STARTED|Overall Study||13
10914486|NCT00127803|12081070|FG001|STARTED|Overall Study||13
10914487|NCT00127803|12081071|FG002|STARTED|Overall Study||12
10914488|NCT00127803|12081072|FG003|STARTED|Overall Study||12
10914489|NCT00127803|12081069|FG000|COMPLETED|Overall Study||10
10914490|NCT00127803|12081070|FG001|COMPLETED|Overall Study||13
10914491|NCT00127803|12081071|FG002|COMPLETED|Overall Study||12
10914492|NCT00127803|12081072|FG003|COMPLETED|Overall Study||11
10914493|NCT00127803|12081069|FG000|NOT COMPLETED|Overall Study||3
10914494|NCT00127803|12081070|FG001|NOT COMPLETED|Overall Study||0
10914495|NCT00127803|12081071|FG002|NOT COMPLETED|Overall Study||0
10914496|NCT00127803|12081072|FG003|NOT COMPLETED|Overall Study||1
10914497|NCT00127842|12081082|FG000|STARTED|Overall Study||110
10914498|NCT00127842|12081082|FG000|COMPLETED|Overall Study||71
10914499|NCT00127842|12081082|FG000|NOT COMPLETED|Overall Study||39
10914500|NCT00127855|12081091|FG000|STARTED|Primary Vaccination Course||82
10914501|NCT00127855|12081092|FG001|STARTED|Primary Vaccination Course||82
10914502|NCT00127855|12081093|FG002|STARTED|Primary Vaccination Course||80
10914503|NCT00127855|12081094|FG003|STARTED|Primary Vaccination Course||81
10914504|NCT00127855|12081095|FG004|STARTED|Primary Vaccination Course||82
10914505|NCT00127855|12081091|FG000|COMPLETED|Primary Vaccination Course||80
10914506|NCT00127855|12081092|FG001|COMPLETED|Primary Vaccination Course||81
10914507|NCT00127855|12081093|FG002|COMPLETED|Primary Vaccination Course||78
10914508|NCT00127855|12081094|FG003|COMPLETED|Primary Vaccination Course||81
10914509|NCT00127855|12081095|FG004|COMPLETED|Primary Vaccination Course||78
10914510|NCT00127855|12081091|FG000|NOT COMPLETED|Primary Vaccination Course||2
10914511|NCT00127855|12081092|FG001|NOT COMPLETED|Primary Vaccination Course||1
10914512|NCT00127855|12081093|FG002|NOT COMPLETED|Primary Vaccination Course||2
10914513|NCT00127855|12081094|FG003|NOT COMPLETED|Primary Vaccination Course||0
10914514|NCT00127855|12081095|FG004|NOT COMPLETED|Primary Vaccination Course||4
10914515|NCT00127855|12081091|FG000|STARTED|Polysaccharide Challenge Dose||80
10914516|NCT00127855|12081092|FG001|STARTED|Polysaccharide Challenge Dose||79
10914517|NCT00127855|12081093|FG002|STARTED|Polysaccharide Challenge Dose||77
10914518|NCT00127855|12081094|FG003|STARTED|Polysaccharide Challenge Dose||81
10914519|NCT00127855|12081095|FG004|STARTED|Polysaccharide Challenge Dose||77
10914520|NCT00127855|12081091|FG000|COMPLETED|Polysaccharide Challenge Dose||80
10914521|NCT00127855|12081092|FG001|COMPLETED|Polysaccharide Challenge Dose||79
10914522|NCT00127855|12081093|FG002|COMPLETED|Polysaccharide Challenge Dose||77
10914523|NCT00127855|12081094|FG003|COMPLETED|Polysaccharide Challenge Dose||81
10914524|NCT00127855|12081095|FG004|COMPLETED|Polysaccharide Challenge Dose||77
10914525|NCT00127855|12081091|FG000|NOT COMPLETED|Polysaccharide Challenge Dose||0
10914526|NCT00127855|12081092|FG001|NOT COMPLETED|Polysaccharide Challenge Dose||0
10914527|NCT00127855|12081093|FG002|NOT COMPLETED|Polysaccharide Challenge Dose||0
10914528|NCT00127855|12081094|FG003|NOT COMPLETED|Polysaccharide Challenge Dose||0
10914529|NCT00127855|12081095|FG004|NOT COMPLETED|Polysaccharide Challenge Dose||0
10914530|NCT00127933|12081109|FG000|STARTED|Overall Study||123
10914531|NCT00127933|12081110|FG001|STARTED|Overall Study||34
10914532|NCT00127933|12081109|FG000|Pathological Response|Overall Study||101
10914533|NCT00127933|12081110|FG001|Pathological Response|Overall Study||28
10914534|NCT00127933|12081109|FG000|Clinical Response|Overall Study||122
10914535|NCT00127933|12081110|FG001|Clinical Response|Overall Study||34
10914536|NCT00127933|12081109|FG000|Safety Population|Overall Study||122
10914537|NCT00127933|12081110|FG001|Safety Population|Overall Study||34
10914538|NCT00127933|12081109|FG000|Quality of Life Population|Overall Study||118
10914539|NCT00127933|12081110|FG001|Quality of Life Population|Overall Study||33
10914540|NCT00127933|12081109|FG000|Postoperative|Overall Study||98
10914541|NCT00127933|12081110|FG001|Postoperative|Overall Study||27
10914542|NCT00127933|12081109|FG000|COMPLETED|Overall Study||122
10914543|NCT00127933|12081110|FG001|COMPLETED|Overall Study||34
10914544|NCT00127933|12081109|FG000|NOT COMPLETED|Overall Study||1
10914545|NCT00127933|12081110|FG001|NOT COMPLETED|Overall Study||0
10914546|NCT00128102|12081118|FG000|STARTED|Overall Study||329
10914547|NCT00128102|12081119|FG001|STARTED|Overall Study||332
10914548|NCT00128102|12081118|FG000|Treated|Overall Study||329
10914549|NCT00128102|12081119|FG001|Treated|Overall Study||329
10914550|NCT00128102|12081118|FG000|COMPLETED|Overall Study||1
10914551|NCT00128102|12081119|FG001|COMPLETED|Overall Study||0
10914552|NCT00128102|12081118|FG000|NOT COMPLETED|Overall Study||328
10914553|NCT00128102|12081119|FG001|NOT COMPLETED|Overall Study||332
10914554|NCT00128180|12081127|FG000|STARTED|Overall Study||32
10914555|NCT00128180|12081128|FG001|STARTED|Overall Study||34
10914556|NCT00128180|12081127|FG000|COMPLETED|Overall Study||32
10914557|NCT00128180|12081128|FG001|COMPLETED|Overall Study||34
10914558|NCT00128180|12081127|FG000|NOT COMPLETED|Overall Study||0
10914559|NCT00128180|12081128|FG001|NOT COMPLETED|Overall Study||0
10914560|NCT00128193|12081146|FG000|STARTED|Overall Study||5
10914561|NCT00128193|12081147|FG001|STARTED|Overall Study||5
10914562|NCT00128193|12081148|FG002|STARTED|Overall Study||45
10914563|NCT00128193|12081149|FG003|STARTED|Overall Study||45
10914564|NCT00128193|12081150|FG004|STARTED|Overall Study||20
10914565|NCT00128193|12081151|FG005|STARTED|Overall Study||20
10914566|NCT00128193|12081152|FG006|STARTED|Overall Study||20
10914567|NCT00128193|12081153|FG007|STARTED|Overall Study||20
10914568|NCT00128193|12081154|FG008|STARTED|Overall Study||20
10914569|NCT00128193|12081155|FG009|STARTED|Overall Study||20
10914570|NCT00128193|12081156|FG010|STARTED|Overall Study||20
10914571|NCT00128193|12081157|FG011|STARTED|Overall Study||20
10914572|NCT00128193|12081146|FG000|COMPLETED|Overall Study||5
10914573|NCT00128193|12081147|FG001|COMPLETED|Overall Study||5
10914574|NCT00128193|12081148|FG002|COMPLETED|Overall Study||42
10914575|NCT00128193|12081149|FG003|COMPLETED|Overall Study||44
10914576|NCT00128193|12081150|FG004|COMPLETED|Overall Study||18
10914577|NCT00128193|12081151|FG005|COMPLETED|Overall Study||17
10914578|NCT00128193|12081152|FG006|COMPLETED|Overall Study||16
10914579|NCT00128193|12081153|FG007|COMPLETED|Overall Study||20
10914580|NCT00128193|12081154|FG008|COMPLETED|Overall Study||18
10914581|NCT00128193|12081155|FG009|COMPLETED|Overall Study||18
10914582|NCT00128193|12081156|FG010|COMPLETED|Overall Study||17
10914583|NCT00128193|12081157|FG011|COMPLETED|Overall Study||18
10914584|NCT00128193|12081146|FG000|NOT COMPLETED|Overall Study||0
10914585|NCT00128193|12081147|FG001|NOT COMPLETED|Overall Study||0
10914586|NCT00128193|12081148|FG002|NOT COMPLETED|Overall Study||3
10914587|NCT00128193|12081149|FG003|NOT COMPLETED|Overall Study||1
10914588|NCT00128193|12081150|FG004|NOT COMPLETED|Overall Study||2
10914589|NCT00128193|12081151|FG005|NOT COMPLETED|Overall Study||3
10914590|NCT00128193|12081152|FG006|NOT COMPLETED|Overall Study||4
10914591|NCT00128193|12081153|FG007|NOT COMPLETED|Overall Study||0
10914592|NCT00128193|12081154|FG008|NOT COMPLETED|Overall Study||2
10914593|NCT00128193|12081155|FG009|NOT COMPLETED|Overall Study||2
10914594|NCT00128193|12081156|FG010|NOT COMPLETED|Overall Study||3
10914595|NCT00128193|12081157|FG011|NOT COMPLETED|Overall Study||2
10914596|NCT00128206|12081239|FG000|STARTED|Overall Study||184
10914597|NCT00128206|12081240|FG001|STARTED|Overall Study||180
10914598|NCT00128206|12081239|FG000|COMPLETED|Overall Study||47
10914599|NCT00128206|12081240|FG001|COMPLETED|Overall Study||60
10914600|NCT00128206|12081239|FG000|NOT COMPLETED|Overall Study||137
10914601|NCT00128206|12081240|FG001|NOT COMPLETED|Overall Study||120
10914602|NCT00128219|12081248|FG000|STARTED|Overall Study||333
10914603|NCT00128219|12081249|FG001|STARTED|Overall Study||334
10914604|NCT00128219|12081248|FG000|COMPLETED|Overall Study||264
10914605|NCT00128219|12081249|FG001|COMPLETED|Overall Study||263
10914606|NCT00128219|12081248|FG000|NOT COMPLETED|Overall Study||69
10914607|NCT00128219|12081249|FG001|NOT COMPLETED|Overall Study||71
10914608|NCT00128401|12081257|FG000|STARTED|Overall Study||20
10914609|NCT00128401|12081258|FG001|STARTED|Overall Study||19
10914610|NCT00128401|12081257|FG000|COMPLETED|Overall Study||14
10914611|NCT00128401|12081258|FG001|COMPLETED|Overall Study||15
10914612|NCT00128401|12081257|FG000|NOT COMPLETED|Overall Study||6
10914613|NCT00128401|12081258|FG001|NOT COMPLETED|Overall Study||4
10914614|NCT00128492|12081267|FG000|STARTED|Overall Study||85
10914615|NCT00128492|12081268|FG001|STARTED|Overall Study||189
10914616|NCT00128492|12081267|FG000|COMPLETED|Overall Study||65
10914617|NCT00128492|12081268|FG001|COMPLETED|Overall Study||130
10914618|NCT00128492|12081267|FG000|NOT COMPLETED|Overall Study||20
10914619|NCT00128492|12081268|FG001|NOT COMPLETED|Overall Study||59
10914620|NCT00128661|12081276|FG000|STARTED|Overall Study||3727
10914621|NCT00128661|12081277|FG001|STARTED|Overall Study||3739
10914622|NCT00128661|12081276|FG000|COMPLETED|Overall Study||3453
10914623|NCT00128661|12081277|FG001|COMPLETED|Overall Study||3481
10914624|NCT00128661|12081276|FG000|NOT COMPLETED|Overall Study||274
10914625|NCT00128661|12081277|FG001|NOT COMPLETED|Overall Study||258
10914626|NCT00128713|12081286|FG000|STARTED|Overall Study||453
10914627|NCT00128713|12081287|FG001|STARTED|Overall Study||449
10914628|NCT00128713|12081288|FG002|STARTED|Overall Study||449
10914629|NCT00128713|12081286|FG000|COMPLETED|Overall Study||453
10914630|NCT00128713|12081287|FG001|COMPLETED|Overall Study||449
10914631|NCT00128713|12081288|FG002|COMPLETED|Overall Study||449
10914632|NCT00128713|12081286|FG000|NOT COMPLETED|Overall Study||0
10914633|NCT00128713|12081287|FG001|NOT COMPLETED|Overall Study||0
10914634|NCT00128713|12081288|FG002|NOT COMPLETED|Overall Study||0
10914635|NCT00128830|12081296|FG000|STARTED|Overall Study||211
10914636|NCT00128830|12081296|FG000|COMPLETED|Overall Study||139
10914637|NCT00128830|12081296|FG000|NOT COMPLETED|Overall Study||72
10914638|NCT00128921|12081305|FG000|STARTED|Overall Study||10
10914639|NCT00128921|12081306|FG001|STARTED|Overall Study||8
10914640|NCT00128921|12081307|FG002|STARTED|Overall Study||0
10914641|NCT00128921|12081305|FG000|Received Bortezomib|Overall Study||10
10914642|NCT00128921|12081306|FG001|Received Bortezomib|Overall Study||6
10914643|NCT00128921|12081307|FG002|Received Bortezomib|Overall Study||0
10914644|NCT00128921|12081305|FG000|COMPLETED|Overall Study||5
10914645|NCT00128921|12081306|FG001|COMPLETED|Overall Study||3
10914646|NCT00128921|12081307|FG002|COMPLETED|Overall Study||0
10914647|NCT00128921|12081305|FG000|NOT COMPLETED|Overall Study||5
10914648|NCT00128921|12081306|FG001|NOT COMPLETED|Overall Study||5
10914649|NCT00128921|12081307|FG002|NOT COMPLETED|Overall Study||0
10914650|NCT00129116|12081322|FG000|STARTED|Primary Phase||78
10914651|NCT00129116|12081323|FG001|STARTED|Primary Phase||77
10914652|NCT00129116|12081324|FG002|STARTED|Primary Phase||78
10914653|NCT00129116|12081325|FG003|STARTED|Primary Phase||78
10914654|NCT00129116|12081326|FG004|STARTED|Primary Phase||77
10914655|NCT00129116|12081322|FG000|COMPLETED|Primary Phase||76
10914656|NCT00129116|12081323|FG001|COMPLETED|Primary Phase||73
10914657|NCT00129116|12081324|FG002|COMPLETED|Primary Phase||77
10914658|NCT00129116|12081325|FG003|COMPLETED|Primary Phase||77
10914659|NCT00129116|12081326|FG004|COMPLETED|Primary Phase||76
10914660|NCT00129116|12081322|FG000|NOT COMPLETED|Primary Phase||2
10914661|NCT00129116|12081323|FG001|NOT COMPLETED|Primary Phase||4
10914662|NCT00129116|12081324|FG002|NOT COMPLETED|Primary Phase||1
10914663|NCT00129116|12081325|FG003|NOT COMPLETED|Primary Phase||1
10914664|NCT00129116|12081326|FG004|NOT COMPLETED|Primary Phase||1
10914665|NCT00129116|12081322|FG000|STARTED|Booster Phase||47
10914666|NCT00129116|12081323|FG001|STARTED|Booster Phase||42
10914667|NCT00129116|12081324|FG002|STARTED|Booster Phase||44
10914668|NCT00129116|12081325|FG003|STARTED|Booster Phase||44
10914669|NCT00129116|12081326|FG004|STARTED|Booster Phase||44
10914670|NCT00129116|12081322|FG000|COMPLETED|Booster Phase||45
10914671|NCT00129116|12081323|FG001|COMPLETED|Booster Phase||42
10914672|NCT00129116|12081324|FG002|COMPLETED|Booster Phase||44
10914673|NCT00129116|12081325|FG003|COMPLETED|Booster Phase||44
10914674|NCT00129116|12081326|FG004|COMPLETED|Booster Phase||43
10914675|NCT00129116|12081322|FG000|NOT COMPLETED|Booster Phase||2
10914676|NCT00129116|12081323|FG001|NOT COMPLETED|Booster Phase||0
10914677|NCT00129116|12081324|FG002|NOT COMPLETED|Booster Phase||0
10914678|NCT00129116|12081325|FG003|NOT COMPLETED|Booster Phase||0
10914679|NCT00129116|12081326|FG004|NOT COMPLETED|Booster Phase||1
10914680|NCT00129129|12081341|FG000|STARTED|Primary Phase||287
10914681|NCT00129129|12081342|FG001|STARTED|Primary Phase||319
10914682|NCT00129129|12081343|FG002|STARTED|Primary Phase||150
10914683|NCT00129129|12081344|FG003|STARTED|Primary Phase||0
10914684|NCT00129129|12081345|FG004|STARTED|Primary Phase||0
10914685|NCT00129129|12081341|FG000|COMPLETED|Primary Phase||262
10914686|NCT00129129|12081342|FG001|COMPLETED|Primary Phase||294
10914687|NCT00129129|12081343|FG002|COMPLETED|Primary Phase||150
10914688|NCT00129129|12081344|FG003|COMPLETED|Primary Phase||0
10914689|NCT00129129|12081345|FG004|COMPLETED|Primary Phase||0
10914690|NCT00129129|12081341|FG000|NOT COMPLETED|Primary Phase||25
10914691|NCT00129129|12081342|FG001|NOT COMPLETED|Primary Phase||25
10914692|NCT00129129|12081343|FG002|NOT COMPLETED|Primary Phase||0
10914693|NCT00129129|12081344|FG003|NOT COMPLETED|Primary Phase||0
10914694|NCT00129129|12081345|FG004|NOT COMPLETED|Primary Phase||0
10914695|NCT00129129|12081341|FG000|STARTED|Fourth Dose Phase||236
10914696|NCT00129129|12081342|FG001|STARTED|Fourth Dose Phase||0
10914697|NCT00129129|12081343|FG002|STARTED|Fourth Dose Phase||0
10914698|NCT00129129|12081344|FG003|STARTED|Fourth Dose Phase||132
10914699|NCT00129129|12081345|FG004|STARTED|Fourth Dose Phase||130
10914700|NCT00129129|12081341|FG000|COMPLETED|Fourth Dose Phase||232
10914701|NCT00129129|12081342|FG001|COMPLETED|Fourth Dose Phase||0
10914702|NCT00129129|12081343|FG002|COMPLETED|Fourth Dose Phase||0
10914703|NCT00129129|12081344|FG003|COMPLETED|Fourth Dose Phase||128
10914704|NCT00129129|12081345|FG004|COMPLETED|Fourth Dose Phase||124
10914705|NCT00129129|12081341|FG000|NOT COMPLETED|Fourth Dose Phase||4
10914706|NCT00129129|12081342|FG001|NOT COMPLETED|Fourth Dose Phase||0
10914707|NCT00129129|12081343|FG002|NOT COMPLETED|Fourth Dose Phase||0
10914708|NCT00129129|12081344|FG003|NOT COMPLETED|Fourth Dose Phase||4
10914709|NCT00129129|12081345|FG004|NOT COMPLETED|Fourth Dose Phase||6
10914710|NCT00129220|12081368|FG000|STARTED|Study Period II||105
10914711|NCT00129220|12081369|FG001|STARTED|Study Period II||20
10914712|NCT00129220|12081370|FG002|STARTED|Study Period II||99
10914713|NCT00129220|12081368|FG000|Received at Least One Dose of Study Drug|Study Period II||104
10914714|NCT00129220|12081369|FG001|Received at Least One Dose of Study Drug|Study Period II||20
10914715|NCT00129220|12081370|FG002|Received at Least One Dose of Study Drug|Study Period II||97
10914716|NCT00129220|12081368|FG000|COMPLETED|Study Period II||72
10914717|NCT00129220|12081369|FG001|COMPLETED|Study Period II||8
10914718|NCT00129220|12081370|FG002|COMPLETED|Study Period II||52
10914719|NCT00129220|12081368|FG000|NOT COMPLETED|Study Period II||33
10914720|NCT00129220|12081369|FG001|NOT COMPLETED|Study Period II||12
10914721|NCT00129220|12081370|FG002|NOT COMPLETED|Study Period II||47
10914722|NCT00129220|12081368|FG000|STARTED|Study Period III||72
10914723|NCT00129220|12081369|FG001|STARTED|Study Period III||8
10914724|NCT00129220|12081370|FG002|STARTED|Study Period III||52
10914725|NCT00129220|12081368|FG000|COMPLETED|Study Period III||59
10914726|NCT00129220|12081369|FG001|COMPLETED|Study Period III||7
10914727|NCT00129220|12081370|FG002|COMPLETED|Study Period III||42
10914728|NCT00129220|12081368|FG000|NOT COMPLETED|Study Period III||13
10914729|NCT00129220|12081369|FG001|NOT COMPLETED|Study Period III||1
10914730|NCT00129220|12081370|FG002|NOT COMPLETED|Study Period III||10
10914731|NCT00129246|12081382|FG000|STARTED|Overall Study||20
10914732|NCT00129246|12081383|FG001|STARTED|Overall Study||20
10914733|NCT00129246|12081382|FG000|COMPLETED|Overall Study||20
10914734|NCT00129246|12081383|FG001|COMPLETED|Overall Study||20
10914735|NCT00129246|12081382|FG000|NOT COMPLETED|Overall Study||0
10914736|NCT00129246|12081383|FG001|NOT COMPLETED|Overall Study||0
10914737|NCT00129259|12081391|FG000|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
10914738|NCT00129259|12081392|FG001|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
10914739|NCT00129259|12081391|FG000|Received All or Part of Cycle 1|Overall Study||52
10914740|NCT00129259|12081392|FG001|Received All or Part of Cycle 1|Overall Study||0
10914741|NCT00129259|12081391|FG000|Received All or Part of Cycle 2|Overall Study||40
10914742|NCT00129259|12081392|FG001|Received All or Part of Cycle 2|Overall Study||0
10914743|NCT00129259|12081391|FG000|COMPLETED|Overall Study||49
10914744|NCT00129259|12081392|FG001|COMPLETED|Overall Study||22
10914745|NCT00129259|12081391|FG000|NOT COMPLETED|Overall Study||3
10914746|NCT00129259|12081392|FG001|NOT COMPLETED|Overall Study||3
10914747|NCT00129272|12081400|FG000|STARTED|Overall Study||71
10914748|NCT00129272|12081401|FG001|STARTED|Overall Study||73
10914749|NCT00129272|12081400|FG000|COMPLETED|Overall Study||54
10914750|NCT00129272|12081401|FG001|COMPLETED|Overall Study||51
10914751|NCT00129272|12081400|FG000|NOT COMPLETED|Overall Study||17
10914752|NCT00129272|12081401|FG001|NOT COMPLETED|Overall Study||22
10914753|NCT00129285|12081410|FG000|STARTED|Overall Study||65
10914754|NCT00129285|12081411|FG001|STARTED|Overall Study||70
10914755|NCT00129285|12081412|FG002|STARTED|Overall Study||75
10914756|NCT00129285|12081410|FG000|COMPLETED|Overall Study||40
10914757|NCT00129285|12081411|FG001|COMPLETED|Overall Study||43
10914758|NCT00129285|12081412|FG002|COMPLETED|Overall Study||37
10914759|NCT00129285|12081410|FG000|NOT COMPLETED|Overall Study||25
10914760|NCT00129285|12081411|FG001|NOT COMPLETED|Overall Study||27
10914761|NCT00129285|12081412|FG002|NOT COMPLETED|Overall Study||38
10914762|NCT00129311|12081426|FG000|STARTED|Overall Study||51
10914763|NCT00129311|12081427|FG001|STARTED|Overall Study||50
10914764|NCT00129311|12081426|FG000|COMPLETED|Overall Study||39
10914765|NCT00129311|12081427|FG001|COMPLETED|Overall Study||31
10914766|NCT00129311|12081426|FG000|NOT COMPLETED|Overall Study||12
10914767|NCT00129311|12081427|FG001|NOT COMPLETED|Overall Study||19
10914768|NCT00129376|12081433|FG000|STARTED|Overall Study||63
10914769|NCT00129376|12081433|FG000|COMPLETED|Overall Study||61
10914770|NCT00129376|12081433|FG000|NOT COMPLETED|Overall Study||2
10914771|NCT00129389|12081439|FG000|STARTED|Overall Study||974
10914772|NCT00129389|12081440|FG001|STARTED|Overall Study||951
10914773|NCT00129389|12081439|FG000|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941
10914774|NCT00129389|12081440|FG001|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811
10914775|NCT00129389|12081439|FG000|NOT COMPLETED|Overall Study||33
10914776|NCT00129389|12081440|FG001|NOT COMPLETED|Overall Study||140
10914777|NCT00129441|12081448|FG000|STARTED|Overall Study||9
10914778|NCT00129441|12081449|FG001|STARTED|Overall Study||6
10914779|NCT00129441|12081448|FG000|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
10914780|NCT00129441|12081449|FG001|Baseline, Visit 1|Overall Study||6
10914781|NCT00129441|12081448|FG000|Week 1, Visit 2|Overall Study||9
10914782|NCT00129441|12081449|FG001|Week 1, Visit 2|Overall Study||6
10914783|NCT00129441|12081448|FG000|Week 2, Visit 3|Overall Study||9
10914784|NCT00129441|12081449|FG001|Week 2, Visit 3|Overall Study||6
10914785|NCT00129441|12081448|FG000|Week 3, Visit 4|Overall Study||9
10914786|NCT00129441|12081449|FG001|Week 3, Visit 4|Overall Study||6
10914787|NCT00129441|12081448|FG000|Week 4, Visit 5|Overall Study||9
10914788|NCT00129441|12081449|FG001|Week 4, Visit 5|Overall Study||6
10914789|NCT00129441|12081448|FG000|Week 5, Visit 6|Overall Study||9
10914790|NCT00129441|12081449|FG001|Week 5, Visit 6|Overall Study||6
10914791|NCT00129441|12081448|FG000|Week 26, Visit 7|Overall Study||9
10914792|NCT00129441|12081449|FG001|Week 26, Visit 7|Overall Study||6
10914793|NCT00129441|12081448|FG000|Year 1, Visit 8|Overall Study||9
10914794|NCT00129441|12081449|FG001|Year 1, Visit 8|Overall Study||6
10914795|NCT00129441|12081448|FG000|COMPLETED|Overall Study||9
10914796|NCT00129441|12081449|FG001|COMPLETED|Overall Study||6
10914797|NCT00129441|12081448|FG000|NOT COMPLETED|Overall Study||0
10914798|NCT00129441|12081449|FG001|NOT COMPLETED|Overall Study||0
10914799|NCT00129467|12081457|FG000|STARTED|Received Intervention||15
10914800|NCT00129467|12081458|FG001|STARTED|Received Intervention||17
10914801|NCT00129467|12081457|FG000|COMPLETED|Received Intervention||9
10914802|NCT00129467|12081458|FG001|COMPLETED|Received Intervention||13
10914803|NCT00129467|12081457|FG000|NOT COMPLETED|Received Intervention||6
10914804|NCT00129467|12081458|FG001|NOT COMPLETED|Received Intervention||4
10914805|NCT00129467|12081457|FG000|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
10914806|NCT00129467|12081458|FG001|STARTED|Open Label for SSRI+Methylphenidate Arm||0
10914807|NCT00129467|12081457|FG000|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
10914808|NCT00129467|12081458|FG001|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
10914809|NCT00129467|12081457|FG000|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
10914810|NCT00129467|12081458|FG001|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
10914811|NCT00129480|12081466|FG000|STARTED|Overall Study||187
10914812|NCT00129480|12081467|FG001|STARTED|Overall Study||214
10914813|NCT00129480|12081466|FG000|COMPLETED|Overall Study||187
10914814|NCT00129480|12081467|FG001|COMPLETED|Overall Study||214
10914815|NCT00129480|12081466|FG000|NOT COMPLETED|Overall Study||0
10914816|NCT00129480|12081467|FG001|NOT COMPLETED|Overall Study||0
10914817|NCT00129545|12081476|FG000|STARTED|Overall Study||93
10914818|NCT00129545|12081477|FG001|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
10914819|NCT00129545|12081478|FG002|STARTED|Overall Study||244
10914820|NCT00129545|12081476|FG000|COMPLETED|Overall Study||67
10914821|NCT00129545|12081477|FG001|COMPLETED|Overall Study||299
10914822|NCT00129545|12081478|FG002|COMPLETED|Overall Study||133
10914823|NCT00129545|12081476|FG000|NOT COMPLETED|Overall Study||26
10914824|NCT00129545|12081477|FG001|NOT COMPLETED|Overall Study||164
10914825|NCT00129545|12081478|FG002|NOT COMPLETED|Overall Study||111
10914826|NCT00129623|12081488|FG000|STARTED|Overall Study||83
10914827|NCT00129623|12081489|FG001|STARTED|Overall Study||77
10914828|NCT00129623|12081488|FG000|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
10914829|NCT00129623|12081489|FG001|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
10914830|NCT00129623|12081488|FG000|COMPLETED|Overall Study||73
10914831|NCT00129623|12081489|FG001|COMPLETED|Overall Study||65
10914832|NCT00129623|12081488|FG000|NOT COMPLETED|Overall Study||10
10914833|NCT00129623|12081489|FG001|NOT COMPLETED|Overall Study||12
10914834|NCT00129649|12081499|FG000|STARTED|Overall Study||258
10914835|NCT00129649|12081500|FG001|STARTED|Overall Study||246
10914836|NCT00129649|12081499|FG000|COMPLETED|Overall Study||182
10914837|NCT00129649|12081500|FG001|COMPLETED|Overall Study||181
10914838|NCT00129649|12081499|FG000|NOT COMPLETED|Overall Study||76
10914839|NCT00129649|12081500|FG001|NOT COMPLETED|Overall Study||65
10914840|NCT00129701|12081506|FG000|STARTED|Overall Study||104
10914841|NCT00129701|12081506|FG000|COMPLETED|Overall Study||71
10914842|NCT00129701|12081506|FG000|NOT COMPLETED|Overall Study||33
10914843|NCT00129727|12081513|FG000|STARTED|Overall Study||62
10914844|NCT00129727|12081513|FG000|COMPLETED|Overall Study||57
10914845|NCT00129727|12081513|FG000|NOT COMPLETED|Overall Study||5
10914846|NCT00129740|12081517|FG000|STARTED|Overall Study||148
10914847|NCT00129740|12081517|FG000|COMPLETED|Overall Study||148
10914848|NCT00129740|12081517|FG000|NOT COMPLETED|Overall Study||0
10914849|NCT00129766|12081523|FG000|STARTED|Overall Study||3306
10914850|NCT00129766|12081524|FG001|STARTED|Overall Study||3329
10914851|NCT00129766|12081523|FG000|COMPLETED|Overall Study||3246
10914852|NCT00129766|12081524|FG001|COMPLETED|Overall Study||3270
10914853|NCT00129766|12081523|FG000|NOT COMPLETED|Overall Study||60
10914854|NCT00129766|12081524|FG001|NOT COMPLETED|Overall Study||59
10914855|NCT00129935|12081533|FG000|STARTED|Overall Study||669
10914856|NCT00129935|12081534|FG001|STARTED|Overall Study||715
10914857|NCT00129935|12081533|FG000|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633
10914858|NCT00129935|12081534|FG001|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623
10914859|NCT00129935|12081533|FG000|NOT COMPLETED|Overall Study||36
10914860|NCT00129935|12081534|FG001|NOT COMPLETED|Overall Study||92
10914861|NCT00129961|12081542|FG000|STARTED|Overall Study||39
10914862|NCT00129961|12081543|FG001|STARTED|Overall Study||47
10914863|NCT00129961|12081542|FG000|COMPLETED|Overall Study||20
10914864|NCT00129961|12081543|FG001|COMPLETED|Overall Study||24
10914865|NCT00129961|12081542|FG000|NOT COMPLETED|Overall Study||19
10914866|NCT00129961|12081543|FG001|NOT COMPLETED|Overall Study||23
10914867|NCT00129987|12081551|FG000|STARTED|1st Educational Session||287
10914868|NCT00129987|12081552|FG001|STARTED|1st Educational Session||280
10914869|NCT00129987|12081551|FG000|COMPLETED|1st Educational Session||146
10914870|NCT00129987|12081552|FG001|COMPLETED|1st Educational Session||171
10914871|NCT00129987|12081551|FG000|NOT COMPLETED|1st Educational Session||141
10914872|NCT00129987|12081552|FG001|NOT COMPLETED|1st Educational Session||109
10914873|NCT00129987|12081551|FG000|STARTED|1 Year||146
10914874|NCT00129987|12081552|FG001|STARTED|1 Year||171
10914875|NCT00129987|12081551|FG000|COMPLETED|1 Year||114
10914876|NCT00129987|12081552|FG001|COMPLETED|1 Year||150
10914877|NCT00129987|12081551|FG000|NOT COMPLETED|1 Year||32
10914878|NCT00129987|12081552|FG001|NOT COMPLETED|1 Year||21
10914879|NCT00130039|12081560|FG000|STARTED|Overall Study||232
10914880|NCT00130039|12081561|FG001|STARTED|Overall Study||225
10914881|NCT00130039|12081560|FG000|COMPLETED|Overall Study|full analysis set|202
10914882|NCT00130039|12081561|FG001|COMPLETED|Overall Study|full analysis set|207
10914883|NCT00130039|12081560|FG000|NOT COMPLETED|Overall Study||30
10914884|NCT00130039|12081561|FG001|NOT COMPLETED|Overall Study||18
10914885|NCT00130117|12081569|FG000|STARTED|Overall Study||11
10914886|NCT00130117|12081570|FG001|STARTED|Overall Study||9
10914887|NCT00130117|12081569|FG000|COMPLETED|Overall Study||7
10914888|NCT00130117|12081570|FG001|COMPLETED|Overall Study||6
10914889|NCT00130117|12081569|FG000|NOT COMPLETED|Overall Study||4
10914890|NCT00130117|12081570|FG001|NOT COMPLETED|Overall Study||3
10914891|NCT00130208|12081579|FG000|STARTED|Maintenance Period (26 Weeks)||524
10914892|NCT00130208|12081580|FG001|STARTED|Maintenance Period (26 Weeks)||532
10914893|NCT00130208|12081579|FG000|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
10914894|NCT00130208|12081580|FG001|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
10914895|NCT00130208|12081579|FG000|COMPLETED|Maintenance Period (26 Weeks)||500
10914896|NCT00130208|12081580|FG001|COMPLETED|Maintenance Period (26 Weeks)||502
10914897|NCT00130208|12081579|FG000|NOT COMPLETED|Maintenance Period (26 Weeks)||24
10914898|NCT00130208|12081580|FG001|NOT COMPLETED|Maintenance Period (26 Weeks)||30
10914899|NCT00130208|12081579|FG000|STARTED|Washout Period (8 Weeks)||500
10914900|NCT00130208|12081580|FG001|STARTED|Washout Period (8 Weeks)||502
10914901|NCT00130208|12081579|FG000|COMPLETED|Washout Period (8 Weeks)||494
10914902|NCT00130208|12081580|FG001|COMPLETED|Washout Period (8 Weeks)||490
10914903|NCT00130208|12081579|FG000|NOT COMPLETED|Washout Period (8 Weeks)||6
10914904|NCT00130208|12081580|FG001|NOT COMPLETED|Washout Period (8 Weeks)||12
10914905|NCT00130247|12081588|FG000|STARTED|Overall Study||196
10914906|NCT00130247|12081589|FG001|STARTED|Overall Study||198
10914907|NCT00130247|12081588|FG000|COMPLETED|Overall Study||194
10914908|NCT00130247|12081589|FG001|COMPLETED|Overall Study||194
10914909|NCT00130247|12081588|FG000|NOT COMPLETED|Overall Study||2
10914910|NCT00130247|12081589|FG001|NOT COMPLETED|Overall Study||4
10914911|NCT00130286|12081599|FG000|STARTED|Overall Study||22
10914912|NCT00130286|12081600|FG001|STARTED|Overall Study||19
10914913|NCT00130286|12081601|FG002|STARTED|Overall Study||17
10914914|NCT00130286|12081602|FG003|STARTED|Overall Study||19
10914915|NCT00130286|12081599|FG000|COMPLETED|Overall Study||22
10914916|NCT00130286|12081600|FG001|COMPLETED|Overall Study||16
10914917|NCT00130286|12081601|FG002|COMPLETED|Overall Study||13
10914918|NCT00130286|12081602|FG003|COMPLETED|Overall Study||17
10914919|NCT00130286|12081599|FG000|NOT COMPLETED|Overall Study||0
10914920|NCT00130286|12081600|FG001|NOT COMPLETED|Overall Study||3
10914921|NCT00130286|12081601|FG002|NOT COMPLETED|Overall Study||4
10914922|NCT00130286|12081602|FG003|NOT COMPLETED|Overall Study||2
10914923|NCT00130520|12081612|FG000|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
10914924|NCT00130520|12081612|FG000|Completion of at Least One Cycle|Overall Study||39
10914925|NCT00130520|12081612|FG000|COMPLETED|Overall Study||1
10914926|NCT00130520|12081612|FG000|NOT COMPLETED|Overall Study||39
10914927|NCT00130533|12081618|FG000|STARTED|Overall Study||448
10914928|NCT00130533|12081619|FG001|STARTED|Overall Study||428
10914929|NCT00130533|12081618|FG000|COMPLETED|Overall Study||337
10914930|NCT00130533|12081619|FG001|COMPLETED|Overall Study||398
10914931|NCT00130533|12081618|FG000|NOT COMPLETED|Overall Study||111
10914932|NCT00130533|12081619|FG001|NOT COMPLETED|Overall Study||30
10914933|NCT00130637|12081625|FG000|STARTED|Overall Study||6
10914934|NCT00130637|12081625|FG000|COMPLETED|Overall Study||3
10914935|NCT00130637|12081625|FG000|NOT COMPLETED|Overall Study||3
10914936|NCT00130689|12081629|FG000|STARTED|Overall Study||43
10914937|NCT00130689|12081629|FG000|Eligible|Overall Study||37
10914938|NCT00130689|12081629|FG000|Treated|Overall Study||35
10914939|NCT00130689|12081629|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
10914940|NCT00130689|12081629|FG000|NOT COMPLETED|Overall Study||43
10914941|NCT00130728|12081635|FG000|STARTED|Overall Study||319
10914942|NCT00130728|12081636|FG001|STARTED|Overall Study||317
10914943|NCT00130728|12081635|FG000|Received Study Drug (Safety Population)|Overall Study||313
10914944|NCT00130728|12081636|FG001|Received Study Drug (Safety Population)|Overall Study||313
10914945|NCT00130728|12081635|FG000|COMPLETED|Overall Study||57
10914946|NCT00130728|12081636|FG001|COMPLETED|Overall Study||57
10914947|NCT00130728|12081635|FG000|NOT COMPLETED|Overall Study||262
10914948|NCT00130728|12081636|FG001|NOT COMPLETED|Overall Study||260
10914949|NCT00130780|12081644|FG000|STARTED|Overall Study||51
10914950|NCT00130780|12081645|FG001|STARTED|Overall Study||20
10914951|NCT00130780|12081644|FG000|COMPLETED|Overall Study||51
10914952|NCT00130780|12081645|FG001|COMPLETED|Overall Study||20
10914953|NCT00130780|12081644|FG000|NOT COMPLETED|Overall Study||0
10914954|NCT00130780|12081645|FG001|NOT COMPLETED|Overall Study||0
10914955|NCT00130793|12081653|FG000|STARTED|Overall Study||183
10914956|NCT00130793|12081654|FG001|STARTED|Overall Study||185
10914957|NCT00130793|12081653|FG000|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
10914958|NCT00130793|12081654|FG001|Vaccinated|Overall Study||185
10914959|NCT00130793|12081653|FG000|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
10914960|NCT00130793|12081654|FG001|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
10914961|NCT00130793|12081653|FG000|NOT COMPLETED|Overall Study||3
10914962|NCT00130793|12081654|FG001|NOT COMPLETED|Overall Study||4
10914963|NCT00130832|12081663|FG000|STARTED|Overall Study||372
10914964|NCT00130832|12081664|FG001|STARTED|Overall Study||363
10914965|NCT00130832|12081663|FG000|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
10914966|NCT00130832|12081664|FG001|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
10914967|NCT00130832|12081663|FG000|NOT COMPLETED|Overall Study||16
10914968|NCT00130832|12081664|FG001|NOT COMPLETED|Overall Study||17
10914969|NCT00130923|12081672|FG000|STARTED|Overall Study||49
10914970|NCT00130923|12081673|FG001|STARTED|Overall Study||46
10914971|NCT00130923|12081672|FG000|COMPLETED|Overall Study||36
10914972|NCT00130923|12081673|FG001|COMPLETED|Overall Study||32
10914973|NCT00130923|12081672|FG000|NOT COMPLETED|Overall Study||13
10914974|NCT00130923|12081673|FG001|NOT COMPLETED|Overall Study||14
10914975|NCT00131248|12081680|FG000|STARTED|Intervention 1 (3-day Course)||9
10914976|NCT00131248|12081681|FG001|STARTED|Intervention 1 (3-day Course)||9
10914977|NCT00131248|12081680|FG000|COMPLETED|Intervention 1 (3-day Course)||8
10914978|NCT00131248|12081681|FG001|COMPLETED|Intervention 1 (3-day Course)||9
10914979|NCT00131248|12081680|FG000|NOT COMPLETED|Intervention 1 (3-day Course)||1
10914980|NCT00131248|12081681|FG001|NOT COMPLETED|Intervention 1 (3-day Course)||0
10914981|NCT00131248|12081680|FG000|STARTED|Washout (24 Hour)||8
10914982|NCT00131248|12081681|FG001|STARTED|Washout (24 Hour)||9
10914983|NCT00131248|12081680|FG000|COMPLETED|Washout (24 Hour)||8
10914984|NCT00131248|12081681|FG001|COMPLETED|Washout (24 Hour)||9
10914985|NCT00131248|12081680|FG000|NOT COMPLETED|Washout (24 Hour)||0
10914986|NCT00131248|12081681|FG001|NOT COMPLETED|Washout (24 Hour)||0
10914987|NCT00131248|12081680|FG000|STARTED|Intervention 2 (7-day Course)||8
10914988|NCT00131248|12081681|FG001|STARTED|Intervention 2 (7-day Course)||9
10914989|NCT00131248|12081680|FG000|COMPLETED|Intervention 2 (7-day Course)||8
10914990|NCT00131248|12081681|FG001|COMPLETED|Intervention 2 (7-day Course)||9
10914991|NCT00131248|12081680|FG000|NOT COMPLETED|Intervention 2 (7-day Course)||0
10914992|NCT00131248|12081681|FG001|NOT COMPLETED|Intervention 2 (7-day Course)||0
10914993|NCT00131248|12081680|FG000|STARTED|Washout 2 (24 Hours)||8
10914994|NCT00131248|12081681|FG001|STARTED|Washout 2 (24 Hours)||9
10914995|NCT00131248|12081680|FG000|COMPLETED|Washout 2 (24 Hours)||8
10914996|NCT00131248|12081681|FG001|COMPLETED|Washout 2 (24 Hours)||9
10914997|NCT00131248|12081680|FG000|NOT COMPLETED|Washout 2 (24 Hours)||0
10914998|NCT00131248|12081681|FG001|NOT COMPLETED|Washout 2 (24 Hours)||0
10914999|NCT00131248|12081680|FG000|STARTED|Intervention 3 (4-day Course)||8
10915000|NCT00131248|12081681|FG001|STARTED|Intervention 3 (4-day Course)||9
10915001|NCT00131248|12081680|FG000|COMPLETED|Intervention 3 (4-day Course)||8
10915002|NCT00131248|12081681|FG001|COMPLETED|Intervention 3 (4-day Course)||9
10915003|NCT00131248|12081680|FG000|NOT COMPLETED|Intervention 3 (4-day Course)||0
10915004|NCT00131248|12081681|FG001|NOT COMPLETED|Intervention 3 (4-day Course)||0
10915005|NCT00131352|12081689|FG000|STARTED|Initial Treatment Period|Safety population|123
10915006|NCT00131352|12081690|FG001|STARTED|Initial Treatment Period|Safety population|130
10915007|NCT00131352|12081689|FG000|Intent to Treat Population|Initial Treatment Period||124
10915008|NCT00131352|12081690|FG001|Intent to Treat Population|Initial Treatment Period||129
10915009|NCT00131352|12081689|FG000|COMPLETED|Initial Treatment Period||114
10915010|NCT00131352|12081690|FG001|COMPLETED|Initial Treatment Period||118
10915011|NCT00131352|12081689|FG000|NOT COMPLETED|Initial Treatment Period||9
10915012|NCT00131352|12081690|FG001|NOT COMPLETED|Initial Treatment Period||12
10915013|NCT00131352|12081689|FG000|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
10915014|NCT00131352|12081690|FG001|STARTED|Repeat Treatment Period||0
10915015|NCT00131352|12081689|FG000|COMPLETED|Repeat Treatment Period||158
10915016|NCT00131352|12081690|FG001|COMPLETED|Repeat Treatment Period||0
10915017|NCT00131352|12081689|FG000|NOT COMPLETED|Repeat Treatment Period||2
10915018|NCT00131352|12081690|FG001|NOT COMPLETED|Repeat Treatment Period||0
10915019|NCT00131365|12081698|FG000|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9
10915020|NCT00131365|12081698|FG000|COMPLETED|Overall Study||5
10915021|NCT00131365|12081698|FG000|NOT COMPLETED|Overall Study||4
10915022|NCT00131378|12081707|FG000|STARTED|Overall Study||40
10915023|NCT00131378|12081708|FG001|STARTED|Overall Study||40
10915024|NCT00131378|12081709|FG002|STARTED|Overall Study||32
10915025|NCT00131378|12081710|FG003|STARTED|Overall Study||30
10915026|NCT00131378|12081707|FG000|COMPLETED|Overall Study||29
10915027|NCT00131378|12081708|FG001|COMPLETED|Overall Study||22
10915028|NCT00131378|12081709|FG002|COMPLETED|Overall Study||22
10915029|NCT00131378|12081710|FG003|COMPLETED|Overall Study||21
10915030|NCT00131378|12081707|FG000|NOT COMPLETED|Overall Study||11
10915031|NCT00131378|12081708|FG001|NOT COMPLETED|Overall Study||18
10915032|NCT00131378|12081709|FG002|NOT COMPLETED|Overall Study||10
10915033|NCT00131378|12081710|FG003|NOT COMPLETED|Overall Study||9
10915034|NCT00131456|12081724|FG000|STARTED|Overall Study||52
10915035|NCT00131456|12081725|FG001|STARTED|Overall Study||51
10915036|NCT00131456|12081724|FG000|COMPLETED|Overall Study||33
10915037|NCT00131456|12081725|FG001|COMPLETED|Overall Study||31
10915038|NCT00131456|12081724|FG000|NOT COMPLETED|Overall Study||19
10915039|NCT00131456|12081725|FG001|NOT COMPLETED|Overall Study||20
10915040|NCT00131469|12081733|FG000|STARTED|Overall Study||38
10915041|NCT00131469|12081734|FG001|STARTED|Overall Study||40
10915042|NCT00131469|12081733|FG000|COMPLETED|Overall Study||29
10915043|NCT00131469|12081734|FG001|COMPLETED|Overall Study||27
10915044|NCT00131469|12081733|FG000|NOT COMPLETED|Overall Study||9
10915045|NCT00131469|12081734|FG001|NOT COMPLETED|Overall Study||13
10915046|NCT00131508|12081742|FG000|STARTED|Overall Study||12
10915047|NCT00131508|12081743|FG001|STARTED|Overall Study||13
10915048|NCT00131508|12081742|FG000|COMPLETED|Overall Study||9
10915049|NCT00131508|12081743|FG001|COMPLETED|Overall Study||5
10915050|NCT00131508|12081742|FG000|NOT COMPLETED|Overall Study||3
10915051|NCT00131508|12081743|FG001|NOT COMPLETED|Overall Study||8
10915052|NCT00131573|12081751|FG000|STARTED|Overall Study||46
10915053|NCT00131573|12081752|FG001|STARTED|Overall Study||39
10915054|NCT00131573|12081751|FG000|COMPLETED|Overall Study||13
10915055|NCT00131573|12081752|FG001|COMPLETED|Overall Study||13
10915056|NCT00131573|12081751|FG000|NOT COMPLETED|Overall Study||33
10915057|NCT00131573|12081752|FG001|NOT COMPLETED|Overall Study||26
10915058|NCT00131664|12081762|FG000|STARTED|First Period (First 6 Months)||136
10915059|NCT00131664|12081763|FG001|STARTED|First Period (First 6 Months)||135
10915060|NCT00131664|12081764|FG002|STARTED|First Period (First 6 Months)||120
10915061|NCT00131664|12081765|FG003|STARTED|First Period (First 6 Months)||0
10915062|NCT00131664|12081766|FG004|STARTED|First Period (First 6 Months)||0
10915063|NCT00131664|12081767|FG005|STARTED|First Period (First 6 Months)||0
10915064|NCT00131664|12081762|FG000|COMPLETED|First Period (First 6 Months)||111
10915065|NCT00131664|12081763|FG001|COMPLETED|First Period (First 6 Months)||117
10915066|NCT00131664|12081764|FG002|COMPLETED|First Period (First 6 Months)||104
10915067|NCT00131664|12081765|FG003|COMPLETED|First Period (First 6 Months)||0
10915068|NCT00131664|12081766|FG004|COMPLETED|First Period (First 6 Months)||0
10915069|NCT00131664|12081767|FG005|COMPLETED|First Period (First 6 Months)||0
10915070|NCT00131664|12081762|FG000|NOT COMPLETED|First Period (First 6 Months)||25
10915071|NCT00131664|12081763|FG001|NOT COMPLETED|First Period (First 6 Months)||18
10915072|NCT00131664|12081764|FG002|NOT COMPLETED|First Period (First 6 Months)||16
10915073|NCT00131664|12081765|FG003|NOT COMPLETED|First Period (First 6 Months)||0
10915074|NCT00131664|12081766|FG004|NOT COMPLETED|First Period (First 6 Months)||0
10915075|NCT00131664|12081767|FG005|NOT COMPLETED|First Period (First 6 Months)||0
10915076|NCT00131664|12081762|FG000|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
10915077|NCT00131664|12081763|FG001|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
10915078|NCT00131664|12081764|FG002|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
10915079|NCT00131664|12081765|FG003|STARTED|Second Period (Additional Drug Added)||21
10915080|NCT00131664|12081766|FG004|STARTED|Second Period (Additional Drug Added)||16
10915081|NCT00131664|12081767|FG005|STARTED|Second Period (Additional Drug Added)||25
10915082|NCT00131664|12081762|FG000|COMPLETED|Second Period (Additional Drug Added)||81
10915083|NCT00131664|12081763|FG001|COMPLETED|Second Period (Additional Drug Added)||97
10915084|NCT00131664|12081764|FG002|COMPLETED|Second Period (Additional Drug Added)||76
10915085|NCT00131664|12081765|FG003|COMPLETED|Second Period (Additional Drug Added)||19
10915086|NCT00131664|12081766|FG004|COMPLETED|Second Period (Additional Drug Added)||15
10915087|NCT00131664|12081767|FG005|COMPLETED|Second Period (Additional Drug Added)||22
10915088|NCT00131664|12081762|FG000|NOT COMPLETED|Second Period (Additional Drug Added)||9
10915089|NCT00131664|12081763|FG001|NOT COMPLETED|Second Period (Additional Drug Added)||4
10915090|NCT00131664|12081764|FG002|NOT COMPLETED|Second Period (Additional Drug Added)||3
10915091|NCT00131664|12081765|FG003|NOT COMPLETED|Second Period (Additional Drug Added)||2
10915092|NCT00131664|12081766|FG004|NOT COMPLETED|Second Period (Additional Drug Added)||1
10915093|NCT00131664|12081767|FG005|NOT COMPLETED|Second Period (Additional Drug Added)||3
10915094|NCT00131677|12081780|FG000|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
10915095|NCT00131677|12081781|FG001|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
10915096|NCT00131677|12081780|FG000|COMPLETED|Overall Study||171
10915097|NCT00131677|12081781|FG001|COMPLETED|Overall Study||160
10915098|NCT00131677|12081780|FG000|NOT COMPLETED|Overall Study||30
10915099|NCT00131677|12081781|FG001|NOT COMPLETED|Overall Study||39
10915100|NCT00131885|12081796|FG000|STARTED|Time 1: First Intervention||9
10915101|NCT00131885|12081797|FG001|STARTED|Time 1: First Intervention||9
10915102|NCT00131885|12081798|FG002|STARTED|Time 1: First Intervention||9
10915103|NCT00131885|12081799|FG003|STARTED|Time 1: First Intervention||9
10915104|NCT00131885|12081796|FG000|COMPLETED|Time 1: First Intervention||9
10915105|NCT00131885|12081797|FG001|COMPLETED|Time 1: First Intervention||9
10915106|NCT00131885|12081798|FG002|COMPLETED|Time 1: First Intervention||9
10915107|NCT00131885|12081799|FG003|COMPLETED|Time 1: First Intervention||9
10915108|NCT00131885|12081796|FG000|NOT COMPLETED|Time 1: First Intervention||0
10915109|NCT00131885|12081797|FG001|NOT COMPLETED|Time 1: First Intervention||0
10915110|NCT00131885|12081798|FG002|NOT COMPLETED|Time 1: First Intervention||0
10915111|NCT00131885|12081799|FG003|NOT COMPLETED|Time 1: First Intervention||0
10915112|NCT00131885|12081796|FG000|STARTED|Time 2: Second Intervention||9
10915113|NCT00131885|12081797|FG001|STARTED|Time 2: Second Intervention||9
10915114|NCT00131885|12081798|FG002|STARTED|Time 2: Second Intervention||9
10915115|NCT00131885|12081799|FG003|STARTED|Time 2: Second Intervention||9
10915116|NCT00131885|12081796|FG000|COMPLETED|Time 2: Second Intervention||9
10915117|NCT00131885|12081797|FG001|COMPLETED|Time 2: Second Intervention||9
10915118|NCT00131885|12081798|FG002|COMPLETED|Time 2: Second Intervention||9
10915119|NCT00131885|12081799|FG003|COMPLETED|Time 2: Second Intervention||9
10915120|NCT00131885|12081796|FG000|NOT COMPLETED|Time 2: Second Intervention||0
10915121|NCT00131885|12081797|FG001|NOT COMPLETED|Time 2: Second Intervention||0
10915122|NCT00131885|12081798|FG002|NOT COMPLETED|Time 2: Second Intervention||0
10915123|NCT00131885|12081799|FG003|NOT COMPLETED|Time 2: Second Intervention||0
10915124|NCT00131911|12081811|FG000|STARTED|Overall Study||51
10915125|NCT00131911|12081812|FG001|STARTED|Overall Study||42
10915126|NCT00131911|12081811|FG000|COMPLETED|Overall Study||50
10915127|NCT00131911|12081812|FG001|COMPLETED|Overall Study||42
10915128|NCT00131911|12081811|FG000|NOT COMPLETED|Overall Study||1
10915129|NCT00131911|12081812|FG001|NOT COMPLETED|Overall Study||0
10915130|NCT00131937|12081817|FG000|STARTED|Overall Study||14
10915131|NCT00131937|12081817|FG000|COMPLETED|Overall Study||0
10915132|NCT00131937|12081817|FG000|NOT COMPLETED|Overall Study||14
10915133|NCT00132002|12081821|FG000|STARTED|Overall Study||14
10915134|NCT00132002|12081821|FG000|COMPLETED|Overall Study||14
10915135|NCT00132002|12081821|FG000|NOT COMPLETED|Overall Study||0
10915136|NCT00132028|12081825|FG000|STARTED|Overall Study||27
10915137|NCT00132028|12081825|FG000|Eligible|Overall Study||25
10915138|NCT00132028|12081825|FG000|Eligible and Began Protocol Therapy|Overall Study||25
10915139|NCT00132028|12081825|FG000|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
10915140|NCT00132028|12081825|FG000|NOT COMPLETED|Overall Study||27
10915141|NCT00132041|12081829|FG000|STARTED|Baseline||51
10915142|NCT00132041|12081829|FG000|Eligible|Baseline||45
10915143|NCT00132041|12081829|FG000|COMPLETED|Baseline||45
10915144|NCT00132041|12081829|FG000|NOT COMPLETED|Baseline||6
10915145|NCT00132041|12081829|FG000|STARTED|3 Months Post Ablation||45
10915146|NCT00132041|12081829|FG000|COMPLETED|3 Months Post Ablation||42
10915147|NCT00132041|12081829|FG000|NOT COMPLETED|3 Months Post Ablation||3
10915148|NCT00132041|12081829|FG000|STARTED|6 Months Post Ablation||42
10915149|NCT00132041|12081829|FG000|COMPLETED|6 Months Post Ablation||32
10915150|NCT00132041|12081829|FG000|NOT COMPLETED|6 Months Post Ablation||10
10915151|NCT00132041|12081829|FG000|STARTED|9 Months Post Ablation||32
10915152|NCT00132041|12081829|FG000|COMPLETED|9 Months Post Ablation||30
10915153|NCT00132041|12081829|FG000|NOT COMPLETED|9 Months Post Ablation||2
10915154|NCT00132041|12081829|FG000|STARTED|12 Months Post Ablation||30
10915155|NCT00132041|12081829|FG000|COMPLETED|12 Months Post Ablation||26
10915156|NCT00132041|12081829|FG000|NOT COMPLETED|12 Months Post Ablation||4
10915157|NCT00132041|12081829|FG000|STARTED|15 Months Post Ablation||26
10915158|NCT00132041|12081829|FG000|COMPLETED|15 Months Post Ablation||18
10915159|NCT00132041|12081829|FG000|NOT COMPLETED|15 Months Post Ablation||8
10915160|NCT00132041|12081829|FG000|STARTED|18 Months Post Ablation||18
10915161|NCT00132041|12081829|FG000|COMPLETED|18 Months Post Ablation||12
10915162|NCT00132041|12081829|FG000|NOT COMPLETED|18 Months Post Ablation||6
10915163|NCT00132132|12081841|FG000|STARTED|Overall Study||15
10915164|NCT00132132|12081842|FG001|STARTED|Overall Study||15
10915165|NCT00132132|12081841|FG000|COMPLETED|Overall Study||8
10915166|NCT00132132|12081842|FG001|COMPLETED|Overall Study||13
10915167|NCT00132132|12081841|FG000|NOT COMPLETED|Overall Study||7
10915168|NCT00132132|12081842|FG001|NOT COMPLETED|Overall Study||2
10915169|NCT00132301|12081850|FG000|STARTED|Overall Study||141
10915170|NCT00132301|12081851|FG001|STARTED|Overall Study||157
10915171|NCT00132301|12081850|FG000|COMPLETED|Overall Study||121
10915172|NCT00132301|12081851|FG001|COMPLETED|Overall Study||144
10915173|NCT00132301|12081850|FG000|NOT COMPLETED|Overall Study||20
10915174|NCT00132301|12081851|FG001|NOT COMPLETED|Overall Study||13
10915175|NCT00132314|12081859|FG000|STARTED|Overall Study||190
10915176|NCT00132314|12081860|FG001|STARTED|Overall Study||192
10915177|NCT00132314|12081859|FG000|Received Treatment|Overall Study||188
10915178|NCT00132314|12081860|FG001|Received Treatment|Overall Study||185
10915179|NCT00132314|12081859|FG000|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
10915180|NCT00132314|12081860|FG001|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
10915181|NCT00132314|12081859|FG000|COMPLETED|Overall Study||117
10915182|NCT00132314|12081860|FG001|COMPLETED|Overall Study||120
10915183|NCT00132314|12081859|FG000|NOT COMPLETED|Overall Study||73
10915184|NCT00132314|12081860|FG001|NOT COMPLETED|Overall Study||72
10915185|NCT00132496|12081868|FG000|STARTED|Overall Study||54
10915186|NCT00132496|12081869|FG001|STARTED|Overall Study||57
10915187|NCT00132496|12081868|FG000|COMPLETED|Overall Study||52
10915188|NCT00132496|12081869|FG001|COMPLETED|Overall Study||55
10915189|NCT00132496|12081868|FG000|NOT COMPLETED|Overall Study||2
10915190|NCT00132496|12081869|FG001|NOT COMPLETED|Overall Study||2
10915191|NCT00132678|12081877|FG000|STARTED|Period II (Open-Label Oral Risperidone)||0
10915192|NCT00132678|12081878|FG001|STARTED|Period II (Open-Label Oral Risperidone)||0
10915193|NCT00132678|12081879|FG002|STARTED|Period II (Open-Label Oral Risperidone)||440
10915194|NCT00132678|12081877|FG000|COMPLETED|Period II (Open-Label Oral Risperidone)||0
10915195|NCT00132678|12081878|FG001|COMPLETED|Period II (Open-Label Oral Risperidone)||0
10915196|NCT00132678|12081879|FG002|COMPLETED|Period II (Open-Label Oral Risperidone)||382
10915197|NCT00132678|12081877|FG000|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
10915198|NCT00132678|12081878|FG001|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
10915199|NCT00132678|12081879|FG002|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
10915200|NCT00132678|12081877|FG000|STARTED|Period III (Open-Label Stabilization)||501
10915201|NCT00132678|12081878|FG001|STARTED|Period III (Open-Label Stabilization)||0
10915202|NCT00132678|12081879|FG002|STARTED|Period III (Open-Label Stabilization)||0
10915203|NCT00132678|12081877|FG000|COMPLETED|Period III (Open-Label Stabilization)||303
10915204|NCT00132678|12081878|FG001|COMPLETED|Period III (Open-Label Stabilization)||0
10915205|NCT00132678|12081879|FG002|COMPLETED|Period III (Open-Label Stabilization)||0
10915206|NCT00132678|12081877|FG000|NOT COMPLETED|Period III (Open-Label Stabilization)||198
10915207|NCT00132678|12081878|FG001|NOT COMPLETED|Period III (Open-Label Stabilization)||0
10915208|NCT00132678|12081879|FG002|NOT COMPLETED|Period III (Open-Label Stabilization)||0
10915209|NCT00132678|12081877|FG000|STARTED|Period IV (Double-Blind Treatment)||154
10915210|NCT00132678|12081878|FG001|STARTED|Period IV (Double-Blind Treatment)||149
10915211|NCT00132678|12081879|FG002|STARTED|Period IV (Double-Blind Treatment)||0
10915212|NCT00132678|12081877|FG000|COMPLETED|Period IV (Double-Blind Treatment)||117
10915213|NCT00132678|12081878|FG001|COMPLETED|Period IV (Double-Blind Treatment)||109
10915214|NCT00132678|12081879|FG002|COMPLETED|Period IV (Double-Blind Treatment)||0
10915215|NCT00132678|12081877|FG000|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
10915216|NCT00132678|12081878|FG001|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
10915217|NCT00132678|12081879|FG002|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
10915218|NCT00132691|12081889|FG000|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
10915219|NCT00132691|12081890|FG001|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
10915220|NCT00132691|12081889|FG000|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
10915221|NCT00132691|12081890|FG001|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
10915222|NCT00132691|12081889|FG000|NOT COMPLETED|Overall Study||11
10915223|NCT00132691|12081890|FG001|NOT COMPLETED|Overall Study||12
10915224|NCT00132730|12081905|FG000|STARTED|Period I - Placebo Run-in (Base)||150
10915225|NCT00132730|12081906|FG001|STARTED|Period I - Placebo Run-in (Base)||148
10915226|NCT00132730|12081907|FG002|STARTED|Period I - Placebo Run-in (Base)||153
10915227|NCT00132730|12081908|FG003|STARTED|Period I - Placebo Run-in (Base)||153
10915228|NCT00132730|12081909|FG004|STARTED|Period I - Placebo Run-in (Base)||0
10915229|NCT00132730|12081910|FG005|STARTED|Period I - Placebo Run-in (Base)||0
10915230|NCT00132730|12081905|FG000|COMPLETED|Period I - Placebo Run-in (Base)||150
10915231|NCT00132730|12081906|FG001|COMPLETED|Period I - Placebo Run-in (Base)||148
10915232|NCT00132730|12081907|FG002|COMPLETED|Period I - Placebo Run-in (Base)||153
10915233|NCT00132730|12081908|FG003|COMPLETED|Period I - Placebo Run-in (Base)||153
10915234|NCT00132730|12081909|FG004|COMPLETED|Period I - Placebo Run-in (Base)||0
10915235|NCT00132730|12081910|FG005|COMPLETED|Period I - Placebo Run-in (Base)||0
10915236|NCT00132730|12081905|FG000|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10915237|NCT00132730|12081906|FG001|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10915238|NCT00132730|12081907|FG002|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10915239|NCT00132730|12081908|FG003|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10915240|NCT00132730|12081909|FG004|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10915241|NCT00132730|12081910|FG005|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
10915242|NCT00132730|12081905|FG000|STARTED|Period II - 12-week Treatment (Base)||150
10915243|NCT00132730|12081906|FG001|STARTED|Period II - 12-week Treatment (Base)||148
10915244|NCT00132730|12081907|FG002|STARTED|Period II - 12-week Treatment (Base)||153
10915245|NCT00132730|12081908|FG003|STARTED|Period II - 12-week Treatment (Base)||153
10915246|NCT00132730|12081909|FG004|STARTED|Period II - 12-week Treatment (Base)||0
10915247|NCT00132730|12081910|FG005|STARTED|Period II - 12-week Treatment (Base)||0
10915248|NCT00132730|12081905|FG000|COMPLETED|Period II - 12-week Treatment (Base)||127
10915249|NCT00132730|12081906|FG001|COMPLETED|Period II - 12-week Treatment (Base)||133
10915250|NCT00132730|12081907|FG002|COMPLETED|Period II - 12-week Treatment (Base)||135
10915251|NCT00132730|12081908|FG003|COMPLETED|Period II - 12-week Treatment (Base)||131
10915252|NCT00132730|12081909|FG004|COMPLETED|Period II - 12-week Treatment (Base)||0
10915253|NCT00132730|12081910|FG005|COMPLETED|Period II - 12-week Treatment (Base)||0
10915254|NCT00132730|12081905|FG000|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
10915255|NCT00132730|12081906|FG001|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
10915256|NCT00132730|12081907|FG002|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
10915257|NCT00132730|12081908|FG003|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
10915258|NCT00132730|12081909|FG004|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
10915259|NCT00132730|12081910|FG005|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
10915260|NCT00132730|12081905|FG000|STARTED|Period III - Blinded Extension (EXT1)||0
10915261|NCT00132730|12081906|FG001|STARTED|Period III - Blinded Extension (EXT1)||0
10915262|NCT00132730|12081907|FG002|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
10915263|NCT00132730|12081908|FG003|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
10915264|NCT00132730|12081909|FG004|STARTED|Period III - Blinded Extension (EXT1)||0
10915265|NCT00132730|12081910|FG005|STARTED|Period III - Blinded Extension (EXT1)||0
10915266|NCT00132730|12081905|FG000|COMPLETED|Period III - Blinded Extension (EXT1)||0
10915267|NCT00132730|12081906|FG001|COMPLETED|Period III - Blinded Extension (EXT1)||0
10915268|NCT00132730|12081907|FG002|COMPLETED|Period III - Blinded Extension (EXT1)||235
10915269|NCT00132730|12081908|FG003|COMPLETED|Period III - Blinded Extension (EXT1)||82
10915270|NCT00132730|12081909|FG004|COMPLETED|Period III - Blinded Extension (EXT1)||0
10915271|NCT00132730|12081910|FG005|COMPLETED|Period III - Blinded Extension (EXT1)||0
10915272|NCT00132730|12081905|FG000|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
10915273|NCT00132730|12081906|FG001|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
10915274|NCT00132730|12081907|FG002|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
10915275|NCT00132730|12081908|FG003|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
10915276|NCT00132730|12081909|FG004|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
10915277|NCT00132730|12081910|FG005|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
10915278|NCT00132730|12081905|FG000|STARTED|Period IV - Open-label Extension (EXT2)||0
10915279|NCT00132730|12081906|FG001|STARTED|Period IV - Open-label Extension (EXT2)||0
10915280|NCT00132730|12081907|FG002|STARTED|Period IV - Open-label Extension (EXT2)||0
10915281|NCT00132730|12081908|FG003|STARTED|Period IV - Open-label Extension (EXT2)||0
10915282|NCT00132730|12081909|FG004|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
10915283|NCT00132730|12081910|FG005|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
10915284|NCT00132730|12081905|FG000|COMPLETED|Period IV - Open-label Extension (EXT2)||0
10915285|NCT00132730|12081906|FG001|COMPLETED|Period IV - Open-label Extension (EXT2)||0
10915286|NCT00132730|12081907|FG002|COMPLETED|Period IV - Open-label Extension (EXT2)||0
10915287|NCT00132730|12081908|FG003|COMPLETED|Period IV - Open-label Extension (EXT2)||0
10915288|NCT00132730|12081909|FG004|COMPLETED|Period IV - Open-label Extension (EXT2)||8
10915289|NCT00132730|12081910|FG005|COMPLETED|Period IV - Open-label Extension (EXT2)||3
10915290|NCT00132730|12081905|FG000|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
10915291|NCT00132730|12081906|FG001|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
10915292|NCT00132730|12081907|FG002|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
10915293|NCT00132730|12081908|FG003|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
10915294|NCT00132730|12081909|FG004|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
10915295|NCT00132730|12081910|FG005|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
10915296|NCT00132730|12081905|FG000|STARTED|Period V - Open-label Extension (EXT2)||0
10915297|NCT00132730|12081906|FG001|STARTED|Period V - Open-label Extension (EXT2)||0
10915298|NCT00132730|12081907|FG002|STARTED|Period V - Open-label Extension (EXT2)||0
10915299|NCT00132730|12081908|FG003|STARTED|Period V - Open-label Extension (EXT2)||0
10915300|NCT00132730|12081909|FG004|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
10915301|NCT00132730|12081910|FG005|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
10915302|NCT00132730|12081905|FG000|COMPLETED|Period V - Open-label Extension (EXT2)||0
10915303|NCT00132730|12081906|FG001|COMPLETED|Period V - Open-label Extension (EXT2)||0
10915304|NCT00132730|12081907|FG002|COMPLETED|Period V - Open-label Extension (EXT2)||0
10915305|NCT00132730|12081908|FG003|COMPLETED|Period V - Open-label Extension (EXT2)||0
10915306|NCT00132730|12081909|FG004|COMPLETED|Period V - Open-label Extension (EXT2)||0
10915307|NCT00132730|12081910|FG005|COMPLETED|Period V - Open-label Extension (EXT2)||0
10915308|NCT00132730|12081905|FG000|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
10915309|NCT00132730|12081906|FG001|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
10915310|NCT00132730|12081907|FG002|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
10915311|NCT00132730|12081908|FG003|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
10915312|NCT00132730|12081909|FG004|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
10915313|NCT00132730|12081910|FG005|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
10915314|NCT00132769|12081926|FG000|STARTED|Overall Study||53
10915315|NCT00132769|12081927|FG001|STARTED|Overall Study||53
10915316|NCT00132769|12081926|FG000|COMPLETED|Overall Study||42
10915317|NCT00132769|12081927|FG001|COMPLETED|Overall Study||42
10915318|NCT00132769|12081926|FG000|NOT COMPLETED|Overall Study||11
10915319|NCT00132769|12081927|FG001|NOT COMPLETED|Overall Study||11
10915320|NCT00132808|12081936|FG000|STARTED|Stratum I||77
10915321|NCT00132808|12081937|FG001|STARTED|Stratum I||70
10915322|NCT00132808|12081938|FG002|STARTED|Stratum I||77
10915323|NCT00132808|12081936|FG000|COMPLETED|Stratum I||68
10915324|NCT00132808|12081937|FG001|COMPLETED|Stratum I||58
10915325|NCT00132808|12081938|FG002|COMPLETED|Stratum I||72
10915326|NCT00132808|12081936|FG000|NOT COMPLETED|Stratum I||9
10915327|NCT00132808|12081937|FG001|NOT COMPLETED|Stratum I||12
10915328|NCT00132808|12081938|FG002|NOT COMPLETED|Stratum I||5
10915329|NCT00132808|12081936|FG000|STARTED|Stratum II||121
10915330|NCT00132808|12081937|FG001|STARTED|Stratum II||111
10915331|NCT00132808|12081938|FG002|STARTED|Stratum II||125
10915332|NCT00132808|12081936|FG000|COMPLETED|Stratum II||113
10915333|NCT00132808|12081937|FG001|COMPLETED|Stratum II||96
10915334|NCT00132808|12081938|FG002|COMPLETED|Stratum II||116
10915335|NCT00132808|12081936|FG000|NOT COMPLETED|Stratum II||8
10915336|NCT00132808|12081937|FG001|NOT COMPLETED|Stratum II||15
10915337|NCT00132808|12081938|FG002|NOT COMPLETED|Stratum II||9
10915338|NCT00132873|12081946|FG000|STARTED|Overall Study||59
10915339|NCT00132873|12081946|FG000|COMPLETED|Overall Study||50
10915340|NCT00132873|12081946|FG000|NOT COMPLETED|Overall Study||9
10915341|NCT00132964|12081952|FG000|STARTED|Overall Study||54
10915342|NCT00132964|12081953|FG001|STARTED|Overall Study||57
10915343|NCT00132964|12081952|FG000|COMPLETED|Overall Study||50
10915344|NCT00132964|12081953|FG001|COMPLETED|Overall Study||54
10915345|NCT00132964|12081952|FG000|NOT COMPLETED|Overall Study||4
10915346|NCT00132964|12081953|FG001|NOT COMPLETED|Overall Study||3
10915347|NCT00133575|12081966|FG000|STARTED|Overall Study||10
10915348|NCT00133575|12081967|FG001|STARTED|Overall Study||10
10915349|NCT00133575|12081968|FG002|STARTED|Overall Study||10
10915350|NCT00133575|12081969|FG003|STARTED|Overall Study||10
10915351|NCT00133575|12081970|FG004|STARTED|Overall Study||10
10915352|NCT00133575|12081971|FG005|STARTED|Overall Study||10
10915353|NCT00133575|12081972|FG006|STARTED|Overall Study||12
10915354|NCT00133575|12081966|FG000|COMPLETED|Overall Study||10
10915355|NCT00133575|12081967|FG001|COMPLETED|Overall Study||10
10915356|NCT00133575|12081968|FG002|COMPLETED|Overall Study||8
10915357|NCT00133575|12081969|FG003|COMPLETED|Overall Study||9
10915358|NCT00133575|12081970|FG004|COMPLETED|Overall Study||6
10915359|NCT00133575|12081971|FG005|COMPLETED|Overall Study||9
10915360|NCT00133575|12081972|FG006|COMPLETED|Overall Study||9
10915361|NCT00133575|12081966|FG000|NOT COMPLETED|Overall Study||0
10915362|NCT00133575|12081967|FG001|NOT COMPLETED|Overall Study||0
10915363|NCT00133575|12081968|FG002|NOT COMPLETED|Overall Study||2
10915364|NCT00133575|12081969|FG003|NOT COMPLETED|Overall Study||1
10915365|NCT00133575|12081970|FG004|NOT COMPLETED|Overall Study||4
10915366|NCT00133575|12081971|FG005|NOT COMPLETED|Overall Study||1
10915367|NCT00133575|12081972|FG006|NOT COMPLETED|Overall Study||3
10915368|NCT00133705|12081990|FG000|STARTED|Overall Study||22
10915369|NCT00133705|12081991|FG001|STARTED|Overall Study||20
10915370|NCT00133705|12081990|FG000|COMPLETED|Overall Study||20
10915371|NCT00133705|12081991|FG001|COMPLETED|Overall Study||17
10915372|NCT00133705|12081990|FG000|NOT COMPLETED|Overall Study||2
10915373|NCT00133705|12081991|FG001|NOT COMPLETED|Overall Study||3
10915374|NCT00133809|12081997|FG000|STARTED|Overall Study||8
10915375|NCT00133809|12081997|FG000|COMPLETED|Overall Study||8
10915376|NCT00133809|12081997|FG000|NOT COMPLETED|Overall Study||0
10915377|NCT00133952|12082003|FG000|STARTED|Overall Study||157
10915378|NCT00133952|12082004|FG001|STARTED|Overall Study||152
10915379|NCT00133952|12082003|FG000|Received at Least One Dose of Study Drug|Overall Study||153
10915380|NCT00133952|12082004|FG001|Received at Least One Dose of Study Drug|Overall Study||149
10915381|NCT00133952|12082003|FG000|COMPLETED|Overall Study||115
10915382|NCT00133952|12082004|FG001|COMPLETED|Overall Study||124
10915383|NCT00133952|12082003|FG000|NOT COMPLETED|Overall Study||42
10915384|NCT00133952|12082004|FG001|NOT COMPLETED|Overall Study||28
10915385|NCT00133978|12082014|FG000|STARTED|Overall Study||303
10915386|NCT00133978|12082015|FG001|STARTED|Overall Study||308
10915387|NCT00133978|12082016|FG002|STARTED|Overall Study||310
10915388|NCT00133978|12082017|FG003|STARTED|Overall Study||302
10915389|NCT00133978|12082014|FG000|COMPLETED|Overall Study||301
10915390|NCT00133978|12082015|FG001|COMPLETED|Overall Study||307
10915391|NCT00133978|12082016|FG002|COMPLETED|Overall Study||310
10915392|NCT00133978|12082017|FG003|COMPLETED|Overall Study||300
10915393|NCT00133978|12082014|FG000|NOT COMPLETED|Overall Study||2
10915394|NCT00133978|12082015|FG001|NOT COMPLETED|Overall Study||1
10915395|NCT00133978|12082016|FG002|NOT COMPLETED|Overall Study||0
10915396|NCT00133978|12082017|FG003|NOT COMPLETED|Overall Study||2
10915397|NCT00133991|12082031|FG000|STARTED|Overall Study||21
10915398|NCT00133991|12082031|FG000|COMPLETED|Overall Study||17
10915399|NCT00133991|12082031|FG000|NOT COMPLETED|Overall Study||4
10915400|NCT00134004|12082035|FG000|STARTED|Overall Study||210
10915401|NCT00134004|12082035|FG000|COMPLETED|Overall Study||210
10915402|NCT00134004|12082035|FG000|NOT COMPLETED|Overall Study||0
10915403|NCT00134017|12082039|FG000|STARTED|Overall Study||142
10915404|NCT00134017|12082039|FG000|COMPLETED|Overall Study||142
10915405|NCT00134017|12082039|FG000|NOT COMPLETED|Overall Study||0
10915406|NCT00134043|12082045|FG000|STARTED|Overall Study||16
10915407|NCT00134043|12082046|FG001|STARTED|Overall Study||3
10915408|NCT00134043|12082045|FG000|COMPLETED|Overall Study||16
10915409|NCT00134043|12082046|FG001|COMPLETED|Overall Study||3
10915410|NCT00134043|12082045|FG000|NOT COMPLETED|Overall Study||0
10915411|NCT00134043|12082046|FG001|NOT COMPLETED|Overall Study||0
10915412|NCT00134056|12082053|FG000|STARTED|Randomization||518
10915413|NCT00134056|12082054|FG001|STARTED|Randomization||520
10915414|NCT00134056|12082053|FG000|COMPLETED|Randomization||496
10915415|NCT00134056|12082054|FG001|COMPLETED|Randomization||500
10915416|NCT00134056|12082053|FG000|NOT COMPLETED|Randomization||22
10915417|NCT00134056|12082054|FG001|NOT COMPLETED|Randomization||20
10915418|NCT00134056|12082053|FG000|STARTED|Eligible for Protocol Assigned Treatment||496
10915419|NCT00134056|12082054|FG001|STARTED|Eligible for Protocol Assigned Treatment||500
10915420|NCT00134056|12082053|FG000|COMPLETED|Eligible for Protocol Assigned Treatment||169
10915421|NCT00134056|12082054|FG001|COMPLETED|Eligible for Protocol Assigned Treatment||185
10915422|NCT00134056|12082053|FG000|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
10915423|NCT00134056|12082054|FG001|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
10915424|NCT00134082|12082063|FG000|STARTED|Overall Study||30
10915425|NCT00134082|12082063|FG000|COMPLETED|Overall Study||27
10915426|NCT00134082|12082063|FG000|NOT COMPLETED|Overall Study||3
10915427|NCT00134381|12082067|FG000|STARTED|Overall Study||1
10915428|NCT00134381|12082068|FG001|STARTED|Overall Study||2
10915429|NCT00134381|12082069|FG002|STARTED|Overall Study||1
10915430|NCT00134381|12082070|FG003|STARTED|Overall Study||2
10915431|NCT00134381|12082071|FG004|STARTED|Overall Study||31
10915432|NCT00134381|12082072|FG005|STARTED|Overall Study||31
10915433|NCT00134381|12082067|FG000|COMPLETED|Overall Study||1
10915434|NCT00134381|12082068|FG001|COMPLETED|Overall Study||2
10915435|NCT00134381|12082069|FG002|COMPLETED|Overall Study||1
10915436|NCT00134381|12082070|FG003|COMPLETED|Overall Study||2
10915437|NCT00134381|12082071|FG004|COMPLETED|Overall Study||31
10915438|NCT00134381|12082072|FG005|COMPLETED|Overall Study||29
10915439|NCT00134381|12082067|FG000|NOT COMPLETED|Overall Study||0
10915440|NCT00134381|12082068|FG001|NOT COMPLETED|Overall Study||0
10915441|NCT00134381|12082069|FG002|NOT COMPLETED|Overall Study||0
10915442|NCT00134381|12082070|FG003|NOT COMPLETED|Overall Study||0
10915443|NCT00134381|12082071|FG004|NOT COMPLETED|Overall Study||0
10915444|NCT00134381|12082072|FG005|NOT COMPLETED|Overall Study||2
10915445|NCT00134563|12082092|FG000|STARTED|Overall Study|Randomized|363
10915446|NCT00134563|12082093|FG001|STARTED|Overall Study|Randomized|366
10915447|NCT00134563|12082094|FG002|STARTED|Overall Study|Randomized|359
10915448|NCT00134563|12082092|FG000|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
10915449|NCT00134563|12082093|FG001|Treated|Overall Study||365
10915450|NCT00134563|12082094|FG002|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
10915451|NCT00134563|12082092|FG000|COMPLETED|Overall Study|completed treatment period|259
10915452|NCT00134563|12082093|FG001|COMPLETED|Overall Study|completed treatment period|274
10915453|NCT00134563|12082094|FG002|COMPLETED|Overall Study|completed treatment period|263
10915454|NCT00134563|12082092|FG000|NOT COMPLETED|Overall Study||104
10915455|NCT00134563|12082093|FG001|NOT COMPLETED|Overall Study||92
10915456|NCT00134563|12082094|FG002|NOT COMPLETED|Overall Study||96
10915457|NCT00134719|12082105|FG000|STARTED|Primary Vaccination Phase||661
10915458|NCT00134719|12082106|FG001|STARTED|Primary Vaccination Phase||221
10915459|NCT00134719|12082107|FG002|STARTED|Primary Vaccination Phase||221
10915460|NCT00134719|12082105|FG000|COMPLETED|Primary Vaccination Phase||647
10915461|NCT00134719|12082106|FG001|COMPLETED|Primary Vaccination Phase||215
10915462|NCT00134719|12082107|FG002|COMPLETED|Primary Vaccination Phase||216
10915463|NCT00134719|12082105|FG000|NOT COMPLETED|Primary Vaccination Phase||14
10915464|NCT00134719|12082106|FG001|NOT COMPLETED|Primary Vaccination Phase||6
10915465|NCT00134719|12082107|FG002|NOT COMPLETED|Primary Vaccination Phase||5
10915466|NCT00134719|12082105|FG000|STARTED|Fourth Dose Vaccination Phase||625
10915467|NCT00134719|12082106|FG001|STARTED|Fourth Dose Vaccination Phase||206
10915468|NCT00134719|12082107|FG002|STARTED|Fourth Dose Vaccination Phase||204
10915469|NCT00134719|12082105|FG000|COMPLETED|Fourth Dose Vaccination Phase||623
10915470|NCT00134719|12082106|FG001|COMPLETED|Fourth Dose Vaccination Phase||203
10915471|NCT00134719|12082107|FG002|COMPLETED|Fourth Dose Vaccination Phase||203
10915472|NCT00134719|12082105|FG000|NOT COMPLETED|Fourth Dose Vaccination Phase||2
10915473|NCT00134719|12082106|FG001|NOT COMPLETED|Fourth Dose Vaccination Phase||3
10915474|NCT00134719|12082107|FG002|NOT COMPLETED|Fourth Dose Vaccination Phase||1
10915475|NCT00134784|12082119|FG000|STARTED|Overall Study||29
10915476|NCT00134784|12082120|FG001|STARTED|Overall Study||38
10915477|NCT00134784|12082121|FG002|STARTED|Overall Study||37
10915478|NCT00134784|12082122|FG003|STARTED|Overall Study||38
10915479|NCT00134784|12082119|FG000|COMPLETED|Overall Study||27
10915480|NCT00134784|12082120|FG001|COMPLETED|Overall Study||36
10915481|NCT00134784|12082121|FG002|COMPLETED|Overall Study||35
10915482|NCT00134784|12082122|FG003|COMPLETED|Overall Study||37
10915483|NCT00134784|12082119|FG000|NOT COMPLETED|Overall Study||2
10915484|NCT00134784|12082120|FG001|NOT COMPLETED|Overall Study||2
10915485|NCT00134784|12082121|FG002|NOT COMPLETED|Overall Study||2
10915486|NCT00134784|12082122|FG003|NOT COMPLETED|Overall Study||1
10915487|NCT00134901|12082131|FG000|STARTED|Overall Study||39
10915488|NCT00134901|12082132|FG001|STARTED|Overall Study||42
10915489|NCT00134901|12082131|FG000|COMPLETED|Overall Study||22
10915490|NCT00134901|12082132|FG001|COMPLETED|Overall Study||27
10915491|NCT00134901|12082131|FG000|NOT COMPLETED|Overall Study||17
10915492|NCT00134901|12082132|FG001|NOT COMPLETED|Overall Study||15
10915493|NCT00135226|12082144|FG000|STARTED|Overall Study||3870
10915494|NCT00135226|12082145|FG001|STARTED|Overall Study||3870
10915495|NCT00135226|12082146|FG002|STARTED|Overall Study||3870
10915496|NCT00135226|12082147|FG003|STARTED|Overall Study||3870
10915497|NCT00135226|12082144|FG000|COMPLETED|Overall Study||3836
10915498|NCT00135226|12082145|FG001|COMPLETED|Overall Study||3835
10915499|NCT00135226|12082146|FG002|COMPLETED|Overall Study||3836
10915500|NCT00135226|12082147|FG003|COMPLETED|Overall Study||3834
10915501|NCT00135226|12082144|FG000|NOT COMPLETED|Overall Study||34
10915502|NCT00135226|12082145|FG001|NOT COMPLETED|Overall Study||35
10915503|NCT00135226|12082146|FG002|NOT COMPLETED|Overall Study||34
10915504|NCT00135226|12082147|FG003|NOT COMPLETED|Overall Study||36
10915505|NCT00135330|12082162|FG000|STARTED|Overall Study||45
10915506|NCT00135330|12082163|FG001|STARTED|Overall Study||47
10915507|NCT00135330|12082164|FG002|STARTED|Overall Study||45
10915508|NCT00135330|12082162|FG000|COMPLETED|Overall Study||33
10915509|NCT00135330|12082163|FG001|COMPLETED|Overall Study||34
10915510|NCT00135330|12082164|FG002|COMPLETED|Overall Study||34
10915511|NCT00135330|12082162|FG000|NOT COMPLETED|Overall Study||12
10915512|NCT00135330|12082163|FG001|NOT COMPLETED|Overall Study||13
10915513|NCT00135330|12082164|FG002|NOT COMPLETED|Overall Study||11
10915514|NCT00135356|12082174|FG000|STARTED|Overall Study|Number randomized and treated|131
10915515|NCT00135356|12082175|FG001|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
10915516|NCT00135356|12082174|FG000|Discontinued Prior to Week 96 Visit|Overall Study||16
10915517|NCT00135356|12082175|FG001|Discontinued Prior to Week 96 Visit|Overall Study||9
10915518|NCT00135356|12082174|FG000|Discontinued on or After Week 96 Visit|Overall Study||1
10915519|NCT00135356|12082175|FG001|Discontinued on or After Week 96 Visit|Overall Study||0
10915520|NCT00135356|12082174|FG000|COMPLETED|Overall Study||114
10915521|NCT00135356|12082175|FG001|COMPLETED|Overall Study||60
10915522|NCT00135356|12082174|FG000|NOT COMPLETED|Overall Study||17
10915523|NCT00135356|12082175|FG001|NOT COMPLETED|Overall Study||9
10915524|NCT00135512|12082181|FG000|STARTED|Overall Study||234
10915525|NCT00135512|12082181|FG000|COMPLETED|Overall Study||111
10915526|NCT00135512|12082181|FG000|NOT COMPLETED|Overall Study||123
10915527|NCT00135694|12082188|FG000|STARTED|Overall Study||180
10915528|NCT00135694|12082189|FG001|STARTED|Overall Study||77
10915529|NCT00135694|12082190|FG002|STARTED|Overall Study||18
10915530|NCT00135694|12082188|FG000|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
10915531|NCT00135694|12082189|FG001|COMPLETED|Overall Study||56
10915532|NCT00135694|12082190|FG002|COMPLETED|Overall Study||11
10915533|NCT00135694|12082188|FG000|NOT COMPLETED|Overall Study||180
10915534|NCT00135694|12082189|FG001|NOT COMPLETED|Overall Study||21
10915535|NCT00135694|12082190|FG002|NOT COMPLETED|Overall Study||7
10915536|NCT00135707|12082200|FG000|STARTED|Overall Study||5088
10915537|NCT00135707|12082201|FG001|STARTED|Overall Study||5066
10915538|NCT00135707|12082200|FG000|COMPLETED|Overall Study||4993
10915539|NCT00135707|12082201|FG001|COMPLETED|Overall Study||4976
10915540|NCT00135707|12082200|FG000|NOT COMPLETED|Overall Study||95
10915541|NCT00135707|12082201|FG001|NOT COMPLETED|Overall Study||90
10915542|NCT00135798|12082214|FG000|STARTED|Overall Study||16
10915543|NCT00135798|12082215|FG001|STARTED|Overall Study||31
10915544|NCT00135798|12082216|FG002|STARTED|Overall Study||32
10915545|NCT00135798|12082214|FG000|COMPLETED|Overall Study||16
10915546|NCT00135798|12082215|FG001|COMPLETED|Overall Study||31
10915547|NCT00135798|12082216|FG002|COMPLETED|Overall Study||32
10915548|NCT00135798|12082214|FG000|NOT COMPLETED|Overall Study||0
10915549|NCT00135798|12082215|FG001|NOT COMPLETED|Overall Study||0
10915550|NCT00135798|12082216|FG002|NOT COMPLETED|Overall Study||0
10915551|NCT00136084|12082225|FG000|STARTED|Overall Study||109
10915552|NCT00136084|12082226|FG001|STARTED|Overall Study||114
10915553|NCT00136084|12082225|FG000|COMPLETED|Overall Study||61
10915554|NCT00136084|12082226|FG001|COMPLETED|Overall Study||72
10915555|NCT00136084|12082225|FG000|NOT COMPLETED|Overall Study||48
10915556|NCT00136084|12082226|FG001|NOT COMPLETED|Overall Study||42
10915557|NCT00136214|12082240|FG000|STARTED|Overall Study||15
10915558|NCT00136214|12082241|FG001|STARTED|Overall Study||7
10915559|NCT00136214|12082240|FG000|COMPLETED|Overall Study||15
10915560|NCT00136214|12082241|FG001|COMPLETED|Overall Study||7
10915561|NCT00136214|12082240|FG000|NOT COMPLETED|Overall Study||0
10915562|NCT00136214|12082241|FG001|NOT COMPLETED|Overall Study||0
10915563|NCT00136318|12082251|FG000|STARTED|Overall Study|Took first dose of study medication|90
10915564|NCT00136318|12082252|FG001|STARTED|Overall Study|Took first dose of study medication|91
10915565|NCT00136318|12082251|FG000|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
10915566|NCT00136318|12082252|FG001|COMPLETED|Overall Study||84
10915567|NCT00136318|12082251|FG000|NOT COMPLETED|Overall Study||7
10915568|NCT00136318|12082252|FG001|NOT COMPLETED|Overall Study||7
10915569|NCT00136357|12082261|FG000|STARTED|Overall Study||41
10915570|NCT00136357|12082262|FG001|STARTED|Overall Study||41
10915571|NCT00136357|12082261|FG000|COMPLETED|Overall Study||38
10915572|NCT00136357|12082262|FG001|COMPLETED|Overall Study||39
10915573|NCT00136357|12082261|FG000|NOT COMPLETED|Overall Study||3
10915574|NCT00136357|12082262|FG001|NOT COMPLETED|Overall Study||2
10915575|NCT00136604|12082273|FG000|STARTED|Overall Study||249
10915576|NCT00136604|12082274|FG001|STARTED|Overall Study||123
10915577|NCT00136604|12082275|FG002|STARTED|Overall Study||79
10915578|NCT00136604|12082276|FG003|STARTED|Overall Study||41
10915579|NCT00136604|12082277|FG004|STARTED|Overall Study||125
10915580|NCT00136604|12082273|FG000|COMPLETED|Overall Study||248
10915581|NCT00136604|12082274|FG001|COMPLETED|Overall Study||122
10915582|NCT00136604|12082275|FG002|COMPLETED|Overall Study||79
10915583|NCT00136604|12082276|FG003|COMPLETED|Overall Study||41
10915584|NCT00136604|12082277|FG004|COMPLETED|Overall Study||124
10915585|NCT00136604|12082273|FG000|NOT COMPLETED|Overall Study||1
10915586|NCT00136604|12082274|FG001|NOT COMPLETED|Overall Study||1
10915587|NCT00136604|12082275|FG002|NOT COMPLETED|Overall Study||0
10915588|NCT00136604|12082276|FG003|NOT COMPLETED|Overall Study||0
10915589|NCT00136604|12082277|FG004|NOT COMPLETED|Overall Study||1
10915590|NCT00136760|12082297|FG000|STARTED|Overall Study||12
10915591|NCT00136760|12082298|FG001|STARTED|Overall Study||16
10915592|NCT00136760|12082299|FG002|STARTED|Overall Study||11
10915593|NCT00136760|12082300|FG003|STARTED|Overall Study||13
10915594|NCT00136760|12082297|FG000|COMPLETED|Overall Study||12
10915595|NCT00136760|12082298|FG001|COMPLETED|Overall Study||16
10915596|NCT00136760|12082299|FG002|COMPLETED|Overall Study||11
10915597|NCT00136760|12082300|FG003|COMPLETED|Overall Study||13
10915598|NCT00136760|12082297|FG000|NOT COMPLETED|Overall Study||0
10915599|NCT00136760|12082298|FG001|NOT COMPLETED|Overall Study||0
10915600|NCT00136760|12082299|FG002|NOT COMPLETED|Overall Study||0
10915601|NCT00136760|12082300|FG003|NOT COMPLETED|Overall Study||0
10915602|NCT00136812|12082312|FG000|STARTED|Overall Study||111
10915603|NCT00136812|12082313|FG001|STARTED|Overall Study||113
10915604|NCT00136812|12082312|FG000|COMPLETED|Overall Study||111
10915605|NCT00136812|12082313|FG001|COMPLETED|Overall Study||113
10915606|NCT00136812|12082312|FG000|NOT COMPLETED|Overall Study||0
10915607|NCT00136812|12082313|FG001|NOT COMPLETED|Overall Study||0
10915608|NCT00136838|12082319|FG000|STARTED|First Intervention ( 5 Days)||6
10915609|NCT00136838|12082320|FG001|STARTED|First Intervention ( 5 Days)||6
10915610|NCT00136838|12082319|FG000|COMPLETED|First Intervention ( 5 Days)||6
10915611|NCT00136838|12082320|FG001|COMPLETED|First Intervention ( 5 Days)||6
10915612|NCT00136838|12082319|FG000|NOT COMPLETED|First Intervention ( 5 Days)||0
10915613|NCT00136838|12082320|FG001|NOT COMPLETED|First Intervention ( 5 Days)||0
10915614|NCT00136838|12082319|FG000|STARTED|Second Intervention ( 5 Days)||6
10915615|NCT00136838|12082320|FG001|STARTED|Second Intervention ( 5 Days)||6
10915616|NCT00136838|12082319|FG000|COMPLETED|Second Intervention ( 5 Days)||6
10915617|NCT00136838|12082320|FG001|COMPLETED|Second Intervention ( 5 Days)||6
10915618|NCT00136838|12082319|FG000|NOT COMPLETED|Second Intervention ( 5 Days)||0
10915619|NCT00136838|12082320|FG001|NOT COMPLETED|Second Intervention ( 5 Days)||0
10915620|NCT00136916|12082330|FG000|STARTED|Overall Study||319
10915621|NCT00136916|12082331|FG001|STARTED|Overall Study||316
10915622|NCT00136916|12082330|FG000|Received Treatment|Overall Study||316
10915623|NCT00136916|12082331|FG001|Received Treatment|Overall Study||311
10915624|NCT00136916|12082330|FG000|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
10915625|NCT00136916|12082331|FG001|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
10915626|NCT00136916|12082330|FG000|NOT COMPLETED|Overall Study||125
10915627|NCT00136916|12082331|FG001|NOT COMPLETED|Overall Study||104
10915628|NCT00136955|12082339|FG000|STARTED|Overall Study||41
10915629|NCT00136955|12082339|FG000|COMPLETED|Overall Study||18
10915630|NCT00136955|12082339|FG000|NOT COMPLETED|Overall Study||23
10915631|NCT00137046|12082345|FG000|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
10915632|NCT00137046|12082346|FG001|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
10915633|NCT00137046|12082345|FG000|Received Study Treatment|Overall Study||290
10915634|NCT00137046|12082346|FG001|Received Study Treatment|Overall Study||290
10915635|NCT00137046|12082345|FG000|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
10915636|NCT00137046|12082346|FG001|COMPLETED|Overall Study||198
10915637|NCT00137046|12082345|FG000|NOT COMPLETED|Overall Study||99
10915638|NCT00137046|12082346|FG001|NOT COMPLETED|Overall Study||93
10915639|NCT00137111|12082360|FG000|STARTED|Window Therapy||0
10915640|NCT00137111|12082361|FG001|STARTED|Window Therapy||176
10915641|NCT00137111|12082362|FG002|STARTED|Window Therapy||180
10915642|NCT00137111|12082363|FG003|STARTED|Window Therapy||142
10915643|NCT00137111|12082360|FG000|COMPLETED|Window Therapy||0
10915644|NCT00137111|12082361|FG001|COMPLETED|Window Therapy||176
10915645|NCT00137111|12082362|FG002|COMPLETED|Window Therapy||180
10915646|NCT00137111|12082363|FG003|COMPLETED|Window Therapy||142
10915647|NCT00137111|12082360|FG000|NOT COMPLETED|Window Therapy||0
10915648|NCT00137111|12082361|FG001|NOT COMPLETED|Window Therapy||0
10915649|NCT00137111|12082362|FG002|NOT COMPLETED|Window Therapy||0
10915650|NCT00137111|12082363|FG003|NOT COMPLETED|Window Therapy||0
10915651|NCT00137111|12082360|FG000|STARTED|Total Therapy||498
10915652|NCT00137111|12082361|FG001|STARTED|Total Therapy||0
10915653|NCT00137111|12082362|FG002|STARTED|Total Therapy||0
10915654|NCT00137111|12082363|FG003|STARTED|Total Therapy||0
10915655|NCT00137111|12082360|FG000|COMPLETED|Total Therapy||458
10915656|NCT00137111|12082361|FG001|COMPLETED|Total Therapy||0
10915657|NCT00137111|12082362|FG002|COMPLETED|Total Therapy||0
10915658|NCT00137111|12082363|FG003|COMPLETED|Total Therapy||0
10915659|NCT00137111|12082360|FG000|NOT COMPLETED|Total Therapy||40
10915660|NCT00137111|12082361|FG001|NOT COMPLETED|Total Therapy||0
10915661|NCT00137111|12082362|FG002|NOT COMPLETED|Total Therapy||0
10915662|NCT00137111|12082363|FG003|NOT COMPLETED|Total Therapy||0
10915663|NCT00137267|12082372|FG000|STARTED|Overall Study||55
10915664|NCT00137267|12082373|FG001|STARTED|Overall Study||47
10915665|NCT00137267|12082372|FG000|COMPLETED|Overall Study||40
10915666|NCT00137267|12082373|FG001|COMPLETED|Overall Study||26
10915667|NCT00137267|12082372|FG000|NOT COMPLETED|Overall Study||15
10915668|NCT00137267|12082373|FG001|NOT COMPLETED|Overall Study||21
10915669|NCT00137280|12082381|FG000|STARTED|Overall Study||389
10915670|NCT00137280|12082382|FG001|STARTED|Overall Study||412
10915671|NCT00137280|12082381|FG000|COMPLETED|Overall Study||305
10915672|NCT00137280|12082382|FG001|COMPLETED|Overall Study||357
10915673|NCT00137280|12082381|FG000|NOT COMPLETED|Overall Study||84
10915674|NCT00137280|12082382|FG001|NOT COMPLETED|Overall Study||55
10915675|NCT00137423|12082390|FG000|STARTED|Overall Study||54
10915676|NCT00137423|12082391|FG001|STARTED|Overall Study||53
10915677|NCT00137423|12082390|FG000|COMPLETED|Overall Study||15
10915678|NCT00137423|12082391|FG001|COMPLETED|Overall Study||9
10915679|NCT00137423|12082390|FG000|NOT COMPLETED|Overall Study||39
10915680|NCT00137423|12082391|FG001|NOT COMPLETED|Overall Study||44
10915681|NCT00137436|12082401|FG000|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
10915682|NCT00137436|12082401|FG000|COMPLETED|Overall Study||12
10915683|NCT00137436|12082401|FG000|NOT COMPLETED|Overall Study||43
10915684|NCT00137449|12082407|FG000|STARTED|Overall Study||30
10915685|NCT00137449|12082408|FG001|STARTED|Overall Study||30
10915686|NCT00137449|12082407|FG000|COMPLETED|Overall Study||14
10915687|NCT00137449|12082408|FG001|COMPLETED|Overall Study||12
10915688|NCT00137449|12082407|FG000|NOT COMPLETED|Overall Study||16
10915689|NCT00137449|12082408|FG001|NOT COMPLETED|Overall Study||18
10915690|NCT00137631|12082417|FG000|STARTED|Overall Study||164
10915691|NCT00137631|12082418|FG001|STARTED|Overall Study||174
10915692|NCT00137631|12082417|FG000|Complete 3-month Follow-up|Overall Study||120
10915693|NCT00137631|12082418|FG001|Complete 3-month Follow-up|Overall Study||125
10915694|NCT00137631|12082417|FG000|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
10915695|NCT00137631|12082418|FG001|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
10915696|NCT00137631|12082417|FG000|COMPLETED|Overall Study||127
10915697|NCT00137631|12082418|FG001|COMPLETED|Overall Study||133
10915698|NCT00137631|12082417|FG000|NOT COMPLETED|Overall Study||37
10915699|NCT00137631|12082418|FG001|NOT COMPLETED|Overall Study||41
10915700|NCT00137839|12082424|FG000|STARTED|Overall Study||84
10915701|NCT00137839|12082424|FG000|Treated|Overall Study||83
10915702|NCT00137839|12082424|FG000|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0
10915703|NCT00137839|12082424|FG000|NOT COMPLETED|Overall Study||84
10915704|NCT00137969|12082433|FG000|STARTED|Overall Study||174
10915705|NCT00137969|12082434|FG001|STARTED|Overall Study||88
10915706|NCT00137969|12082433|FG000|Received Study Drug|Overall Study||169
10915707|NCT00137969|12082434|FG001|Received Study Drug|Overall Study||88
10915708|NCT00137969|12082433|FG000|COMPLETED|Overall Study||107
10915709|NCT00137969|12082434|FG001|COMPLETED|Overall Study||67
10915710|NCT00137969|12082433|FG000|NOT COMPLETED|Overall Study||67
10915711|NCT00137969|12082434|FG001|NOT COMPLETED|Overall Study||21
10915712|NCT00138034|12082442|FG000|STARTED|Overall Study||26
10915713|NCT00138034|12082443|FG001|STARTED|Overall Study||23
10915714|NCT00138034|12082442|FG000|COMPLETED|Overall Study||23
10915715|NCT00138034|12082443|FG001|COMPLETED|Overall Study||20
10915716|NCT00138034|12082442|FG000|NOT COMPLETED|Overall Study||3
10915717|NCT00138034|12082443|FG001|NOT COMPLETED|Overall Study||3
10915718|NCT00138125|12082449|FG000|STARTED|Overall Study||2
10915719|NCT00138125|12082449|FG000|COMPLETED|Overall Study||2
10915720|NCT00138125|12082449|FG000|NOT COMPLETED|Overall Study||0
10915721|NCT00138203|12082454|FG000|STARTED|Overall Study||16
10915722|NCT00138203|12082454|FG000|COMPLETED|Overall Study||16
10915723|NCT00138203|12082454|FG000|NOT COMPLETED|Overall Study||0
10915724|NCT00138294|12082459|FG000|STARTED|Overall Study||29255
10915725|NCT00138294|12082459|FG000|COMPLETED|Overall Study||29255
10915726|NCT00138294|12082459|FG000|NOT COMPLETED|Overall Study||0
10915727|NCT00138424|12082469|FG000|STARTED|Overall Study||9
10915728|NCT00138424|12082470|FG001|STARTED|Overall Study||5
10915729|NCT00138424|12082471|FG002|STARTED|Overall Study||5
10915730|NCT00138424|12082472|FG003|STARTED|Overall Study||3
10915731|NCT00138424|12082469|FG000|COMPLETED|Overall Study||9
10915732|NCT00138424|12082470|FG001|COMPLETED|Overall Study||4
10915733|NCT00138424|12082471|FG002|COMPLETED|Overall Study||5
10915734|NCT00138424|12082472|FG003|COMPLETED|Overall Study||3
10915735|NCT00138424|12082469|FG000|NOT COMPLETED|Overall Study||0
10915736|NCT00138424|12082470|FG001|NOT COMPLETED|Overall Study||1
10915737|NCT00138424|12082471|FG002|NOT COMPLETED|Overall Study||0
10915738|NCT00138424|12082472|FG003|NOT COMPLETED|Overall Study||0
10915739|NCT00138645|12082486|FG000|STARTED|Overall Study||30
10915740|NCT00138645|12082487|FG001|STARTED|Overall Study||30
10915741|NCT00138645|12082486|FG000|COMPLETED|Overall Study||24
10915742|NCT00138645|12082487|FG001|COMPLETED|Overall Study||23
10915743|NCT00138645|12082486|FG000|NOT COMPLETED|Overall Study||6
10915744|NCT00138645|12082487|FG001|NOT COMPLETED|Overall Study||7
10915745|NCT00138658|12082493|FG000|STARTED|Overall Study||81
10915746|NCT00138658|12082493|FG000|COMPLETED|Overall Study||20
10915747|NCT00138658|12082493|FG000|NOT COMPLETED|Overall Study||61
10915748|NCT00138671|12082501|FG000|STARTED|Overall Study||59
10915749|NCT00138671|12082502|FG001|STARTED|Overall Study||46
10915750|NCT00138671|12082501|FG000|COMPLETED|Overall Study||46
10915751|NCT00138671|12082502|FG001|COMPLETED|Overall Study||30
10915752|NCT00138671|12082501|FG000|NOT COMPLETED|Overall Study||13
10915753|NCT00138671|12082502|FG001|NOT COMPLETED|Overall Study||16
10915754|NCT00139399|12082512|FG000|STARTED|Overall Study||60
10915755|NCT00139399|12082513|FG001|STARTED|Overall Study||82
10915756|NCT00139399|12082512|FG000|COMPLETED|Overall Study||44
10915757|NCT00139399|12082513|FG001|COMPLETED|Overall Study||59
10915758|NCT00139399|12082512|FG000|NOT COMPLETED|Overall Study||16
10915759|NCT00139399|12082513|FG001|NOT COMPLETED|Overall Study||23
10915760|NCT00139477|12082521|FG000|STARTED|First Intervention -Baseline to 6Months||31
10915761|NCT00139477|12082522|FG001|STARTED|First Intervention -Baseline to 6Months||35
10915762|NCT00139477|12082521|FG000|COMPLETED|First Intervention -Baseline to 6Months||19
10915763|NCT00139477|12082522|FG001|COMPLETED|First Intervention -Baseline to 6Months||23
10915764|NCT00139477|12082521|FG000|NOT COMPLETED|First Intervention -Baseline to 6Months||12
10915765|NCT00139477|12082522|FG001|NOT COMPLETED|First Intervention -Baseline to 6Months||12
10915766|NCT00139477|12082521|FG000|STARTED|Second Intervention -6Months to 12Months||19
10915767|NCT00139477|12082522|FG001|STARTED|Second Intervention -6Months to 12Months||23
10915768|NCT00139477|12082521|FG000|COMPLETED|Second Intervention -6Months to 12Months||14
10915769|NCT00139477|12082522|FG001|COMPLETED|Second Intervention -6Months to 12Months||18
10915770|NCT00139477|12082521|FG000|NOT COMPLETED|Second Intervention -6Months to 12Months||5
10915771|NCT00139477|12082522|FG001|NOT COMPLETED|Second Intervention -6Months to 12Months||5
10915772|NCT00139659|12082532|FG000|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
10915773|NCT00139659|12082533|FG001|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
10915774|NCT00139659|12082532|FG000|COMPLETED|Overall Study||106
10915775|NCT00139659|12082533|FG001|COMPLETED|Overall Study||123
10915776|NCT00139659|12082532|FG000|NOT COMPLETED|Overall Study||40
10915777|NCT00139659|12082533|FG001|NOT COMPLETED|Overall Study||18
10915778|NCT00139737|12082543|FG000|STARTED|Overall Study||344
10915779|NCT00139737|12082543|FG000|Received Treatment|Overall Study||331
10915780|NCT00139737|12082543|FG000|COMPLETED|Overall Study||3
10915781|NCT00139737|12082543|FG000|NOT COMPLETED|Overall Study||341
10915782|NCT00139776|12082549|FG000|STARTED|Period I||1772
10915783|NCT00139776|12082550|FG001|STARTED|Period I||0
10915784|NCT00139776|12082551|FG002|STARTED|Period I||0
10915785|NCT00139776|12082552|FG003|STARTED|Period I||0
10915786|NCT00139776|12082549|FG000|COMPLETED|Period I||1197
10915787|NCT00139776|12082550|FG001|COMPLETED|Period I||0
10915788|NCT00139776|12082551|FG002|COMPLETED|Period I||0
10915789|NCT00139776|12082552|FG003|COMPLETED|Period I||0
10915790|NCT00139776|12082549|FG000|NOT COMPLETED|Period I||575
10915791|NCT00139776|12082550|FG001|NOT COMPLETED|Period I||0
10915792|NCT00139776|12082551|FG002|NOT COMPLETED|Period I||0
10915793|NCT00139776|12082552|FG003|NOT COMPLETED|Period I||0
10915794|NCT00139776|12082549|FG000|STARTED|Period II||0
10915795|NCT00139776|12082550|FG001|STARTED|Period II||1197
10915796|NCT00139776|12082551|FG002|STARTED|Period II||0
10915797|NCT00139776|12082552|FG003|STARTED|Period II||0
10915798|NCT00139776|12082549|FG000|COMPLETED|Period II||0
10915799|NCT00139776|12082550|FG001|COMPLETED|Period II||875
10915800|NCT00139776|12082551|FG002|COMPLETED|Period II||0
10915801|NCT00139776|12082552|FG003|COMPLETED|Period II||0
10915802|NCT00139776|12082549|FG000|NOT COMPLETED|Period II||0
10915803|NCT00139776|12082550|FG001|NOT COMPLETED|Period II||322
10915804|NCT00139776|12082551|FG002|NOT COMPLETED|Period II||0
10915805|NCT00139776|12082552|FG003|NOT COMPLETED|Period II||0
10915806|NCT00139776|12082549|FG000|STARTED|Period III||0
10915807|NCT00139776|12082550|FG001|STARTED|Period III||0
10915808|NCT00139776|12082551|FG002|STARTED|Period III|Randomized 440: 9 participants not treated|431
10915809|NCT00139776|12082552|FG003|STARTED|Period III|Randomized 435: 8 participants not treated|427
10915810|NCT00139776|12082549|FG000|COMPLETED|Period III||0
10915811|NCT00139776|12082550|FG001|COMPLETED|Period III||0
10915812|NCT00139776|12082551|FG002|COMPLETED|Period III||355
10915813|NCT00139776|12082552|FG003|COMPLETED|Period III||321
10915814|NCT00139776|12082549|FG000|NOT COMPLETED|Period III||0
10915815|NCT00139776|12082550|FG001|NOT COMPLETED|Period III||0
10915816|NCT00139776|12082551|FG002|NOT COMPLETED|Period III||76
10915817|NCT00139776|12082552|FG003|NOT COMPLETED|Period III||106
10915818|NCT00139997|12082561|FG000|STARTED|Overall Study||15
10915819|NCT00139997|12082562|FG001|STARTED|Overall Study||11
10915820|NCT00139997|12082561|FG000|COMPLETED|Overall Study||14
10915821|NCT00139997|12082562|FG001|COMPLETED|Overall Study||9
10915822|NCT00139997|12082561|FG000|NOT COMPLETED|Overall Study||1
10915823|NCT00139997|12082562|FG001|NOT COMPLETED|Overall Study||2
10915824|NCT00140140|12082571|FG000|STARTED|Overall Study||4
10915825|NCT00140140|12082572|FG001|STARTED|Overall Study||6
10915826|NCT00140140|12082573|FG002|STARTED|Overall Study||6
10915827|NCT00140140|12082571|FG000|COMPLETED|Overall Study|Progressive disease|2
10915828|NCT00140140|12082572|FG001|COMPLETED|Overall Study|Progressive disease|4
10915829|NCT00140140|12082573|FG002|COMPLETED|Overall Study|Progressive disease|4
10915830|NCT00140140|12082571|FG000|NOT COMPLETED|Overall Study||2
10915831|NCT00140140|12082572|FG001|NOT COMPLETED|Overall Study||2
10915832|NCT00140140|12082573|FG002|NOT COMPLETED|Overall Study||2
10915833|NCT00140205|12082583|FG000|STARTED|Overall Study||5
10915834|NCT00140205|12082584|FG001|STARTED|Overall Study||5
10915835|NCT00140205|12082585|FG002|STARTED|Overall Study||5
10915836|NCT00140205|12082583|FG000|COMPLETED|Overall Study||5
10915837|NCT00140205|12082584|FG001|COMPLETED|Overall Study||5
10915838|NCT00140205|12082585|FG002|COMPLETED|Overall Study||5
10915839|NCT00140205|12082583|FG000|NOT COMPLETED|Overall Study||0
10915840|NCT00140205|12082584|FG001|NOT COMPLETED|Overall Study||0
10915841|NCT00140205|12082585|FG002|NOT COMPLETED|Overall Study||0
10915842|NCT00140231|12082616|FG000|STARTED|Fed State 1 Day- day5||7
10915843|NCT00140231|12082617|FG001|STARTED|Fed State 1 Day- day5||6
10915844|NCT00140231|12082616|FG000|COMPLETED|Fed State 1 Day- day5||7
10915845|NCT00140231|12082617|FG001|COMPLETED|Fed State 1 Day- day5||6
10915846|NCT00140231|12082616|FG000|NOT COMPLETED|Fed State 1 Day- day5||0
10915847|NCT00140231|12082617|FG001|NOT COMPLETED|Fed State 1 Day- day5||0
10915848|NCT00140231|12082616|FG000|STARTED|Washout 8weeks||7
10915849|NCT00140231|12082617|FG001|STARTED|Washout 8weeks||6
10915850|NCT00140231|12082616|FG000|COMPLETED|Washout 8weeks||7
10915851|NCT00140231|12082617|FG001|COMPLETED|Washout 8weeks||6
10915852|NCT00140231|12082616|FG000|NOT COMPLETED|Washout 8weeks||0
10915853|NCT00140231|12082617|FG001|NOT COMPLETED|Washout 8weeks||0
10915854|NCT00140231|12082616|FG000|STARTED|First Fasting State 3 Days With Placebo||7
10915855|NCT00140231|12082617|FG001|STARTED|First Fasting State 3 Days With Placebo||6
10915856|NCT00140231|12082616|FG000|COMPLETED|First Fasting State 3 Days With Placebo||7
10915857|NCT00140231|12082617|FG001|COMPLETED|First Fasting State 3 Days With Placebo||6
10915858|NCT00140231|12082616|FG000|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
10915859|NCT00140231|12082617|FG001|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
10915860|NCT00140231|12082616|FG000|STARTED|Washout 8 Weeks||7
10915861|NCT00140231|12082617|FG001|STARTED|Washout 8 Weeks||6
10915862|NCT00140231|12082616|FG000|COMPLETED|Washout 8 Weeks||7
10915863|NCT00140231|12082617|FG001|COMPLETED|Washout 8 Weeks||6
10915864|NCT00140231|12082616|FG000|NOT COMPLETED|Washout 8 Weeks||0
10915865|NCT00140231|12082617|FG001|NOT COMPLETED|Washout 8 Weeks||0
10915866|NCT00140231|12082616|FG000|STARTED|Fasting State With Leptin and Crossover||7
10915867|NCT00140231|12082617|FG001|STARTED|Fasting State With Leptin and Crossover||6
10915868|NCT00140231|12082616|FG000|COMPLETED|Fasting State With Leptin and Crossover||7
10915869|NCT00140231|12082617|FG001|COMPLETED|Fasting State With Leptin and Crossover||6
10915870|NCT00140231|12082616|FG000|NOT COMPLETED|Fasting State With Leptin and Crossover||0
10915871|NCT00140231|12082617|FG001|NOT COMPLETED|Fasting State With Leptin and Crossover||0
10915872|NCT00140244|12082623|FG000|STARTED|Intervention 1||3
10915873|NCT00140244|12082624|FG001|STARTED|Intervention 1||4
10915874|NCT00140244|12082623|FG000|COMPLETED|Intervention 1||3
10915875|NCT00140244|12082624|FG001|COMPLETED|Intervention 1||4
10915876|NCT00140244|12082623|FG000|NOT COMPLETED|Intervention 1||0
10915877|NCT00140244|12082624|FG001|NOT COMPLETED|Intervention 1||0
10915878|NCT00140244|12082623|FG000|STARTED|Washout||3
10915879|NCT00140244|12082624|FG001|STARTED|Washout||4
10915880|NCT00140244|12082623|FG000|COMPLETED|Washout||3
10915881|NCT00140244|12082624|FG001|COMPLETED|Washout||4
10915882|NCT00140244|12082623|FG000|NOT COMPLETED|Washout||0
10915883|NCT00140244|12082624|FG001|NOT COMPLETED|Washout||0
10915884|NCT00140244|12082623|FG000|STARTED|Intervention 2||3
10915885|NCT00140244|12082624|FG001|STARTED|Intervention 2||4
10915886|NCT00140244|12082623|FG000|COMPLETED|Intervention 2||3
10915887|NCT00140244|12082624|FG001|COMPLETED|Intervention 2||2
10915888|NCT00140244|12082623|FG000|NOT COMPLETED|Intervention 2||0
10915889|NCT00140244|12082624|FG001|NOT COMPLETED|Intervention 2||2
10915890|NCT00140413|12082634|FG000|STARTED|Overall Study||13
10915891|NCT00140413|12082635|FG001|STARTED|Overall Study||7
10915892|NCT00140413|12082634|FG000|Received at Least One Dose of GH|Overall Study||13
10915893|NCT00140413|12082635|FG001|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
10915894|NCT00140413|12082634|FG000|COMPLETED|Overall Study||10
10915895|NCT00140413|12082635|FG001|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
10915896|NCT00140413|12082634|FG000|NOT COMPLETED|Overall Study||3
10915897|NCT00140413|12082635|FG001|NOT COMPLETED|Overall Study||0
10915898|NCT00140426|12082644|FG000|STARTED|Overall Study||22
10915899|NCT00140426|12082645|FG001|STARTED|Overall Study||19
10915900|NCT00140426|12082644|FG000|COMPLETED|Overall Study||22
10915901|NCT00140426|12082645|FG001|COMPLETED|Overall Study||16
10915902|NCT00140426|12082644|FG000|NOT COMPLETED|Overall Study||0
10915903|NCT00140426|12082645|FG001|NOT COMPLETED|Overall Study||3
10915904|NCT00140556|12082656|FG000|STARTED|Pre Radiation Period: Avastin / Tarceva||28
10915905|NCT00140556|12082656|FG000|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
10915906|NCT00140556|12082656|FG000|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
10915907|NCT00140556|12082656|FG000|STARTED|Chemoradiotherapy Period||28
10915908|NCT00140556|12082656|FG000|COMPLETED|Chemoradiotherapy Period||28
10915909|NCT00140556|12082656|FG000|NOT COMPLETED|Chemoradiotherapy Period||0
10915910|NCT00140621|12082660|FG000|STARTED|Overall Study||6
10915911|NCT00140621|12082660|FG000|COMPLETED|Overall Study||6
10915912|NCT00140621|12082660|FG000|NOT COMPLETED|Overall Study||0
10915913|NCT00140842|12082666|FG000|STARTED|Overall Study||15
10915914|NCT00140842|12082667|FG001|STARTED|Overall Study||15
10915915|NCT00140842|12082666|FG000|COMPLETED|Overall Study||15
10915916|NCT00140842|12082667|FG001|COMPLETED|Overall Study||15
10915917|NCT00140842|12082666|FG000|NOT COMPLETED|Overall Study||0
10915918|NCT00140842|12082667|FG001|NOT COMPLETED|Overall Study||0
10915919|NCT00140855|12082673|FG000|STARTED|Overall Study||6
10915920|NCT00140855|12082673|FG000|COMPLETED|Overall Study||4
10915921|NCT00140855|12082673|FG000|NOT COMPLETED|Overall Study||2
10915922|NCT00141037|12082679|FG000|STARTED|Overall Study||60
10915923|NCT00141037|12082680|FG001|STARTED|Overall Study||70
10915924|NCT00141037|12082679|FG000|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
10915925|NCT00141037|12082680|FG001|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
10915926|NCT00141037|12082679|FG000|NOT COMPLETED|Overall Study||10
10915927|NCT00141037|12082680|FG001|NOT COMPLETED|Overall Study||18
10915928|NCT00141102|12082688|FG000|STARTED|Overall Study||2238
10915929|NCT00141102|12082689|FG001|STARTED|Overall Study||2246
10915930|NCT00141102|12082688|FG000|Received Treatment|Overall Study||2223
10915931|NCT00141102|12082689|FG001|Received Treatment|Overall Study||2237
10915932|NCT00141102|12082688|FG000|COMPLETED|Overall Study||1730
10915933|NCT00141102|12082689|FG001|COMPLETED|Overall Study||1621
10915934|NCT00141102|12082688|FG000|NOT COMPLETED|Overall Study||508
10915935|NCT00141102|12082689|FG001|NOT COMPLETED|Overall Study||625
10915936|NCT00141115|12082696|FG000|STARTED|Overall Study||3
10915937|NCT00141115|12082696|FG000|COMPLETED|Overall Study||2
10915938|NCT00141115|12082696|FG000|NOT COMPLETED|Overall Study||1
10915939|NCT00141219|12082703|FG000|STARTED|Overall Study||162
10915940|NCT00141219|12082704|FG001|STARTED|Overall Study||78
10915941|NCT00141219|12082703|FG000|COMPLETED|Overall Study||138
10915942|NCT00141219|12082704|FG001|COMPLETED|Overall Study||62
10915943|NCT00141219|12082703|FG000|NOT COMPLETED|Overall Study||24
10915944|NCT00141219|12082704|FG001|NOT COMPLETED|Overall Study||16
10915945|NCT00141271|12082713|FG000|STARTED|Overall Study||171
10915946|NCT00141271|12082714|FG001|STARTED|Overall Study||165
10915947|NCT00141271|12082715|FG002|STARTED|Overall Study||168
10915948|NCT00141271|12082713|FG000|COMPLETED|Overall Study||91
10915949|NCT00141271|12082714|FG001|COMPLETED|Overall Study||102
10915950|NCT00141271|12082715|FG002|COMPLETED|Overall Study||111
10915951|NCT00141271|12082713|FG000|NOT COMPLETED|Overall Study||80
10915952|NCT00141271|12082714|FG001|NOT COMPLETED|Overall Study||63
10915953|NCT00141271|12082715|FG002|NOT COMPLETED|Overall Study||57
10915954|NCT00141297|12082725|FG000|STARTED|Overall Study||3
10915955|NCT00141297|12082726|FG001|STARTED|Overall Study||3
10915956|NCT00141297|12082727|FG002|STARTED|Overall Study||7
10915957|NCT00141297|12082728|FG003|STARTED|Overall Study||3
10915958|NCT00141297|12082729|FG004|STARTED|Overall Study||22
10915959|NCT00141297|12082730|FG005|STARTED|Overall Study||3
10915960|NCT00141297|12082731|FG006|STARTED|Overall Study||3
10915961|NCT00141297|12082732|FG007|STARTED|Overall Study||4
10915962|NCT00141297|12082733|FG008|STARTED|Overall Study||20
10915963|NCT00141297|12082734|FG009|STARTED|Overall Study||6
10915964|NCT00141297|12082725|FG000|COMPLETED|Overall Study||0
10915965|NCT00141297|12082726|FG001|COMPLETED|Overall Study||0
10915966|NCT00141297|12082727|FG002|COMPLETED|Overall Study||0
10915967|NCT00141297|12082728|FG003|COMPLETED|Overall Study||0
10915968|NCT00141297|12082729|FG004|COMPLETED|Overall Study||0
10915969|NCT00141297|12082730|FG005|COMPLETED|Overall Study||0
10915970|NCT00141297|12082731|FG006|COMPLETED|Overall Study||0
10915971|NCT00141297|12082732|FG007|COMPLETED|Overall Study||0
10915972|NCT00141297|12082733|FG008|COMPLETED|Overall Study||0
10915973|NCT00141297|12082734|FG009|COMPLETED|Overall Study||0
10915974|NCT00141297|12082725|FG000|NOT COMPLETED|Overall Study||3
10915975|NCT00141297|12082726|FG001|NOT COMPLETED|Overall Study||3
10915976|NCT00141297|12082727|FG002|NOT COMPLETED|Overall Study||7
10915977|NCT00141297|12082728|FG003|NOT COMPLETED|Overall Study||3
10915978|NCT00141297|12082729|FG004|NOT COMPLETED|Overall Study||22
10915979|NCT00141297|12082730|FG005|NOT COMPLETED|Overall Study||3
10915980|NCT00141297|12082731|FG006|NOT COMPLETED|Overall Study||3
10915981|NCT00141297|12082732|FG007|NOT COMPLETED|Overall Study||4
10915982|NCT00141297|12082733|FG008|NOT COMPLETED|Overall Study||20
10915983|NCT00141297|12082734|FG009|NOT COMPLETED|Overall Study||6
10915984|NCT00141453|12082769|FG000|STARTED|Overall Study||288
10915985|NCT00141453|12082770|FG001|STARTED|Overall Study||289
10915986|NCT00141453|12082769|FG000|COMPLETED|Overall Study||282
10915987|NCT00141453|12082770|FG001|COMPLETED|Overall Study||284
10915988|NCT00141453|12082769|FG000|NOT COMPLETED|Overall Study||6
10915989|NCT00141453|12082770|FG001|NOT COMPLETED|Overall Study||5
10915990|NCT00141518|12082779|FG000|STARTED|Overall Study||37
10915991|NCT00141518|12082780|FG001|STARTED|Overall Study||22
10915992|NCT00141518|12082781|FG002|STARTED|Overall Study||18
10915993|NCT00141518|12082779|FG000|Safety Sample|Overall Study||36
10915994|NCT00141518|12082780|FG001|Safety Sample|Overall Study||22
10915995|NCT00141518|12082781|FG002|Safety Sample|Overall Study||18
10915996|NCT00141518|12082779|FG000|Full Analysis Sample|Overall Study||27
10915997|NCT00141518|12082780|FG001|Full Analysis Sample|Overall Study||22
10915998|NCT00141518|12082781|FG002|Full Analysis Sample|Overall Study||18
10915999|NCT00141518|12082779|FG000|COMPLETED|Overall Study||21
10916000|NCT00141518|12082780|FG001|COMPLETED|Overall Study||16
10916001|NCT00141518|12082781|FG002|COMPLETED|Overall Study||12
10916002|NCT00141518|12082779|FG000|NOT COMPLETED|Overall Study||16
10916003|NCT00141518|12082780|FG001|NOT COMPLETED|Overall Study||6
10916004|NCT00141518|12082781|FG002|NOT COMPLETED|Overall Study||6
10916005|NCT00141726|12082791|FG000|STARTED|Overall Study||34
10916006|NCT00141726|12082791|FG000|COMPLETED|Overall Study||31
10916007|NCT00141726|12082791|FG000|NOT COMPLETED|Overall Study||3
10916008|NCT00141739|12082795|FG000|STARTED|Overall Study|Number of evaluable patients|100
10916009|NCT00141739|12082795|FG000|COMPLETED|Overall Study||100
10916010|NCT00141739|12082795|FG000|NOT COMPLETED|Overall Study||0
10916011|NCT00141765|12082801|FG000|STARTED|Overall Study||25
10916012|NCT00141765|12082801|FG000|COMPLETED|Overall Study||25
10916013|NCT00141765|12082801|FG000|NOT COMPLETED|Overall Study||0
10916014|NCT00141778|12082808|FG000|STARTED|Randomization Prior to Study Med||152
10916015|NCT00141778|12082809|FG001|STARTED|Randomization Prior to Study Med||153
10916016|NCT00141778|12082810|FG002|STARTED|Randomization Prior to Study Med||153
10916017|NCT00141778|12082808|FG000|COMPLETED|Randomization Prior to Study Med||147
10916018|NCT00141778|12082809|FG001|COMPLETED|Randomization Prior to Study Med||151
10916019|NCT00141778|12082810|FG002|COMPLETED|Randomization Prior to Study Med||147
10916020|NCT00141778|12082808|FG000|NOT COMPLETED|Randomization Prior to Study Med||5
10916021|NCT00141778|12082809|FG001|NOT COMPLETED|Randomization Prior to Study Med||2
10916022|NCT00141778|12082810|FG002|NOT COMPLETED|Randomization Prior to Study Med||6
10916023|NCT00141778|12082808|FG000|STARTED|Started Study Medication||147
10916024|NCT00141778|12082809|FG001|STARTED|Started Study Medication||151
10916025|NCT00141778|12082810|FG002|STARTED|Started Study Medication||147
10916026|NCT00141778|12082808|FG000|COMPLETED|Started Study Medication||145
10916027|NCT00141778|12082809|FG001|COMPLETED|Started Study Medication||144
10916028|NCT00141778|12082810|FG002|COMPLETED|Started Study Medication||143
10916029|NCT00141778|12082808|FG000|NOT COMPLETED|Started Study Medication||2
10916030|NCT00141778|12082809|FG001|NOT COMPLETED|Started Study Medication||7
10916031|NCT00141778|12082810|FG002|NOT COMPLETED|Started Study Medication||4
10916032|NCT00141817|12082822|FG000|STARTED|Overall Study||7
10916033|NCT00141817|12082823|FG001|STARTED|Overall Study||10
10916034|NCT00141817|12082824|FG002|STARTED|Overall Study||11
10916035|NCT00141817|12082825|FG003|STARTED|Overall Study||13
10916036|NCT00141817|12082822|FG000|COMPLETED|Overall Study||6
10916037|NCT00141817|12082823|FG001|COMPLETED|Overall Study||10
10916038|NCT00141817|12082824|FG002|COMPLETED|Overall Study||10
10916039|NCT00141817|12082825|FG003|COMPLETED|Overall Study||13
10916040|NCT00141817|12082822|FG000|NOT COMPLETED|Overall Study||1
10916041|NCT00141817|12082823|FG001|NOT COMPLETED|Overall Study||0
10916042|NCT00141817|12082824|FG002|NOT COMPLETED|Overall Study||1
10916043|NCT00141817|12082825|FG003|NOT COMPLETED|Overall Study||0
10916044|NCT00141921|12082835|FG000|STARTED|Overall Study||182
10916045|NCT00141921|12082835|FG000|Received Treatment|Overall Study||181
10916046|NCT00141921|12082835|FG000|COMPLETED|Overall Study||41
10916047|NCT00141921|12082835|FG000|NOT COMPLETED|Overall Study||141
10916048|NCT00142116|12082839|FG000|STARTED|Overall Study||25
10916049|NCT00142116|12082839|FG000|COMPLETED|Overall Study||25
10916050|NCT00142116|12082839|FG000|NOT COMPLETED|Overall Study||0
10916051|NCT00142168|12082844|FG000|STARTED|Overall Study||16
10916052|NCT00142168|12082844|FG000|COMPLETED|Overall Study||16
10916053|NCT00142168|12082844|FG000|NOT COMPLETED|Overall Study||0
10916054|NCT00142298|12082858|FG000|STARTED|Overall Study||667
10916055|NCT00142298|12082859|FG001|STARTED|Overall Study||632
10916056|NCT00142298|12082860|FG002|STARTED|Overall Study||123
10916057|NCT00142298|12082861|FG003|STARTED|Overall Study||206
10916058|NCT00142298|12082862|FG004|STARTED|Overall Study||56
10916059|NCT00142298|12082863|FG005|STARTED|Overall Study||26
10916060|NCT00142298|12082864|FG006|STARTED|Overall Study||23
10916061|NCT00142298|12082865|FG007|STARTED|Overall Study||66
10916062|NCT00142298|12082866|FG008|STARTED|Overall Study||57
10916063|NCT00142298|12082867|FG009|STARTED|Overall Study||13
10916064|NCT00142298|12082858|FG000|Safety Population|Overall Study||655
10916065|NCT00142298|12082859|FG001|Safety Population|Overall Study||626
10916066|NCT00142298|12082860|FG002|Safety Population|Overall Study||122
10916067|NCT00142298|12082861|FG003|Safety Population|Overall Study||206
10916068|NCT00142298|12082862|FG004|Safety Population|Overall Study||50
10916069|NCT00142298|12082863|FG005|Safety Population|Overall Study||26
10916070|NCT00142298|12082864|FG006|Safety Population|Overall Study||23
10916071|NCT00142298|12082865|FG007|Safety Population|Overall Study||66
10916072|NCT00142298|12082866|FG008|Safety Population|Overall Study||57
10916073|NCT00142298|12082867|FG009|Safety Population|Overall Study||13
10916074|NCT00142298|12082858|FG000|Per Protocol Population|Overall Study||635
10916075|NCT00142298|12082859|FG001|Per Protocol Population|Overall Study||606
10916076|NCT00142298|12082860|FG002|Per Protocol Population|Overall Study||120
10916077|NCT00142298|12082861|FG003|Per Protocol Population|Overall Study||202
10916078|NCT00142298|12082862|FG004|Per Protocol Population|Overall Study||50
10916079|NCT00142298|12082863|FG005|Per Protocol Population|Overall Study||25
10916080|NCT00142298|12082864|FG006|Per Protocol Population|Overall Study||19
10916081|NCT00142298|12082865|FG007|Per Protocol Population|Overall Study||64
10916082|NCT00142298|12082866|FG008|Per Protocol Population|Overall Study||56
10916083|NCT00142298|12082867|FG009|Per Protocol Population|Overall Study||13
10916084|NCT00142298|12082858|FG000|COMPLETED|Overall Study|Completed week 104/week 208.|507
10916085|NCT00142298|12082859|FG001|COMPLETED|Overall Study||456
10916086|NCT00142298|12082860|FG002|COMPLETED|Overall Study||90
10916087|NCT00142298|12082861|FG003|COMPLETED|Overall Study||121
10916088|NCT00142298|12082862|FG004|COMPLETED|Overall Study||46
10916089|NCT00142298|12082863|FG005|COMPLETED|Overall Study||10
10916090|NCT00142298|12082864|FG006|COMPLETED|Overall Study||15
10916091|NCT00142298|12082865|FG007|COMPLETED|Overall Study||58
10916092|NCT00142298|12082866|FG008|COMPLETED|Overall Study||52
10916093|NCT00142298|12082867|FG009|COMPLETED|Overall Study||13
10916094|NCT00142298|12082858|FG000|NOT COMPLETED|Overall Study||160
10916095|NCT00142298|12082859|FG001|NOT COMPLETED|Overall Study||176
10916096|NCT00142298|12082860|FG002|NOT COMPLETED|Overall Study||33
10916097|NCT00142298|12082861|FG003|NOT COMPLETED|Overall Study||85
10916098|NCT00142298|12082862|FG004|NOT COMPLETED|Overall Study||10
10916099|NCT00142298|12082863|FG005|NOT COMPLETED|Overall Study||16
10916100|NCT00142298|12082864|FG006|NOT COMPLETED|Overall Study||8
10916101|NCT00142298|12082865|FG007|NOT COMPLETED|Overall Study||8
10916102|NCT00142298|12082866|FG008|NOT COMPLETED|Overall Study||5
10916103|NCT00142298|12082867|FG009|NOT COMPLETED|Overall Study||0
10916104|NCT00142415|12082895|FG000|STARTED|Overall Study||3
10916105|NCT00142415|12082896|FG001|STARTED|Overall Study||3
10916106|NCT00142415|12082897|FG002|STARTED|Overall Study||6
10916107|NCT00142415|12082898|FG003|STARTED|Overall Study||3
10916108|NCT00142415|12082899|FG004|STARTED|Overall Study||3
10916109|NCT00142415|12082900|FG005|STARTED|Overall Study||8
10916110|NCT00142415|12082895|FG000|COMPLETED|Overall Study||3
10916111|NCT00142415|12082896|FG001|COMPLETED|Overall Study||3
10916112|NCT00142415|12082897|FG002|COMPLETED|Overall Study||6
10916113|NCT00142415|12082898|FG003|COMPLETED|Overall Study||3
10916114|NCT00142415|12082899|FG004|COMPLETED|Overall Study||2
10916115|NCT00142415|12082900|FG005|COMPLETED|Overall Study||6
10916116|NCT00142415|12082895|FG000|NOT COMPLETED|Overall Study||0
10916117|NCT00142415|12082896|FG001|NOT COMPLETED|Overall Study||0
10916118|NCT00142415|12082897|FG002|NOT COMPLETED|Overall Study||0
10916119|NCT00142415|12082898|FG003|NOT COMPLETED|Overall Study||0
10916120|NCT00142415|12082899|FG004|NOT COMPLETED|Overall Study||1
10916121|NCT00142415|12082900|FG005|NOT COMPLETED|Overall Study||2
10916122|NCT00142454|12082916|FG000|STARTED|Overall Study||9
10916123|NCT00142454|12082916|FG000|COMPLETED|Overall Study||9
10916124|NCT00142454|12082916|FG000|NOT COMPLETED|Overall Study||0
10916125|NCT00142506|12082922|FG000|STARTED|Overall Study||184
10916126|NCT00142506|12082923|FG001|STARTED|Overall Study||106
10916127|NCT00142506|12082922|FG000|COMPLETED|Overall Study||112
10916128|NCT00142506|12082923|FG001|COMPLETED|Overall Study||77
10916129|NCT00142506|12082922|FG000|NOT COMPLETED|Overall Study||72
10916130|NCT00142506|12082923|FG001|NOT COMPLETED|Overall Study||29
10916131|NCT00142597|12082931|FG000|STARTED|Overall Study|N=10 underwent PET imaging|23
10916132|NCT00142597|12082932|FG001|STARTED|Overall Study|N=10 underwent PET imaging|23
10916133|NCT00142597|12082931|FG000|COMPLETED|Overall Study|N=10 completed PET imaging|20
10916134|NCT00142597|12082932|FG001|COMPLETED|Overall Study|N=10 completed PET imaging|22
10916135|NCT00142597|12082931|FG000|NOT COMPLETED|Overall Study||3
10916136|NCT00142597|12082932|FG001|NOT COMPLETED|Overall Study||1
10916137|NCT00142792|12082941|FG000|STARTED|Overall Study||39
10916138|NCT00142792|12082942|FG001|STARTED|Overall Study||41
10916139|NCT00142792|12082943|FG002|STARTED|Overall Study||42
10916140|NCT00142792|12082941|FG000|Completed Intervention|Overall Study||35
10916141|NCT00142792|12082942|FG001|Completed Intervention|Overall Study||37
10916142|NCT00142792|12082943|FG002|Completed Intervention|Overall Study||37
10916143|NCT00142792|12082941|FG000|COMPLETED|Overall Study||27
10916144|NCT00142792|12082942|FG001|COMPLETED|Overall Study||26
10916145|NCT00142792|12082943|FG002|COMPLETED|Overall Study||30
10916146|NCT00142792|12082941|FG000|NOT COMPLETED|Overall Study||12
10916147|NCT00142792|12082942|FG001|NOT COMPLETED|Overall Study||15
10916148|NCT00142792|12082943|FG002|NOT COMPLETED|Overall Study||12
10916149|NCT00142818|12082955|FG000|STARTED|Overall Study||45
10916150|NCT00142818|12082956|FG001|STARTED|Overall Study||40
10916151|NCT00142818|12082957|FG002|STARTED|Overall Study||37
10916152|NCT00142818|12082958|FG003|STARTED|Overall Study||42
10916153|NCT00142818|12082955|FG000|COMPLETED|Overall Study||28
10916154|NCT00142818|12082956|FG001|COMPLETED|Overall Study||19
10916155|NCT00142818|12082957|FG002|COMPLETED|Overall Study||24
10916156|NCT00142818|12082958|FG003|COMPLETED|Overall Study||20
10916157|NCT00142818|12082955|FG000|NOT COMPLETED|Overall Study||17
10916158|NCT00142818|12082956|FG001|NOT COMPLETED|Overall Study||21
10916159|NCT00142818|12082957|FG002|NOT COMPLETED|Overall Study||13
10916160|NCT00142818|12082958|FG003|NOT COMPLETED|Overall Study||22
10916161|NCT00142909|12082974|FG000|STARTED|Randomization||42
10916162|NCT00142909|12082975|FG001|STARTED|Randomization||44
10916163|NCT00142909|12082974|FG000|COMPLETED|Randomization||35
10916164|NCT00142909|12082975|FG001|COMPLETED|Randomization||34
10916165|NCT00142909|12082974|FG000|NOT COMPLETED|Randomization||7
10916166|NCT00142909|12082975|FG001|NOT COMPLETED|Randomization||10
10916167|NCT00142909|12082974|FG000|STARTED|Medications Begin||35
10916168|NCT00142909|12082975|FG001|STARTED|Medications Begin||34
10916169|NCT00142909|12082974|FG000|COMPLETED|Medications Begin||26
10916170|NCT00142909|12082975|FG001|COMPLETED|Medications Begin||31
10916171|NCT00142909|12082974|FG000|NOT COMPLETED|Medications Begin||9
10916172|NCT00142909|12082975|FG001|NOT COMPLETED|Medications Begin||3
10916173|NCT00142935|12082984|FG000|STARTED|Overall Study||29
10916174|NCT00142935|12082985|FG001|STARTED|Overall Study||28
10916175|NCT00142935|12082986|FG002|STARTED|Overall Study||30
10916176|NCT00142935|12082984|FG000|COMPLETED|Overall Study||26
10916177|NCT00142935|12082985|FG001|COMPLETED|Overall Study||20
10916178|NCT00142935|12082986|FG002|COMPLETED|Overall Study||23
10916179|NCT00142935|12082984|FG000|NOT COMPLETED|Overall Study||3
10916180|NCT00142935|12082985|FG001|NOT COMPLETED|Overall Study||8
10916181|NCT00142935|12082986|FG002|NOT COMPLETED|Overall Study||7
10916182|NCT00143247|12082998|FG000|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
10916183|NCT00143247|12082998|FG000|COMPLETED|Overall Study||17
10916184|NCT00143247|12082998|FG000|NOT COMPLETED|Overall Study||156
10916185|NCT00143312|12083002|FG000|STARTED|Overall Study||45
10916186|NCT00143312|12083002|FG000|COMPLETED|Overall Study||29
10916187|NCT00143312|12083002|FG000|NOT COMPLETED|Overall Study||16
10916188|NCT00143390|12083008|FG000|STARTED|Overall Study||149
10916189|NCT00143390|12083009|FG001|STARTED|Overall Study||149
10916190|NCT00143390|12083008|FG000|COMPLETED|Overall Study||0
10916191|NCT00143390|12083009|FG001|COMPLETED|Overall Study||0
10916192|NCT00143390|12083008|FG000|NOT COMPLETED|Overall Study||149
10916193|NCT00143390|12083009|FG001|NOT COMPLETED|Overall Study||149
10916194|NCT00143403|12083017|FG000|STARTED|Overall Study||160
10916195|NCT00143403|12083018|FG001|STARTED|Overall Study||161
10916196|NCT00143403|12083017|FG000|Treated|Overall Study||153
10916197|NCT00143403|12083018|FG001|Treated|Overall Study||153
10916198|NCT00143403|12083017|FG000|COMPLETED|Overall Study|Received maximum number of cycles.|125
10916199|NCT00143403|12083018|FG001|COMPLETED|Overall Study|Received maximum number of cycles.|115
10916200|NCT00143403|12083017|FG000|NOT COMPLETED|Overall Study||35
10916201|NCT00143403|12083018|FG001|NOT COMPLETED|Overall Study||46
10916202|NCT00143455|12083028|FG000|STARTED|Cohort 1||39
10916203|NCT00143455|12083029|FG001|STARTED|Cohort 1||39
10916204|NCT00143455|12083030|FG002|STARTED|Cohort 1||0
10916205|NCT00143455|12083031|FG003|STARTED|Cohort 1||0
10916206|NCT00143455|12083028|FG000|Received Treatment|Cohort 1||39
10916207|NCT00143455|12083029|FG001|Received Treatment|Cohort 1||38
10916208|NCT00143455|12083030|FG002|Received Treatment|Cohort 1||0
10916209|NCT00143455|12083031|FG003|Received Treatment|Cohort 1||0
10916210|NCT00143455|12083028|FG000|COMPLETED|Cohort 1||25
10916211|NCT00143455|12083029|FG001|COMPLETED|Cohort 1||22
10916212|NCT00143455|12083030|FG002|COMPLETED|Cohort 1||0
10916213|NCT00143455|12083031|FG003|COMPLETED|Cohort 1||0
10916214|NCT00143455|12083028|FG000|NOT COMPLETED|Cohort 1||14
10916215|NCT00143455|12083029|FG001|NOT COMPLETED|Cohort 1||17
10916216|NCT00143455|12083030|FG002|NOT COMPLETED|Cohort 1||0
10916217|NCT00143455|12083031|FG003|NOT COMPLETED|Cohort 1||0
10916218|NCT00143455|12083028|FG000|STARTED|Cohort 2||0
10916219|NCT00143455|12083029|FG001|STARTED|Cohort 2||0
10916220|NCT00143455|12083030|FG002|STARTED|Cohort 2||203
10916221|NCT00143455|12083031|FG003|STARTED|Cohort 2||204
10916222|NCT00143455|12083028|FG000|Received Treatment|Cohort 2||0
10916223|NCT00143455|12083029|FG001|Received Treatment|Cohort 2||0
10916224|NCT00143455|12083030|FG002|Received Treatment|Cohort 2||202
10916225|NCT00143455|12083031|FG003|Received Treatment|Cohort 2||203
10916226|NCT00143455|12083028|FG000|COMPLETED|Cohort 2||0
10916227|NCT00143455|12083029|FG001|COMPLETED|Cohort 2||0
10916228|NCT00143455|12083030|FG002|COMPLETED|Cohort 2||97
10916229|NCT00143455|12083031|FG003|COMPLETED|Cohort 2||111
10916230|NCT00143455|12083028|FG000|NOT COMPLETED|Cohort 2||0
10916231|NCT00143455|12083029|FG001|NOT COMPLETED|Cohort 2||0
10916232|NCT00143455|12083030|FG002|NOT COMPLETED|Cohort 2||106
10916233|NCT00143455|12083031|FG003|NOT COMPLETED|Cohort 2||93
10916234|NCT00143507|12083045|FG000|STARTED|Overall Study||5479
10916235|NCT00143507|12083046|FG001|STARTED|Overall Study||5438
10916236|NCT00143507|12083045|FG000|COMPLETED|Overall Study||4792
10916237|NCT00143507|12083046|FG001|COMPLETED|Overall Study||4786
10916238|NCT00143507|12083045|FG000|NOT COMPLETED|Overall Study||687
10916239|NCT00143507|12083046|FG001|NOT COMPLETED|Overall Study||652
10916240|NCT00143598|12083054|FG000|STARTED|Overall Study||410
10916241|NCT00143598|12083055|FG001|STARTED|Overall Study||396
10916242|NCT00143598|12083054|FG000|COMPLETED|Overall Study||318
10916243|NCT00143598|12083055|FG001|COMPLETED|Overall Study||302
10916244|NCT00143598|12083054|FG000|NOT COMPLETED|Overall Study||92
10916245|NCT00143598|12083055|FG001|NOT COMPLETED|Overall Study||94
10916246|NCT00143819|12083063|FG000|STARTED|Overall Study||5
10916247|NCT00143819|12083064|FG001|STARTED|Overall Study||8
10916248|NCT00143819|12083063|FG000|COMPLETED|Overall Study||3
10916249|NCT00143819|12083064|FG001|COMPLETED|Overall Study||5
10916250|NCT00143819|12083063|FG000|NOT COMPLETED|Overall Study||2
10916251|NCT00143819|12083064|FG001|NOT COMPLETED|Overall Study||3
10916252|NCT00143845|12083074|FG000|STARTED|Overall Study||54
10916253|NCT00143845|12083074|FG000|COMPLETED|Overall Study||54
10916254|NCT00143845|12083074|FG000|NOT COMPLETED|Overall Study||0
10916255|NCT00144027|12083080|FG000|STARTED|Overall Study|participants who consented|39
10916256|NCT00144027|12083081|FG001|STARTED|Overall Study|participants who consented|36
10916257|NCT00144027|12083080|FG000|Completed Baseline Assessment|Overall Study||39
10916258|NCT00144027|12083081|FG001|Completed Baseline Assessment|Overall Study||29
10916259|NCT00144027|12083080|FG000|Completed 6 Month Assessment|Overall Study||37
10916260|NCT00144027|12083081|FG001|Completed 6 Month Assessment|Overall Study||24
10916261|NCT00144027|12083080|FG000|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
10916262|NCT00144027|12083081|FG001|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
10916263|NCT00144027|12083080|FG000|NOT COMPLETED|Overall Study||3
10916264|NCT00144027|12083081|FG001|NOT COMPLETED|Overall Study||11
10916265|NCT00144170|12083089|FG000|STARTED|Overall Study||438
10916266|NCT00144170|12083090|FG001|STARTED|Overall Study||428
10916267|NCT00144170|12083089|FG000|COMPLETED|Overall Study||86
10916268|NCT00144170|12083090|FG001|COMPLETED|Overall Study||32
10916269|NCT00144170|12083089|FG000|NOT COMPLETED|Overall Study||352
10916270|NCT00144170|12083090|FG001|NOT COMPLETED|Overall Study||396
10916271|NCT00144300|12083098|FG000|STARTED|Overall Study||121
10916272|NCT00144300|12083099|FG001|STARTED|Overall Study||125
10916273|NCT00144300|12083098|FG000|COMPLETED|Overall Study||92
10916274|NCT00144300|12083099|FG001|COMPLETED|Overall Study||97
10916275|NCT00144300|12083098|FG000|NOT COMPLETED|Overall Study||29
10916276|NCT00144300|12083099|FG001|NOT COMPLETED|Overall Study||28
10916277|NCT00144339|12083107|FG000|STARTED|Overall Study||3006
10916278|NCT00144339|12083108|FG001|STARTED|Overall Study||2986
10916279|NCT00144339|12083107|FG000|COMPLETED|Overall Study||1648
10916280|NCT00144339|12083108|FG001|COMPLETED|Overall Study||1887
10916281|NCT00144339|12083107|FG000|NOT COMPLETED|Overall Study||1358
10916282|NCT00144339|12083108|FG001|NOT COMPLETED|Overall Study||1099
10916283|NCT00144391|12083116|FG000|STARTED|Overall Study||11
10916284|NCT00144391|12083117|FG001|STARTED|Overall Study||9
10916285|NCT00144391|12083116|FG000|COMPLETED|Overall Study||11
10916286|NCT00144391|12083117|FG001|COMPLETED|Overall Study||9
10916287|NCT00144391|12083116|FG000|NOT COMPLETED|Overall Study||0
10916288|NCT00144391|12083117|FG001|NOT COMPLETED|Overall Study||0
10916289|NCT00144781|12083127|FG000|STARTED|Overall Study||8
10916290|NCT00144781|12083128|FG001|STARTED|Overall Study||9
10916291|NCT00144781|12083129|FG002|STARTED|Overall Study||8
10916292|NCT00144781|12083130|FG003|STARTED|Overall Study||9
10916293|NCT00144781|12083127|FG000|COMPLETED|Overall Study||8
10916294|NCT00144781|12083128|FG001|COMPLETED|Overall Study||7
10916295|NCT00144781|12083129|FG002|COMPLETED|Overall Study||8
10916296|NCT00144781|12083130|FG003|COMPLETED|Overall Study||9
10916297|NCT00144781|12083127|FG000|NOT COMPLETED|Overall Study||0
10916298|NCT00144781|12083128|FG001|NOT COMPLETED|Overall Study||2
10916299|NCT00144781|12083129|FG002|NOT COMPLETED|Overall Study||0
10916300|NCT00144781|12083130|FG003|NOT COMPLETED|Overall Study||0
10916301|NCT00144963|12083140|FG000|STARTED|Overall Study||36
10916302|NCT00144963|12083140|FG000|COMPLETED|Overall Study||36
10916303|NCT00144963|12083140|FG000|NOT COMPLETED|Overall Study||0
10916304|NCT00145041|12083144|FG000|STARTED|Overall Study||7
10916305|NCT00145041|12083144|FG000|COMPLETED|Overall Study||7
10916306|NCT00145041|12083144|FG000|NOT COMPLETED|Overall Study||0
10916307|NCT00145119|12083148|FG000|STARTED|Overall Study||312
10916308|NCT00145119|12083148|FG000|COMPLETED|Overall Study||267
10916309|NCT00145119|12083148|FG000|NOT COMPLETED|Overall Study||45
10916310|NCT00145145|12083152|FG000|STARTED|Overall Study||1
10916311|NCT00145145|12083152|FG000|COMPLETED|Overall Study||1
10916312|NCT00145145|12083152|FG000|NOT COMPLETED|Overall Study||0
10916313|NCT00145249|12083159|FG000|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
10916314|NCT00145249|12083160|FG001|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
10916315|NCT00145249|12083161|FG002|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
10916316|NCT00145249|12083159|FG000|COMPLETED|Overall Study||36
10916317|NCT00145249|12083160|FG001|COMPLETED|Overall Study||33
10916318|NCT00145249|12083161|FG002|COMPLETED|Overall Study||31
10916319|NCT00145249|12083159|FG000|NOT COMPLETED|Overall Study||11
10916320|NCT00145249|12083160|FG001|NOT COMPLETED|Overall Study||15
10916321|NCT00145249|12083161|FG002|NOT COMPLETED|Overall Study||17
10916322|NCT00145327|12083172|FG000|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
10916323|NCT00145327|12083173|FG001|STARTED|Overall Study||617
10916324|NCT00145327|12083174|FG002|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
10916325|NCT00145327|12083172|FG000|COMPLETED|Overall Study||474
10916326|NCT00145327|12083173|FG001|COMPLETED|Overall Study||493
10916327|NCT00145327|12083174|FG002|COMPLETED|Overall Study||975
10916328|NCT00145327|12083172|FG000|NOT COMPLETED|Overall Study||142
10916329|NCT00145327|12083173|FG001|NOT COMPLETED|Overall Study||124
10916330|NCT00145327|12083174|FG002|NOT COMPLETED|Overall Study||248
10916331|NCT00145418|12083182|FG000|STARTED|Overall Study||15
10916332|NCT00145418|12083182|FG000|COMPLETED|Overall Study||15
10916333|NCT00145418|12083182|FG000|NOT COMPLETED|Overall Study||0
10916334|NCT00145574|12083189|FG000|STARTED|Double Blind||65
10916335|NCT00145574|12083190|FG001|STARTED|Double Blind||65
10916336|NCT00145574|12083191|FG002|STARTED|Double Blind||64
10916337|NCT00145574|12083189|FG000|COMPLETED|Double Blind||64
10916338|NCT00145574|12083190|FG001|COMPLETED|Double Blind||60
10916339|NCT00145574|12083191|FG002|COMPLETED|Double Blind||62
10916340|NCT00145574|12083189|FG000|NOT COMPLETED|Double Blind||1
10916341|NCT00145574|12083190|FG001|NOT COMPLETED|Double Blind||5
10916342|NCT00145574|12083191|FG002|NOT COMPLETED|Double Blind||2
10916343|NCT00145574|12083189|FG000|STARTED|Open Label Long-term Extension||0
10916344|NCT00145574|12083190|FG001|STARTED|Open Label Long-term Extension||0
10916345|NCT00145574|12083191|FG002|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
10916346|NCT00145574|12083189|FG000|COMPLETED|Open Label Long-term Extension||0
10916347|NCT00145574|12083190|FG001|COMPLETED|Open Label Long-term Extension||0
10916348|NCT00145574|12083191|FG002|COMPLETED|Open Label Long-term Extension||173
10916349|NCT00145574|12083189|FG000|NOT COMPLETED|Open Label Long-term Extension||0
10916350|NCT00145574|12083190|FG001|NOT COMPLETED|Open Label Long-term Extension||0
10916351|NCT00145574|12083191|FG002|NOT COMPLETED|Open Label Long-term Extension||11
10916352|NCT00145587|12083206|FG000|STARTED|Overall Study||5
10916353|NCT00145587|12083207|FG001|STARTED|Overall Study||1
10916354|NCT00145587|12083206|FG000|COMPLETED|Overall Study||5
10916355|NCT00145587|12083207|FG001|COMPLETED|Overall Study||1
10916356|NCT00145587|12083206|FG000|NOT COMPLETED|Overall Study||0
10916357|NCT00145587|12083207|FG001|NOT COMPLETED|Overall Study||0
10916358|NCT00145626|12083215|FG000|STARTED|Overall Study||19
10916359|NCT00145626|12083215|FG000|COMPLETED|Overall Study||14
10916360|NCT00145626|12083215|FG000|NOT COMPLETED|Overall Study||5
10916361|NCT00145977|12083237|FG000|STARTED|Overall Study||19
10916362|NCT00145977|12083238|FG001|STARTED|Overall Study||17
10916363|NCT00145977|12083237|FG000|COMPLETED|Overall Study||17
10916364|NCT00145977|12083238|FG001|COMPLETED|Overall Study||13
10916365|NCT00145977|12083237|FG000|NOT COMPLETED|Overall Study||2
10916366|NCT00145977|12083238|FG001|NOT COMPLETED|Overall Study||4
10916367|NCT00146172|12083252|FG000|STARTED|Overall Study||3
10916368|NCT00146172|12083253|FG001|STARTED|Overall Study||4
10916369|NCT00146172|12083254|FG002|STARTED|Overall Study||4
10916370|NCT00146172|12083255|FG003|STARTED|Overall Study||6
10916371|NCT00146172|12083256|FG004|STARTED|Overall Study||3
10916372|NCT00146172|12083257|FG005|STARTED|Overall Study||7
10916373|NCT00146172|12083258|FG006|STARTED|Overall Study||6
10916374|NCT00146172|12083259|FG007|STARTED|Overall Study||40
10916375|NCT00146172|12083252|FG000|Received Drug|Overall Study||3
10916376|NCT00146172|12083253|FG001|Received Drug|Overall Study||4
10916377|NCT00146172|12083254|FG002|Received Drug|Overall Study||4
10916378|NCT00146172|12083255|FG003|Received Drug|Overall Study||6
10916379|NCT00146172|12083256|FG004|Received Drug|Overall Study||3
10916380|NCT00146172|12083257|FG005|Received Drug|Overall Study||7
10916381|NCT00146172|12083258|FG006|Received Drug|Overall Study||6
10916382|NCT00146172|12083259|FG007|Received Drug|Overall Study||39
10916383|NCT00146172|12083252|FG000|COMPLETED|Overall Study||0
10916384|NCT00146172|12083253|FG001|COMPLETED|Overall Study||0
10916385|NCT00146172|12083254|FG002|COMPLETED|Overall Study||0
10916386|NCT00146172|12083255|FG003|COMPLETED|Overall Study||0
10916387|NCT00146172|12083256|FG004|COMPLETED|Overall Study||0
10916388|NCT00146172|12083257|FG005|COMPLETED|Overall Study||0
10916389|NCT00146172|12083258|FG006|COMPLETED|Overall Study||0
10916390|NCT00146172|12083259|FG007|COMPLETED|Overall Study||0
10916391|NCT00146172|12083252|FG000|NOT COMPLETED|Overall Study||3
10916392|NCT00146172|12083253|FG001|NOT COMPLETED|Overall Study||4
10916393|NCT00146172|12083254|FG002|NOT COMPLETED|Overall Study||4
10916394|NCT00146172|12083255|FG003|NOT COMPLETED|Overall Study||6
10916395|NCT00146172|12083256|FG004|NOT COMPLETED|Overall Study||3
10916396|NCT00146172|12083257|FG005|NOT COMPLETED|Overall Study||7
10916397|NCT00146172|12083258|FG006|NOT COMPLETED|Overall Study||6
10916398|NCT00146172|12083259|FG007|NOT COMPLETED|Overall Study||40
10916399|NCT00146328|12083288|FG000|STARTED|Overall Study||291
10916400|NCT00146328|12083289|FG001|STARTED|Overall Study||255
10916401|NCT00146328|12083290|FG002|STARTED|Overall Study||449
10916402|NCT00146328|12083288|FG000|COMPLETED|Overall Study||150
10916403|NCT00146328|12083289|FG001|COMPLETED|Overall Study||101
10916404|NCT00146328|12083290|FG002|COMPLETED|Overall Study||158
10916405|NCT00146328|12083288|FG000|NOT COMPLETED|Overall Study||141
10916406|NCT00146328|12083289|FG001|NOT COMPLETED|Overall Study||154
10916407|NCT00146328|12083290|FG002|NOT COMPLETED|Overall Study||291
10916408|NCT00146640|12083300|FG000|STARTED|Overall Study||144
10916409|NCT00146640|12083301|FG001|STARTED|Overall Study||144
10916410|NCT00146640|12083300|FG000|COMPLETED|Overall Study||121
10916411|NCT00146640|12083301|FG001|COMPLETED|Overall Study||130
10916412|NCT00146640|12083300|FG000|NOT COMPLETED|Overall Study||23
10916413|NCT00146640|12083301|FG001|NOT COMPLETED|Overall Study||14
10916414|NCT00146757|12083307|FG000|STARTED|Overall Study||16
10916415|NCT00146757|12083308|FG001|STARTED|Overall Study||4
10916416|NCT00146757|12083307|FG000|COMPLETED|Overall Study||14
10916417|NCT00146757|12083308|FG001|COMPLETED|Overall Study||4
10916418|NCT00146757|12083307|FG000|NOT COMPLETED|Overall Study||2
10916419|NCT00146757|12083308|FG001|NOT COMPLETED|Overall Study||0
10916420|NCT00146770|12083316|FG000|STARTED|Overall Study||23
10916421|NCT00146770|12083317|FG001|STARTED|Overall Study||22
10916422|NCT00146770|12083316|FG000|COMPLETED|Overall Study||18
10916423|NCT00146770|12083317|FG001|COMPLETED|Overall Study||22
10916424|NCT00146770|12083316|FG000|NOT COMPLETED|Overall Study||5
10916425|NCT00146770|12083317|FG001|NOT COMPLETED|Overall Study||0
10916426|NCT00146848|12083326|FG000|STARTED|Pre-randomization|Registered|1742
10916427|NCT00146848|12083327|FG001|STARTED|Pre-randomization||0
10916428|NCT00146848|12083328|FG002|STARTED|Pre-randomization||0
10916429|NCT00146848|12083326|FG000|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
10916430|NCT00146848|12083327|FG001|COMPLETED|Pre-randomization||0
10916431|NCT00146848|12083328|FG002|COMPLETED|Pre-randomization||0
10916432|NCT00146848|12083326|FG000|NOT COMPLETED|Pre-randomization||309
10916433|NCT00146848|12083327|FG001|NOT COMPLETED|Pre-randomization||0
10916434|NCT00146848|12083328|FG002|NOT COMPLETED|Pre-randomization||0
10916435|NCT00146848|12083326|FG000|STARTED|Post-randomization||475
10916436|NCT00146848|12083327|FG001|STARTED|Post-randomization||488
10916437|NCT00146848|12083328|FG002|STARTED|Post-randomization||470
10916438|NCT00146848|12083326|FG000|COMPLETED|Post-randomization||437
10916439|NCT00146848|12083327|FG001|COMPLETED|Post-randomization||441
10916440|NCT00146848|12083328|FG002|COMPLETED|Post-randomization||431
10916441|NCT00146848|12083326|FG000|NOT COMPLETED|Post-randomization||38
10916442|NCT00146848|12083327|FG001|NOT COMPLETED|Post-randomization||47
10916443|NCT00146848|12083328|FG002|NOT COMPLETED|Post-randomization||39
10916444|NCT00147017|12083339|FG000|STARTED|Overall Study||6
10916445|NCT00147017|12083340|FG001|STARTED|Overall Study||7
10916446|NCT00147017|12083341|FG002|STARTED|Overall Study||4
10916447|NCT00147017|12083339|FG000|COMPLETED|Overall Study||6
10916448|NCT00147017|12083340|FG001|COMPLETED|Overall Study||7
10916449|NCT00147017|12083341|FG002|COMPLETED|Overall Study||4
10916450|NCT00147017|12083339|FG000|NOT COMPLETED|Overall Study||0
10916451|NCT00147017|12083340|FG001|NOT COMPLETED|Overall Study||0
10916452|NCT00147017|12083341|FG002|NOT COMPLETED|Overall Study||0
10916453|NCT00147030|12083351|FG000|STARTED|Overall Study||163
10916454|NCT00147030|12083352|FG001|STARTED|Overall Study||162
10916455|NCT00147030|12083351|FG000|COMPLETED|Overall Study||163
10916456|NCT00147030|12083352|FG001|COMPLETED|Overall Study||162
10916457|NCT00147030|12083351|FG000|NOT COMPLETED|Overall Study||0
10916458|NCT00147030|12083352|FG001|NOT COMPLETED|Overall Study||0
10916459|NCT00147043|12083360|FG000|STARTED|Overall Study||5
10916460|NCT00147043|12083360|FG000|COMPLETED|Overall Study||5
10916461|NCT00147043|12083360|FG000|NOT COMPLETED|Overall Study||0
10916462|NCT00147069|12083369|FG000|STARTED|Overall Study||15
10916463|NCT00147069|12083370|FG001|STARTED|Overall Study||15
10916464|NCT00147069|12083371|FG002|STARTED|Overall Study||15
10916465|NCT00147069|12083372|FG003|STARTED|Overall Study||15
10916466|NCT00147069|12083369|FG000|COMPLETED|Overall Study||15
10916467|NCT00147069|12083370|FG001|COMPLETED|Overall Study||15
10916468|NCT00147069|12083371|FG002|COMPLETED|Overall Study||15
10916469|NCT00147069|12083372|FG003|COMPLETED|Overall Study||15
10916470|NCT00147069|12083369|FG000|NOT COMPLETED|Overall Study||0
10916471|NCT00147069|12083370|FG001|NOT COMPLETED|Overall Study||0
10916472|NCT00147069|12083371|FG002|NOT COMPLETED|Overall Study||0
10916473|NCT00147069|12083372|FG003|NOT COMPLETED|Overall Study||0
10916474|NCT00147082|12083385|FG000|STARTED|Overall Study||37
10916475|NCT00147082|12083386|FG001|STARTED|Overall Study||33
10916476|NCT00147082|12083387|FG002|STARTED|Overall Study||30
10916477|NCT00147082|12083385|FG000|COMPLETED|Overall Study||37
10916478|NCT00147082|12083386|FG001|COMPLETED|Overall Study||33
10916479|NCT00147082|12083387|FG002|COMPLETED|Overall Study||30
10916480|NCT00147082|12083385|FG000|NOT COMPLETED|Overall Study||0
10916481|NCT00147082|12083386|FG001|NOT COMPLETED|Overall Study||0
10916482|NCT00147082|12083387|FG002|NOT COMPLETED|Overall Study||0
10916483|NCT00147199|12083397|FG000|STARTED|Overall Study||115
10916484|NCT00147199|12083398|FG001|STARTED|Overall Study||120
10916485|NCT00147199|12083397|FG000|COMPLETED|Overall Study||102
10916486|NCT00147199|12083398|FG001|COMPLETED|Overall Study||110
10916487|NCT00147199|12083397|FG000|NOT COMPLETED|Overall Study||13
10916488|NCT00147199|12083398|FG001|NOT COMPLETED|Overall Study||10
10916489|NCT00147212|12083404|FG000|STARTED|Overall Study||50
10916490|NCT00147212|12083404|FG000|COMPLETED|Overall Study||50
10916491|NCT00147212|12083404|FG000|NOT COMPLETED|Overall Study||0
10916492|NCT00147225|12083414|FG000|STARTED|Overall Study||7
10916493|NCT00147225|12083415|FG001|STARTED|Overall Study||6
10916494|NCT00147225|12083416|FG002|STARTED|Overall Study||8
10916495|NCT00147225|12083417|FG003|STARTED|Overall Study||11
10916496|NCT00147225|12083418|FG004|STARTED|Overall Study||11
10916497|NCT00147225|12083419|FG005|STARTED|Overall Study||12
10916498|NCT00147225|12083414|FG000|COMPLETED|Overall Study||6
10916499|NCT00147225|12083415|FG001|COMPLETED|Overall Study||6
10916500|NCT00147225|12083416|FG002|COMPLETED|Overall Study||6
10916501|NCT00147225|12083417|FG003|COMPLETED|Overall Study||10
10916502|NCT00147225|12083418|FG004|COMPLETED|Overall Study||10
10916503|NCT00147225|12083419|FG005|COMPLETED|Overall Study||10
10916504|NCT00147225|12083414|FG000|NOT COMPLETED|Overall Study||1
10916505|NCT00147225|12083415|FG001|NOT COMPLETED|Overall Study||0
10916506|NCT00147225|12083416|FG002|NOT COMPLETED|Overall Study||2
10916507|NCT00147225|12083417|FG003|NOT COMPLETED|Overall Study||1
10916508|NCT00147225|12083418|FG004|NOT COMPLETED|Overall Study||1
10916509|NCT00147225|12083419|FG005|NOT COMPLETED|Overall Study||2
10916510|NCT00147251|12083435|FG000|STARTED|Recruitment and Enrollment||271
10916511|NCT00147251|12083436|FG001|STARTED|Recruitment and Enrollment||277
10916512|NCT00147251|12083435|FG000|COMPLETED|Recruitment and Enrollment||247
10916513|NCT00147251|12083436|FG001|COMPLETED|Recruitment and Enrollment||252
10916514|NCT00147251|12083435|FG000|NOT COMPLETED|Recruitment and Enrollment||24
10916515|NCT00147251|12083436|FG001|NOT COMPLETED|Recruitment and Enrollment||25
10916516|NCT00147251|12083435|FG000|STARTED|Follow up||247
10916517|NCT00147251|12083436|FG001|STARTED|Follow up||252
10916518|NCT00147251|12083435|FG000|COMPLETED|Follow up||247
10916519|NCT00147251|12083436|FG001|COMPLETED|Follow up||252
10916520|NCT00147251|12083435|FG000|NOT COMPLETED|Follow up||0
10916521|NCT00147251|12083436|FG001|NOT COMPLETED|Follow up||0
10916522|NCT00147316|12083444|FG000|STARTED|Overall Study||103
10916523|NCT00147316|12083444|FG000|COMPLETED|Overall Study||103
10916524|NCT00147316|12083444|FG000|NOT COMPLETED|Overall Study||0
10916525|NCT00147446|12083450|FG000|STARTED|Overall Study||60
10916526|NCT00147446|12083451|FG001|STARTED|Overall Study||61
10916527|NCT00147446|12083450|FG000|COMPLETED|Overall Study||60
10916528|NCT00147446|12083451|FG001|COMPLETED|Overall Study||61
10916529|NCT00147446|12083450|FG000|NOT COMPLETED|Overall Study||0
10916530|NCT00147446|12083451|FG001|NOT COMPLETED|Overall Study||0
10916531|NCT00147498|12083463|FG000|STARTED|Overall Study||61
10916532|NCT00147498|12083464|FG001|STARTED|Overall Study||69
10916533|NCT00147498|12083465|FG002|STARTED|Overall Study||69
10916534|NCT00147498|12083466|FG003|STARTED|Overall Study||65
10916535|NCT00147498|12083463|FG000|COMPLETED|Overall Study||58
10916536|NCT00147498|12083464|FG001|COMPLETED|Overall Study||60
10916537|NCT00147498|12083465|FG002|COMPLETED|Overall Study||52
10916538|NCT00147498|12083466|FG003|COMPLETED|Overall Study||48
10916539|NCT00147498|12083463|FG000|NOT COMPLETED|Overall Study||3
10916540|NCT00147498|12083464|FG001|NOT COMPLETED|Overall Study||9
10916541|NCT00147498|12083465|FG002|NOT COMPLETED|Overall Study||17
10916542|NCT00147498|12083466|FG003|NOT COMPLETED|Overall Study||17
10916543|NCT00147537|12083480|FG000|STARTED|Phase 1b||3
10916544|NCT00147537|12083481|FG001|STARTED|Phase 1b||2
10916545|NCT00147537|12083482|FG002|STARTED|Phase 1b||4
10916546|NCT00147537|12083483|FG003|STARTED|Phase 1b||3
10916547|NCT00147537|12083484|FG004|STARTED|Phase 1b||3
10916548|NCT00147537|12083485|FG005|STARTED|Phase 1b||3
10916549|NCT00147537|12083486|FG006|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
10916550|NCT00147537|12083487|FG007|STARTED|Phase 1b||7
10916551|NCT00147537|12083488|FG008|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
10916552|NCT00147537|12083489|FG009|STARTED|Phase 1b||0
10916553|NCT00147537|12083490|FG010|STARTED|Phase 1b||0
10916554|NCT00147537|12083480|FG000|COMPLETED|Phase 1b||1
10916555|NCT00147537|12083481|FG001|COMPLETED|Phase 1b||0
10916556|NCT00147537|12083482|FG002|COMPLETED|Phase 1b||0
10916557|NCT00147537|12083483|FG003|COMPLETED|Phase 1b||1
10916558|NCT00147537|12083484|FG004|COMPLETED|Phase 1b||0
10916559|NCT00147537|12083485|FG005|COMPLETED|Phase 1b||0
10916560|NCT00147537|12083486|FG006|COMPLETED|Phase 1b||0
10916561|NCT00147537|12083487|FG007|COMPLETED|Phase 1b||0
10916562|NCT00147537|12083488|FG008|COMPLETED|Phase 1b||1
10916563|NCT00147537|12083489|FG009|COMPLETED|Phase 1b||0
10916564|NCT00147537|12083490|FG010|COMPLETED|Phase 1b||0
10916565|NCT00147537|12083480|FG000|NOT COMPLETED|Phase 1b||2
10916566|NCT00147537|12083481|FG001|NOT COMPLETED|Phase 1b||2
10916567|NCT00147537|12083482|FG002|NOT COMPLETED|Phase 1b||4
10916568|NCT00147537|12083483|FG003|NOT COMPLETED|Phase 1b||2
10916569|NCT00147537|12083484|FG004|NOT COMPLETED|Phase 1b||3
10916570|NCT00147537|12083485|FG005|NOT COMPLETED|Phase 1b||3
10916571|NCT00147537|12083486|FG006|NOT COMPLETED|Phase 1b||18
10916572|NCT00147537|12083487|FG007|NOT COMPLETED|Phase 1b||7
10916573|NCT00147537|12083488|FG008|NOT COMPLETED|Phase 1b||17
10916574|NCT00147537|12083489|FG009|NOT COMPLETED|Phase 1b||0
10916575|NCT00147537|12083490|FG010|NOT COMPLETED|Phase 1b||0
10916576|NCT00147537|12083480|FG000|STARTED|Phase 2||0
10916577|NCT00147537|12083481|FG001|STARTED|Phase 2||0
10916578|NCT00147537|12083482|FG002|STARTED|Phase 2||0
10916579|NCT00147537|12083483|FG003|STARTED|Phase 2||0
10916580|NCT00147537|12083484|FG004|STARTED|Phase 2||0
10916581|NCT00147537|12083485|FG005|STARTED|Phase 2||0
10916582|NCT00147537|12083486|FG006|STARTED|Phase 2||0
10916583|NCT00147537|12083487|FG007|STARTED|Phase 2||0
10916584|NCT00147537|12083488|FG008|STARTED|Phase 2||0
10916585|NCT00147537|12083489|FG009|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
10916586|NCT00147537|12083490|FG010|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
10916587|NCT00147537|12083480|FG000|COMPLETED|Phase 2||0
10916588|NCT00147537|12083481|FG001|COMPLETED|Phase 2||0
10916589|NCT00147537|12083482|FG002|COMPLETED|Phase 2||0
10916590|NCT00147537|12083483|FG003|COMPLETED|Phase 2||0
10916591|NCT00147537|12083484|FG004|COMPLETED|Phase 2||0
10916592|NCT00147537|12083485|FG005|COMPLETED|Phase 2||0
10916593|NCT00147537|12083486|FG006|COMPLETED|Phase 2||0
10916594|NCT00147537|12083487|FG007|COMPLETED|Phase 2||0
10916595|NCT00147537|12083488|FG008|COMPLETED|Phase 2||0
10916596|NCT00147537|12083489|FG009|COMPLETED|Phase 2||5
10916597|NCT00147537|12083490|FG010|COMPLETED|Phase 2||3
10916598|NCT00147537|12083480|FG000|NOT COMPLETED|Phase 2||0
10916599|NCT00147537|12083481|FG001|NOT COMPLETED|Phase 2||0
10916600|NCT00147537|12083482|FG002|NOT COMPLETED|Phase 2||0
10916601|NCT00147537|12083483|FG003|NOT COMPLETED|Phase 2||0
10916602|NCT00147537|12083484|FG004|NOT COMPLETED|Phase 2||0
10916603|NCT00147537|12083485|FG005|NOT COMPLETED|Phase 2||0
10916604|NCT00147537|12083486|FG006|NOT COMPLETED|Phase 2||0
10916605|NCT00147537|12083487|FG007|NOT COMPLETED|Phase 2||0
10916606|NCT00147537|12083488|FG008|NOT COMPLETED|Phase 2||0
10916607|NCT00147537|12083489|FG009|NOT COMPLETED|Phase 2||161
10916608|NCT00147537|12083490|FG010|NOT COMPLETED|Phase 2||52
10916609|NCT00147745|12083538|FG000|STARTED|Overall Study||16
10916610|NCT00147745|12083539|FG001|STARTED|Overall Study||14
10916611|NCT00147745|12083540|FG002|STARTED|Overall Study||6
10916612|NCT00147745|12083538|FG000|COMPLETED|Overall Study||15
10916613|NCT00147745|12083539|FG001|COMPLETED|Overall Study||14
10916614|NCT00147745|12083540|FG002|COMPLETED|Overall Study||6
10916615|NCT00147745|12083538|FG000|NOT COMPLETED|Overall Study||1
10916616|NCT00147745|12083539|FG001|NOT COMPLETED|Overall Study||0
10916617|NCT00147745|12083540|FG002|NOT COMPLETED|Overall Study||0
10916618|NCT00147823|12083550|FG000|STARTED|Overall Study||32
10916619|NCT00147823|12083551|FG001|STARTED|Overall Study||31
10916620|NCT00147823|12083550|FG000|Week 6 Visit|Overall Study||26
10916621|NCT00147823|12083551|FG001|Week 6 Visit|Overall Study||28
10916622|NCT00147823|12083550|FG000|Month 3 Visit|Overall Study||25
10916623|NCT00147823|12083551|FG001|Month 3 Visit|Overall Study||24
10916624|NCT00147823|12083550|FG000|Month 6 Visit|Overall Study||25
10916625|NCT00147823|12083551|FG001|Month 6 Visit|Overall Study||21
10916626|NCT00147823|12083550|FG000|Month 12 Visit|Overall Study||21
10916627|NCT00147823|12083551|FG001|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
10916628|NCT00147823|12083550|FG000|Month 12 CT Scan|Overall Study||20
10916629|NCT00147823|12083551|FG001|Month 12 CT Scan|Overall Study||25
10916630|NCT00147823|12083550|FG000|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
10916631|NCT00147823|12083551|FG001|Month 18 Visit|Overall Study||20
10916632|NCT00147823|12083550|FG000|Month 24 Visit|Overall Study||21
10916633|NCT00147823|12083551|FG001|Month 24 Visit|Overall Study||18
10916634|NCT00147823|12083550|FG000|COMPLETED|Overall Study||19
10916635|NCT00147823|12083551|FG001|COMPLETED|Overall Study||16
10916636|NCT00147823|12083550|FG000|NOT COMPLETED|Overall Study||13
10916637|NCT00147823|12083551|FG001|NOT COMPLETED|Overall Study||15
10916638|NCT00147966|12083557|FG000|STARTED|Overall Study||24
10916639|NCT00147966|12083557|FG000|COMPLETED|Overall Study||24
10916640|NCT00147966|12083557|FG000|NOT COMPLETED|Overall Study||0
10916641|NCT00148109|12083563|FG000|STARTED|Overall Study||15
10916642|NCT00148109|12083564|FG001|STARTED|Overall Study||21
10916643|NCT00148109|12083563|FG000|COMPLETED|Overall Study||3
10916644|NCT00148109|12083564|FG001|COMPLETED|Overall Study||1
10916645|NCT00148109|12083563|FG000|NOT COMPLETED|Overall Study||12
10916646|NCT00148109|12083564|FG001|NOT COMPLETED|Overall Study||20
10916647|NCT00148122|12083570|FG000|STARTED|Overall Study||40
10916648|NCT00148122|12083570|FG000|COMPLETED|Overall Study||38
10916649|NCT00148122|12083570|FG000|NOT COMPLETED|Overall Study||2
10916650|NCT00148317|12083574|FG000|STARTED|Consolidation (VEL + DEX)||38
10916651|NCT00148317|12083574|FG000|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
10916652|NCT00148317|12083574|FG000|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
10916653|NCT00148317|12083574|FG000|no DOXIL Added|Consolidation (VEL + DEX)||10
10916654|NCT00148317|12083574|FG000|COMPLETED|Consolidation (VEL + DEX)||38
10916655|NCT00148317|12083574|FG000|NOT COMPLETED|Consolidation (VEL + DEX)||0
10916656|NCT00148317|12083574|FG000|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
10916657|NCT00148317|12083574|FG000|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
10916658|NCT00148317|12083574|FG000|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
10916659|NCT00148343|12083583|FG000|STARTED|Overall Study||54
10916660|NCT00148343|12083584|FG001|STARTED|Overall Study||56
10916661|NCT00148343|12083583|FG000|COMPLETED|Overall Study||39
10916662|NCT00148343|12083584|FG001|COMPLETED|Overall Study||45
10916663|NCT00148343|12083583|FG000|NOT COMPLETED|Overall Study||15
10916664|NCT00148343|12083584|FG001|NOT COMPLETED|Overall Study||11
10916665|NCT00148668|12083592|FG000|STARTED|Overall Study||41
10916666|NCT00148668|12083593|FG001|STARTED|Overall Study||40
10916667|NCT00148668|12083592|FG000|COMPLETED|Overall Study||41
10916668|NCT00148668|12083593|FG001|COMPLETED|Overall Study||40
10916669|NCT00148668|12083592|FG000|NOT COMPLETED|Overall Study||0
10916670|NCT00148668|12083593|FG001|NOT COMPLETED|Overall Study||0
10916671|NCT00148759|12083601|FG000|STARTED|Overall Study||11
10916672|NCT00148759|12083602|FG001|STARTED|Overall Study||12
10916673|NCT00148759|12083601|FG000|24-hr PK Sampling|Overall Study||9
10916674|NCT00148759|12083602|FG001|24-hr PK Sampling|Overall Study||11
10916675|NCT00148759|12083601|FG000|COMPLETED|Overall Study||9
10916676|NCT00148759|12083602|FG001|COMPLETED|Overall Study||11
10916677|NCT00148759|12083601|FG000|NOT COMPLETED|Overall Study||2
10916678|NCT00148759|12083602|FG001|NOT COMPLETED|Overall Study||1
10916679|NCT00148798|12083610|FG000|STARTED|Overall Study|Intent To Treat (ITT) Population|557
10916680|NCT00148798|12083611|FG001|STARTED|Overall Study|ITT Population|568
10916681|NCT00148798|12083610|FG000|COMPLETED|Overall Study||557
10916682|NCT00148798|12083611|FG001|COMPLETED|Overall Study||568
10916683|NCT00148798|12083610|FG000|NOT COMPLETED|Overall Study||0
10916684|NCT00148798|12083611|FG001|NOT COMPLETED|Overall Study||0
10916685|NCT00148941|12083623|FG000|STARTED|Overall Study||1053
10916686|NCT00148941|12083624|FG001|STARTED|Overall Study||1051
10916687|NCT00148941|12083625|FG002|STARTED|Overall Study||1052
10916688|NCT00148941|12083626|FG003|STARTED|Overall Study||1053
10916689|NCT00148941|12083623|FG000|COMPLETED|Overall Study||1035
10916690|NCT00148941|12083624|FG001|COMPLETED|Overall Study||1027
10916691|NCT00148941|12083625|FG002|COMPLETED|Overall Study||1032
10916692|NCT00148941|12083626|FG003|COMPLETED|Overall Study||1029
10916693|NCT00148941|12083623|FG000|NOT COMPLETED|Overall Study||18
10916694|NCT00148941|12083624|FG001|NOT COMPLETED|Overall Study||24
10916695|NCT00148941|12083625|FG002|NOT COMPLETED|Overall Study||20
10916696|NCT00148941|12083626|FG003|NOT COMPLETED|Overall Study||24
10916697|NCT00148954|12083638|FG000|STARTED|Overall Study||985
10916698|NCT00148954|12083639|FG001|STARTED|Overall Study||977
10916699|NCT00148954|12083638|FG000|COMPLETED|Overall Study||678
10916700|NCT00148954|12083639|FG001|COMPLETED|Overall Study||677
10916701|NCT00148954|12083638|FG000|NOT COMPLETED|Overall Study||307
10916702|NCT00148954|12083639|FG001|NOT COMPLETED|Overall Study||300
10916703|NCT00149214|12083647|FG000|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
10916704|NCT00149214|12083648|FG001|STARTED|Overall Study||122
10916705|NCT00149214|12083647|FG000|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
10916706|NCT00149214|12083648|FG001|COMPLETED|Overall Study||105
10916707|NCT00149214|12083647|FG000|NOT COMPLETED|Overall Study||26
10916708|NCT00149214|12083648|FG001|NOT COMPLETED|Overall Study||17
10916709|NCT00149227|12083656|FG000|STARTED|Overall Study||1517
10916710|NCT00149227|12083657|FG001|STARTED|Overall Study||1514
10916711|NCT00149227|12083656|FG000|COMPLETED|Overall Study||1517
10916712|NCT00149227|12083657|FG001|COMPLETED|Overall Study||1514
10916713|NCT00149227|12083656|FG000|NOT COMPLETED|Overall Study||0
10916714|NCT00149227|12083657|FG001|NOT COMPLETED|Overall Study||0
10916715|NCT00149396|12083663|FG000|STARTED|Overall Study||32
10916716|NCT00149396|12083663|FG000|Completed NV1020 Therapy|Overall Study||29
10916717|NCT00149396|12083663|FG000|Completed NV1020 and Chemotherapy|Overall Study||9
10916718|NCT00149396|12083663|FG000|COMPLETED|Overall Study||9
10916719|NCT00149396|12083663|FG000|NOT COMPLETED|Overall Study||23
10916720|NCT00149630|12083676|FG000|STARTED|Overall Study||34
10916721|NCT00149630|12083677|FG001|STARTED|Overall Study||40
10916722|NCT00149630|12083676|FG000|COMPLETED|Overall Study||26
10916723|NCT00149630|12083677|FG001|COMPLETED|Overall Study||35
10916724|NCT00149630|12083676|FG000|NOT COMPLETED|Overall Study||8
10916725|NCT00149630|12083677|FG001|NOT COMPLETED|Overall Study||5
10916726|NCT00149643|12083689|FG000|STARTED|Overall Study||34
10916727|NCT00149643|12083690|FG001|STARTED|Overall Study||36
10916728|NCT00149643|12083689|FG000|COMPLETED|Overall Study||0
10916729|NCT00149643|12083690|FG001|COMPLETED|Overall Study||0
10916730|NCT00149643|12083689|FG000|NOT COMPLETED|Overall Study||34
10916731|NCT00149643|12083690|FG001|NOT COMPLETED|Overall Study||36
10916732|NCT00149669|12083698|FG000|STARTED|Overall Study||32
10916733|NCT00149669|12083699|FG001|STARTED|Overall Study||35
10916734|NCT00149669|12083698|FG000|COMPLETED|Overall Study||29
10916735|NCT00149669|12083699|FG001|COMPLETED|Overall Study||30
10916736|NCT00149669|12083698|FG000|NOT COMPLETED|Overall Study||3
10916737|NCT00149669|12083699|FG001|NOT COMPLETED|Overall Study||5
10916738|NCT00149734|12083707|FG000|STARTED|Overall Study||4
10916739|NCT00149734|12083708|FG001|STARTED|Overall Study||4
10916740|NCT00149734|12083707|FG000|Started Intervention 2|Overall Study||4
10916741|NCT00149734|12083708|FG001|Started Intervention 2|Overall Study||4
10916742|NCT00149734|12083707|FG000|COMPLETED|Overall Study||4
10916743|NCT00149734|12083708|FG001|COMPLETED|Overall Study||4
10916744|NCT00149734|12083707|FG000|NOT COMPLETED|Overall Study||0
10916745|NCT00149734|12083708|FG001|NOT COMPLETED|Overall Study||0
10916746|NCT00149747|12083716|FG000|STARTED|Overall Study||36
10916747|NCT00149747|12083717|FG001|STARTED|Overall Study||30
10916748|NCT00149747|12083716|FG000|COMPLETED|Overall Study||32
10916749|NCT00149747|12083717|FG001|COMPLETED|Overall Study||27
10916750|NCT00149747|12083716|FG000|NOT COMPLETED|Overall Study||4
10916751|NCT00149747|12083717|FG001|NOT COMPLETED|Overall Study||3
10916752|NCT00149799|12083725|FG000|STARTED|Open Label Escitalopram (Phase I)||100
10916753|NCT00149799|12083726|FG001|STARTED|Open Label Escitalopram (Phase I)||0
10916754|NCT00149799|12083727|FG002|STARTED|Open Label Escitalopram (Phase I)||0
10916755|NCT00149799|12083725|FG000|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
10916756|NCT00149799|12083726|FG001|COMPLETED|Open Label Escitalopram (Phase I)||0
10916757|NCT00149799|12083727|FG002|COMPLETED|Open Label Escitalopram (Phase I)||0
10916758|NCT00149799|12083725|FG000|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
10916759|NCT00149799|12083726|FG001|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
10916760|NCT00149799|12083727|FG002|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
10916761|NCT00149799|12083725|FG000|STARTED|Discontinuation (Phase II)||0
10916762|NCT00149799|12083726|FG001|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
10916763|NCT00149799|12083727|FG002|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
10916764|NCT00149799|12083725|FG000|COMPLETED|Discontinuation (Phase II)||0
10916765|NCT00149799|12083726|FG001|COMPLETED|Discontinuation (Phase II)||25
10916766|NCT00149799|12083727|FG002|COMPLETED|Discontinuation (Phase II)||21
10916767|NCT00149799|12083725|FG000|NOT COMPLETED|Discontinuation (Phase II)||0
10916768|NCT00149799|12083726|FG001|NOT COMPLETED|Discontinuation (Phase II)||3
10916769|NCT00149799|12083727|FG002|NOT COMPLETED|Discontinuation (Phase II)||9
10916770|NCT00149825|12083737|FG000|STARTED|Overall Study||15
10916771|NCT00149825|12083738|FG001|STARTED|Overall Study||15
10916772|NCT00149825|12083737|FG000|COMPLETED|Overall Study||10
10916773|NCT00149825|12083738|FG001|COMPLETED|Overall Study||12
10916774|NCT00149825|12083737|FG000|NOT COMPLETED|Overall Study||5
10916775|NCT00149825|12083738|FG001|NOT COMPLETED|Overall Study||3
10916776|NCT00149838|12083746|FG000|STARTED|Phase I||92
10916777|NCT00149838|12083747|FG001|STARTED|Phase I||98
10916778|NCT00149838|12083748|FG002|STARTED|Phase I||0
10916779|NCT00149838|12083749|FG003|STARTED|Phase I||0
10916780|NCT00149838|12083746|FG000|COMPLETED|Phase I||72
10916781|NCT00149838|12083747|FG001|COMPLETED|Phase I||82
10916782|NCT00149838|12083748|FG002|COMPLETED|Phase I||0
10916783|NCT00149838|12083749|FG003|COMPLETED|Phase I||0
10916784|NCT00149838|12083746|FG000|NOT COMPLETED|Phase I||20
10916785|NCT00149838|12083747|FG001|NOT COMPLETED|Phase I||16
10916786|NCT00149838|12083748|FG002|NOT COMPLETED|Phase I||0
10916787|NCT00149838|12083749|FG003|NOT COMPLETED|Phase I||0
10916788|NCT00149838|12083746|FG000|STARTED|Phase II||0
10916789|NCT00149838|12083747|FG001|STARTED|Phase II||0
10916790|NCT00149838|12083748|FG002|STARTED|Phase II||144
10916791|NCT00149838|12083749|FG003|STARTED|Phase II||0
10916792|NCT00149838|12083746|FG000|COMPLETED|Phase II||0
10916793|NCT00149838|12083747|FG001|COMPLETED|Phase II||0
10916794|NCT00149838|12083748|FG002|COMPLETED|Phase II||144
10916795|NCT00149838|12083749|FG003|COMPLETED|Phase II||0
10916796|NCT00149838|12083746|FG000|NOT COMPLETED|Phase II||0
10916797|NCT00149838|12083747|FG001|NOT COMPLETED|Phase II||0
10916798|NCT00149838|12083748|FG002|NOT COMPLETED|Phase II||0
10916799|NCT00149838|12083749|FG003|NOT COMPLETED|Phase II||0
10916800|NCT00149838|12083746|FG000|STARTED|Phase III||0
10916801|NCT00149838|12083747|FG001|STARTED|Phase III||0
10916802|NCT00149838|12083748|FG002|STARTED|Phase III||0
10916803|NCT00149838|12083749|FG003|STARTED|Phase III||61
10916804|NCT00149838|12083746|FG000|COMPLETED|Phase III||0
10916805|NCT00149838|12083747|FG001|COMPLETED|Phase III||0
10916806|NCT00149838|12083748|FG002|COMPLETED|Phase III||0
10916807|NCT00149838|12083749|FG003|COMPLETED|Phase III||37
10916808|NCT00149838|12083746|FG000|NOT COMPLETED|Phase III||0
10916809|NCT00149838|12083747|FG001|NOT COMPLETED|Phase III||0
10916810|NCT00149838|12083748|FG002|NOT COMPLETED|Phase III||0
10916811|NCT00149838|12083749|FG003|NOT COMPLETED|Phase III||24
10916812|NCT00149890|12083761|FG000|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
10916813|NCT00149890|12083762|FG001|STARTED|Overall Study||38
10916814|NCT00149890|12083761|FG000|COMPLETED|Overall Study||26
10916815|NCT00149890|12083762|FG001|COMPLETED|Overall Study||20
10916816|NCT00149890|12083761|FG000|NOT COMPLETED|Overall Study||13
10916817|NCT00149890|12083762|FG001|NOT COMPLETED|Overall Study||18
10916818|NCT00149994|12083770|FG000|STARTED|Overall Study|"Started indicates Safety population."|85
10916819|NCT00149994|12083771|FG001|STARTED|Overall Study||86
10916820|NCT00149994|12083770|FG000|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
10916821|NCT00149994|12083771|FG001|COMPLETED|Overall Study||85
10916822|NCT00149994|12083770|FG000|NOT COMPLETED|Overall Study||1
10916823|NCT00149994|12083771|FG001|NOT COMPLETED|Overall Study||1
10916824|NCT00150345|12083779|FG000|STARTED|Overall Study||81
10916825|NCT00150345|12083780|FG001|STARTED|Overall Study||66
10916826|NCT00150345|12083779|FG000|COMPLETED|Overall Study||47
10916827|NCT00150345|12083780|FG001|COMPLETED|Overall Study||34
10916828|NCT00150345|12083779|FG000|NOT COMPLETED|Overall Study||34
10916829|NCT00150345|12083780|FG001|NOT COMPLETED|Overall Study||32
10916830|NCT00150462|12083798|FG000|STARTED|Overall Study||3
10916831|NCT00150462|12083799|FG001|STARTED|Overall Study||3
10916832|NCT00150462|12083800|FG002|STARTED|Overall Study||4
10916833|NCT00150462|12083801|FG003|STARTED|Overall Study||3
10916834|NCT00150462|12083802|FG004|STARTED|Overall Study||3
10916835|NCT00150462|12083803|FG005|STARTED|Overall Study||4
10916836|NCT00150462|12083804|FG006|STARTED|Overall Study||3
10916837|NCT00150462|12083805|FG007|STARTED|Overall Study||8
10916838|NCT00150462|12083806|FG008|STARTED|Overall Study||6
10916839|NCT00150462|12083807|FG009|STARTED|Overall Study||7
10916840|NCT00150462|12083808|FG010|STARTED|Overall Study||4
10916841|NCT00150462|12083798|FG000|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10916842|NCT00150462|12083799|FG001|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10916843|NCT00150462|12083800|FG002|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10916844|NCT00150462|12083801|FG003|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10916845|NCT00150462|12083802|FG004|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10916846|NCT00150462|12083803|FG005|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10916847|NCT00150462|12083804|FG006|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10916848|NCT00150462|12083805|FG007|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10916849|NCT00150462|12083806|FG008|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
10916850|NCT00150462|12083807|FG009|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
10916851|NCT00150462|12083808|FG010|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
10916852|NCT00150462|12083798|FG000|NOT COMPLETED|Overall Study||3
10916853|NCT00150462|12083799|FG001|NOT COMPLETED|Overall Study||3
10916854|NCT00150462|12083800|FG002|NOT COMPLETED|Overall Study||4
10916855|NCT00150462|12083801|FG003|NOT COMPLETED|Overall Study||3
10916856|NCT00150462|12083802|FG004|NOT COMPLETED|Overall Study||3
10916857|NCT00150462|12083803|FG005|NOT COMPLETED|Overall Study||4
10916858|NCT00150462|12083804|FG006|NOT COMPLETED|Overall Study||3
10916859|NCT00150462|12083805|FG007|NOT COMPLETED|Overall Study||8
10916860|NCT00150462|12083806|FG008|NOT COMPLETED|Overall Study||6
10916861|NCT00150462|12083807|FG009|NOT COMPLETED|Overall Study||6
10916862|NCT00150462|12083808|FG010|NOT COMPLETED|Overall Study||3
10916863|NCT00150592|12083837|FG000|STARTED|Overall Study||121
10916864|NCT00150592|12083838|FG001|STARTED|Overall Study||57
10916865|NCT00150592|12083837|FG000|COMPLETED|Overall Study||114
10916866|NCT00150592|12083838|FG001|COMPLETED|Overall Study||54
10916867|NCT00150592|12083837|FG000|NOT COMPLETED|Overall Study||7
10916868|NCT00150592|12083838|FG001|NOT COMPLETED|Overall Study||3
10916869|NCT00150618|12083849|FG000|STARTED|Overall Study||62
10916870|NCT00150618|12083850|FG001|STARTED|Overall Study||65
10916871|NCT00150618|12083851|FG002|STARTED|Overall Study||65
10916872|NCT00150618|12083852|FG003|STARTED|Overall Study||66
10916873|NCT00150618|12083853|FG004|STARTED|Overall Study||66
10916874|NCT00150618|12083849|FG000|COMPLETED|Overall Study||45
10916875|NCT00150618|12083850|FG001|COMPLETED|Overall Study||47
10916876|NCT00150618|12083851|FG002|COMPLETED|Overall Study||38
10916877|NCT00150618|12083852|FG003|COMPLETED|Overall Study||40
10916878|NCT00150618|12083853|FG004|COMPLETED|Overall Study||41
10916879|NCT00150618|12083849|FG000|NOT COMPLETED|Overall Study||17
10916880|NCT00150618|12083850|FG001|NOT COMPLETED|Overall Study||18
10916881|NCT00150618|12083851|FG002|NOT COMPLETED|Overall Study||27
10916882|NCT00150618|12083852|FG003|NOT COMPLETED|Overall Study||26
10916883|NCT00150618|12083853|FG004|NOT COMPLETED|Overall Study||25
10916884|NCT00150800|12083865|FG000|STARTED|Overall Study||667
10916885|NCT00150800|12083865|FG000|COMPLETED|Overall Study||171
10916886|NCT00150800|12083865|FG000|NOT COMPLETED|Overall Study||496
10916887|NCT00150813|12083870|FG000|STARTED|Overall Study||66
10916888|NCT00150813|12083870|FG000|COMPLETED|Overall Study||48
10916889|NCT00150813|12083870|FG000|NOT COMPLETED|Overall Study||18
10916890|NCT00150969|12083876|FG000|STARTED|24 Month Main Study||217
10916891|NCT00150969|12083877|FG001|STARTED|24 Month Main Study||223
10916892|NCT00150969|12083876|FG000|COMPLETED|24 Month Main Study||198
10916893|NCT00150969|12083877|FG001|COMPLETED|24 Month Main Study||202
10916894|NCT00150969|12083876|FG000|NOT COMPLETED|24 Month Main Study||19
10916895|NCT00150969|12083877|FG001|NOT COMPLETED|24 Month Main Study||21
10916896|NCT00150969|12083876|FG000|STARTED|24-48 Month Extension||121
10916897|NCT00150969|12083877|FG001|STARTED|24-48 Month Extension||140
10916898|NCT00150969|12083876|FG000|COMPLETED|24-48 Month Extension||33
10916899|NCT00150969|12083877|FG001|COMPLETED|24-48 Month Extension||40
10916900|NCT00150969|12083876|FG000|NOT COMPLETED|24-48 Month Extension||88
10916901|NCT00150969|12083877|FG001|NOT COMPLETED|24-48 Month Extension||100
10916902|NCT00151281|12083884|FG000|STARTED|Overall Study||25
10916903|NCT00151281|12083884|FG000|COMPLETED|Overall Study||22
10916904|NCT00151281|12083884|FG000|NOT COMPLETED|Overall Study||3
10916905|NCT00151320|12083891|FG000|STARTED|Overall Study||76
10916906|NCT00151320|12083891|FG000|COMPLETED|Overall Study||76
10916907|NCT00151320|12083891|FG000|NOT COMPLETED|Overall Study||0
10916908|NCT00151372|12083898|FG000|STARTED|Overall Study||67
10916909|NCT00151372|12083899|FG001|STARTED|Overall Study||74
10916910|NCT00151372|12083898|FG000|COMPLETED|Overall Study||38
10916911|NCT00151372|12083899|FG001|COMPLETED|Overall Study||45
10916912|NCT00151372|12083898|FG000|NOT COMPLETED|Overall Study||29
10916913|NCT00151372|12083899|FG001|NOT COMPLETED|Overall Study||29
10916914|NCT00151411|12083907|FG000|STARTED|Overall Study||55
10916915|NCT00151411|12083908|FG001|STARTED|Overall Study||59
10916916|NCT00151411|12083907|FG000|COMPLETED|Overall Study||22
10916917|NCT00151411|12083908|FG001|COMPLETED|Overall Study||16
10916918|NCT00151411|12083907|FG000|NOT COMPLETED|Overall Study||33
10916919|NCT00151411|12083908|FG001|NOT COMPLETED|Overall Study||43
10916920|NCT00151476|12083917|FG000|STARTED|FAP Identified Subjects||13
10916921|NCT00151476|12083918|FG001|STARTED|FAP Identified Subjects||55
10916922|NCT00151476|12083917|FG000|COMPLETED|FAP Identified Subjects||13
10916923|NCT00151476|12083918|FG001|COMPLETED|FAP Identified Subjects||54
10916924|NCT00151476|12083917|FG000|NOT COMPLETED|FAP Identified Subjects||0
10916925|NCT00151476|12083918|FG001|NOT COMPLETED|FAP Identified Subjects||1
10916926|NCT00151476|12083917|FG000|STARTED|FAP Analyzed Subjects||13
10916927|NCT00151476|12083918|FG001|STARTED|FAP Analyzed Subjects||54
10916928|NCT00151476|12083917|FG000|COMPLETED|FAP Analyzed Subjects||13
10916929|NCT00151476|12083918|FG001|COMPLETED|FAP Analyzed Subjects||51
10916930|NCT00151476|12083917|FG000|NOT COMPLETED|FAP Analyzed Subjects||0
10916931|NCT00151476|12083918|FG001|NOT COMPLETED|FAP Analyzed Subjects||3
10916932|NCT00151775|12083930|FG000|STARTED|Period 2 - Double-Blind Dose Response||95
10916933|NCT00151775|12083931|FG001|STARTED|Period 2 - Double-Blind Dose Response||95
10916934|NCT00151775|12083932|FG002|STARTED|Period 2 - Double-Blind Dose Response||0
10916935|NCT00151775|12083933|FG003|STARTED|Period 2 - Double-Blind Dose Response||0
10916936|NCT00151775|12083934|FG004|STARTED|Period 2 - Double-Blind Dose Response||0
10916937|NCT00151775|12083935|FG005|STARTED|Period 2 - Double-Blind Dose Response||56
10916938|NCT00151775|12083936|FG006|STARTED|Period 2 - Double-Blind Dose Response||56
10916939|NCT00151775|12083937|FG007|STARTED|Period 2 - Double-Blind Dose Response||0
10916940|NCT00151775|12083938|FG008|STARTED|Period 2 - Double-Blind Dose Response||0
10916941|NCT00151775|12083939|FG009|STARTED|Period 2 - Double-Blind Dose Response||0
10916942|NCT00151775|12083940|FG010|STARTED|Period 2 - Double-Blind Dose Response||60
10916943|NCT00151775|12083941|FG011|STARTED|Period 2 - Double-Blind Dose Response||0
10916944|NCT00151775|12083930|FG000|COMPLETED|Period 2 - Double-Blind Dose Response||93
10916945|NCT00151775|12083931|FG001|COMPLETED|Period 2 - Double-Blind Dose Response||89
10916946|NCT00151775|12083932|FG002|COMPLETED|Period 2 - Double-Blind Dose Response||0
10916947|NCT00151775|12083933|FG003|COMPLETED|Period 2 - Double-Blind Dose Response||0
10916948|NCT00151775|12083934|FG004|COMPLETED|Period 2 - Double-Blind Dose Response||0
10916949|NCT00151775|12083935|FG005|COMPLETED|Period 2 - Double-Blind Dose Response||54
10916950|NCT00151775|12083936|FG006|COMPLETED|Period 2 - Double-Blind Dose Response||53
10916951|NCT00151775|12083937|FG007|COMPLETED|Period 2 - Double-Blind Dose Response||0
10916952|NCT00151775|12083938|FG008|COMPLETED|Period 2 - Double-Blind Dose Response||0
10916953|NCT00151775|12083939|FG009|COMPLETED|Period 2 - Double-Blind Dose Response||0
10916954|NCT00151775|12083940|FG010|COMPLETED|Period 2 - Double-Blind Dose Response||59
10916955|NCT00151775|12083941|FG011|COMPLETED|Period 2 - Double-Blind Dose Response||0
10916956|NCT00151775|12083930|FG000|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
10916957|NCT00151775|12083931|FG001|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
10916958|NCT00151775|12083932|FG002|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
10916959|NCT00151775|12083933|FG003|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
10916960|NCT00151775|12083934|FG004|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
10916961|NCT00151775|12083935|FG005|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
10916962|NCT00151775|12083936|FG006|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
10916963|NCT00151775|12083937|FG007|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
10916964|NCT00151775|12083938|FG008|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
10916965|NCT00151775|12083939|FG009|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
10916966|NCT00151775|12083940|FG010|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
10916967|NCT00151775|12083941|FG011|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
10916968|NCT00151775|12083930|FG000|STARTED|Period 3: Double-blind, Withdrawal||48
10916969|NCT00151775|12083931|FG001|STARTED|Period 3: Double-blind, Withdrawal||45
10916970|NCT00151775|12083932|FG002|STARTED|Period 3: Double-blind, Withdrawal||45
10916971|NCT00151775|12083933|FG003|STARTED|Period 3: Double-blind, Withdrawal||44
10916972|NCT00151775|12083934|FG004|STARTED|Period 3: Double-blind, Withdrawal||0
10916973|NCT00151775|12083935|FG005|STARTED|Period 3: Double-blind, Withdrawal||26
10916974|NCT00151775|12083936|FG006|STARTED|Period 3: Double-blind, Withdrawal||27
10916975|NCT00151775|12083937|FG007|STARTED|Period 3: Double-blind, Withdrawal||28
10916976|NCT00151775|12083938|FG008|STARTED|Period 3: Double-blind, Withdrawal||26
10916977|NCT00151775|12083939|FG009|STARTED|Period 3: Double-blind, Withdrawal||0
10916978|NCT00151775|12083940|FG010|STARTED|Period 3: Double-blind, Withdrawal||29
10916979|NCT00151775|12083941|FG011|STARTED|Period 3: Double-blind, Withdrawal||29
10916980|NCT00151775|12083930|FG000|COMPLETED|Period 3: Double-blind, Withdrawal||48
10916981|NCT00151775|12083931|FG001|COMPLETED|Period 3: Double-blind, Withdrawal||45
10916982|NCT00151775|12083932|FG002|COMPLETED|Period 3: Double-blind, Withdrawal||42
10916983|NCT00151775|12083933|FG003|COMPLETED|Period 3: Double-blind, Withdrawal||44
10916984|NCT00151775|12083934|FG004|COMPLETED|Period 3: Double-blind, Withdrawal||0
10916985|NCT00151775|12083935|FG005|COMPLETED|Period 3: Double-blind, Withdrawal||25
10916986|NCT00151775|12083936|FG006|COMPLETED|Period 3: Double-blind, Withdrawal||26
10916987|NCT00151775|12083937|FG007|COMPLETED|Period 3: Double-blind, Withdrawal||27
10916988|NCT00151775|12083938|FG008|COMPLETED|Period 3: Double-blind, Withdrawal||26
10916989|NCT00151775|12083939|FG009|COMPLETED|Period 3: Double-blind, Withdrawal||0
10916990|NCT00151775|12083940|FG010|COMPLETED|Period 3: Double-blind, Withdrawal||29
10916991|NCT00151775|12083941|FG011|COMPLETED|Period 3: Double-blind, Withdrawal||28
10916992|NCT00151775|12083930|FG000|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
10916993|NCT00151775|12083931|FG001|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
10916994|NCT00151775|12083932|FG002|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
10916995|NCT00151775|12083933|FG003|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
10916996|NCT00151775|12083934|FG004|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
10916997|NCT00151775|12083935|FG005|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
10916998|NCT00151775|12083936|FG006|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
10916999|NCT00151775|12083937|FG007|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
10917000|NCT00151775|12083938|FG008|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
10917001|NCT00151775|12083939|FG009|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
10917002|NCT00151775|12083940|FG010|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
10917003|NCT00151775|12083941|FG011|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
10917004|NCT00151775|12083930|FG000|STARTED|Period 4: Open Label||0
10917005|NCT00151775|12083931|FG001|STARTED|Period 4: Open Label||0
10917006|NCT00151775|12083932|FG002|STARTED|Period 4: Open Label||0
10917007|NCT00151775|12083933|FG003|STARTED|Period 4: Open Label||0
10917008|NCT00151775|12083934|FG004|STARTED|Period 4: Open Label||179
10917009|NCT00151775|12083935|FG005|STARTED|Period 4: Open Label||0
10917010|NCT00151775|12083936|FG006|STARTED|Period 4: Open Label||0
10917011|NCT00151775|12083937|FG007|STARTED|Period 4: Open Label||0
10917012|NCT00151775|12083938|FG008|STARTED|Period 4: Open Label||0
10917013|NCT00151775|12083939|FG009|STARTED|Period 4: Open Label||104
10917014|NCT00151775|12083940|FG010|STARTED|Period 4: Open Label||57
10917015|NCT00151775|12083941|FG011|STARTED|Period 4: Open Label||0
10917016|NCT00151775|12083930|FG000|COMPLETED|Period 4: Open Label||0
10917017|NCT00151775|12083931|FG001|COMPLETED|Period 4: Open Label||0
10917018|NCT00151775|12083932|FG002|COMPLETED|Period 4: Open Label||0
10917019|NCT00151775|12083933|FG003|COMPLETED|Period 4: Open Label||0
10917020|NCT00151775|12083934|FG004|COMPLETED|Period 4: Open Label||149
10917021|NCT00151775|12083935|FG005|COMPLETED|Period 4: Open Label||0
10917022|NCT00151775|12083936|FG006|COMPLETED|Period 4: Open Label||0
10917023|NCT00151775|12083937|FG007|COMPLETED|Period 4: Open Label||0
10917024|NCT00151775|12083938|FG008|COMPLETED|Period 4: Open Label||0
10917025|NCT00151775|12083939|FG009|COMPLETED|Period 4: Open Label||83
10917026|NCT00151775|12083940|FG010|COMPLETED|Period 4: Open Label||57
10917027|NCT00151775|12083941|FG011|COMPLETED|Period 4: Open Label||0
10917028|NCT00151775|12083930|FG000|NOT COMPLETED|Period 4: Open Label||0
10917029|NCT00151775|12083931|FG001|NOT COMPLETED|Period 4: Open Label||0
10917030|NCT00151775|12083932|FG002|NOT COMPLETED|Period 4: Open Label||0
10917031|NCT00151775|12083933|FG003|NOT COMPLETED|Period 4: Open Label||0
10917032|NCT00151775|12083934|FG004|NOT COMPLETED|Period 4: Open Label||30
10917033|NCT00151775|12083935|FG005|NOT COMPLETED|Period 4: Open Label||0
10917034|NCT00151775|12083936|FG006|NOT COMPLETED|Period 4: Open Label||0
10917035|NCT00151775|12083937|FG007|NOT COMPLETED|Period 4: Open Label||0
10917036|NCT00151775|12083938|FG008|NOT COMPLETED|Period 4: Open Label||0
10917037|NCT00151775|12083939|FG009|NOT COMPLETED|Period 4: Open Label||21
10917038|NCT00151775|12083940|FG010|NOT COMPLETED|Period 4: Open Label||0
10917039|NCT00151775|12083941|FG011|NOT COMPLETED|Period 4: Open Label||0
10917040|NCT00151814|12083985|FG000|STARTED|Overall Study||4
10917041|NCT00151814|12083986|FG001|STARTED|Overall Study||10
10917042|NCT00151814|12083987|FG002|STARTED|Overall Study||10
10917043|NCT00151814|12083985|FG000|COMPLETED|Overall Study||4
10917044|NCT00151814|12083986|FG001|COMPLETED|Overall Study||10
10917045|NCT00151814|12083987|FG002|COMPLETED|Overall Study||10
10917046|NCT00151814|12083985|FG000|NOT COMPLETED|Overall Study||0
10917047|NCT00151814|12083986|FG001|NOT COMPLETED|Overall Study||0
10917048|NCT00151814|12083987|FG002|NOT COMPLETED|Overall Study||0
10917049|NCT00151892|12083996|FG000|STARTED|Overall Study||416
10917050|NCT00151892|12083997|FG001|STARTED|Overall Study||413
10917051|NCT00151892|12083996|FG000|COMPLETED|Overall Study||340
10917052|NCT00151892|12083997|FG001|COMPLETED|Overall Study||330
10917053|NCT00151892|12083996|FG000|NOT COMPLETED|Overall Study||76
10917054|NCT00151892|12083997|FG001|NOT COMPLETED|Overall Study||83
10917055|NCT00151996|12084005|FG000|STARTED|Overall Study||42
10917056|NCT00151996|12084006|FG001|STARTED|Overall Study||33
10917057|NCT00151996|12084005|FG000|COMPLETED|Overall Study||37
10917058|NCT00151996|12084006|FG001|COMPLETED|Overall Study||26
10917059|NCT00151996|12084005|FG000|NOT COMPLETED|Overall Study||5
10917060|NCT00151996|12084006|FG001|NOT COMPLETED|Overall Study||7
10917061|NCT00152009|12084016|FG000|STARTED|Overall Study||87
10917062|NCT00152009|12084017|FG001|STARTED|Overall Study||86
10917063|NCT00152009|12084018|FG002|STARTED|Overall Study||86
10917064|NCT00152009|12084019|FG003|STARTED|Overall Study||86
10917065|NCT00152009|12084016|FG000|COMPLETED|Overall Study||58
10917066|NCT00152009|12084017|FG001|COMPLETED|Overall Study||55
10917067|NCT00152009|12084018|FG002|COMPLETED|Overall Study||49
10917068|NCT00152009|12084019|FG003|COMPLETED|Overall Study||53
10917069|NCT00152009|12084016|FG000|NOT COMPLETED|Overall Study||29
10917070|NCT00152009|12084017|FG001|NOT COMPLETED|Overall Study||31
10917071|NCT00152009|12084018|FG002|NOT COMPLETED|Overall Study||37
10917072|NCT00152009|12084019|FG003|NOT COMPLETED|Overall Study||33
10917073|NCT00152464|12084031|FG000|STARTED|Overall Study||255
10917074|NCT00152464|12084032|FG001|STARTED|Overall Study||255
10917075|NCT00152464|12084031|FG000|COMPLETED|Overall Study||215
10917076|NCT00152464|12084032|FG001|COMPLETED|Overall Study||219
10917077|NCT00152464|12084031|FG000|NOT COMPLETED|Overall Study||40
10917078|NCT00152464|12084032|FG001|NOT COMPLETED|Overall Study||36
10917079|NCT00152516|12084038|FG000|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
10917080|NCT00152516|12084038|FG000|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
10917081|NCT00152516|12084038|FG000|NOT COMPLETED|Overall Study||75
10917082|NCT00152763|12084046|FG000|STARTED|Overall Study||77
10917083|NCT00152763|12084047|FG001|STARTED|Overall Study||19
10917084|NCT00152763|12084048|FG002|STARTED|Overall Study||20
10917085|NCT00152763|12084049|FG003|STARTED|Overall Study||77
10917086|NCT00152763|12084046|FG000|COMPLETED|Overall Study||67
10917087|NCT00152763|12084047|FG001|COMPLETED|Overall Study||14
10917088|NCT00152763|12084048|FG002|COMPLETED|Overall Study||16
10917089|NCT00152763|12084049|FG003|COMPLETED|Overall Study||63
10917090|NCT00152763|12084046|FG000|NOT COMPLETED|Overall Study||10
10917091|NCT00152763|12084047|FG001|NOT COMPLETED|Overall Study||5
10917092|NCT00152763|12084048|FG002|NOT COMPLETED|Overall Study||4
10917093|NCT00152763|12084049|FG003|NOT COMPLETED|Overall Study||14
10917094|NCT00152971|12084064|FG000|STARTED|Overall Study||857
10917095|NCT00152971|12084065|FG001|STARTED|Overall Study||871
10917096|NCT00152971|12084066|FG002|STARTED|Overall Study||868
10917097|NCT00152971|12084064|FG000|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
10917098|NCT00152971|12084065|FG001|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
10917099|NCT00152971|12084066|FG002|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
10917100|NCT00152971|12084064|FG000|NOT COMPLETED|Overall Study||51
10917101|NCT00152971|12084065|FG001|NOT COMPLETED|Overall Study||48
10917102|NCT00152971|12084066|FG002|NOT COMPLETED|Overall Study||49
10917103|NCT00152971|12084064|FG000|STARTED|Treatment||857
10917104|NCT00152971|12084065|FG001|STARTED|Treatment||871
10917105|NCT00152971|12084066|FG002|STARTED|Treatment||868
10917106|NCT00152971|12084064|FG000|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
10917107|NCT00152971|12084065|FG001|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
10917108|NCT00152971|12084066|FG002|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
10917109|NCT00152971|12084064|FG000|NOT COMPLETED|Treatment||71
10917110|NCT00152971|12084065|FG001|NOT COMPLETED|Treatment||63
10917111|NCT00152971|12084066|FG002|NOT COMPLETED|Treatment||80
10917112|NCT00153062|12084078|FG000|STARTED|Overall Study||5086
10917113|NCT00153062|12084079|FG001|STARTED|Overall Study||5095
10917114|NCT00153062|12084080|FG002|STARTED|Overall Study||5060
10917115|NCT00153062|12084081|FG003|STARTED|Overall Study||5091
10917116|NCT00153062|12084078|FG000|COMPLETED|Overall Study||4699
10917117|NCT00153062|12084079|FG001|COMPLETED|Overall Study||4689
10917118|NCT00153062|12084080|FG002|COMPLETED|Overall Study||4645
10917119|NCT00153062|12084081|FG003|COMPLETED|Overall Study||4680
10917120|NCT00153062|12084078|FG000|NOT COMPLETED|Overall Study||387
10917121|NCT00153062|12084079|FG001|NOT COMPLETED|Overall Study||406
10917122|NCT00153062|12084080|FG002|NOT COMPLETED|Overall Study||415
10917123|NCT00153062|12084081|FG003|NOT COMPLETED|Overall Study||411
10917124|NCT00153101|12084096|FG000|STARTED|Overall Study||8502
10917125|NCT00153101|12084097|FG001|STARTED|Overall Study||8542
10917126|NCT00153101|12084098|FG002|STARTED|Overall Study||8576
10917127|NCT00153101|12084099|FG003|STARTED|Overall Study||2954
10917128|NCT00153101|12084100|FG004|STARTED|Overall Study||2972
10917129|NCT00153101|12084096|FG000|COMPLETED|Overall Study||8485
10917130|NCT00153101|12084097|FG001|COMPLETED|Overall Study||8524
10917131|NCT00153101|12084098|FG002|COMPLETED|Overall Study||8561
10917132|NCT00153101|12084099|FG003|COMPLETED|Overall Study||2946
10917133|NCT00153101|12084100|FG004|COMPLETED|Overall Study||2962
10917134|NCT00153101|12084096|FG000|NOT COMPLETED|Overall Study||17
10917135|NCT00153101|12084097|FG001|NOT COMPLETED|Overall Study||18
10917136|NCT00153101|12084098|FG002|NOT COMPLETED|Overall Study||15
10917137|NCT00153101|12084099|FG003|NOT COMPLETED|Overall Study||8
10917138|NCT00153101|12084100|FG004|NOT COMPLETED|Overall Study||10
10917139|NCT00153166|12084117|FG000|STARTED|Overall Study||11
10917140|NCT00153166|12084118|FG001|STARTED|Overall Study||37
10917141|NCT00153166|12084119|FG002|STARTED|Overall Study||28
10917142|NCT00153166|12084117|FG000|Received Atorvastatin and Pioglitazone|Overall Study||3
10917143|NCT00153166|12084118|FG001|Received Atorvastatin and Pioglitazone|Overall Study||9
10917144|NCT00153166|12084119|FG002|Received Atorvastatin and Pioglitazone|Overall Study||7
10917145|NCT00153166|12084117|FG000|Received Atorvastatin and Placebo|Overall Study||2
10917146|NCT00153166|12084118|FG001|Received Atorvastatin and Placebo|Overall Study||9
10917147|NCT00153166|12084119|FG002|Received Atorvastatin and Placebo|Overall Study||7
10917148|NCT00153166|12084117|FG000|Received Placebo and Pioglitazone|Overall Study||3
10917149|NCT00153166|12084118|FG001|Received Placebo and Pioglitazone|Overall Study||10
10917150|NCT00153166|12084119|FG002|Received Placebo and Pioglitazone|Overall Study||7
10917151|NCT00153166|12084117|FG000|Received Placebo and Placebo|Overall Study||3
10917152|NCT00153166|12084118|FG001|Received Placebo and Placebo|Overall Study||9
10917153|NCT00153166|12084119|FG002|Received Placebo and Placebo|Overall Study||7
10917154|NCT00153166|12084117|FG000|COMPLETED|Overall Study||11
10917155|NCT00153166|12084118|FG001|COMPLETED|Overall Study||37
10917156|NCT00153166|12084119|FG002|COMPLETED|Overall Study||28
10917157|NCT00153166|12084117|FG000|NOT COMPLETED|Overall Study||0
10917158|NCT00153166|12084118|FG001|NOT COMPLETED|Overall Study||0
10917159|NCT00153166|12084119|FG002|NOT COMPLETED|Overall Study||0
10917160|NCT00153179|12084130|FG000|STARTED|Study Visit Day 1||10
10917161|NCT00153179|12084131|FG001|STARTED|Study Visit Day 1||8
10917162|NCT00153179|12084132|FG002|STARTED|Study Visit Day 1||13
10917163|NCT00153179|12084133|FG003|STARTED|Study Visit Day 1||9
10917164|NCT00153179|12084130|FG000|COMPLETED|Study Visit Day 1||10
10917165|NCT00153179|12084131|FG001|COMPLETED|Study Visit Day 1||8
10917166|NCT00153179|12084132|FG002|COMPLETED|Study Visit Day 1||13
10917167|NCT00153179|12084133|FG003|COMPLETED|Study Visit Day 1||9
10917168|NCT00153179|12084130|FG000|NOT COMPLETED|Study Visit Day 1||0
10917169|NCT00153179|12084131|FG001|NOT COMPLETED|Study Visit Day 1||0
10917170|NCT00153179|12084132|FG002|NOT COMPLETED|Study Visit Day 1||0
10917171|NCT00153179|12084133|FG003|NOT COMPLETED|Study Visit Day 1||0
10917172|NCT00153179|12084130|FG000|STARTED|Study Visit Day 2||10
10917173|NCT00153179|12084131|FG001|STARTED|Study Visit Day 2||8
10917174|NCT00153179|12084132|FG002|STARTED|Study Visit Day 2||13
10917175|NCT00153179|12084133|FG003|STARTED|Study Visit Day 2||9
10917176|NCT00153179|12084130|FG000|COMPLETED|Study Visit Day 2||9
10917177|NCT00153179|12084131|FG001|COMPLETED|Study Visit Day 2||8
10917178|NCT00153179|12084132|FG002|COMPLETED|Study Visit Day 2||11
10917179|NCT00153179|12084133|FG003|COMPLETED|Study Visit Day 2||7
10917180|NCT00153179|12084130|FG000|NOT COMPLETED|Study Visit Day 2||1
10917181|NCT00153179|12084131|FG001|NOT COMPLETED|Study Visit Day 2||0
10917182|NCT00153179|12084132|FG002|NOT COMPLETED|Study Visit Day 2||2
10917183|NCT00153179|12084133|FG003|NOT COMPLETED|Study Visit Day 2||2
10917184|NCT00153803|12084143|FG000|STARTED|Concurrent Chemoradiation||123
10917185|NCT00153803|12084144|FG001|STARTED|Concurrent Chemoradiation||122
10917186|NCT00153803|12084143|FG000|Received Chemoradiation|Concurrent Chemoradiation||118
10917187|NCT00153803|12084144|FG001|Received Chemoradiation|Concurrent Chemoradiation||117
10917188|NCT00153803|12084143|FG000|COMPLETED|Concurrent Chemoradiation||118
10917189|NCT00153803|12084144|FG001|COMPLETED|Concurrent Chemoradiation||117
10917190|NCT00153803|12084143|FG000|NOT COMPLETED|Concurrent Chemoradiation||5
10917191|NCT00153803|12084144|FG001|NOT COMPLETED|Concurrent Chemoradiation||5
10917192|NCT00153803|12084143|FG000|STARTED|Investigational Drug||118
10917193|NCT00153803|12084144|FG001|STARTED|Investigational Drug||117
10917194|NCT00153803|12084143|FG000|Investigational Drug Dispensed|Investigational Drug||77
10917195|NCT00153803|12084144|FG001|Investigational Drug Dispensed|Investigational Drug||75
10917196|NCT00153803|12084143|FG000|COMPLETED|Investigational Drug||77
10917197|NCT00153803|12084144|FG001|COMPLETED|Investigational Drug||75
10917198|NCT00153803|12084143|FG000|NOT COMPLETED|Investigational Drug||41
10917199|NCT00153803|12084144|FG001|NOT COMPLETED|Investigational Drug||42
10917200|NCT00153816|12084159|FG000|STARTED|Overall Study||415
10917201|NCT00153816|12084160|FG001|STARTED|Overall Study||419
10917202|NCT00153816|12084161|FG002|STARTED|Overall Study||420
10917203|NCT00153816|12084162|FG003|STARTED|Overall Study||421
10917204|NCT00153816|12084163|FG004|STARTED|Overall Study||295
10917205|NCT00153816|12084164|FG005|STARTED|Overall Study||289
10917206|NCT00153816|12084159|FG000|COMPLETED|Overall Study||383
10917207|NCT00153816|12084160|FG001|COMPLETED|Overall Study||387
10917208|NCT00153816|12084161|FG002|COMPLETED|Overall Study||388
10917209|NCT00153816|12084162|FG003|COMPLETED|Overall Study||390
10917210|NCT00153816|12084163|FG004|COMPLETED|Overall Study||278
10917211|NCT00153816|12084164|FG005|COMPLETED|Overall Study||262
10917212|NCT00153816|12084159|FG000|NOT COMPLETED|Overall Study||32
10917213|NCT00153816|12084160|FG001|NOT COMPLETED|Overall Study||32
10917214|NCT00153816|12084161|FG002|NOT COMPLETED|Overall Study||32
10917215|NCT00153816|12084162|FG003|NOT COMPLETED|Overall Study||31
10917216|NCT00153816|12084163|FG004|NOT COMPLETED|Overall Study||17
10917217|NCT00153816|12084164|FG005|NOT COMPLETED|Overall Study||27
10917218|NCT00153842|12084180|FG000|STARTED|Overall Study||26
10917219|NCT00153842|12084181|FG001|STARTED|Overall Study||7
10917220|NCT00153842|12084180|FG000|COMPLETED|Overall Study||26
10917221|NCT00153842|12084181|FG001|COMPLETED|Overall Study||7
10917222|NCT00153842|12084180|FG000|NOT COMPLETED|Overall Study||0
10917223|NCT00153842|12084181|FG001|NOT COMPLETED|Overall Study||0
10917224|NCT00153920|12084189|FG000|STARTED|Overall Study||66
10917225|NCT00153920|12084189|FG000|Eligible and Treated|Overall Study||64
10917226|NCT00153920|12084189|FG000|COMPLETED|Overall Study||36
10917227|NCT00153920|12084189|FG000|NOT COMPLETED|Overall Study||30
10917228|NCT00153985|12084193|FG000|STARTED|Overall Study||2
10917229|NCT00153985|12084193|FG000|COMPLETED|Overall Study||2
10917230|NCT00153985|12084193|FG000|NOT COMPLETED|Overall Study||0
10917231|NCT00154063|12084199|FG000|STARTED|Overall Study||104
10917232|NCT00154063|12084200|FG001|STARTED|Overall Study||102
10917233|NCT00154063|12084199|FG000|COMPLETED|Overall Study||92
10917234|NCT00154063|12084200|FG001|COMPLETED|Overall Study||80
10917235|NCT00154063|12084199|FG000|NOT COMPLETED|Overall Study||12
10917236|NCT00154063|12084200|FG001|NOT COMPLETED|Overall Study||22
10917237|NCT00154102|12084212|FG000|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
10917238|NCT00154102|12084213|FG001|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
10917239|NCT00154102|12084212|FG000|COMPLETED|Overall Study||592
10917240|NCT00154102|12084213|FG001|COMPLETED|Overall Study||597
10917241|NCT00154102|12084212|FG000|NOT COMPLETED|Overall Study||7
10917242|NCT00154102|12084213|FG001|NOT COMPLETED|Overall Study||2
10917243|NCT00154284|12084221|FG000|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
10917244|NCT00154284|12084222|FG001|STARTED|Overall Study||55
10917245|NCT00154284|12084221|FG000|Intent to Treat (ITT) Population|Overall Study||57
10917246|NCT00154284|12084222|FG001|Intent to Treat (ITT) Population|Overall Study||53
10917247|NCT00154284|12084221|FG000|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
10917248|NCT00154284|12084222|FG001|COMPLETED|Overall Study||42
10917249|NCT00154284|12084221|FG000|NOT COMPLETED|Overall Study||7
10917250|NCT00154284|12084222|FG001|NOT COMPLETED|Overall Study||13
10917251|NCT00154297|12084232|FG000|STARTED|Overall Study|Randomized population.|65
10917252|NCT00154297|12084233|FG001|STARTED|Overall Study|Randomized population.|74
10917253|NCT00154297|12084232|FG000|COMPLETED|Overall Study|Completed study by 12 month.|57
10917254|NCT00154297|12084233|FG001|COMPLETED|Overall Study|Completed study by 12 month.|67
10917255|NCT00154297|12084232|FG000|NOT COMPLETED|Overall Study||8
10917256|NCT00154297|12084233|FG001|NOT COMPLETED|Overall Study||7
10917257|NCT00154310|12084241|FG000|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
10917258|NCT00154310|12084242|FG001|STARTED|Overall Study||145
10917259|NCT00154310|12084241|FG000|COMPLETED|Overall Study||118
10917260|NCT00154310|12084242|FG001|COMPLETED|Overall Study||117
10917261|NCT00154310|12084241|FG000|NOT COMPLETED|Overall Study||37
10917262|NCT00154310|12084242|FG001|NOT COMPLETED|Overall Study||28
10917263|NCT00154375|12084250|FG000|STARTED|Overall Study||120
10917264|NCT00154375|12084251|FG001|STARTED|Overall Study||120
10917265|NCT00154375|12084250|FG000|Discontinued Study Treatment|Overall Study||111
10917266|NCT00154375|12084251|FG001|Discontinued Study Treatment|Overall Study||104
10917267|NCT00154375|12084250|FG000|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
10917268|NCT00154375|12084251|FG001|Not Exposed to Study Treatment|Overall Study||2
10917269|NCT00154375|12084250|FG000|COMPLETED|Overall Study||7
10917270|NCT00154375|12084251|FG001|COMPLETED|Overall Study||14
10917271|NCT00154375|12084250|FG000|NOT COMPLETED|Overall Study||113
10917272|NCT00154375|12084251|FG001|NOT COMPLETED|Overall Study||106
10917273|NCT00154466|12084261|FG000|STARTED|Overall Study||20
10917274|NCT00154466|12084262|FG001|STARTED|Overall Study||19
10917275|NCT00154466|12084263|FG002|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
10917276|NCT00154466|12084261|FG000|COMPLETED|Overall Study||20
10917277|NCT00154466|12084262|FG001|COMPLETED|Overall Study||19
10917278|NCT00154466|12084263|FG002|COMPLETED|Overall Study||19
10917279|NCT00154466|12084261|FG000|NOT COMPLETED|Overall Study||0
10917280|NCT00154466|12084262|FG001|NOT COMPLETED|Overall Study||0
10917281|NCT00154466|12084263|FG002|NOT COMPLETED|Overall Study||0
10917282|NCT00156013|12084273|FG000|STARTED|Overall Study||33
10917283|NCT00156013|12084273|FG000|COMPLETED|Overall Study||31
10917284|NCT00156013|12084273|FG000|NOT COMPLETED|Overall Study||2
10917285|NCT00156247|12084279|FG000|STARTED|Overall Study||9
10917286|NCT00156247|12084279|FG000|COMPLETED|Overall Study||5
10917287|NCT00156247|12084279|FG000|NOT COMPLETED|Overall Study||4
10917288|NCT00156390|12084285|FG000|STARTED|Overall Study||110
10917289|NCT00156390|12084286|FG001|STARTED|Overall Study||77
10917290|NCT00156390|12084285|FG000|COMPLETED|Overall Study||96
10917291|NCT00156390|12084286|FG001|COMPLETED|Overall Study||69
10917292|NCT00156390|12084285|FG000|NOT COMPLETED|Overall Study||14
10917293|NCT00156390|12084286|FG001|NOT COMPLETED|Overall Study||8
10917294|NCT00156533|12084297|FG000|STARTED|Overall Study||5
10917295|NCT00156533|12084298|FG001|STARTED|Overall Study||5
10917296|NCT00156533|12084299|FG002|STARTED|Overall Study||5
10917297|NCT00156533|12084300|FG003|STARTED|Overall Study||5
10917298|NCT00156533|12084297|FG000|COMPLETED|Overall Study||3
10917299|NCT00156533|12084298|FG001|COMPLETED|Overall Study||3
10917300|NCT00156533|12084299|FG002|COMPLETED|Overall Study||3
10917301|NCT00156533|12084300|FG003|COMPLETED|Overall Study||3
10917302|NCT00156533|12084297|FG000|NOT COMPLETED|Overall Study||2
10917303|NCT00156533|12084298|FG001|NOT COMPLETED|Overall Study||2
10917304|NCT00156533|12084299|FG002|NOT COMPLETED|Overall Study||2
10917305|NCT00156533|12084300|FG003|NOT COMPLETED|Overall Study||2
10917306|NCT00156715|12084312|FG000|STARTED|Overall Study||23
10917307|NCT00156715|12084312|FG000|COMPLETED|Overall Study||16
10917308|NCT00156715|12084312|FG000|NOT COMPLETED|Overall Study||7
10917309|NCT00156819|12084319|FG000|STARTED|Overall Study||169
10917310|NCT00156819|12084320|FG001|STARTED|Overall Study||166
10917311|NCT00156819|12084321|FG002|STARTED|Overall Study||165
10917312|NCT00156819|12084319|FG000|COMPLETED|Overall Study||168
10917313|NCT00156819|12084320|FG001|COMPLETED|Overall Study||165
10917314|NCT00156819|12084321|FG002|COMPLETED|Overall Study||162
10917315|NCT00156819|12084319|FG000|NOT COMPLETED|Overall Study||1
10917316|NCT00156819|12084320|FG001|NOT COMPLETED|Overall Study||1
10917317|NCT00156819|12084321|FG002|NOT COMPLETED|Overall Study||3
10917318|NCT00156910|12084331|FG000|STARTED|Double-Blind Phase (DB)||341
10917319|NCT00156910|12084332|FG001|STARTED|Double-Blind Phase (DB)||338
10917320|NCT00156910|12084331|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
10917321|NCT00156910|12084332|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
10917322|NCT00156910|12084331|FG000|NOT COMPLETED|Double-Blind Phase (DB)||45
10917323|NCT00156910|12084332|FG001|NOT COMPLETED|Double-Blind Phase (DB)||43
10917324|NCT00156910|12084331|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
10917325|NCT00156910|12084332|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
10917326|NCT00156910|12084331|FG000|COMPLETED|Open-Label Phase (OL)||252
10917327|NCT00156910|12084332|FG001|COMPLETED|Open-Label Phase (OL)||231
10917328|NCT00156910|12084331|FG000|NOT COMPLETED|Open-Label Phase (OL)||33
10917329|NCT00156910|12084332|FG001|NOT COMPLETED|Open-Label Phase (OL)||55
10917330|NCT00156923|12084340|FG000|STARTED|Overall Study||56
10917331|NCT00156923|12084341|FG001|STARTED|Overall Study||52
10917332|NCT00156923|12084340|FG000|COMPLETED|Overall Study||22
10917333|NCT00156923|12084341|FG001|COMPLETED|Overall Study||20
10917334|NCT00156923|12084340|FG000|NOT COMPLETED|Overall Study||34
10917335|NCT00156923|12084341|FG001|NOT COMPLETED|Overall Study||32
10917336|NCT00156936|12084349|FG000|STARTED|Overall Study||92
10917337|NCT00156936|12084350|FG001|STARTED|Overall Study||16
10917338|NCT00156936|12084349|FG000|COMPLETED|Overall Study||20
10917339|NCT00156936|12084350|FG001|COMPLETED|Overall Study||5
10917340|NCT00156936|12084349|FG000|NOT COMPLETED|Overall Study||72
10917341|NCT00156936|12084350|FG001|NOT COMPLETED|Overall Study||11
10917342|NCT00157014|12084360|FG000|STARTED|Overall Study||52
10917343|NCT00157014|12084361|FG001|STARTED|Overall Study||46
10917344|NCT00157014|12084362|FG002|STARTED|Overall Study||5
10917345|NCT00157014|12084363|FG003|STARTED|Overall Study||6
10917346|NCT00157014|12084360|FG000|COMPLETED|Overall Study||45
10917347|NCT00157014|12084361|FG001|COMPLETED|Overall Study||41
10917348|NCT00157014|12084362|FG002|COMPLETED|Overall Study||4
10917349|NCT00157014|12084363|FG003|COMPLETED|Overall Study||5
10917350|NCT00157014|12084360|FG000|NOT COMPLETED|Overall Study||7
10917351|NCT00157014|12084361|FG001|NOT COMPLETED|Overall Study||5
10917352|NCT00157014|12084362|FG002|NOT COMPLETED|Overall Study||1
10917353|NCT00157014|12084363|FG003|NOT COMPLETED|Overall Study||1
10917354|NCT00157157|12084373|FG000|STARTED|Overall Study||55
10917355|NCT00157157|12084373|FG000|COMPLETED|Overall Study||44
10917356|NCT00157157|12084373|FG000|NOT COMPLETED|Overall Study||11
10917357|NCT00157196|12084384|FG000|STARTED|Overall Study||22
10917358|NCT00157196|12084384|FG000|COMPLETED|Overall Study||13
10917359|NCT00157196|12084384|FG000|NOT COMPLETED|Overall Study||9
10917360|NCT00157209|12084390|FG000|STARTED|Overall Study||88
10917361|NCT00157209|12084391|FG001|STARTED|Overall Study||83
10917362|NCT00157209|12084390|FG000|COMPLETED|Overall Study||78
10917363|NCT00157209|12084391|FG001|COMPLETED|Overall Study||83
10917364|NCT00157209|12084390|FG000|NOT COMPLETED|Overall Study||10
10917365|NCT00157209|12084391|FG001|NOT COMPLETED|Overall Study||0
10917366|NCT00157248|12084401|FG000|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
10917367|NCT00157248|12084402|FG001|STARTED|Overall Study||89
10917368|NCT00157248|12084403|FG002|STARTED|Overall Study||50
10917369|NCT00157248|12084404|FG003|STARTED|Overall Study||124
10917370|NCT00157248|12084401|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
10917371|NCT00157248|12084402|FG001|COMPLETED|Overall Study||52
10917372|NCT00157248|12084403|FG002|COMPLETED|Overall Study||29
10917373|NCT00157248|12084404|FG003|COMPLETED|Overall Study||77
10917374|NCT00157248|12084401|FG000|NOT COMPLETED|Overall Study||48
10917375|NCT00157248|12084402|FG001|NOT COMPLETED|Overall Study||37
10917376|NCT00157248|12084403|FG002|NOT COMPLETED|Overall Study||21
10917377|NCT00157248|12084404|FG003|NOT COMPLETED|Overall Study||47
10917378|NCT00157573|12084418|FG000|STARTED|Overall Study||35
10917379|NCT00157573|12084419|FG001|STARTED|Overall Study||37
10917380|NCT00157573|12084418|FG000|COMPLETED|Overall Study||35
10917381|NCT00157573|12084419|FG001|COMPLETED|Overall Study||37
10917382|NCT00157573|12084418|FG000|NOT COMPLETED|Overall Study||0
10917383|NCT00157573|12084419|FG001|NOT COMPLETED|Overall Study||0
10917384|NCT00157755|12084426|FG000|STARTED|Overall Study||26
10917385|NCT00157755|12084427|FG001|STARTED|Overall Study||19
10917386|NCT00157755|12084428|FG002|STARTED|Overall Study||10
10917387|NCT00157755|12084429|FG003|STARTED|Overall Study||15
10917388|NCT00157755|12084430|FG004|STARTED|Overall Study||12
10917389|NCT00157755|12084431|FG005|STARTED|Overall Study||5
10917390|NCT00157755|12084426|FG000|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
10917391|NCT00157755|12084427|FG001|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
10917392|NCT00157755|12084428|FG002|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
10917393|NCT00157755|12084429|FG003|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
10917394|NCT00157755|12084430|FG004|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
10917395|NCT00157755|12084431|FG005|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
10917396|NCT00157755|12084426|FG000|NOT COMPLETED|Overall Study||2
10917397|NCT00157755|12084427|FG001|NOT COMPLETED|Overall Study||4
10917398|NCT00157755|12084428|FG002|NOT COMPLETED|Overall Study||7
10917399|NCT00157755|12084429|FG003|NOT COMPLETED|Overall Study||4
10917400|NCT00157755|12084430|FG004|NOT COMPLETED|Overall Study||2
10917401|NCT00157755|12084431|FG005|NOT COMPLETED|Overall Study||5
10917402|NCT00157820|12084440|FG000|STARTED|Randomized||118
10917403|NCT00157820|12084441|FG001|STARTED|Randomized||116
10917404|NCT00157820|12084442|FG002|STARTED|Randomized||120
10917405|NCT00157820|12084440|FG000|COMPLETED|Randomized||111
10917406|NCT00157820|12084441|FG001|COMPLETED|Randomized||111
10917407|NCT00157820|12084442|FG002|COMPLETED|Randomized||112
10917408|NCT00157820|12084440|FG000|NOT COMPLETED|Randomized||7
10917409|NCT00157820|12084441|FG001|NOT COMPLETED|Randomized||5
10917410|NCT00157820|12084442|FG002|NOT COMPLETED|Randomized||8
10917411|NCT00157820|12084440|FG000|STARTED|1st 8 Month||111
10917412|NCT00157820|12084441|FG001|STARTED|1st 8 Month||111
10917413|NCT00157820|12084442|FG002|STARTED|1st 8 Month||112
10917414|NCT00157820|12084440|FG000|COMPLETED|1st 8 Month||103
10917415|NCT00157820|12084441|FG001|COMPLETED|1st 8 Month||99
10917416|NCT00157820|12084442|FG002|COMPLETED|1st 8 Month||106
10917417|NCT00157820|12084440|FG000|NOT COMPLETED|1st 8 Month||8
10917418|NCT00157820|12084441|FG001|NOT COMPLETED|1st 8 Month||12
10917419|NCT00157820|12084442|FG002|NOT COMPLETED|1st 8 Month||6
10917420|NCT00157820|12084440|FG000|STARTED|1 Month Wash Out Period||103
10917421|NCT00157820|12084441|FG001|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
10917422|NCT00157820|12084442|FG002|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
10917423|NCT00157820|12084440|FG000|COMPLETED|1 Month Wash Out Period||103
10917424|NCT00157820|12084441|FG001|COMPLETED|1 Month Wash Out Period||101
10917425|NCT00157820|12084442|FG002|COMPLETED|1 Month Wash Out Period||108
10917426|NCT00157820|12084440|FG000|NOT COMPLETED|1 Month Wash Out Period||0
10917427|NCT00157820|12084441|FG001|NOT COMPLETED|1 Month Wash Out Period||0
10917428|NCT00157820|12084442|FG002|NOT COMPLETED|1 Month Wash Out Period||0
10917429|NCT00157820|12084440|FG000|STARTED|2nd 8 Months||103
10917430|NCT00157820|12084441|FG001|STARTED|2nd 8 Months||101
10917431|NCT00157820|12084442|FG002|STARTED|2nd 8 Months||108
10917432|NCT00157820|12084440|FG000|COMPLETED|2nd 8 Months||98
10917433|NCT00157820|12084441|FG001|COMPLETED|2nd 8 Months||88
10917434|NCT00157820|12084442|FG002|COMPLETED|2nd 8 Months||94
10917435|NCT00157820|12084440|FG000|NOT COMPLETED|2nd 8 Months||5
10917436|NCT00157820|12084441|FG001|NOT COMPLETED|2nd 8 Months||13
10917437|NCT00157820|12084442|FG002|NOT COMPLETED|2nd 8 Months||14
10917438|NCT00157950|12084453|FG000|STARTED|Overall Study||117
10917439|NCT00157950|12084454|FG001|STARTED|Overall Study||59
10917440|NCT00157950|12084453|FG000|Vaccinated at Dose 1|Overall Study||117
10917441|NCT00157950|12084454|FG001|Vaccinated at Dose 1|Overall Study||59
10917442|NCT00157950|12084453|FG000|Vaccinated at Dose 2|Overall Study||117
10917443|NCT00157950|12084454|FG001|Vaccinated at Dose 2|Overall Study||59
10917444|NCT00157950|12084453|FG000|Vaccinated at Dose 3|Overall Study||116
10917445|NCT00157950|12084454|FG001|Vaccinated at Dose 3|Overall Study||59
10917446|NCT00157950|12084453|FG000|COMPLETED|Overall Study||116
10917447|NCT00157950|12084454|FG001|COMPLETED|Overall Study||59
10917448|NCT00157950|12084453|FG000|NOT COMPLETED|Overall Study||1
10917449|NCT00157950|12084454|FG001|NOT COMPLETED|Overall Study||0
10917450|NCT00158054|12084462|FG000|STARTED|Overall Study||80
10917451|NCT00158054|12084463|FG001|STARTED|Overall Study||77
10917452|NCT00158054|12084462|FG000|COMPLETED|Overall Study||70
10917453|NCT00158054|12084463|FG001|COMPLETED|Overall Study||74
10917454|NCT00158054|12084462|FG000|NOT COMPLETED|Overall Study||10
10917455|NCT00158054|12084463|FG001|NOT COMPLETED|Overall Study||3
10917456|NCT00158184|12084471|FG000|STARTED|Overall Study||16
10917457|NCT00158184|12084472|FG001|STARTED|Overall Study||11
10917458|NCT00158184|12084471|FG000|COMPLETED|Overall Study||10
10917459|NCT00158184|12084472|FG001|COMPLETED|Overall Study||9
10917460|NCT00158184|12084471|FG000|NOT COMPLETED|Overall Study||6
10917461|NCT00158184|12084472|FG001|NOT COMPLETED|Overall Study||2
10917462|NCT00158197|12084484|FG000|STARTED|Overall Study||32
10917463|NCT00158197|12084485|FG001|STARTED|Overall Study||30
10917464|NCT00158197|12084486|FG002|STARTED|Overall Study||28
10917465|NCT00158197|12084487|FG003|STARTED|Overall Study||29
10917466|NCT00158197|12084484|FG000|COMPLETED|Overall Study||32
10917467|NCT00158197|12084485|FG001|COMPLETED|Overall Study||30
10917468|NCT00158197|12084486|FG002|COMPLETED|Overall Study||28
10917469|NCT00158197|12084487|FG003|COMPLETED|Overall Study||29
10917470|NCT00158197|12084484|FG000|NOT COMPLETED|Overall Study||0
10917471|NCT00158197|12084485|FG001|NOT COMPLETED|Overall Study||0
10917472|NCT00158197|12084486|FG002|NOT COMPLETED|Overall Study||0
10917473|NCT00158197|12084487|FG003|NOT COMPLETED|Overall Study||0
10917474|NCT00158223|12084499|FG000|STARTED|Overall Study||28
10917475|NCT00158223|12084500|FG001|STARTED|Overall Study||25
10917476|NCT00158223|12084499|FG000|COMPLETED|Overall Study||23
10917477|NCT00158223|12084500|FG001|COMPLETED|Overall Study||22
10917478|NCT00158223|12084499|FG000|NOT COMPLETED|Overall Study||5
10917479|NCT00158223|12084500|FG001|NOT COMPLETED|Overall Study||3
10917480|NCT00158249|12084508|FG000|STARTED|Overall Study||11
10917481|NCT00158249|12084509|FG001|STARTED|Overall Study||10
10917482|NCT00158249|12084508|FG000|COMPLETED|Overall Study||9
10917483|NCT00158249|12084509|FG001|COMPLETED|Overall Study||10
10917484|NCT00158249|12084508|FG000|NOT COMPLETED|Overall Study||2
10917485|NCT00158249|12084509|FG001|NOT COMPLETED|Overall Study||0
10917486|NCT00158262|12084517|FG000|STARTED|Overall Study||21
10917487|NCT00158262|12084518|FG001|STARTED|Overall Study||22
10917488|NCT00158262|12084517|FG000|COMPLETED|Overall Study||20
10917489|NCT00158262|12084518|FG001|COMPLETED|Overall Study||21
10917490|NCT00158262|12084517|FG000|NOT COMPLETED|Overall Study||1
10917491|NCT00158262|12084518|FG001|NOT COMPLETED|Overall Study||1
10917492|NCT00158379|12084524|FG000|STARTED|Overall Study||105
10917493|NCT00158379|12084524|FG000|COMPLETED|Overall Study||105
10917494|NCT00158379|12084524|FG000|NOT COMPLETED|Overall Study||0
10917495|NCT00158600|12084530|FG000|STARTED|Overall Study||60
10917496|NCT00158600|12084531|FG001|STARTED|Overall Study||30
10917497|NCT00158600|12084530|FG000|COMPLETED|Overall Study||55
10917498|NCT00158600|12084531|FG001|COMPLETED|Overall Study||26
10917499|NCT00158600|12084530|FG000|NOT COMPLETED|Overall Study||5
10917500|NCT00158600|12084531|FG001|NOT COMPLETED|Overall Study||4
10917501|NCT00158743|12084540|FG000|STARTED|Overall Study||24
10917502|NCT00158743|12084541|FG001|STARTED|Overall Study||27
10917503|NCT00158743|12084540|FG000|COMPLETED|Overall Study||15
10917504|NCT00158743|12084541|FG001|COMPLETED|Overall Study||20
10917505|NCT00158743|12084540|FG000|NOT COMPLETED|Overall Study||9
10917506|NCT00158743|12084541|FG001|NOT COMPLETED|Overall Study||7
10917507|NCT00158756|12084552|FG000|STARTED|Overall Study||80
10917508|NCT00158756|12084553|FG001|STARTED|Overall Study||25
10917509|NCT00158756|12084554|FG002|STARTED|Overall Study||81
10917510|NCT00158756|12084555|FG003|STARTED|Overall Study||23
10917511|NCT00158756|12084556|FG004|STARTED|Overall Study||99
10917512|NCT00158756|12084552|FG000|COMPLETED|Overall Study||75
10917513|NCT00158756|12084553|FG001|COMPLETED|Overall Study||25
10917514|NCT00158756|12084554|FG002|COMPLETED|Overall Study||73
10917515|NCT00158756|12084555|FG003|COMPLETED|Overall Study||22
10917516|NCT00158756|12084556|FG004|COMPLETED|Overall Study||96
10917517|NCT00158756|12084552|FG000|NOT COMPLETED|Overall Study||5
10917518|NCT00158756|12084553|FG001|NOT COMPLETED|Overall Study||0
10917519|NCT00158756|12084554|FG002|NOT COMPLETED|Overall Study||8
10917520|NCT00158756|12084555|FG003|NOT COMPLETED|Overall Study||1
10917521|NCT00158756|12084556|FG004|NOT COMPLETED|Overall Study||3
10917522|NCT00158860|12084570|FG000|STARTED|Overall Study||128
10917523|NCT00158860|12084571|FG001|STARTED|Overall Study||255
10917524|NCT00158860|12084570|FG000|COMPLETED|Overall Study||93
10917525|NCT00158860|12084571|FG001|COMPLETED|Overall Study||184
10917526|NCT00158860|12084570|FG000|NOT COMPLETED|Overall Study||35
10917527|NCT00158860|12084571|FG001|NOT COMPLETED|Overall Study||71
10917528|NCT00158925|12084578|FG000|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
10917529|NCT00158925|12084578|FG000|COMPLETED|Overall Study||84
10917530|NCT00158925|12084578|FG000|NOT COMPLETED|Overall Study||12
10917531|NCT00159250|12084584|FG000|STARTED|Overall Study||2
10917532|NCT00159250|12084585|FG001|STARTED|Overall Study||5
10917533|NCT00159250|12084584|FG000|COMPLETED|Overall Study||2
10917534|NCT00159250|12084585|FG001|COMPLETED|Overall Study||5
10917535|NCT00159250|12084584|FG000|NOT COMPLETED|Overall Study||0
10917536|NCT00159250|12084585|FG001|NOT COMPLETED|Overall Study||0
10917537|NCT00159263|12084591|FG000|STARTED|First Intervention||1
10917538|NCT00159263|12084592|FG001|STARTED|First Intervention||1
10917539|NCT00159263|12084593|FG002|STARTED|First Intervention||2
10917540|NCT00159263|12084594|FG003|STARTED|First Intervention||2
10917541|NCT00159263|12084595|FG004|STARTED|First Intervention||2
10917542|NCT00159263|12084596|FG005|STARTED|First Intervention||2
10917543|NCT00159263|12084591|FG000|COMPLETED|First Intervention||1
10917544|NCT00159263|12084592|FG001|COMPLETED|First Intervention||1
10917545|NCT00159263|12084593|FG002|COMPLETED|First Intervention||2
10917546|NCT00159263|12084594|FG003|COMPLETED|First Intervention||2
10917547|NCT00159263|12084595|FG004|COMPLETED|First Intervention||2
10917548|NCT00159263|12084596|FG005|COMPLETED|First Intervention||2
10917549|NCT00159263|12084591|FG000|NOT COMPLETED|First Intervention||0
10917550|NCT00159263|12084592|FG001|NOT COMPLETED|First Intervention||0
10917551|NCT00159263|12084593|FG002|NOT COMPLETED|First Intervention||0
10917552|NCT00159263|12084594|FG003|NOT COMPLETED|First Intervention||0
10917553|NCT00159263|12084595|FG004|NOT COMPLETED|First Intervention||0
10917554|NCT00159263|12084596|FG005|NOT COMPLETED|First Intervention||0
10917555|NCT00159263|12084591|FG000|STARTED|Washout||1
10917556|NCT00159263|12084592|FG001|STARTED|Washout||1
10917557|NCT00159263|12084593|FG002|STARTED|Washout||2
10917558|NCT00159263|12084594|FG003|STARTED|Washout||2
10917559|NCT00159263|12084595|FG004|STARTED|Washout||2
10917560|NCT00159263|12084596|FG005|STARTED|Washout||2
10917561|NCT00159263|12084591|FG000|COMPLETED|Washout||1
10917562|NCT00159263|12084592|FG001|COMPLETED|Washout||1
10917563|NCT00159263|12084593|FG002|COMPLETED|Washout||2
10917564|NCT00159263|12084594|FG003|COMPLETED|Washout||2
10917565|NCT00159263|12084595|FG004|COMPLETED|Washout||2
10917566|NCT00159263|12084596|FG005|COMPLETED|Washout||2
10917567|NCT00159263|12084591|FG000|NOT COMPLETED|Washout||0
10917568|NCT00159263|12084592|FG001|NOT COMPLETED|Washout||0
10917569|NCT00159263|12084593|FG002|NOT COMPLETED|Washout||0
10917570|NCT00159263|12084594|FG003|NOT COMPLETED|Washout||0
10917571|NCT00159263|12084595|FG004|NOT COMPLETED|Washout||0
10917572|NCT00159263|12084596|FG005|NOT COMPLETED|Washout||0
10917573|NCT00159263|12084591|FG000|STARTED|Second Intervention||1
10917574|NCT00159263|12084592|FG001|STARTED|Second Intervention||1
10917575|NCT00159263|12084593|FG002|STARTED|Second Intervention||2
10917576|NCT00159263|12084594|FG003|STARTED|Second Intervention||2
10917577|NCT00159263|12084595|FG004|STARTED|Second Intervention||2
10917578|NCT00159263|12084596|FG005|STARTED|Second Intervention||2
10917579|NCT00159263|12084591|FG000|COMPLETED|Second Intervention||1
10917580|NCT00159263|12084592|FG001|COMPLETED|Second Intervention||1
10917581|NCT00159263|12084593|FG002|COMPLETED|Second Intervention||2
10917582|NCT00159263|12084594|FG003|COMPLETED|Second Intervention||2
10917583|NCT00159263|12084595|FG004|COMPLETED|Second Intervention||2
10917584|NCT00159263|12084596|FG005|COMPLETED|Second Intervention||2
10917585|NCT00159263|12084591|FG000|NOT COMPLETED|Second Intervention||0
10917586|NCT00159263|12084592|FG001|NOT COMPLETED|Second Intervention||0
10917587|NCT00159263|12084593|FG002|NOT COMPLETED|Second Intervention||0
10917588|NCT00159263|12084594|FG003|NOT COMPLETED|Second Intervention||0
10917589|NCT00159263|12084595|FG004|NOT COMPLETED|Second Intervention||0
10917590|NCT00159263|12084596|FG005|NOT COMPLETED|Second Intervention||0
10917591|NCT00159263|12084591|FG000|STARTED|Washout||1
10917592|NCT00159263|12084592|FG001|STARTED|Washout||1
10917593|NCT00159263|12084593|FG002|STARTED|Washout||2
10917594|NCT00159263|12084594|FG003|STARTED|Washout||2
10917595|NCT00159263|12084595|FG004|STARTED|Washout||2
10917596|NCT00159263|12084596|FG005|STARTED|Washout||2
10917597|NCT00159263|12084591|FG000|COMPLETED|Washout||1
10917598|NCT00159263|12084592|FG001|COMPLETED|Washout||1
10917599|NCT00159263|12084593|FG002|COMPLETED|Washout||2
10917600|NCT00159263|12084594|FG003|COMPLETED|Washout||2
10917601|NCT00159263|12084595|FG004|COMPLETED|Washout||2
10917602|NCT00159263|12084596|FG005|COMPLETED|Washout||2
10917603|NCT00159263|12084591|FG000|NOT COMPLETED|Washout||0
10917604|NCT00159263|12084592|FG001|NOT COMPLETED|Washout||0
10917605|NCT00159263|12084593|FG002|NOT COMPLETED|Washout||0
10917606|NCT00159263|12084594|FG003|NOT COMPLETED|Washout||0
10917607|NCT00159263|12084595|FG004|NOT COMPLETED|Washout||0
10917608|NCT00159263|12084596|FG005|NOT COMPLETED|Washout||0
10917609|NCT00159263|12084591|FG000|STARTED|Third Intervention||1
10917610|NCT00159263|12084592|FG001|STARTED|Third Intervention||1
10917611|NCT00159263|12084593|FG002|STARTED|Third Intervention||2
10917612|NCT00159263|12084594|FG003|STARTED|Third Intervention||2
10917613|NCT00159263|12084595|FG004|STARTED|Third Intervention||2
10917614|NCT00159263|12084596|FG005|STARTED|Third Intervention||2
10917615|NCT00159263|12084591|FG000|COMPLETED|Third Intervention||1
10917616|NCT00159263|12084592|FG001|COMPLETED|Third Intervention||1
10917617|NCT00159263|12084593|FG002|COMPLETED|Third Intervention||2
10917618|NCT00159263|12084594|FG003|COMPLETED|Third Intervention||2
10917619|NCT00159263|12084595|FG004|COMPLETED|Third Intervention||2
10917620|NCT00159263|12084596|FG005|COMPLETED|Third Intervention||2
10917621|NCT00159263|12084591|FG000|NOT COMPLETED|Third Intervention||0
10917622|NCT00159263|12084592|FG001|NOT COMPLETED|Third Intervention||0
10917623|NCT00159263|12084593|FG002|NOT COMPLETED|Third Intervention||0
10917624|NCT00159263|12084594|FG003|NOT COMPLETED|Third Intervention||0
10917625|NCT00159263|12084595|FG004|NOT COMPLETED|Third Intervention||0
10917626|NCT00159263|12084596|FG005|NOT COMPLETED|Third Intervention||0
10917627|NCT00159263|12084591|FG000|STARTED|Washout||1
10917628|NCT00159263|12084592|FG001|STARTED|Washout||1
10917629|NCT00159263|12084593|FG002|STARTED|Washout||2
10917630|NCT00159263|12084594|FG003|STARTED|Washout||2
10917631|NCT00159263|12084595|FG004|STARTED|Washout||2
10917632|NCT00159263|12084596|FG005|STARTED|Washout||2
10917633|NCT00159263|12084591|FG000|COMPLETED|Washout||1
10917634|NCT00159263|12084592|FG001|COMPLETED|Washout||1
10917635|NCT00159263|12084593|FG002|COMPLETED|Washout||2
10917636|NCT00159263|12084594|FG003|COMPLETED|Washout||2
10917637|NCT00159263|12084595|FG004|COMPLETED|Washout||2
10917638|NCT00159263|12084596|FG005|COMPLETED|Washout||2
10917639|NCT00159263|12084591|FG000|NOT COMPLETED|Washout||0
10917640|NCT00159263|12084592|FG001|NOT COMPLETED|Washout||0
10917641|NCT00159263|12084593|FG002|NOT COMPLETED|Washout||0
10917642|NCT00159263|12084594|FG003|NOT COMPLETED|Washout||0
10917643|NCT00159263|12084595|FG004|NOT COMPLETED|Washout||0
10917644|NCT00159263|12084596|FG005|NOT COMPLETED|Washout||0
10917645|NCT00159263|12084591|FG000|STARTED|Fourth Intervention||1
10917646|NCT00159263|12084592|FG001|STARTED|Fourth Intervention||1
10917647|NCT00159263|12084593|FG002|STARTED|Fourth Intervention||2
10917648|NCT00159263|12084594|FG003|STARTED|Fourth Intervention||2
10917649|NCT00159263|12084595|FG004|STARTED|Fourth Intervention||2
10917650|NCT00159263|12084596|FG005|STARTED|Fourth Intervention||2
10917651|NCT00159263|12084591|FG000|COMPLETED|Fourth Intervention||1
10917652|NCT00159263|12084592|FG001|COMPLETED|Fourth Intervention||1
10917653|NCT00159263|12084593|FG002|COMPLETED|Fourth Intervention||2
10917654|NCT00159263|12084594|FG003|COMPLETED|Fourth Intervention||2
10917655|NCT00159263|12084595|FG004|COMPLETED|Fourth Intervention||2
10917656|NCT00159263|12084596|FG005|COMPLETED|Fourth Intervention||2
10917657|NCT00159263|12084591|FG000|NOT COMPLETED|Fourth Intervention||0
10917658|NCT00159263|12084592|FG001|NOT COMPLETED|Fourth Intervention||0
10917659|NCT00159263|12084593|FG002|NOT COMPLETED|Fourth Intervention||0
10917660|NCT00159263|12084594|FG003|NOT COMPLETED|Fourth Intervention||0
10917661|NCT00159263|12084595|FG004|NOT COMPLETED|Fourth Intervention||0
10917662|NCT00159263|12084596|FG005|NOT COMPLETED|Fourth Intervention||0
10917663|NCT00159263|12084591|FG000|STARTED|Washout||1
10917664|NCT00159263|12084592|FG001|STARTED|Washout||1
10917665|NCT00159263|12084593|FG002|STARTED|Washout||2
10917666|NCT00159263|12084594|FG003|STARTED|Washout||2
10917667|NCT00159263|12084595|FG004|STARTED|Washout||2
10917668|NCT00159263|12084596|FG005|STARTED|Washout||2
10917669|NCT00159263|12084591|FG000|COMPLETED|Washout||1
10917670|NCT00159263|12084592|FG001|COMPLETED|Washout||1
10917671|NCT00159263|12084593|FG002|COMPLETED|Washout||2
10917672|NCT00159263|12084594|FG003|COMPLETED|Washout||2
10917673|NCT00159263|12084595|FG004|COMPLETED|Washout||2
10917674|NCT00159263|12084596|FG005|COMPLETED|Washout||2
10917675|NCT00159263|12084591|FG000|NOT COMPLETED|Washout||0
10917676|NCT00159263|12084592|FG001|NOT COMPLETED|Washout||0
10917677|NCT00159263|12084593|FG002|NOT COMPLETED|Washout||0
10917678|NCT00159263|12084594|FG003|NOT COMPLETED|Washout||0
10917679|NCT00159263|12084595|FG004|NOT COMPLETED|Washout||0
10917680|NCT00159263|12084596|FG005|NOT COMPLETED|Washout||0
10917681|NCT00159263|12084591|FG000|STARTED|Fifth Intervention||1
10917682|NCT00159263|12084592|FG001|STARTED|Fifth Intervention||1
10917683|NCT00159263|12084593|FG002|STARTED|Fifth Intervention||2
10917684|NCT00159263|12084594|FG003|STARTED|Fifth Intervention||2
10917685|NCT00159263|12084595|FG004|STARTED|Fifth Intervention||2
10917686|NCT00159263|12084596|FG005|STARTED|Fifth Intervention||2
10917687|NCT00159263|12084591|FG000|COMPLETED|Fifth Intervention||1
10917688|NCT00159263|12084592|FG001|COMPLETED|Fifth Intervention||1
10917689|NCT00159263|12084593|FG002|COMPLETED|Fifth Intervention||2
10917690|NCT00159263|12084594|FG003|COMPLETED|Fifth Intervention||2
10917691|NCT00159263|12084595|FG004|COMPLETED|Fifth Intervention||2
10917692|NCT00159263|12084596|FG005|COMPLETED|Fifth Intervention||2
10917693|NCT00159263|12084591|FG000|NOT COMPLETED|Fifth Intervention||0
10917694|NCT00159263|12084592|FG001|NOT COMPLETED|Fifth Intervention||0
10917695|NCT00159263|12084593|FG002|NOT COMPLETED|Fifth Intervention||0
10917696|NCT00159263|12084594|FG003|NOT COMPLETED|Fifth Intervention||0
10917697|NCT00159263|12084595|FG004|NOT COMPLETED|Fifth Intervention||0
10917698|NCT00159263|12084596|FG005|NOT COMPLETED|Fifth Intervention||0
10917699|NCT00159263|12084591|FG000|STARTED|Washout||1
10917700|NCT00159263|12084592|FG001|STARTED|Washout||1
10917701|NCT00159263|12084593|FG002|STARTED|Washout||2
10917702|NCT00159263|12084594|FG003|STARTED|Washout||2
10917703|NCT00159263|12084595|FG004|STARTED|Washout||2
10917704|NCT00159263|12084596|FG005|STARTED|Washout||2
10917705|NCT00159263|12084591|FG000|COMPLETED|Washout||1
10917706|NCT00159263|12084592|FG001|COMPLETED|Washout||1
10917707|NCT00159263|12084593|FG002|COMPLETED|Washout||2
10917708|NCT00159263|12084594|FG003|COMPLETED|Washout||2
10917709|NCT00159263|12084595|FG004|COMPLETED|Washout||2
10917710|NCT00159263|12084596|FG005|COMPLETED|Washout||2
10917711|NCT00159263|12084591|FG000|NOT COMPLETED|Washout||0
10917712|NCT00159263|12084592|FG001|NOT COMPLETED|Washout||0
10917713|NCT00159263|12084593|FG002|NOT COMPLETED|Washout||0
10917714|NCT00159263|12084594|FG003|NOT COMPLETED|Washout||0
10917715|NCT00159263|12084595|FG004|NOT COMPLETED|Washout||0
10917716|NCT00159263|12084596|FG005|NOT COMPLETED|Washout||0
10917717|NCT00159263|12084591|FG000|STARTED|Sixth Intervention||1
10917718|NCT00159263|12084592|FG001|STARTED|Sixth Intervention||1
10917719|NCT00159263|12084593|FG002|STARTED|Sixth Intervention||2
10917720|NCT00159263|12084594|FG003|STARTED|Sixth Intervention||2
10917721|NCT00159263|12084595|FG004|STARTED|Sixth Intervention||2
10917722|NCT00159263|12084596|FG005|STARTED|Sixth Intervention||2
10917723|NCT00159263|12084591|FG000|COMPLETED|Sixth Intervention||1
10917724|NCT00159263|12084592|FG001|COMPLETED|Sixth Intervention||1
10917725|NCT00159263|12084593|FG002|COMPLETED|Sixth Intervention||2
10917726|NCT00159263|12084594|FG003|COMPLETED|Sixth Intervention||2
10917727|NCT00159263|12084595|FG004|COMPLETED|Sixth Intervention||2
10917728|NCT00159263|12084596|FG005|COMPLETED|Sixth Intervention||2
10917729|NCT00159263|12084591|FG000|NOT COMPLETED|Sixth Intervention||0
10917730|NCT00159263|12084592|FG001|NOT COMPLETED|Sixth Intervention||0
10917731|NCT00159263|12084593|FG002|NOT COMPLETED|Sixth Intervention||0
10917732|NCT00159263|12084594|FG003|NOT COMPLETED|Sixth Intervention||0
10917733|NCT00159263|12084595|FG004|NOT COMPLETED|Sixth Intervention||0
10917734|NCT00159263|12084596|FG005|NOT COMPLETED|Sixth Intervention||0
10917735|NCT00159419|12084612|FG000|STARTED|Overall Study||9
10917736|NCT00159419|12084613|FG001|STARTED|Overall Study||9
10917737|NCT00159419|12084612|FG000|COMPLETED|Overall Study||9
10917738|NCT00159419|12084613|FG001|COMPLETED|Overall Study||9
10917739|NCT00159419|12084612|FG000|NOT COMPLETED|Overall Study||0
10917740|NCT00159419|12084613|FG001|NOT COMPLETED|Overall Study||0
10917741|NCT00159432|12084619|FG000|STARTED|Overall Study||63
10917742|NCT00159432|12084619|FG000|COMPLETED|Overall Study||53
10917743|NCT00159432|12084619|FG000|NOT COMPLETED|Overall Study||10
10917744|NCT00159822|12084623|FG000|STARTED|Voriconazole Treatment Period||48
10917745|NCT00159822|12084623|FG000|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
10917746|NCT00159822|12084623|FG000|NOT COMPLETED|Voriconazole Treatment Period||22
10917747|NCT00159822|12084623|FG000|STARTED|Post-treatment Follow-up Period||26
10917748|NCT00159822|12084623|FG000|COMPLETED|Post-treatment Follow-up Period||23
10917749|NCT00159822|12084623|FG000|NOT COMPLETED|Post-treatment Follow-up Period||3
10917750|NCT00159861|12084629|FG000|STARTED|Core Study - 16 Weeks||133
10917751|NCT00159861|12084630|FG001|STARTED|Core Study - 16 Weeks||134
10917752|NCT00159861|12084629|FG000|Treated|Core Study - 16 Weeks||131
10917753|NCT00159861|12084630|FG001|Treated|Core Study - 16 Weeks||134
10917754|NCT00159861|12084629|FG000|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
10917755|NCT00159861|12084630|FG001|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
10917756|NCT00159861|12084629|FG000|NOT COMPLETED|Core Study - 16 Weeks||25
10917757|NCT00159861|12084630|FG001|NOT COMPLETED|Core Study - 16 Weeks||12
10917758|NCT00159861|12084629|FG000|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
10917759|NCT00159861|12084630|FG001|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
10917760|NCT00159861|12084629|FG000|Treated|Extension Study - up to 3 Years||115
10917761|NCT00159861|12084630|FG001|Treated|Extension Study - up to 3 Years||127
10917762|NCT00159861|12084629|FG000|COMPLETED|Extension Study - up to 3 Years||53
10917763|NCT00159861|12084630|FG001|COMPLETED|Extension Study - up to 3 Years||56
10917764|NCT00159861|12084629|FG000|NOT COMPLETED|Extension Study - up to 3 Years||62
10917765|NCT00159861|12084630|FG001|NOT COMPLETED|Extension Study - up to 3 Years||71
10917766|NCT00159874|12084648|FG000|STARTED|Overall Study||42
10917767|NCT00159874|12084649|FG001|STARTED|Overall Study||55
10917768|NCT00159874|12084650|FG002|STARTED|Overall Study||77
10917769|NCT00159874|12084651|FG003|STARTED|Overall Study||13
10917770|NCT00159874|12084652|FG004|STARTED|Overall Study||19
10917771|NCT00159874|12084653|FG005|STARTED|Overall Study||23
10917772|NCT00159874|12084654|FG006|STARTED|Overall Study||5
10917773|NCT00159874|12084648|FG000|Treated|Overall Study||42
10917774|NCT00159874|12084649|FG001|Treated|Overall Study||55
10917775|NCT00159874|12084650|FG002|Treated|Overall Study||77
10917776|NCT00159874|12084651|FG003|Treated|Overall Study||13
10917777|NCT00159874|12084652|FG004|Treated|Overall Study||19
10917778|NCT00159874|12084653|FG005|Treated|Overall Study||23
10917779|NCT00159874|12084654|FG006|Treated|Overall Study||5
10917780|NCT00159874|12084648|FG000|COMPLETED|Overall Study||22
10917781|NCT00159874|12084649|FG001|COMPLETED|Overall Study||25
10917782|NCT00159874|12084650|FG002|COMPLETED|Overall Study||34
10917783|NCT00159874|12084651|FG003|COMPLETED|Overall Study||7
10917784|NCT00159874|12084652|FG004|COMPLETED|Overall Study||11
10917785|NCT00159874|12084653|FG005|COMPLETED|Overall Study||11
10917786|NCT00159874|12084654|FG006|COMPLETED|Overall Study||0
10917787|NCT00159874|12084648|FG000|NOT COMPLETED|Overall Study||20
10917788|NCT00159874|12084649|FG001|NOT COMPLETED|Overall Study||30
10917789|NCT00159874|12084650|FG002|NOT COMPLETED|Overall Study||43
10917790|NCT00159874|12084651|FG003|NOT COMPLETED|Overall Study||6
10917791|NCT00159874|12084652|FG004|NOT COMPLETED|Overall Study||8
10917792|NCT00159874|12084653|FG005|NOT COMPLETED|Overall Study||12
10917793|NCT00159874|12084654|FG006|NOT COMPLETED|Overall Study||5
10917794|NCT00159913|12084674|FG000|STARTED|Overall Study||42
10917795|NCT00159913|12084675|FG001|STARTED|Overall Study||55
10917796|NCT00159913|12084676|FG002|STARTED|Overall Study||77
10917797|NCT00159913|12084677|FG003|STARTED|Overall Study||60
10917798|NCT00159913|12084674|FG000|COMPLETED|Overall Study||40
10917799|NCT00159913|12084675|FG001|COMPLETED|Overall Study||55
10917800|NCT00159913|12084676|FG002|COMPLETED|Overall Study||75
10917801|NCT00159913|12084677|FG003|COMPLETED|Overall Study||58
10917802|NCT00159913|12084674|FG000|NOT COMPLETED|Overall Study||2
10917803|NCT00159913|12084675|FG001|NOT COMPLETED|Overall Study||0
10917804|NCT00159913|12084676|FG002|NOT COMPLETED|Overall Study||2
10917805|NCT00159913|12084677|FG003|NOT COMPLETED|Overall Study||2
10917806|NCT00159965|12084691|FG000|STARTED|Overall Study||19
10917807|NCT00159965|12084692|FG001|STARTED|Overall Study||19
10917808|NCT00159965|12084691|FG000|COMPLETED|Overall Study||12
10917809|NCT00159965|12084692|FG001|COMPLETED|Overall Study||14
10917810|NCT00159965|12084691|FG000|NOT COMPLETED|Overall Study||7
10917811|NCT00159965|12084692|FG001|NOT COMPLETED|Overall Study||5
10917812|NCT00160199|12084700|FG000|STARTED|Overall Study||122
10917813|NCT00160199|12084701|FG001|STARTED|Overall Study||118
10917814|NCT00160199|12084700|FG000|COMPLETED|Overall Study||98
10917815|NCT00160199|12084701|FG001|COMPLETED|Overall Study||81
10917816|NCT00160199|12084700|FG000|NOT COMPLETED|Overall Study||24
10917817|NCT00160199|12084701|FG001|NOT COMPLETED|Overall Study||37
10917818|NCT00160251|12084713|FG000|STARTED|Prior to Amendment 2||15
10917819|NCT00160251|12084714|FG001|STARTED|Prior to Amendment 2||34
10917820|NCT00160251|12084715|FG002|STARTED|Prior to Amendment 2||48
10917821|NCT00160251|12084716|FG003|STARTED|Prior to Amendment 2||49
10917822|NCT00160251|12084717|FG004|STARTED|Prior to Amendment 2||49
10917823|NCT00160251|12084718|FG005|STARTED|Prior to Amendment 2||97
10917824|NCT00160251|12084719|FG006|STARTED|Prior to Amendment 2||65
10917825|NCT00160251|12084720|FG007|STARTED|Prior to Amendment 2||0
10917826|NCT00160251|12084713|FG000|COMPLETED|Prior to Amendment 2||6
10917827|NCT00160251|12084714|FG001|COMPLETED|Prior to Amendment 2||28
10917828|NCT00160251|12084715|FG002|COMPLETED|Prior to Amendment 2||4
10917829|NCT00160251|12084716|FG003|COMPLETED|Prior to Amendment 2||9
10917830|NCT00160251|12084717|FG004|COMPLETED|Prior to Amendment 2||21
10917831|NCT00160251|12084718|FG005|COMPLETED|Prior to Amendment 2||14
10917832|NCT00160251|12084719|FG006|COMPLETED|Prior to Amendment 2||61
10917833|NCT00160251|12084720|FG007|COMPLETED|Prior to Amendment 2||0
10917834|NCT00160251|12084713|FG000|NOT COMPLETED|Prior to Amendment 2||9
10917835|NCT00160251|12084714|FG001|NOT COMPLETED|Prior to Amendment 2||6
10917836|NCT00160251|12084715|FG002|NOT COMPLETED|Prior to Amendment 2||44
10917837|NCT00160251|12084716|FG003|NOT COMPLETED|Prior to Amendment 2||40
10917838|NCT00160251|12084717|FG004|NOT COMPLETED|Prior to Amendment 2||28
10917839|NCT00160251|12084718|FG005|NOT COMPLETED|Prior to Amendment 2||83
10917840|NCT00160251|12084719|FG006|NOT COMPLETED|Prior to Amendment 2||4
10917841|NCT00160251|12084720|FG007|NOT COMPLETED|Prior to Amendment 2||0
10917842|NCT00160251|12084713|FG000|STARTED|Post-amendment 2||0
10917843|NCT00160251|12084714|FG001|STARTED|Post-amendment 2||0
10917844|NCT00160251|12084715|FG002|STARTED|Post-amendment 2||0
10917845|NCT00160251|12084716|FG003|STARTED|Post-amendment 2||0
10917846|NCT00160251|12084717|FG004|STARTED|Post-amendment 2||0
10917847|NCT00160251|12084718|FG005|STARTED|Post-amendment 2||0
10917848|NCT00160251|12084719|FG006|STARTED|Post-amendment 2||0
10917849|NCT00160251|12084720|FG007|STARTED|Post-amendment 2||143
10917850|NCT00160251|12084713|FG000|COMPLETED|Post-amendment 2||0
10917851|NCT00160251|12084714|FG001|COMPLETED|Post-amendment 2||0
10917852|NCT00160251|12084715|FG002|COMPLETED|Post-amendment 2||0
10917853|NCT00160251|12084716|FG003|COMPLETED|Post-amendment 2||0
10917854|NCT00160251|12084717|FG004|COMPLETED|Post-amendment 2||0
10917855|NCT00160251|12084718|FG005|COMPLETED|Post-amendment 2||0
10917856|NCT00160251|12084719|FG006|COMPLETED|Post-amendment 2||0
10917857|NCT00160251|12084720|FG007|COMPLETED|Post-amendment 2||88
10917858|NCT00160251|12084713|FG000|NOT COMPLETED|Post-amendment 2||0
10917859|NCT00160251|12084714|FG001|NOT COMPLETED|Post-amendment 2||0
10917860|NCT00160251|12084715|FG002|NOT COMPLETED|Post-amendment 2||0
10917861|NCT00160251|12084716|FG003|NOT COMPLETED|Post-amendment 2||0
10917862|NCT00160251|12084717|FG004|NOT COMPLETED|Post-amendment 2||0
10917863|NCT00160251|12084718|FG005|NOT COMPLETED|Post-amendment 2||0
10917864|NCT00160251|12084719|FG006|NOT COMPLETED|Post-amendment 2||0
10917865|NCT00160251|12084720|FG007|NOT COMPLETED|Post-amendment 2||55
10917866|NCT00160524|12084777|FG000|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
10917867|NCT00160524|12084777|FG000|COMPLETED|Overall Study||117
10917868|NCT00160524|12084777|FG000|NOT COMPLETED|Overall Study||478
10917869|NCT00160615|12084783|FG000|STARTED|Overall Study||50
10917870|NCT00160615|12084784|FG001|STARTED|Overall Study||101
10917871|NCT00160615|12084783|FG000|COMPLETED|Overall Study||32
10917872|NCT00160615|12084784|FG001|COMPLETED|Overall Study||56
10917873|NCT00160615|12084783|FG000|NOT COMPLETED|Overall Study||18
10917874|NCT00160615|12084784|FG001|NOT COMPLETED|Overall Study||45
10917875|NCT00160641|12084792|FG000|STARTED|Overall Study||567
10917876|NCT00160641|12084792|FG000|COMPLETED|Overall Study||346
10917877|NCT00160641|12084792|FG000|NOT COMPLETED|Overall Study||221
10917878|NCT00160654|12084796|FG000|STARTED|Overall Study||251
10917879|NCT00160654|12084796|FG000|COMPLETED|Overall Study||218
10917880|NCT00160654|12084796|FG000|NOT COMPLETED|Overall Study||33
10917881|NCT00160667|12084803|FG000|STARTED|Overall Study||50
10917882|NCT00160667|12084804|FG001|STARTED|Overall Study||51
10917883|NCT00160667|12084805|FG002|STARTED|Overall Study||51
10917884|NCT00160667|12084803|FG000|COMPLETED|Overall Study||45
10917885|NCT00160667|12084804|FG001|COMPLETED|Overall Study||48
10917886|NCT00160667|12084805|FG002|COMPLETED|Overall Study||45
10917887|NCT00160667|12084803|FG000|NOT COMPLETED|Overall Study||5
10917888|NCT00160667|12084804|FG001|NOT COMPLETED|Overall Study||3
10917889|NCT00160667|12084805|FG002|NOT COMPLETED|Overall Study||6
10917890|NCT00160680|12084816|FG000|STARTED|Overall Study||31
10917891|NCT00160680|12084817|FG001|STARTED|Overall Study||31
10917892|NCT00160680|12084816|FG000|COMPLETED|Overall Study||22
10917893|NCT00160680|12084817|FG001|COMPLETED|Overall Study||18
10917894|NCT00160680|12084816|FG000|NOT COMPLETED|Overall Study||9
10917895|NCT00160680|12084817|FG001|NOT COMPLETED|Overall Study||13
10917896|NCT00160693|12084823|FG000|STARTED|Overall Study||402
10917897|NCT00160693|12084823|FG000|COMPLETED|Overall Study||167
10917898|NCT00160693|12084823|FG000|NOT COMPLETED|Overall Study||235
10917899|NCT00160706|12084827|FG000|STARTED|Overall Study||310
10917900|NCT00160706|12084827|FG000|COMPLETED|Overall Study||24
10917901|NCT00160706|12084827|FG000|NOT COMPLETED|Overall Study||286
10917902|NCT00161213|12084831|FG000|STARTED|Overall Study||44
10917903|NCT00161213|12084831|FG000|COMPLETED|Overall Study||42
10917904|NCT00161213|12084831|FG000|NOT COMPLETED|Overall Study||2
10917905|NCT00161382|12084837|FG000|STARTED|Overall Study|Number of students allocated to intervention group|598
10917906|NCT00161382|12084838|FG001|STARTED|Overall Study|Number of students allocated to comparison group|847
10917907|NCT00161382|12084837|FG000|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
10917908|NCT00161382|12084838|FG001|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
10917909|NCT00161382|12084837|FG000|NOT COMPLETED|Overall Study||249
10917910|NCT00161382|12084838|FG001|NOT COMPLETED|Overall Study||289
10917911|NCT00161473|12084846|FG000|STARTED|Overall Study||12
10917912|NCT00161473|12084847|FG001|STARTED|Overall Study||12
10917913|NCT00161473|12084846|FG000|COMPLETED|Overall Study||7
10917914|NCT00161473|12084847|FG001|COMPLETED|Overall Study||6
10917915|NCT00161473|12084846|FG000|NOT COMPLETED|Overall Study||5
10917916|NCT00161473|12084847|FG001|NOT COMPLETED|Overall Study||6
10917917|NCT00161616|12084855|FG000|STARTED|Overall Study||139
10917918|NCT00161616|12084856|FG001|STARTED|Overall Study||138
10917919|NCT00161616|12084855|FG000|COMPLETED|Overall Study||113
10917920|NCT00161616|12084856|FG001|COMPLETED|Overall Study||119
10917921|NCT00161616|12084855|FG000|NOT COMPLETED|Overall Study||26
10917922|NCT00161616|12084856|FG001|NOT COMPLETED|Overall Study||19
10917923|NCT00162032|12084864|FG000|STARTED|Overall Study||329
10917924|NCT00162032|12084865|FG001|STARTED|Overall Study||116
10917925|NCT00162032|12084864|FG000|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
10917926|NCT00162032|12084865|FG001|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
10917927|NCT00162032|12084864|FG000|NOT COMPLETED|Overall Study||5
10917928|NCT00162032|12084865|FG001|NOT COMPLETED|Overall Study||2
10917929|NCT00162097|12084880|FG000|STARTED|Overall Study|Treated on Day 1|6
10917930|NCT00162097|12084881|FG001|STARTED|Overall Study|Treated on Day 1|2
10917931|NCT00162097|12084882|FG002|STARTED|Overall Study|Treated on Day 1|1
10917932|NCT00162097|12084883|FG003|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
10917933|NCT00162097|12084880|FG000|COMPLETED|Overall Study||6
10917934|NCT00162097|12084881|FG001|COMPLETED|Overall Study||2
10917935|NCT00162097|12084882|FG002|COMPLETED|Overall Study||1
10917936|NCT00162097|12084883|FG003|COMPLETED|Overall Study||6
10917937|NCT00162097|12084880|FG000|NOT COMPLETED|Overall Study||0
10917938|NCT00162097|12084881|FG001|NOT COMPLETED|Overall Study||0
10917939|NCT00162097|12084882|FG002|NOT COMPLETED|Overall Study||0
10917940|NCT00162097|12084883|FG003|NOT COMPLETED|Overall Study||1
10917941|NCT00162123|12084907|FG000|STARTED|Overall Study|Enrolled|53
10917942|NCT00162123|12084908|FG001|STARTED|Overall Study|Enrolled|34
10917943|NCT00162123|12084909|FG002|STARTED|Overall Study|Enrolled|24
10917944|NCT00162123|12084910|FG003|STARTED|Overall Study|Enrolled|11
10917945|NCT00162123|12084911|FG004|STARTED|Overall Study|Enrolled|45
10917946|NCT00162123|12084912|FG005|STARTED|Overall Study|Enrolled|13
10917947|NCT00162123|12084913|FG006|STARTED|Overall Study|Enrolled|4
10917948|NCT00162123|12084914|FG007|STARTED|Overall Study|Enrolled|58
10917949|NCT00162123|12084907|FG000|Received Treatment|Overall Study||53
10917950|NCT00162123|12084908|FG001|Received Treatment|Overall Study||34
10917951|NCT00162123|12084909|FG002|Received Treatment|Overall Study||24
10917952|NCT00162123|12084910|FG003|Received Treatment|Overall Study||11
10917953|NCT00162123|12084911|FG004|Received Treatment|Overall Study||33
10917954|NCT00162123|12084912|FG005|Received Treatment|Overall Study||12
10917955|NCT00162123|12084913|FG006|Received Treatment|Overall Study||4
10917956|NCT00162123|12084914|FG007|Received Treatment|Overall Study||0
10917957|NCT00162123|12084907|FG000|COMPLETED|Overall Study|Still on treatment|9
10917958|NCT00162123|12084908|FG001|COMPLETED|Overall Study|Still on treatment|5
10917959|NCT00162123|12084909|FG002|COMPLETED|Overall Study|Still on treatment|3
10917960|NCT00162123|12084910|FG003|COMPLETED|Overall Study|Still on treatment|3
10917961|NCT00162123|12084911|FG004|COMPLETED|Overall Study|Still on treatment|14
10917962|NCT00162123|12084912|FG005|COMPLETED|Overall Study|Still on treatment|4
10917963|NCT00162123|12084913|FG006|COMPLETED|Overall Study|Still on treatment|0
10917964|NCT00162123|12084914|FG007|COMPLETED|Overall Study|Still on treatment|0
10917965|NCT00162123|12084907|FG000|NOT COMPLETED|Overall Study||44
10917966|NCT00162123|12084908|FG001|NOT COMPLETED|Overall Study||29
10917967|NCT00162123|12084909|FG002|NOT COMPLETED|Overall Study||21
10917968|NCT00162123|12084910|FG003|NOT COMPLETED|Overall Study||8
10917969|NCT00162123|12084911|FG004|NOT COMPLETED|Overall Study||31
10917970|NCT00162123|12084912|FG005|NOT COMPLETED|Overall Study||9
10917971|NCT00162123|12084913|FG006|NOT COMPLETED|Overall Study||4
10917972|NCT00162123|12084914|FG007|NOT COMPLETED|Overall Study||58
10917973|NCT00162136|12084939|FG000|STARTED|Overall Study||35
10917974|NCT00162136|12084939|FG000|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
10917975|NCT00162136|12084939|FG000|NOT COMPLETED|Overall Study||35
10917976|NCT00162266|12084966|FG000|STARTED|Double-Blind Period||115
10917977|NCT00162266|12084967|FG001|STARTED|Double-Blind Period||105
10917978|NCT00162266|12084968|FG002|STARTED|Double-Blind Period||119
10917979|NCT00162266|12084969|FG003|STARTED|Double-Blind Period||0
10917980|NCT00162266|12084966|FG000|Completed Day 1 to Day 181|Double-Blind Period||98
10917981|NCT00162266|12084967|FG001|Completed Day 1 to Day 181|Double-Blind Period||80
10917982|NCT00162266|12084968|FG002|Completed Day 1 to Day 181|Double-Blind Period||78
10917983|NCT00162266|12084969|FG003|Completed Day 1 to Day 181|Double-Blind Period||0
10917984|NCT00162266|12084966|FG000|COMPLETED|Double-Blind Period||90
10917985|NCT00162266|12084967|FG001|COMPLETED|Double-Blind Period||74
10917986|NCT00162266|12084968|FG002|COMPLETED|Double-Blind Period||71
10917987|NCT00162266|12084969|FG003|COMPLETED|Double-Blind Period||0
10917988|NCT00162266|12084966|FG000|NOT COMPLETED|Double-Blind Period||25
10917989|NCT00162266|12084967|FG001|NOT COMPLETED|Double-Blind Period||31
10917990|NCT00162266|12084968|FG002|NOT COMPLETED|Double-Blind Period||48
10917991|NCT00162266|12084969|FG003|NOT COMPLETED|Double-Blind Period||0
10917992|NCT00162266|12084966|FG000|STARTED|Open-Label Period||0
10917993|NCT00162266|12084967|FG001|STARTED|Open-Label Period||0
10917994|NCT00162266|12084968|FG002|STARTED|Open-Label Period||0
10917995|NCT00162266|12084969|FG003|STARTED|Open-Label Period||219
10917996|NCT00162266|12084966|FG000|COMPLETED|Open-Label Period||0
10917997|NCT00162266|12084967|FG001|COMPLETED|Open-Label Period||0
10917998|NCT00162266|12084968|FG002|COMPLETED|Open-Label Period||0
10917999|NCT00162266|12084969|FG003|COMPLETED|Open-Label Period||82
10918000|NCT00162266|12084966|FG000|NOT COMPLETED|Open-Label Period||0
10918001|NCT00162266|12084967|FG001|NOT COMPLETED|Open-Label Period||0
10918002|NCT00162266|12084968|FG002|NOT COMPLETED|Open-Label Period||0
10918003|NCT00162266|12084969|FG003|NOT COMPLETED|Open-Label Period||137
10918004|NCT00162981|12085023|FG000|STARTED|Overall Study||32
10918005|NCT00162981|12085024|FG001|STARTED|Overall Study||36
10918006|NCT00162981|12085023|FG000|COMPLETED|Overall Study||28
10918007|NCT00162981|12085024|FG001|COMPLETED|Overall Study||30
10918008|NCT00162981|12085023|FG000|NOT COMPLETED|Overall Study||4
10918009|NCT00162981|12085024|FG001|NOT COMPLETED|Overall Study||6
10918010|NCT00163020|12085032|FG000|STARTED|Overall Study|Twins = 160 Triplets = 56|216
10918011|NCT00163020|12085033|FG001|STARTED|Overall Study|Twins = 80 Triplets = 25|105
10918012|NCT00163020|12085032|FG000|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
10918013|NCT00163020|12085033|FG001|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
10918014|NCT00163020|12085032|FG000|NOT COMPLETED|Overall Study||0
10918015|NCT00163020|12085033|FG001|NOT COMPLETED|Overall Study||2
10918016|NCT00163189|12085041|FG000|STARTED|Overall Study||98
10918017|NCT00163189|12085041|FG000|COMPLETED|Overall Study||35
10918018|NCT00163189|12085041|FG000|NOT COMPLETED|Overall Study||63
10918019|NCT00163215|12085045|FG000|STARTED|Overall Study||46
10918020|NCT00163215|12085045|FG000|COMPLETED|Overall Study||31
10918021|NCT00163215|12085045|FG000|NOT COMPLETED|Overall Study||15
10918022|NCT00163293|12085052|FG000|STARTED|Overall Study||79
10918023|NCT00163293|12085053|FG001|STARTED|Overall Study||76
10918024|NCT00163293|12085054|FG002|STARTED|Overall Study||85
10918025|NCT00163293|12085052|FG000|COMPLETED|Overall Study||66
10918026|NCT00163293|12085053|FG001|COMPLETED|Overall Study||69
10918027|NCT00163293|12085054|FG002|COMPLETED|Overall Study||66
10918028|NCT00163293|12085052|FG000|NOT COMPLETED|Overall Study||13
10918029|NCT00163293|12085053|FG001|NOT COMPLETED|Overall Study||7
10918030|NCT00163293|12085054|FG002|NOT COMPLETED|Overall Study||19
10918031|NCT00163657|12085065|FG000|STARTED|Overall Study||80
10918032|NCT00163657|12085066|FG001|STARTED|Overall Study||79
10918033|NCT00163657|12085067|FG002|STARTED|Overall Study||153
10918034|NCT00163657|12085065|FG000|COMPLETED|Overall Study||60
10918035|NCT00163657|12085066|FG001|COMPLETED|Overall Study||56
10918036|NCT00163657|12085067|FG002|COMPLETED|Overall Study||116
10918037|NCT00163657|12085065|FG000|NOT COMPLETED|Overall Study||20
10918038|NCT00163657|12085066|FG001|NOT COMPLETED|Overall Study||23
10918039|NCT00163657|12085067|FG002|NOT COMPLETED|Overall Study||37
10918040|NCT00165646|12085078|FG000|STARTED|Overall Study||93
10918041|NCT00165646|12085079|FG001|STARTED|Overall Study||93
10918042|NCT00165646|12085080|FG002|STARTED|Overall Study||102
10918043|NCT00165646|12085078|FG000|COMPLETED|Overall Study||88
10918044|NCT00165646|12085079|FG001|COMPLETED|Overall Study||88
10918045|NCT00165646|12085080|FG002|COMPLETED|Overall Study||98
10918046|NCT00165646|12085078|FG000|NOT COMPLETED|Overall Study||5
10918047|NCT00165646|12085079|FG001|NOT COMPLETED|Overall Study||5
10918048|NCT00165646|12085080|FG002|NOT COMPLETED|Overall Study||4
10918049|NCT00165672|12085090|FG000|STARTED|Overall Study||13
10918050|NCT00165672|12085091|FG001|STARTED|Overall Study||13
10918051|NCT00165672|12085090|FG000|COMPLETED|Overall Study||13
10918052|NCT00165672|12085091|FG001|COMPLETED|Overall Study||12
10918053|NCT00165672|12085090|FG000|NOT COMPLETED|Overall Study||0
10918054|NCT00165672|12085091|FG001|NOT COMPLETED|Overall Study||1
10918055|NCT00165698|12085099|FG000|STARTED|Overall Study||120
10918056|NCT00165698|12085100|FG001|STARTED|Overall Study||120
10918057|NCT00165698|12085099|FG000|COMPLETED|Overall Study||112
10918058|NCT00165698|12085100|FG001|COMPLETED|Overall Study||105
10918059|NCT00165698|12085099|FG000|NOT COMPLETED|Overall Study||8
10918060|NCT00165698|12085100|FG001|NOT COMPLETED|Overall Study||15
10918061|NCT00165776|12085110|FG000|STARTED|Overall Study||35
10918062|NCT00165776|12085111|FG001|STARTED|Overall Study||34
10918063|NCT00165776|12085112|FG002|STARTED|Overall Study||33
10918064|NCT00165776|12085113|FG003|STARTED|Overall Study||31
10918065|NCT00165776|12085110|FG000|COMPLETED|Overall Study||31
10918066|NCT00165776|12085111|FG001|COMPLETED|Overall Study||33
10918067|NCT00165776|12085112|FG002|COMPLETED|Overall Study||31
10918068|NCT00165776|12085113|FG003|COMPLETED|Overall Study||29
10918069|NCT00165776|12085110|FG000|NOT COMPLETED|Overall Study||4
10918070|NCT00165776|12085111|FG001|NOT COMPLETED|Overall Study||1
10918071|NCT00165776|12085112|FG002|NOT COMPLETED|Overall Study||2
10918072|NCT00165776|12085113|FG003|NOT COMPLETED|Overall Study||2
10918073|NCT00165789|12085127|FG000|STARTED|Overall Study||8
10918074|NCT00165789|12085128|FG001|STARTED|Overall Study||20
10918075|NCT00165789|12085129|FG002|STARTED|Overall Study||12
10918076|NCT00165789|12085130|FG003|STARTED|Overall Study||35
10918077|NCT00165789|12085127|FG000|COMPLETED|Overall Study||8
10918078|NCT00165789|12085128|FG001|COMPLETED|Overall Study||16
10918079|NCT00165789|12085129|FG002|COMPLETED|Overall Study||11
10918080|NCT00165789|12085130|FG003|COMPLETED|Overall Study||21
10918081|NCT00165789|12085127|FG000|NOT COMPLETED|Overall Study||0
10918082|NCT00165789|12085128|FG001|NOT COMPLETED|Overall Study||4
10918083|NCT00165789|12085129|FG002|NOT COMPLETED|Overall Study||1
10918084|NCT00165789|12085130|FG003|NOT COMPLETED|Overall Study||14
10918085|NCT00165841|12085142|FG000|STARTED|Overall Study||103
10918086|NCT00165841|12085143|FG001|STARTED|Overall Study||97
10918087|NCT00165841|12085142|FG000|COMPLETED|Overall Study||73
10918088|NCT00165841|12085143|FG001|COMPLETED|Overall Study||35
10918089|NCT00165841|12085142|FG000|NOT COMPLETED|Overall Study||30
10918090|NCT00165841|12085143|FG001|NOT COMPLETED|Overall Study||62
10918091|NCT00165958|12085151|FG000|STARTED|Overall Study||19
10918092|NCT00165958|12085152|FG001|STARTED|Overall Study||21
10918093|NCT00165958|12085151|FG000|COMPLETED|Overall Study||18
10918094|NCT00165958|12085152|FG001|COMPLETED|Overall Study||19
10918095|NCT00165958|12085151|FG000|NOT COMPLETED|Overall Study||1
10918096|NCT00165958|12085152|FG001|NOT COMPLETED|Overall Study||2
10918097|NCT00165984|12085158|FG000|STARTED|Overall Study||165
10918098|NCT00165984|12085158|FG000|COMPLETED|Overall Study||150
10918099|NCT00165984|12085158|FG000|NOT COMPLETED|Overall Study||15
10918100|NCT00166036|12085167|FG000|STARTED|Overall Study||17
10918101|NCT00166036|12085168|FG001|STARTED|Overall Study||19
10918102|NCT00166036|12085167|FG000|COMPLETED|Overall Study||17
10918103|NCT00166036|12085168|FG001|COMPLETED|Overall Study||19
10918104|NCT00166036|12085167|FG000|NOT COMPLETED|Overall Study||0
10918105|NCT00166036|12085168|FG001|NOT COMPLETED|Overall Study||0
10918106|NCT00166114|12085177|FG000|STARTED|Overall Study||21
10918107|NCT00166114|12085178|FG001|STARTED|Overall Study||19
10918108|NCT00166114|12085177|FG000|COMPLETED|Overall Study||7
10918109|NCT00166114|12085178|FG001|COMPLETED|Overall Study||13
10918110|NCT00166114|12085177|FG000|NOT COMPLETED|Overall Study||14
10918111|NCT00166114|12085178|FG001|NOT COMPLETED|Overall Study||6
10918112|NCT00166166|12085186|FG000|STARTED|Overall Study||103
10918113|NCT00166166|12085187|FG001|STARTED|Overall Study||71
10918114|NCT00166166|12085186|FG000|COMPLETED|Overall Study||103
10918115|NCT00166166|12085187|FG001|COMPLETED|Overall Study||71
10918116|NCT00166166|12085186|FG000|NOT COMPLETED|Overall Study||0
10918117|NCT00166166|12085187|FG001|NOT COMPLETED|Overall Study||0
10918118|NCT00166205|12085206|FG000|STARTED|Overall Study||276
10918119|NCT00166205|12085206|FG000|Intervention - SAGB Surgery|Overall Study||276
10918120|NCT00166205|12085206|FG000|COMPLETED|Overall Study||228
10918121|NCT00166205|12085206|FG000|NOT COMPLETED|Overall Study||48
10918122|NCT00166296|12085212|FG000|STARTED|Overall Study|Randomized patients|67
10918123|NCT00166296|12085213|FG001|STARTED|Overall Study|Randomized patients|66
10918124|NCT00166296|12085212|FG000|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
10918125|NCT00166296|12085213|FG001|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
10918126|NCT00166296|12085212|FG000|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
10918127|NCT00166296|12085213|FG001|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
10918128|NCT00166296|12085212|FG000|NOT COMPLETED|Overall Study||7
10918129|NCT00166296|12085213|FG001|NOT COMPLETED|Overall Study||9
10918130|NCT00166361|12085221|FG000|STARTED|Overall Study||14
10918131|NCT00166361|12085222|FG001|STARTED|Overall Study||10
10918132|NCT00166361|12085221|FG000|COMPLETED|Overall Study||14
10918133|NCT00166361|12085222|FG001|COMPLETED|Overall Study||10
10918134|NCT00166361|12085221|FG000|NOT COMPLETED|Overall Study||0
10918135|NCT00166361|12085222|FG001|NOT COMPLETED|Overall Study||0
10918136|NCT00166439|12085228|FG000|STARTED|Overall Study||50
10918137|NCT00166439|12085228|FG000|COMPLETED|Overall Study||45
10918138|NCT00166439|12085228|FG000|NOT COMPLETED|Overall Study||5
10918139|NCT00166517|12085234|FG000|STARTED|Overall Study||115
10918140|NCT00166517|12085235|FG001|STARTED|Overall Study||63
10918141|NCT00166517|12085234|FG000|Vaccinated at Visit 1|Overall Study||115
10918142|NCT00166517|12085235|FG001|Vaccinated at Visit 1|Overall Study||63
10918143|NCT00166517|12085234|FG000|Vaccinated at Visit 2|Overall Study||112
10918144|NCT00166517|12085235|FG001|Vaccinated at Visit 2|Overall Study||61
10918145|NCT00166517|12085234|FG000|Vaccinated at Visit 3|Overall Study||110
10918146|NCT00166517|12085235|FG001|Vaccinated at Visit 3|Overall Study||61
10918147|NCT00166517|12085234|FG000|COMPLETED|Overall Study||110
10918148|NCT00166517|12085235|FG001|COMPLETED|Overall Study||61
10918149|NCT00166517|12085234|FG000|NOT COMPLETED|Overall Study||5
10918150|NCT00166517|12085235|FG001|NOT COMPLETED|Overall Study||2
10918151|NCT00166712|12085243|FG000|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
10918152|NCT00166712|12085244|FG001|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
10918153|NCT00166712|12085243|FG000|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
10918154|NCT00166712|12085244|FG001|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
10918155|NCT00166712|12085243|FG000|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
10918156|NCT00166712|12085244|FG001|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
10918157|NCT00166712|12085243|FG000|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
10918158|NCT00166712|12085244|FG001|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
10918159|NCT00166712|12085243|FG000|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
10918160|NCT00166712|12085244|FG001|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
10918161|NCT00166712|12085243|FG000|COMPLETED|Overall Study|Completed study participation.|22
10918162|NCT00166712|12085244|FG001|COMPLETED|Overall Study|Completed study participation.|11
10918163|NCT00166712|12085243|FG000|NOT COMPLETED|Overall Study||2
10918164|NCT00166712|12085244|FG001|NOT COMPLETED|Overall Study||5
10918165|NCT00167102|12085256|FG000|STARTED|Overall Study||23
10918166|NCT00167102|12085257|FG001|STARTED|Overall Study||22
10918167|NCT00167102|12085256|FG000|COMPLETED|Overall Study||23
10918168|NCT00167102|12085257|FG001|COMPLETED|Overall Study||22
10918169|NCT00167102|12085256|FG000|NOT COMPLETED|Overall Study||0
10918170|NCT00167102|12085257|FG001|NOT COMPLETED|Overall Study||0
10918171|NCT00167180|12085267|FG000|STARTED|Overall Study||0
10918172|NCT00167180|12085268|FG001|STARTED|Overall Study||57
10918173|NCT00167180|12085267|FG000|COMPLETED|Overall Study||0
10918174|NCT00167180|12085268|FG001|COMPLETED|Overall Study||57
10918175|NCT00167180|12085267|FG000|NOT COMPLETED|Overall Study||0
10918176|NCT00167180|12085268|FG001|NOT COMPLETED|Overall Study||0
10918177|NCT00167206|12085274|FG000|STARTED|Overall Study||16
10918178|NCT00167206|12085274|FG000|COMPLETED|Overall Study||16
10918179|NCT00167206|12085274|FG000|NOT COMPLETED|Overall Study||0
10918180|NCT00167245|12085280|FG000|STARTED|Overall Study||83
10918181|NCT00167245|12085281|FG001|STARTED|Overall Study||87
10918182|NCT00167245|12085280|FG000|COMPLETED|Overall Study||54
10918183|NCT00167245|12085281|FG001|COMPLETED|Overall Study||46
10918184|NCT00167245|12085280|FG000|NOT COMPLETED|Overall Study||29
10918185|NCT00167245|12085281|FG001|NOT COMPLETED|Overall Study||41
10918186|NCT00167310|12085292|FG000|STARTED|Overall Study||29
10918187|NCT00167310|12085293|FG001|STARTED|Overall Study||28
10918188|NCT00167310|12085292|FG000|COMPLETED|Overall Study||21
10918189|NCT00167310|12085293|FG001|COMPLETED|Overall Study||18
10918190|NCT00167310|12085292|FG000|NOT COMPLETED|Overall Study||8
10918191|NCT00167310|12085293|FG001|NOT COMPLETED|Overall Study||10
10918192|NCT00167388|12085303|FG000|STARTED|Overall Study||5
10918193|NCT00167388|12085304|FG001|STARTED|Overall Study||5
10918194|NCT00167388|12085305|FG002|STARTED|Overall Study||6
10918195|NCT00167388|12085306|FG003|STARTED|Overall Study||6
10918196|NCT00167388|12085303|FG000|Completed Doppler Study|Overall Study||5
10918197|NCT00167388|12085304|FG001|Completed Doppler Study|Overall Study||5
10918198|NCT00167388|12085305|FG002|Completed Doppler Study|Overall Study||6
10918199|NCT00167388|12085306|FG003|Completed Doppler Study|Overall Study||6
10918200|NCT00167388|12085303|FG000|COMPLETED|Overall Study||5
10918201|NCT00167388|12085304|FG001|COMPLETED|Overall Study||5
10918202|NCT00167388|12085305|FG002|COMPLETED|Overall Study||6
10918203|NCT00167388|12085306|FG003|COMPLETED|Overall Study||6
10918204|NCT00167388|12085303|FG000|NOT COMPLETED|Overall Study||0
10918205|NCT00167388|12085304|FG001|NOT COMPLETED|Overall Study||0
10918206|NCT00167388|12085305|FG002|NOT COMPLETED|Overall Study||0
10918207|NCT00167388|12085306|FG003|NOT COMPLETED|Overall Study||0
10918208|NCT00167414|12085314|FG000|STARTED|Overall Study||49
10918209|NCT00167414|12085314|FG000|COMPLETED|Overall Study||39
10918210|NCT00167414|12085314|FG000|NOT COMPLETED|Overall Study||10
10918211|NCT00167544|12085320|FG000|STARTED|Overall Study||31
10918212|NCT00167544|12085321|FG001|STARTED|Overall Study||33
10918213|NCT00167544|12085320|FG000|COMPLETED|Overall Study||30
10918214|NCT00167544|12085321|FG001|COMPLETED|Overall Study||33
10918215|NCT00167544|12085320|FG000|NOT COMPLETED|Overall Study||1
10918216|NCT00167544|12085321|FG001|NOT COMPLETED|Overall Study||0
10918217|NCT00167661|12085327|FG000|STARTED|Overall Study||33
10918218|NCT00167661|12085327|FG000|COMPLETED|Overall Study||33
10918219|NCT00167661|12085327|FG000|NOT COMPLETED|Overall Study||0
10918220|NCT00167778|12085331|FG000|STARTED|Overall Study||11
10918221|NCT00167778|12085331|FG000|COMPLETED|Overall Study||10
10918222|NCT00167778|12085331|FG000|NOT COMPLETED|Overall Study||1
10918223|NCT00167934|12085338|FG000|STARTED|Overall Study||82
10918224|NCT00167934|12085339|FG001|STARTED|Overall Study||82
10918225|NCT00167934|12085338|FG000|COMPLETED|Overall Study||82
10918226|NCT00167934|12085339|FG001|COMPLETED|Overall Study||82
10918227|NCT00167934|12085338|FG000|NOT COMPLETED|Overall Study||0
10918228|NCT00167934|12085339|FG001|NOT COMPLETED|Overall Study||0
10918229|NCT00168038|12085345|FG000|STARTED|Overall Study||57
10918230|NCT00168038|12085345|FG000|COMPLETED|Overall Study||55
10918231|NCT00168038|12085345|FG000|NOT COMPLETED|Overall Study||2
10918232|NCT00168064|12085351|FG000|STARTED|Overall Study|128 participants received PG formulation|130
10918233|NCT00168064|12085352|FG001|STARTED|Overall Study|127 participants received AP formulation|130
10918234|NCT00168064|12085351|FG000|COMPLETED|Overall Study||81
10918235|NCT00168064|12085352|FG001|COMPLETED|Overall Study||86
10918236|NCT00168064|12085351|FG000|NOT COMPLETED|Overall Study||49
10918237|NCT00168064|12085352|FG001|NOT COMPLETED|Overall Study||44
10918238|NCT00168103|12085363|FG000|STARTED|Overall Study||40
10918239|NCT00168103|12085364|FG001|STARTED|Overall Study||43
10918240|NCT00168103|12085365|FG002|STARTED|Overall Study||42
10918241|NCT00168103|12085366|FG003|STARTED|Overall Study||1
10918242|NCT00168103|12085363|FG000|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
10918243|NCT00168103|12085364|FG001|COMPLETED|Overall Study||38
10918244|NCT00168103|12085365|FG002|COMPLETED|Overall Study||41
10918245|NCT00168103|12085366|FG003|COMPLETED|Overall Study||1
10918246|NCT00168103|12085363|FG000|NOT COMPLETED|Overall Study||2
10918247|NCT00168103|12085364|FG001|NOT COMPLETED|Overall Study||5
10918248|NCT00168103|12085365|FG002|NOT COMPLETED|Overall Study||1
10918249|NCT00168103|12085366|FG003|NOT COMPLETED|Overall Study||0
10918250|NCT00168298|12085377|FG000|STARTED|Double-Blind Period||226
10918251|NCT00168298|12085378|FG001|STARTED|Double-Blind Period||218
10918252|NCT00168298|12085379|FG002|STARTED|Double-Blind Period||224
10918253|NCT00168298|12085377|FG000|COMPLETED|Double-Blind Period||214
10918254|NCT00168298|12085378|FG001|COMPLETED|Double-Blind Period||206
10918255|NCT00168298|12085379|FG002|COMPLETED|Double-Blind Period||209
10918256|NCT00168298|12085377|FG000|NOT COMPLETED|Double-Blind Period||12
10918257|NCT00168298|12085378|FG001|NOT COMPLETED|Double-Blind Period||12
10918258|NCT00168298|12085379|FG002|NOT COMPLETED|Double-Blind Period||15
10918259|NCT00168298|12085377|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
10918260|NCT00168298|12085378|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
10918261|NCT00168298|12085379|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
10918262|NCT00168298|12085377|FG000|COMPLETED|Open-Label Period||172
10918263|NCT00168298|12085378|FG001|COMPLETED|Open-Label Period||168
10918264|NCT00168298|12085379|FG002|COMPLETED|Open-Label Period||160
10918265|NCT00168298|12085377|FG000|NOT COMPLETED|Open-Label Period||7
10918266|NCT00168298|12085378|FG001|NOT COMPLETED|Open-Label Period||5
10918267|NCT00168298|12085379|FG002|NOT COMPLETED|Open-Label Period||8
10918268|NCT00168311|12085389|FG000|STARTED|Overall Study||12
10918269|NCT00168311|12085390|FG001|STARTED|Overall Study||10
10918270|NCT00168311|12085389|FG000|COMPLETED|Overall Study||12
10918271|NCT00168311|12085390|FG001|COMPLETED|Overall Study||8
10918272|NCT00168311|12085389|FG000|NOT COMPLETED|Overall Study||0
10918273|NCT00168311|12085390|FG001|NOT COMPLETED|Overall Study||2
10918274|NCT00168324|12085399|FG000|STARTED|Double-Blind Period||201
10918275|NCT00168324|12085400|FG001|STARTED|Double-Blind Period||196
10918276|NCT00168324|12085401|FG002|STARTED|Double-Blind Period||202
10918277|NCT00168324|12085399|FG000|COMPLETED|Double-Blind Period||189
10918278|NCT00168324|12085400|FG001|COMPLETED|Double-Blind Period||189
10918279|NCT00168324|12085401|FG002|COMPLETED|Double-Blind Period||189
10918280|NCT00168324|12085399|FG000|NOT COMPLETED|Double-Blind Period||12
10918281|NCT00168324|12085400|FG001|NOT COMPLETED|Double-Blind Period||7
10918282|NCT00168324|12085401|FG002|NOT COMPLETED|Double-Blind Period||13
10918283|NCT00168324|12085399|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
10918284|NCT00168324|12085400|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
10918285|NCT00168324|12085401|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
10918286|NCT00168324|12085399|FG000|COMPLETED|Open-Label Period||160
10918287|NCT00168324|12085400|FG001|COMPLETED|Open-Label Period||147
10918288|NCT00168324|12085401|FG002|COMPLETED|Open-Label Period||152
10918289|NCT00168324|12085399|FG000|NOT COMPLETED|Open-Label Period||4
10918290|NCT00168324|12085400|FG001|NOT COMPLETED|Open-Label Period||8
10918291|NCT00168324|12085401|FG002|NOT COMPLETED|Open-Label Period||6
10918292|NCT00168337|12085412|FG000|STARTED|Overall Study||188
10918293|NCT00168337|12085413|FG001|STARTED|Overall Study||181
10918294|NCT00168337|12085414|FG002|STARTED|Overall Study||185
10918295|NCT00168337|12085412|FG000|COMPLETED|Overall Study||118
10918296|NCT00168337|12085413|FG001|COMPLETED|Overall Study||112
10918297|NCT00168337|12085414|FG002|COMPLETED|Overall Study||82
10918298|NCT00168337|12085412|FG000|NOT COMPLETED|Overall Study||70
10918299|NCT00168337|12085413|FG001|NOT COMPLETED|Overall Study||69
10918300|NCT00168337|12085414|FG002|NOT COMPLETED|Overall Study||103
10918301|NCT00168389|12085425|FG000|STARTED|Overall Study||163
10918302|NCT00168389|12085426|FG001|STARTED|Overall Study||166
10918303|NCT00168389|12085427|FG002|STARTED|Overall Study||165
10918304|NCT00168389|12085425|FG000|COMPLETED|Overall Study||107
10918305|NCT00168389|12085426|FG001|COMPLETED|Overall Study||118
10918306|NCT00168389|12085427|FG002|COMPLETED|Overall Study||70
10918307|NCT00168389|12085425|FG000|NOT COMPLETED|Overall Study||56
10918308|NCT00168389|12085426|FG001|NOT COMPLETED|Overall Study||48
10918309|NCT00168389|12085427|FG002|NOT COMPLETED|Overall Study||95
10918310|NCT00168428|12085437|FG000|STARTED|Double-Blind Phase (DB)||347
10918311|NCT00168428|12085438|FG001|STARTED|Double-Blind Phase (DB)||358
10918312|NCT00168428|12085437|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
10918313|NCT00168428|12085438|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
10918314|NCT00168428|12085437|FG000|NOT COMPLETED|Double-Blind Phase (DB)||36
10918315|NCT00168428|12085438|FG001|NOT COMPLETED|Double-Blind Phase (DB)||24
10918316|NCT00168428|12085437|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
10918317|NCT00168428|12085438|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
10918318|NCT00168428|12085437|FG000|COMPLETED|Open-Label Phase (OL)||261
10918319|NCT00168428|12085438|FG001|COMPLETED|Open-Label Phase (OL)||261
10918320|NCT00168428|12085437|FG000|NOT COMPLETED|Open-Label Phase (OL)||44
10918321|NCT00168428|12085438|FG001|NOT COMPLETED|Open-Label Phase (OL)||68
10918322|NCT00168454|12085450|FG000|STARTED|Overall Study||44
10918323|NCT00168454|12085451|FG001|STARTED|Overall Study||57
10918324|NCT00168454|12085452|FG002|STARTED|Overall Study||54
10918325|NCT00168454|12085453|FG003|STARTED|Overall Study||49
10918326|NCT00168454|12085454|FG004|STARTED|Overall Study||53
10918327|NCT00168454|12085455|FG005|STARTED|Overall Study||56
10918328|NCT00168454|12085450|FG000|COMPLETED|Overall Study||37
10918329|NCT00168454|12085451|FG001|COMPLETED|Overall Study||50
10918330|NCT00168454|12085452|FG002|COMPLETED|Overall Study||48
10918331|NCT00168454|12085453|FG003|COMPLETED|Overall Study||40
10918332|NCT00168454|12085454|FG004|COMPLETED|Overall Study||47
10918333|NCT00168454|12085455|FG005|COMPLETED|Overall Study||50
10918334|NCT00168454|12085450|FG000|NOT COMPLETED|Overall Study||7
10918335|NCT00168454|12085451|FG001|NOT COMPLETED|Overall Study||7
10918336|NCT00168454|12085452|FG002|NOT COMPLETED|Overall Study||6
10918337|NCT00168454|12085453|FG003|NOT COMPLETED|Overall Study||9
10918338|NCT00168454|12085454|FG004|NOT COMPLETED|Overall Study||6
10918339|NCT00168454|12085455|FG005|NOT COMPLETED|Overall Study||6
10918340|NCT00168805|12085472|FG000|STARTED|Overall Study||679
10918341|NCT00168805|12085473|FG001|STARTED|Overall Study||703
10918342|NCT00168805|12085474|FG002|STARTED|Overall Study||694
10918343|NCT00168805|12085472|FG000|COMPLETED|Overall Study||608
10918344|NCT00168805|12085473|FG001|COMPLETED|Overall Study||625
10918345|NCT00168805|12085474|FG002|COMPLETED|Overall Study||616
10918346|NCT00168805|12085472|FG000|NOT COMPLETED|Overall Study||71
10918347|NCT00168805|12085473|FG001|NOT COMPLETED|Overall Study||78
10918348|NCT00168805|12085474|FG002|NOT COMPLETED|Overall Study||78
10918349|NCT00168805|12085472|FG000|STARTED|Treatment||679
10918350|NCT00168805|12085473|FG001|STARTED|Treatment||703
10918351|NCT00168805|12085474|FG002|STARTED|Treatment||694
10918352|NCT00168805|12085472|FG000|COMPLETED|Treatment||630
10918353|NCT00168805|12085473|FG001|COMPLETED|Treatment||647
10918354|NCT00168805|12085474|FG002|COMPLETED|Treatment||632
10918355|NCT00168805|12085472|FG000|NOT COMPLETED|Treatment||49
10918356|NCT00168805|12085473|FG001|NOT COMPLETED|Treatment||56
10918357|NCT00168805|12085474|FG002|NOT COMPLETED|Treatment||62
10918358|NCT00168818|12085485|FG000|STARTED|Overall Study||1146
10918359|NCT00168818|12085486|FG001|STARTED|Overall Study||1163
10918360|NCT00168818|12085487|FG002|STARTED|Overall Study||1154
10918361|NCT00168818|12085485|FG000|COMPLETED|Overall Study||1029
10918362|NCT00168818|12085486|FG001|COMPLETED|Overall Study||1054
10918363|NCT00168818|12085487|FG002|COMPLETED|Overall Study||1030
10918364|NCT00168818|12085485|FG000|NOT COMPLETED|Overall Study||117
10918365|NCT00168818|12085486|FG001|NOT COMPLETED|Overall Study||109
10918366|NCT00168818|12085487|FG002|NOT COMPLETED|Overall Study||124
10918367|NCT00168818|12085485|FG000|STARTED|Treatment||1146
10918368|NCT00168818|12085486|FG001|STARTED|Treatment||1163
10918369|NCT00168818|12085487|FG002|STARTED|Treatment||1154
10918370|NCT00168818|12085485|FG000|COMPLETED|Treatment||1013
10918371|NCT00168818|12085486|FG001|COMPLETED|Treatment||1012
10918372|NCT00168818|12085487|FG002|COMPLETED|Treatment||1021
10918373|NCT00168818|12085485|FG000|NOT COMPLETED|Treatment||133
10918374|NCT00168818|12085486|FG001|NOT COMPLETED|Treatment||151
10918375|NCT00168818|12085487|FG002|NOT COMPLETED|Treatment||133
10918376|NCT00168831|12085498|FG000|STARTED|Overall Study||338
10918377|NCT00168831|12085499|FG001|STARTED|Overall Study||335
10918378|NCT00168831|12085500|FG002|STARTED|Overall Study||334
10918379|NCT00168831|12085498|FG000|COMPLETED|Overall Study||278
10918380|NCT00168831|12085499|FG001|COMPLETED|Overall Study||254
10918381|NCT00168831|12085500|FG002|COMPLETED|Overall Study||220
10918382|NCT00168831|12085498|FG000|NOT COMPLETED|Overall Study||60
10918383|NCT00168831|12085499|FG001|NOT COMPLETED|Overall Study||81
10918384|NCT00168831|12085500|FG002|NOT COMPLETED|Overall Study||114
10918385|NCT00168844|12085511|FG000|STARTED|Overall Study||332
10918386|NCT00168844|12085512|FG001|STARTED|Overall Study||332
10918387|NCT00168844|12085513|FG002|STARTED|Overall Study||319
10918388|NCT00168844|12085511|FG000|COMPLETED|Overall Study||277
10918389|NCT00168844|12085512|FG001|COMPLETED|Overall Study||277
10918390|NCT00168844|12085513|FG002|COMPLETED|Overall Study||228
10918391|NCT00168844|12085511|FG000|NOT COMPLETED|Overall Study||55
10918392|NCT00168844|12085512|FG001|NOT COMPLETED|Overall Study||55
10918393|NCT00168844|12085513|FG002|NOT COMPLETED|Overall Study||91
10918394|NCT00169104|12085523|FG000|STARTED|Overall Study||13
10918395|NCT00169104|12085524|FG001|STARTED|Overall Study||10
10918396|NCT00169104|12085523|FG000|COMPLETED|Overall Study||11
10918397|NCT00169104|12085524|FG001|COMPLETED|Overall Study||8
10918398|NCT00169104|12085523|FG000|NOT COMPLETED|Overall Study||2
10918399|NCT00169104|12085524|FG001|NOT COMPLETED|Overall Study||2
10918400|NCT00169442|12085537|FG000|STARTED|Overall Study||119
10918401|NCT00169442|12085538|FG001|STARTED|Overall Study||124
10918402|NCT00169442|12085539|FG002|STARTED|Overall Study||167
10918403|NCT00169442|12085540|FG003|STARTED|Overall Study||250
10918404|NCT00169442|12085541|FG004|STARTED|Overall Study||42
10918405|NCT00169442|12085542|FG005|STARTED|Overall Study||43
10918406|NCT00169442|12085537|FG000|COMPLETED|Overall Study||119
10918407|NCT00169442|12085538|FG001|COMPLETED|Overall Study||123
10918408|NCT00169442|12085539|FG002|COMPLETED|Overall Study||166
10918409|NCT00169442|12085540|FG003|COMPLETED|Overall Study||250
10918410|NCT00169442|12085541|FG004|COMPLETED|Overall Study||41
10918411|NCT00169442|12085542|FG005|COMPLETED|Overall Study||41
10918412|NCT00169442|12085537|FG000|NOT COMPLETED|Overall Study||0
10918413|NCT00169442|12085538|FG001|NOT COMPLETED|Overall Study||1
10918414|NCT00169442|12085539|FG002|NOT COMPLETED|Overall Study||1
10918415|NCT00169442|12085540|FG003|NOT COMPLETED|Overall Study||0
10918416|NCT00169442|12085541|FG004|NOT COMPLETED|Overall Study||1
10918417|NCT00169442|12085542|FG005|NOT COMPLETED|Overall Study||2
10918418|NCT00170157|12085558|FG000|STARTED|Treatment Period 1 Initial Randomization||54
10918419|NCT00170157|12085559|FG001|STARTED|Treatment Period 1 Initial Randomization||58
10918420|NCT00170157|12085558|FG000|COMPLETED|Treatment Period 1 Initial Randomization||54
10918421|NCT00170157|12085559|FG001|COMPLETED|Treatment Period 1 Initial Randomization||58
10918422|NCT00170157|12085558|FG000|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
10918423|NCT00170157|12085559|FG001|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
10918424|NCT00170157|12085558|FG000|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
10918425|NCT00170157|12085559|FG001|STARTED|Washout Period of 14 Days||58
10918426|NCT00170157|12085558|FG000|COMPLETED|Washout Period of 14 Days||0
10918427|NCT00170157|12085559|FG001|COMPLETED|Washout Period of 14 Days||41
10918428|NCT00170157|12085558|FG000|NOT COMPLETED|Washout Period of 14 Days||0
10918429|NCT00170157|12085559|FG001|NOT COMPLETED|Washout Period of 14 Days||17
10918430|NCT00170157|12085558|FG000|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
10918431|NCT00170157|12085559|FG001|STARTED|Treatment Period 2 Crossover||41
10918432|NCT00170157|12085558|FG000|COMPLETED|Treatment Period 2 Crossover||0
10918433|NCT00170157|12085559|FG001|COMPLETED|Treatment Period 2 Crossover||41
10918434|NCT00170157|12085558|FG000|NOT COMPLETED|Treatment Period 2 Crossover||0
10918435|NCT00170157|12085559|FG001|NOT COMPLETED|Treatment Period 2 Crossover||0
10918436|NCT00170625|12085565|FG000|STARTED|Overall Study||26
10918437|NCT00170625|12085565|FG000|COMPLETED|Overall Study||26
10918438|NCT00170625|12085565|FG000|NOT COMPLETED|Overall Study||0
10918439|NCT00170846|12085572|FG000|STARTED|Overall Study||123
10918440|NCT00170846|12085573|FG001|STARTED|Overall Study||127
10918441|NCT00170846|12085574|FG002|STARTED|Overall Study||144
10918442|NCT00170846|12085572|FG000|COMPLETED|Overall Study||112
10918443|NCT00170846|12085573|FG001|COMPLETED|Overall Study||108
10918444|NCT00170846|12085574|FG002|COMPLETED|Overall Study||131
10918445|NCT00170846|12085572|FG000|NOT COMPLETED|Overall Study||11
10918446|NCT00170846|12085573|FG001|NOT COMPLETED|Overall Study||19
10918447|NCT00170846|12085574|FG002|NOT COMPLETED|Overall Study||13
10918448|NCT00170950|12085584|FG000|STARTED|Overall Study||5744
10918449|NCT00170950|12085585|FG001|STARTED|Overall Study||5762
10918450|NCT00170950|12085584|FG000|COMPLETED|Overall Study||4859
10918451|NCT00170950|12085585|FG001|COMPLETED|Overall Study||4852
10918452|NCT00170950|12085584|FG000|NOT COMPLETED|Overall Study||885
10918453|NCT00170950|12085585|FG001|NOT COMPLETED|Overall Study||910
10918454|NCT00171054|12085593|FG000|STARTED|Overall Study||63
10918455|NCT00171054|12085594|FG001|STARTED|Overall Study||62
10918456|NCT00171054|12085593|FG000|COMPLETED|Overall Study||53
10918457|NCT00171054|12085594|FG001|COMPLETED|Overall Study||50
10918458|NCT00171054|12085593|FG000|NOT COMPLETED|Overall Study||10
10918459|NCT00171054|12085594|FG001|NOT COMPLETED|Overall Study||12
10918460|NCT00171158|12085600|FG000|STARTED|Core Study||260
10918461|NCT00171158|12085600|FG000|COMPLETED|Core Study||21
10918462|NCT00171158|12085600|FG000|NOT COMPLETED|Core Study||239
10918463|NCT00171158|12085600|FG000|STARTED|E2 Extension||8
10918464|NCT00171158|12085600|FG000|COMPLETED|E2 Extension||1
10918465|NCT00171158|12085600|FG000|NOT COMPLETED|E2 Extension||7
10918466|NCT00171210|12085606|FG000|STARTED|Overall Study||259
10918467|NCT00171210|12085607|FG001|STARTED|Overall Study||296
10918468|NCT00171210|12085606|FG000|STARTED EXTENSION STUDY|Overall Study||259
10918469|NCT00171210|12085607|FG001|STARTED EXTENSION STUDY|Overall Study||247
10918470|NCT00171210|12085606|FG000|COMPLETED|Overall Study||190
10918471|NCT00171210|12085607|FG001|COMPLETED|Overall Study||181
10918472|NCT00171210|12085606|FG000|NOT COMPLETED|Overall Study||69
10918473|NCT00171210|12085607|FG001|NOT COMPLETED|Overall Study||115
10918474|NCT00171223|12085616|FG000|STARTED|Overall Study||152
10918475|NCT00171223|12085617|FG001|STARTED|Overall Study||188
10918476|NCT00171223|12085618|FG002|STARTED|Overall Study||192
10918477|NCT00171223|12085616|FG000|COMPLETED|Overall Study||12
10918478|NCT00171223|12085617|FG001|COMPLETED|Overall Study||47
10918479|NCT00171223|12085618|FG002|COMPLETED|Overall Study||22
10918480|NCT00171223|12085616|FG000|NOT COMPLETED|Overall Study||140
10918481|NCT00171223|12085617|FG001|NOT COMPLETED|Overall Study||141
10918482|NCT00171223|12085618|FG002|NOT COMPLETED|Overall Study||170
10918483|NCT00171249|12085624|FG000|STARTED|Overall Study||77
10918484|NCT00171249|12085625|FG001|STARTED|Overall Study||5
10918485|NCT00171249|12085626|FG002|STARTED|Overall Study||5
10918486|NCT00171249|12085627|FG003|STARTED|Overall Study||158
10918487|NCT00171249|12085628|FG004|STARTED|Overall Study||3
10918488|NCT00171249|12085629|FG005|STARTED|Overall Study||43
10918489|NCT00171249|12085630|FG006|STARTED|Overall Study||2
10918490|NCT00171249|12085624|FG000|Completed Part 1|Overall Study||50
10918491|NCT00171249|12085625|FG001|Completed Part 1|Overall Study||0
10918492|NCT00171249|12085626|FG002|Completed Part 1|Overall Study||1
10918493|NCT00171249|12085627|FG003|Completed Part 1|Overall Study||125
10918494|NCT00171249|12085628|FG004|Completed Part 1|Overall Study||2
10918495|NCT00171249|12085629|FG005|Completed Part 1|Overall Study||6
10918496|NCT00171249|12085630|FG006|Completed Part 1|Overall Study||0
10918497|NCT00171249|12085624|FG000|COMPLETED|Overall Study||1
10918498|NCT00171249|12085625|FG001|COMPLETED|Overall Study||0
10918499|NCT00171249|12085626|FG002|COMPLETED|Overall Study||0
10918500|NCT00171249|12085627|FG003|COMPLETED|Overall Study||6
10918501|NCT00171249|12085628|FG004|COMPLETED|Overall Study||0
10918502|NCT00171249|12085629|FG005|COMPLETED|Overall Study||0
10918503|NCT00171249|12085630|FG006|COMPLETED|Overall Study||0
10918504|NCT00171249|12085624|FG000|NOT COMPLETED|Overall Study||76
10918505|NCT00171249|12085625|FG001|NOT COMPLETED|Overall Study||5
10918506|NCT00171249|12085626|FG002|NOT COMPLETED|Overall Study||5
10918507|NCT00171249|12085627|FG003|NOT COMPLETED|Overall Study||152
10918508|NCT00171249|12085628|FG004|NOT COMPLETED|Overall Study||3
10918509|NCT00171249|12085629|FG005|NOT COMPLETED|Overall Study||43
10918510|NCT00171249|12085630|FG006|NOT COMPLETED|Overall Study||2
10918511|NCT00171301|12085641|FG000|STARTED|Overall Study||162
10918512|NCT00171301|12085642|FG001|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
10918513|NCT00171301|12085641|FG000|Received Deferasirox|Overall Study||162
10918514|NCT00171301|12085642|FG001|Received Deferasirox|Overall Study||69
10918515|NCT00171301|12085641|FG000|COMPLETED|Overall Study||154
10918516|NCT00171301|12085642|FG001|COMPLETED|Overall Study||62
10918517|NCT00171301|12085641|FG000|NOT COMPLETED|Overall Study||8
10918518|NCT00171301|12085642|FG001|NOT COMPLETED|Overall Study||9
10918519|NCT00171314|12085651|FG000|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
10918520|NCT00171314|12085652|FG001|STARTED|Overall Study||264
10918521|NCT00171314|12085651|FG000|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
10918522|NCT00171314|12085652|FG001|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
10918523|NCT00171314|12085651|FG000|COMPLETED|Overall Study||172
10918524|NCT00171314|12085652|FG001|COMPLETED|Overall Study||186
10918525|NCT00171314|12085651|FG000|NOT COMPLETED|Overall Study||91
10918526|NCT00171314|12085652|FG001|NOT COMPLETED|Overall Study||78
10918527|NCT00171340|12085660|FG000|STARTED|Overall Study||532
10918528|NCT00171340|12085661|FG001|STARTED|Overall Study||533
10918529|NCT00171340|12085660|FG000|COMPLETED|Overall Study||408
10918530|NCT00171340|12085661|FG001|COMPLETED|Overall Study||398
10918531|NCT00171340|12085660|FG000|NOT COMPLETED|Overall Study||124
10918532|NCT00171340|12085661|FG001|NOT COMPLETED|Overall Study||135
10918533|NCT00171704|12085671|FG000|STARTED|Overall Study||133
10918534|NCT00171704|12085672|FG001|STARTED|Overall Study||130
10918535|NCT00171704|12085671|FG000|COMPLETED|Overall Study||89
10918536|NCT00171704|12085672|FG001|COMPLETED|Overall Study||81
10918537|NCT00171704|12085671|FG000|NOT COMPLETED|Overall Study||44
10918538|NCT00171704|12085672|FG001|NOT COMPLETED|Overall Study||49
10918539|NCT00171730|12085678|FG000|STARTED|Overall Study||30
10918540|NCT00171730|12085678|FG000|COMPLETED|Overall Study||15
10918541|NCT00171730|12085678|FG000|NOT COMPLETED|Overall Study||15
10918542|NCT00171834|12085695|FG000|STARTED|Overall Study||6
10918543|NCT00171834|12085696|FG001|STARTED|Overall Study||12
10918544|NCT00171834|12085697|FG002|STARTED|Overall Study||12
10918545|NCT00171834|12085698|FG003|STARTED|Overall Study||12
10918546|NCT00171834|12085699|FG004|STARTED|Overall Study||8
10918547|NCT00171834|12085700|FG005|STARTED|Overall Study||35
10918548|NCT00171834|12085701|FG006|STARTED|Overall Study||4
10918549|NCT00171834|12085695|FG000|Completed 6 Cycles of Treatment|Overall Study||0
10918550|NCT00171834|12085696|FG001|Completed 6 Cycles of Treatment|Overall Study||0
10918551|NCT00171834|12085697|FG002|Completed 6 Cycles of Treatment|Overall Study||1
10918552|NCT00171834|12085698|FG003|Completed 6 Cycles of Treatment|Overall Study||0
10918553|NCT00171834|12085699|FG004|Completed 6 Cycles of Treatment|Overall Study||2
10918554|NCT00171834|12085700|FG005|Completed 6 Cycles of Treatment|Overall Study||1
10918555|NCT00171834|12085701|FG006|Completed 6 Cycles of Treatment|Overall Study||0
10918556|NCT00171834|12085695|FG000|COMPLETED|Overall Study||0
10918557|NCT00171834|12085696|FG001|COMPLETED|Overall Study||0
10918558|NCT00171834|12085697|FG002|COMPLETED|Overall Study||0
10918559|NCT00171834|12085698|FG003|COMPLETED|Overall Study||0
10918560|NCT00171834|12085699|FG004|COMPLETED|Overall Study||0
10918561|NCT00171834|12085700|FG005|COMPLETED|Overall Study||0
10918562|NCT00171834|12085701|FG006|COMPLETED|Overall Study||0
10918563|NCT00171834|12085695|FG000|NOT COMPLETED|Overall Study||6
10918564|NCT00171834|12085696|FG001|NOT COMPLETED|Overall Study||12
10918565|NCT00171834|12085697|FG002|NOT COMPLETED|Overall Study||12
10918566|NCT00171834|12085698|FG003|NOT COMPLETED|Overall Study||12
10918567|NCT00171834|12085699|FG004|NOT COMPLETED|Overall Study||8
10918568|NCT00171834|12085700|FG005|NOT COMPLETED|Overall Study||35
10918569|NCT00171834|12085701|FG006|NOT COMPLETED|Overall Study||4
10918570|NCT00171873|12085733|FG000|STARTED|Overall Study||42
10918571|NCT00171873|12085734|FG001|STARTED|Overall Study||43
10918572|NCT00171873|12085733|FG000|COMPLETED|Overall Study||33
10918573|NCT00171873|12085734|FG001|COMPLETED|Overall Study||40
10918574|NCT00171873|12085733|FG000|NOT COMPLETED|Overall Study||9
10918575|NCT00171873|12085734|FG001|NOT COMPLETED|Overall Study||3
10918576|NCT00171925|12085742|FG000|STARTED|Overall Study||72
10918577|NCT00171925|12085743|FG001|STARTED|Overall Study||71
10918578|NCT00171925|12085742|FG000|COMPLETED|Overall Study||42
10918579|NCT00171925|12085743|FG001|COMPLETED|Overall Study||40
10918580|NCT00171925|12085742|FG000|NOT COMPLETED|Overall Study||30
10918581|NCT00171925|12085743|FG001|NOT COMPLETED|Overall Study||31
10918582|NCT00171951|12085749|FG000|STARTED|Overall Study||19
10918583|NCT00171951|12085749|FG000|COMPLETED|Overall Study||3
10918584|NCT00171951|12085749|FG000|NOT COMPLETED|Overall Study||16
10918585|NCT00172042|12085758|FG000|STARTED|Overall Study||226
10918586|NCT00172042|12085759|FG001|STARTED|Overall Study||211
10918587|NCT00172042|12085758|FG000|COMPLETED|Overall Study||68
10918588|NCT00172042|12085759|FG001|COMPLETED|Overall Study||86
10918589|NCT00172042|12085758|FG000|NOT COMPLETED|Overall Study||158
10918590|NCT00172042|12085759|FG001|NOT COMPLETED|Overall Study||125
10918591|NCT00172185|12085769|FG000|STARTED|Overall Study||6
10918592|NCT00172185|12085770|FG001|STARTED|Overall Study||7
10918593|NCT00172185|12085771|FG002|STARTED|Overall Study||25
10918594|NCT00172185|12085772|FG003|STARTED|Overall Study||27
10918595|NCT00172185|12085769|FG000|COMPLETED|Overall Study||6
10918596|NCT00172185|12085770|FG001|COMPLETED|Overall Study||5
10918597|NCT00172185|12085771|FG002|COMPLETED|Overall Study||20
10918598|NCT00172185|12085772|FG003|COMPLETED|Overall Study||23
10918599|NCT00172185|12085769|FG000|NOT COMPLETED|Overall Study||0
10918600|NCT00172185|12085770|FG001|NOT COMPLETED|Overall Study||2
10918601|NCT00172185|12085771|FG002|NOT COMPLETED|Overall Study||5
10918602|NCT00172185|12085772|FG003|NOT COMPLETED|Overall Study||4
10918603|NCT00174187|12085788|FG000|STARTED|Period 1 (up to 3 Years)||15
10918604|NCT00174187|12085789|FG001|STARTED|Period 1 (up to 3 Years)||15
10918605|NCT00174187|12085790|FG002|STARTED|Period 1 (up to 3 Years)||0
10918606|NCT00174187|12085788|FG000|COMPLETED|Period 1 (up to 3 Years)||15
10918607|NCT00174187|12085789|FG001|COMPLETED|Period 1 (up to 3 Years)||11
10918608|NCT00174187|12085790|FG002|COMPLETED|Period 1 (up to 3 Years)||0
10918609|NCT00174187|12085788|FG000|NOT COMPLETED|Period 1 (up to 3 Years)||0
10918610|NCT00174187|12085789|FG001|NOT COMPLETED|Period 1 (up to 3 Years)||4
10918611|NCT00174187|12085790|FG002|NOT COMPLETED|Period 1 (up to 3 Years)||0
10918612|NCT00174187|12085788|FG000|STARTED|Between Period 1 and Period 2||0
10918613|NCT00174187|12085789|FG001|STARTED|Between Period 1 and Period 2||0
10918614|NCT00174187|12085790|FG002|STARTED|Between Period 1 and Period 2||26
10918615|NCT00174187|12085788|FG000|Consented|Between Period 1 and Period 2||0
10918616|NCT00174187|12085789|FG001|Consented|Between Period 1 and Period 2||0
10918617|NCT00174187|12085790|FG002|Consented|Between Period 1 and Period 2||24
10918618|NCT00174187|12085788|FG000|COMPLETED|Between Period 1 and Period 2||0
10918619|NCT00174187|12085789|FG001|COMPLETED|Between Period 1 and Period 2||0
10918620|NCT00174187|12085790|FG002|COMPLETED|Between Period 1 and Period 2||21
10918621|NCT00174187|12085788|FG000|NOT COMPLETED|Between Period 1 and Period 2||0
10918622|NCT00174187|12085789|FG001|NOT COMPLETED|Between Period 1 and Period 2||0
10918623|NCT00174187|12085790|FG002|NOT COMPLETED|Between Period 1 and Period 2||5
10918624|NCT00174187|12085788|FG000|STARTED|Period 2 (After 3 Years)||0
10918625|NCT00174187|12085789|FG001|STARTED|Period 2 (After 3 Years)||0
10918626|NCT00174187|12085790|FG002|STARTED|Period 2 (After 3 Years)||21
10918627|NCT00174187|12085788|FG000|COMPLETED|Period 2 (After 3 Years)||0
10918628|NCT00174187|12085789|FG001|COMPLETED|Period 2 (After 3 Years)||0
10918629|NCT00174187|12085790|FG002|COMPLETED|Period 2 (After 3 Years)||13
10918630|NCT00174187|12085788|FG000|NOT COMPLETED|Period 2 (After 3 Years)||0
10918631|NCT00174187|12085789|FG001|NOT COMPLETED|Period 2 (After 3 Years)||0
10918632|NCT00174187|12085790|FG002|NOT COMPLETED|Period 2 (After 3 Years)||8
10918633|NCT00174252|12085798|FG000|STARTED|Overall Study||57
10918634|NCT00174252|12085798|FG000|COMPLETED|Overall Study||55
10918635|NCT00174252|12085798|FG000|NOT COMPLETED|Overall Study||2
10918636|NCT00174291|12085806|FG000|STARTED|Overall Study||11
10918637|NCT00174291|12085807|FG001|STARTED|Overall Study||10
10918638|NCT00174291|12085806|FG000|COMPLETED|Overall Study||6
10918639|NCT00174291|12085807|FG001|COMPLETED|Overall Study||4
10918640|NCT00174291|12085806|FG000|NOT COMPLETED|Overall Study||5
10918641|NCT00174291|12085807|FG001|NOT COMPLETED|Overall Study||6
10918642|NCT00174382|12085813|FG000|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
10918643|NCT00174382|12085813|FG000|COMPLETED|Overall Study||116
10918644|NCT00174382|12085813|FG000|NOT COMPLETED|Overall Study||33
10918645|NCT00174447|12085817|FG000|STARTED|Overall Study||43
10918646|NCT00174447|12085817|FG000|COMPLETED|Overall Study||5
10918647|NCT00174447|12085817|FG000|NOT COMPLETED|Overall Study||38
10918648|NCT00174460|12085823|FG000|STARTED|Overall Study||18
10918649|NCT00174460|12085824|FG001|STARTED|Overall Study||15
10918650|NCT00174460|12085823|FG000|Received Study Treatment|Overall Study||18
10918651|NCT00174460|12085824|FG001|Received Study Treatment|Overall Study||14
10918652|NCT00174460|12085823|FG000|COMPLETED|Overall Study||18
10918653|NCT00174460|12085824|FG001|COMPLETED|Overall Study||14
10918654|NCT00174460|12085823|FG000|NOT COMPLETED|Overall Study||0
10918655|NCT00174460|12085824|FG001|NOT COMPLETED|Overall Study||1
10918656|NCT00174785|12085833|FG000|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
10918657|NCT00174785|12085834|FG001|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
10918658|NCT00174785|12085833|FG000|COMPLETED|Overall Study|completed study drug|1605
10918659|NCT00174785|12085834|FG001|COMPLETED|Overall Study|completed study drug|1611
10918660|NCT00174785|12085833|FG000|NOT COMPLETED|Overall Study||696
10918661|NCT00174785|12085834|FG001|NOT COMPLETED|Overall Study||716
10918662|NCT00174915|12085845|FG000|STARTED|Overall Study||267
10918663|NCT00174915|12085846|FG001|STARTED|Overall Study||269
10918664|NCT00174915|12085847|FG002|STARTED|Overall Study||134
10918665|NCT00174915|12085848|FG003|STARTED|Overall Study||268
10918666|NCT00174915|12085849|FG004|STARTED|Overall Study||134
10918667|NCT00174915|12085845|FG000|COMPLETED|Overall Study||174
10918668|NCT00174915|12085846|FG001|COMPLETED|Overall Study||200
10918669|NCT00174915|12085847|FG002|COMPLETED|Overall Study||86
10918670|NCT00174915|12085848|FG003|COMPLETED|Overall Study||211
10918671|NCT00174915|12085849|FG004|COMPLETED|Overall Study||101
10918672|NCT00174915|12085845|FG000|NOT COMPLETED|Overall Study||93
10918673|NCT00174915|12085846|FG001|NOT COMPLETED|Overall Study||69
10918674|NCT00174915|12085847|FG002|NOT COMPLETED|Overall Study||48
10918675|NCT00174915|12085848|FG003|NOT COMPLETED|Overall Study||57
10918676|NCT00174915|12085849|FG004|NOT COMPLETED|Overall Study||33
10918677|NCT00174941|12085864|FG000|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
10918678|NCT00174941|12085865|FG001|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
10918679|NCT00174941|12085866|FG002|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
10918680|NCT00174941|12085867|FG003|STARTED|Overall Study||116
10918681|NCT00174941|12085864|FG000|COMPLETED|Overall Study||6
10918682|NCT00174941|12085865|FG001|COMPLETED|Overall Study||41
10918683|NCT00174941|12085866|FG002|COMPLETED|Overall Study||11
10918684|NCT00174941|12085867|FG003|COMPLETED|Overall Study||58
10918685|NCT00174941|12085864|FG000|NOT COMPLETED|Overall Study||2
10918686|NCT00174941|12085865|FG001|NOT COMPLETED|Overall Study||38
10918687|NCT00174941|12085866|FG002|NOT COMPLETED|Overall Study||18
10918688|NCT00174941|12085867|FG003|NOT COMPLETED|Overall Study||58
10918689|NCT00174954|12085877|FG000|STARTED|Overall Study||32
10918690|NCT00174954|12085877|FG000|COMPLETED|Overall Study||28
10918691|NCT00174954|12085877|FG000|NOT COMPLETED|Overall Study||4
10918692|NCT00174967|12085885|FG000|STARTED|Overall Study||37
10918693|NCT00174967|12085886|FG001|STARTED|Overall Study||40
10918694|NCT00174967|12085887|FG002|STARTED|Overall Study||38
10918695|NCT00174967|12085888|FG003|STARTED|Overall Study||38
10918696|NCT00174967|12085885|FG000|COMPLETED|Overall Study||36
10918697|NCT00174967|12085886|FG001|COMPLETED|Overall Study||37
10918698|NCT00174967|12085887|FG002|COMPLETED|Overall Study||36
10918699|NCT00174967|12085888|FG003|COMPLETED|Overall Study||36
10918700|NCT00174967|12085885|FG000|NOT COMPLETED|Overall Study||1
10918701|NCT00174967|12085886|FG001|NOT COMPLETED|Overall Study||3
10918702|NCT00174967|12085887|FG002|NOT COMPLETED|Overall Study||2
10918703|NCT00174967|12085888|FG003|NOT COMPLETED|Overall Study||2
10918704|NCT00175006|12085898|FG000|STARTED|Overall Study||13
10918705|NCT00175006|12085898|FG000|COMPLETED|Overall Study||13
10918706|NCT00175006|12085898|FG000|NOT COMPLETED|Overall Study||0
10918707|NCT00175019|12085905|FG000|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
10918708|NCT00175019|12085906|FG001|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
10918709|NCT00175019|12085907|FG002|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
10918710|NCT00175019|12085905|FG000|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
10918711|NCT00175019|12085906|FG001|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
10918712|NCT00175019|12085907|FG002|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
10918713|NCT00175019|12085905|FG000|NOT COMPLETED|Overall Study||194
10918714|NCT00175019|12085906|FG001|NOT COMPLETED|Overall Study||171
10918715|NCT00175019|12085907|FG002|NOT COMPLETED|Overall Study||57
10918716|NCT00175825|12085919|FG000|STARTED|Overall Study||54
10918717|NCT00175825|12085920|FG001|STARTED|Overall Study||50
10918718|NCT00175825|12085921|FG002|STARTED|Overall Study||52
10918719|NCT00175825|12085922|FG003|STARTED|Overall Study||52
10918720|NCT00175825|12085919|FG000|COMPLETED|Overall Study||49
10918721|NCT00175825|12085920|FG001|COMPLETED|Overall Study||46
10918722|NCT00175825|12085921|FG002|COMPLETED|Overall Study||51
10918723|NCT00175825|12085922|FG003|COMPLETED|Overall Study||51
10918724|NCT00175825|12085919|FG000|NOT COMPLETED|Overall Study||5
10918725|NCT00175825|12085920|FG001|NOT COMPLETED|Overall Study||4
10918726|NCT00175825|12085921|FG002|NOT COMPLETED|Overall Study||1
10918727|NCT00175825|12085922|FG003|NOT COMPLETED|Overall Study||1
10918728|NCT00175877|12085932|FG000|STARTED|Overall Study||846
10918729|NCT00175877|12085932|FG000|COMPLETED|Overall Study||497
10918730|NCT00175877|12085932|FG000|NOT COMPLETED|Overall Study||349
10918731|NCT00175916|12085936|FG000|STARTED|Overall Study||853
10918732|NCT00175916|12085936|FG000|COMPLETED|Overall Study||234
10918733|NCT00175916|12085936|FG000|NOT COMPLETED|Overall Study||619
10918734|NCT00176202|12085943|FG000|STARTED|Overall Study||32
10918735|NCT00176202|12085944|FG001|STARTED|Overall Study||33
10918736|NCT00176202|12085943|FG000|COMPLETED|Overall Study||27
10918737|NCT00176202|12085944|FG001|COMPLETED|Overall Study||17
10918738|NCT00176202|12085943|FG000|NOT COMPLETED|Overall Study||5
10918739|NCT00176202|12085944|FG001|NOT COMPLETED|Overall Study||16
10918740|NCT00176228|12085952|FG000|STARTED|Overall Study|When study began|48
10918741|NCT00176228|12085952|FG000|COMPLETED|Overall Study|Study ended|46
10918742|NCT00176228|12085952|FG000|NOT COMPLETED|Overall Study||2
10918743|NCT00176254|12085957|FG000|STARTED|Overall Study||40
10918744|NCT00176254|12085957|FG000|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
10918745|NCT00176254|12085957|FG000|NOT COMPLETED|Overall Study||1
10918746|NCT00176306|12085961|FG000|STARTED|Overall Study||15
10918747|NCT00176306|12085961|FG000|COMPLETED|Overall Study||15
10918748|NCT00176306|12085961|FG000|NOT COMPLETED|Overall Study||0
10918749|NCT00176423|12085967|FG000|STARTED|Overall Study||42
10918750|NCT00176423|12085968|FG001|STARTED|Overall Study||44
10918751|NCT00176423|12085967|FG000|COMPLETED|Overall Study||35
10918752|NCT00176423|12085968|FG001|COMPLETED|Overall Study||38
10918753|NCT00176423|12085967|FG000|NOT COMPLETED|Overall Study||7
10918754|NCT00176423|12085968|FG001|NOT COMPLETED|Overall Study||6
10918755|NCT00176462|12085976|FG000|STARTED|Induction (4 Weeks)||21
10918756|NCT00176462|12085977|FG001|STARTED|Induction (4 Weeks)||39
10918757|NCT00176462|12085976|FG000|COMPLETED|Induction (4 Weeks)||20
10918758|NCT00176462|12085977|FG001|COMPLETED|Induction (4 Weeks)||34
10918759|NCT00176462|12085976|FG000|NOT COMPLETED|Induction (4 Weeks)||1
10918760|NCT00176462|12085977|FG001|NOT COMPLETED|Induction (4 Weeks)||5
10918761|NCT00176462|12085976|FG000|STARTED|Consolidation (12 Weeks)||20
10918762|NCT00176462|12085977|FG001|STARTED|Consolidation (12 Weeks)||34
10918763|NCT00176462|12085976|FG000|COMPLETED|Consolidation (12 Weeks)||20
10918764|NCT00176462|12085977|FG001|COMPLETED|Consolidation (12 Weeks)||29
10918765|NCT00176462|12085976|FG000|NOT COMPLETED|Consolidation (12 Weeks)||0
10918766|NCT00176462|12085977|FG001|NOT COMPLETED|Consolidation (12 Weeks)||5
10918767|NCT00176462|12085976|FG000|STARTED|Delayed Intensification (8 Weeks)||20
10918768|NCT00176462|12085977|FG001|STARTED|Delayed Intensification (8 Weeks)||29
10918769|NCT00176462|12085976|FG000|COMPLETED|Delayed Intensification (8 Weeks)||20
10918770|NCT00176462|12085977|FG001|COMPLETED|Delayed Intensification (8 Weeks)||29
10918771|NCT00176462|12085976|FG000|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
10918772|NCT00176462|12085977|FG001|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
10918773|NCT00176462|12085976|FG000|STARTED|Intensive Continuation (8X8-week Cycles)||20
10918774|NCT00176462|12085977|FG001|STARTED|Intensive Continuation (8X8-week Cycles)||29
10918775|NCT00176462|12085976|FG000|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
10918776|NCT00176462|12085977|FG001|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
10918777|NCT00176462|12085976|FG000|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
10918778|NCT00176462|12085977|FG001|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
10918779|NCT00176462|12085976|FG000|STARTED|Continuation -up to 30mos Post Remission||19
10918780|NCT00176462|12085977|FG001|STARTED|Continuation -up to 30mos Post Remission||26
10918781|NCT00176462|12085976|FG000|COMPLETED|Continuation -up to 30mos Post Remission||19
10918782|NCT00176462|12085977|FG001|COMPLETED|Continuation -up to 30mos Post Remission||26
10918783|NCT00176462|12085976|FG000|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
10918784|NCT00176462|12085977|FG001|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
10918785|NCT00176592|12085986|FG000|STARTED|Overall Study||36
10918786|NCT00176592|12085987|FG001|STARTED|Overall Study||39
10918787|NCT00176592|12085986|FG000|Followed for 1 Year|Overall Study||35
10918788|NCT00176592|12085987|FG001|Followed for 1 Year|Overall Study||35
10918789|NCT00176592|12085986|FG000|Followed for 2 Years|Overall Study||29
10918790|NCT00176592|12085987|FG001|Followed for 2 Years|Overall Study||35
10918791|NCT00176592|12085986|FG000|COMPLETED|Overall Study||36
10918792|NCT00176592|12085987|FG001|COMPLETED|Overall Study||39
10918793|NCT00176592|12085986|FG000|NOT COMPLETED|Overall Study||0
10918794|NCT00176592|12085987|FG001|NOT COMPLETED|Overall Study||0
10918795|NCT00176605|12085993|FG000|STARTED|Overall Study||15
10918796|NCT00176605|12085993|FG000|COMPLETED|Overall Study||13
10918797|NCT00176605|12085993|FG000|NOT COMPLETED|Overall Study||2
10918798|NCT00176644|12085997|FG000|STARTED|Overall Study||23
10918799|NCT00176644|12085997|FG000|COMPLETED|Overall Study||22
10918800|NCT00176644|12085997|FG000|NOT COMPLETED|Overall Study||1
10918801|NCT00176800|12086001|FG000|STARTED|Overall Study||69
10918802|NCT00176800|12086001|FG000|COMPLETED|Overall Study||69
10918803|NCT00176800|12086001|FG000|NOT COMPLETED|Overall Study||0
10918804|NCT00176826|12086005|FG000|STARTED|Overall Study||22
10918805|NCT00176826|12086005|FG000|COMPLETED|Overall Study||22
10918806|NCT00176826|12086005|FG000|NOT COMPLETED|Overall Study||0
10918807|NCT00176839|12086009|FG000|STARTED|Overall Study||11
10918808|NCT00176839|12086009|FG000|COMPLETED|Overall Study||11
10918809|NCT00176839|12086009|FG000|NOT COMPLETED|Overall Study||0
10918810|NCT00176852|12086016|FG000|STARTED|Overall Study||3
10918811|NCT00176852|12086017|FG001|STARTED|Overall Study||5
10918812|NCT00176852|12086018|FG002|STARTED|Overall Study||14
10918813|NCT00176852|12086016|FG000|COMPLETED|Overall Study||3
10918814|NCT00176852|12086017|FG001|COMPLETED|Overall Study||5
10918815|NCT00176852|12086018|FG002|COMPLETED|Overall Study||14
10918816|NCT00176852|12086016|FG000|NOT COMPLETED|Overall Study||0
10918817|NCT00176852|12086017|FG001|NOT COMPLETED|Overall Study||0
10918818|NCT00176852|12086018|FG002|NOT COMPLETED|Overall Study||0
10918819|NCT00176865|12086029|FG000|STARTED|Overall Study||3
10918820|NCT00176865|12086030|FG001|STARTED|Overall Study||10
10918821|NCT00176865|12086031|FG002|STARTED|Overall Study||6
10918822|NCT00176865|12086029|FG000|COMPLETED|Overall Study||3
10918823|NCT00176865|12086030|FG001|COMPLETED|Overall Study||10
10918824|NCT00176865|12086031|FG002|COMPLETED|Overall Study||6
10918825|NCT00176865|12086029|FG000|NOT COMPLETED|Overall Study||0
10918826|NCT00176865|12086030|FG001|NOT COMPLETED|Overall Study||0
10918827|NCT00176865|12086031|FG002|NOT COMPLETED|Overall Study||0
10918828|NCT00176878|12086039|FG000|STARTED|Overall Study||10
10918829|NCT00176878|12086039|FG000|COMPLETED|Overall Study||10
10918830|NCT00176878|12086039|FG000|NOT COMPLETED|Overall Study||0
10918831|NCT00176891|12086043|FG000|STARTED|Overall Study||25
10918832|NCT00176891|12086043|FG000|COMPLETED|Overall Study||22
10918833|NCT00176891|12086043|FG000|NOT COMPLETED|Overall Study||3
10918834|NCT00176904|12086047|FG000|STARTED|Overall Study||135
10918835|NCT00176904|12086047|FG000|COMPLETED|Overall Study||135
10918836|NCT00176904|12086047|FG000|NOT COMPLETED|Overall Study||0
10918837|NCT00176917|12086051|FG000|STARTED|Overall Study||41
10918838|NCT00176917|12086051|FG000|COMPLETED|Overall Study||41
10918839|NCT00176917|12086051|FG000|NOT COMPLETED|Overall Study||0
10918840|NCT00176930|12086063|FG000|STARTED|Overall Study||12
10918841|NCT00176930|12086064|FG001|STARTED|Overall Study||13
10918842|NCT00176930|12086065|FG002|STARTED|Overall Study||1
10918843|NCT00176930|12086066|FG003|STARTED|Overall Study||1
10918844|NCT00176930|12086067|FG004|STARTED|Overall Study||213
10918845|NCT00176930|12086068|FG005|STARTED|Overall Study||85
10918846|NCT00176930|12086069|FG006|STARTED|Overall Study||2
10918847|NCT00176930|12086070|FG007|STARTED|Overall Study||2
10918848|NCT00176930|12086063|FG000|COMPLETED|Overall Study||12
10918849|NCT00176930|12086064|FG001|COMPLETED|Overall Study||13
10918850|NCT00176930|12086065|FG002|COMPLETED|Overall Study||1
10918851|NCT00176930|12086066|FG003|COMPLETED|Overall Study||1
10918852|NCT00176930|12086067|FG004|COMPLETED|Overall Study||213
10918853|NCT00176930|12086068|FG005|COMPLETED|Overall Study||85
10918854|NCT00176930|12086069|FG006|COMPLETED|Overall Study||2
10918855|NCT00176930|12086070|FG007|COMPLETED|Overall Study||2
10918856|NCT00176930|12086063|FG000|NOT COMPLETED|Overall Study||0
10918857|NCT00176930|12086064|FG001|NOT COMPLETED|Overall Study||0
10918858|NCT00176930|12086065|FG002|NOT COMPLETED|Overall Study||0
10918859|NCT00176930|12086066|FG003|NOT COMPLETED|Overall Study||0
10918860|NCT00176930|12086067|FG004|NOT COMPLETED|Overall Study||0
10918861|NCT00176930|12086068|FG005|NOT COMPLETED|Overall Study||0
10918862|NCT00176930|12086069|FG006|NOT COMPLETED|Overall Study||0
10918863|NCT00176930|12086070|FG007|NOT COMPLETED|Overall Study||0
10918864|NCT00177047|12086088|FG000|STARTED|Overall Study||363
10918865|NCT00177047|12086088|FG000|COMPLETED|Overall Study||363
10918866|NCT00177047|12086088|FG000|NOT COMPLETED|Overall Study||0
10918867|NCT00177164|12086094|FG000|STARTED|Overall Study||23
10918868|NCT00177164|12086095|FG001|STARTED|Overall Study||25
10918869|NCT00177164|12086094|FG000|COMPLETED|Overall Study||14
10918870|NCT00177164|12086095|FG001|COMPLETED|Overall Study||9
10918871|NCT00177164|12086094|FG000|NOT COMPLETED|Overall Study||9
10918872|NCT00177164|12086095|FG001|NOT COMPLETED|Overall Study||16
10918873|NCT00177216|12086104|FG000|STARTED|Overall Study||26
10918874|NCT00177216|12086105|FG001|STARTED|Overall Study||23
10918875|NCT00177216|12086106|FG002|STARTED|Overall Study||20
10918876|NCT00177216|12086104|FG000|COMPLETED|Overall Study||20
10918877|NCT00177216|12086105|FG001|COMPLETED|Overall Study||20
10918878|NCT00177216|12086106|FG002|COMPLETED|Overall Study||19
10918879|NCT00177216|12086104|FG000|NOT COMPLETED|Overall Study||6
10918880|NCT00177216|12086105|FG001|NOT COMPLETED|Overall Study||3
10918881|NCT00177216|12086106|FG002|NOT COMPLETED|Overall Study||1
10918882|NCT00177255|12086118|FG000|STARTED|Overall Study||39
10918883|NCT00177255|12086118|FG000|COMPLETED|Overall Study||39
10918884|NCT00177255|12086118|FG000|NOT COMPLETED|Overall Study||0
10918885|NCT00177294|12086124|FG000|STARTED|Overall Study||60
10918886|NCT00177294|12086125|FG001|STARTED|Overall Study||64
10918887|NCT00177294|12086124|FG000|COMPLETED|Overall Study||53
10918888|NCT00177294|12086125|FG001|COMPLETED|Overall Study||59
10918889|NCT00177294|12086124|FG000|NOT COMPLETED|Overall Study||7
10918890|NCT00177294|12086125|FG001|NOT COMPLETED|Overall Study||5
10918891|NCT00177307|12086131|FG000|STARTED|Overall Study||40
10918892|NCT00177307|12086131|FG000|COMPLETED|Overall Study||39
10918893|NCT00177307|12086131|FG000|NOT COMPLETED|Overall Study||1
10918894|NCT00177671|12086137|FG000|STARTED|Overall Study||67
10918895|NCT00177671|12086138|FG001|STARTED|Overall Study||63
10918896|NCT00177671|12086137|FG000|Month 12|Overall Study||45
10918897|NCT00177671|12086138|FG001|Month 12|Overall Study||57
10918898|NCT00177671|12086137|FG000|Month 24|Overall Study||42
10918899|NCT00177671|12086138|FG001|Month 24|Overall Study||49
10918900|NCT00177671|12086137|FG000|COMPLETED|Overall Study||42
10918901|NCT00177671|12086138|FG001|COMPLETED|Overall Study||49
10918902|NCT00177671|12086137|FG000|NOT COMPLETED|Overall Study||25
10918903|NCT00177671|12086138|FG001|NOT COMPLETED|Overall Study||14
10918904|NCT00178126|12086146|FG000|STARTED|Overall Study||119
10918905|NCT00178126|12086147|FG001|STARTED|Overall Study||113
10918906|NCT00178126|12086146|FG000|COMPLETED|Overall Study||94
10918907|NCT00178126|12086147|FG001|COMPLETED|Overall Study||86
10918908|NCT00178126|12086146|FG000|NOT COMPLETED|Overall Study||25
10918909|NCT00178126|12086147|FG001|NOT COMPLETED|Overall Study||27
10918910|NCT00178178|12086157|FG000|STARTED|Overall Study||24
10918911|NCT00178178|12086158|FG001|STARTED|Overall Study||24
10918912|NCT00178178|12086159|FG002|STARTED|Overall Study||24
10918913|NCT00178178|12086160|FG003|STARTED|Overall Study||24
10918914|NCT00178178|12086157|FG000|COMPLETED|Overall Study||24
10918915|NCT00178178|12086158|FG001|COMPLETED|Overall Study||24
10918916|NCT00178178|12086159|FG002|COMPLETED|Overall Study||24
10918917|NCT00178178|12086160|FG003|COMPLETED|Overall Study||24
10918918|NCT00178178|12086157|FG000|NOT COMPLETED|Overall Study||0
10918919|NCT00178178|12086158|FG001|NOT COMPLETED|Overall Study||0
10918920|NCT00178178|12086159|FG002|NOT COMPLETED|Overall Study||0
10918921|NCT00178178|12086160|FG003|NOT COMPLETED|Overall Study||0
10918922|NCT00178191|12086173|FG000|STARTED|Overall Study||11
10918923|NCT00178191|12086174|FG001|STARTED|Overall Study||10
10918924|NCT00178191|12086175|FG002|STARTED|Overall Study||7
10918925|NCT00178191|12086173|FG000|COMPLETED|Overall Study||11
10918926|NCT00178191|12086174|FG001|COMPLETED|Overall Study||10
10918927|NCT00178191|12086175|FG002|COMPLETED|Overall Study||7
10918928|NCT00178191|12086173|FG000|NOT COMPLETED|Overall Study||0
10918929|NCT00178191|12086174|FG001|NOT COMPLETED|Overall Study||0
10918930|NCT00178191|12086175|FG002|NOT COMPLETED|Overall Study||0
10918931|NCT00178256|12086183|FG000|STARTED|Overall Study||10
10918932|NCT00178256|12086184|FG001|STARTED|Overall Study||7
10918933|NCT00178256|12086185|FG002|STARTED|Overall Study||6
10918934|NCT00178256|12086186|FG003|STARTED|Overall Study||18
10918935|NCT00178256|12086183|FG000|COMPLETED|Overall Study||6
10918936|NCT00178256|12086184|FG001|COMPLETED|Overall Study||6
10918937|NCT00178256|12086185|FG002|COMPLETED|Overall Study||6
10918938|NCT00178256|12086186|FG003|COMPLETED|Overall Study||16
10918939|NCT00178256|12086183|FG000|NOT COMPLETED|Overall Study||4
10918940|NCT00178256|12086184|FG001|NOT COMPLETED|Overall Study||1
10918941|NCT00178256|12086185|FG002|NOT COMPLETED|Overall Study||0
10918942|NCT00178256|12086186|FG003|NOT COMPLETED|Overall Study||2
10918943|NCT00178399|12086193|FG000|STARTED|Overall Study||128
10918944|NCT00178399|12086193|FG000|COMPLETED|Overall Study||115
10918945|NCT00178399|12086193|FG000|NOT COMPLETED|Overall Study||13
10918946|NCT00178464|12086198|FG000|STARTED|Overall Study||11
10918947|NCT00178464|12086198|FG000|COMPLETED|Overall Study||9
10918948|NCT00178464|12086198|FG000|NOT COMPLETED|Overall Study||2
10918949|NCT00178503|12086202|FG000|STARTED|MPH Trial: Placebo||24
10918950|NCT00178503|12086202|FG000|COMPLETED|MPH Trial: Placebo||24
10918951|NCT00178503|12086202|FG000|NOT COMPLETED|MPH Trial: Placebo||0
10918952|NCT00178503|12086202|FG000|STARTED|MPH Trial: Low Dose||24
10918953|NCT00178503|12086202|FG000|COMPLETED|MPH Trial: Low Dose||24
10918954|NCT00178503|12086202|FG000|NOT COMPLETED|MPH Trial: Low Dose||0
10918955|NCT00178503|12086202|FG000|STARTED|MPH Trial: Med Dose||24
10918956|NCT00178503|12086202|FG000|COMPLETED|MPH Trial: Med Dose||24
10918957|NCT00178503|12086202|FG000|NOT COMPLETED|MPH Trial: Med Dose||0
10918958|NCT00178503|12086202|FG000|STARTED|MPH Trial: High Dose||24
10918959|NCT00178503|12086202|FG000|COMPLETED|MPH Trial: High Dose||24
10918960|NCT00178503|12086202|FG000|NOT COMPLETED|MPH Trial: High Dose||0
10918961|NCT00178633|12086217|FG000|STARTED|Overall Study||43
10918962|NCT00178633|12086217|FG000|COMPLETED|Overall Study||37
10918963|NCT00178633|12086217|FG000|NOT COMPLETED|Overall Study||6
10918964|NCT00178646|12086225|FG000|STARTED|Overall Study||12
10918965|NCT00178646|12086226|FG001|STARTED|Overall Study||9
10918966|NCT00178646|12086227|FG002|STARTED|Overall Study||11
10918967|NCT00178646|12086225|FG000|COMPLETED|Overall Study||12
10918968|NCT00178646|12086226|FG001|COMPLETED|Overall Study||8
10918969|NCT00178646|12086227|FG002|COMPLETED|Overall Study||10
10918970|NCT00178646|12086225|FG000|NOT COMPLETED|Overall Study||0
10918971|NCT00178646|12086226|FG001|NOT COMPLETED|Overall Study||1
10918972|NCT00178646|12086227|FG002|NOT COMPLETED|Overall Study||1
10918973|NCT00178685|12086241|FG000|STARTED|Overall Study||172
10918974|NCT00178685|12086242|FG001|STARTED|Overall Study||324
10918975|NCT00178685|12086243|FG002|STARTED|Overall Study||324
10918976|NCT00178685|12086241|FG000|COMPLETED|Overall Study||61
10918977|NCT00178685|12086242|FG001|COMPLETED|Overall Study||120
10918978|NCT00178685|12086243|FG002|COMPLETED|Overall Study||128
10918979|NCT00178685|12086241|FG000|NOT COMPLETED|Overall Study||111
10918980|NCT00178685|12086242|FG001|NOT COMPLETED|Overall Study||204
10918981|NCT00178685|12086243|FG002|NOT COMPLETED|Overall Study||196
10918982|NCT00178711|12086253|FG000|STARTED|Overall Study||52
10918983|NCT00178711|12086254|FG001|STARTED|Overall Study||45
10918984|NCT00178711|12086253|FG000|COMPLETED|Overall Study||52
10918985|NCT00178711|12086254|FG001|COMPLETED|Overall Study||45
10918986|NCT00178711|12086253|FG000|NOT COMPLETED|Overall Study||0
10918987|NCT00178711|12086254|FG001|NOT COMPLETED|Overall Study||0
10918988|NCT00178841|12086262|FG000|STARTED|Overall Study||4
10918989|NCT00178841|12086262|FG000|COMPLETED|Overall Study||4
10918990|NCT00178841|12086262|FG000|NOT COMPLETED|Overall Study||0
10918991|NCT00178919|12086269|FG000|STARTED|Overall Study||19
10918992|NCT00178919|12086270|FG001|STARTED|Overall Study||93
10918993|NCT00178919|12086269|FG000|COMPLETED|Overall Study||19
10918994|NCT00178919|12086270|FG001|COMPLETED|Overall Study||68
10918995|NCT00178919|12086269|FG000|NOT COMPLETED|Overall Study||0
10918996|NCT00178919|12086270|FG001|NOT COMPLETED|Overall Study||25
10918997|NCT00179010|12086278|FG000|STARTED|Overall Study||6
10918998|NCT00179010|12086279|FG001|STARTED|Overall Study||7
10918999|NCT00179010|12086278|FG000|COMPLETED|Overall Study||5
10919000|NCT00179010|12086279|FG001|COMPLETED|Overall Study||5
10919001|NCT00179010|12086278|FG000|NOT COMPLETED|Overall Study||1
10919002|NCT00179010|12086279|FG001|NOT COMPLETED|Overall Study||2
10919003|NCT00179309|12086288|FG000|STARTED|Treatment||25
10919004|NCT00179309|12086289|FG001|STARTED|Treatment||23
10919005|NCT00179309|12086288|FG000|COMPLETED|Treatment||21
10919006|NCT00179309|12086289|FG001|COMPLETED|Treatment||18
10919007|NCT00179309|12086288|FG000|NOT COMPLETED|Treatment||4
10919008|NCT00179309|12086289|FG001|NOT COMPLETED|Treatment||5
10919009|NCT00179309|12086288|FG000|STARTED|Crossover||0
10919010|NCT00179309|12086289|FG001|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
10919011|NCT00179309|12086288|FG000|COMPLETED|Crossover||0
10919012|NCT00179309|12086289|FG001|COMPLETED|Crossover||3
10919013|NCT00179309|12086288|FG000|NOT COMPLETED|Crossover||0
10919014|NCT00179309|12086289|FG001|NOT COMPLETED|Crossover||0
10919015|NCT00179413|12086297|FG000|STARTED|Overall Study||282
10919016|NCT00179413|12086298|FG001|STARTED|Overall Study||267
10919017|NCT00179413|12086297|FG000|COMPLETED|Overall Study||157
10919018|NCT00179413|12086298|FG001|COMPLETED|Overall Study||152
10919019|NCT00179413|12086297|FG000|NOT COMPLETED|Overall Study||125
10919020|NCT00179413|12086298|FG001|NOT COMPLETED|Overall Study||115
10919021|NCT00179478|12086306|FG000|STARTED|Overall Study||81
10919022|NCT00179478|12086307|FG001|STARTED|Overall Study||74
10919023|NCT00179478|12086306|FG000|COMPLETED|Overall Study||68
10919024|NCT00179478|12086307|FG001|COMPLETED|Overall Study||59
10919025|NCT00179478|12086306|FG000|NOT COMPLETED|Overall Study||13
10919026|NCT00179478|12086307|FG001|NOT COMPLETED|Overall Study||15
10919027|NCT00179517|12086314|FG000|STARTED|Overall Study||20
10919028|NCT00179517|12086315|FG001|STARTED|Overall Study||20
10919029|NCT00179517|12086314|FG000|COMPLETED|Overall Study||18
10919030|NCT00179517|12086315|FG001|COMPLETED|Overall Study||19
10919031|NCT00179517|12086314|FG000|NOT COMPLETED|Overall Study||2
10919032|NCT00179517|12086315|FG001|NOT COMPLETED|Overall Study||1
10919033|NCT00179621|12086324|FG000|STARTED|Double-Blind Period||67
10919034|NCT00179621|12086325|FG001|STARTED|Double-Blind Period||69
10919035|NCT00179621|12086326|FG002|STARTED|Double-Blind Period||69
10919036|NCT00179621|12086327|FG003|STARTED|Double-Blind Period||0
10919037|NCT00179621|12086324|FG000|COMPLETED|Double-Blind Period||3
10919038|NCT00179621|12086325|FG001|COMPLETED|Double-Blind Period||23
10919039|NCT00179621|12086326|FG002|COMPLETED|Double-Blind Period||39
10919040|NCT00179621|12086327|FG003|COMPLETED|Double-Blind Period||0
10919041|NCT00179621|12086324|FG000|NOT COMPLETED|Double-Blind Period||64
10919042|NCT00179621|12086325|FG001|NOT COMPLETED|Double-Blind Period||46
10919043|NCT00179621|12086326|FG002|NOT COMPLETED|Double-Blind Period||30
10919044|NCT00179621|12086327|FG003|NOT COMPLETED|Double-Blind Period||0
10919045|NCT00179621|12086324|FG000|STARTED|Open-Label Period||0
10919046|NCT00179621|12086325|FG001|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
10919047|NCT00179621|12086326|FG002|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
10919048|NCT00179621|12086327|FG003|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
10919049|NCT00179621|12086324|FG000|COMPLETED|Open-Label Period||0
10919050|NCT00179621|12086325|FG001|COMPLETED|Open-Label Period||14
10919051|NCT00179621|12086326|FG002|COMPLETED|Open-Label Period||19
10919052|NCT00179621|12086327|FG003|COMPLETED|Open-Label Period||13
10919053|NCT00179621|12086324|FG000|NOT COMPLETED|Open-Label Period||0
10919054|NCT00179621|12086325|FG001|NOT COMPLETED|Open-Label Period||28
10919055|NCT00179621|12086326|FG002|NOT COMPLETED|Open-Label Period||28
10919056|NCT00179621|12086327|FG003|NOT COMPLETED|Open-Label Period||43
10919057|NCT00179647|12086336|FG000|STARTED|Overall Study||1913
10919058|NCT00179647|12086336|FG000|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
10919059|NCT00179647|12086336|FG000|NOT COMPLETED|Overall Study||1913
10919060|NCT00179660|12086340|FG000|STARTED|Overall Study||50
10919061|NCT00179660|12086340|FG000|Received Study Drug|Overall Study||49
10919062|NCT00179660|12086340|FG000|Completed 12 Cycles of Treatment|Overall Study||12
10919063|NCT00179660|12086340|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
10919064|NCT00179660|12086340|FG000|NOT COMPLETED|Overall Study||50
10919065|NCT00179673|12086344|FG000|STARTED|Overall Study||43
10919066|NCT00179673|12086344|FG000|Received Study Drug|Overall Study||43
10919067|NCT00179673|12086344|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
10919068|NCT00179673|12086344|FG000|NOT COMPLETED|Overall Study||43
10919069|NCT00179777|12086350|FG000|STARTED|Overall Study||2613
10919070|NCT00179777|12086351|FG001|STARTED|Overall Study||2543
10919071|NCT00179777|12086350|FG000|COMPLETED|Overall Study||1081
10919072|NCT00179777|12086351|FG001|COMPLETED|Overall Study||1078
10919073|NCT00179777|12086350|FG000|NOT COMPLETED|Overall Study||1532
10919074|NCT00179777|12086351|FG001|NOT COMPLETED|Overall Study||1465
10919075|NCT00179959|12086361|FG000|STARTED|Overall Study||15
10919076|NCT00179959|12086362|FG001|STARTED|Overall Study||16
10919077|NCT00179959|12086361|FG000|COMPLETED|Overall Study||9
10919078|NCT00179959|12086362|FG001|COMPLETED|Overall Study||13
10919079|NCT00179959|12086361|FG000|NOT COMPLETED|Overall Study||6
10919080|NCT00179959|12086362|FG001|NOT COMPLETED|Overall Study||3
10919081|NCT00179998|12086370|FG000|STARTED|Initial Period - 6 Months||12
10919082|NCT00179998|12086371|FG001|STARTED|Initial Period - 6 Months||12
10919083|NCT00179998|12086370|FG000|COMPLETED|Initial Period - 6 Months||12
10919084|NCT00179998|12086371|FG001|COMPLETED|Initial Period - 6 Months||12
10919085|NCT00179998|12086370|FG000|NOT COMPLETED|Initial Period - 6 Months||0
10919086|NCT00179998|12086371|FG001|NOT COMPLETED|Initial Period - 6 Months||0
10919087|NCT00179998|12086370|FG000|STARTED|Crossover Period - 6 Months||12
10919088|NCT00179998|12086371|FG001|STARTED|Crossover Period - 6 Months||12
10919089|NCT00179998|12086370|FG000|COMPLETED|Crossover Period - 6 Months||12
10919090|NCT00179998|12086371|FG001|COMPLETED|Crossover Period - 6 Months||10
10919091|NCT00179998|12086370|FG000|NOT COMPLETED|Crossover Period - 6 Months||0
10919092|NCT00179998|12086371|FG001|NOT COMPLETED|Crossover Period - 6 Months||2
10919093|NCT00180271|12086383|FG000|STARTED|Overall Study||1089
10919094|NCT00180271|12086384|FG001|STARTED|Overall Study||731
10919095|NCT00180271|12086383|FG000|COMPLETED|Overall Study||1089
10919096|NCT00180271|12086384|FG001|COMPLETED|Overall Study||731
10919097|NCT00180271|12086383|FG000|NOT COMPLETED|Overall Study||0
10919098|NCT00180271|12086384|FG001|NOT COMPLETED|Overall Study||0
10919099|NCT00180297|12086394|FG000|STARTED|Overall Study||107
10919100|NCT00180297|12086395|FG001|STARTED|Overall Study||108
10919101|NCT00180297|12086394|FG000|COMPLETED|Overall Study||61
10919102|NCT00180297|12086395|FG001|COMPLETED|Overall Study||67
10919103|NCT00180297|12086394|FG000|NOT COMPLETED|Overall Study||46
10919104|NCT00180297|12086395|FG001|NOT COMPLETED|Overall Study||41
10919105|NCT00180323|12086401|FG000|STARTED|Overall Study||43
10919106|NCT00180323|12086401|FG000|COMPLETED|Overall Study||43
10919107|NCT00180323|12086401|FG000|NOT COMPLETED|Overall Study||0
10919108|NCT00180479|12086409|FG000|STARTED|Overall Study||669
10919109|NCT00180479|12086410|FG001|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
10919110|NCT00180479|12086409|FG000|COMPLETED|Overall Study||653
10919111|NCT00180479|12086410|FG001|COMPLETED|Overall Study||320
10919112|NCT00180479|12086409|FG000|NOT COMPLETED|Overall Study||16
10919113|NCT00180479|12086410|FG001|NOT COMPLETED|Overall Study||13
10919114|NCT00180661|12086418|FG000|STARTED|Overall Study||19
10919115|NCT00180661|12086419|FG001|STARTED|Overall Study||20
10919116|NCT00180661|12086418|FG000|COMPLETED|Overall Study||19
10919117|NCT00180661|12086419|FG001|COMPLETED|Overall Study||20
10919118|NCT00180661|12086418|FG000|NOT COMPLETED|Overall Study||0
10919119|NCT00180661|12086419|FG001|NOT COMPLETED|Overall Study||0
10919120|NCT00180674|12086425|FG000|STARTED|Phase 1, Observation Period||14
10919121|NCT00180674|12086425|FG000|COMPLETED|Phase 1, Observation Period||10
10919122|NCT00180674|12086425|FG000|NOT COMPLETED|Phase 1, Observation Period||4
10919123|NCT00180674|12086425|FG000|STARTED|Phase 2, Warfarin Treatment Period||10
10919124|NCT00180674|12086425|FG000|COMPLETED|Phase 2, Warfarin Treatment Period||9
10919125|NCT00180674|12086425|FG000|NOT COMPLETED|Phase 2, Warfarin Treatment Period||1
10919126|NCT00180687|12086437|FG000|STARTED|Overall Study||20
10919127|NCT00180687|12086438|FG001|STARTED|Overall Study||20
10919128|NCT00180687|12086439|FG002|STARTED|Overall Study||20
10919129|NCT00180687|12086440|FG003|STARTED|Overall Study||20
10919130|NCT00180687|12086437|FG000|COMPLETED|Overall Study||20
10919131|NCT00180687|12086438|FG001|COMPLETED|Overall Study||20
10919132|NCT00180687|12086439|FG002|COMPLETED|Overall Study||20
10919133|NCT00180687|12086440|FG003|COMPLETED|Overall Study||20
10919134|NCT00180687|12086437|FG000|NOT COMPLETED|Overall Study||0
10919135|NCT00180687|12086438|FG001|NOT COMPLETED|Overall Study||0
10919136|NCT00180687|12086439|FG002|NOT COMPLETED|Overall Study||0
10919137|NCT00180687|12086440|FG003|NOT COMPLETED|Overall Study||0
10919138|NCT00180713|12086452|FG000|STARTED|Overall Study||23
10919139|NCT00180713|12086453|FG001|STARTED|Overall Study||19
10919140|NCT00180713|12086452|FG000|COMPLETED|Overall Study||18
10919141|NCT00180713|12086453|FG001|COMPLETED|Overall Study||16
10919142|NCT00180713|12086452|FG000|NOT COMPLETED|Overall Study||5
10919143|NCT00180713|12086453|FG001|NOT COMPLETED|Overall Study||3
10919144|NCT00181155|12086459|FG000|STARTED|Overall Study||15
10919145|NCT00181155|12086460|FG001|STARTED|Overall Study||3
10919146|NCT00181155|12086459|FG000|COMPLETED|Overall Study||13
10919147|NCT00181155|12086460|FG001|COMPLETED|Overall Study||3
10919148|NCT00181155|12086459|FG000|NOT COMPLETED|Overall Study||2
10919149|NCT00181155|12086460|FG001|NOT COMPLETED|Overall Study||0
10919150|NCT00181168|12086469|FG000|STARTED|Overall Study||30
10919151|NCT00181168|12086470|FG001|STARTED|Overall Study||33
10919152|NCT00181168|12086469|FG000|COMPLETED|Overall Study||30
10919153|NCT00181168|12086470|FG001|COMPLETED|Overall Study||33
10919154|NCT00181168|12086469|FG000|NOT COMPLETED|Overall Study||0
10919155|NCT00181168|12086470|FG001|NOT COMPLETED|Overall Study||0
10919156|NCT00181207|12086478|FG000|STARTED|Overall Study||24
10919157|NCT00181207|12086479|FG001|STARTED|Overall Study||26
10919158|NCT00181207|12086478|FG000|COMPLETED|Overall Study||24
10919159|NCT00181207|12086479|FG001|COMPLETED|Overall Study||26
10919160|NCT00181207|12086478|FG000|NOT COMPLETED|Overall Study||0
10919161|NCT00181207|12086479|FG001|NOT COMPLETED|Overall Study||0
10919162|NCT00181285|12086487|FG000|STARTED|Overall Study||27
10919163|NCT00181285|12086488|FG001|STARTED|Overall Study||25
10919164|NCT00181285|12086487|FG000|COMPLETED|Overall Study||27
10919165|NCT00181285|12086488|FG001|COMPLETED|Overall Study||25
10919166|NCT00181285|12086487|FG000|NOT COMPLETED|Overall Study||0
10919167|NCT00181285|12086488|FG001|NOT COMPLETED|Overall Study||0
10919168|NCT00181363|12086494|FG000|STARTED|Overall Study|10|10
10919169|NCT00181363|12086494|FG000|COMPLETED|Overall Study||10
10919170|NCT00181363|12086494|FG000|NOT COMPLETED|Overall Study||0
10919171|NCT00181610|12086504|FG000|STARTED|Overall Study||4
10919172|NCT00181610|12086505|FG001|STARTED|Overall Study||4
10919173|NCT00181610|12086506|FG002|STARTED|Overall Study||3
10919174|NCT00181610|12086504|FG000|COMPLETED|Overall Study||4
10919175|NCT00181610|12086505|FG001|COMPLETED|Overall Study||3
10919176|NCT00181610|12086506|FG002|COMPLETED|Overall Study||3
10919177|NCT00181610|12086504|FG000|NOT COMPLETED|Overall Study||0
10919178|NCT00181610|12086505|FG001|NOT COMPLETED|Overall Study||1
10919179|NCT00181610|12086506|FG002|NOT COMPLETED|Overall Study||0
10919180|NCT00181623|12086515|FG000|STARTED|Overall Study||6
10919181|NCT00181623|12086515|FG000|COMPLETED|Overall Study||5
10919182|NCT00181623|12086515|FG000|NOT COMPLETED|Overall Study||1
10919183|NCT00181714|12086520|FG000|STARTED|Signed Consent/Enrolled||203
10919184|NCT00181714|12086520|FG000|COMPLETED|Signed Consent/Enrolled||154
10919185|NCT00181714|12086520|FG000|NOT COMPLETED|Signed Consent/Enrolled||49
10919186|NCT00181714|12086520|FG000|STARTED|Began Treatment With OROS-MPH||154
10919187|NCT00181714|12086520|FG000|COMPLETED|Began Treatment With OROS-MPH||30
10919188|NCT00181714|12086520|FG000|NOT COMPLETED|Began Treatment With OROS-MPH||124
10919189|NCT00181766|12086524|FG000|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
10919190|NCT00181766|12086524|FG000|COMPLETED|Overall Study|Completed the trial.|33
10919191|NCT00181766|12086524|FG000|NOT COMPLETED|Overall Study||12
10919192|NCT00181844|12086528|FG000|STARTED|Signed Consent||51
10919193|NCT00181844|12086528|FG000|COMPLETED|Signed Consent||39
10919194|NCT00181844|12086528|FG000|NOT COMPLETED|Signed Consent||12
10919195|NCT00181844|12086528|FG000|STARTED|Exposed to Study Medication||39
10919196|NCT00181844|12086528|FG000|COMPLETED|Exposed to Study Medication||22
10919197|NCT00181844|12086528|FG000|NOT COMPLETED|Exposed to Study Medication||17
10919198|NCT00181883|12086532|FG000|STARTED|Overall Study||30
10919199|NCT00181883|12086532|FG000|COMPLETED|Overall Study||20
10919200|NCT00181883|12086532|FG000|NOT COMPLETED|Overall Study||10
10919201|NCT00181961|12086538|FG000|STARTED|Overall Study||7
10919202|NCT00181961|12086539|FG001|STARTED|Overall Study||9
10919203|NCT00181961|12086538|FG000|COMPLETED|Overall Study||6
10919204|NCT00181961|12086539|FG001|COMPLETED|Overall Study||4
10919205|NCT00181961|12086538|FG000|NOT COMPLETED|Overall Study||1
10919206|NCT00181961|12086539|FG001|NOT COMPLETED|Overall Study||5
10919207|NCT00182000|12086547|FG000|STARTED|Overall Study||14
10919208|NCT00182000|12086548|FG001|STARTED|Overall Study||15
10919209|NCT00182000|12086547|FG000|COMPLETED|Overall Study||9
10919210|NCT00182000|12086548|FG001|COMPLETED|Overall Study||13
10919211|NCT00182000|12086547|FG000|NOT COMPLETED|Overall Study||5
10919212|NCT00182000|12086548|FG001|NOT COMPLETED|Overall Study||2
10919213|NCT00182078|12086556|FG000|STARTED|Overall Study||9
10919214|NCT00182078|12086557|FG001|STARTED|Overall Study||17
10919215|NCT00182078|12086556|FG000|COMPLETED|Overall Study||8
10919216|NCT00182078|12086557|FG001|COMPLETED|Overall Study||17
10919217|NCT00182078|12086556|FG000|NOT COMPLETED|Overall Study||1
10919218|NCT00182078|12086557|FG001|NOT COMPLETED|Overall Study||0
10919219|NCT00182091|12086567|FG000|STARTED|Overall Study||15
10919220|NCT00182091|12086568|FG001|STARTED|Overall Study||15
10919221|NCT00182091|12086569|FG002|STARTED|Overall Study||25
10919222|NCT00182091|12086570|FG003|STARTED|Overall Study||20
10919223|NCT00182091|12086567|FG000|COMPLETED|Overall Study||14
10919224|NCT00182091|12086568|FG001|COMPLETED|Overall Study||15
10919225|NCT00182091|12086569|FG002|COMPLETED|Overall Study||25
10919226|NCT00182091|12086570|FG003|COMPLETED|Overall Study||20
10919227|NCT00182091|12086567|FG000|NOT COMPLETED|Overall Study||1
10919228|NCT00182091|12086568|FG001|NOT COMPLETED|Overall Study||0
10919229|NCT00182091|12086569|FG002|NOT COMPLETED|Overall Study||0
10919230|NCT00182091|12086570|FG003|NOT COMPLETED|Overall Study||0
10919231|NCT00182325|12086580|FG000|STARTED|Overall Study||97
10919232|NCT00182325|12086581|FG001|STARTED|Overall Study||96
10919233|NCT00182325|12086580|FG000|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63
10919234|NCT00182325|12086581|FG001|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43
10919235|NCT00182325|12086580|FG000|NOT COMPLETED|Overall Study||34
10919236|NCT00182325|12086581|FG001|NOT COMPLETED|Overall Study||53
10919237|NCT00182689|12086589|FG000|STARTED|Overall Study||40
10919238|NCT00182689|12086590|FG001|STARTED|Overall Study||49
10919239|NCT00182689|12086589|FG000|Eligible|Overall Study||39
10919240|NCT00182689|12086590|FG001|Eligible|Overall Study||45
10919241|NCT00182689|12086589|FG000|Eligible and Began Protocol Therapy|Overall Study||38
10919242|NCT00182689|12086590|FG001|Eligible and Began Protocol Therapy|Overall Study||45
10919243|NCT00182689|12086589|FG000|COMPLETED|Overall Study||0
10919244|NCT00182689|12086590|FG001|COMPLETED|Overall Study||0
10919245|NCT00182689|12086589|FG000|NOT COMPLETED|Overall Study||40
10919246|NCT00182689|12086590|FG001|NOT COMPLETED|Overall Study||49
10919247|NCT00182754|12086602|FG000|STARTED|Overall Study||16
10919248|NCT00182754|12086603|FG001|STARTED|Overall Study||17
10919249|NCT00182754|12086602|FG000|COMPLETED|Overall Study||16
10919250|NCT00182754|12086603|FG001|COMPLETED|Overall Study||17
10919251|NCT00182754|12086602|FG000|NOT COMPLETED|Overall Study||0
10919252|NCT00182754|12086603|FG001|NOT COMPLETED|Overall Study||0
10919253|NCT00182767|12086609|FG000|STARTED|Overall Study||6
10919254|NCT00182767|12086610|FG001|STARTED|Overall Study||6
10919255|NCT00182767|12086611|FG002|STARTED|Overall Study||6
10919256|NCT00182767|12086612|FG003|STARTED|Overall Study||3
10919257|NCT00182767|12086613|FG004|STARTED|Overall Study||24
10919258|NCT00182767|12086609|FG000|COMPLETED|Overall Study||6
10919259|NCT00182767|12086610|FG001|COMPLETED|Overall Study||6
10919260|NCT00182767|12086611|FG002|COMPLETED|Overall Study||6
10919261|NCT00182767|12086612|FG003|COMPLETED|Overall Study||3
10919262|NCT00182767|12086613|FG004|COMPLETED|Overall Study||24
10919263|NCT00182767|12086609|FG000|NOT COMPLETED|Overall Study||0
10919264|NCT00182767|12086610|FG001|NOT COMPLETED|Overall Study||0
10919265|NCT00182767|12086611|FG002|NOT COMPLETED|Overall Study||0
10919266|NCT00182767|12086612|FG003|NOT COMPLETED|Overall Study||0
10919267|NCT00182767|12086613|FG004|NOT COMPLETED|Overall Study||0
10919268|NCT00182793|12086627|FG000|STARTED|Overall Study||32
10919269|NCT00182793|12086627|FG000|COMPLETED|Overall Study||32
10919270|NCT00182793|12086627|FG000|NOT COMPLETED|Overall Study||0
10919271|NCT00183092|12086633|FG000|STARTED|Double-blind (Baseline - Month 2)||23
10919272|NCT00183092|12086634|FG001|STARTED|Double-blind (Baseline - Month 2)||28
10919273|NCT00183092|12086635|FG002|STARTED|Double-blind (Baseline - Month 2)||0
10919274|NCT00183092|12086636|FG003|STARTED|Double-blind (Baseline - Month 2)||0
10919275|NCT00183092|12086633|FG000|Alive at Month 2|Double-blind (Baseline - Month 2)||13
10919276|NCT00183092|12086634|FG001|Alive at Month 2|Double-blind (Baseline - Month 2)||19
10919277|NCT00183092|12086635|FG002|Alive at Month 2|Double-blind (Baseline - Month 2)||0
10919278|NCT00183092|12086636|FG003|Alive at Month 2|Double-blind (Baseline - Month 2)||0
10919279|NCT00183092|12086633|FG000|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
10919280|NCT00183092|12086634|FG001|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
10919281|NCT00183092|12086635|FG002|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
10919282|NCT00183092|12086636|FG003|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
10919283|NCT00183092|12086633|FG000|COMPLETED|Double-blind (Baseline - Month 2)||11
10919284|NCT00183092|12086634|FG001|COMPLETED|Double-blind (Baseline - Month 2)||16
10919285|NCT00183092|12086635|FG002|COMPLETED|Double-blind (Baseline - Month 2)||0
10919286|NCT00183092|12086636|FG003|COMPLETED|Double-blind (Baseline - Month 2)||0
10919287|NCT00183092|12086633|FG000|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
10919288|NCT00183092|12086634|FG001|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
10919289|NCT00183092|12086635|FG002|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
10919290|NCT00183092|12086636|FG003|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
10919291|NCT00183092|12086633|FG000|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
10919292|NCT00183092|12086634|FG001|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
10919293|NCT00183092|12086635|FG002|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
10919294|NCT00183092|12086636|FG003|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
10919295|NCT00183092|12086633|FG000|COMPLETED|Open-label Period (Month 2 Until Death)||0
10919296|NCT00183092|12086634|FG001|COMPLETED|Open-label Period (Month 2 Until Death)||0
10919297|NCT00183092|12086635|FG002|COMPLETED|Open-label Period (Month 2 Until Death)||0
10919298|NCT00183092|12086636|FG003|COMPLETED|Open-label Period (Month 2 Until Death)||0
10919299|NCT00183092|12086633|FG000|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
10919300|NCT00183092|12086634|FG001|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
10919301|NCT00183092|12086635|FG002|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
10919302|NCT00183092|12086636|FG003|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
10919303|NCT00183170|12086645|FG000|STARTED|First Intervention||103
10919304|NCT00183170|12086646|FG001|STARTED|First Intervention||109
10919305|NCT00183170|12086645|FG000|COMPLETED|First Intervention||101
10919306|NCT00183170|12086646|FG001|COMPLETED|First Intervention||109
10919307|NCT00183170|12086645|FG000|NOT COMPLETED|First Intervention||2
10919308|NCT00183170|12086646|FG001|NOT COMPLETED|First Intervention||0
10919309|NCT00183170|12086645|FG000|STARTED|Washout 1 Week||101
10919310|NCT00183170|12086646|FG001|STARTED|Washout 1 Week||109
10919311|NCT00183170|12086645|FG000|COMPLETED|Washout 1 Week||95
10919312|NCT00183170|12086646|FG001|COMPLETED|Washout 1 Week||101
10919313|NCT00183170|12086645|FG000|NOT COMPLETED|Washout 1 Week||6
10919314|NCT00183170|12086646|FG001|NOT COMPLETED|Washout 1 Week||8
10919315|NCT00183170|12086645|FG000|STARTED|Second Intervention||95
10919316|NCT00183170|12086646|FG001|STARTED|Second Intervention||101
10919317|NCT00183170|12086645|FG000|COMPLETED|Second Intervention||94
10919318|NCT00183170|12086646|FG001|COMPLETED|Second Intervention||99
10919319|NCT00183170|12086645|FG000|NOT COMPLETED|Second Intervention||1
10919320|NCT00183170|12086646|FG001|NOT COMPLETED|Second Intervention||2
10919321|NCT00183196|12086655|FG000|STARTED|Overall Study|2 subjects had no post-randomization data|50
10919322|NCT00183196|12086656|FG001|STARTED|Overall Study|1 subject had no post-randomization data|50
10919323|NCT00183196|12086657|FG002|STARTED|Overall Study|1 subject had no post-randomization data|50
10919324|NCT00183196|12086655|FG000|COMPLETED|Overall Study||30
10919325|NCT00183196|12086656|FG001|COMPLETED|Overall Study||35
10919326|NCT00183196|12086657|FG002|COMPLETED|Overall Study||32
10919327|NCT00183196|12086655|FG000|NOT COMPLETED|Overall Study||20
10919328|NCT00183196|12086656|FG001|NOT COMPLETED|Overall Study||15
10919329|NCT00183196|12086657|FG002|NOT COMPLETED|Overall Study||18
10919330|NCT00183248|12086667|FG000|STARTED|Overall Study||4
10919331|NCT00183248|12086668|FG001|STARTED|Overall Study||5
10919332|NCT00183248|12086667|FG000|COMPLETED|Overall Study||3
10919333|NCT00183248|12086668|FG001|COMPLETED|Overall Study||4
10919334|NCT00183248|12086667|FG000|NOT COMPLETED|Overall Study||1
10919335|NCT00183248|12086668|FG001|NOT COMPLETED|Overall Study||1
10919336|NCT00183274|12086674|FG000|STARTED|Phase 1: Open-Label||268
10919337|NCT00183274|12086675|FG001|STARTED|Phase 1: Open-Label||0
10919338|NCT00183274|12086676|FG002|STARTED|Phase 1: Open-Label||0
10919339|NCT00183274|12086677|FG003|STARTED|Phase 1: Open-Label||0
10919340|NCT00183274|12086678|FG004|STARTED|Phase 1: Open-Label||0
10919341|NCT00183274|12086679|FG005|STARTED|Phase 1: Open-Label||0
10919342|NCT00183274|12086674|FG000|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
10919343|NCT00183274|12086675|FG001|COMPLETED|Phase 1: Open-Label||0
10919344|NCT00183274|12086676|FG002|COMPLETED|Phase 1: Open-Label||0
10919345|NCT00183274|12086677|FG003|COMPLETED|Phase 1: Open-Label||0
10919346|NCT00183274|12086678|FG004|COMPLETED|Phase 1: Open-Label||0
10919347|NCT00183274|12086679|FG005|COMPLETED|Phase 1: Open-Label||0
10919348|NCT00183274|12086674|FG000|NOT COMPLETED|Phase 1: Open-Label||110
10919349|NCT00183274|12086675|FG001|NOT COMPLETED|Phase 1: Open-Label||0
10919350|NCT00183274|12086676|FG002|NOT COMPLETED|Phase 1: Open-Label||0
10919351|NCT00183274|12086677|FG003|NOT COMPLETED|Phase 1: Open-Label||0
10919352|NCT00183274|12086678|FG004|NOT COMPLETED|Phase 1: Open-Label||0
10919353|NCT00183274|12086679|FG005|NOT COMPLETED|Phase 1: Open-Label||0
10919354|NCT00183274|12086674|FG000|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
10919355|NCT00183274|12086675|FG001|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
10919356|NCT00183274|12086676|FG002|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
10919357|NCT00183274|12086677|FG003|STARTED|Phase 2: Double-Blind||0
10919358|NCT00183274|12086678|FG004|STARTED|Phase 2: Double-Blind||0
10919359|NCT00183274|12086679|FG005|STARTED|Phase 2: Double-Blind||0
10919360|NCT00183274|12086674|FG000|COMPLETED|Phase 2: Double-Blind||0
10919361|NCT00183274|12086675|FG001|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
10919362|NCT00183274|12086676|FG002|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
10919363|NCT00183274|12086677|FG003|COMPLETED|Phase 2: Double-Blind||0
10919364|NCT00183274|12086678|FG004|COMPLETED|Phase 2: Double-Blind||0
10919365|NCT00183274|12086679|FG005|COMPLETED|Phase 2: Double-Blind||0
10919366|NCT00183274|12086674|FG000|NOT COMPLETED|Phase 2: Double-Blind||0
10919367|NCT00183274|12086675|FG001|NOT COMPLETED|Phase 2: Double-Blind||26
10919368|NCT00183274|12086676|FG002|NOT COMPLETED|Phase 2: Double-Blind||43
10919369|NCT00183274|12086677|FG003|NOT COMPLETED|Phase 2: Double-Blind||0
10919370|NCT00183274|12086678|FG004|NOT COMPLETED|Phase 2: Double-Blind||0
10919371|NCT00183274|12086679|FG005|NOT COMPLETED|Phase 2: Double-Blind||0
10919372|NCT00183274|12086674|FG000|STARTED|Phase 3: Double-Blind||0
10919373|NCT00183274|12086675|FG001|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
10919374|NCT00183274|12086676|FG002|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
10919375|NCT00183274|12086677|FG003|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
10919376|NCT00183274|12086678|FG004|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
10919377|NCT00183274|12086679|FG005|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
10919378|NCT00183274|12086674|FG000|COMPLETED|Phase 3: Double-Blind||0
10919379|NCT00183274|12086675|FG001|COMPLETED|Phase 3: Double-Blind||0
10919380|NCT00183274|12086676|FG002|COMPLETED|Phase 3: Double-Blind||0
10919381|NCT00183274|12086677|FG003|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
10919382|NCT00183274|12086678|FG004|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
10919383|NCT00183274|12086679|FG005|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
10919384|NCT00183274|12086674|FG000|NOT COMPLETED|Phase 3: Double-Blind||0
10919385|NCT00183274|12086675|FG001|NOT COMPLETED|Phase 3: Double-Blind||0
10919386|NCT00183274|12086676|FG002|NOT COMPLETED|Phase 3: Double-Blind||0
10919387|NCT00183274|12086677|FG003|NOT COMPLETED|Phase 3: Double-Blind||2
10919388|NCT00183274|12086678|FG004|NOT COMPLETED|Phase 3: Double-Blind||20
10919389|NCT00183274|12086679|FG005|NOT COMPLETED|Phase 3: Double-Blind||4
10919390|NCT00183339|12086696|FG000|STARTED|Overall Study||10
10919391|NCT00183339|12086697|FG001|STARTED|Overall Study||8
10919392|NCT00183339|12086696|FG000|COMPLETED|Overall Study||4
10919393|NCT00183339|12086697|FG001|COMPLETED|Overall Study||4
10919394|NCT00183339|12086696|FG000|NOT COMPLETED|Overall Study||6
10919395|NCT00183339|12086697|FG001|NOT COMPLETED|Overall Study||4
10919396|NCT00183391|12086708|FG000|STARTED|Block 1 - 5 Weeks||108
10919397|NCT00183391|12086709|FG001|STARTED|Block 1 - 5 Weeks||124
10919398|NCT00183391|12086708|FG000|COMPLETED|Block 1 - 5 Weeks||95
10919399|NCT00183391|12086709|FG001|COMPLETED|Block 1 - 5 Weeks||110
10919400|NCT00183391|12086708|FG000|NOT COMPLETED|Block 1 - 5 Weeks||13
10919401|NCT00183391|12086709|FG001|NOT COMPLETED|Block 1 - 5 Weeks||14
10919402|NCT00183391|12086708|FG000|STARTED|Crossover Placebo - 2 Weeks||95
10919403|NCT00183391|12086709|FG001|STARTED|Crossover Placebo - 2 Weeks||110
10919404|NCT00183391|12086708|FG000|COMPLETED|Crossover Placebo - 2 Weeks||95
10919405|NCT00183391|12086709|FG001|COMPLETED|Crossover Placebo - 2 Weeks||110
10919406|NCT00183391|12086708|FG000|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
10919407|NCT00183391|12086709|FG001|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
10919408|NCT00183391|12086708|FG000|STARTED|Block 2 - 5 Weeks||95
10919409|NCT00183391|12086709|FG001|STARTED|Block 2 - 5 Weeks||110
10919410|NCT00183391|12086708|FG000|COMPLETED|Block 2 - 5 Weeks||91
10919411|NCT00183391|12086709|FG001|COMPLETED|Block 2 - 5 Weeks||108
10919412|NCT00183391|12086708|FG000|NOT COMPLETED|Block 2 - 5 Weeks||4
10919413|NCT00183391|12086709|FG001|NOT COMPLETED|Block 2 - 5 Weeks||2
10919414|NCT00183430|12086719|FG000|STARTED|Overall Study||9
10919415|NCT00183430|12086720|FG001|STARTED|Overall Study||11
10919416|NCT00183430|12086719|FG000|COMPLETED|Overall Study||3
10919417|NCT00183430|12086720|FG001|COMPLETED|Overall Study||11
10919418|NCT00183430|12086719|FG000|NOT COMPLETED|Overall Study||6
10919419|NCT00183430|12086720|FG001|NOT COMPLETED|Overall Study||0
10919420|NCT00183443|12086729|FG000|STARTED|Overall Study||24
10919421|NCT00183443|12086730|FG001|STARTED|Overall Study||26
10919422|NCT00183443|12086731|FG002|STARTED|Overall Study||25
10919423|NCT00183443|12086729|FG000|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
10919424|NCT00183443|12086730|FG001|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
10919425|NCT00183443|12086731|FG002|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
10919426|NCT00183443|12086729|FG000|NOT COMPLETED|Overall Study||0
10919427|NCT00183443|12086730|FG001|NOT COMPLETED|Overall Study||0
10919428|NCT00183443|12086731|FG002|NOT COMPLETED|Overall Study||0
10919429|NCT00183456|12086743|FG000|STARTED|Overall Study||85
10919430|NCT00183456|12086744|FG001|STARTED|Overall Study||84
10919431|NCT00183456|12086745|FG002|STARTED|Overall Study||329
10919432|NCT00183456|12086746|FG003|STARTED|Overall Study||248
10919433|NCT00183456|12086743|FG000|6 Month Follow-up|Overall Study||74
10919434|NCT00183456|12086744|FG001|6 Month Follow-up|Overall Study||77
10919435|NCT00183456|12086745|FG002|6 Month Follow-up|Overall Study||278
10919436|NCT00183456|12086746|FG003|6 Month Follow-up|Overall Study||175
10919437|NCT00183456|12086743|FG000|12 Month Follow-up|Overall Study||76
10919438|NCT00183456|12086744|FG001|12 Month Follow-up|Overall Study||74
10919439|NCT00183456|12086745|FG002|12 Month Follow-up|Overall Study||267
10919440|NCT00183456|12086746|FG003|12 Month Follow-up|Overall Study||186
10919441|NCT00183456|12086743|FG000|18 Month Follow-up|Overall Study||80
10919442|NCT00183456|12086744|FG001|18 Month Follow-up|Overall Study||81
10919443|NCT00183456|12086745|FG002|18 Month Follow-up|Overall Study||303
10919444|NCT00183456|12086746|FG003|18 Month Follow-up|Overall Study||207
10919445|NCT00183456|12086743|FG000|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
10919446|NCT00183456|12086744|FG001|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
10919447|NCT00183456|12086745|FG002|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
10919448|NCT00183456|12086746|FG003|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
10919449|NCT00183456|12086743|FG000|NOT COMPLETED|Overall Study||3
10919450|NCT00183456|12086744|FG001|NOT COMPLETED|Overall Study||1
10919451|NCT00183456|12086745|FG002|NOT COMPLETED|Overall Study||16
10919452|NCT00183456|12086746|FG003|NOT COMPLETED|Overall Study||28
10919453|NCT00183469|12086758|FG000|STARTED|Overall Study||41
10919454|NCT00183469|12086759|FG001|STARTED|Overall Study||45
10919455|NCT00183469|12086758|FG000|COMPLETED|Overall Study||13
10919456|NCT00183469|12086759|FG001|COMPLETED|Overall Study||16
10919457|NCT00183469|12086758|FG000|NOT COMPLETED|Overall Study||28
10919458|NCT00183469|12086759|FG001|NOT COMPLETED|Overall Study||29
10919459|NCT00183625|12086767|FG000|STARTED|Overall Study||27
10919460|NCT00183625|12086768|FG001|STARTED|Overall Study||28
10919461|NCT00183625|12086769|FG002|STARTED|Overall Study||28
10919462|NCT00183625|12086770|FG003|STARTED|Overall Study||24
10919463|NCT00183625|12086767|FG000|Obtained Employment|Overall Study||21
10919464|NCT00183625|12086768|FG001|Obtained Employment|Overall Study||18
10919465|NCT00183625|12086769|FG002|Obtained Employment|Overall Study||14
10919466|NCT00183625|12086770|FG003|Obtained Employment|Overall Study||14
10919467|NCT00183625|12086767|FG000|COMPLETED|Overall Study||9
10919468|NCT00183625|12086768|FG001|COMPLETED|Overall Study||10
10919469|NCT00183625|12086769|FG002|COMPLETED|Overall Study||9
10919470|NCT00183625|12086770|FG003|COMPLETED|Overall Study||10
10919471|NCT00183625|12086767|FG000|NOT COMPLETED|Overall Study||18
10919472|NCT00183625|12086768|FG001|NOT COMPLETED|Overall Study||18
10919473|NCT00183625|12086769|FG002|NOT COMPLETED|Overall Study||19
10919474|NCT00183625|12086770|FG003|NOT COMPLETED|Overall Study||14
10919475|NCT00183677|12086778|FG000|STARTED|Overall Study||97
10919476|NCT00183677|12086778|FG000|COMPLETED|Overall Study||53
10919477|NCT00183677|12086778|FG000|NOT COMPLETED|Overall Study||44
10919478|NCT00183729|12086784|FG000|STARTED|Overall Study||17
10919479|NCT00183729|12086785|FG001|STARTED|Overall Study||18
10919480|NCT00183729|12086784|FG000|COMPLETED|Overall Study||14
10919481|NCT00183729|12086785|FG001|COMPLETED|Overall Study||13
10919482|NCT00183729|12086784|FG000|NOT COMPLETED|Overall Study||3
10919483|NCT00183729|12086785|FG001|NOT COMPLETED|Overall Study||5
10919484|NCT00183794|12086791|FG000|STARTED|Overall Study||20
10919485|NCT00183794|12086791|FG000|COMPLETED|Overall Study||20
10919486|NCT00183794|12086791|FG000|NOT COMPLETED|Overall Study||0
10919487|NCT00183872|12086795|FG000|STARTED|Overall Study||40
10919488|NCT00183872|12086795|FG000|COMPLETED|Overall Study||24
10919489|NCT00183872|12086795|FG000|NOT COMPLETED|Overall Study||16
10919490|NCT00184002|12086799|FG000|STARTED|Overall Study||68
10919491|NCT00184002|12086799|FG000|COMPLETED|Overall Study||51
10919492|NCT00184002|12086799|FG000|NOT COMPLETED|Overall Study||17
10919493|NCT00184028|12086803|FG000|STARTED|Overall Study||12
10919494|NCT00184028|12086803|FG000|COMPLETED|Overall Study||2
10919495|NCT00184028|12086803|FG000|NOT COMPLETED|Overall Study||10
10919496|NCT00184054|12086808|FG000|STARTED|Overall Study||11
10919497|NCT00184054|12086808|FG000|COMPLETED|Overall Study||10
10919498|NCT00184054|12086808|FG000|NOT COMPLETED|Overall Study||1
10919499|NCT00184093|12086812|FG000|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
10919500|NCT00184093|12086812|FG000|COMPLETED|Overall Study||26
10919501|NCT00184093|12086812|FG000|NOT COMPLETED|Overall Study||9
10919502|NCT00184548|12086820|FG000|STARTED|Overall Study||226
10919503|NCT00184548|12086821|FG001|STARTED|Overall Study||255
10919504|NCT00184548|12086822|FG002|STARTED|Overall Study||47
10919505|NCT00184548|12086823|FG003|STARTED|Overall Study||45
10919506|NCT00184548|12086820|FG000|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
10919507|NCT00184548|12086821|FG001|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
10919508|NCT00184548|12086822|FG002|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
10919509|NCT00184548|12086823|FG003|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
10919510|NCT00184548|12086820|FG000|COMPLETED|Overall Study||218
10919511|NCT00184548|12086821|FG001|COMPLETED|Overall Study||242
10919512|NCT00184548|12086822|FG002|COMPLETED|Overall Study||44
10919513|NCT00184548|12086823|FG003|COMPLETED|Overall Study||38
10919514|NCT00184548|12086820|FG000|NOT COMPLETED|Overall Study||8
10919515|NCT00184548|12086821|FG001|NOT COMPLETED|Overall Study||13
10919516|NCT00184548|12086822|FG002|NOT COMPLETED|Overall Study||3
10919517|NCT00184548|12086823|FG003|NOT COMPLETED|Overall Study||7
10919518|NCT00184600|12086836|FG000|STARTED|Overall Study||234
10919519|NCT00184600|12086837|FG001|STARTED|Overall Study||239
10919520|NCT00184600|12086838|FG002|STARTED|Overall Study||235
10919521|NCT00184600|12086836|FG000|COMPLETED|Overall Study||189
10919522|NCT00184600|12086837|FG001|COMPLETED|Overall Study||188
10919523|NCT00184600|12086838|FG002|COMPLETED|Overall Study||201
10919524|NCT00184600|12086836|FG000|NOT COMPLETED|Overall Study||45
10919525|NCT00184600|12086837|FG001|NOT COMPLETED|Overall Study||51
10919526|NCT00184600|12086838|FG002|NOT COMPLETED|Overall Study||34
10919527|NCT00184717|12086849|FG000|STARTED|Main Period (GHLIQUID-1516)||39
10919528|NCT00184717|12086850|FG001|STARTED|Main Period (GHLIQUID-1516)||38
10919529|NCT00184717|12086851|FG002|STARTED|Main Period (GHLIQUID-1516)||21
10919530|NCT00184717|12086852|FG003|STARTED|Main Period (GHLIQUID-1516)||0
10919531|NCT00184717|12086853|FG004|STARTED|Main Period (GHLIQUID-1516)||0
10919532|NCT00184717|12086849|FG000|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
10919533|NCT00184717|12086850|FG001|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
10919534|NCT00184717|12086851|FG002|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
10919535|NCT00184717|12086852|FG003|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
10919536|NCT00184717|12086853|FG004|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
10919537|NCT00184717|12086849|FG000|COMPLETED|Main Period (GHLIQUID-1516)||36
10919538|NCT00184717|12086850|FG001|COMPLETED|Main Period (GHLIQUID-1516)||36
10919539|NCT00184717|12086851|FG002|COMPLETED|Main Period (GHLIQUID-1516)||20
10919540|NCT00184717|12086852|FG003|COMPLETED|Main Period (GHLIQUID-1516)||0
10919541|NCT00184717|12086853|FG004|COMPLETED|Main Period (GHLIQUID-1516)||0
10919542|NCT00184717|12086849|FG000|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
10919543|NCT00184717|12086850|FG001|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
10919544|NCT00184717|12086851|FG002|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
10919545|NCT00184717|12086852|FG003|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
10919546|NCT00184717|12086853|FG004|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
10919547|NCT00184717|12086849|FG000|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
10919548|NCT00184717|12086850|FG001|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
10919549|NCT00184717|12086851|FG002|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
10919550|NCT00184717|12086852|FG003|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
10919551|NCT00184717|12086853|FG004|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
10919552|NCT00184717|12086849|FG000|COMPLETED|Extension Period (GHLIQUID-1517)||23
10919553|NCT00184717|12086850|FG001|COMPLETED|Extension Period (GHLIQUID-1517)||27
10919554|NCT00184717|12086851|FG002|COMPLETED|Extension Period (GHLIQUID-1517)||0
10919555|NCT00184717|12086852|FG003|COMPLETED|Extension Period (GHLIQUID-1517)||7
10919556|NCT00184717|12086853|FG004|COMPLETED|Extension Period (GHLIQUID-1517)||5
10919557|NCT00184717|12086849|FG000|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
10919558|NCT00184717|12086850|FG001|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
10919559|NCT00184717|12086851|FG002|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
10919560|NCT00184717|12086852|FG003|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
10919561|NCT00184717|12086853|FG004|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
10919562|NCT00185211|12086865|FG000|STARTED|Placebo-controlled Study (92012)||292
10919563|NCT00185211|12086866|FG001|STARTED|Placebo-controlled Study (92012)||176
10919564|NCT00185211|12086865|FG000|COMPLETED|Placebo-controlled Study (92012)||271
10919565|NCT00185211|12086866|FG001|COMPLETED|Placebo-controlled Study (92012)||166
10919566|NCT00185211|12086865|FG000|NOT COMPLETED|Placebo-controlled Study (92012)||21
10919567|NCT00185211|12086866|FG001|NOT COMPLETED|Placebo-controlled Study (92012)||10
10919568|NCT00185211|12086865|FG000|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
10919569|NCT00185211|12086866|FG001|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
10919570|NCT00185211|12086865|FG000|COMPLETED|Follow-up Study (91031 - This Study)||235
10919571|NCT00185211|12086866|FG001|COMPLETED|Follow-up Study (91031 - This Study)||123
10919572|NCT00185211|12086865|FG000|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
10919573|NCT00185211|12086866|FG001|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
10919574|NCT00185380|12086876|FG000|STARTED|Overall Study||240
10919575|NCT00185380|12086877|FG001|STARTED|Overall Study||246
10919576|NCT00185380|12086878|FG002|STARTED|Overall Study||256
10919577|NCT00185380|12086876|FG000|Subjects Received Treatment|Overall Study||239
10919578|NCT00185380|12086877|FG001|Subjects Received Treatment|Overall Study||245
10919579|NCT00185380|12086878|FG002|Subjects Received Treatment|Overall Study||254
10919580|NCT00185380|12086876|FG000|COMPLETED|Overall Study||174
10919581|NCT00185380|12086877|FG001|COMPLETED|Overall Study||174
10919582|NCT00185380|12086878|FG002|COMPLETED|Overall Study||182
10919583|NCT00185380|12086876|FG000|NOT COMPLETED|Overall Study||66
10919584|NCT00185380|12086877|FG001|NOT COMPLETED|Overall Study||72
10919585|NCT00185380|12086878|FG002|NOT COMPLETED|Overall Study||74
10919586|NCT00185458|12086886|FG000|STARTED|Contraception Phase||394
10919587|NCT00185458|12086886|FG000|COMPLETED|Contraception Phase||336
10919588|NCT00185458|12086886|FG000|NOT COMPLETED|Contraception Phase||58
10919589|NCT00185458|12086886|FG000|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
10919590|NCT00185458|12086886|FG000|COMPLETED|HRT Phase||141
10919591|NCT00185458|12086886|FG000|NOT COMPLETED|HRT Phase||27
10919592|NCT00185588|12086902|FG000|STARTED|Overall Study||6
10919593|NCT00185588|12086903|FG001|STARTED|Overall Study||4
10919594|NCT00185588|12086904|FG002|STARTED|Overall Study||6
10919595|NCT00185588|12086905|FG003|STARTED|Overall Study||17
10919596|NCT00185588|12086902|FG000|COMPLETED|Overall Study||3
10919597|NCT00185588|12086903|FG001|COMPLETED|Overall Study||2
10919598|NCT00185588|12086904|FG002|COMPLETED|Overall Study||0
10919599|NCT00185588|12086905|FG003|COMPLETED|Overall Study||13
10919600|NCT00185588|12086902|FG000|NOT COMPLETED|Overall Study||3
10919601|NCT00185588|12086903|FG001|NOT COMPLETED|Overall Study||2
10919602|NCT00185588|12086904|FG002|NOT COMPLETED|Overall Study||6
10919603|NCT00185588|12086905|FG003|NOT COMPLETED|Overall Study||4
10919604|NCT00185614|12086915|FG000|STARTED|Autologous HCT (Auto-HCT)||63
10919605|NCT00185614|12086915|FG000|COMPLETED|Autologous HCT (Auto-HCT)||63
10919606|NCT00185614|12086915|FG000|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
10919607|NCT00185614|12086915|FG000|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
10919608|NCT00185614|12086915|FG000|COMPLETED|Inter-treatment Period||59
10919609|NCT00185614|12086915|FG000|NOT COMPLETED|Inter-treatment Period||4
10919610|NCT00185614|12086915|FG000|STARTED|Allogenic HCT (Allo-HCT)||59
10919611|NCT00185614|12086915|FG000|COMPLETED|Allogenic HCT (Allo-HCT)||59
10919612|NCT00185614|12086915|FG000|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
10919613|NCT00185640|12086919|FG000|STARTED|Overall Study||303
10919614|NCT00185640|12086919|FG000|Transplanted|Overall Study||296
10919615|NCT00185640|12086919|FG000|90 Days Post-transplant|Overall Study||161
10919616|NCT00185640|12086919|FG000|COMPLETED|Overall Study||158
10919617|NCT00185640|12086919|FG000|NOT COMPLETED|Overall Study||145
10919618|NCT00185679|12086923|FG000|STARTED|Overall Study||13
10919619|NCT00185679|12086923|FG000|COMPLETED|Overall Study||13
10919620|NCT00185679|12086923|FG000|NOT COMPLETED|Overall Study||0
10919621|NCT00185692|12086927|FG000|STARTED|Overall Study||16
10919622|NCT00185692|12086927|FG000|COMPLETED|Overall Study||0
10919623|NCT00185692|12086927|FG000|NOT COMPLETED|Overall Study||16
10919624|NCT00185731|12086931|FG000|STARTED|Overall Study||25
10919625|NCT00185731|12086931|FG000|COMPLETED|Overall Study||23
10919626|NCT00185731|12086931|FG000|NOT COMPLETED|Overall Study||2
10919627|NCT00185900|12086939|FG000|STARTED|Overall Study||92
10919628|NCT00185900|12086940|FG001|STARTED|Overall Study||100
10919629|NCT00185900|12086939|FG000|COMPLETED|Overall Study||92
10919630|NCT00185900|12086940|FG001|COMPLETED|Overall Study||100
10919631|NCT00185900|12086939|FG000|NOT COMPLETED|Overall Study||0
10919632|NCT00185900|12086940|FG001|NOT COMPLETED|Overall Study||0
10919633|NCT00185965|12086948|FG000|STARTED|Overall Study||15
10919634|NCT00185965|12086949|FG001|STARTED|Overall Study||15
10919635|NCT00185965|12086948|FG000|COMPLETED|Overall Study||15
10919636|NCT00185965|12086949|FG001|COMPLETED|Overall Study||14
10919637|NCT00185965|12086948|FG000|NOT COMPLETED|Overall Study||0
10919638|NCT00185965|12086949|FG001|NOT COMPLETED|Overall Study||1
10919639|NCT00186017|12086957|FG000|STARTED|Overall Study||25
10919640|NCT00186017|12086958|FG001|STARTED|Overall Study||25
10919641|NCT00186017|12086957|FG000|COMPLETED|Overall Study||23
10919642|NCT00186017|12086958|FG001|COMPLETED|Overall Study||22
10919643|NCT00186017|12086957|FG000|NOT COMPLETED|Overall Study||2
10919644|NCT00186017|12086958|FG001|NOT COMPLETED|Overall Study||3
10919645|NCT00186043|12086967|FG000|STARTED|Overall Study||30
10919646|NCT00186043|12086968|FG001|STARTED|Overall Study||25
10919647|NCT00186043|12086967|FG000|COMPLETED|Overall Study||15
10919648|NCT00186043|12086968|FG001|COMPLETED|Overall Study||12
10919649|NCT00186043|12086967|FG000|NOT COMPLETED|Overall Study||15
10919650|NCT00186043|12086968|FG001|NOT COMPLETED|Overall Study||13
10919651|NCT00186056|12086976|FG000|STARTED|Overall Study||14
10919652|NCT00186056|12086977|FG001|STARTED|Overall Study||17
10919653|NCT00186056|12086976|FG000|COMPLETED|Overall Study||12
10919654|NCT00186056|12086977|FG001|COMPLETED|Overall Study||16
10919655|NCT00186056|12086976|FG000|NOT COMPLETED|Overall Study||2
10919656|NCT00186056|12086977|FG001|NOT COMPLETED|Overall Study||1
10919657|NCT00186069|12086985|FG000|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
10919658|NCT00186069|12086986|FG001|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
10919659|NCT00186069|12086985|FG000|COMPLETED|Overall Study||15
10919660|NCT00186069|12086986|FG001|COMPLETED|Overall Study||15
10919661|NCT00186069|12086985|FG000|NOT COMPLETED|Overall Study||0
10919662|NCT00186069|12086986|FG001|NOT COMPLETED|Overall Study||0
10919663|NCT00186121|12086992|FG000|STARTED|Overall Study||35
10919664|NCT00186121|12086992|FG000|COMPLETED|Overall Study||32
10919665|NCT00186121|12086992|FG000|NOT COMPLETED|Overall Study||3
10919666|NCT00186186|12086996|FG000|STARTED|Overall Study||28
10919667|NCT00186186|12086996|FG000|COMPLETED|Overall Study||20
10919668|NCT00186186|12086996|FG000|NOT COMPLETED|Overall Study||8
10919669|NCT00186446|12087001|FG000|STARTED|Overall Study||20
10919670|NCT00186446|12087001|FG000|COMPLETED|Overall Study||11
10919671|NCT00186446|12087001|FG000|NOT COMPLETED|Overall Study||9
10919672|NCT00186485|12087007|FG000|STARTED|Overall Study||28
10919673|NCT00186485|12087007|FG000|COMPLETED|Overall Study||25
10919674|NCT00186485|12087007|FG000|NOT COMPLETED|Overall Study||3
10919675|NCT00186498|12087013|FG000|STARTED|Overall Study||6
10919676|NCT00186498|12087014|FG001|STARTED|Overall Study||5
10919677|NCT00186498|12087013|FG000|COMPLETED|Overall Study||4
10919678|NCT00186498|12087014|FG001|COMPLETED|Overall Study||3
10919679|NCT00186498|12087013|FG000|NOT COMPLETED|Overall Study||2
10919680|NCT00186498|12087014|FG001|NOT COMPLETED|Overall Study||2
10919681|NCT00186537|12087023|FG000|STARTED|Overall Study||19
10919682|NCT00186537|12087024|FG001|STARTED|Overall Study||12
10919683|NCT00186537|12087025|FG002|STARTED|Overall Study||16
10919684|NCT00186537|12087023|FG000|COMPLETED|Overall Study||12
10919685|NCT00186537|12087024|FG001|COMPLETED|Overall Study||12
10919686|NCT00186537|12087025|FG002|COMPLETED|Overall Study||13
10919687|NCT00186537|12087023|FG000|NOT COMPLETED|Overall Study||7
10919688|NCT00186537|12087024|FG001|NOT COMPLETED|Overall Study||0
10919689|NCT00186537|12087025|FG002|NOT COMPLETED|Overall Study||3
10919690|NCT00186628|12087033|FG000|STARTED|Overall Study||36
10919691|NCT00186628|12087033|FG000|COMPLETED|Overall Study||33
10919692|NCT00186628|12087033|FG000|NOT COMPLETED|Overall Study||3
10919693|NCT00186875|12087041|FG000|STARTED|Overall Study||26
10919694|NCT00186875|12087042|FG001|STARTED|Overall Study||14
10919695|NCT00186875|12087041|FG000|COMPLETED|Overall Study||26
10919696|NCT00186875|12087042|FG001|COMPLETED|Overall Study||14
10919697|NCT00186875|12087041|FG000|NOT COMPLETED|Overall Study||0
10919698|NCT00186875|12087042|FG001|NOT COMPLETED|Overall Study||0
10919699|NCT00186901|12087052|FG000|STARTED|Overall Study||134
10919700|NCT00186901|12087053|FG001|STARTED|Overall Study||141
10919701|NCT00186901|12087054|FG002|STARTED|Overall Study||149
10919702|NCT00186901|12087052|FG000|Baseline|Overall Study||134
10919703|NCT00186901|12087053|FG001|Baseline|Overall Study||141
10919704|NCT00186901|12087054|FG002|Baseline|Overall Study||0
10919705|NCT00186901|12087052|FG000|12 Month Follow-up|Overall Study||117
10919706|NCT00186901|12087053|FG001|12 Month Follow-up|Overall Study||122
10919707|NCT00186901|12087054|FG002|12 Month Follow-up|Overall Study||0
10919708|NCT00186901|12087052|FG000|24 Month Follow-up|Overall Study||106
10919709|NCT00186901|12087053|FG001|24 Month Follow-up|Overall Study||107
10919710|NCT00186901|12087054|FG002|24 Month Follow-up|Overall Study||0
10919711|NCT00186901|12087052|FG000|COMPLETED|Overall Study||85
10919712|NCT00186901|12087053|FG001|COMPLETED|Overall Study||96
10919713|NCT00186901|12087054|FG002|COMPLETED|Overall Study||0
10919714|NCT00186901|12087052|FG000|NOT COMPLETED|Overall Study||49
10919715|NCT00186901|12087053|FG001|NOT COMPLETED|Overall Study||45
10919716|NCT00186901|12087054|FG002|NOT COMPLETED|Overall Study||149
10919717|NCT00187096|12087094|FG000|STARTED|Overall Study||10
10919718|NCT00187096|12087095|FG001|STARTED|Overall Study||3
10919719|NCT00187096|12087096|FG002|STARTED|Overall Study||12
10919720|NCT00187096|12087094|FG000|COMPLETED|Overall Study||10
10919721|NCT00187096|12087095|FG001|COMPLETED|Overall Study||3
10919722|NCT00187096|12087096|FG002|COMPLETED|Overall Study||11
10919723|NCT00187096|12087094|FG000|NOT COMPLETED|Overall Study||0
10919724|NCT00187096|12087095|FG001|NOT COMPLETED|Overall Study||0
10919725|NCT00187096|12087096|FG002|NOT COMPLETED|Overall Study||1
10919726|NCT00187135|12087110|FG000|STARTED|Visit One||30
10919727|NCT00187135|12087111|FG001|STARTED|Visit One||28
10919728|NCT00187135|12087112|FG002|STARTED|Visit One||25
10919729|NCT00187135|12087113|FG003|STARTED|Visit One||26
10919730|NCT00187135|12087114|FG004|STARTED|Visit One||25
10919731|NCT00187135|12087115|FG005|STARTED|Visit One||28
10919732|NCT00187135|12087110|FG000|COMPLETED|Visit One||26
10919733|NCT00187135|12087111|FG001|COMPLETED|Visit One||27
10919734|NCT00187135|12087112|FG002|COMPLETED|Visit One||25
10919735|NCT00187135|12087113|FG003|COMPLETED|Visit One||26
10919736|NCT00187135|12087114|FG004|COMPLETED|Visit One||25
10919737|NCT00187135|12087115|FG005|COMPLETED|Visit One||26
10919738|NCT00187135|12087110|FG000|NOT COMPLETED|Visit One||4
10919739|NCT00187135|12087111|FG001|NOT COMPLETED|Visit One||1
10919740|NCT00187135|12087112|FG002|NOT COMPLETED|Visit One||0
10919741|NCT00187135|12087113|FG003|NOT COMPLETED|Visit One||0
10919742|NCT00187135|12087114|FG004|NOT COMPLETED|Visit One||0
10919743|NCT00187135|12087115|FG005|NOT COMPLETED|Visit One||2
10919744|NCT00187135|12087110|FG000|STARTED|Visit Two||26
10919745|NCT00187135|12087111|FG001|STARTED|Visit Two||27
10919746|NCT00187135|12087112|FG002|STARTED|Visit Two||25
10919747|NCT00187135|12087113|FG003|STARTED|Visit Two||26
10919748|NCT00187135|12087114|FG004|STARTED|Visit Two||25
10919749|NCT00187135|12087115|FG005|STARTED|Visit Two||26
10919750|NCT00187135|12087110|FG000|COMPLETED|Visit Two||21
10919751|NCT00187135|12087111|FG001|COMPLETED|Visit Two||24
10919752|NCT00187135|12087112|FG002|COMPLETED|Visit Two||23
10919753|NCT00187135|12087113|FG003|COMPLETED|Visit Two||18
10919754|NCT00187135|12087114|FG004|COMPLETED|Visit Two||19
10919755|NCT00187135|12087115|FG005|COMPLETED|Visit Two||18
10919756|NCT00187135|12087110|FG000|NOT COMPLETED|Visit Two||5
10919757|NCT00187135|12087111|FG001|NOT COMPLETED|Visit Two||3
10919758|NCT00187135|12087112|FG002|NOT COMPLETED|Visit Two||2
10919759|NCT00187135|12087113|FG003|NOT COMPLETED|Visit Two||8
10919760|NCT00187135|12087114|FG004|NOT COMPLETED|Visit Two||6
10919761|NCT00187135|12087115|FG005|NOT COMPLETED|Visit Two||8
10919762|NCT00187135|12087110|FG000|STARTED|Visit Three||21
10919763|NCT00187135|12087111|FG001|STARTED|Visit Three||24
10919764|NCT00187135|12087112|FG002|STARTED|Visit Three||23
10919765|NCT00187135|12087113|FG003|STARTED|Visit Three||18
10919766|NCT00187135|12087114|FG004|STARTED|Visit Three||19
10919767|NCT00187135|12087115|FG005|STARTED|Visit Three||18
10919768|NCT00187135|12087110|FG000|COMPLETED|Visit Three||14
10919769|NCT00187135|12087111|FG001|COMPLETED|Visit Three||17
10919770|NCT00187135|12087112|FG002|COMPLETED|Visit Three||14
10919771|NCT00187135|12087113|FG003|COMPLETED|Visit Three||9
10919772|NCT00187135|12087114|FG004|COMPLETED|Visit Three||11
10919773|NCT00187135|12087115|FG005|COMPLETED|Visit Three||12
10919774|NCT00187135|12087110|FG000|NOT COMPLETED|Visit Three||7
10919775|NCT00187135|12087111|FG001|NOT COMPLETED|Visit Three||7
10919776|NCT00187135|12087112|FG002|NOT COMPLETED|Visit Three||9
10919777|NCT00187135|12087113|FG003|NOT COMPLETED|Visit Three||9
10919778|NCT00187135|12087114|FG004|NOT COMPLETED|Visit Three||8
10919779|NCT00187135|12087115|FG005|NOT COMPLETED|Visit Three||6
10919780|NCT00187200|12087129|FG000|STARTED|Overall Study||49
10919781|NCT00187200|12087130|FG001|STARTED|Overall Study||44
10919782|NCT00187200|12087129|FG000|COMPLETED|Overall Study||31
10919783|NCT00187200|12087130|FG001|COMPLETED|Overall Study||26
10919784|NCT00187200|12087129|FG000|NOT COMPLETED|Overall Study||18
10919785|NCT00187200|12087130|FG001|NOT COMPLETED|Overall Study||18
10919786|NCT00187278|12087140|FG000|STARTED|Overall Study||918
10919787|NCT00187278|12087141|FG001|STARTED|Overall Study||915
10919788|NCT00187278|12087140|FG000|COMPLETED|Overall Study||908
10919789|NCT00187278|12087141|FG001|COMPLETED|Overall Study||902
10919790|NCT00187278|12087140|FG000|NOT COMPLETED|Overall Study||10
10919791|NCT00187278|12087141|FG001|NOT COMPLETED|Overall Study||13
10919792|NCT00187369|12087151|FG000|STARTED|Mothers||1398
10919793|NCT00187369|12087152|FG001|STARTED|Mothers||1406
10919794|NCT00187369|12087151|FG000|Included in the Study|Mothers||1393
10919795|NCT00187369|12087152|FG001|Included in the Study|Mothers||1393
10919796|NCT00187369|12087151|FG000|COMPLETED|Mothers||1392
10919797|NCT00187369|12087152|FG001|COMPLETED|Mothers||1392
10919798|NCT00187369|12087151|FG000|NOT COMPLETED|Mothers||6
10919799|NCT00187369|12087152|FG001|NOT COMPLETED|Mothers||14
10919800|NCT00187369|12087151|FG000|STARTED|Fetuses or Infants||2795
10919801|NCT00187369|12087152|FG001|STARTED|Fetuses or Infants||2812
10919802|NCT00187369|12087151|FG000|Included in the Study|Fetuses or Infants||2785
10919803|NCT00187369|12087152|FG001|Included in the Study|Fetuses or Infants||2786
10919804|NCT00187369|12087151|FG000|COMPLETED|Fetuses or Infants||2783
10919805|NCT00187369|12087152|FG001|COMPLETED|Fetuses or Infants||2782
10919806|NCT00187369|12087151|FG000|NOT COMPLETED|Fetuses or Infants||12
10919807|NCT00187369|12087152|FG001|NOT COMPLETED|Fetuses or Infants||30
10919808|NCT00187486|12087164|FG000|STARTED|Overall Study||66
10919809|NCT00187486|12087164|FG000|COMPLETED|Overall Study||65
10919810|NCT00187486|12087164|FG000|NOT COMPLETED|Overall Study||1
10919811|NCT00187655|12087168|FG000|STARTED|Overall Study||24
10919812|NCT00187655|12087168|FG000|COMPLETED|Overall Study||24
10919813|NCT00187655|12087168|FG000|NOT COMPLETED|Overall Study||0
10919814|NCT00187681|12087175|FG000|STARTED|Overall Study||12
10919815|NCT00187681|12087176|FG001|STARTED|Overall Study||8
10919816|NCT00187681|12087175|FG000|COMPLETED|Overall Study||12
10919817|NCT00187681|12087176|FG001|COMPLETED|Overall Study||8
10919818|NCT00187681|12087175|FG000|NOT COMPLETED|Overall Study||0
10919819|NCT00187681|12087176|FG001|NOT COMPLETED|Overall Study||0
10919820|NCT00187720|12087186|FG000|STARTED|Overall Study||9
10919821|NCT00187720|12087187|FG001|STARTED|Overall Study||14
10919822|NCT00187720|12087186|FG000|COMPLETED|Overall Study||9
10919823|NCT00187720|12087187|FG001|COMPLETED|Overall Study||14
10919824|NCT00187720|12087186|FG000|NOT COMPLETED|Overall Study||0
10919825|NCT00187720|12087187|FG001|NOT COMPLETED|Overall Study||0
10919826|NCT00187876|12087195|FG000|STARTED|Overall Study||24
10919827|NCT00187876|12087196|FG001|STARTED|Overall Study||43
10919828|NCT00187876|12087195|FG000|COMPLETED|Overall Study||24
10919829|NCT00187876|12087196|FG001|COMPLETED|Overall Study||43
10919830|NCT00187876|12087195|FG000|NOT COMPLETED|Overall Study||0
10919831|NCT00187876|12087196|FG001|NOT COMPLETED|Overall Study||0
10919832|NCT00187889|12087204|FG000|STARTED|Overall Study||25
10919833|NCT00187889|12087205|FG001|STARTED|Overall Study||26
10919834|NCT00187889|12087204|FG000|COMPLETED|Overall Study||19
10919835|NCT00187889|12087205|FG001|COMPLETED|Overall Study||22
10919836|NCT00187889|12087204|FG000|NOT COMPLETED|Overall Study||6
10919837|NCT00187889|12087205|FG001|NOT COMPLETED|Overall Study||4
10919838|NCT00189098|12087214|FG000|STARTED|Overall Study||51
10919839|NCT00189098|12087215|FG001|STARTED|Overall Study||50
10919840|NCT00189098|12087214|FG000|COMPLETED|Overall Study||46
10919841|NCT00189098|12087215|FG001|COMPLETED|Overall Study||44
10919842|NCT00189098|12087214|FG000|NOT COMPLETED|Overall Study||5
10919843|NCT00189098|12087215|FG001|NOT COMPLETED|Overall Study||6
10919844|NCT00189137|12087225|FG000|STARTED|Overall Study||37
10919845|NCT00189137|12087226|FG001|STARTED|Overall Study||43
10919846|NCT00189137|12087225|FG000|COMPLETED|Overall Study||37
10919847|NCT00189137|12087226|FG001|COMPLETED|Overall Study||43
10919848|NCT00189137|12087225|FG000|NOT COMPLETED|Overall Study||0
10919849|NCT00189137|12087226|FG001|NOT COMPLETED|Overall Study||0
10919850|NCT00189202|12087232|FG000|STARTED|Overall Study||49
10919851|NCT00189202|12087232|FG000|COMPLETED|Overall Study||44
10919852|NCT00189202|12087232|FG000|NOT COMPLETED|Overall Study||5
10919853|NCT00189228|12087236|FG000|STARTED|Overall Study||18
10919854|NCT00189228|12087236|FG000|COMPLETED|Overall Study||18
10919855|NCT00189228|12087236|FG000|NOT COMPLETED|Overall Study||0
10919856|NCT00189306|12087240|FG000|STARTED|Treatment Period||169
10919857|NCT00189306|12087240|FG000|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
10919858|NCT00189306|12087240|FG000|NOT COMPLETED|Treatment Period||5
10919859|NCT00189306|12087240|FG000|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
10919860|NCT00189306|12087240|FG000|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
10919861|NCT00189306|12087240|FG000|NOT COMPLETED|Posttreatment Period||12
10919862|NCT00189306|12087240|FG000|STARTED|Long-Term Follow-up||157
10919863|NCT00189306|12087240|FG000|COMPLETED|Long-Term Follow-up||119
10919864|NCT00189306|12087240|FG000|NOT COMPLETED|Long-Term Follow-up||38
10919865|NCT00189423|12087246|FG000|STARTED|Overall Study||813
10919866|NCT00189423|12087247|FG001|STARTED|Overall Study||840
10919867|NCT00189423|12087246|FG000|COMPLETED|Overall Study||48
10919868|NCT00189423|12087247|FG001|COMPLETED|Overall Study||74
10919869|NCT00189423|12087246|FG000|NOT COMPLETED|Overall Study||765
10919870|NCT00189423|12087247|FG001|NOT COMPLETED|Overall Study||766
10919871|NCT00189436|12087255|FG000|STARTED|Overall Study||31
10919872|NCT00189436|12087256|FG001|STARTED|Overall Study||30
10919873|NCT00189436|12087255|FG000|COMPLETED|Overall Study||23
10919874|NCT00189436|12087256|FG001|COMPLETED|Overall Study||25
10919875|NCT00189436|12087255|FG000|NOT COMPLETED|Overall Study||8
10919876|NCT00189436|12087256|FG001|NOT COMPLETED|Overall Study||5
10919877|NCT00189462|12087264|FG000|STARTED|Overall Study||50
10919878|NCT00189462|12087265|FG001|STARTED|Overall Study||49
10919879|NCT00189462|12087264|FG000|COMPLETED|Overall Study||27
10919880|NCT00189462|12087265|FG001|COMPLETED|Overall Study||28
10919881|NCT00189462|12087264|FG000|NOT COMPLETED|Overall Study||23
10919882|NCT00189462|12087265|FG001|NOT COMPLETED|Overall Study||21
10919883|NCT00189475|12087273|FG000|STARTED|Overall Study||42
10919884|NCT00189475|12087274|FG001|STARTED|Overall Study||42
10919885|NCT00189475|12087273|FG000|COMPLETED|Overall Study||42
10919886|NCT00189475|12087274|FG001|COMPLETED|Overall Study||42
10919887|NCT00189475|12087273|FG000|NOT COMPLETED|Overall Study||0
10919888|NCT00189475|12087274|FG001|NOT COMPLETED|Overall Study||0
10919889|NCT00189488|12087282|FG000|STARTED|Overall Study||78
10919890|NCT00189488|12087283|FG001|STARTED|Overall Study||77
10919891|NCT00189488|12087282|FG000|Received Palifermin/Placebo|Overall Study||75
10919892|NCT00189488|12087283|FG001|Received Palifermin/Placebo|Overall Study||76
10919893|NCT00189488|12087282|FG000|COMPLETED|Overall Study||63
10919894|NCT00189488|12087283|FG001|COMPLETED|Overall Study||55
10919895|NCT00189488|12087282|FG000|NOT COMPLETED|Overall Study||15
10919896|NCT00189488|12087283|FG001|NOT COMPLETED|Overall Study||22
10919897|NCT00189540|12087292|FG000|STARTED|Overall Study||21
10919898|NCT00189540|12087293|FG001|STARTED|Overall Study||6
10919899|NCT00189540|12087292|FG000|COMPLETED|Overall Study||14
10919900|NCT00189540|12087293|FG001|COMPLETED|Overall Study||5
10919901|NCT00189540|12087292|FG000|NOT COMPLETED|Overall Study||7
10919902|NCT00189540|12087293|FG001|NOT COMPLETED|Overall Study||1
10919903|NCT00190671|12087301|FG000|STARTED|Overall Study||42
10919904|NCT00190671|12087302|FG001|STARTED|Overall Study||61
10919905|NCT00190671|12087301|FG000|COMPLETED|Overall Study||15
10919906|NCT00190671|12087302|FG001|COMPLETED|Overall Study||19
10919907|NCT00190671|12087301|FG000|NOT COMPLETED|Overall Study||27
10919908|NCT00190671|12087302|FG001|NOT COMPLETED|Overall Study||42
10919909|NCT00190684|12087309|FG000|STARTED|Overall Study||1553
10919910|NCT00190684|12087309|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
10919911|NCT00190684|12087309|FG000|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
10919912|NCT00190684|12087309|FG000|NOT COMPLETED|Overall Study||1489
10919913|NCT00190749|12087315|FG000|STARTED|Overall Study||68
10919914|NCT00190749|12087316|FG001|STARTED|Overall Study||62
10919915|NCT00190749|12087315|FG000|COMPLETED|Overall Study||42
10919916|NCT00190749|12087316|FG001|COMPLETED|Overall Study||31
10919917|NCT00190749|12087315|FG000|NOT COMPLETED|Overall Study||26
10919918|NCT00190749|12087316|FG001|NOT COMPLETED|Overall Study||31
10919919|NCT00190775|12087324|FG000|STARTED|Overall Study||268
10919920|NCT00190775|12087325|FG001|STARTED|Overall Study||234
10919921|NCT00190775|12087324|FG000|Received Study Drug|Overall Study||266
10919922|NCT00190775|12087325|FG001|Received Study Drug|Overall Study||234
10919923|NCT00190775|12087324|FG000|COMPLETED|Overall Study||119
10919924|NCT00190775|12087325|FG001|COMPLETED|Overall Study||134
10919925|NCT00190775|12087324|FG000|NOT COMPLETED|Overall Study||149
10919926|NCT00190775|12087325|FG001|NOT COMPLETED|Overall Study||100
10919927|NCT00190983|12087338|FG000|STARTED|Overall Study||29
10919928|NCT00190983|12087338|FG000|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
10919929|NCT00190983|12087338|FG000|NOT COMPLETED|Overall Study||2
10919930|NCT00191100|12087344|FG000|STARTED|Overall Study||259
10919931|NCT00191100|12087345|FG001|STARTED|Overall Study||256
10919932|NCT00191100|12087344|FG000|COMPLETED|Overall Study||217
10919933|NCT00191100|12087345|FG001|COMPLETED|Overall Study||244
10919934|NCT00191100|12087344|FG000|NOT COMPLETED|Overall Study||42
10919935|NCT00191100|12087345|FG001|NOT COMPLETED|Overall Study||12
10919936|NCT00191113|12087353|FG000|STARTED|Core Study||78
10919937|NCT00191113|12087354|FG001|STARTED|Core Study||76
10919938|NCT00191113|12087353|FG000|COMPLETED|Core Study||43
10919939|NCT00191113|12087354|FG001|COMPLETED|Core Study||61
10919940|NCT00191113|12087353|FG000|NOT COMPLETED|Core Study||35
10919941|NCT00191113|12087354|FG001|NOT COMPLETED|Core Study||15
10919942|NCT00191113|12087353|FG000|STARTED|Addendum 1||2
10919943|NCT00191113|12087354|FG001|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
10919944|NCT00191113|12087353|FG000|COMPLETED|Addendum 1||2
10919945|NCT00191113|12087354|FG001|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
10919946|NCT00191113|12087353|FG000|NOT COMPLETED|Addendum 1||0
10919947|NCT00191113|12087354|FG001|NOT COMPLETED|Addendum 1||0
10919948|NCT00191113|12087353|FG000|STARTED|Addendum 2||28
10919949|NCT00191113|12087354|FG001|STARTED|Addendum 2||48
10919950|NCT00191113|12087353|FG000|COMPLETED|Addendum 2||18
10919951|NCT00191113|12087354|FG001|COMPLETED|Addendum 2||31
10919952|NCT00191113|12087353|FG000|NOT COMPLETED|Addendum 2||10
10919953|NCT00191113|12087354|FG001|NOT COMPLETED|Addendum 2||17
10919954|NCT00191113|12087353|FG000|STARTED|Addendum 3||20
10919955|NCT00191113|12087354|FG001|STARTED|Addendum 3||37
10919956|NCT00191113|12087353|FG000|COMPLETED|Addendum 3||20
10919957|NCT00191113|12087354|FG001|COMPLETED|Addendum 3||37
10919958|NCT00191113|12087353|FG000|NOT COMPLETED|Addendum 3||0
10919959|NCT00191113|12087354|FG001|NOT COMPLETED|Addendum 3||0
10919960|NCT00191139|12087368|FG000|STARTED|Overall Study||32
10919961|NCT00191139|12087369|FG001|STARTED|Overall Study||32
10919962|NCT00191139|12087368|FG000|COMPLETED|Overall Study||27
10919963|NCT00191139|12087369|FG001|COMPLETED|Overall Study||20
10919964|NCT00191139|12087368|FG000|NOT COMPLETED|Overall Study||5
10919965|NCT00191139|12087369|FG001|NOT COMPLETED|Overall Study||12
10919966|NCT00191152|12087377|FG000|STARTED|Initial Treatment||239
10919967|NCT00191152|12087378|FG001|STARTED|Initial Treatment||236
10919968|NCT00191152|12087377|FG000|Received Initial Treatment|Initial Treatment||236
10919969|NCT00191152|12087378|FG001|Received Initial Treatment|Initial Treatment||227
10919970|NCT00191152|12087377|FG000|COMPLETED|Initial Treatment||98
10919971|NCT00191152|12087378|FG001|COMPLETED|Initial Treatment||83
10919972|NCT00191152|12087377|FG000|NOT COMPLETED|Initial Treatment||141
10919973|NCT00191152|12087378|FG001|NOT COMPLETED|Initial Treatment||153
10919974|NCT00191152|12087377|FG000|STARTED|Crossover Treatment||77
10919975|NCT00191152|12087378|FG001|STARTED|Crossover Treatment||81
10919976|NCT00191152|12087377|FG000|Received Treatment|Crossover Treatment||76
10919977|NCT00191152|12087378|FG001|Received Treatment|Crossover Treatment||80
10919978|NCT00191152|12087377|FG000|COMPLETED|Crossover Treatment||50
10919979|NCT00191152|12087378|FG001|COMPLETED|Crossover Treatment||53
10919980|NCT00191152|12087377|FG000|NOT COMPLETED|Crossover Treatment||27
10919981|NCT00191152|12087378|FG001|NOT COMPLETED|Crossover Treatment||28
10919982|NCT00191165|12087398|FG000|STARTED|Overall Study||14
10919983|NCT00191165|12087399|FG001|STARTED|Overall Study||13
10919984|NCT00191165|12087398|FG000|COMPLETED|Overall Study||12
10919985|NCT00191165|12087399|FG001|COMPLETED|Overall Study||11
10919986|NCT00191165|12087398|FG000|NOT COMPLETED|Overall Study||2
10919987|NCT00191165|12087399|FG001|NOT COMPLETED|Overall Study||2
10919988|NCT00191191|12087407|FG000|STARTED|Overall Study||114
10919989|NCT00191191|12087408|FG001|STARTED|Overall Study||112
10919990|NCT00191191|12087407|FG000|Safety Analysis Population|Overall Study||114
10919991|NCT00191191|12087408|FG001|Safety Analysis Population|Overall Study||111
10919992|NCT00191191|12087407|FG000|Full Analysis Set Population|Overall Study||108
10919993|NCT00191191|12087408|FG001|Full Analysis Set Population|Overall Study||108
10919994|NCT00191191|12087407|FG000|COMPLETED|Overall Study||0
10919995|NCT00191191|12087408|FG001|COMPLETED|Overall Study||0
10919996|NCT00191191|12087407|FG000|NOT COMPLETED|Overall Study||114
10919997|NCT00191191|12087408|FG001|NOT COMPLETED|Overall Study||112
10919998|NCT00191269|12087416|FG000|STARTED|Overall Study||6
10919999|NCT00191269|12087417|FG001|STARTED|Overall Study||62
10920000|NCT00191269|12087416|FG000|COMPLETED|Overall Study||0
10920001|NCT00191269|12087417|FG001|COMPLETED|Overall Study||4
10920002|NCT00191269|12087416|FG000|NOT COMPLETED|Overall Study||6
10920003|NCT00191269|12087417|FG001|NOT COMPLETED|Overall Study||58
10920004|NCT00191282|12087426|FG000|STARTED|Overall Study||558
10920005|NCT00191282|12087427|FG001|STARTED|Overall Study||558
10920006|NCT00191282|12087426|FG000|COMPLETED|Overall Study||338
10920007|NCT00191282|12087427|FG001|COMPLETED|Overall Study||346
10920008|NCT00191282|12087426|FG000|NOT COMPLETED|Overall Study||220
10920009|NCT00191282|12087427|FG001|NOT COMPLETED|Overall Study||212
10920010|NCT00191308|12087433|FG000|STARTED|Overall Study||30
10920011|NCT00191308|12087433|FG000|COMPLETED|Overall Study||29
10920012|NCT00191308|12087433|FG000|NOT COMPLETED|Overall Study||1
10920013|NCT00191334|12087437|FG000|STARTED|Overall Study||50
10920014|NCT00191334|12087437|FG000|COMPLETED|Overall Study||33
10920015|NCT00191334|12087437|FG000|NOT COMPLETED|Overall Study||17
10920016|NCT00191386|12087441|FG000|STARTED|Overall Study||228
10920017|NCT00191386|12087441|FG000|6 Months|Overall Study||183
10920018|NCT00191386|12087441|FG000|12 Months|Overall Study||149
10920019|NCT00191386|12087441|FG000|2 Years|Overall Study||105
10920020|NCT00191386|12087441|FG000|3 Years|Overall Study||65
10920021|NCT00191386|12087441|FG000|COMPLETED|Overall Study||68
10920022|NCT00191386|12087441|FG000|NOT COMPLETED|Overall Study||160
10920023|NCT00191451|12087448|FG000|STARTED|Overall Study||50
10920024|NCT00191451|12087449|FG001|STARTED|Overall Study||51
10920025|NCT00191451|12087450|FG002|STARTED|Overall Study||49
10920026|NCT00191451|12087448|FG000|Received at Least One Dose of Study Drug|Overall Study||50
10920027|NCT00191451|12087449|FG001|Received at Least One Dose of Study Drug|Overall Study||48
10920028|NCT00191451|12087450|FG002|Received at Least One Dose of Study Drug|Overall Study||47
10920029|NCT00191451|12087448|FG000|COMPLETED|Overall Study||43
10920030|NCT00191451|12087449|FG001|COMPLETED|Overall Study||37
10920031|NCT00191451|12087450|FG002|COMPLETED|Overall Study||35
10920032|NCT00191451|12087448|FG000|NOT COMPLETED|Overall Study||7
10920033|NCT00191451|12087449|FG001|NOT COMPLETED|Overall Study||14
10920034|NCT00191451|12087450|FG002|NOT COMPLETED|Overall Study||14
10920035|NCT00191477|12087460|FG000|STARTED|Overall Study||179
10920036|NCT00191477|12087461|FG001|STARTED|Overall Study||176
10920037|NCT00191477|12087460|FG000|Received Study Drug|Overall Study||166
10920038|NCT00191477|12087461|FG001|Received Study Drug|Overall Study||162
10920039|NCT00191477|12087460|FG000|COMPLETED|Overall Study||41
10920040|NCT00191477|12087461|FG001|COMPLETED|Overall Study||47
10920041|NCT00191477|12087460|FG000|NOT COMPLETED|Overall Study||138
10920042|NCT00191477|12087461|FG001|NOT COMPLETED|Overall Study||129
10920043|NCT00191646|12087469|FG000|STARTED|Overall Study||417
10920044|NCT00191646|12087470|FG001|STARTED|Overall Study||414
10920045|NCT00191646|12087469|FG000|Received Induction Therapy|Overall Study||411
10920046|NCT00191646|12087470|FG001|Received Induction Therapy|Overall Study||409
10920047|NCT00191646|12087469|FG000|Received Consolidation Therapy|Overall Study||169
10920048|NCT00191646|12087470|FG001|Received Consolidation Therapy|Overall Study||183
10920049|NCT00191646|12087469|FG000|Received Crossover Therapy|Overall Study||77
10920050|NCT00191646|12087470|FG001|Received Crossover Therapy|Overall Study||78
10920051|NCT00191646|12087469|FG000|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
10920052|NCT00191646|12087470|FG001|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
10920053|NCT00191646|12087469|FG000|NOT COMPLETED|Overall Study||171
10920054|NCT00191646|12087470|FG001|NOT COMPLETED|Overall Study||153
10920055|NCT00191724|12087489|FG000|STARTED|Overall Study||6
10920056|NCT00191724|12087490|FG001|STARTED|Overall Study||9
10920057|NCT00191724|12087491|FG002|STARTED|Overall Study||9
10920058|NCT00191724|12087492|FG003|STARTED|Overall Study||8
10920059|NCT00191724|12087493|FG004|STARTED|Overall Study||15
10920060|NCT00191724|12087489|FG000|COMPLETED|Overall Study||5
10920061|NCT00191724|12087490|FG001|COMPLETED|Overall Study||8
10920062|NCT00191724|12087491|FG002|COMPLETED|Overall Study||8
10920063|NCT00191724|12087492|FG003|COMPLETED|Overall Study||5
10920064|NCT00191724|12087493|FG004|COMPLETED|Overall Study||12
10920065|NCT00191724|12087489|FG000|NOT COMPLETED|Overall Study||1
10920066|NCT00191724|12087490|FG001|NOT COMPLETED|Overall Study||1
10920067|NCT00191724|12087491|FG002|NOT COMPLETED|Overall Study||1
10920068|NCT00191724|12087492|FG003|NOT COMPLETED|Overall Study||3
10920069|NCT00191724|12087493|FG004|NOT COMPLETED|Overall Study||3
10920070|NCT00191789|12087505|FG000|STARTED|Overall Study||65
10920071|NCT00191789|12087505|FG000|COMPLETED|Overall Study||40
10920072|NCT00191789|12087505|FG000|NOT COMPLETED|Overall Study||25
10920073|NCT00191815|12087509|FG000|STARTED|Overall Study||70
10920074|NCT00191815|12087509|FG000|Treated|Overall Study||67
10920075|NCT00191815|12087509|FG000|COMPLETED|Overall Study||30
10920076|NCT00191815|12087509|FG000|NOT COMPLETED|Overall Study||40
10920077|NCT00191854|12087516|FG000|STARTED|Overall Study||49
10920078|NCT00191854|12087517|FG001|STARTED|Overall Study||47
10920079|NCT00191854|12087518|FG002|STARTED|Overall Study||51
10920080|NCT00191854|12087516|FG000|Received at Least One Dose of Study Drug|Overall Study||49
10920081|NCT00191854|12087517|FG001|Received at Least One Dose of Study Drug|Overall Study||47
10920082|NCT00191854|12087518|FG002|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
10920083|NCT00191854|12087516|FG000|COMPLETED|Overall Study||12
10920084|NCT00191854|12087517|FG001|COMPLETED|Overall Study||17
10920085|NCT00191854|12087518|FG002|COMPLETED|Overall Study||12
10920086|NCT00191854|12087516|FG000|NOT COMPLETED|Overall Study||37
10920087|NCT00191854|12087517|FG001|NOT COMPLETED|Overall Study||30
10920088|NCT00191854|12087518|FG002|NOT COMPLETED|Overall Study||39
10920089|NCT00191906|12087530|FG000|STARTED|Study Period II||39
10920090|NCT00191906|12087531|FG001|STARTED|Study Period II||37
10920091|NCT00191906|12087532|FG002|STARTED|Study Period II||27
10920092|NCT00191906|12087533|FG003|STARTED|Study Period II||18
10920093|NCT00191906|12087530|FG000|COMPLETED|Study Period II||39
10920094|NCT00191906|12087531|FG001|COMPLETED|Study Period II||32
10920095|NCT00191906|12087532|FG002|COMPLETED|Study Period II||26
10920096|NCT00191906|12087533|FG003|COMPLETED|Study Period II||18
10920097|NCT00191906|12087530|FG000|NOT COMPLETED|Study Period II||0
10920098|NCT00191906|12087531|FG001|NOT COMPLETED|Study Period II||5
10920099|NCT00191906|12087532|FG002|NOT COMPLETED|Study Period II||1
10920100|NCT00191906|12087533|FG003|NOT COMPLETED|Study Period II||0
10920101|NCT00191906|12087530|FG000|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
10920102|NCT00191906|12087531|FG001|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
10920103|NCT00191906|12087532|FG002|STARTED|Study Period III||0
10920104|NCT00191906|12087533|FG003|STARTED|Study Period III||0
10920105|NCT00191906|12087530|FG000|COMPLETED|Study Period III||9
10920106|NCT00191906|12087531|FG001|COMPLETED|Study Period III||7
10920107|NCT00191906|12087532|FG002|COMPLETED|Study Period III||0
10920108|NCT00191906|12087533|FG003|COMPLETED|Study Period III||0
10920109|NCT00191906|12087530|FG000|NOT COMPLETED|Study Period III||5
10920110|NCT00191906|12087531|FG001|NOT COMPLETED|Study Period III||4
10920111|NCT00191906|12087532|FG002|NOT COMPLETED|Study Period III||0
10920112|NCT00191906|12087533|FG003|NOT COMPLETED|Study Period III||0
10920113|NCT00191945|12087551|FG000|STARTED|Double-Blind Acute Treatment||100
10920114|NCT00191945|12087552|FG001|STARTED|Double-Blind Acute Treatment||51
10920115|NCT00191945|12087551|FG000|COMPLETED|Double-Blind Acute Treatment||94
10920116|NCT00191945|12087552|FG001|COMPLETED|Double-Blind Acute Treatment||48
10920117|NCT00191945|12087551|FG000|NOT COMPLETED|Double-Blind Acute Treatment||6
10920118|NCT00191945|12087552|FG001|NOT COMPLETED|Double-Blind Acute Treatment||3
10920119|NCT00191945|12087551|FG000|STARTED|Open-Label Treatment Extension||94
10920120|NCT00191945|12087552|FG001|STARTED|Open-Label Treatment Extension||48
10920121|NCT00191945|12087551|FG000|COMPLETED|Open-Label Treatment Extension||94
10920122|NCT00191945|12087552|FG001|COMPLETED|Open-Label Treatment Extension||48
10920123|NCT00191945|12087551|FG000|NOT COMPLETED|Open-Label Treatment Extension||0
10920124|NCT00191945|12087552|FG001|NOT COMPLETED|Open-Label Treatment Extension||0
10920125|NCT00191984|12087559|FG000|STARTED|Overall Study||46
10920126|NCT00191984|12087559|FG000|COMPLETED|Overall Study||7
10920127|NCT00191984|12087559|FG000|NOT COMPLETED|Overall Study||39
10920128|NCT00192023|12087565|FG000|STARTED|Period III - Double-Blind||107
10920129|NCT00192023|12087566|FG001|STARTED|Period III - Double-Blind||32
10920130|NCT00192023|12087565|FG000|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
10920131|NCT00192023|12087566|FG001|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
10920132|NCT00192023|12087565|FG000|NOT COMPLETED|Period III - Double-Blind||7
10920133|NCT00192023|12087566|FG001|NOT COMPLETED|Period III - Double-Blind||0
10920134|NCT00192023|12087565|FG000|STARTED|Period IV - Optional Open-Label||124
10920135|NCT00192023|12087566|FG001|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
10920136|NCT00192023|12087565|FG000|COMPLETED|Period IV - Optional Open-Label||49
10920137|NCT00192023|12087566|FG001|COMPLETED|Period IV - Optional Open-Label||0
10920138|NCT00192023|12087565|FG000|NOT COMPLETED|Period IV - Optional Open-Label||75
10920139|NCT00192023|12087566|FG001|NOT COMPLETED|Period IV - Optional Open-Label||0
10920140|NCT00192036|12087572|FG000|STARTED|Overall Study||49
10920141|NCT00192036|12087572|FG000|COMPLETED|Overall Study||28
10920142|NCT00192036|12087572|FG000|NOT COMPLETED|Overall Study||21
10920143|NCT00192075|12087578|FG000|STARTED|Overall Study||42
10920144|NCT00192075|12087579|FG001|STARTED|Overall Study||42
10920145|NCT00192075|12087578|FG000|COMPLETED|Overall Study||3
10920146|NCT00192075|12087579|FG001|COMPLETED|Overall Study||23
10920147|NCT00192075|12087578|FG000|NOT COMPLETED|Overall Study||39
10920148|NCT00192075|12087579|FG001|NOT COMPLETED|Overall Study||19
10920149|NCT00192114|12087590|FG000|STARTED|Overall Study||28
10920150|NCT00192114|12087590|FG000|Received at Least 1 Dose of Study Drug|Overall Study||28
10920151|NCT00192114|12087590|FG000|COMPLETED|Overall Study||4
10920152|NCT00192114|12087590|FG000|NOT COMPLETED|Overall Study||24
10920153|NCT00192296|12087598|FG000|STARTED|Overall Study||6
10920154|NCT00192296|12087599|FG001|STARTED|Overall Study||6
10920155|NCT00192296|12087600|FG002|STARTED|Overall Study||6
10920156|NCT00192296|12087601|FG003|STARTED|Overall Study||6
10920157|NCT00192296|12087598|FG000|COMPLETED|Overall Study||6
10920158|NCT00192296|12087599|FG001|COMPLETED|Overall Study||5
10920159|NCT00192296|12087600|FG002|COMPLETED|Overall Study||6
10920160|NCT00192296|12087601|FG003|COMPLETED|Overall Study||6
10920161|NCT00192296|12087598|FG000|NOT COMPLETED|Overall Study||0
10920162|NCT00192296|12087599|FG001|NOT COMPLETED|Overall Study||1
10920163|NCT00192296|12087600|FG002|NOT COMPLETED|Overall Study||0
10920164|NCT00192296|12087601|FG003|NOT COMPLETED|Overall Study||0
10920165|NCT00192504|12087615|FG000|STARTED|Overall Study||5
10920166|NCT00192504|12087616|FG001|STARTED|Overall Study||5
10920167|NCT00192504|12087617|FG002|STARTED|Overall Study|Baseline demographics are not available on one patient who did not receive study drug.|6
10920168|NCT00192504|12087618|FG003|STARTED|Overall Study||15
10920169|NCT00192504|12087615|FG000|COMPLETED|Overall Study||4
10920170|NCT00192504|12087616|FG001|COMPLETED|Overall Study||5
10920171|NCT00192504|12087617|FG002|COMPLETED|Overall Study||5
10920172|NCT00192504|12087618|FG003|COMPLETED|Overall Study||15
10920173|NCT00192504|12087615|FG000|NOT COMPLETED|Overall Study||1
10920174|NCT00192504|12087616|FG001|NOT COMPLETED|Overall Study||0
10920175|NCT00192504|12087617|FG002|NOT COMPLETED|Overall Study||1
10920176|NCT00192504|12087618|FG003|NOT COMPLETED|Overall Study||0
10920177|NCT00192647|12087630|FG000|STARTED|Overall Study||448
10920178|NCT00192647|12087631|FG001|STARTED|Overall Study||448
10920179|NCT00192647|12087630|FG000|Treated|Overall Study||433
10920180|NCT00192647|12087631|FG001|Treated|Overall Study||438
10920181|NCT00192647|12087630|FG000|COMPLETED|Overall Study||320
10920182|NCT00192647|12087631|FG001|COMPLETED|Overall Study||302
10920183|NCT00192647|12087630|FG000|NOT COMPLETED|Overall Study||128
10920184|NCT00192647|12087631|FG001|NOT COMPLETED|Overall Study||146
10920185|NCT00193037|12087639|FG000|STARTED|Randomized Treatment||50
10920186|NCT00193037|12087640|FG001|STARTED|Randomized Treatment||52
10920187|NCT00193037|12087639|FG000|COMPLETED|Randomized Treatment||32
10920188|NCT00193037|12087640|FG001|COMPLETED|Randomized Treatment||24
10920189|NCT00193037|12087639|FG000|NOT COMPLETED|Randomized Treatment||18
10920190|NCT00193037|12087640|FG001|NOT COMPLETED|Randomized Treatment||28
10920191|NCT00193037|12087639|FG000|STARTED|Crossover Treatment||32
10920192|NCT00193037|12087640|FG001|STARTED|Crossover Treatment||24
10920193|NCT00193037|12087639|FG000|COMPLETED|Crossover Treatment||32
10920194|NCT00193037|12087640|FG001|COMPLETED|Crossover Treatment||24
10920195|NCT00193037|12087639|FG000|NOT COMPLETED|Crossover Treatment||0
10920196|NCT00193037|12087640|FG001|NOT COMPLETED|Crossover Treatment||0
10920197|NCT00193050|12087646|FG000|STARTED|Neoadjuvant Treatment||110
10920198|NCT00193050|12087646|FG000|COMPLETED|Neoadjuvant Treatment||101
10920199|NCT00193050|12087646|FG000|NOT COMPLETED|Neoadjuvant Treatment||9
10920200|NCT00193050|12087646|FG000|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
10920201|NCT00193050|12087646|FG000|COMPLETED|Surgery||103
10920202|NCT00193050|12087646|FG000|NOT COMPLETED|Surgery||0
10920203|NCT00193050|12087646|FG000|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
10920204|NCT00193050|12087646|FG000|COMPLETED|Adjuvant||77
10920205|NCT00193050|12087646|FG000|NOT COMPLETED|Adjuvant||10
10920206|NCT00193063|12087651|FG000|STARTED|Overall Study||41
10920207|NCT00193063|12087651|FG000|COMPLETED|Overall Study||37
10920208|NCT00193063|12087651|FG000|NOT COMPLETED|Overall Study||4
10920209|NCT00193128|12087657|FG000|STARTED|Overall Study||10
10920210|NCT00193128|12087658|FG001|STARTED|Overall Study||49
10920211|NCT00193128|12087657|FG000|COMPLETED|Overall Study||10
10920212|NCT00193128|12087658|FG001|COMPLETED|Overall Study||39
10920213|NCT00193128|12087657|FG000|NOT COMPLETED|Overall Study||0
10920214|NCT00193128|12087658|FG001|NOT COMPLETED|Overall Study||10
10920215|NCT00193180|12087666|FG000|STARTED|Overall Study||37
10920216|NCT00193180|12087666|FG000|COMPLETED|Overall Study||27
10920217|NCT00193180|12087666|FG000|NOT COMPLETED|Overall Study||10
10920218|NCT00193206|12087671|FG000|STARTED|Preoperative Therapy||123
10920219|NCT00193206|12087671|FG000|COMPLETED|Preoperative Therapy||116
10920220|NCT00193206|12087671|FG000|NOT COMPLETED|Preoperative Therapy||7
10920221|NCT00193206|12087671|FG000|STARTED|Surgery||116
10920222|NCT00193206|12087671|FG000|COMPLETED|Surgery||116
10920223|NCT00193206|12087671|FG000|NOT COMPLETED|Surgery||0
10920224|NCT00193206|12087671|FG000|STARTED|Postoperative Therapy||116
10920225|NCT00193206|12087671|FG000|COMPLETED|Postoperative Therapy||102
10920226|NCT00193206|12087671|FG000|NOT COMPLETED|Postoperative Therapy||14
10920227|NCT00193258|12087675|FG000|STARTED|Overall Study||94
10920228|NCT00193258|12087675|FG000|COMPLETED|Overall Study||94
10920229|NCT00193258|12087675|FG000|NOT COMPLETED|Overall Study||0
10920230|NCT00193375|12087679|FG000|STARTED|Overall Study||60
10920231|NCT00193375|12087679|FG000|COMPLETED|Overall Study||41
10920232|NCT00193375|12087679|FG000|NOT COMPLETED|Overall Study||19
10920233|NCT00193453|12087683|FG000|STARTED|Overall Study||69
10920234|NCT00193453|12087683|FG000|COMPLETED|Overall Study||21
10920235|NCT00193453|12087683|FG000|NOT COMPLETED|Overall Study||48
10920236|NCT00193492|12087689|FG000|STARTED|Overall Study||31
10920237|NCT00193492|12087690|FG001|STARTED|Overall Study||29
10920238|NCT00193492|12087689|FG000|COMPLETED|Overall Study||14
10920239|NCT00193492|12087690|FG001|COMPLETED|Overall Study||14
10920240|NCT00193492|12087689|FG000|NOT COMPLETED|Overall Study||17
10920241|NCT00193492|12087690|FG001|NOT COMPLETED|Overall Study||15
10920242|NCT00193596|12087698|FG000|STARTED|Overall Study||93
10920243|NCT00193596|12087699|FG001|STARTED|Overall Study||105
10920244|NCT00193596|12087698|FG000|COMPLETED|Overall Study||37
10920245|NCT00193596|12087699|FG001|COMPLETED|Overall Study||39
10920246|NCT00193596|12087698|FG000|NOT COMPLETED|Overall Study||56
10920247|NCT00193596|12087699|FG001|NOT COMPLETED|Overall Study||66
10920248|NCT00193609|12087705|FG000|STARTED|Overall Study||48
10920249|NCT00193609|12087705|FG000|COMPLETED|Overall Study||44
10920250|NCT00193609|12087705|FG000|NOT COMPLETED|Overall Study||4
10920251|NCT00194012|12087711|FG000|STARTED|Randomized Phase||31
10920252|NCT00194012|12087712|FG001|STARTED|Randomized Phase||31
10920253|NCT00194012|12087711|FG000|Received More Than One Dose|Randomized Phase||30
10920254|NCT00194012|12087712|FG001|Received More Than One Dose|Randomized Phase||29
10920255|NCT00194012|12087711|FG000|COMPLETED|Randomized Phase||15
10920256|NCT00194012|12087712|FG001|COMPLETED|Randomized Phase||6
10920257|NCT00194012|12087711|FG000|NOT COMPLETED|Randomized Phase||16
10920258|NCT00194012|12087712|FG001|NOT COMPLETED|Randomized Phase||25
10920259|NCT00194012|12087711|FG000|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
10920260|NCT00194012|12087712|FG001|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
10920261|NCT00194012|12087711|FG000|COMPLETED|Open Label Extension (OLE)||17
10920262|NCT00194012|12087712|FG001|COMPLETED|Open Label Extension (OLE)||15
10920263|NCT00194012|12087711|FG000|NOT COMPLETED|Open Label Extension (OLE)||5
10920264|NCT00194012|12087712|FG001|NOT COMPLETED|Open Label Extension (OLE)||6
10920265|NCT00194025|12087724|FG000|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
10920266|NCT00194025|12087724|FG000|COMPLETED|Overall Study|5 participants withdrew prematurely|15
10920267|NCT00194025|12087724|FG000|NOT COMPLETED|Overall Study||5
10920268|NCT00194077|12087730|FG000|STARTED|Overall Study||30
10920269|NCT00194077|12087731|FG001|STARTED|Overall Study||30
10920270|NCT00194077|12087730|FG000|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
10920271|NCT00194077|12087731|FG001|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
10920272|NCT00194077|12087730|FG000|NOT COMPLETED|Overall Study||24
10920273|NCT00194077|12087731|FG001|NOT COMPLETED|Overall Study||30
10920274|NCT00194116|12087739|FG000|STARTED|Overall Study||26
10920275|NCT00194116|12087740|FG001|STARTED|Overall Study||28
10920276|NCT00194116|12087739|FG000|COMPLETED|Overall Study||13
10920277|NCT00194116|12087740|FG001|COMPLETED|Overall Study||13
10920278|NCT00194116|12087739|FG000|NOT COMPLETED|Overall Study||13
10920279|NCT00194116|12087740|FG001|NOT COMPLETED|Overall Study||15
10920280|NCT00194129|12087748|FG000|STARTED|Overall Study||15
10920281|NCT00194129|12087749|FG001|STARTED|Overall Study||16
10920282|NCT00194129|12087748|FG000|COMPLETED|Overall Study||5
10920283|NCT00194129|12087749|FG001|COMPLETED|Overall Study||3
10920284|NCT00194129|12087748|FG000|NOT COMPLETED|Overall Study||10
10920285|NCT00194129|12087749|FG001|NOT COMPLETED|Overall Study||13
10920286|NCT00194532|12087764|FG000|STARTED|Overall Study||150
10920287|NCT00194532|12087765|FG001|STARTED|Overall Study||150
10920288|NCT00194532|12087764|FG000|COMPLETED|Overall Study||150
10920289|NCT00194532|12087765|FG001|COMPLETED|Overall Study||150
10920290|NCT00194532|12087764|FG000|NOT COMPLETED|Overall Study||0
10920291|NCT00194532|12087765|FG001|NOT COMPLETED|Overall Study||0
10920292|NCT00194610|12087773|FG000|STARTED|Overall Study||11
10920293|NCT00194610|12087774|FG001|STARTED|Overall Study||9
10920294|NCT00194610|12087773|FG000|COMPLETED|Overall Study||11
10920295|NCT00194610|12087774|FG001|COMPLETED|Overall Study||9
10920296|NCT00194610|12087773|FG000|NOT COMPLETED|Overall Study||0
10920297|NCT00194610|12087774|FG001|NOT COMPLETED|Overall Study||0
10920298|NCT00194675|12087782|FG000|STARTED|Overall Study||27
10920299|NCT00194675|12087783|FG001|STARTED|Overall Study||26
10920300|NCT00194675|12087782|FG000|COMPLETED|Overall Study||22
10920301|NCT00194675|12087783|FG001|COMPLETED|Overall Study||24
10920302|NCT00194675|12087782|FG000|NOT COMPLETED|Overall Study||5
10920303|NCT00194675|12087783|FG001|NOT COMPLETED|Overall Study||2
10920304|NCT00194779|12087791|FG000|STARTED|Overall Study||50
10920305|NCT00194779|12087791|FG000|COMPLETED|Overall Study||50
10920306|NCT00194779|12087791|FG000|NOT COMPLETED|Overall Study||0
10920307|NCT00194792|12087795|FG000|STARTED|Overall Study||28
10920308|NCT00194792|12087795|FG000|COMPLETED|Overall Study||27
10920309|NCT00194792|12087795|FG000|NOT COMPLETED|Overall Study||1
10920310|NCT00194896|12087803|FG000|STARTED|Overall Study||15
10920311|NCT00194896|12087804|FG001|STARTED|Overall Study||15
10920312|NCT00194896|12087805|FG002|STARTED|Overall Study||13
10920313|NCT00194896|12087806|FG003|STARTED|Overall Study||21
10920314|NCT00194896|12087803|FG000|COMPLETED|Overall Study||4
10920315|NCT00194896|12087804|FG001|COMPLETED|Overall Study||10
10920316|NCT00194896|12087805|FG002|COMPLETED|Overall Study||7
10920317|NCT00194896|12087806|FG003|COMPLETED|Overall Study||9
10920318|NCT00194896|12087803|FG000|NOT COMPLETED|Overall Study||11
10920319|NCT00194896|12087804|FG001|NOT COMPLETED|Overall Study||5
10920320|NCT00194896|12087805|FG002|NOT COMPLETED|Overall Study||6
10920321|NCT00194896|12087806|FG003|NOT COMPLETED|Overall Study||12
10920322|NCT00194987|12087818|FG000|STARTED|Overall Study||51
10920323|NCT00194987|12087819|FG001|STARTED|Overall Study||51
10920324|NCT00194987|12087818|FG000|COMPLETED|Overall Study||51
10920325|NCT00194987|12087819|FG001|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
10920326|NCT00194987|12087818|FG000|NOT COMPLETED|Overall Study||0
10920327|NCT00194987|12087819|FG001|NOT COMPLETED|Overall Study||3
10920328|NCT00195013|12087829|FG000|STARTED|Overall Study||14
10920329|NCT00195013|12087830|FG001|STARTED|Overall Study||16
10920330|NCT00195013|12087829|FG000|COMPLETED|Overall Study||12
10920331|NCT00195013|12087830|FG001|COMPLETED|Overall Study||15
10920332|NCT00195013|12087829|FG000|NOT COMPLETED|Overall Study||2
10920333|NCT00195013|12087830|FG001|NOT COMPLETED|Overall Study||1
10920334|NCT00195039|12087836|FG000|STARTED|Overall Study||47
10920335|NCT00195039|12087836|FG000|COMPLETED|Overall Study||47
10920336|NCT00195039|12087836|FG000|NOT COMPLETED|Overall Study||0
10920337|NCT00195260|12087842|FG000|STARTED|Part 1: Dose Escalation||4
10920338|NCT00195260|12087843|FG001|STARTED|Part 1: Dose Escalation||4
10920339|NCT00195260|12087844|FG002|STARTED|Part 1: Dose Escalation||6
10920340|NCT00195260|12087845|FG003|STARTED|Part 1: Dose Escalation||7
10920341|NCT00195260|12087846|FG004|STARTED|Part 1: Dose Escalation||7
10920342|NCT00195260|12087847|FG005|STARTED|Part 1: Dose Escalation||7
10920343|NCT00195260|12087848|FG006|STARTED|Part 1: Dose Escalation||10
10920344|NCT00195260|12087849|FG007|STARTED|Part 1: Dose Escalation||6
10920345|NCT00195260|12087850|FG008|STARTED|Part 1: Dose Escalation||0
10920346|NCT00195260|12087851|FG009|STARTED|Part 1: Dose Escalation||0
10920347|NCT00195260|12087852|FG010|STARTED|Part 1: Dose Escalation||0
10920348|NCT00195260|12087842|FG000|COMPLETED|Part 1: Dose Escalation||0
10920349|NCT00195260|12087843|FG001|COMPLETED|Part 1: Dose Escalation||0
10920350|NCT00195260|12087844|FG002|COMPLETED|Part 1: Dose Escalation||0
10920351|NCT00195260|12087845|FG003|COMPLETED|Part 1: Dose Escalation||0
10920352|NCT00195260|12087846|FG004|COMPLETED|Part 1: Dose Escalation||0
10920353|NCT00195260|12087847|FG005|COMPLETED|Part 1: Dose Escalation||0
10920354|NCT00195260|12087848|FG006|COMPLETED|Part 1: Dose Escalation||0
10920355|NCT00195260|12087849|FG007|COMPLETED|Part 1: Dose Escalation||0
10920356|NCT00195260|12087850|FG008|COMPLETED|Part 1: Dose Escalation||0
10920357|NCT00195260|12087851|FG009|COMPLETED|Part 1: Dose Escalation||0
10920358|NCT00195260|12087852|FG010|COMPLETED|Part 1: Dose Escalation||0
10920359|NCT00195260|12087842|FG000|NOT COMPLETED|Part 1: Dose Escalation||4
10920360|NCT00195260|12087843|FG001|NOT COMPLETED|Part 1: Dose Escalation||4
10920361|NCT00195260|12087844|FG002|NOT COMPLETED|Part 1: Dose Escalation||6
10920362|NCT00195260|12087845|FG003|NOT COMPLETED|Part 1: Dose Escalation||7
10920363|NCT00195260|12087846|FG004|NOT COMPLETED|Part 1: Dose Escalation||7
10920364|NCT00195260|12087847|FG005|NOT COMPLETED|Part 1: Dose Escalation||7
10920365|NCT00195260|12087848|FG006|NOT COMPLETED|Part 1: Dose Escalation||10
10920366|NCT00195260|12087849|FG007|NOT COMPLETED|Part 1: Dose Escalation||6
10920367|NCT00195260|12087850|FG008|NOT COMPLETED|Part 1: Dose Escalation||0
10920368|NCT00195260|12087851|FG009|NOT COMPLETED|Part 1: Dose Escalation||0
10920369|NCT00195260|12087852|FG010|NOT COMPLETED|Part 1: Dose Escalation||0
10920370|NCT00195260|12087842|FG000|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920371|NCT00195260|12087843|FG001|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920372|NCT00195260|12087844|FG002|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920373|NCT00195260|12087845|FG003|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920374|NCT00195260|12087846|FG004|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920375|NCT00195260|12087847|FG005|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920376|NCT00195260|12087848|FG006|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920377|NCT00195260|12087849|FG007|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920378|NCT00195260|12087850|FG008|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
10920379|NCT00195260|12087851|FG009|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
10920380|NCT00195260|12087852|FG010|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
10920381|NCT00195260|12087842|FG000|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920382|NCT00195260|12087843|FG001|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920383|NCT00195260|12087844|FG002|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920384|NCT00195260|12087845|FG003|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920385|NCT00195260|12087846|FG004|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920386|NCT00195260|12087847|FG005|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920387|NCT00195260|12087848|FG006|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920388|NCT00195260|12087849|FG007|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920389|NCT00195260|12087850|FG008|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
10920390|NCT00195260|12087851|FG009|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920391|NCT00195260|12087852|FG010|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
10920392|NCT00195260|12087842|FG000|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920393|NCT00195260|12087843|FG001|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920394|NCT00195260|12087844|FG002|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920395|NCT00195260|12087845|FG003|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920396|NCT00195260|12087846|FG004|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920397|NCT00195260|12087847|FG005|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920398|NCT00195260|12087848|FG006|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920399|NCT00195260|12087849|FG007|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
10920400|NCT00195260|12087850|FG008|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
10920401|NCT00195260|12087851|FG009|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
10920402|NCT00195260|12087852|FG010|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
10920403|NCT00195273|12087882|FG000|STARTED|Overall Study||31
10920404|NCT00195273|12087883|FG001|STARTED|Overall Study||30
10920405|NCT00195273|12087882|FG000|COMPLETED|Overall Study||10
10920406|NCT00195273|12087883|FG001|COMPLETED|Overall Study||16
10920407|NCT00195273|12087882|FG000|NOT COMPLETED|Overall Study||21
10920408|NCT00195273|12087883|FG001|NOT COMPLETED|Overall Study||14
10920409|NCT00195338|12087889|FG000|STARTED|Overall Study||25
10920410|NCT00195338|12087889|FG000|COMPLETED|Overall Study||13
10920411|NCT00195338|12087889|FG000|NOT COMPLETED|Overall Study||12
10920412|NCT00195351|12087895|FG000|STARTED|Overall Study||236
10920413|NCT00195351|12087896|FG001|STARTED|Overall Study||231
10920414|NCT00195351|12087895|FG000|COMPLETED|Overall Study||215
10920415|NCT00195351|12087896|FG001|COMPLETED|Overall Study||215
10920416|NCT00195351|12087895|FG000|NOT COMPLETED|Overall Study||21
10920417|NCT00195351|12087896|FG001|NOT COMPLETED|Overall Study||16
10920418|NCT00195403|12087902|FG000|STARTED|Overall Study||1014
10920419|NCT00195403|12087902|FG000|COMPLETED|Overall Study||1014
10920420|NCT00195403|12087902|FG000|NOT COMPLETED|Overall Study||0
10920421|NCT00195429|12087908|FG000|STARTED|Overall Study||24
10920422|NCT00195429|12087909|FG001|STARTED|Overall Study||23
10920423|NCT00195429|12087908|FG000|COMPLETED|Overall Study||19
10920424|NCT00195429|12087909|FG001|COMPLETED|Overall Study||18
10920425|NCT00195429|12087908|FG000|NOT COMPLETED|Overall Study||5
10920426|NCT00195429|12087909|FG001|NOT COMPLETED|Overall Study||5
10920427|NCT00195442|12087915|FG000|STARTED|Overall Study||288
10920428|NCT00195442|12087915|FG000|COMPLETED|Overall Study||152
10920429|NCT00195442|12087915|FG000|NOT COMPLETED|Overall Study||136
10920430|NCT00195494|12087921|FG000|STARTED|Year 1||0
10920431|NCT00195494|12087922|FG001|STARTED|Year 1||0
10920432|NCT00195494|12087923|FG002|STARTED|Year 1||0
10920433|NCT00195494|12087924|FG003|STARTED|Year 1||0
10920434|NCT00195494|12087925|FG004|STARTED|Year 1||268
10920435|NCT00195494|12087926|FG005|STARTED|Year 1||274
10920436|NCT00195494|12087921|FG000|COMPLETED|Year 1||0
10920437|NCT00195494|12087922|FG001|COMPLETED|Year 1||0
10920438|NCT00195494|12087923|FG002|COMPLETED|Year 1||0
10920439|NCT00195494|12087924|FG003|COMPLETED|Year 1||0
10920440|NCT00195494|12087925|FG004|COMPLETED|Year 1||189
10920441|NCT00195494|12087926|FG005|COMPLETED|Year 1||221
10920442|NCT00195494|12087921|FG000|NOT COMPLETED|Year 1||0
10920443|NCT00195494|12087922|FG001|NOT COMPLETED|Year 1||0
10920444|NCT00195494|12087923|FG002|NOT COMPLETED|Year 1||0
10920445|NCT00195494|12087924|FG003|NOT COMPLETED|Year 1||0
10920446|NCT00195494|12087925|FG004|NOT COMPLETED|Year 1||79
10920447|NCT00195494|12087926|FG005|NOT COMPLETED|Year 1||53
10920448|NCT00195494|12087921|FG000|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
10920449|NCT00195494|12087922|FG001|STARTED|Year 2||90
10920450|NCT00195494|12087923|FG002|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
10920451|NCT00195494|12087924|FG003|STARTED|Year 2||99
10920452|NCT00195494|12087925|FG004|STARTED|Year 2||0
10920453|NCT00195494|12087926|FG005|STARTED|Year 2||0
10920454|NCT00195494|12087921|FG000|COMPLETED|Year 2||104
10920455|NCT00195494|12087922|FG001|COMPLETED|Year 2||74
10920456|NCT00195494|12087923|FG002|COMPLETED|Year 2||93
10920457|NCT00195494|12087924|FG003|COMPLETED|Year 2||76
10920458|NCT00195494|12087925|FG004|COMPLETED|Year 2||0
10920459|NCT00195494|12087926|FG005|COMPLETED|Year 2||0
10920460|NCT00195494|12087921|FG000|NOT COMPLETED|Year 2||7
10920461|NCT00195494|12087922|FG001|NOT COMPLETED|Year 2||16
10920462|NCT00195494|12087923|FG002|NOT COMPLETED|Year 2||18
10920463|NCT00195494|12087924|FG003|NOT COMPLETED|Year 2||23
10920464|NCT00195494|12087925|FG004|NOT COMPLETED|Year 2||0
10920465|NCT00195494|12087926|FG005|NOT COMPLETED|Year 2||0
10920466|NCT00195507|12087944|FG000|STARTED|Overall Study||357
10920467|NCT00195507|12087945|FG001|STARTED|Overall Study||363
10920468|NCT00195507|12087944|FG000|COMPLETED|Overall Study||258
10920469|NCT00195507|12087945|FG001|COMPLETED|Overall Study||245
10920470|NCT00195507|12087944|FG000|NOT COMPLETED|Overall Study||99
10920471|NCT00195507|12087945|FG001|NOT COMPLETED|Overall Study||118
10920472|NCT00195624|12087953|FG000|STARTED|Overall Study||5
10920473|NCT00195624|12087954|FG001|STARTED|Overall Study||42
10920474|NCT00195624|12087953|FG000|COMPLETED|Overall Study||5
10920475|NCT00195624|12087954|FG001|COMPLETED|Overall Study||42
10920476|NCT00195624|12087953|FG000|NOT COMPLETED|Overall Study||0
10920477|NCT00195624|12087954|FG001|NOT COMPLETED|Overall Study||0
10920478|NCT00195650|12087960|FG000|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
10920479|NCT00195650|12087960|FG000|COMPLETED|Overall Study||321
10920480|NCT00195650|12087960|FG000|NOT COMPLETED|Overall Study||525
10920481|NCT00195663|12087967|FG000|STARTED|2-year Double-blind Treatment Period||257
10920482|NCT00195663|12087968|FG001|STARTED|2-year Double-blind Treatment Period||274
10920483|NCT00195663|12087969|FG002|STARTED|2-year Double-blind Treatment Period||268
10920484|NCT00195663|12087967|FG000|COMPLETED|2-year Double-blind Treatment Period||164
10920485|NCT00195663|12087968|FG001|COMPLETED|2-year Double-blind Treatment Period||166
10920486|NCT00195663|12087969|FG002|COMPLETED|2-year Double-blind Treatment Period||196
10920487|NCT00195663|12087967|FG000|NOT COMPLETED|2-year Double-blind Treatment Period||93
10920488|NCT00195663|12087968|FG001|NOT COMPLETED|2-year Double-blind Treatment Period||108
10920489|NCT00195663|12087969|FG002|NOT COMPLETED|2-year Double-blind Treatment Period||72
10920490|NCT00195663|12087967|FG000|STARTED|Open-Label Extension Period||155
10920491|NCT00195663|12087968|FG001|STARTED|Open-Label Extension Period||159
10920492|NCT00195663|12087969|FG002|STARTED|Open-Label Extension Period||183
10920493|NCT00195663|12087967|FG000|COMPLETED|Open-Label Extension Period||79
10920494|NCT00195663|12087968|FG001|COMPLETED|Open-Label Extension Period||85
10920495|NCT00195663|12087969|FG002|COMPLETED|Open-Label Extension Period||86
10920496|NCT00195663|12087967|FG000|NOT COMPLETED|Open-Label Extension Period||76
10920497|NCT00195663|12087968|FG001|NOT COMPLETED|Open-Label Extension Period||74
10920498|NCT00195663|12087969|FG002|NOT COMPLETED|Open-Label Extension Period||97
10920499|NCT00195676|12087987|FG000|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
10920500|NCT00195676|12087987|FG000|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
10920501|NCT00195676|12087987|FG000|NOT COMPLETED|Period O - Open-label Treatment||606
10920502|NCT00195676|12087987|FG000|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
10920503|NCT00195676|12087987|FG000|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
10920504|NCT00195676|12087987|FG000|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
10920505|NCT00195676|12087987|FG000|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
10920506|NCT00195676|12087987|FG000|COMPLETED|Period R - Retreatment 16 Weeks||490
10920507|NCT00195676|12087987|FG000|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
10920508|NCT00195702|12087998|FG000|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
10920509|NCT00195702|12087999|FG001|STARTED|Double-blind Phase||207
10920510|NCT00195702|12088000|FG002|STARTED|Double-blind Phase||200
10920511|NCT00195702|12088001|FG003|STARTED|Double-blind Phase||0
10920512|NCT00195702|12088002|FG004|STARTED|Double-blind Phase||0
10920513|NCT00195702|12088003|FG005|STARTED|Double-blind Phase||0
10920514|NCT00195702|12087998|FG000|COMPLETED|Double-blind Phase||168
10920515|NCT00195702|12087999|FG001|COMPLETED|Double-blind Phase||159
10920516|NCT00195702|12088000|FG002|COMPLETED|Double-blind Phase||140
10920517|NCT00195702|12088001|FG003|COMPLETED|Double-blind Phase||0
10920518|NCT00195702|12088002|FG004|COMPLETED|Double-blind Phase||0
10920519|NCT00195702|12088003|FG005|COMPLETED|Double-blind Phase||0
10920520|NCT00195702|12087998|FG000|NOT COMPLETED|Double-blind Phase||44
10920521|NCT00195702|12087999|FG001|NOT COMPLETED|Double-blind Phase||48
10920522|NCT00195702|12088000|FG002|NOT COMPLETED|Double-blind Phase||60
10920523|NCT00195702|12088001|FG003|NOT COMPLETED|Double-blind Phase||0
10920524|NCT00195702|12088002|FG004|NOT COMPLETED|Double-blind Phase||0
10920525|NCT00195702|12088003|FG005|NOT COMPLETED|Double-blind Phase||0
10920526|NCT00195702|12087998|FG000|STARTED|Open-label Extension Phase||0
10920527|NCT00195702|12087999|FG001|STARTED|Open-label Extension Phase||0
10920528|NCT00195702|12088000|FG002|STARTED|Open-label Extension Phase||0
10920529|NCT00195702|12088001|FG003|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
10920530|NCT00195702|12088002|FG004|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
10920531|NCT00195702|12088003|FG005|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
10920532|NCT00195702|12087998|FG000|COMPLETED|Open-label Extension Phase||0
10920533|NCT00195702|12087999|FG001|COMPLETED|Open-label Extension Phase||0
10920534|NCT00195702|12088000|FG002|COMPLETED|Open-label Extension Phase||0
10920535|NCT00195702|12088001|FG003|COMPLETED|Open-label Extension Phase||66
10920536|NCT00195702|12088002|FG004|COMPLETED|Open-label Extension Phase||80
10920537|NCT00195702|12088003|FG005|COMPLETED|Open-label Extension Phase||56
10920538|NCT00195702|12087998|FG000|NOT COMPLETED|Open-label Extension Phase||0
10920539|NCT00195702|12087999|FG001|NOT COMPLETED|Open-label Extension Phase||0
10920540|NCT00195702|12088000|FG002|NOT COMPLETED|Open-label Extension Phase||0
10920541|NCT00195702|12088001|FG003|NOT COMPLETED|Open-label Extension Phase||99
10920542|NCT00195702|12088002|FG004|NOT COMPLETED|Open-label Extension Phase||78
10920543|NCT00195702|12088003|FG005|NOT COMPLETED|Open-label Extension Phase||78
10920544|NCT00195715|12088016|FG000|STARTED|Overall Study||777
10920545|NCT00195715|12088016|FG000|COMPLETED|Overall Study||400
10920546|NCT00195715|12088016|FG000|NOT COMPLETED|Overall Study||377
10920547|NCT00195819|12088020|FG000|STARTED|Double-Blind||44
10920548|NCT00195819|12088021|FG001|STARTED|Double-Blind||38
10920549|NCT00195819|12088020|FG000|COMPLETED|Double-Blind||42
10920550|NCT00195819|12088021|FG001|COMPLETED|Double-Blind||38
10920551|NCT00195819|12088020|FG000|NOT COMPLETED|Double-Blind||2
10920552|NCT00195819|12088021|FG001|NOT COMPLETED|Double-Blind||0
10920553|NCT00195819|12088020|FG000|STARTED|Open-label||0
10920554|NCT00195819|12088021|FG001|STARTED|Open-label||82
10920555|NCT00195819|12088020|FG000|COMPLETED|Open-label||0
10920556|NCT00195819|12088021|FG001|COMPLETED|Open-label||62
10920557|NCT00195819|12088020|FG000|NOT COMPLETED|Open-label||0
10920558|NCT00195819|12088021|FG001|NOT COMPLETED|Open-label||20
10920559|NCT00196105|12088036|FG000|STARTED|Overall Study||64
10920560|NCT00196105|12088037|FG001|STARTED|Overall Study||88
10920561|NCT00196105|12088038|FG002|STARTED|Overall Study||89
10920562|NCT00196105|12088036|FG000|COMPLETED|Overall Study||60
10920563|NCT00196105|12088037|FG001|COMPLETED|Overall Study||83
10920564|NCT00196105|12088038|FG002|COMPLETED|Overall Study||82
10920565|NCT00196105|12088036|FG000|NOT COMPLETED|Overall Study||4
10920566|NCT00196105|12088037|FG001|NOT COMPLETED|Overall Study||5
10920567|NCT00196105|12088038|FG002|NOT COMPLETED|Overall Study||7
10920568|NCT00196196|12088046|FG000|STARTED|Overall Study||274
10920569|NCT00196196|12088046|FG000|COMPLETED|Overall Study||267
10920570|NCT00196196|12088046|FG000|NOT COMPLETED|Overall Study||7
10920571|NCT00196313|12088052|FG000|STARTED|Overall Study||47
10920572|NCT00196313|12088053|FG001|STARTED|Overall Study||48
10920573|NCT00196313|12088052|FG000|COMPLETED|Overall Study||36
10920574|NCT00196313|12088053|FG001|COMPLETED|Overall Study||40
10920575|NCT00196313|12088052|FG000|NOT COMPLETED|Overall Study||11
10920576|NCT00196313|12088053|FG001|NOT COMPLETED|Overall Study||8
10920577|NCT00196326|12088060|FG000|STARTED|Overall Study|Took at least one dose of study medication|2235
10920578|NCT00196326|12088060|FG000|Safety Population|Overall Study|Treated participants|2185
10920579|NCT00196326|12088060|FG000|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
10920580|NCT00196326|12088060|FG000|COMPLETED|Overall Study||1249
10920581|NCT00196326|12088060|FG000|NOT COMPLETED|Overall Study||986
10920582|NCT00196716|12088064|FG000|STARTED|1.0 mg/kg Period||21
10920583|NCT00196716|12088064|FG000|COMPLETED|1.0 mg/kg Period||21
10920584|NCT00196716|12088064|FG000|NOT COMPLETED|1.0 mg/kg Period||0
10920585|NCT00196716|12088064|FG000|STARTED|0.3 mg/kg Period||21
10920586|NCT00196716|12088064|FG000|COMPLETED|0.3 mg/kg Period||21
10920587|NCT00196716|12088064|FG000|NOT COMPLETED|0.3 mg/kg Period||0
10920588|NCT00196937|12088073|FG000|STARTED|Overall Study||229
10920589|NCT00196937|12088074|FG001|STARTED|Overall Study||226
10920590|NCT00196937|12088075|FG002|STARTED|Overall Study||211
10920591|NCT00196937|12088073|FG000|COMPLETED|Overall Study||220
10920592|NCT00196937|12088074|FG001|COMPLETED|Overall Study||221
10920593|NCT00196937|12088075|FG002|COMPLETED|Overall Study||204
10920594|NCT00196937|12088073|FG000|NOT COMPLETED|Overall Study||9
10920595|NCT00196937|12088074|FG001|NOT COMPLETED|Overall Study||5
10920596|NCT00196937|12088075|FG002|NOT COMPLETED|Overall Study||7
10920597|NCT00196976|12088098|FG000|STARTED|Primary Study||39
10920598|NCT00196976|12088099|FG001|STARTED|Primary Study||41
10920599|NCT00196976|12088100|FG002|STARTED|Primary Study||41
10920600|NCT00196976|12088101|FG003|STARTED|Primary Study||40
10920601|NCT00196976|12088102|FG004|STARTED|Primary Study||40
10920602|NCT00196976|12088103|FG005|STARTED|Primary Study||54
10920603|NCT00196976|12088104|FG006|STARTED|Primary Study||50
10920604|NCT00196976|12088105|FG007|STARTED|Primary Study||52
10920605|NCT00196976|12088106|FG008|STARTED|Primary Study||52
10920606|NCT00196976|12088107|FG009|STARTED|Primary Study||52
10920607|NCT00196976|12088108|FG010|STARTED|Primary Study||0
10920608|NCT00196976|12088109|FG011|STARTED|Primary Study||0
10920609|NCT00196976|12088110|FG012|STARTED|Primary Study||0
10920610|NCT00196976|12088111|FG013|STARTED|Primary Study||0
10920611|NCT00196976|12088098|FG000|COMPLETED|Primary Study||38
10920612|NCT00196976|12088099|FG001|COMPLETED|Primary Study||40
10920613|NCT00196976|12088100|FG002|COMPLETED|Primary Study||37
10920614|NCT00196976|12088101|FG003|COMPLETED|Primary Study||39
10920615|NCT00196976|12088102|FG004|COMPLETED|Primary Study||37
10920616|NCT00196976|12088103|FG005|COMPLETED|Primary Study||52
10920617|NCT00196976|12088104|FG006|COMPLETED|Primary Study||50
10920618|NCT00196976|12088105|FG007|COMPLETED|Primary Study||49
10920619|NCT00196976|12088106|FG008|COMPLETED|Primary Study||52
10920620|NCT00196976|12088107|FG009|COMPLETED|Primary Study||51
10920621|NCT00196976|12088108|FG010|COMPLETED|Primary Study||0
10920622|NCT00196976|12088109|FG011|COMPLETED|Primary Study||0
10920623|NCT00196976|12088110|FG012|COMPLETED|Primary Study||0
10920624|NCT00196976|12088111|FG013|COMPLETED|Primary Study||0
10920625|NCT00196976|12088098|FG000|NOT COMPLETED|Primary Study||1
10920626|NCT00196976|12088099|FG001|NOT COMPLETED|Primary Study||1
10920627|NCT00196976|12088100|FG002|NOT COMPLETED|Primary Study||4
10920628|NCT00196976|12088101|FG003|NOT COMPLETED|Primary Study||1
10920629|NCT00196976|12088102|FG004|NOT COMPLETED|Primary Study||3
10920630|NCT00196976|12088103|FG005|NOT COMPLETED|Primary Study||2
10920631|NCT00196976|12088104|FG006|NOT COMPLETED|Primary Study||0
10920632|NCT00196976|12088105|FG007|NOT COMPLETED|Primary Study||3
10920633|NCT00196976|12088106|FG008|NOT COMPLETED|Primary Study||0
10920634|NCT00196976|12088107|FG009|NOT COMPLETED|Primary Study||1
10920635|NCT00196976|12088108|FG010|NOT COMPLETED|Primary Study||0
10920636|NCT00196976|12088109|FG011|NOT COMPLETED|Primary Study||0
10920637|NCT00196976|12088110|FG012|NOT COMPLETED|Primary Study||0
10920638|NCT00196976|12088111|FG013|NOT COMPLETED|Primary Study||0
10920639|NCT00196976|12088098|FG000|STARTED|Booster Study||0
10920640|NCT00196976|12088099|FG001|STARTED|Booster Study||0
10920641|NCT00196976|12088100|FG002|STARTED|Booster Study||0
10920642|NCT00196976|12088101|FG003|STARTED|Booster Study||0
10920643|NCT00196976|12088102|FG004|STARTED|Booster Study||0
10920644|NCT00196976|12088103|FG005|STARTED|Booster Study||0
10920645|NCT00196976|12088104|FG006|STARTED|Booster Study||0
10920646|NCT00196976|12088105|FG007|STARTED|Booster Study||0
10920647|NCT00196976|12088106|FG008|STARTED|Booster Study||0
10920648|NCT00196976|12088107|FG009|STARTED|Booster Study||0
10920649|NCT00196976|12088108|FG010|STARTED|Booster Study||33
10920650|NCT00196976|12088109|FG011|STARTED|Booster Study||32
10920651|NCT00196976|12088110|FG012|STARTED|Booster Study||45
10920652|NCT00196976|12088111|FG013|STARTED|Booster Study||43
10920653|NCT00196976|12088098|FG000|COMPLETED|Booster Study||0
10920654|NCT00196976|12088099|FG001|COMPLETED|Booster Study||0
10920655|NCT00196976|12088100|FG002|COMPLETED|Booster Study||0
10920656|NCT00196976|12088101|FG003|COMPLETED|Booster Study||0
10920657|NCT00196976|12088102|FG004|COMPLETED|Booster Study||0
10920658|NCT00196976|12088103|FG005|COMPLETED|Booster Study||0
10920659|NCT00196976|12088104|FG006|COMPLETED|Booster Study||0
10920660|NCT00196976|12088105|FG007|COMPLETED|Booster Study||0
10920661|NCT00196976|12088106|FG008|COMPLETED|Booster Study||0
10920662|NCT00196976|12088107|FG009|COMPLETED|Booster Study||0
10920663|NCT00196976|12088108|FG010|COMPLETED|Booster Study||31
10920664|NCT00196976|12088109|FG011|COMPLETED|Booster Study||30
10920665|NCT00196976|12088110|FG012|COMPLETED|Booster Study||45
10920666|NCT00196976|12088111|FG013|COMPLETED|Booster Study||43
10920667|NCT00196976|12088098|FG000|NOT COMPLETED|Booster Study||0
10920668|NCT00196976|12088099|FG001|NOT COMPLETED|Booster Study||0
10920669|NCT00196976|12088100|FG002|NOT COMPLETED|Booster Study||0
10920670|NCT00196976|12088101|FG003|NOT COMPLETED|Booster Study||0
10920671|NCT00196976|12088102|FG004|NOT COMPLETED|Booster Study||0
10920672|NCT00196976|12088103|FG005|NOT COMPLETED|Booster Study||0
10920673|NCT00196976|12088104|FG006|NOT COMPLETED|Booster Study||0
10920674|NCT00196976|12088105|FG007|NOT COMPLETED|Booster Study||0
10920675|NCT00196976|12088106|FG008|NOT COMPLETED|Booster Study||0
10920676|NCT00196976|12088107|FG009|NOT COMPLETED|Booster Study||0
10920677|NCT00196976|12088108|FG010|NOT COMPLETED|Booster Study||2
10920678|NCT00196976|12088109|FG011|NOT COMPLETED|Booster Study||2
10920679|NCT00196976|12088110|FG012|NOT COMPLETED|Booster Study||0
10920680|NCT00196976|12088111|FG013|NOT COMPLETED|Booster Study||0
10920681|NCT00197002|12088154|FG000|STARTED|Overall Study||147
10920682|NCT00197002|12088155|FG001|STARTED|Overall Study||137
10920683|NCT00197002|12088156|FG002|STARTED|Overall Study||149
10920684|NCT00197002|12088154|FG000|COMPLETED|Overall Study||125
10920685|NCT00197002|12088155|FG001|COMPLETED|Overall Study||119
10920686|NCT00197002|12088156|FG002|COMPLETED|Overall Study||132
10920687|NCT00197002|12088154|FG000|NOT COMPLETED|Overall Study||22
10920688|NCT00197002|12088155|FG001|NOT COMPLETED|Overall Study||18
10920689|NCT00197002|12088156|FG002|NOT COMPLETED|Overall Study||17
10920690|NCT00197015|12088170|FG000|STARTED|Overall Study||324
10920691|NCT00197015|12088171|FG001|STARTED|Overall Study||455
10920692|NCT00197015|12088172|FG002|STARTED|Overall Study||462
10920693|NCT00197015|12088170|FG000|COMPLETED|Overall Study||274
10920694|NCT00197015|12088171|FG001|COMPLETED|Overall Study||366
10920695|NCT00197015|12088172|FG002|COMPLETED|Overall Study||385
10920696|NCT00197015|12088170|FG000|NOT COMPLETED|Overall Study||50
10920697|NCT00197015|12088171|FG001|NOT COMPLETED|Overall Study||89
10920698|NCT00197015|12088172|FG002|NOT COMPLETED|Overall Study||77
10920699|NCT00197028|12088182|FG000|STARTED|Overall Study||107
10920700|NCT00197028|12088183|FG001|STARTED|Overall Study||107
10920701|NCT00197028|12088182|FG000|COMPLETED|Overall Study||91
10920702|NCT00197028|12088183|FG001|COMPLETED|Overall Study||86
10920703|NCT00197028|12088182|FG000|NOT COMPLETED|Overall Study||16
10920704|NCT00197028|12088183|FG001|NOT COMPLETED|Overall Study||21
10920705|NCT00197054|12088192|FG000|STARTED|Overall Study||85
10920706|NCT00197054|12088193|FG001|STARTED|Overall Study||85
10920707|NCT00197054|12088194|FG002|STARTED|Overall Study||85
10920708|NCT00197054|12088192|FG000|COMPLETED|Overall Study||68
10920709|NCT00197054|12088193|FG001|COMPLETED|Overall Study||64
10920710|NCT00197054|12088194|FG002|COMPLETED|Overall Study||73
10920711|NCT00197054|12088192|FG000|NOT COMPLETED|Overall Study||17
10920712|NCT00197054|12088193|FG001|NOT COMPLETED|Overall Study||21
10920713|NCT00197054|12088194|FG002|NOT COMPLETED|Overall Study||12
10920714|NCT00197106|12088214|FG000|STARTED|4-Week Run-In Period||257
10920715|NCT00197106|12088215|FG001|STARTED|4-Week Run-In Period||0
10920716|NCT00197106|12088216|FG002|STARTED|4-Week Run-In Period||0
10920717|NCT00197106|12088214|FG000|COMPLETED|4-Week Run-In Period||158
10920718|NCT00197106|12088215|FG001|COMPLETED|4-Week Run-In Period||0
10920719|NCT00197106|12088216|FG002|COMPLETED|4-Week Run-In Period||0
10920720|NCT00197106|12088214|FG000|NOT COMPLETED|4-Week Run-In Period||99
10920721|NCT00197106|12088215|FG001|NOT COMPLETED|4-Week Run-In Period||0
10920722|NCT00197106|12088216|FG002|NOT COMPLETED|4-Week Run-In Period||0
10920723|NCT00197106|12088214|FG000|STARTED|Overall Treatment Period||0
10920724|NCT00197106|12088215|FG001|STARTED|Overall Treatment Period||78
10920725|NCT00197106|12088216|FG002|STARTED|Overall Treatment Period||80
10920726|NCT00197106|12088214|FG000|COMPLETED|Overall Treatment Period||0
10920727|NCT00197106|12088215|FG001|COMPLETED|Overall Treatment Period||77
10920728|NCT00197106|12088216|FG002|COMPLETED|Overall Treatment Period||74
10920729|NCT00197106|12088214|FG000|NOT COMPLETED|Overall Treatment Period||0
10920730|NCT00197106|12088215|FG001|NOT COMPLETED|Overall Treatment Period||1
10920731|NCT00197106|12088216|FG002|NOT COMPLETED|Overall Treatment Period||6
10920732|NCT00197119|12088224|FG000|STARTED|Year 6||126
10920733|NCT00197119|12088225|FG001|STARTED|Year 6||118
10920734|NCT00197119|12088224|FG000|COMPLETED|Year 6||126
10920735|NCT00197119|12088225|FG001|COMPLETED|Year 6||118
10920736|NCT00197119|12088224|FG000|NOT COMPLETED|Year 6||0
10920737|NCT00197119|12088225|FG001|NOT COMPLETED|Year 6||0
10920738|NCT00197119|12088224|FG000|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
10920739|NCT00197119|12088225|FG001|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
10920740|NCT00197119|12088224|FG000|COMPLETED|Year 7||122
10920741|NCT00197119|12088225|FG001|COMPLETED|Year 7||114
10920742|NCT00197119|12088224|FG000|NOT COMPLETED|Year 7||0
10920743|NCT00197119|12088225|FG001|NOT COMPLETED|Year 7||0
10920744|NCT00197119|12088224|FG000|STARTED|Year 8||122
10920745|NCT00197119|12088225|FG001|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
10920746|NCT00197119|12088224|FG000|COMPLETED|Year 8||122
10920747|NCT00197119|12088225|FG001|COMPLETED|Year 8||115
10920748|NCT00197119|12088224|FG000|NOT COMPLETED|Year 8||0
10920749|NCT00197119|12088225|FG001|NOT COMPLETED|Year 8||0
10920750|NCT00197119|12088224|FG000|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
10920751|NCT00197119|12088225|FG001|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
10920752|NCT00197119|12088224|FG000|COMPLETED|Year 9||121
10920753|NCT00197119|12088225|FG001|COMPLETED|Year 9||114
10920754|NCT00197119|12088224|FG000|NOT COMPLETED|Year 9||0
10920755|NCT00197119|12088225|FG001|NOT COMPLETED|Year 9||0
10920756|NCT00197119|12088224|FG000|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
10920757|NCT00197119|12088225|FG001|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
10920758|NCT00197119|12088224|FG000|COMPLETED|Year 10||120
10920759|NCT00197119|12088225|FG001|COMPLETED|Year 10||108
10920760|NCT00197119|12088224|FG000|NOT COMPLETED|Year 10||0
10920761|NCT00197119|12088225|FG001|NOT COMPLETED|Year 10||0
10920762|NCT00197145|12088233|FG000|STARTED|Period 1: Randomized Treatment Phase||13
10920763|NCT00197145|12088234|FG001|STARTED|Period 1: Randomized Treatment Phase||11
10920764|NCT00197145|12088233|FG000|COMPLETED|Period 1: Randomized Treatment Phase||0
10920765|NCT00197145|12088234|FG001|COMPLETED|Period 1: Randomized Treatment Phase||0
10920766|NCT00197145|12088233|FG000|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
10920767|NCT00197145|12088234|FG001|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
10920768|NCT00197145|12088233|FG000|STARTED|Period 2 : Open Label Phase||10
10920769|NCT00197145|12088234|FG001|STARTED|Period 2 : Open Label Phase||0
10920770|NCT00197145|12088233|FG000|COMPLETED|Period 2 : Open Label Phase||0
10920771|NCT00197145|12088234|FG001|COMPLETED|Period 2 : Open Label Phase||0
10920772|NCT00197145|12088233|FG000|NOT COMPLETED|Period 2 : Open Label Phase||10
10920773|NCT00197145|12088234|FG001|NOT COMPLETED|Period 2 : Open Label Phase||0
10920774|NCT00197184|12088243|FG000|STARTED|Overall Study||139
10920775|NCT00197184|12088244|FG001|STARTED|Overall Study||137
10920776|NCT00197184|12088243|FG000|COMPLETED|Overall Study||139
10920777|NCT00197184|12088244|FG001|COMPLETED|Overall Study||137
10920778|NCT00197184|12088243|FG000|NOT COMPLETED|Overall Study||0
10920779|NCT00197184|12088244|FG001|NOT COMPLETED|Overall Study||0
10920780|NCT00197236|12088253|FG000|STARTED|Overall Study||135
10920781|NCT00197236|12088254|FG001|STARTED|Overall Study||127
10920782|NCT00197236|12088255|FG002|STARTED|Overall Study||132
10920783|NCT00197236|12088253|FG000|COMPLETED|Overall Study||121
10920784|NCT00197236|12088254|FG001|COMPLETED|Overall Study||110
10920785|NCT00197236|12088255|FG002|COMPLETED|Overall Study||109
10920786|NCT00197236|12088253|FG000|NOT COMPLETED|Overall Study||14
10920787|NCT00197236|12088254|FG001|NOT COMPLETED|Overall Study||17
10920788|NCT00197236|12088255|FG002|NOT COMPLETED|Overall Study||23
10920789|NCT00197392|12088268|FG000|STARTED|Overall Study||214
10920790|NCT00197392|12088269|FG001|STARTED|Overall Study||220
10920791|NCT00197392|12088268|FG000|Safety Population|Overall Study||214
10920792|NCT00197392|12088269|FG001|Safety Population|Overall Study||220
10920793|NCT00197392|12088268|FG000|Modified Intent to Treat|Overall Study||209
10920794|NCT00197392|12088269|FG001|Modified Intent to Treat|Overall Study||210
10920795|NCT00197392|12088268|FG000|Evaluable|Overall Study||176
10920796|NCT00197392|12088269|FG001|Evaluable|Overall Study||181
10920797|NCT00197392|12088268|FG000|Per Protocol|Overall Study||126
10920798|NCT00197392|12088269|FG001|Per Protocol|Overall Study||134
10920799|NCT00197392|12088268|FG000|COMPLETED|Overall Study||126
10920800|NCT00197392|12088269|FG001|COMPLETED|Overall Study||134
10920801|NCT00197392|12088268|FG000|NOT COMPLETED|Overall Study||88
10920802|NCT00197392|12088269|FG001|NOT COMPLETED|Overall Study||86
10920803|NCT00197496|12088293|FG000|STARTED|Baseline to Discharge||14
10920804|NCT00197496|12088294|FG001|STARTED|Baseline to Discharge||7
10920805|NCT00197496|12088293|FG000|COMPLETED|Baseline to Discharge||12
10920806|NCT00197496|12088294|FG001|COMPLETED|Baseline to Discharge||5
10920807|NCT00197496|12088293|FG000|NOT COMPLETED|Baseline to Discharge||2
10920808|NCT00197496|12088294|FG001|NOT COMPLETED|Baseline to Discharge||2
10920809|NCT00197496|12088293|FG000|STARTED|Follow-up||12
10920810|NCT00197496|12088294|FG001|STARTED|Follow-up||5
10920811|NCT00197496|12088293|FG000|COMPLETED|Follow-up||10
10920812|NCT00197496|12088294|FG001|COMPLETED|Follow-up||4
10920813|NCT00197496|12088293|FG000|NOT COMPLETED|Follow-up||2
10920814|NCT00197496|12088294|FG001|NOT COMPLETED|Follow-up||1
10920815|NCT00198029|12088300|FG000|STARTED|Overall Study||32
10920816|NCT00198029|12088300|FG000|COMPLETED|Overall Study||28
10920817|NCT00198029|12088300|FG000|NOT COMPLETED|Overall Study||4
10920818|NCT00198042|12088304|FG000|STARTED|Overall Study||18
10920819|NCT00198042|12088304|FG000|COMPLETED|Overall Study||18
10920820|NCT00198042|12088304|FG000|NOT COMPLETED|Overall Study||0
10920821|NCT00198081|12088310|FG000|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
10920822|NCT00198081|12088311|FG001|STARTED|Overall Study|No enrollment on this arm.|0
10920823|NCT00198081|12088310|FG000|COMPLETED|Overall Study||4
10920824|NCT00198081|12088311|FG001|COMPLETED|Overall Study|No enrollment on this arm.|0
10920825|NCT00198081|12088310|FG000|NOT COMPLETED|Overall Study||1
10920826|NCT00198081|12088311|FG001|NOT COMPLETED|Overall Study||0
10920827|NCT00198107|12088324|FG000|STARTED|Double-Blind Period||41
10920828|NCT00198107|12088325|FG001|STARTED|Double-Blind Period||40
10920829|NCT00198107|12088326|FG002|STARTED|Double-Blind Period||0
10920830|NCT00198107|12088324|FG000|1 or More Follow-up Visits|Double-Blind Period||40
10920831|NCT00198107|12088325|FG001|1 or More Follow-up Visits|Double-Blind Period||38
10920832|NCT00198107|12088326|FG002|1 or More Follow-up Visits|Double-Blind Period||0
10920833|NCT00198107|12088324|FG000|COMPLETED|Double-Blind Period||35
10920834|NCT00198107|12088325|FG001|COMPLETED|Double-Blind Period||37
10920835|NCT00198107|12088326|FG002|COMPLETED|Double-Blind Period||0
10920836|NCT00198107|12088324|FG000|NOT COMPLETED|Double-Blind Period||6
10920837|NCT00198107|12088325|FG001|NOT COMPLETED|Double-Blind Period||3
10920838|NCT00198107|12088326|FG002|NOT COMPLETED|Double-Blind Period||0
10920839|NCT00198107|12088324|FG000|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
10920840|NCT00198107|12088325|FG001|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
10920841|NCT00198107|12088326|FG002|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10
10920842|NCT00198107|12088324|FG000|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
10920843|NCT00198107|12088325|FG001|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
10920844|NCT00198107|12088326|FG002|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8
10920845|NCT00198107|12088324|FG000|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
10920846|NCT00198107|12088325|FG001|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
10920847|NCT00198107|12088326|FG002|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2
10920848|NCT00198133|12088336|FG000|STARTED|Overall Study||16
10920849|NCT00198133|12088337|FG001|STARTED|Overall Study||11
10920850|NCT00198133|12088336|FG000|COMPLETED|Overall Study||11
10920851|NCT00198133|12088337|FG001|COMPLETED|Overall Study||3
10920852|NCT00198133|12088336|FG000|NOT COMPLETED|Overall Study||5
10920853|NCT00198133|12088337|FG001|NOT COMPLETED|Overall Study||8
10920854|NCT00198822|12088346|FG000|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
10920855|NCT00198822|12088347|FG001|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
10920856|NCT00198822|12088348|FG002|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
10920857|NCT00198822|12088346|FG000|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
10920858|NCT00198822|12088347|FG001|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
10920859|NCT00198822|12088348|FG002|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
10920860|NCT00198822|12088346|FG000|NOT COMPLETED|Overall Study||14
10920861|NCT00198822|12088347|FG001|NOT COMPLETED|Overall Study||20
10920862|NCT00198822|12088348|FG002|NOT COMPLETED|Overall Study||21
10920863|NCT00199381|12088356|FG000|STARTED|Overall Study||504
10920864|NCT00199381|12088356|FG000|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
10920865|NCT00199381|12088356|FG000|NOT COMPLETED|Overall Study||504
10920866|NCT00199797|12088360|FG000|STARTED|Overall Study||20
10920867|NCT00199797|12088360|FG000|COMPLETED|Overall Study||17
10920868|NCT00199797|12088360|FG000|NOT COMPLETED|Overall Study||3
10920869|NCT00199836|12088365|FG000|STARTED|Overall Study||14
10920870|NCT00199836|12088365|FG000|COMPLETED|Overall Study||8
10920871|NCT00199836|12088365|FG000|NOT COMPLETED|Overall Study||6
10920872|NCT00199849|12088373|FG000|STARTED|Overall Study||3
10920873|NCT00199849|12088374|FG001|STARTED|Overall Study||7
10920874|NCT00199849|12088375|FG002|STARTED|Overall Study||8
10920875|NCT00199849|12088373|FG000|COMPLETED|Overall Study||3
10920876|NCT00199849|12088374|FG001|COMPLETED|Overall Study||6
10920877|NCT00199849|12088375|FG002|COMPLETED|Overall Study||6
10920878|NCT00199849|12088373|FG000|NOT COMPLETED|Overall Study||0
10920879|NCT00199849|12088374|FG001|NOT COMPLETED|Overall Study||1
10920880|NCT00199849|12088375|FG002|NOT COMPLETED|Overall Study||2
10920881|NCT00199875|12088388|FG000|STARTED|Overall Study||3
10920882|NCT00199875|12088389|FG001|STARTED|Overall Study||3
10920883|NCT00199875|12088390|FG002|STARTED|Overall Study||6
10920884|NCT00199875|12088391|FG003|STARTED|Overall Study||3
10920885|NCT00199875|12088392|FG004|STARTED|Overall Study||3
10920886|NCT00199875|12088388|FG000|COMPLETED|Overall Study||3
10920887|NCT00199875|12088389|FG001|COMPLETED|Overall Study||3
10920888|NCT00199875|12088390|FG002|COMPLETED|Overall Study||6
10920889|NCT00199875|12088391|FG003|COMPLETED|Overall Study||3
10920890|NCT00199875|12088392|FG004|COMPLETED|Overall Study||2
10920891|NCT00199875|12088388|FG000|NOT COMPLETED|Overall Study||0
10920892|NCT00199875|12088389|FG001|NOT COMPLETED|Overall Study||0
10920893|NCT00199875|12088390|FG002|NOT COMPLETED|Overall Study||0
10920894|NCT00199875|12088391|FG003|NOT COMPLETED|Overall Study||0
10920895|NCT00199875|12088392|FG004|NOT COMPLETED|Overall Study||1
10920896|NCT00199888|12088404|FG000|STARTED|Overall Study||26
10920897|NCT00199888|12088404|FG000|COMPLETED|Overall Study||25
10920898|NCT00199888|12088404|FG000|NOT COMPLETED|Overall Study||1
10920899|NCT00199901|12088410|FG000|STARTED|Overall Study||56
10920900|NCT00199901|12088411|FG001|STARTED|Overall Study||54
10920901|NCT00199901|12088410|FG000|COMPLETED|Overall Study||29
10920902|NCT00199901|12088411|FG001|COMPLETED|Overall Study||30
10920903|NCT00199901|12088410|FG000|NOT COMPLETED|Overall Study||27
10920904|NCT00199901|12088411|FG001|NOT COMPLETED|Overall Study||24
10920905|NCT00199914|12088421|FG000|STARTED|Overall Study||53
10920906|NCT00199914|12088422|FG001|STARTED|Overall Study||60
10920907|NCT00199914|12088421|FG000|COMPLETED|Overall Study||50
10920908|NCT00199914|12088422|FG001|COMPLETED|Overall Study||54
10920909|NCT00199914|12088421|FG000|NOT COMPLETED|Overall Study||3
10920910|NCT00199914|12088422|FG001|NOT COMPLETED|Overall Study||6
10920911|NCT00200057|12088428|FG000|STARTED|Overall Study||120
10920912|NCT00200057|12088428|FG000|1 Month Follow-up|Overall Study||117
10920913|NCT00200057|12088428|FG000|3 Month Follow-up|Overall Study||116
10920914|NCT00200057|12088428|FG000|6 Month Follow-up|Overall Study||114
10920915|NCT00200057|12088428|FG000|12 Month Follow-up|Overall Study||111
10920916|NCT00200057|12088428|FG000|COMPLETED|Overall Study||111
10920917|NCT00200057|12088428|FG000|NOT COMPLETED|Overall Study||9
10920918|NCT00200161|12088434|FG000|STARTED|Overall Study||43
10920919|NCT00200161|12088435|FG001|STARTED|Overall Study||42
10920920|NCT00200161|12088434|FG000|COMPLETED|Overall Study||43
10920921|NCT00200161|12088435|FG001|COMPLETED|Overall Study||42
10920922|NCT00200161|12088434|FG000|NOT COMPLETED|Overall Study||0
10920923|NCT00200161|12088435|FG001|NOT COMPLETED|Overall Study||0
10920924|NCT00200343|12088444|FG000|STARTED|Overall Study||199
10920925|NCT00200343|12088445|FG001|STARTED|Overall Study||200
10920926|NCT00200343|12088446|FG002|STARTED|Overall Study||197
10920927|NCT00200343|12088444|FG000|COMPLETED|Overall Study||183
10920928|NCT00200343|12088445|FG001|COMPLETED|Overall Study||192
10920929|NCT00200343|12088446|FG002|COMPLETED|Overall Study||184
10920930|NCT00200343|12088444|FG000|NOT COMPLETED|Overall Study||16
10920931|NCT00200343|12088445|FG001|NOT COMPLETED|Overall Study||8
10920932|NCT00200343|12088446|FG002|NOT COMPLETED|Overall Study||13
10920933|NCT00200356|12088456|FG000|STARTED|Overall Study||199
10920934|NCT00200356|12088457|FG001|STARTED|Overall Study||202
10920935|NCT00200356|12088456|FG000|Safety Analysis Set|Overall Study||194
10920936|NCT00200356|12088457|FG001|Safety Analysis Set|Overall Study||198
10920937|NCT00200356|12088456|FG000|COMPLETED|Overall Study||191
10920938|NCT00200356|12088457|FG001|COMPLETED|Overall Study||195
10920939|NCT00200356|12088456|FG000|NOT COMPLETED|Overall Study||8
10920940|NCT00200356|12088457|FG001|NOT COMPLETED|Overall Study||7
10920941|NCT00200785|12088465|FG000|STARTED|First Intervention||9
10920942|NCT00200785|12088466|FG001|STARTED|First Intervention||6
10920943|NCT00200785|12088465|FG000|COMPLETED|First Intervention||9
10920944|NCT00200785|12088466|FG001|COMPLETED|First Intervention||6
10920945|NCT00200785|12088465|FG000|NOT COMPLETED|First Intervention||0
10920946|NCT00200785|12088466|FG001|NOT COMPLETED|First Intervention||0
10920947|NCT00200785|12088465|FG000|STARTED|Washout Period of 1 Week||9
10920948|NCT00200785|12088466|FG001|STARTED|Washout Period of 1 Week||6
10920949|NCT00200785|12088465|FG000|COMPLETED|Washout Period of 1 Week||9
10920950|NCT00200785|12088466|FG001|COMPLETED|Washout Period of 1 Week||6
10920951|NCT00200785|12088465|FG000|NOT COMPLETED|Washout Period of 1 Week||0
10920952|NCT00200785|12088466|FG001|NOT COMPLETED|Washout Period of 1 Week||0
10920953|NCT00200785|12088465|FG000|STARTED|Second Intervention||9
10920954|NCT00200785|12088466|FG001|STARTED|Second Intervention||6
10920955|NCT00200785|12088465|FG000|COMPLETED|Second Intervention||9
10920956|NCT00200785|12088466|FG001|COMPLETED|Second Intervention||6
10920957|NCT00200785|12088465|FG000|NOT COMPLETED|Second Intervention||0
10920958|NCT00200785|12088466|FG001|NOT COMPLETED|Second Intervention||0
10920959|NCT00200850|12088475|FG000|STARTED|Overall Study||10
10920960|NCT00200850|12088476|FG001|STARTED|Overall Study||10
10920961|NCT00200850|12088477|FG002|STARTED|Overall Study||11
10920962|NCT00200850|12088475|FG000|COMPLETED|Overall Study||7
10920963|NCT00200850|12088476|FG001|COMPLETED|Overall Study||9
10920964|NCT00200850|12088477|FG002|COMPLETED|Overall Study||5
10920965|NCT00200850|12088475|FG000|NOT COMPLETED|Overall Study||3
10920966|NCT00200850|12088476|FG001|NOT COMPLETED|Overall Study||1
10920967|NCT00200850|12088477|FG002|NOT COMPLETED|Overall Study||6
10920968|NCT00200902|12088488|FG000|STARTED|Overall Study||39
10920969|NCT00200902|12088489|FG001|STARTED|Overall Study||29
10920970|NCT00200902|12088490|FG002|STARTED|Overall Study||20
10920971|NCT00200902|12088488|FG000|COMPLETED|Overall Study||29
10920972|NCT00200902|12088489|FG001|COMPLETED|Overall Study||26
10920973|NCT00200902|12088490|FG002|COMPLETED|Overall Study||12
10920974|NCT00200902|12088488|FG000|NOT COMPLETED|Overall Study||10
10920975|NCT00200902|12088489|FG001|NOT COMPLETED|Overall Study||3
10920976|NCT00200902|12088490|FG002|NOT COMPLETED|Overall Study||8
10920977|NCT00200967|12088506|FG000|STARTED|First Treatment Period||42
10920978|NCT00200967|12088507|FG001|STARTED|First Treatment Period||45
10920979|NCT00200967|12088506|FG000|First Treatment Period|First Treatment Period||42
10920980|NCT00200967|12088507|FG001|First Treatment Period|First Treatment Period||45
10920981|NCT00200967|12088506|FG000|COMPLETED|First Treatment Period||36
10920982|NCT00200967|12088507|FG001|COMPLETED|First Treatment Period||44
10920983|NCT00200967|12088506|FG000|NOT COMPLETED|First Treatment Period||6
10920984|NCT00200967|12088507|FG001|NOT COMPLETED|First Treatment Period||1
10920985|NCT00200967|12088506|FG000|STARTED|Wash-out Period||36
10920986|NCT00200967|12088507|FG001|STARTED|Wash-out Period||44
10920987|NCT00200967|12088506|FG000|COMPLETED|Wash-out Period||36
10920988|NCT00200967|12088507|FG001|COMPLETED|Wash-out Period||43
10920989|NCT00200967|12088506|FG000|NOT COMPLETED|Wash-out Period||0
10920990|NCT00200967|12088507|FG001|NOT COMPLETED|Wash-out Period||1
10920991|NCT00200967|12088506|FG000|STARTED|Second Treatment Period||36
10920992|NCT00200967|12088507|FG001|STARTED|Second Treatment Period||43
10920993|NCT00200967|12088506|FG000|COMPLETED|Second Treatment Period||35
10920994|NCT00200967|12088507|FG001|COMPLETED|Second Treatment Period||41
10920995|NCT00200967|12088506|FG000|NOT COMPLETED|Second Treatment Period||1
10920996|NCT00200967|12088507|FG001|NOT COMPLETED|Second Treatment Period||2
10920997|NCT00200967|12088506|FG000|STARTED|Run-out Period||35
10920998|NCT00200967|12088507|FG001|STARTED|Run-out Period||41
10920999|NCT00200967|12088506|FG000|COMPLETED|Run-out Period||34
10921000|NCT00200967|12088507|FG001|COMPLETED|Run-out Period||41
10921001|NCT00200967|12088506|FG000|NOT COMPLETED|Run-out Period||1
10921002|NCT00200967|12088507|FG001|NOT COMPLETED|Run-out Period||0
10921003|NCT00201006|12088516|FG000|STARTED|Overall Study||83
10921004|NCT00201006|12088517|FG001|STARTED|Overall Study||72
10921005|NCT00201006|12088518|FG002|STARTED|Overall Study||79
10921006|NCT00201006|12088516|FG000|COMPLETED|Overall Study||75
10921007|NCT00201006|12088517|FG001|COMPLETED|Overall Study||70
10921008|NCT00201006|12088518|FG002|COMPLETED|Overall Study||75
10921009|NCT00201006|12088516|FG000|NOT COMPLETED|Overall Study||8
10921010|NCT00201006|12088517|FG001|NOT COMPLETED|Overall Study||2
10921011|NCT00201006|12088518|FG002|NOT COMPLETED|Overall Study||4
10921012|NCT00201123|12088529|FG000|STARTED|Overall Study||32
10921013|NCT00201123|12088530|FG001|STARTED|Overall Study||32
10921014|NCT00201123|12088531|FG002|STARTED|Overall Study||32
10921015|NCT00201123|12088529|FG000|Did Not Meet Continuation Criteria|Overall Study||2
10921016|NCT00201123|12088530|FG001|Did Not Meet Continuation Criteria|Overall Study||0
10921017|NCT00201123|12088531|FG002|Did Not Meet Continuation Criteria|Overall Study||5
10921018|NCT00201123|12088529|FG000|COMPLETED|Overall Study||26
10921019|NCT00201123|12088530|FG001|COMPLETED|Overall Study||28
10921020|NCT00201123|12088531|FG002|COMPLETED|Overall Study||23
10921021|NCT00201123|12088529|FG000|NOT COMPLETED|Overall Study||6
10921022|NCT00201123|12088530|FG001|NOT COMPLETED|Overall Study||4
10921023|NCT00201123|12088531|FG002|NOT COMPLETED|Overall Study||9
10921024|NCT00201201|12088545|FG000|STARTED|Overall Study||87
10921025|NCT00201201|12088546|FG001|STARTED|Overall Study||73
10921026|NCT00201201|12088545|FG000|COMPLETED|Overall Study||82
10921027|NCT00201201|12088546|FG001|COMPLETED|Overall Study||66
10921028|NCT00201201|12088545|FG000|NOT COMPLETED|Overall Study||5
10921029|NCT00201201|12088546|FG001|NOT COMPLETED|Overall Study||7
10921030|NCT00201240|12088552|FG000|STARTED|Overall Study||47
10921031|NCT00201240|12088552|FG000|COMPLETED|Overall Study||44
10921032|NCT00201240|12088552|FG000|NOT COMPLETED|Overall Study||3
10921033|NCT00201409|12088559|FG000|STARTED|Overall Study||65
10921034|NCT00201409|12088560|FG001|STARTED|Overall Study||67
10921035|NCT00201409|12088559|FG000|COMPLETED|Overall Study||64
10921036|NCT00201409|12088560|FG001|COMPLETED|Overall Study||66
10921037|NCT00201409|12088559|FG000|NOT COMPLETED|Overall Study||1
10921038|NCT00201409|12088560|FG001|NOT COMPLETED|Overall Study||1
10921039|NCT00201448|12088568|FG000|STARTED|Overall Study||42
10921040|NCT00201448|12088569|FG001|STARTED|Overall Study||40
10921041|NCT00201448|12088568|FG000|COMPLETED|Overall Study||42
10921042|NCT00201448|12088569|FG001|COMPLETED|Overall Study||40
10921043|NCT00201448|12088568|FG000|NOT COMPLETED|Overall Study||0
10921044|NCT00201448|12088569|FG001|NOT COMPLETED|Overall Study||0
10921045|NCT00201643|12088579|FG000|STARTED|Overall Study||223
10921046|NCT00201643|12088580|FG001|STARTED|Overall Study||214
10921047|NCT00201643|12088579|FG000|COMPLETED|Overall Study||218
10921048|NCT00201643|12088580|FG001|COMPLETED|Overall Study||210
10921049|NCT00201643|12088579|FG000|NOT COMPLETED|Overall Study||5
10921050|NCT00201643|12088580|FG001|NOT COMPLETED|Overall Study||4
10921051|NCT00201734|12088588|FG000|STARTED|Overall Study||32
10921052|NCT00201734|12088589|FG001|STARTED|Overall Study||25
10921053|NCT00201734|12088588|FG000|Patients Not Evaluable|Overall Study||3
10921054|NCT00201734|12088589|FG001|Patients Not Evaluable|Overall Study||0
10921055|NCT00201734|12088588|FG000|COMPLETED|Overall Study||29
10921056|NCT00201734|12088589|FG001|COMPLETED|Overall Study||25
10921057|NCT00201734|12088588|FG000|NOT COMPLETED|Overall Study||3
10921058|NCT00201734|12088589|FG001|NOT COMPLETED|Overall Study||0
10921059|NCT00201760|12088598|FG000|STARTED|Overall Study||5
10921060|NCT00201760|12088599|FG001|STARTED|Overall Study||5
10921061|NCT00201760|12088598|FG000|COMPLETED|Overall Study||5
10921062|NCT00201760|12088599|FG001|COMPLETED|Overall Study||5
10921063|NCT00201760|12088598|FG000|NOT COMPLETED|Overall Study||0
10921064|NCT00201760|12088599|FG001|NOT COMPLETED|Overall Study||0
10921065|NCT00201773|12088605|FG000|STARTED|Overall Study||22
10921066|NCT00201773|12088605|FG000|Completed 8 Weeks of Planned Therapy|Overall Study||16
10921067|NCT00201773|12088605|FG000|Received All Exemestane Therapy|Overall Study||5
10921068|NCT00201773|12088605|FG000|Stopped Exemestane After 4 Weeks|Overall Study||1
10921069|NCT00201773|12088605|FG000|COMPLETED|Overall Study||16
10921070|NCT00201773|12088605|FG000|NOT COMPLETED|Overall Study||6
10921071|NCT00201825|12088612|FG000|STARTED|Overall Study||29
10921072|NCT00201825|12088612|FG000|COMPLETED|Overall Study||29
10921073|NCT00201825|12088612|FG000|NOT COMPLETED|Overall Study||0
10921074|NCT00201838|12088618|FG000|STARTED|Overall Study||30
10921075|NCT00201838|12088619|FG001|STARTED|Overall Study||8
10921076|NCT00201838|12088618|FG000|Treatment Cohort|Overall Study||30
10921077|NCT00201838|12088619|FG001|Treatment Cohort|Overall Study||8
10921078|NCT00201838|12088618|FG000|COMPLETED|Overall Study||30
10921079|NCT00201838|12088619|FG001|COMPLETED|Overall Study||8
10921080|NCT00201838|12088618|FG000|NOT COMPLETED|Overall Study||0
10921081|NCT00201838|12088619|FG001|NOT COMPLETED|Overall Study||0
10921082|NCT00201851|12088634|FG000|STARTED|Overall Study||252
10921083|NCT00201851|12088635|FG001|STARTED|Overall Study||257
10921084|NCT00201851|12088636|FG002|STARTED|Overall Study||231
10921085|NCT00201851|12088634|FG000|COMPLETED|Overall Study||244
10921086|NCT00201851|12088635|FG001|COMPLETED|Overall Study||255
10921087|NCT00201851|12088636|FG002|COMPLETED|Overall Study||230
10921088|NCT00201851|12088634|FG000|NOT COMPLETED|Overall Study||8
10921089|NCT00201851|12088635|FG001|NOT COMPLETED|Overall Study||2
10921090|NCT00201851|12088636|FG002|NOT COMPLETED|Overall Study||1
10921091|NCT00201864|12088644|FG000|STARTED|Overall Study||40
10921092|NCT00201864|12088644|FG000|COMPLETED|Overall Study||40
10921093|NCT00201864|12088644|FG000|NOT COMPLETED|Overall Study||0
10921094|NCT00201877|12088650|FG000|STARTED|Overall Study||25
10921095|NCT00201877|12088650|FG000|COMPLETED|Overall Study||25
10921096|NCT00201877|12088650|FG000|NOT COMPLETED|Overall Study||0
10921097|NCT00202449|12088658|FG000|STARTED|Overall Study||18
10921098|NCT00202449|12088659|FG001|STARTED|Overall Study||20
10921099|NCT00202449|12088660|FG002|STARTED|Overall Study||21
10921100|NCT00202449|12088658|FG000|COMPLETED|Overall Study||7
10921101|NCT00202449|12088659|FG001|COMPLETED|Overall Study||9
10921102|NCT00202449|12088660|FG002|COMPLETED|Overall Study||9
10921103|NCT00202449|12088658|FG000|NOT COMPLETED|Overall Study||11
10921104|NCT00202449|12088659|FG001|NOT COMPLETED|Overall Study||11
10921105|NCT00202449|12088660|FG002|NOT COMPLETED|Overall Study||12
10921192|NCT00203424|12088768|FG000|COMPLETED|Follow-up Period||10
10921106|NCT00202644|12088670|FG000|STARTED|Overall Study|One participant not randomized but treated.|76
10921107|NCT00202644|12088671|FG001|STARTED|Overall Study||70
10921108|NCT00202644|12088670|FG000|COMPLETED|Overall Study||41
10921109|NCT00202644|12088671|FG001|COMPLETED|Overall Study||43
10921110|NCT00202644|12088670|FG000|NOT COMPLETED|Overall Study||35
10921111|NCT00202644|12088671|FG001|NOT COMPLETED|Overall Study||27
10921112|NCT00202722|12088677|FG000|STARTED|Overall Study||41
10921113|NCT00202722|12088677|FG000|COMPLETED|Overall Study||41
10921114|NCT00202722|12088677|FG000|NOT COMPLETED|Overall Study||0
10921115|NCT00202839|12088684|FG000|STARTED|Overall Study||78
10921116|NCT00202839|12088685|FG001|STARTED|Overall Study||82
10921117|NCT00202839|12088684|FG000|COMPLETED|Overall Study||54
10921118|NCT00202839|12088685|FG001|COMPLETED|Overall Study||72
10921119|NCT00202839|12088684|FG000|NOT COMPLETED|Overall Study||24
10921120|NCT00202839|12088685|FG001|NOT COMPLETED|Overall Study||10
10921121|NCT00202930|12088691|FG000|STARTED|Overall Study||4
10921122|NCT00202930|12088691|FG000|COMPLETED|Overall Study||4
10921123|NCT00202930|12088691|FG000|NOT COMPLETED|Overall Study||0
10921124|NCT00203021|12088697|FG000|STARTED|Overall Study||107
10921125|NCT00203021|12088698|FG001|STARTED|Overall Study||101
10921126|NCT00203021|12088697|FG000|Received at Least 1 Dose of Study Drug|Overall Study||107
10921127|NCT00203021|12088698|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101
10921128|NCT00203021|12088697|FG000|COMPLETED|Overall Study||28
10921129|NCT00203021|12088698|FG001|COMPLETED|Overall Study||24
10921130|NCT00203021|12088697|FG000|NOT COMPLETED|Overall Study||79
10921131|NCT00203021|12088698|FG001|NOT COMPLETED|Overall Study||77
10921132|NCT00203047|12088706|FG000|STARTED|Overall Study||204
10921133|NCT00203047|12088707|FG001|STARTED|Overall Study||210
10921134|NCT00203047|12088706|FG000|In Database as of January 29, 2009|Overall Study||199
10921135|NCT00203047|12088707|FG001|In Database as of January 29, 2009|Overall Study||209
10921136|NCT00203047|12088706|FG000|COMPLETED|Overall Study||13
10921137|NCT00203047|12088707|FG001|COMPLETED|Overall Study||7
10921138|NCT00203047|12088706|FG000|NOT COMPLETED|Overall Study||191
10921139|NCT00203047|12088707|FG001|NOT COMPLETED|Overall Study||203
10921140|NCT00203203|12088715|FG000|STARTED|Overall Study||10
10921141|NCT00203203|12088716|FG001|STARTED|Overall Study||20
10921142|NCT00203203|12088715|FG000|COMPLETED|Overall Study||9
10921143|NCT00203203|12088716|FG001|COMPLETED|Overall Study||20
10921144|NCT00203203|12088715|FG000|NOT COMPLETED|Overall Study||1
10921145|NCT00203203|12088716|FG001|NOT COMPLETED|Overall Study||0
10921146|NCT00203216|12088722|FG000|STARTED|Overall Study||31
10921147|NCT00203216|12088722|FG000|COMPLETED|Overall Study||27
10921148|NCT00203216|12088722|FG000|NOT COMPLETED|Overall Study||4
10921149|NCT00203229|12088728|FG000|STARTED|Overall Study||10
10921150|NCT00203229|12088729|FG001|STARTED|Overall Study||10
10921151|NCT00203229|12088728|FG000|COMPLETED|Overall Study||7
10921152|NCT00203229|12088729|FG001|COMPLETED|Overall Study||7
10921153|NCT00203229|12088728|FG000|NOT COMPLETED|Overall Study||3
10921154|NCT00203229|12088729|FG001|NOT COMPLETED|Overall Study||3
10921155|NCT00203242|12088735|FG000|STARTED|Overall Study||15
10921156|NCT00203242|12088735|FG000|COMPLETED|Overall Study||14
10921157|NCT00203242|12088735|FG000|NOT COMPLETED|Overall Study||1
10921158|NCT00203268|12088739|FG000|STARTED|Early Treatment||13
10921159|NCT00203268|12088739|FG000|COMPLETED|Early Treatment||9
10921160|NCT00203268|12088739|FG000|NOT COMPLETED|Early Treatment||4
10921161|NCT00203268|12088739|FG000|STARTED|Late Treatment||9
10921162|NCT00203268|12088739|FG000|COMPLETED|Late Treatment||9
10921163|NCT00203268|12088739|FG000|NOT COMPLETED|Late Treatment||0
10921164|NCT00203294|12088747|FG000|STARTED|Overall Study||22
10921165|NCT00203294|12088748|FG001|STARTED|Overall Study||23
10921166|NCT00203294|12088747|FG000|COMPLETED|Overall Study||14
10921167|NCT00203294|12088748|FG001|COMPLETED|Overall Study||10
10921168|NCT00203294|12088747|FG000|NOT COMPLETED|Overall Study||8
10921169|NCT00203294|12088748|FG001|NOT COMPLETED|Overall Study||13
10921170|NCT00203307|12088756|FG000|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
10921171|NCT00203307|12088757|FG001|STARTED|First Intervention||0
10921172|NCT00203307|12088756|FG000|COMPLETED|First Intervention||1
10921173|NCT00203307|12088757|FG001|COMPLETED|First Intervention||0
10921174|NCT00203307|12088756|FG000|NOT COMPLETED|First Intervention||2
10921175|NCT00203307|12088757|FG001|NOT COMPLETED|First Intervention||0
10921176|NCT00203307|12088756|FG000|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
10921177|NCT00203307|12088757|FG001|STARTED|Second Intervention||0
10921178|NCT00203307|12088756|FG000|COMPLETED|Second Intervention||1
10921179|NCT00203307|12088757|FG001|COMPLETED|Second Intervention||0
10921180|NCT00203307|12088756|FG000|NOT COMPLETED|Second Intervention||0
10921181|NCT00203307|12088757|FG001|NOT COMPLETED|Second Intervention||0
10921182|NCT00203411|12088763|FG000|STARTED|Treatment Period||45
10921183|NCT00203411|12088763|FG000|COMPLETED|Treatment Period||45
10921184|NCT00203411|12088763|FG000|NOT COMPLETED|Treatment Period||0
10921185|NCT00203411|12088763|FG000|STARTED|Follow-up||45
10921186|NCT00203411|12088763|FG000|COMPLETED|Follow-up||41
10921187|NCT00203411|12088763|FG000|NOT COMPLETED|Follow-up||4
10921188|NCT00203424|12088768|FG000|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
10921189|NCT00203424|12088768|FG000|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
10921190|NCT00203424|12088768|FG000|NOT COMPLETED|Treatment Period||11
10921191|NCT00203424|12088768|FG000|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
10921193|NCT00203424|12088768|FG000|NOT COMPLETED|Follow-up Period||6
10921194|NCT00203476|12088775|FG000|STARTED|Overall Study||10
10921195|NCT00203476|12088776|FG001|STARTED|Overall Study||10
10921196|NCT00203476|12088777|FG002|STARTED|Overall Study||10
10921197|NCT00203476|12088775|FG000|COMPLETED|Overall Study||9
10921198|NCT00203476|12088776|FG001|COMPLETED|Overall Study||9
10921199|NCT00203476|12088777|FG002|COMPLETED|Overall Study||10
10921200|NCT00203476|12088775|FG000|NOT COMPLETED|Overall Study||1
10921201|NCT00203476|12088776|FG001|NOT COMPLETED|Overall Study||1
10921202|NCT00203476|12088777|FG002|NOT COMPLETED|Overall Study||0
10921203|NCT00203502|12088785|FG000|STARTED|Overall Study||40
10921204|NCT00203502|12088785|FG000|COMPLETED|Overall Study||39
10921205|NCT00203502|12088785|FG000|NOT COMPLETED|Overall Study||1
10921206|NCT00203892|12088792|FG000|STARTED|Overall Study||7
10921207|NCT00203892|12088793|FG001|STARTED|Overall Study||10
10921208|NCT00203892|12088794|FG002|STARTED|Overall Study||6
10921209|NCT00203892|12088792|FG000|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
10921210|NCT00203892|12088793|FG001|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
10921211|NCT00203892|12088794|FG002|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
10921212|NCT00203892|12088792|FG000|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
10921213|NCT00203892|12088793|FG001|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
10921214|NCT00203892|12088794|FG002|COMPLETED|Overall Study||6
10921215|NCT00203892|12088792|FG000|NOT COMPLETED|Overall Study||2
10921216|NCT00203892|12088793|FG001|NOT COMPLETED|Overall Study||2
10921217|NCT00203892|12088794|FG002|NOT COMPLETED|Overall Study||0
10921218|NCT00203931|12088804|FG000|STARTED|Overall Study||27
10921219|NCT00203931|12088805|FG001|STARTED|Overall Study||28
10921220|NCT00203931|12088804|FG000|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
10921221|NCT00203931|12088805|FG001|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
10921222|NCT00203931|12088804|FG000|NOT COMPLETED|Overall Study||7
10921223|NCT00203931|12088805|FG001|NOT COMPLETED|Overall Study||5
10921224|NCT00203996|12088821|FG000|STARTED|Overall Study||0
10921225|NCT00203996|12088822|FG001|STARTED|Overall Study||0
10921226|NCT00203996|12088823|FG002|STARTED|Overall Study||0
10921227|NCT00203996|12088824|FG003|STARTED|Overall Study||19
10921228|NCT00203996|12088825|FG004|STARTED|Overall Study||4
10921229|NCT00203996|12088826|FG005|STARTED|Overall Study||3
10921230|NCT00203996|12088827|FG006|STARTED|Overall Study||2
10921231|NCT00203996|12088828|FG007|STARTED|Overall Study||4
10921232|NCT00203996|12088829|FG008|STARTED|Overall Study||2
10921233|NCT00203996|12088830|FG009|STARTED|Overall Study||3
10921234|NCT00203996|12088821|FG000|Aim 3 Only: First Intervention|Overall Study||0
10921235|NCT00203996|12088822|FG001|Aim 3 Only: First Intervention|Overall Study||0
10921236|NCT00203996|12088823|FG002|Aim 3 Only: First Intervention|Overall Study||0
10921237|NCT00203996|12088824|FG003|Aim 3 Only: First Intervention|Overall Study||0
10921238|NCT00203996|12088825|FG004|Aim 3 Only: First Intervention|Overall Study||0
10921239|NCT00203996|12088826|FG005|Aim 3 Only: First Intervention|Overall Study||3
10921240|NCT00203996|12088827|FG006|Aim 3 Only: First Intervention|Overall Study||2
10921241|NCT00203996|12088828|FG007|Aim 3 Only: First Intervention|Overall Study||4
10921242|NCT00203996|12088829|FG008|Aim 3 Only: First Intervention|Overall Study||2
10921243|NCT00203996|12088830|FG009|Aim 3 Only: First Intervention|Overall Study||3
10921244|NCT00203996|12088821|FG000|Aim 3 Only: Washout|Overall Study||0
10921245|NCT00203996|12088822|FG001|Aim 3 Only: Washout|Overall Study||0
10921246|NCT00203996|12088823|FG002|Aim 3 Only: Washout|Overall Study||0
10921247|NCT00203996|12088824|FG003|Aim 3 Only: Washout|Overall Study||0
10921248|NCT00203996|12088825|FG004|Aim 3 Only: Washout|Overall Study||0
10921249|NCT00203996|12088826|FG005|Aim 3 Only: Washout|Overall Study||3
10921250|NCT00203996|12088827|FG006|Aim 3 Only: Washout|Overall Study||2
10921251|NCT00203996|12088828|FG007|Aim 3 Only: Washout|Overall Study||2
10921252|NCT00203996|12088829|FG008|Aim 3 Only: Washout|Overall Study||2
10921253|NCT00203996|12088830|FG009|Aim 3 Only: Washout|Overall Study||2
10921254|NCT00203996|12088821|FG000|Aim 3 Only: Second Intervention|Overall Study||0
10921255|NCT00203996|12088822|FG001|Aim 3 Only: Second Intervention|Overall Study||0
10921256|NCT00203996|12088823|FG002|Aim 3 Only: Second Intervention|Overall Study||0
10921257|NCT00203996|12088824|FG003|Aim 3 Only: Second Intervention|Overall Study||0
10921258|NCT00203996|12088825|FG004|Aim 3 Only: Second Intervention|Overall Study||0
10921259|NCT00203996|12088826|FG005|Aim 3 Only: Second Intervention|Overall Study||3
10921260|NCT00203996|12088827|FG006|Aim 3 Only: Second Intervention|Overall Study||2
10921261|NCT00203996|12088828|FG007|Aim 3 Only: Second Intervention|Overall Study||2
10921262|NCT00203996|12088829|FG008|Aim 3 Only: Second Intervention|Overall Study||2
10921263|NCT00203996|12088830|FG009|Aim 3 Only: Second Intervention|Overall Study||2
10921264|NCT00203996|12088821|FG000|Aim 3 Only: Second Washout|Overall Study||0
10921265|NCT00203996|12088822|FG001|Aim 3 Only: Second Washout|Overall Study||0
10921266|NCT00203996|12088823|FG002|Aim 3 Only: Second Washout|Overall Study||0
10921267|NCT00203996|12088824|FG003|Aim 3 Only: Second Washout|Overall Study||0
10921268|NCT00203996|12088825|FG004|Aim 3 Only: Second Washout|Overall Study||0
10921269|NCT00203996|12088826|FG005|Aim 3 Only: Second Washout|Overall Study||3
10921270|NCT00203996|12088827|FG006|Aim 3 Only: Second Washout|Overall Study||2
10921271|NCT00203996|12088828|FG007|Aim 3 Only: Second Washout|Overall Study||2
10921272|NCT00203996|12088829|FG008|Aim 3 Only: Second Washout|Overall Study||2
10921273|NCT00203996|12088830|FG009|Aim 3 Only: Second Washout|Overall Study||2
10921274|NCT00203996|12088821|FG000|Aim 3 Only: Third Intervention|Overall Study||0
10921275|NCT00203996|12088822|FG001|Aim 3 Only: Third Intervention|Overall Study||0
10921276|NCT00203996|12088823|FG002|Aim 3 Only: Third Intervention|Overall Study||0
10921277|NCT00203996|12088824|FG003|Aim 3 Only: Third Intervention|Overall Study||0
10921278|NCT00203996|12088825|FG004|Aim 3 Only: Third Intervention|Overall Study||0
10921279|NCT00203996|12088826|FG005|Aim 3 Only: Third Intervention|Overall Study||3
10921280|NCT00203996|12088827|FG006|Aim 3 Only: Third Intervention|Overall Study||2
10921281|NCT00203996|12088828|FG007|Aim 3 Only: Third Intervention|Overall Study||2
10921282|NCT00203996|12088829|FG008|Aim 3 Only: Third Intervention|Overall Study||2
10921283|NCT00203996|12088830|FG009|Aim 3 Only: Third Intervention|Overall Study||2
10921284|NCT00203996|12088821|FG000|COMPLETED|Overall Study||0
10921285|NCT00203996|12088822|FG001|COMPLETED|Overall Study||0
10921286|NCT00203996|12088823|FG002|COMPLETED|Overall Study||0
10921287|NCT00203996|12088824|FG003|COMPLETED|Overall Study||9
10921288|NCT00203996|12088825|FG004|COMPLETED|Overall Study||3
10921289|NCT00203996|12088826|FG005|COMPLETED|Overall Study||3
10921290|NCT00203996|12088827|FG006|COMPLETED|Overall Study||2
10921291|NCT00203996|12088828|FG007|COMPLETED|Overall Study||2
10921292|NCT00203996|12088829|FG008|COMPLETED|Overall Study||2
10921293|NCT00203996|12088830|FG009|COMPLETED|Overall Study||2
10921294|NCT00203996|12088821|FG000|NOT COMPLETED|Overall Study||0
10921295|NCT00203996|12088822|FG001|NOT COMPLETED|Overall Study||0
10921296|NCT00203996|12088823|FG002|NOT COMPLETED|Overall Study||0
10921297|NCT00203996|12088824|FG003|NOT COMPLETED|Overall Study||10
10921298|NCT00203996|12088825|FG004|NOT COMPLETED|Overall Study||1
10921299|NCT00203996|12088826|FG005|NOT COMPLETED|Overall Study||0
10921300|NCT00203996|12088827|FG006|NOT COMPLETED|Overall Study||0
10921301|NCT00203996|12088828|FG007|NOT COMPLETED|Overall Study||2
10921302|NCT00203996|12088829|FG008|NOT COMPLETED|Overall Study||0
10921303|NCT00203996|12088830|FG009|NOT COMPLETED|Overall Study||1
10921304|NCT00204373|12088846|FG000|STARTED|Overall Study||72
10921305|NCT00204373|12088846|FG000|COMPLETED|Overall Study||72
10921306|NCT00204373|12088846|FG000|NOT COMPLETED|Overall Study||0
10921307|NCT00204932|12088852|FG000|STARTED|Overall Study||24
10921308|NCT00204932|12088853|FG001|STARTED|Overall Study||24
10921309|NCT00204932|12088852|FG000|COMPLETED|Overall Study||22
10921310|NCT00204932|12088853|FG001|COMPLETED|Overall Study||18
10921311|NCT00204932|12088852|FG000|NOT COMPLETED|Overall Study||2
10921312|NCT00204932|12088853|FG001|NOT COMPLETED|Overall Study||6
10921313|NCT00205179|12088861|FG000|STARTED|Overall Study||32
10921314|NCT00205179|12088862|FG001|STARTED|Overall Study||33
10921315|NCT00205179|12088861|FG000|COMPLETED|Overall Study||30
10921316|NCT00205179|12088862|FG001|COMPLETED|Overall Study||29
10921317|NCT00205179|12088861|FG000|NOT COMPLETED|Overall Study||2
10921318|NCT00205179|12088862|FG001|NOT COMPLETED|Overall Study||4
10921319|NCT00205348|12088869|FG000|STARTED|Overall Study||146
10921320|NCT00205348|12088869|FG000|COMPLETED|Overall Study||116
10921321|NCT00205348|12088869|FG000|NOT COMPLETED|Overall Study||30
10921322|NCT00205374|12088875|FG000|STARTED|Overall Study||10
10921323|NCT00205374|12088876|FG001|STARTED|Overall Study||9
10921324|NCT00205374|12088875|FG000|COMPLETED|Overall Study||10
10921325|NCT00205374|12088876|FG001|COMPLETED|Overall Study||9
10921326|NCT00205374|12088875|FG000|NOT COMPLETED|Overall Study||0
10921327|NCT00205374|12088876|FG001|NOT COMPLETED|Overall Study||0
10921328|NCT00205504|12088884|FG000|STARTED|Overall Study||21
10921329|NCT00205504|12088885|FG001|STARTED|Overall Study||15
10921330|NCT00205504|12088884|FG000|COMPLETED|Overall Study||14
10921331|NCT00205504|12088885|FG001|COMPLETED|Overall Study||15
10921332|NCT00205504|12088884|FG000|NOT COMPLETED|Overall Study||7
10921333|NCT00205504|12088885|FG001|NOT COMPLETED|Overall Study||0
10921334|NCT00205660|12088897|FG000|STARTED|Overall Study||14
10921335|NCT00205660|12088898|FG001|STARTED|Overall Study||37
10921336|NCT00205660|12088897|FG000|COMPLETED|Overall Study||12
10921337|NCT00205660|12088898|FG001|COMPLETED|Overall Study||35
10921338|NCT00205660|12088897|FG000|NOT COMPLETED|Overall Study||2
10921339|NCT00205660|12088898|FG001|NOT COMPLETED|Overall Study||2
10921340|NCT00205699|12088908|FG000|STARTED|Overall Study||49
10921341|NCT00205699|12088909|FG001|STARTED|Overall Study||46
10921342|NCT00205699|12088910|FG002|STARTED|Overall Study||49
10921343|NCT00205699|12088908|FG000|COMPLETED|Overall Study||46
10921344|NCT00205699|12088909|FG001|COMPLETED|Overall Study||40
10921345|NCT00205699|12088910|FG002|COMPLETED|Overall Study||43
10921346|NCT00205699|12088908|FG000|NOT COMPLETED|Overall Study||3
10921347|NCT00205699|12088909|FG001|NOT COMPLETED|Overall Study||6
10921348|NCT00205699|12088910|FG002|NOT COMPLETED|Overall Study||6
10921349|NCT00205712|12088923|FG000|STARTED|Overall Study||20
10921350|NCT00205712|12088924|FG001|STARTED|Overall Study||20
10921351|NCT00205712|12088923|FG000|COMPLETED|Overall Study||20
10921352|NCT00205712|12088924|FG001|COMPLETED|Overall Study||19
10921353|NCT00205712|12088923|FG000|NOT COMPLETED|Overall Study||0
10921354|NCT00205712|12088924|FG001|NOT COMPLETED|Overall Study||1
10921355|NCT00205777|12088936|FG000|STARTED|Core Study (Up to 3 Years)||1907
10921356|NCT00205777|12088937|FG001|STARTED|Core Study (Up to 3 Years)||1904
10921357|NCT00205777|12088938|FG002|STARTED|Core Study (Up to 3 Years)||1884
10921358|NCT00205777|12088939|FG003|STARTED|Core Study (Up to 3 Years)||1914
10921359|NCT00205777|12088940|FG004|STARTED|Core Study (Up to 3 Years)||0
10921360|NCT00205777|12088941|FG005|STARTED|Core Study (Up to 3 Years)||0
10921361|NCT00205777|12088936|FG000|TREATED|Core Study (Up to 3 Years)||1886
10921362|NCT00205777|12088937|FG001|TREATED|Core Study (Up to 3 Years)||1872
10921363|NCT00205777|12088938|FG002|TREATED|Core Study (Up to 3 Years)||1849
10921364|NCT00205777|12088939|FG003|TREATED|Core Study (Up to 3 Years)||1885
10921365|NCT00205777|12088940|FG004|TREATED|Core Study (Up to 3 Years)||0
10921366|NCT00205777|12088941|FG005|TREATED|Core Study (Up to 3 Years)||0
10921367|NCT00205777|12088936|FG000|COMPLETED|Core Study (Up to 3 Years)||1279
10921368|NCT00205777|12088937|FG001|COMPLETED|Core Study (Up to 3 Years)||1245
10921369|NCT00205777|12088938|FG002|COMPLETED|Core Study (Up to 3 Years)||1277
10921370|NCT00205777|12088939|FG003|COMPLETED|Core Study (Up to 3 Years)||1282
10921371|NCT00205777|12088940|FG004|COMPLETED|Core Study (Up to 3 Years)||0
10921372|NCT00205777|12088941|FG005|COMPLETED|Core Study (Up to 3 Years)||0
10921373|NCT00205777|12088936|FG000|NOT COMPLETED|Core Study (Up to 3 Years)||628
10921374|NCT00205777|12088937|FG001|NOT COMPLETED|Core Study (Up to 3 Years)||659
10921375|NCT00205777|12088938|FG002|NOT COMPLETED|Core Study (Up to 3 Years)||607
10921376|NCT00205777|12088939|FG003|NOT COMPLETED|Core Study (Up to 3 Years)||632
10921377|NCT00205777|12088940|FG004|NOT COMPLETED|Core Study (Up to 3 Years)||0
10921378|NCT00205777|12088941|FG005|NOT COMPLETED|Core Study (Up to 3 Years)||0
10921379|NCT00205777|12088936|FG000|STARTED|Completed Core Study, Entered SE I||1279
10921380|NCT00205777|12088937|FG001|STARTED|Completed Core Study, Entered SE I||1245
10921381|NCT00205777|12088938|FG002|STARTED|Completed Core Study, Entered SE I||1277
10921382|NCT00205777|12088939|FG003|STARTED|Completed Core Study, Entered SE I||1282
10921383|NCT00205777|12088940|FG004|STARTED|Completed Core Study, Entered SE I||0
10921384|NCT00205777|12088941|FG005|STARTED|Completed Core Study, Entered SE I||0
10921385|NCT00205777|12088936|FG000|COMPLETED|Completed Core Study, Entered SE I||1047
10921386|NCT00205777|12088937|FG001|COMPLETED|Completed Core Study, Entered SE I||1041
10921387|NCT00205777|12088938|FG002|COMPLETED|Completed Core Study, Entered SE I||1070
10921388|NCT00205777|12088939|FG003|COMPLETED|Completed Core Study, Entered SE I||1058
10921389|NCT00205777|12088940|FG004|COMPLETED|Completed Core Study, Entered SE I||0
10921390|NCT00205777|12088941|FG005|COMPLETED|Completed Core Study, Entered SE I||0
10921391|NCT00205777|12088936|FG000|NOT COMPLETED|Completed Core Study, Entered SE I||232
10921392|NCT00205777|12088937|FG001|NOT COMPLETED|Completed Core Study, Entered SE I||204
10921393|NCT00205777|12088938|FG002|NOT COMPLETED|Completed Core Study, Entered SE I||207
10921394|NCT00205777|12088939|FG003|NOT COMPLETED|Completed Core Study, Entered SE I||224
10921395|NCT00205777|12088940|FG004|NOT COMPLETED|Completed Core Study, Entered SE I||0
10921396|NCT00205777|12088941|FG005|NOT COMPLETED|Completed Core Study, Entered SE I||0
10921397|NCT00205777|12088936|FG000|STARTED|Study Extension I||1047
10921398|NCT00205777|12088937|FG001|STARTED|Study Extension I||0
10921399|NCT00205777|12088938|FG002|STARTED|Study Extension I||1070
10921400|NCT00205777|12088939|FG003|STARTED|Study Extension I||1058
10921401|NCT00205777|12088940|FG004|STARTED|Study Extension I||1041
10921402|NCT00205777|12088941|FG005|STARTED|Study Extension I||0
10921403|NCT00205777|12088936|FG000|COMPLETED|Study Extension I||833
10921404|NCT00205777|12088937|FG001|COMPLETED|Study Extension I||0
10921405|NCT00205777|12088938|FG002|COMPLETED|Study Extension I||0
10921406|NCT00205777|12088939|FG003|COMPLETED|Study Extension I||830
10921407|NCT00205777|12088940|FG004|COMPLETED|Study Extension I||840
10921408|NCT00205777|12088941|FG005|COMPLETED|Study Extension I||0
10921409|NCT00205777|12088936|FG000|NOT COMPLETED|Study Extension I||214
10921410|NCT00205777|12088937|FG001|NOT COMPLETED|Study Extension I||0
10921411|NCT00205777|12088938|FG002|NOT COMPLETED|Study Extension I||1070
10921412|NCT00205777|12088939|FG003|NOT COMPLETED|Study Extension I||228
10921413|NCT00205777|12088940|FG004|NOT COMPLETED|Study Extension I||201
10921414|NCT00205777|12088941|FG005|NOT COMPLETED|Study Extension I||0
10921415|NCT00205777|12088936|FG000|STARTED|Completed SE I, Entered Extension SE II||833
10921416|NCT00205777|12088937|FG001|STARTED|Completed SE I, Entered Extension SE II||0
10921417|NCT00205777|12088938|FG002|STARTED|Completed SE I, Entered Extension SE II||0
10921418|NCT00205777|12088939|FG003|STARTED|Completed SE I, Entered Extension SE II||830
10921419|NCT00205777|12088940|FG004|STARTED|Completed SE I, Entered Extension SE II||840
10921420|NCT00205777|12088941|FG005|STARTED|Completed SE I, Entered Extension SE II||0
10921421|NCT00205777|12088936|FG000|COMPLETED|Completed SE I, Entered Extension SE II||560
10921422|NCT00205777|12088937|FG001|COMPLETED|Completed SE I, Entered Extension SE II||0
10921423|NCT00205777|12088938|FG002|COMPLETED|Completed SE I, Entered Extension SE II||0
10921424|NCT00205777|12088939|FG003|COMPLETED|Completed SE I, Entered Extension SE II||590
10921425|NCT00205777|12088940|FG004|COMPLETED|Completed SE I, Entered Extension SE II||582
10921426|NCT00205777|12088941|FG005|COMPLETED|Completed SE I, Entered Extension SE II||0
10921427|NCT00205777|12088936|FG000|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
10921428|NCT00205777|12088937|FG001|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
10921429|NCT00205777|12088938|FG002|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
10921430|NCT00205777|12088939|FG003|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
10921431|NCT00205777|12088940|FG004|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
10921432|NCT00205777|12088941|FG005|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
10921433|NCT00205777|12088936|FG000|STARTED|Study Extension II||0
10921434|NCT00205777|12088937|FG001|STARTED|Study Extension II||0
10921435|NCT00205777|12088938|FG002|STARTED|Study Extension II||0
10921436|NCT00205777|12088939|FG003|STARTED|Study Extension II||590
10921437|NCT00205777|12088940|FG004|STARTED|Study Extension II||0
10921438|NCT00205777|12088941|FG005|STARTED|Study Extension II||1142
10921439|NCT00205777|12088936|FG000|TREATED|Study Extension II||0
10921440|NCT00205777|12088937|FG001|TREATED|Study Extension II||0
10921441|NCT00205777|12088938|FG002|TREATED|Study Extension II||0
10921442|NCT00205777|12088939|FG003|TREATED|Study Extension II||519
10921443|NCT00205777|12088940|FG004|TREATED|Study Extension II||0
10921444|NCT00205777|12088941|FG005|TREATED|Study Extension II||1011
10921445|NCT00205777|12088936|FG000|COMPLETED|Study Extension II||0
10921446|NCT00205777|12088937|FG001|COMPLETED|Study Extension II||0
10921447|NCT00205777|12088938|FG002|COMPLETED|Study Extension II||0
10921448|NCT00205777|12088939|FG003|COMPLETED|Study Extension II||441
10921449|NCT00205777|12088940|FG004|COMPLETED|Study Extension II||0
10921450|NCT00205777|12088941|FG005|COMPLETED|Study Extension II||860
10921451|NCT00205777|12088936|FG000|NOT COMPLETED|Study Extension II||0
10921452|NCT00205777|12088937|FG001|NOT COMPLETED|Study Extension II||0
10921453|NCT00205777|12088938|FG002|NOT COMPLETED|Study Extension II||0
10921454|NCT00205777|12088939|FG003|NOT COMPLETED|Study Extension II||149
10921455|NCT00205777|12088940|FG004|NOT COMPLETED|Study Extension II||0
10921456|NCT00205777|12088941|FG005|NOT COMPLETED|Study Extension II||282
10921457|NCT00205803|12088958|FG000|STARTED|Infant Series||122
10921458|NCT00205803|12088959|FG001|STARTED|Infant Series||127
10921459|NCT00205803|12088958|FG000|Vaccinated Dose 1|Infant Series||121
10921460|NCT00205803|12088959|FG001|Vaccinated Dose 1|Infant Series||126
10921461|NCT00205803|12088958|FG000|Vaccinated Dose 2|Infant Series||115
10921462|NCT00205803|12088959|FG001|Vaccinated Dose 2|Infant Series||122
10921463|NCT00205803|12088958|FG000|Vaccinated Dose 3|Infant Series||110
10921464|NCT00205803|12088959|FG001|Vaccinated Dose 3|Infant Series||118
10921465|NCT00205803|12088958|FG000|COMPLETED|Infant Series||104
10921466|NCT00205803|12088959|FG001|COMPLETED|Infant Series||116
10921467|NCT00205803|12088958|FG000|NOT COMPLETED|Infant Series||18
10921468|NCT00205803|12088959|FG001|NOT COMPLETED|Infant Series||11
10921469|NCT00205803|12088958|FG000|STARTED|After Infant Series||104
10921470|NCT00205803|12088959|FG001|STARTED|After Infant Series||116
10921471|NCT00205803|12088958|FG000|COMPLETED|After Infant Series||86
10921472|NCT00205803|12088959|FG001|COMPLETED|After Infant Series||103
10921473|NCT00205803|12088958|FG000|NOT COMPLETED|After Infant Series||18
10921474|NCT00205803|12088959|FG001|NOT COMPLETED|After Infant Series||13
10921475|NCT00205803|12088958|FG000|STARTED|Toddler Dose||86
10921476|NCT00205803|12088959|FG001|STARTED|Toddler Dose||103
10921477|NCT00205803|12088958|FG000|COMPLETED|Toddler Dose||84
10921478|NCT00205803|12088959|FG001|COMPLETED|Toddler Dose||100
10921479|NCT00205803|12088958|FG000|NOT COMPLETED|Toddler Dose||2
10921480|NCT00205803|12088959|FG001|NOT COMPLETED|Toddler Dose||3
10921481|NCT00205855|12088983|FG000|STARTED|Overall Study||65
10921482|NCT00205855|12088983|FG000|COMPLETED|Overall Study||44
10921483|NCT00205855|12088983|FG000|NOT COMPLETED|Overall Study||21
10921484|NCT00205881|12088987|FG000|STARTED|Overall Study||32
10921485|NCT00205881|12088987|FG000|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
10921486|NCT00205881|12088987|FG000|NOT COMPLETED|Overall Study||16
10921487|NCT00206076|12088994|FG000|STARTED|Overall Study||9
10921488|NCT00206076|12088995|FG001|STARTED|Overall Study||10
10921489|NCT00206076|12088994|FG000|COMPLETED|Overall Study||6
10921490|NCT00206076|12088995|FG001|COMPLETED|Overall Study||9
10921491|NCT00206076|12088994|FG000|NOT COMPLETED|Overall Study||3
10921492|NCT00206076|12088995|FG001|NOT COMPLETED|Overall Study||1
10921493|NCT00206102|12089005|FG000|STARTED|Overall Study||596
10921494|NCT00206102|12089006|FG001|STARTED|Overall Study||502
10921495|NCT00206102|12089005|FG000|COMPLETED|Overall Study||188
10921496|NCT00206102|12089006|FG001|COMPLETED|Overall Study||187
10921497|NCT00206102|12089005|FG000|NOT COMPLETED|Overall Study||408
10921498|NCT00206102|12089006|FG001|NOT COMPLETED|Overall Study||315
10921499|NCT00206323|12089014|FG000|STARTED|Overall Study||14
10921500|NCT00206323|12089015|FG001|STARTED|Overall Study||15
10921501|NCT00206323|12089014|FG000|COMPLETED|Overall Study||8
10921502|NCT00206323|12089015|FG001|COMPLETED|Overall Study||12
10921503|NCT00206323|12089014|FG000|NOT COMPLETED|Overall Study||6
10921504|NCT00206323|12089015|FG001|NOT COMPLETED|Overall Study||3
10921505|NCT00206336|12089021|FG000|STARTED|Overall Study||20
10921506|NCT00206336|12089021|FG000|COMPLETED|Overall Study||20
10921507|NCT00206336|12089021|FG000|NOT COMPLETED|Overall Study||0
10921508|NCT00206427|12089025|FG000|STARTED|Overall Study|Received First Dose|49
10921509|NCT00206427|12089025|FG000|COMPLETED|Overall Study|Complete 6-week therapy|47
10921510|NCT00206427|12089025|FG000|NOT COMPLETED|Overall Study||2
10921511|NCT00206440|12089031|FG000|STARTED|Overall Study||21
10921512|NCT00206440|12089032|FG001|STARTED|Overall Study||22
10921513|NCT00206440|12089031|FG000|COMPLETED|Overall Study||16
10921514|NCT00206440|12089032|FG001|COMPLETED|Overall Study||18
10921515|NCT00206440|12089031|FG000|NOT COMPLETED|Overall Study||5
10921516|NCT00206440|12089032|FG001|NOT COMPLETED|Overall Study||4
10921517|NCT00206518|12089040|FG000|STARTED|Overall Study||83
10921518|NCT00206518|12089041|FG001|STARTED|Overall Study||84
10921519|NCT00206518|12089040|FG000|COMPLETED|Overall Study||73
10921520|NCT00206518|12089041|FG001|COMPLETED|Overall Study||78
10921521|NCT00206518|12089040|FG000|NOT COMPLETED|Overall Study||10
10921522|NCT00206518|12089041|FG001|NOT COMPLETED|Overall Study||6
10921523|NCT00206726|12089047|FG000|STARTED|Overall Study||60
10921524|NCT00206726|12089047|FG000|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
10921525|NCT00206726|12089047|FG000|4 Cycles Completed|Overall Study|per protocol population|41
10921526|NCT00206726|12089047|FG000|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
10921527|NCT00206726|12089047|FG000|NOT COMPLETED|Overall Study||51
10921528|NCT00207090|12089051|FG000|STARTED|Overall Study|Number of participants treated|15
10921529|NCT00207090|12089051|FG000|COMPLETED|Overall Study||8
10921530|NCT00207090|12089051|FG000|NOT COMPLETED|Overall Study||7
10921531|NCT00207142|12089063|FG000|STARTED|Induction Phase||252
10921532|NCT00207142|12089064|FG001|STARTED|Induction Phase||0
10921533|NCT00207142|12089065|FG002|STARTED|Induction Phase||0
10921534|NCT00207142|12089066|FG003|STARTED|Induction Phase||0
10921535|NCT00207142|12089063|FG000|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
10921536|NCT00207142|12089064|FG001|COMPLETED|Induction Phase||0
10921537|NCT00207142|12089065|FG002|COMPLETED|Induction Phase||0
10921538|NCT00207142|12089066|FG003|COMPLETED|Induction Phase||0
10921539|NCT00207142|12089063|FG000|NOT COMPLETED|Induction Phase||30
10921540|NCT00207142|12089064|FG001|NOT COMPLETED|Induction Phase||0
10921541|NCT00207142|12089065|FG002|NOT COMPLETED|Induction Phase||0
10921542|NCT00207142|12089066|FG003|NOT COMPLETED|Induction Phase||0
10921543|NCT00207142|12089063|FG000|STARTED|Maintenance Phase/Rescue Phase||0
10921544|NCT00207142|12089064|FG001|STARTED|Maintenance Phase/Rescue Phase||87
10921545|NCT00207142|12089065|FG002|STARTED|Maintenance Phase/Rescue Phase||85
10921546|NCT00207142|12089066|FG003|STARTED|Maintenance Phase/Rescue Phase||50
10921547|NCT00207142|12089063|FG000|COMPLETED|Maintenance Phase/Rescue Phase||0
10921548|NCT00207142|12089064|FG001|COMPLETED|Maintenance Phase/Rescue Phase||78
10921549|NCT00207142|12089065|FG002|COMPLETED|Maintenance Phase/Rescue Phase||72
10921550|NCT00207142|12089066|FG003|COMPLETED|Maintenance Phase/Rescue Phase||41
10921551|NCT00207142|12089063|FG000|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
10921552|NCT00207142|12089064|FG001|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
10921553|NCT00207142|12089065|FG002|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
10921554|NCT00207142|12089066|FG003|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
10921555|NCT00207714|12089086|FG000|STARTED|Overall Study||35
10921556|NCT00207714|12089087|FG001|STARTED|Overall Study||35
10921557|NCT00207714|12089088|FG002|STARTED|Overall Study||34
10921558|NCT00207714|12089089|FG003|STARTED|Overall Study||34
10921559|NCT00207714|12089090|FG004|STARTED|Overall Study||34
10921560|NCT00207714|12089086|FG000|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
10921561|NCT00207714|12089087|FG001|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
10921562|NCT00207714|12089088|FG002|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
10921563|NCT00207714|12089089|FG003|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
10921564|NCT00207714|12089090|FG004|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
10921565|NCT00207714|12089086|FG000|NOT COMPLETED|Overall Study||14
10921566|NCT00207714|12089087|FG001|NOT COMPLETED|Overall Study||7
10921567|NCT00207714|12089088|FG002|NOT COMPLETED|Overall Study||10
10921568|NCT00207714|12089089|FG003|NOT COMPLETED|Overall Study||8
10921569|NCT00207714|12089090|FG004|NOT COMPLETED|Overall Study||5
10921570|NCT00207727|12089114|FG000|STARTED|Overall Study||49
10921571|NCT00207727|12089115|FG001|STARTED|Overall Study||50
10921572|NCT00207727|12089116|FG002|STARTED|Overall Study||50
10921573|NCT00207727|12089117|FG003|STARTED|Overall Study||50
10921574|NCT00207727|12089118|FG004|STARTED|Overall Study||50
10921575|NCT00207727|12089114|FG000|COMPLETED|Overall Study||11
10921576|NCT00207727|12089115|FG001|COMPLETED|Overall Study||8
10921577|NCT00207727|12089116|FG002|COMPLETED|Overall Study||9
10921578|NCT00207727|12089117|FG003|COMPLETED|Overall Study||13
10921579|NCT00207727|12089118|FG004|COMPLETED|Overall Study||16
10921580|NCT00207727|12089114|FG000|NOT COMPLETED|Overall Study||38
10921581|NCT00207727|12089115|FG001|NOT COMPLETED|Overall Study||42
10921582|NCT00207727|12089116|FG002|NOT COMPLETED|Overall Study||41
10921583|NCT00207727|12089117|FG003|NOT COMPLETED|Overall Study||37
10921584|NCT00207727|12089118|FG004|NOT COMPLETED|Overall Study||34
10921585|NCT00207740|12089134|FG000|STARTED|Overall Study||78
10921586|NCT00207740|12089135|FG001|STARTED|Overall Study||77
10921587|NCT00207740|12089136|FG002|STARTED|Overall Study||76
10921588|NCT00207740|12089137|FG003|STARTED|Overall Study||78
10921589|NCT00207740|12089134|FG000|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
10921590|NCT00207740|12089135|FG001|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
10921591|NCT00207740|12089136|FG002|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
10921592|NCT00207740|12089137|FG003|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
10921593|NCT00207740|12089134|FG000|NOT COMPLETED|Overall Study||29
10921594|NCT00207740|12089135|FG001|NOT COMPLETED|Overall Study||41
10921595|NCT00207740|12089136|FG002|NOT COMPLETED|Overall Study||40
10921596|NCT00207740|12089137|FG003|NOT COMPLETED|Overall Study||43
10921597|NCT00207883|12089153|FG000|STARTED|Overall Study||93
10921598|NCT00207883|12089154|FG001|STARTED|Overall Study||119
10921599|NCT00207883|12089153|FG000|COMPLETED|Overall Study||93
10921600|NCT00207883|12089154|FG001|COMPLETED|Overall Study||119
10921601|NCT00207883|12089153|FG000|NOT COMPLETED|Overall Study||0
10921602|NCT00207883|12089154|FG001|NOT COMPLETED|Overall Study||0
10921603|NCT00208026|12089160|FG000|STARTED|Overall Study||3
10921604|NCT00208026|12089160|FG000|COMPLETED|Overall Study||3
10921605|NCT00208026|12089160|FG000|NOT COMPLETED|Overall Study||0
10921606|NCT00208091|12089166|FG000|STARTED|Overall Study||16
10921607|NCT00208091|12089166|FG000|COMPLETED|Overall Study||16
10921608|NCT00208091|12089166|FG000|NOT COMPLETED|Overall Study||0
10921609|NCT00208325|12089178|FG000|STARTED|Overall Study||193
10921610|NCT00208325|12089179|FG001|STARTED|Overall Study||196
10921611|NCT00208325|12089180|FG002|STARTED|Overall Study||170
10921612|NCT00208325|12089181|FG003|STARTED|Overall Study||161
10921613|NCT00208325|12089178|FG000|COMPLETED|Overall Study||142
10921614|NCT00208325|12089179|FG001|COMPLETED|Overall Study||142
10921615|NCT00208325|12089180|FG002|COMPLETED|Overall Study||156
10921616|NCT00208325|12089181|FG003|COMPLETED|Overall Study||147
10921617|NCT00208325|12089178|FG000|NOT COMPLETED|Overall Study||51
10921618|NCT00208325|12089179|FG001|NOT COMPLETED|Overall Study||54
10921619|NCT00208325|12089180|FG002|NOT COMPLETED|Overall Study||14
10921620|NCT00208325|12089181|FG003|NOT COMPLETED|Overall Study||14
10921621|NCT00208494|12089193|FG000|STARTED|Overall Study||194
10921622|NCT00208494|12089194|FG001|STARTED|Overall Study||196
10921623|NCT00208494|12089193|FG000|COMPLETED|Overall Study||164
10921624|NCT00208494|12089194|FG001|COMPLETED|Overall Study||162
10921625|NCT00208494|12089193|FG000|NOT COMPLETED|Overall Study||30
10921626|NCT00208494|12089194|FG001|NOT COMPLETED|Overall Study||34
10921627|NCT00208507|12089202|FG000|STARTED|Overall Study||177
10921628|NCT00208507|12089203|FG001|STARTED|Overall Study||87
10921629|NCT00208507|12089202|FG000|COMPLETED|Overall Study||163
10921630|NCT00208507|12089203|FG001|COMPLETED|Overall Study||79
10921631|NCT00208507|12089202|FG000|NOT COMPLETED|Overall Study||14
10921632|NCT00208507|12089203|FG001|NOT COMPLETED|Overall Study||8
10921633|NCT00208767|12089211|FG000|STARTED|Overall Study||80
10921634|NCT00208767|12089212|FG001|STARTED|Overall Study||40
10921635|NCT00208767|12089211|FG000|COMPLETED|Overall Study||53
10921636|NCT00208767|12089212|FG001|COMPLETED|Overall Study||33
10921637|NCT00208767|12089211|FG000|NOT COMPLETED|Overall Study||27
10921638|NCT00208767|12089212|FG001|NOT COMPLETED|Overall Study||7
10921639|NCT00208949|12089220|FG000|STARTED|Overall Study||25
10921640|NCT00208949|12089221|FG001|STARTED|Overall Study||25
10921641|NCT00208949|12089220|FG000|COMPLETED|Overall Study||25
10921642|NCT00208949|12089221|FG001|COMPLETED|Overall Study||25
10921643|NCT00208949|12089220|FG000|NOT COMPLETED|Overall Study||0
10921644|NCT00208949|12089221|FG001|NOT COMPLETED|Overall Study||0
10921645|NCT00208975|12089227|FG000|STARTED|Overall Study||15
10921646|NCT00208975|12089227|FG000|COMPLETED|Overall Study||15
10921647|NCT00208975|12089227|FG000|NOT COMPLETED|Overall Study||0
10921648|NCT00209092|12089234|FG000|STARTED|Overall Study||25
10921649|NCT00209092|12089235|FG001|STARTED|Overall Study||26
10921650|NCT00209092|12089234|FG000|COMPLETED|Overall Study||17
10921651|NCT00209092|12089235|FG001|COMPLETED|Overall Study||24
10921652|NCT00209092|12089234|FG000|NOT COMPLETED|Overall Study||8
10921653|NCT00209092|12089235|FG001|NOT COMPLETED|Overall Study||2
10921654|NCT00209170|12089243|FG000|STARTED|Overall Study||7
10921655|NCT00209170|12089244|FG001|STARTED|Overall Study||7
10921656|NCT00209170|12089243|FG000|COMPLETED|Overall Study||5
10921657|NCT00209170|12089244|FG001|COMPLETED|Overall Study||4
10921658|NCT00209170|12089243|FG000|NOT COMPLETED|Overall Study||2
10921659|NCT00209170|12089244|FG001|NOT COMPLETED|Overall Study||3
10921660|NCT00209274|12089252|FG000|STARTED|Overall Study||184
10921661|NCT00209274|12089253|FG001|STARTED|Overall Study||95
10921662|NCT00209274|12089252|FG000|COMPLETED|Overall Study||113
10921663|NCT00209274|12089253|FG001|COMPLETED|Overall Study||48
10921664|NCT00209274|12089252|FG000|NOT COMPLETED|Overall Study||71
10921665|NCT00209274|12089253|FG001|NOT COMPLETED|Overall Study||47
10921666|NCT00209339|12089259|FG000|STARTED|At 12 Months Follow-up||55
10921667|NCT00209339|12089259|FG000|COMPLETED|At 12 Months Follow-up||40
10921668|NCT00209339|12089259|FG000|NOT COMPLETED|At 12 Months Follow-up||15
10921669|NCT00209339|12089259|FG000|STARTED|At 24 Months Follow-up||40
10921670|NCT00209339|12089259|FG000|COMPLETED|At 24 Months Follow-up||29
10921671|NCT00209339|12089259|FG000|NOT COMPLETED|At 24 Months Follow-up||11
10921672|NCT00209339|12089259|FG000|STARTED|At 3 Years Follow-up||29
10921673|NCT00209339|12089259|FG000|COMPLETED|At 3 Years Follow-up||28
10921674|NCT00209339|12089259|FG000|NOT COMPLETED|At 3 Years Follow-up||1
10921675|NCT00209339|12089259|FG000|STARTED|At 4 Years Follow-up||28
10921676|NCT00209339|12089259|FG000|COMPLETED|At 4 Years Follow-up||23
10921677|NCT00209339|12089259|FG000|NOT COMPLETED|At 4 Years Follow-up||5
10921678|NCT00209339|12089259|FG000|STARTED|At 5 Years Follow-up||23
10921679|NCT00209339|12089259|FG000|COMPLETED|At 5 Years Follow-up||15
10921680|NCT00209339|12089259|FG000|NOT COMPLETED|At 5 Years Follow-up||8
10921681|NCT00209417|12089265|FG000|STARTED|Overall Study||321
10921682|NCT00209417|12089266|FG001|STARTED|Overall Study||327
10921683|NCT00209417|12089265|FG000|COMPLETED|Overall Study||321
10921684|NCT00209417|12089266|FG001|COMPLETED|Overall Study||327
10921685|NCT00209417|12089265|FG000|NOT COMPLETED|Overall Study||0
10921686|NCT00209417|12089266|FG001|NOT COMPLETED|Overall Study||0
10921687|NCT00209560|12089274|FG000|STARTED|Overall Study||121
10921688|NCT00209560|12089275|FG001|STARTED|Overall Study||42
10921689|NCT00209560|12089274|FG000|COMPLETED|Overall Study||120
10921690|NCT00209560|12089275|FG001|COMPLETED|Overall Study||42
10921691|NCT00209560|12089274|FG000|NOT COMPLETED|Overall Study||1
10921692|NCT00209560|12089275|FG001|NOT COMPLETED|Overall Study||0
10921693|NCT00210106|12089281|FG000|STARTED|Overall Study||52
10921694|NCT00210106|12089281|FG000|Safety Population|Overall Study||49
10921695|NCT00210106|12089281|FG000|COMPLETED|Overall Study||38
10921696|NCT00210106|12089281|FG000|NOT COMPLETED|Overall Study||14
10921697|NCT00210119|12089286|FG000|STARTED|Overall Study||19
10921698|NCT00210119|12089286|FG000|COMPLETED|Overall Study||17
10921699|NCT00210119|12089286|FG000|NOT COMPLETED|Overall Study||2
10921700|NCT00210184|12089290|FG000|STARTED|Overall Study||42
10921701|NCT00210184|12089290|FG000|COMPLETED|Overall Study||40
10921702|NCT00210184|12089290|FG000|NOT COMPLETED|Overall Study||2
10921703|NCT00210353|12089297|FG000|STARTED|Overall Study||151
10921704|NCT00210353|12089298|FG001|STARTED|Overall Study||152
10921705|NCT00210353|12089299|FG002|STARTED|Overall Study||151
10921706|NCT00210353|12089297|FG000|COMPLETED|Overall Study||113
10921707|NCT00210353|12089298|FG001|COMPLETED|Overall Study||107
10921708|NCT00210353|12089299|FG002|COMPLETED|Overall Study||125
10921709|NCT00210353|12089297|FG000|NOT COMPLETED|Overall Study||38
10921710|NCT00210353|12089298|FG001|NOT COMPLETED|Overall Study||45
10921711|NCT00210353|12089299|FG002|NOT COMPLETED|Overall Study||26
10921712|NCT00210470|12089312|FG000|STARTED|Overall Study||27
10921713|NCT00210470|12089312|FG000|COMPLETED|Overall Study||27
10921714|NCT00210470|12089312|FG000|NOT COMPLETED|Overall Study||0
10921715|NCT00210626|12089321|FG000|STARTED|Overall Study||97
10921716|NCT00210626|12089322|FG001|STARTED|Overall Study||95
10921717|NCT00210626|12089321|FG000|COMPLETED|Overall Study||49
10921718|NCT00210626|12089322|FG001|COMPLETED|Overall Study||50
10921719|NCT00210626|12089321|FG000|NOT COMPLETED|Overall Study||48
10921720|NCT00210626|12089322|FG001|NOT COMPLETED|Overall Study||45
10921721|NCT00210639|12089330|FG000|STARTED|Overall Study||124
10921722|NCT00210639|12089331|FG001|STARTED|Overall Study||83
10921723|NCT00210639|12089330|FG000|COMPLETED|Overall Study||61
10921724|NCT00210639|12089331|FG001|COMPLETED|Overall Study||41
10921725|NCT00210639|12089330|FG000|NOT COMPLETED|Overall Study||63
10921726|NCT00210639|12089331|FG001|NOT COMPLETED|Overall Study||42
10921727|NCT00211081|12089337|FG000|STARTED|Overall Study||12
10921728|NCT00211081|12089337|FG000|COMPLETED|Overall Study||10
10921729|NCT00211081|12089337|FG000|NOT COMPLETED|Overall Study||2
10921730|NCT00211172|12089343|FG000|STARTED|Overall Study||449
10921731|NCT00211172|12089344|FG001|STARTED|Overall Study||458
10921732|NCT00211172|12089343|FG000|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
10921733|NCT00211172|12089344|FG001|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
10921734|NCT00211172|12089343|FG000|NOT COMPLETED|Overall Study||39
10921735|NCT00211172|12089344|FG001|NOT COMPLETED|Overall Study||32
10921736|NCT00211185|12089350|FG000|STARTED|Overall Study||49
10921737|NCT00211185|12089350|FG000|COMPLETED|Overall Study||29
10921738|NCT00211185|12089350|FG000|NOT COMPLETED|Overall Study||20
10921739|NCT00211237|12089356|FG000|STARTED|Baseline||70
10921740|NCT00211237|12089357|FG001|STARTED|Baseline||64
10921741|NCT00211237|12089358|FG002|STARTED|Baseline||0
10921742|NCT00211237|12089356|FG000|COMPLETED|Baseline||68
10921743|NCT00211237|12089357|FG001|COMPLETED|Baseline||61
10921744|NCT00211237|12089358|FG002|COMPLETED|Baseline||0
10921745|NCT00211237|12089356|FG000|NOT COMPLETED|Baseline||2
10921746|NCT00211237|12089357|FG001|NOT COMPLETED|Baseline||3
10921747|NCT00211237|12089358|FG002|NOT COMPLETED|Baseline||0
10921748|NCT00211237|12089356|FG000|STARTED|1 Month||68
10921749|NCT00211237|12089357|FG001|STARTED|1 Month||61
10921750|NCT00211237|12089358|FG002|STARTED|1 Month||0
10921751|NCT00211237|12089356|FG000|COMPLETED|1 Month||65
10921752|NCT00211237|12089357|FG001|COMPLETED|1 Month||52
10921753|NCT00211237|12089358|FG002|COMPLETED|1 Month||0
10921754|NCT00211237|12089356|FG000|NOT COMPLETED|1 Month||3
10921755|NCT00211237|12089357|FG001|NOT COMPLETED|1 Month||9
10921756|NCT00211237|12089358|FG002|NOT COMPLETED|1 Month||0
10921757|NCT00211237|12089356|FG000|STARTED|3 Months||65
10921758|NCT00211237|12089357|FG001|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
10921759|NCT00211237|12089358|FG002|STARTED|3 Months||34
10921760|NCT00211237|12089356|FG000|COMPLETED|3 Months||57
10921761|NCT00211237|12089357|FG001|COMPLETED|3 Months||14
10921762|NCT00211237|12089358|FG002|COMPLETED|3 Months||33
10921763|NCT00211237|12089356|FG000|NOT COMPLETED|3 Months||8
10921764|NCT00211237|12089357|FG001|NOT COMPLETED|3 Months||4
10921765|NCT00211237|12089358|FG002|NOT COMPLETED|3 Months||1
10921766|NCT00211237|12089356|FG000|STARTED|6 Months||57
10921767|NCT00211237|12089357|FG001|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
10921768|NCT00211237|12089358|FG002|STARTED|6 Months||36
10921769|NCT00211237|12089356|FG000|COMPLETED|6 Months||49
10921770|NCT00211237|12089357|FG001|COMPLETED|6 Months||9
10921771|NCT00211237|12089358|FG002|COMPLETED|6 Months||33
10921772|NCT00211237|12089356|FG000|NOT COMPLETED|6 Months||8
10921773|NCT00211237|12089357|FG001|NOT COMPLETED|6 Months||2
10921774|NCT00211237|12089358|FG002|NOT COMPLETED|6 Months||3
10921775|NCT00211237|12089356|FG000|STARTED|12 Months||49
10921776|NCT00211237|12089357|FG001|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
10921777|NCT00211237|12089358|FG002|STARTED|12 Months||34
10921778|NCT00211237|12089356|FG000|COMPLETED|12 Months||40
10921779|NCT00211237|12089357|FG001|COMPLETED|12 Months||6
10921780|NCT00211237|12089358|FG002|COMPLETED|12 Months||28
10921781|NCT00211237|12089356|FG000|NOT COMPLETED|12 Months||9
10921782|NCT00211237|12089357|FG001|NOT COMPLETED|12 Months||2
10921783|NCT00211237|12089358|FG002|NOT COMPLETED|12 Months||6
10921784|NCT00211510|12089377|FG000|STARTED|Overall Study||72
10921785|NCT00211510|12089378|FG001|STARTED|Overall Study||74
10921786|NCT00211510|12089377|FG000|COMPLETED|Overall Study||66
10921787|NCT00211510|12089378|FG001|COMPLETED|Overall Study||72
10921788|NCT00211510|12089377|FG000|NOT COMPLETED|Overall Study||6
10921789|NCT00211510|12089378|FG001|NOT COMPLETED|Overall Study||2
10921790|NCT00211536|12089389|FG000|STARTED|Overall Study||53
10921791|NCT00211536|12089390|FG001|STARTED|Overall Study||54
10921792|NCT00211536|12089389|FG000|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
10921793|NCT00211536|12089390|FG001|As Treated Data Analysis Set|Overall Study||48
10921794|NCT00211536|12089389|FG000|COMPLETED|Overall Study||49
10921795|NCT00211536|12089390|FG001|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
10921796|NCT00211536|12089389|FG000|NOT COMPLETED|Overall Study||4
10921797|NCT00211536|12089390|FG001|NOT COMPLETED|Overall Study||7
10921798|NCT00211692|12089398|FG000|STARTED|Overall Study||33
10921799|NCT00211692|12089399|FG001|STARTED|Overall Study||31
10921800|NCT00211692|12089398|FG000|COMPLETED|Overall Study||33
10921801|NCT00211692|12089399|FG001|COMPLETED|Overall Study||31
10921802|NCT00211692|12089398|FG000|NOT COMPLETED|Overall Study||0
10921803|NCT00211692|12089399|FG001|NOT COMPLETED|Overall Study||0
10921804|NCT00211757|12089407|FG000|STARTED|Overall Study||11
10921805|NCT00211757|12089408|FG001|STARTED|Overall Study||16
10921806|NCT00211757|12089407|FG000|COMPLETED|Overall Study||10
10921807|NCT00211757|12089408|FG001|COMPLETED|Overall Study||14
10921808|NCT00211757|12089407|FG000|NOT COMPLETED|Overall Study||1
10921809|NCT00211757|12089408|FG001|NOT COMPLETED|Overall Study||2
10921810|NCT00211809|12089416|FG000|STARTED|Overall Study||17
10921811|NCT00211809|12089416|FG000|COMPLETED|Overall Study||11
10921812|NCT00211809|12089416|FG000|NOT COMPLETED|Overall Study||6
10921813|NCT00211887|12089425|FG000|STARTED|Overall Study||499
10921814|NCT00211887|12089426|FG001|STARTED|Overall Study||250
10921815|NCT00211887|12089427|FG002|STARTED|Overall Study||259
10921816|NCT00211887|12089425|FG000|COMPLETED|Overall Study||397
10921817|NCT00211887|12089426|FG001|COMPLETED|Overall Study||194
10921818|NCT00211887|12089427|FG002|COMPLETED|Overall Study||223
10921819|NCT00211887|12089425|FG000|NOT COMPLETED|Overall Study||102
10921820|NCT00211887|12089426|FG001|NOT COMPLETED|Overall Study||56
10921821|NCT00211887|12089427|FG002|NOT COMPLETED|Overall Study||36
10921822|NCT00212264|12089438|FG000|STARTED|Overall Study||70
10921823|NCT00212264|12089439|FG001|STARTED|Overall Study||70
10921824|NCT00212264|12089440|FG002|STARTED|Overall Study||68
10921825|NCT00212264|12089438|FG000|COMPLETED|Overall Study||58
10921826|NCT00212264|12089439|FG001|COMPLETED|Overall Study||54
10921827|NCT00212264|12089440|FG002|COMPLETED|Overall Study||64
10921828|NCT00212264|12089438|FG000|NOT COMPLETED|Overall Study||12
10921829|NCT00212264|12089439|FG001|NOT COMPLETED|Overall Study||16
10921830|NCT00212264|12089440|FG002|NOT COMPLETED|Overall Study||4
10921831|NCT00212355|12089448|FG000|STARTED|Overall Study||37
10921832|NCT00212355|12089448|FG000|COMPLETED|Overall Study||34
10921833|NCT00212355|12089448|FG000|NOT COMPLETED|Overall Study||3
10921834|NCT00212446|12089452|FG000|STARTED|Overall Study||8
10921835|NCT00212446|12089452|FG000|COMPLETED|Overall Study||8
10921836|NCT00212446|12089452|FG000|NOT COMPLETED|Overall Study||0
10921837|NCT00212758|12089456|FG000|STARTED|First Intervention (7 Days)||8
10921838|NCT00212758|12089457|FG001|STARTED|First Intervention (7 Days)||9
10921839|NCT00212758|12089456|FG000|COMPLETED|First Intervention (7 Days)||8
10921840|NCT00212758|12089457|FG001|COMPLETED|First Intervention (7 Days)||9
10921841|NCT00212758|12089456|FG000|NOT COMPLETED|First Intervention (7 Days)||0
10921842|NCT00212758|12089457|FG001|NOT COMPLETED|First Intervention (7 Days)||0
10921843|NCT00212758|12089456|FG000|STARTED|Wash Out Period (2 Weeks)||8
10921844|NCT00212758|12089457|FG001|STARTED|Wash Out Period (2 Weeks)||9
10921845|NCT00212758|12089456|FG000|COMPLETED|Wash Out Period (2 Weeks)||8
10921846|NCT00212758|12089457|FG001|COMPLETED|Wash Out Period (2 Weeks)||9
10921847|NCT00212758|12089456|FG000|NOT COMPLETED|Wash Out Period (2 Weeks)||0
10921848|NCT00212758|12089457|FG001|NOT COMPLETED|Wash Out Period (2 Weeks)||0
10921849|NCT00212758|12089456|FG000|STARTED|Second Intervention (7 Days)||8
10921850|NCT00212758|12089457|FG001|STARTED|Second Intervention (7 Days)||9
10921851|NCT00212758|12089456|FG000|COMPLETED|Second Intervention (7 Days)||8
10921852|NCT00212758|12089457|FG001|COMPLETED|Second Intervention (7 Days)||9
10921853|NCT00212758|12089456|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
10921854|NCT00212758|12089457|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
10921855|NCT00212758|12089456|FG000|STARTED|Standard Therapy of GH (12 Months)||8
10921856|NCT00212758|12089457|FG001|STARTED|Standard Therapy of GH (12 Months)||9
10921857|NCT00212758|12089456|FG000|COMPLETED|Standard Therapy of GH (12 Months)||6
10921858|NCT00212758|12089457|FG001|COMPLETED|Standard Therapy of GH (12 Months)||8
10921859|NCT00212758|12089456|FG000|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
10921860|NCT00212758|12089457|FG001|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
10921861|NCT00212888|12089466|FG000|STARTED|Overall Study||19
10921862|NCT00212888|12089467|FG001|STARTED|Overall Study||18
10921863|NCT00212888|12089468|FG002|STARTED|Overall Study||15
10921864|NCT00212888|12089466|FG000|COMPLETED|Overall Study||16
10921865|NCT00212888|12089467|FG001|COMPLETED|Overall Study||18
10921866|NCT00212888|12089468|FG002|COMPLETED|Overall Study||14
10921867|NCT00212888|12089466|FG000|NOT COMPLETED|Overall Study||3
10921868|NCT00212888|12089467|FG001|NOT COMPLETED|Overall Study||0
10921869|NCT00212888|12089468|FG002|NOT COMPLETED|Overall Study||1
10921870|NCT00213135|12089481|FG000|STARTED|Overall Study||456
10921871|NCT00213135|12089482|FG001|STARTED|Overall Study||433
10921872|NCT00213135|12089483|FG002|STARTED|Overall Study||437
10921873|NCT00213135|12089481|FG000|COMPLETED|Overall Study||406
10921874|NCT00213135|12089482|FG001|COMPLETED|Overall Study||398
10921875|NCT00213135|12089483|FG002|COMPLETED|Overall Study||380
10921876|NCT00213135|12089481|FG000|NOT COMPLETED|Overall Study||50
10921877|NCT00213135|12089482|FG001|NOT COMPLETED|Overall Study||35
10921878|NCT00213135|12089483|FG002|NOT COMPLETED|Overall Study||57
10921879|NCT00213148|12089495|FG000|STARTED|Cycle 1 (1 Month)||77
10921880|NCT00213148|12089496|FG001|STARTED|Cycle 1 (1 Month)||0
10921881|NCT00213148|12089497|FG002|STARTED|Cycle 1 (1 Month)||79
10921882|NCT00213148|12089498|FG003|STARTED|Cycle 1 (1 Month)||76
10921883|NCT00213148|12089499|FG004|STARTED|Cycle 1 (1 Month)||39
10921884|NCT00213148|12089495|FG000|COMPLETED|Cycle 1 (1 Month)||53
10921885|NCT00213148|12089496|FG001|COMPLETED|Cycle 1 (1 Month)||0
10921886|NCT00213148|12089497|FG002|COMPLETED|Cycle 1 (1 Month)||60
10921887|NCT00213148|12089498|FG003|COMPLETED|Cycle 1 (1 Month)||58
10921888|NCT00213148|12089499|FG004|COMPLETED|Cycle 1 (1 Month)||17
10921889|NCT00213148|12089495|FG000|NOT COMPLETED|Cycle 1 (1 Month)||24
10921890|NCT00213148|12089496|FG001|NOT COMPLETED|Cycle 1 (1 Month)||0
10921891|NCT00213148|12089497|FG002|NOT COMPLETED|Cycle 1 (1 Month)||19
10921892|NCT00213148|12089498|FG003|NOT COMPLETED|Cycle 1 (1 Month)||18
10921893|NCT00213148|12089499|FG004|NOT COMPLETED|Cycle 1 (1 Month)||22
10921894|NCT00213148|12089495|FG000|STARTED|Cycle 2 (1 Month)||43
10921895|NCT00213148|12089496|FG001|STARTED|Cycle 2 (1 Month)||10
10921896|NCT00213148|12089497|FG002|STARTED|Cycle 2 (1 Month)||42
10921897|NCT00213148|12089498|FG003|STARTED|Cycle 2 (1 Month)||52
10921898|NCT00213148|12089499|FG004|STARTED|Cycle 2 (1 Month)||41
10921899|NCT00213148|12089495|FG000|COMPLETED|Cycle 2 (1 Month)||29
10921900|NCT00213148|12089496|FG001|COMPLETED|Cycle 2 (1 Month)||4
10921901|NCT00213148|12089497|FG002|COMPLETED|Cycle 2 (1 Month)||28
10921902|NCT00213148|12089498|FG003|COMPLETED|Cycle 2 (1 Month)||33
10921903|NCT00213148|12089499|FG004|COMPLETED|Cycle 2 (1 Month)||11
10921904|NCT00213148|12089495|FG000|NOT COMPLETED|Cycle 2 (1 Month)||14
10921905|NCT00213148|12089496|FG001|NOT COMPLETED|Cycle 2 (1 Month)||6
10921906|NCT00213148|12089497|FG002|NOT COMPLETED|Cycle 2 (1 Month)||14
10921907|NCT00213148|12089498|FG003|NOT COMPLETED|Cycle 2 (1 Month)||19
10921908|NCT00213148|12089499|FG004|NOT COMPLETED|Cycle 2 (1 Month)||30
10921909|NCT00213148|12089495|FG000|STARTED|Cycle 3 (1 Month)||23
10921910|NCT00213148|12089496|FG001|STARTED|Cycle 3 (1 Month)||10
10921911|NCT00213148|12089497|FG002|STARTED|Cycle 3 (1 Month)||26
10921912|NCT00213148|12089498|FG003|STARTED|Cycle 3 (1 Month)||24
10921913|NCT00213148|12089499|FG004|STARTED|Cycle 3 (1 Month)||22
10921914|NCT00213148|12089495|FG000|COMPLETED|Cycle 3 (1 Month)||23
10921915|NCT00213148|12089496|FG001|COMPLETED|Cycle 3 (1 Month)||8
10921916|NCT00213148|12089497|FG002|COMPLETED|Cycle 3 (1 Month)||25
10921917|NCT00213148|12089498|FG003|COMPLETED|Cycle 3 (1 Month)||23
10921918|NCT00213148|12089499|FG004|COMPLETED|Cycle 3 (1 Month)||21
10921919|NCT00213148|12089495|FG000|NOT COMPLETED|Cycle 3 (1 Month)||0
10921920|NCT00213148|12089496|FG001|NOT COMPLETED|Cycle 3 (1 Month)||2
10921921|NCT00213148|12089497|FG002|NOT COMPLETED|Cycle 3 (1 Month)||1
10921922|NCT00213148|12089498|FG003|NOT COMPLETED|Cycle 3 (1 Month)||1
10921923|NCT00213148|12089499|FG004|NOT COMPLETED|Cycle 3 (1 Month)||1
10921924|NCT00213239|12089521|FG000|STARTED|Overall Study||32
10921925|NCT00213239|12089522|FG001|STARTED|Overall Study||32
10921926|NCT00213239|12089521|FG000|COMPLETED|Overall Study||32
10921927|NCT00213239|12089522|FG001|COMPLETED|Overall Study||32
10921928|NCT00213239|12089521|FG000|NOT COMPLETED|Overall Study||0
10921929|NCT00213239|12089522|FG001|NOT COMPLETED|Overall Study||0
10921930|NCT00213980|12089530|FG000|STARTED|Overall Study||32
10921931|NCT00213980|12089531|FG001|STARTED|Overall Study||36
10921932|NCT00213980|12089530|FG000|COMPLETED|Overall Study||26
10921933|NCT00213980|12089531|FG001|COMPLETED|Overall Study||29
10921934|NCT00213980|12089530|FG000|NOT COMPLETED|Overall Study||6
10921935|NCT00213980|12089531|FG001|NOT COMPLETED|Overall Study||7
10921936|NCT00214019|12089537|FG000|STARTED|Overall Study||36
10921937|NCT00214019|12089537|FG000|Placebo/Placebo Arm|Overall Study||6
10921938|NCT00214019|12089537|FG000|Placebo/Salmeterol Arm|Overall Study||6
10921939|NCT00214019|12089537|FG000|Fluticasone/Placebo Arm|Overall Study||6
10921940|NCT00214019|12089537|FG000|Fluticason/Salmeterol Arm|Overall Study||6
10921941|NCT00214019|12089537|FG000|COMPLETED|Overall Study||6
10921942|NCT00214019|12089537|FG000|NOT COMPLETED|Overall Study||30
10921943|NCT00214045|12089546|FG000|STARTED|Overall Study||18
10921944|NCT00214045|12089547|FG001|STARTED|Overall Study||18
10921945|NCT00214045|12089546|FG000|COMPLETED|Overall Study||18
10921946|NCT00214045|12089547|FG001|COMPLETED|Overall Study||18
10921947|NCT00214045|12089546|FG000|NOT COMPLETED|Overall Study||0
10921948|NCT00214045|12089547|FG001|NOT COMPLETED|Overall Study||0
10921949|NCT00214097|12089556|FG000|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101
10921950|NCT00214097|12089557|FG001|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111
10921951|NCT00214097|12089558|FG002|STARTED|Overall Study||135
10921952|NCT00214097|12089556|FG000|COMPLETED|Overall Study||101
10921953|NCT00214097|12089557|FG001|COMPLETED|Overall Study||111
10921954|NCT00214097|12089558|FG002|COMPLETED|Overall Study||135
10921955|NCT00214097|12089556|FG000|NOT COMPLETED|Overall Study||0
10921956|NCT00214097|12089557|FG001|NOT COMPLETED|Overall Study||0
10921957|NCT00214097|12089558|FG002|NOT COMPLETED|Overall Study||0
10921958|NCT00214136|12089572|FG000|STARTED|Overall Study||30
10921959|NCT00214136|12089572|FG000|COMPLETED|Overall Study||25
10921960|NCT00214136|12089572|FG000|NOT COMPLETED|Overall Study||5
10921961|NCT00214201|12089578|FG000|STARTED|Overall Study||20
10921962|NCT00214201|12089579|FG001|STARTED|Overall Study||20
10921963|NCT00214201|12089578|FG000|COMPLETED|Overall Study||18
10921964|NCT00214201|12089579|FG001|COMPLETED|Overall Study||18
10921965|NCT00214201|12089578|FG000|NOT COMPLETED|Overall Study||2
10921966|NCT00214201|12089579|FG001|NOT COMPLETED|Overall Study||2
10921967|NCT00214383|12089588|FG000|STARTED|Overall Study||148
10921968|NCT00214383|12089589|FG001|STARTED|Overall Study||153
10921969|NCT00214383|12089588|FG000|COMPLETED|Overall Study||132
10921970|NCT00214383|12089589|FG001|COMPLETED|Overall Study||127
10921971|NCT00214383|12089588|FG000|NOT COMPLETED|Overall Study||16
10921972|NCT00214383|12089589|FG001|NOT COMPLETED|Overall Study||26
10921973|NCT00214422|12089598|FG000|STARTED|Overall Study||12
10921974|NCT00214422|12089599|FG001|STARTED|Overall Study||3
10921975|NCT00214422|12089600|FG002|STARTED|Overall Study||4
10921976|NCT00214422|12089598|FG000|COMPLETED|Overall Study||7
10921977|NCT00214422|12089599|FG001|COMPLETED|Overall Study||2
10921978|NCT00214422|12089600|FG002|COMPLETED|Overall Study||3
10921979|NCT00214422|12089598|FG000|NOT COMPLETED|Overall Study||5
10921980|NCT00214422|12089599|FG001|NOT COMPLETED|Overall Study||1
10921981|NCT00214422|12089600|FG002|NOT COMPLETED|Overall Study||1
10921982|NCT00214461|12089616|FG000|STARTED|Overall Study||12
10921983|NCT00214461|12089617|FG001|STARTED|Overall Study||12
10921984|NCT00214461|12089618|FG002|STARTED|Overall Study||12
10921985|NCT00214461|12089619|FG003|STARTED|Overall Study||12
10921986|NCT00214461|12089616|FG000|COMPLETED|Overall Study||12
10921987|NCT00214461|12089617|FG001|COMPLETED|Overall Study||12
10921988|NCT00214461|12089618|FG002|COMPLETED|Overall Study||10
10921989|NCT00214461|12089619|FG003|COMPLETED|Overall Study||11
10921990|NCT00214461|12089616|FG000|NOT COMPLETED|Overall Study||0
10921991|NCT00214461|12089617|FG001|NOT COMPLETED|Overall Study||0
10921992|NCT00214461|12089618|FG002|NOT COMPLETED|Overall Study||2
10921993|NCT00214461|12089619|FG003|NOT COMPLETED|Overall Study||1
10921994|NCT00214487|12089631|FG000|STARTED|Overall Study||43
10921995|NCT00214487|12089632|FG001|STARTED|Overall Study||43
10921996|NCT00214487|12089631|FG000|COMPLETED|Overall Study||38
10921997|NCT00214487|12089632|FG001|COMPLETED|Overall Study||40
10921998|NCT00214487|12089631|FG000|NOT COMPLETED|Overall Study||5
10921999|NCT00214487|12089632|FG001|NOT COMPLETED|Overall Study||3
10922000|NCT00214526|12089640|FG000|STARTED|Randomized||56
10922001|NCT00214526|12089641|FG001|STARTED|Randomized||56
10922002|NCT00214526|12089640|FG000|COMPLETED|Randomized||55
10922003|NCT00214526|12089641|FG001|COMPLETED|Randomized||54
10922004|NCT00214526|12089640|FG000|NOT COMPLETED|Randomized||1
10922005|NCT00214526|12089641|FG001|NOT COMPLETED|Randomized||2
10922006|NCT00214526|12089640|FG000|STARTED|Treatment Period||55
10922007|NCT00214526|12089641|FG001|STARTED|Treatment Period||54
10922008|NCT00214526|12089640|FG000|COMPLETED|Treatment Period||53
10922009|NCT00214526|12089641|FG001|COMPLETED|Treatment Period||49
10922010|NCT00214526|12089640|FG000|NOT COMPLETED|Treatment Period||2
10922011|NCT00214526|12089641|FG001|NOT COMPLETED|Treatment Period||5
10922012|NCT00214526|12089640|FG000|STARTED|Post-Treatment Period||53
10922013|NCT00214526|12089641|FG001|STARTED|Post-Treatment Period||49
10922014|NCT00214526|12089640|FG000|COMPLETED|Post-Treatment Period||52
10922015|NCT00214526|12089641|FG001|COMPLETED|Post-Treatment Period||49
10922016|NCT00214526|12089640|FG000|NOT COMPLETED|Post-Treatment Period||1
10922017|NCT00214526|12089641|FG001|NOT COMPLETED|Post-Treatment Period||0
10922018|NCT00214539|12089651|FG000|STARTED|Randomized||17
10922019|NCT00214539|12089652|FG001|STARTED|Randomized||17
10922020|NCT00214539|12089651|FG000|COMPLETED|Randomized||15
10922021|NCT00214539|12089652|FG001|COMPLETED|Randomized||17
10922022|NCT00214539|12089651|FG000|NOT COMPLETED|Randomized||2
10922023|NCT00214539|12089652|FG001|NOT COMPLETED|Randomized||0
10922024|NCT00214539|12089651|FG000|STARTED|Treatment Period||15
10922025|NCT00214539|12089652|FG001|STARTED|Treatment Period||17
10922026|NCT00214539|12089651|FG000|COMPLETED|Treatment Period||15
10922027|NCT00214539|12089652|FG001|COMPLETED|Treatment Period||17
10922028|NCT00214539|12089651|FG000|NOT COMPLETED|Treatment Period||0
10922029|NCT00214539|12089652|FG001|NOT COMPLETED|Treatment Period||0
10922030|NCT00214539|12089651|FG000|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
10922031|NCT00214539|12089652|FG001|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
10922032|NCT00214539|12089651|FG000|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
10922033|NCT00214539|12089652|FG001|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
10922034|NCT00214539|12089651|FG000|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
10922035|NCT00214539|12089652|FG001|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
10922036|NCT00214539|12089651|FG000|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
10922037|NCT00214539|12089652|FG001|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
10922038|NCT00214539|12089651|FG000|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
10922039|NCT00214539|12089652|FG001|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
10922040|NCT00214539|12089651|FG000|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
10922041|NCT00214539|12089652|FG001|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
10922042|NCT00214786|12089662|FG000|STARTED|Overall Study||4
10922043|NCT00214786|12089662|FG000|COMPLETED|Overall Study||1
10922044|NCT00214786|12089662|FG000|NOT COMPLETED|Overall Study||3
10922045|NCT00214890|12089668|FG000|STARTED|Overall Study||10
10922046|NCT00214890|12089669|FG001|STARTED|Overall Study||11
10922047|NCT00214890|12089668|FG000|COMPLETED|Overall Study||10
10922048|NCT00214890|12089669|FG001|COMPLETED|Overall Study||11
10922049|NCT00214890|12089668|FG000|NOT COMPLETED|Overall Study||0
10922050|NCT00214890|12089669|FG001|NOT COMPLETED|Overall Study||0
10922051|NCT00214903|12089679|FG000|STARTED|Overall Study||10043
10922052|NCT00214903|12089680|FG001|STARTED|Overall Study||13384
10922053|NCT00214903|12089681|FG002|STARTED|Overall Study||4113
10922054|NCT00214903|12089682|FG003|STARTED|Overall Study||3057
10922055|NCT00214903|12089679|FG000|COMPLETED|Overall Study||10043
10922056|NCT00214903|12089680|FG001|COMPLETED|Overall Study||13384
10922057|NCT00214903|12089681|FG002|COMPLETED|Overall Study||4113
10922058|NCT00214903|12089682|FG003|COMPLETED|Overall Study||3057
10922059|NCT00214903|12089679|FG000|NOT COMPLETED|Overall Study||0
10922060|NCT00214903|12089680|FG001|NOT COMPLETED|Overall Study||0
10922061|NCT00214903|12089681|FG002|NOT COMPLETED|Overall Study||0
10922062|NCT00214903|12089682|FG003|NOT COMPLETED|Overall Study||0
10922063|NCT00215137|12089692|FG000|STARTED|Open Label Escitalopram||14
10922064|NCT00215137|12089693|FG001|STARTED|Open Label Escitalopram||0
10922065|NCT00215137|12089694|FG002|STARTED|Open Label Escitalopram||0
10922066|NCT00215137|12089692|FG000|COMPLETED|Open Label Escitalopram||13
10922067|NCT00215137|12089693|FG001|COMPLETED|Open Label Escitalopram||0
10922068|NCT00215137|12089694|FG002|COMPLETED|Open Label Escitalopram||0
10922069|NCT00215137|12089692|FG000|NOT COMPLETED|Open Label Escitalopram||1
10922070|NCT00215137|12089693|FG001|NOT COMPLETED|Open Label Escitalopram||0
10922071|NCT00215137|12089694|FG002|NOT COMPLETED|Open Label Escitalopram||0
10922072|NCT00215137|12089692|FG000|STARTED|Randomization Period||0
10922073|NCT00215137|12089693|FG001|STARTED|Randomization Period||7
10922074|NCT00215137|12089694|FG002|STARTED|Randomization Period||5
10922075|NCT00215137|12089692|FG000|COMPLETED|Randomization Period||0
10922076|NCT00215137|12089693|FG001|COMPLETED|Randomization Period||5
10922077|NCT00215137|12089694|FG002|COMPLETED|Randomization Period||5
10922078|NCT00215137|12089692|FG000|NOT COMPLETED|Randomization Period||0
10922079|NCT00215137|12089693|FG001|NOT COMPLETED|Randomization Period||2
10922080|NCT00215137|12089694|FG002|NOT COMPLETED|Randomization Period||0
10922081|NCT00215150|12089702|FG000|STARTED|Open Label Phase|Number of subjects consented|51
10922082|NCT00215150|12089702|FG000|COMPLETED|Open Label Phase||21
10922083|NCT00215150|12089702|FG000|NOT COMPLETED|Open Label Phase||30
10922084|NCT00215150|12089702|FG000|STARTED|Randomization Phase Ziprasidone||10
10922085|NCT00215150|12089702|FG000|COMPLETED|Randomization Phase Ziprasidone||7
10922086|NCT00215150|12089702|FG000|NOT COMPLETED|Randomization Phase Ziprasidone||3
10922087|NCT00215150|12089702|FG000|STARTED|Randomization Phase Placebo||11
10922088|NCT00215150|12089702|FG000|COMPLETED|Randomization Phase Placebo||10
10922089|NCT00215150|12089702|FG000|NOT COMPLETED|Randomization Phase Placebo||1
10922090|NCT00215540|12089713|FG000|STARTED|Overall Study||45
10922091|NCT00215540|12089714|FG001|STARTED|Overall Study||47
10922092|NCT00215540|12089715|FG002|STARTED|Overall Study||44
10922093|NCT00215540|12089713|FG000|COMPLETED|Overall Study||44
10922094|NCT00215540|12089714|FG001|COMPLETED|Overall Study||47
10922095|NCT00215540|12089715|FG002|COMPLETED|Overall Study||44
10922096|NCT00215540|12089713|FG000|NOT COMPLETED|Overall Study||1
10922097|NCT00215540|12089714|FG001|NOT COMPLETED|Overall Study||0
10922098|NCT00215540|12089715|FG002|NOT COMPLETED|Overall Study||0
10922099|NCT00215553|12089730|FG000|STARTED|Overall Study||5
10922100|NCT00215553|12089731|FG001|STARTED|Overall Study||6
10922101|NCT00215553|12089732|FG002|STARTED|Overall Study||6
10922102|NCT00215553|12089733|FG003|STARTED|Overall Study||5
10922103|NCT00215553|12089734|FG004|STARTED|Overall Study||28
10922104|NCT00215553|12089735|FG005|STARTED|Overall Study||38
10922105|NCT00215553|12089736|FG006|STARTED|Overall Study||36
10922106|NCT00215553|12089730|FG000|COMPLETED|Overall Study||5
10922107|NCT00215553|12089731|FG001|COMPLETED|Overall Study||5
10922108|NCT00215553|12089732|FG002|COMPLETED|Overall Study||4
10922109|NCT00215553|12089733|FG003|COMPLETED|Overall Study||4
10922110|NCT00215553|12089734|FG004|COMPLETED|Overall Study||26
10922111|NCT00215553|12089735|FG005|COMPLETED|Overall Study||32
10922112|NCT00215553|12089736|FG006|COMPLETED|Overall Study||36
10922113|NCT00215553|12089730|FG000|NOT COMPLETED|Overall Study||0
10922114|NCT00215553|12089731|FG001|NOT COMPLETED|Overall Study||1
10922115|NCT00215553|12089732|FG002|NOT COMPLETED|Overall Study||2
10922116|NCT00215553|12089733|FG003|NOT COMPLETED|Overall Study||1
10922117|NCT00215553|12089734|FG004|NOT COMPLETED|Overall Study||2
10922118|NCT00215553|12089735|FG005|NOT COMPLETED|Overall Study||6
10922119|NCT00215553|12089736|FG006|NOT COMPLETED|Overall Study||0
10922120|NCT00215644|12089754|FG000|STARTED|Overall Study||36
10922121|NCT00215644|12089755|FG001|STARTED|Overall Study||36
10922122|NCT00215644|12089754|FG000|Treated|Overall Study||35
10922123|NCT00215644|12089755|FG001|Treated|Overall Study||36
10922124|NCT00215644|12089754|FG000|COMPLETED|Overall Study||0
10922125|NCT00215644|12089755|FG001|COMPLETED|Overall Study||0
10922126|NCT00215644|12089754|FG000|NOT COMPLETED|Overall Study||36
10922127|NCT00215644|12089755|FG001|NOT COMPLETED|Overall Study||36
10922128|NCT00215657|12089769|FG000|STARTED|Overall Study||26
10922129|NCT00215657|12089770|FG001|STARTED|Overall Study||12
10922130|NCT00215657|12089771|FG002|STARTED|Overall Study||13
10922131|NCT00215657|12089772|FG003|STARTED|Overall Study||24
10922132|NCT00215657|12089773|FG004|STARTED|Overall Study||27
10922133|NCT00215657|12089774|FG005|STARTED|Overall Study||24
10922134|NCT00215657|12089775|FG006|STARTED|Overall Study||27
10922135|NCT00215657|12089776|FG007|STARTED|Overall Study||27
10922136|NCT00215657|12089769|FG000|Intention-to-treat Population|Overall Study||25
10922137|NCT00215657|12089770|FG001|Intention-to-treat Population|Overall Study||12
10922138|NCT00215657|12089771|FG002|Intention-to-treat Population|Overall Study||12
10922139|NCT00215657|12089772|FG003|Intention-to-treat Population|Overall Study||24
10922140|NCT00215657|12089773|FG004|Intention-to-treat Population|Overall Study||24
10922141|NCT00215657|12089774|FG005|Intention-to-treat Population|Overall Study||24
10922142|NCT00215657|12089775|FG006|Intention-to-treat Population|Overall Study||24
10922143|NCT00215657|12089776|FG007|Intention-to-treat Population|Overall Study||27
10922144|NCT00215657|12089769|FG000|Started FE200486 CS07A|Overall Study||20
10922145|NCT00215657|12089770|FG001|Started FE200486 CS07A|Overall Study||6
10922146|NCT00215657|12089771|FG002|Started FE200486 CS07A|Overall Study||7
10922147|NCT00215657|12089772|FG003|Started FE200486 CS07A|Overall Study||24
10922148|NCT00215657|12089773|FG004|Started FE200486 CS07A|Overall Study||17
10922149|NCT00215657|12089774|FG005|Started FE200486 CS07A|Overall Study||20
10922150|NCT00215657|12089775|FG006|Started FE200486 CS07A|Overall Study||14
10922151|NCT00215657|12089776|FG007|Started FE200486 CS07A|Overall Study||23
10922152|NCT00215657|12089769|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
10922153|NCT00215657|12089770|FG001|COMPLETED|Overall Study||1
10922154|NCT00215657|12089771|FG002|COMPLETED|Overall Study||2
10922155|NCT00215657|12089772|FG003|COMPLETED|Overall Study||6
10922156|NCT00215657|12089773|FG004|COMPLETED|Overall Study||4
10922157|NCT00215657|12089774|FG005|COMPLETED|Overall Study||4
10922158|NCT00215657|12089775|FG006|COMPLETED|Overall Study||4
10922159|NCT00215657|12089776|FG007|COMPLETED|Overall Study||11
10922160|NCT00215657|12089769|FG000|NOT COMPLETED|Overall Study||22
10922161|NCT00215657|12089770|FG001|NOT COMPLETED|Overall Study||11
10922162|NCT00215657|12089771|FG002|NOT COMPLETED|Overall Study||11
10922163|NCT00215657|12089772|FG003|NOT COMPLETED|Overall Study||18
10922164|NCT00215657|12089773|FG004|NOT COMPLETED|Overall Study||23
10922165|NCT00215657|12089774|FG005|NOT COMPLETED|Overall Study||20
10922166|NCT00215657|12089775|FG006|NOT COMPLETED|Overall Study||23
10922167|NCT00215657|12089776|FG007|NOT COMPLETED|Overall Study||16
10922168|NCT00215683|12089797|FG000|STARTED|Overall Study|Safety analysis set|45
10922169|NCT00215683|12089798|FG001|STARTED|Overall Study||48
10922170|NCT00215683|12089799|FG002|STARTED|Overall Study||44
10922171|NCT00215683|12089797|FG000|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
10922172|NCT00215683|12089798|FG001|Switched to 160 mg|Overall Study||41
10922173|NCT00215683|12089799|FG002|Switched to 160 mg|Overall Study||36
10922174|NCT00215683|12089797|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
10922175|NCT00215683|12089798|FG001|COMPLETED|Overall Study||22
10922176|NCT00215683|12089799|FG002|COMPLETED|Overall Study||12
10922177|NCT00215683|12089797|FG000|NOT COMPLETED|Overall Study||29
10922178|NCT00215683|12089798|FG001|NOT COMPLETED|Overall Study||26
10922179|NCT00215683|12089799|FG002|NOT COMPLETED|Overall Study||32
10922180|NCT00215787|12089807|FG000|STARTED|Overall Study||20
10922181|NCT00215787|12089807|FG000|COMPLETED|Overall Study||20
10922182|NCT00215787|12089807|FG000|NOT COMPLETED|Overall Study||0
10922183|NCT00215930|12089811|FG000|STARTED|Overall Study||53
10922184|NCT00215930|12089811|FG000|COMPLETED|Overall Study||53
10922185|NCT00215930|12089811|FG000|NOT COMPLETED|Overall Study||0
10922186|NCT00215943|12089818|FG000|STARTED|Overall Study||36
10922187|NCT00215943|12089819|FG001|STARTED|Overall Study||37
10922188|NCT00215943|12089818|FG000|COMPLETED|Overall Study||27
10922189|NCT00215943|12089819|FG001|COMPLETED|Overall Study||23
10922190|NCT00215943|12089818|FG000|NOT COMPLETED|Overall Study||9
10922191|NCT00215943|12089819|FG001|NOT COMPLETED|Overall Study||14
10922192|NCT00216060|12089827|FG000|STARTED|Overall Study||32
10922193|NCT00216060|12089828|FG001|STARTED|Overall Study||31
10922194|NCT00216060|12089827|FG000|COMPLETED|Overall Study||32
10922195|NCT00216060|12089828|FG001|COMPLETED|Overall Study||31
10922196|NCT00216060|12089827|FG000|NOT COMPLETED|Overall Study||0
10922197|NCT00216060|12089828|FG001|NOT COMPLETED|Overall Study||0
10922198|NCT00216086|12089836|FG000|STARTED|Overall Study||22
10922199|NCT00216086|12089836|FG000|COMPLETED|Overall Study||18
10922200|NCT00216086|12089836|FG000|NOT COMPLETED|Overall Study||4
10922201|NCT00216099|12089840|FG000|STARTED|Overall Study||49
10922202|NCT00216099|12089840|FG000|Toxicity Analysis|Overall Study||49
10922203|NCT00216099|12089840|FG000|Response Analysis|Overall Study||48
10922204|NCT00216099|12089840|FG000|COMPLETED|Overall Study||48
10922205|NCT00216099|12089840|FG000|NOT COMPLETED|Overall Study||1
10922206|NCT00216125|12089844|FG000|STARTED|Pre-Randomization Phase||243
10922207|NCT00216125|12089845|FG001|STARTED|Pre-Randomization Phase||0
10922208|NCT00216125|12089846|FG002|STARTED|Pre-Randomization Phase||0
10922209|NCT00216125|12089844|FG000|DSMB Cohort for Futility|Pre-Randomization Phase||203
10922210|NCT00216125|12089845|FG001|DSMB Cohort for Futility|Pre-Randomization Phase||0
10922211|NCT00216125|12089846|FG002|DSMB Cohort for Futility|Pre-Randomization Phase||0
10922212|NCT00216125|12089844|FG000|COMPLETED|Pre-Randomization Phase||166
10922213|NCT00216125|12089845|FG001|COMPLETED|Pre-Randomization Phase||0
10922214|NCT00216125|12089846|FG002|COMPLETED|Pre-Randomization Phase||0
10922215|NCT00216125|12089844|FG000|NOT COMPLETED|Pre-Randomization Phase||77
10922216|NCT00216125|12089845|FG001|NOT COMPLETED|Pre-Randomization Phase||0
10922217|NCT00216125|12089846|FG002|NOT COMPLETED|Pre-Randomization Phase||0
10922218|NCT00216125|12089844|FG000|STARTED|Randomization Phase||0
10922219|NCT00216125|12089845|FG001|STARTED|Randomization Phase||84
10922220|NCT00216125|12089846|FG002|STARTED|Randomization Phase||82
10922221|NCT00216125|12089844|FG000|DSMB Cohort for Futility|Randomization Phase||0
10922222|NCT00216125|12089845|FG001|DSMB Cohort for Futility|Randomization Phase||73
10922223|NCT00216125|12089846|FG002|DSMB Cohort for Futility|Randomization Phase||74
10922224|NCT00216125|12089844|FG000|COMPLETED|Randomization Phase||0
10922225|NCT00216125|12089845|FG001|COMPLETED|Randomization Phase||73
10922226|NCT00216125|12089846|FG002|COMPLETED|Randomization Phase||74
10922227|NCT00216125|12089844|FG000|NOT COMPLETED|Randomization Phase||0
10922228|NCT00216125|12089845|FG001|NOT COMPLETED|Randomization Phase||11
10922229|NCT00216125|12089846|FG002|NOT COMPLETED|Randomization Phase||8
10922230|NCT00216203|12089853|FG000|STARTED|Overall Study||36
10922231|NCT00216203|12089853|FG000|COMPLETED|Overall Study||34
10922232|NCT00216203|12089853|FG000|NOT COMPLETED|Overall Study||2
10922233|NCT00216320|12089861|FG000|STARTED|Phase 1 (Weeks 0 - 6)||43
10922234|NCT00216320|12089862|FG001|STARTED|Phase 1 (Weeks 0 - 6)||39
10922235|NCT00216320|12089863|FG002|STARTED|Phase 1 (Weeks 0 - 6)||30
10922236|NCT00216320|12089861|FG000|COMPLETED|Phase 1 (Weeks 0 - 6)||43
10922237|NCT00216320|12089862|FG001|COMPLETED|Phase 1 (Weeks 0 - 6)||35
10922238|NCT00216320|12089863|FG002|COMPLETED|Phase 1 (Weeks 0 - 6)||25
10922239|NCT00216320|12089861|FG000|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
10922240|NCT00216320|12089862|FG001|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
10922241|NCT00216320|12089863|FG002|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
10922242|NCT00216320|12089861|FG000|STARTED|Phase 2 (Weeks 6 -12)||43
10922243|NCT00216320|12089862|FG001|STARTED|Phase 2 (Weeks 6 -12)||35
10922244|NCT00216320|12089863|FG002|STARTED|Phase 2 (Weeks 6 -12)||25
10922245|NCT00216320|12089861|FG000|COMPLETED|Phase 2 (Weeks 6 -12)||38
10922246|NCT00216320|12089862|FG001|COMPLETED|Phase 2 (Weeks 6 -12)||31
10922247|NCT00216320|12089863|FG002|COMPLETED|Phase 2 (Weeks 6 -12)||24
10922248|NCT00216320|12089861|FG000|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
10922249|NCT00216320|12089862|FG001|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
10922250|NCT00216320|12089863|FG002|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
10922251|NCT00216476|12089874|FG000|STARTED|Overall Study||329
10922252|NCT00216476|12089875|FG001|STARTED|Overall Study||337
10922253|NCT00216476|12089876|FG002|STARTED|Overall Study||45
10922254|NCT00216476|12089874|FG000|COMPLETED|Overall Study||224
10922255|NCT00216476|12089875|FG001|COMPLETED|Overall Study||230
10922256|NCT00216476|12089876|FG002|COMPLETED|Overall Study||28
10922257|NCT00216476|12089874|FG000|NOT COMPLETED|Overall Study||105
10922258|NCT00216476|12089875|FG001|NOT COMPLETED|Overall Study||107
10922259|NCT00216476|12089876|FG002|NOT COMPLETED|Overall Study||17
10922260|NCT00216671|12089889|FG000|STARTED|Overall Study||110
10922261|NCT00216671|12089890|FG001|STARTED|Overall Study||110
10922262|NCT00216671|12089889|FG000|COMPLETED|Overall Study||75
10922263|NCT00216671|12089890|FG001|COMPLETED|Overall Study||60
10922264|NCT00216671|12089889|FG000|NOT COMPLETED|Overall Study||35
10922265|NCT00216671|12089890|FG001|NOT COMPLETED|Overall Study||50
10922266|NCT00216736|12089898|FG000|STARTED|Overall Study||32
10922267|NCT00216736|12089899|FG001|STARTED|Overall Study||31
10922268|NCT00216736|12089898|FG000|COMPLETED|Overall Study||31
10922269|NCT00216736|12089899|FG001|COMPLETED|Overall Study||30
10922270|NCT00216736|12089898|FG000|NOT COMPLETED|Overall Study||1
10922271|NCT00216736|12089899|FG001|NOT COMPLETED|Overall Study||1
10922272|NCT00217022|12089907|FG000|STARTED|Overall Study||12
10922273|NCT00217022|12089908|FG001|STARTED|Overall Study||4
10922274|NCT00217022|12089907|FG000|COMPLETED|Overall Study||11
10922275|NCT00217022|12089908|FG001|COMPLETED|Overall Study||3
10922276|NCT00217022|12089907|FG000|NOT COMPLETED|Overall Study||1
10922277|NCT00217022|12089908|FG001|NOT COMPLETED|Overall Study||1
10922278|NCT00217087|12089916|FG000|STARTED|Overall Study||36
10922279|NCT00217087|12089917|FG001|STARTED|Overall Study||37
10922280|NCT00217087|12089916|FG000|COMPLETED|Overall Study||25
10922281|NCT00217087|12089917|FG001|COMPLETED|Overall Study||17
10922282|NCT00217087|12089916|FG000|NOT COMPLETED|Overall Study||11
10922283|NCT00217087|12089917|FG001|NOT COMPLETED|Overall Study||20
10922284|NCT00217399|12089929|FG000|STARTED|Overall Study||35
10922285|NCT00217399|12089929|FG000|COMPLETED|Overall Study||35
10922286|NCT00217399|12089929|FG000|NOT COMPLETED|Overall Study||0
10922287|NCT00217425|12089935|FG000|STARTED|Overall Study||46
10922288|NCT00217425|12089935|FG000|Treated|Overall Study||44
10922289|NCT00217425|12089935|FG000|Eligible and Treated|Overall Study||39
10922290|NCT00217425|12089935|FG000|COMPLETED|Overall Study||9
10922291|NCT00217425|12089935|FG000|NOT COMPLETED|Overall Study||37
10922292|NCT00217438|12089941|FG000|STARTED|Overall Study||66
10922293|NCT00217438|12089942|FG001|STARTED|Overall Study||64
10922294|NCT00217438|12089941|FG000|COMPLETED|Overall Study||66
10922295|NCT00217438|12089942|FG001|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
10922296|NCT00217438|12089941|FG000|NOT COMPLETED|Overall Study||0
10922297|NCT00217438|12089942|FG001|NOT COMPLETED|Overall Study||1
10922298|NCT00217464|12089948|FG000|STARTED|Overall Study||17
10922299|NCT00217464|12089948|FG000|COMPLETED|Overall Study||0
10922300|NCT00217464|12089948|FG000|NOT COMPLETED|Overall Study||17
10922301|NCT00217490|12089956|FG000|STARTED|Overall Study||154
10922302|NCT00217490|12089957|FG001|STARTED|Overall Study||153
10922303|NCT00217490|12089958|FG002|STARTED|Overall Study||155
10922304|NCT00217490|12089959|FG003|STARTED|Overall Study||153
10922305|NCT00217490|12089956|FG000|COMPLETED|Overall Study||137
10922306|NCT00217490|12089957|FG001|COMPLETED|Overall Study||128
10922307|NCT00217490|12089958|FG002|COMPLETED|Overall Study||131
10922308|NCT00217490|12089959|FG003|COMPLETED|Overall Study||130
10922309|NCT00217490|12089956|FG000|NOT COMPLETED|Overall Study||17
10922310|NCT00217490|12089957|FG001|NOT COMPLETED|Overall Study||25
10922311|NCT00217490|12089958|FG002|NOT COMPLETED|Overall Study||24
10922312|NCT00217490|12089959|FG003|NOT COMPLETED|Overall Study||23
10922313|NCT00217581|12089973|FG000|STARTED|Overall Study||39
10922314|NCT00217581|12089973|FG000|COMPLETED|Overall Study||38
10922315|NCT00217581|12089973|FG000|NOT COMPLETED|Overall Study||1
10922316|NCT00217594|12089978|FG000|STARTED|Overall Study||31
10922317|NCT00217594|12089978|FG000|COMPLETED|Overall Study||31
10922318|NCT00217594|12089978|FG000|NOT COMPLETED|Overall Study||0
10922319|NCT00217620|12089982|FG000|STARTED|Overall Study||51
10922320|NCT00217620|12089982|FG000|Eligible|Overall Study||38
10922321|NCT00217620|12089982|FG000|Eligible and Began Protocol Therapy|Overall Study||37
10922322|NCT00217620|12089982|FG000|COMPLETED|Overall Study||0
10922323|NCT00217620|12089982|FG000|NOT COMPLETED|Overall Study||51
10922324|NCT00217672|12089990|FG000|STARTED|Allocation||69
10922325|NCT00217672|12089991|FG001|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
10922326|NCT00217672|12089990|FG000|COMPLETED|Allocation||67
10922327|NCT00217672|12089991|FG001|COMPLETED|Allocation||7
10922328|NCT00217672|12089990|FG000|NOT COMPLETED|Allocation||2
10922329|NCT00217672|12089991|FG001|NOT COMPLETED|Allocation||0
10922330|NCT00217672|12089990|FG000|STARTED|Treatment||67
10922331|NCT00217672|12089991|FG001|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
10922332|NCT00217672|12089990|FG000|COMPLETED|Treatment||0
10922333|NCT00217672|12089991|FG001|COMPLETED|Treatment||0
10922334|NCT00217672|12089990|FG000|NOT COMPLETED|Treatment||67
10922335|NCT00217672|12089991|FG001|NOT COMPLETED|Treatment||7
10922336|NCT00217672|12089990|FG000|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
10922337|NCT00217672|12089991|FG001|STARTED|Follow-up||0
10922338|NCT00217672|12089990|FG000|COMPLETED|Follow-up||69
10922339|NCT00217672|12089991|FG001|COMPLETED|Follow-up||0
10922340|NCT00217672|12089990|FG000|NOT COMPLETED|Follow-up||5
10922341|NCT00217672|12089991|FG001|NOT COMPLETED|Follow-up||0
10922342|NCT00217724|12089995|FG000|STARTED|Course 1, (Glutamine/Placebo Arms)||8
10922343|NCT00217724|12089996|FG001|STARTED|Course 1, (Glutamine/Placebo Arms)||10
10922344|NCT00217724|12089995|FG000|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
10922345|NCT00217724|12089996|FG001|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
10922346|NCT00217724|12089995|FG000|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
10922347|NCT00217724|12089996|FG001|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
10922348|NCT00217724|12089995|FG000|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
10922349|NCT00217724|12089996|FG001|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
10922350|NCT00217724|12089995|FG000|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
10922351|NCT00217724|12089996|FG001|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
10922352|NCT00217724|12089995|FG000|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
10922353|NCT00217724|12089996|FG001|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
10922354|NCT00217971|12090004|FG000|STARTED|Overall Study||79
10922355|NCT00217971|12090005|FG001|STARTED|Overall Study||77
10922356|NCT00217971|12090004|FG000|COMPLETED|Overall Study||55
10922357|NCT00217971|12090005|FG001|COMPLETED|Overall Study||44
10922358|NCT00217971|12090004|FG000|NOT COMPLETED|Overall Study||24
10922359|NCT00217971|12090005|FG001|NOT COMPLETED|Overall Study||33
10922360|NCT00218023|12090015|FG000|STARTED|Overall Study||22
10922361|NCT00218023|12090016|FG001|STARTED|Overall Study||25
10922362|NCT00218023|12090017|FG002|STARTED|Overall Study||16
10922363|NCT00218023|12090018|FG003|STARTED|Overall Study||18
10922364|NCT00218023|12090015|FG000|Received Drug or Placebo in Phase II|Overall Study||18
10922365|NCT00218023|12090016|FG001|Received Drug or Placebo in Phase II|Overall Study||24
10922366|NCT00218023|12090017|FG002|Received Drug or Placebo in Phase II|Overall Study||15
10922367|NCT00218023|12090018|FG003|Received Drug or Placebo in Phase II|Overall Study||18
10922368|NCT00218023|12090015|FG000|COMPLETED|Overall Study||9
10922369|NCT00218023|12090016|FG001|COMPLETED|Overall Study||10
10922370|NCT00218023|12090017|FG002|COMPLETED|Overall Study||6
10922371|NCT00218023|12090018|FG003|COMPLETED|Overall Study||11
10922372|NCT00218023|12090015|FG000|NOT COMPLETED|Overall Study||13
10922373|NCT00218023|12090016|FG001|NOT COMPLETED|Overall Study||15
10922374|NCT00218023|12090017|FG002|NOT COMPLETED|Overall Study||10
10922375|NCT00218023|12090018|FG003|NOT COMPLETED|Overall Study||7
10922376|NCT00218062|12090032|FG000|STARTED|Overall Study||22
10922377|NCT00218062|12090033|FG001|STARTED|Overall Study||20
10922378|NCT00218062|12090034|FG002|STARTED|Overall Study||15
10922379|NCT00218062|12090035|FG003|STARTED|Overall Study||16
10922380|NCT00218062|12090032|FG000|Received First Dose of Study Medication|Overall Study||16
10922381|NCT00218062|12090033|FG001|Received First Dose of Study Medication|Overall Study||11
10922382|NCT00218062|12090034|FG002|Received First Dose of Study Medication|Overall Study||10
10922383|NCT00218062|12090035|FG003|Received First Dose of Study Medication|Overall Study||12
10922384|NCT00218062|12090032|FG000|COMPLETED|Overall Study||7
10922385|NCT00218062|12090033|FG001|COMPLETED|Overall Study||4
10922386|NCT00218062|12090034|FG002|COMPLETED|Overall Study||3
10922387|NCT00218062|12090035|FG003|COMPLETED|Overall Study||3
10922388|NCT00218062|12090032|FG000|NOT COMPLETED|Overall Study||15
10922389|NCT00218062|12090033|FG001|NOT COMPLETED|Overall Study||16
10922390|NCT00218062|12090034|FG002|NOT COMPLETED|Overall Study||12
10922391|NCT00218062|12090035|FG003|NOT COMPLETED|Overall Study||13
10922392|NCT00218257|12090045|FG000|STARTED|Intervention 1||23
10922393|NCT00218257|12090046|FG001|STARTED|Intervention 1||22
10922394|NCT00218257|12090045|FG000|COMPLETED|Intervention 1||23
10922395|NCT00218257|12090046|FG001|COMPLETED|Intervention 1||22
10922396|NCT00218257|12090045|FG000|NOT COMPLETED|Intervention 1||0
10922397|NCT00218257|12090046|FG001|NOT COMPLETED|Intervention 1||0
10922398|NCT00218257|12090045|FG000|STARTED|Period Between Visit 1 and 2||23
10922399|NCT00218257|12090046|FG001|STARTED|Period Between Visit 1 and 2||22
10922400|NCT00218257|12090045|FG000|COMPLETED|Period Between Visit 1 and 2||19
10922401|NCT00218257|12090046|FG001|COMPLETED|Period Between Visit 1 and 2||19
10922402|NCT00218257|12090045|FG000|NOT COMPLETED|Period Between Visit 1 and 2||4
10922403|NCT00218257|12090046|FG001|NOT COMPLETED|Period Between Visit 1 and 2||3
10922404|NCT00218257|12090045|FG000|STARTED|Intervention 2||19
10922405|NCT00218257|12090046|FG001|STARTED|Intervention 2||19
10922406|NCT00218257|12090045|FG000|COMPLETED|Intervention 2||19
10922407|NCT00218257|12090046|FG001|COMPLETED|Intervention 2||19
10922408|NCT00218257|12090045|FG000|NOT COMPLETED|Intervention 2||0
10922409|NCT00218257|12090046|FG001|NOT COMPLETED|Intervention 2||0
10922410|NCT00218296|12090057|FG000|STARTED|Overall Study||163
10922411|NCT00218296|12090058|FG001|STARTED|Overall Study||169
10922412|NCT00218296|12090057|FG000|Attended Visti|Overall Study||97
10922413|NCT00218296|12090058|FG001|Attended Visti|Overall Study||102
10922414|NCT00218296|12090057|FG000|COMPLETED|Overall Study||52
10922415|NCT00218296|12090058|FG001|COMPLETED|Overall Study||48
10922416|NCT00218296|12090057|FG000|NOT COMPLETED|Overall Study||111
10922417|NCT00218296|12090058|FG001|NOT COMPLETED|Overall Study||121
10922418|NCT00218335|12090070|FG000|STARTED|Overall Study||114
10922419|NCT00218335|12090071|FG001|STARTED|Overall Study||113
10922420|NCT00218335|12090072|FG002|STARTED|Overall Study||373
10922421|NCT00218335|12090073|FG003|STARTED|Overall Study||424
10922422|NCT00218335|12090070|FG000|6 Month Follow-up|Overall Study||103
10922423|NCT00218335|12090071|FG001|6 Month Follow-up|Overall Study||99
10922424|NCT00218335|12090072|FG002|6 Month Follow-up|Overall Study||219
10922425|NCT00218335|12090073|FG003|6 Month Follow-up|Overall Study||301
10922426|NCT00218335|12090070|FG000|12 Month Follow-up|Overall Study||95
10922427|NCT00218335|12090071|FG001|12 Month Follow-up|Overall Study||102
10922428|NCT00218335|12090072|FG002|12 Month Follow-up|Overall Study||244
10922429|NCT00218335|12090073|FG003|12 Month Follow-up|Overall Study||303
10922430|NCT00218335|12090070|FG000|18 Month Follow-up|Overall Study||101
10922431|NCT00218335|12090071|FG001|18 Month Follow-up|Overall Study||108
10922432|NCT00218335|12090072|FG002|18 Month Follow-up|Overall Study||296
10922433|NCT00218335|12090073|FG003|18 Month Follow-up|Overall Study||368
10922434|NCT00218335|12090070|FG000|COMPLETED|Overall Study||108
10922435|NCT00218335|12090071|FG001|COMPLETED|Overall Study||110
10922436|NCT00218335|12090072|FG002|COMPLETED|Overall Study||319
10922437|NCT00218335|12090073|FG003|COMPLETED|Overall Study||388
10922438|NCT00218335|12090070|FG000|NOT COMPLETED|Overall Study||6
10922439|NCT00218335|12090071|FG001|NOT COMPLETED|Overall Study||3
10922440|NCT00218335|12090072|FG002|NOT COMPLETED|Overall Study||54
10922441|NCT00218335|12090073|FG003|NOT COMPLETED|Overall Study||36
10922442|NCT00218387|12090088|FG000|STARTED|Overall Study||40
10922443|NCT00218387|12090089|FG001|STARTED|Overall Study||43
10922444|NCT00218387|12090090|FG002|STARTED|Overall Study||40
10922445|NCT00218387|12090088|FG000|COMPLETED|Overall Study||25
10922446|NCT00218387|12090089|FG001|COMPLETED|Overall Study||25
10922447|NCT00218387|12090090|FG002|COMPLETED|Overall Study||17
10922448|NCT00218387|12090088|FG000|NOT COMPLETED|Overall Study||15
10922449|NCT00218387|12090089|FG001|NOT COMPLETED|Overall Study||18
10922450|NCT00218387|12090090|FG002|NOT COMPLETED|Overall Study||23
10922451|NCT00218426|12090101|FG000|STARTED|Overall Study||102
10922452|NCT00218426|12090102|FG001|STARTED|Overall Study||102
10922453|NCT00218426|12090103|FG002|STARTED|Overall Study||102
10922454|NCT00218426|12090101|FG000|COMPLETED|Overall Study||54
10922455|NCT00218426|12090102|FG001|COMPLETED|Overall Study||16
10922456|NCT00218426|12090103|FG002|COMPLETED|Overall Study||11
10922457|NCT00218426|12090101|FG000|NOT COMPLETED|Overall Study||48
10922458|NCT00218426|12090102|FG001|NOT COMPLETED|Overall Study||86
10922459|NCT00218426|12090103|FG002|NOT COMPLETED|Overall Study||91
10922460|NCT00218439|12090116|FG000|STARTED|First Intervention (4 Weeks)||58
10922461|NCT00218439|12090117|FG001|STARTED|First Intervention (4 Weeks)||47
10922462|NCT00218439|12090116|FG000|COMPLETED|First Intervention (4 Weeks)||40
10922463|NCT00218439|12090117|FG001|COMPLETED|First Intervention (4 Weeks)||35
10922464|NCT00218439|12090116|FG000|NOT COMPLETED|First Intervention (4 Weeks)||18
10922465|NCT00218439|12090117|FG001|NOT COMPLETED|First Intervention (4 Weeks)||12
10922466|NCT00218439|12090116|FG000|STARTED|Second Intervention (4 Weeks)||40
10922467|NCT00218439|12090117|FG001|STARTED|Second Intervention (4 Weeks)||35
10922468|NCT00218439|12090116|FG000|COMPLETED|Second Intervention (4 Weeks)||33
10922469|NCT00218439|12090117|FG001|COMPLETED|Second Intervention (4 Weeks)||30
10922470|NCT00218439|12090116|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||7
10922471|NCT00218439|12090117|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||5
10922472|NCT00218465|12090133|FG000|STARTED|Overall Study||50
10922473|NCT00218465|12090134|FG001|STARTED|Overall Study||48
10922474|NCT00218465|12090133|FG000|COMPLETED|Overall Study||33
10922475|NCT00218465|12090134|FG001|COMPLETED|Overall Study||30
10922476|NCT00218465|12090133|FG000|NOT COMPLETED|Overall Study||17
10922477|NCT00218465|12090134|FG001|NOT COMPLETED|Overall Study||18
10922478|NCT00218491|12090143|FG000|STARTED|Overall Study||40
10922479|NCT00218491|12090144|FG001|STARTED|Overall Study||33
10922480|NCT00218491|12090145|FG002|STARTED|Overall Study||38
10922481|NCT00218491|12090143|FG000|COMPLETED|Overall Study||40
10922482|NCT00218491|12090144|FG001|COMPLETED|Overall Study||33
10922483|NCT00218491|12090145|FG002|COMPLETED|Overall Study||38
10922484|NCT00218491|12090143|FG000|NOT COMPLETED|Overall Study||0
10922485|NCT00218491|12090144|FG001|NOT COMPLETED|Overall Study||0
10922486|NCT00218491|12090145|FG002|NOT COMPLETED|Overall Study||0
10922487|NCT00218543|12090153|FG000|STARTED|Overall Study||20
10922488|NCT00218543|12090153|FG000|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
10922489|NCT00218543|12090153|FG000|NOT COMPLETED|Overall Study||15
10922490|NCT00218634|12090159|FG000|STARTED|Overall Study||44
10922491|NCT00218634|12090160|FG001|STARTED|Overall Study||45
10922492|NCT00218634|12090159|FG000|COMPLETED|Overall Study||36
10922493|NCT00218634|12090160|FG001|COMPLETED|Overall Study||30
10922494|NCT00218634|12090159|FG000|NOT COMPLETED|Overall Study||8
10922495|NCT00218634|12090160|FG001|NOT COMPLETED|Overall Study||15
10922496|NCT00219141|12090172|FG000|STARTED|Overall Study||154
10922497|NCT00219141|12090173|FG001|STARTED|Overall Study||152
10922498|NCT00219141|12090174|FG002|STARTED|Overall Study||154
10922499|NCT00219141|12090172|FG000|COMPLETED|Overall Study||140
10922500|NCT00219141|12090173|FG001|COMPLETED|Overall Study||131
10922501|NCT00219141|12090174|FG002|COMPLETED|Overall Study||142
10922502|NCT00219141|12090172|FG000|NOT COMPLETED|Overall Study||14
10922503|NCT00219141|12090173|FG001|NOT COMPLETED|Overall Study||21
10922504|NCT00219141|12090174|FG002|NOT COMPLETED|Overall Study||12
10922505|NCT00219284|12090184|FG000|STARTED|Treatment Phase - 16 Weeks||180
10922506|NCT00219284|12090185|FG001|STARTED|Treatment Phase - 16 Weeks||179
10922507|NCT00219284|12090184|FG000|COMPLETED|Treatment Phase - 16 Weeks||136
10922508|NCT00219284|12090185|FG001|COMPLETED|Treatment Phase - 16 Weeks||128
10922509|NCT00219284|12090184|FG000|NOT COMPLETED|Treatment Phase - 16 Weeks||44
10922510|NCT00219284|12090185|FG001|NOT COMPLETED|Treatment Phase - 16 Weeks||51
10922511|NCT00219284|12090184|FG000|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
10922512|NCT00219284|12090185|FG001|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
10922513|NCT00219284|12090184|FG000|COMPLETED|Extension Phase - 8 Weeks||112
10922514|NCT00219284|12090185|FG001|COMPLETED|Extension Phase - 8 Weeks||99
10922515|NCT00219284|12090184|FG000|NOT COMPLETED|Extension Phase - 8 Weeks||2
10922516|NCT00219284|12090185|FG001|NOT COMPLETED|Extension Phase - 8 Weeks||7
10922517|NCT00219349|12090191|FG000|STARTED|Cognitive Behavioral Therapy Phase||25
10922518|NCT00219349|12090191|FG000|COMPLETED|Cognitive Behavioral Therapy Phase||15
10922519|NCT00219349|12090191|FG000|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
10922520|NCT00219349|12090191|FG000|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
10922521|NCT00219349|12090191|FG000|COMPLETED|Escitalopram Phase||4
10922522|NCT00219349|12090191|FG000|NOT COMPLETED|Escitalopram Phase||3
10922523|NCT00219544|12090195|FG000|STARTED|Single Blind Treatment Period||256
10922524|NCT00219544|12090196|FG001|STARTED|Single Blind Treatment Period||0
10922525|NCT00219544|12090195|FG000|COMPLETED|Single Blind Treatment Period||234
10922526|NCT00219544|12090196|FG001|COMPLETED|Single Blind Treatment Period||0
10922527|NCT00219544|12090195|FG000|NOT COMPLETED|Single Blind Treatment Period||22
10922528|NCT00219544|12090196|FG001|NOT COMPLETED|Single Blind Treatment Period||0
10922529|NCT00219544|12090195|FG000|STARTED|Double Blind Treatment Period||80
10922530|NCT00219544|12090196|FG001|STARTED|Double Blind Treatment Period||77
10922531|NCT00219544|12090195|FG000|COMPLETED|Double Blind Treatment Period||80
10922532|NCT00219544|12090196|FG001|COMPLETED|Double Blind Treatment Period||77
10922533|NCT00219544|12090195|FG000|NOT COMPLETED|Double Blind Treatment Period||0
10922534|NCT00219544|12090196|FG001|NOT COMPLETED|Double Blind Treatment Period||0
10922535|NCT00219557|12090207|FG000|STARTED|Phase 1||8
10922536|NCT00219557|12090208|FG001|STARTED|Phase 1||0
10922537|NCT00219557|12090209|FG002|STARTED|Phase 1||0
10922538|NCT00219557|12090207|FG000|COMPLETED|Phase 1||1
10922539|NCT00219557|12090208|FG001|COMPLETED|Phase 1||0
10922540|NCT00219557|12090209|FG002|COMPLETED|Phase 1||0
10922541|NCT00219557|12090207|FG000|NOT COMPLETED|Phase 1||7
10922542|NCT00219557|12090208|FG001|NOT COMPLETED|Phase 1||0
10922543|NCT00219557|12090209|FG002|NOT COMPLETED|Phase 1||0
10922544|NCT00219557|12090207|FG000|STARTED|Phase 2||0
10922545|NCT00219557|12090208|FG001|STARTED|Phase 2||69
10922546|NCT00219557|12090209|FG002|STARTED|Phase 2||34
10922547|NCT00219557|12090207|FG000|Treated|Phase 2||0
10922548|NCT00219557|12090208|FG001|Treated|Phase 2||68
10922549|NCT00219557|12090209|FG002|Treated|Phase 2||31
10922550|NCT00219557|12090207|FG000|COMPLETED|Phase 2||0
10922551|NCT00219557|12090208|FG001|COMPLETED|Phase 2||0
10922552|NCT00219557|12090209|FG002|COMPLETED|Phase 2||1
10922553|NCT00219557|12090207|FG000|NOT COMPLETED|Phase 2||0
10922554|NCT00219557|12090208|FG001|NOT COMPLETED|Phase 2||69
10922555|NCT00219557|12090209|FG002|NOT COMPLETED|Phase 2||33
10922556|NCT00220636|12090218|FG000|STARTED|Overall Study||15
10922557|NCT00220636|12090218|FG000|COMPLETED|Overall Study||11
10922558|NCT00220636|12090218|FG000|NOT COMPLETED|Overall Study||4
10922559|NCT00220701|12090225|FG000|STARTED|Overall Study||17
10922560|NCT00220701|12090226|FG001|STARTED|Overall Study||17
10922561|NCT00220701|12090225|FG000|COMPLETED|Overall Study||12
10922562|NCT00220701|12090226|FG001|COMPLETED|Overall Study||13
10922563|NCT00220701|12090225|FG000|NOT COMPLETED|Overall Study||5
10922564|NCT00220701|12090226|FG001|NOT COMPLETED|Overall Study||4
10922565|NCT00220727|12090234|FG000|STARTED|First Infusion (Week 0)||4
10922566|NCT00220727|12090235|FG001|STARTED|First Infusion (Week 0)||4
10922567|NCT00220727|12090234|FG000|COMPLETED|First Infusion (Week 0)||4
10922568|NCT00220727|12090235|FG001|COMPLETED|First Infusion (Week 0)||4
10922569|NCT00220727|12090234|FG000|NOT COMPLETED|First Infusion (Week 0)||0
10922570|NCT00220727|12090235|FG001|NOT COMPLETED|First Infusion (Week 0)||0
10922571|NCT00220727|12090234|FG000|STARTED|Second Infusion (Week <6)||4
10922572|NCT00220727|12090235|FG001|STARTED|Second Infusion (Week <6)||4
10922573|NCT00220727|12090234|FG000|COMPLETED|Second Infusion (Week <6)||3
10922574|NCT00220727|12090235|FG001|COMPLETED|Second Infusion (Week <6)||4
10922575|NCT00220727|12090234|FG000|NOT COMPLETED|Second Infusion (Week <6)||1
10922576|NCT00220727|12090235|FG001|NOT COMPLETED|Second Infusion (Week <6)||0
10922577|NCT00220740|12090245|FG000|STARTED|Efficacy Period||59
10922578|NCT00220740|12090246|FG001|STARTED|Efficacy Period||58
10922579|NCT00220740|12090245|FG000|COMPLETED|Efficacy Period||33
10922580|NCT00220740|12090246|FG001|COMPLETED|Efficacy Period||12
10922581|NCT00220740|12090245|FG000|NOT COMPLETED|Efficacy Period||26
10922582|NCT00220740|12090246|FG001|NOT COMPLETED|Efficacy Period||46
10922583|NCT00220740|12090245|FG000|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
10922584|NCT00220740|12090246|FG001|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
10922585|NCT00220740|12090245|FG000|COMPLETED|Rescue Treatment||26
10922586|NCT00220740|12090246|FG001|COMPLETED|Rescue Treatment||5
10922587|NCT00220740|12090245|FG000|NOT COMPLETED|Rescue Treatment||19
10922588|NCT00220740|12090246|FG001|NOT COMPLETED|Rescue Treatment||18
10922589|NCT00220740|12090245|FG000|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
10922590|NCT00220740|12090246|FG001|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
10922591|NCT00220740|12090245|FG000|COMPLETED|Withdrawal Period||37
10922592|NCT00220740|12090246|FG001|COMPLETED|Withdrawal Period||16
10922593|NCT00220740|12090245|FG000|NOT COMPLETED|Withdrawal Period||6
10922594|NCT00220740|12090246|FG001|NOT COMPLETED|Withdrawal Period||15
10922595|NCT00220779|12090257|FG000|STARTED|Overall Study||45
10922596|NCT00220779|12090258|FG001|STARTED|Overall Study||42
10922597|NCT00220779|12090259|FG002|STARTED|Overall Study||41
10922598|NCT00220779|12090257|FG000|COMPLETED|Overall Study||38
10922599|NCT00220779|12090258|FG001|COMPLETED|Overall Study||38
10922600|NCT00220779|12090259|FG002|COMPLETED|Overall Study||37
10922601|NCT00220779|12090257|FG000|NOT COMPLETED|Overall Study||7
10922602|NCT00220779|12090258|FG001|NOT COMPLETED|Overall Study||4
10922603|NCT00220779|12090259|FG002|NOT COMPLETED|Overall Study||4
10922604|NCT00220805|12090269|FG000|STARTED|Overall Study||30
10922605|NCT00220805|12090270|FG001|STARTED|Overall Study||27
10922606|NCT00220805|12090269|FG000|COMPLETED|Overall Study||22
10922607|NCT00220805|12090270|FG001|COMPLETED|Overall Study||16
10922608|NCT00220805|12090269|FG000|NOT COMPLETED|Overall Study||8
10922609|NCT00220805|12090270|FG001|NOT COMPLETED|Overall Study||11
10922610|NCT00220961|12090278|FG000|STARTED|Overall Study||299
10922611|NCT00220961|12090279|FG001|STARTED|Overall Study||303
10922612|NCT00220961|12090278|FG000|COMPLETED|Overall Study||228
10922613|NCT00220961|12090279|FG001|COMPLETED|Overall Study||213
10922614|NCT00220961|12090278|FG000|NOT COMPLETED|Overall Study||71
10922615|NCT00220961|12090279|FG001|NOT COMPLETED|Overall Study||90
10922616|NCT00221104|12090287|FG000|STARTED|Overall Study||793
10922617|NCT00221104|12090288|FG001|STARTED|Overall Study||785
10922618|NCT00221104|12090287|FG000|COMPLETED|Overall Study||710
10922619|NCT00221104|12090288|FG001|COMPLETED|Overall Study||709
10922620|NCT00221104|12090287|FG000|NOT COMPLETED|Overall Study||83
10922621|NCT00221104|12090288|FG001|NOT COMPLETED|Overall Study||76
10922622|NCT00221117|12090298|FG000|STARTED|Overall Study||12
10922623|NCT00221117|12090299|FG001|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
10922624|NCT00221117|12090298|FG000|COMPLETED|Overall Study||12
10922625|NCT00221117|12090299|FG001|COMPLETED|Overall Study||9
10922626|NCT00221117|12090298|FG000|NOT COMPLETED|Overall Study||0
10922627|NCT00221117|12090299|FG001|NOT COMPLETED|Overall Study||0
10922628|NCT00221195|12090309|FG000|STARTED|Therapy 1 (Months 1-6)||17
10922629|NCT00221195|12090310|FG001|STARTED|Therapy 1 (Months 1-6)||17
10922630|NCT00221195|12090309|FG000|COMPLETED|Therapy 1 (Months 1-6)||14
10922631|NCT00221195|12090310|FG001|COMPLETED|Therapy 1 (Months 1-6)||15
10922632|NCT00221195|12090309|FG000|NOT COMPLETED|Therapy 1 (Months 1-6)||3
10922633|NCT00221195|12090310|FG001|NOT COMPLETED|Therapy 1 (Months 1-6)||2
10922634|NCT00221195|12090309|FG000|STARTED|Washout Period (Months 7-9)||14
10922635|NCT00221195|12090310|FG001|STARTED|Washout Period (Months 7-9)||15
10922636|NCT00221195|12090309|FG000|COMPLETED|Washout Period (Months 7-9)||14
10922637|NCT00221195|12090310|FG001|COMPLETED|Washout Period (Months 7-9)||14
10922638|NCT00221195|12090309|FG000|NOT COMPLETED|Washout Period (Months 7-9)||0
10922639|NCT00221195|12090310|FG001|NOT COMPLETED|Washout Period (Months 7-9)||1
10922640|NCT00221195|12090309|FG000|STARTED|Therapy 2 (Months 10-15)||14
10922641|NCT00221195|12090310|FG001|STARTED|Therapy 2 (Months 10-15)||14
10922642|NCT00221195|12090309|FG000|COMPLETED|Therapy 2 (Months 10-15)||12
10922643|NCT00221195|12090310|FG001|COMPLETED|Therapy 2 (Months 10-15)||14
10922644|NCT00221195|12090309|FG000|NOT COMPLETED|Therapy 2 (Months 10-15)||2
10922645|NCT00221195|12090310|FG001|NOT COMPLETED|Therapy 2 (Months 10-15)||0
10922646|NCT00221299|12090320|FG000|STARTED|Overall Study||11
10922647|NCT00221299|12090321|FG001|STARTED|Overall Study||13
10922648|NCT00221299|12090322|FG002|STARTED|Overall Study||14
10922649|NCT00221299|12090323|FG003|STARTED|Overall Study||11
10922650|NCT00221299|12090320|FG000|COMPLETED|Overall Study||10
10922651|NCT00221299|12090321|FG001|COMPLETED|Overall Study||11
10922652|NCT00221299|12090322|FG002|COMPLETED|Overall Study||14
10922653|NCT00221299|12090323|FG003|COMPLETED|Overall Study||10
10922654|NCT00221299|12090320|FG000|NOT COMPLETED|Overall Study||1
10922655|NCT00221299|12090321|FG001|NOT COMPLETED|Overall Study||2
10922656|NCT00221299|12090322|FG002|NOT COMPLETED|Overall Study||0
10922657|NCT00221299|12090323|FG003|NOT COMPLETED|Overall Study||1
10922658|NCT00221338|12090333|FG000|STARTED|Overall Study||374
10922659|NCT00221338|12090334|FG001|STARTED|Overall Study||376
10922660|NCT00221338|12090333|FG000|COMPLETED|Overall Study||350
10922661|NCT00221338|12090334|FG001|COMPLETED|Overall Study||347
10922662|NCT00221338|12090333|FG000|NOT COMPLETED|Overall Study||24
10922663|NCT00221338|12090334|FG001|NOT COMPLETED|Overall Study||29
10922664|NCT00221403|12090343|FG000|STARTED|Overall Study||18
10922665|NCT00221403|12090344|FG001|STARTED|Overall Study||21
10922666|NCT00221403|12090345|FG002|STARTED|Overall Study||7
10922667|NCT00221403|12090343|FG000|COMPLETED|Overall Study||16
10922668|NCT00221403|12090344|FG001|COMPLETED|Overall Study||16
10922669|NCT00221403|12090345|FG002|COMPLETED|Overall Study||7
10922670|NCT00221403|12090343|FG000|NOT COMPLETED|Overall Study||2
10922671|NCT00221403|12090344|FG001|NOT COMPLETED|Overall Study||5
10922672|NCT00221403|12090345|FG002|NOT COMPLETED|Overall Study||0
10922673|NCT00222105|12090353|FG000|STARTED|Overall Study||25
10922674|NCT00222105|12090353|FG000|COMPLETED|Overall Study||11
10922675|NCT00222105|12090353|FG000|NOT COMPLETED|Overall Study||14
10922676|NCT00222131|12090359|FG000|STARTED|Overall Study||38
10922677|NCT00222131|12090360|FG001|STARTED|Overall Study||35
10922678|NCT00222131|12090359|FG000|COMPLETED|Overall Study||38
10922679|NCT00222131|12090360|FG001|COMPLETED|Overall Study||35
10922680|NCT00222131|12090359|FG000|NOT COMPLETED|Overall Study||0
10922681|NCT00222131|12090360|FG001|NOT COMPLETED|Overall Study||0
10922682|NCT00222729|12090366|FG000|STARTED|Overall Study||40
10922683|NCT00222729|12090366|FG000|COMPLETED|Overall Study||37
10922684|NCT00222729|12090366|FG000|NOT COMPLETED|Overall Study||3
10922685|NCT00223080|12090372|FG000|STARTED|Overall Study||8197
10922686|NCT00223080|12090373|FG001|STARTED|Overall Study||8198
10922687|NCT00223080|12090372|FG000|COMPLETED|Overall Study||7401
10922688|NCT00223080|12090373|FG001|COMPLETED|Overall Study||7401
10922689|NCT00223080|12090372|FG000|NOT COMPLETED|Overall Study||796
10922690|NCT00223080|12090373|FG001|NOT COMPLETED|Overall Study||797
10922691|NCT00223236|12090381|FG000|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
10922692|NCT00223236|12090382|FG001|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
10922693|NCT00223236|12090381|FG000|COMPLETED|Overall Study|9 completed 12 week trial.|9
10922694|NCT00223236|12090382|FG001|COMPLETED|Overall Study|4 completed 12 week trial.|4
10922695|NCT00223236|12090381|FG000|NOT COMPLETED|Overall Study||7
10922696|NCT00223236|12090382|FG001|NOT COMPLETED|Overall Study||14
10922697|NCT00223262|12090390|FG000|STARTED|Overall Study||16
10922698|NCT00223262|12090391|FG001|STARTED|Overall Study||12
10922699|NCT00223262|12090390|FG000|COMPLETED|Overall Study||8
10922700|NCT00223262|12090391|FG001|COMPLETED|Overall Study||11
10922701|NCT00223262|12090390|FG000|NOT COMPLETED|Overall Study||8
10922702|NCT00223262|12090391|FG001|NOT COMPLETED|Overall Study||1
10922703|NCT00223496|12090397|FG000|STARTED|Overall Study|32 people consented, 19 were baselined|32
10922704|NCT00223496|12090397|FG000|COMPLETED|Overall Study||10
10922705|NCT00223496|12090397|FG000|NOT COMPLETED|Overall Study||22
10922706|NCT00223652|12090403|FG000|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
10922707|NCT00223652|12090404|FG001|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
10922708|NCT00223652|12090403|FG000|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
10922709|NCT00223652|12090404|FG001|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
10922710|NCT00223652|12090403|FG000|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
10922711|NCT00223652|12090404|FG001|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
10922712|NCT00223652|12090403|FG000|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
10922713|NCT00223652|12090404|FG001|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
10922714|NCT00223652|12090403|FG000|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
10922715|NCT00223652|12090404|FG001|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
10922716|NCT00223652|12090403|FG000|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
10922717|NCT00223652|12090404|FG001|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
10922718|NCT00223652|12090403|FG000|STARTED|T-CBT and TAU 6 Month Follow-up||40
10922719|NCT00223652|12090404|FG001|STARTED|T-CBT and TAU 6 Month Follow-up||41
10922720|NCT00223652|12090403|FG000|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
10922721|NCT00223652|12090404|FG001|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
10922722|NCT00223652|12090403|FG000|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
10922723|NCT00223652|12090404|FG001|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
10922724|NCT00223665|12090411|FG000|STARTED|Overall Study||102
10922725|NCT00223665|12090411|FG000|COMPLETED|Overall Study||102
10922726|NCT00223665|12090411|FG000|NOT COMPLETED|Overall Study||0
10922727|NCT00223678|12090418|FG000|STARTED|Overall Study||13
10922728|NCT00223678|12090419|FG001|STARTED|Overall Study||7
10922729|NCT00223678|12090418|FG000|COMPLETED|Overall Study||13
10922730|NCT00223678|12090419|FG001|COMPLETED|Overall Study||7
10922731|NCT00223678|12090418|FG000|NOT COMPLETED|Overall Study||0
10922732|NCT00223678|12090419|FG001|NOT COMPLETED|Overall Study||0
10922733|NCT00223704|12090428|FG000|STARTED|Overall Study||38
10922734|NCT00223704|12090429|FG001|STARTED|Overall Study||37
10922735|NCT00223704|12090430|FG002|STARTED|Overall Study||40
10922736|NCT00223704|12090428|FG000|COMPLETED|Overall Study||38
10922737|NCT00223704|12090429|FG001|COMPLETED|Overall Study||37
10922738|NCT00223704|12090430|FG002|COMPLETED|Overall Study||40
10922739|NCT00223704|12090428|FG000|NOT COMPLETED|Overall Study||0
10922740|NCT00223704|12090429|FG001|NOT COMPLETED|Overall Study||0
10922741|NCT00223704|12090430|FG002|NOT COMPLETED|Overall Study||0
10922742|NCT00223795|12090438|FG000|STARTED|First Intervention - Eight Weeks||26
10922743|NCT00223795|12090439|FG001|STARTED|First Intervention - Eight Weeks||27
10922744|NCT00223795|12090438|FG000|COMPLETED|First Intervention - Eight Weeks||19
10922745|NCT00223795|12090439|FG001|COMPLETED|First Intervention - Eight Weeks||18
10922746|NCT00223795|12090438|FG000|NOT COMPLETED|First Intervention - Eight Weeks||7
10922747|NCT00223795|12090439|FG001|NOT COMPLETED|First Intervention - Eight Weeks||9
10922748|NCT00223795|12090438|FG000|STARTED|Second Intervention - All Use Canes 4 mo||19
10922749|NCT00223795|12090439|FG001|STARTED|Second Intervention - All Use Canes 4 mo||18
10922750|NCT00223795|12090438|FG000|COMPLETED|Second Intervention - All Use Canes 4 mo||18
10922751|NCT00223795|12090439|FG001|COMPLETED|Second Intervention - All Use Canes 4 mo||17
10922752|NCT00223795|12090438|FG000|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
10922753|NCT00223795|12090439|FG001|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
10922754|NCT00223808|12090449|FG000|STARTED|Overall Study||22
10922755|NCT00223808|12090450|FG001|STARTED|Overall Study||22
10922756|NCT00223808|12090451|FG002|STARTED|Overall Study||23
10922757|NCT00223808|12090449|FG000|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
10922758|NCT00223808|12090450|FG001|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
10922759|NCT00223808|12090451|FG002|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
10922760|NCT00223808|12090449|FG000|NOT COMPLETED|Overall Study||3
10922761|NCT00223808|12090450|FG001|NOT COMPLETED|Overall Study||5
10922762|NCT00223808|12090451|FG002|NOT COMPLETED|Overall Study||5
10922763|NCT00223821|12090461|FG000|STARTED|Overall Study||32
10922764|NCT00223821|12090462|FG001|STARTED|Overall Study||32
10922765|NCT00223821|12090461|FG000|Completed Therapy|Overall Study||31
10922766|NCT00223821|12090462|FG001|Completed Therapy|Overall Study||28
10922767|NCT00223821|12090461|FG000|Completed Post-treatment Assessment|Overall Study||31
10922768|NCT00223821|12090462|FG001|Completed Post-treatment Assessment|Overall Study||27
10922769|NCT00223821|12090461|FG000|Completed 6-month Follow-up|Overall Study||28
10922770|NCT00223821|12090462|FG001|Completed 6-month Follow-up|Overall Study||25
10922771|NCT00223821|12090461|FG000|COMPLETED|Overall Study||28
10922772|NCT00223821|12090462|FG001|COMPLETED|Overall Study||22
10922773|NCT00223821|12090461|FG000|NOT COMPLETED|Overall Study||4
10922774|NCT00223821|12090462|FG001|NOT COMPLETED|Overall Study||10
10922775|NCT00223977|12090471|FG000|STARTED|Overall Study||46
10922776|NCT00223977|12090472|FG001|STARTED|Overall Study||58
10922777|NCT00223977|12090473|FG002|STARTED|Overall Study||42
10922778|NCT00223977|12090471|FG000|COMPLETED|Overall Study||37
10922779|NCT00223977|12090472|FG001|COMPLETED|Overall Study||47
10922780|NCT00223977|12090473|FG002|COMPLETED|Overall Study||39
10922781|NCT00223977|12090471|FG000|NOT COMPLETED|Overall Study||9
10922782|NCT00223977|12090472|FG001|NOT COMPLETED|Overall Study||11
10922783|NCT00223977|12090473|FG002|NOT COMPLETED|Overall Study||3
10922784|NCT00223990|12090483|FG000|STARTED|Overall Study||200
10922785|NCT00223990|12090484|FG001|STARTED|Overall Study||200
10922786|NCT00223990|12090483|FG000|COMPLETED|Overall Study||193
10922787|NCT00223990|12090484|FG001|COMPLETED|Overall Study||191
10922788|NCT00223990|12090483|FG000|NOT COMPLETED|Overall Study||7
10922789|NCT00223990|12090484|FG001|NOT COMPLETED|Overall Study||9
10922790|NCT00224016|12090492|FG000|STARTED|Titration Period||39
10922791|NCT00224016|12090493|FG001|STARTED|Titration Period||16
10922792|NCT00224016|12090492|FG000|COMPLETED|Titration Period||38
10922793|NCT00224016|12090493|FG001|COMPLETED|Titration Period||15
10922794|NCT00224016|12090492|FG000|NOT COMPLETED|Titration Period||1
10922795|NCT00224016|12090493|FG001|NOT COMPLETED|Titration Period||1
10922796|NCT00224016|12090492|FG000|STARTED|Maintenance Period||38
10922797|NCT00224016|12090493|FG001|STARTED|Maintenance Period||15
10922798|NCT00224016|12090492|FG000|COMPLETED|Maintenance Period||36
10922799|NCT00224016|12090493|FG001|COMPLETED|Maintenance Period||14
10922800|NCT00224016|12090492|FG000|NOT COMPLETED|Maintenance Period||2
10922801|NCT00224016|12090493|FG001|NOT COMPLETED|Maintenance Period||1
10922802|NCT00224016|12090492|FG000|STARTED|Follow-Up Period||35
10922803|NCT00224016|12090493|FG001|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
10922804|NCT00224016|12090492|FG000|COMPLETED|Follow-Up Period||35
10922805|NCT00224016|12090493|FG001|COMPLETED|Follow-Up Period||0
10922806|NCT00224016|12090492|FG000|NOT COMPLETED|Follow-Up Period||0
10922807|NCT00224016|12090493|FG001|NOT COMPLETED|Follow-Up Period||0
10922808|NCT00224029|12090499|FG000|STARTED|Overall Study||24
10922809|NCT00224029|12090499|FG000|COMPLETED|Overall Study||18
10922810|NCT00224029|12090499|FG000|NOT COMPLETED|Overall Study||6
10922811|NCT00224042|12090505|FG000|STARTED|Overall Study||26
10922812|NCT00224042|12090506|FG001|STARTED|Overall Study||26
10922813|NCT00224042|12090505|FG000|COMPLETED|Overall Study||20
10922814|NCT00224042|12090506|FG001|COMPLETED|Overall Study||20
10922815|NCT00224042|12090505|FG000|NOT COMPLETED|Overall Study||6
10922816|NCT00224042|12090506|FG001|NOT COMPLETED|Overall Study||6
10922817|NCT00224055|12090514|FG000|STARTED|Overall Study||44
10922818|NCT00224055|12090515|FG001|STARTED|Overall Study||45
10922819|NCT00224055|12090514|FG000|COMPLETED|Overall Study||29
10922820|NCT00224055|12090515|FG001|COMPLETED|Overall Study||31
10922821|NCT00224055|12090514|FG000|NOT COMPLETED|Overall Study||15
10922822|NCT00224055|12090515|FG001|NOT COMPLETED|Overall Study||14
10922823|NCT00224107|12090523|FG000|STARTED|Overall Study||233
10922824|NCT00224107|12090524|FG001|STARTED|Overall Study||228
10922825|NCT00224107|12090523|FG000|COMPLETED|Overall Study||202
10922826|NCT00224107|12090524|FG001|COMPLETED|Overall Study||214
10922827|NCT00224107|12090523|FG000|NOT COMPLETED|Overall Study||31
10922828|NCT00224107|12090524|FG001|NOT COMPLETED|Overall Study||14
10922829|NCT00224120|12090532|FG000|STARTED|Overall Study||233
10922830|NCT00224120|12090533|FG001|STARTED|Overall Study||229
10922831|NCT00224120|12090532|FG000|COMPLETED|Overall Study||211
10922832|NCT00224120|12090533|FG001|COMPLETED|Overall Study||205
10922833|NCT00224120|12090532|FG000|NOT COMPLETED|Overall Study||22
10922834|NCT00224120|12090533|FG001|NOT COMPLETED|Overall Study||24
10922835|NCT00224133|12090539|FG000|STARTED|Overall Study||661
10922836|NCT00224133|12090539|FG000|COMPLETED|Overall Study||435
10922837|NCT00224133|12090539|FG000|NOT COMPLETED|Overall Study||226
10922838|NCT00224289|12090543|FG000|STARTED|Overall Study||17
10922839|NCT00224289|12090543|FG000|COMPLETED|Overall Study||17
10922840|NCT00224289|12090543|FG000|NOT COMPLETED|Overall Study||0
10922841|NCT00224484|12090550|FG000|STARTED|Overall Study||2977
10922842|NCT00224484|12090551|FG001|STARTED|Overall Study||1491
10922843|NCT00224484|12090552|FG002|STARTED|Overall Study||1487
10922844|NCT00224484|12090550|FG000|COMPLETED|Overall Study||2831
10922845|NCT00224484|12090551|FG001|COMPLETED|Overall Study||1426
10922846|NCT00224484|12090552|FG002|COMPLETED|Overall Study||1425
10922847|NCT00224484|12090550|FG000|NOT COMPLETED|Overall Study||146
10922848|NCT00224484|12090551|FG001|NOT COMPLETED|Overall Study||65
10922849|NCT00224484|12090552|FG002|NOT COMPLETED|Overall Study||62
10922850|NCT00224770|12090566|FG000|STARTED|Overall Study||42
10922851|NCT00224770|12090567|FG001|STARTED|Overall Study||54
10922852|NCT00224770|12090568|FG002|STARTED|Overall Study||14
10922853|NCT00224770|12090566|FG000|COMPLETED|Overall Study||38
10922854|NCT00224770|12090567|FG001|COMPLETED|Overall Study||52
10922855|NCT00224770|12090568|FG002|COMPLETED|Overall Study||14
10922856|NCT00224770|12090566|FG000|NOT COMPLETED|Overall Study||4
10922857|NCT00224770|12090567|FG001|NOT COMPLETED|Overall Study||2
10922858|NCT00224770|12090568|FG002|NOT COMPLETED|Overall Study||0
10922859|NCT00224874|12090581|FG000|STARTED|Overall Study||46
10922860|NCT00224874|12090582|FG001|STARTED|Overall Study||45
10922861|NCT00224874|12090583|FG002|STARTED|Overall Study||47
10922862|NCT00224874|12090584|FG003|STARTED|Overall Study||42
10922863|NCT00224874|12090581|FG000|COMPLETED|Overall Study||46
10922864|NCT00224874|12090582|FG001|COMPLETED|Overall Study||45
10922865|NCT00224874|12090583|FG002|COMPLETED|Overall Study||46
10922866|NCT00224874|12090584|FG003|COMPLETED|Overall Study||42
10922867|NCT00224874|12090581|FG000|NOT COMPLETED|Overall Study||0
10922868|NCT00224874|12090582|FG001|NOT COMPLETED|Overall Study||0
10922869|NCT00224874|12090583|FG002|NOT COMPLETED|Overall Study||1
10922870|NCT00224874|12090584|FG003|NOT COMPLETED|Overall Study||0
10922871|NCT00224887|12090596|FG000|STARTED|Overall Study||154
10922872|NCT00224887|12090597|FG001|STARTED|Overall Study||153
10922873|NCT00224887|12090596|FG000|COMPLETED|Overall Study||148
10922874|NCT00224887|12090597|FG001|COMPLETED|Overall Study||147
10922875|NCT00224887|12090596|FG000|NOT COMPLETED|Overall Study||6
10922876|NCT00224887|12090597|FG001|NOT COMPLETED|Overall Study||6
10922877|NCT00224952|12090606|FG000|STARTED|Overall Study||53
10922878|NCT00224952|12090607|FG001|STARTED|Overall Study||87
10922879|NCT00224952|12090608|FG002|STARTED|Overall Study||134
10922880|NCT00224952|12090606|FG000|COMPLETED|Overall Study||53
10922881|NCT00224952|12090607|FG001|COMPLETED|Overall Study||87
10922882|NCT00224952|12090608|FG002|COMPLETED|Overall Study||134
10922883|NCT00224952|12090606|FG000|NOT COMPLETED|Overall Study||0
10922884|NCT00224952|12090607|FG001|NOT COMPLETED|Overall Study||0
10922885|NCT00224952|12090608|FG002|NOT COMPLETED|Overall Study||0
10922886|NCT00225017|12090619|FG000|STARTED|Overall Study||26
10922887|NCT00225017|12090620|FG001|STARTED|Overall Study||24
10922888|NCT00225017|12090619|FG000|COMPLETED|Overall Study||26
10922889|NCT00225017|12090620|FG001|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
10922890|NCT00225017|12090619|FG000|NOT COMPLETED|Overall Study||0
10922891|NCT00225017|12090620|FG001|NOT COMPLETED|Overall Study||1
10922892|NCT00225147|12090630|FG000|STARTED|Double-blind Phase||13
10922893|NCT00225147|12090631|FG001|STARTED|Double-blind Phase||12
10922894|NCT00225147|12090632|FG002|STARTED|Double-blind Phase||13
10922895|NCT00225147|12090633|FG003|STARTED|Double-blind Phase||0
10922896|NCT00225147|12090630|FG000|COMPLETED|Double-blind Phase||13
10922897|NCT00225147|12090631|FG001|COMPLETED|Double-blind Phase||12
10922898|NCT00225147|12090632|FG002|COMPLETED|Double-blind Phase||13
10922899|NCT00225147|12090633|FG003|COMPLETED|Double-blind Phase||0
10922900|NCT00225147|12090630|FG000|NOT COMPLETED|Double-blind Phase||0
10922901|NCT00225147|12090631|FG001|NOT COMPLETED|Double-blind Phase||0
10922902|NCT00225147|12090632|FG002|NOT COMPLETED|Double-blind Phase||0
10922903|NCT00225147|12090633|FG003|NOT COMPLETED|Double-blind Phase||0
10922904|NCT00225147|12090630|FG000|STARTED|Open-label Phase||0
10922905|NCT00225147|12090631|FG001|STARTED|Open-label Phase||0
10922906|NCT00225147|12090632|FG002|STARTED|Open-label Phase||0
10922907|NCT00225147|12090633|FG003|STARTED|Open-label Phase||62
10922908|NCT00225147|12090630|FG000|COMPLETED|Open-label Phase||0
10922909|NCT00225147|12090631|FG001|COMPLETED|Open-label Phase||0
10922910|NCT00225147|12090632|FG002|COMPLETED|Open-label Phase||0
10922911|NCT00225147|12090633|FG003|COMPLETED|Open-label Phase||52
10922912|NCT00225147|12090630|FG000|NOT COMPLETED|Open-label Phase||0
10922913|NCT00225147|12090631|FG001|NOT COMPLETED|Open-label Phase||0
10922914|NCT00225147|12090632|FG002|NOT COMPLETED|Open-label Phase||0
10922915|NCT00225147|12090633|FG003|NOT COMPLETED|Open-label Phase||10
10922916|NCT00225212|12090645|FG000|STARTED|Overall Study||35
10922917|NCT00225212|12090645|FG000|COMPLETED|Overall Study||29
10922918|NCT00225212|12090645|FG000|NOT COMPLETED|Overall Study||6
10922919|NCT00225251|12090651|FG000|STARTED|Overall Study||11
10922920|NCT00225251|12090652|FG001|STARTED|Overall Study||7
10922921|NCT00225251|12090651|FG000|COMPLETED|Overall Study||10
10922922|NCT00225251|12090652|FG001|COMPLETED|Overall Study||6
10922923|NCT00225251|12090651|FG000|NOT COMPLETED|Overall Study||1
10922924|NCT00225251|12090652|FG001|NOT COMPLETED|Overall Study||1
10922925|NCT00225277|12090660|FG000|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
10922926|NCT00225277|12090661|FG001|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
10922927|NCT00225277|12090660|FG000|COMPLETED|Overall Study||177
10922928|NCT00225277|12090661|FG001|COMPLETED|Overall Study||178
10922929|NCT00225277|12090660|FG000|NOT COMPLETED|Overall Study||97
10922930|NCT00225277|12090661|FG001|NOT COMPLETED|Overall Study||95
10922931|NCT00225420|12090667|FG000|STARTED|Overall Study||9
10922932|NCT00225420|12090668|FG001|STARTED|Overall Study||6
10922933|NCT00225420|12090669|FG002|STARTED|Overall Study||3
10922934|NCT00225420|12090667|FG000|COMPLETED|Overall Study||9
10922935|NCT00225420|12090668|FG001|COMPLETED|Overall Study||6
10922936|NCT00225420|12090669|FG002|COMPLETED|Overall Study||3
10922937|NCT00225420|12090667|FG000|NOT COMPLETED|Overall Study||0
10922938|NCT00225420|12090668|FG001|NOT COMPLETED|Overall Study||0
10922939|NCT00225420|12090669|FG002|NOT COMPLETED|Overall Study||0
10922940|NCT00225498|12090676|FG000|STARTED|Overall Study||10
10922941|NCT00225498|12090676|FG000|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
10922942|NCT00225498|12090676|FG000|NOT COMPLETED|Overall Study||0
10922943|NCT00225732|12090682|FG000|STARTED|Overall Study||153
10922944|NCT00225732|12090683|FG001|STARTED|Overall Study||166
10922945|NCT00225732|12090682|FG000|COMPLETED|Overall Study||153
10922946|NCT00225732|12090683|FG001|COMPLETED|Overall Study||166
10922947|NCT00225732|12090682|FG000|NOT COMPLETED|Overall Study||0
10922948|NCT00225732|12090683|FG001|NOT COMPLETED|Overall Study||0
10922949|NCT00225758|12090689|FG000|STARTED|Overall Study||27
10922950|NCT00225758|12090689|FG000|COMPLETED|Overall Study||23
10922951|NCT00225758|12090689|FG000|NOT COMPLETED|Overall Study||4
10922952|NCT00225784|12090695|FG000|STARTED|Overall Study||37
10922953|NCT00225784|12090695|FG000|COMPLETED|Overall Study||33
10922954|NCT00225784|12090695|FG000|NOT COMPLETED|Overall Study||4
10922955|NCT00226239|12090702|FG000|STARTED|TPE, Induction Therapy||39
10922956|NCT00226239|12090702|FG000|COMPLETED|TPE, Induction Therapy||37
10922957|NCT00226239|12090702|FG000|NOT COMPLETED|TPE, Induction Therapy||2
10922958|NCT00226239|12090702|FG000|STARTED|XPE, Definitive Therapy||37
10922959|NCT00226239|12090702|FG000|COMPLETED|XPE, Definitive Therapy||33
10922960|NCT00226239|12090702|FG000|NOT COMPLETED|XPE, Definitive Therapy||4
10922961|NCT00226239|12090702|FG000|STARTED|Maintenance Cetuximab||31
10922962|NCT00226239|12090702|FG000|COMPLETED|Maintenance Cetuximab||17
10922963|NCT00226239|12090702|FG000|NOT COMPLETED|Maintenance Cetuximab||14
10922964|NCT00226499|12090710|FG000|STARTED|Overall Study||2489
10922965|NCT00226499|12090711|FG001|STARTED|Overall Study||2487
10922966|NCT00226499|12090712|FG002|STARTED|Overall Study||827
10922967|NCT00226499|12090710|FG000|COMPLETED|Overall Study||1415
10922968|NCT00226499|12090711|FG001|COMPLETED|Overall Study||1415
10922969|NCT00226499|12090712|FG002|COMPLETED|Overall Study||468
10922970|NCT00226499|12090710|FG000|NOT COMPLETED|Overall Study||1074
10922971|NCT00226499|12090711|FG001|NOT COMPLETED|Overall Study||1072
10922972|NCT00226499|12090712|FG002|NOT COMPLETED|Overall Study||359
10922973|NCT00226577|12090722|FG000|STARTED|Overall Study||52
10922974|NCT00226577|12090722|FG000|COMPLETED|Overall Study||52
10922975|NCT00226577|12090722|FG000|NOT COMPLETED|Overall Study||0
10922976|NCT00226590|12090726|FG000|STARTED|Overall Study||39
10922977|NCT00226590|12090726|FG000|COMPLETED|Overall Study||39
10922978|NCT00226590|12090726|FG000|NOT COMPLETED|Overall Study||0
10922979|NCT00226655|12090731|FG000|STARTED|Overall Study||112
10922980|NCT00226655|12090731|FG000|COMPLETED|Overall Study||33
10922981|NCT00226655|12090731|FG000|NOT COMPLETED|Overall Study||79
10922982|NCT00226811|12090735|FG000|STARTED|Overall Study||78
10922983|NCT00226811|12090735|FG000|COMPLETED|Overall Study||2
10922984|NCT00226811|12090735|FG000|NOT COMPLETED|Overall Study||76
10922985|NCT00226941|12090743|FG000|STARTED|Overall Study||6
10922986|NCT00226941|12090744|FG001|STARTED|Overall Study||6
10922987|NCT00226941|12090745|FG002|STARTED|Overall Study||4
10922988|NCT00226941|12090746|FG003|STARTED|Overall Study||7
10922989|NCT00226941|12090743|FG000|COMPLETED|Overall Study||6
10922990|NCT00226941|12090744|FG001|COMPLETED|Overall Study||6
10922991|NCT00226941|12090745|FG002|COMPLETED|Overall Study||4
10922992|NCT00226941|12090746|FG003|COMPLETED|Overall Study||5
10922993|NCT00226941|12090743|FG000|NOT COMPLETED|Overall Study||0
10922994|NCT00226941|12090744|FG001|NOT COMPLETED|Overall Study||0
10922995|NCT00226941|12090745|FG002|NOT COMPLETED|Overall Study||0
10922996|NCT00226941|12090746|FG003|NOT COMPLETED|Overall Study||2
10922997|NCT00227019|12090762|FG000|STARTED|Overall Study||16
10922998|NCT00227019|12090762|FG000|COMPLETED|Overall Study||16
10922999|NCT00227019|12090762|FG000|NOT COMPLETED|Overall Study||0
10923000|NCT00227266|12090770|FG000|STARTED|Overall Study||31
10923001|NCT00227266|12090771|FG001|STARTED|Overall Study||30
10923002|NCT00227266|12090772|FG002|STARTED|Overall Study||33
10923003|NCT00227266|12090770|FG000|COMPLETED|Overall Study||30
10923004|NCT00227266|12090771|FG001|COMPLETED|Overall Study||30
10923005|NCT00227266|12090772|FG002|COMPLETED|Overall Study||29
10923006|NCT00227266|12090770|FG000|NOT COMPLETED|Overall Study||1
10923007|NCT00227266|12090771|FG001|NOT COMPLETED|Overall Study||0
10923008|NCT00227266|12090772|FG002|NOT COMPLETED|Overall Study||4
10923009|NCT00227305|12090783|FG000|STARTED|Overall Study|enrolled|381
10923010|NCT00227305|12090783|FG000|Drug Received|Overall Study|safety population|380
10923011|NCT00227305|12090783|FG000|COMPLETED|Overall Study|Completed 26 weeks|237
10923012|NCT00227305|12090783|FG000|NOT COMPLETED|Overall Study||144
10923013|NCT00227344|12090789|FG000|STARTED|Overall Study||87
10923014|NCT00227344|12090790|FG001|STARTED|Overall Study||42
10923015|NCT00227344|12090789|FG000|COMPLETED|Overall Study||75
10923016|NCT00227344|12090790|FG001|COMPLETED|Overall Study||37
10923017|NCT00227344|12090789|FG000|NOT COMPLETED|Overall Study||12
10923018|NCT00227344|12090790|FG001|NOT COMPLETED|Overall Study||5
10923019|NCT00227370|12090798|FG000|STARTED|Overall Study|Placebo Group|66
10923020|NCT00227370|12090799|FG001|STARTED|Overall Study|Treatment Group|70
10923021|NCT00227370|12090798|FG000|COMPLETED|Overall Study||45
10923022|NCT00227370|12090799|FG001|COMPLETED|Overall Study||46
10923023|NCT00227370|12090798|FG000|NOT COMPLETED|Overall Study||21
10923024|NCT00227370|12090799|FG001|NOT COMPLETED|Overall Study||24
10923025|NCT00227539|12090805|FG000|STARTED|Overall Study||25
10923026|NCT00227539|12090805|FG000|COMPLETED|Overall Study||24
10923027|NCT00227539|12090805|FG000|NOT COMPLETED|Overall Study||1
10923028|NCT00227591|12090809|FG000|STARTED|Overall Study|48 pts registered to the study|48
10923029|NCT00227591|12090809|FG000|Began Treatment|Overall Study||47
10923030|NCT00227591|12090809|FG000|COMPLETED|Overall Study||47
10923031|NCT00227591|12090809|FG000|NOT COMPLETED|Overall Study||1
10923032|NCT00227617|12090813|FG000|STARTED|Stage 1||22
10923033|NCT00227617|12090814|FG001|STARTED|Stage 1||12
10923034|NCT00227617|12090815|FG002|STARTED|Stage 1||2
10923035|NCT00227617|12090813|FG000|COMPLETED|Stage 1||22
10923036|NCT00227617|12090814|FG001|COMPLETED|Stage 1||12
10923037|NCT00227617|12090815|FG002|COMPLETED|Stage 1||2
10923038|NCT00227617|12090813|FG000|NOT COMPLETED|Stage 1||0
10923039|NCT00227617|12090814|FG001|NOT COMPLETED|Stage 1||0
10923040|NCT00227617|12090815|FG002|NOT COMPLETED|Stage 1||0
10923041|NCT00227617|12090813|FG000|STARTED|Stage 2||0
10923042|NCT00227617|12090814|FG001|STARTED|Stage 2||0
10923043|NCT00227617|12090815|FG002|STARTED|Stage 2||0
10923044|NCT00227617|12090813|FG000|COMPLETED|Stage 2||0
10923045|NCT00227617|12090814|FG001|COMPLETED|Stage 2||0
10923046|NCT00227617|12090815|FG002|COMPLETED|Stage 2||0
10923047|NCT00227617|12090813|FG000|NOT COMPLETED|Stage 2||0
10923048|NCT00227617|12090814|FG001|NOT COMPLETED|Stage 2||0
10923049|NCT00227617|12090815|FG002|NOT COMPLETED|Stage 2||0
10923050|NCT00227721|12090827|FG000|STARTED|Overall Study||30
10923051|NCT00227721|12090827|FG000|COMPLETED|Overall Study||29
10923052|NCT00227721|12090827|FG000|NOT COMPLETED|Overall Study||1
10923053|NCT00227760|12090831|FG000|STARTED|Overall Study||44
10923054|NCT00227760|12090831|FG000|COMPLETED|Overall Study||44
10923055|NCT00227760|12090831|FG000|NOT COMPLETED|Overall Study||0
10923056|NCT00227877|12090839|FG000|STARTED|Pre-visit Assessment||1075
10923057|NCT00227877|12090840|FG001|STARTED|Pre-visit Assessment||1031
10923058|NCT00227877|12090841|FG002|STARTED|Pre-visit Assessment||297
10923059|NCT00227877|12090842|FG003|STARTED|Pre-visit Assessment||292
10923060|NCT00227877|12090839|FG000|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
10923061|NCT00227877|12090840|FG001|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
10923062|NCT00227877|12090841|FG002|COMPLETED|Pre-visit Assessment|Final analysis sample|297
10923063|NCT00227877|12090842|FG003|COMPLETED|Pre-visit Assessment|Final analysis sample|292
10923064|NCT00227877|12090839|FG000|NOT COMPLETED|Pre-visit Assessment||7
10923065|NCT00227877|12090840|FG001|NOT COMPLETED|Pre-visit Assessment||3
10923066|NCT00227877|12090841|FG002|NOT COMPLETED|Pre-visit Assessment||0
10923067|NCT00227877|12090842|FG003|NOT COMPLETED|Pre-visit Assessment||0
10923068|NCT00227877|12090839|FG000|STARTED|Post-visit Checklist||1068
10923069|NCT00227877|12090840|FG001|STARTED|Post-visit Checklist||1028
10923070|NCT00227877|12090841|FG002|STARTED|Post-visit Checklist||297
10923071|NCT00227877|12090842|FG003|STARTED|Post-visit Checklist||292
10923072|NCT00227877|12090839|FG000|COMPLETED|Post-visit Checklist||1044
10923073|NCT00227877|12090840|FG001|COMPLETED|Post-visit Checklist||1015
10923074|NCT00227877|12090841|FG002|COMPLETED|Post-visit Checklist||296
10923075|NCT00227877|12090842|FG003|COMPLETED|Post-visit Checklist||292
10923076|NCT00227877|12090839|FG000|NOT COMPLETED|Post-visit Checklist||24
10923077|NCT00227877|12090840|FG001|NOT COMPLETED|Post-visit Checklist||13
10923078|NCT00227877|12090841|FG002|NOT COMPLETED|Post-visit Checklist||1
10923079|NCT00227877|12090842|FG003|NOT COMPLETED|Post-visit Checklist||0
10923080|NCT00227877|12090839|FG000|STARTED|3-months Follow-up||1068
10923081|NCT00227877|12090840|FG001|STARTED|3-months Follow-up||1028
10923082|NCT00227877|12090841|FG002|STARTED|3-months Follow-up||297
10923083|NCT00227877|12090842|FG003|STARTED|3-months Follow-up||292
10923084|NCT00227877|12090839|FG000|COMPLETED|3-months Follow-up||755
10923085|NCT00227877|12090840|FG001|COMPLETED|3-months Follow-up||761
10923086|NCT00227877|12090841|FG002|COMPLETED|3-months Follow-up||245
10923087|NCT00227877|12090842|FG003|COMPLETED|3-months Follow-up||271
10923088|NCT00227877|12090839|FG000|NOT COMPLETED|3-months Follow-up||313
10923089|NCT00227877|12090840|FG001|NOT COMPLETED|3-months Follow-up||267
10923090|NCT00227877|12090841|FG002|NOT COMPLETED|3-months Follow-up||52
10923091|NCT00227877|12090842|FG003|NOT COMPLETED|3-months Follow-up||21
10923092|NCT00227877|12090839|FG000|STARTED|12-months Follow-up||1068
10923093|NCT00227877|12090840|FG001|STARTED|12-months Follow-up||1028
10923094|NCT00227877|12090841|FG002|STARTED|12-months Follow-up||297
10923095|NCT00227877|12090842|FG003|STARTED|12-months Follow-up||292
10923096|NCT00227877|12090839|FG000|COMPLETED|12-months Follow-up||758
10923097|NCT00227877|12090840|FG001|COMPLETED|12-months Follow-up||765
10923098|NCT00227877|12090841|FG002|COMPLETED|12-months Follow-up||266
10923099|NCT00227877|12090842|FG003|COMPLETED|12-months Follow-up||266
10923100|NCT00227877|12090839|FG000|NOT COMPLETED|12-months Follow-up||310
10923101|NCT00227877|12090840|FG001|NOT COMPLETED|12-months Follow-up||263
10923102|NCT00227877|12090841|FG002|NOT COMPLETED|12-months Follow-up||31
10923103|NCT00227877|12090842|FG003|NOT COMPLETED|12-months Follow-up||26
10923104|NCT00227903|12090856|FG000|STARTED|Overall Study||91
10923105|NCT00227903|12090857|FG001|STARTED|Overall Study||92
10923106|NCT00227903|12090856|FG000|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
10923107|NCT00227903|12090857|FG001|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
10923108|NCT00227903|12090856|FG000|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
10923109|NCT00227903|12090857|FG001|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
10923110|NCT00227903|12090856|FG000|NOT COMPLETED|Overall Study||5
10923111|NCT00227903|12090857|FG001|NOT COMPLETED|Overall Study||10
10923112|NCT00227994|12090865|FG000|STARTED|Overall Study||20
10923113|NCT00227994|12090866|FG001|STARTED|Overall Study||20
10923114|NCT00227994|12090865|FG000|COMPLETED|Overall Study||13
10923115|NCT00227994|12090866|FG001|COMPLETED|Overall Study||13
10923116|NCT00227994|12090865|FG000|NOT COMPLETED|Overall Study||7
10923117|NCT00227994|12090866|FG001|NOT COMPLETED|Overall Study||7
10923118|NCT00228384|12090874|FG000|STARTED|Overall Study||72
10923119|NCT00228384|12090875|FG001|STARTED|Overall Study||76
10923120|NCT00228384|12090874|FG000|Baseline|Overall Study||72
10923121|NCT00228384|12090875|FG001|Baseline|Overall Study||76
10923122|NCT00228384|12090874|FG000|30-Day Follow-up (Safety Outcome)|Overall Study||69
10923123|NCT00228384|12090875|FG001|30-Day Follow-up (Safety Outcome)|Overall Study||72
10923124|NCT00228384|12090874|FG000|Three Year Follow-up (Final)|Overall Study||43
10923125|NCT00228384|12090875|FG001|Three Year Follow-up (Final)|Overall Study||47
10923126|NCT00228384|12090874|FG000|COMPLETED|Overall Study||43
10923127|NCT00228384|12090875|FG001|COMPLETED|Overall Study||47
10923128|NCT00228384|12090874|FG000|NOT COMPLETED|Overall Study||29
10923129|NCT00228384|12090875|FG001|NOT COMPLETED|Overall Study||29
10923130|NCT00228423|12090883|FG000|STARTED|Overall Study||56
10923131|NCT00228423|12090884|FG001|STARTED|Overall Study||57
10923132|NCT00228423|12090883|FG000|COMPLETED|Overall Study||46
10923133|NCT00228423|12090884|FG001|COMPLETED|Overall Study||45
10923134|NCT00228423|12090883|FG000|NOT COMPLETED|Overall Study||10
10923135|NCT00228423|12090884|FG001|NOT COMPLETED|Overall Study||12
10923136|NCT00228553|12090890|FG000|STARTED|Overall Study||743
10923137|NCT00228553|12090890|FG000|COMPLETED|Overall Study||313
10923138|NCT00228553|12090890|FG000|NOT COMPLETED|Overall Study||430
10923139|NCT00228566|12090894|FG000|STARTED|Overall Study||247
10923140|NCT00228566|12090894|FG000|COMPLETED|Overall Study||176
10923141|NCT00228566|12090894|FG000|NOT COMPLETED|Overall Study||71
10923142|NCT00228813|12090898|FG000|STARTED|Overall Study||8
10923143|NCT00228813|12090898|FG000|COMPLETED|Overall Study||4
10923144|NCT00228813|12090898|FG000|NOT COMPLETED|Overall Study||4
10923145|NCT00228917|12090910|FG000|STARTED|Overall Study||193
10923146|NCT00228917|12090911|FG001|STARTED|Overall Study||96
10923147|NCT00228917|12090912|FG002|STARTED|Overall Study||65
10923148|NCT00228917|12090913|FG003|STARTED|Overall Study||33
10923149|NCT00228917|12090914|FG004|STARTED|Overall Study||205
10923150|NCT00228917|12090915|FG005|STARTED|Overall Study||104
10923151|NCT00228917|12090916|FG006|STARTED|Overall Study||69
10923152|NCT00228917|12090917|FG007|STARTED|Overall Study||33
10923153|NCT00228917|12090910|FG000|COMPLETED|Overall Study||193
10923154|NCT00228917|12090911|FG001|COMPLETED|Overall Study||96
10923155|NCT00228917|12090912|FG002|COMPLETED|Overall Study||65
10923156|NCT00228917|12090913|FG003|COMPLETED|Overall Study||33
10923157|NCT00228917|12090914|FG004|COMPLETED|Overall Study||205
10923158|NCT00228917|12090915|FG005|COMPLETED|Overall Study||102
10923159|NCT00228917|12090916|FG006|COMPLETED|Overall Study||69
10923160|NCT00228917|12090917|FG007|COMPLETED|Overall Study||33
10923161|NCT00228917|12090910|FG000|NOT COMPLETED|Overall Study||0
10923162|NCT00228917|12090911|FG001|NOT COMPLETED|Overall Study||0
10923163|NCT00228917|12090912|FG002|NOT COMPLETED|Overall Study||0
10923164|NCT00228917|12090913|FG003|NOT COMPLETED|Overall Study||0
10923165|NCT00228917|12090914|FG004|NOT COMPLETED|Overall Study||0
10923166|NCT00228917|12090915|FG005|NOT COMPLETED|Overall Study||2
10923167|NCT00228917|12090916|FG006|NOT COMPLETED|Overall Study||0
10923168|NCT00228917|12090917|FG007|NOT COMPLETED|Overall Study||0
10923169|NCT00228943|12090931|FG000|STARTED|Week 1||28
10923170|NCT00228943|12090931|FG000|COMPLETED|Week 1||28
10923171|NCT00228943|12090931|FG000|NOT COMPLETED|Week 1||0
10923172|NCT00228943|12090931|FG000|STARTED|Week 2||28
10923173|NCT00228943|12090931|FG000|COMPLETED|Week 2||27
10923174|NCT00228943|12090931|FG000|NOT COMPLETED|Week 2||1
10923175|NCT00229203|12090939|FG000|STARTED|Overall Study||32
10923176|NCT00229203|12090940|FG001|STARTED|Overall Study||19
10923177|NCT00229203|12090939|FG000|COMPLETED|Overall Study||0
10923178|NCT00229203|12090940|FG001|COMPLETED|Overall Study||0
10923179|NCT00229203|12090939|FG000|NOT COMPLETED|Overall Study||32
10923180|NCT00229203|12090940|FG001|NOT COMPLETED|Overall Study||19
10923181|NCT00229619|12090946|FG000|STARTED|Overall Study||11
10923182|NCT00229619|12090946|FG000|COMPLETED|Overall Study||11
10923183|NCT00229619|12090946|FG000|NOT COMPLETED|Overall Study||0
10923184|NCT00229658|12090954|FG000|STARTED|Overall Study||766
10923185|NCT00229658|12090955|FG001|STARTED|Overall Study||531
10923186|NCT00229658|12090954|FG000|COMPLETED|Overall Study||541
10923187|NCT00229658|12090955|FG001|COMPLETED|Overall Study||364
10923188|NCT00229658|12090954|FG000|NOT COMPLETED|Overall Study||225
10923189|NCT00229658|12090955|FG001|NOT COMPLETED|Overall Study||167
10923190|NCT00229723|12090968|FG000|STARTED|Concomitant Phase|Received randomized treatment|60
10923191|NCT00229723|12090969|FG001|STARTED|Concomitant Phase|Received randomized treatment|24
10923192|NCT00229723|12090970|FG002|STARTED|Concomitant Phase|Received randomized treatment|31
10923193|NCT00229723|12090971|FG003|STARTED|Concomitant Phase|Received randomized treatment|31
10923194|NCT00229723|12090972|FG004|STARTED|Concomitant Phase|Received randomized treatment|24
10923195|NCT00229723|12090973|FG005|STARTED|Concomitant Phase|Received randomized treatment|34
10923196|NCT00229723|12090974|FG006|STARTED|Concomitant Phase|Received randomized treatment|22
10923197|NCT00229723|12090968|FG000|COMPLETED|Concomitant Phase||50
10923198|NCT00229723|12090969|FG001|COMPLETED|Concomitant Phase||19
10923199|NCT00229723|12090970|FG002|COMPLETED|Concomitant Phase||25
10923200|NCT00229723|12090971|FG003|COMPLETED|Concomitant Phase||26
10923201|NCT00229723|12090972|FG004|COMPLETED|Concomitant Phase||22
10923202|NCT00229723|12090973|FG005|COMPLETED|Concomitant Phase||31
10923203|NCT00229723|12090974|FG006|COMPLETED|Concomitant Phase||19
10923204|NCT00229723|12090968|FG000|NOT COMPLETED|Concomitant Phase||10
10923205|NCT00229723|12090969|FG001|NOT COMPLETED|Concomitant Phase||5
10923206|NCT00229723|12090970|FG002|NOT COMPLETED|Concomitant Phase||6
10923207|NCT00229723|12090971|FG003|NOT COMPLETED|Concomitant Phase||5
10923208|NCT00229723|12090972|FG004|NOT COMPLETED|Concomitant Phase||2
10923209|NCT00229723|12090973|FG005|NOT COMPLETED|Concomitant Phase||3
10923210|NCT00229723|12090974|FG006|NOT COMPLETED|Concomitant Phase||3
10923211|NCT00229723|12090968|FG000|STARTED|Maintenance Phase||50
10923212|NCT00229723|12090969|FG001|STARTED|Maintenance Phase||19
10923213|NCT00229723|12090970|FG002|STARTED|Maintenance Phase||25
10923214|NCT00229723|12090971|FG003|STARTED|Maintenance Phase||26
10923215|NCT00229723|12090972|FG004|STARTED|Maintenance Phase||22
10923216|NCT00229723|12090973|FG005|STARTED|Maintenance Phase||31
10923217|NCT00229723|12090974|FG006|STARTED|Maintenance Phase||19
10923218|NCT00229723|12090968|FG000|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
10923219|NCT00229723|12090969|FG001|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
10923220|NCT00229723|12090970|FG002|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
10923221|NCT00229723|12090971|FG003|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
10923222|NCT00229723|12090972|FG004|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
10923223|NCT00229723|12090973|FG005|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
10923224|NCT00229723|12090974|FG006|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
10923225|NCT00229723|12090968|FG000|NOT COMPLETED|Maintenance Phase||25
10923226|NCT00229723|12090969|FG001|NOT COMPLETED|Maintenance Phase||14
10923227|NCT00229723|12090970|FG002|NOT COMPLETED|Maintenance Phase||9
10923228|NCT00229723|12090971|FG003|NOT COMPLETED|Maintenance Phase||17
10923229|NCT00229723|12090972|FG004|NOT COMPLETED|Maintenance Phase||15
10923230|NCT00229723|12090973|FG005|NOT COMPLETED|Maintenance Phase||19
10923231|NCT00229723|12090974|FG006|NOT COMPLETED|Maintenance Phase||10
10923232|NCT00229957|12090992|FG000|STARTED|Overall Study||152
10923233|NCT00229957|12090993|FG001|STARTED|Overall Study||151
10923234|NCT00229957|12090992|FG000|COMPLETED|Overall Study||132
10923235|NCT00229957|12090993|FG001|COMPLETED|Overall Study||139
10923236|NCT00229957|12090992|FG000|NOT COMPLETED|Overall Study||20
10923237|NCT00229957|12090993|FG001|NOT COMPLETED|Overall Study||12
10923238|NCT00230009|12091001|FG000|STARTED|Single Session Intervention/Control||50
10923239|NCT00230009|12091002|FG001|STARTED|Single Session Intervention/Control||50
10923240|NCT00230009|12091001|FG000|COMPLETED|Single Session Intervention/Control||50
10923241|NCT00230009|12091002|FG001|COMPLETED|Single Session Intervention/Control||50
10923242|NCT00230009|12091001|FG000|NOT COMPLETED|Single Session Intervention/Control||0
10923243|NCT00230009|12091002|FG001|NOT COMPLETED|Single Session Intervention/Control||0
10923244|NCT00230009|12091001|FG000|STARTED|Follow-up||50
10923245|NCT00230009|12091002|FG001|STARTED|Follow-up||50
10923246|NCT00230009|12091001|FG000|COMPLETED|Follow-up||19
10923247|NCT00230009|12091002|FG001|COMPLETED|Follow-up||24
10923248|NCT00230009|12091001|FG000|NOT COMPLETED|Follow-up||31
10923249|NCT00230009|12091002|FG001|NOT COMPLETED|Follow-up||26
10923250|NCT00230022|12091010|FG000|STARTED|Overall Study||15
10923251|NCT00230022|12091011|FG001|STARTED|Overall Study||15
10923252|NCT00230022|12091010|FG000|COMPLETED|Overall Study||15
10923253|NCT00230022|12091011|FG001|COMPLETED|Overall Study||15
10923254|NCT00230022|12091010|FG000|NOT COMPLETED|Overall Study||0
10923255|NCT00230022|12091011|FG001|NOT COMPLETED|Overall Study||0
10923256|NCT00230048|12091019|FG000|STARTED|Overall Study||52
10923257|NCT00230048|12091020|FG001|STARTED|Overall Study||55
10923258|NCT00230048|12091019|FG000|Completed Intervention/Control Session|Overall Study||52
10923259|NCT00230048|12091020|FG001|Completed Intervention/Control Session|Overall Study||55
10923260|NCT00230048|12091019|FG000|COMPLETED|Overall Study||39
10923261|NCT00230048|12091020|FG001|COMPLETED|Overall Study||37
10923262|NCT00230048|12091019|FG000|NOT COMPLETED|Overall Study||13
10923263|NCT00230048|12091020|FG001|NOT COMPLETED|Overall Study||18
10923264|NCT00230100|12091030|FG000|STARTED|Overall Study||29
10923265|NCT00230100|12091031|FG001|STARTED|Overall Study||17
10923266|NCT00230100|12091030|FG000|COMPLETED|Overall Study||29
10923267|NCT00230100|12091031|FG001|COMPLETED|Overall Study||17
10923268|NCT00230100|12091030|FG000|NOT COMPLETED|Overall Study||0
10923269|NCT00230100|12091031|FG001|NOT COMPLETED|Overall Study||0
10923270|NCT00230126|12091039|FG000|STARTED|Overall Study||30
10923271|NCT00230126|12091040|FG001|STARTED|Overall Study||28
10923272|NCT00230126|12091039|FG000|COMPLETED|Overall Study||28
10923273|NCT00230126|12091040|FG001|COMPLETED|Overall Study||27
10923274|NCT00230126|12091039|FG000|NOT COMPLETED|Overall Study||2
10923275|NCT00230126|12091040|FG001|NOT COMPLETED|Overall Study||1
10923276|NCT00230178|12091051|FG000|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
10923277|NCT00230178|12091052|FG001|STARTED|Overall Study||93
10923278|NCT00230178|12091053|FG002|STARTED|Overall Study||93
10923279|NCT00230178|12091051|FG000|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
10923280|NCT00230178|12091052|FG001|Treated|Overall Study||92
10923281|NCT00230178|12091053|FG002|Treated|Overall Study||91
10923282|NCT00230178|12091051|FG000|COMPLETED|Overall Study||90
10923283|NCT00230178|12091052|FG001|COMPLETED|Overall Study||86
10923284|NCT00230178|12091053|FG002|COMPLETED|Overall Study||86
10923285|NCT00230178|12091051|FG000|NOT COMPLETED|Overall Study||4
10923286|NCT00230178|12091052|FG001|NOT COMPLETED|Overall Study||7
10923287|NCT00230178|12091053|FG002|NOT COMPLETED|Overall Study||7
10923288|NCT00230282|12091061|FG000|STARTED|Fludarabine + Cyclophosphamide||25
10923289|NCT00230282|12091061|FG000|COMPLETED|Fludarabine + Cyclophosphamide||17
10923290|NCT00230282|12091061|FG000|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
10923291|NCT00230282|12091061|FG000|STARTED|Maintanence Therapy With Alemtuzumab||17
10923292|NCT00230282|12091061|FG000|COMPLETED|Maintanence Therapy With Alemtuzumab||17
10923293|NCT00230282|12091061|FG000|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
10923294|NCT00230737|12091068|FG000|STARTED|Overall Study||9
10923295|NCT00230737|12091069|FG001|STARTED|Overall Study||10
10923296|NCT00230737|12091070|FG002|STARTED|Overall Study||8
10923297|NCT00230737|12091068|FG000|COMPLETED|Overall Study||9
10923298|NCT00230737|12091069|FG001|COMPLETED|Overall Study||10
10923299|NCT00230737|12091070|FG002|COMPLETED|Overall Study||8
10923300|NCT00230737|12091068|FG000|NOT COMPLETED|Overall Study||0
10923301|NCT00230737|12091069|FG001|NOT COMPLETED|Overall Study||0
10923302|NCT00230737|12091070|FG002|NOT COMPLETED|Overall Study||0
10923303|NCT00230802|12091080|FG000|STARTED|Overall Study||25
10923304|NCT00230802|12091081|FG001|STARTED|Overall Study||23
10923305|NCT00230802|12091080|FG000|COMPLETED|Overall Study||25
10923306|NCT00230802|12091081|FG001|COMPLETED|Overall Study||23
10923307|NCT00230802|12091080|FG000|NOT COMPLETED|Overall Study||0
10923308|NCT00230802|12091081|FG001|NOT COMPLETED|Overall Study||0
10923309|NCT00230971|12091091|FG000|STARTED|Randomization||235
10923310|NCT00230971|12091092|FG001|STARTED|Randomization||238
10923311|NCT00230971|12091091|FG000|COMPLETED|Randomization||232
10923312|NCT00230971|12091092|FG001|COMPLETED|Randomization||235
10923313|NCT00230971|12091091|FG000|NOT COMPLETED|Randomization||3
10923314|NCT00230971|12091092|FG001|NOT COMPLETED|Randomization||3
10923315|NCT00230971|12091091|FG000|STARTED|Baseline Participants||232
10923316|NCT00230971|12091092|FG001|STARTED|Baseline Participants||235
10923317|NCT00230971|12091091|FG000|COMPLETED|Baseline Participants||210
10923318|NCT00230971|12091092|FG001|COMPLETED|Baseline Participants||216
10923319|NCT00230971|12091091|FG000|NOT COMPLETED|Baseline Participants||22
10923320|NCT00230971|12091092|FG001|NOT COMPLETED|Baseline Participants||19
10923321|NCT00231062|12091098|FG000|STARTED|Overall Study||115
10923322|NCT00231062|12091098|FG000|COMPLETED|Overall Study||109
10923323|NCT00231062|12091098|FG000|NOT COMPLETED|Overall Study||6
10923324|NCT00231114|12091104|FG000|STARTED|Randomized||196
10923325|NCT00231114|12091105|FG001|STARTED|Randomized||101
10923326|NCT00231114|12091104|FG000|COMPLETED|Randomized||190
10923327|NCT00231114|12091105|FG001|COMPLETED|Randomized||98
10923328|NCT00231114|12091104|FG000|NOT COMPLETED|Randomized||6
10923329|NCT00231114|12091105|FG001|NOT COMPLETED|Randomized||3
10923330|NCT00231114|12091104|FG000|STARTED|Treatment Period||190
10923331|NCT00231114|12091105|FG001|STARTED|Treatment Period||98
10923332|NCT00231114|12091104|FG000|COMPLETED|Treatment Period||189
10923333|NCT00231114|12091105|FG001|COMPLETED|Treatment Period||98
10923334|NCT00231114|12091104|FG000|NOT COMPLETED|Treatment Period||1
10923335|NCT00231114|12091105|FG001|NOT COMPLETED|Treatment Period||0
10923336|NCT00231114|12091104|FG000|STARTED|Post-Treatment Period||189
10923337|NCT00231114|12091105|FG001|STARTED|Post-Treatment Period||98
10923338|NCT00231114|12091104|FG000|COMPLETED|Post-Treatment Period||181
10923339|NCT00231114|12091105|FG001|COMPLETED|Post-Treatment Period||97
10923340|NCT00231114|12091104|FG000|NOT COMPLETED|Post-Treatment Period||8
10923341|NCT00231114|12091105|FG001|NOT COMPLETED|Post-Treatment Period||1
10923342|NCT00231179|12091115|FG000|STARTED|Overall Study||152
10923343|NCT00231179|12091116|FG001|STARTED|Overall Study||150
10923344|NCT00231179|12091115|FG000|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
10923345|NCT00231179|12091116|FG001|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
10923346|NCT00231179|12091115|FG000|NOT COMPLETED|Overall Study||24
10923347|NCT00231179|12091116|FG001|NOT COMPLETED|Overall Study||24
10923348|NCT00231283|12091122|FG000|STARTED|Overall Study||100
10923349|NCT00231283|12091122|FG000|COMPLETED|Overall Study||95
10923350|NCT00231283|12091122|FG000|NOT COMPLETED|Overall Study||5
10923351|NCT00231309|12091126|FG000|STARTED|Overall Study||10
10923352|NCT00231309|12091126|FG000|COMPLETED|Overall Study||10
10923353|NCT00231309|12091126|FG000|NOT COMPLETED|Overall Study||0
10923354|NCT00231413|12091138|FG000|STARTED|Overall Study||88
10923355|NCT00231413|12091139|FG001|STARTED|Overall Study||50
10923356|NCT00231413|12091140|FG002|STARTED|Overall Study||49
10923357|NCT00231413|12091141|FG003|STARTED|Overall Study||48
10923358|NCT00231413|12091142|FG004|STARTED|Overall Study||48
10923359|NCT00231413|12091143|FG005|STARTED|Overall Study||50
10923360|NCT00231413|12091144|FG006|STARTED|Overall Study||50
10923361|NCT00231413|12091138|FG000|COMPLETED|Overall Study||80
10923362|NCT00231413|12091139|FG001|COMPLETED|Overall Study||45
10923363|NCT00231413|12091140|FG002|COMPLETED|Overall Study||42
10923364|NCT00231413|12091141|FG003|COMPLETED|Overall Study||45
10923365|NCT00231413|12091142|FG004|COMPLETED|Overall Study||45
10923366|NCT00231413|12091143|FG005|COMPLETED|Overall Study||45
10923367|NCT00231413|12091144|FG006|COMPLETED|Overall Study||46
10923368|NCT00231413|12091138|FG000|NOT COMPLETED|Overall Study||8
10923369|NCT00231413|12091139|FG001|NOT COMPLETED|Overall Study||5
10923370|NCT00231413|12091140|FG002|NOT COMPLETED|Overall Study||7
10923371|NCT00231413|12091141|FG003|NOT COMPLETED|Overall Study||3
10923372|NCT00231413|12091142|FG004|NOT COMPLETED|Overall Study||3
10923373|NCT00231413|12091143|FG005|NOT COMPLETED|Overall Study||5
10923374|NCT00231413|12091144|FG006|NOT COMPLETED|Overall Study||4
10923375|NCT00231465|12091160|FG000|STARTED|Overall Study||44
10923376|NCT00231465|12091160|FG000|COMPLETED|Overall Study||42
10923377|NCT00231465|12091160|FG000|NOT COMPLETED|Overall Study||2
10923378|NCT00231478|12091166|FG000|STARTED|Overall Study||87
10923379|NCT00231478|12091167|FG001|STARTED|Overall Study||84
10923380|NCT00231478|12091166|FG000|COMPLETED|Overall Study||79
10923381|NCT00231478|12091167|FG001|COMPLETED|Overall Study||78
10923382|NCT00231478|12091166|FG000|NOT COMPLETED|Overall Study||8
10923383|NCT00231478|12091167|FG001|NOT COMPLETED|Overall Study||6
10923384|NCT00231777|12091175|FG000|STARTED|Overall Study||170
10923385|NCT00231777|12091176|FG001|STARTED|Overall Study||46
10923386|NCT00231777|12091175|FG000|COMPLETED|Overall Study||164
10923387|NCT00231777|12091176|FG001|COMPLETED|Overall Study||44
10923388|NCT00231777|12091175|FG000|NOT COMPLETED|Overall Study||6
10923389|NCT00231777|12091176|FG001|NOT COMPLETED|Overall Study||2
10923390|NCT00231816|12091184|FG000|STARTED|Overall Study||382
10923391|NCT00231816|12091185|FG001|STARTED|Overall Study||381
10923392|NCT00231816|12091184|FG000|Vaccinated at Visit 1|Overall Study||382
10923393|NCT00231816|12091185|FG001|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
10923394|NCT00231816|12091184|FG000|Vaccinated at Visit 2|Overall Study||369
10923395|NCT00231816|12091185|FG001|Vaccinated at Visit 2|Overall Study||371
10923396|NCT00231816|12091184|FG000|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
10923397|NCT00231816|12091185|FG001|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
10923398|NCT00231816|12091184|FG000|NOT COMPLETED|Overall Study||16
10923399|NCT00231816|12091185|FG001|NOT COMPLETED|Overall Study||12
10923400|NCT00231842|12091192|FG000|STARTED|Overall Study||30
10923401|NCT00231842|12091192|FG000|Initiated Therapy|Overall Study||27
10923402|NCT00231842|12091192|FG000|Completed First 3 Cycles|Overall Study||27
10923403|NCT00231842|12091192|FG000|Completed Prescribed RT|Overall Study||27
10923404|NCT00231842|12091192|FG000|Completed Full Prescribed Therapy|Overall Study||19
10923405|NCT00231842|12091192|FG000|COMPLETED|Overall Study||19
10923406|NCT00231842|12091192|FG000|NOT COMPLETED|Overall Study||11
10923407|NCT00231868|12091197|FG000|STARTED|Overall Study||81
10923408|NCT00231868|12091197|FG000|COMPLETED|Overall Study||65
10923409|NCT00231868|12091197|FG000|NOT COMPLETED|Overall Study||16
10923410|NCT00231894|12091203|FG000|STARTED|Overall Study||31
10923411|NCT00231894|12091204|FG001|STARTED|Overall Study||25
10923412|NCT00231894|12091203|FG000|COMPLETED|Overall Study||30
10923413|NCT00231894|12091204|FG001|COMPLETED|Overall Study||24
10923414|NCT00231894|12091203|FG000|NOT COMPLETED|Overall Study||1
10923415|NCT00231894|12091204|FG001|NOT COMPLETED|Overall Study||1
10923416|NCT00232180|12091218|FG000|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
10923417|NCT00232180|12091219|FG001|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
10923418|NCT00232180|12091220|FG002|STARTED|Double-blind (DB) Phase||0
10923419|NCT00232180|12091218|FG000|Treated|Double-blind (DB) Phase||1364
10923420|NCT00232180|12091219|FG001|Treated|Double-blind (DB) Phase||1372
10923421|NCT00232180|12091220|FG002|Treated|Double-blind (DB) Phase||0
10923422|NCT00232180|12091218|FG000|COMPLETED|Double-blind (DB) Phase||826
10923423|NCT00232180|12091219|FG001|COMPLETED|Double-blind (DB) Phase||771
10923424|NCT00232180|12091220|FG002|COMPLETED|Double-blind (DB) Phase||0
10923425|NCT00232180|12091218|FG000|NOT COMPLETED|Double-blind (DB) Phase||541
10923426|NCT00232180|12091219|FG001|NOT COMPLETED|Double-blind (DB) Phase||605
10923427|NCT00232180|12091220|FG002|NOT COMPLETED|Double-blind (DB) Phase||0
10923428|NCT00232180|12091218|FG000|STARTED|Open Label Phase||0
10923429|NCT00232180|12091219|FG001|STARTED|Open Label Phase||0
10923430|NCT00232180|12091220|FG002|STARTED|Open Label Phase||1246
10923431|NCT00232180|12091218|FG000|Treated|Open Label Phase||0
10923432|NCT00232180|12091219|FG001|Treated|Open Label Phase||0
10923433|NCT00232180|12091220|FG002|Treated|Open Label Phase||1245
10923434|NCT00232180|12091218|FG000|COMPLETED|Open Label Phase||0
10923435|NCT00232180|12091219|FG001|COMPLETED|Open Label Phase||0
10923436|NCT00232180|12091220|FG002|COMPLETED|Open Label Phase||1098
10923437|NCT00232180|12091218|FG000|NOT COMPLETED|Open Label Phase||0
10923438|NCT00232180|12091219|FG001|NOT COMPLETED|Open Label Phase||0
10923439|NCT00232180|12091220|FG002|NOT COMPLETED|Open Label Phase||148
10923440|NCT00232479|12091229|FG000|STARTED|Overall Study||44
10923441|NCT00232479|12091229|FG000|COMPLETED|Overall Study||44
10923442|NCT00232479|12091229|FG000|NOT COMPLETED|Overall Study||0
10923443|NCT00232505|12091236|FG000|STARTED|Overall Study||31
10923444|NCT00232505|12091237|FG001|STARTED|Overall Study||71
10923445|NCT00232505|12091236|FG000|Not Evaluable|Overall Study||0
10923446|NCT00232505|12091237|FG001|Not Evaluable|Overall Study||6
10923447|NCT00232505|12091236|FG000|Early Progressors|Overall Study||2
10923448|NCT00232505|12091237|FG001|Early Progressors|Overall Study||5
10923449|NCT00232505|12091236|FG000|Off Protocol|Overall Study||5
10923450|NCT00232505|12091237|FG001|Off Protocol|Overall Study||0
10923451|NCT00232505|12091236|FG000|COMPLETED|Overall Study||26
10923452|NCT00232505|12091237|FG001|COMPLETED|Overall Study||60
10923453|NCT00232505|12091236|FG000|NOT COMPLETED|Overall Study||5
10923454|NCT00232505|12091237|FG001|NOT COMPLETED|Overall Study||11
10923455|NCT00232544|12091249|FG000|STARTED|Overall Study||124
10923456|NCT00232544|12091250|FG001|STARTED|Overall Study||126
10923457|NCT00232544|12091249|FG000|COMPLETED|Overall Study||104
10923458|NCT00232544|12091250|FG001|COMPLETED|Overall Study||111
10923459|NCT00232544|12091249|FG000|NOT COMPLETED|Overall Study||20
10923460|NCT00232544|12091250|FG001|NOT COMPLETED|Overall Study||15
10923461|NCT00232557|12091258|FG000|STARTED|Overall Study||71
10923462|NCT00232557|12091259|FG001|STARTED|Overall Study||65
10923463|NCT00232557|12091258|FG000|COMPLETED|Overall Study||68
10923464|NCT00232557|12091259|FG001|COMPLETED|Overall Study||60
10923465|NCT00232557|12091258|FG000|NOT COMPLETED|Overall Study||3
10923466|NCT00232557|12091259|FG001|NOT COMPLETED|Overall Study||5
10923467|NCT00232583|12091267|FG000|STARTED|Overall Study||29
10923468|NCT00232583|12091268|FG001|STARTED|Overall Study||29
10923469|NCT00232583|12091267|FG000|COMPLETED|Overall Study||19
10923470|NCT00232583|12091268|FG001|COMPLETED|Overall Study||16
10923471|NCT00232583|12091267|FG000|NOT COMPLETED|Overall Study||10
10923472|NCT00232583|12091268|FG001|NOT COMPLETED|Overall Study||13
10923473|NCT00232596|12091280|FG000|STARTED|6-Week Titration Phase||152
10923474|NCT00232596|12091281|FG001|STARTED|6-Week Titration Phase||154
10923475|NCT00232596|12091280|FG000|COMPLETED|6-Week Titration Phase||138
10923476|NCT00232596|12091281|FG001|COMPLETED|6-Week Titration Phase||125
10923477|NCT00232596|12091280|FG000|NOT COMPLETED|6-Week Titration Phase||14
10923478|NCT00232596|12091281|FG001|NOT COMPLETED|6-Week Titration Phase||29
10923479|NCT00232596|12091280|FG000|STARTED|12-Week Maintenance Phase||138
10923480|NCT00232596|12091281|FG001|STARTED|12-Week Maintenance Phase||125
10923481|NCT00232596|12091280|FG000|COMPLETED|12-Week Maintenance Phase|"One participant withdrew after being considered a completer and is listed as an early withdraw."|126
10923482|NCT00232596|12091281|FG001|COMPLETED|12-Week Maintenance Phase||97
10923483|NCT00232596|12091280|FG000|NOT COMPLETED|12-Week Maintenance Phase||12
10923484|NCT00232596|12091281|FG001|NOT COMPLETED|12-Week Maintenance Phase||28
10923485|NCT00232739|12091299|FG000|STARTED|Overall Study||100
10923486|NCT00232739|12091299|FG000|COMPLETED|Overall Study||91
10923487|NCT00232739|12091299|FG000|NOT COMPLETED|Overall Study||9
10923488|NCT00233064|12091305|FG000|STARTED|Overall Study||211
10923489|NCT00233064|12091306|FG001|STARTED|Overall Study||202
10923490|NCT00233064|12091305|FG000|COMPLETED|Overall Study||197
10923491|NCT00233064|12091306|FG001|COMPLETED|Overall Study||190
10923492|NCT00233064|12091305|FG000|NOT COMPLETED|Overall Study||14
10923493|NCT00233064|12091306|FG001|NOT COMPLETED|Overall Study||12
10923494|NCT00233103|12091315|FG000|STARTED|Overall Study||27
10923495|NCT00233103|12091316|FG001|STARTED|Overall Study||25
10923496|NCT00233103|12091315|FG000|COMPLETED|Overall Study||22
10923497|NCT00233103|12091316|FG001|COMPLETED|Overall Study||19
10923498|NCT00233103|12091315|FG000|NOT COMPLETED|Overall Study||5
10923499|NCT00233103|12091316|FG001|NOT COMPLETED|Overall Study||6
10923500|NCT00233324|12091326|FG000|STARTED|Main Study||318
10923501|NCT00233324|12091327|FG001|STARTED|Main Study||335
10923502|NCT00233324|12091328|FG002|STARTED|Main Study||336
10923503|NCT00233324|12091329|FG003|STARTED|Main Study||327
10923504|NCT00233324|12091326|FG000|COMPLETED|Main Study||250
10923505|NCT00233324|12091327|FG001|COMPLETED|Main Study||275
10923506|NCT00233324|12091328|FG002|COMPLETED|Main Study||274
10923507|NCT00233324|12091329|FG003|COMPLETED|Main Study||280
10923508|NCT00233324|12091326|FG000|NOT COMPLETED|Main Study||68
10923509|NCT00233324|12091327|FG001|NOT COMPLETED|Main Study||60
10923510|NCT00233324|12091328|FG002|NOT COMPLETED|Main Study||62
10923511|NCT00233324|12091329|FG003|NOT COMPLETED|Main Study||47
10923512|NCT00233324|12091326|FG000|STARTED|Follow up at 18-22 Months Corrected Age||250
10923513|NCT00233324|12091327|FG001|STARTED|Follow up at 18-22 Months Corrected Age||275
10923514|NCT00233324|12091328|FG002|STARTED|Follow up at 18-22 Months Corrected Age||274
10923515|NCT00233324|12091329|FG003|STARTED|Follow up at 18-22 Months Corrected Age||280
10923516|NCT00233324|12091326|FG000|COMPLETED|Follow up at 18-22 Months Corrected Age||237
10923517|NCT00233324|12091327|FG001|COMPLETED|Follow up at 18-22 Months Corrected Age||261
10923518|NCT00233324|12091328|FG002|COMPLETED|Follow up at 18-22 Months Corrected Age||256
10923519|NCT00233324|12091329|FG003|COMPLETED|Follow up at 18-22 Months Corrected Age||269
10923520|NCT00233324|12091326|FG000|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
10923521|NCT00233324|12091327|FG001|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
10923522|NCT00233324|12091328|FG002|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
10923523|NCT00233324|12091329|FG003|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
10923524|NCT00233363|12091348|FG000|STARTED|Overall Study||53
10923525|NCT00233363|12091349|FG001|STARTED|Overall Study||51
10923526|NCT00233363|12091348|FG000|COMPLETED|Overall Study||50
10923527|NCT00233363|12091349|FG001|COMPLETED|Overall Study||46
10923528|NCT00233363|12091348|FG000|NOT COMPLETED|Overall Study||3
10923529|NCT00233363|12091349|FG001|NOT COMPLETED|Overall Study||5
10923530|NCT00233389|12091357|FG000|STARTED|Overall Study||154
10923531|NCT00233389|12091358|FG001|STARTED|Overall Study||147
10923532|NCT00233389|12091357|FG000|COMPLETED|Overall Study||136
10923533|NCT00233389|12091358|FG001|COMPLETED|Overall Study||131
10923534|NCT00233389|12091357|FG000|NOT COMPLETED|Overall Study||18
10923535|NCT00233389|12091358|FG001|NOT COMPLETED|Overall Study||16
10923536|NCT00233402|12091366|FG000|STARTED|Overall Study||384
10923537|NCT00233402|12091367|FG001|STARTED|Overall Study||395
10923538|NCT00233402|12091366|FG000|COMPLETED|Overall Study||280
10923539|NCT00233402|12091367|FG001|COMPLETED|Overall Study||271
10923540|NCT00233402|12091366|FG000|NOT COMPLETED|Overall Study||104
10923541|NCT00233402|12091367|FG001|NOT COMPLETED|Overall Study||124
10923542|NCT00233454|12091375|FG000|STARTED|Overall Study||26
10923543|NCT00233454|12091375|FG000|2 Months (for Response Rate)|Overall Study||26
10923544|NCT00233454|12091375|FG000|COMPLETED|Overall Study||20
10923545|NCT00233454|12091375|FG000|NOT COMPLETED|Overall Study||6
10923546|NCT00233480|12091381|FG000|STARTED|Overall Study||14
10923547|NCT00233480|12091382|FG001|STARTED|Overall Study||13
10923548|NCT00233480|12091381|FG000|COMPLETED|Overall Study||14
10923549|NCT00233480|12091382|FG001|COMPLETED|Overall Study||12
10923550|NCT00233480|12091381|FG000|NOT COMPLETED|Overall Study||0
10923551|NCT00233480|12091382|FG001|NOT COMPLETED|Overall Study||1
10923552|NCT00233519|12091392|FG000|STARTED|Overall Study||7
10923553|NCT00233519|12091393|FG001|STARTED|Overall Study||10
10923554|NCT00233519|12091392|FG000|COMPLETED|Overall Study||6
10923555|NCT00233519|12091393|FG001|COMPLETED|Overall Study||9
10923556|NCT00233519|12091392|FG000|NOT COMPLETED|Overall Study||1
10923557|NCT00233519|12091393|FG001|NOT COMPLETED|Overall Study||1
10923558|NCT00233948|12091401|FG000|STARTED|Overall Study||4
10923559|NCT00233948|12091402|FG001|STARTED|Overall Study||3
10923560|NCT00233948|12091403|FG002|STARTED|Overall Study||3
10923561|NCT00233948|12091404|FG003|STARTED|Overall Study||3
10923562|NCT00233948|12091405|FG004|STARTED|Overall Study||4
10923563|NCT00233948|12091406|FG005|STARTED|Overall Study||12
10923564|NCT00233948|12091401|FG000|COMPLETED|Overall Study||3
10923565|NCT00233948|12091402|FG001|COMPLETED|Overall Study||3
10923566|NCT00233948|12091403|FG002|COMPLETED|Overall Study||3
10923567|NCT00233948|12091404|FG003|COMPLETED|Overall Study||3
10923568|NCT00233948|12091405|FG004|COMPLETED|Overall Study||4
10923569|NCT00233948|12091406|FG005|COMPLETED|Overall Study||12
10923570|NCT00233948|12091401|FG000|NOT COMPLETED|Overall Study||1
10923571|NCT00233948|12091402|FG001|NOT COMPLETED|Overall Study||0
10923572|NCT00233948|12091403|FG002|NOT COMPLETED|Overall Study||0
10923573|NCT00233948|12091404|FG003|NOT COMPLETED|Overall Study||0
10923574|NCT00233948|12091405|FG004|NOT COMPLETED|Overall Study||0
10923575|NCT00233948|12091406|FG005|NOT COMPLETED|Overall Study||0
10923576|NCT00233987|12091421|FG000|STARTED|Overall Study||98
10923577|NCT00233987|12091421|FG000|Eligible|Overall Study||94
10923578|NCT00233987|12091421|FG000|Eligible and Treated|Overall Study||92
10923579|NCT00233987|12091421|FG000|COMPLETED|Overall Study||83
10923580|NCT00233987|12091421|FG000|NOT COMPLETED|Overall Study||15
10923581|NCT00234039|12091425|FG000|STARTED|Overall Study||58
10923582|NCT00234039|12091425|FG000|Eligible|Overall Study||49
10923583|NCT00234039|12091425|FG000|Eligible and Began Protocol Therapy|Overall Study||47
10923584|NCT00234039|12091425|FG000|COMPLETED|Overall Study||8
10923585|NCT00234039|12091425|FG000|NOT COMPLETED|Overall Study||50
10923586|NCT00234052|12091429|FG000|STARTED|Treatment||51
10923587|NCT00234052|12091429|FG000|Started Treatment|Treatment||50
10923588|NCT00234052|12091429|FG000|Completed 6 Cycles|Treatment||33
10923589|NCT00234052|12091429|FG000|Went Into Maintenance Phase|Treatment||30
10923590|NCT00234052|12091429|FG000|COMPLETED|Treatment||30
10923591|NCT00234052|12091429|FG000|NOT COMPLETED|Treatment||21
10923592|NCT00234052|12091429|FG000|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50
10923593|NCT00234052|12091429|FG000|COMPLETED|Follow-up for 5 Years||1
10923594|NCT00234052|12091429|FG000|NOT COMPLETED|Follow-up for 5 Years||49
10923595|NCT00234065|12091435|FG000|STARTED|Overall Study||1356
10923596|NCT00234065|12091436|FG001|STARTED|Overall Study||1360
10923597|NCT00234065|12091435|FG000|COMPLETED|Overall Study||881
10923598|NCT00234065|12091436|FG001|COMPLETED|Overall Study||1004
10923599|NCT00234065|12091435|FG000|NOT COMPLETED|Overall Study||475
10923600|NCT00234065|12091436|FG001|NOT COMPLETED|Overall Study||356
10923601|NCT00234078|12091446|FG000|STARTED|Overall Study||72
10923602|NCT00234078|12091447|FG001|STARTED|Overall Study||72
10923603|NCT00234078|12091448|FG002|STARTED|Overall Study||74
10923604|NCT00234078|12091449|FG003|STARTED|Overall Study||72
10923605|NCT00234078|12091446|FG000|COMPLETED|Overall Study||66
10923606|NCT00234078|12091447|FG001|COMPLETED|Overall Study||63
10923607|NCT00234078|12091448|FG002|COMPLETED|Overall Study||64
10923608|NCT00234078|12091449|FG003|COMPLETED|Overall Study||68
10923609|NCT00234078|12091446|FG000|NOT COMPLETED|Overall Study||6
10923610|NCT00234078|12091447|FG001|NOT COMPLETED|Overall Study||9
10923611|NCT00234078|12091448|FG002|NOT COMPLETED|Overall Study||10
10923612|NCT00234078|12091449|FG003|NOT COMPLETED|Overall Study||4
10923613|NCT00234104|12091463|FG000|STARTED|Overall Study||30
10923614|NCT00234104|12091464|FG001|STARTED|Overall Study||29
10923615|NCT00234104|12091465|FG002|STARTED|Overall Study||34
10923616|NCT00234104|12091466|FG003|STARTED|Overall Study||29
10923617|NCT00234104|12091463|FG000|COMPLETED|Overall Study||26
10923618|NCT00234104|12091464|FG001|COMPLETED|Overall Study||28
10923619|NCT00234104|12091465|FG002|COMPLETED|Overall Study||29
10923620|NCT00234104|12091466|FG003|COMPLETED|Overall Study||21
10923621|NCT00234104|12091463|FG000|NOT COMPLETED|Overall Study||4
10923622|NCT00234104|12091464|FG001|NOT COMPLETED|Overall Study||1
10923623|NCT00234104|12091465|FG002|NOT COMPLETED|Overall Study||5
10923624|NCT00234104|12091466|FG003|NOT COMPLETED|Overall Study||8
10923625|NCT00234286|12091476|FG000|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
10923626|NCT00234286|12091476|FG000|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
10923627|NCT00234286|12091476|FG000|NOT COMPLETED|Overall Study||0
10923628|NCT00234494|12091509|FG000|STARTED|Overall Study||45
10923629|NCT00234494|12091509|FG000|COMPLETED|Overall Study||43
10923630|NCT00234494|12091509|FG000|NOT COMPLETED|Overall Study||2
10923631|NCT00234533|12091513|FG000|STARTED|Overall Study||251
10923632|NCT00234533|12091513|FG000|COMPLETED|Overall Study||240
10923633|NCT00234533|12091513|FG000|NOT COMPLETED|Overall Study||11
10923634|NCT00234832|12091520|FG000|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
10923635|NCT00234832|12091521|FG001|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
10923636|NCT00234832|12091520|FG000|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
10923637|NCT00234832|12091521|FG001|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
10923638|NCT00234832|12091520|FG000|NOT COMPLETED|Overall Study||1016
10923639|NCT00234832|12091521|FG001|NOT COMPLETED|Overall Study||996
10923640|NCT00234884|12091534|FG000|STARTED|Overall Study||3435
10923641|NCT00234884|12091534|FG000|COMPLETED|Overall Study||1805
10923642|NCT00234884|12091534|FG000|NOT COMPLETED|Overall Study||1630
10923643|NCT00235391|12091544|FG000|STARTED|Overall Study||97
10923644|NCT00235391|12091545|FG001|STARTED|Overall Study||200
10923645|NCT00235391|12091546|FG002|STARTED|Overall Study||172
10923646|NCT00235391|12091547|FG003|STARTED|Overall Study||1164
10923647|NCT00235391|12091548|FG004|STARTED|Overall Study||43
10923648|NCT00235391|12091549|FG005|STARTED|Overall Study||7
10923649|NCT00235391|12091544|FG000|Deferasirox Treatment|Overall Study||97
10923650|NCT00235391|12091545|FG001|Deferasirox Treatment|Overall Study||200
10923651|NCT00235391|12091546|FG002|Deferasirox Treatment|Overall Study||172
10923652|NCT00235391|12091547|FG003|Deferasirox Treatment|Overall Study||1164
10923653|NCT00235391|12091548|FG004|Deferasirox Treatment|Overall Study||43
10923654|NCT00235391|12091549|FG005|Deferasirox Treatment|Overall Study||7
10923655|NCT00235391|12091544|FG000|COMPLETED|Overall Study||85
10923656|NCT00235391|12091545|FG001|COMPLETED|Overall Study||182
10923657|NCT00235391|12091546|FG002|COMPLETED|Overall Study||148
10923658|NCT00235391|12091547|FG003|COMPLETED|Overall Study||944
10923659|NCT00235391|12091548|FG004|COMPLETED|Overall Study||31
10923660|NCT00235391|12091549|FG005|COMPLETED|Overall Study||3
10923661|NCT00235391|12091544|FG000|NOT COMPLETED|Overall Study||12
10923662|NCT00235391|12091545|FG001|NOT COMPLETED|Overall Study||18
10923663|NCT00235391|12091546|FG002|NOT COMPLETED|Overall Study||24
10923664|NCT00235391|12091547|FG003|NOT COMPLETED|Overall Study||220
10923665|NCT00235391|12091548|FG004|NOT COMPLETED|Overall Study||12
10923666|NCT00235391|12091549|FG005|NOT COMPLETED|Overall Study||4
10923667|NCT00235443|12091564|FG000|STARTED|Overall Study||11
10923668|NCT00235443|12091565|FG001|STARTED|Overall Study||57
10923669|NCT00235443|12091566|FG002|STARTED|Overall Study||85
10923670|NCT00235443|12091567|FG003|STARTED|Overall Study||205
10923671|NCT00235443|12091568|FG004|STARTED|Overall Study||39
10923672|NCT00235443|12091569|FG005|STARTED|Overall Study||54
10923673|NCT00235443|12091564|FG000|COMPLETED|Overall Study||3
10923674|NCT00235443|12091565|FG001|COMPLETED|Overall Study||19
10923675|NCT00235443|12091566|FG002|COMPLETED|Overall Study||23
10923676|NCT00235443|12091567|FG003|COMPLETED|Overall Study||108
10923677|NCT00235443|12091568|FG004|COMPLETED|Overall Study||9
10923678|NCT00235443|12091569|FG005|COMPLETED|Overall Study||9
10923679|NCT00235443|12091564|FG000|NOT COMPLETED|Overall Study||8
10923680|NCT00235443|12091565|FG001|NOT COMPLETED|Overall Study||38
10923681|NCT00235443|12091566|FG002|NOT COMPLETED|Overall Study||62
10923682|NCT00235443|12091567|FG003|NOT COMPLETED|Overall Study||97
10923683|NCT00235443|12091568|FG004|NOT COMPLETED|Overall Study||30
10923684|NCT00235443|12091569|FG005|NOT COMPLETED|Overall Study||45
10923685|NCT00235456|12091587|FG000|STARTED|Overall Study||150
10923686|NCT00235456|12091588|FG001|STARTED|Overall Study||150
10923687|NCT00235456|12091587|FG000|COMPLETED|Overall Study||148
10923688|NCT00235456|12091588|FG001|COMPLETED|Overall Study||143
10923689|NCT00235456|12091587|FG000|NOT COMPLETED|Overall Study||2
10923690|NCT00235456|12091588|FG001|NOT COMPLETED|Overall Study||7
10923691|NCT00235495|12091596|FG000|STARTED|Overall Study||422
10923692|NCT00235495|12091597|FG001|STARTED|Overall Study||419
10923693|NCT00235495|12091596|FG000|COMPLETED|Overall Study||354
10923694|NCT00235495|12091597|FG001|COMPLETED|Overall Study||351
10923695|NCT00235495|12091596|FG000|NOT COMPLETED|Overall Study||68
10923696|NCT00235495|12091597|FG001|NOT COMPLETED|Overall Study||68
10923697|NCT00235547|12091605|FG000|STARTED|2 Month Follow-up Survey||154
10923698|NCT00235547|12091606|FG001|STARTED|2 Month Follow-up Survey||144
10923699|NCT00235547|12091605|FG000|COMPLETED|2 Month Follow-up Survey||108
10923700|NCT00235547|12091606|FG001|COMPLETED|2 Month Follow-up Survey||104
10923701|NCT00235547|12091605|FG000|NOT COMPLETED|2 Month Follow-up Survey||46
10923702|NCT00235547|12091606|FG001|NOT COMPLETED|2 Month Follow-up Survey||40
10923703|NCT00235547|12091605|FG000|STARTED|6 Month Follow-up Survey||154
10923704|NCT00235547|12091606|FG001|STARTED|6 Month Follow-up Survey||144
10923705|NCT00235547|12091605|FG000|COMPLETED|6 Month Follow-up Survey||83
10923706|NCT00235547|12091606|FG001|COMPLETED|6 Month Follow-up Survey||76
10923707|NCT00235547|12091605|FG000|NOT COMPLETED|6 Month Follow-up Survey||71
10923708|NCT00235547|12091606|FG001|NOT COMPLETED|6 Month Follow-up Survey||68
10923709|NCT00235573|12091612|FG000|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
10923710|NCT00235573|12091612|FG000|COMPLETED|Overall Study||21
10923711|NCT00235573|12091612|FG000|NOT COMPLETED|Overall Study||0
10923712|NCT00235716|12091620|FG000|STARTED|Overall Study||152
10923713|NCT00235716|12091621|FG001|STARTED|Overall Study||155
10923714|NCT00235716|12091622|FG002|STARTED|Overall Study||154
10923715|NCT00235716|12091623|FG003|STARTED|Overall Study||152
10923716|NCT00235716|12091620|FG000|COMPLETED|Overall Study||90
10923717|NCT00235716|12091621|FG001|COMPLETED|Overall Study||88
10923718|NCT00235716|12091622|FG002|COMPLETED|Overall Study||89
10923719|NCT00235716|12091623|FG003|COMPLETED|Overall Study||90
10923720|NCT00235716|12091620|FG000|NOT COMPLETED|Overall Study||62
10923721|NCT00235716|12091621|FG001|NOT COMPLETED|Overall Study||67
10923722|NCT00235716|12091622|FG002|NOT COMPLETED|Overall Study||65
10923723|NCT00235716|12091623|FG003|NOT COMPLETED|Overall Study||62
10923724|NCT00235755|12091636|FG000|STARTED|4-Week Titration Phase||179
10923725|NCT00235755|12091637|FG001|STARTED|4-Week Titration Phase||181
10923726|NCT00235755|12091638|FG002|STARTED|4-Week Titration Phase||179
10923727|NCT00235755|12091636|FG000|COMPLETED|4-Week Titration Phase||168
10923728|NCT00235755|12091637|FG001|COMPLETED|4-Week Titration Phase||162
10923729|NCT00235755|12091638|FG002|COMPLETED|4-Week Titration Phase||153
10923730|NCT00235755|12091636|FG000|NOT COMPLETED|4-Week Titration Phase||11
10923731|NCT00235755|12091637|FG001|NOT COMPLETED|4-Week Titration Phase||19
10923732|NCT00235755|12091638|FG002|NOT COMPLETED|4-Week Titration Phase||26
10923733|NCT00235755|12091636|FG000|STARTED|12-Week Maintenance Phase||168
10923734|NCT00235755|12091637|FG001|STARTED|12-Week Maintenance Phase||162
10923735|NCT00235755|12091638|FG002|STARTED|12-Week Maintenance Phase||153
10923736|NCT00235755|12091636|FG000|COMPLETED|12-Week Maintenance Phase||152
10923737|NCT00235755|12091637|FG001|COMPLETED|12-Week Maintenance Phase||135
10923738|NCT00235755|12091638|FG002|COMPLETED|12-Week Maintenance Phase||122
10923739|NCT00235755|12091636|FG000|NOT COMPLETED|12-Week Maintenance Phase||16
10923740|NCT00235755|12091637|FG001|NOT COMPLETED|12-Week Maintenance Phase||27
10923741|NCT00235755|12091638|FG002|NOT COMPLETED|12-Week Maintenance Phase||31
10923742|NCT00235833|12091661|FG000|STARTED|Overall Study||25
10923743|NCT00235833|12091661|FG000|COMPLETED|Overall Study||9
10923744|NCT00235833|12091661|FG000|NOT COMPLETED|Overall Study||16
10923745|NCT00235872|12091665|FG000|STARTED|Overall Study||309
10923746|NCT00235872|12091665|FG000|COMPLETED|Overall Study||162
10923747|NCT00235872|12091665|FG000|NOT COMPLETED|Overall Study||147
10923748|NCT00235989|12091673|FG000|STARTED|Core Treatment Period (CT)||0
10923749|NCT00235989|12091674|FG001|STARTED|Core Treatment Period (CT)||0
10923750|NCT00235989|12091675|FG002|STARTED|Core Treatment Period (CT)||0
10923751|NCT00235989|12091676|FG003|STARTED|Core Treatment Period (CT)||0
10923752|NCT00235989|12091677|FG004|STARTED|Core Treatment Period (CT)||36
10923753|NCT00235989|12091678|FG005|STARTED|Core Treatment Period (CT)||27
10923754|NCT00235989|12091673|FG000|COMPLETED|Core Treatment Period (CT)||0
10923755|NCT00235989|12091674|FG001|COMPLETED|Core Treatment Period (CT)||0
10923756|NCT00235989|12091675|FG002|COMPLETED|Core Treatment Period (CT)||0
10923757|NCT00235989|12091676|FG003|COMPLETED|Core Treatment Period (CT)||0
10923758|NCT00235989|12091677|FG004|COMPLETED|Core Treatment Period (CT)||36
10923759|NCT00235989|12091678|FG005|COMPLETED|Core Treatment Period (CT)||25
10923760|NCT00235989|12091673|FG000|NOT COMPLETED|Core Treatment Period (CT)||0
10923761|NCT00235989|12091674|FG001|NOT COMPLETED|Core Treatment Period (CT)||0
10923762|NCT00235989|12091675|FG002|NOT COMPLETED|Core Treatment Period (CT)||0
10923763|NCT00235989|12091676|FG003|NOT COMPLETED|Core Treatment Period (CT)||0
10923764|NCT00235989|12091677|FG004|NOT COMPLETED|Core Treatment Period (CT)||0
10923765|NCT00235989|12091678|FG005|NOT COMPLETED|Core Treatment Period (CT)||2
10923766|NCT00235989|12091673|FG000|STARTED|Extension Treatment Period (ET)||16
10923767|NCT00235989|12091674|FG001|STARTED|Extension Treatment Period (ET)||6
10923768|NCT00235989|12091675|FG002|STARTED|Extension Treatment Period (ET)||19
10923769|NCT00235989|12091676|FG003|STARTED|Extension Treatment Period (ET)||20
10923770|NCT00235989|12091677|FG004|STARTED|Extension Treatment Period (ET)||0
10923771|NCT00235989|12091678|FG005|STARTED|Extension Treatment Period (ET)||0
10923772|NCT00235989|12091673|FG000|COMPLETED|Extension Treatment Period (ET)||8
10923773|NCT00235989|12091674|FG001|COMPLETED|Extension Treatment Period (ET)||2
10923774|NCT00235989|12091675|FG002|COMPLETED|Extension Treatment Period (ET)||14
10923775|NCT00235989|12091676|FG003|COMPLETED|Extension Treatment Period (ET)||14
10923776|NCT00235989|12091677|FG004|COMPLETED|Extension Treatment Period (ET)||0
10923777|NCT00235989|12091678|FG005|COMPLETED|Extension Treatment Period (ET)||0
10923778|NCT00235989|12091673|FG000|NOT COMPLETED|Extension Treatment Period (ET)||8
10923779|NCT00235989|12091674|FG001|NOT COMPLETED|Extension Treatment Period (ET)||4
10923780|NCT00235989|12091675|FG002|NOT COMPLETED|Extension Treatment Period (ET)||5
10923781|NCT00235989|12091676|FG003|NOT COMPLETED|Extension Treatment Period (ET)||6
10923782|NCT00235989|12091677|FG004|NOT COMPLETED|Extension Treatment Period (ET)||0
10923783|NCT00235989|12091678|FG005|NOT COMPLETED|Extension Treatment Period (ET)||0
10923784|NCT00236080|12091693|FG000|STARTED|Overall Study||29
10923785|NCT00236080|12091694|FG001|STARTED|Overall Study||28
10923786|NCT00236080|12091695|FG002|STARTED|Overall Study||27
10923787|NCT00236080|12091696|FG003|STARTED|Overall Study||25
10923788|NCT00236080|12091697|FG004|STARTED|Overall Study||27
10923789|NCT00236080|12091693|FG000|COMPLETED|Overall Study||27
10923790|NCT00236080|12091694|FG001|COMPLETED|Overall Study||27
10923791|NCT00236080|12091695|FG002|COMPLETED|Overall Study||22
10923792|NCT00236080|12091696|FG003|COMPLETED|Overall Study||23
10923793|NCT00236080|12091697|FG004|COMPLETED|Overall Study||26
10923794|NCT00236080|12091693|FG000|NOT COMPLETED|Overall Study||2
10923795|NCT00236080|12091694|FG001|NOT COMPLETED|Overall Study||1
10923796|NCT00236080|12091695|FG002|NOT COMPLETED|Overall Study||5
10923797|NCT00236080|12091696|FG003|NOT COMPLETED|Overall Study||2
10923798|NCT00236080|12091697|FG004|NOT COMPLETED|Overall Study||1
10923799|NCT00236184|12091711|FG000|STARTED|Overall Study||310
10923800|NCT00236184|12091712|FG001|STARTED|Overall Study||319
10923801|NCT00236184|12091711|FG000|COMPLETED|Overall Study||292
10923802|NCT00236184|12091712|FG001|COMPLETED|Overall Study||308
10923803|NCT00236184|12091711|FG000|NOT COMPLETED|Overall Study||18
10923804|NCT00236184|12091712|FG001|NOT COMPLETED|Overall Study||11
10923805|NCT00236197|12091720|FG000|STARTED|Overall Study||312
10923806|NCT00236197|12091721|FG001|STARTED|Overall Study||307
10923807|NCT00236197|12091720|FG000|COMPLETED|Overall Study||307
10923808|NCT00236197|12091721|FG001|COMPLETED|Overall Study||293
10923809|NCT00236197|12091720|FG000|NOT COMPLETED|Overall Study||5
10923810|NCT00236197|12091721|FG001|NOT COMPLETED|Overall Study||14
10923811|NCT00236899|12091731|FG000|STARTED|Overall Study||60
10923812|NCT00236899|12091732|FG001|STARTED|Overall Study||64
10923813|NCT00236899|12091733|FG002|STARTED|Overall Study||58
10923814|NCT00236899|12091734|FG003|STARTED|Overall Study||59
10923815|NCT00236899|12091731|FG000|COMPLETED|Overall Study||18
10923816|NCT00236899|12091732|FG001|COMPLETED|Overall Study||24
10923817|NCT00236899|12091733|FG002|COMPLETED|Overall Study||14
10923818|NCT00236899|12091734|FG003|COMPLETED|Overall Study||19
10923819|NCT00236899|12091731|FG000|NOT COMPLETED|Overall Study||42
10923820|NCT00236899|12091732|FG001|NOT COMPLETED|Overall Study||40
10923821|NCT00236899|12091733|FG002|NOT COMPLETED|Overall Study||44
10923822|NCT00236899|12091734|FG003|NOT COMPLETED|Overall Study||40
10923823|NCT00236938|12091753|FG000|STARTED|Overall Study||75
10923824|NCT00236938|12091754|FG001|STARTED|Overall Study||46
10923825|NCT00236938|12091753|FG000|COMPLETED|Overall Study||62
10923826|NCT00236938|12091754|FG001|COMPLETED|Overall Study||26
10923827|NCT00236938|12091753|FG000|NOT COMPLETED|Overall Study||13
10923828|NCT00236938|12091754|FG001|NOT COMPLETED|Overall Study||20
10923829|NCT00236951|12091764|FG000|STARTED|Overall Study||59
10923830|NCT00236951|12091765|FG001|STARTED|Overall Study||77
10923831|NCT00236951|12091766|FG002|STARTED|Overall Study||40
10923832|NCT00236951|12091767|FG003|STARTED|Overall Study||48
10923833|NCT00236951|12091764|FG000|COMPLETED|Overall Study||33
10923834|NCT00236951|12091765|FG001|COMPLETED|Overall Study||46
10923835|NCT00236951|12091766|FG002|COMPLETED|Overall Study||21
10923836|NCT00236951|12091767|FG003|COMPLETED|Overall Study||17
10923837|NCT00236951|12091764|FG000|NOT COMPLETED|Overall Study||26
10923838|NCT00236951|12091765|FG001|NOT COMPLETED|Overall Study||31
10923839|NCT00236951|12091766|FG002|NOT COMPLETED|Overall Study||19
10923840|NCT00236951|12091767|FG003|NOT COMPLETED|Overall Study||31
10923841|NCT00236977|12091779|FG000|STARTED|Overall Study||91
10923842|NCT00236977|12091780|FG001|STARTED|Overall Study||91
10923843|NCT00236977|12091779|FG000|COMPLETED|Overall Study||70
10923844|NCT00236977|12091780|FG001|COMPLETED|Overall Study||72
10923845|NCT00236977|12091779|FG000|NOT COMPLETED|Overall Study||21
10923846|NCT00236977|12091780|FG001|NOT COMPLETED|Overall Study||19
10923847|NCT00237042|12091789|FG000|STARTED|Treatment||60
10923848|NCT00237042|12091790|FG001|STARTED|Treatment||57
10923849|NCT00237042|12091791|FG002|STARTED|Treatment||74
10923850|NCT00237042|12091789|FG000|COMPLETED|Treatment||54
10923851|NCT00237042|12091790|FG001|COMPLETED|Treatment||50
10923852|NCT00237042|12091791|FG002|COMPLETED|Treatment||36
10923853|NCT00237042|12091789|FG000|NOT COMPLETED|Treatment||6
10923854|NCT00237042|12091790|FG001|NOT COMPLETED|Treatment||7
10923855|NCT00237042|12091791|FG002|NOT COMPLETED|Treatment||38
10923856|NCT00237042|12091789|FG000|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
10923857|NCT00237042|12091790|FG001|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
10923858|NCT00237042|12091791|FG002|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
10923859|NCT00237042|12091789|FG000|COMPLETED|Short Term (6 Month) Follow up||50
10923860|NCT00237042|12091790|FG001|COMPLETED|Short Term (6 Month) Follow up||47
10923861|NCT00237042|12091791|FG002|COMPLETED|Short Term (6 Month) Follow up||46
10923862|NCT00237042|12091789|FG000|NOT COMPLETED|Short Term (6 Month) Follow up||9
10923863|NCT00237042|12091790|FG001|NOT COMPLETED|Short Term (6 Month) Follow up||8
10923864|NCT00237042|12091791|FG002|NOT COMPLETED|Short Term (6 Month) Follow up||11
10923865|NCT00237042|12091789|FG000|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
10923866|NCT00237042|12091790|FG001|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
10923867|NCT00237042|12091791|FG002|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
10923868|NCT00237042|12091789|FG000|COMPLETED|Long Term (12 Month) Follow up||48
10923869|NCT00237042|12091790|FG001|COMPLETED|Long Term (12 Month) Follow up||46
10923870|NCT00237042|12091791|FG002|COMPLETED|Long Term (12 Month) Follow up||48
10923871|NCT00237042|12091789|FG000|NOT COMPLETED|Long Term (12 Month) Follow up||11
10923872|NCT00237042|12091790|FG001|NOT COMPLETED|Long Term (12 Month) Follow up||9
10923873|NCT00237042|12091791|FG002|NOT COMPLETED|Long Term (12 Month) Follow up||9
10923874|NCT00237185|12091801|FG000|STARTED|Core||74
10923875|NCT00237185|12091802|FG001|STARTED|Core||74
10923876|NCT00237185|12091801|FG000|Treated Participants|Core||73
10923877|NCT00237185|12091802|FG001|Treated Participants|Core||74
10923878|NCT00237185|12091801|FG000|COMPLETED|Core||30
10923879|NCT00237185|12091802|FG001|COMPLETED|Core||37
10923880|NCT00237185|12091801|FG000|NOT COMPLETED|Core||44
10923881|NCT00237185|12091802|FG001|NOT COMPLETED|Core||37
10923882|NCT00237185|12091801|FG000|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
10923883|NCT00237185|12091802|FG001|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
10923884|NCT00237185|12091801|FG000|COMPLETED|Extension||8
10923885|NCT00237185|12091802|FG001|COMPLETED|Extension||13
10923886|NCT00237185|12091801|FG000|NOT COMPLETED|Extension||16
10923887|NCT00237185|12091802|FG001|NOT COMPLETED|Extension||19
10923888|NCT00237458|12091808|FG000|STARTED|Overall Study||7
10923889|NCT00237458|12091808|FG000|COMPLETED|Overall Study||4
10923890|NCT00237458|12091808|FG000|NOT COMPLETED|Overall Study||3
10923891|NCT00237666|12091812|FG000|STARTED|Overall Study||30
10923892|NCT00237666|12091812|FG000|COMPLETED|Overall Study||24
10923893|NCT00237666|12091812|FG000|NOT COMPLETED|Overall Study||6
10923894|NCT00237692|12091820|FG000|STARTED|Overall Study||147
10923895|NCT00237692|12091821|FG001|STARTED|Overall Study||148
10923896|NCT00237692|12091822|FG002|STARTED|Overall Study||149
10923897|NCT00237692|12091823|FG003|STARTED|Overall Study||147
10923898|NCT00237692|12091820|FG000|6 Month f/u|Overall Study||132
10923899|NCT00237692|12091821|FG001|6 Month f/u|Overall Study||134
10923900|NCT00237692|12091822|FG002|6 Month f/u|Overall Study||135
10923901|NCT00237692|12091823|FG003|6 Month f/u|Overall Study||134
10923902|NCT00237692|12091820|FG000|12 Month f/u|Overall Study||137
10923903|NCT00237692|12091821|FG001|12 Month f/u|Overall Study||127
10923904|NCT00237692|12091822|FG002|12 Month f/u|Overall Study||132
10923905|NCT00237692|12091823|FG003|12 Month f/u|Overall Study||127
10923906|NCT00237692|12091820|FG000|18 Month f/u|Overall Study||124
10923907|NCT00237692|12091821|FG001|18 Month f/u|Overall Study||131
10923908|NCT00237692|12091822|FG002|18 Month f/u|Overall Study||126
10923909|NCT00237692|12091823|FG003|18 Month f/u|Overall Study||122
10923910|NCT00237692|12091820|FG000|COMPLETED|Overall Study||129
10923911|NCT00237692|12091821|FG001|COMPLETED|Overall Study||134
10923912|NCT00237692|12091822|FG002|COMPLETED|Overall Study||127
10923913|NCT00237692|12091823|FG003|COMPLETED|Overall Study||128
10923914|NCT00237692|12091820|FG000|NOT COMPLETED|Overall Study||18
10923915|NCT00237692|12091821|FG001|NOT COMPLETED|Overall Study||14
10923916|NCT00237692|12091822|FG002|NOT COMPLETED|Overall Study||22
10923917|NCT00237692|12091823|FG003|NOT COMPLETED|Overall Study||19
10923918|NCT00237718|12091835|FG000|STARTED|Overall Study||160
10923919|NCT00237718|12091836|FG001|STARTED|Overall Study||165
10923920|NCT00237718|12091835|FG000|COMPLETED|Overall Study||114
10923921|NCT00237718|12091836|FG001|COMPLETED|Overall Study||124
10923922|NCT00237718|12091835|FG000|NOT COMPLETED|Overall Study||46
10923923|NCT00237718|12091836|FG001|NOT COMPLETED|Overall Study||41
10923924|NCT00237744|12091845|FG000|STARTED|Overall Study||11
10923925|NCT00237744|12091846|FG001|STARTED|Overall Study||11
10923926|NCT00237744|12091847|FG002|STARTED|Overall Study||18
10923927|NCT00237744|12091845|FG000|COMPLETED|Overall Study||8
10923928|NCT00237744|12091846|FG001|COMPLETED|Overall Study||10
10923929|NCT00237744|12091847|FG002|COMPLETED|Overall Study||18
10923930|NCT00237744|12091845|FG000|NOT COMPLETED|Overall Study||3
10923931|NCT00237744|12091846|FG001|NOT COMPLETED|Overall Study||1
10923932|NCT00237744|12091847|FG002|NOT COMPLETED|Overall Study||0
10923933|NCT00237770|12091860|FG000|STARTED|Overall Study||9
10923934|NCT00237770|12091861|FG001|STARTED|Overall Study||7
10923935|NCT00237770|12091860|FG000|COMPLETED|Overall Study||9
10923936|NCT00237770|12091861|FG001|COMPLETED|Overall Study||7
10923937|NCT00237770|12091860|FG000|NOT COMPLETED|Overall Study||0
10923938|NCT00237770|12091861|FG001|NOT COMPLETED|Overall Study||0
10923939|NCT00237796|12091873|FG000|STARTED|Overall Study||41
10923940|NCT00237796|12091874|FG001|STARTED|Overall Study||38
10923941|NCT00237796|12091873|FG000|COMPLETED|Overall Study||31
10923942|NCT00237796|12091874|FG001|COMPLETED|Overall Study||33
10923943|NCT00237796|12091873|FG000|NOT COMPLETED|Overall Study||10
10923944|NCT00237796|12091874|FG001|NOT COMPLETED|Overall Study||5
10923945|NCT00237809|12091885|FG000|STARTED|Overall Study||27
10923946|NCT00237809|12091886|FG001|STARTED|Overall Study||27
10923947|NCT00237809|12091887|FG002|STARTED|Overall Study||24
10923948|NCT00237809|12091888|FG003|STARTED|Overall Study||26
10923949|NCT00237809|12091885|FG000|COMPLETED|Overall Study||16
10923950|NCT00237809|12091886|FG001|COMPLETED|Overall Study||17
10923951|NCT00237809|12091887|FG002|COMPLETED|Overall Study||15
10923952|NCT00237809|12091888|FG003|COMPLETED|Overall Study||17
10923953|NCT00237809|12091885|FG000|NOT COMPLETED|Overall Study||11
10923954|NCT00237809|12091886|FG001|NOT COMPLETED|Overall Study||10
10923955|NCT00237809|12091887|FG002|NOT COMPLETED|Overall Study||9
10923956|NCT00237809|12091888|FG003|NOT COMPLETED|Overall Study||9
10923957|NCT00238108|12091900|FG000|STARTED|Overall Study||8
10923958|NCT00238108|12091901|FG001|STARTED|Overall Study||8
10923959|NCT00238108|12091900|FG000|COMPLETED|Overall Study||8
10923960|NCT00238108|12091901|FG001|COMPLETED|Overall Study||8
10923961|NCT00238108|12091900|FG000|NOT COMPLETED|Overall Study||0
10923962|NCT00238108|12091901|FG001|NOT COMPLETED|Overall Study||0
10923963|NCT00238121|12091909|FG000|STARTED|Overall Study||40
10923964|NCT00238121|12091910|FG001|STARTED|Overall Study||16
10923965|NCT00238121|12091909|FG000|COMPLETED|Overall Study||37
10923966|NCT00238121|12091910|FG001|COMPLETED|Overall Study||14
10923967|NCT00238121|12091909|FG000|NOT COMPLETED|Overall Study||3
10923968|NCT00238121|12091910|FG001|NOT COMPLETED|Overall Study||2
10923969|NCT00238238|12091918|FG000|STARTED|Overall Study||3
10923970|NCT00238238|12091919|FG001|STARTED|Overall Study||48
10923971|NCT00238238|12091920|FG002|STARTED|Overall Study||46
10923972|NCT00238238|12091918|FG000|COMPLETED|Overall Study||3
10923973|NCT00238238|12091919|FG001|COMPLETED|Overall Study||45
10923974|NCT00238238|12091920|FG002|COMPLETED|Overall Study||46
10923975|NCT00238238|12091918|FG000|NOT COMPLETED|Overall Study||0
10923976|NCT00238238|12091919|FG001|NOT COMPLETED|Overall Study||3
10923977|NCT00238238|12091920|FG002|NOT COMPLETED|Overall Study||0
10923978|NCT00238264|12091928|FG000|STARTED|Overall Study||92
10923979|NCT00238264|12091928|FG000|COMPLETED|Overall Study||56
10923980|NCT00238264|12091928|FG000|NOT COMPLETED|Overall Study||36
10923981|NCT00238303|12091935|FG000|STARTED|Overall Study||68
10923982|NCT00238303|12091936|FG001|STARTED|Overall Study||15
10923983|NCT00238303|12091937|FG002|STARTED|Overall Study||20
10923984|NCT00238303|12091935|FG000|COMPLETED|Overall Study||53
10923985|NCT00238303|12091936|FG001|COMPLETED|Overall Study||13
10923986|NCT00238303|12091937|FG002|COMPLETED|Overall Study||11
10923987|NCT00238303|12091935|FG000|NOT COMPLETED|Overall Study||15
10923988|NCT00238303|12091936|FG001|NOT COMPLETED|Overall Study||2
10923989|NCT00238303|12091937|FG002|NOT COMPLETED|Overall Study||9
10923990|NCT00238355|12091946|FG000|STARTED|Overall Study||13
10923991|NCT00238355|12091946|FG000|COMPLETED|Overall Study||10
10923992|NCT00238355|12091946|FG000|NOT COMPLETED|Overall Study||3
10923993|NCT00238433|12091950|FG000|STARTED|Overall Study||37
10923994|NCT00238433|12091950|FG000|COMPLETED|Overall Study||34
10923995|NCT00238433|12091950|FG000|NOT COMPLETED|Overall Study||3
10923996|NCT00238615|12091955|FG000|STARTED|Overall Study||13
10923997|NCT00238615|12091955|FG000|COMPLETED|Overall Study||13
10923998|NCT00238615|12091955|FG000|NOT COMPLETED|Overall Study||0
10923999|NCT00239005|12091963|FG000|STARTED|Overall Study||69
10924000|NCT00239005|12091964|FG001|STARTED|Overall Study||65
10924001|NCT00239005|12091963|FG000|Intention-to-treat Population (ITT)|Overall Study||68
10924002|NCT00239005|12091964|FG001|Intention-to-treat Population (ITT)|Overall Study||61
10924003|NCT00239005|12091963|FG000|COMPLETED|Overall Study||57
10924004|NCT00239005|12091964|FG001|COMPLETED|Overall Study||53
10924005|NCT00239005|12091963|FG000|NOT COMPLETED|Overall Study||12
10924006|NCT00239005|12091964|FG001|NOT COMPLETED|Overall Study||12
10924007|NCT00239226|12091974|FG000|STARTED|Overall Study||30
10924008|NCT00239226|12091975|FG001|STARTED|Overall Study||18
10924009|NCT00239226|12091976|FG002|STARTED|Overall Study||37
10924010|NCT00239226|12091977|FG003|STARTED|Overall Study||17
10924011|NCT00239226|12091974|FG000|COMPLETED|Overall Study||29
10924012|NCT00239226|12091975|FG001|COMPLETED|Overall Study||18
10924013|NCT00239226|12091976|FG002|COMPLETED|Overall Study||36
10924014|NCT00239226|12091977|FG003|COMPLETED|Overall Study||14
10924015|NCT00239226|12091974|FG000|NOT COMPLETED|Overall Study||1
10924016|NCT00239226|12091975|FG001|NOT COMPLETED|Overall Study||0
10924017|NCT00239226|12091976|FG002|NOT COMPLETED|Overall Study||1
10924018|NCT00239226|12091977|FG003|NOT COMPLETED|Overall Study||3
10924019|NCT00239356|12091989|FG000|STARTED|Overall Study||97
10924020|NCT00239356|12091990|FG001|STARTED|Overall Study||20
10924021|NCT00239356|12091989|FG000|COMPLETED|Overall Study||58
10924022|NCT00239356|12091990|FG001|COMPLETED|Overall Study||11
10924023|NCT00239356|12091989|FG000|NOT COMPLETED|Overall Study||39
10924024|NCT00239356|12091990|FG001|NOT COMPLETED|Overall Study||9
10924025|NCT00239577|12092000|FG000|STARTED|Primary Phase||22
10924026|NCT00239577|12092001|FG001|STARTED|Primary Phase||22
10924027|NCT00239577|12092002|FG002|STARTED|Primary Phase||21
10924028|NCT00239577|12092003|FG003|STARTED|Primary Phase||21
10924029|NCT00239577|12092000|FG000|COMPLETED|Primary Phase||17
10924030|NCT00239577|12092001|FG001|COMPLETED|Primary Phase||19
10924031|NCT00239577|12092002|FG002|COMPLETED|Primary Phase||18
10924032|NCT00239577|12092003|FG003|COMPLETED|Primary Phase||21
10924033|NCT00239577|12092000|FG000|NOT COMPLETED|Primary Phase||5
10924034|NCT00239577|12092001|FG001|NOT COMPLETED|Primary Phase||3
10924035|NCT00239577|12092002|FG002|NOT COMPLETED|Primary Phase||3
10924036|NCT00239577|12092003|FG003|NOT COMPLETED|Primary Phase||0
10924037|NCT00239577|12092000|FG000|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
10924038|NCT00239577|12092001|FG001|STARTED|Booster Phase||9
10924039|NCT00239577|12092002|FG002|STARTED|Booster Phase||12
10924040|NCT00239577|12092003|FG003|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
10924041|NCT00239577|12092000|FG000|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
10924042|NCT00239577|12092001|FG001|COMPLETED|Booster Phase||9
10924043|NCT00239577|12092002|FG002|COMPLETED|Booster Phase||12
10924044|NCT00239577|12092003|FG003|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
10924045|NCT00239577|12092000|FG000|NOT COMPLETED|Booster Phase||0
10924046|NCT00239577|12092001|FG001|NOT COMPLETED|Booster Phase||0
10924047|NCT00239577|12092002|FG002|NOT COMPLETED|Booster Phase||0
10924048|NCT00239577|12092003|FG003|NOT COMPLETED|Booster Phase||0
10924049|NCT00239590|12092015|FG000|STARTED|Randomized||14
10924050|NCT00239590|12092016|FG001|STARTED|Randomized||14
10924051|NCT00239590|12092015|FG000|COMPLETED|Randomized||14
10924052|NCT00239590|12092016|FG001|COMPLETED|Randomized||12
10924053|NCT00239590|12092015|FG000|NOT COMPLETED|Randomized||0
10924054|NCT00239590|12092016|FG001|NOT COMPLETED|Randomized||2
10924055|NCT00239590|12092015|FG000|STARTED|Started Intervention After Randomization||14
10924056|NCT00239590|12092016|FG001|STARTED|Started Intervention After Randomization||12
10924057|NCT00239590|12092015|FG000|COMPLETED|Started Intervention After Randomization||14
10924058|NCT00239590|12092016|FG001|COMPLETED|Started Intervention After Randomization||12
10924059|NCT00239590|12092015|FG000|NOT COMPLETED|Started Intervention After Randomization||0
10924060|NCT00239590|12092016|FG001|NOT COMPLETED|Started Intervention After Randomization||0
10924061|NCT00239590|12092015|FG000|STARTED|Completed Study Protocol||14
10924062|NCT00239590|12092016|FG001|STARTED|Completed Study Protocol||12
10924063|NCT00239590|12092015|FG000|COMPLETED|Completed Study Protocol||13
10924064|NCT00239590|12092016|FG001|COMPLETED|Completed Study Protocol||10
10924065|NCT00239590|12092015|FG000|NOT COMPLETED|Completed Study Protocol||1
10924066|NCT00239590|12092016|FG001|NOT COMPLETED|Completed Study Protocol||2
10924067|NCT00239642|12092027|FG000|STARTED|Overall Study||49
10924068|NCT00239642|12092028|FG001|STARTED|Overall Study||47
10924069|NCT00239642|12092029|FG002|STARTED|Overall Study||49
10924070|NCT00239642|12092027|FG000|COMPLETED|Overall Study||47
10924071|NCT00239642|12092028|FG001|COMPLETED|Overall Study||47
10924072|NCT00239642|12092029|FG002|COMPLETED|Overall Study||47
10924073|NCT00239642|12092027|FG000|NOT COMPLETED|Overall Study||2
10924074|NCT00239642|12092028|FG001|NOT COMPLETED|Overall Study||0
10924075|NCT00239642|12092029|FG002|NOT COMPLETED|Overall Study||2
10924076|NCT00239681|12092039|FG000|STARTED|Overall Study||8901
10924077|NCT00239681|12092040|FG001|STARTED|Overall Study||8901
10924078|NCT00239681|12092039|FG000|Randomized and Treated (Safety Pop)|Overall Study||8869
10924079|NCT00239681|12092040|FG001|Randomized and Treated (Safety Pop)|Overall Study||8864
10924080|NCT00239681|12092039|FG000|COMPLETED|Overall Study||8208
10924081|NCT00239681|12092040|FG001|COMPLETED|Overall Study||8186
10924082|NCT00239681|12092039|FG000|NOT COMPLETED|Overall Study||693
10924083|NCT00239681|12092040|FG001|NOT COMPLETED|Overall Study||715
10924084|NCT00239733|12092046|FG000|STARTED|Overall Study||6
10924085|NCT00239733|12092046|FG000|COMPLETED|Overall Study||6
10924086|NCT00239733|12092046|FG000|NOT COMPLETED|Overall Study||0
10924087|NCT00239837|12092052|FG000|STARTED|Overall Study||48
10924088|NCT00239837|12092053|FG001|STARTED|Overall Study||52
10924089|NCT00239837|12092052|FG000|6 Months|Overall Study||48
10924090|NCT00239837|12092053|FG001|6 Months|Overall Study||50
10924091|NCT00239837|12092052|FG000|COMPLETED|Overall Study|3-year follow-up|45
10924092|NCT00239837|12092053|FG001|COMPLETED|Overall Study|3-year follow-up|45
10924093|NCT00239837|12092052|FG000|NOT COMPLETED|Overall Study||3
10924094|NCT00239837|12092053|FG001|NOT COMPLETED|Overall Study||7
10924095|NCT00239928|12092061|FG000|STARTED|Overall Study||61
10924096|NCT00239928|12092061|FG000|COMPLETED|Overall Study||51
10924097|NCT00239928|12092061|FG000|NOT COMPLETED|Overall Study||10
10924098|NCT00240071|12092065|FG000|STARTED|Overall Study||30
10924099|NCT00240071|12092065|FG000|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
10924100|NCT00240071|12092065|FG000|NOT COMPLETED|Overall Study||3
10924101|NCT00240097|12092070|FG000|STARTED|Part I||30
10924102|NCT00240097|12092070|FG000|COMPLETED|Part I||26
10924103|NCT00240097|12092070|FG000|NOT COMPLETED|Part I||4
10924104|NCT00240097|12092070|FG000|STARTED|Part II||26
10924105|NCT00240097|12092070|FG000|COMPLETED|Part II||3
10924106|NCT00240097|12092070|FG000|NOT COMPLETED|Part II||23
10924107|NCT00240110|12092080|FG000|STARTED|Overall Study||13
10924108|NCT00240110|12092081|FG001|STARTED|Overall Study||13
10924109|NCT00240110|12092080|FG000|COMPLETED|Overall Study||7
10924110|NCT00240110|12092081|FG001|COMPLETED|Overall Study||6
10924111|NCT00240110|12092080|FG000|NOT COMPLETED|Overall Study||6
10924112|NCT00240110|12092081|FG001|NOT COMPLETED|Overall Study||7
10924113|NCT00240162|12092089|FG000|STARTED|Overall Study||21
10924114|NCT00240162|12092089|FG000|COMPLETED|Overall Study||21
10924115|NCT00240162|12092089|FG000|NOT COMPLETED|Overall Study||0
10924116|NCT00240331|12092095|FG000|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
10924117|NCT00240331|12092096|FG001|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
10924118|NCT00240331|12092095|FG000|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
10924119|NCT00240331|12092096|FG001|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
10924120|NCT00240331|12092095|FG000|NOT COMPLETED|Overall Study||126
10924121|NCT00240331|12092096|FG001|NOT COMPLETED|Overall Study||134
10924122|NCT00240487|12092104|FG000|STARTED|Overall Study||24
10924123|NCT00240487|12092105|FG001|STARTED|Overall Study||28
10924124|NCT00240487|12092104|FG000|COMPLETED|Overall Study||24
10924125|NCT00240487|12092105|FG001|COMPLETED|Overall Study||28
10924126|NCT00240487|12092104|FG000|NOT COMPLETED|Overall Study||0
10924127|NCT00240487|12092105|FG001|NOT COMPLETED|Overall Study||0
10924128|NCT00240526|12092115|FG000|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
10924129|NCT00240526|12092116|FG001|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
10924130|NCT00240526|12092117|FG002|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
10924131|NCT00240526|12092118|FG003|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
10924132|NCT00240526|12092115|FG000|COMPLETED|Year 15||19
10924133|NCT00240526|12092116|FG001|COMPLETED|Year 15||19
10924134|NCT00240526|12092117|FG002|COMPLETED|Year 15||14
10924135|NCT00240526|12092118|FG003|COMPLETED|Year 15||21
10924136|NCT00240526|12092115|FG000|NOT COMPLETED|Year 15||0
10924137|NCT00240526|12092116|FG001|NOT COMPLETED|Year 15||0
10924138|NCT00240526|12092117|FG002|NOT COMPLETED|Year 15||0
10924139|NCT00240526|12092118|FG003|NOT COMPLETED|Year 15||0
10924140|NCT00240526|12092115|FG000|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
10924141|NCT00240526|12092116|FG001|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
10924142|NCT00240526|12092117|FG002|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
10924143|NCT00240526|12092118|FG003|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
10924144|NCT00240526|12092115|FG000|COMPLETED|Year 16||17
10924145|NCT00240526|12092116|FG001|COMPLETED|Year 16||19
10924146|NCT00240526|12092117|FG002|COMPLETED|Year 16||16
10924147|NCT00240526|12092118|FG003|COMPLETED|Year 16||22
10924148|NCT00240526|12092115|FG000|NOT COMPLETED|Year 16||0
10924149|NCT00240526|12092116|FG001|NOT COMPLETED|Year 16||0
10924150|NCT00240526|12092117|FG002|NOT COMPLETED|Year 16||0
10924151|NCT00240526|12092118|FG003|NOT COMPLETED|Year 16||0
10924152|NCT00240526|12092115|FG000|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
10924153|NCT00240526|12092116|FG001|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
10924154|NCT00240526|12092117|FG002|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
10924155|NCT00240526|12092118|FG003|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
10924156|NCT00240526|12092115|FG000|COMPLETED|Year 17||19
10924157|NCT00240526|12092116|FG001|COMPLETED|Year 17||17
10924158|NCT00240526|12092117|FG002|COMPLETED|Year 17||13
10924159|NCT00240526|12092118|FG003|COMPLETED|Year 17||20
10924160|NCT00240526|12092115|FG000|NOT COMPLETED|Year 17||0
10924161|NCT00240526|12092116|FG001|NOT COMPLETED|Year 17||0
10924162|NCT00240526|12092117|FG002|NOT COMPLETED|Year 17||0
10924163|NCT00240526|12092118|FG003|NOT COMPLETED|Year 17||0
10924164|NCT00240526|12092115|FG000|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
10924165|NCT00240526|12092116|FG001|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
10924166|NCT00240526|12092117|FG002|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
10924167|NCT00240526|12092118|FG003|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
10924168|NCT00240526|12092115|FG000|COMPLETED|Year 18||16
10924169|NCT00240526|12092116|FG001|COMPLETED|Year 18||17
10924170|NCT00240526|12092117|FG002|COMPLETED|Year 18||14
10924171|NCT00240526|12092118|FG003|COMPLETED|Year 18||20
10924172|NCT00240526|12092115|FG000|NOT COMPLETED|Year 18||0
10924173|NCT00240526|12092116|FG001|NOT COMPLETED|Year 18||0
10924174|NCT00240526|12092117|FG002|NOT COMPLETED|Year 18||0
10924175|NCT00240526|12092118|FG003|NOT COMPLETED|Year 18||0
10924176|NCT00240526|12092115|FG000|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
10924177|NCT00240526|12092116|FG001|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
10924178|NCT00240526|12092117|FG002|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
10924179|NCT00240526|12092118|FG003|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
10924180|NCT00240526|12092115|FG000|COMPLETED|Year 19||17
10924181|NCT00240526|12092116|FG001|COMPLETED|Year 19||16
10924182|NCT00240526|12092117|FG002|COMPLETED|Year 19||12
10924183|NCT00240526|12092118|FG003|COMPLETED|Year 19||18
10924184|NCT00240526|12092115|FG000|NOT COMPLETED|Year 19||0
10924185|NCT00240526|12092116|FG001|NOT COMPLETED|Year 19||0
10924186|NCT00240526|12092117|FG002|NOT COMPLETED|Year 19||0
10924187|NCT00240526|12092118|FG003|NOT COMPLETED|Year 19||0
10924188|NCT00240526|12092115|FG000|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
10924189|NCT00240526|12092116|FG001|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
10924190|NCT00240526|12092117|FG002|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
10924191|NCT00240526|12092118|FG003|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
10924192|NCT00240526|12092115|FG000|COMPLETED|Year 20||19
10924193|NCT00240526|12092116|FG001|COMPLETED|Year 20||17
10924194|NCT00240526|12092117|FG002|COMPLETED|Year 20||13
10924195|NCT00240526|12092118|FG003|COMPLETED|Year 20||20
10924196|NCT00240526|12092115|FG000|NOT COMPLETED|Year 20||0
10924197|NCT00240526|12092116|FG001|NOT COMPLETED|Year 20||0
10924198|NCT00240526|12092117|FG002|NOT COMPLETED|Year 20||0
10924199|NCT00240526|12092118|FG003|NOT COMPLETED|Year 20||0
10924200|NCT00240539|12092136|FG000|STARTED|Overall Study||2
10924201|NCT00240539|12092137|FG001|STARTED|Overall Study||2
10924202|NCT00240539|12092138|FG002|STARTED|Overall Study||31
10924203|NCT00240539|12092139|FG003|STARTED|Overall Study||1
10924204|NCT00240539|12092136|FG000|COMPLETED|Overall Study||2
10924205|NCT00240539|12092137|FG001|COMPLETED|Overall Study||2
10924206|NCT00240539|12092138|FG002|COMPLETED|Overall Study||31
10924207|NCT00240539|12092139|FG003|COMPLETED|Overall Study||1
10924208|NCT00240539|12092136|FG000|NOT COMPLETED|Overall Study||0
10924209|NCT00240539|12092137|FG001|NOT COMPLETED|Overall Study||0
10924210|NCT00240539|12092138|FG002|NOT COMPLETED|Overall Study||0
10924211|NCT00240539|12092139|FG003|NOT COMPLETED|Overall Study||0
10924212|NCT00240981|12092151|FG000|STARTED|Overall Study||106
10924213|NCT00240981|12092152|FG001|STARTED|Overall Study||103
10924214|NCT00240981|12092151|FG000|Intent to Treat Sample|Overall Study||82
10924215|NCT00240981|12092152|FG001|Intent to Treat Sample|Overall Study||83
10924216|NCT00240981|12092151|FG000|COMPLETED|Overall Study||68
10924217|NCT00240981|12092152|FG001|COMPLETED|Overall Study||70
10924218|NCT00240981|12092151|FG000|NOT COMPLETED|Overall Study||38
10924219|NCT00240981|12092152|FG001|NOT COMPLETED|Overall Study||33
10924220|NCT00240994|12092159|FG000|STARTED|Overall Study||35
10924221|NCT00240994|12092159|FG000|COMPLETED|Overall Study||32
10924222|NCT00240994|12092159|FG000|NOT COMPLETED|Overall Study||3
10924223|NCT00241176|12092163|FG000|STARTED|Overall Study||11
10924224|NCT00241176|12092163|FG000|COMPLETED|Overall Study||11
10924225|NCT00241176|12092163|FG000|NOT COMPLETED|Overall Study||0
10924226|NCT00241280|12092170|FG000|STARTED|Overall Study||247
10924227|NCT00241280|12092171|FG001|STARTED|Overall Study||254
10924228|NCT00241280|12092170|FG000|COMPLETED|Overall Study||199
10924229|NCT00241280|12092171|FG001|COMPLETED|Overall Study||186
10924230|NCT00241280|12092170|FG000|NOT COMPLETED|Overall Study||48
10924231|NCT00241280|12092171|FG001|NOT COMPLETED|Overall Study||68
10924232|NCT00241358|12092181|FG000|STARTED|Overall Study||25
10924233|NCT00241358|12092182|FG001|STARTED|Overall Study||46
10924234|NCT00241358|12092183|FG002|STARTED|Overall Study||21
10924235|NCT00241358|12092181|FG000|COMPLETED|Overall Study||25
10924236|NCT00241358|12092182|FG001|COMPLETED|Overall Study||45
10924237|NCT00241358|12092183|FG002|COMPLETED|Overall Study||20
10924238|NCT00241358|12092181|FG000|NOT COMPLETED|Overall Study||0
10924239|NCT00241358|12092182|FG001|NOT COMPLETED|Overall Study||1
10924240|NCT00241358|12092183|FG002|NOT COMPLETED|Overall Study||1
10924241|NCT00241631|12092192|FG000|STARTED|Run in (2 Weeks)||25
10924242|NCT00241631|12092193|FG001|STARTED|Run in (2 Weeks)||24
10924243|NCT00241631|12092192|FG000|COMPLETED|Run in (2 Weeks)||22
10924244|NCT00241631|12092193|FG001|COMPLETED|Run in (2 Weeks)||21
10924245|NCT00241631|12092192|FG000|NOT COMPLETED|Run in (2 Weeks)||3
10924246|NCT00241631|12092193|FG001|NOT COMPLETED|Run in (2 Weeks)||3
10924247|NCT00241631|12092192|FG000|STARTED|Phase 1 (4 Weeks)||22
10924248|NCT00241631|12092193|FG001|STARTED|Phase 1 (4 Weeks)||21
10924249|NCT00241631|12092192|FG000|COMPLETED|Phase 1 (4 Weeks)||14
10924250|NCT00241631|12092193|FG001|COMPLETED|Phase 1 (4 Weeks)||16
10924251|NCT00241631|12092192|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||8
10924252|NCT00241631|12092193|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5
10924253|NCT00241631|12092192|FG000|STARTED|Wash Out (2 Weeks)||14
10924254|NCT00241631|12092193|FG001|STARTED|Wash Out (2 Weeks)||16
10924255|NCT00241631|12092192|FG000|COMPLETED|Wash Out (2 Weeks)||14
10924256|NCT00241631|12092193|FG001|COMPLETED|Wash Out (2 Weeks)||16
10924257|NCT00241631|12092192|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0
10924258|NCT00241631|12092193|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0
10924259|NCT00241631|12092192|FG000|STARTED|Phase 2 (4 Weeks)||14
10924260|NCT00241631|12092193|FG001|STARTED|Phase 2 (4 Weeks)||16
10924261|NCT00241631|12092192|FG000|COMPLETED|Phase 2 (4 Weeks)||14
10924262|NCT00241631|12092193|FG001|COMPLETED|Phase 2 (4 Weeks)||16
10924263|NCT00241631|12092192|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||0
10924264|NCT00241631|12092193|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||0
10924265|NCT00241644|12092203|FG000|STARTED|First Efficacy Period (Year 1)||1647
10924266|NCT00241644|12092204|FG001|STARTED|First Efficacy Period (Year 1)||1651
10924267|NCT00241644|12092205|FG002|STARTED|First Efficacy Period (Year 1)||1641
10924268|NCT00241644|12092206|FG003|STARTED|First Efficacy Period (Year 1)||3298
10924269|NCT00241644|12092203|FG000|COMPLETED|First Efficacy Period (Year 1)||1420
10924270|NCT00241644|12092204|FG001|COMPLETED|First Efficacy Period (Year 1)||1383
10924271|NCT00241644|12092205|FG002|COMPLETED|First Efficacy Period (Year 1)||1392
10924272|NCT00241644|12092206|FG003|COMPLETED|First Efficacy Period (Year 1)||2803
10924273|NCT00241644|12092203|FG000|NOT COMPLETED|First Efficacy Period (Year 1)||227
10924274|NCT00241644|12092204|FG001|NOT COMPLETED|First Efficacy Period (Year 1)||268
10924275|NCT00241644|12092205|FG002|NOT COMPLETED|First Efficacy Period (Year 1)||249
10924276|NCT00241644|12092206|FG003|NOT COMPLETED|First Efficacy Period (Year 1)||495
10924277|NCT00241644|12092203|FG000|STARTED|Second Efficacy Period (Year 2)||771
10924278|NCT00241644|12092204|FG001|STARTED|Second Efficacy Period (Year 2)||754
10924279|NCT00241644|12092205|FG002|STARTED|Second Efficacy Period (Year 2)||746
10924280|NCT00241644|12092206|FG003|STARTED|Second Efficacy Period (Year 2)||1525
10924281|NCT00241644|12092203|FG000|COMPLETED|Second Efficacy Period (Year 2)||710
10924282|NCT00241644|12092204|FG001|COMPLETED|Second Efficacy Period (Year 2)||697
10924283|NCT00241644|12092205|FG002|COMPLETED|Second Efficacy Period (Year 2)||682
10924284|NCT00241644|12092206|FG003|COMPLETED|Second Efficacy Period (Year 2)||1407
10924285|NCT00241644|12092203|FG000|NOT COMPLETED|Second Efficacy Period (Year 2)||61
10924286|NCT00241644|12092204|FG001|NOT COMPLETED|Second Efficacy Period (Year 2)||57
10924287|NCT00241644|12092205|FG002|NOT COMPLETED|Second Efficacy Period (Year 2)||64
10924288|NCT00241644|12092206|FG003|NOT COMPLETED|Second Efficacy Period (Year 2)||118
10924289|NCT00241839|12092218|FG000|STARTED|Overall Study||71
10924290|NCT00241839|12092219|FG001|STARTED|Overall Study||71
10924291|NCT00241839|12092218|FG000|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
10924292|NCT00241839|12092219|FG001|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
10924293|NCT00241839|12092218|FG000|NOT COMPLETED|Overall Study||19
10924294|NCT00241839|12092219|FG001|NOT COMPLETED|Overall Study||18
10924295|NCT00241904|12092227|FG000|STARTED|Overall Study||261
10924296|NCT00241904|12092228|FG001|STARTED|Overall Study||264
10924297|NCT00241904|12092227|FG000|COMPLETED|Overall Study||227
10924298|NCT00241904|12092228|FG001|COMPLETED|Overall Study||240
10924299|NCT00241904|12092227|FG000|NOT COMPLETED|Overall Study||34
10924300|NCT00241904|12092228|FG001|NOT COMPLETED|Overall Study||24
10924301|NCT00241969|12092237|FG000|STARTED|Overall Study||36
10924302|NCT00241969|12092238|FG001|STARTED|Overall Study||42
10924303|NCT00241969|12092237|FG000|COMPLETED|Overall Study||36
10924304|NCT00241969|12092238|FG001|COMPLETED|Overall Study||42
10924305|NCT00241969|12092237|FG000|NOT COMPLETED|Overall Study||0
10924306|NCT00241969|12092238|FG001|NOT COMPLETED|Overall Study||0
10924307|NCT00242216|12092246|FG000|STARTED|Overall Study||39
10924308|NCT00242216|12092247|FG001|STARTED|Overall Study||37
10924309|NCT00242216|12092246|FG000|COMPLETED|Overall Study||21
10924310|NCT00242216|12092247|FG001|COMPLETED|Overall Study||15
10924311|NCT00242216|12092246|FG000|NOT COMPLETED|Overall Study||18
10924312|NCT00242216|12092247|FG001|NOT COMPLETED|Overall Study||22
10924313|NCT00242385|12092253|FG000|STARTED|Period 1||14
10924314|NCT00242385|12092254|FG001|STARTED|Period 1||11
10924315|NCT00242385|12092253|FG000|COMPLETED|Period 1||14
10924316|NCT00242385|12092254|FG001|COMPLETED|Period 1||11
10924317|NCT00242385|12092253|FG000|NOT COMPLETED|Period 1||0
10924318|NCT00242385|12092254|FG001|NOT COMPLETED|Period 1||0
10924319|NCT00242385|12092253|FG000|STARTED|Period 2||14
10924320|NCT00242385|12092254|FG001|STARTED|Period 2||11
10924321|NCT00242385|12092253|FG000|COMPLETED|Period 2||14
10924322|NCT00242385|12092254|FG001|COMPLETED|Period 2||11
10924323|NCT00242385|12092253|FG000|NOT COMPLETED|Period 2||0
10924324|NCT00242385|12092254|FG001|NOT COMPLETED|Period 2||0
10924325|NCT00242502|12092260|FG000|STARTED|Overall Study||59
10924326|NCT00242502|12092260|FG000|COMPLETED|Overall Study||59
10924327|NCT00242502|12092260|FG000|NOT COMPLETED|Overall Study||0
10924328|NCT00242567|12092266|FG000|STARTED|Overall Study||259
10924329|NCT00242567|12092267|FG001|STARTED|Overall Study||263
10924330|NCT00242567|12092266|FG000|Received at Least 1 Dose of Study Drug|Overall Study||259
10924331|NCT00242567|12092267|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
10924332|NCT00242567|12092266|FG000|Never Received Study Drug|Overall Study||0
10924333|NCT00242567|12092267|FG001|Never Received Study Drug|Overall Study||191
10924334|NCT00242567|12092266|FG000|COMPLETED|Overall Study||93
10924335|NCT00242567|12092267|FG001|COMPLETED|Overall Study||123
10924336|NCT00242567|12092266|FG000|NOT COMPLETED|Overall Study||166
10924337|NCT00242567|12092267|FG001|NOT COMPLETED|Overall Study||140
10924338|NCT00242580|12092278|FG000|STARTED|Overall Study||32
10924339|NCT00242580|12092279|FG001|STARTED|Overall Study||41
10924340|NCT00242580|12092280|FG002|STARTED|Overall Study||38
10924341|NCT00242580|12092278|FG000|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
10924342|NCT00242580|12092279|FG001|COMPLETED|Overall Study||29
10924343|NCT00242580|12092280|FG002|COMPLETED|Overall Study||24
10924344|NCT00242580|12092278|FG000|NOT COMPLETED|Overall Study||10
10924345|NCT00242580|12092279|FG001|NOT COMPLETED|Overall Study||12
10924346|NCT00242580|12092280|FG002|NOT COMPLETED|Overall Study||14
10924347|NCT00242619|12092290|FG000|STARTED|Overall Study||8
10924348|NCT00242619|12092291|FG001|STARTED|Overall Study||4
10924349|NCT00242619|12092290|FG000|COMPLETED|Overall Study||8
10924350|NCT00242619|12092291|FG001|COMPLETED|Overall Study||4
10924351|NCT00242619|12092290|FG000|NOT COMPLETED|Overall Study||0
10924352|NCT00242619|12092291|FG001|NOT COMPLETED|Overall Study||0
10924353|NCT00242632|12092301|FG000|STARTED|Overall Study||11
10924354|NCT00242632|12092302|FG001|STARTED|Overall Study||11
10924355|NCT00242632|12092301|FG000|COMPLETED|Overall Study||11
10924356|NCT00242632|12092302|FG001|COMPLETED|Overall Study||11
10924357|NCT00242632|12092301|FG000|NOT COMPLETED|Overall Study||0
10924358|NCT00242632|12092302|FG001|NOT COMPLETED|Overall Study||0
10924359|NCT00242658|12092309|FG000|STARTED|Overall Study||187
10924360|NCT00242658|12092310|FG001|STARTED|Overall Study||207
10924361|NCT00242658|12092309|FG000|COMPLETED|Overall Study||165
10924362|NCT00242658|12092310|FG001|COMPLETED|Overall Study||188
10924363|NCT00242658|12092309|FG000|NOT COMPLETED|Overall Study||22
10924364|NCT00242658|12092310|FG001|NOT COMPLETED|Overall Study||19
10924365|NCT00242684|12092316|FG000|STARTED|Overall Study||446
10924366|NCT00242684|12092316|FG000|COMPLETED|Overall Study||446
10924367|NCT00242684|12092316|FG000|NOT COMPLETED|Overall Study||0
10924368|NCT00242710|12092324|FG000|STARTED|Core Study (up to Year 1)||373
10924369|NCT00242710|12092325|FG001|STARTED|Core Study (up to Year 1)||353
10924370|NCT00242710|12092326|FG002|STARTED|Core Study (up to Year 1)||183
10924371|NCT00242710|12092327|FG003|STARTED|Core Study (up to Year 1)||174
10924372|NCT00242710|12092324|FG000|Treated|Core Study (up to Year 1)||361
10924373|NCT00242710|12092325|FG001|Treated|Core Study (up to Year 1)||349
10924374|NCT00242710|12092326|FG002|Treated|Core Study (up to Year 1)||179
10924375|NCT00242710|12092327|FG003|Treated|Core Study (up to Year 1)||172
10924376|NCT00242710|12092324|FG000|COMPLETED|Core Study (up to Year 1)||287
10924377|NCT00242710|12092325|FG001|COMPLETED|Core Study (up to Year 1)||289
10924378|NCT00242710|12092326|FG002|COMPLETED|Core Study (up to Year 1)||132
10924379|NCT00242710|12092327|FG003|COMPLETED|Core Study (up to Year 1)||143
10924380|NCT00242710|12092324|FG000|NOT COMPLETED|Core Study (up to Year 1)||86
10924381|NCT00242710|12092325|FG001|NOT COMPLETED|Core Study (up to Year 1)||64
10924382|NCT00242710|12092326|FG002|NOT COMPLETED|Core Study (up to Year 1)||51
10924383|NCT00242710|12092327|FG003|NOT COMPLETED|Core Study (up to Year 1)||31
10924384|NCT00242710|12092324|FG000|STARTED|Period Between Core Study and Extension||287
10924385|NCT00242710|12092325|FG001|STARTED|Period Between Core Study and Extension||289
10924386|NCT00242710|12092326|FG002|STARTED|Period Between Core Study and Extension||132
10924387|NCT00242710|12092327|FG003|STARTED|Period Between Core Study and Extension||143
10924388|NCT00242710|12092324|FG000|COMPLETED|Period Between Core Study and Extension||168
10924389|NCT00242710|12092325|FG001|COMPLETED|Period Between Core Study and Extension||177
10924390|NCT00242710|12092326|FG002|COMPLETED|Period Between Core Study and Extension||84
10924391|NCT00242710|12092327|FG003|COMPLETED|Period Between Core Study and Extension||94
10924392|NCT00242710|12092324|FG000|NOT COMPLETED|Period Between Core Study and Extension||119
10924393|NCT00242710|12092325|FG001|NOT COMPLETED|Period Between Core Study and Extension||112
10924394|NCT00242710|12092326|FG002|NOT COMPLETED|Period Between Core Study and Extension||48
10924395|NCT00242710|12092327|FG003|NOT COMPLETED|Period Between Core Study and Extension||49
10924396|NCT00242710|12092324|FG000|STARTED|Study Extension (up to Year 2)||168
10924397|NCT00242710|12092325|FG001|STARTED|Study Extension (up to Year 2)||177
10924398|NCT00242710|12092326|FG002|STARTED|Study Extension (up to Year 2)||84
10924399|NCT00242710|12092327|FG003|STARTED|Study Extension (up to Year 2)||94
10924400|NCT00242710|12092324|FG000|COMPLETED|Study Extension (up to Year 2)||141
10924401|NCT00242710|12092325|FG001|COMPLETED|Study Extension (up to Year 2)||148
10924402|NCT00242710|12092326|FG002|COMPLETED|Study Extension (up to Year 2)||69
10924403|NCT00242710|12092327|FG003|COMPLETED|Study Extension (up to Year 2)||84
10924404|NCT00242710|12092324|FG000|NOT COMPLETED|Study Extension (up to Year 2)||27
10924405|NCT00242710|12092325|FG001|NOT COMPLETED|Study Extension (up to Year 2)||29
10924406|NCT00242710|12092326|FG002|NOT COMPLETED|Study Extension (up to Year 2)||15
10924407|NCT00242710|12092327|FG003|NOT COMPLETED|Study Extension (up to Year 2)||10
10924408|NCT00243022|12092339|FG000|STARTED|Overall Study||7
10924409|NCT00243022|12092340|FG001|STARTED|Overall Study||5
10924410|NCT00243022|12092339|FG000|COMPLETED|Overall Study||5
10924411|NCT00243022|12092340|FG001|COMPLETED|Overall Study||4
10924412|NCT00243022|12092339|FG000|NOT COMPLETED|Overall Study||2
10924413|NCT00243022|12092340|FG001|NOT COMPLETED|Overall Study||1
10924414|NCT00243061|12092347|FG000|STARTED|Overall Study||24
10924415|NCT00243061|12092347|FG000|COMPLETED|Overall Study||24
10924416|NCT00243061|12092347|FG000|NOT COMPLETED|Overall Study||0
10924417|NCT00243074|12092352|FG000|STARTED|Overall Study||54
10924418|NCT00243074|12092352|FG000|COMPLETED|Overall Study||0
10924419|NCT00243074|12092352|FG000|NOT COMPLETED|Overall Study||54
10924420|NCT00243152|12092357|FG000|STARTED|Overall Study||3
10924421|NCT00243152|12092358|FG001|STARTED|Overall Study||3
10924422|NCT00243152|12092357|FG000|Scan 1: Drug or Placebo|Overall Study||3
10924423|NCT00243152|12092358|FG001|Scan 1: Drug or Placebo|Overall Study||3
10924424|NCT00243152|12092357|FG000|Scan 2: Placebo or Drug|Overall Study||3
10924425|NCT00243152|12092358|FG001|Scan 2: Placebo or Drug|Overall Study||3
10924426|NCT00243152|12092357|FG000|COMPLETED|Overall Study||3
10924427|NCT00243152|12092358|FG001|COMPLETED|Overall Study||3
10924428|NCT00243152|12092357|FG000|NOT COMPLETED|Overall Study||0
10924429|NCT00243152|12092358|FG001|NOT COMPLETED|Overall Study||0
10924430|NCT00243191|12092365|FG000|STARTED|Overall Study||18
10924431|NCT00243191|12092365|FG000|COMPLETED|Overall Study||18
10924432|NCT00243191|12092365|FG000|NOT COMPLETED|Overall Study||0
10924433|NCT00243230|12092372|FG000|STARTED|Double-Blind Period||39
10924434|NCT00243230|12092373|FG001|STARTED|Double-Blind Period||40
10924435|NCT00243230|12092374|FG002|STARTED|Double-Blind Period||37
10924436|NCT00243230|12092375|FG003|STARTED|Double-Blind Period||0
10924437|NCT00243230|12092372|FG000|Treated|Double-Blind Period||39
10924438|NCT00243230|12092373|FG001|Treated|Double-Blind Period||40
10924439|NCT00243230|12092374|FG002|Treated|Double-Blind Period||35
10924440|NCT00243230|12092375|FG003|Treated|Double-Blind Period||0
10924441|NCT00243230|12092372|FG000|COMPLETED|Double-Blind Period||33
10924442|NCT00243230|12092373|FG001|COMPLETED|Double-Blind Period||35
10924443|NCT00243230|12092374|FG002|COMPLETED|Double-Blind Period||18
10924444|NCT00243230|12092375|FG003|COMPLETED|Double-Blind Period||0
10924445|NCT00243230|12092372|FG000|NOT COMPLETED|Double-Blind Period||6
10924446|NCT00243230|12092373|FG001|NOT COMPLETED|Double-Blind Period||5
10924447|NCT00243230|12092374|FG002|NOT COMPLETED|Double-Blind Period||19
10924448|NCT00243230|12092375|FG003|NOT COMPLETED|Double-Blind Period||0
10924449|NCT00243230|12092372|FG000|STARTED|Open Label Period||0
10924450|NCT00243230|12092373|FG001|STARTED|Open Label Period||0
10924451|NCT00243230|12092374|FG002|STARTED|Open Label Period||0
10924452|NCT00243230|12092375|FG003|STARTED|Open Label Period||85
10924453|NCT00243230|12092372|FG000|COMPLETED|Open Label Period||0
10924454|NCT00243230|12092373|FG001|COMPLETED|Open Label Period||0
10924455|NCT00243230|12092374|FG002|COMPLETED|Open Label Period||0
10924456|NCT00243230|12092375|FG003|COMPLETED|Open Label Period||0
10924457|NCT00243230|12092372|FG000|NOT COMPLETED|Open Label Period||0
10924458|NCT00243230|12092373|FG001|NOT COMPLETED|Open Label Period||0
10924459|NCT00243230|12092374|FG002|NOT COMPLETED|Open Label Period||0
10924460|NCT00243230|12092375|FG003|NOT COMPLETED|Open Label Period||85
10924461|NCT00243243|12092387|FG000|STARTED|Overall Study||10
10924462|NCT00243243|12092388|FG001|STARTED|Overall Study||10
10924463|NCT00243243|12092387|FG000|COMPLETED|Overall Study||10
10924464|NCT00243243|12092388|FG001|COMPLETED|Overall Study||10
10924465|NCT00243243|12092387|FG000|NOT COMPLETED|Overall Study||0
10924466|NCT00243243|12092388|FG001|NOT COMPLETED|Overall Study||0
10924467|NCT00243269|12092398|FG000|STARTED|Overall Study||31
10924468|NCT00243269|12092399|FG001|STARTED|Overall Study||11
10924469|NCT00243269|12092400|FG002|STARTED|Overall Study||12
10924470|NCT00243269|12092401|FG003|STARTED|Overall Study||29
10924471|NCT00243269|12092398|FG000|COMPLETED|Overall Study||28
10924472|NCT00243269|12092399|FG001|COMPLETED|Overall Study||10
10924473|NCT00243269|12092400|FG002|COMPLETED|Overall Study||11
10924474|NCT00243269|12092401|FG003|COMPLETED|Overall Study||25
10924475|NCT00243269|12092398|FG000|NOT COMPLETED|Overall Study||3
10924476|NCT00243269|12092399|FG001|NOT COMPLETED|Overall Study||1
10924477|NCT00243269|12092400|FG002|NOT COMPLETED|Overall Study||1
10924478|NCT00243269|12092401|FG003|NOT COMPLETED|Overall Study||4
10924479|NCT00243347|12092411|FG000|STARTED|Overall Study|Treated|19
10924480|NCT00243347|12092411|FG000|COMPLETED|Overall Study|Completed study|0
10924481|NCT00243347|12092411|FG000|NOT COMPLETED|Overall Study||19
10924482|NCT00243386|12092415|FG000|STARTED|On-Demand Regimen (Study Part 1)||73
10924483|NCT00243386|12092416|FG001|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
10924484|NCT00243386|12092417|FG002|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
10924485|NCT00243386|12092415|FG000|COMPLETED|On-Demand Regimen (Study Part 1)||69
10924486|NCT00243386|12092416|FG001|COMPLETED|On-Demand Regimen (Study Part 1)||0
10924487|NCT00243386|12092417|FG002|COMPLETED|On-Demand Regimen (Study Part 1)||0
10924488|NCT00243386|12092415|FG000|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
10924489|NCT00243386|12092416|FG001|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
10924490|NCT00243386|12092417|FG002|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
10924491|NCT00243386|12092415|FG000|STARTED|End of Part 1, But Prior to Prophylaxis||69
10924492|NCT00243386|12092416|FG001|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
10924493|NCT00243386|12092417|FG002|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
10924494|NCT00243386|12092415|FG000|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
10924495|NCT00243386|12092416|FG001|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
10924496|NCT00243386|12092417|FG002|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
10924497|NCT00243386|12092415|FG000|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
10924498|NCT00243386|12092416|FG001|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
10924499|NCT00243386|12092417|FG002|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
10924500|NCT00243386|12092415|FG000|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
10924501|NCT00243386|12092416|FG001|STARTED|PK-Driven or Standard Prophylaxis||34
10924502|NCT00243386|12092417|FG002|STARTED|PK-Driven or Standard Prophylaxis||32
10924503|NCT00243386|12092415|FG000|COMPLETED|PK-Driven or Standard Prophylaxis||0
10924504|NCT00243386|12092416|FG001|COMPLETED|PK-Driven or Standard Prophylaxis||31
10924505|NCT00243386|12092417|FG002|COMPLETED|PK-Driven or Standard Prophylaxis||32
10924506|NCT00243386|12092415|FG000|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
10924507|NCT00243386|12092416|FG001|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
10924508|NCT00243386|12092417|FG002|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
10924509|NCT00243412|12092455|FG000|STARTED|Overall Study|Intent to treat|21
10924510|NCT00243412|12092456|FG001|STARTED|Overall Study|Intent to treat|21
10924511|NCT00243412|12092455|FG000|Safety Evaluable|Overall Study||21
10924512|NCT00243412|12092456|FG001|Safety Evaluable|Overall Study||20
10924513|NCT00243412|12092455|FG000|COMPLETED|Overall Study|Completed Week 104|11
10924514|NCT00243412|12092456|FG001|COMPLETED|Overall Study|Completed Week 104|10
10924515|NCT00243412|12092455|FG000|NOT COMPLETED|Overall Study||10
10924516|NCT00243412|12092456|FG001|NOT COMPLETED|Overall Study||11
10924517|NCT00243503|12092462|FG000|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
10924518|NCT00243503|12092462|FG000|COMPLETED|Overall Study||2
10924519|NCT00243503|12092462|FG000|NOT COMPLETED|Overall Study||58
10924520|NCT00243659|12092469|FG000|STARTED|Overall Study||22
10924521|NCT00243659|12092470|FG001|STARTED|Overall Study||8
10924522|NCT00243659|12092469|FG000|COMPLETED|Overall Study||20
10924523|NCT00243659|12092470|FG001|COMPLETED|Overall Study||5
10924524|NCT00243659|12092469|FG000|NOT COMPLETED|Overall Study||2
10924525|NCT00243659|12092470|FG001|NOT COMPLETED|Overall Study||3
10924526|NCT00243841|12092479|FG000|STARTED|Overall Study||3
10924527|NCT00243841|12092480|FG001|STARTED|Overall Study||6
10924528|NCT00243841|12092481|FG002|STARTED|Overall Study||5
10924529|NCT00243841|12092482|FG003|STARTED|Overall Study||3
10924530|NCT00243841|12092483|FG004|STARTED|Overall Study||39
10924531|NCT00243841|12092484|FG005|STARTED|Overall Study||21
10924532|NCT00243841|12092479|FG000|COMPLETED|Overall Study||3
10924533|NCT00243841|12092480|FG001|COMPLETED|Overall Study||6
10924534|NCT00243841|12092481|FG002|COMPLETED|Overall Study||4
10924535|NCT00243841|12092482|FG003|COMPLETED|Overall Study||3
10924536|NCT00243841|12092483|FG004|COMPLETED|Overall Study||39
10924537|NCT00243841|12092484|FG005|COMPLETED|Overall Study||19
10924538|NCT00243841|12092479|FG000|NOT COMPLETED|Overall Study||0
10924539|NCT00243841|12092480|FG001|NOT COMPLETED|Overall Study||0
10924540|NCT00243841|12092481|FG002|NOT COMPLETED|Overall Study||1
10924541|NCT00243841|12092482|FG003|NOT COMPLETED|Overall Study||0
10924542|NCT00243841|12092483|FG004|NOT COMPLETED|Overall Study||0
10924543|NCT00243841|12092484|FG005|NOT COMPLETED|Overall Study||2
10924544|NCT00243919|12092503|FG000|STARTED|Overall Study||139
10924545|NCT00243919|12092504|FG001|STARTED|Overall Study||143
10924546|NCT00243919|12092505|FG002|STARTED|Overall Study||126
10924547|NCT00243919|12092503|FG000|COMPLETED|Overall Study||122
10924548|NCT00243919|12092504|FG001|COMPLETED|Overall Study||125
10924549|NCT00243919|12092505|FG002|COMPLETED|Overall Study||115
10924550|NCT00243919|12092503|FG000|NOT COMPLETED|Overall Study||17
10924551|NCT00243919|12092504|FG001|NOT COMPLETED|Overall Study||18
10924552|NCT00243919|12092505|FG002|NOT COMPLETED|Overall Study||11
10924553|NCT00243932|12092516|FG000|STARTED|Stage 1: Dose Selection||35
10924554|NCT00243932|12092517|FG001|STARTED|Stage 1: Dose Selection||35
10924555|NCT00243932|12092518|FG002|STARTED|Stage 1: Dose Selection||35
10924556|NCT00243932|12092516|FG000|COMPLETED|Stage 1: Dose Selection||33
10924557|NCT00243932|12092517|FG001|COMPLETED|Stage 1: Dose Selection||35
10924558|NCT00243932|12092518|FG002|COMPLETED|Stage 1: Dose Selection||35
10924559|NCT00243932|12092516|FG000|NOT COMPLETED|Stage 1: Dose Selection||2
10924560|NCT00243932|12092517|FG001|NOT COMPLETED|Stage 1: Dose Selection||0
10924561|NCT00243932|12092518|FG002|NOT COMPLETED|Stage 1: Dose Selection||0
10924562|NCT00243932|12092516|FG000|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
10924563|NCT00243932|12092517|FG001|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
10924564|NCT00243932|12092518|FG002|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
10924565|NCT00243932|12092516|FG000|COMPLETED|Stage 2: Efficacy||40
10924566|NCT00243932|12092517|FG001|COMPLETED|Stage 2: Efficacy||40
10924567|NCT00243932|12092518|FG002|COMPLETED|Stage 2: Efficacy||0
10924568|NCT00243932|12092516|FG000|NOT COMPLETED|Stage 2: Efficacy||0
10924569|NCT00243932|12092517|FG001|NOT COMPLETED|Stage 2: Efficacy||0
10924570|NCT00243932|12092518|FG002|NOT COMPLETED|Stage 2: Efficacy||0
10924571|NCT00244101|12092529|FG000|STARTED|Overall Study||209
10924572|NCT00244101|12092530|FG001|STARTED|Overall Study||223
10924573|NCT00244101|12092531|FG002|STARTED|Overall Study||216
10924574|NCT00244101|12092529|FG000|COMPLETED|Overall Study||209
10924575|NCT00244101|12092530|FG001|COMPLETED|Overall Study||223
10924576|NCT00244101|12092531|FG002|COMPLETED|Overall Study||216
10924577|NCT00244101|12092529|FG000|NOT COMPLETED|Overall Study||0
10924578|NCT00244101|12092530|FG001|NOT COMPLETED|Overall Study||0
10924579|NCT00244101|12092531|FG002|NOT COMPLETED|Overall Study||0
10924580|NCT00244140|12092541|FG000|STARTED|Overall Study||412
10924581|NCT00244140|12092542|FG001|STARTED|Overall Study||22
10924582|NCT00244140|12092541|FG000|COMPLETED|Overall Study||412
10924583|NCT00244140|12092542|FG001|COMPLETED|Overall Study||22
10924584|NCT00244140|12092541|FG000|NOT COMPLETED|Overall Study||0
10924585|NCT00244140|12092542|FG001|NOT COMPLETED|Overall Study||0
10924586|NCT00244374|12092548|FG000|STARTED|Pre-Randomization Cross-sectional Study||546
10924587|NCT00244374|12092549|FG001|STARTED|Pre-Randomization Cross-sectional Study||0
10924588|NCT00244374|12092550|FG002|STARTED|Pre-Randomization Cross-sectional Study||0
10924589|NCT00244374|12092551|FG003|STARTED|Pre-Randomization Cross-sectional Study||0
10924590|NCT00244374|12092552|FG004|STARTED|Pre-Randomization Cross-sectional Study||0
10924591|NCT00244374|12092548|FG000|COMPLETED|Pre-Randomization Cross-sectional Study||409
10924592|NCT00244374|12092549|FG001|COMPLETED|Pre-Randomization Cross-sectional Study||0
10924593|NCT00244374|12092550|FG002|COMPLETED|Pre-Randomization Cross-sectional Study||0
10924594|NCT00244374|12092551|FG003|COMPLETED|Pre-Randomization Cross-sectional Study||0
10924595|NCT00244374|12092552|FG004|COMPLETED|Pre-Randomization Cross-sectional Study||0
10924596|NCT00244374|12092548|FG000|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
10924597|NCT00244374|12092549|FG001|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
10924598|NCT00244374|12092550|FG002|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
10924599|NCT00244374|12092551|FG003|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
10924600|NCT00244374|12092552|FG004|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
10924601|NCT00244374|12092548|FG000|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
10924602|NCT00244374|12092549|FG001|STARTED|Evaluation for Vaccine Adherence Cohort||0
10924603|NCT00244374|12092550|FG002|STARTED|Evaluation for Vaccine Adherence Cohort||0
10924604|NCT00244374|12092551|FG003|STARTED|Evaluation for Vaccine Adherence Cohort||0
10924605|NCT00244374|12092552|FG004|STARTED|Evaluation for Vaccine Adherence Cohort||0
10924606|NCT00244374|12092548|FG000|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
10924607|NCT00244374|12092549|FG001|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
10924608|NCT00244374|12092550|FG002|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
10924609|NCT00244374|12092551|FG003|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
10924610|NCT00244374|12092552|FG004|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
10924611|NCT00244374|12092548|FG000|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
10924612|NCT00244374|12092549|FG001|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10924613|NCT00244374|12092550|FG002|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10924614|NCT00244374|12092551|FG003|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10924615|NCT00244374|12092552|FG004|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10924616|NCT00244374|12092548|FG000|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
10924617|NCT00244374|12092549|FG001|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10924618|NCT00244374|12092550|FG002|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10924619|NCT00244374|12092551|FG003|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10924620|NCT00244374|12092552|FG004|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
10924621|NCT00244374|12092548|FG000|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
10924622|NCT00244374|12092549|FG001|STARTED|Vaccine Adherence Cohort||47
10924623|NCT00244374|12092550|FG002|STARTED|Vaccine Adherence Cohort||43
10924624|NCT00244374|12092551|FG003|STARTED|Vaccine Adherence Cohort||36
10924625|NCT00244374|12092552|FG004|STARTED|Vaccine Adherence Cohort||41
10924626|NCT00244374|12092548|FG000|COMPLETED|Vaccine Adherence Cohort||0
10924627|NCT00244374|12092549|FG001|COMPLETED|Vaccine Adherence Cohort||47
10924628|NCT00244374|12092550|FG002|COMPLETED|Vaccine Adherence Cohort||43
10924629|NCT00244374|12092551|FG003|COMPLETED|Vaccine Adherence Cohort||36
10924630|NCT00244374|12092552|FG004|COMPLETED|Vaccine Adherence Cohort||41
10924631|NCT00244374|12092548|FG000|NOT COMPLETED|Vaccine Adherence Cohort||0
10924632|NCT00244374|12092549|FG001|NOT COMPLETED|Vaccine Adherence Cohort||0
10924633|NCT00244374|12092550|FG002|NOT COMPLETED|Vaccine Adherence Cohort||0
10924634|NCT00244374|12092551|FG003|NOT COMPLETED|Vaccine Adherence Cohort||0
10924635|NCT00244374|12092552|FG004|NOT COMPLETED|Vaccine Adherence Cohort||0
10924636|NCT00244621|12092571|FG000|STARTED|Double-blind Treatment Period||29
10924637|NCT00244621|12092572|FG001|STARTED|Double-blind Treatment Period||32
10924638|NCT00244621|12092573|FG002|STARTED|Double-blind Treatment Period||32
10924639|NCT00244621|12092571|FG000|COMPLETED|Double-blind Treatment Period||27
10924640|NCT00244621|12092572|FG001|COMPLETED|Double-blind Treatment Period||29
10924641|NCT00244621|12092573|FG002|COMPLETED|Double-blind Treatment Period||30
10924642|NCT00244621|12092571|FG000|NOT COMPLETED|Double-blind Treatment Period||2
10924643|NCT00244621|12092572|FG001|NOT COMPLETED|Double-blind Treatment Period||3
10924644|NCT00244621|12092573|FG002|NOT COMPLETED|Double-blind Treatment Period||2
10924645|NCT00244621|12092571|FG000|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
10924646|NCT00244621|12092572|FG001|STARTED|Open-label Treatment Period||29
10924647|NCT00244621|12092573|FG002|STARTED|Open-label Treatment Period||30
10924648|NCT00244621|12092571|FG000|COMPLETED|Open-label Treatment Period||25
10924649|NCT00244621|12092572|FG001|COMPLETED|Open-label Treatment Period||28
10924650|NCT00244621|12092573|FG002|COMPLETED|Open-label Treatment Period||28
10924651|NCT00244621|12092571|FG000|NOT COMPLETED|Open-label Treatment Period||1
10924652|NCT00244621|12092572|FG001|NOT COMPLETED|Open-label Treatment Period||1
10924653|NCT00244621|12092573|FG002|NOT COMPLETED|Open-label Treatment Period||2
10924654|NCT00244712|12092583|FG000|STARTED|Overall Study||343
10924655|NCT00244712|12092584|FG001|STARTED|Overall Study||345
10924656|NCT00244712|12092583|FG000|COMPLETED|Overall Study||234
10924657|NCT00244712|12092584|FG001|COMPLETED|Overall Study||221
10924658|NCT00244712|12092583|FG000|NOT COMPLETED|Overall Study||109
10924659|NCT00244712|12092584|FG001|NOT COMPLETED|Overall Study||124
10924660|NCT00244725|12092594|FG000|STARTED|Overall Study||237
10924661|NCT00244725|12092595|FG001|STARTED|Overall Study||245
10924662|NCT00244725|12092596|FG002|STARTED|Overall Study||239
10924663|NCT00244725|12092597|FG003|STARTED|Overall Study||237
10924664|NCT00244725|12092594|FG000|COMPLETED|Overall Study||214
10924665|NCT00244725|12092595|FG001|COMPLETED|Overall Study||226
10924666|NCT00244725|12092596|FG002|COMPLETED|Overall Study||215
10924667|NCT00244725|12092597|FG003|COMPLETED|Overall Study||216
10924668|NCT00244725|12092594|FG000|NOT COMPLETED|Overall Study||23
10924669|NCT00244725|12092595|FG001|NOT COMPLETED|Overall Study||19
10924670|NCT00244725|12092596|FG002|NOT COMPLETED|Overall Study||24
10924671|NCT00244725|12092597|FG003|NOT COMPLETED|Overall Study||21
10924672|NCT00244751|12092610|FG000|STARTED|Overall Study||88
10924673|NCT00244751|12092611|FG001|STARTED|Overall Study||89
10924674|NCT00244751|12092612|FG002|STARTED|Overall Study||88
10924675|NCT00244751|12092610|FG000|COMPLETED|Overall Study||72
10924676|NCT00244751|12092611|FG001|COMPLETED|Overall Study||74
10924677|NCT00244751|12092612|FG002|COMPLETED|Overall Study||78
10924678|NCT00244751|12092610|FG000|NOT COMPLETED|Overall Study||16
10924679|NCT00244751|12092611|FG001|NOT COMPLETED|Overall Study||15
10924680|NCT00244751|12092612|FG002|NOT COMPLETED|Overall Study||10
10924681|NCT00244764|12092629|FG000|STARTED|Overall Study||225
10924682|NCT00244764|12092629|FG000|COMPLETED|Overall Study||129
10924683|NCT00244764|12092629|FG000|NOT COMPLETED|Overall Study||96
10924684|NCT00244855|12092636|FG000|STARTED|Overall Study||7
10924685|NCT00244855|12092637|FG001|STARTED|Overall Study||25
10924686|NCT00244855|12092636|FG000|COMPLETED|Overall Study||7
10924687|NCT00244855|12092637|FG001|COMPLETED|Overall Study||24
10924688|NCT00244855|12092636|FG000|NOT COMPLETED|Overall Study||0
10924689|NCT00244855|12092637|FG001|NOT COMPLETED|Overall Study||1
10924690|NCT00244881|12092645|FG000|STARTED|Overall Study||26
10924691|NCT00244881|12092645|FG000|COMPLETED|Overall Study||23
10924692|NCT00244881|12092645|FG000|NOT COMPLETED|Overall Study||3
10924693|NCT00244933|12092649|FG000|STARTED|Overall Study||19
10924694|NCT00244933|12092649|FG000|COMPLETED|Overall Study||17
10924695|NCT00244933|12092649|FG000|NOT COMPLETED|Overall Study||2
10924696|NCT00244985|12092653|FG000|STARTED|Overall Study||42
10924697|NCT00244985|12092653|FG000|COMPLETED|Overall Study||42
10924698|NCT00244985|12092653|FG000|NOT COMPLETED|Overall Study||0
10924699|NCT00245011|12092657|FG000|STARTED|Overall Study||11
10924700|NCT00245011|12092657|FG000|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
10924701|NCT00245011|12092657|FG000|NOT COMPLETED|Overall Study||1
10924702|NCT00245037|12092661|FG000|STARTED|Overall Study||147
10924703|NCT00245037|12092661|FG000|COMPLETED|Overall Study|17 participants died from infectious complications.|130
10924704|NCT00245037|12092661|FG000|NOT COMPLETED|Overall Study||17
10924705|NCT00245050|12092667|FG000|STARTED|Overall Study||18
10924706|NCT00245050|12092668|FG001|STARTED|Overall Study||16
10924707|NCT00245050|12092667|FG000|COMPLETED|Overall Study||15
10924708|NCT00245050|12092668|FG001|COMPLETED|Overall Study||14
10924709|NCT00245050|12092667|FG000|NOT COMPLETED|Overall Study||3
10924710|NCT00245050|12092668|FG001|NOT COMPLETED|Overall Study||2
10924711|NCT00245063|12092676|FG000|STARTED|Overall Study||12
10924712|NCT00245063|12092677|FG001|STARTED|Overall Study||13
10924713|NCT00245063|12092676|FG000|COMPLETED|Overall Study||5
10924714|NCT00245063|12092677|FG001|COMPLETED|Overall Study||8
10924715|NCT00245063|12092676|FG000|NOT COMPLETED|Overall Study||7
10924716|NCT00245063|12092677|FG001|NOT COMPLETED|Overall Study||5
10924717|NCT00245102|12092689|FG000|STARTED|Overall Study||44
10924718|NCT00245102|12092690|FG001|STARTED|Overall Study||16
10924719|NCT00245102|12092691|FG002|STARTED|Overall Study||46
10924720|NCT00245102|12092692|FG003|STARTED|Overall Study||13
10924721|NCT00245102|12092693|FG004|STARTED|Overall Study||5
10924722|NCT00245102|12092694|FG005|STARTED|Overall Study||23
10924723|NCT00245102|12092689|FG000|COMPLETED|Overall Study||37
10924724|NCT00245102|12092690|FG001|COMPLETED|Overall Study||12
10924725|NCT00245102|12092691|FG002|COMPLETED|Overall Study||39
10924726|NCT00245102|12092692|FG003|COMPLETED|Overall Study||10
10924727|NCT00245102|12092693|FG004|COMPLETED|Overall Study||5
10924728|NCT00245102|12092694|FG005|COMPLETED|Overall Study||19
10924729|NCT00245102|12092689|FG000|NOT COMPLETED|Overall Study||7
10924730|NCT00245102|12092690|FG001|NOT COMPLETED|Overall Study||4
10924731|NCT00245102|12092691|FG002|NOT COMPLETED|Overall Study||7
10924732|NCT00245102|12092692|FG003|NOT COMPLETED|Overall Study||3
10924733|NCT00245102|12092693|FG004|NOT COMPLETED|Overall Study||0
10924734|NCT00245102|12092694|FG005|NOT COMPLETED|Overall Study||4
10924735|NCT00245219|12092711|FG000|STARTED|Overall Study||91
10924736|NCT00245219|12092712|FG001|STARTED|Overall Study||94
10924737|NCT00245219|12092713|FG002|STARTED|Overall Study||60
10924738|NCT00245219|12092711|FG000|COMPLETED|Overall Study||85
10924739|NCT00245219|12092712|FG001|COMPLETED|Overall Study||88
10924740|NCT00245219|12092713|FG002|COMPLETED|Overall Study||58
10924741|NCT00245219|12092711|FG000|NOT COMPLETED|Overall Study||6
10924742|NCT00245219|12092712|FG001|NOT COMPLETED|Overall Study||6
10924743|NCT00245219|12092713|FG002|NOT COMPLETED|Overall Study||2
10924744|NCT00245466|12092724|FG000|STARTED|Overall Study||43
10924745|NCT00245466|12092725|FG001|STARTED|Overall Study||46
10924746|NCT00245466|12092726|FG002|STARTED|Overall Study||40
10924747|NCT00245466|12092724|FG000|Started FE200486 CS02A|Overall Study||32
10924748|NCT00245466|12092725|FG001|Started FE200486 CS02A|Overall Study||30
10924749|NCT00245466|12092726|FG002|Started FE200486 CS02A|Overall Study||26
10924750|NCT00245466|12092724|FG000|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
10924751|NCT00245466|12092725|FG001|COMPLETED|Overall Study||2
10924752|NCT00245466|12092726|FG002|COMPLETED|Overall Study||3
10924753|NCT00245466|12092724|FG000|NOT COMPLETED|Overall Study||36
10924754|NCT00245466|12092725|FG001|NOT COMPLETED|Overall Study||44
10924755|NCT00245466|12092726|FG002|NOT COMPLETED|Overall Study||37
10924756|NCT00245518|12092736|FG000|STARTED|Overall Study||17
10924757|NCT00245518|12092737|FG001|STARTED|Overall Study||16
10924758|NCT00245518|12092736|FG000|COMPLETED|Overall Study||17
10924759|NCT00245518|12092737|FG001|COMPLETED|Overall Study||16
10924760|NCT00245518|12092736|FG000|NOT COMPLETED|Overall Study||0
10924761|NCT00245518|12092737|FG001|NOT COMPLETED|Overall Study||0
10924762|NCT00245557|12092745|FG000|STARTED|Overall Study||17
10924763|NCT00245557|12092746|FG001|STARTED|Overall Study||26
10924764|NCT00245557|12092745|FG000|COMPLETED|Overall Study||11
10924765|NCT00245557|12092746|FG001|COMPLETED|Overall Study||10
10924766|NCT00245557|12092745|FG000|NOT COMPLETED|Overall Study||6
10924767|NCT00245557|12092746|FG001|NOT COMPLETED|Overall Study||16
10924768|NCT00245583|12092755|FG000|STARTED|Overall Study||20
10924769|NCT00245583|12092756|FG001|STARTED|Overall Study||22
10924770|NCT00245583|12092755|FG000|COMPLETED|Overall Study||14
10924771|NCT00245583|12092756|FG001|COMPLETED|Overall Study||13
10924772|NCT00245583|12092755|FG000|NOT COMPLETED|Overall Study||6
10924773|NCT00245583|12092756|FG001|NOT COMPLETED|Overall Study||9
10924774|NCT00245635|12092764|FG000|STARTED|Overall Study||25
10924775|NCT00245635|12092765|FG001|STARTED|Overall Study||18
10924776|NCT00245635|12092764|FG000|COMPLETED|Overall Study||25
10924777|NCT00245635|12092765|FG001|COMPLETED|Overall Study||18
10924778|NCT00245635|12092764|FG000|NOT COMPLETED|Overall Study||0
10924779|NCT00245635|12092765|FG001|NOT COMPLETED|Overall Study||0
10924780|NCT00245765|12092774|FG000|STARTED|Overall Study||59
10924781|NCT00245765|12092775|FG001|STARTED|Overall Study||59
10924782|NCT00245765|12092776|FG002|STARTED|Overall Study||58
10924783|NCT00245765|12092774|FG000|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58
10924784|NCT00245765|12092775|FG001|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60
10924785|NCT00245765|12092776|FG002|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57
10924786|NCT00245765|12092774|FG000|COMPLETED|Overall Study||27
10924787|NCT00245765|12092775|FG001|COMPLETED|Overall Study||45
10924788|NCT00245765|12092776|FG002|COMPLETED|Overall Study||50
10924789|NCT00245765|12092774|FG000|NOT COMPLETED|Overall Study||32
10924790|NCT00245765|12092775|FG001|NOT COMPLETED|Overall Study||14
10924791|NCT00245765|12092776|FG002|NOT COMPLETED|Overall Study||8
10924792|NCT00245856|12092784|FG000|STARTED|Period One||28
10924793|NCT00245856|12092785|FG001|STARTED|Period One||0
10924794|NCT00245856|12092784|FG000|COMPLETED|Period One||28
10924795|NCT00245856|12092785|FG001|COMPLETED|Period One||0
10924796|NCT00245856|12092784|FG000|NOT COMPLETED|Period One||0
10924797|NCT00245856|12092785|FG001|NOT COMPLETED|Period One||0
10924798|NCT00245856|12092784|FG000|STARTED|Period Two||0
10924799|NCT00245856|12092785|FG001|STARTED|Period Two||39
10924800|NCT00245856|12092784|FG000|COMPLETED|Period Two||0
10924801|NCT00245856|12092785|FG001|COMPLETED|Period Two||38
10924802|NCT00245856|12092784|FG000|NOT COMPLETED|Period Two||0
10924803|NCT00245856|12092785|FG001|NOT COMPLETED|Period Two||1
10924804|NCT00246012|12092801|FG000|STARTED|Overall Study||3
10924805|NCT00246012|12092802|FG001|STARTED|Overall Study||3
10924806|NCT00246012|12092803|FG002|STARTED|Overall Study||3
10924807|NCT00246012|12092804|FG003|STARTED|Overall Study||3
10924808|NCT00246012|12092805|FG004|STARTED|Overall Study||3
10924809|NCT00246012|12092806|FG005|STARTED|Overall Study||32
10924810|NCT00246012|12092807|FG006|STARTED|Overall Study||32
10924811|NCT00246012|12092808|FG007|STARTED|Overall Study||33
10924812|NCT00246012|12092809|FG008|STARTED|Overall Study||32
10924813|NCT00246012|12092801|FG000|Treated|Overall Study||3
10924814|NCT00246012|12092802|FG001|Treated|Overall Study||3
10924815|NCT00246012|12092803|FG002|Treated|Overall Study||3
10924816|NCT00246012|12092804|FG003|Treated|Overall Study||3
10924817|NCT00246012|12092805|FG004|Treated|Overall Study||3
10924818|NCT00246012|12092806|FG005|Treated|Overall Study||31
10924819|NCT00246012|12092807|FG006|Treated|Overall Study||31
10924820|NCT00246012|12092808|FG007|Treated|Overall Study||33
10924821|NCT00246012|12092809|FG008|Treated|Overall Study||32
10924822|NCT00246012|12092801|FG000|COMPLETED|Overall Study||0
10924823|NCT00246012|12092802|FG001|COMPLETED|Overall Study||2
10924824|NCT00246012|12092803|FG002|COMPLETED|Overall Study||1
10924825|NCT00246012|12092804|FG003|COMPLETED|Overall Study||0
10924826|NCT00246012|12092805|FG004|COMPLETED|Overall Study||0
10924827|NCT00246012|12092806|FG005|COMPLETED|Overall Study||4
10924828|NCT00246012|12092807|FG006|COMPLETED|Overall Study||1
10924829|NCT00246012|12092808|FG007|COMPLETED|Overall Study||5
10924830|NCT00246012|12092809|FG008|COMPLETED|Overall Study||4
10924831|NCT00246012|12092801|FG000|NOT COMPLETED|Overall Study||3
10924832|NCT00246012|12092802|FG001|NOT COMPLETED|Overall Study||1
10924833|NCT00246012|12092803|FG002|NOT COMPLETED|Overall Study||2
10924834|NCT00246012|12092804|FG003|NOT COMPLETED|Overall Study||3
10924835|NCT00246012|12092805|FG004|NOT COMPLETED|Overall Study||3
10924836|NCT00246012|12092806|FG005|NOT COMPLETED|Overall Study||28
10924837|NCT00246012|12092807|FG006|NOT COMPLETED|Overall Study||31
10924838|NCT00246012|12092808|FG007|NOT COMPLETED|Overall Study||28
10924839|NCT00246012|12092809|FG008|NOT COMPLETED|Overall Study||28
10924840|NCT00246025|12092835|FG000|STARTED|Overall Study||124
10924841|NCT00246025|12092836|FG001|STARTED|Overall Study||133
10924842|NCT00246025|12092837|FG002|STARTED|Overall Study||126
10924843|NCT00246025|12092838|FG003|STARTED|Overall Study||129
10924844|NCT00246025|12092835|FG000|COMPLETED|Overall Study||114
10924845|NCT00246025|12092836|FG001|COMPLETED|Overall Study||124
10924846|NCT00246025|12092837|FG002|COMPLETED|Overall Study||116
10924847|NCT00246025|12092838|FG003|COMPLETED|Overall Study||116
10924848|NCT00246025|12092835|FG000|NOT COMPLETED|Overall Study||10
10924849|NCT00246025|12092836|FG001|NOT COMPLETED|Overall Study||9
10924850|NCT00246025|12092837|FG002|NOT COMPLETED|Overall Study||10
10924851|NCT00246025|12092838|FG003|NOT COMPLETED|Overall Study||13
10924852|NCT00246090|12092848|FG000|STARTED|Overall Study||298
10924853|NCT00246090|12092848|FG000|COMPLETED|Overall Study||3
10924854|NCT00246090|12092848|FG000|NOT COMPLETED|Overall Study||295
10924855|NCT00246129|12092854|FG000|STARTED|Overall Study||82
10924856|NCT00246129|12092855|FG001|STARTED|Overall Study||41
10924857|NCT00246129|12092854|FG000|COMPLETED|Overall Study||75
10924858|NCT00246129|12092855|FG001|COMPLETED|Overall Study||39
10924859|NCT00246129|12092854|FG000|NOT COMPLETED|Overall Study||7
10924860|NCT00246129|12092855|FG001|NOT COMPLETED|Overall Study||2
10924861|NCT00246259|12092866|FG000|STARTED|Overall Study||44
10924862|NCT00246259|12092867|FG001|STARTED|Overall Study||41
10924863|NCT00246259|12092866|FG000|Eligible for Intent-to-treat (ITT)|Overall Study||42
10924864|NCT00246259|12092867|FG001|Eligible for Intent-to-treat (ITT)|Overall Study||35
10924865|NCT00246259|12092866|FG000|COMPLETED|Overall Study||16
10924866|NCT00246259|12092867|FG001|COMPLETED|Overall Study||15
10924867|NCT00246259|12092866|FG000|NOT COMPLETED|Overall Study||28
10924868|NCT00246259|12092867|FG001|NOT COMPLETED|Overall Study||26
10924869|NCT00246324|12092873|FG000|STARTED|Overall Study||16
10924870|NCT00246324|12092873|FG000|COMPLETED|Overall Study||15
10924871|NCT00246324|12092873|FG000|NOT COMPLETED|Overall Study||1
10924872|NCT00246337|12092886|FG000|STARTED|Overall Study||147
10924873|NCT00246337|12092887|FG001|STARTED|Overall Study||16
10924874|NCT00246337|12092888|FG002|STARTED|Overall Study||18
10924875|NCT00246337|12092889|FG003|STARTED|Overall Study||17
10924876|NCT00246337|12092890|FG004|STARTED|Overall Study||16
10924877|NCT00246337|12092891|FG005|STARTED|Overall Study||54
10924878|NCT00246337|12092892|FG006|STARTED|Overall Study||54
10924879|NCT00246337|12092893|FG007|STARTED|Overall Study||53
10924880|NCT00246337|12092894|FG008|STARTED|Overall Study||45
10924881|NCT00246337|12092886|FG000|Completed Period (Initial Dose)|Overall Study||46
10924882|NCT00246337|12092887|FG001|Completed Period (Initial Dose)|Overall Study||4
10924883|NCT00246337|12092888|FG002|Completed Period (Initial Dose)|Overall Study||9
10924884|NCT00246337|12092889|FG003|Completed Period (Initial Dose)|Overall Study||5
10924885|NCT00246337|12092890|FG004|Completed Period (Initial Dose)|Overall Study||8
10924886|NCT00246337|12092891|FG005|Completed Period (Initial Dose)|Overall Study||29
10924887|NCT00246337|12092892|FG006|Completed Period (Initial Dose)|Overall Study||29
10924888|NCT00246337|12092893|FG007|Completed Period (Initial Dose)|Overall Study||27
10924889|NCT00246337|12092894|FG008|Completed Period (Initial Dose)|Overall Study||19
10924890|NCT00246337|12092886|FG000|Completed Period (Both Doses)|Overall Study||69
10924891|NCT00246337|12092887|FG001|Completed Period (Both Doses)|Overall Study||10
10924892|NCT00246337|12092888|FG002|Completed Period (Both Doses)|Overall Study||6
10924893|NCT00246337|12092889|FG003|Completed Period (Both Doses)|Overall Study||11
10924894|NCT00246337|12092890|FG004|Completed Period (Both Doses)|Overall Study||4
10924895|NCT00246337|12092891|FG005|Completed Period (Both Doses)|Overall Study||10
10924896|NCT00246337|12092892|FG006|Completed Period (Both Doses)|Overall Study||16
10924897|NCT00246337|12092893|FG007|Completed Period (Both Doses)|Overall Study||13
10924898|NCT00246337|12092894|FG008|Completed Period (Both Doses)|Overall Study||15
10924899|NCT00246337|12092886|FG000|COMPLETED|Overall Study||115
10924900|NCT00246337|12092887|FG001|COMPLETED|Overall Study||14
10924901|NCT00246337|12092888|FG002|COMPLETED|Overall Study||15
10924902|NCT00246337|12092889|FG003|COMPLETED|Overall Study||16
10924903|NCT00246337|12092890|FG004|COMPLETED|Overall Study||12
10924904|NCT00246337|12092891|FG005|COMPLETED|Overall Study||39
10924905|NCT00246337|12092892|FG006|COMPLETED|Overall Study||45
10924906|NCT00246337|12092893|FG007|COMPLETED|Overall Study||40
10924907|NCT00246337|12092894|FG008|COMPLETED|Overall Study||34
10924908|NCT00246337|12092886|FG000|NOT COMPLETED|Overall Study||32
10924909|NCT00246337|12092887|FG001|NOT COMPLETED|Overall Study||2
10924910|NCT00246337|12092888|FG002|NOT COMPLETED|Overall Study||3
10924911|NCT00246337|12092889|FG003|NOT COMPLETED|Overall Study||1
10924912|NCT00246337|12092890|FG004|NOT COMPLETED|Overall Study||4
10924913|NCT00246337|12092891|FG005|NOT COMPLETED|Overall Study||15
10924914|NCT00246337|12092892|FG006|NOT COMPLETED|Overall Study||9
10924915|NCT00246337|12092893|FG007|NOT COMPLETED|Overall Study||13
10924916|NCT00246337|12092894|FG008|NOT COMPLETED|Overall Study||11
10924917|NCT00246376|12092919|FG000|STARTED|Overall Study||41
10924918|NCT00246376|12092920|FG001|STARTED|Overall Study||43
10924919|NCT00246376|12092921|FG002|STARTED|Overall Study||45
10924920|NCT00246376|12092922|FG003|STARTED|Overall Study||47
10924921|NCT00246376|12092923|FG004|STARTED|Overall Study||45
10924922|NCT00246376|12092919|FG000|After Dietary run-in at Two Weeks|Overall Study||30
10924923|NCT00246376|12092920|FG001|After Dietary run-in at Two Weeks|Overall Study||38
10924924|NCT00246376|12092921|FG002|After Dietary run-in at Two Weeks|Overall Study||41
10924925|NCT00246376|12092922|FG003|After Dietary run-in at Two Weeks|Overall Study||40
10924926|NCT00246376|12092923|FG004|After Dietary run-in at Two Weeks|Overall Study||42
10924927|NCT00246376|12092919|FG000|COMPLETED|Overall Study||26
10924928|NCT00246376|12092920|FG001|COMPLETED|Overall Study||24
10924929|NCT00246376|12092921|FG002|COMPLETED|Overall Study||29
10924930|NCT00246376|12092922|FG003|COMPLETED|Overall Study||21
10924931|NCT00246376|12092923|FG004|COMPLETED|Overall Study||28
10924932|NCT00246376|12092919|FG000|NOT COMPLETED|Overall Study||15
10924933|NCT00246376|12092920|FG001|NOT COMPLETED|Overall Study||19
10924934|NCT00246376|12092921|FG002|NOT COMPLETED|Overall Study||16
10924935|NCT00246376|12092922|FG003|NOT COMPLETED|Overall Study||26
10924936|NCT00246376|12092923|FG004|NOT COMPLETED|Overall Study||17
10924937|NCT00246441|12092943|FG000|STARTED|Overall Study||20
10924938|NCT00246441|12092944|FG001|STARTED|Overall Study||22
10924939|NCT00246441|12092943|FG000|COMPLETED|Overall Study||19
10924940|NCT00246441|12092944|FG001|COMPLETED|Overall Study||22
10924941|NCT00246441|12092943|FG000|NOT COMPLETED|Overall Study||1
10924942|NCT00246441|12092944|FG001|NOT COMPLETED|Overall Study||0
10924943|NCT00246519|12092952|FG000|STARTED|Overall Study||442
10924944|NCT00246519|12092953|FG001|STARTED|Overall Study||446
10924945|NCT00246519|12092952|FG000|COMPLETED|Overall Study||386
10924946|NCT00246519|12092953|FG001|COMPLETED|Overall Study||382
10924947|NCT00246519|12092952|FG000|NOT COMPLETED|Overall Study||56
10924948|NCT00246519|12092953|FG001|NOT COMPLETED|Overall Study||64
10924949|NCT00246571|12092961|FG000|STARTED|Overall Study||113
10924950|NCT00246571|12092962|FG001|STARTED|Overall Study||104
10924951|NCT00246571|12092961|FG000|Randomized But Not Treated|Overall Study||3
10924952|NCT00246571|12092962|FG001|Randomized But Not Treated|Overall Study||1
10924953|NCT00246571|12092961|FG000|COMPLETED|Overall Study||0
10924954|NCT00246571|12092962|FG001|COMPLETED|Overall Study||0
10924955|NCT00246571|12092961|FG000|NOT COMPLETED|Overall Study||113
10924956|NCT00246571|12092962|FG001|NOT COMPLETED|Overall Study||104
10924957|NCT00246740|12092970|FG000|STARTED|Initial Enrollment||28
10924958|NCT00246740|12092971|FG001|STARTED|Initial Enrollment||28
10924959|NCT00246740|12092970|FG000|COMPLETED|Initial Enrollment||22
10924960|NCT00246740|12092971|FG001|COMPLETED|Initial Enrollment||20
10924961|NCT00246740|12092970|FG000|NOT COMPLETED|Initial Enrollment||6
10924962|NCT00246740|12092971|FG001|NOT COMPLETED|Initial Enrollment||8
10924963|NCT00246740|12092970|FG000|STARTED|Experimental Phase||22
10924964|NCT00246740|12092971|FG001|STARTED|Experimental Phase||20
10924965|NCT00246740|12092970|FG000|COMPLETED|Experimental Phase||22
10924966|NCT00246740|12092971|FG001|COMPLETED|Experimental Phase||20
10924967|NCT00246740|12092970|FG000|NOT COMPLETED|Experimental Phase||0
10924968|NCT00246740|12092971|FG001|NOT COMPLETED|Experimental Phase||0
10924969|NCT00246753|12092977|FG000|STARTED|Overall Study||29
10924970|NCT00246753|12092977|FG000|COMPLETED|Overall Study||21
10924971|NCT00246753|12092977|FG000|NOT COMPLETED|Overall Study||8
10924972|NCT00246805|12092983|FG000|STARTED|Phase 1||34
10924973|NCT00246805|12092984|FG001|STARTED|Phase 1||33
10924974|NCT00246805|12092983|FG000|COMPLETED|Phase 1||33
10924975|NCT00246805|12092984|FG001|COMPLETED|Phase 1||33
10924976|NCT00246805|12092983|FG000|NOT COMPLETED|Phase 1||1
10924977|NCT00246805|12092984|FG001|NOT COMPLETED|Phase 1||0
10924978|NCT00246805|12092983|FG000|STARTED|Phase 2||33
10924979|NCT00246805|12092984|FG001|STARTED|Phase 2||33
10924980|NCT00246805|12092983|FG000|COMPLETED|Phase 2||33
10924981|NCT00246805|12092984|FG001|COMPLETED|Phase 2||33
10924982|NCT00246805|12092983|FG000|NOT COMPLETED|Phase 2||0
10924983|NCT00246805|12092984|FG001|NOT COMPLETED|Phase 2||0
10924984|NCT00247273|12092992|FG000|STARTED|Overall Study||644
10924985|NCT00247273|12092993|FG001|STARTED|Overall Study||650
10924986|NCT00247273|12092992|FG000|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
10924987|NCT00247273|12092993|FG001|Intent to Treat Population|Overall Study||650
10924988|NCT00247273|12092992|FG000|COMPLETED|Overall Study||498
10924989|NCT00247273|12092993|FG001|COMPLETED|Overall Study||513
10924990|NCT00247273|12092992|FG000|NOT COMPLETED|Overall Study||146
10924991|NCT00247273|12092993|FG001|NOT COMPLETED|Overall Study||137
10924992|NCT00247377|12093001|FG000|STARTED|Overall Study||111
10924993|NCT00247377|12093002|FG001|STARTED|Overall Study||86
10924994|NCT00247377|12093001|FG000|COMPLETED|Overall Study||111
10924995|NCT00247377|12093002|FG001|COMPLETED|Overall Study||86
10924996|NCT00247377|12093001|FG000|NOT COMPLETED|Overall Study||0
10924997|NCT00247377|12093002|FG001|NOT COMPLETED|Overall Study||0
10924998|NCT00247416|12093010|FG000|STARTED|Overall Study||26
10924999|NCT00247416|12093011|FG001|STARTED|Overall Study||33
10925000|NCT00247416|12093010|FG000|COMPLETED|Overall Study||25
10925001|NCT00247416|12093011|FG001|COMPLETED|Overall Study||31
10925002|NCT00247416|12093010|FG000|NOT COMPLETED|Overall Study||1
10925003|NCT00247416|12093011|FG001|NOT COMPLETED|Overall Study||2
10925004|NCT00247611|12093021|FG000|STARTED|Baselined|Participants randomized|304
10925005|NCT00247611|12093022|FG001|STARTED|Baselined|Participants randomized|290
10925006|NCT00247611|12093021|FG000|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
10925007|NCT00247611|12093022|FG001|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
10925008|NCT00247611|12093021|FG000|NOT COMPLETED|Baselined||17
10925009|NCT00247611|12093022|FG001|NOT COMPLETED|Baselined||13
10925010|NCT00247611|12093021|FG000|STARTED|Intention to Treat Sample|Participants randomized|304
10925011|NCT00247611|12093022|FG001|STARTED|Intention to Treat Sample|Participants randomized|290
10925012|NCT00247611|12093021|FG000|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
10925013|NCT00247611|12093022|FG001|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
10925014|NCT00247611|12093021|FG000|NOT COMPLETED|Intention to Treat Sample||17
10925015|NCT00247611|12093022|FG001|NOT COMPLETED|Intention to Treat Sample||13
10925016|NCT00247611|12093021|FG000|STARTED|On Protocol Sample|ITT sample participants|287
10925017|NCT00247611|12093022|FG001|STARTED|On Protocol Sample|ITT sample participants|277
10925018|NCT00247611|12093021|FG000|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
10925019|NCT00247611|12093022|FG001|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
10925020|NCT00247611|12093021|FG000|NOT COMPLETED|On Protocol Sample||111
10925021|NCT00247611|12093022|FG001|NOT COMPLETED|On Protocol Sample||125
10925022|NCT00247624|12093036|FG000|STARTED|Overall Study||30
10925023|NCT00247624|12093037|FG001|STARTED|Overall Study||30
10925024|NCT00247624|12093036|FG000|COMPLETED|Overall Study||25
10925025|NCT00247624|12093037|FG001|COMPLETED|Overall Study||26
10925026|NCT00247624|12093036|FG000|NOT COMPLETED|Overall Study||5
10925027|NCT00247624|12093037|FG001|NOT COMPLETED|Overall Study||4
10925028|NCT00247676|12093043|FG000|STARTED|Overall Study||37
10925029|NCT00247676|12093043|FG000|COMPLETED|Overall Study||1
10925030|NCT00247676|12093043|FG000|NOT COMPLETED|Overall Study||36
10925031|NCT00247962|12093049|FG000|STARTED|Overall Study||379
10925032|NCT00247962|12093050|FG001|STARTED|Overall Study||187
10925033|NCT00247962|12093049|FG000|COMPLETED|Overall Study||353
10925034|NCT00247962|12093050|FG001|COMPLETED|Overall Study||168
10925035|NCT00247962|12093049|FG000|NOT COMPLETED|Overall Study||26
10925036|NCT00247962|12093050|FG001|NOT COMPLETED|Overall Study||19
10925037|NCT00248040|12093059|FG000|STARTED|Overall Study||25
10925038|NCT00248040|12093060|FG001|STARTED|Overall Study||23
10925039|NCT00248040|12093061|FG002|STARTED|Overall Study||26
10925040|NCT00248040|12093059|FG000|COMPLETED|Overall Study||22
10925041|NCT00248040|12093060|FG001|COMPLETED|Overall Study||22
10925042|NCT00248040|12093061|FG002|COMPLETED|Overall Study||22
10925043|NCT00248040|12093059|FG000|NOT COMPLETED|Overall Study||3
10925044|NCT00248040|12093060|FG001|NOT COMPLETED|Overall Study||1
10925045|NCT00248040|12093061|FG002|NOT COMPLETED|Overall Study||4
10925046|NCT00248170|12093072|FG000|STARTED|Overall Study||2078
10925047|NCT00248170|12093073|FG001|STARTED|Overall Study||2094
10925048|NCT00248170|12093072|FG000|Intent-to-treat (ITT)|Overall Study||2061
10925049|NCT00248170|12093073|FG001|Intent-to-treat (ITT)|Overall Study||2075
10925050|NCT00248170|12093072|FG000|Safety Set|Overall Study||2049
10925051|NCT00248170|12093073|FG001|Safety Set|Overall Study||2062
10925052|NCT00248170|12093072|FG000|COMPLETED|Overall Study||1317
10925053|NCT00248170|12093073|FG001|COMPLETED|Overall Study||1286
10925054|NCT00248170|12093072|FG000|NOT COMPLETED|Overall Study||761
10925055|NCT00248170|12093073|FG001|NOT COMPLETED|Overall Study||808
10925056|NCT00248495|12093079|FG000|STARTED|Overall Study||38
10925057|NCT00248495|12093079|FG000|COMPLETED|Overall Study||37
10925058|NCT00248495|12093079|FG000|NOT COMPLETED|Overall Study||1
10925059|NCT00248534|12093083|FG000|STARTED|Overall Study||16
10925060|NCT00248534|12093083|FG000|COMPLETED|Overall Study||16
10925061|NCT00248534|12093083|FG000|NOT COMPLETED|Overall Study||0
10925062|NCT00248547|12093089|FG000|STARTED|Overall Study||20
10925063|NCT00248547|12093090|FG001|STARTED|Overall Study||20
10925064|NCT00248547|12093089|FG000|COMPLETED|Overall Study||20
10925065|NCT00248547|12093090|FG001|COMPLETED|Overall Study||20
10925066|NCT00248547|12093089|FG000|NOT COMPLETED|Overall Study||0
10925067|NCT00248547|12093090|FG001|NOT COMPLETED|Overall Study||0
10925068|NCT00248560|12093096|FG000|STARTED|Overall Study||36
10925069|NCT00248560|12093096|FG000|COMPLETED|Overall Study||36
10925070|NCT00248560|12093096|FG000|NOT COMPLETED|Overall Study||0
10925071|NCT00248612|12093105|FG000|STARTED|Overall Study||24
10925072|NCT00248612|12093106|FG001|STARTED|Overall Study||21
10925073|NCT00248612|12093107|FG002|STARTED|Overall Study||14
10925074|NCT00248612|12093108|FG003|STARTED|Overall Study||22
10925075|NCT00248612|12093105|FG000|COMPLETED|Overall Study||24
10925076|NCT00248612|12093106|FG001|COMPLETED|Overall Study||21
10925077|NCT00248612|12093107|FG002|COMPLETED|Overall Study||14
10925078|NCT00248612|12093108|FG003|COMPLETED|Overall Study||22
10925079|NCT00248612|12093105|FG000|NOT COMPLETED|Overall Study||0
10925080|NCT00248612|12093106|FG001|NOT COMPLETED|Overall Study||0
10925081|NCT00248612|12093107|FG002|NOT COMPLETED|Overall Study||0
10925082|NCT00248612|12093108|FG003|NOT COMPLETED|Overall Study||0
10925083|NCT00248625|12093122|FG000|STARTED|Overall Study||92
10925084|NCT00248625|12093123|FG001|STARTED|Overall Study||92
10925085|NCT00248625|12093122|FG000|COMPLETED|Overall Study||92
10925086|NCT00248625|12093123|FG001|COMPLETED|Overall Study||90
10925087|NCT00248625|12093122|FG000|NOT COMPLETED|Overall Study||0
10925088|NCT00248625|12093123|FG001|NOT COMPLETED|Overall Study||2
10925089|NCT00248638|12093131|FG000|STARTED|Overall Study||75
10925090|NCT00248638|12093132|FG001|STARTED|Overall Study||75
10925091|NCT00248638|12093131|FG000|COMPLETED|Overall Study||75
10925092|NCT00248638|12093132|FG001|COMPLETED|Overall Study||75
10925093|NCT00248638|12093131|FG000|NOT COMPLETED|Overall Study||0
10925094|NCT00248638|12093132|FG001|NOT COMPLETED|Overall Study||0
10925095|NCT00248651|12093143|FG000|STARTED|Overall Study||97
10925096|NCT00248651|12093144|FG001|STARTED|Overall Study||98
10925097|NCT00248651|12093145|FG002|STARTED|Overall Study||97
10925098|NCT00248651|12093143|FG000|Completed 12 Weeks of Treatment|Overall Study||78
10925099|NCT00248651|12093144|FG001|Completed 12 Weeks of Treatment|Overall Study||66
10925100|NCT00248651|12093145|FG002|Completed 12 Weeks of Treatment|Overall Study||75
10925101|NCT00248651|12093143|FG000|COMPLETED|Overall Study||69
10925102|NCT00248651|12093144|FG001|COMPLETED|Overall Study||58
10925103|NCT00248651|12093145|FG002|COMPLETED|Overall Study||65
10925104|NCT00248651|12093143|FG000|NOT COMPLETED|Overall Study||28
10925105|NCT00248651|12093144|FG001|NOT COMPLETED|Overall Study||40
10925106|NCT00248651|12093145|FG002|NOT COMPLETED|Overall Study||32
10925107|NCT00248781|12093155|FG000|STARTED|Overall Study||52
10925108|NCT00248781|12093156|FG001|STARTED|Overall Study||51
10925109|NCT00248781|12093155|FG000|COMPLETED|Overall Study||42
10925110|NCT00248781|12093156|FG001|COMPLETED|Overall Study||47
10925111|NCT00248781|12093155|FG000|NOT COMPLETED|Overall Study||10
10925112|NCT00248781|12093156|FG001|NOT COMPLETED|Overall Study||4
10925113|NCT00248794|12093165|FG000|STARTED|Overall Study||25
10925114|NCT00248794|12093166|FG001|STARTED|Overall Study||24
10925115|NCT00248794|12093167|FG002|STARTED|Overall Study||10
10925116|NCT00248794|12093165|FG000|COMPLETED|Overall Study||19
10925117|NCT00248794|12093166|FG001|COMPLETED|Overall Study||16
10925118|NCT00248794|12093167|FG002|COMPLETED|Overall Study||7
10925119|NCT00248794|12093165|FG000|NOT COMPLETED|Overall Study||6
10925120|NCT00248794|12093166|FG001|NOT COMPLETED|Overall Study||8
10925121|NCT00248794|12093167|FG002|NOT COMPLETED|Overall Study||3
10925122|NCT00248807|12093183|FG000|STARTED|Overall Study||19
10925123|NCT00248807|12093184|FG001|STARTED|Overall Study||11
10925124|NCT00248807|12093183|FG000|COMPLETED|Overall Study||19
10925125|NCT00248807|12093184|FG001|COMPLETED|Overall Study||11
10925126|NCT00248807|12093183|FG000|NOT COMPLETED|Overall Study||0
10925127|NCT00248807|12093184|FG001|NOT COMPLETED|Overall Study||0
10925128|NCT00248833|12093199|FG000|STARTED|Overall Study||12
10925129|NCT00248833|12093200|FG001|STARTED|Overall Study||11
10925130|NCT00248833|12093201|FG002|STARTED|Overall Study||11
10925131|NCT00248833|12093199|FG000|COMPLETED|Overall Study||9
10925132|NCT00248833|12093200|FG001|COMPLETED|Overall Study||8
10925133|NCT00248833|12093201|FG002|COMPLETED|Overall Study||9
10925134|NCT00248833|12093199|FG000|NOT COMPLETED|Overall Study||3
10925135|NCT00248833|12093200|FG001|NOT COMPLETED|Overall Study||3
10925136|NCT00248833|12093201|FG002|NOT COMPLETED|Overall Study||2
10925137|NCT00249002|12093211|FG000|STARTED|Overall Study||9
10925138|NCT00249002|12093211|FG000|COMPLETED|Overall Study||2
10925139|NCT00249002|12093211|FG000|NOT COMPLETED|Overall Study||7
10925140|NCT00249249|12093219|FG000|STARTED|Overall Study||321
10925141|NCT00249249|12093220|FG001|STARTED|Overall Study||103
10925142|NCT00249249|12093221|FG002|STARTED|Overall Study||303
10925143|NCT00249249|12093222|FG003|STARTED|Overall Study||103
10925144|NCT00249249|12093219|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
10925145|NCT00249249|12093220|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
10925146|NCT00249249|12093221|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
10925147|NCT00249249|12093222|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
10925148|NCT00249249|12093219|FG000|COMPLETED|Overall Study||301
10925149|NCT00249249|12093220|FG001|COMPLETED|Overall Study||98
10925150|NCT00249249|12093221|FG002|COMPLETED|Overall Study||288
10925151|NCT00249249|12093222|FG003|COMPLETED|Overall Study||100
10925152|NCT00249249|12093219|FG000|NOT COMPLETED|Overall Study||20
10925153|NCT00249249|12093220|FG001|NOT COMPLETED|Overall Study||5
10925154|NCT00249249|12093221|FG002|NOT COMPLETED|Overall Study||15
10925155|NCT00249249|12093222|FG003|NOT COMPLETED|Overall Study||3
10925156|NCT00249288|12093234|FG000|STARTED|Overall Study||19
10925157|NCT00249288|12093235|FG001|STARTED|Overall Study||19
10925158|NCT00249288|12093234|FG000|Initiated Treatment|Overall Study||17
10925159|NCT00249288|12093235|FG001|Initiated Treatment|Overall Study||15
10925160|NCT00249288|12093234|FG000|COMPLETED|Overall Study||14
10925161|NCT00249288|12093235|FG001|COMPLETED|Overall Study||14
10925162|NCT00249288|12093234|FG000|NOT COMPLETED|Overall Study||5
10925163|NCT00249288|12093235|FG001|NOT COMPLETED|Overall Study||5
10925164|NCT00249379|12093251|FG000|STARTED|Overall Study||14
10925165|NCT00249379|12093252|FG001|STARTED|Overall Study||12
10925166|NCT00249379|12093251|FG000|COMPLETED|Overall Study||6
10925167|NCT00249379|12093252|FG001|COMPLETED|Overall Study||4
10925168|NCT00249379|12093251|FG000|NOT COMPLETED|Overall Study||8
10925169|NCT00249379|12093252|FG001|NOT COMPLETED|Overall Study||8
10925170|NCT00249444|12093260|FG000|STARTED|Overall Study||42
10925171|NCT00249444|12093261|FG001|STARTED|Overall Study||44
10925172|NCT00249444|12093260|FG000|COMPLETED|Overall Study||30
10925173|NCT00249444|12093261|FG001|COMPLETED|Overall Study||29
10925174|NCT00249444|12093260|FG000|NOT COMPLETED|Overall Study||12
10925175|NCT00249444|12093261|FG001|NOT COMPLETED|Overall Study||15
10925176|NCT00249470|12093269|FG000|STARTED|Overall Study||28
10925177|NCT00249470|12093270|FG001|STARTED|Overall Study||28
10925178|NCT00249470|12093269|FG000|COMPLETED|Overall Study||28
10925179|NCT00249470|12093270|FG001|COMPLETED|Overall Study||28
10925180|NCT00249470|12093269|FG000|NOT COMPLETED|Overall Study||0
10925181|NCT00249470|12093270|FG001|NOT COMPLETED|Overall Study||0
10925182|NCT00249496|12093278|FG000|STARTED|Overall Study||24
10925183|NCT00249496|12093279|FG001|STARTED|Overall Study||27
10925184|NCT00249496|12093278|FG000|COMPLETED|Overall Study||24
10925185|NCT00249496|12093279|FG001|COMPLETED|Overall Study||26
10925186|NCT00249496|12093278|FG000|NOT COMPLETED|Overall Study||0
10925187|NCT00249496|12093279|FG001|NOT COMPLETED|Overall Study||1
10925188|NCT00249613|12093289|FG000|STARTED|Baseline||152
10925189|NCT00249613|12093290|FG001|STARTED|Baseline||139
10925190|NCT00249613|12093289|FG000|COMPLETED|Baseline||152
10925191|NCT00249613|12093290|FG001|COMPLETED|Baseline||139
10925192|NCT00249613|12093289|FG000|NOT COMPLETED|Baseline||0
10925193|NCT00249613|12093290|FG001|NOT COMPLETED|Baseline||0
10925194|NCT00249613|12093289|FG000|STARTED|12 Month Follow-up||152
10925195|NCT00249613|12093290|FG001|STARTED|12 Month Follow-up||139
10925196|NCT00249613|12093289|FG000|COMPLETED|12 Month Follow-up||135
10925197|NCT00249613|12093290|FG001|COMPLETED|12 Month Follow-up||124
10925198|NCT00249613|12093289|FG000|NOT COMPLETED|12 Month Follow-up||17
10925199|NCT00249613|12093290|FG001|NOT COMPLETED|12 Month Follow-up||15
10925200|NCT00249769|12093302|FG000|STARTED|Overall Study||100
10925201|NCT00249769|12093303|FG001|STARTED|Overall Study||250
10925202|NCT00249769|12093304|FG002|STARTED|Overall Study||250
10925203|NCT00249769|12093302|FG000|Received LJEV|Overall Study||100
10925204|NCT00249769|12093303|FG001|Received LJEV|Overall Study||236
10925205|NCT00249769|12093304|FG002|Received LJEV|Overall Study||224
10925206|NCT00249769|12093302|FG000|Received Measles Vaccine|Overall Study||97
10925207|NCT00249769|12093303|FG001|Received Measles Vaccine|Overall Study||236
10925208|NCT00249769|12093304|FG002|Received Measles Vaccine|Overall Study||235
10925209|NCT00249769|12093302|FG000|COMPLETED|Overall Study||98
10925210|NCT00249769|12093303|FG001|COMPLETED|Overall Study||235
10925211|NCT00249769|12093304|FG002|COMPLETED|Overall Study||222
10925212|NCT00249769|12093302|FG000|NOT COMPLETED|Overall Study||2
10925213|NCT00249769|12093303|FG001|NOT COMPLETED|Overall Study||15
10925214|NCT00249769|12093304|FG002|NOT COMPLETED|Overall Study||28
10925215|NCT00249795|12093314|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
10925216|NCT00249795|12093315|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
10925217|NCT00249795|12093314|FG000|COMPLETED|Overall Study|started and completed study drug|3124
10925218|NCT00249795|12093315|FG001|COMPLETED|Overall Study|started and completed study drug|3108
10925219|NCT00249795|12093314|FG000|NOT COMPLETED|Overall Study||1394
10925220|NCT00249795|12093315|FG001|NOT COMPLETED|Overall Study||1390
10925221|NCT00249808|12093321|FG000|STARTED|Overall Study||1266
10925222|NCT00249808|12093321|FG000|COMPLETED|Overall Study||1084
10925223|NCT00249808|12093321|FG000|NOT COMPLETED|Overall Study||182
10925224|NCT00249821|12093327|FG000|STARTED|Overall Study||10
10925225|NCT00249821|12093328|FG001|STARTED|Overall Study||12
10925226|NCT00249821|12093327|FG000|COMPLETED|Overall Study||10
10925227|NCT00249821|12093328|FG001|COMPLETED|Overall Study||11
10925228|NCT00249821|12093327|FG000|NOT COMPLETED|Overall Study||0
10925229|NCT00249821|12093328|FG001|NOT COMPLETED|Overall Study||1
10925230|NCT00249834|12093342|FG000|STARTED|Overall Study||1
10925231|NCT00249834|12093343|FG001|STARTED|Overall Study||48
10925232|NCT00249834|12093344|FG002|STARTED|Overall Study||45
10925233|NCT00249834|12093345|FG003|STARTED|Overall Study||34
10925234|NCT00249834|12093346|FG004|STARTED|Overall Study||24
10925235|NCT00249834|12093347|FG005|STARTED|Overall Study||10
10925236|NCT00249834|12093348|FG006|STARTED|Overall Study||2
10925237|NCT00249834|12093349|FG007|STARTED|Overall Study||2
10925238|NCT00249834|12093342|FG000|COMPLETED|Overall Study||0
10925239|NCT00249834|12093343|FG001|COMPLETED|Overall Study||29
10925240|NCT00249834|12093344|FG002|COMPLETED|Overall Study||31
10925241|NCT00249834|12093345|FG003|COMPLETED|Overall Study||26
10925242|NCT00249834|12093346|FG004|COMPLETED|Overall Study||19
10925243|NCT00249834|12093347|FG005|COMPLETED|Overall Study||8
10925244|NCT00249834|12093348|FG006|COMPLETED|Overall Study||1
10925245|NCT00249834|12093349|FG007|COMPLETED|Overall Study||2
10925246|NCT00249834|12093342|FG000|NOT COMPLETED|Overall Study||1
10925247|NCT00249834|12093343|FG001|NOT COMPLETED|Overall Study||19
10925248|NCT00249834|12093344|FG002|NOT COMPLETED|Overall Study||14
10925249|NCT00249834|12093345|FG003|NOT COMPLETED|Overall Study||8
10925250|NCT00249834|12093346|FG004|NOT COMPLETED|Overall Study||5
10925251|NCT00249834|12093347|FG005|NOT COMPLETED|Overall Study||2
10925252|NCT00249834|12093348|FG006|NOT COMPLETED|Overall Study||1
10925253|NCT00249834|12093349|FG007|NOT COMPLETED|Overall Study||0
10925254|NCT00249873|12093363|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
10925255|NCT00249873|12093364|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
10925256|NCT00249873|12093363|FG000|COMPLETED|Overall Study|started and completed study drug|2442
10925257|NCT00249873|12093364|FG001|COMPLETED|Overall Study|started and completed study drug|2528
10925258|NCT00249873|12093363|FG000|NOT COMPLETED|Overall Study||1330
10925259|NCT00249873|12093364|FG001|NOT COMPLETED|Overall Study||1254
10925260|NCT00250276|12093374|FG000|STARTED|Overall Study||199
10925261|NCT00250276|12093375|FG001|STARTED|Overall Study||198
10925262|NCT00250276|12093376|FG002|STARTED|Overall Study||201
10925263|NCT00250276|12093377|FG003|STARTED|Overall Study||200
10925264|NCT00250276|12093374|FG000|COMPLETED|Overall Study||182
10925265|NCT00250276|12093375|FG001|COMPLETED|Overall Study||177
10925266|NCT00250276|12093376|FG002|COMPLETED|Overall Study||182
10925267|NCT00250276|12093377|FG003|COMPLETED|Overall Study||181
10925268|NCT00250276|12093374|FG000|NOT COMPLETED|Overall Study||17
10925269|NCT00250276|12093375|FG001|NOT COMPLETED|Overall Study||21
10925270|NCT00250276|12093376|FG002|NOT COMPLETED|Overall Study||19
10925271|NCT00250276|12093377|FG003|NOT COMPLETED|Overall Study||19
10925272|NCT00250432|12093394|FG000|STARTED|Overall Study||104
10925273|NCT00250432|12093395|FG001|STARTED|Overall Study||100
10925274|NCT00250432|12093394|FG000|COMPLETED|Overall Study||59
10925275|NCT00250432|12093395|FG001|COMPLETED|Overall Study||53
10925276|NCT00250432|12093394|FG000|NOT COMPLETED|Overall Study||45
10925277|NCT00250432|12093395|FG001|NOT COMPLETED|Overall Study||47
10925278|NCT00250484|12093403|FG000|STARTED|Overall Study||9
10925279|NCT00250484|12093404|FG001|STARTED|Overall Study||8
10925280|NCT00250484|12093403|FG000|COMPLETED|Overall Study||9
10925281|NCT00250484|12093404|FG001|COMPLETED|Overall Study||8
10925282|NCT00250484|12093403|FG000|NOT COMPLETED|Overall Study||0
10925283|NCT00250484|12093404|FG001|NOT COMPLETED|Overall Study||0
10925284|NCT00250497|12093412|FG000|STARTED|Overall Study||182
10925285|NCT00250497|12093413|FG001|STARTED|Overall Study||174
10925286|NCT00250497|12093412|FG000|COMPLETED|Overall Study||177
10925287|NCT00250497|12093413|FG001|COMPLETED|Overall Study||159
10925288|NCT00250497|12093412|FG000|NOT COMPLETED|Overall Study||5
10925289|NCT00250497|12093413|FG001|NOT COMPLETED|Overall Study||15
10925290|NCT00250588|12093422|FG000|STARTED|Overall Study||81
10925291|NCT00250588|12093423|FG001|STARTED|Overall Study||84
10925292|NCT00250588|12093424|FG002|STARTED|Overall Study||87
10925293|NCT00250588|12093422|FG000|COMPLETED|Overall Study||72
10925294|NCT00250588|12093423|FG001|COMPLETED|Overall Study||65
10925295|NCT00250588|12093424|FG002|COMPLETED|Overall Study||74
10925296|NCT00250588|12093422|FG000|NOT COMPLETED|Overall Study||9
10925297|NCT00250588|12093423|FG001|NOT COMPLETED|Overall Study||19
10925298|NCT00250588|12093424|FG002|NOT COMPLETED|Overall Study||13
10925299|NCT00250679|12093435|FG000|STARTED|Overall Study||147
10925300|NCT00250679|12093436|FG001|STARTED|Overall Study||149
10925301|NCT00250679|12093437|FG002|STARTED|Overall Study||147
10925302|NCT00250679|12093435|FG000|COMPLETED|Overall Study||108
10925303|NCT00250679|12093436|FG001|COMPLETED|Overall Study||100
10925304|NCT00250679|12093437|FG002|COMPLETED|Overall Study||103
10925305|NCT00250679|12093435|FG000|NOT COMPLETED|Overall Study||39
10925306|NCT00250679|12093436|FG001|NOT COMPLETED|Overall Study||49
10925307|NCT00250679|12093437|FG002|NOT COMPLETED|Overall Study||44
10925308|NCT00250705|12093445|FG000|STARTED|Overall Study||12
10925309|NCT00250705|12093445|FG000|COMPLETED|Overall Study||10
10925310|NCT00250705|12093445|FG000|NOT COMPLETED|Overall Study||2
10925311|NCT00250835|12093451|FG000|STARTED|Overall Study||38
10925312|NCT00250835|12093451|FG000|COMPLETED|Overall Study||37
10925313|NCT00250835|12093451|FG000|NOT COMPLETED|Overall Study||1
10925314|NCT00250926|12093455|FG000|STARTED|Overall Study||23
10925315|NCT00250926|12093455|FG000|COMPLETED|Overall Study||23
10925316|NCT00250926|12093455|FG000|NOT COMPLETED|Overall Study||0
10925317|NCT00251004|12093463|FG000|STARTED|Overall Study||277
10925318|NCT00251004|12093464|FG001|STARTED|Overall Study||279
10925319|NCT00251004|12093465|FG002|STARTED|Overall Study||277
10925320|NCT00251004|12093463|FG000|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
10925321|NCT00251004|12093464|FG001|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
10925322|NCT00251004|12093465|FG002|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
10925323|NCT00251004|12093463|FG000|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
10925324|NCT00251004|12093464|FG001|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
10925325|NCT00251004|12093465|FG002|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
10925326|NCT00251004|12093463|FG000|COMPLETED|Overall Study||232
10925327|NCT00251004|12093464|FG001|COMPLETED|Overall Study||238
10925328|NCT00251004|12093465|FG002|COMPLETED|Overall Study||246
10925329|NCT00251004|12093463|FG000|NOT COMPLETED|Overall Study||45
10925330|NCT00251004|12093464|FG001|NOT COMPLETED|Overall Study||41
10925331|NCT00251004|12093465|FG002|NOT COMPLETED|Overall Study||31
10925332|NCT00251225|12093473|FG000|STARTED|Overall Study||49
10925333|NCT00251225|12093473|FG000|COMPLETED|Overall Study||49
10925334|NCT00251225|12093473|FG000|NOT COMPLETED|Overall Study||0
10925335|NCT00251238|12093479|FG000|STARTED|Overall Study||21
10925336|NCT00251238|12093480|FG001|STARTED|Overall Study||20
10925337|NCT00251238|12093479|FG000|COMPLETED|Overall Study||21
10925338|NCT00251238|12093480|FG001|COMPLETED|Overall Study||20
10925339|NCT00251238|12093479|FG000|NOT COMPLETED|Overall Study||0
10925340|NCT00251238|12093480|FG001|NOT COMPLETED|Overall Study||0
10925341|NCT00251303|12093488|FG000|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
10925342|NCT00251303|12093489|FG001|STARTED|Overall Study||30
10925343|NCT00251303|12093488|FG000|COMPLETED|Overall Study||22
10925344|NCT00251303|12093489|FG001|COMPLETED|Overall Study||29
10925345|NCT00251303|12093488|FG000|NOT COMPLETED|Overall Study||8
10925346|NCT00251303|12093489|FG001|NOT COMPLETED|Overall Study||1
10925347|NCT00251316|12093499|FG000|STARTED|Overall Study||17
10925348|NCT00251316|12093500|FG001|STARTED|Overall Study||17
10925349|NCT00251316|12093499|FG000|COMPLETED|Overall Study||15
10925350|NCT00251316|12093500|FG001|COMPLETED|Overall Study||14
10925351|NCT00251316|12093499|FG000|NOT COMPLETED|Overall Study||2
10925352|NCT00251316|12093500|FG001|NOT COMPLETED|Overall Study||3
10925353|NCT00251589|12093510|FG000|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
10925354|NCT00251589|12093511|FG001|STARTED|Overall Study||3
10925355|NCT00251589|12093512|FG002|STARTED|Overall Study||2
10925356|NCT00251589|12093513|FG003|STARTED|Overall Study||2
10925357|NCT00251589|12093510|FG000|COMPLETED|Overall Study||1
10925358|NCT00251589|12093511|FG001|COMPLETED|Overall Study||0
10925359|NCT00251589|12093512|FG002|COMPLETED|Overall Study||0
10925360|NCT00251589|12093513|FG003|COMPLETED|Overall Study||0
10925361|NCT00251589|12093510|FG000|NOT COMPLETED|Overall Study||15
10925362|NCT00251589|12093511|FG001|NOT COMPLETED|Overall Study||3
10925363|NCT00251589|12093512|FG002|NOT COMPLETED|Overall Study||2
10925364|NCT00251589|12093513|FG003|NOT COMPLETED|Overall Study||2
10925365|NCT00251641|12093525|FG000|STARTED|Overall Study||653
10925366|NCT00251641|12093526|FG001|STARTED|Overall Study||215
10925367|NCT00251641|12093525|FG000|COMPLETED|Overall Study||541
10925368|NCT00251641|12093526|FG001|COMPLETED|Overall Study||127
10925369|NCT00251641|12093525|FG000|NOT COMPLETED|Overall Study||112
10925370|NCT00251641|12093526|FG001|NOT COMPLETED|Overall Study||88
10925371|NCT00251693|12093537|FG000|STARTED|Overall Study||680
10925372|NCT00251693|12093538|FG001|STARTED|Overall Study||668
10925373|NCT00251693|12093539|FG002|STARTED|Overall Study||690
10925374|NCT00251693|12093537|FG000|COMPLETED|Overall Study||629
10925375|NCT00251693|12093538|FG001|COMPLETED|Overall Study||624
10925376|NCT00251693|12093539|FG002|COMPLETED|Overall Study||644
10925377|NCT00251693|12093537|FG000|NOT COMPLETED|Overall Study||51
10925378|NCT00251693|12093538|FG001|NOT COMPLETED|Overall Study||44
10925379|NCT00251693|12093539|FG002|NOT COMPLETED|Overall Study||46
10925380|NCT00251719|12093550|FG000|STARTED|Overall Study||694
10925381|NCT00251719|12093551|FG001|STARTED|Overall Study||687
10925382|NCT00251719|12093552|FG002|STARTED|Overall Study||673
10925383|NCT00251719|12093550|FG000|COMPLETED|Overall Study||641
10925384|NCT00251719|12093551|FG001|COMPLETED|Overall Study||642
10925385|NCT00251719|12093552|FG002|COMPLETED|Overall Study||643
10925386|NCT00251719|12093550|FG000|NOT COMPLETED|Overall Study||53
10925387|NCT00251719|12093551|FG001|NOT COMPLETED|Overall Study||45
10925388|NCT00251719|12093552|FG002|NOT COMPLETED|Overall Study||30
10925389|NCT00251745|12093563|FG000|STARTED|Overall Study||292
10925390|NCT00251745|12093564|FG001|STARTED|Overall Study||312
10925391|NCT00251745|12093565|FG002|STARTED|Overall Study||304
10925392|NCT00251745|12093563|FG000|COMPLETED|Overall Study||264
10925393|NCT00251745|12093564|FG001|COMPLETED|Overall Study||285
10925394|NCT00251745|12093565|FG002|COMPLETED|Overall Study||277
10925395|NCT00251745|12093563|FG000|NOT COMPLETED|Overall Study||28
10925396|NCT00251745|12093564|FG001|NOT COMPLETED|Overall Study||27
10925397|NCT00251745|12093565|FG002|NOT COMPLETED|Overall Study||27
10925398|NCT00251758|12093576|FG000|STARTED|Overall Study||292
10925399|NCT00251758|12093577|FG001|STARTED|Overall Study||312
10925400|NCT00251758|12093578|FG002|STARTED|Overall Study||304
10925401|NCT00251758|12093576|FG000|COMPLETED|Overall Study||264
10925402|NCT00251758|12093577|FG001|COMPLETED|Overall Study||285
10925403|NCT00251758|12093578|FG002|COMPLETED|Overall Study||277
10925404|NCT00251758|12093576|FG000|NOT COMPLETED|Overall Study||28
10925405|NCT00251758|12093577|FG001|NOT COMPLETED|Overall Study||27
10925406|NCT00251758|12093578|FG002|NOT COMPLETED|Overall Study||27
10925407|NCT00251862|12093589|FG000|STARTED|Overall Study||280
10925408|NCT00251862|12093590|FG001|STARTED|Overall Study||269
10925409|NCT00251862|12093591|FG002|STARTED|Overall Study||276
10925410|NCT00251862|12093589|FG000|COMPLETED|Overall Study||280
10925411|NCT00251862|12093590|FG001|COMPLETED|Overall Study||269
10925412|NCT00251862|12093591|FG002|COMPLETED|Overall Study||276
10925413|NCT00251862|12093589|FG000|NOT COMPLETED|Overall Study||0
10925414|NCT00251862|12093590|FG001|NOT COMPLETED|Overall Study||0
10925415|NCT00251862|12093591|FG002|NOT COMPLETED|Overall Study||0
10925416|NCT00251927|12093601|FG000|STARTED|Overall Study|Randomised|288
10925417|NCT00251927|12093602|FG001|STARTED|Overall Study|Randomised|266
10925418|NCT00251927|12093601|FG000|COMPLETED|Overall Study|Completed 5 year visit|180
10925419|NCT00251927|12093602|FG001|COMPLETED|Overall Study|Completed 5 year visit|192
10925420|NCT00251927|12093601|FG000|NOT COMPLETED|Overall Study||108
10925421|NCT00251927|12093602|FG001|NOT COMPLETED|Overall Study||74
10925422|NCT00251979|12093611|FG000|STARTED|Overall Study|ITT population|375
10925423|NCT00251979|12093612|FG001|STARTED|Overall Study|ITT population|389
10925424|NCT00251979|12093611|FG000|COMPLETED|Overall Study||337
10925425|NCT00251979|12093612|FG001|COMPLETED|Overall Study||349
10925426|NCT00251979|12093611|FG000|NOT COMPLETED|Overall Study||38
10925427|NCT00251979|12093612|FG001|NOT COMPLETED|Overall Study||40
10925428|NCT00252057|12093620|FG000|STARTED|Overall Study||373
10925429|NCT00252057|12093621|FG001|STARTED|Overall Study||376
10925430|NCT00252057|12093620|FG000|COMPLETED|Overall Study||370
10925431|NCT00252057|12093621|FG001|COMPLETED|Overall Study||368
10925432|NCT00252057|12093620|FG000|NOT COMPLETED|Overall Study||3
10925433|NCT00252057|12093621|FG001|NOT COMPLETED|Overall Study||8
10925434|NCT00252187|12093629|FG000|STARTED|Overall Study||24
10925435|NCT00252187|12093630|FG001|STARTED|Overall Study||21
10925436|NCT00252187|12093629|FG000|COMPLETED|Overall Study||20
10925437|NCT00252187|12093630|FG001|COMPLETED|Overall Study||20
10925438|NCT00252187|12093629|FG000|NOT COMPLETED|Overall Study||4
10925439|NCT00252187|12093630|FG001|NOT COMPLETED|Overall Study||1
10925440|NCT00252239|12093640|FG000|STARTED|Overall Study||31
10925441|NCT00252239|12093641|FG001|STARTED|Overall Study||31
10925442|NCT00252239|12093642|FG002|STARTED|Overall Study||19
10925443|NCT00252239|12093643|FG003|STARTED|Overall Study||31
10925444|NCT00252239|12093640|FG000|COMPLETED|Overall Study||30
10925445|NCT00252239|12093641|FG001|COMPLETED|Overall Study||31
10925446|NCT00252239|12093642|FG002|COMPLETED|Overall Study||17
10925447|NCT00252239|12093643|FG003|COMPLETED|Overall Study||30
10925448|NCT00252239|12093640|FG000|NOT COMPLETED|Overall Study||1
10925449|NCT00252239|12093641|FG001|NOT COMPLETED|Overall Study||0
10925450|NCT00252239|12093642|FG002|NOT COMPLETED|Overall Study||2
10925451|NCT00252239|12093643|FG003|NOT COMPLETED|Overall Study||1
10925452|NCT00252382|12093653|FG000|STARTED|Overall Study||31
10925453|NCT00252382|12093653|FG000|COMPLETED|Overall Study||5
10925454|NCT00252382|12093653|FG000|NOT COMPLETED|Overall Study||26
10925455|NCT00252499|12093660|FG000|STARTED|Overall Study||5
10925456|NCT00252499|12093661|FG001|STARTED|Overall Study||2
10925457|NCT00252499|12093662|FG002|STARTED|Overall Study||6
10925458|NCT00252499|12093660|FG000|COMPLETED|Overall Study||4
10925459|NCT00252499|12093661|FG001|COMPLETED|Overall Study||2
10925460|NCT00252499|12093662|FG002|COMPLETED|Overall Study||6
10925461|NCT00252499|12093660|FG000|NOT COMPLETED|Overall Study||1
10925462|NCT00252499|12093661|FG001|NOT COMPLETED|Overall Study||0
10925463|NCT00252499|12093662|FG002|NOT COMPLETED|Overall Study||0
10925464|NCT00252512|12093672|FG000|STARTED|Intervention||165
10925465|NCT00252512|12093673|FG001|STARTED|Intervention||165
10925466|NCT00252512|12093672|FG000|COMPLETED|Intervention||136
10925467|NCT00252512|12093673|FG001|COMPLETED|Intervention||134
10925468|NCT00252512|12093672|FG000|NOT COMPLETED|Intervention||29
10925469|NCT00252512|12093673|FG001|NOT COMPLETED|Intervention||31
10925470|NCT00252512|12093672|FG000|STARTED|Six Month Follow up||136
10925471|NCT00252512|12093673|FG001|STARTED|Six Month Follow up||134
10925472|NCT00252512|12093672|FG000|COMPLETED|Six Month Follow up||132
10925473|NCT00252512|12093673|FG001|COMPLETED|Six Month Follow up||122
10925474|NCT00252512|12093672|FG000|NOT COMPLETED|Six Month Follow up||4
10925475|NCT00252512|12093673|FG001|NOT COMPLETED|Six Month Follow up||12
10925476|NCT00252512|12093672|FG000|STARTED|12 Month Follow up||132
10925477|NCT00252512|12093673|FG001|STARTED|12 Month Follow up||122
10925478|NCT00252512|12093672|FG000|COMPLETED|12 Month Follow up||123
10925479|NCT00252512|12093673|FG001|COMPLETED|12 Month Follow up||121
10925480|NCT00252512|12093672|FG000|NOT COMPLETED|12 Month Follow up||9
10925481|NCT00252512|12093673|FG001|NOT COMPLETED|12 Month Follow up||1
10925482|NCT00252538|12093679|FG000|STARTED|Overall Study||19
10925483|NCT00252538|12093680|FG001|STARTED|Overall Study||114
10925484|NCT00252538|12093679|FG000|COMPLETED|Overall Study||19
10925485|NCT00252538|12093680|FG001|COMPLETED|Overall Study||114
10925486|NCT00252538|12093679|FG000|NOT COMPLETED|Overall Study||0
10925487|NCT00252538|12093680|FG001|NOT COMPLETED|Overall Study||0
10925488|NCT00252564|12093687|FG000|STARTED|Overall Study|From randomization|124
10925489|NCT00252564|12093688|FG001|STARTED|Overall Study|From randomization|123
10925490|NCT00252564|12093687|FG000|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
10925491|NCT00252564|12093688|FG001|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
10925492|NCT00252564|12093687|FG000|NOT COMPLETED|Overall Study||39
10925493|NCT00252564|12093688|FG001|NOT COMPLETED|Overall Study||44
10925494|NCT00252577|12093694|FG000|STARTED|Overall Study||130
10925495|NCT00252577|12093694|FG000|COMPLETED|Overall Study||110
10925496|NCT00252577|12093694|FG000|NOT COMPLETED|Overall Study||20
10925497|NCT00252590|12093701|FG000|STARTED|Overall Study||35
10925498|NCT00252590|12093702|FG001|STARTED|Overall Study||30
10925499|NCT00252590|12093703|FG002|STARTED|Overall Study||34
10925500|NCT00252590|12093701|FG000|COMPLETED|Overall Study||33
10925501|NCT00252590|12093702|FG001|COMPLETED|Overall Study||28
10925502|NCT00252590|12093703|FG002|COMPLETED|Overall Study||31
10925503|NCT00252590|12093701|FG000|NOT COMPLETED|Overall Study||2
10925504|NCT00252590|12093702|FG001|NOT COMPLETED|Overall Study||2
10925505|NCT00252590|12093703|FG002|NOT COMPLETED|Overall Study||3
10925506|NCT00252629|12093714|FG000|STARTED|Overall Study||9
10925507|NCT00252629|12093715|FG001|STARTED|Overall Study||9
10925508|NCT00252629|12093716|FG002|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
10925509|NCT00252629|12093714|FG000|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
10925510|NCT00252629|12093715|FG001|COMPLETED|Overall Study||9
10925511|NCT00252629|12093716|FG002|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
10925512|NCT00252629|12093714|FG000|NOT COMPLETED|Overall Study||1
10925513|NCT00252629|12093715|FG001|NOT COMPLETED|Overall Study||0
10925514|NCT00252629|12093716|FG002|NOT COMPLETED|Overall Study||0
10925515|NCT00252694|12093731|FG000|STARTED|Overall Study||951
10925516|NCT00252694|12093732|FG001|STARTED|Overall Study||954
10925517|NCT00252694|12093731|FG000|COMPLETED|Overall Study||807
10925518|NCT00252694|12093732|FG001|COMPLETED|Overall Study||800
10925519|NCT00252694|12093731|FG000|NOT COMPLETED|Overall Study||144
10925520|NCT00252694|12093732|FG001|NOT COMPLETED|Overall Study||154
10925521|NCT00252720|12093740|FG000|STARTED|Overall Study||951
10925522|NCT00252720|12093741|FG001|STARTED|Overall Study||954
10925523|NCT00252720|12093740|FG000|COMPLETED|Overall Study||819
10925524|NCT00252720|12093741|FG001|COMPLETED|Overall Study||789
10925525|NCT00252720|12093740|FG000|NOT COMPLETED|Overall Study||132
10925526|NCT00252720|12093741|FG001|NOT COMPLETED|Overall Study||165
10925527|NCT00252733|12093749|FG000|STARTED|Overall Study||711
10925528|NCT00252733|12093750|FG001|STARTED|Overall Study||710
10925529|NCT00252733|12093749|FG000|COMPLETED|Overall Study||605
10925530|NCT00252733|12093750|FG001|COMPLETED|Overall Study||618
10925531|NCT00252733|12093749|FG000|NOT COMPLETED|Overall Study||106
10925532|NCT00252733|12093750|FG001|NOT COMPLETED|Overall Study||92
10925533|NCT00252967|12093758|FG000|STARTED|Overall Study||31
10925534|NCT00252967|12093759|FG001|STARTED|Overall Study||33
10925535|NCT00252967|12093758|FG000|COMPLETED|Overall Study||31
10925536|NCT00252967|12093759|FG001|COMPLETED|Overall Study||33
10925537|NCT00252967|12093758|FG000|NOT COMPLETED|Overall Study||0
10925538|NCT00252967|12093759|FG001|NOT COMPLETED|Overall Study||0
10925539|NCT00253019|12093768|FG000|STARTED|Overall Study||111
10925540|NCT00253019|12093769|FG001|STARTED|Overall Study||109
10925541|NCT00253019|12093770|FG002|STARTED|Overall Study||101
10925542|NCT00253019|12093768|FG000|COMPLETED|Overall Study||82
10925543|NCT00253019|12093769|FG001|COMPLETED|Overall Study||78
10925544|NCT00253019|12093770|FG002|COMPLETED|Overall Study||83
10925545|NCT00253019|12093768|FG000|NOT COMPLETED|Overall Study||29
10925546|NCT00253019|12093769|FG001|NOT COMPLETED|Overall Study||31
10925547|NCT00253019|12093770|FG002|NOT COMPLETED|Overall Study||18
10925548|NCT00253370|12093778|FG000|STARTED|Overall Study||44
10925549|NCT00253370|12093778|FG000|COMPLETED|Overall Study||1
10925550|NCT00253370|12093778|FG000|NOT COMPLETED|Overall Study||43
10925551|NCT00253435|12093785|FG000|STARTED|Overall Study|Total number is 42|42
10925552|NCT00253435|12093786|FG001|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
10925553|NCT00253435|12093785|FG000|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
10925554|NCT00253435|12093786|FG001|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
10925555|NCT00253435|12093785|FG000|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
10925556|NCT00253435|12093786|FG001|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
10925557|NCT00253435|12093785|FG000|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
10925558|NCT00253435|12093786|FG001|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
10925559|NCT00253435|12093785|FG000|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
10925560|NCT00253435|12093786|FG001|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
10925561|NCT00253435|12093785|FG000|NOT COMPLETED|Overall Study||0
10925562|NCT00253435|12093786|FG001|NOT COMPLETED|Overall Study||0
10925563|NCT00253448|12093792|FG000|STARTED|Overall Study||35
10925564|NCT00253448|12093792|FG000|COMPLETED|Overall Study||34
10925565|NCT00253448|12093792|FG000|NOT COMPLETED|Overall Study||1
10925566|NCT00253513|12093796|FG000|STARTED|Overall Study||60
10925567|NCT00253513|12093796|FG000|COMPLETED|Overall Study||60
10925568|NCT00253513|12093796|FG000|NOT COMPLETED|Overall Study||0
10925569|NCT00253630|12093800|FG000|STARTED|Overall Study||37
10925570|NCT00253630|12093800|FG000|COMPLETED|Overall Study||35
10925571|NCT00253630|12093800|FG000|NOT COMPLETED|Overall Study||2
10925572|NCT00253643|12093808|FG000|STARTED|Overall Study||14
10925573|NCT00253643|12093809|FG001|STARTED|Overall Study||15
10925574|NCT00253643|12093810|FG002|STARTED|Overall Study||29
10925575|NCT00253643|12093811|FG003|STARTED|Overall Study||31
10925576|NCT00253643|12093808|FG000|COMPLETED|Overall Study||14
10925577|NCT00253643|12093809|FG001|COMPLETED|Overall Study||15
10925578|NCT00253643|12093810|FG002|COMPLETED|Overall Study||28
10925579|NCT00253643|12093811|FG003|COMPLETED|Overall Study||28
10925580|NCT00253643|12093808|FG000|NOT COMPLETED|Overall Study||0
10925581|NCT00253643|12093809|FG001|NOT COMPLETED|Overall Study||0
10925582|NCT00253643|12093810|FG002|NOT COMPLETED|Overall Study||1
10925583|NCT00253643|12093811|FG003|NOT COMPLETED|Overall Study||3
10925584|NCT00253708|12093824|FG000|STARTED|Overall Study||20
10925585|NCT00253708|12093825|FG001|STARTED|Overall Study||10
10925586|NCT00253708|12093826|FG002|STARTED|Overall Study||9
10925587|NCT00253708|12093824|FG000|COMPLETED|Overall Study||20
10925588|NCT00253708|12093825|FG001|COMPLETED|Overall Study||10
10925589|NCT00253708|12093826|FG002|COMPLETED|Overall Study||8
10925590|NCT00253708|12093824|FG000|NOT COMPLETED|Overall Study||0
10925591|NCT00253708|12093825|FG001|NOT COMPLETED|Overall Study||0
10925592|NCT00253708|12093826|FG002|NOT COMPLETED|Overall Study||1
10925593|NCT00253747|12093836|FG000|STARTED|Overall Study||127
10925594|NCT00253747|12093837|FG001|STARTED|Overall Study||128
10925595|NCT00253747|12093836|FG000|COMPLETED|Overall Study||103
10925596|NCT00253747|12093837|FG001|COMPLETED|Overall Study||101
10925597|NCT00253747|12093836|FG000|NOT COMPLETED|Overall Study||24
10925598|NCT00253747|12093837|FG001|NOT COMPLETED|Overall Study||27
10925599|NCT00253890|12093855|FG000|STARTED|Overall Study||69
10925600|NCT00253890|12093856|FG001|STARTED|Overall Study||68
10925601|NCT00253890|12093855|FG000|COMPLETED|Overall Study||62
10925602|NCT00253890|12093856|FG001|COMPLETED|Overall Study||61
10925603|NCT00253890|12093855|FG000|NOT COMPLETED|Overall Study||7
10925604|NCT00253890|12093856|FG001|NOT COMPLETED|Overall Study||7
10925605|NCT00254072|12093864|FG000|STARTED|Overall Study||180
10925606|NCT00254072|12093865|FG001|STARTED|Overall Study||175
10925607|NCT00254072|12093864|FG000|COMPLETED|Overall Study||180
10925608|NCT00254072|12093865|FG001|COMPLETED|Overall Study||175
10925609|NCT00254072|12093864|FG000|NOT COMPLETED|Overall Study||0
10925610|NCT00254072|12093865|FG001|NOT COMPLETED|Overall Study||0
10925611|NCT00254163|12093873|FG000|STARTED|Overall Study||92
10925612|NCT00254163|12093874|FG001|STARTED|Overall Study||92
10925613|NCT00254163|12093873|FG000|COMPLETED|Overall Study||47
10925614|NCT00254163|12093874|FG001|COMPLETED|Overall Study||46
10925615|NCT00254163|12093873|FG000|NOT COMPLETED|Overall Study||45
10925616|NCT00254163|12093874|FG001|NOT COMPLETED|Overall Study||46
10925617|NCT00254293|12093886|FG000|STARTED|Short Term (12 Week) Randomized Dosing||7
10925618|NCT00254293|12093887|FG001|STARTED|Short Term (12 Week) Randomized Dosing||4
10925619|NCT00254293|12093888|FG002|STARTED|Short Term (12 Week) Randomized Dosing||29
10925620|NCT00254293|12093889|FG003|STARTED|Short Term (12 Week) Randomized Dosing||6
10925621|NCT00254293|12093890|FG004|STARTED|Short Term (12 Week) Randomized Dosing||5
10925622|NCT00254293|12093891|FG005|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
10925623|NCT00254293|12093892|FG006|STARTED|Short Term (12 Week) Randomized Dosing||0
10925624|NCT00254293|12093886|FG000|COMPLETED|Short Term (12 Week) Randomized Dosing||7
10925625|NCT00254293|12093887|FG001|COMPLETED|Short Term (12 Week) Randomized Dosing||3
10925626|NCT00254293|12093888|FG002|COMPLETED|Short Term (12 Week) Randomized Dosing||26
10925627|NCT00254293|12093889|FG003|COMPLETED|Short Term (12 Week) Randomized Dosing||5
10925628|NCT00254293|12093890|FG004|COMPLETED|Short Term (12 Week) Randomized Dosing||5
10925629|NCT00254293|12093891|FG005|COMPLETED|Short Term (12 Week) Randomized Dosing||17
10925630|NCT00254293|12093892|FG006|COMPLETED|Short Term (12 Week) Randomized Dosing||0
10925631|NCT00254293|12093886|FG000|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
10925632|NCT00254293|12093887|FG001|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
10925633|NCT00254293|12093888|FG002|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
10925634|NCT00254293|12093889|FG003|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
10925635|NCT00254293|12093890|FG004|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
10925636|NCT00254293|12093891|FG005|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
10925637|NCT00254293|12093892|FG006|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
10925638|NCT00254293|12093886|FG000|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
10925639|NCT00254293|12093887|FG001|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
10925640|NCT00254293|12093888|FG002|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
10925641|NCT00254293|12093889|FG003|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
10925642|NCT00254293|12093890|FG004|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
10925643|NCT00254293|12093891|FG005|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
10925644|NCT00254293|12093892|FG006|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
10925645|NCT00254293|12093886|FG000|COMPLETED|LTE Open Label Variable SC Dosing||8
10925646|NCT00254293|12093887|FG001|COMPLETED|LTE Open Label Variable SC Dosing||0
10925647|NCT00254293|12093888|FG002|COMPLETED|LTE Open Label Variable SC Dosing||32
10925648|NCT00254293|12093889|FG003|COMPLETED|LTE Open Label Variable SC Dosing||0
10925649|NCT00254293|12093890|FG004|COMPLETED|LTE Open Label Variable SC Dosing||8
10925650|NCT00254293|12093891|FG005|COMPLETED|LTE Open Label Variable SC Dosing||0
10925651|NCT00254293|12093892|FG006|COMPLETED|LTE Open Label Variable SC Dosing||0
10925652|NCT00254293|12093886|FG000|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
10925653|NCT00254293|12093887|FG001|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
10925654|NCT00254293|12093888|FG002|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
10925655|NCT00254293|12093889|FG003|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
10925656|NCT00254293|12093890|FG004|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
10925657|NCT00254293|12093891|FG005|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
10925658|NCT00254293|12093892|FG006|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
10925659|NCT00254293|12093886|FG000|STARTED|LTE Open Label Fixed Dosing||0
10925660|NCT00254293|12093887|FG001|STARTED|LTE Open Label Fixed Dosing||0
10925661|NCT00254293|12093888|FG002|STARTED|LTE Open Label Fixed Dosing||0
10925662|NCT00254293|12093889|FG003|STARTED|LTE Open Label Fixed Dosing||0
10925663|NCT00254293|12093890|FG004|STARTED|LTE Open Label Fixed Dosing||0
10925664|NCT00254293|12093891|FG005|STARTED|LTE Open Label Fixed Dosing||0
10925665|NCT00254293|12093892|FG006|STARTED|LTE Open Label Fixed Dosing||48
10925666|NCT00254293|12093886|FG000|COMPLETED|LTE Open Label Fixed Dosing||0
10925667|NCT00254293|12093887|FG001|COMPLETED|LTE Open Label Fixed Dosing||0
10925668|NCT00254293|12093888|FG002|COMPLETED|LTE Open Label Fixed Dosing||0
10925669|NCT00254293|12093889|FG003|COMPLETED|LTE Open Label Fixed Dosing||0
10925670|NCT00254293|12093890|FG004|COMPLETED|LTE Open Label Fixed Dosing||0
10925671|NCT00254293|12093891|FG005|COMPLETED|LTE Open Label Fixed Dosing||0
10925672|NCT00254293|12093892|FG006|COMPLETED|LTE Open Label Fixed Dosing||35
10925673|NCT00254293|12093886|FG000|NOT COMPLETED|LTE Open Label Fixed Dosing||0
10925674|NCT00254293|12093887|FG001|NOT COMPLETED|LTE Open Label Fixed Dosing||0
10925675|NCT00254293|12093888|FG002|NOT COMPLETED|LTE Open Label Fixed Dosing||0
10925676|NCT00254293|12093889|FG003|NOT COMPLETED|LTE Open Label Fixed Dosing||0
10925677|NCT00254293|12093890|FG004|NOT COMPLETED|LTE Open Label Fixed Dosing||0
10925678|NCT00254293|12093891|FG005|NOT COMPLETED|LTE Open Label Fixed Dosing||0
10925679|NCT00254293|12093892|FG006|NOT COMPLETED|LTE Open Label Fixed Dosing||13
10925680|NCT00254397|12093939|FG000|STARTED|Overall Study||10
10925681|NCT00254397|12093940|FG001|STARTED|Overall Study||6
10925682|NCT00254397|12093941|FG002|STARTED|Overall Study||37
10925683|NCT00254397|12093942|FG003|STARTED|Overall Study||45
10925684|NCT00254397|12093939|FG000|COMPLETED|Overall Study||4
10925685|NCT00254397|12093940|FG001|COMPLETED|Overall Study||5
10925686|NCT00254397|12093941|FG002|COMPLETED|Overall Study||18
10925687|NCT00254397|12093942|FG003|COMPLETED|Overall Study||20
10925688|NCT00254397|12093939|FG000|NOT COMPLETED|Overall Study||6
10925689|NCT00254397|12093940|FG001|NOT COMPLETED|Overall Study||1
10925690|NCT00254397|12093941|FG002|NOT COMPLETED|Overall Study||19
10925691|NCT00254397|12093942|FG003|NOT COMPLETED|Overall Study||25
10925692|NCT00254410|12093951|FG000|STARTED|Overall Study||30
10925693|NCT00254410|12093951|FG000|COMPLETED|Overall Study||30
10925694|NCT00254410|12093951|FG000|NOT COMPLETED|Overall Study||0
10925695|NCT00254462|12093957|FG000|STARTED|Overall Study||44
10925696|NCT00254462|12093958|FG001|STARTED|Overall Study||49
10925697|NCT00254462|12093957|FG000|COMPLETED|Overall Study||36
10925698|NCT00254462|12093958|FG001|COMPLETED|Overall Study||39
10925699|NCT00254462|12093957|FG000|NOT COMPLETED|Overall Study||8
10925700|NCT00254462|12093958|FG001|NOT COMPLETED|Overall Study||10
10925701|NCT00254488|12093968|FG000|STARTED|Overall Study||112
10925702|NCT00254488|12093969|FG001|STARTED|Overall Study||112
10925703|NCT00254488|12093968|FG000|COMPLETED|Overall Study||55
10925704|NCT00254488|12093969|FG001|COMPLETED|Overall Study||63
10925705|NCT00254488|12093968|FG000|NOT COMPLETED|Overall Study||57
10925706|NCT00254488|12093969|FG001|NOT COMPLETED|Overall Study||49
10925707|NCT00254501|12093977|FG000|STARTED|Overall Study||32
10925708|NCT00254501|12093978|FG001|STARTED|Overall Study||37
10925709|NCT00254501|12093977|FG000|COMPLETED|Overall Study||31
10925710|NCT00254501|12093978|FG001|COMPLETED|Overall Study||36
10925711|NCT00254501|12093977|FG000|NOT COMPLETED|Overall Study||1
10925712|NCT00254501|12093978|FG001|NOT COMPLETED|Overall Study||1
10925713|NCT00254540|12093988|FG000|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
10925714|NCT00254540|12093989|FG001|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
10925715|NCT00254540|12093988|FG000|COMPLETED|Overall Study||6
10925716|NCT00254540|12093989|FG001|COMPLETED|Overall Study||4
10925717|NCT00254540|12093988|FG000|NOT COMPLETED|Overall Study||19
10925718|NCT00254540|12093989|FG001|NOT COMPLETED|Overall Study||22
10925719|NCT00254566|12093998|FG000|STARTED|Overall Study||198
10925720|NCT00254566|12093999|FG001|STARTED|Overall Study||198
10925721|NCT00254566|12093998|FG000|COMPLETED|Overall Study||167
10925722|NCT00254566|12093999|FG001|COMPLETED|Overall Study||172
10925723|NCT00254566|12093998|FG000|NOT COMPLETED|Overall Study||31
10925724|NCT00254566|12093999|FG001|NOT COMPLETED|Overall Study||26
10925725|NCT00254592|12094005|FG000|STARTED|Overall Study||43
10925726|NCT00254592|12094005|FG000|COMPLETED|Overall Study||41
10925727|NCT00254592|12094005|FG000|NOT COMPLETED|Overall Study||2
10925728|NCT00254982|12094011|FG000|STARTED|Overall Study||297
10925729|NCT00254982|12094012|FG001|STARTED|Overall Study||296
10925730|NCT00254982|12094011|FG000|COMPLETED|Overall Study||261
10925731|NCT00254982|12094012|FG001|COMPLETED|Overall Study||265
10925732|NCT00254982|12094011|FG000|NOT COMPLETED|Overall Study||36
10925733|NCT00254982|12094012|FG001|NOT COMPLETED|Overall Study||31
10925734|NCT00254995|12094020|FG000|STARTED|Overall Study||31561
10925735|NCT00254995|12094021|FG001|STARTED|Overall Study||31065
10925736|NCT00254995|12094020|FG000|COMPLETED|Overall Study||31561
10925737|NCT00254995|12094021|FG001|COMPLETED|Overall Study||31065
10925738|NCT00254995|12094020|FG000|NOT COMPLETED|Overall Study||0
10925739|NCT00254995|12094021|FG001|NOT COMPLETED|Overall Study||0
10925740|NCT00255008|12094033|FG000|STARTED|Overall Study||45
10925741|NCT00255008|12094034|FG001|STARTED|Overall Study||9
10925742|NCT00255008|12094035|FG002|STARTED|Overall Study||33
10925743|NCT00255008|12094036|FG003|STARTED|Overall Study||34
10925744|NCT00255008|12094033|FG000|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
10925745|NCT00255008|12094034|FG001|COMPLETED|Overall Study||0
10925746|NCT00255008|12094035|FG002|COMPLETED|Overall Study||17
10925747|NCT00255008|12094036|FG003|COMPLETED|Overall Study||12
10925748|NCT00255008|12094033|FG000|NOT COMPLETED|Overall Study||32
10925749|NCT00255008|12094034|FG001|NOT COMPLETED|Overall Study||9
10925750|NCT00255008|12094035|FG002|NOT COMPLETED|Overall Study||16
10925751|NCT00255008|12094036|FG003|NOT COMPLETED|Overall Study||22
10925752|NCT00255034|12094048|FG000|STARTED|Overall Study||79
10925753|NCT00255034|12094049|FG001|STARTED|Overall Study||64
10925754|NCT00255034|12094048|FG000|COMPLETED|Overall Study||64
10925755|NCT00255034|12094049|FG001|COMPLETED|Overall Study||26
10925756|NCT00255034|12094048|FG000|NOT COMPLETED|Overall Study||15
10925757|NCT00255034|12094049|FG001|NOT COMPLETED|Overall Study||38
10925758|NCT00255047|12094059|FG000|STARTED|Overall Study||538
10925759|NCT00255047|12094060|FG001|STARTED|Overall Study||535
10925760|NCT00255047|12094061|FG002|STARTED|Overall Study||546
10925761|NCT00255047|12094062|FG003|STARTED|Overall Study||548
10925762|NCT00255047|12094059|FG000|COMPLETED|Overall Study||490
10925763|NCT00255047|12094060|FG001|COMPLETED|Overall Study||487
10925764|NCT00255047|12094061|FG002|COMPLETED|Overall Study||496
10925765|NCT00255047|12094062|FG003|COMPLETED|Overall Study||502
10925766|NCT00255047|12094059|FG000|NOT COMPLETED|Overall Study||48
10925767|NCT00255047|12094060|FG001|NOT COMPLETED|Overall Study||48
10925768|NCT00255047|12094061|FG002|NOT COMPLETED|Overall Study||50
10925769|NCT00255047|12094062|FG003|NOT COMPLETED|Overall Study||46
10925770|NCT00255086|12094074|FG000|STARTED|Overall Study||9
10925771|NCT00255086|12094075|FG001|STARTED|Overall Study||8
10925772|NCT00255086|12094074|FG000|COMPLETED|Overall Study||7
10925773|NCT00255086|12094075|FG001|COMPLETED|Overall Study||6
10925774|NCT00255086|12094074|FG000|NOT COMPLETED|Overall Study||2
10925775|NCT00255086|12094075|FG001|NOT COMPLETED|Overall Study||2
10925776|NCT00255125|12094084|FG000|STARTED|Overall Study||42
10925777|NCT00255125|12094085|FG001|STARTED|Overall Study||44
10925778|NCT00255125|12094084|FG000|COMPLETED|Overall Study||42
10925779|NCT00255125|12094085|FG001|COMPLETED|Overall Study||44
10925780|NCT00255125|12094084|FG000|NOT COMPLETED|Overall Study||0
10925781|NCT00255125|12094085|FG001|NOT COMPLETED|Overall Study||0
10925782|NCT00255151|12094096|FG000|STARTED|Overall Study||140
10925783|NCT00255151|12094097|FG001|STARTED|Overall Study||159
10925784|NCT00255151|12094098|FG002|STARTED|Overall Study||152
10925785|NCT00255151|12094096|FG000|COMPLETED|Overall Study||17
10925786|NCT00255151|12094097|FG001|COMPLETED|Overall Study||110
10925787|NCT00255151|12094098|FG002|COMPLETED|Overall Study||103
10925788|NCT00255151|12094096|FG000|NOT COMPLETED|Overall Study||123
10925789|NCT00255151|12094097|FG001|NOT COMPLETED|Overall Study||49
10925790|NCT00255151|12094098|FG002|NOT COMPLETED|Overall Study||49
10925791|NCT00255164|12094109|FG000|STARTED|Overall Study||140
10925792|NCT00255164|12094110|FG001|STARTED|Overall Study||159
10925793|NCT00255164|12094111|FG002|STARTED|Overall Study||152
10925794|NCT00255164|12094109|FG000|COMPLETED|Overall Study||17
10925795|NCT00255164|12094110|FG001|COMPLETED|Overall Study||110
10925796|NCT00255164|12094111|FG002|COMPLETED|Overall Study||103
10925797|NCT00255164|12094109|FG000|NOT COMPLETED|Overall Study||123
10925798|NCT00255164|12094110|FG001|NOT COMPLETED|Overall Study||49
10925799|NCT00255164|12094111|FG002|NOT COMPLETED|Overall Study||49
10925800|NCT00255177|12094123|FG000|STARTED|Overall Study||11
10925801|NCT00255177|12094124|FG001|STARTED|Overall Study||14
10925802|NCT00255177|12094125|FG002|STARTED|Overall Study||13
10925803|NCT00255177|12094126|FG003|STARTED|Overall Study||6
10925804|NCT00255177|12094123|FG000|COMPLETED|Overall Study||9
10925805|NCT00255177|12094124|FG001|COMPLETED|Overall Study||13
10925806|NCT00255177|12094125|FG002|COMPLETED|Overall Study||12
10925807|NCT00255177|12094126|FG003|COMPLETED|Overall Study||4
10925808|NCT00255177|12094123|FG000|NOT COMPLETED|Overall Study||2
10925809|NCT00255177|12094124|FG001|NOT COMPLETED|Overall Study||1
10925810|NCT00255177|12094125|FG002|NOT COMPLETED|Overall Study||1
10925811|NCT00255177|12094126|FG003|NOT COMPLETED|Overall Study||2
10925812|NCT00255190|12094138|FG000|STARTED|Overall Study||153
10925813|NCT00255190|12094139|FG001|STARTED|Overall Study||438
10925814|NCT00255190|12094138|FG000|COMPLETED|Overall Study||103
10925815|NCT00255190|12094139|FG001|COMPLETED|Overall Study||281
10925816|NCT00255190|12094138|FG000|NOT COMPLETED|Overall Study||50
10925817|NCT00255190|12094139|FG001|NOT COMPLETED|Overall Study||157
10925818|NCT00255346|12094150|FG000|STARTED|Overall Study||10
10925819|NCT00255346|12094151|FG001|STARTED|Overall Study||6
10925820|NCT00255346|12094152|FG002|STARTED|Overall Study||8
10925821|NCT00255346|12094153|FG003|STARTED|Overall Study||11
10925822|NCT00255346|12094154|FG004|STARTED|Overall Study||33
10925823|NCT00255346|12094150|FG000|COMPLETED|Overall Study||9
10925824|NCT00255346|12094151|FG001|COMPLETED|Overall Study||6
10925825|NCT00255346|12094152|FG002|COMPLETED|Overall Study||8
10925826|NCT00255346|12094153|FG003|COMPLETED|Overall Study||11
10925827|NCT00255346|12094154|FG004|COMPLETED|Overall Study||33
10925828|NCT00255346|12094150|FG000|NOT COMPLETED|Overall Study||1
10925829|NCT00255346|12094151|FG001|NOT COMPLETED|Overall Study||0
10925830|NCT00255346|12094152|FG002|NOT COMPLETED|Overall Study||0
10925831|NCT00255346|12094153|FG003|NOT COMPLETED|Overall Study||0
10925832|NCT00255346|12094154|FG004|NOT COMPLETED|Overall Study||0
10925833|NCT00255684|12094162|FG000|STARTED|Overall Study||16
10925834|NCT00255684|12094162|FG000|COMPLETED|Overall Study||16
10925835|NCT00255684|12094162|FG000|NOT COMPLETED|Overall Study||0
10925836|NCT00255723|12094168|FG000|STARTED|Overall Study||56
10925837|NCT00255723|12094169|FG001|STARTED|Overall Study||41
10925838|NCT00255723|12094168|FG000|COMPLETED|Overall Study||54
10925839|NCT00255723|12094169|FG001|COMPLETED|Overall Study||39
10925840|NCT00255723|12094168|FG000|NOT COMPLETED|Overall Study||2
10925841|NCT00255723|12094169|FG001|NOT COMPLETED|Overall Study||2
10925842|NCT00255801|12094175|FG000|STARTED|Overall Study||37
10925843|NCT00255801|12094175|FG000|COMPLETED|Overall Study||37
10925844|NCT00255801|12094175|FG000|NOT COMPLETED|Overall Study||0
10925845|NCT00255840|12094181|FG000|STARTED|Overall Study||408
10925846|NCT00255840|12094182|FG001|STARTED|Overall Study||404
10925847|NCT00255840|12094181|FG000|COMPLETED|Overall Study||345
10925848|NCT00255840|12094182|FG001|COMPLETED|Overall Study||334
10925849|NCT00255840|12094181|FG000|NOT COMPLETED|Overall Study||63
10925850|NCT00255840|12094182|FG001|NOT COMPLETED|Overall Study||70
10925851|NCT00255944|12094190|FG000|STARTED|Overall Study||1311
10925852|NCT00255944|12094191|FG001|STARTED|Overall Study||1311
10925853|NCT00255944|12094190|FG000|COMPLETED|Overall Study||514
10925854|NCT00255944|12094191|FG001|COMPLETED|Overall Study||477
10925855|NCT00255944|12094190|FG000|NOT COMPLETED|Overall Study||797
10925856|NCT00255944|12094191|FG001|NOT COMPLETED|Overall Study||834
10925857|NCT00255970|12094199|FG000|STARTED|Overall Study||21
10925858|NCT00255970|12094200|FG001|STARTED|Overall Study||19
10925859|NCT00255970|12094199|FG000|Screening Visit|Overall Study||21
10925860|NCT00255970|12094200|FG001|Screening Visit|Overall Study||19
10925861|NCT00255970|12094199|FG000|Final Visit Week 24|Overall Study||21
10925862|NCT00255970|12094200|FG001|Final Visit Week 24|Overall Study||19
10925863|NCT00255970|12094199|FG000|COMPLETED|Overall Study||21
10925864|NCT00255970|12094200|FG001|COMPLETED|Overall Study||19
10925865|NCT00255970|12094199|FG000|NOT COMPLETED|Overall Study||0
10925866|NCT00255970|12094200|FG001|NOT COMPLETED|Overall Study||0
10925867|NCT00256126|12094208|FG000|STARTED|Overall Study||149
10925868|NCT00256126|12094209|FG001|STARTED|Overall Study||169
10925869|NCT00256126|12094208|FG000|COMPLETED|Overall Study||147
10925870|NCT00256126|12094209|FG001|COMPLETED|Overall Study||167
10925871|NCT00256126|12094208|FG000|NOT COMPLETED|Overall Study||2
10925872|NCT00256126|12094209|FG001|NOT COMPLETED|Overall Study||2
10925873|NCT00256204|12094219|FG000|STARTED|Overall Study||298
10925874|NCT00256204|12094220|FG001|STARTED|Overall Study||288
10925875|NCT00256204|12094221|FG002|STARTED|Overall Study||295
10925876|NCT00256204|12094222|FG003|STARTED|Overall Study||293
10925877|NCT00256204|12094219|FG000|COMPLETED|Overall Study||231
10925878|NCT00256204|12094220|FG001|COMPLETED|Overall Study||238
10925879|NCT00256204|12094221|FG002|COMPLETED|Overall Study||241
10925880|NCT00256204|12094222|FG003|COMPLETED|Overall Study||244
10925881|NCT00256204|12094219|FG000|NOT COMPLETED|Overall Study||67
10925882|NCT00256204|12094220|FG001|NOT COMPLETED|Overall Study||50
10925883|NCT00256204|12094221|FG002|NOT COMPLETED|Overall Study||54
10925884|NCT00256204|12094222|FG003|NOT COMPLETED|Overall Study||49
10925885|NCT00256217|12094235|FG000|STARTED|Overall Study||42
10925886|NCT00256217|12094235|FG000|COMPLETED|Overall Study||34
10925887|NCT00256217|12094235|FG000|NOT COMPLETED|Overall Study||8
10925888|NCT00256243|12094239|FG000|STARTED|Overall Study||48
10925889|NCT00256243|12094239|FG000|COMPLETED|Overall Study||38
10925890|NCT00256243|12094239|FG000|NOT COMPLETED|Overall Study||10
10925891|NCT00256282|12094244|FG000|STARTED|Overall Study||52
10925892|NCT00256282|12094244|FG000|COMPLETED|Overall Study||36
10925893|NCT00256282|12094244|FG000|NOT COMPLETED|Overall Study||16
10925894|NCT00256308|12094248|FG000|STARTED|Overall Study||6
10925895|NCT00256308|12094248|FG000|COMPLETED|Overall Study||4
10925896|NCT00256308|12094248|FG000|NOT COMPLETED|Overall Study||2
10925897|NCT00256451|12094252|FG000|STARTED|Session1||10
10925898|NCT00256451|12094253|FG001|STARTED|Session1||11
10925899|NCT00256451|12094254|FG002|STARTED|Session1||11
10925900|NCT00256451|12094255|FG003|STARTED|Session1||11
10925901|NCT00256451|12094252|FG000|COMPLETED|Session1||10
10925902|NCT00256451|12094253|FG001|COMPLETED|Session1||11
10925903|NCT00256451|12094254|FG002|COMPLETED|Session1||11
10925904|NCT00256451|12094255|FG003|COMPLETED|Session1||11
10925905|NCT00256451|12094252|FG000|NOT COMPLETED|Session1||0
10925906|NCT00256451|12094253|FG001|NOT COMPLETED|Session1||0
10925907|NCT00256451|12094254|FG002|NOT COMPLETED|Session1||0
10925908|NCT00256451|12094255|FG003|NOT COMPLETED|Session1||0
10925909|NCT00256451|12094252|FG000|STARTED|Session2||9
10925910|NCT00256451|12094253|FG001|STARTED|Session2||11
10925911|NCT00256451|12094254|FG002|STARTED|Session2||10
10925912|NCT00256451|12094255|FG003|STARTED|Session2||10
10925913|NCT00256451|12094252|FG000|COMPLETED|Session2||9
10925914|NCT00256451|12094253|FG001|COMPLETED|Session2||11
10925915|NCT00256451|12094254|FG002|COMPLETED|Session2||10
10925916|NCT00256451|12094255|FG003|COMPLETED|Session2||10
10925917|NCT00256451|12094252|FG000|NOT COMPLETED|Session2||0
10925918|NCT00256451|12094253|FG001|NOT COMPLETED|Session2||0
10925919|NCT00256451|12094254|FG002|NOT COMPLETED|Session2||0
10925920|NCT00256451|12094255|FG003|NOT COMPLETED|Session2||0
10925921|NCT00256451|12094252|FG000|STARTED|Session3||9
10925922|NCT00256451|12094253|FG001|STARTED|Session3||9
10925923|NCT00256451|12094254|FG002|STARTED|Session3||10
10925924|NCT00256451|12094255|FG003|STARTED|Session3||9
10925925|NCT00256451|12094252|FG000|COMPLETED|Session3||9
10925926|NCT00256451|12094253|FG001|COMPLETED|Session3||9
10925927|NCT00256451|12094254|FG002|COMPLETED|Session3||10
10925928|NCT00256451|12094255|FG003|COMPLETED|Session3||9
10925929|NCT00256451|12094252|FG000|NOT COMPLETED|Session3||0
10925930|NCT00256451|12094253|FG001|NOT COMPLETED|Session3||0
10925931|NCT00256451|12094254|FG002|NOT COMPLETED|Session3||0
10925932|NCT00256451|12094255|FG003|NOT COMPLETED|Session3||0
10925933|NCT00256451|12094252|FG000|STARTED|Session4||9
10925934|NCT00256451|12094253|FG001|STARTED|Session4||8
10925935|NCT00256451|12094254|FG002|STARTED|Session4||10
10925936|NCT00256451|12094255|FG003|STARTED|Session4||8
10925937|NCT00256451|12094252|FG000|COMPLETED|Session4||9
10925938|NCT00256451|12094253|FG001|COMPLETED|Session4||8
10925939|NCT00256451|12094254|FG002|COMPLETED|Session4||10
10925940|NCT00256451|12094255|FG003|COMPLETED|Session4||8
10925941|NCT00256451|12094252|FG000|NOT COMPLETED|Session4||0
10925942|NCT00256451|12094253|FG001|NOT COMPLETED|Session4||0
10925943|NCT00256451|12094254|FG002|NOT COMPLETED|Session4||0
10925944|NCT00256451|12094255|FG003|NOT COMPLETED|Session4||0
10925945|NCT00256698|12094267|FG000|STARTED|Overall Study||258
10925946|NCT00256698|12094268|FG001|STARTED|Overall Study||256
10925947|NCT00256698|12094267|FG000|COMPLETED|Overall Study||91
10925948|NCT00256698|12094268|FG001|COMPLETED|Overall Study||84
10925949|NCT00256698|12094267|FG000|NOT COMPLETED|Overall Study||167
10925950|NCT00256698|12094268|FG001|NOT COMPLETED|Overall Study||172
10925951|NCT00256724|12094276|FG000|STARTED|Overall Study||23
10925952|NCT00256724|12094277|FG001|STARTED|Overall Study||24
10925953|NCT00256724|12094276|FG000|COMPLETED|Overall Study||18
10925954|NCT00256724|12094277|FG001|COMPLETED|Overall Study||16
10925955|NCT00256724|12094276|FG000|NOT COMPLETED|Overall Study||5
10925956|NCT00256724|12094277|FG001|NOT COMPLETED|Overall Study||8
10925957|NCT00256750|12094286|FG000|STARTED|Transplanted Pre-Treatment||221
10925958|NCT00256750|12094287|FG001|STARTED|Transplanted Pre-Treatment||226
10925959|NCT00256750|12094288|FG002|STARTED|Transplanted Pre-Treatment||219
10925960|NCT00256750|12094286|FG000|COMPLETED|Transplanted Pre-Treatment||215
10925961|NCT00256750|12094287|FG001|COMPLETED|Transplanted Pre-Treatment||226
10925962|NCT00256750|12094288|FG002|COMPLETED|Transplanted Pre-Treatment||219
10925963|NCT00256750|12094286|FG000|NOT COMPLETED|Transplanted Pre-Treatment||6
10925964|NCT00256750|12094287|FG001|NOT COMPLETED|Transplanted Pre-Treatment||0
10925965|NCT00256750|12094288|FG002|NOT COMPLETED|Transplanted Pre-Treatment||0
10925966|NCT00256750|12094286|FG000|STARTED|Post-Transplant Treated (12 Months)||215
10925967|NCT00256750|12094287|FG001|STARTED|Post-Transplant Treated (12 Months)||226
10925968|NCT00256750|12094288|FG002|STARTED|Post-Transplant Treated (12 Months)||219
10925969|NCT00256750|12094286|FG000|COMPLETED|Post-Transplant Treated (12 Months)||174
10925970|NCT00256750|12094287|FG001|COMPLETED|Post-Transplant Treated (12 Months)||183
10925971|NCT00256750|12094288|FG002|COMPLETED|Post-Transplant Treated (12 Months)||173
10925972|NCT00256750|12094286|FG000|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
10925973|NCT00256750|12094287|FG001|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
10925974|NCT00256750|12094288|FG002|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
10925975|NCT00256750|12094286|FG000|STARTED|Post-Transplant Treated (24 Months)||174
10925976|NCT00256750|12094287|FG001|STARTED|Post-Transplant Treated (24 Months)||183
10925977|NCT00256750|12094288|FG002|STARTED|Post-Transplant Treated (24 Months)||173
10925978|NCT00256750|12094286|FG000|COMPLETED|Post-Transplant Treated (24 Months)||153
10925979|NCT00256750|12094287|FG001|COMPLETED|Post-Transplant Treated (24 Months)||176
10925980|NCT00256750|12094288|FG002|COMPLETED|Post-Transplant Treated (24 Months)||164
10925981|NCT00256750|12094286|FG000|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
10925982|NCT00256750|12094287|FG001|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
10925983|NCT00256750|12094288|FG002|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
10925984|NCT00256750|12094286|FG000|STARTED|Post-Transplant Treated (36 Months)||153
10925985|NCT00256750|12094287|FG001|STARTED|Post-Transplant Treated (36 Months)||176
10925986|NCT00256750|12094288|FG002|STARTED|Post-Transplant Treated (36 Months)||164
10925987|NCT00256750|12094286|FG000|COMPLETED|Post-Transplant Treated (36 Months)||143
10925988|NCT00256750|12094287|FG001|COMPLETED|Post-Transplant Treated (36 Months)||170
10925989|NCT00256750|12094288|FG002|COMPLETED|Post-Transplant Treated (36 Months)||158
10925990|NCT00256750|12094286|FG000|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
10925991|NCT00256750|12094287|FG001|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
10925992|NCT00256750|12094288|FG002|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
10925993|NCT00256750|12094286|FG000|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
10925994|NCT00256750|12094287|FG001|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
10925995|NCT00256750|12094288|FG002|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
10925996|NCT00256750|12094286|FG000|COMPLETED|Long Term Extension (LTE; 84 Months)||89
10925997|NCT00256750|12094287|FG001|COMPLETED|Long Term Extension (LTE; 84 Months)||136
10925998|NCT00256750|12094288|FG002|COMPLETED|Long Term Extension (LTE; 84 Months)||127
10925999|NCT00256750|12094286|FG000|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
10926000|NCT00256750|12094287|FG001|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
10926001|NCT00256750|12094288|FG002|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
10926002|NCT00256776|12094299|FG000|STARTED|Overall Study||135
10926003|NCT00256776|12094300|FG001|STARTED|Overall Study||134
10926004|NCT00256776|12094299|FG000|COMPLETED|Overall Study||52
10926005|NCT00256776|12094300|FG001|COMPLETED|Overall Study||54
10926006|NCT00256776|12094299|FG000|NOT COMPLETED|Overall Study||83
10926007|NCT00256776|12094300|FG001|NOT COMPLETED|Overall Study||80
10926008|NCT00256854|12094314|FG000|STARTED|Overall Study||26
10926009|NCT00256854|12094315|FG001|STARTED|Overall Study||26
10926010|NCT00256854|12094316|FG002|STARTED|Overall Study||26
10926011|NCT00256854|12094317|FG003|STARTED|Overall Study||27
10926012|NCT00256854|12094318|FG004|STARTED|Overall Study||16
10926013|NCT00256854|12094319|FG005|STARTED|Overall Study||14
10926014|NCT00256854|12094314|FG000|COMPLETED|Overall Study||23
10926015|NCT00256854|12094315|FG001|COMPLETED|Overall Study||22
10926016|NCT00256854|12094316|FG002|COMPLETED|Overall Study||23
10926017|NCT00256854|12094317|FG003|COMPLETED|Overall Study||24
10926018|NCT00256854|12094318|FG004|COMPLETED|Overall Study||15
10926019|NCT00256854|12094319|FG005|COMPLETED|Overall Study||13
10926020|NCT00256854|12094314|FG000|NOT COMPLETED|Overall Study||3
10926021|NCT00256854|12094315|FG001|NOT COMPLETED|Overall Study||4
10926022|NCT00256854|12094316|FG002|NOT COMPLETED|Overall Study||3
10926023|NCT00256854|12094317|FG003|NOT COMPLETED|Overall Study||3
10926024|NCT00256854|12094318|FG004|NOT COMPLETED|Overall Study||1
10926025|NCT00256854|12094319|FG005|NOT COMPLETED|Overall Study||1
10926026|NCT00256867|12094342|FG000|STARTED|Overall Study||47
10926027|NCT00256867|12094343|FG001|STARTED|Overall Study||44
10926028|NCT00256867|12094344|FG002|STARTED|Overall Study||45
10926029|NCT00256867|12094345|FG003|STARTED|Overall Study||46
10926030|NCT00256867|12094346|FG004|STARTED|Overall Study||48
10926031|NCT00256867|12094347|FG005|STARTED|Overall Study||46
10926032|NCT00256867|12094348|FG006|STARTED|Overall Study||46
10926033|NCT00256867|12094349|FG007|STARTED|Overall Study||47
10926034|NCT00256867|12094342|FG000|COMPLETED|Overall Study||45
10926035|NCT00256867|12094343|FG001|COMPLETED|Overall Study||39
10926036|NCT00256867|12094344|FG002|COMPLETED|Overall Study||40
10926037|NCT00256867|12094345|FG003|COMPLETED|Overall Study||40
10926038|NCT00256867|12094346|FG004|COMPLETED|Overall Study||41
10926039|NCT00256867|12094347|FG005|COMPLETED|Overall Study||40
10926040|NCT00256867|12094348|FG006|COMPLETED|Overall Study||41
10926041|NCT00256867|12094349|FG007|COMPLETED|Overall Study||36
10926042|NCT00256867|12094342|FG000|NOT COMPLETED|Overall Study||2
10926043|NCT00256867|12094343|FG001|NOT COMPLETED|Overall Study||5
10926044|NCT00256867|12094344|FG002|NOT COMPLETED|Overall Study||5
10926045|NCT00256867|12094345|FG003|NOT COMPLETED|Overall Study||6
10926046|NCT00256867|12094346|FG004|NOT COMPLETED|Overall Study||7
10926047|NCT00256867|12094347|FG005|NOT COMPLETED|Overall Study||6
10926048|NCT00256867|12094348|FG006|NOT COMPLETED|Overall Study||5
10926049|NCT00256867|12094349|FG007|NOT COMPLETED|Overall Study||11
10926050|NCT00256984|12094372|FG000|STARTED|Overall Study||75
10926051|NCT00256984|12094372|FG000|COMPLETED|Overall Study||59
10926052|NCT00256984|12094372|FG000|NOT COMPLETED|Overall Study||16
10926053|NCT00256997|12094378|FG000|STARTED|Overall Study||81
10926054|NCT00256997|12094379|FG001|STARTED|Overall Study||86
10926055|NCT00256997|12094378|FG000|Treated|Overall Study||79
10926056|NCT00256997|12094379|FG001|Treated|Overall Study||86
10926057|NCT00256997|12094378|FG000|COMPLETED|Overall Study||33
10926058|NCT00256997|12094379|FG001|COMPLETED|Overall Study||31
10926059|NCT00256997|12094378|FG000|NOT COMPLETED|Overall Study||48
10926060|NCT00256997|12094379|FG001|NOT COMPLETED|Overall Study||55
10926061|NCT00257010|12094386|FG000|STARTED|Overall Study||447
10926062|NCT00257010|12094386|FG000|COMPLETED|Overall Study||319
10926063|NCT00257010|12094386|FG000|NOT COMPLETED|Overall Study||128
10926064|NCT00257166|12094392|FG000|STARTED|Overall Study||150
10926065|NCT00257166|12094393|FG001|STARTED|Overall Study||88
10926066|NCT00257166|12094392|FG000|Treated|Overall Study||149
10926067|NCT00257166|12094393|FG001|Treated|Overall Study||88
10926068|NCT00257166|12094392|FG000|COMPLETED|Overall Study||97
10926069|NCT00257166|12094393|FG001|COMPLETED|Overall Study||51
10926070|NCT00257166|12094392|FG000|NOT COMPLETED|Overall Study||53
10926071|NCT00257166|12094393|FG001|NOT COMPLETED|Overall Study||37
10926072|NCT00257192|12094401|FG000|STARTED|Overall Study||193
10926073|NCT00257192|12094402|FG001|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
10926074|NCT00257192|12094401|FG000|Received Study Treatment|Overall Study||193
10926075|NCT00257192|12094402|FG001|Received Study Treatment|Overall Study||90
10926076|NCT00257192|12094401|FG000|COMPLETED|Overall Study||135
10926077|NCT00257192|12094402|FG001|COMPLETED|Overall Study||52
10926078|NCT00257192|12094401|FG000|NOT COMPLETED|Overall Study||58
10926079|NCT00257192|12094402|FG001|NOT COMPLETED|Overall Study||39
10926080|NCT00257309|12094410|FG000|STARTED|Overall Study||134
10926081|NCT00257309|12094411|FG001|STARTED|Overall Study||132
10926082|NCT00257309|12094410|FG000|COMPLETED|Overall Study||132
10926083|NCT00257309|12094411|FG001|COMPLETED|Overall Study||130
10926084|NCT00257309|12094410|FG000|NOT COMPLETED|Overall Study||2
10926085|NCT00257309|12094411|FG001|NOT COMPLETED|Overall Study||2
10926086|NCT00257322|12094417|FG000|STARTED|Overall Study|20 subjects accrued.|20
10926087|NCT00257322|12094417|FG000|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
10926088|NCT00257322|12094417|FG000|NOT COMPLETED|Overall Study||4
10926089|NCT00257556|12094423|FG000|STARTED|Overall Study||38
10926090|NCT00257556|12094424|FG001|STARTED|Overall Study||42
10926091|NCT00257556|12094423|FG000|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
10926092|NCT00257556|12094424|FG001|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
10926093|NCT00257556|12094423|FG000|COMPLETED|Overall Study||24
10926094|NCT00257556|12094424|FG001|COMPLETED|Overall Study||32
10926095|NCT00257556|12094423|FG000|NOT COMPLETED|Overall Study||14
10926096|NCT00257556|12094424|FG001|NOT COMPLETED|Overall Study||10
10926097|NCT00257608|12094432|FG000|STARTED|Chemotherapy Phase||1145
10926098|NCT00257608|12094433|FG001|STARTED|Chemotherapy Phase||0
10926099|NCT00257608|12094434|FG002|STARTED|Chemotherapy Phase||0
10926100|NCT00257608|12094432|FG000|COMPLETED|Chemotherapy Phase||769
10926101|NCT00257608|12094433|FG001|COMPLETED|Chemotherapy Phase||0
10926102|NCT00257608|12094434|FG002|COMPLETED|Chemotherapy Phase||0
10926103|NCT00257608|12094432|FG000|NOT COMPLETED|Chemotherapy Phase||376
10926104|NCT00257608|12094433|FG001|NOT COMPLETED|Chemotherapy Phase||0
10926105|NCT00257608|12094434|FG002|NOT COMPLETED|Chemotherapy Phase||0
10926106|NCT00257608|12094432|FG000|STARTED|Post Chemotherapy Phase||0
10926107|NCT00257608|12094433|FG001|STARTED|Post Chemotherapy Phase||373
10926108|NCT00257608|12094434|FG002|STARTED|Post Chemotherapy Phase||370
10926109|NCT00257608|12094432|FG000|COMPLETED|Post Chemotherapy Phase||0
10926110|NCT00257608|12094433|FG001|COMPLETED|Post Chemotherapy Phase||109
10926111|NCT00257608|12094434|FG002|COMPLETED|Post Chemotherapy Phase||126
10926112|NCT00257608|12094432|FG000|NOT COMPLETED|Post Chemotherapy Phase||0
10926113|NCT00257608|12094433|FG001|NOT COMPLETED|Post Chemotherapy Phase||264
10926114|NCT00257608|12094434|FG002|NOT COMPLETED|Post Chemotherapy Phase||244
10926115|NCT00257686|12094453|FG000|STARTED|Overall Study||209
10926116|NCT00257686|12094454|FG001|STARTED|Overall Study||108
10926117|NCT00257686|12094455|FG002|STARTED|Overall Study||226
10926118|NCT00257686|12094456|FG003|STARTED|Overall Study||99
10926119|NCT00257686|12094457|FG004|STARTED|Overall Study||216
10926120|NCT00257686|12094458|FG005|STARTED|Overall Study||104
10926121|NCT00257686|12094453|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
10926122|NCT00257686|12094454|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
10926123|NCT00257686|12094455|FG002|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
10926124|NCT00257686|12094456|FG003|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
10926125|NCT00257686|12094457|FG004|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
10926126|NCT00257686|12094458|FG005|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
10926127|NCT00257686|12094453|FG000|COMPLETED|Overall Study||188
10926128|NCT00257686|12094454|FG001|COMPLETED|Overall Study||89
10926129|NCT00257686|12094455|FG002|COMPLETED|Overall Study||208
10926130|NCT00257686|12094456|FG003|COMPLETED|Overall Study||88
10926131|NCT00257686|12094457|FG004|COMPLETED|Overall Study||194
10926132|NCT00257686|12094458|FG005|COMPLETED|Overall Study||95
10926133|NCT00257686|12094453|FG000|NOT COMPLETED|Overall Study||21
10926134|NCT00257686|12094454|FG001|NOT COMPLETED|Overall Study||19
10926135|NCT00257686|12094455|FG002|NOT COMPLETED|Overall Study||18
10926136|NCT00257686|12094456|FG003|NOT COMPLETED|Overall Study||11
10926137|NCT00257686|12094457|FG004|NOT COMPLETED|Overall Study||22
10926138|NCT00257686|12094458|FG005|NOT COMPLETED|Overall Study||9
10926139|NCT00257725|12094472|FG000|STARTED|Overall Study||11
10926140|NCT00257725|12094472|FG000|COMPLETED|Overall Study||8
10926141|NCT00257725|12094472|FG000|NOT COMPLETED|Overall Study||3
10926142|NCT00257894|12094479|FG000|STARTED|Overall Study||21
10926143|NCT00257894|12094480|FG001|STARTED|Overall Study||20
10926144|NCT00257894|12094479|FG000|COMPLETED|Overall Study||17
10926145|NCT00257894|12094480|FG001|COMPLETED|Overall Study||15
10926146|NCT00257894|12094479|FG000|NOT COMPLETED|Overall Study||4
10926147|NCT00257894|12094480|FG001|NOT COMPLETED|Overall Study||5
10926148|NCT00257920|12094488|FG000|STARTED|Period: First Intervention||21
10926149|NCT00257920|12094489|FG001|STARTED|Period: First Intervention||20
10926150|NCT00257920|12094488|FG000|COMPLETED|Period: First Intervention||21
10926151|NCT00257920|12094489|FG001|COMPLETED|Period: First Intervention||20
10926152|NCT00257920|12094488|FG000|NOT COMPLETED|Period: First Intervention||0
10926153|NCT00257920|12094489|FG001|NOT COMPLETED|Period: First Intervention||0
10926154|NCT00257920|12094488|FG000|STARTED|Period: Washout Period of Two Weeks||21
10926155|NCT00257920|12094489|FG001|STARTED|Period: Washout Period of Two Weeks||20
10926156|NCT00257920|12094488|FG000|COMPLETED|Period: Washout Period of Two Weeks||21
10926157|NCT00257920|12094489|FG001|COMPLETED|Period: Washout Period of Two Weeks||19
10926158|NCT00257920|12094488|FG000|NOT COMPLETED|Period: Washout Period of Two Weeks||0
10926159|NCT00257920|12094489|FG001|NOT COMPLETED|Period: Washout Period of Two Weeks||1
10926160|NCT00257920|12094488|FG000|STARTED|Period: Second Intervention||21
10926161|NCT00257920|12094489|FG001|STARTED|Period: Second Intervention||19
10926162|NCT00257920|12094488|FG000|COMPLETED|Period: Second Intervention||19
10926163|NCT00257920|12094489|FG001|COMPLETED|Period: Second Intervention||18
10926164|NCT00257920|12094488|FG000|NOT COMPLETED|Period: Second Intervention||2
10926165|NCT00257920|12094489|FG001|NOT COMPLETED|Period: Second Intervention||1
10926166|NCT00257933|12094498|FG000|STARTED|Overall Study||74
10926167|NCT00257933|12094499|FG001|STARTED|Overall Study||78
10926168|NCT00257933|12094498|FG000|COMPLETED|Overall Study||74
10926169|NCT00257933|12094499|FG001|COMPLETED|Overall Study||78
10926170|NCT00257933|12094498|FG000|NOT COMPLETED|Overall Study||0
10926171|NCT00257933|12094499|FG001|NOT COMPLETED|Overall Study||0
10926172|NCT00258011|12094505|FG000|STARTED|Overall Study||3
10926173|NCT00258011|12094505|FG000|COMPLETED|Overall Study||3
10926174|NCT00258011|12094505|FG000|NOT COMPLETED|Overall Study||0
10926175|NCT00258128|12094511|FG000|STARTED|Overall Study||8
10926176|NCT00258128|12094512|FG001|STARTED|Overall Study||9
10926177|NCT00258128|12094511|FG000|COMPLETED|Overall Study||8
10926178|NCT00258128|12094512|FG001|COMPLETED|Overall Study||9
10926179|NCT00258128|12094511|FG000|NOT COMPLETED|Overall Study||0
10926180|NCT00258128|12094512|FG001|NOT COMPLETED|Overall Study||0
10926181|NCT00258154|12094522|FG000|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
10926182|NCT00258154|12094523|FG001|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
10926183|NCT00258154|12094522|FG000|Vaccinated at Visit 1|Overall Study||201
10926184|NCT00258154|12094523|FG001|Vaccinated at Visit 1|Overall Study||202
10926185|NCT00258154|12094522|FG000|Vaccinated at Visit 2|Overall Study||198
10926186|NCT00258154|12094523|FG001|Vaccinated at Visit 2|Overall Study||198
10926187|NCT00258154|12094522|FG000|Vaccinated at Visit 3|Overall Study||195
10926188|NCT00258154|12094523|FG001|Vaccinated at Visit 3|Overall Study||197
10926189|NCT00258154|12094522|FG000|COMPLETED|Overall Study|Subjects who completed the study.|192
10926190|NCT00258154|12094523|FG001|COMPLETED|Overall Study|Subjects who completed the study.|195
10926191|NCT00258154|12094522|FG000|NOT COMPLETED|Overall Study||9
10926192|NCT00258154|12094523|FG001|NOT COMPLETED|Overall Study||7
10926193|NCT00258180|12094529|FG000|STARTED|Overall Study||2
10926194|NCT00258180|12094529|FG000|COMPLETED|Overall Study||2
10926195|NCT00258180|12094529|FG000|NOT COMPLETED|Overall Study||0
10926196|NCT00258206|12094534|FG000|STARTED|Overall Study||21
10926197|NCT00258206|12094534|FG000|COMPLETED|Overall Study||21
10926198|NCT00258206|12094534|FG000|NOT COMPLETED|Overall Study||0
10926199|NCT00258310|12094538|FG000|STARTED|Overall Study||35
10926200|NCT00258310|12094538|FG000|COMPLETED|Overall Study||35
10926201|NCT00258310|12094538|FG000|NOT COMPLETED|Overall Study||0
10926202|NCT00258349|12094542|FG000|STARTED|Overall Study||16
10926203|NCT00258349|12094542|FG000|HER2-positive by Central Review|Overall Study||10
10926204|NCT00258349|12094542|FG000|COMPLETED|Overall Study||16
10926205|NCT00258349|12094542|FG000|NOT COMPLETED|Overall Study||0
10926206|NCT00258362|12094548|FG000|STARTED|Overall Study||41
10926207|NCT00258362|12094548|FG000|COMPLETED|Overall Study||41
10926208|NCT00258362|12094548|FG000|NOT COMPLETED|Overall Study||0
10926209|NCT00258440|12094556|FG000|STARTED|Overall Study||1
10926210|NCT00258440|12094557|FG001|STARTED|Overall Study||0
10926211|NCT00258440|12094558|FG002|STARTED|Overall Study||6
10926212|NCT00258440|12094556|FG000|COMPLETED|Overall Study||1
10926213|NCT00258440|12094557|FG001|COMPLETED|Overall Study||0
10926214|NCT00258440|12094558|FG002|COMPLETED|Overall Study||5
10926215|NCT00258440|12094556|FG000|NOT COMPLETED|Overall Study||0
10926216|NCT00258440|12094557|FG001|NOT COMPLETED|Overall Study||0
10926217|NCT00258440|12094558|FG002|NOT COMPLETED|Overall Study||1
10926218|NCT00258674|12094569|FG000|STARTED|Overall Study||597
10926219|NCT00258674|12094570|FG001|STARTED|Overall Study||811
10926220|NCT00258674|12094571|FG002|STARTED|Overall Study||602
10926221|NCT00258674|12094569|FG000|COMPLETED|Overall Study||565
10926222|NCT00258674|12094570|FG001|COMPLETED|Overall Study||758
10926223|NCT00258674|12094571|FG002|COMPLETED|Overall Study||568
10926224|NCT00258674|12094569|FG000|NOT COMPLETED|Overall Study||32
10926225|NCT00258674|12094570|FG001|NOT COMPLETED|Overall Study||53
10926226|NCT00258674|12094571|FG002|NOT COMPLETED|Overall Study||34
10926227|NCT00258817|12094581|FG000|STARTED|Overall Study||15
10926228|NCT00258817|12094582|FG001|STARTED|Overall Study||15
10926229|NCT00258817|12094581|FG000|COMPLETED|Overall Study||15
10926230|NCT00258817|12094582|FG001|COMPLETED|Overall Study||15
10926231|NCT00258817|12094581|FG000|NOT COMPLETED|Overall Study||0
10926232|NCT00258817|12094582|FG001|NOT COMPLETED|Overall Study||0
10926233|NCT00258830|12094590|FG000|STARTED|Overall Study||60
10926234|NCT00258830|12094591|FG001|STARTED|Overall Study||60
10926235|NCT00258830|12094590|FG000|COMPLETED|Overall Study||60
10926236|NCT00258830|12094591|FG001|COMPLETED|Overall Study||60
10926237|NCT00258830|12094590|FG000|NOT COMPLETED|Overall Study||0
10926238|NCT00258830|12094591|FG001|NOT COMPLETED|Overall Study||0
10926239|NCT00258856|12094601|FG000|STARTED|Overall Study||59
10926240|NCT00258856|12094602|FG001|STARTED|Overall Study||58
10926241|NCT00258856|12094603|FG002|STARTED|Overall Study||58
10926242|NCT00258856|12094604|FG003|STARTED|Overall Study||59
10926243|NCT00258856|12094601|FG000|COMPLETED|Overall Study||56
10926244|NCT00258856|12094602|FG001|COMPLETED|Overall Study||58
10926245|NCT00258856|12094603|FG002|COMPLETED|Overall Study||56
10926246|NCT00258856|12094604|FG003|COMPLETED|Overall Study||58
10926247|NCT00258856|12094601|FG000|NOT COMPLETED|Overall Study||3
10926248|NCT00258856|12094602|FG001|NOT COMPLETED|Overall Study||0
10926249|NCT00258856|12094603|FG002|NOT COMPLETED|Overall Study||2
10926250|NCT00258856|12094604|FG003|NOT COMPLETED|Overall Study||1
10926251|NCT00258882|12094616|FG000|STARTED|Adacel Recipients Historic Cohort Method||124139
10926252|NCT00258882|12094617|FG001|STARTED|Adacel Recipients Historic Cohort Method||203154
10926253|NCT00258882|12094616|FG000|COMPLETED|Adacel Recipients Historic Cohort Method||124139
10926254|NCT00258882|12094617|FG001|COMPLETED|Adacel Recipients Historic Cohort Method||203154
10926255|NCT00258882|12094616|FG000|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
10926256|NCT00258882|12094617|FG001|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
10926257|NCT00258882|12094616|FG000|STARTED|Adacel Recipients-Risk Interval Method||124139
10926258|NCT00258882|12094617|FG001|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
10926259|NCT00258882|12094616|FG000|COMPLETED|Adacel Recipients-Risk Interval Method||124139
10926260|NCT00258882|12094617|FG001|COMPLETED|Adacel Recipients-Risk Interval Method||0
10926261|NCT00258882|12094616|FG000|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
10926262|NCT00258882|12094617|FG001|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
10926263|NCT00258882|12094616|FG000|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
10926264|NCT00258882|12094617|FG001|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
10926265|NCT00258882|12094616|FG000|COMPLETED|Pregnancy Surveillance||225
10926266|NCT00258882|12094617|FG001|COMPLETED|Pregnancy Surveillance||675
10926267|NCT00258882|12094616|FG000|NOT COMPLETED|Pregnancy Surveillance||0
10926268|NCT00258882|12094617|FG001|NOT COMPLETED|Pregnancy Surveillance||0
10926269|NCT00258895|12094627|FG000|STARTED|Overall Study||487
10926270|NCT00258895|12094628|FG001|STARTED|Overall Study||162
10926271|NCT00258895|12094627|FG000|COMPLETED|Overall Study||477
10926272|NCT00258895|12094628|FG001|COMPLETED|Overall Study||159
10926273|NCT00258895|12094627|FG000|NOT COMPLETED|Overall Study||10
10926274|NCT00258895|12094628|FG001|NOT COMPLETED|Overall Study||3
10926275|NCT00258908|12094634|FG000|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
10926276|NCT00258908|12094634|FG000|COMPLETED|Overall Study||112
10926277|NCT00258908|12094634|FG000|NOT COMPLETED|Overall Study||0
10926278|NCT00258960|12094638|FG000|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49
10926279|NCT00258960|12094638|FG000|COMPLETED|Overall Study||32
10926280|NCT00258960|12094638|FG000|NOT COMPLETED|Overall Study||17
10926281|NCT00259012|12094644|FG000|STARTED|Overall Study||33
10926282|NCT00259012|12094645|FG001|STARTED|Overall Study||34
10926283|NCT00259012|12094644|FG000|COMPLETED|Overall Study||31
10926284|NCT00259012|12094645|FG001|COMPLETED|Overall Study||30
10926285|NCT00259012|12094644|FG000|NOT COMPLETED|Overall Study||2
10926286|NCT00259012|12094645|FG001|NOT COMPLETED|Overall Study||4
10926287|NCT00259090|12094654|FG000|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
10926288|NCT00259090|12094655|FG001|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
10926289|NCT00259090|12094656|FG002|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
10926290|NCT00259090|12094654|FG000|COMPLETED|Overall Study||35
10926291|NCT00259090|12094655|FG001|COMPLETED|Overall Study||31
10926292|NCT00259090|12094656|FG002|COMPLETED|Overall Study||37
10926293|NCT00259090|12094654|FG000|NOT COMPLETED|Overall Study||0
10926294|NCT00259090|12094655|FG001|NOT COMPLETED|Overall Study||0
10926295|NCT00259090|12094656|FG002|NOT COMPLETED|Overall Study||0
10926296|NCT00259272|12094668|FG000|STARTED|Overall Study||36
10926297|NCT00259272|12094669|FG001|STARTED|Overall Study||31
10926298|NCT00259272|12094670|FG002|STARTED|Overall Study||26
10926299|NCT00259272|12094671|FG003|STARTED|Overall Study||48
10926300|NCT00259272|12094668|FG000|COMPLETED|Overall Study||21
10926301|NCT00259272|12094669|FG001|COMPLETED|Overall Study||24
10926302|NCT00259272|12094670|FG002|COMPLETED|Overall Study||21
10926303|NCT00259272|12094671|FG003|COMPLETED|Overall Study||27
10926304|NCT00259272|12094668|FG000|NOT COMPLETED|Overall Study||15
10926305|NCT00259272|12094669|FG001|NOT COMPLETED|Overall Study||7
10926306|NCT00259272|12094670|FG002|NOT COMPLETED|Overall Study||5
10926307|NCT00259272|12094671|FG003|NOT COMPLETED|Overall Study||21
10926308|NCT00259285|12094686|FG000|STARTED|Overall Study||10
10926309|NCT00259285|12094686|FG000|COMPLETED|Overall Study||10
10926310|NCT00259285|12094686|FG000|NOT COMPLETED|Overall Study||0
10926311|NCT00259298|12094690|FG000|STARTED|Overall Study||12
10926312|NCT00259298|12094690|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10
10926313|NCT00259298|12094690|FG000|COMPLETED|Overall Study||9
10926314|NCT00259298|12094690|FG000|NOT COMPLETED|Overall Study||3
10926315|NCT00259610|12094698|FG000|STARTED|Overall Study||244
10926316|NCT00259610|12094699|FG001|STARTED|Overall Study||132
10926317|NCT00259610|12094700|FG002|STARTED|Overall Study||255
10926318|NCT00259610|12094701|FG003|STARTED|Overall Study||124
10926319|NCT00259610|12094698|FG000|COMPLETED|Overall Study||168
10926320|NCT00259610|12094699|FG001|COMPLETED|Overall Study||86
10926321|NCT00259610|12094700|FG002|COMPLETED|Overall Study||182
10926322|NCT00259610|12094701|FG003|COMPLETED|Overall Study||81
10926323|NCT00259610|12094698|FG000|NOT COMPLETED|Overall Study||76
10926324|NCT00259610|12094699|FG001|NOT COMPLETED|Overall Study||46
10926325|NCT00259610|12094700|FG002|NOT COMPLETED|Overall Study||73
10926326|NCT00259610|12094701|FG003|NOT COMPLETED|Overall Study||43
10926327|NCT00259649|12094711|FG000|STARTED|Overall Study||71
10926328|NCT00259649|12094711|FG000|COMPLETED|Overall Study||61
10926329|NCT00259649|12094711|FG000|NOT COMPLETED|Overall Study||10
10926330|NCT00259740|12094717|FG000|STARTED|Overall Study||43
10926331|NCT00259740|12094718|FG001|STARTED|Overall Study||53
10926332|NCT00259740|12094717|FG000|Received Study Medication|Overall Study||42
10926333|NCT00259740|12094718|FG001|Received Study Medication|Overall Study||53
10926334|NCT00259740|12094717|FG000|COMPLETED|Overall Study||0
10926335|NCT00259740|12094718|FG001|COMPLETED|Overall Study||0
10926336|NCT00259740|12094717|FG000|NOT COMPLETED|Overall Study||43
10926337|NCT00259740|12094718|FG001|NOT COMPLETED|Overall Study||53
10926338|NCT00259857|12094726|FG000|STARTED|12 Months Treatment||11
10926339|NCT00259857|12094727|FG001|STARTED|12 Months Treatment||11
10926340|NCT00259857|12094726|FG000|COMPLETED|12 Months Treatment||10
10926341|NCT00259857|12094727|FG001|COMPLETED|12 Months Treatment||9
10926342|NCT00259857|12094726|FG000|NOT COMPLETED|12 Months Treatment||1
10926343|NCT00259857|12094727|FG001|NOT COMPLETED|12 Months Treatment||2
10926344|NCT00259857|12094726|FG000|STARTED|24 Months Treatment||10
10926345|NCT00259857|12094727|FG001|STARTED|24 Months Treatment||9
10926346|NCT00259857|12094726|FG000|COMPLETED|24 Months Treatment||10
10926347|NCT00259857|12094727|FG001|COMPLETED|24 Months Treatment||6
10926348|NCT00259857|12094726|FG000|NOT COMPLETED|24 Months Treatment||0
10926349|NCT00259857|12094727|FG001|NOT COMPLETED|24 Months Treatment||3
10926350|NCT00260065|12094733|FG000|STARTED|Overall Study||99
10926351|NCT00260065|12094733|FG000|COMPLETED|Overall Study||6
10926352|NCT00260065|12094733|FG000|NOT COMPLETED|Overall Study||93
10926353|NCT00260195|12094739|FG000|STARTED|Overall Study||39
10926354|NCT00260195|12094740|FG001|STARTED|Overall Study||37
10926355|NCT00260195|12094739|FG000|COMPLETED|Overall Study||39
10926356|NCT00260195|12094740|FG001|COMPLETED|Overall Study||37
10926357|NCT00260195|12094739|FG000|NOT COMPLETED|Overall Study||0
10926358|NCT00260195|12094740|FG001|NOT COMPLETED|Overall Study||0
10926359|NCT00260208|12094749|FG000|STARTED|Overall Study|"Started indicates safety population."|184
10926360|NCT00260208|12094750|FG001|STARTED|Overall Study||172
10926361|NCT00260208|12094749|FG000|Intent to Treat (ITT) Population|Overall Study||182
10926362|NCT00260208|12094750|FG001|Intent to Treat (ITT) Population|Overall Study||169
10926363|NCT00260208|12094749|FG000|Modified ITT|Overall Study||101
10926364|NCT00260208|12094750|FG001|Modified ITT|Overall Study||96
10926365|NCT00260208|12094749|FG000|COMPLETED|Overall Study||137
10926366|NCT00260208|12094750|FG001|COMPLETED|Overall Study||138
10926367|NCT00260208|12094749|FG000|NOT COMPLETED|Overall Study||47
10926368|NCT00260208|12094750|FG001|NOT COMPLETED|Overall Study||34
10926369|NCT00260429|12094758|FG000|STARTED|Overall Study||23
10926370|NCT00260429|12094759|FG001|STARTED|Overall Study||12
10926371|NCT00260429|12094758|FG000|COMPLETED|Overall Study||21
10926372|NCT00260429|12094759|FG001|COMPLETED|Overall Study||12
10926373|NCT00260429|12094758|FG000|NOT COMPLETED|Overall Study||2
10926374|NCT00260429|12094759|FG001|NOT COMPLETED|Overall Study||0
10926375|NCT00260533|12094767|FG000|STARTED|Overall Study||14
10926376|NCT00260533|12094768|FG001|STARTED|Overall Study||13
10926377|NCT00260533|12094767|FG000|COMPLETED|Overall Study||11
10926378|NCT00260533|12094768|FG001|COMPLETED|Overall Study||10
10926379|NCT00260533|12094767|FG000|NOT COMPLETED|Overall Study||3
10926380|NCT00260533|12094768|FG001|NOT COMPLETED|Overall Study||3
10926381|NCT00260689|12094777|FG000|STARTED|Overall Study||60
10926382|NCT00260689|12094778|FG001|STARTED|Overall Study||60
10926383|NCT00260689|12094779|FG002|STARTED|Overall Study||16
10926384|NCT00260689|12094777|FG000|COMPLETED|Overall Study||19
10926385|NCT00260689|12094778|FG001|COMPLETED|Overall Study||11
10926386|NCT00260689|12094779|FG002|COMPLETED|Overall Study||1
10926387|NCT00260689|12094777|FG000|NOT COMPLETED|Overall Study||41
10926388|NCT00260689|12094778|FG001|NOT COMPLETED|Overall Study||49
10926389|NCT00260689|12094779|FG002|NOT COMPLETED|Overall Study||15
10926390|NCT00260832|12094789|FG000|STARTED|Overall Study||243
10926391|NCT00260832|12094790|FG001|STARTED|Overall Study||242
10926392|NCT00260832|12094789|FG000|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
10926393|NCT00260832|12094790|FG001|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
10926394|NCT00260832|12094789|FG000|NOT COMPLETED|Overall Study||228
10926395|NCT00260832|12094790|FG001|NOT COMPLETED|Overall Study||211
10926396|NCT00260962|12094798|FG000|STARTED|Overall Study||18
10926397|NCT00260962|12094799|FG001|STARTED|Overall Study||16
10926398|NCT00260962|12094798|FG000|COMPLETED|Overall Study||14
10926399|NCT00260962|12094799|FG001|COMPLETED|Overall Study||14
10926400|NCT00260962|12094798|FG000|NOT COMPLETED|Overall Study||4
10926401|NCT00260962|12094799|FG001|NOT COMPLETED|Overall Study||2
10926402|NCT00261040|12094807|FG000|STARTED|Overall Study||20
10926403|NCT00261040|12094808|FG001|STARTED|Overall Study||20
10926404|NCT00261040|12094807|FG000|COMPLETED|Overall Study||19
10926405|NCT00261040|12094808|FG001|COMPLETED|Overall Study||20
10926406|NCT00261040|12094807|FG000|NOT COMPLETED|Overall Study||1
10926407|NCT00261040|12094808|FG001|NOT COMPLETED|Overall Study||0
10926408|NCT00261443|12094816|FG000|STARTED|1: Confirmation of Partial Nonresponse||1270
10926409|NCT00261443|12094817|FG001|STARTED|1: Confirmation of Partial Nonresponse||0
10926410|NCT00261443|12094818|FG002|STARTED|1: Confirmation of Partial Nonresponse||0
10926411|NCT00261443|12094816|FG000|COMPLETED|1: Confirmation of Partial Nonresponse||686
10926412|NCT00261443|12094817|FG001|COMPLETED|1: Confirmation of Partial Nonresponse||0
10926413|NCT00261443|12094818|FG002|COMPLETED|1: Confirmation of Partial Nonresponse||0
10926414|NCT00261443|12094816|FG000|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
10926415|NCT00261443|12094817|FG001|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
10926416|NCT00261443|12094818|FG002|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
10926417|NCT00261443|12094816|FG000|STARTED|2: Stability & Maintenance of Stability||686
10926418|NCT00261443|12094817|FG001|STARTED|2: Stability & Maintenance of Stability||0
10926419|NCT00261443|12094818|FG002|STARTED|2: Stability & Maintenance of Stability||0
10926420|NCT00261443|12094816|FG000|COMPLETED|2: Stability & Maintenance of Stability||346
10926421|NCT00261443|12094817|FG001|COMPLETED|2: Stability & Maintenance of Stability||0
10926422|NCT00261443|12094818|FG002|COMPLETED|2: Stability & Maintenance of Stability||0
10926423|NCT00261443|12094816|FG000|NOT COMPLETED|2: Stability & Maintenance of Stability||340
10926424|NCT00261443|12094817|FG001|NOT COMPLETED|2: Stability & Maintenance of Stability||0
10926425|NCT00261443|12094818|FG002|NOT COMPLETED|2: Stability & Maintenance of Stability||0
10926426|NCT00261443|12094816|FG000|STARTED|3: Assessment of Relapse||0
10926427|NCT00261443|12094817|FG001|STARTED|3: Assessment of Relapse||169
10926428|NCT00261443|12094818|FG002|STARTED|3: Assessment of Relapse||168
10926429|NCT00261443|12094816|FG000|COMPLETED|3: Assessment of Relapse||0
10926430|NCT00261443|12094817|FG001|COMPLETED|3: Assessment of Relapse||89
10926431|NCT00261443|12094818|FG002|COMPLETED|3: Assessment of Relapse||103
10926432|NCT00261443|12094816|FG000|NOT COMPLETED|3: Assessment of Relapse||0
10926433|NCT00261443|12094817|FG001|NOT COMPLETED|3: Assessment of Relapse||80
10926434|NCT00261443|12094818|FG002|NOT COMPLETED|3: Assessment of Relapse||65
10926435|NCT00261443|12094816|FG000|STARTED|4: Extension Phase||0
10926436|NCT00261443|12094817|FG001|STARTED|4: Extension Phase||19
10926437|NCT00261443|12094818|FG002|STARTED|4: Extension Phase||23
10926438|NCT00261443|12094816|FG000|COMPLETED|4: Extension Phase||0
10926439|NCT00261443|12094817|FG001|COMPLETED|4: Extension Phase||16
10926440|NCT00261443|12094818|FG002|COMPLETED|4: Extension Phase||21
10926441|NCT00261443|12094816|FG000|NOT COMPLETED|4: Extension Phase||0
10926442|NCT00261443|12094817|FG001|NOT COMPLETED|4: Extension Phase||3
10926443|NCT00261443|12094818|FG002|NOT COMPLETED|4: Extension Phase||2
10926444|NCT00261495|12094831|FG000|STARTED|Titration Phase (Weeks 0 to 4)||254
10926445|NCT00261495|12094832|FG001|STARTED|Titration Phase (Weeks 0 to 4)||250
10926446|NCT00261495|12094831|FG000|COMPLETED|Titration Phase (Weeks 0 to 4)||206
10926447|NCT00261495|12094832|FG001|COMPLETED|Titration Phase (Weeks 0 to 4)||185
10926448|NCT00261495|12094831|FG000|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
10926449|NCT00261495|12094832|FG001|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
10926450|NCT00261495|12094831|FG000|STARTED|Maintenance Phase (Weeks 4 to 24)||206
10926451|NCT00261495|12094832|FG001|STARTED|Maintenance Phase (Weeks 4 to 24)||185
10926452|NCT00261495|12094831|FG000|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
10926453|NCT00261495|12094832|FG001|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
10926454|NCT00261495|12094831|FG000|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
10926455|NCT00261495|12094832|FG001|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
10926456|NCT00261495|12094831|FG000|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
10926457|NCT00261495|12094832|FG001|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
10926458|NCT00261495|12094831|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||50
10926459|NCT00261495|12094832|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||47
10926460|NCT00261495|12094831|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
10926461|NCT00261495|12094832|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
10926462|NCT00261716|12094840|FG000|STARTED|Overall Study||17
10926463|NCT00261716|12094841|FG001|STARTED|Overall Study||21
10926464|NCT00261716|12094840|FG000|COMPLETED|Overall Study||11
10926465|NCT00261716|12094841|FG001|COMPLETED|Overall Study||11
10926466|NCT00261716|12094840|FG000|NOT COMPLETED|Overall Study||6
10926467|NCT00261716|12094841|FG001|NOT COMPLETED|Overall Study||10
10926468|NCT00261833|12094853|FG000|STARTED|Overall Study||93
10926469|NCT00261833|12094854|FG001|STARTED|Overall Study||87
10926470|NCT00261833|12094853|FG000|COMPLETED|Overall Study||84
10926471|NCT00261833|12094854|FG001|COMPLETED|Overall Study||69
10926472|NCT00261833|12094853|FG000|NOT COMPLETED|Overall Study||9
10926473|NCT00261833|12094854|FG001|NOT COMPLETED|Overall Study||18
10926474|NCT00261846|12094870|FG000|STARTED|Period 1: Part 1 (Dose Escalation)||3
10926475|NCT00261846|12094871|FG001|STARTED|Period 1: Part 1 (Dose Escalation)||3
10926476|NCT00261846|12094872|FG002|STARTED|Period 1: Part 1 (Dose Escalation)||12
10926477|NCT00261846|12094873|FG003|STARTED|Period 1: Part 1 (Dose Escalation)||0
10926478|NCT00261846|12094874|FG004|STARTED|Period 1: Part 1 (Dose Escalation)||0
10926479|NCT00261846|12094875|FG005|STARTED|Period 1: Part 1 (Dose Escalation)||0
10926480|NCT00261846|12094876|FG006|STARTED|Period 1: Part 1 (Dose Escalation)||0
10926481|NCT00261846|12094877|FG007|STARTED|Period 1: Part 1 (Dose Escalation)||0
10926482|NCT00261846|12094878|FG008|STARTED|Period 1: Part 1 (Dose Escalation)||0
10926483|NCT00261846|12094879|FG009|STARTED|Period 1: Part 1 (Dose Escalation)||0
10926484|NCT00261846|12094880|FG010|STARTED|Period 1: Part 1 (Dose Escalation)||0
10926485|NCT00261846|12094881|FG011|STARTED|Period 1: Part 1 (Dose Escalation)||0
10926486|NCT00261846|12094870|FG000|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926487|NCT00261846|12094871|FG001|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926488|NCT00261846|12094872|FG002|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926489|NCT00261846|12094873|FG003|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926490|NCT00261846|12094874|FG004|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926491|NCT00261846|12094875|FG005|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926492|NCT00261846|12094876|FG006|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926493|NCT00261846|12094877|FG007|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926494|NCT00261846|12094878|FG008|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926495|NCT00261846|12094879|FG009|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926496|NCT00261846|12094880|FG010|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926497|NCT00261846|12094881|FG011|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926498|NCT00261846|12094870|FG000|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
10926499|NCT00261846|12094871|FG001|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
10926500|NCT00261846|12094872|FG002|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
10926501|NCT00261846|12094873|FG003|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926502|NCT00261846|12094874|FG004|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926503|NCT00261846|12094875|FG005|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926504|NCT00261846|12094876|FG006|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926505|NCT00261846|12094877|FG007|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926506|NCT00261846|12094878|FG008|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926507|NCT00261846|12094879|FG009|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926508|NCT00261846|12094880|FG010|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926509|NCT00261846|12094881|FG011|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
10926510|NCT00261846|12094870|FG000|STARTED|Period 2: Part 2 (Efficacy)||0
10926511|NCT00261846|12094871|FG001|STARTED|Period 2: Part 2 (Efficacy)||0
10926512|NCT00261846|12094872|FG002|STARTED|Period 2: Part 2 (Efficacy)||0
10926513|NCT00261846|12094873|FG003|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
10926514|NCT00261846|12094874|FG004|STARTED|Period 2: Part 2 (Efficacy)||89
10926515|NCT00261846|12094875|FG005|STARTED|Period 2: Part 2 (Efficacy)||5
10926516|NCT00261846|12094876|FG006|STARTED|Period 2: Part 2 (Efficacy)||38
10926517|NCT00261846|12094877|FG007|STARTED|Period 2: Part 2 (Efficacy)||50
10926518|NCT00261846|12094878|FG008|STARTED|Period 2: Part 2 (Efficacy)||26
10926519|NCT00261846|12094879|FG009|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
10926520|NCT00261846|12094880|FG010|STARTED|Period 2: Part 2 (Efficacy)||64
10926521|NCT00261846|12094881|FG011|STARTED|Period 2: Part 2 (Efficacy)||24
10926522|NCT00261846|12094870|FG000|COMPLETED|Period 2: Part 2 (Efficacy)||0
10926523|NCT00261846|12094871|FG001|COMPLETED|Period 2: Part 2 (Efficacy)||0
10926524|NCT00261846|12094872|FG002|COMPLETED|Period 2: Part 2 (Efficacy)||0
10926525|NCT00261846|12094873|FG003|COMPLETED|Period 2: Part 2 (Efficacy)||60
10926526|NCT00261846|12094874|FG004|COMPLETED|Period 2: Part 2 (Efficacy)||39
10926527|NCT00261846|12094875|FG005|COMPLETED|Period 2: Part 2 (Efficacy)||3
10926528|NCT00261846|12094876|FG006|COMPLETED|Period 2: Part 2 (Efficacy)||16
10926529|NCT00261846|12094877|FG007|COMPLETED|Period 2: Part 2 (Efficacy)||21
10926530|NCT00261846|12094878|FG008|COMPLETED|Period 2: Part 2 (Efficacy)||12
10926531|NCT00261846|12094879|FG009|COMPLETED|Period 2: Part 2 (Efficacy)||30
10926532|NCT00261846|12094880|FG010|COMPLETED|Period 2: Part 2 (Efficacy)||15
10926533|NCT00261846|12094881|FG011|COMPLETED|Period 2: Part 2 (Efficacy)||1
10926534|NCT00261846|12094870|FG000|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
10926535|NCT00261846|12094871|FG001|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
10926536|NCT00261846|12094872|FG002|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
10926537|NCT00261846|12094873|FG003|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
10926538|NCT00261846|12094874|FG004|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
10926539|NCT00261846|12094875|FG005|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
10926540|NCT00261846|12094876|FG006|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
10926541|NCT00261846|12094877|FG007|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
10926542|NCT00261846|12094878|FG008|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
10926543|NCT00261846|12094879|FG009|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
10926544|NCT00261846|12094880|FG010|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
10926545|NCT00261846|12094881|FG011|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
10926546|NCT00261950|12094920|FG000|STARTED|Overall Study||110
10926547|NCT00261950|12094920|FG000|COMPLETED|Overall Study||84
10926548|NCT00261950|12094920|FG000|NOT COMPLETED|Overall Study||26
10926549|NCT00262002|12094931|FG000|STARTED|Overall Study||90
10926550|NCT00262002|12094932|FG001|STARTED|Overall Study||90
10926551|NCT00262002|12094933|FG002|STARTED|Overall Study||45
10926552|NCT00262002|12094934|FG003|STARTED|Overall Study||98
10926553|NCT00262002|12094935|FG004|STARTED|Overall Study||98
10926554|NCT00262002|12094936|FG005|STARTED|Overall Study||90
10926555|NCT00262002|12094937|FG006|STARTED|Overall Study||90
10926556|NCT00262002|12094931|FG000|COMPLETED|Overall Study||79
10926557|NCT00262002|12094932|FG001|COMPLETED|Overall Study||84
10926558|NCT00262002|12094933|FG002|COMPLETED|Overall Study||45
10926559|NCT00262002|12094934|FG003|COMPLETED|Overall Study||93
10926560|NCT00262002|12094935|FG004|COMPLETED|Overall Study||91
10926561|NCT00262002|12094936|FG005|COMPLETED|Overall Study||83
10926562|NCT00262002|12094937|FG006|COMPLETED|Overall Study||84
10926563|NCT00262002|12094931|FG000|NOT COMPLETED|Overall Study||11
10926564|NCT00262002|12094932|FG001|NOT COMPLETED|Overall Study||6
10926565|NCT00262002|12094933|FG002|NOT COMPLETED|Overall Study||0
10926566|NCT00262002|12094934|FG003|NOT COMPLETED|Overall Study||5
10926567|NCT00262002|12094935|FG004|NOT COMPLETED|Overall Study||7
10926568|NCT00262002|12094936|FG005|NOT COMPLETED|Overall Study||7
10926569|NCT00262002|12094937|FG006|NOT COMPLETED|Overall Study||6
10926570|NCT00262028|12095011|FG000|STARTED|Overall Study||152
10926571|NCT00262028|12095012|FG001|STARTED|Overall Study||153
10926572|NCT00262028|12095013|FG002|STARTED|Overall Study||157
10926573|NCT00262028|12095014|FG003|STARTED|Overall Study||157
10926574|NCT00262028|12095015|FG004|STARTED|Overall Study||74
10926575|NCT00262028|12095016|FG005|STARTED|Overall Study||73
10926576|NCT00262028|12095017|FG006|STARTED|Overall Study||71
10926577|NCT00262028|12095018|FG007|STARTED|Overall Study||73
10926578|NCT00262028|12095019|FG008|STARTED|Overall Study||100
10926579|NCT00262028|12095011|FG000|COMPLETED|Overall Study||128
10926580|NCT00262028|12095012|FG001|COMPLETED|Overall Study||126
10926581|NCT00262028|12095013|FG002|COMPLETED|Overall Study||137
10926582|NCT00262028|12095014|FG003|COMPLETED|Overall Study||134
10926583|NCT00262028|12095015|FG004|COMPLETED|Overall Study||62
10926584|NCT00262028|12095016|FG005|COMPLETED|Overall Study||60
10926585|NCT00262028|12095017|FG006|COMPLETED|Overall Study||59
10926586|NCT00262028|12095018|FG007|COMPLETED|Overall Study||55
10926587|NCT00262028|12095019|FG008|COMPLETED|Overall Study||81
10926588|NCT00262028|12095011|FG000|NOT COMPLETED|Overall Study||24
10926589|NCT00262028|12095012|FG001|NOT COMPLETED|Overall Study||27
10926590|NCT00262028|12095013|FG002|NOT COMPLETED|Overall Study||20
10926591|NCT00262028|12095014|FG003|NOT COMPLETED|Overall Study||23
10926592|NCT00262028|12095015|FG004|NOT COMPLETED|Overall Study||12
10926593|NCT00262028|12095016|FG005|NOT COMPLETED|Overall Study||13
10926594|NCT00262028|12095017|FG006|NOT COMPLETED|Overall Study||12
10926595|NCT00262028|12095018|FG007|NOT COMPLETED|Overall Study||18
10926596|NCT00262028|12095019|FG008|NOT COMPLETED|Overall Study||19
10926597|NCT00262041|12095065|FG000|STARTED|Overall Study||164
10926598|NCT00262041|12095066|FG001|STARTED|Overall Study||151
10926599|NCT00262041|12095067|FG002|STARTED|Overall Study||209
10926600|NCT00262041|12095065|FG000|COMPLETED|Overall Study||162
10926601|NCT00262041|12095066|FG001|COMPLETED|Overall Study||147
10926602|NCT00262041|12095067|FG002|COMPLETED|Overall Study||203
10926603|NCT00262041|12095065|FG000|NOT COMPLETED|Overall Study||2
10926604|NCT00262041|12095066|FG001|NOT COMPLETED|Overall Study||4
10926605|NCT00262041|12095067|FG002|NOT COMPLETED|Overall Study||6
10926606|NCT00262067|12095085|FG000|STARTED|Overall Study||415
10926607|NCT00262067|12095086|FG001|STARTED|Overall Study||207
10926608|NCT00262067|12095087|FG002|STARTED|Overall Study||409
10926609|NCT00262067|12095088|FG003|STARTED|Overall Study||206
10926610|NCT00262067|12095085|FG000|COMPLETED|Overall Study||196
10926611|NCT00262067|12095086|FG001|COMPLETED|Overall Study||107
10926612|NCT00262067|12095087|FG002|COMPLETED|Overall Study||193
10926613|NCT00262067|12095088|FG003|COMPLETED|Overall Study||93
10926614|NCT00262067|12095085|FG000|NOT COMPLETED|Overall Study||219
10926615|NCT00262067|12095086|FG001|NOT COMPLETED|Overall Study||100
10926616|NCT00262067|12095087|FG002|NOT COMPLETED|Overall Study||216
10926617|NCT00262067|12095088|FG003|NOT COMPLETED|Overall Study||113
10926618|NCT00262080|12095101|FG000|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
10926619|NCT00262080|12095102|FG001|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
10926620|NCT00262080|12095103|FG002|STARTED|Double Blind Treatment Period||0
10926621|NCT00262080|12095101|FG000|COMPLETED|Double Blind Treatment Period||35
10926622|NCT00262080|12095102|FG001|COMPLETED|Double Blind Treatment Period||36
10926623|NCT00262080|12095103|FG002|COMPLETED|Double Blind Treatment Period||0
10926624|NCT00262080|12095101|FG000|NOT COMPLETED|Double Blind Treatment Period||1
10926625|NCT00262080|12095102|FG001|NOT COMPLETED|Double Blind Treatment Period||0
10926626|NCT00262080|12095103|FG002|NOT COMPLETED|Double Blind Treatment Period||0
10926627|NCT00262080|12095101|FG000|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
10926628|NCT00262080|12095102|FG001|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
10926629|NCT00262080|12095103|FG002|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
10926630|NCT00262080|12095101|FG000|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
10926631|NCT00262080|12095102|FG001|COMPLETED|Repeat Dose Treatment Period||25
10926632|NCT00262080|12095103|FG002|COMPLETED|Repeat Dose Treatment Period||14
10926633|NCT00262080|12095101|FG000|NOT COMPLETED|Repeat Dose Treatment Period||4
10926634|NCT00262080|12095102|FG001|NOT COMPLETED|Repeat Dose Treatment Period||1
10926635|NCT00262080|12095103|FG002|NOT COMPLETED|Repeat Dose Treatment Period||5
10926636|NCT00262119|12095114|FG000|STARTED|Overall Study||385
10926637|NCT00262119|12095115|FG001|STARTED|Overall Study||398
10926638|NCT00262119|12095116|FG002|STARTED|Overall Study||383
10926639|NCT00262119|12095114|FG000|COMPLETED|Overall Study||327
10926640|NCT00262119|12095115|FG001|COMPLETED|Overall Study||328
10926641|NCT00262119|12095116|FG002|COMPLETED|Overall Study||325
10926642|NCT00262119|12095114|FG000|NOT COMPLETED|Overall Study||58
10926643|NCT00262119|12095115|FG001|NOT COMPLETED|Overall Study||70
10926644|NCT00262119|12095116|FG002|NOT COMPLETED|Overall Study||58
10926645|NCT00262223|12095126|FG000|STARTED|Treatment Phase||32
10926646|NCT00262223|12095127|FG001|STARTED|Treatment Phase||37
10926647|NCT00262223|12095126|FG000|COMPLETED|Treatment Phase||28
10926648|NCT00262223|12095127|FG001|COMPLETED|Treatment Phase||29
10926649|NCT00262223|12095126|FG000|NOT COMPLETED|Treatment Phase||4
10926650|NCT00262223|12095127|FG001|NOT COMPLETED|Treatment Phase||8
10926651|NCT00262223|12095126|FG000|STARTED|1-week Post-treatment Follow-up||28
10926652|NCT00262223|12095127|FG001|STARTED|1-week Post-treatment Follow-up||29
10926653|NCT00262223|12095126|FG000|COMPLETED|1-week Post-treatment Follow-up||24
10926654|NCT00262223|12095127|FG001|COMPLETED|1-week Post-treatment Follow-up||25
10926655|NCT00262223|12095126|FG000|NOT COMPLETED|1-week Post-treatment Follow-up||4
10926656|NCT00262223|12095127|FG001|NOT COMPLETED|1-week Post-treatment Follow-up||4
10926657|NCT00262223|12095126|FG000|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
10926658|NCT00262223|12095127|FG001|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
10926659|NCT00262223|12095126|FG000|COMPLETED|6-month Post-treatment Follow-up||22
10926660|NCT00262223|12095127|FG001|COMPLETED|6-month Post-treatment Follow-up||28
10926661|NCT00262223|12095126|FG000|NOT COMPLETED|6-month Post-treatment Follow-up||6
10926662|NCT00262223|12095127|FG001|NOT COMPLETED|6-month Post-treatment Follow-up||1
10926663|NCT00262223|12095126|FG000|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
10926664|NCT00262223|12095127|FG001|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
10926665|NCT00262223|12095126|FG000|COMPLETED|12-month Post-treatment Follow-up||21
10926666|NCT00262223|12095127|FG001|COMPLETED|12-month Post-treatment Follow-up||22
10926667|NCT00262223|12095126|FG000|NOT COMPLETED|12-month Post-treatment Follow-up||7
10926668|NCT00262223|12095127|FG001|NOT COMPLETED|12-month Post-treatment Follow-up||7
10926669|NCT00262301|12095137|FG000|STARTED|Double-blind Phase||16
10926670|NCT00262301|12095138|FG001|STARTED|Double-blind Phase||16
10926671|NCT00262301|12095139|FG002|STARTED|Double-blind Phase||0
10926672|NCT00262301|12095137|FG000|COMPLETED|Double-blind Phase||15
10926673|NCT00262301|12095138|FG001|COMPLETED|Double-blind Phase||15
10926674|NCT00262301|12095139|FG002|COMPLETED|Double-blind Phase||0
10926675|NCT00262301|12095137|FG000|NOT COMPLETED|Double-blind Phase||1
10926676|NCT00262301|12095138|FG001|NOT COMPLETED|Double-blind Phase||1
10926677|NCT00262301|12095139|FG002|NOT COMPLETED|Double-blind Phase||0
10926678|NCT00262301|12095137|FG000|STARTED|Open-label Phase||0
10926679|NCT00262301|12095138|FG001|STARTED|Open-label Phase||0
10926680|NCT00262301|12095139|FG002|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
10926681|NCT00262301|12095137|FG000|COMPLETED|Open-label Phase||0
10926682|NCT00262301|12095138|FG001|COMPLETED|Open-label Phase||0
10926683|NCT00262301|12095139|FG002|COMPLETED|Open-label Phase||57
10926684|NCT00262301|12095137|FG000|NOT COMPLETED|Open-label Phase||0
10926685|NCT00262301|12095138|FG001|NOT COMPLETED|Open-label Phase||0
10926686|NCT00262301|12095139|FG002|NOT COMPLETED|Open-label Phase||0
10926687|NCT00262314|12095147|FG000|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
10926688|NCT00262314|12095147|FG000|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
10926689|NCT00262314|12095147|FG000|NOT COMPLETED|Overall Study||337
10926690|NCT00262509|12095153|FG000|STARTED|Overall Study||8
10926691|NCT00262509|12095154|FG001|STARTED|Overall Study||9
10926692|NCT00262509|12095153|FG000|COMPLETED|Overall Study||8
10926693|NCT00262509|12095154|FG001|COMPLETED|Overall Study||9
10926694|NCT00262509|12095153|FG000|NOT COMPLETED|Overall Study||0
10926695|NCT00262509|12095154|FG001|NOT COMPLETED|Overall Study||0
10926696|NCT00262522|12095164|FG000|STARTED|Study Start Through 8 Weeks||167
10926697|NCT00262522|12095165|FG001|STARTED|Study Start Through 8 Weeks||166
10926698|NCT00262522|12095166|FG002|STARTED|Study Start Through 8 Weeks||166
10926699|NCT00262522|12095167|FG003|STARTED|Study Start Through 8 Weeks||165
10926700|NCT00262522|12095164|FG000|COMPLETED|Study Start Through 8 Weeks||163
10926701|NCT00262522|12095165|FG001|COMPLETED|Study Start Through 8 Weeks||161
10926702|NCT00262522|12095166|FG002|COMPLETED|Study Start Through 8 Weeks||155
10926703|NCT00262522|12095167|FG003|COMPLETED|Study Start Through 8 Weeks||160
10926704|NCT00262522|12095164|FG000|NOT COMPLETED|Study Start Through 8 Weeks||4
10926705|NCT00262522|12095165|FG001|NOT COMPLETED|Study Start Through 8 Weeks||5
10926706|NCT00262522|12095166|FG002|NOT COMPLETED|Study Start Through 8 Weeks||11
10926707|NCT00262522|12095167|FG003|NOT COMPLETED|Study Start Through 8 Weeks||5
10926708|NCT00262522|12095164|FG000|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
10926709|NCT00262522|12095165|FG001|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
10926710|NCT00262522|12095166|FG002|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
10926711|NCT00262522|12095167|FG003|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
10926712|NCT00262522|12095164|FG000|COMPLETED|Study Start Through 48 Weeks||284
10926713|NCT00262522|12095165|FG001|COMPLETED|Study Start Through 48 Weeks||0
10926714|NCT00262522|12095166|FG002|COMPLETED|Study Start Through 48 Weeks||276
10926715|NCT00262522|12095167|FG003|COMPLETED|Study Start Through 48 Weeks||0
10926716|NCT00262522|12095164|FG000|NOT COMPLETED|Study Start Through 48 Weeks||49
10926717|NCT00262522|12095165|FG001|NOT COMPLETED|Study Start Through 48 Weeks||0
10926718|NCT00262522|12095166|FG002|NOT COMPLETED|Study Start Through 48 Weeks||55
10926719|NCT00262522|12095167|FG003|NOT COMPLETED|Study Start Through 48 Weeks||0
10926720|NCT00262522|12095164|FG000|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
10926721|NCT00262522|12095165|FG001|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
10926722|NCT00262522|12095166|FG002|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
10926723|NCT00262522|12095167|FG003|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
10926724|NCT00262522|12095164|FG000|COMPLETED|Study Start Through 96 Weeks||256
10926725|NCT00262522|12095165|FG001|COMPLETED|Study Start Through 96 Weeks||0
10926726|NCT00262522|12095166|FG002|COMPLETED|Study Start Through 96 Weeks||254
10926727|NCT00262522|12095167|FG003|COMPLETED|Study Start Through 96 Weeks||0
10926728|NCT00262522|12095164|FG000|NOT COMPLETED|Study Start Through 96 Weeks||77
10926729|NCT00262522|12095165|FG001|NOT COMPLETED|Study Start Through 96 Weeks||0
10926730|NCT00262522|12095166|FG002|NOT COMPLETED|Study Start Through 96 Weeks||77
10926731|NCT00262522|12095167|FG003|NOT COMPLETED|Study Start Through 96 Weeks||0
10926732|NCT00262600|12095178|FG000|STARTED|Overall Study||6015
10926733|NCT00262600|12095179|FG001|STARTED|Overall Study||6076
10926734|NCT00262600|12095180|FG002|STARTED|Overall Study||6022
10926735|NCT00262600|12095178|FG000|COMPLETED|Overall Study||5780
10926736|NCT00262600|12095179|FG001|COMPLETED|Overall Study||5824
10926737|NCT00262600|12095180|FG002|COMPLETED|Overall Study||5756
10926738|NCT00262600|12095178|FG000|NOT COMPLETED|Overall Study||235
10926739|NCT00262600|12095179|FG001|NOT COMPLETED|Overall Study||252
10926740|NCT00262600|12095180|FG002|NOT COMPLETED|Overall Study||266
10926741|NCT00262639|12095192|FG000|STARTED|Overall Study||18
10926742|NCT00262639|12095193|FG001|STARTED|Overall Study||26
10926743|NCT00262639|12095194|FG002|STARTED|Overall Study||9
10926744|NCT00262639|12095195|FG003|STARTED|Overall Study||7
10926745|NCT00262639|12095192|FG000|COMPLETED|Overall Study||18
10926746|NCT00262639|12095193|FG001|COMPLETED|Overall Study||26
10926747|NCT00262639|12095194|FG002|COMPLETED|Overall Study||9
10926748|NCT00262639|12095195|FG003|COMPLETED|Overall Study||7
10926749|NCT00262639|12095192|FG000|NOT COMPLETED|Overall Study||0
10926750|NCT00262639|12095193|FG001|NOT COMPLETED|Overall Study||0
10926751|NCT00262639|12095194|FG002|NOT COMPLETED|Overall Study||0
10926752|NCT00262639|12095195|FG003|NOT COMPLETED|Overall Study||0
10926753|NCT00262730|12095205|FG000|STARTED|Overall Study||97
10926754|NCT00262730|12095205|FG000|COMPLETED|Overall Study||97
10926755|NCT00262730|12095205|FG000|NOT COMPLETED|Overall Study||0
10926756|NCT00262743|12095211|FG000|STARTED|Overall Study||27
10926757|NCT00262743|12095212|FG001|STARTED|Overall Study||42
10926758|NCT00262743|12095211|FG000|COMPLETED|Overall Study||27
10926759|NCT00262743|12095212|FG001|COMPLETED|Overall Study||30
10926760|NCT00262743|12095211|FG000|NOT COMPLETED|Overall Study||0
10926761|NCT00262743|12095212|FG001|NOT COMPLETED|Overall Study||12
10926762|NCT00262821|12095218|FG000|STARTED|Overall Study||198
10926763|NCT00262821|12095219|FG001|STARTED|Overall Study||204
10926764|NCT00262821|12095218|FG000|COMPLETED|Overall Study||194
10926765|NCT00262821|12095219|FG001|COMPLETED|Overall Study||185
10926766|NCT00262821|12095218|FG000|NOT COMPLETED|Overall Study||4
10926767|NCT00262821|12095219|FG001|NOT COMPLETED|Overall Study||19
10926768|NCT00262834|12095227|FG000|STARTED|Overall Study||25
10926769|NCT00262834|12095228|FG001|STARTED|Overall Study||29
10926770|NCT00262834|12095227|FG000|COMPLETED|Overall Study||24
10926771|NCT00262834|12095228|FG001|COMPLETED|Overall Study||25
10926772|NCT00262834|12095227|FG000|NOT COMPLETED|Overall Study||1
10926773|NCT00262834|12095228|FG001|NOT COMPLETED|Overall Study||4
10926774|NCT00262847|12095237|FG000|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
10926775|NCT00262847|12095238|FG001|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
10926776|NCT00262847|12095239|FG002|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
10926777|NCT00262847|12095237|FG000|COMPLETED|Overall Study||107
10926778|NCT00262847|12095238|FG001|COMPLETED|Overall Study||112
10926779|NCT00262847|12095239|FG002|COMPLETED|Overall Study||227
10926780|NCT00262847|12095237|FG000|NOT COMPLETED|Overall Study||518
10926781|NCT00262847|12095238|FG001|NOT COMPLETED|Overall Study||513
10926782|NCT00262847|12095239|FG002|NOT COMPLETED|Overall Study||396
10926783|NCT00262860|12095250|FG000|STARTED|Overall Study||18
10926784|NCT00262860|12095250|FG000|COMPLETED|Overall Study||16
10926785|NCT00262860|12095250|FG000|NOT COMPLETED|Overall Study||2
10926786|NCT00262873|12095254|FG000|STARTED|Overall Study||8
10926787|NCT00262873|12095254|FG000|COMPLETED|Overall Study||0
10926788|NCT00262873|12095254|FG000|NOT COMPLETED|Overall Study||8
10926789|NCT00262925|12095258|FG000|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
10926790|NCT00262925|12095258|FG000|COMPLETED|Overall Study||1
10926791|NCT00262925|12095258|FG000|NOT COMPLETED|Overall Study||11
10926792|NCT00262951|12095264|FG000|STARTED|Overall Study||23
10926793|NCT00262951|12095264|FG000|COMPLETED|Overall Study||7
10926794|NCT00262951|12095264|FG000|NOT COMPLETED|Overall Study||16
10926795|NCT00262964|12095270|FG000|STARTED|Overall Study||11
10926796|NCT00262964|12095271|FG001|STARTED|Overall Study||11
10926797|NCT00262964|12095272|FG002|STARTED|Overall Study||17
10926798|NCT00262964|12095273|FG003|STARTED|Overall Study||12
10926799|NCT00262964|12095270|FG000|COMPLETED|Overall Study||11
10926800|NCT00262964|12095271|FG001|COMPLETED|Overall Study||11
10926801|NCT00262964|12095272|FG002|COMPLETED|Overall Study||17
10926802|NCT00262964|12095273|FG003|COMPLETED|Overall Study||12
10926803|NCT00262964|12095270|FG000|NOT COMPLETED|Overall Study||0
10926804|NCT00262964|12095271|FG001|NOT COMPLETED|Overall Study||0
10926805|NCT00262964|12095272|FG002|NOT COMPLETED|Overall Study||0
10926806|NCT00262964|12095273|FG003|NOT COMPLETED|Overall Study||0
10926807|NCT00263211|12095297|FG000|STARTED|Overall Study||24
10926808|NCT00263211|12095298|FG001|STARTED|Overall Study||24
10926809|NCT00263211|12095297|FG000|COMPLETED|Overall Study||19
10926810|NCT00263211|12095298|FG001|COMPLETED|Overall Study||23
10926811|NCT00263211|12095297|FG000|NOT COMPLETED|Overall Study||5
10926812|NCT00263211|12095298|FG001|NOT COMPLETED|Overall Study||1
10926813|NCT00263328|12095310|FG000|STARTED|Overall Study||18
10926814|NCT00263328|12095311|FG001|STARTED|Overall Study||14
10926815|NCT00263328|12095312|FG002|STARTED|Overall Study||13
10926816|NCT00263328|12095310|FG000|COMPLETED|Overall Study||10
10926817|NCT00263328|12095311|FG001|COMPLETED|Overall Study||12
10926818|NCT00263328|12095312|FG002|COMPLETED|Overall Study||6
10926819|NCT00263328|12095310|FG000|NOT COMPLETED|Overall Study||8
10926820|NCT00263328|12095311|FG001|NOT COMPLETED|Overall Study||2
10926821|NCT00263328|12095312|FG002|NOT COMPLETED|Overall Study||7
10926822|NCT00263562|12095324|FG000|STARTED|Overall Study||9
10926823|NCT00263562|12095325|FG001|STARTED|Overall Study||9
10926824|NCT00263562|12095324|FG000|COMPLETED|Overall Study||6
10926825|NCT00263562|12095325|FG001|COMPLETED|Overall Study||9
10926826|NCT00263562|12095324|FG000|NOT COMPLETED|Overall Study||3
10926827|NCT00263562|12095325|FG001|NOT COMPLETED|Overall Study||0
10926828|NCT00263575|12095333|FG000|STARTED|Titration Period||139
10926829|NCT00263575|12095333|FG000|COMPLETED|Titration Period||96
10926830|NCT00263575|12095333|FG000|NOT COMPLETED|Titration Period||43
10926831|NCT00263575|12095333|FG000|STARTED|Maintence Period||96
10926832|NCT00263575|12095333|FG000|COMPLETED|Maintence Period||19
10926833|NCT00263575|12095333|FG000|NOT COMPLETED|Maintence Period||77
10926834|NCT00263588|12095341|FG000|STARTED|Overall Study||95
10926835|NCT00263588|12095342|FG001|STARTED|Overall Study||147
10926836|NCT00263588|12095341|FG000|COMPLETED|Overall Study||14
10926837|NCT00263588|12095342|FG001|COMPLETED|Overall Study||15
10926838|NCT00263588|12095341|FG000|NOT COMPLETED|Overall Study||81
10926839|NCT00263588|12095342|FG001|NOT COMPLETED|Overall Study||132
10926840|NCT00263666|12095351|FG000|STARTED|Overall Study||50
10926841|NCT00263666|12095352|FG001|STARTED|Overall Study||50
10926842|NCT00263666|12095351|FG000|COMPLETED|Overall Study||43
10926843|NCT00263666|12095352|FG001|COMPLETED|Overall Study||39
10926844|NCT00263666|12095351|FG000|NOT COMPLETED|Overall Study||7
10926845|NCT00263666|12095352|FG001|NOT COMPLETED|Overall Study||11
10926846|NCT00263757|12095360|FG000|STARTED|Overall Study||12
10926847|NCT00263757|12095361|FG001|STARTED|Overall Study||13
10926848|NCT00263757|12095360|FG000|COMPLETED|Overall Study||4
10926849|NCT00263757|12095361|FG001|COMPLETED|Overall Study||5
10926850|NCT00263757|12095360|FG000|NOT COMPLETED|Overall Study||8
10926851|NCT00263757|12095361|FG001|NOT COMPLETED|Overall Study||8
10926852|NCT00263887|12095369|FG000|STARTED|Overall Study||38
10926853|NCT00263887|12095370|FG001|STARTED|Overall Study||39
10926854|NCT00263887|12095369|FG000|COMPLETED|Overall Study||35
10926855|NCT00263887|12095370|FG001|COMPLETED|Overall Study||32
10926856|NCT00263887|12095369|FG000|NOT COMPLETED|Overall Study||3
10926857|NCT00263887|12095370|FG001|NOT COMPLETED|Overall Study||7
10926858|NCT00264004|12095380|FG000|STARTED|Overall Study|Randomised|30
10926859|NCT00264004|12095381|FG001|STARTED|Overall Study|Randomised|32
10926860|NCT00264004|12095382|FG002|STARTED|Overall Study|Randomised|30
10926861|NCT00264004|12095383|FG003|STARTED|Overall Study|Randomised|34
10926862|NCT00264004|12095380|FG000|COMPLETED|Overall Study|Completed 12 weeks treatment|13
10926863|NCT00264004|12095381|FG001|COMPLETED|Overall Study|Completed 12 weeks treatment|21
10926864|NCT00264004|12095382|FG002|COMPLETED|Overall Study|Completed 12 weeks treatment|16
10926865|NCT00264004|12095383|FG003|COMPLETED|Overall Study|Completed 12 weeks treatment|19
10926866|NCT00264004|12095380|FG000|NOT COMPLETED|Overall Study||17
10926867|NCT00264004|12095381|FG001|NOT COMPLETED|Overall Study||11
10926868|NCT00264004|12095382|FG002|NOT COMPLETED|Overall Study||14
10926869|NCT00264004|12095383|FG003|NOT COMPLETED|Overall Study||15
10926870|NCT00264238|12095393|FG000|STARTED|Overall Study||15
10926871|NCT00264238|12095393|FG000|COMPLETED|Overall Study||14
10926872|NCT00264238|12095393|FG000|NOT COMPLETED|Overall Study||1
10926873|NCT00264290|12095401|FG000|STARTED|Intervention (8 Weeks)||16
10926874|NCT00264290|12095402|FG001|STARTED|Intervention (8 Weeks)||14
10926875|NCT00264290|12095401|FG000|COMPLETED|Intervention (8 Weeks)||15
10926876|NCT00264290|12095402|FG001|COMPLETED|Intervention (8 Weeks)||14
10926877|NCT00264290|12095401|FG000|NOT COMPLETED|Intervention (8 Weeks)||1
10926878|NCT00264290|12095402|FG001|NOT COMPLETED|Intervention (8 Weeks)||0
10926879|NCT00264290|12095401|FG000|STARTED|Observation (4 Weeks)||15
10926880|NCT00264290|12095402|FG001|STARTED|Observation (4 Weeks)||14
10926881|NCT00264290|12095401|FG000|COMPLETED|Observation (4 Weeks)||15
10926882|NCT00264290|12095402|FG001|COMPLETED|Observation (4 Weeks)||14
10926883|NCT00264290|12095401|FG000|NOT COMPLETED|Observation (4 Weeks)||0
10926884|NCT00264290|12095402|FG001|NOT COMPLETED|Observation (4 Weeks)||0
10926885|NCT00264303|12095414|FG000|STARTED|Overall Study||438
10926886|NCT00264303|12095415|FG001|STARTED|Overall Study||448
10926887|NCT00264303|12095414|FG000|COMPLETED|Overall Study||413
10926888|NCT00264303|12095415|FG001|COMPLETED|Overall Study||419
10926889|NCT00264303|12095414|FG000|NOT COMPLETED|Overall Study||25
10926890|NCT00264303|12095415|FG001|NOT COMPLETED|Overall Study||29
10926891|NCT00264381|12095423|FG000|STARTED|Overall Study||35
10926892|NCT00264381|12095424|FG001|STARTED|Overall Study||37
10926893|NCT00264381|12095423|FG000|COMPLETED|Overall Study||35
10926894|NCT00264381|12095424|FG001|COMPLETED|Overall Study||37
10926895|NCT00264381|12095423|FG000|NOT COMPLETED|Overall Study||0
10926896|NCT00264381|12095424|FG001|NOT COMPLETED|Overall Study||0
10926897|NCT00264498|12095432|FG000|STARTED|Randomized Treatment||17
10926898|NCT00264498|12095433|FG001|STARTED|Randomized Treatment||18
10926899|NCT00264498|12095432|FG000|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
10926900|NCT00264498|12095433|FG001|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
10926901|NCT00264498|12095432|FG000|NOT COMPLETED|Randomized Treatment||17
10926902|NCT00264498|12095433|FG001|NOT COMPLETED|Randomized Treatment||18
10926903|NCT00264498|12095432|FG000|STARTED|Crossover Treatment||6
10926904|NCT00264498|12095433|FG001|STARTED|Crossover Treatment||9
10926905|NCT00264498|12095432|FG000|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
10926906|NCT00264498|12095433|FG001|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
10926907|NCT00264498|12095432|FG000|NOT COMPLETED|Crossover Treatment||6
10926908|NCT00264498|12095433|FG001|NOT COMPLETED|Crossover Treatment||9
10926909|NCT00264537|12095443|FG000|STARTED|Overall Study||160
10926910|NCT00264537|12095444|FG001|STARTED|Overall Study||159
10926911|NCT00264537|12095445|FG002|STARTED|Overall Study||159
10926912|NCT00264537|12095446|FG003|STARTED|Overall Study||159
10926913|NCT00264537|12095443|FG000|COMPLETED|Overall Study||110
10926914|NCT00264537|12095444|FG001|COMPLETED|Overall Study||101
10926915|NCT00264537|12095445|FG002|COMPLETED|Overall Study||109
10926916|NCT00264537|12095446|FG003|COMPLETED|Overall Study||99
10926917|NCT00264537|12095443|FG000|NOT COMPLETED|Overall Study||50
10926918|NCT00264537|12095444|FG001|NOT COMPLETED|Overall Study||58
10926919|NCT00264537|12095445|FG002|NOT COMPLETED|Overall Study||50
10926920|NCT00264537|12095446|FG003|NOT COMPLETED|Overall Study||60
10926921|NCT00264550|12095462|FG000|STARTED|Overall Study||133
10926922|NCT00264550|12095463|FG001|STARTED|Overall Study||133
10926923|NCT00264550|12095464|FG002|STARTED|Overall Study||89
10926924|NCT00264550|12095465|FG003|STARTED|Overall Study||89
10926925|NCT00264550|12095462|FG000|COMPLETED|Overall Study||90
10926926|NCT00264550|12095463|FG001|COMPLETED|Overall Study||92
10926927|NCT00264550|12095464|FG002|COMPLETED|Overall Study||72
10926928|NCT00264550|12095465|FG003|COMPLETED|Overall Study||59
10926929|NCT00264550|12095462|FG000|NOT COMPLETED|Overall Study||43
10926930|NCT00264550|12095463|FG001|NOT COMPLETED|Overall Study||41
10926931|NCT00264550|12095464|FG002|NOT COMPLETED|Overall Study||17
10926932|NCT00264550|12095465|FG003|NOT COMPLETED|Overall Study||30
10926933|NCT00264576|12095477|FG000|STARTED|Overall Study||308
10926934|NCT00264576|12095478|FG001|STARTED|Overall Study||305
10926935|NCT00264576|12095477|FG000|COMPLETED|Overall Study||307
10926936|NCT00264576|12095478|FG001|COMPLETED|Overall Study||304
10926937|NCT00264576|12095477|FG000|NOT COMPLETED|Overall Study||1
10926938|NCT00264576|12095478|FG001|NOT COMPLETED|Overall Study||1
10926939|NCT00264641|12095487|FG000|STARTED|Overall Study||10
10926940|NCT00264641|12095488|FG001|STARTED|Overall Study||10
10926941|NCT00264641|12095487|FG000|Initiation of the Study|Overall Study||10
10926942|NCT00264641|12095488|FG001|Initiation of the Study|Overall Study||10
10926943|NCT00264641|12095487|FG000|COMPLETED|Overall Study||10
10926944|NCT00264641|12095488|FG001|COMPLETED|Overall Study||10
10926945|NCT00264641|12095487|FG000|NOT COMPLETED|Overall Study||0
10926946|NCT00264641|12095488|FG001|NOT COMPLETED|Overall Study||0
10926947|NCT00264797|12095495|FG000|STARTED|Overall Study||151
10926948|NCT00264797|12095496|FG001|STARTED|Overall Study||152
10926949|NCT00264797|12095495|FG000|COMPLETED|Overall Study||118
10926950|NCT00264797|12095496|FG001|COMPLETED|Overall Study||109
10926951|NCT00264797|12095495|FG000|NOT COMPLETED|Overall Study||33
10926952|NCT00264797|12095496|FG001|NOT COMPLETED|Overall Study||43
10926953|NCT00264810|12095504|FG000|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
10926954|NCT00264810|12095505|FG001|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
10926955|NCT00264810|12095504|FG000|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
10926956|NCT00264810|12095505|FG001|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
10926957|NCT00264810|12095504|FG000|NOT COMPLETED|Baseline||23
10926958|NCT00264810|12095505|FG001|NOT COMPLETED|Baseline||26
10926959|NCT00264810|12095504|FG000|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
10926960|NCT00264810|12095505|FG001|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
10926961|NCT00264810|12095504|FG000|COMPLETED|Post-Operative Stabilization Period||97
10926962|NCT00264810|12095505|FG001|COMPLETED|Post-Operative Stabilization Period||94
10926963|NCT00264810|12095504|FG000|NOT COMPLETED|Post-Operative Stabilization Period||0
10926964|NCT00264810|12095505|FG001|NOT COMPLETED|Post-Operative Stabilization Period||0
10926965|NCT00264810|12095504|FG000|STARTED|Stimulation Optimization Period||97
10926966|NCT00264810|12095505|FG001|STARTED|Stimulation Optimization Period||94
10926967|NCT00264810|12095504|FG000|COMPLETED|Stimulation Optimization Period||96
10926968|NCT00264810|12095505|FG001|COMPLETED|Stimulation Optimization Period||93
10926969|NCT00264810|12095504|FG000|NOT COMPLETED|Stimulation Optimization Period||1
10926970|NCT00264810|12095505|FG001|NOT COMPLETED|Stimulation Optimization Period||1
10926971|NCT00264810|12095504|FG000|STARTED|Blinded Evaluation Period||96
10926972|NCT00264810|12095505|FG001|STARTED|Blinded Evaluation Period||93
10926973|NCT00264810|12095504|FG000|COMPLETED|Blinded Evaluation Period||95
10926974|NCT00264810|12095505|FG001|COMPLETED|Blinded Evaluation Period||92
10926975|NCT00264810|12095504|FG000|NOT COMPLETED|Blinded Evaluation Period||1
10926976|NCT00264810|12095505|FG001|NOT COMPLETED|Blinded Evaluation Period||1
10926977|NCT00264810|12095504|FG000|STARTED|Open Label Evaluation Period||95
10926978|NCT00264810|12095505|FG001|STARTED|Open Label Evaluation Period||92
10926979|NCT00264810|12095504|FG000|1-year Post-implant|Open Label Evaluation Period||92
10926980|NCT00264810|12095505|FG001|1-year Post-implant|Open Label Evaluation Period||90
10926981|NCT00264810|12095504|FG000|COMPLETED|Open Label Evaluation Period||89
10926982|NCT00264810|12095505|FG001|COMPLETED|Open Label Evaluation Period||86
10926983|NCT00264810|12095504|FG000|NOT COMPLETED|Open Label Evaluation Period||6
10926984|NCT00264810|12095505|FG001|NOT COMPLETED|Open Label Evaluation Period||6
10926985|NCT00264849|12095515|FG000|STARTED|Overall Study||275
10926986|NCT00264849|12095516|FG001|STARTED|Overall Study||131
10926987|NCT00264849|12095515|FG000|COMPLETED|Overall Study||253
10926988|NCT00264849|12095516|FG001|COMPLETED|Overall Study||106
10926989|NCT00264849|12095515|FG000|NOT COMPLETED|Overall Study||22
10926990|NCT00264849|12095516|FG001|NOT COMPLETED|Overall Study||25
10926991|NCT00264875|12095522|FG000|STARTED|Overall Study||220
10926992|NCT00264875|12095522|FG000|COMPLETED|Overall Study||190
10926993|NCT00264875|12095522|FG000|NOT COMPLETED|Overall Study||30
10926994|NCT00265083|12095529|FG000|STARTED|Overall Study||78
10926995|NCT00265083|12095530|FG001|STARTED|Overall Study|One patient did not receive study agent.|138
10926996|NCT00265083|12095531|FG002|STARTED|Overall Study||140
10926997|NCT00265083|12095529|FG000|COMPLETED|Overall Study||61
10926998|NCT00265083|12095530|FG001|COMPLETED|Overall Study|One patient did not receive study agent.|96
10926999|NCT00265083|12095531|FG002|COMPLETED|Overall Study||98
10927000|NCT00265083|12095529|FG000|NOT COMPLETED|Overall Study||17
10927001|NCT00265083|12095530|FG001|NOT COMPLETED|Overall Study||42
10927002|NCT00265083|12095531|FG002|NOT COMPLETED|Overall Study||42
10927003|NCT00265096|12095543|FG000|STARTED|Overall Study||113
10927004|NCT00265096|12095544|FG001|STARTED|Overall Study||146
10927005|NCT00265096|12095545|FG002|STARTED|Overall Study||146
10927006|NCT00265096|12095543|FG000|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
10927007|NCT00265096|12095544|FG001|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
10927008|NCT00265096|12095545|FG002|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
10927009|NCT00265096|12095543|FG000|NOT COMPLETED|Overall Study||36
10927010|NCT00265096|12095544|FG001|NOT COMPLETED|Overall Study||51
10927011|NCT00265096|12095545|FG002|NOT COMPLETED|Overall Study||39
10927012|NCT00265109|12095555|FG000|STARTED|Overall Study||17
10927013|NCT00265109|12095555|FG000|COMPLETED|Overall Study||11
10927014|NCT00265109|12095555|FG000|NOT COMPLETED|Overall Study||6
10927015|NCT00265122|12095566|FG000|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
10927016|NCT00265122|12095567|FG001|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
10927017|NCT00265122|12095568|FG002|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
10927018|NCT00265122|12095569|FG003|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
10927019|NCT00265122|12095570|FG004|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
10927020|NCT00265122|12095571|FG005|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
10927021|NCT00265122|12095566|FG000|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
10927022|NCT00265122|12095567|FG001|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
10927023|NCT00265122|12095568|FG002|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
10927024|NCT00265122|12095569|FG003|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
10927025|NCT00265122|12095570|FG004|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
10927026|NCT00265122|12095571|FG005|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
10927027|NCT00265122|12095566|FG000|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
10927028|NCT00265122|12095567|FG001|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
10927029|NCT00265122|12095568|FG002|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
10927030|NCT00265122|12095569|FG003|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
10927031|NCT00265122|12095570|FG004|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
10927032|NCT00265122|12095571|FG005|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
10927033|NCT00265122|12095566|FG000|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
10927034|NCT00265122|12095567|FG001|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
10927035|NCT00265122|12095568|FG002|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
10927036|NCT00265122|12095569|FG003|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
10927037|NCT00265122|12095570|FG004|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
10927038|NCT00265122|12095571|FG005|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
10927039|NCT00265122|12095566|FG000|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
10927040|NCT00265122|12095567|FG001|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
10927041|NCT00265122|12095568|FG002|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
10927042|NCT00265122|12095569|FG003|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
10927043|NCT00265122|12095570|FG004|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
10927044|NCT00265122|12095571|FG005|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
10927045|NCT00265122|12095566|FG000|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
10927046|NCT00265122|12095567|FG001|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
10927047|NCT00265122|12095568|FG002|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
10927048|NCT00265122|12095569|FG003|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
10927049|NCT00265122|12095570|FG004|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
10927050|NCT00265122|12095571|FG005|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
10927051|NCT00265148|12095592|FG000|STARTED|Overall Study||40
10927052|NCT00265148|12095593|FG001|STARTED|Overall Study||40
10927053|NCT00265148|12095592|FG000|COMPLETED|Overall Study||31
10927054|NCT00265148|12095593|FG001|COMPLETED|Overall Study||31
10927055|NCT00265148|12095592|FG000|NOT COMPLETED|Overall Study||9
10927056|NCT00265148|12095593|FG001|NOT COMPLETED|Overall Study||9
10927057|NCT00265200|12095600|FG000|STARTED|Overall Study||28
10927058|NCT00265200|12095600|FG000|COMPLETED|Overall Study||24
10927059|NCT00265200|12095600|FG000|NOT COMPLETED|Overall Study||4
10927060|NCT00265239|12095606|FG000|STARTED|Overall Study||52
10927061|NCT00265239|12095607|FG001|STARTED|Overall Study||52
10927062|NCT00265239|12095606|FG000|COMPLETED|Overall Study||50
10927063|NCT00265239|12095607|FG001|COMPLETED|Overall Study||51
10927064|NCT00265239|12095606|FG000|NOT COMPLETED|Overall Study||2
10927065|NCT00265239|12095607|FG001|NOT COMPLETED|Overall Study||1
10927066|NCT00265317|12095617|FG000|STARTED|Lead-In||13
10927067|NCT00265317|12095618|FG001|STARTED|Lead-In||17
10927068|NCT00265317|12095619|FG002|STARTED|Lead-In||0
10927069|NCT00265317|12095620|FG003|STARTED|Lead-In||0
10927070|NCT00265317|12095617|FG000|COMPLETED|Lead-In||1
10927071|NCT00265317|12095618|FG001|COMPLETED|Lead-In||0
10927072|NCT00265317|12095619|FG002|COMPLETED|Lead-In||0
10927073|NCT00265317|12095620|FG003|COMPLETED|Lead-In||0
10927074|NCT00265317|12095617|FG000|NOT COMPLETED|Lead-In||12
10927075|NCT00265317|12095618|FG001|NOT COMPLETED|Lead-In||17
10927076|NCT00265317|12095619|FG002|NOT COMPLETED|Lead-In||0
10927077|NCT00265317|12095620|FG003|NOT COMPLETED|Lead-In||0
10927078|NCT00265317|12095617|FG000|STARTED|Phase 2||0
10927079|NCT00265317|12095618|FG001|STARTED|Phase 2||0
10927080|NCT00265317|12095619|FG002|STARTED|Phase 2||65
10927081|NCT00265317|12095620|FG003|STARTED|Phase 2||67
10927082|NCT00265317|12095617|FG000|COMPLETED|Phase 2||0
10927083|NCT00265317|12095618|FG001|COMPLETED|Phase 2||0
10927084|NCT00265317|12095619|FG002|COMPLETED|Phase 2||1
10927085|NCT00265317|12095620|FG003|COMPLETED|Phase 2||2
10927086|NCT00265317|12095617|FG000|NOT COMPLETED|Phase 2||0
10927087|NCT00265317|12095618|FG001|NOT COMPLETED|Phase 2||0
10927088|NCT00265317|12095619|FG002|NOT COMPLETED|Phase 2||64
10927089|NCT00265317|12095620|FG003|NOT COMPLETED|Phase 2||65
10927090|NCT00265330|12095639|FG000|STARTED|Overall Study||162
10927091|NCT00265330|12095639|FG000|COMPLETED|Overall Study||67
10927092|NCT00265330|12095639|FG000|NOT COMPLETED|Overall Study||95
10927093|NCT00265382|12095643|FG000|STARTED|Overall Study||221
10927094|NCT00265382|12095643|FG000|COMPLETED|Overall Study||76
10927095|NCT00265382|12095643|FG000|NOT COMPLETED|Overall Study||145
10927096|NCT00265395|12095649|FG000|STARTED|Overall Study||86
10927097|NCT00265395|12095650|FG001|STARTED|Overall Study||73
10927098|NCT00265395|12095649|FG000|COMPLETED|Overall Study||78
10927099|NCT00265395|12095650|FG001|COMPLETED|Overall Study||56
10927100|NCT00265395|12095649|FG000|NOT COMPLETED|Overall Study||8
10927101|NCT00265395|12095650|FG001|NOT COMPLETED|Overall Study||17
10927102|NCT00265473|12095655|FG000|STARTED|Overall Study||5
10927103|NCT00265473|12095655|FG000|COMPLETED|Overall Study||5
10927104|NCT00265473|12095655|FG000|NOT COMPLETED|Overall Study||0
10927105|NCT00265512|12095662|FG000|STARTED|Overall Study||213
10927106|NCT00265512|12095663|FG001|STARTED|Overall Study||454
10927107|NCT00265512|12095662|FG000|COMPLETED|Overall Study||168
10927108|NCT00265512|12095663|FG001|COMPLETED|Overall Study||359
10927109|NCT00265512|12095662|FG000|NOT COMPLETED|Overall Study||45
10927110|NCT00265512|12095663|FG001|NOT COMPLETED|Overall Study||95
10927111|NCT00265538|12095671|FG000|STARTED|Overall Study||196
10927112|NCT00265538|12095672|FG001|STARTED|Overall Study||170
10927113|NCT00265538|12095673|FG002|STARTED|Overall Study||182
10927114|NCT00265538|12095674|FG003|STARTED|Overall Study||286
10927115|NCT00265538|12095671|FG000|COMPLETED|Overall Study||186
10927116|NCT00265538|12095672|FG001|COMPLETED|Overall Study||161
10927117|NCT00265538|12095673|FG002|COMPLETED|Overall Study||171
10927118|NCT00265538|12095674|FG003|COMPLETED|Overall Study||267
10927119|NCT00265538|12095671|FG000|NOT COMPLETED|Overall Study||10
10927120|NCT00265538|12095672|FG001|NOT COMPLETED|Overall Study||9
10927121|NCT00265538|12095673|FG002|NOT COMPLETED|Overall Study||11
10927122|NCT00265538|12095674|FG003|NOT COMPLETED|Overall Study||19
10927123|NCT00265564|12095688|FG000|STARTED|Overall Study||59
10927124|NCT00265564|12095689|FG001|STARTED|Overall Study||58
10927125|NCT00265564|12095688|FG000|COMPLETED|Overall Study||49
10927126|NCT00265564|12095689|FG001|COMPLETED|Overall Study||49
10927127|NCT00265564|12095688|FG000|NOT COMPLETED|Overall Study||10
10927128|NCT00265564|12095689|FG001|NOT COMPLETED|Overall Study||9
10927129|NCT00265616|12095697|FG000|STARTED|Overall Study||14
10927130|NCT00265616|12095698|FG001|STARTED|Overall Study||9
10927131|NCT00265616|12095697|FG000|COMPLETED|Overall Study||14
10927132|NCT00265616|12095698|FG001|COMPLETED|Overall Study||9
10927133|NCT00265616|12095697|FG000|NOT COMPLETED|Overall Study||0
10927134|NCT00265616|12095698|FG001|NOT COMPLETED|Overall Study||0
10927135|NCT00265759|12095710|FG000|STARTED|Overall Study||124
10927136|NCT00265759|12095711|FG001|STARTED|Overall Study||128
10927137|NCT00265759|12095712|FG002|STARTED|Overall Study||125
10927138|NCT00265759|12095713|FG003|STARTED|Overall Study||245
10927139|NCT00265759|12095710|FG000|COMPLETED|Overall Study||124
10927140|NCT00265759|12095711|FG001|COMPLETED|Overall Study||127
10927141|NCT00265759|12095712|FG002|COMPLETED|Overall Study||123
10927142|NCT00265759|12095713|FG003|COMPLETED|Overall Study||236
10927143|NCT00265759|12095710|FG000|NOT COMPLETED|Overall Study||0
10927144|NCT00265759|12095711|FG001|NOT COMPLETED|Overall Study||1
10927145|NCT00265759|12095712|FG002|NOT COMPLETED|Overall Study||2
10927146|NCT00265759|12095713|FG003|NOT COMPLETED|Overall Study||9
10927147|NCT00265785|12095724|FG000|STARTED|Overall Study||27
10927148|NCT00265785|12095724|FG000|Eligible|Overall Study||26
10927149|NCT00265785|12095724|FG000|Eligible and Began Protocol Treatment|Overall Study||24
10927150|NCT00265785|12095724|FG000|COMPLETED|Overall Study||0
10927151|NCT00265785|12095724|FG000|NOT COMPLETED|Overall Study||27
10927152|NCT00265850|12095731|FG000|STARTED|Overall Study||899
10927153|NCT00265850|12095732|FG001|STARTED|Overall Study||902
10927154|NCT00265850|12095733|FG002|STARTED|Overall Study||533
10927155|NCT00265850|12095731|FG000|COMPLETED|Overall Study||899
10927156|NCT00265850|12095732|FG001|COMPLETED|Overall Study||902
10927157|NCT00265850|12095733|FG002|COMPLETED|Overall Study||533
10927158|NCT00265850|12095731|FG000|NOT COMPLETED|Overall Study||0
10927159|NCT00265850|12095732|FG001|NOT COMPLETED|Overall Study||0
10927160|NCT00265850|12095733|FG002|NOT COMPLETED|Overall Study||0
10927161|NCT00265889|12095740|FG000|STARTED|Overall Study||42
10927162|NCT00265889|12095740|FG000|Cycle 1: 1st Regimen/Transplant|Overall Study||37
10927163|NCT00265889|12095740|FG000|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
10927164|NCT00265889|12095740|FG000|COMPLETED|Overall Study||37
10927165|NCT00265889|12095740|FG000|NOT COMPLETED|Overall Study||5
10927166|NCT00265980|12095744|FG000|STARTED|Overall Study||22
10927167|NCT00265980|12095744|FG000|Weight Initial|Overall Study||22
10927168|NCT00265980|12095744|FG000|Weight -10% Placebo|Overall Study||22
10927169|NCT00265980|12095744|FG000|Weight -10% Leptin|Overall Study||22
10927170|NCT00265980|12095744|FG000|COMPLETED|Overall Study||22
10927171|NCT00265980|12095744|FG000|NOT COMPLETED|Overall Study||0
10927172|NCT00266032|12095751|FG000|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
10927173|NCT00266032|12095752|FG001|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
10927174|NCT00266032|12095753|FG002|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
10927175|NCT00266032|12095751|FG000|Patients Treated|Treatment||684
10927176|NCT00266032|12095752|FG001|Patients Treated|Treatment||221
10927177|NCT00266032|12095753|FG002|Patients Treated|Treatment||229
10927178|NCT00266032|12095751|FG000|Patients Treated and in FAS|Treatment|FAS|642
10927179|NCT00266032|12095752|FG001|Patients Treated and in FAS|Treatment|FAS|209
10927180|NCT00266032|12095753|FG002|Patients Treated and in FAS|Treatment|FAS|216
10927181|NCT00266032|12095751|FG000|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
10927182|NCT00266032|12095752|FG001|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
10927183|NCT00266032|12095753|FG002|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
10927184|NCT00266032|12095751|FG000|NOT COMPLETED|Treatment||111
10927185|NCT00266032|12095752|FG001|NOT COMPLETED|Treatment||64
10927186|NCT00266032|12095753|FG002|NOT COMPLETED|Treatment||47
10927187|NCT00266032|12095751|FG000|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
10927188|NCT00266032|12095752|FG001|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
10927189|NCT00266032|12095753|FG002|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
10927190|NCT00266032|12095751|FG000|COMPLETED|Open-label Safety Extension||448
10927191|NCT00266032|12095752|FG001|COMPLETED|Open-label Safety Extension||115
10927192|NCT00266032|12095753|FG002|COMPLETED|Open-label Safety Extension||140
10927193|NCT00266032|12095751|FG000|NOT COMPLETED|Open-label Safety Extension||41
10927194|NCT00266032|12095752|FG001|NOT COMPLETED|Open-label Safety Extension||14
10927195|NCT00266032|12095753|FG002|NOT COMPLETED|Open-label Safety Extension||25
10927196|NCT00266110|12095761|FG000|STARTED|Overall Study||17
10927197|NCT00266110|12095761|FG000|COMPLETED|Overall Study||10
10927198|NCT00266110|12095761|FG000|NOT COMPLETED|Overall Study||7
10927199|NCT00266227|12095768|FG000|STARTED|Initial Treatment||0
10927200|NCT00266227|12095769|FG001|STARTED|Initial Treatment||0
10927201|NCT00266227|12095770|FG002|STARTED|Initial Treatment||559
10927202|NCT00266227|12095768|FG000|COMPLETED|Initial Treatment||0
10927203|NCT00266227|12095769|FG001|COMPLETED|Initial Treatment||0
10927204|NCT00266227|12095770|FG002|COMPLETED|Initial Treatment||482
10927205|NCT00266227|12095768|FG000|NOT COMPLETED|Initial Treatment||0
10927206|NCT00266227|12095769|FG001|NOT COMPLETED|Initial Treatment||0
10927207|NCT00266227|12095770|FG002|NOT COMPLETED|Initial Treatment||77
10927208|NCT00266227|12095768|FG000|STARTED|Retreatment: Up to Week 48||318
10927209|NCT00266227|12095769|FG001|STARTED|Retreatment: Up to Week 48||157
10927210|NCT00266227|12095770|FG002|STARTED|Retreatment: Up to Week 48||0
10927211|NCT00266227|12095768|FG000|COMPLETED|Retreatment: Up to Week 48||291
10927212|NCT00266227|12095769|FG001|COMPLETED|Retreatment: Up to Week 48||134
10927213|NCT00266227|12095770|FG002|COMPLETED|Retreatment: Up to Week 48||0
10927214|NCT00266227|12095768|FG000|NOT COMPLETED|Retreatment: Up to Week 48||27
10927215|NCT00266227|12095769|FG001|NOT COMPLETED|Retreatment: Up to Week 48||23
10927216|NCT00266227|12095770|FG002|NOT COMPLETED|Retreatment: Up to Week 48||0
10927217|NCT00266227|12095768|FG000|STARTED|Retreatment: Week 48 to Week 72||291
10927218|NCT00266227|12095769|FG001|STARTED|Retreatment: Week 48 to Week 72||134
10927219|NCT00266227|12095770|FG002|STARTED|Retreatment: Week 48 to Week 72||0
10927220|NCT00266227|12095768|FG000|COMPLETED|Retreatment: Week 48 to Week 72||227
10927221|NCT00266227|12095769|FG001|COMPLETED|Retreatment: Week 48 to Week 72||92
10927222|NCT00266227|12095770|FG002|COMPLETED|Retreatment: Week 48 to Week 72||0
10927223|NCT00266227|12095768|FG000|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
10927224|NCT00266227|12095769|FG001|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
10927225|NCT00266227|12095770|FG002|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
10927226|NCT00266279|12095779|FG000|STARTED|Overall Study||17
10927227|NCT00266279|12095779|FG000|COMPLETED|Overall Study||15
10927228|NCT00266279|12095779|FG000|NOT COMPLETED|Overall Study||2
10927229|NCT00266409|12095788|FG000|STARTED|Overall Study||137
10927230|NCT00266409|12095789|FG001|STARTED|Overall Study||138
10927231|NCT00266409|12095790|FG002|STARTED|Overall Study||72
10927232|NCT00266409|12095791|FG003|STARTED|Overall Study||71
10927233|NCT00266409|12095788|FG000|COMPLETED|Overall Study||92
10927234|NCT00266409|12095789|FG001|COMPLETED|Overall Study||92
10927235|NCT00266409|12095790|FG002|COMPLETED|Overall Study||55
10927236|NCT00266409|12095791|FG003|COMPLETED|Overall Study||49
10927237|NCT00266409|12095788|FG000|NOT COMPLETED|Overall Study||45
10927238|NCT00266409|12095789|FG001|NOT COMPLETED|Overall Study||46
10927239|NCT00266409|12095790|FG002|NOT COMPLETED|Overall Study||17
10927240|NCT00266409|12095791|FG003|NOT COMPLETED|Overall Study||22
10927241|NCT00266630|12095803|FG000|STARTED|Overall Study||100
10927242|NCT00266630|12095804|FG001|STARTED|Overall Study||39
10927243|NCT00266630|12095803|FG000|COMPLETED|Overall Study||58
10927244|NCT00266630|12095804|FG001|COMPLETED|Overall Study||11
10927245|NCT00266630|12095803|FG000|NOT COMPLETED|Overall Study||42
10927246|NCT00266630|12095804|FG001|NOT COMPLETED|Overall Study||28
10927247|NCT00266656|12095814|FG000|STARTED|Overall Study||36
10927248|NCT00266656|12095815|FG001|STARTED|Overall Study||33
10927249|NCT00266656|12095814|FG000|COMPLETED|Overall Study||22
10927250|NCT00266656|12095815|FG001|COMPLETED|Overall Study||20
10927251|NCT00266656|12095814|FG000|NOT COMPLETED|Overall Study||14
10927252|NCT00266656|12095815|FG001|NOT COMPLETED|Overall Study||13
10927253|NCT00266695|12095821|FG000|STARTED|Overall Study||203
10927254|NCT00266695|12095821|FG000|COMPLETED|Overall Study||174
10927255|NCT00266695|12095821|FG000|NOT COMPLETED|Overall Study||29
10927256|NCT00266708|12095827|FG000|STARTED|Overall Study||20
10927257|NCT00266708|12095828|FG001|STARTED|Overall Study||22
10927258|NCT00266708|12095827|FG000|COMPLETED|Overall Study||16
10927259|NCT00266708|12095828|FG001|COMPLETED|Overall Study||13
10927260|NCT00266708|12095827|FG000|NOT COMPLETED|Overall Study||4
10927261|NCT00266708|12095828|FG001|NOT COMPLETED|Overall Study||9
10927262|NCT00266799|12095836|FG000|STARTED|Overall Study||98
10927263|NCT00266799|12095837|FG001|STARTED|Overall Study||102
10927264|NCT00266799|12095836|FG000|COMPLETED|Overall Study||62
10927265|NCT00266799|12095837|FG001|COMPLETED|Overall Study||68
10927266|NCT00266799|12095836|FG000|NOT COMPLETED|Overall Study||36
10927267|NCT00266799|12095837|FG001|NOT COMPLETED|Overall Study||34
10927268|NCT00266812|12095845|FG000|STARTED|Overall Study||22
10927269|NCT00266812|12095846|FG001|STARTED|Overall Study||13
10927270|NCT00266812|12095845|FG000|COMPLETED|Overall Study||1
10927271|NCT00266812|12095846|FG001|COMPLETED|Overall Study||2
10927272|NCT00266812|12095845|FG000|NOT COMPLETED|Overall Study||21
10927273|NCT00266812|12095846|FG001|NOT COMPLETED|Overall Study||11
10927274|NCT00266825|12095854|FG000|STARTED|Enrolled and Allocated Intervention||172
10927275|NCT00266825|12095855|FG001|STARTED|Enrolled and Allocated Intervention||178
10927276|NCT00266825|12095854|FG000|COMPLETED|Enrolled and Allocated Intervention||172
10927277|NCT00266825|12095855|FG001|COMPLETED|Enrolled and Allocated Intervention||178
10927278|NCT00266825|12095854|FG000|NOT COMPLETED|Enrolled and Allocated Intervention||0
10927279|NCT00266825|12095855|FG001|NOT COMPLETED|Enrolled and Allocated Intervention||0
10927280|NCT00266825|12095854|FG000|STARTED|Completed Follow-Up||172
10927281|NCT00266825|12095855|FG001|STARTED|Completed Follow-Up||178
10927282|NCT00266825|12095854|FG000|COMPLETED|Completed Follow-Up||147
10927283|NCT00266825|12095855|FG001|COMPLETED|Completed Follow-Up||154
10927284|NCT00266825|12095854|FG000|NOT COMPLETED|Completed Follow-Up||25
10927285|NCT00266825|12095855|FG001|NOT COMPLETED|Completed Follow-Up||24
10927286|NCT00266851|12095866|FG000|STARTED|Overall Study||37
10927287|NCT00266851|12095867|FG001|STARTED|Overall Study||38
10927288|NCT00266851|12095868|FG002|STARTED|Overall Study||22
10927289|NCT00266851|12095866|FG000|Completed 3 Month Follow up|Overall Study||26
10927290|NCT00266851|12095867|FG001|Completed 3 Month Follow up|Overall Study||22
10927291|NCT00266851|12095868|FG002|Completed 3 Month Follow up|Overall Study||15
10927292|NCT00266851|12095866|FG000|Completed 6 Month Follow up|Overall Study||27
10927293|NCT00266851|12095867|FG001|Completed 6 Month Follow up|Overall Study||22
10927294|NCT00266851|12095868|FG002|Completed 6 Month Follow up|Overall Study||17
10927295|NCT00266851|12095866|FG000|Completed 9 Month Follow up|Overall Study||22
10927296|NCT00266851|12095867|FG001|Completed 9 Month Follow up|Overall Study||23
10927297|NCT00266851|12095868|FG002|Completed 9 Month Follow up|Overall Study||15
10927298|NCT00266851|12095866|FG000|Completed 12 Month Follow up|Overall Study||25
10927299|NCT00266851|12095867|FG001|Completed 12 Month Follow up|Overall Study||19
10927300|NCT00266851|12095868|FG002|Completed 12 Month Follow up|Overall Study||13
10927301|NCT00266851|12095866|FG000|COMPLETED|Overall Study||37
10927302|NCT00266851|12095867|FG001|COMPLETED|Overall Study||38
10927303|NCT00266851|12095868|FG002|COMPLETED|Overall Study||22
10927304|NCT00266851|12095866|FG000|NOT COMPLETED|Overall Study||0
10927305|NCT00266851|12095867|FG001|NOT COMPLETED|Overall Study||0
10927306|NCT00266851|12095868|FG002|NOT COMPLETED|Overall Study||0
10927307|NCT00266864|12095882|FG000|STARTED|Overall Study||18
10927308|NCT00266864|12095883|FG001|STARTED|Overall Study||13
10927309|NCT00266864|12095882|FG000|COMPLETED|Overall Study||13
10927310|NCT00266864|12095883|FG001|COMPLETED|Overall Study||11
10927311|NCT00266864|12095882|FG000|NOT COMPLETED|Overall Study||5
10927312|NCT00266864|12095883|FG001|NOT COMPLETED|Overall Study||2
10927313|NCT00266877|12095892|FG000|STARTED|Overall Study||91
10927314|NCT00266877|12095893|FG001|STARTED|Overall Study||48
10927315|NCT00266877|12095894|FG002|STARTED|Overall Study||28
10927316|NCT00266877|12095892|FG000|COMPLETED|Overall Study||0
10927317|NCT00266877|12095893|FG001|COMPLETED|Overall Study||0
10927318|NCT00266877|12095894|FG002|COMPLETED|Overall Study||0
10927319|NCT00266877|12095892|FG000|NOT COMPLETED|Overall Study||91
10927320|NCT00266877|12095893|FG001|NOT COMPLETED|Overall Study||48
10927321|NCT00266877|12095894|FG002|NOT COMPLETED|Overall Study||28
10927322|NCT00267007|12095904|FG000|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
10927323|NCT00267007|12095905|FG001|STARTED|Overall Study||11
10927324|NCT00267007|12095904|FG000|COMPLETED|Overall Study||11
10927325|NCT00267007|12095905|FG001|COMPLETED|Overall Study||10
10927326|NCT00267007|12095904|FG000|NOT COMPLETED|Overall Study||8
10927327|NCT00267007|12095905|FG001|NOT COMPLETED|Overall Study||1
10927328|NCT00267020|12095913|FG000|STARTED|Overall Study||86
10927329|NCT00267020|12095914|FG001|STARTED|Overall Study||44
10927330|NCT00267020|12095913|FG000|Received at Least 1 Dose|Overall Study||82
10927331|NCT00267020|12095914|FG001|Received at Least 1 Dose|Overall Study||39
10927332|NCT00267020|12095913|FG000|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|81
10927333|NCT00267020|12095914|FG001|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|38
10927334|NCT00267020|12095913|FG000|COMPLETED|Overall Study||0
10927335|NCT00267020|12095914|FG001|COMPLETED|Overall Study||1
10927336|NCT00267020|12095913|FG000|NOT COMPLETED|Overall Study||86
10927337|NCT00267020|12095914|FG001|NOT COMPLETED|Overall Study||43
10927338|NCT00267046|12095922|FG000|STARTED|Overall Study||32
10927339|NCT00267046|12095923|FG001|STARTED|Overall Study||16
10927340|NCT00267046|12095922|FG000|COMPLETED|Overall Study||20
10927341|NCT00267046|12095923|FG001|COMPLETED|Overall Study||5
10927342|NCT00267046|12095922|FG000|NOT COMPLETED|Overall Study||12
10927343|NCT00267046|12095923|FG001|NOT COMPLETED|Overall Study||11
10927344|NCT00267059|12095929|FG000|STARTED|Overall Study||44
10927345|NCT00267059|12095929|FG000|COMPLETED|Overall Study||44
10927346|NCT00267059|12095929|FG000|NOT COMPLETED|Overall Study||0
10927347|NCT00267085|12095933|FG000|STARTED|Overall Study||10
10927348|NCT00267085|12095933|FG000|COMPLETED|Overall Study||10
10927349|NCT00267085|12095933|FG000|NOT COMPLETED|Overall Study||0
10927350|NCT00267098|12095945|FG000|STARTED|Overall Study||109
10927351|NCT00267098|12095946|FG001|STARTED|Overall Study||51
10927352|NCT00267098|12095947|FG002|STARTED|Overall Study||243
10927353|NCT00267098|12095948|FG003|STARTED|Overall Study||241
10927354|NCT00267098|12095949|FG004|STARTED|Overall Study||47
10927355|NCT00267098|12095950|FG005|STARTED|Overall Study||106
10927356|NCT00267098|12095951|FG006|STARTED|Overall Study||101
10927357|NCT00267098|12095952|FG007|STARTED|Overall Study||20
10927358|NCT00267098|12095945|FG000|COMPLETED|Overall Study||0
10927359|NCT00267098|12095946|FG001|COMPLETED|Overall Study||0
10927360|NCT00267098|12095947|FG002|COMPLETED|Overall Study||149
10927361|NCT00267098|12095948|FG003|COMPLETED|Overall Study||135
10927362|NCT00267098|12095949|FG004|COMPLETED|Overall Study||10
10927363|NCT00267098|12095950|FG005|COMPLETED|Overall Study||66
10927364|NCT00267098|12095951|FG006|COMPLETED|Overall Study||55
10927365|NCT00267098|12095952|FG007|COMPLETED|Overall Study||5
10927366|NCT00267098|12095945|FG000|NOT COMPLETED|Overall Study||109
10927367|NCT00267098|12095946|FG001|NOT COMPLETED|Overall Study||51
10927368|NCT00267098|12095947|FG002|NOT COMPLETED|Overall Study||94
10927369|NCT00267098|12095948|FG003|NOT COMPLETED|Overall Study||106
10927370|NCT00267098|12095949|FG004|NOT COMPLETED|Overall Study||37
10927371|NCT00267098|12095950|FG005|NOT COMPLETED|Overall Study||40
10927372|NCT00267098|12095951|FG006|NOT COMPLETED|Overall Study||46
10927373|NCT00267098|12095952|FG007|NOT COMPLETED|Overall Study||15
10927374|NCT00267111|12095977|FG000|STARTED|Overall Study||55
10927375|NCT00267111|12095978|FG001|STARTED|Overall Study||55
10927376|NCT00267111|12095977|FG000|COMPLETED|Overall Study||55
10927377|NCT00267111|12095978|FG001|COMPLETED|Overall Study||55
10927378|NCT00267111|12095977|FG000|NOT COMPLETED|Overall Study||0
10927379|NCT00267111|12095978|FG001|NOT COMPLETED|Overall Study||0
10927380|NCT00267150|12095985|FG000|STARTED|Overall Study||31
10927381|NCT00267150|12095985|FG000|COMPLETED|Overall Study||30
10927382|NCT00267150|12095985|FG000|NOT COMPLETED|Overall Study||1
10927383|NCT00267189|12095991|FG000|STARTED|Overall Study|Intention to treat (ITT) population.|72
10927384|NCT00267189|12095992|FG001|STARTED|Overall Study||73
10927385|NCT00267189|12095991|FG000|Completed Study Medication|Overall Study||54
10927386|NCT00267189|12095992|FG001|Completed Study Medication|Overall Study||72
10927387|NCT00267189|12095991|FG000|COMPLETED|Overall Study|"Completed indicates completed study."|67
10927388|NCT00267189|12095992|FG001|COMPLETED|Overall Study||72
10927389|NCT00267189|12095991|FG000|NOT COMPLETED|Overall Study||5
10927390|NCT00267189|12095992|FG001|NOT COMPLETED|Overall Study||1
10927391|NCT00267202|12096000|FG000|STARTED|Overall Study||136
10927392|NCT00267202|12096001|FG001|STARTED|Overall Study||139
10927393|NCT00267202|12096000|FG000|COMPLETED|Overall Study||83
10927394|NCT00267202|12096001|FG001|COMPLETED|Overall Study||105
10927395|NCT00267202|12096000|FG000|NOT COMPLETED|Overall Study||53
10927396|NCT00267202|12096001|FG001|NOT COMPLETED|Overall Study||34
10927397|NCT00267293|12096011|FG000|STARTED|Overall Study||20
10927398|NCT00267293|12096012|FG001|STARTED|Overall Study||20
10927399|NCT00267293|12096013|FG002|STARTED|Overall Study||20
10927400|NCT00267293|12096011|FG000|COMPLETED|Overall Study||20
10927401|NCT00267293|12096012|FG001|COMPLETED|Overall Study||20
10927402|NCT00267293|12096013|FG002|COMPLETED|Overall Study||20
10927403|NCT00267293|12096011|FG000|NOT COMPLETED|Overall Study||0
10927404|NCT00267293|12096012|FG001|NOT COMPLETED|Overall Study||0
10927405|NCT00267293|12096013|FG002|NOT COMPLETED|Overall Study||0
10927406|NCT00267488|12096021|FG000|STARTED|Overall Study||37
10927407|NCT00267488|12096021|FG000|COMPLETED|Overall Study||26
10927408|NCT00267488|12096021|FG000|NOT COMPLETED|Overall Study||11
10927409|NCT00267631|12096027|FG000|STARTED|Overall Study||2361
10927410|NCT00267631|12096028|FG001|STARTED|Overall Study||3031
10927411|NCT00267631|12096027|FG000|COMPLETED|Overall Study||2361
10927412|NCT00267631|12096028|FG001|COMPLETED|Overall Study||3031
10927413|NCT00267631|12096027|FG000|NOT COMPLETED|Overall Study||0
10927414|NCT00267631|12096028|FG001|NOT COMPLETED|Overall Study||0
10927415|NCT00267644|12096036|FG000|STARTED|Overall Study||13
10927416|NCT00267644|12096037|FG001|STARTED|Overall Study||63
10927417|NCT00267644|12096036|FG000|COMPLETED|Overall Study||13
10927418|NCT00267644|12096037|FG001|COMPLETED|Overall Study||63
10927419|NCT00267644|12096036|FG000|NOT COMPLETED|Overall Study||0
10927420|NCT00267644|12096037|FG001|NOT COMPLETED|Overall Study||0
10927421|NCT00267670|12096047|FG000|STARTED|Overall Study||19
10927422|NCT00267670|12096048|FG001|STARTED|Overall Study||7
10927423|NCT00267670|12096047|FG000|COMPLETED|Overall Study||15
10927424|NCT00267670|12096048|FG001|COMPLETED|Overall Study||7
10927425|NCT00267670|12096047|FG000|NOT COMPLETED|Overall Study||4
10927426|NCT00267670|12096048|FG001|NOT COMPLETED|Overall Study||0
10927427|NCT00267696|12096055|FG000|STARTED|Overall Study||45
10927428|NCT00267696|12096055|FG000|COMPLETED|Overall Study||45
10927429|NCT00267696|12096055|FG000|NOT COMPLETED|Overall Study||0
10927430|NCT00267748|12096062|FG000|STARTED|Non-randomized Period||25
10927431|NCT00267748|12096063|FG001|STARTED|Non-randomized Period||0
10927432|NCT00267748|12096064|FG002|STARTED|Non-randomized Period||0
10927433|NCT00267748|12096062|FG000|COMPLETED|Non-randomized Period||2
10927434|NCT00267748|12096063|FG001|COMPLETED|Non-randomized Period||0
10927435|NCT00267748|12096064|FG002|COMPLETED|Non-randomized Period||0
10927436|NCT00267748|12096062|FG000|NOT COMPLETED|Non-randomized Period||23
10927437|NCT00267748|12096063|FG001|NOT COMPLETED|Non-randomized Period||0
10927438|NCT00267748|12096064|FG002|NOT COMPLETED|Non-randomized Period||0
10927439|NCT00267748|12096062|FG000|STARTED|Randomized Period||0
10927440|NCT00267748|12096063|FG001|STARTED|Randomized Period||146
10927441|NCT00267748|12096064|FG002|STARTED|Randomized Period||146
10927442|NCT00267748|12096062|FG000|Treated|Randomized Period||0
10927443|NCT00267748|12096063|FG001|Treated|Randomized Period||146
10927444|NCT00267748|12096064|FG002|Treated|Randomized Period||143
10927445|NCT00267748|12096062|FG000|COMPLETED|Randomized Period||0
10927446|NCT00267748|12096063|FG001|COMPLETED|Randomized Period||19
10927447|NCT00267748|12096064|FG002|COMPLETED|Randomized Period||14
10927448|NCT00267748|12096062|FG000|NOT COMPLETED|Randomized Period||0
10927449|NCT00267748|12096063|FG001|NOT COMPLETED|Randomized Period||127
10927450|NCT00267748|12096064|FG002|NOT COMPLETED|Randomized Period||132
10927451|NCT00267774|12096073|FG000|STARTED|Overall Study||509
10927452|NCT00267774|12096074|FG001|STARTED|Overall Study||496
10927453|NCT00267774|12096073|FG000|COMPLETED|Overall Study||509
10927454|NCT00267774|12096074|FG001|COMPLETED|Overall Study||496
10927455|NCT00267774|12096073|FG000|NOT COMPLETED|Overall Study||0
10927456|NCT00267774|12096074|FG001|NOT COMPLETED|Overall Study||0
10927457|NCT00267865|12096080|FG000|STARTED|Induction Treatment||12
10927458|NCT00267865|12096080|FG000|COMPLETED|Induction Treatment||9
10927459|NCT00267865|12096080|FG000|NOT COMPLETED|Induction Treatment||3
10927460|NCT00267865|12096080|FG000|STARTED|Consolidation Treatment||5
10927461|NCT00267865|12096080|FG000|COMPLETED|Consolidation Treatment||5
10927462|NCT00267865|12096080|FG000|NOT COMPLETED|Consolidation Treatment||0
10927463|NCT00267956|12096086|FG000|STARTED|Controlled Period||70
10927464|NCT00267956|12096087|FG001|STARTED|Controlled Period||76
10927465|NCT00267956|12096088|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10927466|NCT00267956|12096089|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10927467|NCT00267956|12096086|FG000|COMPLETED|Controlled Period||57
10927468|NCT00267956|12096087|FG001|COMPLETED|Controlled Period||72
10927469|NCT00267956|12096088|FG002|COMPLETED|Controlled Period||0
10927470|NCT00267956|12096089|FG003|COMPLETED|Controlled Period||0
10927471|NCT00267956|12096086|FG000|NOT COMPLETED|Controlled Period||13
10927472|NCT00267956|12096087|FG001|NOT COMPLETED|Controlled Period||4
10927473|NCT00267956|12096088|FG002|NOT COMPLETED|Controlled Period||0
10927474|NCT00267956|12096089|FG003|NOT COMPLETED|Controlled Period||0
10927475|NCT00267956|12096086|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10927476|NCT00267956|12096087|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10927477|NCT00267956|12096088|FG002|STARTED|After Controlled Period||57
10927478|NCT00267956|12096089|FG003|STARTED|After Controlled Period||72
10927479|NCT00267956|12096086|FG000|COMPLETED|After Controlled Period||0
10927480|NCT00267956|12096087|FG001|COMPLETED|After Controlled Period||0
10927481|NCT00267956|12096088|FG002|COMPLETED|After Controlled Period||52
10927482|NCT00267956|12096089|FG003|COMPLETED|After Controlled Period||70
10927483|NCT00267956|12096086|FG000|NOT COMPLETED|After Controlled Period||0
10927484|NCT00267956|12096087|FG001|NOT COMPLETED|After Controlled Period||0
10927485|NCT00267956|12096088|FG002|NOT COMPLETED|After Controlled Period||5
10927486|NCT00267956|12096089|FG003|NOT COMPLETED|After Controlled Period||2
10927487|NCT00267969|12096100|FG000|STARTED|Controlled Period|Number of patients randomized|255
10927488|NCT00267969|12096101|FG001|STARTED|Controlled Period|Number of patients randomized|255
10927489|NCT00267969|12096102|FG002|STARTED|Controlled Period|Number of patients randomized|256
10927490|NCT00267969|12096103|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10927491|NCT00267969|12096104|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10927492|NCT00267969|12096105|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10927493|NCT00267969|12096106|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10927494|NCT00267969|12096100|FG000|COMPLETED|Controlled Period||243
10927495|NCT00267969|12096101|FG001|COMPLETED|Controlled Period||254
10927496|NCT00267969|12096102|FG002|COMPLETED|Controlled Period||245
10927497|NCT00267969|12096103|FG003|COMPLETED|Controlled Period||0
10927498|NCT00267969|12096104|FG004|COMPLETED|Controlled Period||0
10927499|NCT00267969|12096105|FG005|COMPLETED|Controlled Period||0
10927500|NCT00267969|12096106|FG006|COMPLETED|Controlled Period||0
10927501|NCT00267969|12096100|FG000|NOT COMPLETED|Controlled Period||12
10927502|NCT00267969|12096101|FG001|NOT COMPLETED|Controlled Period||1
10927503|NCT00267969|12096102|FG002|NOT COMPLETED|Controlled Period||11
10927504|NCT00267969|12096103|FG003|NOT COMPLETED|Controlled Period||0
10927505|NCT00267969|12096104|FG004|NOT COMPLETED|Controlled Period||0
10927506|NCT00267969|12096105|FG005|NOT COMPLETED|Controlled Period||0
10927507|NCT00267969|12096106|FG006|NOT COMPLETED|Controlled Period||0
10927508|NCT00267969|12096100|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10927509|NCT00267969|12096101|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10927510|NCT00267969|12096102|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10927511|NCT00267969|12096103|FG003|STARTED|After Controlled Period||123
10927512|NCT00267969|12096104|FG004|STARTED|After Controlled Period||120
10927513|NCT00267969|12096105|FG005|STARTED|After Controlled Period||254
10927514|NCT00267969|12096106|FG006|STARTED|After Controlled Period||245
10927515|NCT00267969|12096100|FG000|COMPLETED|After Controlled Period||0
10927516|NCT00267969|12096101|FG001|COMPLETED|After Controlled Period||0
10927517|NCT00267969|12096102|FG002|COMPLETED|After Controlled Period||0
10927518|NCT00267969|12096103|FG003|COMPLETED|After Controlled Period||87
10927519|NCT00267969|12096104|FG004|COMPLETED|After Controlled Period||85
10927520|NCT00267969|12096105|FG005|COMPLETED|After Controlled Period||172
10927521|NCT00267969|12096106|FG006|COMPLETED|After Controlled Period||173
10927522|NCT00267969|12096100|FG000|NOT COMPLETED|After Controlled Period||0
10927523|NCT00267969|12096101|FG001|NOT COMPLETED|After Controlled Period||0
10927524|NCT00267969|12096102|FG002|NOT COMPLETED|After Controlled Period||0
10927525|NCT00267969|12096103|FG003|NOT COMPLETED|After Controlled Period||36
10927526|NCT00267969|12096104|FG004|NOT COMPLETED|After Controlled Period||35
10927527|NCT00267969|12096105|FG005|NOT COMPLETED|After Controlled Period||82
10927528|NCT00267969|12096106|FG006|NOT COMPLETED|After Controlled Period||72
10927529|NCT00268203|12096124|FG000|STARTED|Overall Study||765
10927530|NCT00268203|12096124|FG000|Completed 2 Years of Follow-up|Overall Study||62
10927531|NCT00268203|12096124|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
10927532|NCT00268203|12096124|FG000|NOT COMPLETED|Overall Study||647
10927533|NCT00268242|12096128|FG000|STARTED|Overall Study||24
10927534|NCT00268242|12096128|FG000|COMPLETED|Overall Study||23
10927535|NCT00268242|12096128|FG000|NOT COMPLETED|Overall Study||1
10927536|NCT00268346|12096134|FG000|STARTED|Overall Study||18
10927537|NCT00268346|12096135|FG001|STARTED|Overall Study||40
10927538|NCT00268346|12096134|FG000|Started Treatment|Overall Study||18
10927539|NCT00268346|12096135|FG001|Started Treatment|Overall Study||40
10927540|NCT00268346|12096134|FG000|COMPLETED|Overall Study||18
10927541|NCT00268346|12096135|FG001|COMPLETED|Overall Study||37
10927542|NCT00268346|12096134|FG000|NOT COMPLETED|Overall Study||0
10927543|NCT00268346|12096135|FG001|NOT COMPLETED|Overall Study||3
10927544|NCT00268437|12096141|FG000|STARTED|Overall Study||27
10927545|NCT00268437|12096141|FG000|COMPLETED|Overall Study||26
10927546|NCT00268437|12096141|FG000|NOT COMPLETED|Overall Study||1
10927547|NCT00268762|12096146|FG000|STARTED|Overall Study||65
10927548|NCT00268762|12096146|FG000|COMPLETED|Overall Study||65
10927549|NCT00268762|12096146|FG000|NOT COMPLETED|Overall Study||0
10927550|NCT00268892|12096153|FG000|STARTED|Overall Study||90
10927551|NCT00268892|12096154|FG001|STARTED|Overall Study||95
10927552|NCT00268892|12096155|FG002|STARTED|Overall Study||93
10927553|NCT00268892|12096153|FG000|Switched to Higher Dose|Overall Study||59
10927554|NCT00268892|12096154|FG001|Switched to Higher Dose|Overall Study||68
10927555|NCT00268892|12096155|FG002|Switched to Higher Dose|Overall Study||76
10927556|NCT00268892|12096153|FG000|COMPLETED|Overall Study||51
10927557|NCT00268892|12096154|FG001|COMPLETED|Overall Study||53
10927558|NCT00268892|12096155|FG002|COMPLETED|Overall Study||54
10927559|NCT00268892|12096153|FG000|NOT COMPLETED|Overall Study||39
10927560|NCT00268892|12096154|FG001|NOT COMPLETED|Overall Study||42
10927561|NCT00268892|12096155|FG002|NOT COMPLETED|Overall Study||39
10927562|NCT00268905|12096166|FG000|STARTED|Overall Study||43
10927563|NCT00268905|12096167|FG001|STARTED|Overall Study||9
10927564|NCT00268905|12096168|FG002|STARTED|Overall Study||12
10927565|NCT00268905|12096166|FG000|COMPLETED|Overall Study||0
10927566|NCT00268905|12096167|FG001|COMPLETED|Overall Study||0
10927567|NCT00268905|12096168|FG002|COMPLETED|Overall Study||0
10927568|NCT00268905|12096166|FG000|NOT COMPLETED|Overall Study||43
10927569|NCT00268905|12096167|FG001|NOT COMPLETED|Overall Study||9
10927570|NCT00268905|12096168|FG002|NOT COMPLETED|Overall Study||12
10927571|NCT00268983|12096178|FG000|STARTED|Overall Study||6
10927572|NCT00268983|12096179|FG001|STARTED|Overall Study||8
10927573|NCT00268983|12096178|FG000|COMPLETED|Overall Study||3
10927574|NCT00268983|12096179|FG001|COMPLETED|Overall Study||8
10927575|NCT00268983|12096178|FG000|NOT COMPLETED|Overall Study||3
10927576|NCT00268983|12096179|FG001|NOT COMPLETED|Overall Study||0
10927577|NCT00268996|12096187|FG000|STARTED|Overall Study||151
10927578|NCT00268996|12096188|FG001|STARTED|Overall Study||172
10927579|NCT00268996|12096187|FG000|COMPLETED|Overall Study||130
10927580|NCT00268996|12096188|FG001|COMPLETED|Overall Study||152
10927581|NCT00268996|12096187|FG000|NOT COMPLETED|Overall Study||21
10927582|NCT00268996|12096188|FG001|NOT COMPLETED|Overall Study||20
10927583|NCT00269087|12096196|FG000|STARTED|Overall Study||122
10927584|NCT00269087|12096196|FG000|COMPLETED|Overall Study||88
10927585|NCT00269087|12096196|FG000|NOT COMPLETED|Overall Study||34
10927586|NCT00269113|12096202|FG000|STARTED|Overall Study||177
10927587|NCT00269113|12096203|FG001|STARTED|Overall Study||183
10927588|NCT00269113|12096202|FG000|COMPLETED|Overall Study||103
10927589|NCT00269113|12096203|FG001|COMPLETED|Overall Study||146
10927590|NCT00269113|12096202|FG000|NOT COMPLETED|Overall Study||74
10927591|NCT00269113|12096203|FG001|NOT COMPLETED|Overall Study||37
10927592|NCT00269152|12096211|FG000|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
10927593|NCT00269152|12096212|FG001|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
10927594|NCT00269152|12096211|FG000|COMPLETED|Overall Study||45
10927595|NCT00269152|12096212|FG001|COMPLETED|Overall Study||49
10927596|NCT00269152|12096211|FG000|NOT COMPLETED|Overall Study||18
10927597|NCT00269152|12096212|FG001|NOT COMPLETED|Overall Study||10
10927598|NCT00269399|12096220|FG000|STARTED|Overall Study||119
10927599|NCT00269399|12096221|FG001|STARTED|Overall Study||118
10927600|NCT00269399|12096220|FG000|COMPLETED|Overall Study||78
10927601|NCT00269399|12096221|FG001|COMPLETED|Overall Study||91
10927602|NCT00269399|12096220|FG000|NOT COMPLETED|Overall Study||41
10927603|NCT00269399|12096221|FG001|NOT COMPLETED|Overall Study||27
10927604|NCT00269477|12096231|FG000|STARTED|Overall Study||9
10927605|NCT00269477|12096232|FG001|STARTED|Overall Study||18
10927606|NCT00269477|12096233|FG002|STARTED|Overall Study||58
10927607|NCT00269477|12096234|FG003|STARTED|Overall Study||60
10927608|NCT00269477|12096231|FG000|COMPLETED|Overall Study||4
10927609|NCT00269477|12096232|FG001|COMPLETED|Overall Study||12
10927610|NCT00269477|12096233|FG002|COMPLETED|Overall Study||57
10927611|NCT00269477|12096234|FG003|COMPLETED|Overall Study||60
10927612|NCT00269477|12096231|FG000|NOT COMPLETED|Overall Study||5
10927613|NCT00269477|12096232|FG001|NOT COMPLETED|Overall Study||6
10927614|NCT00269477|12096233|FG002|NOT COMPLETED|Overall Study||1
10927615|NCT00269477|12096234|FG003|NOT COMPLETED|Overall Study||0
10927616|NCT00269633|12096246|FG000|STARTED|Overall Study||4
10927617|NCT00269633|12096247|FG001|STARTED|Overall Study||5
10927618|NCT00269633|12096246|FG000|COMPLETED|Overall Study||3
10927619|NCT00269633|12096247|FG001|COMPLETED|Overall Study||5
10927620|NCT00269633|12096246|FG000|NOT COMPLETED|Overall Study||1
10927621|NCT00269633|12096247|FG001|NOT COMPLETED|Overall Study||0
10927622|NCT00269919|12096253|FG000|STARTED|Overall Study||40
10927623|NCT00269919|12096253|FG000|Treated|Overall Study||39
10927624|NCT00269919|12096253|FG000|COMPLETED|Overall Study||13
10927625|NCT00269919|12096253|FG000|NOT COMPLETED|Overall Study||27
10927626|NCT00270205|12096262|FG000|STARTED|Overall Study||6
10927627|NCT00270205|12096263|FG001|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
10927628|NCT00270205|12096264|FG002|STARTED|Overall Study||6
10927629|NCT00270205|12096265|FG003|STARTED|Overall Study||7
10927630|NCT00270205|12096262|FG000|COMPLETED|Overall Study||5
10927631|NCT00270205|12096263|FG001|COMPLETED|Overall Study||6
10927632|NCT00270205|12096264|FG002|COMPLETED|Overall Study||6
10927633|NCT00270205|12096265|FG003|COMPLETED|Overall Study||6
10927634|NCT00270205|12096262|FG000|NOT COMPLETED|Overall Study||1
10927635|NCT00270205|12096263|FG001|NOT COMPLETED|Overall Study||0
10927636|NCT00270205|12096264|FG002|NOT COMPLETED|Overall Study||0
10927637|NCT00270205|12096265|FG003|NOT COMPLETED|Overall Study||1
10927638|NCT00270231|12096275|FG000|STARTED|First Intervention||32
10927639|NCT00270231|12096276|FG001|STARTED|First Intervention||32
10927640|NCT00270231|12096275|FG000|COMPLETED|First Intervention||31
10927641|NCT00270231|12096276|FG001|COMPLETED|First Intervention||31
10927642|NCT00270231|12096275|FG000|NOT COMPLETED|First Intervention||1
10927643|NCT00270231|12096276|FG001|NOT COMPLETED|First Intervention||1
10927644|NCT00270231|12096275|FG000|STARTED|Washout Period||31
10927645|NCT00270231|12096276|FG001|STARTED|Washout Period||31
10927646|NCT00270231|12096275|FG000|COMPLETED|Washout Period||30
10927647|NCT00270231|12096276|FG001|COMPLETED|Washout Period||31
10927648|NCT00270231|12096275|FG000|NOT COMPLETED|Washout Period||1
10927649|NCT00270231|12096276|FG001|NOT COMPLETED|Washout Period||0
10927650|NCT00270231|12096275|FG000|STARTED|Second Intervention||30
10927651|NCT00270231|12096276|FG001|STARTED|Second Intervention||31
10927652|NCT00270231|12096275|FG000|COMPLETED|Second Intervention||30
10927653|NCT00270231|12096276|FG001|COMPLETED|Second Intervention||30
10927654|NCT00270231|12096275|FG000|NOT COMPLETED|Second Intervention||0
10927655|NCT00270231|12096276|FG001|NOT COMPLETED|Second Intervention||1
10927656|NCT00270257|12096284|FG000|STARTED|Overall Study||623
10927657|NCT00270257|12096285|FG001|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
10927658|NCT00270257|12096284|FG000|Week 8|Overall Study||510
10927659|NCT00270257|12096285|FG001|Week 8|Overall Study||443
10927660|NCT00270257|12096284|FG000|Week 26|Overall Study||460
10927661|NCT00270257|12096285|FG001|Week 26|Overall Study||440
10927662|NCT00270257|12096284|FG000|Week 52|Overall Study||362
10927663|NCT00270257|12096285|FG001|Week 52|Overall Study||340
10927664|NCT00270257|12096284|FG000|Week 78|Overall Study||283
10927665|NCT00270257|12096285|FG001|Week 78|Overall Study||285
10927666|NCT00270257|12096284|FG000|Visit 104|Overall Study||211
10927667|NCT00270257|12096285|FG001|Visit 104|Overall Study||204
10927668|NCT00270257|12096284|FG000|COMPLETED|Overall Study||211
10927669|NCT00270257|12096285|FG001|COMPLETED|Overall Study||204
10927670|NCT00270257|12096284|FG000|NOT COMPLETED|Overall Study||412
10927671|NCT00270257|12096285|FG001|NOT COMPLETED|Overall Study||424
10927672|NCT00270296|12096296|FG000|STARTED|Overall Study||285
10927673|NCT00270296|12096297|FG001|STARTED|Overall Study||275
10927674|NCT00270296|12096298|FG002|STARTED|Overall Study||170
10927675|NCT00270296|12096296|FG000|COMPLETED|Overall Study||186
10927676|NCT00270296|12096297|FG001|COMPLETED|Overall Study||185
10927677|NCT00270296|12096298|FG002|COMPLETED|Overall Study||109
10927678|NCT00270296|12096296|FG000|NOT COMPLETED|Overall Study||99
10927679|NCT00270296|12096297|FG001|NOT COMPLETED|Overall Study||90
10927680|NCT00270296|12096298|FG002|NOT COMPLETED|Overall Study||61
10927681|NCT00270634|12096310|FG000|STARTED|Overall Study||87
10927682|NCT00270634|12096311|FG001|STARTED|Overall Study||77
10927683|NCT00270634|12096312|FG002|STARTED|Overall Study||84
10927684|NCT00270634|12096313|FG003|STARTED|Overall Study||86
10927685|NCT00270634|12096310|FG000|COMPLETED|Overall Study||70
10927686|NCT00270634|12096311|FG001|COMPLETED|Overall Study||64
10927687|NCT00270634|12096312|FG002|COMPLETED|Overall Study||62
10927688|NCT00270634|12096313|FG003|COMPLETED|Overall Study||81
10927689|NCT00270634|12096310|FG000|NOT COMPLETED|Overall Study||17
10927690|NCT00270634|12096311|FG001|NOT COMPLETED|Overall Study||13
10927691|NCT00270634|12096312|FG002|NOT COMPLETED|Overall Study||22
10927692|NCT00270634|12096313|FG003|NOT COMPLETED|Overall Study||5
10927693|NCT00270790|12096327|FG000|STARTED|Overall Study||21
10927694|NCT00270790|12096327|FG000|COMPLETED|Overall Study||16
10927695|NCT00270790|12096327|FG000|NOT COMPLETED|Overall Study||5
10927696|NCT00270842|12096334|FG000|STARTED|Overall Study||33
10927697|NCT00270842|12096335|FG001|STARTED|Overall Study||34
10927698|NCT00270842|12096336|FG002|STARTED|Overall Study||34
10927699|NCT00270842|12096334|FG000|COMPLETED|Overall Study||18
10927700|NCT00270842|12096335|FG001|COMPLETED|Overall Study||18
10927701|NCT00270842|12096336|FG002|COMPLETED|Overall Study||18
10927702|NCT00270842|12096334|FG000|NOT COMPLETED|Overall Study||15
10927703|NCT00270842|12096335|FG001|NOT COMPLETED|Overall Study||16
10927704|NCT00270842|12096336|FG002|NOT COMPLETED|Overall Study||16
10927705|NCT00270855|12096346|FG000|STARTED|Overall Study||15
10927706|NCT00270855|12096347|FG001|STARTED|Overall Study||14
10927707|NCT00270855|12096346|FG000|COMPLETED|Overall Study||7
10927708|NCT00270855|12096347|FG001|COMPLETED|Overall Study||6
10927709|NCT00270855|12096346|FG000|NOT COMPLETED|Overall Study||8
10927710|NCT00270855|12096347|FG001|NOT COMPLETED|Overall Study||8
10927711|NCT00270894|12096355|FG000|STARTED|Overall Study||30
10927712|NCT00270894|12096355|FG000|COMPLETED|Overall Study||28
10927713|NCT00270894|12096355|FG000|NOT COMPLETED|Overall Study||2
10927714|NCT00270998|12096362|FG000|STARTED|3 Month Follow-up||149
10927715|NCT00270998|12096363|FG001|STARTED|3 Month Follow-up||146
10927716|NCT00270998|12096364|FG002|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
10927717|NCT00270998|12096362|FG000|COMPLETED|3 Month Follow-up||110
10927718|NCT00270998|12096363|FG001|COMPLETED|3 Month Follow-up||124
10927719|NCT00270998|12096364|FG002|COMPLETED|3 Month Follow-up||132
10927720|NCT00270998|12096362|FG000|NOT COMPLETED|3 Month Follow-up||39
10927721|NCT00270998|12096363|FG001|NOT COMPLETED|3 Month Follow-up||22
10927722|NCT00270998|12096364|FG002|NOT COMPLETED|3 Month Follow-up||18
10927723|NCT00270998|12096362|FG000|STARTED|12 Month Follow-up||110
10927724|NCT00270998|12096363|FG001|STARTED|12 Month Follow-up||124
10927725|NCT00270998|12096364|FG002|STARTED|12 Month Follow-up||132
10927726|NCT00270998|12096362|FG000|COMPLETED|12 Month Follow-up||96
10927727|NCT00270998|12096363|FG001|COMPLETED|12 Month Follow-up||99
10927728|NCT00270998|12096364|FG002|COMPLETED|12 Month Follow-up||111
10927729|NCT00270998|12096362|FG000|NOT COMPLETED|12 Month Follow-up||14
10927730|NCT00270998|12096363|FG001|NOT COMPLETED|12 Month Follow-up||25
10927731|NCT00270998|12096364|FG002|NOT COMPLETED|12 Month Follow-up||21
10927732|NCT00271024|12096378|FG000|STARTED|Overall Study||80
10927733|NCT00271024|12096379|FG001|STARTED|Overall Study||77
10927734|NCT00271024|12096380|FG002|STARTED|Overall Study||88
10927735|NCT00271024|12096381|FG003|STARTED|Overall Study||88
10927736|NCT00271024|12096378|FG000|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
10927737|NCT00271024|12096379|FG001|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
10927738|NCT00271024|12096380|FG002|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
10927739|NCT00271024|12096381|FG003|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
10927740|NCT00271024|12096378|FG000|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
10927741|NCT00271024|12096379|FG001|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
10927742|NCT00271024|12096380|FG002|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
10927743|NCT00271024|12096381|FG003|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
10927744|NCT00271024|12096378|FG000|NOT COMPLETED|Overall Study||22
10927745|NCT00271024|12096379|FG001|NOT COMPLETED|Overall Study||26
10927746|NCT00271024|12096380|FG002|NOT COMPLETED|Overall Study||23
10927747|NCT00271024|12096381|FG003|NOT COMPLETED|Overall Study||24
10927748|NCT00271154|12096393|FG000|STARTED|Overall Study||191
10927749|NCT00271154|12096394|FG001|STARTED|Overall Study||419
10927750|NCT00271154|12096393|FG000|COMPLETED|Overall Study||191
10927751|NCT00271154|12096394|FG001|COMPLETED|Overall Study||419
10927752|NCT00271154|12096393|FG000|NOT COMPLETED|Overall Study||0
10927753|NCT00271154|12096394|FG001|NOT COMPLETED|Overall Study||0
10927754|NCT00271219|12096403|FG000|STARTED|Overall Study||89
10927755|NCT00271219|12096404|FG001|STARTED|Overall Study||86
10927756|NCT00271219|12096403|FG000|COMPLETED|Overall Study||73
10927757|NCT00271219|12096404|FG001|COMPLETED|Overall Study||58
10927758|NCT00271219|12096403|FG000|NOT COMPLETED|Overall Study||16
10927759|NCT00271219|12096404|FG001|NOT COMPLETED|Overall Study||28
10927760|NCT00271375|12096417|FG000|STARTED|Overall Study||114
10927761|NCT00271375|12096418|FG001|STARTED|Overall Study||83
10927762|NCT00271375|12096419|FG002|STARTED|Overall Study||57
10927763|NCT00271375|12096417|FG000|COMPLETED|Overall Study||114
10927764|NCT00271375|12096418|FG001|COMPLETED|Overall Study||83
10927765|NCT00271375|12096419|FG002|COMPLETED|Overall Study||57
10927766|NCT00271375|12096417|FG000|NOT COMPLETED|Overall Study||0
10927767|NCT00271375|12096418|FG001|NOT COMPLETED|Overall Study||0
10927768|NCT00271375|12096419|FG002|NOT COMPLETED|Overall Study||0
10927769|NCT00271505|12096428|FG000|STARTED|Overall Study||43
10927770|NCT00271505|12096428|FG000|COMPLETED|Overall Study||38
10927771|NCT00271505|12096428|FG000|NOT COMPLETED|Overall Study||5
10927772|NCT00271570|12096435|FG000|STARTED|Overall Study||12
10927773|NCT00271570|12096436|FG001|STARTED|Overall Study||12
10927774|NCT00271570|12096435|FG000|COMPLETED|Overall Study||12
10927775|NCT00271570|12096436|FG001|COMPLETED|Overall Study||12
10927776|NCT00271570|12096435|FG000|NOT COMPLETED|Overall Study||0
10927777|NCT00271570|12096436|FG001|NOT COMPLETED|Overall Study||0
10927778|NCT00271596|12096444|FG000|STARTED|Overall Study||17
10927779|NCT00271596|12096445|FG001|STARTED|Overall Study||16
10927780|NCT00271596|12096444|FG000|COMPLETED|Overall Study||16
10927781|NCT00271596|12096445|FG001|COMPLETED|Overall Study||15
10927782|NCT00271596|12096444|FG000|NOT COMPLETED|Overall Study||1
10927783|NCT00271596|12096445|FG001|NOT COMPLETED|Overall Study||1
10927784|NCT00271609|12096453|FG000|STARTED|Overall Study||56
10927785|NCT00271609|12096454|FG001|STARTED|Overall Study||32
10927786|NCT00271609|12096453|FG000|COMPLETED|Overall Study||43
10927787|NCT00271609|12096454|FG001|COMPLETED|Overall Study||29
10927788|NCT00271609|12096453|FG000|NOT COMPLETED|Overall Study||13
10927789|NCT00271609|12096454|FG001|NOT COMPLETED|Overall Study||3
10927790|NCT00271739|12096462|FG000|STARTED|Overall Study||844
10927791|NCT00271739|12096463|FG001|STARTED|Overall Study||821
10927792|NCT00271739|12096462|FG000|COMPLETED|Overall Study||729
10927793|NCT00271739|12096463|FG001|COMPLETED|Overall Study||716
10927794|NCT00271739|12096462|FG000|NOT COMPLETED|Overall Study||115
10927795|NCT00271739|12096463|FG001|NOT COMPLETED|Overall Study||105
10927796|NCT00271856|12096471|FG000|STARTED|Overall Study||89
10927797|NCT00271856|12096472|FG001|STARTED|Overall Study||88
10927798|NCT00271856|12096471|FG000|COMPLETED|Overall Study||78
10927799|NCT00271856|12096472|FG001|COMPLETED|Overall Study||70
10927800|NCT00271856|12096471|FG000|NOT COMPLETED|Overall Study||11
10927801|NCT00271856|12096472|FG001|NOT COMPLETED|Overall Study||18
10927802|NCT00272038|12096478|FG000|STARTED|Overall Study||29
10927803|NCT00272038|12096478|FG000|COMPLETED|Overall Study||22
10927804|NCT00272038|12096478|FG000|NOT COMPLETED|Overall Study||7
10927805|NCT00272168|12096485|FG000|STARTED|Overall Study||47
10927806|NCT00272168|12096486|FG001|STARTED|Overall Study||41
10927807|NCT00272168|12096485|FG000|COMPLETED|Overall Study||37
10927808|NCT00272168|12096486|FG001|COMPLETED|Overall Study||31
10927809|NCT00272168|12096485|FG000|NOT COMPLETED|Overall Study||10
10927810|NCT00272168|12096486|FG001|NOT COMPLETED|Overall Study||10
10927811|NCT00272311|12096497|FG000|STARTED|Overall Study||14
10927812|NCT00272311|12096498|FG001|STARTED|Overall Study||14
10927813|NCT00272311|12096499|FG002|STARTED|Overall Study||14
10927814|NCT00272311|12096500|FG003|STARTED|Overall Study||14
10927815|NCT00272311|12096501|FG004|STARTED|Overall Study||14
10927816|NCT00272311|12096497|FG000|COMPLETED|Overall Study||14
10927817|NCT00272311|12096498|FG001|COMPLETED|Overall Study||14
10927818|NCT00272311|12096499|FG002|COMPLETED|Overall Study||14
10927819|NCT00272311|12096500|FG003|COMPLETED|Overall Study||14
10927820|NCT00272311|12096501|FG004|COMPLETED|Overall Study||14
10927821|NCT00272311|12096497|FG000|NOT COMPLETED|Overall Study||0
10927822|NCT00272311|12096498|FG001|NOT COMPLETED|Overall Study||0
10927823|NCT00272311|12096499|FG002|NOT COMPLETED|Overall Study||0
10927824|NCT00272311|12096500|FG003|NOT COMPLETED|Overall Study||0
10927825|NCT00272311|12096501|FG004|NOT COMPLETED|Overall Study||0
10927826|NCT00272337|12096518|FG000|STARTED|Overall Study||8
10927827|NCT00272337|12096519|FG001|STARTED|Overall Study||7
10927828|NCT00272337|12096520|FG002|STARTED|Overall Study||7
10927829|NCT00272337|12096521|FG003|STARTED|Overall Study||7
10927830|NCT00272337|12096522|FG004|STARTED|Overall Study||8
10927831|NCT00272337|12096518|FG000|COMPLETED|Overall Study||8
10927832|NCT00272337|12096519|FG001|COMPLETED|Overall Study||7
10927833|NCT00272337|12096520|FG002|COMPLETED|Overall Study||7
10927834|NCT00272337|12096521|FG003|COMPLETED|Overall Study||7
10927835|NCT00272337|12096522|FG004|COMPLETED|Overall Study||8
10927836|NCT00272337|12096518|FG000|NOT COMPLETED|Overall Study||0
10927837|NCT00272337|12096519|FG001|NOT COMPLETED|Overall Study||0
10927838|NCT00272337|12096520|FG002|NOT COMPLETED|Overall Study||0
10927839|NCT00272337|12096521|FG003|NOT COMPLETED|Overall Study||0
10927840|NCT00272337|12096522|FG004|NOT COMPLETED|Overall Study||0
10927841|NCT00272779|12096536|FG000|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
10927842|NCT00272779|12096537|FG001|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
10927843|NCT00272779|12096536|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
10927844|NCT00272779|12096537|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
10927845|NCT00272779|12096536|FG000|TREATED AS RANDOMIZED|Baseline Through Week 48||438
10927846|NCT00272779|12096537|FG001|TREATED AS RANDOMIZED|Baseline Through Week 48||440
10927847|NCT00272779|12096536|FG000|Discontinued Before Week 48|Baseline Through Week 48||39
10927848|NCT00272779|12096537|FG001|Discontinued Before Week 48|Baseline Through Week 48||58
10927849|NCT00272779|12096536|FG000|Discontinued on or After Week 48|Baseline Through Week 48||14
10927850|NCT00272779|12096537|FG001|Discontinued on or After Week 48|Baseline Through Week 48||14
10927851|NCT00272779|12096536|FG000|STILL ON TREATMENT|Baseline Through Week 48||385
10927852|NCT00272779|12096537|FG001|STILL ON TREATMENT|Baseline Through Week 48||368
10927853|NCT00272779|12096536|FG000|COMPLETED|Baseline Through Week 48||0
10927854|NCT00272779|12096537|FG001|COMPLETED|Baseline Through Week 48||0
10927855|NCT00272779|12096536|FG000|NOT COMPLETED|Baseline Through Week 48||440
10927856|NCT00272779|12096537|FG001|NOT COMPLETED|Baseline Through Week 48||443
10927857|NCT00272779|12096536|FG000|STARTED|Baseline Through Week 96|Number randomized to ATV|440
10927858|NCT00272779|12096537|FG001|STARTED|Baseline Through Week 96|Number randomized to LPV|443
10927859|NCT00272779|12096536|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
10927860|NCT00272779|12096537|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
10927861|NCT00272779|12096536|FG000|COMPLETED|Baseline Through Week 96||301
10927862|NCT00272779|12096537|FG001|COMPLETED|Baseline Through Week 96||307
10927863|NCT00272779|12096536|FG000|NOT COMPLETED|Baseline Through Week 96||139
10927864|NCT00272779|12096537|FG001|NOT COMPLETED|Baseline Through Week 96||136
10927865|NCT00272792|12096546|FG000|STARTED|Part 1: Responsiveness||90
10927866|NCT00272792|12096547|FG001|STARTED|Part 1: Responsiveness||0
10927867|NCT00272792|12096546|FG000|COMPLETED|Part 1: Responsiveness||89
10927868|NCT00272792|12096547|FG001|COMPLETED|Part 1: Responsiveness||0
10927869|NCT00272792|12096546|FG000|NOT COMPLETED|Part 1: Responsiveness||1
10927870|NCT00272792|12096547|FG001|NOT COMPLETED|Part 1: Responsiveness||0
10927871|NCT00272792|12096546|FG000|STARTED|Part 2: Blinded, Placebo Control Period||33
10927872|NCT00272792|12096547|FG001|STARTED|Part 2: Blinded, Placebo Control Period||12
10927873|NCT00272792|12096546|FG000|COMPLETED|Part 2: Blinded, Placebo Control Period||32
10927874|NCT00272792|12096547|FG001|COMPLETED|Part 2: Blinded, Placebo Control Period||9
10927875|NCT00272792|12096546|FG000|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
10927876|NCT00272792|12096547|FG001|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
10927877|NCT00272844|12096553|FG000|STARTED|Overall Study||23
10927878|NCT00272844|12096553|FG000|COMPLETED|Overall Study||18
10927879|NCT00272844|12096553|FG000|NOT COMPLETED|Overall Study||5
10927880|NCT00272961|12096562|FG000|STARTED|Placebo Run-in Phase: Up to Week 2||60
10927881|NCT00272961|12096563|FG001|STARTED|Placebo Run-in Phase: Up to Week 2||0
10927882|NCT00272961|12096564|FG002|STARTED|Placebo Run-in Phase: Up to Week 2||0
10927883|NCT00272961|12096565|FG003|STARTED|Placebo Run-in Phase: Up to Week 2||0
10927884|NCT00272961|12096566|FG004|STARTED|Placebo Run-in Phase: Up to Week 2||0
10927885|NCT00272961|12096562|FG000|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
10927886|NCT00272961|12096563|FG001|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10927887|NCT00272961|12096564|FG002|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10927888|NCT00272961|12096565|FG003|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10927889|NCT00272961|12096566|FG004|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10927890|NCT00272961|12096562|FG000|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
10927891|NCT00272961|12096563|FG001|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10927892|NCT00272961|12096564|FG002|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10927893|NCT00272961|12096565|FG003|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10927894|NCT00272961|12096566|FG004|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
10927895|NCT00272961|12096562|FG000|STARTED|Treatment Phase: Week 3 Up to Week 12||10
10927896|NCT00272961|12096563|FG001|STARTED|Treatment Phase: Week 3 Up to Week 12||8
10927897|NCT00272961|12096564|FG002|STARTED|Treatment Phase: Week 3 Up to Week 12||11
10927898|NCT00272961|12096565|FG003|STARTED|Treatment Phase: Week 3 Up to Week 12||10
10927899|NCT00272961|12096566|FG004|STARTED|Treatment Phase: Week 3 Up to Week 12||10
10927900|NCT00272961|12096562|FG000|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
10927901|NCT00272961|12096563|FG001|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
10927902|NCT00272961|12096564|FG002|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
10927903|NCT00272961|12096565|FG003|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
10927904|NCT00272961|12096566|FG004|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
10927905|NCT00272961|12096562|FG000|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
10927906|NCT00272961|12096563|FG001|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
10927907|NCT00272961|12096564|FG002|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
10927908|NCT00272961|12096565|FG003|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
10927909|NCT00272961|12096566|FG004|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
10927910|NCT00272987|12096581|FG000|STARTED|Overall Study||29
10927911|NCT00272987|12096582|FG001|STARTED|Overall Study||14
10927912|NCT00272987|12096583|FG002|STARTED|Overall Study||20
10927913|NCT00272987|12096581|FG000|COMPLETED|Overall Study||20
10927914|NCT00272987|12096582|FG001|COMPLETED|Overall Study||10
10927915|NCT00272987|12096583|FG002|COMPLETED|Overall Study||9
10927916|NCT00272987|12096581|FG000|NOT COMPLETED|Overall Study||9
10927917|NCT00272987|12096582|FG001|NOT COMPLETED|Overall Study||4
10927918|NCT00272987|12096583|FG002|NOT COMPLETED|Overall Study||11
10927919|NCT00273052|12096593|FG000|STARTED|Overall Study||290
10927920|NCT00273052|12096594|FG001|STARTED|Overall Study||278
10927921|NCT00273052|12096593|FG000|COMPLETED|Overall Study||221
10927922|NCT00273052|12096594|FG001|COMPLETED|Overall Study||190
10927923|NCT00273052|12096593|FG000|NOT COMPLETED|Overall Study||69
10927924|NCT00273052|12096594|FG001|NOT COMPLETED|Overall Study||88
10927925|NCT00273182|12096600|FG000|STARTED|Overall Study||1999
10927926|NCT00273182|12096600|FG000|COMPLETED|Overall Study||1014
10927927|NCT00273182|12096600|FG000|NOT COMPLETED|Overall Study||985
10927928|NCT00273364|12096607|FG000|STARTED|Overall Study||55
10927929|NCT00273364|12096608|FG001|STARTED|Overall Study||55
10927930|NCT00273364|12096607|FG000|COMPLETED|Overall Study||55
10927931|NCT00273364|12096608|FG001|COMPLETED|Overall Study||55
10927932|NCT00273364|12096607|FG000|NOT COMPLETED|Overall Study||0
10927933|NCT00273364|12096608|FG001|NOT COMPLETED|Overall Study||0
10927934|NCT00273754|12096616|FG000|STARTED|Overall Study||36
10927935|NCT00273754|12096617|FG001|STARTED|Overall Study||36
10927936|NCT00273754|12096616|FG000|COMPLETED|Overall Study||36
10927937|NCT00273754|12096617|FG001|COMPLETED|Overall Study||36
10927938|NCT00273754|12096616|FG000|NOT COMPLETED|Overall Study||0
10927939|NCT00273754|12096617|FG001|NOT COMPLETED|Overall Study||0
10927940|NCT00273793|12096629|FG000|STARTED|Overall Study||36
10927941|NCT00273793|12096630|FG001|STARTED|Overall Study||38
10927942|NCT00273793|12096631|FG002|STARTED|Overall Study||18
10927943|NCT00273793|12096632|FG003|STARTED|Overall Study||60
10927944|NCT00273793|12096633|FG004|STARTED|Overall Study||58
10927945|NCT00273793|12096634|FG005|STARTED|Overall Study||29
10927946|NCT00273793|12096629|FG000|COMPLETED|Overall Study||36
10927947|NCT00273793|12096630|FG001|COMPLETED|Overall Study||38
10927948|NCT00273793|12096631|FG002|COMPLETED|Overall Study||18
10927949|NCT00273793|12096632|FG003|COMPLETED|Overall Study||60
10927950|NCT00273793|12096633|FG004|COMPLETED|Overall Study||58
10927951|NCT00273793|12096634|FG005|COMPLETED|Overall Study||29
10927952|NCT00273793|12096629|FG000|NOT COMPLETED|Overall Study||0
10927953|NCT00273793|12096630|FG001|NOT COMPLETED|Overall Study||0
10927954|NCT00273793|12096631|FG002|NOT COMPLETED|Overall Study||0
10927955|NCT00273793|12096632|FG003|NOT COMPLETED|Overall Study||0
10927956|NCT00273793|12096633|FG004|NOT COMPLETED|Overall Study||0
10927957|NCT00273793|12096634|FG005|NOT COMPLETED|Overall Study||0
10927958|NCT00273858|12096648|FG000|STARTED|Overall Study||880
10927959|NCT00273858|12096648|FG000|COMPLETED|Overall Study||343
10927960|NCT00273858|12096648|FG000|NOT COMPLETED|Overall Study||537
10927961|NCT00273910|12096658|FG000|STARTED|Overall Study||19
10927962|NCT00273910|12096659|FG001|STARTED|Overall Study||19
10927963|NCT00273910|12096660|FG002|STARTED|Overall Study||18
10927964|NCT00273910|12096661|FG003|STARTED|Overall Study||19
10927965|NCT00273910|12096662|FG004|STARTED|Overall Study||15
10927966|NCT00273910|12096663|FG005|STARTED|Overall Study||14
10927967|NCT00273910|12096658|FG000|COMPLETED|Overall Study||19
10927968|NCT00273910|12096659|FG001|COMPLETED|Overall Study||19
10927969|NCT00273910|12096660|FG002|COMPLETED|Overall Study||18
10927970|NCT00273910|12096661|FG003|COMPLETED|Overall Study||19
10927971|NCT00273910|12096662|FG004|COMPLETED|Overall Study||15
10927972|NCT00273910|12096663|FG005|COMPLETED|Overall Study||14
10927973|NCT00273910|12096658|FG000|NOT COMPLETED|Overall Study||0
10927974|NCT00273910|12096659|FG001|NOT COMPLETED|Overall Study||0
10927975|NCT00273910|12096660|FG002|NOT COMPLETED|Overall Study||0
10927976|NCT00273910|12096661|FG003|NOT COMPLETED|Overall Study||0
10927977|NCT00273910|12096662|FG004|NOT COMPLETED|Overall Study||0
10927978|NCT00273910|12096663|FG005|NOT COMPLETED|Overall Study||0
10927979|NCT00274261|12096679|FG000|STARTED|Overall Study||932
10927980|NCT00274261|12096680|FG001|STARTED|Overall Study||633
10927981|NCT00274261|12096679|FG000|COMPLETED|Overall Study||443
10927982|NCT00274261|12096680|FG001|COMPLETED|Overall Study||296
10927983|NCT00274261|12096679|FG000|NOT COMPLETED|Overall Study||489
10927984|NCT00274261|12096680|FG001|NOT COMPLETED|Overall Study||337
10927985|NCT00274287|12096688|FG000|STARTED|Overall Study||15
10927986|NCT00274287|12096688|FG000|COMPLETED|Overall Study||13
10927987|NCT00274287|12096688|FG000|NOT COMPLETED|Overall Study||2
10927988|NCT00274456|12096697|FG000|STARTED|Overall Study||76
10927989|NCT00274456|12096698|FG001|STARTED|Overall Study||76
10927990|NCT00274456|12096699|FG002|STARTED|Overall Study||74
10927991|NCT00274456|12096700|FG003|STARTED|Overall Study||74
10927992|NCT00274456|12096697|FG000|At Least One Response Assessment|Overall Study||73
10927993|NCT00274456|12096698|FG001|At Least One Response Assessment|Overall Study||76
10927994|NCT00274456|12096699|FG002|At Least One Response Assessment|Overall Study||73
10927995|NCT00274456|12096700|FG003|At Least One Response Assessment|Overall Study||70
10927996|NCT00274456|12096697|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
10927997|NCT00274456|12096698|FG001|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
10927998|NCT00274456|12096699|FG002|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
10927999|NCT00274456|12096700|FG003|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
10928000|NCT00274456|12096697|FG000|NOT COMPLETED|Overall Study||37
10928001|NCT00274456|12096698|FG001|NOT COMPLETED|Overall Study||27
10928002|NCT00274456|12096699|FG002|NOT COMPLETED|Overall Study||35
10928003|NCT00274456|12096700|FG003|NOT COMPLETED|Overall Study||45
10928004|NCT00274469|12096712|FG000|STARTED|Overall Study|Number of patients randomized|102
10928005|NCT00274469|12096713|FG001|STARTED|Overall Study|Number of patients randomized|103
10928006|NCT00274469|12096712|FG000|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23
10928007|NCT00274469|12096713|FG001|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10
10928008|NCT00274469|12096712|FG000|NOT COMPLETED|Overall Study||79
10928009|NCT00274469|12096713|FG001|NOT COMPLETED|Overall Study||93
10928010|NCT00274625|12096721|FG000|STARTED|Overall Study||199
10928011|NCT00274625|12096722|FG001|STARTED|Overall Study||203
10928012|NCT00274625|12096721|FG000|COMPLETED|Overall Study||139
10928013|NCT00274625|12096722|FG001|COMPLETED|Overall Study||141
10928014|NCT00274625|12096721|FG000|NOT COMPLETED|Overall Study||60
10928015|NCT00274625|12096722|FG001|NOT COMPLETED|Overall Study||62
10928016|NCT00274651|12096730|FG000|STARTED|Overall Study||29
10928017|NCT00274651|12096731|FG001|STARTED|Overall Study||24
10928018|NCT00274651|12096730|FG000|COMPLETED|Overall Study||1
10928019|NCT00274651|12096731|FG001|COMPLETED|Overall Study||4
10928020|NCT00274651|12096730|FG000|NOT COMPLETED|Overall Study||28
10928021|NCT00274651|12096731|FG001|NOT COMPLETED|Overall Study||20
10928022|NCT00274716|12096744|FG000|STARTED|Phase A||54
10928023|NCT00274716|12096745|FG001|STARTED|Phase A||54
10928024|NCT00274716|12096746|FG002|STARTED|Phase A||52
10928025|NCT00274716|12096747|FG003|STARTED|Phase A||51
10928026|NCT00274716|12096748|FG004|STARTED|Phase A||19
10928027|NCT00274716|12096749|FG005|STARTED|Phase A||19
10928028|NCT00274716|12096744|FG000|COMPLETED|Phase A||43
10928029|NCT00274716|12096745|FG001|COMPLETED|Phase A||44
10928030|NCT00274716|12096746|FG002|COMPLETED|Phase A||44
10928031|NCT00274716|12096747|FG003|COMPLETED|Phase A||42
10928032|NCT00274716|12096748|FG004|COMPLETED|Phase A||16
10928033|NCT00274716|12096749|FG005|COMPLETED|Phase A||15
10928034|NCT00274716|12096744|FG000|NOT COMPLETED|Phase A||11
10928035|NCT00274716|12096745|FG001|NOT COMPLETED|Phase A||10
10928036|NCT00274716|12096746|FG002|NOT COMPLETED|Phase A||8
10928037|NCT00274716|12096747|FG003|NOT COMPLETED|Phase A||9
10928038|NCT00274716|12096748|FG004|NOT COMPLETED|Phase A||3
10928039|NCT00274716|12096749|FG005|NOT COMPLETED|Phase A||4
10928040|NCT00274716|12096744|FG000|STARTED|Phase B||43
10928041|NCT00274716|12096745|FG001|STARTED|Phase B||44
10928042|NCT00274716|12096746|FG002|STARTED|Phase B||44
10928043|NCT00274716|12096747|FG003|STARTED|Phase B||42
10928044|NCT00274716|12096748|FG004|STARTED|Phase B||16
10928045|NCT00274716|12096749|FG005|STARTED|Phase B||15
10928046|NCT00274716|12096744|FG000|COMPLETED|Phase B||42
10928047|NCT00274716|12096745|FG001|COMPLETED|Phase B||40
10928048|NCT00274716|12096746|FG002|COMPLETED|Phase B||41
10928049|NCT00274716|12096747|FG003|COMPLETED|Phase B||41
10928050|NCT00274716|12096748|FG004|COMPLETED|Phase B||16
10928051|NCT00274716|12096749|FG005|COMPLETED|Phase B||14
10928052|NCT00274716|12096744|FG000|NOT COMPLETED|Phase B||1
10928053|NCT00274716|12096745|FG001|NOT COMPLETED|Phase B||4
10928054|NCT00274716|12096746|FG002|NOT COMPLETED|Phase B||3
10928055|NCT00274716|12096747|FG003|NOT COMPLETED|Phase B||1
10928056|NCT00274716|12096748|FG004|NOT COMPLETED|Phase B||0
10928057|NCT00274716|12096749|FG005|NOT COMPLETED|Phase B||1
10928058|NCT00274742|12096773|FG000|STARTED|Overall Study||12
10928059|NCT00274742|12096774|FG001|STARTED|Overall Study||13
10928060|NCT00274742|12096775|FG002|STARTED|Overall Study||6
10928061|NCT00274742|12096776|FG003|STARTED|Overall Study||9
10928062|NCT00274742|12096777|FG004|STARTED|Overall Study||32
10928063|NCT00274742|12096778|FG005|STARTED|Overall Study||4
10928064|NCT00274742|12096773|FG000|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
10928065|NCT00274742|12096774|FG001|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
10928066|NCT00274742|12096775|FG002|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
10928067|NCT00274742|12096776|FG003|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
10928068|NCT00274742|12096777|FG004|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
10928069|NCT00274742|12096778|FG005|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
10928070|NCT00274742|12096773|FG000|NOT COMPLETED|Overall Study||0
10928071|NCT00274742|12096774|FG001|NOT COMPLETED|Overall Study||8
10928072|NCT00274742|12096775|FG002|NOT COMPLETED|Overall Study||2
10928073|NCT00274742|12096776|FG003|NOT COMPLETED|Overall Study||5
10928074|NCT00274742|12096777|FG004|NOT COMPLETED|Overall Study||16
10928075|NCT00274742|12096778|FG005|NOT COMPLETED|Overall Study||3
10928076|NCT00274768|12096798|FG000|STARTED|Overall Study||26
10928077|NCT00274768|12096798|FG000|COMPLETED|Overall Study||26
10928078|NCT00274768|12096798|FG000|NOT COMPLETED|Overall Study||0
10928079|NCT00274781|12096802|FG000|STARTED|Overall Study||30
10928080|NCT00274781|12096802|FG000|COMPLETED|Overall Study||30
10928081|NCT00274781|12096802|FG000|NOT COMPLETED|Overall Study||0
10928082|NCT00274846|12096807|FG000|STARTED|Overall Study||21
10928083|NCT00274846|12096807|FG000|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
10928084|NCT00274846|12096807|FG000|NOT COMPLETED|Overall Study||1
10928085|NCT00274924|12096815|FG000|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
10928086|NCT00274924|12096816|FG001|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
10928087|NCT00274924|12096817|FG002|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
10928088|NCT00274924|12096815|FG000|Treated|Step 1 (R-CHOP X 3 Cycles)||17
10928089|NCT00274924|12096816|FG001|Treated|Step 1 (R-CHOP X 3 Cycles)||77
10928090|NCT00274924|12096817|FG002|Treated|Step 1 (R-CHOP X 3 Cycles)||5
10928091|NCT00274924|12096815|FG000|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
10928092|NCT00274924|12096816|FG001|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
10928093|NCT00274924|12096817|FG002|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
10928094|NCT00274924|12096815|FG000|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
10928095|NCT00274924|12096816|FG001|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
10928096|NCT00274924|12096817|FG002|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
10928097|NCT00274924|12096815|FG000|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
10928098|NCT00274924|12096816|FG001|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
10928099|NCT00274924|12096817|FG002|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
10928100|NCT00274924|12096815|FG000|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
10928101|NCT00274924|12096816|FG001|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
10928102|NCT00274924|12096817|FG002|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
10928190|NCT00276250|12096938|FG000|STARTED|Overall Study||4
10928103|NCT00274924|12096815|FG000|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
10928104|NCT00274924|12096816|FG001|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
10928105|NCT00274924|12096817|FG002|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
10928106|NCT00274924|12096815|FG000|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
10928107|NCT00274924|12096816|FG001|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
10928108|NCT00274924|12096817|FG002|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
10928109|NCT00274924|12096815|FG000|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
10928110|NCT00274924|12096816|FG001|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
10928111|NCT00274924|12096817|FG002|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
10928112|NCT00275002|12096826|FG000|STARTED|Overall Study||25
10928113|NCT00275002|12096827|FG001|STARTED|Overall Study||16
10928114|NCT00275002|12096826|FG000|COMPLETED|Overall Study||3
10928115|NCT00275002|12096827|FG001|COMPLETED|Overall Study||0
10928116|NCT00275002|12096826|FG000|NOT COMPLETED|Overall Study||22
10928117|NCT00275002|12096827|FG001|NOT COMPLETED|Overall Study||16
10928118|NCT00275028|12096833|FG000|STARTED|Overall Study||47
10928119|NCT00275028|12096833|FG000|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
10928120|NCT00275028|12096833|FG000|NOT COMPLETED|Overall Study||47
10928121|NCT00275262|12096839|FG000|STARTED|Overall Study||12
10928122|NCT00275262|12096840|FG001|STARTED|Overall Study||13
10928123|NCT00275262|12096839|FG000|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
10928124|NCT00275262|12096840|FG001|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
10928125|NCT00275262|12096839|FG000|NOT COMPLETED|Overall Study||6
10928126|NCT00275262|12096840|FG001|NOT COMPLETED|Overall Study||9
10928127|NCT00275275|12096849|FG000|STARTED|Overall Study||20
10928128|NCT00275275|12096850|FG001|STARTED|Overall Study||20
10928129|NCT00275275|12096851|FG002|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
10928130|NCT00275275|12096849|FG000|COMPLETED|Overall Study||14
10928131|NCT00275275|12096850|FG001|COMPLETED|Overall Study||18
10928132|NCT00275275|12096851|FG002|COMPLETED|Overall Study||15
10928133|NCT00275275|12096849|FG000|NOT COMPLETED|Overall Study||6
10928134|NCT00275275|12096850|FG001|NOT COMPLETED|Overall Study||2
10928135|NCT00275275|12096851|FG002|NOT COMPLETED|Overall Study||6
10928136|NCT00275301|12096859|FG000|STARTED|Overall Study||19
10928137|NCT00275301|12096859|FG000|COMPLETED|Overall Study||14
10928138|NCT00275301|12096859|FG000|NOT COMPLETED|Overall Study||5
10928139|NCT00275392|12096865|FG000|STARTED|Overall Study||20
10928140|NCT00275392|12096866|FG001|STARTED|Overall Study||19
10928141|NCT00275392|12096865|FG000|COMPLETED|Overall Study||20
10928142|NCT00275392|12096866|FG001|COMPLETED|Overall Study||17
10928143|NCT00275392|12096865|FG000|NOT COMPLETED|Overall Study||0
10928144|NCT00275392|12096866|FG001|NOT COMPLETED|Overall Study||2
10928145|NCT00275509|12096874|FG000|STARTED|Overall Study||30
10928146|NCT00275509|12096875|FG001|STARTED|Overall Study||26
10928147|NCT00275509|12096874|FG000|COMPLETED|Overall Study||30
10928148|NCT00275509|12096875|FG001|COMPLETED|Overall Study||25
10928149|NCT00275509|12096874|FG000|NOT COMPLETED|Overall Study||0
10928150|NCT00275509|12096875|FG001|NOT COMPLETED|Overall Study||1
10928151|NCT00275561|12096883|FG000|STARTED|Overall Study||21
10928152|NCT00275561|12096884|FG001|STARTED|Overall Study||21
10928153|NCT00275561|12096883|FG000|COMPLETED|Overall Study||19
10928154|NCT00275561|12096884|FG001|COMPLETED|Overall Study||15
10928155|NCT00275561|12096883|FG000|NOT COMPLETED|Overall Study||2
10928156|NCT00275561|12096884|FG001|NOT COMPLETED|Overall Study||6
10928157|NCT00275821|12096893|FG000|STARTED|Overall Study||120
10928158|NCT00275821|12096894|FG001|STARTED|Overall Study||118
10928159|NCT00275821|12096895|FG002|STARTED|Overall Study||115
10928160|NCT00275821|12096893|FG000|COMPLETED|Overall Study||106
10928161|NCT00275821|12096894|FG001|COMPLETED|Overall Study||95
10928162|NCT00275821|12096895|FG002|COMPLETED|Overall Study||103
10928163|NCT00275821|12096893|FG000|NOT COMPLETED|Overall Study||14
10928164|NCT00275821|12096894|FG001|NOT COMPLETED|Overall Study||23
10928165|NCT00275821|12096895|FG002|NOT COMPLETED|Overall Study||12
10928166|NCT00275834|12096906|FG000|STARTED|Overall Study||74
10928167|NCT00275834|12096907|FG001|STARTED|Overall Study||76
10928168|NCT00275834|12096908|FG002|STARTED|Overall Study||75
10928169|NCT00275834|12096906|FG000|Completed Study While on Study Drug|Overall Study||54
10928170|NCT00275834|12096907|FG001|Completed Study While on Study Drug|Overall Study||51
10928171|NCT00275834|12096908|FG002|Completed Study While on Study Drug|Overall Study||62
10928172|NCT00275834|12096906|FG000|COMPLETED|Overall Study||71
10928173|NCT00275834|12096907|FG001|COMPLETED|Overall Study||73
10928174|NCT00275834|12096908|FG002|COMPLETED|Overall Study||74
10928175|NCT00275834|12096906|FG000|NOT COMPLETED|Overall Study||3
10928176|NCT00275834|12096907|FG001|NOT COMPLETED|Overall Study||3
10928177|NCT00275834|12096908|FG002|NOT COMPLETED|Overall Study||1
10928178|NCT00276094|12096921|FG000|STARTED|Overall Study||282
10928179|NCT00276094|12096922|FG001|STARTED|Overall Study||276
10928180|NCT00276094|12096923|FG002|STARTED|Overall Study||268
10928181|NCT00276094|12096921|FG000|COMPLETED|Overall Study||225
10928182|NCT00276094|12096922|FG001|COMPLETED|Overall Study||234
10928183|NCT00276094|12096923|FG002|COMPLETED|Overall Study||230
10928184|NCT00276094|12096921|FG000|NOT COMPLETED|Overall Study||57
10928185|NCT00276094|12096922|FG001|NOT COMPLETED|Overall Study||42
10928186|NCT00276094|12096923|FG002|NOT COMPLETED|Overall Study||38
10928187|NCT00276159|12096931|FG000|STARTED|Overall Study||6
10928188|NCT00276159|12096931|FG000|COMPLETED|Overall Study||0
10928189|NCT00276159|12096931|FG000|NOT COMPLETED|Overall Study||6
10928191|NCT00276250|12096939|FG001|STARTED|Overall Study||1
10928192|NCT00276250|12096940|FG002|STARTED|Overall Study||0
10928193|NCT00276250|12096938|FG000|COMPLETED|Overall Study||4
10928194|NCT00276250|12096939|FG001|COMPLETED|Overall Study||1
10928195|NCT00276250|12096940|FG002|COMPLETED|Overall Study||0
10928196|NCT00276250|12096938|FG000|NOT COMPLETED|Overall Study||0
10928197|NCT00276250|12096939|FG001|NOT COMPLETED|Overall Study||0
10928198|NCT00276250|12096940|FG002|NOT COMPLETED|Overall Study||0
10928199|NCT00276380|12096950|FG000|STARTED|Overall Study||102
10928200|NCT00276380|12096951|FG001|STARTED|Overall Study||102
10928201|NCT00276380|12096950|FG000|COMPLETED|Overall Study||88
10928202|NCT00276380|12096951|FG001|COMPLETED|Overall Study||88
10928203|NCT00276380|12096950|FG000|NOT COMPLETED|Overall Study||14
10928204|NCT00276380|12096951|FG001|NOT COMPLETED|Overall Study||14
10928205|NCT00276406|12096960|FG000|STARTED|Overall Study||16
10928206|NCT00276406|12096961|FG001|STARTED|Overall Study||14
10928207|NCT00276406|12096960|FG000|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
10928208|NCT00276406|12096961|FG001|COMPLETED|Overall Study||14
10928209|NCT00276406|12096960|FG000|NOT COMPLETED|Overall Study||0
10928210|NCT00276406|12096961|FG001|NOT COMPLETED|Overall Study||0
10928211|NCT00276549|12096967|FG000|STARTED|Overall Study||35
10928212|NCT00276549|12096967|FG000|COMPLETED|Overall Study||35
10928213|NCT00276549|12096967|FG000|NOT COMPLETED|Overall Study||0
10928214|NCT00276614|12096971|FG000|STARTED|Overall Study||4
10928215|NCT00276614|12096971|FG000|COMPLETED|Overall Study||1
10928216|NCT00276614|12096971|FG000|NOT COMPLETED|Overall Study||3
10928217|NCT00276744|12096975|FG000|STARTED|PART A||240
10928218|NCT00276744|12096975|FG000|COMPLETED|PART A||142
10928219|NCT00276744|12096975|FG000|NOT COMPLETED|PART A||98
10928220|NCT00276744|12096975|FG000|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
10928221|NCT00276744|12096975|FG000|COMPLETED|PART B||0
10928222|NCT00276744|12096975|FG000|NOT COMPLETED|PART B||0
10928223|NCT00276861|12096979|FG000|STARTED|Overall Study||10
10928224|NCT00276861|12096979|FG000|COMPLETED|Overall Study||10
10928225|NCT00276861|12096979|FG000|NOT COMPLETED|Overall Study||0
10928226|NCT00277095|12096984|FG000|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
10928227|NCT00277095|12096984|FG000|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
10928228|NCT00277095|12096984|FG000|NOT COMPLETED|Overall Study||21
10928229|NCT00277212|12096988|FG000|STARTED|Phase 1 - Single-Blind Treatment||787
10928230|NCT00277212|12096989|FG001|STARTED|Phase 1 - Single-Blind Treatment||0
10928231|NCT00277212|12096990|FG002|STARTED|Phase 1 - Single-Blind Treatment||0
10928232|NCT00277212|12096988|FG000|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
10928233|NCT00277212|12096989|FG001|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
10928234|NCT00277212|12096990|FG002|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
10928235|NCT00277212|12096988|FG000|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
10928236|NCT00277212|12096989|FG001|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
10928237|NCT00277212|12096990|FG002|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
10928238|NCT00277212|12096988|FG000|COMPLETED|Phase 1 - Single-Blind Treatment||352
10928239|NCT00277212|12096989|FG001|COMPLETED|Phase 1 - Single-Blind Treatment||0
10928240|NCT00277212|12096990|FG002|COMPLETED|Phase 1 - Single-Blind Treatment||0
10928241|NCT00277212|12096988|FG000|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
10928242|NCT00277212|12096989|FG001|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
10928243|NCT00277212|12096990|FG002|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
10928244|NCT00277212|12096988|FG000|STARTED|Phase 2 - Double-Blind Treatment||0
10928245|NCT00277212|12096989|FG001|STARTED|Phase 2 - Double-Blind Treatment||173
10928246|NCT00277212|12096990|FG002|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
10928247|NCT00277212|12096988|FG000|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
10928248|NCT00277212|12096989|FG001|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
10928249|NCT00277212|12096990|FG002|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
10928250|NCT00277212|12096988|FG000|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
10928251|NCT00277212|12096989|FG001|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
10928252|NCT00277212|12096990|FG002|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
10928253|NCT00277212|12096988|FG000|COMPLETED|Phase 2 - Double-Blind Treatment||0
10928254|NCT00277212|12096989|FG001|COMPLETED|Phase 2 - Double-Blind Treatment||53
10928255|NCT00277212|12096990|FG002|COMPLETED|Phase 2 - Double-Blind Treatment||65
10928256|NCT00277212|12096988|FG000|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
10928257|NCT00277212|12096989|FG001|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
10928258|NCT00277212|12096990|FG002|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
10928259|NCT00277355|12097000|FG000|STARTED|Overall Study||87
10928260|NCT00277355|12097001|FG001|STARTED|Overall Study||27
10928261|NCT00277355|12097000|FG000|COMPLETED|Overall Study||73
10928262|NCT00277355|12097001|FG001|COMPLETED|Overall Study||22
10928263|NCT00277355|12097000|FG000|NOT COMPLETED|Overall Study||14
10928264|NCT00277355|12097001|FG001|NOT COMPLETED|Overall Study||5
10928265|NCT00277394|12097010|FG000|STARTED|Overall Study||269
10928266|NCT00277394|12097011|FG001|STARTED|Overall Study||270
10928267|NCT00277394|12097010|FG000|COMPLETED|Overall Study||232
10928268|NCT00277394|12097011|FG001|COMPLETED|Overall Study||246
10928269|NCT00277394|12097010|FG000|NOT COMPLETED|Overall Study||37
10928270|NCT00277394|12097011|FG001|NOT COMPLETED|Overall Study||24
10928271|NCT00277446|12097017|FG000|STARTED|Overall Study||13
10928272|NCT00277446|12097017|FG000|COMPLETED|Overall Study||13
10928273|NCT00277446|12097017|FG000|NOT COMPLETED|Overall Study||0
10928274|NCT00277524|12097021|FG000|STARTED|Overall Study||621
10928275|NCT00277524|12097022|FG001|STARTED|Overall Study||324
10928276|NCT00277524|12097023|FG002|STARTED|Overall Study||1088
10928277|NCT00277524|12097024|FG003|STARTED|Overall Study||850
10928278|NCT00277524|12097021|FG000|COMPLETED|Overall Study||621
10928279|NCT00277524|12097022|FG001|COMPLETED|Overall Study||324
10928280|NCT00277524|12097023|FG002|COMPLETED|Overall Study||1088
10928281|NCT00277524|12097024|FG003|COMPLETED|Overall Study||850
10928282|NCT00277524|12097021|FG000|NOT COMPLETED|Overall Study||0
10928283|NCT00277524|12097022|FG001|NOT COMPLETED|Overall Study||0
10928284|NCT00277524|12097023|FG002|NOT COMPLETED|Overall Study||0
10928285|NCT00277524|12097024|FG003|NOT COMPLETED|Overall Study||0
10928286|NCT00278109|12097042|FG000|STARTED|Overall Study||25
10928287|NCT00278109|12097042|FG000|Completed 3 Cycles of Chemotherapy|Overall Study||25
10928288|NCT00278109|12097042|FG000|COMPLETED|Overall Study||21
10928289|NCT00278109|12097042|FG000|NOT COMPLETED|Overall Study||4
10928290|NCT00278148|12097046|FG000|STARTED|Phase I - Dose Escalation||4
10928291|NCT00278148|12097047|FG001|STARTED|Phase I - Dose Escalation||2
10928292|NCT00278148|12097048|FG002|STARTED|Phase I - Dose Escalation||3
10928293|NCT00278148|12097046|FG000|COMPLETED|Phase I - Dose Escalation||4
10928294|NCT00278148|12097047|FG001|COMPLETED|Phase I - Dose Escalation||2
10928295|NCT00278148|12097048|FG002|COMPLETED|Phase I - Dose Escalation||3
10928296|NCT00278148|12097046|FG000|NOT COMPLETED|Phase I - Dose Escalation||0
10928297|NCT00278148|12097047|FG001|NOT COMPLETED|Phase I - Dose Escalation||0
10928298|NCT00278148|12097048|FG002|NOT COMPLETED|Phase I - Dose Escalation||0
10928299|NCT00278148|12097046|FG000|STARTED|Phase II - Expansion Phase||0
10928300|NCT00278148|12097047|FG001|STARTED|Phase II - Expansion Phase||0
10928301|NCT00278148|12097048|FG002|STARTED|Phase II - Expansion Phase|Includes the 3 participants from phase I|26
10928302|NCT00278148|12097046|FG000|COMPLETED|Phase II - Expansion Phase||0
10928303|NCT00278148|12097047|FG001|COMPLETED|Phase II - Expansion Phase||0
10928304|NCT00278148|12097048|FG002|COMPLETED|Phase II - Expansion Phase||20
10928305|NCT00278148|12097046|FG000|NOT COMPLETED|Phase II - Expansion Phase||0
10928306|NCT00278148|12097047|FG001|NOT COMPLETED|Phase II - Expansion Phase||0
10928307|NCT00278148|12097048|FG002|NOT COMPLETED|Phase II - Expansion Phase||6
10928308|NCT00278161|12097055|FG000|STARTED|Overall Study||81
10928309|NCT00278161|12097055|FG000|COMPLETED|Overall Study||70
10928310|NCT00278161|12097055|FG000|NOT COMPLETED|Overall Study||11
10928311|NCT00278200|12097061|FG000|STARTED|Overall Study||2
10928312|NCT00278200|12097062|FG001|STARTED|Overall Study||12
10928313|NCT00278200|12097061|FG000|COMPLETED|Overall Study||1
10928314|NCT00278200|12097062|FG001|COMPLETED|Overall Study||8
10928315|NCT00278200|12097061|FG000|NOT COMPLETED|Overall Study||1
10928316|NCT00278200|12097062|FG001|NOT COMPLETED|Overall Study||4
10928317|NCT00278395|12097068|FG000|STARTED|Overall Study||14
10928318|NCT00278395|12097068|FG000|COMPLETED|Overall Study||11
10928319|NCT00278395|12097068|FG000|NOT COMPLETED|Overall Study||3
10928320|NCT00278473|12097077|FG000|STARTED|Overall Study||45
10928321|NCT00278473|12097078|FG001|STARTED|Overall Study||43
10928322|NCT00278473|12097077|FG000|COMPLETED|Overall Study||41
10928323|NCT00278473|12097078|FG001|COMPLETED|Overall Study||40
10928324|NCT00278473|12097077|FG000|NOT COMPLETED|Overall Study||4
10928325|NCT00278473|12097078|FG001|NOT COMPLETED|Overall Study||3
10928326|NCT00278512|12097086|FG000|STARTED|Overall Study||7
10928327|NCT00278512|12097087|FG001|STARTED|Overall Study||0
10928328|NCT00278512|12097086|FG000|COMPLETED|Overall Study||6
10928329|NCT00278512|12097087|FG001|COMPLETED|Overall Study||0
10928330|NCT00278512|12097086|FG000|NOT COMPLETED|Overall Study||1
10928331|NCT00278512|12097087|FG001|NOT COMPLETED|Overall Study||0
10928332|NCT00278525|12097095|FG000|STARTED|Overall Study||9
10928333|NCT00278525|12097096|FG001|STARTED|Overall Study||10
10928334|NCT00278525|12097095|FG000|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
10928335|NCT00278525|12097096|FG001|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
10928336|NCT00278525|12097095|FG000|NOT COMPLETED|Overall Study||0
10928337|NCT00278525|12097096|FG001|NOT COMPLETED|Overall Study||0
10928338|NCT00278538|12097102|FG000|STARTED|Overall Study||32
10928339|NCT00278538|12097102|FG000|COMPLETED|Overall Study||30
10928340|NCT00278538|12097102|FG000|NOT COMPLETED|Overall Study||2
10928341|NCT00278564|12097106|FG000|STARTED|Overall Study||7
10928342|NCT00278564|12097106|FG000|COMPLETED|Overall Study||3
10928343|NCT00278564|12097106|FG000|NOT COMPLETED|Overall Study||4
10928344|NCT00278629|12097110|FG000|STARTED|Overall Study||80
10928345|NCT00278629|12097110|FG000|COMPLETED|Overall Study||66
10928346|NCT00278629|12097110|FG000|NOT COMPLETED|Overall Study||14
10928347|NCT00278655|12097115|FG000|STARTED|Overall Study||21
10928348|NCT00278655|12097115|FG000|COMPLETED|Overall Study||21
10928349|NCT00278655|12097115|FG000|NOT COMPLETED|Overall Study||0
10928350|NCT00278863|12097122|FG000|STARTED|Overall Study||49
10928351|NCT00278863|12097123|FG001|STARTED|Overall Study||47
10928352|NCT00278863|12097122|FG000|COMPLETED|Overall Study||44
10928353|NCT00278863|12097123|FG001|COMPLETED|Overall Study||45
10928354|NCT00278863|12097122|FG000|NOT COMPLETED|Overall Study||5
10928355|NCT00278863|12097123|FG001|NOT COMPLETED|Overall Study||2
10928356|NCT00278876|12097129|FG000|STARTED|Overall Study||47
10928357|NCT00278876|12097129|FG000|COMPLETED|Overall Study||38
10928358|NCT00278876|12097129|FG000|NOT COMPLETED|Overall Study||9
10928359|NCT00278889|12097136|FG000|STARTED|Overall Study|Randomised|73
10928360|NCT00278889|12097137|FG001|STARTED|Overall Study|Randomised|74
10928361|NCT00278889|12097138|FG002|STARTED|Overall Study|Randomised|68
10928362|NCT00278889|12097136|FG000|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
10928363|NCT00278889|12097137|FG001|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
10928364|NCT00278889|12097138|FG002|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
10928365|NCT00278889|12097136|FG000|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
10928366|NCT00278889|12097137|FG001|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
10928367|NCT00278889|12097138|FG002|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
10928368|NCT00278889|12097136|FG000|NOT COMPLETED|Overall Study||25
10928369|NCT00278889|12097137|FG001|NOT COMPLETED|Overall Study||27
10928370|NCT00278889|12097138|FG002|NOT COMPLETED|Overall Study||20
10928371|NCT00278954|12097146|FG000|STARTED|Overall Study||50
10928372|NCT00278954|12097146|FG000|COMPLETED|Overall Study||45
10928373|NCT00278954|12097146|FG000|NOT COMPLETED|Overall Study||5
10928374|NCT00278993|12097150|FG000|STARTED|Overall Study||108
10928375|NCT00278993|12097150|FG000|COMPLETED|Overall Study||1
10928376|NCT00278993|12097150|FG000|NOT COMPLETED|Overall Study||107
10928377|NCT00279201|12097156|FG000|STARTED|Initiation||1046
10928378|NCT00279201|12097157|FG001|STARTED|Initiation||1045
10928379|NCT00279201|12097158|FG002|STARTED|Initiation||0
10928380|NCT00279201|12097159|FG003|STARTED|Initiation||0
10928381|NCT00279201|12097160|FG004|STARTED|Initiation||0
10928382|NCT00279201|12097161|FG005|STARTED|Initiation||0
10928383|NCT00279201|12097156|FG000|COMPLETED|Initiation||918
10928384|NCT00279201|12097157|FG001|COMPLETED|Initiation||900
10928385|NCT00279201|12097158|FG002|COMPLETED|Initiation||0
10928386|NCT00279201|12097159|FG003|COMPLETED|Initiation||0
10928387|NCT00279201|12097160|FG004|COMPLETED|Initiation||0
10928388|NCT00279201|12097161|FG005|COMPLETED|Initiation||0
10928389|NCT00279201|12097156|FG000|NOT COMPLETED|Initiation||128
10928390|NCT00279201|12097157|FG001|NOT COMPLETED|Initiation||145
10928391|NCT00279201|12097158|FG002|NOT COMPLETED|Initiation||0
10928392|NCT00279201|12097159|FG003|NOT COMPLETED|Initiation||0
10928393|NCT00279201|12097160|FG004|NOT COMPLETED|Initiation||0
10928394|NCT00279201|12097161|FG005|NOT COMPLETED|Initiation||0
10928395|NCT00279201|12097156|FG000|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
10928396|NCT00279201|12097157|FG001|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
10928397|NCT00279201|12097158|FG002|STARTED|Maintenance||0
10928398|NCT00279201|12097159|FG003|STARTED|Maintenance||0
10928399|NCT00279201|12097160|FG004|STARTED|Maintenance||0
10928400|NCT00279201|12097161|FG005|STARTED|Maintenance||0
10928401|NCT00279201|12097156|FG000|COMPLETED|Maintenance||188
10928402|NCT00279201|12097157|FG001|COMPLETED|Maintenance||239
10928403|NCT00279201|12097158|FG002|COMPLETED|Maintenance||0
10928404|NCT00279201|12097159|FG003|COMPLETED|Maintenance||0
10928405|NCT00279201|12097160|FG004|COMPLETED|Maintenance||0
10928406|NCT00279201|12097161|FG005|COMPLETED|Maintenance||0
10928407|NCT00279201|12097156|FG000|NOT COMPLETED|Maintenance||231
10928408|NCT00279201|12097157|FG001|NOT COMPLETED|Maintenance||234
10928409|NCT00279201|12097158|FG002|NOT COMPLETED|Maintenance||0
10928410|NCT00279201|12097159|FG003|NOT COMPLETED|Maintenance||0
10928411|NCT00279201|12097160|FG004|NOT COMPLETED|Maintenance||0
10928412|NCT00279201|12097161|FG005|NOT COMPLETED|Maintenance||0
10928413|NCT00279201|12097156|FG000|STARTED|Intensification Addendum||0
10928414|NCT00279201|12097157|FG001|STARTED|Intensification Addendum||0
10928415|NCT00279201|12097158|FG002|STARTED|Intensification Addendum||174
10928416|NCT00279201|12097159|FG003|STARTED|Intensification Addendum||200
10928417|NCT00279201|12097160|FG004|STARTED|Intensification Addendum||171
10928418|NCT00279201|12097161|FG005|STARTED|Intensification Addendum||199
10928419|NCT00279201|12097156|FG000|COMPLETED|Intensification Addendum||0
10928420|NCT00279201|12097157|FG001|COMPLETED|Intensification Addendum||0
10928421|NCT00279201|12097158|FG002|COMPLETED|Intensification Addendum||151
10928422|NCT00279201|12097159|FG003|COMPLETED|Intensification Addendum||172
10928423|NCT00279201|12097160|FG004|COMPLETED|Intensification Addendum||142
10928424|NCT00279201|12097161|FG005|COMPLETED|Intensification Addendum||162
10928425|NCT00279201|12097156|FG000|NOT COMPLETED|Intensification Addendum||0
10928426|NCT00279201|12097157|FG001|NOT COMPLETED|Intensification Addendum||0
10928427|NCT00279201|12097158|FG002|NOT COMPLETED|Intensification Addendum||23
10928428|NCT00279201|12097159|FG003|NOT COMPLETED|Intensification Addendum||28
10928429|NCT00279201|12097160|FG004|NOT COMPLETED|Intensification Addendum||29
10928430|NCT00279201|12097161|FG005|NOT COMPLETED|Intensification Addendum||37
10928431|NCT00279214|12097196|FG000|STARTED|Overall Study||22
10928432|NCT00279214|12097197|FG001|STARTED|Overall Study||21
10928433|NCT00279214|12097196|FG000|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
10928434|NCT00279214|12097197|FG001|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
10928435|NCT00279214|12097196|FG000|NOT COMPLETED|Overall Study||3
10928436|NCT00279214|12097197|FG001|NOT COMPLETED|Overall Study||2
10928437|NCT00279305|12097205|FG000|STARTED|Overall Study||57
10928438|NCT00279305|12097206|FG001|STARTED|Overall Study||30
10928439|NCT00279305|12097205|FG000|COMPLETED|Overall Study||49
10928440|NCT00279305|12097206|FG001|COMPLETED|Overall Study||29
10928441|NCT00279305|12097205|FG000|NOT COMPLETED|Overall Study||8
10928442|NCT00279305|12097206|FG001|NOT COMPLETED|Overall Study||1
10928443|NCT00279500|12097212|FG000|STARTED|Overall Study|6 patients treated|6
10928444|NCT00279500|12097212|FG000|COMPLETED|Overall Study|6 patients treated|6
10928445|NCT00279500|12097212|FG000|NOT COMPLETED|Overall Study||0
10928446|NCT00279591|12097218|FG000|STARTED|Overall Study||48
10928447|NCT00279591|12097219|FG001|STARTED|Overall Study||46
10928448|NCT00279591|12097218|FG000|COMPLETED|Overall Study||48
10928449|NCT00279591|12097219|FG001|COMPLETED|Overall Study||46
10928450|NCT00279591|12097218|FG000|NOT COMPLETED|Overall Study||0
10928451|NCT00279591|12097219|FG001|NOT COMPLETED|Overall Study||0
10928452|NCT00279708|12097229|FG000|STARTED|Overall Study|"Started meaning randomized"|27
10928453|NCT00279708|12097230|FG001|STARTED|Overall Study||28
10928454|NCT00279708|12097229|FG000|COMPLETED|Overall Study||24
10928455|NCT00279708|12097230|FG001|COMPLETED|Overall Study||24
10928456|NCT00279708|12097229|FG000|NOT COMPLETED|Overall Study||3
10928457|NCT00279708|12097230|FG001|NOT COMPLETED|Overall Study||4
10928458|NCT00279812|12097242|FG000|STARTED|Overall Study||21
10928459|NCT00279812|12097243|FG001|STARTED|Overall Study||26
10928460|NCT00279812|12097244|FG002|STARTED|Overall Study||24
10928461|NCT00279812|12097245|FG003|STARTED|Overall Study||23
10928462|NCT00279812|12097246|FG004|STARTED|Overall Study||20
10928463|NCT00279812|12097247|FG005|STARTED|Overall Study||19
10928464|NCT00279812|12097242|FG000|COMPLETED|Overall Study||20
10928465|NCT00279812|12097243|FG001|COMPLETED|Overall Study||20
10928466|NCT00279812|12097244|FG002|COMPLETED|Overall Study||21
10928467|NCT00279812|12097245|FG003|COMPLETED|Overall Study||23
10928468|NCT00279812|12097246|FG004|COMPLETED|Overall Study||17
10928469|NCT00279812|12097247|FG005|COMPLETED|Overall Study||18
10928470|NCT00279812|12097242|FG000|NOT COMPLETED|Overall Study||1
10928471|NCT00279812|12097243|FG001|NOT COMPLETED|Overall Study||6
10928472|NCT00279812|12097244|FG002|NOT COMPLETED|Overall Study||3
10928473|NCT00279812|12097245|FG003|NOT COMPLETED|Overall Study||0
10928474|NCT00279812|12097246|FG004|NOT COMPLETED|Overall Study||3
10928475|NCT00279812|12097247|FG005|NOT COMPLETED|Overall Study||1
10928476|NCT00279916|12097263|FG000|STARTED|Overall Study||45
10928477|NCT00279916|12097264|FG001|STARTED|Overall Study||46
10928478|NCT00279916|12097263|FG000|COMPLETED|Overall Study||38
10928479|NCT00279916|12097264|FG001|COMPLETED|Overall Study||41
10928480|NCT00279916|12097263|FG000|NOT COMPLETED|Overall Study||7
10928481|NCT00279916|12097264|FG001|NOT COMPLETED|Overall Study||5
10928482|NCT00279955|12097273|FG000|STARTED|Overall Study||157
10928483|NCT00279955|12097274|FG001|STARTED|Overall Study||486
10928484|NCT00279955|12097275|FG002|STARTED|Overall Study||358
10928485|NCT00279955|12097273|FG000|COMPLETED|Overall Study||157
10928486|NCT00279955|12097274|FG001|COMPLETED|Overall Study||486
10928487|NCT00279955|12097275|FG002|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
10928488|NCT00279955|12097273|FG000|NOT COMPLETED|Overall Study||0
10928489|NCT00279955|12097274|FG001|NOT COMPLETED|Overall Study||0
10928490|NCT00279955|12097275|FG002|NOT COMPLETED|Overall Study||0
10928491|NCT00280059|12097284|FG000|STARTED|Efficacy Assessment Phase||330
10928492|NCT00280059|12097285|FG001|STARTED|Efficacy Assessment Phase||330
10928493|NCT00280059|12097284|FG000|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
10928494|NCT00280059|12097285|FG001|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
10928495|NCT00280059|12097284|FG000|NOT COMPLETED|Efficacy Assessment Phase||94
10928496|NCT00280059|12097285|FG001|NOT COMPLETED|Efficacy Assessment Phase||80
10928497|NCT00280059|12097284|FG000|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
10928498|NCT00280059|12097285|FG001|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
10928499|NCT00280059|12097284|FG000|COMPLETED|Extension Phase||145
10928500|NCT00280059|12097285|FG001|COMPLETED|Extension Phase||177
10928501|NCT00280059|12097284|FG000|NOT COMPLETED|Extension Phase||49
10928502|NCT00280059|12097285|FG001|NOT COMPLETED|Extension Phase||38
10928503|NCT00280150|12097303|FG000|STARTED|Overall Study||5
10928504|NCT00280150|12097304|FG001|STARTED|Overall Study||5
10928505|NCT00280150|12097305|FG002|STARTED|Overall Study||6
10928506|NCT00280150|12097306|FG003|STARTED|Overall Study||30
10928507|NCT00280150|12097303|FG000|Cohort Induction|Overall Study||5
10928508|NCT00280150|12097304|FG001|Cohort Induction|Overall Study||5
10928509|NCT00280150|12097305|FG002|Cohort Induction|Overall Study||6
10928510|NCT00280150|12097306|FG003|Cohort Induction|Overall Study||30
10928511|NCT00280150|12097303|FG000|Consolidation Therapy|Overall Study||2
10928512|NCT00280150|12097304|FG001|Consolidation Therapy|Overall Study||5
10928513|NCT00280150|12097305|FG002|Consolidation Therapy|Overall Study||3
10928514|NCT00280150|12097306|FG003|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
10928515|NCT00280150|12097303|FG000|COMPLETED|Overall Study||2
10928516|NCT00280150|12097304|FG001|COMPLETED|Overall Study||4
10928517|NCT00280150|12097305|FG002|COMPLETED|Overall Study||1
10928518|NCT00280150|12097306|FG003|COMPLETED|Overall Study||20
10928519|NCT00280150|12097303|FG000|NOT COMPLETED|Overall Study||3
10928520|NCT00280150|12097304|FG001|NOT COMPLETED|Overall Study||1
10928521|NCT00280150|12097305|FG002|NOT COMPLETED|Overall Study||5
10928522|NCT00280150|12097306|FG003|NOT COMPLETED|Overall Study||10
10928523|NCT00280241|12097317|FG000|STARTED|Overall Study||65
10928524|NCT00280241|12097317|FG000|COMPLETED|Overall Study||55
10928525|NCT00280241|12097317|FG000|NOT COMPLETED|Overall Study||10
10928526|NCT00280293|12097323|FG000|STARTED|Overall Study||55
10928527|NCT00280293|12097324|FG001|STARTED|Overall Study||57
10928528|NCT00280293|12097323|FG000|COMPLETED|Overall Study||29
10928529|NCT00280293|12097324|FG001|COMPLETED|Overall Study||34
10928530|NCT00280293|12097323|FG000|NOT COMPLETED|Overall Study||26
10928531|NCT00280293|12097324|FG001|NOT COMPLETED|Overall Study||23
10928532|NCT00280384|12097338|FG000|STARTED|Overall Study||6
10928533|NCT00280384|12097339|FG001|STARTED|Overall Study||6
10928534|NCT00280384|12097340|FG002|STARTED|Overall Study||6
10928535|NCT00280384|12097341|FG003|STARTED|Overall Study||6
10928536|NCT00280384|12097342|FG004|STARTED|Overall Study||6
10928537|NCT00280384|12097343|FG005|STARTED|Overall Study||6
10928538|NCT00280384|12097344|FG006|STARTED|Overall Study||6
10928539|NCT00280384|12097345|FG007|STARTED|Overall Study||6
10928540|NCT00280384|12097338|FG000|COMPLETED|Overall Study||6
10928541|NCT00280384|12097339|FG001|COMPLETED|Overall Study||6
10928542|NCT00280384|12097340|FG002|COMPLETED|Overall Study||6
10928543|NCT00280384|12097341|FG003|COMPLETED|Overall Study||6
10928544|NCT00280384|12097342|FG004|COMPLETED|Overall Study||6
10928545|NCT00280384|12097343|FG005|COMPLETED|Overall Study||6
10928546|NCT00280384|12097344|FG006|COMPLETED|Overall Study||6
10928547|NCT00280384|12097345|FG007|COMPLETED|Overall Study||6
10928548|NCT00280384|12097338|FG000|NOT COMPLETED|Overall Study||0
10928549|NCT00280384|12097339|FG001|NOT COMPLETED|Overall Study||0
10928550|NCT00280384|12097340|FG002|NOT COMPLETED|Overall Study||0
10928551|NCT00280384|12097341|FG003|NOT COMPLETED|Overall Study||0
10928552|NCT00280384|12097342|FG004|NOT COMPLETED|Overall Study||0
10928553|NCT00280384|12097343|FG005|NOT COMPLETED|Overall Study||0
10928554|NCT00280384|12097344|FG006|NOT COMPLETED|Overall Study||0
10928555|NCT00280384|12097345|FG007|NOT COMPLETED|Overall Study||0
10928556|NCT00280397|12097363|FG000|STARTED|Overall Study||27
10928557|NCT00280397|12097363|FG000|COMPLETED|Overall Study||26
10928558|NCT00280397|12097363|FG000|NOT COMPLETED|Overall Study||1
10928559|NCT00280566|12097371|FG000|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
10928560|NCT00280566|12097372|FG001|STARTED|Period 1 Open Label Ziprasidone||0
10928561|NCT00280566|12097373|FG002|STARTED|Period 1 Open Label Ziprasidone||0
10928562|NCT00280566|12097371|FG000|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
10928563|NCT00280566|12097372|FG001|COMPLETED|Period 1 Open Label Ziprasidone||0
10928564|NCT00280566|12097373|FG002|COMPLETED|Period 1 Open Label Ziprasidone||0
10928565|NCT00280566|12097371|FG000|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
10928566|NCT00280566|12097372|FG001|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
10928567|NCT00280566|12097373|FG002|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
10928568|NCT00280566|12097371|FG000|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
10928569|NCT00280566|12097372|FG001|STARTED|Period 2 Double Blind||127
10928570|NCT00280566|12097373|FG002|STARTED|Period 2 Double Blind||111
10928571|NCT00280566|12097371|FG000|COMPLETED|Period 2 Double Blind||0
10928572|NCT00280566|12097372|FG001|COMPLETED|Period 2 Double Blind||84
10928573|NCT00280566|12097373|FG002|COMPLETED|Period 2 Double Blind||54
10928574|NCT00280566|12097371|FG000|NOT COMPLETED|Period 2 Double Blind||0
10928575|NCT00280566|12097372|FG001|NOT COMPLETED|Period 2 Double Blind||43
10928576|NCT00280566|12097373|FG002|NOT COMPLETED|Period 2 Double Blind||57
10928577|NCT00280683|12097382|FG000|STARTED|Overall Study||10
10928578|NCT00280683|12097383|FG001|STARTED|Overall Study||10
10928579|NCT00280683|12097382|FG000|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
10928580|NCT00280683|12097383|FG001|COMPLETED|Overall Study||7
10928581|NCT00280683|12097382|FG000|NOT COMPLETED|Overall Study||2
10928582|NCT00280683|12097383|FG001|NOT COMPLETED|Overall Study||3
10928583|NCT00280735|12097391|FG000|STARTED|Overall Study||75
10928584|NCT00280735|12097391|FG000|Received Treatment|Overall Study||72
10928585|NCT00280735|12097391|FG000|Received Adequate Exposure|Overall Study||57
10928586|NCT00280735|12097391|FG000|COMPLETED|Overall Study||57
10928587|NCT00280735|12097391|FG000|NOT COMPLETED|Overall Study||18
10928588|NCT00280748|12097399|FG000|STARTED|Overall Study||10
10928589|NCT00280748|12097399|FG000|COMPLETED|Overall Study||6
10928590|NCT00280748|12097399|FG000|NOT COMPLETED|Overall Study||4
10928591|NCT00280826|12097403|FG000|STARTED|Overall Study||6
10928592|NCT00280826|12097403|FG000|COMPLETED|Overall Study||6
10928593|NCT00280826|12097403|FG000|NOT COMPLETED|Overall Study||0
10928594|NCT00280904|12097407|FG000|STARTED|Overall Study||433
10928595|NCT00280904|12097407|FG000|COMPLETED|Overall Study||433
10928596|NCT00280904|12097407|FG000|NOT COMPLETED|Overall Study||0
10928597|NCT00280917|12097416|FG000|STARTED|Overall Study||65
10928598|NCT00280917|12097417|FG001|STARTED|Overall Study||63
10928599|NCT00280917|12097418|FG002|STARTED|Overall Study||63
10928600|NCT00280917|12097419|FG003|STARTED|Overall Study||63
10928601|NCT00280917|12097416|FG000|COMPLETED|Overall Study||63
10928602|NCT00280917|12097417|FG001|COMPLETED|Overall Study||57
10928603|NCT00280917|12097418|FG002|COMPLETED|Overall Study||57
10928604|NCT00280917|12097419|FG003|COMPLETED|Overall Study||61
10928605|NCT00280917|12097416|FG000|NOT COMPLETED|Overall Study||2
10928606|NCT00280917|12097417|FG001|NOT COMPLETED|Overall Study||6
10928607|NCT00280917|12097418|FG002|NOT COMPLETED|Overall Study||6
10928608|NCT00280917|12097419|FG003|NOT COMPLETED|Overall Study||2
10928609|NCT00281021|12097429|FG000|STARTED|Overall Study||26
10928610|NCT00281021|12097429|FG000|COMPLETED|Overall Study||24
10928611|NCT00281021|12097429|FG000|NOT COMPLETED|Overall Study||2
10928612|NCT00281099|12097435|FG000|STARTED|Overall Study||513
10928613|NCT00281099|12097436|FG001|STARTED|Overall Study||518
10928614|NCT00281099|12097435|FG000|COMPLETED|Overall Study||308
10928615|NCT00281099|12097436|FG001|COMPLETED|Overall Study||296
10928616|NCT00281099|12097435|FG000|NOT COMPLETED|Overall Study||205
10928617|NCT00281099|12097436|FG001|NOT COMPLETED|Overall Study||222
10928618|NCT00281463|12097443|FG000|STARTED|Overall Study||45
10928619|NCT00281463|12097443|FG000|COMPLETED|Overall Study||45
10928620|NCT00281463|12097443|FG000|NOT COMPLETED|Overall Study||0
10928621|NCT00281528|12097450|FG000|STARTED|Overall Study||75
10928622|NCT00281528|12097451|FG001|STARTED|Overall Study||54
10928623|NCT00281528|12097452|FG002|STARTED|Overall Study||79
10928624|NCT00281528|12097450|FG000|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
10928625|NCT00281528|12097451|FG001|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
10928626|NCT00281528|12097452|FG002|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
10928627|NCT00281528|12097450|FG000|NOT COMPLETED|Overall Study||75
10928628|NCT00281528|12097451|FG001|NOT COMPLETED|Overall Study||54
10928629|NCT00281528|12097452|FG002|NOT COMPLETED|Overall Study||79
10928630|NCT00281580|12097476|FG000|STARTED|Overall Study||46
10928631|NCT00281580|12097477|FG001|STARTED|Overall Study||42
10928632|NCT00281580|12097478|FG002|STARTED|Overall Study||130
10928633|NCT00281580|12097479|FG003|STARTED|Overall Study||135
10928634|NCT00281580|12097480|FG004|STARTED|Overall Study||44
10928635|NCT00281580|12097481|FG005|STARTED|Overall Study||46
10928636|NCT00281580|12097482|FG006|STARTED|Overall Study||44
10928637|NCT00281580|12097483|FG007|STARTED|Overall Study||47
10928638|NCT00281580|12097484|FG008|STARTED|Overall Study||143
10928639|NCT00281580|12097485|FG009|STARTED|Overall Study||129
10928640|NCT00281580|12097486|FG010|STARTED|Overall Study||48
10928641|NCT00281580|12097487|FG011|STARTED|Overall Study||146
10928642|NCT00281580|12097488|FG012|STARTED|Overall Study||142
10928643|NCT00281580|12097489|FG013|STARTED|Overall Study||50
10928644|NCT00281580|12097490|FG014|STARTED|Overall Study||140
10928645|NCT00281580|12097491|FG015|STARTED|Overall Study||129
10928646|NCT00281580|12097476|FG000|COMPLETED|Overall Study||39
10928647|NCT00281580|12097477|FG001|COMPLETED|Overall Study||41
10928648|NCT00281580|12097478|FG002|COMPLETED|Overall Study||125
10928649|NCT00281580|12097479|FG003|COMPLETED|Overall Study||118
10928650|NCT00281580|12097480|FG004|COMPLETED|Overall Study||40
10928651|NCT00281580|12097481|FG005|COMPLETED|Overall Study||43
10928652|NCT00281580|12097482|FG006|COMPLETED|Overall Study||39
10928653|NCT00281580|12097483|FG007|COMPLETED|Overall Study||46
10928654|NCT00281580|12097484|FG008|COMPLETED|Overall Study||135
10928655|NCT00281580|12097485|FG009|COMPLETED|Overall Study||117
10928656|NCT00281580|12097486|FG010|COMPLETED|Overall Study||44
10928657|NCT00281580|12097487|FG011|COMPLETED|Overall Study||136
10928658|NCT00281580|12097488|FG012|COMPLETED|Overall Study||129
10928659|NCT00281580|12097489|FG013|COMPLETED|Overall Study||43
10928660|NCT00281580|12097490|FG014|COMPLETED|Overall Study||133
10928661|NCT00281580|12097491|FG015|COMPLETED|Overall Study||116
10928662|NCT00281580|12097476|FG000|NOT COMPLETED|Overall Study||7
10928663|NCT00281580|12097477|FG001|NOT COMPLETED|Overall Study||1
10928664|NCT00281580|12097478|FG002|NOT COMPLETED|Overall Study||5
10928665|NCT00281580|12097479|FG003|NOT COMPLETED|Overall Study||17
10928666|NCT00281580|12097480|FG004|NOT COMPLETED|Overall Study||4
10928667|NCT00281580|12097481|FG005|NOT COMPLETED|Overall Study||3
10928668|NCT00281580|12097482|FG006|NOT COMPLETED|Overall Study||5
10928669|NCT00281580|12097483|FG007|NOT COMPLETED|Overall Study||1
10928670|NCT00281580|12097484|FG008|NOT COMPLETED|Overall Study||8
10928671|NCT00281580|12097485|FG009|NOT COMPLETED|Overall Study||12
10928672|NCT00281580|12097486|FG010|NOT COMPLETED|Overall Study||4
10928673|NCT00281580|12097487|FG011|NOT COMPLETED|Overall Study||10
10928674|NCT00281580|12097488|FG012|NOT COMPLETED|Overall Study||13
10928675|NCT00281580|12097489|FG013|NOT COMPLETED|Overall Study||7
10928676|NCT00281580|12097490|FG014|NOT COMPLETED|Overall Study||7
10928677|NCT00281580|12097491|FG015|NOT COMPLETED|Overall Study||13
10928678|NCT00281632|12097560|FG000|STARTED|Overall Study||36
10928679|NCT00281632|12097560|FG000|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
10928680|NCT00281632|12097560|FG000|NOT COMPLETED|Overall Study||36
10928681|NCT00281671|12097572|FG000|STARTED|Overall Study||5
10928682|NCT00281671|12097573|FG001|STARTED|Overall Study||4
10928683|NCT00281671|12097572|FG000|COMPLETED|Overall Study||5
10928684|NCT00281671|12097573|FG001|COMPLETED|Overall Study||4
10928685|NCT00281671|12097572|FG000|NOT COMPLETED|Overall Study||0
10928686|NCT00281671|12097573|FG001|NOT COMPLETED|Overall Study||0
10928687|NCT00281684|12097586|FG000|STARTED|Overall Study||37
10928688|NCT00281684|12097587|FG001|STARTED|Overall Study||36
10928689|NCT00281684|12097588|FG002|STARTED|Overall Study||34
10928690|NCT00281684|12097589|FG003|STARTED|Overall Study||38
10928691|NCT00281684|12097586|FG000|COMPLETED|Overall Study||36
10928692|NCT00281684|12097587|FG001|COMPLETED|Overall Study||36
10928693|NCT00281684|12097588|FG002|COMPLETED|Overall Study||33
10928694|NCT00281684|12097589|FG003|COMPLETED|Overall Study||38
10928695|NCT00281684|12097586|FG000|NOT COMPLETED|Overall Study||1
10928696|NCT00281684|12097587|FG001|NOT COMPLETED|Overall Study||0
10928697|NCT00281684|12097588|FG002|NOT COMPLETED|Overall Study||1
10928698|NCT00281684|12097589|FG003|NOT COMPLETED|Overall Study||0
10928699|NCT00281697|12097603|FG000|STARTED|Overall Study||459
10928700|NCT00281697|12097604|FG001|STARTED|Overall Study||225
10928701|NCT00281697|12097603|FG000|COMPLETED|Overall Study||58
10928702|NCT00281697|12097604|FG001|COMPLETED|Overall Study||28
10928703|NCT00281697|12097603|FG000|NOT COMPLETED|Overall Study||401
10928704|NCT00281697|12097604|FG001|NOT COMPLETED|Overall Study||197
10928705|NCT00281827|12097610|FG000|STARTED|Overall Study||22
10928706|NCT00281827|12097610|FG000|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
10928707|NCT00281827|12097610|FG000|NOT COMPLETED|Overall Study||0
10928708|NCT00281840|12097616|FG000|STARTED|Overall Study||30
10928709|NCT00281840|12097616|FG000|COMPLETED|Overall Study||5
10928710|NCT00281840|12097616|FG000|NOT COMPLETED|Overall Study||25
10928711|NCT00281918|12097623|FG000|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
10928712|NCT00281918|12097624|FG001|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
10928713|NCT00281918|12097623|FG000|Safety Population; Received Study Drug|Overall Study||398
10928714|NCT00281918|12097624|FG001|Safety Population; Received Study Drug|Overall Study||402
10928715|NCT00281918|12097623|FG000|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
10928716|NCT00281918|12097624|FG001|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
10928717|NCT00281918|12097623|FG000|NOT COMPLETED|Overall Study||142
10928718|NCT00281918|12097624|FG001|NOT COMPLETED|Overall Study||108
10928719|NCT00281957|12097632|FG000|STARTED|Overall Study||67
10928720|NCT00281957|12097633|FG001|STARTED|Overall Study||42
10928721|NCT00281957|12097632|FG000|Eligible|Overall Study||66
10928722|NCT00281957|12097633|FG001|Eligible|Overall Study||40
10928723|NCT00281957|12097632|FG000|Eligible and Received Treatment|Overall Study||63
10928724|NCT00281957|12097633|FG001|Eligible and Received Treatment|Overall Study||39
10928725|NCT00281957|12097632|FG000|COMPLETED|Overall Study||0
10928726|NCT00281957|12097633|FG001|COMPLETED|Overall Study||0
10928727|NCT00281957|12097632|FG000|NOT COMPLETED|Overall Study||67
10928728|NCT00281957|12097633|FG001|NOT COMPLETED|Overall Study||42
10928729|NCT00282048|12097641|FG000|STARTED|Overall Study||62
10928730|NCT00282048|12097641|FG000|COMPLETED|Overall Study||0
10928731|NCT00282048|12097641|FG000|NOT COMPLETED|Overall Study||62
10928732|NCT00282087|12097645|FG000|STARTED|Overall Study||47
10928733|NCT00282087|12097645|FG000|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
10928734|NCT00282087|12097645|FG000|NOT COMPLETED|Overall Study||1
10928735|NCT00282113|12097653|FG000|STARTED|Overall Study||31
10928736|NCT00282113|12097654|FG001|STARTED|Overall Study||30
10928737|NCT00282113|12097655|FG002|STARTED|Overall Study||29
10928738|NCT00282113|12097653|FG000|COMPLETED|Overall Study||30
10928739|NCT00282113|12097654|FG001|COMPLETED|Overall Study||30
10928740|NCT00282113|12097655|FG002|COMPLETED|Overall Study||29
10928741|NCT00282113|12097653|FG000|NOT COMPLETED|Overall Study||1
10928742|NCT00282113|12097654|FG001|NOT COMPLETED|Overall Study||0
10928743|NCT00282113|12097655|FG002|NOT COMPLETED|Overall Study||0
10928744|NCT00282152|12097665|FG000|STARTED|Overall Study||15
10928745|NCT00282152|12097666|FG001|STARTED|Overall Study||15
10928746|NCT00282152|12097665|FG000|COMPLETED|Overall Study||14
10928747|NCT00282152|12097666|FG001|COMPLETED|Overall Study||15
10928748|NCT00282152|12097665|FG000|NOT COMPLETED|Overall Study||1
10928749|NCT00282152|12097666|FG001|NOT COMPLETED|Overall Study||0
10928750|NCT00282243|12097673|FG000|STARTED|Pharmacokinetic Treatment Period||70
10928751|NCT00282243|12097673|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||70
10928752|NCT00282243|12097673|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
10928753|NCT00282243|12097673|FG000|COMPLETED|Pharmacokinetic Treatment Period||65
10928754|NCT00282243|12097673|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||5
10928755|NCT00282243|12097673|FG000|STARTED|Extension Treatment Period||65
10928756|NCT00282243|12097673|FG000|COMPLETED|Extension Treatment Period||43
10928757|NCT00282243|12097673|FG000|NOT COMPLETED|Extension Treatment Period||22
10928758|NCT00282256|12097677|FG000|STARTED|Pharmacokinetic Treatment Period||19
10928759|NCT00282256|12097677|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||19
10928760|NCT00282256|12097677|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
10928761|NCT00282256|12097677|FG000|COMPLETED|Pharmacokinetic Treatment Period||18
10928762|NCT00282256|12097677|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||1
10928763|NCT00282256|12097677|FG000|STARTED|Extension Treatment Period||18
10928764|NCT00282256|12097677|FG000|COMPLETED|Extension Treatment Period||16
10928765|NCT00282256|12097677|FG000|NOT COMPLETED|Extension Treatment Period||2
10928766|NCT00282282|12097681|FG000|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
10928767|NCT00282282|12097681|FG000|COMPLETED|Overall Study||29
10928768|NCT00282282|12097681|FG000|NOT COMPLETED|Overall Study||0
10928769|NCT00282295|12097689|FG000|STARTED|Overall Study||446
10928770|NCT00282295|12097690|FG001|STARTED|Overall Study||446
10928771|NCT00282295|12097691|FG002|STARTED|Overall Study||449
10928772|NCT00282295|12097689|FG000|COMPLETED|Overall Study||443
10928773|NCT00282295|12097690|FG001|COMPLETED|Overall Study||429
10928774|NCT00282295|12097691|FG002|COMPLETED|Overall Study||441
10928775|NCT00282295|12097689|FG000|NOT COMPLETED|Overall Study||3
10928776|NCT00282295|12097690|FG001|NOT COMPLETED|Overall Study||17
10928777|NCT00282295|12097691|FG002|NOT COMPLETED|Overall Study||8
10928778|NCT00282308|12097706|FG000|STARTED|Treatment Period||69
10928779|NCT00282308|12097707|FG001|STARTED|Treatment Period||34
10928780|NCT00282308|12097708|FG002|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
10928781|NCT00282308|12097706|FG000|COMPLETED|Treatment Period||65
10928782|NCT00282308|12097707|FG001|COMPLETED|Treatment Period||28
10928783|NCT00282308|12097708|FG002|COMPLETED|Treatment Period||0
10928784|NCT00282308|12097706|FG000|NOT COMPLETED|Treatment Period||4
10928785|NCT00282308|12097707|FG001|NOT COMPLETED|Treatment Period||6
10928786|NCT00282308|12097708|FG002|NOT COMPLETED|Treatment Period||0
10928787|NCT00282308|12097706|FG000|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
10928788|NCT00282308|12097707|FG001|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
10928789|NCT00282308|12097708|FG002|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
10928790|NCT00282308|12097706|FG000|COMPLETED|Optional Extension Re-treatment Period||0
10928791|NCT00282308|12097707|FG001|COMPLETED|Optional Extension Re-treatment Period||0
10928792|NCT00282308|12097708|FG002|COMPLETED|Optional Extension Re-treatment Period||72
10928793|NCT00282308|12097706|FG000|NOT COMPLETED|Optional Extension Re-treatment Period||0
10928794|NCT00282308|12097707|FG001|NOT COMPLETED|Optional Extension Re-treatment Period||0
10928795|NCT00282308|12097708|FG002|NOT COMPLETED|Optional Extension Re-treatment Period||6
10928796|NCT00282308|12097706|FG000|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
10928797|NCT00282308|12097707|FG001|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
10928798|NCT00282308|12097708|FG002|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
10928799|NCT00282308|12097706|FG000|COMPLETED|Safety Follow-up Period||0
10928800|NCT00282308|12097707|FG001|COMPLETED|Safety Follow-up Period||0
10928801|NCT00282308|12097708|FG002|COMPLETED|Safety Follow-up Period||81
10928802|NCT00282308|12097706|FG000|NOT COMPLETED|Safety Follow-up Period||0
10928803|NCT00282308|12097707|FG001|NOT COMPLETED|Safety Follow-up Period||0
10928804|NCT00282308|12097708|FG002|NOT COMPLETED|Safety Follow-up Period||19
10928805|NCT00282334|12097720|FG000|STARTED|Overall Study||113
10928806|NCT00282334|12097721|FG001|STARTED|Overall Study||123
10928807|NCT00282334|12097720|FG000|COMPLETED|Overall Study||105
10928808|NCT00282334|12097721|FG001|COMPLETED|Overall Study||118
10928809|NCT00282334|12097720|FG000|NOT COMPLETED|Overall Study||8
10928810|NCT00282334|12097721|FG001|NOT COMPLETED|Overall Study||5
10928811|NCT00282347|12097729|FG000|STARTED|Treatment Period||72
10928812|NCT00282347|12097730|FG001|STARTED|Treatment Period||72
10928813|NCT00282347|12097729|FG000|COMPLETED|Treatment Period||67
10928814|NCT00282347|12097730|FG001|COMPLETED|Treatment Period||63
10928815|NCT00282347|12097729|FG000|NOT COMPLETED|Treatment Period||5
10928816|NCT00282347|12097730|FG001|NOT COMPLETED|Treatment Period||9
10928817|NCT00282347|12097729|FG000|STARTED|Safety Follow-up Period||67
10928818|NCT00282347|12097730|FG001|STARTED|Safety Follow-up Period||63
10928819|NCT00282347|12097729|FG000|COMPLETED|Safety Follow-up Period||64
10928820|NCT00282347|12097730|FG001|COMPLETED|Safety Follow-up Period||57
10928821|NCT00282347|12097729|FG000|NOT COMPLETED|Safety Follow-up Period||3
10928822|NCT00282347|12097730|FG001|NOT COMPLETED|Safety Follow-up Period||6
10928823|NCT00282347|12097729|FG000|STARTED|B Cell Follow-up Period||20
10928824|NCT00282347|12097730|FG001|STARTED|B Cell Follow-up Period||4
10928825|NCT00282347|12097729|FG000|COMPLETED|B Cell Follow-up Period||15
10928826|NCT00282347|12097730|FG001|COMPLETED|B Cell Follow-up Period||4
10928827|NCT00282347|12097729|FG000|NOT COMPLETED|B Cell Follow-up Period||5
10928828|NCT00282347|12097730|FG001|NOT COMPLETED|B Cell Follow-up Period||0
10928829|NCT00282412|12097738|FG000|STARTED|Overall Study||4
10928830|NCT00282412|12097738|FG000|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
10928831|NCT00282412|12097738|FG000|NOT COMPLETED|Overall Study||2
10928832|NCT00282438|12097744|FG000|STARTED|Overall Study||1
10928833|NCT00282438|12097745|FG001|STARTED|Overall Study||1
10928834|NCT00282438|12097744|FG000|COMPLETED|Overall Study||0
10928835|NCT00282438|12097745|FG001|COMPLETED|Overall Study||0
10928836|NCT00282438|12097744|FG000|NOT COMPLETED|Overall Study||1
10928837|NCT00282438|12097745|FG001|NOT COMPLETED|Overall Study||1
10928838|NCT00282464|12097753|FG000|STARTED|Overall Study||185
10928839|NCT00282464|12097754|FG001|STARTED|Overall Study||196
10928840|NCT00282464|12097753|FG000|COMPLETED|Overall Study||112
10928841|NCT00282464|12097754|FG001|COMPLETED|Overall Study||134
10928842|NCT00282464|12097753|FG000|NOT COMPLETED|Overall Study||73
10928843|NCT00282464|12097754|FG001|NOT COMPLETED|Overall Study||62
10928844|NCT00282568|12097760|FG000|STARTED|Pharmacokinetic Treatment Period||70
10928845|NCT00282568|12097760|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||68
10928846|NCT00282568|12097760|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
10928847|NCT00282568|12097760|FG000|COMPLETED|Pharmacokinetic Treatment Period||67
10928848|NCT00282568|12097760|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||3
10928849|NCT00282568|12097760|FG000|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
10928850|NCT00282568|12097760|FG000|COMPLETED|Extended Treatment Period||42
10928851|NCT00282568|12097760|FG000|NOT COMPLETED|Extended Treatment Period||24
10928852|NCT00282672|12097768|FG000|STARTED|1 Year||22
10928853|NCT00282672|12097769|FG001|STARTED|1 Year||42
10928854|NCT00282672|12097770|FG002|STARTED|1 Year||21
10928855|NCT00282672|12097771|FG003|STARTED|1 Year||42
10928856|NCT00282672|12097768|FG000|COMPLETED|1 Year||19
10928857|NCT00282672|12097769|FG001|COMPLETED|1 Year||40
10928858|NCT00282672|12097770|FG002|COMPLETED|1 Year||20
10928859|NCT00282672|12097771|FG003|COMPLETED|1 Year||38
10928860|NCT00282672|12097768|FG000|NOT COMPLETED|1 Year||3
10928861|NCT00282672|12097769|FG001|NOT COMPLETED|1 Year||2
10928862|NCT00282672|12097770|FG002|NOT COMPLETED|1 Year||1
10928863|NCT00282672|12097771|FG003|NOT COMPLETED|1 Year||4
10928864|NCT00282672|12097768|FG000|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
10928865|NCT00282672|12097769|FG001|STARTED|2 Year: Sham Crossed Over to RFA||40
10928866|NCT00282672|12097770|FG002|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
10928867|NCT00282672|12097771|FG003|STARTED|2 Year: Sham Crossed Over to RFA||38
10928868|NCT00282672|12097768|FG000|COMPLETED|2 Year: Sham Crossed Over to RFA||16
10928869|NCT00282672|12097769|FG001|COMPLETED|2 Year: Sham Crossed Over to RFA||39
10928870|NCT00282672|12097770|FG002|COMPLETED|2 Year: Sham Crossed Over to RFA||15
10928871|NCT00282672|12097771|FG003|COMPLETED|2 Year: Sham Crossed Over to RFA||36
10928872|NCT00282672|12097768|FG000|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
10928873|NCT00282672|12097769|FG001|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
10928874|NCT00282672|12097770|FG002|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
10928875|NCT00282672|12097771|FG003|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
10928876|NCT00282672|12097768|FG000|STARTED|5 Year: Follow up|1 withdrew|15
10928877|NCT00282672|12097769|FG001|STARTED|5 Year: Follow up|7 withdrew|32
10928878|NCT00282672|12097770|FG002|STARTED|5 Year: Follow up|3 withdrew|12
10928879|NCT00282672|12097771|FG003|STARTED|5 Year: Follow up|11 withdrew|25
10928880|NCT00282672|12097768|FG000|COMPLETED|5 Year: Follow up||14
10928881|NCT00282672|12097769|FG001|COMPLETED|5 Year: Follow up||27
10928882|NCT00282672|12097770|FG002|COMPLETED|5 Year: Follow up||12
10928883|NCT00282672|12097771|FG003|COMPLETED|5 Year: Follow up||20
10928884|NCT00282672|12097768|FG000|NOT COMPLETED|5 Year: Follow up||1
10928885|NCT00282672|12097769|FG001|NOT COMPLETED|5 Year: Follow up||5
10928886|NCT00282672|12097770|FG002|NOT COMPLETED|5 Year: Follow up||0
10928887|NCT00282672|12097771|FG003|NOT COMPLETED|5 Year: Follow up||5
10928888|NCT00282815|12097807|FG000|STARTED|Overall Study||15
10928889|NCT00282815|12097808|FG001|STARTED|Overall Study||17
10928890|NCT00282815|12097807|FG000|COMPLETED|Overall Study||8
10928891|NCT00282815|12097808|FG001|COMPLETED|Overall Study||11
10928892|NCT00282815|12097807|FG000|NOT COMPLETED|Overall Study||7
10928893|NCT00282815|12097808|FG001|NOT COMPLETED|Overall Study||6
10928894|NCT00282828|12097820|FG000|STARTED|Overall Study||63
10928895|NCT00282828|12097821|FG001|STARTED|Overall Study||59
10928896|NCT00282828|12097822|FG002|STARTED|Overall Study||59
10928897|NCT00282828|12097820|FG000|COMPLETED|Overall Study||57
10928898|NCT00282828|12097821|FG001|COMPLETED|Overall Study||47
10928899|NCT00282828|12097822|FG002|COMPLETED|Overall Study||50
10928900|NCT00282828|12097820|FG000|NOT COMPLETED|Overall Study||6
10928901|NCT00282828|12097821|FG001|NOT COMPLETED|Overall Study||12
10928902|NCT00282828|12097822|FG002|NOT COMPLETED|Overall Study||9
10928903|NCT00282841|12097830|FG000|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61
10928904|NCT00282841|12097830|FG000|COMPLETED|Overall Study||61
10928905|NCT00282841|12097830|FG000|NOT COMPLETED|Overall Study||0
10928906|NCT00282919|12097835|FG000|STARTED|Overall Study||110
10928907|NCT00282919|12097835|FG000|COMPLETED|Overall Study||103
10928908|NCT00282919|12097835|FG000|NOT COMPLETED|Overall Study||7
10928909|NCT00282971|12097841|FG000|STARTED|Overall Study||180
10928910|NCT00282971|12097842|FG001|STARTED|Overall Study||171
10928911|NCT00282971|12097841|FG000|COMPLETED|Overall Study||146
10928912|NCT00282971|12097842|FG001|COMPLETED|Overall Study||149
10928913|NCT00282971|12097841|FG000|NOT COMPLETED|Overall Study||34
10928914|NCT00282971|12097842|FG001|NOT COMPLETED|Overall Study||22
10928915|NCT00282984|12097850|FG000|STARTED|Overall Study||353
10928916|NCT00282984|12097851|FG001|STARTED|Overall Study||350
10928917|NCT00282984|12097850|FG000|COMPLETED|Overall Study||302
10928918|NCT00282984|12097851|FG001|COMPLETED|Overall Study||289
10928919|NCT00282984|12097850|FG000|NOT COMPLETED|Overall Study||51
10928920|NCT00282984|12097851|FG001|NOT COMPLETED|Overall Study||61
10928921|NCT00283049|12097860|FG000|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
10928922|NCT00283049|12097861|FG001|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
10928923|NCT00283049|12097862|FG002|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
10928924|NCT00283049|12097860|FG000|COMPLETED|Overall Study||70
10928925|NCT00283049|12097861|FG001|COMPLETED|Overall Study||83
10928926|NCT00283049|12097862|FG002|COMPLETED|Overall Study||76
10928927|NCT00283049|12097860|FG000|NOT COMPLETED|Overall Study||58
10928928|NCT00283049|12097861|FG001|NOT COMPLETED|Overall Study||45
10928929|NCT00283049|12097862|FG002|NOT COMPLETED|Overall Study||54
10928930|NCT00283062|12097874|FG000|STARTED|Overall Study||55
10928931|NCT00283062|12097875|FG001|STARTED|Overall Study||55
10928932|NCT00283062|12097876|FG002|STARTED|Overall Study||56
10928933|NCT00283062|12097877|FG003|STARTED|Overall Study||62
10928934|NCT00283062|12097874|FG000|ADMINISTERED STUDY TREATMENT|Overall Study||50
10928935|NCT00283062|12097875|FG001|ADMINISTERED STUDY TREATMENT|Overall Study||51
10928936|NCT00283062|12097876|FG002|ADMINISTERED STUDY TREATMENT|Overall Study||20
10928937|NCT00283062|12097877|FG003|ADMINISTERED STUDY TREATMENT|Overall Study||17
10928938|NCT00283062|12097874|FG000|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
10928939|NCT00283062|12097875|FG001|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
10928940|NCT00283062|12097876|FG002|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
10928941|NCT00283062|12097877|FG003|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
10928942|NCT00283062|12097874|FG000|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
10928943|NCT00283062|12097875|FG001|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
10928944|NCT00283062|12097876|FG002|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
10928945|NCT00283062|12097877|FG003|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
10928946|NCT00283062|12097874|FG000|COMPLETED|Overall Study||43
10928947|NCT00283062|12097875|FG001|COMPLETED|Overall Study||48
10928948|NCT00283062|12097876|FG002|COMPLETED|Overall Study||15
10928949|NCT00283062|12097877|FG003|COMPLETED|Overall Study||13
10928950|NCT00283062|12097874|FG000|NOT COMPLETED|Overall Study||12
10928951|NCT00283062|12097875|FG001|NOT COMPLETED|Overall Study||7
10928952|NCT00283062|12097876|FG002|NOT COMPLETED|Overall Study||41
10928953|NCT00283062|12097877|FG003|NOT COMPLETED|Overall Study||49
10928954|NCT00283075|12097887|FG000|STARTED|Overall Study||25
10928955|NCT00283075|12097888|FG001|STARTED|Overall Study||6
10928956|NCT00283075|12097887|FG000|COMPLETED|Overall Study||25
10928957|NCT00283075|12097888|FG001|COMPLETED|Overall Study||6
10928958|NCT00283075|12097887|FG000|NOT COMPLETED|Overall Study||0
10928959|NCT00283075|12097888|FG001|NOT COMPLETED|Overall Study||0
10928960|NCT00283244|12097902|FG000|STARTED|Overall Study||44
10928961|NCT00283244|12097903|FG001|STARTED|Overall Study||51
10928962|NCT00283244|12097904|FG002|STARTED|Overall Study||51
10928963|NCT00283244|12097902|FG000|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
10928964|NCT00283244|12097903|FG001|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
10928965|NCT00283244|12097904|FG002|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
10928966|NCT00283244|12097902|FG000|NOT COMPLETED|Overall Study||18
10928967|NCT00283244|12097903|FG001|NOT COMPLETED|Overall Study||51
10928968|NCT00283244|12097904|FG002|NOT COMPLETED|Overall Study||51
10928969|NCT00283283|12097917|FG000|STARTED|Overall Study||274
10928970|NCT00283283|12097918|FG001|STARTED|Overall Study||284
10928971|NCT00283283|12097919|FG002|STARTED|Overall Study||280
10928972|NCT00283283|12097920|FG003|STARTED|Overall Study||276
10928973|NCT00283283|12097917|FG000|COMPLETED|Overall Study||274
10928974|NCT00283283|12097918|FG001|COMPLETED|Overall Study||284
10928975|NCT00283283|12097919|FG002|COMPLETED|Overall Study||280
10928976|NCT00283283|12097920|FG003|COMPLETED|Overall Study||276
10928977|NCT00283283|12097917|FG000|NOT COMPLETED|Overall Study||0
10928978|NCT00283283|12097918|FG001|NOT COMPLETED|Overall Study||0
10928979|NCT00283283|12097919|FG002|NOT COMPLETED|Overall Study||0
10928980|NCT00283283|12097920|FG003|NOT COMPLETED|Overall Study||0
10928981|NCT00283296|12097935|FG000|STARTED|Overall Study||14
10928982|NCT00283296|12097935|FG000|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
10928983|NCT00283296|12097935|FG000|NOT COMPLETED|Overall Study||5
10928984|NCT00283387|12097940|FG000|STARTED|First Intervention||6
10928985|NCT00283387|12097941|FG001|STARTED|First Intervention||7
10928986|NCT00283387|12097940|FG000|COMPLETED|First Intervention||5
10928987|NCT00283387|12097941|FG001|COMPLETED|First Intervention||5
10928988|NCT00283387|12097940|FG000|NOT COMPLETED|First Intervention||1
10928989|NCT00283387|12097941|FG001|NOT COMPLETED|First Intervention||2
10928990|NCT00283387|12097940|FG000|STARTED|Washout Period of 2 Months||5
10928991|NCT00283387|12097941|FG001|STARTED|Washout Period of 2 Months||5
10928992|NCT00283387|12097940|FG000|COMPLETED|Washout Period of 2 Months||5
10928993|NCT00283387|12097941|FG001|COMPLETED|Washout Period of 2 Months||5
10928994|NCT00283387|12097940|FG000|NOT COMPLETED|Washout Period of 2 Months||0
10928995|NCT00283387|12097941|FG001|NOT COMPLETED|Washout Period of 2 Months||0
10928996|NCT00283387|12097940|FG000|STARTED|Second Intervention||5
10928997|NCT00283387|12097941|FG001|STARTED|Second Intervention||5
10928998|NCT00283387|12097940|FG000|COMPLETED|Second Intervention||5
10928999|NCT00283387|12097941|FG001|COMPLETED|Second Intervention||5
10929000|NCT00283387|12097940|FG000|NOT COMPLETED|Second Intervention||0
10929001|NCT00283387|12097941|FG001|NOT COMPLETED|Second Intervention||0
10929002|NCT00283400|12097951|FG000|STARTED|Overall Study||20
10929003|NCT00283400|12097952|FG001|STARTED|Overall Study||20
10929004|NCT00283400|12097953|FG002|STARTED|Overall Study||7
10929005|NCT00283400|12097954|FG003|STARTED|Overall Study||0
10929006|NCT00283400|12097951|FG000|COMPLETED|Overall Study||18
10929007|NCT00283400|12097952|FG001|COMPLETED|Overall Study||19
10929008|NCT00283400|12097953|FG002|COMPLETED|Overall Study||6
10929009|NCT00283400|12097954|FG003|COMPLETED|Overall Study||0
10929010|NCT00283400|12097951|FG000|NOT COMPLETED|Overall Study||2
10929011|NCT00283400|12097952|FG001|NOT COMPLETED|Overall Study||1
10929012|NCT00283400|12097953|FG002|NOT COMPLETED|Overall Study||1
10929013|NCT00283400|12097954|FG003|NOT COMPLETED|Overall Study||0
10929014|NCT00283439|12097968|FG000|STARTED|Overall Study||8
10929015|NCT00283439|12097969|FG001|STARTED|Overall Study||11
10929016|NCT00283439|12097970|FG002|STARTED|Overall Study||11
10929017|NCT00283439|12097971|FG003|STARTED|Overall Study||9
10929018|NCT00283439|12097968|FG000|COMPLETED|Overall Study||0
10929019|NCT00283439|12097969|FG001|COMPLETED|Overall Study||0
10929020|NCT00283439|12097970|FG002|COMPLETED|Overall Study||0
10929021|NCT00283439|12097971|FG003|COMPLETED|Overall Study||0
10929022|NCT00283439|12097968|FG000|NOT COMPLETED|Overall Study||8
10929023|NCT00283439|12097969|FG001|NOT COMPLETED|Overall Study||11
10929024|NCT00283439|12097970|FG002|NOT COMPLETED|Overall Study||11
10929025|NCT00283439|12097971|FG003|NOT COMPLETED|Overall Study||9
10929026|NCT00283504|12097983|FG000|STARTED|Overall Study||7
10929027|NCT00283504|12097984|FG001|STARTED|Overall Study||6
10929028|NCT00283504|12097983|FG000|COMPLETED|Overall Study||7
10929029|NCT00283504|12097984|FG001|COMPLETED|Overall Study||6
10929030|NCT00283504|12097983|FG000|NOT COMPLETED|Overall Study||0
10929031|NCT00283504|12097984|FG001|NOT COMPLETED|Overall Study||0
10929032|NCT00283595|12097994|FG000|STARTED|Overall Study||10
10929033|NCT00283595|12097995|FG001|STARTED|Overall Study||11
10929034|NCT00283595|12097994|FG000|COMPLETED|Overall Study||9
10929035|NCT00283595|12097995|FG001|COMPLETED|Overall Study||9
10929036|NCT00283595|12097994|FG000|NOT COMPLETED|Overall Study||1
10929037|NCT00283595|12097995|FG001|NOT COMPLETED|Overall Study||2
10929038|NCT00283686|12098005|FG000|STARTED|Overall Study||140
10929039|NCT00283686|12098006|FG001|STARTED|Overall Study||133
10929040|NCT00283686|12098007|FG002|STARTED|Overall Study||144
10929041|NCT00283686|12098008|FG003|STARTED|Overall Study||141
10929042|NCT00283686|12098005|FG000|COMPLETED|Overall Study||111
10929043|NCT00283686|12098006|FG001|COMPLETED|Overall Study||92
10929044|NCT00283686|12098007|FG002|COMPLETED|Overall Study||111
10929045|NCT00283686|12098008|FG003|COMPLETED|Overall Study||109
10929046|NCT00283686|12098005|FG000|NOT COMPLETED|Overall Study||29
10929047|NCT00283686|12098006|FG001|NOT COMPLETED|Overall Study||41
10929048|NCT00283686|12098007|FG002|NOT COMPLETED|Overall Study||33
10929049|NCT00283686|12098008|FG003|NOT COMPLETED|Overall Study||32
10929050|NCT00283712|12098020|FG000|STARTED|Overall Study||10
10929051|NCT00283712|12098021|FG001|STARTED|Overall Study||10
10929052|NCT00283712|12098020|FG000|Intent-to-treat Sample|Overall Study||10
10929053|NCT00283712|12098021|FG001|Intent-to-treat Sample|Overall Study||10
10929054|NCT00283712|12098020|FG000|Safety Sample|Overall Study||10
10929055|NCT00283712|12098021|FG001|Safety Sample|Overall Study||10
10929056|NCT00283712|12098020|FG000|Per-Protocol Sample|Overall Study||6
10929057|NCT00283712|12098021|FG001|Per-Protocol Sample|Overall Study||7
10929058|NCT00283712|12098020|FG000|COMPLETED|Overall Study||10
10929059|NCT00283712|12098021|FG001|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
10929060|NCT00283712|12098020|FG000|NOT COMPLETED|Overall Study||0
10929061|NCT00283712|12098021|FG001|NOT COMPLETED|Overall Study||1
10929062|NCT00283803|12098027|FG000|STARTED|Overall Study||32
10929063|NCT00283803|12098027|FG000|COMPLETED|Overall Study||19
10929064|NCT00283803|12098027|FG000|NOT COMPLETED|Overall Study||13
10929065|NCT00283816|12098033|FG000|STARTED|Overall Study||18
10929066|NCT00283816|12098034|FG001|STARTED|Overall Study||18
10929067|NCT00283816|12098033|FG000|COMPLETED|Overall Study||16
10929068|NCT00283816|12098034|FG001|COMPLETED|Overall Study||16
10929069|NCT00283816|12098033|FG000|NOT COMPLETED|Overall Study||2
10929070|NCT00283816|12098034|FG001|NOT COMPLETED|Overall Study||2
10929071|NCT00283842|12098047|FG000|STARTED|Overall Study||63
10929072|NCT00283842|12098048|FG001|STARTED|Overall Study||87
10929073|NCT00283842|12098049|FG002|STARTED|Overall Study||99
10929074|NCT00283842|12098050|FG003|STARTED|Overall Study||69
10929075|NCT00283842|12098051|FG004|STARTED|Overall Study||90
10929076|NCT00283842|12098047|FG000|COMPLETED|Overall Study||51
10929077|NCT00283842|12098048|FG001|COMPLETED|Overall Study||69
10929078|NCT00283842|12098049|FG002|COMPLETED|Overall Study||68
10929079|NCT00283842|12098050|FG003|COMPLETED|Overall Study||42
10929080|NCT00283842|12098051|FG004|COMPLETED|Overall Study||75
10929081|NCT00283842|12098047|FG000|NOT COMPLETED|Overall Study||12
10929082|NCT00283842|12098048|FG001|NOT COMPLETED|Overall Study||18
10929083|NCT00283842|12098049|FG002|NOT COMPLETED|Overall Study||31
10929084|NCT00283842|12098050|FG003|NOT COMPLETED|Overall Study||27
10929085|NCT00283842|12098051|FG004|NOT COMPLETED|Overall Study||15
10929086|NCT00283933|12098063|FG000|STARTED|Treatment Period||5
10929087|NCT00283933|12098063|FG000|Safety Population|Treatment Period||5
10929088|NCT00283933|12098063|FG000|Pharmacodynamic (PD) Population|Treatment Period||5
10929089|NCT00283933|12098063|FG000|COMPLETED|Treatment Period||5
10929090|NCT00283933|12098063|FG000|NOT COMPLETED|Treatment Period||0
10929091|NCT00283933|12098063|FG000|STARTED|Extension Period||5
10929092|NCT00283933|12098063|FG000|COMPLETED|Extension Period||5
10929093|NCT00283933|12098063|FG000|NOT COMPLETED|Extension Period||0
10929094|NCT00284050|12098070|FG000|STARTED|Overall Study||51
10929095|NCT00284050|12098071|FG001|STARTED|Overall Study||51
10929096|NCT00284050|12098072|FG002|STARTED|Overall Study||49
10929097|NCT00284050|12098070|FG000|COMPLETED|Overall Study||46
10929098|NCT00284050|12098071|FG001|COMPLETED|Overall Study||46
10929099|NCT00284050|12098072|FG002|COMPLETED|Overall Study||40
10929100|NCT00284050|12098070|FG000|NOT COMPLETED|Overall Study||5
10929101|NCT00284050|12098071|FG001|NOT COMPLETED|Overall Study||5
10929102|NCT00284050|12098072|FG002|NOT COMPLETED|Overall Study||9
10929103|NCT00284089|12098084|FG000|STARTED|Single Dose Phase||6
10929104|NCT00284089|12098085|FG001|STARTED|Single Dose Phase||6
10929105|NCT00284089|12098086|FG002|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
10929106|NCT00284089|12098087|FG003|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
10929107|NCT00284089|12098084|FG000|COMPLETED|Single Dose Phase||6
10929108|NCT00284089|12098085|FG001|COMPLETED|Single Dose Phase||6
10929109|NCT00284089|12098086|FG002|COMPLETED|Single Dose Phase||0
10929110|NCT00284089|12098087|FG003|COMPLETED|Single Dose Phase||0
10929111|NCT00284089|12098084|FG000|NOT COMPLETED|Single Dose Phase||0
10929112|NCT00284089|12098085|FG001|NOT COMPLETED|Single Dose Phase||0
10929113|NCT00284089|12098086|FG002|NOT COMPLETED|Single Dose Phase||0
10929114|NCT00284089|12098087|FG003|NOT COMPLETED|Single Dose Phase||0
10929115|NCT00284089|12098084|FG000|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
10929116|NCT00284089|12098085|FG001|STARTED|Multiple Dose Phase||6
10929117|NCT00284089|12098086|FG002|STARTED|Multiple Dose Phase||35
10929118|NCT00284089|12098087|FG003|STARTED|Multiple Dose Phase||41
10929119|NCT00284089|12098084|FG000|COMPLETED|Multiple Dose Phase||4
10929120|NCT00284089|12098085|FG001|COMPLETED|Multiple Dose Phase||6
10929121|NCT00284089|12098086|FG002|COMPLETED|Multiple Dose Phase||31
10929122|NCT00284089|12098087|FG003|COMPLETED|Multiple Dose Phase||37
10929123|NCT00284089|12098084|FG000|NOT COMPLETED|Multiple Dose Phase||1
10929124|NCT00284089|12098085|FG001|NOT COMPLETED|Multiple Dose Phase||0
10929125|NCT00284089|12098086|FG002|NOT COMPLETED|Multiple Dose Phase||4
10929126|NCT00284089|12098087|FG003|NOT COMPLETED|Multiple Dose Phase||4
10929127|NCT00284089|12098084|FG000|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
10929128|NCT00284089|12098085|FG001|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
10929129|NCT00284089|12098086|FG002|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
10929130|NCT00284089|12098087|FG003|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
10929131|NCT00284089|12098084|FG000|COMPLETED|Extension Phase||1
10929132|NCT00284089|12098085|FG001|COMPLETED|Extension Phase||6
10929133|NCT00284089|12098086|FG002|COMPLETED|Extension Phase||22
10929134|NCT00284089|12098087|FG003|COMPLETED|Extension Phase||21
10929135|NCT00284089|12098084|FG000|NOT COMPLETED|Extension Phase||2
10929136|NCT00284089|12098085|FG001|NOT COMPLETED|Extension Phase||0
10929137|NCT00284089|12098086|FG002|NOT COMPLETED|Extension Phase||6
10929138|NCT00284089|12098087|FG003|NOT COMPLETED|Extension Phase||12
10929139|NCT00284141|12098097|FG000|STARTED|Overall Study||98
10929140|NCT00284141|12098097|FG000|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
10929141|NCT00284141|12098097|FG000|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
10929142|NCT00284141|12098097|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
10929143|NCT00284141|12098097|FG000|NOT COMPLETED|Overall Study||98
10929144|NCT00284154|12098103|FG000|STARTED|Overall Study||51
10929145|NCT00284154|12098103|FG000|COMPLETED|Overall Study||9
10929146|NCT00284154|12098103|FG000|NOT COMPLETED|Overall Study||42
10929147|NCT00284180|12098109|FG000|STARTED|Overall Study||11
10929148|NCT00284180|12098110|FG001|STARTED|Overall Study||21
10929149|NCT00284180|12098109|FG000|COMPLETED|Overall Study||11
10929150|NCT00284180|12098110|FG001|COMPLETED|Overall Study||17
10929151|NCT00284180|12098109|FG000|NOT COMPLETED|Overall Study||0
10929152|NCT00284180|12098110|FG001|NOT COMPLETED|Overall Study||4
10929153|NCT00284518|12098120|FG000|STARTED|Overall Study||97
10929154|NCT00284518|12098121|FG001|STARTED|Overall Study||94
10929155|NCT00284518|12098122|FG002|STARTED|Overall Study||95
10929156|NCT00284518|12098123|FG003|STARTED|Overall Study||94
10929157|NCT00284518|12098120|FG000|COMPLETED|Overall Study||71
10929158|NCT00284518|12098121|FG001|COMPLETED|Overall Study||66
10929159|NCT00284518|12098122|FG002|COMPLETED|Overall Study||67
10929160|NCT00284518|12098123|FG003|COMPLETED|Overall Study||61
10929161|NCT00284518|12098120|FG000|NOT COMPLETED|Overall Study||26
10929162|NCT00284518|12098121|FG001|NOT COMPLETED|Overall Study||28
10929163|NCT00284518|12098122|FG002|NOT COMPLETED|Overall Study||28
10929164|NCT00284518|12098123|FG003|NOT COMPLETED|Overall Study||33
10929165|NCT00284557|12098135|FG000|STARTED|Overall Study||67
10929166|NCT00284557|12098136|FG001|STARTED|Overall Study||63
10929167|NCT00284557|12098135|FG000|COMPLETED|Overall Study||58
10929168|NCT00284557|12098136|FG001|COMPLETED|Overall Study||50
10929169|NCT00284557|12098135|FG000|NOT COMPLETED|Overall Study||9
10929170|NCT00284557|12098136|FG001|NOT COMPLETED|Overall Study||13
10929171|NCT00284739|12098144|FG000|STARTED|Overall Study||11
10929172|NCT00284739|12098145|FG001|STARTED|Overall Study||9
10929173|NCT00284739|12098144|FG000|COMPLETED|Overall Study||11
10929174|NCT00284739|12098145|FG001|COMPLETED|Overall Study||9
10929175|NCT00284739|12098144|FG000|NOT COMPLETED|Overall Study||0
10929176|NCT00284739|12098145|FG001|NOT COMPLETED|Overall Study||0
10929177|NCT00284934|12098153|FG000|STARTED|Overall Study||48
10929178|NCT00284934|12098154|FG001|STARTED|Overall Study||46
10929179|NCT00284934|12098153|FG000|Intent-to-treat Population (ITT)|Overall Study||47
10929180|NCT00284934|12098154|FG001|Intent-to-treat Population (ITT)|Overall Study||45
10929181|NCT00284934|12098153|FG000|COMPLETED|Overall Study||44
10929182|NCT00284934|12098154|FG001|COMPLETED|Overall Study||43
10929183|NCT00284934|12098153|FG000|NOT COMPLETED|Overall Study||4
10929184|NCT00284934|12098154|FG001|NOT COMPLETED|Overall Study||3
10929185|NCT00285012|12098162|FG000|STARTED|Assigned to Study Treatment (Tx)||250
10929186|NCT00285012|12098163|FG001|STARTED|Assigned to Study Treatment (Tx)||254
10929187|NCT00285012|12098162|FG000|COMPLETED|Assigned to Study Treatment (Tx)||248
10929188|NCT00285012|12098163|FG001|COMPLETED|Assigned to Study Treatment (Tx)||251
10929189|NCT00285012|12098162|FG000|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
10929190|NCT00285012|12098163|FG001|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
10929191|NCT00285012|12098162|FG000|STARTED|Received Study Tx||248
10929192|NCT00285012|12098163|FG001|STARTED|Received Study Tx||251
10929193|NCT00285012|12098162|FG000|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
10929194|NCT00285012|12098163|FG001|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
10929195|NCT00285012|12098162|FG000|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
10929196|NCT00285012|12098163|FG001|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
10929197|NCT00285012|12098162|FG000|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
10929198|NCT00285012|12098163|FG001|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
10929199|NCT00285012|12098162|FG000|NOT COMPLETED|Received Study Tx||72
10929200|NCT00285012|12098163|FG001|NOT COMPLETED|Received Study Tx||94
10929201|NCT00285207|12098171|FG000|STARTED|Overall Study||70
10929202|NCT00285207|12098172|FG001|STARTED|Overall Study||77
10929203|NCT00285207|12098171|FG000|Treated|Overall Study||63
10929204|NCT00285207|12098172|FG001|Treated|Overall Study||75
10929205|NCT00285207|12098171|FG000|COMPLETED|Overall Study||61
10929206|NCT00285207|12098172|FG001|COMPLETED|Overall Study||71
10929207|NCT00285207|12098171|FG000|NOT COMPLETED|Overall Study||9
10929208|NCT00285207|12098172|FG001|NOT COMPLETED|Overall Study||6
10929209|NCT00285246|12098178|FG000|STARTED|Overall Study||838
10929210|NCT00285246|12098178|FG000|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
10929211|NCT00285246|12098178|FG000|NOT COMPLETED|Overall Study||48
10929212|NCT00285467|12098184|FG000|STARTED|Overall Study||25
10929213|NCT00285467|12098185|FG001|STARTED|Overall Study||22
10929214|NCT00285467|12098184|FG000|COMPLETED|Overall Study||25
10929215|NCT00285467|12098185|FG001|COMPLETED|Overall Study||22
10929216|NCT00285467|12098184|FG000|NOT COMPLETED|Overall Study||0
10929217|NCT00285467|12098185|FG001|NOT COMPLETED|Overall Study||0
10929218|NCT00285584|12098193|FG000|STARTED|Enrollment (Month 0)||20
10929219|NCT00285584|12098194|FG001|STARTED|Enrollment (Month 0)||21
10929220|NCT00285584|12098193|FG000|COMPLETED|Enrollment (Month 0)||20
10929221|NCT00285584|12098194|FG001|COMPLETED|Enrollment (Month 0)||21
10929222|NCT00285584|12098193|FG000|NOT COMPLETED|Enrollment (Month 0)||0
10929223|NCT00285584|12098194|FG001|NOT COMPLETED|Enrollment (Month 0)||0
10929224|NCT00285584|12098193|FG000|STARTED|Month 3||20
10929225|NCT00285584|12098194|FG001|STARTED|Month 3||21
10929226|NCT00285584|12098193|FG000|COMPLETED|Month 3||16
10929227|NCT00285584|12098194|FG001|COMPLETED|Month 3||18
10929228|NCT00285584|12098193|FG000|NOT COMPLETED|Month 3||4
10929229|NCT00285584|12098194|FG001|NOT COMPLETED|Month 3||3
10929230|NCT00285584|12098193|FG000|STARTED|Month 6||16
10929231|NCT00285584|12098194|FG001|STARTED|Month 6||18
10929232|NCT00285584|12098193|FG000|COMPLETED|Month 6||16
10929233|NCT00285584|12098194|FG001|COMPLETED|Month 6||17
10929234|NCT00285584|12098193|FG000|NOT COMPLETED|Month 6||0
10929235|NCT00285584|12098194|FG001|NOT COMPLETED|Month 6||1
10929236|NCT00285584|12098193|FG000|STARTED|Month 9||16
10929237|NCT00285584|12098194|FG001|STARTED|Month 9||17
10929238|NCT00285584|12098193|FG000|COMPLETED|Month 9||15
10929239|NCT00285584|12098194|FG001|COMPLETED|Month 9||14
10929240|NCT00285584|12098193|FG000|NOT COMPLETED|Month 9||1
10929241|NCT00285584|12098194|FG001|NOT COMPLETED|Month 9||3
10929242|NCT00285649|12098207|FG000|STARTED|Overall Study||72
10929243|NCT00285649|12098208|FG001|STARTED|Overall Study||72
10929244|NCT00285649|12098209|FG002|STARTED|Overall Study||48
10929245|NCT00285649|12098207|FG000|COMPLETED|Overall Study||63
10929246|NCT00285649|12098208|FG001|COMPLETED|Overall Study||66
10929247|NCT00285649|12098209|FG002|COMPLETED|Overall Study||42
10929248|NCT00285649|12098207|FG000|NOT COMPLETED|Overall Study||9
10929249|NCT00285649|12098208|FG001|NOT COMPLETED|Overall Study||6
10929250|NCT00285649|12098209|FG002|NOT COMPLETED|Overall Study||6
10929251|NCT00285779|12098219|FG000|STARTED|Placebo-controlled Period (wk 1-12)||14
10929252|NCT00285779|12098220|FG001|STARTED|Placebo-controlled Period (wk 1-12)||13
10929253|NCT00285779|12098219|FG000|COMPLETED|Placebo-controlled Period (wk 1-12)||11
10929254|NCT00285779|12098220|FG001|COMPLETED|Placebo-controlled Period (wk 1-12)||12
10929255|NCT00285779|12098219|FG000|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
10929256|NCT00285779|12098220|FG001|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
10929257|NCT00285779|12098219|FG000|STARTED|Open Label Period (wk 12-24)||11
10929258|NCT00285779|12098220|FG001|STARTED|Open Label Period (wk 12-24)||12
10929259|NCT00285779|12098219|FG000|COMPLETED|Open Label Period (wk 12-24)||9
10929260|NCT00285779|12098220|FG001|COMPLETED|Open Label Period (wk 12-24)||10
10929261|NCT00285779|12098219|FG000|NOT COMPLETED|Open Label Period (wk 12-24)||2
10929262|NCT00285779|12098220|FG001|NOT COMPLETED|Open Label Period (wk 12-24)||2
10929263|NCT00285779|12098219|FG000|STARTED|Follow-up Period (wk 24-32)||9
10929264|NCT00285779|12098220|FG001|STARTED|Follow-up Period (wk 24-32)||10
10929265|NCT00285779|12098219|FG000|COMPLETED|Follow-up Period (wk 24-32)||8
10929266|NCT00285779|12098220|FG001|COMPLETED|Follow-up Period (wk 24-32)||10
10929267|NCT00285779|12098219|FG000|NOT COMPLETED|Follow-up Period (wk 24-32)||1
10929268|NCT00285779|12098220|FG001|NOT COMPLETED|Follow-up Period (wk 24-32)||0
10929269|NCT00285818|12098228|FG000|STARTED|Overall Study||6
10929270|NCT00285818|12098229|FG001|STARTED|Overall Study||5
10929271|NCT00285818|12098228|FG000|COMPLETED|Overall Study||2
10929272|NCT00285818|12098229|FG001|COMPLETED|Overall Study||3
10929273|NCT00285818|12098228|FG000|NOT COMPLETED|Overall Study||4
10929274|NCT00285818|12098229|FG001|NOT COMPLETED|Overall Study||2
10929275|NCT00285857|12098235|FG000|STARTED|Overall Study||30
10929276|NCT00285857|12098235|FG000|COMPLETED|Overall Study||26
10929277|NCT00285857|12098235|FG000|NOT COMPLETED|Overall Study||4
10929278|NCT00286078|12098246|FG000|STARTED|Overall Study||72
10929279|NCT00286078|12098247|FG001|STARTED|Overall Study||68
10929280|NCT00286078|12098246|FG000|12 Weeks|Overall Study||63
10929281|NCT00286078|12098247|FG001|12 Weeks|Overall Study||62
10929282|NCT00286078|12098246|FG000|COMPLETED|Overall Study||40
10929283|NCT00286078|12098247|FG001|COMPLETED|Overall Study||34
10929284|NCT00286078|12098246|FG000|NOT COMPLETED|Overall Study||32
10929285|NCT00286078|12098247|FG001|NOT COMPLETED|Overall Study||34
10929286|NCT00286091|12098255|FG000|STARTED|Double-blind Treatment Phase||716
10929287|NCT00286091|12098256|FG001|STARTED|Double-blind Treatment Phase||716
10929288|NCT00286091|12098255|FG000|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
10929289|NCT00286091|12098256|FG001|Received Treatment|Double-blind Treatment Phase||716
10929290|NCT00286091|12098255|FG000|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
10929291|NCT00286091|12098256|FG001|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
10929292|NCT00286091|12098255|FG000|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
10929293|NCT00286091|12098256|FG001|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
10929294|NCT00286091|12098255|FG000|NOT COMPLETED|Double-blind Treatment Phase||584
10929295|NCT00286091|12098256|FG001|NOT COMPLETED|Double-blind Treatment Phase||593
10929296|NCT00286091|12098255|FG000|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
10929297|NCT00286091|12098256|FG001|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
10929298|NCT00286091|12098255|FG000|Received Treatment|Open-label Treatment Phase||109
10929299|NCT00286091|12098256|FG001|Received Treatment|Open-label Treatment Phase||101
10929300|NCT00286091|12098255|FG000|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
10929301|NCT00286091|12098256|FG001|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
10929302|NCT00286091|12098255|FG000|NOT COMPLETED|Open-label Treatment Phase||77
10929303|NCT00286091|12098256|FG001|NOT COMPLETED|Open-label Treatment Phase||71
10929304|NCT00286156|12098267|FG000|STARTED|Overall Study||10
10929305|NCT00286156|12098268|FG001|STARTED|Overall Study||10
10929306|NCT00286156|12098269|FG002|STARTED|Overall Study||10
10929307|NCT00286156|12098267|FG000|COMPLETED|Overall Study||8
10929308|NCT00286156|12098268|FG001|COMPLETED|Overall Study||9
10929309|NCT00286156|12098269|FG002|COMPLETED|Overall Study||9
10929310|NCT00286156|12098267|FG000|NOT COMPLETED|Overall Study||2
10929311|NCT00286156|12098268|FG001|NOT COMPLETED|Overall Study||1
10929312|NCT00286156|12098269|FG002|NOT COMPLETED|Overall Study||1
10929313|NCT00286182|12098279|FG000|STARTED|Overall Study||28
10929314|NCT00286182|12098280|FG001|STARTED|Overall Study||28
10929315|NCT00286182|12098279|FG000|COMPLETED|Overall Study||23
10929316|NCT00286182|12098280|FG001|COMPLETED|Overall Study||25
10929317|NCT00286182|12098279|FG000|NOT COMPLETED|Overall Study||5
10929318|NCT00286182|12098280|FG001|NOT COMPLETED|Overall Study||3
10929319|NCT00286221|12098290|FG000|STARTED|Overall Study||39
10929320|NCT00286221|12098291|FG001|STARTED|Overall Study||40
10929321|NCT00286221|12098292|FG002|STARTED|Overall Study||40
10929322|NCT00286221|12098293|FG003|STARTED|Overall Study||40
10929323|NCT00286221|12098290|FG000|COMPLETED|Overall Study||29
10929324|NCT00286221|12098291|FG001|COMPLETED|Overall Study||35
10929325|NCT00286221|12098292|FG002|COMPLETED|Overall Study||31
10929326|NCT00286221|12098293|FG003|COMPLETED|Overall Study||34
10929327|NCT00286221|12098290|FG000|NOT COMPLETED|Overall Study||10
10929328|NCT00286221|12098291|FG001|NOT COMPLETED|Overall Study||5
10929329|NCT00286221|12098292|FG002|NOT COMPLETED|Overall Study||9
10929330|NCT00286221|12098293|FG003|NOT COMPLETED|Overall Study||6
10929331|NCT00286234|12098307|FG000|STARTED|Overall Study||17
10929332|NCT00286234|12098308|FG001|STARTED|Overall Study||17
10929333|NCT00286234|12098309|FG002|STARTED|Overall Study||17
10929334|NCT00286234|12098310|FG003|STARTED|Overall Study||17
10929335|NCT00286234|12098307|FG000|COMPLETED|Overall Study||15
10929336|NCT00286234|12098308|FG001|COMPLETED|Overall Study||15
10929337|NCT00286234|12098309|FG002|COMPLETED|Overall Study||17
10929338|NCT00286234|12098310|FG003|COMPLETED|Overall Study||13
10929339|NCT00286234|12098307|FG000|NOT COMPLETED|Overall Study||2
10929340|NCT00286234|12098308|FG001|NOT COMPLETED|Overall Study||2
10929341|NCT00286234|12098309|FG002|NOT COMPLETED|Overall Study||0
10929342|NCT00286234|12098310|FG003|NOT COMPLETED|Overall Study||4
10929343|NCT00286325|12098320|FG000|STARTED|Overall Study||8
10929344|NCT00286325|12098320|FG000|COMPLETED|Overall Study||8
10929345|NCT00286325|12098320|FG000|NOT COMPLETED|Overall Study||0
10929346|NCT00286429|12098327|FG000|STARTED|Overall Study||130
10929347|NCT00286429|12098328|FG001|STARTED|Overall Study||131
10929348|NCT00286429|12098329|FG002|STARTED|Overall Study||129
10929349|NCT00286429|12098327|FG000|COMPLETED|Overall Study||55
10929350|NCT00286429|12098328|FG001|COMPLETED|Overall Study||83
10929351|NCT00286429|12098329|FG002|COMPLETED|Overall Study||77
10929352|NCT00286429|12098327|FG000|NOT COMPLETED|Overall Study||75
10929353|NCT00286429|12098328|FG001|NOT COMPLETED|Overall Study||48
10929354|NCT00286429|12098329|FG002|NOT COMPLETED|Overall Study||52
10929355|NCT00286442|12098340|FG000|STARTED|Overall Study||213
10929356|NCT00286442|12098341|FG001|STARTED|Overall Study||210
10929357|NCT00286442|12098342|FG002|STARTED|Overall Study||104
10929358|NCT00286442|12098340|FG000|COMPLETED|Overall Study||176
10929359|NCT00286442|12098341|FG001|COMPLETED|Overall Study||165
10929360|NCT00286442|12098342|FG002|COMPLETED|Overall Study||72
10929361|NCT00286442|12098340|FG000|NOT COMPLETED|Overall Study||37
10929362|NCT00286442|12098341|FG001|NOT COMPLETED|Overall Study||45
10929363|NCT00286442|12098342|FG002|NOT COMPLETED|Overall Study||32
10929364|NCT00286455|12098353|FG000|STARTED|Overall Study||65
10929365|NCT00286455|12098354|FG001|STARTED|Overall Study||133
10929366|NCT00286455|12098355|FG002|STARTED|Overall Study||131
10929367|NCT00286455|12098353|FG000|COMPLETED|Overall Study||40
10929368|NCT00286455|12098354|FG001|COMPLETED|Overall Study||105
10929369|NCT00286455|12098355|FG002|COMPLETED|Overall Study||107
10929370|NCT00286455|12098353|FG000|NOT COMPLETED|Overall Study||25
10929371|NCT00286455|12098354|FG001|NOT COMPLETED|Overall Study||28
10929372|NCT00286455|12098355|FG002|NOT COMPLETED|Overall Study||24
10929373|NCT00286468|12098366|FG000|STARTED|Overall Study||99
10929374|NCT00286468|12098367|FG001|STARTED|Overall Study||203
10929375|NCT00286468|12098368|FG002|STARTED|Overall Study||198
10929376|NCT00286468|12098366|FG000|COMPLETED|Overall Study||62
10929377|NCT00286468|12098367|FG001|COMPLETED|Overall Study||153
10929378|NCT00286468|12098368|FG002|COMPLETED|Overall Study||148
10929379|NCT00286468|12098366|FG000|NOT COMPLETED|Overall Study||37
10929380|NCT00286468|12098367|FG001|NOT COMPLETED|Overall Study||50
10929381|NCT00286468|12098368|FG002|NOT COMPLETED|Overall Study||50
10929382|NCT00286494|12098379|FG000|STARTED|Overall Study||97
10929383|NCT00286494|12098380|FG001|STARTED|Overall Study||197
10929384|NCT00286494|12098381|FG002|STARTED|Overall Study||199
10929385|NCT00286494|12098379|FG000|COMPLETED|Overall Study||71
10929386|NCT00286494|12098380|FG001|COMPLETED|Overall Study||153
10929387|NCT00286494|12098381|FG002|COMPLETED|Overall Study||160
10929388|NCT00286494|12098379|FG000|NOT COMPLETED|Overall Study||26
10929389|NCT00286494|12098380|FG001|NOT COMPLETED|Overall Study||44
10929390|NCT00286494|12098381|FG002|NOT COMPLETED|Overall Study||39
10929391|NCT00286728|12098391|FG000|STARTED|Overall Study||142
10929392|NCT00286728|12098392|FG001|STARTED|Overall Study||145
10929393|NCT00286728|12098391|FG000|COMPLETED|Overall Study||106
10929394|NCT00286728|12098392|FG001|COMPLETED|Overall Study||116
10929395|NCT00286728|12098391|FG000|NOT COMPLETED|Overall Study||36
10929396|NCT00286728|12098392|FG001|NOT COMPLETED|Overall Study||29
10929397|NCT00286741|12098400|FG000|STARTED|Overall Study||133
10929398|NCT00286741|12098401|FG001|STARTED|Overall Study||106
10929399|NCT00286741|12098400|FG000|COMPLETED|Overall Study||122
10929400|NCT00286741|12098401|FG001|COMPLETED|Overall Study||89
10929401|NCT00286741|12098400|FG000|NOT COMPLETED|Overall Study||11
10929402|NCT00286741|12098401|FG001|NOT COMPLETED|Overall Study||17
10929403|NCT00286754|12098413|FG000|STARTED|Overall Study||176
10929404|NCT00286754|12098414|FG001|STARTED|Overall Study||177
10929405|NCT00286754|12098415|FG002|STARTED|Overall Study||180
10929406|NCT00286754|12098413|FG000|COMPLETED|Overall Study||156
10929407|NCT00286754|12098414|FG001|COMPLETED|Overall Study||159
10929408|NCT00286754|12098415|FG002|COMPLETED|Overall Study||170
10929409|NCT00286754|12098413|FG000|NOT COMPLETED|Overall Study||20
10929410|NCT00286754|12098414|FG001|NOT COMPLETED|Overall Study||18
10929411|NCT00286754|12098415|FG002|NOT COMPLETED|Overall Study||10
10929412|NCT00286949|12098429|FG000|STARTED|Overall Study||12
10929413|NCT00286949|12098429|FG000|COMPLETED|Overall Study||12
10929414|NCT00286949|12098429|FG000|NOT COMPLETED|Overall Study||0
10929415|NCT00287053|12098437|FG000|STARTED|Overall Study||30
10929416|NCT00287053|12098438|FG001|STARTED|Overall Study||27
10929417|NCT00287053|12098437|FG000|COMPLETED|Overall Study||26
10929418|NCT00287053|12098438|FG001|COMPLETED|Overall Study||26
10929419|NCT00287053|12098437|FG000|NOT COMPLETED|Overall Study||4
10929420|NCT00287053|12098438|FG001|NOT COMPLETED|Overall Study||1
10929421|NCT00287079|12098446|FG000|STARTED|Overall Study||32
10929422|NCT00287079|12098447|FG001|STARTED|Overall Study||3
10929423|NCT00287079|12098446|FG000|COMPLETED|Overall Study||10
10929424|NCT00287079|12098447|FG001|COMPLETED|Overall Study||2
10929425|NCT00287079|12098446|FG000|NOT COMPLETED|Overall Study||22
10929426|NCT00287079|12098447|FG001|NOT COMPLETED|Overall Study||1
10929427|NCT00287118|12098453|FG000|STARTED|Overall Study||189
10929428|NCT00287118|12098453|FG000|COMPLETED|Overall Study||137
10929429|NCT00287118|12098453|FG000|NOT COMPLETED|Overall Study||52
10929430|NCT00287222|12098457|FG000|STARTED|Overall Study||21
10929431|NCT00287222|12098457|FG000|COMPLETED|Overall Study||21
10929432|NCT00287222|12098457|FG000|NOT COMPLETED|Overall Study||0
10929433|NCT00287287|12098461|FG000|STARTED|Overall Study||25
10929434|NCT00287287|12098461|FG000|COMPLETED|Overall Study||25
10929435|NCT00287287|12098461|FG000|NOT COMPLETED|Overall Study||0
10929436|NCT00287339|12098467|FG000|STARTED|Overall Study||22
10929437|NCT00287339|12098468|FG001|STARTED|Overall Study||18
10929438|NCT00287339|12098467|FG000|COMPLETED|Overall Study||22
10929439|NCT00287339|12098468|FG001|COMPLETED|Overall Study||18
10929440|NCT00287339|12098467|FG000|NOT COMPLETED|Overall Study||0
10929441|NCT00287339|12098468|FG001|NOT COMPLETED|Overall Study||0
10929442|NCT00287365|12098474|FG000|STARTED|Overall Study||25
10929443|NCT00287365|12098474|FG000|COMPLETED|Overall Study||12
10929444|NCT00287365|12098474|FG000|NOT COMPLETED|Overall Study||13
10929445|NCT00287469|12098481|FG000|STARTED|Overall Study||1000
10929446|NCT00287469|12098482|FG001|STARTED|Overall Study||1000
10929447|NCT00287469|12098481|FG000|COMPLETED|Overall Study||780
10929448|NCT00287469|12098482|FG001|COMPLETED|Overall Study||786
10929449|NCT00287469|12098481|FG000|NOT COMPLETED|Overall Study||220
10929450|NCT00287469|12098482|FG001|NOT COMPLETED|Overall Study||214
10929451|NCT00287586|12098492|FG000|STARTED|Overall Study||156
10929452|NCT00287586|12098493|FG001|STARTED|Overall Study||152
10929453|NCT00287586|12098492|FG000|Intent-to-treat: Received Study Drug|Overall Study||155
10929454|NCT00287586|12098493|FG001|Intent-to-treat: Received Study Drug|Overall Study||151
10929455|NCT00287586|12098492|FG000|COMPLETED|Overall Study||111
10929456|NCT00287586|12098493|FG001|COMPLETED|Overall Study||100
10929457|NCT00287586|12098492|FG000|NOT COMPLETED|Overall Study||45
10929458|NCT00287586|12098493|FG001|NOT COMPLETED|Overall Study||52
10929459|NCT00287690|12098501|FG000|STARTED|Overall Study||33
10929460|NCT00287690|12098502|FG001|STARTED|Overall Study||38
10929461|NCT00287690|12098501|FG000|COMPLETED|Overall Study||13
10929462|NCT00287690|12098502|FG001|COMPLETED|Overall Study||12
10929463|NCT00287690|12098501|FG000|NOT COMPLETED|Overall Study||20
10929464|NCT00287690|12098502|FG001|NOT COMPLETED|Overall Study||26
10929465|NCT00287716|12098511|FG000|STARTED|Overall Study||174
10929466|NCT00287716|12098512|FG001|STARTED|Overall Study||87
10929467|NCT00287716|12098513|FG002|STARTED|Overall Study||174
10929468|NCT00287716|12098511|FG000|COMPLETED|Overall Study||136
10929469|NCT00287716|12098512|FG001|COMPLETED|Overall Study||70
10929470|NCT00287716|12098513|FG002|COMPLETED|Overall Study||143
10929471|NCT00287716|12098511|FG000|NOT COMPLETED|Overall Study||38
10929472|NCT00287716|12098512|FG001|NOT COMPLETED|Overall Study||17
10929473|NCT00287716|12098513|FG002|NOT COMPLETED|Overall Study||31
10929474|NCT00287729|12098523|FG000|STARTED|Overall Study||171
10929475|NCT00287729|12098524|FG001|STARTED|Overall Study||173
10929476|NCT00287729|12098523|FG000|COMPLETED|Overall Study||137
10929477|NCT00287729|12098524|FG001|COMPLETED|Overall Study||142
10929478|NCT00287729|12098523|FG000|NOT COMPLETED|Overall Study||34
10929479|NCT00287729|12098524|FG001|NOT COMPLETED|Overall Study||31
10929480|NCT00287872|12098530|FG000|STARTED|Overall Study||30
10929481|NCT00287872|12098530|FG000|COMPLETED|Overall Study||30
10929482|NCT00287872|12098530|FG000|NOT COMPLETED|Overall Study||0
10929483|NCT00287989|12098538|FG000|STARTED|Overall Study||28
10929484|NCT00287989|12098539|FG001|STARTED|Overall Study||29
10929485|NCT00287989|12098540|FG002|STARTED|Overall Study||29
10929486|NCT00287989|12098538|FG000|COMPLETED|Overall Study||28
10929487|NCT00287989|12098539|FG001|COMPLETED|Overall Study||29
10929488|NCT00287989|12098540|FG002|COMPLETED|Overall Study||29
10929489|NCT00287989|12098538|FG000|NOT COMPLETED|Overall Study||0
10929490|NCT00287989|12098539|FG001|NOT COMPLETED|Overall Study||0
10929491|NCT00287989|12098540|FG002|NOT COMPLETED|Overall Study||0
10929492|NCT00288015|12098548|FG000|STARTED|Registered to Study||32
10929493|NCT00288015|12098548|FG000|COMPLETED|Registered to Study||32
10929494|NCT00288015|12098548|FG000|NOT COMPLETED|Registered to Study||0
10929495|NCT00288015|12098548|FG000|STARTED|Bevacizumab Treatment Cycles 1-2||32
10929496|NCT00288015|12098548|FG000|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
10929497|NCT00288015|12098548|FG000|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
10929498|NCT00288015|12098548|FG000|STARTED|First Response Assessment||30
10929499|NCT00288015|12098548|FG000|COMPLETED|First Response Assessment||26
10929500|NCT00288015|12098548|FG000|NOT COMPLETED|First Response Assessment||4
10929501|NCT00288015|12098548|FG000|STARTED|Continued Bevacizumab Cycle 3+||26
10929502|NCT00288015|12098548|FG000|COMPLETED|Continued Bevacizumab Cycle 3+||19
10929503|NCT00288015|12098548|FG000|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
10929504|NCT00288015|12098548|FG000|STARTED|Follow up for Survival x 2 Years||29
10929505|NCT00288015|12098548|FG000|COMPLETED|Follow up for Survival x 2 Years||3
10929506|NCT00288015|12098548|FG000|NOT COMPLETED|Follow up for Survival x 2 Years||26
10929507|NCT00288054|12098552|FG000|STARTED|Overall Study||24
10929508|NCT00288054|12098552|FG000|COMPLETED|Overall Study||0
10929509|NCT00288054|12098552|FG000|NOT COMPLETED|Overall Study||24
10929510|NCT00288067|12098558|FG000|STARTED|Overall Study||32
10929511|NCT00288067|12098558|FG000|COMPLETED|Overall Study||32
10929512|NCT00288067|12098558|FG000|NOT COMPLETED|Overall Study||0
10929513|NCT00288366|12098566|FG000|STARTED|Overall Study||23
10929514|NCT00288366|12098567|FG001|STARTED|Overall Study||26
10929515|NCT00288366|12098566|FG000|COMPLETED|Overall Study||23
10929516|NCT00288366|12098567|FG001|COMPLETED|Overall Study||26
10929517|NCT00288366|12098566|FG000|NOT COMPLETED|Overall Study||0
10929518|NCT00288366|12098567|FG001|NOT COMPLETED|Overall Study||0
10929519|NCT00288574|12098575|FG000|STARTED|Overall Study||49
10929520|NCT00288574|12098576|FG001|STARTED|Overall Study||44
10929521|NCT00288574|12098575|FG000|COMPLETED|Overall Study||49
10929522|NCT00288574|12098576|FG001|COMPLETED|Overall Study||44
10929523|NCT00288574|12098575|FG000|NOT COMPLETED|Overall Study||0
10929524|NCT00288574|12098576|FG001|NOT COMPLETED|Overall Study||0
10929525|NCT00288587|12098587|FG000|STARTED|Overall Study||19
10929526|NCT00288587|12098588|FG001|STARTED|Overall Study||17
10929527|NCT00288587|12098587|FG000|COMPLETED|Overall Study||14
10929528|NCT00288587|12098588|FG001|COMPLETED|Overall Study||7
10929529|NCT00288587|12098587|FG000|NOT COMPLETED|Overall Study||5
10929530|NCT00288587|12098588|FG001|NOT COMPLETED|Overall Study||10
10929531|NCT00288600|12098596|FG000|STARTED|Overall Study||46
10929532|NCT00288600|12098597|FG001|STARTED|Overall Study||46
10929533|NCT00288600|12098596|FG000|COMPLETED|Overall Study||46
10929534|NCT00288600|12098597|FG001|COMPLETED|Overall Study||46
10929535|NCT00288600|12098596|FG000|NOT COMPLETED|Overall Study||0
10929536|NCT00288600|12098597|FG001|NOT COMPLETED|Overall Study||0
10929537|NCT00288626|12098603|FG000|STARTED|Overall Study||24
10929538|NCT00288626|12098603|FG000|COMPLETED|Overall Study||17
10929539|NCT00288626|12098603|FG000|NOT COMPLETED|Overall Study||7
10929540|NCT00288639|12098609|FG000|STARTED|Overall Study||98
10929541|NCT00288639|12098609|FG000|COMPLETED|Overall Study||86
10929542|NCT00288639|12098609|FG000|NOT COMPLETED|Overall Study||12
10929543|NCT00288704|12098616|FG000|STARTED|Part A, Double Blind, Weeks 1-6||24
10929544|NCT00288704|12098617|FG001|STARTED|Part A, Double Blind, Weeks 1-6||23
10929545|NCT00288704|12098618|FG002|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
10929546|NCT00288704|12098616|FG000|COMPLETED|Part A, Double Blind, Weeks 1-6||24
10929547|NCT00288704|12098617|FG001|COMPLETED|Part A, Double Blind, Weeks 1-6||22
10929548|NCT00288704|12098618|FG002|COMPLETED|Part A, Double Blind, Weeks 1-6||0
10929549|NCT00288704|12098616|FG000|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
10929550|NCT00288704|12098617|FG001|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
10929551|NCT00288704|12098618|FG002|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
10929552|NCT00288704|12098616|FG000|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
10929553|NCT00288704|12098617|FG001|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
10929554|NCT00288704|12098618|FG002|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
10929555|NCT00288704|12098616|FG000|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
10929556|NCT00288704|12098617|FG001|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
10929557|NCT00288704|12098618|FG002|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
10929558|NCT00288704|12098616|FG000|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
10929559|NCT00288704|12098617|FG001|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
10929560|NCT00288704|12098618|FG002|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
10929561|NCT00288704|12098616|FG000|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
10929562|NCT00288704|12098617|FG001|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
10929563|NCT00288704|12098618|FG002|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
10929564|NCT00288704|12098616|FG000|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
10929565|NCT00288704|12098617|FG001|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
10929566|NCT00288704|12098618|FG002|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
10929567|NCT00288704|12098616|FG000|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
10929568|NCT00288704|12098617|FG001|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
10929569|NCT00288704|12098618|FG002|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
10929570|NCT00288860|12098627|FG000|STARTED|Overall Study||412
10929571|NCT00288860|12098628|FG001|STARTED|Overall Study||425
10929572|NCT00288860|12098627|FG000|Completed Intake Survey|Overall Study||408
10929573|NCT00288860|12098628|FG001|Completed Intake Survey|Overall Study||417
10929574|NCT00288860|12098627|FG000|Completed 4 Month fu Survey|Overall Study||275
10929575|NCT00288860|12098628|FG001|Completed 4 Month fu Survey|Overall Study||299
10929576|NCT00288860|12098627|FG000|Completed 12 Month fu Survey|Overall Study||257
10929577|NCT00288860|12098628|FG001|Completed 12 Month fu Survey|Overall Study||281
10929578|NCT00288860|12098627|FG000|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
10929579|NCT00288860|12098628|FG001|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
10929580|NCT00288860|12098627|FG000|NOT COMPLETED|Overall Study||102
10929581|NCT00288860|12098628|FG001|NOT COMPLETED|Overall Study||97
10929582|NCT00288886|12098639|FG000|STARTED|Overall Study||91
10929583|NCT00288886|12098640|FG001|STARTED|Overall Study||92
10929584|NCT00288886|12098639|FG000|3-month Follow Up|Overall Study||82
10929585|NCT00288886|12098640|FG001|3-month Follow Up|Overall Study||85
10929586|NCT00288886|12098639|FG000|6-month Follow Up|Overall Study||85
10929587|NCT00288886|12098640|FG001|6-month Follow Up|Overall Study||84
10929588|NCT00288886|12098639|FG000|12-month Follow Up|Overall Study||80
10929589|NCT00288886|12098640|FG001|12-month Follow Up|Overall Study||81
10929590|NCT00288886|12098639|FG000|COMPLETED|Overall Study||80
10929591|NCT00288886|12098640|FG001|COMPLETED|Overall Study||81
10929592|NCT00288886|12098639|FG000|NOT COMPLETED|Overall Study||11
10929593|NCT00288886|12098640|FG001|NOT COMPLETED|Overall Study||11
10929594|NCT00288912|12098649|FG000|STARTED|Overall Study||175
10929595|NCT00288912|12098650|FG001|STARTED|Overall Study||174
10929596|NCT00288912|12098651|FG002|STARTED|Overall Study||174
10929597|NCT00288912|12098649|FG000|COMPLETED|Overall Study||158
10929598|NCT00288912|12098650|FG001|COMPLETED|Overall Study||157
10929599|NCT00288912|12098651|FG002|COMPLETED|Overall Study||146
10929600|NCT00288912|12098649|FG000|NOT COMPLETED|Overall Study||17
10929601|NCT00288912|12098650|FG001|NOT COMPLETED|Overall Study||17
10929602|NCT00288912|12098651|FG002|NOT COMPLETED|Overall Study||28
10929603|NCT00289016|12098659|FG000|STARTED|Overall Study||50
10929604|NCT00289016|12098659|FG000|COMPLETED|Overall Study||13
10929605|NCT00289016|12098659|FG000|NOT COMPLETED|Overall Study||37
10929606|NCT00289107|12098665|FG000|STARTED|Overall Study||77
10929607|NCT00289107|12098666|FG001|STARTED|Overall Study||72
10929608|NCT00289107|12098665|FG000|COMPLETED|Overall Study||24
10929609|NCT00289107|12098666|FG001|COMPLETED|Overall Study||28
10929610|NCT00289107|12098665|FG000|NOT COMPLETED|Overall Study||53
10929611|NCT00289107|12098666|FG001|NOT COMPLETED|Overall Study||44
10929612|NCT00289120|12098672|FG000|STARTED|Overall Study||13
10929613|NCT00289120|12098672|FG000|COMPLETED|Overall Study||13
10929614|NCT00289120|12098672|FG000|NOT COMPLETED|Overall Study||0
10929615|NCT00289133|12098682|FG000|STARTED|Overall Study||461
10929616|NCT00289133|12098683|FG001|STARTED|Overall Study||477
10929617|NCT00289133|12098682|FG000|COMPLETED|Overall Study||189
10929618|NCT00289133|12098683|FG001|COMPLETED|Overall Study||179
10929619|NCT00289133|12098682|FG000|NOT COMPLETED|Overall Study||272
10929620|NCT00289133|12098683|FG001|NOT COMPLETED|Overall Study||298
10929621|NCT00289185|12098695|FG000|STARTED|Overall Study||170
10929622|NCT00289185|12098696|FG001|STARTED|Overall Study||170
10929623|NCT00289185|12098695|FG000|COMPLETED|Overall Study||142
10929624|NCT00289185|12098696|FG001|COMPLETED|Overall Study||144
10929625|NCT00289185|12098695|FG000|NOT COMPLETED|Overall Study||28
10929626|NCT00289185|12098696|FG001|NOT COMPLETED|Overall Study||26
10929627|NCT00289198|12098705|FG000|STARTED|Overall Study||151
10929628|NCT00289198|12098706|FG001|STARTED|Overall Study||151
10929629|NCT00289198|12098705|FG000|COMPLETED|Overall Study||120
10929630|NCT00289198|12098706|FG001|COMPLETED|Overall Study||121
10929631|NCT00289198|12098705|FG000|NOT COMPLETED|Overall Study||31
10929632|NCT00289198|12098706|FG001|NOT COMPLETED|Overall Study||30
10929633|NCT00289211|12098716|FG000|STARTED|Overall Study||36
10929634|NCT00289211|12098717|FG001|STARTED|Overall Study||35
10929635|NCT00289211|12098718|FG002|STARTED|Overall Study||12
10929636|NCT00289211|12098716|FG000|COMPLETED|Overall Study||36
10929637|NCT00289211|12098717|FG001|COMPLETED|Overall Study||34
10929638|NCT00289211|12098718|FG002|COMPLETED|Overall Study||2
10929639|NCT00289211|12098716|FG000|NOT COMPLETED|Overall Study||0
10929640|NCT00289211|12098717|FG001|NOT COMPLETED|Overall Study||1
10929641|NCT00289211|12098718|FG002|NOT COMPLETED|Overall Study||10
10929642|NCT00289276|12098726|FG000|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
10929643|NCT00289276|12098727|FG001|STARTED|First Part of FAST Study (Pivotal)||0
10929644|NCT00289276|12098726|FG000|COMPLETED|First Part of FAST Study (Pivotal)||47
10929645|NCT00289276|12098727|FG001|COMPLETED|First Part of FAST Study (Pivotal)||0
10929646|NCT00289276|12098726|FG000|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
10929647|NCT00289276|12098727|FG001|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
10929648|NCT00289276|12098726|FG000|STARTED|Second Part of FAST Study (Expansion)||0
10929649|NCT00289276|12098727|FG001|STARTED|Second Part of FAST Study (Expansion)||109
10929650|NCT00289276|12098726|FG000|COMPLETED|Second Part of FAST Study (Expansion)||0
10929651|NCT00289276|12098727|FG001|COMPLETED|Second Part of FAST Study (Expansion)||106
10929652|NCT00289276|12098726|FG000|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
10929653|NCT00289276|12098727|FG001|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
10929654|NCT00289289|12098736|FG000|STARTED|Overall Study||132
10929655|NCT00289289|12098737|FG001|STARTED|Overall Study||124
10929656|NCT00289289|12098738|FG002|STARTED|Overall Study||144
10929657|NCT00289289|12098736|FG000|COMPLETED|Overall Study||113
10929658|NCT00289289|12098737|FG001|COMPLETED|Overall Study||114
10929659|NCT00289289|12098738|FG002|COMPLETED|Overall Study||95
10929660|NCT00289289|12098736|FG000|NOT COMPLETED|Overall Study||19
10929661|NCT00289289|12098737|FG001|NOT COMPLETED|Overall Study||10
10929662|NCT00289289|12098738|FG002|NOT COMPLETED|Overall Study||49
10929663|NCT00289315|12098748|FG000|STARTED|Overall Study||713
10929664|NCT00289315|12098749|FG001|STARTED|Overall Study||760
10929665|NCT00289315|12098750|FG002|STARTED|Overall Study||587
10929666|NCT00289315|12098748|FG000|COMPLETED|Overall Study||612
10929667|NCT00289315|12098749|FG001|COMPLETED|Overall Study||638
10929668|NCT00289315|12098750|FG002|COMPLETED|Overall Study||447
10929669|NCT00289315|12098748|FG000|NOT COMPLETED|Overall Study||101
10929670|NCT00289315|12098749|FG001|NOT COMPLETED|Overall Study||122
10929671|NCT00289315|12098750|FG002|NOT COMPLETED|Overall Study||140
10929672|NCT00289341|12098760|FG000|STARTED|Overall Study||12
10929673|NCT00289341|12098761|FG001|STARTED|Overall Study||12
10929674|NCT00289341|12098760|FG000|COMPLETED|Overall Study||12
10929675|NCT00289341|12098761|FG001|COMPLETED|Overall Study||12
10929676|NCT00289341|12098760|FG000|NOT COMPLETED|Overall Study||0
10929677|NCT00289341|12098761|FG001|NOT COMPLETED|Overall Study||0
10929678|NCT00289458|12098774|FG000|STARTED|Overall Study||25
10929679|NCT00289458|12098775|FG001|STARTED|Overall Study||26
10929680|NCT00289458|12098776|FG002|STARTED|Overall Study||28
10929681|NCT00289458|12098774|FG000|COMPLETED|Overall Study||19
10929682|NCT00289458|12098775|FG001|COMPLETED|Overall Study||20
10929683|NCT00289458|12098776|FG002|COMPLETED|Overall Study||22
10929684|NCT00289458|12098774|FG000|NOT COMPLETED|Overall Study||6
10929685|NCT00289458|12098775|FG001|NOT COMPLETED|Overall Study||6
10929686|NCT00289458|12098776|FG002|NOT COMPLETED|Overall Study||6
10929687|NCT00289471|12098784|FG000|STARTED|Overall Study||630
10929688|NCT00289471|12098784|FG000|COMPLETED|Overall Study||630
10929689|NCT00289471|12098784|FG000|NOT COMPLETED|Overall Study||0
10929690|NCT00289536|12098788|FG000|STARTED|Period 1||9
10929691|NCT00289536|12098789|FG001|STARTED|Period 1||8
10929692|NCT00289536|12098790|FG002|STARTED|Period 1||9
10929693|NCT00289536|12098788|FG000|COMPLETED|Period 1||9
10929694|NCT00289536|12098789|FG001|COMPLETED|Period 1||8
10929695|NCT00289536|12098790|FG002|COMPLETED|Period 1||9
10929696|NCT00289536|12098788|FG000|NOT COMPLETED|Period 1||0
10929697|NCT00289536|12098789|FG001|NOT COMPLETED|Period 1||0
10929698|NCT00289536|12098790|FG002|NOT COMPLETED|Period 1||0
10929699|NCT00289536|12098788|FG000|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
10929700|NCT00289536|12098789|FG001|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
10929701|NCT00289536|12098790|FG002|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
10929702|NCT00289536|12098788|FG000|COMPLETED|Period 2||10
10929703|NCT00289536|12098789|FG001|COMPLETED|Period 2||9
10929704|NCT00289536|12098790|FG002|COMPLETED|Period 2||7
10929705|NCT00289536|12098788|FG000|NOT COMPLETED|Period 2||0
10929706|NCT00289536|12098789|FG001|NOT COMPLETED|Period 2||0
10929707|NCT00289536|12098790|FG002|NOT COMPLETED|Period 2||0
10929708|NCT00289536|12098788|FG000|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
10929709|NCT00289536|12098789|FG001|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
10929710|NCT00289536|12098790|FG002|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
10929711|NCT00289536|12098788|FG000|COMPLETED|Period 3||7
10929712|NCT00289536|12098789|FG001|COMPLETED|Period 3||9
10929713|NCT00289536|12098790|FG002|COMPLETED|Period 3||9
10929714|NCT00289536|12098788|FG000|NOT COMPLETED|Period 3||0
10929715|NCT00289536|12098789|FG001|NOT COMPLETED|Period 3||0
10929716|NCT00289536|12098790|FG002|NOT COMPLETED|Period 3||1
10929717|NCT00289653|12098796|FG000|STARTED|Overall Study||23
10929718|NCT00289653|12098796|FG000|COMPLETED|Overall Study||12
10929719|NCT00289653|12098796|FG000|NOT COMPLETED|Overall Study||11
10929720|NCT00289718|12098801|FG000|STARTED|Overall Study||51
10929721|NCT00289718|12098801|FG000|COMPLETED|Overall Study||51
10929722|NCT00289718|12098801|FG000|NOT COMPLETED|Overall Study||0
10929723|NCT00289731|12098813|FG000|STARTED|Overall Study||199
10929724|NCT00289731|12098814|FG001|STARTED|Overall Study||200
10929725|NCT00289731|12098815|FG002|STARTED|Overall Study||197
10929726|NCT00289731|12098813|FG000|COMPLETED|Overall Study||197
10929727|NCT00289731|12098814|FG001|COMPLETED|Overall Study||198
10929728|NCT00289731|12098815|FG002|COMPLETED|Overall Study||195
10929729|NCT00289731|12098813|FG000|NOT COMPLETED|Overall Study||2
10929730|NCT00289731|12098814|FG001|NOT COMPLETED|Overall Study||2
10929731|NCT00289731|12098815|FG002|NOT COMPLETED|Overall Study||2
10929732|NCT00289744|12098825|FG000|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
10929733|NCT00289744|12098826|FG001|STARTED|Year 6 Long-term Follow-up||0
10929734|NCT00289744|12098827|FG002|STARTED|Year 6 Long-term Follow-up||0
10929735|NCT00289744|12098825|FG000|COMPLETED|Year 6 Long-term Follow-up||178
10929736|NCT00289744|12098826|FG001|COMPLETED|Year 6 Long-term Follow-up||0
10929737|NCT00289744|12098827|FG002|COMPLETED|Year 6 Long-term Follow-up||0
10929738|NCT00289744|12098825|FG000|NOT COMPLETED|Year 6 Long-term Follow-up||0
10929739|NCT00289744|12098826|FG001|NOT COMPLETED|Year 6 Long-term Follow-up||0
10929740|NCT00289744|12098827|FG002|NOT COMPLETED|Year 6 Long-term Follow-up||0
10929741|NCT00289744|12098825|FG000|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
10929742|NCT00289744|12098826|FG001|STARTED|Year 7 Long-term Follow-up||0
10929743|NCT00289744|12098827|FG002|STARTED|Year 7 Long-term Follow-up||0
10929744|NCT00289744|12098825|FG000|COMPLETED|Year 7 Long-term Follow-up||175
10929745|NCT00289744|12098826|FG001|COMPLETED|Year 7 Long-term Follow-up||0
10929746|NCT00289744|12098827|FG002|COMPLETED|Year 7 Long-term Follow-up||0
10929747|NCT00289744|12098825|FG000|NOT COMPLETED|Year 7 Long-term Follow-up||0
10929748|NCT00289744|12098826|FG001|NOT COMPLETED|Year 7 Long-term Follow-up||0
10929749|NCT00289744|12098827|FG002|NOT COMPLETED|Year 7 Long-term Follow-up||0
10929750|NCT00289744|12098825|FG000|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
10929751|NCT00289744|12098826|FG001|STARTED|Year 8 Long-term Follow-up||0
10929752|NCT00289744|12098827|FG002|STARTED|Year 8 Long-term Follow-up||0
10929753|NCT00289744|12098825|FG000|COMPLETED|Year 8 Long-term Follow-up||174
10929754|NCT00289744|12098826|FG001|COMPLETED|Year 8 Long-term Follow-up||0
10929755|NCT00289744|12098827|FG002|COMPLETED|Year 8 Long-term Follow-up||0
10929756|NCT00289744|12098825|FG000|NOT COMPLETED|Year 8 Long-term Follow-up||0
10929757|NCT00289744|12098826|FG001|NOT COMPLETED|Year 8 Long-term Follow-up||0
10929758|NCT00289744|12098827|FG002|NOT COMPLETED|Year 8 Long-term Follow-up||0
10929759|NCT00289744|12098825|FG000|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
10929760|NCT00289744|12098826|FG001|STARTED|Year 9 Long-term Follow-up||0
10929761|NCT00289744|12098827|FG002|STARTED|Year 9 Long-term Follow-up||0
10929762|NCT00289744|12098825|FG000|COMPLETED|Year 9 Long-term Follow-up||173
10929763|NCT00289744|12098826|FG001|COMPLETED|Year 9 Long-term Follow-up||0
10929764|NCT00289744|12098827|FG002|COMPLETED|Year 9 Long-term Follow-up||0
10929765|NCT00289744|12098825|FG000|NOT COMPLETED|Year 9 Long-term Follow-up||0
10929766|NCT00289744|12098826|FG001|NOT COMPLETED|Year 9 Long-term Follow-up||0
10929767|NCT00289744|12098827|FG002|NOT COMPLETED|Year 9 Long-term Follow-up||0
10929768|NCT00289744|12098825|FG000|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
10929769|NCT00289744|12098826|FG001|STARTED|Year 10 Long-term Follow-up||0
10929770|NCT00289744|12098827|FG002|STARTED|Year 10 Long-term Follow-up||0
10929771|NCT00289744|12098825|FG000|COMPLETED|Year 10 Long-term Follow-up||171
10929772|NCT00289744|12098826|FG001|COMPLETED|Year 10 Long-term Follow-up||0
10929773|NCT00289744|12098827|FG002|COMPLETED|Year 10 Long-term Follow-up||0
10929774|NCT00289744|12098825|FG000|NOT COMPLETED|Year 10 Long-term Follow-up||0
10929775|NCT00289744|12098826|FG001|NOT COMPLETED|Year 10 Long-term Follow-up||0
10929776|NCT00289744|12098827|FG002|NOT COMPLETED|Year 10 Long-term Follow-up||0
10929777|NCT00289744|12098825|FG000|STARTED|Additional Dose Phase||0
10929778|NCT00289744|12098826|FG001|STARTED|Additional Dose Phase||19
10929779|NCT00289744|12098827|FG002|STARTED|Additional Dose Phase||6
10929780|NCT00289744|12098825|FG000|COMPLETED|Additional Dose Phase||0
10929781|NCT00289744|12098826|FG001|COMPLETED|Additional Dose Phase||19
10929782|NCT00289744|12098827|FG002|COMPLETED|Additional Dose Phase||6
10929783|NCT00289744|12098825|FG000|NOT COMPLETED|Additional Dose Phase||0
10929784|NCT00289744|12098826|FG001|NOT COMPLETED|Additional Dose Phase||0
10929785|NCT00289744|12098827|FG002|NOT COMPLETED|Additional Dose Phase||0
10929786|NCT00289757|12098835|FG000|STARTED|Overall Study||78
10929787|NCT00289757|12098835|FG000|COMPLETED|Overall Study||78
10929788|NCT00289757|12098835|FG000|NOT COMPLETED|Overall Study||0
10929789|NCT00289770|12098839|FG000|STARTED|Year 11||37
10929790|NCT00289770|12098839|FG000|COMPLETED|Year 11||37
10929791|NCT00289770|12098839|FG000|NOT COMPLETED|Year 11||0
10929792|NCT00289770|12098839|FG000|STARTED|Year 12||40
10929793|NCT00289770|12098839|FG000|COMPLETED|Year 12||40
10929794|NCT00289770|12098839|FG000|NOT COMPLETED|Year 12||0
10929795|NCT00289770|12098839|FG000|STARTED|Year 13||37
10929796|NCT00289770|12098839|FG000|COMPLETED|Year 13||37
10929797|NCT00289770|12098839|FG000|NOT COMPLETED|Year 13||0
10929798|NCT00289770|12098839|FG000|STARTED|Year 14||43
10929799|NCT00289770|12098839|FG000|COMPLETED|Year 14||43
10929800|NCT00289770|12098839|FG000|NOT COMPLETED|Year 14||0
10929801|NCT00289770|12098839|FG000|STARTED|Year 15||50
10929802|NCT00289770|12098839|FG000|COMPLETED|Year 15||49
10929803|NCT00289770|12098839|FG000|NOT COMPLETED|Year 15||1
10929804|NCT00289783|12098845|FG000|STARTED|Primary Phase||3136
10929805|NCT00289783|12098846|FG001|STARTED|Primary Phase||1044
10929806|NCT00289783|12098845|FG000|COMPLETED|Primary Phase||2888
10929807|NCT00289783|12098846|FG001|COMPLETED|Primary Phase||961
10929808|NCT00289783|12098845|FG000|NOT COMPLETED|Primary Phase||248
10929809|NCT00289783|12098846|FG001|NOT COMPLETED|Primary Phase||83
10929810|NCT00289783|12098845|FG000|STARTED|Fourth Dose Phase||2769
10929811|NCT00289783|12098846|FG001|STARTED|Fourth Dose Phase||923
10929812|NCT00289783|12098845|FG000|COMPLETED|Fourth Dose Phase||2682
10929813|NCT00289783|12098846|FG001|COMPLETED|Fourth Dose Phase||899
10929814|NCT00289783|12098845|FG000|NOT COMPLETED|Fourth Dose Phase||87
10929815|NCT00289783|12098846|FG001|NOT COMPLETED|Fourth Dose Phase||24
10929816|NCT00289848|12098862|FG000|STARTED|Overall Study||352
10929817|NCT00289848|12098863|FG001|STARTED|Overall Study||178
10929818|NCT00289848|12098862|FG000|COMPLETED|Overall Study||306
10929819|NCT00289848|12098863|FG001|COMPLETED|Overall Study||133
10929820|NCT00289848|12098862|FG000|NOT COMPLETED|Overall Study||46
10929821|NCT00289848|12098863|FG001|NOT COMPLETED|Overall Study||45
10929822|NCT00289900|12098875|FG000|STARTED|Overall Study||297
10929823|NCT00289900|12098876|FG001|STARTED|Overall Study||436
10929824|NCT00289900|12098877|FG002|STARTED|Overall Study||298
10929825|NCT00289900|12098878|FG003|STARTED|Overall Study||439
10929826|NCT00289900|12098879|FG004|STARTED|Overall Study||437
10929827|NCT00289900|12098880|FG005|STARTED|Overall Study||433
10929828|NCT00289900|12098875|FG000|Treated|Overall Study||297
10929829|NCT00289900|12098876|FG001|Treated|Overall Study||435
10929830|NCT00289900|12098877|FG002|Treated|Overall Study||298
10929831|NCT00289900|12098878|FG003|Treated|Overall Study||439
10929832|NCT00289900|12098879|FG004|Treated|Overall Study||437
10929833|NCT00289900|12098880|FG005|Treated|Overall Study||433
10929834|NCT00289900|12098875|FG000|COMPLETED|Overall Study||229
10929835|NCT00289900|12098876|FG001|COMPLETED|Overall Study||316
10929836|NCT00289900|12098877|FG002|COMPLETED|Overall Study||265
10929837|NCT00289900|12098878|FG003|COMPLETED|Overall Study||380
10929838|NCT00289900|12098879|FG004|COMPLETED|Overall Study||392
10929839|NCT00289900|12098880|FG005|COMPLETED|Overall Study||372
10929840|NCT00289900|12098875|FG000|NOT COMPLETED|Overall Study||68
10929841|NCT00289900|12098876|FG001|NOT COMPLETED|Overall Study||120
10929842|NCT00289900|12098877|FG002|NOT COMPLETED|Overall Study||33
10929843|NCT00289900|12098878|FG003|NOT COMPLETED|Overall Study||59
10929844|NCT00289900|12098879|FG004|NOT COMPLETED|Overall Study||45
10929845|NCT00289900|12098880|FG005|NOT COMPLETED|Overall Study||61
10929846|NCT00289913|12098902|FG000|STARTED|Visit 1 (Stage I and Stage II)||155
10929847|NCT00289913|12098903|FG001|STARTED|Visit 1 (Stage I and Stage II)||151
10929848|NCT00289913|12098904|FG002|STARTED|Visit 1 (Stage I and Stage II)||159
10929849|NCT00289913|12098905|FG003|STARTED|Visit 1 (Stage I and Stage II)||152
10929850|NCT00289913|12098906|FG004|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
10929851|NCT00289913|12098902|FG000|COMPLETED|Visit 1 (Stage I and Stage II)||146
10929852|NCT00289913|12098903|FG001|COMPLETED|Visit 1 (Stage I and Stage II)||135
10929853|NCT00289913|12098904|FG002|COMPLETED|Visit 1 (Stage I and Stage II)||150
10929854|NCT00289913|12098905|FG003|COMPLETED|Visit 1 (Stage I and Stage II)||141
10929855|NCT00289913|12098906|FG004|COMPLETED|Visit 1 (Stage I and Stage II)||645
10929856|NCT00289913|12098902|FG000|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
10929857|NCT00289913|12098903|FG001|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
10929858|NCT00289913|12098904|FG002|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
10929859|NCT00289913|12098905|FG003|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
10929860|NCT00289913|12098906|FG004|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
10929861|NCT00289913|12098902|FG000|STARTED|Visit 2 (Stage I and Stage II)||146
10929862|NCT00289913|12098903|FG001|STARTED|Visit 2 (Stage I and Stage II)||135
10929863|NCT00289913|12098904|FG002|STARTED|Visit 2 (Stage I and Stage II)||150
10929864|NCT00289913|12098905|FG003|STARTED|Visit 2 (Stage I and Stage II)||141
10929865|NCT00289913|12098906|FG004|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
10929866|NCT00289913|12098902|FG000|COMPLETED|Visit 2 (Stage I and Stage II)||131
10929867|NCT00289913|12098903|FG001|COMPLETED|Visit 2 (Stage I and Stage II)||114
10929868|NCT00289913|12098904|FG002|COMPLETED|Visit 2 (Stage I and Stage II)||140
10929869|NCT00289913|12098905|FG003|COMPLETED|Visit 2 (Stage I and Stage II)||135
10929870|NCT00289913|12098906|FG004|COMPLETED|Visit 2 (Stage I and Stage II)||605
10929871|NCT00289913|12098902|FG000|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
10929872|NCT00289913|12098903|FG001|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
10929873|NCT00289913|12098904|FG002|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
10929874|NCT00289913|12098905|FG003|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
10929875|NCT00289913|12098906|FG004|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
10929876|NCT00289913|12098902|FG000|STARTED|Visit 3 (Stage I and Stage II)||131
10929877|NCT00289913|12098903|FG001|STARTED|Visit 3 (Stage I and Stage II)||114
10929878|NCT00289913|12098904|FG002|STARTED|Visit 3 (Stage I and Stage II)||140
10929879|NCT00289913|12098905|FG003|STARTED|Visit 3 (Stage I and Stage II)||135
10929880|NCT00289913|12098906|FG004|STARTED|Visit 3 (Stage I and Stage II)||605
10929881|NCT00289913|12098902|FG000|COMPLETED|Visit 3 (Stage I and Stage II)||122
10929882|NCT00289913|12098903|FG001|COMPLETED|Visit 3 (Stage I and Stage II)||106
10929883|NCT00289913|12098904|FG002|COMPLETED|Visit 3 (Stage I and Stage II)||138
10929884|NCT00289913|12098905|FG003|COMPLETED|Visit 3 (Stage I and Stage II)||131
10929885|NCT00289913|12098906|FG004|COMPLETED|Visit 3 (Stage I and Stage II)||597
10929886|NCT00289913|12098902|FG000|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
10929887|NCT00289913|12098903|FG001|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
10929888|NCT00289913|12098904|FG002|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
10929889|NCT00289913|12098905|FG003|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
10929890|NCT00289913|12098906|FG004|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
10929891|NCT00289913|12098902|FG000|STARTED|Visit 4 (Stage I and Stage II)||122
10929892|NCT00289913|12098903|FG001|STARTED|Visit 4 (Stage I and Stage II)||106
10929893|NCT00289913|12098904|FG002|STARTED|Visit 4 (Stage I and Stage II)||138
10929894|NCT00289913|12098905|FG003|STARTED|Visit 4 (Stage I and Stage II)||131
10929895|NCT00289913|12098906|FG004|STARTED|Visit 4 (Stage I and Stage II)||597
10929896|NCT00289913|12098902|FG000|COMPLETED|Visit 4 (Stage I and Stage II)||122
10929897|NCT00289913|12098903|FG001|COMPLETED|Visit 4 (Stage I and Stage II)||106
10929898|NCT00289913|12098904|FG002|COMPLETED|Visit 4 (Stage I and Stage II)||138
10929899|NCT00289913|12098905|FG003|COMPLETED|Visit 4 (Stage I and Stage II)||131
10929900|NCT00289913|12098906|FG004|COMPLETED|Visit 4 (Stage I and Stage II)||597
10929901|NCT00289913|12098902|FG000|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
10929902|NCT00289913|12098903|FG001|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
10929903|NCT00289913|12098904|FG002|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
10929904|NCT00289913|12098905|FG003|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
10929905|NCT00289913|12098906|FG004|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
10929906|NCT00289978|12098924|FG000|STARTED|Overall Study||429
10929907|NCT00289978|12098925|FG001|STARTED|Overall Study||425
10929908|NCT00289978|12098926|FG002|STARTED|Overall Study||418
10929909|NCT00289978|12098924|FG000|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
10929910|NCT00289978|12098925|FG001|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
10929911|NCT00289978|12098926|FG002|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
10929912|NCT00289978|12098924|FG000|NOT COMPLETED|Overall Study||97
10929913|NCT00289978|12098925|FG001|NOT COMPLETED|Overall Study||56
10929914|NCT00289978|12098926|FG002|NOT COMPLETED|Overall Study||86
10929915|NCT00289991|12098936|FG000|STARTED|Overall Study||234
10929916|NCT00289991|12098937|FG001|STARTED|Overall Study||255
10929917|NCT00289991|12098936|FG000|COMPLETED|Overall Study||176
10929918|NCT00289991|12098937|FG001|COMPLETED|Overall Study||175
10929919|NCT00289991|12098936|FG000|NOT COMPLETED|Overall Study||58
10929920|NCT00289991|12098937|FG001|NOT COMPLETED|Overall Study||80
10929921|NCT00290147|12098945|FG000|STARTED|Overall Study||10
10929922|NCT00290147|12098946|FG001|STARTED|Overall Study||12
10929923|NCT00290147|12098945|FG000|COMPLETED|Overall Study||10
10929924|NCT00290147|12098946|FG001|COMPLETED|Overall Study||12
10929925|NCT00290147|12098945|FG000|NOT COMPLETED|Overall Study||0
10929926|NCT00290147|12098946|FG001|NOT COMPLETED|Overall Study||0
10929927|NCT00290186|12098954|FG000|STARTED|Overall Study||25
10929928|NCT00290186|12098955|FG001|STARTED|Overall Study||24
10929929|NCT00290186|12098954|FG000|Completed Baseline Assessments|Overall Study||25
10929930|NCT00290186|12098955|FG001|Completed Baseline Assessments|Overall Study||24
10929931|NCT00290186|12098954|FG000|Completed 8 Weeks of Treatment|Overall Study||24
10929932|NCT00290186|12098955|FG001|Completed 8 Weeks of Treatment|Overall Study||22
10929933|NCT00290186|12098954|FG000|Completed Post-treatment Assessments|Overall Study||24
10929934|NCT00290186|12098955|FG001|Completed Post-treatment Assessments|Overall Study||22
10929935|NCT00290186|12098954|FG000|Completed 3-month Followup Assessments|Overall Study||20
10929936|NCT00290186|12098955|FG001|Completed 3-month Followup Assessments|Overall Study||21
10929937|NCT00290186|12098954|FG000|Completed 6-month Followup Assessments|Overall Study||20
10929938|NCT00290186|12098955|FG001|Completed 6-month Followup Assessments|Overall Study||19
10929939|NCT00290186|12098954|FG000|COMPLETED|Overall Study||20
10929940|NCT00290186|12098955|FG001|COMPLETED|Overall Study||19
10929941|NCT00290186|12098954|FG000|NOT COMPLETED|Overall Study||5
10929942|NCT00290186|12098955|FG001|NOT COMPLETED|Overall Study||5
10929943|NCT00290199|12098965|FG000|STARTED|Overall Study||87
10929944|NCT00290199|12098966|FG001|STARTED|Overall Study||82
10929945|NCT00290199|12098965|FG000|COMPLETED|Overall Study||87
10929946|NCT00290199|12098966|FG001|COMPLETED|Overall Study||82
10929947|NCT00290199|12098965|FG000|NOT COMPLETED|Overall Study||0
10929948|NCT00290199|12098966|FG001|NOT COMPLETED|Overall Study||0
10929949|NCT00290238|12098976|FG000|STARTED|Overall Study||57
10929950|NCT00290238|12098977|FG001|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
10929951|NCT00290238|12098976|FG000|COMPLETED|Overall Study||15
10929952|NCT00290238|12098977|FG001|COMPLETED|Overall Study||24
10929953|NCT00290238|12098976|FG000|NOT COMPLETED|Overall Study||42
10929954|NCT00290238|12098977|FG001|NOT COMPLETED|Overall Study||41
10929955|NCT00290290|12098985|FG000|STARTED|Overall Study||440
10929956|NCT00290290|12098986|FG001|STARTED|Overall Study||409
10929957|NCT00290290|12098985|FG000|COMPLETED|Overall Study||422
10929958|NCT00290290|12098986|FG001|COMPLETED|Overall Study||391
10929959|NCT00290290|12098985|FG000|NOT COMPLETED|Overall Study||18
10929960|NCT00290290|12098986|FG001|NOT COMPLETED|Overall Study||18
10929961|NCT00290329|12098995|FG000|STARTED|Overall Study||102
10929962|NCT00290329|12098996|FG001|STARTED|Overall Study||86
10929963|NCT00290329|12098997|FG002|STARTED|Overall Study||61
10929964|NCT00290329|12098995|FG000|COMPLETED|Overall Study||102
10929965|NCT00290329|12098996|FG001|COMPLETED|Overall Study||86
10929966|NCT00290329|12098997|FG002|COMPLETED|Overall Study||61
10929967|NCT00290329|12098995|FG000|NOT COMPLETED|Overall Study||0
10929968|NCT00290329|12098996|FG001|NOT COMPLETED|Overall Study||0
10929969|NCT00290329|12098997|FG002|NOT COMPLETED|Overall Study||0
10929970|NCT00290342|12099009|FG000|STARTED|Overall Study||224
10929971|NCT00290342|12099010|FG001|STARTED|Overall Study||228
10929972|NCT00290342|12099009|FG000|COMPLETED|Overall Study||217
10929973|NCT00290342|12099010|FG001|COMPLETED|Overall Study||223
10929974|NCT00290342|12099009|FG000|NOT COMPLETED|Overall Study||7
10929975|NCT00290342|12099010|FG001|NOT COMPLETED|Overall Study||5
10929976|NCT00290355|12099018|FG000|STARTED|Overall Study||122
10929977|NCT00290355|12099019|FG001|STARTED|Overall Study||60
10929978|NCT00290355|12099018|FG000|COMPLETED|Overall Study||105
10929979|NCT00290355|12099019|FG001|COMPLETED|Overall Study||55
10929980|NCT00290355|12099018|FG000|NOT COMPLETED|Overall Study||17
10929981|NCT00290355|12099019|FG001|NOT COMPLETED|Overall Study||5
10929982|NCT00290433|12099025|FG000|STARTED|Overall Study||53
10929983|NCT00290433|12099025|FG000|COMPLETED|Overall Study||17
10929984|NCT00290433|12099025|FG000|NOT COMPLETED|Overall Study||36
10929985|NCT00290472|12099032|FG000|STARTED|Overall Study||32
10929986|NCT00290472|12099033|FG001|STARTED|Overall Study||39
10929987|NCT00290472|12099034|FG002|STARTED|Overall Study||18
10929988|NCT00290472|12099032|FG000|COMPLETED|Overall Study||32
10929989|NCT00290472|12099033|FG001|COMPLETED|Overall Study||39
10929990|NCT00290472|12099034|FG002|COMPLETED|Overall Study||18
10929991|NCT00290472|12099032|FG000|NOT COMPLETED|Overall Study||0
10929992|NCT00290472|12099033|FG001|NOT COMPLETED|Overall Study||0
10929993|NCT00290472|12099034|FG002|NOT COMPLETED|Overall Study||0
10929994|NCT00290498|12099042|FG000|STARTED|Overall Study||49
10929995|NCT00290498|12099043|FG001|STARTED|Overall Study||10
10929996|NCT00290498|12099042|FG000|COMPLETED|Overall Study||41
10929997|NCT00290498|12099043|FG001|COMPLETED|Overall Study||10
10929998|NCT00290498|12099042|FG000|NOT COMPLETED|Overall Study||8
10929999|NCT00290498|12099043|FG001|NOT COMPLETED|Overall Study||0
10930000|NCT00290537|12099050|FG000|STARTED|Overall Study||4
10930001|NCT00290537|12099051|FG001|STARTED|Overall Study||0
10930002|NCT00290537|12099050|FG000|COMPLETED|Overall Study||4
10930003|NCT00290537|12099051|FG001|COMPLETED|Overall Study||0
10930004|NCT00290537|12099050|FG000|NOT COMPLETED|Overall Study||0
10930005|NCT00290537|12099051|FG001|NOT COMPLETED|Overall Study||0
10930006|NCT00290589|12099058|FG000|STARTED|Overall Study||39
10930007|NCT00290589|12099059|FG001|STARTED|Overall Study||43
10930008|NCT00290589|12099058|FG000|COMPLETED|Overall Study||37
10930009|NCT00290589|12099059|FG001|COMPLETED|Overall Study||41
10930010|NCT00290589|12099058|FG000|NOT COMPLETED|Overall Study||2
10930011|NCT00290589|12099059|FG001|NOT COMPLETED|Overall Study||2
10930012|NCT00290615|12099065|FG000|STARTED|Overall Study||30
10930013|NCT00290615|12099065|FG000|COMPLETED|Overall Study||30
10930014|NCT00290615|12099065|FG000|NOT COMPLETED|Overall Study||0
10930015|NCT00290654|12099069|FG000|STARTED|Overall Study||41
10930016|NCT00290654|12099069|FG000|COMPLETED|Overall Study||41
10930017|NCT00290654|12099069|FG000|NOT COMPLETED|Overall Study||0
10930018|NCT00290693|12099073|FG000|STARTED|Overall Study||45
10930019|NCT00290693|12099073|FG000|COMPLETED|Overall Study||43
10930020|NCT00290693|12099073|FG000|NOT COMPLETED|Overall Study||2
10930021|NCT00290706|12099082|FG000|STARTED|Overall Study||5
10930022|NCT00290706|12099083|FG001|STARTED|Overall Study||6
10930023|NCT00290706|12099084|FG002|STARTED|Overall Study||7
10930024|NCT00290706|12099085|FG003|STARTED|Overall Study||14
10930025|NCT00290706|12099082|FG000|Attempted1st Cycle|Overall Study||5
10930026|NCT00290706|12099083|FG001|Attempted1st Cycle|Overall Study||6
10930027|NCT00290706|12099084|FG002|Attempted1st Cycle|Overall Study||7
10930028|NCT00290706|12099085|FG003|Attempted1st Cycle|Overall Study||14
10930029|NCT00290706|12099082|FG000|Reached 1st Response/Cycle 3|Overall Study||0
10930030|NCT00290706|12099083|FG001|Reached 1st Response/Cycle 3|Overall Study||0
10930031|NCT00290706|12099084|FG002|Reached 1st Response/Cycle 3|Overall Study||1
10930032|NCT00290706|12099085|FG003|Reached 1st Response/Cycle 3|Overall Study||2
10930033|NCT00290706|12099082|FG000|COMPLETED|Overall Study||0
10930034|NCT00290706|12099083|FG001|COMPLETED|Overall Study||0
10930035|NCT00290706|12099084|FG002|COMPLETED|Overall Study||1
10930036|NCT00290706|12099085|FG003|COMPLETED|Overall Study||2
10930037|NCT00290706|12099082|FG000|NOT COMPLETED|Overall Study||5
10930038|NCT00290706|12099083|FG001|NOT COMPLETED|Overall Study||6
10930039|NCT00290706|12099084|FG002|NOT COMPLETED|Overall Study||6
10930040|NCT00290706|12099085|FG003|NOT COMPLETED|Overall Study||12
10930041|NCT00290732|12099098|FG000|STARTED|Overall Study||3
10930042|NCT00290732|12099099|FG001|STARTED|Overall Study||4
10930043|NCT00290732|12099100|FG002|STARTED|Overall Study||4
10930044|NCT00290732|12099101|FG003|STARTED|Overall Study||6
10930045|NCT00290732|12099102|FG004|STARTED|Overall Study||3
10930046|NCT00290732|12099098|FG000|COMPLETED|Overall Study||3
10930047|NCT00290732|12099099|FG001|COMPLETED|Overall Study||3
10930048|NCT00290732|12099100|FG002|COMPLETED|Overall Study||3
10930049|NCT00290732|12099101|FG003|COMPLETED|Overall Study||6
10930050|NCT00290732|12099102|FG004|COMPLETED|Overall Study||3
10930051|NCT00290732|12099098|FG000|NOT COMPLETED|Overall Study||0
10930052|NCT00290732|12099099|FG001|NOT COMPLETED|Overall Study||1
10930053|NCT00290732|12099100|FG002|NOT COMPLETED|Overall Study||1
10930054|NCT00290732|12099101|FG003|NOT COMPLETED|Overall Study||0
10930055|NCT00290732|12099102|FG004|NOT COMPLETED|Overall Study||0
10930056|NCT00290745|12099115|FG000|STARTED|Overall Study||79
10930057|NCT00290745|12099115|FG000|COMPLETED|Overall Study||67
10930058|NCT00290745|12099115|FG000|NOT COMPLETED|Overall Study||12
10930059|NCT00290771|12099121|FG000|STARTED|Overall Study||131
10930060|NCT00290771|12099122|FG001|STARTED|Overall Study||100
10930061|NCT00290771|12099121|FG000|COMPLETED|Overall Study||4
10930062|NCT00290771|12099122|FG001|COMPLETED|Overall Study||3
10930063|NCT00290771|12099121|FG000|NOT COMPLETED|Overall Study||127
10930064|NCT00290771|12099122|FG001|NOT COMPLETED|Overall Study||97
10930065|NCT00290810|12099129|FG000|STARTED|Overall Study||12
10930066|NCT00290810|12099129|FG000|COMPLETED|Overall Study||12
10930067|NCT00290810|12099129|FG000|NOT COMPLETED|Overall Study||0
10930068|NCT00290888|12099135|FG000|STARTED|Overall Study||41
10930069|NCT00290888|12099136|FG001|STARTED|Overall Study||45
10930070|NCT00290888|12099135|FG000|COMPLETED|Overall Study||38
10930071|NCT00290888|12099136|FG001|COMPLETED|Overall Study||44
10930072|NCT00290888|12099135|FG000|NOT COMPLETED|Overall Study||3
10930073|NCT00290888|12099136|FG001|NOT COMPLETED|Overall Study||1
10930074|NCT00291018|12099146|FG000|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
10930075|NCT00291018|12099147|FG001|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
10930076|NCT00291018|12099148|FG002|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
10930077|NCT00291018|12099146|FG000|Evaluated at 24 Months|Overall Study||99
10930078|NCT00291018|12099147|FG001|Evaluated at 24 Months|Overall Study||92
10930079|NCT00291018|12099148|FG002|Evaluated at 24 Months|Overall Study||105
10930080|NCT00291018|12099146|FG000|COMPLETED|Overall Study|Evaluated at 84 Months|78
10930081|NCT00291018|12099147|FG001|COMPLETED|Overall Study|Evaluated at 84 Months|64
10930082|NCT00291018|12099148|FG002|COMPLETED|Overall Study|Evaluated at 84 Months|93
10930083|NCT00291018|12099146|FG000|NOT COMPLETED|Overall Study||25
10930084|NCT00291018|12099147|FG001|NOT COMPLETED|Overall Study||42
10930085|NCT00291018|12099148|FG002|NOT COMPLETED|Overall Study||43
10930086|NCT00291135|12099159|FG000|STARTED|Overall Study||42
10930087|NCT00291135|12099159|FG000|COMPLETED|Overall Study||42
10930088|NCT00291135|12099159|FG000|NOT COMPLETED|Overall Study||0
10930089|NCT00291161|12099167|FG000|STARTED|Overall Study||316
10930090|NCT00291161|12099168|FG001|STARTED|Overall Study||192
10930091|NCT00291161|12099169|FG002|STARTED|Overall Study||299
10930092|NCT00291161|12099170|FG003|STARTED|Overall Study||187
10930093|NCT00291161|12099167|FG000|COMPLETED|Overall Study||235
10930094|NCT00291161|12099168|FG001|COMPLETED|Overall Study||134
10930095|NCT00291161|12099169|FG002|COMPLETED|Overall Study||206
10930096|NCT00291161|12099170|FG003|COMPLETED|Overall Study||122
10930097|NCT00291161|12099167|FG000|NOT COMPLETED|Overall Study||81
10930098|NCT00291161|12099168|FG001|NOT COMPLETED|Overall Study||58
10930099|NCT00291161|12099169|FG002|NOT COMPLETED|Overall Study||93
10930100|NCT00291161|12099170|FG003|NOT COMPLETED|Overall Study||65
10930101|NCT00291187|12099182|FG000|STARTED|Overall Study||103
10930102|NCT00291187|12099183|FG001|STARTED|Overall Study||100
10930103|NCT00291187|12099184|FG002|STARTED|Overall Study||103
10930104|NCT00291187|12099185|FG003|STARTED|Overall Study||106
10930105|NCT00291187|12099182|FG000|COMPLETED|Overall Study||103
10930106|NCT00291187|12099183|FG001|COMPLETED|Overall Study||100
10930107|NCT00291187|12099184|FG002|COMPLETED|Overall Study||102
10930108|NCT00291187|12099185|FG003|COMPLETED|Overall Study||106
10930109|NCT00291187|12099182|FG000|NOT COMPLETED|Overall Study||0
10930110|NCT00291187|12099183|FG001|NOT COMPLETED|Overall Study||0
10930111|NCT00291187|12099184|FG002|NOT COMPLETED|Overall Study||1
10930112|NCT00291187|12099185|FG003|NOT COMPLETED|Overall Study||0
10930113|NCT00291226|12099201|FG000|STARTED|Overall Study||4
10930114|NCT00291226|12099202|FG001|STARTED|Overall Study||4
10930115|NCT00291226|12099201|FG000|COMPLETED|Overall Study||3
10930116|NCT00291226|12099202|FG001|COMPLETED|Overall Study||3
10930117|NCT00291226|12099201|FG000|NOT COMPLETED|Overall Study||1
10930118|NCT00291226|12099202|FG001|NOT COMPLETED|Overall Study||1
10930119|NCT00291317|12099208|FG000|STARTED|Overall Study||6
10930120|NCT00291317|12099208|FG000|COMPLETED|Overall Study||6
10930121|NCT00291317|12099208|FG000|NOT COMPLETED|Overall Study||0
10930122|NCT00291330|12099215|FG000|STARTED|Overall Study|Started Treatment|1273
10930123|NCT00291330|12099216|FG001|STARTED|Overall Study|Started Treatment|1266
10930124|NCT00291330|12099215|FG000|COMPLETED|Overall Study|Completed planned observation time|1172
10930125|NCT00291330|12099216|FG001|COMPLETED|Overall Study|Completed planned observation time|1169
10930126|NCT00291330|12099215|FG000|NOT COMPLETED|Overall Study||101
10930127|NCT00291330|12099216|FG001|NOT COMPLETED|Overall Study||97
10930128|NCT00291343|12099224|FG000|STARTED|Overall Study||203
10930129|NCT00291343|12099225|FG001|STARTED|Overall Study||93
10930130|NCT00291343|12099224|FG000|COMPLETED|Overall Study||203
10930131|NCT00291343|12099225|FG001|COMPLETED|Overall Study||93
10930132|NCT00291343|12099224|FG000|NOT COMPLETED|Overall Study||0
10930133|NCT00291343|12099225|FG001|NOT COMPLETED|Overall Study||0
10930134|NCT00291447|12099235|FG000|STARTED|Overall Study||2
10930135|NCT00291447|12099236|FG001|STARTED|Overall Study||2
10930136|NCT00291447|12099237|FG002|STARTED|Overall Study||2
10930137|NCT00291447|12099238|FG003|STARTED|Overall Study||2
10930138|NCT00291447|12099235|FG000|COMPLETED|Overall Study||2
10930139|NCT00291447|12099236|FG001|COMPLETED|Overall Study||2
10930140|NCT00291447|12099237|FG002|COMPLETED|Overall Study||2
10930141|NCT00291447|12099238|FG003|COMPLETED|Overall Study||2
10930142|NCT00291447|12099235|FG000|NOT COMPLETED|Overall Study||0
10930143|NCT00291447|12099236|FG001|NOT COMPLETED|Overall Study||0
10930144|NCT00291447|12099237|FG002|NOT COMPLETED|Overall Study||0
10930145|NCT00291447|12099238|FG003|NOT COMPLETED|Overall Study||0
10930146|NCT00291499|12099251|FG000|STARTED|Overall Study||81
10930147|NCT00291499|12099252|FG001|STARTED|Overall Study||82
10930148|NCT00291499|12099251|FG000|Intention to Treat (ITT)|Overall Study||80
10930149|NCT00291499|12099252|FG001|Intention to Treat (ITT)|Overall Study||82
10930150|NCT00291499|12099251|FG000|Per Protocol (PP)|Overall Study||72
10930151|NCT00291499|12099252|FG001|Per Protocol (PP)|Overall Study||67
10930152|NCT00291499|12099251|FG000|Safety Population|Overall Study||81
10930153|NCT00291499|12099252|FG001|Safety Population|Overall Study||82
10930154|NCT00291499|12099251|FG000|COMPLETED|Overall Study||72
10930155|NCT00291499|12099252|FG001|COMPLETED|Overall Study||67
10930156|NCT00291499|12099251|FG000|NOT COMPLETED|Overall Study||9
10930157|NCT00291499|12099252|FG001|NOT COMPLETED|Overall Study||15
10930158|NCT00291551|12099258|FG000|STARTED|Overall Study||39
10930159|NCT00291551|12099258|FG000|COMPLETED|Overall Study||26
10930160|NCT00291551|12099258|FG000|NOT COMPLETED|Overall Study||13
10930161|NCT00291577|12099263|FG000|STARTED|Overall Study||22
10930162|NCT00291577|12099263|FG000|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
10930163|NCT00291577|12099263|FG000|NOT COMPLETED|Overall Study||21
10930164|NCT00291642|12099272|FG000|STARTED|Overall Study||78
10930165|NCT00291642|12099273|FG001|STARTED|Overall Study||116
10930166|NCT00291642|12099274|FG002|STARTED|Overall Study||119
10930167|NCT00291642|12099275|FG003|STARTED|Overall Study||119
10930168|NCT00291642|12099276|FG004|STARTED|Overall Study||119
10930169|NCT00291642|12099272|FG000|COMPLETED|Overall Study||76
10930170|NCT00291642|12099273|FG001|COMPLETED|Overall Study||116
10930171|NCT00291642|12099274|FG002|COMPLETED|Overall Study||117
10930172|NCT00291642|12099275|FG003|COMPLETED|Overall Study||119
10930173|NCT00291642|12099276|FG004|COMPLETED|Overall Study||118
10930174|NCT00291642|12099272|FG000|NOT COMPLETED|Overall Study||2
10930175|NCT00291642|12099273|FG001|NOT COMPLETED|Overall Study||0
10930176|NCT00291642|12099274|FG002|NOT COMPLETED|Overall Study||2
10930177|NCT00291642|12099275|FG003|NOT COMPLETED|Overall Study||0
10930178|NCT00291642|12099276|FG004|NOT COMPLETED|Overall Study||1
10930179|NCT00291655|12099288|FG000|STARTED|Overall Study||130
10930180|NCT00291655|12099288|FG000|COMPLETED|Overall Study||115
10930181|NCT00291655|12099288|FG000|NOT COMPLETED|Overall Study||15
10930182|NCT00291668|12099295|FG000|STARTED|Overall Study||32
10930183|NCT00291668|12099296|FG001|STARTED|Overall Study||30
10930184|NCT00291668|12099297|FG002|STARTED|Overall Study||32
10930185|NCT00291668|12099295|FG000|COMPLETED|Overall Study||28
10930186|NCT00291668|12099296|FG001|COMPLETED|Overall Study||29
10930187|NCT00291668|12099297|FG002|COMPLETED|Overall Study||31
10930188|NCT00291668|12099295|FG000|NOT COMPLETED|Overall Study||4
10930189|NCT00291668|12099296|FG001|NOT COMPLETED|Overall Study||1
10930190|NCT00291668|12099297|FG002|NOT COMPLETED|Overall Study||1
10930191|NCT00291694|12099307|FG000|STARTED|Overall Study||24
10930192|NCT00291694|12099308|FG001|STARTED|Overall Study||48
10930193|NCT00291694|12099307|FG000|COMPLETED|Overall Study||21
10930194|NCT00291694|12099308|FG001|COMPLETED|Overall Study||43
10930195|NCT00291694|12099307|FG000|NOT COMPLETED|Overall Study||3
10930196|NCT00291694|12099308|FG001|NOT COMPLETED|Overall Study||5
10930197|NCT00291876|12099316|FG000|STARTED|Month 138||107
10930198|NCT00291876|12099316|FG000|COMPLETED|Month 138||107
10930199|NCT00291876|12099316|FG000|NOT COMPLETED|Month 138||0
10930200|NCT00291876|12099316|FG000|STARTED|Month 150||117
10930201|NCT00291876|12099316|FG000|COMPLETED|Month 150||117
10930202|NCT00291876|12099316|FG000|NOT COMPLETED|Month 150||0
10930203|NCT00291876|12099316|FG000|STARTED|Month 162||127
10930204|NCT00291876|12099316|FG000|COMPLETED|Month 162||127
10930205|NCT00291876|12099316|FG000|NOT COMPLETED|Month 162||0
10930206|NCT00291876|12099316|FG000|STARTED|Month 174||127
10930207|NCT00291876|12099316|FG000|COMPLETED|Month 174||127
10930208|NCT00291876|12099316|FG000|NOT COMPLETED|Month 174||0
10930209|NCT00291876|12099316|FG000|STARTED|Month 186||129
10930210|NCT00291876|12099316|FG000|COMPLETED|Month 186||129
10930211|NCT00291876|12099316|FG000|NOT COMPLETED|Month 186||0
10930212|NCT00291876|12099316|FG000|STARTED|Month 198||135
10930213|NCT00291876|12099316|FG000|COMPLETED|Month 198||135
10930214|NCT00291876|12099316|FG000|NOT COMPLETED|Month 198||0
10930215|NCT00291876|12099316|FG000|STARTED|Month 210||124
10930216|NCT00291876|12099316|FG000|COMPLETED|Month 210||124
10930217|NCT00291876|12099316|FG000|NOT COMPLETED|Month 210||0
10930218|NCT00291876|12099316|FG000|STARTED|Month 222||114
10930219|NCT00291876|12099316|FG000|COMPLETED|Month 222||114
10930220|NCT00291876|12099316|FG000|NOT COMPLETED|Month 222||0
10930221|NCT00291876|12099316|FG000|STARTED|Month 234||110
10930222|NCT00291876|12099316|FG000|COMPLETED|Month 234||110
10930223|NCT00291876|12099316|FG000|NOT COMPLETED|Month 234||0
10930224|NCT00291876|12099316|FG000|STARTED|Month 246||116
10930225|NCT00291876|12099316|FG000|COMPLETED|Month 246||116
10930226|NCT00291876|12099316|FG000|NOT COMPLETED|Month 246||0
10930227|NCT00292045|12099320|FG000|STARTED|Core Study (Through Week 13)||15
10930228|NCT00292045|12099320|FG000|COMPLETED|Core Study (Through Week 13)||13
10930229|NCT00292045|12099320|FG000|NOT COMPLETED|Core Study (Through Week 13)||2
10930230|NCT00292045|12099320|FG000|STARTED|Extended Treatment Beyond Week 13||10
10930231|NCT00292045|12099320|FG000|COMPLETED|Extended Treatment Beyond Week 13||10
10930232|NCT00292045|12099320|FG000|NOT COMPLETED|Extended Treatment Beyond Week 13||0
10930233|NCT00292162|12099326|FG000|STARTED|Overall Study||19
10930234|NCT00292162|12099327|FG001|STARTED|Overall Study||22
10930235|NCT00292162|12099326|FG000|COMPLETED|Overall Study||18
10930236|NCT00292162|12099327|FG001|COMPLETED|Overall Study||20
10930237|NCT00292162|12099326|FG000|NOT COMPLETED|Overall Study||1
10930238|NCT00292162|12099327|FG001|NOT COMPLETED|Overall Study||2
10930239|NCT00292188|12099335|FG000|STARTED|Single-Blind||368
10930240|NCT00292188|12099336|FG001|STARTED|Single-Blind||0
10930241|NCT00292188|12099337|FG002|STARTED|Single-Blind||0
10930242|NCT00292188|12099335|FG000|Received Treatment|Single-Blind||367
10930243|NCT00292188|12099336|FG001|Received Treatment|Single-Blind||0
10930244|NCT00292188|12099337|FG002|Received Treatment|Single-Blind||0
10930245|NCT00292188|12099335|FG000|COMPLETED|Single-Blind||254
10930246|NCT00292188|12099336|FG001|COMPLETED|Single-Blind||0
10930247|NCT00292188|12099337|FG002|COMPLETED|Single-Blind||0
10930248|NCT00292188|12099335|FG000|NOT COMPLETED|Single-Blind||114
10930249|NCT00292188|12099336|FG001|NOT COMPLETED|Single-Blind||0
10930250|NCT00292188|12099337|FG002|NOT COMPLETED|Single-Blind||0
10930251|NCT00292188|12099335|FG000|STARTED|Double-Blind||0
10930252|NCT00292188|12099336|FG001|STARTED|Double-Blind||127
10930253|NCT00292188|12099337|FG002|STARTED|Double-Blind||127
10930254|NCT00292188|12099335|FG000|COMPLETED|Double-Blind||0
10930255|NCT00292188|12099336|FG001|COMPLETED|Double-Blind||96
10930256|NCT00292188|12099337|FG002|COMPLETED|Double-Blind||98
10930257|NCT00292188|12099335|FG000|NOT COMPLETED|Double-Blind||0
10930258|NCT00292188|12099336|FG001|NOT COMPLETED|Double-Blind||31
10930259|NCT00292188|12099337|FG002|NOT COMPLETED|Double-Blind||29
10930260|NCT00292227|12099346|FG000|STARTED|Patch Period||66
10930261|NCT00292227|12099347|FG001|STARTED|Patch Period||31
10930262|NCT00292227|12099348|FG002|STARTED|Patch Period||33
10930263|NCT00292227|12099346|FG000|COMPLETED|Patch Period||65
10930264|NCT00292227|12099347|FG001|COMPLETED|Patch Period||31
10930265|NCT00292227|12099348|FG002|COMPLETED|Patch Period||30
10930266|NCT00292227|12099346|FG000|NOT COMPLETED|Patch Period||1
10930267|NCT00292227|12099347|FG001|NOT COMPLETED|Patch Period||0
10930268|NCT00292227|12099348|FG002|NOT COMPLETED|Patch Period||3
10930269|NCT00292227|12099346|FG000|STARTED|Cross-over Period 1 (Day 32)||65
10930270|NCT00292227|12099347|FG001|STARTED|Cross-over Period 1 (Day 32)||31
10930271|NCT00292227|12099348|FG002|STARTED|Cross-over Period 1 (Day 32)||30
10930272|NCT00292227|12099346|FG000|COMPLETED|Cross-over Period 1 (Day 32)||65
10930273|NCT00292227|12099347|FG001|COMPLETED|Cross-over Period 1 (Day 32)||31
10930274|NCT00292227|12099348|FG002|COMPLETED|Cross-over Period 1 (Day 32)||30
10930275|NCT00292227|12099346|FG000|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
10930276|NCT00292227|12099347|FG001|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
10930277|NCT00292227|12099348|FG002|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
10930278|NCT00292227|12099346|FG000|STARTED|Cross-over Period 2 (Day 39)||65
10930279|NCT00292227|12099347|FG001|STARTED|Cross-over Period 2 (Day 39)||31
10930280|NCT00292227|12099348|FG002|STARTED|Cross-over Period 2 (Day 39)||30
10930281|NCT00292227|12099346|FG000|COMPLETED|Cross-over Period 2 (Day 39)||65
10930282|NCT00292227|12099347|FG001|COMPLETED|Cross-over Period 2 (Day 39)||31
10930283|NCT00292227|12099348|FG002|COMPLETED|Cross-over Period 2 (Day 39)||30
10930284|NCT00292227|12099346|FG000|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
10930285|NCT00292227|12099347|FG001|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
10930286|NCT00292227|12099348|FG002|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
10930287|NCT00292318|12099358|FG000|STARTED|Overall Study||4
10930288|NCT00292318|12099359|FG001|STARTED|Overall Study||3
10930289|NCT00292318|12099358|FG000|COMPLETED|Overall Study||2
10930290|NCT00292318|12099359|FG001|COMPLETED|Overall Study||2
10930291|NCT00292318|12099358|FG000|NOT COMPLETED|Overall Study||2
10930292|NCT00292318|12099359|FG001|NOT COMPLETED|Overall Study||1
10930293|NCT00292370|12099368|FG000|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
10930294|NCT00292370|12099369|FG001|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
10930295|NCT00292370|12099370|FG002|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
10930296|NCT00292370|12099368|FG000|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
10930297|NCT00292370|12099369|FG001|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
10930298|NCT00292370|12099370|FG002|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
10930299|NCT00292370|12099368|FG000|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
10930300|NCT00292370|12099369|FG001|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
10930301|NCT00292370|12099370|FG002|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
10930302|NCT00292370|12099368|FG000|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
10930303|NCT00292370|12099369|FG001|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
10930304|NCT00292370|12099370|FG002|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
10930305|NCT00292370|12099368|FG000|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
10930306|NCT00292370|12099369|FG001|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
10930307|NCT00292370|12099370|FG002|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
10930308|NCT00292370|12099368|FG000|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
10930309|NCT00292370|12099369|FG001|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
10930310|NCT00292370|12099370|FG002|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
10930311|NCT00292461|12099379|FG000|STARTED|Overall Study||34
10930312|NCT00292461|12099380|FG001|STARTED|Overall Study||30
10930313|NCT00292461|12099379|FG000|COMPLETED|Overall Study||24
10930314|NCT00292461|12099380|FG001|COMPLETED|Overall Study||24
10930315|NCT00292461|12099379|FG000|NOT COMPLETED|Overall Study||10
10930316|NCT00292461|12099380|FG001|NOT COMPLETED|Overall Study||6
10930317|NCT00292591|12099389|FG000|STARTED|Overall Study||166
10930318|NCT00292591|12099390|FG001|STARTED|Overall Study||167
10930319|NCT00292591|12099391|FG002|STARTED|Overall Study||168
10930320|NCT00292591|12099389|FG000|COMPLETED|Overall Study||102
10930321|NCT00292591|12099390|FG001|COMPLETED|Overall Study||111
10930322|NCT00292591|12099391|FG002|COMPLETED|Overall Study||110
10930323|NCT00292591|12099389|FG000|NOT COMPLETED|Overall Study||64
10930324|NCT00292591|12099390|FG001|NOT COMPLETED|Overall Study||56
10930325|NCT00292591|12099391|FG002|NOT COMPLETED|Overall Study||58
10930326|NCT00292942|12099403|FG000|STARTED|Overall Study||6
10930327|NCT00292942|12099404|FG001|STARTED|Overall Study||6
10930328|NCT00292942|12099405|FG002|STARTED|Overall Study||7
10930329|NCT00292942|12099406|FG003|STARTED|Overall Study||7
10930330|NCT00292942|12099403|FG000|COMPLETED|Overall Study||6
10930331|NCT00292942|12099404|FG001|COMPLETED|Overall Study||6
10930332|NCT00292942|12099405|FG002|COMPLETED|Overall Study||6
10930333|NCT00292942|12099406|FG003|COMPLETED|Overall Study||6
10930334|NCT00292942|12099403|FG000|NOT COMPLETED|Overall Study||0
10930335|NCT00292942|12099404|FG001|NOT COMPLETED|Overall Study||0
10930336|NCT00292942|12099405|FG002|NOT COMPLETED|Overall Study||1
10930337|NCT00292942|12099406|FG003|NOT COMPLETED|Overall Study||1
10930338|NCT00292981|12099419|FG000|STARTED|Overall Study||57
10930339|NCT00292981|12099419|FG000|COMPLETED|Overall Study||18
10930340|NCT00292981|12099419|FG000|NOT COMPLETED|Overall Study||39
10930341|NCT00293020|12099423|FG000|STARTED|Overall Study||244
10930342|NCT00293020|12099423|FG000|COMPLETED|Overall Study||82
10930343|NCT00293020|12099423|FG000|NOT COMPLETED|Overall Study||162
10930344|NCT00293033|12099427|FG000|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151
10930345|NCT00293033|12099427|FG000|COMPLETED|Open-label Titration Period||82
10930346|NCT00293033|12099427|FG000|NOT COMPLETED|Open-label Titration Period||69
10930347|NCT00293033|12099427|FG000|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82
10930348|NCT00293033|12099427|FG000|COMPLETED|Double-blind Treatment Period||70
10930349|NCT00293033|12099427|FG000|NOT COMPLETED|Double-blind Treatment Period||12
10930350|NCT00293059|12099437|FG000|STARTED|Overall Study||120
10930351|NCT00293059|12099438|FG001|STARTED|Overall Study||70
10930352|NCT00293059|12099437|FG000|Subjects Received Treatment|Overall Study||119
10930353|NCT00293059|12099438|FG001|Subjects Received Treatment|Overall Study||66
10930354|NCT00293059|12099437|FG000|Cycle 1/Treatment Day 28|Overall Study||115
10930355|NCT00293059|12099438|FG001|Cycle 1/Treatment Day 28|Overall Study||64
10930356|NCT00293059|12099437|FG000|Cycle 3/Treatment Day 84|Overall Study||100
10930357|NCT00293059|12099438|FG001|Cycle 3/Treatment Day 84|Overall Study||55
10930358|NCT00293059|12099437|FG000|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
10930359|NCT00293059|12099438|FG001|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
10930360|NCT00293059|12099437|FG000|COMPLETED|Overall Study||85
10930361|NCT00293059|12099438|FG001|COMPLETED|Overall Study||51
10930362|NCT00293059|12099437|FG000|NOT COMPLETED|Overall Study||35
10930363|NCT00293059|12099438|FG001|NOT COMPLETED|Overall Study||19
10930364|NCT00293202|12099446|FG000|STARTED|Overall Study||5
10930365|NCT00293202|12099447|FG001|STARTED|Overall Study||5
10930366|NCT00293202|12099446|FG000|COMPLETED|Overall Study||2
10930367|NCT00293202|12099447|FG001|COMPLETED|Overall Study||3
10930368|NCT00293202|12099446|FG000|NOT COMPLETED|Overall Study||3
10930369|NCT00293202|12099447|FG001|NOT COMPLETED|Overall Study||2
10930370|NCT00293215|12099459|FG000|STARTED|Overall Study||6
10930371|NCT00293215|12099460|FG001|STARTED|Overall Study||3
10930372|NCT00293215|12099459|FG000|COMPLETED|Overall Study||1
10930373|NCT00293215|12099460|FG001|COMPLETED|Overall Study||0
10930374|NCT00293215|12099459|FG000|NOT COMPLETED|Overall Study||5
10930375|NCT00293215|12099460|FG001|NOT COMPLETED|Overall Study||3
10930376|NCT00293241|12099468|FG000|STARTED|Overall Study||299
10930377|NCT00293241|12099469|FG001|STARTED|Overall Study||306
10930378|NCT00293241|12099468|FG000|COMPLETED|Overall Study||263
10930379|NCT00293241|12099469|FG001|COMPLETED|Overall Study||265
10930380|NCT00293241|12099468|FG000|NOT COMPLETED|Overall Study||36
10930381|NCT00293241|12099469|FG001|NOT COMPLETED|Overall Study||41
10930382|NCT00293254|12099480|FG000|STARTED|Primary Study - Double-Blind Week 0-48||232
10930383|NCT00293254|12099481|FG001|STARTED|Primary Study - Double-Blind Week 0-48||119
10930384|NCT00293254|12099480|FG000|Treated|Primary Study - Double-Blind Week 0-48||230
10930385|NCT00293254|12099481|FG001|Treated|Primary Study - Double-Blind Week 0-48||119
10930386|NCT00293254|12099480|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
10930387|NCT00293254|12099481|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
10930388|NCT00293254|12099480|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||177
10930389|NCT00293254|12099481|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||55
10930390|NCT00293254|12099480|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
10930391|NCT00293254|12099481|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
10930392|NCT00293254|12099480|FG000|STARTED|Extension - Double-Blind Week 49-156||177
10930393|NCT00293254|12099481|FG001|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
10930394|NCT00293254|12099480|FG000|COMPLETED|Extension - Double-Blind Week 49-156||120
10930395|NCT00293254|12099481|FG001|COMPLETED|Extension - Double-Blind Week 49-156||25
10930396|NCT00293254|12099480|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
10930397|NCT00293254|12099481|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
10930398|NCT00293254|12099480|FG000|STARTED|Extension - Open-Label Week 157-240||120
10930399|NCT00293254|12099481|FG001|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
10930400|NCT00293254|12099480|FG000|COMPLETED|Extension - Open-Label Week 157-240||110
10930401|NCT00293254|12099481|FG001|COMPLETED|Extension - Open-Label Week 157-240||18
10930402|NCT00293254|12099480|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||10
10930403|NCT00293254|12099481|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||1
10930404|NCT00293254|12099480|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
10930405|NCT00293254|12099481|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
10930406|NCT00293254|12099480|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||19
10930407|NCT00293254|12099481|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||37
10930408|NCT00293254|12099480|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
10930409|NCT00293254|12099481|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
10930410|NCT00293267|12099491|FG000|STARTED|Primary Study - Double-Blind Week 0-48||234
10930411|NCT00293267|12099492|FG001|STARTED|Primary Study - Double-Blind Week 0-48||118
10930412|NCT00293267|12099491|FG000|Treated|Primary Study - Double-Blind Week 0-48||232
10930413|NCT00293267|12099492|FG001|Treated|Primary Study - Double-Blind Week 0-48||118
10930414|NCT00293267|12099491|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
10930415|NCT00293267|12099492|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
10930416|NCT00293267|12099491|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||193
10930417|NCT00293267|12099492|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||50
10930418|NCT00293267|12099491|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
10930419|NCT00293267|12099492|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
10930420|NCT00293267|12099491|FG000|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
10930421|NCT00293267|12099492|FG001|STARTED|Extension - Double-Blind Week 49-156||50
10930422|NCT00293267|12099491|FG000|COMPLETED|Extension - Double-Blind Week 49-156||139
10930423|NCT00293267|12099492|FG001|COMPLETED|Extension - Double-Blind Week 49-156||35
10930424|NCT00293267|12099491|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
10930425|NCT00293267|12099492|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
10930426|NCT00293267|12099491|FG000|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
10930427|NCT00293267|12099492|FG001|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
10930428|NCT00293267|12099491|FG000|COMPLETED|Extension - Open-Label Week 157-240||111
10930429|NCT00293267|12099492|FG001|COMPLETED|Extension - Open-Label Week 157-240||26
10930430|NCT00293267|12099491|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||20
10930431|NCT00293267|12099492|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||2
10930432|NCT00293267|12099491|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
10930433|NCT00293267|12099492|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
10930434|NCT00293267|12099491|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||15
10930435|NCT00293267|12099492|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||29
10930436|NCT00293267|12099491|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
10930437|NCT00293267|12099492|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
10930438|NCT00293293|12099502|FG000|STARTED|Overall Study||20
10930439|NCT00293293|12099503|FG001|STARTED|Overall Study||23
10930440|NCT00293293|12099502|FG000|COMPLETED|Overall Study||18
10930441|NCT00293293|12099503|FG001|COMPLETED|Overall Study||21
10930442|NCT00293293|12099502|FG000|NOT COMPLETED|Overall Study||2
10930443|NCT00293293|12099503|FG001|NOT COMPLETED|Overall Study||2
10930444|NCT00293384|12099510|FG000|STARTED|Overall Study||40
10930445|NCT00293384|12099510|FG000|COMPLETED|Overall Study||35
10930446|NCT00293384|12099510|FG000|NOT COMPLETED|Overall Study||5
10930447|NCT00293397|12099514|FG000|STARTED|Overall Study||20
10930448|NCT00293397|12099514|FG000|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
10930449|NCT00293397|12099514|FG000|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
10930450|NCT00293397|12099514|FG000|NOT COMPLETED|Overall Study||2
10930451|NCT00293423|12099521|FG000|STARTED|Surgical Resection||28
10930452|NCT00293423|12099522|FG001|STARTED|Surgical Resection||68
10930453|NCT00293423|12099521|FG000|COMPLETED|Surgical Resection||12
10930454|NCT00293423|12099522|FG001|COMPLETED|Surgical Resection||41
10930455|NCT00293423|12099521|FG000|NOT COMPLETED|Surgical Resection||16
10930456|NCT00293423|12099522|FG001|NOT COMPLETED|Surgical Resection||27
10930457|NCT00293423|12099521|FG000|STARTED|Vaccination Treatment Period||12
10930458|NCT00293423|12099522|FG001|STARTED|Vaccination Treatment Period||41
10930459|NCT00293423|12099521|FG000|COMPLETED|Vaccination Treatment Period||12
10930460|NCT00293423|12099522|FG001|COMPLETED|Vaccination Treatment Period||38
10930461|NCT00293423|12099521|FG000|NOT COMPLETED|Vaccination Treatment Period||0
10930462|NCT00293423|12099522|FG001|NOT COMPLETED|Vaccination Treatment Period||3
10930463|NCT00293462|12099531|FG000|STARTED|Overall Study||31
10930464|NCT00293462|12099532|FG001|STARTED|Overall Study||29
10930465|NCT00293462|12099533|FG002|STARTED|Overall Study||31
10930466|NCT00293462|12099531|FG000|COMPLETED|Overall Study||24
10930467|NCT00293462|12099532|FG001|COMPLETED|Overall Study||21
10930468|NCT00293462|12099533|FG002|COMPLETED|Overall Study||19
10930469|NCT00293462|12099531|FG000|NOT COMPLETED|Overall Study||7
10930470|NCT00293462|12099532|FG001|NOT COMPLETED|Overall Study||8
10930471|NCT00293462|12099533|FG002|NOT COMPLETED|Overall Study||12
10930472|NCT00293540|12099543|FG000|STARTED|Overall Study||122
10930473|NCT00293540|12099544|FG001|STARTED|Overall Study||127
10930474|NCT00293540|12099543|FG000|COMPLETED|Overall Study||115
10930475|NCT00293540|12099544|FG001|COMPLETED|Overall Study||119
10930476|NCT00293540|12099543|FG000|NOT COMPLETED|Overall Study||7
10930477|NCT00293540|12099544|FG001|NOT COMPLETED|Overall Study||8
10930478|NCT00293579|12099550|FG000|STARTED|Overall Study||5
10930479|NCT00293579|12099550|FG000|COMPLETED|Overall Study||4
10930480|NCT00293579|12099550|FG000|NOT COMPLETED|Overall Study||1
10930481|NCT00293709|12099555|FG000|STARTED|Overall Study||149
10930482|NCT00293709|12099555|FG000|COMPLETED|Overall Study||102
10930483|NCT00293709|12099555|FG000|NOT COMPLETED|Overall Study||47
10930484|NCT00293722|12099559|FG000|STARTED|Overall Study||1291
10930485|NCT00293722|12099559|FG000|COMPLETED|Overall Study||864
10930486|NCT00293722|12099559|FG000|NOT COMPLETED|Overall Study||427
10930487|NCT00293813|12099566|FG000|STARTED|Overall Study||82
10930488|NCT00293813|12099567|FG001|STARTED|Overall Study||83
10930489|NCT00293813|12099568|FG002|STARTED|Overall Study||82
10930490|NCT00293813|12099566|FG000|COMPLETED|Overall Study||69
10930491|NCT00293813|12099567|FG001|COMPLETED|Overall Study||74
10930492|NCT00293813|12099568|FG002|COMPLETED|Overall Study||74
10930493|NCT00293813|12099566|FG000|NOT COMPLETED|Overall Study||13
10930494|NCT00293813|12099567|FG001|NOT COMPLETED|Overall Study||9
10930495|NCT00293813|12099568|FG002|NOT COMPLETED|Overall Study||8
10930496|NCT00294047|12099578|FG000|STARTED|Month 48||2881
10930497|NCT00294047|12099579|FG001|STARTED|Month 48||2871
10930498|NCT00294047|12099578|FG000|Participated up to Month 48|Month 48||2305
10930499|NCT00294047|12099579|FG001|Participated up to Month 48|Month 48||2281
10930500|NCT00294047|12099578|FG000|COMPLETED|Month 48||2456
10930501|NCT00294047|12099579|FG001|COMPLETED|Month 48||2438
10930502|NCT00294047|12099578|FG000|NOT COMPLETED|Month 48||425
10930503|NCT00294047|12099579|FG001|NOT COMPLETED|Month 48||433
10930504|NCT00294047|12099578|FG000|STARTED|Month 84||2877
10930505|NCT00294047|12099579|FG001|STARTED|Month 84||2870
10930506|NCT00294047|12099578|FG000|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
10930507|NCT00294047|12099579|FG001|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
10930508|NCT00294047|12099578|FG000|NOT COMPLETED|Month 84||973
10930509|NCT00294047|12099579|FG001|NOT COMPLETED|Month 84||989
10930510|NCT00294060|12099586|FG000|STARTED|Overall Study||2013
10930511|NCT00294060|12099586|FG000|COMPLETED|Overall Study||840
10930512|NCT00294060|12099586|FG000|NOT COMPLETED|Overall Study||1173
10930513|NCT00294398|12099592|FG000|STARTED|Overall Study||78
10930514|NCT00294398|12099593|FG001|STARTED|Overall Study||74
10930515|NCT00294398|12099592|FG000|COMPLETED|Overall Study||57
10930516|NCT00294398|12099593|FG001|COMPLETED|Overall Study||48
10930517|NCT00294398|12099592|FG000|NOT COMPLETED|Overall Study||21
10930518|NCT00294398|12099593|FG001|NOT COMPLETED|Overall Study||26
10930519|NCT00294515|12099601|FG000|STARTED|Overall Study|Randomized|166
10930520|NCT00294515|12099602|FG001|STARTED|Overall Study|Randomized|160
10930521|NCT00294515|12099601|FG000|COMPLETED|Overall Study||132
10930522|NCT00294515|12099602|FG001|COMPLETED|Overall Study||132
10930523|NCT00294515|12099601|FG000|NOT COMPLETED|Overall Study||34
10930524|NCT00294515|12099602|FG001|NOT COMPLETED|Overall Study||28
10930525|NCT00294554|12099610|FG000|STARTED|Overall Study||10
10930526|NCT00294554|12099611|FG001|STARTED|Overall Study||10
10930527|NCT00294554|12099610|FG000|COMPLETED|Overall Study||10
10930528|NCT00294554|12099611|FG001|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit~1 S withdrawn @ 13 wks b/o extreme agitation"|8
10930529|NCT00294554|12099610|FG000|NOT COMPLETED|Overall Study||0
10930530|NCT00294554|12099611|FG001|NOT COMPLETED|Overall Study||2
10930531|NCT00294632|12099619|FG000|STARTED|Phase I Dose Escalation Period||14
10930532|NCT00294632|12099620|FG001|STARTED|Phase I Dose Escalation Period||0
10930533|NCT00294632|12099619|FG000|Cohort 1: 10 mg|Phase I Dose Escalation Period||3
10930534|NCT00294632|12099620|FG001|Cohort 1: 10 mg|Phase I Dose Escalation Period||0
10930535|NCT00294632|12099619|FG000|Cohort 2: 15 mg|Phase I Dose Escalation Period||3
10930536|NCT00294632|12099620|FG001|Cohort 2: 15 mg|Phase I Dose Escalation Period||0
10930537|NCT00294632|12099619|FG000|Cohort 3: 20 mg|Phase I Dose Escalation Period||6
10930538|NCT00294632|12099620|FG001|Cohort 3: 20 mg|Phase I Dose Escalation Period||0
10930539|NCT00294632|12099619|FG000|Cohort 4: 25 mg|Phase I Dose Escalation Period||2
10930540|NCT00294632|12099620|FG001|Cohort 4: 25 mg|Phase I Dose Escalation Period||0
10930541|NCT00294632|12099619|FG000|COMPLETED|Phase I Dose Escalation Period||14
10930542|NCT00294632|12099620|FG001|COMPLETED|Phase I Dose Escalation Period||0
10930543|NCT00294632|12099619|FG000|NOT COMPLETED|Phase I Dose Escalation Period||0
10930544|NCT00294632|12099620|FG001|NOT COMPLETED|Phase I Dose Escalation Period||0
10930545|NCT00294632|12099619|FG000|STARTED|Phase II: 20 mg Lenalidomide||6
10930546|NCT00294632|12099620|FG001|STARTED|Phase II: 20 mg Lenalidomide||38
10930547|NCT00294632|12099619|FG000|COMPLETED|Phase II: 20 mg Lenalidomide||6
10930548|NCT00294632|12099620|FG001|COMPLETED|Phase II: 20 mg Lenalidomide||38
10930549|NCT00294632|12099619|FG000|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
10930550|NCT00294632|12099620|FG001|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
10930551|NCT00294645|12099629|FG000|STARTED|Overall Study||295
10930552|NCT00294645|12099630|FG001|STARTED|Overall Study||602
10930553|NCT00294645|12099629|FG000|COMPLETED|Overall Study||247
10930554|NCT00294645|12099630|FG001|COMPLETED|Overall Study||510
10930555|NCT00294645|12099629|FG000|NOT COMPLETED|Overall Study||48
10930556|NCT00294645|12099630|FG001|NOT COMPLETED|Overall Study||92
10930557|NCT00294658|12099638|FG000|STARTED|Overall Study||66
10930558|NCT00294658|12099639|FG001|STARTED|Overall Study||60
10930559|NCT00294658|12099638|FG000|COMPLETED|Overall Study||60
10930560|NCT00294658|12099639|FG001|COMPLETED|Overall Study||51
10930561|NCT00294658|12099638|FG000|NOT COMPLETED|Overall Study||6
10930562|NCT00294658|12099639|FG001|NOT COMPLETED|Overall Study||9
10930563|NCT00294671|12099647|FG000|STARTED|Overall Study||64
10930564|NCT00294671|12099648|FG001|STARTED|Overall Study||66
10930565|NCT00294671|12099647|FG000|COMPLETED|Overall Study||37
10930566|NCT00294671|12099648|FG001|COMPLETED|Overall Study||26
10930567|NCT00294671|12099647|FG000|NOT COMPLETED|Overall Study||27
10930568|NCT00294671|12099648|FG001|NOT COMPLETED|Overall Study||40
10930569|NCT00294684|12099656|FG000|STARTED|Overall Study||70
10930570|NCT00294684|12099657|FG001|STARTED|Overall Study||70
10930571|NCT00294684|12099656|FG000|COMPLETED|Overall Study||65
10930572|NCT00294684|12099657|FG001|COMPLETED|Overall Study||62
10930573|NCT00294684|12099656|FG000|NOT COMPLETED|Overall Study||5
10930574|NCT00294684|12099657|FG001|NOT COMPLETED|Overall Study||8
10930575|NCT00294723|12099666|FG000|STARTED|Double-Blind Period 52 Weeks|Randomised|247
10930576|NCT00294723|12099667|FG001|STARTED|Double-Blind Period 52 Weeks|Randomised|251
10930577|NCT00294723|12099668|FG002|STARTED|Double-Blind Period 52 Weeks|Randomised|248
10930578|NCT00294723|12099666|FG000|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
10930579|NCT00294723|12099667|FG001|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
10930580|NCT00294723|12099668|FG002|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
10930581|NCT00294723|12099666|FG000|COMPLETED|Double-Blind Period 52 Weeks||173
10930582|NCT00294723|12099667|FG001|COMPLETED|Double-Blind Period 52 Weeks||162
10930583|NCT00294723|12099668|FG002|COMPLETED|Double-Blind Period 52 Weeks||152
10930584|NCT00294723|12099666|FG000|NOT COMPLETED|Double-Blind Period 52 Weeks||74
10930585|NCT00294723|12099667|FG001|NOT COMPLETED|Double-Blind Period 52 Weeks||89
10930586|NCT00294723|12099668|FG002|NOT COMPLETED|Double-Blind Period 52 Weeks||96
10930587|NCT00294723|12099666|FG000|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
10930588|NCT00294723|12099667|FG001|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
10930589|NCT00294723|12099668|FG002|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
10930590|NCT00294723|12099666|FG000|COMPLETED|Open-Label Extension 52 Weeks||114
10930591|NCT00294723|12099667|FG001|COMPLETED|Open-Label Extension 52 Weeks||110
10930592|NCT00294723|12099668|FG002|COMPLETED|Open-Label Extension 52 Weeks||97
10930593|NCT00294723|12099666|FG000|NOT COMPLETED|Open-Label Extension 52 Weeks||40
10930594|NCT00294723|12099667|FG001|NOT COMPLETED|Open-Label Extension 52 Weeks||39
10930595|NCT00294723|12099668|FG002|NOT COMPLETED|Open-Label Extension 52 Weeks||40
10930596|NCT00294723|12099666|FG000|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
10930597|NCT00294723|12099667|FG001|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
10930598|NCT00294723|12099668|FG002|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
10930599|NCT00294723|12099666|FG000|COMPLETED|Additional Open-Label Extension 91 Weeks||34
10930600|NCT00294723|12099667|FG001|COMPLETED|Additional Open-Label Extension 91 Weeks||32
10930601|NCT00294723|12099668|FG002|COMPLETED|Additional Open-Label Extension 91 Weeks||8
10930602|NCT00294723|12099666|FG000|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
10930603|NCT00294723|12099667|FG001|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
10930604|NCT00294723|12099668|FG002|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
10930605|NCT00294762|12099681|FG000|STARTED|Overall Study||72
10930606|NCT00294762|12099682|FG001|STARTED|Overall Study||71
10930607|NCT00294762|12099681|FG000|COMPLETED|Overall Study||69
10930608|NCT00294762|12099682|FG001|COMPLETED|Overall Study||68
10930609|NCT00294762|12099681|FG000|NOT COMPLETED|Overall Study||3
10930610|NCT00294762|12099682|FG001|NOT COMPLETED|Overall Study||3
10930611|NCT00295009|12099694|FG000|STARTED|Overall Study||93
10930612|NCT00295009|12099695|FG001|STARTED|Overall Study||183
10930613|NCT00295009|12099696|FG002|STARTED|Overall Study||51
10930614|NCT00295009|12099697|FG003|STARTED|Overall Study||82
10930615|NCT00295009|12099698|FG004|STARTED|Overall Study||174
10930616|NCT00295009|12099699|FG005|STARTED|Overall Study||269
10930617|NCT00295009|12099694|FG000|Treated|Overall Study||80
10930618|NCT00295009|12099695|FG001|Treated|Overall Study||162
10930619|NCT00295009|12099696|FG002|Treated|Overall Study||50
10930620|NCT00295009|12099697|FG003|Treated|Overall Study||72
10930621|NCT00295009|12099698|FG004|Treated|Overall Study||165
10930622|NCT00295009|12099699|FG005|Treated|Overall Study||259
10930623|NCT00295009|12099694|FG000|Completed 24 Month Analysis|Overall Study||71
10930624|NCT00295009|12099695|FG001|Completed 24 Month Analysis|Overall Study||148
10930625|NCT00295009|12099696|FG002|Completed 24 Month Analysis|Overall Study||45
10930626|NCT00295009|12099697|FG003|Completed 24 Month Analysis|Overall Study||60
10930627|NCT00295009|12099698|FG004|Completed 24 Month Analysis|Overall Study||133
10930628|NCT00295009|12099699|FG005|Completed 24 Month Analysis|Overall Study||198
10930629|NCT00295009|12099694|FG000|COMPLETED|Overall Study|Completed 60 month visit|52
10930630|NCT00295009|12099695|FG001|COMPLETED|Overall Study|Completed 60 month visit|134
10930631|NCT00295009|12099696|FG002|COMPLETED|Overall Study|Completed 60 month visit|39
10930632|NCT00295009|12099697|FG003|COMPLETED|Overall Study|Completed 60 month visit|57
10930633|NCT00295009|12099698|FG004|COMPLETED|Overall Study|Completed 60 month visit|116
10930634|NCT00295009|12099699|FG005|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
10930635|NCT00295009|12099694|FG000|NOT COMPLETED|Overall Study||41
10930636|NCT00295009|12099695|FG001|NOT COMPLETED|Overall Study||49
10930637|NCT00295009|12099696|FG002|NOT COMPLETED|Overall Study||12
10930638|NCT00295009|12099697|FG003|NOT COMPLETED|Overall Study||25
10930639|NCT00295009|12099698|FG004|NOT COMPLETED|Overall Study||58
10930640|NCT00295009|12099699|FG005|NOT COMPLETED|Overall Study||269
10930641|NCT00295022|12099716|FG000|STARTED|Overall Study||105
10930642|NCT00295022|12099717|FG001|STARTED|Overall Study||157
10930643|NCT00295022|12099718|FG002|STARTED|Overall Study||156
10930644|NCT00295022|12099716|FG000|COMPLETED|Overall Study||104
10930645|NCT00295022|12099717|FG001|COMPLETED|Overall Study||156
10930646|NCT00295022|12099718|FG002|COMPLETED|Overall Study||151
10930647|NCT00295022|12099716|FG000|NOT COMPLETED|Overall Study||1
10930648|NCT00295022|12099717|FG001|NOT COMPLETED|Overall Study||1
10930649|NCT00295022|12099718|FG002|NOT COMPLETED|Overall Study||5
10930650|NCT00295061|12099730|FG000|STARTED|Overall Study||12
10930651|NCT00295061|12099731|FG001|STARTED|Overall Study||12
10930652|NCT00295061|12099730|FG000|COMPLETED|Overall Study||12
10930653|NCT00295061|12099731|FG001|COMPLETED|Overall Study||12
10930654|NCT00295061|12099730|FG000|NOT COMPLETED|Overall Study||0
10930655|NCT00295061|12099731|FG001|NOT COMPLETED|Overall Study||0
10930656|NCT00295503|12099737|FG000|STARTED|Overall Study||53
10930657|NCT00295503|12099737|FG000|COMPLETED|Overall Study||53
10930658|NCT00295503|12099737|FG000|NOT COMPLETED|Overall Study||0
10930659|NCT00295620|12099744|FG000|STARTED|Overall Study||1732
10930660|NCT00295620|12099745|FG001|STARTED|Overall Study||1738
10930661|NCT00295620|12099744|FG000|Safety Analysis Set|Overall Study||1705
10930662|NCT00295620|12099745|FG001|Safety Analysis Set|Overall Study||1710
10930663|NCT00295620|12099744|FG000|COMPLETED|Overall Study||860
10930664|NCT00295620|12099745|FG001|COMPLETED|Overall Study||842
10930665|NCT00295620|12099744|FG000|NOT COMPLETED|Overall Study||872
10930666|NCT00295620|12099745|FG001|NOT COMPLETED|Overall Study||896
10930667|NCT00295633|12099754|FG000|STARTED|Overall Study||195
10930668|NCT00295633|12099755|FG001|STARTED|Overall Study||186
10930669|NCT00295633|12099756|FG002|STARTED|Overall Study||184
10930670|NCT00295633|12099754|FG000|Completed Study Without Being Rescued|Overall Study||88
10930671|NCT00295633|12099755|FG001|Completed Study Without Being Rescued|Overall Study||82
10930672|NCT00295633|12099756|FG002|Completed Study Without Being Rescued|Overall Study||51
10930673|NCT00295633|12099754|FG000|COMPLETED|Overall Study||133
10930674|NCT00295633|12099755|FG001|COMPLETED|Overall Study||119
10930675|NCT00295633|12099756|FG002|COMPLETED|Overall Study||108
10930676|NCT00295633|12099754|FG000|NOT COMPLETED|Overall Study||62
10930677|NCT00295633|12099755|FG001|NOT COMPLETED|Overall Study||67
10930678|NCT00295633|12099756|FG002|NOT COMPLETED|Overall Study||76
10930679|NCT00295750|12099767|FG000|STARTED|Overall Study|randomized|206
10930680|NCT00295750|12099768|FG001|STARTED|Overall Study|randomized|210
10930681|NCT00295750|12099769|FG002|STARTED|Overall Study|randomized|204
10930682|NCT00295750|12099767|FG000|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
10930683|NCT00295750|12099768|FG001|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
10930684|NCT00295750|12099769|FG002|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
10930685|NCT00295750|12099767|FG000|COMPLETED|Overall Study||163
10930686|NCT00295750|12099768|FG001|COMPLETED|Overall Study||169
10930687|NCT00295750|12099769|FG002|COMPLETED|Overall Study||172
10930688|NCT00295750|12099767|FG000|NOT COMPLETED|Overall Study||43
10930689|NCT00295750|12099768|FG001|NOT COMPLETED|Overall Study||41
10930690|NCT00295750|12099769|FG002|NOT COMPLETED|Overall Study||32
10930691|NCT00295854|12099780|FG000|STARTED|Overall Study||95
10930692|NCT00295854|12099781|FG001|STARTED|Overall Study||108
10930693|NCT00295854|12099782|FG002|STARTED|Overall Study||102
10930694|NCT00295854|12099780|FG000|Safety Population (N=304)|Overall Study||95
10930695|NCT00295854|12099781|FG001|Safety Population (N=304)|Overall Study||108
10930696|NCT00295854|12099782|FG002|Safety Population (N=304)|Overall Study||101
10930697|NCT00295854|12099780|FG000|ITT Population (N=296)|Overall Study||92
10930698|NCT00295854|12099781|FG001|ITT Population (N=296)|Overall Study||105
10930699|NCT00295854|12099782|FG002|ITT Population (N=296)|Overall Study||99
10930700|NCT00295854|12099780|FG000|COMPLETED|Overall Study||77
10930701|NCT00295854|12099781|FG001|COMPLETED|Overall Study||87
10930702|NCT00295854|12099782|FG002|COMPLETED|Overall Study||87
10930703|NCT00295854|12099780|FG000|NOT COMPLETED|Overall Study||18
10930704|NCT00295854|12099781|FG001|NOT COMPLETED|Overall Study||21
10930705|NCT00295854|12099782|FG002|NOT COMPLETED|Overall Study||15
10930706|NCT00295867|12099790|FG000|STARTED|Overall Study||45
10930707|NCT00295867|12099790|FG000|COMPLETED|Overall Study||34
10930708|NCT00295867|12099790|FG000|NOT COMPLETED|Overall Study||11
10930709|NCT00295880|12099794|FG000|STARTED|Overall Study||12
10930710|NCT00295880|12099794|FG000|COMPLETED|Overall Study||10
10930711|NCT00295880|12099794|FG000|NOT COMPLETED|Overall Study||2
10930712|NCT00295932|12099809|FG000|STARTED|Overall Study||4
10930713|NCT00295932|12099810|FG001|STARTED|Overall Study||6
10930714|NCT00295932|12099811|FG002|STARTED|Overall Study||3
10930715|NCT00295932|12099812|FG003|STARTED|Overall Study||4
10930716|NCT00295932|12099813|FG004|STARTED|Overall Study||2
10930717|NCT00295932|12099814|FG005|STARTED|Overall Study||18
10930718|NCT00295932|12099815|FG006|STARTED|Overall Study||3
10930719|NCT00295932|12099816|FG007|STARTED|Overall Study||4
10930720|NCT00295932|12099817|FG008|STARTED|Overall Study||10
10930721|NCT00295932|12099818|FG009|STARTED|Overall Study||12
10930722|NCT00295932|12099819|FG010|STARTED|Overall Study||13
10930723|NCT00295932|12099809|FG000|COMPLETED|Overall Study||4
10930724|NCT00295932|12099810|FG001|COMPLETED|Overall Study||6
10930725|NCT00295932|12099811|FG002|COMPLETED|Overall Study||3
10930726|NCT00295932|12099812|FG003|COMPLETED|Overall Study||4
10930727|NCT00295932|12099813|FG004|COMPLETED|Overall Study||2
10930728|NCT00295932|12099814|FG005|COMPLETED|Overall Study||18
10930729|NCT00295932|12099815|FG006|COMPLETED|Overall Study||3
10930730|NCT00295932|12099816|FG007|COMPLETED|Overall Study||4
10930731|NCT00295932|12099817|FG008|COMPLETED|Overall Study||10
10930732|NCT00295932|12099818|FG009|COMPLETED|Overall Study||12
10930733|NCT00295932|12099819|FG010|COMPLETED|Overall Study||12
10930734|NCT00295932|12099809|FG000|NOT COMPLETED|Overall Study||0
10930735|NCT00295932|12099810|FG001|NOT COMPLETED|Overall Study||0
10930736|NCT00295932|12099811|FG002|NOT COMPLETED|Overall Study||0
10930737|NCT00295932|12099812|FG003|NOT COMPLETED|Overall Study||0
10930738|NCT00295932|12099813|FG004|NOT COMPLETED|Overall Study||0
10930739|NCT00295932|12099814|FG005|NOT COMPLETED|Overall Study||0
10930740|NCT00295932|12099815|FG006|NOT COMPLETED|Overall Study||0
10930741|NCT00295932|12099816|FG007|NOT COMPLETED|Overall Study||0
10930742|NCT00295932|12099817|FG008|NOT COMPLETED|Overall Study||0
10930743|NCT00295932|12099818|FG009|NOT COMPLETED|Overall Study||0
10930744|NCT00295932|12099819|FG010|NOT COMPLETED|Overall Study||1
10930745|NCT00296036|12099847|FG000|STARTED|Overall Study||19
10930746|NCT00296036|12099848|FG001|STARTED|Overall Study||18
10930747|NCT00296036|12099849|FG002|STARTED|Overall Study||18
10930748|NCT00296036|12099850|FG003|STARTED|Overall Study||17
10930749|NCT00296036|12099851|FG004|STARTED|Overall Study||33
10930750|NCT00296036|12099852|FG005|STARTED|Overall Study||32
10930751|NCT00296036|12099847|FG000|COMPLETED|Overall Study||18
10930752|NCT00296036|12099848|FG001|COMPLETED|Overall Study||18
10930753|NCT00296036|12099849|FG002|COMPLETED|Overall Study||16
10930754|NCT00296036|12099850|FG003|COMPLETED|Overall Study||16
10930755|NCT00296036|12099851|FG004|COMPLETED|Overall Study||31
10930756|NCT00296036|12099852|FG005|COMPLETED|Overall Study||28
10930757|NCT00296036|12099847|FG000|NOT COMPLETED|Overall Study||1
10930758|NCT00296036|12099848|FG001|NOT COMPLETED|Overall Study||0
10930759|NCT00296036|12099849|FG002|NOT COMPLETED|Overall Study||2
10930760|NCT00296036|12099850|FG003|NOT COMPLETED|Overall Study||1
10930761|NCT00296036|12099851|FG004|NOT COMPLETED|Overall Study||2
10930762|NCT00296036|12099852|FG005|NOT COMPLETED|Overall Study||4
10930763|NCT00296140|12099871|FG000|STARTED|Overall Study||33
10930764|NCT00296140|12099872|FG001|STARTED|Overall Study||33
10930765|NCT00296140|12099871|FG000|COMPLETED|Overall Study||30
10930766|NCT00296140|12099872|FG001|COMPLETED|Overall Study||33
10930767|NCT00296140|12099871|FG000|NOT COMPLETED|Overall Study||3
10930768|NCT00296140|12099872|FG001|NOT COMPLETED|Overall Study||0
10930769|NCT00296192|12099883|FG000|STARTED|Overall Study||17
10930770|NCT00296192|12099884|FG001|STARTED|Overall Study||16
10930771|NCT00296192|12099885|FG002|STARTED|Overall Study||16
10930772|NCT00296192|12099886|FG003|STARTED|Overall Study||17
10930773|NCT00296192|12099887|FG004|STARTED|Overall Study||16
10930774|NCT00296192|12099883|FG000|COMPLETED|Overall Study||17
10930775|NCT00296192|12099884|FG001|COMPLETED|Overall Study||16
10930776|NCT00296192|12099885|FG002|COMPLETED|Overall Study||16
10930777|NCT00296192|12099886|FG003|COMPLETED|Overall Study||17
10930778|NCT00296192|12099887|FG004|COMPLETED|Overall Study||16
10930779|NCT00296192|12099883|FG000|NOT COMPLETED|Overall Study||0
10930780|NCT00296192|12099884|FG001|NOT COMPLETED|Overall Study||0
10930781|NCT00296192|12099885|FG002|NOT COMPLETED|Overall Study||0
10930782|NCT00296192|12099886|FG003|NOT COMPLETED|Overall Study||0
10930783|NCT00296192|12099887|FG004|NOT COMPLETED|Overall Study||0
10930784|NCT00296231|12099899|FG000|STARTED|Overall Study||14
10930785|NCT00296231|12099899|FG000|COMPLETED|Overall Study||14
10930786|NCT00296231|12099899|FG000|NOT COMPLETED|Overall Study||0
10930787|NCT00296244|12099905|FG000|STARTED|Overall Study||20
10930788|NCT00296244|12099906|FG001|STARTED|Overall Study||20
10930789|NCT00296244|12099905|FG000|COMPLETED|Overall Study||20
10930790|NCT00296244|12099906|FG001|COMPLETED|Overall Study||19
10930791|NCT00296244|12099905|FG000|NOT COMPLETED|Overall Study||0
10930792|NCT00296244|12099906|FG001|NOT COMPLETED|Overall Study||1
10930793|NCT00296296|12099919|FG000|STARTED|Overall Study||11
10930794|NCT00296296|12099920|FG001|STARTED|Overall Study||18
10930795|NCT00296296|12099919|FG000|COMPLETED|Overall Study||9
10930796|NCT00296296|12099920|FG001|COMPLETED|Overall Study||5
10930797|NCT00296296|12099919|FG000|NOT COMPLETED|Overall Study||2
10930798|NCT00296296|12099920|FG001|NOT COMPLETED|Overall Study||13
10930799|NCT00296322|12099928|FG000|STARTED|Overall Study||258
10930800|NCT00296322|12099929|FG001|STARTED|Overall Study||263
10930801|NCT00296322|12099928|FG000|COMPLETED|Overall Study||237
10930802|NCT00296322|12099929|FG001|COMPLETED|Overall Study||184
10930803|NCT00296322|12099928|FG000|NOT COMPLETED|Overall Study||21
10930804|NCT00296322|12099929|FG001|NOT COMPLETED|Overall Study||79
10930805|NCT00296335|12099937|FG000|STARTED|Overall Study||424
10930806|NCT00296335|12099938|FG001|STARTED|Overall Study||431
10930807|NCT00296335|12099937|FG000|COMPLETED|Overall Study||394
10930808|NCT00296335|12099938|FG001|COMPLETED|Overall Study||309
10930809|NCT00296335|12099937|FG000|NOT COMPLETED|Overall Study||30
10930810|NCT00296335|12099938|FG001|NOT COMPLETED|Overall Study||122
10930811|NCT00296374|12099949|FG000|STARTED|Overall Study||118
10930812|NCT00296374|12099950|FG001|STARTED|Overall Study||124
10930813|NCT00296374|12099951|FG002|STARTED|Overall Study||111
10930814|NCT00296374|12099949|FG000|COMPLETED|Overall Study||93
10930815|NCT00296374|12099950|FG001|COMPLETED|Overall Study||101
10930816|NCT00296374|12099951|FG002|COMPLETED|Overall Study||82
10930817|NCT00296374|12099949|FG000|NOT COMPLETED|Overall Study||25
10930818|NCT00296374|12099950|FG001|NOT COMPLETED|Overall Study||23
10930819|NCT00296374|12099951|FG002|NOT COMPLETED|Overall Study||29
10930820|NCT00296400|12099968|FG000|STARTED|Overall Study||70
10930821|NCT00296400|12099969|FG001|STARTED|Overall Study||87
10930822|NCT00296400|12099970|FG002|STARTED|Overall Study||80
10930823|NCT00296400|12099968|FG000|COMPLETED|Overall Study||53
10930824|NCT00296400|12099969|FG001|COMPLETED|Overall Study||69
10930825|NCT00296400|12099970|FG002|COMPLETED|Overall Study||67
10930826|NCT00296400|12099968|FG000|NOT COMPLETED|Overall Study||17
10930827|NCT00296400|12099969|FG001|NOT COMPLETED|Overall Study||18
10930828|NCT00296400|12099970|FG002|NOT COMPLETED|Overall Study||13
10930829|NCT00296491|12099985|FG000|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
10930830|NCT00296491|12099986|FG001|STARTED|Overall Study||182
10930831|NCT00296491|12099987|FG002|STARTED|Overall Study||180
10930832|NCT00296491|12099988|FG003|STARTED|Overall Study||181
10930833|NCT00296491|12099985|FG000|COMPLETED|Overall Study||140
10930834|NCT00296491|12099986|FG001|COMPLETED|Overall Study||129
10930835|NCT00296491|12099987|FG002|COMPLETED|Overall Study||137
10930836|NCT00296491|12099988|FG003|COMPLETED|Overall Study||138
10930837|NCT00296491|12099985|FG000|NOT COMPLETED|Overall Study||42
10930838|NCT00296491|12099986|FG001|NOT COMPLETED|Overall Study||53
10930839|NCT00296491|12099987|FG002|NOT COMPLETED|Overall Study||43
10930840|NCT00296491|12099988|FG003|NOT COMPLETED|Overall Study||43
10930841|NCT00296504|12100013|FG000|STARTED|Interim Analysis||119
10930842|NCT00296504|12100014|FG001|STARTED|Interim Analysis||18
10930843|NCT00296504|12100015|FG002|STARTED|Interim Analysis||221
10930844|NCT00296504|12100016|FG003|STARTED|Interim Analysis||54
10930845|NCT00296504|12100017|FG004|STARTED|Interim Analysis||73
10930846|NCT00296504|12100018|FG005|STARTED|Interim Analysis||78
10930847|NCT00296504|12100019|FG006|STARTED|Interim Analysis||104
10930848|NCT00296504|12100020|FG007|STARTED|Interim Analysis||86
10930849|NCT00296504|12100021|FG008|STARTED|Interim Analysis||0
10930850|NCT00296504|12100013|FG000|Ongoing|Interim Analysis||32
10930851|NCT00296504|12100014|FG001|Ongoing|Interim Analysis||12
10930852|NCT00296504|12100015|FG002|Ongoing|Interim Analysis||16
10930853|NCT00296504|12100016|FG003|Ongoing|Interim Analysis||22
10930854|NCT00296504|12100017|FG004|Ongoing|Interim Analysis||0
10930855|NCT00296504|12100018|FG005|Ongoing|Interim Analysis||0
10930856|NCT00296504|12100019|FG006|Ongoing|Interim Analysis||30
10930857|NCT00296504|12100020|FG007|Ongoing|Interim Analysis||1
10930858|NCT00296504|12100021|FG008|Ongoing|Interim Analysis||0
10930859|NCT00296504|12100013|FG000|COMPLETED|Interim Analysis||43
10930860|NCT00296504|12100014|FG001|COMPLETED|Interim Analysis||0
10930861|NCT00296504|12100015|FG002|COMPLETED|Interim Analysis||116
10930862|NCT00296504|12100016|FG003|COMPLETED|Interim Analysis||11
10930863|NCT00296504|12100017|FG004|COMPLETED|Interim Analysis||36
10930864|NCT00296504|12100018|FG005|COMPLETED|Interim Analysis||41
10930865|NCT00296504|12100019|FG006|COMPLETED|Interim Analysis||30
10930866|NCT00296504|12100020|FG007|COMPLETED|Interim Analysis||37
10930867|NCT00296504|12100021|FG008|COMPLETED|Interim Analysis||0
10930868|NCT00296504|12100013|FG000|NOT COMPLETED|Interim Analysis||76
10930869|NCT00296504|12100014|FG001|NOT COMPLETED|Interim Analysis||18
10930870|NCT00296504|12100015|FG002|NOT COMPLETED|Interim Analysis||105
10930871|NCT00296504|12100016|FG003|NOT COMPLETED|Interim Analysis||43
10930872|NCT00296504|12100017|FG004|NOT COMPLETED|Interim Analysis||37
10930873|NCT00296504|12100018|FG005|NOT COMPLETED|Interim Analysis||37
10930874|NCT00296504|12100019|FG006|NOT COMPLETED|Interim Analysis||74
10930875|NCT00296504|12100020|FG007|NOT COMPLETED|Interim Analysis||49
10930876|NCT00296504|12100021|FG008|NOT COMPLETED|Interim Analysis||0
10930877|NCT00296504|12100013|FG000|STARTED|Final Analysis||0
10930878|NCT00296504|12100014|FG001|STARTED|Final Analysis||0
10930879|NCT00296504|12100015|FG002|STARTED|Final Analysis||0
10930880|NCT00296504|12100016|FG003|STARTED|Final Analysis||0
10930881|NCT00296504|12100017|FG004|STARTED|Final Analysis||0
10930882|NCT00296504|12100018|FG005|STARTED|Final Analysis||0
10930883|NCT00296504|12100019|FG006|STARTED|Final Analysis||0
10930884|NCT00296504|12100020|FG007|STARTED|Final Analysis||0
10930885|NCT00296504|12100021|FG008|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
10930886|NCT00296504|12100013|FG000|COMPLETED|Final Analysis||0
10930887|NCT00296504|12100014|FG001|COMPLETED|Final Analysis||0
10930888|NCT00296504|12100015|FG002|COMPLETED|Final Analysis||0
10930889|NCT00296504|12100016|FG003|COMPLETED|Final Analysis||0
10930890|NCT00296504|12100017|FG004|COMPLETED|Final Analysis||0
10930891|NCT00296504|12100018|FG005|COMPLETED|Final Analysis||0
10930892|NCT00296504|12100019|FG006|COMPLETED|Final Analysis||0
10930893|NCT00296504|12100020|FG007|COMPLETED|Final Analysis||0
10930894|NCT00296504|12100021|FG008|COMPLETED|Final Analysis||90
10930895|NCT00296504|12100013|FG000|NOT COMPLETED|Final Analysis||0
10930896|NCT00296504|12100014|FG001|NOT COMPLETED|Final Analysis||0
10930897|NCT00296504|12100015|FG002|NOT COMPLETED|Final Analysis||0
10930898|NCT00296504|12100016|FG003|NOT COMPLETED|Final Analysis||0
10930899|NCT00296504|12100017|FG004|NOT COMPLETED|Final Analysis||0
10930900|NCT00296504|12100018|FG005|NOT COMPLETED|Final Analysis||0
10930901|NCT00296504|12100019|FG006|NOT COMPLETED|Final Analysis||0
10930902|NCT00296504|12100020|FG007|NOT COMPLETED|Final Analysis||0
10930903|NCT00296504|12100021|FG008|NOT COMPLETED|Final Analysis||21
10930904|NCT00296517|12100048|FG000|STARTED|Dose Level 1 - Week 1||159
10930905|NCT00296517|12100049|FG001|STARTED|Dose Level 1 - Week 1||166
10930906|NCT00296517|12100048|FG000|COMPLETED|Dose Level 1 - Week 1||159
10930907|NCT00296517|12100049|FG001|COMPLETED|Dose Level 1 - Week 1||166
10930908|NCT00296517|12100048|FG000|NOT COMPLETED|Dose Level 1 - Week 1||0
10930909|NCT00296517|12100049|FG001|NOT COMPLETED|Dose Level 1 - Week 1||0
10930910|NCT00296517|12100048|FG000|STARTED|Dose Level 2 - Week 2||159
10930911|NCT00296517|12100049|FG001|STARTED|Dose Level 2 - Week 2||166
10930912|NCT00296517|12100048|FG000|COMPLETED|Dose Level 2 - Week 2||157
10930913|NCT00296517|12100049|FG001|COMPLETED|Dose Level 2 - Week 2||161
10930914|NCT00296517|12100048|FG000|NOT COMPLETED|Dose Level 2 - Week 2||2
10930915|NCT00296517|12100049|FG001|NOT COMPLETED|Dose Level 2 - Week 2||5
10930916|NCT00296517|12100048|FG000|STARTED|Dose Level 3 - Weeks 3-12||157
10930917|NCT00296517|12100049|FG001|STARTED|Dose Level 3 - Weeks 3-12||161
10930918|NCT00296517|12100048|FG000|COMPLETED|Dose Level 3 - Weeks 3-12||112
10930919|NCT00296517|12100049|FG001|COMPLETED|Dose Level 3 - Weeks 3-12||99
10930920|NCT00296517|12100048|FG000|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
10930921|NCT00296517|12100049|FG001|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
10930922|NCT00296647|12100060|FG000|STARTED|Overall Study||282
10930923|NCT00296647|12100061|FG001|STARTED|Overall Study||261
10930924|NCT00296647|12100062|FG002|STARTED|Overall Study||256
10930925|NCT00296647|12100063|FG003|STARTED|Overall Study||279
10930926|NCT00296647|12100064|FG004|STARTED|Overall Study||268
10930927|NCT00296647|12100060|FG000|COMPLETED|Overall Study||250
10930928|NCT00296647|12100061|FG001|COMPLETED|Overall Study||233
10930929|NCT00296647|12100062|FG002|COMPLETED|Overall Study||222
10930930|NCT00296647|12100063|FG003|COMPLETED|Overall Study||262
10930931|NCT00296647|12100064|FG004|COMPLETED|Overall Study||248
10930932|NCT00296647|12100060|FG000|NOT COMPLETED|Overall Study||32
10930933|NCT00296647|12100061|FG001|NOT COMPLETED|Overall Study||28
10930934|NCT00296647|12100062|FG002|NOT COMPLETED|Overall Study||34
10930935|NCT00296647|12100063|FG003|NOT COMPLETED|Overall Study||17
10930936|NCT00296647|12100064|FG004|NOT COMPLETED|Overall Study||20
10930937|NCT00296725|12100076|FG000|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17
10930938|NCT00296725|12100076|FG000|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12
10930939|NCT00296725|12100076|FG000|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5
10930940|NCT00296725|12100076|FG000|STARTED|Phase 2: Imipramine (1-6 Weeks)||8
10930941|NCT00296725|12100076|FG000|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7
10930942|NCT00296725|12100076|FG000|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1
10930943|NCT00296816|12100084|FG000|STARTED|Overall Study||132
10930944|NCT00296816|12100084|FG000|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
10930945|NCT00296816|12100084|FG000|NOT COMPLETED|Overall Study||74
10930946|NCT00297037|12100090|FG000|STARTED|Overall Study||10
10930947|NCT00297037|12100091|FG001|STARTED|Overall Study||11
10930948|NCT00297037|12100090|FG000|COMPLETED|Overall Study||8
10930949|NCT00297037|12100091|FG001|COMPLETED|Overall Study||11
10930950|NCT00297037|12100090|FG000|NOT COMPLETED|Overall Study||2
10930951|NCT00297037|12100091|FG001|NOT COMPLETED|Overall Study||0
10930952|NCT00297102|12100101|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
10930953|NCT00297102|12100102|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
10930954|NCT00297102|12100101|FG000|COMPLETED|Overall Study||502
10930955|NCT00297102|12100102|FG001|COMPLETED|Overall Study||525
10930956|NCT00297102|12100101|FG000|NOT COMPLETED|Overall Study||263
10930957|NCT00297102|12100102|FG001|NOT COMPLETED|Overall Study||233
10930958|NCT00297115|12100110|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
10930959|NCT00297115|12100111|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
10930960|NCT00297115|12100110|FG000|COMPLETED|Overall Study||527
10930961|NCT00297115|12100111|FG001|COMPLETED|Overall Study||550
10930962|NCT00297115|12100110|FG000|NOT COMPLETED|Overall Study||245
10930963|NCT00297115|12100111|FG001|NOT COMPLETED|Overall Study||246
10930964|NCT00297167|12100117|FG000|STARTED|First Double-blind Intervention Period||17
10930965|NCT00297167|12100118|FG001|STARTED|First Double-blind Intervention Period||16
10930966|NCT00297167|12100119|FG002|STARTED|First Double-blind Intervention Period||0
10930967|NCT00297167|12100117|FG000|COMPLETED|First Double-blind Intervention Period||17
10930968|NCT00297167|12100118|FG001|COMPLETED|First Double-blind Intervention Period||16
10930969|NCT00297167|12100119|FG002|COMPLETED|First Double-blind Intervention Period||0
10930970|NCT00297167|12100117|FG000|NOT COMPLETED|First Double-blind Intervention Period||0
10930971|NCT00297167|12100118|FG001|NOT COMPLETED|First Double-blind Intervention Period||0
10930972|NCT00297167|12100119|FG002|NOT COMPLETED|First Double-blind Intervention Period||0
10930973|NCT00297167|12100117|FG000|STARTED|Open-label Dose Normalization Period 1||0
10930974|NCT00297167|12100118|FG001|STARTED|Open-label Dose Normalization Period 1||0
10930975|NCT00297167|12100119|FG002|STARTED|Open-label Dose Normalization Period 1||33
10930976|NCT00297167|12100117|FG000|COMPLETED|Open-label Dose Normalization Period 1||0
10930977|NCT00297167|12100118|FG001|COMPLETED|Open-label Dose Normalization Period 1||0
10930978|NCT00297167|12100119|FG002|COMPLETED|Open-label Dose Normalization Period 1||32
10930979|NCT00297167|12100117|FG000|NOT COMPLETED|Open-label Dose Normalization Period 1||0
10930980|NCT00297167|12100118|FG001|NOT COMPLETED|Open-label Dose Normalization Period 1||0
10930981|NCT00297167|12100119|FG002|NOT COMPLETED|Open-label Dose Normalization Period 1||1
10930982|NCT00297167|12100117|FG000|STARTED|Second Double-blind Intervention Period||17
10930983|NCT00297167|12100118|FG001|STARTED|Second Double-blind Intervention Period||15
10930984|NCT00297167|12100119|FG002|STARTED|Second Double-blind Intervention Period||0
10930985|NCT00297167|12100117|FG000|COMPLETED|Second Double-blind Intervention Period||16
10930986|NCT00297167|12100118|FG001|COMPLETED|Second Double-blind Intervention Period||15
10930987|NCT00297167|12100119|FG002|COMPLETED|Second Double-blind Intervention Period||0
10930988|NCT00297167|12100117|FG000|NOT COMPLETED|Second Double-blind Intervention Period||1
10930989|NCT00297167|12100118|FG001|NOT COMPLETED|Second Double-blind Intervention Period||0
10930990|NCT00297167|12100119|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0
10930991|NCT00297167|12100117|FG000|STARTED|Open-label Dose Normalization Period 2||0
10930992|NCT00297167|12100118|FG001|STARTED|Open-label Dose Normalization Period 2||0
10930993|NCT00297167|12100119|FG002|STARTED|Open-label Dose Normalization Period 2||31
10930994|NCT00297167|12100117|FG000|COMPLETED|Open-label Dose Normalization Period 2||0
10930995|NCT00297167|12100118|FG001|COMPLETED|Open-label Dose Normalization Period 2||0
10930996|NCT00297167|12100119|FG002|COMPLETED|Open-label Dose Normalization Period 2||31
10930997|NCT00297167|12100117|FG000|NOT COMPLETED|Open-label Dose Normalization Period 2||0
10930998|NCT00297167|12100118|FG001|NOT COMPLETED|Open-label Dose Normalization Period 2||0
10930999|NCT00297167|12100119|FG002|NOT COMPLETED|Open-label Dose Normalization Period 2||0
10931000|NCT00297232|12100126|FG000|STARTED|Overall Study||1094
10931001|NCT00297232|12100126|FG000|COMPLETED|Overall Study||489
10931002|NCT00297232|12100126|FG000|NOT COMPLETED|Overall Study||605
10931003|NCT00297258|12100130|FG000|STARTED|Overall Study||142
10931004|NCT00297258|12100130|FG000|COMPLETED|Overall Study||0
10931005|NCT00297258|12100130|FG000|NOT COMPLETED|Overall Study||142
10931006|NCT00297427|12100139|FG000|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
10931007|NCT00297427|12100140|FG001|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
10931008|NCT00297427|12100139|FG000|COMPLETED|Phase 1: Initial Intervention||56
10931009|NCT00297427|12100140|FG001|COMPLETED|Phase 1: Initial Intervention||54
10931010|NCT00297427|12100139|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8
10931011|NCT00297427|12100140|FG001|NOT COMPLETED|Phase 1: Initial Intervention||9
10931012|NCT00297427|12100139|FG000|STARTED|Phase 2: Optional Crossover for Sham||54
10931013|NCT00297427|12100140|FG001|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
10931014|NCT00297427|12100139|FG000|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
10931015|NCT00297427|12100140|FG001|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
10931016|NCT00297427|12100139|FG000|COMPLETED|Phase 2: Optional Crossover for Sham||38
10931017|NCT00297427|12100140|FG001|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
10931018|NCT00297427|12100139|FG000|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
10931019|NCT00297427|12100140|FG001|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
10931020|NCT00297427|12100139|FG000|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
10931021|NCT00297427|12100140|FG001|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
10931022|NCT00297427|12100139|FG000|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
10931023|NCT00297427|12100140|FG001|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
10931024|NCT00297427|12100139|FG000|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
10931025|NCT00297427|12100140|FG001|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
10931026|NCT00297479|12100157|FG000|STARTED|Overall Study||103
10931027|NCT00297479|12100158|FG001|STARTED|Overall Study||155
10931028|NCT00297479|12100159|FG002|STARTED|Overall Study||154
10931029|NCT00297479|12100157|FG000|4-Week Follow Up|Overall Study||78
10931030|NCT00297479|12100158|FG001|4-Week Follow Up|Overall Study||132
10931031|NCT00297479|12100159|FG002|4-Week Follow Up|Overall Study||128
10931032|NCT00297479|12100157|FG000|26- Week Follow Up|Overall Study||66
10931033|NCT00297479|12100158|FG001|26- Week Follow Up|Overall Study||101
10931034|NCT00297479|12100159|FG002|26- Week Follow Up|Overall Study||103
10931035|NCT00297479|12100157|FG000|COMPLETED|Overall Study||66
10931036|NCT00297479|12100158|FG001|COMPLETED|Overall Study||101
10931037|NCT00297479|12100159|FG002|COMPLETED|Overall Study||103
10931038|NCT00297479|12100157|FG000|NOT COMPLETED|Overall Study||37
10931039|NCT00297479|12100158|FG001|NOT COMPLETED|Overall Study||54
10931040|NCT00297479|12100159|FG002|NOT COMPLETED|Overall Study||51
10931041|NCT00297492|12100170|FG000|STARTED|Set Quit Date||297
10931042|NCT00297492|12100171|FG001|STARTED|Set Quit Date||299
10931043|NCT00297492|12100172|FG002|STARTED|Set Quit Date||150
10931044|NCT00297492|12100170|FG000|COMPLETED|Set Quit Date||290
10931045|NCT00297492|12100171|FG001|COMPLETED|Set Quit Date||286
10931046|NCT00297492|12100172|FG002|COMPLETED|Set Quit Date||145
10931047|NCT00297492|12100170|FG000|NOT COMPLETED|Set Quit Date||7
10931048|NCT00297492|12100171|FG001|NOT COMPLETED|Set Quit Date||13
10931049|NCT00297492|12100172|FG002|NOT COMPLETED|Set Quit Date||5
10931050|NCT00297492|12100170|FG000|STARTED|6 Month Follow-up||290
10931051|NCT00297492|12100171|FG001|STARTED|6 Month Follow-up||286
10931052|NCT00297492|12100172|FG002|STARTED|6 Month Follow-up||145
10931053|NCT00297492|12100170|FG000|COMPLETED|6 Month Follow-up||227
10931054|NCT00297492|12100171|FG001|COMPLETED|6 Month Follow-up||237
10931055|NCT00297492|12100172|FG002|COMPLETED|6 Month Follow-up||118
10931056|NCT00297492|12100170|FG000|NOT COMPLETED|6 Month Follow-up||63
10931057|NCT00297492|12100171|FG001|NOT COMPLETED|6 Month Follow-up||49
10931058|NCT00297492|12100172|FG002|NOT COMPLETED|6 Month Follow-up||27
10931059|NCT00297596|12100180|FG000|STARTED|Overall Study||25
10931060|NCT00297596|12100180|FG000|COMPLETED|Overall Study||25
10931061|NCT00297596|12100180|FG000|NOT COMPLETED|Overall Study||0
10931062|NCT00297648|12100184|FG000|STARTED|Overall Study||89
10931063|NCT00297648|12100184|FG000|COMPLETED|Overall Study||53
10931064|NCT00297648|12100184|FG000|NOT COMPLETED|Overall Study||36
10931065|NCT00297778|12100190|FG000|STARTED|Overall Study||152
10931066|NCT00297778|12100191|FG001|STARTED|Overall Study||144
10931067|NCT00297778|12100190|FG000|COMPLETED|Overall Study||133
10931068|NCT00297778|12100191|FG001|COMPLETED|Overall Study||124
10931069|NCT00297778|12100190|FG000|NOT COMPLETED|Overall Study||19
10931070|NCT00297778|12100191|FG001|NOT COMPLETED|Overall Study||20
10931071|NCT00297830|12100200|FG000|STARTED|Baseline||41
10931072|NCT00297830|12100201|FG001|STARTED|Baseline||43
10931073|NCT00297830|12100202|FG002|STARTED|Baseline||27
10931074|NCT00297830|12100200|FG000|COMPLETED|Baseline||41
10931075|NCT00297830|12100201|FG001|COMPLETED|Baseline||43
10931076|NCT00297830|12100202|FG002|COMPLETED|Baseline||27
10931077|NCT00297830|12100200|FG000|NOT COMPLETED|Baseline||0
10931078|NCT00297830|12100201|FG001|NOT COMPLETED|Baseline||0
10931079|NCT00297830|12100202|FG002|NOT COMPLETED|Baseline||0
10931080|NCT00297830|12100200|FG000|STARTED|6 Month Visit||41
10931081|NCT00297830|12100201|FG001|STARTED|6 Month Visit||43
10931082|NCT00297830|12100202|FG002|STARTED|6 Month Visit||27
10931083|NCT00297830|12100200|FG000|COMPLETED|6 Month Visit||38
10931084|NCT00297830|12100201|FG001|COMPLETED|6 Month Visit||41
10931085|NCT00297830|12100202|FG002|COMPLETED|6 Month Visit||24
10931086|NCT00297830|12100200|FG000|NOT COMPLETED|6 Month Visit||3
10931087|NCT00297830|12100201|FG001|NOT COMPLETED|6 Month Visit||2
10931088|NCT00297830|12100202|FG002|NOT COMPLETED|6 Month Visit||3
10931089|NCT00297830|12100200|FG000|STARTED|12 Month Visit||38
10931090|NCT00297830|12100201|FG001|STARTED|12 Month Visit||41
10931091|NCT00297830|12100202|FG002|STARTED|12 Month Visit||24
10931092|NCT00297830|12100200|FG000|COMPLETED|12 Month Visit||37
10931093|NCT00297830|12100201|FG001|COMPLETED|12 Month Visit||35
10931094|NCT00297830|12100202|FG002|COMPLETED|12 Month Visit||24
10931095|NCT00297830|12100200|FG000|NOT COMPLETED|12 Month Visit||1
10931096|NCT00297830|12100201|FG001|NOT COMPLETED|12 Month Visit||6
10931097|NCT00297830|12100202|FG002|NOT COMPLETED|12 Month Visit||0
10931098|NCT00297882|12100212|FG000|STARTED|Day 14||204
10931099|NCT00297882|12100213|FG001|STARTED|Day 14||612
10931100|NCT00297882|12100212|FG000|COMPLETED|Day 14||192
10931101|NCT00297882|12100213|FG001|COMPLETED|Day 14||563
10931102|NCT00297882|12100212|FG000|NOT COMPLETED|Day 14||12
10931103|NCT00297882|12100213|FG001|NOT COMPLETED|Day 14||49
10931104|NCT00297882|12100212|FG000|STARTED|Day 28||192
10931105|NCT00297882|12100213|FG001|STARTED|Day 28||563
10931106|NCT00297882|12100212|FG000|COMPLETED|Day 28||176
10931107|NCT00297882|12100213|FG001|COMPLETED|Day 28||540
10931108|NCT00297882|12100212|FG000|NOT COMPLETED|Day 28||16
10931109|NCT00297882|12100213|FG001|NOT COMPLETED|Day 28||23
10931110|NCT00298038|12100223|FG000|STARTED|Overall Study||140
10931111|NCT00298038|12100224|FG001|STARTED|Overall Study||159
10931112|NCT00298038|12100223|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||140
10931113|NCT00298038|12100224|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||159
10931114|NCT00298038|12100223|FG000|COMPLETED|Overall Study||88
10931115|NCT00298038|12100224|FG001|COMPLETED|Overall Study||66
10931116|NCT00298038|12100223|FG000|NOT COMPLETED|Overall Study||52
10931117|NCT00298038|12100224|FG001|NOT COMPLETED|Overall Study||93
10931118|NCT00298090|12100230|FG000|STARTED|Overall Study||47
10931119|NCT00298090|12100230|FG000|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
10931120|NCT00298090|12100230|FG000|NOT COMPLETED|Overall Study||18
10931121|NCT00298155|12100237|FG000|STARTED|Overall Study||12
10931122|NCT00298155|12100238|FG001|STARTED|Overall Study||10
10931123|NCT00298155|12100239|FG002|STARTED|Overall Study||13
10931124|NCT00298155|12100237|FG000|COMPLETED|Overall Study||12
10931125|NCT00298155|12100238|FG001|COMPLETED|Overall Study||10
10931126|NCT00298155|12100239|FG002|COMPLETED|Overall Study||13
10931127|NCT00298155|12100237|FG000|NOT COMPLETED|Overall Study||0
10931128|NCT00298155|12100238|FG001|NOT COMPLETED|Overall Study||0
10931129|NCT00298155|12100239|FG002|NOT COMPLETED|Overall Study||0
10931130|NCT00298233|12100249|FG000|STARTED|Overall Study||39
10931131|NCT00298233|12100250|FG001|STARTED|Overall Study||41
10931132|NCT00298233|12100251|FG002|STARTED|Overall Study||122
10931133|NCT00298233|12100252|FG003|STARTED|Overall Study||124
10931134|NCT00298233|12100249|FG000|COMPLETED|Overall Study||39
10931135|NCT00298233|12100250|FG001|COMPLETED|Overall Study||41
10931136|NCT00298233|12100251|FG002|COMPLETED|Overall Study||122
10931137|NCT00298233|12100252|FG003|COMPLETED|Overall Study||124
10931138|NCT00298233|12100249|FG000|NOT COMPLETED|Overall Study||0
10931139|NCT00298233|12100250|FG001|NOT COMPLETED|Overall Study||0
10931140|NCT00298233|12100251|FG002|NOT COMPLETED|Overall Study||0
10931141|NCT00298233|12100252|FG003|NOT COMPLETED|Overall Study||0
10931142|NCT00298272|12100260|FG000|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
10931143|NCT00298272|12100261|FG001|STARTED|Double-blind Phase||18
10931144|NCT00298272|12100260|FG000|Safety Population|Double-blind Phase|received treatment|33
10931145|NCT00298272|12100261|FG001|Safety Population|Double-blind Phase||18
10931146|NCT00298272|12100260|FG000|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
10931147|NCT00298272|12100261|FG001|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
10931148|NCT00298272|12100260|FG000|Completed to Week 56|Double-blind Phase||8
10931149|NCT00298272|12100261|FG001|Completed to Week 56|Double-blind Phase||3
10931150|NCT00298272|12100260|FG000|COMPLETED|Double-blind Phase||28
10931151|NCT00298272|12100261|FG001|COMPLETED|Double-blind Phase||18
10931152|NCT00298272|12100260|FG000|NOT COMPLETED|Double-blind Phase||8
10931153|NCT00298272|12100261|FG001|NOT COMPLETED|Double-blind Phase||0
10931154|NCT00298272|12100260|FG000|STARTED|Open Label Retreatment Phase||22
10931155|NCT00298272|12100261|FG001|STARTED|Open Label Retreatment Phase||16
10931156|NCT00298272|12100260|FG000|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
10931157|NCT00298272|12100261|FG001|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
10931158|NCT00298272|12100260|FG000|Completed to Week 56|Open Label Retreatment Phase||13
10931159|NCT00298272|12100261|FG001|Completed to Week 56|Open Label Retreatment Phase||12
10931160|NCT00298272|12100260|FG000|COMPLETED|Open Label Retreatment Phase||13
10931161|NCT00298272|12100261|FG001|COMPLETED|Open Label Retreatment Phase||12
10931162|NCT00298272|12100260|FG000|NOT COMPLETED|Open Label Retreatment Phase||9
10931163|NCT00298272|12100261|FG001|NOT COMPLETED|Open Label Retreatment Phase||4
10931164|NCT00298272|12100260|FG000|STARTED|Safety Follow-up Phase||22
10931165|NCT00298272|12100261|FG001|STARTED|Safety Follow-up Phase||17
10931166|NCT00298272|12100260|FG000|COMPLETED|Safety Follow-up Phase||18
10931167|NCT00298272|12100261|FG001|COMPLETED|Safety Follow-up Phase||13
10931168|NCT00298272|12100260|FG000|NOT COMPLETED|Safety Follow-up Phase||4
10931169|NCT00298272|12100261|FG001|NOT COMPLETED|Safety Follow-up Phase||4
10931170|NCT00298363|12100273|FG000|STARTED|Overall Study||45
10931171|NCT00298363|12100274|FG001|STARTED|Overall Study||45
10931172|NCT00298363|12100275|FG002|STARTED|Overall Study||22
10931173|NCT00298363|12100273|FG000|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
10931174|NCT00298363|12100274|FG001|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
10931175|NCT00298363|12100275|FG002|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
10931176|NCT00298363|12100273|FG000|NOT COMPLETED|Overall Study||17
10931177|NCT00298363|12100274|FG001|NOT COMPLETED|Overall Study||8
10931178|NCT00298363|12100275|FG002|NOT COMPLETED|Overall Study||6
10931179|NCT00298389|12100292|FG000|STARTED|Overall Study||20
10931180|NCT00298389|12100293|FG001|STARTED|Overall Study||17
10931181|NCT00298389|12100294|FG002|STARTED|Overall Study||19
10931182|NCT00298389|12100292|FG000|COMPLETED|Overall Study||20
10931183|NCT00298389|12100293|FG001|COMPLETED|Overall Study||17
10931184|NCT00298389|12100294|FG002|COMPLETED|Overall Study||19
10931185|NCT00298389|12100292|FG000|NOT COMPLETED|Overall Study||0
10931186|NCT00298389|12100293|FG001|NOT COMPLETED|Overall Study||0
10931187|NCT00298389|12100294|FG002|NOT COMPLETED|Overall Study||0
10931188|NCT00298558|12100306|FG000|STARTED|Baseline||711
10931189|NCT00298558|12100307|FG001|STARTED|Baseline||705
10931190|NCT00298558|12100308|FG002|STARTED|Baseline||712
10931191|NCT00298558|12100309|FG003|STARTED|Baseline||704
10931192|NCT00298558|12100306|FG000|COMPLETED|Baseline||711
10931193|NCT00298558|12100307|FG001|COMPLETED|Baseline||705
10931194|NCT00298558|12100308|FG002|COMPLETED|Baseline||712
10931195|NCT00298558|12100309|FG003|COMPLETED|Baseline||704
10931196|NCT00298558|12100306|FG000|NOT COMPLETED|Baseline||0
10931197|NCT00298558|12100307|FG001|NOT COMPLETED|Baseline||0
10931198|NCT00298558|12100308|FG002|NOT COMPLETED|Baseline||0
10931199|NCT00298558|12100309|FG003|NOT COMPLETED|Baseline||0
10931200|NCT00298558|12100306|FG000|STARTED|Intervention||711
10931201|NCT00298558|12100307|FG001|STARTED|Intervention||705
10931202|NCT00298558|12100308|FG002|STARTED|Intervention||712
10931203|NCT00298558|12100309|FG003|STARTED|Intervention||704
10931204|NCT00298558|12100306|FG000|COMPLETED|Intervention||620
10931205|NCT00298558|12100307|FG001|COMPLETED|Intervention||627
10931206|NCT00298558|12100308|FG002|COMPLETED|Intervention||637
10931207|NCT00298558|12100309|FG003|COMPLETED|Intervention||285
10931208|NCT00298558|12100306|FG000|NOT COMPLETED|Intervention||91
10931209|NCT00298558|12100307|FG001|NOT COMPLETED|Intervention||78
10931210|NCT00298558|12100308|FG002|NOT COMPLETED|Intervention||75
10931211|NCT00298558|12100309|FG003|NOT COMPLETED|Intervention||419
10931212|NCT00298558|12100306|FG000|STARTED|Immediate Post Test||711
10931213|NCT00298558|12100307|FG001|STARTED|Immediate Post Test||705
10931214|NCT00298558|12100308|FG002|STARTED|Immediate Post Test||712
10931215|NCT00298558|12100309|FG003|STARTED|Immediate Post Test||704
10931216|NCT00298558|12100306|FG000|COMPLETED|Immediate Post Test||640
10931217|NCT00298558|12100307|FG001|COMPLETED|Immediate Post Test||629
10931218|NCT00298558|12100308|FG002|COMPLETED|Immediate Post Test||653
10931219|NCT00298558|12100309|FG003|COMPLETED|Immediate Post Test||639
10931220|NCT00298558|12100306|FG000|NOT COMPLETED|Immediate Post Test||71
10931221|NCT00298558|12100307|FG001|NOT COMPLETED|Immediate Post Test||76
10931222|NCT00298558|12100308|FG002|NOT COMPLETED|Immediate Post Test||59
10931223|NCT00298558|12100309|FG003|NOT COMPLETED|Immediate Post Test||65
10931224|NCT00298558|12100306|FG000|STARTED|Booster||372
10931225|NCT00298558|12100307|FG001|STARTED|Booster||371
10931226|NCT00298558|12100308|FG002|STARTED|Booster||370
10931227|NCT00298558|12100309|FG003|STARTED|Booster||0
10931228|NCT00298558|12100306|FG000|COMPLETED|Booster||283
10931229|NCT00298558|12100307|FG001|COMPLETED|Booster||301
10931230|NCT00298558|12100308|FG002|COMPLETED|Booster||295
10931231|NCT00298558|12100309|FG003|COMPLETED|Booster||0
10931232|NCT00298558|12100306|FG000|NOT COMPLETED|Booster||89
10931233|NCT00298558|12100307|FG001|NOT COMPLETED|Booster||70
10931234|NCT00298558|12100308|FG002|NOT COMPLETED|Booster||75
10931235|NCT00298558|12100309|FG003|NOT COMPLETED|Booster||0
10931236|NCT00298558|12100306|FG000|STARTED|1st Annual (A1)||640
10931237|NCT00298558|12100307|FG001|STARTED|1st Annual (A1)||629
10931238|NCT00298558|12100308|FG002|STARTED|1st Annual (A1)||653
10931239|NCT00298558|12100309|FG003|STARTED|1st Annual (A1)||639
10931240|NCT00298558|12100306|FG000|COMPLETED|1st Annual (A1)||585
10931241|NCT00298558|12100307|FG001|COMPLETED|1st Annual (A1)||566
10931242|NCT00298558|12100308|FG002|COMPLETED|1st Annual (A1)||601
10931243|NCT00298558|12100309|FG003|COMPLETED|1st Annual (A1)||584
10931244|NCT00298558|12100306|FG000|NOT COMPLETED|1st Annual (A1)||55
10931245|NCT00298558|12100307|FG001|NOT COMPLETED|1st Annual (A1)||63
10931246|NCT00298558|12100308|FG002|NOT COMPLETED|1st Annual (A1)||52
10931247|NCT00298558|12100309|FG003|NOT COMPLETED|1st Annual (A1)||55
10931248|NCT00298558|12100306|FG000|STARTED|2nd Annual (A2)||585
10931249|NCT00298558|12100307|FG001|STARTED|2nd Annual (A2)||566
10931250|NCT00298558|12100308|FG002|STARTED|2nd Annual (A2)||601
10931251|NCT00298558|12100309|FG003|STARTED|2nd Annual (A2)||584
10931252|NCT00298558|12100306|FG000|COMPLETED|2nd Annual (A2)||563
10931253|NCT00298558|12100307|FG001|COMPLETED|2nd Annual (A2)||555
10931254|NCT00298558|12100308|FG002|COMPLETED|2nd Annual (A2)||574
10931255|NCT00298558|12100309|FG003|COMPLETED|2nd Annual (A2)||552
10931256|NCT00298558|12100306|FG000|NOT COMPLETED|2nd Annual (A2)||22
10931257|NCT00298558|12100307|FG001|NOT COMPLETED|2nd Annual (A2)||11
10931258|NCT00298558|12100308|FG002|NOT COMPLETED|2nd Annual (A2)||27
10931259|NCT00298558|12100309|FG003|NOT COMPLETED|2nd Annual (A2)||32
10931260|NCT00298558|12100306|FG000|STARTED|3rd Annual Booster||372
10931261|NCT00298558|12100307|FG001|STARTED|3rd Annual Booster||371
10931262|NCT00298558|12100308|FG002|STARTED|3rd Annual Booster||370
10931263|NCT00298558|12100309|FG003|STARTED|3rd Annual Booster||0
10931264|NCT00298558|12100306|FG000|COMPLETED|3rd Annual Booster||250
10931265|NCT00298558|12100307|FG001|COMPLETED|3rd Annual Booster||243
10931266|NCT00298558|12100308|FG002|COMPLETED|3rd Annual Booster||230
10931267|NCT00298558|12100309|FG003|COMPLETED|3rd Annual Booster||0
10931268|NCT00298558|12100306|FG000|NOT COMPLETED|3rd Annual Booster||122
10931269|NCT00298558|12100307|FG001|NOT COMPLETED|3rd Annual Booster||128
10931270|NCT00298558|12100308|FG002|NOT COMPLETED|3rd Annual Booster||140
10931271|NCT00298558|12100309|FG003|NOT COMPLETED|3rd Annual Booster||0
10931272|NCT00298558|12100306|FG000|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
10931273|NCT00298558|12100307|FG001|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
10931274|NCT00298558|12100308|FG002|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
10931275|NCT00298558|12100309|FG003|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
10931276|NCT00298558|12100306|FG000|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
10931277|NCT00298558|12100307|FG001|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
10931278|NCT00298558|12100308|FG002|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
10931279|NCT00298558|12100309|FG003|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
10931280|NCT00298558|12100306|FG000|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
10931281|NCT00298558|12100307|FG001|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
10931282|NCT00298558|12100308|FG002|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
10931283|NCT00298558|12100309|FG003|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
10931284|NCT00298558|12100306|FG000|STARTED|10th Annual (A10)||472
10931285|NCT00298558|12100307|FG001|STARTED|10th Annual (A10)||469
10931286|NCT00298558|12100308|FG002|STARTED|10th Annual (A10)||490
10931287|NCT00298558|12100309|FG003|STARTED|10th Annual (A10)||448
10931288|NCT00298558|12100306|FG000|COMPLETED|10th Annual (A10)||300
10931289|NCT00298558|12100307|FG001|COMPLETED|10th Annual (A10)||316
10931290|NCT00298558|12100308|FG002|COMPLETED|10th Annual (A10)||319
10931291|NCT00298558|12100309|FG003|COMPLETED|10th Annual (A10)||285
10931292|NCT00298558|12100306|FG000|NOT COMPLETED|10th Annual (A10)||172
10931293|NCT00298558|12100307|FG001|NOT COMPLETED|10th Annual (A10)||153
10931294|NCT00298558|12100308|FG002|NOT COMPLETED|10th Annual (A10)||171
10931295|NCT00298558|12100309|FG003|NOT COMPLETED|10th Annual (A10)||163
10931296|NCT00298610|12100319|FG000|STARTED|Overall Study||30
10931297|NCT00298610|12100319|FG000|COMPLETED|Overall Study||30
10931298|NCT00298610|12100319|FG000|NOT COMPLETED|Overall Study||0
10931299|NCT00298766|12100323|FG000|STARTED|Overall Study||70
10931300|NCT00298766|12100323|FG000|COMPLETED|Overall Study||24
10931301|NCT00298766|12100323|FG000|NOT COMPLETED|Overall Study||46
10931302|NCT00298831|12100327|FG000|STARTED|Overall Study||224
10931303|NCT00298831|12100327|FG000|Treated|Overall Study||197
10931304|NCT00298831|12100327|FG000|COMPLETED|Overall Study||192
10931305|NCT00298831|12100327|FG000|NOT COMPLETED|Overall Study||32
10931306|NCT00298896|12100331|FG000|STARTED|Overall Study||55
10931307|NCT00298896|12100331|FG000|COMPLETED|Overall Study||5
10931308|NCT00298896|12100331|FG000|NOT COMPLETED|Overall Study||50
10931309|NCT00299000|12100337|FG000|STARTED|Overall Study||2
10931310|NCT00299000|12100338|FG001|STARTED|Overall Study||2
10931311|NCT00299000|12100337|FG000|COMPLETED|Overall Study||2
10931312|NCT00299000|12100338|FG001|COMPLETED|Overall Study||2
10931313|NCT00299000|12100337|FG000|NOT COMPLETED|Overall Study||0
10931314|NCT00299000|12100338|FG001|NOT COMPLETED|Overall Study||0
10931315|NCT00299104|12100347|FG000|STARTED|Treatment Period||251
10931316|NCT00299104|12100348|FG001|STARTED|Treatment Period||252
10931317|NCT00299104|12100349|FG002|STARTED|Treatment Period||252
10931318|NCT00299104|12100347|FG000|Safety/ITT: Received Study Drug|Treatment Period||249
10931319|NCT00299104|12100348|FG001|Safety/ITT: Received Study Drug|Treatment Period||249
10931320|NCT00299104|12100349|FG002|Safety/ITT: Received Study Drug|Treatment Period||250
10931321|NCT00299104|12100347|FG000|Completed Week 24|Treatment Period||227
10931322|NCT00299104|12100348|FG001|Completed Week 24|Treatment Period||240
10931323|NCT00299104|12100349|FG002|Completed Week 24|Treatment Period||241
10931324|NCT00299104|12100347|FG000|Completed Week 52|Treatment Period||213
10931325|NCT00299104|12100348|FG001|Completed Week 52|Treatment Period||227
10931326|NCT00299104|12100349|FG002|Completed Week 52|Treatment Period||232
10931327|NCT00299104|12100347|FG000|Completed Week 104|Treatment Period||178
10931328|NCT00299104|12100348|FG001|Completed Week 104|Treatment Period||213
10931329|NCT00299104|12100349|FG002|Completed Week 104|Treatment Period||216
10931330|NCT00299104|12100347|FG000|COMPLETED|Treatment Period|Completed Week 152|62
10931331|NCT00299104|12100348|FG001|COMPLETED|Treatment Period||77
10931332|NCT00299104|12100349|FG002|COMPLETED|Treatment Period||80
10931333|NCT00299104|12100347|FG000|NOT COMPLETED|Treatment Period||189
10931334|NCT00299104|12100348|FG001|NOT COMPLETED|Treatment Period||175
10931335|NCT00299104|12100349|FG002|NOT COMPLETED|Treatment Period||172
10931336|NCT00299104|12100347|FG000|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
10931337|NCT00299104|12100348|FG001|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
10931338|NCT00299104|12100349|FG002|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
10931339|NCT00299104|12100347|FG000|COMPLETED|Safety Follow-Up (SFU) Period||129
10931340|NCT00299104|12100348|FG001|COMPLETED|Safety Follow-Up (SFU) Period||171
10931341|NCT00299104|12100349|FG002|COMPLETED|Safety Follow-Up (SFU) Period||176
10931342|NCT00299104|12100347|FG000|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
10931343|NCT00299104|12100348|FG001|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
10931344|NCT00299104|12100349|FG002|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
10931345|NCT00299104|12100347|FG000|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
10931346|NCT00299104|12100348|FG001|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
10931347|NCT00299104|12100349|FG002|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
10931348|NCT00299104|12100347|FG000|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
10931349|NCT00299104|12100348|FG001|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
10931350|NCT00299104|12100349|FG002|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
10931351|NCT00299104|12100347|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
10931352|NCT00299104|12100348|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
10931353|NCT00299104|12100349|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
10931354|NCT00299130|12100360|FG000|STARTED|Treatment Period (up to 5 Years)||172
10931355|NCT00299130|12100361|FG001|STARTED|Treatment Period (up to 5 Years)||168
10931356|NCT00299130|12100362|FG002|STARTED|Treatment Period (up to 5 Years)||171
10931357|NCT00299130|12100360|FG000|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
10931358|NCT00299130|12100361|FG001|Treated|Treatment Period (up to 5 Years)||167
10931359|NCT00299130|12100362|FG002|Treated|Treatment Period (up to 5 Years)||170
10931360|NCT00299130|12100360|FG000|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
10931361|NCT00299130|12100361|FG001|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
10931362|NCT00299130|12100362|FG002|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
10931363|NCT00299130|12100360|FG000|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
10931364|NCT00299130|12100361|FG001|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
10931365|NCT00299130|12100362|FG002|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
10931366|NCT00299130|12100360|FG000|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
10931367|NCT00299130|12100361|FG001|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
10931368|NCT00299130|12100362|FG002|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
10931369|NCT00299130|12100360|FG000|COMPLETED|Treatment Period (up to 5 Years)||119
10931370|NCT00299130|12100361|FG001|COMPLETED|Treatment Period (up to 5 Years)||125
10931371|NCT00299130|12100362|FG002|COMPLETED|Treatment Period (up to 5 Years)||121
10931372|NCT00299130|12100360|FG000|NOT COMPLETED|Treatment Period (up to 5 Years)||53
10931373|NCT00299130|12100361|FG001|NOT COMPLETED|Treatment Period (up to 5 Years)||43
10931374|NCT00299130|12100362|FG002|NOT COMPLETED|Treatment Period (up to 5 Years)||50
10931375|NCT00299130|12100360|FG000|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
10931376|NCT00299130|12100361|FG001|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
10931377|NCT00299130|12100362|FG002|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
10931378|NCT00299130|12100360|FG000|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
10931379|NCT00299130|12100361|FG001|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
10931380|NCT00299130|12100362|FG002|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
10931381|NCT00299130|12100360|FG000|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
10931382|NCT00299130|12100361|FG001|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
10931383|NCT00299130|12100362|FG002|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
10931384|NCT00299130|12100360|FG000|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
10931385|NCT00299130|12100361|FG001|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
10931386|NCT00299130|12100362|FG002|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
10931387|NCT00299130|12100360|FG000|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
10931388|NCT00299130|12100361|FG001|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
10931389|NCT00299130|12100362|FG002|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
10931390|NCT00299130|12100360|FG000|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
10931391|NCT00299130|12100361|FG001|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
10931392|NCT00299130|12100362|FG002|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
10931393|NCT00299156|12100380|FG000|STARTED|Period 1 (Non-Randomized)||32
10931394|NCT00299156|12100381|FG001|STARTED|Period 1 (Non-Randomized)||0
10931395|NCT00299156|12100382|FG002|STARTED|Period 1 (Non-Randomized)||0
10931396|NCT00299156|12100380|FG000|COMPLETED|Period 1 (Non-Randomized)||32
10931397|NCT00299156|12100381|FG001|COMPLETED|Period 1 (Non-Randomized)||0
10931398|NCT00299156|12100382|FG002|COMPLETED|Period 1 (Non-Randomized)||0
10931399|NCT00299156|12100380|FG000|NOT COMPLETED|Period 1 (Non-Randomized)||0
10931400|NCT00299156|12100381|FG001|NOT COMPLETED|Period 1 (Non-Randomized)||0
10931401|NCT00299156|12100382|FG002|NOT COMPLETED|Period 1 (Non-Randomized)||0
10931402|NCT00299156|12100380|FG000|STARTED|Period 2 (Randomized)||0
10931403|NCT00299156|12100381|FG001|STARTED|Period 2 (Randomized)||17
10931404|NCT00299156|12100382|FG002|STARTED|Period 2 (Randomized)||16
10931405|NCT00299156|12100380|FG000|COMPLETED|Period 2 (Randomized)||0
10931406|NCT00299156|12100381|FG001|COMPLETED|Period 2 (Randomized)||16
10931407|NCT00299156|12100382|FG002|COMPLETED|Period 2 (Randomized)||16
10931408|NCT00299156|12100380|FG000|NOT COMPLETED|Period 2 (Randomized)||0
10931409|NCT00299156|12100381|FG001|NOT COMPLETED|Period 2 (Randomized)||1
10931410|NCT00299156|12100382|FG002|NOT COMPLETED|Period 2 (Randomized)||0
10931411|NCT00299182|12100397|FG000|STARTED|Overall Study||6
10931412|NCT00299182|12100398|FG001|STARTED|Overall Study||4
10931413|NCT00299182|12100399|FG002|STARTED|Overall Study||6
10931414|NCT00299182|12100400|FG003|STARTED|Overall Study||14
10931415|NCT00299182|12100401|FG004|STARTED|Overall Study||8
10931416|NCT00299182|12100402|FG005|STARTED|Overall Study||7
10931417|NCT00299182|12100403|FG006|STARTED|Overall Study||5
10931418|NCT00299182|12100397|FG000|COMPLETED|Overall Study||6
10931419|NCT00299182|12100398|FG001|COMPLETED|Overall Study||4
10931420|NCT00299182|12100399|FG002|COMPLETED|Overall Study||4
10931421|NCT00299182|12100400|FG003|COMPLETED|Overall Study||14
10931422|NCT00299182|12100401|FG004|COMPLETED|Overall Study||5
10931423|NCT00299182|12100402|FG005|COMPLETED|Overall Study||4
10931424|NCT00299182|12100403|FG006|COMPLETED|Overall Study||4
10931425|NCT00299182|12100397|FG000|NOT COMPLETED|Overall Study||0
10931426|NCT00299182|12100398|FG001|NOT COMPLETED|Overall Study||0
10931427|NCT00299182|12100399|FG002|NOT COMPLETED|Overall Study||2
10931428|NCT00299182|12100400|FG003|NOT COMPLETED|Overall Study||0
10931429|NCT00299182|12100401|FG004|NOT COMPLETED|Overall Study||3
10931430|NCT00299182|12100402|FG005|NOT COMPLETED|Overall Study||3
10931431|NCT00299182|12100403|FG006|NOT COMPLETED|Overall Study||1
10931432|NCT00299221|12100423|FG000|STARTED|Overall Study||79
10931433|NCT00299221|12100424|FG001|STARTED|Overall Study||71
10931434|NCT00299221|12100423|FG000|COMPLETED|Overall Study||79
10931435|NCT00299221|12100424|FG001|COMPLETED|Overall Study||71
10931436|NCT00299221|12100423|FG000|NOT COMPLETED|Overall Study||0
10931437|NCT00299221|12100424|FG001|NOT COMPLETED|Overall Study||0
10931438|NCT00299416|12100430|FG000|STARTED|Overall Study||30
10931439|NCT00299416|12100430|FG000|COMPLETED|Overall Study||30
10931440|NCT00299416|12100430|FG000|NOT COMPLETED|Overall Study||0
10931441|NCT00299494|12100440|FG000|STARTED|Overall Study||5
10931442|NCT00299494|12100441|FG001|STARTED|Overall Study||3
10931443|NCT00299494|12100442|FG002|STARTED|Overall Study||7
10931444|NCT00299494|12100443|FG003|STARTED|Overall Study||34
10931445|NCT00299494|12100444|FG004|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
10931446|NCT00299494|12100445|FG005|STARTED|Overall Study||30
10931447|NCT00299494|12100440|FG000|COMPLETED|Overall Study||2
10931448|NCT00299494|12100441|FG001|COMPLETED|Overall Study||2
10931449|NCT00299494|12100442|FG002|COMPLETED|Overall Study||3
10931450|NCT00299494|12100443|FG003|COMPLETED|Overall Study||24
10931451|NCT00299494|12100444|FG004|COMPLETED|Overall Study||13
10931452|NCT00299494|12100445|FG005|COMPLETED|Overall Study||4
10931453|NCT00299494|12100440|FG000|NOT COMPLETED|Overall Study||3
10931454|NCT00299494|12100441|FG001|NOT COMPLETED|Overall Study||1
10931455|NCT00299494|12100442|FG002|NOT COMPLETED|Overall Study||4
10931456|NCT00299494|12100443|FG003|NOT COMPLETED|Overall Study||10
10931457|NCT00299494|12100444|FG004|NOT COMPLETED|Overall Study||27
10931458|NCT00299494|12100445|FG005|NOT COMPLETED|Overall Study||26
10931459|NCT00299546|12100473|FG000|STARTED|Overall Study||155
10931460|NCT00299546|12100474|FG001|STARTED|Overall Study||153
10931461|NCT00299546|12100475|FG002|STARTED|Overall Study||153
10931462|NCT00299546|12100473|FG000|COMPLETED|Overall Study||55
10931463|NCT00299546|12100474|FG001|COMPLETED|Overall Study||61
10931464|NCT00299546|12100475|FG002|COMPLETED|Overall Study||67
10931465|NCT00299546|12100473|FG000|NOT COMPLETED|Overall Study||100
10931466|NCT00299546|12100474|FG001|NOT COMPLETED|Overall Study||92
10931467|NCT00299546|12100475|FG002|NOT COMPLETED|Overall Study||86
10931468|NCT00299689|12100484|FG000|STARTED|Overall Study||69
10931469|NCT00299689|12100484|FG000|COMPLETED|Overall Study||69
10931470|NCT00299689|12100484|FG000|NOT COMPLETED|Overall Study||0
10931471|NCT00299702|12100490|FG000|STARTED|Overall Study||179
10931472|NCT00299702|12100491|FG001|STARTED|Overall Study||176
10931473|NCT00299702|12100490|FG000|COMPLETED|Overall Study||126
10931474|NCT00299702|12100491|FG001|COMPLETED|Overall Study||126
10931475|NCT00299702|12100490|FG000|NOT COMPLETED|Overall Study||53
10931476|NCT00299702|12100491|FG001|NOT COMPLETED|Overall Study||50
10931477|NCT00299741|12100497|FG000|STARTED|Overall Study||36
10931478|NCT00299741|12100497|FG000|COMPLETED|Overall Study||36
10931479|NCT00299741|12100497|FG000|NOT COMPLETED|Overall Study||0
10931480|NCT00299975|12100504|FG000|STARTED|Overall Study||32
10931481|NCT00299975|12100505|FG001|STARTED|Overall Study||32
10931482|NCT00299975|12100506|FG002|STARTED|Overall Study||33
10931483|NCT00299975|12100504|FG000|Received Allocated Intervention|Overall Study||32
10931484|NCT00299975|12100505|FG001|Received Allocated Intervention|Overall Study||32
10931485|NCT00299975|12100506|FG002|Received Allocated Intervention|Overall Study||32
10931486|NCT00299975|12100504|FG000|COMPLETED|Overall Study||29
10931487|NCT00299975|12100505|FG001|COMPLETED|Overall Study||31
10931488|NCT00299975|12100506|FG002|COMPLETED|Overall Study||25
10931489|NCT00299975|12100504|FG000|NOT COMPLETED|Overall Study||3
10931490|NCT00299975|12100505|FG001|NOT COMPLETED|Overall Study||1
10931491|NCT00299975|12100506|FG002|NOT COMPLETED|Overall Study||8
10931492|NCT00299988|12100516|FG000|STARTED|Overall Study||16
10931493|NCT00299988|12100517|FG001|STARTED|Overall Study||8
10931494|NCT00299988|12100516|FG000|COMPLETED|Overall Study||16
10931495|NCT00299988|12100517|FG001|COMPLETED|Overall Study||8
10931496|NCT00299988|12100516|FG000|NOT COMPLETED|Overall Study||0
10931497|NCT00299988|12100517|FG001|NOT COMPLETED|Overall Study||0
10931498|NCT00300053|12100527|FG000|STARTED|Overall Study|started = randomized and treated/injected|55
10931499|NCT00300053|12100528|FG001|STARTED|Overall Study|started = randomized and treated/injected|56
10931500|NCT00300053|12100529|FG002|STARTED|Overall Study|started = randomized and treated/injected|56
10931501|NCT00300053|12100527|FG000|3-Month Evaluation|Overall Study||55
10931502|NCT00300053|12100528|FG001|3-Month Evaluation|Overall Study||56
10931503|NCT00300053|12100529|FG002|3-Month Evaluation|Overall Study||54
10931504|NCT00300053|12100527|FG000|6-Month Evaluation|Overall Study||54
10931505|NCT00300053|12100528|FG001|6-Month Evaluation|Overall Study||55
10931506|NCT00300053|12100529|FG002|6-Month Evaluation|Overall Study||53
10931507|NCT00300053|12100527|FG000|COMPLETED|Overall Study||53
10931508|NCT00300053|12100528|FG001|COMPLETED|Overall Study||53
10931509|NCT00300053|12100529|FG002|COMPLETED|Overall Study||50
10931510|NCT00300053|12100527|FG000|NOT COMPLETED|Overall Study||2
10931511|NCT00300053|12100528|FG001|NOT COMPLETED|Overall Study||3
10931512|NCT00300053|12100529|FG002|NOT COMPLETED|Overall Study||6
10931513|NCT00300235|12100543|FG000|STARTED|Overall Study||208
10931514|NCT00300235|12100544|FG001|STARTED|Overall Study||240
10931515|NCT00300235|12100545|FG002|STARTED|Overall Study||398
10931516|NCT00300235|12100546|FG003|STARTED|Overall Study||362
10931517|NCT00300235|12100547|FG004|STARTED|Overall Study||251
10931518|NCT00300235|12100543|FG000|COMPLETED|Overall Study||208
10931519|NCT00300235|12100544|FG001|COMPLETED|Overall Study||240
10931520|NCT00300235|12100545|FG002|COMPLETED|Overall Study||398
10931521|NCT00300235|12100546|FG003|COMPLETED|Overall Study||362
10931522|NCT00300235|12100547|FG004|COMPLETED|Overall Study||251
10931523|NCT00300235|12100543|FG000|NOT COMPLETED|Overall Study||0
10931524|NCT00300235|12100544|FG001|NOT COMPLETED|Overall Study||0
10931525|NCT00300235|12100545|FG002|NOT COMPLETED|Overall Study||0
10931526|NCT00300235|12100546|FG003|NOT COMPLETED|Overall Study||0
10931527|NCT00300235|12100547|FG004|NOT COMPLETED|Overall Study||0
10931528|NCT00300274|12100562|FG000|STARTED|Overall Study||282
10931529|NCT00300274|12100563|FG001|STARTED|Overall Study||168
10931530|NCT00300274|12100564|FG002|STARTED|Overall Study||271
10931531|NCT00300274|12100562|FG000|Completed 12 Month|Overall Study||250
10931532|NCT00300274|12100563|FG001|Completed 12 Month|Overall Study||149
10931533|NCT00300274|12100564|FG002|Completed 12 Month|Overall Study||248
10931534|NCT00300274|12100562|FG000|COMPLETED|Overall Study||236
10931535|NCT00300274|12100563|FG001|COMPLETED|Overall Study||141
10931536|NCT00300274|12100564|FG002|COMPLETED|Overall Study||226
10931537|NCT00300274|12100562|FG000|NOT COMPLETED|Overall Study||46
10931538|NCT00300274|12100563|FG001|NOT COMPLETED|Overall Study||27
10931539|NCT00300274|12100564|FG002|NOT COMPLETED|Overall Study||45
10931540|NCT00300365|12100574|FG000|STARTED|Overall Study||38
10931541|NCT00300365|12100575|FG001|STARTED|Overall Study||40
10931542|NCT00300365|12100574|FG000|COMPLETED|Overall Study||34
10931543|NCT00300365|12100575|FG001|COMPLETED|Overall Study||38
10931544|NCT00300365|12100574|FG000|NOT COMPLETED|Overall Study||4
10931545|NCT00300365|12100575|FG001|NOT COMPLETED|Overall Study||2
10931546|NCT00300391|12100583|FG000|STARTED|Overall Study||16
10931547|NCT00300391|12100584|FG001|STARTED|Overall Study||14
10931548|NCT00300391|12100583|FG000|COMPLETED|Overall Study||16
10931549|NCT00300391|12100584|FG001|COMPLETED|Overall Study||14
10931550|NCT00300391|12100583|FG000|NOT COMPLETED|Overall Study||0
10931551|NCT00300391|12100584|FG001|NOT COMPLETED|Overall Study||0
10931552|NCT00300430|12100594|FG000|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
10931553|NCT00300430|12100595|FG001|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
10931554|NCT00300430|12100596|FG002|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
10931555|NCT00300430|12100594|FG000|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
10931556|NCT00300430|12100595|FG001|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
10931557|NCT00300430|12100596|FG002|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
10931558|NCT00300430|12100594|FG000|NOT COMPLETED|Overall Study||367
10931559|NCT00300430|12100595|FG001|NOT COMPLETED|Overall Study||169
10931560|NCT00300430|12100596|FG002|NOT COMPLETED|Overall Study||151
10931561|NCT00300456|12100610|FG000|STARTED|Overall Study|"For all arms, started means treated."|119
10931562|NCT00300456|12100611|FG001|STARTED|Overall Study||118
10931563|NCT00300456|12100612|FG002|STARTED|Overall Study||119
10931564|NCT00300456|12100613|FG003|STARTED|Overall Study||119
10931565|NCT00300456|12100614|FG004|STARTED|Overall Study||116
10931566|NCT00300456|12100615|FG005|STARTED|Overall Study||59
10931567|NCT00300456|12100610|FG000|COMPLETED|Overall Study||103
10931568|NCT00300456|12100611|FG001|COMPLETED|Overall Study||102
10931569|NCT00300456|12100612|FG002|COMPLETED|Overall Study||98
10931570|NCT00300456|12100613|FG003|COMPLETED|Overall Study||105
10931571|NCT00300456|12100614|FG004|COMPLETED|Overall Study||99
10931572|NCT00300456|12100615|FG005|COMPLETED|Overall Study||48
10931573|NCT00300456|12100610|FG000|NOT COMPLETED|Overall Study||16
10931574|NCT00300456|12100611|FG001|NOT COMPLETED|Overall Study||16
10931575|NCT00300456|12100612|FG002|NOT COMPLETED|Overall Study||21
10931576|NCT00300456|12100613|FG003|NOT COMPLETED|Overall Study||14
10931577|NCT00300456|12100614|FG004|NOT COMPLETED|Overall Study||17
10931578|NCT00300456|12100615|FG005|NOT COMPLETED|Overall Study||11
10931579|NCT00300469|12100635|FG000|STARTED|Overall Study|"For all arms, started means treated."|110
10931580|NCT00300469|12100636|FG001|STARTED|Overall Study||110
10931581|NCT00300469|12100637|FG002|STARTED|Overall Study||112
10931582|NCT00300469|12100638|FG003|STARTED|Overall Study||113
10931583|NCT00300469|12100639|FG004|STARTED|Overall Study||109
10931584|NCT00300469|12100640|FG005|STARTED|Overall Study||55
10931585|NCT00300469|12100635|FG000|COMPLETED|Overall Study||89
10931586|NCT00300469|12100636|FG001|COMPLETED|Overall Study||89
10931587|NCT00300469|12100637|FG002|COMPLETED|Overall Study||95
10931588|NCT00300469|12100638|FG003|COMPLETED|Overall Study||104
10931589|NCT00300469|12100639|FG004|COMPLETED|Overall Study||95
10931590|NCT00300469|12100640|FG005|COMPLETED|Overall Study||46
10931591|NCT00300469|12100635|FG000|NOT COMPLETED|Overall Study||21
10931592|NCT00300469|12100636|FG001|NOT COMPLETED|Overall Study||21
10931593|NCT00300469|12100637|FG002|NOT COMPLETED|Overall Study||17
10931594|NCT00300469|12100638|FG003|NOT COMPLETED|Overall Study||9
10931595|NCT00300469|12100639|FG004|NOT COMPLETED|Overall Study||14
10931596|NCT00300469|12100640|FG005|NOT COMPLETED|Overall Study||9
10931597|NCT00300482|12100660|FG000|STARTED|Overall Study|"For all arms, started means treated."|261
10931598|NCT00300482|12100661|FG001|STARTED|Overall Study||261
10931599|NCT00300482|12100662|FG002|STARTED|Overall Study||259
10931600|NCT00300482|12100663|FG003|STARTED|Overall Study||261
10931601|NCT00300482|12100664|FG004|STARTED|Overall Study||266
10931602|NCT00300482|12100665|FG005|STARTED|Overall Study||131
10931603|NCT00300482|12100660|FG000|COMPLETED|Overall Study||220
10931604|NCT00300482|12100661|FG001|COMPLETED|Overall Study||220
10931605|NCT00300482|12100662|FG002|COMPLETED|Overall Study||208
10931606|NCT00300482|12100663|FG003|COMPLETED|Overall Study||237
10931607|NCT00300482|12100664|FG004|COMPLETED|Overall Study||243
10931608|NCT00300482|12100665|FG005|COMPLETED|Overall Study||115
10931609|NCT00300482|12100660|FG000|NOT COMPLETED|Overall Study||41
10931610|NCT00300482|12100661|FG001|NOT COMPLETED|Overall Study||41
10931611|NCT00300482|12100662|FG002|NOT COMPLETED|Overall Study||51
10931612|NCT00300482|12100663|FG003|NOT COMPLETED|Overall Study||24
10931613|NCT00300482|12100664|FG004|NOT COMPLETED|Overall Study||23
10931614|NCT00300482|12100665|FG005|NOT COMPLETED|Overall Study||16
10931615|NCT00300495|12100681|FG000|STARTED|Overall Study||10
10931616|NCT00300495|12100682|FG001|STARTED|Overall Study||9
10931617|NCT00300495|12100681|FG000|COMPLETED|Overall Study||6
10931618|NCT00300495|12100682|FG001|COMPLETED|Overall Study||8
10931619|NCT00300495|12100681|FG000|NOT COMPLETED|Overall Study||4
10931620|NCT00300495|12100682|FG001|NOT COMPLETED|Overall Study||1
10931621|NCT00300677|12100688|FG000|STARTED|Overall Study||12
10931622|NCT00300677|12100688|FG000|COMPLETED|Overall Study||12
10931623|NCT00300677|12100688|FG000|NOT COMPLETED|Overall Study||0
10931624|NCT00300742|12100692|FG000|STARTED|Overall Study||5
10931625|NCT00300742|12100692|FG000|COMPLETED|Overall Study||3
10931626|NCT00300742|12100692|FG000|NOT COMPLETED|Overall Study||2
10931627|NCT00300755|12100700|FG000|STARTED|Overall Study||18
10931628|NCT00300755|12100701|FG001|STARTED|Overall Study||21
10931629|NCT00300755|12100702|FG002|STARTED|Overall Study||21
10931630|NCT00300755|12100700|FG000|COMPLETED|Overall Study||17
10931631|NCT00300755|12100701|FG001|COMPLETED|Overall Study||17
10931632|NCT00300755|12100702|FG002|COMPLETED|Overall Study||19
10931633|NCT00300755|12100700|FG000|NOT COMPLETED|Overall Study||1
10931634|NCT00300755|12100701|FG001|NOT COMPLETED|Overall Study||4
10931635|NCT00300755|12100702|FG002|NOT COMPLETED|Overall Study||2
10931636|NCT00300781|12100712|FG000|STARTED|Overall Study||66
10931637|NCT00300781|12100713|FG001|STARTED|Overall Study||70
10931638|NCT00300781|12100712|FG000|COMPLETED|Overall Study||3
10931639|NCT00300781|12100713|FG001|COMPLETED|Overall Study||8
10931640|NCT00300781|12100712|FG000|NOT COMPLETED|Overall Study||63
10931641|NCT00300781|12100713|FG001|NOT COMPLETED|Overall Study||62
10931642|NCT00300885|12100721|FG000|STARTED|Treatment||464
10931643|NCT00300885|12100722|FG001|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
10931644|NCT00300885|12100721|FG000|Received Treatment|Treatment||463
10931645|NCT00300885|12100722|FG001|Received Treatment|Treatment||459
10931646|NCT00300885|12100721|FG000|COMPLETED|Treatment||91
10931647|NCT00300885|12100722|FG001|COMPLETED|Treatment||88
10931648|NCT00300885|12100721|FG000|NOT COMPLETED|Treatment||373
10931649|NCT00300885|12100722|FG001|NOT COMPLETED|Treatment||374
10931650|NCT00300885|12100721|FG000|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
10931651|NCT00300885|12100722|FG001|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
10931652|NCT00300885|12100721|FG000|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
10931653|NCT00300885|12100722|FG001|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
10931654|NCT00300885|12100721|FG000|NOT COMPLETED|Follow-up||178
10931655|NCT00300885|12100722|FG001|NOT COMPLETED|Follow-up||195
10931656|NCT00301028|12100728|FG000|STARTED|Overall Study||47
10931657|NCT00301028|12100728|FG000|COMPLETED|Overall Study||47
10931658|NCT00301028|12100728|FG000|NOT COMPLETED|Overall Study||0
10931659|NCT00301067|12100732|FG000|STARTED|Completed DLT Period/1st Cycle||4
10931660|NCT00301067|12100733|FG001|STARTED|Completed DLT Period/1st Cycle||3
10931661|NCT00301067|12100734|FG002|STARTED|Completed DLT Period/1st Cycle||3
10931662|NCT00301067|12100735|FG003|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
10931663|NCT00301067|12100732|FG000|COMPLETED|Completed DLT Period/1st Cycle||3
10931664|NCT00301067|12100733|FG001|COMPLETED|Completed DLT Period/1st Cycle||3
10931665|NCT00301067|12100734|FG002|COMPLETED|Completed DLT Period/1st Cycle||3
10931666|NCT00301067|12100735|FG003|COMPLETED|Completed DLT Period/1st Cycle||9
10931667|NCT00301067|12100732|FG000|NOT COMPLETED|Completed DLT Period/1st Cycle||1
10931668|NCT00301067|12100733|FG001|NOT COMPLETED|Completed DLT Period/1st Cycle||0
10931669|NCT00301067|12100734|FG002|NOT COMPLETED|Completed DLT Period/1st Cycle||0
10931670|NCT00301067|12100735|FG003|NOT COMPLETED|Completed DLT Period/1st Cycle||1
10931671|NCT00301067|12100732|FG000|STARTED|Reached 1st Response/2 Cycles||3
10931672|NCT00301067|12100733|FG001|STARTED|Reached 1st Response/2 Cycles||3
10931673|NCT00301067|12100734|FG002|STARTED|Reached 1st Response/2 Cycles||3
10931674|NCT00301067|12100735|FG003|STARTED|Reached 1st Response/2 Cycles||9
10931675|NCT00301067|12100732|FG000|COMPLETED|Reached 1st Response/2 Cycles||1
10931676|NCT00301067|12100733|FG001|COMPLETED|Reached 1st Response/2 Cycles||2
10931677|NCT00301067|12100734|FG002|COMPLETED|Reached 1st Response/2 Cycles||2
10931678|NCT00301067|12100735|FG003|COMPLETED|Reached 1st Response/2 Cycles||7
10931679|NCT00301067|12100732|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2
10931680|NCT00301067|12100733|FG001|NOT COMPLETED|Reached 1st Response/2 Cycles||1
10931681|NCT00301067|12100734|FG002|NOT COMPLETED|Reached 1st Response/2 Cycles||1
10931682|NCT00301067|12100735|FG003|NOT COMPLETED|Reached 1st Response/2 Cycles||2
10931683|NCT00301067|12100732|FG000|STARTED|Completed 4 Cycles of Treatment||1
10931684|NCT00301067|12100733|FG001|STARTED|Completed 4 Cycles of Treatment||2
10931685|NCT00301067|12100734|FG002|STARTED|Completed 4 Cycles of Treatment||2
10931686|NCT00301067|12100735|FG003|STARTED|Completed 4 Cycles of Treatment||7
10931687|NCT00301067|12100732|FG000|COMPLETED|Completed 4 Cycles of Treatment||0
10931688|NCT00301067|12100733|FG001|COMPLETED|Completed 4 Cycles of Treatment||1
10931689|NCT00301067|12100734|FG002|COMPLETED|Completed 4 Cycles of Treatment||0
10931690|NCT00301067|12100735|FG003|COMPLETED|Completed 4 Cycles of Treatment||2
10931691|NCT00301067|12100732|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||1
10931692|NCT00301067|12100733|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||1
10931693|NCT00301067|12100734|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||2
10931694|NCT00301067|12100735|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||5
10931695|NCT00301067|12100732|FG000|STARTED|Completed 12 Cycles of Treatment||0
10931696|NCT00301067|12100733|FG001|STARTED|Completed 12 Cycles of Treatment||1
10931697|NCT00301067|12100734|FG002|STARTED|Completed 12 Cycles of Treatment||0
10931698|NCT00301067|12100735|FG003|STARTED|Completed 12 Cycles of Treatment||2
10931699|NCT00301067|12100732|FG000|COMPLETED|Completed 12 Cycles of Treatment||0
10931700|NCT00301067|12100733|FG001|COMPLETED|Completed 12 Cycles of Treatment||0
10931701|NCT00301067|12100734|FG002|COMPLETED|Completed 12 Cycles of Treatment||0
10931702|NCT00301067|12100735|FG003|COMPLETED|Completed 12 Cycles of Treatment||0
10931703|NCT00301067|12100732|FG000|NOT COMPLETED|Completed 12 Cycles of Treatment||0
10931704|NCT00301067|12100733|FG001|NOT COMPLETED|Completed 12 Cycles of Treatment||1
10931705|NCT00301067|12100734|FG002|NOT COMPLETED|Completed 12 Cycles of Treatment||0
10931706|NCT00301067|12100735|FG003|NOT COMPLETED|Completed 12 Cycles of Treatment||2
10931707|NCT00301067|12100732|FG000|STARTED|Follow up Until Death||4
10931708|NCT00301067|12100733|FG001|STARTED|Follow up Until Death||3
10931709|NCT00301067|12100734|FG002|STARTED|Follow up Until Death||3
10931710|NCT00301067|12100735|FG003|STARTED|Follow up Until Death||3
10931711|NCT00301067|12100732|FG000|COMPLETED|Follow up Until Death||3
10931712|NCT00301067|12100733|FG001|COMPLETED|Follow up Until Death||3
10931713|NCT00301067|12100734|FG002|COMPLETED|Follow up Until Death||3
10931714|NCT00301067|12100735|FG003|COMPLETED|Follow up Until Death||2
10931715|NCT00301067|12100732|FG000|NOT COMPLETED|Follow up Until Death||1
10931716|NCT00301067|12100733|FG001|NOT COMPLETED|Follow up Until Death||0
10931717|NCT00301067|12100734|FG002|NOT COMPLETED|Follow up Until Death||0
10931718|NCT00301067|12100735|FG003|NOT COMPLETED|Follow up Until Death||1
10931719|NCT00301366|12100746|FG000|STARTED|Overall Study||38
10931720|NCT00301366|12100746|FG000|COMPLETED|Overall Study||37
10931721|NCT00301366|12100746|FG000|NOT COMPLETED|Overall Study||1
10931722|NCT00301418|12100750|FG000|STARTED|Overall Study||11
10931723|NCT00301418|12100750|FG000|COMPLETED|Overall Study||11
10931724|NCT00301418|12100750|FG000|NOT COMPLETED|Overall Study||0
10931725|NCT00301756|12100754|FG000|STARTED|Overall Study||32
10931726|NCT00301756|12100754|FG000|COMPLETED|Overall Study||32
10931727|NCT00301756|12100754|FG000|NOT COMPLETED|Overall Study||0
10931728|NCT00301808|12100760|FG000|STARTED|Overall Study||29
10931729|NCT00301808|12100760|FG000|COMPLETED|Overall Study||17
10931730|NCT00301808|12100760|FG000|NOT COMPLETED|Overall Study||12
10931731|NCT00301821|12100764|FG000|STARTED|Overall Study||107
10931732|NCT00301821|12100764|FG000|COMPLETED|Overall Study||81
10931733|NCT00301821|12100764|FG000|NOT COMPLETED|Overall Study||26
10931734|NCT00301834|12100768|FG000|STARTED|Overall Study||35
10931735|NCT00301834|12100768|FG000|COMPLETED|Overall Study||34
10931736|NCT00301834|12100768|FG000|NOT COMPLETED|Overall Study||1
10931737|NCT00301873|12100775|FG000|STARTED|Overall Study||59
10931738|NCT00301873|12100775|FG000|COMPLETED|Overall Study||59
10931739|NCT00301873|12100775|FG000|NOT COMPLETED|Overall Study||0
10931740|NCT00301964|12100779|FG000|STARTED|Overall Study||56
10931741|NCT00301964|12100779|FG000|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
10931742|NCT00301964|12100779|FG000|NOT COMPLETED|Overall Study||4
10931743|NCT00302003|12100789|FG000|STARTED|Overall Study||287
10931744|NCT00302003|12100789|FG000|COMPLETED|Overall Study||207
10931745|NCT00302003|12100789|FG000|NOT COMPLETED|Overall Study||80
10931746|NCT00302042|12100795|FG000|STARTED|Overall Study||46
10931747|NCT00302042|12100796|FG001|STARTED|Overall Study||46
10931748|NCT00302042|12100795|FG000|COMPLETED|Overall Study||39
10931749|NCT00302042|12100796|FG001|COMPLETED|Overall Study||38
10931750|NCT00302042|12100795|FG000|NOT COMPLETED|Overall Study||7
10931751|NCT00302042|12100796|FG001|NOT COMPLETED|Overall Study||8
10931752|NCT00302055|12100804|FG000|STARTED|Overall Study||23
10931753|NCT00302055|12100805|FG001|STARTED|Overall Study||49
10931754|NCT00302055|12100804|FG000|COMPLETED|Overall Study||14
10931755|NCT00302055|12100805|FG001|COMPLETED|Overall Study||36
10931756|NCT00302055|12100804|FG000|NOT COMPLETED|Overall Study||9
10931757|NCT00302055|12100805|FG001|NOT COMPLETED|Overall Study||13
10931758|NCT00302068|12100814|FG000|STARTED|Overall Study||37
10931759|NCT00302068|12100815|FG001|STARTED|Overall Study||40
10931760|NCT00302068|12100816|FG002|STARTED|Overall Study||24
10931761|NCT00302068|12100814|FG000|COMPLETED|Overall Study||36
10931762|NCT00302068|12100815|FG001|COMPLETED|Overall Study||36
10931763|NCT00302068|12100816|FG002|COMPLETED|Overall Study||23
10931764|NCT00302068|12100814|FG000|NOT COMPLETED|Overall Study||1
10931765|NCT00302068|12100815|FG001|NOT COMPLETED|Overall Study||4
10931766|NCT00302068|12100816|FG002|NOT COMPLETED|Overall Study||1
10931767|NCT00302081|12100828|FG000|STARTED|Overall Study||237
10931768|NCT00302081|12100829|FG001|STARTED|Overall Study||229
10931769|NCT00302081|12100830|FG002|STARTED|Overall Study||230
10931770|NCT00302081|12100828|FG000|COMPLETED|Overall Study||181
10931771|NCT00302081|12100829|FG001|COMPLETED|Overall Study||186
10931772|NCT00302081|12100830|FG002|COMPLETED|Overall Study||178
10931773|NCT00302081|12100828|FG000|NOT COMPLETED|Overall Study||56
10931774|NCT00302081|12100829|FG001|NOT COMPLETED|Overall Study||43
10931775|NCT00302081|12100830|FG002|NOT COMPLETED|Overall Study||52
10931776|NCT00302107|12100840|FG000|STARTED|Overall Study||39
10931777|NCT00302107|12100841|FG001|STARTED|Overall Study||39
10931778|NCT00302107|12100840|FG000|COMPLETED|Overall Study||31
10931779|NCT00302107|12100841|FG001|COMPLETED|Overall Study||30
10931780|NCT00302107|12100840|FG000|NOT COMPLETED|Overall Study||8
10931781|NCT00302107|12100841|FG001|NOT COMPLETED|Overall Study||9
10931782|NCT00302133|12100849|FG000|STARTED|Overall Study||9
10931783|NCT00302133|12100850|FG001|STARTED|Overall Study||9
10931784|NCT00302133|12100849|FG000|COMPLETED|Overall Study||5
10931785|NCT00302133|12100850|FG001|COMPLETED|Overall Study||5
10931786|NCT00302133|12100849|FG000|NOT COMPLETED|Overall Study||4
10931787|NCT00302133|12100850|FG001|NOT COMPLETED|Overall Study||4
10931788|NCT00302159|12100856|FG000|STARTED|Overall Study||43
10931789|NCT00302159|12100856|FG000|COMPLETED|Overall Study||41
10931790|NCT00302159|12100856|FG000|NOT COMPLETED|Overall Study||2
10931791|NCT00302211|12100864|FG000|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26
10931792|NCT00302211|12100865|FG001|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27
10931793|NCT00302211|12100866|FG002|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14
10931794|NCT00302211|12100867|FG003|STARTED|Double Blind Period (New Patients)||0
10931795|NCT00302211|12100868|FG004|STARTED|Double Blind Period (New Patients)||0
10931796|NCT00302211|12100864|FG000|COMPLETED|Double Blind Period (New Patients)||23
10931797|NCT00302211|12100865|FG001|COMPLETED|Double Blind Period (New Patients)||25
10931798|NCT00302211|12100866|FG002|COMPLETED|Double Blind Period (New Patients)||10
10931799|NCT00302211|12100867|FG003|COMPLETED|Double Blind Period (New Patients)||0
10931800|NCT00302211|12100868|FG004|COMPLETED|Double Blind Period (New Patients)||0
10931801|NCT00302211|12100864|FG000|NOT COMPLETED|Double Blind Period (New Patients)||3
10931802|NCT00302211|12100865|FG001|NOT COMPLETED|Double Blind Period (New Patients)||2
10931803|NCT00302211|12100866|FG002|NOT COMPLETED|Double Blind Period (New Patients)||4
10931804|NCT00302211|12100867|FG003|NOT COMPLETED|Double Blind Period (New Patients)||0
10931805|NCT00302211|12100868|FG004|NOT COMPLETED|Double Blind Period (New Patients)||0
10931806|NCT00302211|12100864|FG000|STARTED|Open Label-Patients From Double-Blind||0
10931807|NCT00302211|12100865|FG001|STARTED|Open Label-Patients From Double-Blind||0
10931808|NCT00302211|12100866|FG002|STARTED|Open Label-Patients From Double-Blind||0
10931809|NCT00302211|12100867|FG003|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
10931810|NCT00302211|12100868|FG004|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
10931811|NCT00302211|12100864|FG000|COMPLETED|Open Label-Patients From Double-Blind||0
10931812|NCT00302211|12100865|FG001|COMPLETED|Open Label-Patients From Double-Blind||0
10931813|NCT00302211|12100866|FG002|COMPLETED|Open Label-Patients From Double-Blind||0
10931814|NCT00302211|12100867|FG003|COMPLETED|Open Label-Patients From Double-Blind||18
10931815|NCT00302211|12100868|FG004|COMPLETED|Open Label-Patients From Double-Blind||24
10931816|NCT00302211|12100864|FG000|NOT COMPLETED|Open Label-Patients From Double-Blind||0
10931817|NCT00302211|12100865|FG001|NOT COMPLETED|Open Label-Patients From Double-Blind||0
10931818|NCT00302211|12100866|FG002|NOT COMPLETED|Open Label-Patients From Double-Blind||0
10931819|NCT00302211|12100867|FG003|NOT COMPLETED|Open Label-Patients From Double-Blind||8
10931820|NCT00302211|12100868|FG004|NOT COMPLETED|Open Label-Patients From Double-Blind||8
10931821|NCT00302328|12100883|FG000|STARTED|Overall Study||25
10931822|NCT00302328|12100884|FG001|STARTED|Overall Study||35
10931823|NCT00302328|12100885|FG002|STARTED|Overall Study||18
10931824|NCT00302328|12100883|FG000|COMPLETED|Overall Study||25
10931825|NCT00302328|12100884|FG001|COMPLETED|Overall Study|developed cancer during the study|34
10931826|NCT00302328|12100885|FG002|COMPLETED|Overall Study||18
10931827|NCT00302328|12100883|FG000|NOT COMPLETED|Overall Study||0
10931828|NCT00302328|12100884|FG001|NOT COMPLETED|Overall Study||1
10931829|NCT00302328|12100885|FG002|NOT COMPLETED|Overall Study||0
10931830|NCT00302458|12100896|FG000|STARTED|Overall Study||29
10931831|NCT00302458|12100896|FG000|COMPLETED|Overall Study||26
10931832|NCT00302458|12100896|FG000|NOT COMPLETED|Overall Study||3
10931833|NCT00302718|12100908|FG000|STARTED|Overall Study||20
10931834|NCT00302718|12100909|FG001|STARTED|Overall Study||21
10931835|NCT00302718|12100910|FG002|STARTED|Overall Study||21
10931836|NCT00302718|12100911|FG003|STARTED|Overall Study||21
10931837|NCT00302718|12100908|FG000|COMPLETED|Overall Study||19
10931838|NCT00302718|12100909|FG001|COMPLETED|Overall Study||20
10931839|NCT00302718|12100910|FG002|COMPLETED|Overall Study||19
10931840|NCT00302718|12100911|FG003|COMPLETED|Overall Study||19
10931841|NCT00302718|12100908|FG000|NOT COMPLETED|Overall Study||1
10931842|NCT00302718|12100909|FG001|NOT COMPLETED|Overall Study||1
10931843|NCT00302718|12100910|FG002|NOT COMPLETED|Overall Study||2
10931844|NCT00302718|12100911|FG003|NOT COMPLETED|Overall Study||2
10931845|NCT00302731|12100930|FG000|STARTED|Overall Study||6
10931846|NCT00302731|12100931|FG001|STARTED|Overall Study||6
10931847|NCT00302731|12100932|FG002|STARTED|Overall Study||5
10931848|NCT00302731|12100933|FG003|STARTED|Overall Study||4
10931849|NCT00302731|12100930|FG000|COMPLETED|Overall Study||2
10931850|NCT00302731|12100931|FG001|COMPLETED|Overall Study||1
10931851|NCT00302731|12100932|FG002|COMPLETED|Overall Study||2
10931852|NCT00302731|12100933|FG003|COMPLETED|Overall Study||4
10931853|NCT00302731|12100930|FG000|NOT COMPLETED|Overall Study||4
10931854|NCT00302731|12100931|FG001|NOT COMPLETED|Overall Study||5
10931855|NCT00302731|12100932|FG002|NOT COMPLETED|Overall Study||3
10931856|NCT00302731|12100933|FG003|NOT COMPLETED|Overall Study||0
10931857|NCT00302848|12100946|FG000|STARTED|Overall Study||16534
10931858|NCT00302848|12100947|FG001|STARTED|Overall Study||15428
10931859|NCT00302848|12100948|FG002|STARTED|Overall Study||26341
10931860|NCT00302848|12100946|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
10931861|NCT00302848|12100947|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
10931862|NCT00302848|12100948|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
10931863|NCT00302848|12100946|FG000|NOT COMPLETED|Overall Study||401
10931864|NCT00302848|12100947|FG001|NOT COMPLETED|Overall Study||419
10931865|NCT00302848|12100948|FG002|NOT COMPLETED|Overall Study||579
10931866|NCT00303069|12100959|FG000|STARTED|Overall Study||31
10931867|NCT00303069|12100960|FG001|STARTED|Overall Study||28
10931868|NCT00303069|12100961|FG002|STARTED|Overall Study||34
10931869|NCT00303069|12100962|FG003|STARTED|Overall Study||31
10931870|NCT00303069|12100959|FG000|COMPLETED|Overall Study||29
10931871|NCT00303069|12100960|FG001|COMPLETED|Overall Study||28
10931872|NCT00303069|12100961|FG002|COMPLETED|Overall Study||33
10931873|NCT00303069|12100962|FG003|COMPLETED|Overall Study||29
10931874|NCT00303069|12100959|FG000|NOT COMPLETED|Overall Study||2
10931875|NCT00303069|12100960|FG001|NOT COMPLETED|Overall Study||0
10931876|NCT00303069|12100961|FG002|NOT COMPLETED|Overall Study||1
10931877|NCT00303069|12100962|FG003|NOT COMPLETED|Overall Study||2
10931878|NCT00303108|12100975|FG000|STARTED|Overall Study||43
10931879|NCT00303108|12100976|FG001|STARTED|Overall Study||46
10931880|NCT00303108|12100977|FG002|STARTED|Overall Study||47
10931881|NCT00303108|12100975|FG000|COMPLETED|Overall Study||31
10931882|NCT00303108|12100976|FG001|COMPLETED|Overall Study||37
10931883|NCT00303108|12100977|FG002|COMPLETED|Overall Study||31
10931884|NCT00303108|12100975|FG000|NOT COMPLETED|Overall Study||12
10931885|NCT00303108|12100976|FG001|NOT COMPLETED|Overall Study||9
10931886|NCT00303108|12100977|FG002|NOT COMPLETED|Overall Study||16
10931887|NCT00303186|12100984|FG000|STARTED|Overall Study||107
10931888|NCT00303186|12100984|FG000|COMPLETED|Overall Study||55
10931889|NCT00303186|12100984|FG000|NOT COMPLETED|Overall Study||52
10931890|NCT00303316|12100990|FG000|STARTED|Overall Study||232
10931891|NCT00303316|12100991|FG001|STARTED|Overall Study||226
10931892|NCT00303316|12100990|FG000|COMPLETED|Overall Study||230
10931893|NCT00303316|12100991|FG001|COMPLETED|Overall Study||223
10931894|NCT00303316|12100990|FG000|NOT COMPLETED|Overall Study||2
10931895|NCT00303316|12100991|FG001|NOT COMPLETED|Overall Study||3
10931896|NCT00303329|12100999|FG000|STARTED|Overall Study||85
10931897|NCT00303329|12101000|FG001|STARTED|Overall Study||99
10931898|NCT00303329|12100999|FG000|COMPLETED|Overall Study||50
10931899|NCT00303329|12101000|FG001|COMPLETED|Overall Study||37
10931900|NCT00303329|12100999|FG000|NOT COMPLETED|Overall Study||35
10931901|NCT00303329|12101000|FG001|NOT COMPLETED|Overall Study||62
10931902|NCT00303446|12101008|FG000|STARTED|Overall Study||25
10931903|NCT00303446|12101009|FG001|STARTED|Overall Study||25
10931904|NCT00303446|12101008|FG000|COMPLETED|Overall Study||23
10931905|NCT00303446|12101009|FG001|COMPLETED|Overall Study||21
10931906|NCT00303446|12101008|FG000|NOT COMPLETED|Overall Study||2
10931907|NCT00303446|12101009|FG001|NOT COMPLETED|Overall Study||4
10931908|NCT00303459|12101017|FG000|STARTED|Overall Study||159
10931909|NCT00303459|12101018|FG001|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
10931910|NCT00303459|12101017|FG000|COMPLETED|Overall Study||76
10931911|NCT00303459|12101018|FG001|COMPLETED|Overall Study||86
10931912|NCT00303459|12101017|FG000|NOT COMPLETED|Overall Study||83
10931913|NCT00303459|12101018|FG001|NOT COMPLETED|Overall Study||89
10931914|NCT00303472|12101032|FG000|STARTED|Treatment Period||6
10931915|NCT00303472|12101033|FG001|STARTED|Treatment Period||11
10931916|NCT00303472|12101034|FG002|STARTED|Treatment Period||11
10931917|NCT00303472|12101035|FG003|STARTED|Treatment Period||16
10931918|NCT00303472|12101036|FG004|STARTED|Treatment Period||11
10931919|NCT00303472|12101037|FG005|STARTED|Treatment Period||12
10931920|NCT00303472|12101038|FG006|STARTED|Treatment Period||5
10931921|NCT00303472|12101032|FG000|COMPLETED|Treatment Period||6
10931922|NCT00303472|12101033|FG001|COMPLETED|Treatment Period||11
10931923|NCT00303472|12101034|FG002|COMPLETED|Treatment Period||11
10931924|NCT00303472|12101035|FG003|COMPLETED|Treatment Period||14
10931925|NCT00303472|12101036|FG004|COMPLETED|Treatment Period||8
10931926|NCT00303472|12101037|FG005|COMPLETED|Treatment Period||11
10931927|NCT00303472|12101038|FG006|COMPLETED|Treatment Period||3
10931928|NCT00303472|12101032|FG000|NOT COMPLETED|Treatment Period||0
10931929|NCT00303472|12101033|FG001|NOT COMPLETED|Treatment Period||0
10931930|NCT00303472|12101034|FG002|NOT COMPLETED|Treatment Period||0
10931931|NCT00303472|12101035|FG003|NOT COMPLETED|Treatment Period||2
10931932|NCT00303472|12101036|FG004|NOT COMPLETED|Treatment Period||3
10931933|NCT00303472|12101037|FG005|NOT COMPLETED|Treatment Period||1
10931934|NCT00303472|12101038|FG006|NOT COMPLETED|Treatment Period||2
10931935|NCT00303472|12101032|FG000|STARTED|Treatment Extension (Optional)||6
10931936|NCT00303472|12101033|FG001|STARTED|Treatment Extension (Optional)||11
10931937|NCT00303472|12101034|FG002|STARTED|Treatment Extension (Optional)||11
10931938|NCT00303472|12101035|FG003|STARTED|Treatment Extension (Optional)||13
10931939|NCT00303472|12101036|FG004|STARTED|Treatment Extension (Optional)||5
10931940|NCT00303472|12101037|FG005|STARTED|Treatment Extension (Optional)||5
10931941|NCT00303472|12101038|FG006|STARTED|Treatment Extension (Optional)||1
10931942|NCT00303472|12101032|FG000|COMPLETED|Treatment Extension (Optional)||1
10931943|NCT00303472|12101033|FG001|COMPLETED|Treatment Extension (Optional)||5
10931944|NCT00303472|12101034|FG002|COMPLETED|Treatment Extension (Optional)||2
10931945|NCT00303472|12101035|FG003|COMPLETED|Treatment Extension (Optional)||5
10931946|NCT00303472|12101036|FG004|COMPLETED|Treatment Extension (Optional)||1
10931947|NCT00303472|12101037|FG005|COMPLETED|Treatment Extension (Optional)||4
10931948|NCT00303472|12101038|FG006|COMPLETED|Treatment Extension (Optional)||1
10931949|NCT00303472|12101032|FG000|NOT COMPLETED|Treatment Extension (Optional)||5
10931950|NCT00303472|12101033|FG001|NOT COMPLETED|Treatment Extension (Optional)||6
10931951|NCT00303472|12101034|FG002|NOT COMPLETED|Treatment Extension (Optional)||9
10931952|NCT00303472|12101035|FG003|NOT COMPLETED|Treatment Extension (Optional)||8
10931953|NCT00303472|12101036|FG004|NOT COMPLETED|Treatment Extension (Optional)||4
10931954|NCT00303472|12101037|FG005|NOT COMPLETED|Treatment Extension (Optional)||1
10931955|NCT00303472|12101038|FG006|NOT COMPLETED|Treatment Extension (Optional)||0
10931956|NCT00303485|12101056|FG000|STARTED|Overall Study||49
10931957|NCT00303485|12101057|FG001|STARTED|Overall Study||17
10931958|NCT00303485|12101056|FG000|COMPLETED|Overall Study||48
10931959|NCT00303485|12101057|FG001|COMPLETED|Overall Study||15
10931960|NCT00303485|12101056|FG000|NOT COMPLETED|Overall Study||1
10931961|NCT00303485|12101057|FG001|NOT COMPLETED|Overall Study||2
10931962|NCT00303511|12101063|FG000|STARTED|Overall Study||10
10931963|NCT00303511|12101063|FG000|COMPLETED|Overall Study||10
10931964|NCT00303511|12101063|FG000|NOT COMPLETED|Overall Study||0
10931965|NCT00303602|12101069|FG000|STARTED|Overall Study||84
10931966|NCT00303602|12101070|FG001|STARTED|Overall Study||65
10931967|NCT00303602|12101069|FG000|COMPLETED|Overall Study||65
10931968|NCT00303602|12101070|FG001|COMPLETED|Overall Study||50
10931969|NCT00303602|12101069|FG000|NOT COMPLETED|Overall Study||19
10931970|NCT00303602|12101070|FG001|NOT COMPLETED|Overall Study||15
10931971|NCT00303628|12101078|FG000|STARTED|Overall Study||176
10931972|NCT00303628|12101079|FG001|STARTED|Overall Study||179
10931973|NCT00303628|12101078|FG000|Eligible|Overall Study||171
10931974|NCT00303628|12101079|FG001|Eligible|Overall Study||177
10931975|NCT00303628|12101078|FG000|Treated|Overall Study||173
10931976|NCT00303628|12101079|FG001|Treated|Overall Study||174
10931977|NCT00303628|12101078|FG000|COMPLETED|Overall Study||126
10931978|NCT00303628|12101079|FG001|COMPLETED|Overall Study||106
10931979|NCT00303628|12101078|FG000|NOT COMPLETED|Overall Study||50
10931980|NCT00303628|12101079|FG001|NOT COMPLETED|Overall Study||73
10931981|NCT00303667|12101087|FG000|STARTED|Overall Study||8
10931982|NCT00303667|12101088|FG001|STARTED|Overall Study||39
10931983|NCT00303667|12101087|FG000|COMPLETED|Overall Study||8
10931984|NCT00303667|12101088|FG001|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
10931985|NCT00303667|12101087|FG000|NOT COMPLETED|Overall Study||0
10931986|NCT00303667|12101088|FG001|NOT COMPLETED|Overall Study||4
10931987|NCT00303719|12101096|FG000|STARTED|Overall Study||13
10931988|NCT00303719|12101097|FG001|STARTED|Overall Study||329
10931989|NCT00303719|12101096|FG000|COMPLETED|Overall Study||13
10931990|NCT00303719|12101097|FG001|COMPLETED|Overall Study||292
10931991|NCT00303719|12101096|FG000|NOT COMPLETED|Overall Study||0
10931992|NCT00303719|12101097|FG001|NOT COMPLETED|Overall Study||37
10931993|NCT00303823|12101106|FG000|STARTED|Overall Study||50
10931994|NCT00303823|12101107|FG001|STARTED|Overall Study||48
10931995|NCT00303823|12101106|FG000|COMPLETED|Overall Study||35
10931996|NCT00303823|12101107|FG001|COMPLETED|Overall Study||38
10931997|NCT00303823|12101106|FG000|NOT COMPLETED|Overall Study||15
10931998|NCT00303823|12101107|FG001|NOT COMPLETED|Overall Study||10
10931999|NCT00303862|12101113|FG000|STARTED|Overall Study||10
10932000|NCT00303862|12101113|FG000|COMPLETED|Overall Study||10
10932001|NCT00303862|12101113|FG000|NOT COMPLETED|Overall Study||0
10932002|NCT00303901|12101117|FG000|STARTED|Overall Study||40
10932003|NCT00303901|12101117|FG000|COMPLETED|Overall Study||40
10932004|NCT00303901|12101117|FG000|NOT COMPLETED|Overall Study||0
10932005|NCT00303953|12101121|FG000|STARTED|Overall Study||22
10932006|NCT00303953|12101121|FG000|Eligible|Overall Study||21
10932007|NCT00303953|12101121|FG000|Eligible and Treated|Overall Study||20
10932008|NCT00303953|12101121|FG000|COMPLETED|Overall Study||3
10932009|NCT00303953|12101121|FG000|NOT COMPLETED|Overall Study||19
10932010|NCT00303966|12101125|FG000|STARTED|Overall Study||5
10932011|NCT00303966|12101125|FG000|COMPLETED|Overall Study||5
10932012|NCT00303966|12101125|FG000|NOT COMPLETED|Overall Study||0
10932013|NCT00303979|12101132|FG000|STARTED|Overall Study|at baseline|15177
10932014|NCT00303979|12101133|FG001|STARTED|Overall Study|at 6 months|9992
10932015|NCT00303979|12101134|FG002|STARTED|Overall Study|at 18 months|9641
10932016|NCT00303979|12101132|FG000|COMPLETED|Overall Study|at 24 Months|7605
10932017|NCT00303979|12101133|FG001|COMPLETED|Overall Study|at 6 months|9992
10932018|NCT00303979|12101134|FG002|COMPLETED|Overall Study|at 18 months|9641
10932019|NCT00303979|12101132|FG000|NOT COMPLETED|Overall Study||7572
10932020|NCT00303979|12101133|FG001|NOT COMPLETED|Overall Study||0
10932021|NCT00303979|12101134|FG002|NOT COMPLETED|Overall Study||0
10932022|NCT00304031|12101154|FG000|STARTED|Concomitant RT+TMZ (Pre-randomization)|All participants registered to concomitant treatment; randomized after completing this treatment.|1125
10932023|NCT00304031|12101155|FG001|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
10932024|NCT00304031|12101156|FG002|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
10932025|NCT00304031|12101154|FG000|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||1125
10932026|NCT00304031|12101155|FG001|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
10932027|NCT00304031|12101156|FG002|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
10932028|NCT00304031|12101154|FG000|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||1120
10932029|NCT00304031|12101155|FG001|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
10932030|NCT00304031|12101156|FG002|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
10932031|NCT00304031|12101154|FG000|COMPLETED|Concomitant RT+TMZ (Pre-randomization)|These participants completed concomitant treatment and met requirements for randomization.|833
10932032|NCT00304031|12101155|FG001|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
10932033|NCT00304031|12101156|FG002|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
10932034|NCT00304031|12101154|FG000|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||292
10932035|NCT00304031|12101155|FG001|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
10932036|NCT00304031|12101156|FG002|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
10932037|NCT00304031|12101154|FG000|STARTED|Randomization to Adjuvant TMZ Arm||0
10932038|NCT00304031|12101155|FG001|STARTED|Randomization to Adjuvant TMZ Arm||411
10932039|NCT00304031|12101156|FG002|STARTED|Randomization to Adjuvant TMZ Arm||422
10932040|NCT00304031|12101154|FG000|Eligible Population|Randomization to Adjuvant TMZ Arm||0
10932041|NCT00304031|12101155|FG001|Eligible Population|Randomization to Adjuvant TMZ Arm||411
10932042|NCT00304031|12101156|FG002|Eligible Population|Randomization to Adjuvant TMZ Arm||420
10932043|NCT00304031|12101154|FG000|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
10932044|NCT00304031|12101155|FG001|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||254
10932045|NCT00304031|12101156|FG002|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||262
10932046|NCT00304031|12101154|FG000|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
10932047|NCT00304031|12101155|FG001|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
10932048|NCT00304031|12101156|FG002|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
10932049|NCT00304031|12101154|FG000|Quality of Life Population|Randomization to Adjuvant TMZ Arm||0
10932050|NCT00304031|12101155|FG001|Quality of Life Population|Randomization to Adjuvant TMZ Arm||96
10932051|NCT00304031|12101156|FG002|Quality of Life Population|Randomization to Adjuvant TMZ Arm||95
10932052|NCT00304031|12101154|FG000|COMPLETED|Randomization to Adjuvant TMZ Arm||0
10932053|NCT00304031|12101155|FG001|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|411
10932054|NCT00304031|12101156|FG002|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|420
10932055|NCT00304031|12101154|FG000|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
10932056|NCT00304031|12101155|FG001|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
10932057|NCT00304031|12101156|FG002|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
10932058|NCT00304083|12101173|FG000|STARTED|Overall Study||34
10932059|NCT00304083|12101174|FG001|STARTED|Overall Study||14
10932060|NCT00304083|12101173|FG000|Completed 4 Cycles|Overall Study||22
10932061|NCT00304083|12101174|FG001|Completed 4 Cycles|Overall Study||7
10932062|NCT00304083|12101173|FG000|Patients Treated With Surgery|Overall Study||7
10932063|NCT00304083|12101174|FG001|Patients Treated With Surgery|Overall Study||3
10932064|NCT00304083|12101173|FG000|Patients Treated With Surgery and RT|Overall Study||5
10932065|NCT00304083|12101174|FG001|Patients Treated With Surgery and RT|Overall Study||1
10932066|NCT00304083|12101173|FG000|Patients Treated With RT Only|Overall Study||4
10932067|NCT00304083|12101174|FG001|Patients Treated With RT Only|Overall Study||2
10932068|NCT00304083|12101173|FG000|Patients Had Neither RT or Surgery|Overall Study||6
10932069|NCT00304083|12101174|FG001|Patients Had Neither RT or Surgery|Overall Study||1
10932070|NCT00304083|12101173|FG000|COMPLETED|Overall Study||12
10932071|NCT00304083|12101174|FG001|COMPLETED|Overall Study||6
10932072|NCT00304083|12101173|FG000|NOT COMPLETED|Overall Study||22
10932073|NCT00304083|12101174|FG001|NOT COMPLETED|Overall Study||8
10932074|NCT00304096|12101182|FG000|STARTED|Overall Study||6
10932075|NCT00304096|12101183|FG001|STARTED|Overall Study||5
10932076|NCT00304096|12101182|FG000|COMPLETED|Overall Study||6
10932077|NCT00304096|12101183|FG001|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
10932078|NCT00304096|12101182|FG000|NOT COMPLETED|Overall Study||0
10932079|NCT00304096|12101183|FG001|NOT COMPLETED|Overall Study||0
10932080|NCT00304161|12101191|FG000|STARTED|Overall Study||28
10932081|NCT00304161|12101192|FG001|STARTED|Overall Study||27
10932082|NCT00304161|12101191|FG000|COMPLETED|Overall Study||22
10932083|NCT00304161|12101192|FG001|COMPLETED|Overall Study||21
10932084|NCT00304161|12101191|FG000|NOT COMPLETED|Overall Study||6
10932085|NCT00304161|12101192|FG001|NOT COMPLETED|Overall Study||6
10932086|NCT00304187|12101200|FG000|STARTED|Overall Study||15
10932087|NCT00304187|12101201|FG001|STARTED|Overall Study||14
10932088|NCT00304187|12101200|FG000|COMPLETED|Overall Study||13
10932089|NCT00304187|12101201|FG001|COMPLETED|Overall Study||13
10932090|NCT00304187|12101200|FG000|NOT COMPLETED|Overall Study||2
10932091|NCT00304187|12101201|FG001|NOT COMPLETED|Overall Study||1
10932092|NCT00304265|12101211|FG000|STARTED|Overall Study||117
10932093|NCT00304265|12101212|FG001|STARTED|Overall Study||98
10932094|NCT00304265|12101211|FG000|COMPLETED|Overall Study||117
10932095|NCT00304265|12101212|FG001|COMPLETED|Overall Study||98
10932096|NCT00304265|12101211|FG000|NOT COMPLETED|Overall Study||0
10932097|NCT00304265|12101212|FG001|NOT COMPLETED|Overall Study||0
10932098|NCT00304278|12101218|FG000|STARTED|Overall Study||21
10932099|NCT00304278|12101218|FG000|COMPLETED|Overall Study||19
10932100|NCT00304278|12101218|FG000|NOT COMPLETED|Overall Study||2
10932101|NCT00304356|12101222|FG000|STARTED|Nitazoxanide||27
10932102|NCT00304356|12101222|FG000|COMPLETED|Nitazoxanide||22
10932103|NCT00304356|12101222|FG000|NOT COMPLETED|Nitazoxanide||5
10932104|NCT00304356|12101222|FG000|STARTED|Nitazoxanide||27
10932105|NCT00304356|12101222|FG000|COMPLETED|Nitazoxanide||22
10932106|NCT00304356|12101222|FG000|NOT COMPLETED|Nitazoxanide||5
10932107|NCT00304512|12101229|FG000|STARTED|Treatment Period||2
10932108|NCT00304512|12101230|FG001|STARTED|Treatment Period||4
10932109|NCT00304512|12101231|FG002|STARTED|Treatment Period||3
10932110|NCT00304512|12101229|FG000|Safety Population|Treatment Period||2
10932111|NCT00304512|12101230|FG001|Safety Population|Treatment Period||4
10932112|NCT00304512|12101231|FG002|Safety Population|Treatment Period||3
10932113|NCT00304512|12101229|FG000|Pharmacokinetic (PK) Population|Treatment Period||2
10932114|NCT00304512|12101230|FG001|Pharmacokinetic (PK) Population|Treatment Period||4
10932115|NCT00304512|12101231|FG002|Pharmacokinetic (PK) Population|Treatment Period||3
10932116|NCT00304512|12101229|FG000|Pharmacodynamic (PD) Population|Treatment Period||2
10932117|NCT00304512|12101230|FG001|Pharmacodynamic (PD) Population|Treatment Period||4
10932118|NCT00304512|12101231|FG002|Pharmacodynamic (PD) Population|Treatment Period||3
10932119|NCT00304512|12101229|FG000|COMPLETED|Treatment Period||2
10932120|NCT00304512|12101230|FG001|COMPLETED|Treatment Period||4
10932121|NCT00304512|12101231|FG002|COMPLETED|Treatment Period||3
10932122|NCT00304512|12101229|FG000|NOT COMPLETED|Treatment Period||0
10932123|NCT00304512|12101230|FG001|NOT COMPLETED|Treatment Period||0
10932124|NCT00304512|12101231|FG002|NOT COMPLETED|Treatment Period||0
10932125|NCT00304512|12101229|FG000|STARTED|Extension Period||2
10932126|NCT00304512|12101230|FG001|STARTED|Extension Period||4
10932127|NCT00304512|12101231|FG002|STARTED|Extension Period||3
10932128|NCT00304512|12101229|FG000|COMPLETED|Extension Period||2
10932129|NCT00304512|12101230|FG001|COMPLETED|Extension Period||4
10932130|NCT00304512|12101231|FG002|COMPLETED|Extension Period||3
10932131|NCT00304512|12101229|FG000|NOT COMPLETED|Extension Period||0
10932132|NCT00304512|12101230|FG001|NOT COMPLETED|Extension Period||0
10932133|NCT00304512|12101231|FG002|NOT COMPLETED|Extension Period||0
10932134|NCT00304707|12101241|FG000|STARTED|Overall Study||73
10932135|NCT00304707|12101242|FG001|STARTED|Overall Study||70
10932136|NCT00304707|12101241|FG000|COMPLETED|Overall Study||66
10932137|NCT00304707|12101242|FG001|COMPLETED|Overall Study||64
10932138|NCT00304707|12101241|FG000|NOT COMPLETED|Overall Study||7
10932139|NCT00304707|12101242|FG001|NOT COMPLETED|Overall Study||6
10932140|NCT00304746|12101250|FG000|STARTED|Overall Study||50
10932141|NCT00304746|12101251|FG001|STARTED|Overall Study||50
10932142|NCT00304746|12101250|FG000|COMPLETED|Overall Study||50
10932143|NCT00304746|12101251|FG001|COMPLETED|Overall Study||50
10932144|NCT00304746|12101250|FG000|NOT COMPLETED|Overall Study||0
10932145|NCT00304746|12101251|FG001|NOT COMPLETED|Overall Study||0
10932146|NCT04721171|12101259|FG000|STARTED|Overall Study||2
10932147|NCT04721171|12101260|FG001|STARTED|Overall Study||2
10932148|NCT04721171|12101259|FG000|COMPLETED|Overall Study||2
10932149|NCT04721171|12101260|FG001|COMPLETED|Overall Study||2
10932150|NCT04721171|12101259|FG000|NOT COMPLETED|Overall Study||0
10932151|NCT04721171|12101260|FG001|NOT COMPLETED|Overall Study||0
10932152|NCT04717323|12101270|FG000|STARTED|Overall Study||0
10932153|NCT04717323|12101271|FG001|STARTED|Overall Study||10
10932154|NCT04717323|12101270|FG000|COMPLETED|Overall Study||0
10932155|NCT04717323|12101271|FG001|COMPLETED|Overall Study||10
10932156|NCT04717323|12101270|FG000|NOT COMPLETED|Overall Study||0
10932157|NCT04717323|12101271|FG001|NOT COMPLETED|Overall Study||0
10932158|NCT04511338|12101279|FG000|STARTED|Period 1||8
10932159|NCT04511338|12101280|FG001|STARTED|Period 1||8
10932160|NCT04511338|12101279|FG000|COMPLETED|Period 1||7
10932161|NCT04511338|12101280|FG001|COMPLETED|Period 1||8
10932162|NCT04511338|12101279|FG000|NOT COMPLETED|Period 1||1
10932163|NCT04511338|12101280|FG001|NOT COMPLETED|Period 1||0
10932164|NCT04511338|12101279|FG000|STARTED|Washout|"We followed the rules in protocol (brief version in SARP sec. 3.1) to withdraw or move subjects to the next period.~Period 1:~Dialyzer with Endexo has grade 4 clotting, subjects is withdrawn from the study~CombiSet with grade 4 clotting only (not the dialyzer): subjects end Period 1, move to Washout, and then Period 2~There was a subject with CombiSet bloodline grade 4 clotting in the 50% heparin reduction HD. The subject was moved to washout period without any heparin free sessions."|8
10932165|NCT04511338|12101280|FG001|STARTED|Washout||8
10932166|NCT04511338|12101279|FG000|COMPLETED|Washout||8
10932167|NCT04511338|12101280|FG001|COMPLETED|Washout||8
10932168|NCT04511338|12101279|FG000|NOT COMPLETED|Washout||0
10932169|NCT04511338|12101280|FG001|NOT COMPLETED|Washout||0
10932170|NCT04511338|12101279|FG000|STARTED|Period 2||8
10932171|NCT04511338|12101280|FG001|STARTED|Period 2||8
10932172|NCT04511338|12101279|FG000|COMPLETED|Period 2||8
10932173|NCT04511338|12101280|FG001|COMPLETED|Period 2||5
10932174|NCT04511338|12101279|FG000|NOT COMPLETED|Period 2||0
10932175|NCT04511338|12101280|FG001|NOT COMPLETED|Period 2||3
10932176|NCT04493931|12101293|FG000|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||14
10932177|NCT04493931|12101294|FG001|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932178|NCT04493931|12101295|FG002|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932179|NCT04493931|12101296|FG003|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932180|NCT04493931|12101297|FG004|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932181|NCT04493931|12101298|FG005|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932182|NCT04493931|12101299|FG006|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932183|NCT04493931|12101293|FG000|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||13
10932184|NCT04493931|12101294|FG001|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932185|NCT04493931|12101295|FG002|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932186|NCT04493931|12101296|FG003|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932187|NCT04493931|12101297|FG004|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932188|NCT04493931|12101298|FG005|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932189|NCT04493931|12101299|FG006|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932190|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||1
10932191|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932192|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932193|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932194|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932195|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932196|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
10932197|NCT04493931|12101293|FG000|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||13
10932198|NCT04493931|12101294|FG001|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932199|NCT04493931|12101295|FG002|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932200|NCT04493931|12101296|FG003|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932201|NCT04493931|12101297|FG004|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932202|NCT04493931|12101298|FG005|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932203|NCT04493931|12101299|FG006|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932204|NCT04493931|12101293|FG000|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||13
10932205|NCT04493931|12101294|FG001|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932206|NCT04493931|12101295|FG002|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932207|NCT04493931|12101296|FG003|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932208|NCT04493931|12101297|FG004|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932209|NCT04493931|12101298|FG005|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932210|NCT04493931|12101299|FG006|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932211|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932212|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932213|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932214|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932215|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932216|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932217|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
10932218|NCT04493931|12101293|FG000|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||13
10932219|NCT04493931|12101294|FG001|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932220|NCT04493931|12101295|FG002|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932221|NCT04493931|12101296|FG003|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932222|NCT04493931|12101297|FG004|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932223|NCT04493931|12101298|FG005|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932224|NCT04493931|12101299|FG006|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932225|NCT04493931|12101293|FG000|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||13
10932226|NCT04493931|12101294|FG001|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932227|NCT04493931|12101295|FG002|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932228|NCT04493931|12101296|FG003|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932229|NCT04493931|12101297|FG004|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932230|NCT04493931|12101298|FG005|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932231|NCT04493931|12101299|FG006|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932232|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932233|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932234|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932235|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932236|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932237|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932238|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
10932239|NCT04493931|12101293|FG000|STARTED|Cohort 1: Follow-up (Up to 7 Days)||13
10932240|NCT04493931|12101294|FG001|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
10932241|NCT04493931|12101295|FG002|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
10932242|NCT04493931|12101296|FG003|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
10932243|NCT04493931|12101297|FG004|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
10932244|NCT04493931|12101298|FG005|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
10932245|NCT04493931|12101299|FG006|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
10932246|NCT04493931|12101293|FG000|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||13
10932247|NCT04493931|12101294|FG001|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10932248|NCT04493931|12101295|FG002|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10932249|NCT04493931|12101296|FG003|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10932250|NCT04493931|12101297|FG004|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10932251|NCT04493931|12101298|FG005|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10932252|NCT04493931|12101299|FG006|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10932253|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10932254|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10932255|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10932256|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10932257|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10932258|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10932259|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
10932260|NCT04493931|12101293|FG000|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932261|NCT04493931|12101294|FG001|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||17
10932262|NCT04493931|12101295|FG002|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932263|NCT04493931|12101296|FG003|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932264|NCT04493931|12101297|FG004|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932265|NCT04493931|12101298|FG005|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932266|NCT04493931|12101299|FG006|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932267|NCT04493931|12101293|FG000|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932268|NCT04493931|12101294|FG001|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||17
10932269|NCT04493931|12101295|FG002|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932270|NCT04493931|12101296|FG003|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932271|NCT04493931|12101297|FG004|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932272|NCT04493931|12101298|FG005|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932273|NCT04493931|12101299|FG006|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932274|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932275|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932276|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932277|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932278|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932279|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932280|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
10932281|NCT04493931|12101293|FG000|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932282|NCT04493931|12101294|FG001|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||17
10932283|NCT04493931|12101295|FG002|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932284|NCT04493931|12101296|FG003|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932285|NCT04493931|12101297|FG004|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932286|NCT04493931|12101298|FG005|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932287|NCT04493931|12101299|FG006|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932288|NCT04493931|12101293|FG000|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932289|NCT04493931|12101294|FG001|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||17
10932290|NCT04493931|12101295|FG002|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932291|NCT04493931|12101296|FG003|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932292|NCT04493931|12101297|FG004|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932293|NCT04493931|12101298|FG005|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932294|NCT04493931|12101299|FG006|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932295|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932296|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932297|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932298|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932299|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932300|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932301|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
10932302|NCT04493931|12101293|FG000|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932303|NCT04493931|12101294|FG001|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||17
10932304|NCT04493931|12101295|FG002|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932305|NCT04493931|12101296|FG003|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932306|NCT04493931|12101297|FG004|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932307|NCT04493931|12101298|FG005|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932308|NCT04493931|12101299|FG006|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932309|NCT04493931|12101293|FG000|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932310|NCT04493931|12101294|FG001|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||14
10932311|NCT04493931|12101295|FG002|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932312|NCT04493931|12101296|FG003|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932313|NCT04493931|12101297|FG004|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932314|NCT04493931|12101298|FG005|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932315|NCT04493931|12101299|FG006|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932316|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932317|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||3
10932318|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932319|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932320|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932321|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932322|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
10932323|NCT04493931|12101293|FG000|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
10932324|NCT04493931|12101294|FG001|STARTED|Cohort 2: Follow-up (Up to 10 Days)||14
10932325|NCT04493931|12101295|FG002|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
10932326|NCT04493931|12101296|FG003|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
10932327|NCT04493931|12101297|FG004|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
10932328|NCT04493931|12101298|FG005|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
10932329|NCT04493931|12101299|FG006|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
10932330|NCT04493931|12101293|FG000|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10932331|NCT04493931|12101294|FG001|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||14
10932332|NCT04493931|12101295|FG002|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10932333|NCT04493931|12101296|FG003|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10932334|NCT04493931|12101297|FG004|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10932335|NCT04493931|12101298|FG005|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10932336|NCT04493931|12101299|FG006|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10932337|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10932338|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10932339|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10932340|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10932341|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10932342|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10932343|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
10932344|NCT04493931|12101293|FG000|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932345|NCT04493931|12101294|FG001|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932346|NCT04493931|12101295|FG002|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||10
10932347|NCT04493931|12101296|FG003|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||9
10932348|NCT04493931|12101297|FG004|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932349|NCT04493931|12101298|FG005|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932350|NCT04493931|12101299|FG006|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932351|NCT04493931|12101293|FG000|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932352|NCT04493931|12101294|FG001|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932353|NCT04493931|12101295|FG002|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||9
10932354|NCT04493931|12101296|FG003|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||9
10932355|NCT04493931|12101297|FG004|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932356|NCT04493931|12101298|FG005|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932357|NCT04493931|12101299|FG006|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932358|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932359|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932360|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||1
10932361|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932362|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932363|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932364|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
10932365|NCT04493931|12101293|FG000|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932366|NCT04493931|12101294|FG001|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932367|NCT04493931|12101295|FG002|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||9
10932368|NCT04493931|12101296|FG003|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||9
10932369|NCT04493931|12101297|FG004|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932370|NCT04493931|12101298|FG005|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932371|NCT04493931|12101299|FG006|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932372|NCT04493931|12101293|FG000|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932373|NCT04493931|12101294|FG001|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932374|NCT04493931|12101295|FG002|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||9
10932375|NCT04493931|12101296|FG003|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||9
10932376|NCT04493931|12101297|FG004|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932377|NCT04493931|12101298|FG005|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932378|NCT04493931|12101299|FG006|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932379|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932380|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932381|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932382|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932383|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932384|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932385|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
10932386|NCT04493931|12101293|FG000|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932387|NCT04493931|12101294|FG001|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932388|NCT04493931|12101295|FG002|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||9
10932389|NCT04493931|12101296|FG003|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||9
10932390|NCT04493931|12101297|FG004|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932391|NCT04493931|12101298|FG005|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932392|NCT04493931|12101299|FG006|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932393|NCT04493931|12101293|FG000|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932394|NCT04493931|12101294|FG001|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932395|NCT04493931|12101295|FG002|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||9
10932396|NCT04493931|12101296|FG003|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||9
10932397|NCT04493931|12101297|FG004|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932398|NCT04493931|12101298|FG005|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932399|NCT04493931|12101299|FG006|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932400|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932401|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932402|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932403|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932404|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932405|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932406|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
10932407|NCT04493931|12101293|FG000|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
10932408|NCT04493931|12101294|FG001|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
10932409|NCT04493931|12101295|FG002|STARTED|Cohort 3: Follow-up (Up to 10 Days)||9
10932410|NCT04493931|12101296|FG003|STARTED|Cohort 3: Follow-up (Up to 10 Days)||9
10932411|NCT04493931|12101297|FG004|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
10932412|NCT04493931|12101298|FG005|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
10932413|NCT04493931|12101299|FG006|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
10932414|NCT04493931|12101293|FG000|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10932415|NCT04493931|12101294|FG001|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10932416|NCT04493931|12101295|FG002|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||9
10932417|NCT04493931|12101296|FG003|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||9
10932418|NCT04493931|12101297|FG004|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10932419|NCT04493931|12101298|FG005|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10932420|NCT04493931|12101299|FG006|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10932421|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10932422|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10932423|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10932424|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10932425|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10932426|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10932427|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
10932428|NCT04493931|12101293|FG000|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932429|NCT04493931|12101294|FG001|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932430|NCT04493931|12101295|FG002|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932431|NCT04493931|12101296|FG003|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932432|NCT04493931|12101297|FG004|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||6
10932433|NCT04493931|12101298|FG005|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||5
10932434|NCT04493931|12101299|FG006|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||3
10932435|NCT04493931|12101293|FG000|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932436|NCT04493931|12101294|FG001|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932437|NCT04493931|12101295|FG002|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932438|NCT04493931|12101296|FG003|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932439|NCT04493931|12101297|FG004|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||6
10932440|NCT04493931|12101298|FG005|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||5
10932441|NCT04493931|12101299|FG006|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||3
10932442|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932443|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932444|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932445|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932446|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932447|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932448|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
10932449|NCT04493931|12101293|FG000|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932450|NCT04493931|12101294|FG001|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932451|NCT04493931|12101295|FG002|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932452|NCT04493931|12101296|FG003|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932453|NCT04493931|12101297|FG004|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||6
10932454|NCT04493931|12101298|FG005|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||5
10932455|NCT04493931|12101299|FG006|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||3
10932456|NCT04493931|12101293|FG000|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932457|NCT04493931|12101294|FG001|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932458|NCT04493931|12101295|FG002|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932459|NCT04493931|12101296|FG003|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932460|NCT04493931|12101297|FG004|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||6
10932461|NCT04493931|12101298|FG005|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||5
10932462|NCT04493931|12101299|FG006|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||3
10932463|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932464|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932465|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932466|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932467|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932468|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932469|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
10932470|NCT04493931|12101293|FG000|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932471|NCT04493931|12101294|FG001|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932472|NCT04493931|12101295|FG002|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932473|NCT04493931|12101296|FG003|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932474|NCT04493931|12101297|FG004|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||6
10932475|NCT04493931|12101298|FG005|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||5
10932476|NCT04493931|12101299|FG006|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||3
10932477|NCT04493931|12101293|FG000|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932478|NCT04493931|12101294|FG001|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932479|NCT04493931|12101295|FG002|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932480|NCT04493931|12101296|FG003|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932481|NCT04493931|12101297|FG004|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||6
10932482|NCT04493931|12101298|FG005|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||5
10932483|NCT04493931|12101299|FG006|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||3
10932484|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932485|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932486|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932487|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932488|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932489|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932490|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
10932491|NCT04493931|12101293|FG000|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932492|NCT04493931|12101294|FG001|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932493|NCT04493931|12101295|FG002|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932494|NCT04493931|12101296|FG003|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932495|NCT04493931|12101297|FG004|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||6
10932496|NCT04493931|12101298|FG005|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||5
10932497|NCT04493931|12101299|FG006|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||3
10932498|NCT04493931|12101293|FG000|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932499|NCT04493931|12101294|FG001|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932500|NCT04493931|12101295|FG002|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932501|NCT04493931|12101296|FG003|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932502|NCT04493931|12101297|FG004|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||6
10932503|NCT04493931|12101298|FG005|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||5
10932504|NCT04493931|12101299|FG006|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||3
10932505|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932506|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932507|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932508|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932509|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932510|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932511|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
10932512|NCT04493931|12101293|FG000|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932513|NCT04493931|12101294|FG001|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932514|NCT04493931|12101295|FG002|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932515|NCT04493931|12101296|FG003|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932516|NCT04493931|12101297|FG004|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||6
10932517|NCT04493931|12101298|FG005|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||5
10932518|NCT04493931|12101299|FG006|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||3
10932519|NCT04493931|12101293|FG000|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932520|NCT04493931|12101294|FG001|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932521|NCT04493931|12101295|FG002|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932522|NCT04493931|12101296|FG003|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932523|NCT04493931|12101297|FG004|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||6
10932524|NCT04493931|12101298|FG005|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||5
10932525|NCT04493931|12101299|FG006|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||3
10932526|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932527|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932528|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932529|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932530|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932531|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932532|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
10932533|NCT04493931|12101293|FG000|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
10932534|NCT04493931|12101294|FG001|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
10932535|NCT04493931|12101295|FG002|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
10932536|NCT04493931|12101296|FG003|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
10932537|NCT04493931|12101297|FG004|STARTED|Cohort 4: Follow-up (Up to 7 Days)||6
10932538|NCT04493931|12101298|FG005|STARTED|Cohort 4: Follow-up (Up to 7 Days)||5
10932539|NCT04493931|12101299|FG006|STARTED|Cohort 4: Follow-up (Up to 7 Days)||3
10932540|NCT04493931|12101293|FG000|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10932698|NCT00304915|12101480|FG001|COMPLETED|Overall Study||110
10932541|NCT04493931|12101294|FG001|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10932542|NCT04493931|12101295|FG002|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10932543|NCT04493931|12101296|FG003|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10932544|NCT04493931|12101297|FG004|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||6
10932545|NCT04493931|12101298|FG005|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||5
10932546|NCT04493931|12101299|FG006|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||3
10932547|NCT04493931|12101293|FG000|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10932548|NCT04493931|12101294|FG001|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10932549|NCT04493931|12101295|FG002|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10932550|NCT04493931|12101296|FG003|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10932551|NCT04493931|12101297|FG004|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10932552|NCT04493931|12101298|FG005|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10932553|NCT04493931|12101299|FG006|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
10932554|NCT04262947|12101332|FG000|STARTED|Overall Study||13
10932555|NCT04262947|12101333|FG001|STARTED|Overall Study||13
10932556|NCT04262947|12101334|FG002|STARTED|Overall Study||12
10932557|NCT04262947|12101332|FG000|COMPLETED|Overall Study||13
10932558|NCT04262947|12101333|FG001|COMPLETED|Overall Study||13
10932559|NCT04262947|12101334|FG002|COMPLETED|Overall Study||12
10932560|NCT04262947|12101332|FG000|NOT COMPLETED|Overall Study||0
10932561|NCT04262947|12101333|FG001|NOT COMPLETED|Overall Study||0
10932562|NCT04262947|12101334|FG002|NOT COMPLETED|Overall Study||0
10932563|NCT04177680|12101342|FG000|STARTED|Overall Study||49
10932564|NCT04177680|12101343|FG001|STARTED|Overall Study||51
10932565|NCT04177680|12101342|FG000|COMPLETED|Overall Study||47
10932566|NCT04177680|12101343|FG001|COMPLETED|Overall Study||48
10932567|NCT04177680|12101342|FG000|NOT COMPLETED|Overall Study||2
10932568|NCT04177680|12101343|FG001|NOT COMPLETED|Overall Study||3
10932569|NCT03999554|12101354|FG000|STARTED|Overall Study||42
10932570|NCT03999554|12101355|FG001|STARTED|Overall Study||41
10932571|NCT03999554|12101356|FG002|STARTED|Overall Study||40
10932572|NCT03999554|12101357|FG003|STARTED|Overall Study||42
10932573|NCT03999554|12101358|FG004|STARTED|Overall Study||41
10932574|NCT03999554|12101354|FG000|COMPLETED|Overall Study||36
10932575|NCT03999554|12101355|FG001|COMPLETED|Overall Study||34
10932576|NCT03999554|12101356|FG002|COMPLETED|Overall Study||28
10932577|NCT03999554|12101357|FG003|COMPLETED|Overall Study||35
10932578|NCT03999554|12101358|FG004|COMPLETED|Overall Study||32
10932579|NCT03999554|12101354|FG000|NOT COMPLETED|Overall Study||6
10932580|NCT03999554|12101355|FG001|NOT COMPLETED|Overall Study||7
10932581|NCT03999554|12101356|FG002|NOT COMPLETED|Overall Study||12
10932582|NCT03999554|12101357|FG003|NOT COMPLETED|Overall Study||7
10932583|NCT03999554|12101358|FG004|NOT COMPLETED|Overall Study||9
10932584|NCT03651622|12101374|FG000|STARTED|Diet Period 1 (Randomization 1)||23
10932585|NCT03651622|12101375|FG001|STARTED|Diet Period 1 (Randomization 1)||24
10932586|NCT03651622|12101376|FG002|STARTED|Diet Period 1 (Randomization 1)||21
10932587|NCT03651622|12101374|FG000|COMPLETED|Diet Period 1 (Randomization 1)||19
10932588|NCT03651622|12101375|FG001|COMPLETED|Diet Period 1 (Randomization 1)||17
10932589|NCT03651622|12101376|FG002|COMPLETED|Diet Period 1 (Randomization 1)||12
10932590|NCT03651622|12101374|FG000|NOT COMPLETED|Diet Period 1 (Randomization 1)||4
10932591|NCT03651622|12101375|FG001|NOT COMPLETED|Diet Period 1 (Randomization 1)||7
10932592|NCT03651622|12101376|FG002|NOT COMPLETED|Diet Period 1 (Randomization 1)||9
10932593|NCT03651622|12101374|FG000|STARTED|Diet Period 2 (Randomization 2)||19
10932594|NCT03651622|12101375|FG001|STARTED|Diet Period 2 (Randomization 2)||15
10932595|NCT03651622|12101376|FG002|STARTED|Diet Period 2 (Randomization 2)||14
10932596|NCT03651622|12101374|FG000|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||0
10932597|NCT03651622|12101375|FG001|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||5
10932598|NCT03651622|12101376|FG002|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||5
10932599|NCT03651622|12101374|FG000|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||5
10932600|NCT03651622|12101375|FG001|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||0
10932601|NCT03651622|12101376|FG002|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||6
10932602|NCT03651622|12101374|FG000|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||5
10932603|NCT03651622|12101375|FG001|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||4
10932604|NCT03651622|12101376|FG002|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||0
10932605|NCT03651622|12101374|FG000|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||9
10932606|NCT03651622|12101375|FG001|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||6
10932607|NCT03651622|12101376|FG002|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||3
10932608|NCT03651622|12101374|FG000|COMPLETED|Diet Period 2 (Randomization 2)||17
10932609|NCT03651622|12101375|FG001|COMPLETED|Diet Period 2 (Randomization 2)||13
10932610|NCT03651622|12101376|FG002|COMPLETED|Diet Period 2 (Randomization 2)||11
10932611|NCT03651622|12101374|FG000|NOT COMPLETED|Diet Period 2 (Randomization 2)||2
10932612|NCT03651622|12101375|FG001|NOT COMPLETED|Diet Period 2 (Randomization 2)||2
10932613|NCT03651622|12101376|FG002|NOT COMPLETED|Diet Period 2 (Randomization 2)||3
10932614|NCT03651622|12101374|FG000|STARTED|Diet Period 3 (Randomization 3)||14
10932615|NCT03651622|12101375|FG001|STARTED|Diet Period 3 (Randomization 3)||9
10932616|NCT03651622|12101376|FG002|STARTED|Diet Period 3 (Randomization 3)||18
10932617|NCT03651622|12101374|FG000|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||0
10932618|NCT03651622|12101375|FG001|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||2
10932619|NCT03651622|12101376|FG002|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||10
10932620|NCT03651622|12101374|FG000|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||4
10932621|NCT03651622|12101375|FG001|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||0
10932622|NCT03651622|12101376|FG002|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||6
10932623|NCT03651622|12101374|FG000|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||6
10932624|NCT03651622|12101375|FG001|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||4
10932625|NCT03651622|12101376|FG002|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||0
10932626|NCT03651622|12101374|FG000|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||4
10932627|NCT03651622|12101375|FG001|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||3
10932628|NCT03651622|12101376|FG002|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||2
10932629|NCT03651622|12101374|FG000|COMPLETED|Diet Period 3 (Randomization 3)||14
10932630|NCT03651622|12101375|FG001|COMPLETED|Diet Period 3 (Randomization 3)||9
10932631|NCT03651622|12101376|FG002|COMPLETED|Diet Period 3 (Randomization 3)||17
10932632|NCT03651622|12101374|FG000|NOT COMPLETED|Diet Period 3 (Randomization 3)||0
10932633|NCT03651622|12101375|FG001|NOT COMPLETED|Diet Period 3 (Randomization 3)||0
10932634|NCT03651622|12101376|FG002|NOT COMPLETED|Diet Period 3 (Randomization 3)||1
10932635|NCT03138096|12101389|FG000|STARTED|Overall Study||3
10932636|NCT03138096|12101390|FG001|STARTED|Overall Study||3
10932637|NCT03138096|12101391|FG002|STARTED|Overall Study||12
10932638|NCT03138096|12101392|FG003|STARTED|Overall Study||6
10932639|NCT03138096|12101393|FG004|STARTED|Overall Study|Phase 2 was not started because of unsufficient effectivity of the Pb(PfCS@UIS4) immunizations as pre-determined in the study protocol.|0
10932640|NCT03138096|12101389|FG000|COMPLETED|Overall Study||3
10932641|NCT03138096|12101390|FG001|COMPLETED|Overall Study||3
10932642|NCT03138096|12101391|FG002|COMPLETED|Overall Study||12
10932643|NCT03138096|12101392|FG003|COMPLETED|Overall Study||6
10932644|NCT03138096|12101393|FG004|COMPLETED|Overall Study||0
10932645|NCT03138096|12101389|FG000|NOT COMPLETED|Overall Study||0
10932646|NCT03138096|12101390|FG001|NOT COMPLETED|Overall Study||0
10932647|NCT03138096|12101391|FG002|NOT COMPLETED|Overall Study||0
10932648|NCT03138096|12101392|FG003|NOT COMPLETED|Overall Study||0
10932649|NCT03138096|12101393|FG004|NOT COMPLETED|Overall Study||0
10932650|NCT02678351|12101416|FG000|STARTED|Overall Study||74
10932651|NCT02678351|12101416|FG000|COMPLETED|Overall Study||73
10932652|NCT02678351|12101416|FG000|NOT COMPLETED|Overall Study||1
10932653|NCT02578732|12101420|FG000|STARTED|Overall Study||28
10932654|NCT02578732|12101420|FG000|COMPLETED|Overall Study||28
10932655|NCT02578732|12101420|FG000|NOT COMPLETED|Overall Study||0
10932656|NCT01961531|12101424|FG000|STARTED|Overall Study||40
10932657|NCT01961531|12101424|FG000|COMPLETED|Overall Study||40
10932658|NCT01961531|12101424|FG000|NOT COMPLETED|Overall Study||0
10932659|NCT01880541|12101430|FG000|STARTED|Overall Study||10
10932660|NCT01880541|12101431|FG001|STARTED|Overall Study||20
10932661|NCT01880541|12101430|FG000|COMPLETED|Overall Study||10
10932662|NCT01880541|12101431|FG001|COMPLETED|Overall Study||20
10932663|NCT01880541|12101430|FG000|NOT COMPLETED|Overall Study||0
10932664|NCT01880541|12101431|FG001|NOT COMPLETED|Overall Study||0
10932665|NCT01693692|12101440|FG000|STARTED|Overall Study||130
10932666|NCT01693692|12101441|FG001|STARTED|Overall Study||131
10932667|NCT01693692|12101442|FG002|STARTED|Overall Study||131
10932668|NCT01693692|12101440|FG000|Received Study Drug|Overall Study||128
10932669|NCT01693692|12101441|FG001|Received Study Drug|Overall Study||127
10932670|NCT01693692|12101442|FG002|Received Study Drug|Overall Study||128
10932671|NCT01693692|12101440|FG000|COMPLETED|Overall Study||100
10932672|NCT01693692|12101441|FG001|COMPLETED|Overall Study||97
10932673|NCT01693692|12101442|FG002|COMPLETED|Overall Study||95
10932674|NCT01693692|12101440|FG000|NOT COMPLETED|Overall Study||30
10932675|NCT01693692|12101441|FG001|NOT COMPLETED|Overall Study||34
10932676|NCT01693692|12101442|FG002|NOT COMPLETED|Overall Study||36
10932677|NCT01685606|12101450|FG000|STARTED|Overall Study||6
10932678|NCT01685606|12101450|FG000|COMPLETED|Overall Study||5
10932679|NCT01685606|12101450|FG000|NOT COMPLETED|Overall Study||1
10932680|NCT01650350|12101454|FG000|STARTED|Overall Study||7
10932681|NCT01650350|12101454|FG000|COMPLETED|Overall Study||7
10932682|NCT01650350|12101454|FG000|NOT COMPLETED|Overall Study||0
10932683|NCT01650285|12101460|FG000|STARTED|Overall Study||5
10932684|NCT01650285|12101460|FG000|COMPLETED|Overall Study||4
10932685|NCT01650285|12101460|FG000|NOT COMPLETED|Overall Study||1
10932686|NCT01083771|12101464|FG000|STARTED|Overall Study||21
10932687|NCT01083771|12101464|FG000|COMPLETED|Overall Study||16
10932688|NCT01083771|12101464|FG000|NOT COMPLETED|Overall Study||5
10932689|NCT00743197|12101470|FG000|STARTED|Overall Study||1
10932690|NCT00743197|12101471|FG001|STARTED|Overall Study||2
10932691|NCT00743197|12101470|FG000|COMPLETED|Overall Study||0
10932692|NCT00743197|12101471|FG001|COMPLETED|Overall Study||0
10932693|NCT00743197|12101470|FG000|NOT COMPLETED|Overall Study||1
10932694|NCT00743197|12101471|FG001|NOT COMPLETED|Overall Study||2
10932695|NCT00304915|12101479|FG000|STARTED|Overall Study||123
10932696|NCT00304915|12101480|FG001|STARTED|Overall Study||126
10932697|NCT00304915|12101479|FG000|COMPLETED|Overall Study||105
10932699|NCT00304915|12101479|FG000|NOT COMPLETED|Overall Study||18
10932700|NCT00304915|12101480|FG001|NOT COMPLETED|Overall Study||16
10932701|NCT00304954|12101490|FG000|STARTED|Overall Study||4
10932702|NCT00304954|12101491|FG001|STARTED|Overall Study||3
10932703|NCT00304954|12101492|FG002|STARTED|Overall Study||3
10932704|NCT00304954|12101493|FG003|STARTED|Overall Study||3
10932705|NCT00304954|12101490|FG000|COMPLETED|Overall Study||3
10932706|NCT00304954|12101491|FG001|COMPLETED|Overall Study||3
10932707|NCT00304954|12101492|FG002|COMPLETED|Overall Study||2
10932708|NCT00304954|12101493|FG003|COMPLETED|Overall Study||3
10932709|NCT00304954|12101490|FG000|NOT COMPLETED|Overall Study||1
10932710|NCT00304954|12101491|FG001|NOT COMPLETED|Overall Study||0
10932711|NCT00304954|12101492|FG002|NOT COMPLETED|Overall Study||1
10932712|NCT00304954|12101493|FG003|NOT COMPLETED|Overall Study||0
10932713|NCT00305006|12101513|FG000|STARTED|Overall Study||22
10932714|NCT00305006|12101514|FG001|STARTED|Overall Study||22
10932715|NCT00305006|12101513|FG000|COMPLETED|Overall Study||21
10932716|NCT00305006|12101514|FG001|COMPLETED|Overall Study||21
10932717|NCT00305006|12101513|FG000|NOT COMPLETED|Overall Study||1
10932718|NCT00305006|12101514|FG001|NOT COMPLETED|Overall Study||1
10932719|NCT00305058|12101522|FG000|STARTED|Overall Study||97
10932720|NCT00305058|12101523|FG001|STARTED|Overall Study||97
10932721|NCT00305058|12101522|FG000|Inclusion/Exclusion Verification|Overall Study||96
10932722|NCT00305058|12101523|FG001|Inclusion/Exclusion Verification|Overall Study||97
10932723|NCT00305058|12101522|FG000|All Outcome Data Collected|Overall Study||93
10932724|NCT00305058|12101523|FG001|All Outcome Data Collected|Overall Study||95
10932725|NCT00305058|12101522|FG000|Data Collection Forms Filed for Analysis|Overall Study||90
10932726|NCT00305058|12101523|FG001|Data Collection Forms Filed for Analysis|Overall Study||93
10932727|NCT00305058|12101522|FG000|COMPLETED|Overall Study||90
10932728|NCT00305058|12101523|FG001|COMPLETED|Overall Study||93
10932729|NCT00305058|12101522|FG000|NOT COMPLETED|Overall Study||7
10932730|NCT00305058|12101523|FG001|NOT COMPLETED|Overall Study||4
10932731|NCT00305084|12101534|FG000|STARTED|Overall Study||3
10932732|NCT00305084|12101535|FG001|STARTED|Overall Study||3
10932733|NCT00305084|12101536|FG002|STARTED|Overall Study||3
10932734|NCT00305084|12101537|FG003|STARTED|Overall Study||3
10932735|NCT00305084|12101538|FG004|STARTED|Overall Study||3
10932736|NCT00305084|12101534|FG000|COMPLETED|Overall Study||3
10932737|NCT00305084|12101535|FG001|COMPLETED|Overall Study||3
10932738|NCT00305084|12101536|FG002|COMPLETED|Overall Study||3
10932739|NCT00305084|12101537|FG003|COMPLETED|Overall Study||3
10932740|NCT00305084|12101538|FG004|COMPLETED|Overall Study||3
10932741|NCT00305084|12101534|FG000|NOT COMPLETED|Overall Study||0
10932742|NCT00305084|12101535|FG001|NOT COMPLETED|Overall Study||0
10932743|NCT00305084|12101536|FG002|NOT COMPLETED|Overall Study||0
10932744|NCT00305084|12101537|FG003|NOT COMPLETED|Overall Study||0
10932745|NCT00305084|12101538|FG004|NOT COMPLETED|Overall Study||0
10932746|NCT00305110|12101578|FG000|STARTED|Overall Study||298
10932747|NCT00305110|12101578|FG000|All Necessary Data Collected|Overall Study||269
10932748|NCT00305110|12101578|FG000|COMPLETED|Overall Study||269
10932749|NCT00305110|12101578|FG000|NOT COMPLETED|Overall Study||29
10932750|NCT00305162|12101584|FG000|STARTED|48 Hour Follow-up Period||4435
10932751|NCT00305162|12101585|FG001|STARTED|48 Hour Follow-up Period||4447
10932752|NCT00305162|12101584|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
10932753|NCT00305162|12101585|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
10932754|NCT00305162|12101584|FG000|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
10932755|NCT00305162|12101585|FG001|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
10932756|NCT00305162|12101584|FG000|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
10932757|NCT00305162|12101585|FG001|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
10932758|NCT00305162|12101584|FG000|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
10932759|NCT00305162|12101585|FG001|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
10932760|NCT00305162|12101584|FG000|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
10932761|NCT00305162|12101585|FG001|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
10932762|NCT00305162|12101584|FG000|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
10932763|NCT00305162|12101585|FG001|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
10932764|NCT00305162|12101584|FG000|NOT COMPLETED|48 Hour Follow-up Period||20
10932765|NCT00305162|12101585|FG001|NOT COMPLETED|48 Hour Follow-up Period||16
10932766|NCT00305162|12101584|FG000|STARTED|30-day Follow-up Period||4435
10932767|NCT00305162|12101585|FG001|STARTED|30-day Follow-up Period||4447
10932768|NCT00305162|12101584|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
10932769|NCT00305162|12101585|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
10932770|NCT00305162|12101584|FG000|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
10932771|NCT00305162|12101585|FG001|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
10932772|NCT00305162|12101584|FG000|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
10932773|NCT00305162|12101585|FG001|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
10932774|NCT00305162|12101584|FG000|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
10932775|NCT00305162|12101585|FG001|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
10932776|NCT00305162|12101584|FG000|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
10932777|NCT00305162|12101585|FG001|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
10932778|NCT00305162|12101584|FG000|NOT COMPLETED|30-day Follow-up Period||62
10932779|NCT00305162|12101585|FG001|NOT COMPLETED|30-day Follow-up Period||63
10932780|NCT00305162|12101584|FG000|STARTED|1 Year Follow-up Period||4435
10932781|NCT00305162|12101585|FG001|STARTED|1 Year Follow-up Period||4447
10932782|NCT00305162|12101584|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
10932783|NCT00305162|12101585|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
10932784|NCT00305162|12101584|FG000|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
10932785|NCT00305162|12101585|FG001|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
10932786|NCT00305162|12101584|FG000|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
10932787|NCT00305162|12101585|FG001|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
10932788|NCT00305162|12101584|FG000|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
10932789|NCT00305162|12101585|FG001|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
10932790|NCT00305162|12101584|FG000|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
10932791|NCT00305162|12101585|FG001|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
10932792|NCT00305162|12101584|FG000|NOT COMPLETED|1 Year Follow-up Period||55
10932793|NCT00305162|12101585|FG001|NOT COMPLETED|1 Year Follow-up Period||65
10932794|NCT00305227|12101594|FG000|STARTED|Overall Study||50
10932795|NCT00305227|12101595|FG001|STARTED|Overall Study||50
10932796|NCT00305227|12101594|FG000|COMPLETED|Overall Study|with at least 8 weeks of observation|43
10932797|NCT00305227|12101595|FG001|COMPLETED|Overall Study|with at least 8 weeks of observation|44
10932798|NCT00305227|12101594|FG000|NOT COMPLETED|Overall Study||7
10932799|NCT00305227|12101595|FG001|NOT COMPLETED|Overall Study||6
10932800|NCT00305253|12101603|FG000|STARTED|Overall Study||432
10932801|NCT00305253|12101604|FG001|STARTED|Overall Study||559
10932802|NCT00305253|12101603|FG000|COMPLETED|Overall Study||432
10932803|NCT00305253|12101604|FG001|COMPLETED|Overall Study||558
10932804|NCT00305253|12101603|FG000|NOT COMPLETED|Overall Study||0
10932805|NCT00305253|12101604|FG001|NOT COMPLETED|Overall Study||1
10932806|NCT00305448|12101613|FG000|STARTED|Overall Study||45
10932807|NCT00305448|12101614|FG001|STARTED|Overall Study||51
10932808|NCT00305448|12101615|FG002|STARTED|Overall Study||47
10932809|NCT00305448|12101613|FG000|COMPLETED|Overall Study||14
10932810|NCT00305448|12101614|FG001|COMPLETED|Overall Study||17
10932811|NCT00305448|12101615|FG002|COMPLETED|Overall Study||14
10932812|NCT00305448|12101613|FG000|NOT COMPLETED|Overall Study||31
10932813|NCT00305448|12101614|FG001|NOT COMPLETED|Overall Study||34
10932814|NCT00305448|12101615|FG002|NOT COMPLETED|Overall Study||33
10932815|NCT00305565|12101627|FG000|STARTED|Overall Study (Safety Population)||111
10932816|NCT00305565|12101628|FG001|STARTED|Overall Study (Safety Population)||107
10932817|NCT00305565|12101629|FG002|STARTED|Overall Study (Safety Population)||113
10932818|NCT00305565|12101627|FG000|COMPLETED|Overall Study (Safety Population)||97
10932819|NCT00305565|12101628|FG001|COMPLETED|Overall Study (Safety Population)||95
10932820|NCT00305565|12101629|FG002|COMPLETED|Overall Study (Safety Population)||106
10932821|NCT00305565|12101627|FG000|NOT COMPLETED|Overall Study (Safety Population)||14
10932822|NCT00305565|12101628|FG001|NOT COMPLETED|Overall Study (Safety Population)||12
10932823|NCT00305565|12101629|FG002|NOT COMPLETED|Overall Study (Safety Population)||7
10932824|NCT00305565|12101627|FG000|STARTED|Overall Study (ITT Population)||102
10932825|NCT00305565|12101628|FG001|STARTED|Overall Study (ITT Population)||101
10932826|NCT00305565|12101629|FG002|STARTED|Overall Study (ITT Population)||107
10932827|NCT00305565|12101627|FG000|COMPLETED|Overall Study (ITT Population)||89
10932828|NCT00305565|12101628|FG001|COMPLETED|Overall Study (ITT Population)||90
10932829|NCT00305565|12101629|FG002|COMPLETED|Overall Study (ITT Population)||102
10932830|NCT00305565|12101627|FG000|NOT COMPLETED|Overall Study (ITT Population)||13
10932831|NCT00305565|12101628|FG001|NOT COMPLETED|Overall Study (ITT Population)||11
10932832|NCT00305565|12101629|FG002|NOT COMPLETED|Overall Study (ITT Population)||5
10932833|NCT00305578|12101640|FG000|STARTED|Overall Study||15
10932834|NCT00305578|12101641|FG001|STARTED|Overall Study||14
10932835|NCT00305578|12101640|FG000|COMPLETED|Overall Study||12
10932836|NCT00305578|12101641|FG001|COMPLETED|Overall Study||12
10932837|NCT00305578|12101640|FG000|NOT COMPLETED|Overall Study||3
10932838|NCT00305578|12101641|FG001|NOT COMPLETED|Overall Study||2
10932839|NCT00305604|12101649|FG000|STARTED|Overall Study||102
10932840|NCT00305604|12101650|FG001|STARTED|Overall Study||104
10932841|NCT00305604|12101649|FG000|COMPLETED|Overall Study||70
10932842|NCT00305604|12101650|FG001|COMPLETED|Overall Study||57
10932843|NCT00305604|12101649|FG000|NOT COMPLETED|Overall Study||32
10932844|NCT00305604|12101650|FG001|NOT COMPLETED|Overall Study||47
10932845|NCT00305682|12101662|FG000|STARTED|Overall Study||98
10932846|NCT00305682|12101663|FG001|STARTED|Overall Study||71
10932847|NCT00305682|12101664|FG002|STARTED|Overall Study||7
10932848|NCT00305682|12101665|FG003|STARTED|Overall Study||34
10932849|NCT00305682|12101666|FG004|STARTED|Overall Study||39
10932850|NCT00305682|12101667|FG005|STARTED|Overall Study||35
10932851|NCT00305682|12101662|FG000|COMPLETED|Overall Study||98
10932852|NCT00305682|12101663|FG001|COMPLETED|Overall Study||71
10932853|NCT00305682|12101664|FG002|COMPLETED|Overall Study||7
10932854|NCT00305682|12101665|FG003|COMPLETED|Overall Study||34
10932855|NCT00305682|12101666|FG004|COMPLETED|Overall Study||39
10932856|NCT00305682|12101667|FG005|COMPLETED|Overall Study||35
10932857|NCT00305682|12101662|FG000|NOT COMPLETED|Overall Study||0
10932858|NCT00305682|12101663|FG001|NOT COMPLETED|Overall Study||0
10932859|NCT00305682|12101664|FG002|NOT COMPLETED|Overall Study||0
10932860|NCT00305682|12101665|FG003|NOT COMPLETED|Overall Study||0
10932861|NCT00305682|12101666|FG004|NOT COMPLETED|Overall Study||0
10932862|NCT00305682|12101667|FG005|NOT COMPLETED|Overall Study||0
10932863|NCT00305695|12101683|FG000|STARTED|Overall Study||81
10932864|NCT00305695|12101684|FG001|STARTED|Overall Study||79
10932865|NCT00305695|12101683|FG000|COMPLETED|Overall Study||40
10932866|NCT00305695|12101684|FG001|COMPLETED|Overall Study||52
10932867|NCT00305695|12101683|FG000|NOT COMPLETED|Overall Study||41
10932868|NCT00305695|12101684|FG001|NOT COMPLETED|Overall Study||27
10932869|NCT00305760|12101690|FG000|STARTED|Overall Study||60
10932870|NCT00305760|12101690|FG000|COMPLETED|Overall Study||13
10932871|NCT00305760|12101690|FG000|NOT COMPLETED|Overall Study||47
10932872|NCT00305773|12101696|FG000|STARTED|Overall Study||15
10932873|NCT00305773|12101697|FG001|STARTED|Overall Study||22
10932874|NCT00305773|12101696|FG000|COMPLETED|Overall Study||1
10932875|NCT00305773|12101697|FG001|COMPLETED|Overall Study||4
10932876|NCT00305773|12101696|FG000|NOT COMPLETED|Overall Study||14
10932877|NCT00305773|12101697|FG001|NOT COMPLETED|Overall Study||18
10932878|NCT00305864|12101707|FG000|STARTED|Overall Study||7
10932879|NCT00305864|12101708|FG001|STARTED|Overall Study||10
10932880|NCT00305864|12101709|FG002|STARTED|Overall Study||7
10932881|NCT00305864|12101710|FG003|STARTED|Overall Study||94
10932882|NCT00305864|12101707|FG000|COMPLETED|Overall Study||7
10932883|NCT00305864|12101708|FG001|COMPLETED|Overall Study||9
10932884|NCT00305864|12101709|FG002|COMPLETED|Overall Study||6
10932885|NCT00305864|12101710|FG003|COMPLETED|Overall Study||81
10932886|NCT00305864|12101707|FG000|NOT COMPLETED|Overall Study||0
10932887|NCT00305864|12101708|FG001|NOT COMPLETED|Overall Study||1
10932888|NCT00305864|12101709|FG002|NOT COMPLETED|Overall Study||1
10932889|NCT00305864|12101710|FG003|NOT COMPLETED|Overall Study||13
10932890|NCT00305877|12101722|FG000|STARTED|Overall Study||69
10932891|NCT00305877|12101723|FG001|STARTED|Overall Study||68
10932892|NCT00305877|12101722|FG000|Treated|Overall Study||67
10932893|NCT00305877|12101723|FG001|Treated|Overall Study||63
10932894|NCT00305877|12101722|FG000|Eligible|Overall Study||66
10932895|NCT00305877|12101723|FG001|Eligible|Overall Study||66
10932896|NCT00305877|12101722|FG000|Included in Efficacy Analysis|Overall Study||65
10932897|NCT00305877|12101723|FG001|Included in Efficacy Analysis|Overall Study||62
10932898|NCT00305877|12101722|FG000|COMPLETED|Overall Study||45
10932899|NCT00305877|12101723|FG001|COMPLETED|Overall Study||34
10932900|NCT00305877|12101722|FG000|NOT COMPLETED|Overall Study||24
10932901|NCT00305877|12101723|FG001|NOT COMPLETED|Overall Study||34
10932902|NCT00305942|12101729|FG000|STARTED|Overall Study||61
10932903|NCT00305942|12101729|FG000|COMPLETED|Overall Study||23
10932904|NCT00305942|12101729|FG000|NOT COMPLETED|Overall Study||38
10932905|NCT00306163|12101735|FG000|STARTED|Overall Study||19
10932906|NCT00306163|12101736|FG001|STARTED|Overall Study||18
10932907|NCT00306163|12101735|FG000|COMPLETED|Overall Study||19
10932908|NCT00306163|12101736|FG001|COMPLETED|Overall Study||18
10932909|NCT00306163|12101735|FG000|NOT COMPLETED|Overall Study||0
10932910|NCT00306163|12101736|FG001|NOT COMPLETED|Overall Study||0
10932911|NCT00306189|12101746|FG000|STARTED|Overall Study||57
10932912|NCT00306189|12101747|FG001|STARTED|Overall Study||56
10932913|NCT00306189|12101748|FG002|STARTED|Overall Study||56
10932914|NCT00306189|12101749|FG003|STARTED|Overall Study||57
10932915|NCT00306189|12101746|FG000|COMPLETED|Overall Study||48
10932916|NCT00306189|12101747|FG001|COMPLETED|Overall Study||50
10932917|NCT00306189|12101748|FG002|COMPLETED|Overall Study||45
10932918|NCT00306189|12101749|FG003|COMPLETED|Overall Study||52
10932919|NCT00306189|12101746|FG000|NOT COMPLETED|Overall Study||9
10932920|NCT00306189|12101747|FG001|NOT COMPLETED|Overall Study||6
10932921|NCT00306189|12101748|FG002|NOT COMPLETED|Overall Study||11
10932922|NCT00306189|12101749|FG003|NOT COMPLETED|Overall Study||5
10932923|NCT00306202|12101762|FG000|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
10932924|NCT00306202|12101763|FG001|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
10932925|NCT00306202|12101764|FG002|STARTED|Overall Study|Started = Treated. 25 were enrolled; 1 no longer met study criteria and was never treated|24
10932926|NCT00306202|12101762|FG000|COMPLETED|Overall Study|Completed = Off-treatment|17
10932927|NCT00306202|12101763|FG001|COMPLETED|Overall Study|Completed = Off-treatment|17
10932928|NCT00306202|12101764|FG002|COMPLETED|Overall Study|Completed = Off-treatment|24
10932929|NCT00306202|12101762|FG000|NOT COMPLETED|Overall Study||0
10932930|NCT00306202|12101763|FG001|NOT COMPLETED|Overall Study||0
10932931|NCT00306202|12101764|FG002|NOT COMPLETED|Overall Study||0
10932932|NCT00306293|12101810|FG000|STARTED|Period 1 (Day 1 to Day 60)||35
10932933|NCT00306293|12101811|FG001|STARTED|Period 1 (Day 1 to Day 60)||35
10932934|NCT00306293|12101810|FG000|COMPLETED|Period 1 (Day 1 to Day 60)||27
10932935|NCT00306293|12101811|FG001|COMPLETED|Period 1 (Day 1 to Day 60)||27
10932936|NCT00306293|12101810|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
10932937|NCT00306293|12101811|FG001|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
10932938|NCT00306293|12101810|FG000|STARTED|Washout (Day 61 to Day 66)||27
10932939|NCT00306293|12101811|FG001|STARTED|Washout (Day 61 to Day 66)||27
10932940|NCT00306293|12101810|FG000|COMPLETED|Washout (Day 61 to Day 66)||27
10932941|NCT00306293|12101811|FG001|COMPLETED|Washout (Day 61 to Day 66)||27
10932942|NCT00306293|12101810|FG000|NOT COMPLETED|Washout (Day 61 to Day 66)||0
10932943|NCT00306293|12101811|FG001|NOT COMPLETED|Washout (Day 61 to Day 66)||0
10932944|NCT00306293|12101810|FG000|STARTED|Period 2 (Day 67 to Day 126 )||27
10932945|NCT00306293|12101811|FG001|STARTED|Period 2 (Day 67 to Day 126 )||27
10932946|NCT00306293|12101810|FG000|COMPLETED|Period 2 (Day 67 to Day 126 )||24
10932947|NCT00306293|12101811|FG001|COMPLETED|Period 2 (Day 67 to Day 126 )||26
10932948|NCT00306293|12101810|FG000|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
10932949|NCT00306293|12101811|FG001|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
10932950|NCT00306384|12101822|FG000|STARTED|Overall Study||1396
10932951|NCT00306384|12101823|FG001|STARTED|Overall Study||1399
10932952|NCT00306384|12101824|FG002|STARTED|Overall Study||528
10932953|NCT00306384|12101822|FG000|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
10932954|NCT00306384|12101823|FG001|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
10932955|NCT00306384|12101824|FG002|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
10932956|NCT00306384|12101822|FG000|COMPLETED|Overall Study||854
10932957|NCT00306384|12101823|FG001|COMPLETED|Overall Study||891
10932958|NCT00306384|12101824|FG002|COMPLETED|Overall Study||251
10932959|NCT00306384|12101822|FG000|NOT COMPLETED|Overall Study||542
10932960|NCT00306384|12101823|FG001|NOT COMPLETED|Overall Study||508
10932961|NCT00306384|12101824|FG002|NOT COMPLETED|Overall Study||277
10932962|NCT00306488|12101832|FG000|STARTED|Overall Study||11
10932963|NCT00306488|12101832|FG000|COMPLETED|Overall Study||10
10932964|NCT00306488|12101832|FG000|NOT COMPLETED|Overall Study||1
10932965|NCT00306527|12101841|FG000|STARTED|Overall Study||533
10932966|NCT00306527|12101842|FG001|STARTED|Overall Study||534
10932967|NCT00306527|12101843|FG002|STARTED|Overall Study||572
10932968|NCT00306527|12101844|FG003|STARTED|Overall Study||596
10932969|NCT00306527|12101841|FG000|COMPLETED|Overall Study||527
10932970|NCT00306527|12101842|FG001|COMPLETED|Overall Study||527
10932971|NCT00306527|12101843|FG002|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567
10932972|NCT00306527|12101844|FG003|COMPLETED|Overall Study||590
10932973|NCT00306527|12101841|FG000|NOT COMPLETED|Overall Study||6
10932974|NCT00306527|12101842|FG001|NOT COMPLETED|Overall Study||7
10932975|NCT00306527|12101843|FG002|NOT COMPLETED|Overall Study||5
10932976|NCT00306527|12101844|FG003|NOT COMPLETED|Overall Study||6
10932977|NCT00306592|12101858|FG000|STARTED|Overall Study||404
10932978|NCT00306592|12101859|FG001|STARTED|Overall Study||690
10932979|NCT00306592|12101858|FG000|Completed at 24 Weeks|Overall Study||207
10932980|NCT00306592|12101859|FG001|Completed at 24 Weeks|Overall Study||0
10932981|NCT00306592|12101858|FG000|Completed Between 24 and 48 Weeks|Overall Study||85
10932982|NCT00306592|12101859|FG001|Completed Between 24 and 48 Weeks|Overall Study||0
10932983|NCT00306592|12101858|FG000|Completed at 48 Weeks|Overall Study||81
10932984|NCT00306592|12101859|FG001|Completed at 48 Weeks|Overall Study||632
10932985|NCT00306592|12101858|FG000|Entered 101-MS-321 Extension Study|Overall Study||22
10932986|NCT00306592|12101859|FG001|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
10932987|NCT00306592|12101858|FG000|COMPLETED|Overall Study||373
10932988|NCT00306592|12101859|FG001|COMPLETED|Overall Study||632
10932989|NCT00306592|12101858|FG000|NOT COMPLETED|Overall Study||31
10932990|NCT00306592|12101859|FG001|NOT COMPLETED|Overall Study||58
10932991|NCT00306670|12101865|FG000|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
10932992|NCT00306670|12101866|FG001|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
10932993|NCT00306670|12101865|FG000|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
10932994|NCT00306670|12101866|FG001|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
10932995|NCT00306670|12101865|FG000|NOT COMPLETED|Overall Study||0
10932996|NCT00306670|12101866|FG001|NOT COMPLETED|Overall Study||2
10932997|NCT00306787|12101874|FG000|STARTED|Overall Study||579
10932998|NCT00306787|12101875|FG001|STARTED|Overall Study||600
10932999|NCT00306787|12101874|FG000|Received Study Drug (Safety Population)|Overall Study||371
10933000|NCT00306787|12101875|FG001|Received Study Drug (Safety Population)|Overall Study||385
10933001|NCT00306787|12101874|FG000|Intent to Treat (ITT) Population|Overall Study||370
10933002|NCT00306787|12101875|FG001|Intent to Treat (ITT) Population|Overall Study||381
10933003|NCT00306787|12101874|FG000|COMPLETED|Overall Study||345
10933004|NCT00306787|12101875|FG001|COMPLETED|Overall Study||359
10933005|NCT00306787|12101874|FG000|NOT COMPLETED|Overall Study||234
10933006|NCT00306787|12101875|FG001|NOT COMPLETED|Overall Study||241
10933007|NCT00306852|12101883|FG000|STARTED|Overall Study||105
10933008|NCT00306852|12101884|FG001|STARTED|Overall Study||107
10933009|NCT00306852|12101883|FG000|COMPLETED|Overall Study||76
10933010|NCT00306852|12101884|FG001|COMPLETED|Overall Study||69
10933011|NCT00306852|12101883|FG000|NOT COMPLETED|Overall Study||29
10933012|NCT00306852|12101884|FG001|NOT COMPLETED|Overall Study||38
10933013|NCT00306891|12101894|FG000|STARTED|Part A||23
10933014|NCT00306891|12101895|FG001|STARTED|Part A||22
10933015|NCT00306891|12101896|FG002|STARTED|Part A||0
10933016|NCT00306891|12101897|FG003|STARTED|Part A||0
10933017|NCT00306891|12101894|FG000|COMPLETED|Part A||18
10933018|NCT00306891|12101895|FG001|COMPLETED|Part A||16
10933019|NCT00306891|12101896|FG002|COMPLETED|Part A||0
10933020|NCT00306891|12101897|FG003|COMPLETED|Part A||0
10933021|NCT00306891|12101894|FG000|NOT COMPLETED|Part A||5
10933022|NCT00306891|12101895|FG001|NOT COMPLETED|Part A||6
10933023|NCT00306891|12101896|FG002|NOT COMPLETED|Part A||0
10933024|NCT00306891|12101897|FG003|NOT COMPLETED|Part A||0
10933025|NCT00306891|12101894|FG000|STARTED|Part B||0
10933026|NCT00306891|12101895|FG001|STARTED|Part B||0
10933027|NCT00306891|12101896|FG002|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
10933028|NCT00306891|12101897|FG003|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
10933029|NCT00306891|12101894|FG000|COMPLETED|Part B||0
10933030|NCT00306891|12101895|FG001|COMPLETED|Part B||0
10933031|NCT00306891|12101896|FG002|COMPLETED|Part B||5
10933032|NCT00306891|12101897|FG003|COMPLETED|Part B||14
10933033|NCT00306891|12101894|FG000|NOT COMPLETED|Part B||0
10933034|NCT00306891|12101895|FG001|NOT COMPLETED|Part B||0
10933035|NCT00306891|12101896|FG002|NOT COMPLETED|Part B||11
10933036|NCT00306891|12101897|FG003|NOT COMPLETED|Part B||17
10933037|NCT00306995|12101915|FG000|STARTED|Study Part I||55
10933038|NCT00306995|12101916|FG001|STARTED|Study Part I||55
10933039|NCT00306995|12101917|FG002|STARTED|Study Part I||55
10933040|NCT00306995|12101918|FG003|STARTED|Study Part I||55
10933041|NCT00306995|12101919|FG004|STARTED|Study Part I||55
10933042|NCT00306995|12101920|FG005|STARTED|Study Part I||55
10933043|NCT00306995|12101921|FG006|STARTED|Study Part I||55
10933044|NCT00306995|12101915|FG000|COMPLETED|Study Part I||55
10933045|NCT00306995|12101916|FG001|COMPLETED|Study Part I||55
10933046|NCT00306995|12101917|FG002|COMPLETED|Study Part I||55
10933047|NCT00306995|12101918|FG003|COMPLETED|Study Part I||55
10933048|NCT00306995|12101919|FG004|COMPLETED|Study Part I||55
10933049|NCT00306995|12101920|FG005|COMPLETED|Study Part I||55
10933050|NCT00306995|12101921|FG006|COMPLETED|Study Part I||54
10933051|NCT00306995|12101915|FG000|NOT COMPLETED|Study Part I||0
10933052|NCT00306995|12101916|FG001|NOT COMPLETED|Study Part I||0
10933053|NCT00306995|12101917|FG002|NOT COMPLETED|Study Part I||0
10933054|NCT00306995|12101918|FG003|NOT COMPLETED|Study Part I||0
10933055|NCT00306995|12101919|FG004|NOT COMPLETED|Study Part I||0
10933056|NCT00306995|12101920|FG005|NOT COMPLETED|Study Part I||0
10933057|NCT00306995|12101921|FG006|NOT COMPLETED|Study Part I||1
10933058|NCT00306995|12101915|FG000|STARTED|Study Part II for Subset 1||27
10933059|NCT00306995|12101916|FG001|STARTED|Study Part II for Subset 1||26
10933060|NCT00306995|12101917|FG002|STARTED|Study Part II for Subset 1||27
10933061|NCT00306995|12101918|FG003|STARTED|Study Part II for Subset 1||27
10933062|NCT00306995|12101919|FG004|STARTED|Study Part II for Subset 1||27
10933063|NCT00306995|12101920|FG005|STARTED|Study Part II for Subset 1||26
10933064|NCT00306995|12101921|FG006|STARTED|Study Part II for Subset 1||23
10933065|NCT00306995|12101915|FG000|COMPLETED|Study Part II for Subset 1||27
10933066|NCT00306995|12101916|FG001|COMPLETED|Study Part II for Subset 1||26
10933067|NCT00306995|12101917|FG002|COMPLETED|Study Part II for Subset 1||27
10933068|NCT00306995|12101918|FG003|COMPLETED|Study Part II for Subset 1||27
10933069|NCT00306995|12101919|FG004|COMPLETED|Study Part II for Subset 1||27
10933070|NCT00306995|12101920|FG005|COMPLETED|Study Part II for Subset 1||26
10933071|NCT00306995|12101921|FG006|COMPLETED|Study Part II for Subset 1||23
10933072|NCT00306995|12101915|FG000|NOT COMPLETED|Study Part II for Subset 1||0
10933073|NCT00306995|12101916|FG001|NOT COMPLETED|Study Part II for Subset 1||0
10933074|NCT00306995|12101917|FG002|NOT COMPLETED|Study Part II for Subset 1||0
10933075|NCT00306995|12101918|FG003|NOT COMPLETED|Study Part II for Subset 1||0
10933076|NCT00306995|12101919|FG004|NOT COMPLETED|Study Part II for Subset 1||0
10933077|NCT00306995|12101920|FG005|NOT COMPLETED|Study Part II for Subset 1||0
10933078|NCT00306995|12101921|FG006|NOT COMPLETED|Study Part II for Subset 1||0
10933079|NCT00306995|12101915|FG000|STARTED|Study Part II for Subset 2||23
10933080|NCT00306995|12101916|FG001|STARTED|Study Part II for Subset 2||24
10933081|NCT00306995|12101917|FG002|STARTED|Study Part II for Subset 2||23
10933082|NCT00306995|12101918|FG003|STARTED|Study Part II for Subset 2||22
10933083|NCT00306995|12101919|FG004|STARTED|Study Part II for Subset 2||23
10933084|NCT00306995|12101920|FG005|STARTED|Study Part II for Subset 2||26
10933085|NCT00306995|12101921|FG006|STARTED|Study Part II for Subset 2||24
10933086|NCT00306995|12101915|FG000|COMPLETED|Study Part II for Subset 2||23
10933087|NCT00306995|12101916|FG001|COMPLETED|Study Part II for Subset 2||23
10933088|NCT00306995|12101917|FG002|COMPLETED|Study Part II for Subset 2||23
10933089|NCT00306995|12101918|FG003|COMPLETED|Study Part II for Subset 2||22
10933090|NCT00306995|12101919|FG004|COMPLETED|Study Part II for Subset 2||23
10933091|NCT00306995|12101920|FG005|COMPLETED|Study Part II for Subset 2||26
10933092|NCT00306995|12101921|FG006|COMPLETED|Study Part II for Subset 2||24
10933093|NCT00306995|12101915|FG000|NOT COMPLETED|Study Part II for Subset 2||0
10933094|NCT00306995|12101916|FG001|NOT COMPLETED|Study Part II for Subset 2||1
10933095|NCT00306995|12101917|FG002|NOT COMPLETED|Study Part II for Subset 2||0
10933096|NCT00306995|12101918|FG003|NOT COMPLETED|Study Part II for Subset 2||0
10933097|NCT00306995|12101919|FG004|NOT COMPLETED|Study Part II for Subset 2||0
10933098|NCT00306995|12101920|FG005|NOT COMPLETED|Study Part II for Subset 2||0
10933099|NCT00306995|12101921|FG006|NOT COMPLETED|Study Part II for Subset 2||0
10933100|NCT00307034|12101968|FG000|STARTED|Overall Study||175
10933101|NCT00307034|12101969|FG001|STARTED|Overall Study||176
10933102|NCT00307034|12101968|FG000|COMPLETED|Overall Study||173
10933103|NCT00307034|12101969|FG001|COMPLETED|Overall Study||169
10933104|NCT00307034|12101968|FG000|NOT COMPLETED|Overall Study||2
10933105|NCT00307034|12101969|FG001|NOT COMPLETED|Overall Study||7
10933106|NCT00307047|12101977|FG000|STARTED|Overall Study||2458
10933107|NCT00307047|12101978|FG001|STARTED|Overall Study||1229
10933108|NCT00307047|12101977|FG000|COMPLETED|Overall Study||2389
10933109|NCT00307047|12101978|FG001|COMPLETED|Overall Study||1180
10933110|NCT00307047|12101977|FG000|NOT COMPLETED|Overall Study||69
10933111|NCT00307047|12101978|FG001|NOT COMPLETED|Overall Study||49
10933112|NCT00307086|12101984|FG000|STARTED|Overall Study||30
10933113|NCT00307086|12101984|FG000|COMPLETED|Overall Study||25
10933114|NCT00307086|12101984|FG000|NOT COMPLETED|Overall Study||5
10933115|NCT00307125|12101990|FG000|STARTED|Screening Phase||757
10933116|NCT00307125|12101991|FG001|STARTED|Screening Phase||0
10933117|NCT00307125|12101992|FG002|STARTED|Screening Phase||0
10933118|NCT00307125|12101990|FG000|COMPLETED|Screening Phase||303
10933119|NCT00307125|12101991|FG001|COMPLETED|Screening Phase||0
10933120|NCT00307125|12101992|FG002|COMPLETED|Screening Phase||0
10933121|NCT00307125|12101990|FG000|NOT COMPLETED|Screening Phase||454
10933122|NCT00307125|12101991|FG001|NOT COMPLETED|Screening Phase||0
10933123|NCT00307125|12101992|FG002|NOT COMPLETED|Screening Phase||0
10933124|NCT00307125|12101990|FG000|STARTED|Pilot Phase||0
10933125|NCT00307125|12101991|FG001|STARTED|Pilot Phase||15
10933126|NCT00307125|12101992|FG002|STARTED|Pilot Phase||7
10933127|NCT00307125|12101990|FG000|COMPLETED|Pilot Phase||0
10933128|NCT00307125|12101991|FG001|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
10933129|NCT00307125|12101992|FG002|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
10933130|NCT00307125|12101990|FG000|NOT COMPLETED|Pilot Phase||0
10933131|NCT00307125|12101991|FG001|NOT COMPLETED|Pilot Phase||2
10933132|NCT00307125|12101992|FG002|NOT COMPLETED|Pilot Phase||1
10933133|NCT00307151|12102006|FG000|STARTED|Overall Study||82
10933134|NCT00307151|12102007|FG001|STARTED|Overall Study||82
10933135|NCT00307151|12102008|FG002|STARTED|Overall Study||147
10933136|NCT00307151|12102009|FG003|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
10933137|NCT00307151|12102006|FG000|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
10933138|NCT00307151|12102007|FG001|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
10933139|NCT00307151|12102008|FG002|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
10933140|NCT00307151|12102009|FG003|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
10933141|NCT00307151|12102006|FG000|NOT COMPLETED|Overall Study||11
10933142|NCT00307151|12102007|FG001|NOT COMPLETED|Overall Study||7
10933143|NCT00307151|12102008|FG002|NOT COMPLETED|Overall Study||20
10933144|NCT00307151|12102009|FG003|NOT COMPLETED|Overall Study||11
10933145|NCT00307164|12102021|FG000|STARTED|Overall Study||83
10933146|NCT00307164|12102022|FG001|STARTED|Overall Study||82
10933147|NCT00307164|12102021|FG000|COMPLETED|Overall Study||68
10933148|NCT00307164|12102022|FG001|COMPLETED|Overall Study||68
10933149|NCT00307164|12102021|FG000|NOT COMPLETED|Overall Study||15
10933150|NCT00307164|12102022|FG001|NOT COMPLETED|Overall Study||14
10933151|NCT00307294|12102028|FG000|STARTED|Overall Study||40
10933152|NCT00307294|12102028|FG000|COMPLETED|Overall Study||39
10933153|NCT00307294|12102028|FG000|NOT COMPLETED|Overall Study||1
10933154|NCT00307333|12102035|FG000|STARTED|Overall Study||1511
10933155|NCT00307333|12102036|FG001|STARTED|Overall Study||1492
10933156|NCT00307333|12102035|FG000|COMPLETED|Overall Study||1500
10933157|NCT00307333|12102036|FG001|COMPLETED|Overall Study||1489
10933158|NCT00307333|12102035|FG000|NOT COMPLETED|Overall Study||11
10933159|NCT00307333|12102036|FG001|NOT COMPLETED|Overall Study||3
10933160|NCT00307437|12102045|FG000|STARTED|Controlled Period||410
10933161|NCT00307437|12102046|FG001|STARTED|Controlled Period||409
10933162|NCT00307437|12102047|FG002|STARTED|Controlled Period||411
10933163|NCT00307437|12102048|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10933164|NCT00307437|12102049|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10933165|NCT00307437|12102050|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10933166|NCT00307437|12102051|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
10933167|NCT00307437|12102045|FG000|COMPLETED|Controlled Period||394
10933168|NCT00307437|12102046|FG001|COMPLETED|Controlled Period||403
10933169|NCT00307437|12102047|FG002|COMPLETED|Controlled Period||402
10933170|NCT00307437|12102048|FG003|COMPLETED|Controlled Period||0
10933171|NCT00307437|12102049|FG004|COMPLETED|Controlled Period||0
10933172|NCT00307437|12102050|FG005|COMPLETED|Controlled Period||0
10933173|NCT00307437|12102051|FG006|COMPLETED|Controlled Period||0
10933174|NCT00307437|12102045|FG000|NOT COMPLETED|Controlled Period||16
10933175|NCT00307437|12102046|FG001|NOT COMPLETED|Controlled Period||6
10933176|NCT00307437|12102047|FG002|NOT COMPLETED|Controlled Period||9
10933177|NCT00307437|12102048|FG003|NOT COMPLETED|Controlled Period||0
10933178|NCT00307437|12102049|FG004|NOT COMPLETED|Controlled Period||0
10933179|NCT00307437|12102050|FG005|NOT COMPLETED|Controlled Period||0
10933180|NCT00307437|12102051|FG006|NOT COMPLETED|Controlled Period||0
10933181|NCT00307437|12102045|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
10933182|NCT00307437|12102046|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
10933183|NCT00307437|12102047|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
10933184|NCT00307437|12102048|FG003|STARTED|After Controlled Period||197
10933185|NCT00307437|12102049|FG004|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
10933186|NCT00307437|12102050|FG005|STARTED|After Controlled Period||403
10933187|NCT00307437|12102051|FG006|STARTED|After Controlled Period||402
10933188|NCT00307437|12102045|FG000|COMPLETED|After Controlled Period||0
10933189|NCT00307437|12102046|FG001|COMPLETED|After Controlled Period||0
10933190|NCT00307437|12102047|FG002|COMPLETED|After Controlled Period||0
10933191|NCT00307437|12102048|FG003|COMPLETED|After Controlled Period||139
10933192|NCT00307437|12102049|FG004|COMPLETED|After Controlled Period||140
10933193|NCT00307437|12102050|FG005|COMPLETED|After Controlled Period||281
10933194|NCT00307437|12102051|FG006|COMPLETED|After Controlled Period||289
10933195|NCT00307437|12102045|FG000|NOT COMPLETED|After Controlled Period||0
10933196|NCT00307437|12102046|FG001|NOT COMPLETED|After Controlled Period||0
10933197|NCT00307437|12102047|FG002|NOT COMPLETED|After Controlled Period||0
10933198|NCT00307437|12102048|FG003|NOT COMPLETED|After Controlled Period||58
10933199|NCT00307437|12102049|FG004|NOT COMPLETED|After Controlled Period||55
10933200|NCT00307437|12102050|FG005|NOT COMPLETED|After Controlled Period||122
10933201|NCT00307437|12102051|FG006|NOT COMPLETED|After Controlled Period||113
10933202|NCT00307489|12102075|FG000|STARTED|Baseline Through Week 48||53
10933203|NCT00307489|12102076|FG001|STARTED|Baseline Through Week 48||52
10933204|NCT00307489|12102075|FG000|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
10933205|NCT00307489|12102076|FG001|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
10933206|NCT00307489|12102075|FG000|NOT COMPLETED|Baseline Through Week 48||1
10933207|NCT00307489|12102076|FG001|NOT COMPLETED|Baseline Through Week 48||2
10933208|NCT00307489|12102075|FG000|STARTED|Week 48 Through Week 168||52
10933209|NCT00307489|12102076|FG001|STARTED|Week 48 Through Week 168||50
10933210|NCT00307489|12102075|FG000|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
10933211|NCT00307489|12102076|FG001|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
10933212|NCT00307489|12102075|FG000|NOT COMPLETED|Week 48 Through Week 168||6
10933213|NCT00307489|12102076|FG001|NOT COMPLETED|Week 48 Through Week 168||6
10933214|NCT00307684|12102082|FG000|STARTED|Open Label Phase||0
10933215|NCT00307684|12102083|FG001|STARTED|Open Label Phase||0
10933216|NCT00307684|12102084|FG002|STARTED|Open Label Phase|1 screening failure|155
10933217|NCT00307684|12102082|FG000|COMPLETED|Open Label Phase||0
10933218|NCT00307684|12102083|FG001|COMPLETED|Open Label Phase||0
10933219|NCT00307684|12102084|FG002|COMPLETED|Open Label Phase||99
10933220|NCT00307684|12102082|FG000|NOT COMPLETED|Open Label Phase||0
10933221|NCT00307684|12102083|FG001|NOT COMPLETED|Open Label Phase||0
10933222|NCT00307684|12102084|FG002|NOT COMPLETED|Open Label Phase||56
10933223|NCT00307684|12102082|FG000|STARTED|Double Blind Phase||23
10933224|NCT00307684|12102083|FG001|STARTED|Double Blind Phase||22
10933225|NCT00307684|12102084|FG002|STARTED|Double Blind Phase||0
10933226|NCT00307684|12102082|FG000|COMPLETED|Double Blind Phase||21
10933227|NCT00307684|12102083|FG001|COMPLETED|Double Blind Phase||17
10933228|NCT00307684|12102084|FG002|COMPLETED|Double Blind Phase||0
10933229|NCT00307684|12102082|FG000|NOT COMPLETED|Double Blind Phase||2
10933230|NCT00307684|12102083|FG001|NOT COMPLETED|Double Blind Phase||5
10933231|NCT00307684|12102084|FG002|NOT COMPLETED|Double Blind Phase||0
10933232|NCT00307736|12102092|FG000|STARTED|Overall Study||3
10933233|NCT00307736|12102093|FG001|STARTED|Overall Study||3
10933234|NCT00307736|12102094|FG002|STARTED|Overall Study||3
10933235|NCT00307736|12102095|FG003|STARTED|Overall Study||23
10933236|NCT00307736|12102092|FG000|COMPLETED|Overall Study||3
10933237|NCT00307736|12102093|FG001|COMPLETED|Overall Study||3
10933238|NCT00307736|12102094|FG002|COMPLETED|Overall Study||0
10933239|NCT00307736|12102095|FG003|COMPLETED|Overall Study||20
10933240|NCT00307736|12102092|FG000|NOT COMPLETED|Overall Study||0
10933241|NCT00307736|12102093|FG001|NOT COMPLETED|Overall Study||0
10933242|NCT00307736|12102094|FG002|NOT COMPLETED|Overall Study||3
10933243|NCT00307736|12102095|FG003|NOT COMPLETED|Overall Study||3
10933244|NCT00307801|12102108|FG000|STARTED|Overall Study||149
10933245|NCT00307801|12102109|FG001|STARTED|Overall Study||82
10933246|NCT00307801|12102108|FG000|Subjects Received Treatment|Overall Study||145
10933247|NCT00307801|12102109|FG001|Subjects Received Treatment|Overall Study||81
10933248|NCT00307801|12102108|FG000|Cycle 1, Visit 5, Baseline|Overall Study||145
10933249|NCT00307801|12102109|FG001|Cycle 1, Visit 5, Baseline|Overall Study||81
10933250|NCT00307801|12102108|FG000|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
10933251|NCT00307801|12102109|FG001|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
10933252|NCT00307801|12102108|FG000|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
10933253|NCT00307801|12102109|FG001|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
10933254|NCT00307801|12102108|FG000|COMPLETED|Overall Study||117
10933255|NCT00307801|12102109|FG001|COMPLETED|Overall Study||65
10933256|NCT00307801|12102108|FG000|NOT COMPLETED|Overall Study||32
10933257|NCT00307801|12102109|FG001|NOT COMPLETED|Overall Study||17
10933258|NCT00307931|12102116|FG000|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
10933259|NCT00307931|12102116|FG000|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
10933260|NCT00307931|12102116|FG000|NOT COMPLETED|Overall Study||1
10933261|NCT00308061|12102122|FG000|STARTED|Overall Study||20
10933262|NCT00308061|12102123|FG001|STARTED|Overall Study||20
10933263|NCT00308061|12102122|FG000|COMPLETED|Overall Study||20
10933264|NCT00308061|12102123|FG001|COMPLETED|Overall Study||20
10933265|NCT00308061|12102122|FG000|NOT COMPLETED|Overall Study||0
10933266|NCT00308061|12102123|FG001|NOT COMPLETED|Overall Study||0
10933267|NCT00308074|12102130|FG000|STARTED|Overall Study||14
10933268|NCT00308074|12102130|FG000|COMPLETED|Overall Study||13
10933269|NCT00308074|12102130|FG000|NOT COMPLETED|Overall Study||1
10933270|NCT00308087|12102136|FG000|STARTED|Overall Study||37
10933271|NCT00308087|12102137|FG001|STARTED|Overall Study||38
10933272|NCT00308087|12102136|FG000|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
10933273|NCT00308087|12102137|FG001|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
10933274|NCT00308087|12102136|FG000|NOT COMPLETED|Overall Study||36
10933275|NCT00308087|12102137|FG001|NOT COMPLETED|Overall Study||37
10933276|NCT00308139|12102145|FG000|STARTED|Overall Study||152
10933277|NCT00308139|12102146|FG001|STARTED|Overall Study||151
10933278|NCT00308139|12102145|FG000|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
10933279|NCT00308139|12102146|FG001|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
10933280|NCT00308139|12102145|FG000|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
10933281|NCT00308139|12102146|FG001|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
10933282|NCT00308139|12102145|FG000|Pharmacokinetics Population|Overall Study||129
10933283|NCT00308139|12102146|FG001|Pharmacokinetics Population|Overall Study||0
10933284|NCT00308139|12102145|FG000|Evaluable Meal Tolerance Cohort|Overall Study||27
10933285|NCT00308139|12102146|FG001|Evaluable Meal Tolerance Cohort|Overall Study||24
10933286|NCT00308139|12102145|FG000|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
10933287|NCT00308139|12102146|FG001|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
10933288|NCT00308139|12102145|FG000|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
10933289|NCT00308139|12102146|FG001|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
10933290|NCT00308139|12102145|FG000|NOT COMPLETED|Overall Study||94
10933291|NCT00308139|12102146|FG001|NOT COMPLETED|Overall Study||87
10933292|NCT00308230|12102175|FG000|STARTED|Overall Study||6
10933293|NCT00308230|12102176|FG001|STARTED|Overall Study||8
10933294|NCT00308230|12102177|FG002|STARTED|Overall Study||20
10933295|NCT00308230|12102175|FG000|COMPLETED|Overall Study||6
10933296|NCT00308230|12102176|FG001|COMPLETED|Overall Study||8
10933297|NCT00308230|12102177|FG002|COMPLETED|Overall Study||20
10933298|NCT00308230|12102175|FG000|NOT COMPLETED|Overall Study||0
10933299|NCT00308230|12102176|FG001|NOT COMPLETED|Overall Study||0
10933300|NCT00308230|12102177|FG002|NOT COMPLETED|Overall Study||0
10933301|NCT00308282|12102189|FG000|STARTED|Overall Study||34
10933302|NCT00308282|12102190|FG001|STARTED|Overall Study||34
10933303|NCT00308282|12102191|FG002|STARTED|Overall Study||34
10933304|NCT00308282|12102192|FG003|STARTED|Overall Study||34
10933305|NCT00308282|12102189|FG000|Received at Least One Dose of Study Drug|Overall Study||34
10933306|NCT00308282|12102190|FG001|Received at Least One Dose of Study Drug|Overall Study||34
10933307|NCT00308282|12102191|FG002|Received at Least One Dose of Study Drug|Overall Study||34
10933308|NCT00308282|12102192|FG003|Received at Least One Dose of Study Drug|Overall Study||34
10933309|NCT00308282|12102189|FG000|COMPLETED|Overall Study||31
10933310|NCT00308282|12102190|FG001|COMPLETED|Overall Study||30
10933311|NCT00308282|12102191|FG002|COMPLETED|Overall Study||33
10933312|NCT00308282|12102192|FG003|COMPLETED|Overall Study||32
10933313|NCT00308282|12102189|FG000|NOT COMPLETED|Overall Study||3
10933314|NCT00308282|12102190|FG001|NOT COMPLETED|Overall Study||4
10933315|NCT00308282|12102191|FG002|NOT COMPLETED|Overall Study||1
10933316|NCT00308282|12102192|FG003|NOT COMPLETED|Overall Study||2
10933317|NCT00308308|12102207|FG000|STARTED|Overall Study||301
10933318|NCT00308308|12102208|FG001|STARTED|Overall Study||288
10933319|NCT00308308|12102207|FG000|COMPLETED|Overall Study||198
10933320|NCT00308308|12102208|FG001|COMPLETED|Overall Study||220
10933321|NCT00308308|12102207|FG000|NOT COMPLETED|Overall Study||103
10933322|NCT00308308|12102208|FG001|NOT COMPLETED|Overall Study||68
10933323|NCT00308555|12102216|FG000|STARTED|Overall Study||13
10933324|NCT00308555|12102217|FG001|STARTED|Overall Study||11
10933325|NCT00308555|12102216|FG000|COMPLETED|Overall Study||10
10933326|NCT00308555|12102217|FG001|COMPLETED|Overall Study||11
10933327|NCT00308555|12102216|FG000|NOT COMPLETED|Overall Study||3
10933328|NCT00308555|12102217|FG001|NOT COMPLETED|Overall Study||0
10933329|NCT00308581|12102223|FG000|STARTED|Induction Phase|Not applicable in this period|0
10933330|NCT00308581|12102224|FG001|STARTED|Induction Phase|Not applicable in this period|0
10933331|NCT00308581|12102225|FG002|STARTED|Induction Phase||539
10933332|NCT00308581|12102223|FG000|COMPLETED|Induction Phase|Not applicable in this period|0
10933333|NCT00308581|12102224|FG001|COMPLETED|Induction Phase|Not applicable in this period|0
10933334|NCT00308581|12102225|FG002|COMPLETED|Induction Phase||373
10933335|NCT00308581|12102223|FG000|NOT COMPLETED|Induction Phase||0
10933336|NCT00308581|12102224|FG001|NOT COMPLETED|Induction Phase||0
10933337|NCT00308581|12102225|FG002|NOT COMPLETED|Induction Phase||166
10933338|NCT00308581|12102223|FG000|STARTED|Randomized Maintenance Phase||187
10933339|NCT00308581|12102224|FG001|STARTED|Randomized Maintenance Phase||186
10933340|NCT00308581|12102225|FG002|STARTED|Randomized Maintenance Phase||0
10933341|NCT00308581|12102223|FG000|COMPLETED|Randomized Maintenance Phase||82
10933342|NCT00308581|12102224|FG001|COMPLETED|Randomized Maintenance Phase||83
10933343|NCT00308581|12102225|FG002|COMPLETED|Randomized Maintenance Phase||0
10933344|NCT00308581|12102223|FG000|NOT COMPLETED|Randomized Maintenance Phase||105
10933345|NCT00308581|12102224|FG001|NOT COMPLETED|Randomized Maintenance Phase||103
10933346|NCT00308581|12102225|FG002|NOT COMPLETED|Randomized Maintenance Phase||0
10933347|NCT00308620|12102236|FG000|STARTED|Overall Study||3
10933348|NCT00308620|12102237|FG001|STARTED|Overall Study||4
10933349|NCT00308620|12102238|FG002|STARTED|Overall Study||6
10933350|NCT00308620|12102236|FG000|COMPLETED|Overall Study||2
10933351|NCT00308620|12102237|FG001|COMPLETED|Overall Study||3
10933352|NCT00308620|12102238|FG002|COMPLETED|Overall Study||5
10933353|NCT00308620|12102236|FG000|NOT COMPLETED|Overall Study||1
10933354|NCT00308620|12102237|FG001|NOT COMPLETED|Overall Study||1
10933355|NCT00308620|12102238|FG002|NOT COMPLETED|Overall Study||1
10933356|NCT00308711|12102249|FG000|STARTED|Overall Study||428
10933357|NCT00308711|12102250|FG001|STARTED|Overall Study||444
10933358|NCT00308711|12102251|FG002|STARTED|Overall Study||436
10933359|NCT00308711|12102249|FG000|COMPLETED|Overall Study||426
10933360|NCT00308711|12102250|FG001|COMPLETED|Overall Study||440
10933361|NCT00308711|12102251|FG002|COMPLETED|Overall Study||431
10933362|NCT00308711|12102249|FG000|NOT COMPLETED|Overall Study||2
10933363|NCT00308711|12102250|FG001|NOT COMPLETED|Overall Study||4
10933364|NCT00308711|12102251|FG002|NOT COMPLETED|Overall Study||5
10933365|NCT00308737|12102262|FG000|STARTED|Overall Study||938
10933366|NCT00308737|12102263|FG001|STARTED|Overall Study||951
10933367|NCT00308737|12102264|FG002|STARTED|Overall Study||164
10933368|NCT00308737|12102262|FG000|COMPLETED|Overall Study||475
10933369|NCT00308737|12102263|FG001|COMPLETED|Overall Study||662
10933370|NCT00308737|12102264|FG002|COMPLETED|Overall Study||127
10933371|NCT00308737|12102262|FG000|NOT COMPLETED|Overall Study||463
10933372|NCT00308737|12102263|FG001|NOT COMPLETED|Overall Study||289
10933373|NCT00308737|12102264|FG002|NOT COMPLETED|Overall Study||37
10933374|NCT00308750|12102275|FG000|STARTED|Overall Study||72
10933375|NCT00308750|12102276|FG001|STARTED|Overall Study||74
10933376|NCT00308750|12102277|FG002|STARTED|Overall Study||72
10933377|NCT00308750|12102275|FG000|Received at Least 1 Dose of Study Drug|Overall Study||67
10933378|NCT00308750|12102276|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
10933379|NCT00308750|12102277|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70
10933380|NCT00308750|12102275|FG000|COMPLETED|Overall Study||0
10933381|NCT00308750|12102276|FG001|COMPLETED|Overall Study||34
10933382|NCT00308750|12102277|FG002|COMPLETED|Overall Study||23
10933383|NCT00308750|12102275|FG000|NOT COMPLETED|Overall Study||72
10933384|NCT00308750|12102276|FG001|NOT COMPLETED|Overall Study||40
10933385|NCT00308750|12102277|FG002|NOT COMPLETED|Overall Study||49
10933386|NCT00308997|12102288|FG000|STARTED|Overall Study||56
10933387|NCT00308997|12102289|FG001|STARTED|Overall Study||29
10933388|NCT00308997|12102288|FG000|COMPLETED|Overall Study||55
10933389|NCT00308997|12102289|FG001|COMPLETED|Overall Study||28
10933390|NCT00308997|12102288|FG000|NOT COMPLETED|Overall Study||1
10933391|NCT00308997|12102289|FG001|NOT COMPLETED|Overall Study||1
10933392|NCT00309140|12102295|FG000|STARTED|Overall Study||23
10933393|NCT00309140|12102295|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
10933394|NCT00309140|12102295|FG000|COMPLETED|Overall Study||23
10933395|NCT00309140|12102295|FG000|NOT COMPLETED|Overall Study||0
10933396|NCT00309166|12102301|FG000|STARTED|Overall Study||181
10933397|NCT00309166|12102302|FG001|STARTED|Overall Study||89
10933398|NCT00309166|12102301|FG000|COMPLETED|Overall Study||176
10933399|NCT00309166|12102302|FG001|COMPLETED|Overall Study||86
10933400|NCT00309166|12102301|FG000|NOT COMPLETED|Overall Study||5
10933401|NCT00309166|12102302|FG001|NOT COMPLETED|Overall Study||3
10933402|NCT00309244|12102310|FG000|STARTED|Overall Study||334
10933403|NCT00309244|12102311|FG001|STARTED|Overall Study||343
10933404|NCT00309244|12102310|FG000|COMPLETED|Overall Study||216
10933405|NCT00309244|12102311|FG001|COMPLETED|Overall Study||246
10933406|NCT00309244|12102310|FG000|NOT COMPLETED|Overall Study||118
10933407|NCT00309244|12102311|FG001|NOT COMPLETED|Overall Study||97
10933408|NCT00309387|12102319|FG000|STARTED|Overall Study||510
10933409|NCT00309387|12102320|FG001|STARTED|Overall Study||510
10933410|NCT00309387|12102319|FG000|COMPLETED|Overall Study||368
10933411|NCT00309387|12102320|FG001|COMPLETED|Overall Study||351
10933412|NCT00309387|12102319|FG000|NOT COMPLETED|Overall Study||142
10933413|NCT00309387|12102320|FG001|NOT COMPLETED|Overall Study||159
10933414|NCT00309452|12102329|FG000|STARTED|Overall Study||60
10933415|NCT00309452|12102330|FG001|STARTED|Overall Study||60
10933416|NCT00309452|12102329|FG000|COMPLETED|Overall Study||57
10933417|NCT00309452|12102330|FG001|COMPLETED|Overall Study||60
10933418|NCT00309452|12102329|FG000|NOT COMPLETED|Overall Study||3
10933419|NCT00309452|12102330|FG001|NOT COMPLETED|Overall Study||0
10933420|NCT00309465|12102342|FG000|STARTED|Overall Study||58
10933421|NCT00309465|12102343|FG001|STARTED|Overall Study||58
10933422|NCT00309465|12102344|FG002|STARTED|Overall Study||58
10933423|NCT00309465|12102345|FG003|STARTED|Overall Study||76
10933424|NCT00309465|12102346|FG004|STARTED|Overall Study||76
10933425|NCT00309465|12102347|FG005|STARTED|Overall Study||76
10933426|NCT00309465|12102342|FG000|COMPLETED|Overall Study||58
10933427|NCT00309465|12102343|FG001|COMPLETED|Overall Study||58
10933428|NCT00309465|12102344|FG002|COMPLETED|Overall Study||58
10933429|NCT00309465|12102345|FG003|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
10933430|NCT00309465|12102346|FG004|COMPLETED|Overall Study||76
10933431|NCT00309465|12102347|FG005|COMPLETED|Overall Study||76
10933432|NCT00309465|12102342|FG000|NOT COMPLETED|Overall Study||0
10933433|NCT00309465|12102343|FG001|NOT COMPLETED|Overall Study||0
10933434|NCT00309465|12102344|FG002|NOT COMPLETED|Overall Study||0
10933435|NCT00309465|12102345|FG003|NOT COMPLETED|Overall Study||1
10933436|NCT00309465|12102346|FG004|NOT COMPLETED|Overall Study||0
10933437|NCT00309465|12102347|FG005|NOT COMPLETED|Overall Study||0
10933438|NCT00309608|12102366|FG000|STARTED|Overall Study||71
10933439|NCT00309608|12102367|FG001|STARTED|Overall Study||65
10933440|NCT00309608|12102368|FG002|STARTED|Overall Study||66
10933441|NCT00309608|12102369|FG003|STARTED|Overall Study||66
10933442|NCT00309608|12102370|FG004|STARTED|Overall Study||65
10933443|NCT00309608|12102366|FG000|COMPLETED|Overall Study||57
10933444|NCT00309608|12102367|FG001|COMPLETED|Overall Study||52
10933445|NCT00309608|12102368|FG002|COMPLETED|Overall Study||56
10933446|NCT00309608|12102369|FG003|COMPLETED|Overall Study||60
10933447|NCT00309608|12102370|FG004|COMPLETED|Overall Study||61
10933448|NCT00309608|12102366|FG000|NOT COMPLETED|Overall Study||14
10933449|NCT00309608|12102367|FG001|NOT COMPLETED|Overall Study||13
10933450|NCT00309608|12102368|FG002|NOT COMPLETED|Overall Study||10
10933451|NCT00309608|12102369|FG003|NOT COMPLETED|Overall Study||6
10933452|NCT00309608|12102370|FG004|NOT COMPLETED|Overall Study||4
10933453|NCT00309738|12102384|FG000|STARTED|Overall Study||236
10933454|NCT00309738|12102385|FG001|STARTED|Overall Study||119
10933455|NCT00309738|12102384|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
10933456|NCT00309738|12102385|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
10933457|NCT00309738|12102384|FG000|COMPLETED|Overall Study||223
10933458|NCT00309738|12102385|FG001|COMPLETED|Overall Study||107
10933459|NCT00309738|12102384|FG000|NOT COMPLETED|Overall Study||13
10933460|NCT00309738|12102385|FG001|NOT COMPLETED|Overall Study||12
10933461|NCT00309751|12102393|FG000|STARTED|Overall Study||279
10933462|NCT00309751|12102394|FG001|STARTED|Overall Study||139
10933463|NCT00309751|12102393|FG000|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
10933464|NCT00309751|12102394|FG001|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
10933465|NCT00309751|12102393|FG000|COMPLETED|Overall Study||248
10933466|NCT00309751|12102394|FG001|COMPLETED|Overall Study||124
10933467|NCT00309751|12102393|FG000|NOT COMPLETED|Overall Study||31
10933468|NCT00309751|12102394|FG001|NOT COMPLETED|Overall Study||15
10933469|NCT00309777|12102404|FG000|STARTED|Overall Study||315
10933470|NCT00309777|12102405|FG001|STARTED|Overall Study||108
10933471|NCT00309777|12102406|FG002|STARTED|Overall Study||323
10933472|NCT00309777|12102407|FG003|STARTED|Overall Study||111
10933473|NCT00309777|12102404|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
10933474|NCT00309777|12102405|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
10933475|NCT00309777|12102406|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
10933476|NCT00309777|12102407|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
10933477|NCT00309777|12102404|FG000|COMPLETED|Overall Study||292
10933478|NCT00309777|12102405|FG001|COMPLETED|Overall Study||99
10933479|NCT00309777|12102406|FG002|COMPLETED|Overall Study||304
10933480|NCT00309777|12102407|FG003|COMPLETED|Overall Study||107
10933481|NCT00309777|12102404|FG000|NOT COMPLETED|Overall Study||23
10933482|NCT00309777|12102405|FG001|NOT COMPLETED|Overall Study||9
10933483|NCT00309777|12102406|FG002|NOT COMPLETED|Overall Study||19
10933484|NCT00309777|12102407|FG003|NOT COMPLETED|Overall Study||4
10933485|NCT00309842|12102417|FG000|STARTED|Overall Study||213
10933486|NCT00309842|12102417|FG000|COMPLETED|Overall Study||212
10933487|NCT00309842|12102417|FG000|NOT COMPLETED|Overall Study||1
10933488|NCT00309907|12102421|FG000|STARTED|Overall Study||39
10933489|NCT00309907|12102421|FG000|COMPLETED|Overall Study||19
10933490|NCT00309907|12102421|FG000|NOT COMPLETED|Overall Study||20
10933491|NCT00309946|12102426|FG000|STARTED|Overall Study||51
10933492|NCT00309946|12102426|FG000|COMPLETED|Overall Study||50
10933493|NCT00309946|12102426|FG000|NOT COMPLETED|Overall Study||1
10933494|NCT00309959|12102430|FG000|STARTED|Overall Study||37
10933495|NCT00309959|12102430|FG000|COMPLETED|Overall Study||35
10933496|NCT00309959|12102430|FG000|NOT COMPLETED|Overall Study||2
10933497|NCT00310037|12102441|FG000|STARTED|Overall Study||52
10933498|NCT00310037|12102442|FG001|STARTED|Overall Study||50
10933499|NCT00310037|12102441|FG000|COMPLETED|Overall Study||34
10933500|NCT00310037|12102442|FG001|COMPLETED|Overall Study||33
10933501|NCT00310037|12102441|FG000|NOT COMPLETED|Overall Study||18
10933502|NCT00310037|12102442|FG001|NOT COMPLETED|Overall Study||17
10933503|NCT00310050|12102448|FG000|STARTED|Overall Study||4
10933504|NCT00310050|12102448|FG000|COMPLETED|Overall Study||3
10933505|NCT00310050|12102448|FG000|NOT COMPLETED|Overall Study||1
10933506|NCT00310076|12102452|FG000|STARTED|Overall Study||29
10933507|NCT00310076|12102452|FG000|COMPLETED|Overall Study||26
10933508|NCT00310076|12102452|FG000|NOT COMPLETED|Overall Study||3
10933509|NCT00310310|12102458|FG000|STARTED|Overall Study||120
10933510|NCT00310310|12102459|FG001|STARTED|Overall Study||120
10933511|NCT00310310|12102458|FG000|COMPLETED|Overall Study||90
10933512|NCT00310310|12102459|FG001|COMPLETED|Overall Study||100
10933513|NCT00310310|12102458|FG000|NOT COMPLETED|Overall Study||30
10933514|NCT00310310|12102459|FG001|NOT COMPLETED|Overall Study||20
10933515|NCT00310362|12102468|FG000|STARTED|Overall Study||1199
10933516|NCT00310362|12102469|FG001|STARTED|Overall Study||1205
10933517|NCT00310362|12102470|FG002|STARTED|Overall Study||1206
10933518|NCT00310362|12102468|FG000|COMPLETED|Overall Study||1199
10933519|NCT00310362|12102469|FG001|COMPLETED|Overall Study||1205
10933520|NCT00310362|12102470|FG002|COMPLETED|Overall Study||1206
10933521|NCT00310362|12102468|FG000|NOT COMPLETED|Overall Study||0
10933522|NCT00310362|12102469|FG001|NOT COMPLETED|Overall Study||0
10933523|NCT00310362|12102470|FG002|NOT COMPLETED|Overall Study||0
10933524|NCT00310375|12102486|FG000|STARTED|Primary Reporting Phase||102
10933525|NCT00310375|12102487|FG001|STARTED|Primary Reporting Phase||79
10933526|NCT00310375|12102488|FG002|STARTED|Primary Reporting Phase||0
10933527|NCT00310375|12102486|FG000|COMPLETED|Primary Reporting Phase||11
10933528|NCT00310375|12102487|FG001|COMPLETED|Primary Reporting Phase||11
10933529|NCT00310375|12102488|FG002|COMPLETED|Primary Reporting Phase||0
10933530|NCT00310375|12102486|FG000|NOT COMPLETED|Primary Reporting Phase||91
10933531|NCT00310375|12102487|FG001|NOT COMPLETED|Primary Reporting Phase||68
10933532|NCT00310375|12102488|FG002|NOT COMPLETED|Primary Reporting Phase||0
10933533|NCT00310375|12102486|FG000|STARTED|Safety Follow-up Continuation Phase||0
10933534|NCT00310375|12102487|FG001|STARTED|Safety Follow-up Continuation Phase||0
10933535|NCT00310375|12102488|FG002|STARTED|Safety Follow-up Continuation Phase||19
10933536|NCT00310375|12102486|FG000|COMPLETED|Safety Follow-up Continuation Phase||0
10933537|NCT00310375|12102487|FG001|COMPLETED|Safety Follow-up Continuation Phase||0
10933538|NCT00310375|12102488|FG002|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
10933539|NCT00310375|12102486|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0
10933540|NCT00310375|12102487|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||0
10933541|NCT00310375|12102488|FG002|NOT COMPLETED|Safety Follow-up Continuation Phase||1
10933542|NCT00310401|12102499|FG000|STARTED|Overall Study||260
10933543|NCT00310401|12102500|FG001|STARTED|Overall Study||246
10933544|NCT00310401|12102499|FG000|COMPLETED|Overall Study||260
10933545|NCT00310401|12102500|FG001|COMPLETED|Overall Study||246
10933546|NCT00310401|12102499|FG000|NOT COMPLETED|Overall Study||0
10933547|NCT00310401|12102500|FG001|NOT COMPLETED|Overall Study||0
10933548|NCT00310427|12102510|FG000|STARTED|Overall Study||27
10933549|NCT00310427|12102511|FG001|STARTED|Overall Study||26
10933550|NCT00310427|12102510|FG000|COMPLETED|Overall Study||25
10933551|NCT00310427|12102511|FG001|COMPLETED|Overall Study||25
10933552|NCT00310427|12102510|FG000|NOT COMPLETED|Overall Study||2
10933553|NCT00310427|12102511|FG001|NOT COMPLETED|Overall Study||1
10933554|NCT00310440|12102519|FG000|STARTED|Overall Study||165
10933555|NCT00310440|12102520|FG001|STARTED|Overall Study||154
10933556|NCT00310440|12102519|FG000|COMPLETED|Overall Study||139
10933557|NCT00310440|12102520|FG001|COMPLETED|Overall Study||141
10933558|NCT00310440|12102519|FG000|NOT COMPLETED|Overall Study||26
10933559|NCT00310440|12102520|FG001|NOT COMPLETED|Overall Study||13
10933560|NCT00310466|12102528|FG000|STARTED|Overall Study||113
10933561|NCT00310466|12102529|FG001|STARTED|Overall Study||113
10933562|NCT00310466|12102528|FG000|COMPLETED|Overall Study||95
10933563|NCT00310466|12102529|FG001|COMPLETED|Overall Study||101
10933564|NCT00310466|12102528|FG000|NOT COMPLETED|Overall Study||18
10933565|NCT00310466|12102529|FG001|NOT COMPLETED|Overall Study||12
10933566|NCT00310791|12102537|FG000|STARTED|Overall Study||40
10933567|NCT00310791|12102538|FG001|STARTED|Overall Study||40
10933568|NCT00310791|12102537|FG000|COMPLETED|Overall Study||30
10933569|NCT00310791|12102538|FG001|COMPLETED|Overall Study||30
10933570|NCT00310791|12102537|FG000|NOT COMPLETED|Overall Study||10
10933571|NCT00310791|12102538|FG001|NOT COMPLETED|Overall Study||10
10933572|NCT00310804|12102546|FG000|STARTED|Overall Study||1029
10933573|NCT00310804|12102547|FG001|STARTED|Overall Study||171
10933574|NCT00310804|12102546|FG000|COMPLETED|Overall Study||1024
10933575|NCT00310804|12102547|FG001|COMPLETED|Overall Study||171
10933576|NCT00310804|12102546|FG000|NOT COMPLETED|Overall Study||5
10933577|NCT00310804|12102547|FG001|NOT COMPLETED|Overall Study||0
10933578|NCT00310817|12102571|FG000|STARTED|Overall Study||207
10933579|NCT00310817|12102572|FG001|STARTED|Overall Study||206
10933580|NCT00310817|12102573|FG002|STARTED|Overall Study||128
10933581|NCT00310817|12102574|FG003|STARTED|Overall Study||82
10933582|NCT00310817|12102571|FG000|COMPLETED|Overall Study||196
10933583|NCT00310817|12102572|FG001|COMPLETED|Overall Study||198
10933584|NCT00310817|12102573|FG002|COMPLETED|Overall Study||120
10933585|NCT00310817|12102574|FG003|COMPLETED|Overall Study||74
10933586|NCT00310817|12102571|FG000|NOT COMPLETED|Overall Study||11
10933587|NCT00310817|12102572|FG001|NOT COMPLETED|Overall Study||8
10933588|NCT00310817|12102573|FG002|NOT COMPLETED|Overall Study||8
10933589|NCT00310817|12102574|FG003|NOT COMPLETED|Overall Study||8
10933590|NCT00310856|12102620|FG000|STARTED|Overall Study||64
10933591|NCT00310856|12102621|FG001|STARTED|Overall Study||61
10933592|NCT00310856|12102622|FG002|STARTED|Overall Study||50
10933593|NCT00310856|12102620|FG000|COMPLETED|Overall Study||59
10933594|NCT00310856|12102621|FG001|COMPLETED|Overall Study||56
10933595|NCT00310856|12102622|FG002|COMPLETED|Overall Study||42
10933596|NCT00310856|12102620|FG000|NOT COMPLETED|Overall Study||5
10933597|NCT00310856|12102621|FG001|NOT COMPLETED|Overall Study||5
10933598|NCT00310856|12102622|FG002|NOT COMPLETED|Overall Study||8
10933599|NCT00311155|12102631|FG000|STARTED|Overall Study||694
10933600|NCT00311155|12102631|FG000|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
10933601|NCT00311155|12102631|FG000|NOT COMPLETED|Overall Study||93
10933602|NCT00311168|12102637|FG000|STARTED|First Intervention||66
10933603|NCT00311168|12102638|FG001|STARTED|First Intervention||68
10933604|NCT00311168|12102637|FG000|COMPLETED|First Intervention||59
10933605|NCT00311168|12102638|FG001|COMPLETED|First Intervention||62
10933606|NCT00311168|12102637|FG000|NOT COMPLETED|First Intervention||7
10933607|NCT00311168|12102638|FG001|NOT COMPLETED|First Intervention||6
10933608|NCT00311168|12102637|FG000|STARTED|Second Intervention||59
10933609|NCT00311168|12102638|FG001|STARTED|Second Intervention||62
10933610|NCT00311168|12102637|FG000|COMPLETED|Second Intervention||49
10933611|NCT00311168|12102638|FG001|COMPLETED|Second Intervention||58
10933612|NCT00311168|12102637|FG000|NOT COMPLETED|Second Intervention||10
10933613|NCT00311168|12102638|FG001|NOT COMPLETED|Second Intervention||4
10933614|NCT00311181|12102646|FG000|STARTED|Overall Study||217
10933615|NCT00311181|12102646|FG000|COMPLETED|Overall Study||121
10933616|NCT00311181|12102646|FG000|NOT COMPLETED|Overall Study||96
10933617|NCT00311246|12102650|FG000|STARTED|Overall Study||11
10933618|NCT00311246|12102650|FG000|COMPLETED|Overall Study||11
10933619|NCT00311246|12102650|FG000|NOT COMPLETED|Overall Study||0
10933620|NCT00311311|12102659|FG000|STARTED|Overall Study||37
10933621|NCT00311311|12102660|FG001|STARTED|Overall Study||35
10933622|NCT00311311|12102659|FG000|COMPLETED|Overall Study||29
10933623|NCT00311311|12102660|FG001|COMPLETED|Overall Study||26
10933624|NCT00311311|12102659|FG000|NOT COMPLETED|Overall Study||8
10933625|NCT00311311|12102660|FG001|NOT COMPLETED|Overall Study||9
10933626|NCT00311363|12102669|FG000|STARTED|24-Week Single-Blind Treatment Period||327
10933627|NCT00311363|12102670|FG001|STARTED|24-Week Single-Blind Treatment Period||0
10933628|NCT00311363|12102671|FG002|STARTED|24-Week Single-Blind Treatment Period||0
10933629|NCT00311363|12102669|FG000|COMPLETED|24-Week Single-Blind Treatment Period||221
10933630|NCT00311363|12102670|FG001|COMPLETED|24-Week Single-Blind Treatment Period||0
10933631|NCT00311363|12102671|FG002|COMPLETED|24-Week Single-Blind Treatment Period||0
10933632|NCT00311363|12102669|FG000|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
10933633|NCT00311363|12102670|FG001|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
10933634|NCT00311363|12102671|FG002|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
10933635|NCT00311363|12102669|FG000|STARTED|12-Week Double-Blind Treatment Period||0
10933636|NCT00311363|12102670|FG001|STARTED|12-Week Double-Blind Treatment Period||98
10933637|NCT00311363|12102671|FG002|STARTED|12-Week Double-Blind Treatment Period||96
10933638|NCT00311363|12102669|FG000|COMPLETED|12-Week Double-Blind Treatment Period||0
10933639|NCT00311363|12102670|FG001|COMPLETED|12-Week Double-Blind Treatment Period||84
10933640|NCT00311363|12102671|FG002|COMPLETED|12-Week Double-Blind Treatment Period||84
10933641|NCT00311363|12102669|FG000|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
10933642|NCT00311363|12102670|FG001|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
10933643|NCT00311363|12102671|FG002|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
10933644|NCT00311376|12102684|FG000|STARTED|Treatment Cycle 1||132
10933645|NCT00311376|12102685|FG001|STARTED|Treatment Cycle 1||135
10933646|NCT00311376|12102686|FG002|STARTED|Treatment Cycle 1||149
10933647|NCT00311376|12102684|FG000|COMPLETED|Treatment Cycle 1||105
10933648|NCT00311376|12102685|FG001|COMPLETED|Treatment Cycle 1||118
10933649|NCT00311376|12102686|FG002|COMPLETED|Treatment Cycle 1||132
10933650|NCT00311376|12102684|FG000|NOT COMPLETED|Treatment Cycle 1||27
10933651|NCT00311376|12102685|FG001|NOT COMPLETED|Treatment Cycle 1||17
10933652|NCT00311376|12102686|FG002|NOT COMPLETED|Treatment Cycle 1||17
10933653|NCT00311376|12102684|FG000|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
10933654|NCT00311376|12102685|FG001|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
10933655|NCT00311376|12102686|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
10933656|NCT00311376|12102684|FG000|COMPLETED|Treatment Cycle 2||106
10933657|NCT00311376|12102685|FG001|COMPLETED|Treatment Cycle 2||112
10933658|NCT00311376|12102686|FG002|COMPLETED|Treatment Cycle 2||0
10933659|NCT00311376|12102684|FG000|NOT COMPLETED|Treatment Cycle 2||9
10933660|NCT00311376|12102685|FG001|NOT COMPLETED|Treatment Cycle 2||13
10933661|NCT00311376|12102686|FG002|NOT COMPLETED|Treatment Cycle 2||0
10933662|NCT00311402|12102696|FG000|STARTED|Overall Study||655
10933663|NCT00311402|12102697|FG001|STARTED|Overall Study||639
10933664|NCT00311402|12102696|FG000|COMPLETED|Overall Study||445
10933665|NCT00311402|12102697|FG001|COMPLETED|Overall Study||462
10933666|NCT00311402|12102696|FG000|NOT COMPLETED|Overall Study||210
10933667|NCT00311402|12102697|FG001|NOT COMPLETED|Overall Study||177
10933668|NCT00311584|12102705|FG000|STARTED|Overall Study||29
10933669|NCT00311584|12102706|FG001|STARTED|Overall Study||30
10933670|NCT00311584|12102705|FG000|COMPLETED|Overall Study||9
10933671|NCT00311584|12102706|FG001|COMPLETED|Overall Study||7
10933672|NCT00311584|12102705|FG000|NOT COMPLETED|Overall Study||20
10933673|NCT00311584|12102706|FG001|NOT COMPLETED|Overall Study||23
10933674|NCT00311623|12102715|FG000|STARTED|Overall Study||10
10933675|NCT00311623|12102716|FG001|STARTED|Overall Study||20
10933676|NCT00311623|12102717|FG002|STARTED|Overall Study||2
10933677|NCT00311623|12102715|FG000|COMPLETED|Overall Study||10
10933678|NCT00311623|12102716|FG001|COMPLETED|Overall Study||20
10933679|NCT00311623|12102717|FG002|COMPLETED|Overall Study||0
10933680|NCT00311623|12102715|FG000|NOT COMPLETED|Overall Study||0
10933681|NCT00311623|12102716|FG001|NOT COMPLETED|Overall Study||0
10933682|NCT00311623|12102717|FG002|NOT COMPLETED|Overall Study||2
10933683|NCT00311766|12102728|FG000|STARTED|Overall Study||8
10933684|NCT00311766|12102729|FG001|STARTED|Overall Study||22
10933685|NCT00311766|12102728|FG000|COMPLETED|Overall Study||8
10933686|NCT00311766|12102729|FG001|COMPLETED|Overall Study||17
10933687|NCT00311766|12102728|FG000|NOT COMPLETED|Overall Study||0
10933688|NCT00311766|12102729|FG001|NOT COMPLETED|Overall Study||5
10933689|NCT00312195|12102737|FG000|STARTED|Overall Study||138
10933690|NCT00312195|12102738|FG001|STARTED|Overall Study||129
10933691|NCT00312195|12102737|FG000|COMPLETED|Overall Study||132
10933692|NCT00312195|12102738|FG001|COMPLETED|Overall Study||123
10933693|NCT00312195|12102737|FG000|NOT COMPLETED|Overall Study||6
10933694|NCT00312195|12102738|FG001|NOT COMPLETED|Overall Study||6
10933695|NCT00312208|12102748|FG000|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
10933696|NCT00312208|12102749|FG001|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
10933697|NCT00312208|12102748|FG000|COMPLETED|Overall Study||1477
10933698|NCT00312208|12102749|FG001|COMPLETED|Overall Study||1526
10933699|NCT00312208|12102748|FG000|NOT COMPLETED|Overall Study||172
10933700|NCT00312208|12102749|FG001|NOT COMPLETED|Overall Study||123
10933701|NCT00312221|12102758|FG000|STARTED|Open-label Run-in Period||652
10933702|NCT00312221|12102759|FG001|STARTED|Open-label Run-in Period||0
10933703|NCT00312221|12102760|FG002|STARTED|Open-label Run-in Period||0
10933704|NCT00312221|12102761|FG003|STARTED|Open-label Run-in Period||0
10933705|NCT00312221|12102758|FG000|COMPLETED|Open-label Run-in Period||418
10933706|NCT00312221|12102759|FG001|COMPLETED|Open-label Run-in Period||0
10933707|NCT00312221|12102760|FG002|COMPLETED|Open-label Run-in Period||0
10933708|NCT00312221|12102761|FG003|COMPLETED|Open-label Run-in Period||0
10933709|NCT00312221|12102758|FG000|NOT COMPLETED|Open-label Run-in Period||234
10933710|NCT00312221|12102759|FG001|NOT COMPLETED|Open-label Run-in Period||0
10933711|NCT00312221|12102760|FG002|NOT COMPLETED|Open-label Run-in Period||0
10933712|NCT00312221|12102761|FG003|NOT COMPLETED|Open-label Run-in Period||0
10933713|NCT00312221|12102758|FG000|STARTED|Double-blind Phase||0
10933714|NCT00312221|12102759|FG001|STARTED|Double-blind Phase||136
10933715|NCT00312221|12102760|FG002|STARTED|Double-blind Phase||149
10933716|NCT00312221|12102761|FG003|STARTED|Double-blind Phase||133
10933717|NCT00312221|12102758|FG000|COMPLETED|Double-blind Phase||0
10933718|NCT00312221|12102759|FG001|COMPLETED|Double-blind Phase||77
10933719|NCT00312221|12102760|FG002|COMPLETED|Double-blind Phase||77
10933720|NCT00312221|12102761|FG003|COMPLETED|Double-blind Phase||63
10933721|NCT00312221|12102758|FG000|NOT COMPLETED|Double-blind Phase||0
10933722|NCT00312221|12102759|FG001|NOT COMPLETED|Double-blind Phase||59
10933723|NCT00312221|12102760|FG002|NOT COMPLETED|Double-blind Phase||72
10933724|NCT00312221|12102761|FG003|NOT COMPLETED|Double-blind Phase||70
10933725|NCT00312338|12102772|FG000|STARTED|Overall Study||105
10933726|NCT00312338|12102773|FG001|STARTED|Overall Study||57
10933727|NCT00312338|12102772|FG000|COMPLETED|Overall Study||83
10933728|NCT00312338|12102773|FG001|COMPLETED|Overall Study||54
10933729|NCT00312338|12102772|FG000|NOT COMPLETED|Overall Study||22
10933730|NCT00312338|12102773|FG001|NOT COMPLETED|Overall Study||3
10933731|NCT00312377|12102781|FG000|STARTED|Overall Study|randomised patients|694
10933732|NCT00312377|12102782|FG001|STARTED|Overall Study|randomised patients|697
10933733|NCT00312377|12102781|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
10933734|NCT00312377|12102782|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
10933735|NCT00312377|12102781|FG000|NOT COMPLETED|Overall Study||644
10933736|NCT00312377|12102782|FG001|NOT COMPLETED|Overall Study||668
10933737|NCT00312494|12102791|FG000|STARTED|Overall Study||232
10933738|NCT00312494|12102792|FG001|STARTED|Overall Study||226
10933739|NCT00312494|12102793|FG002|STARTED|Overall Study||222
10933740|NCT00312494|12102791|FG000|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
10933741|NCT00312494|12102792|FG001|Received Study Treatment|Overall Study||216
10933742|NCT00312494|12102793|FG002|Received Study Treatment|Overall Study||217
10933743|NCT00312494|12102791|FG000|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
10933744|NCT00312494|12102792|FG001|COMPLETED|Overall Study||168
10933745|NCT00312494|12102793|FG002|COMPLETED|Overall Study||179
10933746|NCT00312494|12102791|FG000|NOT COMPLETED|Overall Study||71
10933747|NCT00312494|12102792|FG001|NOT COMPLETED|Overall Study||58
10933748|NCT00312494|12102793|FG002|NOT COMPLETED|Overall Study||43
10933749|NCT00312572|12102803|FG000|STARTED|Overall Study||101
10933750|NCT00312572|12102804|FG001|STARTED|Overall Study||103
10933751|NCT00312572|12102803|FG000|COMPLETED|Overall Study||85
10933752|NCT00312572|12102804|FG001|COMPLETED|Overall Study||82
10933753|NCT00312572|12102803|FG000|NOT COMPLETED|Overall Study||16
10933754|NCT00312572|12102804|FG001|NOT COMPLETED|Overall Study||21
10933755|NCT00312663|12102815|FG000|STARTED|Immunization Phase||5
10933756|NCT00312663|12102816|FG001|STARTED|Immunization Phase||13
10933757|NCT00312663|12102817|FG002|STARTED|Immunization Phase||0
10933758|NCT00312663|12102815|FG000|COMPLETED|Immunization Phase||5
10933759|NCT00312663|12102816|FG001|COMPLETED|Immunization Phase||12
10933760|NCT00312663|12102817|FG002|COMPLETED|Immunization Phase||0
10933761|NCT00312663|12102815|FG000|NOT COMPLETED|Immunization Phase||0
10933762|NCT00312663|12102816|FG001|NOT COMPLETED|Immunization Phase||1
10933763|NCT00312663|12102817|FG002|NOT COMPLETED|Immunization Phase||0
10933764|NCT00312663|12102815|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
10933765|NCT00312663|12102816|FG001|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
10933766|NCT00312663|12102817|FG002|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
10933767|NCT00312663|12102815|FG000|COMPLETED|Challenge Phase||0
10933768|NCT00312663|12102816|FG001|COMPLETED|Challenge Phase||10
10933769|NCT00312663|12102817|FG002|COMPLETED|Challenge Phase||6
10933770|NCT00312663|12102815|FG000|NOT COMPLETED|Challenge Phase||0
10933771|NCT00312663|12102816|FG001|NOT COMPLETED|Challenge Phase||0
10933772|NCT00312663|12102817|FG002|NOT COMPLETED|Challenge Phase||0
10933773|NCT00312702|12102829|FG000|STARTED|Immunization Phase||5
10933774|NCT00312702|12102830|FG001|STARTED|Immunization Phase||13
10933775|NCT00312702|12102831|FG002|STARTED|Immunization Phase||0
10933776|NCT00312702|12102829|FG000|COMPLETED|Immunization Phase||5
10933777|NCT00312702|12102830|FG001|COMPLETED|Immunization Phase||12
10933778|NCT00312702|12102831|FG002|COMPLETED|Immunization Phase||0
10933779|NCT00312702|12102829|FG000|NOT COMPLETED|Immunization Phase||0
10933780|NCT00312702|12102830|FG001|NOT COMPLETED|Immunization Phase||1
10933781|NCT00312702|12102831|FG002|NOT COMPLETED|Immunization Phase||0
10933946|NCT00313586|12102997|FG003|Treated|Overall Study||23
10933782|NCT00312702|12102829|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
10933783|NCT00312702|12102830|FG001|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
10933784|NCT00312702|12102831|FG002|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
10933785|NCT00312702|12102829|FG000|COMPLETED|Challenge Phase||0
10933786|NCT00312702|12102830|FG001|COMPLETED|Challenge Phase||12
10933787|NCT00312702|12102831|FG002|COMPLETED|Challenge Phase||1
10933788|NCT00312702|12102829|FG000|NOT COMPLETED|Challenge Phase||0
10933789|NCT00312702|12102830|FG001|NOT COMPLETED|Challenge Phase||0
10933790|NCT00312702|12102831|FG002|NOT COMPLETED|Challenge Phase||0
10933791|NCT00312728|12102839|FG000|STARTED|Overall Study||115
10933792|NCT00312728|12102839|FG000|COMPLETED|Overall Study||5
10933793|NCT00312728|12102839|FG000|NOT COMPLETED|Overall Study||110
10933794|NCT00312845|12102845|FG000|STARTED|Overall Study||336
10933795|NCT00312845|12102846|FG001|STARTED|Overall Study||340
10933796|NCT00312845|12102845|FG000|COMPLETED|Overall Study||237
10933797|NCT00312845|12102846|FG001|COMPLETED|Overall Study||245
10933798|NCT00312845|12102845|FG000|NOT COMPLETED|Overall Study||99
10933799|NCT00312845|12102846|FG001|NOT COMPLETED|Overall Study||95
10933800|NCT00312858|12102854|FG000|STARTED|Overall Study||330
10933801|NCT00312858|12102855|FG001|STARTED|Overall Study||323
10933802|NCT00312858|12102854|FG000|Visit 1|Overall Study||330
10933803|NCT00312858|12102855|FG001|Visit 1|Overall Study||323
10933804|NCT00312858|12102854|FG000|Visit 2|Overall Study||305
10933805|NCT00312858|12102855|FG001|Visit 2|Overall Study||294
10933806|NCT00312858|12102854|FG000|Visit 3|Overall Study||273
10933807|NCT00312858|12102855|FG001|Visit 3|Overall Study||261
10933808|NCT00312858|12102854|FG000|Visit 4|Overall Study||262
10933809|NCT00312858|12102855|FG001|Visit 4|Overall Study||240
10933810|NCT00312858|12102854|FG000|COMPLETED|Overall Study||262
10933811|NCT00312858|12102855|FG001|COMPLETED|Overall Study||230
10933812|NCT00312858|12102854|FG000|NOT COMPLETED|Overall Study||68
10933813|NCT00312858|12102855|FG001|NOT COMPLETED|Overall Study||93
10933814|NCT00312884|12102863|FG000|STARTED|Overall Study||91
10933815|NCT00312884|12102864|FG001|STARTED|Overall Study||91
10933816|NCT00312884|12102863|FG000|COMPLETED|Overall Study||74
10933817|NCT00312884|12102864|FG001|COMPLETED|Overall Study||79
10933818|NCT00312884|12102863|FG000|NOT COMPLETED|Overall Study||17
10933819|NCT00312884|12102864|FG001|NOT COMPLETED|Overall Study||12
10933820|NCT00312897|12102872|FG000|STARTED|Overall Study||27
10933821|NCT00312897|12102873|FG001|STARTED|Overall Study||24
10933822|NCT00312897|12102872|FG000|COMPLETED|Overall Study||21
10933823|NCT00312897|12102873|FG001|COMPLETED|Overall Study||18
10933824|NCT00312897|12102872|FG000|NOT COMPLETED|Overall Study||6
10933825|NCT00312897|12102873|FG001|NOT COMPLETED|Overall Study||6
10933826|NCT00312923|12102881|FG000|STARTED|Overall Study||28
10933827|NCT00312923|12102882|FG001|STARTED|Overall Study||26
10933828|NCT00312923|12102881|FG000|COMPLETED|Overall Study||19
10933829|NCT00312923|12102882|FG001|COMPLETED|Overall Study||20
10933830|NCT00312923|12102881|FG000|NOT COMPLETED|Overall Study||9
10933831|NCT00312923|12102882|FG001|NOT COMPLETED|Overall Study||6
10933832|NCT00313014|12102891|FG000|STARTED|Overall Study||221
10933833|NCT00313014|12102892|FG001|STARTED|Overall Study||219
10933834|NCT00313014|12102893|FG002|STARTED|Overall Study||220
10933835|NCT00313014|12102891|FG000|COMPLETED|Overall Study||128
10933836|NCT00313014|12102892|FG001|COMPLETED|Overall Study||146
10933837|NCT00313014|12102893|FG002|COMPLETED|Overall Study||159
10933838|NCT00313014|12102891|FG000|NOT COMPLETED|Overall Study||93
10933839|NCT00313014|12102892|FG001|NOT COMPLETED|Overall Study||73
10933840|NCT00313014|12102893|FG002|NOT COMPLETED|Overall Study||61
10933841|NCT00313144|12102902|FG000|STARTED|Overall Study||127
10933842|NCT00313144|12102902|FG000|COMPLETED|Overall Study||17
10933843|NCT00313144|12102902|FG000|NOT COMPLETED|Overall Study||110
10933844|NCT00313170|12102918|FG000|STARTED|Overall Study||47
10933845|NCT00313170|12102919|FG001|STARTED|Overall Study||51
10933846|NCT00313170|12102920|FG002|STARTED|Overall Study||46
10933847|NCT00313170|12102918|FG000|COMPLETED|Overall Study||11
10933848|NCT00313170|12102919|FG001|COMPLETED|Overall Study||17
10933849|NCT00313170|12102920|FG002|COMPLETED|Overall Study||14
10933850|NCT00313170|12102918|FG000|NOT COMPLETED|Overall Study||36
10933851|NCT00313170|12102919|FG001|NOT COMPLETED|Overall Study||34
10933852|NCT00313170|12102920|FG002|NOT COMPLETED|Overall Study||32
10933853|NCT00313209|12102931|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
10933854|NCT00313209|12102932|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
10933855|NCT00313209|12102931|FG000|COMPLETED|Overall Study||359
10933856|NCT00313209|12102932|FG001|COMPLETED|Overall Study||385
10933857|NCT00313209|12102931|FG000|NOT COMPLETED|Overall Study||107
10933858|NCT00313209|12102932|FG001|NOT COMPLETED|Overall Study||82
10933859|NCT00313300|12102943|FG000|STARTED|Randomized in Phase A (26 Weeks)||184
10933860|NCT00313300|12102944|FG001|STARTED|Randomized in Phase A (26 Weeks)||179
10933861|NCT00313300|12102945|FG002|STARTED|Randomized in Phase A (26 Weeks)||184
10933862|NCT00313300|12102946|FG003|STARTED|Randomized in Phase A (26 Weeks)||0
10933863|NCT00313300|12102947|FG004|STARTED|Randomized in Phase A (26 Weeks)||0
10933864|NCT00313300|12102943|FG000|COMPLETED|Randomized in Phase A (26 Weeks)||130
10933865|NCT00313300|12102944|FG001|COMPLETED|Randomized in Phase A (26 Weeks)||140
10933866|NCT00313300|12102945|FG002|COMPLETED|Randomized in Phase A (26 Weeks)||149
10933867|NCT00313300|12102946|FG003|COMPLETED|Randomized in Phase A (26 Weeks)||0
10933868|NCT00313300|12102947|FG004|COMPLETED|Randomized in Phase A (26 Weeks)||0
10933947|NCT00313586|12102994|FG000|COMPLETED|Overall Study||5
10933869|NCT00313300|12102943|FG000|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
10933870|NCT00313300|12102944|FG001|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
10933871|NCT00313300|12102945|FG002|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
10933872|NCT00313300|12102946|FG003|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
10933873|NCT00313300|12102947|FG004|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
10933874|NCT00313300|12102943|FG000|STARTED|Randomized in Phase B (26 Weeks)||427
10933875|NCT00313300|12102944|FG001|STARTED|Randomized in Phase B (26 Weeks)||138
10933876|NCT00313300|12102945|FG002|STARTED|Randomized in Phase B (26 Weeks)||134
10933877|NCT00313300|12102946|FG003|STARTED|Randomized in Phase B (26 Weeks)||248
10933878|NCT00313300|12102947|FG004|STARTED|Randomized in Phase B (26 Weeks)||221
10933879|NCT00313300|12102943|FG000|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
10933880|NCT00313300|12102944|FG001|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
10933881|NCT00313300|12102945|FG002|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
10933882|NCT00313300|12102946|FG003|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
10933883|NCT00313300|12102947|FG004|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
10933884|NCT00313300|12102943|FG000|COMPLETED|Randomized in Phase B (26 Weeks)||333
10933885|NCT00313300|12102944|FG001|COMPLETED|Randomized in Phase B (26 Weeks)||105
10933886|NCT00313300|12102945|FG002|COMPLETED|Randomized in Phase B (26 Weeks)||94
10933887|NCT00313300|12102946|FG003|COMPLETED|Randomized in Phase B (26 Weeks)||15
10933888|NCT00313300|12102947|FG004|COMPLETED|Randomized in Phase B (26 Weeks)||13
10933889|NCT00313300|12102943|FG000|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
10933890|NCT00313300|12102944|FG001|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
10933891|NCT00313300|12102945|FG002|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
10933892|NCT00313300|12102946|FG003|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
10933893|NCT00313300|12102947|FG004|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
10933894|NCT00313300|12102943|FG000|STARTED|Follow-Up(30days)-Randomized Phase A||163
10933895|NCT00313300|12102944|FG001|STARTED|Follow-Up(30days)-Randomized Phase A||162
10933896|NCT00313300|12102945|FG002|STARTED|Follow-Up(30days)-Randomized Phase A||174
10933897|NCT00313300|12102946|FG003|STARTED|Follow-Up(30days)-Randomized Phase A||0
10933898|NCT00313300|12102947|FG004|STARTED|Follow-Up(30days)-Randomized Phase A||0
10933899|NCT00313300|12102943|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
10933900|NCT00313300|12102944|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
10933901|NCT00313300|12102945|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
10933902|NCT00313300|12102946|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
10933903|NCT00313300|12102947|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
10933904|NCT00313300|12102943|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
10933905|NCT00313300|12102944|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
10933906|NCT00313300|12102945|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
10933907|NCT00313300|12102946|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
10933908|NCT00313300|12102947|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
10933909|NCT00313300|12102943|FG000|STARTED|Follow-Up(30days)-Randomized Phase B||383
10933910|NCT00313300|12102944|FG001|STARTED|Follow-Up(30days)-Randomized Phase B||123
10933911|NCT00313300|12102945|FG002|STARTED|Follow-Up(30days)-Randomized Phase B||119
10933912|NCT00313300|12102946|FG003|STARTED|Follow-Up(30days)-Randomized Phase B||222
10933913|NCT00313300|12102947|FG004|STARTED|Follow-Up(30days)-Randomized Phase B||201
10933914|NCT00313300|12102943|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
10933915|NCT00313300|12102944|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
10933916|NCT00313300|12102945|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
10933917|NCT00313300|12102946|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
10933918|NCT00313300|12102947|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
10933919|NCT00313300|12102943|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
10933920|NCT00313300|12102944|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
10933921|NCT00313300|12102945|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
10933922|NCT00313300|12102946|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
10933923|NCT00313300|12102947|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
10933924|NCT00313313|12102968|FG000|STARTED|Overall Study||248
10933925|NCT00313313|12102969|FG001|STARTED|Overall Study||253
10933926|NCT00313313|12102970|FG002|STARTED|Overall Study||267
10933927|NCT00313313|12102968|FG000|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
10933928|NCT00313313|12102969|FG001|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
10933929|NCT00313313|12102970|FG002|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
10933930|NCT00313313|12102968|FG000|NOT COMPLETED|Overall Study||63
10933931|NCT00313313|12102969|FG001|NOT COMPLETED|Overall Study||66
10933932|NCT00313313|12102970|FG002|NOT COMPLETED|Overall Study||82
10933933|NCT00313443|12102978|FG000|STARTED|Overall Study||30
10933934|NCT00313443|12102978|FG000|COMPLETED|Overall Study||30
10933935|NCT00313443|12102978|FG000|NOT COMPLETED|Overall Study||0
10933936|NCT00313560|12102982|FG000|STARTED|Overall Study||48
10933937|NCT00313560|12102982|FG000|COMPLETED|Overall Study||48
10933938|NCT00313560|12102982|FG000|NOT COMPLETED|Overall Study||0
10933939|NCT00313586|12102994|FG000|STARTED|Overall Study||75
10933940|NCT00313586|12102995|FG001|STARTED|Overall Study||75
10933941|NCT00313586|12102996|FG002|STARTED|Overall Study||24
10933942|NCT00313586|12102997|FG003|STARTED|Overall Study||23
10933943|NCT00313586|12102994|FG000|Treated|Overall Study||74
10933944|NCT00313586|12102995|FG001|Treated|Overall Study||75
10933945|NCT00313586|12102996|FG002|Treated|Overall Study||24
10933948|NCT00313586|12102995|FG001|COMPLETED|Overall Study||5
10933949|NCT00313586|12102996|FG002|COMPLETED|Overall Study||0
10933950|NCT00313586|12102997|FG003|COMPLETED|Overall Study||0
10933951|NCT00313586|12102994|FG000|NOT COMPLETED|Overall Study||70
10933952|NCT00313586|12102995|FG001|NOT COMPLETED|Overall Study||70
10933953|NCT00313586|12102996|FG002|NOT COMPLETED|Overall Study||24
10933954|NCT00313586|12102997|FG003|NOT COMPLETED|Overall Study||23
10933955|NCT00313612|12103007|FG000|STARTED|Overall Study||19
10933956|NCT00313612|12103008|FG001|STARTED|Overall Study||20
10933957|NCT00313612|12103007|FG000|COMPLETED|Overall Study||19
10933958|NCT00313612|12103008|FG001|COMPLETED|Overall Study||19
10933959|NCT00313612|12103007|FG000|NOT COMPLETED|Overall Study||0
10933960|NCT00313612|12103008|FG001|NOT COMPLETED|Overall Study||1
10933961|NCT00313703|12103018|FG000|STARTED|Overall Study||186
10933962|NCT00313703|12103019|FG001|STARTED|Overall Study||34
10933963|NCT00313703|12103020|FG002|STARTED|Overall Study||77
10933964|NCT00313703|12103021|FG003|STARTED|Overall Study||12
10933965|NCT00313703|12103018|FG000|COMPLETED|Overall Study|Some subjects lost to follow-up|175
10933966|NCT00313703|12103019|FG001|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
10933967|NCT00313703|12103020|FG002|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
10933968|NCT00313703|12103021|FG003|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
10933969|NCT00313703|12103018|FG000|NOT COMPLETED|Overall Study||11
10933970|NCT00313703|12103019|FG001|NOT COMPLETED|Overall Study||2
10933971|NCT00313703|12103020|FG002|NOT COMPLETED|Overall Study||5
10933972|NCT00313703|12103021|FG003|NOT COMPLETED|Overall Study||12
10933973|NCT00313716|12103037|FG000|STARTED|Overall Study||18
10933974|NCT00313716|12103038|FG001|STARTED|Overall Study||31
10933975|NCT00313716|12103039|FG002|STARTED|Overall Study||50
10933976|NCT00313716|12103040|FG003|STARTED|Overall Study||20
10933977|NCT00313716|12103041|FG004|STARTED|Overall Study||33
10933978|NCT00313716|12103042|FG005|STARTED|Overall Study||48
10933979|NCT00313716|12103037|FG000|COMPLETED|Overall Study||13
10933980|NCT00313716|12103038|FG001|COMPLETED|Overall Study||23
10933981|NCT00313716|12103039|FG002|COMPLETED|Overall Study||38
10933982|NCT00313716|12103040|FG003|COMPLETED|Overall Study||16
10933983|NCT00313716|12103041|FG004|COMPLETED|Overall Study||27
10933984|NCT00313716|12103042|FG005|COMPLETED|Overall Study||35
10933985|NCT00313716|12103037|FG000|NOT COMPLETED|Overall Study||5
10933986|NCT00313716|12103038|FG001|NOT COMPLETED|Overall Study||8
10933987|NCT00313716|12103039|FG002|NOT COMPLETED|Overall Study||12
10933988|NCT00313716|12103040|FG003|NOT COMPLETED|Overall Study||4
10933989|NCT00313716|12103041|FG004|NOT COMPLETED|Overall Study||6
10933990|NCT00313716|12103042|FG005|NOT COMPLETED|Overall Study||13
10933991|NCT00313729|12103060|FG000|STARTED|Overall Study||120
10933992|NCT00313729|12103060|FG000|COMPLETED|Overall Study||120
10933993|NCT00313729|12103060|FG000|NOT COMPLETED|Overall Study||0
10933994|NCT00313781|12103066|FG000|STARTED|Before Crossover||102
10933995|NCT00313781|12103067|FG001|STARTED|Before Crossover||102
10933996|NCT00313781|12103068|FG002|STARTED|Before Crossover||0
10933997|NCT00313781|12103066|FG000|Treated|Before Crossover||97
10933998|NCT00313781|12103067|FG001|Treated|Before Crossover||102
10933999|NCT00313781|12103068|FG002|Treated|Before Crossover||0
10934000|NCT00313781|12103066|FG000|COMPLETED|Before Crossover||27
10934001|NCT00313781|12103067|FG001|COMPLETED|Before Crossover||23
10934002|NCT00313781|12103068|FG002|COMPLETED|Before Crossover||0
10934003|NCT00313781|12103066|FG000|NOT COMPLETED|Before Crossover||75
10934004|NCT00313781|12103067|FG001|NOT COMPLETED|Before Crossover||79
10934005|NCT00313781|12103068|FG002|NOT COMPLETED|Before Crossover||0
10934006|NCT00313781|12103066|FG000|STARTED|After Crossover||0
10934007|NCT00313781|12103067|FG001|STARTED|After Crossover||0
10934008|NCT00313781|12103068|FG002|STARTED|After Crossover||37
10934009|NCT00313781|12103066|FG000|COMPLETED|After Crossover||0
10934010|NCT00313781|12103067|FG001|COMPLETED|After Crossover||0
10934011|NCT00313781|12103068|FG002|COMPLETED|After Crossover||10
10934012|NCT00313781|12103066|FG000|NOT COMPLETED|After Crossover||0
10934013|NCT00313781|12103067|FG001|NOT COMPLETED|After Crossover||0
10934014|NCT00313781|12103068|FG002|NOT COMPLETED|After Crossover||27
10934015|NCT00313820|12103079|FG000|STARTED|Assigned to Treatment||111
10934016|NCT00313820|12103080|FG001|STARTED|Assigned to Treatment||109
10934017|NCT00313820|12103079|FG000|COMPLETED|Assigned to Treatment||110
10934018|NCT00313820|12103080|FG001|COMPLETED|Assigned to Treatment||109
10934019|NCT00313820|12103079|FG000|NOT COMPLETED|Assigned to Treatment||1
10934020|NCT00313820|12103080|FG001|NOT COMPLETED|Assigned to Treatment||0
10934021|NCT00313820|12103079|FG000|STARTED|Pregabalin or Placebo Treatment Period||110
10934022|NCT00313820|12103080|FG001|STARTED|Pregabalin or Placebo Treatment Period||109
10934023|NCT00313820|12103079|FG000|COMPLETED|Pregabalin or Placebo Treatment Period||93
10934024|NCT00313820|12103080|FG001|COMPLETED|Pregabalin or Placebo Treatment Period||90
10934025|NCT00313820|12103079|FG000|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
10934026|NCT00313820|12103080|FG001|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
10934027|NCT00313846|12103088|FG000|STARTED|Overall Study||162
10934028|NCT00313846|12103089|FG001|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
10934029|NCT00313846|12103088|FG000|COMPLETED|Overall Study||157
10934030|NCT00313846|12103089|FG001|COMPLETED|Overall Study||153
10934031|NCT00313846|12103088|FG000|NOT COMPLETED|Overall Study||5
10934032|NCT00313846|12103089|FG001|NOT COMPLETED|Overall Study||11
10934033|NCT00313911|12103098|FG000|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
10934123|NCT00315120|12103206|FG001|COMPLETED|Overall Study||118
10934124|NCT00315120|12103207|FG002|COMPLETED|Overall Study||115
10934034|NCT00313911|12103099|FG001|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
10934035|NCT00313911|12103098|FG000|COMPLETED|Overall Study||1328
10934036|NCT00313911|12103099|FG001|COMPLETED|Overall Study||670
10934037|NCT00313911|12103098|FG000|NOT COMPLETED|Overall Study||94
10934038|NCT00313911|12103099|FG001|NOT COMPLETED|Overall Study||41
10934039|NCT00314106|12103107|FG000|STARTED|Overall Study||18
10934040|NCT00314106|12103108|FG001|STARTED|Overall Study||8
10934041|NCT00314106|12103107|FG000|COMPLETED|Overall Study||18
10934042|NCT00314106|12103108|FG001|COMPLETED|Overall Study||8
10934043|NCT00314106|12103107|FG000|NOT COMPLETED|Overall Study||0
10934044|NCT00314106|12103108|FG001|NOT COMPLETED|Overall Study||0
10934045|NCT00314132|12103116|FG000|STARTED|Overall Study||403
10934046|NCT00314132|12103117|FG001|STARTED|Overall Study||1601
10934047|NCT00314132|12103116|FG000|COMPLETED|Overall Study||395
10934048|NCT00314132|12103117|FG001|COMPLETED|Overall Study||1583
10934049|NCT00314132|12103116|FG000|NOT COMPLETED|Overall Study||8
10934050|NCT00314132|12103117|FG001|NOT COMPLETED|Overall Study||18
10934051|NCT00314145|12103127|FG000|STARTED|Overall Study||410
10934052|NCT00314145|12103128|FG001|STARTED|Overall Study||410
10934053|NCT00314145|12103127|FG000|COMPLETED|Overall Study||389
10934054|NCT00314145|12103128|FG001|COMPLETED|Overall Study||381
10934055|NCT00314145|12103127|FG000|NOT COMPLETED|Overall Study||21
10934056|NCT00314145|12103128|FG001|NOT COMPLETED|Overall Study||29
10934057|NCT00314236|12103137|FG000|STARTED|Overall Study||41
10934058|NCT00314236|12103138|FG001|STARTED|Overall Study||39
10934059|NCT00314236|12103137|FG000|COMPLETED|Overall Study||41
10934060|NCT00314236|12103138|FG001|COMPLETED|Overall Study||37
10934061|NCT00314236|12103137|FG000|NOT COMPLETED|Overall Study||0
10934062|NCT00314236|12103138|FG001|NOT COMPLETED|Overall Study||2
10934063|NCT00314249|12103146|FG000|STARTED|Overall Study||509
10934064|NCT00314249|12103147|FG001|STARTED|Overall Study||516
10934065|NCT00314249|12103146|FG000|COMPLETED|Overall Study||357
10934066|NCT00314249|12103147|FG001|COMPLETED|Overall Study||353
10934067|NCT00314249|12103146|FG000|NOT COMPLETED|Overall Study||152
10934068|NCT00314249|12103147|FG001|NOT COMPLETED|Overall Study||163
10934069|NCT00314262|12103153|FG000|STARTED|Overall Study||12
10934070|NCT00314262|12103153|FG000|COMPLETED|Overall Study||7
10934071|NCT00314262|12103153|FG000|NOT COMPLETED|Overall Study||5
10934072|NCT00314340|12103157|FG000|STARTED|Overall Study||12
10934073|NCT00314340|12103157|FG000|ER Morphine|Overall Study||11
10934074|NCT00314340|12103157|FG000|Hydrocodone Plus APAP|Overall Study||12
10934075|NCT00314340|12103157|FG000|Placebo|Overall Study||12
10934076|NCT00314340|12103157|FG000|COMPLETED|Overall Study||11
10934077|NCT00314340|12103157|FG000|NOT COMPLETED|Overall Study||1
10934078|NCT00314574|12103165|FG000|STARTED|Overall Study||423
10934079|NCT00314574|12103166|FG001|STARTED|Overall Study||427
10934080|NCT00314574|12103165|FG000|Received at Least One Dose of Study Drug|Overall Study||421
10934081|NCT00314574|12103166|FG001|Received at Least One Dose of Study Drug|Overall Study||427
10934082|NCT00314574|12103165|FG000|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
10934083|NCT00314574|12103166|FG001|Safety Population|Overall Study||428
10934084|NCT00314574|12103165|FG000|COMPLETED|Overall Study||329
10934085|NCT00314574|12103166|FG001|COMPLETED|Overall Study||344
10934086|NCT00314574|12103165|FG000|NOT COMPLETED|Overall Study||94
10934087|NCT00314574|12103166|FG001|NOT COMPLETED|Overall Study||83
10934088|NCT00314795|12103172|FG000|STARTED|Overall Study||22
10934089|NCT00314795|12103172|FG000|COMPLETED|Overall Study||2
10934090|NCT00314795|12103172|FG000|NOT COMPLETED|Overall Study||20
10934091|NCT00314808|12103176|FG000|STARTED|Overall Study||33
10934092|NCT00314808|12103176|FG000|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
10934093|NCT00314808|12103176|FG000|NOT COMPLETED|Overall Study||8
10934094|NCT00314951|12103182|FG000|STARTED|Enrollment||323
10934095|NCT00314951|12103183|FG001|STARTED|Enrollment||306
10934096|NCT00314951|12103182|FG000|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
10934097|NCT00314951|12103183|FG001|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
10934098|NCT00314951|12103182|FG000|NOT COMPLETED|Enrollment||0
10934099|NCT00314951|12103183|FG001|NOT COMPLETED|Enrollment||6
10934100|NCT00314951|12103182|FG000|STARTED|Treatment||323
10934101|NCT00314951|12103183|FG001|STARTED|Treatment||300
10934102|NCT00314951|12103182|FG000|COMPLETED|Treatment||307
10934103|NCT00314951|12103183|FG001|COMPLETED|Treatment||289
10934104|NCT00314951|12103182|FG000|NOT COMPLETED|Treatment||16
10934105|NCT00314951|12103183|FG001|NOT COMPLETED|Treatment||11
10934106|NCT00314951|12103182|FG000|STARTED|Follow-up||307
10934107|NCT00314951|12103183|FG001|STARTED|Follow-up||289
10934108|NCT00314951|12103182|FG000|COMPLETED|Follow-up||263
10934109|NCT00314951|12103183|FG001|COMPLETED|Follow-up||255
10934110|NCT00314951|12103182|FG000|NOT COMPLETED|Follow-up||44
10934111|NCT00314951|12103183|FG001|NOT COMPLETED|Follow-up||34
10934112|NCT00315055|12103191|FG000|STARTED|Overall Study||155
10934113|NCT00315055|12103192|FG001|STARTED|Overall Study||155
10934114|NCT00315055|12103191|FG000|COMPLETED|Overall Study||152
10934115|NCT00315055|12103192|FG001|COMPLETED|Overall Study||150
10934116|NCT00315055|12103191|FG000|NOT COMPLETED|Overall Study||3
10934117|NCT00315055|12103192|FG001|NOT COMPLETED|Overall Study||5
10934118|NCT00315120|12103205|FG000|STARTED|Overall Study||115
10934119|NCT00315120|12103206|FG001|STARTED|Overall Study||118
10934120|NCT00315120|12103207|FG002|STARTED|Overall Study||115
10934121|NCT00315120|12103208|FG003|STARTED|Overall Study||107
10934122|NCT00315120|12103205|FG000|COMPLETED|Overall Study||115
10934125|NCT00315120|12103208|FG003|COMPLETED|Overall Study||107
10934126|NCT00315120|12103205|FG000|NOT COMPLETED|Overall Study||0
10934127|NCT00315120|12103206|FG001|NOT COMPLETED|Overall Study||0
10934128|NCT00315120|12103207|FG002|NOT COMPLETED|Overall Study||0
10934129|NCT00315120|12103208|FG003|NOT COMPLETED|Overall Study||0
10934130|NCT00315146|12103224|FG000|STARTED|Overall Study||22
10934131|NCT00315146|12103225|FG001|STARTED|Overall Study||22
10934132|NCT00315146|12103226|FG002|STARTED|Overall Study||22
10934133|NCT00315146|12103227|FG003|STARTED|Overall Study||22
10934134|NCT00315146|12103224|FG000|COMPLETED|Overall Study||20
10934135|NCT00315146|12103225|FG001|COMPLETED|Overall Study||19
10934136|NCT00315146|12103226|FG002|COMPLETED|Overall Study||20
10934137|NCT00315146|12103227|FG003|COMPLETED|Overall Study||22
10934138|NCT00315146|12103224|FG000|NOT COMPLETED|Overall Study||2
10934139|NCT00315146|12103225|FG001|NOT COMPLETED|Overall Study||3
10934140|NCT00315146|12103226|FG002|NOT COMPLETED|Overall Study||2
10934141|NCT00315146|12103227|FG003|NOT COMPLETED|Overall Study||0
10934142|NCT00315302|12103245|FG000|STARTED|Overall Study||90
10934143|NCT00315302|12103246|FG001|STARTED|Overall Study||90
10934144|NCT00315302|12103247|FG002|STARTED|Overall Study||26
10934145|NCT00315302|12103248|FG003|STARTED|Overall Study||34
10934146|NCT00315302|12103245|FG000|5 Week Visit|Overall Study||85
10934147|NCT00315302|12103246|FG001|5 Week Visit|Overall Study||86
10934148|NCT00315302|12103247|FG002|5 Week Visit|Overall Study||26
10934149|NCT00315302|12103248|FG003|5 Week Visit|Overall Study||30
10934150|NCT00315302|12103245|FG000|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
10934151|NCT00315302|12103246|FG001|10 Week Visit|Overall Study||85
10934152|NCT00315302|12103247|FG002|10 Week Visit|Overall Study||24
10934153|NCT00315302|12103248|FG003|10 Week Visit|Overall Study||29
10934154|NCT00315302|12103245|FG000|18 Week Primary Outcome Visit|Overall Study||84
10934155|NCT00315302|12103246|FG001|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
10934156|NCT00315302|12103247|FG002|18 Week Primary Outcome Visit|Overall Study||24
10934157|NCT00315302|12103248|FG003|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
10934158|NCT00315302|12103245|FG000|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
10934159|NCT00315302|12103246|FG001|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
10934160|NCT00315302|12103247|FG002|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
10934161|NCT00315302|12103248|FG003|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
10934162|NCT00315302|12103245|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
10934163|NCT00315302|12103246|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
10934164|NCT00315302|12103247|FG002|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
10934165|NCT00315302|12103248|FG003|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
10934166|NCT00315302|12103245|FG000|NOT COMPLETED|Overall Study||6
10934167|NCT00315302|12103246|FG001|NOT COMPLETED|Overall Study||2
10934168|NCT00315302|12103247|FG002|NOT COMPLETED|Overall Study||2
10934169|NCT00315302|12103248|FG003|NOT COMPLETED|Overall Study||3
10934170|NCT00315328|12103262|FG000|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
10934171|NCT00315328|12103263|FG001|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
10934172|NCT00315328|12103264|FG002|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
10934173|NCT00315328|12103265|FG003|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
10934174|NCT00315328|12103262|FG000|5 Week Visit|Overall Study||91
10934175|NCT00315328|12103263|FG001|5 Week Visit|Overall Study||89
10934176|NCT00315328|12103264|FG002|5 Week Visit|Overall Study||17
10934177|NCT00315328|12103265|FG003|5 Week Visit|Overall Study||19
10934178|NCT00315328|12103262|FG000|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
10934179|NCT00315328|12103263|FG001|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
10934180|NCT00315328|12103264|FG002|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
10934181|NCT00315328|12103265|FG003|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
10934182|NCT00315328|12103262|FG000|NOT COMPLETED|Overall Study||14
10934183|NCT00315328|12103263|FG001|NOT COMPLETED|Overall Study||7
10934184|NCT00315328|12103264|FG002|NOT COMPLETED|Overall Study||5
10934185|NCT00315328|12103265|FG003|NOT COMPLETED|Overall Study||2
10934186|NCT00315341|12103277|FG000|STARTED|Overall Study||740
10934187|NCT00315341|12103278|FG001|STARTED|Overall Study||529
10934188|NCT00315341|12103277|FG000|COMPLETED|Overall Study||340
10934189|NCT00315341|12103278|FG001|COMPLETED|Overall Study||391
10934190|NCT00315341|12103277|FG000|NOT COMPLETED|Overall Study||400
10934191|NCT00315341|12103278|FG001|NOT COMPLETED|Overall Study||138
10934192|NCT00315445|12103287|FG000|STARTED|Overall Study||45
10934193|NCT00315445|12103288|FG001|STARTED|Overall Study||43
10934194|NCT00315445|12103289|FG002|STARTED|Overall Study||46
10934195|NCT00315445|12103287|FG000|COMPLETED|Overall Study||18
10934196|NCT00315445|12103288|FG001|COMPLETED|Overall Study||27
10934197|NCT00315445|12103289|FG002|COMPLETED|Overall Study||22
10934198|NCT00315445|12103287|FG000|NOT COMPLETED|Overall Study||27
10934199|NCT00315445|12103288|FG001|NOT COMPLETED|Overall Study||16
10934200|NCT00315445|12103289|FG002|NOT COMPLETED|Overall Study||24
10934201|NCT00315458|12103299|FG000|STARTED|Overall Study||51
10934202|NCT00315458|12103300|FG001|STARTED|Overall Study||56
10934203|NCT00315458|12103301|FG002|STARTED|Overall Study||159
10934204|NCT00315458|12103302|FG003|STARTED|Overall Study||39
10934205|NCT00315458|12103299|FG000|COMPLETED|Overall Study||48
10934206|NCT00315458|12103300|FG001|COMPLETED|Overall Study||44
10934207|NCT00315458|12103301|FG002|COMPLETED|Overall Study||107
10934208|NCT00315458|12103302|FG003|COMPLETED|Overall Study||10
10934209|NCT00315458|12103299|FG000|NOT COMPLETED|Overall Study||3
10934210|NCT00315458|12103300|FG001|NOT COMPLETED|Overall Study||12
10934211|NCT00315458|12103301|FG002|NOT COMPLETED|Overall Study||52
10934212|NCT00315458|12103302|FG003|NOT COMPLETED|Overall Study||29
10934213|NCT00315588|12103312|FG000|STARTED|Overall Study||7
10934214|NCT00315588|12103312|FG000|COMPLETED|Overall Study||7
10934215|NCT00315588|12103312|FG000|NOT COMPLETED|Overall Study||0
10934216|NCT00315614|12103318|FG000|STARTED|Overall Study||3
10934217|NCT00315614|12103318|FG000|COMPLETED|Overall Study||3
10934218|NCT00315614|12103318|FG000|NOT COMPLETED|Overall Study||0
10934219|NCT00315627|12103323|FG000|STARTED|Overall Study||3
10934220|NCT00315627|12103323|FG000|COMPLETED|Overall Study||3
10934221|NCT00315627|12103323|FG000|NOT COMPLETED|Overall Study||0
10934222|NCT00315705|12103331|FG000|STARTED|Phase 1||25
10934223|NCT00315705|12103331|FG000|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
10934224|NCT00315705|12103331|FG000|NOT COMPLETED|Phase 1||25
10934225|NCT00315705|12103331|FG000|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
10934226|NCT00315705|12103331|FG000|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
10934227|NCT00315705|12103331|FG000|NOT COMPLETED|Phase 2||25
10934228|NCT00315731|12103348|FG000|STARTED|Overall Study||15
10934229|NCT00315731|12103348|FG000|COMPLETED|Overall Study||9
10934230|NCT00315731|12103348|FG000|NOT COMPLETED|Overall Study||6
10934231|NCT00315822|12103356|FG000|STARTED|Overall Study||198
10934232|NCT00315822|12103357|FG001|STARTED|Overall Study||202
10934233|NCT00315822|12103356|FG000|COMPLETED|Overall Study||198
10934234|NCT00315822|12103357|FG001|COMPLETED|Overall Study||202
10934235|NCT00315822|12103356|FG000|NOT COMPLETED|Overall Study||0
10934236|NCT00315822|12103357|FG001|NOT COMPLETED|Overall Study||0
10934237|NCT00315939|12103365|FG000|STARTED|Admission 1 (3 Months)||59
10934238|NCT00315939|12103366|FG001|STARTED|Admission 1 (3 Months)||61
10934239|NCT00315939|12103365|FG000|COMPLETED|Admission 1 (3 Months)||56
10934240|NCT00315939|12103366|FG001|COMPLETED|Admission 1 (3 Months)||55
10934241|NCT00315939|12103365|FG000|NOT COMPLETED|Admission 1 (3 Months)||3
10934242|NCT00315939|12103366|FG001|NOT COMPLETED|Admission 1 (3 Months)||6
10934243|NCT00315939|12103365|FG000|STARTED|Admission 2 (3 Months)||56
10934244|NCT00315939|12103366|FG001|STARTED|Admission 2 (3 Months)||55
10934245|NCT00315939|12103365|FG000|COMPLETED|Admission 2 (3 Months)||52
10934246|NCT00315939|12103366|FG001|COMPLETED|Admission 2 (3 Months)||51
10934247|NCT00315939|12103365|FG000|NOT COMPLETED|Admission 2 (3 Months)||4
10934248|NCT00315939|12103366|FG001|NOT COMPLETED|Admission 2 (3 Months)||4
10934249|NCT00315939|12103365|FG000|STARTED|Admission 3 (3 Months)||52
10934250|NCT00315939|12103366|FG001|STARTED|Admission 3 (3 Months)||51
10934251|NCT00315939|12103365|FG000|COMPLETED|Admission 3 (3 Months)||48
10934252|NCT00315939|12103366|FG001|COMPLETED|Admission 3 (3 Months)||49
10934253|NCT00315939|12103365|FG000|NOT COMPLETED|Admission 3 (3 Months)||4
10934254|NCT00315939|12103366|FG001|NOT COMPLETED|Admission 3 (3 Months)||2
10934255|NCT00316004|12103374|FG000|STARTED|Overall Study||373
10934256|NCT00316004|12103375|FG001|STARTED|Overall Study||355
10934257|NCT00316004|12103376|FG002|STARTED|Overall Study||603
10934258|NCT00316004|12103374|FG000|COMPLETED|Overall Study||359
10934259|NCT00316004|12103375|FG001|COMPLETED|Overall Study||341
10934260|NCT00316004|12103376|FG002|COMPLETED|Overall Study||582
10934261|NCT00316004|12103374|FG000|NOT COMPLETED|Overall Study||14
10934262|NCT00316004|12103375|FG001|NOT COMPLETED|Overall Study||14
10934263|NCT00316004|12103376|FG002|NOT COMPLETED|Overall Study||21
10934264|NCT00316017|12103387|FG000|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
10934265|NCT00316017|12103388|FG001|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
10934266|NCT00316017|12103389|FG002|STARTED|Overall Study|19 of 19 not complete due to BONG|395
10934267|NCT00316017|12103387|FG000|COMPLETED|Overall Study||220
10934268|NCT00316017|12103388|FG001|COMPLETED|Overall Study||256
10934269|NCT00316017|12103389|FG002|COMPLETED|Overall Study||376
10934270|NCT00316017|12103387|FG000|NOT COMPLETED|Overall Study||11
10934271|NCT00316017|12103388|FG001|NOT COMPLETED|Overall Study||13
10934272|NCT00316017|12103389|FG002|NOT COMPLETED|Overall Study||19
10934273|NCT00316082|12103402|FG000|STARTED|Overall Study||74
10934274|NCT00316082|12103403|FG001|STARTED|Overall Study||74
10934275|NCT00316082|12103404|FG002|STARTED|Overall Study||71
10934276|NCT00316082|12103405|FG003|STARTED|Overall Study||72
10934277|NCT00316082|12103406|FG004|STARTED|Overall Study||74
10934278|NCT00316082|12103402|FG000|Completed Study Without Being Rescued|Overall Study||25
10934279|NCT00316082|12103403|FG001|Completed Study Without Being Rescued|Overall Study||35
10934280|NCT00316082|12103404|FG002|Completed Study Without Being Rescued|Overall Study||29
10934281|NCT00316082|12103405|FG003|Completed Study Without Being Rescued|Overall Study||27
10934282|NCT00316082|12103406|FG004|Completed Study Without Being Rescued|Overall Study||31
10934283|NCT00316082|12103402|FG000|COMPLETED|Overall Study||41
10934284|NCT00316082|12103403|FG001|COMPLETED|Overall Study||52
10934285|NCT00316082|12103404|FG002|COMPLETED|Overall Study||44
10934286|NCT00316082|12103405|FG003|COMPLETED|Overall Study||46
10934287|NCT00316082|12103406|FG004|COMPLETED|Overall Study||48
10934288|NCT00316082|12103402|FG000|NOT COMPLETED|Overall Study||33
10934289|NCT00316082|12103403|FG001|NOT COMPLETED|Overall Study||22
10934290|NCT00316082|12103404|FG002|NOT COMPLETED|Overall Study||27
10934291|NCT00316082|12103405|FG003|NOT COMPLETED|Overall Study||26
10934292|NCT00316082|12103406|FG004|NOT COMPLETED|Overall Study||26
10934293|NCT00316121|12103424|FG000|STARTED|Overall Study||92
10934294|NCT00316121|12103425|FG001|STARTED|Overall Study||46
10934295|NCT00316121|12103424|FG000|COMPLETED|Overall Study||70
10934296|NCT00316121|12103425|FG001|COMPLETED|Overall Study||37
10934297|NCT00316121|12103424|FG000|NOT COMPLETED|Overall Study||22
10934298|NCT00316121|12103425|FG001|NOT COMPLETED|Overall Study||9
10934299|NCT00316173|12103433|FG000|STARTED|Run-in Phase||22
10934300|NCT00316173|12103434|FG001|STARTED|Run-in Phase||0
10934301|NCT00316173|12103433|FG000|COMPLETED|Run-in Phase||15
10934302|NCT00316173|12103434|FG001|COMPLETED|Run-in Phase||0
10934303|NCT00316173|12103433|FG000|NOT COMPLETED|Run-in Phase||7
10934304|NCT00316173|12103434|FG001|NOT COMPLETED|Run-in Phase||0
10934305|NCT00316173|12103433|FG000|STARTED|Treatment Phase||0
10934306|NCT00316173|12103434|FG001|STARTED|Treatment Phase||55
10934307|NCT00316173|12103433|FG000|COMPLETED|Treatment Phase||0
10934308|NCT00316173|12103434|FG001|COMPLETED|Treatment Phase||13
10934309|NCT00316173|12103433|FG000|NOT COMPLETED|Treatment Phase||0
10934310|NCT00316173|12103434|FG001|NOT COMPLETED|Treatment Phase||42
10934311|NCT00316186|12103439|FG000|STARTED|Overall Study||33
10934312|NCT00316186|12103439|FG000|COMPLETED|Overall Study||21
10934313|NCT00316186|12103439|FG000|NOT COMPLETED|Overall Study||12
10934314|NCT00316199|12103443|FG000|STARTED|Overall Study||60
10934315|NCT00316199|12103443|FG000|COMPLETED|Overall Study||48
10934316|NCT00316199|12103443|FG000|NOT COMPLETED|Overall Study||12
10934317|NCT00316225|12103447|FG000|STARTED|Overall Study||31
10934318|NCT00316225|12103447|FG000|COMPLETED|Overall Study||6
10934319|NCT00316225|12103447|FG000|NOT COMPLETED|Overall Study||25
10934320|NCT00316264|12103454|FG000|STARTED|Overall Study||83
10934321|NCT00316264|12103455|FG001|STARTED|Overall Study||84
10934322|NCT00316264|12103456|FG002|STARTED|Overall Study||93
10934323|NCT00316264|12103454|FG000|COMPLETED|Overall Study||77
10934324|NCT00316264|12103455|FG001|COMPLETED|Overall Study||77
10934325|NCT00316264|12103456|FG002|COMPLETED|Overall Study||87
10934326|NCT00316264|12103454|FG000|NOT COMPLETED|Overall Study||6
10934327|NCT00316264|12103455|FG001|NOT COMPLETED|Overall Study||7
10934328|NCT00316264|12103456|FG002|NOT COMPLETED|Overall Study||6
10934329|NCT00316277|12103466|FG000|STARTED|Phase 1 (12 Weeks)||329
10934330|NCT00316277|12103467|FG001|STARTED|Phase 1 (12 Weeks)||324
10934331|NCT00316277|12103466|FG000|COMPLETED|Phase 1 (12 Weeks)||19
10934332|NCT00316277|12103467|FG001|COMPLETED|Phase 1 (12 Weeks)||24
10934333|NCT00316277|12103466|FG000|NOT COMPLETED|Phase 1 (12 Weeks)||310
10934334|NCT00316277|12103467|FG001|NOT COMPLETED|Phase 1 (12 Weeks)||300
10934335|NCT00316277|12103466|FG000|STARTED|Phase 2 (24 Weeks)||180
10934336|NCT00316277|12103467|FG001|STARTED|Phase 2 (24 Weeks)||180
10934337|NCT00316277|12103466|FG000|COMPLETED|Phase 2 (24 Weeks)||161
10934338|NCT00316277|12103467|FG001|COMPLETED|Phase 2 (24 Weeks)||161
10934339|NCT00316277|12103466|FG000|NOT COMPLETED|Phase 2 (24 Weeks)||19
10934340|NCT00316277|12103467|FG001|NOT COMPLETED|Phase 2 (24 Weeks)||19
10934341|NCT00316303|12103483|FG000|STARTED|Overall Study||118
10934342|NCT00316303|12103484|FG001|STARTED|Overall Study||118
10934343|NCT00316303|12103483|FG000|COMPLETED|Overall Study||107
10934344|NCT00316303|12103484|FG001|COMPLETED|Overall Study||102
10934345|NCT00316303|12103483|FG000|NOT COMPLETED|Overall Study||11
10934346|NCT00316303|12103484|FG001|NOT COMPLETED|Overall Study||16
10934347|NCT00316355|12103495|FG000|STARTED|Overall Study||15
10934348|NCT00316355|12103496|FG001|STARTED|Overall Study||19
10934349|NCT00316355|12103495|FG000|Started Treatment|Overall Study||12
10934350|NCT00316355|12103496|FG001|Started Treatment|Overall Study||18
10934351|NCT00316355|12103495|FG000|COMPLETED|Overall Study||10
10934352|NCT00316355|12103496|FG001|COMPLETED|Overall Study||12
10934353|NCT00316355|12103495|FG000|NOT COMPLETED|Overall Study||5
10934354|NCT00316355|12103496|FG001|NOT COMPLETED|Overall Study||7
10934355|NCT00316524|12103506|FG000|STARTED|Overall Study||183
10934356|NCT00316524|12103507|FG001|STARTED|Overall Study||181
10934357|NCT00316524|12103508|FG002|STARTED|Overall Study||181
10934358|NCT00316524|12103509|FG003|STARTED|Overall Study||200
10934359|NCT00316524|12103506|FG000|COMPLETED|Overall Study||175
10934360|NCT00316524|12103507|FG001|COMPLETED|Overall Study||173
10934361|NCT00316524|12103508|FG002|COMPLETED|Overall Study||175
10934362|NCT00316524|12103509|FG003|COMPLETED|Overall Study||200
10934363|NCT00316524|12103506|FG000|NOT COMPLETED|Overall Study||8
10934364|NCT00316524|12103507|FG001|NOT COMPLETED|Overall Study||8
10934365|NCT00316524|12103508|FG002|NOT COMPLETED|Overall Study||6
10934366|NCT00316524|12103509|FG003|NOT COMPLETED|Overall Study||0
10934367|NCT00316589|12103527|FG000|STARTED|Overall Study||88
10934368|NCT00316589|12103528|FG001|STARTED|Overall Study||352
10934369|NCT00316589|12103529|FG002|STARTED|Overall Study||9
10934370|NCT00316589|12103530|FG003|STARTED|Overall Study||132
10934371|NCT00316589|12103527|FG000|COMPLETED|Overall Study||87
10934372|NCT00316589|12103528|FG001|COMPLETED|Overall Study||328
10934373|NCT00316589|12103529|FG002|COMPLETED|Overall Study||8
10934374|NCT00316589|12103530|FG003|COMPLETED|Overall Study||127
10934375|NCT00316589|12103527|FG000|NOT COMPLETED|Overall Study||1
10934376|NCT00316589|12103528|FG001|NOT COMPLETED|Overall Study||24
10934377|NCT00316589|12103529|FG002|NOT COMPLETED|Overall Study||1
10934378|NCT00316589|12103530|FG003|NOT COMPLETED|Overall Study||5
10934379|NCT00316602|12103544|FG000|STARTED|Overall Study||282
10934380|NCT00316602|12103545|FG001|STARTED|Overall Study||350
10934381|NCT00316602|12103544|FG000|COMPLETED|Overall Study||272
10934382|NCT00316602|12103545|FG001|COMPLETED|Overall Study||325
10934383|NCT00316602|12103544|FG000|NOT COMPLETED|Overall Study||10
10934384|NCT00316602|12103545|FG001|NOT COMPLETED|Overall Study||25
10934385|NCT00316693|12103553|FG000|STARTED|Overall Study||519
10934386|NCT00316693|12103554|FG001|STARTED|Overall Study||521
10934387|NCT00316693|12103553|FG000|COMPLETED|Overall Study||442
10934388|NCT00316693|12103554|FG001|COMPLETED|Overall Study||436
10934389|NCT00316693|12103553|FG000|NOT COMPLETED|Overall Study||77
10934390|NCT00316693|12103554|FG001|NOT COMPLETED|Overall Study||85
10934391|NCT00316706|12103562|FG000|STARTED|Overall Study||626
10934392|NCT00316706|12103563|FG001|STARTED|Overall Study||619
10934393|NCT00316706|12103562|FG000|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
10934394|NCT00316706|12103563|FG001|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
10934395|NCT00316706|12103562|FG000|NOT COMPLETED|Overall Study||38
10934396|NCT00316706|12103563|FG001|NOT COMPLETED|Overall Study||48
10934397|NCT00316719|12103571|FG000|STARTED|Overall Study||52
10934398|NCT00316719|12103572|FG001|STARTED|Overall Study||53
10934399|NCT00316719|12103571|FG000|COMPLETED|Overall Study||50
10934400|NCT00316719|12103572|FG001|COMPLETED|Overall Study||47
10934401|NCT00316719|12103571|FG000|NOT COMPLETED|Overall Study||2
10934402|NCT00316719|12103572|FG001|NOT COMPLETED|Overall Study||6
10934403|NCT00316862|12103578|FG000|STARTED|Overall Study||82
10934404|NCT00316862|12103578|FG000|COMPLETED|Overall Study||82
10934405|NCT00316862|12103578|FG000|NOT COMPLETED|Overall Study||0
10934406|NCT00316914|12103584|FG000|STARTED|Overall Study||50
10934407|NCT00316914|12103585|FG001|STARTED|Overall Study||52
10934408|NCT00316914|12103584|FG000|COMPLETED|Overall Study||17
10934409|NCT00316914|12103585|FG001|COMPLETED|Overall Study||16
10934410|NCT00316914|12103584|FG000|NOT COMPLETED|Overall Study||33
10934411|NCT00316914|12103585|FG001|NOT COMPLETED|Overall Study||36
10934412|NCT00317044|12103594|FG000|STARTED|Overall Study||320
10934413|NCT00317044|12103595|FG001|STARTED|Overall Study||313
10934414|NCT00317044|12103596|FG002|STARTED|Overall Study||328
10934415|NCT00317044|12103594|FG000|COMPLETED|Overall Study||272
10934416|NCT00317044|12103595|FG001|COMPLETED|Overall Study||273
10934417|NCT00317044|12103596|FG002|COMPLETED|Overall Study||283
10934418|NCT00317044|12103594|FG000|NOT COMPLETED|Overall Study||48
10934419|NCT00317044|12103595|FG001|NOT COMPLETED|Overall Study||40
10934420|NCT00317044|12103596|FG002|NOT COMPLETED|Overall Study||45
10934421|NCT00317109|12103606|FG000|STARTED|Overall Study||84
10934422|NCT00317109|12103607|FG001|STARTED|Overall Study||84
10934423|NCT00317109|12103606|FG000|COMPLETED|Overall Study||81
10934424|NCT00317109|12103607|FG001|COMPLETED|Overall Study||84
10934425|NCT00317109|12103606|FG000|NOT COMPLETED|Overall Study||3
10934426|NCT00317109|12103607|FG001|NOT COMPLETED|Overall Study||0
10934427|NCT00317226|12103613|FG000|STARTED|Overall Study||127
10934428|NCT00317226|12103613|FG000|COMPLETED|Overall Study||104
10934429|NCT00317226|12103613|FG000|NOT COMPLETED|Overall Study||23
10934430|NCT00317239|12103619|FG000|STARTED|Overall Study||147
10934431|NCT00317239|12103620|FG001|STARTED|Overall Study||103
10934432|NCT00317239|12103619|FG000|COMPLETED|Overall Study||134
10934433|NCT00317239|12103620|FG001|COMPLETED|Overall Study||84
10934434|NCT00317239|12103619|FG000|NOT COMPLETED|Overall Study||13
10934435|NCT00317239|12103620|FG001|NOT COMPLETED|Overall Study||19
10934436|NCT00317356|12103630|FG000|STARTED|Overall Study||11
10934437|NCT00317356|12103631|FG001|STARTED|Overall Study||11
10934438|NCT00317356|12103632|FG002|STARTED|Overall Study||10
10934439|NCT00317356|12103633|FG003|STARTED|Overall Study||11
10934440|NCT00317356|12103630|FG000|COMPLETED|Overall Study||10
10934441|NCT00317356|12103631|FG001|COMPLETED|Overall Study||9
10934442|NCT00317356|12103632|FG002|COMPLETED|Overall Study||9
10934443|NCT00317356|12103633|FG003|COMPLETED|Overall Study||8
10934444|NCT00317356|12103630|FG000|NOT COMPLETED|Overall Study||1
10934445|NCT00317356|12103631|FG001|NOT COMPLETED|Overall Study||2
10934446|NCT00317356|12103632|FG002|NOT COMPLETED|Overall Study||1
10934447|NCT00317356|12103633|FG003|NOT COMPLETED|Overall Study||3
10934448|NCT00317369|12103646|FG000|STARTED|Overall Study||10
10934449|NCT00317369|12103647|FG001|STARTED|Overall Study||9
10934450|NCT00317369|12103648|FG002|STARTED|Overall Study||10
10934451|NCT00317369|12103646|FG000|COMPLETED|Overall Study||8
10934452|NCT00317369|12103647|FG001|COMPLETED|Overall Study||7
10934453|NCT00317369|12103648|FG002|COMPLETED|Overall Study||8
10934454|NCT00317369|12103646|FG000|NOT COMPLETED|Overall Study||2
10934455|NCT00317369|12103647|FG001|NOT COMPLETED|Overall Study||2
10934456|NCT00317369|12103648|FG002|NOT COMPLETED|Overall Study||2
10934457|NCT00317473|12103662|FG000|STARTED|Overall Study||30
10934458|NCT00317473|12103663|FG001|STARTED|Overall Study||15
10934459|NCT00317473|12103664|FG002|STARTED|Overall Study||30
10934460|NCT00317473|12103665|FG003|STARTED|Overall Study||15
10934461|NCT00317473|12103666|FG004|STARTED|Overall Study||30
10934462|NCT00317473|12103667|FG005|STARTED|Overall Study||15
10934463|NCT00317473|12103662|FG000|COMPLETED|Overall Study||26
10934464|NCT00317473|12103663|FG001|COMPLETED|Overall Study||12
10934465|NCT00317473|12103664|FG002|COMPLETED|Overall Study||27
10934466|NCT00317473|12103665|FG003|COMPLETED|Overall Study||13
10934467|NCT00317473|12103666|FG004|COMPLETED|Overall Study||22
10934468|NCT00317473|12103667|FG005|COMPLETED|Overall Study||12
10934469|NCT00317473|12103662|FG000|NOT COMPLETED|Overall Study||4
10934470|NCT00317473|12103663|FG001|NOT COMPLETED|Overall Study||3
10934471|NCT00317473|12103664|FG002|NOT COMPLETED|Overall Study||3
10934472|NCT00317473|12103665|FG003|NOT COMPLETED|Overall Study||2
10934473|NCT00317473|12103666|FG004|NOT COMPLETED|Overall Study||8
10934474|NCT00317473|12103667|FG005|NOT COMPLETED|Overall Study||3
10934475|NCT00317603|12103691|FG000|STARTED|Overall Study||15
10934476|NCT00317603|12103691|FG000|Treated|Overall Study||12
10934477|NCT00317603|12103691|FG000|COMPLETED|Overall Study||12
10934478|NCT00317603|12103691|FG000|NOT COMPLETED|Overall Study||3
10934479|NCT00317642|12103697|FG000|STARTED|Overall Study||163
10934480|NCT00317642|12103698|FG001|STARTED|Overall Study||163
10934481|NCT00317642|12103697|FG000|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
10934482|NCT00317642|12103698|FG001|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
10934483|NCT00317642|12103697|FG000|Received >= 1 Study Drug (Safety Set)|Overall Study||161
10934484|NCT00317642|12103698|FG001|Received >= 1 Study Drug (Safety Set)|Overall Study||155
10934485|NCT00317642|12103697|FG000|COMPLETED|Overall Study|achieved remission and completed consolidation|41
10934486|NCT00317642|12103698|FG001|COMPLETED|Overall Study|achieved remission and completed consolidation|28
10934487|NCT00317642|12103697|FG000|NOT COMPLETED|Overall Study||122
10934488|NCT00317642|12103698|FG001|NOT COMPLETED|Overall Study||135
10934489|NCT00317720|12103711|FG000|STARTED|Overall Study||40
10934490|NCT00317720|12103712|FG001|STARTED|Overall Study||7
10934491|NCT00317720|12103711|FG000|COMPLETED|Overall Study||40
10934492|NCT00317720|12103712|FG001|COMPLETED|Overall Study||7
10934493|NCT00317720|12103711|FG000|NOT COMPLETED|Overall Study||0
10934494|NCT00317720|12103712|FG001|NOT COMPLETED|Overall Study||0
10934495|NCT00317941|12103718|FG000|STARTED|Overall Study||73
10934496|NCT00317941|12103719|FG001|STARTED|Overall Study||79
10934497|NCT00317941|12103720|FG002|STARTED|Overall Study||68
10934498|NCT00317941|12103718|FG000|Participants Received Treatment|Overall Study||73
10934499|NCT00317941|12103719|FG001|Participants Received Treatment|Overall Study||79
10934500|NCT00317941|12103720|FG002|Participants Received Treatment|Overall Study||68
10934501|NCT00317941|12103718|FG000|Fulfilled Requirement Safety Population|Overall Study||73
10934502|NCT00317941|12103719|FG001|Fulfilled Requirement Safety Population|Overall Study||77
10934503|NCT00317941|12103720|FG002|Fulfilled Requirement Safety Population|Overall Study||65
10934504|NCT00317941|12103718|FG000|Fulfilled Requirements PP Population|Overall Study||66
10934505|NCT00317941|12103719|FG001|Fulfilled Requirements PP Population|Overall Study||76
10934506|NCT00317941|12103720|FG002|Fulfilled Requirements PP Population|Overall Study||63
10934507|NCT00317941|12103718|FG000|COMPLETED|Overall Study||66
10934508|NCT00317941|12103719|FG001|COMPLETED|Overall Study||74
10934509|NCT00317941|12103720|FG002|COMPLETED|Overall Study||60
10934510|NCT00317941|12103718|FG000|NOT COMPLETED|Overall Study||7
10934511|NCT00317941|12103719|FG001|NOT COMPLETED|Overall Study||5
10934512|NCT00317941|12103720|FG002|NOT COMPLETED|Overall Study||8
10934513|NCT00318136|12103729|FG000|STARTED|Overall Study||47
10934514|NCT00318136|12103729|FG000|COMPLETED|Overall Study||2
10934515|NCT00318136|12103729|FG000|NOT COMPLETED|Overall Study||45
10934516|NCT00318149|12103739|FG000|STARTED|Overall Study||75
10934517|NCT00318149|12103740|FG001|STARTED|Overall Study||50
10934518|NCT00318149|12103741|FG002|STARTED|Overall Study||75
10934519|NCT00318149|12103742|FG003|STARTED|Overall Study||75
10934520|NCT00318149|12103743|FG004|STARTED|Overall Study||75
10934521|NCT00318149|12103744|FG005|STARTED|Overall Study||75
10934522|NCT00318149|12103739|FG000|COMPLETED|Overall Study||75
10934523|NCT00318149|12103740|FG001|COMPLETED|Overall Study||50
10934524|NCT00318149|12103741|FG002|COMPLETED|Overall Study||75
10934525|NCT00318149|12103742|FG003|COMPLETED|Overall Study||75
10934526|NCT00318149|12103743|FG004|COMPLETED|Overall Study||75
10934527|NCT00318149|12103744|FG005|COMPLETED|Overall Study||73
10934528|NCT00318149|12103739|FG000|NOT COMPLETED|Overall Study||0
10934529|NCT00318149|12103740|FG001|NOT COMPLETED|Overall Study||0
10934530|NCT00318149|12103741|FG002|NOT COMPLETED|Overall Study||0
10934531|NCT00318149|12103742|FG003|NOT COMPLETED|Overall Study||0
10934532|NCT00318149|12103743|FG004|NOT COMPLETED|Overall Study||0
10934533|NCT00318149|12103744|FG005|NOT COMPLETED|Overall Study||2
10934534|NCT00318292|12103762|FG000|STARTED|Overall Study||45
10934535|NCT00318292|12103763|FG001|STARTED|Overall Study||45
10934536|NCT00318292|12103762|FG000|COMPLETED|Overall Study||45
10934537|NCT00318292|12103763|FG001|COMPLETED|Overall Study||45
10934538|NCT00318292|12103762|FG000|NOT COMPLETED|Overall Study||0
10934539|NCT00318292|12103763|FG001|NOT COMPLETED|Overall Study||0
10934540|NCT00318357|12103771|FG000|STARTED|Overall Study||173
10934541|NCT00318357|12103772|FG001|STARTED|Overall Study||136
10934542|NCT00318357|12103771|FG000|COMPLETED|Overall Study||134
10934543|NCT00318357|12103772|FG001|COMPLETED|Overall Study||104
10934544|NCT00318357|12103771|FG000|NOT COMPLETED|Overall Study||39
10934545|NCT00318357|12103772|FG001|NOT COMPLETED|Overall Study||32
10934546|NCT00318370|12103778|FG000|STARTED|Period 1||28
10934547|NCT00318370|12103779|FG001|STARTED|Period 1||0
10934548|NCT00318370|12103780|FG002|STARTED|Period 1||0
10934549|NCT00318370|12103778|FG000|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
10934550|NCT00318370|12103779|FG001|COMPLETED|Period 1||0
10934551|NCT00318370|12103780|FG002|COMPLETED|Period 1||0
10934552|NCT00318370|12103778|FG000|NOT COMPLETED|Period 1||7
10934553|NCT00318370|12103779|FG001|NOT COMPLETED|Period 1||0
10934554|NCT00318370|12103780|FG002|NOT COMPLETED|Period 1||0
10934555|NCT00318370|12103778|FG000|STARTED|Period 2||0
10934556|NCT00318370|12103779|FG001|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
10934557|NCT00318370|12103780|FG002|STARTED|Period 2||0
10934558|NCT00318370|12103778|FG000|COMPLETED|Period 2||0
10934559|NCT00318370|12103779|FG001|COMPLETED|Period 2||36
10934560|NCT00318370|12103780|FG002|COMPLETED|Period 2||0
10934561|NCT00318370|12103778|FG000|NOT COMPLETED|Period 2||0
10934562|NCT00318370|12103779|FG001|NOT COMPLETED|Period 2||11
10934563|NCT00318370|12103780|FG002|NOT COMPLETED|Period 2||0
10934564|NCT00318370|12103778|FG000|STARTED|Period 3||0
10934565|NCT00318370|12103779|FG001|STARTED|Period 3||0
10934566|NCT00318370|12103780|FG002|STARTED|Period 3||36
10934567|NCT00318370|12103778|FG000|COMPLETED|Period 3||0
10934568|NCT00318370|12103779|FG001|COMPLETED|Period 3||0
10934569|NCT00318370|12103780|FG002|COMPLETED|Period 3||3
10934570|NCT00318370|12103778|FG000|NOT COMPLETED|Period 3||0
10934571|NCT00318370|12103779|FG001|NOT COMPLETED|Period 3||0
10934572|NCT00318370|12103780|FG002|NOT COMPLETED|Period 3||33
10934573|NCT00318409|12103788|FG000|STARTED|Overall Study||20
10934574|NCT00318409|12103789|FG001|STARTED|Overall Study||10
10934575|NCT00318409|12103788|FG000|COMPLETED|Overall Study||18
10934576|NCT00318409|12103789|FG001|COMPLETED|Overall Study||9
10934577|NCT00318409|12103788|FG000|NOT COMPLETED|Overall Study||2
10934578|NCT00318409|12103789|FG001|NOT COMPLETED|Overall Study||1
10934579|NCT00318461|12103801|FG000|STARTED|Double-Blind, 6 Months|Randomised|242
10934580|NCT00318461|12103802|FG001|STARTED|Double-Blind, 6 Months|Randomised|241
10934581|NCT00318461|12103803|FG002|STARTED|Double-Blind, 6 Months|Randomised|242
10934582|NCT00318461|12103804|FG003|STARTED|Double-Blind, 6 Months|Randomised|122
10934583|NCT00318461|12103805|FG004|STARTED|Double-Blind, 6 Months|Randomised|244
10934584|NCT00318461|12103801|FG000|Exposed to Study Drug|Double-Blind, 6 Months||242
10934585|NCT00318461|12103802|FG001|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
10934586|NCT00318461|12103803|FG002|Exposed to Study Drug|Double-Blind, 6 Months||242
10934587|NCT00318461|12103804|FG003|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
10934588|NCT00318461|12103805|FG004|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
10934589|NCT00318461|12103801|FG000|COMPLETED|Double-Blind, 6 Months||208
10934590|NCT00318461|12103802|FG001|COMPLETED|Double-Blind, 6 Months||197
10934591|NCT00318461|12103803|FG002|COMPLETED|Double-Blind, 6 Months||191
10934592|NCT00318461|12103804|FG003|COMPLETED|Double-Blind, 6 Months||74
10934593|NCT00318461|12103805|FG004|COMPLETED|Double-Blind, 6 Months||210
10934594|NCT00318461|12103801|FG000|NOT COMPLETED|Double-Blind, 6 Months||34
10934595|NCT00318461|12103802|FG001|NOT COMPLETED|Double-Blind, 6 Months||44
10934596|NCT00318461|12103803|FG002|NOT COMPLETED|Double-Blind, 6 Months||51
10934597|NCT00318461|12103804|FG003|NOT COMPLETED|Double-Blind, 6 Months||48
10934598|NCT00318461|12103805|FG004|NOT COMPLETED|Double-Blind, 6 Months||34
10934599|NCT00318461|12103801|FG000|STARTED|Open-Label Extension, 18 Months||208
10934600|NCT00318461|12103802|FG001|STARTED|Open-Label Extension, 18 Months||197
10934601|NCT00318461|12103803|FG002|STARTED|Open-Label Extension, 18 Months||191
10934602|NCT00318461|12103804|FG003|STARTED|Open-Label Extension, 18 Months||74
10934603|NCT00318461|12103805|FG004|STARTED|Open-Label Extension, 18 Months||210
10934604|NCT00318461|12103801|FG000|COMPLETED|Open-Label Extension, 18 Months||130
10934605|NCT00318461|12103802|FG001|COMPLETED|Open-Label Extension, 18 Months||137
10934606|NCT00318461|12103803|FG002|COMPLETED|Open-Label Extension, 18 Months||118
10934607|NCT00318461|12103804|FG003|COMPLETED|Open-Label Extension, 18 Months||31
10934608|NCT00318461|12103805|FG004|COMPLETED|Open-Label Extension, 18 Months||113
10934609|NCT00318461|12103801|FG000|NOT COMPLETED|Open-Label Extension, 18 Months||78
10934610|NCT00318461|12103802|FG001|NOT COMPLETED|Open-Label Extension, 18 Months||60
10934611|NCT00318461|12103803|FG002|NOT COMPLETED|Open-Label Extension, 18 Months||73
10934612|NCT00318461|12103804|FG003|NOT COMPLETED|Open-Label Extension, 18 Months||43
10934613|NCT00318461|12103805|FG004|NOT COMPLETED|Open-Label Extension, 18 Months||97
10934614|NCT00318474|12103819|FG000|STARTED|Overall Study||25
10934615|NCT00318474|12103820|FG001|STARTED|Overall Study||27
10934616|NCT00318474|12103819|FG000|COMPLETED|Overall Study||7
10934617|NCT00318474|12103820|FG001|COMPLETED|Overall Study||10
10934618|NCT00318474|12103819|FG000|NOT COMPLETED|Overall Study||18
10934619|NCT00318474|12103820|FG001|NOT COMPLETED|Overall Study||17
10934620|NCT00318565|12103826|FG000|STARTED|Overall Study||291
10934621|NCT00318565|12103826|FG000|COMPLETED|Overall Study||267
10934622|NCT00318565|12103826|FG000|NOT COMPLETED|Overall Study||24
10934623|NCT00318591|12103832|FG000|STARTED|Overall Study||105
10934624|NCT00318591|12103833|FG001|STARTED|Overall Study||114
10934625|NCT00318591|12103832|FG000|COMPLETED|Overall Study||45
10934626|NCT00318591|12103833|FG001|COMPLETED|Overall Study||69
10934627|NCT00318591|12103832|FG000|NOT COMPLETED|Overall Study||60
10934628|NCT00318591|12103833|FG001|NOT COMPLETED|Overall Study||45
10934629|NCT00318643|12103846|FG000|STARTED|Overall Study||3
10934630|NCT00318643|12103847|FG001|STARTED|Overall Study||3
10934631|NCT00318643|12103848|FG002|STARTED|Overall Study||6
10934632|NCT00318643|12103849|FG003|STARTED|Overall Study||3
10934633|NCT00318643|12103850|FG004|STARTED|Overall Study||12
10934634|NCT00318643|12103846|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10934635|NCT00318643|12103847|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
10934636|NCT00318643|12103848|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
10934637|NCT00318643|12103849|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10934638|NCT00318643|12103850|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
10934639|NCT00318643|12103846|FG000|COMPLETED|Overall Study||3
10934640|NCT00318643|12103847|FG001|COMPLETED|Overall Study||3
10934641|NCT00318643|12103848|FG002|COMPLETED|Overall Study||6
10934642|NCT00318643|12103849|FG003|COMPLETED|Overall Study||3
10934643|NCT00318643|12103850|FG004|COMPLETED|Overall Study||9
10934644|NCT00318643|12103846|FG000|NOT COMPLETED|Overall Study||0
10934645|NCT00318643|12103847|FG001|NOT COMPLETED|Overall Study||0
10934646|NCT00318643|12103848|FG002|NOT COMPLETED|Overall Study||0
10934647|NCT00318643|12103849|FG003|NOT COMPLETED|Overall Study||0
10934648|NCT00318643|12103850|FG004|NOT COMPLETED|Overall Study||3
10934649|NCT00318708|12103865|FG000|STARTED|Overall Study||47
10934650|NCT00318708|12103866|FG001|STARTED|Overall Study||45
10934651|NCT00318708|12103865|FG000|8-week Milestone|Overall Study||42
10934652|NCT00318708|12103866|FG001|8-week Milestone|Overall Study||42
10934653|NCT00318708|12103865|FG000|COMPLETED|Overall Study||39
10934654|NCT00318708|12103866|FG001|COMPLETED|Overall Study||40
10934655|NCT00318708|12103865|FG000|NOT COMPLETED|Overall Study||8
10934656|NCT00318708|12103866|FG001|NOT COMPLETED|Overall Study||5
10934657|NCT00318812|12103878|FG000|STARTED|Overall Study||18
10934658|NCT00318812|12103879|FG001|STARTED|Overall Study||22
10934659|NCT00318812|12103878|FG000|COMPLETED|Overall Study||18
10934660|NCT00318812|12103879|FG001|COMPLETED|Overall Study||22
10934661|NCT00318812|12103878|FG000|NOT COMPLETED|Overall Study||0
10934662|NCT00318812|12103879|FG001|NOT COMPLETED|Overall Study||0
10934663|NCT00318929|12103885|FG000|STARTED|Overall Study||14
10934664|NCT00318929|12103885|FG000|COMPLETED|Overall Study||14
10934665|NCT00318929|12103885|FG000|NOT COMPLETED|Overall Study||0
10934666|NCT00319020|12103891|FG000|STARTED|Overall Study||15
10934667|NCT00319020|12103892|FG001|STARTED|Overall Study||21
10934668|NCT00319020|12103891|FG000|Enrollment in FUTURE 2 (F-2)|Overall Study||13
10934669|NCT00319020|12103892|FG001|Enrollment in FUTURE 2 (F-2)|Overall Study||20
10934670|NCT00319020|12103891|FG000|COMPLETED|Overall Study||8
10934671|NCT00319020|12103892|FG001|COMPLETED|Overall Study||8
10934672|NCT00319020|12103891|FG000|NOT COMPLETED|Overall Study||7
10934673|NCT00319020|12103892|FG001|NOT COMPLETED|Overall Study||13
10934674|NCT00319046|12103900|FG000|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
10934675|NCT00319046|12103900|FG000|COMPLETED|Overall Study||34
10934676|NCT00319046|12103900|FG000|NOT COMPLETED|Overall Study||8
10934677|NCT00319098|12103908|FG000|STARTED|Overall Study||3802
10934678|NCT00319098|12103909|FG001|STARTED|Overall Study||1269
10934679|NCT00319098|12103908|FG000|COMPLETED|Overall Study||3667
10934680|NCT00319098|12103909|FG001|COMPLETED|Overall Study||1237
10934681|NCT00319098|12103908|FG000|NOT COMPLETED|Overall Study||135
10934682|NCT00319098|12103909|FG001|NOT COMPLETED|Overall Study||32
10934683|NCT00319111|12103919|FG000|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
10934684|NCT00319111|12103919|FG000|COMPLETED|Overall Study||104
10934685|NCT00319111|12103919|FG000|NOT COMPLETED|Overall Study||47
10934686|NCT00319254|12103923|FG000|STARTED|Overall Study||75
10934687|NCT00319254|12103923|FG000|Treated|Overall Study||73
10934688|NCT00319254|12103923|FG000|COMPLETED|Overall Study||21
10934689|NCT00319254|12103923|FG000|NOT COMPLETED|Overall Study||54
10934690|NCT00319436|12103929|FG000|STARTED|Overall Study||23
10934691|NCT00319436|12103930|FG001|STARTED|Overall Study||24
10934692|NCT00319436|12103929|FG000|COMPLETED|Overall Study||17
10934693|NCT00319436|12103930|FG001|COMPLETED|Overall Study||17
10934694|NCT00319436|12103929|FG000|NOT COMPLETED|Overall Study||6
10934695|NCT00319436|12103930|FG001|NOT COMPLETED|Overall Study||7
10934696|NCT00319501|12103938|FG000|STARTED|Double-blind Period|Randomized participants|124
10934697|NCT00319501|12103939|FG001|STARTED|Double-blind Period|Randomized participants|110
10934698|NCT00319501|12103938|FG000|Received Treatment|Double-blind Period||82
10934699|NCT00319501|12103939|FG001|Received Treatment|Double-blind Period||81
10934700|NCT00319501|12103938|FG000|COMPLETED|Double-blind Period||81
10934701|NCT00319501|12103939|FG001|COMPLETED|Double-blind Period||78
10934702|NCT00319501|12103938|FG000|NOT COMPLETED|Double-blind Period||43
10934703|NCT00319501|12103939|FG001|NOT COMPLETED|Double-blind Period||32
10934704|NCT00319501|12103938|FG000|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
10934705|NCT00319501|12103939|FG001|STARTED|Open-label Period||0
10934706|NCT00319501|12103938|FG000|Received Treatment|Open-label Period||128
10934707|NCT00319501|12103939|FG001|Received Treatment|Open-label Period||0
10934708|NCT00319501|12103938|FG000|COMPLETED|Open-label Period|Competed=continuing treatment|45
10934709|NCT00319501|12103939|FG001|COMPLETED|Open-label Period||0
10934710|NCT00319501|12103938|FG000|NOT COMPLETED|Open-label Period||116
10934711|NCT00319501|12103939|FG001|NOT COMPLETED|Open-label Period||0
10934712|NCT00319501|12103938|FG000|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
10934713|NCT00319501|12103939|FG001|STARTED|Open-label Extension Period||0
10934714|NCT00319501|12103938|FG000|Received Treatment|Open-label Extension Period||33
10934715|NCT00319501|12103939|FG001|Received Treatment|Open-label Extension Period||0
10934716|NCT00319501|12103938|FG000|COMPLETED|Open-label Extension Period||0
10934717|NCT00319501|12103939|FG001|COMPLETED|Open-label Extension Period||0
10934718|NCT00319501|12103938|FG000|NOT COMPLETED|Open-label Extension Period||51
10934719|NCT00319501|12103939|FG001|NOT COMPLETED|Open-label Extension Period||0
10934720|NCT00319553|12103952|FG000|STARTED|Overall Study||323
10934721|NCT00319553|12103953|FG001|STARTED|Overall Study||321
10934722|NCT00319553|12103952|FG000|COMPLETED|Overall Study||319
10934723|NCT00319553|12103953|FG001|COMPLETED|Overall Study||317
10934724|NCT00319553|12103952|FG000|NOT COMPLETED|Overall Study||4
10934725|NCT00319553|12103953|FG001|NOT COMPLETED|Overall Study||4
10934726|NCT00319592|12103961|FG000|STARTED|Overall Study||30
10934727|NCT00319592|12103962|FG001|STARTED|Overall Study||30
10934728|NCT00319592|12103961|FG000|COMPLETED|Overall Study||29
10934729|NCT00319592|12103962|FG001|COMPLETED|Overall Study||29
10934730|NCT00319592|12103961|FG000|NOT COMPLETED|Overall Study||1
10934731|NCT00319592|12103962|FG001|NOT COMPLETED|Overall Study||1
10934732|NCT00319644|12103970|FG000|STARTED|Overall Study||21
10934733|NCT00319644|12103971|FG001|STARTED|Overall Study||16
10934734|NCT00319644|12103970|FG000|COMPLETED|Overall Study||21
10934735|NCT00319644|12103971|FG001|COMPLETED|Overall Study||16
10934736|NCT00319644|12103970|FG000|NOT COMPLETED|Overall Study||0
10934737|NCT00319644|12103971|FG001|NOT COMPLETED|Overall Study||0
10934738|NCT00319696|12103977|FG000|STARTED|Overall Study||116
10934739|NCT00319696|12103977|FG000|COMPLETED|Overall Study||56
10934740|NCT00319696|12103977|FG000|NOT COMPLETED|Overall Study||60
10934741|NCT00319735|12103987|FG000|STARTED|Overall Study||41
10934742|NCT00319735|12103987|FG000|COMPLETED|Overall Study||39
10934743|NCT00319735|12103987|FG000|NOT COMPLETED|Overall Study||2
10934744|NCT00319748|12103992|FG000|STARTED|Overall Study||13
10934745|NCT00319748|12103992|FG000|COMPLETED|Overall Study||13
10934746|NCT00319748|12103992|FG000|NOT COMPLETED|Overall Study||0
10934747|NCT00319956|12104004|FG000|STARTED|Overall Study||111
10934748|NCT00319956|12104005|FG001|STARTED|Overall Study||109
10934749|NCT00319956|12104004|FG000|COMPLETED|Overall Study||91
10934750|NCT00319956|12104005|FG001|COMPLETED|Overall Study||85
10934751|NCT00319956|12104004|FG000|NOT COMPLETED|Overall Study||20
10934752|NCT00319956|12104005|FG001|NOT COMPLETED|Overall Study||24
10934753|NCT00319982|12104013|FG000|STARTED|Overall Study||19
10934754|NCT00319982|12104014|FG001|STARTED|Overall Study||20
10934755|NCT00319982|12104013|FG000|COMPLETED|Overall Study||18
10934756|NCT00319982|12104014|FG001|COMPLETED|Overall Study||20
10934757|NCT00319982|12104013|FG000|NOT COMPLETED|Overall Study||1
10934758|NCT00319982|12104014|FG001|NOT COMPLETED|Overall Study||0
10934759|NCT00320112|12104022|FG000|STARTED|Overall Study||125
10934760|NCT00320112|12104023|FG001|STARTED|Overall Study||119
10934761|NCT00320112|12104022|FG000|COMPLETED|Overall Study||117
10934762|NCT00320112|12104023|FG001|COMPLETED|Overall Study||114
10934763|NCT00320112|12104022|FG000|NOT COMPLETED|Overall Study||8
10934764|NCT00320112|12104023|FG001|NOT COMPLETED|Overall Study||5
10934765|NCT00320190|12104037|FG000|STARTED|First 12 Months||19
10934766|NCT00320190|12104038|FG001|STARTED|First 12 Months||13
10934767|NCT00320190|12104037|FG000|COMPLETED|First 12 Months||11
10934768|NCT00320190|12104038|FG001|COMPLETED|First 12 Months||3
10934769|NCT00320190|12104037|FG000|NOT COMPLETED|First 12 Months||8
10934770|NCT00320190|12104038|FG001|NOT COMPLETED|First 12 Months||10
10934771|NCT00320190|12104037|FG000|STARTED|Long-term (12-month) Extension||11
10934772|NCT00320190|12104038|FG001|STARTED|Long-term (12-month) Extension||3
10934773|NCT00320190|12104037|FG000|COMPLETED|Long-term (12-month) Extension||2
10934774|NCT00320190|12104038|FG001|COMPLETED|Long-term (12-month) Extension||1
10934775|NCT00320190|12104037|FG000|NOT COMPLETED|Long-term (12-month) Extension||9
10934776|NCT00320190|12104038|FG001|NOT COMPLETED|Long-term (12-month) Extension||2
10934777|NCT00320216|12104049|FG000|STARTED|Overall Study||64
10934778|NCT00320216|12104050|FG001|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
10934779|NCT00320216|12104051|FG002|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
10934780|NCT00320216|12104052|FG003|STARTED|Overall Study||64
10934781|NCT00320216|12104053|FG004|STARTED|Overall Study||64
10934782|NCT00320216|12104049|FG000|COMPLETED|Overall Study||48
10934783|NCT00320216|12104050|FG001|COMPLETED|Overall Study||54
10934784|NCT00320216|12104051|FG002|COMPLETED|Overall Study||58
10934785|NCT00320216|12104052|FG003|COMPLETED|Overall Study||61
10934786|NCT00320216|12104053|FG004|COMPLETED|Overall Study||58
10934787|NCT00320216|12104049|FG000|NOT COMPLETED|Overall Study||16
10934788|NCT00320216|12104050|FG001|NOT COMPLETED|Overall Study||10
10934789|NCT00320216|12104051|FG002|NOT COMPLETED|Overall Study||6
10934790|NCT00320216|12104052|FG003|NOT COMPLETED|Overall Study||3
10934791|NCT00320216|12104053|FG004|NOT COMPLETED|Overall Study||6
10934792|NCT00320242|12104070|FG000|STARTED|Overall Study||16
10934793|NCT00320242|12104071|FG001|STARTED|Overall Study||16
10934794|NCT00320242|12104070|FG000|COMPLETED|Overall Study||14
10934795|NCT00320242|12104071|FG001|COMPLETED|Overall Study||12
10934796|NCT00320242|12104070|FG000|NOT COMPLETED|Overall Study||2
10934797|NCT00320242|12104071|FG001|NOT COMPLETED|Overall Study||4
10934798|NCT00320255|12104084|FG000|STARTED|Overall Study||30
10934799|NCT00320255|12104085|FG001|STARTED|Overall Study||32
10934800|NCT00320255|12104086|FG002|STARTED|Overall Study||30
10934801|NCT00320255|12104087|FG003|STARTED|Overall Study||33
10934802|NCT00320255|12104088|FG004|STARTED|Overall Study||2
10934803|NCT00320255|12104089|FG005|STARTED|Overall Study||3
10934804|NCT00320255|12104084|FG000|Received Treatment|Overall Study||29
10934805|NCT00320255|12104085|FG001|Received Treatment|Overall Study||32
10934806|NCT00320255|12104086|FG002|Received Treatment|Overall Study||29
10934807|NCT00320255|12104087|FG003|Received Treatment|Overall Study||32
10934808|NCT00320255|12104088|FG004|Received Treatment|Overall Study||2
10934809|NCT00320255|12104089|FG005|Received Treatment|Overall Study||3
10934810|NCT00320255|12104084|FG000|COMPLETED|Overall Study||19
10934811|NCT00320255|12104085|FG001|COMPLETED|Overall Study||25
10934812|NCT00320255|12104086|FG002|COMPLETED|Overall Study||24
10934813|NCT00320255|12104087|FG003|COMPLETED|Overall Study||25
10934814|NCT00320255|12104088|FG004|COMPLETED|Overall Study||2
10934815|NCT00320255|12104089|FG005|COMPLETED|Overall Study||3
10934816|NCT00320255|12104084|FG000|NOT COMPLETED|Overall Study||11
10934817|NCT00320255|12104085|FG001|NOT COMPLETED|Overall Study||7
10934818|NCT00320255|12104086|FG002|NOT COMPLETED|Overall Study||6
10934819|NCT00320255|12104087|FG003|NOT COMPLETED|Overall Study||8
10934820|NCT00320255|12104088|FG004|NOT COMPLETED|Overall Study||0
10934821|NCT00320255|12104089|FG005|NOT COMPLETED|Overall Study||0
10934822|NCT00320281|12104106|FG000|STARTED|Overall Study||10
10934823|NCT00320281|12104107|FG001|STARTED|Overall Study||9
10934824|NCT00320281|12104106|FG000|COMPLETED|Overall Study||10
10934825|NCT00320281|12104107|FG001|COMPLETED|Overall Study||9
10934826|NCT00320281|12104106|FG000|NOT COMPLETED|Overall Study||0
10934827|NCT00320281|12104107|FG001|NOT COMPLETED|Overall Study||0
10934828|NCT00320372|12104118|FG000|STARTED|Overall Study||494
10934829|NCT00320372|12104119|FG001|STARTED|Overall Study||301
10934830|NCT00320372|12104118|FG000|VNS Therapy D-23 Original|Overall Study||335
10934831|NCT00320372|12104119|FG001|VNS Therapy D-23 Original|Overall Study||0
10934832|NCT00320372|12104118|FG000|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
10934833|NCT00320372|12104119|FG001|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
10934834|NCT00320372|12104118|FG000|COMPLETED|Overall Study||299
10934835|NCT00320372|12104119|FG001|COMPLETED|Overall Study||138
10934836|NCT00320372|12104118|FG000|NOT COMPLETED|Overall Study||195
10934837|NCT00320372|12104119|FG001|NOT COMPLETED|Overall Study||163
10934838|NCT00320385|12104135|FG000|STARTED|Overall Study||148
10934839|NCT00320385|12104136|FG001|STARTED|Overall Study||148
10934840|NCT00320385|12104135|FG000|COMPLETED|Overall Study||130
10934841|NCT00320385|12104136|FG001|COMPLETED|Overall Study||126
10934842|NCT00320385|12104135|FG000|NOT COMPLETED|Overall Study||18
10934843|NCT00320385|12104136|FG001|NOT COMPLETED|Overall Study||22
10934844|NCT00320398|12104144|FG000|STARTED|Overall Study||58
10934845|NCT00320398|12104145|FG001|STARTED|Overall Study||56
10934846|NCT00320398|12104144|FG000|COMPLETED|Overall Study||56
10934847|NCT00320398|12104145|FG001|COMPLETED|Overall Study||52
10934848|NCT00320398|12104144|FG000|NOT COMPLETED|Overall Study||2
10934849|NCT00320398|12104145|FG001|NOT COMPLETED|Overall Study||4
10934850|NCT00320411|12104152|FG000|STARTED|Overall Study||62
10934851|NCT00320411|12104152|FG000|COMPLETED|Overall Study||58
10934852|NCT00320411|12104152|FG000|NOT COMPLETED|Overall Study||4
10934853|NCT00320424|12104156|FG000|STARTED|Overall Study||48
10934854|NCT00320424|12104156|FG000|COMPLETED|Overall Study||42
10934855|NCT00320424|12104156|FG000|NOT COMPLETED|Overall Study||6
10934856|NCT00320489|12104162|FG000|STARTED|Overall Study||264
10934857|NCT00320489|12104163|FG001|STARTED|Overall Study||260
10934858|NCT00320489|12104162|FG000|COMPLETED|Overall Study||119
10934859|NCT00320489|12104163|FG001|COMPLETED|Overall Study||124
10934860|NCT00320489|12104162|FG000|NOT COMPLETED|Overall Study||145
10934861|NCT00320489|12104163|FG001|NOT COMPLETED|Overall Study||136
10934862|NCT00320515|12104169|FG000|STARTED|Overall Study||69
10934863|NCT00320515|12104169|FG000|COMPLETED|Overall Study||20
10934864|NCT00320515|12104169|FG000|NOT COMPLETED|Overall Study||49
10934865|NCT00320528|12104176|FG000|STARTED|Study Period II||98
10934866|NCT00320528|12104177|FG001|STARTED|Study Period II||41
10934867|NCT00320528|12104178|FG002|STARTED|Study Period II||130
10934868|NCT00320528|12104176|FG000|Received at Least One Dose of Study Drug|Study Period II||97
10934869|NCT00320528|12104177|FG001|Received at Least One Dose of Study Drug|Study Period II||38
10934870|NCT00320528|12104178|FG002|Received at Least One Dose of Study Drug|Study Period II||128
10934871|NCT00320528|12104176|FG000|COMPLETED|Study Period II||87
10934872|NCT00320528|12104177|FG001|COMPLETED|Study Period II||31
10934873|NCT00320528|12104178|FG002|COMPLETED|Study Period II||108
10934874|NCT00320528|12104176|FG000|NOT COMPLETED|Study Period II||11
10934875|NCT00320528|12104177|FG001|NOT COMPLETED|Study Period II||10
10934876|NCT00320528|12104178|FG002|NOT COMPLETED|Study Period II||22
10934877|NCT00320528|12104176|FG000|STARTED|Study Period III||87
10934878|NCT00320528|12104177|FG001|STARTED|Study Period III||31
10934879|NCT00320528|12104178|FG002|STARTED|Study Period III||108
10934880|NCT00320528|12104176|FG000|COMPLETED|Study Period III||0
10934881|NCT00320528|12104177|FG001|COMPLETED|Study Period III||0
10934882|NCT00320528|12104178|FG002|COMPLETED|Study Period III||2
10934883|NCT00320528|12104176|FG000|NOT COMPLETED|Study Period III||87
10934884|NCT00320528|12104177|FG001|NOT COMPLETED|Study Period III||31
10934885|NCT00320528|12104178|FG002|NOT COMPLETED|Study Period III||106
10934886|NCT00320541|12104188|FG000|STARTED|Overall Study||94
10934887|NCT00320541|12104189|FG001|STARTED|Overall Study||93
10934888|NCT00320541|12104188|FG000|COMPLETED|Overall Study||44
10934889|NCT00320541|12104189|FG001|COMPLETED|Overall Study||36
10934890|NCT00320541|12104188|FG000|NOT COMPLETED|Overall Study||50
10934891|NCT00320541|12104189|FG001|NOT COMPLETED|Overall Study||57
10934892|NCT00320593|12104197|FG000|STARTED|Overall Study||59
10934893|NCT00320593|12104198|FG001|STARTED|Overall Study||59
10934894|NCT00320593|12104197|FG000|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
10934895|NCT00320593|12104198|FG001|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
10934896|NCT00320593|12104197|FG000|NOT COMPLETED|Overall Study||7
10934897|NCT00320593|12104198|FG001|NOT COMPLETED|Overall Study||1
10934898|NCT00320606|12104204|FG000|STARTED|Overall Study||20
10934899|NCT00320606|12104204|FG000|COMPLETED|Overall Study||17
10934900|NCT00320606|12104204|FG000|NOT COMPLETED|Overall Study||3
10934901|NCT00320671|12104211|FG000|STARTED|Overall Study||102
10934902|NCT00320671|12104212|FG001|STARTED|Overall Study||96
10934903|NCT00320671|12104211|FG000|COMPLETED|Overall Study||69
10934904|NCT00320671|12104212|FG001|COMPLETED|Overall Study||58
10934905|NCT00320671|12104211|FG000|NOT COMPLETED|Overall Study||33
10934906|NCT00320671|12104212|FG001|NOT COMPLETED|Overall Study||38
10934907|NCT00320710|12104221|FG000|STARTED|Overall Study||200
10934908|NCT00320710|12104222|FG001|STARTED|Overall Study||203
10934909|NCT00320710|12104223|FG002|STARTED|Overall Study||13
10934910|NCT00320710|12104221|FG000|Treated (Safety Set)|Overall Study||198
10934911|NCT00320710|12104222|FG001|Treated (Safety Set)|Overall Study||202
10934912|NCT00320710|12104223|FG002|Treated (Safety Set)|Overall Study||13
10934913|NCT00320710|12104221|FG000|COMPLETED|Overall Study||106
10934914|NCT00320710|12104222|FG001|COMPLETED|Overall Study||127
10934915|NCT00320710|12104223|FG002|COMPLETED|Overall Study||8
10934916|NCT00320710|12104221|FG000|NOT COMPLETED|Overall Study||94
10934917|NCT00320710|12104222|FG001|NOT COMPLETED|Overall Study||76
10934918|NCT00320710|12104223|FG002|NOT COMPLETED|Overall Study||5
10934919|NCT00320749|12104230|FG000|STARTED|Overall Study||3
10934920|NCT00320749|12104231|FG001|STARTED|Overall Study||8
10934921|NCT00320749|12104232|FG002|STARTED|Overall Study||10
10934922|NCT00320749|12104230|FG000|COMPLETED|Overall Study||3
10934923|NCT00320749|12104231|FG001|COMPLETED|Overall Study||6
10934924|NCT00320749|12104232|FG002|COMPLETED|Overall Study||1
10934925|NCT00320749|12104230|FG000|NOT COMPLETED|Overall Study||0
10934926|NCT00320749|12104231|FG001|NOT COMPLETED|Overall Study||2
10934927|NCT00320749|12104232|FG002|NOT COMPLETED|Overall Study||9
10934928|NCT00320788|12104242|FG000|STARTED|Overall Study||32
10934929|NCT00320788|12104243|FG001|STARTED|Overall Study||32
10934930|NCT00320788|12104244|FG002|STARTED|Overall Study||32
10934931|NCT00320788|12104245|FG003|STARTED|Overall Study|Participants Randomized|32
10934932|NCT00320788|12104246|FG004|STARTED|Overall Study||31
10934933|NCT00320788|12104242|FG000|Participants Received Treatment (SAF)|Overall Study||32
10934934|NCT00320788|12104243|FG001|Participants Received Treatment (SAF)|Overall Study||32
10934935|NCT00320788|12104244|FG002|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
10934936|NCT00320788|12104245|FG003|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
10934937|NCT00320788|12104246|FG004|Participants Received Treatment (SAF)|Overall Study||31
10934938|NCT00320788|12104242|FG000|COMPLETED|Overall Study||26
10934939|NCT00320788|12104243|FG001|COMPLETED|Overall Study||26
10934940|NCT00320788|12104244|FG002|COMPLETED|Overall Study||29
10934941|NCT00320788|12104245|FG003|COMPLETED|Overall Study||27
10934942|NCT00320788|12104246|FG004|COMPLETED|Overall Study||26
10934943|NCT00320788|12104242|FG000|NOT COMPLETED|Overall Study||6
10934944|NCT00320788|12104243|FG001|NOT COMPLETED|Overall Study||6
10934945|NCT00320788|12104244|FG002|NOT COMPLETED|Overall Study||3
10934946|NCT00320788|12104245|FG003|NOT COMPLETED|Overall Study||5
10934947|NCT00320788|12104246|FG004|NOT COMPLETED|Overall Study||5
10934948|NCT00320801|12104266|FG000|STARTED|Open-label Run-in Period||188
10934949|NCT00320801|12104267|FG001|STARTED|Open-label Run-in Period||0
10934950|NCT00320801|12104268|FG002|STARTED|Open-label Run-in Period||0
10934951|NCT00320801|12104269|FG003|STARTED|Open-label Run-in Period||0
10934952|NCT00320801|12104266|FG000|COMPLETED|Open-label Run-in Period||96
10934953|NCT00320801|12104267|FG001|COMPLETED|Open-label Run-in Period||0
10934954|NCT00320801|12104268|FG002|COMPLETED|Open-label Run-in Period||0
10934955|NCT00320801|12104269|FG003|COMPLETED|Open-label Run-in Period||0
10934956|NCT00320801|12104266|FG000|NOT COMPLETED|Open-label Run-in Period||92
10934957|NCT00320801|12104267|FG001|NOT COMPLETED|Open-label Run-in Period||0
10934958|NCT00320801|12104268|FG002|NOT COMPLETED|Open-label Run-in Period||0
10934959|NCT00320801|12104269|FG003|NOT COMPLETED|Open-label Run-in Period||0
10934960|NCT00320801|12104266|FG000|STARTED|Double-blind Phase||0
10934961|NCT00320801|12104267|FG001|STARTED|Double-blind Phase||47
10934962|NCT00320801|12104268|FG002|STARTED|Double-blind Phase||49
10934963|NCT00320801|12104269|FG003|STARTED|Double-blind Phase||0
10934964|NCT00320801|12104266|FG000|COMPLETED|Double-blind Phase||0
10934965|NCT00320801|12104267|FG001|COMPLETED|Double-blind Phase||36
10934966|NCT00320801|12104268|FG002|COMPLETED|Double-blind Phase||35
10934967|NCT00320801|12104269|FG003|COMPLETED|Double-blind Phase||0
10934968|NCT00320801|12104266|FG000|NOT COMPLETED|Double-blind Phase||0
10934969|NCT00320801|12104267|FG001|NOT COMPLETED|Double-blind Phase||11
10934970|NCT00320801|12104268|FG002|NOT COMPLETED|Double-blind Phase||14
10934971|NCT00320801|12104269|FG003|NOT COMPLETED|Double-blind Phase||0
10934972|NCT00320801|12104266|FG000|STARTED|Extension Phase||0
10934973|NCT00320801|12104267|FG001|STARTED|Extension Phase||0
10934974|NCT00320801|12104268|FG002|STARTED|Extension Phase||0
10934975|NCT00320801|12104269|FG003|STARTED|Extension Phase||55
10934976|NCT00320801|12104266|FG000|COMPLETED|Extension Phase||0
10934977|NCT00320801|12104267|FG001|COMPLETED|Extension Phase||0
10934978|NCT00320801|12104268|FG002|COMPLETED|Extension Phase||0
10934979|NCT00320801|12104269|FG003|COMPLETED|Extension Phase||7
10934980|NCT00320801|12104266|FG000|NOT COMPLETED|Extension Phase||0
10934981|NCT00320801|12104267|FG001|NOT COMPLETED|Extension Phase||0
10934982|NCT00320801|12104268|FG002|NOT COMPLETED|Extension Phase||0
10934983|NCT00320801|12104269|FG003|NOT COMPLETED|Extension Phase||48
10934984|NCT00321048|12104281|FG000|STARTED|Overall Study||28
10934985|NCT00321048|12104282|FG001|STARTED|Overall Study||29
10934986|NCT00321048|12104281|FG000|COMPLETED|Overall Study||22
10934987|NCT00321048|12104282|FG001|COMPLETED|Overall Study||21
10934988|NCT00321048|12104281|FG000|NOT COMPLETED|Overall Study||6
10934989|NCT00321048|12104282|FG001|NOT COMPLETED|Overall Study||8
10934990|NCT00321269|12104290|FG000|STARTED|Overall Study||74
10934991|NCT00321269|12104291|FG001|STARTED|Overall Study||74
10934992|NCT00321269|12104290|FG000|COMPLETED|Overall Study||66
10934993|NCT00321269|12104291|FG001|COMPLETED|Overall Study||68
10934994|NCT00321269|12104290|FG000|NOT COMPLETED|Overall Study||8
10934995|NCT00321269|12104291|FG001|NOT COMPLETED|Overall Study||6
10934996|NCT00321321|12104299|FG000|STARTED|Overall Study||12
10934997|NCT00321321|12104299|FG000|COMPLETED|Overall Study||12
10934998|NCT00321321|12104299|FG000|NOT COMPLETED|Overall Study||0
10934999|NCT00321373|12104306|FG000|STARTED|Overall Study||407
10935000|NCT00321373|12104307|FG001|STARTED|Overall Study||406
10935001|NCT00321373|12104308|FG002|STARTED|Overall Study||407
10935002|NCT00321373|12104306|FG000|COMPLETED|Overall Study||405
10935003|NCT00321373|12104307|FG001|COMPLETED|Overall Study||406
10935004|NCT00321373|12104308|FG002|COMPLETED|Overall Study||404
10935005|NCT00321373|12104306|FG000|NOT COMPLETED|Overall Study||2
10935006|NCT00321373|12104307|FG001|NOT COMPLETED|Overall Study||0
10935007|NCT00321373|12104308|FG002|NOT COMPLETED|Overall Study||3
10935008|NCT00321464|12104318|FG000|STARTED|Overall Study||1020
10935009|NCT00321464|12104319|FG001|STARTED|Overall Study||1026
10935010|NCT00321464|12104318|FG000|Received Investigational Product|Overall Study||1014
10935011|NCT00321464|12104319|FG001|Received Investigational Product|Overall Study||1019
10935012|NCT00321464|12104318|FG000|COMPLETED|Overall Study||461
10935013|NCT00321464|12104319|FG001|COMPLETED|Overall Study||468
10935014|NCT00321464|12104318|FG000|NOT COMPLETED|Overall Study||559
10935015|NCT00321464|12104319|FG001|NOT COMPLETED|Overall Study||558
10935016|NCT00321594|12104327|FG000|STARTED|Phase I, Level 1-4||3
10935017|NCT00321594|12104328|FG001|STARTED|Phase I, Level 1-4||3
10935018|NCT00321594|12104329|FG002|STARTED|Phase I, Level 1-4||6
10935019|NCT00321594|12104330|FG003|STARTED|Phase I, Level 1-4||6
10935020|NCT00321594|12104331|FG004|STARTED|Phase I, Level 1-4||0
10935021|NCT00321594|12104327|FG000|COMPLETED|Phase I, Level 1-4||3
10935022|NCT00321594|12104328|FG001|COMPLETED|Phase I, Level 1-4||3
10935023|NCT00321594|12104329|FG002|COMPLETED|Phase I, Level 1-4||6
10935024|NCT00321594|12104330|FG003|COMPLETED|Phase I, Level 1-4||6
10935025|NCT00321594|12104331|FG004|COMPLETED|Phase I, Level 1-4||0
10935026|NCT00321594|12104327|FG000|NOT COMPLETED|Phase I, Level 1-4||0
10935027|NCT00321594|12104328|FG001|NOT COMPLETED|Phase I, Level 1-4||0
10935028|NCT00321594|12104329|FG002|NOT COMPLETED|Phase I, Level 1-4||0
10935029|NCT00321594|12104330|FG003|NOT COMPLETED|Phase I, Level 1-4||0
10935030|NCT00321594|12104331|FG004|NOT COMPLETED|Phase I, Level 1-4||0
10935031|NCT00321594|12104327|FG000|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
10935032|NCT00321594|12104328|FG001|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
10935033|NCT00321594|12104329|FG002|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
10935034|NCT00321594|12104330|FG003|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
10935035|NCT00321594|12104331|FG004|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
10935036|NCT00321594|12104327|FG000|COMPLETED|Phase II, MTD Dose||0
10935037|NCT00321594|12104328|FG001|COMPLETED|Phase II, MTD Dose||0
10935038|NCT00321594|12104329|FG002|COMPLETED|Phase II, MTD Dose||0
10935039|NCT00321594|12104330|FG003|COMPLETED|Phase II, MTD Dose||6
10935040|NCT00321594|12104331|FG004|COMPLETED|Phase II, MTD Dose||36
10935041|NCT00321594|12104327|FG000|NOT COMPLETED|Phase II, MTD Dose||0
10935042|NCT00321594|12104328|FG001|NOT COMPLETED|Phase II, MTD Dose||0
10935043|NCT00321594|12104329|FG002|NOT COMPLETED|Phase II, MTD Dose||0
10935044|NCT00321594|12104330|FG003|NOT COMPLETED|Phase II, MTD Dose||0
10935045|NCT00321594|12104331|FG004|NOT COMPLETED|Phase II, MTD Dose||0
10935046|NCT00321620|12104345|FG000|STARTED|Overall Study||951
10935047|NCT00321620|12104346|FG001|STARTED|Overall Study||950
10935048|NCT00321620|12104345|FG000|Received Investigational Product|Overall Study||946
10935049|NCT00321620|12104346|FG001|Received Investigational Product|Overall Study||942
10935050|NCT00321620|12104345|FG000|COMPLETED|Overall Study||208
10935051|NCT00321620|12104346|FG001|COMPLETED|Overall Study||228
10935052|NCT00321620|12104345|FG000|NOT COMPLETED|Overall Study||743
10935053|NCT00321620|12104346|FG001|NOT COMPLETED|Overall Study||722
10935054|NCT00321646|12104352|FG000|STARTED|Neoadjuvant Chemotherapy||42
10935055|NCT00321646|12104352|FG000|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
10935056|NCT00321646|12104352|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||4
10935057|NCT00321646|12104352|FG000|STARTED|Prostatectomy||37
10935058|NCT00321646|12104352|FG000|COMPLETED|Prostatectomy||37
10935059|NCT00321646|12104352|FG000|NOT COMPLETED|Prostatectomy||0
10935060|NCT00321672|12104360|FG000|STARTED|Overall Study||165
10935061|NCT00321672|12104361|FG001|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
10935062|NCT00321672|12104362|FG002|STARTED|Overall Study||167
10935063|NCT00321672|12104363|FG003|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
10935064|NCT00321672|12104360|FG000|COMPLETED|Overall Study||153
10935065|NCT00321672|12104361|FG001|COMPLETED|Overall Study||81
10935066|NCT00321672|12104362|FG002|COMPLETED|Overall Study||156
10935067|NCT00321672|12104363|FG003|COMPLETED|Overall Study||71
10935068|NCT00321672|12104360|FG000|NOT COMPLETED|Overall Study||12
10935069|NCT00321672|12104361|FG001|NOT COMPLETED|Overall Study||8
10935070|NCT00321672|12104362|FG002|NOT COMPLETED|Overall Study||11
10935071|NCT00321672|12104363|FG003|NOT COMPLETED|Overall Study||2
10935072|NCT00321685|12104377|FG000|STARTED|Overall Study||57
10935073|NCT00321685|12104377|FG000|Eligible|Overall Study||55
10935074|NCT00321685|12104377|FG000|Started Protocol Therapy|Overall Study||55
10935075|NCT00321685|12104377|FG000|Eligible and Treated|Overall Study||53
10935076|NCT00321685|12104377|FG000|COMPLETED|Overall Study||18
10935077|NCT00321685|12104377|FG000|NOT COMPLETED|Overall Study||39
10935078|NCT00321711|12104386|FG000|STARTED|Part A||13
10935079|NCT00321711|12104387|FG001|STARTED|Part A||13
10935080|NCT00321711|12104388|FG002|STARTED|Part A||14
10935081|NCT00321711|12104389|FG003|STARTED|Part A||0
10935082|NCT00321711|12104390|FG004|STARTED|Part A||0
10935083|NCT00321711|12104386|FG000|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
10935084|NCT00321711|12104387|FG001|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
10935085|NCT00321711|12104388|FG002|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
10935086|NCT00321711|12104389|FG003|COMPLETED|Part A||0
10935087|NCT00321711|12104390|FG004|COMPLETED|Part A||0
10935088|NCT00321711|12104386|FG000|NOT COMPLETED|Part A||5
10935089|NCT00321711|12104387|FG001|NOT COMPLETED|Part A||10
10935090|NCT00321711|12104388|FG002|NOT COMPLETED|Part A||11
10935091|NCT00321711|12104389|FG003|NOT COMPLETED|Part A||0
10935092|NCT00321711|12104390|FG004|NOT COMPLETED|Part A||0
10935093|NCT00321711|12104386|FG000|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
10935094|NCT00321711|12104387|FG001|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
10935095|NCT00321711|12104388|FG002|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
10935096|NCT00321711|12104389|FG003|STARTED|Part B||14
10935097|NCT00321711|12104390|FG004|STARTED|Part B||15
10935098|NCT00321711|12104386|FG000|COMPLETED|Part B||0
10935099|NCT00321711|12104387|FG001|COMPLETED|Part B||0
10935100|NCT00321711|12104388|FG002|COMPLETED|Part B||0
10935101|NCT00321711|12104389|FG003|COMPLETED|Part B||8
10935102|NCT00321711|12104390|FG004|COMPLETED|Part B||10
10935103|NCT00321711|12104386|FG000|NOT COMPLETED|Part B||0
10935104|NCT00321711|12104387|FG001|NOT COMPLETED|Part B||0
10935105|NCT00321711|12104388|FG002|NOT COMPLETED|Part B||0
10935106|NCT00321711|12104389|FG003|NOT COMPLETED|Part B||6
10935107|NCT00321711|12104390|FG004|NOT COMPLETED|Part B||5
10935108|NCT00321737|12104405|FG000|STARTED|Overall Study||147
10935109|NCT00321737|12104406|FG001|STARTED|Overall Study||140
10935110|NCT00321737|12104407|FG002|STARTED|Overall Study||158
10935111|NCT00321737|12104405|FG000|COMPLETED|Overall Study||25
10935112|NCT00321737|12104406|FG001|COMPLETED|Overall Study||92
10935113|NCT00321737|12104407|FG002|COMPLETED|Overall Study||104
10935114|NCT00321737|12104405|FG000|NOT COMPLETED|Overall Study||122
10935115|NCT00321737|12104406|FG001|NOT COMPLETED|Overall Study||48
10935116|NCT00321737|12104407|FG002|NOT COMPLETED|Overall Study||54
10935117|NCT00321763|12104419|FG000|STARTED|Overall Study||850
10935118|NCT00321763|12104420|FG001|STARTED|Overall Study||850
10935119|NCT00321763|12104421|FG002|STARTED|Overall Study||854
10935120|NCT00321763|12104422|FG003|STARTED|Overall Study||570
10935121|NCT00321763|12104419|FG000|COMPLETED|Overall Study||844
10935122|NCT00321763|12104420|FG001|COMPLETED|Overall Study||848
10935123|NCT00321763|12104421|FG002|COMPLETED|Overall Study||848
10935124|NCT00321763|12104422|FG003|COMPLETED|Overall Study||565
10935125|NCT00321763|12104419|FG000|NOT COMPLETED|Overall Study||6
10935126|NCT00321763|12104420|FG001|NOT COMPLETED|Overall Study||2
10935127|NCT00321763|12104421|FG002|NOT COMPLETED|Overall Study||6
10935128|NCT00321763|12104422|FG003|NOT COMPLETED|Overall Study||5
10935129|NCT00321789|12104436|FG000|STARTED|Overall Study||127
10935130|NCT00321789|12104437|FG001|STARTED|Overall Study||128
10935131|NCT00321789|12104436|FG000|COMPLETED|Overall Study||112
10935132|NCT00321789|12104437|FG001|COMPLETED|Overall Study||112
10935133|NCT00321789|12104436|FG000|NOT COMPLETED|Overall Study||15
10935134|NCT00321789|12104437|FG001|NOT COMPLETED|Overall Study||16
10935135|NCT00321828|12104443|FG000|STARTED|Overall Study||90
10935136|NCT00321828|12104443|FG000|COMPLETED|Overall Study||86
10935137|NCT00321828|12104443|FG000|NOT COMPLETED|Overall Study||4
10935138|NCT00321854|12104449|FG000|STARTED|Overall Study||261
10935139|NCT00321854|12104450|FG001|STARTED|Overall Study||274
10935140|NCT00321854|12104449|FG000|COMPLETED|Overall Study||198
10935141|NCT00321854|12104450|FG001|COMPLETED|Overall Study||192
10935142|NCT00321854|12104449|FG000|NOT COMPLETED|Overall Study||63
10935143|NCT00321854|12104450|FG001|NOT COMPLETED|Overall Study||82
10935144|NCT00321893|12104460|FG000|STARTED|Overall Study||101
10935145|NCT00321893|12104461|FG001|STARTED|Overall Study||101
10935146|NCT00321893|12104460|FG000|COMPLETED|Overall Study||77
10935147|NCT00321893|12104461|FG001|COMPLETED|Overall Study||87
10935148|NCT00321893|12104460|FG000|NOT COMPLETED|Overall Study||24
10935149|NCT00321893|12104461|FG001|NOT COMPLETED|Overall Study||14
10935150|NCT00321906|12104469|FG000|STARTED|Overall Study||94
10935151|NCT00321906|12104470|FG001|STARTED|Overall Study||87
10935152|NCT00321906|12104469|FG000|COMPLETED|Overall Study||48
10935153|NCT00321906|12104470|FG001|COMPLETED|Overall Study||31
10935154|NCT00321906|12104469|FG000|NOT COMPLETED|Overall Study||46
10935155|NCT00321906|12104470|FG001|NOT COMPLETED|Overall Study||56
10935156|NCT00321919|12104478|FG000|STARTED|Overall Study||301
10935157|NCT00321919|12104479|FG001|STARTED|Overall Study||302
10935158|NCT00321919|12104478|FG000|COMPLETED|Overall Study||226
10935159|NCT00321919|12104479|FG001|COMPLETED|Overall Study||250
10935160|NCT00321919|12104478|FG000|NOT COMPLETED|Overall Study||75
10935161|NCT00321919|12104479|FG001|NOT COMPLETED|Overall Study||52
10935162|NCT00321932|12104488|FG000|STARTED|Overall Study||29
10935163|NCT00321932|12104489|FG001|STARTED|Overall Study||32
10935164|NCT00321932|12104488|FG000|COMPLETED|Overall Study||19
10935165|NCT00321932|12104489|FG001|COMPLETED|Overall Study||11
10935166|NCT00321932|12104488|FG000|NOT COMPLETED|Overall Study||10
10935167|NCT00321932|12104489|FG001|NOT COMPLETED|Overall Study||21
10935336|NCT00322374|12104628|FG003|NOT COMPLETED|Second Escalation||0
10935168|NCT00321971|12104498|FG000|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
10935169|NCT00321971|12104499|FG001|STARTED|Overall Study||37
10935170|NCT00321971|12104498|FG000|COMPLETED|Overall Study||28
10935171|NCT00321971|12104499|FG001|COMPLETED|Overall Study||26
10935172|NCT00321971|12104498|FG000|NOT COMPLETED|Overall Study||8
10935173|NCT00321971|12104499|FG001|NOT COMPLETED|Overall Study||11
10935174|NCT00321984|12104508|FG000|STARTED|Overall Study||317
10935175|NCT00321984|12104509|FG001|STARTED|Overall Study||315
10935176|NCT00321984|12104510|FG002|STARTED|Overall Study||315
10935177|NCT00321984|12104508|FG000|COMPLETED|Overall Study||290
10935178|NCT00321984|12104509|FG001|COMPLETED|Overall Study||294
10935179|NCT00321984|12104510|FG002|COMPLETED|Overall Study||289
10935180|NCT00321984|12104508|FG000|NOT COMPLETED|Overall Study||27
10935181|NCT00321984|12104509|FG001|NOT COMPLETED|Overall Study||21
10935182|NCT00321984|12104510|FG002|NOT COMPLETED|Overall Study||26
10935183|NCT00322023|12104521|FG000|STARTED|Overall Study||12
10935184|NCT00322023|12104522|FG001|STARTED|Overall Study||21
10935185|NCT00322023|12104523|FG002|STARTED|Overall Study||22
10935186|NCT00322023|12104521|FG000|COMPLETED|Overall Study||12
10935187|NCT00322023|12104522|FG001|COMPLETED|Overall Study||19
10935188|NCT00322023|12104523|FG002|COMPLETED|Overall Study||16
10935189|NCT00322023|12104521|FG000|NOT COMPLETED|Overall Study||0
10935190|NCT00322023|12104522|FG001|NOT COMPLETED|Overall Study||2
10935191|NCT00322023|12104523|FG002|NOT COMPLETED|Overall Study||6
10935192|NCT00322049|12104535|FG000|STARTED|Overall Study||4
10935193|NCT00322049|12104536|FG001|STARTED|Overall Study||10
10935194|NCT00322049|12104537|FG002|STARTED|Overall Study||20
10935195|NCT00322049|12104538|FG003|STARTED|Overall Study||17
10935196|NCT00322049|12104535|FG000|COMPLETED|Overall Study||4
10935197|NCT00322049|12104536|FG001|COMPLETED|Overall Study||9
10935198|NCT00322049|12104537|FG002|COMPLETED|Overall Study||20
10935199|NCT00322049|12104538|FG003|COMPLETED|Overall Study||16
10935200|NCT00322049|12104535|FG000|NOT COMPLETED|Overall Study||0
10935201|NCT00322049|12104536|FG001|NOT COMPLETED|Overall Study||1
10935202|NCT00322049|12104537|FG002|NOT COMPLETED|Overall Study||0
10935203|NCT00322049|12104538|FG003|NOT COMPLETED|Overall Study||1
10935204|NCT00322101|12104559|FG000|STARTED|Overall Study||14
10935205|NCT00322101|12104560|FG001|STARTED|Overall Study||11
10935206|NCT00322101|12104559|FG000|COMPLETED|Overall Study||14
10935207|NCT00322101|12104560|FG001|COMPLETED|Overall Study||11
10935208|NCT00322101|12104559|FG000|NOT COMPLETED|Overall Study||0
10935209|NCT00322101|12104560|FG001|NOT COMPLETED|Overall Study||0
10935210|NCT00322153|12104568|FG000|STARTED|Overall Study|Randomized to placebo|335
10935211|NCT00322153|12104569|FG001|STARTED|Overall Study|Randomized to Memantine ER|342
10935212|NCT00322153|12104568|FG000|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
10935213|NCT00322153|12104569|FG001|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
10935214|NCT00322153|12104568|FG000|COMPLETED|Overall Study||272
10935215|NCT00322153|12104569|FG001|COMPLETED|Overall Study||273
10935216|NCT00322153|12104568|FG000|NOT COMPLETED|Overall Study||63
10935217|NCT00322153|12104569|FG001|NOT COMPLETED|Overall Study||69
10935218|NCT00322231|12104577|FG000|STARTED|Period 1||51
10935219|NCT00322231|12104578|FG001|STARTED|Period 1||50
10935220|NCT00322231|12104577|FG000|COMPLETED|Period 1||51
10935221|NCT00322231|12104578|FG001|COMPLETED|Period 1||50
10935222|NCT00322231|12104577|FG000|NOT COMPLETED|Period 1||0
10935223|NCT00322231|12104578|FG001|NOT COMPLETED|Period 1||0
10935224|NCT00322231|12104577|FG000|STARTED|Period 2||51
10935225|NCT00322231|12104578|FG001|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
10935226|NCT00322231|12104577|FG000|COMPLETED|Period 2||51
10935227|NCT00322231|12104578|FG001|COMPLETED|Period 2||49
10935228|NCT00322231|12104577|FG000|NOT COMPLETED|Period 2||0
10935229|NCT00322231|12104578|FG001|NOT COMPLETED|Period 2||0
10935230|NCT00322309|12104590|FG000|STARTED|Overall Study||11
10935231|NCT00322309|12104591|FG001|STARTED|Overall Study||13
10935232|NCT00322309|12104590|FG000|COMPLETED|Overall Study||9
10935233|NCT00322309|12104591|FG001|COMPLETED|Overall Study||9
10935234|NCT00322309|12104590|FG000|NOT COMPLETED|Overall Study||2
10935235|NCT00322309|12104591|FG001|NOT COMPLETED|Overall Study||4
10935236|NCT00322335|12104603|FG000|STARTED|Subjects 18 Months After Booster Dose||58
10935237|NCT00322335|12104604|FG001|STARTED|Subjects 18 Months After Booster Dose||123
10935238|NCT00322335|12104605|FG002|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
10935239|NCT00322335|12104603|FG000|COMPLETED|Subjects 18 Months After Booster Dose||58
10935240|NCT00322335|12104604|FG001|COMPLETED|Subjects 18 Months After Booster Dose||123
10935241|NCT00322335|12104605|FG002|COMPLETED|Subjects 18 Months After Booster Dose||3
10935242|NCT00322335|12104603|FG000|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
10935243|NCT00322335|12104604|FG001|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
10935244|NCT00322335|12104605|FG002|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
10935245|NCT00322335|12104603|FG000|STARTED|Subjects 30 Months After Booster Dose||54
10935246|NCT00322335|12104604|FG001|STARTED|Subjects 30 Months After Booster Dose||119
10935247|NCT00322335|12104605|FG002|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
10935248|NCT00322335|12104603|FG000|COMPLETED|Subjects 30 Months After Booster Dose||54
10935249|NCT00322335|12104604|FG001|COMPLETED|Subjects 30 Months After Booster Dose||119
10935250|NCT00322335|12104605|FG002|COMPLETED|Subjects 30 Months After Booster Dose||57
10935251|NCT00322335|12104603|FG000|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
10935252|NCT00322335|12104604|FG001|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
10935253|NCT00322335|12104605|FG002|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
10935254|NCT00322335|12104603|FG000|STARTED|Subjects 42 Months After Booster Dose||51
10935255|NCT00322335|12104604|FG001|STARTED|Subjects 42 Months After Booster Dose||113
10935256|NCT00322335|12104605|FG002|STARTED|Subjects 42 Months After Booster Dose||56
10935257|NCT00322335|12104603|FG000|COMPLETED|Subjects 42 Months After Booster Dose||51
10935258|NCT00322335|12104604|FG001|COMPLETED|Subjects 42 Months After Booster Dose||113
10935259|NCT00322335|12104605|FG002|COMPLETED|Subjects 42 Months After Booster Dose||56
10935260|NCT00322335|12104603|FG000|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
10935261|NCT00322335|12104604|FG001|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
10935262|NCT00322335|12104605|FG002|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
10935263|NCT00322335|12104603|FG000|STARTED|Subjects 54 Months After Booster Dose||50
10935264|NCT00322335|12104604|FG001|STARTED|Subjects 54 Months After Booster Dose||108
10935265|NCT00322335|12104605|FG002|STARTED|Subjects 54 Months After Booster Dose||56
10935266|NCT00322335|12104603|FG000|COMPLETED|Subjects 54 Months After Booster Dose||50
10935267|NCT00322335|12104604|FG001|COMPLETED|Subjects 54 Months After Booster Dose||108
10935268|NCT00322335|12104605|FG002|COMPLETED|Subjects 54 Months After Booster Dose||56
10935269|NCT00322335|12104603|FG000|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
10935270|NCT00322335|12104604|FG001|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
10935271|NCT00322335|12104605|FG002|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
10935272|NCT00322335|12104603|FG000|STARTED|Subjects 66 Months After Booster Dose||48
10935273|NCT00322335|12104604|FG001|STARTED|Subjects 66 Months After Booster Dose||104
10935274|NCT00322335|12104605|FG002|STARTED|Subjects 66 Months After Booster Dose||53
10935275|NCT00322335|12104603|FG000|COMPLETED|Subjects 66 Months After Booster Dose||48
10935276|NCT00322335|12104604|FG001|COMPLETED|Subjects 66 Months After Booster Dose||104
10935277|NCT00322335|12104605|FG002|COMPLETED|Subjects 66 Months After Booster Dose||53
10935278|NCT00322335|12104603|FG000|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
10935279|NCT00322335|12104604|FG001|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
10935280|NCT00322335|12104605|FG002|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
10935281|NCT00322348|12104615|FG000|STARTED|Overall Study||49
10935282|NCT00322348|12104616|FG001|STARTED|Overall Study||49
10935283|NCT00322348|12104615|FG000|Received Study Treatment|Overall Study||50
10935284|NCT00322348|12104616|FG001|Received Study Treatment|Overall Study||48
10935285|NCT00322348|12104615|FG000|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
10935286|NCT00322348|12104616|FG001|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
10935287|NCT00322348|12104615|FG000|NOT COMPLETED|Overall Study||37
10935288|NCT00322348|12104616|FG001|NOT COMPLETED|Overall Study||33
10935289|NCT00322374|12104625|FG000|STARTED|Enrollment||0
10935290|NCT00322374|12104626|FG001|STARTED|Enrollment||0
10935291|NCT00322374|12104627|FG002|STARTED|Enrollment||0
10935292|NCT00322374|12104628|FG003|STARTED|Enrollment||42
10935293|NCT00322374|12104625|FG000|COMPLETED|Enrollment||0
10935294|NCT00322374|12104626|FG001|COMPLETED|Enrollment||0
10935295|NCT00322374|12104627|FG002|COMPLETED|Enrollment||0
10935296|NCT00322374|12104628|FG003|COMPLETED|Enrollment||42
10935297|NCT00322374|12104625|FG000|NOT COMPLETED|Enrollment||0
10935298|NCT00322374|12104626|FG001|NOT COMPLETED|Enrollment||0
10935299|NCT00322374|12104627|FG002|NOT COMPLETED|Enrollment||0
10935300|NCT00322374|12104628|FG003|NOT COMPLETED|Enrollment||0
10935301|NCT00322374|12104625|FG000|STARTED|Starting Dose||6
10935302|NCT00322374|12104626|FG001|STARTED|Starting Dose||0
10935303|NCT00322374|12104627|FG002|STARTED|Starting Dose||0
10935304|NCT00322374|12104628|FG003|STARTED|Starting Dose||0
10935305|NCT00322374|12104625|FG000|COMPLETED|Starting Dose||0
10935306|NCT00322374|12104626|FG001|COMPLETED|Starting Dose||0
10935307|NCT00322374|12104627|FG002|COMPLETED|Starting Dose||0
10935308|NCT00322374|12104628|FG003|COMPLETED|Starting Dose||0
10935309|NCT00322374|12104625|FG000|NOT COMPLETED|Starting Dose||6
10935310|NCT00322374|12104626|FG001|NOT COMPLETED|Starting Dose||0
10935311|NCT00322374|12104627|FG002|NOT COMPLETED|Starting Dose||0
10935312|NCT00322374|12104628|FG003|NOT COMPLETED|Starting Dose||0
10935313|NCT00322374|12104625|FG000|STARTED|First Escalation||0
10935314|NCT00322374|12104626|FG001|STARTED|First Escalation||30
10935315|NCT00322374|12104627|FG002|STARTED|First Escalation||0
10935316|NCT00322374|12104628|FG003|STARTED|First Escalation||0
10935317|NCT00322374|12104625|FG000|COMPLETED|First Escalation||0
10935318|NCT00322374|12104626|FG001|COMPLETED|First Escalation||0
10935319|NCT00322374|12104627|FG002|COMPLETED|First Escalation||0
10935320|NCT00322374|12104628|FG003|COMPLETED|First Escalation||0
10935321|NCT00322374|12104625|FG000|NOT COMPLETED|First Escalation||0
10935322|NCT00322374|12104626|FG001|NOT COMPLETED|First Escalation||30
10935323|NCT00322374|12104627|FG002|NOT COMPLETED|First Escalation||0
10935324|NCT00322374|12104628|FG003|NOT COMPLETED|First Escalation||0
10935325|NCT00322374|12104625|FG000|STARTED|Second Escalation||0
10935326|NCT00322374|12104626|FG001|STARTED|Second Escalation||0
10935327|NCT00322374|12104627|FG002|STARTED|Second Escalation||6
10935328|NCT00322374|12104628|FG003|STARTED|Second Escalation||0
10935329|NCT00322374|12104625|FG000|COMPLETED|Second Escalation||0
10935330|NCT00322374|12104626|FG001|COMPLETED|Second Escalation||0
10935331|NCT00322374|12104627|FG002|COMPLETED|Second Escalation||0
10935332|NCT00322374|12104628|FG003|COMPLETED|Second Escalation||0
10935333|NCT00322374|12104625|FG000|NOT COMPLETED|Second Escalation||0
10935334|NCT00322374|12104626|FG001|NOT COMPLETED|Second Escalation||0
10935335|NCT00322374|12104627|FG002|NOT COMPLETED|Second Escalation||6
10935337|NCT00322387|12104643|FG000|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
10935338|NCT00322387|12104644|FG001|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
10935339|NCT00322387|12104643|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
10935340|NCT00322387|12104644|FG001|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
10935341|NCT00322387|12104643|FG000|NOT COMPLETED|Treatment Period||0
10935342|NCT00322387|12104644|FG001|NOT COMPLETED|Treatment Period||1
10935343|NCT00322387|12104643|FG000|STARTED|Follow-up Period|Participants who had transplants|14
10935344|NCT00322387|12104644|FG001|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
10935345|NCT00322387|12104643|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
10935346|NCT00322387|12104644|FG001|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
10935347|NCT00322387|12104643|FG000|NOT COMPLETED|Follow-up Period||2
10935348|NCT00322387|12104644|FG001|NOT COMPLETED|Follow-up Period||3
10935349|NCT00322439|12104661|FG000|STARTED|Overall Study||2511
10935350|NCT00322439|12104661|FG000|Received at Least 1 Dose of Etanercept|Overall Study||2510
10935351|NCT00322439|12104661|FG000|COMPLETED|Overall Study||1455
10935352|NCT00322439|12104661|FG000|NOT COMPLETED|Overall Study||1056
10935353|NCT00322452|12104667|FG000|STARTED|Overall Study|Number of patients randomized|609
10935354|NCT00322452|12104668|FG001|STARTED|Overall Study|Number of patients randomized|608
10935355|NCT00322452|12104667|FG000|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
10935356|NCT00322452|12104668|FG001|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
10935357|NCT00322452|12104667|FG000|NOT COMPLETED|Overall Study||247
10935358|NCT00322452|12104668|FG001|NOT COMPLETED|Overall Study||276
10935359|NCT00322465|12104678|FG000|STARTED|Overall Study|Randomized|76
10935360|NCT00322465|12104679|FG001|STARTED|Overall Study|Randomized|73
10935361|NCT00322465|12104680|FG002|STARTED|Overall Study|Randomized|77
10935362|NCT00322465|12104681|FG003|STARTED|Overall Study|Randomized|79
10935363|NCT00322465|12104678|FG000|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
10935364|NCT00322465|12104679|FG001|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
10935365|NCT00322465|12104680|FG002|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
10935366|NCT00322465|12104681|FG003|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
10935367|NCT00322465|12104678|FG000|NOT COMPLETED|Overall Study||20
10935368|NCT00322465|12104679|FG001|NOT COMPLETED|Overall Study||24
10935369|NCT00322465|12104680|FG002|NOT COMPLETED|Overall Study||26
10935370|NCT00322465|12104681|FG003|NOT COMPLETED|Overall Study||26
10935371|NCT00322491|12104696|FG000|STARTED|Overall Study||23
10935372|NCT00322491|12104697|FG001|STARTED|Overall Study||26
10935373|NCT00322491|12104696|FG000|COMPLETED|Overall Study||21
10935374|NCT00322491|12104697|FG001|COMPLETED|Overall Study||24
10935375|NCT00322491|12104696|FG000|NOT COMPLETED|Overall Study||2
10935376|NCT00322491|12104697|FG001|NOT COMPLETED|Overall Study||2
10935377|NCT00322556|12104704|FG000|STARTED|Overall Study||55
10935378|NCT00322556|12104704|FG000|COMPLETED|Overall Study||43
10935379|NCT00322556|12104704|FG000|NOT COMPLETED|Overall Study||12
10935380|NCT00322621|12104711|FG000|STARTED|Period II - Acute Therapy Phase||216
10935381|NCT00322621|12104712|FG001|STARTED|Period II - Acute Therapy Phase||0
10935382|NCT00322621|12104713|FG002|STARTED|Period II - Acute Therapy Phase||0
10935383|NCT00322621|12104711|FG000|COMPLETED|Period II - Acute Therapy Phase||184
10935384|NCT00322621|12104712|FG001|COMPLETED|Period II - Acute Therapy Phase||0
10935385|NCT00322621|12104713|FG002|COMPLETED|Period II - Acute Therapy Phase||0
10935386|NCT00322621|12104711|FG000|NOT COMPLETED|Period II - Acute Therapy Phase||32
10935387|NCT00322621|12104712|FG001|NOT COMPLETED|Period II - Acute Therapy Phase||0
10935388|NCT00322621|12104713|FG002|NOT COMPLETED|Period II - Acute Therapy Phase||0
10935389|NCT00322621|12104711|FG000|STARTED|Period III - Maintenance / Rescue Phase||0
10935390|NCT00322621|12104712|FG001|STARTED|Period III - Maintenance / Rescue Phase||115
10935391|NCT00322621|12104713|FG002|STARTED|Period III - Maintenance / Rescue Phase||69
10935392|NCT00322621|12104711|FG000|COMPLETED|Period III - Maintenance / Rescue Phase||0
10935393|NCT00322621|12104712|FG001|COMPLETED|Period III - Maintenance / Rescue Phase||86
10935394|NCT00322621|12104713|FG002|COMPLETED|Period III - Maintenance / Rescue Phase||33
10935395|NCT00322621|12104711|FG000|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
10935396|NCT00322621|12104712|FG001|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
10935397|NCT00322621|12104713|FG002|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
10935398|NCT00322712|12104726|FG000|STARTED|Overall Study||12
10935399|NCT00322712|12104726|FG000|COMPLETED|Overall Study||11
10935400|NCT00322712|12104726|FG000|NOT COMPLETED|Overall Study||1
10935401|NCT00322777|12104732|FG000|STARTED|Overall Study||39
10935402|NCT00322777|12104733|FG001|STARTED|Overall Study||45
10935403|NCT00322777|12104732|FG000|"Data Collection at BASELINE|"|Overall Study||39
10935404|NCT00322777|12104733|FG001|"Data Collection at BASELINE|"|Overall Study||45
10935405|NCT00322777|12104732|FG000|Data Collection at Week 8|Overall Study||39
10935406|NCT00322777|12104733|FG001|Data Collection at Week 8|Overall Study||45
10935407|NCT00322777|12104732|FG000|Data Collection at Week 16|Overall Study||39
10935408|NCT00322777|12104733|FG001|Data Collection at Week 16|Overall Study||45
10935409|NCT00322777|12104732|FG000|Data Collection at Week 24|Overall Study||39
10935410|NCT00322777|12104733|FG001|Data Collection at Week 24|Overall Study||45
10935411|NCT00322777|12104732|FG000|COMPLETED|Overall Study||39
10935412|NCT00322777|12104733|FG001|COMPLETED|Overall Study||45
10935413|NCT00322777|12104732|FG000|NOT COMPLETED|Overall Study||0
10935414|NCT00322777|12104733|FG001|NOT COMPLETED|Overall Study||0
10935415|NCT00322842|12104741|FG000|STARTED|Overall Study||4
10935416|NCT00322842|12104742|FG001|STARTED|Overall Study||31
10935417|NCT00322842|12104741|FG000|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
10935418|NCT00322842|12104742|FG001|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
10935419|NCT00322842|12104741|FG000|NOT COMPLETED|Overall Study||2
10935420|NCT00322842|12104742|FG001|NOT COMPLETED|Overall Study||2
10935421|NCT00322868|12104749|FG000|STARTED|Overall Study||21
10935422|NCT00322868|12104749|FG000|COMPLETED|Overall Study||20
10935423|NCT00322868|12104749|FG000|NOT COMPLETED|Overall Study||1
10935424|NCT00322881|12104754|FG000|STARTED|Overall Study||12
10935425|NCT00322881|12104754|FG000|COMPLETED|Overall Study||7
10935426|NCT00322881|12104754|FG000|NOT COMPLETED|Overall Study||5
10935427|NCT00323115|12104758|FG000|STARTED|Vaccine Administration||11
10935428|NCT00323115|12104758|FG000|COMPLETED|Vaccine Administration||10
10935429|NCT00323115|12104758|FG000|NOT COMPLETED|Vaccine Administration||1
10935430|NCT00323115|12104758|FG000|STARTED|Adjuvant Therapy & Survival Follow-Up||10
10935431|NCT00323115|12104758|FG000|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
10935432|NCT00323115|12104758|FG000|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
10935433|NCT00323193|12104769|FG000|STARTED|Overall Study||53
10935434|NCT00323193|12104770|FG001|STARTED|Overall Study||56
10935435|NCT00323193|12104769|FG000|COMPLETED|Overall Study||30
10935436|NCT00323193|12104770|FG001|COMPLETED|Overall Study||41
10935437|NCT00323193|12104769|FG000|NOT COMPLETED|Overall Study||23
10935438|NCT00323193|12104770|FG001|NOT COMPLETED|Overall Study||15
10935439|NCT00323258|12104778|FG000|STARTED|Primary Outcome (Phone Call at 6 Months)||71
10935440|NCT00323258|12104779|FG001|STARTED|Primary Outcome (Phone Call at 6 Months)||72
10935441|NCT00323258|12104778|FG000|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
10935442|NCT00323258|12104779|FG001|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
10935443|NCT00323258|12104778|FG000|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
10935444|NCT00323258|12104779|FG001|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
10935445|NCT00323258|12104778|FG000|STARTED|Secondary Outcome (6 Mon Refill Records)||71
10935446|NCT00323258|12104779|FG001|STARTED|Secondary Outcome (6 Mon Refill Records)||72
10935447|NCT00323258|12104778|FG000|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
10935448|NCT00323258|12104779|FG001|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
10935449|NCT00323258|12104778|FG000|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
10935450|NCT00323258|12104779|FG001|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
10935451|NCT00323271|12104787|FG000|STARTED|Overall Study||13
10935452|NCT00323271|12104788|FG001|STARTED|Overall Study||12
10935453|NCT00323271|12104787|FG000|COMPLETED|Overall Study||11
10935454|NCT00323271|12104788|FG001|COMPLETED|Overall Study||9
10935455|NCT00323271|12104787|FG000|NOT COMPLETED|Overall Study||2
10935456|NCT00323271|12104788|FG001|NOT COMPLETED|Overall Study||3
10935457|NCT00323284|12104796|FG000|STARTED|12 Months Follow-up||116
10935458|NCT00323284|12104797|FG001|STARTED|12 Months Follow-up||123
10935459|NCT00323284|12104796|FG000|COMPLETED|12 Months Follow-up||111
10935460|NCT00323284|12104797|FG001|COMPLETED|12 Months Follow-up||114
10935461|NCT00323284|12104796|FG000|NOT COMPLETED|12 Months Follow-up||5
10935462|NCT00323284|12104797|FG001|NOT COMPLETED|12 Months Follow-up||9
10935463|NCT00323284|12104796|FG000|STARTED|24 Months Follow-up||116
10935464|NCT00323284|12104797|FG001|STARTED|24 Months Follow-up||123
10935465|NCT00323284|12104796|FG000|COMPLETED|24 Months Follow-up||98
10935466|NCT00323284|12104797|FG001|COMPLETED|24 Months Follow-up||101
10935467|NCT00323284|12104796|FG000|NOT COMPLETED|24 Months Follow-up||18
10935468|NCT00323284|12104797|FG001|NOT COMPLETED|24 Months Follow-up||22
10935469|NCT00323297|12104805|FG000|STARTED|Part A (Double Blind Randomized)||53
10935470|NCT00323297|12104806|FG001|STARTED|Part A (Double Blind Randomized)||50
10935471|NCT00323297|12104805|FG000|COMPLETED|Part A (Double Blind Randomized)||48
10935472|NCT00323297|12104806|FG001|COMPLETED|Part A (Double Blind Randomized)||43
10935473|NCT00323297|12104805|FG000|NOT COMPLETED|Part A (Double Blind Randomized)||5
10935474|NCT00323297|12104806|FG001|NOT COMPLETED|Part A (Double Blind Randomized)||7
10935475|NCT00323297|12104805|FG000|STARTED|Part B (Open-label)||48
10935476|NCT00323297|12104806|FG001|STARTED|Part B (Open-label)||43
10935477|NCT00323297|12104805|FG000|COMPLETED|Part B (Open-label)||39
10935478|NCT00323297|12104806|FG001|COMPLETED|Part B (Open-label)||31
10935479|NCT00323297|12104805|FG000|NOT COMPLETED|Part B (Open-label)||9
10935480|NCT00323297|12104806|FG001|NOT COMPLETED|Part B (Open-label)||12
10935481|NCT00323310|12104812|FG000|STARTED|Overall Study||92
10935482|NCT00323310|12104812|FG000|COMPLETED|Overall Study||89
10935483|NCT00323310|12104812|FG000|NOT COMPLETED|Overall Study||3
10935484|NCT00323362|12104816|FG000|STARTED|Overall Study||17
10935485|NCT00323362|12104816|FG000|COMPLETED|Overall Study||17
10935486|NCT00323362|12104816|FG000|NOT COMPLETED|Overall Study||0
10935487|NCT00323414|12104822|FG000|STARTED|Overall Study||18
10935488|NCT00323414|12104823|FG001|STARTED|Overall Study||19
10935489|NCT00323414|12104822|FG000|COMPLETED|Overall Study||18
10935490|NCT00323414|12104823|FG001|COMPLETED|Overall Study||18
10935491|NCT00323414|12104822|FG000|NOT COMPLETED|Overall Study||0
10935492|NCT00323414|12104823|FG001|NOT COMPLETED|Overall Study||1
10935493|NCT00323427|12104831|FG000|STARTED|Overall Study||69
10935494|NCT00323427|12104832|FG001|STARTED|Overall Study||66
10935495|NCT00323427|12104831|FG000|COMPLETED|Overall Study||38
10935496|NCT00323427|12104832|FG001|COMPLETED|Overall Study||43
10935497|NCT00323427|12104831|FG000|NOT COMPLETED|Overall Study||31
10935498|NCT00323427|12104832|FG001|NOT COMPLETED|Overall Study||23
10935499|NCT00323453|12104840|FG000|STARTED|Overall Study||61
10935500|NCT00323453|12104841|FG001|STARTED|Overall Study||48
10935501|NCT00323453|12104840|FG000|COMPLETED|Overall Study||61
10935502|NCT00323453|12104841|FG001|COMPLETED|Overall Study||48
10935503|NCT00323453|12104840|FG000|NOT COMPLETED|Overall Study||0
10935504|NCT00323453|12104841|FG001|NOT COMPLETED|Overall Study||0
10935505|NCT00323479|12104847|FG000|STARTED|Overall Study||114
10935506|NCT00323479|12104847|FG000|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
10935507|NCT00323479|12104847|FG000|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
10935508|NCT00323479|12104847|FG000|NOT COMPLETED|Overall Study||8
10935509|NCT00323492|12104853|FG000|STARTED|Study Phase 1||47
10935510|NCT00323492|12104854|FG001|STARTED|Study Phase 1||45
10935511|NCT00323492|12104855|FG002|STARTED|Study Phase 1|Not applicable to Phase 1.|0
10935512|NCT00323492|12104853|FG000|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
10935513|NCT00323492|12104854|FG001|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
10935514|NCT00323492|12104855|FG002|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
10935515|NCT00323492|12104853|FG000|COMPLETED|Study Phase 1||45
10935516|NCT00323492|12104854|FG001|COMPLETED|Study Phase 1||45
10935517|NCT00323492|12104855|FG002|COMPLETED|Study Phase 1||0
10935518|NCT00323492|12104853|FG000|NOT COMPLETED|Study Phase 1||2
10935519|NCT00323492|12104854|FG001|NOT COMPLETED|Study Phase 1||0
10935520|NCT00323492|12104855|FG002|NOT COMPLETED|Study Phase 1||0
10935521|NCT00323492|12104853|FG000|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
10935522|NCT00323492|12104854|FG001|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
10935523|NCT00323492|12104855|FG002|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
10935524|NCT00323492|12104853|FG000|COMPLETED|Study Phase 2||40
10935525|NCT00323492|12104854|FG001|COMPLETED|Study Phase 2||17
10935526|NCT00323492|12104855|FG002|COMPLETED|Study Phase 2||24
10935527|NCT00323492|12104853|FG000|NOT COMPLETED|Study Phase 2||4
10935528|NCT00323492|12104854|FG001|NOT COMPLETED|Study Phase 2||1
10935529|NCT00323492|12104855|FG002|NOT COMPLETED|Study Phase 2||1
10935530|NCT00323557|12104864|FG000|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
10935531|NCT00323557|12104865|FG001|STARTED|Overall Study||7
10935532|NCT00323557|12104864|FG000|COMPLETED|Overall Study||24
10935533|NCT00323557|12104865|FG001|COMPLETED|Overall Study||7
10935534|NCT00323557|12104864|FG000|NOT COMPLETED|Overall Study||1
10935535|NCT00323557|12104865|FG001|NOT COMPLETED|Overall Study||0
10935536|NCT00323609|12104874|FG000|STARTED|Overall Study||191
10935537|NCT00323609|12104875|FG001|STARTED|Overall Study||190
10935538|NCT00323609|12104876|FG002|STARTED|Overall Study||8
10935539|NCT00323609|12104877|FG003|STARTED|Overall Study||15
10935540|NCT00323609|12104874|FG000|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
10935541|NCT00323609|12104875|FG001|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
10935542|NCT00323609|12104876|FG002|COMPLETED|Overall Study||0
10935543|NCT00323609|12104877|FG003|COMPLETED|Overall Study||0
10935544|NCT00323609|12104874|FG000|NOT COMPLETED|Overall Study||91
10935545|NCT00323609|12104875|FG001|NOT COMPLETED|Overall Study||99
10935546|NCT00323609|12104876|FG002|NOT COMPLETED|Overall Study||8
10935547|NCT00323609|12104877|FG003|NOT COMPLETED|Overall Study||15
10935548|NCT00323622|12104891|FG000|STARTED|Overall Study||176
10935549|NCT00323622|12104892|FG001|STARTED|Overall Study||515
10935550|NCT00323622|12104893|FG002|STARTED|Overall Study||42
10935551|NCT00323622|12104894|FG003|STARTED|Overall Study||134
10935552|NCT00323622|12104895|FG004|STARTED|Overall Study||159
10935553|NCT00323622|12104896|FG005|STARTED|Overall Study||528
10935554|NCT00323622|12104897|FG006|STARTED|Overall Study||43
10935555|NCT00323622|12104898|FG007|STARTED|Overall Study||140
10935556|NCT00323622|12104891|FG000|COMPLETED|Overall Study||145
10935557|NCT00323622|12104892|FG001|COMPLETED|Overall Study||423
10935558|NCT00323622|12104893|FG002|COMPLETED|Overall Study||38
10935559|NCT00323622|12104894|FG003|COMPLETED|Overall Study||122
10935560|NCT00323622|12104895|FG004|COMPLETED|Overall Study||120
10935561|NCT00323622|12104896|FG005|COMPLETED|Overall Study||454
10935562|NCT00323622|12104897|FG006|COMPLETED|Overall Study||38
10935563|NCT00323622|12104898|FG007|COMPLETED|Overall Study||125
10935564|NCT00323622|12104891|FG000|NOT COMPLETED|Overall Study||31
10935565|NCT00323622|12104892|FG001|NOT COMPLETED|Overall Study||92
10935566|NCT00323622|12104893|FG002|NOT COMPLETED|Overall Study||4
10935567|NCT00323622|12104894|FG003|NOT COMPLETED|Overall Study||12
10935568|NCT00323622|12104895|FG004|NOT COMPLETED|Overall Study||39
10935569|NCT00323622|12104896|FG005|NOT COMPLETED|Overall Study||74
10935570|NCT00323622|12104897|FG006|NOT COMPLETED|Overall Study||5
10935571|NCT00323622|12104898|FG007|NOT COMPLETED|Overall Study||15
10935572|NCT00323739|12104924|FG000|STARTED|Overall Study||80
10935573|NCT00323739|12104924|FG000|COMPLETED|Overall Study||80
10935574|NCT00323739|12104924|FG000|NOT COMPLETED|Overall Study||0
10935575|NCT00323869|12104928|FG000|STARTED|Overall Study|Enrollment|48
10935576|NCT00323869|12104928|FG000|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
10935577|NCT00323869|12104928|FG000|COMPLETED|Overall Study||47
10935578|NCT00323869|12104928|FG000|NOT COMPLETED|Overall Study||1
10935579|NCT00323882|12104937|FG000|STARTED|Overall Study||8
10935580|NCT00323882|12104938|FG001|STARTED|Overall Study||6
10935581|NCT00323882|12104939|FG002|STARTED|Overall Study||16
10935582|NCT00323882|12104940|FG003|STARTED|Overall Study||7
10935583|NCT00323882|12104941|FG004|STARTED|Overall Study||34
10935584|NCT00323882|12104937|FG000|COMPLETED|Overall Study||0
10935585|NCT00323882|12104938|FG001|COMPLETED|Overall Study||0
10935586|NCT00323882|12104939|FG002|COMPLETED|Overall Study||3
10935587|NCT00323882|12104940|FG003|COMPLETED|Overall Study||0
10935588|NCT00323882|12104941|FG004|COMPLETED|Overall Study||2
10935589|NCT00323882|12104937|FG000|NOT COMPLETED|Overall Study||8
10935590|NCT00323882|12104938|FG001|NOT COMPLETED|Overall Study||6
10935591|NCT00323882|12104939|FG002|NOT COMPLETED|Overall Study||13
10935592|NCT00323882|12104940|FG003|NOT COMPLETED|Overall Study||7
10935593|NCT00323882|12104941|FG004|NOT COMPLETED|Overall Study||32
10935594|NCT00323960|12104965|FG000|STARTED|Overall Study||47
10935595|NCT00323960|12104966|FG001|STARTED|Overall Study||46
10935596|NCT00323960|12104967|FG002|STARTED|Overall Study||46
10935597|NCT00323960|12104965|FG000|COMPLETED|Overall Study||47
10935598|NCT00323960|12104966|FG001|COMPLETED|Overall Study||46
10935599|NCT00323960|12104967|FG002|COMPLETED|Overall Study||46
10935600|NCT00323960|12104965|FG000|NOT COMPLETED|Overall Study||0
10935601|NCT00323960|12104966|FG001|NOT COMPLETED|Overall Study||0
10935602|NCT00323960|12104967|FG002|NOT COMPLETED|Overall Study||0
10935603|NCT00324038|12104980|FG000|STARTED|Overall Study||110
10935604|NCT00324038|12104981|FG001|STARTED|Overall Study||109
10935605|NCT00324038|12104980|FG000|COMPLETED|Overall Study||61
10935606|NCT00324038|12104981|FG001|COMPLETED|Overall Study||58
10935607|NCT00324038|12104980|FG000|NOT COMPLETED|Overall Study||49
10935608|NCT00324038|12104981|FG001|NOT COMPLETED|Overall Study||51
10935609|NCT00324116|12104987|FG000|STARTED|Overall Study|subjects received treatment|81
10935610|NCT00324116|12104987|FG000|COMPLETED|Overall Study||49
10935611|NCT00324116|12104987|FG000|NOT COMPLETED|Overall Study||32
10935612|NCT00324155|12104993|FG000|STARTED|Enrolled and Randomized||250
10935613|NCT00324155|12104994|FG001|STARTED|Enrolled and Randomized||252
10935614|NCT00324155|12104993|FG000|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
10935615|NCT00324155|12104994|FG001|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
10935616|NCT00324155|12104993|FG000|NOT COMPLETED|Enrolled and Randomized||3
10935617|NCT00324155|12104994|FG001|NOT COMPLETED|Enrolled and Randomized||1
10935618|NCT00324155|12104993|FG000|STARTED|Received Treatment in Induction Phase||247
10935619|NCT00324155|12104994|FG001|STARTED|Received Treatment in Induction Phase||251
10935620|NCT00324155|12104993|FG000|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
10935621|NCT00324155|12104994|FG001|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
10935622|NCT00324155|12104993|FG000|NOT COMPLETED|Received Treatment in Induction Phase||202
10935623|NCT00324155|12104994|FG001|NOT COMPLETED|Received Treatment in Induction Phase||197
10935624|NCT00324155|12104993|FG000|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
10935625|NCT00324155|12104994|FG001|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
10935626|NCT00324155|12104993|FG000|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
10935627|NCT00324155|12104994|FG001|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
10935628|NCT00324155|12104993|FG000|NOT COMPLETED|Received Treatment in Maintenance Phase||32
10935629|NCT00324155|12104994|FG001|NOT COMPLETED|Received Treatment in Maintenance Phase||47
10935630|NCT00324155|12104993|FG000|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
10935631|NCT00324155|12104994|FG001|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
10935632|NCT00324155|12104993|FG000|COMPLETED|Follow-up Phase||236
10935633|NCT00324155|12104994|FG001|COMPLETED|Follow-up Phase||245
10935634|NCT00324155|12104993|FG000|NOT COMPLETED|Follow-up Phase||11
10935635|NCT00324155|12104994|FG001|NOT COMPLETED|Follow-up Phase||6
10935636|NCT00324168|12105015|FG000|STARTED|Overall Study||250
10935637|NCT00324168|12105016|FG001|STARTED|Overall Study||250
10935638|NCT00324168|12105015|FG000|COMPLETED|Overall Study||222
10935639|NCT00324168|12105016|FG001|COMPLETED|Overall Study||220
10935640|NCT00324168|12105015|FG000|NOT COMPLETED|Overall Study||28
10935641|NCT00324168|12105016|FG001|NOT COMPLETED|Overall Study||30
10935642|NCT00324233|12105024|FG000|STARTED|First Period||18
10935643|NCT00324233|12105025|FG001|STARTED|First Period||18
10935644|NCT00324233|12105024|FG000|COMPLETED|First Period||17
10935645|NCT00324233|12105025|FG001|COMPLETED|First Period||18
10935646|NCT00324233|12105024|FG000|NOT COMPLETED|First Period||1
10935647|NCT00324233|12105025|FG001|NOT COMPLETED|First Period||0
10935648|NCT00324233|12105024|FG000|STARTED|Second Period||17
10935649|NCT00324233|12105025|FG001|STARTED|Second Period||18
10935650|NCT00324233|12105024|FG000|COMPLETED|Second Period||12
10935651|NCT00324233|12105025|FG001|COMPLETED|Second Period||11
10935652|NCT00324233|12105024|FG000|NOT COMPLETED|Second Period||5
10935653|NCT00324233|12105025|FG001|NOT COMPLETED|Second Period||7
10935654|NCT00324259|12105033|FG000|STARTED|Overall Study||34
10935655|NCT00324259|12105034|FG001|STARTED|Overall Study||32
10935656|NCT00324259|12105033|FG000|COMPLETED|Overall Study||34
10935657|NCT00324259|12105034|FG001|COMPLETED|Overall Study||32
10935658|NCT00324259|12105033|FG000|NOT COMPLETED|Overall Study||0
10935659|NCT00324259|12105034|FG001|NOT COMPLETED|Overall Study||0
10935660|NCT00324272|12105045|FG000|STARTED|Overall Study||18
10935661|NCT00324272|12105046|FG001|STARTED|Overall Study||20
10935662|NCT00324272|12105047|FG002|STARTED|Overall Study||18
10935663|NCT00324272|12105048|FG003|STARTED|Overall Study||18
10935664|NCT00324272|12105045|FG000|COMPLETED|Overall Study||18
10935665|NCT00324272|12105046|FG001|COMPLETED|Overall Study||20
10935666|NCT00324272|12105047|FG002|COMPLETED|Overall Study||18
10935667|NCT00324272|12105048|FG003|COMPLETED|Overall Study||18
10935668|NCT00324272|12105045|FG000|NOT COMPLETED|Overall Study||0
10935669|NCT00324272|12105046|FG001|NOT COMPLETED|Overall Study||0
10935670|NCT00324272|12105047|FG002|NOT COMPLETED|Overall Study||0
10935671|NCT00324272|12105048|FG003|NOT COMPLETED|Overall Study||0
10935672|NCT00324350|12105060|FG000|STARTED|Overall Study||3655
10935673|NCT00324350|12105061|FG001|STARTED|Overall Study||3632
10935674|NCT00324350|12105060|FG000|Non-Vertebral Fracture Follow-Up|Overall Study||3655
10935675|NCT00324350|12105061|FG001|Non-Vertebral Fracture Follow-Up|Overall Study||3632
10935676|NCT00324350|12105060|FG000|Falls Follow-Up|Overall Study||3364
10935677|NCT00324350|12105061|FG001|Falls Follow-Up|Overall Study||3418
10935678|NCT00324350|12105060|FG000|COMPLETED|Overall Study||3655
10935679|NCT00324350|12105061|FG001|COMPLETED|Overall Study||3632
10935680|NCT00324350|12105060|FG000|NOT COMPLETED|Overall Study||0
10935681|NCT00324350|12105061|FG001|NOT COMPLETED|Overall Study||0
10935682|NCT00324415|12105068|FG000|STARTED|Overall Study||45
10935683|NCT00324415|12105068|FG000|COMPLETED|Overall Study||45
10935684|NCT00324415|12105068|FG000|NOT COMPLETED|Overall Study||0
10935685|NCT00324649|12105075|FG000|STARTED|Overall Study||39
10935686|NCT00324649|12105076|FG001|STARTED|Overall Study||41
10935687|NCT00324649|12105075|FG000|COMPLETED|Overall Study||37
10935688|NCT00324649|12105076|FG001|COMPLETED|Overall Study||36
10935689|NCT00324649|12105075|FG000|NOT COMPLETED|Overall Study||2
10935690|NCT00324649|12105076|FG001|NOT COMPLETED|Overall Study||5
10935691|NCT00324675|12105084|FG000|STARTED|Overall Study||14
10935692|NCT00324675|12105085|FG001|STARTED|Overall Study||14
10935693|NCT00324675|12105084|FG000|COMPLETED|Overall Study||13
10935694|NCT00324675|12105085|FG001|COMPLETED|Overall Study||14
10935695|NCT00324675|12105084|FG000|NOT COMPLETED|Overall Study||1
10935696|NCT00324675|12105085|FG001|NOT COMPLETED|Overall Study||0
10935697|NCT00324701|12105093|FG000|STARTED|Overall Study||120
10935698|NCT00324701|12105094|FG001|STARTED|Overall Study||121
10935699|NCT00324701|12105093|FG000|Week 8 Assessment|Overall Study||108
10935700|NCT00324701|12105094|FG001|Week 8 Assessment|Overall Study||107
10935701|NCT00324701|12105093|FG000|COMPLETED|Overall Study||100
10935702|NCT00324701|12105094|FG001|COMPLETED|Overall Study||104
10935703|NCT00324701|12105093|FG000|NOT COMPLETED|Overall Study||20
10935704|NCT00324701|12105094|FG001|NOT COMPLETED|Overall Study||17
10935705|NCT00324740|12105100|FG000|STARTED|Overall Study||7
10935706|NCT00324740|12105101|FG001|STARTED|Overall Study||3
10935707|NCT00324740|12105102|FG002|STARTED|Overall Study||4
10935708|NCT00324740|12105100|FG000|COMPLETED|Overall Study||6
10935709|NCT00324740|12105101|FG001|COMPLETED|Overall Study||3
10935710|NCT00324740|12105102|FG002|COMPLETED|Overall Study||3
10935711|NCT00324740|12105100|FG000|NOT COMPLETED|Overall Study||1
10935712|NCT00324740|12105101|FG001|NOT COMPLETED|Overall Study||0
10935713|NCT00324740|12105102|FG002|NOT COMPLETED|Overall Study||1
10935714|NCT00324753|12105111|FG000|STARTED|Overall Study||190
10935715|NCT00324753|12105112|FG001|STARTED|Overall Study||264
10935716|NCT00324753|12105111|FG000|COMPLETED|Overall Study||190
10935717|NCT00324753|12105112|FG001|COMPLETED|Overall Study||264
10935718|NCT00324753|12105111|FG000|NOT COMPLETED|Overall Study||0
10935719|NCT00324753|12105112|FG001|NOT COMPLETED|Overall Study||0
10935720|NCT00324857|12105124|FG000|STARTED|Overall Study||167
10935721|NCT00324857|12105125|FG001|STARTED|Overall Study||168
10935722|NCT00324857|12105126|FG002|STARTED|Overall Study||165
10935723|NCT00324857|12105127|FG003|STARTED|Overall Study||163
10935724|NCT00324857|12105124|FG000|COMPLETED|Overall Study||161
10935725|NCT00324857|12105125|FG001|COMPLETED|Overall Study||162
10935726|NCT00324857|12105126|FG002|COMPLETED|Overall Study||158
10935727|NCT00324857|12105127|FG003|COMPLETED|Overall Study||158
10935728|NCT00324857|12105124|FG000|NOT COMPLETED|Overall Study||6
10935729|NCT00324857|12105125|FG001|NOT COMPLETED|Overall Study||6
10935730|NCT00324857|12105126|FG002|NOT COMPLETED|Overall Study||7
10935731|NCT00324857|12105127|FG003|NOT COMPLETED|Overall Study||5
10935732|NCT00324870|12105141|FG000|STARTED|Overall Study||37
10935733|NCT00324870|12105141|FG000|COMPLETED|Overall Study||37
10935734|NCT00324870|12105141|FG000|NOT COMPLETED|Overall Study||0
10935735|NCT00324896|12105147|FG000|STARTED|Overall Study||15
10935736|NCT00324896|12105148|FG001|STARTED|Overall Study||15
10935737|NCT00324896|12105147|FG000|COMPLETED|Overall Study||12
10935738|NCT00324896|12105148|FG001|COMPLETED|Overall Study||7
10935739|NCT00324896|12105147|FG000|NOT COMPLETED|Overall Study||3
10935740|NCT00324896|12105148|FG001|NOT COMPLETED|Overall Study||8
10935741|NCT00324961|12105154|FG000|STARTED|Overall Study||533
10935742|NCT00324961|12105154|FG000|COMPLETED|Overall Study||490
10935743|NCT00324961|12105154|FG000|NOT COMPLETED|Overall Study||43
10935744|NCT00324987|12105162|FG000|STARTED|Overall Study||6
10935745|NCT00324987|12105163|FG001|STARTED|Overall Study||6
10935746|NCT00324987|12105162|FG000|COMPLETED|Overall Study|Patients were to be treated until progression|0
10935747|NCT00324987|12105163|FG001|COMPLETED|Overall Study|Patients were to be treated until progression|0
10935748|NCT00324987|12105162|FG000|NOT COMPLETED|Overall Study||6
10935749|NCT00324987|12105163|FG001|NOT COMPLETED|Overall Study||6
10935750|NCT00325039|12105171|FG000|STARTED|Overall Study||298
10935751|NCT00325039|12105172|FG001|STARTED|Overall Study||299
10935752|NCT00325039|12105171|FG000|COMPLETED|Overall Study||280
10935753|NCT00325039|12105172|FG001|COMPLETED|Overall Study||285
10935754|NCT00325039|12105171|FG000|NOT COMPLETED|Overall Study||18
10935755|NCT00325039|12105172|FG001|NOT COMPLETED|Overall Study||14
10935756|NCT00325078|12105181|FG000|STARTED|Overall Study||8
10935757|NCT00325078|12105182|FG001|STARTED|Overall Study||7
10935758|NCT00325078|12105183|FG002|STARTED|Overall Study||25
10935759|NCT00325078|12105181|FG000|COMPLETED|Overall Study||3
10935760|NCT00325078|12105182|FG001|COMPLETED|Overall Study||2
10935761|NCT00325078|12105183|FG002|COMPLETED|Overall Study||23
10935762|NCT00325078|12105181|FG000|NOT COMPLETED|Overall Study||5
10935763|NCT00325078|12105182|FG001|NOT COMPLETED|Overall Study||5
10935764|NCT00325078|12105183|FG002|NOT COMPLETED|Overall Study||2
10935765|NCT00325130|12105194|FG000|STARTED|Overall Study||518
10935766|NCT00325130|12105195|FG001|STARTED|Overall Study||524
10935767|NCT00325130|12105194|FG000|COMPLETED|Overall Study||499
10935768|NCT00325130|12105195|FG001|COMPLETED|Overall Study||494
10935769|NCT00325130|12105194|FG000|NOT COMPLETED|Overall Study||19
10935770|NCT00325130|12105195|FG001|NOT COMPLETED|Overall Study||30
10935771|NCT00325143|12105201|FG000|STARTED|Overall Study||702
10935772|NCT00325143|12105201|FG000|COMPLETED|Overall Study||676
10935773|NCT00325143|12105201|FG000|NOT COMPLETED|Overall Study||26
10935774|NCT00325156|12105205|FG000|STARTED|Overall Study||2590
10935775|NCT00325156|12105205|FG000|COMPLETED|Overall Study||2478
10935776|NCT00325156|12105205|FG000|NOT COMPLETED|Overall Study||112
10935777|NCT00325195|12105212|FG000|STARTED|Randomized||90
10935778|NCT00325195|12105213|FG001|STARTED|Randomized||89
10935779|NCT00325195|12105214|FG002|STARTED|Randomized||46
10935780|NCT00325195|12105212|FG000|COMPLETED|Randomized||85
10935781|NCT00325195|12105213|FG001|COMPLETED|Randomized||84
10935782|NCT00325195|12105214|FG002|COMPLETED|Randomized||43
10935783|NCT00325195|12105212|FG000|NOT COMPLETED|Randomized||5
10935784|NCT00325195|12105213|FG001|NOT COMPLETED|Randomized||5
10935785|NCT00325195|12105214|FG002|NOT COMPLETED|Randomized||3
10935786|NCT00325195|12105212|FG000|STARTED|Received Intervention: ITT Population||85
10935787|NCT00325195|12105213|FG001|STARTED|Received Intervention: ITT Population||84
10935788|NCT00325195|12105214|FG002|STARTED|Received Intervention: ITT Population||43
10935789|NCT00325195|12105212|FG000|COMPLETED|Received Intervention: ITT Population||59
10935790|NCT00325195|12105213|FG001|COMPLETED|Received Intervention: ITT Population||59
10935791|NCT00325195|12105214|FG002|COMPLETED|Received Intervention: ITT Population||39
10935792|NCT00325195|12105212|FG000|NOT COMPLETED|Received Intervention: ITT Population||26
10935793|NCT00325195|12105213|FG001|NOT COMPLETED|Received Intervention: ITT Population||25
10935794|NCT00325195|12105214|FG002|NOT COMPLETED|Received Intervention: ITT Population||4
10935795|NCT00325234|12105224|FG000|STARTED|Overall Study||69
10935796|NCT00325234|12105225|FG001|STARTED|Overall Study||66
10935797|NCT00325234|12105224|FG000|Received At Least 1 Dose of Study Drug|Overall Study||65
10935798|NCT00325234|12105225|FG001|Received At Least 1 Dose of Study Drug|Overall Study||66
10935799|NCT00325234|12105224|FG000|COMPLETED|Overall Study||0
10935800|NCT00325234|12105225|FG001|COMPLETED|Overall Study||0
10935801|NCT00325234|12105224|FG000|NOT COMPLETED|Overall Study||69
10935802|NCT00325234|12105225|FG001|NOT COMPLETED|Overall Study||66
10935803|NCT00325403|12105235|FG000|STARTED|Overall Study||116
10935804|NCT00325403|12105236|FG001|STARTED|Overall Study||233
10935805|NCT00325403|12105235|FG000|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
10935806|NCT00325403|12105236|FG001|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
10935807|NCT00325403|12105235|FG000|NOT COMPLETED|Overall Study||18
10935808|NCT00325403|12105236|FG001|NOT COMPLETED|Overall Study||51
10935809|NCT00325416|12105246|FG000|STARTED|Phase I: Dose Escalation||70
10935810|NCT00325416|12105247|FG001|STARTED|Phase I: Dose Escalation||60
10935811|NCT00325416|12105246|FG000|COMPLETED|Phase I: Dose Escalation||48
10935812|NCT00325416|12105247|FG001|COMPLETED|Phase I: Dose Escalation||44
10935813|NCT00325416|12105246|FG000|NOT COMPLETED|Phase I: Dose Escalation||22
10935814|NCT00325416|12105247|FG001|NOT COMPLETED|Phase I: Dose Escalation||16
10935815|NCT00325416|12105246|FG000|STARTED|Phase II: Treatment at MTD||78
10935816|NCT00325416|12105247|FG001|STARTED|Phase II: Treatment at MTD||42
10935817|NCT00325416|12105246|FG000|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
10935818|NCT00325416|12105247|FG001|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
10935819|NCT00325416|12105246|FG000|Enrolled During Phase II|Phase II: Treatment at MTD||40
10935820|NCT00325416|12105247|FG001|Enrolled During Phase II|Phase II: Treatment at MTD||8
10935821|NCT00325416|12105246|FG000|COMPLETED|Phase II: Treatment at MTD||78
10935822|NCT00325416|12105247|FG001|COMPLETED|Phase II: Treatment at MTD||40
10935823|NCT00325416|12105246|FG000|NOT COMPLETED|Phase II: Treatment at MTD||0
10935824|NCT00325416|12105247|FG001|NOT COMPLETED|Phase II: Treatment at MTD||2
10935825|NCT00325442|12105255|FG000|STARTED|Overall Study||176
10935826|NCT00325442|12105256|FG001|STARTED|Overall Study||174
10935827|NCT00325442|12105255|FG000|COMPLETED|Overall Study||167
10935828|NCT00325442|12105256|FG001|COMPLETED|Overall Study||153
10935829|NCT00325442|12105255|FG000|NOT COMPLETED|Overall Study||9
10935830|NCT00325442|12105256|FG001|NOT COMPLETED|Overall Study||21
10935831|NCT00325468|12105270|FG000|STARTED|Overall Study||23
10935832|NCT00325468|12105271|FG001|STARTED|Overall Study||17
10935833|NCT00325468|12105272|FG002|STARTED|Overall Study||14
10935834|NCT00325468|12105273|FG003|STARTED|Overall Study||124
10935835|NCT00325468|12105274|FG004|STARTED|Overall Study||22
10935836|NCT00325468|12105270|FG000|COMPLETED|Overall Study||12
10935837|NCT00325468|12105271|FG001|COMPLETED|Overall Study||12
10935838|NCT00325468|12105272|FG002|COMPLETED|Overall Study||10
10935839|NCT00325468|12105273|FG003|COMPLETED|Overall Study||90
10935840|NCT00325468|12105274|FG004|COMPLETED|Overall Study||14
10935841|NCT00325468|12105270|FG000|NOT COMPLETED|Overall Study||11
10935842|NCT00325468|12105271|FG001|NOT COMPLETED|Overall Study||5
10935843|NCT00325468|12105272|FG002|NOT COMPLETED|Overall Study||4
10935844|NCT00325468|12105273|FG003|NOT COMPLETED|Overall Study||34
10935845|NCT00325468|12105274|FG004|NOT COMPLETED|Overall Study||8
10935846|NCT00325598|12105289|FG000|STARTED|Overall Study||50
10935847|NCT00325598|12105290|FG001|STARTED|Overall Study||50
10935848|NCT00325598|12105289|FG000|COMPLETED|Overall Study||50
10935849|NCT00325598|12105290|FG001|COMPLETED|Overall Study||50
10935850|NCT00325598|12105289|FG000|NOT COMPLETED|Overall Study||0
10935851|NCT00325598|12105290|FG001|NOT COMPLETED|Overall Study||0
10935852|NCT00325754|12105300|FG000|STARTED|Overall Study||11
10935853|NCT00325754|12105301|FG001|STARTED|Overall Study||11
10935854|NCT00325754|12105300|FG000|COMPLETED|Overall Study||7
10935855|NCT00325754|12105301|FG001|COMPLETED|Overall Study||10
10935856|NCT00325754|12105300|FG000|NOT COMPLETED|Overall Study||4
10935857|NCT00325754|12105301|FG001|NOT COMPLETED|Overall Study||1
10935858|NCT00325780|12105307|FG000|STARTED|Overall Study||1355
10935859|NCT00325780|12105307|FG000|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
10935860|NCT00325780|12105307|FG000|COMPLETED|Overall Study||1200
10935861|NCT00325780|12105307|FG000|NOT COMPLETED|Overall Study||155
10935862|NCT00325819|12105313|FG000|STARTED|Overall Study||185
10935863|NCT00325819|12105314|FG001|STARTED|Overall Study||189
10935864|NCT00325819|12105313|FG000|COMPLETED|Overall Study||176
10935865|NCT00325819|12105314|FG001|COMPLETED|Overall Study||176
10935866|NCT00325819|12105313|FG000|NOT COMPLETED|Overall Study||9
10935867|NCT00325819|12105314|FG001|NOT COMPLETED|Overall Study||13
10935868|NCT00325897|12105324|FG000|STARTED|Overall Study||570
10935869|NCT00325897|12105325|FG001|STARTED|Overall Study||572
10935870|NCT00325897|12105324|FG000|COMPLETED|Overall Study||558
10935871|NCT00325897|12105325|FG001|COMPLETED|Overall Study||559
10935872|NCT00325897|12105324|FG000|NOT COMPLETED|Overall Study||12
10935873|NCT00325897|12105325|FG001|NOT COMPLETED|Overall Study||13
10935874|NCT00326001|12105336|FG000|STARTED|Overall Study||236
10935875|NCT00326001|12105337|FG001|STARTED|Overall Study||227
10935876|NCT00326001|12105336|FG000|COMPLETED|Overall Study||229
10935877|NCT00326001|12105337|FG001|COMPLETED|Overall Study||219
10935878|NCT00326001|12105336|FG000|NOT COMPLETED|Overall Study||7
10935879|NCT00326001|12105337|FG001|NOT COMPLETED|Overall Study||8
10935880|NCT00326118|12105345|FG000|STARTED|Active Phase||324
10935881|NCT00326118|12105346|FG001|STARTED|Active Phase||109
10935882|NCT00326118|12105345|FG000|COMPLETED|Active Phase||320
10935883|NCT00326118|12105346|FG001|COMPLETED|Active Phase||108
10935884|NCT00326118|12105345|FG000|NOT COMPLETED|Active Phase||4
10935885|NCT00326118|12105346|FG001|NOT COMPLETED|Active Phase||1
10935886|NCT00326118|12105345|FG000|STARTED|Year 1 Follow-up||295
10935887|NCT00326118|12105346|FG001|STARTED|Year 1 Follow-up||100
10935888|NCT00326118|12105345|FG000|COMPLETED|Year 1 Follow-up||295
10935889|NCT00326118|12105346|FG001|COMPLETED|Year 1 Follow-up||100
10935890|NCT00326118|12105345|FG000|NOT COMPLETED|Year 1 Follow-up||0
10935891|NCT00326118|12105346|FG001|NOT COMPLETED|Year 1 Follow-up||0
10935892|NCT00326118|12105345|FG000|STARTED|Year 2 Follow-up||270
10935893|NCT00326118|12105346|FG001|STARTED|Year 2 Follow-up||92
10935894|NCT00326118|12105345|FG000|COMPLETED|Year 2 Follow-up||270
10935895|NCT00326118|12105346|FG001|COMPLETED|Year 2 Follow-up||92
10935896|NCT00326118|12105345|FG000|NOT COMPLETED|Year 2 Follow-up||0
10935897|NCT00326118|12105346|FG001|NOT COMPLETED|Year 2 Follow-up||0
10935898|NCT00326118|12105345|FG000|STARTED|Year 3 Follow-up||256
10935899|NCT00326118|12105346|FG001|STARTED|Year 3 Follow-up||89
10935900|NCT00326118|12105345|FG000|COMPLETED|Year 3 Follow-up||256
10935901|NCT00326118|12105346|FG001|COMPLETED|Year 3 Follow-up||89
10935902|NCT00326118|12105345|FG000|NOT COMPLETED|Year 3 Follow-up||0
10935903|NCT00326118|12105346|FG001|NOT COMPLETED|Year 3 Follow-up||0
10935904|NCT00326118|12105345|FG000|STARTED|Year 4 Follow-up||228
10935905|NCT00326118|12105346|FG001|STARTED|Year 4 Follow-up||80
10935906|NCT00326118|12105345|FG000|COMPLETED|Year 4 Follow-up||228
10935907|NCT00326118|12105346|FG001|COMPLETED|Year 4 Follow-up||80
10935908|NCT00326118|12105345|FG000|NOT COMPLETED|Year 4 Follow-up||0
10935909|NCT00326118|12105346|FG001|NOT COMPLETED|Year 4 Follow-up||0
10935910|NCT00326118|12105345|FG000|STARTED|Year 5 Follow up||217
10935911|NCT00326118|12105346|FG001|STARTED|Year 5 Follow up||78
10935912|NCT00326118|12105345|FG000|COMPLETED|Year 5 Follow up||217
10935913|NCT00326118|12105346|FG001|COMPLETED|Year 5 Follow up||78
10935914|NCT00326118|12105345|FG000|NOT COMPLETED|Year 5 Follow up||0
10935915|NCT00326118|12105346|FG001|NOT COMPLETED|Year 5 Follow up||0
10935916|NCT00326170|12105353|FG000|STARTED|Overall Study||34
10935917|NCT00326170|12105353|FG000|COMPLETED|Overall Study||34
10935918|NCT00326170|12105353|FG000|NOT COMPLETED|Overall Study||0
10935919|NCT00326196|12105359|FG000|STARTED|Overall Study||101
10935920|NCT00326196|12105360|FG001|STARTED|Overall Study||97
10935921|NCT00326196|12105359|FG000|COMPLETED|Overall Study||101
10935922|NCT00326196|12105360|FG001|COMPLETED|Overall Study||97
10935923|NCT00326196|12105359|FG000|NOT COMPLETED|Overall Study||0
10935924|NCT00326196|12105360|FG001|NOT COMPLETED|Overall Study||0
10935925|NCT00326209|12105366|FG000|STARTED|Overall Study||393
10935926|NCT00326209|12105366|FG000|Safety Population|Overall Study||388
10935927|NCT00326209|12105366|FG000|COMPLETED|Overall Study||111
10935928|NCT00326209|12105366|FG000|NOT COMPLETED|Overall Study||282
10935929|NCT00326417|12105372|FG000|STARTED|Overall Study||14
10935930|NCT00326417|12105373|FG001|STARTED|Overall Study||41
10935931|NCT00326417|12105374|FG002|STARTED|Overall Study||39
10935932|NCT00326417|12105375|FG003|STARTED|Overall Study||3
10935933|NCT00326417|12105372|FG000|Phase I|Overall Study||6
10935934|NCT00326417|12105373|FG001|Phase I|Overall Study||6
10935935|NCT00326417|12105374|FG002|Phase I|Overall Study||6
10935936|NCT00326417|12105375|FG003|Phase I|Overall Study||3
10935937|NCT00326417|12105372|FG000|Phase II|Overall Study||8
10935938|NCT00326417|12105373|FG001|Phase II|Overall Study||35
10935939|NCT00326417|12105374|FG002|Phase II|Overall Study||33
10935940|NCT00326417|12105375|FG003|Phase II|Overall Study||0
10935941|NCT00326417|12105372|FG000|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
10935942|NCT00326417|12105373|FG001|COMPLETED|Overall Study||41
10935943|NCT00326417|12105374|FG002|COMPLETED|Overall Study||38
10935944|NCT00326417|12105375|FG003|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
10935945|NCT00326417|12105372|FG000|NOT COMPLETED|Overall Study||14
10935946|NCT00326417|12105373|FG001|NOT COMPLETED|Overall Study||0
10935947|NCT00326417|12105374|FG002|NOT COMPLETED|Overall Study||1
10935948|NCT00326417|12105375|FG003|NOT COMPLETED|Overall Study||3
10935949|NCT00326495|12105383|FG000|STARTED|Overall Study||51
10935950|NCT00326495|12105383|FG000|COMPLETED|Overall Study||46
10935951|NCT00326495|12105383|FG000|NOT COMPLETED|Overall Study||5
10935952|NCT00326599|12105391|FG000|STARTED|Overall Study||6
10935953|NCT00326599|12105392|FG001|STARTED|Overall Study||3
10935954|NCT00326599|12105393|FG002|STARTED|Overall Study||58
10935955|NCT00326599|12105394|FG003|STARTED|Overall Study||29
10935956|NCT00326599|12105391|FG000|COMPLETED|Overall Study||0
10935957|NCT00326599|12105392|FG001|COMPLETED|Overall Study||2
10935958|NCT00326599|12105393|FG002|COMPLETED|Overall Study||5
10935959|NCT00326599|12105394|FG003|COMPLETED|Overall Study||10
10935960|NCT00326599|12105391|FG000|NOT COMPLETED|Overall Study||6
10935961|NCT00326599|12105392|FG001|NOT COMPLETED|Overall Study||1
10935962|NCT00326599|12105393|FG002|NOT COMPLETED|Overall Study||53
10935963|NCT00326599|12105394|FG003|NOT COMPLETED|Overall Study||19
10935964|NCT00326612|12105405|FG000|STARTED|Overall Study||179
10935965|NCT00326612|12105406|FG001|STARTED|Overall Study||179
10935966|NCT00326612|12105405|FG000|COMPLETED|Overall Study||50
10935967|NCT00326612|12105406|FG001|COMPLETED|Overall Study||42
10935968|NCT00326612|12105405|FG000|NOT COMPLETED|Overall Study||129
10935969|NCT00326612|12105406|FG001|NOT COMPLETED|Overall Study||137
10935970|NCT00326716|12105418|FG000|STARTED|Pre-Natal Mothers||20
10935971|NCT00326716|12105419|FG001|STARTED|Pre-Natal Mothers||21
10935972|NCT00326716|12105420|FG002|STARTED|Pre-Natal Mothers||0
10935973|NCT00326716|12105421|FG003|STARTED|Pre-Natal Mothers||0
10935974|NCT00326716|12105418|FG000|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
10935975|NCT00326716|12105419|FG001|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
10935976|NCT00326716|12105420|FG002|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
10935977|NCT00326716|12105421|FG003|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
10935978|NCT00326716|12105418|FG000|NOT COMPLETED|Pre-Natal Mothers||1
10935979|NCT00326716|12105419|FG001|NOT COMPLETED|Pre-Natal Mothers||2
10935980|NCT00326716|12105420|FG002|NOT COMPLETED|Pre-Natal Mothers||0
10935981|NCT00326716|12105421|FG003|NOT COMPLETED|Pre-Natal Mothers||0
10935982|NCT00326716|12105418|FG000|STARTED|Infants||0
10935983|NCT00326716|12105419|FG001|STARTED|Infants||0
10935984|NCT00326716|12105420|FG002|STARTED|Infants|All infants were followed.|20
10935985|NCT00326716|12105421|FG003|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
10935986|NCT00326716|12105418|FG000|COMPLETED|Infants||0
10935987|NCT00326716|12105419|FG001|COMPLETED|Infants||0
10935988|NCT00326716|12105420|FG002|COMPLETED|Infants||20
10935989|NCT00326716|12105421|FG003|COMPLETED|Infants||20
10935990|NCT00326716|12105418|FG000|NOT COMPLETED|Infants||0
10935991|NCT00326716|12105419|FG001|NOT COMPLETED|Infants||0
10935992|NCT00326716|12105420|FG002|NOT COMPLETED|Infants||0
10935993|NCT00326716|12105421|FG003|NOT COMPLETED|Infants||0
10935994|NCT00326781|12105453|FG000|STARTED|Overall Study||344
10935995|NCT00326781|12105454|FG001|STARTED|Overall Study||330
10935996|NCT00326781|12105453|FG000|COMPLETED|Overall Study||302
10935997|NCT00326781|12105454|FG001|COMPLETED|Overall Study||298
10935998|NCT00326781|12105453|FG000|NOT COMPLETED|Overall Study||42
10935999|NCT00326781|12105454|FG001|NOT COMPLETED|Overall Study||32
10936000|NCT00326872|12105460|FG000|STARTED|Overall Study||26
10936001|NCT00326872|12105460|FG000|COMPLETED|Overall Study||26
10936002|NCT00326872|12105460|FG000|NOT COMPLETED|Overall Study||0
10936003|NCT00326885|12105464|FG000|STARTED|Overall Study||32
10936004|NCT00326885|12105464|FG000|COMPLETED|Overall Study||25
10936005|NCT00326885|12105464|FG000|NOT COMPLETED|Overall Study||7
10936006|NCT00326911|12105471|FG000|STARTED|Overall Study|This number reflects all randomized patients.|30
10936007|NCT00326911|12105472|FG001|STARTED|Overall Study|This number reflects all randomized patients.|31
10936008|NCT00326911|12105471|FG000|COMPLETED|Overall Study|This number reflects all treated patients.|29
10936009|NCT00326911|12105472|FG001|COMPLETED|Overall Study|This number reflects all treated patients.|29
10936010|NCT00326911|12105471|FG000|NOT COMPLETED|Overall Study||1
10936011|NCT00326911|12105472|FG001|NOT COMPLETED|Overall Study||2
10936012|NCT00326924|12105480|FG000|STARTED|Overall Study||188
10936013|NCT00326924|12105481|FG001|STARTED|Overall Study||189
10936014|NCT00326924|12105480|FG000|COMPLETED|Overall Study||187
10936015|NCT00326924|12105481|FG001|COMPLETED|Overall Study||188
10936016|NCT00326924|12105480|FG000|NOT COMPLETED|Overall Study||1
10936017|NCT00326924|12105481|FG001|NOT COMPLETED|Overall Study||1
10936018|NCT00326950|12105487|FG000|STARTED|Overall Study||15
10936019|NCT00326950|12105487|FG000|COMPLETED|Overall Study||14
10936020|NCT00326950|12105487|FG000|NOT COMPLETED|Overall Study||1
10936021|NCT00326963|12105491|FG000|STARTED|Overall Study||140
10936022|NCT00326963|12105491|FG000|COMPLETED|Overall Study||107
10936023|NCT00326963|12105491|FG000|NOT COMPLETED|Overall Study||33
10936024|NCT00327015|12105500|FG000|STARTED|Overall Study||320
10936025|NCT00327015|12105501|FG001|STARTED|Overall Study||323
10936026|NCT00327015|12105502|FG002|STARTED|Overall Study||335
10936027|NCT00327015|12105503|FG003|STARTED|Overall Study||328
10936028|NCT00327015|12105500|FG000|Completed Study Without Being Rescued|Overall Study||179
10936029|NCT00327015|12105501|FG001|Completed Study Without Being Rescued|Overall Study||177
10936030|NCT00327015|12105502|FG002|Completed Study Without Being Rescued|Overall Study||113
10936031|NCT00327015|12105503|FG003|Completed Study Without Being Rescued|Overall Study||144
10936032|NCT00327015|12105500|FG000|COMPLETED|Overall Study||229
10936033|NCT00327015|12105501|FG001|COMPLETED|Overall Study||231
10936034|NCT00327015|12105502|FG002|COMPLETED|Overall Study||209
10936035|NCT00327015|12105503|FG003|COMPLETED|Overall Study||219
10936036|NCT00327015|12105500|FG000|NOT COMPLETED|Overall Study||91
10936037|NCT00327015|12105501|FG001|NOT COMPLETED|Overall Study||92
10936038|NCT00327015|12105502|FG002|NOT COMPLETED|Overall Study||126
10936039|NCT00327015|12105503|FG003|NOT COMPLETED|Overall Study||109
10936040|NCT00327171|12105515|FG000|STARTED|Overall Study||109
10936041|NCT00327171|12105516|FG001|STARTED|Overall Study||109
10936042|NCT00327171|12105515|FG000|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
10936043|NCT00327171|12105516|FG001|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
10936044|NCT00327171|12105515|FG000|NOT COMPLETED|Overall Study||108
10936045|NCT00327171|12105516|FG001|NOT COMPLETED|Overall Study||109
10936046|NCT00327340|12105524|FG000|STARTED|Overall Study||23
10936047|NCT00327340|12105525|FG001|STARTED|Overall Study||46
10936048|NCT00327340|12105524|FG000|COMPLETED|Overall Study||8
10936049|NCT00327340|12105525|FG001|COMPLETED|Overall Study||16
10936050|NCT00327340|12105524|FG000|NOT COMPLETED|Overall Study||15
10936051|NCT00327340|12105525|FG001|NOT COMPLETED|Overall Study||30
10936052|NCT00327392|12105533|FG000|STARTED|Overall Study||123
10936053|NCT00327392|12105533|FG000|COMPLETED|Overall Study||123
10936054|NCT00327392|12105533|FG000|NOT COMPLETED|Overall Study||0
10936055|NCT00327444|12105539|FG000|STARTED|Double Blind Treatment (DB) Period||26
10936056|NCT00327444|12105540|FG001|STARTED|Double Blind Treatment (DB) Period||29
10936057|NCT00327444|12105539|FG000|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
10936058|NCT00327444|12105540|FG001|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
10936059|NCT00327444|12105539|FG000|COMPLETED|Double Blind Treatment (DB) Period||0
10936060|NCT00327444|12105540|FG001|COMPLETED|Double Blind Treatment (DB) Period||0
10936061|NCT00327444|12105539|FG000|NOT COMPLETED|Double Blind Treatment (DB) Period||26
10936062|NCT00327444|12105540|FG001|NOT COMPLETED|Double Blind Treatment (DB) Period||29
10936063|NCT00327444|12105539|FG000|STARTED|Open Label Treatment (OL) Period||11
10936064|NCT00327444|12105540|FG001|STARTED|Open Label Treatment (OL) Period||10
10936065|NCT00327444|12105539|FG000|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
10936066|NCT00327444|12105540|FG001|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
10936067|NCT00327444|12105539|FG000|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
10936068|NCT00327444|12105540|FG001|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
10936069|NCT00327444|12105539|FG000|NOT COMPLETED|Open Label Treatment (OL) Period||11
10936070|NCT00327444|12105540|FG001|NOT COMPLETED|Open Label Treatment (OL) Period||10
10936071|NCT00327470|12105550|FG000|STARTED|Overall Study||107
10936072|NCT00327470|12105551|FG001|STARTED|Overall Study||181
10936073|NCT00327470|12105550|FG000|Treated|Overall Study||107
10936074|NCT00327470|12105551|FG001|Treated|Overall Study||179
10936075|NCT00327470|12105550|FG000|COMPLETED|Overall Study||78
10936076|NCT00327470|12105551|FG001|COMPLETED|Overall Study||118
10936077|NCT00327470|12105550|FG000|NOT COMPLETED|Overall Study||29
10936078|NCT00327470|12105551|FG001|NOT COMPLETED|Overall Study||63
10936079|NCT00327717|12105559|FG000|STARTED|Overall Study||120
10936080|NCT00327717|12105560|FG001|STARTED|Overall Study||120
10936081|NCT00327717|12105559|FG000|COMPLETED|Overall Study||111
10936082|NCT00327717|12105560|FG001|COMPLETED|Overall Study||106
10936083|NCT00327717|12105559|FG000|NOT COMPLETED|Overall Study||9
10936084|NCT00327717|12105560|FG001|NOT COMPLETED|Overall Study||14
10936085|NCT00328016|12105568|FG000|STARTED|Overall Study||23
10936086|NCT00328016|12105569|FG001|STARTED|Overall Study||21
10936087|NCT00328016|12105568|FG000|COMPLETED|Overall Study||23
10936088|NCT00328016|12105569|FG001|COMPLETED|Overall Study||21
10936089|NCT00328016|12105568|FG000|NOT COMPLETED|Overall Study||0
10936090|NCT00328016|12105569|FG001|NOT COMPLETED|Overall Study||0
10936091|NCT00328042|12105578|FG000|STARTED|Overall Study||69
10936092|NCT00328042|12105579|FG001|STARTED|Overall Study||65
10936093|NCT00328042|12105578|FG000|COMPLETED|Overall Study||69
10936094|NCT00328042|12105579|FG001|COMPLETED|Overall Study||63
10936095|NCT00328042|12105578|FG000|NOT COMPLETED|Overall Study||0
10936096|NCT00328042|12105579|FG001|NOT COMPLETED|Overall Study||2
10936097|NCT00328094|12105589|FG000|STARTED|Overall Study||117
10936098|NCT00328094|12105590|FG001|STARTED|Overall Study||125
10936099|NCT00328094|12105589|FG000|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
10936100|NCT00328094|12105590|FG001|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
10936101|NCT00328094|12105589|FG000|NOT COMPLETED|Overall Study||3
10936102|NCT00328094|12105590|FG001|NOT COMPLETED|Overall Study||3
10936103|NCT00328172|12105601|FG000|STARTED|Overall Study||67
10936104|NCT00328172|12105602|FG001|STARTED|Overall Study||58
10936105|NCT00328172|12105603|FG002|STARTED|Overall Study||57
10936106|NCT00328172|12105604|FG003|STARTED|Overall Study||55
10936107|NCT00328172|12105605|FG004|STARTED|Overall Study||65
10936108|NCT00328172|12105601|FG000|COMPLETED|Overall Study||45
10936109|NCT00328172|12105602|FG001|COMPLETED|Overall Study||44
10936110|NCT00328172|12105603|FG002|COMPLETED|Overall Study||47
10936111|NCT00328172|12105604|FG003|COMPLETED|Overall Study||42
10936112|NCT00328172|12105605|FG004|COMPLETED|Overall Study||60
10936113|NCT00328172|12105601|FG000|NOT COMPLETED|Overall Study||22
10936114|NCT00328172|12105602|FG001|NOT COMPLETED|Overall Study||14
10936115|NCT00328172|12105603|FG002|NOT COMPLETED|Overall Study||10
10936116|NCT00328172|12105604|FG003|NOT COMPLETED|Overall Study||13
10936117|NCT00328172|12105605|FG004|NOT COMPLETED|Overall Study||5
10936118|NCT00328198|12105617|FG000|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
10936119|NCT00328198|12105617|FG000|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
10936120|NCT00328198|12105617|FG000|NOT COMPLETED|Treatment||38
10936121|NCT00328198|12105617|FG000|STARTED|Follow-up|Eight participants did not enter Follow-up|78
10936122|NCT00328198|12105617|FG000|COMPLETED|Follow-up||43
10936123|NCT00328198|12105617|FG000|NOT COMPLETED|Follow-up||35
10936124|NCT00328263|12105623|FG000|STARTED|Overall Study||216
10936125|NCT00328263|12105624|FG001|STARTED|Overall Study||221
10936126|NCT00328263|12105623|FG000|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
10936127|NCT00328263|12105624|FG001|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
10936128|NCT00328263|12105623|FG000|NOT COMPLETED|Overall Study||3
10936129|NCT00328263|12105624|FG001|NOT COMPLETED|Overall Study||4
10936130|NCT00328510|12105632|FG000|STARTED|Overall Study||42
10936131|NCT00328510|12105633|FG001|STARTED|Overall Study||41
10936132|NCT00328510|12105632|FG000|COMPLETED|Overall Study||32
10936133|NCT00328510|12105633|FG001|COMPLETED|Overall Study||37
10936134|NCT00328510|12105632|FG000|NOT COMPLETED|Overall Study||10
10936135|NCT00328510|12105633|FG001|NOT COMPLETED|Overall Study||4
10936136|NCT00328562|12105639|FG000|STARTED|Overall Study||13
10936137|NCT00328562|12105639|FG000|COMPLETED|Overall Study||12
10936138|NCT00328562|12105639|FG000|NOT COMPLETED|Overall Study||1
10936139|NCT00328614|12105649|FG000|STARTED|Overall Study||4
10936140|NCT00328614|12105650|FG001|STARTED|Overall Study||4
10936141|NCT00328614|12105651|FG002|STARTED|Overall Study||6
10936142|NCT00328614|12105652|FG003|STARTED|Overall Study||6
10936143|NCT00328614|12105653|FG004|STARTED|Overall Study||6
10936144|NCT00328614|12105654|FG005|STARTED|Overall Study||6
10936145|NCT00328614|12105649|FG000|COMPLETED|Overall Study||4
10936146|NCT00328614|12105650|FG001|COMPLETED|Overall Study||4
10936147|NCT00328614|12105651|FG002|COMPLETED|Overall Study||6
10936148|NCT00328614|12105652|FG003|COMPLETED|Overall Study||5
10936149|NCT00328614|12105653|FG004|COMPLETED|Overall Study||5
10936150|NCT00328614|12105654|FG005|COMPLETED|Overall Study||5
10936151|NCT00328614|12105649|FG000|NOT COMPLETED|Overall Study||0
10936152|NCT00328614|12105650|FG001|NOT COMPLETED|Overall Study||0
10936153|NCT00328614|12105651|FG002|NOT COMPLETED|Overall Study||0
10936154|NCT00328614|12105652|FG003|NOT COMPLETED|Overall Study||1
10936155|NCT00328614|12105653|FG004|NOT COMPLETED|Overall Study||1
10936156|NCT00328614|12105654|FG005|NOT COMPLETED|Overall Study||1
10936157|NCT00328627|12105675|FG000|STARTED|Overall Study||129
10936158|NCT00328627|12105676|FG001|STARTED|Overall Study||128
10936159|NCT00328627|12105677|FG002|STARTED|Overall Study||129
10936160|NCT00328627|12105678|FG003|STARTED|Overall Study||130
10936161|NCT00328627|12105679|FG004|STARTED|Overall Study||130
10936162|NCT00328627|12105680|FG005|STARTED|Overall Study||130
10936163|NCT00328627|12105681|FG006|STARTED|Overall Study||129
10936164|NCT00328627|12105682|FG007|STARTED|Overall Study||130
10936165|NCT00328627|12105683|FG008|STARTED|Overall Study||130
10936166|NCT00328627|12105684|FG009|STARTED|Overall Study||129
10936167|NCT00328627|12105685|FG010|STARTED|Overall Study||130
10936168|NCT00328627|12105686|FG011|STARTED|Overall Study||130
10936169|NCT00328627|12105675|FG000|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
10936170|NCT00328627|12105676|FG001|Safety Set|Overall Study||128
10936171|NCT00328627|12105677|FG002|Safety Set|Overall Study||129
10936172|NCT00328627|12105678|FG003|Safety Set|Overall Study||129
10936173|NCT00328627|12105679|FG004|Safety Set|Overall Study||130
10936174|NCT00328627|12105680|FG005|Safety Set|Overall Study||130
10936175|NCT00328627|12105681|FG006|Safety Set|Overall Study||129
10936176|NCT00328627|12105682|FG007|Safety Set|Overall Study||130
10936177|NCT00328627|12105683|FG008|Safety Set|Overall Study||130
10936178|NCT00328627|12105684|FG009|Safety Set|Overall Study||129
10936179|NCT00328627|12105685|FG010|Safety Set|Overall Study||130
10936180|NCT00328627|12105686|FG011|Safety Set|Overall Study||130
10936181|NCT00328627|12105675|FG000|COMPLETED|Overall Study||70
10936182|NCT00328627|12105676|FG001|COMPLETED|Overall Study||97
10936183|NCT00328627|12105677|FG002|COMPLETED|Overall Study||101
10936184|NCT00328627|12105678|FG003|COMPLETED|Overall Study||93
10936185|NCT00328627|12105679|FG004|COMPLETED|Overall Study||115
10936186|NCT00328627|12105680|FG005|COMPLETED|Overall Study||110
10936187|NCT00328627|12105681|FG006|COMPLETED|Overall Study||94
10936188|NCT00328627|12105682|FG007|COMPLETED|Overall Study||116
10936189|NCT00328627|12105683|FG008|COMPLETED|Overall Study||113
10936190|NCT00328627|12105684|FG009|COMPLETED|Overall Study||97
10936191|NCT00328627|12105685|FG010|COMPLETED|Overall Study||112
10936192|NCT00328627|12105686|FG011|COMPLETED|Overall Study||114
10936193|NCT00328627|12105675|FG000|NOT COMPLETED|Overall Study||59
10936194|NCT00328627|12105676|FG001|NOT COMPLETED|Overall Study||31
10936195|NCT00328627|12105677|FG002|NOT COMPLETED|Overall Study||28
10936196|NCT00328627|12105678|FG003|NOT COMPLETED|Overall Study||37
10936197|NCT00328627|12105679|FG004|NOT COMPLETED|Overall Study||15
10936198|NCT00328627|12105680|FG005|NOT COMPLETED|Overall Study||20
10936199|NCT00328627|12105681|FG006|NOT COMPLETED|Overall Study||35
10936200|NCT00328627|12105682|FG007|NOT COMPLETED|Overall Study||14
10936201|NCT00328627|12105683|FG008|NOT COMPLETED|Overall Study||17
10936202|NCT00328627|12105684|FG009|NOT COMPLETED|Overall Study||32
10936203|NCT00328627|12105685|FG010|NOT COMPLETED|Overall Study||18
10936204|NCT00328627|12105686|FG011|NOT COMPLETED|Overall Study||16
10936205|NCT00328770|12105720|FG000|STARTED|Overall Study||70
10936206|NCT00328770|12105720|FG000|COMPLETED|Overall Study||70
10936207|NCT00328770|12105720|FG000|NOT COMPLETED|Overall Study||0
10936208|NCT00328783|12105725|FG000|STARTED|Overall Study||112
10936209|NCT00328783|12105725|FG000|COMPLETED|Overall Study||86
10936210|NCT00328783|12105725|FG000|NOT COMPLETED|Overall Study||26
10936211|NCT00328861|12105733|FG000|STARTED|Overall Study||7
10936212|NCT00328861|12105734|FG001|STARTED|Overall Study||1
10936213|NCT00328861|12105733|FG000|COMPLETED|Overall Study||7
10936214|NCT00328861|12105734|FG001|COMPLETED|Overall Study||1
10936215|NCT00328861|12105733|FG000|NOT COMPLETED|Overall Study||0
10936216|NCT00328861|12105734|FG001|NOT COMPLETED|Overall Study||0
10936217|NCT00328926|12105743|FG000|STARTED|Overall Study||5
10936218|NCT00328926|12105744|FG001|STARTED|Overall Study||3
10936219|NCT00328926|12105745|FG002|STARTED|Overall Study||3
10936220|NCT00328926|12105743|FG000|COMPLETED|Overall Study||3
10936221|NCT00328926|12105744|FG001|COMPLETED|Overall Study||0
10936222|NCT00328926|12105745|FG002|COMPLETED|Overall Study||1
10936223|NCT00328926|12105743|FG000|NOT COMPLETED|Overall Study||2
10936224|NCT00328926|12105744|FG001|NOT COMPLETED|Overall Study||3
10936225|NCT00328926|12105745|FG002|NOT COMPLETED|Overall Study||2
10936226|NCT00329030|12105755|FG000|STARTED|Overall Study||111
10936227|NCT00329030|12105756|FG001|STARTED|Overall Study||113
10936228|NCT00329030|12105755|FG000|COMPLETED|Overall Study||103
10936229|NCT00329030|12105756|FG001|COMPLETED|Overall Study||107
10936230|NCT00329030|12105755|FG000|NOT COMPLETED|Overall Study||8
10936231|NCT00329030|12105756|FG001|NOT COMPLETED|Overall Study||6
10936232|NCT00329160|12105762|FG000|STARTED|Overall Study||214
10936233|NCT00329160|12105762|FG000|Observation Period|Overall Study||214
10936234|NCT00329160|12105762|FG000|Treatment Period|Overall Study||214
10936235|NCT00329160|12105762|FG000|COMPLETED|Overall Study||126
10936236|NCT00329160|12105762|FG000|NOT COMPLETED|Overall Study||88
10936237|NCT00329238|12105768|FG000|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
10936238|NCT00329238|12105769|FG001|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
10936239|NCT00329238|12105768|FG000|COMPLETED|Overall Study||1154
10936240|NCT00329238|12105769|FG001|COMPLETED|Overall Study||1145
10936241|NCT00329238|12105768|FG000|NOT COMPLETED|Overall Study||276
10936242|NCT00329238|12105769|FG001|NOT COMPLETED|Overall Study||281
10936243|NCT00329303|12105779|FG000|STARTED|Overall Study||34
10936244|NCT00329303|12105780|FG001|STARTED|Overall Study||37
10936245|NCT00329303|12105779|FG000|COMPLETED|Overall Study||32
10936246|NCT00329303|12105780|FG001|COMPLETED|Overall Study||35
10936247|NCT00329303|12105779|FG000|NOT COMPLETED|Overall Study||2
10936248|NCT00329303|12105780|FG001|NOT COMPLETED|Overall Study||2
10936249|NCT00329407|12105787|FG000|STARTED|Overall Study||10
10936250|NCT00329407|12105787|FG000|COMPLETED|Overall Study||9
10936251|NCT00329407|12105787|FG000|NOT COMPLETED|Overall Study||1
10936252|NCT00329420|12105794|FG000|STARTED|Re-induction Phase||18
10936253|NCT00329420|12105795|FG001|STARTED|Re-induction Phase||13
10936254|NCT00329420|12105796|FG002|STARTED|Re-induction Phase||15
10936255|NCT00329420|12105794|FG000|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
10936256|NCT00329420|12105795|FG001|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
10936257|NCT00329420|12105796|FG002|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
10936258|NCT00329420|12105794|FG000|NOT COMPLETED|Re-induction Phase||6
10936259|NCT00329420|12105795|FG001|NOT COMPLETED|Re-induction Phase||6
10936260|NCT00329420|12105796|FG002|NOT COMPLETED|Re-induction Phase||8
10936261|NCT00329420|12105794|FG000|STARTED|4-weekly Dosing Phase (Responders Only)||12
10936262|NCT00329420|12105795|FG001|STARTED|4-weekly Dosing Phase (Responders Only)||7
10936263|NCT00329420|12105796|FG002|STARTED|4-weekly Dosing Phase (Responders Only)||7
10936264|NCT00329420|12105794|FG000|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
10936265|NCT00329420|12105795|FG001|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
10936266|NCT00329420|12105796|FG002|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
10936267|NCT00329420|12105794|FG000|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
10936268|NCT00329420|12105795|FG001|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
10936269|NCT00329420|12105796|FG002|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
10936270|NCT00329433|12105808|FG000|STARTED|Overall Study||61
10936271|NCT00329433|12105809|FG001|STARTED|Overall Study||59
10936272|NCT00329433|12105808|FG000|COMPLETED|Overall Study||61
10936273|NCT00329433|12105809|FG001|COMPLETED|Overall Study||59
10936274|NCT00329433|12105808|FG000|NOT COMPLETED|Overall Study||0
10936275|NCT00329433|12105809|FG001|NOT COMPLETED|Overall Study||0
10936276|NCT00329524|12105815|FG000|STARTED|Overall Study||5
10936277|NCT00329524|12105815|FG000|COMPLETED|Overall Study||5
10936278|NCT00329524|12105815|FG000|NOT COMPLETED|Overall Study||0
10936279|NCT00329550|12105822|FG000|STARTED|Overall Study||9
10936280|NCT00329550|12105823|FG001|STARTED|Overall Study||15
10936281|NCT00329550|12105824|FG002|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
10936282|NCT00329550|12105822|FG000|COMPLETED|Overall Study||5
10936283|NCT00329550|12105823|FG001|COMPLETED|Overall Study||11
10936284|NCT00329550|12105824|FG002|COMPLETED|Overall Study||12
10936285|NCT00329550|12105822|FG000|NOT COMPLETED|Overall Study||4
10936286|NCT00329550|12105823|FG001|NOT COMPLETED|Overall Study||4
10936287|NCT00329550|12105824|FG002|NOT COMPLETED|Overall Study||4
10936288|NCT00329602|12105836|FG000|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
10936289|NCT00329602|12105837|FG001|STARTED|26-Week Double-Blind Treatment Phase||197
10936290|NCT00329602|12105838|FG002|STARTED|26-Week Double-Blind Treatment Phase||0
10936291|NCT00329602|12105836|FG000|COMPLETED|26-Week Double-Blind Treatment Phase||88
10936292|NCT00329602|12105837|FG001|COMPLETED|26-Week Double-Blind Treatment Phase||98
10936293|NCT00329602|12105838|FG002|COMPLETED|26-Week Double-Blind Treatment Phase||0
10936294|NCT00329602|12105836|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
10936295|NCT00329602|12105837|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
10936296|NCT00329602|12105838|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
10936297|NCT00329602|12105836|FG000|STARTED|40-Week Open-Label Treatment Phase||0
10936298|NCT00329602|12105837|FG001|STARTED|40-Week Open-Label Treatment Phase||0
10936299|NCT00329602|12105838|FG002|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
10936300|NCT00329602|12105836|FG000|COMPLETED|40-Week Open-Label Treatment Phase||0
10936301|NCT00329602|12105837|FG001|COMPLETED|40-Week Open-Label Treatment Phase||0
10936302|NCT00329602|12105838|FG002|COMPLETED|40-Week Open-Label Treatment Phase||233
10936303|NCT00329602|12105836|FG000|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
10936304|NCT00329602|12105837|FG001|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
10936305|NCT00329602|12105838|FG002|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
10936306|NCT00329641|12105854|FG000|STARTED|Overall Study||25
10936307|NCT00329641|12105854|FG000|Eligible|Overall Study||25
10936308|NCT00329641|12105854|FG000|Eligible and Received Treatment|Overall Study||24
10936309|NCT00329641|12105854|FG000|COMPLETED|Overall Study||19
10936310|NCT00329641|12105854|FG000|NOT COMPLETED|Overall Study||6
10936311|NCT00329719|12105863|FG000|STARTED|Overall Study||12
10936312|NCT00329719|12105864|FG001|STARTED|Overall Study||49
10936313|NCT00329719|12105865|FG002|STARTED|Overall Study||9
10936314|NCT00329719|12105866|FG003|STARTED|Overall Study||45
10936315|NCT00329719|12105863|FG000|COMPLETED|Overall Study||12
10936316|NCT00329719|12105864|FG001|COMPLETED|Overall Study||49
10936317|NCT00329719|12105865|FG002|COMPLETED|Overall Study||9
10936318|NCT00329719|12105866|FG003|COMPLETED|Overall Study||44
10936319|NCT00329719|12105863|FG000|NOT COMPLETED|Overall Study||0
10936320|NCT00329719|12105864|FG001|NOT COMPLETED|Overall Study||0
10936321|NCT00329719|12105865|FG002|NOT COMPLETED|Overall Study||0
10936322|NCT00329719|12105866|FG003|NOT COMPLETED|Overall Study||1
10936323|NCT00329745|12105878|FG000|STARTED|Overall Study||4359
10936324|NCT00329745|12105879|FG001|STARTED|Overall Study||4328
10936325|NCT00329745|12105878|FG000|COMPLETED|Overall Study||4272
10936326|NCT00329745|12105879|FG001|COMPLETED|Overall Study||4226
10936327|NCT00329745|12105878|FG000|NOT COMPLETED|Overall Study||87
10936328|NCT00329745|12105879|FG001|NOT COMPLETED|Overall Study||102
10936329|NCT00329771|12105885|FG000|STARTED|Overall Study||28
10936330|NCT00329771|12105885|FG000|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
10936331|NCT00329771|12105885|FG000|NOT COMPLETED|Overall Study||3
10936332|NCT00329784|12105893|FG000|STARTED|Overall Study||270
10936333|NCT00329784|12105894|FG001|STARTED|Overall Study||272
10936334|NCT00329784|12105895|FG002|STARTED|Overall Study||51
10936335|NCT00329784|12105896|FG003|STARTED|Overall Study||47
10936336|NCT00329784|12105893|FG000|COMPLETED|Overall Study||265
10936337|NCT00329784|12105894|FG001|COMPLETED|Overall Study||267
10936338|NCT00329784|12105895|FG002|COMPLETED|Overall Study||51
10936339|NCT00329784|12105896|FG003|COMPLETED|Overall Study||47
10936340|NCT00329784|12105893|FG000|NOT COMPLETED|Overall Study||5
10936341|NCT00329784|12105894|FG001|NOT COMPLETED|Overall Study||5
10936342|NCT00329784|12105895|FG002|NOT COMPLETED|Overall Study||0
10936343|NCT00329784|12105896|FG003|NOT COMPLETED|Overall Study||0
10936344|NCT00329797|12105910|FG000|STARTED|Overall Study||57
10936345|NCT00329797|12105911|FG001|STARTED|Overall Study||52
10936346|NCT00329797|12105910|FG000|COMPLETED|Overall Study||50
10936347|NCT00329797|12105911|FG001|COMPLETED|Overall Study||46
10936348|NCT00329797|12105910|FG000|NOT COMPLETED|Overall Study||7
10936349|NCT00329797|12105911|FG001|NOT COMPLETED|Overall Study||6
10936350|NCT00329836|12105917|FG000|STARTED|Overall Study||41
10936351|NCT00329836|12105917|FG000|COMPLETED|Overall Study||41
10936352|NCT00329836|12105917|FG000|NOT COMPLETED|Overall Study||0
10936353|NCT00329849|12105923|FG000|STARTED|Overall Study||950
10936354|NCT00329849|12105924|FG001|STARTED|Overall Study||550
10936355|NCT00329849|12105923|FG000|COMPLETED|Overall Study||944
10936356|NCT00329849|12105924|FG001|COMPLETED|Overall Study||546
10936357|NCT00329849|12105923|FG000|NOT COMPLETED|Overall Study||6
10936358|NCT00329849|12105924|FG001|NOT COMPLETED|Overall Study||4
10936359|NCT00329901|12105937|FG000|STARTED|Overall Study||361
10936360|NCT00329901|12105938|FG001|STARTED|Overall Study||354
10936361|NCT00329901|12105939|FG002|STARTED|Overall Study||357
10936362|NCT00329901|12105937|FG000|COMPLETED|Overall Study||352
10936363|NCT00329901|12105938|FG001|COMPLETED|Overall Study||349
10936364|NCT00329901|12105939|FG002|COMPLETED|Overall Study||353
10936365|NCT00329901|12105937|FG000|NOT COMPLETED|Overall Study||9
10936366|NCT00329901|12105938|FG001|NOT COMPLETED|Overall Study||5
10936367|NCT00329901|12105939|FG002|NOT COMPLETED|Overall Study||4
10936368|NCT00330161|12105951|FG000|STARTED|Overall Study||29
10936369|NCT00330161|12105951|FG000|COMPLETED|Overall Study||29
10936370|NCT00330161|12105951|FG000|NOT COMPLETED|Overall Study||0
10936371|NCT00330174|12105957|FG000|STARTED|Overall Study||45
10936372|NCT00330174|12105958|FG001|STARTED|Overall Study||45
10936373|NCT00330174|12105957|FG000|COMPLETED|Overall Study||23
10936374|NCT00330174|12105958|FG001|COMPLETED|Overall Study||26
10936375|NCT00330174|12105957|FG000|NOT COMPLETED|Overall Study||22
10936376|NCT00330174|12105958|FG001|NOT COMPLETED|Overall Study||19
10936377|NCT00330187|12105968|FG000|STARTED|Overall Study||37
10936378|NCT00330187|12105969|FG001|STARTED|Overall Study||36
10936379|NCT00330187|12105970|FG002|STARTED|Overall Study||29
10936380|NCT00330187|12105971|FG003|STARTED|Overall Study||32
10936381|NCT00330187|12105968|FG000|COMPLETED|Overall Study||17
10936382|NCT00330187|12105969|FG001|COMPLETED|Overall Study||18
10936383|NCT00330187|12105970|FG002|COMPLETED|Overall Study||11
10936384|NCT00330187|12105971|FG003|COMPLETED|Overall Study||18
10936385|NCT00330187|12105968|FG000|NOT COMPLETED|Overall Study||20
10936386|NCT00330187|12105969|FG001|NOT COMPLETED|Overall Study||18
10936387|NCT00330187|12105970|FG002|NOT COMPLETED|Overall Study||18
10936388|NCT00330187|12105971|FG003|NOT COMPLETED|Overall Study||14
10936389|NCT00330343|12105981|FG000|STARTED|Overall Study||64
10936390|NCT00330343|12105981|FG000|COMPLETED|Overall Study||59
10936391|NCT00330343|12105981|FG000|NOT COMPLETED|Overall Study||5
10936392|NCT00330382|12105987|FG000|STARTED|Overall Study||67
10936393|NCT00330382|12105988|FG001|STARTED|Overall Study||65
10936394|NCT00330382|12105987|FG000|COMPLETED|Overall Study||43
10936395|NCT00330382|12105988|FG001|COMPLETED|Overall Study||48
10936396|NCT00330382|12105987|FG000|NOT COMPLETED|Overall Study||24
10936397|NCT00330382|12105988|FG001|NOT COMPLETED|Overall Study||17
10936398|NCT00330421|12105995|FG000|STARTED|Overall Study||15
10936399|NCT00330421|12105996|FG001|STARTED|Overall Study||0
10936400|NCT00330421|12105995|FG000|COMPLETED|Overall Study||15
10936401|NCT00330421|12105996|FG001|COMPLETED|Overall Study||0
10936402|NCT00330421|12105995|FG000|NOT COMPLETED|Overall Study||0
10936403|NCT00330421|12105996|FG001|NOT COMPLETED|Overall Study||0
10936404|NCT00330460|12106002|FG000|STARTED|Overall Study||595
10936405|NCT00330460|12106003|FG001|STARTED|Overall Study||594
10936406|NCT00330460|12106002|FG000|COMPLETED|Overall Study||553
10936407|NCT00330460|12106003|FG001|COMPLETED|Overall Study||561
10936408|NCT00330460|12106002|FG000|NOT COMPLETED|Overall Study||42
10936409|NCT00330460|12106003|FG001|NOT COMPLETED|Overall Study||33
10936410|NCT00330551|12106011|FG000|STARTED|Overall Study||40
10936411|NCT00330551|12106012|FG001|STARTED|Overall Study||43
10936412|NCT00330551|12106011|FG000|COMPLETED|Overall Study||30
10936413|NCT00330551|12106012|FG001|COMPLETED|Overall Study||27
10936414|NCT00330551|12106011|FG000|NOT COMPLETED|Overall Study||10
10936415|NCT00330551|12106012|FG001|NOT COMPLETED|Overall Study||16
10936416|NCT00330564|12106020|FG000|STARTED|Overall Study||15
10936417|NCT00330564|12106020|FG000|COMPLETED|Overall Study||15
10936418|NCT00330564|12106020|FG000|NOT COMPLETED|Overall Study||0
10936419|NCT00330616|12106024|FG000|STARTED|Overall Study||35
10936420|NCT00330616|12106024|FG000|COMPLETED|Overall Study||14
10936421|NCT00330616|12106024|FG000|NOT COMPLETED|Overall Study||21
10936422|NCT00330668|12106028|FG000|STARTED|BID Dosing Period||114
10936423|NCT00330668|12106028|FG000|COMPLETED|BID Dosing Period||78
10936424|NCT00330668|12106028|FG000|NOT COMPLETED|BID Dosing Period||36
10936425|NCT00330668|12106028|FG000|STARTED|QD Dosing Period||78
10936426|NCT00330668|12106028|FG000|COMPLETED|QD Dosing Period||0
10936427|NCT00330668|12106028|FG000|NOT COMPLETED|QD Dosing Period||78
10936428|NCT00330681|12106034|FG000|STARTED|Overall Study||102
10936429|NCT00330681|12106035|FG001|STARTED|Overall Study||104
10936430|NCT00330681|12106034|FG000|COMPLETED|Overall Study||93
10936431|NCT00330681|12106035|FG001|COMPLETED|Overall Study||90
10936432|NCT00330681|12106034|FG000|NOT COMPLETED|Overall Study||9
10936433|NCT00330681|12106035|FG001|NOT COMPLETED|Overall Study||14
10936434|NCT00330733|12106043|FG000|STARTED|Overall Study||37
10936435|NCT00330733|12106044|FG001|STARTED|Overall Study||34
10936436|NCT00330733|12106043|FG000|Received Study Medication|Overall Study||36
10936437|NCT00330733|12106044|FG001|Received Study Medication|Overall Study||34
10936438|NCT00330733|12106043|FG000|COMPLETED|Overall Study||30
10936439|NCT00330733|12106044|FG001|COMPLETED|Overall Study||29
10936440|NCT00330733|12106043|FG000|NOT COMPLETED|Overall Study||7
10936441|NCT00330733|12106044|FG001|NOT COMPLETED|Overall Study||5
10936442|NCT00330759|12106052|FG000|STARTED|Overall Study||890
10936443|NCT00330759|12106053|FG001|STARTED|Overall Study||886
10936444|NCT00330759|12106052|FG000|Received Investigational Product|Overall Study||878
10936445|NCT00330759|12106053|FG001|Received Investigational Product|Overall Study||878
10936446|NCT00330759|12106052|FG000|COMPLETED|Overall Study||178
10936447|NCT00330759|12106053|FG001|COMPLETED|Overall Study||180
10936448|NCT00330759|12106052|FG000|NOT COMPLETED|Overall Study||712
10936449|NCT00330759|12106053|FG001|NOT COMPLETED|Overall Study||706
10936450|NCT00330863|12106061|FG000|STARTED|Overall Study||153
10936451|NCT00330863|12106062|FG001|STARTED|Overall Study||152
10936452|NCT00330863|12106061|FG000|COMPLETED|Overall Study||72
10936453|NCT00330863|12106062|FG001|COMPLETED|Overall Study||72
10936454|NCT00330863|12106061|FG000|NOT COMPLETED|Overall Study||81
10936455|NCT00330863|12106062|FG001|NOT COMPLETED|Overall Study||80
10936456|NCT00330876|12106068|FG000|STARTED|Overall Study||449
10936457|NCT00330876|12106069|FG001|STARTED|Overall Study||90
10936458|NCT00330876|12106068|FG000|COMPLETED|Overall Study||378
10936459|NCT00330876|12106069|FG001|COMPLETED|Overall Study||77
10936460|NCT00330876|12106068|FG000|NOT COMPLETED|Overall Study||71
10936461|NCT00330876|12106069|FG001|NOT COMPLETED|Overall Study||13
10936462|NCT00330915|12106075|FG000|STARTED|Overall Study||37
10936463|NCT00330915|12106075|FG000|COMPLETED|Overall Study||37
10936464|NCT00330915|12106075|FG000|NOT COMPLETED|Overall Study||0
10936465|NCT00330928|12106079|FG000|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
10936466|NCT00330928|12106079|FG000|7 Day Phone Contact|Overall Study||99
10936467|NCT00330928|12106079|FG000|1 Year Phone Contact|Overall Study||89
10936468|NCT00330928|12106079|FG000|COMPLETED|Overall Study||89
10936469|NCT00330928|12106079|FG000|NOT COMPLETED|Overall Study||17
10936470|NCT00330967|12106085|FG000|STARTED|Overall Study||0
10936471|NCT00330967|12106086|FG001|STARTED|Overall Study||25
10936472|NCT00330967|12106085|FG000|COMPLETED|Overall Study||0
10936473|NCT00330967|12106086|FG001|COMPLETED|Overall Study||11
10936474|NCT00330967|12106085|FG000|NOT COMPLETED|Overall Study||0
10936475|NCT00330967|12106086|FG001|NOT COMPLETED|Overall Study||14
10936476|NCT00331006|12106092|FG000|STARTED|Screening Phase||23
10936477|NCT00331006|12106092|FG000|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
10936478|NCT00331006|12106092|FG000|NOT COMPLETED|Screening Phase||7
10936479|NCT00331006|12106092|FG000|STARTED|Treatment Phase||16
10936480|NCT00331006|12106092|FG000|COMPLETED|Treatment Phase||15
10936481|NCT00331006|12106092|FG000|NOT COMPLETED|Treatment Phase||1
10936482|NCT00331006|12106092|FG000|STARTED|Follow-Up Phase I||15
10936483|NCT00331006|12106092|FG000|COMPLETED|Follow-Up Phase I||14
10936484|NCT00331006|12106092|FG000|NOT COMPLETED|Follow-Up Phase I||1
10936485|NCT00331006|12106092|FG000|STARTED|Follow-Up Phase II||14
10936486|NCT00331006|12106092|FG000|COMPLETED|Follow-Up Phase II||11
10936487|NCT00331006|12106092|FG000|NOT COMPLETED|Follow-Up Phase II||3
10936488|NCT00331136|12106100|FG000|STARTED|Overall Study||15
10936489|NCT00331136|12106101|FG001|STARTED|Overall Study||15
10936490|NCT00331136|12106102|FG002|STARTED|Overall Study||15
10936491|NCT00331136|12106103|FG003|STARTED|Overall Study||15
10936492|NCT00331136|12106100|FG000|COMPLETED|Overall Study||10
10936493|NCT00331136|12106101|FG001|COMPLETED|Overall Study||8
10936494|NCT00331136|12106102|FG002|COMPLETED|Overall Study||15
10936495|NCT00331136|12106103|FG003|COMPLETED|Overall Study||14
10936496|NCT00331136|12106100|FG000|NOT COMPLETED|Overall Study||5
10936497|NCT00331136|12106101|FG001|NOT COMPLETED|Overall Study||7
10936498|NCT00331136|12106102|FG002|NOT COMPLETED|Overall Study||0
10936499|NCT00331136|12106103|FG003|NOT COMPLETED|Overall Study||1
10936500|NCT00331162|12106115|FG000|STARTED|Overall Study||113
10936501|NCT00331162|12106116|FG001|STARTED|Overall Study||109
10936502|NCT00331162|12106115|FG000|COMPLETED|Overall Study||113
10936503|NCT00331162|12106116|FG001|COMPLETED|Overall Study||109
10936504|NCT00331162|12106115|FG000|NOT COMPLETED|Overall Study||0
10936505|NCT00331162|12106116|FG001|NOT COMPLETED|Overall Study||0
10936506|NCT00331344|12106122|FG000|STARTED|Phase I||3
10936507|NCT00331344|12106123|FG001|STARTED|Phase I||3
10936508|NCT00331344|12106124|FG002|STARTED|Phase I||3
10936509|NCT00331344|12106125|FG003|STARTED|Phase I||6
10936510|NCT00331344|12106126|FG004|STARTED|Phase I||6
10936511|NCT00331344|12106127|FG005|STARTED|Phase I||5
10936512|NCT00331344|12106128|FG006|STARTED|Phase I||4
10936513|NCT00331344|12106129|FG007|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
10936514|NCT00331344|12106130|FG008|STARTED|Phase I||0
10936515|NCT00331344|12106122|FG000|COMPLETED|Phase I||3
10936516|NCT00331344|12106123|FG001|COMPLETED|Phase I||3
10936517|NCT00331344|12106124|FG002|COMPLETED|Phase I||3
10936518|NCT00331344|12106125|FG003|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
10936519|NCT00331344|12106126|FG004|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
10936520|NCT00331344|12106127|FG005|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
10936521|NCT00331344|12106128|FG006|COMPLETED|Phase I||4
10936522|NCT00331344|12106129|FG007|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
10936523|NCT00331344|12106130|FG008|COMPLETED|Phase I||0
10936524|NCT00331344|12106122|FG000|NOT COMPLETED|Phase I||0
10936525|NCT00331344|12106123|FG001|NOT COMPLETED|Phase I||0
10936526|NCT00331344|12106124|FG002|NOT COMPLETED|Phase I||0
10936527|NCT00331344|12106125|FG003|NOT COMPLETED|Phase I||1
10936528|NCT00331344|12106126|FG004|NOT COMPLETED|Phase I||2
10936529|NCT00331344|12106127|FG005|NOT COMPLETED|Phase I||2
10936530|NCT00331344|12106128|FG006|NOT COMPLETED|Phase I||0
10936531|NCT00331344|12106129|FG007|NOT COMPLETED|Phase I||1
10936532|NCT00331344|12106130|FG008|NOT COMPLETED|Phase I||0
10936533|NCT00331344|12106122|FG000|STARTED|Phase II||0
10936534|NCT00331344|12106123|FG001|STARTED|Phase II||0
10936535|NCT00331344|12106124|FG002|STARTED|Phase II||0
10936536|NCT00331344|12106125|FG003|STARTED|Phase II||0
10936537|NCT00331344|12106126|FG004|STARTED|Phase II||0
10936538|NCT00331344|12106127|FG005|STARTED|Phase II||0
10936539|NCT00331344|12106128|FG006|STARTED|Phase II||0
10936540|NCT00331344|12106129|FG007|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
10936541|NCT00331344|12106130|FG008|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
10936542|NCT00331344|12106122|FG000|COMPLETED|Phase II||0
10936543|NCT00331344|12106123|FG001|COMPLETED|Phase II||0
10936544|NCT00331344|12106124|FG002|COMPLETED|Phase II||0
10936545|NCT00331344|12106125|FG003|COMPLETED|Phase II||0
10936546|NCT00331344|12106126|FG004|COMPLETED|Phase II||0
10936547|NCT00331344|12106127|FG005|COMPLETED|Phase II||0
10936548|NCT00331344|12106128|FG006|COMPLETED|Phase II||0
10936549|NCT00331344|12106129|FG007|COMPLETED|Phase II||6
10936550|NCT00331344|12106130|FG008|COMPLETED|Phase II||48
10936551|NCT00331344|12106122|FG000|NOT COMPLETED|Phase II||0
10936552|NCT00331344|12106123|FG001|NOT COMPLETED|Phase II||0
10936553|NCT00331344|12106124|FG002|NOT COMPLETED|Phase II||0
10936554|NCT00331344|12106125|FG003|NOT COMPLETED|Phase II||0
10936555|NCT00331344|12106126|FG004|NOT COMPLETED|Phase II||0
10936556|NCT00331344|12106127|FG005|NOT COMPLETED|Phase II||0
10936557|NCT00331344|12106128|FG006|NOT COMPLETED|Phase II||0
10936558|NCT00331344|12106129|FG007|NOT COMPLETED|Phase II||0
10936559|NCT00331344|12106130|FG008|NOT COMPLETED|Phase II||4
10936560|NCT00331409|12106143|FG000|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
10936561|NCT00331409|12106143|FG000|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
10936562|NCT00331409|12106143|FG000|NOT COMPLETED|Overall Study||4
10936563|NCT00331422|12106147|FG000|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
10936564|NCT00331422|12106147|FG000|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
10936565|NCT00331422|12106147|FG000|NOT COMPLETED|Overall Study||5
10936566|NCT00331552|12106154|FG000|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
10936567|NCT00331552|12106155|FG001|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
10936568|NCT00331552|12106154|FG000|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
10936569|NCT00331552|12106155|FG001|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
10936570|NCT00331552|12106154|FG000|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
10936571|NCT00331552|12106155|FG001|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
10936572|NCT00331552|12106154|FG000|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
10936573|NCT00331552|12106155|FG001|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
10936574|NCT00331552|12106154|FG000|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
10936575|NCT00331552|12106155|FG001|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
10936576|NCT00331552|12106154|FG000|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
10936577|NCT00331552|12106155|FG001|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
10936578|NCT00331552|12106154|FG000|STARTED|Period 3: Phase II||24
10936579|NCT00331552|12106155|FG001|STARTED|Period 3: Phase II||0
10936580|NCT00331552|12106154|FG000|COMPLETED|Period 3: Phase II||22
10936581|NCT00331552|12106155|FG001|COMPLETED|Period 3: Phase II||0
10936582|NCT00331552|12106154|FG000|NOT COMPLETED|Period 3: Phase II||2
10936583|NCT00331552|12106155|FG001|NOT COMPLETED|Period 3: Phase II||0
10936584|NCT00331630|12106166|FG000|STARTED|Treatment on Study||30
10936585|NCT00331630|12106166|FG000|Completed 1st Cycle|Treatment on Study||30
10936586|NCT00331630|12106166|FG000|Completed 4 Cycles|Treatment on Study||30
10936587|NCT00331630|12106166|FG000|COMPLETED|Treatment on Study||30
10936588|NCT00331630|12106166|FG000|NOT COMPLETED|Treatment on Study||0
10936589|NCT00331630|12106166|FG000|STARTED|Evaluated for and Completed SOC Surgery||30
10936590|NCT00331630|12106166|FG000|COMPLETED|Evaluated for and Completed SOC Surgery||28
10936591|NCT00331630|12106166|FG000|NOT COMPLETED|Evaluated for and Completed SOC Surgery||2
10936592|NCT00331630|12106166|FG000|STARTED|Follow up for 5 Years|One patient did not enter follow up as was lost to follow up|29
10936593|NCT00331630|12106166|FG000|COMPLETED|Follow up for 5 Years||0
10936594|NCT00331630|12106166|FG000|NOT COMPLETED|Follow up for 5 Years||29
10936595|NCT00331682|12106170|FG000|STARTED|Overall Study||10
10936596|NCT00331682|12106170|FG000|COMPLETED|Overall Study||9
10936597|NCT00331682|12106170|FG000|NOT COMPLETED|Overall Study||1
10936598|NCT00331760|12106176|FG000|STARTED|Overall Study||58
10936599|NCT00331760|12106177|FG001|STARTED|Overall Study||48
10936600|NCT00331760|12106176|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
10936601|NCT00331760|12106177|FG001|COMPLETED|Overall Study||40
10936602|NCT00331760|12106176|FG000|NOT COMPLETED|Overall Study||15
10936603|NCT00331760|12106177|FG001|NOT COMPLETED|Overall Study||8
10936604|NCT00331799|12106184|FG000|STARTED|Overall Study||18
10936605|NCT00331799|12106184|FG000|COMPLETED|Overall Study||15
10936606|NCT00331799|12106184|FG000|NOT COMPLETED|Overall Study||3
10936607|NCT00331864|12106190|FG000|STARTED|Overall Study||513
10936608|NCT00331864|12106191|FG001|STARTED|Overall Study||18
10936609|NCT00331864|12106190|FG000|COMPLETED|Overall Study||455
10936610|NCT00331864|12106191|FG001|COMPLETED|Overall Study||14
10936611|NCT00331864|12106190|FG000|NOT COMPLETED|Overall Study||58
10936612|NCT00331864|12106191|FG001|NOT COMPLETED|Overall Study||4
10936613|NCT00332163|12106199|FG000|STARTED|Overall Study||48
10936614|NCT00332163|12106200|FG001|STARTED|Overall Study||47
10936615|NCT00332163|12106199|FG000|Received Treatment|Overall Study||48
10936616|NCT00332163|12106200|FG001|Received Treatment|Overall Study||47
10936617|NCT00332163|12106199|FG000|COMPLETED|Overall Study||48
10936618|NCT00332163|12106200|FG001|COMPLETED|Overall Study||47
10936619|NCT00332163|12106199|FG000|NOT COMPLETED|Overall Study||0
10936620|NCT00332163|12106200|FG001|NOT COMPLETED|Overall Study||0
10936621|NCT00332189|12106206|FG000|STARTED|Overall Study||111
10936622|NCT00332189|12106206|FG000|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
10936623|NCT00332189|12106206|FG000|NOT COMPLETED|Overall Study||21
10936624|NCT00332202|12106213|FG000|STARTED|Overall Study||504
10936625|NCT00332202|12106214|FG001|STARTED|Overall Study||254
10936626|NCT00332202|12106213|FG000|Received At Least One Dose of Study Drug|Overall Study||493
10936627|NCT00332202|12106214|FG001|Received At Least One Dose of Study Drug|Overall Study||249
10936628|NCT00332202|12106213|FG000|COMPLETED|Overall Study||263
10936629|NCT00332202|12106214|FG001|COMPLETED|Overall Study||129
10936630|NCT00332202|12106213|FG000|NOT COMPLETED|Overall Study||241
10936631|NCT00332202|12106214|FG001|NOT COMPLETED|Overall Study||125
10936632|NCT00332241|12106231|FG000|STARTED|Overall Study||51
10936633|NCT00332241|12106232|FG001|STARTED|Overall Study||47
10936634|NCT00332241|12106231|FG000|COMPLETED|Overall Study||36
10936635|NCT00332241|12106232|FG001|COMPLETED|Overall Study||39
10936636|NCT00332241|12106231|FG000|NOT COMPLETED|Overall Study||15
10936637|NCT00332241|12106232|FG001|NOT COMPLETED|Overall Study||8
10936638|NCT00332332|12106238|FG000|STARTED|Overall Study||246
10936639|NCT00332332|12106238|FG000|Received Study Medication|Overall Study||230
10936640|NCT00332332|12106238|FG000|COMPLETED|Overall Study||178
10936641|NCT00332332|12106238|FG000|NOT COMPLETED|Overall Study||68
10936642|NCT00332462|12106242|FG000|STARTED|Overall Study|Safety and Intention to treat population.|34
10936643|NCT00332462|12106242|FG000|Patients Treated With Sandimmun® i.v.|Overall Study||34
10936644|NCT00332462|12106242|FG000|Patients Treated With Sandimmun® Optoral|Overall Study||29
10936645|NCT00332462|12106242|FG000|COMPLETED|Overall Study||18
10936646|NCT00332462|12106242|FG000|NOT COMPLETED|Overall Study||16
10936647|NCT00332488|12106252|FG000|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
10936648|NCT00332488|12106253|FG001|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
10936649|NCT00332488|12106254|FG002|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
10936650|NCT00332488|12106252|FG000|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
10936651|NCT00332488|12106253|FG001|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
10936652|NCT00332488|12106254|FG002|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
10936653|NCT00332488|12106252|FG000|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
10936654|NCT00332488|12106253|FG001|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
10936655|NCT00332488|12106254|FG002|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
10936656|NCT00332488|12106252|FG000|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
10936657|NCT00332488|12106253|FG001|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
10936658|NCT00332488|12106254|FG002|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
10936659|NCT00332488|12106252|FG000|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||27
10936660|NCT00332488|12106253|FG001|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||70
10936661|NCT00332488|12106254|FG002|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||233
10936662|NCT00332488|12106252|FG000|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
10936663|NCT00332488|12106253|FG001|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
10936664|NCT00332488|12106254|FG002|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||21
10936665|NCT00332579|12106266|FG000|STARTED|Overall Study||12
10936666|NCT00332579|12106267|FG001|STARTED|Overall Study||13
10936667|NCT00332579|12106266|FG000|COMPLETED|Overall Study||11
10936668|NCT00332579|12106267|FG001|COMPLETED|Overall Study||12
10936669|NCT00332579|12106266|FG000|NOT COMPLETED|Overall Study||1
10936670|NCT00332579|12106267|FG001|NOT COMPLETED|Overall Study||1
10936671|NCT00332644|12106279|FG000|STARTED|Overall Study||262
10936672|NCT00332644|12106280|FG001|STARTED|Overall Study||260
10936673|NCT00332644|12106281|FG002|STARTED|Overall Study||267
10936674|NCT00332644|12106282|FG003|STARTED|Overall Study||264
10936675|NCT00332644|12106283|FG004|STARTED|Overall Study||262
10936676|NCT00332644|12106284|FG005|STARTED|Overall Study||189
10936677|NCT00332644|12106279|FG000|COMPLETED|Overall Study||250
10936678|NCT00332644|12106280|FG001|COMPLETED|Overall Study||238
10936679|NCT00332644|12106281|FG002|COMPLETED|Overall Study||258
10936680|NCT00332644|12106282|FG003|COMPLETED|Overall Study||244
10936681|NCT00332644|12106283|FG004|COMPLETED|Overall Study||250
10936682|NCT00332644|12106284|FG005|COMPLETED|Overall Study||174
10936683|NCT00332644|12106279|FG000|NOT COMPLETED|Overall Study||12
10936684|NCT00332644|12106280|FG001|NOT COMPLETED|Overall Study||22
10936685|NCT00332644|12106281|FG002|NOT COMPLETED|Overall Study||9
10936686|NCT00332644|12106282|FG003|NOT COMPLETED|Overall Study||20
10936687|NCT00332644|12106283|FG004|NOT COMPLETED|Overall Study||12
10936688|NCT00332644|12106284|FG005|NOT COMPLETED|Overall Study||15
10936689|NCT00332696|12106300|FG000|STARTED|Overall Study||32
10936690|NCT00332696|12106301|FG001|STARTED|Overall Study||32
10936691|NCT00332696|12106300|FG000|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
10936692|NCT00332696|12106301|FG001|Completed Day 14 Visit|Overall Study||15
10936693|NCT00332696|12106300|FG000|COMPLETED|Overall Study|Completed Month 3 Visit|2
10936694|NCT00332696|12106301|FG001|COMPLETED|Overall Study||2
10936695|NCT00332696|12106300|FG000|NOT COMPLETED|Overall Study||30
10936696|NCT00332696|12106301|FG001|NOT COMPLETED|Overall Study||30
10936697|NCT00332709|12106309|FG000|STARTED|Overall Study||40
10936698|NCT00332709|12106310|FG001|STARTED|Overall Study||41
10936699|NCT00332709|12106309|FG000|COMPLETED|Overall Study||24
10936700|NCT00332709|12106310|FG001|COMPLETED|Overall Study||21
10936701|NCT00332709|12106309|FG000|NOT COMPLETED|Overall Study||16
10936702|NCT00332709|12106310|FG001|NOT COMPLETED|Overall Study||20
10936703|NCT00332722|12106318|FG000|STARTED|Overall Study||60
10936704|NCT00332722|12106319|FG001|STARTED|Overall Study||60
10936705|NCT00332722|12106318|FG000|COMPLETED|Overall Study||60
10936706|NCT00332722|12106319|FG001|COMPLETED|Overall Study||60
10936707|NCT00332722|12106318|FG000|NOT COMPLETED|Overall Study||0
10936708|NCT00332722|12106319|FG001|NOT COMPLETED|Overall Study||0
10936709|NCT00332839|12106327|FG000|STARTED|Core (Months 0 - 12)||47
10936710|NCT00332839|12106328|FG001|STARTED|Core (Months 0 - 12)||46
10936711|NCT00332839|12106327|FG000|Safety Set|Core (Months 0 - 12)||47
10936712|NCT00332839|12106328|FG001|Safety Set|Core (Months 0 - 12)||46
10936713|NCT00332839|12106327|FG000|COMPLETED|Core (Months 0 - 12)||37
10936714|NCT00332839|12106328|FG001|COMPLETED|Core (Months 0 - 12)||28
10936715|NCT00332839|12106327|FG000|NOT COMPLETED|Core (Months 0 - 12)||10
10936716|NCT00332839|12106328|FG001|NOT COMPLETED|Core (Months 0 - 12)||18
10936717|NCT00332839|12106327|FG000|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
10936718|NCT00332839|12106328|FG001|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
10936719|NCT00332839|12106327|FG000|COMPLETED|Follow-up (Months 12 - 60)||29
10936720|NCT00332839|12106328|FG001|COMPLETED|Follow-up (Months 12 - 60)||31
10936721|NCT00332839|12106327|FG000|NOT COMPLETED|Follow-up (Months 12 - 60)||4
10936722|NCT00332839|12106328|FG001|NOT COMPLETED|Follow-up (Months 12 - 60)||3
10936723|NCT00333138|12106337|FG000|STARTED|Core Study (6 Months)||93
10936724|NCT00333138|12106338|FG001|STARTED|Core Study (6 Months)||94
10936725|NCT00333138|12106339|FG002|STARTED|Core Study (6 Months)||94
10936726|NCT00333138|12106337|FG000|COMPLETED|Core Study (6 Months)||86
10936727|NCT00333138|12106338|FG001|COMPLETED|Core Study (6 Months)||88
10936728|NCT00333138|12106339|FG002|COMPLETED|Core Study (6 Months)||82
10936729|NCT00333138|12106337|FG000|NOT COMPLETED|Core Study (6 Months)||7
10936730|NCT00333138|12106338|FG001|NOT COMPLETED|Core Study (6 Months)||6
10936731|NCT00333138|12106339|FG002|NOT COMPLETED|Core Study (6 Months)||12
10936732|NCT00333138|12106337|FG000|STARTED|Extension Study (Month6 to End of Study)||83
10936733|NCT00333138|12106338|FG001|STARTED|Extension Study (Month6 to End of Study)||87
10936734|NCT00333138|12106339|FG002|STARTED|Extension Study (Month6 to End of Study)||80
10936735|NCT00333138|12106337|FG000|COMPLETED|Extension Study (Month6 to End of Study)||40
10936736|NCT00333138|12106338|FG001|COMPLETED|Extension Study (Month6 to End of Study)||45
10936737|NCT00333138|12106339|FG002|COMPLETED|Extension Study (Month6 to End of Study)||37
10936738|NCT00333138|12106337|FG000|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
10936739|NCT00333138|12106338|FG001|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
10936740|NCT00333138|12106339|FG002|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
10936741|NCT00333177|12106353|FG000|STARTED|Overall Study||12
10936742|NCT00333177|12106354|FG001|STARTED|Overall Study||17
10936743|NCT00333177|12106355|FG002|STARTED|Overall Study||17
10936744|NCT00333177|12106356|FG003|STARTED|Overall Study||14
10936745|NCT00333177|12106353|FG000|Received Intervention|Overall Study||12
10936746|NCT00333177|12106354|FG001|Received Intervention|Overall Study||16
10936747|NCT00333177|12106355|FG002|Received Intervention|Overall Study||16
10936748|NCT00333177|12106356|FG003|Received Intervention|Overall Study||12
10936749|NCT00333177|12106353|FG000|COMPLETED|Overall Study||12
10936750|NCT00333177|12106354|FG001|COMPLETED|Overall Study||16
10936751|NCT00333177|12106355|FG002|COMPLETED|Overall Study||16
10936752|NCT00333177|12106356|FG003|COMPLETED|Overall Study||12
10936753|NCT00333177|12106353|FG000|NOT COMPLETED|Overall Study||0
10936754|NCT00333177|12106354|FG001|NOT COMPLETED|Overall Study||1
10936755|NCT00333177|12106355|FG002|NOT COMPLETED|Overall Study||1
10936756|NCT00333177|12106356|FG003|NOT COMPLETED|Overall Study||2
10936757|NCT00333359|12106370|FG000|STARTED|Overall Study||199
10936758|NCT00333359|12106371|FG001|STARTED|Overall Study||382
10936759|NCT00333359|12106370|FG000|COMPLETED|Overall Study||126
10936760|NCT00333359|12106371|FG001|COMPLETED|Overall Study||260
10936761|NCT00333359|12106370|FG000|NOT COMPLETED|Overall Study||73
10936762|NCT00333359|12106371|FG001|NOT COMPLETED|Overall Study||122
10936763|NCT00333437|12106379|FG000|STARTED|Overall Study||7
10936764|NCT00333437|12106379|FG000|COMPLETED|Overall Study||7
10936765|NCT00333437|12106379|FG000|NOT COMPLETED|Overall Study||0
10936766|NCT00333606|12106386|FG000|STARTED|Overall Study||30
10936767|NCT00333606|12106387|FG001|STARTED|Overall Study||30
10936768|NCT00333606|12106386|FG000|COMPLETED|Overall Study||30
10936769|NCT00333606|12106387|FG001|COMPLETED|Overall Study||30
10936770|NCT00333606|12106386|FG000|NOT COMPLETED|Overall Study||0
10936771|NCT00333606|12106387|FG001|NOT COMPLETED|Overall Study||0
10936772|NCT00333619|12106397|FG000|STARTED|Overall Study||110
10936773|NCT00333619|12106398|FG001|STARTED|Overall Study||109
10936774|NCT00333619|12106397|FG000|Post-treatment|Overall Study||109
10936775|NCT00333619|12106398|FG001|Post-treatment|Overall Study||109
10936776|NCT00333619|12106397|FG000|3-month Follow-up|Overall Study||101
10936777|NCT00333619|12106398|FG001|3-month Follow-up|Overall Study||105
10936778|NCT00333619|12106397|FG000|COMPLETED|Overall Study||89
10936779|NCT00333619|12106398|FG001|COMPLETED|Overall Study||99
10936780|NCT00333619|12106397|FG000|NOT COMPLETED|Overall Study||21
10936781|NCT00333619|12106398|FG001|NOT COMPLETED|Overall Study||10
10936782|NCT00333710|12106409|FG000|STARTED|Overall Study||19
10936783|NCT00333710|12106410|FG001|STARTED|Overall Study||18
10936784|NCT00333710|12106411|FG002|STARTED|Overall Study||16
10936785|NCT00333710|12106409|FG000|COMPLETED|Overall Study||8
10936786|NCT00333710|12106410|FG001|COMPLETED|Overall Study||14
10936787|NCT00333710|12106411|FG002|COMPLETED|Overall Study||15
10936788|NCT00333710|12106409|FG000|NOT COMPLETED|Overall Study||11
10936789|NCT00333710|12106410|FG001|NOT COMPLETED|Overall Study||4
10936790|NCT00333710|12106411|FG002|NOT COMPLETED|Overall Study||1
10936791|NCT00333775|12106422|FG000|STARTED|Overall Study||241
10936792|NCT00333775|12106423|FG001|STARTED|Overall Study||248
10936793|NCT00333775|12106424|FG002|STARTED|Overall Study||247
10936794|NCT00333775|12106422|FG000|Received Treatment|Overall Study||238
10936795|NCT00333775|12106423|FG001|Received Treatment|Overall Study||247
10936796|NCT00333775|12106424|FG002|Received Treatment|Overall Study||245
10936797|NCT00333775|12106422|FG000|COMPLETED|Overall Study||0
10936798|NCT00333775|12106423|FG001|COMPLETED|Overall Study||0
10936799|NCT00333775|12106424|FG002|COMPLETED|Overall Study||0
10936800|NCT00333775|12106422|FG000|NOT COMPLETED|Overall Study||241
10936801|NCT00333775|12106423|FG001|NOT COMPLETED|Overall Study||248
10936802|NCT00333775|12106424|FG002|NOT COMPLETED|Overall Study||247
10936803|NCT00333788|12106432|FG000|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
10936804|NCT00333788|12106432|FG000|COMPLETED|Overall Study||71
10936805|NCT00333788|12106432|FG000|NOT COMPLETED|Overall Study||162
10936806|NCT00333801|12106438|FG000|STARTED|Overall Study||43
10936807|NCT00333801|12106439|FG001|STARTED|Overall Study||42
10936808|NCT00333801|12106438|FG000|COMPLETED|Overall Study||35
10936809|NCT00333801|12106439|FG001|COMPLETED|Overall Study||36
10936810|NCT00333801|12106438|FG000|NOT COMPLETED|Overall Study||8
10936811|NCT00333801|12106439|FG001|NOT COMPLETED|Overall Study||6
10936812|NCT00333814|12106448|FG000|STARTED|Overall Study||76
10936813|NCT00333814|12106449|FG001|STARTED|Overall Study||77
10936814|NCT00333814|12106450|FG002|STARTED|Overall Study||76
10936815|NCT00333814|12106448|FG000|COMPLETED|Overall Study||73
10936816|NCT00333814|12106449|FG001|COMPLETED|Overall Study||73
10936817|NCT00333814|12106450|FG002|COMPLETED|Overall Study||71
10936818|NCT00333814|12106448|FG000|NOT COMPLETED|Overall Study||3
10936819|NCT00333814|12106449|FG001|NOT COMPLETED|Overall Study||4
10936820|NCT00333814|12106450|FG002|NOT COMPLETED|Overall Study||5
10936821|NCT00333840|12106460|FG000|STARTED|First-line Treatment Period||553
10936822|NCT00333840|12106461|FG001|STARTED|First-line Treatment Period||553
10936823|NCT00333840|12106462|FG002|STARTED|First-line Treatment Period||0
10936824|NCT00333840|12106463|FG003|STARTED|First-line Treatment Period||0
10936825|NCT00333840|12106460|FG000|Safety Population; Received Study Drug|First-line Treatment Period||551
10936826|NCT00333840|12106461|FG001|Safety Population; Received Study Drug|First-line Treatment Period||533
10936827|NCT00333840|12106462|FG002|Safety Population; Received Study Drug|First-line Treatment Period||0
10936828|NCT00333840|12106463|FG003|Safety Population; Received Study Drug|First-line Treatment Period||0
10936829|NCT00333840|12106460|FG000|COMPLETED|First-line Treatment Period||267
10936830|NCT00333840|12106461|FG001|COMPLETED|First-line Treatment Period||7
10936831|NCT00333840|12106462|FG002|COMPLETED|First-line Treatment Period||0
10936832|NCT00333840|12106463|FG003|COMPLETED|First-line Treatment Period||0
10936833|NCT00333840|12106460|FG000|NOT COMPLETED|First-line Treatment Period||286
10936834|NCT00333840|12106461|FG001|NOT COMPLETED|First-line Treatment Period||546
10936835|NCT00333840|12106462|FG002|NOT COMPLETED|First-line Treatment Period||0
10936836|NCT00333840|12106463|FG003|NOT COMPLETED|First-line Treatment Period||0
10936837|NCT00333840|12106460|FG000|STARTED|Second-line Treatment Period||0
10936838|NCT00333840|12106461|FG001|STARTED|Second-line Treatment Period||0
10936839|NCT00333840|12106462|FG002|STARTED|Second-line Treatment Period||14
10936840|NCT00333840|12106463|FG003|STARTED|Second-line Treatment Period||363
10936841|NCT00333840|12106460|FG000|COMPLETED|Second-line Treatment Period||0
10936842|NCT00333840|12106461|FG001|COMPLETED|Second-line Treatment Period||0
10936843|NCT00333840|12106462|FG002|COMPLETED|Second-line Treatment Period||0
10936844|NCT00333840|12106463|FG003|COMPLETED|Second-line Treatment Period||175
10936845|NCT00333840|12106460|FG000|NOT COMPLETED|Second-line Treatment Period||0
10936846|NCT00333840|12106461|FG001|NOT COMPLETED|Second-line Treatment Period||0
10936847|NCT00333840|12106462|FG002|NOT COMPLETED|Second-line Treatment Period||14
10936848|NCT00333840|12106463|FG003|NOT COMPLETED|Second-line Treatment Period||188
10936849|NCT00333866|12106481|FG000|STARTED|Overall Study||189
10936850|NCT00333866|12106482|FG001|STARTED|Overall Study||187
10936851|NCT00333866|12106483|FG002|STARTED|Overall Study||184
10936852|NCT00333866|12106484|FG003|STARTED|Overall Study||187
10936853|NCT00333866|12106481|FG000|TREATED|Overall Study||184
10936854|NCT00333866|12106482|FG001|TREATED|Overall Study||184
10936855|NCT00333866|12106483|FG002|TREATED|Overall Study||182
10936856|NCT00333866|12106484|FG003|TREATED|Overall Study||186
10936857|NCT00333866|12106481|FG000|COMPLETED|Overall Study||141
10936858|NCT00333866|12106482|FG001|COMPLETED|Overall Study||123
10936859|NCT00333866|12106483|FG002|COMPLETED|Overall Study||133
10936860|NCT00333866|12106484|FG003|COMPLETED|Overall Study||121
10936861|NCT00333866|12106481|FG000|NOT COMPLETED|Overall Study||48
10936862|NCT00333866|12106482|FG001|NOT COMPLETED|Overall Study||64
10936863|NCT00333866|12106483|FG002|NOT COMPLETED|Overall Study||51
10936864|NCT00333866|12106484|FG003|NOT COMPLETED|Overall Study||66
10936865|NCT00333879|12106494|FG000|STARTED|Overall Study||4
10936866|NCT00333879|12106494|FG000|COMPLETED|Overall Study||4
10936867|NCT00333879|12106494|FG000|NOT COMPLETED|Overall Study||0
10936868|NCT00333970|12106500|FG000|STARTED|Overall Study||50
10936869|NCT00333970|12106501|FG001|STARTED|Overall Study||25
10936870|NCT00333970|12106500|FG000|COMPLETED|Overall Study||37
10936871|NCT00333970|12106501|FG001|COMPLETED|Overall Study||18
10936872|NCT00333970|12106500|FG000|NOT COMPLETED|Overall Study||13
10936873|NCT00333970|12106501|FG001|NOT COMPLETED|Overall Study||7
10936874|NCT00333983|12106510|FG000|STARTED|Overall Study||20
10936875|NCT00333983|12106511|FG001|STARTED|Overall Study||21
10936876|NCT00333983|12106512|FG002|STARTED|Overall Study||21
10936877|NCT00333983|12106510|FG000|COMPLETED|Overall Study||17
10936878|NCT00333983|12106511|FG001|COMPLETED|Overall Study||16
10936879|NCT00333983|12106512|FG002|COMPLETED|Overall Study||19
10936880|NCT00333983|12106510|FG000|NOT COMPLETED|Overall Study||3
10936881|NCT00333983|12106511|FG001|NOT COMPLETED|Overall Study||5
10936882|NCT00333983|12106512|FG002|NOT COMPLETED|Overall Study||2
10936883|NCT00334061|12106520|FG000|STARTED|Overall Study|June 2006|125
10936884|NCT00334061|12106520|FG000|COMPLETED|Overall Study|November 2007|125
10936885|NCT00334061|12106520|FG000|NOT COMPLETED|Overall Study||0
10936886|NCT00334074|12106524|FG000|STARTED|Overall Study||30
10936887|NCT00334074|12106524|FG000|COMPLETED|Overall Study||30
10936888|NCT00334074|12106524|FG000|NOT COMPLETED|Overall Study||0
10936889|NCT00334113|12106531|FG000|STARTED|Overall Study||32
10936890|NCT00334113|12106532|FG001|STARTED|Overall Study||34
10936891|NCT00334113|12106531|FG000|COMPLETED|Overall Study||30
10936892|NCT00334113|12106532|FG001|COMPLETED|Overall Study||31
10936893|NCT00334113|12106531|FG000|NOT COMPLETED|Overall Study||2
10936894|NCT00334113|12106532|FG001|NOT COMPLETED|Overall Study||3
10936895|NCT00334204|12106538|FG000|STARTED|Overall Study||58
10936896|NCT00334204|12106538|FG000|COMPLETED|Overall Study||56
10936897|NCT00334204|12106538|FG000|NOT COMPLETED|Overall Study||2
10936898|NCT00334282|12106545|FG000|STARTED|Overall Study||290
10936899|NCT00334282|12106546|FG001|STARTED|Overall Study||145
10936900|NCT00334282|12106545|FG000|COMPLETED|Overall Study||68
10936901|NCT00334282|12106546|FG001|COMPLETED|Overall Study||37
10936902|NCT00334282|12106545|FG000|NOT COMPLETED|Overall Study||222
10936903|NCT00334282|12106546|FG001|NOT COMPLETED|Overall Study||108
10936904|NCT00334295|12106556|FG000|STARTED|Overall Study||35
10936905|NCT00334295|12106556|FG000|COMPLETED|Overall Study||30
10936906|NCT00334295|12106556|FG000|NOT COMPLETED|Overall Study||5
10936907|NCT00334542|12106560|FG000|STARTED|Overall Study||50
10936908|NCT00334542|12106560|FG000|COMPLETED|Overall Study||45
10936909|NCT00334542|12106560|FG000|NOT COMPLETED|Overall Study||5
10936910|NCT00334633|12106568|FG000|STARTED|Overall Study||197
10936911|NCT00334633|12106569|FG001|STARTED|Overall Study||200
10936912|NCT00334633|12106570|FG002|STARTED|Overall Study||196
10936913|NCT00334633|12106568|FG000|COMPLETED|Overall Study||117
10936914|NCT00334633|12106569|FG001|COMPLETED|Overall Study||118
10936915|NCT00334633|12106570|FG002|COMPLETED|Overall Study||114
10936916|NCT00334633|12106568|FG000|NOT COMPLETED|Overall Study||80
10936917|NCT00334633|12106569|FG001|NOT COMPLETED|Overall Study||82
10936918|NCT00334633|12106570|FG002|NOT COMPLETED|Overall Study||82
10936919|NCT00334737|12106584|FG000|STARTED|Hospital Phase||34
10936920|NCT00334737|12106585|FG001|STARTED|Hospital Phase||34
10936921|NCT00334737|12106586|FG002|STARTED|Hospital Phase||34
10936922|NCT00334737|12106584|FG000|COMPLETED|Hospital Phase||32
10936923|NCT00334737|12106585|FG001|COMPLETED|Hospital Phase||32
10936924|NCT00334737|12106586|FG002|COMPLETED|Hospital Phase||30
10936925|NCT00334737|12106584|FG000|NOT COMPLETED|Hospital Phase||2
10936926|NCT00334737|12106585|FG001|NOT COMPLETED|Hospital Phase||2
10936927|NCT00334737|12106586|FG002|NOT COMPLETED|Hospital Phase||4
10936928|NCT00334737|12106584|FG000|STARTED|Follow up Phase||32
10936929|NCT00334737|12106585|FG001|STARTED|Follow up Phase||32
10936930|NCT00334737|12106586|FG002|STARTED|Follow up Phase||30
10936931|NCT00334737|12106584|FG000|COMPLETED|Follow up Phase||27
10936932|NCT00334737|12106585|FG001|COMPLETED|Follow up Phase||29
10936933|NCT00334737|12106586|FG002|COMPLETED|Follow up Phase||24
10936934|NCT00334737|12106584|FG000|NOT COMPLETED|Follow up Phase||5
10936935|NCT00334737|12106585|FG001|NOT COMPLETED|Follow up Phase||3
10936936|NCT00334737|12106586|FG002|NOT COMPLETED|Follow up Phase||6
10936937|NCT00334802|12106596|FG000|STARTED|Overall Study||6
10936938|NCT00334802|12106597|FG001|STARTED|Overall Study||56
10936939|NCT00334802|12106596|FG000|COMPLETED|Overall Study||0
10936940|NCT00334802|12106597|FG001|COMPLETED|Overall Study||16
10936941|NCT00334802|12106596|FG000|NOT COMPLETED|Overall Study||6
10936942|NCT00334802|12106597|FG001|NOT COMPLETED|Overall Study||40
10936943|NCT00334893|12106608|FG000|STARTED|Overall Study||37
10936944|NCT00334893|12106609|FG001|STARTED|Overall Study||37
10936945|NCT00334893|12106608|FG000|COMPLETED|Overall Study||36
10936946|NCT00334893|12106609|FG001|COMPLETED|Overall Study||37
10936947|NCT00334893|12106608|FG000|NOT COMPLETED|Overall Study||1
10936948|NCT00334893|12106609|FG001|NOT COMPLETED|Overall Study||0
10936949|NCT00334958|12106619|FG000|STARTED|Overall Study||176
10936950|NCT00334958|12106620|FG001|STARTED|Overall Study|1 participant withdrawn prior to study drug dosing due to not obtaining labs|180
10936951|NCT00334958|12106619|FG000|COMPLETED|Overall Study||139
10936952|NCT00334958|12106620|FG001|COMPLETED|Overall Study||156
10936953|NCT00334958|12106619|FG000|NOT COMPLETED|Overall Study||37
10936954|NCT00334958|12106620|FG001|NOT COMPLETED|Overall Study||24
10936955|NCT00335140|12106626|FG000|STARTED|Overall Study||26
10936956|NCT00335140|12106626|FG000|Eligible|Overall Study||25
10936957|NCT00335140|12106626|FG000|Treated|Overall Study||25
10936958|NCT00335140|12106626|FG000|COMPLETED|Overall Study||25
10936959|NCT00335140|12106626|FG000|NOT COMPLETED|Overall Study||1
10936960|NCT00335153|12106630|FG000|STARTED|Nasojejunal (NJ) Test Period||354
10936961|NCT00335153|12106630|FG000|COMPLETED|Nasojejunal (NJ) Test Period||324
10936962|NCT00335153|12106630|FG000|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
10936963|NCT00335153|12106630|FG000|STARTED|Post-PEG-J Long-Term Treatment Period||324
10936964|NCT00335153|12106630|FG000|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
10936965|NCT00335153|12106630|FG000|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
10936966|NCT00335257|12106637|FG000|STARTED|Overall Study||15542
10936967|NCT00335257|12106638|FG001|STARTED|Overall Study||9377
10936968|NCT00335257|12106639|FG002|STARTED|Overall Study||60190
10936969|NCT00335257|12106637|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
10936970|NCT00335257|12106638|FG001|COMPLETED|Overall Study||9377
10936971|NCT00335257|12106639|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
10936972|NCT00335257|12106637|FG000|NOT COMPLETED|Overall Study||0
10936973|NCT00335257|12106638|FG001|NOT COMPLETED|Overall Study||0
10936974|NCT00335257|12106639|FG002|NOT COMPLETED|Overall Study||0
10936975|NCT00335283|12106655|FG000|STARTED|Overall Study||36
10936976|NCT00335283|12106656|FG001|STARTED|Overall Study||39
10936977|NCT00335283|12106655|FG000|COMPLETED|Overall Study||30
10936978|NCT00335283|12106656|FG001|COMPLETED|Overall Study||34
10936979|NCT00335283|12106655|FG000|NOT COMPLETED|Overall Study||6
10936980|NCT00335283|12106656|FG001|NOT COMPLETED|Overall Study||5
10936981|NCT00335322|12106665|FG000|STARTED|Overall Study||115
10936982|NCT00335322|12106666|FG001|STARTED|Overall Study||107
10936983|NCT00335322|12106667|FG002|STARTED|Overall Study||105
10936984|NCT00335322|12106665|FG000|COMPLETED|Overall Study||114
10936985|NCT00335322|12106666|FG001|COMPLETED|Overall Study||105
10936986|NCT00335322|12106667|FG002|COMPLETED|Overall Study||103
10936987|NCT00335322|12106665|FG000|NOT COMPLETED|Overall Study||1
10936988|NCT00335322|12106666|FG001|NOT COMPLETED|Overall Study||2
10936989|NCT00335322|12106667|FG002|NOT COMPLETED|Overall Study||2
10936990|NCT00335452|12106682|FG000|STARTED|Overall Study|Randomized|6312
10936991|NCT00335452|12106683|FG001|STARTED|Overall Study|Randomized|6254
10936992|NCT00335452|12106684|FG002|STARTED|Overall Study|Randomized|6267
10936993|NCT00335452|12106685|FG003|STARTED|Overall Study|Randomized|6253
10936994|NCT00335452|12106682|FG000|TREATED WITH CLOPIDOGREL|Overall Study||6271
10936995|NCT00335452|12106683|FG001|TREATED WITH CLOPIDOGREL|Overall Study||6218
10936996|NCT00335452|12106684|FG002|TREATED WITH CLOPIDOGREL|Overall Study||6228
10936997|NCT00335452|12106685|FG003|TREATED WITH CLOPIDOGREL|Overall Study||6217
10936998|NCT00335452|12106682|FG000|TREATED WITH ASA|Overall Study||6302
10936999|NCT00335452|12106683|FG001|TREATED WITH ASA|Overall Study||6251
10937000|NCT00335452|12106684|FG002|TREATED WITH ASA|Overall Study||6261
10937001|NCT00335452|12106685|FG003|TREATED WITH ASA|Overall Study||6247
10937002|NCT00335452|12106682|FG000|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
10937003|NCT00335452|12106683|FG001|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
10937004|NCT00335452|12106684|FG002|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
10937005|NCT00335452|12106685|FG003|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
10937006|NCT00335452|12106682|FG000|NOT COMPLETED|Overall Study||158
10937007|NCT00335452|12106683|FG001|NOT COMPLETED|Overall Study||147
10937008|NCT00335452|12106684|FG002|NOT COMPLETED|Overall Study||159
10937009|NCT00335452|12106685|FG003|NOT COMPLETED|Overall Study||131
10937010|NCT00335478|12106700|FG000|STARTED|Overall Study||54
10937011|NCT00335478|12106700|FG000|COMPLETED|Overall Study||30
10937012|NCT00335478|12106700|FG000|NOT COMPLETED|Overall Study||24
10937013|NCT00335504|12106708|FG000|STARTED|Overall Study||22
10937014|NCT00335504|12106709|FG001|STARTED|Overall Study||21
10937015|NCT00335504|12106710|FG002|STARTED|Overall Study||20
10937016|NCT00335504|12106711|FG003|STARTED|Overall Study||22
10937017|NCT00335504|12106708|FG000|COMPLETED|Overall Study||22
10937018|NCT00335504|12106709|FG001|COMPLETED|Overall Study||21
10937019|NCT00335504|12106710|FG002|COMPLETED|Overall Study||20
10937020|NCT00335504|12106711|FG003|COMPLETED|Overall Study||22
10937021|NCT00335504|12106708|FG000|NOT COMPLETED|Overall Study||0
10937022|NCT00335504|12106709|FG001|NOT COMPLETED|Overall Study||0
10937023|NCT00335504|12106710|FG002|NOT COMPLETED|Overall Study||0
10937024|NCT00335504|12106711|FG003|NOT COMPLETED|Overall Study||0
10937025|NCT00335517|12106721|FG000|STARTED|Overall Study||100
10937026|NCT00335517|12106721|FG000|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
10937027|NCT00335517|12106721|FG000|NOT COMPLETED|Overall Study||2
10937028|NCT00335556|12106731|FG000|STARTED|Overall Study||68
10937029|NCT00335556|12106732|FG001|STARTED|Overall Study||98
10937030|NCT00335556|12106733|FG002|STARTED|Overall Study||7
10937031|NCT00335556|12106734|FG003|STARTED|Overall Study||10
10937032|NCT00335556|12106735|FG004|STARTED|Overall Study||78
10937033|NCT00335556|12106736|FG005|STARTED|Overall Study||30
10937034|NCT00335556|12106731|FG000|COMPLETED|Overall Study||66
10937035|NCT00335556|12106732|FG001|COMPLETED|Overall Study||64
10937036|NCT00335556|12106733|FG002|COMPLETED|Overall Study||2
10937037|NCT00335556|12106734|FG003|COMPLETED|Overall Study||5
10937038|NCT00335556|12106735|FG004|COMPLETED|Overall Study||77
10937039|NCT00335556|12106736|FG005|COMPLETED|Overall Study||29
10937040|NCT00335556|12106731|FG000|NOT COMPLETED|Overall Study||2
10937041|NCT00335556|12106732|FG001|NOT COMPLETED|Overall Study||34
10937042|NCT00335556|12106733|FG002|NOT COMPLETED|Overall Study||5
10937043|NCT00335556|12106734|FG003|NOT COMPLETED|Overall Study||5
10937044|NCT00335556|12106735|FG004|NOT COMPLETED|Overall Study||1
10937045|NCT00335556|12106736|FG005|NOT COMPLETED|Overall Study||1
10937046|NCT00335725|12106757|FG000|STARTED|Overall Study||75
10937047|NCT00335725|12106758|FG001|STARTED|Overall Study||76
10937048|NCT00335725|12106757|FG000|COMPLETED|Overall Study||71
10937049|NCT00335725|12106758|FG001|COMPLETED|Overall Study||71
10937050|NCT00335725|12106757|FG000|NOT COMPLETED|Overall Study||4
10937051|NCT00335725|12106758|FG001|NOT COMPLETED|Overall Study||5
10937052|NCT00335738|12106767|FG000|STARTED|Overall Study||108
10937053|NCT00335738|12106768|FG001|STARTED|Overall Study||223
10937054|NCT00335738|12106767|FG000|COMPLETED|Overall Study||97
10937055|NCT00335738|12106768|FG001|COMPLETED|Overall Study||219
10937056|NCT00335738|12106767|FG000|NOT COMPLETED|Overall Study||11
10937057|NCT00335738|12106768|FG001|NOT COMPLETED|Overall Study||4
10937058|NCT00335764|12106780|FG000|STARTED|Overall Study||17
10937059|NCT00335764|12106781|FG001|STARTED|Overall Study||13
10937060|NCT00335764|12106782|FG002|STARTED|Overall Study||24
10937061|NCT00335764|12106783|FG003|STARTED|Overall Study||19
10937062|NCT00335764|12106784|FG004|STARTED|Overall Study||19
10937063|NCT00335764|12106780|FG000|COMPLETED|Overall Study||16
10937064|NCT00335764|12106781|FG001|COMPLETED|Overall Study||13
10937065|NCT00335764|12106782|FG002|COMPLETED|Overall Study||24
10937066|NCT00335764|12106783|FG003|COMPLETED|Overall Study||19
10937067|NCT00335764|12106784|FG004|COMPLETED|Overall Study||18
10937068|NCT00335764|12106780|FG000|NOT COMPLETED|Overall Study||1
10937069|NCT00335764|12106781|FG001|NOT COMPLETED|Overall Study||0
10937070|NCT00335764|12106782|FG002|NOT COMPLETED|Overall Study||0
10937071|NCT00335764|12106783|FG003|NOT COMPLETED|Overall Study||0
10937072|NCT00335764|12106784|FG004|NOT COMPLETED|Overall Study||1
10937073|NCT00335829|12106820|FG000|STARTED|Overall Study||26
10937074|NCT00335829|12106820|FG000|Received Bevacizumab|Overall Study||26
10937075|NCT00335829|12106820|FG000|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
10937076|NCT00335829|12106820|FG000|COMPLETED|Overall Study||23
10937077|NCT00335829|12106820|FG000|NOT COMPLETED|Overall Study||3
10937078|NCT00335959|12106824|FG000|STARTED|Overall Study||7
10937079|NCT00335959|12106824|FG000|Eligible|Overall Study||6
10937080|NCT00335959|12106824|FG000|Eligible and Began Protocol Therapy|Overall Study||6
10937081|NCT00335959|12106824|FG000|COMPLETED|Overall Study||4
10937082|NCT00335959|12106824|FG000|NOT COMPLETED|Overall Study||3
10937083|NCT00335972|12106831|FG000|STARTED|Overall Study||71
10937084|NCT00335972|12106832|FG001|STARTED|Overall Study||71
10937085|NCT00335972|12106831|FG000|COMPLETED|Overall Study||71
10937086|NCT00335972|12106832|FG001|COMPLETED|Overall Study||68
10937087|NCT00335972|12106831|FG000|NOT COMPLETED|Overall Study||0
10937088|NCT00335972|12106832|FG001|NOT COMPLETED|Overall Study||3
10937089|NCT00336232|12106838|FG000|STARTED|Baseline (200mcg Daily)||59
10937090|NCT00336232|12106838|FG000|COMPLETED|Baseline (200mcg Daily)||42
10937091|NCT00336232|12106838|FG000|NOT COMPLETED|Baseline (200mcg Daily)||17
10937092|NCT00336232|12106838|FG000|STARTED|Low Vitamin K (10mcg Daily)||42
10937093|NCT00336232|12106838|FG000|COMPLETED|Low Vitamin K (10mcg Daily)||42
10937094|NCT00336232|12106838|FG000|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
10937095|NCT00336232|12106838|FG000|STARTED|High Vitamin K (500mcg Daily)||42
10937096|NCT00336232|12106838|FG000|COMPLETED|High Vitamin K (500mcg Daily)||42
10937097|NCT00336232|12106838|FG000|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
10937098|NCT00336284|12106844|FG000|STARTED|Overall Study||977
10937099|NCT00336284|12106845|FG001|STARTED|Overall Study||473
10937100|NCT00336284|12106844|FG000|COMPLETED|Overall Study||741
10937101|NCT00336284|12106845|FG001|COMPLETED|Overall Study||322
10937102|NCT00336284|12106844|FG000|NOT COMPLETED|Overall Study||236
10937103|NCT00336284|12106845|FG001|NOT COMPLETED|Overall Study||151
10937104|NCT00336323|12106856|FG000|STARTED|Overall Study||19
10937105|NCT00336323|12106857|FG001|STARTED|Overall Study||22
10937106|NCT00336323|12106858|FG002|STARTED|Overall Study||24
10937107|NCT00336323|12106859|FG003|STARTED|Overall Study||22
10937108|NCT00336323|12106860|FG004|STARTED|Overall Study||22
10937109|NCT00336323|12106856|FG000|3 Week Visit|Overall Study||18
10937110|NCT00336323|12106857|FG001|3 Week Visit|Overall Study||21
10937111|NCT00336323|12106858|FG002|3 Week Visit|Overall Study||24
10937112|NCT00336323|12106859|FG003|3 Week Visit|Overall Study||22
10937113|NCT00336323|12106860|FG004|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
10937114|NCT00336323|12106856|FG000|6 Week Visit|Overall Study||18
10937115|NCT00336323|12106857|FG001|6 Week Visit|Overall Study||22
10937116|NCT00336323|12106858|FG002|6 Week Visit|Overall Study||24
10937117|NCT00336323|12106859|FG003|6 Week Visit|Overall Study||22
10937118|NCT00336323|12106860|FG004|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
10937119|NCT00336323|12106856|FG000|9 Week Visit|Overall Study||18
10937120|NCT00336323|12106857|FG001|9 Week Visit|Overall Study||21
10937121|NCT00336323|12106858|FG002|9 Week Visit|Overall Study||23
10937122|NCT00336323|12106859|FG003|9 Week Visit|Overall Study||21
10937123|NCT00336323|12106860|FG004|9 Week Visit|Overall Study||19
10937124|NCT00336323|12106856|FG000|12 Week Visit|Overall Study||19
10937125|NCT00336323|12106857|FG001|12 Week Visit|Overall Study||21
10937126|NCT00336323|12106858|FG002|12 Week Visit|Overall Study||24
10937127|NCT00336323|12106859|FG003|12 Week Visit|Overall Study||22
10937128|NCT00336323|12106860|FG004|12 Week Visit|Overall Study|1 patient was dropped from study|20
10937129|NCT00336323|12106856|FG000|18 Week Visit|Overall Study||19
10937130|NCT00336323|12106857|FG001|18 Week Visit|Overall Study||22
10937131|NCT00336323|12106858|FG002|18 Week Visit|Overall Study||23
10937132|NCT00336323|12106859|FG003|18 Week Visit|Overall Study||21
10937133|NCT00336323|12106860|FG004|18 Week Visit|Overall Study|1 patient was dropped from the study|18
10937134|NCT00336323|12106856|FG000|24 Week Visit|Overall Study||18
10937135|NCT00336323|12106857|FG001|24 Week Visit|Overall Study|1 patient was dropped from the study|20
10937136|NCT00336323|12106858|FG002|24 Week Visit|Overall Study|1 patient was dropped from the study|22
10937137|NCT00336323|12106859|FG003|24 Week Visit|Overall Study||22
10937138|NCT00336323|12106860|FG004|24 Week Visit|Overall Study||19
10937139|NCT00336323|12106856|FG000|COMPLETED|Overall Study||19
10937140|NCT00336323|12106857|FG001|COMPLETED|Overall Study||21
10937141|NCT00336323|12106858|FG002|COMPLETED|Overall Study||23
10937142|NCT00336323|12106859|FG003|COMPLETED|Overall Study||22
10937143|NCT00336323|12106860|FG004|COMPLETED|Overall Study||19
10937144|NCT00336323|12106856|FG000|NOT COMPLETED|Overall Study||0
10937145|NCT00336323|12106857|FG001|NOT COMPLETED|Overall Study||1
10937146|NCT00336323|12106858|FG002|NOT COMPLETED|Overall Study||1
10937147|NCT00336323|12106859|FG003|NOT COMPLETED|Overall Study||0
10937148|NCT00336323|12106860|FG004|NOT COMPLETED|Overall Study||3
10937149|NCT00336479|12106880|FG000|STARTED|Overall Study||75
10937150|NCT00336479|12106881|FG001|STARTED|Overall Study||79
10937151|NCT00336479|12106882|FG002|STARTED|Overall Study||79
10937152|NCT00336479|12106883|FG003|STARTED|Overall Study||17
10937153|NCT00336479|12106880|FG000|COMPLETED|Overall Study||38
10937154|NCT00336479|12106881|FG001|COMPLETED|Overall Study||54
10937155|NCT00336479|12106882|FG002|COMPLETED|Overall Study||53
10937156|NCT00336479|12106883|FG003|COMPLETED|Overall Study||13
10937157|NCT00336479|12106880|FG000|NOT COMPLETED|Overall Study||37
10937158|NCT00336479|12106881|FG001|NOT COMPLETED|Overall Study||25
10937159|NCT00336479|12106882|FG002|NOT COMPLETED|Overall Study||26
10937160|NCT00336479|12106883|FG003|NOT COMPLETED|Overall Study||4
10937161|NCT00336492|12106897|FG000|STARTED|Overall Study||15
10937162|NCT00336492|12106898|FG001|STARTED|Overall Study||22
10937163|NCT00336492|12106899|FG002|STARTED|Overall Study||23
10937164|NCT00336492|12106897|FG000|COMPLETED|Overall Study||0
10937165|NCT00336492|12106898|FG001|COMPLETED|Overall Study||18
10937166|NCT00336492|12106899|FG002|COMPLETED|Overall Study||12
10937167|NCT00336492|12106897|FG000|NOT COMPLETED|Overall Study||15
10937168|NCT00336492|12106898|FG001|NOT COMPLETED|Overall Study||4
10937169|NCT00336492|12106899|FG002|NOT COMPLETED|Overall Study||11
10937170|NCT00336505|12106909|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|291
10937171|NCT00336505|12106910|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|291
10937172|NCT00336505|12106909|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
10937173|NCT00336505|12106910|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
10937174|NCT00336505|12106909|FG000|NOT COMPLETED|Overall Study||37
10937175|NCT00336505|12106910|FG001|NOT COMPLETED|Overall Study||27
10937176|NCT00336544|12106918|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|261
10937177|NCT00336544|12106919|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|260
10937178|NCT00336544|12106918|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
10937179|NCT00336544|12106919|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
10937180|NCT00336544|12106918|FG000|NOT COMPLETED|Overall Study||19
10937181|NCT00336544|12106919|FG001|NOT COMPLETED|Overall Study||22
10937182|NCT00336583|12106925|FG000|STARTED|Overall Study||27
10937183|NCT00336583|12106925|FG000|COMPLETED|Overall Study||25
10937184|NCT00336583|12106925|FG000|NOT COMPLETED|Overall Study||2
10937185|NCT00336700|12106929|FG000|STARTED|Overall Study||25
10937186|NCT00336700|12106929|FG000|COMPLETED|Overall Study||25
10937187|NCT00336700|12106929|FG000|NOT COMPLETED|Overall Study||0
10937188|NCT00336817|12106935|FG000|STARTED|Overall Study||15
10937189|NCT00336817|12106936|FG001|STARTED|Overall Study||15
10937190|NCT00336817|12106935|FG000|COMPLETED|Overall Study||14
10937191|NCT00336817|12106936|FG001|COMPLETED|Overall Study||13
10937192|NCT00336817|12106935|FG000|NOT COMPLETED|Overall Study||1
10937193|NCT00336817|12106936|FG001|NOT COMPLETED|Overall Study||2
10937194|NCT00336856|12106944|FG000|STARTED|Overall Study|Number of patients consented and registered for the study|35
10937195|NCT00336856|12106944|FG000|COMPLETED|Overall Study||31
10937196|NCT00336856|12106944|FG000|NOT COMPLETED|Overall Study||4
10937197|NCT00336895|12106948|FG000|STARTED|Overall Study||30
10937198|NCT00336895|12106948|FG000|COMPLETED|Overall Study||26
10937199|NCT00336895|12106948|FG000|NOT COMPLETED|Overall Study||4
10937200|NCT00337077|12106955|FG000|STARTED|Overall Study||43
10937201|NCT00337077|12106956|FG001|STARTED|Overall Study||53
10937202|NCT00337077|12106957|FG002|STARTED|Overall Study||25
10937203|NCT00337077|12106955|FG000|Treated|Overall Study||42
10937204|NCT00337077|12106956|FG001|Treated|Overall Study||52
10937205|NCT00337077|12106957|FG002|Treated|Overall Study||25
10937206|NCT00337077|12106955|FG000|Toxicity Assessed|Overall Study||42
10937207|NCT00337077|12106956|FG001|Toxicity Assessed|Overall Study||51
10937208|NCT00337077|12106957|FG002|Toxicity Assessed|Overall Study||25
10937209|NCT00337077|12106955|FG000|Eligible and Treated|Overall Study||41
10937210|NCT00337077|12106956|FG001|Eligible and Treated|Overall Study||51
10937211|NCT00337077|12106957|FG002|Eligible and Treated|Overall Study||24
10937212|NCT00337077|12106955|FG000|Patients With Measurable Disease|Overall Study||26
10937213|NCT00337077|12106956|FG001|Patients With Measurable Disease|Overall Study||38
10937214|NCT00337077|12106957|FG002|Patients With Measurable Disease|Overall Study||13
10937215|NCT00337077|12106955|FG000|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
10937216|NCT00337077|12106956|FG001|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
10937217|NCT00337077|12106957|FG002|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
10937218|NCT00337077|12106955|FG000|NOT COMPLETED|Overall Study||43
10937219|NCT00337077|12106956|FG001|NOT COMPLETED|Overall Study||53
10937220|NCT00337077|12106957|FG002|NOT COMPLETED|Overall Study||25
10937221|NCT00337103|12106965|FG000|STARTED|Overall Study||554
10937222|NCT00337103|12106966|FG001|STARTED|Overall Study||548
10937223|NCT00337103|12106965|FG000|Treated (Safety Population)|Overall Study||544
10937224|NCT00337103|12106966|FG001|Treated (Safety Population)|Overall Study||546
10937225|NCT00337103|12106965|FG000|COMPLETED|Overall Study||0
10937226|NCT00337103|12106966|FG001|COMPLETED|Overall Study||0
10937227|NCT00337103|12106965|FG000|NOT COMPLETED|Overall Study||554
10937228|NCT00337103|12106966|FG001|NOT COMPLETED|Overall Study||548
10937229|NCT00337129|12106973|FG000|STARTED|Overall Study||40
10937230|NCT00337129|12106973|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
10937231|NCT00337129|12106973|FG000|NOT COMPLETED|Overall Study||40
10937232|NCT00337168|12106977|FG000|STARTED|Overall Study||37
10937233|NCT00337168|12106977|FG000|Eligible|Overall Study||37
10937234|NCT00337168|12106977|FG000|Eligible and Treated|Overall Study||36
10937235|NCT00337168|12106977|FG000|COMPLETED|Overall Study||29
10937236|NCT00337168|12106977|FG000|NOT COMPLETED|Overall Study||8
10937237|NCT00337181|12106984|FG000|STARTED|Overall Study||49
10937238|NCT00337181|12106985|FG001|STARTED|Overall Study||65
10937239|NCT00337181|12106984|FG000|COMPLETED|Overall Study||49
10937240|NCT00337181|12106985|FG001|COMPLETED|Overall Study||65
10937241|NCT00337181|12106984|FG000|NOT COMPLETED|Overall Study||0
10937242|NCT00337181|12106985|FG001|NOT COMPLETED|Overall Study||0
10937243|NCT00337194|12106993|FG000|STARTED|Overall Study||23
10937244|NCT00337194|12106994|FG001|STARTED|Overall Study||7
10937245|NCT00337194|12106993|FG000|COMPLETED|Overall Study||11
10937246|NCT00337194|12106994|FG001|COMPLETED|Overall Study||3
10937247|NCT00337194|12106993|FG000|NOT COMPLETED|Overall Study||12
10937248|NCT00337194|12106994|FG001|NOT COMPLETED|Overall Study||4
10937249|NCT00337207|12107002|FG000|STARTED|Overall Study||55
10937250|NCT00337207|12107002|FG000|COMPLETED|Overall Study||52
10937251|NCT00337207|12107002|FG000|NOT COMPLETED|Overall Study||3
10937252|NCT00337272|12107009|FG000|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
10937253|NCT00337272|12107010|FG001|STARTED|Screening Period (Pre-randomization)||0
10937254|NCT00337272|12107009|FG000|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
10937255|NCT00337272|12107010|FG001|COMPLETED|Screening Period (Pre-randomization)||0
10937256|NCT00337272|12107009|FG000|NOT COMPLETED|Screening Period (Pre-randomization)||6
10937257|NCT00337272|12107010|FG001|NOT COMPLETED|Screening Period (Pre-randomization)||0
10937258|NCT00337272|12107009|FG000|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
10937259|NCT00337272|12107010|FG001|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
10937260|NCT00337272|12107009|FG000|Randomization|Treatment Period||7
10937261|NCT00337272|12107010|FG001|Randomization|Treatment Period||9
10937262|NCT00337272|12107009|FG000|COMPLETED|Treatment Period||6
10937263|NCT00337272|12107010|FG001|COMPLETED|Treatment Period||7
10937264|NCT00337272|12107009|FG000|NOT COMPLETED|Treatment Period||1
10937265|NCT00337272|12107010|FG001|NOT COMPLETED|Treatment Period||2
10937266|NCT00337272|12107009|FG000|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
10937267|NCT00337272|12107010|FG001|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
10937268|NCT00337272|12107009|FG000|COMPLETED|Withdrawal Period||6
10937269|NCT00337272|12107010|FG001|COMPLETED|Withdrawal Period||6
10937270|NCT00337272|12107009|FG000|NOT COMPLETED|Withdrawal Period||0
10937271|NCT00337272|12107010|FG001|NOT COMPLETED|Withdrawal Period||1
10937272|NCT00337285|12107016|FG000|STARTED|Overall Study||349
10937273|NCT00337285|12107016|FG000|COMPLETED|Overall Study||191
10937274|NCT00337285|12107016|FG000|NOT COMPLETED|Overall Study||158
10937275|NCT00337350|12107022|FG000|STARTED|Overall Study||9
10937276|NCT00337350|12107023|FG001|STARTED|Overall Study||11
10937277|NCT00337350|12107022|FG000|COMPLETED|Overall Study||8
10937278|NCT00337350|12107023|FG001|COMPLETED|Overall Study||10
10937279|NCT00337350|12107022|FG000|NOT COMPLETED|Overall Study||1
10937280|NCT00337350|12107023|FG001|NOT COMPLETED|Overall Study||1
10937281|NCT00337428|12107031|FG000|STARTED|Overall Study||419
10937282|NCT00337428|12107032|FG001|STARTED|Overall Study||424
10937283|NCT00337428|12107031|FG000|COMPLETED|Overall Study||415
10937284|NCT00337428|12107032|FG001|COMPLETED|Overall Study||421
10937285|NCT00337428|12107031|FG000|NOT COMPLETED|Overall Study||4
10937286|NCT00337428|12107032|FG001|NOT COMPLETED|Overall Study||3
10937287|NCT00337467|12107038|FG000|STARTED|Overall Study||61
10937288|NCT00337467|12107038|FG000|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
10937289|NCT00337467|12107038|FG000|COMPLETED|Overall Study||51
10937290|NCT00337467|12107038|FG000|NOT COMPLETED|Overall Study||10
10937291|NCT00337571|12107049|FG000|STARTED|Overall Study||52
10937292|NCT00337571|12107050|FG001|STARTED|Overall Study||53
10937293|NCT00337571|12107051|FG002|STARTED|Overall Study||59
10937294|NCT00337571|12107052|FG003|STARTED|Overall Study||54
10937295|NCT00337571|12107049|FG000|COMPLETED|Overall Study||38
10937296|NCT00337571|12107050|FG001|COMPLETED|Overall Study||44
10937297|NCT00337571|12107051|FG002|COMPLETED|Overall Study||49
10937298|NCT00337571|12107052|FG003|COMPLETED|Overall Study||47
10937299|NCT00337571|12107049|FG000|NOT COMPLETED|Overall Study||14
10937300|NCT00337571|12107050|FG001|NOT COMPLETED|Overall Study||9
10937301|NCT00337571|12107051|FG002|NOT COMPLETED|Overall Study||10
10937302|NCT00337571|12107052|FG003|NOT COMPLETED|Overall Study||7
10937303|NCT00337610|12107064|FG000|STARTED|Overall Study||96
10937304|NCT00337610|12107065|FG001|STARTED|Overall Study||94
10937305|NCT00337610|12107064|FG000|Completed Week 18|Overall Study||89
10937306|NCT00337610|12107065|FG001|Completed Week 18|Overall Study||82
10937307|NCT00337610|12107064|FG000|COMPLETED|Overall Study||79
10937308|NCT00337610|12107065|FG001|COMPLETED|Overall Study||80
10937309|NCT00337610|12107064|FG000|NOT COMPLETED|Overall Study||17
10937310|NCT00337610|12107065|FG001|NOT COMPLETED|Overall Study||14
10937311|NCT00337662|12107074|FG000|STARTED|Study Period II||0
10937312|NCT00337662|12107075|FG001|STARTED|Study Period II||0
10937313|NCT00337662|12107076|FG002|STARTED|Study Period II||0
10937314|NCT00337662|12107077|FG003|STARTED|Study Period II||628
10937315|NCT00337662|12107074|FG000|COMPLETED|Study Period II||0
10937316|NCT00337662|12107075|FG001|COMPLETED|Study Period II||0
10937317|NCT00337662|12107076|FG002|COMPLETED|Study Period II||0
10937318|NCT00337662|12107077|FG003|COMPLETED|Study Period II||522
10937319|NCT00337662|12107074|FG000|NOT COMPLETED|Study Period II||0
10937320|NCT00337662|12107075|FG001|NOT COMPLETED|Study Period II||0
10937321|NCT00337662|12107076|FG002|NOT COMPLETED|Study Period II||0
10937322|NCT00337662|12107077|FG003|NOT COMPLETED|Study Period II||106
10937323|NCT00337662|12107074|FG000|STARTED|Study Period III||186
10937324|NCT00337662|12107075|FG001|STARTED|Study Period III||192
10937325|NCT00337662|12107076|FG002|STARTED|Study Period III||144
10937326|NCT00337662|12107077|FG003|STARTED|Study Period III||0
10937327|NCT00337662|12107074|FG000|COMPLETED|Study Period III||126
10937328|NCT00337662|12107075|FG001|COMPLETED|Study Period III||134
10937329|NCT00337662|12107076|FG002|COMPLETED|Study Period III||100
10937330|NCT00337662|12107077|FG003|COMPLETED|Study Period III||0
10937331|NCT00337662|12107074|FG000|NOT COMPLETED|Study Period III||60
10937332|NCT00337662|12107075|FG001|NOT COMPLETED|Study Period III||58
10937333|NCT00337662|12107076|FG002|NOT COMPLETED|Study Period III||44
10937334|NCT00337662|12107077|FG003|NOT COMPLETED|Study Period III||0
10937335|NCT00337727|12107090|FG000|STARTED|Overall Study||430
10937336|NCT00337727|12107091|FG001|STARTED|Overall Study||418
10937337|NCT00337727|12107090|FG000|COMPLETED|Overall Study||412
10937338|NCT00337727|12107091|FG001|COMPLETED|Overall Study||406
10937339|NCT00337727|12107090|FG000|NOT COMPLETED|Overall Study||18
10937340|NCT00337727|12107091|FG001|NOT COMPLETED|Overall Study||12
10937341|NCT00337779|12107099|FG000|STARTED|Overall Study||586
10937342|NCT00337779|12107100|FG001|STARTED|Overall Study||569
10937343|NCT00337779|12107099|FG000|COMPLETED|Overall Study||534
10937344|NCT00337779|12107100|FG001|COMPLETED|Overall Study||490
10937345|NCT00337779|12107099|FG000|NOT COMPLETED|Overall Study||52
10937346|NCT00337779|12107100|FG001|NOT COMPLETED|Overall Study||79
10937347|NCT00337818|12107109|FG000|STARTED|Overall Study||458
10937348|NCT00337818|12107110|FG001|STARTED|Overall Study||154
10937349|NCT00337818|12107111|FG002|STARTED|Overall Study||158
10937350|NCT00337818|12107109|FG000|COMPLETED|Overall Study||169
10937351|NCT00337818|12107110|FG001|COMPLETED|Overall Study||63
10937352|NCT00337818|12107111|FG002|COMPLETED|Overall Study||51
10937353|NCT00337818|12107109|FG000|NOT COMPLETED|Overall Study||289
10937354|NCT00337818|12107110|FG001|NOT COMPLETED|Overall Study||91
10937355|NCT00337818|12107111|FG002|NOT COMPLETED|Overall Study||107
10937356|NCT00337935|12107121|FG000|STARTED|Overall Study||39
10937357|NCT00337935|12107122|FG001|STARTED|Overall Study||118
10937358|NCT00337935|12107121|FG000|COMPLETED|Overall Study||29
10937359|NCT00337935|12107122|FG001|COMPLETED|Overall Study||91
10937360|NCT00337935|12107121|FG000|NOT COMPLETED|Overall Study||10
10937361|NCT00337935|12107122|FG001|NOT COMPLETED|Overall Study||27
10937362|NCT00337987|12107129|FG000|STARTED|Overall Study||49
10937363|NCT00337987|12107129|FG000|COMPLETED|Overall Study||49
10937364|NCT00337987|12107129|FG000|NOT COMPLETED|Overall Study||0
10937365|NCT00338039|12107133|FG000|STARTED|Overall Study||69
10937366|NCT00338039|12107133|FG000|COMPLETED|Overall Study||69
10937367|NCT00338039|12107133|FG000|NOT COMPLETED|Overall Study||0
10937368|NCT00338286|12107139|FG000|STARTED|Overall Study||1048
10937369|NCT00338286|12107140|FG001|STARTED|Overall Study||1050
10937370|NCT00338286|12107139|FG000|COMPLETED|Overall Study||815
10937371|NCT00338286|12107140|FG001|COMPLETED|Overall Study||837
10937372|NCT00338286|12107139|FG000|NOT COMPLETED|Overall Study||233
10937373|NCT00338286|12107140|FG001|NOT COMPLETED|Overall Study||213
10937374|NCT00338598|12107148|FG000|STARTED|Overall Study||10
10937375|NCT00338598|12107149|FG001|STARTED|Overall Study||10
10937376|NCT00338598|12107148|FG000|COMPLETED|Overall Study||10
10937377|NCT00338598|12107149|FG001|COMPLETED|Overall Study||8
10937378|NCT00338598|12107148|FG000|NOT COMPLETED|Overall Study||0
10937379|NCT00338598|12107149|FG001|NOT COMPLETED|Overall Study||2
10937380|NCT00338728|12107155|FG000|STARTED|Overall Study||59
10937381|NCT00338728|12107155|FG000|COMPLETED|Overall Study||45
10937382|NCT00338728|12107155|FG000|NOT COMPLETED|Overall Study||14
10937383|NCT00338741|12107161|FG000|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
10937384|NCT00338741|12107162|FG001|STARTED|Overall Study||2
10937385|NCT00338741|12107161|FG000|COMPLETED|Overall Study||32
10937386|NCT00338741|12107162|FG001|COMPLETED|Overall Study||2
10937387|NCT00338741|12107161|FG000|NOT COMPLETED|Overall Study||2
10937388|NCT00338741|12107162|FG001|NOT COMPLETED|Overall Study||0
10937389|NCT00338806|12107170|FG000|STARTED|Acute Phase||2
10937390|NCT00338806|12107171|FG001|STARTED|Acute Phase||5
10937391|NCT00338806|12107170|FG000|COMPLETED|Acute Phase||2
10937392|NCT00338806|12107171|FG001|COMPLETED|Acute Phase||4
10937393|NCT00338806|12107170|FG000|NOT COMPLETED|Acute Phase||0
10937394|NCT00338806|12107171|FG001|NOT COMPLETED|Acute Phase||1
10937395|NCT00338806|12107170|FG000|STARTED|Follow-up||2
10937396|NCT00338806|12107171|FG001|STARTED|Follow-up||4
10937397|NCT00338806|12107170|FG000|COMPLETED|Follow-up||1
10937398|NCT00338806|12107171|FG001|COMPLETED|Follow-up||1
10937399|NCT00338806|12107170|FG000|NOT COMPLETED|Follow-up||1
10937400|NCT00338806|12107171|FG001|NOT COMPLETED|Follow-up||3
10937401|NCT00338884|12107179|FG000|STARTED|Overall Study||120
10937402|NCT00338884|12107179|FG000|Received Treatment|Overall Study||119
10937403|NCT00338884|12107179|FG000|COMPLETED|Overall Study||42
10937404|NCT00338884|12107179|FG000|NOT COMPLETED|Overall Study||78
10937405|NCT00338949|12107185|FG000|STARTED|Subject Screening||36
10937406|NCT00338949|12107186|FG001|STARTED|Subject Screening||41
10937407|NCT00338949|12107185|FG000|COMPLETED|Subject Screening||25
10937408|NCT00338949|12107186|FG001|COMPLETED|Subject Screening||30
10937409|NCT00338949|12107185|FG000|NOT COMPLETED|Subject Screening||11
10937410|NCT00338949|12107186|FG001|NOT COMPLETED|Subject Screening||11
10937411|NCT00338949|12107185|FG000|STARTED|Randomization||25
10937412|NCT00338949|12107186|FG001|STARTED|Randomization||30
10937413|NCT00338949|12107185|FG000|COMPLETED|Randomization|1 subject withdrew after relapse and hospitalization|24
10937414|NCT00338949|12107186|FG001|COMPLETED|Randomization|"Reasons for drop out:~2- insomnia 2- symptom exacerbation~1- akathisia"|25
10937415|NCT00338949|12107185|FG000|NOT COMPLETED|Randomization||1
10937416|NCT00338949|12107186|FG001|NOT COMPLETED|Randomization||5
10937417|NCT00338962|12107196|FG000|STARTED|Overall Study||22
10937418|NCT00338962|12107197|FG001|STARTED|Overall Study||20
10937419|NCT00338962|12107198|FG002|STARTED|Overall Study||22
10937420|NCT00338962|12107199|FG003|STARTED|Overall Study||24
10937421|NCT00338962|12107196|FG000|COMPLETED|Overall Study||14
10937422|NCT00338962|12107197|FG001|COMPLETED|Overall Study||16
10937423|NCT00338962|12107198|FG002|COMPLETED|Overall Study||16
10937424|NCT00338962|12107199|FG003|COMPLETED|Overall Study||21
10937425|NCT00338962|12107196|FG000|NOT COMPLETED|Overall Study||8
10937426|NCT00338962|12107197|FG001|NOT COMPLETED|Overall Study||4
10937427|NCT00338962|12107198|FG002|NOT COMPLETED|Overall Study||6
10937428|NCT00338962|12107199|FG003|NOT COMPLETED|Overall Study||3
10937429|NCT00338988|12107209|FG000|STARTED|Overall Study||44
10937430|NCT00338988|12107209|FG000|COMPLETED|Overall Study||43
10937431|NCT00338988|12107209|FG000|NOT COMPLETED|Overall Study||1
10937432|NCT00339040|12107216|FG000|STARTED|Stage I||96
10937433|NCT00339040|12107217|FG001|STARTED|Stage I||30
10937434|NCT00339040|12107216|FG000|Vaccination 1 at Week 0|Stage I||96
10937435|NCT00339040|12107217|FG001|Vaccination 1 at Week 0|Stage I||30
10937436|NCT00339040|12107216|FG000|Vaccination 2 at Week 8|Stage I||95
10937437|NCT00339040|12107217|FG001|Vaccination 2 at Week 8|Stage I||30
10937438|NCT00339040|12107216|FG000|Vaccination 3 at Week 24|Stage I||94
10937439|NCT00339040|12107217|FG001|Vaccination 3 at Week 24|Stage I||30
10937440|NCT00339040|12107216|FG000|COMPLETED|Stage I||94
10937441|NCT00339040|12107217|FG001|COMPLETED|Stage I||29
10937442|NCT00339040|12107216|FG000|NOT COMPLETED|Stage I||2
10937443|NCT00339040|12107217|FG001|NOT COMPLETED|Stage I||1
10937444|NCT00339040|12107216|FG000|STARTED|Stage II||94
10937445|NCT00339040|12107217|FG001|STARTED|Stage II||29
10937446|NCT00339040|12107216|FG000|Vaccination 4 at Week 96|Stage II||84
10937447|NCT00339040|12107217|FG001|Vaccination 4 at Week 96|Stage II||29
10937448|NCT00339040|12107216|FG000|Vaccination 5 at Week 104|Stage II||0
10937449|NCT00339040|12107217|FG001|Vaccination 5 at Week 104|Stage II||28
10937450|NCT00339040|12107216|FG000|Vaccination 6 at Week 120|Stage II||0
10937451|NCT00339040|12107217|FG001|Vaccination 6 at Week 120|Stage II||27
10937452|NCT00339040|12107216|FG000|COMPLETED|Stage II||84
10937453|NCT00339040|12107217|FG001|COMPLETED|Stage II||27
10937454|NCT00339040|12107216|FG000|NOT COMPLETED|Stage II||10
10937455|NCT00339040|12107217|FG001|NOT COMPLETED|Stage II||2
10937456|NCT00339079|12107227|FG000|STARTED|Overall Study||53
10937457|NCT00339079|12107228|FG001|STARTED|Overall Study||44
10937458|NCT00339079|12107229|FG002|STARTED|Overall Study||45
10937459|NCT00339079|12107230|FG003|STARTED|Overall Study||53
10937460|NCT00339079|12107227|FG000|COMPLETED|Overall Study||20
10937461|NCT00339079|12107228|FG001|COMPLETED|Overall Study||21
10937462|NCT00339079|12107229|FG002|COMPLETED|Overall Study||27
10937463|NCT00339079|12107230|FG003|COMPLETED|Overall Study||29
10937464|NCT00339079|12107227|FG000|NOT COMPLETED|Overall Study||33
10937465|NCT00339079|12107228|FG001|NOT COMPLETED|Overall Study||23
10937466|NCT00339079|12107229|FG002|NOT COMPLETED|Overall Study||18
10937467|NCT00339079|12107230|FG003|NOT COMPLETED|Overall Study||24
10937468|NCT00339144|12107247|FG000|STARTED|Overall Study|Number of participants enrolled and treated|9
10937469|NCT00339144|12107248|FG001|STARTED|Overall Study|Number of participants enrolled and treated|3
10937470|NCT00339144|12107249|FG002|STARTED|Overall Study|Number of participants enrolled and treated|4
10937471|NCT00339144|12107247|FG000|COMPLETED|Overall Study||0
10937472|NCT00339144|12107248|FG001|COMPLETED|Overall Study||0
10937473|NCT00339144|12107249|FG002|COMPLETED|Overall Study||0
10937474|NCT00339144|12107247|FG000|NOT COMPLETED|Overall Study||9
10937475|NCT00339144|12107248|FG001|NOT COMPLETED|Overall Study||3
10937476|NCT00339144|12107249|FG002|NOT COMPLETED|Overall Study||4
10937477|NCT00339833|12107260|FG000|STARTED|Overall Study||28
10937478|NCT00339833|12107261|FG001|STARTED|Overall Study||26
10937479|NCT00339833|12107260|FG000|COMPLETED|Overall Study||22
10937480|NCT00339833|12107261|FG001|COMPLETED|Overall Study||18
10937481|NCT00339833|12107260|FG000|NOT COMPLETED|Overall Study||6
10937482|NCT00339833|12107261|FG001|NOT COMPLETED|Overall Study||8
10937483|NCT00340379|12107269|FG000|STARTED|Overall Study||35
10937484|NCT00340379|12107270|FG001|STARTED|Overall Study||37
10937485|NCT00340379|12107269|FG000|COMPLETED|Overall Study||27
10937486|NCT00340379|12107270|FG001|COMPLETED|Overall Study||28
10937487|NCT00340379|12107269|FG000|NOT COMPLETED|Overall Study||8
10937488|NCT00340379|12107270|FG001|NOT COMPLETED|Overall Study||9
10937489|NCT00340678|12107280|FG000|STARTED|Overall Study||46
10937490|NCT00340678|12107281|FG001|STARTED|Overall Study||46
10937491|NCT00340678|12107282|FG002|STARTED|Overall Study||39
10937492|NCT00340678|12107283|FG003|STARTED|Overall Study||39
10937493|NCT00340678|12107280|FG000|COMPLETED|Overall Study||45
10937494|NCT00340678|12107281|FG001|COMPLETED|Overall Study||46
10937495|NCT00340678|12107282|FG002|COMPLETED|Overall Study||39
10937496|NCT00340678|12107283|FG003|COMPLETED|Overall Study||39
10937497|NCT00340678|12107280|FG000|NOT COMPLETED|Overall Study||1
10937498|NCT00340678|12107281|FG001|NOT COMPLETED|Overall Study||0
10937499|NCT00340678|12107282|FG002|NOT COMPLETED|Overall Study||0
10937500|NCT00340678|12107283|FG003|NOT COMPLETED|Overall Study||0
10937501|NCT00340704|12107300|FG000|STARTED|PK Study||10
10937502|NCT00340704|12107301|FG001|STARTED|PK Study||10
10937503|NCT00340704|12107302|FG002|STARTED|PK Study||11
10937504|NCT00340704|12107303|FG003|STARTED|PK Study||0
10937505|NCT00340704|12107304|FG004|STARTED|PK Study||0
10937506|NCT00340704|12107305|FG005|STARTED|PK Study||0
10937507|NCT00340704|12107306|FG006|STARTED|PK Study||0
10937508|NCT00340704|12107307|FG007|STARTED|PK Study||0
10937509|NCT00340704|12107308|FG008|STARTED|PK Study||0
10937510|NCT00340704|12107300|FG000|COMPLETED|PK Study||10
10937511|NCT00340704|12107301|FG001|COMPLETED|PK Study||9
10937512|NCT00340704|12107302|FG002|COMPLETED|PK Study||10
10937513|NCT00340704|12107303|FG003|COMPLETED|PK Study||0
10937514|NCT00340704|12107304|FG004|COMPLETED|PK Study||0
10937515|NCT00340704|12107305|FG005|COMPLETED|PK Study||0
10937516|NCT00340704|12107306|FG006|COMPLETED|PK Study||0
10937517|NCT00340704|12107307|FG007|COMPLETED|PK Study||0
10937518|NCT00340704|12107308|FG008|COMPLETED|PK Study||0
10937519|NCT00340704|12107300|FG000|NOT COMPLETED|PK Study||0
10937520|NCT00340704|12107301|FG001|NOT COMPLETED|PK Study||1
10937521|NCT00340704|12107302|FG002|NOT COMPLETED|PK Study||1
10937522|NCT00340704|12107303|FG003|NOT COMPLETED|PK Study||0
10937523|NCT00340704|12107304|FG004|NOT COMPLETED|PK Study||0
10937524|NCT00340704|12107305|FG005|NOT COMPLETED|PK Study||0
10937525|NCT00340704|12107306|FG006|NOT COMPLETED|PK Study||0
10937526|NCT00340704|12107307|FG007|NOT COMPLETED|PK Study||0
10937527|NCT00340704|12107308|FG008|NOT COMPLETED|PK Study||0
10937528|NCT00340704|12107300|FG000|STARTED|Group D- Denovo & 527.51 Rollover Study||0
10937529|NCT00340704|12107301|FG001|STARTED|Group D- Denovo & 527.51 Rollover Study||0
10937530|NCT00340704|12107302|FG002|STARTED|Group D- Denovo & 527.51 Rollover Study||0
10937531|NCT00340704|12107303|FG003|STARTED|Group D- Denovo & 527.51 Rollover Study||29
10937532|NCT00340704|12107304|FG004|STARTED|Group D- Denovo & 527.51 Rollover Study||21
10937533|NCT00340704|12107305|FG005|STARTED|Group D- Denovo & 527.51 Rollover Study||37
10937534|NCT00340704|12107306|FG006|STARTED|Group D- Denovo & 527.51 Rollover Study||54
10937535|NCT00340704|12107307|FG007|STARTED|Group D- Denovo & 527.51 Rollover Study||13
10937536|NCT00340704|12107308|FG008|STARTED|Group D- Denovo & 527.51 Rollover Study||29
10937537|NCT00340704|12107300|FG000|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
10937538|NCT00340704|12107301|FG001|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
10937539|NCT00340704|12107302|FG002|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
10937540|NCT00340704|12107303|FG003|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
10937541|NCT00340704|12107304|FG004|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
10937542|NCT00340704|12107305|FG005|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
10937543|NCT00340704|12107306|FG006|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
10937544|NCT00340704|12107307|FG007|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
10937545|NCT00340704|12107308|FG008|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
10937546|NCT00340704|12107300|FG000|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
10937547|NCT00340704|12107301|FG001|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
10937548|NCT00340704|12107302|FG002|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
10937549|NCT00340704|12107303|FG003|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
10937550|NCT00340704|12107304|FG004|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
10937551|NCT00340704|12107305|FG005|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
10937552|NCT00340704|12107306|FG006|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
10937553|NCT00340704|12107307|FG007|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
10937554|NCT00340704|12107308|FG008|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
10937555|NCT00340704|12107300|FG000|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
10937556|NCT00340704|12107301|FG001|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
10937557|NCT00340704|12107302|FG002|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
10937558|NCT00340704|12107303|FG003|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
10937559|NCT00340704|12107304|FG004|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
10937560|NCT00340704|12107305|FG005|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
10937561|NCT00340704|12107306|FG006|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
10937562|NCT00340704|12107307|FG007|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
10937563|NCT00340704|12107308|FG008|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
10937564|NCT00340834|12107339|FG000|STARTED|Core Phase of Study||426
10937565|NCT00340834|12107340|FG001|STARTED|Core Phase of Study||431
10937566|NCT00340834|12107341|FG002|STARTED|Core Phase of Study||435
10937567|NCT00340834|12107342|FG003|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
10937568|NCT00340834|12107343|FG004|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
10937569|NCT00340834|12107339|FG000|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
10937570|NCT00340834|12107340|FG001|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
10937571|NCT00340834|12107341|FG002|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
10937572|NCT00340834|12107342|FG003|COMPLETED|Core Phase of Study||0
10937573|NCT00340834|12107343|FG004|COMPLETED|Core Phase of Study||0
10937574|NCT00340834|12107339|FG000|NOT COMPLETED|Core Phase of Study||57
10937575|NCT00340834|12107340|FG001|NOT COMPLETED|Core Phase of Study||33
10937576|NCT00340834|12107341|FG002|NOT COMPLETED|Core Phase of Study||49
10937577|NCT00340834|12107342|FG003|NOT COMPLETED|Core Phase of Study||0
10937578|NCT00340834|12107343|FG004|NOT COMPLETED|Core Phase of Study||0
10937579|NCT00340834|12107339|FG000|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
10937580|NCT00340834|12107340|FG001|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
10937581|NCT00340834|12107341|FG002|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
10937582|NCT00340834|12107342|FG003|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
10937583|NCT00340834|12107343|FG004|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
10937584|NCT00340834|12107339|FG000|Received Study Drug|Extension Phase of Study||330
10937585|NCT00340834|12107340|FG001|Received Study Drug|Extension Phase of Study||356
10937586|NCT00340834|12107341|FG002|Received Study Drug|Extension Phase of Study||0
10937587|NCT00340834|12107342|FG003|Received Study Drug|Extension Phase of Study||174
10937588|NCT00340834|12107343|FG004|Received Study Drug|Extension Phase of Study||167
10937589|NCT00340834|12107339|FG000|COMPLETED|Extension Phase of Study||245
10937590|NCT00340834|12107340|FG001|COMPLETED|Extension Phase of Study||281
10937591|NCT00340834|12107341|FG002|COMPLETED|Extension Phase of Study||0
10937592|NCT00340834|12107342|FG003|COMPLETED|Extension Phase of Study||123
10937593|NCT00340834|12107343|FG004|COMPLETED|Extension Phase of Study||123
10937594|NCT00340834|12107339|FG000|NOT COMPLETED|Extension Phase of Study||85
10937595|NCT00340834|12107340|FG001|NOT COMPLETED|Extension Phase of Study||76
10937596|NCT00340834|12107341|FG002|NOT COMPLETED|Extension Phase of Study||0
10937597|NCT00340834|12107342|FG003|NOT COMPLETED|Extension Phase of Study||53
10937598|NCT00340834|12107343|FG004|NOT COMPLETED|Extension Phase of Study||44
10937599|NCT00342355|12107357|FG000|STARTED|Overall Study||444
10937600|NCT00342355|12107358|FG001|STARTED|Overall Study||440
10937601|NCT00342355|12107359|FG002|STARTED|Overall Study||444
10937602|NCT00342355|12107360|FG003|STARTED|Overall Study||443
10937603|NCT00342355|12107357|FG000|COMPLETED|Overall Study||444
10937604|NCT00342355|12107358|FG001|COMPLETED|Overall Study||440
10937605|NCT00342355|12107359|FG002|COMPLETED|Overall Study||444
10937606|NCT00342355|12107360|FG003|COMPLETED|Overall Study||443
10937607|NCT00342355|12107357|FG000|NOT COMPLETED|Overall Study||0
10937608|NCT00342355|12107358|FG001|NOT COMPLETED|Overall Study||0
10937609|NCT00342355|12107359|FG002|NOT COMPLETED|Overall Study||0
10937610|NCT00342355|12107360|FG003|NOT COMPLETED|Overall Study||0
10937611|NCT00342563|12107374|FG000|STARTED|Overall Study||41
10937612|NCT00342563|12107375|FG001|STARTED|Overall Study||27
10937613|NCT00342563|12107376|FG002|STARTED|Overall Study||40
10937614|NCT00342563|12107377|FG003|STARTED|Overall Study||28
10937615|NCT00342563|12107374|FG000|COMPLETED|Overall Study||35
10937616|NCT00342563|12107375|FG001|COMPLETED|Overall Study||19
10937617|NCT00342563|12107376|FG002|COMPLETED|Overall Study||26
10937618|NCT00342563|12107377|FG003|COMPLETED|Overall Study||22
10937619|NCT00342563|12107374|FG000|NOT COMPLETED|Overall Study||6
10937620|NCT00342563|12107375|FG001|NOT COMPLETED|Overall Study||8
10937621|NCT00342563|12107376|FG002|NOT COMPLETED|Overall Study||14
10937622|NCT00342563|12107377|FG003|NOT COMPLETED|Overall Study||6
10937623|NCT00342628|12107392|FG000|STARTED|Overall Study||100
10937624|NCT00342628|12107393|FG001|STARTED|Overall Study||101
10937625|NCT00342628|12107394|FG002|STARTED|Overall Study||100
10937626|NCT00342628|12107392|FG000|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
10937627|NCT00342628|12107393|FG001|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
10937628|NCT00342628|12107394|FG002|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
10937629|NCT00342628|12107392|FG000|NOT COMPLETED|Overall Study||20
10937630|NCT00342628|12107393|FG001|NOT COMPLETED|Overall Study||21
10937631|NCT00342628|12107394|FG002|NOT COMPLETED|Overall Study||19
10937632|NCT00343044|12107402|FG000|STARTED|Overall Study||40
10937633|NCT00343044|12107402|FG000|COMPLETED|Overall Study||40
10937634|NCT00343044|12107402|FG000|NOT COMPLETED|Overall Study||0
10937635|NCT00343083|12107406|FG000|STARTED|Overall Study||43
10937636|NCT00343083|12107406|FG000|COMPLETED|Overall Study||22
10937637|NCT00343083|12107406|FG000|NOT COMPLETED|Overall Study||21
10937638|NCT00343252|12107413|FG000|STARTED|All Randomized Participants||361
10937639|NCT00343252|12107414|FG001|STARTED|All Randomized Participants||351
10937640|NCT00343252|12107413|FG000|COMPLETED|All Randomized Participants||259
10937641|NCT00343252|12107414|FG001|COMPLETED|All Randomized Participants||269
10937642|NCT00343252|12107413|FG000|NOT COMPLETED|All Randomized Participants||102
10937643|NCT00343252|12107414|FG001|NOT COMPLETED|All Randomized Participants||82
10937644|NCT00343252|12107413|FG000|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
10937645|NCT00343252|12107414|FG001|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
10937646|NCT00343252|12107413|FG000|COMPLETED|6 Months (All Treated Participants)||304
10937647|NCT00343252|12107414|FG001|COMPLETED|6 Months (All Treated Participants)||306
10937648|NCT00343252|12107413|FG000|NOT COMPLETED|6 Months (All Treated Participants)||56
10937649|NCT00343252|12107414|FG001|NOT COMPLETED|6 Months (All Treated Participants)||44
10937650|NCT00343252|12107413|FG000|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
10937651|NCT00343252|12107414|FG001|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
10937652|NCT00343252|12107413|FG000|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
10937653|NCT00343252|12107414|FG001|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
10937654|NCT00343252|12107413|FG000|NOT COMPLETED|12 Months (All Treated Participants)||86
10937655|NCT00343252|12107414|FG001|NOT COMPLETED|12 Months (All Treated Participants)||69
10937656|NCT00343252|12107413|FG000|STARTED|18 Months (All Treated Participants)||360
10937657|NCT00343252|12107414|FG001|STARTED|18 Months (All Treated Participants)||350
10937658|NCT00343252|12107413|FG000|COMPLETED|18 Months (All Treated Participants)||259
10937659|NCT00343252|12107414|FG001|COMPLETED|18 Months (All Treated Participants)||269
10937660|NCT00343252|12107413|FG000|NOT COMPLETED|18 Months (All Treated Participants)||101
10937661|NCT00343252|12107414|FG001|NOT COMPLETED|18 Months (All Treated Participants)||81
10937662|NCT00343291|12107422|FG000|STARTED|Overall Study||60
10937663|NCT00343291|12107423|FG001|STARTED|Overall Study||61
10937664|NCT00343291|12107422|FG000|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
10937665|NCT00343291|12107423|FG001|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
10937666|NCT00343291|12107422|FG000|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
10937667|NCT00343291|12107423|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
10937668|NCT00343291|12107422|FG000|NOT COMPLETED|Overall Study||57
10937669|NCT00343291|12107423|FG001|NOT COMPLETED|Overall Study||56
10937670|NCT00343382|12107432|FG000|STARTED|Overall Study||64
10937671|NCT00343382|12107433|FG001|STARTED|Overall Study||65
10937672|NCT00343382|12107434|FG002|STARTED|Overall Study||66
10937673|NCT00343382|12107432|FG000|COMPLETED|Overall Study||60
10937674|NCT00343382|12107433|FG001|COMPLETED|Overall Study||51
10937675|NCT00343382|12107434|FG002|COMPLETED|Overall Study||49
10937676|NCT00343382|12107432|FG000|NOT COMPLETED|Overall Study||4
10937677|NCT00343382|12107433|FG001|NOT COMPLETED|Overall Study||14
10937678|NCT00343382|12107434|FG002|NOT COMPLETED|Overall Study||17
10937679|NCT00343460|12107448|FG000|STARTED|Cycle 1||475
10937680|NCT00343460|12107449|FG001|STARTED|Cycle 1||481
10937681|NCT00343460|12107450|FG002|STARTED|Cycle 1||472
10937682|NCT00343460|12107448|FG000|COMPLETED|Cycle 1||453
10937683|NCT00343460|12107449|FG001|COMPLETED|Cycle 1||459
10937684|NCT00343460|12107450|FG002|COMPLETED|Cycle 1||454
10937685|NCT00343460|12107448|FG000|NOT COMPLETED|Cycle 1||22
10937686|NCT00343460|12107449|FG001|NOT COMPLETED|Cycle 1||22
10937687|NCT00343460|12107450|FG002|NOT COMPLETED|Cycle 1||18
10937688|NCT00343460|12107448|FG000|STARTED|Cycle 2 - 4||584
10937689|NCT00343460|12107449|FG001|STARTED|Cycle 2 - 4||565
10937690|NCT00343460|12107450|FG002|STARTED|Cycle 2 - 4||0
10937691|NCT00343460|12107448|FG000|COMPLETED|Cycle 2 - 4||528
10937692|NCT00343460|12107449|FG001|COMPLETED|Cycle 2 - 4||515
10937693|NCT00343460|12107450|FG002|COMPLETED|Cycle 2 - 4||0
10937694|NCT00343460|12107448|FG000|NOT COMPLETED|Cycle 2 - 4||56
10937695|NCT00343460|12107449|FG001|NOT COMPLETED|Cycle 2 - 4||50
10937696|NCT00343460|12107450|FG002|NOT COMPLETED|Cycle 2 - 4||0
10937697|NCT00343512|12107468|FG000|STARTED|Overall Study||34
10937698|NCT00343512|12107468|FG000|COMPLETED|Overall Study||32
10937699|NCT00343512|12107468|FG000|NOT COMPLETED|Overall Study||2
10937700|NCT00343564|12107484|FG000|STARTED|Overall Study||6
10937701|NCT00343564|12107485|FG001|STARTED|Overall Study||7
10937702|NCT00343564|12107486|FG002|STARTED|Overall Study||3
10937703|NCT00343564|12107487|FG003|STARTED|Overall Study||7
10937704|NCT00343564|12107488|FG004|STARTED|Overall Study||10
10937705|NCT00343564|12107489|FG005|STARTED|Overall Study||9
10937706|NCT00343564|12107490|FG006|STARTED|Overall Study||4
10937707|NCT00343564|12107491|FG007|STARTED|Overall Study||3
10937708|NCT00343564|12107492|FG008|STARTED|Overall Study||3
10937709|NCT00343564|12107493|FG009|STARTED|Overall Study||8
10937710|NCT00343564|12107494|FG010|STARTED|Overall Study||8
10937711|NCT00343564|12107484|FG000|COMPLETED|Overall Study||6
10937712|NCT00343564|12107485|FG001|COMPLETED|Overall Study||7
10937713|NCT00343564|12107486|FG002|COMPLETED|Overall Study||3
10937714|NCT00343564|12107487|FG003|COMPLETED|Overall Study||7
10937715|NCT00343564|12107488|FG004|COMPLETED|Overall Study||10
10937716|NCT00343564|12107489|FG005|COMPLETED|Overall Study||9
10937717|NCT00343564|12107490|FG006|COMPLETED|Overall Study||4
10937718|NCT00343564|12107491|FG007|COMPLETED|Overall Study||3
10937719|NCT00343564|12107492|FG008|COMPLETED|Overall Study||3
10937720|NCT00343564|12107493|FG009|COMPLETED|Overall Study||8
10937721|NCT00343564|12107494|FG010|COMPLETED|Overall Study||8
10937722|NCT00343564|12107484|FG000|NOT COMPLETED|Overall Study||0
10937723|NCT00343564|12107485|FG001|NOT COMPLETED|Overall Study||0
10937724|NCT00343564|12107486|FG002|NOT COMPLETED|Overall Study||0
10937725|NCT00343564|12107487|FG003|NOT COMPLETED|Overall Study||0
10937726|NCT00343564|12107488|FG004|NOT COMPLETED|Overall Study||0
10937727|NCT00343564|12107489|FG005|NOT COMPLETED|Overall Study||0
10937728|NCT00343564|12107490|FG006|NOT COMPLETED|Overall Study||0
10937729|NCT00343564|12107491|FG007|NOT COMPLETED|Overall Study||0
10937730|NCT00343564|12107492|FG008|NOT COMPLETED|Overall Study||0
10937731|NCT00343564|12107493|FG009|NOT COMPLETED|Overall Study||0
10937732|NCT00343564|12107494|FG010|NOT COMPLETED|Overall Study||0
10937733|NCT00343642|12107592|FG000|STARTED|Overall Study||19
10937734|NCT00343642|12107593|FG001|STARTED|Overall Study||19
10937735|NCT00343642|12107594|FG002|STARTED|Overall Study||16
10937736|NCT00343642|12107592|FG000|Upto 3 Months Complete or Flare|Overall Study||2
10937737|NCT00343642|12107593|FG001|Upto 3 Months Complete or Flare|Overall Study||0
10937738|NCT00343642|12107594|FG002|Upto 3 Months Complete or Flare|Overall Study||1
10937739|NCT00343642|12107592|FG000|3-6 Months Complete or Flare|Overall Study||4
10937740|NCT00343642|12107593|FG001|3-6 Months Complete or Flare|Overall Study||2
10937741|NCT00343642|12107594|FG002|3-6 Months Complete or Flare|Overall Study||2
10937742|NCT00343642|12107592|FG000|COMPLETED|Overall Study||10
10937743|NCT00343642|12107593|FG001|COMPLETED|Overall Study||11
10937744|NCT00343642|12107594|FG002|COMPLETED|Overall Study||9
10937745|NCT00343642|12107592|FG000|NOT COMPLETED|Overall Study||9
10937746|NCT00343642|12107593|FG001|NOT COMPLETED|Overall Study||8
10937747|NCT00343642|12107594|FG002|NOT COMPLETED|Overall Study||7
10937748|NCT00343785|12107605|FG000|STARTED|Overall Study||21
10937749|NCT00343785|12107605|FG000|COMPLETED|Overall Study||21
10937750|NCT00343785|12107605|FG000|NOT COMPLETED|Overall Study||0
10937751|NCT00343863|12107612|FG000|STARTED|Overall Study||7
10937752|NCT00343863|12107613|FG001|STARTED|Overall Study||34
10937753|NCT00343863|12107612|FG000|COMPLETED|Overall Study||7
10937754|NCT00343863|12107613|FG001|COMPLETED|Overall Study||34
10937755|NCT00343863|12107612|FG000|NOT COMPLETED|Overall Study||0
10937756|NCT00343863|12107613|FG001|NOT COMPLETED|Overall Study||0
10937757|NCT00343889|12107623|FG000|STARTED|Overall Study||190
10937758|NCT00343889|12107624|FG001|STARTED|Overall Study||189
10937759|NCT00343889|12107623|FG000|COMPLETED|Overall Study||187
10937760|NCT00343889|12107624|FG001|COMPLETED|Overall Study||188
10937761|NCT00343889|12107623|FG000|NOT COMPLETED|Overall Study||3
10937762|NCT00343889|12107624|FG001|NOT COMPLETED|Overall Study||1
10937763|NCT00343915|12107632|FG000|STARTED|Primary Study||258
10937764|NCT00343915|12107633|FG001|STARTED|Primary Study||126
10937765|NCT00343915|12107632|FG000|COMPLETED|Primary Study||254
10937766|NCT00343915|12107633|FG001|COMPLETED|Primary Study||123
10937767|NCT00343915|12107632|FG000|NOT COMPLETED|Primary Study||4
10937768|NCT00343915|12107633|FG001|NOT COMPLETED|Primary Study||3
10937769|NCT00343915|12107632|FG000|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
10937770|NCT00343915|12107633|FG001|STARTED|Month 30 Follow-up||88
10937771|NCT00343915|12107632|FG000|COMPLETED|Month 30 Follow-up||179
10937772|NCT00343915|12107633|FG001|COMPLETED|Month 30 Follow-up||88
10937773|NCT00343915|12107632|FG000|NOT COMPLETED|Month 30 Follow-up||0
10937774|NCT00343915|12107633|FG001|NOT COMPLETED|Month 30 Follow-up||0
10937775|NCT00343915|12107632|FG000|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
10937776|NCT00343915|12107633|FG001|STARTED|Month 42 Follow-up||84
10937777|NCT00343915|12107632|FG000|COMPLETED|Month 42 Follow-up||174
10937778|NCT00343915|12107633|FG001|COMPLETED|Month 42 Follow-up||84
10937779|NCT00343915|12107632|FG000|NOT COMPLETED|Month 42 Follow-up||0
10937780|NCT00343915|12107633|FG001|NOT COMPLETED|Month 42 Follow-up||0
10937781|NCT00343915|12107632|FG000|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
10937782|NCT00343915|12107633|FG001|STARTED|Month 54 Follow-up||79
10937783|NCT00343915|12107632|FG000|COMPLETED|Month 54 Follow-up||166
10937784|NCT00343915|12107633|FG001|COMPLETED|Month 54 Follow-up||79
10937785|NCT00343915|12107632|FG000|NOT COMPLETED|Month 54 Follow-up||0
10937786|NCT00343915|12107633|FG001|NOT COMPLETED|Month 54 Follow-up||0
10937787|NCT00343915|12107632|FG000|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
10937788|NCT00343915|12107633|FG001|STARTED|Month 66 Follow-up||76
10937789|NCT00343915|12107632|FG000|COMPLETED|Month 66 Follow-up||158
10937790|NCT00343915|12107633|FG001|COMPLETED|Month 66 Follow-up||76
10937791|NCT00343915|12107632|FG000|NOT COMPLETED|Month 66 Follow-up||0
10937792|NCT00343915|12107633|FG001|NOT COMPLETED|Month 66 Follow-up||0
10937793|NCT00344032|12107644|FG000|STARTED|Overall Study||176
10937794|NCT00344032|12107645|FG001|STARTED|Overall Study||178
10937795|NCT00344032|12107644|FG000|COMPLETED|Overall Study||162
10937796|NCT00344032|12107645|FG001|COMPLETED|Overall Study||168
10937797|NCT00344032|12107644|FG000|NOT COMPLETED|Overall Study||14
10937798|NCT00344032|12107645|FG001|NOT COMPLETED|Overall Study||10
10937799|NCT00344175|12107653|FG000|STARTED|Overall Study||121
10937800|NCT00344175|12107654|FG001|STARTED|Overall Study||57
10937801|NCT00344175|12107653|FG000|COMPLETED|Overall Study||109
10937802|NCT00344175|12107654|FG001|COMPLETED|Overall Study||47
10937803|NCT00344175|12107653|FG000|NOT COMPLETED|Overall Study||12
10937804|NCT00344175|12107654|FG001|NOT COMPLETED|Overall Study||10
10937805|NCT00344305|12107662|FG000|STARTED|Overall Study||100
10937806|NCT00344305|12107663|FG001|STARTED|Overall Study||100
10937807|NCT00344305|12107662|FG000|COMPLETED|Overall Study||98
10937808|NCT00344305|12107663|FG001|COMPLETED|Overall Study||99
10937809|NCT00344305|12107662|FG000|NOT COMPLETED|Overall Study||2
10937810|NCT00344305|12107663|FG001|NOT COMPLETED|Overall Study||1
10937811|NCT00344318|12107674|FG000|STARTED|Overall Study||300
10937812|NCT00344318|12107675|FG001|STARTED|Overall Study||303
10937813|NCT00344318|12107676|FG002|STARTED|Overall Study||100
10937814|NCT00344318|12107677|FG003|STARTED|Overall Study||103
10937815|NCT00344318|12107674|FG000|COMPLETED|Overall Study||296
10937816|NCT00344318|12107675|FG001|COMPLETED|Overall Study||298
10937817|NCT00344318|12107676|FG002|COMPLETED|Overall Study||99
10937818|NCT00344318|12107677|FG003|COMPLETED|Overall Study||100
10937819|NCT00344318|12107674|FG000|NOT COMPLETED|Overall Study||4
10937820|NCT00344318|12107675|FG001|NOT COMPLETED|Overall Study||5
10937821|NCT00344318|12107676|FG002|NOT COMPLETED|Overall Study||1
10937822|NCT00344318|12107677|FG003|NOT COMPLETED|Overall Study||3
10937823|NCT00344370|12107691|FG000|STARTED|Overall Study||143
10937824|NCT00344370|12107692|FG001|STARTED|Overall Study||71
10937825|NCT00344370|12107691|FG000|COMPLETED|Overall Study||128
10937826|NCT00344370|12107692|FG001|COMPLETED|Overall Study||68
10937827|NCT00344370|12107691|FG000|NOT COMPLETED|Overall Study||15
10937828|NCT00344370|12107692|FG001|NOT COMPLETED|Overall Study||3
10937829|NCT00344448|12107700|FG000|STARTED|Screening|No randomization during the screening phase|6
10937830|NCT00344448|12107701|FG001|STARTED|Screening||4
10937831|NCT00344448|12107700|FG000|COMPLETED|Screening||6
10937832|NCT00344448|12107701|FG001|COMPLETED|Screening||3
10937833|NCT00344448|12107700|FG000|NOT COMPLETED|Screening||0
10937834|NCT00344448|12107701|FG001|NOT COMPLETED|Screening||1
10937835|NCT00344448|12107700|FG000|STARTED|Double Blind, Placebo Controlled||6
10937836|NCT00344448|12107701|FG001|STARTED|Double Blind, Placebo Controlled||3
10937837|NCT00344448|12107700|FG000|COMPLETED|Double Blind, Placebo Controlled||4
10937838|NCT00344448|12107701|FG001|COMPLETED|Double Blind, Placebo Controlled||3
10937839|NCT00344448|12107700|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||2
10937840|NCT00344448|12107701|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||0
10937841|NCT00344448|12107700|FG000|STARTED|Open Label||4
10937842|NCT00344448|12107701|FG001|STARTED|Open Label||3
10937843|NCT00344448|12107700|FG000|COMPLETED|Open Label||2
10937844|NCT00344448|12107701|FG001|COMPLETED|Open Label||2
10937845|NCT00344448|12107700|FG000|NOT COMPLETED|Open Label||2
10937846|NCT00344448|12107701|FG001|NOT COMPLETED|Open Label||1
10937847|NCT00344461|12107707|FG000|STARTED|Overall Study||54
10937848|NCT00344461|12107707|FG000|COMPLETED|Overall Study||33
10937849|NCT00344461|12107707|FG000|NOT COMPLETED|Overall Study||21
10937850|NCT00344500|12107714|FG000|STARTED|Overall Study||48
10937851|NCT00344500|12107715|FG001|STARTED|Overall Study||60
10937852|NCT00344500|12107716|FG002|STARTED|Overall Study||14
10937853|NCT00344500|12107714|FG000|COMPLETED|Overall Study||25
10937854|NCT00344500|12107715|FG001|COMPLETED|Overall Study||25
10937855|NCT00344500|12107716|FG002|COMPLETED|Overall Study||12
10937856|NCT00344500|12107714|FG000|NOT COMPLETED|Overall Study||23
10937857|NCT00344500|12107715|FG001|NOT COMPLETED|Overall Study||35
10937858|NCT00344500|12107716|FG002|NOT COMPLETED|Overall Study||2
10937859|NCT00344682|12107725|FG000|STARTED|Overall Study||16
10937860|NCT00344682|12107726|FG001|STARTED|Overall Study||15
10937861|NCT00344682|12107725|FG000|COMPLETED|Overall Study||12
10937862|NCT00344682|12107726|FG001|COMPLETED|Overall Study||14
10937863|NCT00344682|12107725|FG000|NOT COMPLETED|Overall Study||4
10937864|NCT00344682|12107726|FG001|NOT COMPLETED|Overall Study||1
10937865|NCT00344773|12107732|FG000|STARTED|Overall Study||46
10937866|NCT00344773|12107732|FG000|COMPLETED|Overall Study||25
10937867|NCT00344773|12107732|FG000|NOT COMPLETED|Overall Study||21
10937868|NCT00344968|12107739|FG000|STARTED|Overall Study||185
10937869|NCT00344968|12107740|FG001|STARTED|Overall Study||376
10937870|NCT00344968|12107741|FG002|STARTED|Overall Study||395
10937871|NCT00344968|12107739|FG000|COMPLETED|Overall Study||126
10937872|NCT00344968|12107740|FG001|COMPLETED|Overall Study||274
10937873|NCT00344968|12107741|FG002|COMPLETED|Overall Study||279
10937874|NCT00344968|12107739|FG000|NOT COMPLETED|Overall Study||59
10937875|NCT00344968|12107740|FG001|NOT COMPLETED|Overall Study||102
10937876|NCT00344968|12107741|FG002|NOT COMPLETED|Overall Study||116
10937877|NCT00345033|12107752|FG000|STARTED|Overall Study||20
10937878|NCT00345033|12107753|FG001|STARTED|Overall Study||18
10937879|NCT00345033|12107752|FG000|COMPLETED|Overall Study||16
10937880|NCT00345033|12107753|FG001|COMPLETED|Overall Study||14
10937881|NCT00345033|12107752|FG000|NOT COMPLETED|Overall Study||4
10937882|NCT00345033|12107753|FG001|NOT COMPLETED|Overall Study||4
10937883|NCT00345046|12107762|FG000|STARTED|Overall Study||18
10937884|NCT00345046|12107763|FG001|STARTED|Overall Study||22
10937885|NCT00345046|12107764|FG002|STARTED|Overall Study||16
10937886|NCT00345046|12107762|FG000|COMPLETED|Overall Study||17
10937887|NCT00345046|12107763|FG001|COMPLETED|Overall Study||21
10937888|NCT00345046|12107764|FG002|COMPLETED|Overall Study||14
10937889|NCT00345046|12107762|FG000|NOT COMPLETED|Overall Study||1
10937890|NCT00345046|12107763|FG001|NOT COMPLETED|Overall Study||1
10937891|NCT00345046|12107764|FG002|NOT COMPLETED|Overall Study||2
10937892|NCT00345176|12107776|FG000|STARTED|Overall Study||1012
10937893|NCT00345176|12107777|FG001|STARTED|Overall Study||1044
10937894|NCT00345176|12107778|FG002|STARTED|Overall Study||1068
10937895|NCT00345176|12107779|FG003|STARTED|Overall Study||1079
10937896|NCT00345176|12107776|FG000|COMPLETED|Overall Study||1007
10937897|NCT00345176|12107777|FG001|COMPLETED|Overall Study||1038
10937898|NCT00345176|12107778|FG002|COMPLETED|Overall Study||1062
10937899|NCT00345176|12107779|FG003|COMPLETED|Overall Study||1069
10937900|NCT00345176|12107776|FG000|NOT COMPLETED|Overall Study||5
10937901|NCT00345176|12107777|FG001|NOT COMPLETED|Overall Study||6
10937902|NCT00345176|12107778|FG002|NOT COMPLETED|Overall Study||6
10937903|NCT00345176|12107779|FG003|NOT COMPLETED|Overall Study||10
10937904|NCT00345254|12107793|FG000|STARTED|Overall Study||30
10937905|NCT00345254|12107794|FG001|STARTED|Overall Study||30
10937906|NCT00345254|12107793|FG000|COMPLETED|Overall Study||30
10937907|NCT00345254|12107794|FG001|COMPLETED|Overall Study||30
10937908|NCT00345254|12107793|FG000|NOT COMPLETED|Overall Study||0
10937909|NCT00345254|12107794|FG001|NOT COMPLETED|Overall Study||0
10937910|NCT00345293|12107800|FG000|STARTED|Overall Study||10
10937911|NCT00345293|12107801|FG001|STARTED|Overall Study||3
10937912|NCT00345293|12107800|FG000|COMPLETED|Overall Study||8
10937913|NCT00345293|12107801|FG001|COMPLETED|Overall Study||3
10937914|NCT00345293|12107800|FG000|NOT COMPLETED|Overall Study||2
10937915|NCT00345293|12107801|FG001|NOT COMPLETED|Overall Study||0
10937916|NCT00345332|12107809|FG000|STARTED|Overall Study||11
10937917|NCT00345332|12107810|FG001|STARTED|Overall Study||20
10937918|NCT00345332|12107809|FG000|COMPLETED|Overall Study||11
10937919|NCT00345332|12107810|FG001|COMPLETED|Overall Study||20
10937920|NCT00345332|12107809|FG000|NOT COMPLETED|Overall Study||0
10937921|NCT00345332|12107810|FG001|NOT COMPLETED|Overall Study||0
10937922|NCT00345371|12107818|FG000|STARTED|Overall Study||69
10937923|NCT00345371|12107819|FG001|STARTED|Overall Study||71
10937924|NCT00345371|12107818|FG000|COMPLETED|Overall Study||39
10937925|NCT00345371|12107819|FG001|COMPLETED|Overall Study||38
10937926|NCT00345371|12107818|FG000|NOT COMPLETED|Overall Study||30
10937927|NCT00345371|12107819|FG001|NOT COMPLETED|Overall Study||33
10937928|NCT00345384|12107827|FG000|STARTED|Overall Study||19
10937929|NCT00345384|12107828|FG001|STARTED|Overall Study||19
10937930|NCT00345384|12107827|FG000|COMPLETED|Overall Study||19
10937931|NCT00345384|12107828|FG001|COMPLETED|Overall Study||19
10937932|NCT00345384|12107827|FG000|NOT COMPLETED|Overall Study||0
10937933|NCT00345384|12107828|FG001|NOT COMPLETED|Overall Study||0
10937934|NCT00345397|12107836|FG000|STARTED|Overall Study||7
10937935|NCT00345397|12107836|FG000|COMPLETED|Overall Study||6
10937936|NCT00345397|12107836|FG000|NOT COMPLETED|Overall Study||1
10937937|NCT00345540|12107841|FG000|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
10937938|NCT00345540|12107841|FG000|COMPLETED|Overall Study||15
10937939|NCT00345540|12107841|FG000|NOT COMPLETED|Overall Study||1
10937940|NCT00345579|12107847|FG000|STARTED|Overall Study||3278
10937941|NCT00345579|12107848|FG001|STARTED|Overall Study||1113
10937942|NCT00345579|12107847|FG000|COMPLETED|Overall Study||3114
10937943|NCT00345579|12107848|FG001|COMPLETED|Overall Study||1048
10937944|NCT00345579|12107847|FG000|NOT COMPLETED|Overall Study||164
10937945|NCT00345579|12107848|FG001|NOT COMPLETED|Overall Study||65
10937946|NCT00345592|12107857|FG000|STARTED|Overall Study||199
10937947|NCT00345592|12107858|FG001|STARTED|Overall Study||197
10937948|NCT00345592|12107857|FG000|COMPLETED|Overall Study||174
10937949|NCT00345592|12107858|FG001|COMPLETED|Overall Study||173
10937950|NCT00345592|12107857|FG000|NOT COMPLETED|Overall Study||25
10937951|NCT00345592|12107858|FG001|NOT COMPLETED|Overall Study||24
10937952|NCT00345605|12107864|FG000|STARTED|Initial Washout||6
10937953|NCT00345605|12107865|FG001|STARTED|Initial Washout||6
10937954|NCT00345605|12107864|FG000|COMPLETED|Initial Washout||6
10937955|NCT00345605|12107865|FG001|COMPLETED|Initial Washout||6
10937956|NCT00345605|12107864|FG000|NOT COMPLETED|Initial Washout||0
10937957|NCT00345605|12107865|FG001|NOT COMPLETED|Initial Washout||0
10937958|NCT00345605|12107864|FG000|STARTED|Arm 1||6
10937959|NCT00345605|12107865|FG001|STARTED|Arm 1||6
10937960|NCT00345605|12107864|FG000|COMPLETED|Arm 1||6
10937961|NCT00345605|12107865|FG001|COMPLETED|Arm 1||5
10937962|NCT00345605|12107864|FG000|NOT COMPLETED|Arm 1||0
10937963|NCT00345605|12107865|FG001|NOT COMPLETED|Arm 1||1
10937964|NCT00345605|12107864|FG000|STARTED|Interval||6
10937965|NCT00345605|12107865|FG001|STARTED|Interval||6
10937966|NCT00345605|12107864|FG000|COMPLETED|Interval||6
10937967|NCT00345605|12107865|FG001|COMPLETED|Interval||6
10937968|NCT00345605|12107864|FG000|NOT COMPLETED|Interval||0
10937969|NCT00345605|12107865|FG001|NOT COMPLETED|Interval||0
10937970|NCT00345605|12107864|FG000|STARTED|Crossover Wash-out||6
10937971|NCT00345605|12107865|FG001|STARTED|Crossover Wash-out||6
10937972|NCT00345605|12107864|FG000|COMPLETED|Crossover Wash-out||6
10937973|NCT00345605|12107865|FG001|COMPLETED|Crossover Wash-out||6
10937974|NCT00345605|12107864|FG000|NOT COMPLETED|Crossover Wash-out||0
10937975|NCT00345605|12107865|FG001|NOT COMPLETED|Crossover Wash-out||0
10937976|NCT00345605|12107864|FG000|STARTED|Arm 2, Opposite Treatment||6
10937977|NCT00345605|12107865|FG001|STARTED|Arm 2, Opposite Treatment||6
10937978|NCT00345605|12107864|FG000|COMPLETED|Arm 2, Opposite Treatment||5
10937979|NCT00345605|12107865|FG001|COMPLETED|Arm 2, Opposite Treatment||6
10937980|NCT00345605|12107864|FG000|NOT COMPLETED|Arm 2, Opposite Treatment||1
10937981|NCT00345605|12107865|FG001|NOT COMPLETED|Arm 2, Opposite Treatment||0
10937982|NCT00345631|12107876|FG000|STARTED|Overall Study||87
10937983|NCT00345631|12107877|FG001|STARTED|Overall Study||267
10937984|NCT00345631|12107878|FG002|STARTED|Overall Study||134
10937985|NCT00345631|12107876|FG000|COMPLETED|Overall Study||83
10937986|NCT00345631|12107877|FG001|COMPLETED|Overall Study||259
10937987|NCT00345631|12107878|FG002|COMPLETED|Overall Study||128
10937988|NCT00345631|12107876|FG000|NOT COMPLETED|Overall Study||4
10937989|NCT00345631|12107877|FG001|NOT COMPLETED|Overall Study||8
10937990|NCT00345631|12107878|FG002|NOT COMPLETED|Overall Study||6
10937991|NCT00345683|12107890|FG000|STARTED|Overall Study||3010
10937992|NCT00345683|12107891|FG001|STARTED|Overall Study||1010
10937993|NCT00345683|12107890|FG000|COMPLETED|Overall Study||2985
10937994|NCT00345683|12107891|FG001|COMPLETED|Overall Study||1001
10937995|NCT00345683|12107890|FG000|NOT COMPLETED|Overall Study||25
10937996|NCT00345683|12107891|FG001|NOT COMPLETED|Overall Study||9
10937997|NCT00345865|12107902|FG000|STARTED|Overall Study||171
10937998|NCT00345865|12107903|FG001|STARTED|Overall Study||149
10937999|NCT00345865|12107904|FG002|STARTED|Overall Study||2
10938000|NCT00345865|12107905|FG003|STARTED|Overall Study||5
10938001|NCT00345865|12107906|FG004|STARTED|Overall Study||146
10938002|NCT00345865|12107902|FG000|COMPLETED|Overall Study||171
10938003|NCT00345865|12107903|FG001|COMPLETED|Overall Study||149
10938004|NCT00345865|12107904|FG002|COMPLETED|Overall Study||2
10938005|NCT00345865|12107905|FG003|COMPLETED|Overall Study||5
10938006|NCT00345865|12107906|FG004|COMPLETED|Overall Study||146
10938007|NCT00345865|12107902|FG000|NOT COMPLETED|Overall Study||0
10938008|NCT00345865|12107903|FG001|NOT COMPLETED|Overall Study||0
10938009|NCT00345865|12107904|FG002|NOT COMPLETED|Overall Study||0
10938010|NCT00345865|12107905|FG003|NOT COMPLETED|Overall Study||0
10938011|NCT00345865|12107906|FG004|NOT COMPLETED|Overall Study||0
10938012|NCT00345878|12107920|FG000|STARTED|Overall Study||135
10938013|NCT00345878|12107921|FG001|STARTED|Overall Study||136
10938014|NCT00345878|12107920|FG000|COMPLETED|Overall Study||131
10938015|NCT00345878|12107921|FG001|COMPLETED|Overall Study||135
10938016|NCT00345878|12107920|FG000|NOT COMPLETED|Overall Study||4
10938017|NCT00345878|12107921|FG001|NOT COMPLETED|Overall Study||1
10938018|NCT00345969|12107929|FG000|STARTED|Overall Study||12
10938019|NCT00345969|12107930|FG001|STARTED|Overall Study||13
10938020|NCT00345969|12107929|FG000|COMPLETED|Overall Study||11
10938021|NCT00345969|12107930|FG001|COMPLETED|Overall Study||11
10938022|NCT00345969|12107929|FG000|NOT COMPLETED|Overall Study||1
10938023|NCT00345969|12107930|FG001|NOT COMPLETED|Overall Study||2
10938024|NCT00346034|12107936|FG000|STARTED|Overall Study||357
10938025|NCT00346034|12107936|FG000|COMPLETED|Overall Study||300
10938026|NCT00346034|12107936|FG000|NOT COMPLETED|Overall Study||57
10938027|NCT00346073|12107942|FG000|STARTED|Overall Study||1522
10938028|NCT00346073|12107943|FG001|STARTED|Overall Study||762
10938029|NCT00346073|12107942|FG000|COMPLETED|Overall Study||1481
10938030|NCT00346073|12107943|FG001|COMPLETED|Overall Study||738
10938031|NCT00346073|12107942|FG000|NOT COMPLETED|Overall Study||41
10938032|NCT00346073|12107943|FG001|NOT COMPLETED|Overall Study||24
10938033|NCT00346151|12107949|FG000|STARTED|Overall Study||5
10938034|NCT00346151|12107949|FG000|COMPLETED|Overall Study||2
10938035|NCT00346151|12107949|FG000|NOT COMPLETED|Overall Study||3
10938036|NCT00346216|12107956|FG000|STARTED|Overall Study||8072
10938037|NCT00346216|12107957|FG001|STARTED|Overall Study||8040
10938038|NCT00346216|12107958|FG002|STARTED|Overall Study||7969
10938039|NCT00346216|12107956|FG000|COMPLETED|Overall Study||5664
10938040|NCT00346216|12107957|FG001|COMPLETED|Overall Study||5580
10938041|NCT00346216|12107958|FG002|COMPLETED|Overall Study||5621
10938042|NCT00346216|12107956|FG000|NOT COMPLETED|Overall Study||2408
10938043|NCT00346216|12107957|FG001|NOT COMPLETED|Overall Study||2460
10938044|NCT00346216|12107958|FG002|NOT COMPLETED|Overall Study||2348
10938045|NCT00346268|12107968|FG000|STARTED|Overall Study||52
10938046|NCT00346268|12107969|FG001|STARTED|Overall Study||53
10938047|NCT00346268|12107968|FG000|COMPLETED|Overall Study||50
10938048|NCT00346268|12107969|FG001|COMPLETED|Overall Study||50
10938049|NCT00346268|12107968|FG000|NOT COMPLETED|Overall Study||2
10938050|NCT00346268|12107969|FG001|NOT COMPLETED|Overall Study||3
10938051|NCT00346333|12107977|FG000|STARTED|Overall Study||121
10938052|NCT00346333|12107978|FG001|STARTED|Overall Study||119
10938053|NCT00346333|12107977|FG000|COMPLETED|Overall Study||116
10938054|NCT00346333|12107978|FG001|COMPLETED|Overall Study||111
10938055|NCT00346333|12107977|FG000|NOT COMPLETED|Overall Study||5
10938056|NCT00346333|12107978|FG001|NOT COMPLETED|Overall Study||8
10938057|NCT00346398|12107988|FG000|STARTED|Overall Study||25
10938058|NCT00346398|12107989|FG001|STARTED|Overall Study||26
10938059|NCT00346398|12107988|FG000|COMPLETED|Overall Study||22
10938060|NCT00346398|12107989|FG001|COMPLETED|Overall Study||24
10938061|NCT00346398|12107988|FG000|NOT COMPLETED|Overall Study||3
10938062|NCT00346398|12107989|FG001|NOT COMPLETED|Overall Study||2
10938063|NCT00346476|12107995|FG000|STARTED|Overall Study||1250
10938064|NCT00346476|12107995|FG000|COMPLETED|Overall Study||1250
10938065|NCT00346476|12107995|FG000|NOT COMPLETED|Overall Study||0
10938066|NCT00346632|12108001|FG000|STARTED|Overall Study||3
10938067|NCT00346632|12108002|FG001|STARTED|Overall Study||3
10938068|NCT00346632|12108003|FG002|STARTED|Overall Study||6
10938069|NCT00346632|12108004|FG003|STARTED|Overall Study||3
10938070|NCT00346632|12108005|FG004|STARTED|Overall Study||4
10938071|NCT00346632|12108006|FG005|STARTED|Overall Study||2
10938072|NCT00346632|12108007|FG006|STARTED|Overall Study||5
10938073|NCT00346632|12108008|FG007|STARTED|Overall Study||4
10938074|NCT00346632|12108009|FG008|STARTED|Overall Study||4
10938075|NCT00346632|12108010|FG009|STARTED|Overall Study||3
10938076|NCT00346632|12108001|FG000|COMPLETED|Overall Study||0
10938077|NCT00346632|12108002|FG001|COMPLETED|Overall Study||0
10938078|NCT00346632|12108003|FG002|COMPLETED|Overall Study||0
10938079|NCT00346632|12108004|FG003|COMPLETED|Overall Study||0
10938080|NCT00346632|12108005|FG004|COMPLETED|Overall Study||0
10938081|NCT00346632|12108006|FG005|COMPLETED|Overall Study||0
10938082|NCT00346632|12108007|FG006|COMPLETED|Overall Study||0
10938083|NCT00346632|12108008|FG007|COMPLETED|Overall Study||0
10938084|NCT00346632|12108009|FG008|COMPLETED|Overall Study||0
10938085|NCT00346632|12108010|FG009|COMPLETED|Overall Study||0
10938086|NCT00346632|12108001|FG000|NOT COMPLETED|Overall Study||3
10938087|NCT00346632|12108002|FG001|NOT COMPLETED|Overall Study||3
10938088|NCT00346632|12108003|FG002|NOT COMPLETED|Overall Study||6
10938089|NCT00346632|12108004|FG003|NOT COMPLETED|Overall Study||3
10938090|NCT00346632|12108005|FG004|NOT COMPLETED|Overall Study||4
10938091|NCT00346632|12108006|FG005|NOT COMPLETED|Overall Study||2
10938092|NCT00346632|12108007|FG006|NOT COMPLETED|Overall Study||5
10938093|NCT00346632|12108008|FG007|NOT COMPLETED|Overall Study||4
10938094|NCT00346632|12108009|FG008|NOT COMPLETED|Overall Study||4
10938095|NCT00346632|12108010|FG009|NOT COMPLETED|Overall Study||3
10938096|NCT00346697|12108074|FG000|STARTED|Overall Study||24
10938097|NCT00346697|12108075|FG001|STARTED|Overall Study||24
10938098|NCT00346697|12108074|FG000|COMPLETED|Overall Study||24
10938099|NCT00346697|12108075|FG001|COMPLETED|Overall Study||23
10938100|NCT00346697|12108074|FG000|NOT COMPLETED|Overall Study||0
10938101|NCT00346697|12108075|FG001|NOT COMPLETED|Overall Study||1
10938102|NCT00346775|12108083|FG000|STARTED|Period 1: Intervention Period 1||49
10938103|NCT00346775|12108084|FG001|STARTED|Period 1: Intervention Period 1||48
10938104|NCT00346775|12108083|FG000|COMPLETED|Period 1: Intervention Period 1||44
10938105|NCT00346775|12108084|FG001|COMPLETED|Period 1: Intervention Period 1||45
10938106|NCT00346775|12108083|FG000|NOT COMPLETED|Period 1: Intervention Period 1||5
10938107|NCT00346775|12108084|FG001|NOT COMPLETED|Period 1: Intervention Period 1||3
10938108|NCT00346775|12108083|FG000|STARTED|Period 2: Washout Period (7 Days)||44
10938109|NCT00346775|12108084|FG001|STARTED|Period 2: Washout Period (7 Days)||45
10938110|NCT00346775|12108083|FG000|COMPLETED|Period 2: Washout Period (7 Days)||44
10938111|NCT00346775|12108084|FG001|COMPLETED|Period 2: Washout Period (7 Days)||45
10938112|NCT00346775|12108083|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
10938113|NCT00346775|12108084|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
10938114|NCT00346775|12108083|FG000|STARTED|Period 3: Intervention Period 2||44
10938115|NCT00346775|12108084|FG001|STARTED|Period 3: Intervention Period 2||45
10938116|NCT00346775|12108083|FG000|COMPLETED|Period 3: Intervention Period 2||44
10938117|NCT00346775|12108084|FG001|COMPLETED|Period 3: Intervention Period 2||45
10938118|NCT00346775|12108083|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
10938119|NCT00346775|12108084|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
10938120|NCT00346905|12108094|FG000|STARTED|Overall Study||16
10938121|NCT00346905|12108094|FG000|COMPLETED|Overall Study||12
10938122|NCT00346905|12108094|FG000|NOT COMPLETED|Overall Study||4
10938123|NCT00347009|12108098|FG000|STARTED|Overall Study||155
10938124|NCT00347009|12108098|FG000|COMPLETED|Overall Study||128
10938125|NCT00347009|12108098|FG000|NOT COMPLETED|Overall Study||27
10938126|NCT00347022|12108104|FG000|STARTED|Overall Study||74
10938127|NCT00347022|12108105|FG001|STARTED|Overall Study||71
10938128|NCT00347022|12108104|FG000|COMPLETED|Overall Study||62
10938129|NCT00347022|12108105|FG001|COMPLETED|Overall Study||66
10938130|NCT00347022|12108104|FG000|NOT COMPLETED|Overall Study||12
10938131|NCT00347022|12108105|FG001|NOT COMPLETED|Overall Study||5
10938132|NCT00347269|12108113|FG000|STARTED|Overall Study||503
10938133|NCT00347269|12108114|FG001|STARTED|Overall Study||501
10938134|NCT00347269|12108113|FG000|COMPLETED|Overall Study||409
10938135|NCT00347269|12108114|FG001|COMPLETED|Overall Study||395
10938136|NCT00347269|12108113|FG000|NOT COMPLETED|Overall Study||94
10938137|NCT00347269|12108114|FG001|NOT COMPLETED|Overall Study||106
10938138|NCT00347308|12108120|FG000|STARTED|Overall Study||40
10938139|NCT00347308|12108120|FG000|COMPLETED|Overall Study||40
10938140|NCT00347308|12108120|FG000|NOT COMPLETED|Overall Study||0
10938141|NCT00347360|12108139|FG000|STARTED|Overall Study||44
10938142|NCT00347360|12108140|FG001|STARTED|Overall Study||43
10938143|NCT00347360|12108141|FG002|STARTED|Overall Study||43
10938144|NCT00347360|12108142|FG003|STARTED|Overall Study||43
10938145|NCT00347360|12108143|FG004|STARTED|Overall Study||44
10938146|NCT00347360|12108144|FG005|STARTED|Overall Study||44
10938147|NCT00347360|12108145|FG006|STARTED|Overall Study||44
10938148|NCT00347360|12108146|FG007|STARTED|Overall Study||43
10938149|NCT00347360|12108147|FG008|STARTED|Overall Study||44
10938150|NCT00347360|12108148|FG009|STARTED|Overall Study||44
10938151|NCT00347360|12108149|FG010|STARTED|Overall Study||44
10938152|NCT00347360|12108150|FG011|STARTED|Overall Study||43
10938153|NCT00347360|12108151|FG012|STARTED|Overall Study||44
10938154|NCT00347360|12108152|FG013|STARTED|Overall Study||44
10938155|NCT00347360|12108153|FG014|STARTED|Overall Study||43
10938156|NCT00347360|12108139|FG000|COMPLETED|Overall Study||39
10938157|NCT00347360|12108140|FG001|COMPLETED|Overall Study||35
10938158|NCT00347360|12108141|FG002|COMPLETED|Overall Study||37
10938159|NCT00347360|12108142|FG003|COMPLETED|Overall Study||30
10938160|NCT00347360|12108143|FG004|COMPLETED|Overall Study||39
10938161|NCT00347360|12108144|FG005|COMPLETED|Overall Study||36
10938162|NCT00347360|12108145|FG006|COMPLETED|Overall Study||37
10938163|NCT00347360|12108146|FG007|COMPLETED|Overall Study||40
10938164|NCT00347360|12108147|FG008|COMPLETED|Overall Study||38
10938165|NCT00347360|12108148|FG009|COMPLETED|Overall Study||35
10938166|NCT00347360|12108149|FG010|COMPLETED|Overall Study||39
10938167|NCT00347360|12108150|FG011|COMPLETED|Overall Study||37
10938168|NCT00347360|12108151|FG012|COMPLETED|Overall Study||34
10938169|NCT00347360|12108152|FG013|COMPLETED|Overall Study||36
10938170|NCT00347360|12108153|FG014|COMPLETED|Overall Study||39
10938171|NCT00347360|12108139|FG000|NOT COMPLETED|Overall Study||5
10938172|NCT00347360|12108140|FG001|NOT COMPLETED|Overall Study||8
10938173|NCT00347360|12108141|FG002|NOT COMPLETED|Overall Study||6
10938174|NCT00347360|12108142|FG003|NOT COMPLETED|Overall Study||13
10938175|NCT00347360|12108143|FG004|NOT COMPLETED|Overall Study||5
10938176|NCT00347360|12108144|FG005|NOT COMPLETED|Overall Study||8
10938177|NCT00347360|12108145|FG006|NOT COMPLETED|Overall Study||7
10938178|NCT00347360|12108146|FG007|NOT COMPLETED|Overall Study||3
10938179|NCT00347360|12108147|FG008|NOT COMPLETED|Overall Study||6
10938180|NCT00347360|12108148|FG009|NOT COMPLETED|Overall Study||9
10938181|NCT00347360|12108149|FG010|NOT COMPLETED|Overall Study||5
10938182|NCT00347360|12108150|FG011|NOT COMPLETED|Overall Study||6
10938183|NCT00347360|12108151|FG012|NOT COMPLETED|Overall Study||10
10938184|NCT00347360|12108152|FG013|NOT COMPLETED|Overall Study||8
10938185|NCT00347360|12108153|FG014|NOT COMPLETED|Overall Study||4
10938186|NCT00347438|12108185|FG000|STARTED|Overall Study||18
10938187|NCT00347438|12108185|FG000|COMPLETED|Overall Study||16
10938188|NCT00347438|12108185|FG000|NOT COMPLETED|Overall Study||2
10938189|NCT00347776|12108192|FG000|STARTED|1.5 Month Follow-up||484
10938190|NCT00347776|12108193|FG001|STARTED|1.5 Month Follow-up||483
10938191|NCT00347776|12108194|FG002|STARTED|1.5 Month Follow-up||485
10938192|NCT00347776|12108192|FG000|COMPLETED|1.5 Month Follow-up||470
10938371|NCT00348881|12108351|FG001|COMPLETED|Overall Study||697
10938193|NCT00347776|12108193|FG001|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
10938194|NCT00347776|12108194|FG002|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
10938195|NCT00347776|12108192|FG000|NOT COMPLETED|1.5 Month Follow-up||14
10938196|NCT00347776|12108193|FG001|NOT COMPLETED|1.5 Month Follow-up||8
10938197|NCT00347776|12108194|FG002|NOT COMPLETED|1.5 Month Follow-up||12
10938198|NCT00347776|12108192|FG000|STARTED|6 Month Follow-up||470
10938199|NCT00347776|12108193|FG001|STARTED|6 Month Follow-up||475
10938200|NCT00347776|12108194|FG002|STARTED|6 Month Follow-up||473
10938201|NCT00347776|12108192|FG000|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
10938202|NCT00347776|12108193|FG001|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
10938203|NCT00347776|12108194|FG002|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
10938204|NCT00347776|12108192|FG000|NOT COMPLETED|6 Month Follow-up||22
10938205|NCT00347776|12108193|FG001|NOT COMPLETED|6 Month Follow-up||13
10938206|NCT00347776|12108194|FG002|NOT COMPLETED|6 Month Follow-up||18
10938207|NCT00347776|12108192|FG000|STARTED|12 Month Follow-up||448
10938208|NCT00347776|12108193|FG001|STARTED|12 Month Follow-up||462
10938209|NCT00347776|12108194|FG002|STARTED|12 Month Follow-up||455
10938210|NCT00347776|12108192|FG000|COMPLETED|12 Month Follow-up||425
10938211|NCT00347776|12108193|FG001|COMPLETED|12 Month Follow-up||446
10938212|NCT00347776|12108194|FG002|COMPLETED|12 Month Follow-up||436
10938213|NCT00347776|12108192|FG000|NOT COMPLETED|12 Month Follow-up||23
10938214|NCT00347776|12108193|FG001|NOT COMPLETED|12 Month Follow-up||16
10938215|NCT00347776|12108194|FG002|NOT COMPLETED|12 Month Follow-up||19
10938216|NCT00347919|12108205|FG000|STARTED|Overall Study|Safety Population|73
10938217|NCT00347919|12108206|FG001|STARTED|Overall Study|Safety Population|76
10938218|NCT00347919|12108207|FG002|STARTED|Overall Study|Safety Population|40
10938219|NCT00347919|12108205|FG000|COMPLETED|Overall Study||2
10938220|NCT00347919|12108206|FG001|COMPLETED|Overall Study||0
10938221|NCT00347919|12108207|FG002|COMPLETED|Overall Study||2
10938222|NCT00347919|12108205|FG000|NOT COMPLETED|Overall Study||71
10938223|NCT00347919|12108206|FG001|NOT COMPLETED|Overall Study||76
10938224|NCT00347919|12108207|FG002|NOT COMPLETED|Overall Study||38
10938225|NCT00347932|12108219|FG000|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
10938226|NCT00347932|12108220|FG001|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
10938227|NCT00347932|12108219|FG000|COMPLETED|Overall Study||444
10938228|NCT00347932|12108220|FG001|COMPLETED|Overall Study||430
10938229|NCT00347932|12108219|FG000|NOT COMPLETED|Overall Study||31
10938230|NCT00347932|12108220|FG001|NOT COMPLETED|Overall Study||52
10938231|NCT00347958|12108226|FG000|STARTED|Overall Study||544
10938232|NCT00347958|12108226|FG000|COMPLETED|Overall Study||540
10938233|NCT00347958|12108226|FG000|NOT COMPLETED|Overall Study||4
10938234|NCT00348140|12108233|FG000|STARTED|Overall Study||487
10938235|NCT00348140|12108234|FG001|STARTED|Overall Study||490
10938236|NCT00348140|12108235|FG002|STARTED|Overall Study||491
10938237|NCT00348140|12108233|FG000|COMPLETED|Overall Study||361
10938238|NCT00348140|12108234|FG001|COMPLETED|Overall Study||351
10938239|NCT00348140|12108235|FG002|COMPLETED|Overall Study||328
10938240|NCT00348140|12108233|FG000|NOT COMPLETED|Overall Study||126
10938241|NCT00348140|12108234|FG001|NOT COMPLETED|Overall Study||139
10938242|NCT00348140|12108235|FG002|NOT COMPLETED|Overall Study||163
10938243|NCT00348205|12108244|FG000|STARTED|Overall Study||80
10938244|NCT00348205|12108244|FG000|COMPLETED|Overall Study||78
10938245|NCT00348205|12108244|FG000|NOT COMPLETED|Overall Study||2
10938246|NCT00348283|12108250|FG000|STARTED|Induction||0
10938247|NCT00348283|12108251|FG001|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
10938248|NCT00348283|12108250|FG000|COMPLETED|Induction||0
10938249|NCT00348283|12108251|FG001|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
10938250|NCT00348283|12108250|FG000|NOT COMPLETED|Induction||0
10938251|NCT00348283|12108251|FG001|NOT COMPLETED|Induction||6
10938252|NCT00348283|12108250|FG000|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
10938253|NCT00348283|12108251|FG001|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
10938254|NCT00348283|12108250|FG000|COMPLETED|Double Blind||60
10938255|NCT00348283|12108251|FG001|COMPLETED|Double Blind||54
10938256|NCT00348283|12108250|FG000|NOT COMPLETED|Double Blind||5
10938257|NCT00348283|12108251|FG001|NOT COMPLETED|Double Blind||10
10938258|NCT00348283|12108250|FG000|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
10938259|NCT00348283|12108251|FG001|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
10938260|NCT00348283|12108250|FG000|COMPLETED|Open Label||0
10938261|NCT00348283|12108251|FG001|COMPLETED|Open Label||66
10938262|NCT00348283|12108250|FG000|NOT COMPLETED|Open Label||0
10938263|NCT00348283|12108251|FG001|NOT COMPLETED|Open Label||34
10938264|NCT00348309|12108260|FG000|STARTED|Overall Study||496
10938265|NCT00348309|12108261|FG001|STARTED|Overall Study||494
10938266|NCT00348309|12108262|FG002|STARTED|Overall Study||489
10938267|NCT00348309|12108260|FG000|COMPLETED|Overall Study||362
10938268|NCT00348309|12108261|FG001|COMPLETED|Overall Study||396
10938269|NCT00348309|12108262|FG002|COMPLETED|Overall Study||346
10938270|NCT00348309|12108260|FG000|NOT COMPLETED|Overall Study||134
10938271|NCT00348309|12108261|FG001|NOT COMPLETED|Overall Study||98
10938272|NCT00348309|12108262|FG002|NOT COMPLETED|Overall Study||143
10938273|NCT00348348|12108273|FG000|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
10938274|NCT00348348|12108274|FG001|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
10938275|NCT00348348|12108273|FG000|COMPLETED|Overall Study||554
10938276|NCT00348348|12108274|FG001|COMPLETED|Overall Study||555
10938277|NCT00348348|12108273|FG000|NOT COMPLETED|Overall Study||25
10938278|NCT00348348|12108274|FG001|NOT COMPLETED|Overall Study||27
10938279|NCT00348374|12108282|FG000|STARTED|Overall Study||88
10938280|NCT00348374|12108283|FG001|STARTED|Overall Study||103
10938281|NCT00348374|12108282|FG000|Received Study Treatment|Overall Study||88
10938282|NCT00348374|12108283|FG001|Received Study Treatment|Overall Study||96
10938283|NCT00348374|12108282|FG000|COMPLETED|Overall Study||69
10938284|NCT00348374|12108283|FG001|COMPLETED|Overall Study||71
10938285|NCT00348374|12108282|FG000|NOT COMPLETED|Overall Study||19
10938286|NCT00348374|12108283|FG001|NOT COMPLETED|Overall Study||32
10938287|NCT00348595|12108292|FG000|STARTED|Overall Study||26
10938288|NCT00348595|12108293|FG001|STARTED|Overall Study||34
10938289|NCT00348595|12108292|FG000|COMPLETED|Overall Study||21
10938290|NCT00348595|12108293|FG001|COMPLETED|Overall Study||26
10938291|NCT00348595|12108292|FG000|NOT COMPLETED|Overall Study||5
10938292|NCT00348595|12108293|FG001|NOT COMPLETED|Overall Study||8
10938293|NCT00348673|12108307|FG000|STARTED|Stage 1||6
10938294|NCT00348673|12108308|FG001|STARTED|Stage 1||6
10938295|NCT00348673|12108309|FG002|STARTED|Stage 1||7
10938296|NCT00348673|12108310|FG003|STARTED|Stage 1||6
10938297|NCT00348673|12108311|FG004|STARTED|Stage 1||4
10938298|NCT00348673|12108312|FG005|STARTED|Stage 1||0
10938299|NCT00348673|12108313|FG006|STARTED|Stage 1||0
10938300|NCT00348673|12108314|FG007|STARTED|Stage 1||0
10938301|NCT00348673|12108315|FG008|STARTED|Stage 1||0
10938302|NCT00348673|12108307|FG000|Treated|Stage 1||6
10938303|NCT00348673|12108308|FG001|Treated|Stage 1||6
10938304|NCT00348673|12108309|FG002|Treated|Stage 1||6
10938305|NCT00348673|12108310|FG003|Treated|Stage 1||6
10938306|NCT00348673|12108311|FG004|Treated|Stage 1||4
10938307|NCT00348673|12108312|FG005|Treated|Stage 1||0
10938308|NCT00348673|12108313|FG006|Treated|Stage 1||0
10938309|NCT00348673|12108314|FG007|Treated|Stage 1||0
10938310|NCT00348673|12108315|FG008|Treated|Stage 1||0
10938311|NCT00348673|12108307|FG000|COMPLETED|Stage 1||6
10938312|NCT00348673|12108308|FG001|COMPLETED|Stage 1||6
10938313|NCT00348673|12108309|FG002|COMPLETED|Stage 1||6
10938314|NCT00348673|12108310|FG003|COMPLETED|Stage 1||6
10938315|NCT00348673|12108311|FG004|COMPLETED|Stage 1||4
10938316|NCT00348673|12108312|FG005|COMPLETED|Stage 1||0
10938317|NCT00348673|12108313|FG006|COMPLETED|Stage 1||0
10938318|NCT00348673|12108314|FG007|COMPLETED|Stage 1||0
10938319|NCT00348673|12108315|FG008|COMPLETED|Stage 1||0
10938320|NCT00348673|12108307|FG000|NOT COMPLETED|Stage 1||0
10938321|NCT00348673|12108308|FG001|NOT COMPLETED|Stage 1||0
10938322|NCT00348673|12108309|FG002|NOT COMPLETED|Stage 1||1
10938323|NCT00348673|12108310|FG003|NOT COMPLETED|Stage 1||0
10938324|NCT00348673|12108311|FG004|NOT COMPLETED|Stage 1||0
10938325|NCT00348673|12108312|FG005|NOT COMPLETED|Stage 1||0
10938326|NCT00348673|12108313|FG006|NOT COMPLETED|Stage 1||0
10938327|NCT00348673|12108314|FG007|NOT COMPLETED|Stage 1||0
10938328|NCT00348673|12108315|FG008|NOT COMPLETED|Stage 1||0
10938329|NCT00348673|12108307|FG000|STARTED|Stage 2||0
10938330|NCT00348673|12108308|FG001|STARTED|Stage 2||0
10938331|NCT00348673|12108309|FG002|STARTED|Stage 2||0
10938332|NCT00348673|12108310|FG003|STARTED|Stage 2||0
10938333|NCT00348673|12108311|FG004|STARTED|Stage 2||0
10938334|NCT00348673|12108312|FG005|STARTED|Stage 2||6
10938335|NCT00348673|12108313|FG006|STARTED|Stage 2||6
10938336|NCT00348673|12108314|FG007|STARTED|Stage 2||6
10938337|NCT00348673|12108315|FG008|STARTED|Stage 2||2
10938338|NCT00348673|12108307|FG000|COMPLETED|Stage 2||0
10938339|NCT00348673|12108308|FG001|COMPLETED|Stage 2||0
10938340|NCT00348673|12108309|FG002|COMPLETED|Stage 2||0
10938341|NCT00348673|12108310|FG003|COMPLETED|Stage 2||0
10938342|NCT00348673|12108311|FG004|COMPLETED|Stage 2||0
10938343|NCT00348673|12108312|FG005|COMPLETED|Stage 2||6
10938344|NCT00348673|12108313|FG006|COMPLETED|Stage 2||6
10938345|NCT00348673|12108314|FG007|COMPLETED|Stage 2||6
10938346|NCT00348673|12108315|FG008|COMPLETED|Stage 2||2
10938347|NCT00348673|12108307|FG000|NOT COMPLETED|Stage 2||0
10938348|NCT00348673|12108308|FG001|NOT COMPLETED|Stage 2||0
10938349|NCT00348673|12108309|FG002|NOT COMPLETED|Stage 2||0
10938350|NCT00348673|12108310|FG003|NOT COMPLETED|Stage 2||0
10938351|NCT00348673|12108311|FG004|NOT COMPLETED|Stage 2||0
10938352|NCT00348673|12108312|FG005|NOT COMPLETED|Stage 2||0
10938353|NCT00348673|12108313|FG006|NOT COMPLETED|Stage 2||0
10938354|NCT00348673|12108314|FG007|NOT COMPLETED|Stage 2||0
10938355|NCT00348673|12108315|FG008|NOT COMPLETED|Stage 2||0
10938356|NCT00348686|12108333|FG000|STARTED|Overall Study||315
10938357|NCT00348686|12108333|FG000|COMPLETED|Overall Study||249
10938358|NCT00348686|12108333|FG000|NOT COMPLETED|Overall Study||66
10938359|NCT00348790|12108337|FG000|STARTED|Began Treatment||25
10938360|NCT00348790|12108337|FG000|COMPLETED|Began Treatment||25
10938361|NCT00348790|12108337|FG000|NOT COMPLETED|Began Treatment||0
10938362|NCT00348790|12108337|FG000|STARTED|Completed Treatment||25
10938363|NCT00348790|12108337|FG000|COMPLETED|Completed Treatment||0
10938364|NCT00348790|12108337|FG000|NOT COMPLETED|Completed Treatment||25
10938365|NCT00348816|12108342|FG000|STARTED|Overall Study||20
10938366|NCT00348816|12108342|FG000|COMPLETED|Overall Study||19
10938367|NCT00348816|12108342|FG000|NOT COMPLETED|Overall Study||1
10938368|NCT00348881|12108350|FG000|STARTED|Overall Study||1424
10938369|NCT00348881|12108351|FG001|STARTED|Overall Study||709
10938370|NCT00348881|12108350|FG000|COMPLETED|Overall Study||1407
10938372|NCT00348881|12108350|FG000|NOT COMPLETED|Overall Study||17
10938373|NCT00348881|12108351|FG001|NOT COMPLETED|Overall Study||12
10938374|NCT00348933|12108361|FG000|STARTED|Overall Study||90
10938375|NCT00348933|12108361|FG000|COMPLETED|Overall Study||65
10938376|NCT00348933|12108361|FG000|NOT COMPLETED|Overall Study||25
10938377|NCT00348946|12108368|FG000|STARTED|Overall Study||46
10938378|NCT00348946|12108369|FG001|STARTED|Overall Study||47
10938379|NCT00348946|12108368|FG000|COMPLETED|Overall Study||35
10938380|NCT00348946|12108369|FG001|COMPLETED|Overall Study||35
10938381|NCT00348946|12108368|FG000|NOT COMPLETED|Overall Study||11
10938382|NCT00348946|12108369|FG001|NOT COMPLETED|Overall Study||12
10938383|NCT00349336|12108379|FG000|STARTED|Overall Study||32
10938384|NCT00349336|12108380|FG001|STARTED|Overall Study||32
10938385|NCT00349336|12108379|FG000|COMPLETED|Overall Study||19
10938386|NCT00349336|12108380|FG001|COMPLETED|Overall Study||18
10938387|NCT00349336|12108379|FG000|NOT COMPLETED|Overall Study||13
10938388|NCT00349336|12108380|FG001|NOT COMPLETED|Overall Study||14
10938389|NCT00349349|12108389|FG000|STARTED|Overall Study||95
10938390|NCT00349349|12108390|FG001|STARTED|Overall Study||112
10938391|NCT00349349|12108391|FG002|STARTED|Overall Study||16
10938392|NCT00349349|12108389|FG000|COMPLETED|Overall Study||42
10938393|NCT00349349|12108390|FG001|COMPLETED|Overall Study||50
10938394|NCT00349349|12108391|FG002|COMPLETED|Overall Study||10
10938395|NCT00349349|12108389|FG000|NOT COMPLETED|Overall Study||53
10938396|NCT00349349|12108390|FG001|NOT COMPLETED|Overall Study||62
10938397|NCT00349349|12108391|FG002|NOT COMPLETED|Overall Study||6
10938398|NCT00349388|12108403|FG000|STARTED|Overall Study|no patients enrolled|0
10938399|NCT00349388|12108404|FG001|STARTED|Overall Study||1
10938400|NCT00349388|12108403|FG000|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
10938401|NCT00349388|12108404|FG001|COMPLETED|Overall Study||1
10938402|NCT00349388|12108403|FG000|NOT COMPLETED|Overall Study||0
10938403|NCT00349388|12108404|FG001|NOT COMPLETED|Overall Study||0
10938404|NCT00349622|12108412|FG000|STARTED|Overall Study||340
10938405|NCT00349622|12108413|FG001|STARTED|Overall Study||173
10938406|NCT00349622|12108412|FG000|COMPLETED|Overall Study||162
10938407|NCT00349622|12108413|FG001|COMPLETED|Overall Study||77
10938408|NCT00349622|12108412|FG000|NOT COMPLETED|Overall Study||178
10938409|NCT00349622|12108413|FG001|NOT COMPLETED|Overall Study||96
10938410|NCT00349713|12108422|FG000|STARTED|Overall Study||20
10938411|NCT00349713|12108423|FG001|STARTED|Overall Study||20
10938412|NCT00349713|12108424|FG002|STARTED|Overall Study||20
10938413|NCT00349713|12108422|FG000|COMPLETED|Overall Study||20
10938414|NCT00349713|12108423|FG001|COMPLETED|Overall Study||20
10938415|NCT00349713|12108424|FG002|COMPLETED|Overall Study||20
10938416|NCT00349713|12108422|FG000|NOT COMPLETED|Overall Study||0
10938417|NCT00349713|12108423|FG001|NOT COMPLETED|Overall Study||0
10938418|NCT00349713|12108424|FG002|NOT COMPLETED|Overall Study||0
10938419|NCT00349752|12108434|FG000|STARTED|Overall Study||87
10938420|NCT00349752|12108435|FG001|STARTED|Overall Study||87
10938421|NCT00349752|12108434|FG000|COMPLETED|Overall Study||28
10938422|NCT00349752|12108435|FG001|COMPLETED|Overall Study||23
10938423|NCT00349752|12108434|FG000|NOT COMPLETED|Overall Study||59
10938424|NCT00349752|12108435|FG001|NOT COMPLETED|Overall Study||64
10938425|NCT00349778|12108441|FG000|STARTED|Overall Study||102
10938426|NCT00349778|12108441|FG000|COMPLETED|Overall Study||102
10938427|NCT00349778|12108441|FG000|NOT COMPLETED|Overall Study||0
10938428|NCT00349908|12108447|FG000|STARTED|Overall Study||10
10938429|NCT00349908|12108448|FG001|STARTED|Overall Study||10
10938430|NCT00349908|12108447|FG000|COMPLETED|Overall Study||10
10938431|NCT00349908|12108448|FG001|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
10938432|NCT00349908|12108447|FG000|NOT COMPLETED|Overall Study||0
10938433|NCT00349908|12108448|FG001|NOT COMPLETED|Overall Study||4
10938434|NCT00349921|12108459|FG000|STARTED|First Spinal Injection||10
10938435|NCT00349921|12108460|FG001|STARTED|First Spinal Injection||10
10938436|NCT00349921|12108461|FG002|STARTED|First Spinal Injection||1
10938437|NCT00349921|12108462|FG003|STARTED|First Spinal Injection||1
10938438|NCT00349921|12108459|FG000|COMPLETED|First Spinal Injection||9
10938439|NCT00349921|12108460|FG001|COMPLETED|First Spinal Injection||10
10938440|NCT00349921|12108461|FG002|COMPLETED|First Spinal Injection||0
10938441|NCT00349921|12108462|FG003|COMPLETED|First Spinal Injection||1
10938442|NCT00349921|12108459|FG000|NOT COMPLETED|First Spinal Injection||1
10938443|NCT00349921|12108460|FG001|NOT COMPLETED|First Spinal Injection||0
10938444|NCT00349921|12108461|FG002|NOT COMPLETED|First Spinal Injection||1
10938445|NCT00349921|12108462|FG003|NOT COMPLETED|First Spinal Injection||0
10938446|NCT00349921|12108459|FG000|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
10938447|NCT00349921|12108460|FG001|STARTED|Second Spinal Injection||10
10938448|NCT00349921|12108461|FG002|STARTED|Second Spinal Injection||0
10938449|NCT00349921|12108462|FG003|STARTED|Second Spinal Injection||1
10938450|NCT00349921|12108459|FG000|COMPLETED|Second Spinal Injection||9
10938451|NCT00349921|12108460|FG001|COMPLETED|Second Spinal Injection||10
10938452|NCT00349921|12108461|FG002|COMPLETED|Second Spinal Injection||0
10938453|NCT00349921|12108462|FG003|COMPLETED|Second Spinal Injection||1
10938454|NCT00349921|12108459|FG000|NOT COMPLETED|Second Spinal Injection||0
10938455|NCT00349921|12108460|FG001|NOT COMPLETED|Second Spinal Injection||0
10938456|NCT00349921|12108461|FG002|NOT COMPLETED|Second Spinal Injection||0
10938457|NCT00349921|12108462|FG003|NOT COMPLETED|Second Spinal Injection||0
10938458|NCT00349973|12108473|FG000|STARTED|Overall Study||12
10938459|NCT00349973|12108474|FG001|STARTED|Overall Study||8
10938460|NCT00349973|12108473|FG000|COMPLETED|Overall Study||8
10938461|NCT00349973|12108474|FG001|COMPLETED|Overall Study||5
10938462|NCT00349973|12108473|FG000|NOT COMPLETED|Overall Study||4
10938463|NCT00349973|12108474|FG001|NOT COMPLETED|Overall Study||3
10938464|NCT00350025|12108482|FG000|STARTED|Overall Study||11
10938465|NCT00350025|12108483|FG001|STARTED|Overall Study||30
10938466|NCT00350025|12108482|FG000|COMPLETED|Overall Study||11
10938467|NCT00350025|12108483|FG001|COMPLETED|Overall Study||28
10938468|NCT00350025|12108482|FG000|NOT COMPLETED|Overall Study||0
10938469|NCT00350025|12108483|FG001|NOT COMPLETED|Overall Study||2
10938470|NCT00350142|12108489|FG000|STARTED|Overall Study||20
10938471|NCT00350142|12108489|FG000|COMPLETED|Overall Study||20
10938472|NCT00350142|12108489|FG000|NOT COMPLETED|Overall Study||0
10938473|NCT00350207|12108497|FG000|STARTED|Overall Study||128
10938474|NCT00350207|12108498|FG001|STARTED|Overall Study||134
10938475|NCT00350207|12108499|FG002|STARTED|Overall Study||126
10938476|NCT00350207|12108497|FG000|COMPLETED|Overall Study||120
10938477|NCT00350207|12108498|FG001|COMPLETED|Overall Study||128
10938478|NCT00350207|12108499|FG002|COMPLETED|Overall Study||119
10938479|NCT00350207|12108497|FG000|NOT COMPLETED|Overall Study||8
10938480|NCT00350207|12108498|FG001|NOT COMPLETED|Overall Study||6
10938481|NCT00350207|12108499|FG002|NOT COMPLETED|Overall Study||7
10938482|NCT00350220|12108509|FG000|STARTED|Overall Study||30
10938483|NCT00350220|12108510|FG001|STARTED|Overall Study||30
10938484|NCT00350220|12108509|FG000|COMPLETED|Overall Study||30
10938485|NCT00350220|12108510|FG001|COMPLETED|Overall Study||30
10938486|NCT00350220|12108509|FG000|NOT COMPLETED|Overall Study||0
10938487|NCT00350220|12108510|FG001|NOT COMPLETED|Overall Study||0
10938488|NCT00350272|12108518|FG000|STARTED|Blinded 12 Week Treatment||39
10938489|NCT00350272|12108519|FG001|STARTED|Blinded 12 Week Treatment||37
10938490|NCT00350272|12108518|FG000|COMPLETED|Blinded 12 Week Treatment||30
10938491|NCT00350272|12108519|FG001|COMPLETED|Blinded 12 Week Treatment||35
10938492|NCT00350272|12108518|FG000|NOT COMPLETED|Blinded 12 Week Treatment||9
10938493|NCT00350272|12108519|FG001|NOT COMPLETED|Blinded 12 Week Treatment||2
10938494|NCT00350272|12108518|FG000|STARTED|Open-Label 84 Week Treatment||30
10938495|NCT00350272|12108519|FG001|STARTED|Open-Label 84 Week Treatment||35
10938496|NCT00350272|12108518|FG000|COMPLETED|Open-Label 84 Week Treatment||21
10938497|NCT00350272|12108519|FG001|COMPLETED|Open-Label 84 Week Treatment||27
10938498|NCT00350272|12108518|FG000|NOT COMPLETED|Open-Label 84 Week Treatment||9
10938499|NCT00350272|12108519|FG001|NOT COMPLETED|Open-Label 84 Week Treatment||8
10938500|NCT00350298|12108529|FG000|STARTED|Overall Study||101
10938501|NCT00350298|12108530|FG001|STARTED|Overall Study||99
10938502|NCT00350298|12108529|FG000|COMPLETED|Overall Study||92
10938503|NCT00350298|12108530|FG001|COMPLETED|Overall Study||86
10938504|NCT00350298|12108529|FG000|NOT COMPLETED|Overall Study||9
10938505|NCT00350298|12108530|FG001|NOT COMPLETED|Overall Study||13
10938506|NCT00350337|12108540|FG000|STARTED|Overall Study||22
10938507|NCT00350337|12108541|FG001|STARTED|Overall Study||22
10938508|NCT00350337|12108542|FG002|STARTED|Overall Study||21
10938509|NCT00350337|12108543|FG003|STARTED|Overall Study||21
10938510|NCT00350337|12108540|FG000|COMPLETED|Overall Study||17
10938511|NCT00350337|12108541|FG001|COMPLETED|Overall Study||19
10938512|NCT00350337|12108542|FG002|COMPLETED|Overall Study||18
10938513|NCT00350337|12108543|FG003|COMPLETED|Overall Study||21
10938514|NCT00350337|12108540|FG000|NOT COMPLETED|Overall Study||5
10938515|NCT00350337|12108541|FG001|NOT COMPLETED|Overall Study||3
10938516|NCT00350337|12108542|FG002|NOT COMPLETED|Overall Study||3
10938517|NCT00350337|12108543|FG003|NOT COMPLETED|Overall Study||0
10938518|NCT00350363|12108554|FG000|STARTED|Overall Study||60
10938519|NCT00350363|12108554|FG000|COMPLETED|Overall Study||60
10938520|NCT00350363|12108554|FG000|NOT COMPLETED|Overall Study||0
10938521|NCT00350402|12108560|FG000|STARTED|Overall Study||21
10938522|NCT00350402|12108561|FG001|STARTED|Overall Study||21
10938523|NCT00350402|12108560|FG000|COMPLETED|Overall Study||20
10938524|NCT00350402|12108561|FG001|COMPLETED|Overall Study||20
10938525|NCT00350402|12108560|FG000|NOT COMPLETED|Overall Study||1
10938526|NCT00350402|12108561|FG001|NOT COMPLETED|Overall Study||1
10938527|NCT00350519|12108575|FG000|STARTED|Overall Study||18
10938528|NCT00350519|12108576|FG001|STARTED|Overall Study||19
10938529|NCT00350519|12108575|FG000|COMPLETED|Overall Study||14
10938530|NCT00350519|12108576|FG001|COMPLETED|Overall Study||13
10938531|NCT00350519|12108575|FG000|NOT COMPLETED|Overall Study||4
10938532|NCT00350519|12108576|FG001|NOT COMPLETED|Overall Study||6
10938533|NCT00350532|12108584|FG000|STARTED|Overall Study||24
10938534|NCT00350532|12108585|FG001|STARTED|Overall Study||19
10938535|NCT00350532|12108584|FG000|COMPLETED|Overall Study||24
10938536|NCT00350532|12108585|FG001|COMPLETED|Overall Study||19
10938537|NCT00350532|12108584|FG000|NOT COMPLETED|Overall Study||0
10938538|NCT00350532|12108585|FG001|NOT COMPLETED|Overall Study||0
10938539|NCT00350545|12108591|FG000|STARTED|Overall Study||37
10938540|NCT00350545|12108591|FG000|COMPLETED|Overall Study||35
10938541|NCT00350545|12108591|FG000|NOT COMPLETED|Overall Study||2
10938542|NCT00350636|12108597|FG000|STARTED|Overall Study||389
10938543|NCT00350636|12108598|FG001|STARTED|Overall Study||400
10938544|NCT00350636|12108597|FG000|COMPLETED|Overall Study||346
10938545|NCT00350636|12108598|FG001|COMPLETED|Overall Study||355
10938546|NCT00350636|12108597|FG000|NOT COMPLETED|Overall Study||43
10938547|NCT00350636|12108598|FG001|NOT COMPLETED|Overall Study||45
10938548|NCT00350727|12108607|FG000|STARTED|Phase I: Dose Escalation||34
10938549|NCT00350727|12108608|FG001|STARTED|Phase I: Dose Escalation||0
10938550|NCT00350727|12108609|FG002|STARTED|Phase I: Dose Escalation||0
10938551|NCT00350727|12108607|FG000|COMPLETED|Phase I: Dose Escalation||0
10938552|NCT00350727|12108608|FG001|COMPLETED|Phase I: Dose Escalation||0
10938553|NCT00350727|12108609|FG002|COMPLETED|Phase I: Dose Escalation||0
10938554|NCT00350727|12108607|FG000|NOT COMPLETED|Phase I: Dose Escalation||34
10938555|NCT00350727|12108608|FG001|NOT COMPLETED|Phase I: Dose Escalation||0
10938556|NCT00350727|12108609|FG002|NOT COMPLETED|Phase I: Dose Escalation||0
10938557|NCT00350727|12108607|FG000|STARTED|Phase II||0
10938558|NCT00350727|12108608|FG001|STARTED|Phase II||19
10938559|NCT00350727|12108609|FG002|STARTED|Phase II||22
10938560|NCT00350727|12108607|FG000|COMPLETED|Phase II||0
10938561|NCT00350727|12108608|FG001|COMPLETED|Phase II||0
10938562|NCT00350727|12108609|FG002|COMPLETED|Phase II||0
10938563|NCT00350727|12108607|FG000|NOT COMPLETED|Phase II||0
10938564|NCT00350727|12108608|FG001|NOT COMPLETED|Phase II||19
10938565|NCT00350727|12108609|FG002|NOT COMPLETED|Phase II||22
10938566|NCT00350779|12108630|FG000|STARTED|Overall Study||170
10938567|NCT00350779|12108631|FG001|STARTED|Overall Study||92
10938568|NCT00350779|12108630|FG000|COMPLETED|Overall Study||148
10938569|NCT00350779|12108631|FG001|COMPLETED|Overall Study||71
10938570|NCT00350779|12108630|FG000|NOT COMPLETED|Overall Study||22
10938571|NCT00350779|12108631|FG001|NOT COMPLETED|Overall Study||21
10938572|NCT00350792|12108639|FG000|STARTED|Overall Study||62
10938573|NCT00350792|12108639|FG000|COMPLETED|Overall Study||29
10938574|NCT00350792|12108639|FG000|NOT COMPLETED|Overall Study||33
10938575|NCT00350870|12108647|FG000|STARTED|Overall Study||27
10938576|NCT00350870|12108648|FG001|STARTED|Overall Study||28
10938577|NCT00350870|12108649|FG002|STARTED|Overall Study||22
10938578|NCT00350870|12108650|FG003|STARTED|Overall Study||22
10938579|NCT00350870|12108647|FG000|Had at Least 1 Day of Med|Overall Study||19
10938580|NCT00350870|12108648|FG001|Had at Least 1 Day of Med|Overall Study||24
10938581|NCT00350870|12108649|FG002|Had at Least 1 Day of Med|Overall Study||18
10938582|NCT00350870|12108650|FG003|Had at Least 1 Day of Med|Overall Study||19
10938583|NCT00350870|12108647|FG000|COMPLETED|Overall Study||5
10938584|NCT00350870|12108648|FG001|COMPLETED|Overall Study||11
10938585|NCT00350870|12108649|FG002|COMPLETED|Overall Study||6
10938586|NCT00350870|12108650|FG003|COMPLETED|Overall Study||7
10938587|NCT00350870|12108647|FG000|NOT COMPLETED|Overall Study||22
10938588|NCT00350870|12108648|FG001|NOT COMPLETED|Overall Study||17
10938589|NCT00350870|12108649|FG002|NOT COMPLETED|Overall Study||16
10938590|NCT00350870|12108650|FG003|NOT COMPLETED|Overall Study||15
10938591|NCT00351000|12108660|FG000|STARTED|Overall Study||24
10938592|NCT00351000|12108660|FG000|COMPLETED|Overall Study||21
10938593|NCT00351000|12108660|FG000|NOT COMPLETED|Overall Study||3
10938594|NCT00351039|12108667|FG000|STARTED|Overall Study||8
10938595|NCT00351039|12108667|FG000|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
10938596|NCT00351039|12108667|FG000|NOT COMPLETED|Overall Study||0
10938597|NCT00351273|12108675|FG000|STARTED|Overall Study||15
10938598|NCT00351273|12108676|FG001|STARTED|Overall Study||12
10938599|NCT00351273|12108677|FG002|STARTED|Overall Study||15
10938600|NCT00351273|12108675|FG000|COMPLETED|Overall Study||14
10938601|NCT00351273|12108676|FG001|COMPLETED|Overall Study||10
10938602|NCT00351273|12108677|FG002|COMPLETED|Overall Study||10
10938603|NCT00351273|12108675|FG000|NOT COMPLETED|Overall Study||1
10938604|NCT00351273|12108676|FG001|NOT COMPLETED|Overall Study||2
10938605|NCT00351273|12108677|FG002|NOT COMPLETED|Overall Study||5
10938606|NCT00351299|12108692|FG000|STARTED|Overall Study||25
10938607|NCT00351299|12108693|FG001|STARTED|Overall Study||28
10938608|NCT00351299|12108692|FG000|COMPLETED|Overall Study||25
10938609|NCT00351299|12108693|FG001|COMPLETED|Overall Study||28
10938610|NCT00351299|12108692|FG000|NOT COMPLETED|Overall Study||0
10938611|NCT00351299|12108693|FG001|NOT COMPLETED|Overall Study||0
10938612|NCT00351351|12108705|FG000|STARTED|Overall Study||34
10938613|NCT00351351|12108706|FG001|STARTED|Overall Study||36
10938614|NCT00351351|12108705|FG000|COMPLETED|Overall Study||25
10938615|NCT00351351|12108706|FG001|COMPLETED|Overall Study||32
10938616|NCT00351351|12108705|FG000|NOT COMPLETED|Overall Study||9
10938617|NCT00351351|12108706|FG001|NOT COMPLETED|Overall Study||4
10938618|NCT00351377|12108712|FG000|STARTED|Overall Study||111
10938619|NCT00351377|12108712|FG000|COMPLETED|Overall Study||104
10938620|NCT00351377|12108712|FG000|NOT COMPLETED|Overall Study||7
10938621|NCT00351416|12108718|FG000|STARTED|Overall Study||6
10938622|NCT00351416|12108719|FG001|STARTED|Overall Study||9
10938623|NCT00351416|12108718|FG000|COMPLETED|Overall Study||6
10938624|NCT00351416|12108719|FG001|COMPLETED|Overall Study||9
10938625|NCT00351416|12108718|FG000|NOT COMPLETED|Overall Study||0
10938626|NCT00351416|12108719|FG001|NOT COMPLETED|Overall Study||0
10938627|NCT00351468|12108725|FG000|STARTED|Overall Study||302
10938628|NCT00351468|12108725|FG000|Subjects From TRA100773A|Overall Study||51
10938629|NCT00351468|12108725|FG000|Subjects From TRA100773B|Overall Study||61
10938630|NCT00351468|12108725|FG000|Subjects From TRA102537 Raise|Overall Study||146
10938631|NCT00351468|12108725|FG000|Subjects From TRA108057 Repeat|Overall Study||43
10938632|NCT00351468|12108725|FG000|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
10938633|NCT00351468|12108725|FG000|COMPLETED|Overall Study||135
10938634|NCT00351468|12108725|FG000|NOT COMPLETED|Overall Study||167
10938635|NCT00351533|12108732|FG000|STARTED|Overall Study||41
10938636|NCT00351533|12108733|FG001|STARTED|Overall Study||49
10938637|NCT00351533|12108732|FG000|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
10938638|NCT00351533|12108733|FG001|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
10938639|NCT00351533|12108732|FG000|NOT COMPLETED|Overall Study||2
10938640|NCT00351533|12108733|FG001|NOT COMPLETED|Overall Study||5
10938641|NCT00351611|12108741|FG000|STARTED|Overall Study||89
10938642|NCT00351611|12108742|FG001|STARTED|Overall Study||98
10938643|NCT00351611|12108741|FG000|Treated|Overall Study||89
10938644|NCT00351611|12108742|FG001|Treated|Overall Study||98
10938645|NCT00351611|12108741|FG000|COMPLETED|Overall Study||75
10938646|NCT00351611|12108742|FG001|COMPLETED|Overall Study||88
10938647|NCT00351611|12108741|FG000|NOT COMPLETED|Overall Study||14
10938648|NCT00351611|12108742|FG001|NOT COMPLETED|Overall Study||10
10938649|NCT00351741|12108750|FG000|STARTED|Overall Study||31
10938650|NCT00351741|12108751|FG001|STARTED|Overall Study||31
10938651|NCT00351741|12108750|FG000|COMPLETED|Overall Study||31
10938652|NCT00351741|12108751|FG001|COMPLETED|Overall Study||31
10938653|NCT00351741|12108750|FG000|NOT COMPLETED|Overall Study||0
10938654|NCT00351741|12108751|FG001|NOT COMPLETED|Overall Study||0
10938655|NCT00351819|12108759|FG000|STARTED|Overall Study||43
10938656|NCT00351819|12108760|FG001|STARTED|Overall Study||41
10938657|NCT00351819|12108759|FG000|COMPLETED|Overall Study||36
10938658|NCT00351819|12108760|FG001|COMPLETED|Overall Study||29
10938659|NCT00351819|12108759|FG000|NOT COMPLETED|Overall Study||7
10938660|NCT00351819|12108760|FG001|NOT COMPLETED|Overall Study||12
10938661|NCT00351936|12108766|FG000|STARTED|Overall Study||15
10938662|NCT00351936|12108766|FG000|COMPLETED|Overall Study||15
10938663|NCT00351936|12108766|FG000|NOT COMPLETED|Overall Study||0
10938664|NCT00352001|12108771|FG000|STARTED|Overall Study||37
10938665|NCT00352001|12108771|FG000|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
10938666|NCT00352001|12108771|FG000|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
10938667|NCT00352001|12108771|FG000|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
10938668|NCT00352001|12108771|FG000|COMPLETED|Overall Study||37
10938669|NCT00352001|12108771|FG000|NOT COMPLETED|Overall Study||0
10938670|NCT00352053|12108777|FG000|STARTED|Double-Blind Phase (Through Week 48)||45
10938671|NCT00352053|12108778|FG001|STARTED|Double-Blind Phase (Through Week 48)||42
10938672|NCT00352053|12108777|FG000|COMPLETED|Double-Blind Phase (Through Week 48)||27
10938673|NCT00352053|12108778|FG001|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
10938674|NCT00352053|12108777|FG000|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
10938675|NCT00352053|12108778|FG001|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
10938676|NCT00352053|12108777|FG000|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
10938677|NCT00352053|12108778|FG001|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
10938678|NCT00352053|12108777|FG000|COMPLETED|First Extension Phase (Weeks 48-144)||12
10938679|NCT00352053|12108778|FG001|COMPLETED|First Extension Phase (Weeks 48-144)||19
10938680|NCT00352053|12108777|FG000|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
10938681|NCT00352053|12108778|FG001|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
10938682|NCT00352053|12108777|FG000|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
10938683|NCT00352053|12108778|FG001|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
10938684|NCT00352053|12108777|FG000|COMPLETED|Second Extension Phase (Weeks 144-240)||4
10938685|NCT00352053|12108778|FG001|COMPLETED|Second Extension Phase (Weeks 144-240)||9
10938686|NCT00352053|12108777|FG000|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
10938687|NCT00352053|12108778|FG001|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
10938688|NCT00352053|12108777|FG000|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
10938689|NCT00352053|12108778|FG001|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
10938690|NCT00352053|12108777|FG000|COMPLETED|Third Extension Phase (Weeks 240-294)||0
10938691|NCT00352053|12108778|FG001|COMPLETED|Third Extension Phase (Weeks 240-294)||2
10938692|NCT00352053|12108777|FG000|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
10938693|NCT00352053|12108778|FG001|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
10938694|NCT00352105|12108792|FG000|STARTED|Overall Study||60
10938695|NCT00352105|12108792|FG000|COMPLETED|Overall Study||20
10938696|NCT00352105|12108792|FG000|NOT COMPLETED|Overall Study||40
10938697|NCT00352365|12108796|FG000|STARTED|Induction Therapy||41
10938698|NCT00352365|12108796|FG000|Eligible|Induction Therapy||38
10938699|NCT00352365|12108796|FG000|Eligible and Began Protocol Therapy|Induction Therapy||37
10938700|NCT00352365|12108796|FG000|COMPLETED|Induction Therapy||14
10938701|NCT00352365|12108796|FG000|NOT COMPLETED|Induction Therapy||27
10938702|NCT00352365|12108796|FG000|STARTED|Maintenance Therapy||12
10938703|NCT00352365|12108796|FG000|Eligible and Began Protocol Therapy|Maintenance Therapy||8
10938704|NCT00352365|12108796|FG000|COMPLETED|Maintenance Therapy||0
10938705|NCT00352365|12108796|FG000|NOT COMPLETED|Maintenance Therapy||12
10938706|NCT00352417|12108806|FG000|STARTED|Overall Study||24
10938707|NCT00352417|12108807|FG001|STARTED|Overall Study||26
10938708|NCT00352417|12108806|FG000|COMPLETED|Overall Study||19
10938709|NCT00352417|12108807|FG001|COMPLETED|Overall Study||21
10938710|NCT00352417|12108806|FG000|NOT COMPLETED|Overall Study||5
10938711|NCT00352417|12108807|FG001|NOT COMPLETED|Overall Study||5
10938712|NCT00352612|12108815|FG000|STARTED|Overall Study||100
10938713|NCT00352612|12108816|FG001|STARTED|Overall Study||100
10938714|NCT00352612|12108815|FG000|COMPLETED|Overall Study||100
10938715|NCT00352612|12108816|FG001|COMPLETED|Overall Study||100
10938716|NCT00352612|12108815|FG000|NOT COMPLETED|Overall Study||0
10938717|NCT00352612|12108816|FG001|NOT COMPLETED|Overall Study||0
10938718|NCT00352664|12108824|FG000|STARTED|Overall Study||27
10938719|NCT00352664|12108825|FG001|STARTED|Overall Study||0
10938720|NCT00352664|12108824|FG000|COMPLETED|Overall Study||20
10938721|NCT00352664|12108825|FG001|COMPLETED|Overall Study||0
10938722|NCT00352664|12108824|FG000|NOT COMPLETED|Overall Study||7
10938723|NCT00352664|12108825|FG001|NOT COMPLETED|Overall Study||0
10938724|NCT00352690|12108833|FG000|STARTED|Overall Study||10
10938725|NCT00352690|12108834|FG001|STARTED|Overall Study||0
10938726|NCT00352690|12108833|FG000|COMPLETED|Overall Study||8
10938727|NCT00352690|12108834|FG001|COMPLETED|Overall Study||0
10938728|NCT00352690|12108833|FG000|NOT COMPLETED|Overall Study||2
10938729|NCT00352690|12108834|FG001|NOT COMPLETED|Overall Study||0
10938730|NCT00352755|12108840|FG000|STARTED|Overall Study||18
10938731|NCT00352755|12108840|FG000|COMPLETED|Overall Study||16
10938732|NCT00352755|12108840|FG000|NOT COMPLETED|Overall Study||2
10938733|NCT00352781|12108844|FG000|STARTED|Overall Study||1767
10938734|NCT00352781|12108844|FG000|COMPLETED|Overall Study||884
10938735|NCT00352781|12108844|FG000|NOT COMPLETED|Overall Study||883
10938736|NCT00352794|12108848|FG000|STARTED|Overall Study||40
10938737|NCT00352794|12108848|FG000|COMPLETED|Overall Study||40
10938738|NCT00352794|12108848|FG000|NOT COMPLETED|Overall Study||0
10938739|NCT00352846|12108854|FG000|STARTED|Overall Study||37
10938740|NCT00352846|12108855|FG001|STARTED|Overall Study||37
10938741|NCT00352846|12108854|FG000|COMPLETED|Overall Study||29
10938742|NCT00352846|12108855|FG001|COMPLETED|Overall Study||24
10938743|NCT00352846|12108854|FG000|NOT COMPLETED|Overall Study||8
10938744|NCT00352846|12108855|FG001|NOT COMPLETED|Overall Study||13
10938745|NCT00352885|12108863|FG000|STARTED|Overall Study||9
10938746|NCT00352885|12108864|FG001|STARTED|Overall Study||11
10938747|NCT00352885|12108863|FG000|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
10938748|NCT00352885|12108864|FG001|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
10938749|NCT00352885|12108863|FG000|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
10938750|NCT00352885|12108864|FG001|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
10938751|NCT00352885|12108863|FG000|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
10938752|NCT00352885|12108864|FG001|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
10938753|NCT00352885|12108863|FG000|COMPLETED|Overall Study||3
10938754|NCT00352885|12108864|FG001|COMPLETED|Overall Study||4
10938755|NCT00352885|12108863|FG000|NOT COMPLETED|Overall Study||6
10938756|NCT00352885|12108864|FG001|NOT COMPLETED|Overall Study||7
10938757|NCT00352911|12108872|FG000|STARTED|150mg Twice Daily (14 Days)||16
10938758|NCT00352911|12108873|FG001|STARTED|150mg Twice Daily (14 Days)||3
10938759|NCT00352911|12108872|FG000|COMPLETED|150mg Twice Daily (14 Days)||16
10938760|NCT00352911|12108873|FG001|COMPLETED|150mg Twice Daily (14 Days)||3
10938761|NCT00352911|12108872|FG000|NOT COMPLETED|150mg Twice Daily (14 Days)||0
10938762|NCT00352911|12108873|FG001|NOT COMPLETED|150mg Twice Daily (14 Days)||0
10938763|NCT00352911|12108872|FG000|STARTED|300mg Twice Daily (14 Days)||16
10938764|NCT00352911|12108873|FG001|STARTED|300mg Twice Daily (14 Days)||3
10938765|NCT00352911|12108872|FG000|COMPLETED|300mg Twice Daily (14 Days)||15
10938766|NCT00352911|12108873|FG001|COMPLETED|300mg Twice Daily (14 Days)||3
10938767|NCT00352911|12108872|FG000|NOT COMPLETED|300mg Twice Daily (14 Days)||1
10938768|NCT00352911|12108873|FG001|NOT COMPLETED|300mg Twice Daily (14 Days)||0
10938769|NCT00352976|12108879|FG000|STARTED|Overall Study||83
10938770|NCT00352976|12108879|FG000|COMPLETED|Overall Study||83
10938771|NCT00352976|12108879|FG000|NOT COMPLETED|Overall Study||0
10938772|NCT00353119|12108886|FG000|STARTED|First Intervention Day 0 to Week 12||5
10938773|NCT00353119|12108887|FG001|STARTED|First Intervention Day 0 to Week 12||10
10938774|NCT00353119|12108886|FG000|COMPLETED|First Intervention Day 0 to Week 12||5
10938775|NCT00353119|12108887|FG001|COMPLETED|First Intervention Day 0 to Week 12||10
10938776|NCT00353119|12108886|FG000|NOT COMPLETED|First Intervention Day 0 to Week 12||0
10938777|NCT00353119|12108887|FG001|NOT COMPLETED|First Intervention Day 0 to Week 12||0
10938778|NCT00353119|12108886|FG000|STARTED|Second Intervention Week 12 to Week 28||5
10938779|NCT00353119|12108887|FG001|STARTED|Second Intervention Week 12 to Week 28||10
10938780|NCT00353119|12108886|FG000|COMPLETED|Second Intervention Week 12 to Week 28||5
10938781|NCT00353119|12108887|FG001|COMPLETED|Second Intervention Week 12 to Week 28||10
10938782|NCT00353119|12108886|FG000|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
10938783|NCT00353119|12108887|FG001|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
10938784|NCT00353262|12108896|FG000|STARTED|Overall Study||36
10938785|NCT00353262|12108896|FG000|COMPLETED|Overall Study||7
10938786|NCT00353262|12108896|FG000|NOT COMPLETED|Overall Study||29
10938787|NCT00353301|12108900|FG000|STARTED|Overall Study||25
10938788|NCT00353301|12108900|FG000|COMPLETED|Overall Study||25
10938789|NCT00353301|12108900|FG000|NOT COMPLETED|Overall Study||0
10938790|NCT00353366|12108904|FG000|STARTED|Overall Study||1439
10938791|NCT00353366|12108904|FG000|COMPLETED|Overall Study||1296
10938792|NCT00353366|12108904|FG000|NOT COMPLETED|Overall Study||143
10938793|NCT00353418|12108910|FG000|STARTED|Overall Study||138
10938794|NCT00353418|12108911|FG001|STARTED|Overall Study||277
10938795|NCT00353418|12108910|FG000|COMPLETED|Overall Study||55
10938796|NCT00353418|12108911|FG001|COMPLETED|Overall Study||119
10938797|NCT00353418|12108910|FG000|NOT COMPLETED|Overall Study||83
10938798|NCT00353418|12108911|FG001|NOT COMPLETED|Overall Study||158
10938799|NCT00353431|12108919|FG000|STARTED|Overall Study||63
10938800|NCT00353431|12108920|FG001|STARTED|Overall Study||67
10938801|NCT00353431|12108919|FG000|COMPLETED|Overall Study||63
10938802|NCT00353431|12108920|FG001|COMPLETED|Overall Study||67
10938803|NCT00353431|12108919|FG000|NOT COMPLETED|Overall Study||0
10938804|NCT00353431|12108920|FG001|NOT COMPLETED|Overall Study||0
10938805|NCT00353496|12108928|FG000|STARTED|Overall Study||101
10938806|NCT00353496|12108929|FG001|STARTED|Overall Study||103
10938807|NCT00353496|12108928|FG000|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
10938808|NCT00353496|12108929|FG001|COMPLETED|Overall Study||86
10938809|NCT00353496|12108928|FG000|NOT COMPLETED|Overall Study||16
10938810|NCT00353496|12108929|FG001|NOT COMPLETED|Overall Study||17
10938811|NCT00353522|12108938|FG000|STARTED|Overall Study||89
10938812|NCT00353522|12108939|FG001|STARTED|Overall Study||46
10938813|NCT00353522|12108938|FG000|COMPLETED|Overall Study||74
10938814|NCT00353522|12108939|FG001|COMPLETED|Overall Study||37
10938815|NCT00353522|12108938|FG000|NOT COMPLETED|Overall Study||15
10938816|NCT00353522|12108939|FG001|NOT COMPLETED|Overall Study||9
10938817|NCT00353652|12108947|FG000|STARTED|First Intervention - 3 Months||15
10938818|NCT00353652|12108948|FG001|STARTED|First Intervention - 3 Months||15
10938819|NCT00353652|12108949|FG002|STARTED|First Intervention - 3 Months||6
10938820|NCT00353652|12108950|FG003|STARTED|First Intervention - 3 Months||7
10938821|NCT00353652|12108951|FG004|STARTED|First Intervention - 3 Months||3
10938822|NCT00353652|12108952|FG005|STARTED|First Intervention - 3 Months||0
10938823|NCT00353652|12108953|FG006|STARTED|First Intervention - 3 Months||1
10938824|NCT00353652|12108954|FG007|STARTED|First Intervention - 3 Months||0
10938825|NCT00353652|12108947|FG000|COMPLETED|First Intervention - 3 Months||12
10938826|NCT00353652|12108948|FG001|COMPLETED|First Intervention - 3 Months||11
10938827|NCT00353652|12108949|FG002|COMPLETED|First Intervention - 3 Months||6
10938828|NCT00353652|12108950|FG003|COMPLETED|First Intervention - 3 Months||7
10938829|NCT00353652|12108951|FG004|COMPLETED|First Intervention - 3 Months||3
10938830|NCT00353652|12108952|FG005|COMPLETED|First Intervention - 3 Months||0
10938831|NCT00353652|12108953|FG006|COMPLETED|First Intervention - 3 Months||1
10938832|NCT00353652|12108954|FG007|COMPLETED|First Intervention - 3 Months||0
10938833|NCT00353652|12108947|FG000|NOT COMPLETED|First Intervention - 3 Months||3
10938834|NCT00353652|12108948|FG001|NOT COMPLETED|First Intervention - 3 Months||4
10938835|NCT00353652|12108949|FG002|NOT COMPLETED|First Intervention - 3 Months||0
10938836|NCT00353652|12108950|FG003|NOT COMPLETED|First Intervention - 3 Months||0
10938837|NCT00353652|12108951|FG004|NOT COMPLETED|First Intervention - 3 Months||0
10938838|NCT00353652|12108952|FG005|NOT COMPLETED|First Intervention - 3 Months||0
10938839|NCT00353652|12108953|FG006|NOT COMPLETED|First Intervention - 3 Months||0
10938840|NCT00353652|12108954|FG007|NOT COMPLETED|First Intervention - 3 Months||0
10938841|NCT00353652|12108947|FG000|STARTED|Second Intervention - 3 Months||12
10938842|NCT00353652|12108948|FG001|STARTED|Second Intervention - 3 Months||11
10938843|NCT00353652|12108949|FG002|STARTED|Second Intervention - 3 Months||6
10938844|NCT00353652|12108950|FG003|STARTED|Second Intervention - 3 Months||7
10938845|NCT00353652|12108951|FG004|STARTED|Second Intervention - 3 Months||3
10938846|NCT00353652|12108952|FG005|STARTED|Second Intervention - 3 Months||0
10938847|NCT00353652|12108953|FG006|STARTED|Second Intervention - 3 Months||1
10938848|NCT00353652|12108954|FG007|STARTED|Second Intervention - 3 Months||0
10938849|NCT00353652|12108947|FG000|COMPLETED|Second Intervention - 3 Months||12
10938850|NCT00353652|12108948|FG001|COMPLETED|Second Intervention - 3 Months||11
10938851|NCT00353652|12108949|FG002|COMPLETED|Second Intervention - 3 Months||6
10938852|NCT00353652|12108950|FG003|COMPLETED|Second Intervention - 3 Months||7
10938853|NCT00353652|12108951|FG004|COMPLETED|Second Intervention - 3 Months||3
10938854|NCT00353652|12108952|FG005|COMPLETED|Second Intervention - 3 Months||0
10938855|NCT00353652|12108953|FG006|COMPLETED|Second Intervention - 3 Months||1
10938856|NCT00353652|12108954|FG007|COMPLETED|Second Intervention - 3 Months||0
10938857|NCT00353652|12108947|FG000|NOT COMPLETED|Second Intervention - 3 Months||0
10938858|NCT00353652|12108948|FG001|NOT COMPLETED|Second Intervention - 3 Months||0
10938859|NCT00353652|12108949|FG002|NOT COMPLETED|Second Intervention - 3 Months||0
10938860|NCT00353652|12108950|FG003|NOT COMPLETED|Second Intervention - 3 Months||0
10938861|NCT00353652|12108951|FG004|NOT COMPLETED|Second Intervention - 3 Months||0
10938862|NCT00353652|12108952|FG005|NOT COMPLETED|Second Intervention - 3 Months||0
10938863|NCT00353652|12108953|FG006|NOT COMPLETED|Second Intervention - 3 Months||0
10938864|NCT00353652|12108954|FG007|NOT COMPLETED|Second Intervention - 3 Months||0
10938865|NCT00353652|12108947|FG000|STARTED|Third Intervention - 3 Months||0
10938866|NCT00353652|12108948|FG001|STARTED|Third Intervention - 3 Months||0
10938867|NCT00353652|12108949|FG002|STARTED|Third Intervention - 3 Months||6
10938868|NCT00353652|12108950|FG003|STARTED|Third Intervention - 3 Months||7
10938869|NCT00353652|12108951|FG004|STARTED|Third Intervention - 3 Months||3
10938870|NCT00353652|12108952|FG005|STARTED|Third Intervention - 3 Months||0
10938871|NCT00353652|12108953|FG006|STARTED|Third Intervention - 3 Months||1
10938872|NCT00353652|12108954|FG007|STARTED|Third Intervention - 3 Months||0
10938873|NCT00353652|12108947|FG000|COMPLETED|Third Intervention - 3 Months||0
10938874|NCT00353652|12108948|FG001|COMPLETED|Third Intervention - 3 Months||0
10938875|NCT00353652|12108949|FG002|COMPLETED|Third Intervention - 3 Months||6
10938876|NCT00353652|12108950|FG003|COMPLETED|Third Intervention - 3 Months||6
10938877|NCT00353652|12108951|FG004|COMPLETED|Third Intervention - 3 Months||3
10938878|NCT00353652|12108952|FG005|COMPLETED|Third Intervention - 3 Months||0
10938879|NCT00353652|12108953|FG006|COMPLETED|Third Intervention - 3 Months||1
10938880|NCT00353652|12108954|FG007|COMPLETED|Third Intervention - 3 Months||0
10938881|NCT00353652|12108947|FG000|NOT COMPLETED|Third Intervention - 3 Months||0
10938882|NCT00353652|12108948|FG001|NOT COMPLETED|Third Intervention - 3 Months||0
10938883|NCT00353652|12108949|FG002|NOT COMPLETED|Third Intervention - 3 Months||0
10938884|NCT00353652|12108950|FG003|NOT COMPLETED|Third Intervention - 3 Months||1
10938885|NCT00353652|12108951|FG004|NOT COMPLETED|Third Intervention - 3 Months||0
10938886|NCT00353652|12108952|FG005|NOT COMPLETED|Third Intervention - 3 Months||0
10938887|NCT00353652|12108953|FG006|NOT COMPLETED|Third Intervention - 3 Months||0
10938888|NCT00353652|12108954|FG007|NOT COMPLETED|Third Intervention - 3 Months||0
10938889|NCT00353704|12108971|FG000|STARTED|Overall Study||25
10938890|NCT00353704|12108972|FG001|STARTED|Overall Study||25
10938891|NCT00353704|12108971|FG000|COMPLETED|Overall Study||22
10938892|NCT00353704|12108972|FG001|COMPLETED|Overall Study||24
10938893|NCT00353704|12108971|FG000|NOT COMPLETED|Overall Study||3
10938894|NCT00353704|12108972|FG001|NOT COMPLETED|Overall Study||1
10938895|NCT00353795|12108978|FG000|STARTED|Overall Study||179
10938896|NCT00353795|12108978|FG000|COMPLETED|Overall Study||179
10938897|NCT00353795|12108978|FG000|NOT COMPLETED|Overall Study||0
10938898|NCT00353834|12108984|FG000|STARTED|Overall Study||26
10938899|NCT00353834|12108985|FG001|STARTED|Overall Study||27
10938900|NCT00353834|12108984|FG000|COMPLETED|Overall Study||26
10938901|NCT00353834|12108985|FG001|COMPLETED|Overall Study||27
10938902|NCT00353834|12108984|FG000|NOT COMPLETED|Overall Study||0
10938903|NCT00353834|12108985|FG001|NOT COMPLETED|Overall Study||0
10938904|NCT00353873|12108993|FG000|STARTED|Overall Study||153
10938905|NCT00353873|12108994|FG001|STARTED|Overall Study||150
10938906|NCT00353873|12108993|FG000|COMPLETED|Overall Study||147
10938907|NCT00353873|12108994|FG001|COMPLETED|Overall Study||147
10938908|NCT00353873|12108993|FG000|NOT COMPLETED|Overall Study||6
10938909|NCT00353873|12108994|FG001|NOT COMPLETED|Overall Study||3
10938910|NCT00353977|12109000|FG000|STARTED|Overall Study||38
10938911|NCT00353977|12109000|FG000|COMPLETED|Overall Study||38
10938912|NCT00353977|12109000|FG000|NOT COMPLETED|Overall Study||0
10938913|NCT00354029|12109006|FG000|STARTED|Overall Study||43
10938914|NCT00354029|12109007|FG001|STARTED|Overall Study||40
10938915|NCT00354029|12109006|FG000|COMPLETED|Overall Study||39
10938916|NCT00354029|12109007|FG001|COMPLETED|Overall Study||38
10938917|NCT00354029|12109006|FG000|NOT COMPLETED|Overall Study||4
10938918|NCT00354029|12109007|FG001|NOT COMPLETED|Overall Study||2
10938919|NCT00354107|12109013|FG000|STARTED|Overall Study||5
10938920|NCT00354107|12109013|FG000|COMPLETED|Overall Study||0
10938921|NCT00354107|12109013|FG000|NOT COMPLETED|Overall Study||5
10938922|NCT00354159|12109019|FG000|STARTED|Randomized Study Period||202
10938923|NCT00354159|12109020|FG001|STARTED|Randomized Study Period||198
10938924|NCT00354159|12109019|FG000|COMPLETED|Randomized Study Period||180
10938925|NCT00354159|12109020|FG001|COMPLETED|Randomized Study Period||176
10938926|NCT00354159|12109019|FG000|NOT COMPLETED|Randomized Study Period||22
10938927|NCT00354159|12109020|FG001|NOT COMPLETED|Randomized Study Period||22
10938928|NCT00354159|12109019|FG000|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
10938929|NCT00354159|12109020|FG001|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
10938930|NCT00354159|12109019|FG000|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
10938931|NCT00354159|12109020|FG001|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
10938932|NCT00354159|12109019|FG000|NOT COMPLETED|Long-term Follow-up||180
10938933|NCT00354159|12109020|FG001|NOT COMPLETED|Long-term Follow-up||176
10938934|NCT00354172|12109033|FG000|STARTED|Overall Study||16
10938935|NCT00354172|12109033|FG000|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
10938936|NCT00354172|12109033|FG000|NOT COMPLETED|Overall Study||1
10938937|NCT00354224|12109037|FG000|STARTED|Overall Study||10
10938938|NCT00354224|12109037|FG000|COMPLETED|Overall Study||10
10938939|NCT00354224|12109037|FG000|NOT COMPLETED|Overall Study||0
10938940|NCT00354341|12109043|FG000|STARTED|Overall Study||88
10938941|NCT00354341|12109044|FG001|STARTED|Overall Study||82
10938942|NCT00354341|12109043|FG000|COMPLETED|Overall Study||85
10938943|NCT00354341|12109044|FG001|COMPLETED|Overall Study||75
10938944|NCT00354341|12109043|FG000|NOT COMPLETED|Overall Study||3
10938945|NCT00354341|12109044|FG001|NOT COMPLETED|Overall Study||7
10938946|NCT00354432|12109054|FG000|STARTED|Overall Study||30
10938947|NCT00354432|12109055|FG001|STARTED|Overall Study||30
10938948|NCT00354432|12109056|FG002|STARTED|Overall Study||30
10938949|NCT00354432|12109057|FG003|STARTED|Overall Study||30
10938950|NCT00354432|12109054|FG000|COMPLETED|Overall Study||24
10938951|NCT00354432|12109055|FG001|COMPLETED|Overall Study||22
10938952|NCT00354432|12109056|FG002|COMPLETED|Overall Study||20
10938953|NCT00354432|12109057|FG003|COMPLETED|Overall Study||20
10938954|NCT00354432|12109054|FG000|NOT COMPLETED|Overall Study||6
10938955|NCT00354432|12109055|FG001|NOT COMPLETED|Overall Study||8
10938956|NCT00354432|12109056|FG002|NOT COMPLETED|Overall Study||10
10938957|NCT00354432|12109057|FG003|NOT COMPLETED|Overall Study||10
10938958|NCT00354484|12109069|FG000|STARTED|Overall Study||142
10938959|NCT00354484|12109070|FG001|STARTED|Overall Study||147
10938960|NCT00354484|12109069|FG000|COMPLETED|Overall Study||138
10938961|NCT00354484|12109070|FG001|COMPLETED|Overall Study||144
10938962|NCT00354484|12109069|FG000|NOT COMPLETED|Overall Study||4
10938963|NCT00354484|12109070|FG001|NOT COMPLETED|Overall Study||3
10938964|NCT00354601|12109076|FG000|STARTED|Overall Study||2
10938965|NCT00354601|12109076|FG000|COMPLETED|Overall Study||0
10938966|NCT00354601|12109076|FG000|NOT COMPLETED|Overall Study||2
10938967|NCT00354614|12109080|FG000|STARTED|Overall Study||81
10938968|NCT00354614|12109080|FG000|COMPLETED|Overall Study||53
10938969|NCT00354614|12109080|FG000|NOT COMPLETED|Overall Study||28
10938970|NCT00354640|12109084|FG000|STARTED|Overall Study||11
10938971|NCT00354640|12109084|FG000|COMPLETED|Overall Study||11
10938972|NCT00354640|12109084|FG000|NOT COMPLETED|Overall Study||0
10938973|NCT00354679|12109088|FG000|STARTED|Overall Study||34
10938974|NCT00354679|12109088|FG000|COMPLETED|Overall Study||33
10938975|NCT00354679|12109088|FG000|NOT COMPLETED|Overall Study||1
10938976|NCT00354744|12109092|FG000|STARTED|Overall Study||109
10938977|NCT00354744|12109092|FG000|COMPLETED|Overall Study||67
10938978|NCT00354744|12109092|FG000|NOT COMPLETED|Overall Study||42
10938979|NCT00354770|12109100|FG000|STARTED|Overall Study||25
10938980|NCT00354770|12109101|FG001|STARTED|Overall Study||25
10938981|NCT00354770|12109100|FG000|COMPLETED|Overall Study||22
10938982|NCT00354770|12109101|FG001|COMPLETED|Overall Study||22
10938983|NCT00354770|12109100|FG000|NOT COMPLETED|Overall Study||3
10938984|NCT00354770|12109101|FG001|NOT COMPLETED|Overall Study||3
10938985|NCT00354887|12109107|FG000|STARTED|Overall Study||30
10938986|NCT00354887|12109107|FG000|COMPLETED|Overall Study||29
10938987|NCT00354887|12109107|FG000|NOT COMPLETED|Overall Study||1
10938988|NCT00354913|12109111|FG000|STARTED|Overall Study||21
10938989|NCT00354913|12109111|FG000|COMPLETED|Overall Study||21
10938990|NCT00354913|12109111|FG000|NOT COMPLETED|Overall Study||0
10938991|NCT00354978|12109115|FG000|STARTED|Overall Study||43
10938992|NCT00354978|12109115|FG000|COMPLETED|Overall Study||43
10938993|NCT00354978|12109115|FG000|NOT COMPLETED|Overall Study||0
10938994|NCT00355030|12109121|FG000|STARTED|Study Period 1 Treatment||46
10938995|NCT00355030|12109122|FG001|STARTED|Study Period 1 Treatment||45
10938996|NCT00355030|12109121|FG000|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
10938997|NCT00355030|12109122|FG001|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
10938998|NCT00355030|12109121|FG000|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
10938999|NCT00355030|12109122|FG001|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
10939000|NCT00355030|12109121|FG000|NOT COMPLETED|Study Period 1 Treatment||45
10939001|NCT00355030|12109122|FG001|NOT COMPLETED|Study Period 1 Treatment||44
10939002|NCT00355030|12109121|FG000|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
10939003|NCT00355030|12109122|FG001|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
10939004|NCT00355030|12109121|FG000|COMPLETED|Study Period 2 Long Term Follow-Up||19
10939005|NCT00355030|12109122|FG001|COMPLETED|Study Period 2 Long Term Follow-Up||17
10939006|NCT00355030|12109121|FG000|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
10939007|NCT00355030|12109122|FG001|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
10939008|NCT00355056|12109130|FG000|STARTED|Randomization Period||107
10939009|NCT00355056|12109131|FG001|STARTED|Randomization Period||123
10939010|NCT00355056|12109130|FG000|COMPLETED|Randomization Period||103
10939011|NCT00355056|12109131|FG001|COMPLETED|Randomization Period||117
10939012|NCT00355056|12109130|FG000|NOT COMPLETED|Randomization Period||4
10939013|NCT00355056|12109131|FG001|NOT COMPLETED|Randomization Period||6
10939014|NCT00355056|12109130|FG000|STARTED|Optional Patent Foramen Ovale Closure|A sham procedure was not part of this period.|0
10939015|NCT00355056|12109131|FG001|STARTED|Optional Patent Foramen Ovale Closure|Participants who completed Sham Procedure randomization Arm were eligible. 87/103 consented.|87
10939016|NCT00355056|12109130|FG000|COMPLETED|Optional Patent Foramen Ovale Closure||0
10939017|NCT00355056|12109131|FG001|COMPLETED|Optional Patent Foramen Ovale Closure||84
10939018|NCT00355056|12109130|FG000|NOT COMPLETED|Optional Patent Foramen Ovale Closure||0
10939019|NCT00355056|12109131|FG001|NOT COMPLETED|Optional Patent Foramen Ovale Closure||3
10939020|NCT00355082|12109147|FG000|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
10939021|NCT00355082|12109148|FG001|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
10939022|NCT00355082|12109149|FG002|STARTED|Double-Blind (DB) Treatment Phase||0
10939023|NCT00355082|12109147|FG000|COMPLETED|Double-Blind (DB) Treatment Phase||94
10939024|NCT00355082|12109148|FG001|COMPLETED|Double-Blind (DB) Treatment Phase||79
10939025|NCT00355082|12109149|FG002|COMPLETED|Double-Blind (DB) Treatment Phase||0
10939026|NCT00355082|12109147|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
10939027|NCT00355082|12109148|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
10939028|NCT00355082|12109149|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
10939029|NCT00355082|12109147|FG000|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
10939030|NCT00355082|12109148|FG001|STARTED|Continuation Phase||0
10939031|NCT00355082|12109149|FG002|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
10939032|NCT00355082|12109147|FG000|COMPLETED|Continuation Phase||160
10939033|NCT00355082|12109148|FG001|COMPLETED|Continuation Phase||0
10939034|NCT00355082|12109149|FG002|COMPLETED|Continuation Phase||8
10939035|NCT00355082|12109147|FG000|NOT COMPLETED|Continuation Phase||24
10939036|NCT00355082|12109148|FG001|NOT COMPLETED|Continuation Phase||0
10939037|NCT00355082|12109149|FG002|NOT COMPLETED|Continuation Phase||3
10939038|NCT00355121|12109163|FG000|STARTED|Overall Study||353
10939039|NCT00355121|12109164|FG001|STARTED|Overall Study||353
10939040|NCT00355121|12109165|FG002|STARTED|Overall Study||175
10939041|NCT00355121|12109163|FG000|COMPLETED|Overall Study||332
10939042|NCT00355121|12109164|FG001|COMPLETED|Overall Study||324
10939043|NCT00355121|12109165|FG002|COMPLETED|Overall Study||170
10939044|NCT00355121|12109163|FG000|NOT COMPLETED|Overall Study||21
10939045|NCT00355121|12109164|FG001|NOT COMPLETED|Overall Study||29
10939046|NCT00355121|12109165|FG002|NOT COMPLETED|Overall Study||5
10939047|NCT00355134|12109181|FG000|STARTED|Core Phase||370
10939048|NCT00355134|12109182|FG001|STARTED|Core Phase||358
10939049|NCT00355134|12109183|FG002|STARTED|Core Phase||355
10939050|NCT00355134|12109184|FG003|STARTED|Core Phase||0
10939051|NCT00355134|12109185|FG004|STARTED|Core Phase||0
10939052|NCT00355134|12109181|FG000|COMPLETED|Core Phase||251
10939053|NCT00355134|12109182|FG001|COMPLETED|Core Phase||272
10939054|NCT00355134|12109183|FG002|COMPLETED|Core Phase||255
10939055|NCT00355134|12109184|FG003|COMPLETED|Core Phase||0
10939056|NCT00355134|12109185|FG004|COMPLETED|Core Phase||0
10939057|NCT00355134|12109181|FG000|NOT COMPLETED|Core Phase||119
10939058|NCT00355134|12109182|FG001|NOT COMPLETED|Core Phase||86
10939059|NCT00355134|12109183|FG002|NOT COMPLETED|Core Phase||100
10939060|NCT00355134|12109184|FG003|NOT COMPLETED|Core Phase||0
10939061|NCT00355134|12109185|FG004|NOT COMPLETED|Core Phase||0
10939062|NCT00355134|12109181|FG000|STARTED|Extension Phase||203
10939063|NCT00355134|12109182|FG001|STARTED|Extension Phase||217
10939064|NCT00355134|12109183|FG002|STARTED|Extension Phase||0
10939065|NCT00355134|12109184|FG003|STARTED|Extension Phase||105
10939066|NCT00355134|12109185|FG004|STARTED|Extension Phase||107
10939067|NCT00355134|12109181|FG000|COMPLETED|Extension Phase||172
10939068|NCT00355134|12109182|FG001|COMPLETED|Extension Phase||180
10939069|NCT00355134|12109183|FG002|COMPLETED|Extension Phase||0
10939070|NCT00355134|12109184|FG003|COMPLETED|Extension Phase||89
10939071|NCT00355134|12109185|FG004|COMPLETED|Extension Phase||88
10939072|NCT00355134|12109181|FG000|NOT COMPLETED|Extension Phase||31
10939073|NCT00355134|12109182|FG001|NOT COMPLETED|Extension Phase||37
10939074|NCT00355134|12109183|FG002|NOT COMPLETED|Extension Phase||0
10939075|NCT00355134|12109184|FG003|NOT COMPLETED|Extension Phase||16
10939076|NCT00355134|12109185|FG004|NOT COMPLETED|Extension Phase||19
10939077|NCT00355147|12109197|FG000|STARTED|Overall Study||87
10939078|NCT00355147|12109198|FG001|STARTED|Overall Study||87
10939079|NCT00355147|12109197|FG000|COMPLETED|Overall Study||69
10939080|NCT00355147|12109198|FG001|COMPLETED|Overall Study||67
10939081|NCT00355147|12109197|FG000|NOT COMPLETED|Overall Study||18
10939082|NCT00355147|12109198|FG001|NOT COMPLETED|Overall Study||20
10939083|NCT00355199|12109210|FG000|STARTED|Overall Study||120
10939084|NCT00355199|12109211|FG001|STARTED|Overall Study||126
10939085|NCT00355199|12109210|FG000|COMPLETED|Overall Study||113
10939086|NCT00355199|12109211|FG001|COMPLETED|Overall Study||122
10939087|NCT00355199|12109210|FG000|NOT COMPLETED|Overall Study||7
10939088|NCT00355199|12109211|FG001|NOT COMPLETED|Overall Study||4
10939089|NCT00355264|12109217|FG000|STARTED|Part 1 (2 Weeks)||12
10939090|NCT00355264|12109217|FG000|COMPLETED|Part 1 (2 Weeks)||12
10939091|NCT00355264|12109217|FG000|NOT COMPLETED|Part 1 (2 Weeks)||0
10939092|NCT00355264|12109217|FG000|STARTED|Part 2 (8 Weeks)||12
10939093|NCT00355264|12109217|FG000|COMPLETED|Part 2 (8 Weeks)||12
10939094|NCT00355264|12109217|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0
10939095|NCT00355264|12109217|FG000|STARTED|Part 3 (7 Weeks of Extension)||2
10939096|NCT00355264|12109217|FG000|COMPLETED|Part 3 (7 Weeks of Extension)||2
10939097|NCT00355264|12109217|FG000|NOT COMPLETED|Part 3 (7 Weeks of Extension)||0
10939098|NCT00355264|12109217|FG000|STARTED|Extension (Variable Duration)||12
10939099|NCT00355264|12109217|FG000|COMPLETED|Extension (Variable Duration)||10
10939100|NCT00355264|12109217|FG000|NOT COMPLETED|Extension (Variable Duration)||2
10939101|NCT00355342|12109228|FG000|STARTED|Overall Study||94
10939102|NCT00355342|12109229|FG001|STARTED|Overall Study||92
10939103|NCT00355342|12109228|FG000|COMPLETED|Overall Study||55
10939104|NCT00355342|12109229|FG001|COMPLETED|Overall Study||56
10939105|NCT00355342|12109228|FG000|NOT COMPLETED|Overall Study||39
10939106|NCT00355342|12109229|FG001|NOT COMPLETED|Overall Study||36
10939107|NCT00355368|12109237|FG000|STARTED|Overall Study||210
10939108|NCT00355368|12109238|FG001|STARTED|Overall Study||210
10939109|NCT00355368|12109237|FG000|COMPLETED|Overall Study||200
10939110|NCT00355368|12109238|FG001|COMPLETED|Overall Study||201
10939111|NCT00355368|12109237|FG000|NOT COMPLETED|Overall Study||10
10939112|NCT00355368|12109238|FG001|NOT COMPLETED|Overall Study||9
10939113|NCT00355394|12109246|FG000|STARTED|Overall Study||15
10939114|NCT00355394|12109247|FG001|STARTED|Overall Study||16
10939115|NCT00355394|12109246|FG000|COMPLETED|Overall Study||15
10939116|NCT00355394|12109247|FG001|COMPLETED|Overall Study||16
10939117|NCT00355394|12109246|FG000|NOT COMPLETED|Overall Study||0
10939118|NCT00355394|12109247|FG001|NOT COMPLETED|Overall Study||0
10939119|NCT00355472|12109255|FG000|STARTED|Overall Study||16
10939120|NCT00355472|12109255|FG000|COMPLETED|Overall Study||15
10939121|NCT00355472|12109255|FG000|NOT COMPLETED|Overall Study||1
10939122|NCT00355615|12109271|FG000|STARTED|Randomized Double Blind Period||42
10939123|NCT00355615|12109272|FG001|STARTED|Randomized Double Blind Period||44
10939124|NCT00355615|12109273|FG002|STARTED|Randomized Double Blind Period||45
10939125|NCT00355615|12109274|FG003|STARTED|Randomized Double Blind Period||46
10939126|NCT00355615|12109275|FG004|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
10939127|NCT00355615|12109271|FG000|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
10939128|NCT00355615|12109272|FG001|COMPLETED|Randomized Double Blind Period||44
10939129|NCT00355615|12109273|FG002|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
10939130|NCT00355615|12109274|FG003|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
10939131|NCT00355615|12109275|FG004|COMPLETED|Randomized Double Blind Period||0
10939132|NCT00355615|12109271|FG000|NOT COMPLETED|Randomized Double Blind Period||1
10939133|NCT00355615|12109272|FG001|NOT COMPLETED|Randomized Double Blind Period||0
10939134|NCT00355615|12109273|FG002|NOT COMPLETED|Randomized Double Blind Period||1
10939135|NCT00355615|12109274|FG003|NOT COMPLETED|Randomized Double Blind Period||1
10939136|NCT00355615|12109275|FG004|NOT COMPLETED|Randomized Double Blind Period||0
10939137|NCT00355615|12109271|FG000|STARTED|40-week Rosuvastatin Open Label Period||0
10939138|NCT00355615|12109272|FG001|STARTED|40-week Rosuvastatin Open Label Period||0
10939139|NCT00355615|12109273|FG002|STARTED|40-week Rosuvastatin Open Label Period||0
10939140|NCT00355615|12109274|FG003|STARTED|40-week Rosuvastatin Open Label Period||0
10939141|NCT00355615|12109275|FG004|STARTED|40-week Rosuvastatin Open Label Period||173
10939142|NCT00355615|12109271|FG000|COMPLETED|40-week Rosuvastatin Open Label Period||0
10939143|NCT00355615|12109272|FG001|COMPLETED|40-week Rosuvastatin Open Label Period||0
10939144|NCT00355615|12109273|FG002|COMPLETED|40-week Rosuvastatin Open Label Period||0
10939145|NCT00355615|12109274|FG003|COMPLETED|40-week Rosuvastatin Open Label Period||0
10939146|NCT00355615|12109275|FG004|COMPLETED|40-week Rosuvastatin Open Label Period||164
10939147|NCT00355615|12109271|FG000|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
10939148|NCT00355615|12109272|FG001|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
10939149|NCT00355615|12109273|FG002|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
10939150|NCT00355615|12109274|FG003|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
10939151|NCT00355615|12109275|FG004|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
10939152|NCT00355706|12109288|FG000|STARTED|Overall Study||50
10939153|NCT00355706|12109289|FG001|STARTED|Overall Study||50
10939154|NCT00355706|12109288|FG000|COMPLETED|Overall Study||50
10939155|NCT00355706|12109289|FG001|COMPLETED|Overall Study||50
10939156|NCT00355706|12109288|FG000|NOT COMPLETED|Overall Study||0
10939157|NCT00355706|12109289|FG001|NOT COMPLETED|Overall Study||0
10939158|NCT00355784|12109300|FG000|STARTED|Overall Study||9
10939159|NCT00355784|12109301|FG001|STARTED|Overall Study||8
10939160|NCT00355784|12109302|FG002|STARTED|Overall Study||7
10939161|NCT00355784|12109300|FG000|COMPLETED|Overall Study||9
10939162|NCT00355784|12109301|FG001|COMPLETED|Overall Study||8
10939163|NCT00355784|12109302|FG002|COMPLETED|Overall Study||5
10939164|NCT00355784|12109300|FG000|NOT COMPLETED|Overall Study||0
10939165|NCT00355784|12109301|FG001|NOT COMPLETED|Overall Study||0
10939166|NCT00355784|12109302|FG002|NOT COMPLETED|Overall Study||2
10939167|NCT00355797|12109314|FG000|STARTED|Overall Study||741
10939168|NCT00355797|12109315|FG001|STARTED|Overall Study||369
10939169|NCT00355797|12109316|FG002|STARTED|Overall Study||381
10939170|NCT00355797|12109314|FG000|COMPLETED|Overall Study||501
10939171|NCT00355797|12109315|FG001|COMPLETED|Overall Study||221
10939172|NCT00355797|12109316|FG002|COMPLETED|Overall Study||239
10939173|NCT00355797|12109314|FG000|NOT COMPLETED|Overall Study||240
10939174|NCT00355797|12109315|FG001|NOT COMPLETED|Overall Study||148
10939175|NCT00355797|12109316|FG002|NOT COMPLETED|Overall Study||142
10939176|NCT00355914|12109326|FG000|STARTED|Overall Study||60
10939177|NCT00355914|12109327|FG001|STARTED|Overall Study||60
10939178|NCT00355914|12109326|FG000|COMPLETED|Overall Study||60
10939179|NCT00355914|12109327|FG001|COMPLETED|Overall Study||60
10939180|NCT00355914|12109326|FG000|NOT COMPLETED|Overall Study||0
10939181|NCT00355914|12109327|FG001|NOT COMPLETED|Overall Study||0
10939182|NCT00356031|12109335|FG000|STARTED|Overall Study||20
10939183|NCT00356031|12109335|FG000|COMPLETED|Overall Study||20
10939184|NCT00356031|12109335|FG000|NOT COMPLETED|Overall Study||0
10939185|NCT00356057|12109344|FG000|STARTED|Overall Study||58
10939186|NCT00356057|12109345|FG001|STARTED|Overall Study||61
10939187|NCT00356057|12109346|FG002|STARTED|Overall Study||34
10939188|NCT00356057|12109344|FG000|IMPLANTED|Overall Study||49
10939189|NCT00356057|12109345|FG001|IMPLANTED|Overall Study||52
10939190|NCT00356057|12109346|FG002|IMPLANTED|Overall Study||25
10939191|NCT00356057|12109344|FG000|COMPLETED|Overall Study||45
10939192|NCT00356057|12109345|FG001|COMPLETED|Overall Study||47
10939193|NCT00356057|12109346|FG002|COMPLETED|Overall Study||22
10939194|NCT00356057|12109344|FG000|NOT COMPLETED|Overall Study||13
10939195|NCT00356057|12109345|FG001|NOT COMPLETED|Overall Study||14
10939196|NCT00356057|12109346|FG002|NOT COMPLETED|Overall Study||12
10939197|NCT00356122|12109358|FG000|STARTED|TREATMENT||53
10939198|NCT00356122|12109358|FG000|COMPLETED|TREATMENT||8
10939199|NCT00356122|12109358|FG000|NOT COMPLETED|TREATMENT||45
10939200|NCT00356122|12109358|FG000|STARTED|FOLLOW-UP||53
10939201|NCT00356122|12109358|FG000|COMPLETED|FOLLOW-UP||12
10939202|NCT00356122|12109358|FG000|NOT COMPLETED|FOLLOW-UP||41
10939203|NCT00356135|12109365|FG000|STARTED|Overall Study||47
10939204|NCT00356135|12109366|FG001|STARTED|Overall Study||48
10939205|NCT00356135|12109367|FG002|STARTED|Overall Study||44
10939206|NCT00356135|12109365|FG000|COMPLETED|Overall Study||43
10939207|NCT00356135|12109366|FG001|COMPLETED|Overall Study||46
10939208|NCT00356135|12109367|FG002|COMPLETED|Overall Study||39
10939209|NCT00356135|12109365|FG000|NOT COMPLETED|Overall Study||4
10939210|NCT00356135|12109366|FG001|NOT COMPLETED|Overall Study||2
10939211|NCT00356135|12109367|FG002|NOT COMPLETED|Overall Study||5
10939212|NCT00356148|12109379|FG000|STARTED|Overall Study||189
10939213|NCT00356148|12109380|FG001|STARTED|Overall Study||183
10939214|NCT00356148|12109379|FG000|COMPLETED|Overall Study||187
10939215|NCT00356148|12109380|FG001|COMPLETED|Overall Study||182
10939216|NCT00356148|12109379|FG000|NOT COMPLETED|Overall Study||2
10939217|NCT00356148|12109380|FG001|NOT COMPLETED|Overall Study||1
10939218|NCT00356200|12109389|FG000|STARTED|Cohort 1: 10 ug/ml||5
10939219|NCT00356200|12109390|FG001|STARTED|Cohort 1: 10 ug/ml||0
10939220|NCT00356200|12109389|FG000|COMPLETED|Cohort 1: 10 ug/ml||4
10939221|NCT00356200|12109390|FG001|COMPLETED|Cohort 1: 10 ug/ml||0
10939222|NCT00356200|12109389|FG000|NOT COMPLETED|Cohort 1: 10 ug/ml||1
10939223|NCT00356200|12109390|FG001|NOT COMPLETED|Cohort 1: 10 ug/ml||0
10939224|NCT00356200|12109389|FG000|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
10939225|NCT00356200|12109390|FG001|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
10939226|NCT00356200|12109389|FG000|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
10939227|NCT00356200|12109390|FG001|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
10939228|NCT00356200|12109389|FG000|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
10939229|NCT00356200|12109390|FG001|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
10939230|NCT00356265|12109405|FG000|STARTED|Overall Study||7
10939231|NCT00356265|12109406|FG001|STARTED|Overall Study||2
10939232|NCT00356265|12109407|FG002|STARTED|Overall Study||6
10939233|NCT00356265|12109405|FG000|COMPLETED|Overall Study||7
10939234|NCT00356265|12109406|FG001|COMPLETED|Overall Study||2
10939235|NCT00356265|12109407|FG002|COMPLETED|Overall Study||5
10939236|NCT00356265|12109405|FG000|NOT COMPLETED|Overall Study||0
10939237|NCT00356265|12109406|FG001|NOT COMPLETED|Overall Study||0
10939238|NCT00356265|12109407|FG002|NOT COMPLETED|Overall Study||1
10939239|NCT00356278|12109419|FG000|STARTED|Overall Study||53
10939240|NCT00356278|12109420|FG001|STARTED|Overall Study||50
10939241|NCT00356278|12109421|FG002|STARTED|Overall Study||53
10939242|NCT00356278|12109419|FG000|COMPLETED|Overall Study||28
10939243|NCT00356278|12109420|FG001|COMPLETED|Overall Study||35
10939244|NCT00356278|12109421|FG002|COMPLETED|Overall Study||34
10939245|NCT00356278|12109419|FG000|NOT COMPLETED|Overall Study||25
10939246|NCT00356278|12109420|FG001|NOT COMPLETED|Overall Study||15
10939247|NCT00356278|12109421|FG002|NOT COMPLETED|Overall Study||19
10939248|NCT00356304|12109431|FG000|STARTED|Overall Study||26
10939249|NCT00356304|12109432|FG001|STARTED|Overall Study||24
10939250|NCT00356304|12109431|FG000|COMPLETED|Overall Study||24
10939251|NCT00356304|12109432|FG001|COMPLETED|Overall Study||20
10939252|NCT00356304|12109431|FG000|NOT COMPLETED|Overall Study||2
10939253|NCT00356304|12109432|FG001|NOT COMPLETED|Overall Study||4
10939254|NCT00356369|12109440|FG000|STARTED|Active Phase||374
10939255|NCT00356369|12109441|FG001|STARTED|Active Phase||126
10939256|NCT00356369|12109440|FG000|COMPLETED|Active Phase||372
10939257|NCT00356369|12109441|FG001|COMPLETED|Active Phase||125
10939258|NCT00356369|12109440|FG000|NOT COMPLETED|Active Phase||2
10939259|NCT00356369|12109441|FG001|NOT COMPLETED|Active Phase||1
10939260|NCT00356369|12109440|FG000|STARTED|Year 1||364
10939261|NCT00356369|12109441|FG001|STARTED|Year 1||121
10939262|NCT00356369|12109440|FG000|COMPLETED|Year 1||364
10939263|NCT00356369|12109441|FG001|COMPLETED|Year 1||121
10939264|NCT00356369|12109440|FG000|NOT COMPLETED|Year 1||0
10939265|NCT00356369|12109441|FG001|NOT COMPLETED|Year 1||0
10939266|NCT00356369|12109440|FG000|STARTED|Year 2||354
10939267|NCT00356369|12109441|FG001|STARTED|Year 2||117
10939268|NCT00356369|12109440|FG000|COMPLETED|Year 2||354
10939269|NCT00356369|12109441|FG001|COMPLETED|Year 2||117
10939270|NCT00356369|12109440|FG000|NOT COMPLETED|Year 2||0
10939271|NCT00356369|12109441|FG001|NOT COMPLETED|Year 2||0
10939272|NCT00356369|12109440|FG000|STARTED|Year 3||344
10939273|NCT00356369|12109441|FG001|STARTED|Year 3||116
10939274|NCT00356369|12109440|FG000|COMPLETED|Year 3||344
10939275|NCT00356369|12109441|FG001|COMPLETED|Year 3||116
10939276|NCT00356369|12109440|FG000|NOT COMPLETED|Year 3||0
10939277|NCT00356369|12109441|FG001|NOT COMPLETED|Year 3||0
10939278|NCT00356369|12109440|FG000|STARTED|Year 4||317
10939279|NCT00356369|12109441|FG001|STARTED|Year 4||109
10939280|NCT00356369|12109440|FG000|COMPLETED|Year 4||317
10939281|NCT00356369|12109441|FG001|COMPLETED|Year 4||109
10939282|NCT00356369|12109440|FG000|NOT COMPLETED|Year 4||0
10939283|NCT00356369|12109441|FG001|NOT COMPLETED|Year 4||0
10939284|NCT00356369|12109440|FG000|STARTED|Year 5||299
10939285|NCT00356369|12109441|FG001|STARTED|Year 5||105
10939286|NCT00356369|12109440|FG000|COMPLETED|Year 5||299
10939287|NCT00356369|12109441|FG001|COMPLETED|Year 5||105
10939288|NCT00356369|12109440|FG000|NOT COMPLETED|Year 5||0
10939289|NCT00356369|12109441|FG001|NOT COMPLETED|Year 5||0
10939290|NCT00356408|12109451|FG000|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
10939291|NCT00356408|12109451|FG000|COMPLETED|Overall Study||43
10939292|NCT00356408|12109451|FG000|NOT COMPLETED|Overall Study||60
10939293|NCT00356434|12109464|FG000|STARTED|Overall Study||4
10939294|NCT00356434|12109465|FG001|STARTED|Overall Study||7
10939295|NCT00356434|12109464|FG000|COMPLETED|Overall Study||4
10939296|NCT00356434|12109465|FG001|COMPLETED|Overall Study||7
10939297|NCT00356434|12109464|FG000|NOT COMPLETED|Overall Study||0
10939298|NCT00356434|12109465|FG001|NOT COMPLETED|Overall Study||0
10939299|NCT00356525|12109476|FG000|STARTED|Overall Study||14
10939300|NCT00356525|12109477|FG001|STARTED|Overall Study||11
10939301|NCT00356525|12109478|FG002|STARTED|Overall Study||7
10939302|NCT00356525|12109479|FG003|STARTED|Overall Study||9
10939303|NCT00356525|12109476|FG000|COMPLETED|Overall Study||0
10939304|NCT00356525|12109477|FG001|COMPLETED|Overall Study||0
10939305|NCT00356525|12109478|FG002|COMPLETED|Overall Study||0
10939306|NCT00356525|12109479|FG003|COMPLETED|Overall Study||0
10939307|NCT00356525|12109476|FG000|NOT COMPLETED|Overall Study||14
10939308|NCT00356525|12109477|FG001|NOT COMPLETED|Overall Study||11
10939309|NCT00356525|12109478|FG002|NOT COMPLETED|Overall Study||7
10939310|NCT00356525|12109479|FG003|NOT COMPLETED|Overall Study||9
10939311|NCT00356590|12109489|FG000|STARTED|Overall Study||468
10939312|NCT00356590|12109489|FG000|COMPLETED|Overall Study||194
10939313|NCT00356590|12109489|FG000|NOT COMPLETED|Overall Study||274
10939314|NCT00356603|12109495|FG000|STARTED|Overall Study||39
10939315|NCT00356603|12109496|FG001|STARTED|Overall Study||36
10939316|NCT00356603|12109495|FG000|COMPLETED|Overall Study||33
10939317|NCT00356603|12109496|FG001|COMPLETED|Overall Study||33
10939318|NCT00356603|12109495|FG000|NOT COMPLETED|Overall Study||6
10939319|NCT00356603|12109496|FG001|NOT COMPLETED|Overall Study||3
10939320|NCT00356759|12109506|FG000|STARTED|Overall Study||126
10939321|NCT00356759|12109507|FG001|STARTED|Overall Study||124
10939322|NCT00356759|12109506|FG000|COMPLETED|Overall Study||112
10939323|NCT00356759|12109507|FG001|COMPLETED|Overall Study||114
10939324|NCT00356759|12109506|FG000|NOT COMPLETED|Overall Study||14
10939325|NCT00356759|12109507|FG001|NOT COMPLETED|Overall Study||10
10939326|NCT00356811|12109513|FG000|STARTED|Overall Study||57
10939327|NCT00356811|12109513|FG000|COMPLETED|Overall Study||8
10939328|NCT00356811|12109513|FG000|NOT COMPLETED|Overall Study||49
10939329|NCT00356863|12109520|FG000|STARTED|Overall Study||504
10939330|NCT00356863|12109521|FG001|STARTED|Overall Study||520
10939331|NCT00356863|12109520|FG000|COMPLETED|Overall Study||412
10939332|NCT00356863|12109521|FG001|COMPLETED|Overall Study||445
10939333|NCT00356863|12109520|FG000|NOT COMPLETED|Overall Study||92
10939334|NCT00356863|12109521|FG001|NOT COMPLETED|Overall Study||75
10939335|NCT00356889|12109531|FG000|STARTED|Overall Study||56
10939336|NCT00356889|12109531|FG000|COMPLETED|Overall Study||53
10939337|NCT00356889|12109531|FG000|NOT COMPLETED|Overall Study||3
10939338|NCT00356915|12109539|FG000|STARTED|Overall Study||593
10939339|NCT00356915|12109540|FG001|STARTED|Overall Study||590
10939340|NCT00356915|12109541|FG002|STARTED|Overall Study||198
10939341|NCT00356915|12109539|FG000|COMPLETED|Overall Study||517
10939342|NCT00356915|12109540|FG001|COMPLETED|Overall Study||496
10939343|NCT00356915|12109541|FG002|COMPLETED|Overall Study||156
10939344|NCT00356915|12109539|FG000|NOT COMPLETED|Overall Study||76
10939345|NCT00356915|12109540|FG001|NOT COMPLETED|Overall Study||94
10939346|NCT00356915|12109541|FG002|NOT COMPLETED|Overall Study||42
10939347|NCT00356993|12109555|FG000|STARTED|Overall Study||6009
10939348|NCT00356993|12109555|FG000|COMPLETED|Overall Study||2088
10939349|NCT00356993|12109555|FG000|NOT COMPLETED|Overall Study||3921
10939350|NCT00357006|12109562|FG000|STARTED|Overall Study||62
10939351|NCT00357006|12109563|FG001|STARTED|Overall Study||56
10939352|NCT00357006|12109564|FG002|STARTED|Overall Study||62
10939353|NCT00357006|12109562|FG000|COMPLETED|Overall Study||60
10939354|NCT00357006|12109563|FG001|COMPLETED|Overall Study||51
10939355|NCT00357006|12109564|FG002|COMPLETED|Overall Study||59
10939356|NCT00357006|12109562|FG000|NOT COMPLETED|Overall Study||2
10939357|NCT00357006|12109563|FG001|NOT COMPLETED|Overall Study||5
10939358|NCT00357006|12109564|FG002|NOT COMPLETED|Overall Study||3
10939359|NCT00357032|12109572|FG000|STARTED|Overall Study||12
10939360|NCT00357032|12109572|FG000|COMPLETED|Overall Study||12
10939361|NCT00357032|12109572|FG000|NOT COMPLETED|Overall Study||0
10939362|NCT00357097|12109578|FG000|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
10939363|NCT00357097|12109579|FG001|STARTED|Overall Study||67
10939364|NCT00357097|12109578|FG000|COMPLETED|Overall Study||145
10939365|NCT00357097|12109579|FG001|COMPLETED|Overall Study||38
10939366|NCT00357097|12109578|FG000|NOT COMPLETED|Overall Study||54
10939367|NCT00357097|12109579|FG001|NOT COMPLETED|Overall Study||29
10939368|NCT00357110|12109587|FG000|STARTED|Overall Study||6
10939369|NCT00357110|12109588|FG001|STARTED|Overall Study||7
10939370|NCT00357110|12109587|FG000|COMPLETED|Overall Study||1
10939371|NCT00357110|12109588|FG001|COMPLETED|Overall Study||2
10939372|NCT00357110|12109587|FG000|NOT COMPLETED|Overall Study||5
10939373|NCT00357110|12109588|FG001|NOT COMPLETED|Overall Study||5
10939374|NCT00357162|12109594|FG000|STARTED|Overall Study||21
10939375|NCT00357162|12109594|FG000|COMPLETED|Overall Study||21
10939376|NCT00357162|12109594|FG000|NOT COMPLETED|Overall Study||0
10939377|NCT00357214|12109602|FG000|STARTED|Overall Study||43
10939378|NCT00357214|12109603|FG001|STARTED|Overall Study||43
10939379|NCT00357214|12109604|FG002|STARTED|Overall Study||42
10939380|NCT00357214|12109605|FG003|STARTED|Overall Study||43
10939381|NCT00357214|12109602|FG000|COMPLETED|Overall Study||39
10939382|NCT00357214|12109603|FG001|COMPLETED|Overall Study||39
10939383|NCT00357214|12109604|FG002|COMPLETED|Overall Study||42
10939384|NCT00357214|12109605|FG003|COMPLETED|Overall Study||42
10939385|NCT00357214|12109602|FG000|NOT COMPLETED|Overall Study||4
10939386|NCT00357214|12109603|FG001|NOT COMPLETED|Overall Study||4
10939387|NCT00357214|12109604|FG002|NOT COMPLETED|Overall Study||0
10939388|NCT00357214|12109605|FG003|NOT COMPLETED|Overall Study||1
10939389|NCT00357331|12109617|FG000|STARTED|Overall Study||42
10939390|NCT00357331|12109618|FG001|STARTED|Overall Study||41
10939391|NCT00357331|12109617|FG000|COMPLETED|Overall Study||42
10939392|NCT00357331|12109618|FG001|COMPLETED|Overall Study||41
10939393|NCT00357331|12109617|FG000|NOT COMPLETED|Overall Study||0
10939394|NCT00357331|12109618|FG001|NOT COMPLETED|Overall Study||0
10939395|NCT00357370|12109627|FG000|STARTED|Cohort 1||4
10939396|NCT00357370|12109628|FG001|STARTED|Cohort 1||0
10939397|NCT00357370|12109629|FG002|STARTED|Cohort 1||0
10939398|NCT00357370|12109627|FG000|COMPLETED|Cohort 1||4
10939399|NCT00357370|12109628|FG001|COMPLETED|Cohort 1||0
10939400|NCT00357370|12109629|FG002|COMPLETED|Cohort 1||0
10939401|NCT00357370|12109627|FG000|NOT COMPLETED|Cohort 1||0
10939402|NCT00357370|12109628|FG001|NOT COMPLETED|Cohort 1||0
10939403|NCT00357370|12109629|FG002|NOT COMPLETED|Cohort 1||0
10939404|NCT00357370|12109627|FG000|STARTED|Cohort 2||24
10939405|NCT00357370|12109628|FG001|STARTED|Cohort 2||23
10939406|NCT00357370|12109629|FG002|STARTED|Cohort 2||24
10939407|NCT00357370|12109627|FG000|COMPLETED|Cohort 2||22
10939408|NCT00357370|12109628|FG001|COMPLETED|Cohort 2||16
10939409|NCT00357370|12109629|FG002|COMPLETED|Cohort 2||22
10939410|NCT00357370|12109627|FG000|NOT COMPLETED|Cohort 2||2
10939411|NCT00357370|12109628|FG001|NOT COMPLETED|Cohort 2||7
10939412|NCT00357370|12109629|FG002|NOT COMPLETED|Cohort 2||2
10939413|NCT00357396|12109639|FG000|STARTED|Overall Study||6
10939414|NCT00357396|12109640|FG001|STARTED|Overall Study||4
10939415|NCT00357396|12109639|FG000|COMPLETED|Overall Study||5
10939416|NCT00357396|12109640|FG001|COMPLETED|Overall Study||4
10939417|NCT00357396|12109639|FG000|NOT COMPLETED|Overall Study||1
10939418|NCT00357396|12109640|FG001|NOT COMPLETED|Overall Study||0
10939419|NCT00357500|12109645|FG000|STARTED|Overall Study||101
10939420|NCT00357500|12109645|FG000|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
10939421|NCT00357500|12109645|FG000|COMPLETED|Overall Study||24
10939422|NCT00357500|12109645|FG000|NOT COMPLETED|Overall Study||77
10939423|NCT00357552|12109649|FG000|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
10939424|NCT00357552|12109649|FG000|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
10939425|NCT00357552|12109649|FG000|NOT COMPLETED|Screening||84
10939426|NCT00357552|12109649|FG000|STARTED|Weeks 0 to 24||123
10939427|NCT00357552|12109649|FG000|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
10939428|NCT00357552|12109649|FG000|NOT COMPLETED|Weeks 0 to 24||1
10939429|NCT00357552|12109649|FG000|STARTED|Weeks 24 to 104||122
10939430|NCT00357552|12109649|FG000|COMPLETED|Weeks 24 to 104||117
10939431|NCT00357552|12109649|FG000|NOT COMPLETED|Weeks 24 to 104||5
10939432|NCT00357656|12109659|FG000|STARTED|Overall Study||31
10939433|NCT00357656|12109660|FG001|STARTED|Overall Study||32
10939434|NCT00357656|12109659|FG000|COMPLETED|Overall Study||31
10939435|NCT00357656|12109660|FG001|COMPLETED|Overall Study||29
10939436|NCT00357656|12109659|FG000|NOT COMPLETED|Overall Study||0
10939437|NCT00357656|12109660|FG001|NOT COMPLETED|Overall Study||3
10939438|NCT00357734|12109678|FG000|STARTED|Overall Study||14
10939439|NCT00357734|12109678|FG000|Patients Received 250 mg of ZD1839|Overall Study||13
10939440|NCT00357734|12109678|FG000|Patient Received 500 mg of ZD1839|Overall Study||1
10939441|NCT00357734|12109678|FG000|COMPLETED|Overall Study||10
10939442|NCT00357734|12109678|FG000|NOT COMPLETED|Overall Study||4
10939443|NCT00357760|12109684|FG000|STARTED|Overall Study||59
10939444|NCT00357760|12109685|FG001|STARTED|Overall Study||35
10939445|NCT00357760|12109684|FG000|Patients Who Started Treatment|Overall Study||57
10939446|NCT00357760|12109685|FG001|Patients Who Started Treatment|Overall Study||34
10939447|NCT00357760|12109684|FG000|Eligible and Treated Patients|Overall Study||57
10939448|NCT00357760|12109685|FG001|Eligible and Treated Patients|Overall Study||32
10939449|NCT00357760|12109684|FG000|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
10939450|NCT00357760|12109685|FG001|Patients Who Undergo Dose Escalation|Overall Study||16
10939451|NCT00357760|12109684|FG000|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
10939452|NCT00357760|12109685|FG001|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
10939453|NCT00357760|12109684|FG000|NOT COMPLETED|Overall Study||59
10939454|NCT00357760|12109685|FG001|NOT COMPLETED|Overall Study||35
10939455|NCT00357877|12109693|FG000|STARTED|Overall Study||493
10939456|NCT00357877|12109694|FG001|STARTED|Overall Study||490
10939457|NCT00357877|12109693|FG000|COMPLETED|Overall Study||467
10939458|NCT00357877|12109694|FG001|COMPLETED|Overall Study||460
10939459|NCT00357877|12109693|FG000|NOT COMPLETED|Overall Study||26
10939460|NCT00357877|12109694|FG001|NOT COMPLETED|Overall Study||30
10939461|NCT00357903|12109704|FG000|STARTED|Overall Study||581
10939462|NCT00357903|12109705|FG001|STARTED|Overall Study||58
10939463|NCT00357903|12109704|FG000|COMPLETED|Overall Study||218
10939464|NCT00357903|12109705|FG001|COMPLETED|Overall Study||15
10939465|NCT00357903|12109704|FG000|NOT COMPLETED|Overall Study||363
10939466|NCT00357903|12109705|FG001|NOT COMPLETED|Overall Study||43
10939467|NCT00357955|12109714|FG000|STARTED|Overall Study||64
10939468|NCT00357955|12109715|FG001|STARTED|Overall Study||54
10939469|NCT00357955|12109714|FG000|COMPLETED|Overall Study||58
10939470|NCT00357955|12109715|FG001|COMPLETED|Overall Study||51
10939471|NCT00357955|12109714|FG000|NOT COMPLETED|Overall Study||6
10939472|NCT00357955|12109715|FG001|NOT COMPLETED|Overall Study||3
10939473|NCT00357968|12109723|FG000|STARTED|First Maintenance Dose Phase||102
10939474|NCT00357968|12109724|FG001|STARTED|First Maintenance Dose Phase||99
10939475|NCT00357968|12109723|FG000|Received Loading Dose|First Maintenance Dose Phase||102
10939476|NCT00357968|12109724|FG001|Received Loading Dose|First Maintenance Dose Phase||99
10939477|NCT00357968|12109723|FG000|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
10939478|NCT00357968|12109724|FG001|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
10939479|NCT00357968|12109723|FG000|Started Maintenance Dose|First Maintenance Dose Phase||55
10939480|NCT00357968|12109724|FG001|Started Maintenance Dose|First Maintenance Dose Phase||55
10939481|NCT00357968|12109723|FG000|COMPLETED|First Maintenance Dose Phase||54
10939482|NCT00357968|12109724|FG001|COMPLETED|First Maintenance Dose Phase||55
10939483|NCT00357968|12109723|FG000|NOT COMPLETED|First Maintenance Dose Phase||48
10939484|NCT00357968|12109724|FG001|NOT COMPLETED|First Maintenance Dose Phase||44
10939485|NCT00357968|12109723|FG000|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
10939486|NCT00357968|12109724|FG001|STARTED|Crossover Maintenance Dose Phase||55
10939487|NCT00357968|12109723|FG000|COMPLETED|Crossover Maintenance Dose Phase||54
10939488|NCT00357968|12109724|FG001|COMPLETED|Crossover Maintenance Dose Phase||55
10939489|NCT00357968|12109723|FG000|NOT COMPLETED|Crossover Maintenance Dose Phase||0
10939490|NCT00357968|12109724|FG001|NOT COMPLETED|Crossover Maintenance Dose Phase||0
10939491|NCT00357994|12109747|FG000|STARTED|Overall Study||37
10939492|NCT00357994|12109748|FG001|STARTED|Overall Study||34
10939493|NCT00357994|12109747|FG000|COMPLETED|Overall Study||35
10939494|NCT00357994|12109748|FG001|COMPLETED|Overall Study||31
10939495|NCT00357994|12109747|FG000|NOT COMPLETED|Overall Study||2
10939496|NCT00357994|12109748|FG001|NOT COMPLETED|Overall Study||3
10939497|NCT00358007|12109754|FG000|STARTED|Overall Study||30
10939498|NCT00358007|12109754|FG000|COMPLETED|Overall Study||28
10939499|NCT00358007|12109754|FG000|NOT COMPLETED|Overall Study||2
10939500|NCT00358150|12109758|FG000|STARTED|Overall Study||26
10939501|NCT00358150|12109758|FG000|COMPLETED|Overall Study||19
10939502|NCT00358150|12109758|FG000|NOT COMPLETED|Overall Study||7
10939503|NCT00358215|12109767|FG000|STARTED|Overall Study||1142
10939504|NCT00358215|12109768|FG001|STARTED|Overall Study||1136
10939505|NCT00358215|12109767|FG000|Received Investigational Product|Overall Study||1140
10939506|NCT00358215|12109768|FG001|Received Investigational Product|Overall Study||1133
10939507|NCT00358215|12109767|FG000|COMPLETED|Overall Study|Participants who completed investigational product|463
10939508|NCT00358215|12109768|FG001|COMPLETED|Overall Study|Participants who completed investigational product|484
10939509|NCT00358215|12109767|FG000|NOT COMPLETED|Overall Study||679
10939510|NCT00358215|12109768|FG001|NOT COMPLETED|Overall Study||652
10939511|NCT00358332|12109778|FG000|STARTED|Overall Study||15
10939512|NCT00358332|12109779|FG001|STARTED|Overall Study||30
10939513|NCT00358332|12109780|FG002|STARTED|Overall Study||30
10939514|NCT00358332|12109781|FG003|STARTED|Overall Study||25
10939515|NCT00358332|12109778|FG000|COMPLETED|Overall Study||15
10939516|NCT00358332|12109779|FG001|COMPLETED|Overall Study||27
10939517|NCT00358332|12109780|FG002|COMPLETED|Overall Study||29
10939518|NCT00358332|12109781|FG003|COMPLETED|Overall Study||25
10939519|NCT00358332|12109778|FG000|NOT COMPLETED|Overall Study||0
10939520|NCT00358332|12109779|FG001|NOT COMPLETED|Overall Study||3
10939521|NCT00358332|12109780|FG002|NOT COMPLETED|Overall Study||1
10939522|NCT00358332|12109781|FG003|NOT COMPLETED|Overall Study||0
10939523|NCT00358436|12109793|FG000|STARTED|Overall Study||600
10939524|NCT00358436|12109794|FG001|STARTED|Overall Study||204
10939525|NCT00358436|12109793|FG000|COMPLETED|Overall Study||446
10939526|NCT00358436|12109794|FG001|COMPLETED|Overall Study||118
10939527|NCT00358436|12109793|FG000|NOT COMPLETED|Overall Study||154
10939528|NCT00358436|12109794|FG001|NOT COMPLETED|Overall Study||86
10939529|NCT00358449|12109805|FG000|STARTED|Overall Study||19
10939530|NCT00358449|12109806|FG001|STARTED|Overall Study||20
10939531|NCT00358449|12109807|FG002|STARTED|Overall Study||20
10939532|NCT00358449|12109805|FG000|COMPLETED|Overall Study||15
10939533|NCT00358449|12109806|FG001|COMPLETED|Overall Study||19
10939534|NCT00358449|12109807|FG002|COMPLETED|Overall Study||18
10939535|NCT00358449|12109805|FG000|NOT COMPLETED|Overall Study||4
10939536|NCT00358449|12109806|FG001|NOT COMPLETED|Overall Study||1
10939537|NCT00358449|12109807|FG002|NOT COMPLETED|Overall Study||2
10939538|NCT00358462|12109819|FG000|STARTED|Overall Study||304
10939539|NCT00358462|12109820|FG001|STARTED|Overall Study||302
10939540|NCT00358462|12109819|FG000|COMPLETED|Overall Study||245
10939541|NCT00358462|12109820|FG001|COMPLETED|Overall Study||238
10939542|NCT00358462|12109819|FG000|NOT COMPLETED|Overall Study||59
10939543|NCT00358462|12109820|FG001|NOT COMPLETED|Overall Study||64
10939544|NCT00358501|12109838|FG000|STARTED|Overall Study||102
10939545|NCT00358501|12109839|FG001|STARTED|Overall Study||32
10939546|NCT00358501|12109838|FG000|COMPLETED|Overall Study||102
10939547|NCT00358501|12109839|FG001|COMPLETED|Overall Study||32
10939548|NCT00358501|12109838|FG000|NOT COMPLETED|Overall Study||0
10939549|NCT00358501|12109839|FG001|NOT COMPLETED|Overall Study||0
10939550|NCT00358579|12109848|FG000|STARTED|Overall Study||353
10939551|NCT00358579|12109849|FG001|STARTED|Overall Study||374
10939552|NCT00358579|12109848|FG000|COMPLETED|Overall Study||353
10939553|NCT00358579|12109849|FG001|COMPLETED|Overall Study||374
10939554|NCT00358579|12109848|FG000|NOT COMPLETED|Overall Study||0
10939555|NCT00358579|12109849|FG001|NOT COMPLETED|Overall Study||0
10939556|NCT00358644|12109855|FG000|STARTED|Overall Study||55
10939557|NCT00358644|12109855|FG000|COMPLETED|Overall Study||5
10939558|NCT00358644|12109855|FG000|NOT COMPLETED|Overall Study||50
10939559|NCT00358657|12109859|FG000|STARTED|Overall Study||14
10939560|NCT00358657|12109859|FG000|COMPLETED|Overall Study||14
10939561|NCT00358657|12109859|FG000|NOT COMPLETED|Overall Study||0
10939562|NCT00358670|12109865|FG000|STARTED|Overall Study||222
10939563|NCT00358670|12109866|FG001|STARTED|Overall Study||219
10939564|NCT00358670|12109865|FG000|COMPLETED|Overall Study||0
10939565|NCT00358670|12109866|FG001|COMPLETED|Overall Study||0
10939566|NCT00358670|12109865|FG000|NOT COMPLETED|Overall Study||222
10939567|NCT00358670|12109866|FG001|NOT COMPLETED|Overall Study||219
10939568|NCT00358735|12109874|FG000|STARTED|Overall Study||204
10939569|NCT00358735|12109875|FG001|STARTED|Overall Study||207
10939570|NCT00358735|12109874|FG000|Completed Safety|Overall Study||198
10939571|NCT00358735|12109875|FG001|Completed Safety|Overall Study||194
10939572|NCT00358735|12109874|FG000|Not Completed Safety|Overall Study||6
10939573|NCT00358735|12109875|FG001|Not Completed Safety|Overall Study||13
10939574|NCT00358735|12109874|FG000|COMPLETED|Overall Study|Efficacy|196
10939575|NCT00358735|12109875|FG001|COMPLETED|Overall Study|Efficacy|190
10939576|NCT00358735|12109874|FG000|NOT COMPLETED|Overall Study||8
10939577|NCT00358735|12109875|FG001|NOT COMPLETED|Overall Study||17
10939578|NCT00358826|12109885|FG000|STARTED|Core Study||49
10939579|NCT00358826|12109886|FG001|STARTED|Core Study||46
10939580|NCT00358826|12109887|FG002|STARTED|Core Study||44
10939581|NCT00358826|12109888|FG003|STARTED|Core Study||52
10939582|NCT00358826|12109889|FG004|STARTED|Core Study||0
10939583|NCT00358826|12109890|FG005|STARTED|Core Study||0
10939584|NCT00358826|12109891|FG006|STARTED|Core Study||0
10939585|NCT00358826|12109892|FG007|STARTED|Core Study||0
10939586|NCT00358826|12109885|FG000|COMPLETED|Core Study||46
10939587|NCT00358826|12109886|FG001|COMPLETED|Core Study||41
10939588|NCT00358826|12109887|FG002|COMPLETED|Core Study||42
10939589|NCT00358826|12109888|FG003|COMPLETED|Core Study||50
10939590|NCT00358826|12109889|FG004|COMPLETED|Core Study||0
10939591|NCT00358826|12109890|FG005|COMPLETED|Core Study||0
10939592|NCT00358826|12109891|FG006|COMPLETED|Core Study||0
10939593|NCT00358826|12109892|FG007|COMPLETED|Core Study||0
10939594|NCT00358826|12109885|FG000|NOT COMPLETED|Core Study||3
10939595|NCT00358826|12109886|FG001|NOT COMPLETED|Core Study||5
10939596|NCT00358826|12109887|FG002|NOT COMPLETED|Core Study||2
10939597|NCT00358826|12109888|FG003|NOT COMPLETED|Core Study||2
10939598|NCT00358826|12109889|FG004|NOT COMPLETED|Core Study||0
10939599|NCT00358826|12109890|FG005|NOT COMPLETED|Core Study||0
10939600|NCT00358826|12109891|FG006|NOT COMPLETED|Core Study||0
10939601|NCT00358826|12109892|FG007|NOT COMPLETED|Core Study||0
10939602|NCT00358826|12109885|FG000|STARTED|MDCT Substudy||0
10939603|NCT00358826|12109886|FG001|STARTED|MDCT Substudy||0
10939604|NCT00358826|12109887|FG002|STARTED|MDCT Substudy||0
10939605|NCT00358826|12109888|FG003|STARTED|MDCT Substudy||0
10939606|NCT00358826|12109889|FG004|STARTED|MDCT Substudy||25
10939607|NCT00358826|12109890|FG005|STARTED|MDCT Substudy||22
10939608|NCT00358826|12109891|FG006|STARTED|MDCT Substudy||19
10939609|NCT00358826|12109892|FG007|STARTED|MDCT Substudy||27
10939610|NCT00358826|12109885|FG000|COMPLETED|MDCT Substudy||0
10939611|NCT00358826|12109886|FG001|COMPLETED|MDCT Substudy||0
10939612|NCT00358826|12109887|FG002|COMPLETED|MDCT Substudy||0
10939613|NCT00358826|12109888|FG003|COMPLETED|MDCT Substudy||0
10939614|NCT00358826|12109889|FG004|COMPLETED|MDCT Substudy||24
10939615|NCT00358826|12109890|FG005|COMPLETED|MDCT Substudy||20
10939616|NCT00358826|12109891|FG006|COMPLETED|MDCT Substudy||19
10939617|NCT00358826|12109892|FG007|COMPLETED|MDCT Substudy||27
10939618|NCT00358826|12109885|FG000|NOT COMPLETED|MDCT Substudy||0
10939619|NCT00358826|12109886|FG001|NOT COMPLETED|MDCT Substudy||0
10939620|NCT00358826|12109887|FG002|NOT COMPLETED|MDCT Substudy||0
10939621|NCT00358826|12109888|FG003|NOT COMPLETED|MDCT Substudy||0
10939622|NCT00358826|12109889|FG004|NOT COMPLETED|MDCT Substudy||1
10939623|NCT00358826|12109890|FG005|NOT COMPLETED|MDCT Substudy||2
10939624|NCT00358826|12109891|FG006|NOT COMPLETED|MDCT Substudy||0
10939625|NCT00358826|12109892|FG007|NOT COMPLETED|MDCT Substudy||0
10939626|NCT00358917|12109908|FG000|STARTED|Overall Study||300
10939627|NCT00358917|12109909|FG001|STARTED|Overall Study||299
10939628|NCT00358917|12109908|FG000|COMPLETED|Overall Study||234
10939629|NCT00358917|12109909|FG001|COMPLETED|Overall Study||230
10939630|NCT00358917|12109908|FG000|NOT COMPLETED|Overall Study||66
10939631|NCT00358917|12109909|FG001|NOT COMPLETED|Overall Study||69
10939632|NCT00358956|12109917|FG000|STARTED|Overall Study||19
10939633|NCT00358956|12109917|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
10939634|NCT00358956|12109917|FG000|NOT COMPLETED|Overall Study||8
10939635|NCT00359021|12109923|FG000|STARTED|Overall Study||256
10939636|NCT00359021|12109924|FG001|STARTED|Overall Study||247
10939637|NCT00359021|12109923|FG000|COMPLETED|Overall Study||175
10939638|NCT00359021|12109924|FG001|COMPLETED|Overall Study||195
10939639|NCT00359021|12109923|FG000|NOT COMPLETED|Overall Study||81
10939640|NCT00359021|12109924|FG001|NOT COMPLETED|Overall Study||52
10939641|NCT00359073|12109934|FG000|STARTED|Overall Study||12
10939642|NCT00359073|12109935|FG001|STARTED|Overall Study||13
10939643|NCT00359073|12109934|FG000|COMPLETED|Overall Study||8
10939644|NCT00359073|12109935|FG001|COMPLETED|Overall Study||11
10939645|NCT00359073|12109934|FG000|NOT COMPLETED|Overall Study||4
10939646|NCT00359073|12109935|FG001|NOT COMPLETED|Overall Study||2
10939647|NCT00359203|12109945|FG000|STARTED|Overall Study||39
10939648|NCT00359203|12109946|FG001|STARTED|Overall Study||38
10939649|NCT00359203|12109945|FG000|COMPLETED|Overall Study||39
10939650|NCT00359203|12109946|FG001|COMPLETED|Overall Study||38
10939651|NCT00359203|12109945|FG000|NOT COMPLETED|Overall Study||0
10939652|NCT00359203|12109946|FG001|NOT COMPLETED|Overall Study||0
10939653|NCT00359281|12109961|FG000|STARTED|Overall Study||16
10939654|NCT00359281|12109962|FG001|STARTED|Overall Study||15
10939655|NCT00359281|12109963|FG002|STARTED|Overall Study||10
10939656|NCT00359281|12109964|FG003|STARTED|Overall Study||10
10939657|NCT00359281|12109965|FG004|STARTED|Overall Study||10
10939658|NCT00359281|12109966|FG005|STARTED|Overall Study||15
10939659|NCT00359281|12109967|FG006|STARTED|Overall Study||18
10939660|NCT00359281|12109968|FG007|STARTED|Overall Study||15
10939661|NCT00359281|12109969|FG008|STARTED|Overall Study||20
10939662|NCT00359281|12109961|FG000|COMPLETED|Overall Study||15
10939663|NCT00359281|12109962|FG001|COMPLETED|Overall Study||15
10939664|NCT00359281|12109963|FG002|COMPLETED|Overall Study||10
10939665|NCT00359281|12109964|FG003|COMPLETED|Overall Study||10
10939666|NCT00359281|12109965|FG004|COMPLETED|Overall Study||10
10939667|NCT00359281|12109966|FG005|COMPLETED|Overall Study||15
10939668|NCT00359281|12109967|FG006|COMPLETED|Overall Study||16
10939669|NCT00359281|12109968|FG007|COMPLETED|Overall Study||15
10939670|NCT00359281|12109969|FG008|COMPLETED|Overall Study||20
10939671|NCT00359281|12109961|FG000|NOT COMPLETED|Overall Study||1
10939672|NCT00359281|12109962|FG001|NOT COMPLETED|Overall Study||0
10939673|NCT00359281|12109963|FG002|NOT COMPLETED|Overall Study||0
10939674|NCT00359281|12109964|FG003|NOT COMPLETED|Overall Study||0
10939675|NCT00359281|12109965|FG004|NOT COMPLETED|Overall Study||0
10939676|NCT00359281|12109966|FG005|NOT COMPLETED|Overall Study||0
10939677|NCT00359281|12109967|FG006|NOT COMPLETED|Overall Study||2
10939678|NCT00359281|12109968|FG007|NOT COMPLETED|Overall Study||0
10939679|NCT00359281|12109969|FG008|NOT COMPLETED|Overall Study||0
10939680|NCT00359294|12110001|FG000|STARTED|Overall Study||1
10939681|NCT00359294|12110002|FG001|STARTED|Overall Study||1
10939682|NCT00359294|12110003|FG002|STARTED|Overall Study||3
10939683|NCT00359294|12110004|FG003|STARTED|Overall Study||4
10939684|NCT00359294|12110005|FG004|STARTED|Overall Study||3
10939685|NCT00359294|12110001|FG000|COMPLETED|Overall Study||0
10939686|NCT00359294|12110002|FG001|COMPLETED|Overall Study||0
10939687|NCT00359294|12110003|FG002|COMPLETED|Overall Study||0
10939688|NCT00359294|12110004|FG003|COMPLETED|Overall Study||0
10939689|NCT00359294|12110005|FG004|COMPLETED|Overall Study||0
10939690|NCT00359294|12110001|FG000|NOT COMPLETED|Overall Study||1
10939691|NCT00359294|12110002|FG001|NOT COMPLETED|Overall Study||1
10939692|NCT00359294|12110003|FG002|NOT COMPLETED|Overall Study||3
10939693|NCT00359294|12110004|FG003|NOT COMPLETED|Overall Study||4
10939694|NCT00359294|12110005|FG004|NOT COMPLETED|Overall Study||3
10939695|NCT00359424|12110015|FG000|STARTED|Overall Study||434
10939696|NCT00359424|12110016|FG001|STARTED|Overall Study||222
10939697|NCT00359424|12110015|FG000|90 Day Follow up|Overall Study||343
10939698|NCT00359424|12110016|FG001|90 Day Follow up|Overall Study||172
10939699|NCT00359424|12110015|FG000|180 Day Follow up|Overall Study||325
10939700|NCT00359424|12110016|FG001|180 Day Follow up|Overall Study||167
10939701|NCT00359424|12110015|FG000|270 Day Follow up|Overall Study||313
10939702|NCT00359424|12110016|FG001|270 Day Follow up|Overall Study||159
10939703|NCT00359424|12110015|FG000|COMPLETED|Overall Study||304
10939704|NCT00359424|12110016|FG001|COMPLETED|Overall Study||155
10939705|NCT00359424|12110015|FG000|NOT COMPLETED|Overall Study||130
10939706|NCT00359424|12110016|FG001|NOT COMPLETED|Overall Study||67
10939707|NCT00359619|12110029|FG000|STARTED|Overall Study||88
10939708|NCT00359619|12110030|FG001|STARTED|Overall Study||50
10939709|NCT00359619|12110031|FG002|STARTED|Overall Study||49
10939710|NCT00359619|12110032|FG003|STARTED|Overall Study||48
10939711|NCT00359619|12110033|FG004|STARTED|Overall Study||48
10939712|NCT00359619|12110034|FG005|STARTED|Overall Study||50
10939713|NCT00359619|12110035|FG006|STARTED|Overall Study||50
10939714|NCT00359619|12110029|FG000|COMPLETED|Overall Study||80
10939715|NCT00359619|12110030|FG001|COMPLETED|Overall Study||45
10939716|NCT00359619|12110031|FG002|COMPLETED|Overall Study||42
10939717|NCT00359619|12110032|FG003|COMPLETED|Overall Study||45
10939718|NCT00359619|12110033|FG004|COMPLETED|Overall Study||45
10939719|NCT00359619|12110034|FG005|COMPLETED|Overall Study||45
10939720|NCT00359619|12110035|FG006|COMPLETED|Overall Study||46
10939721|NCT00359619|12110029|FG000|NOT COMPLETED|Overall Study||8
10939722|NCT00359619|12110030|FG001|NOT COMPLETED|Overall Study||5
10939723|NCT00359619|12110031|FG002|NOT COMPLETED|Overall Study||7
10939724|NCT00359619|12110032|FG003|NOT COMPLETED|Overall Study||3
10939725|NCT00359619|12110033|FG004|NOT COMPLETED|Overall Study||3
10939726|NCT00359619|12110034|FG005|NOT COMPLETED|Overall Study||5
10939727|NCT00359619|12110035|FG006|NOT COMPLETED|Overall Study||4
10939728|NCT00359632|12110053|FG000|STARTED|Overall Study||24
10939729|NCT00359632|12110054|FG001|STARTED|Overall Study||9
10939730|NCT00359632|12110053|FG000|COMPLETED|Overall Study||20
10939731|NCT00359632|12110054|FG001|COMPLETED|Overall Study||9
10939732|NCT00359632|12110053|FG000|NOT COMPLETED|Overall Study||4
10939733|NCT00359632|12110054|FG001|NOT COMPLETED|Overall Study||0
10939734|NCT00359736|12110062|FG000|STARTED|Overall Study||14
10939735|NCT00359736|12110063|FG001|STARTED|Overall Study||15
10939736|NCT00359736|12110062|FG000|COMPLETED|Overall Study||14
10939737|NCT00359736|12110063|FG001|COMPLETED|Overall Study||15
10939738|NCT00359736|12110062|FG000|NOT COMPLETED|Overall Study||0
10939739|NCT00359736|12110063|FG001|NOT COMPLETED|Overall Study||0
10939740|NCT00359762|12110073|FG000|STARTED|Period II||514
10939741|NCT00359762|12110074|FG001|STARTED|Period II||0
10939742|NCT00359762|12110075|FG002|STARTED|Period II||0
10939743|NCT00359762|12110076|FG003|STARTED|Period II||0
10939744|NCT00359762|12110077|FG004|STARTED|Period II||515
10939745|NCT00359762|12110073|FG000|Intent to Treat (ITT) Safety Population|Period II||508
10939746|NCT00359762|12110074|FG001|Intent to Treat (ITT) Safety Population|Period II||0
10939747|NCT00359762|12110075|FG002|Intent to Treat (ITT) Safety Population|Period II||0
10939748|NCT00359762|12110076|FG003|Intent to Treat (ITT) Safety Population|Period II||0
10939749|NCT00359762|12110077|FG004|Intent to Treat (ITT) Safety Population|Period II||511
10939750|NCT00359762|12110073|FG000|ITT Efficacy Population|Period II||487
10939751|NCT00359762|12110074|FG001|ITT Efficacy Population|Period II||0
10939752|NCT00359762|12110075|FG002|ITT Efficacy Population|Period II||0
10939753|NCT00359762|12110076|FG003|ITT Efficacy Population|Period II||0
10939754|NCT00359762|12110077|FG004|ITT Efficacy Population|Period II||490
10939755|NCT00359762|12110073|FG000|Met Primary Endpoint|Period II||262
10939756|NCT00359762|12110074|FG001|Met Primary Endpoint|Period II||0
10939757|NCT00359762|12110075|FG002|Met Primary Endpoint|Period II||0
10939758|NCT00359762|12110076|FG003|Met Primary Endpoint|Period II||0
10939759|NCT00359762|12110077|FG004|Met Primary Endpoint|Period II||203
10939760|NCT00359762|12110073|FG000|Without Treatment Failure|Period II||124
10939761|NCT00359762|12110074|FG001|Without Treatment Failure|Period II||0
10939762|NCT00359762|12110075|FG002|Without Treatment Failure|Period II||0
10939763|NCT00359762|12110076|FG003|Without Treatment Failure|Period II||0
10939764|NCT00359762|12110077|FG004|Without Treatment Failure|Period II||138
10939765|NCT00359762|12110073|FG000|COMPLETED|Period II||386
10939766|NCT00359762|12110074|FG001|COMPLETED|Period II||0
10939767|NCT00359762|12110075|FG002|COMPLETED|Period II||0
10939768|NCT00359762|12110076|FG003|COMPLETED|Period II||0
10939769|NCT00359762|12110077|FG004|COMPLETED|Period II||341
10939770|NCT00359762|12110073|FG000|NOT COMPLETED|Period II||128
10939771|NCT00359762|12110074|FG001|NOT COMPLETED|Period II||0
10939772|NCT00359762|12110075|FG002|NOT COMPLETED|Period II||0
10939773|NCT00359762|12110076|FG003|NOT COMPLETED|Period II||0
10939774|NCT00359762|12110077|FG004|NOT COMPLETED|Period II||174
10939775|NCT00359762|12110073|FG000|STARTED|Period III||0
10939776|NCT00359762|12110074|FG001|STARTED|Period III||77
10939777|NCT00359762|12110075|FG002|STARTED|Period III||77
10939778|NCT00359762|12110076|FG003|STARTED|Period III||166
10939779|NCT00359762|12110077|FG004|STARTED|Period III||0
10939780|NCT00359762|12110073|FG000|Extension ITT Safety Population|Period III||0
10939781|NCT00359762|12110074|FG001|Extension ITT Safety Population|Period III||74
10939782|NCT00359762|12110075|FG002|Extension ITT Safety Population|Period III||76
10939783|NCT00359762|12110076|FG003|Extension ITT Safety Population|Period III||166
10939784|NCT00359762|12110077|FG004|Extension ITT Safety Population|Period III||0
10939785|NCT00359762|12110073|FG000|Extension ITT Efficacy Population|Period III||0
10939786|NCT00359762|12110074|FG001|Extension ITT Efficacy Population|Period III||73
10939787|NCT00359762|12110075|FG002|Extension ITT Efficacy Population|Period III||75
10939788|NCT00359762|12110076|FG003|Extension ITT Efficacy Population|Period III||164
10939789|NCT00359762|12110077|FG004|Extension ITT Efficacy Population|Period III||0
10939790|NCT00359762|12110073|FG000|COMPLETED|Period III||0
10939791|NCT00359762|12110074|FG001|COMPLETED|Period III||48
10939792|NCT00359762|12110075|FG002|COMPLETED|Period III||47
10939793|NCT00359762|12110076|FG003|COMPLETED|Period III||101
10939794|NCT00359762|12110077|FG004|COMPLETED|Period III||0
10939795|NCT00359762|12110073|FG000|NOT COMPLETED|Period III||0
10939796|NCT00359762|12110074|FG001|NOT COMPLETED|Period III||29
10939797|NCT00359762|12110075|FG002|NOT COMPLETED|Period III||30
10939798|NCT00359762|12110076|FG003|NOT COMPLETED|Period III||65
10939799|NCT00359762|12110077|FG004|NOT COMPLETED|Period III||0
10939800|NCT00359762|12110073|FG000|STARTED|Period I||0
10939801|NCT00359762|12110074|FG001|STARTED|Period I||0
10939802|NCT00359762|12110075|FG002|STARTED|Period I||0
10939803|NCT00359762|12110076|FG003|STARTED|Period I||0
10939804|NCT00359762|12110077|FG004|STARTED|Period I||0
10939805|NCT00359762|12110073|FG000|COMPLETED|Period I||0
10939806|NCT00359762|12110074|FG001|COMPLETED|Period I||0
10939807|NCT00359762|12110075|FG002|COMPLETED|Period I||0
10939808|NCT00359762|12110076|FG003|COMPLETED|Period I||0
10939809|NCT00359762|12110077|FG004|COMPLETED|Period I||0
10939810|NCT00359762|12110073|FG000|NOT COMPLETED|Period I||0
10939811|NCT00359762|12110074|FG001|NOT COMPLETED|Period I||0
10939812|NCT00359762|12110075|FG002|NOT COMPLETED|Period I||0
10939813|NCT00359762|12110076|FG003|NOT COMPLETED|Period I||0
10939814|NCT00359762|12110077|FG004|NOT COMPLETED|Period I||0
10939815|NCT00359788|12110093|FG000|STARTED|Overall Study||173
10939816|NCT00359788|12110094|FG001|STARTED|Overall Study||176
10939817|NCT00359788|12110093|FG000|COMPLETED|Overall Study||150
10939818|NCT00359788|12110094|FG001|COMPLETED|Overall Study||159
10939819|NCT00359788|12110093|FG000|NOT COMPLETED|Overall Study||23
10939820|NCT00359788|12110094|FG001|NOT COMPLETED|Overall Study||17
10939821|NCT00359801|12110102|FG000|STARTED|Overall Study||987
10939822|NCT00359801|12110103|FG001|STARTED|Overall Study||989
10939823|NCT00359801|12110102|FG000|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
10939824|NCT00359801|12110103|FG001|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
10939825|NCT00359801|12110102|FG000|NOT COMPLETED|Overall Study||305
10939826|NCT00359801|12110103|FG001|NOT COMPLETED|Overall Study||220
10939827|NCT00359944|12110112|FG000|STARTED|Overall Study||50
10939828|NCT00359944|12110113|FG001|STARTED|Overall Study||47
10939829|NCT00359944|12110114|FG002|STARTED|Overall Study||57
10939830|NCT00359944|12110112|FG000|COMPLETED|Overall Study||34
10939831|NCT00359944|12110113|FG001|COMPLETED|Overall Study||28
10939832|NCT00359944|12110114|FG002|COMPLETED|Overall Study||38
10939833|NCT00359944|12110112|FG000|NOT COMPLETED|Overall Study||16
10939834|NCT00359944|12110113|FG001|NOT COMPLETED|Overall Study||19
10939835|NCT00359944|12110114|FG002|NOT COMPLETED|Overall Study||19
10939836|NCT00359983|12110125|FG000|STARTED|Year 1 Persistence Follow-up||138
10939837|NCT00359983|12110126|FG001|STARTED|Year 1 Persistence Follow-up||70
10939838|NCT00359983|12110127|FG002|STARTED|Year 1 Persistence Follow-up||62
10939839|NCT00359983|12110125|FG000|COMPLETED|Year 1 Persistence Follow-up||138
10939840|NCT00359983|12110126|FG001|COMPLETED|Year 1 Persistence Follow-up||70
10939841|NCT00359983|12110127|FG002|COMPLETED|Year 1 Persistence Follow-up||62
10939842|NCT00359983|12110125|FG000|NOT COMPLETED|Year 1 Persistence Follow-up||0
10939843|NCT00359983|12110126|FG001|NOT COMPLETED|Year 1 Persistence Follow-up||0
10939844|NCT00359983|12110127|FG002|NOT COMPLETED|Year 1 Persistence Follow-up||0
10939845|NCT00359983|12110125|FG000|STARTED|Year 3 Persistence Follow-up||103
10939846|NCT00359983|12110126|FG001|STARTED|Year 3 Persistence Follow-up||47
10939847|NCT00359983|12110127|FG002|STARTED|Year 3 Persistence Follow-up||51
10939848|NCT00359983|12110125|FG000|COMPLETED|Year 3 Persistence Follow-up||103
10939849|NCT00359983|12110126|FG001|COMPLETED|Year 3 Persistence Follow-up||47
10939850|NCT00359983|12110127|FG002|COMPLETED|Year 3 Persistence Follow-up||51
10939851|NCT00359983|12110125|FG000|NOT COMPLETED|Year 3 Persistence Follow-up||0
10939852|NCT00359983|12110126|FG001|NOT COMPLETED|Year 3 Persistence Follow-up||0
10939853|NCT00359983|12110127|FG002|NOT COMPLETED|Year 3 Persistence Follow-up||0
10939854|NCT00359983|12110125|FG000|STARTED|Year 5 Persistence Follow-up||95
10939855|NCT00359983|12110126|FG001|STARTED|Year 5 Persistence Follow-up||44
10939856|NCT00359983|12110127|FG002|STARTED|Year 5 Persistence Follow-up||42
10939857|NCT00359983|12110125|FG000|COMPLETED|Year 5 Persistence Follow-up||95
10939858|NCT00359983|12110126|FG001|COMPLETED|Year 5 Persistence Follow-up||44
10939859|NCT00359983|12110127|FG002|COMPLETED|Year 5 Persistence Follow-up||42
10939860|NCT00359983|12110125|FG000|NOT COMPLETED|Year 5 Persistence Follow-up||0
10939861|NCT00359983|12110126|FG001|NOT COMPLETED|Year 5 Persistence Follow-up||0
10939862|NCT00359983|12110127|FG002|NOT COMPLETED|Year 5 Persistence Follow-up||0
10939863|NCT00360009|12110138|FG000|STARTED|Overall Study||10
10939864|NCT00360009|12110139|FG001|STARTED|Overall Study||26
10939865|NCT00360009|12110140|FG002|STARTED|Overall Study||26
10939866|NCT00360009|12110138|FG000|COMPLETED|Overall Study||10
10939867|NCT00360009|12110139|FG001|COMPLETED|Overall Study||22
10939868|NCT00360009|12110140|FG002|COMPLETED|Overall Study||23
10939869|NCT00360009|12110138|FG000|NOT COMPLETED|Overall Study||0
10939870|NCT00360009|12110139|FG001|NOT COMPLETED|Overall Study||4
10939871|NCT00360009|12110140|FG002|NOT COMPLETED|Overall Study||3
10939872|NCT00360126|12110148|FG000|STARTED|Overall Study||11
10939873|NCT00360126|12110148|FG000|COMPLETED|Overall Study||11
10939874|NCT00360126|12110148|FG000|NOT COMPLETED|Overall Study||0
10939875|NCT00360230|12110159|FG000|STARTED|Overall Study||90
10939876|NCT00360230|12110160|FG001|STARTED|Overall Study||90
10939877|NCT00360230|12110161|FG002|STARTED|Overall Study||45
10939878|NCT00360230|12110162|FG003|STARTED|Overall Study||90
10939879|NCT00360230|12110163|FG004|STARTED|Overall Study||90
10939880|NCT00360230|12110164|FG005|STARTED|Overall Study||90
10939881|NCT00360230|12110165|FG006|STARTED|Overall Study||45
10939882|NCT00360230|12110159|FG000|COMPLETED|Overall Study||84
10939883|NCT00360230|12110160|FG001|COMPLETED|Overall Study||87
10939884|NCT00360230|12110161|FG002|COMPLETED|Overall Study||42
10939885|NCT00360230|12110162|FG003|COMPLETED|Overall Study||88
10939886|NCT00360230|12110163|FG004|COMPLETED|Overall Study||85
10939887|NCT00360230|12110164|FG005|COMPLETED|Overall Study||86
10939888|NCT00360230|12110165|FG006|COMPLETED|Overall Study||43
10939889|NCT00360230|12110159|FG000|NOT COMPLETED|Overall Study||6
10939890|NCT00360230|12110160|FG001|NOT COMPLETED|Overall Study||3
10939891|NCT00360230|12110161|FG002|NOT COMPLETED|Overall Study||3
10939892|NCT00360230|12110162|FG003|NOT COMPLETED|Overall Study||2
10939893|NCT00360230|12110163|FG004|NOT COMPLETED|Overall Study||5
10939894|NCT00360230|12110164|FG005|NOT COMPLETED|Overall Study||4
10939895|NCT00360230|12110165|FG006|NOT COMPLETED|Overall Study||2
10939896|NCT00360243|12110187|FG000|STARTED|Overall Study||337
10939897|NCT00360243|12110188|FG001|STARTED|Overall Study||363
10939898|NCT00360243|12110189|FG002|STARTED|Overall Study||336
10939899|NCT00360243|12110190|FG003|STARTED|Overall Study||349
10939900|NCT00360243|12110187|FG000|COMPLETED|Overall Study||235
10939901|NCT00360243|12110188|FG001|COMPLETED|Overall Study||243
10939902|NCT00360243|12110189|FG002|COMPLETED|Overall Study||180
10939903|NCT00360243|12110190|FG003|COMPLETED|Overall Study||224
10939904|NCT00360243|12110187|FG000|NOT COMPLETED|Overall Study||102
10939905|NCT00360243|12110188|FG001|NOT COMPLETED|Overall Study||120
10939906|NCT00360243|12110189|FG002|NOT COMPLETED|Overall Study||156
10939907|NCT00360243|12110190|FG003|NOT COMPLETED|Overall Study||125
10939908|NCT00360269|12110202|FG000|STARTED|Overall Study||19
10939909|NCT00360269|12110203|FG001|STARTED|Overall Study||19
10939910|NCT00360269|12110202|FG000|COMPLETED|Overall Study||9
10939911|NCT00360269|12110203|FG001|COMPLETED|Overall Study||7
10939912|NCT00360269|12110202|FG000|NOT COMPLETED|Overall Study||10
10939913|NCT00360269|12110203|FG001|NOT COMPLETED|Overall Study||12
10939914|NCT00360282|12110209|FG000|STARTED|First Intervention||6
10939915|NCT00360282|12110210|FG001|STARTED|First Intervention||8
10939916|NCT00360282|12110211|FG002|STARTED|First Intervention||7
10939917|NCT00360282|12110212|FG003|STARTED|First Intervention||6
10939918|NCT00360282|12110209|FG000|COMPLETED|First Intervention||6
10939919|NCT00360282|12110210|FG001|COMPLETED|First Intervention||8
10939920|NCT00360282|12110211|FG002|COMPLETED|First Intervention||7
10939921|NCT00360282|12110212|FG003|COMPLETED|First Intervention||6
10939922|NCT00360282|12110209|FG000|NOT COMPLETED|First Intervention||0
10939923|NCT00360282|12110210|FG001|NOT COMPLETED|First Intervention||0
10939924|NCT00360282|12110211|FG002|NOT COMPLETED|First Intervention||0
10939925|NCT00360282|12110212|FG003|NOT COMPLETED|First Intervention||0
10939926|NCT00360282|12110209|FG000|STARTED|Washout 1-3 Weeks||6
10939927|NCT00360282|12110210|FG001|STARTED|Washout 1-3 Weeks||8
10939928|NCT00360282|12110211|FG002|STARTED|Washout 1-3 Weeks||7
10939929|NCT00360282|12110212|FG003|STARTED|Washout 1-3 Weeks||6
10939930|NCT00360282|12110209|FG000|COMPLETED|Washout 1-3 Weeks||6
10939931|NCT00360282|12110210|FG001|COMPLETED|Washout 1-3 Weeks||8
10939932|NCT00360282|12110211|FG002|COMPLETED|Washout 1-3 Weeks||6
10939933|NCT00360282|12110212|FG003|COMPLETED|Washout 1-3 Weeks||6
10939934|NCT00360282|12110209|FG000|NOT COMPLETED|Washout 1-3 Weeks||0
10939935|NCT00360282|12110210|FG001|NOT COMPLETED|Washout 1-3 Weeks||0
10939936|NCT00360282|12110211|FG002|NOT COMPLETED|Washout 1-3 Weeks||1
10939937|NCT00360282|12110212|FG003|NOT COMPLETED|Washout 1-3 Weeks||0
10939938|NCT00360282|12110209|FG000|STARTED|Second Intervention||6
10939939|NCT00360282|12110210|FG001|STARTED|Second Intervention||8
10939940|NCT00360282|12110211|FG002|STARTED|Second Intervention||6
10939941|NCT00360282|12110212|FG003|STARTED|Second Intervention||6
10939942|NCT00360282|12110209|FG000|COMPLETED|Second Intervention||6
10939943|NCT00360282|12110210|FG001|COMPLETED|Second Intervention||7
10939944|NCT00360282|12110211|FG002|COMPLETED|Second Intervention||6
10939945|NCT00360282|12110212|FG003|COMPLETED|Second Intervention||6
10939946|NCT00360282|12110209|FG000|NOT COMPLETED|Second Intervention||0
10939947|NCT00360282|12110210|FG001|NOT COMPLETED|Second Intervention||1
10939948|NCT00360282|12110211|FG002|NOT COMPLETED|Second Intervention||0
10939949|NCT00360282|12110212|FG003|NOT COMPLETED|Second Intervention||0
10939950|NCT00360308|12110223|FG000|STARTED|Overall Study||247
10939951|NCT00360308|12110224|FG001|STARTED|Overall Study||234
10939952|NCT00360308|12110225|FG002|STARTED|Overall Study||242
10939953|NCT00360308|12110223|FG000|COMPLETED|Overall Study||171
10939954|NCT00360308|12110224|FG001|COMPLETED|Overall Study||155
10939955|NCT00360308|12110225|FG002|COMPLETED|Overall Study||154
10939956|NCT00360308|12110223|FG000|NOT COMPLETED|Overall Study||76
10939957|NCT00360308|12110224|FG001|NOT COMPLETED|Overall Study||79
10939958|NCT00360308|12110225|FG002|NOT COMPLETED|Overall Study||88
10939959|NCT00360334|12110239|FG000|STARTED|Overall Study||118
10939960|NCT00360334|12110240|FG001|STARTED|Overall Study||117
10939961|NCT00360334|12110239|FG000|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
10939962|NCT00360334|12110240|FG001|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
10939963|NCT00360334|12110239|FG000|COMPLETED|Overall Study||99
10939964|NCT00360334|12110240|FG001|COMPLETED|Overall Study||104
10939965|NCT00360334|12110239|FG000|NOT COMPLETED|Overall Study||19
10939966|NCT00360334|12110240|FG001|NOT COMPLETED|Overall Study||13
10939967|NCT00360360|12110246|FG000|STARTED|Overall Study||60
10939968|NCT00360360|12110246|FG000|COMPLETED|Overall Study||54
10939969|NCT00360360|12110246|FG000|NOT COMPLETED|Overall Study||6
10939970|NCT00360399|12110253|FG000|STARTED|Overall Study||114
10939971|NCT00360399|12110254|FG001|STARTED|Overall Study||115
10939972|NCT00360399|12110255|FG002|STARTED|Overall Study||115
10939973|NCT00360399|12110253|FG000|Had Post-randomization Assessment|Overall Study||105
10939974|NCT00360399|12110254|FG001|Had Post-randomization Assessment|Overall Study||106
10939975|NCT00360399|12110255|FG002|Had Post-randomization Assessment|Overall Study||105
10939976|NCT00360399|12110253|FG000|COMPLETED|Overall Study||86
10939977|NCT00360399|12110254|FG001|COMPLETED|Overall Study||79
10939978|NCT00360399|12110255|FG002|COMPLETED|Overall Study||69
10939979|NCT00360399|12110253|FG000|NOT COMPLETED|Overall Study||28
10939980|NCT00360399|12110254|FG001|NOT COMPLETED|Overall Study||36
10939981|NCT00360399|12110255|FG002|NOT COMPLETED|Overall Study||46
10939982|NCT00360412|12110265|FG000|STARTED|Overall Study||333
10939983|NCT00360412|12110266|FG001|STARTED|Overall Study||664
10939984|NCT00360412|12110265|FG000|COMPLETED|Overall Study||0
10939985|NCT00360412|12110266|FG001|COMPLETED|Overall Study||2
10939986|NCT00360412|12110265|FG000|NOT COMPLETED|Overall Study||333
10939987|NCT00360412|12110266|FG001|NOT COMPLETED|Overall Study||662
10939988|NCT00360490|12110274|FG000|STARTED|Overall Study||82
10939989|NCT00360490|12110275|FG001|STARTED|Overall Study||83
10939990|NCT00360490|12110274|FG000|COMPLETED|Overall Study||73
10939991|NCT00360490|12110275|FG001|COMPLETED|Overall Study||72
10939992|NCT00360490|12110274|FG000|NOT COMPLETED|Overall Study||9
10939993|NCT00360490|12110275|FG001|NOT COMPLETED|Overall Study||11
10939994|NCT00360529|12110284|FG000|STARTED|Overall Study||295
10939995|NCT00360529|12110285|FG001|STARTED|Overall Study||295
10939996|NCT00360529|12110286|FG002|STARTED|Overall Study||290
10939997|NCT00360529|12110284|FG000|COMPLETED|Overall Study||234
10939998|NCT00360529|12110285|FG001|COMPLETED|Overall Study||230
10939999|NCT00360529|12110286|FG002|COMPLETED|Overall Study||199
10940000|NCT00360529|12110284|FG000|NOT COMPLETED|Overall Study||61
10940001|NCT00360529|12110285|FG001|NOT COMPLETED|Overall Study||65
10940002|NCT00360529|12110286|FG002|NOT COMPLETED|Overall Study||91
10940003|NCT00360555|12110298|FG000|STARTED|Overall Study||396
10940004|NCT00360555|12110299|FG001|STARTED|Overall Study||393
10940005|NCT00360555|12110300|FG002|STARTED|Overall Study||396
10940006|NCT00360555|12110301|FG003|STARTED|Overall Study||399
10940007|NCT00360555|12110298|FG000|COMPLETED|Overall Study||274
10940008|NCT00360555|12110299|FG001|COMPLETED|Overall Study||259
10940009|NCT00360555|12110300|FG002|COMPLETED|Overall Study||251
10940010|NCT00360555|12110301|FG003|COMPLETED|Overall Study||287
10940011|NCT00360555|12110298|FG000|NOT COMPLETED|Overall Study||122
10940012|NCT00360555|12110299|FG001|NOT COMPLETED|Overall Study||134
10940013|NCT00360555|12110300|FG002|NOT COMPLETED|Overall Study||145
10940014|NCT00360555|12110301|FG003|NOT COMPLETED|Overall Study||112
10940015|NCT00360568|12110313|FG000|STARTED|Overall Study||33
10940016|NCT00360568|12110314|FG001|STARTED|Overall Study||29
10940017|NCT00360568|12110313|FG000|COMPLETED|Overall Study||31
10940018|NCT00360568|12110314|FG001|COMPLETED|Overall Study||24
10940019|NCT00360568|12110313|FG000|NOT COMPLETED|Overall Study||2
10940020|NCT00360568|12110314|FG001|NOT COMPLETED|Overall Study||5
10940021|NCT00360672|12110322|FG000|STARTED|Overall Study||27
10940022|NCT00360672|12110322|FG000|COMPLETED|Overall Study||27
10940023|NCT00360672|12110322|FG000|NOT COMPLETED|Overall Study||0
10940024|NCT00360685|12110328|FG000|STARTED|Overall Study||47
10940025|NCT00360685|12110329|FG001|STARTED|Overall Study||42
10940026|NCT00360685|12110328|FG000|COMPLETED|Overall Study||47
10940027|NCT00360685|12110329|FG001|COMPLETED|Overall Study||42
10940028|NCT00360685|12110328|FG000|NOT COMPLETED|Overall Study||0
10940029|NCT00360685|12110329|FG001|NOT COMPLETED|Overall Study||0
10940030|NCT00360698|12110338|FG000|STARTED|Run-In||0
10940031|NCT00360698|12110339|FG001|STARTED|Run-In||135
10940032|NCT00360698|12110338|FG000|COMPLETED|Run-In||0
10940033|NCT00360698|12110339|FG001|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
10940034|NCT00360698|12110338|FG000|NOT COMPLETED|Run-In||0
10940035|NCT00360698|12110339|FG001|NOT COMPLETED|Run-In||10
10940036|NCT00360698|12110338|FG000|STARTED|Treatment Period||49
10940037|NCT00360698|12110339|FG001|STARTED|Treatment Period||57
10940038|NCT00360698|12110338|FG000|COMPLETED|Treatment Period||48
10940039|NCT00360698|12110339|FG001|COMPLETED|Treatment Period||56
10940040|NCT00360698|12110338|FG000|NOT COMPLETED|Treatment Period||1
10940041|NCT00360698|12110339|FG001|NOT COMPLETED|Treatment Period||1
10940042|NCT00360724|12110347|FG000|STARTED|Overall Study||33
10940043|NCT00360724|12110348|FG001|STARTED|Overall Study||32
10940044|NCT00360724|12110347|FG000|COMPLETED|Overall Study||29
10940045|NCT00360724|12110348|FG001|COMPLETED|Overall Study||28
10940046|NCT00360724|12110347|FG000|NOT COMPLETED|Overall Study||4
10940047|NCT00360724|12110348|FG001|NOT COMPLETED|Overall Study||4
10940048|NCT00360828|12110357|FG000|STARTED|Overall Study||10
10940049|NCT00360828|12110357|FG000|COMPLETED|Overall Study||9
10940050|NCT00360828|12110357|FG000|NOT COMPLETED|Overall Study||1
10940051|NCT00360971|12110363|FG000|STARTED|Overall Study||10
10940052|NCT00360971|12110364|FG001|STARTED|Overall Study||11
10940053|NCT00360971|12110363|FG000|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
10940054|NCT00360971|12110364|FG001|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
10940055|NCT00360971|12110363|FG000|NOT COMPLETED|Overall Study||0
10940056|NCT00360971|12110364|FG001|NOT COMPLETED|Overall Study||0
10940057|NCT00361140|12110373|FG000|STARTED|Overall Study||40
10940058|NCT00361140|12110374|FG001|STARTED|Overall Study||29
10940059|NCT00361140|12110375|FG002|STARTED|Overall Study||3
10940060|NCT00361140|12110373|FG000|COMPLETED|Overall Study||40
10940061|NCT00361140|12110374|FG001|COMPLETED|Overall Study||29
10940062|NCT00361140|12110375|FG002|COMPLETED|Overall Study||3
10940063|NCT00361140|12110373|FG000|NOT COMPLETED|Overall Study||0
10940064|NCT00361140|12110374|FG001|NOT COMPLETED|Overall Study||0
10940065|NCT00361140|12110375|FG002|NOT COMPLETED|Overall Study||0
10940066|NCT00361218|12110383|FG000|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
10940067|NCT00361218|12110383|FG000|Completed Baseline Assessment|Overall Study||47
10940068|NCT00361218|12110383|FG000|COMPLETED|Overall Study||30
10940069|NCT00361218|12110383|FG000|NOT COMPLETED|Overall Study||23
10940070|NCT00361231|12110387|FG000|STARTED|Overall Study||35
10940071|NCT00361231|12110387|FG000|COMPLETED|Overall Study||1
10940072|NCT00361231|12110387|FG000|NOT COMPLETED|Overall Study||34
10940073|NCT00361257|12110393|FG000|STARTED|Step 1: Minocycline vs. Placebo||52
10940074|NCT00361257|12110394|FG001|STARTED|Step 1: Minocycline vs. Placebo||55
10940075|NCT00361257|12110393|FG000|COMPLETED|Step 1: Minocycline vs. Placebo||40
10940076|NCT00361257|12110394|FG001|COMPLETED|Step 1: Minocycline vs. Placebo||43
10940077|NCT00361257|12110393|FG000|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
10940078|NCT00361257|12110394|FG001|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
10940079|NCT00361257|12110393|FG000|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
10940080|NCT00361257|12110394|FG001|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
10940081|NCT00361257|12110393|FG000|COMPLETED|Step 2: Minocycline(Open Label) for All||13
10940082|NCT00361257|12110394|FG001|COMPLETED|Step 2: Minocycline(Open Label) for All||19
10940083|NCT00361257|12110393|FG000|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
10940084|NCT00361257|12110394|FG001|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
10940085|NCT00361270|12110406|FG000|STARTED|Overall Study||49
10940086|NCT00361270|12110407|FG001|STARTED|Overall Study||39
10940087|NCT00361270|12110408|FG002|STARTED|Overall Study||35
10940088|NCT00361270|12110409|FG003|STARTED|Overall Study||38
10940089|NCT00361270|12110406|FG000|COMPLETED|Overall Study||25
10940090|NCT00361270|12110407|FG001|COMPLETED|Overall Study||25
10940091|NCT00361270|12110408|FG002|COMPLETED|Overall Study||25
10940092|NCT00361270|12110409|FG003|COMPLETED|Overall Study||25
10940093|NCT00361270|12110406|FG000|NOT COMPLETED|Overall Study||24
10940094|NCT00361270|12110407|FG001|NOT COMPLETED|Overall Study||14
10940095|NCT00361270|12110408|FG002|NOT COMPLETED|Overall Study||10
10940096|NCT00361270|12110409|FG003|NOT COMPLETED|Overall Study||13
10940097|NCT00361283|12110426|FG000|STARTED|Overall Study||108
10940098|NCT00361283|12110426|FG000|COMPLETED|Overall Study||81
10940099|NCT00361283|12110426|FG000|NOT COMPLETED|Overall Study||27
10940100|NCT00361296|12110430|FG000|STARTED|Overall Study||5
10940101|NCT00361296|12110430|FG000|COMPLETED|Overall Study||2
10940102|NCT00361296|12110430|FG000|NOT COMPLETED|Overall Study||3
10940103|NCT00361335|12110439|FG000|STARTED|IV Period: Baseline to E0||129
10940104|NCT00361335|12110440|FG001|STARTED|IV Period: Baseline to E0||128
10940105|NCT00361335|12110441|FG002|STARTED|IV Period: Baseline to E0||128
10940106|NCT00361335|12110442|FG003|STARTED|IV Period: Baseline to E0||129
10940107|NCT00361335|12110443|FG004|STARTED|IV Period: Baseline to E0||129
10940108|NCT00361335|12110444|FG005|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
10940109|NCT00361335|12110445|FG006|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
10940110|NCT00361335|12110439|FG000|COMPLETED|IV Period: Baseline to E0||109
10940111|NCT00361335|12110440|FG001|COMPLETED|IV Period: Baseline to E0||99
10940112|NCT00361335|12110441|FG002|COMPLETED|IV Period: Baseline to E0||107
10940113|NCT00361335|12110442|FG003|COMPLETED|IV Period: Baseline to E0||102
10940114|NCT00361335|12110443|FG004|COMPLETED|IV Period: Baseline to E0||105
10940115|NCT00361335|12110444|FG005|COMPLETED|IV Period: Baseline to E0||0
10940116|NCT00361335|12110445|FG006|COMPLETED|IV Period: Baseline to E0||0
10940117|NCT00361335|12110439|FG000|NOT COMPLETED|IV Period: Baseline to E0||20
10940118|NCT00361335|12110440|FG001|NOT COMPLETED|IV Period: Baseline to E0||29
10940119|NCT00361335|12110441|FG002|NOT COMPLETED|IV Period: Baseline to E0||21
10940120|NCT00361335|12110442|FG003|NOT COMPLETED|IV Period: Baseline to E0||27
10940121|NCT00361335|12110443|FG004|NOT COMPLETED|IV Period: Baseline to E0||24
10940122|NCT00361335|12110444|FG005|NOT COMPLETED|IV Period: Baseline to E0||0
10940123|NCT00361335|12110445|FG006|NOT COMPLETED|IV Period: Baseline to E0||0
10940124|NCT00361335|12110439|FG000|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
10940125|NCT00361335|12110440|FG001|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
10940126|NCT00361335|12110441|FG002|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
10940127|NCT00361335|12110442|FG003|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
10940128|NCT00361335|12110443|FG004|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
10940129|NCT00361335|12110444|FG005|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
10940130|NCT00361335|12110445|FG006|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
10940131|NCT00361335|12110439|FG000|COMPLETED|SC Period: Week E0 to Week E24||80
10940132|NCT00361335|12110440|FG001|COMPLETED|SC Period: Week E0 to Week E24||56
10940133|NCT00361335|12110441|FG002|COMPLETED|SC Period: Week E0 to Week E24||99
10940134|NCT00361335|12110442|FG003|COMPLETED|SC Period: Week E0 to Week E24||59
10940135|NCT00361335|12110443|FG004|COMPLETED|SC Period: Week E0 to Week E24||3
10940136|NCT00361335|12110444|FG005|COMPLETED|SC Period: Week E0 to Week E24||23
10940137|NCT00361335|12110445|FG006|COMPLETED|SC Period: Week E0 to Week E24||164
10940138|NCT00361335|12110439|FG000|NOT COMPLETED|SC Period: Week E0 to Week E24||2
10940139|NCT00361335|12110440|FG001|NOT COMPLETED|SC Period: Week E0 to Week E24||3
10940140|NCT00361335|12110441|FG002|NOT COMPLETED|SC Period: Week E0 to Week E24||5
10940141|NCT00361335|12110442|FG003|NOT COMPLETED|SC Period: Week E0 to Week E24||4
10940142|NCT00361335|12110443|FG004|NOT COMPLETED|SC Period: Week E0 to Week E24||0
10940143|NCT00361335|12110444|FG005|NOT COMPLETED|SC Period: Week E0 to Week E24||1
10940144|NCT00361335|12110445|FG006|NOT COMPLETED|SC Period: Week E0 to Week E24||9
10940145|NCT00361374|12110464|FG000|STARTED|Overall Study||66
10940146|NCT00361374|12110465|FG001|STARTED|Overall Study||65
10940147|NCT00361374|12110466|FG002|STARTED|Overall Study||65
10940148|NCT00361374|12110464|FG000|COMPLETED|Overall Study||51
10940149|NCT00361374|12110465|FG001|COMPLETED|Overall Study||50
10940150|NCT00361374|12110466|FG002|COMPLETED|Overall Study||53
10940151|NCT00361374|12110464|FG000|NOT COMPLETED|Overall Study||15
10940152|NCT00361374|12110465|FG001|NOT COMPLETED|Overall Study||15
10940153|NCT00361374|12110466|FG002|NOT COMPLETED|Overall Study||12
10940154|NCT00361439|12110476|FG000|STARTED|Overall Study||8
10940155|NCT00361439|12110477|FG001|STARTED|Overall Study||9
10940156|NCT00361439|12110476|FG000|COMPLETED|Overall Study||8
10940157|NCT00361439|12110477|FG001|COMPLETED|Overall Study||9
10940158|NCT00361439|12110476|FG000|NOT COMPLETED|Overall Study||0
10940159|NCT00361439|12110477|FG001|NOT COMPLETED|Overall Study||0
10940160|NCT00361504|12110485|FG000|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
10940161|NCT00361504|12110486|FG001|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
10940162|NCT00361504|12110485|FG000|COMPLETED|Overall Study||413
10940163|NCT00361504|12110486|FG001|COMPLETED|Overall Study||78
10940164|NCT00361504|12110485|FG000|NOT COMPLETED|Overall Study||481
10940165|NCT00361504|12110486|FG001|NOT COMPLETED|Overall Study||145
10940166|NCT00361569|12110496|FG000|STARTED|Overall Study||150
10940167|NCT00361569|12110497|FG001|STARTED|Overall Study||161
10940168|NCT00361569|12110498|FG002|STARTED|Overall Study||155
10940169|NCT00361569|12110499|FG003|STARTED|Overall Study||156
10940170|NCT00361569|12110496|FG000|COMPLETED|Overall Study||138
10940171|NCT00361569|12110497|FG001|COMPLETED|Overall Study||150
10940172|NCT00361569|12110498|FG002|COMPLETED|Overall Study||137
10940173|NCT00361569|12110499|FG003|COMPLETED|Overall Study||135
10940174|NCT00361569|12110496|FG000|NOT COMPLETED|Overall Study||12
10940175|NCT00361569|12110497|FG001|NOT COMPLETED|Overall Study||11
10940176|NCT00361569|12110498|FG002|NOT COMPLETED|Overall Study||18
10940177|NCT00361569|12110499|FG003|NOT COMPLETED|Overall Study||21
10940178|NCT00361595|12110509|FG000|STARTED|Overall Study||35
10940179|NCT00361595|12110509|FG000|COMPLETED|Overall Study||35
10940180|NCT00361595|12110509|FG000|NOT COMPLETED|Overall Study||0
10940181|NCT00361634|12110513|FG000|STARTED|Overall Study||14
10940182|NCT00361634|12110513|FG000|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
10940183|NCT00361634|12110513|FG000|COMPLETED|Overall Study||12
10940184|NCT00361634|12110513|FG000|NOT COMPLETED|Overall Study||2
10940185|NCT00361712|12110519|FG000|STARTED|Overall Study||20
10940186|NCT00361712|12110520|FG001|STARTED|Overall Study||21
10940187|NCT00361712|12110519|FG000|COMPLETED|Overall Study||20
10940188|NCT00361712|12110520|FG001|COMPLETED|Overall Study||21
10940189|NCT00361712|12110519|FG000|NOT COMPLETED|Overall Study||0
10940190|NCT00361712|12110520|FG001|NOT COMPLETED|Overall Study||0
10940191|NCT00361842|12110528|FG000|STARTED|Overall Study||28
10940192|NCT00361842|12110529|FG001|STARTED|Overall Study||35
10940193|NCT00361842|12110528|FG000|COMPLETED|Overall Study||1
10940194|NCT00361842|12110529|FG001|COMPLETED|Overall Study||1
10940195|NCT00361842|12110528|FG000|NOT COMPLETED|Overall Study||27
10940196|NCT00361842|12110529|FG001|NOT COMPLETED|Overall Study||34
10940197|NCT00361972|12110539|FG000|STARTED|Overall Study||8
10940198|NCT00361972|12110540|FG001|STARTED|Overall Study||9
10940199|NCT00361972|12110539|FG000|COMPLETED|Overall Study||8
10940200|NCT00361972|12110540|FG001|COMPLETED|Overall Study||9
10940201|NCT00361972|12110539|FG000|NOT COMPLETED|Overall Study||0
10940202|NCT00361972|12110540|FG001|NOT COMPLETED|Overall Study||0
10940203|NCT00362115|12110554|FG000|STARTED|Overall Study||65
10940204|NCT00362115|12110555|FG001|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
10940205|NCT00362115|12110556|FG002|STARTED|Overall Study||64
10940206|NCT00362115|12110557|FG003|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
10940207|NCT00362115|12110558|FG004|STARTED|Overall Study||64
10940208|NCT00362115|12110559|FG005|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
10940209|NCT00362115|12110560|FG006|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
10940210|NCT00362115|12110554|FG000|COMPLETED|Overall Study||63
10940211|NCT00362115|12110555|FG001|COMPLETED|Overall Study||59
10940212|NCT00362115|12110556|FG002|COMPLETED|Overall Study||57
10940213|NCT00362115|12110557|FG003|COMPLETED|Overall Study||59
10940214|NCT00362115|12110558|FG004|COMPLETED|Overall Study||57
10940215|NCT00362115|12110559|FG005|COMPLETED|Overall Study||57
10940216|NCT00362115|12110560|FG006|COMPLETED|Overall Study||52
10940217|NCT00362115|12110554|FG000|NOT COMPLETED|Overall Study||2
10940218|NCT00362115|12110555|FG001|NOT COMPLETED|Overall Study||6
10940219|NCT00362115|12110556|FG002|NOT COMPLETED|Overall Study||7
10940220|NCT00362115|12110557|FG003|NOT COMPLETED|Overall Study||4
10940221|NCT00362115|12110558|FG004|NOT COMPLETED|Overall Study||7
10940222|NCT00362115|12110559|FG005|NOT COMPLETED|Overall Study||7
10940223|NCT00362115|12110560|FG006|NOT COMPLETED|Overall Study||12
10940224|NCT00362128|12110576|FG000|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
10940225|NCT00362128|12110576|FG000|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
10940226|NCT00362128|12110576|FG000|NOT COMPLETED|Overall Study||0
10940227|NCT00362180|12110589|FG000|STARTED|Treated Period||4
10940228|NCT00362180|12110590|FG001|STARTED|Treated Period||2
10940229|NCT00362180|12110591|FG002|STARTED|Treated Period||1
10940230|NCT00362180|12110592|FG003|STARTED|Treated Period||0
10940231|NCT00362180|12110593|FG004|STARTED|Treated Period||11
10940232|NCT00362180|12110594|FG005|STARTED|Treated Period||10
10940233|NCT00362180|12110595|FG006|STARTED|Treated Period||6
10940234|NCT00362180|12110596|FG007|STARTED|Treated Period||3
10940235|NCT00362180|12110597|FG008|STARTED|Treated Period||1
10940236|NCT00362180|12110589|FG000|COMPLETED|Treated Period||3
10940237|NCT00362180|12110590|FG001|COMPLETED|Treated Period||2
10940238|NCT00362180|12110591|FG002|COMPLETED|Treated Period||1
10940239|NCT00362180|12110592|FG003|COMPLETED|Treated Period||0
10940240|NCT00362180|12110593|FG004|COMPLETED|Treated Period||11
10940241|NCT00362180|12110594|FG005|COMPLETED|Treated Period||9
10940242|NCT00362180|12110595|FG006|COMPLETED|Treated Period||6
10940243|NCT00362180|12110596|FG007|COMPLETED|Treated Period||2
10940244|NCT00362180|12110597|FG008|COMPLETED|Treated Period||1
10940245|NCT00362180|12110589|FG000|NOT COMPLETED|Treated Period||1
10940246|NCT00362180|12110590|FG001|NOT COMPLETED|Treated Period||0
10940247|NCT00362180|12110591|FG002|NOT COMPLETED|Treated Period||0
10940248|NCT00362180|12110592|FG003|NOT COMPLETED|Treated Period||0
10940249|NCT00362180|12110593|FG004|NOT COMPLETED|Treated Period||0
10940250|NCT00362180|12110594|FG005|NOT COMPLETED|Treated Period||1
10940251|NCT00362180|12110595|FG006|NOT COMPLETED|Treated Period||0
10940252|NCT00362180|12110596|FG007|NOT COMPLETED|Treated Period||1
10940253|NCT00362180|12110597|FG008|NOT COMPLETED|Treated Period||0
10940254|NCT00362180|12110589|FG000|STARTED|20 Week Safety Follow-up||3
10940255|NCT00362180|12110590|FG001|STARTED|20 Week Safety Follow-up||2
10940256|NCT00362180|12110591|FG002|STARTED|20 Week Safety Follow-up||1
10940257|NCT00362180|12110592|FG003|STARTED|20 Week Safety Follow-up||0
10940258|NCT00362180|12110593|FG004|STARTED|20 Week Safety Follow-up||11
10940259|NCT00362180|12110594|FG005|STARTED|20 Week Safety Follow-up||9
10940260|NCT00362180|12110595|FG006|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
10940261|NCT00362180|12110596|FG007|STARTED|20 Week Safety Follow-up||3
10940262|NCT00362180|12110597|FG008|STARTED|20 Week Safety Follow-up||1
10940263|NCT00362180|12110589|FG000|COMPLETED|20 Week Safety Follow-up||3
10940264|NCT00362180|12110590|FG001|COMPLETED|20 Week Safety Follow-up||2
10940265|NCT00362180|12110591|FG002|COMPLETED|20 Week Safety Follow-up||1
10940266|NCT00362180|12110592|FG003|COMPLETED|20 Week Safety Follow-up||0
10940267|NCT00362180|12110593|FG004|COMPLETED|20 Week Safety Follow-up||11
10940268|NCT00362180|12110594|FG005|COMPLETED|20 Week Safety Follow-up||9
10940269|NCT00362180|12110595|FG006|COMPLETED|20 Week Safety Follow-up||0
10940270|NCT00362180|12110596|FG007|COMPLETED|20 Week Safety Follow-up||3
10940271|NCT00362180|12110597|FG008|COMPLETED|20 Week Safety Follow-up||1
10940272|NCT00362180|12110589|FG000|NOT COMPLETED|20 Week Safety Follow-up||0
10940273|NCT00362180|12110590|FG001|NOT COMPLETED|20 Week Safety Follow-up||0
10940274|NCT00362180|12110591|FG002|NOT COMPLETED|20 Week Safety Follow-up||0
10940275|NCT00362180|12110592|FG003|NOT COMPLETED|20 Week Safety Follow-up||0
10940276|NCT00362180|12110593|FG004|NOT COMPLETED|20 Week Safety Follow-up||0
10940277|NCT00362180|12110594|FG005|NOT COMPLETED|20 Week Safety Follow-up||0
10940278|NCT00362180|12110595|FG006|NOT COMPLETED|20 Week Safety Follow-up||0
10940279|NCT00362180|12110596|FG007|NOT COMPLETED|20 Week Safety Follow-up||0
10940280|NCT00362180|12110597|FG008|NOT COMPLETED|20 Week Safety Follow-up||0
10940281|NCT00362232|12110617|FG000|STARTED|Treatment (12 +/- 2 Days)||1584
10940282|NCT00362232|12110618|FG001|STARTED|Treatment (12 +/- 2 Days)||1564
10940283|NCT00362232|12110617|FG000|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
10940284|NCT00362232|12110618|FG001|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
10940285|NCT00362232|12110617|FG000|COMPLETED|Treatment (12 +/- 2 Days)||1425
10940286|NCT00362232|12110618|FG001|COMPLETED|Treatment (12 +/- 2 Days)||1413
10940287|NCT00362232|12110617|FG000|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
10940288|NCT00362232|12110618|FG001|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
10940289|NCT00362232|12110617|FG000|STARTED|Follow-up (30 (+ 5) Days)||1471
10940290|NCT00362232|12110618|FG001|STARTED|Follow-up (30 (+ 5) Days)||1455
10940291|NCT00362232|12110617|FG000|COMPLETED|Follow-up (30 (+ 5) Days)||1433
10940292|NCT00362232|12110618|FG001|COMPLETED|Follow-up (30 (+ 5) Days)||1416
10940293|NCT00362232|12110617|FG000|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
10940294|NCT00362232|12110618|FG001|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
10940295|NCT00362297|12110626|FG000|STARTED|Treatment 1 (Initial Drug Assignment)||16
10940296|NCT00362297|12110627|FG001|STARTED|Treatment 1 (Initial Drug Assignment)||15
10940297|NCT00362297|12110626|FG000|COMPLETED|Treatment 1 (Initial Drug Assignment)||16
10940298|NCT00362297|12110627|FG001|COMPLETED|Treatment 1 (Initial Drug Assignment)||11
10940299|NCT00362297|12110626|FG000|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||0
10940300|NCT00362297|12110627|FG001|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||4
10940301|NCT00362297|12110626|FG000|STARTED|Treatment 2||16
10940302|NCT00362297|12110627|FG001|STARTED|Treatment 2||11
10940303|NCT00362297|12110626|FG000|COMPLETED|Treatment 2||16
10940304|NCT00362297|12110627|FG001|COMPLETED|Treatment 2||11
10940305|NCT00362297|12110626|FG000|NOT COMPLETED|Treatment 2||0
10940306|NCT00362297|12110627|FG001|NOT COMPLETED|Treatment 2||0
10940307|NCT00362336|12110636|FG000|STARTED|Overall Study||243
10940308|NCT00362336|12110637|FG001|STARTED|Overall Study||242
10940309|NCT00362336|12110638|FG002|STARTED|Overall Study||137
10940310|NCT00362336|12110636|FG000|COMPLETED|Overall Study||233
10940311|NCT00362336|12110637|FG001|COMPLETED|Overall Study||235
10940312|NCT00362336|12110638|FG002|COMPLETED|Overall Study||134
10940313|NCT00362336|12110636|FG000|NOT COMPLETED|Overall Study||10
10940314|NCT00362336|12110637|FG001|NOT COMPLETED|Overall Study||7
10940315|NCT00362336|12110638|FG002|NOT COMPLETED|Overall Study||3
10940316|NCT00362375|12110655|FG000|STARTED|Overall Study|Number eligible and randomized|161
10940317|NCT00362375|12110656|FG001|STARTED|Overall Study|Number eligible and randomized|152
10940318|NCT00362375|12110655|FG000|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
10940319|NCT00362375|12110656|FG001|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
10940320|NCT00362375|12110655|FG000|NOT COMPLETED|Overall Study||40
10940321|NCT00362375|12110656|FG001|NOT COMPLETED|Overall Study||35
10940322|NCT00362414|12110662|FG000|STARTED|Overall Study||15
10940323|NCT00362414|12110662|FG000|COMPLETED|Overall Study||12
10940324|NCT00362414|12110662|FG000|NOT COMPLETED|Overall Study||3
10940325|NCT00362440|12110671|FG000|STARTED|Overall Study||5
10940326|NCT00362440|12110672|FG001|STARTED|Overall Study||4
10940327|NCT00362440|12110671|FG000|COMPLETED|Overall Study||3
10940328|NCT00362440|12110672|FG001|COMPLETED|Overall Study||3
10940329|NCT00362440|12110671|FG000|NOT COMPLETED|Overall Study||2
10940330|NCT00362440|12110672|FG001|NOT COMPLETED|Overall Study||1
10940331|NCT00362453|12110680|FG000|STARTED|Overall Study||20
10940332|NCT00362453|12110681|FG001|STARTED|Overall Study||20
10940333|NCT00362453|12110680|FG000|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
10940334|NCT00362453|12110681|FG001|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
10940335|NCT00362453|12110680|FG000|NOT COMPLETED|Overall Study||0
10940336|NCT00362453|12110681|FG001|NOT COMPLETED|Overall Study||0
10940337|NCT00362466|12110689|FG000|STARTED|Overall Study||2
10940338|NCT00362466|12110690|FG001|STARTED|Overall Study||1
10940339|NCT00362466|12110689|FG000|COMPLETED|Overall Study||2
10940340|NCT00362466|12110690|FG001|COMPLETED|Overall Study||1
10940341|NCT00362466|12110689|FG000|NOT COMPLETED|Overall Study||0
10940342|NCT00362466|12110690|FG001|NOT COMPLETED|Overall Study||0
10940343|NCT00362609|12110698|FG000|STARTED|Overall Study||19
10940344|NCT00362609|12110699|FG001|STARTED|Overall Study||40
10940345|NCT00362609|12110698|FG000|COMPLETED|Overall Study||19
10940346|NCT00362609|12110699|FG001|COMPLETED|Overall Study||38
10940347|NCT00362609|12110698|FG000|NOT COMPLETED|Overall Study||0
10940348|NCT00362609|12110699|FG001|NOT COMPLETED|Overall Study||2
10940349|NCT00362648|12110709|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
10940350|NCT00362648|12110710|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
10940351|NCT00362648|12110711|FG002|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
10940352|NCT00362648|12110712|FG003|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
10940353|NCT00362648|12110709|FG000|Vaccinated at Visit 1|Overall Study||2733
10940354|NCT00362648|12110710|FG001|Vaccinated at Visit 1|Overall Study||2735
10940355|NCT00362648|12110711|FG002|Vaccinated at Visit 1|Overall Study||1018
10940356|NCT00362648|12110712|FG003|Vaccinated at Visit 1|Overall Study||1018
10940357|NCT00362648|12110709|FG000|Vaccinated at Visit 2|Overall Study||2657
10940358|NCT00362648|12110710|FG001|Vaccinated at Visit 2|Overall Study||2666
10940359|NCT00362648|12110711|FG002|Vaccinated at Visit 2|Overall Study||1013
10940360|NCT00362648|12110712|FG003|Vaccinated at Visit 2|Overall Study||1009
10940361|NCT00362648|12110709|FG000|Vaccinated at Visit 3|Overall Study||2613
10940362|NCT00362648|12110710|FG001|Vaccinated at Visit 3|Overall Study||2612
10940363|NCT00362648|12110711|FG002|Vaccinated at Visit 3|Overall Study||1009
10940364|NCT00362648|12110712|FG003|Vaccinated at Visit 3|Overall Study||1007
10940365|NCT00362648|12110709|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
10940366|NCT00362648|12110710|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
10940367|NCT00362648|12110711|FG002|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
10940368|NCT00362648|12110712|FG003|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
10940369|NCT00362648|12110709|FG000|NOT COMPLETED|Overall Study||126
10940370|NCT00362648|12110710|FG001|NOT COMPLETED|Overall Study||134
10940371|NCT00362648|12110711|FG002|NOT COMPLETED|Overall Study||9
10940372|NCT00362648|12110712|FG003|NOT COMPLETED|Overall Study||11
10940373|NCT00362817|12110726|FG000|STARTED|Overall Study||17
10940374|NCT00362817|12110726|FG000|COMPLETED|Overall Study||17
10940375|NCT00362817|12110726|FG000|NOT COMPLETED|Overall Study||0
10940376|NCT00362882|12110733|FG000|STARTED|Overall Study||40
10940377|NCT00362882|12110734|FG001|STARTED|Overall Study||41
10940378|NCT00362882|12110733|FG000|COMPLETED|Overall Study||40
10940379|NCT00362882|12110734|FG001|COMPLETED|Overall Study||41
10940380|NCT00362882|12110733|FG000|NOT COMPLETED|Overall Study||0
10940381|NCT00362882|12110734|FG001|NOT COMPLETED|Overall Study||0
10940382|NCT00363051|12110742|FG000|STARTED|Overall Study||115
10940383|NCT00363051|12110743|FG001|STARTED|Overall Study||45
10940384|NCT00363051|12110742|FG000|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
10940385|NCT00363051|12110743|FG001|COMPLETED|Overall Study||23
10940386|NCT00363051|12110742|FG000|NOT COMPLETED|Overall Study||38
10940387|NCT00363051|12110743|FG001|NOT COMPLETED|Overall Study||22
10940388|NCT00363077|12110753|FG000|STARTED|Overall Study||75
10940389|NCT00363077|12110754|FG001|STARTED|Overall Study||75
10940390|NCT00363077|12110753|FG000|COMPLETED|Overall Study||75
10940391|NCT00363077|12110754|FG001|COMPLETED|Overall Study||75
10940392|NCT00363077|12110753|FG000|NOT COMPLETED|Overall Study||0
10940393|NCT00363077|12110754|FG001|NOT COMPLETED|Overall Study||0
10940394|NCT00363129|12110762|FG000|STARTED|Overall Study||96
10940395|NCT00363129|12110763|FG001|STARTED|Overall Study||93
10940396|NCT00363129|12110762|FG000|COMPLETED|Overall Study||67
10940397|NCT00363129|12110763|FG001|COMPLETED|Overall Study||60
10940398|NCT00363129|12110762|FG000|NOT COMPLETED|Overall Study||29
10940399|NCT00363129|12110763|FG001|NOT COMPLETED|Overall Study||33
10940400|NCT00363142|12110771|FG000|STARTED|Overall Study||140
10940401|NCT00363142|12110772|FG001|STARTED|Overall Study||69
10940402|NCT00363142|12110771|FG000|COMPLETED|Overall Study||133
10940403|NCT00363142|12110772|FG001|COMPLETED|Overall Study||66
10940404|NCT00363142|12110771|FG000|NOT COMPLETED|Overall Study||7
10940405|NCT00363142|12110772|FG001|NOT COMPLETED|Overall Study||3
10940406|NCT00363168|12110783|FG000|STARTED|Overall Study||5
10940407|NCT00363168|12110784|FG001|STARTED|Overall Study||2
10940408|NCT00363168|12110783|FG000|COMPLETED|Overall Study||5
10940409|NCT00363168|12110784|FG001|COMPLETED|Overall Study||2
10940410|NCT00363168|12110783|FG000|NOT COMPLETED|Overall Study||0
10940411|NCT00363168|12110784|FG001|NOT COMPLETED|Overall Study||0
10940412|NCT00363246|12110790|FG000|STARTED|Overall Study||766
10940413|NCT00363246|12110790|FG000|COMPLETED|Overall Study||669
10940414|NCT00363246|12110790|FG000|NOT COMPLETED|Overall Study||97
10940415|NCT00363298|12110797|FG000|STARTED|First Study Week||12
10940416|NCT00363298|12110798|FG001|STARTED|First Study Week||12
10940417|NCT00363298|12110797|FG000|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
10940418|NCT00363298|12110798|FG001|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
10940419|NCT00363298|12110797|FG000|NOT COMPLETED|First Study Week||6
10940420|NCT00363298|12110798|FG001|NOT COMPLETED|First Study Week||5
10940421|NCT00363298|12110797|FG000|STARTED|4-week Study Continuation Phase||6
10940422|NCT00363298|12110798|FG001|STARTED|4-week Study Continuation Phase||7
10940423|NCT00363298|12110797|FG000|COMPLETED|4-week Study Continuation Phase||5
10940424|NCT00363298|12110798|FG001|COMPLETED|4-week Study Continuation Phase||7
10940425|NCT00363298|12110797|FG000|NOT COMPLETED|4-week Study Continuation Phase||1
10940426|NCT00363298|12110798|FG001|NOT COMPLETED|4-week Study Continuation Phase||0
10940427|NCT00363311|12110807|FG000|STARTED|Overall Study||155
10940428|NCT00363311|12110808|FG001|STARTED|Overall Study||147
10940429|NCT00363311|12110807|FG000|COMPLETED|Overall Study||79
10940430|NCT00363311|12110808|FG001|COMPLETED|Overall Study||102
10940431|NCT00363311|12110807|FG000|NOT COMPLETED|Overall Study||76
10940432|NCT00363311|12110808|FG001|NOT COMPLETED|Overall Study||45
10940433|NCT00363415|12110816|FG000|STARTED|Overall Study||453
10940434|NCT00363415|12110817|FG001|STARTED|Overall Study||455
10940435|NCT00363415|12110816|FG000|Received at Least One Dose of Study Drug|Overall Study||433
10940436|NCT00363415|12110817|FG001|Received at Least One Dose of Study Drug|Overall Study||447
10940437|NCT00363415|12110816|FG000|COMPLETED|Overall Study||92
10940438|NCT00363415|12110817|FG001|COMPLETED|Overall Study||206
10940439|NCT00363415|12110816|FG000|NOT COMPLETED|Overall Study||361
10940440|NCT00363415|12110817|FG001|NOT COMPLETED|Overall Study||249
10940441|NCT00363467|12110823|FG000|STARTED|Overall Study||3
10940442|NCT00363467|12110823|FG000|COMPLETED|Overall Study||2
10940443|NCT00363467|12110823|FG000|NOT COMPLETED|Overall Study||1
10940444|NCT00363480|12110827|FG000|STARTED|Overall Study||221
10940445|NCT00363480|12110827|FG000|COMPLETED|Overall Study||204
10940446|NCT00363480|12110827|FG000|NOT COMPLETED|Overall Study||17
10940447|NCT00363545|12110833|FG000|STARTED|Overall Study||636
10940448|NCT00363545|12110834|FG001|STARTED|Overall Study||638
10940449|NCT00363545|12110833|FG000|COMPLETED|Overall Study||592
10940450|NCT00363545|12110834|FG001|COMPLETED|Overall Study||581
10940451|NCT00363545|12110833|FG000|NOT COMPLETED|Overall Study||44
10940452|NCT00363545|12110834|FG001|NOT COMPLETED|Overall Study||57
10940453|NCT00363649|12110842|FG000|STARTED|Overall Study||18
10940454|NCT00363649|12110843|FG001|STARTED|Overall Study||16
10940455|NCT00363649|12110842|FG000|Crossed Over to Arm B|Overall Study||9
10940456|NCT00363649|12110843|FG001|Crossed Over to Arm B|Overall Study||0
10940457|NCT00363649|12110842|FG000|Crossed Over to Arm A|Overall Study||0
10940458|NCT00363649|12110843|FG001|Crossed Over to Arm A|Overall Study||12
10940459|NCT00363649|12110842|FG000|Did Not Cross Over|Overall Study||2
10940460|NCT00363649|12110843|FG001|Did Not Cross Over|Overall Study||3
10940461|NCT00363649|12110842|FG000|COMPLETED|Overall Study||11
10940462|NCT00363649|12110843|FG001|COMPLETED|Overall Study||15
10940463|NCT00363649|12110842|FG000|NOT COMPLETED|Overall Study||7
10940464|NCT00363649|12110843|FG001|NOT COMPLETED|Overall Study||1
10940465|NCT00363675|12110849|FG000|STARTED|Overall Study||3
10940466|NCT00363675|12110849|FG000|Completed Testing|Overall Study||3
10940467|NCT00363675|12110849|FG000|COMPLETED|Overall Study||3
10940468|NCT00363675|12110849|FG000|NOT COMPLETED|Overall Study||0
10940469|NCT00363766|12110856|FG000|STARTED|Overall Study||32
10940470|NCT00363766|12110857|FG001|STARTED|Overall Study||20
10940471|NCT00363766|12110856|FG000|COMPLETED|Overall Study||0
10940472|NCT00363766|12110857|FG001|COMPLETED|Overall Study||0
10940473|NCT00363766|12110856|FG000|NOT COMPLETED|Overall Study||32
10940474|NCT00363766|12110857|FG001|NOT COMPLETED|Overall Study||20
10940475|NCT00363779|12110864|FG000|STARTED|Overall Study||5
10940476|NCT00363779|12110864|FG000|COMPLETED|Overall Study||5
10940477|NCT00363779|12110864|FG000|NOT COMPLETED|Overall Study||0
10940478|NCT00363805|12110871|FG000|STARTED|Overall Study||42
10940479|NCT00363805|12110872|FG001|STARTED|Overall Study||63
10940480|NCT00363805|12110873|FG002|STARTED|Overall Study||73
10940481|NCT00363805|12110871|FG000|COMPLETED|Overall Study||38
10940482|NCT00363805|12110872|FG001|COMPLETED|Overall Study||57
10940483|NCT00363805|12110873|FG002|COMPLETED|Overall Study||70
10940484|NCT00363805|12110871|FG000|NOT COMPLETED|Overall Study||4
10940485|NCT00363805|12110872|FG001|NOT COMPLETED|Overall Study||6
10940486|NCT00363805|12110873|FG002|NOT COMPLETED|Overall Study||3
10940487|NCT00363883|12110881|FG000|STARTED|Overall Study||14
10940488|NCT00363883|12110881|FG000|COMPLETED|Overall Study||14
10940489|NCT00363883|12110881|FG000|NOT COMPLETED|Overall Study||0
10940490|NCT00363896|12110887|FG000|STARTED|Overall Study||627
10940491|NCT00363896|12110888|FG001|STARTED|Overall Study||216
10940492|NCT00363896|12110887|FG000|COMPLETED|Overall Study||538
10940493|NCT00363896|12110888|FG001|COMPLETED|Overall Study||169
10940494|NCT00363896|12110887|FG000|NOT COMPLETED|Overall Study||89
10940495|NCT00363896|12110888|FG001|NOT COMPLETED|Overall Study||47
10940496|NCT00364130|12110899|FG000|STARTED|Intervention Period||69
10940497|NCT00364130|12110900|FG001|STARTED|Intervention Period||69
10940498|NCT00364130|12110899|FG000|COMPLETED|Intervention Period||60
10940499|NCT00364130|12110900|FG001|COMPLETED|Intervention Period||61
10940500|NCT00364130|12110899|FG000|NOT COMPLETED|Intervention Period||9
10940501|NCT00364130|12110900|FG001|NOT COMPLETED|Intervention Period||8
10940502|NCT00364130|12110899|FG000|STARTED|Post Intervention Follow-up Period||60
10940503|NCT00364130|12110900|FG001|STARTED|Post Intervention Follow-up Period||61
10940504|NCT00364130|12110899|FG000|COMPLETED|Post Intervention Follow-up Period||55
10940505|NCT00364130|12110900|FG001|COMPLETED|Post Intervention Follow-up Period||50
10940506|NCT00364130|12110899|FG000|NOT COMPLETED|Post Intervention Follow-up Period||5
10940507|NCT00364130|12110900|FG001|NOT COMPLETED|Post Intervention Follow-up Period||11
10940508|NCT00364156|12110910|FG000|STARTED|Overall Study||282
10940509|NCT00364156|12110911|FG001|STARTED|Overall Study||286
10940510|NCT00364156|12110910|FG000|COMPLETED|Overall Study||203
10940511|NCT00364156|12110911|FG001|COMPLETED|Overall Study||205
10940512|NCT00364156|12110910|FG000|NOT COMPLETED|Overall Study||79
10940513|NCT00364156|12110911|FG001|NOT COMPLETED|Overall Study||81
10940514|NCT00364182|12110920|FG000|STARTED|First Intervention||3
10940515|NCT00364182|12110921|FG001|STARTED|First Intervention||22
10940516|NCT00364182|12110922|FG002|STARTED|First Intervention||25
10940517|NCT00364182|12110920|FG000|COMPLETED|First Intervention||0
10940518|NCT00364182|12110921|FG001|COMPLETED|First Intervention||22
10940519|NCT00364182|12110922|FG002|COMPLETED|First Intervention||25
10940520|NCT00364182|12110920|FG000|NOT COMPLETED|First Intervention||3
10940521|NCT00364182|12110921|FG001|NOT COMPLETED|First Intervention||0
10940522|NCT00364182|12110922|FG002|NOT COMPLETED|First Intervention||0
10940523|NCT00364182|12110920|FG000|STARTED|Second Intervention||0
10940524|NCT00364182|12110921|FG001|STARTED|Second Intervention||22
10940525|NCT00364182|12110922|FG002|STARTED|Second Intervention||25
10940526|NCT00364182|12110920|FG000|Randomized|Second Intervention||0
10940527|NCT00364182|12110921|FG001|Randomized|Second Intervention||22
10940528|NCT00364182|12110922|FG002|Randomized|Second Intervention||25
10940529|NCT00364182|12110920|FG000|COMPLETED|Second Intervention||0
10940530|NCT00364182|12110921|FG001|COMPLETED|Second Intervention||20
10940531|NCT00364182|12110922|FG002|COMPLETED|Second Intervention||23
10940532|NCT00364182|12110920|FG000|NOT COMPLETED|Second Intervention||0
10940533|NCT00364182|12110921|FG001|NOT COMPLETED|Second Intervention||2
10940534|NCT00364182|12110922|FG002|NOT COMPLETED|Second Intervention||2
10940535|NCT00364182|12110920|FG000|STARTED|Third Intervention||0
10940536|NCT00364182|12110921|FG001|STARTED|Third Intervention||20
10940537|NCT00364182|12110922|FG002|STARTED|Third Intervention||23
10940538|NCT00364182|12110920|FG000|COMPLETED|Third Intervention||0
10940539|NCT00364182|12110921|FG001|COMPLETED|Third Intervention||19
10940540|NCT00364182|12110922|FG002|COMPLETED|Third Intervention||22
10940541|NCT00364182|12110920|FG000|NOT COMPLETED|Third Intervention||0
10940542|NCT00364182|12110921|FG001|NOT COMPLETED|Third Intervention||1
10940543|NCT00364182|12110922|FG002|NOT COMPLETED|Third Intervention||1
10940544|NCT00364182|12110920|FG000|STARTED|Fourth Intervention||0
10940545|NCT00364182|12110921|FG001|STARTED|Fourth Intervention||19
10940546|NCT00364182|12110922|FG002|STARTED|Fourth Intervention||22
10940547|NCT00364182|12110920|FG000|COMPLETED|Fourth Intervention||0
10940548|NCT00364182|12110921|FG001|COMPLETED|Fourth Intervention||19
10940549|NCT00364182|12110922|FG002|COMPLETED|Fourth Intervention||22
10940550|NCT00364182|12110920|FG000|NOT COMPLETED|Fourth Intervention||0
10940551|NCT00364182|12110921|FG001|NOT COMPLETED|Fourth Intervention||0
10940552|NCT00364182|12110922|FG002|NOT COMPLETED|Fourth Intervention||0
10940553|NCT00364286|12110932|FG000|STARTED|Overall Study||17
10940554|NCT00364286|12110932|FG000|COMPLETED|Overall Study||14
10940555|NCT00364286|12110932|FG000|NOT COMPLETED|Overall Study||3
10940556|NCT00364351|12110938|FG000|STARTED|Overall Study|randomised patients|623
10940557|NCT00364351|12110939|FG001|STARTED|Overall Study|randomised patients|617
10940558|NCT00364351|12110938|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
10940559|NCT00364351|12110939|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
10940560|NCT00364351|12110938|FG000|NOT COMPLETED|Overall Study||592
10940561|NCT00364351|12110939|FG001|NOT COMPLETED|Overall Study||583
10940562|NCT00364377|12110947|FG000|STARTED|Overall Study||11
10940563|NCT00364377|12110948|FG001|STARTED|Overall Study||11
10940564|NCT00364377|12110947|FG000|COMPLETED|Overall Study||11
10940565|NCT00364377|12110948|FG001|COMPLETED|Overall Study||11
10940566|NCT00364377|12110947|FG000|NOT COMPLETED|Overall Study||0
10940567|NCT00364377|12110948|FG001|NOT COMPLETED|Overall Study||0
10940568|NCT00364533|12110959|FG000|STARTED|Overall Study||77
10940569|NCT00364533|12110960|FG001|STARTED|Overall Study||71
10940570|NCT00364533|12110961|FG002|STARTED|Overall Study||75
10940571|NCT00364533|12110962|FG003|STARTED|Overall Study||67
10940572|NCT00364533|12110963|FG004|STARTED|Overall Study||75
10940573|NCT00364533|12110959|FG000|COMPLETED|Overall Study||35
10940574|NCT00364533|12110960|FG001|COMPLETED|Overall Study||31
10940575|NCT00364533|12110961|FG002|COMPLETED|Overall Study||30
10940576|NCT00364533|12110962|FG003|COMPLETED|Overall Study||36
10940577|NCT00364533|12110963|FG004|COMPLETED|Overall Study||24
10940578|NCT00364533|12110959|FG000|NOT COMPLETED|Overall Study||42
10940579|NCT00364533|12110960|FG001|NOT COMPLETED|Overall Study||40
10940580|NCT00364533|12110961|FG002|NOT COMPLETED|Overall Study||45
10940581|NCT00364533|12110962|FG003|NOT COMPLETED|Overall Study||31
10940582|NCT00364533|12110963|FG004|NOT COMPLETED|Overall Study||51
10940583|NCT00364611|12110977|FG000|STARTED|Overall Study||52
10940584|NCT00364611|12110978|FG001|STARTED|Overall Study||21
10940585|NCT00364611|12110977|FG000|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
10940586|NCT00364611|12110978|FG001|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
10940587|NCT00364611|12110977|FG000|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
10940588|NCT00364611|12110978|FG001|COMPLETED|Overall Study||0
10940589|NCT00364611|12110977|FG000|NOT COMPLETED|Overall Study||51
10940590|NCT00364611|12110978|FG001|NOT COMPLETED|Overall Study||21
10940591|NCT00364793|12110988|FG000|STARTED|Overall Study||15
10940592|NCT00364793|12110989|FG001|STARTED|Overall Study||10
10940593|NCT00364793|12110990|FG002|STARTED|Overall Study||4
10940594|NCT00364793|12110991|FG003|STARTED|Overall Study||8
10940595|NCT00364793|12110988|FG000|COMPLETED|Overall Study||7
10940596|NCT00364793|12110989|FG001|COMPLETED|Overall Study||5
10940597|NCT00364793|12110990|FG002|COMPLETED|Overall Study||0
10940598|NCT00364793|12110991|FG003|COMPLETED|Overall Study||5
10940599|NCT00364793|12110988|FG000|NOT COMPLETED|Overall Study||8
10940600|NCT00364793|12110989|FG001|NOT COMPLETED|Overall Study||5
10940601|NCT00364793|12110990|FG002|NOT COMPLETED|Overall Study||4
10940602|NCT00364793|12110991|FG003|NOT COMPLETED|Overall Study||3
10940603|NCT00364819|12111004|FG000|STARTED|Overall Study||6
10940604|NCT00364819|12111004|FG000|COMPLETED|Overall Study||6
10940605|NCT00364819|12111004|FG000|NOT COMPLETED|Overall Study||0
10940606|NCT00364832|12111017|FG000|STARTED|Core Period||16
10940607|NCT00364832|12111018|FG001|STARTED|Core Period||15
10940608|NCT00364832|12111019|FG002|STARTED|Core Period||15
10940609|NCT00364832|12111020|FG003|STARTED|Core Period||16
10940610|NCT00364832|12111021|FG004|STARTED|Core Period||16
10940611|NCT00364832|12111022|FG005|STARTED|Core Period||12
10940612|NCT00364832|12111023|FG006|STARTED|Core Period||16
10940613|NCT00364832|12111024|FG007|STARTED|Core Period||15
10940614|NCT00364832|12111025|FG008|STARTED|Core Period||16
10940615|NCT00364832|12111026|FG009|STARTED|Core Period||0
10940616|NCT00364832|12111027|FG010|STARTED|Core Period||0
10940617|NCT00364832|12111028|FG011|STARTED|Core Period||0
10940618|NCT00364832|12111017|FG000|COMPLETED|Core Period||14
10940619|NCT00364832|12111018|FG001|COMPLETED|Core Period||13
10940620|NCT00364832|12111019|FG002|COMPLETED|Core Period||14
10940621|NCT00364832|12111020|FG003|COMPLETED|Core Period||15
10940622|NCT00364832|12111021|FG004|COMPLETED|Core Period||16
10940623|NCT00364832|12111022|FG005|COMPLETED|Core Period||12
10940624|NCT00364832|12111023|FG006|COMPLETED|Core Period||12
10940625|NCT00364832|12111024|FG007|COMPLETED|Core Period||14
10940626|NCT00364832|12111025|FG008|COMPLETED|Core Period||16
10940627|NCT00364832|12111026|FG009|COMPLETED|Core Period||0
10940628|NCT00364832|12111027|FG010|COMPLETED|Core Period||0
10940629|NCT00364832|12111028|FG011|COMPLETED|Core Period||0
10940630|NCT00364832|12111017|FG000|NOT COMPLETED|Core Period||2
10940631|NCT00364832|12111018|FG001|NOT COMPLETED|Core Period||2
10940632|NCT00364832|12111019|FG002|NOT COMPLETED|Core Period||1
10940633|NCT00364832|12111020|FG003|NOT COMPLETED|Core Period||1
10940634|NCT00364832|12111021|FG004|NOT COMPLETED|Core Period||0
10940635|NCT00364832|12111022|FG005|NOT COMPLETED|Core Period||0
10940636|NCT00364832|12111023|FG006|NOT COMPLETED|Core Period||4
10940637|NCT00364832|12111024|FG007|NOT COMPLETED|Core Period||1
10940638|NCT00364832|12111025|FG008|NOT COMPLETED|Core Period||0
10940639|NCT00364832|12111026|FG009|NOT COMPLETED|Core Period||0
10940640|NCT00364832|12111027|FG010|NOT COMPLETED|Core Period||0
10940641|NCT00364832|12111028|FG011|NOT COMPLETED|Core Period||0
10940642|NCT00364832|12111017|FG000|STARTED|Extension Year 1||0
10940643|NCT00364832|12111018|FG001|STARTED|Extension Year 1||0
10940644|NCT00364832|12111019|FG002|STARTED|Extension Year 1||0
10940645|NCT00364832|12111020|FG003|STARTED|Extension Year 1||0
10940646|NCT00364832|12111021|FG004|STARTED|Extension Year 1||0
10940647|NCT00364832|12111022|FG005|STARTED|Extension Year 1||0
10940648|NCT00364832|12111023|FG006|STARTED|Extension Year 1||0
10940649|NCT00364832|12111024|FG007|STARTED|Extension Year 1||0
10940650|NCT00364832|12111025|FG008|STARTED|Extension Year 1||0
10940651|NCT00364832|12111026|FG009|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
10940652|NCT00364832|12111027|FG010|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
10940653|NCT00364832|12111028|FG011|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
10940654|NCT00364832|12111017|FG000|COMPLETED|Extension Year 1||0
10940655|NCT00364832|12111018|FG001|COMPLETED|Extension Year 1||0
10940656|NCT00364832|12111019|FG002|COMPLETED|Extension Year 1||0
10940657|NCT00364832|12111020|FG003|COMPLETED|Extension Year 1||0
10940658|NCT00364832|12111021|FG004|COMPLETED|Extension Year 1||0
10940659|NCT00364832|12111022|FG005|COMPLETED|Extension Year 1||0
10940660|NCT00364832|12111023|FG006|COMPLETED|Extension Year 1||0
10940661|NCT00364832|12111024|FG007|COMPLETED|Extension Year 1||0
10940662|NCT00364832|12111025|FG008|COMPLETED|Extension Year 1||0
10940663|NCT00364832|12111026|FG009|COMPLETED|Extension Year 1||14
10940664|NCT00364832|12111027|FG010|COMPLETED|Extension Year 1||15
10940665|NCT00364832|12111028|FG011|COMPLETED|Extension Year 1||17
10940666|NCT00364832|12111017|FG000|NOT COMPLETED|Extension Year 1||0
10940667|NCT00364832|12111018|FG001|NOT COMPLETED|Extension Year 1||0
10940668|NCT00364832|12111019|FG002|NOT COMPLETED|Extension Year 1||0
10940669|NCT00364832|12111020|FG003|NOT COMPLETED|Extension Year 1||0
10940670|NCT00364832|12111021|FG004|NOT COMPLETED|Extension Year 1||0
10940671|NCT00364832|12111022|FG005|NOT COMPLETED|Extension Year 1||0
10940672|NCT00364832|12111023|FG006|NOT COMPLETED|Extension Year 1||0
10940673|NCT00364832|12111024|FG007|NOT COMPLETED|Extension Year 1||0
10940674|NCT00364832|12111025|FG008|NOT COMPLETED|Extension Year 1||0
10940675|NCT00364832|12111026|FG009|NOT COMPLETED|Extension Year 1||4
10940676|NCT00364832|12111027|FG010|NOT COMPLETED|Extension Year 1||2
10940677|NCT00364832|12111028|FG011|NOT COMPLETED|Extension Year 1||10
10940678|NCT00364832|12111017|FG000|STARTED|Extension Year 2||0
10940679|NCT00364832|12111018|FG001|STARTED|Extension Year 2||0
10940680|NCT00364832|12111019|FG002|STARTED|Extension Year 2||0
10940681|NCT00364832|12111020|FG003|STARTED|Extension Year 2||0
10940682|NCT00364832|12111021|FG004|STARTED|Extension Year 2||0
10940683|NCT00364832|12111022|FG005|STARTED|Extension Year 2||0
10940684|NCT00364832|12111023|FG006|STARTED|Extension Year 2||0
10940685|NCT00364832|12111024|FG007|STARTED|Extension Year 2||0
10940686|NCT00364832|12111025|FG008|STARTED|Extension Year 2||0
10940687|NCT00364832|12111026|FG009|STARTED|Extension Year 2||14
10940688|NCT00364832|12111027|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
10940689|NCT00364832|12111028|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
10940690|NCT00364832|12111017|FG000|COMPLETED|Extension Year 2||0
10940691|NCT00364832|12111018|FG001|COMPLETED|Extension Year 2||0
10940692|NCT00364832|12111019|FG002|COMPLETED|Extension Year 2||0
10940693|NCT00364832|12111020|FG003|COMPLETED|Extension Year 2||0
10940694|NCT00364832|12111021|FG004|COMPLETED|Extension Year 2||0
10940695|NCT00364832|12111022|FG005|COMPLETED|Extension Year 2||0
10940696|NCT00364832|12111023|FG006|COMPLETED|Extension Year 2||0
10940697|NCT00364832|12111024|FG007|COMPLETED|Extension Year 2||0
10940698|NCT00364832|12111025|FG008|COMPLETED|Extension Year 2||0
10940699|NCT00364832|12111026|FG009|COMPLETED|Extension Year 2||9
10940700|NCT00364832|12111027|FG010|COMPLETED|Extension Year 2||9
10940701|NCT00364832|12111028|FG011|COMPLETED|Extension Year 2||11
10940702|NCT00364832|12111017|FG000|NOT COMPLETED|Extension Year 2||0
10940703|NCT00364832|12111018|FG001|NOT COMPLETED|Extension Year 2||0
10940704|NCT00364832|12111019|FG002|NOT COMPLETED|Extension Year 2||0
10940705|NCT00364832|12111020|FG003|NOT COMPLETED|Extension Year 2||0
10940706|NCT00364832|12111021|FG004|NOT COMPLETED|Extension Year 2||0
10940707|NCT00364832|12111022|FG005|NOT COMPLETED|Extension Year 2||0
10940708|NCT00364832|12111023|FG006|NOT COMPLETED|Extension Year 2||0
10940709|NCT00364832|12111024|FG007|NOT COMPLETED|Extension Year 2||0
10940710|NCT00364832|12111025|FG008|NOT COMPLETED|Extension Year 2||0
10940711|NCT00364832|12111026|FG009|NOT COMPLETED|Extension Year 2||5
10940712|NCT00364832|12111027|FG010|NOT COMPLETED|Extension Year 2||5
10940713|NCT00364832|12111028|FG011|NOT COMPLETED|Extension Year 2||3
10940714|NCT00364845|12111047|FG000|STARTED|Overall Study||28
10940715|NCT00364845|12111048|FG001|STARTED|Overall Study||23
10940716|NCT00364845|12111047|FG000|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
10940717|NCT00364845|12111048|FG001|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
10940718|NCT00364845|12111047|FG000|NOT COMPLETED|Overall Study||11
10940719|NCT00364845|12111048|FG001|NOT COMPLETED|Overall Study||11
10940720|NCT00364858|12111056|FG000|STARTED|Overall Study||33
10940721|NCT00364858|12111057|FG001|STARTED|Overall Study||62
10940722|NCT00364858|12111056|FG000|COMPLETED|Overall Study||26
10940723|NCT00364858|12111057|FG001|COMPLETED|Overall Study||40
10940724|NCT00364858|12111056|FG000|NOT COMPLETED|Overall Study||7
10940725|NCT00364858|12111057|FG001|NOT COMPLETED|Overall Study||22
10940726|NCT00364923|12111064|FG000|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
10940727|NCT00364923|12111064|FG000|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
10940728|NCT00364923|12111064|FG000|NOT COMPLETED|Treatment With Pralatrexate||4
10940729|NCT00364923|12111064|FG000|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
10940730|NCT00364923|12111064|FG000|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
10940731|NCT00364923|12111064|FG000|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
10940732|NCT00364949|12111070|FG000|STARTED|Overall Study||31
10940733|NCT00364949|12111071|FG001|STARTED|Overall Study||39
10940734|NCT00364949|12111070|FG000|COMPLETED|Overall Study||31
10940735|NCT00364949|12111071|FG001|COMPLETED|Overall Study||39
10940736|NCT00364949|12111070|FG000|NOT COMPLETED|Overall Study||0
10940737|NCT00364949|12111071|FG001|NOT COMPLETED|Overall Study||0
10940738|NCT00365053|12111077|FG000|STARTED|Overall Study||13
10940739|NCT00365053|12111077|FG000|COMPLETED|Overall Study||13
10940740|NCT00365053|12111077|FG000|NOT COMPLETED|Overall Study||0
10940741|NCT00365105|12111083|FG000|STARTED|Overall Study||129
10940742|NCT00365105|12111084|FG001|STARTED|Overall Study||132
10940743|NCT00365105|12111083|FG000|Eligible|Overall Study||124
10940744|NCT00365105|12111084|FG001|Eligible|Overall Study||124
10940745|NCT00365105|12111083|FG000|Eligible With Adverse Event Data|Overall Study||123
10940746|NCT00365105|12111084|FG001|Eligible With Adverse Event Data|Overall Study||124
10940747|NCT00365105|12111083|FG000|COMPLETED|Overall Study||124
10940748|NCT00365105|12111084|FG001|COMPLETED|Overall Study||124
10940749|NCT00365105|12111083|FG000|NOT COMPLETED|Overall Study||5
10940750|NCT00365105|12111084|FG001|NOT COMPLETED|Overall Study||8
10940751|NCT00365144|12111090|FG000|STARTED|Overall Study||36
10940752|NCT00365144|12111090|FG000|COMPLETED|Overall Study||36
10940753|NCT00365144|12111090|FG000|NOT COMPLETED|Overall Study||0
10940754|NCT00365209|12111095|FG000|STARTED|Stage 1: Receiving 2g Curcumin||23
10940755|NCT00365209|12111095|FG000|COMPLETED|Stage 1: Receiving 2g Curcumin||21
10940756|NCT00365209|12111095|FG000|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
10940757|NCT00365209|12111095|FG000|STARTED|Stage 2: Receiving 4g Curcumin||21
10940758|NCT00365209|12111095|FG000|COMPLETED|Stage 2: Receiving 4g Curcumin||19
10940759|NCT00365209|12111095|FG000|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
10940760|NCT00365261|12111102|FG000|STARTED|Overall Study||23
10940761|NCT00365261|12111103|FG001|STARTED|Overall Study||22
10940762|NCT00365261|12111102|FG000|COMPLETED|Overall Study||20
10940763|NCT00365261|12111103|FG001|COMPLETED|Overall Study||19
10940764|NCT00365261|12111102|FG000|NOT COMPLETED|Overall Study||3
10940765|NCT00365261|12111103|FG001|NOT COMPLETED|Overall Study||3
10940766|NCT00365274|12111111|FG000|STARTED|Overall Study||6
10940767|NCT00365274|12111111|FG000|COMPLETED|Overall Study||6
10940768|NCT00365274|12111111|FG000|NOT COMPLETED|Overall Study||0
10940769|NCT00365300|12111117|FG000|STARTED|Open-label Phase||129
10940770|NCT00365300|12111118|FG001|STARTED|Open-label Phase||0
10940771|NCT00365300|12111117|FG000|COMPLETED|Open-label Phase||107
10940772|NCT00365300|12111118|FG001|COMPLETED|Open-label Phase||0
10940773|NCT00365300|12111117|FG000|NOT COMPLETED|Open-label Phase||22
10940774|NCT00365300|12111118|FG001|NOT COMPLETED|Open-label Phase||0
10940775|NCT00365300|12111117|FG000|STARTED|Double-blind Phase||54
10940776|NCT00365300|12111118|FG001|STARTED|Double-blind Phase||54
10940777|NCT00365300|12111117|FG000|COMPLETED|Double-blind Phase||43
10940778|NCT00365300|12111118|FG001|COMPLETED|Double-blind Phase||45
10940779|NCT00365300|12111117|FG000|NOT COMPLETED|Double-blind Phase||11
10940780|NCT00365300|12111118|FG001|NOT COMPLETED|Double-blind Phase||9
10940781|NCT00365352|12111130|FG000|STARTED|Overall Study||97
10940782|NCT00365352|12111131|FG001|STARTED|Overall Study||115
10940783|NCT00365352|12111132|FG002|STARTED|Overall Study||113
10940784|NCT00365352|12111130|FG000|Safety Population|Overall Study||96
10940785|NCT00365352|12111131|FG001|Safety Population|Overall Study||115
10940786|NCT00365352|12111132|FG002|Safety Population|Overall Study||111
10940787|NCT00365352|12111130|FG000|Modified Intent-to-Treat Population|Overall Study||96
10940788|NCT00365352|12111131|FG001|Modified Intent-to-Treat Population|Overall Study||114
10940789|NCT00365352|12111132|FG002|Modified Intent-to-Treat Population|Overall Study||111
10940790|NCT00365352|12111130|FG000|COMPLETED|Overall Study||77
10940791|NCT00365352|12111131|FG001|COMPLETED|Overall Study||104
10940792|NCT00365352|12111132|FG002|COMPLETED|Overall Study||98
10940793|NCT00365352|12111130|FG000|NOT COMPLETED|Overall Study||20
10940794|NCT00365352|12111131|FG001|NOT COMPLETED|Overall Study||11
10940795|NCT00365352|12111132|FG002|NOT COMPLETED|Overall Study||15
10940796|NCT00365365|12111146|FG000|STARTED|Overall Study||78
10940797|NCT00365365|12111147|FG001|STARTED|Overall Study||77
10940798|NCT00365365|12111148|FG002|STARTED|Overall Study||59
10940799|NCT00365365|12111146|FG000|TREATED (SAFETY POPULATION)|Overall Study||78
10940800|NCT00365365|12111147|FG001|TREATED (SAFETY POPULATION)|Overall Study||75
10940801|NCT00365365|12111148|FG002|TREATED (SAFETY POPULATION)|Overall Study||59
10940802|NCT00365365|12111146|FG000|COMPLETED TREATMENT|Overall Study||38
10940803|NCT00365365|12111147|FG001|COMPLETED TREATMENT|Overall Study||36
10940804|NCT00365365|12111148|FG002|COMPLETED TREATMENT|Overall Study||45
10940805|NCT00365365|12111146|FG000|COMPLETED|Overall Study||44
10940806|NCT00365365|12111147|FG001|COMPLETED|Overall Study||41
10940807|NCT00365365|12111148|FG002|COMPLETED|Overall Study||44
10940808|NCT00365365|12111146|FG000|NOT COMPLETED|Overall Study||34
10940809|NCT00365365|12111147|FG001|NOT COMPLETED|Overall Study||36
10940810|NCT00365365|12111148|FG002|NOT COMPLETED|Overall Study||15
10940811|NCT00365378|12111158|FG000|STARTED|Vaccination (Day 1 to Month 7)||1204
10940812|NCT00365378|12111159|FG001|STARTED|Vaccination (Day 1 to Month 7)||1205
10940813|NCT00365378|12111160|FG002|STARTED|Vaccination (Day 1 to Month 7)||0
10940814|NCT00365378|12111158|FG000|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
10940815|NCT00365378|12111159|FG001|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
10940816|NCT00365378|12111160|FG002|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
10940817|NCT00365378|12111158|FG000|COMPLETED|Vaccination (Day 1 to Month 7)||993
10940818|NCT00365378|12111159|FG001|COMPLETED|Vaccination (Day 1 to Month 7)||1038
10940819|NCT00365378|12111160|FG002|COMPLETED|Vaccination (Day 1 to Month 7)||0
10940820|NCT00365378|12111158|FG000|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
10940821|NCT00365378|12111159|FG001|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
10940822|NCT00365378|12111160|FG002|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
10940823|NCT00365378|12111158|FG000|STARTED|Follow-up (Month 7 Though Month 48)||993
10940824|NCT00365378|12111159|FG001|STARTED|Follow-up (Month 7 Though Month 48)||1038
10940825|NCT00365378|12111160|FG002|STARTED|Follow-up (Month 7 Though Month 48)||0
10940826|NCT00365378|12111158|FG000|COMPLETED|Follow-up (Month 7 Though Month 48)||835
10940827|NCT00365378|12111159|FG001|COMPLETED|Follow-up (Month 7 Though Month 48)||836
10940828|NCT00365378|12111160|FG002|COMPLETED|Follow-up (Month 7 Though Month 48)||0
10940829|NCT00365378|12111158|FG000|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
10940830|NCT00365378|12111159|FG001|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
10940831|NCT00365378|12111160|FG002|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
10940832|NCT00365378|12111158|FG000|STARTED|Extension||0
10940833|NCT00365378|12111159|FG001|STARTED|Extension||0
10940834|NCT00365378|12111160|FG002|STARTED|Extension||400
10940835|NCT00365378|12111158|FG000|COMPLETED|Extension||0
10940836|NCT00365378|12111159|FG001|COMPLETED|Extension||0
10940837|NCT00365378|12111160|FG002|COMPLETED|Extension||203
10940838|NCT00365378|12111158|FG000|NOT COMPLETED|Extension||0
10940839|NCT00365378|12111159|FG001|NOT COMPLETED|Extension||0
10940840|NCT00365378|12111160|FG002|NOT COMPLETED|Extension||197
10940841|NCT00365391|12111167|FG000|STARTED|Overall Study||27
10940842|NCT00365391|12111167|FG000|COMPLETED|Overall Study||27
10940843|NCT00365391|12111167|FG000|NOT COMPLETED|Overall Study||0
10940844|NCT00365417|12111171|FG000|STARTED|Overall Study||45
10940845|NCT00365417|12111171|FG000|COMPLETED|Overall Study||45
10940846|NCT00365417|12111171|FG000|NOT COMPLETED|Overall Study||0
10940847|NCT00365456|12111176|FG000|STARTED|Trial Period I (12 Months)||407
10940848|NCT00365456|12111177|FG001|STARTED|Trial Period I (12 Months)||0
10940849|NCT00365456|12111176|FG000|COMPLETED|Trial Period I (12 Months)||282
10940850|NCT00365456|12111177|FG001|COMPLETED|Trial Period I (12 Months)||0
10940851|NCT00365456|12111176|FG000|NOT COMPLETED|Trial Period I (12 Months)||125
10940852|NCT00365456|12111177|FG001|NOT COMPLETED|Trial Period I (12 Months)||0
10940853|NCT00365456|12111176|FG000|STARTED|Trial Period II (12 Months)||0
10940854|NCT00365456|12111177|FG001|STARTED|Trial Period II (12 Months)||282
10940855|NCT00365456|12111176|FG000|COMPLETED|Trial Period II (12 Months)||0
10940856|NCT00365456|12111177|FG001|COMPLETED|Trial Period II (12 Months)||268
10940857|NCT00365456|12111176|FG000|NOT COMPLETED|Trial Period II (12 Months)||0
10940858|NCT00365456|12111177|FG001|NOT COMPLETED|Trial Period II (12 Months)||14
10940859|NCT00365456|12111176|FG000|STARTED|Trial Period III (12 Months)||136
10940860|NCT00365456|12111177|FG001|STARTED|Trial Period III (12 Months)||132
10940861|NCT00365456|12111176|FG000|COMPLETED|Trial Period III (12 Months)||118
10940862|NCT00365456|12111177|FG001|COMPLETED|Trial Period III (12 Months)||127
10940863|NCT00365456|12111176|FG000|NOT COMPLETED|Trial Period III (12 Months)||18
10940864|NCT00365456|12111177|FG001|NOT COMPLETED|Trial Period III (12 Months)||5
10940865|NCT00365508|12111185|FG000|STARTED|Overall Study||321
10940866|NCT00365508|12111186|FG001|STARTED|Overall Study||321
10940867|NCT00365508|12111185|FG000|COMPLETED|Overall Study||182
10940868|NCT00365508|12111186|FG001|COMPLETED|Overall Study||167
10940869|NCT00365508|12111185|FG000|NOT COMPLETED|Overall Study||139
10940870|NCT00365508|12111186|FG001|NOT COMPLETED|Overall Study||154
10940871|NCT00365547|12111192|FG000|STARTED|Overall Study||46
10940872|NCT00365547|12111192|FG000|COMPLETED|Overall Study||43
10940873|NCT00365547|12111192|FG000|NOT COMPLETED|Overall Study||3
10940874|NCT00365599|12111199|FG000|STARTED|Overall Study||43
10940875|NCT00365599|12111199|FG000|COMPLETED|Overall Study||43
10940876|NCT00365599|12111199|FG000|NOT COMPLETED|Overall Study||0
10940877|NCT00365716|12111208|FG000|STARTED|Base Study (Day 1 to Month 7)||290
10940878|NCT00365716|12111209|FG001|STARTED|Base Study (Day 1 to Month 7)||284
10940879|NCT00365716|12111210|FG002|STARTED|Base Study (Day 1 to Month 7)||292
10940880|NCT00365716|12111211|FG003|STARTED|Base Study (Day 1 to Month 7)||146
10940881|NCT00365716|12111212|FG004|STARTED|Base Study (Day 1 to Month 7)||146
10940882|NCT00365716|12111213|FG005|STARTED|Base Study (Day 1 to Month 7)||0
10940883|NCT00365716|12111214|FG006|STARTED|Base Study (Day 1 to Month 7)||0
10940884|NCT00365716|12111208|FG000|COMPLETED|Base Study (Day 1 to Month 7)||269
10940885|NCT00365716|12111209|FG001|COMPLETED|Base Study (Day 1 to Month 7)||260
10940886|NCT00365716|12111210|FG002|COMPLETED|Base Study (Day 1 to Month 7)||271
10940887|NCT00365716|12111211|FG003|COMPLETED|Base Study (Day 1 to Month 7)||136
10940888|NCT00365716|12111212|FG004|COMPLETED|Base Study (Day 1 to Month 7)||139
10940889|NCT00365716|12111213|FG005|COMPLETED|Base Study (Day 1 to Month 7)||0
10940890|NCT00365716|12111214|FG006|COMPLETED|Base Study (Day 1 to Month 7)||0
10940891|NCT00365716|12111208|FG000|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
10940892|NCT00365716|12111209|FG001|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
10940893|NCT00365716|12111210|FG002|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
10940894|NCT00365716|12111211|FG003|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
10940895|NCT00365716|12111212|FG004|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
10940896|NCT00365716|12111213|FG005|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
10940897|NCT00365716|12111214|FG006|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
10940898|NCT00365716|12111208|FG000|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
10940899|NCT00365716|12111209|FG001|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
10940900|NCT00365716|12111210|FG002|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
10940901|NCT00365716|12111211|FG003|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
10940902|NCT00365716|12111212|FG004|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
10940903|NCT00365716|12111213|FG005|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
10940904|NCT00365716|12111214|FG006|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
10940905|NCT00365716|12111208|FG000|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
10940906|NCT00365716|12111209|FG001|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
10940907|NCT00365716|12111210|FG002|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
10940908|NCT00365716|12111211|FG003|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
10940909|NCT00365716|12111212|FG004|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
10940910|NCT00365716|12111213|FG005|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
10940911|NCT00365716|12111214|FG006|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
10940912|NCT00365716|12111208|FG000|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
10940913|NCT00365716|12111209|FG001|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
10940914|NCT00365716|12111210|FG002|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
10940915|NCT00365716|12111211|FG003|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
10940916|NCT00365716|12111212|FG004|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
10940917|NCT00365716|12111213|FG005|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
10940918|NCT00365716|12111214|FG006|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
10940919|NCT00365716|12111208|FG000|STARTED|Extension 1||0
10940920|NCT00365716|12111209|FG001|STARTED|Extension 1||0
10940921|NCT00365716|12111210|FG002|STARTED|Extension 1||0
10940922|NCT00365716|12111211|FG003|STARTED|Extension 1||0
10940923|NCT00365716|12111212|FG004|STARTED|Extension 1||0
10940924|NCT00365716|12111213|FG005|STARTED|Extension 1||241
10940925|NCT00365716|12111214|FG006|STARTED|Extension 1||0
10940926|NCT00365716|12111208|FG000|COMPLETED|Extension 1||0
10940927|NCT00365716|12111209|FG001|COMPLETED|Extension 1||0
10940928|NCT00365716|12111210|FG002|COMPLETED|Extension 1||0
10940929|NCT00365716|12111211|FG003|COMPLETED|Extension 1||0
10940930|NCT00365716|12111212|FG004|COMPLETED|Extension 1||0
10940931|NCT00365716|12111213|FG005|COMPLETED|Extension 1||219
10940932|NCT00365716|12111214|FG006|COMPLETED|Extension 1||0
10940933|NCT00365716|12111208|FG000|NOT COMPLETED|Extension 1||0
10940934|NCT00365716|12111209|FG001|NOT COMPLETED|Extension 1||0
10940935|NCT00365716|12111210|FG002|NOT COMPLETED|Extension 1||0
10940936|NCT00365716|12111211|FG003|NOT COMPLETED|Extension 1||0
10940937|NCT00365716|12111212|FG004|NOT COMPLETED|Extension 1||0
10940938|NCT00365716|12111213|FG005|NOT COMPLETED|Extension 1||22
10940939|NCT00365716|12111214|FG006|NOT COMPLETED|Extension 1||0
10940940|NCT00365716|12111208|FG000|STARTED|Extension 2||0
10940941|NCT00365716|12111209|FG001|STARTED|Extension 2||0
10940942|NCT00365716|12111210|FG002|STARTED|Extension 2||0
10940943|NCT00365716|12111211|FG003|STARTED|Extension 2||0
10940944|NCT00365716|12111212|FG004|STARTED|Extension 2||0
10940945|NCT00365716|12111213|FG005|STARTED|Extension 2||0
10940946|NCT00365716|12111214|FG006|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
10940947|NCT00365716|12111208|FG000|COMPLETED|Extension 2||0
10940948|NCT00365716|12111209|FG001|COMPLETED|Extension 2||0
10940949|NCT00365716|12111210|FG002|COMPLETED|Extension 2||0
10940950|NCT00365716|12111211|FG003|COMPLETED|Extension 2||0
10940951|NCT00365716|12111212|FG004|COMPLETED|Extension 2||0
10940952|NCT00365716|12111213|FG005|COMPLETED|Extension 2||0
10940953|NCT00365716|12111214|FG006|COMPLETED|Extension 2||7
10940954|NCT00365716|12111208|FG000|NOT COMPLETED|Extension 2||0
10940955|NCT00365716|12111209|FG001|NOT COMPLETED|Extension 2||0
10940956|NCT00365716|12111210|FG002|NOT COMPLETED|Extension 2||0
10940957|NCT00365716|12111211|FG003|NOT COMPLETED|Extension 2||0
10940958|NCT00365716|12111212|FG004|NOT COMPLETED|Extension 2||0
10940959|NCT00365716|12111213|FG005|NOT COMPLETED|Extension 2||0
10940960|NCT00365716|12111214|FG006|NOT COMPLETED|Extension 2||10
10940961|NCT00365768|12111230|FG000|STARTED|Overall Study||24
10940962|NCT00365768|12111231|FG001|STARTED|Overall Study||25
10940963|NCT00365768|12111230|FG000|COMPLETED|Overall Study||24
10940964|NCT00365768|12111231|FG001|COMPLETED|Overall Study||25
10940965|NCT00365768|12111230|FG000|NOT COMPLETED|Overall Study||0
10940966|NCT00365768|12111231|FG001|NOT COMPLETED|Overall Study||0
10940967|NCT00365794|12111237|FG000|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22
10940968|NCT00365794|12111237|FG000|COMPLETED|Overall Study||20
10940969|NCT00365794|12111237|FG000|NOT COMPLETED|Overall Study||2
10940970|NCT00365846|12111242|FG000|STARTED|Overall Study||29
10940971|NCT00365846|12111242|FG000|COMPLETED|Overall Study||28
10940972|NCT00365846|12111242|FG000|NOT COMPLETED|Overall Study||1
10940973|NCT00365859|12111251|FG000|STARTED|Overall Study||86
10940974|NCT00365859|12111252|FG001|STARTED|Overall Study||70
10940975|NCT00365859|12111253|FG002|STARTED|Overall Study||174
10940976|NCT00365859|12111254|FG003|STARTED|Overall Study||330
10940977|NCT00365859|12111251|FG000|Safety Population|Overall Study||86
10940978|NCT00365859|12111252|FG001|Safety Population|Overall Study||70
10940979|NCT00365859|12111253|FG002|Safety Population|Overall Study||174
10940980|NCT00365859|12111254|FG003|Safety Population|Overall Study||330
10940981|NCT00365859|12111251|FG000|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
10940982|NCT00365859|12111252|FG001|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
10940983|NCT00365859|12111253|FG002|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
10940984|NCT00365859|12111254|FG003|Efficacy Population|Overall Study||322
10940985|NCT00365859|12111251|FG000|COMPLETED|Overall Study||55
10940986|NCT00365859|12111252|FG001|COMPLETED|Overall Study||37
10940987|NCT00365859|12111253|FG002|COMPLETED|Overall Study||107
10940988|NCT00365859|12111254|FG003|COMPLETED|Overall Study||199
10940989|NCT00365859|12111251|FG000|NOT COMPLETED|Overall Study||31
10940990|NCT00365859|12111252|FG001|NOT COMPLETED|Overall Study||33
10940991|NCT00365859|12111253|FG002|NOT COMPLETED|Overall Study||67
10940992|NCT00365859|12111254|FG003|NOT COMPLETED|Overall Study||131
10940993|NCT00365872|12111266|FG000|STARTED|Overall Study||5
10940994|NCT00365872|12111267|FG001|STARTED|Overall Study||6
10940995|NCT00365872|12111268|FG002|STARTED|Overall Study||6
10940996|NCT00365872|12111266|FG000|COMPLETED|Overall Study||5
10940997|NCT00365872|12111267|FG001|COMPLETED|Overall Study||6
10940998|NCT00365872|12111268|FG002|COMPLETED|Overall Study||6
10940999|NCT00365872|12111266|FG000|NOT COMPLETED|Overall Study||0
10941000|NCT00365872|12111267|FG001|NOT COMPLETED|Overall Study||0
10941001|NCT00365872|12111268|FG002|NOT COMPLETED|Overall Study||0
10941002|NCT00365976|12111277|FG000|STARTED|Overall Study||33
10941003|NCT00365976|12111278|FG001|STARTED|Overall Study||25
10941004|NCT00365976|12111277|FG000|COMPLETED|Overall Study||32
10941005|NCT00365976|12111278|FG001|COMPLETED|Overall Study||20
10941006|NCT00365976|12111277|FG000|NOT COMPLETED|Overall Study||1
10941007|NCT00365976|12111278|FG001|NOT COMPLETED|Overall Study||5
10941008|NCT00365989|12111284|FG000|STARTED|Overall Study||50
10941009|NCT00365989|12111284|FG000|COMPLETED|Overall Study||48
10941010|NCT00365989|12111284|FG000|NOT COMPLETED|Overall Study||2
10941011|NCT00366028|12111291|FG000|STARTED|Overall Study||889
10941012|NCT00366028|12111292|FG001|STARTED|Overall Study||735
10941013|NCT00366028|12111291|FG000|COMPLETED|Overall Study||889
10941014|NCT00366028|12111292|FG001|COMPLETED|Overall Study||735
10941015|NCT00366028|12111291|FG000|NOT COMPLETED|Overall Study||0
10941016|NCT00366028|12111292|FG001|NOT COMPLETED|Overall Study||0
10941017|NCT00366106|12111300|FG000|STARTED|Overall Study||32
10941018|NCT00366106|12111300|FG000|COMPLETED|Overall Study||32
10941019|NCT00366106|12111300|FG000|NOT COMPLETED|Overall Study||0
10941020|NCT00366249|12111306|FG000|STARTED|Overall Study||553
10941021|NCT00366249|12111307|FG001|STARTED|Overall Study||508
10941022|NCT00366249|12111306|FG000|COMPLETED|Overall Study||422
10941023|NCT00366249|12111307|FG001|COMPLETED|Overall Study||430
10941024|NCT00366249|12111306|FG000|NOT COMPLETED|Overall Study||131
10941025|NCT00366249|12111307|FG001|NOT COMPLETED|Overall Study||78
10941026|NCT00366275|12111313|FG000|STARTED|Overall Study||64
10941027|NCT00366275|12111313|FG000|COMPLETED|Overall Study||58
10941028|NCT00366275|12111313|FG000|NOT COMPLETED|Overall Study||6
10941029|NCT00366301|12111321|FG000|STARTED|Overall Study||124
10941030|NCT00366301|12111322|FG001|STARTED|Overall Study||126
10941031|NCT00366301|12111323|FG002|STARTED|Overall Study||126
10941032|NCT00366301|12111324|FG003|STARTED|Overall Study||124
10941033|NCT00366301|12111321|FG000|Either 6W or 14W CRP Obtained|Overall Study||120
10941034|NCT00366301|12111322|FG001|Either 6W or 14W CRP Obtained|Overall Study||124
10941035|NCT00366301|12111323|FG002|Either 6W or 14W CRP Obtained|Overall Study||124
10941036|NCT00366301|12111324|FG003|Either 6W or 14W CRP Obtained|Overall Study||119
10941037|NCT00366301|12111321|FG000|COMPLETED|Overall Study||116
10941038|NCT00366301|12111322|FG001|COMPLETED|Overall Study||120
10941039|NCT00366301|12111323|FG002|COMPLETED|Overall Study||122
10941040|NCT00366301|12111324|FG003|COMPLETED|Overall Study||116
10941041|NCT00366301|12111321|FG000|NOT COMPLETED|Overall Study||8
10941042|NCT00366301|12111322|FG001|NOT COMPLETED|Overall Study||6
10941043|NCT00366301|12111323|FG002|NOT COMPLETED|Overall Study||4
10941044|NCT00366301|12111324|FG003|NOT COMPLETED|Overall Study||8
10941045|NCT00366340|12111336|FG000|STARTED|Infant Series||301
10941046|NCT00366340|12111337|FG001|STARTED|Infant Series||303
10941047|NCT00366340|12111336|FG000|Vaccinated Dose 1|Infant Series||300
10941048|NCT00366340|12111337|FG001|Vaccinated Dose 1|Infant Series||303
10941049|NCT00366340|12111336|FG000|Vaccinated Dose 2|Infant Series||296
10941050|NCT00366340|12111337|FG001|Vaccinated Dose 2|Infant Series||297
10941051|NCT00366340|12111336|FG000|Vaccinated Dose 3|Infant Series||294
10941052|NCT00366340|12111337|FG001|Vaccinated Dose 3|Infant Series||293
10941053|NCT00366340|12111336|FG000|COMPLETED|Infant Series||293
10941054|NCT00366340|12111337|FG001|COMPLETED|Infant Series||293
10941055|NCT00366340|12111336|FG000|NOT COMPLETED|Infant Series||8
10941056|NCT00366340|12111337|FG001|NOT COMPLETED|Infant Series||10
10941057|NCT00366340|12111336|FG000|STARTED|After the Infant Series||293
10941058|NCT00366340|12111337|FG001|STARTED|After the Infant Series||293
10941059|NCT00366340|12111336|FG000|COMPLETED|After the Infant Series||290
10941060|NCT00366340|12111337|FG001|COMPLETED|After the Infant Series||287
10941061|NCT00366340|12111336|FG000|NOT COMPLETED|After the Infant Series||3
10941062|NCT00366340|12111337|FG001|NOT COMPLETED|After the Infant Series||6
10941063|NCT00366340|12111336|FG000|STARTED|Toddler Dose||290
10941064|NCT00366340|12111337|FG001|STARTED|Toddler Dose||287
10941065|NCT00366340|12111336|FG000|COMPLETED|Toddler Dose||289
10941066|NCT00366340|12111337|FG001|COMPLETED|Toddler Dose||286
10941067|NCT00366340|12111336|FG000|NOT COMPLETED|Toddler Dose||1
10941068|NCT00366340|12111337|FG001|NOT COMPLETED|Toddler Dose||1
10941069|NCT00366444|12111369|FG000|STARTED|Overall Study||102
10941070|NCT00366444|12111370|FG001|STARTED|Overall Study||99
10941071|NCT00366444|12111369|FG000|COMPLETED|Overall Study||101
10941072|NCT00366444|12111370|FG001|COMPLETED|Overall Study||97
10941073|NCT00366444|12111369|FG000|NOT COMPLETED|Overall Study||1
10941074|NCT00366444|12111370|FG001|NOT COMPLETED|Overall Study||2
10941075|NCT00366457|12111376|FG000|STARTED|Overall Study||32
10941076|NCT00366457|12111376|FG000|COMPLETED|Overall Study||30
10941077|NCT00366457|12111376|FG000|NOT COMPLETED|Overall Study||2
10941078|NCT00366535|12111382|FG000|STARTED|First Phase: 12 Weeks||27
10941079|NCT00366535|12111383|FG001|STARTED|First Phase: 12 Weeks||29
10941080|NCT00366535|12111382|FG000|COMPLETED|First Phase: 12 Weeks||24
10941081|NCT00366535|12111383|FG001|COMPLETED|First Phase: 12 Weeks||21
10941082|NCT00366535|12111382|FG000|NOT COMPLETED|First Phase: 12 Weeks||3
10941083|NCT00366535|12111383|FG001|NOT COMPLETED|First Phase: 12 Weeks||8
10941084|NCT00366535|12111382|FG000|STARTED|Washout Period (at Least a Week)||24
10941085|NCT00366535|12111383|FG001|STARTED|Washout Period (at Least a Week)||21
10941086|NCT00366535|12111382|FG000|COMPLETED|Washout Period (at Least a Week)||24
10941087|NCT00366535|12111383|FG001|COMPLETED|Washout Period (at Least a Week)||21
10941088|NCT00366535|12111382|FG000|NOT COMPLETED|Washout Period (at Least a Week)||0
10941089|NCT00366535|12111383|FG001|NOT COMPLETED|Washout Period (at Least a Week)||0
10941090|NCT00366535|12111382|FG000|STARTED|Second Phase: 12 Weeks||24
10941091|NCT00366535|12111383|FG001|STARTED|Second Phase: 12 Weeks||21
10941092|NCT00366535|12111382|FG000|COMPLETED|Second Phase: 12 Weeks||21
10941093|NCT00366535|12111383|FG001|COMPLETED|Second Phase: 12 Weeks||18
10941094|NCT00366535|12111382|FG000|NOT COMPLETED|Second Phase: 12 Weeks||3
10941095|NCT00366535|12111383|FG001|NOT COMPLETED|Second Phase: 12 Weeks||3
10941096|NCT00366548|12111399|FG000|STARTED|Infant Series||250
10941097|NCT00366548|12111400|FG001|STARTED|Infant Series||250
10941098|NCT00366548|12111399|FG000|Vaccinated Dose 1|Infant Series||250
10941099|NCT00366548|12111400|FG001|Vaccinated Dose 1|Infant Series||250
10941100|NCT00366548|12111399|FG000|Vaccinated Dose 2|Infant Series||246
10941101|NCT00366548|12111400|FG001|Vaccinated Dose 2|Infant Series||249
10941102|NCT00366548|12111399|FG000|Vaccinated Dose 3|Infant Series||246
10941103|NCT00366548|12111400|FG001|Vaccinated Dose 3|Infant Series||247
10941104|NCT00366548|12111399|FG000|COMPLETED|Infant Series||246
10941105|NCT00366548|12111400|FG001|COMPLETED|Infant Series||245
10941106|NCT00366548|12111399|FG000|NOT COMPLETED|Infant Series||4
10941107|NCT00366548|12111400|FG001|NOT COMPLETED|Infant Series||5
10941108|NCT00366548|12111399|FG000|STARTED|After Infant Series||246
10941109|NCT00366548|12111400|FG001|STARTED|After Infant Series||245
10941110|NCT00366548|12111399|FG000|COMPLETED|After Infant Series||240
10941111|NCT00366548|12111400|FG001|COMPLETED|After Infant Series||244
10941112|NCT00366548|12111399|FG000|NOT COMPLETED|After Infant Series||6
10941113|NCT00366548|12111400|FG001|NOT COMPLETED|After Infant Series||1
10941114|NCT00366548|12111399|FG000|STARTED|Toddler Dose||240
10941115|NCT00366548|12111400|FG001|STARTED|Toddler Dose||244
10941116|NCT00366548|12111399|FG000|COMPLETED|Toddler Dose||240
10941117|NCT00366548|12111400|FG001|COMPLETED|Toddler Dose||244
10941118|NCT00366548|12111399|FG000|NOT COMPLETED|Toddler Dose||0
10941119|NCT00366548|12111400|FG001|NOT COMPLETED|Toddler Dose||0
10941120|NCT00366626|12111426|FG000|STARTED|Overall Study||38
10941121|NCT00366626|12111427|FG001|STARTED|Overall Study||45
10941122|NCT00366626|12111426|FG000|COMPLETED|Overall Study||38
10941123|NCT00366626|12111427|FG001|COMPLETED|Overall Study||45
10941124|NCT00366626|12111426|FG000|NOT COMPLETED|Overall Study||0
10941125|NCT00366626|12111427|FG001|NOT COMPLETED|Overall Study||0
10941126|NCT00366678|12111437|FG000|STARTED|Infant Series||304
10941127|NCT00366678|12111438|FG001|STARTED|Infant Series||309
10941128|NCT00366678|12111439|FG002|STARTED|Infant Series||0
10941129|NCT00366678|12111437|FG000|Vaccinated Dose 1|Infant Series||302
10941130|NCT00366678|12111438|FG001|Vaccinated Dose 1|Infant Series||309
10941131|NCT00366678|12111439|FG002|Vaccinated Dose 1|Infant Series||0
10941132|NCT00366678|12111437|FG000|Vaccinated Dose 2|Infant Series||295
10941133|NCT00366678|12111438|FG001|Vaccinated Dose 2|Infant Series||304
10941134|NCT00366678|12111439|FG002|Vaccinated Dose 2|Infant Series||0
10941135|NCT00366678|12111437|FG000|Vaccinated Dose 3|Infant Series||291
10941136|NCT00366678|12111438|FG001|Vaccinated Dose 3|Infant Series||302
10941137|NCT00366678|12111439|FG002|Vaccinated Dose 3|Infant Series||0
10941138|NCT00366678|12111437|FG000|COMPLETED|Infant Series||290
10941139|NCT00366678|12111438|FG001|COMPLETED|Infant Series||299
10941140|NCT00366678|12111439|FG002|COMPLETED|Infant Series||0
10941141|NCT00366678|12111437|FG000|NOT COMPLETED|Infant Series||14
10941142|NCT00366678|12111438|FG001|NOT COMPLETED|Infant Series||10
10941143|NCT00366678|12111439|FG002|NOT COMPLETED|Infant Series||0
10941144|NCT00366678|12111437|FG000|STARTED|After Infant||290
10941145|NCT00366678|12111438|FG001|STARTED|After Infant||299
10941146|NCT00366678|12111439|FG002|STARTED|After Infant||0
10941147|NCT00366678|12111437|FG000|COMPLETED|After Infant||273
10941148|NCT00366678|12111438|FG001|COMPLETED|After Infant||289
10941149|NCT00366678|12111439|FG002|COMPLETED|After Infant||0
10941150|NCT00366678|12111437|FG000|NOT COMPLETED|After Infant||17
10941151|NCT00366678|12111438|FG001|NOT COMPLETED|After Infant||10
10941152|NCT00366678|12111439|FG002|NOT COMPLETED|After Infant||0
10941153|NCT00366678|12111437|FG000|STARTED|Toddler Dose||273
10941154|NCT00366678|12111438|FG001|STARTED|Toddler Dose||152
10941155|NCT00366678|12111439|FG002|STARTED|Toddler Dose||137
10941156|NCT00366678|12111437|FG000|COMPLETED|Toddler Dose||268
10941157|NCT00366678|12111438|FG001|COMPLETED|Toddler Dose||151
10941158|NCT00366678|12111439|FG002|COMPLETED|Toddler Dose||137
10941159|NCT00366678|12111437|FG000|NOT COMPLETED|Toddler Dose||5
10941160|NCT00366678|12111438|FG001|NOT COMPLETED|Toddler Dose||1
10941161|NCT00366678|12111439|FG002|NOT COMPLETED|Toddler Dose||0
10941162|NCT00366899|12111486|FG000|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
10941163|NCT00366899|12111487|FG001|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
10941164|NCT00366899|12111486|FG000|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
10941165|NCT00366899|12111487|FG001|Vaccinated Dose 1|Infant Series||302
10941166|NCT00366899|12111486|FG000|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
10941167|NCT00366899|12111487|FG001|Vaccinated Dose 2|Infant Series||293
10941168|NCT00366899|12111486|FG000|COMPLETED|Infant Series||294
10941169|NCT00366899|12111487|FG001|COMPLETED|Infant Series||291
10941170|NCT00366899|12111486|FG000|NOT COMPLETED|Infant Series||9
10941171|NCT00366899|12111487|FG001|NOT COMPLETED|Infant Series||12
10941172|NCT00366899|12111486|FG000|STARTED|After Infant Series||294
10941173|NCT00366899|12111487|FG001|STARTED|After Infant Series||291
10941174|NCT00366899|12111486|FG000|COMPLETED|After Infant Series||287
10941175|NCT00366899|12111487|FG001|COMPLETED|After Infant Series||282
10941176|NCT00366899|12111486|FG000|NOT COMPLETED|After Infant Series||7
10941177|NCT00366899|12111487|FG001|NOT COMPLETED|After Infant Series||9
10941178|NCT00366899|12111486|FG000|STARTED|Toddler Dose||287
10941179|NCT00366899|12111487|FG001|STARTED|Toddler Dose||282
10941180|NCT00366899|12111486|FG000|COMPLETED|Toddler Dose||285
10941181|NCT00366899|12111487|FG001|COMPLETED|Toddler Dose||281
10941182|NCT00366899|12111486|FG000|NOT COMPLETED|Toddler Dose||2
10941183|NCT00366899|12111487|FG001|NOT COMPLETED|Toddler Dose||1
10941184|NCT00367016|12111521|FG000|STARTED|Overall Study||3
10941185|NCT00367016|12111522|FG001|STARTED|Overall Study||3
10941186|NCT00367016|12111521|FG000|First Intervention|Overall Study||3
10941187|NCT00367016|12111522|FG001|First Intervention|Overall Study||3
10941188|NCT00367016|12111521|FG000|Second Intervention|Overall Study||3
10941189|NCT00367016|12111522|FG001|Second Intervention|Overall Study||3
10941190|NCT00367016|12111521|FG000|COMPLETED|Overall Study||3
10941191|NCT00367016|12111522|FG001|COMPLETED|Overall Study||3
10941192|NCT00367016|12111521|FG000|NOT COMPLETED|Overall Study||0
10941193|NCT00367016|12111522|FG001|NOT COMPLETED|Overall Study||0
10941194|NCT00367055|12111532|FG000|STARTED|Overall Study||43
10941195|NCT00367055|12111533|FG001|STARTED|Overall Study||41
10941196|NCT00367055|12111532|FG000|COMPLETED|Overall Study||32
10941197|NCT00367055|12111533|FG001|COMPLETED|Overall Study||30
10941198|NCT00367055|12111532|FG000|NOT COMPLETED|Overall Study||11
10941199|NCT00367055|12111533|FG001|NOT COMPLETED|Overall Study||11
10941200|NCT00367133|12111542|FG000|STARTED|2 Years|Number of Eyes|330
10941201|NCT00367133|12111543|FG001|STARTED|2 Years|Number of Eyes|256
10941202|NCT00367133|12111544|FG002|STARTED|2 Years|Number of Eyes|254
10941203|NCT00367133|12111542|FG000|COMPLETED|2 Years||272
10941204|NCT00367133|12111543|FG001|COMPLETED|2 Years||220
10941205|NCT00367133|12111544|FG002|COMPLETED|2 Years||205
10941206|NCT00367133|12111542|FG000|NOT COMPLETED|2 Years||58
10941207|NCT00367133|12111543|FG001|NOT COMPLETED|2 Years||36
10941208|NCT00367133|12111544|FG002|NOT COMPLETED|2 Years||49
10941209|NCT00367133|12111542|FG000|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
10941210|NCT00367133|12111543|FG001|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
10941211|NCT00367133|12111544|FG002|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
10941212|NCT00367133|12111542|FG000|COMPLETED|3 Years||115
10941213|NCT00367133|12111543|FG001|COMPLETED|3 Years||93
10941214|NCT00367133|12111544|FG002|COMPLETED|3 Years||98
10941215|NCT00367133|12111542|FG000|NOT COMPLETED|3 Years||28
10941216|NCT00367133|12111543|FG001|NOT COMPLETED|3 Years||23
10941217|NCT00367133|12111544|FG002|NOT COMPLETED|3 Years||18
10941218|NCT00367237|12111554|FG000|STARTED|Overall Study|Number of subjects randomized|57
10941219|NCT00367237|12111555|FG001|STARTED|Overall Study|Number of subjects randomized|58
10941220|NCT00367237|12111554|FG000|COMPLETED|Overall Study||47
10941221|NCT00367237|12111555|FG001|COMPLETED|Overall Study||47
10941222|NCT00367237|12111554|FG000|NOT COMPLETED|Overall Study||10
10941223|NCT00367237|12111555|FG001|NOT COMPLETED|Overall Study||11
10941224|NCT00367341|12111563|FG000|STARTED|Overall Study||42
10941225|NCT00367341|12111564|FG001|STARTED|Overall Study||40
10941226|NCT00367341|12111563|FG000|COMPLETED|Overall Study||40
10941227|NCT00367341|12111564|FG001|COMPLETED|Overall Study||40
10941228|NCT00367341|12111563|FG000|NOT COMPLETED|Overall Study||2
10941229|NCT00367341|12111564|FG001|NOT COMPLETED|Overall Study||0
10941230|NCT00367380|12111573|FG000|STARTED|Overall Study||6
10941231|NCT00367380|12111574|FG001|STARTED|Overall Study||6
10941232|NCT00367380|12111575|FG002|STARTED|Overall Study||6
10941233|NCT00367380|12111573|FG000|COMPLETED|Overall Study||6
10941234|NCT00367380|12111574|FG001|COMPLETED|Overall Study||6
10941235|NCT00367380|12111575|FG002|COMPLETED|Overall Study||6
10941236|NCT00367380|12111573|FG000|NOT COMPLETED|Overall Study||0
10941237|NCT00367380|12111574|FG001|NOT COMPLETED|Overall Study||0
10941238|NCT00367380|12111575|FG002|NOT COMPLETED|Overall Study||0
10941239|NCT00367432|12111583|FG000|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
10941240|NCT00367432|12111584|FG001|STARTED|First Period (16 Weeks)||0
10941241|NCT00367432|12111583|FG000|COMPLETED|First Period (16 Weeks)||275
10941242|NCT00367432|12111584|FG001|COMPLETED|First Period (16 Weeks)||0
10941243|NCT00367432|12111583|FG000|NOT COMPLETED|First Period (16 Weeks)||38
10941244|NCT00367432|12111584|FG001|NOT COMPLETED|First Period (16 Weeks)||0
10941245|NCT00367432|12111583|FG000|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
10941246|NCT00367432|12111584|FG001|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
10941247|NCT00367432|12111583|FG000|COMPLETED|Second Period (up to 54 Months)||188
10941248|NCT00367432|12111584|FG001|COMPLETED|Second Period (up to 54 Months)||69
10941249|NCT00367432|12111583|FG000|NOT COMPLETED|Second Period (up to 54 Months)||87
10941250|NCT00367432|12111584|FG001|NOT COMPLETED|Second Period (up to 54 Months)||16
10941251|NCT00367458|12111590|FG000|STARTED|First Intervention - 8 Weeks||12
10941252|NCT00367458|12111591|FG001|STARTED|First Intervention - 8 Weeks||12
10941253|NCT00367458|12111590|FG000|COMPLETED|First Intervention - 8 Weeks||10
10941254|NCT00367458|12111591|FG001|COMPLETED|First Intervention - 8 Weeks||12
10941255|NCT00367458|12111590|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2
10941256|NCT00367458|12111591|FG001|NOT COMPLETED|First Intervention - 8 Weeks||0
10941257|NCT00367458|12111590|FG000|STARTED|Washout Period - 4-6 Weeks||10
10941258|NCT00367458|12111591|FG001|STARTED|Washout Period - 4-6 Weeks||12
10941259|NCT00367458|12111590|FG000|COMPLETED|Washout Period - 4-6 Weeks||10
10941260|NCT00367458|12111591|FG001|COMPLETED|Washout Period - 4-6 Weeks||12
10941261|NCT00367458|12111590|FG000|NOT COMPLETED|Washout Period - 4-6 Weeks||0
10941262|NCT00367458|12111591|FG001|NOT COMPLETED|Washout Period - 4-6 Weeks||0
10941263|NCT00367458|12111590|FG000|STARTED|Second Intervention - 8 Weeks||10
10941264|NCT00367458|12111591|FG001|STARTED|Second Intervention - 8 Weeks||12
10941265|NCT00367458|12111590|FG000|COMPLETED|Second Intervention - 8 Weeks||10
10941266|NCT00367458|12111591|FG001|COMPLETED|Second Intervention - 8 Weeks||12
10941267|NCT00367458|12111590|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0
10941268|NCT00367458|12111591|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0
10941269|NCT00367484|12111597|FG000|STARTED|Overall Study||460
10941270|NCT00367484|12111597|FG000|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
10941271|NCT00367484|12111597|FG000|NOT COMPLETED|Overall Study||17
10941272|NCT00367601|12111601|FG000|STARTED|Overall Study||25
10941273|NCT00367601|12111601|FG000|COMPLETED|Overall Study||25
10941274|NCT00367601|12111601|FG000|NOT COMPLETED|Overall Study||0
10941275|NCT00367640|12111610|FG000|STARTED|Overall Study||157
10941276|NCT00367640|12111611|FG001|STARTED|Overall Study||155
10941277|NCT00367640|12111612|FG002|STARTED|Overall Study||160
10941278|NCT00367640|12111613|FG003|STARTED|Overall Study||156
10941279|NCT00367640|12111610|FG000|COMPLETED|Overall Study||139
10941280|NCT00367640|12111611|FG001|COMPLETED|Overall Study||133
10941281|NCT00367640|12111612|FG002|COMPLETED|Overall Study||141
10941282|NCT00367640|12111613|FG003|COMPLETED|Overall Study||146
10941283|NCT00367640|12111610|FG000|NOT COMPLETED|Overall Study||18
10941284|NCT00367640|12111611|FG001|NOT COMPLETED|Overall Study||22
10941285|NCT00367640|12111612|FG002|NOT COMPLETED|Overall Study||19
10941286|NCT00367640|12111613|FG003|NOT COMPLETED|Overall Study||10
10941287|NCT00367679|12111623|FG000|STARTED|Overall Study||35
10941288|NCT00367679|12111623|FG000|COMPLETED|Overall Study||35
10941289|NCT00367679|12111623|FG000|NOT COMPLETED|Overall Study||0
10941290|NCT00367744|12111631|FG000|STARTED|Overall Study||34
10941291|NCT00367744|12111632|FG001|STARTED|Overall Study||37
10941292|NCT00367744|12111631|FG000|COMPLETED|Overall Study||30
10941293|NCT00367744|12111632|FG001|COMPLETED|Overall Study||32
10941294|NCT00367744|12111631|FG000|NOT COMPLETED|Overall Study||4
10941295|NCT00367744|12111632|FG001|NOT COMPLETED|Overall Study||5
10941296|NCT00367770|12111639|FG000|STARTED|Overall Study||37
10941297|NCT00367770|12111639|FG000|COMPLETED|Overall Study||35
10941298|NCT00367770|12111639|FG000|NOT COMPLETED|Overall Study||2
10941299|NCT00367835|12111645|FG000|STARTED|Overall Study||138
10941300|NCT00367835|12111646|FG001|STARTED|Overall Study||79
10941301|NCT00367835|12111645|FG000|COMPLETED|Overall Study||109
10941302|NCT00367835|12111646|FG001|COMPLETED|Overall Study||48
10941303|NCT00367835|12111645|FG000|NOT COMPLETED|Overall Study||29
10941304|NCT00367835|12111646|FG001|NOT COMPLETED|Overall Study||31
10941305|NCT00367991|12111654|FG000|STARTED|Overall Study||29
10941306|NCT00367991|12111655|FG001|STARTED|Overall Study||15
10941307|NCT00367991|12111654|FG000|COMPLETED|Overall Study||27
10941308|NCT00367991|12111655|FG001|COMPLETED|Overall Study||13
10941309|NCT00367991|12111654|FG000|NOT COMPLETED|Overall Study||2
10941310|NCT00367991|12111655|FG001|NOT COMPLETED|Overall Study||2
10941311|NCT00368069|12111663|FG000|STARTED|Overall Study||79
10941312|NCT00368069|12111664|FG001|STARTED|Overall Study||79
10941313|NCT00368069|12111663|FG000|COMPLETED|Overall Study||71
10941314|NCT00368069|12111664|FG001|COMPLETED|Overall Study||72
10941315|NCT00368069|12111663|FG000|NOT COMPLETED|Overall Study||8
10941316|NCT00368069|12111664|FG001|NOT COMPLETED|Overall Study||7
10941317|NCT00368108|12111673|FG000|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
10941318|NCT00368108|12111674|FG001|STARTED|Overall Study||251
10941319|NCT00368108|12111675|FG002|STARTED|Overall Study||250
10941320|NCT00368108|12111673|FG000|COMPLETED|Overall Study||187
10941321|NCT00368108|12111674|FG001|COMPLETED|Overall Study||198
10941322|NCT00368108|12111675|FG002|COMPLETED|Overall Study||182
10941323|NCT00368108|12111673|FG000|NOT COMPLETED|Overall Study||64
10941324|NCT00368108|12111674|FG001|NOT COMPLETED|Overall Study||53
10941325|NCT00368108|12111675|FG002|NOT COMPLETED|Overall Study||68
10941326|NCT00368251|12111686|FG000|STARTED|Overall Study||18
10941327|NCT00368251|12111687|FG001|STARTED|Overall Study||20
10941328|NCT00368251|12111688|FG002|STARTED|Overall Study||18
10941329|NCT00368251|12111686|FG000|COMPLETED|Overall Study||17
10941330|NCT00368251|12111687|FG001|COMPLETED|Overall Study||20
10941331|NCT00368251|12111688|FG002|COMPLETED|Overall Study||17
10941332|NCT00368251|12111686|FG000|NOT COMPLETED|Overall Study||1
10941333|NCT00368251|12111687|FG001|NOT COMPLETED|Overall Study||0
10941334|NCT00368251|12111688|FG002|NOT COMPLETED|Overall Study||1
10941335|NCT00368277|12111698|FG000|STARTED|Overall Study||457
10941336|NCT00368277|12111699|FG001|STARTED|Overall Study||444
10941337|NCT00368277|12111698|FG000|COMPLETED|Overall Study||344
10941338|NCT00368277|12111699|FG001|COMPLETED|Overall Study||336
10941339|NCT00368277|12111698|FG000|NOT COMPLETED|Overall Study||113
10941340|NCT00368277|12111699|FG001|NOT COMPLETED|Overall Study||108
10941341|NCT00368290|12111707|FG000|STARTED|Overall Study||47
10941342|NCT00368290|12111708|FG001|STARTED|Overall Study||47
10941343|NCT00368290|12111707|FG000|COMPLETED|Overall Study||34
10941344|NCT00368290|12111708|FG001|COMPLETED|Overall Study||37
10941345|NCT00368290|12111707|FG000|NOT COMPLETED|Overall Study||13
10941346|NCT00368290|12111708|FG001|NOT COMPLETED|Overall Study||10
10941347|NCT00368316|12111716|FG000|STARTED|Overall Study||1434
10941348|NCT00368316|12111717|FG001|STARTED|Overall Study||1365
10941349|NCT00368316|12111716|FG000|COMPLETED|Overall Study||1392
10941350|NCT00368316|12111717|FG001|COMPLETED|Overall Study||1319
10941351|NCT00368316|12111716|FG000|NOT COMPLETED|Overall Study||42
10941352|NCT00368316|12111717|FG001|NOT COMPLETED|Overall Study||46
10941353|NCT00368355|12111725|FG000|STARTED|Overall Study||18
10941354|NCT00368355|12111726|FG001|STARTED|Overall Study||28
10941355|NCT00368355|12111725|FG000|COMPLETED|Overall Study||7
10941356|NCT00368355|12111726|FG001|COMPLETED|Overall Study||11
10941357|NCT00368355|12111725|FG000|NOT COMPLETED|Overall Study||11
10941358|NCT00368355|12111726|FG001|NOT COMPLETED|Overall Study||17
10941359|NCT00368459|12111734|FG000|STARTED|Overall Study||21
10941360|NCT00368459|12111735|FG001|STARTED|Overall Study||21
10941361|NCT00368459|12111734|FG000|COMPLETED|Overall Study||19
10941362|NCT00368459|12111735|FG001|COMPLETED|Overall Study||20
10941363|NCT00368459|12111734|FG000|NOT COMPLETED|Overall Study||2
10941364|NCT00368459|12111735|FG001|NOT COMPLETED|Overall Study||1
10941365|NCT00368472|12111741|FG000|STARTED|Overall Study||138
10941366|NCT00368472|12111741|FG000|COMPLETED|Overall Study||33
10941367|NCT00368472|12111741|FG000|NOT COMPLETED|Overall Study||105
10941368|NCT00368537|12111747|FG000|STARTED|Randomization||281
10941369|NCT00368537|12111748|FG001|STARTED|Randomization||269
10941370|NCT00368537|12111747|FG000|COMPLETED|Randomization||268
10941371|NCT00368537|12111748|FG001|COMPLETED|Randomization||263
10941372|NCT00368537|12111747|FG000|NOT COMPLETED|Randomization||13
10941373|NCT00368537|12111748|FG001|NOT COMPLETED|Randomization||6
10941374|NCT00368537|12111747|FG000|STARTED|Baseline Participants||268
10941375|NCT00368537|12111748|FG001|STARTED|Baseline Participants||263
10941376|NCT00368537|12111747|FG000|COMPLETED|Baseline Participants||244
10941377|NCT00368537|12111748|FG001|COMPLETED|Baseline Participants||239
10941378|NCT00368537|12111747|FG000|NOT COMPLETED|Baseline Participants||24
10941379|NCT00368537|12111748|FG001|NOT COMPLETED|Baseline Participants||24
10941380|NCT00368550|12111756|FG000|STARTED|Overall Study||63
10941381|NCT00368550|12111757|FG001|STARTED|Overall Study||71
10941382|NCT00368550|12111756|FG000|COMPLETED|Overall Study||35
10941383|NCT00368550|12111757|FG001|COMPLETED|Overall Study||48
10941384|NCT00368550|12111756|FG000|NOT COMPLETED|Overall Study||28
10941385|NCT00368550|12111757|FG001|NOT COMPLETED|Overall Study||23
10941386|NCT00368641|12111765|FG000|STARTED|Overall Study||6
10941387|NCT00368641|12111766|FG001|STARTED|Overall Study||6
10941388|NCT00368641|12111765|FG000|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
10941389|NCT00368641|12111766|FG001|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
10941390|NCT00368641|12111765|FG000|NOT COMPLETED|Overall Study||6
10941391|NCT00368641|12111766|FG001|NOT COMPLETED|Overall Study||6
10941392|NCT00368745|12111774|FG000|STARTED|Randomized to Double-blind Treatment||57
10941393|NCT00368745|12111775|FG001|STARTED|Randomized to Double-blind Treatment||51
10941394|NCT00368745|12111774|FG000|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
10941395|NCT00368745|12111775|FG001|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
10941396|NCT00368745|12111774|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||1
10941397|NCT00368745|12111775|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1
10941398|NCT00368745|12111774|FG000|STARTED|Double-blind Treatment Period||56
10941399|NCT00368745|12111775|FG001|STARTED|Double-blind Treatment Period||50
10941400|NCT00368745|12111774|FG000|COMPLETED|Double-blind Treatment Period||30
10941401|NCT00368745|12111775|FG001|COMPLETED|Double-blind Treatment Period||19
10941402|NCT00368745|12111774|FG000|NOT COMPLETED|Double-blind Treatment Period||26
10941403|NCT00368745|12111775|FG001|NOT COMPLETED|Double-blind Treatment Period||31
10941404|NCT00368849|12111781|FG000|STARTED|Overall Study||10
10941405|NCT00368849|12111782|FG001|STARTED|Overall Study||10
10941406|NCT00368849|12111781|FG000|COMPLETED|Overall Study||10
10941407|NCT00368849|12111782|FG001|COMPLETED|Overall Study||8
10941408|NCT00368849|12111781|FG000|NOT COMPLETED|Overall Study||0
10941409|NCT00368849|12111782|FG001|NOT COMPLETED|Overall Study||2
10941410|NCT00368875|12111789|FG000|STARTED|Overall Study||6
10941411|NCT00368875|12111790|FG001|STARTED|Overall Study||48
10941412|NCT00368875|12111789|FG000|COMPLETED|Overall Study||0
10941413|NCT00368875|12111790|FG001|COMPLETED|Overall Study||0
10941414|NCT00368875|12111789|FG000|NOT COMPLETED|Overall Study||6
10941415|NCT00368875|12111790|FG001|NOT COMPLETED|Overall Study||48
10941416|NCT00368927|12111798|FG000|STARTED|Overall Study||31
10941417|NCT00368927|12111799|FG001|STARTED|Overall Study||30
10941418|NCT00368927|12111798|FG000|COMPLETED|Overall Study||26
10941419|NCT00368927|12111799|FG001|COMPLETED|Overall Study||27
10941420|NCT00368927|12111798|FG000|NOT COMPLETED|Overall Study||5
10941421|NCT00368927|12111799|FG001|NOT COMPLETED|Overall Study||3
10941422|NCT00368940|12111807|FG000|STARTED|Intention-to-Treat||37
10941423|NCT00368940|12111808|FG001|STARTED|Intention-to-Treat||37
10941424|NCT00368940|12111807|FG000|COMPLETED|Intention-to-Treat||37
10941425|NCT00368940|12111808|FG001|COMPLETED|Intention-to-Treat||37
10941426|NCT00368940|12111807|FG000|NOT COMPLETED|Intention-to-Treat||0
10941427|NCT00368940|12111808|FG001|NOT COMPLETED|Intention-to-Treat||0
10941428|NCT00368940|12111807|FG000|STARTED|Completed 12-wk Treatment||37
10941429|NCT00368940|12111808|FG001|STARTED|Completed 12-wk Treatment||37
10941430|NCT00368940|12111807|FG000|COMPLETED|Completed 12-wk Treatment||31
10941431|NCT00368940|12111808|FG001|COMPLETED|Completed 12-wk Treatment||32
10941432|NCT00368940|12111807|FG000|NOT COMPLETED|Completed 12-wk Treatment||6
10941433|NCT00368940|12111808|FG001|NOT COMPLETED|Completed 12-wk Treatment||5
10941434|NCT00368966|12111817|FG000|STARTED|Infant Series||315
10941435|NCT00368966|12111818|FG001|STARTED|Infant Series||304
10941436|NCT00368966|12111817|FG000|Vaccinated Dose 1|Infant Series||314
10941437|NCT00368966|12111818|FG001|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
10941438|NCT00368966|12111817|FG000|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
10941439|NCT00368966|12111818|FG001|Vaccinated Dose 2|Infant Series||298
10941440|NCT00368966|12111817|FG000|Vaccinated Dose 3|Infant Series||301
10941441|NCT00368966|12111818|FG001|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
10941442|NCT00368966|12111817|FG000|COMPLETED|Infant Series||299
10941443|NCT00368966|12111818|FG001|COMPLETED|Infant Series||294
10941444|NCT00368966|12111817|FG000|NOT COMPLETED|Infant Series||16
10941445|NCT00368966|12111818|FG001|NOT COMPLETED|Infant Series||10
10941446|NCT00368966|12111817|FG000|STARTED|After Infant||299
10941447|NCT00368966|12111818|FG001|STARTED|After Infant||294
10941448|NCT00368966|12111817|FG000|COMPLETED|After Infant||293
10941449|NCT00368966|12111818|FG001|COMPLETED|After Infant||289
10941450|NCT00368966|12111817|FG000|NOT COMPLETED|After Infant||6
10941451|NCT00368966|12111818|FG001|NOT COMPLETED|After Infant||5
10941452|NCT00368966|12111817|FG000|STARTED|Toddler Dose||293
10941453|NCT00368966|12111818|FG001|STARTED|Toddler Dose||289
10941454|NCT00368966|12111817|FG000|COMPLETED|Toddler Dose||292
10941455|NCT00368966|12111818|FG001|COMPLETED|Toddler Dose||286
10941456|NCT00368966|12111817|FG000|NOT COMPLETED|Toddler Dose||1
10941457|NCT00368966|12111818|FG001|NOT COMPLETED|Toddler Dose||3
10941458|NCT00368979|12111851|FG000|STARTED|Overall Study||185
10941459|NCT00368979|12111852|FG001|STARTED|Overall Study||193
10941460|NCT00368979|12111851|FG000|COMPLETED|Overall Study||160
10941461|NCT00368979|12111852|FG001|COMPLETED|Overall Study||163
10941462|NCT00368979|12111851|FG000|NOT COMPLETED|Overall Study||25
10941463|NCT00368979|12111852|FG001|NOT COMPLETED|Overall Study||30
10941464|NCT00368992|12111858|FG000|STARTED|Overall Study||110
10941465|NCT00368992|12111858|FG000|COMPLETED|Overall Study||0
10941466|NCT00368992|12111858|FG000|NOT COMPLETED|Overall Study||110
10941467|NCT00369122|12111863|FG000|STARTED|Overall Study||60
10941468|NCT00369122|12111863|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
10941469|NCT00369122|12111863|FG000|NOT COMPLETED|Overall Study||11
10941470|NCT00369161|12111869|FG000|STARTED|Overall Study|"Started indicates randomized and safety population."|109
10941471|NCT00369161|12111870|FG001|STARTED|Overall Study||119
10941472|NCT00369161|12111869|FG000|Intention to Treat (ITT)|Overall Study||107
10941473|NCT00369161|12111870|FG001|Intention to Treat (ITT)|Overall Study||117
10941474|NCT00369161|12111869|FG000|COMPLETED|Overall Study||82
10941475|NCT00369161|12111870|FG001|COMPLETED|Overall Study||95
10941476|NCT00369161|12111869|FG000|NOT COMPLETED|Overall Study||27
10941477|NCT00369161|12111870|FG001|NOT COMPLETED|Overall Study||24
10941478|NCT00369226|12111878|FG000|STARTED|Phase I (45 Days)||13
10941479|NCT00369226|12111879|FG001|STARTED|Phase I (45 Days)||0
10941480|NCT00369226|12111878|FG000|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
10941481|NCT00369226|12111879|FG001|COMPLETED|Phase I (45 Days)||0
10941482|NCT00369226|12111878|FG000|NOT COMPLETED|Phase I (45 Days)||0
10941483|NCT00369226|12111879|FG001|NOT COMPLETED|Phase I (45 Days)||0
10941484|NCT00369226|12111878|FG000|STARTED|Phase II (45 Days)||0
10941485|NCT00369226|12111879|FG001|STARTED|Phase II (45 Days)||32
10941486|NCT00369226|12111878|FG000|COMPLETED|Phase II (45 Days)||0
10941487|NCT00369226|12111879|FG001|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
10941488|NCT00369226|12111878|FG000|NOT COMPLETED|Phase II (45 Days)||0
10941489|NCT00369226|12111879|FG001|NOT COMPLETED|Phase II (45 Days)||0
10941490|NCT00369278|12111890|FG000|STARTED|Overall Study||63
10941491|NCT00369278|12111891|FG001|STARTED|Overall Study||65
10941492|NCT00369278|12111890|FG000|COMPLETED|Overall Study||39
10941493|NCT00369278|12111891|FG001|COMPLETED|Overall Study||44
10941494|NCT00369278|12111890|FG000|NOT COMPLETED|Overall Study||24
10941495|NCT00369278|12111891|FG001|NOT COMPLETED|Overall Study||21
10941496|NCT00369343|12111899|FG000|STARTED|Double-blind Phase||256
10941497|NCT00369343|12111900|FG001|STARTED|Double-blind Phase||125
10941498|NCT00369343|12111899|FG000|COMPLETED|Double-blind Phase||212
10941499|NCT00369343|12111900|FG001|COMPLETED|Double-blind Phase||109
10941500|NCT00369343|12111899|FG000|NOT COMPLETED|Double-blind Phase||44
10941501|NCT00369343|12111900|FG001|NOT COMPLETED|Double-blind Phase||16
10941502|NCT00369343|12111899|FG000|STARTED|Open-label Phase||212
10941503|NCT00369343|12111900|FG001|STARTED|Open-label Phase||109
10941504|NCT00369343|12111899|FG000|COMPLETED|Open-label Phase||155
10941505|NCT00369343|12111900|FG001|COMPLETED|Open-label Phase||79
10941506|NCT00369343|12111899|FG000|NOT COMPLETED|Open-label Phase||57
10941507|NCT00369343|12111900|FG001|NOT COMPLETED|Open-label Phase||30
10941508|NCT00369382|12111915|FG000|STARTED|Overall Study||59
10941509|NCT00369382|12111916|FG001|STARTED|Overall Study||57
10941510|NCT00369382|12111915|FG000|Received Treatment|Overall Study||57
10941511|NCT00369382|12111916|FG001|Received Treatment|Overall Study||57
10941512|NCT00369382|12111915|FG000|Completed Assigned Treatment Regimen|Overall Study||48
10941513|NCT00369382|12111916|FG001|Completed Assigned Treatment Regimen|Overall Study||33
10941514|NCT00369382|12111915|FG000|COMPLETED|Overall Study||49
10941515|NCT00369382|12111916|FG001|COMPLETED|Overall Study||54
10941516|NCT00369382|12111915|FG000|NOT COMPLETED|Overall Study||10
10941517|NCT00369382|12111916|FG001|NOT COMPLETED|Overall Study||3
10941518|NCT00369486|12111928|FG000|STARTED|4-Week Visit|Number of eyes|38
10941519|NCT00369486|12111929|FG001|STARTED|4-Week Visit|Number of eyes|21
10941520|NCT00369486|12111930|FG002|STARTED|4-Week Visit|Number of eyes|23
10941521|NCT00369486|12111931|FG003|STARTED|4-Week Visit|Number of eyes|22
10941522|NCT00369486|12111932|FG004|STARTED|4-Week Visit|Number of eyes|25
10941523|NCT00369486|12111928|FG000|COMPLETED|4-Week Visit|Number of eyes|36
10941524|NCT00369486|12111929|FG001|COMPLETED|4-Week Visit|Number of eyes;|19
10941525|NCT00369486|12111930|FG002|COMPLETED|4-Week Visit|Number of eyes|22
10941526|NCT00369486|12111931|FG003|COMPLETED|4-Week Visit|Number of eyes|20
10941527|NCT00369486|12111932|FG004|COMPLETED|4-Week Visit|Number of eyes|24
10941528|NCT00369486|12111928|FG000|NOT COMPLETED|4-Week Visit||2
10941529|NCT00369486|12111929|FG001|NOT COMPLETED|4-Week Visit||2
10941530|NCT00369486|12111930|FG002|NOT COMPLETED|4-Week Visit||1
10941531|NCT00369486|12111931|FG003|NOT COMPLETED|4-Week Visit||2
10941532|NCT00369486|12111932|FG004|NOT COMPLETED|4-Week Visit||1
10941533|NCT00369486|12111928|FG000|STARTED|8-Week Visit|Number of eyes|38
10941534|NCT00369486|12111929|FG001|STARTED|8-Week Visit|Number of eyes|21
10941535|NCT00369486|12111930|FG002|STARTED|8-Week Visit|Number of eyes|22
10941536|NCT00369486|12111931|FG003|STARTED|8-Week Visit|Number of eyes|22
10941537|NCT00369486|12111932|FG004|STARTED|8-Week Visit|Number of eyes|25
10941538|NCT00369486|12111928|FG000|COMPLETED|8-Week Visit|Number of eyes|38
10941539|NCT00369486|12111929|FG001|COMPLETED|8-Week Visit|Number of eyes|20
10941540|NCT00369486|12111930|FG002|COMPLETED|8-Week Visit|Number of eyes|22
10941541|NCT00369486|12111931|FG003|COMPLETED|8-Week Visit|Number of eyes|21
10941542|NCT00369486|12111932|FG004|COMPLETED|8-Week Visit|Number of eyes|24
10941543|NCT00369486|12111928|FG000|NOT COMPLETED|8-Week Visit||0
10941544|NCT00369486|12111929|FG001|NOT COMPLETED|8-Week Visit||1
10941545|NCT00369486|12111930|FG002|NOT COMPLETED|8-Week Visit||0
10941546|NCT00369486|12111931|FG003|NOT COMPLETED|8-Week Visit||1
10941547|NCT00369486|12111932|FG004|NOT COMPLETED|8-Week Visit||1
10941548|NCT00369486|12111928|FG000|STARTED|17-Week Visit|Number of eyes|38
10941549|NCT00369486|12111929|FG001|STARTED|17-Week Visit|Number of eyes|21
10941550|NCT00369486|12111930|FG002|STARTED|17-Week Visit|Number of eyes|23
10941551|NCT00369486|12111931|FG003|STARTED|17-Week Visit|Number of eyes|22
10941552|NCT00369486|12111932|FG004|STARTED|17-Week Visit|Number of eyes|25
10941553|NCT00369486|12111928|FG000|COMPLETED|17-Week Visit|Number of eyes|38
10941554|NCT00369486|12111929|FG001|COMPLETED|17-Week Visit|Number of eyes|21
10941555|NCT00369486|12111930|FG002|COMPLETED|17-Week Visit|Number of eyes|22
10941556|NCT00369486|12111931|FG003|COMPLETED|17-Week Visit|Number of eyes|21
10941557|NCT00369486|12111932|FG004|COMPLETED|17-Week Visit|Number of eyes|24
10941558|NCT00369486|12111928|FG000|NOT COMPLETED|17-Week Visit||0
10941559|NCT00369486|12111929|FG001|NOT COMPLETED|17-Week Visit||0
10941560|NCT00369486|12111930|FG002|NOT COMPLETED|17-Week Visit||1
10941561|NCT00369486|12111931|FG003|NOT COMPLETED|17-Week Visit||1
10941562|NCT00369486|12111932|FG004|NOT COMPLETED|17-Week Visit||1
10941563|NCT00369486|12111928|FG000|STARTED|34-Week Visit|Number of eyes|38
10941564|NCT00369486|12111929|FG001|STARTED|34-Week Visit|Number of eyes|21
10941565|NCT00369486|12111930|FG002|STARTED|34-Week Visit|Number of eyes|23
10941566|NCT00369486|12111931|FG003|STARTED|34-Week Visit|Number of eyes|22
10941567|NCT00369486|12111932|FG004|STARTED|34-Week Visit|Number of eyes that|25
10941568|NCT00369486|12111928|FG000|COMPLETED|34-Week Visit|Number of eyes|38
10941569|NCT00369486|12111929|FG001|COMPLETED|34-Week Visit|Number of eyes|20
10941570|NCT00369486|12111930|FG002|COMPLETED|34-Week Visit|Number of eyes|22
10941571|NCT00369486|12111931|FG003|COMPLETED|34-Week Visit|Number of eyes|19
10941572|NCT00369486|12111932|FG004|COMPLETED|34-Week Visit|Number of eyes|22
10941573|NCT00369486|12111928|FG000|NOT COMPLETED|34-Week Visit||0
10941574|NCT00369486|12111929|FG001|NOT COMPLETED|34-Week Visit||1
10941575|NCT00369486|12111930|FG002|NOT COMPLETED|34-Week Visit||1
10941576|NCT00369486|12111931|FG003|NOT COMPLETED|34-Week Visit||3
10941577|NCT00369486|12111932|FG004|NOT COMPLETED|34-Week Visit||3
10941578|NCT00369512|12111944|FG000|STARTED|Overall Study||15
10941579|NCT00369512|12111944|FG000|COMPLETED|Overall Study||15
10941580|NCT00369512|12111944|FG000|NOT COMPLETED|Overall Study||0
10941581|NCT00369564|12111950|FG000|STARTED|Overall Study||127
10941582|NCT00369564|12111951|FG001|STARTED|Overall Study||123
10941583|NCT00369564|12111950|FG000|COMPLETED|Overall Study||84
10941584|NCT00369564|12111951|FG001|COMPLETED|Overall Study||100
10941585|NCT00369564|12111950|FG000|NOT COMPLETED|Overall Study||43
10941586|NCT00369564|12111951|FG001|NOT COMPLETED|Overall Study||23
10941587|NCT00369577|12111964|FG000|STARTED|Overall Study||43
10941588|NCT00369577|12111965|FG001|STARTED|Overall Study||45
10941589|NCT00369577|12111966|FG002|STARTED|Overall Study||41
10941590|NCT00369577|12111964|FG000|COMPLETED|Overall Study||43
10941591|NCT00369577|12111965|FG001|COMPLETED|Overall Study||45
10941592|NCT00369577|12111966|FG002|COMPLETED|Overall Study||40
10941593|NCT00369577|12111964|FG000|NOT COMPLETED|Overall Study||0
10941594|NCT00369577|12111965|FG001|NOT COMPLETED|Overall Study||0
10941595|NCT00369577|12111966|FG002|NOT COMPLETED|Overall Study||1
10941596|NCT00369590|12111976|FG000|STARTED|Overall Study||16
10941597|NCT00369590|12111977|FG001|STARTED|Overall Study||42
10941598|NCT00369590|12111976|FG000|COMPLETED|Overall Study||16
10941599|NCT00369590|12111977|FG001|COMPLETED|Overall Study||42
10941600|NCT00369590|12111976|FG000|NOT COMPLETED|Overall Study||0
10941601|NCT00369590|12111977|FG001|NOT COMPLETED|Overall Study||0
10941602|NCT00369629|12111982|FG000|STARTED|Treated 2 Cycles/Reached First Response||6
10941603|NCT00369629|12111983|FG001|STARTED|Treated 2 Cycles/Reached First Response||3
10941604|NCT00369629|12111984|FG002|STARTED|Treated 2 Cycles/Reached First Response||5
10941605|NCT00369629|12111985|FG003|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
10941606|NCT00369629|12111982|FG000|COMPLETED|Treated 2 Cycles/Reached First Response||4
10941607|NCT00369629|12111983|FG001|COMPLETED|Treated 2 Cycles/Reached First Response||2
10941608|NCT00369629|12111984|FG002|COMPLETED|Treated 2 Cycles/Reached First Response||3
10941609|NCT00369629|12111985|FG003|COMPLETED|Treated 2 Cycles/Reached First Response||0
10941610|NCT00369629|12111982|FG000|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
10941611|NCT00369629|12111983|FG001|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
10941612|NCT00369629|12111984|FG002|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
10941613|NCT00369629|12111985|FG003|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
10941614|NCT00369629|12111982|FG000|STARTED|Moved on to 4 More Cycles||4
10941615|NCT00369629|12111983|FG001|STARTED|Moved on to 4 More Cycles||2
10941616|NCT00369629|12111984|FG002|STARTED|Moved on to 4 More Cycles||3
10941617|NCT00369629|12111985|FG003|STARTED|Moved on to 4 More Cycles||0
10941618|NCT00369629|12111982|FG000|COMPLETED|Moved on to 4 More Cycles||4
10941619|NCT00369629|12111983|FG001|COMPLETED|Moved on to 4 More Cycles||2
10941620|NCT00369629|12111984|FG002|COMPLETED|Moved on to 4 More Cycles||2
10941621|NCT00369629|12111985|FG003|COMPLETED|Moved on to 4 More Cycles||0
10941622|NCT00369629|12111982|FG000|NOT COMPLETED|Moved on to 4 More Cycles||0
10941623|NCT00369629|12111983|FG001|NOT COMPLETED|Moved on to 4 More Cycles||0
10941624|NCT00369629|12111984|FG002|NOT COMPLETED|Moved on to 4 More Cycles||1
10941625|NCT00369629|12111985|FG003|NOT COMPLETED|Moved on to 4 More Cycles||0
10941626|NCT00369629|12111982|FG000|STARTED|Completed 4 More Cycles||4
10941627|NCT00369629|12111983|FG001|STARTED|Completed 4 More Cycles||2
10941628|NCT00369629|12111984|FG002|STARTED|Completed 4 More Cycles||2
10941629|NCT00369629|12111985|FG003|STARTED|Completed 4 More Cycles||0
10941630|NCT00369629|12111982|FG000|COMPLETED|Completed 4 More Cycles||0
10941631|NCT00369629|12111983|FG001|COMPLETED|Completed 4 More Cycles||0
10941632|NCT00369629|12111984|FG002|COMPLETED|Completed 4 More Cycles||0
10941633|NCT00369629|12111985|FG003|COMPLETED|Completed 4 More Cycles||0
10941634|NCT00369629|12111982|FG000|NOT COMPLETED|Completed 4 More Cycles||4
10941635|NCT00369629|12111983|FG001|NOT COMPLETED|Completed 4 More Cycles||2
10941636|NCT00369629|12111984|FG002|NOT COMPLETED|Completed 4 More Cycles||2
10941637|NCT00369629|12111985|FG003|NOT COMPLETED|Completed 4 More Cycles||0
10941638|NCT00369629|12111982|FG000|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
10941639|NCT00369629|12111983|FG001|STARTED|Follow up for 1 Year||3
10941640|NCT00369629|12111984|FG002|STARTED|Follow up for 1 Year||5
10941641|NCT00369629|12111985|FG003|STARTED|Follow up for 1 Year||0
10941642|NCT00369629|12111982|FG000|COMPLETED|Follow up for 1 Year||4
10941643|NCT00369629|12111983|FG001|COMPLETED|Follow up for 1 Year||1
10941644|NCT00369629|12111984|FG002|COMPLETED|Follow up for 1 Year||2
10941645|NCT00369629|12111985|FG003|COMPLETED|Follow up for 1 Year||0
10941646|NCT00369629|12111982|FG000|NOT COMPLETED|Follow up for 1 Year||2
10941647|NCT00369629|12111983|FG001|NOT COMPLETED|Follow up for 1 Year||2
10941648|NCT00369629|12111984|FG002|NOT COMPLETED|Follow up for 1 Year||3
10941649|NCT00369629|12111985|FG003|NOT COMPLETED|Follow up for 1 Year||0
10941650|NCT00369655|12111995|FG000|STARTED|Overall Study||21
10941651|NCT00369655|12111995|FG000|COMPLETED|Overall Study||19
10941652|NCT00369655|12111995|FG000|NOT COMPLETED|Overall Study||2
10941653|NCT00369668|12112002|FG000|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
10941654|NCT00369668|12112003|FG001|STARTED|Overall Study||10
10941655|NCT00369668|12112004|FG002|STARTED|Overall Study||10
10941656|NCT00369668|12112002|FG000|COMPLETED|Overall Study||6
10941657|NCT00369668|12112003|FG001|COMPLETED|Overall Study||5
10941658|NCT00369668|12112004|FG002|COMPLETED|Overall Study||3
10941659|NCT00369668|12112002|FG000|NOT COMPLETED|Overall Study||4
10941660|NCT00369668|12112003|FG001|NOT COMPLETED|Overall Study||5
10941661|NCT00369668|12112004|FG002|NOT COMPLETED|Overall Study||7
10941662|NCT00369681|12112015|FG000|STARTED|Overall Study||50
10941663|NCT00369681|12112015|FG000|COMPLETED|Overall Study||49
10941664|NCT00369681|12112015|FG000|NOT COMPLETED|Overall Study||1
10941665|NCT00369707|12112019|FG000|STARTED|Induction Part A (1 Cycle -35 Days)||42
10941666|NCT00369707|12112019|FG000|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
10941667|NCT00369707|12112019|FG000|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
10941668|NCT00369707|12112019|FG000|STARTED|Induction Part B (2 Cycles)||42
10941669|NCT00369707|12112019|FG000|COMPLETED|Induction Part B (2 Cycles)||35
10941670|NCT00369707|12112019|FG000|NOT COMPLETED|Induction Part B (2 Cycles)||7
10941671|NCT00369707|12112019|FG000|STARTED|Maintenance Period (up to 4 Cycles)||35
10941672|NCT00369707|12112019|FG000|COMPLETED|Maintenance Period (up to 4 Cycles)||27
10941673|NCT00369707|12112019|FG000|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
10941674|NCT00369707|12112019|FG000|STARTED|Follow up for 2 Years After Treatment||41
10941675|NCT00369707|12112019|FG000|COMPLETED|Follow up for 2 Years After Treatment||38
10941676|NCT00369707|12112019|FG000|NOT COMPLETED|Follow up for 2 Years After Treatment||3
10941677|NCT00369746|12112025|FG000|STARTED|Overall Study||138
10941678|NCT00369746|12112026|FG001|STARTED|Overall Study||536
10941679|NCT00369746|12112025|FG000|COMPLETED|Overall Study||138
10941680|NCT00369746|12112026|FG001|COMPLETED|Overall Study||536
10941681|NCT00369746|12112025|FG000|NOT COMPLETED|Overall Study||0
10941682|NCT00369746|12112026|FG001|NOT COMPLETED|Overall Study||0
10941683|NCT00369785|12112034|FG000|STARTED|Overall Study||99
10941684|NCT00369785|12112035|FG001|STARTED|Overall Study||99
10941685|NCT00369785|12112034|FG000|COMPLETED|Overall Study||72
10941686|NCT00369785|12112035|FG001|COMPLETED|Overall Study||74
10941687|NCT00369785|12112034|FG000|NOT COMPLETED|Overall Study||27
10941688|NCT00369785|12112035|FG001|NOT COMPLETED|Overall Study||25
10941689|NCT00369824|12112047|FG000|STARTED|Overall Study||212
10941690|NCT00369824|12112048|FG001|STARTED|Overall Study||214
10941691|NCT00369824|12112049|FG002|STARTED|Overall Study||214
10941692|NCT00369824|12112050|FG003|STARTED|Overall Study||214
10941693|NCT00369824|12112051|FG004|STARTED|Overall Study||214
10941694|NCT00369824|12112052|FG005|STARTED|Overall Study||215
10941695|NCT00369824|12112047|FG000|COMPLETED|Overall Study||197
10941696|NCT00369824|12112048|FG001|COMPLETED|Overall Study||195
10941697|NCT00369824|12112049|FG002|COMPLETED|Overall Study||202
10941698|NCT00369824|12112050|FG003|COMPLETED|Overall Study||199
10941699|NCT00369824|12112051|FG004|COMPLETED|Overall Study||196
10941700|NCT00369824|12112052|FG005|COMPLETED|Overall Study||204
10941701|NCT00369824|12112047|FG000|NOT COMPLETED|Overall Study||15
10941702|NCT00369824|12112048|FG001|NOT COMPLETED|Overall Study||19
10941703|NCT00369824|12112049|FG002|NOT COMPLETED|Overall Study||12
10941704|NCT00369824|12112050|FG003|NOT COMPLETED|Overall Study||15
10941705|NCT00369824|12112051|FG004|NOT COMPLETED|Overall Study||18
10941706|NCT00369824|12112052|FG005|NOT COMPLETED|Overall Study||11
10941707|NCT00369915|12112068|FG000|STARTED|Overall Study||10
10941708|NCT00369915|12112069|FG001|STARTED|Overall Study||7
10941709|NCT00369915|12112068|FG000|COMPLETED|Overall Study||4
10941710|NCT00369915|12112069|FG001|COMPLETED|Overall Study||4
10941711|NCT00369915|12112068|FG000|NOT COMPLETED|Overall Study||6
10941712|NCT00369915|12112069|FG001|NOT COMPLETED|Overall Study||3
10941713|NCT00369928|12112078|FG000|STARTED|Overall Study||85
10941714|NCT00369928|12112079|FG001|STARTED|Overall Study||85
10941715|NCT00369928|12112080|FG002|STARTED|Overall Study||86
10941716|NCT00369928|12112078|FG000|COMPLETED|Overall Study||77
10941717|NCT00369928|12112079|FG001|COMPLETED|Overall Study||69
10941718|NCT00369928|12112080|FG002|COMPLETED|Overall Study||66
10941719|NCT00369928|12112078|FG000|NOT COMPLETED|Overall Study||8
10941720|NCT00369928|12112079|FG001|NOT COMPLETED|Overall Study||16
10941721|NCT00369928|12112080|FG002|NOT COMPLETED|Overall Study||20
10941722|NCT00369941|12112090|FG000|STARTED|Overall Study||282
10941723|NCT00369941|12112091|FG001|STARTED|Overall Study||284
10941724|NCT00369941|12112090|FG000|Treated|Overall Study||281
10941725|NCT00369941|12112091|FG001|Treated|Overall Study||282
10941726|NCT00369941|12112090|FG000|COMPLETED|Overall Study||210
10941727|NCT00369941|12112091|FG001|COMPLETED|Overall Study||184
10941728|NCT00369941|12112090|FG000|NOT COMPLETED|Overall Study||72
10941729|NCT00369941|12112091|FG001|NOT COMPLETED|Overall Study||100
10941730|NCT00369967|12112100|FG000|STARTED|Overall Study||31
10941731|NCT00369967|12112101|FG001|STARTED|Overall Study||17
10941732|NCT00369967|12112100|FG000|COMPLETED|Overall Study||8
10941733|NCT00369967|12112101|FG001|COMPLETED|Overall Study||5
10941734|NCT00369967|12112100|FG000|NOT COMPLETED|Overall Study||23
10941735|NCT00369967|12112101|FG001|NOT COMPLETED|Overall Study||12
10941736|NCT00370032|12112113|FG000|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
10941737|NCT00370032|12112114|FG001|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
10941738|NCT00370032|12112113|FG000|COMPLETED|Treatment Period 1||24
10941739|NCT00370032|12112114|FG001|COMPLETED|Treatment Period 1||24
10941740|NCT00370032|12112113|FG000|NOT COMPLETED|Treatment Period 1||0
10941741|NCT00370032|12112114|FG001|NOT COMPLETED|Treatment Period 1||1
10941742|NCT00370032|12112113|FG000|STARTED|Washout Period||24
10941743|NCT00370032|12112114|FG001|STARTED|Washout Period||24
10941744|NCT00370032|12112113|FG000|COMPLETED|Washout Period||23
10941745|NCT00370032|12112114|FG001|COMPLETED|Washout Period||22
10941746|NCT00370032|12112113|FG000|NOT COMPLETED|Washout Period||1
10941747|NCT00370032|12112114|FG001|NOT COMPLETED|Washout Period||2
10941748|NCT00370032|12112113|FG000|STARTED|Treatment Period 2||23
10941749|NCT00370032|12112114|FG001|STARTED|Treatment Period 2||22
10941750|NCT00370032|12112113|FG000|COMPLETED|Treatment Period 2||23
10941751|NCT00370032|12112114|FG001|COMPLETED|Treatment Period 2||22
10941752|NCT00370032|12112113|FG000|NOT COMPLETED|Treatment Period 2||0
10941753|NCT00370032|12112114|FG001|NOT COMPLETED|Treatment Period 2||0
10941754|NCT00370032|12112113|FG000|STARTED|Follow-up Period||23
10941755|NCT00370032|12112114|FG001|STARTED|Follow-up Period||22
10941756|NCT00370032|12112113|FG000|COMPLETED|Follow-up Period||22
10941757|NCT00370032|12112114|FG001|COMPLETED|Follow-up Period||22
10941758|NCT00370032|12112113|FG000|NOT COMPLETED|Follow-up Period||1
10941759|NCT00370032|12112114|FG001|NOT COMPLETED|Follow-up Period||0
10941760|NCT00370071|12112129|FG000|STARTED|Overall Study||39
10941761|NCT00370071|12112129|FG000|COMPLETED|Overall Study||37
10941762|NCT00370071|12112129|FG000|NOT COMPLETED|Overall Study||2
10941763|NCT00370149|12112135|FG000|STARTED|Overall Study||165
10941764|NCT00370149|12112136|FG001|STARTED|Overall Study||161
10941765|NCT00370149|12112135|FG000|COMPLETED|Overall Study||146
10941766|NCT00370149|12112136|FG001|COMPLETED|Overall Study||142
10941767|NCT00370149|12112135|FG000|NOT COMPLETED|Overall Study||19
10941768|NCT00370149|12112136|FG001|NOT COMPLETED|Overall Study||19
10941769|NCT00370292|12112147|FG000|STARTED|Overall Study||19
10941770|NCT00370292|12112147|FG000|COMPLETED|Overall Study||6
10941771|NCT00370292|12112147|FG000|NOT COMPLETED|Overall Study||13
10941772|NCT04876274|12112160|FG000|STARTED|Overall Study||91
10941773|NCT04876274|12112161|FG001|STARTED|Overall Study||90
10941774|NCT04876274|12112160|FG000|COMPLETED|Overall Study||82
10941775|NCT04876274|12112161|FG001|COMPLETED|Overall Study||78
10941776|NCT04876274|12112160|FG000|NOT COMPLETED|Overall Study||9
10941777|NCT04876274|12112161|FG001|NOT COMPLETED|Overall Study||12
10941778|NCT04656691|12112167|FG000|STARTED|Overall Study||139
10941779|NCT04656691|12112167|FG000|COMPLETED|Overall Study||138
10941780|NCT04656691|12112167|FG000|NOT COMPLETED|Overall Study||1
10941781|NCT04615299|12112173|FG000|STARTED|Overall Study||36
10941782|NCT04615299|12112174|FG001|STARTED|Overall Study||36
10941783|NCT04615299|12112173|FG000|COMPLETED|Overall Study||36
10941784|NCT04615299|12112174|FG001|COMPLETED|Overall Study||36
10941785|NCT04615299|12112173|FG000|NOT COMPLETED|Overall Study||0
10941786|NCT04615299|12112174|FG001|NOT COMPLETED|Overall Study||0
10941787|NCT04555096|12112182|FG000|STARTED|Overall Study||9
10941788|NCT04555096|12112183|FG001|STARTED|Overall Study||7
10941789|NCT04555096|12112182|FG000|COMPLETED|Overall Study||4
10941790|NCT04555096|12112183|FG001|COMPLETED|Overall Study||2
10941791|NCT04555096|12112182|FG000|NOT COMPLETED|Overall Study||5
10941792|NCT04555096|12112183|FG001|NOT COMPLETED|Overall Study||5
10941793|NCT04150341|12112189|FG000|STARTED|Overall Study||4
10941794|NCT04150341|12112190|FG001|STARTED|Overall Study||4
10941795|NCT04150341|12112191|FG002|STARTED|Overall Study||4
10941796|NCT04150341|12112192|FG003|STARTED|Overall Study||4
10941797|NCT04150341|12112193|FG004|STARTED|Overall Study||4
10941798|NCT04150341|12112194|FG005|STARTED|Overall Study||4
10941799|NCT04150341|12112189|FG000|COMPLETED|Overall Study||4
10941800|NCT04150341|12112190|FG001|COMPLETED|Overall Study||4
10941801|NCT04150341|12112191|FG002|COMPLETED|Overall Study||3
10941802|NCT04150341|12112192|FG003|COMPLETED|Overall Study||4
10941803|NCT04150341|12112193|FG004|COMPLETED|Overall Study||3
10941804|NCT04150341|12112194|FG005|COMPLETED|Overall Study||4
10941805|NCT04150341|12112189|FG000|NOT COMPLETED|Overall Study||0
10941806|NCT04150341|12112190|FG001|NOT COMPLETED|Overall Study||0
10941807|NCT04150341|12112191|FG002|NOT COMPLETED|Overall Study||1
10941808|NCT04150341|12112192|FG003|NOT COMPLETED|Overall Study||0
10941809|NCT04150341|12112193|FG004|NOT COMPLETED|Overall Study||1
10941810|NCT04150341|12112194|FG005|NOT COMPLETED|Overall Study||0
10941811|NCT04115839|12112207|FG000|STARTED|Main Study (Up to 16 Weeks)||36
10941812|NCT04115839|12112208|FG001|STARTED|Main Study (Up to 16 Weeks)||34
10941813|NCT04115839|12112209|FG002|STARTED|Main Study (Up to 16 Weeks)||36
10941814|NCT04115839|12112210|FG003|STARTED|Main Study (Up to 16 Weeks)||0
10941815|NCT04115839|12112211|FG004|STARTED|Main Study (Up to 16 Weeks)||0
10941816|NCT04115839|12112212|FG005|STARTED|Main Study (Up to 16 Weeks)||0
10941817|NCT04115839|12112213|FG006|STARTED|Main Study (Up to 16 Weeks)||0
10941818|NCT04115839|12112207|FG000|COMPLETED|Main Study (Up to 16 Weeks)||18
10941819|NCT04115839|12112208|FG001|COMPLETED|Main Study (Up to 16 Weeks)||20
10941820|NCT04115839|12112209|FG002|COMPLETED|Main Study (Up to 16 Weeks)||18
10941821|NCT04115839|12112210|FG003|COMPLETED|Main Study (Up to 16 Weeks)||0
10941822|NCT04115839|12112211|FG004|COMPLETED|Main Study (Up to 16 Weeks)||0
10941823|NCT04115839|12112212|FG005|COMPLETED|Main Study (Up to 16 Weeks)||0
10941824|NCT04115839|12112213|FG006|COMPLETED|Main Study (Up to 16 Weeks)||0
10941825|NCT04115839|12112207|FG000|NOT COMPLETED|Main Study (Up to 16 Weeks)||18
10941826|NCT04115839|12112208|FG001|NOT COMPLETED|Main Study (Up to 16 Weeks)||14
10941827|NCT04115839|12112209|FG002|NOT COMPLETED|Main Study (Up to 16 Weeks)||18
10941828|NCT04115839|12112210|FG003|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10941829|NCT04115839|12112211|FG004|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10941830|NCT04115839|12112212|FG005|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10941831|NCT04115839|12112213|FG006|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
10941832|NCT04115839|12112207|FG000|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|0
10941833|NCT04115839|12112208|FG001|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|0
10941834|NCT04115839|12112209|FG002|STARTED|LTE Phase (After Week 16 to Week 63)|18 participants who completed main study did not enter LTE phase.|0
10941915|NCT03751098|12112272|FG000|COMPLETED|Overall Study||37
10941835|NCT04115839|12112210|FG003|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|18
10941836|NCT04115839|12112211|FG004|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|20
10941837|NCT04115839|12112212|FG005|STARTED|LTE Phase (After Week 16 to Week 63)|10 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|10
10941838|NCT04115839|12112213|FG006|STARTED|LTE Phase (After Week 16 to Week 63)|8 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|8
10941839|NCT04115839|12112207|FG000|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10941840|NCT04115839|12112208|FG001|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10941841|NCT04115839|12112209|FG002|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10941842|NCT04115839|12112210|FG003|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10941843|NCT04115839|12112211|FG004|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10941844|NCT04115839|12112212|FG005|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10941845|NCT04115839|12112213|FG006|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10941846|NCT04115839|12112207|FG000|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10941847|NCT04115839|12112208|FG001|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10941848|NCT04115839|12112209|FG002|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
10941849|NCT04115839|12112210|FG003|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||18
10941850|NCT04115839|12112211|FG004|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||20
10941851|NCT04115839|12112212|FG005|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||10
10941852|NCT04115839|12112213|FG006|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||8
10941853|NCT04078126|12112238|FG000|STARTED|Period 1||18
10941854|NCT04078126|12112239|FG001|STARTED|Period 1||17
10941855|NCT04078126|12112238|FG000|COMPLETED|Period 1||18
10941856|NCT04078126|12112239|FG001|COMPLETED|Period 1||17
10941857|NCT04078126|12112238|FG000|NOT COMPLETED|Period 1||0
10941858|NCT04078126|12112239|FG001|NOT COMPLETED|Period 1||0
10941859|NCT04078126|12112238|FG000|STARTED|Washout||18
10941860|NCT04078126|12112239|FG001|STARTED|Washout||17
10941861|NCT04078126|12112238|FG000|COMPLETED|Washout||18
10941862|NCT04078126|12112239|FG001|COMPLETED|Washout||15
10941863|NCT04078126|12112238|FG000|NOT COMPLETED|Washout||0
10941864|NCT04078126|12112239|FG001|NOT COMPLETED|Washout||2
10941865|NCT04078126|12112238|FG000|STARTED|Period 2||18
10941866|NCT04078126|12112239|FG001|STARTED|Period 2||15
10941867|NCT04078126|12112238|FG000|COMPLETED|Period 2||17
10941868|NCT04078126|12112239|FG001|COMPLETED|Period 2||14
10941869|NCT04078126|12112238|FG000|NOT COMPLETED|Period 2||1
10941870|NCT04078126|12112239|FG001|NOT COMPLETED|Period 2||1
10941871|NCT03825341|12112247|FG000|STARTED|Overall Study||0
10941872|NCT03825341|12112248|FG001|STARTED|Overall Study||1
10941873|NCT03825341|12112247|FG000|COMPLETED|Overall Study||0
10941874|NCT03825341|12112248|FG001|COMPLETED|Overall Study||0
10941875|NCT03825341|12112247|FG000|NOT COMPLETED|Overall Study||0
10941876|NCT03825341|12112248|FG001|NOT COMPLETED|Overall Study||1
10941877|NCT03751631|12112256|FG000|STARTED|Overall Study||10
10941878|NCT03751631|12112257|FG001|STARTED|Overall Study||11
10941879|NCT03751631|12112258|FG002|STARTED|Overall Study||11
10941880|NCT03751631|12112259|FG003|STARTED|Overall Study||11
10941881|NCT03751631|12112260|FG004|STARTED|Overall Study||10
10941882|NCT03751631|12112261|FG005|STARTED|Overall Study||11
10941883|NCT03751631|12112256|FG000|Received 1st Drug in Sequence|Overall Study||10
10941884|NCT03751631|12112257|FG001|Received 1st Drug in Sequence|Overall Study||11
10941885|NCT03751631|12112258|FG002|Received 1st Drug in Sequence|Overall Study||11
10941886|NCT03751631|12112259|FG003|Received 1st Drug in Sequence|Overall Study||11
10941887|NCT03751631|12112260|FG004|Received 1st Drug in Sequence|Overall Study||10
10941888|NCT03751631|12112261|FG005|Received 1st Drug in Sequence|Overall Study||11
10941889|NCT03751631|12112256|FG000|Received 2nd Drug in Sequence|Overall Study||10
10941890|NCT03751631|12112257|FG001|Received 2nd Drug in Sequence|Overall Study||11
10941891|NCT03751631|12112258|FG002|Received 2nd Drug in Sequence|Overall Study||10
10941892|NCT03751631|12112259|FG003|Received 2nd Drug in Sequence|Overall Study||10
10941893|NCT03751631|12112260|FG004|Received 2nd Drug in Sequence|Overall Study||10
10941894|NCT03751631|12112261|FG005|Received 2nd Drug in Sequence|Overall Study||11
10941895|NCT03751631|12112256|FG000|Received 3rd Drug in Sequence|Overall Study||10
10941896|NCT03751631|12112257|FG001|Received 3rd Drug in Sequence|Overall Study||11
10941897|NCT03751631|12112258|FG002|Received 3rd Drug in Sequence|Overall Study||10
10941898|NCT03751631|12112259|FG003|Received 3rd Drug in Sequence|Overall Study||10
10941899|NCT03751631|12112260|FG004|Received 3rd Drug in Sequence|Overall Study||10
10941900|NCT03751631|12112261|FG005|Received 3rd Drug in Sequence|Overall Study||11
10941901|NCT03751631|12112256|FG000|COMPLETED|Overall Study||10
10941902|NCT03751631|12112257|FG001|COMPLETED|Overall Study||11
10941903|NCT03751631|12112258|FG002|COMPLETED|Overall Study||10
10941904|NCT03751631|12112259|FG003|COMPLETED|Overall Study||10
10941905|NCT03751631|12112260|FG004|COMPLETED|Overall Study||10
10941906|NCT03751631|12112261|FG005|COMPLETED|Overall Study||11
10941907|NCT03751631|12112256|FG000|NOT COMPLETED|Overall Study||0
10941908|NCT03751631|12112257|FG001|NOT COMPLETED|Overall Study||0
10941909|NCT03751631|12112258|FG002|NOT COMPLETED|Overall Study||1
10941910|NCT03751631|12112259|FG003|NOT COMPLETED|Overall Study||1
10941911|NCT03751631|12112260|FG004|NOT COMPLETED|Overall Study||0
10941912|NCT03751631|12112261|FG005|NOT COMPLETED|Overall Study||0
10941913|NCT03751098|12112272|FG000|STARTED|Overall Study||37
10941914|NCT03751098|12112273|FG001|STARTED|Overall Study||33
10941916|NCT03751098|12112273|FG001|COMPLETED|Overall Study||32
10941917|NCT03751098|12112272|FG000|NOT COMPLETED|Overall Study||0
10941918|NCT03751098|12112273|FG001|NOT COMPLETED|Overall Study||1
10941919|NCT03673345|12112289|FG000|STARTED|Overall Study||5
10941920|NCT03673345|12112290|FG001|STARTED|Overall Study||3
10941921|NCT03673345|12112291|FG002|STARTED|Overall Study||57
10941922|NCT03673345|12112292|FG003|STARTED|Overall Study||12
10941923|NCT03673345|12112293|FG004|STARTED|Overall Study||21
10941924|NCT03673345|12112294|FG005|STARTED|Overall Study||7
10941925|NCT03673345|12112295|FG006|STARTED|Overall Study||20
10941926|NCT03673345|12112296|FG007|STARTED|Overall Study||0
10941927|NCT03673345|12112289|FG000|COMPLETED|Overall Study||3
10941928|NCT03673345|12112290|FG001|COMPLETED|Overall Study||3
10941929|NCT03673345|12112291|FG002|COMPLETED|Overall Study||48
10941930|NCT03673345|12112292|FG003|COMPLETED|Overall Study||7
10941931|NCT03673345|12112293|FG004|COMPLETED|Overall Study||19
10941932|NCT03673345|12112294|FG005|COMPLETED|Overall Study||6
10941933|NCT03673345|12112295|FG006|COMPLETED|Overall Study||20
10941934|NCT03673345|12112296|FG007|COMPLETED|Overall Study||0
10941935|NCT03673345|12112289|FG000|NOT COMPLETED|Overall Study||2
10941936|NCT03673345|12112290|FG001|NOT COMPLETED|Overall Study||0
10941937|NCT03673345|12112291|FG002|NOT COMPLETED|Overall Study||9
10941938|NCT03673345|12112292|FG003|NOT COMPLETED|Overall Study||5
10941939|NCT03673345|12112293|FG004|NOT COMPLETED|Overall Study||2
10941940|NCT03673345|12112294|FG005|NOT COMPLETED|Overall Study||1
10941941|NCT03673345|12112295|FG006|NOT COMPLETED|Overall Study||0
10941942|NCT03673345|12112296|FG007|NOT COMPLETED|Overall Study||0
10941943|NCT03418675|12112316|FG000|STARTED|Overall Study||40
10941944|NCT03418675|12112317|FG001|STARTED|Overall Study||40
10941945|NCT03418675|12112316|FG000|Completed All Baseline Measures|Overall Study||37
10941946|NCT03418675|12112317|FG001|Completed All Baseline Measures|Overall Study||40
10941947|NCT03418675|12112316|FG000|Completed One-post Randomization Visit|Overall Study||34
10941948|NCT03418675|12112317|FG001|Completed One-post Randomization Visit|Overall Study||35
10941949|NCT03418675|12112316|FG000|COMPLETED|Overall Study||25
10941950|NCT03418675|12112317|FG001|COMPLETED|Overall Study||30
10941951|NCT03418675|12112316|FG000|NOT COMPLETED|Overall Study||15
10941952|NCT03418675|12112317|FG001|NOT COMPLETED|Overall Study||10
10941953|NCT03367910|12112323|FG000|STARTED|Overall Study||1
10941954|NCT03367910|12112323|FG000|COMPLETED|Overall Study||1
10941955|NCT03367910|12112323|FG000|NOT COMPLETED|Overall Study||0
10941956|NCT03329690|12112332|FG000|STARTED|Overall Study||126
10941957|NCT03329690|12112333|FG001|STARTED|Overall Study||55
10941958|NCT03329690|12112334|FG002|STARTED|Overall Study||7
10941959|NCT03329690|12112335|FG003|STARTED|Overall Study||21
10941960|NCT03329690|12112336|FG004|STARTED|Overall Study||24
10941961|NCT03329690|12112332|FG000|Received Treatment|Overall Study||125
10941962|NCT03329690|12112333|FG001|Received Treatment|Overall Study||55
10941963|NCT03329690|12112334|FG002|Received Treatment|Overall Study||7
10941964|NCT03329690|12112335|FG003|Received Treatment|Overall Study||20
10941965|NCT03329690|12112336|FG004|Received Treatment|Overall Study||24
10941966|NCT03329690|12112332|FG000|COMPLETED|Overall Study||0
10941967|NCT03329690|12112333|FG001|COMPLETED|Overall Study||0
10941968|NCT03329690|12112334|FG002|COMPLETED|Overall Study||0
10941969|NCT03329690|12112335|FG003|COMPLETED|Overall Study||0
10941970|NCT03329690|12112336|FG004|COMPLETED|Overall Study||0
10941971|NCT03329690|12112332|FG000|NOT COMPLETED|Overall Study||126
10941972|NCT03329690|12112333|FG001|NOT COMPLETED|Overall Study||55
10941973|NCT03329690|12112334|FG002|NOT COMPLETED|Overall Study||7
10941974|NCT03329690|12112335|FG003|NOT COMPLETED|Overall Study||21
10941975|NCT03329690|12112336|FG004|NOT COMPLETED|Overall Study||24
10941976|NCT03320564|12112354|FG000|STARTED|Overall Study||2
10941977|NCT03320564|12112354|FG000|COMPLETED|Overall Study||1
10941978|NCT03320564|12112354|FG000|NOT COMPLETED|Overall Study||1
10941979|NCT03235817|12112361|FG000|STARTED|Overall Study||13
10941980|NCT03235817|12112362|FG001|STARTED|Overall Study||13
10941981|NCT03235817|12112363|FG002|STARTED|Overall Study||13
10941982|NCT03235817|12112361|FG000|COMPLETED|Overall Study||10
10941983|NCT03235817|12112362|FG001|COMPLETED|Overall Study||12
10941984|NCT03235817|12112363|FG002|COMPLETED|Overall Study||11
10941985|NCT03235817|12112361|FG000|NOT COMPLETED|Overall Study||3
10941986|NCT03235817|12112362|FG001|NOT COMPLETED|Overall Study||1
10941987|NCT03235817|12112363|FG002|NOT COMPLETED|Overall Study||2
10941988|NCT03165955|12112372|FG000|STARTED|Screening/Baseline||31
10941989|NCT03165955|12112372|FG000|COMPLETED|Screening/Baseline||28
10941990|NCT03165955|12112372|FG000|NOT COMPLETED|Screening/Baseline||3
10941991|NCT03165955|12112372|FG000|STARTED|Treatment||28
10941992|NCT03165955|12112372|FG000|COMPLETED|Treatment||20
10941993|NCT03165955|12112372|FG000|NOT COMPLETED|Treatment||8
10941994|NCT03133793|12112380|FG000|STARTED|Overall Study||39
10941995|NCT03133793|12112381|FG001|STARTED|Overall Study||39
10941996|NCT03133793|12112382|FG002|STARTED|Overall Study||37
10941997|NCT03133793|12112383|FG003|STARTED|Overall Study||38
10941998|NCT03133793|12112380|FG000|COMPLETED|Overall Study||38
10941999|NCT03133793|12112381|FG001|COMPLETED|Overall Study||35
10942000|NCT03133793|12112382|FG002|COMPLETED|Overall Study||33
10942001|NCT03133793|12112383|FG003|COMPLETED|Overall Study||33
10942002|NCT03133793|12112380|FG000|NOT COMPLETED|Overall Study||1
10942003|NCT03133793|12112381|FG001|NOT COMPLETED|Overall Study||4
10942004|NCT03133793|12112382|FG002|NOT COMPLETED|Overall Study||4
10942005|NCT03133793|12112383|FG003|NOT COMPLETED|Overall Study||5
10942006|NCT03103542|12112397|FG000|STARTED|Overall Study|18 - screened 16 - enrolled|16
10942007|NCT03103542|12112397|FG000|COMPLETED|Overall Study||9
10942008|NCT03103542|12112397|FG000|NOT COMPLETED|Overall Study||7
10942009|NCT03086317|12112404|FG000|STARTED|Overall Study||10
10942010|NCT03086317|12112405|FG001|STARTED|Overall Study||8
10942011|NCT03086317|12112404|FG000|COMPLETED|Overall Study||10
10942012|NCT03086317|12112405|FG001|COMPLETED|Overall Study||8
10942013|NCT03086317|12112404|FG000|NOT COMPLETED|Overall Study||0
10942014|NCT03086317|12112405|FG001|NOT COMPLETED|Overall Study||0
10942015|NCT02676765|12112413|FG000|STARTED|Overall Study||10
10942016|NCT02676765|12112414|FG001|STARTED|Overall Study||10
10942017|NCT02676765|12112413|FG000|COMPLETED|Overall Study||10
10942018|NCT02676765|12112414|FG001|COMPLETED|Overall Study||9
10942019|NCT02676765|12112413|FG000|NOT COMPLETED|Overall Study||0
10942020|NCT02676765|12112414|FG001|NOT COMPLETED|Overall Study||1
10942021|NCT02539563|12112422|FG000|STARTED|Overall Study||45
10942022|NCT02539563|12112423|FG001|STARTED|Overall Study||56
10942023|NCT02539563|12112422|FG000|COMPLETED|Overall Study||39
10942024|NCT02539563|12112423|FG001|COMPLETED|Overall Study||42
10942025|NCT02539563|12112422|FG000|NOT COMPLETED|Overall Study||6
10942026|NCT02539563|12112423|FG001|NOT COMPLETED|Overall Study||14
10942027|NCT02422446|12112431|FG000|STARTED|Overall Study||1
10942028|NCT02422446|12112432|FG001|STARTED|Overall Study||1
10942029|NCT02422446|12112431|FG000|COMPLETED|Overall Study||1
10942030|NCT02422446|12112432|FG001|COMPLETED|Overall Study||1
10942031|NCT02422446|12112431|FG000|NOT COMPLETED|Overall Study||0
10942032|NCT02422446|12112432|FG001|NOT COMPLETED|Overall Study||0
10942033|NCT02362451|12112440|FG000|STARTED|Overall Study||6
10942034|NCT02362451|12112441|FG001|STARTED|Overall Study||1
10942035|NCT02362451|12112440|FG000|COMPLETED|Overall Study||2
10942036|NCT02362451|12112441|FG001|COMPLETED|Overall Study||0
10942037|NCT02362451|12112440|FG000|NOT COMPLETED|Overall Study||4
10942038|NCT02362451|12112441|FG001|NOT COMPLETED|Overall Study||1
10942039|NCT02271230|12112451|FG000|STARTED|Overall Study||6463
10942040|NCT02271230|12112452|FG001|STARTED|Overall Study||6464
10942041|NCT02271230|12112453|FG002|STARTED|Overall Study||6470
10942042|NCT02271230|12112454|FG003|STARTED|Overall Study||6474
10942043|NCT02271230|12112451|FG000|COMPLETED|Overall Study||6463
10942044|NCT02271230|12112452|FG001|COMPLETED|Overall Study||6464
10942045|NCT02271230|12112453|FG002|COMPLETED|Overall Study||6470
10942046|NCT02271230|12112454|FG003|COMPLETED|Overall Study||6474
10942047|NCT02271230|12112451|FG000|NOT COMPLETED|Overall Study||0
10942048|NCT02271230|12112452|FG001|NOT COMPLETED|Overall Study||0
10942049|NCT02271230|12112453|FG002|NOT COMPLETED|Overall Study||0
10942050|NCT02271230|12112454|FG003|NOT COMPLETED|Overall Study||0
10942051|NCT02180724|12112466|FG000|STARTED|Overall Study||92
10942052|NCT02180724|12112467|FG001|STARTED|Overall Study||14
10942053|NCT02180724|12112466|FG000|Enrolled|Overall Study||92
10942054|NCT02180724|12112467|FG001|Enrolled|Overall Study||14
10942055|NCT02180724|12112466|FG000|Received Study Medication|Overall Study||92
10942056|NCT02180724|12112467|FG001|Received Study Medication|Overall Study||14
10942057|NCT02180724|12112466|FG000|Discontinued Study|Overall Study||14
10942058|NCT02180724|12112467|FG001|Discontinued Study|Overall Study||3
10942059|NCT02180724|12112466|FG000|Discontinued Treatment|Overall Study||23
10942060|NCT02180724|12112467|FG001|Discontinued Treatment|Overall Study||7
10942061|NCT02180724|12112466|FG000|COMPLETED|Overall Study||0
10942062|NCT02180724|12112467|FG001|COMPLETED|Overall Study||0
10942063|NCT02180724|12112466|FG000|NOT COMPLETED|Overall Study||92
10942064|NCT02180724|12112467|FG001|NOT COMPLETED|Overall Study||14
10942065|NCT02038777|12112481|FG000|STARTED|Overall Study||3
10942066|NCT02038777|12112482|FG001|STARTED|Overall Study||5
10942067|NCT02038777|12112483|FG002|STARTED|Overall Study||6
10942068|NCT02038777|12112484|FG003|STARTED|Overall Study||6
10942069|NCT02038777|12112485|FG004|STARTED|Overall Study||6
10942070|NCT02038777|12112486|FG005|STARTED|Overall Study||6
10942071|NCT02038777|12112487|FG006|STARTED|Overall Study||1
10942072|NCT02038777|12112488|FG007|STARTED|Overall Study||15
10942073|NCT02038777|12112481|FG000|Treated (Safety Set)|Overall Study||3
10942074|NCT02038777|12112482|FG001|Treated (Safety Set)|Overall Study||4
10942075|NCT02038777|12112483|FG002|Treated (Safety Set)|Overall Study||6
10942076|NCT02038777|12112484|FG003|Treated (Safety Set)|Overall Study||6
10942077|NCT02038777|12112485|FG004|Treated (Safety Set)|Overall Study||6
10942078|NCT02038777|12112486|FG005|Treated (Safety Set)|Overall Study||6
10942079|NCT02038777|12112487|FG006|Treated (Safety Set)|Overall Study||1
10942080|NCT02038777|12112488|FG007|Treated (Safety Set)|Overall Study||15
10942081|NCT02038777|12112481|FG000|COMPLETED|Overall Study||2
10942082|NCT02038777|12112482|FG001|COMPLETED|Overall Study||1
10942083|NCT02038777|12112483|FG002|COMPLETED|Overall Study||3
10942084|NCT02038777|12112484|FG003|COMPLETED|Overall Study||2
10942085|NCT02038777|12112485|FG004|COMPLETED|Overall Study||3
10942086|NCT02038777|12112486|FG005|COMPLETED|Overall Study||2
10942087|NCT02038777|12112487|FG006|COMPLETED|Overall Study||1
10942088|NCT02038777|12112488|FG007|COMPLETED|Overall Study||5
10942089|NCT02038777|12112481|FG000|NOT COMPLETED|Overall Study||1
10942090|NCT02038777|12112482|FG001|NOT COMPLETED|Overall Study||4
10942091|NCT02038777|12112483|FG002|NOT COMPLETED|Overall Study||3
10942092|NCT02038777|12112484|FG003|NOT COMPLETED|Overall Study||4
10942093|NCT02038777|12112485|FG004|NOT COMPLETED|Overall Study||3
10942094|NCT02038777|12112486|FG005|NOT COMPLETED|Overall Study||4
10942095|NCT02038777|12112487|FG006|NOT COMPLETED|Overall Study||0
10942096|NCT02038777|12112488|FG007|NOT COMPLETED|Overall Study||10
10942097|NCT01996449|12112507|FG000|STARTED|Period 1: First Drug||6
10942098|NCT01996449|12112508|FG001|STARTED|Period 1: First Drug||8
10942099|NCT01996449|12112507|FG000|COMPLETED|Period 1: First Drug||6
10942100|NCT01996449|12112508|FG001|COMPLETED|Period 1: First Drug||8
10942101|NCT01996449|12112507|FG000|NOT COMPLETED|Period 1: First Drug||0
10942102|NCT01996449|12112508|FG001|NOT COMPLETED|Period 1: First Drug||0
10942103|NCT01996449|12112507|FG000|STARTED|Period 2: Second Drug||6
10942104|NCT01996449|12112508|FG001|STARTED|Period 2: Second Drug||8
10942105|NCT01996449|12112507|FG000|COMPLETED|Period 2: Second Drug||6
10942106|NCT01996449|12112508|FG001|COMPLETED|Period 2: Second Drug||8
10942107|NCT01996449|12112507|FG000|NOT COMPLETED|Period 2: Second Drug||0
10942108|NCT01996449|12112508|FG001|NOT COMPLETED|Period 2: Second Drug||0
10942109|NCT01927419|12112518|FG000|STARTED|Pre-Treatment Period||95
10942110|NCT01927419|12112519|FG001|STARTED|Pre-Treatment Period||47
10942111|NCT01927419|12112518|FG000|COMPLETED|Pre-Treatment Period||94
10942112|NCT01927419|12112519|FG001|COMPLETED|Pre-Treatment Period||46
10942113|NCT01927419|12112518|FG000|NOT COMPLETED|Pre-Treatment Period||1
10942114|NCT01927419|12112519|FG001|NOT COMPLETED|Pre-Treatment Period||1
10942115|NCT01927419|12112518|FG000|STARTED|Treatment Period||94
10942116|NCT01927419|12112519|FG001|STARTED|Treatment Period||46
10942117|NCT01927419|12112518|FG000|COMPLETED|Treatment Period||0
10942118|NCT01927419|12112519|FG001|COMPLETED|Treatment Period||0
10942119|NCT01927419|12112518|FG000|NOT COMPLETED|Treatment Period||94
10942120|NCT01927419|12112519|FG001|NOT COMPLETED|Treatment Period||46
10942121|NCT01856140|12112527|FG000|STARTED|Overall Study||6
10942122|NCT01856140|12112528|FG001|STARTED|Overall Study||6
10942123|NCT01856140|12112527|FG000|COMPLETED|Overall Study||6
10942124|NCT01856140|12112528|FG001|COMPLETED|Overall Study||6
10942125|NCT01856140|12112527|FG000|NOT COMPLETED|Overall Study||0
10942126|NCT01856140|12112528|FG001|NOT COMPLETED|Overall Study||0
10942127|NCT01711879|12112536|FG000|STARTED|Overall Study||3
10942128|NCT01711879|12112537|FG001|STARTED|Overall Study||4
10942129|NCT01711879|12112536|FG000|COMPLETED|Overall Study||2
10942130|NCT01711879|12112537|FG001|COMPLETED|Overall Study||4
10942131|NCT01711879|12112536|FG000|NOT COMPLETED|Overall Study||1
10942132|NCT01711879|12112537|FG001|NOT COMPLETED|Overall Study||0
10942133|NCT01697267|12112547|FG000|STARTED|Overall Study||85
10942134|NCT01697267|12112548|FG001|STARTED|Overall Study||85
10942135|NCT01697267|12112547|FG000|Month 24|Overall Study||78
10942136|NCT01697267|12112548|FG001|Month 24|Overall Study||78
10942137|NCT01697267|12112547|FG000|COMPLETED|Overall Study||71
10942138|NCT01697267|12112548|FG001|COMPLETED|Overall Study||70
10942139|NCT01697267|12112547|FG000|NOT COMPLETED|Overall Study||14
10942140|NCT01697267|12112548|FG001|NOT COMPLETED|Overall Study||15
10942141|NCT01527149|12112554|FG000|STARTED|Overall Study||37
10942142|NCT01527149|12112554|FG000|COMPLETED|Overall Study||35
10942143|NCT01527149|12112554|FG000|NOT COMPLETED|Overall Study||2
10942144|NCT01388920|12112561|FG000|STARTED|Overall Study||1
10942145|NCT01388920|12112562|FG001|STARTED|Overall Study||1
10942146|NCT01388920|12112563|FG002|STARTED|Overall Study||0
10942147|NCT01388920|12112561|FG000|COMPLETED|Overall Study||1
10942148|NCT01388920|12112562|FG001|COMPLETED|Overall Study||1
10942149|NCT01388920|12112563|FG002|COMPLETED|Overall Study||0
10942150|NCT01388920|12112561|FG000|NOT COMPLETED|Overall Study||0
10942151|NCT01388920|12112562|FG001|NOT COMPLETED|Overall Study||0
10942152|NCT01388920|12112563|FG002|NOT COMPLETED|Overall Study||0
10942153|NCT01164202|12112573|FG000|STARTED|Overall Study||39
10942154|NCT01164202|12112574|FG001|STARTED|Overall Study||39
10942155|NCT01164202|12112573|FG000|COMPLETED|Overall Study||38
10942156|NCT01164202|12112574|FG001|COMPLETED|Overall Study||39
10942157|NCT01164202|12112573|FG000|NOT COMPLETED|Overall Study||1
10942158|NCT01164202|12112574|FG001|NOT COMPLETED|Overall Study||0
10942159|NCT00554840|12112584|FG000|STARTED|Overall Study||4
10942160|NCT00554840|12112585|FG001|STARTED|Overall Study||5
10942161|NCT00554840|12112584|FG000|COMPLETED|Overall Study||4
10942162|NCT00554840|12112585|FG001|COMPLETED|Overall Study||4
10942163|NCT00554840|12112584|FG000|NOT COMPLETED|Overall Study||0
10942164|NCT00554840|12112585|FG001|NOT COMPLETED|Overall Study||1
10942165|NCT00003656|12112595|FG000|STARTED|Overall Study||12
10942166|NCT00003656|12112596|FG001|STARTED|Overall Study||14
10942167|NCT00003656|12112595|FG000|COMPLETED|Overall Study||12
10942168|NCT00003656|12112596|FG001|COMPLETED|Overall Study||13
10942169|NCT00003656|12112595|FG000|NOT COMPLETED|Overall Study||0
10942170|NCT00003656|12112596|FG001|NOT COMPLETED|Overall Study||1
10942171|NCT00370331|12112605|FG000|STARTED|Overall Study||62
10942172|NCT00370331|12112606|FG001|STARTED|Overall Study||135
10942173|NCT00370331|12112605|FG000|COMPLETED|Overall Study||55
10942174|NCT00370331|12112606|FG001|COMPLETED|Overall Study||112
10942175|NCT00370331|12112605|FG000|NOT COMPLETED|Overall Study||7
10942176|NCT00370331|12112606|FG001|NOT COMPLETED|Overall Study||23
10942177|NCT00370396|12112615|FG000|STARTED|Overall Study||737
10942178|NCT00370396|12112616|FG001|STARTED|Overall Study||92
10942179|NCT00370396|12112617|FG002|STARTED|Overall Study||283
10942180|NCT00370396|12112615|FG000|COMPLETED|Overall Study||726
10942181|NCT00370396|12112616|FG001|COMPLETED|Overall Study||91
10942182|NCT00370396|12112617|FG002|COMPLETED|Overall Study||282
10942183|NCT00370396|12112615|FG000|NOT COMPLETED|Overall Study||11
10942184|NCT00370396|12112616|FG001|NOT COMPLETED|Overall Study||1
10942185|NCT00370396|12112617|FG002|NOT COMPLETED|Overall Study||1
10942186|NCT00370552|12112628|FG000|STARTED|Overall Study|Randomized|46
10942187|NCT00370552|12112629|FG001|STARTED|Overall Study|Randomized|45
10942188|NCT00370552|12112630|FG002|STARTED|Overall Study|Randomized|32
10942189|NCT00370552|12112628|FG000|COMPLETED|Overall Study||0
10942190|NCT00370552|12112629|FG001|COMPLETED|Overall Study||0
10942191|NCT00370552|12112630|FG002|COMPLETED|Overall Study||0
10942192|NCT00370552|12112628|FG000|NOT COMPLETED|Overall Study||46
10942193|NCT00370552|12112629|FG001|NOT COMPLETED|Overall Study||45
10942194|NCT00370552|12112630|FG002|NOT COMPLETED|Overall Study||32
10942195|NCT00370682|12112641|FG000|STARTED|Overall Study||40
10942196|NCT00370682|12112642|FG001|STARTED|Overall Study||40
10942197|NCT00370682|12112643|FG002|STARTED|Overall Study||40
10942198|NCT00370682|12112641|FG000|COMPLETED|Overall Study||40
10942199|NCT00370682|12112642|FG001|COMPLETED|Overall Study||37
10942200|NCT00370682|12112643|FG002|COMPLETED|Overall Study||39
10942201|NCT00370682|12112641|FG000|NOT COMPLETED|Overall Study||0
10942202|NCT00370682|12112642|FG001|NOT COMPLETED|Overall Study||3
10942203|NCT00370682|12112643|FG002|NOT COMPLETED|Overall Study||1
10942204|NCT00370838|12112657|FG000|STARTED|Period 1 (Days 8-50)||7
10942205|NCT00370838|12112658|FG001|STARTED|Period 1 (Days 8-50)||3
10942206|NCT00370838|12112657|FG000|COMPLETED|Period 1 (Days 8-50)||7
10942207|NCT00370838|12112658|FG001|COMPLETED|Period 1 (Days 8-50)||3
10942208|NCT00370838|12112657|FG000|NOT COMPLETED|Period 1 (Days 8-50)||0
10942209|NCT00370838|12112658|FG001|NOT COMPLETED|Period 1 (Days 8-50)||0
10942210|NCT00370838|12112657|FG000|STARTED|Washout (Days 51-64)||7
10942211|NCT00370838|12112658|FG001|STARTED|Washout (Days 51-64)||3
10942212|NCT00370838|12112657|FG000|COMPLETED|Washout (Days 51-64)||7
10942213|NCT00370838|12112658|FG001|COMPLETED|Washout (Days 51-64)||3
10942214|NCT00370838|12112657|FG000|NOT COMPLETED|Washout (Days 51-64)||0
10942215|NCT00370838|12112658|FG001|NOT COMPLETED|Washout (Days 51-64)||0
10942216|NCT00370838|12112657|FG000|STARTED|Period 2 (Days 65-107)||7
10942217|NCT00370838|12112658|FG001|STARTED|Period 2 (Days 65-107)||3
10942218|NCT00370838|12112657|FG000|COMPLETED|Period 2 (Days 65-107)||7
10942219|NCT00370838|12112658|FG001|COMPLETED|Period 2 (Days 65-107)||3
10942220|NCT00370838|12112657|FG000|NOT COMPLETED|Period 2 (Days 65-107)||0
10942221|NCT00370838|12112658|FG001|NOT COMPLETED|Period 2 (Days 65-107)||0
10942222|NCT00370838|12112657|FG000|STARTED|Taper||7
10942223|NCT00370838|12112658|FG001|STARTED|Taper||3
10942224|NCT00370838|12112657|FG000|COMPLETED|Taper||7
10942225|NCT00370838|12112658|FG001|COMPLETED|Taper||3
10942226|NCT00370838|12112657|FG000|NOT COMPLETED|Taper||0
10942227|NCT00370838|12112658|FG001|NOT COMPLETED|Taper||0
10942228|NCT00370994|12112666|FG000|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
10942229|NCT00370994|12112667|FG001|STARTED|Overall Study||60
10942230|NCT00370994|12112666|FG000|COMPLETED|Overall Study||60
10942231|NCT00370994|12112667|FG001|COMPLETED|Overall Study||60
10942232|NCT00370994|12112666|FG000|NOT COMPLETED|Overall Study||0
10942233|NCT00370994|12112667|FG001|NOT COMPLETED|Overall Study||0
10942234|NCT00371137|12112676|FG000|STARTED|Overall Study||183
10942235|NCT00371137|12112677|FG001|STARTED|Overall Study||182
10942236|NCT00371137|12112678|FG002|STARTED|Overall Study||183
10942237|NCT00371137|12112676|FG000|Treated|Overall Study||183
10942238|NCT00371137|12112677|FG001|Treated|Overall Study||182
10942239|NCT00371137|12112678|FG002|Treated|Overall Study||182
10942240|NCT00371137|12112676|FG000|COMPLETED|Overall Study||111
10942241|NCT00371137|12112677|FG001|COMPLETED|Overall Study||119
10942242|NCT00371137|12112678|FG002|COMPLETED|Overall Study||104
10942243|NCT00371137|12112676|FG000|NOT COMPLETED|Overall Study||72
10942244|NCT00371137|12112677|FG001|NOT COMPLETED|Overall Study||63
10942245|NCT00371137|12112678|FG002|NOT COMPLETED|Overall Study||79
10942246|NCT00371150|12112688|FG000|STARTED|Overall Study||40
10942247|NCT00371150|12112689|FG001|STARTED|Overall Study||6
10942248|NCT00371150|12112688|FG000|Discontinued Prior to Week 48 Visit|Overall Study||1
10942249|NCT00371150|12112689|FG001|Discontinued Prior to Week 48 Visit|Overall Study||1
10942250|NCT00371150|12112688|FG000|Discontinued at or After Week 48 Visit|Overall Study||2
10942251|NCT00371150|12112689|FG001|Discontinued at or After Week 48 Visit|Overall Study||1
10942252|NCT00371150|12112688|FG000|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|37
10942253|NCT00371150|12112689|FG001|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|4
10942254|NCT00371150|12112688|FG000|NOT COMPLETED|Overall Study||3
10942255|NCT00371150|12112689|FG001|NOT COMPLETED|Overall Study||2
10942256|NCT00371176|12112701|FG000|STARTED|Overall Study||13
10942257|NCT00371176|12112702|FG001|STARTED|Overall Study||13
10942258|NCT00371176|12112701|FG000|Completed Treatment|Overall Study||10
10942259|NCT00371176|12112702|FG001|Completed Treatment|Overall Study||9
10942260|NCT00371176|12112701|FG000|COMPLETED|Overall Study||8
10942261|NCT00371176|12112702|FG001|COMPLETED|Overall Study||5
10942262|NCT00371176|12112701|FG000|NOT COMPLETED|Overall Study||5
10942263|NCT00371176|12112702|FG001|NOT COMPLETED|Overall Study||8
10942264|NCT00371254|12112710|FG000|STARTED|Overall Study|Number of participants treated|23
10942265|NCT00371254|12112711|FG001|STARTED|Overall Study|Number of participants treated|21
10942266|NCT00371254|12112710|FG000|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
10942267|NCT00371254|12112711|FG001|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
10942268|NCT00371254|12112710|FG000|NOT COMPLETED|Overall Study||23
10942269|NCT00371254|12112711|FG001|NOT COMPLETED|Overall Study||21
10942270|NCT00371267|12112719|FG000|STARTED|Overall Study||48
10942271|NCT00371267|12112720|FG001|STARTED|Overall Study||50
10942272|NCT00371267|12112719|FG000|COMPLETED|Overall Study||39
10942273|NCT00371267|12112720|FG001|COMPLETED|Overall Study||32
10942274|NCT00371267|12112719|FG000|NOT COMPLETED|Overall Study||9
10942275|NCT00371267|12112720|FG001|NOT COMPLETED|Overall Study||18
10942276|NCT00371293|12112729|FG000|STARTED|Overall Study||58
10942277|NCT00371293|12112730|FG001|STARTED|Overall Study||61
10942278|NCT00371293|12112731|FG002|STARTED|Overall Study||62
10942279|NCT00371293|12112729|FG000|COMPLETED|Overall Study||48
10942280|NCT00371293|12112730|FG001|COMPLETED|Overall Study||42
10942281|NCT00371293|12112731|FG002|COMPLETED|Overall Study||46
10942282|NCT00371293|12112729|FG000|NOT COMPLETED|Overall Study||10
10942283|NCT00371293|12112730|FG001|NOT COMPLETED|Overall Study||19
10942284|NCT00371293|12112731|FG002|NOT COMPLETED|Overall Study||16
10942285|NCT00371345|12112742|FG000|STARTED|Overall Study||24
10942286|NCT00371345|12112743|FG001|STARTED|Overall Study||46
10942287|NCT00371345|12112742|FG000|COMPLETED|Overall Study||0
10942288|NCT00371345|12112743|FG001|COMPLETED|Overall Study||0
10942289|NCT00371345|12112742|FG000|NOT COMPLETED|Overall Study||24
10942290|NCT00371345|12112743|FG001|NOT COMPLETED|Overall Study||46
10942291|NCT00371397|12112763|FG000|STARTED|Session 1||5
10942292|NCT00371397|12112764|FG001|STARTED|Session 1||7
10942293|NCT00371397|12112765|FG002|STARTED|Session 1||5
10942294|NCT00371397|12112766|FG003|STARTED|Session 1||2
10942295|NCT00371397|12112767|FG004|STARTED|Session 1||3
10942296|NCT00371397|12112768|FG005|STARTED|Session 1||4
10942297|NCT00371397|12112769|FG006|STARTED|Session 1||4
10942298|NCT00371397|12112770|FG007|STARTED|Session 1||5
10942299|NCT00371397|12112771|FG008|STARTED|Session 1||6
10942300|NCT00371397|12112772|FG009|STARTED|Session 1||5
10942301|NCT00371397|12112773|FG010|STARTED|Session 1||4
10942302|NCT00371397|12112774|FG011|STARTED|Session 1||2
10942303|NCT00371397|12112763|FG000|COMPLETED|Session 1||4
10942304|NCT00371397|12112764|FG001|COMPLETED|Session 1||7
10942305|NCT00371397|12112765|FG002|COMPLETED|Session 1||5
10942306|NCT00371397|12112766|FG003|COMPLETED|Session 1||2
10942307|NCT00371397|12112767|FG004|COMPLETED|Session 1||3
10942308|NCT00371397|12112768|FG005|COMPLETED|Session 1||4
10942309|NCT00371397|12112769|FG006|COMPLETED|Session 1||4
10942310|NCT00371397|12112770|FG007|COMPLETED|Session 1||4
10942311|NCT00371397|12112771|FG008|COMPLETED|Session 1||6
10942312|NCT00371397|12112772|FG009|COMPLETED|Session 1||5
10942313|NCT00371397|12112773|FG010|COMPLETED|Session 1||4
10942314|NCT00371397|12112774|FG011|COMPLETED|Session 1||2
10942315|NCT00371397|12112763|FG000|NOT COMPLETED|Session 1||1
10942316|NCT00371397|12112764|FG001|NOT COMPLETED|Session 1||0
10942317|NCT00371397|12112765|FG002|NOT COMPLETED|Session 1||0
10942318|NCT00371397|12112766|FG003|NOT COMPLETED|Session 1||0
10942319|NCT00371397|12112767|FG004|NOT COMPLETED|Session 1||0
10942320|NCT00371397|12112768|FG005|NOT COMPLETED|Session 1||0
10942321|NCT00371397|12112769|FG006|NOT COMPLETED|Session 1||0
10942322|NCT00371397|12112770|FG007|NOT COMPLETED|Session 1||1
10942323|NCT00371397|12112771|FG008|NOT COMPLETED|Session 1||0
10942324|NCT00371397|12112772|FG009|NOT COMPLETED|Session 1||0
10942325|NCT00371397|12112773|FG010|NOT COMPLETED|Session 1||0
10942326|NCT00371397|12112774|FG011|NOT COMPLETED|Session 1||0
10942327|NCT00371397|12112763|FG000|STARTED|Session 2||4
10942328|NCT00371397|12112764|FG001|STARTED|Session 2||7
10942329|NCT00371397|12112765|FG002|STARTED|Session 2||5
10942330|NCT00371397|12112766|FG003|STARTED|Session 2||2
10942331|NCT00371397|12112767|FG004|STARTED|Session 2||3
10942332|NCT00371397|12112768|FG005|STARTED|Session 2||4
10942333|NCT00371397|12112769|FG006|STARTED|Session 2||4
10942334|NCT00371397|12112770|FG007|STARTED|Session 2||4
10942335|NCT00371397|12112771|FG008|STARTED|Session 2||6
10942336|NCT00371397|12112772|FG009|STARTED|Session 2||5
10942337|NCT00371397|12112773|FG010|STARTED|Session 2||4
10942338|NCT00371397|12112774|FG011|STARTED|Session 2||2
10942339|NCT00371397|12112763|FG000|COMPLETED|Session 2||4
10942340|NCT00371397|12112764|FG001|COMPLETED|Session 2||7
10942341|NCT00371397|12112765|FG002|COMPLETED|Session 2||5
10942342|NCT00371397|12112766|FG003|COMPLETED|Session 2||2
10942343|NCT00371397|12112767|FG004|COMPLETED|Session 2||3
10942344|NCT00371397|12112768|FG005|COMPLETED|Session 2||4
10942345|NCT00371397|12112769|FG006|COMPLETED|Session 2||4
10942346|NCT00371397|12112770|FG007|COMPLETED|Session 2||4
10942347|NCT00371397|12112771|FG008|COMPLETED|Session 2||6
10942348|NCT00371397|12112772|FG009|COMPLETED|Session 2||5
10942349|NCT00371397|12112773|FG010|COMPLETED|Session 2||4
10942350|NCT00371397|12112774|FG011|COMPLETED|Session 2||2
10942351|NCT00371397|12112763|FG000|NOT COMPLETED|Session 2||0
10942352|NCT00371397|12112764|FG001|NOT COMPLETED|Session 2||0
10942353|NCT00371397|12112765|FG002|NOT COMPLETED|Session 2||0
10942354|NCT00371397|12112766|FG003|NOT COMPLETED|Session 2||0
10942355|NCT00371397|12112767|FG004|NOT COMPLETED|Session 2||0
10942356|NCT00371397|12112768|FG005|NOT COMPLETED|Session 2||0
10942357|NCT00371397|12112769|FG006|NOT COMPLETED|Session 2||0
10942358|NCT00371397|12112770|FG007|NOT COMPLETED|Session 2||0
10942359|NCT00371397|12112771|FG008|NOT COMPLETED|Session 2||0
10942360|NCT00371397|12112772|FG009|NOT COMPLETED|Session 2||0
10942361|NCT00371397|12112773|FG010|NOT COMPLETED|Session 2||0
10942362|NCT00371397|12112774|FG011|NOT COMPLETED|Session 2||0
10942363|NCT00371397|12112763|FG000|STARTED|Session 3||4
10942364|NCT00371397|12112764|FG001|STARTED|Session 3||7
10942365|NCT00371397|12112765|FG002|STARTED|Session 3||5
10942366|NCT00371397|12112766|FG003|STARTED|Session 3||2
10942367|NCT00371397|12112767|FG004|STARTED|Session 3||3
10942368|NCT00371397|12112768|FG005|STARTED|Session 3||4
10942369|NCT00371397|12112769|FG006|STARTED|Session 3||4
10942370|NCT00371397|12112770|FG007|STARTED|Session 3||4
10942371|NCT00371397|12112771|FG008|STARTED|Session 3||6
10942372|NCT00371397|12112772|FG009|STARTED|Session 3||5
10942373|NCT00371397|12112773|FG010|STARTED|Session 3||4
10942374|NCT00371397|12112774|FG011|STARTED|Session 3||2
10942375|NCT00371397|12112763|FG000|COMPLETED|Session 3||4
10942376|NCT00371397|12112764|FG001|COMPLETED|Session 3||7
10942377|NCT00371397|12112765|FG002|COMPLETED|Session 3||5
10942378|NCT00371397|12112766|FG003|COMPLETED|Session 3||2
10942379|NCT00371397|12112767|FG004|COMPLETED|Session 3||3
10942380|NCT00371397|12112768|FG005|COMPLETED|Session 3||4
10942381|NCT00371397|12112769|FG006|COMPLETED|Session 3||4
10942382|NCT00371397|12112770|FG007|COMPLETED|Session 3||4
10942383|NCT00371397|12112771|FG008|COMPLETED|Session 3||6
10942384|NCT00371397|12112772|FG009|COMPLETED|Session 3||5
10942385|NCT00371397|12112773|FG010|COMPLETED|Session 3||4
10942386|NCT00371397|12112774|FG011|COMPLETED|Session 3||2
10942387|NCT00371397|12112763|FG000|NOT COMPLETED|Session 3||0
10942388|NCT00371397|12112764|FG001|NOT COMPLETED|Session 3||0
10942389|NCT00371397|12112765|FG002|NOT COMPLETED|Session 3||0
10942390|NCT00371397|12112766|FG003|NOT COMPLETED|Session 3||0
10942391|NCT00371397|12112767|FG004|NOT COMPLETED|Session 3||0
10942392|NCT00371397|12112768|FG005|NOT COMPLETED|Session 3||0
10942393|NCT00371397|12112769|FG006|NOT COMPLETED|Session 3||0
10942394|NCT00371397|12112770|FG007|NOT COMPLETED|Session 3||0
10942395|NCT00371397|12112771|FG008|NOT COMPLETED|Session 3||0
10942396|NCT00371397|12112772|FG009|NOT COMPLETED|Session 3||0
10942397|NCT00371397|12112773|FG010|NOT COMPLETED|Session 3||0
10942398|NCT00371397|12112774|FG011|NOT COMPLETED|Session 3||0
10942399|NCT00371436|12112782|FG000|STARTED|Overall Study||92
10942400|NCT00371436|12112783|FG001|STARTED|Overall Study||89
10942401|NCT00371436|12112782|FG000|COMPLETED|Overall Study||58
10942402|NCT00371436|12112783|FG001|COMPLETED|Overall Study||68
10942403|NCT00371436|12112782|FG000|NOT COMPLETED|Overall Study||34
10942404|NCT00371436|12112783|FG001|NOT COMPLETED|Overall Study||21
10942405|NCT00371449|12112789|FG000|STARTED|Overall Study||120
10942406|NCT00371449|12112789|FG000|COMPLETED|Overall Study||120
10942407|NCT00371449|12112789|FG000|NOT COMPLETED|Overall Study||0
10942408|NCT00371540|12112797|FG000|STARTED|Overall Study||112
10942409|NCT00371540|12112798|FG001|STARTED|Overall Study||96
10942410|NCT00371540|12112797|FG000|COMPLETED|Overall Study||102
10942411|NCT00371540|12112798|FG001|COMPLETED|Overall Study||87
10942412|NCT00371540|12112797|FG000|NOT COMPLETED|Overall Study||10
10942413|NCT00371540|12112798|FG001|NOT COMPLETED|Overall Study||9
10942414|NCT00371566|12112806|FG000|STARTED|Treatment Phase||36
10942415|NCT00371566|12112807|FG001|STARTED|Treatment Phase||71
10942416|NCT00371566|12112806|FG000|COMPLETED|Treatment Phase||36
10942417|NCT00371566|12112807|FG001|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
10942418|NCT00371566|12112806|FG000|NOT COMPLETED|Treatment Phase||0
10942419|NCT00371566|12112807|FG001|NOT COMPLETED|Treatment Phase||3
10942420|NCT00371566|12112806|FG000|STARTED|Chemoradiation Phase||36
10942421|NCT00371566|12112807|FG001|STARTED|Chemoradiation Phase||68
10942422|NCT00371566|12112806|FG000|COMPLETED|Chemoradiation Phase||31
10942423|NCT00371566|12112807|FG001|COMPLETED|Chemoradiation Phase||65
10942424|NCT00371566|12112806|FG000|NOT COMPLETED|Chemoradiation Phase||5
10942425|NCT00371566|12112807|FG001|NOT COMPLETED|Chemoradiation Phase||3
10942426|NCT00371566|12112806|FG000|STARTED|Follow Up Phase||31
10942427|NCT00371566|12112807|FG001|STARTED|Follow Up Phase||65
10942428|NCT00371566|12112806|FG000|COMPLETED|Follow Up Phase||28
10942429|NCT00371566|12112807|FG001|COMPLETED|Follow Up Phase||58
10942430|NCT00371566|12112806|FG000|NOT COMPLETED|Follow Up Phase||3
10942431|NCT00371566|12112807|FG001|NOT COMPLETED|Follow Up Phase||7
10942432|NCT00371631|12112813|FG000|STARTED|Overall Study||13
10942433|NCT00371631|12112813|FG000|COMPLETED|Overall Study||13
10942434|NCT00371631|12112813|FG000|NOT COMPLETED|Overall Study||0
10942435|NCT00371644|12112819|FG000|STARTED|Overall Study||72
10942436|NCT00371644|12112820|FG001|STARTED|Overall Study||57
10942437|NCT00371644|12112819|FG000|COMPLETED|Overall Study||44
10942438|NCT00371644|12112820|FG001|COMPLETED|Overall Study||44
10942439|NCT00371644|12112819|FG000|NOT COMPLETED|Overall Study||28
10942440|NCT00371644|12112820|FG001|NOT COMPLETED|Overall Study||13
10942441|NCT00371683|12112828|FG000|STARTED|DB Treatment Period-Randomized Patients||1599
10942442|NCT00371683|12112829|FG001|STARTED|DB Treatment Period-Randomized Patients||1596
10942443|NCT00371683|12112828|FG000|COMPLETED|DB Treatment Period-Randomized Patients||1509
10942444|NCT00371683|12112829|FG001|COMPLETED|DB Treatment Period-Randomized Patients||1489
10942445|NCT00371683|12112828|FG000|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
10942446|NCT00371683|12112829|FG001|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
10942447|NCT00371683|12112828|FG000|STARTED|Follow-Up Period - Randomized Patients||1553
10942448|NCT00371683|12112829|FG001|STARTED|Follow-Up Period - Randomized Patients||1533
10942449|NCT00371683|12112828|FG000|COMPLETED|Follow-Up Period - Randomized Patients||1492
10942450|NCT00371683|12112829|FG001|COMPLETED|Follow-Up Period - Randomized Patients||1461
10942451|NCT00371683|12112828|FG000|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
10942452|NCT00371683|12112829|FG001|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
10942453|NCT00371761|12112847|FG000|STARTED|Overall Study||13
10942454|NCT00371761|12112848|FG001|STARTED|Overall Study||12
10942455|NCT00371761|12112847|FG000|COMPLETED|Overall Study||5
10942456|NCT00371761|12112848|FG001|COMPLETED|Overall Study||2
10942457|NCT00371761|12112847|FG000|NOT COMPLETED|Overall Study||8
10942458|NCT00371761|12112848|FG001|NOT COMPLETED|Overall Study||10
10942459|NCT00371787|12112856|FG000|STARTED|Overall Study||26
10942460|NCT00371787|12112857|FG001|STARTED|Overall Study||12
10942461|NCT00371787|12112856|FG000|COMPLETED|Overall Study||23
10942462|NCT00371787|12112857|FG001|COMPLETED|Overall Study||11
10942463|NCT00371787|12112856|FG000|NOT COMPLETED|Overall Study||3
10942464|NCT00371787|12112857|FG001|NOT COMPLETED|Overall Study||1
10942465|NCT00371826|12112866|FG000|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
10942466|NCT00371826|12112867|FG001|STARTED|Core Phase (12 Months)||47
10942467|NCT00371826|12112868|FG002|STARTED|Core Phase (12 Months)||30
10942468|NCT00371826|12112866|FG000|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
10942469|NCT00371826|12112867|FG001|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
10942470|NCT00371826|12112868|FG002|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
10942471|NCT00371826|12112866|FG000|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
10942472|NCT00371826|12112867|FG001|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
10942473|NCT00371826|12112868|FG002|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
10942474|NCT00371826|12112866|FG000|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
10942475|NCT00371826|12112867|FG001|COMPLETED|Core Phase (12 Months)||39
10942476|NCT00371826|12112868|FG002|COMPLETED|Core Phase (12 Months)||6
10942477|NCT00371826|12112866|FG000|NOT COMPLETED|Core Phase (12 Months)||24
10942478|NCT00371826|12112867|FG001|NOT COMPLETED|Core Phase (12 Months)||8
10942479|NCT00371826|12112868|FG002|NOT COMPLETED|Core Phase (12 Months)||24
10942480|NCT00371826|12112866|FG000|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
10942481|NCT00371826|12112867|FG001|STARTED|Extension Phase (24 Months)||39
10942482|NCT00371826|12112868|FG002|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
10942483|NCT00371826|12112866|FG000|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
10942484|NCT00371826|12112867|FG001|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
10942485|NCT00371826|12112868|FG002|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
10942486|NCT00371826|12112866|FG000|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
10942487|NCT00371826|12112867|FG001|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
10942488|NCT00371826|12112868|FG002|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
10942489|NCT00371826|12112866|FG000|COMPLETED|Extension Phase (24 Months)||18
10942490|NCT00371826|12112867|FG001|COMPLETED|Extension Phase (24 Months)||29
10942491|NCT00371826|12112868|FG002|COMPLETED|Extension Phase (24 Months)||3
10942492|NCT00371826|12112866|FG000|NOT COMPLETED|Extension Phase (24 Months)||5
10942493|NCT00371826|12112867|FG001|NOT COMPLETED|Extension Phase (24 Months)||10
10942494|NCT00371826|12112868|FG002|NOT COMPLETED|Extension Phase (24 Months)||2
10942495|NCT00371839|12112879|FG000|STARTED|Overall Study||49
10942496|NCT00371839|12112880|FG001|STARTED|Overall Study||20
10942497|NCT00371839|12112881|FG002|STARTED|Overall Study||9
10942498|NCT00371839|12112879|FG000|COMPLETED|Overall Study||32
10942499|NCT00371839|12112880|FG001|COMPLETED|Overall Study||13
10942500|NCT00371839|12112881|FG002|COMPLETED|Overall Study||7
10942501|NCT00371839|12112879|FG000|NOT COMPLETED|Overall Study||17
10942502|NCT00371839|12112880|FG001|NOT COMPLETED|Overall Study||7
10942503|NCT00371839|12112881|FG002|NOT COMPLETED|Overall Study||2
10942504|NCT00371865|12112889|FG000|STARTED|Overall Study||57
10942505|NCT00371865|12112890|FG001|STARTED|Overall Study||57
10942506|NCT00371865|12112889|FG000|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
10942507|NCT00371865|12112890|FG001|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
10942508|NCT00371865|12112889|FG000|NOT COMPLETED|Overall Study||15
10942509|NCT00371865|12112890|FG001|NOT COMPLETED|Overall Study||14
10942510|NCT00372060|12112898|FG000|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
10942511|NCT00372060|12112899|FG001|STARTED|Period I - Double-blind (Weeks 0-12)||68
10942512|NCT00372060|12112898|FG000|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
10942513|NCT00372060|12112899|FG001|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
10942514|NCT00372060|12112898|FG000|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
10942515|NCT00372060|12112899|FG001|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
10942516|NCT00372060|12112898|FG000|STARTED|Period II - Open-label (Weeks 12-52)||63
10942517|NCT00372060|12112899|FG001|STARTED|Period II - Open-label (Weeks 12-52)||67
10942518|NCT00372060|12112898|FG000|COMPLETED|Period II - Open-label (Weeks 12-52)||49
10942519|NCT00372060|12112899|FG001|COMPLETED|Period II - Open-label (Weeks 12-52)||59
10942520|NCT00372060|12112898|FG000|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
10942521|NCT00372060|12112899|FG001|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
10942522|NCT00372112|12112912|FG000|STARTED|Overall Study||17
10942523|NCT00372112|12112913|FG001|STARTED|Overall Study||16
10942524|NCT00372112|12112914|FG002|STARTED|Overall Study||17
10942525|NCT00372112|12112915|FG003|STARTED|Overall Study||18
10942526|NCT00372112|12112912|FG000|COMPLETED|Overall Study||16
10942527|NCT00372112|12112913|FG001|COMPLETED|Overall Study||15
10942528|NCT00372112|12112914|FG002|COMPLETED|Overall Study||13
10942529|NCT00372112|12112915|FG003|COMPLETED|Overall Study||14
10942530|NCT00372112|12112912|FG000|NOT COMPLETED|Overall Study||1
10942531|NCT00372112|12112913|FG001|NOT COMPLETED|Overall Study||1
10942532|NCT00372112|12112914|FG002|NOT COMPLETED|Overall Study||4
10942533|NCT00372112|12112915|FG003|NOT COMPLETED|Overall Study||4
10942534|NCT00372190|12112930|FG000|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
10942535|NCT00372190|12112931|FG001|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
10942536|NCT00372190|12112930|FG000|COMPLETED|Overall Study||90
10942537|NCT00372190|12112931|FG001|COMPLETED|Overall Study||96
10942538|NCT00372190|12112930|FG000|NOT COMPLETED|Overall Study||3
10942539|NCT00372190|12112931|FG001|NOT COMPLETED|Overall Study||1
10942540|NCT00372255|12112941|FG000|STARTED|Overall Study||110
10942541|NCT00372255|12112942|FG001|STARTED|Overall Study||114
10942542|NCT00372255|12112941|FG000|COMPLETED|Overall Study||108
10942543|NCT00372255|12112942|FG001|COMPLETED|Overall Study||113
10942544|NCT00372255|12112941|FG000|NOT COMPLETED|Overall Study||2
10942545|NCT00372255|12112942|FG001|NOT COMPLETED|Overall Study||1
10942546|NCT00372385|12112953|FG000|STARTED|Overall Study||82
10942547|NCT00372385|12112954|FG001|STARTED|Overall Study||81
10942548|NCT00372385|12112955|FG002|STARTED|Overall Study||82
10942549|NCT00372385|12112956|FG003|STARTED|Overall Study||78
10942550|NCT00372385|12112953|FG000|COMPLETED|Overall Study||49
10942551|NCT00372385|12112954|FG001|COMPLETED|Overall Study||61
10942552|NCT00372385|12112955|FG002|COMPLETED|Overall Study||72
10942553|NCT00372385|12112956|FG003|COMPLETED|Overall Study||70
10942554|NCT00372385|12112953|FG000|NOT COMPLETED|Overall Study||33
10942555|NCT00372385|12112954|FG001|NOT COMPLETED|Overall Study||20
10942556|NCT00372385|12112955|FG002|NOT COMPLETED|Overall Study||10
10942557|NCT00372385|12112956|FG003|NOT COMPLETED|Overall Study||8
10942558|NCT00372411|12112970|FG000|STARTED|Overall Study||49
10942559|NCT00372411|12112971|FG001|STARTED|Overall Study||50
10942560|NCT00372411|12112972|FG002|STARTED|Overall Study||28
10942561|NCT00372411|12112970|FG000|COMPLETED|Overall Study||44
10942562|NCT00372411|12112971|FG001|COMPLETED|Overall Study||42
10942563|NCT00372411|12112972|FG002|COMPLETED|Overall Study||25
10942564|NCT00372411|12112970|FG000|NOT COMPLETED|Overall Study||5
10942565|NCT00372411|12112971|FG001|NOT COMPLETED|Overall Study||8
10942566|NCT00372411|12112972|FG002|NOT COMPLETED|Overall Study||3
10942567|NCT00372424|12112980|FG000|STARTED|Overall Study||26
10942568|NCT00372424|12112980|FG000|Treated|Overall Study||25
10942569|NCT00372424|12112980|FG000|COMPLETED|Overall Study||0
10942570|NCT00372424|12112980|FG000|NOT COMPLETED|Overall Study||26
10942571|NCT00372489|12112984|FG000|STARTED|Overall Study||81
10942572|NCT00372489|12112984|FG000|COMPLETED|Overall Study||2
10942573|NCT00372489|12112984|FG000|NOT COMPLETED|Overall Study||79
10942574|NCT00372528|12112988|FG000|STARTED|Overall Study||21
10942575|NCT00372528|12112988|FG000|COMPLETED|Overall Study||0
10942576|NCT00372528|12112988|FG000|NOT COMPLETED|Overall Study||21
10942577|NCT00372567|12112995|FG000|STARTED|Phase 1 Sub-study||0
10942578|NCT00372567|12112996|FG001|STARTED|Phase 1 Sub-study||0
10942579|NCT00372567|12112997|FG002|STARTED|Phase 1 Sub-study||12
10942580|NCT00372567|12112995|FG000|COMPLETED|Phase 1 Sub-study||0
10942581|NCT00372567|12112996|FG001|COMPLETED|Phase 1 Sub-study||0
10942582|NCT00372567|12112997|FG002|COMPLETED|Phase 1 Sub-study||12
10942583|NCT00372567|12112995|FG000|NOT COMPLETED|Phase 1 Sub-study||0
10942584|NCT00372567|12112996|FG001|NOT COMPLETED|Phase 1 Sub-study||0
10942585|NCT00372567|12112997|FG002|NOT COMPLETED|Phase 1 Sub-study||0
10942586|NCT00372567|12112995|FG000|STARTED|Phase 3 Study||31
10942587|NCT00372567|12112996|FG001|STARTED|Phase 3 Study||26
10942588|NCT00372567|12112997|FG002|STARTED|Phase 3 Study||12
10942589|NCT00372567|12112995|FG000|Received Treatment|Phase 3 Study||31
10942590|NCT00372567|12112996|FG001|Received Treatment|Phase 3 Study||25
10942591|NCT00372567|12112997|FG002|Received Treatment|Phase 3 Study||12
10942592|NCT00372567|12112995|FG000|COMPLETED|Phase 3 Study||0
10942593|NCT00372567|12112996|FG001|COMPLETED|Phase 3 Study||0
10942594|NCT00372567|12112997|FG002|COMPLETED|Phase 3 Study||0
10942595|NCT00372567|12112995|FG000|NOT COMPLETED|Phase 3 Study||31
10942596|NCT00372567|12112996|FG001|NOT COMPLETED|Phase 3 Study||26
10942597|NCT00372567|12112997|FG002|NOT COMPLETED|Phase 3 Study||12
10942598|NCT00372593|12113008|FG000|STARTED|Overall Study||531
10942599|NCT00372593|12113009|FG001|STARTED|Overall Study||532
10942600|NCT00372593|12113010|FG002|STARTED|Overall Study||7
10942601|NCT00372593|12113008|FG000|COMPLETED|Overall Study||327
10942602|NCT00372593|12113009|FG001|COMPLETED|Overall Study||334
10942603|NCT00372593|12113010|FG002|COMPLETED|Overall Study||3
10942604|NCT00372593|12113008|FG000|NOT COMPLETED|Overall Study||204
10942605|NCT00372593|12113009|FG001|NOT COMPLETED|Overall Study||198
10942606|NCT00372593|12113010|FG002|NOT COMPLETED|Overall Study||4
10942607|NCT00372619|12113026|FG000|STARTED|Overall Study||8
10942608|NCT00372619|12113027|FG001|STARTED|Overall Study||2
10942609|NCT00372619|12113028|FG002|STARTED|Overall Study||3
10942610|NCT00372619|12113029|FG003|STARTED|Overall Study||10
10942611|NCT00372619|12113030|FG004|STARTED|Overall Study||7
10942612|NCT00372619|12113031|FG005|STARTED|Overall Study||42
10942613|NCT00372619|12113032|FG006|STARTED|Overall Study||2
10942614|NCT00372619|12113026|FG000|COMPLETED|Overall Study||8
10942615|NCT00372619|12113027|FG001|COMPLETED|Overall Study||2
10942616|NCT00372619|12113028|FG002|COMPLETED|Overall Study||3
10942617|NCT00372619|12113029|FG003|COMPLETED|Overall Study||10
10942618|NCT00372619|12113030|FG004|COMPLETED|Overall Study||7
10942619|NCT00372619|12113031|FG005|COMPLETED|Overall Study||39
10942620|NCT00372619|12113032|FG006|COMPLETED|Overall Study||2
10942621|NCT00372619|12113026|FG000|NOT COMPLETED|Overall Study||0
10942622|NCT00372619|12113027|FG001|NOT COMPLETED|Overall Study||0
10942623|NCT00372619|12113028|FG002|NOT COMPLETED|Overall Study||0
10942624|NCT00372619|12113029|FG003|NOT COMPLETED|Overall Study||0
10942625|NCT00372619|12113030|FG004|NOT COMPLETED|Overall Study||0
10942626|NCT00372619|12113031|FG005|NOT COMPLETED|Overall Study||3
10942627|NCT00372619|12113032|FG006|NOT COMPLETED|Overall Study||0
10942628|NCT00372697|12113050|FG000|STARTED|Overall Study||16
10942629|NCT00372697|12113051|FG001|STARTED|Overall Study||12
10942630|NCT00372697|12113050|FG000|COMPLETED|Overall Study||15
10942631|NCT00372697|12113051|FG001|COMPLETED|Overall Study||11
10942632|NCT00372697|12113050|FG000|NOT COMPLETED|Overall Study||1
10942633|NCT00372697|12113051|FG001|NOT COMPLETED|Overall Study||1
10942634|NCT00372775|12113057|FG000|STARTED|Overall Study||66
10942635|NCT00372775|12113057|FG000|Received Treatment|Overall Study||64
10942636|NCT00372775|12113057|FG000|COMPLETED|Overall Study||3
10942637|NCT00372775|12113057|FG000|NOT COMPLETED|Overall Study||63
10942638|NCT00372905|12113061|FG000|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
10942639|NCT00372905|12113062|FG001|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
10942640|NCT00372905|12113063|FG002|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
10942641|NCT00372905|12113064|FG003|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
10942642|NCT00372905|12113061|FG000|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
10942643|NCT00372905|12113062|FG001|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
10942644|NCT00372905|12113063|FG002|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
10942645|NCT00372905|12113064|FG003|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
10942646|NCT00372905|12113061|FG000|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
10942647|NCT00372905|12113062|FG001|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
10942648|NCT00372905|12113063|FG002|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
10942649|NCT00372905|12113064|FG003|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
10942650|NCT00372905|12113061|FG000|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
10942651|NCT00372905|12113062|FG001|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
10942652|NCT00372905|12113063|FG002|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
10942653|NCT00372905|12113064|FG003|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
10942654|NCT00372905|12113061|FG000|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
10942655|NCT00372905|12113062|FG001|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
10942656|NCT00372905|12113063|FG002|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
10942657|NCT00372905|12113064|FG003|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
10942658|NCT00372905|12113061|FG000|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
10942659|NCT00372905|12113062|FG001|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
10942660|NCT00372905|12113063|FG002|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
10942661|NCT00372905|12113064|FG003|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
10942662|NCT00372905|12113061|FG000|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
10942663|NCT00372905|12113062|FG001|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
10942664|NCT00372905|12113063|FG002|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
10942665|NCT00372905|12113064|FG003|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
10942666|NCT00372905|12113061|FG000|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
10942667|NCT00372905|12113062|FG001|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
10942668|NCT00372905|12113063|FG002|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
10942669|NCT00372905|12113064|FG003|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
10942670|NCT00372905|12113061|FG000|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
10942671|NCT00372905|12113062|FG001|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
10942672|NCT00372905|12113063|FG002|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
10942673|NCT00372905|12113064|FG003|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
10942674|NCT00372905|12113061|FG000|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
10942675|NCT00372905|12113062|FG001|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
10942676|NCT00372905|12113063|FG002|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
10942677|NCT00372905|12113064|FG003|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
10942678|NCT00372905|12113061|FG000|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
10942679|NCT00372905|12113062|FG001|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
10942680|NCT00372905|12113063|FG002|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
10942681|NCT00372905|12113064|FG003|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
10942682|NCT00372905|12113061|FG000|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
10942683|NCT00372905|12113062|FG001|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
10942684|NCT00372905|12113063|FG002|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
10942685|NCT00372905|12113064|FG003|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
10942686|NCT00372905|12113061|FG000|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
10942687|NCT00372905|12113062|FG001|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
10942688|NCT00372905|12113063|FG002|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
10942689|NCT00372905|12113064|FG003|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
10942690|NCT00372905|12113061|FG000|Registered|Cohort 3: Dose Level 1.6mg/m2||0
10942691|NCT00372905|12113062|FG001|Registered|Cohort 3: Dose Level 1.6mg/m2||0
10942692|NCT00372905|12113063|FG002|Registered|Cohort 3: Dose Level 1.6mg/m2||4
10942693|NCT00372905|12113064|FG003|Registered|Cohort 3: Dose Level 1.6mg/m2||0
10942694|NCT00372905|12113061|FG000|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
10942695|NCT00372905|12113062|FG001|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
10942696|NCT00372905|12113063|FG002|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
10942697|NCT00372905|12113064|FG003|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
10942698|NCT00372905|12113061|FG000|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
10942699|NCT00372905|12113062|FG001|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
10942700|NCT00372905|12113063|FG002|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
10942701|NCT00372905|12113064|FG003|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
10942702|NCT00372905|12113061|FG000|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
10942703|NCT00372905|12113062|FG001|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
10942704|NCT00372905|12113063|FG002|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
10942705|NCT00372905|12113064|FG003|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
10942706|NCT00372905|12113061|FG000|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
10942707|NCT00372905|12113062|FG001|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
10942708|NCT00372905|12113063|FG002|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
10942709|NCT00372905|12113064|FG003|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
10942710|NCT00372905|12113061|FG000|STARTED|Expansion Phase at Dose 1.3mg/m2||0
10942711|NCT00372905|12113062|FG001|STARTED|Expansion Phase at Dose 1.3mg/m2||0
10942712|NCT00372905|12113063|FG002|STARTED|Expansion Phase at Dose 1.3mg/m2||0
10942713|NCT00372905|12113064|FG003|STARTED|Expansion Phase at Dose 1.3mg/m2||8
10942714|NCT00372905|12113061|FG000|Registration|Expansion Phase at Dose 1.3mg/m2||0
10942715|NCT00372905|12113062|FG001|Registration|Expansion Phase at Dose 1.3mg/m2||0
10942716|NCT00372905|12113063|FG002|Registration|Expansion Phase at Dose 1.3mg/m2||0
10942717|NCT00372905|12113064|FG003|Registration|Expansion Phase at Dose 1.3mg/m2||8
10942718|NCT00372905|12113061|FG000|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
10942719|NCT00372905|12113062|FG001|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
10942720|NCT00372905|12113063|FG002|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
10942721|NCT00372905|12113064|FG003|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
10942722|NCT00372905|12113061|FG000|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
10942723|NCT00372905|12113062|FG001|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
10942724|NCT00372905|12113063|FG002|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
10942725|NCT00372905|12113064|FG003|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
10942726|NCT00372905|12113061|FG000|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
10942727|NCT00372905|12113062|FG001|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
10942728|NCT00372905|12113063|FG002|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
10942729|NCT00372905|12113064|FG003|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
10942730|NCT00372905|12113061|FG000|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
10942731|NCT00372905|12113062|FG001|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
10942732|NCT00372905|12113063|FG002|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
10942733|NCT00372905|12113064|FG003|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
10942734|NCT00372905|12113061|FG000|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
10942735|NCT00372905|12113062|FG001|STARTED|Follow up Until Relapse or Progression||3
10942736|NCT00372905|12113063|FG002|STARTED|Follow up Until Relapse or Progression||3
10942737|NCT00372905|12113064|FG003|STARTED|Follow up Until Relapse or Progression||8
10942738|NCT00372905|12113061|FG000|COMPLETED|Follow up Until Relapse or Progression||3
10942739|NCT00372905|12113062|FG001|COMPLETED|Follow up Until Relapse or Progression||2
10942740|NCT00372905|12113063|FG002|COMPLETED|Follow up Until Relapse or Progression||3
10942741|NCT00372905|12113064|FG003|COMPLETED|Follow up Until Relapse or Progression||5
10942742|NCT00372905|12113061|FG000|NOT COMPLETED|Follow up Until Relapse or Progression||0
10942743|NCT00372905|12113062|FG001|NOT COMPLETED|Follow up Until Relapse or Progression||1
10942744|NCT00372905|12113063|FG002|NOT COMPLETED|Follow up Until Relapse or Progression||0
10942745|NCT00372905|12113064|FG003|NOT COMPLETED|Follow up Until Relapse or Progression||3
10942746|NCT00372957|12113077|FG000|STARTED|Overall Study||10
10942747|NCT00372957|12113078|FG001|STARTED|Overall Study||10
10942748|NCT00372957|12113079|FG002|STARTED|Overall Study||10
10942749|NCT00372957|12113077|FG000|COMPLETED|Overall Study||10
10942750|NCT00372957|12113078|FG001|COMPLETED|Overall Study||10
10942751|NCT00372957|12113079|FG002|COMPLETED|Overall Study||10
10942752|NCT00372957|12113077|FG000|NOT COMPLETED|Overall Study||0
10942753|NCT00372957|12113078|FG001|NOT COMPLETED|Overall Study||0
10942754|NCT00372957|12113079|FG002|NOT COMPLETED|Overall Study||0
10942755|NCT00372970|12113091|FG000|STARTED|Overall Study||16
10942756|NCT00372970|12113092|FG001|STARTED|Overall Study||16
10942757|NCT00372970|12113091|FG000|COMPLETED|Overall Study||16
10942758|NCT00372970|12113092|FG001|COMPLETED|Overall Study||16
10942759|NCT00372970|12113091|FG000|NOT COMPLETED|Overall Study||0
10942760|NCT00372970|12113092|FG001|NOT COMPLETED|Overall Study||0
10942761|NCT00372996|12113100|FG000|STARTED|Overall Study||79
10942762|NCT00372996|12113101|FG001|STARTED|Overall Study||36
10942763|NCT00372996|12113102|FG002|STARTED|Overall Study||61
10942764|NCT00372996|12113103|FG003|STARTED|Overall Study||43
10942765|NCT00372996|12113100|FG000|COMPLETED|Overall Study||42
10942766|NCT00372996|12113101|FG001|COMPLETED|Overall Study||22
10942767|NCT00372996|12113102|FG002|COMPLETED|Overall Study||33
10942768|NCT00372996|12113103|FG003|COMPLETED|Overall Study||23
10942769|NCT00372996|12113100|FG000|NOT COMPLETED|Overall Study||37
10942770|NCT00372996|12113101|FG001|NOT COMPLETED|Overall Study||14
10942771|NCT00372996|12113102|FG002|NOT COMPLETED|Overall Study||28
10942772|NCT00372996|12113103|FG003|NOT COMPLETED|Overall Study||20
10942773|NCT00373113|12113115|FG000|STARTED|Overall Study||238
10942774|NCT00373113|12113116|FG001|STARTED|Overall Study||244
10942775|NCT00373113|12113115|FG000|Received Treatment|Overall Study||238
10942776|NCT00373113|12113116|FG001|Received Treatment|Overall Study||240
10942777|NCT00373113|12113115|FG000|COMPLETED|Overall Study||0
10942778|NCT00373113|12113116|FG001|COMPLETED|Overall Study||0
10942779|NCT00373113|12113115|FG000|NOT COMPLETED|Overall Study||238
10942780|NCT00373113|12113116|FG001|NOT COMPLETED|Overall Study||244
10942781|NCT00373256|12113124|FG000|STARTED|Overall Study||241
10942782|NCT00373256|12113125|FG001|STARTED|Overall Study||247
10942783|NCT00373256|12113124|FG000|Treated|Overall Study||235
10942784|NCT00373256|12113125|FG001|Treated|Overall Study||236
10942785|NCT00373256|12113124|FG000|COMPLETED|Overall Study||0
10942786|NCT00373256|12113125|FG001|COMPLETED|Overall Study||0
10942787|NCT00373256|12113124|FG000|NOT COMPLETED|Overall Study||241
10942788|NCT00373256|12113125|FG001|NOT COMPLETED|Overall Study||247
10942789|NCT00373269|12113133|FG000|STARTED|Overall Study||11
10942790|NCT00373269|12113134|FG001|STARTED|Overall Study||10
10942791|NCT00373269|12113133|FG000|COMPLETED|Overall Study||11
10942792|NCT00373269|12113134|FG001|COMPLETED|Overall Study||10
10942793|NCT00373269|12113133|FG000|NOT COMPLETED|Overall Study||0
10942794|NCT00373269|12113134|FG001|NOT COMPLETED|Overall Study||0
10942795|NCT00373295|12113140|FG000|STARTED|Intervention 1 (8 Days)||2
10942796|NCT00373295|12113141|FG001|STARTED|Intervention 1 (8 Days)||3
10942797|NCT00373295|12113142|FG002|STARTED|Intervention 1 (8 Days)||1
10942798|NCT00373295|12113143|FG003|STARTED|Intervention 1 (8 Days)||2
10942799|NCT00373295|12113144|FG004|STARTED|Intervention 1 (8 Days)||3
10942800|NCT00373295|12113145|FG005|STARTED|Intervention 1 (8 Days)||2
10942801|NCT00373295|12113140|FG000|COMPLETED|Intervention 1 (8 Days)||2
10942802|NCT00373295|12113141|FG001|COMPLETED|Intervention 1 (8 Days)||1
10942803|NCT00373295|12113142|FG002|COMPLETED|Intervention 1 (8 Days)||1
10942804|NCT00373295|12113143|FG003|COMPLETED|Intervention 1 (8 Days)||2
10942805|NCT00373295|12113144|FG004|COMPLETED|Intervention 1 (8 Days)||2
10942806|NCT00373295|12113145|FG005|COMPLETED|Intervention 1 (8 Days)||2
10942807|NCT00373295|12113140|FG000|NOT COMPLETED|Intervention 1 (8 Days)||0
10942808|NCT00373295|12113141|FG001|NOT COMPLETED|Intervention 1 (8 Days)||2
10942809|NCT00373295|12113142|FG002|NOT COMPLETED|Intervention 1 (8 Days)||0
10942810|NCT00373295|12113143|FG003|NOT COMPLETED|Intervention 1 (8 Days)||0
10942811|NCT00373295|12113144|FG004|NOT COMPLETED|Intervention 1 (8 Days)||1
10942812|NCT00373295|12113145|FG005|NOT COMPLETED|Intervention 1 (8 Days)||0
10942813|NCT00373295|12113140|FG000|STARTED|Intervention 2 (8 Days)||2
10942814|NCT00373295|12113141|FG001|STARTED|Intervention 2 (8 Days)||1
10942815|NCT00373295|12113142|FG002|STARTED|Intervention 2 (8 Days)||1
10942816|NCT00373295|12113143|FG003|STARTED|Intervention 2 (8 Days)||2
10942817|NCT00373295|12113144|FG004|STARTED|Intervention 2 (8 Days)||2
10942818|NCT00373295|12113145|FG005|STARTED|Intervention 2 (8 Days)||2
10942819|NCT00373295|12113140|FG000|COMPLETED|Intervention 2 (8 Days)||2
10942820|NCT00373295|12113141|FG001|COMPLETED|Intervention 2 (8 Days)||1
10942821|NCT00373295|12113142|FG002|COMPLETED|Intervention 2 (8 Days)||1
10942822|NCT00373295|12113143|FG003|COMPLETED|Intervention 2 (8 Days)||2
10942823|NCT00373295|12113144|FG004|COMPLETED|Intervention 2 (8 Days)||2
10942824|NCT00373295|12113145|FG005|COMPLETED|Intervention 2 (8 Days)||2
10942825|NCT00373295|12113140|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0
10942826|NCT00373295|12113141|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0
10942827|NCT00373295|12113142|FG002|NOT COMPLETED|Intervention 2 (8 Days)||0
10942828|NCT00373295|12113143|FG003|NOT COMPLETED|Intervention 2 (8 Days)||0
10942829|NCT00373295|12113144|FG004|NOT COMPLETED|Intervention 2 (8 Days)||0
10942830|NCT00373295|12113145|FG005|NOT COMPLETED|Intervention 2 (8 Days)||0
10942831|NCT00373295|12113140|FG000|STARTED|Intervention 3 (8 Days)||2
10942832|NCT00373295|12113141|FG001|STARTED|Intervention 3 (8 Days)||1
10942833|NCT00373295|12113142|FG002|STARTED|Intervention 3 (8 Days)||1
10942834|NCT00373295|12113143|FG003|STARTED|Intervention 3 (8 Days)||2
10942835|NCT00373295|12113144|FG004|STARTED|Intervention 3 (8 Days)||2
10942836|NCT00373295|12113145|FG005|STARTED|Intervention 3 (8 Days)||2
10942837|NCT00373295|12113140|FG000|COMPLETED|Intervention 3 (8 Days)||2
10942838|NCT00373295|12113141|FG001|COMPLETED|Intervention 3 (8 Days)||1
10942839|NCT00373295|12113142|FG002|COMPLETED|Intervention 3 (8 Days)||1
10942840|NCT00373295|12113143|FG003|COMPLETED|Intervention 3 (8 Days)||2
10942841|NCT00373295|12113144|FG004|COMPLETED|Intervention 3 (8 Days)||2
10942842|NCT00373295|12113145|FG005|COMPLETED|Intervention 3 (8 Days)||2
10942843|NCT00373295|12113140|FG000|NOT COMPLETED|Intervention 3 (8 Days)||0
10942844|NCT00373295|12113141|FG001|NOT COMPLETED|Intervention 3 (8 Days)||0
10942845|NCT00373295|12113142|FG002|NOT COMPLETED|Intervention 3 (8 Days)||0
10942846|NCT00373295|12113143|FG003|NOT COMPLETED|Intervention 3 (8 Days)||0
10942847|NCT00373295|12113144|FG004|NOT COMPLETED|Intervention 3 (8 Days)||0
10942848|NCT00373295|12113145|FG005|NOT COMPLETED|Intervention 3 (8 Days)||0
10942849|NCT00373334|12113156|FG000|STARTED|Overall Study||43
10942850|NCT00373334|12113157|FG001|STARTED|Overall Study||50
10942851|NCT00373334|12113158|FG002|STARTED|Overall Study||45
10942852|NCT00373334|12113156|FG000|COMPLETED|Overall Study||33
10942853|NCT00373334|12113157|FG001|COMPLETED|Overall Study||32
10942854|NCT00373334|12113158|FG002|COMPLETED|Overall Study||32
10942855|NCT00373334|12113156|FG000|NOT COMPLETED|Overall Study||10
10942856|NCT00373334|12113157|FG001|NOT COMPLETED|Overall Study||18
10942857|NCT00373334|12113158|FG002|NOT COMPLETED|Overall Study||13
10942858|NCT00373360|12113166|FG000|STARTED|Overall Study||10
10942859|NCT00373360|12113166|FG000|COMPLETED|Overall Study||10
10942860|NCT00373360|12113166|FG000|NOT COMPLETED|Overall Study||0
10942861|NCT00373386|12113170|FG000|STARTED|Overall Study||9
10942862|NCT00373386|12113170|FG000|COMPLETED|Overall Study||9
10942863|NCT00373386|12113170|FG000|NOT COMPLETED|Overall Study||0
10942864|NCT00373399|12113176|FG000|STARTED|Overall Study||5
10942865|NCT00373399|12113177|FG001|STARTED|Overall Study||7
10942866|NCT00373399|12113178|FG002|STARTED|Overall Study||4
10942867|NCT00373399|12113179|FG003|STARTED|Overall Study||6
10942868|NCT00373399|12113180|FG004|STARTED|Overall Study||7
10942869|NCT00373399|12113181|FG005|STARTED|Overall Study||7
10942870|NCT00373399|12113176|FG000|COMPLETED|Overall Study||5
10942871|NCT00373399|12113177|FG001|COMPLETED|Overall Study||7
10942872|NCT00373399|12113178|FG002|COMPLETED|Overall Study||4
10942873|NCT00373399|12113179|FG003|COMPLETED|Overall Study||6
10942874|NCT00373399|12113180|FG004|COMPLETED|Overall Study||7
10942875|NCT00373399|12113181|FG005|COMPLETED|Overall Study||7
10942876|NCT00373399|12113176|FG000|NOT COMPLETED|Overall Study||0
10942877|NCT00373399|12113177|FG001|NOT COMPLETED|Overall Study||0
10942878|NCT00373399|12113178|FG002|NOT COMPLETED|Overall Study||0
10942879|NCT00373399|12113179|FG003|NOT COMPLETED|Overall Study||0
10942880|NCT00373399|12113180|FG004|NOT COMPLETED|Overall Study||0
10942881|NCT00373399|12113181|FG005|NOT COMPLETED|Overall Study||0
10942882|NCT00373425|12113194|FG000|STARTED|Overall Study||623
10942883|NCT00373425|12113195|FG001|STARTED|Overall Study||350
10942884|NCT00373425|12113196|FG002|STARTED|Overall Study||134
10942885|NCT00373425|12113197|FG003|STARTED|Overall Study||11
10942886|NCT00373425|12113198|FG004|STARTED|Overall Study||132
10942887|NCT00373425|12113194|FG000|Received Treatment|Overall Study||612
10942888|NCT00373425|12113195|FG001|Received Treatment|Overall Study||342
10942889|NCT00373425|12113196|FG002|Received Treatment|Overall Study||134
10942890|NCT00373425|12113197|FG003|Received Treatment|Overall Study||7
10942891|NCT00373425|12113198|FG004|Received Treatment|Overall Study||132
10942892|NCT00373425|12113194|FG000|COMPLETED|Overall Study|Completed 2 years of study treatment|253
10942893|NCT00373425|12113195|FG001|COMPLETED|Overall Study|Completed 2 years of study treatment|197
10942894|NCT00373425|12113196|FG002|COMPLETED|Overall Study|Completed 2 years of study treatment|0
10942895|NCT00373425|12113197|FG003|COMPLETED|Overall Study|Completed 2 years of study treatment|0
10942896|NCT00373425|12113198|FG004|COMPLETED|Overall Study|Completed 2 years of study treatment|60
10942897|NCT00373425|12113194|FG000|NOT COMPLETED|Overall Study||370
10942898|NCT00373425|12113195|FG001|NOT COMPLETED|Overall Study||153
10942899|NCT00373425|12113196|FG002|NOT COMPLETED|Overall Study||134
10942900|NCT00373425|12113197|FG003|NOT COMPLETED|Overall Study||11
10942901|NCT00373425|12113198|FG004|NOT COMPLETED|Overall Study||72
10942902|NCT00373490|12113209|FG000|STARTED|Overall Study||10
10942903|NCT00373490|12113210|FG001|STARTED|Overall Study||6
10942904|NCT00373490|12113209|FG000|COMPLETED|Overall Study||1
10942905|NCT00373490|12113210|FG001|COMPLETED|Overall Study||0
10942906|NCT00373490|12113209|FG000|NOT COMPLETED|Overall Study||9
10942907|NCT00373490|12113210|FG001|NOT COMPLETED|Overall Study||6
10942908|NCT00373529|12113216|FG000|STARTED|Overall Study||116
10942909|NCT00373529|12113216|FG000|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
10942910|NCT00373529|12113216|FG000|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
10942911|NCT00373529|12113216|FG000|NOT COMPLETED|Overall Study||108
10942912|NCT00373685|12113222|FG000|STARTED|Overall Study||4035
10942913|NCT00373685|12113223|FG001|STARTED|Overall Study||4032
10942914|NCT00373685|12113222|FG000|Treated|Overall Study||3984
10942915|NCT00373685|12113223|FG001|Treated|Overall Study||3955
10942916|NCT00373685|12113222|FG000|COMPLETED|Overall Study||2596
10942917|NCT00373685|12113223|FG001|COMPLETED|Overall Study||2611
10942918|NCT00373685|12113222|FG000|NOT COMPLETED|Overall Study||1439
10942919|NCT00373685|12113223|FG001|NOT COMPLETED|Overall Study||1421
10942920|NCT00373698|12113231|FG000|STARTED|Overall Study||96
10942921|NCT00373698|12113232|FG001|STARTED|Overall Study||99
10942922|NCT00373698|12113231|FG000|COMPLETED|Overall Study||85
10942923|NCT00373698|12113232|FG001|COMPLETED|Overall Study||99
10942924|NCT00373698|12113231|FG000|NOT COMPLETED|Overall Study||11
10942925|NCT00373698|12113232|FG001|NOT COMPLETED|Overall Study||0
10942926|NCT00373880|12113240|FG000|STARTED|Overall Study||26
10942927|NCT00373880|12113240|FG000|COMPLETED|Overall Study||8
10942928|NCT00373880|12113240|FG000|NOT COMPLETED|Overall Study||18
10942929|NCT00373958|12113254|FG000|STARTED|Infant Series|One participant was prerandomized but not consented.|334
10942930|NCT00373958|12113255|FG001|STARTED|Infant Series||332
10942931|NCT00373958|12113254|FG000|Vaccinated Dose 1|Infant Series||332
10942932|NCT00373958|12113255|FG001|Vaccinated Dose 1|Infant Series||331
10942933|NCT00373958|12113254|FG000|Vaccinated Dose 2|Infant Series||309
10942934|NCT00373958|12113255|FG001|Vaccinated Dose 2|Infant Series||305
10942935|NCT00373958|12113254|FG000|Vaccinated Dose 3|Infant Series||298
10942936|NCT00373958|12113255|FG001|Vaccinated Dose 3|Infant Series||300
10942937|NCT00373958|12113254|FG000|COMPLETED|Infant Series||294
10942938|NCT00373958|12113255|FG001|COMPLETED|Infant Series||290
10942939|NCT00373958|12113254|FG000|NOT COMPLETED|Infant Series||40
10942940|NCT00373958|12113255|FG001|NOT COMPLETED|Infant Series||42
10942941|NCT00373958|12113254|FG000|STARTED|Toddler Dose||294
10942942|NCT00373958|12113255|FG001|STARTED|Toddler Dose||290
10942943|NCT00373958|12113254|FG000|Withdrawn After Infant Series|Toddler Dose||22
10942944|NCT00373958|12113255|FG001|Withdrawn After Infant Series|Toddler Dose||25
10942945|NCT00373958|12113254|FG000|Vaccinated Toddler Dose|Toddler Dose||272
10942946|NCT00373958|12113255|FG001|Vaccinated Toddler Dose|Toddler Dose||265
10942947|NCT00373958|12113254|FG000|COMPLETED|Toddler Dose||264
10942948|NCT00373958|12113255|FG001|COMPLETED|Toddler Dose||252
10942949|NCT00373958|12113254|FG000|NOT COMPLETED|Toddler Dose||30
10942950|NCT00373958|12113255|FG001|NOT COMPLETED|Toddler Dose||38
10942951|NCT00374088|12113286|FG000|STARTED|Overall Study||10
10942952|NCT00374088|12113287|FG001|STARTED|Overall Study||11
10942953|NCT00374088|12113286|FG000|COMPLETED|Overall Study||9
10942954|NCT00374088|12113287|FG001|COMPLETED|Overall Study||10
10942955|NCT00374088|12113286|FG000|NOT COMPLETED|Overall Study||1
10942956|NCT00374088|12113287|FG001|NOT COMPLETED|Overall Study||1
10942957|NCT00374127|12113293|FG000|STARTED|Overall Study||35
10942958|NCT00374127|12113293|FG000|COMPLETED|Overall Study||24
10942959|NCT00374127|12113293|FG000|NOT COMPLETED|Overall Study||11
10942960|NCT00374140|12113303|FG000|STARTED|Overall Study||40
10942961|NCT00374140|12113303|FG000|COMPLETED|Overall Study||38
10942962|NCT00374140|12113303|FG000|NOT COMPLETED|Overall Study||2
10942963|NCT00374231|12113307|FG000|STARTED|Overall Study||40
10942964|NCT00374231|12113307|FG000|COMPLETED|Overall Study||40
10942965|NCT00374231|12113307|FG000|NOT COMPLETED|Overall Study||0
10942966|NCT00374244|12113314|FG000|STARTED|Overall Study||14
10942967|NCT00374244|12113315|FG001|STARTED|Overall Study||14
10942968|NCT00374244|12113314|FG000|COMPLETED|Overall Study||14
10942969|NCT00374244|12113315|FG001|COMPLETED|Overall Study||14
10942970|NCT00374244|12113314|FG000|NOT COMPLETED|Overall Study||0
10942971|NCT00374244|12113315|FG001|NOT COMPLETED|Overall Study||0
10942972|NCT00374322|12113323|FG000|STARTED|Overall Study||1579
10942973|NCT00374322|12113324|FG001|STARTED|Overall Study||1582
10942974|NCT00374322|12113323|FG000|Received >=1 Dose of Study Treatment|Overall Study||1571
10942975|NCT00374322|12113324|FG001|Received >=1 Dose of Study Treatment|Overall Study||1576
10942976|NCT00374322|12113323|FG000|COMPLETED|Overall Study||322
10942977|NCT00374322|12113324|FG001|COMPLETED|Overall Study||278
10942978|NCT00374322|12113323|FG000|NOT COMPLETED|Overall Study||1257
10942979|NCT00374322|12113324|FG001|NOT COMPLETED|Overall Study||1304
10942980|NCT00374335|12113331|FG000|STARTED|Overall Study||261
10942981|NCT00374335|12113331|FG000|COMPLETED|Overall Study||261
10942982|NCT00374335|12113331|FG000|NOT COMPLETED|Overall Study||0
10942983|NCT00374452|12113337|FG000|STARTED|Overall Study||34
10942984|NCT00374452|12113338|FG001|STARTED|Overall Study||48
10942985|NCT00374452|12113337|FG000|Intervention Started|Overall Study||30
10942986|NCT00374452|12113338|FG001|Intervention Started|Overall Study||46
10942987|NCT00374452|12113337|FG000|COMPLETED|Overall Study||29
10942988|NCT00374452|12113338|FG001|COMPLETED|Overall Study||43
10942989|NCT00374452|12113337|FG000|NOT COMPLETED|Overall Study||5
10942990|NCT00374452|12113338|FG001|NOT COMPLETED|Overall Study||5
10942991|NCT00374556|12113346|FG000|STARTED|Overall Study||14
10942992|NCT00374556|12113347|FG001|STARTED|Overall Study||16
10942993|NCT00374556|12113346|FG000|COMPLETED|Overall Study||13
10942994|NCT00374556|12113347|FG001|COMPLETED|Overall Study||15
10942995|NCT00374556|12113346|FG000|NOT COMPLETED|Overall Study||1
10942996|NCT00374556|12113347|FG001|NOT COMPLETED|Overall Study||1
10942997|NCT00374803|12113355|FG000|STARTED|Overall Study||22
10942998|NCT00374803|12113356|FG001|STARTED|Overall Study||23
10942999|NCT00374803|12113355|FG000|COMPLETED|Overall Study||22
10943000|NCT00374803|12113356|FG001|COMPLETED|Overall Study||23
10943001|NCT00374803|12113355|FG000|NOT COMPLETED|Overall Study||0
10943002|NCT00374803|12113356|FG001|NOT COMPLETED|Overall Study||0
10943003|NCT00374842|12113367|FG000|STARTED|Overall Study||100
10943004|NCT00374842|12113368|FG001|STARTED|Overall Study||100
10943005|NCT00374842|12113369|FG002|STARTED|Overall Study||100
10943006|NCT00374842|12113367|FG000|COMPLETED|Overall Study||100
10943007|NCT00374842|12113368|FG001|COMPLETED|Overall Study||100
10943008|NCT00374842|12113369|FG002|COMPLETED|Overall Study||100
10943009|NCT00374842|12113367|FG000|NOT COMPLETED|Overall Study||0
10943010|NCT00374842|12113368|FG001|NOT COMPLETED|Overall Study||0
10943011|NCT00374842|12113369|FG002|NOT COMPLETED|Overall Study||0
10943012|NCT00374868|12113379|FG000|STARTED|Overall Study||38
10943013|NCT00374868|12113379|FG000|COMPLETED|Overall Study||2
10943014|NCT00374868|12113379|FG000|NOT COMPLETED|Overall Study||36
10943015|NCT00374907|12113385|FG000|STARTED|12-Week Short-term Period||20
10943016|NCT00374907|12113386|FG001|STARTED|12-Week Short-term Period||16
10943017|NCT00374907|12113385|FG000|COMPLETED|12-Week Short-term Period||17
10943018|NCT00374907|12113386|FG001|COMPLETED|12-Week Short-term Period||15
10943019|NCT00374907|12113385|FG000|NOT COMPLETED|12-Week Short-term Period||3
10943020|NCT00374907|12113386|FG001|NOT COMPLETED|12-Week Short-term Period||1
10943021|NCT00374907|12113385|FG000|STARTED|116-Week Short-term + Long-term Period||20
10943022|NCT00374907|12113386|FG001|STARTED|116-Week Short-term + Long-term Period||16
10943023|NCT00374907|12113385|FG000|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
10943024|NCT00374907|12113386|FG001|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
10943025|NCT00374907|12113385|FG000|COMPLETED|116-Week Short-term + Long-term Period||7
10943026|NCT00374907|12113386|FG001|COMPLETED|116-Week Short-term + Long-term Period||2
10943027|NCT00374907|12113385|FG000|NOT COMPLETED|116-Week Short-term + Long-term Period||13
10943028|NCT00374907|12113386|FG001|NOT COMPLETED|116-Week Short-term + Long-term Period||14
10943029|NCT00375167|12113396|FG000|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16
10943030|NCT00375167|12113397|FG001|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17
10943031|NCT00375167|12113396|FG000|COMPLETED|Overall Study||16
10943032|NCT00375167|12113397|FG001|COMPLETED|Overall Study||17
10943033|NCT00375167|12113396|FG000|NOT COMPLETED|Overall Study||0
10943034|NCT00375167|12113397|FG001|NOT COMPLETED|Overall Study||0
10943035|NCT00375219|12113408|FG000|STARTED|Overall Study||62
10943036|NCT00375219|12113409|FG001|STARTED|Overall Study||20
10943037|NCT00375219|12113410|FG002|STARTED|Overall Study||21
10943038|NCT00375219|12113408|FG000|COMPLETED|Overall Study||3
10943039|NCT00375219|12113409|FG001|COMPLETED|Overall Study||0
10943040|NCT00375219|12113410|FG002|COMPLETED|Overall Study||0
10943041|NCT00375219|12113408|FG000|NOT COMPLETED|Overall Study||59
10943042|NCT00375219|12113409|FG001|NOT COMPLETED|Overall Study||20
10943043|NCT00375219|12113410|FG002|NOT COMPLETED|Overall Study||21
10943044|NCT00375427|12113419|FG000|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
10943045|NCT00375427|12113420|FG001|STARTED|Overall Study||216
10943046|NCT00375427|12113419|FG000|COMPLETED|Overall Study||149
10943047|NCT00375427|12113420|FG001|COMPLETED|Overall Study||142
10943048|NCT00375427|12113419|FG000|NOT COMPLETED|Overall Study||60
10943049|NCT00375427|12113420|FG001|NOT COMPLETED|Overall Study||74
10943050|NCT00375492|12113428|FG000|STARTED|Overall Study||96
10943051|NCT00375492|12113429|FG001|STARTED|Overall Study||98
10943052|NCT00375492|12113428|FG000|COMPLETED|Overall Study||70
10943053|NCT00375492|12113429|FG001|COMPLETED|Overall Study||72
10943054|NCT00375492|12113428|FG000|NOT COMPLETED|Overall Study||26
10943055|NCT00375492|12113429|FG001|NOT COMPLETED|Overall Study||26
10943056|NCT00375505|12113437|FG000|STARTED|Overall Study||36
10943057|NCT00375505|12113438|FG001|STARTED|Overall Study||34
10943058|NCT00375505|12113437|FG000|COMPLETED|Overall Study||35
10943059|NCT00375505|12113438|FG001|COMPLETED|Overall Study||32
10943060|NCT00375505|12113437|FG000|NOT COMPLETED|Overall Study||1
10943061|NCT00375505|12113438|FG001|NOT COMPLETED|Overall Study||2
10943062|NCT00375518|12113446|FG000|STARTED|Overall Study||80
10943063|NCT00375518|12113447|FG001|STARTED|Overall Study||82
10943064|NCT00375518|12113446|FG000|COMPLETED|Overall Study||72
10943065|NCT00375518|12113447|FG001|COMPLETED|Overall Study||65
10943066|NCT00375518|12113446|FG000|NOT COMPLETED|Overall Study||8
10943067|NCT00375518|12113447|FG001|NOT COMPLETED|Overall Study||17
10943068|NCT00375609|12113456|FG000|STARTED|Overall Study||88
10943069|NCT00375609|12113457|FG001|STARTED|Overall Study||84
10943070|NCT00375609|12113458|FG002|STARTED|Overall Study||43
10943071|NCT00375609|12113456|FG000|COMPLETED|Overall Study||84
10943072|NCT00375609|12113457|FG001|COMPLETED|Overall Study||77
10943073|NCT00375609|12113458|FG002|COMPLETED|Overall Study||42
10943074|NCT00375609|12113456|FG000|NOT COMPLETED|Overall Study||4
10943075|NCT00375609|12113457|FG001|NOT COMPLETED|Overall Study||7
10943076|NCT00375609|12113458|FG002|NOT COMPLETED|Overall Study||1
10943077|NCT00375674|12113468|FG000|STARTED|Overall Study||309
10943078|NCT00375674|12113469|FG001|STARTED|Overall Study||306
10943079|NCT00375674|12113468|FG000|Intent-to-Treat Population|Overall Study||309
10943080|NCT00375674|12113469|FG001|Intent-to-Treat Population|Overall Study||306
10943081|NCT00375674|12113468|FG000|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
10943082|NCT00375674|12113469|FG001|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
10943083|NCT00375674|12113468|FG000|COMPLETED|Overall Study||165
10943084|NCT00375674|12113469|FG001|COMPLETED|Overall Study||165
10943085|NCT00375674|12113468|FG000|NOT COMPLETED|Overall Study||144
10943086|NCT00375674|12113469|FG001|NOT COMPLETED|Overall Study||141
10943087|NCT00375713|12113477|FG000|STARTED|Overall Study|Randomized population (N=232).|232
10943088|NCT00375713|12113478|FG001|STARTED|Overall Study|Randomized population (N=234).|234
10943089|NCT00375713|12113477|FG000|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
10943090|NCT00375713|12113478|FG001|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
10943091|NCT00375713|12113477|FG000|NOT COMPLETED|Overall Study||20
10943092|NCT00375713|12113478|FG001|NOT COMPLETED|Overall Study||23
10943093|NCT00375752|12113486|FG000|STARTED|Overall Study||79
10943094|NCT00375752|12113487|FG001|STARTED|Overall Study||89
10943095|NCT00375752|12113486|FG000|COMPLETED|Overall Study||67
10943096|NCT00375752|12113487|FG001|COMPLETED|Overall Study||74
10943097|NCT00375752|12113486|FG000|NOT COMPLETED|Overall Study||12
10943098|NCT00375752|12113487|FG001|NOT COMPLETED|Overall Study||15
10943099|NCT00375830|12113496|FG000|STARTED|Overall Study||10
10943100|NCT00375830|12113497|FG001|STARTED|Overall Study||30
10943101|NCT00375830|12113498|FG002|STARTED|Overall Study||74
10943102|NCT00375830|12113496|FG000|COMPLETED|Overall Study||10
10943103|NCT00375830|12113497|FG001|COMPLETED|Overall Study||30
10943104|NCT00375830|12113498|FG002|COMPLETED|Overall Study||74
10943105|NCT00375830|12113496|FG000|NOT COMPLETED|Overall Study||0
10943106|NCT00375830|12113497|FG001|NOT COMPLETED|Overall Study||0
10943107|NCT00375830|12113498|FG002|NOT COMPLETED|Overall Study||0
10943108|NCT00375934|12113520|FG000|STARTED|Overall Study||99
10943109|NCT00375934|12113521|FG001|STARTED|Overall Study||101
10943110|NCT00375934|12113520|FG000|COMPLETED|Overall Study||96
10943111|NCT00375934|12113521|FG001|COMPLETED|Overall Study||95
10943112|NCT00375934|12113520|FG000|NOT COMPLETED|Overall Study||3
10943113|NCT00375934|12113521|FG001|NOT COMPLETED|Overall Study||6
10943114|NCT00375973|12113529|FG000|STARTED|Overall Study||30
10943115|NCT00375973|12113530|FG001|STARTED|Overall Study||30
10943116|NCT00375973|12113529|FG000|COMPLETED|Overall Study||20
10943117|NCT00375973|12113530|FG001|COMPLETED|Overall Study||28
10943118|NCT00375973|12113529|FG000|NOT COMPLETED|Overall Study||10
10943119|NCT00375973|12113530|FG001|NOT COMPLETED|Overall Study||2
10943120|NCT00375999|12113536|FG000|STARTED|Overall Study||34
10943121|NCT00375999|12113536|FG000|COMPLETED|Overall Study||32
10943122|NCT00375999|12113536|FG000|NOT COMPLETED|Overall Study||2
10943123|NCT00376168|12113542|FG000|STARTED|Overall Study||16
10943124|NCT00376168|12113543|FG001|STARTED|Overall Study|One patient randomized but not treated|16
10943125|NCT00376168|12113542|FG000|COMPLETED|Overall Study||14
10943126|NCT00376168|12113543|FG001|COMPLETED|Overall Study||15
10943127|NCT00376168|12113542|FG000|NOT COMPLETED|Overall Study||2
10943128|NCT00376168|12113543|FG001|NOT COMPLETED|Overall Study||1
10943129|NCT00376220|12113551|FG000|STARTED|Overall Study||47
10943130|NCT00376220|12113552|FG001|STARTED|Overall Study||47
10943131|NCT00376220|12113551|FG000|COMPLETED|Overall Study||37
10943132|NCT00376220|12113552|FG001|COMPLETED|Overall Study||35
10943133|NCT00376220|12113551|FG000|NOT COMPLETED|Overall Study||10
10943134|NCT00376220|12113552|FG001|NOT COMPLETED|Overall Study||12
10943135|NCT00376246|12113558|FG000|STARTED|First Intervention (2 Weeks)||14
10943136|NCT00376246|12113559|FG001|STARTED|First Intervention (2 Weeks)||14
10943137|NCT00376246|12113558|FG000|COMPLETED|First Intervention (2 Weeks)||10
10943138|NCT00376246|12113559|FG001|COMPLETED|First Intervention (2 Weeks)||12
10943139|NCT00376246|12113558|FG000|NOT COMPLETED|First Intervention (2 Weeks)||4
10943140|NCT00376246|12113559|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2
10943141|NCT00376246|12113558|FG000|STARTED|Washout (2 Weeks)||10
10943142|NCT00376246|12113559|FG001|STARTED|Washout (2 Weeks)||12
10943143|NCT00376246|12113558|FG000|COMPLETED|Washout (2 Weeks)||10
10943144|NCT00376246|12113559|FG001|COMPLETED|Washout (2 Weeks)||12
10943145|NCT00376246|12113558|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10943146|NCT00376246|12113559|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10943147|NCT00376246|12113558|FG000|STARTED|Second Intervention (2 Weeks)||10
10943148|NCT00376246|12113559|FG001|STARTED|Second Intervention (2 Weeks)||12
10943149|NCT00376246|12113558|FG000|COMPLETED|Second Intervention (2 Weeks)||10
10943150|NCT00376246|12113559|FG001|COMPLETED|Second Intervention (2 Weeks)||12
10943151|NCT00376246|12113558|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10943152|NCT00376246|12113559|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10943153|NCT00376259|12113569|FG000|STARTED|Overall Study||22
10943154|NCT00376259|12113570|FG001|STARTED|Overall Study||21
10943155|NCT00376259|12113569|FG000|Received Study Drug|Overall Study||21
10943156|NCT00376259|12113570|FG001|Received Study Drug|Overall Study||21
10943157|NCT00376259|12113569|FG000|COMPLETED|Overall Study||0
10943158|NCT00376259|12113570|FG001|COMPLETED|Overall Study||0
10943159|NCT00376259|12113569|FG000|NOT COMPLETED|Overall Study||22
10943160|NCT00376259|12113570|FG001|NOT COMPLETED|Overall Study||21
10943161|NCT00376363|12113578|FG000|STARTED|Overall Study||143
10943162|NCT00376363|12113579|FG001|STARTED|Overall Study||133
10943163|NCT00376363|12113578|FG000|COMPLETED|Overall Study||87
10943164|NCT00376363|12113579|FG001|COMPLETED|Overall Study||87
10943165|NCT00376363|12113578|FG000|NOT COMPLETED|Overall Study||56
10943166|NCT00376363|12113579|FG001|NOT COMPLETED|Overall Study||46
10943167|NCT00376506|12113587|FG000|STARTED|Overall Study||4
10943168|NCT00376506|12113588|FG001|STARTED|Overall Study||6
10943169|NCT00376506|12113587|FG000|COMPLETED|Overall Study||4
10943170|NCT00376506|12113588|FG001|COMPLETED|Overall Study||4
10943171|NCT00376506|12113587|FG000|NOT COMPLETED|Overall Study||0
10943172|NCT00376506|12113588|FG001|NOT COMPLETED|Overall Study||2
10943173|NCT00376532|12113599|FG000|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
10943174|NCT00376532|12113600|FG001|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
10943175|NCT00376532|12113599|FG000|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
10943176|NCT00376532|12113600|FG001|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
10943177|NCT00376532|12113599|FG000|NOT COMPLETED|Overall Study||6
10943178|NCT00376532|12113600|FG001|NOT COMPLETED|Overall Study||6
10943179|NCT00376558|12113608|FG000|STARTED|Overall Study||25
10943180|NCT00376558|12113609|FG001|STARTED|Overall Study||25
10943181|NCT00376558|12113608|FG000|COMPLETED|Overall Study||25
10943182|NCT00376558|12113609|FG001|COMPLETED|Overall Study||25
10943183|NCT00376558|12113608|FG000|NOT COMPLETED|Overall Study||0
10943184|NCT00376558|12113609|FG001|NOT COMPLETED|Overall Study||0
10943185|NCT00376597|12113618|FG000|STARTED|Overall Study||253
10943186|NCT00376597|12113619|FG001|STARTED|Overall Study||315
10943187|NCT00376597|12113618|FG000|COMPLETED|Overall Study||242
10943188|NCT00376597|12113619|FG001|COMPLETED|Overall Study||312
10943189|NCT00376597|12113618|FG000|NOT COMPLETED|Overall Study||11
10943190|NCT00376597|12113619|FG001|NOT COMPLETED|Overall Study||3
10943191|NCT00376675|12113629|FG000|STARTED|Overall Study||69
10943192|NCT00376675|12113630|FG001|STARTED|Overall Study||70
10943193|NCT00376675|12113629|FG000|COMPLETED|Overall Study||49
10943194|NCT00376675|12113630|FG001|COMPLETED|Overall Study||56
10943195|NCT00376675|12113629|FG000|NOT COMPLETED|Overall Study||20
10943196|NCT00376675|12113630|FG001|NOT COMPLETED|Overall Study||14
10943197|NCT00376688|12113636|FG000|STARTED|Overall Study||31
10943198|NCT00376688|12113636|FG000|COMPLETED|Overall Study||27
10943199|NCT00376688|12113636|FG000|NOT COMPLETED|Overall Study||4
10943200|NCT00376805|12113640|FG000|STARTED|Overall Study||6
10943201|NCT00376805|12113640|FG000|COMPLETED|Overall Study||6
10943202|NCT00376805|12113640|FG000|NOT COMPLETED|Overall Study||0
10943203|NCT00376935|12113648|FG000|STARTED|Overall Study||25
10943204|NCT00376935|12113649|FG001|STARTED|Overall Study||25
10943205|NCT00376935|12113650|FG002|STARTED|Overall Study||25
10943206|NCT00376935|12113651|FG003|STARTED|Overall Study||24
10943207|NCT00376935|12113648|FG000|COMPLETED|Overall Study||25
10943208|NCT00376935|12113649|FG001|COMPLETED|Overall Study||25
10943209|NCT00376935|12113650|FG002|COMPLETED|Overall Study||25
10943210|NCT00376935|12113651|FG003|COMPLETED|Overall Study||24
10943211|NCT00376935|12113648|FG000|NOT COMPLETED|Overall Study||0
10943212|NCT00376935|12113649|FG001|NOT COMPLETED|Overall Study||0
10943213|NCT00376935|12113650|FG002|NOT COMPLETED|Overall Study||0
10943214|NCT00376935|12113651|FG003|NOT COMPLETED|Overall Study||0
10943215|NCT00376948|12113661|FG000|STARTED|Overall Study||20
10943216|NCT00376948|12113661|FG000|COMPLETED|Overall Study||20
10943217|NCT00376948|12113661|FG000|NOT COMPLETED|Overall Study||0
10943218|NCT00376961|12113665|FG000|STARTED|Initial Registration||68
10943219|NCT00376961|12113666|FG001|STARTED|Initial Registration||0
10943220|NCT00376961|12113665|FG000|Eligible|Initial Registration||65
10943221|NCT00376961|12113666|FG001|Eligible|Initial Registration||0
10943222|NCT00376961|12113665|FG000|COMPLETED|Initial Registration||61
10943223|NCT00376961|12113666|FG001|COMPLETED|Initial Registration||0
10943224|NCT00376961|12113665|FG000|NOT COMPLETED|Initial Registration||7
10943225|NCT00376961|12113666|FG001|NOT COMPLETED|Initial Registration||0
10943226|NCT00376961|12113665|FG000|STARTED|Maintenance||0
10943227|NCT00376961|12113666|FG001|STARTED|Maintenance||50
10943228|NCT00376961|12113665|FG000|Eligible|Maintenance||0
10943229|NCT00376961|12113666|FG001|Eligible|Maintenance||47
10943230|NCT00376961|12113665|FG000|COMPLETED|Maintenance||0
10943231|NCT00376961|12113666|FG001|COMPLETED|Maintenance||27
10943232|NCT00376961|12113665|FG000|NOT COMPLETED|Maintenance||0
10943233|NCT00376961|12113666|FG001|NOT COMPLETED|Maintenance||23
10943234|NCT00377234|12113676|FG000|STARTED|Overall Study||180
10943235|NCT00377234|12113677|FG001|STARTED|Overall Study||176
10943236|NCT00377234|12113676|FG000|Randomized|Overall Study||180
10943237|NCT00377234|12113677|FG001|Randomized|Overall Study||176
10943238|NCT00377234|12113676|FG000|Did Not Receive Study Treatment|Overall Study||3
10943239|NCT00377234|12113677|FG001|Did Not Receive Study Treatment|Overall Study||2
10943240|NCT00377234|12113676|FG000|Received Treatment|Overall Study||177
10943241|NCT00377234|12113677|FG001|Received Treatment|Overall Study||174
10943242|NCT00377234|12113676|FG000|Safety Analysis Set: Period 1|Overall Study||177
10943243|NCT00377234|12113677|FG001|Safety Analysis Set: Period 1|Overall Study||174
10943244|NCT00377234|12113676|FG000|Safety Analysis Set: Period 2|Overall Study||153
10943245|NCT00377234|12113677|FG001|Safety Analysis Set: Period 2|Overall Study||150
10943246|NCT00377234|12113676|FG000|Safety Analysis Set: Ibandronate|Overall Study||177
10943247|NCT00377234|12113677|FG001|Safety Analysis Set: Ibandronate|Overall Study||150
10943248|NCT00377234|12113676|FG000|Safety Analysis Set: Risedronate|Overall Study||153
10943249|NCT00377234|12113677|FG001|Safety Analysis Set: Risedronate|Overall Study||174
10943250|NCT00377234|12113676|FG000|COMPLETED|Overall Study||146
10943251|NCT00377234|12113677|FG001|COMPLETED|Overall Study||145
10943252|NCT00377234|12113676|FG000|NOT COMPLETED|Overall Study||34
10943253|NCT00377234|12113677|FG001|NOT COMPLETED|Overall Study||31
10943254|NCT00377260|12113691|FG000|STARTED|Overall Study||144
10943255|NCT00377260|12113692|FG001|STARTED|Overall Study||147
10943256|NCT00377260|12113691|FG000|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
10943257|NCT00377260|12113692|FG001|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
10943258|NCT00377260|12113691|FG000|NOT COMPLETED|Overall Study||2
10943259|NCT00377260|12113692|FG001|NOT COMPLETED|Overall Study||5
10943260|NCT00377299|12113700|FG000|STARTED|Overall Study||32
10943261|NCT00377299|12113701|FG001|STARTED|Overall Study||28
10943262|NCT00377299|12113700|FG000|COMPLETED|Overall Study||13
10943263|NCT00377299|12113701|FG001|COMPLETED|Overall Study||4
10943264|NCT00377299|12113700|FG000|NOT COMPLETED|Overall Study||19
10943265|NCT00377299|12113701|FG001|NOT COMPLETED|Overall Study||24
10943266|NCT00377312|12113710|FG000|STARTED|Overall Study||6
10943267|NCT00377312|12113711|FG001|STARTED|Overall Study||5
10943268|NCT00377312|12113710|FG000|COMPLETED|Overall Study||5
10943269|NCT00377312|12113711|FG001|COMPLETED|Overall Study||4
10943270|NCT00377312|12113710|FG000|NOT COMPLETED|Overall Study||1
10943271|NCT00377312|12113711|FG001|NOT COMPLETED|Overall Study||1
10943272|NCT00377364|12113719|FG000|STARTED|Overall Study||16
10943273|NCT00377364|12113720|FG001|STARTED|Overall Study||14
10943274|NCT00377364|12113719|FG000|COMPLETED|Overall Study||14
10943275|NCT00377364|12113720|FG001|COMPLETED|Overall Study||14
10943276|NCT00377364|12113719|FG000|NOT COMPLETED|Overall Study||2
10943277|NCT00377364|12113720|FG001|NOT COMPLETED|Overall Study||0
10943278|NCT00377403|12113730|FG000|STARTED|Overall Study||85
10943279|NCT00377403|12113731|FG001|STARTED|Overall Study||81
10943280|NCT00377403|12113730|FG000|Day -3 Assessment|Overall Study||81
10943281|NCT00377403|12113731|FG001|Day -3 Assessment|Overall Study||74
10943282|NCT00377403|12113730|FG000|Day 7 Assessment|Overall Study||80
10943283|NCT00377403|12113731|FG001|Day 7 Assessment|Overall Study||75
10943284|NCT00377403|12113730|FG000|Day 10 Assessment|Overall Study||81
10943285|NCT00377403|12113731|FG001|Day 10 Assessment|Overall Study||71
10943286|NCT00377403|12113730|FG000|Day 28 Assessment|Overall Study||82
10943287|NCT00377403|12113731|FG001|Day 28 Assessment|Overall Study||77
10943288|NCT00377403|12113730|FG000|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
10943289|NCT00377403|12113731|FG001|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
10943290|NCT00377403|12113730|FG000|NOT COMPLETED|Overall Study||4
10943291|NCT00377403|12113731|FG001|NOT COMPLETED|Overall Study||7
10943292|NCT00377429|12113737|FG000|STARTED|Overall Study|Treated|47
10943293|NCT00377429|12113737|FG000|COMPLETED|Overall Study|Completed main study|32
10943294|NCT00377429|12113737|FG000|NOT COMPLETED|Overall Study||15
10943295|NCT00377520|12113741|FG000|STARTED|Overall Study||27
10943296|NCT00377520|12113741|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
10943297|NCT00377520|12113741|FG000|NOT COMPLETED|Overall Study||1
10943298|NCT00377572|12113747|FG000|STARTED|Overall Study||208
10943299|NCT00377572|12113748|FG001|STARTED|Overall Study||211
10943300|NCT00377572|12113747|FG000|COMPLETED|Overall Study||155
10943301|NCT00377572|12113748|FG001|COMPLETED|Overall Study||157
10943302|NCT00377572|12113747|FG000|NOT COMPLETED|Overall Study||53
10943303|NCT00377572|12113748|FG001|NOT COMPLETED|Overall Study||54
10943304|NCT00377611|12113756|FG000|STARTED|Overall Study||1047
10943305|NCT00377611|12113757|FG001|STARTED|Overall Study||2007
10943306|NCT00377611|12113756|FG000|COMPLETED|Overall Study||1025
10943307|NCT00377611|12113757|FG001|COMPLETED|Overall Study||1974
10943308|NCT00377611|12113756|FG000|NOT COMPLETED|Overall Study||22
10943309|NCT00377611|12113757|FG001|NOT COMPLETED|Overall Study||33
10943310|NCT00377637|12113768|FG000|STARTED|Induction Phase|Intent-To-Treat|185
10943311|NCT00377637|12113769|FG001|STARTED|Induction Phase|Intent-To-Treat|185
10943312|NCT00377637|12113770|FG002|STARTED|Induction Phase||0
10943313|NCT00377637|12113771|FG003|STARTED|Induction Phase||0
10943314|NCT00377637|12113768|FG000|Safety Population|Induction Phase||180
10943315|NCT00377637|12113769|FG001|Safety Population|Induction Phase||184
10943316|NCT00377637|12113770|FG002|Safety Population|Induction Phase||0
10943317|NCT00377637|12113771|FG003|Safety Population|Induction Phase||0
10943318|NCT00377637|12113768|FG000|COMPLETED|Induction Phase||156
10943319|NCT00377637|12113769|FG001|COMPLETED|Induction Phase||150
10943320|NCT00377637|12113770|FG002|COMPLETED|Induction Phase||0
10943321|NCT00377637|12113771|FG003|COMPLETED|Induction Phase||0
10943322|NCT00377637|12113768|FG000|NOT COMPLETED|Induction Phase||29
10943323|NCT00377637|12113769|FG001|NOT COMPLETED|Induction Phase||35
10943324|NCT00377637|12113770|FG002|NOT COMPLETED|Induction Phase||0
10943325|NCT00377637|12113771|FG003|NOT COMPLETED|Induction Phase||0
10943326|NCT00377637|12113768|FG000|STARTED|Maintenance Phase||0
10943327|NCT00377637|12113769|FG001|STARTED|Maintenance Phase||0
10943328|NCT00377637|12113770|FG002|STARTED|Maintenance Phase||116
10943329|NCT00377637|12113771|FG003|STARTED|Maintenance Phase||111
10943330|NCT00377637|12113768|FG000|COMPLETED|Maintenance Phase||0
10943331|NCT00377637|12113769|FG001|COMPLETED|Maintenance Phase||0
10943332|NCT00377637|12113770|FG002|COMPLETED|Maintenance Phase||73
10943333|NCT00377637|12113771|FG003|COMPLETED|Maintenance Phase||54
10943334|NCT00377637|12113768|FG000|NOT COMPLETED|Maintenance Phase||0
10943335|NCT00377637|12113769|FG001|NOT COMPLETED|Maintenance Phase||0
10943336|NCT00377637|12113770|FG002|NOT COMPLETED|Maintenance Phase||43
10943337|NCT00377637|12113771|FG003|NOT COMPLETED|Maintenance Phase||57
10943338|NCT00377676|12113787|FG000|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
10943339|NCT00377676|12113788|FG001|STARTED|Overall Study||1016
10943340|NCT00377676|12113787|FG000|COMPLETED|Overall Study||1093
10943341|NCT00377676|12113788|FG001|COMPLETED|Overall Study||694
10943342|NCT00377676|12113787|FG000|NOT COMPLETED|Overall Study||961
10943343|NCT00377676|12113788|FG001|NOT COMPLETED|Overall Study||322
10943344|NCT00377741|12113796|FG000|STARTED|Overall Study||16
10943345|NCT00377741|12113797|FG001|STARTED|Overall Study||15
10943346|NCT00377741|12113796|FG000|COMPLETED|Overall Study||16
10943347|NCT00377741|12113797|FG001|COMPLETED|Overall Study||15
10943348|NCT00377741|12113796|FG000|NOT COMPLETED|Overall Study||0
10943349|NCT00377741|12113797|FG001|NOT COMPLETED|Overall Study||0
10943350|NCT00377819|12113805|FG000|STARTED|Overall Study||251
10943351|NCT00377819|12113806|FG001|STARTED|Overall Study||253
10943352|NCT00377819|12113805|FG000|Received Study Medication|Overall Study||249
10943353|NCT00377819|12113806|FG001|Received Study Medication|Overall Study||253
10943354|NCT00377819|12113805|FG000|COMPLETED|Overall Study||238
10943355|NCT00377819|12113806|FG001|COMPLETED|Overall Study||243
10943356|NCT00377819|12113805|FG000|NOT COMPLETED|Overall Study||13
10943357|NCT00377819|12113806|FG001|NOT COMPLETED|Overall Study||10
10943358|NCT00377832|12113814|FG000|STARTED|Overall Study||7
10943359|NCT00377832|12113815|FG001|STARTED|Overall Study||6
10943360|NCT00377832|12113814|FG000|COMPLETED|Overall Study||7
10943361|NCT00377832|12113815|FG001|COMPLETED|Overall Study||6
10943362|NCT00377832|12113814|FG000|NOT COMPLETED|Overall Study||0
10943363|NCT00377832|12113815|FG001|NOT COMPLETED|Overall Study||0
10943364|NCT00377858|12113826|FG000|STARTED|Overall Study||242
10943365|NCT00377858|12113827|FG001|STARTED|Overall Study||242
10943366|NCT00377858|12113826|FG000|Had at Least One Post-Baseline Value|Overall Study||239
10943367|NCT00377858|12113827|FG001|Had at Least One Post-Baseline Value|Overall Study||240
10943368|NCT00377858|12113826|FG000|COMPLETED|Overall Study||211
10943369|NCT00377858|12113827|FG001|COMPLETED|Overall Study||215
10943370|NCT00377858|12113826|FG000|NOT COMPLETED|Overall Study||31
10943371|NCT00377858|12113827|FG001|NOT COMPLETED|Overall Study||27
10943372|NCT00377962|12113835|FG000|STARTED|Core Study: 0-12 Months||140
10943373|NCT00377962|12113836|FG001|STARTED|Core Study: 0-12 Months||142
10943374|NCT00377962|12113835|FG000|COMPLETED|Core Study: 0-12 Months||112
10943375|NCT00377962|12113836|FG001|COMPLETED|Core Study: 0-12 Months||133
10943376|NCT00377962|12113835|FG000|NOT COMPLETED|Core Study: 0-12 Months||28
10943377|NCT00377962|12113836|FG001|NOT COMPLETED|Core Study: 0-12 Months||9
10943378|NCT00377962|12113835|FG000|STARTED|Extension Study: 12-24 Months||108
10943379|NCT00377962|12113836|FG001|STARTED|Extension Study: 12-24 Months||127
10943380|NCT00377962|12113835|FG000|COMPLETED|Extension Study: 12-24 Months||98
10943381|NCT00377962|12113836|FG001|COMPLETED|Extension Study: 12-24 Months||123
10943382|NCT00377962|12113835|FG000|NOT COMPLETED|Extension Study: 12-24 Months||10
10943383|NCT00377962|12113836|FG001|NOT COMPLETED|Extension Study: 12-24 Months||4
10943384|NCT00378014|12113850|FG000|STARTED|Core (Randomization to Month 11)||101
10943385|NCT00378014|12113851|FG001|STARTED|Core (Randomization to Month 11)||102
10943386|NCT00378014|12113850|FG000|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
10943387|NCT00378014|12113851|FG001|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
10943388|NCT00378014|12113850|FG000|COMPLETED|Core (Randomization to Month 11)||87
10943389|NCT00378014|12113851|FG001|COMPLETED|Core (Randomization to Month 11)||90
10943390|NCT00378014|12113850|FG000|NOT COMPLETED|Core (Randomization to Month 11)||14
10943391|NCT00378014|12113851|FG001|NOT COMPLETED|Core (Randomization to Month 11)||12
10943392|NCT00378014|12113850|FG000|STARTED|Extension (Month 12 to Month 59)||41
10943393|NCT00378014|12113851|FG001|STARTED|Extension (Month 12 to Month 59)||40
10943394|NCT00378014|12113850|FG000|COMPLETED|Extension (Month 12 to Month 59)||27
10943395|NCT00378014|12113851|FG001|COMPLETED|Extension (Month 12 to Month 59)||26
10943396|NCT00378014|12113850|FG000|NOT COMPLETED|Extension (Month 12 to Month 59)||14
10943397|NCT00378014|12113851|FG001|NOT COMPLETED|Extension (Month 12 to Month 59)||14
10943398|NCT00378079|12113862|FG000|STARTED|Overall Study||70
10943399|NCT00378079|12113863|FG001|STARTED|Overall Study||70
10943400|NCT00378079|12113864|FG002|STARTED|Overall Study||71
10943401|NCT00378079|12113862|FG000|COMPLETED|Overall Study||64
10943402|NCT00378079|12113863|FG001|COMPLETED|Overall Study||69
10943403|NCT00378079|12113864|FG002|COMPLETED|Overall Study||71
10943404|NCT00378079|12113862|FG000|NOT COMPLETED|Overall Study||6
10943405|NCT00378079|12113863|FG001|NOT COMPLETED|Overall Study||1
10943406|NCT00378079|12113864|FG002|NOT COMPLETED|Overall Study||0
10943407|NCT00378105|12113874|FG000|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
10943408|NCT00378105|12113875|FG001|STARTED|Overall Study||35
10943409|NCT00378105|12113874|FG000|COMPLETED|Overall Study||11
10943410|NCT00378105|12113875|FG001|COMPLETED|Overall Study||5
10943411|NCT00378105|12113874|FG000|NOT COMPLETED|Overall Study||20
10943412|NCT00378105|12113875|FG001|NOT COMPLETED|Overall Study||30
10943413|NCT00378209|12113882|FG000|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
10943414|NCT00378209|12113882|FG000|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
10943415|NCT00378209|12113882|FG000|NOT COMPLETED|Overall Study||22
10943416|NCT00378326|12113887|FG000|STARTED|Overall Study||26
10943417|NCT00378326|12113887|FG000|COMPLETED|Overall Study||26
10943418|NCT00378326|12113887|FG000|NOT COMPLETED|Overall Study||0
10943419|NCT00378352|12113895|FG000|STARTED|Dose Escalation 15,000 Units||20
10943420|NCT00378352|12113896|FG001|STARTED|Dose Escalation 15,000 Units||0
10943421|NCT00378352|12113897|FG002|STARTED|Dose Escalation 15,000 Units||0
10943422|NCT00378352|12113898|FG003|STARTED|Dose Escalation 15,000 Units||11
10943423|NCT00378352|12113899|FG004|STARTED|Dose Escalation 15,000 Units||0
10943424|NCT00378352|12113900|FG005|STARTED|Dose Escalation 15,000 Units||0
10943425|NCT00378352|12113895|FG000|Safety Analysis|Dose Escalation 15,000 Units||19
10943426|NCT00378352|12113896|FG001|Safety Analysis|Dose Escalation 15,000 Units||0
10943427|NCT00378352|12113897|FG002|Safety Analysis|Dose Escalation 15,000 Units||0
10943428|NCT00378352|12113898|FG003|Safety Analysis|Dose Escalation 15,000 Units||11
10943429|NCT00378352|12113899|FG004|Safety Analysis|Dose Escalation 15,000 Units||0
10943430|NCT00378352|12113900|FG005|Safety Analysis|Dose Escalation 15,000 Units||0
10943431|NCT00378352|12113895|FG000|COMPLETED|Dose Escalation 15,000 Units||15
10943432|NCT00378352|12113896|FG001|COMPLETED|Dose Escalation 15,000 Units||0
10943433|NCT00378352|12113897|FG002|COMPLETED|Dose Escalation 15,000 Units||0
10943434|NCT00378352|12113898|FG003|COMPLETED|Dose Escalation 15,000 Units||10
10943435|NCT00378352|12113899|FG004|COMPLETED|Dose Escalation 15,000 Units||0
10943436|NCT00378352|12113900|FG005|COMPLETED|Dose Escalation 15,000 Units||0
10943437|NCT00378352|12113895|FG000|NOT COMPLETED|Dose Escalation 15,000 Units||5
10943438|NCT00378352|12113896|FG001|NOT COMPLETED|Dose Escalation 15,000 Units||0
10943439|NCT00378352|12113897|FG002|NOT COMPLETED|Dose Escalation 15,000 Units||0
10943440|NCT00378352|12113898|FG003|NOT COMPLETED|Dose Escalation 15,000 Units||1
10943441|NCT00378352|12113899|FG004|NOT COMPLETED|Dose Escalation 15,000 Units||0
10943442|NCT00378352|12113900|FG005|NOT COMPLETED|Dose Escalation 15,000 Units||0
10943443|NCT00378352|12113895|FG000|STARTED|Dose Escalation 30,000 Units||0
10943444|NCT00378352|12113896|FG001|STARTED|Dose Escalation 30,000 Units||19
10943445|NCT00378352|12113897|FG002|STARTED|Dose Escalation 30,000 Units||0
10943446|NCT00378352|12113898|FG003|STARTED|Dose Escalation 30,000 Units||11
10943447|NCT00378352|12113899|FG004|STARTED|Dose Escalation 30,000 Units||0
10943448|NCT00378352|12113900|FG005|STARTED|Dose Escalation 30,000 Units||0
10943449|NCT00378352|12113895|FG000|Safety Analysis|Dose Escalation 30,000 Units||0
10943450|NCT00378352|12113896|FG001|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
10943451|NCT00378352|12113897|FG002|Safety Analysis|Dose Escalation 30,000 Units||0
10943452|NCT00378352|12113898|FG003|Safety Analysis|Dose Escalation 30,000 Units||11
10943453|NCT00378352|12113899|FG004|Safety Analysis|Dose Escalation 30,000 Units||0
10943454|NCT00378352|12113900|FG005|Safety Analysis|Dose Escalation 30,000 Units||0
10943455|NCT00378352|12113895|FG000|COMPLETED|Dose Escalation 30,000 Units||0
10943456|NCT00378352|12113896|FG001|COMPLETED|Dose Escalation 30,000 Units||16
10943457|NCT00378352|12113897|FG002|COMPLETED|Dose Escalation 30,000 Units||0
10943458|NCT00378352|12113898|FG003|COMPLETED|Dose Escalation 30,000 Units||9
10943459|NCT00378352|12113899|FG004|COMPLETED|Dose Escalation 30,000 Units||0
10943460|NCT00378352|12113900|FG005|COMPLETED|Dose Escalation 30,000 Units||0
10943461|NCT00378352|12113895|FG000|NOT COMPLETED|Dose Escalation 30,000 Units||0
10943462|NCT00378352|12113896|FG001|NOT COMPLETED|Dose Escalation 30,000 Units||3
10943463|NCT00378352|12113897|FG002|NOT COMPLETED|Dose Escalation 30,000 Units||0
10943464|NCT00378352|12113898|FG003|NOT COMPLETED|Dose Escalation 30,000 Units||2
10943465|NCT00378352|12113899|FG004|NOT COMPLETED|Dose Escalation 30,000 Units||0
10943466|NCT00378352|12113900|FG005|NOT COMPLETED|Dose Escalation 30,000 Units||0
10943467|NCT00378352|12113895|FG000|STARTED|Dose Escalation 60,000 Units||0
10943468|NCT00378352|12113896|FG001|STARTED|Dose Escalation 60,000 Units||0
10943469|NCT00378352|12113897|FG002|STARTED|Dose Escalation 60,000 Units||20
10943470|NCT00378352|12113898|FG003|STARTED|Dose Escalation 60,000 Units||11
10943471|NCT00378352|12113899|FG004|STARTED|Dose Escalation 60,000 Units||0
10943472|NCT00378352|12113900|FG005|STARTED|Dose Escalation 60,000 Units||0
10943473|NCT00378352|12113895|FG000|Safety Analysis|Dose Escalation 60,000 Units||0
10943474|NCT00378352|12113896|FG001|Safety Analysis|Dose Escalation 60,000 Units||0
10943475|NCT00378352|12113897|FG002|Safety Analysis|Dose Escalation 60,000 Units||19
10943476|NCT00378352|12113898|FG003|Safety Analysis|Dose Escalation 60,000 Units||11
10943477|NCT00378352|12113899|FG004|Safety Analysis|Dose Escalation 60,000 Units||0
10943478|NCT00378352|12113900|FG005|Safety Analysis|Dose Escalation 60,000 Units||0
10943479|NCT00378352|12113895|FG000|COMPLETED|Dose Escalation 60,000 Units||0
10943480|NCT00378352|12113896|FG001|COMPLETED|Dose Escalation 60,000 Units||0
10943481|NCT00378352|12113897|FG002|COMPLETED|Dose Escalation 60,000 Units||17
10943482|NCT00378352|12113898|FG003|COMPLETED|Dose Escalation 60,000 Units||10
10943483|NCT00378352|12113899|FG004|COMPLETED|Dose Escalation 60,000 Units||0
10943484|NCT00378352|12113900|FG005|COMPLETED|Dose Escalation 60,000 Units||0
10943485|NCT00378352|12113895|FG000|NOT COMPLETED|Dose Escalation 60,000 Units||0
10943486|NCT00378352|12113896|FG001|NOT COMPLETED|Dose Escalation 60,000 Units||0
10943487|NCT00378352|12113897|FG002|NOT COMPLETED|Dose Escalation 60,000 Units||3
10943488|NCT00378352|12113898|FG003|NOT COMPLETED|Dose Escalation 60,000 Units||1
10943489|NCT00378352|12113899|FG004|NOT COMPLETED|Dose Escalation 60,000 Units||0
10943490|NCT00378352|12113900|FG005|NOT COMPLETED|Dose Escalation 60,000 Units||0
10943491|NCT00378352|12113895|FG000|STARTED|Efficacy Phase||0
10943492|NCT00378352|12113896|FG001|STARTED|Efficacy Phase||0
10943493|NCT00378352|12113897|FG002|STARTED|Efficacy Phase||0
10943494|NCT00378352|12113898|FG003|STARTED|Efficacy Phase||0
10943495|NCT00378352|12113899|FG004|STARTED|Efficacy Phase||65
10943496|NCT00378352|12113900|FG005|STARTED|Efficacy Phase||66
10943497|NCT00378352|12113895|FG000|Safety Analysis|Efficacy Phase||0
10943498|NCT00378352|12113896|FG001|Safety Analysis|Efficacy Phase||0
10943499|NCT00378352|12113897|FG002|Safety Analysis|Efficacy Phase||0
10943500|NCT00378352|12113898|FG003|Safety Analysis|Efficacy Phase||0
10943501|NCT00378352|12113899|FG004|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
10943502|NCT00378352|12113900|FG005|Safety Analysis|Efficacy Phase||64
10943503|NCT00378352|12113895|FG000|COMPLETED|Efficacy Phase||0
10943504|NCT00378352|12113896|FG001|COMPLETED|Efficacy Phase||0
10943505|NCT00378352|12113897|FG002|COMPLETED|Efficacy Phase||0
10943506|NCT00378352|12113898|FG003|COMPLETED|Efficacy Phase||0
10943507|NCT00378352|12113899|FG004|COMPLETED|Efficacy Phase||54
10943508|NCT00378352|12113900|FG005|COMPLETED|Efficacy Phase||59
10943509|NCT00378352|12113895|FG000|NOT COMPLETED|Efficacy Phase||0
10943510|NCT00378352|12113896|FG001|NOT COMPLETED|Efficacy Phase||0
10943511|NCT00378352|12113897|FG002|NOT COMPLETED|Efficacy Phase||0
10943512|NCT00378352|12113898|FG003|NOT COMPLETED|Efficacy Phase||0
10943513|NCT00378352|12113899|FG004|NOT COMPLETED|Efficacy Phase||11
10943514|NCT00378352|12113900|FG005|NOT COMPLETED|Efficacy Phase||7
10943515|NCT00378508|12113910|FG000|STARTED|Overall Study||29
10943516|NCT00378508|12113911|FG001|STARTED|Overall Study||34
10943517|NCT00378508|12113910|FG000|Randomized|Overall Study||29
10943518|NCT00378508|12113911|FG001|Randomized|Overall Study||34
10943519|NCT00378508|12113910|FG000|Received Intervention/Placebo|Overall Study||28
10943520|NCT00378508|12113911|FG001|Received Intervention/Placebo|Overall Study||31
10943521|NCT00378508|12113910|FG000|COMPLETED|Overall Study||27
10943522|NCT00378508|12113911|FG001|COMPLETED|Overall Study||31
10943523|NCT00378508|12113910|FG000|NOT COMPLETED|Overall Study||2
10943524|NCT00378508|12113911|FG001|NOT COMPLETED|Overall Study||3
10943525|NCT00378534|12113920|FG000|STARTED|Overall Study||58
10943526|NCT00378534|12113921|FG001|STARTED|Overall Study||58
10943527|NCT00378534|12113920|FG000|COMPLETED|Overall Study||55
10943528|NCT00378534|12113921|FG001|COMPLETED|Overall Study||58
10943529|NCT00378534|12113920|FG000|NOT COMPLETED|Overall Study||3
10943530|NCT00378534|12113921|FG001|NOT COMPLETED|Overall Study||0
10943531|NCT00378560|12113928|FG000|STARTED|Overall Study||509
10943532|NCT00378560|12113929|FG001|STARTED|Overall Study||512
10943533|NCT00378560|12113928|FG000|Vaccinated|Overall Study||509
10943534|NCT00378560|12113929|FG001|Vaccinated|Overall Study||512
10943535|NCT00378560|12113928|FG000|COMPLETED|Overall Study||453
10943536|NCT00378560|12113929|FG001|COMPLETED|Overall Study||454
10943537|NCT00378560|12113928|FG000|NOT COMPLETED|Overall Study||56
10943538|NCT00378560|12113929|FG001|NOT COMPLETED|Overall Study||58
10943539|NCT00378573|12113935|FG000|STARTED|Treatment Period||17
10943540|NCT00378573|12113935|FG000|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
10943541|NCT00378573|12113935|FG000|NOT COMPLETED|Treatment Period||17
10943542|NCT00378573|12113935|FG000|STARTED|Follow-up||17
10943543|NCT00378573|12113935|FG000|COMPLETED|Follow-up||3
10943544|NCT00378573|12113935|FG000|NOT COMPLETED|Follow-up||14
10943545|NCT00378599|12113939|FG000|STARTED|Overall Study||125
10943546|NCT00378599|12113939|FG000|COMPLETED|Overall Study||73
10943547|NCT00378599|12113939|FG000|NOT COMPLETED|Overall Study||52
10943548|NCT00378703|12113947|FG000|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
10943549|NCT00378703|12113948|FG001|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
10943550|NCT00378703|12113949|FG002|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
10943551|NCT00378703|12113950|FG003|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
10943552|NCT00378703|12113947|FG000|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
10943553|NCT00378703|12113948|FG001|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
10943554|NCT00378703|12113949|FG002|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
10943555|NCT00378703|12113950|FG003|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
10943556|NCT00378703|12113947|FG000|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
10943557|NCT00378703|12113948|FG001|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
10943558|NCT00378703|12113949|FG002|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
10943559|NCT00378703|12113950|FG003|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
10943560|NCT00378703|12113947|FG000|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
10943561|NCT00378703|12113948|FG001|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
10943562|NCT00378703|12113949|FG002|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
10943563|NCT00378703|12113950|FG003|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
10943564|NCT00378703|12113947|FG000|NOT COMPLETED|Overall Study||89
10943565|NCT00378703|12113948|FG001|NOT COMPLETED|Overall Study||91
10943566|NCT00378703|12113949|FG002|NOT COMPLETED|Overall Study||90
10943567|NCT00378703|12113950|FG003|NOT COMPLETED|Overall Study||91
10943568|NCT00378898|12113962|FG000|STARTED|Overall Study||22
10943569|NCT00378898|12113963|FG001|STARTED|Overall Study||17
10943570|NCT00378898|12113962|FG000|COMPLETED|Overall Study||11
10943571|NCT00378898|12113963|FG001|COMPLETED|Overall Study||11
10943572|NCT00378898|12113962|FG000|NOT COMPLETED|Overall Study||11
10943573|NCT00378898|12113963|FG001|NOT COMPLETED|Overall Study||6
10943574|NCT00379080|12113974|FG000|STARTED|Overall Study||6
10943575|NCT00379080|12113975|FG001|STARTED|Overall Study||19
10943576|NCT00379080|12113976|FG002|STARTED|Overall Study||31
10943577|NCT00379080|12113974|FG000|COMPLETED|Overall Study||6
10943578|NCT00379080|12113975|FG001|COMPLETED|Overall Study||15
10943579|NCT00379080|12113976|FG002|COMPLETED|Overall Study||31
10943580|NCT00379080|12113974|FG000|NOT COMPLETED|Overall Study||0
10943581|NCT00379080|12113975|FG001|NOT COMPLETED|Overall Study||4
10943582|NCT00379080|12113976|FG002|NOT COMPLETED|Overall Study||0
10943583|NCT00379145|12113999|FG000|STARTED|Overall Study||20
10943584|NCT00379145|12113999|FG000|COMPLETED|Overall Study||20
10943585|NCT00379145|12113999|FG000|NOT COMPLETED|Overall Study||0
10943586|NCT00379197|12114008|FG000|STARTED|Overall Study||13
10943587|NCT00379197|12114008|FG000|COMPLETED|Overall Study||8
10943588|NCT00379197|12114008|FG000|NOT COMPLETED|Overall Study||5
10943589|NCT00379210|12114015|FG000|STARTED|Overall Study||30
10943590|NCT00379210|12114016|FG001|STARTED|Overall Study||30
10943591|NCT00379210|12114015|FG000|COMPLETED|Overall Study||20
10943592|NCT00379210|12114016|FG001|COMPLETED|Overall Study||23
10943593|NCT00379210|12114015|FG000|NOT COMPLETED|Overall Study||10
10943594|NCT00379210|12114016|FG001|NOT COMPLETED|Overall Study||7
10943595|NCT00379236|12114024|FG000|STARTED|Double-blind||293
10943596|NCT00379236|12114025|FG001|STARTED|Double-blind||295
10943597|NCT00379236|12114026|FG002|STARTED|Double-blind||0
10943598|NCT00379236|12114024|FG000|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
10943599|NCT00379236|12114025|FG001|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
10943600|NCT00379236|12114026|FG002|COMPLETED|Double-blind||0
10943601|NCT00379236|12114024|FG000|NOT COMPLETED|Double-blind||36
10943602|NCT00379236|12114025|FG001|NOT COMPLETED|Double-blind||36
10943603|NCT00379236|12114026|FG002|NOT COMPLETED|Double-blind||0
10943604|NCT00379236|12114024|FG000|STARTED|Open-label Extension||0
10943605|NCT00379236|12114025|FG001|STARTED|Open-label Extension||0
10943606|NCT00379236|12114026|FG002|STARTED|Open-label Extension||433
10943607|NCT00379236|12114024|FG000|COMPLETED|Open-label Extension||0
10943608|NCT00379236|12114025|FG001|COMPLETED|Open-label Extension||0
10943609|NCT00379236|12114026|FG002|COMPLETED|Open-label Extension||378
10943610|NCT00379236|12114024|FG000|NOT COMPLETED|Open-label Extension||0
10943611|NCT00379236|12114025|FG001|NOT COMPLETED|Open-label Extension||0
10943612|NCT00379236|12114026|FG002|NOT COMPLETED|Open-label Extension||55
10943613|NCT00379353|12114040|FG000|STARTED|Overall Study||16
10943614|NCT00379353|12114041|FG001|STARTED|Overall Study||15
10943615|NCT00379353|12114040|FG000|COMPLETED|Overall Study||5
10943616|NCT00379353|12114041|FG001|COMPLETED|Overall Study||9
10943617|NCT00379353|12114040|FG000|NOT COMPLETED|Overall Study||11
10943618|NCT00379353|12114041|FG001|NOT COMPLETED|Overall Study||6
10943619|NCT00379574|12114057|FG000|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
10943620|NCT00379574|12114057|FG000|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
10943621|NCT00379574|12114057|FG000|NOT COMPLETED|Overall Study||0
10943622|NCT00379587|12114061|FG000|STARTED|Overall Study||65
10943623|NCT00379587|12114061|FG000|COMPLETED|Overall Study||63
10943624|NCT00379587|12114061|FG000|NOT COMPLETED|Overall Study||2
10943625|NCT00379639|12114070|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
10943626|NCT00379639|12114071|FG001|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
10943627|NCT00379639|12114072|FG002|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
10943628|NCT00379639|12114073|FG003|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
10943629|NCT00379639|12114074|FG004|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
10943630|NCT00379639|12114070|FG000|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
10943631|NCT00379639|12114071|FG001|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
10943632|NCT00379639|12114072|FG002|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
10943633|NCT00379639|12114073|FG003|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
10943634|NCT00379639|12114074|FG004|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
10943635|NCT00379639|12114070|FG000|Completed 6 Cycles of Therapy|Overall Study||4
10943636|NCT00379639|12114071|FG001|Completed 6 Cycles of Therapy|Overall Study||2
10943637|NCT00379639|12114072|FG002|Completed 6 Cycles of Therapy|Overall Study||1
10943638|NCT00379639|12114073|FG003|Completed 6 Cycles of Therapy|Overall Study||0
10943639|NCT00379639|12114074|FG004|Completed 6 Cycles of Therapy|Overall Study||0
10943640|NCT00379639|12114070|FG000|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
10943641|NCT00379639|12114071|FG001|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
10943642|NCT00379639|12114072|FG002|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
10943643|NCT00379639|12114073|FG003|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
10943644|NCT00379639|12114074|FG004|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
10943645|NCT00379639|12114070|FG000|NOT COMPLETED|Overall Study||3
10943646|NCT00379639|12114071|FG001|NOT COMPLETED|Overall Study||5
10943647|NCT00379639|12114072|FG002|NOT COMPLETED|Overall Study||9
10943648|NCT00379639|12114073|FG003|NOT COMPLETED|Overall Study||6
10943649|NCT00379639|12114074|FG004|NOT COMPLETED|Overall Study||6
10943650|NCT00379769|12114090|FG000|STARTED|Main Study||1117
10943651|NCT00379769|12114091|FG001|STARTED|Main Study||1105
10943652|NCT00379769|12114092|FG002|STARTED|Main Study||1103
10943653|NCT00379769|12114093|FG003|STARTED|Main Study||1122
10943654|NCT00379769|12114094|FG004|STARTED|Main Study||0
10943655|NCT00379769|12114095|FG005|STARTED|Main Study||0
10943656|NCT00379769|12114090|FG000|COMPLETED|Main Study||939
10943657|NCT00379769|12114091|FG001|COMPLETED|Main Study||906
10943658|NCT00379769|12114092|FG002|COMPLETED|Main Study||896
10943659|NCT00379769|12114093|FG003|COMPLETED|Main Study||892
10943660|NCT00379769|12114094|FG004|COMPLETED|Main Study||0
10943661|NCT00379769|12114095|FG005|COMPLETED|Main Study||0
10943662|NCT00379769|12114090|FG000|NOT COMPLETED|Main Study||178
10943663|NCT00379769|12114091|FG001|NOT COMPLETED|Main Study||199
10943664|NCT00379769|12114092|FG002|NOT COMPLETED|Main Study||207
10943665|NCT00379769|12114093|FG003|NOT COMPLETED|Main Study||230
10943666|NCT00379769|12114094|FG004|NOT COMPLETED|Main Study||0
10943667|NCT00379769|12114095|FG005|NOT COMPLETED|Main Study||0
10943668|NCT00379769|12114090|FG000|STARTED|Observational Follow-up||0
10943669|NCT00379769|12114091|FG001|STARTED|Observational Follow-up||0
10943670|NCT00379769|12114092|FG002|STARTED|Observational Follow-up||0
10943671|NCT00379769|12114093|FG003|STARTED|Observational Follow-up||0
10943672|NCT00379769|12114094|FG004|STARTED|Observational Follow-up|"665 from RSG in Addition to Background MET arm; 615 from RGS in Addition to Background SU arm."|1280
10943673|NCT00379769|12114095|FG005|STARTED|Observational Follow-up|"647 from SU in Addition to Background MET arm; 603 from MET in Addition to Background SU arm."|1250
10943674|NCT00379769|12114090|FG000|COMPLETED|Observational Follow-up||0
10943675|NCT00379769|12114091|FG001|COMPLETED|Observational Follow-up||0
10943676|NCT00379769|12114092|FG002|COMPLETED|Observational Follow-up||0
10943677|NCT00379769|12114093|FG003|COMPLETED|Observational Follow-up||0
10943678|NCT00379769|12114094|FG004|COMPLETED|Observational Follow-up||1131
10943679|NCT00379769|12114095|FG005|COMPLETED|Observational Follow-up||1102
10943680|NCT00379769|12114090|FG000|NOT COMPLETED|Observational Follow-up||0
10943681|NCT00379769|12114091|FG001|NOT COMPLETED|Observational Follow-up||0
10943682|NCT00379769|12114092|FG002|NOT COMPLETED|Observational Follow-up||0
10943683|NCT00379769|12114093|FG003|NOT COMPLETED|Observational Follow-up||0
10943684|NCT00379769|12114094|FG004|NOT COMPLETED|Observational Follow-up||149
10943685|NCT00379769|12114095|FG005|NOT COMPLETED|Observational Follow-up||148
10943686|NCT00379795|12114127|FG000|STARTED|Overall Study||526
10943687|NCT00379795|12114128|FG001|STARTED|Overall Study||74
10943688|NCT00379795|12114129|FG002|STARTED|Overall Study||116
10943689|NCT00379795|12114130|FG003|STARTED|Overall Study||74
10943690|NCT00379795|12114131|FG004|STARTED|Overall Study||63
10943691|NCT00379795|12114127|FG000|Received Ranibizumab in Extension Study|Overall Study||377
10943692|NCT00379795|12114128|FG001|Received Ranibizumab in Extension Study|Overall Study||41
10943693|NCT00379795|12114129|FG002|Received Ranibizumab in Extension Study|Overall Study||113
10943694|NCT00379795|12114130|FG003|Received Ranibizumab in Extension Study|Overall Study||55
10943695|NCT00379795|12114131|FG004|Received Ranibizumab in Extension Study|Overall Study||0
10943696|NCT00379795|12114127|FG000|COMPLETED|Overall Study||50
10943697|NCT00379795|12114128|FG001|COMPLETED|Overall Study||23
10943698|NCT00379795|12114129|FG002|COMPLETED|Overall Study||23
10943699|NCT00379795|12114130|FG003|COMPLETED|Overall Study||6
10943700|NCT00379795|12114131|FG004|COMPLETED|Overall Study||14
10943701|NCT00379795|12114127|FG000|NOT COMPLETED|Overall Study||476
10943702|NCT00379795|12114128|FG001|NOT COMPLETED|Overall Study||51
10943703|NCT00379795|12114129|FG002|NOT COMPLETED|Overall Study||93
10943704|NCT00379795|12114130|FG003|NOT COMPLETED|Overall Study||68
10943705|NCT00379795|12114131|FG004|NOT COMPLETED|Overall Study||49
10943706|NCT00379808|12114146|FG000|STARTED|Intervention Period 1 (4 Weeks)||11
10943707|NCT00379808|12114147|FG001|STARTED|Intervention Period 1 (4 Weeks)||11
10943708|NCT00379808|12114146|FG000|COMPLETED|Intervention Period 1 (4 Weeks)||11
10943709|NCT00379808|12114147|FG001|COMPLETED|Intervention Period 1 (4 Weeks)||11
10943710|NCT00379808|12114146|FG000|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
10943711|NCT00379808|12114147|FG001|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
10943712|NCT00379808|12114146|FG000|STARTED|Intervention Period 2 (4 Weeks)||11
10943713|NCT00379808|12114147|FG001|STARTED|Intervention Period 2 (4 Weeks)||11
10943714|NCT00379808|12114146|FG000|COMPLETED|Intervention Period 2 (4 Weeks)||11
10943715|NCT00379808|12114147|FG001|COMPLETED|Intervention Period 2 (4 Weeks)||10
10943716|NCT00379808|12114146|FG000|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
10943717|NCT00379808|12114147|FG001|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
10943718|NCT00379821|12114157|FG000|STARTED|Overall Study||160
10943719|NCT00379821|12114158|FG001|STARTED|Overall Study||160
10943720|NCT00379821|12114159|FG002|STARTED|Overall Study||160
10943721|NCT00379821|12114160|FG003|STARTED|Overall Study||160
10943722|NCT00379821|12114157|FG000|COMPLETED|Overall Study||87
10943723|NCT00379821|12114158|FG001|COMPLETED|Overall Study||71
10943724|NCT00379821|12114159|FG002|COMPLETED|Overall Study||93
10943725|NCT00379821|12114160|FG003|COMPLETED|Overall Study||81
10943726|NCT00379821|12114157|FG000|NOT COMPLETED|Overall Study||73
10943727|NCT00379821|12114158|FG001|NOT COMPLETED|Overall Study||89
10943728|NCT00379821|12114159|FG002|NOT COMPLETED|Overall Study||67
10943729|NCT00379821|12114160|FG003|NOT COMPLETED|Overall Study||79
10943730|NCT00379834|12114177|FG000|STARTED|Overall Study||10
10943731|NCT00379834|12114177|FG000|COMPLETED|Overall Study||8
10943732|NCT00379834|12114177|FG000|NOT COMPLETED|Overall Study||2
10943733|NCT00379899|12114183|FG000|STARTED|Overall Study||180
10943734|NCT00379899|12114184|FG001|STARTED|Overall Study||180
10943735|NCT00379899|12114183|FG000|COMPLETED|Overall Study||140
10943736|NCT00379899|12114184|FG001|COMPLETED|Overall Study||140
10943737|NCT00379899|12114183|FG000|NOT COMPLETED|Overall Study||40
10943738|NCT00379899|12114184|FG001|NOT COMPLETED|Overall Study||40
10943739|NCT00379912|12114192|FG000|STARTED|Overall Study||7
10943740|NCT00379912|12114193|FG001|STARTED|Overall Study||8
10943741|NCT00379912|12114192|FG000|COMPLETED|Overall Study||6
10943742|NCT00379912|12114193|FG001|COMPLETED|Overall Study||8
10943743|NCT00379912|12114192|FG000|NOT COMPLETED|Overall Study||1
10943744|NCT00379912|12114193|FG001|NOT COMPLETED|Overall Study||0
10943745|NCT00380029|12114205|FG000|STARTED|Overall Study||20
10943746|NCT00380029|12114205|FG000|COMPLETED|Overall Study||20
10943747|NCT00380029|12114205|FG000|NOT COMPLETED|Overall Study||0
10943748|NCT00380068|12114213|FG000|STARTED|Overall Study||224
10943749|NCT00380068|12114213|FG000|COMPLETED|Overall Study||155
10943750|NCT00380068|12114213|FG000|NOT COMPLETED|Overall Study||69
10943751|NCT00380081|12114223|FG000|STARTED|Overall Study||14
10943752|NCT00380081|12114224|FG001|STARTED|Overall Study||13
10943753|NCT00380081|12114225|FG002|STARTED|Overall Study||13
10943754|NCT00380081|12114226|FG003|STARTED|Overall Study||15
10943755|NCT00380081|12114227|FG004|STARTED|Overall Study||13
10943756|NCT00380081|12114228|FG005|STARTED|Overall Study||14
10943757|NCT00380081|12114223|FG000|COMPLETED|Overall Study||14
10943758|NCT00380081|12114224|FG001|COMPLETED|Overall Study||13
10943759|NCT00380081|12114225|FG002|COMPLETED|Overall Study||13
10943760|NCT00380081|12114226|FG003|COMPLETED|Overall Study||15
10943761|NCT00380081|12114227|FG004|COMPLETED|Overall Study||12
10943762|NCT00380081|12114228|FG005|COMPLETED|Overall Study||13
10943763|NCT00380081|12114223|FG000|NOT COMPLETED|Overall Study||0
10943764|NCT00380081|12114224|FG001|NOT COMPLETED|Overall Study||0
10943765|NCT00380081|12114225|FG002|NOT COMPLETED|Overall Study||0
10943766|NCT00380081|12114226|FG003|NOT COMPLETED|Overall Study||0
10943767|NCT00380081|12114227|FG004|NOT COMPLETED|Overall Study||1
10943768|NCT00380081|12114228|FG005|NOT COMPLETED|Overall Study||1
10943769|NCT00380250|12114238|FG000|STARTED|Overall Study||396
10943770|NCT00380250|12114239|FG001|STARTED|Overall Study||194
10943771|NCT00380250|12114238|FG000|COMPLETED|Overall Study||297
10943772|NCT00380250|12114239|FG001|COMPLETED|Overall Study||139
10943773|NCT00380250|12114238|FG000|NOT COMPLETED|Overall Study||99
10943774|NCT00380250|12114239|FG001|NOT COMPLETED|Overall Study||55
10943775|NCT00380367|12114245|FG000|STARTED|Overall Study||110
10943776|NCT00380367|12114245|FG000|COMPLETED|Overall Study||108
10943777|NCT00380367|12114245|FG000|NOT COMPLETED|Overall Study||2
10943778|NCT00380393|12114251|FG000|STARTED|Month 8 (Cross-sectional Visit)||447
10943779|NCT00380393|12114252|FG001|STARTED|Month 8 (Cross-sectional Visit)||447
10943780|NCT00380393|12114251|FG000|COMPLETED|Month 8 (Cross-sectional Visit)||398
10943781|NCT00380393|12114252|FG001|COMPLETED|Month 8 (Cross-sectional Visit)||407
10943782|NCT00380393|12114251|FG000|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
10943783|NCT00380393|12114252|FG001|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
10943784|NCT00380393|12114251|FG000|STARTED|Month 14||447
10943785|NCT00380393|12114252|FG001|STARTED|Month 14||447
10943786|NCT00380393|12114251|FG000|COMPLETED|Month 14||390
10943787|NCT00380393|12114252|FG001|COMPLETED|Month 14||391
10943788|NCT00380393|12114251|FG000|NOT COMPLETED|Month 14||57
10943789|NCT00380393|12114252|FG001|NOT COMPLETED|Month 14||56
10943790|NCT00380588|12114260|FG000|STARTED|Overall Study||42
10943791|NCT00380588|12114261|FG001|STARTED|Overall Study||42
10943792|NCT00380588|12114260|FG000|Received at Least One Dose of Study Drug|Overall Study||41
10943793|NCT00380588|12114261|FG001|Received at Least One Dose of Study Drug|Overall Study||42
10943794|NCT00380588|12114260|FG000|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
10943795|NCT00380588|12114261|FG001|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
10943796|NCT00380588|12114260|FG000|NOT COMPLETED|Overall Study||39
10943797|NCT00380588|12114261|FG001|NOT COMPLETED|Overall Study||40
10943798|NCT00380692|12114269|FG000|STARTED|Study Period II - Double Blind||48
10943799|NCT00380692|12114270|FG001|STARTED|Study Period II - Double Blind||49
10943800|NCT00380692|12114269|FG000|COMPLETED|Study Period II - Double Blind||43
10943801|NCT00380692|12114270|FG001|COMPLETED|Study Period II - Double Blind||46
10943802|NCT00380692|12114269|FG000|NOT COMPLETED|Study Period II - Double Blind||5
10943803|NCT00380692|12114270|FG001|NOT COMPLETED|Study Period II - Double Blind||3
10943804|NCT00380692|12114269|FG000|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
10943805|NCT00380692|12114270|FG001|STARTED|Study Period III - Open Label||46
10943806|NCT00380692|12114269|FG000|COMPLETED|Study Period III - Open Label||36
10943807|NCT00380692|12114270|FG001|COMPLETED|Study Period III - Open Label||34
10943808|NCT00380692|12114269|FG000|NOT COMPLETED|Study Period III - Open Label||6
10943809|NCT00380692|12114270|FG001|NOT COMPLETED|Study Period III - Open Label||12
10943810|NCT00380718|12114276|FG000|STARTED|Overall Study||33
10943811|NCT00380718|12114276|FG000|Received at Least One Dose of Study Drug|Overall Study||33
10943812|NCT00380718|12114276|FG000|Received Escalated Dose in Cycle 2|Overall Study||25
10943813|NCT00380718|12114276|FG000|COMPLETED|Overall Study||15
10943814|NCT00380718|12114276|FG000|NOT COMPLETED|Overall Study||18
10943815|NCT00380744|12114287|FG000|STARTED|Overall Study||20
10943816|NCT00380744|12114288|FG001|STARTED|Overall Study||4
10943817|NCT00380744|12114289|FG002|STARTED|Overall Study||20
10943818|NCT00380744|12114290|FG003|STARTED|Overall Study||4
10943819|NCT00380744|12114291|FG004|STARTED|Overall Study||23
10943820|NCT00380744|12114292|FG005|STARTED|Overall Study||25
10943821|NCT00380744|12114293|FG006|STARTED|Overall Study||25
10943822|NCT00380744|12114287|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
10943823|NCT00380744|12114288|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
10943824|NCT00380744|12114289|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
10943825|NCT00380744|12114290|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
10943826|NCT00380744|12114291|FG004|Received at Least 1 Dose of Study Drug|Overall Study||23
10943827|NCT00380744|12114292|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
10943828|NCT00380744|12114293|FG006|Received at Least 1 Dose of Study Drug|Overall Study||25
10943829|NCT00380744|12114287|FG000|COMPLETED|Overall Study||19
10943830|NCT00380744|12114288|FG001|COMPLETED|Overall Study||4
10943831|NCT00380744|12114289|FG002|COMPLETED|Overall Study||20
10943832|NCT00380744|12114290|FG003|COMPLETED|Overall Study||4
10943833|NCT00380744|12114291|FG004|COMPLETED|Overall Study||23
10943834|NCT00380744|12114292|FG005|COMPLETED|Overall Study||25
10943835|NCT00380744|12114293|FG006|COMPLETED|Overall Study||24
10943836|NCT00380744|12114287|FG000|NOT COMPLETED|Overall Study||1
10943837|NCT00380744|12114288|FG001|NOT COMPLETED|Overall Study||0
10943838|NCT00380744|12114289|FG002|NOT COMPLETED|Overall Study||0
10943839|NCT00380744|12114290|FG003|NOT COMPLETED|Overall Study||0
10943840|NCT00380744|12114291|FG004|NOT COMPLETED|Overall Study||0
10943841|NCT00380744|12114292|FG005|NOT COMPLETED|Overall Study||0
10943842|NCT00380744|12114293|FG006|NOT COMPLETED|Overall Study||1
10943843|NCT00380861|12114312|FG000|STARTED|Overall Study||93
10943844|NCT00380861|12114313|FG001|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
10943845|NCT00380861|12114312|FG000|COMPLETED|Overall Study||75
10943846|NCT00380861|12114313|FG001|COMPLETED|Overall Study||74
10943847|NCT00380861|12114312|FG000|NOT COMPLETED|Overall Study||18
10943848|NCT00380861|12114313|FG001|NOT COMPLETED|Overall Study||17
10943849|NCT00380874|12114321|FG000|STARTED|Overall Study||32
10943850|NCT00380874|12114322|FG001|STARTED|Overall Study||29
10943851|NCT00380874|12114321|FG000|COMPLETED|Overall Study||19
10943852|NCT00380874|12114322|FG001|COMPLETED|Overall Study||19
10943853|NCT00380874|12114321|FG000|NOT COMPLETED|Overall Study||13
10943854|NCT00380874|12114322|FG001|NOT COMPLETED|Overall Study||10
10943855|NCT00380978|12114330|FG000|STARTED|Overall Study||408
10943856|NCT00380978|12114331|FG001|STARTED|Overall Study||410
10943857|NCT00380978|12114330|FG000|COMPLETED|Overall Study||406
10943858|NCT00380978|12114331|FG001|COMPLETED|Overall Study||400
10943859|NCT00380978|12114330|FG000|NOT COMPLETED|Overall Study||2
10943860|NCT00380978|12114331|FG001|NOT COMPLETED|Overall Study||10
10943861|NCT00381004|12114337|FG000|STARTED|Overall Study||60
10943862|NCT00381004|12114337|FG000|COMPLETED|Overall Study||60
10943863|NCT00381004|12114337|FG000|NOT COMPLETED|Overall Study||0
10943864|NCT00381043|12114343|FG000|STARTED|Overall Study||51
10943865|NCT00381043|12114344|FG001|STARTED|Overall Study||49
10943866|NCT00381043|12114343|FG000|COMPLETED|Overall Study||39
10943867|NCT00381043|12114344|FG001|COMPLETED|Overall Study||41
10943868|NCT00381043|12114343|FG000|NOT COMPLETED|Overall Study||12
10943869|NCT00381043|12114344|FG001|NOT COMPLETED|Overall Study||8
10943870|NCT00381095|12114352|FG000|STARTED|Overall Study||72
10943871|NCT00381095|12114353|FG001|STARTED|Overall Study||80
10943872|NCT00381095|12114352|FG000|COMPLETED|Overall Study||59
10943873|NCT00381095|12114353|FG001|COMPLETED|Overall Study||59
10943874|NCT00381095|12114352|FG000|NOT COMPLETED|Overall Study||13
10943875|NCT00381095|12114353|FG001|NOT COMPLETED|Overall Study||21
10943876|NCT00381238|12114359|FG000|STARTED|Overall Study||33
10943877|NCT00381238|12114359|FG000|COMPLETED|Overall Study||21
10943878|NCT00381238|12114359|FG000|NOT COMPLETED|Overall Study||12
10943879|NCT00381303|12114365|FG000|STARTED|Overall Study||287
10943880|NCT00381303|12114366|FG001|STARTED|Overall Study||142
10943881|NCT00381303|12114365|FG000|COMPLETED|Overall Study||193
10943882|NCT00381303|12114366|FG001|COMPLETED|Overall Study||109
10943883|NCT00381303|12114365|FG000|NOT COMPLETED|Overall Study||94
10943884|NCT00381303|12114366|FG001|NOT COMPLETED|Overall Study||33
10943885|NCT00381550|12114384|FG000|STARTED|Overall Study||35
10943886|NCT00381550|12114384|FG000|COMPLETED|Overall Study||35
10943887|NCT00381550|12114384|FG000|NOT COMPLETED|Overall Study||0
10943888|NCT00381563|12114390|FG000|STARTED|Overall Study||41
10943889|NCT00381563|12114391|FG001|STARTED|Overall Study||39
10943890|NCT00381563|12114390|FG000|COMPLETED|Overall Study||34
10943891|NCT00381563|12114391|FG001|COMPLETED|Overall Study||33
10943892|NCT00381563|12114390|FG000|NOT COMPLETED|Overall Study||7
10943893|NCT00381563|12114391|FG001|NOT COMPLETED|Overall Study||6
10943894|NCT00381615|12114400|FG000|STARTED|Overall Study||48
10943895|NCT00381615|12114401|FG001|STARTED|Overall Study||50
10943896|NCT00381615|12114402|FG002|STARTED|Overall Study||25
10943897|NCT00381615|12114403|FG003|STARTED|Overall Study||24
10943898|NCT00381615|12114400|FG000|COMPLETED|Overall Study||44
10943899|NCT00381615|12114401|FG001|COMPLETED|Overall Study||45
10943900|NCT00381615|12114402|FG002|COMPLETED|Overall Study||24
10943901|NCT00381615|12114403|FG003|COMPLETED|Overall Study||22
10943902|NCT00381615|12114400|FG000|NOT COMPLETED|Overall Study||4
10943903|NCT00381615|12114401|FG001|NOT COMPLETED|Overall Study||5
10943904|NCT00381615|12114402|FG002|NOT COMPLETED|Overall Study||1
10943905|NCT00381615|12114403|FG003|NOT COMPLETED|Overall Study||2
10943906|NCT00381628|12114419|FG000|STARTED|Overall Study||18
10943907|NCT00381628|12114420|FG001|STARTED|Overall Study||27
10943908|NCT00381628|12114421|FG002|STARTED|Overall Study||0
10943909|NCT00381628|12114422|FG003|STARTED|Overall Study||14
10943910|NCT00381628|12114419|FG000|COMPLETED|Overall Study||18
10943911|NCT00381628|12114420|FG001|COMPLETED|Overall Study||27
10943912|NCT00381628|12114421|FG002|COMPLETED|Overall Study||0
10943913|NCT00381628|12114422|FG003|COMPLETED|Overall Study||14
10943914|NCT00381628|12114419|FG000|NOT COMPLETED|Overall Study||0
10943915|NCT00381628|12114420|FG001|NOT COMPLETED|Overall Study||0
10943916|NCT00381628|12114421|FG002|NOT COMPLETED|Overall Study||0
10943917|NCT00381628|12114422|FG003|NOT COMPLETED|Overall Study||0
10943918|NCT00381680|12114434|FG000|STARTED|Overall Study||206
10943919|NCT00381680|12114435|FG001|STARTED|Overall Study||69
10943920|NCT00381680|12114434|FG000|COMPLETED|Overall Study||81
10943921|NCT00381680|12114435|FG001|COMPLETED|Overall Study||19
10943922|NCT00381680|12114434|FG000|NOT COMPLETED|Overall Study||125
10943923|NCT00381680|12114435|FG001|NOT COMPLETED|Overall Study||50
10943924|NCT00381693|12114445|FG000|STARTED|Overall Study||10
10943925|NCT00381693|12114445|FG000|COMPLETED|Overall Study||2
10943926|NCT00381693|12114445|FG000|NOT COMPLETED|Overall Study||8
10943927|NCT00381706|12114455|FG000|STARTED|Overall Study||82
10943928|NCT00381706|12114456|FG001|STARTED|Overall Study||83
10943929|NCT00381706|12114457|FG002|STARTED|Overall Study||80
10943930|NCT00381706|12114455|FG000|COMPLETED|Overall Study||75
10943931|NCT00381706|12114456|FG001|COMPLETED|Overall Study||81
10943932|NCT00381706|12114457|FG002|COMPLETED|Overall Study||79
10943933|NCT00381706|12114455|FG000|NOT COMPLETED|Overall Study||7
10943934|NCT00381706|12114456|FG001|NOT COMPLETED|Overall Study||2
10943935|NCT00381706|12114457|FG002|NOT COMPLETED|Overall Study||1
10943936|NCT00381797|12114476|FG000|STARTED|Overall Study||18
10943937|NCT00381797|12114477|FG001|STARTED|Overall Study||17
10943938|NCT00381797|12114478|FG002|STARTED|Overall Study||10
10943939|NCT00381797|12114479|FG003|STARTED|Overall Study||15
10943940|NCT00381797|12114480|FG004|STARTED|Overall Study||37
10943941|NCT00381797|12114476|FG000|COMPLETED|Overall Study||17
10943942|NCT00381797|12114477|FG001|COMPLETED|Overall Study||16
10943943|NCT00381797|12114478|FG002|COMPLETED|Overall Study||10
10943944|NCT00381797|12114479|FG003|COMPLETED|Overall Study||14
10943945|NCT00381797|12114480|FG004|COMPLETED|Overall Study||35
10943946|NCT00381797|12114476|FG000|NOT COMPLETED|Overall Study||1
10943947|NCT00381797|12114477|FG001|NOT COMPLETED|Overall Study||1
10943948|NCT00381797|12114478|FG002|NOT COMPLETED|Overall Study||0
10943949|NCT00381797|12114479|FG003|NOT COMPLETED|Overall Study||1
10943950|NCT00381797|12114480|FG004|NOT COMPLETED|Overall Study||2
10943951|NCT00381810|12114513|FG000|STARTED|Treatment and Safety Follow-up||31
10943952|NCT00381810|12114513|FG000|COMPLETED|Treatment and Safety Follow-up||16
10943953|NCT00381810|12114513|FG000|NOT COMPLETED|Treatment and Safety Follow-up||15
10943954|NCT00381810|12114513|FG000|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
10943955|NCT00381810|12114513|FG000|COMPLETED|B Cell Follow-up||0
10943956|NCT00381810|12114513|FG000|NOT COMPLETED|B Cell Follow-up||7
10943957|NCT00381849|12114519|FG000|STARTED|First Intervention||10
10943958|NCT00381849|12114520|FG001|STARTED|First Intervention||10
10943959|NCT00381849|12114519|FG000|COMPLETED|First Intervention||10
10943960|NCT00381849|12114520|FG001|COMPLETED|First Intervention||10
10943961|NCT00381849|12114519|FG000|NOT COMPLETED|First Intervention||0
10943962|NCT00381849|12114520|FG001|NOT COMPLETED|First Intervention||0
10943963|NCT00381849|12114519|FG000|STARTED|Wash Out||10
10943964|NCT00381849|12114520|FG001|STARTED|Wash Out||10
10943965|NCT00381849|12114519|FG000|COMPLETED|Wash Out||10
10943966|NCT00381849|12114520|FG001|COMPLETED|Wash Out||9
10943967|NCT00381849|12114519|FG000|NOT COMPLETED|Wash Out||0
10943968|NCT00381849|12114520|FG001|NOT COMPLETED|Wash Out||1
10943969|NCT00381849|12114519|FG000|STARTED|Second Intervention||10
10943970|NCT00381849|12114520|FG001|STARTED|Second Intervention||9
10943971|NCT00381849|12114519|FG000|COMPLETED|Second Intervention||10
10943972|NCT00381849|12114520|FG001|COMPLETED|Second Intervention||9
10943973|NCT00381849|12114519|FG000|NOT COMPLETED|Second Intervention||0
10943974|NCT00381849|12114520|FG001|NOT COMPLETED|Second Intervention||0
10943975|NCT00381849|12114519|FG000|STARTED|Open-label||10
10943976|NCT00381849|12114520|FG001|STARTED|Open-label||9
10943977|NCT00381849|12114519|FG000|COMPLETED|Open-label||10
10943978|NCT00381849|12114520|FG001|COMPLETED|Open-label||9
10943979|NCT00381849|12114519|FG000|NOT COMPLETED|Open-label||0
10943980|NCT00381849|12114520|FG001|NOT COMPLETED|Open-label||0
10943981|NCT00381862|12114526|FG000|STARTED|Overall Study||54
10943982|NCT00381862|12114526|FG000|COMPLETED|Overall Study||44
10943983|NCT00381862|12114526|FG000|NOT COMPLETED|Overall Study||10
10943984|NCT00381888|12114530|FG000|STARTED|Overall Study||44
10943985|NCT00381888|12114530|FG000|COMPLETED|Overall Study||27
10943986|NCT00381888|12114530|FG000|NOT COMPLETED|Overall Study||17
10943987|NCT00381940|12114534|FG000|STARTED|Overall Study||26
10943988|NCT00381940|12114534|FG000|COMPLETED|Overall Study||21
10943989|NCT00381940|12114534|FG000|NOT COMPLETED|Overall Study||5
10943990|NCT00381966|12114538|FG000|STARTED|Overall Study||5
10943991|NCT00381966|12114538|FG000|COMPLETED|Overall Study||5
10943992|NCT00381966|12114538|FG000|NOT COMPLETED|Overall Study||0
10943993|NCT00382018|12114546|FG000|STARTED|Overall Study||276
10943994|NCT00382018|12114547|FG001|STARTED|Overall Study||165
10943995|NCT00382018|12114548|FG002|STARTED|Overall Study||64
10943996|NCT00382018|12114549|FG003|STARTED|Overall Study||59
10943997|NCT00382018|12114546|FG000|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
10943998|NCT00382018|12114547|FG001|COMPLETED|Overall Study||0
10943999|NCT00382018|12114548|FG002|COMPLETED|Overall Study||0
10944000|NCT00382018|12114549|FG003|COMPLETED|Overall Study||0
10944001|NCT00382018|12114546|FG000|NOT COMPLETED|Overall Study||0
10944002|NCT00382018|12114547|FG001|NOT COMPLETED|Overall Study||165
10944003|NCT00382018|12114548|FG002|NOT COMPLETED|Overall Study||64
10944004|NCT00382018|12114549|FG003|NOT COMPLETED|Overall Study||59
10944005|NCT00382031|12114564|FG000|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
10944006|NCT00382031|12114565|FG001|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
10944007|NCT00382031|12114564|FG000|COMPLETED|Overall Study||191
10944008|NCT00382031|12114565|FG001|COMPLETED|Overall Study||95
10944009|NCT00382031|12114564|FG000|NOT COMPLETED|Overall Study||0
10944010|NCT00382031|12114565|FG001|NOT COMPLETED|Overall Study||0
10944011|NCT00382070|12114573|FG000|STARTED|Overall Study||1983
10944012|NCT00382070|12114574|FG001|STARTED|Overall Study||1983
10944013|NCT00382070|12114573|FG000|COMPLETED|Overall Study||1950
10944014|NCT00382070|12114574|FG001|COMPLETED|Overall Study||1953
10944015|NCT00382070|12114573|FG000|NOT COMPLETED|Overall Study||33
10944016|NCT00382070|12114574|FG001|NOT COMPLETED|Overall Study||30
10944017|NCT00382109|12114582|FG000|STARTED|Overall Study||76
10944018|NCT00382109|12114583|FG001|STARTED|Overall Study||70
10944019|NCT00382109|12114582|FG000|COMPLETED|Overall Study||64
10944020|NCT00382109|12114583|FG001|COMPLETED|Overall Study||66
10944021|NCT00382109|12114582|FG000|NOT COMPLETED|Overall Study||12
10944022|NCT00382109|12114583|FG001|NOT COMPLETED|Overall Study||4
10944023|NCT00382148|12114594|FG000|STARTED|Overall Study||4
10944024|NCT00382148|12114595|FG001|STARTED|Overall Study||7
10944025|NCT00382148|12114594|FG000|COMPLETED|Overall Study||3
10944026|NCT00382148|12114595|FG001|COMPLETED|Overall Study||7
10944027|NCT00382148|12114594|FG000|NOT COMPLETED|Overall Study||1
10944028|NCT00382148|12114595|FG001|NOT COMPLETED|Overall Study||0
10944029|NCT00382174|12114603|FG000|STARTED|Overall Study||18
10944030|NCT00382174|12114604|FG001|STARTED|Overall Study||54
10944031|NCT00382174|12114605|FG002|STARTED|Overall Study||72
10944032|NCT00382174|12114603|FG000|COMPLETED|Overall Study||14
10944033|NCT00382174|12114604|FG001|COMPLETED|Overall Study||37
10944034|NCT00382174|12114605|FG002|COMPLETED|Overall Study||51
10944035|NCT00382174|12114603|FG000|NOT COMPLETED|Overall Study||4
10944036|NCT00382174|12114604|FG001|NOT COMPLETED|Overall Study||17
10944037|NCT00382174|12114605|FG002|NOT COMPLETED|Overall Study||21
10944038|NCT00382265|12114615|FG000|STARTED|Overall Study||267
10944039|NCT00382265|12114616|FG001|STARTED|Overall Study||245
10944040|NCT00382265|12114615|FG000|COMPLETED|Overall Study||258
10944041|NCT00382265|12114616|FG001|COMPLETED|Overall Study||239
10944042|NCT00382265|12114615|FG000|NOT COMPLETED|Overall Study||9
10944043|NCT00382265|12114616|FG001|NOT COMPLETED|Overall Study||6
10944044|NCT00382291|12114629|FG000|STARTED|Overall Study||18
10944045|NCT00382291|12114630|FG001|STARTED|Overall Study||17
10944046|NCT00382291|12114631|FG002|STARTED|Overall Study||21
10944047|NCT00382291|12114629|FG000|COMPLETED|Overall Study||14
10944048|NCT00382291|12114630|FG001|COMPLETED|Overall Study||10
10944049|NCT00382291|12114631|FG002|COMPLETED|Overall Study||13
10944050|NCT00382291|12114629|FG000|NOT COMPLETED|Overall Study||4
10944051|NCT00382291|12114630|FG001|NOT COMPLETED|Overall Study||7
10944052|NCT00382291|12114631|FG002|NOT COMPLETED|Overall Study||8
10944053|NCT00382408|12114643|FG000|STARTED|Overall Study||3031
10944054|NCT00382408|12114644|FG001|STARTED|Overall Study||1009
10944055|NCT00382408|12114643|FG000|COMPLETED|Overall Study||2887
10944056|NCT00382408|12114644|FG001|COMPLETED|Overall Study||955
10944057|NCT00382408|12114643|FG000|NOT COMPLETED|Overall Study||144
10944058|NCT00382408|12114644|FG001|NOT COMPLETED|Overall Study||54
10944059|NCT00382590|12114652|FG000|STARTED|Overall Study||4
10944060|NCT00382590|12114653|FG001|STARTED|Overall Study||6
10944061|NCT00382590|12114652|FG000|COMPLETED|Overall Study||4
10944062|NCT00382590|12114653|FG001|COMPLETED|Overall Study||6
10944063|NCT00382590|12114652|FG000|NOT COMPLETED|Overall Study||0
10944064|NCT00382590|12114653|FG001|NOT COMPLETED|Overall Study||0
10944065|NCT00382720|12114662|FG000|STARTED|Overall Study||79
10944066|NCT00382720|12114663|FG001|STARTED|Overall Study||89
10944067|NCT00382720|12114664|FG002|STARTED|Overall Study||86
10944068|NCT00382720|12114662|FG000|Administered Non-Optimal Dose (Part I)|Overall Study||10
10944069|NCT00382720|12114663|FG001|Administered Non-Optimal Dose (Part I)|Overall Study||11
10944070|NCT00382720|12114664|FG002|Administered Non-Optimal Dose (Part I)|Overall Study||0
10944071|NCT00382720|12114662|FG000|Administered Optimal Dose (Parts I & II)|Overall Study||78
10944072|NCT00382720|12114663|FG001|Administered Optimal Dose (Parts I & II)|Overall Study||88
10944073|NCT00382720|12114664|FG002|Administered Optimal Dose (Parts I & II)|Overall Study||82
10944074|NCT00382720|12114662|FG000|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
10944075|NCT00382720|12114663|FG001|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
10944076|NCT00382720|12114664|FG002|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
10944077|NCT00382720|12114662|FG000|COMPLETED|Overall Study||0
10944078|NCT00382720|12114663|FG001|COMPLETED|Overall Study||0
10944079|NCT00382720|12114664|FG002|COMPLETED|Overall Study||0
10944080|NCT00382720|12114662|FG000|NOT COMPLETED|Overall Study||79
10944081|NCT00382720|12114663|FG001|NOT COMPLETED|Overall Study||89
10944082|NCT00382720|12114664|FG002|NOT COMPLETED|Overall Study||86
10944083|NCT00382733|12114672|FG000|STARTED|Overall Study||3
10944084|NCT00382733|12114673|FG001|STARTED|Overall Study||4
10944085|NCT00382733|12114674|FG002|STARTED|Overall Study||3
10944086|NCT00382733|12114675|FG003|STARTED|Overall Study||14
10944087|NCT00382733|12114676|FG004|STARTED|Overall Study||2
10944088|NCT00382733|12114672|FG000|COMPLETED|Overall Study||3
10944089|NCT00382733|12114673|FG001|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
10944090|NCT00382733|12114674|FG002|COMPLETED|Overall Study||3
10944091|NCT00382733|12114675|FG003|COMPLETED|Overall Study||14
10944092|NCT00382733|12114676|FG004|COMPLETED|Overall Study||2
10944093|NCT00382733|12114672|FG000|NOT COMPLETED|Overall Study||0
10944094|NCT00382733|12114673|FG001|NOT COMPLETED|Overall Study||1
10944095|NCT00382733|12114674|FG002|NOT COMPLETED|Overall Study||0
10944096|NCT00382733|12114675|FG003|NOT COMPLETED|Overall Study||0
10944097|NCT00382733|12114676|FG004|NOT COMPLETED|Overall Study||0
10944098|NCT00382785|12114691|FG000|STARTED|Overall Study||25
10944099|NCT00382785|12114692|FG001|STARTED|Overall Study||26
10944100|NCT00382785|12114691|FG000|COMPLETED|Overall Study||25
10944101|NCT00382785|12114692|FG001|COMPLETED|Overall Study||26
10944102|NCT00382785|12114691|FG000|NOT COMPLETED|Overall Study||0
10944103|NCT00382785|12114692|FG001|NOT COMPLETED|Overall Study||0
10944104|NCT00382824|12114700|FG000|STARTED|Overall Study||32
10944105|NCT00382824|12114701|FG001|STARTED|Overall Study||29
10944106|NCT00382824|12114700|FG000|COMPLETED|Overall Study||20
10944107|NCT00382824|12114701|FG001|COMPLETED|Overall Study||16
10944108|NCT00382824|12114700|FG000|NOT COMPLETED|Overall Study||12
10944109|NCT00382824|12114701|FG001|NOT COMPLETED|Overall Study||13
10944110|NCT00382863|12114709|FG000|STARTED|Overall Study||96
10944111|NCT00382863|12114710|FG001|STARTED|Overall Study||114
10944112|NCT00382863|12114709|FG000|COMPLETED|Overall Study||81
10944113|NCT00382863|12114710|FG001|COMPLETED|Overall Study||78
10944114|NCT00382863|12114709|FG000|NOT COMPLETED|Overall Study||15
10944115|NCT00382863|12114710|FG001|NOT COMPLETED|Overall Study||36
10944116|NCT00382928|12114718|FG000|STARTED|Overall Study||97
10944117|NCT00382928|12114719|FG001|STARTED|Overall Study||95
10944118|NCT00382928|12114718|FG000|COMPLETED|Overall Study||97
10944119|NCT00382928|12114719|FG001|COMPLETED|Overall Study||95
10944120|NCT00382928|12114718|FG000|NOT COMPLETED|Overall Study||0
10944121|NCT00382928|12114719|FG001|NOT COMPLETED|Overall Study||0
10944122|NCT00382967|12114732|FG000|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
10944123|NCT00382967|12114733|FG001|STARTED|Overall Study||138
10944124|NCT00382967|12114732|FG000|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
10944125|NCT00382967|12114733|FG001|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
10944126|NCT00382967|12114732|FG000|NOT COMPLETED|Overall Study||1
10944127|NCT00382967|12114733|FG001|NOT COMPLETED|Overall Study||1
10944128|NCT00382993|12114739|FG000|STARTED|Migraine Attack 1 (Period 1)||84
10944129|NCT00382993|12114740|FG001|STARTED|Migraine Attack 1 (Period 1)||85
10944130|NCT00382993|12114739|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
10944131|NCT00382993|12114740|FG001|COMPLETED|Migraine Attack 1 (Period 1)||67
10944132|NCT00382993|12114739|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
10944133|NCT00382993|12114740|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
10944134|NCT00382993|12114739|FG000|STARTED|Migraine Attack 2 (Period 2)||70
10944135|NCT00382993|12114740|FG001|STARTED|Migraine Attack 2 (Period 2)||67
10944136|NCT00382993|12114739|FG000|COMPLETED|Migraine Attack 2 (Period 2)||68
10944137|NCT00382993|12114740|FG001|COMPLETED|Migraine Attack 2 (Period 2)||63
10944138|NCT00382993|12114739|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
10944139|NCT00382993|12114740|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
10944140|NCT00383019|12114748|FG000|STARTED|Overall Study||144
10944141|NCT00383019|12114749|FG001|STARTED|Overall Study||145
10944142|NCT00383019|12114748|FG000|COMPLETED|Overall Study||139
10944143|NCT00383019|12114749|FG001|COMPLETED|Overall Study||143
10944144|NCT00383019|12114748|FG000|NOT COMPLETED|Overall Study||5
10944145|NCT00383019|12114749|FG001|NOT COMPLETED|Overall Study||2
10944146|NCT00383071|12114759|FG000|STARTED|Overall Study||25
10944147|NCT00383071|12114760|FG001|STARTED|Overall Study||25
10944148|NCT00383071|12114761|FG002|STARTED|Overall Study||51
10944149|NCT00383071|12114762|FG003|STARTED|Overall Study||25
10944150|NCT00383071|12114759|FG000|COMPLETED|Overall Study||25
10944151|NCT00383071|12114760|FG001|COMPLETED|Overall Study||21
10944152|NCT00383071|12114761|FG002|COMPLETED|Overall Study||44
10944153|NCT00383071|12114762|FG003|COMPLETED|Overall Study||22
10944154|NCT00383071|12114759|FG000|NOT COMPLETED|Overall Study||0
10944155|NCT00383071|12114760|FG001|NOT COMPLETED|Overall Study||4
10944156|NCT00383071|12114761|FG002|NOT COMPLETED|Overall Study||7
10944157|NCT00383071|12114762|FG003|NOT COMPLETED|Overall Study||3
10944158|NCT00383084|12114774|FG000|STARTED|Overall Study||46
10944159|NCT00383084|12114775|FG001|STARTED|Overall Study||38
10944160|NCT00383084|12114774|FG000|COMPLETED|Overall Study||34
10944161|NCT00383084|12114775|FG001|COMPLETED|Overall Study||28
10944162|NCT00383084|12114774|FG000|NOT COMPLETED|Overall Study||12
10944163|NCT00383084|12114775|FG001|NOT COMPLETED|Overall Study||10
10944164|NCT00383110|12114783|FG000|STARTED|Overall Study||150
10944165|NCT00383110|12114784|FG001|STARTED|Overall Study||150
10944166|NCT00383110|12114783|FG000|COMPLETED|Overall Study||150
10944167|NCT00383110|12114784|FG001|COMPLETED|Overall Study||150
10944168|NCT00383110|12114783|FG000|NOT COMPLETED|Overall Study||0
10944169|NCT00383110|12114784|FG001|NOT COMPLETED|Overall Study||0
10944170|NCT00383123|12114793|FG000|STARTED|Overall Study||2115
10944171|NCT00383123|12114794|FG001|STARTED|Overall Study||1210
10944172|NCT00383123|12114793|FG000|COMPLETED|Overall Study||2004
10944173|NCT00383123|12114794|FG001|COMPLETED|Overall Study||1124
10944174|NCT00383123|12114793|FG000|NOT COMPLETED|Overall Study||111
10944175|NCT00383123|12114794|FG001|NOT COMPLETED|Overall Study||86
10944176|NCT00383149|12114800|FG000|STARTED|Overall Study||54
10944177|NCT00383149|12114800|FG000|COMPLETED|Overall Study||0
10944178|NCT00383149|12114800|FG000|NOT COMPLETED|Overall Study||54
10944179|NCT00383162|12114806|FG000|STARTED|Migraine Attack 1 (Period 1)||87
10944180|NCT00383162|12114807|FG001|STARTED|Migraine Attack 1 (Period 1)||86
10944181|NCT00383162|12114806|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
10944182|NCT00383162|12114807|FG001|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
10944183|NCT00383162|12114806|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
10944184|NCT00383162|12114807|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
10944185|NCT00383162|12114806|FG000|STARTED|Migraine Attack 2 (Period 2)||67
10944186|NCT00383162|12114807|FG001|STARTED|Migraine Attack 2 (Period 2)||73
10944187|NCT00383162|12114806|FG000|COMPLETED|Migraine Attack 2 (Period 2)||65
10944188|NCT00383162|12114807|FG001|COMPLETED|Migraine Attack 2 (Period 2)||66
10944189|NCT00383162|12114806|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
10944190|NCT00383162|12114807|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
10944191|NCT00383188|12114818|FG000|STARTED|Overall Study||69
10944192|NCT00383188|12114819|FG001|STARTED|Overall Study||74
10944193|NCT00383188|12114820|FG002|STARTED|Overall Study||44
10944194|NCT00383188|12114821|FG003|STARTED|Overall Study||40
10944195|NCT00383188|12114822|FG004|STARTED|Overall Study||75
10944196|NCT00383188|12114818|FG000|COMPLETED|Overall Study||52
10944197|NCT00383188|12114819|FG001|COMPLETED|Overall Study||63
10944198|NCT00383188|12114820|FG002|COMPLETED|Overall Study||31
10944199|NCT00383188|12114821|FG003|COMPLETED|Overall Study||28
10944200|NCT00383188|12114822|FG004|COMPLETED|Overall Study||52
10944201|NCT00383188|12114818|FG000|NOT COMPLETED|Overall Study||17
10944202|NCT00383188|12114819|FG001|NOT COMPLETED|Overall Study||11
10944203|NCT00383188|12114820|FG002|NOT COMPLETED|Overall Study||13
10944204|NCT00383188|12114821|FG003|NOT COMPLETED|Overall Study||12
10944205|NCT00383188|12114822|FG004|NOT COMPLETED|Overall Study||23
10944206|NCT00383266|12114836|FG000|STARTED|Overall Study||9
10944207|NCT00383266|12114836|FG000|COMPLETED|Overall Study||9
10944208|NCT00383266|12114836|FG000|NOT COMPLETED|Overall Study||0
10944209|NCT00383292|12114843|FG000|STARTED|Overall Study||68
10944210|NCT00383292|12114844|FG001|STARTED|Overall Study||32
10944211|NCT00383292|12114845|FG002|STARTED|Overall Study||30
10944212|NCT00383292|12114843|FG000|Received at Least One Dose of Study Drug|Overall Study||68
10944213|NCT00383292|12114844|FG001|Received at Least One Dose of Study Drug|Overall Study||32
10944214|NCT00383292|12114845|FG002|Received at Least One Dose of Study Drug|Overall Study||30
10944215|NCT00383292|12114843|FG000|COMPLETED|Overall Study||53
10944216|NCT00383292|12114844|FG001|COMPLETED|Overall Study||26
10944217|NCT00383292|12114845|FG002|COMPLETED|Overall Study||22
10944218|NCT00383292|12114843|FG000|NOT COMPLETED|Overall Study||15
10944219|NCT00383292|12114844|FG001|NOT COMPLETED|Overall Study||6
10944220|NCT00383292|12114845|FG002|NOT COMPLETED|Overall Study||8
10944221|NCT00383331|12114856|FG000|STARTED|Overall Study||10
10944222|NCT00383331|12114857|FG001|STARTED|Overall Study||9
10944223|NCT00383331|12114856|FG000|COMPLETED|Overall Study||10
10944224|NCT00383331|12114857|FG001|COMPLETED|Overall Study||8
10944225|NCT00383331|12114856|FG000|NOT COMPLETED|Overall Study||0
10944226|NCT00383331|12114857|FG001|NOT COMPLETED|Overall Study||1
10944227|NCT00383448|12114863|FG000|STARTED|Overall Study||38
10944228|NCT00383448|12114863|FG000|COMPLETED|Overall Study||38
10944229|NCT00383448|12114863|FG000|NOT COMPLETED|Overall Study||0
10944230|NCT00383500|12114871|FG000|STARTED|Overall Study||27
10944231|NCT00383500|12114872|FG001|STARTED|Overall Study||24
10944232|NCT00383500|12114873|FG002|STARTED|Overall Study||24
10944233|NCT00383500|12114871|FG000|COMPLETED|Overall Study||19
10944234|NCT00383500|12114872|FG001|COMPLETED|Overall Study||21
10944235|NCT00383500|12114873|FG002|COMPLETED|Overall Study||22
10944236|NCT00383500|12114871|FG000|NOT COMPLETED|Overall Study||8
10944237|NCT00383500|12114872|FG001|NOT COMPLETED|Overall Study||3
10944238|NCT00383500|12114873|FG002|NOT COMPLETED|Overall Study||2
10944239|NCT00383565|12114882|FG000|STARTED|Overall Study||9
10944240|NCT00383565|12114882|FG000|COMPLETED|Overall Study||9
10944241|NCT00383565|12114882|FG000|NOT COMPLETED|Overall Study||0
10944242|NCT00383643|12114889|FG000|STARTED|Overall Study||18
10944243|NCT00383643|12114890|FG001|STARTED|Overall Study||16
10944244|NCT00383643|12114891|FG002|STARTED|Overall Study||14
10944245|NCT00383643|12114889|FG000|COMPLETED|Overall Study||17
10944246|NCT00383643|12114890|FG001|COMPLETED|Overall Study||15
10944247|NCT00383643|12114891|FG002|COMPLETED|Overall Study||13
10944248|NCT00383643|12114889|FG000|NOT COMPLETED|Overall Study||1
10944249|NCT00383643|12114890|FG001|NOT COMPLETED|Overall Study||1
10944250|NCT00383643|12114891|FG002|NOT COMPLETED|Overall Study||1
10944251|NCT00383747|12114901|FG000|STARTED|Visit 1||14
10944252|NCT00383747|12114902|FG001|STARTED|Visit 1||14
10944253|NCT00383747|12114903|FG002|STARTED|Visit 1||16
10944254|NCT00383747|12114904|FG003|STARTED|Visit 1||16
10944255|NCT00383747|12114901|FG000|COMPLETED|Visit 1||14
10944256|NCT00383747|12114902|FG001|COMPLETED|Visit 1||14
10944257|NCT00383747|12114903|FG002|COMPLETED|Visit 1||16
10944258|NCT00383747|12114904|FG003|COMPLETED|Visit 1||16
10944259|NCT00383747|12114901|FG000|NOT COMPLETED|Visit 1||0
10944260|NCT00383747|12114902|FG001|NOT COMPLETED|Visit 1||0
10944261|NCT00383747|12114903|FG002|NOT COMPLETED|Visit 1||0
10944262|NCT00383747|12114904|FG003|NOT COMPLETED|Visit 1||0
10944263|NCT00383747|12114901|FG000|STARTED|Visit 2||14
10944264|NCT00383747|12114902|FG001|STARTED|Visit 2||14
10944265|NCT00383747|12114903|FG002|STARTED|Visit 2||16
10944266|NCT00383747|12114904|FG003|STARTED|Visit 2||16
10944267|NCT00383747|12114901|FG000|COMPLETED|Visit 2||14
10944268|NCT00383747|12114902|FG001|COMPLETED|Visit 2||14
10944269|NCT00383747|12114903|FG002|COMPLETED|Visit 2||16
10944270|NCT00383747|12114904|FG003|COMPLETED|Visit 2||16
10944271|NCT00383747|12114901|FG000|NOT COMPLETED|Visit 2||0
10944272|NCT00383747|12114902|FG001|NOT COMPLETED|Visit 2||0
10944273|NCT00383747|12114903|FG002|NOT COMPLETED|Visit 2||0
10944274|NCT00383747|12114904|FG003|NOT COMPLETED|Visit 2||0
10944275|NCT00383760|12114917|FG000|STARTED|Overall Study||15
10944276|NCT00383760|12114917|FG000|COMPLETED|Overall Study||15
10944277|NCT00383760|12114917|FG000|NOT COMPLETED|Overall Study||0
10944278|NCT00383786|12114924|FG000|STARTED|Overall Study||22
10944279|NCT00383786|12114925|FG001|STARTED|Overall Study||25
10944280|NCT00383786|12114924|FG000|COMPLETED|Overall Study||18
10944281|NCT00383786|12114925|FG001|COMPLETED|Overall Study||13
10944282|NCT00383786|12114924|FG000|NOT COMPLETED|Overall Study||4
10944283|NCT00383786|12114925|FG001|NOT COMPLETED|Overall Study||12
10944284|NCT00383942|12114933|FG000|STARTED|Overall Study||40
10944285|NCT00383942|12114934|FG001|STARTED|Overall Study||40
10944286|NCT00383942|12114933|FG000|COMPLETED|Overall Study||40
10944287|NCT00383942|12114934|FG001|COMPLETED|Overall Study||40
10944288|NCT00383942|12114933|FG000|NOT COMPLETED|Overall Study||0
10944289|NCT00383942|12114934|FG001|NOT COMPLETED|Overall Study||0
10944290|NCT00384033|12114944|FG000|STARTED|Overall Study||164
10944291|NCT00384033|12114945|FG001|STARTED|Overall Study||155
10944292|NCT00384033|12114946|FG002|STARTED|Overall Study||160
10944293|NCT00384033|12114947|FG003|STARTED|Overall Study||159
10944294|NCT00384033|12114944|FG000|Treated|Overall Study||161
10944295|NCT00384033|12114945|FG001|Treated|Overall Study||148
10944296|NCT00384033|12114946|FG002|Treated|Overall Study||150
10944297|NCT00384033|12114947|FG003|Treated|Overall Study||157
10944298|NCT00384033|12114944|FG000|COMPLETED|Overall Study||123
10944299|NCT00384033|12114945|FG001|COMPLETED|Overall Study||120
10944300|NCT00384033|12114946|FG002|COMPLETED|Overall Study||117
10944301|NCT00384033|12114947|FG003|COMPLETED|Overall Study||119
10944302|NCT00384033|12114944|FG000|NOT COMPLETED|Overall Study||41
10944303|NCT00384033|12114945|FG001|NOT COMPLETED|Overall Study||35
10944304|NCT00384033|12114946|FG002|NOT COMPLETED|Overall Study||43
10944305|NCT00384033|12114947|FG003|NOT COMPLETED|Overall Study||40
10944306|NCT00384059|12114959|FG000|STARTED|Infant Series||141
10944307|NCT00384059|12114960|FG001|STARTED|Infant Series||145
10944308|NCT00384059|12114959|FG000|Vaccinated Dose 1|Infant Series||139
10944309|NCT00384059|12114960|FG001|Vaccinated Dose 1|Infant Series||139
10944310|NCT00384059|12114959|FG000|Vaccinated Dose 2|Infant Series||136
10944311|NCT00384059|12114960|FG001|Vaccinated Dose 2|Infant Series||135
10944312|NCT00384059|12114959|FG000|COMPLETED|Infant Series||135
10944313|NCT00384059|12114960|FG001|COMPLETED|Infant Series||132
10944314|NCT00384059|12114959|FG000|NOT COMPLETED|Infant Series||6
10944315|NCT00384059|12114960|FG001|NOT COMPLETED|Infant Series||13
10944316|NCT00384059|12114959|FG000|STARTED|After Infant Series||135
10944317|NCT00384059|12114960|FG001|STARTED|After Infant Series||132
10944318|NCT00384059|12114959|FG000|COMPLETED|After Infant Series||131
10944319|NCT00384059|12114960|FG001|COMPLETED|After Infant Series||122
10944320|NCT00384059|12114959|FG000|NOT COMPLETED|After Infant Series||4
10944321|NCT00384059|12114960|FG001|NOT COMPLETED|After Infant Series||10
10944322|NCT00384059|12114959|FG000|STARTED|Toddler Dose||131
10944323|NCT00384059|12114960|FG001|STARTED|Toddler Dose||122
10944324|NCT00384059|12114959|FG000|COMPLETED|Toddler Dose||130
10944325|NCT00384059|12114960|FG001|COMPLETED|Toddler Dose||120
10944326|NCT00384059|12114959|FG000|NOT COMPLETED|Toddler Dose||1
10944327|NCT00384059|12114960|FG001|NOT COMPLETED|Toddler Dose||2
10944328|NCT00384085|12114990|FG000|STARTED|Overall Study|Randomized|195
10944329|NCT00384085|12114991|FG001|STARTED|Overall Study|Randomized|196
10944330|NCT00384085|12114992|FG002|STARTED|Overall Study|Randomized|197
10944331|NCT00384085|12114990|FG000|Intent-To-Treat (ITT)|Overall Study||195
10944332|NCT00384085|12114991|FG001|Intent-To-Treat (ITT)|Overall Study||196
10944333|NCT00384085|12114992|FG002|Intent-To-Treat (ITT)|Overall Study||197
10944334|NCT00384085|12114990|FG000|Treated (Safety Population)|Overall Study||194
10944335|NCT00384085|12114991|FG001|Treated (Safety Population)|Overall Study||194
10944336|NCT00384085|12114992|FG002|Treated (Safety Population)|Overall Study||194
10944337|NCT00384085|12114990|FG000|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
10944338|NCT00384085|12114991|FG001|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
10944339|NCT00384085|12114992|FG002|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
10944340|NCT00384085|12114990|FG000|COMPLETED|Overall Study|Based on the entire ITT population|156
10944341|NCT00384085|12114991|FG001|COMPLETED|Overall Study|Based on the entire ITT population|150
10944342|NCT00384085|12114992|FG002|COMPLETED|Overall Study|Based on the entire ITT population|141
10944343|NCT00384085|12114990|FG000|NOT COMPLETED|Overall Study||39
10944344|NCT00384085|12114991|FG001|NOT COMPLETED|Overall Study||46
10944345|NCT00384085|12114992|FG002|NOT COMPLETED|Overall Study||56
10944346|NCT00384176|12115005|FG000|STARTED|Overall Study||709
10944347|NCT00384176|12115006|FG001|STARTED|Overall Study||713
10944348|NCT00384176|12115007|FG002|STARTED|Overall Study||192
10944349|NCT00384176|12115005|FG000|COMPLETED|Overall Study||397
10944350|NCT00384176|12115006|FG001|COMPLETED|Overall Study||394
10944351|NCT00384176|12115007|FG002|COMPLETED|Overall Study||60
10944352|NCT00384176|12115005|FG000|NOT COMPLETED|Overall Study||312
10944353|NCT00384176|12115006|FG001|NOT COMPLETED|Overall Study||319
10944354|NCT00384176|12115007|FG002|NOT COMPLETED|Overall Study||132
10944355|NCT00384189|12115019|FG000|STARTED|Overall Study||305
10944356|NCT00384189|12115020|FG001|STARTED|Overall Study||312
10944357|NCT00384189|12115021|FG002|STARTED|Overall Study||313
10944358|NCT00384189|12115022|FG003|STARTED|Overall Study||150
10944359|NCT00384189|12115019|FG000|Randomized, Not Treated|Overall Study||1
10944360|NCT00384189|12115020|FG001|Randomized, Not Treated|Overall Study||0
10944361|NCT00384189|12115021|FG002|Randomized, Not Treated|Overall Study||2
10944362|NCT00384189|12115022|FG003|Randomized, Not Treated|Overall Study||4
10944363|NCT00384189|12115019|FG000|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
10944364|NCT00384189|12115020|FG001|Actual Treatment Received|Overall Study||312
10944365|NCT00384189|12115021|FG002|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
10944366|NCT00384189|12115022|FG003|Actual Treatment Received|Overall Study||146
10944367|NCT00384189|12115019|FG000|COMPLETED|Overall Study||255
10944368|NCT00384189|12115020|FG001|COMPLETED|Overall Study||255
10944369|NCT00384189|12115021|FG002|COMPLETED|Overall Study||255
10944370|NCT00384189|12115022|FG003|COMPLETED|Overall Study||110
10944371|NCT00384189|12115019|FG000|NOT COMPLETED|Overall Study||50
10944372|NCT00384189|12115020|FG001|NOT COMPLETED|Overall Study||57
10944373|NCT00384189|12115021|FG002|NOT COMPLETED|Overall Study||58
10944374|NCT00384189|12115022|FG003|NOT COMPLETED|Overall Study||40
10944375|NCT00384241|12115034|FG000|STARTED|Overall Study||500
10944376|NCT00384241|12115035|FG001|STARTED|Overall Study||599
10944377|NCT00384241|12115034|FG000|COMPLETED|Overall Study||500
10944378|NCT00384241|12115035|FG001|COMPLETED|Overall Study||599
10944379|NCT00384241|12115034|FG000|NOT COMPLETED|Overall Study||0
10944380|NCT00384241|12115035|FG001|NOT COMPLETED|Overall Study||0
10944381|NCT00384332|12115042|FG000|STARTED|Overall Study||13
10944382|NCT00384332|12115043|FG001|STARTED|Overall Study||10
10944383|NCT00384332|12115042|FG000|COMPLETED|Overall Study||9
10944384|NCT00384332|12115043|FG001|COMPLETED|Overall Study||10
10944385|NCT00384332|12115042|FG000|NOT COMPLETED|Overall Study||4
10944386|NCT00384332|12115043|FG001|NOT COMPLETED|Overall Study||0
10944387|NCT00384397|12115054|FG000|STARTED|Overall Study||407
10944388|NCT00384397|12115055|FG001|STARTED|Overall Study||293
10944389|NCT00384397|12115056|FG002|STARTED|Overall Study||418
10944390|NCT00384397|12115054|FG000|COMPLETED|Overall Study||375
10944391|NCT00384397|12115055|FG001|COMPLETED|Overall Study||247
10944392|NCT00384397|12115056|FG002|COMPLETED|Overall Study||385
10944393|NCT00384397|12115054|FG000|NOT COMPLETED|Overall Study||32
10944394|NCT00384397|12115055|FG001|NOT COMPLETED|Overall Study||46
10944395|NCT00384397|12115056|FG002|NOT COMPLETED|Overall Study||33
10944396|NCT00384449|12115064|FG000|STARTED|Overall Study||1
10944397|NCT00384449|12115064|FG000|COMPLETED|Overall Study||1
10944398|NCT00384449|12115064|FG000|NOT COMPLETED|Overall Study||0
10944399|NCT00384670|12115068|FG000|STARTED|Overall Study||7
10944400|NCT00384670|12115068|FG000|COMPLETED|Overall Study||7
10944401|NCT00384670|12115068|FG000|NOT COMPLETED|Overall Study||0
10944402|NCT00384748|12115074|FG000|STARTED|Overall Study||25
10944403|NCT00384748|12115075|FG001|STARTED|Overall Study||23
10944404|NCT00384748|12115074|FG000|COMPLETED|Overall Study||25
10944405|NCT00384748|12115075|FG001|COMPLETED|Overall Study||23
10944406|NCT00384748|12115074|FG000|NOT COMPLETED|Overall Study||0
10944407|NCT00384748|12115075|FG001|NOT COMPLETED|Overall Study||0
10944408|NCT00384774|12115088|FG000|STARTED|Overall Study||42
10944409|NCT00384774|12115089|FG001|STARTED|Overall Study||4
10944410|NCT00384774|12115090|FG002|STARTED|Overall Study||12
10944411|NCT00384774|12115091|FG003|STARTED|Overall Study||24
10944412|NCT00384774|12115092|FG004|STARTED|Overall Study||28
10944413|NCT00384774|12115093|FG005|STARTED|Overall Study||16
10944414|NCT00384774|12115094|FG006|STARTED|Overall Study||4
10944415|NCT00384774|12115088|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
10944416|NCT00384774|12115089|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
10944417|NCT00384774|12115090|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
10944418|NCT00384774|12115091|FG003|Received at Least 1 Dose of Study Drug|Overall Study||24
10944419|NCT00384774|12115092|FG004|Received at Least 1 Dose of Study Drug|Overall Study||28
10944420|NCT00384774|12115093|FG005|Received at Least 1 Dose of Study Drug|Overall Study||16
10944421|NCT00384774|12115094|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4
10944422|NCT00384774|12115088|FG000|COMPLETED|Overall Study||42
10944423|NCT00384774|12115089|FG001|COMPLETED|Overall Study||4
10944424|NCT00384774|12115090|FG002|COMPLETED|Overall Study||12
10944425|NCT00384774|12115091|FG003|COMPLETED|Overall Study||24
10944426|NCT00384774|12115092|FG004|COMPLETED|Overall Study||28
10944427|NCT00384774|12115093|FG005|COMPLETED|Overall Study||16
10944428|NCT00384774|12115094|FG006|COMPLETED|Overall Study||4
10944429|NCT00384774|12115088|FG000|NOT COMPLETED|Overall Study||0
10944430|NCT00384774|12115089|FG001|NOT COMPLETED|Overall Study||0
10944431|NCT00384774|12115090|FG002|NOT COMPLETED|Overall Study||0
10944432|NCT00384774|12115091|FG003|NOT COMPLETED|Overall Study||0
10944433|NCT00384774|12115092|FG004|NOT COMPLETED|Overall Study||0
10944434|NCT00384774|12115093|FG005|NOT COMPLETED|Overall Study||0
10944435|NCT00384774|12115094|FG006|NOT COMPLETED|Overall Study||0
10944436|NCT00384813|12115112|FG000|STARTED|Overall Study||23
10944437|NCT00384813|12115113|FG001|STARTED|Overall Study||20
10944438|NCT00384813|12115112|FG000|COMPLETED|Overall Study||21
10944439|NCT00384813|12115113|FG001|COMPLETED|Overall Study||20
10944440|NCT00384813|12115112|FG000|NOT COMPLETED|Overall Study||2
10944441|NCT00384813|12115113|FG001|NOT COMPLETED|Overall Study||0
10944442|NCT00384839|12115119|FG000|STARTED|Overall Study||36
10944443|NCT00384839|12115119|FG000|COMPLETED|Overall Study||28
10944444|NCT00384839|12115119|FG000|NOT COMPLETED|Overall Study||8
10944445|NCT00384865|12115127|FG000|STARTED|Overall Study||16
10944446|NCT00384865|12115128|FG001|STARTED|Overall Study||16
10944447|NCT00384865|12115129|FG002|STARTED|Overall Study||16
10944448|NCT00384865|12115130|FG003|STARTED|Overall Study||16
10944449|NCT00384865|12115127|FG000|Completed Six Month Assessment|Overall Study||11
10944450|NCT00384865|12115128|FG001|Completed Six Month Assessment|Overall Study||12
10944451|NCT00384865|12115129|FG002|Completed Six Month Assessment|Overall Study||15
10944452|NCT00384865|12115130|FG003|Completed Six Month Assessment|Overall Study||11
10944453|NCT00384865|12115127|FG000|COMPLETED|Overall Study||16
10944454|NCT00384865|12115128|FG001|COMPLETED|Overall Study||16
10944455|NCT00384865|12115129|FG002|COMPLETED|Overall Study||16
10944456|NCT00384865|12115130|FG003|COMPLETED|Overall Study||16
10944457|NCT00384865|12115127|FG000|NOT COMPLETED|Overall Study||0
10944458|NCT00384865|12115128|FG001|NOT COMPLETED|Overall Study||0
10944459|NCT00384865|12115129|FG002|NOT COMPLETED|Overall Study||0
10944460|NCT00384865|12115130|FG003|NOT COMPLETED|Overall Study||0
10944461|NCT00384930|12115145|FG000|STARTED|Overall Study||212
10944462|NCT00384930|12115146|FG001|STARTED|Overall Study||209
10944463|NCT00384930|12115147|FG002|STARTED|Overall Study||212
10944464|NCT00384930|12115148|FG003|STARTED|Overall Study||216
10944465|NCT00384930|12115149|FG004|STARTED|Overall Study||209
10944466|NCT00384930|12115145|FG000|Received Double-Blind Study Drug|Overall Study||211
10944467|NCT00384930|12115146|FG001|Received Double-Blind Study Drug|Overall Study||208
10944468|NCT00384930|12115147|FG002|Received Double-Blind Study Drug|Overall Study||212
10944469|NCT00384930|12115148|FG003|Received Double-Blind Study Drug|Overall Study||216
10944470|NCT00384930|12115149|FG004|Received Double-Blind Study Drug|Overall Study||209
10944471|NCT00384930|12115145|FG000|COMPLETED|Overall Study||185
10944472|NCT00384930|12115146|FG001|COMPLETED|Overall Study||182
10944473|NCT00384930|12115147|FG002|COMPLETED|Overall Study||182
10944474|NCT00384930|12115148|FG003|COMPLETED|Overall Study||175
10944475|NCT00384930|12115149|FG004|COMPLETED|Overall Study||162
10944476|NCT00384930|12115145|FG000|NOT COMPLETED|Overall Study||27
10944477|NCT00384930|12115146|FG001|NOT COMPLETED|Overall Study||27
10944478|NCT00384930|12115147|FG002|NOT COMPLETED|Overall Study||30
10944479|NCT00384930|12115148|FG003|NOT COMPLETED|Overall Study||41
10944480|NCT00384930|12115149|FG004|NOT COMPLETED|Overall Study||47
10944481|NCT00384956|12115164|FG000|STARTED|Overall Study||25
10944482|NCT00384956|12115164|FG000|COMPLETED|Overall Study||22
10944483|NCT00384956|12115164|FG000|NOT COMPLETED|Overall Study||3
10944484|NCT00385008|12115170|FG000|STARTED|Overall Study||10
10944485|NCT00385008|12115171|FG001|STARTED|Overall Study||10
10944486|NCT00385008|12115170|FG000|In Absence of Migraine|Overall Study||10
10944487|NCT00385008|12115171|FG001|In Absence of Migraine|Overall Study||10
10944488|NCT00385008|12115170|FG000|In Presence of Migraine|Overall Study||5
10944489|NCT00385008|12115171|FG001|In Presence of Migraine|Overall Study||5
10944490|NCT00385008|12115170|FG000|COMPLETED|Overall Study||10
10944491|NCT00385008|12115171|FG001|COMPLETED|Overall Study||10
10944492|NCT00385008|12115170|FG000|NOT COMPLETED|Overall Study||0
10944493|NCT00385008|12115171|FG001|NOT COMPLETED|Overall Study||0
10944494|NCT00385138|12115180|FG000|STARTED|Overall Study||2695
10944495|NCT00385138|12115181|FG001|STARTED|Overall Study||2669
10944496|NCT00385138|12115180|FG000|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
10944497|NCT00385138|12115181|FG001|Intent-to-treat (ITT)|Overall Study||2669
10944498|NCT00385138|12115180|FG000|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
10944499|NCT00385138|12115181|FG001|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
10944500|NCT00385138|12115180|FG000|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
10944501|NCT00385138|12115181|FG001|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
10944502|NCT00385138|12115180|FG000|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
10944503|NCT00385138|12115181|FG001|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
10944504|NCT00385138|12115180|FG000|NOT COMPLETED|Overall Study||30
10944505|NCT00385138|12115181|FG001|NOT COMPLETED|Overall Study||28
10944506|NCT00385203|12115189|FG000|STARTED|Overall Study||26
10944507|NCT00385203|12115190|FG001|STARTED|Overall Study||10
10944508|NCT00385203|12115189|FG000|COMPLETED|Overall Study||0
10944509|NCT00385203|12115190|FG001|COMPLETED|Overall Study||3
10944510|NCT00385203|12115189|FG000|NOT COMPLETED|Overall Study||26
10944511|NCT00385203|12115190|FG001|NOT COMPLETED|Overall Study||7
10944512|NCT00385216|12115197|FG000|STARTED|First Intervention||11
10944513|NCT00385216|12115198|FG001|STARTED|First Intervention||9
10944514|NCT00385216|12115197|FG000|COMPLETED|First Intervention||11
10944515|NCT00385216|12115198|FG001|COMPLETED|First Intervention||9
10944516|NCT00385216|12115197|FG000|NOT COMPLETED|First Intervention||0
10944517|NCT00385216|12115198|FG001|NOT COMPLETED|First Intervention||0
10944518|NCT00385216|12115197|FG000|STARTED|Second Intervention||11
10944519|NCT00385216|12115198|FG001|STARTED|Second Intervention||9
10944520|NCT00385216|12115197|FG000|COMPLETED|Second Intervention||11
10944521|NCT00385216|12115198|FG001|COMPLETED|Second Intervention||9
10944522|NCT00385216|12115197|FG000|NOT COMPLETED|Second Intervention||0
10944523|NCT00385216|12115198|FG001|NOT COMPLETED|Second Intervention||0
10944524|NCT00385255|12115206|FG000|STARTED|Overall Study||860
10944525|NCT00385255|12115207|FG001|STARTED|Overall Study||858
10944526|NCT00385255|12115206|FG000|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
10944527|NCT00385255|12115207|FG001|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
10944528|NCT00385255|12115206|FG000|19-64 Years of Age (YOA) Cohort|Overall Study||748
10944529|NCT00385255|12115207|FG001|19-64 Years of Age (YOA) Cohort|Overall Study||749
10944530|NCT00385255|12115206|FG000|COMPLETED|Overall Study||839
10944531|NCT00385255|12115207|FG001|COMPLETED|Overall Study||785
10944532|NCT00385255|12115206|FG000|NOT COMPLETED|Overall Study||21
10944533|NCT00385255|12115207|FG001|NOT COMPLETED|Overall Study||73
10944534|NCT00385268|12115219|FG000|STARTED|Overall Study||34
10944535|NCT00385268|12115220|FG001|STARTED|Overall Study||26
10944536|NCT00385268|12115219|FG000|COMPLETED|Overall Study||18
10944537|NCT00385268|12115220|FG001|COMPLETED|Overall Study||18
10944538|NCT00385268|12115219|FG000|NOT COMPLETED|Overall Study||16
10944539|NCT00385268|12115220|FG001|NOT COMPLETED|Overall Study||8
10944540|NCT00385541|12115228|FG000|STARTED|Overall Study||25
10944541|NCT00385541|12115229|FG001|STARTED|Overall Study||25
10944542|NCT00385541|12115228|FG000|COMPLETED|Overall Study||25
10944543|NCT00385541|12115229|FG001|COMPLETED|Overall Study||24
10944544|NCT00385541|12115228|FG000|NOT COMPLETED|Overall Study||0
10944545|NCT00385541|12115229|FG001|NOT COMPLETED|Overall Study||1
10944546|NCT00385580|12115237|FG000|STARTED|Overall Study|Number of participants treated.|48
10944547|NCT00385580|12115238|FG001|STARTED|Overall Study|Number of participants treated.|47
10944548|NCT00385580|12115237|FG000|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
10944549|NCT00385580|12115238|FG001|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
10944550|NCT00385580|12115237|FG000|NOT COMPLETED|Overall Study||0
10944551|NCT00385580|12115238|FG001|NOT COMPLETED|Overall Study||0
10944552|NCT00385593|12115256|FG000|STARTED|Overall Study||328
10944553|NCT00385593|12115257|FG001|STARTED|Overall Study||326
10944554|NCT00385593|12115256|FG000|COMPLETED|Overall Study||270
10944555|NCT00385593|12115257|FG001|COMPLETED|Overall Study||289
10944556|NCT00385593|12115256|FG000|NOT COMPLETED|Overall Study||58
10944557|NCT00385593|12115257|FG001|NOT COMPLETED|Overall Study||37
10944558|NCT00385671|12115266|FG000|STARTED|Overall Study||134
10944559|NCT00385671|12115267|FG001|STARTED|Overall Study||138
10944560|NCT00385671|12115268|FG002|STARTED|Overall Study||135
10944561|NCT00385671|12115266|FG000|COMPLETED|Overall Study||96
10944562|NCT00385671|12115267|FG001|COMPLETED|Overall Study||87
10944563|NCT00385671|12115268|FG002|COMPLETED|Overall Study||99
10944564|NCT00385671|12115266|FG000|NOT COMPLETED|Overall Study||38
10944565|NCT00385671|12115267|FG001|NOT COMPLETED|Overall Study||51
10944566|NCT00385671|12115268|FG002|NOT COMPLETED|Overall Study||36
10944567|NCT00385684|12115278|FG000|STARTED|FIRST INTERVENTION OF PHASE A||6
10944568|NCT00385684|12115279|FG001|STARTED|FIRST INTERVENTION OF PHASE A||5
10944569|NCT00385684|12115278|FG000|COMPLETED|FIRST INTERVENTION OF PHASE A||5
10944570|NCT00385684|12115279|FG001|COMPLETED|FIRST INTERVENTION OF PHASE A||5
10944571|NCT00385684|12115278|FG000|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
10944572|NCT00385684|12115279|FG001|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
10944573|NCT00385684|12115278|FG000|STARTED|SECOND INTERVENTION OF PHASE A||5
10944574|NCT00385684|12115279|FG001|STARTED|SECOND INTERVENTION OF PHASE A||5
10944575|NCT00385684|12115278|FG000|COMPLETED|SECOND INTERVENTION OF PHASE A||5
10944576|NCT00385684|12115279|FG001|COMPLETED|SECOND INTERVENTION OF PHASE A||3
10944577|NCT00385684|12115278|FG000|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
10944578|NCT00385684|12115279|FG001|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
10944579|NCT00385684|12115278|FG000|STARTED|PHASE B||5
10944580|NCT00385684|12115279|FG001|STARTED|PHASE B||3
10944581|NCT00385684|12115278|FG000|COMPLETED|PHASE B||5
10944582|NCT00385684|12115279|FG001|COMPLETED|PHASE B||3
10944583|NCT00385684|12115278|FG000|NOT COMPLETED|PHASE B||0
10944584|NCT00385684|12115279|FG001|NOT COMPLETED|PHASE B||0
10944585|NCT00385723|12115288|FG000|STARTED|Overall Study||46
10944586|NCT00385723|12115289|FG001|STARTED|Overall Study||46
10944587|NCT00385723|12115290|FG002|STARTED|Overall Study||46
10944588|NCT00385723|12115288|FG000|COMPLETED|Overall Study||44
10944589|NCT00385723|12115289|FG001|COMPLETED|Overall Study||45
10944590|NCT00385723|12115290|FG002|COMPLETED|Overall Study||44
10944591|NCT00385723|12115288|FG000|NOT COMPLETED|Overall Study||2
10944592|NCT00385723|12115289|FG001|NOT COMPLETED|Overall Study||1
10944593|NCT00385723|12115290|FG002|NOT COMPLETED|Overall Study||2
10944594|NCT00385736|12115301|FG000|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
10944595|NCT00385736|12115302|FG001|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
10944596|NCT00385736|12115303|FG002|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
10944597|NCT00385736|12115301|FG000|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
10944598|NCT00385736|12115302|FG001|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
10944599|NCT00385736|12115303|FG002|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
10944600|NCT00385736|12115301|FG000|NOT COMPLETED|Efficacy Analysis Set - Induction||9
10944601|NCT00385736|12115302|FG001|NOT COMPLETED|Efficacy Analysis Set - Induction||12
10944602|NCT00385736|12115303|FG002|NOT COMPLETED|Efficacy Analysis Set - Induction||9
10944603|NCT00385736|12115301|FG000|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
10944604|NCT00385736|12115302|FG001|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
10944605|NCT00385736|12115303|FG002|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
10944606|NCT00385736|12115301|FG000|COMPLETED|Efficacy Analysis Set - Maintenance||153
10944607|NCT00385736|12115302|FG001|COMPLETED|Efficacy Analysis Set - Maintenance||86
10944608|NCT00385736|12115303|FG002|COMPLETED|Efficacy Analysis Set - Maintenance||143
10944609|NCT00385736|12115301|FG000|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
10944610|NCT00385736|12115302|FG001|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
10944611|NCT00385736|12115303|FG002|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
10944612|NCT00385736|12115301|FG000|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
10944613|NCT00385736|12115302|FG001|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
10944614|NCT00385736|12115303|FG002|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
10944615|NCT00385736|12115301|FG000|COMPLETED|Safety Analysis Set||153
10944616|NCT00385736|12115302|FG001|COMPLETED|Safety Analysis Set||86
10944617|NCT00385736|12115303|FG002|COMPLETED|Safety Analysis Set||143
10944618|NCT00385736|12115301|FG000|NOT COMPLETED|Safety Analysis Set||70
10944619|NCT00385736|12115302|FG001|NOT COMPLETED|Safety Analysis Set||44
10944620|NCT00385736|12115303|FG002|NOT COMPLETED|Safety Analysis Set||80
10944621|NCT00385762|12115314|FG000|STARTED|Overall Study||35
10944622|NCT00385762|12115314|FG000|COMPLETED|Overall Study||33
10944623|NCT00385762|12115314|FG000|NOT COMPLETED|Overall Study||2
10944624|NCT00385788|12115320|FG000|STARTED|Overall Study||12
10944625|NCT00385788|12115321|FG001|STARTED|Overall Study||40
10944626|NCT00385788|12115320|FG000|COMPLETED|Overall Study||12
10944627|NCT00385788|12115321|FG001|COMPLETED|Overall Study||40
10944628|NCT00385788|12115320|FG000|NOT COMPLETED|Overall Study||0
10944629|NCT00385788|12115321|FG001|NOT COMPLETED|Overall Study||0
10944630|NCT00385801|12115329|FG000|STARTED|Overall Study||15
10944631|NCT00385801|12115330|FG001|STARTED|Overall Study||16
10944632|NCT00385801|12115329|FG000|COMPLETED|Overall Study||6
10944633|NCT00385801|12115330|FG001|COMPLETED|Overall Study||8
10944634|NCT00385801|12115329|FG000|NOT COMPLETED|Overall Study||9
10944635|NCT00385801|12115330|FG001|NOT COMPLETED|Overall Study||8
10944636|NCT00385827|12115340|FG000|STARTED|Part 1||9
10944637|NCT00385827|12115341|FG001|STARTED|Part 1||0
10944638|NCT00385827|12115342|FG002|STARTED|Part 1||0
10944639|NCT00385827|12115340|FG000|Treated|Part 1||9
10944640|NCT00385827|12115341|FG001|Treated|Part 1||0
10944641|NCT00385827|12115342|FG002|Treated|Part 1||0
10944642|NCT00385827|12115340|FG000|COMPLETED|Part 1||0
10944643|NCT00385827|12115341|FG001|COMPLETED|Part 1||0
10944644|NCT00385827|12115342|FG002|COMPLETED|Part 1||0
10944645|NCT00385827|12115340|FG000|NOT COMPLETED|Part 1||9
10944646|NCT00385827|12115341|FG001|NOT COMPLETED|Part 1||0
10944647|NCT00385827|12115342|FG002|NOT COMPLETED|Part 1||0
10944648|NCT00385827|12115340|FG000|STARTED|Part 2||0
10944649|NCT00385827|12115341|FG001|STARTED|Part 2||49
10944650|NCT00385827|12115342|FG002|STARTED|Part 2||48
10944651|NCT00385827|12115340|FG000|Treated|Part 2||0
10944652|NCT00385827|12115341|FG001|Treated|Part 2||47
10944653|NCT00385827|12115342|FG002|Treated|Part 2||46
10944654|NCT00385827|12115340|FG000|COMPLETED|Part 2||0
10944655|NCT00385827|12115341|FG001|COMPLETED|Part 2||16
10944656|NCT00385827|12115342|FG002|COMPLETED|Part 2||0
10944657|NCT00385827|12115340|FG000|NOT COMPLETED|Part 2||0
10944658|NCT00385827|12115341|FG001|NOT COMPLETED|Part 2||33
10944659|NCT00385827|12115342|FG002|NOT COMPLETED|Part 2||48
10944660|NCT00385840|12115354|FG000|STARTED|Overall Study||133
10944661|NCT00385840|12115355|FG001|STARTED|Overall Study||545
10944662|NCT00385840|12115354|FG000|COMPLETED|Overall Study||129
10944663|NCT00385840|12115355|FG001|COMPLETED|Overall Study||531
10944664|NCT00385840|12115354|FG000|NOT COMPLETED|Overall Study||4
10944665|NCT00385840|12115355|FG001|NOT COMPLETED|Overall Study||14
10944666|NCT00385918|12115363|FG000|STARTED|Feasibility & Baseline Measurement Phase||0
10944667|NCT00385918|12115364|FG001|STARTED|Feasibility & Baseline Measurement Phase||0
10944668|NCT00385918|12115365|FG002|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
10944669|NCT00385918|12115363|FG000|Number Eligible|Feasibility & Baseline Measurement Phase||0
10944670|NCT00385918|12115364|FG001|Number Eligible|Feasibility & Baseline Measurement Phase||0
10944671|NCT00385918|12115365|FG002|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
10944833|NCT00386607|12115517|FG000|STARTED|Extension||0
10944672|NCT00385918|12115363|FG000|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
10944673|NCT00385918|12115364|FG001|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
10944674|NCT00385918|12115365|FG002|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
10944675|NCT00385918|12115363|FG000|COMPLETED|Feasibility & Baseline Measurement Phase||0
10944676|NCT00385918|12115364|FG001|COMPLETED|Feasibility & Baseline Measurement Phase||0
10944677|NCT00385918|12115365|FG002|COMPLETED|Feasibility & Baseline Measurement Phase||21
10944678|NCT00385918|12115363|FG000|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
10944679|NCT00385918|12115364|FG001|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
10944680|NCT00385918|12115365|FG002|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
10944681|NCT00385918|12115363|FG000|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
10944682|NCT00385918|12115364|FG001|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
10944683|NCT00385918|12115365|FG002|STARTED|Intervention Phase After Randomization||0
10944684|NCT00385918|12115363|FG000|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
10944685|NCT00385918|12115364|FG001|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
10944686|NCT00385918|12115365|FG002|COMPLETED|Intervention Phase After Randomization||0
10944687|NCT00385918|12115363|FG000|NOT COMPLETED|Intervention Phase After Randomization||3
10944688|NCT00385918|12115364|FG001|NOT COMPLETED|Intervention Phase After Randomization||0
10944689|NCT00385918|12115365|FG002|NOT COMPLETED|Intervention Phase After Randomization||0
10944690|NCT00385944|12115374|FG000|STARTED|Loading Dose||0
10944691|NCT00385944|12115375|FG001|STARTED|Loading Dose||0
10944692|NCT00385944|12115376|FG002|STARTED|Loading Dose||56
10944693|NCT00385944|12115374|FG000|COMPLETED|Loading Dose||0
10944694|NCT00385944|12115375|FG001|COMPLETED|Loading Dose||0
10944695|NCT00385944|12115376|FG002|COMPLETED|Loading Dose||56
10944696|NCT00385944|12115374|FG000|NOT COMPLETED|Loading Dose||0
10944697|NCT00385944|12115375|FG001|NOT COMPLETED|Loading Dose||0
10944698|NCT00385944|12115376|FG002|NOT COMPLETED|Loading Dose||0
10944699|NCT00385944|12115374|FG000|STARTED|1st Maintenance Dose Period||29
10944700|NCT00385944|12115375|FG001|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
10944701|NCT00385944|12115376|FG002|STARTED|1st Maintenance Dose Period||0
10944702|NCT00385944|12115374|FG000|COMPLETED|1st Maintenance Dose Period||25
10944703|NCT00385944|12115375|FG001|COMPLETED|1st Maintenance Dose Period||24
10944704|NCT00385944|12115376|FG002|COMPLETED|1st Maintenance Dose Period||0
10944705|NCT00385944|12115374|FG000|NOT COMPLETED|1st Maintenance Dose Period||4
10944706|NCT00385944|12115375|FG001|NOT COMPLETED|1st Maintenance Dose Period||1
10944707|NCT00385944|12115376|FG002|NOT COMPLETED|1st Maintenance Dose Period||0
10944708|NCT00385944|12115374|FG000|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
10944709|NCT00385944|12115375|FG001|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
10944710|NCT00385944|12115376|FG002|STARTED|2nd Maintenance Dose Period||0
10944711|NCT00385944|12115374|FG000|COMPLETED|2nd Maintenance Dose Period||22
10944712|NCT00385944|12115375|FG001|COMPLETED|2nd Maintenance Dose Period||19
10944713|NCT00385944|12115376|FG002|COMPLETED|2nd Maintenance Dose Period||0
10944714|NCT00385944|12115374|FG000|NOT COMPLETED|2nd Maintenance Dose Period||2
10944715|NCT00385944|12115375|FG001|NOT COMPLETED|2nd Maintenance Dose Period||3
10944716|NCT00385944|12115376|FG002|NOT COMPLETED|2nd Maintenance Dose Period||0
10944717|NCT00385996|12115391|FG000|STARTED|Overall Study||22
10944718|NCT00385996|12115391|FG000|COMPLETED|Overall Study||22
10944719|NCT00385996|12115391|FG000|NOT COMPLETED|Overall Study||0
10944720|NCT00386009|12115398|FG000|STARTED|Overall Study||101
10944721|NCT00386009|12115399|FG001|STARTED|Overall Study||99
10944722|NCT00386009|12115398|FG000|COMPLETED|Overall Study||92
10944723|NCT00386009|12115399|FG001|COMPLETED|Overall Study||89
10944724|NCT00386009|12115398|FG000|NOT COMPLETED|Overall Study||9
10944725|NCT00386009|12115399|FG001|NOT COMPLETED|Overall Study||10
10944726|NCT00386022|12115407|FG000|STARTED|Baseline||10
10944727|NCT00386022|12115408|FG001|STARTED|Baseline||9
10944728|NCT00386022|12115407|FG000|All Doses of GnRH|Baseline||10
10944729|NCT00386022|12115408|FG001|All Doses of GnRH|Baseline||9
10944730|NCT00386022|12115407|FG000|COMPLETED|Baseline||10
10944731|NCT00386022|12115408|FG001|COMPLETED|Baseline||9
10944732|NCT00386022|12115407|FG000|NOT COMPLETED|Baseline||0
10944733|NCT00386022|12115408|FG001|NOT COMPLETED|Baseline||0
10944734|NCT00386022|12115407|FG000|STARTED|Plus Estrogen||10
10944735|NCT00386022|12115408|FG001|STARTED|Plus Estrogen||9
10944736|NCT00386022|12115407|FG000|Estrogen Patch|Plus Estrogen||8
10944737|NCT00386022|12115408|FG001|Estrogen Patch|Plus Estrogen||9
10944738|NCT00386022|12115407|FG000|All Doses GnRH|Plus Estrogen||8
10944739|NCT00386022|12115408|FG001|All Doses GnRH|Plus Estrogen||8
10944740|NCT00386022|12115407|FG000|COMPLETED|Plus Estrogen||8
10944741|NCT00386022|12115408|FG001|COMPLETED|Plus Estrogen||8
10944742|NCT00386022|12115407|FG000|NOT COMPLETED|Plus Estrogen||2
10944743|NCT00386022|12115408|FG001|NOT COMPLETED|Plus Estrogen||1
10944744|NCT00386100|12115418|FG000|STARTED|Overall Study||340
10944745|NCT00386100|12115419|FG001|STARTED|Overall Study||348
10944746|NCT00386100|12115418|FG000|COMPLETED|Overall Study||186
10944747|NCT00386100|12115419|FG001|COMPLETED|Overall Study||217
10944748|NCT00386100|12115418|FG000|NOT COMPLETED|Overall Study||154
10944749|NCT00386100|12115419|FG001|NOT COMPLETED|Overall Study||131
10944750|NCT00386152|12115428|FG000|STARTED|Overall Study|number of subjects treated|75
10944751|NCT00386152|12115429|FG001|STARTED|Overall Study|number of subjects treated|77
10944752|NCT00386152|12115430|FG002|STARTED|Overall Study|number of subjects treated|75
10944753|NCT00386152|12115428|FG000|COMPLETED|Overall Study||31
10944754|NCT00386152|12115429|FG001|COMPLETED|Overall Study||37
10944755|NCT00386152|12115430|FG002|COMPLETED|Overall Study||42
10944756|NCT00386152|12115428|FG000|NOT COMPLETED|Overall Study||44
10944757|NCT00386152|12115429|FG001|NOT COMPLETED|Overall Study||40
10944758|NCT00386152|12115430|FG002|NOT COMPLETED|Overall Study||33
10944759|NCT00386243|12115440|FG000|STARTED|Overall Study||121
10944760|NCT00386243|12115441|FG001|STARTED|Overall Study||121
10944761|NCT00386243|12115440|FG000|COMPLETED|Overall Study||114
10944762|NCT00386243|12115441|FG001|COMPLETED|Overall Study||108
10944763|NCT00386243|12115440|FG000|NOT COMPLETED|Overall Study||7
10944764|NCT00386243|12115441|FG001|NOT COMPLETED|Overall Study||13
10944765|NCT00386256|12115451|FG000|STARTED|Overall Study||16
10944766|NCT00386256|12115452|FG001|STARTED|Overall Study||15
10944767|NCT00386256|12115453|FG002|STARTED|Overall Study||4
10944768|NCT00386256|12115454|FG003|STARTED|Overall Study||3
10944769|NCT00386256|12115451|FG000|COMPLETED|Overall Study||16
10944770|NCT00386256|12115452|FG001|COMPLETED|Overall Study||15
10944771|NCT00386256|12115453|FG002|COMPLETED|Overall Study||4
10944772|NCT00386256|12115454|FG003|COMPLETED|Overall Study||3
10944773|NCT00386256|12115451|FG000|NOT COMPLETED|Overall Study||0
10944774|NCT00386256|12115452|FG001|NOT COMPLETED|Overall Study||0
10944775|NCT00386256|12115453|FG002|NOT COMPLETED|Overall Study||0
10944776|NCT00386256|12115454|FG003|NOT COMPLETED|Overall Study||0
10944777|NCT00386308|12115466|FG000|STARTED|Overall Study||123
10944778|NCT00386308|12115467|FG001|STARTED|Overall Study||73
10944779|NCT00386308|12115466|FG000|Intent to Treat Population|Overall Study||117
10944780|NCT00386308|12115467|FG001|Intent to Treat Population|Overall Study||72
10944781|NCT00386308|12115466|FG000|Modified Intent to Treat Population|Overall Study||115
10944782|NCT00386308|12115467|FG001|Modified Intent to Treat Population|Overall Study||72
10944783|NCT00386308|12115466|FG000|COMPLETED|Overall Study||94
10944784|NCT00386308|12115467|FG001|COMPLETED|Overall Study||54
10944785|NCT00386308|12115466|FG000|NOT COMPLETED|Overall Study||29
10944786|NCT00386308|12115467|FG001|NOT COMPLETED|Overall Study||19
10944787|NCT00386334|12115475|FG000|STARTED|Double Blind Period||194
10944788|NCT00386334|12115476|FG001|STARTED|Double Blind Period||194
10944789|NCT00386334|12115475|FG000|COMPLETED|Double Blind Period||148
10944790|NCT00386334|12115476|FG001|COMPLETED|Double Blind Period||147
10944791|NCT00386334|12115475|FG000|NOT COMPLETED|Double Blind Period||46
10944792|NCT00386334|12115476|FG001|NOT COMPLETED|Double Blind Period||47
10944793|NCT00386334|12115475|FG000|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
10944794|NCT00386334|12115476|FG001|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
10944795|NCT00386334|12115475|FG000|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
10944796|NCT00386334|12115476|FG001|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
10944797|NCT00386334|12115475|FG000|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
10944798|NCT00386334|12115476|FG001|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
10944799|NCT00386360|12115484|FG000|STARTED|Overall Study||49
10944800|NCT00386360|12115485|FG001|STARTED|Overall Study||112
10944801|NCT00386360|12115484|FG000|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
10944802|NCT00386360|12115485|FG001|Intent to Treat Population (ITT)|Overall Study||110
10944803|NCT00386360|12115484|FG000|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
10944804|NCT00386360|12115485|FG001|Primary Efficacy|Overall Study||77
10944805|NCT00386360|12115484|FG000|COMPLETED|Overall Study||40
10944806|NCT00386360|12115485|FG001|COMPLETED|Overall Study||95
10944807|NCT00386360|12115484|FG000|NOT COMPLETED|Overall Study||9
10944808|NCT00386360|12115485|FG001|NOT COMPLETED|Overall Study||17
10944809|NCT00386425|12115494|FG000|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
10944810|NCT00386425|12115495|FG001|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
10944811|NCT00386425|12115496|FG002|STARTED|Overall Study||53
10944812|NCT00386425|12115494|FG000|Received Study Drug|Overall Study||227
10944813|NCT00386425|12115495|FG001|Received Study Drug|Overall Study||206
10944814|NCT00386425|12115496|FG002|Received Study Drug|Overall Study||53
10944815|NCT00386425|12115494|FG000|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
10944816|NCT00386425|12115495|FG001|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
10944817|NCT00386425|12115496|FG002|COMPLETED|Overall Study||53
10944818|NCT00386425|12115494|FG000|NOT COMPLETED|Overall Study||3
10944819|NCT00386425|12115495|FG001|NOT COMPLETED|Overall Study||1
10944820|NCT00386425|12115496|FG002|NOT COMPLETED|Overall Study||0
10944821|NCT00386477|12115510|FG000|STARTED|Overall Study||155
10944822|NCT00386477|12115511|FG001|STARTED|Overall Study||145
10944823|NCT00386477|12115510|FG000|COMPLETED|Overall Study||155
10944824|NCT00386477|12115511|FG001|COMPLETED|Overall Study||145
10944825|NCT00386477|12115510|FG000|NOT COMPLETED|Overall Study||0
10944826|NCT00386477|12115511|FG001|NOT COMPLETED|Overall Study||0
10944827|NCT00386607|12115517|FG000|STARTED|Core||601
10944828|NCT00386607|12115518|FG001|STARTED|Core||0
10944829|NCT00386607|12115517|FG000|COMPLETED|Core||486
10944830|NCT00386607|12115518|FG001|COMPLETED|Core||0
10944831|NCT00386607|12115517|FG000|NOT COMPLETED|Core||115
10944832|NCT00386607|12115518|FG001|NOT COMPLETED|Core||0
10944834|NCT00386607|12115518|FG001|STARTED|Extension||162
10944835|NCT00386607|12115517|FG000|COMPLETED|Extension||0
10944836|NCT00386607|12115518|FG001|COMPLETED|Extension||145
10944837|NCT00386607|12115517|FG000|NOT COMPLETED|Extension||0
10944838|NCT00386607|12115518|FG001|NOT COMPLETED|Extension||17
10944839|NCT00386776|12115530|FG000|STARTED|Overall Study||40
10944840|NCT00386776|12115530|FG000|COMPLETED|Overall Study||32
10944841|NCT00386776|12115530|FG000|NOT COMPLETED|Overall Study||8
10944842|NCT00386880|12115536|FG000|STARTED|Overall Study||30
10944843|NCT00386880|12115537|FG001|STARTED|Overall Study||8
10944844|NCT00386880|12115536|FG000|COMPLETED|Overall Study||30
10944845|NCT00386880|12115537|FG001|COMPLETED|Overall Study||8
10944846|NCT00386880|12115536|FG000|NOT COMPLETED|Overall Study||0
10944847|NCT00386880|12115537|FG001|NOT COMPLETED|Overall Study||0
10944848|NCT00387010|12115542|FG000|STARTED|Dose Titration Period||218
10944849|NCT00387010|12115542|FG000|COMPLETED|Dose Titration Period||180
10944850|NCT00387010|12115542|FG000|NOT COMPLETED|Dose Titration Period||38
10944851|NCT00387010|12115542|FG000|STARTED|Treatment Period||180
10944852|NCT00387010|12115542|FG000|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
10944853|NCT00387010|12115542|FG000|COMPLETED|Treatment Period||169
10944854|NCT00387010|12115542|FG000|NOT COMPLETED|Treatment Period||11
10944855|NCT00387023|12115546|FG000|STARTED|Overall Study||12
10944856|NCT00387023|12115546|FG000|COMPLETED|Overall Study||12
10944857|NCT00387023|12115546|FG000|NOT COMPLETED|Overall Study||0
10944858|NCT00387036|12115550|FG000|STARTED|2-Week First Intervention||6
10944859|NCT00387036|12115551|FG001|STARTED|2-Week First Intervention||6
10944860|NCT00387036|12115550|FG000|COMPLETED|2-Week First Intervention||6
10944861|NCT00387036|12115551|FG001|COMPLETED|2-Week First Intervention||6
10944862|NCT00387036|12115550|FG000|NOT COMPLETED|2-Week First Intervention||0
10944863|NCT00387036|12115551|FG001|NOT COMPLETED|2-Week First Intervention||0
10944864|NCT00387036|12115550|FG000|STARTED|2-Week Placebo Washout||6
10944865|NCT00387036|12115551|FG001|STARTED|2-Week Placebo Washout||6
10944866|NCT00387036|12115550|FG000|COMPLETED|2-Week Placebo Washout||6
10944867|NCT00387036|12115551|FG001|COMPLETED|2-Week Placebo Washout||6
10944868|NCT00387036|12115550|FG000|NOT COMPLETED|2-Week Placebo Washout||0
10944869|NCT00387036|12115551|FG001|NOT COMPLETED|2-Week Placebo Washout||0
10944870|NCT00387036|12115550|FG000|STARTED|2-Week Crossover Second Intervention||6
10944871|NCT00387036|12115551|FG001|STARTED|2-Week Crossover Second Intervention||6
10944872|NCT00387036|12115550|FG000|COMPLETED|2-Week Crossover Second Intervention||6
10944873|NCT00387036|12115551|FG001|COMPLETED|2-Week Crossover Second Intervention||6
10944874|NCT00387036|12115550|FG000|NOT COMPLETED|2-Week Crossover Second Intervention||0
10944875|NCT00387036|12115551|FG001|NOT COMPLETED|2-Week Crossover Second Intervention||0
10944876|NCT00387088|12115559|FG000|STARTED|Overall Study||1989
10944877|NCT00387088|12115560|FG001|STARTED|Overall Study||2002
10944878|NCT00387088|12115559|FG000|COMPLETED|Overall Study||1671
10944879|NCT00387088|12115560|FG001|COMPLETED|Overall Study||1629
10944880|NCT00387088|12115559|FG000|NOT COMPLETED|Overall Study||318
10944881|NCT00387088|12115560|FG001|NOT COMPLETED|Overall Study||373
10944882|NCT00387127|12115568|FG000|STARTED|Overall Study||33
10944883|NCT00387127|12115569|FG001|STARTED|Overall Study||34
10944884|NCT00387127|12115568|FG000|COMPLETED|Overall Study||0
10944885|NCT00387127|12115569|FG001|COMPLETED|Overall Study||0
10944886|NCT00387127|12115568|FG000|NOT COMPLETED|Overall Study||33
10944887|NCT00387127|12115569|FG001|NOT COMPLETED|Overall Study||34
10944888|NCT00387153|12115577|FG000|STARTED|Overall Study||8
10944889|NCT00387153|12115577|FG000|COMPLETED|Overall Study||0
10944890|NCT00387153|12115577|FG000|NOT COMPLETED|Overall Study||8
10944891|NCT00387335|12115583|FG000|STARTED|Overall Study||15
10944892|NCT00387335|12115584|FG001|STARTED|Overall Study||7
10944893|NCT00387335|12115583|FG000|COMPLETED|Overall Study||15
10944894|NCT00387335|12115584|FG001|COMPLETED|Overall Study||7
10944895|NCT00387335|12115583|FG000|NOT COMPLETED|Overall Study||0
10944896|NCT00387335|12115584|FG001|NOT COMPLETED|Overall Study||0
10944897|NCT00387348|12115593|FG000|STARTED|Overall Study||8
10944898|NCT00387348|12115594|FG001|STARTED|Overall Study||5
10944899|NCT00387348|12115595|FG002|STARTED|Overall Study||11
10944900|NCT00387348|12115593|FG000|COMPLETED|Overall Study||5
10944901|NCT00387348|12115594|FG001|COMPLETED|Overall Study||2
10944902|NCT00387348|12115595|FG002|COMPLETED|Overall Study||7
10944903|NCT00387348|12115593|FG000|NOT COMPLETED|Overall Study||3
10944904|NCT00387348|12115594|FG001|NOT COMPLETED|Overall Study||3
10944905|NCT00387348|12115595|FG002|NOT COMPLETED|Overall Study||4
10944906|NCT00387426|12115608|FG000|STARTED|Overall Study||14
10944907|NCT00387426|12115608|FG000|COMPLETED|Overall Study||0
10944908|NCT00387426|12115608|FG000|NOT COMPLETED|Overall Study||14
10944909|NCT00387465|12115615|FG000|STARTED|Overall Study||3
10944910|NCT00387465|12115616|FG001|STARTED|Overall Study||7
10944911|NCT00387465|12115617|FG002|STARTED|Overall Study||35
10944912|NCT00387465|12115615|FG000|COMPLETED|Overall Study||3
10944913|NCT00387465|12115616|FG001|COMPLETED|Overall Study||6
10944914|NCT00387465|12115617|FG002|COMPLETED|Overall Study||35
10944915|NCT00387465|12115615|FG000|NOT COMPLETED|Overall Study||0
10944916|NCT00387465|12115616|FG001|NOT COMPLETED|Overall Study||1
10944917|NCT00387465|12115617|FG002|NOT COMPLETED|Overall Study||0
10944918|NCT00387621|12115628|FG000|STARTED|First Intervention||29
10944919|NCT00387621|12115629|FG001|STARTED|First Intervention||29
10944920|NCT00387621|12115628|FG000|COMPLETED|First Intervention||29
10944921|NCT00387621|12115629|FG001|COMPLETED|First Intervention||29
10944922|NCT00387621|12115628|FG000|NOT COMPLETED|First Intervention||0
10944923|NCT00387621|12115629|FG001|NOT COMPLETED|First Intervention||0
10944924|NCT00387621|12115628|FG000|STARTED|Washout Period of 2 Weeks||29
10944925|NCT00387621|12115629|FG001|STARTED|Washout Period of 2 Weeks||29
10944926|NCT00387621|12115628|FG000|COMPLETED|Washout Period of 2 Weeks||29
10944927|NCT00387621|12115629|FG001|COMPLETED|Washout Period of 2 Weeks||29
10944928|NCT00387621|12115628|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10944929|NCT00387621|12115629|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10944930|NCT00387621|12115628|FG000|STARTED|Second Intervention||29
10944931|NCT00387621|12115629|FG001|STARTED|Second Intervention||29
10944932|NCT00387621|12115628|FG000|COMPLETED|Second Intervention||29
10944933|NCT00387621|12115629|FG001|COMPLETED|Second Intervention||29
10944934|NCT00387621|12115628|FG000|NOT COMPLETED|Second Intervention||0
10944935|NCT00387621|12115629|FG001|NOT COMPLETED|Second Intervention||0
10944936|NCT00387647|12115641|FG000|STARTED|Overall Study||24
10944937|NCT00387647|12115641|FG000|COMPLETED|Overall Study||6
10944938|NCT00387647|12115641|FG000|NOT COMPLETED|Overall Study||18
10944939|NCT00387660|12115647|FG000|STARTED|Overall Study||40
10944940|NCT00387660|12115648|FG001|STARTED|Overall Study||40
10944941|NCT00387660|12115647|FG000|COMPLETED|Overall Study||40
10944942|NCT00387660|12115648|FG001|COMPLETED|Overall Study||40
10944943|NCT00387660|12115647|FG000|NOT COMPLETED|Overall Study||0
10944944|NCT00387660|12115648|FG001|NOT COMPLETED|Overall Study||0
10944945|NCT00387712|12115656|FG000|STARTED|Overall Study||47
10944946|NCT00387712|12115657|FG001|STARTED|Overall Study||52
10944947|NCT00387712|12115656|FG000|COMPLETED|Overall Study||18
10944948|NCT00387712|12115657|FG001|COMPLETED|Overall Study||16
10944949|NCT00387712|12115656|FG000|NOT COMPLETED|Overall Study||29
10944950|NCT00387712|12115657|FG001|NOT COMPLETED|Overall Study||36
10944951|NCT00387725|12115667|FG000|STARTED|Overall Study||21
10944952|NCT00387725|12115668|FG001|STARTED|Overall Study||16
10944953|NCT00387725|12115669|FG002|STARTED|Overall Study||45
10944954|NCT00387725|12115670|FG003|STARTED|Overall Study||45
10944955|NCT00387725|12115667|FG000|COMPLETED|Overall Study||20
10944956|NCT00387725|12115668|FG001|COMPLETED|Overall Study||15
10944957|NCT00387725|12115669|FG002|COMPLETED|Overall Study||43
10944958|NCT00387725|12115670|FG003|COMPLETED|Overall Study||43
10944959|NCT00387725|12115667|FG000|NOT COMPLETED|Overall Study||1
10944960|NCT00387725|12115668|FG001|NOT COMPLETED|Overall Study||1
10944961|NCT00387725|12115669|FG002|NOT COMPLETED|Overall Study||2
10944962|NCT00387725|12115670|FG003|NOT COMPLETED|Overall Study||2
10944963|NCT00387751|12115680|FG000|STARTED|Overall Study||14
10944964|NCT00387751|12115680|FG000|COMPLETED|Overall Study||14
10944965|NCT00387751|12115680|FG000|NOT COMPLETED|Overall Study||0
10944966|NCT00387764|12115686|FG000|STARTED|Overall Study||80
10944967|NCT00387764|12115686|FG000|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
10944968|NCT00387764|12115686|FG000|NOT COMPLETED|Overall Study||31
10944969|NCT00387790|12115690|FG000|STARTED|Overall Study||64
10944970|NCT00387790|12115690|FG000|COMPLETED|Overall Study||50
10944971|NCT00387790|12115690|FG000|NOT COMPLETED|Overall Study||14
10944972|NCT00387829|12115696|FG000|STARTED|Safety Population||178
10944973|NCT00387829|12115697|FG001|STARTED|Safety Population||169
10944974|NCT00387829|12115696|FG000|COMPLETED|Safety Population||139
10944975|NCT00387829|12115697|FG001|COMPLETED|Safety Population||136
10944976|NCT00387829|12115696|FG000|NOT COMPLETED|Safety Population||39
10944977|NCT00387829|12115697|FG001|NOT COMPLETED|Safety Population||33
10944978|NCT00387829|12115696|FG000|STARTED|Intent-to-treat Population||177
10944979|NCT00387829|12115697|FG001|STARTED|Intent-to-treat Population||166
10944980|NCT00387829|12115696|FG000|COMPLETED|Intent-to-treat Population||139
10944981|NCT00387829|12115697|FG001|COMPLETED|Intent-to-treat Population||136
10944982|NCT00387829|12115696|FG000|NOT COMPLETED|Intent-to-treat Population||38
10944983|NCT00387829|12115697|FG001|NOT COMPLETED|Intent-to-treat Population||30
10944984|NCT00387881|12115705|FG000|STARTED|Overall Study||334
10944985|NCT00387881|12115706|FG001|STARTED|Overall Study||345
10944986|NCT00387881|12115705|FG000|COMPLETED|Overall Study||245
10944987|NCT00387881|12115706|FG001|COMPLETED|Overall Study||243
10944988|NCT00387881|12115705|FG000|NOT COMPLETED|Overall Study||89
10944989|NCT00387881|12115706|FG001|NOT COMPLETED|Overall Study||102
10944990|NCT00387894|12115712|FG000|STARTED|Overall Study||6
10944991|NCT00387894|12115712|FG000|COMPLETED|Overall Study||5
10944992|NCT00387894|12115712|FG000|NOT COMPLETED|Overall Study||1
10944993|NCT00387959|12115716|FG000|STARTED|Overall Study||17
10944994|NCT00387959|12115716|FG000|COMPLETED|Overall Study||16
10944995|NCT00387959|12115716|FG000|NOT COMPLETED|Overall Study||1
10944996|NCT00388037|12115720|FG000|STARTED|Overall Study||31
10944997|NCT00388037|12115720|FG000|COMPLETED|Overall Study||30
10944998|NCT00388037|12115720|FG000|NOT COMPLETED|Overall Study||1
10944999|NCT00388154|12115724|FG000|STARTED|Overall Study||21
10945000|NCT00388154|12115724|FG000|COMPLETED|Overall Study||20
10945001|NCT00388154|12115724|FG000|NOT COMPLETED|Overall Study||1
10945002|NCT00388297|12115732|FG000|STARTED|Overall Study||339
10945003|NCT00388297|12115733|FG001|STARTED|Overall Study||338
10945004|NCT00388297|12115734|FG002|STARTED|Overall Study||265
10945005|NCT00388297|12115735|FG003|STARTED|Overall Study||261
10945006|NCT00388297|12115732|FG000|COMPLETED|Overall Study||323
10945007|NCT00388297|12115733|FG001|COMPLETED|Overall Study||326
10945008|NCT00388297|12115734|FG002|COMPLETED|Overall Study||254
10945009|NCT00388297|12115735|FG003|COMPLETED|Overall Study||253
10945010|NCT00388297|12115732|FG000|NOT COMPLETED|Overall Study||16
10945011|NCT00388297|12115733|FG001|NOT COMPLETED|Overall Study||12
10945012|NCT00388297|12115734|FG002|NOT COMPLETED|Overall Study||11
10945013|NCT00388297|12115735|FG003|NOT COMPLETED|Overall Study||8
10945014|NCT00388349|12115745|FG000|STARTED|Phase I Dose Escalation||3
10945015|NCT00388349|12115746|FG001|STARTED|Phase I Dose Escalation||4
10945016|NCT00388349|12115745|FG000|COMPLETED|Phase I Dose Escalation||3
10945017|NCT00388349|12115746|FG001|COMPLETED|Phase I Dose Escalation||1
10945018|NCT00388349|12115745|FG000|NOT COMPLETED|Phase I Dose Escalation||0
10945019|NCT00388349|12115746|FG001|NOT COMPLETED|Phase I Dose Escalation||3
10945020|NCT00388349|12115745|FG000|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
10945021|NCT00388349|12115746|FG001|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
10945022|NCT00388349|12115745|FG000|COMPLETED|Phase 2 Dose Expansion||139
10945023|NCT00388349|12115746|FG001|COMPLETED|Phase 2 Dose Expansion||0
10945024|NCT00388349|12115745|FG000|NOT COMPLETED|Phase 2 Dose Expansion||0
10945025|NCT00388349|12115746|FG001|NOT COMPLETED|Phase 2 Dose Expansion||0
10945026|NCT00388362|12115754|FG000|STARTED|Enrolled||36
10945027|NCT00388362|12115754|FG000|COMPLETED|Enrolled||23
10945028|NCT00388362|12115754|FG000|NOT COMPLETED|Enrolled||13
10945029|NCT00388362|12115754|FG000|STARTED|Remained on Study Median of 514 Days||23
10945030|NCT00388362|12115754|FG000|COMPLETED|Remained on Study Median of 514 Days||21
10945031|NCT00388362|12115754|FG000|NOT COMPLETED|Remained on Study Median of 514 Days||2
10945032|NCT00388414|12115760|FG000|STARTED|First Intervention (8 Weeks)||7
10945033|NCT00388414|12115761|FG001|STARTED|First Intervention (8 Weeks)||7
10945034|NCT00388414|12115760|FG000|COMPLETED|First Intervention (8 Weeks)||7
10945035|NCT00388414|12115761|FG001|COMPLETED|First Intervention (8 Weeks)||7
10945036|NCT00388414|12115760|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
10945037|NCT00388414|12115761|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
10945038|NCT00388414|12115760|FG000|STARTED|Washout (1 Week)||7
10945039|NCT00388414|12115761|FG001|STARTED|Washout (1 Week)||7
10945040|NCT00388414|12115760|FG000|COMPLETED|Washout (1 Week)||7
10945041|NCT00388414|12115761|FG001|COMPLETED|Washout (1 Week)||7
10945042|NCT00388414|12115760|FG000|NOT COMPLETED|Washout (1 Week)||0
10945043|NCT00388414|12115761|FG001|NOT COMPLETED|Washout (1 Week)||0
10945044|NCT00388414|12115760|FG000|STARTED|Second Intervention (8 Weeks)||7
10945045|NCT00388414|12115761|FG001|STARTED|Second Intervention (8 Weeks)||7
10945046|NCT00388414|12115760|FG000|COMPLETED|Second Intervention (8 Weeks)||7
10945047|NCT00388414|12115761|FG001|COMPLETED|Second Intervention (8 Weeks)||7
10945048|NCT00388414|12115760|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
10945049|NCT00388414|12115761|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
10945050|NCT00388453|12115772|FG000|STARTED|Overall Study||20
10945051|NCT00388453|12115773|FG001|STARTED|Overall Study||17
10945052|NCT00388453|12115774|FG002|STARTED|Overall Study||10
10945053|NCT00388453|12115772|FG000|COMPLETED|Overall Study||20
10945054|NCT00388453|12115773|FG001|COMPLETED|Overall Study||17
10945055|NCT00388453|12115774|FG002|COMPLETED|Overall Study||10
10945056|NCT00388453|12115772|FG000|NOT COMPLETED|Overall Study||0
10945057|NCT00388453|12115773|FG001|NOT COMPLETED|Overall Study||0
10945058|NCT00388453|12115774|FG002|NOT COMPLETED|Overall Study||0
10945059|NCT00388505|12115784|FG000|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
10945060|NCT00388505|12115785|FG001|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
10945061|NCT00388505|12115784|FG000|COMPLETED|Overall Study||225
10945062|NCT00388505|12115785|FG001|COMPLETED|Overall Study||171
10945063|NCT00388505|12115784|FG000|NOT COMPLETED|Overall Study||83
10945064|NCT00388505|12115785|FG001|NOT COMPLETED|Overall Study||38
10945065|NCT00388583|12115793|FG000|STARTED|Overall Study||407
10945066|NCT00388583|12115794|FG001|STARTED|Overall Study||410
10945067|NCT00388583|12115793|FG000|COMPLETED|Overall Study||401
10945068|NCT00388583|12115794|FG001|COMPLETED|Overall Study||406
10945069|NCT00388583|12115793|FG000|NOT COMPLETED|Overall Study||6
10945070|NCT00388583|12115794|FG001|NOT COMPLETED|Overall Study||4
10945071|NCT00388674|12115802|FG000|STARTED|Initial Treatment||6216
10945072|NCT00388674|12115803|FG001|STARTED|Initial Treatment||6162
10945073|NCT00388674|12115802|FG000|COMPLETED|Initial Treatment|Completed=Reason of 'successful treatment', 'other: successful treatment' or 'other: end of study'|4388
10945074|NCT00388674|12115803|FG001|COMPLETED|Initial Treatment|"Completed=discontinued initial treatment reason of successful treatment or end of study"|3576
10945075|NCT00388674|12115802|FG000|NOT COMPLETED|Initial Treatment||1828
10945076|NCT00388674|12115803|FG001|NOT COMPLETED|Initial Treatment||2586
10945077|NCT00388674|12115802|FG000|STARTED|End of Study||6216
10945078|NCT00388674|12115803|FG001|STARTED|End of Study||6162
10945079|NCT00388674|12115802|FG000|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|4482
10945080|NCT00388674|12115803|FG001|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|3993
10945081|NCT00388674|12115802|FG000|NOT COMPLETED|End of Study||1734
10945082|NCT00388674|12115803|FG001|NOT COMPLETED|End of Study||2169
10945083|NCT00388726|12115811|FG000|STARTED|Overall Study||508
10945084|NCT00388726|12115812|FG001|STARTED|Overall Study||254
10945085|NCT00388726|12115811|FG000|COMPLETED|Overall Study||24
10945086|NCT00388726|12115812|FG001|COMPLETED|Overall Study||10
10945087|NCT00388726|12115811|FG000|NOT COMPLETED|Overall Study||484
10945088|NCT00388726|12115812|FG001|NOT COMPLETED|Overall Study||244
10945089|NCT00388804|12115820|FG000|STARTED|Overall Study||17
10945090|NCT00388804|12115821|FG001|STARTED|Overall Study||21
10945091|NCT00388804|12115820|FG000|COMPLETED|Overall Study||17
10945092|NCT00388804|12115821|FG001|COMPLETED|Overall Study||21
10945093|NCT00388804|12115820|FG000|NOT COMPLETED|Overall Study||0
10945094|NCT00388804|12115821|FG001|NOT COMPLETED|Overall Study||0
10945095|NCT00388947|12115827|FG000|STARTED|Overall Study||1590
10945096|NCT00388947|12115827|FG000|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
10945097|NCT00388947|12115827|FG000|NOT COMPLETED|Overall Study||47
10945098|NCT00388973|12115833|FG000|STARTED|Overall Study|Randomized|166
10945099|NCT00388973|12115834|FG001|STARTED|Overall Study|Randomized|172
10945100|NCT00388973|12115833|FG000|Completed Study|Overall Study||110
10945101|NCT00388973|12115834|FG001|Completed Study|Overall Study||114
10945102|NCT00388973|12115833|FG000|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
10945103|NCT00388973|12115834|FG001|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
10945104|NCT00388973|12115833|FG000|NOT COMPLETED|Overall Study||56
10945105|NCT00388973|12115834|FG001|NOT COMPLETED|Overall Study||58
10945106|NCT00389064|12115842|FG000|STARTED|Overall Study||223
10945107|NCT00389064|12115843|FG001|STARTED|Overall Study||227
10945108|NCT00389064|12115842|FG000|COMPLETED|Overall Study||178
10945109|NCT00389064|12115843|FG001|COMPLETED|Overall Study||168
10945110|NCT00389064|12115842|FG000|NOT COMPLETED|Overall Study||45
10945111|NCT00389064|12115843|FG001|NOT COMPLETED|Overall Study||59
10945112|NCT00389168|12115851|FG000|STARTED|Overall Study||56
10945113|NCT00389168|12115852|FG001|STARTED|Overall Study||58
10945114|NCT00389168|12115851|FG000|COMPLETED|Overall Study||47
10945115|NCT00389168|12115852|FG001|COMPLETED|Overall Study||53
10945116|NCT00389168|12115851|FG000|NOT COMPLETED|Overall Study||9
10945117|NCT00389168|12115852|FG001|NOT COMPLETED|Overall Study||5
10945118|NCT00389207|12115861|FG000|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
10945119|NCT00389207|12115862|FG001|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
10945120|NCT00389207|12115863|FG002|STARTED|Overall Study||193
10945121|NCT00389207|12115861|FG000|COMPLETED|Overall Study||125
10945122|NCT00389207|12115862|FG001|COMPLETED|Overall Study||116
10945123|NCT00389207|12115863|FG002|COMPLETED|Overall Study||152
10945124|NCT00389207|12115861|FG000|NOT COMPLETED|Overall Study||63
10945125|NCT00389207|12115862|FG001|NOT COMPLETED|Overall Study||72
10945126|NCT00389207|12115863|FG002|NOT COMPLETED|Overall Study||41
10945127|NCT00389324|12115876|FG000|STARTED|Run-In Phase||21
10945128|NCT00389324|12115876|FG000|COMPLETED|Run-In Phase||18
10945129|NCT00389324|12115876|FG000|NOT COMPLETED|Run-In Phase||3
10945130|NCT00389324|12115876|FG000|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
10945131|NCT00389324|12115876|FG000|COMPLETED|Intravenous Phase||32
10945132|NCT00389324|12115876|FG000|NOT COMPLETED|Intravenous Phase||0
10945133|NCT00389324|12115876|FG000|STARTED|Subcutaneous Phase||32
10945134|NCT00389324|12115876|FG000|COMPLETED|Subcutaneous Phase||25
10945135|NCT00389324|12115876|FG000|NOT COMPLETED|Subcutaneous Phase||7
10945136|NCT00389441|12115883|FG000|STARTED|Overall Study||52
10945137|NCT00389441|12115883|FG000|COMPLETED|Overall Study||0
10945138|NCT00389441|12115883|FG000|NOT COMPLETED|Overall Study||52
10945139|NCT00389467|12115891|FG000|STARTED|Overall Study||34
10945140|NCT00389467|12115892|FG001|STARTED|Overall Study||34
10945141|NCT00389467|12115893|FG002|STARTED|Overall Study||30
10945142|NCT00389467|12115894|FG003|STARTED|Overall Study||20
10945143|NCT00389467|12115891|FG000|COMPLETED|Overall Study||34
10945144|NCT00389467|12115892|FG001|COMPLETED|Overall Study||34
10945145|NCT00389467|12115893|FG002|COMPLETED|Overall Study||30
10945146|NCT00389467|12115894|FG003|COMPLETED|Overall Study||20
10945147|NCT00389467|12115891|FG000|NOT COMPLETED|Overall Study||0
10945148|NCT00389467|12115892|FG001|NOT COMPLETED|Overall Study||0
10945149|NCT00389467|12115893|FG002|NOT COMPLETED|Overall Study||0
10945150|NCT00389467|12115894|FG003|NOT COMPLETED|Overall Study||0
10945151|NCT00389493|12115908|FG000|STARTED|Overall Study||40
10945152|NCT00389493|12115909|FG001|STARTED|Overall Study||40
10945153|NCT00389493|12115910|FG002|STARTED|Overall Study||20
10945154|NCT00389493|12115908|FG000|COMPLETED|Overall Study||37
10945155|NCT00389493|12115909|FG001|COMPLETED|Overall Study||32
10945156|NCT00389493|12115910|FG002|COMPLETED|Overall Study||17
10945157|NCT00389493|12115908|FG000|NOT COMPLETED|Overall Study||3
10945158|NCT00389493|12115909|FG001|NOT COMPLETED|Overall Study||8
10945159|NCT00389493|12115910|FG002|NOT COMPLETED|Overall Study||3
10945160|NCT00389519|12115925|FG000|STARTED|Placebo Run-In||422
10945161|NCT00389519|12115926|FG001|STARTED|Placebo Run-In||0
10945162|NCT00389519|12115927|FG002|STARTED|Placebo Run-In||0
10945163|NCT00389519|12115928|FG003|STARTED|Placebo Run-In||0
10945164|NCT00389519|12115925|FG000|COMPLETED|Placebo Run-In||244
10945165|NCT00389519|12115926|FG001|COMPLETED|Placebo Run-In||0
10945166|NCT00389519|12115927|FG002|COMPLETED|Placebo Run-In||0
10945167|NCT00389519|12115928|FG003|COMPLETED|Placebo Run-In||0
10945168|NCT00389519|12115925|FG000|NOT COMPLETED|Placebo Run-In||178
10945169|NCT00389519|12115926|FG001|NOT COMPLETED|Placebo Run-In||0
10945170|NCT00389519|12115927|FG002|NOT COMPLETED|Placebo Run-In||0
10945171|NCT00389519|12115928|FG003|NOT COMPLETED|Placebo Run-In||0
10945172|NCT00389519|12115925|FG000|STARTED|Randomized||83
10945173|NCT00389519|12115926|FG001|STARTED|Randomized||41
10945174|NCT00389519|12115927|FG002|STARTED|Randomized||40
10945175|NCT00389519|12115928|FG003|STARTED|Randomized||80
10945176|NCT00389519|12115925|FG000|COMPLETED|Randomized||81
10945177|NCT00389519|12115926|FG001|COMPLETED|Randomized||41
10945178|NCT00389519|12115927|FG002|COMPLETED|Randomized||40
10945179|NCT00389519|12115928|FG003|COMPLETED|Randomized||80
10945180|NCT00389519|12115925|FG000|NOT COMPLETED|Randomized||2
10945181|NCT00389519|12115926|FG001|NOT COMPLETED|Randomized||0
10945182|NCT00389519|12115927|FG002|NOT COMPLETED|Randomized||0
10945183|NCT00389519|12115928|FG003|NOT COMPLETED|Randomized||0
10945184|NCT00389519|12115925|FG000|STARTED|Treated||81
10945185|NCT00389519|12115926|FG001|STARTED|Treated||41
10945186|NCT00389519|12115927|FG002|STARTED|Treated||40
10945187|NCT00389519|12115928|FG003|STARTED|Treated||80
10945188|NCT00389519|12115925|FG000|COMPLETED|Treated||79
10945189|NCT00389519|12115926|FG001|COMPLETED|Treated||40
10945190|NCT00389519|12115927|FG002|COMPLETED|Treated||40
10945191|NCT00389519|12115928|FG003|COMPLETED|Treated||76
10945192|NCT00389519|12115925|FG000|NOT COMPLETED|Treated||2
10945193|NCT00389519|12115926|FG001|NOT COMPLETED|Treated||1
10945194|NCT00389519|12115927|FG002|NOT COMPLETED|Treated||0
10945195|NCT00389519|12115928|FG003|NOT COMPLETED|Treated||4
10945196|NCT00389532|12115940|FG000|STARTED|Overall Study||60
10945197|NCT00389532|12115941|FG001|STARTED|Overall Study||56
10945198|NCT00389532|12115940|FG000|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
10945199|NCT00389532|12115941|FG001|COMPLETED|Overall Study||56
10945200|NCT00389532|12115940|FG000|NOT COMPLETED|Overall Study||0
10945201|NCT00389532|12115941|FG001|NOT COMPLETED|Overall Study||0
10945202|NCT00389597|12115951|FG000|STARTED|Overall Study||164
10945203|NCT00389597|12115952|FG001|STARTED|Overall Study||81
10945204|NCT00389597|12115953|FG002|STARTED|Overall Study||225
10945205|NCT00389597|12115954|FG003|STARTED|Overall Study||105
10945206|NCT00389597|12115951|FG000|24 mo|Overall Study||156
10945207|NCT00389597|12115952|FG001|24 mo|Overall Study||75
10945208|NCT00389597|12115953|FG002|24 mo|Overall Study||221
10945209|NCT00389597|12115954|FG003|24 mo|Overall Study||99
10945210|NCT00389597|12115951|FG000|COMPLETED|Overall Study||156
10945211|NCT00389597|12115952|FG001|COMPLETED|Overall Study||75
10945212|NCT00389597|12115953|FG002|COMPLETED|Overall Study||221
10945213|NCT00389597|12115954|FG003|COMPLETED|Overall Study||99
10945214|NCT00389597|12115951|FG000|NOT COMPLETED|Overall Study||8
10945215|NCT00389597|12115952|FG001|NOT COMPLETED|Overall Study||6
10945216|NCT00389597|12115953|FG002|NOT COMPLETED|Overall Study||4
10945217|NCT00389597|12115954|FG003|NOT COMPLETED|Overall Study||6
10945218|NCT00389805|12115966|FG000|STARTED|Phase I||15
10945219|NCT00389805|12115967|FG001|STARTED|Phase I||12
10945220|NCT00389805|12115966|FG000|COMPLETED|Phase I||15
10945221|NCT00389805|12115967|FG001|COMPLETED|Phase I||12
10945222|NCT00389805|12115966|FG000|NOT COMPLETED|Phase I||0
10945223|NCT00389805|12115967|FG001|NOT COMPLETED|Phase I||0
10945224|NCT00389805|12115966|FG000|STARTED|Phase II|The Phase II study was not conducted.|0
10945225|NCT00389805|12115967|FG001|STARTED|Phase II|The Phase II study was not conducted.|0
10945226|NCT00389805|12115966|FG000|COMPLETED|Phase II||0
10945227|NCT00389805|12115967|FG001|COMPLETED|Phase II||0
10945228|NCT00389805|12115966|FG000|NOT COMPLETED|Phase II||0
10945229|NCT00389805|12115967|FG001|NOT COMPLETED|Phase II||0
10945230|NCT00389818|12115973|FG000|STARTED|Overall Study||43
10945231|NCT00389818|12115973|FG000|COMPLETED|Overall Study||40
10945232|NCT00389818|12115973|FG000|NOT COMPLETED|Overall Study||3
10945233|NCT00389831|12115979|FG000|STARTED|Overall Study||10
10945234|NCT00389831|12115980|FG001|STARTED|Overall Study||34
10945235|NCT00389831|12115979|FG000|COMPLETED|Overall Study||10
10945236|NCT00389831|12115980|FG001|COMPLETED|Overall Study||27
10945237|NCT00389831|12115979|FG000|NOT COMPLETED|Overall Study||0
10945238|NCT00389831|12115980|FG001|NOT COMPLETED|Overall Study||7
10945239|NCT00389857|12116000|FG000|STARTED|Overall Study||14
10945240|NCT00389857|12116001|FG001|STARTED|Overall Study||17
10945241|NCT00389857|12116000|FG000|COMPLETED|Overall Study||14
10945242|NCT00389857|12116001|FG001|COMPLETED|Overall Study||17
10945243|NCT00389857|12116000|FG000|NOT COMPLETED|Overall Study||0
10945244|NCT00389857|12116001|FG001|NOT COMPLETED|Overall Study||0
10945245|NCT00389974|12116007|FG000|STARTED|Overall Study||19
10945246|NCT00389974|12116007|FG000|COMPLETED|Overall Study||19
10945247|NCT00389974|12116007|FG000|NOT COMPLETED|Overall Study||0
10945248|NCT00390013|12116014|FG000|STARTED|Phase 1||0
10945249|NCT00390013|12116015|FG001|STARTED|Phase 1||0
10945250|NCT00390013|12116016|FG002|STARTED|Phase 1||2
10945251|NCT00390013|12116017|FG003|STARTED|Phase 1||2
10945252|NCT00390013|12116014|FG000|COMPLETED|Phase 1||0
10945253|NCT00390013|12116015|FG001|COMPLETED|Phase 1||0
10945254|NCT00390013|12116016|FG002|COMPLETED|Phase 1||2
10945255|NCT00390013|12116017|FG003|COMPLETED|Phase 1||1
10945256|NCT00390013|12116014|FG000|NOT COMPLETED|Phase 1||0
10945257|NCT00390013|12116015|FG001|NOT COMPLETED|Phase 1||0
10945258|NCT00390013|12116016|FG002|NOT COMPLETED|Phase 1||0
10945259|NCT00390013|12116017|FG003|NOT COMPLETED|Phase 1||1
10945260|NCT00390013|12116014|FG000|STARTED|Phase 2 First Treatment||3
10945261|NCT00390013|12116015|FG001|STARTED|Phase 2 First Treatment||2
10945262|NCT00390013|12116016|FG002|STARTED|Phase 2 First Treatment||0
10945263|NCT00390013|12116017|FG003|STARTED|Phase 2 First Treatment||0
10945264|NCT00390013|12116014|FG000|COMPLETED|Phase 2 First Treatment||2
10945265|NCT00390013|12116015|FG001|COMPLETED|Phase 2 First Treatment||1
10945266|NCT00390013|12116016|FG002|COMPLETED|Phase 2 First Treatment||0
10945267|NCT00390013|12116017|FG003|COMPLETED|Phase 2 First Treatment||0
10945268|NCT00390013|12116014|FG000|NOT COMPLETED|Phase 2 First Treatment||1
10945269|NCT00390013|12116015|FG001|NOT COMPLETED|Phase 2 First Treatment||1
10945270|NCT00390013|12116016|FG002|NOT COMPLETED|Phase 2 First Treatment||0
10945271|NCT00390013|12116017|FG003|NOT COMPLETED|Phase 2 First Treatment||0
10945272|NCT00390013|12116014|FG000|STARTED|Phase 2 Second Treatment||2
10945273|NCT00390013|12116015|FG001|STARTED|Phase 2 Second Treatment||1
10945274|NCT00390013|12116016|FG002|STARTED|Phase 2 Second Treatment||0
10945275|NCT00390013|12116017|FG003|STARTED|Phase 2 Second Treatment||0
10945276|NCT00390013|12116014|FG000|COMPLETED|Phase 2 Second Treatment||2
10945277|NCT00390013|12116015|FG001|COMPLETED|Phase 2 Second Treatment||1
10945278|NCT00390013|12116016|FG002|COMPLETED|Phase 2 Second Treatment||0
10945279|NCT00390013|12116017|FG003|COMPLETED|Phase 2 Second Treatment||0
10945280|NCT00390013|12116014|FG000|NOT COMPLETED|Phase 2 Second Treatment||0
10945281|NCT00390013|12116015|FG001|NOT COMPLETED|Phase 2 Second Treatment||0
10945282|NCT00390013|12116016|FG002|NOT COMPLETED|Phase 2 Second Treatment||0
10945283|NCT00390013|12116017|FG003|NOT COMPLETED|Phase 2 Second Treatment||0
10945284|NCT00390182|12116023|FG000|STARTED|Overall Study||38
10945285|NCT00390182|12116023|FG000|COMPLETED|Overall Study||33
10945286|NCT00390182|12116023|FG000|NOT COMPLETED|Overall Study||5
10945287|NCT00390221|12116030|FG000|STARTED|Overall Study||204
10945288|NCT00390221|12116031|FG001|STARTED|Overall Study||208
10945289|NCT00390221|12116032|FG002|STARTED|Overall Study||209
10945290|NCT00390221|12116030|FG000|COMPLETED|Overall Study||186
10945291|NCT00390221|12116031|FG001|COMPLETED|Overall Study||188
10945292|NCT00390221|12116032|FG002|COMPLETED|Overall Study||194
10945293|NCT00390221|12116030|FG000|NOT COMPLETED|Overall Study||18
10945294|NCT00390221|12116031|FG001|NOT COMPLETED|Overall Study||20
10945295|NCT00390221|12116032|FG002|NOT COMPLETED|Overall Study||15
10945296|NCT00390234|12116041|FG000|STARTED|Overall Study||63
10945297|NCT00390234|12116041|FG000|COMPLETED|Overall Study||63
10945298|NCT00390234|12116041|FG000|NOT COMPLETED|Overall Study||0
10945299|NCT00390299|12116051|FG000|STARTED|Overall Study||4
10945300|NCT00390299|12116052|FG001|STARTED|Overall Study||3
10945301|NCT00390299|12116053|FG002|STARTED|Overall Study||3
10945302|NCT00390299|12116054|FG003|STARTED|Overall Study||3
10945303|NCT00390299|12116055|FG004|STARTED|Overall Study||10
10945304|NCT00390299|12116051|FG000|COMPLETED|Overall Study||3
10945305|NCT00390299|12116052|FG001|COMPLETED|Overall Study||3
10945306|NCT00390299|12116053|FG002|COMPLETED|Overall Study||3
10945307|NCT00390299|12116054|FG003|COMPLETED|Overall Study||3
10945308|NCT00390299|12116055|FG004|COMPLETED|Overall Study||10
10945309|NCT00390299|12116051|FG000|NOT COMPLETED|Overall Study||1
10945310|NCT00390299|12116052|FG001|NOT COMPLETED|Overall Study||0
10945311|NCT00390299|12116053|FG002|NOT COMPLETED|Overall Study||0
10945312|NCT00390299|12116054|FG003|NOT COMPLETED|Overall Study||0
10945313|NCT00390299|12116055|FG004|NOT COMPLETED|Overall Study||0
10945314|NCT00390364|12116069|FG000|STARTED|Overall Study||1
10945315|NCT00390364|12116069|FG000|COMPLETED|Overall Study||1
10945316|NCT00390364|12116069|FG000|NOT COMPLETED|Overall Study||0
10945317|NCT00390416|12116073|FG000|STARTED|Overall Study||48
10945318|NCT00390416|12116073|FG000|COMPLETED|Overall Study||44
10945319|NCT00390416|12116073|FG000|NOT COMPLETED|Overall Study||4
10945320|NCT00390429|12116080|FG000|STARTED|Overall Study||5
10945321|NCT00390429|12116081|FG001|STARTED|Overall Study||12
10945322|NCT00390429|12116082|FG002|STARTED|Overall Study||25
10945323|NCT00390429|12116083|FG003|STARTED|Overall Study||39
10945324|NCT00390429|12116080|FG000|COMPLETED|Overall Study||5
10945325|NCT00390429|12116081|FG001|COMPLETED|Overall Study||12
10945326|NCT00390429|12116082|FG002|COMPLETED|Overall Study||25
10945327|NCT00390429|12116083|FG003|COMPLETED|Overall Study||39
10945328|NCT00390429|12116080|FG000|NOT COMPLETED|Overall Study||0
10945329|NCT00390429|12116081|FG001|NOT COMPLETED|Overall Study||0
10945330|NCT00390429|12116082|FG002|NOT COMPLETED|Overall Study||0
10945331|NCT00390429|12116083|FG003|NOT COMPLETED|Overall Study||0
10945332|NCT00390455|12116096|FG000|STARTED|Overall Study||148
10945333|NCT00390455|12116097|FG001|STARTED|Overall Study||147
10945334|NCT00390455|12116096|FG000|COMPLETED|Overall Study||116
10945335|NCT00390455|12116097|FG001|COMPLETED|Overall Study||124
10945336|NCT00390455|12116096|FG000|NOT COMPLETED|Overall Study||32
10945337|NCT00390455|12116097|FG001|NOT COMPLETED|Overall Study||23
10945338|NCT00390468|12116103|FG000|STARTED|Overall Study||18
10945339|NCT00390468|12116103|FG000|COMPLETED|Overall Study||15
10945340|NCT00390468|12116103|FG000|NOT COMPLETED|Overall Study||3
10945341|NCT00390546|12116109|FG000|STARTED|Overall Study||33
10945342|NCT00390546|12116110|FG001|STARTED|Overall Study||39
10945343|NCT00390546|12116109|FG000|COMPLETED|Overall Study||27
10945344|NCT00390546|12116110|FG001|COMPLETED|Overall Study||34
10945345|NCT00390546|12116109|FG000|NOT COMPLETED|Overall Study||6
10945346|NCT00390546|12116110|FG001|NOT COMPLETED|Overall Study||5
10945347|NCT00390559|12116117|FG000|STARTED|Overall Study||124
10945348|NCT00390559|12116117|FG000|Received PlaceboP/Active C|Overall Study||93
10945349|NCT00390559|12116117|FG000|ActiveP/ActiveC|Overall Study||87
10945350|NCT00390559|12116117|FG000|PlaceboP/PlaceboC|Overall Study||93
10945351|NCT00390559|12116117|FG000|ActiveP/PlaceboC|Overall Study||90
10945352|NCT00390559|12116117|FG000|COMPLETED|Overall Study||80
10945353|NCT00390559|12116117|FG000|NOT COMPLETED|Overall Study||44
10945354|NCT00390572|12116129|FG000|STARTED|Overall Study||68
10945355|NCT00390572|12116130|FG001|STARTED|Overall Study||69
10945356|NCT00390572|12116129|FG000|COMPLETED|Overall Study||60
10945357|NCT00390572|12116130|FG001|COMPLETED|Overall Study||64
10945358|NCT00390572|12116129|FG000|NOT COMPLETED|Overall Study||8
10945359|NCT00390572|12116130|FG001|NOT COMPLETED|Overall Study||5
10945360|NCT00390611|12116138|FG000|STARTED|6 Cycles of Study Treatment||43
10945361|NCT00390611|12116139|FG001|STARTED|6 Cycles of Study Treatment||42
10945362|NCT00390611|12116138|FG000|COMPLETED|6 Cycles of Study Treatment||34
10945363|NCT00390611|12116139|FG001|COMPLETED|6 Cycles of Study Treatment||37
10945364|NCT00390611|12116138|FG000|NOT COMPLETED|6 Cycles of Study Treatment||9
10945365|NCT00390611|12116139|FG001|NOT COMPLETED|6 Cycles of Study Treatment||5
10945366|NCT00390611|12116138|FG000|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
10945453|NCT00391092|12116267|FG001|Received Treatment|Overall Study||215
10945367|NCT00390611|12116139|FG001|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
10945368|NCT00390611|12116138|FG000|COMPLETED|Maintenance Sorafenib to Month 12||13
10945369|NCT00390611|12116139|FG001|COMPLETED|Maintenance Sorafenib to Month 12||0
10945370|NCT00390611|12116138|FG000|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
10945371|NCT00390611|12116139|FG001|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
10945372|NCT00390689|12116150|FG000|STARTED|Overall Study||48
10945373|NCT00390689|12116151|FG001|STARTED|Overall Study||53
10945374|NCT00390689|12116152|FG002|STARTED|Overall Study||53
10945375|NCT00390689|12116150|FG000|COMPLETED|Overall Study||43
10945376|NCT00390689|12116151|FG001|COMPLETED|Overall Study||48
10945377|NCT00390689|12116152|FG002|COMPLETED|Overall Study||50
10945378|NCT00390689|12116150|FG000|NOT COMPLETED|Overall Study||5
10945379|NCT00390689|12116151|FG001|NOT COMPLETED|Overall Study||5
10945380|NCT00390689|12116152|FG002|NOT COMPLETED|Overall Study||3
10945381|NCT00390780|12116171|FG000|STARTED|Overall Study||291
10945382|NCT00390780|12116172|FG001|STARTED|Overall Study||287
10945383|NCT00390780|12116171|FG000|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
10945384|NCT00390780|12116172|FG001|Treatment|Overall Study||287
10945385|NCT00390780|12116171|FG000|COMPLETED|Overall Study||268
10945386|NCT00390780|12116172|FG001|COMPLETED|Overall Study||260
10945387|NCT00390780|12116171|FG000|NOT COMPLETED|Overall Study||23
10945388|NCT00390780|12116172|FG001|NOT COMPLETED|Overall Study||27
10945389|NCT00390806|12116180|FG000|STARTED|Overall Study||236
10945390|NCT00390806|12116181|FG001|STARTED|Overall Study||236
10945391|NCT00390806|12116180|FG000|Ongoing|Overall Study||4
10945392|NCT00390806|12116181|FG001|Ongoing|Overall Study||2
10945393|NCT00390806|12116180|FG000|COMPLETED|Overall Study||206
10945394|NCT00390806|12116181|FG001|COMPLETED|Overall Study||204
10945395|NCT00390806|12116180|FG000|NOT COMPLETED|Overall Study||30
10945396|NCT00390806|12116181|FG001|NOT COMPLETED|Overall Study||32
10945397|NCT00390858|12116189|FG000|STARTED|Overall Study|20 participants started the Core Study|20
10945398|NCT00390858|12116190|FG001|STARTED|Overall Study|20 Participants started the Core Study|20
10945399|NCT00390858|12116189|FG000|Completed Core & Entered Extension Study|Overall Study||19
10945400|NCT00390858|12116190|FG001|Completed Core & Entered Extension Study|Overall Study||20
10945401|NCT00390858|12116189|FG000|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
10945402|NCT00390858|12116190|FG001|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
10945403|NCT00390858|12116189|FG000|NOT COMPLETED|Overall Study||9
10945404|NCT00390858|12116190|FG001|NOT COMPLETED|Overall Study||7
10945405|NCT00390884|12116198|FG000|STARTED|Overall Study||116
10945406|NCT00390884|12116199|FG001|STARTED|Overall Study||57
10945407|NCT00390884|12116198|FG000|COMPLETED|Overall Study||114
10945408|NCT00390884|12116199|FG001|COMPLETED|Overall Study||55
10945409|NCT00390884|12116198|FG000|NOT COMPLETED|Overall Study||2
10945410|NCT00390884|12116199|FG001|NOT COMPLETED|Overall Study||2
10945411|NCT00390910|12116208|FG000|STARTED|Overall Study||50
10945412|NCT00390910|12116209|FG001|STARTED|Overall Study||87
10945413|NCT00390910|12116210|FG002|STARTED|Overall Study||149
10945414|NCT00390910|12116208|FG000|COMPLETED|Overall Study||48
10945415|NCT00390910|12116209|FG001|COMPLETED|Overall Study||83
10945416|NCT00390910|12116210|FG002|COMPLETED|Overall Study||139
10945417|NCT00390910|12116208|FG000|NOT COMPLETED|Overall Study||2
10945418|NCT00390910|12116209|FG001|NOT COMPLETED|Overall Study||4
10945419|NCT00390910|12116210|FG002|NOT COMPLETED|Overall Study||10
10945420|NCT00390949|12116222|FG000|STARTED|Overall Study||4662
10945421|NCT00390949|12116223|FG001|STARTED|Overall Study||4792
10945422|NCT00390949|12116222|FG000|COMPLETED|Overall Study||2564
10945423|NCT00390949|12116223|FG001|COMPLETED|Overall Study||2664
10945424|NCT00390949|12116222|FG000|NOT COMPLETED|Overall Study||2098
10945425|NCT00390949|12116223|FG001|NOT COMPLETED|Overall Study||2128
10945426|NCT00391027|12116231|FG000|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
10945427|NCT00391027|12116232|FG001|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
10945428|NCT00391027|12116231|FG000|COMPLETED|Overall Study||110
10945429|NCT00391027|12116232|FG001|COMPLETED|Overall Study||110
10945430|NCT00391027|12116231|FG000|NOT COMPLETED|Overall Study||25
10945431|NCT00391027|12116232|FG001|NOT COMPLETED|Overall Study||12
10945432|NCT00391053|12116242|FG000|STARTED|Overall Study||857
10945433|NCT00391053|12116243|FG001|STARTED|Overall Study||848
10945434|NCT00391053|12116244|FG002|STARTED|Overall Study||870
10945435|NCT00391053|12116245|FG003|STARTED|Overall Study||1262
10945436|NCT00391053|12116242|FG000|COMPLETED|Overall Study||848
10945437|NCT00391053|12116243|FG001|COMPLETED|Overall Study||847
10945438|NCT00391053|12116244|FG002|COMPLETED|Overall Study||868
10945439|NCT00391053|12116245|FG003|COMPLETED|Overall Study||1252
10945440|NCT00391053|12116242|FG000|NOT COMPLETED|Overall Study||9
10945441|NCT00391053|12116243|FG001|NOT COMPLETED|Overall Study||1
10945442|NCT00391053|12116244|FG002|NOT COMPLETED|Overall Study||2
10945443|NCT00391053|12116245|FG003|NOT COMPLETED|Overall Study||10
10945444|NCT00391079|12116257|FG000|STARTED|Overall Study||167
10945445|NCT00391079|12116258|FG001|STARTED|Overall Study||172
10945446|NCT00391079|12116257|FG000|COMPLETED|Overall Study||141
10945447|NCT00391079|12116258|FG001|COMPLETED|Overall Study||156
10945448|NCT00391079|12116257|FG000|NOT COMPLETED|Overall Study||26
10945449|NCT00391079|12116258|FG001|NOT COMPLETED|Overall Study||16
10945450|NCT00391092|12116266|FG000|STARTED|Overall Study||208
10945451|NCT00391092|12116267|FG001|STARTED|Overall Study||216
10945452|NCT00391092|12116266|FG000|Received Treatment|Overall Study||206
10945454|NCT00391092|12116266|FG000|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
10945455|NCT00391092|12116267|FG001|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
10945456|NCT00391092|12116266|FG000|NOT COMPLETED|Overall Study||208
10945457|NCT00391092|12116267|FG001|NOT COMPLETED|Overall Study||216
10945458|NCT00391118|12116276|FG000|STARTED|Overall Study||11
10945459|NCT00391118|12116277|FG001|STARTED|Overall Study||69
10945460|NCT00391118|12116278|FG002|STARTED|Overall Study||73
10945461|NCT00391118|12116276|FG000|Received ≥1 Dose of Assigned Study Drug|Overall Study||11
10945462|NCT00391118|12116277|FG001|Received ≥1 Dose of Assigned Study Drug|Overall Study||67
10945463|NCT00391118|12116278|FG002|Received ≥1 Dose of Assigned Study Drug|Overall Study||72
10945464|NCT00391118|12116276|FG000|COMPLETED|Overall Study||0
10945465|NCT00391118|12116277|FG001|COMPLETED|Overall Study||14
10945466|NCT00391118|12116278|FG002|COMPLETED|Overall Study||15
10945467|NCT00391118|12116276|FG000|NOT COMPLETED|Overall Study||11
10945468|NCT00391118|12116277|FG001|NOT COMPLETED|Overall Study||55
10945469|NCT00391118|12116278|FG002|NOT COMPLETED|Overall Study||58
10945470|NCT00391222|12116292|FG000|STARTED|Period II (Open-label Risperidone LAI)||0
10945471|NCT00391222|12116293|FG001|STARTED|Period II (Open-label Risperidone LAI)||0
10945472|NCT00391222|12116294|FG002|STARTED|Period II (Open-label Risperidone LAI)||0
10945473|NCT00391222|12116295|FG003|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
10945474|NCT00391222|12116292|FG000|COMPLETED|Period II (Open-label Risperidone LAI)||0
10945475|NCT00391222|12116293|FG001|COMPLETED|Period II (Open-label Risperidone LAI)||0
10945476|NCT00391222|12116294|FG002|COMPLETED|Period II (Open-label Risperidone LAI)||0
10945477|NCT00391222|12116295|FG003|COMPLETED|Period II (Open-label Risperidone LAI)||398
10945478|NCT00391222|12116292|FG000|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
10945479|NCT00391222|12116293|FG001|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
10945480|NCT00391222|12116294|FG002|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
10945481|NCT00391222|12116295|FG003|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
10945482|NCT00391222|12116292|FG000|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
10945483|NCT00391222|12116293|FG001|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
10945484|NCT00391222|12116294|FG002|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
10945485|NCT00391222|12116295|FG003|STARTED|Period III (Double-Blind Treatment)||0
10945486|NCT00391222|12116292|FG000|COMPLETED|Period III (Double-Blind Treatment)||104
10945487|NCT00391222|12116293|FG001|COMPLETED|Period III (Double-Blind Treatment)||113
10945488|NCT00391222|12116294|FG002|COMPLETED|Period III (Double-Blind Treatment)||108
10945489|NCT00391222|12116295|FG003|COMPLETED|Period III (Double-Blind Treatment)||0
10945490|NCT00391222|12116292|FG000|NOT COMPLETED|Period III (Double-Blind Treatment)||28
10945491|NCT00391222|12116293|FG001|NOT COMPLETED|Period III (Double-Blind Treatment)||22
10945492|NCT00391222|12116294|FG002|NOT COMPLETED|Period III (Double-Blind Treatment)||23
10945493|NCT00391222|12116295|FG003|NOT COMPLETED|Period III (Double-Blind Treatment)||0
10945494|NCT00391274|12116307|FG000|STARTED|Overall Study||107
10945495|NCT00391274|12116308|FG001|STARTED|Overall Study||104
10945496|NCT00391274|12116307|FG000|Received at Least One Dose of Study Drug|Overall Study||106
10945497|NCT00391274|12116308|FG001|Received at Least One Dose of Study Drug|Overall Study||102
10945498|NCT00391274|12116307|FG000|COMPLETED|Overall Study||46
10945499|NCT00391274|12116308|FG001|COMPLETED|Overall Study||47
10945500|NCT00391274|12116307|FG000|NOT COMPLETED|Overall Study||61
10945501|NCT00391274|12116308|FG001|NOT COMPLETED|Overall Study||57
10945502|NCT00391391|12116318|FG000|STARTED|Overall Study|1 participant was not vaccinated.|98
10945503|NCT00391391|12116319|FG001|STARTED|Overall Study||97
10945504|NCT00391391|12116320|FG002|STARTED|Overall Study|1 participant was not vaccinated.|161
10945505|NCT00391391|12116321|FG003|STARTED|Overall Study|1 participant was not vaccinated.|164
10945506|NCT00391391|12116318|FG000|COMPLETED|Overall Study||89
10945507|NCT00391391|12116319|FG001|COMPLETED|Overall Study||87
10945508|NCT00391391|12116320|FG002|COMPLETED|Overall Study||138
10945509|NCT00391391|12116321|FG003|COMPLETED|Overall Study||145
10945510|NCT00391391|12116318|FG000|NOT COMPLETED|Overall Study||9
10945511|NCT00391391|12116319|FG001|NOT COMPLETED|Overall Study||10
10945512|NCT00391391|12116320|FG002|NOT COMPLETED|Overall Study||23
10945513|NCT00391391|12116321|FG003|NOT COMPLETED|Overall Study||19
10945514|NCT00391443|12116333|FG000|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
10945515|NCT00391443|12116334|FG001|STARTED|Overall Study||407
10945516|NCT00391443|12116333|FG000|COMPLETED|Overall Study||209
10945517|NCT00391443|12116334|FG001|COMPLETED|Overall Study||407
10945518|NCT00391443|12116333|FG000|NOT COMPLETED|Overall Study||0
10945519|NCT00391443|12116334|FG001|NOT COMPLETED|Overall Study||0
10945520|NCT00391469|12116344|FG000|STARTED|Overall Study||688
10945521|NCT00391469|12116345|FG001|STARTED|Overall Study||671
10945522|NCT00391469|12116344|FG000|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
10945523|NCT00391469|12116345|FG001|COMPLETED|Overall Study||671
10945524|NCT00391469|12116344|FG000|NOT COMPLETED|Overall Study||0
10945525|NCT00391469|12116345|FG001|NOT COMPLETED|Overall Study||0
10945526|NCT00391586|12116353|FG000|STARTED|Overall Study||45
10945527|NCT00391586|12116353|FG000|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
10945614|NCT00391976|12116491|FG002|NOT COMPLETED|Overall Study||35
10945615|NCT00391989|12116501|FG000|STARTED|Overall Study||55
10945528|NCT00391586|12116353|FG000|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
10945529|NCT00391586|12116353|FG000|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
10945530|NCT00391586|12116353|FG000|NOT COMPLETED|Overall Study||24
10945531|NCT00391599|12116359|FG000|STARTED|Overall Study||65
10945532|NCT00391599|12116360|FG001|STARTED|Overall Study||65
10945533|NCT00391599|12116359|FG000|COMPLETED|Overall Study||65
10945534|NCT00391599|12116360|FG001|COMPLETED|Overall Study||65
10945535|NCT00391599|12116359|FG000|NOT COMPLETED|Overall Study||0
10945536|NCT00391599|12116360|FG001|NOT COMPLETED|Overall Study||0
10945537|NCT00391625|12116368|FG000|STARTED|Baseline||10
10945538|NCT00391625|12116368|FG000|COMPLETED|Baseline||10
10945539|NCT00391625|12116368|FG000|NOT COMPLETED|Baseline||0
10945540|NCT00391625|12116368|FG000|STARTED|Month 14||10
10945541|NCT00391625|12116368|FG000|COMPLETED|Month 14||9
10945542|NCT00391625|12116368|FG000|NOT COMPLETED|Month 14||1
10945543|NCT00391625|12116368|FG000|STARTED|Month 50||9
10945544|NCT00391625|12116368|FG000|COMPLETED|Month 50||8
10945545|NCT00391625|12116368|FG000|NOT COMPLETED|Month 50||1
10945546|NCT00391625|12116368|FG000|STARTED|Month 84||8
10945547|NCT00391625|12116368|FG000|COMPLETED|Month 84||8
10945548|NCT00391625|12116368|FG000|NOT COMPLETED|Month 84||0
10945549|NCT00391716|12116398|FG000|STARTED|Overall Study||54
10945550|NCT00391716|12116399|FG001|STARTED|Overall Study||47
10945551|NCT00391716|12116400|FG002|STARTED|Overall Study||49
10945552|NCT00391716|12116398|FG000|COMPLETED|Overall Study||27
10945553|NCT00391716|12116399|FG001|COMPLETED|Overall Study||28
10945554|NCT00391716|12116400|FG002|COMPLETED|Overall Study||30
10945555|NCT00391716|12116398|FG000|NOT COMPLETED|Overall Study||27
10945556|NCT00391716|12116399|FG001|NOT COMPLETED|Overall Study||19
10945557|NCT00391716|12116400|FG002|NOT COMPLETED|Overall Study||19
10945558|NCT00391768|12116415|FG000|STARTED|Overall Study||12
10945559|NCT00391768|12116416|FG001|STARTED|Overall Study||3
10945560|NCT00391768|12116417|FG002|STARTED|Overall Study||7
10945561|NCT00391768|12116418|FG003|STARTED|Overall Study||8
10945562|NCT00391768|12116419|FG004|STARTED|Overall Study||24
10945563|NCT00391768|12116420|FG005|STARTED|Overall Study||10
10945564|NCT00391768|12116421|FG006|STARTED|Overall Study||23
10945565|NCT00391768|12116415|FG000|COMPLETED|Overall Study||12
10945566|NCT00391768|12116416|FG001|COMPLETED|Overall Study||3
10945567|NCT00391768|12116417|FG002|COMPLETED|Overall Study||6
10945568|NCT00391768|12116418|FG003|COMPLETED|Overall Study||7
10945569|NCT00391768|12116419|FG004|COMPLETED|Overall Study||22
10945570|NCT00391768|12116420|FG005|COMPLETED|Overall Study||7
10945571|NCT00391768|12116421|FG006|COMPLETED|Overall Study||19
10945572|NCT00391768|12116415|FG000|NOT COMPLETED|Overall Study||0
10945573|NCT00391768|12116416|FG001|NOT COMPLETED|Overall Study||0
10945574|NCT00391768|12116417|FG002|NOT COMPLETED|Overall Study||1
10945575|NCT00391768|12116418|FG003|NOT COMPLETED|Overall Study||1
10945576|NCT00391768|12116419|FG004|NOT COMPLETED|Overall Study||2
10945577|NCT00391768|12116420|FG005|NOT COMPLETED|Overall Study||3
10945578|NCT00391768|12116421|FG006|NOT COMPLETED|Overall Study||4
10945579|NCT00391807|12116455|FG000|STARTED|Overall Study||1683
10945580|NCT00391807|12116455|FG000|COMPLETED|Overall Study||968
10945581|NCT00391807|12116455|FG000|NOT COMPLETED|Overall Study||715
10945582|NCT00391846|12116461|FG000|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
10945583|NCT00391846|12116462|FG001|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
10945584|NCT00391846|12116461|FG000|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
10945585|NCT00391846|12116462|FG001|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
10945586|NCT00391846|12116461|FG000|NOT COMPLETED|Overall Study||8
10945587|NCT00391846|12116462|FG001|NOT COMPLETED|Overall Study||7
10945588|NCT00391872|12116470|FG000|STARTED|Overall Study||9333
10945589|NCT00391872|12116471|FG001|STARTED|Overall Study||9291
10945590|NCT00391872|12116470|FG000|COMPLETED|Overall Study||9026
10945591|NCT00391872|12116471|FG001|COMPLETED|Overall Study||9036
10945592|NCT00391872|12116470|FG000|NOT COMPLETED|Overall Study||307
10945593|NCT00391872|12116471|FG001|NOT COMPLETED|Overall Study||255
10945594|NCT00391898|12116479|FG000|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
10945595|NCT00391898|12116480|FG001|STARTED|Overall Study||49
10945596|NCT00391898|12116479|FG000|COMPLETED|Overall Study||35
10945597|NCT00391898|12116480|FG001|COMPLETED|Overall Study||39
10945598|NCT00391898|12116479|FG000|NOT COMPLETED|Overall Study||11
10945599|NCT00391898|12116480|FG001|NOT COMPLETED|Overall Study||10
10945600|NCT00391976|12116489|FG000|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
10945601|NCT00391976|12116490|FG001|STARTED|Overall Study||43
10945602|NCT00391976|12116491|FG002|STARTED|Overall Study||35
10945603|NCT00391976|12116489|FG000|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
10945604|NCT00391976|12116490|FG001|Randomized|Overall Study||43
10945605|NCT00391976|12116491|FG002|Randomized|Overall Study||0
10945606|NCT00391976|12116489|FG000|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
10945607|NCT00391976|12116490|FG001|Safety Population|Overall Study||43
10945608|NCT00391976|12116491|FG002|Safety Population|Overall Study||35
10945609|NCT00391976|12116489|FG000|COMPLETED|Overall Study||18
10945610|NCT00391976|12116490|FG001|COMPLETED|Overall Study||18
10945611|NCT00391976|12116491|FG002|COMPLETED|Overall Study||0
10945612|NCT00391976|12116489|FG000|NOT COMPLETED|Overall Study||27
10945613|NCT00391976|12116490|FG001|NOT COMPLETED|Overall Study||25
10945616|NCT00391989|12116501|FG000|COMPLETED|Overall Study||53
10945617|NCT00391989|12116501|FG000|NOT COMPLETED|Overall Study||2
10945618|NCT00392015|12116511|FG000|STARTED|Overall Study||6
10945619|NCT00392015|12116512|FG001|STARTED|Overall Study||6
10945620|NCT00392015|12116513|FG002|STARTED|Overall Study||20
10945621|NCT00392015|12116514|FG003|STARTED|Overall Study||6
10945622|NCT00392015|12116515|FG004|STARTED|Overall Study||15
10945623|NCT00392015|12116516|FG005|STARTED|Overall Study||6
10945624|NCT00392015|12116511|FG000|COMPLETED|Overall Study||4
10945625|NCT00392015|12116512|FG001|COMPLETED|Overall Study||6
10945626|NCT00392015|12116513|FG002|COMPLETED|Overall Study||16
10945627|NCT00392015|12116514|FG003|COMPLETED|Overall Study||5
10945628|NCT00392015|12116515|FG004|COMPLETED|Overall Study||12
10945629|NCT00392015|12116516|FG005|COMPLETED|Overall Study||6
10945630|NCT00392015|12116511|FG000|NOT COMPLETED|Overall Study||2
10945631|NCT00392015|12116512|FG001|NOT COMPLETED|Overall Study||0
10945632|NCT00392015|12116513|FG002|NOT COMPLETED|Overall Study||4
10945633|NCT00392015|12116514|FG003|NOT COMPLETED|Overall Study||1
10945634|NCT00392015|12116515|FG004|NOT COMPLETED|Overall Study||3
10945635|NCT00392015|12116516|FG005|NOT COMPLETED|Overall Study||0
10945636|NCT00392041|12116537|FG000|STARTED|First 4 Weeks||19
10945637|NCT00392041|12116538|FG001|STARTED|First 4 Weeks||17
10945638|NCT00392041|12116537|FG000|COMPLETED|First 4 Weeks||11
10945639|NCT00392041|12116538|FG001|COMPLETED|First 4 Weeks||14
10945640|NCT00392041|12116537|FG000|NOT COMPLETED|First 4 Weeks||8
10945641|NCT00392041|12116538|FG001|NOT COMPLETED|First 4 Weeks||3
10945642|NCT00392041|12116537|FG000|STARTED|Weeks 5 - 12||11
10945643|NCT00392041|12116538|FG001|STARTED|Weeks 5 - 12||14
10945644|NCT00392041|12116537|FG000|COMPLETED|Weeks 5 - 12||7
10945645|NCT00392041|12116538|FG001|COMPLETED|Weeks 5 - 12||9
10945646|NCT00392041|12116537|FG000|NOT COMPLETED|Weeks 5 - 12||4
10945647|NCT00392041|12116538|FG001|NOT COMPLETED|Weeks 5 - 12||5
10945648|NCT00392054|12116546|FG000|STARTED|Overall Study|All participants randomized are included in final analysis|66
10945649|NCT00392054|12116547|FG001|STARTED|Overall Study|All participants randomized are included in final analysis|61
10945650|NCT00392054|12116546|FG000|Received Allocated Intervention|Overall Study||65
10945651|NCT00392054|12116547|FG001|Received Allocated Intervention|Overall Study||60
10945652|NCT00392054|12116546|FG000|COMPLETED|Overall Study||66
10945653|NCT00392054|12116547|FG001|COMPLETED|Overall Study||61
10945654|NCT00392054|12116546|FG000|NOT COMPLETED|Overall Study||0
10945655|NCT00392054|12116547|FG001|NOT COMPLETED|Overall Study||0
10945656|NCT00392171|12116557|FG000|STARTED|Overall Study||120
10945657|NCT00392171|12116557|FG000|COMPLETED|Overall Study||15
10945658|NCT00392171|12116557|FG000|NOT COMPLETED|Overall Study||105
10945659|NCT00392197|12116563|FG000|STARTED|Overall Study||48
10945660|NCT00392197|12116564|FG001|STARTED|Overall Study||63
10945661|NCT00392197|12116563|FG000|COMPLETED|Overall Study||27
10945662|NCT00392197|12116564|FG001|COMPLETED|Overall Study||33
10945663|NCT00392197|12116563|FG000|NOT COMPLETED|Overall Study||21
10945664|NCT00392197|12116564|FG001|NOT COMPLETED|Overall Study||30
10945665|NCT00392210|12116572|FG000|STARTED|First Voiding Trial||36
10945666|NCT00392210|12116573|FG001|STARTED|First Voiding Trial||33
10945667|NCT00392210|12116572|FG000|COMPLETED|First Voiding Trial||34
10945668|NCT00392210|12116573|FG001|COMPLETED|First Voiding Trial||31
10945669|NCT00392210|12116572|FG000|NOT COMPLETED|First Voiding Trial||2
10945670|NCT00392210|12116573|FG001|NOT COMPLETED|First Voiding Trial||2
10945671|NCT00392210|12116572|FG000|STARTED|Second Voiding Trial||34
10945672|NCT00392210|12116573|FG001|STARTED|Second Voiding Trial||31
10945673|NCT00392210|12116572|FG000|COMPLETED|Second Voiding Trial||34
10945674|NCT00392210|12116573|FG001|COMPLETED|Second Voiding Trial||31
10945675|NCT00392210|12116572|FG000|NOT COMPLETED|Second Voiding Trial||0
10945676|NCT00392210|12116573|FG001|NOT COMPLETED|Second Voiding Trial||0
10945677|NCT00392223|12116581|FG000|STARTED|Overall Study||58
10945678|NCT00392223|12116582|FG001|STARTED|Overall Study||60
10945679|NCT00392223|12116581|FG000|COMPLETED|Overall Study||49
10945680|NCT00392223|12116582|FG001|COMPLETED|Overall Study||47
10945681|NCT00392223|12116581|FG000|NOT COMPLETED|Overall Study||9
10945682|NCT00392223|12116582|FG001|NOT COMPLETED|Overall Study||13
10945683|NCT00392236|12116590|FG000|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
10945684|NCT00392236|12116591|FG001|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
10945685|NCT00392236|12116590|FG000|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
10945686|NCT00392236|12116591|FG001|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
10945687|NCT00392236|12116590|FG000|NOT COMPLETED|Overall Study||12
10945688|NCT00392236|12116591|FG001|NOT COMPLETED|Overall Study||6
10945689|NCT00392288|12116600|FG000|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
10945690|NCT00392288|12116601|FG001|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
10945691|NCT00392288|12116602|FG002|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
10945692|NCT00392288|12116600|FG000|Treatment Period|Overall Study||172
10945693|NCT00392288|12116601|FG001|Treatment Period|Overall Study||174
10945694|NCT00392288|12116602|FG002|Treatment Period|Overall Study||175
10945695|NCT00392288|12116600|FG000|COMPLETED|Overall Study|ITT set = 163 patients|143
10945696|NCT00392288|12116601|FG001|COMPLETED|Overall Study|ITT set = 166 patients|155
10945697|NCT00392288|12116602|FG002|COMPLETED|Overall Study|ITT set = 172 patients|159
10945698|NCT00392288|12116600|FG000|NOT COMPLETED|Overall Study||32
10945699|NCT00392288|12116601|FG001|NOT COMPLETED|Overall Study||22
10945700|NCT00392288|12116602|FG002|NOT COMPLETED|Overall Study||17
10945701|NCT00392379|12116612|FG000|STARTED|Overall Study|Medication period|136
10945702|NCT00392379|12116613|FG001|STARTED|Overall Study|Medication period|134
10945703|NCT00392379|12116612|FG000|COMPLETED|Overall Study|Medication period|114
10945704|NCT00392379|12116613|FG001|COMPLETED|Overall Study|Medication period|96
10945705|NCT00392379|12116612|FG000|NOT COMPLETED|Overall Study||22
10945706|NCT00392379|12116613|FG001|NOT COMPLETED|Overall Study||38
10945707|NCT00392392|12116619|FG000|STARTED|Overall Study||29
10945708|NCT00392392|12116619|FG000|COMPLETED|Overall Study||9
10945709|NCT00392392|12116619|FG000|NOT COMPLETED|Overall Study||20
10945710|NCT00392444|12116623|FG000|STARTED|Overall Study||39
10945711|NCT00392444|12116623|FG000|COMPLETED|Overall Study||39
10945712|NCT00392444|12116623|FG000|NOT COMPLETED|Overall Study||0
10945713|NCT00392496|12116627|FG000|STARTED|Overall Study||19
10945714|NCT00392496|12116627|FG000|COMPLETED|Overall Study||19
10945715|NCT00392496|12116627|FG000|NOT COMPLETED|Overall Study||0
10945716|NCT00392665|12116633|FG000|STARTED|Overall Study||18
10945717|NCT00392665|12116634|FG001|STARTED|Overall Study||18
10945718|NCT00392665|12116633|FG000|COMPLETED|Overall Study||1
10945719|NCT00392665|12116634|FG001|COMPLETED|Overall Study||3
10945720|NCT00392665|12116633|FG000|NOT COMPLETED|Overall Study||17
10945721|NCT00392665|12116634|FG001|NOT COMPLETED|Overall Study||15
10945722|NCT00392678|12116644|FG000|STARTED|Overall Study||27
10945723|NCT00392678|12116645|FG001|STARTED|Overall Study||27
10945724|NCT00392678|12116646|FG002|STARTED|Overall Study||27
10945725|NCT00392678|12116647|FG003|STARTED|Overall Study||27
10945726|NCT00392678|12116644|FG000|COMPLETED|Overall Study||27
10945727|NCT00392678|12116645|FG001|COMPLETED|Overall Study||26
10945728|NCT00392678|12116646|FG002|COMPLETED|Overall Study||25
10945729|NCT00392678|12116647|FG003|COMPLETED|Overall Study||26
10945730|NCT00392678|12116644|FG000|NOT COMPLETED|Overall Study||0
10945731|NCT00392678|12116645|FG001|NOT COMPLETED|Overall Study||1
10945732|NCT00392678|12116646|FG002|NOT COMPLETED|Overall Study||2
10945733|NCT00392678|12116647|FG003|NOT COMPLETED|Overall Study||1
10945734|NCT00392704|12116666|FG000|STARTED|Neoadjuvant Chemotherapy||60
10945735|NCT00392704|12116666|FG000|COMPLETED|Neoadjuvant Chemotherapy||54
10945736|NCT00392704|12116666|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||6
10945737|NCT00392704|12116666|FG000|STARTED|Combined Modality Therapy||54
10945738|NCT00392704|12116666|FG000|COMPLETED|Combined Modality Therapy||49
10945739|NCT00392704|12116666|FG000|NOT COMPLETED|Combined Modality Therapy||5
10945740|NCT00392769|12116670|FG000|STARTED|Overall Study||33
10945741|NCT00392769|12116670|FG000|COMPLETED|Overall Study||23
10945742|NCT00392769|12116670|FG000|NOT COMPLETED|Overall Study||10
10945743|NCT00392782|12116674|FG000|STARTED|Overall Study||24
10945744|NCT00392782|12116674|FG000|COMPLETED|Overall Study||24
10945745|NCT00392782|12116674|FG000|NOT COMPLETED|Overall Study||0
10945746|NCT00392808|12116682|FG000|STARTED|Overall Study||87
10945747|NCT00392808|12116683|FG001|STARTED|Overall Study||89
10945748|NCT00392808|12116684|FG002|STARTED|Overall Study||109
10945749|NCT00392808|12116685|FG003|STARTED|Overall Study||104
10945750|NCT00392808|12116682|FG000|COMPLETED|Overall Study||81
10945751|NCT00392808|12116683|FG001|COMPLETED|Overall Study||86
10945752|NCT00392808|12116684|FG002|COMPLETED|Overall Study||107
10945753|NCT00392808|12116685|FG003|COMPLETED|Overall Study||100
10945754|NCT00392808|12116682|FG000|NOT COMPLETED|Overall Study||6
10945755|NCT00392808|12116683|FG001|NOT COMPLETED|Overall Study||3
10945756|NCT00392808|12116684|FG002|NOT COMPLETED|Overall Study||2
10945757|NCT00392808|12116685|FG003|NOT COMPLETED|Overall Study||4
10945758|NCT00392834|12116697|FG000|STARTED|Overall Study||2
10945759|NCT00392834|12116698|FG001|STARTED|Overall Study||32
10945760|NCT00392834|12116697|FG000|COMPLETED|Overall Study||2
10945761|NCT00392834|12116698|FG001|COMPLETED|Overall Study||32
10945762|NCT00392834|12116697|FG000|NOT COMPLETED|Overall Study||0
10945763|NCT00392834|12116698|FG001|NOT COMPLETED|Overall Study||0
10945764|NCT00392925|12116708|FG000|STARTED|4 Week Lead-In Period - Non-Randomized||177
10945765|NCT00392925|12116709|FG001|STARTED|4 Week Lead-In Period - Non-Randomized||0
10945766|NCT00392925|12116710|FG002|STARTED|4 Week Lead-In Period - Non-Randomized||0
10945767|NCT00392925|12116711|FG003|STARTED|4 Week Lead-In Period - Non-Randomized||0
10945768|NCT00392925|12116708|FG000|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
10945769|NCT00392925|12116709|FG001|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
10945770|NCT00392925|12116710|FG002|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
10945771|NCT00392925|12116711|FG003|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
10945772|NCT00392925|12116708|FG000|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
10945773|NCT00392925|12116709|FG001|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
10945774|NCT00392925|12116710|FG002|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
10945775|NCT00392925|12116711|FG003|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
10945776|NCT00392925|12116708|FG000|STARTED|Randomization to Treatment Group Period||0
10945777|NCT00392925|12116709|FG001|STARTED|Randomization to Treatment Group Period||27
10945778|NCT00392925|12116710|FG002|STARTED|Randomization to Treatment Group Period||56
10945779|NCT00392925|12116711|FG003|STARTED|Randomization to Treatment Group Period||56
10945780|NCT00392925|12116708|FG000|COMPLETED|Randomization to Treatment Group Period||0
10945781|NCT00392925|12116709|FG001|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
10945782|NCT00392925|12116710|FG002|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
10945783|NCT00392925|12116711|FG003|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
10945784|NCT00392925|12116708|FG000|NOT COMPLETED|Randomization to Treatment Group Period||0
10945785|NCT00392925|12116709|FG001|NOT COMPLETED|Randomization to Treatment Group Period||8
10945786|NCT00392925|12116710|FG002|NOT COMPLETED|Randomization to Treatment Group Period||19
10945787|NCT00392925|12116711|FG003|NOT COMPLETED|Randomization to Treatment Group Period||18
10945788|NCT00392951|12116727|FG000|STARTED|Overall Study||30
10945789|NCT00392951|12116727|FG000|COMPLETED|Overall Study||30
10945790|NCT00392951|12116727|FG000|NOT COMPLETED|Overall Study||0
10945791|NCT00392990|12116733|FG000|STARTED|Treatment on Study||20
10945792|NCT00392990|12116734|FG001|STARTED|Treatment on Study||5
10945793|NCT00392990|12116733|FG000|COMPLETED|Treatment on Study||17
10945794|NCT00392990|12116734|FG001|COMPLETED|Treatment on Study||4
10945795|NCT00392990|12116733|FG000|NOT COMPLETED|Treatment on Study||3
10945796|NCT00392990|12116734|FG001|NOT COMPLETED|Treatment on Study||1
10945797|NCT00392990|12116733|FG000|STARTED|Follow up for 2 Years||20
10945798|NCT00392990|12116734|FG001|STARTED|Follow up for 2 Years||5
10945799|NCT00392990|12116733|FG000|COMPLETED|Follow up for 2 Years||16
10945800|NCT00392990|12116734|FG001|COMPLETED|Follow up for 2 Years||5
10945801|NCT00392990|12116733|FG000|NOT COMPLETED|Follow up for 2 Years||4
10945802|NCT00392990|12116734|FG001|NOT COMPLETED|Follow up for 2 Years||0
10945803|NCT00393029|12116742|FG000|STARTED|Overall Study||2
10945804|NCT00393029|12116743|FG001|STARTED|Overall Study||10
10945805|NCT00393029|12116742|FG000|COMPLETED|Overall Study||2
10945806|NCT00393029|12116743|FG001|COMPLETED|Overall Study||9
10945807|NCT00393029|12116742|FG000|NOT COMPLETED|Overall Study||0
10945808|NCT00393029|12116743|FG001|NOT COMPLETED|Overall Study||1
10945809|NCT00393042|12116750|FG000|STARTED|First Intervention||31
10945810|NCT00393042|12116751|FG001|STARTED|First Intervention||33
10945811|NCT00393042|12116750|FG000|Completed the Placebo Dosage|First Intervention||27
10945812|NCT00393042|12116751|FG001|Completed the Placebo Dosage|First Intervention||29
10945813|NCT00393042|12116750|FG000|Completed 10mg Dosage|First Intervention||29
10945814|NCT00393042|12116751|FG001|Completed 10mg Dosage|First Intervention||29
10945815|NCT00393042|12116750|FG000|Completed 20 mg Dosage|First Intervention||26
10945816|NCT00393042|12116751|FG001|Completed 20 mg Dosage|First Intervention||28
10945817|NCT00393042|12116750|FG000|Completed 25/30mg Dosage|First Intervention||27
10945818|NCT00393042|12116751|FG001|Completed 25/30mg Dosage|First Intervention||27
10945819|NCT00393042|12116750|FG000|COMPLETED|First Intervention||26
10945820|NCT00393042|12116751|FG001|COMPLETED|First Intervention||27
10945821|NCT00393042|12116750|FG000|NOT COMPLETED|First Intervention||5
10945822|NCT00393042|12116751|FG001|NOT COMPLETED|First Intervention||6
10945823|NCT00393042|12116750|FG000|STARTED|Second Intervetion||26
10945824|NCT00393042|12116751|FG001|STARTED|Second Intervetion||27
10945825|NCT00393042|12116750|FG000|Completed Placebo Dosage|Second Intervetion||25
10945826|NCT00393042|12116751|FG001|Completed Placebo Dosage|Second Intervetion||21
10945827|NCT00393042|12116750|FG000|Completed 10 mg Dosage|Second Intervetion||26
10945828|NCT00393042|12116751|FG001|Completed 10 mg Dosage|Second Intervetion||24
10945829|NCT00393042|12116750|FG000|Completed the 20mg Dosage|Second Intervetion||24
10945830|NCT00393042|12116751|FG001|Completed the 20mg Dosage|Second Intervetion||21
10945831|NCT00393042|12116750|FG000|Completed 25/30 mg Dosage|Second Intervetion||24
10945832|NCT00393042|12116751|FG001|Completed 25/30 mg Dosage|Second Intervetion||20
10945833|NCT00393042|12116750|FG000|COMPLETED|Second Intervetion||24
10945834|NCT00393042|12116751|FG001|COMPLETED|Second Intervetion||19
10945835|NCT00393042|12116750|FG000|NOT COMPLETED|Second Intervetion||2
10945836|NCT00393042|12116751|FG001|NOT COMPLETED|Second Intervetion||8
10945837|NCT00393094|12116805|FG000|STARTED|Period1Bevacizumab & Irinotecan Patients||31
10945838|NCT00393094|12116805|FG000|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
10945839|NCT00393094|12116805|FG000|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
10945840|NCT00393094|12116805|FG000|STARTED|Disease Progression After Trtmt: Onstudy||30
10945841|NCT00393094|12116805|FG000|COMPLETED|Disease Progression After Trtmt: Onstudy||29
10945842|NCT00393094|12116805|FG000|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
10945843|NCT00393367|12116813|FG000|STARTED|Overall Study||91
10945844|NCT00393367|12116814|FG001|STARTED|Overall Study||88
10945845|NCT00393367|12116813|FG000|COMPLETED|Overall Study||89
10945846|NCT00393367|12116814|FG001|COMPLETED|Overall Study||81
10945847|NCT00393367|12116813|FG000|NOT COMPLETED|Overall Study||2
10945848|NCT00393367|12116814|FG001|NOT COMPLETED|Overall Study||7
10945849|NCT00393380|12116822|FG000|STARTED|Overall Study||13
10945850|NCT00393380|12116822|FG000|COMPLETED|Overall Study||13
10945851|NCT00393380|12116822|FG000|NOT COMPLETED|Overall Study||0
10945852|NCT00393458|12116830|FG000|STARTED|Overall Study||437
10945853|NCT00393458|12116831|FG001|STARTED|Overall Study||428
10945854|NCT00393458|12116832|FG002|STARTED|Overall Study||435
10945855|NCT00393458|12116833|FG003|STARTED|Overall Study||432
10945856|NCT00393458|12116830|FG000|Exposed to Study Medication or Placebo|Overall Study||437
10945857|NCT00393458|12116831|FG001|Exposed to Study Medication or Placebo|Overall Study||425
10945858|NCT00393458|12116832|FG002|Exposed to Study Medication or Placebo|Overall Study||434
10945859|NCT00393458|12116833|FG003|Exposed to Study Medication or Placebo|Overall Study||432
10945860|NCT00393458|12116830|FG000|COMPLETED|Overall Study||338
10945861|NCT00393458|12116831|FG001|COMPLETED|Overall Study||326
10945862|NCT00393458|12116832|FG002|COMPLETED|Overall Study||323
10945863|NCT00393458|12116833|FG003|COMPLETED|Overall Study||295
10945864|NCT00393458|12116830|FG000|NOT COMPLETED|Overall Study||99
10945865|NCT00393458|12116831|FG001|NOT COMPLETED|Overall Study||102
10945866|NCT00393458|12116832|FG002|NOT COMPLETED|Overall Study||112
10945867|NCT00393458|12116833|FG003|NOT COMPLETED|Overall Study||137
10945868|NCT00393484|12116845|FG000|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
10945869|NCT00393484|12116846|FG001|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
10945870|NCT00393484|12116845|FG000|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
10945871|NCT00393484|12116846|FG001|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
10945872|NCT00393484|12116845|FG000|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
10945873|NCT00393484|12116846|FG001|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
10945874|NCT00393484|12116845|FG000|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
10945875|NCT00393484|12116846|FG001|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
10945876|NCT00393484|12116845|FG000|STARTED|Open-label Period (Weeks 96 to 240)||48
10945877|NCT00393484|12116846|FG001|STARTED|Open-label Period (Weeks 96 to 240)||44
10945878|NCT00393484|12116845|FG000|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
10945879|NCT00393484|12116846|FG001|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
10945880|NCT00393484|12116845|FG000|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
10945881|NCT00393484|12116846|FG001|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
10945882|NCT00393484|12116845|FG000|COMPLETED|Open-label Period (Weeks 96 to 240)||40
10945883|NCT00393484|12116846|FG001|COMPLETED|Open-label Period (Weeks 96 to 240)||21
10945884|NCT00393484|12116845|FG000|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
10945885|NCT00393484|12116846|FG001|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
10945886|NCT00393510|12116856|FG000|STARTED|Overall Study||40
10945887|NCT00393510|12116857|FG001|STARTED|Overall Study||40
10945888|NCT00393510|12116856|FG000|COMPLETED|Overall Study||37
10945889|NCT00393510|12116857|FG001|COMPLETED|Overall Study||31
10945890|NCT00393510|12116856|FG000|NOT COMPLETED|Overall Study||3
10945891|NCT00393510|12116857|FG001|NOT COMPLETED|Overall Study||9
10945892|NCT00393523|12116868|FG000|STARTED|Overall Study||376
10945893|NCT00393523|12116869|FG001|STARTED|Overall Study||375
10945894|NCT00393523|12116870|FG002|STARTED|Overall Study||353
10945895|NCT00393523|12116871|FG003|STARTED|Overall Study||354
10945896|NCT00393523|12116872|FG004|STARTED|Overall Study||20
10945897|NCT00393523|12116868|FG000|Vaccination Visit 1|Overall Study||374
10945898|NCT00393523|12116869|FG001|Vaccination Visit 1|Overall Study||375
10945899|NCT00393523|12116870|FG002|Vaccination Visit 1|Overall Study||349
10945900|NCT00393523|12116871|FG003|Vaccination Visit 1|Overall Study||352
10945901|NCT00393523|12116872|FG004|Vaccination Visit 1|Overall Study||20
10945902|NCT00393523|12116868|FG000|COMPLETED|Overall Study||364
10945903|NCT00393523|12116869|FG001|COMPLETED|Overall Study||366
10945904|NCT00393523|12116870|FG002|COMPLETED|Overall Study||349
10945905|NCT00393523|12116871|FG003|COMPLETED|Overall Study||348
10945906|NCT00393523|12116872|FG004|COMPLETED|Overall Study||19
10945907|NCT00393523|12116868|FG000|NOT COMPLETED|Overall Study||12
10945908|NCT00393523|12116869|FG001|NOT COMPLETED|Overall Study||9
10945909|NCT00393523|12116870|FG002|NOT COMPLETED|Overall Study||4
10945910|NCT00393523|12116871|FG003|NOT COMPLETED|Overall Study||6
10945911|NCT00393523|12116872|FG004|NOT COMPLETED|Overall Study||1
10945912|NCT00393705|12116885|FG000|STARTED|Overall Study||151
10945913|NCT00393705|12116886|FG001|STARTED|Overall Study||151
10945914|NCT00393705|12116885|FG000|Received at Least One Dose of Study Drug|Overall Study||139
10945915|NCT00393705|12116886|FG001|Received at Least One Dose of Study Drug|Overall Study||139
10945916|NCT00393705|12116885|FG000|COMPLETED|Overall Study||128
10945917|NCT00393705|12116886|FG001|COMPLETED|Overall Study||128
10945918|NCT00393705|12116885|FG000|NOT COMPLETED|Overall Study||23
10945919|NCT00393705|12116886|FG001|NOT COMPLETED|Overall Study||23
10945920|NCT00393718|12116894|FG000|STARTED|Overall Study||268
10945921|NCT00393718|12116895|FG001|STARTED|Overall Study||132
10945922|NCT00393718|12116894|FG000|COMPLETED|Overall Study||225
10945923|NCT00393718|12116895|FG001|COMPLETED|Overall Study||110
10945924|NCT00393718|12116894|FG000|NOT COMPLETED|Overall Study||43
10945925|NCT00393718|12116895|FG001|NOT COMPLETED|Overall Study||22
10945926|NCT00393796|12116903|FG000|STARTED|Double Blind Period||26
10945927|NCT00393796|12116904|FG001|STARTED|Double Blind Period||28
10945928|NCT00393796|12116903|FG000|COMPLETED|Double Blind Period||26
10945929|NCT00393796|12116904|FG001|COMPLETED|Double Blind Period||28
10945930|NCT00393796|12116903|FG000|NOT COMPLETED|Double Blind Period||0
10945931|NCT00393796|12116904|FG001|NOT COMPLETED|Double Blind Period||0
10945932|NCT00393796|12116903|FG000|STARTED|Open Label Period - Placebo to SUTENT||0
10945933|NCT00393796|12116904|FG001|STARTED|Open Label Period - Placebo to SUTENT||16
10945934|NCT00393796|12116903|FG000|COMPLETED|Open Label Period - Placebo to SUTENT||0
10945935|NCT00393796|12116904|FG001|COMPLETED|Open Label Period - Placebo to SUTENT||16
10945936|NCT00393796|12116903|FG000|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
10945937|NCT00393796|12116904|FG001|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
10945938|NCT00393848|12116914|FG000|STARTED|Overall Study||16
10945939|NCT00393848|12116915|FG001|STARTED|Overall Study||9
10945940|NCT00393848|12116916|FG002|STARTED|Overall Study||6
10945941|NCT00393848|12116917|FG003|STARTED|Overall Study||9
10945942|NCT00393848|12116914|FG000|COMPLETED|Overall Study||16
10945943|NCT00393848|12116915|FG001|COMPLETED|Overall Study||9
10945944|NCT00393848|12116916|FG002|COMPLETED|Overall Study||4
10945945|NCT00393848|12116917|FG003|COMPLETED|Overall Study||8
10945946|NCT00393848|12116914|FG000|NOT COMPLETED|Overall Study||0
10945947|NCT00393848|12116915|FG001|NOT COMPLETED|Overall Study||0
10945948|NCT00393848|12116916|FG002|NOT COMPLETED|Overall Study||2
10945949|NCT00393848|12116917|FG003|NOT COMPLETED|Overall Study||1
10945950|NCT00393861|12116928|FG000|STARTED|Overall Study||29
10945951|NCT00393861|12116928|FG000|COMPLETED|Overall Study||3
10945952|NCT00393861|12116928|FG000|NOT COMPLETED|Overall Study||26
10945953|NCT00393874|12116935|FG000|STARTED|Overall Study||18
10945954|NCT00393874|12116936|FG001|STARTED|Overall Study||17
10945955|NCT00393874|12116937|FG002|STARTED|Overall Study||15
10945956|NCT00393874|12116935|FG000|COMPLETED|Overall Study||15
10945957|NCT00393874|12116936|FG001|COMPLETED|Overall Study||13
10945958|NCT00393874|12116937|FG002|COMPLETED|Overall Study||13
10945959|NCT00393874|12116935|FG000|NOT COMPLETED|Overall Study||3
10945960|NCT00393874|12116936|FG001|NOT COMPLETED|Overall Study||4
10945961|NCT00393874|12116937|FG002|NOT COMPLETED|Overall Study||2
10945962|NCT00393887|12116950|FG000|STARTED|Overall Study||50
10945963|NCT00393887|12116951|FG001|STARTED|Overall Study||50
10945964|NCT00393887|12116950|FG000|1 Year|Overall Study||45
10945965|NCT00393887|12116951|FG001|1 Year|Overall Study||50
10945966|NCT00393887|12116950|FG000|COMPLETED|Overall Study||34
10945967|NCT00393887|12116951|FG001|COMPLETED|Overall Study||41
10945968|NCT00393887|12116950|FG000|NOT COMPLETED|Overall Study||16
10945969|NCT00393887|12116951|FG001|NOT COMPLETED|Overall Study||9
10945970|NCT00393913|12116957|FG000|STARTED|Initial Assessment||144
10945971|NCT00393913|12116957|FG000|COMPLETED|Initial Assessment||107
10945972|NCT00393913|12116957|FG000|NOT COMPLETED|Initial Assessment||37
10945973|NCT00393913|12116957|FG000|STARTED|CPAP|Excludes normal volunteers without OSA|100
10945974|NCT00393913|12116957|FG000|COMPLETED|CPAP||93
10945975|NCT00393913|12116957|FG000|NOT COMPLETED|CPAP||7
10945976|NCT00393913|12116957|FG000|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
10945977|NCT00393913|12116957|FG000|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
10945978|NCT00393913|12116957|FG000|COMPLETED|CPAP Withdrawal||42
10945979|NCT00393913|12116957|FG000|NOT COMPLETED|CPAP Withdrawal||0
10945980|NCT00393939|12116964|FG000|STARTED|Overall Study||296
10945981|NCT00393939|12116965|FG001|STARTED|Overall Study||297
10945982|NCT00393939|12116964|FG000|Treated|Overall Study||295
10945983|NCT00393939|12116965|FG001|Treated|Overall Study||293
10945984|NCT00393939|12116964|FG000|COMPLETED|Overall Study||0
10945985|NCT00393939|12116965|FG001|COMPLETED|Overall Study||0
10945986|NCT00393939|12116964|FG000|NOT COMPLETED|Overall Study||296
10945987|NCT00393939|12116965|FG001|NOT COMPLETED|Overall Study||297
10945988|NCT00393978|12116973|FG000|STARTED|Overall Study||37
10945989|NCT00393978|12116974|FG001|STARTED|Overall Study||38
10945990|NCT00393978|12116973|FG000|COMPLETED|Overall Study||21
10945991|NCT00393978|12116974|FG001|COMPLETED|Overall Study||18
10945992|NCT00393978|12116973|FG000|NOT COMPLETED|Overall Study||16
10945993|NCT00393978|12116974|FG001|NOT COMPLETED|Overall Study||20
10945994|NCT00394082|12116980|FG000|STARTED|Overall Study||50
10945995|NCT00394082|12116980|FG000|At Least One Response Assessment|Overall Study||43
10945996|NCT00394082|12116980|FG000|COMPLETED|Overall Study|Treatment completed upon disease progression|24
10945997|NCT00394082|12116980|FG000|NOT COMPLETED|Overall Study||26
10945998|NCT00394095|12116986|FG000|STARTED|Overall Study||17
10945999|NCT00394095|12116987|FG001|STARTED|Overall Study||14
10946000|NCT00394095|12116986|FG000|Screened|Overall Study||17
10946001|NCT00394095|12116987|FG001|Screened|Overall Study||14
10946002|NCT00394095|12116986|FG000|COMPLETED|Overall Study||16
10946003|NCT00394095|12116987|FG001|COMPLETED|Overall Study||14
10946004|NCT00394095|12116986|FG000|NOT COMPLETED|Overall Study||1
10946005|NCT00394095|12116987|FG001|NOT COMPLETED|Overall Study||0
10946006|NCT00394212|12116996|FG000|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
10946007|NCT00394212|12116997|FG001|STARTED|Overall Study||27
10946008|NCT00394212|12116996|FG000|6 Week Follow-up|Overall Study||45
10946009|NCT00394212|12116997|FG001|6 Week Follow-up|Overall Study||26
10946010|NCT00394212|12116996|FG000|3 Month Follow-up|Overall Study||45
10946011|NCT00394212|12116997|FG001|3 Month Follow-up|Overall Study||26
10946012|NCT00394212|12116996|FG000|6 Month Follow-up|Overall Study||43
10946013|NCT00394212|12116997|FG001|6 Month Follow-up|Overall Study||26
10946014|NCT00394212|12116996|FG000|COMPLETED|Overall Study||43
10946015|NCT00394212|12116997|FG001|COMPLETED|Overall Study||26
10946016|NCT00394212|12116996|FG000|NOT COMPLETED|Overall Study||7
10946017|NCT00394212|12116997|FG001|NOT COMPLETED|Overall Study||1
10946018|NCT00394251|12117005|FG000|STARTED|Overall Study||98
10946019|NCT00394251|12117006|FG001|STARTED|Overall Study||99
10946020|NCT00394251|12117005|FG000|At Least One Dose of Taxane|Overall Study||93
10946021|NCT00394251|12117006|FG001|At Least One Dose of Taxane|Overall Study||93
10946022|NCT00394251|12117005|FG000|COMPLETED|Overall Study||61
10946023|NCT00394251|12117006|FG001|COMPLETED|Overall Study||61
10946024|NCT00394251|12117005|FG000|NOT COMPLETED|Overall Study||37
10946025|NCT00394251|12117006|FG001|NOT COMPLETED|Overall Study||38
10946026|NCT00394277|12117020|FG000|STARTED|Overall Study||195
10946027|NCT00394277|12117021|FG001|STARTED|Overall Study||196
10946028|NCT00394277|12117022|FG002|STARTED|Overall Study||393
10946029|NCT00394277|12117023|FG003|STARTED|Overall Study||391
10946030|NCT00394277|12117020|FG000|COMPLETED|Overall Study||137
10946031|NCT00394277|12117021|FG001|COMPLETED|Overall Study||136
10946032|NCT00394277|12117022|FG002|COMPLETED|Overall Study||273
10946033|NCT00394277|12117023|FG003|COMPLETED|Overall Study||266
10946034|NCT00394277|12117020|FG000|NOT COMPLETED|Overall Study||58
10946035|NCT00394277|12117021|FG001|NOT COMPLETED|Overall Study||60
10946036|NCT00394277|12117022|FG002|NOT COMPLETED|Overall Study||120
10946037|NCT00394277|12117023|FG003|NOT COMPLETED|Overall Study||125
10946038|NCT00394329|12117037|FG000|STARTED|Overall Study||71
10946039|NCT00394329|12117038|FG001|STARTED|Overall Study||72
10946040|NCT00394329|12117039|FG002|STARTED|Overall Study||71
10946041|NCT00394329|12117040|FG003|STARTED|Overall Study||74
10946042|NCT00394329|12117037|FG000|COMPLETED|Overall Study||63
10946043|NCT00394329|12117038|FG001|COMPLETED|Overall Study||63
10946044|NCT00394329|12117039|FG002|COMPLETED|Overall Study||58
10946045|NCT00394329|12117040|FG003|COMPLETED|Overall Study||50
10946046|NCT00394329|12117037|FG000|NOT COMPLETED|Overall Study||8
10946047|NCT00394329|12117038|FG001|NOT COMPLETED|Overall Study||9
10946048|NCT00394329|12117039|FG002|NOT COMPLETED|Overall Study||13
10946049|NCT00394329|12117040|FG003|NOT COMPLETED|Overall Study||24
10946050|NCT00394433|12117056|FG000|STARTED|Overall Study||38
10946051|NCT00394433|12117056|FG000|Evaluable and Treated|Overall Study||35
10946052|NCT00394433|12117056|FG000|COMPLETED|Overall Study||35
10946053|NCT00394433|12117056|FG000|NOT COMPLETED|Overall Study||3
10946054|NCT00394472|12117062|FG000|STARTED|Overall Study||122
10946055|NCT00394472|12117063|FG001|STARTED|Overall Study||122
10946056|NCT00394472|12117062|FG000|COMPLETED|Overall Study||113
10946057|NCT00394472|12117063|FG001|COMPLETED|Overall Study||111
10946058|NCT00394472|12117062|FG000|NOT COMPLETED|Overall Study||9
10946059|NCT00394472|12117063|FG001|NOT COMPLETED|Overall Study||11
10946060|NCT00394524|12117071|FG000|STARTED|Overall Study||80
10946061|NCT00394524|12117072|FG001|STARTED|Overall Study||80
10946062|NCT00394524|12117071|FG000|COMPLETED|Overall Study||77
10946063|NCT00394524|12117072|FG001|COMPLETED|Overall Study||76
10946064|NCT00394524|12117071|FG000|NOT COMPLETED|Overall Study||3
10946065|NCT00394524|12117072|FG001|NOT COMPLETED|Overall Study||4
10946066|NCT00394589|12117083|FG000|STARTED|Overall Study||14
10946067|NCT00394589|12117084|FG001|STARTED|Overall Study||11
10946068|NCT00394589|12117085|FG002|STARTED|Overall Study||18
10946069|NCT00394589|12117083|FG000|COMPLETED|Overall Study||6
10946070|NCT00394589|12117084|FG001|COMPLETED|Overall Study||8
10946071|NCT00394589|12117085|FG002|COMPLETED|Overall Study||11
10946072|NCT00394589|12117083|FG000|NOT COMPLETED|Overall Study||8
10946073|NCT00394589|12117084|FG001|NOT COMPLETED|Overall Study||3
10946074|NCT00394589|12117085|FG002|NOT COMPLETED|Overall Study||7
10946075|NCT00394654|12117095|FG000|STARTED|Overall Study||15
10946076|NCT00394654|12117096|FG001|STARTED|Overall Study||15
10946077|NCT00394654|12117095|FG000|COMPLETED|Overall Study||13
10946078|NCT00394654|12117096|FG001|COMPLETED|Overall Study||15
10946079|NCT00394654|12117095|FG000|NOT COMPLETED|Overall Study||2
10946080|NCT00394654|12117096|FG001|NOT COMPLETED|Overall Study||0
10946081|NCT00394706|12117110|FG000|STARTED|Overall Study||1819
10946082|NCT00394706|12117111|FG001|STARTED|Overall Study||1862
10946083|NCT00394706|12117112|FG002|STARTED|Overall Study||1624
10946084|NCT00394706|12117113|FG003|STARTED|Overall Study||1633
10946085|NCT00394706|12117114|FG004|STARTED|Overall Study||1636
10946086|NCT00394706|12117115|FG005|STARTED|Overall Study||1384
10946087|NCT00394706|12117116|FG006|STARTED|Overall Study||929
10946088|NCT00394706|12117117|FG007|STARTED|Overall Study||851
10946089|NCT00394706|12117110|FG000|COMPLETED|Overall Study||1815
10946090|NCT00394706|12117111|FG001|COMPLETED|Overall Study||1860
10946091|NCT00394706|12117112|FG002|COMPLETED|Overall Study||1615
10946092|NCT00394706|12117113|FG003|COMPLETED|Overall Study||1632
10946093|NCT00394706|12117114|FG004|COMPLETED|Overall Study||1634
10946094|NCT00394706|12117115|FG005|COMPLETED|Overall Study||1377
10946095|NCT00394706|12117116|FG006|COMPLETED|Overall Study||926
10946096|NCT00394706|12117117|FG007|COMPLETED|Overall Study||851
10946097|NCT00394706|12117110|FG000|NOT COMPLETED|Overall Study||4
10946098|NCT00394706|12117111|FG001|NOT COMPLETED|Overall Study||2
10946099|NCT00394706|12117112|FG002|NOT COMPLETED|Overall Study||9
10946100|NCT00394706|12117113|FG003|NOT COMPLETED|Overall Study||1
10946101|NCT00394706|12117114|FG004|NOT COMPLETED|Overall Study||2
10946102|NCT00394706|12117115|FG005|NOT COMPLETED|Overall Study||7
10946103|NCT00394706|12117116|FG006|NOT COMPLETED|Overall Study||3
10946104|NCT00394706|12117117|FG007|NOT COMPLETED|Overall Study||0
10946105|NCT00394771|12117135|FG000|STARTED|Overall Study|Safety population of treated participants|140
10946106|NCT00394771|12117136|FG001|STARTED|Overall Study|Safety population of treated participants|136
10946107|NCT00394771|12117137|FG002|STARTED|Overall Study|Safety population of treated participants|143
10946108|NCT00394771|12117138|FG003|STARTED|Overall Study|Safety population of treated participants|148
10946109|NCT00394771|12117135|FG000|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
10946110|NCT00394771|12117136|FG001|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
10946111|NCT00394771|12117137|FG002|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
10946112|NCT00394771|12117138|FG003|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
10946113|NCT00394771|12117135|FG000|COMPLETED|Overall Study||99
10946114|NCT00394771|12117136|FG001|COMPLETED|Overall Study||102
10946115|NCT00394771|12117137|FG002|COMPLETED|Overall Study||96
10946116|NCT00394771|12117138|FG003|COMPLETED|Overall Study||109
10946117|NCT00394771|12117135|FG000|NOT COMPLETED|Overall Study||41
10946118|NCT00394771|12117136|FG001|NOT COMPLETED|Overall Study||34
10946119|NCT00394771|12117137|FG002|NOT COMPLETED|Overall Study||47
10946120|NCT00394771|12117138|FG003|NOT COMPLETED|Overall Study||39
10946121|NCT00394836|12117150|FG000|STARTED|Teatment or Follow-up Phase||30
10946122|NCT00394836|12117151|FG001|STARTED|Teatment or Follow-up Phase||86
10946123|NCT00394836|12117150|FG000|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
10946124|NCT00394836|12117151|FG001|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
10946125|NCT00394836|12117150|FG000|COMPLETED|Teatment or Follow-up Phase||2
10946126|NCT00394836|12117151|FG001|COMPLETED|Teatment or Follow-up Phase||8
10946127|NCT00394836|12117150|FG000|NOT COMPLETED|Teatment or Follow-up Phase||28
10946128|NCT00394836|12117151|FG001|NOT COMPLETED|Teatment or Follow-up Phase||78
10946305|NCT00395304|12117295|FG000|COMPLETED|Treatment Period 1||30
10946129|NCT00394836|12117150|FG000|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
10946130|NCT00394836|12117151|FG001|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
10946131|NCT00394836|12117150|FG000|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
10946132|NCT00394836|12117151|FG001|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
10946133|NCT00394836|12117150|FG000|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
10946134|NCT00394836|12117151|FG001|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
10946135|NCT00394888|12117162|FG000|STARTED|Overall Study||108
10946136|NCT00394888|12117163|FG001|STARTED|Overall Study||48
10946137|NCT00394888|12117164|FG002|STARTED|Overall Study||201
10946138|NCT00394888|12117162|FG000|COMPLETED|Overall Study||108
10946139|NCT00394888|12117163|FG001|COMPLETED|Overall Study||48
10946140|NCT00394888|12117164|FG002|COMPLETED|Overall Study||201
10946141|NCT00394888|12117162|FG000|NOT COMPLETED|Overall Study||0
10946142|NCT00394888|12117163|FG001|NOT COMPLETED|Overall Study||0
10946143|NCT00394888|12117164|FG002|NOT COMPLETED|Overall Study||0
10946144|NCT00394901|12117174|FG000|STARTED|Baseline Phase|Subjects randomized|98
10946145|NCT00394901|12117175|FG001|STARTED|Baseline Phase|Subjects randomized|87
10946146|NCT00394901|12117176|FG002|STARTED|Baseline Phase|Subjects randomized|90
10946147|NCT00394901|12117177|FG003|STARTED|Baseline Phase|Subjects randomized|97
10946148|NCT00394901|12117174|FG000|COMPLETED|Baseline Phase||98
10946149|NCT00394901|12117175|FG001|COMPLETED|Baseline Phase||87
10946150|NCT00394901|12117176|FG002|COMPLETED|Baseline Phase||89
10946151|NCT00394901|12117177|FG003|COMPLETED|Baseline Phase||97
10946152|NCT00394901|12117174|FG000|NOT COMPLETED|Baseline Phase||0
10946153|NCT00394901|12117175|FG001|NOT COMPLETED|Baseline Phase||0
10946154|NCT00394901|12117176|FG002|NOT COMPLETED|Baseline Phase||1
10946155|NCT00394901|12117177|FG003|NOT COMPLETED|Baseline Phase||0
10946156|NCT00394901|12117174|FG000|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
10946157|NCT00394901|12117175|FG001|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
10946158|NCT00394901|12117176|FG002|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
10946159|NCT00394901|12117177|FG003|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
10946160|NCT00394901|12117174|FG000|COMPLETED|Double-blind Phase||83
10946161|NCT00394901|12117175|FG001|COMPLETED|Double-blind Phase||73
10946162|NCT00394901|12117176|FG002|COMPLETED|Double-blind Phase||71
10946163|NCT00394901|12117177|FG003|COMPLETED|Double-blind Phase||70
10946164|NCT00394901|12117174|FG000|NOT COMPLETED|Double-blind Phase||15
10946165|NCT00394901|12117175|FG001|NOT COMPLETED|Double-blind Phase||14
10946166|NCT00394901|12117176|FG002|NOT COMPLETED|Double-blind Phase||18
10946167|NCT00394901|12117177|FG003|NOT COMPLETED|Double-blind Phase||27
10946168|NCT00394914|12117192|FG000|STARTED|Screening Period||311
10946169|NCT00394914|12117193|FG001|STARTED|Screening Period||0
10946170|NCT00394914|12117194|FG002|STARTED|Screening Period||0
10946171|NCT00394914|12117192|FG000|COMPLETED|Screening Period||311
10946172|NCT00394914|12117193|FG001|COMPLETED|Screening Period||0
10946173|NCT00394914|12117194|FG002|COMPLETED|Screening Period||0
10946174|NCT00394914|12117192|FG000|NOT COMPLETED|Screening Period||0
10946175|NCT00394914|12117193|FG001|NOT COMPLETED|Screening Period||0
10946176|NCT00394914|12117194|FG002|NOT COMPLETED|Screening Period||0
10946177|NCT00394914|12117192|FG000|STARTED|Pre-exposure Period||311
10946178|NCT00394914|12117193|FG001|STARTED|Pre-exposure Period||0
10946179|NCT00394914|12117194|FG002|STARTED|Pre-exposure Period||0
10946180|NCT00394914|12117192|FG000|COMPLETED|Pre-exposure Period||311
10946181|NCT00394914|12117193|FG001|COMPLETED|Pre-exposure Period||0
10946182|NCT00394914|12117194|FG002|COMPLETED|Pre-exposure Period||0
10946183|NCT00394914|12117192|FG000|NOT COMPLETED|Pre-exposure Period||0
10946184|NCT00394914|12117193|FG001|NOT COMPLETED|Pre-exposure Period||0
10946185|NCT00394914|12117194|FG002|NOT COMPLETED|Pre-exposure Period||0
10946186|NCT00394914|12117192|FG000|STARTED|Treatment Period||0
10946187|NCT00394914|12117193|FG001|STARTED|Treatment Period||154
10946188|NCT00394914|12117194|FG002|STARTED|Treatment Period||157
10946189|NCT00394914|12117192|FG000|COMPLETED|Treatment Period||0
10946190|NCT00394914|12117193|FG001|COMPLETED|Treatment Period||144
10946191|NCT00394914|12117194|FG002|COMPLETED|Treatment Period||151
10946192|NCT00394914|12117192|FG000|NOT COMPLETED|Treatment Period||0
10946193|NCT00394914|12117193|FG001|NOT COMPLETED|Treatment Period||10
10946194|NCT00394914|12117194|FG002|NOT COMPLETED|Treatment Period||6
10946195|NCT00394953|12117202|FG000|STARTED|First Treatment Period||245
10946196|NCT00394953|12117203|FG001|STARTED|First Treatment Period||244
10946197|NCT00394953|12117202|FG000|COMPLETED|First Treatment Period||216
10946198|NCT00394953|12117203|FG001|COMPLETED|First Treatment Period||222
10946199|NCT00394953|12117202|FG000|NOT COMPLETED|First Treatment Period||29
10946200|NCT00394953|12117203|FG001|NOT COMPLETED|First Treatment Period||22
10946201|NCT00394953|12117202|FG000|STARTED|Second Treatment Period||216
10946202|NCT00394953|12117203|FG001|STARTED|Second Treatment Period||222
10946203|NCT00394953|12117202|FG000|COMPLETED|Second Treatment Period||187
10946204|NCT00394953|12117203|FG001|COMPLETED|Second Treatment Period||148
10946205|NCT00394953|12117202|FG000|NOT COMPLETED|Second Treatment Period||29
10946206|NCT00394953|12117203|FG001|NOT COMPLETED|Second Treatment Period||74
10946207|NCT00395018|12117209|FG000|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
10946208|NCT00395018|12117209|FG000|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
10946209|NCT00395018|12117209|FG000|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
10946210|NCT00395018|12117209|FG000|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
10946211|NCT00395018|12117209|FG000|NOT COMPLETED|On-Treatment||10
10946212|NCT00395018|12117209|FG000|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
10946213|NCT00395018|12117209|FG000|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
10946214|NCT00395018|12117209|FG000|NOT COMPLETED|Off-Treatment Follow-up||4
10946215|NCT00395044|12117215|FG000|STARTED|Overall Study||25
10946216|NCT00395044|12117216|FG001|STARTED|Overall Study||25
10946217|NCT00395044|12117215|FG000|COMPLETED|Overall Study||7
10946218|NCT00395044|12117216|FG001|COMPLETED|Overall Study||11
10946219|NCT00395044|12117215|FG000|NOT COMPLETED|Overall Study||18
10946220|NCT00395044|12117216|FG001|NOT COMPLETED|Overall Study||14
10946221|NCT00395057|12117226|FG000|STARTED|Overall Study||34
10946222|NCT00395057|12117227|FG001|STARTED|Overall Study||35
10946223|NCT00395057|12117228|FG002|STARTED|Overall Study||35
10946224|NCT00395057|12117229|FG003|STARTED|Overall Study||34
10946225|NCT00395057|12117226|FG000|COMPLETED|Overall Study||2
10946226|NCT00395057|12117227|FG001|COMPLETED|Overall Study||1
10946227|NCT00395057|12117228|FG002|COMPLETED|Overall Study||2
10946228|NCT00395057|12117229|FG003|COMPLETED|Overall Study||1
10946229|NCT00395057|12117226|FG000|NOT COMPLETED|Overall Study||32
10946230|NCT00395057|12117227|FG001|NOT COMPLETED|Overall Study||34
10946231|NCT00395057|12117228|FG002|NOT COMPLETED|Overall Study||33
10946232|NCT00395057|12117229|FG003|NOT COMPLETED|Overall Study||33
10946233|NCT00395083|12117241|FG000|STARTED|Overall Study||217
10946234|NCT00395083|12117242|FG001|STARTED|Overall Study||209
10946235|NCT00395083|12117241|FG000|COMPLETED|Overall Study||207
10946236|NCT00395083|12117242|FG001|COMPLETED|Overall Study||201
10946237|NCT00395083|12117241|FG000|NOT COMPLETED|Overall Study||10
10946238|NCT00395083|12117242|FG001|NOT COMPLETED|Overall Study||8
10946239|NCT00395135|12117250|FG000|STARTED|Year 1||1595
10946240|NCT00395135|12117251|FG001|STARTED|Year 1||1587
10946241|NCT00395135|12117252|FG002|STARTED|Year 1||0
10946242|NCT00395135|12117253|FG003|STARTED|Year 1||0
10946243|NCT00395135|12117254|FG004|STARTED|Year 1||0
10946244|NCT00395135|12117250|FG000|COMPLETED|Year 1||883
10946245|NCT00395135|12117251|FG001|COMPLETED|Year 1||716
10946246|NCT00395135|12117252|FG002|COMPLETED|Year 1||0
10946247|NCT00395135|12117253|FG003|COMPLETED|Year 1||0
10946248|NCT00395135|12117254|FG004|COMPLETED|Year 1||0
10946249|NCT00395135|12117250|FG000|NOT COMPLETED|Year 1||712
10946250|NCT00395135|12117251|FG001|NOT COMPLETED|Year 1||871
10946251|NCT00395135|12117252|FG002|NOT COMPLETED|Year 1||0
10946252|NCT00395135|12117253|FG003|NOT COMPLETED|Year 1||0
10946253|NCT00395135|12117254|FG004|NOT COMPLETED|Year 1||0
10946254|NCT00395135|12117250|FG000|STARTED|Year 2||0
10946255|NCT00395135|12117251|FG001|STARTED|Year 2||0
10946256|NCT00395135|12117252|FG002|STARTED|Year 2||573
10946257|NCT00395135|12117253|FG003|STARTED|Year 2||283
10946258|NCT00395135|12117254|FG004|STARTED|Year 2||697
10946259|NCT00395135|12117250|FG000|COMPLETED|Year 2||0
10946260|NCT00395135|12117251|FG001|COMPLETED|Year 2||0
10946261|NCT00395135|12117252|FG002|COMPLETED|Year 2||426
10946262|NCT00395135|12117253|FG003|COMPLETED|Year 2||195
10946263|NCT00395135|12117254|FG004|COMPLETED|Year 2||507
10946264|NCT00395135|12117250|FG000|NOT COMPLETED|Year 2||0
10946265|NCT00395135|12117251|FG001|NOT COMPLETED|Year 2||0
10946266|NCT00395135|12117252|FG002|NOT COMPLETED|Year 2||147
10946267|NCT00395135|12117253|FG003|NOT COMPLETED|Year 2||88
10946268|NCT00395135|12117254|FG004|NOT COMPLETED|Year 2||190
10946269|NCT00395161|12117270|FG000|STARTED|Overall Study||149
10946270|NCT00395161|12117271|FG001|STARTED|Overall Study||144
10946271|NCT00395161|12117270|FG000|COMPLETED|Overall Study||149
10946272|NCT00395161|12117271|FG001|COMPLETED|Overall Study||144
10946273|NCT00395161|12117270|FG000|NOT COMPLETED|Overall Study||0
10946274|NCT00395161|12117271|FG001|NOT COMPLETED|Overall Study||0
10946275|NCT00395226|12117281|FG000|STARTED|Overall Study||26
10946276|NCT00395226|12117282|FG001|STARTED|Overall Study||27
10946277|NCT00395226|12117281|FG000|COMPLETED|Overall Study||22
10946278|NCT00395226|12117282|FG001|COMPLETED|Overall Study||22
10946279|NCT00395226|12117281|FG000|NOT COMPLETED|Overall Study||4
10946280|NCT00395226|12117282|FG001|NOT COMPLETED|Overall Study||5
10946281|NCT00395291|12117288|FG000|STARTED|First Intervention||17
10946282|NCT00395291|12117289|FG001|STARTED|First Intervention||9
10946283|NCT00395291|12117288|FG000|COMPLETED|First Intervention||15
10946284|NCT00395291|12117289|FG001|COMPLETED|First Intervention||9
10946285|NCT00395291|12117288|FG000|NOT COMPLETED|First Intervention||2
10946286|NCT00395291|12117289|FG001|NOT COMPLETED|First Intervention||0
10946287|NCT00395291|12117288|FG000|STARTED|Washout Period for 30 Days||15
10946288|NCT00395291|12117289|FG001|STARTED|Washout Period for 30 Days||9
10946289|NCT00395291|12117288|FG000|COMPLETED|Washout Period for 30 Days||13
10946290|NCT00395291|12117289|FG001|COMPLETED|Washout Period for 30 Days||9
10946291|NCT00395291|12117288|FG000|NOT COMPLETED|Washout Period for 30 Days||2
10946292|NCT00395291|12117289|FG001|NOT COMPLETED|Washout Period for 30 Days||0
10946293|NCT00395291|12117288|FG000|STARTED|Second Intervention||13
10946294|NCT00395291|12117289|FG001|STARTED|Second Intervention||9
10946295|NCT00395291|12117288|FG000|COMPLETED|Second Intervention||13
10946296|NCT00395291|12117289|FG001|COMPLETED|Second Intervention||9
10946297|NCT00395291|12117288|FG000|NOT COMPLETED|Second Intervention||0
10946298|NCT00395291|12117289|FG001|NOT COMPLETED|Second Intervention||0
10946299|NCT00395304|12117295|FG000|STARTED|Treatment Period 1||31
10946300|NCT00395304|12117296|FG001|STARTED|Treatment Period 1||30
10946301|NCT00395304|12117297|FG002|STARTED|Treatment Period 1||30
10946302|NCT00395304|12117298|FG003|STARTED|Treatment Period 1||31
10946303|NCT00395304|12117299|FG004|STARTED|Treatment Period 1||28
10946304|NCT00395304|12117300|FG005|STARTED|Treatment Period 1||32
10946306|NCT00395304|12117296|FG001|COMPLETED|Treatment Period 1||26
10946307|NCT00395304|12117297|FG002|COMPLETED|Treatment Period 1||30
10946308|NCT00395304|12117298|FG003|COMPLETED|Treatment Period 1||28
10946309|NCT00395304|12117299|FG004|COMPLETED|Treatment Period 1||27
10946310|NCT00395304|12117300|FG005|COMPLETED|Treatment Period 1||30
10946311|NCT00395304|12117295|FG000|NOT COMPLETED|Treatment Period 1||1
10946312|NCT00395304|12117296|FG001|NOT COMPLETED|Treatment Period 1||4
10946313|NCT00395304|12117297|FG002|NOT COMPLETED|Treatment Period 1||0
10946314|NCT00395304|12117298|FG003|NOT COMPLETED|Treatment Period 1||3
10946315|NCT00395304|12117299|FG004|NOT COMPLETED|Treatment Period 1||1
10946316|NCT00395304|12117300|FG005|NOT COMPLETED|Treatment Period 1||2
10946317|NCT00395304|12117295|FG000|STARTED|Treatment Period 2||30
10946318|NCT00395304|12117296|FG001|STARTED|Treatment Period 2||26
10946319|NCT00395304|12117297|FG002|STARTED|Treatment Period 2||30
10946320|NCT00395304|12117298|FG003|STARTED|Treatment Period 2||28
10946321|NCT00395304|12117299|FG004|STARTED|Treatment Period 2||27
10946322|NCT00395304|12117300|FG005|STARTED|Treatment Period 2||30
10946323|NCT00395304|12117295|FG000|COMPLETED|Treatment Period 2||30
10946324|NCT00395304|12117296|FG001|COMPLETED|Treatment Period 2||22
10946325|NCT00395304|12117297|FG002|COMPLETED|Treatment Period 2||29
10946326|NCT00395304|12117298|FG003|COMPLETED|Treatment Period 2||27
10946327|NCT00395304|12117299|FG004|COMPLETED|Treatment Period 2||27
10946328|NCT00395304|12117300|FG005|COMPLETED|Treatment Period 2||28
10946329|NCT00395304|12117295|FG000|NOT COMPLETED|Treatment Period 2||0
10946330|NCT00395304|12117296|FG001|NOT COMPLETED|Treatment Period 2||4
10946331|NCT00395304|12117297|FG002|NOT COMPLETED|Treatment Period 2||1
10946332|NCT00395304|12117298|FG003|NOT COMPLETED|Treatment Period 2||1
10946333|NCT00395304|12117299|FG004|NOT COMPLETED|Treatment Period 2||0
10946334|NCT00395304|12117300|FG005|NOT COMPLETED|Treatment Period 2||2
10946335|NCT00395304|12117295|FG000|STARTED|Treatment Period 3||30
10946336|NCT00395304|12117296|FG001|STARTED|Treatment Period 3||22
10946337|NCT00395304|12117297|FG002|STARTED|Treatment Period 3||29
10946338|NCT00395304|12117298|FG003|STARTED|Treatment Period 3||27
10946339|NCT00395304|12117299|FG004|STARTED|Treatment Period 3||27
10946340|NCT00395304|12117300|FG005|STARTED|Treatment Period 3||28
10946341|NCT00395304|12117295|FG000|COMPLETED|Treatment Period 3||29
10946342|NCT00395304|12117296|FG001|COMPLETED|Treatment Period 3||20
10946343|NCT00395304|12117297|FG002|COMPLETED|Treatment Period 3||29
10946344|NCT00395304|12117298|FG003|COMPLETED|Treatment Period 3||25
10946345|NCT00395304|12117299|FG004|COMPLETED|Treatment Period 3||27
10946346|NCT00395304|12117300|FG005|COMPLETED|Treatment Period 3||27
10946347|NCT00395304|12117295|FG000|NOT COMPLETED|Treatment Period 3||1
10946348|NCT00395304|12117296|FG001|NOT COMPLETED|Treatment Period 3||2
10946349|NCT00395304|12117297|FG002|NOT COMPLETED|Treatment Period 3||0
10946350|NCT00395304|12117298|FG003|NOT COMPLETED|Treatment Period 3||2
10946351|NCT00395304|12117299|FG004|NOT COMPLETED|Treatment Period 3||0
10946352|NCT00395304|12117300|FG005|NOT COMPLETED|Treatment Period 3||1
10946353|NCT00395343|12117309|FG000|STARTED|Overall Study||322
10946354|NCT00395343|12117310|FG001|STARTED|Overall Study||319
10946355|NCT00395343|12117309|FG000|COMPLETED|Overall Study||281
10946356|NCT00395343|12117310|FG001|COMPLETED|Overall Study||283
10946357|NCT00395343|12117309|FG000|NOT COMPLETED|Overall Study||41
10946358|NCT00395343|12117310|FG001|NOT COMPLETED|Overall Study||36
10946359|NCT00395447|12117318|FG000|STARTED|Overall Study||1031
10946360|NCT00395447|12117319|FG001|STARTED|Overall Study||713
10946361|NCT00395447|12117318|FG000|COMPLETED|Overall Study||910
10946362|NCT00395447|12117319|FG001|COMPLETED|Overall Study||602
10946363|NCT00395447|12117318|FG000|NOT COMPLETED|Overall Study||121
10946364|NCT00395447|12117319|FG001|NOT COMPLETED|Overall Study||111
10946365|NCT00395460|12117327|FG000|STARTED|Overall Study||72
10946366|NCT00395460|12117328|FG001|STARTED|Overall Study||75
10946367|NCT00395460|12117327|FG000|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
10946368|NCT00395460|12117328|FG001|Received Treatment|Overall Study||75
10946369|NCT00395460|12117327|FG000|COMPLETED|Overall Study||71
10946370|NCT00395460|12117328|FG001|COMPLETED|Overall Study||75
10946371|NCT00395460|12117327|FG000|NOT COMPLETED|Overall Study||1
10946372|NCT00395460|12117328|FG001|NOT COMPLETED|Overall Study||0
10946373|NCT00395486|12117336|FG000|STARTED|Overall Study|Randomized subjects|132
10946374|NCT00395486|12117337|FG001|STARTED|Overall Study|Randomized subjects|126
10946375|NCT00395486|12117336|FG000|COMPLETED|Overall Study|Completed subjects|126
10946376|NCT00395486|12117337|FG001|COMPLETED|Overall Study|Completed subjects|121
10946377|NCT00395486|12117336|FG000|NOT COMPLETED|Overall Study||6
10946378|NCT00395486|12117337|FG001|NOT COMPLETED|Overall Study||5
10946379|NCT00395512|12117347|FG000|STARTED|Overall Study||164
10946380|NCT00395512|12117348|FG001|STARTED|Overall Study||163
10946381|NCT00395512|12117349|FG002|STARTED|Overall Study||164
10946382|NCT00395512|12117350|FG003|STARTED|Overall Study||164
10946383|NCT00395512|12117347|FG000|Safety Set|Overall Study||164
10946384|NCT00395512|12117348|FG001|Safety Set|Overall Study||163
10946385|NCT00395512|12117349|FG002|Safety Set|Overall Study||164
10946386|NCT00395512|12117350|FG003|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
10946387|NCT00395512|12117347|FG000|COMPLETED|Overall Study||126
10946388|NCT00395512|12117348|FG001|COMPLETED|Overall Study||126
10946389|NCT00395512|12117349|FG002|COMPLETED|Overall Study||136
10946390|NCT00395512|12117350|FG003|COMPLETED|Overall Study||126
10946391|NCT00395512|12117347|FG000|NOT COMPLETED|Overall Study||38
10946392|NCT00395512|12117348|FG001|NOT COMPLETED|Overall Study||37
10946393|NCT00395512|12117349|FG002|NOT COMPLETED|Overall Study||28
10946394|NCT00395512|12117350|FG003|NOT COMPLETED|Overall Study||38
10946395|NCT00395538|12117363|FG000|STARTED|Overall Study||8
10946396|NCT00395538|12117364|FG001|STARTED|Overall Study||15
10946397|NCT00395538|12117365|FG002|STARTED|Overall Study||23
10946398|NCT00395538|12117363|FG000|Signed Consent to the New Protocol|Overall Study||7
10946399|NCT00395538|12117364|FG001|Signed Consent to the New Protocol|Overall Study||5
10946400|NCT00395538|12117365|FG002|Signed Consent to the New Protocol|Overall Study||23
10946401|NCT00395538|12117363|FG000|Received HPTH on New Protocol|Overall Study||7
10946402|NCT00395538|12117364|FG001|Received HPTH on New Protocol|Overall Study||5
10946403|NCT00395538|12117365|FG002|Received HPTH on New Protocol|Overall Study||19
10946404|NCT00395538|12117363|FG000|Randomized to Bone Biopsy Year 1|Overall Study||0
10946405|NCT00395538|12117364|FG001|Randomized to Bone Biopsy Year 1|Overall Study||1
10946406|NCT00395538|12117365|FG002|Randomized to Bone Biopsy Year 1|Overall Study||5
10946407|NCT00395538|12117363|FG000|Randomized to Bone Biopsy Year 2|Overall Study||0
10946408|NCT00395538|12117364|FG001|Randomized to Bone Biopsy Year 2|Overall Study||2
10946409|NCT00395538|12117365|FG002|Randomized to Bone Biopsy Year 2|Overall Study||6
10946410|NCT00395538|12117363|FG000|Randomized to Bone Biospy Year 4|Overall Study||0
10946411|NCT00395538|12117364|FG001|Randomized to Bone Biospy Year 4|Overall Study||2
10946412|NCT00395538|12117365|FG002|Randomized to Bone Biospy Year 4|Overall Study||8
10946413|NCT00395538|12117363|FG000|Completed Bone Biopsy Year 1|Overall Study||0
10946414|NCT00395538|12117364|FG001|Completed Bone Biopsy Year 1|Overall Study||1
10946415|NCT00395538|12117365|FG002|Completed Bone Biopsy Year 1|Overall Study||4
10946416|NCT00395538|12117363|FG000|Completed Bone Biopsy Year 2|Overall Study||0
10946417|NCT00395538|12117364|FG001|Completed Bone Biopsy Year 2|Overall Study||2
10946418|NCT00395538|12117365|FG002|Completed Bone Biopsy Year 2|Overall Study||3
10946419|NCT00395538|12117363|FG000|Completed Bone Biopsy Year 4|Overall Study||0
10946420|NCT00395538|12117364|FG001|Completed Bone Biopsy Year 4|Overall Study||1
10946421|NCT00395538|12117365|FG002|Completed Bone Biopsy Year 4|Overall Study||1
10946422|NCT00395538|12117363|FG000|COMPLETED|Overall Study||5
10946423|NCT00395538|12117364|FG001|COMPLETED|Overall Study||2
10946424|NCT00395538|12117365|FG002|COMPLETED|Overall Study||0
10946425|NCT00395538|12117363|FG000|NOT COMPLETED|Overall Study||3
10946426|NCT00395538|12117364|FG001|NOT COMPLETED|Overall Study||13
10946427|NCT00395538|12117365|FG002|NOT COMPLETED|Overall Study||23
10946428|NCT00395629|12117376|FG000|STARTED|Core Study||11
10946429|NCT00395629|12117377|FG001|STARTED|Core Study||15
10946430|NCT00395629|12117378|FG002|STARTED|Core Study||23
10946431|NCT00395629|12117376|FG000|COMPLETED|Core Study||10
10946432|NCT00395629|12117377|FG001|COMPLETED|Core Study||11
10946433|NCT00395629|12117378|FG002|COMPLETED|Core Study||16
10946434|NCT00395629|12117376|FG000|NOT COMPLETED|Core Study||1
10946435|NCT00395629|12117377|FG001|NOT COMPLETED|Core Study||4
10946436|NCT00395629|12117378|FG002|NOT COMPLETED|Core Study||7
10946437|NCT00395629|12117376|FG000|STARTED|Extension Study||9
10946438|NCT00395629|12117377|FG001|STARTED|Extension Study||6
10946439|NCT00395629|12117378|FG002|STARTED|Extension Study||11
10946440|NCT00395629|12117376|FG000|COMPLETED|Extension Study||9
10946441|NCT00395629|12117377|FG001|COMPLETED|Extension Study||6
10946442|NCT00395629|12117378|FG002|COMPLETED|Extension Study||8
10946443|NCT00395629|12117376|FG000|NOT COMPLETED|Extension Study||0
10946444|NCT00395629|12117377|FG001|NOT COMPLETED|Extension Study||0
10946445|NCT00395629|12117378|FG002|NOT COMPLETED|Extension Study||3
10946446|NCT00395642|12117389|FG000|STARTED|Overall Study||66
10946447|NCT00395642|12117389|FG000|COMPLETED|Overall Study||53
10946448|NCT00395642|12117389|FG000|NOT COMPLETED|Overall Study||13
10946449|NCT00395694|12117395|FG000|STARTED|Escalation Phase + Maintenance Phase||51
10946450|NCT00395694|12117396|FG001|STARTED|Escalation Phase + Maintenance Phase||51
10946451|NCT00395694|12117395|FG000|COMPLETED|Escalation Phase + Maintenance Phase||50
10946452|NCT00395694|12117396|FG001|COMPLETED|Escalation Phase + Maintenance Phase||49
10946453|NCT00395694|12117395|FG000|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
10946454|NCT00395694|12117396|FG001|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
10946455|NCT00395694|12117395|FG000|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
10946456|NCT00395694|12117396|FG001|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
10946457|NCT00395694|12117395|FG000|COMPLETED|Continuation Phase||34
10946458|NCT00395694|12117396|FG001|COMPLETED|Continuation Phase||35
10946459|NCT00395694|12117395|FG000|NOT COMPLETED|Continuation Phase||15
10946460|NCT00395694|12117396|FG001|NOT COMPLETED|Continuation Phase||13
10946461|NCT00395733|12117407|FG000|STARTED|Period 1||41
10946462|NCT00395733|12117408|FG001|STARTED|Period 1||42
10946463|NCT00395733|12117407|FG000|COMPLETED|Period 1||41
10946464|NCT00395733|12117408|FG001|COMPLETED|Period 1||42
10946465|NCT00395733|12117407|FG000|NOT COMPLETED|Period 1||0
10946466|NCT00395733|12117408|FG001|NOT COMPLETED|Period 1||0
10946467|NCT00395733|12117407|FG000|STARTED|Period 2||41
10946468|NCT00395733|12117408|FG001|STARTED|Period 2||42
10946469|NCT00395733|12117407|FG000|COMPLETED|Period 2||39
10946470|NCT00395733|12117408|FG001|COMPLETED|Period 2||37
10946471|NCT00395733|12117407|FG000|NOT COMPLETED|Period 2||2
10946472|NCT00395733|12117408|FG001|NOT COMPLETED|Period 2||5
10946473|NCT00395746|12117417|FG000|STARTED|Overall Study|Exposed to study drug|88
10946474|NCT00395746|12117418|FG001|STARTED|Overall Study|Exposed to study drug|88
10946475|NCT00395746|12117419|FG002|STARTED|Overall Study|Exposed to study drug|88
10946476|NCT00395746|12117417|FG000|COMPLETED|Overall Study|Completed 52 weeks treatment|78
10946477|NCT00395746|12117418|FG001|COMPLETED|Overall Study|Completed 52 weeks treatment|84
10946478|NCT00395746|12117419|FG002|COMPLETED|Overall Study|Completed 52 weeks treatment|66
10946479|NCT00395746|12117417|FG000|NOT COMPLETED|Overall Study||10
10946480|NCT00395746|12117418|FG001|NOT COMPLETED|Overall Study||4
10946481|NCT00395746|12117419|FG002|NOT COMPLETED|Overall Study||22
10946482|NCT00395850|12117431|FG000|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
10946483|NCT00395850|12117432|FG001|STARTED|Pre-randomization Baseline/Induction||0
10946484|NCT00395850|12117433|FG002|STARTED|Pre-randomization Baseline/Induction||0
10946485|NCT00395850|12117434|FG003|STARTED|Pre-randomization Baseline/Induction||0
10946486|NCT00395850|12117431|FG000|COMPLETED|Pre-randomization Baseline/Induction||107
10946487|NCT00395850|12117432|FG001|COMPLETED|Pre-randomization Baseline/Induction||0
10946488|NCT00395850|12117433|FG002|COMPLETED|Pre-randomization Baseline/Induction||0
10946489|NCT00395850|12117434|FG003|COMPLETED|Pre-randomization Baseline/Induction||0
10946490|NCT00395850|12117431|FG000|NOT COMPLETED|Pre-randomization Baseline/Induction||11
10946491|NCT00395850|12117432|FG001|NOT COMPLETED|Pre-randomization Baseline/Induction||0
10946492|NCT00395850|12117433|FG002|NOT COMPLETED|Pre-randomization Baseline/Induction||0
10946493|NCT00395850|12117434|FG003|NOT COMPLETED|Pre-randomization Baseline/Induction||0
10946494|NCT00395850|12117431|FG000|STARTED|Randomization to Disulfiram/ Pre-admin||27
10946495|NCT00395850|12117432|FG001|STARTED|Randomization to Disulfiram/ Pre-admin||25
10946496|NCT00395850|12117433|FG002|STARTED|Randomization to Disulfiram/ Pre-admin||30
10946497|NCT00395850|12117434|FG003|STARTED|Randomization to Disulfiram/ Pre-admin||25
10946498|NCT00395850|12117431|FG000|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
10946499|NCT00395850|12117432|FG001|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
10946500|NCT00395850|12117433|FG002|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
10946501|NCT00395850|12117434|FG003|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
10946502|NCT00395850|12117431|FG000|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
10946503|NCT00395850|12117432|FG001|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
10946504|NCT00395850|12117433|FG002|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
10946505|NCT00395850|12117434|FG003|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
10946506|NCT00395850|12117431|FG000|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
10946507|NCT00395850|12117432|FG001|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
10946508|NCT00395850|12117433|FG002|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
10946509|NCT00395850|12117434|FG003|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
10946510|NCT00395850|12117431|FG000|COMPLETED|Disulfiram/Placebo Treatment||11
10946511|NCT00395850|12117432|FG001|COMPLETED|Disulfiram/Placebo Treatment||9
10946512|NCT00395850|12117433|FG002|COMPLETED|Disulfiram/Placebo Treatment||5
10946513|NCT00395850|12117434|FG003|COMPLETED|Disulfiram/Placebo Treatment||8
10946514|NCT00395850|12117431|FG000|NOT COMPLETED|Disulfiram/Placebo Treatment||9
10946515|NCT00395850|12117432|FG001|NOT COMPLETED|Disulfiram/Placebo Treatment||14
10946516|NCT00395850|12117433|FG002|NOT COMPLETED|Disulfiram/Placebo Treatment||19
10946517|NCT00395850|12117434|FG003|NOT COMPLETED|Disulfiram/Placebo Treatment||13
10946518|NCT00395863|12117446|FG000|STARTED|Overall Study||23
10946519|NCT00395863|12117447|FG001|STARTED|Overall Study||23
10946520|NCT00395863|12117446|FG000|COMPLETED|Overall Study||21
10946521|NCT00395863|12117447|FG001|COMPLETED|Overall Study||20
10946522|NCT00395863|12117446|FG000|NOT COMPLETED|Overall Study||2
10946523|NCT00395863|12117447|FG001|NOT COMPLETED|Overall Study||3
10946524|NCT00395876|12117458|FG000|STARTED|Overall Study||50
10946525|NCT00395876|12117459|FG001|STARTED|Overall Study||50
10946526|NCT00395876|12117458|FG000|COMPLETED|Overall Study||47
10946527|NCT00395876|12117459|FG001|COMPLETED|Overall Study||50
10946528|NCT00395876|12117458|FG000|NOT COMPLETED|Overall Study||3
10946529|NCT00395876|12117459|FG001|NOT COMPLETED|Overall Study||0
10946530|NCT00395967|12117465|FG000|STARTED|Treatment Period||5
10946531|NCT00395967|12117465|FG000|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
10946532|NCT00395967|12117465|FG000|NOT COMPLETED|Treatment Period||1
10946533|NCT00395967|12117465|FG000|STARTED|Follow-up Period|Participants who had transplants.|5
10946534|NCT00395967|12117465|FG000|COMPLETED|Follow-up Period||3
10946535|NCT00395967|12117465|FG000|NOT COMPLETED|Follow-up Period||2
10946536|NCT00395993|12117471|FG000|STARTED|Overall Study||246
10946537|NCT00395993|12117472|FG001|STARTED|Overall Study||231
10946538|NCT00395993|12117471|FG000|COMPLETED|Overall Study||211
10946539|NCT00395993|12117472|FG001|COMPLETED|Overall Study||212
10946540|NCT00395993|12117471|FG000|NOT COMPLETED|Overall Study||35
10946541|NCT00395993|12117472|FG001|NOT COMPLETED|Overall Study||19
10946542|NCT00396006|12117478|FG000|STARTED|Overall Study||13
10946543|NCT00396006|12117478|FG000|COMPLETED|Overall Study||13
10946544|NCT00396006|12117478|FG000|NOT COMPLETED|Overall Study||0
10946545|NCT00396019|12117486|FG000|STARTED|Overall Study||27
10946546|NCT00396019|12117487|FG001|STARTED|Overall Study||29
10946547|NCT00396019|12117488|FG002|STARTED|Overall Study||30
10946548|NCT00396019|12117486|FG000|COMPLETED|Overall Study||27
10946549|NCT00396019|12117487|FG001|COMPLETED|Overall Study||26
10946550|NCT00396019|12117488|FG002|COMPLETED|Overall Study||29
10946551|NCT00396019|12117486|FG000|NOT COMPLETED|Overall Study||0
10946552|NCT00396019|12117487|FG001|NOT COMPLETED|Overall Study||3
10946553|NCT00396019|12117488|FG002|NOT COMPLETED|Overall Study||1
10946554|NCT00396032|12117499|FG000|STARTED|Overall Study||74
10946555|NCT00396032|12117500|FG001|STARTED|Overall Study||76
10946556|NCT00396032|12117499|FG000|COMPLETED|Overall Study||70
10946557|NCT00396032|12117500|FG001|COMPLETED|Overall Study||71
10946558|NCT00396032|12117499|FG000|NOT COMPLETED|Overall Study||4
10946559|NCT00396032|12117500|FG001|NOT COMPLETED|Overall Study||5
10946560|NCT00396084|12117512|FG000|STARTED|Overall Study||10
10946561|NCT00396084|12117513|FG001|STARTED|Overall Study||10
10946562|NCT00396084|12117514|FG002|STARTED|Overall Study||10
10946563|NCT00396084|12117515|FG003|STARTED|Overall Study||10
10946564|NCT00396084|12117516|FG004|STARTED|Overall Study||10
10946565|NCT00396084|12117517|FG005|STARTED|Overall Study||20
10946566|NCT00396084|12117512|FG000|COMPLETED|Overall Study||10
10946567|NCT00396084|12117513|FG001|COMPLETED|Overall Study||10
10946568|NCT00396084|12117514|FG002|COMPLETED|Overall Study||10
10946569|NCT00396084|12117515|FG003|COMPLETED|Overall Study||9
10946570|NCT00396084|12117516|FG004|COMPLETED|Overall Study||9
10946571|NCT00396084|12117517|FG005|COMPLETED|Overall Study||18
10946572|NCT00396084|12117512|FG000|NOT COMPLETED|Overall Study||0
10946573|NCT00396084|12117513|FG001|NOT COMPLETED|Overall Study||0
10946574|NCT00396084|12117514|FG002|NOT COMPLETED|Overall Study||0
10946575|NCT00396084|12117515|FG003|NOT COMPLETED|Overall Study||1
10946576|NCT00396084|12117516|FG004|NOT COMPLETED|Overall Study||1
10946577|NCT00396084|12117517|FG005|NOT COMPLETED|Overall Study||2
10946578|NCT00396097|12117537|FG000|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
10946579|NCT00396097|12117538|FG001|STARTED|Overall Study||202
10946580|NCT00396097|12117537|FG000|COMPLETED|Overall Study||88
10946581|NCT00396097|12117538|FG001|COMPLETED|Overall Study||156
10946582|NCT00396097|12117537|FG000|NOT COMPLETED|Overall Study||26
10946583|NCT00396097|12117538|FG001|NOT COMPLETED|Overall Study||46
10946584|NCT00396136|12117548|FG000|STARTED|Overall Study||221
10946585|NCT00396136|12117548|FG000|COMPLETED|Overall Study||96
10946586|NCT00396136|12117548|FG000|NOT COMPLETED|Overall Study||125
10946587|NCT00396162|12117554|FG000|STARTED|Overall Study||39
10946588|NCT00396162|12117555|FG001|STARTED|Overall Study||38
10946589|NCT00396162|12117554|FG000|COMPLETED|Overall Study||37
10946590|NCT00396162|12117555|FG001|COMPLETED|Overall Study||35
10946591|NCT00396162|12117554|FG000|NOT COMPLETED|Overall Study||2
10946592|NCT00396162|12117555|FG001|NOT COMPLETED|Overall Study||3
10946593|NCT00396201|12117565|FG000|STARTED|Treatment Period||22
10946594|NCT00396201|12117565|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
10946595|NCT00396201|12117565|FG000|NOT COMPLETED|Treatment Period||0
10946596|NCT00396201|12117565|FG000|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
10946597|NCT00396201|12117565|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
10946598|NCT00396201|12117565|FG000|NOT COMPLETED|Follow-up Period||0
10946599|NCT00396253|12117570|FG000|STARTED|Overall Study||223
10946600|NCT00396253|12117570|FG000|COMPLETED|Overall Study||210
10946601|NCT00396253|12117570|FG000|NOT COMPLETED|Overall Study||13
10946602|NCT00396266|12117576|FG000|STARTED|Overall Study||8
10946603|NCT00396266|12117577|FG001|STARTED|Overall Study||14
10946604|NCT00396266|12117576|FG000|COMPLETED|Overall Study||8
10946605|NCT00396266|12117577|FG001|COMPLETED|Overall Study||14
10946606|NCT00396266|12117576|FG000|NOT COMPLETED|Overall Study||0
10946607|NCT00396266|12117577|FG001|NOT COMPLETED|Overall Study||0
10946608|NCT00396279|12117587|FG000|STARTED|Overall Study||37
10946609|NCT00396279|12117587|FG000|COMPLETED|Overall Study|Defined as participants with a complete resection|7
10946610|NCT00396279|12117587|FG000|NOT COMPLETED|Overall Study||30
10946611|NCT00396292|12117593|FG000|STARTED|Overall Study||174
10946612|NCT00396292|12117594|FG001|STARTED|Overall Study||178
10946613|NCT00396292|12117593|FG000|COMPLETED|Overall Study||165
10946614|NCT00396292|12117594|FG001|COMPLETED|Overall Study||162
10946615|NCT00396292|12117593|FG000|NOT COMPLETED|Overall Study||9
10946616|NCT00396292|12117594|FG001|NOT COMPLETED|Overall Study||16
10946617|NCT00396318|12117600|FG000|STARTED|At Least One Dose of Tenecteplase (MITT)||246
10946618|NCT00396318|12117600|FG000|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
10946619|NCT00396318|12117600|FG000|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
10946620|NCT00396318|12117600|FG000|STARTED|48- to 96-Hour Follow-Up Period||246
10946621|NCT00396318|12117600|FG000|COMPLETED|48- to 96-Hour Follow-Up Period||241
10946622|NCT00396318|12117600|FG000|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
10946623|NCT00396318|12117600|FG000|STARTED|7-Day Post-Treatment Contact||241
10946624|NCT00396318|12117600|FG000|COMPLETED|7-Day Post-Treatment Contact||240
10946625|NCT00396318|12117600|FG000|NOT COMPLETED|7-Day Post-Treatment Contact||1
10946626|NCT00396331|12117608|FG000|STARTED|Overall Study||100
10946627|NCT00396331|12117608|FG000|Number of Participants Treated|Overall Study||100
10946628|NCT00396331|12117608|FG000|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
10946629|NCT00396331|12117608|FG000|COMPLETED|Overall Study||68
10946630|NCT00396331|12117608|FG000|NOT COMPLETED|Overall Study||32
10946631|NCT00396383|12117620|FG000|STARTED|Overall Study||9
10946632|NCT00396383|12117620|FG000|COMPLETED|Overall Study||6
10946633|NCT00396383|12117620|FG000|NOT COMPLETED|Overall Study||3
10946634|NCT00396409|12117626|FG000|STARTED|Period 1 - 2007||65
10946635|NCT00396409|12117627|FG001|STARTED|Period 1 - 2007||63
10946636|NCT00396409|12117626|FG000|COMPLETED|Period 1 - 2007||62
10946637|NCT00396409|12117627|FG001|COMPLETED|Period 1 - 2007||57
10946638|NCT00396409|12117626|FG000|NOT COMPLETED|Period 1 - 2007||3
10946639|NCT00396409|12117627|FG001|NOT COMPLETED|Period 1 - 2007||6
10946640|NCT00396409|12117626|FG000|STARTED|Between Period 1 and Period 2||62
10946641|NCT00396409|12117627|FG001|STARTED|Between Period 1 and Period 2||57
10946642|NCT00396409|12117626|FG000|COMPLETED|Between Period 1 and Period 2||59
10946643|NCT00396409|12117627|FG001|COMPLETED|Between Period 1 and Period 2||55
10946644|NCT00396409|12117626|FG000|NOT COMPLETED|Between Period 1 and Period 2||3
10946645|NCT00396409|12117627|FG001|NOT COMPLETED|Between Period 1 and Period 2||2
10946646|NCT00396409|12117626|FG000|STARTED|Period 2 - 2008||59
10946647|NCT00396409|12117627|FG001|STARTED|Period 2 - 2008||55
10946648|NCT00396409|12117626|FG000|COMPLETED|Period 2 - 2008||52
10946649|NCT00396409|12117627|FG001|COMPLETED|Period 2 - 2008||53
10946650|NCT00396409|12117626|FG000|NOT COMPLETED|Period 2 - 2008||7
10946651|NCT00396409|12117627|FG001|NOT COMPLETED|Period 2 - 2008||2
10946652|NCT00396565|12117638|FG000|STARTED|Overall Study||136
10946653|NCT00396565|12117639|FG001|STARTED|Overall Study||138
10946654|NCT00396565|12117640|FG002|STARTED|Overall Study||47
10946655|NCT00396565|12117638|FG000|COMPLETED|Overall Study||88
10946656|NCT00396565|12117639|FG001|COMPLETED|Overall Study||47
10946657|NCT00396565|12117640|FG002|COMPLETED|Overall Study||30
10946658|NCT00396565|12117638|FG000|NOT COMPLETED|Overall Study||48
10946659|NCT00396565|12117639|FG001|NOT COMPLETED|Overall Study||91
10946660|NCT00396565|12117640|FG002|NOT COMPLETED|Overall Study||17
10946661|NCT00396591|12117648|FG000|STARTED|Overall Study||16
10946662|NCT00396591|12117648|FG000|COMPLETED|Overall Study||0
10946663|NCT00396591|12117648|FG000|NOT COMPLETED|Overall Study||16
10946664|NCT00396630|12117654|FG000|STARTED|Overall Study||100
10946665|NCT00396630|12117655|FG001|STARTED|Overall Study||100
10946666|NCT00396630|12117654|FG000|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
10946667|NCT00396630|12117655|FG001|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
10946668|NCT00396630|12117654|FG000|NOT COMPLETED|Overall Study||5
10946669|NCT00396630|12117655|FG001|NOT COMPLETED|Overall Study||5
10946670|NCT00396656|12117662|FG000|STARTED|First Treatment Period||15
10946671|NCT00396656|12117663|FG001|STARTED|First Treatment Period||15
10946672|NCT00396656|12117662|FG000|COMPLETED|First Treatment Period||15
10946673|NCT00396656|12117663|FG001|COMPLETED|First Treatment Period||13
10946674|NCT00396656|12117662|FG000|NOT COMPLETED|First Treatment Period||0
10946675|NCT00396656|12117663|FG001|NOT COMPLETED|First Treatment Period||2
10946676|NCT00396656|12117662|FG000|STARTED|Second Treatment Period||15
10946677|NCT00396656|12117663|FG001|STARTED|Second Treatment Period||13
10946678|NCT00396656|12117662|FG000|COMPLETED|Second Treatment Period||15
10946679|NCT00396656|12117663|FG001|COMPLETED|Second Treatment Period||12
10946680|NCT00396656|12117662|FG000|NOT COMPLETED|Second Treatment Period||0
10946681|NCT00396656|12117663|FG001|NOT COMPLETED|Second Treatment Period||1
10946682|NCT00396812|12117669|FG000|STARTED|Overall Study||4
10946683|NCT00396812|12117669|FG000|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
10946684|NCT00396812|12117669|FG000|NOT COMPLETED|Overall Study||1
10946685|NCT00396877|12117675|FG000|STARTED|Overall Study|Randomized|439
10946686|NCT00396877|12117676|FG001|STARTED|Overall Study|Randomized|467
10946687|NCT00396877|12117675|FG000|Treated|Overall Study||436
10946688|NCT00396877|12117676|FG001|Treated|Overall Study||464
10946689|NCT00396877|12117675|FG000|Completed Treatment|Overall Study||356
10946690|NCT00396877|12117676|FG001|Completed Treatment|Overall Study||352
10946691|NCT00396877|12117675|FG000|COMPLETED|Overall Study|Completed follow-up|433
10946692|NCT00396877|12117676|FG001|COMPLETED|Overall Study|Completed follow-up|459
10946693|NCT00396877|12117675|FG000|NOT COMPLETED|Overall Study||6
10946694|NCT00396877|12117676|FG001|NOT COMPLETED|Overall Study||8
10946695|NCT00396981|12117684|FG000|STARTED|Overall Study||311
10946696|NCT00396981|12117685|FG001|STARTED|Overall Study||315
10946697|NCT00396981|12117684|FG000|COMPLETED|Overall Study||296
10946698|NCT00396981|12117685|FG001|COMPLETED|Overall Study||306
10946699|NCT00396981|12117684|FG000|NOT COMPLETED|Overall Study||15
10946700|NCT00396981|12117685|FG001|NOT COMPLETED|Overall Study||9
10946701|NCT00397020|12117693|FG000|STARTED|Overall Study||14
10946702|NCT00397020|12117694|FG001|STARTED|Overall Study||16
10946703|NCT00397020|12117693|FG000|COMPLETED|Overall Study||13
10946704|NCT00397020|12117694|FG001|COMPLETED|Overall Study||15
10946705|NCT00397020|12117693|FG000|NOT COMPLETED|Overall Study||1
10946706|NCT00397020|12117694|FG001|NOT COMPLETED|Overall Study||1
10946707|NCT00397033|12117703|FG000|STARTED|Overall Study||107
10946708|NCT00397033|12117704|FG001|STARTED|Overall Study||109
10946709|NCT00397033|12117705|FG002|STARTED|Overall Study||100
10946710|NCT00397033|12117703|FG000|Safety Population: >= 1 Dose of Drug|Overall Study||107
10946711|NCT00397033|12117704|FG001|Safety Population: >= 1 Dose of Drug|Overall Study||108
10946712|NCT00397033|12117705|FG002|Safety Population: >= 1 Dose of Drug|Overall Study||98
10946713|NCT00397033|12117703|FG000|ITT Population|Overall Study||107
10946714|NCT00397033|12117704|FG001|ITT Population|Overall Study||105
10946715|NCT00397033|12117705|FG002|ITT Population|Overall Study||98
10946716|NCT00397033|12117703|FG000|COMPLETED|Overall Study||63
10946717|NCT00397033|12117704|FG001|COMPLETED|Overall Study||72
10946718|NCT00397033|12117705|FG002|COMPLETED|Overall Study||77
10946719|NCT00397033|12117703|FG000|NOT COMPLETED|Overall Study||44
10946720|NCT00397033|12117704|FG001|NOT COMPLETED|Overall Study||37
10946721|NCT00397033|12117705|FG002|NOT COMPLETED|Overall Study||23
10946722|NCT00397046|12117717|FG000|STARTED|Overall Study||3
10946723|NCT00397046|12117718|FG001|STARTED|Overall Study||3
10946724|NCT00397046|12117719|FG002|STARTED|Overall Study||10
10946725|NCT00397046|12117720|FG003|STARTED|Overall Study||5
10946726|NCT00397046|12117717|FG000|COMPLETED|Overall Study||0
10946727|NCT00397046|12117718|FG001|COMPLETED|Overall Study||0
10946728|NCT00397046|12117719|FG002|COMPLETED|Overall Study||0
10946729|NCT00397046|12117720|FG003|COMPLETED|Overall Study||0
10946730|NCT00397046|12117717|FG000|NOT COMPLETED|Overall Study||3
10946731|NCT00397046|12117718|FG001|NOT COMPLETED|Overall Study||3
10946732|NCT00397046|12117719|FG002|NOT COMPLETED|Overall Study||10
10946733|NCT00397046|12117720|FG003|NOT COMPLETED|Overall Study||5
10946734|NCT00397150|12117733|FG000|STARTED|Overall Study||1323
10946735|NCT00397150|12117734|FG001|STARTED|Overall Study||1256
10946736|NCT00397150|12117733|FG000|COMPLETED|Overall Study||1188
10946737|NCT00397150|12117734|FG001|COMPLETED|Overall Study||1111
10946738|NCT00397150|12117733|FG000|NOT COMPLETED|Overall Study||135
10946739|NCT00397150|12117734|FG001|NOT COMPLETED|Overall Study||145
10946740|NCT00397189|12117742|FG000|STARTED|3 Weeks Period||394
10946741|NCT00397189|12117743|FG001|STARTED|3 Weeks Period||395
10946742|NCT00397189|12117742|FG000|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
10946743|NCT00397189|12117743|FG001|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
10946744|NCT00397189|12117742|FG000|NOT COMPLETED|3 Weeks Period||21
10946745|NCT00397189|12117743|FG001|NOT COMPLETED|3 Weeks Period||22
10946746|NCT00397189|12117742|FG000|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
10946747|NCT00397189|12117743|FG001|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
10946748|NCT00397189|12117742|FG000|COMPLETED|Extension Period||421
10946749|NCT00397189|12117743|FG001|COMPLETED|Extension Period||134
10946750|NCT00397189|12117742|FG000|NOT COMPLETED|Extension Period||113
10946751|NCT00397189|12117743|FG001|NOT COMPLETED|Extension Period||43
10946752|NCT00397215|12117755|FG000|STARTED|Month 0 (Day 0)||165
10946753|NCT00397215|12117756|FG001|STARTED|Month 0 (Day 0)||61
10946754|NCT00397215|12117757|FG002|STARTED|Month 0 (Day 0)||159
10946755|NCT00397215|12117758|FG003|STARTED|Month 0 (Day 0)||52
10946756|NCT00397215|12117755|FG000|COMPLETED|Month 0 (Day 0)||158
10946757|NCT00397215|12117756|FG001|COMPLETED|Month 0 (Day 0)||56
10946758|NCT00397215|12117757|FG002|COMPLETED|Month 0 (Day 0)||153
10946759|NCT00397215|12117758|FG003|COMPLETED|Month 0 (Day 0)||48
10946760|NCT00397215|12117755|FG000|NOT COMPLETED|Month 0 (Day 0)||7
10946761|NCT00397215|12117756|FG001|NOT COMPLETED|Month 0 (Day 0)||5
10946762|NCT00397215|12117757|FG002|NOT COMPLETED|Month 0 (Day 0)||6
10946763|NCT00397215|12117758|FG003|NOT COMPLETED|Month 0 (Day 0)||4
10946764|NCT00397215|12117755|FG000|STARTED|Month 6 (Day 180)||164
10946765|NCT00397215|12117756|FG001|STARTED|Month 6 (Day 180)||58
10946766|NCT00397215|12117757|FG002|STARTED|Month 6 (Day 180)||158
10946767|NCT00397215|12117758|FG003|STARTED|Month 6 (Day 180)||51
10946768|NCT00397215|12117755|FG000|COMPLETED|Month 6 (Day 180)||162
10946769|NCT00397215|12117756|FG001|COMPLETED|Month 6 (Day 180)||55
10946770|NCT00397215|12117757|FG002|COMPLETED|Month 6 (Day 180)||153
10946771|NCT00397215|12117758|FG003|COMPLETED|Month 6 (Day 180)||51
10946772|NCT00397215|12117755|FG000|NOT COMPLETED|Month 6 (Day 180)||2
10946773|NCT00397215|12117756|FG001|NOT COMPLETED|Month 6 (Day 180)||3
10946774|NCT00397215|12117757|FG002|NOT COMPLETED|Month 6 (Day 180)||5
10946775|NCT00397215|12117758|FG003|NOT COMPLETED|Month 6 (Day 180)||0
10946776|NCT00397215|12117755|FG000|STARTED|Month 12 (Day 360)||130
10946777|NCT00397215|12117756|FG001|STARTED|Month 12 (Day 360)||48
10946778|NCT00397215|12117757|FG002|STARTED|Month 12 (Day 360)||125
10946779|NCT00397215|12117758|FG003|STARTED|Month 12 (Day 360)||42
10946780|NCT00397215|12117755|FG000|COMPLETED|Month 12 (Day 360)||130
10946781|NCT00397215|12117756|FG001|COMPLETED|Month 12 (Day 360)||48
10946782|NCT00397215|12117757|FG002|COMPLETED|Month 12 (Day 360)||125
10946783|NCT00397215|12117758|FG003|COMPLETED|Month 12 (Day 360)||42
10946784|NCT00397215|12117755|FG000|NOT COMPLETED|Month 12 (Day 360)||0
10946785|NCT00397215|12117756|FG001|NOT COMPLETED|Month 12 (Day 360)||0
10946786|NCT00397215|12117757|FG002|NOT COMPLETED|Month 12 (Day 360)||0
10946787|NCT00397215|12117758|FG003|NOT COMPLETED|Month 12 (Day 360)||0
10946788|NCT00397215|12117755|FG000|STARTED|Month 24 (Day 720)||122
10946789|NCT00397215|12117756|FG001|STARTED|Month 24 (Day 720)||45
10946790|NCT00397215|12117757|FG002|STARTED|Month 24 (Day 720)||117
10946791|NCT00397215|12117758|FG003|STARTED|Month 24 (Day 720)||36
10946792|NCT00397215|12117755|FG000|COMPLETED|Month 24 (Day 720)||122
10946793|NCT00397215|12117756|FG001|COMPLETED|Month 24 (Day 720)||45
10946794|NCT00397215|12117757|FG002|COMPLETED|Month 24 (Day 720)||117
10946795|NCT00397215|12117758|FG003|COMPLETED|Month 24 (Day 720)||36
10946796|NCT00397215|12117755|FG000|NOT COMPLETED|Month 24 (Day 720)||0
10946797|NCT00397215|12117756|FG001|NOT COMPLETED|Month 24 (Day 720)||0
10946798|NCT00397215|12117757|FG002|NOT COMPLETED|Month 24 (Day 720)||0
10946799|NCT00397215|12117758|FG003|NOT COMPLETED|Month 24 (Day 720)||0
10946800|NCT00397462|12117774|FG000|STARTED|Overall Study||16
10946801|NCT00397462|12117775|FG001|STARTED|Overall Study||13
10946802|NCT00397462|12117776|FG002|STARTED|Overall Study||15
10946803|NCT00397462|12117774|FG000|COMPLETED|Overall Study||16
10946804|NCT00397462|12117775|FG001|COMPLETED|Overall Study||13
10946805|NCT00397462|12117776|FG002|COMPLETED|Overall Study||15
10946806|NCT00397462|12117774|FG000|NOT COMPLETED|Overall Study||0
10946807|NCT00397462|12117775|FG001|NOT COMPLETED|Overall Study||0
10946808|NCT00397462|12117776|FG002|NOT COMPLETED|Overall Study||0
10946809|NCT00397488|12117784|FG000|STARTED|Overall Study||78
10946810|NCT00397488|12117784|FG000|COMPLETED|Overall Study||71
10946811|NCT00397488|12117784|FG000|NOT COMPLETED|Overall Study||7
10946812|NCT00397514|12117788|FG000|STARTED|Overall Study||34
10946813|NCT00397514|12117788|FG000|COMPLETED|Overall Study||25
10946814|NCT00397514|12117788|FG000|NOT COMPLETED|Overall Study||9
10946815|NCT00397540|12117800|FG000|STARTED|Overall Study||60
10946816|NCT00397540|12117801|FG001|STARTED|Overall Study||85
10946817|NCT00397540|12117800|FG000|COMPLETED|Overall Study||59
10946818|NCT00397540|12117801|FG001|COMPLETED|Overall Study||85
10946819|NCT00397540|12117800|FG000|NOT COMPLETED|Overall Study||1
10946820|NCT00397540|12117801|FG001|NOT COMPLETED|Overall Study||0
10946821|NCT00397579|12117808|FG000|STARTED|Overall Study||11
10946822|NCT00397579|12117808|FG000|COMPLETED|Overall Study||11
10946823|NCT00397579|12117808|FG000|NOT COMPLETED|Overall Study||0
10946824|NCT00397631|12117814|FG000|STARTED|Overall Study|Randomization ratio was 1:1|261
10946825|NCT00397631|12117815|FG001|STARTED|Overall Study||259
10946826|NCT00397631|12117814|FG000|COMPLETED|Overall Study||231
10946827|NCT00397631|12117815|FG001|COMPLETED|Overall Study||215
10946828|NCT00397631|12117814|FG000|NOT COMPLETED|Overall Study||30
10946829|NCT00397631|12117815|FG001|NOT COMPLETED|Overall Study||44
10946830|NCT00397813|12117827|FG000|STARTED|Overall Study||36
10946831|NCT00397813|12117828|FG001|STARTED|Overall Study||0
10946832|NCT00397813|12117829|FG002|STARTED|Overall Study||0
10946833|NCT00397813|12117830|FG003|STARTED|Overall Study||12
10946834|NCT00397813|12117831|FG004|STARTED|Overall Study||5
10946835|NCT00397813|12117832|FG005|STARTED|Overall Study||24
10946836|NCT00397813|12117827|FG000|COMPLETED|Overall Study||36
10946837|NCT00397813|12117828|FG001|COMPLETED|Overall Study||0
10946838|NCT00397813|12117829|FG002|COMPLETED|Overall Study||0
10946839|NCT00397813|12117830|FG003|COMPLETED|Overall Study||12
10946840|NCT00397813|12117831|FG004|COMPLETED|Overall Study||5
10946841|NCT00397813|12117832|FG005|COMPLETED|Overall Study||24
10946842|NCT00397813|12117827|FG000|NOT COMPLETED|Overall Study||0
10946843|NCT00397813|12117828|FG001|NOT COMPLETED|Overall Study||0
10946844|NCT00397813|12117829|FG002|NOT COMPLETED|Overall Study||0
10946845|NCT00397813|12117830|FG003|NOT COMPLETED|Overall Study||0
10946846|NCT00397813|12117831|FG004|NOT COMPLETED|Overall Study||0
10946847|NCT00397813|12117832|FG005|NOT COMPLETED|Overall Study||0
10946848|NCT00397839|12117848|FG000|STARTED|Overall Study||48
10946849|NCT00397839|12117849|FG001|STARTED|Overall Study||87
10946850|NCT00397839|12117848|FG000|COMPLETED|Overall Study||41
10946851|NCT00397839|12117849|FG001|COMPLETED|Overall Study||69
10946852|NCT00397839|12117848|FG000|NOT COMPLETED|Overall Study||7
10946853|NCT00397839|12117849|FG001|NOT COMPLETED|Overall Study||18
10946854|NCT00397878|12117855|FG000|STARTED|Overall Study||10
10946855|NCT00397878|12117855|FG000|COMPLETED|Overall Study||10
10946856|NCT00397878|12117855|FG000|NOT COMPLETED|Overall Study||0
10946857|NCT00397891|12117864|FG000|STARTED|Overall Study||6
10946858|NCT00397891|12117865|FG001|STARTED|Overall Study||6
10946859|NCT00397891|12117866|FG002|STARTED|Overall Study||6
10946860|NCT00397891|12117867|FG003|STARTED|Overall Study||6
10946861|NCT00397891|12117868|FG004|STARTED|Overall Study||8
10946862|NCT00397891|12117864|FG000|COMPLETED|Overall Study||5
10946863|NCT00397891|12117865|FG001|COMPLETED|Overall Study||6
10946864|NCT00397891|12117866|FG002|COMPLETED|Overall Study||6
10946865|NCT00397891|12117867|FG003|COMPLETED|Overall Study||6
10946866|NCT00397891|12117868|FG004|COMPLETED|Overall Study||7
10946867|NCT00397891|12117864|FG000|NOT COMPLETED|Overall Study||1
10946868|NCT00397891|12117865|FG001|NOT COMPLETED|Overall Study||0
10946869|NCT00397891|12117866|FG002|NOT COMPLETED|Overall Study||0
10946870|NCT00397891|12117867|FG003|NOT COMPLETED|Overall Study||0
10946871|NCT00397891|12117868|FG004|NOT COMPLETED|Overall Study||1
10946872|NCT00397904|12117880|FG000|STARTED|Overall Study||16
10946873|NCT00397904|12117880|FG000|COMPLETED|Overall Study||16
10946874|NCT00397904|12117880|FG000|NOT COMPLETED|Overall Study||0
10946875|NCT00397930|12117886|FG000|STARTED|Overall Study||206
10946876|NCT00397930|12117887|FG001|STARTED|Overall Study||204
10946877|NCT00397930|12117886|FG000|COMPLETED|Overall Study||168
10946878|NCT00397930|12117887|FG001|COMPLETED|Overall Study||153
10946879|NCT00397930|12117886|FG000|NOT COMPLETED|Overall Study||38
10946880|NCT00397930|12117887|FG001|NOT COMPLETED|Overall Study||51
10946881|NCT00397943|12117898|FG000|STARTED|Overall Study||40
10946882|NCT00397943|12117899|FG001|STARTED|Overall Study||40
10946883|NCT00397943|12117900|FG002|STARTED|Overall Study||10
10946884|NCT00397943|12117901|FG003|STARTED|Overall Study||10
10946885|NCT00397943|12117902|FG004|STARTED|Overall Study||10
10946886|NCT00397943|12117898|FG000|COMPLETED|Overall Study||28
10946887|NCT00397943|12117899|FG001|COMPLETED|Overall Study||31
10946888|NCT00397943|12117900|FG002|COMPLETED|Overall Study||10
10946889|NCT00397943|12117901|FG003|COMPLETED|Overall Study||10
10946890|NCT00397943|12117902|FG004|COMPLETED|Overall Study||10
10946891|NCT00397943|12117898|FG000|NOT COMPLETED|Overall Study||12
10946892|NCT00397943|12117899|FG001|NOT COMPLETED|Overall Study||9
10946893|NCT00397943|12117900|FG002|NOT COMPLETED|Overall Study||0
10946894|NCT00397943|12117901|FG003|NOT COMPLETED|Overall Study||0
10946895|NCT00397943|12117902|FG004|NOT COMPLETED|Overall Study||0
10946896|NCT00397982|12117914|FG000|STARTED|Overall Study||17
10946897|NCT00397982|12117914|FG000|COMPLETED|Overall Study||13
10946898|NCT00397982|12117914|FG000|NOT COMPLETED|Overall Study||4
10946899|NCT00398047|12117919|FG000|STARTED|Overall Study||3
10946900|NCT00398047|12117919|FG000|COMPLETED|Overall Study|all three patients progressed before completing|0
10946901|NCT00398047|12117919|FG000|NOT COMPLETED|Overall Study||3
10946902|NCT00398073|12117926|FG000|STARTED|Overall Study||18
10946903|NCT00398073|12117927|FG001|STARTED|Overall Study||17
10946904|NCT00398073|12117926|FG000|COMPLETED|Overall Study||17
10946905|NCT00398073|12117927|FG001|COMPLETED|Overall Study||17
10946906|NCT00398073|12117926|FG000|NOT COMPLETED|Overall Study||1
10946907|NCT00398073|12117927|FG001|NOT COMPLETED|Overall Study||0
10946908|NCT00398086|12117936|FG000|STARTED|Overall Study||20
10946909|NCT00398086|12117937|FG001|STARTED|Overall Study||44
10946910|NCT00398086|12117938|FG002|STARTED|Overall Study||3
10946911|NCT00398086|12117936|FG000|Phase 1, Dose Escalation Population|Overall Study||20
10946912|NCT00398086|12117937|FG001|Phase 1, Dose Escalation Population|Overall Study||7
10946913|NCT00398086|12117938|FG002|Phase 1, Dose Escalation Population|Overall Study||3
10946914|NCT00398086|12117936|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
10946915|NCT00398086|12117937|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
10946916|NCT00398086|12117938|FG002|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
10946917|NCT00398086|12117936|FG000|NOT COMPLETED|Overall Study||9
10946918|NCT00398086|12117937|FG001|NOT COMPLETED|Overall Study||23
10946919|NCT00398086|12117938|FG002|NOT COMPLETED|Overall Study||2
10946920|NCT00398112|12117946|FG000|STARTED|Overall Study||18
10946921|NCT00398112|12117946|FG000|COMPLETED|Overall Study||0
10946922|NCT00398112|12117946|FG000|NOT COMPLETED|Overall Study||18
10946923|NCT00398138|12117950|FG000|STARTED|Overall Study||12
10946924|NCT00398138|12117950|FG000|COMPLETED|Overall Study||10
10946925|NCT00398138|12117950|FG000|NOT COMPLETED|Overall Study||2
10946926|NCT00398216|12117959|FG000|STARTED|Overall Study||192
10946927|NCT00398216|12117960|FG001|STARTED|Overall Study||170
10946928|NCT00398216|12117961|FG002|STARTED|Overall Study||185
10946929|NCT00398216|12117962|FG003|STARTED|Overall Study||177
10946930|NCT00398216|12117963|FG004|STARTED|Overall Study||172
10946931|NCT00398216|12117959|FG000|COMPLETED|Overall Study||181
10946932|NCT00398216|12117960|FG001|COMPLETED|Overall Study||151
10946933|NCT00398216|12117961|FG002|COMPLETED|Overall Study||164
10946934|NCT00398216|12117962|FG003|COMPLETED|Overall Study||155
10946935|NCT00398216|12117963|FG004|COMPLETED|Overall Study||157
10946936|NCT00398216|12117959|FG000|NOT COMPLETED|Overall Study||11
10946937|NCT00398216|12117960|FG001|NOT COMPLETED|Overall Study||19
10946938|NCT00398216|12117961|FG002|NOT COMPLETED|Overall Study||21
10946939|NCT00398216|12117962|FG003|NOT COMPLETED|Overall Study||22
10946940|NCT00398216|12117963|FG004|NOT COMPLETED|Overall Study||15
10946941|NCT00398320|12117975|FG000|STARTED|Overall Study||40
10946942|NCT00398320|12117975|FG000|COMPLETED|Overall Study||34
10946943|NCT00398320|12117975|FG000|NOT COMPLETED|Overall Study||6
10946944|NCT00398398|12117979|FG000|STARTED|Overall Study||44
10946945|NCT00398398|12117979|FG000|COMPLETED|Overall Study||44
10946946|NCT00398398|12117979|FG000|NOT COMPLETED|Overall Study||0
10946947|NCT00398411|12117985|FG000|STARTED|Overall Study||34
10946948|NCT00398411|12117986|FG001|STARTED|Overall Study||32
10946949|NCT00398411|12117985|FG000|COMPLETED|Overall Study||34
10946950|NCT00398411|12117986|FG001|COMPLETED|Overall Study||31
10946951|NCT00398411|12117985|FG000|NOT COMPLETED|Overall Study||0
10946952|NCT00398411|12117986|FG001|NOT COMPLETED|Overall Study||1
10946953|NCT00398476|12117992|FG000|STARTED|Treatment Period 1||63
10946954|NCT00398476|12117993|FG001|STARTED|Treatment Period 1||64
10946955|NCT00398476|12117992|FG000|COMPLETED|Treatment Period 1||63
10946956|NCT00398476|12117993|FG001|COMPLETED|Treatment Period 1||64
10946957|NCT00398476|12117992|FG000|NOT COMPLETED|Treatment Period 1||0
10946958|NCT00398476|12117993|FG001|NOT COMPLETED|Treatment Period 1||0
10946959|NCT00398476|12117992|FG000|STARTED|Washout Period (20 Minutes)||63
10946960|NCT00398476|12117993|FG001|STARTED|Washout Period (20 Minutes)||64
10946961|NCT00398476|12117992|FG000|COMPLETED|Washout Period (20 Minutes)||63
10946962|NCT00398476|12117993|FG001|COMPLETED|Washout Period (20 Minutes)||64
10946963|NCT00398476|12117992|FG000|NOT COMPLETED|Washout Period (20 Minutes)||0
10946964|NCT00398476|12117993|FG001|NOT COMPLETED|Washout Period (20 Minutes)||0
10946965|NCT00398476|12117992|FG000|STARTED|Treatment Period 2||63
10946966|NCT00398476|12117993|FG001|STARTED|Treatment Period 2||64
10946967|NCT00398476|12117992|FG000|COMPLETED|Treatment Period 2||63
10946968|NCT00398476|12117993|FG001|COMPLETED|Treatment Period 2||64
10946969|NCT00398476|12117992|FG000|NOT COMPLETED|Treatment Period 2||0
10946970|NCT00398476|12117993|FG001|NOT COMPLETED|Treatment Period 2||0
10946971|NCT00398567|12118004|FG000|STARTED|Overall Study||4
10946972|NCT00398567|12118005|FG001|STARTED|Overall Study||4
10946973|NCT00398567|12118006|FG002|STARTED|Overall Study||37
10946974|NCT00398567|12118004|FG000|COMPLETED|Overall Study||0
10946975|NCT00398567|12118005|FG001|COMPLETED|Overall Study||0
10946976|NCT00398567|12118006|FG002|COMPLETED|Overall Study||3
10946977|NCT00398567|12118004|FG000|NOT COMPLETED|Overall Study||4
10946978|NCT00398567|12118005|FG001|NOT COMPLETED|Overall Study||4
10946979|NCT00398567|12118006|FG002|NOT COMPLETED|Overall Study||34
10946980|NCT00398632|12118012|FG000|STARTED|Overall Study||6
10946981|NCT00398632|12118012|FG000|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
10946982|NCT00398632|12118012|FG000|NOT COMPLETED|Overall Study||2
10946983|NCT00398866|12118020|FG000|STARTED|Overall Study||66
10946984|NCT00398866|12118021|FG001|STARTED|Overall Study||68
10946985|NCT00398866|12118022|FG002|STARTED|Overall Study||66
10946986|NCT00398866|12118020|FG000|COMPLETED|Overall Study||52
10946987|NCT00398866|12118021|FG001|COMPLETED|Overall Study||60
10946988|NCT00398866|12118022|FG002|COMPLETED|Overall Study||58
10946989|NCT00398866|12118020|FG000|NOT COMPLETED|Overall Study||14
10946990|NCT00398866|12118021|FG001|NOT COMPLETED|Overall Study||8
10946991|NCT00398866|12118022|FG002|NOT COMPLETED|Overall Study||8
10946992|NCT00398918|12118031|FG000|STARTED|Overall Study||10
10946993|NCT00398918|12118031|FG000|COMPLETED|Overall Study||10
10946994|NCT00398918|12118031|FG000|NOT COMPLETED|Overall Study||0
10946995|NCT00398983|12118037|FG000|STARTED|Overall Study||20
10946996|NCT00398983|12118038|FG001|STARTED|Overall Study||25
10946997|NCT00398983|12118037|FG000|COMPLETED|Overall Study||20
10946998|NCT00398983|12118038|FG001|COMPLETED|Overall Study||25
10946999|NCT00398983|12118037|FG000|NOT COMPLETED|Overall Study||0
10947000|NCT00398983|12118038|FG001|NOT COMPLETED|Overall Study||0
10947001|NCT00399035|12118047|FG000|STARTED|Overall Study||502
10947002|NCT00399035|12118048|FG001|STARTED|Overall Study||216
10947003|NCT00399035|12118049|FG002|STARTED|Overall Study||358
10947004|NCT00399035|12118047|FG000|COMPLETED|Overall Study||189
10947005|NCT00399035|12118048|FG001|COMPLETED|Overall Study||58
10947006|NCT00399035|12118049|FG002|COMPLETED|Overall Study||106
10947007|NCT00399035|12118047|FG000|NOT COMPLETED|Overall Study||313
10947008|NCT00399035|12118048|FG001|NOT COMPLETED|Overall Study||158
10947009|NCT00399035|12118049|FG002|NOT COMPLETED|Overall Study||252
10947010|NCT00399308|12118059|FG000|STARTED|Overall Study||13
10947011|NCT00399308|12118060|FG001|STARTED|Overall Study||15
10947012|NCT00399308|12118061|FG002|STARTED|Overall Study||12
10947013|NCT00399308|12118059|FG000|COMPLETED|Overall Study||13
10947014|NCT00399308|12118060|FG001|COMPLETED|Overall Study||15
10947015|NCT00399308|12118061|FG002|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
10947016|NCT00399308|12118059|FG000|NOT COMPLETED|Overall Study||0
10947017|NCT00399308|12118060|FG001|NOT COMPLETED|Overall Study||0
10947018|NCT00399308|12118061|FG002|NOT COMPLETED|Overall Study||1
10947019|NCT00399360|12118073|FG000|STARTED|Overall Study||11
10947020|NCT00399360|12118074|FG001|STARTED|Overall Study||11
10947021|NCT00399360|12118075|FG002|STARTED|Overall Study||13
10947022|NCT00399360|12118076|FG003|STARTED|Overall Study||15
10947023|NCT00399360|12118073|FG000|COMPLETED|Overall Study||9
10947024|NCT00399360|12118074|FG001|COMPLETED|Overall Study||8
10947025|NCT00399360|12118075|FG002|COMPLETED|Overall Study||10
10947026|NCT00399360|12118076|FG003|COMPLETED|Overall Study||9
10947027|NCT00399360|12118073|FG000|NOT COMPLETED|Overall Study||2
10947028|NCT00399360|12118074|FG001|NOT COMPLETED|Overall Study||3
10947029|NCT00399360|12118075|FG002|NOT COMPLETED|Overall Study||3
10947030|NCT00399360|12118076|FG003|NOT COMPLETED|Overall Study||6
10947031|NCT00399490|12118091|FG000|STARTED|Overall Study||281
10947032|NCT00399490|12118091|FG000|COMPLETED|Overall Study||183
10947033|NCT00399490|12118091|FG000|NOT COMPLETED|Overall Study||98
10947034|NCT00399516|12118097|FG000|STARTED|Overall Study||21
10947035|NCT00399516|12118097|FG000|COMPLETED|Overall Study||19
10947036|NCT00399516|12118097|FG000|NOT COMPLETED|Overall Study||2
10947037|NCT00399529|12118101|FG000|STARTED|Overall Study||22
10947038|NCT00399529|12118101|FG000|COMPLETED|Overall Study||20
10947039|NCT00399529|12118101|FG000|NOT COMPLETED|Overall Study||2
10947040|NCT00399542|12118108|FG000|STARTED|Overall Study||387
10947041|NCT00399542|12118109|FG001|STARTED|Overall Study||194
10947042|NCT00399542|12118108|FG000|COMPLETED|Overall Study||303
10947043|NCT00399542|12118109|FG001|COMPLETED|Overall Study||151
10947044|NCT00399542|12118108|FG000|NOT COMPLETED|Overall Study||84
10947045|NCT00399542|12118109|FG001|NOT COMPLETED|Overall Study||43
10947046|NCT00399568|12118117|FG000|STARTED|Overall Study||166
10947047|NCT00399568|12118118|FG001|STARTED|Overall Study||165
10947048|NCT00399568|12118117|FG000|COMPLETED|Overall Study||154
10947049|NCT00399568|12118118|FG001|COMPLETED|Overall Study||156
10947050|NCT00399568|12118117|FG000|NOT COMPLETED|Overall Study||12
10947051|NCT00399568|12118118|FG001|NOT COMPLETED|Overall Study||9
10947052|NCT00399763|12118128|FG000|STARTED|Overall Study||35
10947053|NCT00399763|12118129|FG001|STARTED|Overall Study||35
10947054|NCT00399763|12118128|FG000|COMPLETED|Overall Study||33
10947055|NCT00399763|12118129|FG001|COMPLETED|Overall Study||32
10947056|NCT00399763|12118128|FG000|NOT COMPLETED|Overall Study||2
10947057|NCT00399763|12118129|FG001|NOT COMPLETED|Overall Study||3
10947058|NCT00399802|12118137|FG000|STARTED|Overall Study||14
10947059|NCT00399802|12118138|FG001|STARTED|Overall Study||29
10947060|NCT00399802|12118137|FG000|COMPLETED|Overall Study||14
10947061|NCT00399802|12118138|FG001|COMPLETED|Overall Study||26
10947062|NCT00399802|12118137|FG000|NOT COMPLETED|Overall Study||0
10947063|NCT00399802|12118138|FG001|NOT COMPLETED|Overall Study||3
10947064|NCT00399880|12118146|FG000|STARTED|Overall Study||65
10947065|NCT00399880|12118147|FG001|STARTED|Overall Study||65
10947066|NCT00399880|12118146|FG000|COMPLETED|Overall Study||65
10947067|NCT00399880|12118147|FG001|COMPLETED|Overall Study||65
10947068|NCT00399880|12118146|FG000|NOT COMPLETED|Overall Study||0
10947069|NCT00399880|12118147|FG001|NOT COMPLETED|Overall Study||0
10947070|NCT00399893|12118155|FG000|STARTED|Overall Study||2
10947071|NCT00399893|12118156|FG001|STARTED|Overall Study||3
10947072|NCT00399893|12118155|FG000|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
10947073|NCT00399893|12118156|FG001|COMPLETED|Overall Study||3
10947074|NCT00399893|12118155|FG000|NOT COMPLETED|Overall Study||1
10947075|NCT00399893|12118156|FG001|NOT COMPLETED|Overall Study||0
10947076|NCT00400153|12118165|FG000|STARTED|Overall Study||486
10947077|NCT00400153|12118166|FG001|STARTED|Overall Study||491
10947078|NCT00400153|12118167|FG002|STARTED|Overall Study||483
10947079|NCT00400153|12118165|FG000|COMPLETED|Overall Study||438
10947080|NCT00400153|12118166|FG001|COMPLETED|Overall Study||436
10947081|NCT00400153|12118167|FG002|COMPLETED|Overall Study||422
10947082|NCT00400153|12118165|FG000|NOT COMPLETED|Overall Study||48
10947083|NCT00400153|12118166|FG001|NOT COMPLETED|Overall Study||55
10947084|NCT00400153|12118167|FG002|NOT COMPLETED|Overall Study||61
10947085|NCT00400179|12118182|FG000|STARTED|Overall Study|Signed informed consent form and randomized|527
10947086|NCT00400179|12118183|FG001|STARTED|Overall Study||526
10947087|NCT00400179|12118182|FG000|COMPLETED|Overall Study|Received Treatment|521
10947088|NCT00400179|12118183|FG001|COMPLETED|Overall Study||508
10947089|NCT00400179|12118182|FG000|NOT COMPLETED|Overall Study||6
10947090|NCT00400179|12118183|FG001|NOT COMPLETED|Overall Study||18
10947091|NCT00400205|12118189|FG000|STARTED|Overall Study||14
10947092|NCT00400205|12118189|FG000|COMPLETED|Overall Study||9
10947093|NCT00400205|12118189|FG000|NOT COMPLETED|Overall Study||5
10947094|NCT00400400|12118196|FG000|STARTED|Overall Study||200
10947095|NCT00400400|12118197|FG001|STARTED|Overall Study||200
10947096|NCT00400400|12118196|FG000|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
10947097|NCT00400400|12118197|FG001|Intent-to-Treat Population|Overall Study||197
10947098|NCT00400400|12118196|FG000|COMPLETED|Overall Study||186
10947099|NCT00400400|12118197|FG001|COMPLETED|Overall Study||185
10947100|NCT00400400|12118196|FG000|NOT COMPLETED|Overall Study||14
10947101|NCT00400400|12118197|FG001|NOT COMPLETED|Overall Study||15
10947102|NCT00400439|12118205|FG000|STARTED|Overall Study||52
10947103|NCT00400439|12118206|FG001|STARTED|Overall Study||25
10947104|NCT00400439|12118205|FG000|COMPLETED|Overall Study||47
10947105|NCT00400439|12118206|FG001|COMPLETED|Overall Study||23
10947106|NCT00400439|12118205|FG000|NOT COMPLETED|Overall Study||5
10947107|NCT00400439|12118206|FG001|NOT COMPLETED|Overall Study||2
10947108|NCT00400517|12118212|FG000|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
10947109|NCT00400517|12118212|FG000|COMPLETED|Overall Study||26
10947110|NCT00400517|12118212|FG000|NOT COMPLETED|Overall Study||2
10947111|NCT00400569|12118216|FG000|STARTED|Overall Study||48
10947112|NCT00400569|12118216|FG000|COMPLETED|Overall Study||47
10947113|NCT00400569|12118216|FG000|NOT COMPLETED|Overall Study||1
10947114|NCT00400634|12118225|FG000|STARTED|Overall Study||38
10947115|NCT00400634|12118226|FG001|STARTED|Overall Study||20
10947116|NCT00400634|12118225|FG000|COMPLETED|Overall Study||34
10947117|NCT00400634|12118226|FG001|COMPLETED|Overall Study||19
10947118|NCT00400634|12118225|FG000|NOT COMPLETED|Overall Study||4
10947119|NCT00400634|12118226|FG001|NOT COMPLETED|Overall Study||1
10947120|NCT00400686|12118232|FG000|STARTED|Overall Study||31
10947121|NCT00400686|12118232|FG000|COMPLETED|Overall Study||31
10947122|NCT00400686|12118232|FG000|NOT COMPLETED|Overall Study||0
10947123|NCT00400712|12118238|FG000|STARTED|Overall Study||52
10947124|NCT00400712|12118239|FG001|STARTED|Overall Study||51
10947125|NCT00400712|12118238|FG000|COMPLETED|Overall Study||35
10947126|NCT00400712|12118239|FG001|COMPLETED|Overall Study||35
10947127|NCT00400712|12118238|FG000|NOT COMPLETED|Overall Study||17
10947128|NCT00400712|12118239|FG001|NOT COMPLETED|Overall Study||16
10947129|NCT00400764|12118252|FG000|STARTED|Phase Ib||6
10947130|NCT00400764|12118253|FG001|STARTED|Phase Ib||6
10947131|NCT00400764|12118254|FG002|STARTED|Phase Ib||0
10947132|NCT00400764|12118255|FG003|STARTED|Phase Ib||0
10947133|NCT00400764|12118256|FG004|STARTED|Phase Ib||0
10947134|NCT00400764|12118252|FG000|Treated|Phase Ib||6
10947135|NCT00400764|12118253|FG001|Treated|Phase Ib||6
10947136|NCT00400764|12118254|FG002|Treated|Phase Ib||0
10947137|NCT00400764|12118255|FG003|Treated|Phase Ib||0
10947138|NCT00400764|12118256|FG004|Treated|Phase Ib||0
10947139|NCT00400764|12118252|FG000|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
10947140|NCT00400764|12118253|FG001|COMPLETED|Phase Ib||2
10947141|NCT00400764|12118254|FG002|COMPLETED|Phase Ib||0
10947142|NCT00400764|12118255|FG003|COMPLETED|Phase Ib||0
10947143|NCT00400764|12118256|FG004|COMPLETED|Phase Ib||0
10947144|NCT00400764|12118252|FG000|NOT COMPLETED|Phase Ib||6
10947145|NCT00400764|12118253|FG001|NOT COMPLETED|Phase Ib||4
10947146|NCT00400764|12118254|FG002|NOT COMPLETED|Phase Ib||0
10947147|NCT00400764|12118255|FG003|NOT COMPLETED|Phase Ib||0
10947148|NCT00400764|12118256|FG004|NOT COMPLETED|Phase Ib||0
10947149|NCT00400764|12118252|FG000|STARTED|Phase II||0
10947150|NCT00400764|12118253|FG001|STARTED|Phase II||0
10947151|NCT00400764|12118254|FG002|STARTED|Phase II||23
10947152|NCT00400764|12118255|FG003|STARTED|Phase II||26
10947153|NCT00400764|12118256|FG004|STARTED|Phase II||11
10947154|NCT00400764|12118252|FG000|Treated|Phase II||0
10947155|NCT00400764|12118253|FG001|Treated|Phase II||0
10947156|NCT00400764|12118254|FG002|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
10947157|NCT00400764|12118255|FG003|Treated|Phase II||26
10947158|NCT00400764|12118256|FG004|Treated|Phase II||11
10947159|NCT00400764|12118252|FG000|COMPLETED|Phase II||0
10947160|NCT00400764|12118253|FG001|COMPLETED|Phase II||0
10947161|NCT00400764|12118254|FG002|COMPLETED|Phase II||0
10947162|NCT00400764|12118255|FG003|COMPLETED|Phase II||0
10947163|NCT00400764|12118256|FG004|COMPLETED|Phase II||0
10947164|NCT00400764|12118252|FG000|NOT COMPLETED|Phase II||0
10947165|NCT00400764|12118253|FG001|NOT COMPLETED|Phase II||0
10947166|NCT00400764|12118254|FG002|NOT COMPLETED|Phase II||23
10947167|NCT00400764|12118255|FG003|NOT COMPLETED|Phase II||26
10947168|NCT00400764|12118256|FG004|NOT COMPLETED|Phase II||11
10947169|NCT00400803|12118273|FG000|STARTED|Overall Study||35
10947170|NCT00400803|12118273|FG000|COMPLETED|Overall Study||35
10947171|NCT00400803|12118273|FG000|NOT COMPLETED|Overall Study||0
10947172|NCT00400829|12118281|FG000|STARTED|Overall Study||66
10947173|NCT00400829|12118281|FG000|COMPLETED|Overall Study||66
10947174|NCT00400829|12118281|FG000|NOT COMPLETED|Overall Study||0
10947175|NCT00400881|12118287|FG000|STARTED|Overall Study||62
10947176|NCT00400881|12118288|FG001|STARTED|Overall Study||60
10947177|NCT00400881|12118287|FG000|COMPLETED|Overall Study||62
10947178|NCT00400881|12118288|FG001|COMPLETED|Overall Study||60
10947179|NCT00400881|12118287|FG000|NOT COMPLETED|Overall Study||0
10947180|NCT00400881|12118288|FG001|NOT COMPLETED|Overall Study||0
10947181|NCT00400985|12118295|FG000|STARTED|Overall Study||501
10947182|NCT00400985|12118295|FG000|COMPLETED|Overall Study||449
10947183|NCT00400985|12118295|FG000|NOT COMPLETED|Overall Study||52
10947184|NCT00401102|12118299|FG000|STARTED|Overall Study||12
10947185|NCT00401102|12118299|FG000|COMPLETED|Overall Study||5
10947186|NCT00401102|12118299|FG000|NOT COMPLETED|Overall Study||7
10947187|NCT00401193|12118306|FG000|STARTED|Overall Study||118
10947188|NCT00401193|12118307|FG001|STARTED|Overall Study||117
10947189|NCT00401193|12118308|FG002|STARTED|Overall Study||69
10947190|NCT00401193|12118306|FG000|Intent to Treat Population|Overall Study||115
10947191|NCT00401193|12118307|FG001|Intent to Treat Population|Overall Study||115
10947192|NCT00401193|12118308|FG002|Intent to Treat Population|Overall Study||67
10947193|NCT00401193|12118306|FG000|Modified Intent to Treat Population|Overall Study||112
10947194|NCT00401193|12118307|FG001|Modified Intent to Treat Population|Overall Study||115
10947195|NCT00401193|12118308|FG002|Modified Intent to Treat Population|Overall Study||67
10947196|NCT00401193|12118306|FG000|COMPLETED|Overall Study||103
10947197|NCT00401193|12118307|FG001|COMPLETED|Overall Study||106
10947198|NCT00401193|12118308|FG002|COMPLETED|Overall Study||63
10947199|NCT00401193|12118306|FG000|NOT COMPLETED|Overall Study||15
10947200|NCT00401193|12118307|FG001|NOT COMPLETED|Overall Study||11
10947201|NCT00401193|12118308|FG002|NOT COMPLETED|Overall Study||6
10947202|NCT00401245|12118321|FG000|STARTED|Double Blind Titration Phase||126
10947203|NCT00401245|12118322|FG001|STARTED|Double Blind Titration Phase||121
10947204|NCT00401245|12118323|FG002|STARTED|Double Blind Titration Phase||124
10947205|NCT00401245|12118324|FG003|STARTED|Double Blind Titration Phase||122
10947206|NCT00401245|12118325|FG004|STARTED|Double Blind Titration Phase||0
10947207|NCT00401245|12118326|FG005|STARTED|Double Blind Titration Phase||0
10947208|NCT00401245|12118327|FG006|STARTED|Double Blind Titration Phase||0
10947209|NCT00401245|12118328|FG007|STARTED|Double Blind Titration Phase||0
10947210|NCT00401245|12118321|FG000|COMPLETED|Double Blind Titration Phase||122
10947211|NCT00401245|12118322|FG001|COMPLETED|Double Blind Titration Phase||118
10947212|NCT00401245|12118323|FG002|COMPLETED|Double Blind Titration Phase||118
10947213|NCT00401245|12118324|FG003|COMPLETED|Double Blind Titration Phase||107
10947214|NCT00401245|12118325|FG004|COMPLETED|Double Blind Titration Phase||0
10947215|NCT00401245|12118326|FG005|COMPLETED|Double Blind Titration Phase||0
10947216|NCT00401245|12118327|FG006|COMPLETED|Double Blind Titration Phase||0
10947217|NCT00401245|12118328|FG007|COMPLETED|Double Blind Titration Phase||0
10947218|NCT00401245|12118321|FG000|NOT COMPLETED|Double Blind Titration Phase||4
10947219|NCT00401245|12118322|FG001|NOT COMPLETED|Double Blind Titration Phase||3
10947220|NCT00401245|12118323|FG002|NOT COMPLETED|Double Blind Titration Phase||6
10947221|NCT00401245|12118324|FG003|NOT COMPLETED|Double Blind Titration Phase||15
10947222|NCT00401245|12118325|FG004|NOT COMPLETED|Double Blind Titration Phase||0
10947223|NCT00401245|12118326|FG005|NOT COMPLETED|Double Blind Titration Phase||0
10947224|NCT00401245|12118327|FG006|NOT COMPLETED|Double Blind Titration Phase||0
10947225|NCT00401245|12118328|FG007|NOT COMPLETED|Double Blind Titration Phase||0
10947226|NCT00401245|12118321|FG000|STARTED|Between Titration and Open Label Phase||122
10947227|NCT00401245|12118322|FG001|STARTED|Between Titration and Open Label Phase||118
10947228|NCT00401245|12118323|FG002|STARTED|Between Titration and Open Label Phase||118
10947229|NCT00401245|12118324|FG003|STARTED|Between Titration and Open Label Phase||107
10947230|NCT00401245|12118325|FG004|STARTED|Between Titration and Open Label Phase||0
10947231|NCT00401245|12118326|FG005|STARTED|Between Titration and Open Label Phase||0
10947232|NCT00401245|12118327|FG006|STARTED|Between Titration and Open Label Phase||0
10947233|NCT00401245|12118328|FG007|STARTED|Between Titration and Open Label Phase||0
10947234|NCT00401245|12118321|FG000|COMPLETED|Between Titration and Open Label Phase||122
10947235|NCT00401245|12118322|FG001|COMPLETED|Between Titration and Open Label Phase||116
10947236|NCT00401245|12118323|FG002|COMPLETED|Between Titration and Open Label Phase||118
10947237|NCT00401245|12118324|FG003|COMPLETED|Between Titration and Open Label Phase||105
10947238|NCT00401245|12118325|FG004|COMPLETED|Between Titration and Open Label Phase||0
10947239|NCT00401245|12118326|FG005|COMPLETED|Between Titration and Open Label Phase||0
10947240|NCT00401245|12118327|FG006|COMPLETED|Between Titration and Open Label Phase||0
10947241|NCT00401245|12118328|FG007|COMPLETED|Between Titration and Open Label Phase||0
10947242|NCT00401245|12118321|FG000|NOT COMPLETED|Between Titration and Open Label Phase||0
10947243|NCT00401245|12118322|FG001|NOT COMPLETED|Between Titration and Open Label Phase||2
10947244|NCT00401245|12118323|FG002|NOT COMPLETED|Between Titration and Open Label Phase||0
10947245|NCT00401245|12118324|FG003|NOT COMPLETED|Between Titration and Open Label Phase||2
10947246|NCT00401245|12118325|FG004|NOT COMPLETED|Between Titration and Open Label Phase||0
10947247|NCT00401245|12118326|FG005|NOT COMPLETED|Between Titration and Open Label Phase||0
10947248|NCT00401245|12118327|FG006|NOT COMPLETED|Between Titration and Open Label Phase||0
10947249|NCT00401245|12118328|FG007|NOT COMPLETED|Between Titration and Open Label Phase||0
10947250|NCT00401245|12118321|FG000|STARTED|Open Label Phase||122
10947251|NCT00401245|12118322|FG001|STARTED|Open Label Phase||116
10947252|NCT00401245|12118323|FG002|STARTED|Open Label Phase||118
10947253|NCT00401245|12118324|FG003|STARTED|Open Label Phase||105
10947254|NCT00401245|12118325|FG004|STARTED|Open Label Phase||0
10947255|NCT00401245|12118326|FG005|STARTED|Open Label Phase||0
10947256|NCT00401245|12118327|FG006|STARTED|Open Label Phase||0
10947257|NCT00401245|12118328|FG007|STARTED|Open Label Phase||0
10947258|NCT00401245|12118321|FG000|COMPLETED|Open Label Phase||101
10947259|NCT00401245|12118322|FG001|COMPLETED|Open Label Phase||81
10947260|NCT00401245|12118323|FG002|COMPLETED|Open Label Phase||95
10947261|NCT00401245|12118324|FG003|COMPLETED|Open Label Phase||84
10947262|NCT00401245|12118325|FG004|COMPLETED|Open Label Phase||0
10947263|NCT00401245|12118326|FG005|COMPLETED|Open Label Phase||0
10947264|NCT00401245|12118327|FG006|COMPLETED|Open Label Phase||0
10947265|NCT00401245|12118328|FG007|COMPLETED|Open Label Phase||0
10947266|NCT00401245|12118321|FG000|NOT COMPLETED|Open Label Phase||21
10947267|NCT00401245|12118322|FG001|NOT COMPLETED|Open Label Phase||35
10947268|NCT00401245|12118323|FG002|NOT COMPLETED|Open Label Phase||23
10947269|NCT00401245|12118324|FG003|NOT COMPLETED|Open Label Phase||21
10947270|NCT00401245|12118325|FG004|NOT COMPLETED|Open Label Phase||0
10947271|NCT00401245|12118326|FG005|NOT COMPLETED|Open Label Phase||0
10947272|NCT00401245|12118327|FG006|NOT COMPLETED|Open Label Phase||0
10947273|NCT00401245|12118328|FG007|NOT COMPLETED|Open Label Phase||0
10947274|NCT00401245|12118321|FG000|STARTED|Double Blind Tapering Phase||0
10947275|NCT00401245|12118322|FG001|STARTED|Double Blind Tapering Phase||0
10947276|NCT00401245|12118323|FG002|STARTED|Double Blind Tapering Phase||0
10947277|NCT00401245|12118324|FG003|STARTED|Double Blind Tapering Phase||0
10947278|NCT00401245|12118325|FG004|STARTED|Double Blind Tapering Phase||101
10947279|NCT00401245|12118326|FG005|STARTED|Double Blind Tapering Phase||94
10947280|NCT00401245|12118327|FG006|STARTED|Double Blind Tapering Phase||87
10947281|NCT00401245|12118328|FG007|STARTED|Double Blind Tapering Phase||102
10947282|NCT00401245|12118321|FG000|COMPLETED|Double Blind Tapering Phase||0
10947283|NCT00401245|12118322|FG001|COMPLETED|Double Blind Tapering Phase||0
10947284|NCT00401245|12118323|FG002|COMPLETED|Double Blind Tapering Phase||0
10947285|NCT00401245|12118324|FG003|COMPLETED|Double Blind Tapering Phase||0
10947286|NCT00401245|12118325|FG004|COMPLETED|Double Blind Tapering Phase||97
10947287|NCT00401245|12118326|FG005|COMPLETED|Double Blind Tapering Phase||90
10947288|NCT00401245|12118327|FG006|COMPLETED|Double Blind Tapering Phase||80
10947289|NCT00401245|12118328|FG007|COMPLETED|Double Blind Tapering Phase||95
10947290|NCT00401245|12118321|FG000|NOT COMPLETED|Double Blind Tapering Phase||0
10947291|NCT00401245|12118322|FG001|NOT COMPLETED|Double Blind Tapering Phase||0
10947292|NCT00401245|12118323|FG002|NOT COMPLETED|Double Blind Tapering Phase||0
10947293|NCT00401245|12118324|FG003|NOT COMPLETED|Double Blind Tapering Phase||0
10947294|NCT00401245|12118325|FG004|NOT COMPLETED|Double Blind Tapering Phase||4
10947295|NCT00401245|12118326|FG005|NOT COMPLETED|Double Blind Tapering Phase||4
10947296|NCT00401245|12118327|FG006|NOT COMPLETED|Double Blind Tapering Phase||7
10947297|NCT00401245|12118328|FG007|NOT COMPLETED|Double Blind Tapering Phase||7
10947298|NCT00401258|12118348|FG000|STARTED|Overall Study||15
10947299|NCT00401258|12118348|FG000|COMPLETED|Overall Study||8
10947300|NCT00401258|12118348|FG000|NOT COMPLETED|Overall Study||7
10947301|NCT00401375|12118355|FG000|STARTED|Overall Study||174
10947302|NCT00401375|12118356|FG001|STARTED|Overall Study||176
10947303|NCT00401375|12118357|FG002|STARTED|Overall Study||174
10947304|NCT00401375|12118355|FG000|Received at Least 1 Dose of Study Drug|Overall Study||171
10947305|NCT00401375|12118356|FG001|Received at Least 1 Dose of Study Drug|Overall Study||173
10947306|NCT00401375|12118357|FG002|Received at Least 1 Dose of Study Drug|Overall Study||171
10947307|NCT00401375|12118355|FG000|COMPLETED|Overall Study||152
10947308|NCT00401375|12118356|FG001|COMPLETED|Overall Study||151
10947309|NCT00401375|12118357|FG002|COMPLETED|Overall Study||149
10947310|NCT00401375|12118355|FG000|NOT COMPLETED|Overall Study||22
10947311|NCT00401375|12118356|FG001|NOT COMPLETED|Overall Study||25
10947312|NCT00401375|12118357|FG002|NOT COMPLETED|Overall Study||25
10947313|NCT00401401|12118369|FG000|STARTED|Overall Study||6
10947314|NCT00401401|12118370|FG001|STARTED|Overall Study||6
10947315|NCT00401401|12118371|FG002|STARTED|Overall Study||6
10947316|NCT00401401|12118372|FG003|STARTED|Overall Study||12
10947317|NCT00401401|12118369|FG000|COMPLETED|Overall Study||6
10947318|NCT00401401|12118370|FG001|COMPLETED|Overall Study||6
10947319|NCT00401401|12118371|FG002|COMPLETED|Overall Study||5
10947320|NCT00401401|12118372|FG003|COMPLETED|Overall Study||9
10947321|NCT00401401|12118369|FG000|NOT COMPLETED|Overall Study||0
10947322|NCT00401401|12118370|FG001|NOT COMPLETED|Overall Study||0
10947323|NCT00401401|12118371|FG002|NOT COMPLETED|Overall Study||1
10947324|NCT00401401|12118372|FG003|NOT COMPLETED|Overall Study||3
10947325|NCT00401414|12118389|FG000|STARTED|Overall Study||118
10947326|NCT00401414|12118390|FG001|STARTED|Overall Study||147
10947327|NCT00401414|12118391|FG002|STARTED|Overall Study||79
10947328|NCT00401414|12118389|FG000|COMPLETED|Overall Study||118
10947329|NCT00401414|12118390|FG001|COMPLETED|Overall Study||147
10947330|NCT00401414|12118391|FG002|COMPLETED|Overall Study||79
10947331|NCT00401414|12118389|FG000|NOT COMPLETED|Overall Study||0
10947332|NCT00401414|12118390|FG001|NOT COMPLETED|Overall Study||0
10947333|NCT00401414|12118391|FG002|NOT COMPLETED|Overall Study||0
10947334|NCT00401518|12118404|FG000|STARTED|Overall Study||46
10947335|NCT00401518|12118405|FG001|STARTED|Overall Study||227
10947336|NCT00401518|12118406|FG002|STARTED|Overall Study||117
10947337|NCT00401518|12118404|FG000|COMPLETED|Overall Study||40
10947338|NCT00401518|12118405|FG001|COMPLETED|Overall Study||190
10947339|NCT00401518|12118406|FG002|COMPLETED|Overall Study||94
10947340|NCT00401518|12118404|FG000|NOT COMPLETED|Overall Study||6
10947341|NCT00401518|12118405|FG001|NOT COMPLETED|Overall Study||37
10947342|NCT00401518|12118406|FG002|NOT COMPLETED|Overall Study||23
10947343|NCT00401531|12118416|FG000|STARTED|Overall Study||206
10947344|NCT00401531|12118417|FG001|STARTED|Overall Study||206
10947345|NCT00401531|12118416|FG000|COMPLETED|Overall Study||197
10947346|NCT00401531|12118417|FG001|COMPLETED|Overall Study||196
10947347|NCT00401531|12118416|FG000|NOT COMPLETED|Overall Study||9
10947348|NCT00401531|12118417|FG001|NOT COMPLETED|Overall Study||10
10947349|NCT00401544|12118427|FG000|STARTED|Overall Study|Randomized and treated|56
10947350|NCT00401544|12118428|FG001|STARTED|Overall Study|Randomized and treated|62
10947351|NCT00401544|12118429|FG002|STARTED|Overall Study|Randomized and treated|60
10947352|NCT00401544|12118430|FG003|STARTED|Overall Study|Randomized and treated|60
10947353|NCT00401544|12118427|FG000|COMPLETED|Overall Study||38
10947354|NCT00401544|12118428|FG001|COMPLETED|Overall Study||44
10947355|NCT00401544|12118429|FG002|COMPLETED|Overall Study||48
10947356|NCT00401544|12118430|FG003|COMPLETED|Overall Study||44
10947357|NCT00401544|12118427|FG000|NOT COMPLETED|Overall Study||18
10947358|NCT00401544|12118428|FG001|NOT COMPLETED|Overall Study||18
10947359|NCT00401544|12118429|FG002|NOT COMPLETED|Overall Study||12
10947360|NCT00401544|12118430|FG003|NOT COMPLETED|Overall Study||16
10947361|NCT00401622|12118447|FG000|STARTED|Overall Study||160
10947362|NCT00401622|12118448|FG001|STARTED|Overall Study||160
10947363|NCT00401622|12118447|FG000|COMPLETED|Overall Study||126
10947364|NCT00401622|12118448|FG001|COMPLETED|Overall Study||117
10947365|NCT00401622|12118447|FG000|NOT COMPLETED|Overall Study||34
10947366|NCT00401622|12118448|FG001|NOT COMPLETED|Overall Study||43
10947367|NCT00401726|12118456|FG000|STARTED|Overall Study||269
10947368|NCT00401726|12118457|FG001|STARTED|Overall Study||268
10947369|NCT00401726|12118456|FG000|COMPLETED|Overall Study||172
10947370|NCT00401726|12118457|FG001|COMPLETED|Overall Study||156
10947371|NCT00401726|12118456|FG000|NOT COMPLETED|Overall Study||97
10947372|NCT00401726|12118457|FG001|NOT COMPLETED|Overall Study||112
10947373|NCT00401752|12118465|FG000|STARTED|Overall Study||107
10947374|NCT00401752|12118466|FG001|STARTED|Overall Study||112
10947375|NCT00401752|12118465|FG000|Number of Patients Received Treatment|Overall Study||107
10947376|NCT00401752|12118466|FG001|Number of Patients Received Treatment|Overall Study||111
10947377|NCT00401752|12118465|FG000|Patients Included in ITT Population|Overall Study||106
10947378|NCT00401752|12118466|FG001|Patients Included in ITT Population|Overall Study||111
10947379|NCT00401752|12118465|FG000|Patients Included in Safety Population|Overall Study||107
10947380|NCT00401752|12118466|FG001|Patients Included in Safety Population|Overall Study||110
10947381|NCT00401752|12118465|FG000|Patients Included in Per-Protocol Popula|Overall Study||100
10947382|NCT00401752|12118466|FG001|Patients Included in Per-Protocol Popula|Overall Study||99
10947383|NCT00401752|12118465|FG000|COMPLETED|Overall Study||97
10947384|NCT00401752|12118466|FG001|COMPLETED|Overall Study||94
10947385|NCT00401752|12118465|FG000|NOT COMPLETED|Overall Study||10
10947386|NCT00401752|12118466|FG001|NOT COMPLETED|Overall Study||18
10947387|NCT00401778|12118475|FG000|STARTED|Overall Study||10
10947388|NCT00401778|12118476|FG001|STARTED|Overall Study||12
10947389|NCT00401778|12118477|FG002|STARTED|Overall Study||11
10947390|NCT00401778|12118475|FG000|COMPLETED|Overall Study||9
10947391|NCT00401778|12118476|FG001|COMPLETED|Overall Study||11
10947392|NCT00401778|12118477|FG002|COMPLETED|Overall Study||10
10947393|NCT00401778|12118475|FG000|NOT COMPLETED|Overall Study||1
10947394|NCT00401778|12118476|FG001|NOT COMPLETED|Overall Study||1
10947395|NCT00401778|12118477|FG002|NOT COMPLETED|Overall Study||1
10947396|NCT00401817|12118485|FG000|STARTED|Overall Study||11
10947397|NCT00401817|12118485|FG000|COMPLETED|Overall Study||11
10947398|NCT00401817|12118485|FG000|NOT COMPLETED|Overall Study||0
10947399|NCT00401830|12118492|FG000|STARTED|Overall Study||81
10947400|NCT00401830|12118493|FG001|STARTED|Overall Study||78
10947401|NCT00401830|12118492|FG000|COMPLETED|Overall Study||50
10947402|NCT00401830|12118493|FG001|COMPLETED|Overall Study||46
10947403|NCT00401830|12118492|FG000|NOT COMPLETED|Overall Study||31
10947404|NCT00401830|12118493|FG001|NOT COMPLETED|Overall Study||32
10947405|NCT00401843|12118502|FG000|STARTED|Overall Study||21
10947406|NCT00401843|12118503|FG001|STARTED|Overall Study||144
10947407|NCT00401843|12118504|FG002|STARTED|Overall Study||142
10947408|NCT00401843|12118502|FG000|Treated|Overall Study||21
10947409|NCT00401843|12118503|FG001|Treated|Overall Study||142
10947410|NCT00401843|12118504|FG002|Treated|Overall Study||139
10947411|NCT00401843|12118502|FG000|COMPLETED|Overall Study||0
10947412|NCT00401843|12118503|FG001|COMPLETED|Overall Study||0
10947413|NCT00401843|12118504|FG002|COMPLETED|Overall Study||0
10947414|NCT00401843|12118502|FG000|NOT COMPLETED|Overall Study||21
10947415|NCT00401843|12118503|FG001|NOT COMPLETED|Overall Study||144
10947416|NCT00401843|12118504|FG002|NOT COMPLETED|Overall Study||142
10947417|NCT00401882|12118516|FG000|STARTED|Overall Study||2
10947418|NCT00401882|12118517|FG001|STARTED|Overall Study||5
10947419|NCT00401882|12118516|FG000|COMPLETED|Overall Study||2
10947420|NCT00401882|12118517|FG001|COMPLETED|Overall Study||5
10947421|NCT00401882|12118516|FG000|NOT COMPLETED|Overall Study||0
10947422|NCT00401882|12118517|FG001|NOT COMPLETED|Overall Study||0
10947423|NCT00401960|12118531|FG000|STARTED|Overall Study||5
10947424|NCT00401960|12118532|FG001|STARTED|Overall Study||1
10947425|NCT00401960|12118531|FG000|COMPLETED|Overall Study||0
10947426|NCT00401960|12118532|FG001|COMPLETED|Overall Study||1
10947427|NCT00401960|12118531|FG000|NOT COMPLETED|Overall Study||5
10947428|NCT00401960|12118532|FG001|NOT COMPLETED|Overall Study||0
10947429|NCT00401973|12118543|FG000|STARTED|Overall Study||50
10947430|NCT00401973|12118544|FG001|STARTED|Overall Study||76
10947431|NCT00401973|12118545|FG002|STARTED|Overall Study||73
10947432|NCT00401973|12118543|FG000|COMPLETED|Overall Study||39
10947433|NCT00401973|12118544|FG001|COMPLETED|Overall Study||50
10947434|NCT00401973|12118545|FG002|COMPLETED|Overall Study||50
10947435|NCT00401973|12118543|FG000|NOT COMPLETED|Overall Study||11
10947436|NCT00401973|12118544|FG001|NOT COMPLETED|Overall Study||26
10947437|NCT00401973|12118545|FG002|NOT COMPLETED|Overall Study||23
10947438|NCT00401986|12118555|FG000|STARTED|Overall Study||14
10947439|NCT00401986|12118555|FG000|COMPLETED|Overall Study||12
10947440|NCT00401986|12118555|FG000|NOT COMPLETED|Overall Study||2
10947441|NCT00402025|12118567|FG000|STARTED|Overall Study||3
10947442|NCT00402025|12118568|FG001|STARTED|Overall Study||4
10947443|NCT00402025|12118569|FG002|STARTED|Overall Study||10
10947444|NCT00402025|12118567|FG000|COMPLETED|Overall Study||1
10947445|NCT00402025|12118568|FG001|COMPLETED|Overall Study||1
10947446|NCT00402025|12118569|FG002|COMPLETED|Overall Study||0
10947447|NCT00402025|12118567|FG000|NOT COMPLETED|Overall Study||2
10947448|NCT00402025|12118568|FG001|NOT COMPLETED|Overall Study||3
10947449|NCT00402025|12118569|FG002|NOT COMPLETED|Overall Study||10
10947450|NCT00402051|12118579|FG000|STARTED|Overall Study||66
10947451|NCT00402051|12118580|FG001|STARTED|Overall Study||67
10947452|NCT00402051|12118579|FG000|Received Treatment|Overall Study||65
10947453|NCT00402051|12118580|FG001|Received Treatment|Overall Study||65
10947454|NCT00402051|12118579|FG000|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
10947455|NCT00402051|12118580|FG001|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
10947456|NCT00402051|12118579|FG000|NOT COMPLETED|Overall Study||38
10947457|NCT00402051|12118580|FG001|NOT COMPLETED|Overall Study||35
10947458|NCT00402103|12118588|FG000|STARTED|Overall Study||470
10947459|NCT00402103|12118589|FG001|STARTED|Overall Study||86
10947460|NCT00402103|12118588|FG000|COMPLETED|Overall Study||379
10947461|NCT00402103|12118589|FG001|COMPLETED|Overall Study||73
10947462|NCT00402103|12118588|FG000|NOT COMPLETED|Overall Study||91
10947463|NCT00402103|12118589|FG001|NOT COMPLETED|Overall Study||13
10947464|NCT00402116|12118602|FG000|STARTED|Overall Study||6
10947465|NCT00402116|12118603|FG001|STARTED|Overall Study||6
10947466|NCT00402116|12118604|FG002|STARTED|Overall Study||60
10947467|NCT00402116|12118602|FG000|COMPLETED|Overall Study||3
10947468|NCT00402116|12118603|FG001|COMPLETED|Overall Study||0
10947469|NCT00402116|12118604|FG002|COMPLETED|Overall Study||5
10947470|NCT00402116|12118602|FG000|NOT COMPLETED|Overall Study||3
10947471|NCT00402116|12118603|FG001|NOT COMPLETED|Overall Study||6
10947472|NCT00402116|12118604|FG002|NOT COMPLETED|Overall Study||55
10947473|NCT00402168|12118634|FG000|STARTED|Randomized||84
10947474|NCT00402168|12118635|FG001|STARTED|Randomized||89
10947475|NCT00402168|12118634|FG000|COMPLETED|Randomized||83
10947476|NCT00402168|12118635|FG001|COMPLETED|Randomized||88
10947477|NCT00402168|12118634|FG000|NOT COMPLETED|Randomized||1
10947478|NCT00402168|12118635|FG001|NOT COMPLETED|Randomized||1
10947479|NCT00402168|12118634|FG000|STARTED|Treatment (up to 12 Months)||83
10947480|NCT00402168|12118635|FG001|STARTED|Treatment (up to 12 Months)||88
10947481|NCT00402168|12118634|FG000|COMPLETED|Treatment (up to 12 Months)||81
10947482|NCT00402168|12118635|FG001|COMPLETED|Treatment (up to 12 Months)||86
10947483|NCT00402168|12118634|FG000|NOT COMPLETED|Treatment (up to 12 Months)||2
10947484|NCT00402168|12118635|FG001|NOT COMPLETED|Treatment (up to 12 Months)||2
10947485|NCT00402168|12118634|FG000|STARTED|Long Term (LT)||81
10947486|NCT00402168|12118635|FG001|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
10947487|NCT00402168|12118634|FG000|COMPLETED|Long Term (LT)||70
10947488|NCT00402168|12118635|FG001|COMPLETED|Long Term (LT)||64
10947489|NCT00402168|12118634|FG000|NOT COMPLETED|Long Term (LT)||11
10947490|NCT00402168|12118635|FG001|NOT COMPLETED|Long Term (LT)||17
10947491|NCT00402168|12118634|FG000|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
10947492|NCT00402168|12118635|FG001|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
10947493|NCT00402168|12118634|FG000|COMPLETED|Switched From CNI to Belatacept in LT||32
10947494|NCT00402168|12118635|FG001|COMPLETED|Switched From CNI to Belatacept in LT||0
10947495|NCT00402168|12118634|FG000|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
10947496|NCT00402168|12118635|FG001|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
10947497|NCT00402194|12118651|FG000|STARTED|Overall Study||9
10947498|NCT00402194|12118652|FG001|STARTED|Overall Study||8
10947499|NCT00402194|12118651|FG000|COMPLETED|Overall Study||9
10947500|NCT00402194|12118652|FG001|COMPLETED|Overall Study||8
10947501|NCT00402194|12118651|FG000|NOT COMPLETED|Overall Study||0
10947502|NCT00402194|12118652|FG001|NOT COMPLETED|Overall Study||0
10947503|NCT00402233|12118662|FG000|STARTED|Overall Study||77
10947504|NCT00402233|12118663|FG001|STARTED|Overall Study||80
10947505|NCT00402233|12118664|FG002|STARTED|Overall Study||81
10947506|NCT00402233|12118665|FG003|STARTED|Overall Study||73
10947507|NCT00402233|12118662|FG000|COMPLETED|Overall Study||72
10947508|NCT00402233|12118663|FG001|COMPLETED|Overall Study||70
10947509|NCT00402233|12118664|FG002|COMPLETED|Overall Study||70
10947510|NCT00402233|12118665|FG003|COMPLETED|Overall Study||62
10947511|NCT00402233|12118662|FG000|NOT COMPLETED|Overall Study||5
10947512|NCT00402233|12118663|FG001|NOT COMPLETED|Overall Study||10
10947513|NCT00402233|12118664|FG002|NOT COMPLETED|Overall Study||11
10947514|NCT00402233|12118665|FG003|NOT COMPLETED|Overall Study||11
10947515|NCT00402246|12118677|FG000|STARTED|Overall Study||1014
10947516|NCT00402246|12118678|FG001|STARTED|Overall Study||983
10947517|NCT00402246|12118677|FG000|COMPLETED|Overall Study||794
10947518|NCT00402246|12118678|FG001|COMPLETED|Overall Study||749
10947519|NCT00402246|12118677|FG000|NOT COMPLETED|Overall Study||220
10947520|NCT00402246|12118678|FG001|NOT COMPLETED|Overall Study||234
10947521|NCT00402285|12118689|FG000|STARTED|Overall Study||29
10947522|NCT00402285|12118690|FG001|STARTED|Overall Study||27
10947523|NCT00402285|12118691|FG002|STARTED|Overall Study||28
10947524|NCT00402285|12118689|FG000|COMPLETED|Overall Study||22
10947525|NCT00402285|12118690|FG001|COMPLETED|Overall Study||21
10947526|NCT00402285|12118691|FG002|COMPLETED|Overall Study||26
10947527|NCT00402285|12118689|FG000|NOT COMPLETED|Overall Study||7
10947528|NCT00402285|12118690|FG001|NOT COMPLETED|Overall Study||6
10947529|NCT00402285|12118691|FG002|NOT COMPLETED|Overall Study||2
10947530|NCT00402324|12118699|FG000|STARTED|Overall Study||101
10947531|NCT00402324|12118700|FG001|STARTED|Overall Study||101
10947532|NCT00402324|12118699|FG000|COMPLETED|Overall Study||58
10947533|NCT00402324|12118700|FG001|COMPLETED|Overall Study||60
10947534|NCT00402324|12118699|FG000|NOT COMPLETED|Overall Study||43
10947535|NCT00402324|12118700|FG001|NOT COMPLETED|Overall Study||41
10947536|NCT00402337|12118711|FG000|STARTED|Overall Study||59
10947537|NCT00402337|12118712|FG001|STARTED|Overall Study||57
10947538|NCT00402337|12118713|FG002|STARTED|Overall Study||62
10947539|NCT00402337|12118714|FG003|STARTED|Overall Study||63
10947540|NCT00402337|12118715|FG004|STARTED|Overall Study||69
10947541|NCT00402337|12118711|FG000|COMPLETED|Overall Study||54
10947542|NCT00402337|12118712|FG001|COMPLETED|Overall Study||51
10947543|NCT00402337|12118713|FG002|COMPLETED|Overall Study||58
10947544|NCT00402337|12118714|FG003|COMPLETED|Overall Study||51
10947545|NCT00402337|12118715|FG004|COMPLETED|Overall Study||61
10947546|NCT00402337|12118711|FG000|NOT COMPLETED|Overall Study||5
10947547|NCT00402337|12118712|FG001|NOT COMPLETED|Overall Study||6
10947548|NCT00402337|12118713|FG002|NOT COMPLETED|Overall Study||4
10947549|NCT00402337|12118714|FG003|NOT COMPLETED|Overall Study||12
10947550|NCT00402337|12118715|FG004|NOT COMPLETED|Overall Study||8
10947551|NCT00402363|12118731|FG000|STARTED|Overall Study||266
10947552|NCT00402363|12118732|FG001|STARTED|Overall Study||276
10947553|NCT00402363|12118733|FG002|STARTED|Overall Study||66
10947554|NCT00402363|12118734|FG003|STARTED|Overall Study||55
10947555|NCT00402363|12118731|FG000|COMPLETED|Overall Study||233
10947556|NCT00402363|12118732|FG001|COMPLETED|Overall Study||246
10947557|NCT00402363|12118733|FG002|COMPLETED|Overall Study||60
10947558|NCT00402363|12118734|FG003|COMPLETED|Overall Study||45
10947559|NCT00402363|12118731|FG000|NOT COMPLETED|Overall Study||33
10947560|NCT00402363|12118732|FG001|NOT COMPLETED|Overall Study||30
10947561|NCT00402363|12118733|FG002|NOT COMPLETED|Overall Study||6
10947562|NCT00402363|12118734|FG003|NOT COMPLETED|Overall Study||10
10947563|NCT00402597|12118755|FG000|STARTED|Overall Study||1153
10947564|NCT00402597|12118756|FG001|STARTED|Overall Study||307
10947565|NCT00402597|12118757|FG002|STARTED|Overall Study||1046
10947566|NCT00402597|12118758|FG003|STARTED|Overall Study||353
10947567|NCT00402597|12118759|FG004|STARTED|Overall Study||603
10947568|NCT00402597|12118755|FG000|COMPLETED|Overall Study||962
10947569|NCT00402597|12118756|FG001|COMPLETED|Overall Study||261
10947570|NCT00402597|12118757|FG002|COMPLETED|Overall Study||834
10947571|NCT00402597|12118758|FG003|COMPLETED|Overall Study||279
10947572|NCT00402597|12118759|FG004|COMPLETED|Overall Study||479
10947573|NCT00402597|12118755|FG000|NOT COMPLETED|Overall Study||191
10947574|NCT00402597|12118756|FG001|NOT COMPLETED|Overall Study||46
10947575|NCT00402597|12118757|FG002|NOT COMPLETED|Overall Study||212
10947576|NCT00402597|12118758|FG003|NOT COMPLETED|Overall Study||74
10947577|NCT00402597|12118759|FG004|NOT COMPLETED|Overall Study||124
10947578|NCT00402649|12118771|FG000|STARTED|Overall Study||35
10947579|NCT00402649|12118771|FG000|COMPLETED|Overall Study||33
10947580|NCT00402649|12118771|FG000|NOT COMPLETED|Overall Study||2
10947581|NCT00402688|12118778|FG000|STARTED|Overall Study||81
10947582|NCT00402688|12118779|FG001|STARTED|Overall Study||81
10947583|NCT00402688|12118780|FG002|STARTED|Overall Study||80
10947584|NCT00402688|12118778|FG000|COMPLETED|Overall Study||60
10947585|NCT00402688|12118779|FG001|COMPLETED|Overall Study||65
10947586|NCT00402688|12118780|FG002|COMPLETED|Overall Study||65
10947587|NCT00402688|12118778|FG000|NOT COMPLETED|Overall Study||21
10947588|NCT00402688|12118779|FG001|NOT COMPLETED|Overall Study||16
10947589|NCT00402688|12118780|FG002|NOT COMPLETED|Overall Study||15
10947590|NCT00402714|12118790|FG000|STARTED|Overall Study||3
10947591|NCT00402714|12118791|FG001|STARTED|Overall Study||11
10947592|NCT00402714|12118790|FG000|COMPLETED|Overall Study||3
10947593|NCT00402714|12118791|FG001|COMPLETED|Overall Study||11
10947594|NCT00402714|12118790|FG000|NOT COMPLETED|Overall Study||0
10947595|NCT00402714|12118791|FG001|NOT COMPLETED|Overall Study||0
10947596|NCT00402727|12118801|FG000|STARTED|Overall Study||432
10947597|NCT00402727|12118802|FG001|STARTED|Overall Study||381
10947598|NCT00402727|12118801|FG000|Achieving End Of Treatment (EOT)|Overall Study||408
10947599|NCT00402727|12118802|FG001|Achieving End Of Treatment (EOT)|Overall Study||355
10947600|NCT00402727|12118801|FG000|Achieving Test Of Cure (TOC)|Overall Study||390
10947601|NCT00402727|12118802|FG001|Achieving Test Of Cure (TOC)|Overall Study||347
10947602|NCT00402727|12118801|FG000|COMPLETED|Overall Study||390
10947603|NCT00402727|12118802|FG001|COMPLETED|Overall Study||347
10947604|NCT00402727|12118801|FG000|NOT COMPLETED|Overall Study||42
10947605|NCT00402727|12118802|FG001|NOT COMPLETED|Overall Study||34
10947606|NCT00402740|12118808|FG000|STARTED|Overall Study||322
10947607|NCT00402740|12118808|FG000|COMPLETED|Overall Study||242
10947608|NCT00402740|12118808|FG000|NOT COMPLETED|Overall Study||80
10947609|NCT00402779|12118818|FG000|STARTED|Overall Study||152
10947610|NCT00402779|12118819|FG001|STARTED|Overall Study||151
10947611|NCT00402779|12118818|FG000|COMPLETED|Overall Study||75
10947612|NCT00402779|12118819|FG001|COMPLETED|Overall Study||75
10947613|NCT00402779|12118818|FG000|NOT COMPLETED|Overall Study||77
10947614|NCT00402779|12118819|FG001|NOT COMPLETED|Overall Study||76
10947615|NCT00402831|12118827|FG000|STARTED|Overall Study||202
10947616|NCT00402831|12118828|FG001|STARTED|Overall Study||203
10947617|NCT00402831|12118827|FG000|ProQuad® Dose 1 (Day 1)|Overall Study||202
10947618|NCT00402831|12118828|FG001|ProQuad® Dose 1 (Day 1)|Overall Study||203
10947619|NCT00402831|12118827|FG000|ProQuad® Dose 1 (Day 30)|Overall Study||202
10947620|NCT00402831|12118828|FG001|ProQuad® Dose 1 (Day 30)|Overall Study||203
10947621|NCT00402831|12118827|FG000|COMPLETED|Overall Study||201
10947622|NCT00402831|12118828|FG001|COMPLETED|Overall Study||200
10947623|NCT00402831|12118827|FG000|NOT COMPLETED|Overall Study||1
10947624|NCT00402831|12118828|FG001|NOT COMPLETED|Overall Study||3
10947625|NCT00402896|12118836|FG000|STARTED|Overall Study||20
10947626|NCT00402896|12118836|FG000|COMPLETED|Overall Study||20
10947627|NCT00402896|12118836|FG000|NOT COMPLETED|Overall Study||0
10947628|NCT00402987|12118844|FG000|STARTED|Overall Study||90
10947629|NCT00402987|12118845|FG001|STARTED|Overall Study||45
10947630|NCT00402987|12118846|FG002|STARTED|Overall Study||45
10947631|NCT00402987|12118847|FG003|STARTED|Overall Study||89
10947632|NCT00402987|12118844|FG000|COMPLETED|Overall Study||90
10947633|NCT00402987|12118845|FG001|COMPLETED|Overall Study||45
10947634|NCT00402987|12118846|FG002|COMPLETED|Overall Study||44
10947635|NCT00402987|12118847|FG003|COMPLETED|Overall Study||89
10947636|NCT00402987|12118844|FG000|NOT COMPLETED|Overall Study||0
10947637|NCT00402987|12118845|FG001|NOT COMPLETED|Overall Study||0
10947638|NCT00402987|12118846|FG002|NOT COMPLETED|Overall Study||1
10947639|NCT00402987|12118847|FG003|NOT COMPLETED|Overall Study||0
10947640|NCT00403117|12118871|FG000|STARTED|Overall Study||49
10947641|NCT00403117|12118871|FG000|COMPLETED|Overall Study||29
10947642|NCT00403117|12118871|FG000|NOT COMPLETED|Overall Study||20
10947643|NCT00403130|12118902|FG000|STARTED|2 Years From Start of Treatment||31
10947644|NCT00403130|12118902|FG000|COMPLETED|2 Years From Start of Treatment||26
10947645|NCT00403130|12118902|FG000|NOT COMPLETED|2 Years From Start of Treatment||5
10947646|NCT00403130|12118902|FG000|STARTED|Survival Follow-up up to 6 Years||26
10947647|NCT00403130|12118902|FG000|COMPLETED|Survival Follow-up up to 6 Years||16
10947648|NCT00403130|12118902|FG000|NOT COMPLETED|Survival Follow-up up to 6 Years||10
10947649|NCT00403234|12118910|FG000|STARTED|Overall Study||2
10947650|NCT00403234|12118911|FG001|STARTED|Overall Study||3
10947651|NCT00403234|12118912|FG002|STARTED|Overall Study||3
10947652|NCT00403234|12118913|FG003|STARTED|Overall Study||2
10947653|NCT00403234|12118910|FG000|COMPLETED|Overall Study||1
10947654|NCT00403234|12118911|FG001|COMPLETED|Overall Study||2
10947655|NCT00403234|12118912|FG002|COMPLETED|Overall Study||2
10947656|NCT00403234|12118913|FG003|COMPLETED|Overall Study||2
10947657|NCT00403234|12118910|FG000|NOT COMPLETED|Overall Study||1
10947658|NCT00403234|12118911|FG001|NOT COMPLETED|Overall Study||1
10947659|NCT00403234|12118912|FG002|NOT COMPLETED|Overall Study||1
10947660|NCT00403234|12118913|FG003|NOT COMPLETED|Overall Study||0
10947661|NCT00403260|12118925|FG000|STARTED|Overall Study|Patients randomized and treated.|848
10947662|NCT00403260|12118926|FG001|STARTED|Overall Study|Patients randomized and treated.|423
10947663|NCT00403260|12118925|FG000|COMPLETED|Overall Study||723
10947664|NCT00403260|12118926|FG001|COMPLETED|Overall Study||357
10947665|NCT00403260|12118925|FG000|NOT COMPLETED|Overall Study||125
10947666|NCT00403260|12118926|FG001|NOT COMPLETED|Overall Study||66
10947667|NCT00403273|12118934|FG000|STARTED|Overall Study||25
10947668|NCT00403273|12118935|FG001|STARTED|Overall Study||29
10947669|NCT00403273|12118934|FG000|COMPLETED|Overall Study||22
10947670|NCT00403273|12118935|FG001|COMPLETED|Overall Study||25
10947671|NCT00403273|12118934|FG000|NOT COMPLETED|Overall Study||3
10947672|NCT00403273|12118935|FG001|NOT COMPLETED|Overall Study||4
10947673|NCT00403390|12118945|FG000|STARTED|Overall Study||16
10947674|NCT00403390|12118946|FG001|STARTED|Overall Study||18
10947675|NCT00403390|12118945|FG000|COMPLETED|Overall Study||13
10947676|NCT00403390|12118946|FG001|COMPLETED|Overall Study||18
10947677|NCT00403390|12118945|FG000|NOT COMPLETED|Overall Study||3
10947678|NCT00403390|12118946|FG001|NOT COMPLETED|Overall Study||0
10947679|NCT00403403|12118954|FG000|STARTED|Overall Study||50
10947680|NCT00403403|12118955|FG001|STARTED|Overall Study||52
10947681|NCT00403403|12118954|FG000|Safety-Evaluable Patients|Overall Study||47
10947682|NCT00403403|12118955|FG001|Safety-Evaluable Patients|Overall Study||51
10947683|NCT00403403|12118954|FG000|COMPLETED|Overall Study||50
10947684|NCT00403403|12118955|FG001|COMPLETED|Overall Study||52
10947685|NCT00403403|12118954|FG000|NOT COMPLETED|Overall Study||0
10947686|NCT00403403|12118955|FG001|NOT COMPLETED|Overall Study||0
10947687|NCT00403455|12118961|FG000|STARTED|Overall Study||38
10947688|NCT00403455|12118961|FG000|COMPLETED|Overall Study||37
10947689|NCT00403455|12118961|FG000|NOT COMPLETED|Overall Study||1
10947690|NCT00403481|12118965|FG000|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
10947691|NCT00403481|12118965|FG000|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
10947692|NCT00403481|12118965|FG000|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
10947693|NCT00403481|12118965|FG000|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
10947694|NCT00403481|12118965|FG000|COMPLETED|Olm 40 mg||177
10947695|NCT00403481|12118965|FG000|NOT COMPLETED|Olm 40 mg||5
10947696|NCT00403481|12118965|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
10947697|NCT00403481|12118965|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
10947698|NCT00403481|12118965|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
10947699|NCT00403481|12118965|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
10947700|NCT00403481|12118965|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
10947701|NCT00403481|12118965|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
10947702|NCT00403494|12118974|FG000|STARTED|Overall Study||96
10947703|NCT00403494|12118975|FG001|STARTED|Overall Study||94
10947704|NCT00403494|12118974|FG000|Intent to Treat|Overall Study||87
10947705|NCT00403494|12118975|FG001|Intent to Treat|Overall Study||83
10947706|NCT00403494|12118974|FG000|Per-protocol|Overall Study||69
10947707|NCT00403494|12118975|FG001|Per-protocol|Overall Study||69
10947708|NCT00403494|12118974|FG000|Safety Population|Overall Study||97
10947709|NCT00403494|12118975|FG001|Safety Population|Overall Study||91
10947710|NCT00403494|12118974|FG000|COMPLETED|Overall Study||81
10947711|NCT00403494|12118975|FG001|COMPLETED|Overall Study||80
10947712|NCT00403494|12118974|FG000|NOT COMPLETED|Overall Study||15
10947713|NCT00403494|12118975|FG001|NOT COMPLETED|Overall Study||14
10947714|NCT00403546|12118985|FG000|STARTED|Signed Informed Consent/Open-Label||131
10947715|NCT00403546|12118986|FG001|STARTED|Signed Informed Consent/Open-Label||0
10947716|NCT00403546|12118987|FG002|STARTED|Signed Informed Consent/Open-Label||0
10947717|NCT00403546|12118985|FG000|COMPLETED|Signed Informed Consent/Open-Label||103
10947718|NCT00403546|12118986|FG001|COMPLETED|Signed Informed Consent/Open-Label||0
10947719|NCT00403546|12118987|FG002|COMPLETED|Signed Informed Consent/Open-Label||0
10947720|NCT00403546|12118985|FG000|NOT COMPLETED|Signed Informed Consent/Open-Label||28
10947721|NCT00403546|12118986|FG001|NOT COMPLETED|Signed Informed Consent/Open-Label||0
10947722|NCT00403546|12118987|FG002|NOT COMPLETED|Signed Informed Consent/Open-Label||0
10947723|NCT00403546|12118985|FG000|STARTED|Screening Phase||103
10947724|NCT00403546|12118986|FG001|STARTED|Screening Phase||0
10947725|NCT00403546|12118987|FG002|STARTED|Screening Phase||0
10947726|NCT00403546|12118985|FG000|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
10947727|NCT00403546|12118986|FG001|COMPLETED|Screening Phase||0
10947728|NCT00403546|12118987|FG002|COMPLETED|Screening Phase||0
10947729|NCT00403546|12118985|FG000|NOT COMPLETED|Screening Phase||28
10947730|NCT00403546|12118986|FG001|NOT COMPLETED|Screening Phase||0
10947731|NCT00403546|12118987|FG002|NOT COMPLETED|Screening Phase||0
10947732|NCT00403546|12118985|FG000|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
10947733|NCT00403546|12118986|FG001|STARTED|Randomized Trial||38
10947734|NCT00403546|12118987|FG002|STARTED|Randomized Trial||37
10947735|NCT00403546|12118985|FG000|COMPLETED|Randomized Trial||0
10947736|NCT00403546|12118986|FG001|COMPLETED|Randomized Trial||21
10947737|NCT00403546|12118987|FG002|COMPLETED|Randomized Trial||21
10947738|NCT00403546|12118985|FG000|NOT COMPLETED|Randomized Trial||0
10947739|NCT00403546|12118986|FG001|NOT COMPLETED|Randomized Trial||17
10947740|NCT00403546|12118987|FG002|NOT COMPLETED|Randomized Trial||16
10947741|NCT00403585|12118996|FG000|STARTED|Initial Treatment Phase||104
10947742|NCT00403585|12118996|FG000|COMPLETED|Initial Treatment Phase||102
10947743|NCT00403585|12118996|FG000|NOT COMPLETED|Initial Treatment Phase||2
10947744|NCT00403585|12118996|FG000|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
10947745|NCT00403585|12118996|FG000|COMPLETED|Open-Label Phase; Extension Study||74
10947746|NCT00403585|12118996|FG000|NOT COMPLETED|Open-Label Phase; Extension Study||6
10947747|NCT00403754|12119000|FG000|STARTED|Core Treatment Period 1||11
10947748|NCT00403754|12119001|FG001|STARTED|Core Treatment Period 1||10
10947749|NCT00403754|12119002|FG002|STARTED|Core Treatment Period 1||9
10947750|NCT00403754|12119003|FG003|STARTED|Core Treatment Period 1||11
10947751|NCT00403754|12119000|FG000|COMPLETED|Core Treatment Period 1||11
10947752|NCT00403754|12119001|FG001|COMPLETED|Core Treatment Period 1||9
10947753|NCT00403754|12119002|FG002|COMPLETED|Core Treatment Period 1||9
10947754|NCT00403754|12119003|FG003|COMPLETED|Core Treatment Period 1||11
10947755|NCT00403754|12119000|FG000|NOT COMPLETED|Core Treatment Period 1||0
10947756|NCT00403754|12119001|FG001|NOT COMPLETED|Core Treatment Period 1||1
10947757|NCT00403754|12119002|FG002|NOT COMPLETED|Core Treatment Period 1||0
10947758|NCT00403754|12119003|FG003|NOT COMPLETED|Core Treatment Period 1||0
10947759|NCT00403754|12119000|FG000|STARTED|Core Treatment Period 2||11
10947760|NCT00403754|12119001|FG001|STARTED|Core Treatment Period 2||9
10947761|NCT00403754|12119002|FG002|STARTED|Core Treatment Period 2||9
10947762|NCT00403754|12119003|FG003|STARTED|Core Treatment Period 2||11
10947763|NCT00403754|12119000|FG000|COMPLETED|Core Treatment Period 2||11
10947764|NCT00403754|12119001|FG001|COMPLETED|Core Treatment Period 2||9
10947765|NCT00403754|12119002|FG002|COMPLETED|Core Treatment Period 2||8
10947766|NCT00403754|12119003|FG003|COMPLETED|Core Treatment Period 2||11
10947767|NCT00403754|12119000|FG000|NOT COMPLETED|Core Treatment Period 2||0
10947768|NCT00403754|12119001|FG001|NOT COMPLETED|Core Treatment Period 2||0
10947769|NCT00403754|12119002|FG002|NOT COMPLETED|Core Treatment Period 2||1
10947770|NCT00403754|12119003|FG003|NOT COMPLETED|Core Treatment Period 2||0
10947771|NCT00403754|12119000|FG000|STARTED|Core Treatment Period 3||11
10947772|NCT00403754|12119001|FG001|STARTED|Core Treatment Period 3||9
10947773|NCT00403754|12119002|FG002|STARTED|Core Treatment Period 3||8
10947774|NCT00403754|12119003|FG003|STARTED|Core Treatment Period 3||11
10947775|NCT00403754|12119000|FG000|COMPLETED|Core Treatment Period 3||11
10947776|NCT00403754|12119001|FG001|COMPLETED|Core Treatment Period 3||9
10947777|NCT00403754|12119002|FG002|COMPLETED|Core Treatment Period 3||8
10947778|NCT00403754|12119003|FG003|COMPLETED|Core Treatment Period 3||11
10947779|NCT00403754|12119000|FG000|NOT COMPLETED|Core Treatment Period 3||0
10947780|NCT00403754|12119001|FG001|NOT COMPLETED|Core Treatment Period 3||0
10947781|NCT00403754|12119002|FG002|NOT COMPLETED|Core Treatment Period 3||0
10947782|NCT00403754|12119003|FG003|NOT COMPLETED|Core Treatment Period 3||0
10947783|NCT00403754|12119000|FG000|STARTED|Core Treatment Period 4||11
10947784|NCT00403754|12119001|FG001|STARTED|Core Treatment Period 4||9
10947785|NCT00403754|12119002|FG002|STARTED|Core Treatment Period 4||8
10947786|NCT00403754|12119003|FG003|STARTED|Core Treatment Period 4||11
10947787|NCT00403754|12119000|FG000|COMPLETED|Core Treatment Period 4||11
10947788|NCT00403754|12119001|FG001|COMPLETED|Core Treatment Period 4||9
10947789|NCT00403754|12119002|FG002|COMPLETED|Core Treatment Period 4||8
10947790|NCT00403754|12119003|FG003|COMPLETED|Core Treatment Period 4||11
10947791|NCT00403754|12119000|FG000|NOT COMPLETED|Core Treatment Period 4||0
10947792|NCT00403754|12119001|FG001|NOT COMPLETED|Core Treatment Period 4||0
10947793|NCT00403754|12119002|FG002|NOT COMPLETED|Core Treatment Period 4||0
10947794|NCT00403754|12119003|FG003|NOT COMPLETED|Core Treatment Period 4||0
10947795|NCT00403754|12119000|FG000|STARTED|Open Label: Salmeterol||11
10947796|NCT00403754|12119001|FG001|STARTED|Open Label: Salmeterol||9
10947797|NCT00403754|12119002|FG002|STARTED|Open Label: Salmeterol||8
10947798|NCT00403754|12119003|FG003|STARTED|Open Label: Salmeterol||11
10947799|NCT00403754|12119000|FG000|COMPLETED|Open Label: Salmeterol||11
10947800|NCT00403754|12119001|FG001|COMPLETED|Open Label: Salmeterol||9
10947801|NCT00403754|12119002|FG002|COMPLETED|Open Label: Salmeterol||8
10947802|NCT00403754|12119003|FG003|COMPLETED|Open Label: Salmeterol||11
10947803|NCT00403754|12119000|FG000|NOT COMPLETED|Open Label: Salmeterol||0
10947804|NCT00403754|12119001|FG001|NOT COMPLETED|Open Label: Salmeterol||0
10947805|NCT00403754|12119002|FG002|NOT COMPLETED|Open Label: Salmeterol||0
10947806|NCT00403754|12119003|FG003|NOT COMPLETED|Open Label: Salmeterol||0
10947807|NCT00403767|12119017|FG000|STARTED|Overall Study||7111
10947808|NCT00403767|12119018|FG001|STARTED|Overall Study||7125
10947809|NCT00403767|12119017|FG000|COMPLETED|Overall Study||4591
10947810|NCT00403767|12119018|FG001|COMPLETED|Overall Study||4657
10947811|NCT00403767|12119017|FG000|NOT COMPLETED|Overall Study||2520
10947812|NCT00403767|12119018|FG001|NOT COMPLETED|Overall Study||2468
10947813|NCT00403845|12119024|FG000|STARTED|Treatment Period 1||12
10947814|NCT00403845|12119025|FG001|STARTED|Treatment Period 1||13
10947815|NCT00403845|12119026|FG002|STARTED|Treatment Period 1||11
10947816|NCT00403845|12119027|FG003|STARTED|Treatment Period 1||14
10947817|NCT00403845|12119024|FG000|COMPLETED|Treatment Period 1||11
10947818|NCT00403845|12119025|FG001|COMPLETED|Treatment Period 1||13
10947819|NCT00403845|12119026|FG002|COMPLETED|Treatment Period 1||11
10947820|NCT00403845|12119027|FG003|COMPLETED|Treatment Period 1||13
10947821|NCT00403845|12119024|FG000|NOT COMPLETED|Treatment Period 1||1
10947822|NCT00403845|12119025|FG001|NOT COMPLETED|Treatment Period 1||0
10947823|NCT00403845|12119026|FG002|NOT COMPLETED|Treatment Period 1||0
10947824|NCT00403845|12119027|FG003|NOT COMPLETED|Treatment Period 1||1
10947825|NCT00403845|12119024|FG000|STARTED|Treatment Period 2||11
10947826|NCT00403845|12119025|FG001|STARTED|Treatment Period 2||13
10947827|NCT00403845|12119026|FG002|STARTED|Treatment Period 2||11
10947828|NCT00403845|12119027|FG003|STARTED|Treatment Period 2||13
10947829|NCT00403845|12119024|FG000|COMPLETED|Treatment Period 2||10
10947830|NCT00403845|12119025|FG001|COMPLETED|Treatment Period 2||13
10947831|NCT00403845|12119026|FG002|COMPLETED|Treatment Period 2||11
10947832|NCT00403845|12119027|FG003|COMPLETED|Treatment Period 2||13
10947833|NCT00403845|12119024|FG000|NOT COMPLETED|Treatment Period 2||1
10947834|NCT00403845|12119025|FG001|NOT COMPLETED|Treatment Period 2||0
10947835|NCT00403845|12119026|FG002|NOT COMPLETED|Treatment Period 2||0
10947836|NCT00403845|12119027|FG003|NOT COMPLETED|Treatment Period 2||0
10947837|NCT00403845|12119024|FG000|STARTED|Treatment Period 3||10
10947838|NCT00403845|12119025|FG001|STARTED|Treatment Period 3||13
10947839|NCT00403845|12119026|FG002|STARTED|Treatment Period 3||11
10947840|NCT00403845|12119027|FG003|STARTED|Treatment Period 3||13
10947841|NCT00403845|12119024|FG000|COMPLETED|Treatment Period 3||10
10947842|NCT00403845|12119025|FG001|COMPLETED|Treatment Period 3||13
10947843|NCT00403845|12119026|FG002|COMPLETED|Treatment Period 3||11
10947844|NCT00403845|12119027|FG003|COMPLETED|Treatment Period 3||11
10947845|NCT00403845|12119024|FG000|NOT COMPLETED|Treatment Period 3||0
10947846|NCT00403845|12119025|FG001|NOT COMPLETED|Treatment Period 3||0
10947847|NCT00403845|12119026|FG002|NOT COMPLETED|Treatment Period 3||0
10947848|NCT00403845|12119027|FG003|NOT COMPLETED|Treatment Period 3||2
10947849|NCT00403845|12119024|FG000|STARTED|Treatment Period 4||10
10947850|NCT00403845|12119025|FG001|STARTED|Treatment Period 4||13
10947851|NCT00403845|12119026|FG002|STARTED|Treatment Period 4||11
10947852|NCT00403845|12119027|FG003|STARTED|Treatment Period 4||11
10947853|NCT00403845|12119024|FG000|COMPLETED|Treatment Period 4||10
10947854|NCT00403845|12119025|FG001|COMPLETED|Treatment Period 4||13
10947855|NCT00403845|12119026|FG002|COMPLETED|Treatment Period 4||11
10947856|NCT00403845|12119027|FG003|COMPLETED|Treatment Period 4||11
10947857|NCT00403845|12119024|FG000|NOT COMPLETED|Treatment Period 4||0
10947858|NCT00403845|12119025|FG001|NOT COMPLETED|Treatment Period 4||0
10947859|NCT00403845|12119026|FG002|NOT COMPLETED|Treatment Period 4||0
10947860|NCT00403845|12119027|FG003|NOT COMPLETED|Treatment Period 4||0
10947861|NCT00404066|12119037|FG000|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
10947862|NCT00404066|12119037|FG000|COMPLETED|Overall Study||18
10947863|NCT00404066|12119037|FG000|NOT COMPLETED|Overall Study||3
10947864|NCT00404079|12119043|FG000|STARTED|Overall Study||125
10947865|NCT00404079|12119044|FG001|STARTED|Overall Study||125
10947866|NCT00404079|12119043|FG000|COMPLETED|Overall Study||103
10947867|NCT00404079|12119044|FG001|COMPLETED|Overall Study||105
10947868|NCT00404079|12119043|FG000|NOT COMPLETED|Overall Study||22
10947869|NCT00404079|12119044|FG001|NOT COMPLETED|Overall Study||20
10947870|NCT00404092|12119054|FG000|STARTED|Overall Study||9
10947871|NCT00404092|12119055|FG001|STARTED|Overall Study||8
10947872|NCT00404092|12119056|FG002|STARTED|Overall Study||9
10947873|NCT00404092|12119057|FG003|STARTED|Overall Study||20
10947874|NCT00404092|12119054|FG000|COMPLETED|Overall Study||8
10947875|NCT00404092|12119055|FG001|COMPLETED|Overall Study||8
10947876|NCT00404092|12119056|FG002|COMPLETED|Overall Study||8
10947877|NCT00404092|12119057|FG003|COMPLETED|Overall Study||20
10947878|NCT00404092|12119054|FG000|NOT COMPLETED|Overall Study||1
10947879|NCT00404092|12119055|FG001|NOT COMPLETED|Overall Study||0
10947880|NCT00404092|12119056|FG002|NOT COMPLETED|Overall Study||1
10947881|NCT00404092|12119057|FG003|NOT COMPLETED|Overall Study||0
10947882|NCT00404235|12119069|FG000|STARTED|Overall Study||35
10947883|NCT00404235|12119070|FG001|STARTED|Overall Study||41
10947884|NCT00404235|12119069|FG000|COMPLETED|Overall Study||34
10947885|NCT00404235|12119070|FG001|COMPLETED|Overall Study||39
10947886|NCT00404235|12119069|FG000|NOT COMPLETED|Overall Study||1
10947887|NCT00404235|12119070|FG001|NOT COMPLETED|Overall Study||2
10947888|NCT00404248|12119079|FG000|STARTED|Overall Study||3
10947889|NCT00404248|12119080|FG001|STARTED|Overall Study||4
10947890|NCT00404248|12119081|FG002|STARTED|Overall Study||5
10947891|NCT00404248|12119082|FG003|STARTED|Overall Study||2
10947892|NCT00404248|12119083|FG004|STARTED|Overall Study||3
10947893|NCT00404248|12119084|FG005|STARTED|Overall Study||3
10947894|NCT00404248|12119085|FG006|STARTED|Overall Study||6
10947895|NCT00404248|12119086|FG007|STARTED|Overall Study||6
10947896|NCT00404248|12119087|FG008|STARTED|Overall Study||3
10947897|NCT00404248|12119079|FG000|COMPLETED|Overall Study||3
10947898|NCT00404248|12119080|FG001|COMPLETED|Overall Study||3
10947899|NCT00404248|12119081|FG002|COMPLETED|Overall Study||5
10947900|NCT00404248|12119082|FG003|COMPLETED|Overall Study||2
10947901|NCT00404248|12119083|FG004|COMPLETED|Overall Study||3
10947902|NCT00404248|12119084|FG005|COMPLETED|Overall Study||3
10947903|NCT00404248|12119085|FG006|COMPLETED|Overall Study||6
10947904|NCT00404248|12119086|FG007|COMPLETED|Overall Study||6
10947905|NCT00404248|12119087|FG008|COMPLETED|Overall Study||3
10947906|NCT00404248|12119079|FG000|NOT COMPLETED|Overall Study||0
10947907|NCT00404248|12119080|FG001|NOT COMPLETED|Overall Study||1
10947908|NCT00404248|12119081|FG002|NOT COMPLETED|Overall Study||0
10947909|NCT00404248|12119082|FG003|NOT COMPLETED|Overall Study||0
10947910|NCT00404248|12119083|FG004|NOT COMPLETED|Overall Study||0
10947911|NCT00404248|12119084|FG005|NOT COMPLETED|Overall Study||0
10947912|NCT00404248|12119085|FG006|NOT COMPLETED|Overall Study||0
10947913|NCT00404248|12119086|FG007|NOT COMPLETED|Overall Study||0
10947914|NCT00404248|12119087|FG008|NOT COMPLETED|Overall Study||0
10947915|NCT00404352|12119116|FG000|STARTED|Double Blind (up to 24 Month)||171
10947916|NCT00404352|12119117|FG001|STARTED|Double Blind (up to 24 Month)||175
10947917|NCT00404352|12119118|FG002|STARTED|Double Blind (up to 24 Month)||171
10947918|NCT00404352|12119119|FG003|STARTED|Double Blind (up to 24 Month)||0
10947919|NCT00404352|12119120|FG004|STARTED|Double Blind (up to 24 Month)||0
10947920|NCT00404352|12119121|FG005|STARTED|Double Blind (up to 24 Month)||0
10947921|NCT00404352|12119122|FG006|STARTED|Double Blind (up to 24 Month)||0
10947922|NCT00404352|12119123|FG007|STARTED|Double Blind (up to 24 Month)||0
10947923|NCT00404352|12119124|FG008|STARTED|Double Blind (up to 24 Month)||0
10947924|NCT00404352|12119116|FG000|Treated|Double Blind (up to 24 Month)||171
10947925|NCT00404352|12119117|FG001|Treated|Double Blind (up to 24 Month)||173
10947926|NCT00404352|12119118|FG002|Treated|Double Blind (up to 24 Month)||171
10947927|NCT00404352|12119119|FG003|Treated|Double Blind (up to 24 Month)||0
10947928|NCT00404352|12119120|FG004|Treated|Double Blind (up to 24 Month)||0
10947929|NCT00404352|12119121|FG005|Treated|Double Blind (up to 24 Month)||0
10947930|NCT00404352|12119122|FG006|Treated|Double Blind (up to 24 Month)||0
10947931|NCT00404352|12119123|FG007|Treated|Double Blind (up to 24 Month)||0
10947932|NCT00404352|12119124|FG008|Treated|Double Blind (up to 24 Month)||0
10947933|NCT00404352|12119116|FG000|COMPLETED|Double Blind (up to 24 Month)||119
10947934|NCT00404352|12119117|FG001|COMPLETED|Double Blind (up to 24 Month)||128
10947935|NCT00404352|12119118|FG002|COMPLETED|Double Blind (up to 24 Month)||92
10947936|NCT00404352|12119119|FG003|COMPLETED|Double Blind (up to 24 Month)||0
10947937|NCT00404352|12119120|FG004|COMPLETED|Double Blind (up to 24 Month)||0
10947938|NCT00404352|12119121|FG005|COMPLETED|Double Blind (up to 24 Month)||0
10947939|NCT00404352|12119122|FG006|COMPLETED|Double Blind (up to 24 Month)||0
10947940|NCT00404352|12119123|FG007|COMPLETED|Double Blind (up to 24 Month)||0
10947941|NCT00404352|12119124|FG008|COMPLETED|Double Blind (up to 24 Month)||0
10947942|NCT00404352|12119116|FG000|NOT COMPLETED|Double Blind (up to 24 Month)||52
10947943|NCT00404352|12119117|FG001|NOT COMPLETED|Double Blind (up to 24 Month)||47
10947944|NCT00404352|12119118|FG002|NOT COMPLETED|Double Blind (up to 24 Month)||79
10947945|NCT00404352|12119119|FG003|NOT COMPLETED|Double Blind (up to 24 Month)||0
10947946|NCT00404352|12119120|FG004|NOT COMPLETED|Double Blind (up to 24 Month)||0
10947947|NCT00404352|12119121|FG005|NOT COMPLETED|Double Blind (up to 24 Month)||0
10947948|NCT00404352|12119122|FG006|NOT COMPLETED|Double Blind (up to 24 Month)||0
10947949|NCT00404352|12119123|FG007|NOT COMPLETED|Double Blind (up to 24 Month)||0
10947950|NCT00404352|12119124|FG008|NOT COMPLETED|Double Blind (up to 24 Month)||0
10947951|NCT00404352|12119116|FG000|STARTED|Open Label (up to 24 Month)||0
10947952|NCT00404352|12119117|FG001|STARTED|Open Label (up to 24 Month)||0
10947953|NCT00404352|12119118|FG002|STARTED|Open Label (up to 24 Month)||0
10947954|NCT00404352|12119119|FG003|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
10947955|NCT00404352|12119120|FG004|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
10947956|NCT00404352|12119121|FG005|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
10947957|NCT00404352|12119122|FG006|STARTED|Open Label (up to 24 Month)||0
10947958|NCT00404352|12119123|FG007|STARTED|Open Label (up to 24 Month)||0
10947959|NCT00404352|12119124|FG008|STARTED|Open Label (up to 24 Month)||0
10947960|NCT00404352|12119116|FG000|COMPLETED|Open Label (up to 24 Month)||0
10947961|NCT00404352|12119117|FG001|COMPLETED|Open Label (up to 24 Month)||0
10947962|NCT00404352|12119118|FG002|COMPLETED|Open Label (up to 24 Month)||0
10947963|NCT00404352|12119119|FG003|COMPLETED|Open Label (up to 24 Month)||28
10947964|NCT00404352|12119120|FG004|COMPLETED|Open Label (up to 24 Month)||28
10947965|NCT00404352|12119121|FG005|COMPLETED|Open Label (up to 24 Month)||52
10947966|NCT00404352|12119122|FG006|COMPLETED|Open Label (up to 24 Month)||0
10947967|NCT00404352|12119123|FG007|COMPLETED|Open Label (up to 24 Month)||0
10947968|NCT00404352|12119124|FG008|COMPLETED|Open Label (up to 24 Month)||0
10947969|NCT00404352|12119116|FG000|NOT COMPLETED|Open Label (up to 24 Month)||0
10947970|NCT00404352|12119117|FG001|NOT COMPLETED|Open Label (up to 24 Month)||0
10947971|NCT00404352|12119118|FG002|NOT COMPLETED|Open Label (up to 24 Month)||0
10947972|NCT00404352|12119119|FG003|NOT COMPLETED|Open Label (up to 24 Month)||3
10947973|NCT00404352|12119120|FG004|NOT COMPLETED|Open Label (up to 24 Month)||2
10947974|NCT00404352|12119121|FG005|NOT COMPLETED|Open Label (up to 24 Month)||7
10947975|NCT00404352|12119122|FG006|NOT COMPLETED|Open Label (up to 24 Month)||0
10947976|NCT00404352|12119123|FG007|NOT COMPLETED|Open Label (up to 24 Month)||0
10947977|NCT00404352|12119124|FG008|NOT COMPLETED|Open Label (up to 24 Month)||0
10947978|NCT00404352|12119116|FG000|STARTED|Open Label Extension (up to 36 Months)||0
10947979|NCT00404352|12119117|FG001|STARTED|Open Label Extension (up to 36 Months)||0
10947980|NCT00404352|12119118|FG002|STARTED|Open Label Extension (up to 36 Months)||0
10947981|NCT00404352|12119119|FG003|STARTED|Open Label Extension (up to 36 Months)||0
10947982|NCT00404352|12119120|FG004|STARTED|Open Label Extension (up to 36 Months)||0
10947983|NCT00404352|12119121|FG005|STARTED|Open Label Extension (up to 36 Months)||0
10947984|NCT00404352|12119122|FG006|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
10947985|NCT00404352|12119123|FG007|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
10947986|NCT00404352|12119124|FG008|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
10947987|NCT00404352|12119116|FG000|COMPLETED|Open Label Extension (up to 36 Months)||0
10947988|NCT00404352|12119117|FG001|COMPLETED|Open Label Extension (up to 36 Months)||0
10947989|NCT00404352|12119118|FG002|COMPLETED|Open Label Extension (up to 36 Months)||0
10947990|NCT00404352|12119119|FG003|COMPLETED|Open Label Extension (up to 36 Months)||0
10947991|NCT00404352|12119120|FG004|COMPLETED|Open Label Extension (up to 36 Months)||0
10947992|NCT00404352|12119121|FG005|COMPLETED|Open Label Extension (up to 36 Months)||0
10947993|NCT00404352|12119122|FG006|COMPLETED|Open Label Extension (up to 36 Months)||3
10947994|NCT00404352|12119123|FG007|COMPLETED|Open Label Extension (up to 36 Months)||4
10947995|NCT00404352|12119124|FG008|COMPLETED|Open Label Extension (up to 36 Months)||9
10947996|NCT00404352|12119116|FG000|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
10947997|NCT00404352|12119117|FG001|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
10947998|NCT00404352|12119118|FG002|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
10947999|NCT00404352|12119119|FG003|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
10948000|NCT00404352|12119120|FG004|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
10948001|NCT00404352|12119121|FG005|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
10948002|NCT00404352|12119122|FG006|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
10948003|NCT00404352|12119123|FG007|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
10948004|NCT00404352|12119124|FG008|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
10948005|NCT00404495|12119143|FG000|STARTED|Overall Study||66
10948006|NCT00404495|12119144|FG001|STARTED|Overall Study||17
10948007|NCT00404495|12119143|FG000|COMPLETED|Overall Study||22
10948008|NCT00404495|12119144|FG001|COMPLETED|Overall Study||6
10948009|NCT00404495|12119143|FG000|NOT COMPLETED|Overall Study||44
10948010|NCT00404495|12119144|FG001|NOT COMPLETED|Overall Study||11
10948011|NCT00404547|12119152|FG000|STARTED|Overall Study||762
10948012|NCT00404547|12119153|FG001|STARTED|Overall Study||359
10948013|NCT00404547|12119152|FG000|COMPLETED|Overall Study||672
10948014|NCT00404547|12119153|FG001|COMPLETED|Overall Study||334
10948015|NCT00404547|12119152|FG000|NOT COMPLETED|Overall Study||90
10948016|NCT00404547|12119153|FG001|NOT COMPLETED|Overall Study||25
10948017|NCT00404651|12119163|FG000|STARTED|Overall Study||340
10948018|NCT00404651|12119164|FG001|STARTED|Overall Study||343
10948019|NCT00404651|12119165|FG002|STARTED|Overall Study||339
10948020|NCT00404651|12119166|FG003|STARTED|Overall Study||167
10948021|NCT00404651|12119163|FG000|COMPLETED|Overall Study||301
10948022|NCT00404651|12119164|FG001|COMPLETED|Overall Study||315
10948023|NCT00404651|12119165|FG002|COMPLETED|Overall Study||294
10948024|NCT00404651|12119166|FG003|COMPLETED|Overall Study||146
10948025|NCT00404651|12119163|FG000|NOT COMPLETED|Overall Study||39
10948026|NCT00404651|12119164|FG001|NOT COMPLETED|Overall Study||28
10948027|NCT00404651|12119165|FG002|NOT COMPLETED|Overall Study||45
10948028|NCT00404651|12119166|FG003|NOT COMPLETED|Overall Study||21
10948029|NCT00404755|12119176|FG000|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
10948030|NCT00404755|12119176|FG000|COMPLETED|Phase I (Bupropion)||13
10948031|NCT00404755|12119176|FG000|NOT COMPLETED|Phase I (Bupropion)||4
10948032|NCT00404755|12119176|FG000|STARTED|Phase II (Escitalopram)||11
10948033|NCT00404755|12119176|FG000|COMPLETED|Phase II (Escitalopram)||9
10948034|NCT00404755|12119176|FG000|NOT COMPLETED|Phase II (Escitalopram)||2
10948035|NCT00404755|12119176|FG000|STARTED|Phase III (Imipramine)||3
10948036|NCT00404755|12119176|FG000|COMPLETED|Phase III (Imipramine)||3
10948037|NCT00404755|12119176|FG000|NOT COMPLETED|Phase III (Imipramine)||0
10948038|NCT00404768|12119188|FG000|STARTED|Part A and B||20
10948039|NCT00404768|12119189|FG001|STARTED|Part A and B||9
10948040|NCT00404768|12119190|FG002|STARTED|Part A and B||0
10948041|NCT00404768|12119191|FG003|STARTED|Part A and B||0
10948042|NCT00404768|12119188|FG000|COMPLETED|Part A and B||19
10948043|NCT00404768|12119189|FG001|COMPLETED|Part A and B||8
10948044|NCT00404768|12119190|FG002|COMPLETED|Part A and B||0
10948045|NCT00404768|12119191|FG003|COMPLETED|Part A and B||0
10948046|NCT00404768|12119188|FG000|NOT COMPLETED|Part A and B||1
10948047|NCT00404768|12119189|FG001|NOT COMPLETED|Part A and B||1
10948048|NCT00404768|12119190|FG002|NOT COMPLETED|Part A and B||0
10948049|NCT00404768|12119191|FG003|NOT COMPLETED|Part A and B||0
10948050|NCT00404768|12119188|FG000|STARTED|Part C||0
10948051|NCT00404768|12119189|FG001|STARTED|Part C||0
10948052|NCT00404768|12119190|FG002|STARTED|Part C||30
10948053|NCT00404768|12119191|FG003|STARTED|Part C||34
10948054|NCT00404768|12119188|FG000|COMPLETED|Part C||0
10948055|NCT00404768|12119189|FG001|COMPLETED|Part C||0
10948056|NCT00404768|12119190|FG002|COMPLETED|Part C||22
10948057|NCT00404768|12119191|FG003|COMPLETED|Part C||20
10948058|NCT00404768|12119188|FG000|NOT COMPLETED|Part C||0
10948059|NCT00404768|12119189|FG001|NOT COMPLETED|Part C||0
10948060|NCT00404768|12119190|FG002|NOT COMPLETED|Part C||8
10948061|NCT00404768|12119191|FG003|NOT COMPLETED|Part C||14
10948062|NCT00404820|12119208|FG000|STARTED|Overall Study||408
10948063|NCT00404820|12119209|FG001|STARTED|Overall Study||196
10948064|NCT00404820|12119208|FG000|Started Treatment|Overall Study||408
10948065|NCT00404820|12119209|FG001|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
10948066|NCT00404820|12119208|FG000|COMPLETED|Overall Study||389
10948067|NCT00404820|12119209|FG001|COMPLETED|Overall Study||172
10948068|NCT00404820|12119208|FG000|NOT COMPLETED|Overall Study||19
10948069|NCT00404820|12119209|FG001|NOT COMPLETED|Overall Study||24
10948070|NCT00404924|12119217|FG000|STARTED|Overall Study|randomised patients|617
10948071|NCT00404924|12119218|FG001|STARTED|Overall Study|randomised patients|307
10948072|NCT00404924|12119217|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
10948073|NCT00404924|12119218|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
10948074|NCT00404924|12119217|FG000|NOT COMPLETED|Overall Study||603
10948075|NCT00404924|12119218|FG001|NOT COMPLETED|Overall Study||306
10948076|NCT00405067|12119227|FG000|STARTED|Overall Study||28
10948077|NCT00405067|12119228|FG001|STARTED|Overall Study||28
10948078|NCT00405067|12119229|FG002|STARTED|Overall Study||29
10948079|NCT00405067|12119227|FG000|COMPLETED|Overall Study||24
10948080|NCT00405067|12119228|FG001|COMPLETED|Overall Study||19
10948081|NCT00405067|12119229|FG002|COMPLETED|Overall Study||24
10948082|NCT00405067|12119227|FG000|NOT COMPLETED|Overall Study||4
10948083|NCT00405067|12119228|FG001|NOT COMPLETED|Overall Study||9
10948084|NCT00405067|12119229|FG002|NOT COMPLETED|Overall Study||5
10948085|NCT00405275|12119239|FG000|STARTED|Overall Study||178
10948086|NCT00405275|12119240|FG001|STARTED|Overall Study||175
10948087|NCT00405275|12119239|FG000|24 Weeks (Total)|Overall Study||163
10948088|NCT00405275|12119240|FG001|24 Weeks (Total)|Overall Study||165
10948089|NCT00405275|12119239|FG000|24 Week (no Switch)|Overall Study||119
10948090|NCT00405275|12119240|FG001|24 Week (no Switch)|Overall Study||121
10948091|NCT00405275|12119239|FG000|24 Week (Switch)|Overall Study||44
10948092|NCT00405275|12119240|FG001|24 Week (Switch)|Overall Study||44
10948093|NCT00405275|12119239|FG000|COMPLETED|Overall Study||155
10948094|NCT00405275|12119240|FG001|COMPLETED|Overall Study||156
10948095|NCT00405275|12119239|FG000|NOT COMPLETED|Overall Study||23
10948096|NCT00405275|12119240|FG001|NOT COMPLETED|Overall Study||19
10948097|NCT00405288|12119248|FG000|STARTED|Overall Study||204
10948098|NCT00405288|12119249|FG001|STARTED|Overall Study||204
10948099|NCT00405288|12119248|FG000|COMPLETED|Overall Study||204
10948100|NCT00405288|12119249|FG001|COMPLETED|Overall Study||204
10948101|NCT00405288|12119248|FG000|NOT COMPLETED|Overall Study||0
10948102|NCT00405288|12119249|FG001|NOT COMPLETED|Overall Study||0
10948103|NCT00405353|12119255|FG000|STARTED|Overall Study||10
10948104|NCT00405353|12119255|FG000|COMPLETED|Overall Study||10
10948105|NCT00405353|12119255|FG000|NOT COMPLETED|Overall Study||0
10948106|NCT00405392|12119261|FG000|STARTED|Overall Study||183
10948107|NCT00405392|12119262|FG001|STARTED|Overall Study||182
10948108|NCT00405392|12119261|FG000|COMPLETED|Overall Study||153
10948109|NCT00405392|12119262|FG001|COMPLETED|Overall Study||155
10948110|NCT00405392|12119261|FG000|NOT COMPLETED|Overall Study||30
10948111|NCT00405392|12119262|FG001|NOT COMPLETED|Overall Study||27
10948112|NCT00405509|12119270|FG000|STARTED|Overall Study||11
10948113|NCT00405509|12119271|FG001|STARTED|Overall Study||22
10948114|NCT00405509|12119270|FG000|COMPLETED|Overall Study||11
10948115|NCT00405509|12119271|FG001|COMPLETED|Overall Study||22
10948116|NCT00405509|12119270|FG000|NOT COMPLETED|Overall Study||0
10948117|NCT00405509|12119271|FG001|NOT COMPLETED|Overall Study||0
10948118|NCT00405522|12119279|FG000|STARTED|Overall Study||17
10948119|NCT00405522|12119280|FG001|STARTED|Overall Study||17
10948120|NCT00405522|12119279|FG000|COMPLETED|Overall Study||17
10948121|NCT00405522|12119280|FG001|COMPLETED|Overall Study||17
10948122|NCT00405522|12119279|FG000|NOT COMPLETED|Overall Study||0
10948123|NCT00405522|12119280|FG001|NOT COMPLETED|Overall Study||0
10948124|NCT00405548|12119288|FG000|STARTED|Overall Study||28
10948125|NCT00405548|12119289|FG001|STARTED|Overall Study||13
10948126|NCT00405548|12119288|FG000|COMPLETED|Overall Study||24
10948127|NCT00405548|12119289|FG001|COMPLETED|Overall Study||12
10948128|NCT00405548|12119288|FG000|NOT COMPLETED|Overall Study||4
10948129|NCT00405548|12119289|FG001|NOT COMPLETED|Overall Study||1
10948130|NCT00405587|12119299|FG000|STARTED|Overall Study||26
10948131|NCT00405587|12119300|FG001|STARTED|Overall Study||30
10948132|NCT00405587|12119301|FG002|STARTED|Overall Study||32
10948133|NCT00405587|12119302|FG003|STARTED|Overall Study||21
10948134|NCT00405587|12119299|FG000|COMPLETED|Overall Study||0
10948135|NCT00405587|12119300|FG001|COMPLETED|Overall Study||2
10948136|NCT00405587|12119301|FG002|COMPLETED|Overall Study||10
10948137|NCT00405587|12119302|FG003|COMPLETED|Overall Study||1
10948138|NCT00405587|12119299|FG000|NOT COMPLETED|Overall Study||26
10948139|NCT00405587|12119300|FG001|NOT COMPLETED|Overall Study||28
10948140|NCT00405587|12119301|FG002|NOT COMPLETED|Overall Study||22
10948141|NCT00405587|12119302|FG003|NOT COMPLETED|Overall Study||20
10948142|NCT00405639|12119340|FG000|STARTED|Overall Study||25
10948143|NCT00405639|12119341|FG001|STARTED|Overall Study||12
10948144|NCT00405639|12119340|FG000|COMPLETED|Overall Study||22
10948145|NCT00405639|12119341|FG001|COMPLETED|Overall Study||12
10948146|NCT00405639|12119340|FG000|NOT COMPLETED|Overall Study||3
10948147|NCT00405639|12119341|FG001|NOT COMPLETED|Overall Study||0
10948148|NCT00405652|12119347|FG000|STARTED|Overall Study||34
10948149|NCT00405652|12119347|FG000|COMPLETED|Overall Study||30
10948150|NCT00405652|12119347|FG000|NOT COMPLETED|Overall Study||4
10948151|NCT00405704|12119353|FG000|STARTED|Overall Study||302
10948152|NCT00405704|12119354|FG001|STARTED|Overall Study||305
10948153|NCT00405704|12119353|FG000|Completed Outcome Renal Scan|Overall Study||227
10948154|NCT00405704|12119354|FG001|Completed Outcome Renal Scan|Overall Study||235
10948155|NCT00405704|12119353|FG000|Completed Assessments for New Scarring|Overall Study||220
10948156|NCT00405704|12119354|FG001|Completed Assessments for New Scarring|Overall Study||227
10948157|NCT00405704|12119353|FG000|Outcome Stool Assessed|Overall Study||203
10948158|NCT00405704|12119354|FG001|Outcome Stool Assessed|Overall Study||210
10948159|NCT00405704|12119353|FG000|Recurrent UTI With E. Coli|Overall Study||30
10948160|NCT00405704|12119354|FG001|Recurrent UTI With E. Coli|Overall Study||57
10948161|NCT00405704|12119353|FG000|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
10948162|NCT00405704|12119354|FG001|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
10948163|NCT00405704|12119353|FG000|COMPLETED|Overall Study||261
10948164|NCT00405704|12119354|FG001|COMPLETED|Overall Study||259
10948165|NCT00405704|12119353|FG000|NOT COMPLETED|Overall Study||41
10948166|NCT00405704|12119354|FG001|NOT COMPLETED|Overall Study||46
10948167|NCT00405756|12119364|FG000|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
10948168|NCT00405756|12119365|FG001|STARTED|Double-blind Treatment||153
10948169|NCT00405756|12119366|FG002|STARTED|Double-blind Treatment||154
10948170|NCT00405756|12119364|FG000|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
10948171|NCT00405756|12119365|FG001|Safety Population|Double-blind Treatment||152
10948172|NCT00405756|12119366|FG002|Safety Population|Double-blind Treatment||153
10948173|NCT00405756|12119364|FG000|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
10948174|NCT00405756|12119365|FG001|COMPLETED|Double-blind Treatment||0
10948175|NCT00405756|12119366|FG002|COMPLETED|Double-blind Treatment||0
10948176|NCT00405756|12119364|FG000|NOT COMPLETED|Double-blind Treatment||152
10948177|NCT00405756|12119365|FG001|NOT COMPLETED|Double-blind Treatment||153
10948178|NCT00405756|12119366|FG002|NOT COMPLETED|Double-blind Treatment||154
10948179|NCT00405756|12119364|FG000|STARTED|Open-label Extension||19
10948180|NCT00405756|12119365|FG001|STARTED|Open-label Extension||47
10948181|NCT00405756|12119366|FG002|STARTED|Open-label Extension||72
10948182|NCT00405756|12119364|FG000|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
10948183|NCT00405756|12119365|FG001|COMPLETED|Open-label Extension||0
10948184|NCT00405756|12119366|FG002|COMPLETED|Open-label Extension||0
10948185|NCT00405756|12119364|FG000|NOT COMPLETED|Open-label Extension||19
10948186|NCT00405756|12119365|FG001|NOT COMPLETED|Open-label Extension||47
10948187|NCT00405756|12119366|FG002|NOT COMPLETED|Open-label Extension||72
10948188|NCT00405756|12119364|FG000|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
10948189|NCT00405756|12119365|FG001|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
10948190|NCT00405756|12119366|FG002|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
10948191|NCT00405756|12119364|FG000|COMPLETED|Follow-up||0
10948192|NCT00405756|12119365|FG001|COMPLETED|Follow-up||0
10948193|NCT00405756|12119366|FG002|COMPLETED|Follow-up||0
10948194|NCT00405756|12119364|FG000|NOT COMPLETED|Follow-up||75
10948195|NCT00405756|12119365|FG001|NOT COMPLETED|Follow-up||90
10948196|NCT00405756|12119366|FG002|NOT COMPLETED|Follow-up||88
10948197|NCT00405821|12119376|FG000|STARTED|Overall Study||220
10948198|NCT00405821|12119377|FG001|STARTED|Overall Study||220
10948199|NCT00405821|12119376|FG000|COMPLETED|Overall Study||198
10948200|NCT00405821|12119377|FG001|COMPLETED|Overall Study||198
10948201|NCT00405821|12119376|FG000|NOT COMPLETED|Overall Study||22
10948202|NCT00405821|12119377|FG001|NOT COMPLETED|Overall Study||22
10948203|NCT00405912|12119386|FG000|STARTED|Overall Study||39
10948204|NCT00405912|12119387|FG001|STARTED|Overall Study||40
10948205|NCT00405912|12119388|FG002|STARTED|Overall Study||39
10948206|NCT00405912|12119386|FG000|COMPLETED|Overall Study||23
10948207|NCT00405912|12119387|FG001|COMPLETED|Overall Study||21
10948208|NCT00405912|12119388|FG002|COMPLETED|Overall Study||23
10948209|NCT00405912|12119386|FG000|NOT COMPLETED|Overall Study||16
10948210|NCT00405912|12119387|FG001|NOT COMPLETED|Overall Study||19
10948211|NCT00405912|12119388|FG002|NOT COMPLETED|Overall Study||16
10948212|NCT00405938|12119398|FG000|STARTED|Overall Study||38
10948213|NCT00405938|12119399|FG001|STARTED|Overall Study||41
10948214|NCT00405938|12119398|FG000|COMPLETED|Overall Study||38
10948215|NCT00405938|12119399|FG001|COMPLETED|Overall Study||41
10948216|NCT00405938|12119398|FG000|NOT COMPLETED|Overall Study||0
10948217|NCT00405938|12119399|FG001|NOT COMPLETED|Overall Study||0
10948218|NCT00406029|12119410|FG000|STARTED|Overall Study||49
10948219|NCT00406029|12119411|FG001|STARTED|Overall Study||49
10948220|NCT00406029|12119412|FG002|STARTED|Overall Study||49
10948221|NCT00406029|12119413|FG003|STARTED|Overall Study||57
10948222|NCT00406029|12119414|FG004|STARTED|Overall Study||49
10948223|NCT00406029|12119410|FG000|Treated|Overall Study||49
10948224|NCT00406029|12119411|FG001|Treated|Overall Study||49
10948225|NCT00406029|12119412|FG002|Treated|Overall Study||47
10948226|NCT00406029|12119413|FG003|Treated|Overall Study||54
10948227|NCT00406029|12119414|FG004|Treated|Overall Study||47
10948228|NCT00406029|12119410|FG000|COMPLETED|Overall Study||33
10948229|NCT00406029|12119411|FG001|COMPLETED|Overall Study||41
10948230|NCT00406029|12119412|FG002|COMPLETED|Overall Study||39
10948231|NCT00406029|12119413|FG003|COMPLETED|Overall Study||40
10948232|NCT00406029|12119414|FG004|COMPLETED|Overall Study||41
10948233|NCT00406029|12119410|FG000|NOT COMPLETED|Overall Study||16
10948234|NCT00406029|12119411|FG001|NOT COMPLETED|Overall Study||8
10948235|NCT00406029|12119412|FG002|NOT COMPLETED|Overall Study||10
10948236|NCT00406029|12119413|FG003|NOT COMPLETED|Overall Study||17
10948237|NCT00406029|12119414|FG004|NOT COMPLETED|Overall Study||8
10948238|NCT00406107|12119428|FG000|STARTED|Overall Study||15
10948239|NCT00406107|12119429|FG001|STARTED|Overall Study||5
10948240|NCT00406107|12119428|FG000|COMPLETED|Overall Study||14
10948241|NCT00406107|12119429|FG001|COMPLETED|Overall Study||4
10948242|NCT00406107|12119428|FG000|NOT COMPLETED|Overall Study||1
10948243|NCT00406107|12119429|FG001|NOT COMPLETED|Overall Study||1
10948244|NCT00406133|12119440|FG000|STARTED|Phase 1 (First 26 Week Period)||165
10948245|NCT00406133|12119441|FG001|STARTED|Phase 1 (First 26 Week Period)||157
10948246|NCT00406133|12119442|FG002|STARTED|Phase 1 (First 26 Week Period)||67
10948247|NCT00406133|12119443|FG003|STARTED|Phase 1 (First 26 Week Period)||62
10948248|NCT00406133|12119440|FG000|COMPLETED|Phase 1 (First 26 Week Period)||162
10948249|NCT00406133|12119441|FG001|COMPLETED|Phase 1 (First 26 Week Period)||155
10948250|NCT00406133|12119442|FG002|COMPLETED|Phase 1 (First 26 Week Period)||67
10948251|NCT00406133|12119443|FG003|COMPLETED|Phase 1 (First 26 Week Period)||60
10948252|NCT00406133|12119440|FG000|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
10948253|NCT00406133|12119441|FG001|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
10948254|NCT00406133|12119442|FG002|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
10948255|NCT00406133|12119443|FG003|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
10948256|NCT00406133|12119440|FG000|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
10948257|NCT00406133|12119441|FG001|STARTED|Phase 2 (Second 26 Week Period)||155
10948258|NCT00406133|12119442|FG002|STARTED|Phase 2 (Second 26 Week Period)||67
10948259|NCT00406133|12119443|FG003|STARTED|Phase 2 (Second 26 Week Period)||60
10948260|NCT00406133|12119440|FG000|COMPLETED|Phase 2 (Second 26 Week Period)||157
10948261|NCT00406133|12119441|FG001|COMPLETED|Phase 2 (Second 26 Week Period)||152
10948262|NCT00406133|12119442|FG002|COMPLETED|Phase 2 (Second 26 Week Period)||67
10948263|NCT00406133|12119443|FG003|COMPLETED|Phase 2 (Second 26 Week Period)||60
10948264|NCT00406133|12119440|FG000|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
10948265|NCT00406133|12119441|FG001|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
10948266|NCT00406133|12119442|FG002|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
10948267|NCT00406133|12119443|FG003|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
10948268|NCT00406276|12119458|FG000|STARTED|Overall Study||28
10948269|NCT00406276|12119458|FG000|COMPLETED|Overall Study||24
10948270|NCT00406276|12119458|FG000|NOT COMPLETED|Overall Study||4
10948271|NCT00406315|12119463|FG000|STARTED|Overall Study|Started = Treated|241
10948272|NCT00406315|12119463|FG000|COMPLETED|Overall Study||100
10948273|NCT00406315|12119463|FG000|NOT COMPLETED|Overall Study||141
10948274|NCT00406354|12119470|FG000|STARTED|All Randomized Patients||60
10948275|NCT00406354|12119471|FG001|STARTED|All Randomized Patients||61
10948276|NCT00406354|12119472|FG002|STARTED|All Randomized Patients||60
10948277|NCT00406354|12119470|FG000|COMPLETED|All Randomized Patients||60
10948278|NCT00406354|12119471|FG001|COMPLETED|All Randomized Patients||61
10948279|NCT00406354|12119472|FG002|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
10948280|NCT00406354|12119470|FG000|NOT COMPLETED|All Randomized Patients||0
10948281|NCT00406354|12119471|FG001|NOT COMPLETED|All Randomized Patients||0
10948282|NCT00406354|12119472|FG002|NOT COMPLETED|All Randomized Patients||1
10948283|NCT00406354|12119470|FG000|STARTED|All Randomized and Treated Patients||60
10948284|NCT00406354|12119471|FG001|STARTED|All Randomized and Treated Patients||61
10948285|NCT00406354|12119472|FG002|STARTED|All Randomized and Treated Patients||59
10948286|NCT00406354|12119470|FG000|COMPLETED|All Randomized and Treated Patients||44
10948287|NCT00406354|12119471|FG001|COMPLETED|All Randomized and Treated Patients||48
10948288|NCT00406354|12119472|FG002|COMPLETED|All Randomized and Treated Patients||37
10948289|NCT00406354|12119470|FG000|NOT COMPLETED|All Randomized and Treated Patients||16
10948290|NCT00406354|12119471|FG001|NOT COMPLETED|All Randomized and Treated Patients||13
10948291|NCT00406354|12119472|FG002|NOT COMPLETED|All Randomized and Treated Patients||22
10948292|NCT00406367|12119482|FG000|STARTED|Main Period - 6 to 20 Weeks||75
10948293|NCT00406367|12119483|FG001|STARTED|Main Period - 6 to 20 Weeks||34
10948294|NCT00406367|12119482|FG000|COMPLETED|Main Period - 6 to 20 Weeks||70
10948295|NCT00406367|12119483|FG001|COMPLETED|Main Period - 6 to 20 Weeks||32
10948296|NCT00406367|12119482|FG000|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
10948297|NCT00406367|12119483|FG001|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
10948298|NCT00406367|12119482|FG000|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
10948299|NCT00406367|12119483|FG001|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
10948300|NCT00406367|12119482|FG000|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
10948301|NCT00406367|12119483|FG001|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
10948302|NCT00406367|12119482|FG000|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
10948303|NCT00406367|12119483|FG001|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
10948304|NCT00406393|12119491|FG000|STARTED|Overall Study||151
10948305|NCT00406393|12119492|FG001|STARTED|Overall Study||153
10948306|NCT00406393|12119491|FG000|COMPLETED|Overall Study||149
10948307|NCT00406393|12119492|FG001|COMPLETED|Overall Study||152
10948308|NCT00406393|12119491|FG000|NOT COMPLETED|Overall Study||2
10948309|NCT00406393|12119492|FG001|NOT COMPLETED|Overall Study||1
10948310|NCT00406419|12119501|FG000|STARTED|Overall Study||324
10948311|NCT00406419|12119502|FG001|STARTED|Overall Study||344
10948312|NCT00406419|12119503|FG002|STARTED|Overall Study||347
10948313|NCT00406419|12119501|FG000|COMPLETED|Overall Study||0
10948314|NCT00406419|12119502|FG001|COMPLETED|Overall Study||0
10948315|NCT00406419|12119503|FG002|COMPLETED|Overall Study||0
10948316|NCT00406419|12119501|FG000|NOT COMPLETED|Overall Study||324
10948317|NCT00406419|12119502|FG001|NOT COMPLETED|Overall Study||344
10948318|NCT00406419|12119503|FG002|NOT COMPLETED|Overall Study||347
10948319|NCT00406640|12119513|FG000|STARTED|Acute Phase||296
10948320|NCT00406640|12119514|FG001|STARTED|Acute Phase||299
10948321|NCT00406640|12119513|FG000|COMPLETED|Acute Phase||245
10948322|NCT00406640|12119514|FG001|COMPLETED|Acute Phase||256
10948323|NCT00406640|12119513|FG000|NOT COMPLETED|Acute Phase||51
10948324|NCT00406640|12119514|FG001|NOT COMPLETED|Acute Phase||43
10948325|NCT00406640|12119513|FG000|STARTED|DB Continuation Phase for Responders||172
10948326|NCT00406640|12119514|FG001|STARTED|DB Continuation Phase for Responders||188
10948327|NCT00406640|12119513|FG000|COMPLETED|DB Continuation Phase for Responders||139
10948328|NCT00406640|12119514|FG001|COMPLETED|DB Continuation Phase for Responders||151
10948329|NCT00406640|12119513|FG000|NOT COMPLETED|DB Continuation Phase for Responders||33
10948330|NCT00406640|12119514|FG001|NOT COMPLETED|DB Continuation Phase for Responders||37
10948331|NCT00406640|12119513|FG000|STARTED|OL Extension Phase for Non-Responders||69
10948332|NCT00406640|12119514|FG001|STARTED|OL Extension Phase for Non-Responders||60
10948333|NCT00406640|12119513|FG000|COMPLETED|OL Extension Phase for Non-Responders||47
10948334|NCT00406640|12119514|FG001|COMPLETED|OL Extension Phase for Non-Responders||36
10948335|NCT00406640|12119513|FG000|NOT COMPLETED|OL Extension Phase for Non-Responders||22
10948336|NCT00406640|12119514|FG001|NOT COMPLETED|OL Extension Phase for Non-Responders||24
10948337|NCT00406653|12119530|FG000|STARTED|Induction Period||65
10948338|NCT00406653|12119531|FG001|STARTED|Induction Period||128
10948339|NCT00406653|12119532|FG002|STARTED|Induction Period||130
10948340|NCT00406653|12119533|FG003|STARTED|Induction Period||128
10948341|NCT00406653|12119534|FG004|STARTED|Induction Period||0
10948342|NCT00406653|12119535|FG005|STARTED|Induction Period||0
10948343|NCT00406653|12119536|FG006|STARTED|Induction Period||0
10948344|NCT00406653|12119530|FG000|COMPLETED|Induction Period||50
10948345|NCT00406653|12119531|FG001|COMPLETED|Induction Period||94
10948346|NCT00406653|12119532|FG002|COMPLETED|Induction Period||112
10948347|NCT00406653|12119533|FG003|COMPLETED|Induction Period||102
10948348|NCT00406653|12119534|FG004|COMPLETED|Induction Period||0
10948349|NCT00406653|12119535|FG005|COMPLETED|Induction Period||0
10948350|NCT00406653|12119536|FG006|COMPLETED|Induction Period||0
10948351|NCT00406653|12119530|FG000|NOT COMPLETED|Induction Period||15
10948352|NCT00406653|12119531|FG001|NOT COMPLETED|Induction Period||34
10948353|NCT00406653|12119532|FG002|NOT COMPLETED|Induction Period||18
10948354|NCT00406653|12119533|FG003|NOT COMPLETED|Induction Period||26
10948355|NCT00406653|12119534|FG004|NOT COMPLETED|Induction Period||0
10948356|NCT00406653|12119535|FG005|NOT COMPLETED|Induction Period||0
10948357|NCT00406653|12119536|FG006|NOT COMPLETED|Induction Period||0
10948358|NCT00406653|12119530|FG000|STARTED|Maintenance Period||0
10948359|NCT00406653|12119531|FG001|STARTED|Maintenance Period||0
10948360|NCT00406653|12119532|FG002|STARTED|Maintenance Period||0
10948361|NCT00406653|12119533|FG003|STARTED|Maintenance Period||0
10948362|NCT00406653|12119534|FG004|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
10948363|NCT00406653|12119535|FG005|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
10948364|NCT00406653|12119536|FG006|STARTED|Maintenance Period||0
10948365|NCT00406653|12119530|FG000|COMPLETED|Maintenance Period||0
10948366|NCT00406653|12119531|FG001|COMPLETED|Maintenance Period||0
10948367|NCT00406653|12119532|FG002|COMPLETED|Maintenance Period||0
10948368|NCT00406653|12119533|FG003|COMPLETED|Maintenance Period||0
10948369|NCT00406653|12119534|FG004|COMPLETED|Maintenance Period||14
10948370|NCT00406653|12119535|FG005|COMPLETED|Maintenance Period||10
10948371|NCT00406653|12119536|FG006|COMPLETED|Maintenance Period||0
10948372|NCT00406653|12119530|FG000|NOT COMPLETED|Maintenance Period||0
10948373|NCT00406653|12119531|FG001|NOT COMPLETED|Maintenance Period||0
10948374|NCT00406653|12119532|FG002|NOT COMPLETED|Maintenance Period||0
10948375|NCT00406653|12119533|FG003|NOT COMPLETED|Maintenance Period||0
10948376|NCT00406653|12119534|FG004|NOT COMPLETED|Maintenance Period||30
10948377|NCT00406653|12119535|FG005|NOT COMPLETED|Maintenance Period||36
10948378|NCT00406653|12119536|FG006|NOT COMPLETED|Maintenance Period||0
10948379|NCT00406653|12119530|FG000|STARTED|Open-Label Period||0
10948380|NCT00406653|12119531|FG001|STARTED|Open-Label Period||0
10948381|NCT00406653|12119532|FG002|STARTED|Open-Label Period||0
10948382|NCT00406653|12119533|FG003|STARTED|Open-Label Period||0
10948383|NCT00406653|12119534|FG004|STARTED|Open-Label Period||0
10948384|NCT00406653|12119535|FG005|STARTED|Open-Label Period||0
10948385|NCT00406653|12119536|FG006|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
10948386|NCT00406653|12119530|FG000|COMPLETED|Open-Label Period||0
10948387|NCT00406653|12119531|FG001|COMPLETED|Open-Label Period||0
10948388|NCT00406653|12119532|FG002|COMPLETED|Open-Label Period||0
10948389|NCT00406653|12119533|FG003|COMPLETED|Open-Label Period||0
10948390|NCT00406653|12119534|FG004|COMPLETED|Open-Label Period||0
10948391|NCT00406653|12119535|FG005|COMPLETED|Open-Label Period||0
10948392|NCT00406653|12119536|FG006|COMPLETED|Open-Label Period||0
10948393|NCT00406653|12119530|FG000|NOT COMPLETED|Open-Label Period||0
10948394|NCT00406653|12119531|FG001|NOT COMPLETED|Open-Label Period||0
10948395|NCT00406653|12119532|FG002|NOT COMPLETED|Open-Label Period||0
10948396|NCT00406653|12119533|FG003|NOT COMPLETED|Open-Label Period||0
10948397|NCT00406653|12119534|FG004|NOT COMPLETED|Open-Label Period||0
10948398|NCT00406653|12119535|FG005|NOT COMPLETED|Open-Label Period||0
10948399|NCT00406653|12119536|FG006|NOT COMPLETED|Open-Label Period||324
10948400|NCT00406692|12119556|FG000|STARTED|Overall Study||16
10948401|NCT00406692|12119556|FG000|COMPLETED|Overall Study||9
10948402|NCT00406692|12119556|FG000|NOT COMPLETED|Overall Study||7
10948403|NCT00406718|12119563|FG000|STARTED|Overall Study||47
10948404|NCT00406718|12119564|FG001|STARTED|Overall Study||48
10948405|NCT00406718|12119565|FG002|STARTED|Overall Study||47
10948406|NCT00406718|12119563|FG000|COMPLETED|Overall Study||43
10948407|NCT00406718|12119564|FG001|COMPLETED|Overall Study||34
10948408|NCT00406718|12119565|FG002|COMPLETED|Overall Study||39
10948409|NCT00406718|12119563|FG000|NOT COMPLETED|Overall Study||4
10948410|NCT00406718|12119564|FG001|NOT COMPLETED|Overall Study||14
10948411|NCT00406718|12119565|FG002|NOT COMPLETED|Overall Study||8
10948412|NCT00406848|12119577|FG000|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
10948413|NCT00406848|12119578|FG001|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
10948414|NCT00406848|12119577|FG000|COMPLETED|Overall Study||156
10948415|NCT00406848|12119578|FG001|COMPLETED|Overall Study||67
10948416|NCT00406848|12119577|FG000|NOT COMPLETED|Overall Study||93
10948417|NCT00406848|12119578|FG001|NOT COMPLETED|Overall Study||54
10948418|NCT00407030|12119590|FG000|STARTED|Main Period - 8 to 20 Weeks||81
10948419|NCT00407030|12119591|FG001|STARTED|Main Period - 8 to 20 Weeks||78
10948420|NCT00407030|12119592|FG002|STARTED|Main Period - 8 to 20 Weeks||74
10948421|NCT00407030|12119590|FG000|COMPLETED|Main Period - 8 to 20 Weeks||76
10948422|NCT00407030|12119591|FG001|COMPLETED|Main Period - 8 to 20 Weeks||75
10948423|NCT00407030|12119592|FG002|COMPLETED|Main Period - 8 to 20 Weeks||68
10948424|NCT00407030|12119590|FG000|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
10948425|NCT00407030|12119591|FG001|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
10948426|NCT00407030|12119592|FG002|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
10948427|NCT00407030|12119590|FG000|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
10948428|NCT00407030|12119591|FG001|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
10948429|NCT00407030|12119592|FG002|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
10948430|NCT00407030|12119590|FG000|COMPLETED|Extension Period - up to 68 Weeks||84
10948431|NCT00407030|12119591|FG001|COMPLETED|Extension Period - up to 68 Weeks||74
10948432|NCT00407030|12119592|FG002|COMPLETED|Extension Period - up to 68 Weeks||0
10948433|NCT00407030|12119590|FG000|NOT COMPLETED|Extension Period - up to 68 Weeks||27
10948434|NCT00407030|12119591|FG001|NOT COMPLETED|Extension Period - up to 68 Weeks||29
10948435|NCT00407030|12119592|FG002|NOT COMPLETED|Extension Period - up to 68 Weeks||0
10948436|NCT00407355|12119604|FG000|STARTED|Overall Study||20
10948437|NCT00407355|12119605|FG001|STARTED|Overall Study||20
10948438|NCT00407355|12119604|FG000|COMPLETED|Overall Study||10
10948439|NCT00407355|12119605|FG001|COMPLETED|Overall Study||9
10948440|NCT00407355|12119604|FG000|NOT COMPLETED|Overall Study||10
10948441|NCT00407355|12119605|FG001|NOT COMPLETED|Overall Study||11
10948442|NCT00407381|12119614|FG000|STARTED|Overall Study||42
10948443|NCT00407381|12119615|FG001|STARTED|Overall Study||42
10948444|NCT00407381|12119616|FG002|STARTED|Overall Study||42
10948445|NCT00407381|12119614|FG000|COMPLETED|Overall Study||39
10948446|NCT00407381|12119615|FG001|COMPLETED|Overall Study||38
10948447|NCT00407381|12119616|FG002|COMPLETED|Overall Study||40
10948448|NCT00407381|12119614|FG000|NOT COMPLETED|Overall Study||3
10948449|NCT00407381|12119615|FG001|NOT COMPLETED|Overall Study||4
10948450|NCT00407381|12119616|FG002|NOT COMPLETED|Overall Study||2
10948451|NCT00407420|12119626|FG000|STARTED|Overall Study||54
10948452|NCT00407420|12119627|FG001|STARTED|Overall Study||52
10948453|NCT00407420|12119626|FG000|COMPLETED|Overall Study||45
10948454|NCT00407420|12119627|FG001|COMPLETED|Overall Study||46
10948455|NCT00407420|12119626|FG000|NOT COMPLETED|Overall Study||9
10948456|NCT00407420|12119627|FG001|NOT COMPLETED|Overall Study||6
10948457|NCT00407485|12119635|FG000|STARTED|Overall Study||22
10948458|NCT00407485|12119635|FG000|COMPLETED|Overall Study||22
10948459|NCT00407485|12119635|FG000|NOT COMPLETED|Overall Study||0
10948460|NCT00407511|12119640|FG000|STARTED|Overall Study||121
10948461|NCT00407511|12119640|FG000|COMPLETED|Overall Study||99
10948462|NCT00407511|12119640|FG000|NOT COMPLETED|Overall Study||22
10948463|NCT00407537|12119646|FG000|STARTED|Overall Study||779
10948464|NCT00407537|12119647|FG001|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
10948465|NCT00407537|12119646|FG000|Eligible for Efficacy Analysis|Overall Study||760
10948466|NCT00407537|12119647|FG001|Eligible for Efficacy Analysis|Overall Study||657
10948467|NCT00407537|12119646|FG000|COMPLETED|Overall Study||686
10948468|NCT00407537|12119647|FG001|COMPLETED|Overall Study||638
10948469|NCT00407537|12119646|FG000|NOT COMPLETED|Overall Study||93
10948470|NCT00407537|12119647|FG001|NOT COMPLETED|Overall Study||44
10948471|NCT00407550|12119655|FG000|STARTED|Overall Study||10
10948472|NCT00407550|12119656|FG001|STARTED|Overall Study||9
10948473|NCT00407550|12119655|FG000|COMPLETED|Overall Study||7
10948474|NCT00407550|12119656|FG001|COMPLETED|Overall Study||5
10948475|NCT00407550|12119655|FG000|NOT COMPLETED|Overall Study||3
10948476|NCT00407550|12119656|FG001|NOT COMPLETED|Overall Study||4
10948477|NCT00407563|12119662|FG000|STARTED|Overall Study||48
10948478|NCT00407563|12119662|FG000|COMPLETED|Overall Study|One patient remains on study treatment.|47
10948479|NCT00407563|12119662|FG000|NOT COMPLETED|Overall Study||1
10948480|NCT00407654|12119666|FG000|STARTED|Overall Study||75
10948481|NCT00407654|12119666|FG000|COMPLETED|Overall Study||75
10948482|NCT00407654|12119666|FG000|NOT COMPLETED|Overall Study||0
10948483|NCT00407745|12119673|FG000|STARTED|Overall Study||112
10948484|NCT00407745|12119674|FG001|STARTED|Overall Study||108
10948485|NCT00407745|12119673|FG000|Treated|Overall Study||112
10948486|NCT00407745|12119674|FG001|Treated|Overall Study||107
10948487|NCT00407745|12119673|FG000|COMPLETED|Overall Study||93
10948488|NCT00407745|12119674|FG001|COMPLETED|Overall Study||91
10948489|NCT00407745|12119673|FG000|NOT COMPLETED|Overall Study||19
10948490|NCT00407745|12119674|FG001|NOT COMPLETED|Overall Study||17
10948491|NCT00407758|12119680|FG000|STARTED|Overall Study||28
10948492|NCT00407758|12119680|FG000|COMPLETED|Overall Study||27
10948493|NCT00407758|12119680|FG000|NOT COMPLETED|Overall Study||1
10948494|NCT00407797|12119684|FG000|STARTED|Overall Study||136
10948495|NCT00407797|12119684|FG000|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
10948496|NCT00407797|12119684|FG000|COMPLETED|Overall Study||118
10948497|NCT00407797|12119684|FG000|NOT COMPLETED|Overall Study||18
10948498|NCT00407888|12119688|FG000|STARTED|Overall Study||60
10948499|NCT00407888|12119688|FG000|COMPLETED|Overall Study||60
10948500|NCT00407888|12119688|FG000|NOT COMPLETED|Overall Study||0
10948501|NCT00407966|12119692|FG000|STARTED|Overall Study||45
10948502|NCT00407966|12119692|FG000|CR|Overall Study||30
10948503|NCT00407966|12119692|FG000|COMPLETED|Overall Study||45
10948504|NCT00407966|12119692|FG000|NOT COMPLETED|Overall Study||0
10948505|NCT00408070|12119696|FG000|STARTED|Overall Study||5
10948506|NCT00408070|12119696|FG000|COMPLETED|Overall Study||5
10948507|NCT00408070|12119696|FG000|NOT COMPLETED|Overall Study||0
10948508|NCT00408200|12119702|FG000|STARTED|Overall Study||57
10948509|NCT00408200|12119703|FG001|STARTED|Overall Study||53
10948510|NCT00408200|12119702|FG000|COMPLETED|Overall Study||57
10948511|NCT00408200|12119703|FG001|COMPLETED|Overall Study||53
10948512|NCT00408200|12119702|FG000|NOT COMPLETED|Overall Study||0
10948513|NCT00408200|12119703|FG001|NOT COMPLETED|Overall Study||0
10948514|NCT00408317|12119709|FG000|STARTED|First Intervention Period||14
10948515|NCT00408317|12119710|FG001|STARTED|First Intervention Period||17
10948516|NCT00408317|12119709|FG000|COMPLETED|First Intervention Period||14
10948517|NCT00408317|12119710|FG001|COMPLETED|First Intervention Period||16
10948518|NCT00408317|12119709|FG000|NOT COMPLETED|First Intervention Period||0
10948519|NCT00408317|12119710|FG001|NOT COMPLETED|First Intervention Period||1
10948520|NCT00408317|12119709|FG000|STARTED|Second Intervention Period||14
10948521|NCT00408317|12119710|FG001|STARTED|Second Intervention Period||16
10948522|NCT00408317|12119709|FG000|COMPLETED|Second Intervention Period||12
10948523|NCT00408317|12119710|FG001|COMPLETED|Second Intervention Period||14
10948524|NCT00408317|12119709|FG000|NOT COMPLETED|Second Intervention Period||2
10948525|NCT00408317|12119710|FG001|NOT COMPLETED|Second Intervention Period||2
10948526|NCT00408408|12119722|FG000|STARTED|Overall Study||201
10948527|NCT00408408|12119723|FG001|STARTED|Overall Study||199
10948528|NCT00408408|12119724|FG002|STARTED|Overall Study||204
10948529|NCT00408408|12119725|FG003|STARTED|Overall Study||201
10948530|NCT00408408|12119726|FG004|STARTED|Overall Study||197
10948531|NCT00408408|12119727|FG005|STARTED|Overall Study||204
10948532|NCT00408408|12119722|FG000|COMPLETED|Overall Study||199
10948533|NCT00408408|12119723|FG001|COMPLETED|Overall Study||196
10948534|NCT00408408|12119724|FG002|COMPLETED|Overall Study||204
10948535|NCT00408408|12119725|FG003|COMPLETED|Overall Study||194
10948536|NCT00408408|12119726|FG004|COMPLETED|Overall Study||192
10948537|NCT00408408|12119727|FG005|COMPLETED|Overall Study||201
10948538|NCT00408408|12119722|FG000|NOT COMPLETED|Overall Study||2
10948539|NCT00408408|12119723|FG001|NOT COMPLETED|Overall Study||3
10948540|NCT00408408|12119724|FG002|NOT COMPLETED|Overall Study||0
10948541|NCT00408408|12119725|FG003|NOT COMPLETED|Overall Study||7
10948542|NCT00408408|12119726|FG004|NOT COMPLETED|Overall Study||5
10948543|NCT00408408|12119727|FG005|NOT COMPLETED|Overall Study||3
10948544|NCT00408421|12119743|FG000|STARTED|Treatment Initial Randomization||120
10948545|NCT00408421|12119744|FG001|STARTED|Treatment Initial Randomization||111
10948546|NCT00408421|12119745|FG002|STARTED|Treatment Initial Randomization||0
10948547|NCT00408421|12119743|FG000|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
10948548|NCT00408421|12119744|FG001|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
10948549|NCT00408421|12119745|FG002|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
10948550|NCT00408421|12119743|FG000|NOT COMPLETED|Treatment Initial Randomization||17
10948551|NCT00408421|12119744|FG001|NOT COMPLETED|Treatment Initial Randomization||22
10948552|NCT00408421|12119745|FG002|NOT COMPLETED|Treatment Initial Randomization||0
10948553|NCT00408421|12119743|FG000|STARTED|Treatment Re-Randomization||103
10948554|NCT00408421|12119744|FG001|STARTED|Treatment Re-Randomization||46
10948555|NCT00408421|12119745|FG002|STARTED|Treatment Re-Randomization||43
10948556|NCT00408421|12119743|FG000|COMPLETED|Treatment Re-Randomization||96
10948557|NCT00408421|12119744|FG001|COMPLETED|Treatment Re-Randomization||39
10948558|NCT00408421|12119745|FG002|COMPLETED|Treatment Re-Randomization||38
10948559|NCT00408421|12119743|FG000|NOT COMPLETED|Treatment Re-Randomization||7
10948560|NCT00408421|12119744|FG001|NOT COMPLETED|Treatment Re-Randomization||7
10948561|NCT00408421|12119745|FG002|NOT COMPLETED|Treatment Re-Randomization||5
10948562|NCT00408434|12119760|FG000|STARTED|Overall Study||6
10948563|NCT00408434|12119761|FG001|STARTED|Overall Study||3
10948564|NCT00408434|12119762|FG002|STARTED|Overall Study||6
10948565|NCT00408434|12119763|FG003|STARTED|Overall Study||3
10948566|NCT00408434|12119764|FG004|STARTED|Overall Study||6
10948567|NCT00408434|12119765|FG005|STARTED|Overall Study||3
10948568|NCT00408434|12119766|FG006|STARTED|Overall Study||4
10948569|NCT00408434|12119760|FG000|COMPLETED|Overall Study||0
10948570|NCT00408434|12119761|FG001|COMPLETED|Overall Study||0
10948571|NCT00408434|12119762|FG002|COMPLETED|Overall Study||0
10948572|NCT00408434|12119763|FG003|COMPLETED|Overall Study||0
10948573|NCT00408434|12119764|FG004|COMPLETED|Overall Study||0
10948574|NCT00408434|12119765|FG005|COMPLETED|Overall Study||0
10948575|NCT00408434|12119766|FG006|COMPLETED|Overall Study||0
10948576|NCT00408434|12119760|FG000|NOT COMPLETED|Overall Study||6
10948577|NCT00408434|12119761|FG001|NOT COMPLETED|Overall Study||3
10948578|NCT00408434|12119762|FG002|NOT COMPLETED|Overall Study||6
10948579|NCT00408434|12119763|FG003|NOT COMPLETED|Overall Study||3
10948580|NCT00408434|12119764|FG004|NOT COMPLETED|Overall Study||6
10948581|NCT00408434|12119765|FG005|NOT COMPLETED|Overall Study||3
10948582|NCT00408434|12119766|FG006|NOT COMPLETED|Overall Study||4
10948583|NCT00408460|12119783|FG000|STARTED|Overall Study||34
10948584|NCT00408460|12119783|FG000|COMPLETED|Overall Study||34
10948585|NCT00408460|12119783|FG000|NOT COMPLETED|Overall Study||0
10948586|NCT00408499|12119787|FG000|STARTED|Phase 1: Dose Levels 1-4||4
10948587|NCT00408499|12119788|FG001|STARTED|Phase 1: Dose Levels 1-4||7
10948588|NCT00408499|12119789|FG002|STARTED|Phase 1: Dose Levels 1-4||3
10948589|NCT00408499|12119790|FG003|STARTED|Phase 1: Dose Levels 1-4||6
10948590|NCT00408499|12119791|FG004|STARTED|Phase 1: Dose Levels 1-4||0
10948591|NCT00408499|12119787|FG000|COMPLETED|Phase 1: Dose Levels 1-4||2
10948592|NCT00408499|12119788|FG001|COMPLETED|Phase 1: Dose Levels 1-4||5
10948593|NCT00408499|12119789|FG002|COMPLETED|Phase 1: Dose Levels 1-4||2
10948594|NCT00408499|12119790|FG003|COMPLETED|Phase 1: Dose Levels 1-4||6
10948595|NCT00408499|12119791|FG004|COMPLETED|Phase 1: Dose Levels 1-4||0
10948596|NCT00408499|12119787|FG000|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
10948597|NCT00408499|12119788|FG001|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
10948598|NCT00408499|12119789|FG002|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
10948599|NCT00408499|12119790|FG003|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
10948600|NCT00408499|12119791|FG004|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
10948601|NCT00408499|12119787|FG000|STARTED|Phase II- MTD Expansion||0
10948602|NCT00408499|12119788|FG001|STARTED|Phase II- MTD Expansion||0
10948603|NCT00408499|12119789|FG002|STARTED|Phase II- MTD Expansion||0
10948604|NCT00408499|12119790|FG003|STARTED|Phase II- MTD Expansion||0
10948605|NCT00408499|12119791|FG004|STARTED|Phase II- MTD Expansion||44
10948606|NCT00408499|12119787|FG000|COMPLETED|Phase II- MTD Expansion||0
10948607|NCT00408499|12119788|FG001|COMPLETED|Phase II- MTD Expansion||0
10948608|NCT00408499|12119789|FG002|COMPLETED|Phase II- MTD Expansion||0
10948609|NCT00408499|12119790|FG003|COMPLETED|Phase II- MTD Expansion||0
10948610|NCT00408499|12119791|FG004|COMPLETED|Phase II- MTD Expansion||24
10948611|NCT00408499|12119787|FG000|NOT COMPLETED|Phase II- MTD Expansion||0
10948612|NCT00408499|12119788|FG001|NOT COMPLETED|Phase II- MTD Expansion||0
10948613|NCT00408499|12119789|FG002|NOT COMPLETED|Phase II- MTD Expansion||0
10948614|NCT00408499|12119790|FG003|NOT COMPLETED|Phase II- MTD Expansion||0
10948615|NCT00408499|12119791|FG004|NOT COMPLETED|Phase II- MTD Expansion||20
10948616|NCT00408564|12119800|FG000|STARTED|Overall Study||39
10948617|NCT00408564|12119800|FG000|COMPLETED|Overall Study||39
10948618|NCT00408564|12119800|FG000|NOT COMPLETED|Overall Study||0
10948619|NCT00408590|12119807|FG000|STARTED|Overall Study||3
10948620|NCT00408590|12119808|FG001|STARTED|Overall Study||3
10948621|NCT00408590|12119809|FG002|STARTED|Overall Study||3
10948622|NCT00408590|12119810|FG003|STARTED|Overall Study||3
10948623|NCT00408590|12119811|FG004|STARTED|Overall Study||3
10948624|NCT00408590|12119812|FG005|STARTED|Overall Study||3
10948625|NCT00408590|12119813|FG006|STARTED|Overall Study||3
10948626|NCT00408590|12119814|FG007|STARTED|Overall Study||3
10948627|NCT00408590|12119815|FG008|STARTED|Overall Study||13
10948628|NCT00408590|12119807|FG000|COMPLETED|Overall Study||3
10948629|NCT00408590|12119808|FG001|COMPLETED|Overall Study||3
10948630|NCT00408590|12119809|FG002|COMPLETED|Overall Study||3
10948631|NCT00408590|12119810|FG003|COMPLETED|Overall Study||3
10948632|NCT00408590|12119811|FG004|COMPLETED|Overall Study||3
10948633|NCT00408590|12119812|FG005|COMPLETED|Overall Study||3
10948634|NCT00408590|12119813|FG006|COMPLETED|Overall Study||3
10948635|NCT00408590|12119814|FG007|COMPLETED|Overall Study||3
10948636|NCT00408590|12119815|FG008|COMPLETED|Overall Study||13
10948637|NCT00408590|12119807|FG000|NOT COMPLETED|Overall Study||0
10948638|NCT00408590|12119808|FG001|NOT COMPLETED|Overall Study||0
10948639|NCT00408590|12119809|FG002|NOT COMPLETED|Overall Study||0
10948640|NCT00408590|12119810|FG003|NOT COMPLETED|Overall Study||0
10948641|NCT00408590|12119811|FG004|NOT COMPLETED|Overall Study||0
10948642|NCT00408590|12119812|FG005|NOT COMPLETED|Overall Study||0
10948643|NCT00408590|12119813|FG006|NOT COMPLETED|Overall Study||0
10948644|NCT00408590|12119814|FG007|NOT COMPLETED|Overall Study||0
10948645|NCT00408590|12119815|FG008|NOT COMPLETED|Overall Study||0
10948646|NCT00408603|12119833|FG000|STARTED|Overall Study||69
10948647|NCT00408603|12119834|FG001|STARTED|Overall Study||39
10948648|NCT00408603|12119835|FG002|STARTED|Overall Study||75
10948649|NCT00408603|12119833|FG000|COMPLETED|Overall Study||65
10948650|NCT00408603|12119834|FG001|COMPLETED|Overall Study||37
10948651|NCT00408603|12119835|FG002|COMPLETED|Overall Study||35
10948652|NCT00408603|12119833|FG000|NOT COMPLETED|Overall Study||4
10948653|NCT00408603|12119834|FG001|NOT COMPLETED|Overall Study||2
10948654|NCT00408603|12119835|FG002|NOT COMPLETED|Overall Study||40
10948655|NCT00408629|12119847|FG000|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
10948656|NCT00408629|12119848|FG001|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
10948657|NCT00408629|12119847|FG000|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
10948658|NCT00408629|12119848|FG001|COMPLETED|Overall Study||135
10948659|NCT00408629|12119847|FG000|NOT COMPLETED|Overall Study||97
10948660|NCT00408629|12119848|FG001|NOT COMPLETED|Overall Study||125
10948661|NCT00408681|12119855|FG000|STARTED|Overall Study||20
10948662|NCT00408681|12119855|FG000|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
10948663|NCT00408681|12119855|FG000|NOT COMPLETED|Overall Study||9
10948664|NCT00408694|12119860|FG000|STARTED|Overall Study||46
10948665|NCT00408694|12119860|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
10948666|NCT00408694|12119860|FG000|NOT COMPLETED|Overall Study||2
10948667|NCT00408876|12119868|FG000|STARTED|Overall Study||59
10948668|NCT00408876|12119869|FG001|STARTED|Overall Study||116
10948669|NCT00408876|12119870|FG002|STARTED|Overall Study||112
10948670|NCT00408876|12119871|FG003|STARTED|Overall Study||117
10948671|NCT00408876|12119868|FG000|COMPLETED|Overall Study||43
10948672|NCT00408876|12119869|FG001|COMPLETED|Overall Study||80
10948673|NCT00408876|12119870|FG002|COMPLETED|Overall Study||62
10948674|NCT00408876|12119871|FG003|COMPLETED|Overall Study||82
10948675|NCT00408876|12119868|FG000|NOT COMPLETED|Overall Study||16
10948676|NCT00408876|12119869|FG001|NOT COMPLETED|Overall Study||36
10948677|NCT00408876|12119870|FG002|NOT COMPLETED|Overall Study||50
10948678|NCT00408876|12119871|FG003|NOT COMPLETED|Overall Study||35
10948679|NCT00408902|12119881|FG000|STARTED|Overall Study||10
10948680|NCT00408902|12119881|FG000|COMPLETED|Overall Study||0
10948681|NCT00408902|12119881|FG000|NOT COMPLETED|Overall Study||10
10948682|NCT00408928|12119886|FG000|STARTED|Overall Study||11
10948683|NCT00408928|12119886|FG000|COMPLETED|Overall Study||8
10948684|NCT00408928|12119886|FG000|NOT COMPLETED|Overall Study||3
10948685|NCT00408993|12119892|FG000|STARTED|Overall Study||106
10948686|NCT00408993|12119893|FG001|STARTED|Overall Study||109
10948687|NCT00408993|12119892|FG000|COMPLETED|Overall Study||87
10948688|NCT00408993|12119893|FG001|COMPLETED|Overall Study||92
10948689|NCT00408993|12119892|FG000|NOT COMPLETED|Overall Study||19
10948690|NCT00408993|12119893|FG001|NOT COMPLETED|Overall Study||17
10948691|NCT00409006|12119905|FG000|STARTED|Overall Study||39
10948692|NCT00409006|12119906|FG001|STARTED|Overall Study||31
10948693|NCT00409006|12119905|FG000|COMPLETED|Overall Study||19
10948694|NCT00409006|12119906|FG001|COMPLETED|Overall Study||19
10948695|NCT00409006|12119905|FG000|NOT COMPLETED|Overall Study||20
10948696|NCT00409006|12119906|FG001|NOT COMPLETED|Overall Study||12
10948697|NCT00409175|12119914|FG000|STARTED|Overall Study||65
10948698|NCT00409175|12119915|FG001|STARTED|Overall Study||63
10948699|NCT00409175|12119914|FG000|COMPLETED|Overall Study||47
10948700|NCT00409175|12119915|FG001|COMPLETED|Overall Study||44
10948701|NCT00409175|12119914|FG000|NOT COMPLETED|Overall Study||18
10948702|NCT00409175|12119915|FG001|NOT COMPLETED|Overall Study||19
10948703|NCT00409188|12119923|FG000|STARTED|Overall Study||1006
10948704|NCT00409188|12119924|FG001|STARTED|Overall Study||507
10948705|NCT00409188|12119923|FG000|COMPLETED|Overall Study||623
10948706|NCT00409188|12119924|FG001|COMPLETED|Overall Study||332
10948707|NCT00409188|12119923|FG000|NOT COMPLETED|Overall Study||383
10948708|NCT00409188|12119924|FG001|NOT COMPLETED|Overall Study||175
10948709|NCT00409240|12119932|FG000|STARTED|Overall Study||53
10948710|NCT00409240|12119933|FG001|STARTED|Overall Study||50
10948711|NCT00409240|12119932|FG000|COMPLETED|Overall Study||50
10948712|NCT00409240|12119933|FG001|COMPLETED|Overall Study||49
10948713|NCT00409240|12119932|FG000|NOT COMPLETED|Overall Study||3
10948714|NCT00409240|12119933|FG001|NOT COMPLETED|Overall Study||1
10948715|NCT00409292|12119939|FG000|STARTED|Overall Study||33
10948716|NCT00409292|12119939|FG000|COMPLETED|Overall Study||33
10948717|NCT00409292|12119939|FG000|NOT COMPLETED|Overall Study||0
10948718|NCT00409409|12119947|FG000|STARTED|Overall Study||139
10948719|NCT00409409|12119948|FG001|STARTED|Overall Study||139
10948720|NCT00409409|12119947|FG000|COMPLETED|Overall Study||131
10948721|NCT00409409|12119948|FG001|COMPLETED|Overall Study||135
10948722|NCT00409409|12119947|FG000|NOT COMPLETED|Overall Study||8
10948723|NCT00409409|12119948|FG001|NOT COMPLETED|Overall Study||4
10948724|NCT00409539|12119959|FG000|STARTED|Overall Study||111
10948725|NCT00409539|12119960|FG001|STARTED|Overall Study||111
10948726|NCT00409539|12119961|FG002|STARTED|Overall Study||109
10948727|NCT00409539|12119962|FG003|STARTED|Overall Study||109
10948728|NCT00409539|12119963|FG004|STARTED|Overall Study||110
10948729|NCT00409539|12119959|FG000|COMPLETED|Overall Study||100
10948730|NCT00409539|12119960|FG001|COMPLETED|Overall Study||100
10948731|NCT00409539|12119961|FG002|COMPLETED|Overall Study||95
10948732|NCT00409539|12119962|FG003|COMPLETED|Overall Study||97
10948733|NCT00409539|12119963|FG004|COMPLETED|Overall Study||85
10948734|NCT00409539|12119959|FG000|NOT COMPLETED|Overall Study||11
10948735|NCT00409539|12119960|FG001|NOT COMPLETED|Overall Study||11
10948736|NCT00409539|12119961|FG002|NOT COMPLETED|Overall Study||14
10948737|NCT00409539|12119962|FG003|NOT COMPLETED|Overall Study||12
10948738|NCT00409539|12119963|FG004|NOT COMPLETED|Overall Study||25
10948739|NCT00409565|12119975|FG000|STARTED|Overall Study||46
10948740|NCT00409565|12119975|FG000|Overall Response Rate|Overall Study||7
10948741|NCT00409565|12119975|FG000|COMPLETED|Overall Study||45
10948742|NCT00409565|12119975|FG000|NOT COMPLETED|Overall Study||1
10948743|NCT00409578|12119983|FG000|STARTED|Overall Study||280
10948744|NCT00409578|12119984|FG001|STARTED|Overall Study||271
10948745|NCT00409578|12119985|FG002|STARTED|Overall Study||269
10948746|NCT00409578|12119986|FG003|STARTED|Overall Study||281
10948747|NCT00409578|12119983|FG000|COMPLETED|Overall Study||228
10948748|NCT00409578|12119984|FG001|COMPLETED|Overall Study||201
10948749|NCT00409578|12119985|FG002|COMPLETED|Overall Study||215
10948750|NCT00409578|12119986|FG003|COMPLETED|Overall Study||214
10948751|NCT00409578|12119983|FG000|NOT COMPLETED|Overall Study||52
10948752|NCT00409578|12119984|FG001|NOT COMPLETED|Overall Study||70
10948753|NCT00409578|12119985|FG002|NOT COMPLETED|Overall Study||54
10948754|NCT00409578|12119986|FG003|NOT COMPLETED|Overall Study||67
10948755|NCT00409617|12119996|FG000|STARTED|Overall Study||945
10948756|NCT00409617|12119996|FG000|COMPLETED|Overall Study||785
10948757|NCT00409617|12119996|FG000|NOT COMPLETED|Overall Study||160
10948758|NCT00409682|12120003|FG000|STARTED|Open-label Induction Period||192
10948759|NCT00409682|12120004|FG001|STARTED|Open-label Induction Period||0
10948760|NCT00409682|12120005|FG002|STARTED|Open-label Induction Period||0
10948761|NCT00409682|12120003|FG000|COMPLETED|Open-label Induction Period||188
10948762|NCT00409682|12120004|FG001|COMPLETED|Open-label Induction Period||0
10948763|NCT00409682|12120005|FG002|COMPLETED|Open-label Induction Period||0
10948764|NCT00409682|12120003|FG000|NOT COMPLETED|Open-label Induction Period||4
10948765|NCT00409682|12120004|FG001|NOT COMPLETED|Open-label Induction Period||0
10948766|NCT00409682|12120005|FG002|NOT COMPLETED|Open-label Induction Period||0
10948767|NCT00409682|12120003|FG000|STARTED|EOW Double-blind Maintenance Period||0
10948768|NCT00409682|12120004|FG001|STARTED|EOW Double-blind Maintenance Period||95
10948769|NCT00409682|12120005|FG002|STARTED|EOW Double-blind Maintenance Period||93
10948770|NCT00409682|12120003|FG000|COMPLETED|EOW Double-blind Maintenance Period||0
10948771|NCT00409682|12120004|FG001|COMPLETED|EOW Double-blind Maintenance Period||58
10948772|NCT00409682|12120005|FG002|COMPLETED|EOW Double-blind Maintenance Period||66
10948773|NCT00409682|12120003|FG000|NOT COMPLETED|EOW Double-blind Maintenance Period||0
10948774|NCT00409682|12120004|FG001|NOT COMPLETED|EOW Double-blind Maintenance Period||37
10948775|NCT00409682|12120005|FG002|NOT COMPLETED|EOW Double-blind Maintenance Period||27
10948776|NCT00409708|12120014|FG000|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
10948777|NCT00409708|12120015|FG001|STARTED|Treatment||56
10948778|NCT00409708|12120014|FG000|COMPLETED|Treatment||38
10948779|NCT00409708|12120015|FG001|COMPLETED|Treatment||39
10948780|NCT00409708|12120014|FG000|NOT COMPLETED|Treatment||15
10948781|NCT00409708|12120015|FG001|NOT COMPLETED|Treatment||17
10948782|NCT00409708|12120014|FG000|STARTED|Washout||38
10948783|NCT00409708|12120015|FG001|STARTED|Washout||39
10948784|NCT00409708|12120014|FG000|COMPLETED|Washout||17
10948785|NCT00409708|12120015|FG001|COMPLETED|Washout||29
10948786|NCT00409708|12120014|FG000|NOT COMPLETED|Washout||21
10948787|NCT00409708|12120015|FG001|NOT COMPLETED|Washout||10
10948788|NCT00409747|12120021|FG000|STARTED|Overall Study||11
10948789|NCT00409747|12120021|FG000|COMPLETED|Overall Study||10
10948790|NCT00409747|12120021|FG000|NOT COMPLETED|Overall Study||1
10948791|NCT00409786|12120025|FG000|STARTED|Overall Study||50
10948792|NCT00409786|12120025|FG000|COMPLETED|Overall Study||47
10948793|NCT00409786|12120025|FG000|NOT COMPLETED|Overall Study||3
10948794|NCT00409825|12120029|FG000|STARTED|Overall Study||61
10948795|NCT00409825|12120029|FG000|COMPLETED|Overall Study||61
10948796|NCT00409825|12120029|FG000|NOT COMPLETED|Overall Study||0
10948797|NCT00409838|12120035|FG000|STARTED|Short-term Period|Randomized|56
10948798|NCT00409838|12120036|FG001|STARTED|Short-term Period|Randomized|57
10948799|NCT00409838|12120035|FG000|Treated (Baseline) Population|Short-term Period||55
10948800|NCT00409838|12120036|FG001|Treated (Baseline) Population|Short-term Period||57
10948801|NCT00409838|12120035|FG000|COMPLETED|Short-term Period||53
10948802|NCT00409838|12120036|FG001|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
10948803|NCT00409838|12120035|FG000|NOT COMPLETED|Short-term Period||3
10948804|NCT00409838|12120036|FG001|NOT COMPLETED|Short-term Period||5
10948805|NCT00409838|12120035|FG000|STARTED|Long-term Extension Period||105
10948806|NCT00409838|12120036|FG001|STARTED|Long-term Extension Period||0
10948807|NCT00409838|12120035|FG000|COMPLETED|Long-term Extension Period||87
10948808|NCT00409838|12120036|FG001|COMPLETED|Long-term Extension Period||0
10948809|NCT00409838|12120035|FG000|NOT COMPLETED|Long-term Extension Period||18
10948810|NCT00409838|12120036|FG001|NOT COMPLETED|Long-term Extension Period||0
10948811|NCT00410046|12120059|FG000|STARTED|Overall Study||84
10948812|NCT00410046|12120059|FG000|COMPLETED|Overall Study||79
10948813|NCT00410046|12120059|FG000|NOT COMPLETED|Overall Study||5
10948814|NCT00410059|12120064|FG000|STARTED|Overall Study||59
10948815|NCT00410059|12120064|FG000|COMPLETED|Overall Study||59
10948816|NCT00410059|12120064|FG000|NOT COMPLETED|Overall Study||0
10948817|NCT00410072|12120070|FG000|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
10948818|NCT00410072|12120071|FG001|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
10948819|NCT00410072|12120070|FG000|COMPLETED|Day 1 to Week 48||176
10948820|NCT00410072|12120071|FG001|COMPLETED|Day 1 to Week 48||185
10948821|NCT00410072|12120070|FG000|NOT COMPLETED|Day 1 to Week 48||6
10948822|NCT00410072|12120071|FG001|NOT COMPLETED|Day 1 to Week 48||12
10948823|NCT00410072|12120070|FG000|STARTED|After Week 48 to Week 96||176
10948824|NCT00410072|12120071|FG001|STARTED|After Week 48 to Week 96||185
10948825|NCT00410072|12120070|FG000|COMPLETED|After Week 48 to Week 96||170
10948826|NCT00410072|12120071|FG001|COMPLETED|After Week 48 to Week 96||174
10948827|NCT00410072|12120070|FG000|NOT COMPLETED|After Week 48 to Week 96||6
10948828|NCT00410072|12120071|FG001|NOT COMPLETED|After Week 48 to Week 96||11
10948829|NCT00410124|12120079|FG000|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
10948830|NCT00410124|12120080|FG001|STARTED|Core Phase Double Blind (15 Months)||139
10948831|NCT00410124|12120079|FG000|Ongoing|Core Phase Double Blind (15 Months)||13
10948832|NCT00410124|12120080|FG001|Ongoing|Core Phase Double Blind (15 Months)||4
10948833|NCT00410124|12120079|FG000|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
10948834|NCT00410124|12120080|FG001|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
10948835|NCT00410124|12120079|FG000|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
10948836|NCT00410124|12120080|FG001|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
10948837|NCT00410124|12120079|FG000|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
10948838|NCT00410124|12120080|FG001|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
10948839|NCT00410124|12120079|FG000|STARTED|Extension Phase - Open Label (45 Months)||67
10948840|NCT00410124|12120080|FG001|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
10948841|NCT00410124|12120079|FG000|COMPLETED|Extension Phase - Open Label (45 Months)||0
10948842|NCT00410124|12120080|FG001|COMPLETED|Extension Phase - Open Label (45 Months)||0
10948843|NCT00410124|12120079|FG000|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
10948844|NCT00410124|12120080|FG001|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
10948845|NCT00410150|12120092|FG000|STARTED|Overall Study||22
10948846|NCT00410150|12120093|FG001|STARTED|Overall Study||20
10948847|NCT00410150|12120092|FG000|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
10948848|NCT00410150|12120093|FG001|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
10948849|NCT00410150|12120092|FG000|NOT COMPLETED|Overall Study||2
10948850|NCT00410150|12120093|FG001|NOT COMPLETED|Overall Study||3
10948851|NCT00410163|12120101|FG000|STARTED|Treatment and Follow-up Phase (2 Years)||31
10948852|NCT00410163|12120102|FG001|STARTED|Treatment and Follow-up Phase (2 Years)||30
10948853|NCT00410163|12120101|FG000|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
10948854|NCT00410163|12120102|FG001|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
10948855|NCT00410163|12120101|FG000|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
10948856|NCT00410163|12120102|FG001|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
10948857|NCT00410163|12120101|FG000|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
10948858|NCT00410163|12120102|FG001|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
10948859|NCT00410163|12120101|FG000|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
10948860|NCT00410163|12120102|FG001|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
10948861|NCT00410163|12120101|FG000|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
10948862|NCT00410163|12120102|FG001|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
10948863|NCT00410189|12120112|FG000|STARTED|Overall Study||54
10948864|NCT00410189|12120112|FG000|COMPLETED|Overall Study||54
10948865|NCT00410189|12120112|FG000|NOT COMPLETED|Overall Study||0
10948866|NCT00410202|12120119|FG000|STARTED|On-Treatment||138
10948867|NCT00410202|12120120|FG001|STARTED|On-Treatment||140
10948868|NCT00410202|12120121|FG002|STARTED|On-Treatment||137
10948869|NCT00410202|12120119|FG000|Discontinued Prior to Week 48 Visit|On-Treatment||4
10948870|NCT00410202|12120120|FG001|Discontinued Prior to Week 48 Visit|On-Treatment||2
10948871|NCT00410202|12120121|FG002|Discontinued Prior to Week 48 Visit|On-Treatment||2
10948872|NCT00410202|12120119|FG000|Discontinued at or After Week 48 Visit|On-Treatment||2
10948873|NCT00410202|12120120|FG001|Discontinued at or After Week 48 Visit|On-Treatment||6
10948874|NCT00410202|12120121|FG002|Discontinued at or After Week 48 Visit|On-Treatment||3
10948875|NCT00410202|12120119|FG000|COMPLETED|On-Treatment|Completed the 100 week dosing|63
10948876|NCT00410202|12120120|FG001|COMPLETED|On-Treatment|Completed the 100 week dosing|61
10948877|NCT00410202|12120121|FG002|COMPLETED|On-Treatment|Completed the 100 week dosing|66
10948878|NCT00410202|12120119|FG000|NOT COMPLETED|On-Treatment||75
10948879|NCT00410202|12120120|FG001|NOT COMPLETED|On-Treatment||79
10948880|NCT00410202|12120121|FG002|NOT COMPLETED|On-Treatment||71
10948881|NCT00410202|12120119|FG000|STARTED|Off-treatment Follow up||15
10948882|NCT00410202|12120120|FG001|STARTED|Off-treatment Follow up||8
10948883|NCT00410202|12120121|FG002|STARTED|Off-treatment Follow up||14
10948884|NCT00410202|12120119|FG000|COMPLETED|Off-treatment Follow up||1
10948885|NCT00410202|12120120|FG001|COMPLETED|Off-treatment Follow up||0
10948886|NCT00410202|12120121|FG002|COMPLETED|Off-treatment Follow up||2
10948887|NCT00410202|12120119|FG000|NOT COMPLETED|Off-treatment Follow up||14
10948888|NCT00410202|12120120|FG001|NOT COMPLETED|Off-treatment Follow up||8
10948889|NCT00410202|12120121|FG002|NOT COMPLETED|Off-treatment Follow up||12
10948890|NCT00410280|12120132|FG000|STARTED|Overall Study||14
10948891|NCT00410280|12120133|FG001|STARTED|Overall Study||13
10948892|NCT00410280|12120132|FG000|COMPLETED|Overall Study||14
10948893|NCT00410280|12120133|FG001|COMPLETED|Overall Study||13
10948894|NCT00410280|12120132|FG000|NOT COMPLETED|Overall Study||0
10948895|NCT00410280|12120133|FG001|NOT COMPLETED|Overall Study||0
10948896|NCT00410384|12120142|FG000|STARTED|Overall Study||275
10948897|NCT00410384|12120143|FG001|STARTED|Overall Study||271
10948898|NCT00410384|12120144|FG002|STARTED|Overall Study||273
10948899|NCT00410384|12120142|FG000|COMPLETED|Overall Study||186
10948900|NCT00410384|12120143|FG001|COMPLETED|Overall Study||199
10948901|NCT00410384|12120144|FG002|COMPLETED|Overall Study||191
10948902|NCT00410384|12120142|FG000|NOT COMPLETED|Overall Study||89
10948903|NCT00410384|12120143|FG001|NOT COMPLETED|Overall Study||72
10948904|NCT00410384|12120144|FG002|NOT COMPLETED|Overall Study||82
10948905|NCT00410410|12120158|FG000|STARTED|Induction Period (IP)||141
10948906|NCT00410410|12120159|FG001|STARTED|Induction Period (IP)||139
10948907|NCT00410410|12120160|FG002|STARTED|Induction Period (IP)||70
10948908|NCT00410410|12120161|FG003|STARTED|Induction Period (IP)||140
10948909|NCT00410410|12120162|FG004|STARTED|Induction Period (IP)||51
10948910|NCT00410410|12120163|FG005|STARTED|Induction Period (IP)||50
10948911|NCT00410410|12120164|FG006|STARTED|Induction Period (IP)||0
10948912|NCT00410410|12120165|FG007|STARTED|Induction Period (IP)||0
10948913|NCT00410410|12120166|FG008|STARTED|Induction Period (IP)||0
10948914|NCT00410410|12120158|FG000|COMPLETED|Induction Period (IP)||106
10948915|NCT00410410|12120159|FG001|COMPLETED|Induction Period (IP)||104
10948916|NCT00410410|12120160|FG002|COMPLETED|Induction Period (IP)||53
10948917|NCT00410410|12120161|FG003|COMPLETED|Induction Period (IP)||120
10948918|NCT00410410|12120162|FG004|COMPLETED|Induction Period (IP)||19
10948919|NCT00410410|12120163|FG005|COMPLETED|Induction Period (IP)||21
10948920|NCT00410410|12120164|FG006|COMPLETED|Induction Period (IP)||0
10948921|NCT00410410|12120165|FG007|COMPLETED|Induction Period (IP)||0
10948922|NCT00410410|12120166|FG008|COMPLETED|Induction Period (IP)||0
10948923|NCT00410410|12120158|FG000|NOT COMPLETED|Induction Period (IP)||35
10948924|NCT00410410|12120159|FG001|NOT COMPLETED|Induction Period (IP)||35
10948925|NCT00410410|12120160|FG002|NOT COMPLETED|Induction Period (IP)||17
10948926|NCT00410410|12120161|FG003|NOT COMPLETED|Induction Period (IP)||20
10948927|NCT00410410|12120162|FG004|NOT COMPLETED|Induction Period (IP)||32
10948928|NCT00410410|12120163|FG005|NOT COMPLETED|Induction Period (IP)||29
10948929|NCT00410410|12120164|FG006|NOT COMPLETED|Induction Period (IP)||0
10948930|NCT00410410|12120165|FG007|NOT COMPLETED|Induction Period (IP)||0
10948931|NCT00410410|12120166|FG008|NOT COMPLETED|Induction Period (IP)||0
10948932|NCT00410410|12120158|FG000|STARTED|Maintenance Period (MP)||0
10948933|NCT00410410|12120159|FG001|STARTED|Maintenance Period (MP)||0
10948934|NCT00410410|12120160|FG002|STARTED|Maintenance Period (MP)||0
10948935|NCT00410410|12120161|FG003|STARTED|Maintenance Period (MP)||0
10948936|NCT00410410|12120162|FG004|STARTED|Maintenance Period (MP)||0
10948937|NCT00410410|12120163|FG005|STARTED|Maintenance Period (MP)||0
10948938|NCT00410410|12120164|FG006|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
10948939|NCT00410410|12120165|FG007|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
10948940|NCT00410410|12120166|FG008|STARTED|Maintenance Period (MP)||0
10948941|NCT00410410|12120158|FG000|COMPLETED|Maintenance Period (MP)||0
10948942|NCT00410410|12120159|FG001|COMPLETED|Maintenance Period (MP)||0
10948943|NCT00410410|12120160|FG002|COMPLETED|Maintenance Period (MP)||0
10948944|NCT00410410|12120161|FG003|COMPLETED|Maintenance Period (MP)||0
10948945|NCT00410410|12120162|FG004|COMPLETED|Maintenance Period (MP)||0
10948946|NCT00410410|12120163|FG005|COMPLETED|Maintenance Period (MP)||0
10948947|NCT00410410|12120164|FG006|COMPLETED|Maintenance Period (MP)||15
10948948|NCT00410410|12120165|FG007|COMPLETED|Maintenance Period (MP)||11
10948949|NCT00410410|12120166|FG008|COMPLETED|Maintenance Period (MP)||0
10948950|NCT00410410|12120158|FG000|NOT COMPLETED|Maintenance Period (MP)||0
10948951|NCT00410410|12120159|FG001|NOT COMPLETED|Maintenance Period (MP)||0
10948952|NCT00410410|12120160|FG002|NOT COMPLETED|Maintenance Period (MP)||0
10948953|NCT00410410|12120161|FG003|NOT COMPLETED|Maintenance Period (MP)||0
10948954|NCT00410410|12120162|FG004|NOT COMPLETED|Maintenance Period (MP)||0
10948955|NCT00410410|12120163|FG005|NOT COMPLETED|Maintenance Period (MP)||0
10948956|NCT00410410|12120164|FG006|NOT COMPLETED|Maintenance Period (MP)||50
10948957|NCT00410410|12120165|FG007|NOT COMPLETED|Maintenance Period (MP)||55
10948958|NCT00410410|12120166|FG008|NOT COMPLETED|Maintenance Period (MP)||0
10948959|NCT00410410|12120158|FG000|STARTED|Open-Label Period (OL)||0
10948960|NCT00410410|12120159|FG001|STARTED|Open-Label Period (OL)||0
10948961|NCT00410410|12120160|FG002|STARTED|Open-Label Period (OL)||0
10948962|NCT00410410|12120161|FG003|STARTED|Open-Label Period (OL)||0
10948963|NCT00410410|12120162|FG004|STARTED|Open-Label Period (OL)||0
10948964|NCT00410410|12120163|FG005|STARTED|Open-Label Period (OL)||0
10948965|NCT00410410|12120164|FG006|STARTED|Open-Label Period (OL)||0
10948966|NCT00410410|12120165|FG007|STARTED|Open-Label Period (OL)||0
10948967|NCT00410410|12120166|FG008|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
10948968|NCT00410410|12120158|FG000|COMPLETED|Open-Label Period (OL)||0
10948969|NCT00410410|12120159|FG001|COMPLETED|Open-Label Period (OL)||0
10948970|NCT00410410|12120160|FG002|COMPLETED|Open-Label Period (OL)||0
10948971|NCT00410410|12120161|FG003|COMPLETED|Open-Label Period (OL)||0
10948972|NCT00410410|12120162|FG004|COMPLETED|Open-Label Period (OL)||0
10948973|NCT00410410|12120163|FG005|COMPLETED|Open-Label Period (OL)||0
10948974|NCT00410410|12120164|FG006|COMPLETED|Open-Label Period (OL)||0
10948975|NCT00410410|12120165|FG007|COMPLETED|Open-Label Period (OL)||0
10948976|NCT00410410|12120166|FG008|COMPLETED|Open-Label Period (OL)||0
10948977|NCT00410410|12120158|FG000|NOT COMPLETED|Open-Label Period (OL)||0
10948978|NCT00410410|12120159|FG001|NOT COMPLETED|Open-Label Period (OL)||0
10948979|NCT00410410|12120160|FG002|NOT COMPLETED|Open-Label Period (OL)||0
10948980|NCT00410410|12120161|FG003|NOT COMPLETED|Open-Label Period (OL)||0
10948981|NCT00410410|12120162|FG004|NOT COMPLETED|Open-Label Period (OL)||0
10948982|NCT00410410|12120163|FG005|NOT COMPLETED|Open-Label Period (OL)||0
10948983|NCT00410410|12120164|FG006|NOT COMPLETED|Open-Label Period (OL)||0
10948984|NCT00410410|12120165|FG007|NOT COMPLETED|Open-Label Period (OL)||0
10948985|NCT00410410|12120166|FG008|NOT COMPLETED|Open-Label Period (OL)||349
10948986|NCT00410423|12120201|FG000|STARTED|Phase 1 - Dose Level 1||3
10948987|NCT00410423|12120202|FG001|STARTED|Phase 1 - Dose Level 1||0
10948988|NCT00410423|12120203|FG002|STARTED|Phase 1 - Dose Level 1||0
10948989|NCT00410423|12120204|FG003|STARTED|Phase 1 - Dose Level 1||0
10948990|NCT00410423|12120201|FG000|COMPLETED|Phase 1 - Dose Level 1||3
10948991|NCT00410423|12120202|FG001|COMPLETED|Phase 1 - Dose Level 1||0
10948992|NCT00410423|12120203|FG002|COMPLETED|Phase 1 - Dose Level 1||0
10948993|NCT00410423|12120204|FG003|COMPLETED|Phase 1 - Dose Level 1||0
10948994|NCT00410423|12120201|FG000|NOT COMPLETED|Phase 1 - Dose Level 1||0
10948995|NCT00410423|12120202|FG001|NOT COMPLETED|Phase 1 - Dose Level 1||0
10948996|NCT00410423|12120203|FG002|NOT COMPLETED|Phase 1 - Dose Level 1||0
10948997|NCT00410423|12120204|FG003|NOT COMPLETED|Phase 1 - Dose Level 1||0
10948998|NCT00410423|12120201|FG000|STARTED|Phase 1 - Dose Level 2||0
10948999|NCT00410423|12120202|FG001|STARTED|Phase 1 - Dose Level 2||5
10949000|NCT00410423|12120203|FG002|STARTED|Phase 1 - Dose Level 2||0
10949001|NCT00410423|12120204|FG003|STARTED|Phase 1 - Dose Level 2||0
10949002|NCT00410423|12120201|FG000|COMPLETED|Phase 1 - Dose Level 2||0
10949003|NCT00410423|12120202|FG001|COMPLETED|Phase 1 - Dose Level 2||5
10949004|NCT00410423|12120203|FG002|COMPLETED|Phase 1 - Dose Level 2||0
10949005|NCT00410423|12120204|FG003|COMPLETED|Phase 1 - Dose Level 2||0
10949006|NCT00410423|12120201|FG000|NOT COMPLETED|Phase 1 - Dose Level 2||0
10949007|NCT00410423|12120202|FG001|NOT COMPLETED|Phase 1 - Dose Level 2||0
10949008|NCT00410423|12120203|FG002|NOT COMPLETED|Phase 1 - Dose Level 2||0
10949009|NCT00410423|12120204|FG003|NOT COMPLETED|Phase 1 - Dose Level 2||0
10949010|NCT00410423|12120201|FG000|STARTED|Phase 1 - Dose Level 3||0
10949011|NCT00410423|12120202|FG001|STARTED|Phase 1 - Dose Level 3||0
10949012|NCT00410423|12120203|FG002|STARTED|Phase 1 - Dose Level 3||3
10949013|NCT00410423|12120204|FG003|STARTED|Phase 1 - Dose Level 3||0
10949014|NCT00410423|12120201|FG000|COMPLETED|Phase 1 - Dose Level 3||0
10949015|NCT00410423|12120202|FG001|COMPLETED|Phase 1 - Dose Level 3||0
10949016|NCT00410423|12120203|FG002|COMPLETED|Phase 1 - Dose Level 3||3
10949017|NCT00410423|12120204|FG003|COMPLETED|Phase 1 - Dose Level 3||0
10949018|NCT00410423|12120201|FG000|NOT COMPLETED|Phase 1 - Dose Level 3||0
10949019|NCT00410423|12120202|FG001|NOT COMPLETED|Phase 1 - Dose Level 3||0
10949020|NCT00410423|12120203|FG002|NOT COMPLETED|Phase 1 - Dose Level 3||0
10949021|NCT00410423|12120204|FG003|NOT COMPLETED|Phase 1 - Dose Level 3||0
10949022|NCT00410423|12120201|FG000|STARTED|Phase 2||0
10949023|NCT00410423|12120202|FG001|STARTED|Phase 2||0
10949024|NCT00410423|12120203|FG002|STARTED|Phase 2||0
10949025|NCT00410423|12120204|FG003|STARTED|Phase 2||44
10949026|NCT00410423|12120201|FG000|COMPLETED|Phase 2||0
10949027|NCT00410423|12120202|FG001|COMPLETED|Phase 2||0
10949028|NCT00410423|12120203|FG002|COMPLETED|Phase 2||0
10949029|NCT00410423|12120204|FG003|COMPLETED|Phase 2||44
10949030|NCT00410423|12120201|FG000|NOT COMPLETED|Phase 2||0
10949031|NCT00410423|12120202|FG001|NOT COMPLETED|Phase 2||0
10949032|NCT00410423|12120203|FG002|NOT COMPLETED|Phase 2||0
10949033|NCT00410423|12120204|FG003|NOT COMPLETED|Phase 2||0
10949034|NCT00410488|12120213|FG000|STARTED|Overall Study||16
10949035|NCT00410488|12120214|FG001|STARTED|Overall Study||34
10949036|NCT00410488|12120213|FG000|COMPLETED|Overall Study||16
10949037|NCT00410488|12120214|FG001|COMPLETED|Overall Study||34
10949038|NCT00410488|12120213|FG000|NOT COMPLETED|Overall Study||0
10949039|NCT00410488|12120214|FG001|NOT COMPLETED|Overall Study||0
10949040|NCT00410514|12120222|FG000|STARTED|Overall Study||65
10949041|NCT00410514|12120223|FG001|STARTED|Overall Study||70
10949042|NCT00410514|12120224|FG002|STARTED|Overall Study||65
10949043|NCT00410514|12120222|FG000|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
10949044|NCT00410514|12120223|FG001|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
10949045|NCT00410514|12120224|FG002|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
10949046|NCT00410514|12120222|FG000|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
10949047|NCT00410514|12120223|FG001|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
10949048|NCT00410514|12120224|FG002|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
10949049|NCT00410514|12120222|FG000|COMPLETED|Overall Study||63
10949050|NCT00410514|12120223|FG001|COMPLETED|Overall Study||67
10949051|NCT00410514|12120224|FG002|COMPLETED|Overall Study||58
10949052|NCT00410514|12120222|FG000|NOT COMPLETED|Overall Study||2
10949053|NCT00410514|12120223|FG001|NOT COMPLETED|Overall Study||3
10949054|NCT00410514|12120224|FG002|NOT COMPLETED|Overall Study||7
10949055|NCT00410605|12120232|FG000|STARTED|Overall Study||39
10949056|NCT00410605|12120232|FG000|COMPLETED|Overall Study||14
10949057|NCT00410605|12120232|FG000|NOT COMPLETED|Overall Study||25
10949058|NCT00410761|12120238|FG000|STARTED|Overall Study|randomised patients|231
10949059|NCT00410761|12120239|FG001|STARTED|Overall Study|randomised patients|100
10949060|NCT00410761|12120238|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
10949061|NCT00410761|12120239|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
10949062|NCT00410761|12120238|FG000|NOT COMPLETED|Overall Study||120
10949063|NCT00410761|12120239|FG001|NOT COMPLETED|Overall Study||72
10949064|NCT00410813|12120247|FG000|STARTED|Overall Study||43
10949065|NCT00410813|12120248|FG001|STARTED|Overall Study||42
10949066|NCT00410813|12120247|FG000|Eligible|Overall Study||41
10949067|NCT00410813|12120248|FG001|Eligible|Overall Study||38
10949068|NCT00410813|12120247|FG000|COMPLETED|Overall Study|Patients treated until progression.|0
10949069|NCT00410813|12120248|FG001|COMPLETED|Overall Study||0
10949070|NCT00410813|12120247|FG000|NOT COMPLETED|Overall Study||43
10949071|NCT00410813|12120248|FG001|NOT COMPLETED|Overall Study||42
10949072|NCT00410826|12120279|FG000|STARTED|Overall Study||105
10949073|NCT00410826|12120280|FG001|STARTED|Overall Study||99
10949074|NCT00410826|12120279|FG000|COMPLETED|Overall Study||96
10949075|NCT00410826|12120280|FG001|COMPLETED|Overall Study||95
10949076|NCT00410826|12120279|FG000|NOT COMPLETED|Overall Study||9
10949077|NCT00410826|12120280|FG001|NOT COMPLETED|Overall Study||4
10949078|NCT00410891|12120286|FG000|STARTED|Overall Study||129
10949079|NCT00410891|12120286|FG000|COMPLETED|Overall Study||129
10949080|NCT00410891|12120286|FG000|NOT COMPLETED|Overall Study||0
10949081|NCT00410904|12120292|FG000|STARTED|Overall Study||40
10949082|NCT00410904|12120293|FG001|STARTED|Overall Study||20
10949083|NCT00410904|12120292|FG000|COMPLETED|Overall Study||40
10949084|NCT00410904|12120293|FG001|COMPLETED|Overall Study||20
10949085|NCT00410904|12120292|FG000|NOT COMPLETED|Overall Study||0
10949086|NCT00410904|12120293|FG001|NOT COMPLETED|Overall Study||0
10949087|NCT00411086|12120300|FG000|STARTED|Overall Study||52
10949088|NCT00411086|12120300|FG000|COMPLETED|Overall Study||52
10949089|NCT00411086|12120300|FG000|NOT COMPLETED|Overall Study||0
10949090|NCT00411151|12120304|FG000|STARTED|Overall Study||52
10949091|NCT00411151|12120304|FG000|COMPLETED|Overall Study||5
10949092|NCT00411151|12120304|FG000|NOT COMPLETED|Overall Study||47
10949093|NCT00411216|12120310|FG000|STARTED|Overall Study||13
10949094|NCT00411216|12120311|FG001|STARTED|Overall Study||10
10949095|NCT00411216|12120310|FG000|COMPLETED|Overall Study||13
10949096|NCT00411216|12120311|FG001|COMPLETED|Overall Study||8
10949097|NCT00411216|12120310|FG000|NOT COMPLETED|Overall Study||0
10949098|NCT00411216|12120311|FG001|NOT COMPLETED|Overall Study||2
10949099|NCT00411398|12120317|FG000|STARTED|Overall Study||15
10949100|NCT00411398|12120317|FG000|COMPLETED|Overall Study||10
10949101|NCT00411398|12120317|FG000|NOT COMPLETED|Overall Study||5
10949102|NCT00411411|12120323|FG000|STARTED|Overall Study||24
10949103|NCT00411411|12120324|FG001|STARTED|Overall Study||25
10949104|NCT00411411|12120323|FG000|COMPLETED|Overall Study||24
10949105|NCT00411411|12120324|FG001|COMPLETED|Overall Study||25
10949106|NCT00411411|12120323|FG000|NOT COMPLETED|Overall Study||0
10949107|NCT00411411|12120324|FG001|NOT COMPLETED|Overall Study||0
10949108|NCT00411450|12120331|FG000|STARTED|Overall Study||116
10949109|NCT00411450|12120331|FG000|Received Treatment|Overall Study||115
10949110|NCT00411450|12120331|FG000|COMPLETED|Overall Study|Ended second-line treatment|113
10949111|NCT00411450|12120331|FG000|NOT COMPLETED|Overall Study||3
10949112|NCT00411463|12120339|FG000|STARTED|Overall Study||14
10949113|NCT00411463|12120340|FG001|STARTED|Overall Study||11
10949114|NCT00411463|12120339|FG000|COMPLETED|Overall Study||11
10949115|NCT00411463|12120340|FG001|COMPLETED|Overall Study||8
10949116|NCT00411463|12120339|FG000|NOT COMPLETED|Overall Study||3
10949117|NCT00411463|12120340|FG001|NOT COMPLETED|Overall Study||3
10949118|NCT00411554|12120351|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
10949119|NCT00411554|12120352|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
10949120|NCT00411554|12120351|FG000|COMPLETED|Overall Study||155
10949121|NCT00411554|12120352|FG001|COMPLETED|Overall Study||147
10949122|NCT00411554|12120351|FG000|NOT COMPLETED|Overall Study||8
10949123|NCT00411554|12120352|FG001|NOT COMPLETED|Overall Study||9
10949124|NCT00411619|12120358|FG000|STARTED|Overall Study||28
10949125|NCT00411619|12120358|FG000|COMPLETED|Overall Study||22
10949126|NCT00411619|12120358|FG000|NOT COMPLETED|Overall Study||6
10949127|NCT00411632|12120363|FG000|STARTED|Overall Study||37
10949128|NCT00411632|12120363|FG000|COMPLETED|Overall Study||36
10949129|NCT00411632|12120363|FG000|NOT COMPLETED|Overall Study||1
10949130|NCT00411645|12120369|FG000|STARTED|Overall Study||227
10949131|NCT00411645|12120370|FG001|STARTED|Overall Study||454
10949132|NCT00411645|12120369|FG000|COMPLETED|Overall Study||146
10949133|NCT00411645|12120370|FG001|COMPLETED|Overall Study||290
10949134|NCT00411645|12120369|FG000|NOT COMPLETED|Overall Study||81
10949135|NCT00411645|12120370|FG001|NOT COMPLETED|Overall Study||164
10949136|NCT00411671|12120377|FG000|STARTED|Overall Study||105
10949137|NCT00411671|12120377|FG000|COMPLETED|Overall Study||85
10949138|NCT00411671|12120377|FG000|NOT COMPLETED|Overall Study||20
10949139|NCT00411684|12120381|FG000|STARTED|Overall Study||1533
10949140|NCT00411684|12120381|FG000|COMPLETED|Overall Study||1241
10949141|NCT00411684|12120381|FG000|NOT COMPLETED|Overall Study||292
10949142|NCT00411749|12120387|FG000|STARTED|Overall Study||82
10949143|NCT00411749|12120388|FG001|STARTED|Overall Study||25
10949144|NCT00411749|12120387|FG000|Vaccinated|Overall Study||82
10949145|NCT00411749|12120388|FG001|Vaccinated|Overall Study||25
10949146|NCT00411749|12120387|FG000|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
10949147|NCT00411749|12120388|FG001|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
10949148|NCT00411749|12120387|FG000|NOT COMPLETED|Overall Study||0
10949149|NCT00411749|12120388|FG001|NOT COMPLETED|Overall Study||0
10949150|NCT00411762|12120398|FG000|STARTED|Overall Study||25
10949151|NCT00411762|12120398|FG000|COMPLETED|Overall Study||20
10949152|NCT00411762|12120398|FG000|NOT COMPLETED|Overall Study||5
10949153|NCT00411788|12120402|FG000|STARTED|Overall Study||11
10949154|NCT00411788|12120402|FG000|COMPLETED|Overall Study||9
10949155|NCT00411788|12120402|FG000|NOT COMPLETED|Overall Study||2
10949156|NCT00412061|12120408|FG000|STARTED|Double Blind Phase||216
10949157|NCT00412061|12120409|FG001|STARTED|Double Blind Phase||213
10949158|NCT00412061|12120408|FG000|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
10949159|NCT00412061|12120409|FG001|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
10949160|NCT00412061|12120408|FG000|COMPLETED|Double Blind Phase||0
10949161|NCT00412061|12120409|FG001|COMPLETED|Double Blind Phase||0
10949162|NCT00412061|12120408|FG000|NOT COMPLETED|Double Blind Phase||216
10949163|NCT00412061|12120409|FG001|NOT COMPLETED|Double Blind Phase||213
10949164|NCT00412061|12120408|FG000|STARTED|Open Label Phase||0
10949165|NCT00412061|12120409|FG001|STARTED|Open Label Phase||170
10949166|NCT00412061|12120408|FG000|COMPLETED|Open Label Phase||0
10949167|NCT00412061|12120409|FG001|COMPLETED|Open Label Phase||0
10949168|NCT00412061|12120408|FG000|NOT COMPLETED|Open Label Phase||0
10949169|NCT00412061|12120409|FG001|NOT COMPLETED|Open Label Phase||170
10949170|NCT00412074|12120421|FG000|STARTED|Overall Study||199
10949171|NCT00412074|12120422|FG001|STARTED|Overall Study||66
10949172|NCT00412074|12120423|FG002|STARTED|Overall Study||195
10949173|NCT00412074|12120421|FG000|COMPLETED|Overall Study||122
10949174|NCT00412074|12120422|FG001|COMPLETED|Overall Study||44
10949175|NCT00412074|12120423|FG002|COMPLETED|Overall Study||128
10949176|NCT00412074|12120421|FG000|NOT COMPLETED|Overall Study||77
10949177|NCT00412074|12120422|FG001|NOT COMPLETED|Overall Study||22
10949178|NCT00412074|12120423|FG002|NOT COMPLETED|Overall Study||67
10949179|NCT00412087|12120436|FG000|STARTED|Overall Study||134
10949180|NCT00412087|12120437|FG001|STARTED|Overall Study||131
10949181|NCT00412087|12120436|FG000|COMPLETED|Overall Study||72
10949182|NCT00412087|12120437|FG001|COMPLETED|Overall Study||66
10949183|NCT00412087|12120436|FG000|NOT COMPLETED|Overall Study||62
10949184|NCT00412087|12120437|FG001|NOT COMPLETED|Overall Study||65
10949185|NCT00412113|12120445|FG000|STARTED|Overall Study|15-January-2007|123
10949186|NCT00412113|12120446|FG001|STARTED|Overall Study|15-January-2007|122
10949187|NCT00412113|12120445|FG000|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
10949188|NCT00412113|12120446|FG001|Received Treatment|Overall Study||122
10949189|NCT00412113|12120445|FG000|COMPLETED|Overall Study|15-April-2008|111
10949190|NCT00412113|12120446|FG001|COMPLETED|Overall Study|15-April-2008|107
10949191|NCT00412113|12120445|FG000|NOT COMPLETED|Overall Study||12
10949192|NCT00412113|12120446|FG001|NOT COMPLETED|Overall Study||15
10949193|NCT00412217|12120454|FG000|STARTED|Overall Study||46
10949194|NCT00412217|12120455|FG001|STARTED|Overall Study||48
10949195|NCT00412217|12120454|FG000|COMPLETED|Overall Study||0
10949196|NCT00412217|12120455|FG001|COMPLETED|Overall Study||0
10949197|NCT00412217|12120454|FG000|NOT COMPLETED|Overall Study||46
10949198|NCT00412217|12120455|FG001|NOT COMPLETED|Overall Study||48
10949199|NCT00412243|12120461|FG000|STARTED|Overall Study||50
10949200|NCT00412243|12120461|FG000|COMPLETED|Overall Study||50
10949201|NCT00412243|12120461|FG000|NOT COMPLETED|Overall Study||0
10949202|NCT00412360|12120467|FG000|STARTED|Overall Study||113
10949203|NCT00412360|12120468|FG001|STARTED|Overall Study||111
10949204|NCT00412360|12120467|FG000|COMPLETED|Overall Study||112
10949205|NCT00412360|12120468|FG001|COMPLETED|Overall Study||108
10949206|NCT00412360|12120467|FG000|NOT COMPLETED|Overall Study||1
10949207|NCT00412360|12120468|FG001|NOT COMPLETED|Overall Study||3
10949208|NCT00412373|12120476|FG000|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
10949209|NCT00412373|12120477|FG001|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
10949210|NCT00412373|12120476|FG000|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
10949211|NCT00412373|12120477|FG001|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
10949212|NCT00412373|12120476|FG000|NOT COMPLETED|Overall Study||41
10949213|NCT00412373|12120477|FG001|NOT COMPLETED|Overall Study||77
10949214|NCT00412425|12120485|FG000|STARTED|Overall Study||15
10949215|NCT00412425|12120486|FG001|STARTED|Overall Study||15
10949216|NCT00412425|12120485|FG000|COMPLETED|Overall Study||15
10949217|NCT00412425|12120486|FG001|COMPLETED|Overall Study||15
10949218|NCT00412425|12120485|FG000|NOT COMPLETED|Overall Study||0
10949219|NCT00412425|12120486|FG001|NOT COMPLETED|Overall Study||0
10949220|NCT00412451|12120496|FG000|STARTED|Overall Study||8
10949221|NCT00412451|12120497|FG001|STARTED|Overall Study||15
10949222|NCT00412451|12120498|FG002|STARTED|Overall Study||15
10949223|NCT00412451|12120499|FG003|STARTED|Overall Study||13
10949224|NCT00412451|12120496|FG000|COMPLETED|Overall Study||8
10949225|NCT00412451|12120497|FG001|COMPLETED|Overall Study||15
10949226|NCT00412451|12120498|FG002|COMPLETED|Overall Study||14
10949227|NCT00412451|12120499|FG003|COMPLETED|Overall Study||11
10949228|NCT00412451|12120496|FG000|NOT COMPLETED|Overall Study||0
10949229|NCT00412451|12120497|FG001|NOT COMPLETED|Overall Study||0
10949230|NCT00412451|12120498|FG002|NOT COMPLETED|Overall Study||1
10949231|NCT00412451|12120499|FG003|NOT COMPLETED|Overall Study||2
10949232|NCT00412464|12120509|FG000|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
10949233|NCT00412464|12120509|FG000|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
10949234|NCT00412464|12120509|FG000|NOT COMPLETED|Overall Study||0
10949235|NCT00412516|12120516|FG000|STARTED|Overall Study||93
10949236|NCT00412516|12120517|FG001|STARTED|Overall Study||212
10949237|NCT00412516|12120518|FG002|STARTED|Overall Study||214
10949238|NCT00412516|12120516|FG000|COMPLETED|Overall Study||93
10949239|NCT00412516|12120517|FG001|COMPLETED|Overall Study||212
10949240|NCT00412516|12120518|FG002|COMPLETED|Overall Study||214
10949241|NCT00412516|12120516|FG000|NOT COMPLETED|Overall Study||0
10949242|NCT00412516|12120517|FG001|NOT COMPLETED|Overall Study||0
10949243|NCT00412516|12120518|FG002|NOT COMPLETED|Overall Study||0
10949244|NCT00412529|12120528|FG000|STARTED|Overall Study||23
10949245|NCT00412529|12120529|FG001|STARTED|Overall Study||21
10949246|NCT00412529|12120528|FG000|COMPLETED|Overall Study||23
10949247|NCT00412529|12120529|FG001|COMPLETED|Overall Study||21
10949248|NCT00412529|12120528|FG000|NOT COMPLETED|Overall Study||0
10949249|NCT00412529|12120529|FG001|NOT COMPLETED|Overall Study||0
10949250|NCT00412542|12120537|FG000|STARTED|Overall Study||33
10949251|NCT00412542|12120538|FG001|STARTED|Overall Study||45
10949252|NCT00412542|12120537|FG000|COMPLETED|Overall Study||33
10949253|NCT00412542|12120538|FG001|COMPLETED|Overall Study||42
10949254|NCT00412542|12120537|FG000|NOT COMPLETED|Overall Study||0
10949255|NCT00412542|12120538|FG001|NOT COMPLETED|Overall Study||3
10949256|NCT00412607|12120542|FG000|STARTED|Overall Study||249
10949257|NCT00412607|12120542|FG000|Started Study Catheter|Overall Study||233
10949258|NCT00412607|12120542|FG000|COMPLETED|Overall Study||145
10949259|NCT00412607|12120542|FG000|NOT COMPLETED|Overall Study||104
10949260|NCT00412737|12120551|FG000|STARTED|Overall Study||237
10949261|NCT00412737|12120552|FG001|STARTED|Overall Study||238
10949262|NCT00412737|12120551|FG000|COMPLETED|Overall Study||221
10949263|NCT00412737|12120552|FG001|COMPLETED|Overall Study||232
10949264|NCT00412737|12120551|FG000|NOT COMPLETED|Overall Study||16
10949265|NCT00412737|12120552|FG001|NOT COMPLETED|Overall Study||6
10949266|NCT00412750|12120561|FG000|STARTED|Overall Study||50
10949267|NCT00412750|12120562|FG001|STARTED|Overall Study||55
10949268|NCT00412750|12120563|FG002|STARTED|Overall Study||54
10949269|NCT00412750|12120561|FG000|COMPLETED|Overall Study||19
10949270|NCT00412750|12120562|FG001|COMPLETED|Overall Study||34
10949271|NCT00412750|12120563|FG002|COMPLETED|Overall Study||31
10949272|NCT00412750|12120561|FG000|NOT COMPLETED|Overall Study||31
10949273|NCT00412750|12120562|FG001|NOT COMPLETED|Overall Study||21
10949274|NCT00412750|12120563|FG002|NOT COMPLETED|Overall Study||23
10949275|NCT00412841|12120575|FG000|STARTED|Overall Study||22
10949276|NCT00412841|12120576|FG001|STARTED|Overall Study||21
10949277|NCT00412841|12120575|FG000|COMPLETED|Overall Study||12
10949278|NCT00412841|12120576|FG001|COMPLETED|Overall Study||16
10949279|NCT00412841|12120575|FG000|NOT COMPLETED|Overall Study||10
10949280|NCT00412841|12120576|FG001|NOT COMPLETED|Overall Study||5
10949281|NCT00412854|12120585|FG000|STARTED|Overall Study||330
10949282|NCT00412854|12120586|FG001|STARTED|Overall Study||330
10949283|NCT00412854|12120585|FG000|COMPLETED|Overall Study||316
10949284|NCT00412854|12120586|FG001|COMPLETED|Overall Study||314
10949285|NCT00412854|12120585|FG000|NOT COMPLETED|Overall Study||14
10949286|NCT00412854|12120586|FG001|NOT COMPLETED|Overall Study||16
10949287|NCT00412867|12120592|FG000|STARTED|Overall Study||58
10949288|NCT00412867|12120592|FG000|COMPLETED|Overall Study||58
10949289|NCT00412867|12120592|FG000|NOT COMPLETED|Overall Study||0
10949290|NCT00412893|12120599|FG000|STARTED|Overall Study||263
10949291|NCT00412893|12120600|FG001|STARTED|Overall Study||264
10949292|NCT00412893|12120599|FG000|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
10949293|NCT00412893|12120600|FG001|Received Treatment|Overall Study||258
10949294|NCT00412893|12120599|FG000|COMPLETED|Overall Study|Defined as completed treatment|118
10949295|NCT00412893|12120600|FG001|COMPLETED|Overall Study|Defined as completed treatment|120
10949296|NCT00412893|12120599|FG000|NOT COMPLETED|Overall Study||145
10949297|NCT00412893|12120600|FG001|NOT COMPLETED|Overall Study||144
10949298|NCT00412958|12120610|FG000|STARTED|Overall Study||29
10949299|NCT00412958|12120611|FG001|STARTED|Overall Study||33
10949300|NCT00412958|12120612|FG002|STARTED|Overall Study||32
10949301|NCT00412958|12120613|FG003|STARTED|Overall Study||31
10949302|NCT00412958|12120610|FG000|COMPLETED|Overall Study||26
10949303|NCT00412958|12120611|FG001|COMPLETED|Overall Study||29
10949304|NCT00412958|12120612|FG002|COMPLETED|Overall Study||32
10949305|NCT00412958|12120613|FG003|COMPLETED|Overall Study||30
10949306|NCT00412958|12120610|FG000|NOT COMPLETED|Overall Study||3
10949307|NCT00412958|12120611|FG001|NOT COMPLETED|Overall Study||4
10949308|NCT00412958|12120612|FG002|NOT COMPLETED|Overall Study||0
10949309|NCT00412958|12120613|FG003|NOT COMPLETED|Overall Study||1
10949310|NCT00412971|12120625|FG000|STARTED|Overall Study||115
10949311|NCT00412971|12120626|FG001|STARTED|Overall Study||118
10949312|NCT00412971|12120625|FG000|COMPLETED|Overall Study||85
10949313|NCT00412971|12120626|FG001|COMPLETED|Overall Study||108
10949314|NCT00412971|12120625|FG000|NOT COMPLETED|Overall Study||30
10949315|NCT00412971|12120626|FG001|NOT COMPLETED|Overall Study||10
10949316|NCT00412984|12120634|FG000|STARTED|Overall Study|Randomized participants|9120
10949317|NCT00412984|12120635|FG001|STARTED|Overall Study|Randomized participants|9081
10949318|NCT00412984|12120634|FG000|COMPLETED|Overall Study||6810
10949319|NCT00412984|12120635|FG001|COMPLETED|Overall Study||6588
10949320|NCT00412984|12120634|FG000|NOT COMPLETED|Overall Study||2310
10949321|NCT00412984|12120635|FG001|NOT COMPLETED|Overall Study||2493
10949322|NCT00413010|12120643|FG000|STARTED|Overall Study||180
10949323|NCT00413010|12120644|FG001|STARTED|Overall Study||176
10949324|NCT00413010|12120643|FG000|COMPLETED|Overall Study||108
10949325|NCT00413010|12120644|FG001|COMPLETED|Overall Study||113
10949326|NCT00413010|12120643|FG000|NOT COMPLETED|Overall Study||72
10949327|NCT00413010|12120644|FG001|NOT COMPLETED|Overall Study||63
10949328|NCT00413036|12120650|FG000|STARTED|Overall Study||217
10949329|NCT00413036|12120650|FG000|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
10949330|NCT00413036|12120650|FG000|NOT COMPLETED|Overall Study||217
10949331|NCT00413049|12120656|FG000|STARTED|Overall Study||349
10949332|NCT00413049|12120657|FG001|STARTED|Overall Study||349
10949333|NCT00413049|12120656|FG000|COMPLETED|Overall Study||325
10949334|NCT00413049|12120657|FG001|COMPLETED|Overall Study||331
10949335|NCT00413049|12120656|FG000|NOT COMPLETED|Overall Study||24
10949336|NCT00413049|12120657|FG001|NOT COMPLETED|Overall Study||18
10949337|NCT00413153|12120665|FG000|STARTED|Overall Study||7
10949338|NCT00413153|12120666|FG001|STARTED|Overall Study||8
10949339|NCT00413153|12120665|FG000|COMPLETED|Overall Study||5
10949340|NCT00413153|12120666|FG001|COMPLETED|Overall Study||7
10949341|NCT00413153|12120665|FG000|NOT COMPLETED|Overall Study||2
10949342|NCT00413153|12120666|FG001|NOT COMPLETED|Overall Study||1
10949343|NCT00413166|12120675|FG000|STARTED|Overall Study||57
10949344|NCT00413166|12120676|FG001|STARTED|Overall Study||5
10949345|NCT00413166|12120677|FG002|STARTED|Overall Study||16
10949346|NCT00413166|12120675|FG000|COMPLETED|Overall Study||57
10949347|NCT00413166|12120676|FG001|COMPLETED|Overall Study||5
10949348|NCT00413166|12120677|FG002|COMPLETED|Overall Study||16
10949349|NCT00413166|12120675|FG000|NOT COMPLETED|Overall Study||0
10949350|NCT00413166|12120676|FG001|NOT COMPLETED|Overall Study||0
10949351|NCT00413166|12120677|FG002|NOT COMPLETED|Overall Study||0
10949352|NCT00413192|12120689|FG000|STARTED|Overall Study||37
10949353|NCT00413192|12120690|FG001|STARTED|Overall Study||40
10949354|NCT00413192|12120691|FG002|STARTED|Overall Study||19
10949355|NCT00413192|12120692|FG003|STARTED|Overall Study||32
10949356|NCT00413192|12120689|FG000|COMPLETED|Overall Study||0
10949357|NCT00413192|12120690|FG001|COMPLETED|Overall Study||0
10949358|NCT00413192|12120691|FG002|COMPLETED|Overall Study||0
10949359|NCT00413192|12120692|FG003|COMPLETED|Overall Study||0
10949360|NCT00413192|12120689|FG000|NOT COMPLETED|Overall Study||37
10949361|NCT00413192|12120690|FG001|NOT COMPLETED|Overall Study||40
10949362|NCT00413192|12120691|FG002|NOT COMPLETED|Overall Study||19
10949363|NCT00413192|12120692|FG003|NOT COMPLETED|Overall Study||32
10949364|NCT00413218|12120704|FG000|STARTED|Overall Study||223
10949365|NCT00413218|12120705|FG001|STARTED|Overall Study||227
10949366|NCT00413218|12120704|FG000|Intent to Treat Population (ITT)|Overall Study||221
10949367|NCT00413218|12120705|FG001|Intent to Treat Population (ITT)|Overall Study||219
10949368|NCT00413218|12120704|FG000|COMPLETED|Overall Study||120
10949369|NCT00413218|12120705|FG001|COMPLETED|Overall Study||131
10949370|NCT00413218|12120704|FG000|NOT COMPLETED|Overall Study||103
10949371|NCT00413218|12120705|FG001|NOT COMPLETED|Overall Study||96
10949372|NCT00413231|12120712|FG000|STARTED|0 to 30-day Post Treatment||160
10949373|NCT00413231|12120712|FG000|COMPLETED|0 to 30-day Post Treatment||152
10949374|NCT00413231|12120712|FG000|NOT COMPLETED|0 to 30-day Post Treatment||8
10949375|NCT00413231|12120712|FG000|STARTED|30-day to 365-day Post Treatment||152
10949376|NCT00413231|12120712|FG000|COMPLETED|30-day to 365-day Post Treatment||139
10949377|NCT00413231|12120712|FG000|NOT COMPLETED|30-day to 365-day Post Treatment||13
10949378|NCT00413231|12120712|FG000|STARTED|365-day to 60-month Post Treatment||139
10949379|NCT00413231|12120712|FG000|COMPLETED|365-day to 60-month Post Treatment||93
10949380|NCT00413231|12120712|FG000|NOT COMPLETED|365-day to 60-month Post Treatment||46
10949381|NCT00413244|12120719|FG000|STARTED|Overall Study||31
10949382|NCT00413244|12120720|FG001|STARTED|Overall Study||20
10949383|NCT00413244|12120719|FG000|COMPLETED|Overall Study||21
10949384|NCT00413244|12120720|FG001|COMPLETED|Overall Study||19
10949385|NCT00413244|12120719|FG000|NOT COMPLETED|Overall Study||10
10949386|NCT00413244|12120720|FG001|NOT COMPLETED|Overall Study||1
10949387|NCT00413283|12120730|FG000|STARTED|Overall Study||12
10949388|NCT00413283|12120731|FG001|STARTED|Overall Study||16
10949389|NCT00413283|12120732|FG002|STARTED|Overall Study||18
10949390|NCT00413283|12120733|FG003|STARTED|Overall Study||17
10949391|NCT00413283|12120730|FG000|Received Study Drug|Overall Study||12
10949392|NCT00413283|12120731|FG001|Received Study Drug|Overall Study||16
10949393|NCT00413283|12120732|FG002|Received Study Drug|Overall Study||18
10949394|NCT00413283|12120733|FG003|Received Study Drug|Overall Study||16
10949395|NCT00413283|12120730|FG000|COMPLETED|Overall Study||11
10949396|NCT00413283|12120731|FG001|COMPLETED|Overall Study||13
10949397|NCT00413283|12120732|FG002|COMPLETED|Overall Study||16
10949398|NCT00413283|12120733|FG003|COMPLETED|Overall Study||13
10949399|NCT00413283|12120730|FG000|NOT COMPLETED|Overall Study||1
10949400|NCT00413283|12120731|FG001|NOT COMPLETED|Overall Study||3
10949401|NCT00413283|12120732|FG002|NOT COMPLETED|Overall Study||2
10949402|NCT00413283|12120733|FG003|NOT COMPLETED|Overall Study||4
10949403|NCT00413335|12120745|FG000|STARTED|Overall Study||12
10949404|NCT00413335|12120746|FG001|STARTED|Overall Study||9
10949405|NCT00413335|12120745|FG000|COMPLETED|Overall Study||12
10949406|NCT00413335|12120746|FG001|COMPLETED|Overall Study||9
10949407|NCT00413335|12120745|FG000|NOT COMPLETED|Overall Study||0
10949408|NCT00413335|12120746|FG001|NOT COMPLETED|Overall Study||0
10949409|NCT00413374|12120754|FG000|STARTED|Overall Study||40
10949410|NCT00413374|12120755|FG001|STARTED|Overall Study||80
10949411|NCT00413374|12120754|FG000|COMPLETED|Overall Study||34
10949412|NCT00413374|12120755|FG001|COMPLETED|Overall Study||80
10949413|NCT00413374|12120754|FG000|NOT COMPLETED|Overall Study||6
10949414|NCT00413374|12120755|FG001|NOT COMPLETED|Overall Study||0
10949415|NCT00413400|12120766|FG000|STARTED|Overall Study||24
10949416|NCT00413400|12120767|FG001|STARTED|Overall Study||16
10949417|NCT00413400|12120766|FG000|3 Month Visit|Overall Study||22
10949418|NCT00413400|12120767|FG001|3 Month Visit|Overall Study||12
10949419|NCT00413400|12120766|FG000|COMPLETED|Overall Study||22
10949420|NCT00413400|12120767|FG001|COMPLETED|Overall Study||12
10949421|NCT00413400|12120766|FG000|NOT COMPLETED|Overall Study||2
10949422|NCT00413400|12120767|FG001|NOT COMPLETED|Overall Study||4
10949423|NCT00413413|12120776|FG000|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
10949424|NCT00413413|12120777|FG001|STARTED|Single-Blind||1134
10949425|NCT00413413|12120778|FG002|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
10949426|NCT00413413|12120776|FG000|COMPLETED|Single-Blind||0
10949427|NCT00413413|12120777|FG001|COMPLETED|Single-Blind||918
10949428|NCT00413413|12120778|FG002|COMPLETED|Single-Blind||0
10949429|NCT00413413|12120776|FG000|NOT COMPLETED|Single-Blind||0
10949430|NCT00413413|12120777|FG001|NOT COMPLETED|Single-Blind||216
10949431|NCT00413413|12120778|FG002|NOT COMPLETED|Single-Blind||0
10949432|NCT00413413|12120776|FG000|STARTED|Double-Blind||308
10949433|NCT00413413|12120777|FG001|STARTED|Double-Blind||307
10949434|NCT00413413|12120778|FG002|STARTED|Double-Blind||303
10949435|NCT00413413|12120776|FG000|COMPLETED|Double-Blind||293
10949436|NCT00413413|12120777|FG001|COMPLETED|Double-Blind||293
10949437|NCT00413413|12120778|FG002|COMPLETED|Double-Blind||285
10949438|NCT00413413|12120776|FG000|NOT COMPLETED|Double-Blind||15
10949439|NCT00413413|12120777|FG001|NOT COMPLETED|Double-Blind||14
10949440|NCT00413413|12120778|FG002|NOT COMPLETED|Double-Blind||18
10949441|NCT00413478|12120786|FG000|STARTED|Overall Study||9
10949442|NCT00413478|12120786|FG000|COMPLETED|Overall Study||9
10949443|NCT00413478|12120786|FG000|NOT COMPLETED|Overall Study||0
10949444|NCT00413582|12120792|FG000|STARTED|Overall Study|all enrolled completed|55
10949445|NCT00413582|12120793|FG001|STARTED|Overall Study|all enrolled completed|55
10949446|NCT00413582|12120792|FG000|Completion of Study|Overall Study|all enrolled completed|55
10949447|NCT00413582|12120793|FG001|Completion of Study|Overall Study|all enrolled completed|55
10949448|NCT00413582|12120792|FG000|COMPLETED|Overall Study|all enrolled completed|55
10949449|NCT00413582|12120793|FG001|COMPLETED|Overall Study|all enrolled completed|55
10949450|NCT00413582|12120792|FG000|NOT COMPLETED|Overall Study||0
10949451|NCT00413582|12120793|FG001|NOT COMPLETED|Overall Study||0
10949452|NCT00413634|12120801|FG000|STARTED|Overall Study||12
10949453|NCT00413634|12120802|FG001|STARTED|Overall Study||12
10949454|NCT00413634|12120801|FG000|COMPLETED|Overall Study||12
10949455|NCT00413634|12120802|FG001|COMPLETED|Overall Study||12
10949456|NCT00413634|12120801|FG000|NOT COMPLETED|Overall Study||0
10949457|NCT00413634|12120802|FG001|NOT COMPLETED|Overall Study||0
10949458|NCT00413660|12120817|FG000|STARTED|Up To Week 12||71
10949459|NCT00413660|12120818|FG001|STARTED|Up To Week 12||68
10949460|NCT00413660|12120819|FG002|STARTED|Up To Week 12||71
10949461|NCT00413660|12120820|FG003|STARTED|Up To Week 12||75
10949462|NCT00413660|12120821|FG004|STARTED|Up To Week 12||75
10949463|NCT00413660|12120822|FG005|STARTED|Up To Week 12||80
10949464|NCT00413660|12120823|FG006|STARTED|Up To Week 12||69
10949465|NCT00413660|12120824|FG007|STARTED|Up To Week 12||0
10949466|NCT00413660|12120825|FG008|STARTED|Up To Week 12||0
10949467|NCT00413660|12120826|FG009|STARTED|Up To Week 12||0
10949468|NCT00413660|12120827|FG010|STARTED|Up To Week 12||0
10949469|NCT00413660|12120817|FG000|Treated|Up To Week 12||70
10949470|NCT00413660|12120818|FG001|Treated|Up To Week 12||68
10949471|NCT00413660|12120819|FG002|Treated|Up To Week 12||71
10949472|NCT00413660|12120820|FG003|Treated|Up To Week 12||74
10949473|NCT00413660|12120821|FG004|Treated|Up To Week 12||75
10949474|NCT00413660|12120822|FG005|Treated|Up To Week 12||80
10949475|NCT00413660|12120823|FG006|Treated|Up To Week 12||69
10949476|NCT00413660|12120824|FG007|Treated|Up To Week 12||0
10949477|NCT00413660|12120825|FG008|Treated|Up To Week 12||0
10949478|NCT00413660|12120826|FG009|Treated|Up To Week 12||0
10949479|NCT00413660|12120827|FG010|Treated|Up To Week 12||0
10949480|NCT00413660|12120817|FG000|COMPLETED|Up To Week 12||64
10949481|NCT00413660|12120818|FG001|COMPLETED|Up To Week 12||61
10949482|NCT00413660|12120819|FG002|COMPLETED|Up To Week 12||64
10949483|NCT00413660|12120820|FG003|COMPLETED|Up To Week 12||67
10949484|NCT00413660|12120821|FG004|COMPLETED|Up To Week 12||66
10949485|NCT00413660|12120822|FG005|COMPLETED|Up To Week 12||70
10949486|NCT00413660|12120823|FG006|COMPLETED|Up To Week 12||58
10949487|NCT00413660|12120824|FG007|COMPLETED|Up To Week 12||0
10949488|NCT00413660|12120825|FG008|COMPLETED|Up To Week 12||0
10949489|NCT00413660|12120826|FG009|COMPLETED|Up To Week 12||0
10949490|NCT00413660|12120827|FG010|COMPLETED|Up To Week 12||0
10949491|NCT00413660|12120817|FG000|NOT COMPLETED|Up To Week 12||7
10949492|NCT00413660|12120818|FG001|NOT COMPLETED|Up To Week 12||7
10949493|NCT00413660|12120819|FG002|NOT COMPLETED|Up To Week 12||7
10949494|NCT00413660|12120820|FG003|NOT COMPLETED|Up To Week 12||8
10949495|NCT00413660|12120821|FG004|NOT COMPLETED|Up To Week 12||9
10949496|NCT00413660|12120822|FG005|NOT COMPLETED|Up To Week 12||10
10949497|NCT00413660|12120823|FG006|NOT COMPLETED|Up To Week 12||11
10949498|NCT00413660|12120824|FG007|NOT COMPLETED|Up To Week 12||0
10949499|NCT00413660|12120825|FG008|NOT COMPLETED|Up To Week 12||0
10949500|NCT00413660|12120826|FG009|NOT COMPLETED|Up To Week 12||0
10949501|NCT00413660|12120827|FG010|NOT COMPLETED|Up To Week 12||0
10949502|NCT00413660|12120817|FG000|STARTED|Post Week 12||43
10949503|NCT00413660|12120818|FG001|STARTED|Post Week 12||48
10949504|NCT00413660|12120819|FG002|STARTED|Post Week 12||64
10949505|NCT00413660|12120820|FG003|STARTED|Post Week 12||67
10949506|NCT00413660|12120821|FG004|STARTED|Post Week 12||66
10949507|NCT00413660|12120822|FG005|STARTED|Post Week 12||57
10949508|NCT00413660|12120823|FG006|STARTED|Post Week 12||40
10949509|NCT00413660|12120824|FG007|STARTED|Post Week 12||21
10949510|NCT00413660|12120825|FG008|STARTED|Post Week 12||13
10949511|NCT00413660|12120826|FG009|STARTED|Post Week 12||13
10949512|NCT00413660|12120827|FG010|STARTED|Post Week 12||18
10949513|NCT00413660|12120817|FG000|COMPLETED|Post Week 12||40
10949514|NCT00413660|12120818|FG001|COMPLETED|Post Week 12||44
10949515|NCT00413660|12120819|FG002|COMPLETED|Post Week 12||56
10949516|NCT00413660|12120820|FG003|COMPLETED|Post Week 12||66
10949517|NCT00413660|12120821|FG004|COMPLETED|Post Week 12||60
10949518|NCT00413660|12120822|FG005|COMPLETED|Post Week 12||54
10949519|NCT00413660|12120823|FG006|COMPLETED|Post Week 12||37
10949520|NCT00413660|12120824|FG007|COMPLETED|Post Week 12||21
10949521|NCT00413660|12120825|FG008|COMPLETED|Post Week 12||13
10949522|NCT00413660|12120826|FG009|COMPLETED|Post Week 12||12
10949523|NCT00413660|12120827|FG010|COMPLETED|Post Week 12||17
10949524|NCT00413660|12120817|FG000|NOT COMPLETED|Post Week 12||3
10949525|NCT00413660|12120818|FG001|NOT COMPLETED|Post Week 12||4
10949526|NCT00413660|12120819|FG002|NOT COMPLETED|Post Week 12||8
10949527|NCT00413660|12120820|FG003|NOT COMPLETED|Post Week 12||1
10949528|NCT00413660|12120821|FG004|NOT COMPLETED|Post Week 12||6
10949529|NCT00413660|12120822|FG005|NOT COMPLETED|Post Week 12||3
10949530|NCT00413660|12120823|FG006|NOT COMPLETED|Post Week 12||3
10949531|NCT00413660|12120824|FG007|NOT COMPLETED|Post Week 12||0
10949532|NCT00413660|12120825|FG008|NOT COMPLETED|Post Week 12||0
10949533|NCT00413660|12120826|FG009|NOT COMPLETED|Post Week 12||1
10949534|NCT00413660|12120827|FG010|NOT COMPLETED|Post Week 12||1
10949535|NCT00413777|12120859|FG000|STARTED|Fixed-dose Period||22
10949536|NCT00413777|12120860|FG001|STARTED|Fixed-dose Period||24
10949537|NCT00413777|12120859|FG000|COMPLETED|Fixed-dose Period||18
10949538|NCT00413777|12120860|FG001|COMPLETED|Fixed-dose Period||21
10949539|NCT00413777|12120859|FG000|NOT COMPLETED|Fixed-dose Period||4
10949540|NCT00413777|12120860|FG001|NOT COMPLETED|Fixed-dose Period||3
10949541|NCT00413777|12120859|FG000|STARTED|Extension Period||17
10949542|NCT00413777|12120860|FG001|STARTED|Extension Period||18
10949543|NCT00413777|12120859|FG000|COMPLETED|Extension Period||17
10949544|NCT00413777|12120860|FG001|COMPLETED|Extension Period||18
10949545|NCT00413777|12120859|FG000|NOT COMPLETED|Extension Period||0
10949546|NCT00413777|12120860|FG001|NOT COMPLETED|Extension Period||0
10949547|NCT00413894|12120866|FG000|STARTED|Overall Study||424
10949548|NCT00413894|12120866|FG000|COMPLETED|Overall Study||344
10949549|NCT00413894|12120866|FG000|NOT COMPLETED|Overall Study||80
10949550|NCT00413920|12120875|FG000|STARTED|Overall Study||112
10949551|NCT00413920|12120876|FG001|STARTED|Overall Study||110
10949552|NCT00413920|12120875|FG000|COMPLETED|Overall Study||84
10949553|NCT00413920|12120876|FG001|COMPLETED|Overall Study||82
10949554|NCT00413920|12120875|FG000|NOT COMPLETED|Overall Study||28
10949555|NCT00413920|12120876|FG001|NOT COMPLETED|Overall Study||28
10949556|NCT00413959|12120882|FG000|STARTED|Overall Study||12
10949557|NCT00413959|12120882|FG000|COMPLETED|Overall Study||11
10949558|NCT00413959|12120882|FG000|NOT COMPLETED|Overall Study||1
10949559|NCT00414011|12120886|FG000|STARTED|Overall Study||40
10949560|NCT00414011|12120886|FG000|COMPLETED|Overall Study||35
10949561|NCT00414011|12120886|FG000|NOT COMPLETED|Overall Study||5
10949562|NCT00414050|12120895|FG000|STARTED|Overall Study||431
10949563|NCT00414050|12120896|FG001|STARTED|Overall Study||427
10949564|NCT00414050|12120897|FG002|STARTED|Overall Study||429
10949565|NCT00414050|12120898|FG003|STARTED|Overall Study||431
10949566|NCT00414050|12120895|FG000|Received Vaccination 1|Overall Study||431
10949567|NCT00414050|12120896|FG001|Received Vaccination 1|Overall Study||426
10949568|NCT00414050|12120897|FG002|Received Vaccination 1|Overall Study||429
10949569|NCT00414050|12120898|FG003|Received Vaccination 1|Overall Study||431
10949570|NCT00414050|12120895|FG000|Received Vaccination 2|Overall Study||425
10949571|NCT00414050|12120896|FG001|Received Vaccination 2|Overall Study||421
10949572|NCT00414050|12120897|FG002|Received Vaccination 2|Overall Study||425
10949573|NCT00414050|12120898|FG003|Received Vaccination 2|Overall Study||425
10949574|NCT00414050|12120895|FG000|Received Vaccination 3|Overall Study||424
10949575|NCT00414050|12120896|FG001|Received Vaccination 3|Overall Study||419
10949576|NCT00414050|12120897|FG002|Received Vaccination 3|Overall Study||425
10949577|NCT00414050|12120898|FG003|Received Vaccination 3|Overall Study||424
10949578|NCT00414050|12120895|FG000|COMPLETED|Overall Study||422
10949579|NCT00414050|12120896|FG001|COMPLETED|Overall Study||419
10949580|NCT00414050|12120897|FG002|COMPLETED|Overall Study||423
10949581|NCT00414050|12120898|FG003|COMPLETED|Overall Study||423
10949582|NCT00414050|12120895|FG000|NOT COMPLETED|Overall Study||9
10949583|NCT00414050|12120896|FG001|NOT COMPLETED|Overall Study||8
10949584|NCT00414050|12120897|FG002|NOT COMPLETED|Overall Study||6
10949585|NCT00414050|12120898|FG003|NOT COMPLETED|Overall Study||8
10949586|NCT00414076|12120910|FG000|STARTED|Overall Study||4
10949587|NCT00414076|12120911|FG001|STARTED|Overall Study||5
10949588|NCT00414076|12120910|FG000|COMPLETED|Overall Study||1
10949589|NCT00414076|12120911|FG001|COMPLETED|Overall Study||0
10949590|NCT00414076|12120910|FG000|NOT COMPLETED|Overall Study||3
10949591|NCT00414076|12120911|FG001|NOT COMPLETED|Overall Study||5
10949592|NCT00414167|12120919|FG000|STARTED|Overall Study||31
10949593|NCT00414167|12120920|FG001|STARTED|Overall Study||30
10949594|NCT00414167|12120919|FG000|COMPLETED|Overall Study||27
10949595|NCT00414167|12120920|FG001|COMPLETED|Overall Study||27
10949596|NCT00414167|12120919|FG000|NOT COMPLETED|Overall Study||4
10949597|NCT00414167|12120920|FG001|NOT COMPLETED|Overall Study||3
10949598|NCT00414206|12120931|FG000|STARTED|Overall Study||115
10949599|NCT00414206|12120932|FG001|STARTED|Overall Study||114
10949600|NCT00414206|12120933|FG002|STARTED|Overall Study||114
10949601|NCT00414206|12120931|FG000|COMPLETED|Overall Study||57
10949602|NCT00414206|12120932|FG001|COMPLETED|Overall Study||58
10949603|NCT00414206|12120933|FG002|COMPLETED|Overall Study||59
10949604|NCT00414206|12120931|FG000|NOT COMPLETED|Overall Study||58
10949605|NCT00414206|12120932|FG001|NOT COMPLETED|Overall Study||56
10949606|NCT00414206|12120933|FG002|NOT COMPLETED|Overall Study||55
10949607|NCT00414271|12120941|FG000|STARTED|Overall Study||18
10949608|NCT00414271|12120941|FG000|COMPLETED|Overall Study||18
10949609|NCT00414271|12120941|FG000|NOT COMPLETED|Overall Study||0
10949610|NCT00414310|12120947|FG000|STARTED|Overall Study||71
10949611|NCT00414310|12120948|FG001|STARTED|Overall Study||79
10949612|NCT00414310|12120947|FG000|COMPLETED|Overall Study||70
10949613|NCT00414310|12120948|FG001|COMPLETED|Overall Study||79
10949614|NCT00414310|12120947|FG000|NOT COMPLETED|Overall Study||1
10949615|NCT00414310|12120948|FG001|NOT COMPLETED|Overall Study||0
10949616|NCT00414388|12120956|FG000|STARTED|Overall Study||22
10949617|NCT00414388|12120956|FG000|COMPLETED|Overall Study||21
10949618|NCT00414388|12120956|FG000|NOT COMPLETED|Overall Study||1
10949619|NCT00414440|12120963|FG000|STARTED|Core Period|Core period|214
10949620|NCT00414440|12120964|FG001|STARTED|Core Period|Core period|217
10949621|NCT00414440|12120963|FG000|COMPLETED|Core Period|Core period|144
10949622|NCT00414440|12120964|FG001|COMPLETED|Core Period|Core period|185
10949623|NCT00414440|12120963|FG000|NOT COMPLETED|Core Period||70
10949624|NCT00414440|12120964|FG001|NOT COMPLETED|Core Period||32
10949625|NCT00414440|12120963|FG000|STARTED|Extension Period|Extension|214
10949626|NCT00414440|12120964|FG001|STARTED|Extension Period|Extension|217
10949627|NCT00414440|12120963|FG000|COMPLETED|Extension Period|Extension|64
10949628|NCT00414440|12120964|FG001|COMPLETED|Extension Period|Extension|77
10949629|NCT00414440|12120963|FG000|NOT COMPLETED|Extension Period||150
10949630|NCT00414440|12120964|FG001|NOT COMPLETED|Extension Period||140
10949631|NCT00414466|12120974|FG000|STARTED|Overall Study||44
10949632|NCT00414466|12120975|FG001|STARTED|Overall Study||42
10949633|NCT00414466|12120976|FG002|STARTED|Overall Study||41
10949634|NCT00414466|12120977|FG003|STARTED|Overall Study||43
10949635|NCT00414466|12120974|FG000|COMPLETED|Overall Study||42
10949636|NCT00414466|12120975|FG001|COMPLETED|Overall Study||42
10949637|NCT00414466|12120976|FG002|COMPLETED|Overall Study||40
10949638|NCT00414466|12120977|FG003|COMPLETED|Overall Study||42
10949639|NCT00414466|12120974|FG000|NOT COMPLETED|Overall Study||2
10949640|NCT00414466|12120975|FG001|NOT COMPLETED|Overall Study||0
10949641|NCT00414466|12120976|FG002|NOT COMPLETED|Overall Study||1
10949642|NCT00414466|12120977|FG003|NOT COMPLETED|Overall Study||1
10949643|NCT00414518|12120992|FG000|STARTED|Overall Study||7
10949644|NCT00414518|12120993|FG001|STARTED|Overall Study||9
10949645|NCT00414518|12120992|FG000|COMPLETED|Overall Study||7
10949646|NCT00414518|12120993|FG001|COMPLETED|Overall Study||9
10949647|NCT00414518|12120992|FG000|NOT COMPLETED|Overall Study||0
10949648|NCT00414518|12120993|FG001|NOT COMPLETED|Overall Study||0
10949649|NCT00414544|12121003|FG000|STARTED|Overall Study||145
10949650|NCT00414544|12121003|FG000|COMPLETED|Overall Study||131
10949651|NCT00414544|12121003|FG000|NOT COMPLETED|Overall Study||14
10949652|NCT00414596|12121009|FG000|STARTED|Overall Study|December 2006|20
10949653|NCT00414596|12121009|FG000|COMPLETED|Overall Study|April 2007|18
10949654|NCT00414596|12121009|FG000|NOT COMPLETED|Overall Study||2
10949655|NCT00414609|12121015|FG000|STARTED|Core Study||397
10949656|NCT00414609|12121016|FG001|STARTED|Core Study||423
10949657|NCT00414609|12121017|FG002|STARTED|Core Study||0
10949658|NCT00414609|12121015|FG000|Received Study Drug|Core Study||397
10949659|NCT00414609|12121016|FG001|Received Study Drug|Core Study||422
10949660|NCT00414609|12121017|FG002|Received Study Drug|Core Study||0
10949661|NCT00414609|12121015|FG000|Echocardiogram Evaluable Set|Core Study||330
10949662|NCT00414609|12121016|FG001|Echocardiogram Evaluable Set|Core Study||343
10949663|NCT00414609|12121017|FG002|Echocardiogram Evaluable Set|Core Study||0
10949664|NCT00414609|12121015|FG000|COMPLETED|Core Study||363
10949665|NCT00414609|12121016|FG001|COMPLETED|Core Study||378
10949666|NCT00414609|12121017|FG002|COMPLETED|Core Study||0
10949667|NCT00414609|12121015|FG000|NOT COMPLETED|Core Study||34
10949668|NCT00414609|12121016|FG001|NOT COMPLETED|Core Study||45
10949669|NCT00414609|12121017|FG002|NOT COMPLETED|Core Study||0
10949670|NCT00414609|12121015|FG000|STARTED|Extension Study||0
10949671|NCT00414609|12121016|FG001|STARTED|Extension Study||0
10949672|NCT00414609|12121017|FG002|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
10949673|NCT00414609|12121015|FG000|Echocardiogram (ECHO) Analysis Set|Extension Study||0
10949674|NCT00414609|12121016|FG001|Echocardiogram (ECHO) Analysis Set|Extension Study||0
10949675|NCT00414609|12121017|FG002|Echocardiogram (ECHO) Analysis Set|Extension Study||400
10949676|NCT00414609|12121015|FG000|COMPLETED|Extension Study||0
10949677|NCT00414609|12121016|FG001|COMPLETED|Extension Study||0
10949678|NCT00414609|12121017|FG002|COMPLETED|Extension Study||365
10949679|NCT00414609|12121015|FG000|NOT COMPLETED|Extension Study||0
10949680|NCT00414609|12121016|FG001|NOT COMPLETED|Extension Study||0
10949681|NCT00414609|12121017|FG002|NOT COMPLETED|Extension Study||57
10949682|NCT00414635|12121028|FG000|STARTED|Overall Study||30
10949683|NCT00414635|12121029|FG001|STARTED|Overall Study||30
10949684|NCT00414635|12121028|FG000|COMPLETED|Overall Study||25
10949685|NCT00414635|12121029|FG001|COMPLETED|Overall Study||28
10949686|NCT00414635|12121028|FG000|NOT COMPLETED|Overall Study||5
10949687|NCT00414635|12121029|FG001|NOT COMPLETED|Overall Study||2
10949688|NCT00414661|12121039|FG000|STARTED|Overall Study||48
10949689|NCT00414661|12121040|FG001|STARTED|Overall Study||89
10949690|NCT00414661|12121041|FG002|STARTED|Overall Study||22
10949691|NCT00414661|12121042|FG003|STARTED|Overall Study||3
10949692|NCT00414661|12121039|FG000|COMPLETED|Overall Study||34
10949693|NCT00414661|12121040|FG001|COMPLETED|Overall Study||75
10949694|NCT00414661|12121041|FG002|COMPLETED|Overall Study||20
10949695|NCT00414661|12121042|FG003|COMPLETED|Overall Study||0
10949696|NCT00414661|12121039|FG000|NOT COMPLETED|Overall Study||14
10949697|NCT00414661|12121040|FG001|NOT COMPLETED|Overall Study||14
10949698|NCT00414661|12121041|FG002|NOT COMPLETED|Overall Study||2
10949699|NCT00414661|12121042|FG003|NOT COMPLETED|Overall Study||3
10949700|NCT00414700|12121054|FG000|STARTED|Overall Study||57
10949701|NCT00414700|12121055|FG001|STARTED|Overall Study||61
10949702|NCT00414700|12121054|FG000|COMPLETED|Overall Study||51
10949703|NCT00414700|12121055|FG001|COMPLETED|Overall Study||58
10949704|NCT00414700|12121054|FG000|NOT COMPLETED|Overall Study||6
10949705|NCT00414700|12121055|FG001|NOT COMPLETED|Overall Study||3
10949706|NCT00414726|12121063|FG000|STARTED|Overall Study||43
10949707|NCT00414726|12121064|FG001|STARTED|Overall Study||42
10949708|NCT00414726|12121063|FG000|COMPLETED|Overall Study||43
10949709|NCT00414726|12121064|FG001|COMPLETED|Overall Study||41
10949710|NCT00414726|12121063|FG000|NOT COMPLETED|Overall Study||0
10949711|NCT00414726|12121064|FG001|NOT COMPLETED|Overall Study||1
10949712|NCT00414765|12121072|FG000|STARTED|Overall Study||7
10949713|NCT00414765|12121073|FG001|STARTED|Overall Study||19
10949714|NCT00414765|12121072|FG000|Completed Study|Overall Study||7
10949715|NCT00414765|12121073|FG001|Completed Study|Overall Study||18
10949716|NCT00414765|12121072|FG000|Completed Cycle 1|Overall Study||7
10949717|NCT00414765|12121073|FG001|Completed Cycle 1|Overall Study||19
10949718|NCT00414765|12121072|FG000|Completed Cycle 2|Overall Study||4
10949719|NCT00414765|12121073|FG001|Completed Cycle 2|Overall Study||16
10949720|NCT00414765|12121072|FG000|COMPLETED|Overall Study||1
10949721|NCT00414765|12121073|FG001|COMPLETED|Overall Study||8
10949722|NCT00414765|12121072|FG000|NOT COMPLETED|Overall Study||6
10949723|NCT00414765|12121073|FG001|NOT COMPLETED|Overall Study||11
10949724|NCT00414817|12121081|FG000|STARTED|Overall Study||7033
10949725|NCT00414817|12121082|FG001|STARTED|Overall Study||7031
10949726|NCT00414817|12121081|FG000|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
10949727|NCT00414817|12121082|FG001|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
10949728|NCT00414817|12121081|FG000|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
10949729|NCT00414817|12121082|FG001|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
10949730|NCT00414817|12121081|FG000|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
10949731|NCT00414817|12121082|FG001|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
10949732|NCT00414817|12121081|FG000|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
10949733|NCT00414817|12121082|FG001|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
10949734|NCT00414817|12121081|FG000|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
10949735|NCT00414817|12121082|FG001|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
10949736|NCT00414817|12121081|FG000|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
10949737|NCT00414817|12121082|FG001|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
10949738|NCT00414817|12121081|FG000|NOT COMPLETED|Overall Study||3130
10949739|NCT00414817|12121082|FG001|NOT COMPLETED|Overall Study||3016
10949740|NCT00414908|12121090|FG000|STARTED|Overall Study||25
10949741|NCT00414908|12121091|FG001|STARTED|Overall Study||29
10949742|NCT00414908|12121090|FG000|COMPLETED|Overall Study||24
10949743|NCT00414908|12121091|FG001|COMPLETED|Overall Study||28
10949744|NCT00414908|12121090|FG000|NOT COMPLETED|Overall Study||1
10949745|NCT00414908|12121091|FG001|NOT COMPLETED|Overall Study||1
10949746|NCT00414960|12121101|FG000|STARTED|Overall Study||25
10949747|NCT00414960|12121102|FG001|STARTED|Overall Study||15
10949748|NCT00414960|12121101|FG000|Received at Least One Dose of Study Drug|Overall Study||24
10949749|NCT00414960|12121102|FG001|Received at Least One Dose of Study Drug|Overall Study||15
10949750|NCT00414960|12121101|FG000|COMPLETED|Overall Study||18
10949751|NCT00414960|12121102|FG001|COMPLETED|Overall Study||14
10949752|NCT00414960|12121101|FG000|NOT COMPLETED|Overall Study||7
10949753|NCT00414960|12121102|FG001|NOT COMPLETED|Overall Study||1
10949754|NCT00414973|12121112|FG000|STARTED|Overall Study||218
10949755|NCT00414973|12121113|FG001|STARTED|Overall Study||109
10949756|NCT00414973|12121114|FG002|STARTED|Overall Study||24
10949757|NCT00414973|12121115|FG003|STARTED|Overall Study||11
10949758|NCT00414973|12121112|FG000|COMPLETED|Overall Study||190
10949759|NCT00414973|12121113|FG001|COMPLETED|Overall Study||99
10949760|NCT00414973|12121114|FG002|COMPLETED|Overall Study||21
10949761|NCT00414973|12121115|FG003|COMPLETED|Overall Study||11
10949762|NCT00414973|12121112|FG000|NOT COMPLETED|Overall Study||28
10949763|NCT00414973|12121113|FG001|NOT COMPLETED|Overall Study||10
10949764|NCT00414973|12121114|FG002|NOT COMPLETED|Overall Study||3
10949765|NCT00414973|12121115|FG003|NOT COMPLETED|Overall Study||0
10949766|NCT00415051|12121125|FG000|STARTED|Overall Study||20
10949767|NCT00415051|12121125|FG000|COMPLETED|Overall Study||19
10949768|NCT00415051|12121125|FG000|NOT COMPLETED|Overall Study||1
10949769|NCT00415168|12121129|FG000|STARTED|Overall Study||53
10949770|NCT00415168|12121129|FG000|Completed Treatment|Overall Study||15
10949771|NCT00415168|12121129|FG000|COMPLETED|Overall Study||1
10949772|NCT00415168|12121129|FG000|NOT COMPLETED|Overall Study||52
10949773|NCT00415194|12121135|FG000|STARTED|Overall Study||398
10949774|NCT00415194|12121136|FG001|STARTED|Overall Study||397
10949775|NCT00415194|12121135|FG000|Received at Least 1 Dose of Study Drug|Overall Study||392
10949776|NCT00415194|12121136|FG001|Received at Least 1 Dose of Study Drug|Overall Study||385
10949777|NCT00415194|12121135|FG000|COMPLETED|Overall Study||70
10949778|NCT00415194|12121136|FG001|COMPLETED|Overall Study||55
10949779|NCT00415194|12121135|FG000|NOT COMPLETED|Overall Study||328
10949780|NCT00415194|12121136|FG001|NOT COMPLETED|Overall Study||342
10949781|NCT00415363|12121144|FG000|STARTED|Overall Study||55
10949782|NCT00415363|12121145|FG001|STARTED|Overall Study||54
10949783|NCT00415363|12121144|FG000|Safety Population|Overall Study||54
10949784|NCT00415363|12121145|FG001|Safety Population|Overall Study||53
10949785|NCT00415363|12121144|FG000|COMPLETED|Overall Study||0
10949786|NCT00415363|12121145|FG001|COMPLETED|Overall Study||0
10949787|NCT00415363|12121144|FG000|NOT COMPLETED|Overall Study||55
10949788|NCT00415363|12121145|FG001|NOT COMPLETED|Overall Study||54
10949789|NCT00415493|12121154|FG000|STARTED|Overall Study||12
10949790|NCT00415493|12121155|FG001|STARTED|Overall Study||12
10949791|NCT00415493|12121154|FG000|COMPLETED|Overall Study||12
10949792|NCT00415493|12121155|FG001|COMPLETED|Overall Study||12
10949793|NCT00415493|12121154|FG000|NOT COMPLETED|Overall Study||0
10949794|NCT00415493|12121155|FG001|NOT COMPLETED|Overall Study||0
10949795|NCT00415506|12121163|FG000|STARTED|Overall Study||12
10949796|NCT00415506|12121164|FG001|STARTED|Overall Study||10
10949797|NCT00415506|12121163|FG000|COMPLETED|Overall Study||9
10949798|NCT00415506|12121164|FG001|COMPLETED|Overall Study||9
10949799|NCT00415506|12121163|FG000|NOT COMPLETED|Overall Study||3
10949800|NCT00415506|12121164|FG001|NOT COMPLETED|Overall Study||1
10949801|NCT00415519|12121172|FG000|STARTED|Overall Study||13
10949802|NCT00415519|12121173|FG001|STARTED|Overall Study||12
10949803|NCT00415519|12121172|FG000|COMPLETED|Overall Study||9
10949804|NCT00415519|12121173|FG001|COMPLETED|Overall Study||12
10949805|NCT00415519|12121172|FG000|NOT COMPLETED|Overall Study||4
10949806|NCT00415519|12121173|FG001|NOT COMPLETED|Overall Study||0
10949807|NCT00415597|12121179|FG000|STARTED|Enrollment||467
10949808|NCT00415597|12121179|FG000|COMPLETED|Enrollment||465
10949809|NCT00415597|12121179|FG000|NOT COMPLETED|Enrollment||2
10949810|NCT00415597|12121179|FG000|STARTED|Treatment||465
10949811|NCT00415597|12121179|FG000|COMPLETED|Treatment||160
10949812|NCT00415597|12121179|FG000|NOT COMPLETED|Treatment||305
10949813|NCT00415610|12121186|FG000|STARTED|Overall Study||18
10949814|NCT00415610|12121187|FG001|STARTED|Overall Study||20
10949815|NCT00415610|12121188|FG002|STARTED|Overall Study||22
10949816|NCT00415610|12121186|FG000|COMPLETED|Overall Study||15
10949817|NCT00415610|12121187|FG001|COMPLETED|Overall Study||18
10949818|NCT00415610|12121188|FG002|COMPLETED|Overall Study||17
10949819|NCT00415610|12121186|FG000|NOT COMPLETED|Overall Study||3
10949820|NCT00415610|12121187|FG001|NOT COMPLETED|Overall Study||2
10949821|NCT00415610|12121188|FG002|NOT COMPLETED|Overall Study||5
10949822|NCT00415636|12121202|FG000|STARTED|Overall Study||3
10949823|NCT00415636|12121203|FG001|STARTED|Overall Study||3
10949824|NCT00415636|12121204|FG002|STARTED|Overall Study||3
10949825|NCT00415636|12121205|FG003|STARTED|Overall Study||13
10949826|NCT00415636|12121206|FG004|STARTED|Overall Study||6
10949827|NCT00415636|12121207|FG005|STARTED|Overall Study||3
10949828|NCT00415636|12121202|FG000|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
10949829|NCT00415636|12121203|FG001|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
10949830|NCT00415636|12121204|FG002|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
10949831|NCT00415636|12121205|FG003|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
10949832|NCT00415636|12121206|FG004|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
10949833|NCT00415636|12121207|FG005|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
10949834|NCT00415636|12121202|FG000|NOT COMPLETED|Overall Study||1
10949835|NCT00415636|12121203|FG001|NOT COMPLETED|Overall Study||0
10949836|NCT00415636|12121204|FG002|NOT COMPLETED|Overall Study||1
10949837|NCT00415636|12121205|FG003|NOT COMPLETED|Overall Study||6
10949838|NCT00415636|12121206|FG004|NOT COMPLETED|Overall Study||2
10949839|NCT00415636|12121207|FG005|NOT COMPLETED|Overall Study||2
10949840|NCT00415857|12121231|FG000|STARTED|Overall Study||2
10949841|NCT00415857|12121232|FG001|STARTED|Overall Study||3
10949842|NCT00415857|12121231|FG000|COMPLETED|Overall Study||2
10949843|NCT00415857|12121232|FG001|COMPLETED|Overall Study||3
10949844|NCT00415857|12121231|FG000|NOT COMPLETED|Overall Study||0
10949845|NCT00415857|12121232|FG001|NOT COMPLETED|Overall Study||0
10949846|NCT00415870|12121240|FG000|STARTED|Overall Study||32
10949847|NCT00415870|12121241|FG001|STARTED|Overall Study||33
10949848|NCT00415870|12121240|FG000|COMPLETED|Overall Study||26
10949849|NCT00415870|12121241|FG001|COMPLETED|Overall Study||26
10949850|NCT00415870|12121240|FG000|NOT COMPLETED|Overall Study||6
10949851|NCT00415870|12121241|FG001|NOT COMPLETED|Overall Study||7
10949852|NCT00415909|12121247|FG000|STARTED|Overall Study||3
10949853|NCT00415909|12121247|FG000|COMPLETED|Overall Study||0
10949854|NCT00415909|12121247|FG000|NOT COMPLETED|Overall Study||3
10949855|NCT00416078|12121253|FG000|STARTED|Overall Study||29
10949856|NCT00416078|12121254|FG001|STARTED|Overall Study||24
10949857|NCT00416078|12121253|FG000|COMPLETED|Overall Study||18
10949858|NCT00416078|12121254|FG001|COMPLETED|Overall Study||16
10949859|NCT00416078|12121253|FG000|NOT COMPLETED|Overall Study||11
10949860|NCT00416078|12121254|FG001|NOT COMPLETED|Overall Study||8
10949861|NCT00416182|12121262|FG000|STARTED|Overall Study||8
10949862|NCT00416182|12121263|FG001|STARTED|Overall Study||8
10949863|NCT00416182|12121262|FG000|COMPLETED|Overall Study||5
10949864|NCT00416182|12121263|FG001|COMPLETED|Overall Study||6
10949865|NCT00416182|12121262|FG000|NOT COMPLETED|Overall Study||3
10949866|NCT00416182|12121263|FG001|NOT COMPLETED|Overall Study||2
10949867|NCT00416195|12121277|FG000|STARTED|Overall Study||10
10949868|NCT00416195|12121278|FG001|STARTED|Overall Study||38
10949869|NCT00416195|12121277|FG000|COMPLETED|Overall Study||8
10949870|NCT00416195|12121278|FG001|COMPLETED|Overall Study||34
10949871|NCT00416195|12121277|FG000|NOT COMPLETED|Overall Study||2
10949872|NCT00416195|12121278|FG001|NOT COMPLETED|Overall Study||4
10949873|NCT00416312|12121284|FG000|STARTED|Overall Study||9
10949874|NCT00416312|12121284|FG000|Conventional Dosimetry|Overall Study||9
10949875|NCT00416312|12121284|FG000|Patient-specific Dosimetry|Overall Study||9
10949876|NCT00416312|12121284|FG000|COMPLETED|Overall Study||7
10949877|NCT00416312|12121284|FG000|NOT COMPLETED|Overall Study||2
10949878|NCT00416455|12121290|FG000|STARTED|Overall Study|This is a diagnostic imaging study.|169
10949879|NCT00416455|12121291|FG001|STARTED|Overall Study|This is a diagnostic imaging study.|215
10949880|NCT00416455|12121290|FG000|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
10949881|NCT00416455|12121291|FG001|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
10949882|NCT00416455|12121290|FG000|NOT COMPLETED|Overall Study||16
10949883|NCT00416455|12121291|FG001|NOT COMPLETED|Overall Study||8
10949884|NCT00416494|12121310|FG000|STARTED|Overall Study||19
10949885|NCT00416494|12121311|FG001|STARTED|Overall Study||31
10949886|NCT00416494|12121310|FG000|COMPLETED|Overall Study||19
10949887|NCT00416494|12121311|FG001|COMPLETED|Overall Study||31
10949888|NCT00416494|12121310|FG000|NOT COMPLETED|Overall Study||0
10949889|NCT00416494|12121311|FG001|NOT COMPLETED|Overall Study||0
10949890|NCT00416520|12121319|FG000|STARTED|Open-label Period||165
10949891|NCT00416520|12121320|FG001|STARTED|Open-label Period||171
10949892|NCT00416520|12121321|FG002|STARTED|Open-label Period||0
10949893|NCT00416520|12121322|FG003|STARTED|Open-label Period||0
10949894|NCT00416520|12121319|FG000|COMPLETED|Open-label Period||105
10949895|NCT00416520|12121320|FG001|COMPLETED|Open-label Period||139
10949896|NCT00416520|12121321|FG002|COMPLETED|Open-label Period||0
10949897|NCT00416520|12121322|FG003|COMPLETED|Open-label Period||0
10949898|NCT00416520|12121319|FG000|NOT COMPLETED|Open-label Period||60
10949899|NCT00416520|12121320|FG001|NOT COMPLETED|Open-label Period||32
10949900|NCT00416520|12121321|FG002|NOT COMPLETED|Open-label Period||0
10949901|NCT00416520|12121322|FG003|NOT COMPLETED|Open-label Period||0
10949902|NCT00416520|12121319|FG000|STARTED|Placebo-controlled Withdrawal Period||0
10949903|NCT00416520|12121320|FG001|STARTED|Placebo-controlled Withdrawal Period||0
10949904|NCT00416520|12121321|FG002|STARTED|Placebo-controlled Withdrawal Period||50
10949905|NCT00416520|12121322|FG003|STARTED|Placebo-controlled Withdrawal Period||54
10949906|NCT00416520|12121319|FG000|COMPLETED|Placebo-controlled Withdrawal Period||0
10949907|NCT00416520|12121320|FG001|COMPLETED|Placebo-controlled Withdrawal Period||0
10949908|NCT00416520|12121321|FG002|COMPLETED|Placebo-controlled Withdrawal Period||49
10949909|NCT00416520|12121322|FG003|COMPLETED|Placebo-controlled Withdrawal Period||49
10949910|NCT00416520|12121319|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
10949911|NCT00416520|12121320|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
10949912|NCT00416520|12121321|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
10949913|NCT00416520|12121322|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
10949914|NCT00416572|12121335|FG000|STARTED|Overall Study||83
10949915|NCT00416572|12121336|FG001|STARTED|Overall Study||85
10949916|NCT00416572|12121337|FG002|STARTED|Overall Study||84
10949917|NCT00416572|12121335|FG000|COMPLETED|Overall Study||70
10949918|NCT00416572|12121336|FG001|COMPLETED|Overall Study||78
10949919|NCT00416572|12121337|FG002|COMPLETED|Overall Study||76
10949920|NCT00416572|12121335|FG000|NOT COMPLETED|Overall Study||13
10949921|NCT00416572|12121336|FG001|NOT COMPLETED|Overall Study||7
10949922|NCT00416572|12121337|FG002|NOT COMPLETED|Overall Study||8
10949923|NCT00416598|12121345|FG000|STARTED|Induction & Intensification||546
10949924|NCT00416598|12121345|FG000|COMPLETED|Induction & Intensification||134
10949925|NCT00416598|12121345|FG000|NOT COMPLETED|Induction & Intensification||412
10949926|NCT00416598|12121345|FG000|STARTED|Decitabine Maintenance||134
10949927|NCT00416598|12121345|FG000|COMPLETED|Decitabine Maintenance||62
10949928|NCT00416598|12121345|FG000|NOT COMPLETED|Decitabine Maintenance||72
10949929|NCT00416624|12121353|FG000|STARTED|Overall Study||61
10949930|NCT00416624|12121354|FG001|STARTED|Overall Study||60
10949931|NCT00416624|12121355|FG002|STARTED|Overall Study||58
10949932|NCT00416624|12121356|FG003|STARTED|Overall Study||57
10949933|NCT00416624|12121353|FG000|COMPLETED|Overall Study||39
10949934|NCT00416624|12121354|FG001|COMPLETED|Overall Study||33
10949935|NCT00416624|12121355|FG002|COMPLETED|Overall Study||40
10949936|NCT00416624|12121356|FG003|COMPLETED|Overall Study||40
10949937|NCT00416624|12121353|FG000|NOT COMPLETED|Overall Study||22
10949938|NCT00416624|12121354|FG001|NOT COMPLETED|Overall Study||27
10949939|NCT00416624|12121355|FG002|NOT COMPLETED|Overall Study||18
10949940|NCT00416624|12121356|FG003|NOT COMPLETED|Overall Study||17
10949941|NCT00416715|12121366|FG000|STARTED|Overall Study||100
10949942|NCT00416715|12121366|FG000|COMPLETED|Overall Study||85
10949943|NCT00416715|12121366|FG000|NOT COMPLETED|Overall Study||15
10949944|NCT00416793|12121373|FG000|STARTED|Overall Study||9
10949945|NCT00416793|12121373|FG000|COMPLETED|Overall Study||9
10949946|NCT00416793|12121373|FG000|NOT COMPLETED|Overall Study||0
10949947|NCT00416884|12121377|FG000|STARTED|Overall Study||1
10949948|NCT00416884|12121377|FG000|COMPLETED|Overall Study||0
10949949|NCT00416884|12121377|FG000|NOT COMPLETED|Overall Study||1
10949950|NCT00416949|12121381|FG000|STARTED|Overall Study||9
10949951|NCT00416949|12121381|FG000|COMPLETED|Overall Study||4
10949952|NCT00416949|12121381|FG000|NOT COMPLETED|Overall Study||5
10949953|NCT00417027|12121388|FG000|STARTED|Overall Study||66
10949954|NCT00417027|12121389|FG001|STARTED|Overall Study||65
10949955|NCT00417027|12121390|FG002|STARTED|Overall Study||59
10949956|NCT00417027|12121388|FG000|COMPLETED|Overall Study||66
10949957|NCT00417027|12121389|FG001|COMPLETED|Overall Study||60
10949958|NCT00417027|12121390|FG002|COMPLETED|Overall Study||54
10949959|NCT00417027|12121388|FG000|NOT COMPLETED|Overall Study||0
10949960|NCT00417027|12121389|FG001|NOT COMPLETED|Overall Study||5
10949961|NCT00417027|12121390|FG002|NOT COMPLETED|Overall Study||5
10949962|NCT00417079|12121400|FG000|STARTED|Overall Study|Randomized patients|377
10949963|NCT00417079|12121401|FG001|STARTED|Overall Study|Randomized patients|378
10949964|NCT00417079|12121400|FG000|COMPLETED|Overall Study|Randomized patients|46
10949965|NCT00417079|12121401|FG001|COMPLETED|Overall Study|Randomized patients|105
10949966|NCT00417079|12121400|FG000|NOT COMPLETED|Overall Study||331
10949967|NCT00417079|12121401|FG001|NOT COMPLETED|Overall Study||273
10949968|NCT00417170|12121409|FG000|STARTED|Overall Study|"Started indicates Safety population."|23
10949969|NCT00417170|12121410|FG001|STARTED|Overall Study||25
10949970|NCT00417170|12121409|FG000|Pharmacodynamics Population|Overall Study||21
10949971|NCT00417170|12121410|FG001|Pharmacodynamics Population|Overall Study||23
10949972|NCT00417170|12121409|FG000|COMPLETED|Overall Study||21
10949973|NCT00417170|12121410|FG001|COMPLETED|Overall Study||22
10949974|NCT00417170|12121409|FG000|NOT COMPLETED|Overall Study||2
10949975|NCT00417170|12121410|FG001|NOT COMPLETED|Overall Study||3
10949976|NCT00417274|12121416|FG000|STARTED|Overall Study||31
10949977|NCT00417274|12121416|FG000|COMPLETED|Overall Study||31
10949978|NCT00417274|12121416|FG000|NOT COMPLETED|Overall Study||0
10949979|NCT00417417|12121422|FG000|STARTED|Overall Study||4
10949980|NCT00417417|12121423|FG001|STARTED|Overall Study||6
10949981|NCT00417417|12121422|FG000|COMPLETED|Overall Study||4
10949982|NCT00417417|12121423|FG001|COMPLETED|Overall Study||6
10949983|NCT00417417|12121422|FG000|NOT COMPLETED|Overall Study||0
10949984|NCT00417417|12121423|FG001|NOT COMPLETED|Overall Study||0
10949985|NCT00417482|12121434|FG000|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
10949986|NCT00417482|12121435|FG001|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
10949987|NCT00417482|12121436|FG002|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
10949988|NCT00417482|12121434|FG000|COMPLETED|Phase B 1st 16 Weeks||13
10949989|NCT00417482|12121435|FG001|COMPLETED|Phase B 1st 16 Weeks||27
10949990|NCT00417482|12121436|FG002|COMPLETED|Phase B 1st 16 Weeks||13
10949991|NCT00417482|12121434|FG000|NOT COMPLETED|Phase B 1st 16 Weeks||19
10949992|NCT00417482|12121435|FG001|NOT COMPLETED|Phase B 1st 16 Weeks||11
10949993|NCT00417482|12121436|FG002|NOT COMPLETED|Phase B 1st 16 Weeks||27
10949994|NCT00417482|12121434|FG000|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
10949995|NCT00417482|12121435|FG001|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
10949996|NCT00417482|12121436|FG002|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
10949997|NCT00417482|12121434|FG000|COMPLETED|Phase B 2nd 16 Weeks||10
10949998|NCT00417482|12121435|FG001|COMPLETED|Phase B 2nd 16 Weeks||14
10949999|NCT00417482|12121436|FG002|COMPLETED|Phase B 2nd 16 Weeks||10
10950000|NCT00417482|12121434|FG000|NOT COMPLETED|Phase B 2nd 16 Weeks||3
10950001|NCT00417482|12121435|FG001|NOT COMPLETED|Phase B 2nd 16 Weeks||13
10950002|NCT00417482|12121436|FG002|NOT COMPLETED|Phase B 2nd 16 Weeks||3
10950003|NCT00417612|12121452|FG000|STARTED|Overall Study||22
10950004|NCT00417612|12121453|FG001|STARTED|Overall Study||11
10950005|NCT00417612|12121452|FG000|COMPLETED|Overall Study||19
10950006|NCT00417612|12121453|FG001|COMPLETED|Overall Study||8
10950007|NCT00417612|12121452|FG000|NOT COMPLETED|Overall Study||3
10950008|NCT00417612|12121453|FG001|NOT COMPLETED|Overall Study||3
10950009|NCT00417859|12121463|FG000|STARTED|Overall Study||26
10950010|NCT00417859|12121464|FG001|STARTED|Overall Study||30
10950011|NCT00417859|12121463|FG000|COMPLETED|Overall Study||26
10950012|NCT00417859|12121464|FG001|COMPLETED|Overall Study||29
10950013|NCT00417859|12121463|FG000|NOT COMPLETED|Overall Study||0
10950014|NCT00417859|12121464|FG001|NOT COMPLETED|Overall Study||1
10950015|NCT00417885|12121472|FG000|STARTED|Overall Study||6
10950016|NCT00417885|12121472|FG000|COMPLETED|Overall Study||0
10950017|NCT00417885|12121472|FG000|NOT COMPLETED|Overall Study||6
10950018|NCT00417963|12121476|FG000|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
10950019|NCT00417963|12121476|FG000|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
10950020|NCT00417963|12121476|FG000|NOT COMPLETED|Overall Study||41
10950021|NCT00417976|12121485|FG000|STARTED|Overall Study||42
10950022|NCT00417976|12121485|FG000|COMPLETED|Overall Study||39
10950023|NCT00417976|12121485|FG000|NOT COMPLETED|Overall Study||3
10950024|NCT00417989|12121492|FG000|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
10950025|NCT00417989|12121493|FG001|STARTED|Overall Study||241
10950026|NCT00417989|12121492|FG000|COMPLETED|Overall Study||224
10950027|NCT00417989|12121493|FG001|COMPLETED|Overall Study||219
10950028|NCT00417989|12121492|FG000|NOT COMPLETED|Overall Study||20
10950029|NCT00417989|12121493|FG001|NOT COMPLETED|Overall Study||22
10950030|NCT00418015|12121505|FG000|STARTED|Overall Study||144
10950031|NCT00418015|12121506|FG001|STARTED|Overall Study||46
10950032|NCT00418015|12121507|FG002|STARTED|Overall Study||78
10950033|NCT00418015|12121508|FG003|STARTED|Overall Study||25
10950034|NCT00418015|12121505|FG000|COMPLETED|Overall Study||144
10950035|NCT00418015|12121506|FG001|COMPLETED|Overall Study||46
10950036|NCT00418015|12121507|FG002|COMPLETED|Overall Study||78
10950037|NCT00418015|12121508|FG003|COMPLETED|Overall Study||25
10950038|NCT00418015|12121505|FG000|NOT COMPLETED|Overall Study||0
10950039|NCT00418015|12121506|FG001|NOT COMPLETED|Overall Study||0
10950040|NCT00418015|12121507|FG002|NOT COMPLETED|Overall Study||0
10950041|NCT00418015|12121508|FG003|NOT COMPLETED|Overall Study||0
10950042|NCT00418028|12121520|FG000|STARTED|Overall Study||97
10950043|NCT00418028|12121521|FG001|STARTED|Overall Study||98
10950044|NCT00418028|12121520|FG000|COMPLETED|Overall Study||95
10950045|NCT00418028|12121521|FG001|COMPLETED|Overall Study||97
10950046|NCT00418028|12121520|FG000|NOT COMPLETED|Overall Study||2
10950047|NCT00418028|12121521|FG001|NOT COMPLETED|Overall Study||1
10950048|NCT00418093|12121527|FG000|STARTED|Overall Study||19
10950049|NCT00418093|12121527|FG000|Completed Study|Overall Study||19
10950050|NCT00418093|12121527|FG000|COMPLETED|Overall Study||19
10950051|NCT00418093|12121527|FG000|NOT COMPLETED|Overall Study||0
10950052|NCT00418184|12121533|FG000|STARTED|Double-blind Phase||137
10950053|NCT00418184|12121534|FG001|STARTED|Double-blind Phase||63
10950054|NCT00418184|12121533|FG000|COMPLETED|Double-blind Phase||110
10950055|NCT00418184|12121534|FG001|COMPLETED|Double-blind Phase||52
10950056|NCT00418184|12121533|FG000|NOT COMPLETED|Double-blind Phase||27
10950057|NCT00418184|12121534|FG001|NOT COMPLETED|Double-blind Phase||11
10950058|NCT00418184|12121533|FG000|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
10950059|NCT00418184|12121534|FG001|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
10950060|NCT00418184|12121533|FG000|COMPLETED|Open-label Phase|5 dropped out|97
10950061|NCT00418184|12121534|FG001|COMPLETED|Open-label Phase|5 dropped out|43
10950062|NCT00418184|12121533|FG000|NOT COMPLETED|Open-label Phase||5
10950063|NCT00418184|12121534|FG001|NOT COMPLETED|Open-label Phase||5
10950064|NCT00418262|12121540|FG000|STARTED|Visits 1 (Baseline) Thru 5||27
10950065|NCT00418262|12121540|FG000|COMPLETED|Visits 1 (Baseline) Thru 5||25
10950066|NCT00418262|12121540|FG000|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
10950067|NCT00418262|12121540|FG000|STARTED|Visits 5 Thru 8||25
10950068|NCT00418262|12121540|FG000|COMPLETED|Visits 5 Thru 8||16
10950069|NCT00418262|12121540|FG000|NOT COMPLETED|Visits 5 Thru 8||9
10950070|NCT00418262|12121540|FG000|STARTED|Visits 8 Thru 10||16
10950071|NCT00418262|12121540|FG000|COMPLETED|Visits 8 Thru 10||11
10950072|NCT00418262|12121540|FG000|NOT COMPLETED|Visits 8 Thru 10||5
10950073|NCT00418314|12121550|FG000|STARTED|Overall Study||817
10950074|NCT00418314|12121551|FG001|STARTED|Overall Study||830
10950075|NCT00418314|12121550|FG000|COMPLETED|Overall Study||816
10950076|NCT00418314|12121551|FG001|COMPLETED|Overall Study||828
10950077|NCT00418314|12121550|FG000|NOT COMPLETED|Overall Study||1
10950078|NCT00418314|12121551|FG001|NOT COMPLETED|Overall Study||2
10950079|NCT00418379|12121560|FG000|STARTED|Year 1||207
10950080|NCT00418379|12121561|FG001|STARTED|Year 1||207
10950081|NCT00418379|12121562|FG002|STARTED|Year 1||219
10950082|NCT00418379|12121560|FG000|COMPLETED|Year 1||189
10950083|NCT00418379|12121561|FG001|COMPLETED|Year 1||179
10950084|NCT00418379|12121562|FG002|COMPLETED|Year 1||204
10950085|NCT00418379|12121560|FG000|NOT COMPLETED|Year 1||18
10950086|NCT00418379|12121561|FG001|NOT COMPLETED|Year 1||28
10950087|NCT00418379|12121562|FG002|NOT COMPLETED|Year 1||15
10950088|NCT00418379|12121560|FG000|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
10950089|NCT00418379|12121561|FG001|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
10950090|NCT00418379|12121562|FG002|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
10950091|NCT00418379|12121560|FG000|COMPLETED|Year 2||159
10950092|NCT00418379|12121561|FG001|COMPLETED|Year 2||155
10950093|NCT00418379|12121562|FG002|COMPLETED|Year 2||172
10950094|NCT00418379|12121560|FG000|NOT COMPLETED|Year 2||8
10950095|NCT00418379|12121561|FG001|NOT COMPLETED|Year 2||4
10950096|NCT00418379|12121562|FG002|NOT COMPLETED|Year 2||10
10950097|NCT00418379|12121560|FG000|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
10950098|NCT00418379|12121561|FG001|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
10950099|NCT00418379|12121562|FG002|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
10950100|NCT00418379|12121560|FG000|COMPLETED|Year 3||148
10950101|NCT00418379|12121561|FG001|COMPLETED|Year 3||146
10950102|NCT00418379|12121562|FG002|COMPLETED|Year 3||163
10950103|NCT00418379|12121560|FG000|NOT COMPLETED|Year 3||3
10950104|NCT00418379|12121561|FG001|NOT COMPLETED|Year 3||2
10950105|NCT00418379|12121562|FG002|NOT COMPLETED|Year 3||3
10950106|NCT00418379|12121560|FG000|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
10950107|NCT00418379|12121561|FG001|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
10950108|NCT00418379|12121562|FG002|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
10950109|NCT00418379|12121560|FG000|COMPLETED|Year 4||142
10950110|NCT00418379|12121561|FG001|COMPLETED|Year 4||136
10950111|NCT00418379|12121562|FG002|COMPLETED|Year 4||154
10950112|NCT00418379|12121560|FG000|NOT COMPLETED|Year 4||3
10950113|NCT00418379|12121561|FG001|NOT COMPLETED|Year 4||5
10950114|NCT00418379|12121562|FG002|NOT COMPLETED|Year 4||2
10950115|NCT00418379|12121560|FG000|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
10950116|NCT00418379|12121561|FG001|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
10950117|NCT00418379|12121562|FG002|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
10950118|NCT00418379|12121560|FG000|COMPLETED|Year 5||126
10950119|NCT00418379|12121561|FG001|COMPLETED|Year 5||115
10950120|NCT00418379|12121562|FG002|COMPLETED|Year 5||131
10950121|NCT00418379|12121560|FG000|NOT COMPLETED|Year 5||2
10950122|NCT00418379|12121561|FG001|NOT COMPLETED|Year 5||5
10950123|NCT00418379|12121562|FG002|NOT COMPLETED|Year 5||3
10950124|NCT00418457|12121572|FG000|STARTED|Overall Study||1065
10950125|NCT00418457|12121573|FG001|STARTED|Overall Study||1043
10950126|NCT00418457|12121572|FG000|COMPLETED|Overall Study||1065
10950127|NCT00418457|12121573|FG001|COMPLETED|Overall Study||1043
10950128|NCT00418457|12121572|FG000|NOT COMPLETED|Overall Study||0
10950129|NCT00418457|12121573|FG001|NOT COMPLETED|Overall Study||0
10950130|NCT00418522|12121581|FG000|STARTED|Overall Study||219
10950131|NCT00418522|12121582|FG001|STARTED|Overall Study||194
10950132|NCT00418522|12121581|FG000|Received Treatment|Overall Study||212
10950133|NCT00418522|12121582|FG001|Received Treatment|Overall Study||190
10950134|NCT00418522|12121581|FG000|COMPLETED|Overall Study||136
10950135|NCT00418522|12121582|FG001|COMPLETED|Overall Study||152
10950136|NCT00418522|12121581|FG000|NOT COMPLETED|Overall Study||83
10950137|NCT00418522|12121582|FG001|NOT COMPLETED|Overall Study||42
10950138|NCT00418561|12121591|FG000|STARTED|Overall Study||4
10950139|NCT00418561|12121592|FG001|STARTED|Overall Study||5
10950140|NCT00418561|12121593|FG002|STARTED|Overall Study||4
10950141|NCT00418561|12121591|FG000|COMPLETED|Overall Study||4
10950142|NCT00418561|12121592|FG001|COMPLETED|Overall Study||4
10950143|NCT00418561|12121593|FG002|COMPLETED|Overall Study||4
10950144|NCT00418561|12121591|FG000|NOT COMPLETED|Overall Study||0
10950145|NCT00418561|12121592|FG001|NOT COMPLETED|Overall Study||1
10950146|NCT00418561|12121593|FG002|NOT COMPLETED|Overall Study||0
10950147|NCT00418574|12121603|FG000|STARTED|Overall Study||593
10950148|NCT00418574|12121604|FG001|STARTED|Overall Study||295
10950149|NCT00418574|12121603|FG000|TREATED|Overall Study||592
10950150|NCT00418574|12121604|FG001|TREATED|Overall Study||294
10950151|NCT00418574|12121603|FG000|COMPLETED|Overall Study||545
10950152|NCT00418574|12121604|FG001|COMPLETED|Overall Study||272
10950153|NCT00418574|12121603|FG000|NOT COMPLETED|Overall Study||48
10950154|NCT00418574|12121604|FG001|NOT COMPLETED|Overall Study||23
10950155|NCT00418665|12121613|FG000|STARTED|Treatment Period||12
10950156|NCT00418665|12121614|FG001|STARTED|Treatment Period||14
10950157|NCT00418665|12121615|FG002|STARTED|Treatment Period||13
10950158|NCT00418665|12121613|FG000|Received Study Medication|Treatment Period||11
10950159|NCT00418665|12121614|FG001|Received Study Medication|Treatment Period||13
10950160|NCT00418665|12121615|FG002|Received Study Medication|Treatment Period||13
10950161|NCT00418665|12121613|FG000|COMPLETED|Treatment Period||7
10950162|NCT00418665|12121614|FG001|COMPLETED|Treatment Period||8
10950163|NCT00418665|12121615|FG002|COMPLETED|Treatment Period||9
10950164|NCT00418665|12121613|FG000|NOT COMPLETED|Treatment Period||5
10950165|NCT00418665|12121614|FG001|NOT COMPLETED|Treatment Period||6
10950166|NCT00418665|12121615|FG002|NOT COMPLETED|Treatment Period||4
10950167|NCT00418665|12121613|FG000|STARTED|Treatment Extension||7
10950168|NCT00418665|12121614|FG001|STARTED|Treatment Extension||8
10950169|NCT00418665|12121615|FG002|STARTED|Treatment Extension||9
10950170|NCT00418665|12121613|FG000|COMPLETED|Treatment Extension||1
10950171|NCT00418665|12121614|FG001|COMPLETED|Treatment Extension||4
10950172|NCT00418665|12121615|FG002|COMPLETED|Treatment Extension||7
10950173|NCT00418665|12121613|FG000|NOT COMPLETED|Treatment Extension||6
10950174|NCT00418665|12121614|FG001|NOT COMPLETED|Treatment Extension||4
10950175|NCT00418665|12121615|FG002|NOT COMPLETED|Treatment Extension||2
10950176|NCT00418691|12121626|FG000|STARTED|Overall Study||11
10950177|NCT00418691|12121627|FG001|STARTED|Overall Study||12
10950178|NCT00418691|12121628|FG002|STARTED|Overall Study||10
10950179|NCT00418691|12121626|FG000|COMPLETED|Overall Study||9
10950180|NCT00418691|12121627|FG001|COMPLETED|Overall Study||10
10950181|NCT00418691|12121628|FG002|COMPLETED|Overall Study||5
10950182|NCT00418691|12121626|FG000|NOT COMPLETED|Overall Study||2
10950183|NCT00418691|12121627|FG001|NOT COMPLETED|Overall Study||2
10950184|NCT00418691|12121628|FG002|NOT COMPLETED|Overall Study||5
10950185|NCT00418717|12121636|FG000|STARTED|Treatment Period A - Weeks 1-4||42
10950186|NCT00418717|12121636|FG000|COMPLETED|Treatment Period A - Weeks 1-4||41
10950187|NCT00418717|12121636|FG000|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
10950188|NCT00418717|12121636|FG000|STARTED|Treatment Period B - Weeks 5-12||41
10950189|NCT00418717|12121636|FG000|COMPLETED|Treatment Period B - Weeks 5-12||39
10950190|NCT00418717|12121636|FG000|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
10950191|NCT00418886|12121642|FG000|STARTED|Overall Study|randomised patients|256
10950192|NCT00418886|12121643|FG001|STARTED|Overall Study|randomised patients|278
10950193|NCT00418886|12121642|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
10950194|NCT00418886|12121643|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
10950195|NCT00418886|12121642|FG000|NOT COMPLETED|Overall Study||226
10950196|NCT00418886|12121643|FG001|NOT COMPLETED|Overall Study||255
10950197|NCT00418938|12121651|FG000|STARTED|Overall Study||133
10950198|NCT00418938|12121652|FG001|STARTED|Overall Study||131
10950199|NCT00418938|12121651|FG000|COMPLETED|Overall Study||109
10950200|NCT00418938|12121652|FG001|COMPLETED|Overall Study||108
10950201|NCT00418938|12121651|FG000|NOT COMPLETED|Overall Study||24
10950202|NCT00418938|12121652|FG001|NOT COMPLETED|Overall Study||23
10950203|NCT00418951|12121661|FG000|STARTED|Overall Study||39
10950204|NCT00418951|12121662|FG001|STARTED|Overall Study||33
10950205|NCT00418951|12121663|FG002|STARTED|Overall Study||40
10950206|NCT00418951|12121661|FG000|COMPLETED|Overall Study||39
10950207|NCT00418951|12121662|FG001|COMPLETED|Overall Study||33
10950208|NCT00418951|12121663|FG002|COMPLETED|Overall Study||40
10950209|NCT00418951|12121661|FG000|NOT COMPLETED|Overall Study||0
10950210|NCT00418951|12121662|FG001|NOT COMPLETED|Overall Study||0
10950211|NCT00418951|12121663|FG002|NOT COMPLETED|Overall Study||0
10950212|NCT00418964|12121674|FG000|STARTED|Overall Study||22
10950213|NCT00418964|12121675|FG001|STARTED|Overall Study||20
10950214|NCT00418964|12121676|FG002|STARTED|Overall Study||20
10950215|NCT00418964|12121674|FG000|COMPLETED|Overall Study||21
10950216|NCT00418964|12121675|FG001|COMPLETED|Overall Study||17
10950217|NCT00418964|12121676|FG002|COMPLETED|Overall Study||14
10950218|NCT00418964|12121674|FG000|NOT COMPLETED|Overall Study||1
10950219|NCT00418964|12121675|FG001|NOT COMPLETED|Overall Study||3
10950220|NCT00418964|12121676|FG002|NOT COMPLETED|Overall Study||6
10950221|NCT00418977|12121686|FG000|STARTED|Overall Study||43
10950222|NCT00418977|12121687|FG001|STARTED|Overall Study||16
10950223|NCT00418977|12121686|FG000|COMPLETED|Overall Study||40
10950224|NCT00418977|12121687|FG001|COMPLETED|Overall Study||13
10950225|NCT00418977|12121686|FG000|NOT COMPLETED|Overall Study||3
10950226|NCT00418977|12121687|FG001|NOT COMPLETED|Overall Study||3
10950227|NCT00419003|12121695|FG000|STARTED|Phase I, Ketamine Infusion||13
10950228|NCT00419003|12121696|FG001|STARTED|Phase I, Ketamine Infusion||13
10950229|NCT00419003|12121695|FG000|COMPLETED|Phase I, Ketamine Infusion||7
10950230|NCT00419003|12121696|FG001|COMPLETED|Phase I, Ketamine Infusion||7
10950231|NCT00419003|12121695|FG000|NOT COMPLETED|Phase I, Ketamine Infusion||6
10950232|NCT00419003|12121696|FG001|NOT COMPLETED|Phase I, Ketamine Infusion||6
10950233|NCT00419003|12121695|FG000|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|6
10950234|NCT00419003|12121696|FG001|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|8
10950235|NCT00419003|12121695|FG000|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
10950236|NCT00419003|12121696|FG001|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
10950237|NCT00419003|12121695|FG000|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
10950238|NCT00419003|12121696|FG001|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
10950239|NCT00419094|12121707|FG000|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
10950240|NCT00419094|12121708|FG001|STARTED|Overall Study||171
10950241|NCT00419094|12121707|FG000|COMPLETED|Overall Study||50
10950242|NCT00419094|12121708|FG001|COMPLETED|Overall Study||141
10950243|NCT00419094|12121707|FG000|NOT COMPLETED|Overall Study||7
10950244|NCT00419094|12121708|FG001|NOT COMPLETED|Overall Study||30
10950245|NCT00419120|12121714|FG000|STARTED|Primary Study Period||10
10950246|NCT00419120|12121714|FG000|COMPLETED|Primary Study Period||10
10950247|NCT00419120|12121714|FG000|NOT COMPLETED|Primary Study Period||0
10950248|NCT00419120|12121714|FG000|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
10950249|NCT00419120|12121714|FG000|COMPLETED|Long Term Follow up Period||0
10950250|NCT00419120|12121714|FG000|NOT COMPLETED|Long Term Follow up Period||10
10950251|NCT00419159|12121720|FG000|STARTED|Overall Study|Full Analysis Set|99
10950252|NCT00419159|12121721|FG001|STARTED|Overall Study||100
10950253|NCT00419159|12121720|FG000|COMPLETED|Overall Study||0
10950254|NCT00419159|12121721|FG001|COMPLETED|Overall Study||0
10950255|NCT00419159|12121720|FG000|NOT COMPLETED|Overall Study||99
10950256|NCT00419159|12121721|FG001|NOT COMPLETED|Overall Study||100
10950257|NCT00419263|12121738|FG000|STARTED|Overall Study||115
10950258|NCT00419263|12121739|FG001|STARTED|Overall Study||114
10950259|NCT00419263|12121740|FG002|STARTED|Overall Study||115
10950260|NCT00419263|12121738|FG000|COMPLETED|Overall Study||112
10950261|NCT00419263|12121739|FG001|COMPLETED|Overall Study||112
10950262|NCT00419263|12121740|FG002|COMPLETED|Overall Study||112
10950263|NCT00419263|12121738|FG000|NOT COMPLETED|Overall Study||3
10950264|NCT00419263|12121739|FG001|NOT COMPLETED|Overall Study||2
10950265|NCT00419263|12121740|FG002|NOT COMPLETED|Overall Study||3
10950266|NCT00419315|12121751|FG000|STARTED|Overall Study||85
10950267|NCT00419315|12121752|FG001|STARTED|Overall Study||78
10950268|NCT00419315|12121751|FG000|COMPLETED|Overall Study||85
10950269|NCT00419315|12121752|FG001|COMPLETED|Overall Study||78
10950270|NCT00419315|12121751|FG000|NOT COMPLETED|Overall Study||0
10950271|NCT00419315|12121752|FG001|NOT COMPLETED|Overall Study||0
10950272|NCT00419341|12121758|FG000|STARTED|Wash in/Wash Out Period||49
10950273|NCT00419341|12121758|FG000|COMPLETED|Wash in/Wash Out Period||38
10950274|NCT00419341|12121758|FG000|NOT COMPLETED|Wash in/Wash Out Period||11
10950275|NCT00419341|12121758|FG000|STARTED|Efficacy Period||38
10950276|NCT00419341|12121758|FG000|COMPLETED|Efficacy Period||28
10950277|NCT00419341|12121758|FG000|NOT COMPLETED|Efficacy Period||10
10950278|NCT00419380|12121766|FG000|STARTED|Overall Study||19
10950279|NCT00419380|12121767|FG001|STARTED|Overall Study||22
10950280|NCT00419380|12121766|FG000|COMPLETED|Overall Study||18
10950281|NCT00419380|12121767|FG001|COMPLETED|Overall Study||12
10950282|NCT00419380|12121766|FG000|NOT COMPLETED|Overall Study||1
10950283|NCT00419380|12121767|FG001|NOT COMPLETED|Overall Study||10
10950284|NCT00419393|12121773|FG000|STARTED|Overall Study|One subject did not receive medication|190
10950285|NCT00419393|12121773|FG000|COMPLETED|Overall Study||166
10950286|NCT00419393|12121773|FG000|NOT COMPLETED|Overall Study||24
10950287|NCT00419445|12121780|FG000|STARTED|Overall Study||8
10950288|NCT00419445|12121781|FG001|STARTED|Overall Study||16
10950289|NCT00419445|12121782|FG002|STARTED|Overall Study||8
10950290|NCT00419445|12121780|FG000|COMPLETED|Overall Study||7
10950291|NCT00419445|12121781|FG001|COMPLETED|Overall Study||14
10950292|NCT00419445|12121782|FG002|COMPLETED|Overall Study||7
10950293|NCT00419445|12121780|FG000|NOT COMPLETED|Overall Study||1
10950294|NCT00419445|12121781|FG001|NOT COMPLETED|Overall Study||2
10950295|NCT00419445|12121782|FG002|NOT COMPLETED|Overall Study||1
10950296|NCT00419562|12121792|FG000|STARTED|Overall Study||283
10950297|NCT00419562|12121793|FG001|STARTED|Overall Study||277
10950298|NCT00419562|12121792|FG000|COMPLETED|Overall Study||250
10950299|NCT00419562|12121793|FG001|COMPLETED|Overall Study||246
10950300|NCT00419562|12121792|FG000|NOT COMPLETED|Overall Study||33
10950301|NCT00419562|12121793|FG001|NOT COMPLETED|Overall Study||31
10950302|NCT00419666|12121799|FG000|STARTED|Overall Study||25
10950303|NCT00419666|12121799|FG000|COMPLETED|Overall Study||25
10950304|NCT00419666|12121799|FG000|NOT COMPLETED|Overall Study||0
10950305|NCT00419744|12121806|FG000|STARTED|Overall Study||407
10950306|NCT00419744|12121807|FG001|STARTED|Overall Study||408
10950307|NCT00419744|12121808|FG002|STARTED|Overall Study||404
10950308|NCT00419744|12121806|FG000|COMPLETED|Overall Study||290
10950309|NCT00419744|12121807|FG001|COMPLETED|Overall Study||290
10950310|NCT00419744|12121808|FG002|COMPLETED|Overall Study||271
10950311|NCT00419744|12121806|FG000|NOT COMPLETED|Overall Study||117
10950312|NCT00419744|12121807|FG001|NOT COMPLETED|Overall Study||118
10950313|NCT00419744|12121808|FG002|NOT COMPLETED|Overall Study||133
10950314|NCT00419757|12121818|FG000|STARTED|Overall Study|Randomized patients|127
10950315|NCT00419757|12121819|FG001|STARTED|Overall Study|Randomized patients|123
10950316|NCT00419757|12121818|FG000|COMPLETED|Overall Study|Randomized patients|109
10950317|NCT00419757|12121819|FG001|COMPLETED|Overall Study|Randomized patients|102
10950318|NCT00419757|12121818|FG000|NOT COMPLETED|Overall Study||18
10950319|NCT00419757|12121819|FG001|NOT COMPLETED|Overall Study||21
10950320|NCT00419770|12121829|FG000|STARTED|Overall Study||11
10950321|NCT00419770|12121830|FG001|STARTED|Overall Study||9
10950322|NCT00419770|12121829|FG000|COMPLETED|Overall Study||6
10950323|NCT00419770|12121830|FG001|COMPLETED|Overall Study||8
10950324|NCT00419770|12121829|FG000|NOT COMPLETED|Overall Study||5
10950325|NCT00419770|12121830|FG001|NOT COMPLETED|Overall Study||1
10950326|NCT00419926|12121838|FG000|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
10950327|NCT00419926|12121839|FG001|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
10950328|NCT00419926|12121838|FG000|COMPLETED|Overall Study||141
10950329|NCT00419926|12121839|FG001|COMPLETED|Overall Study||148
10950330|NCT00419926|12121838|FG000|NOT COMPLETED|Overall Study||14
10950331|NCT00419926|12121839|FG001|NOT COMPLETED|Overall Study||10
10950332|NCT00419952|12121847|FG000|STARTED|Overall Study||377
10950333|NCT00419952|12121848|FG001|STARTED|Overall Study||365
10950334|NCT00419952|12121847|FG000|COMPLETED|Overall Study||228
10950335|NCT00419952|12121848|FG001|COMPLETED|Overall Study||240
10950336|NCT00419952|12121847|FG000|NOT COMPLETED|Overall Study||149
10950337|NCT00419952|12121848|FG001|NOT COMPLETED|Overall Study||125
10950338|NCT00420004|12121857|FG000|STARTED|Overall Study||269
10950339|NCT00420004|12121858|FG001|STARTED|Overall Study||138
10950340|NCT00420004|12121859|FG002|STARTED|Overall Study||62
10950341|NCT00420004|12121857|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
10950342|NCT00420004|12121858|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
10950343|NCT00420004|12121859|FG002|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
10950344|NCT00420004|12121857|FG000|COMPLETED|Overall Study||140
10950345|NCT00420004|12121858|FG001|COMPLETED|Overall Study||67
10950346|NCT00420004|12121859|FG002|COMPLETED|Overall Study||30
10950347|NCT00420004|12121857|FG000|NOT COMPLETED|Overall Study||129
10950348|NCT00420004|12121858|FG001|NOT COMPLETED|Overall Study||71
10950349|NCT00420004|12121859|FG002|NOT COMPLETED|Overall Study||32
10950350|NCT00420017|12121873|FG000|STARTED|Overall Study||40
10950351|NCT00420017|12121874|FG001|STARTED|Overall Study||40
10950352|NCT00420017|12121873|FG000|COMPLETED|Overall Study|40 completed analysis|38
10950353|NCT00420017|12121874|FG001|COMPLETED|Overall Study||40
10950354|NCT00420017|12121873|FG000|NOT COMPLETED|Overall Study||2
10950355|NCT00420017|12121874|FG001|NOT COMPLETED|Overall Study||0
10950356|NCT00420056|12121880|FG000|STARTED|Overall Study||17
10950357|NCT00420056|12121880|FG000|COMPLETED|Overall Study||0
10950358|NCT00420056|12121880|FG000|NOT COMPLETED|Overall Study||17
10950359|NCT00420095|12121886|FG000|STARTED|Overall Study||57
10950360|NCT00420095|12121887|FG001|STARTED|Overall Study||60
10950361|NCT00420095|12121886|FG000|COMPLETED|Overall Study||54
10950362|NCT00420095|12121887|FG001|COMPLETED|Overall Study||59
10950363|NCT00420095|12121886|FG000|NOT COMPLETED|Overall Study||3
10950364|NCT00420095|12121887|FG001|NOT COMPLETED|Overall Study||1
10950365|NCT00420147|12121895|FG000|STARTED|Overall Study||19
10950366|NCT00420147|12121896|FG001|STARTED|Overall Study||19
10950367|NCT00420147|12121895|FG000|COMPLETED|Overall Study||19
10950368|NCT00420147|12121896|FG001|COMPLETED|Overall Study||19
10950369|NCT00420147|12121895|FG000|NOT COMPLETED|Overall Study||0
10950370|NCT00420147|12121896|FG001|NOT COMPLETED|Overall Study||0
10950371|NCT00420199|12121904|FG000|STARTED|Overall Study||27
10950372|NCT00420199|12121905|FG001|STARTED|Overall Study||23
10950373|NCT00420199|12121904|FG000|COMPLETED|Overall Study||26
10950374|NCT00420199|12121905|FG001|COMPLETED|Overall Study||23
10950375|NCT00420199|12121904|FG000|NOT COMPLETED|Overall Study||1
10950376|NCT00420199|12121905|FG001|NOT COMPLETED|Overall Study||0
10950377|NCT00420212|12121919|FG000|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
10950378|NCT00420212|12121920|FG001|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
10950379|NCT00420212|12121921|FG002|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
10950380|NCT00420212|12121919|FG000|COMPLETED|Overall Study||317
10950381|NCT00420212|12121920|FG001|COMPLETED|Overall Study||315
10950382|NCT00420212|12121921|FG002|COMPLETED|Overall Study||320
10950383|NCT00420212|12121919|FG000|NOT COMPLETED|Overall Study||91
10950384|NCT00420212|12121920|FG001|NOT COMPLETED|Overall Study||95
10950385|NCT00420212|12121921|FG002|NOT COMPLETED|Overall Study||96
10950386|NCT00420238|12121934|FG000|STARTED|12 Week Double-Blind Treatment Period 1||39
10950387|NCT00420238|12121935|FG001|STARTED|12 Week Double-Blind Treatment Period 1||43
10950388|NCT00420238|12121934|FG000|COMPLETED|12 Week Double-Blind Treatment Period 1||38
10950389|NCT00420238|12121935|FG001|COMPLETED|12 Week Double-Blind Treatment Period 1||39
10950390|NCT00420238|12121934|FG000|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
10950391|NCT00420238|12121935|FG001|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
10950392|NCT00420238|12121934|FG000|STARTED|12 Week Open-Label Treatment Period 2||38
10950393|NCT00420238|12121935|FG001|STARTED|12 Week Open-Label Treatment Period 2||39
10950394|NCT00420238|12121934|FG000|COMPLETED|12 Week Open-Label Treatment Period 2||36
10950395|NCT00420238|12121935|FG001|COMPLETED|12 Week Open-Label Treatment Period 2||38
10950396|NCT00420238|12121934|FG000|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
10950397|NCT00420238|12121935|FG001|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
10950398|NCT00420290|12121949|FG000|STARTED|Overall Study||11
10950399|NCT00420290|12121950|FG001|STARTED|Overall Study||11
10950400|NCT00420290|12121949|FG000|COMPLETED|Overall Study||7
10950401|NCT00420290|12121950|FG001|COMPLETED|Overall Study||7
10950402|NCT00420290|12121949|FG000|NOT COMPLETED|Overall Study||4
10950403|NCT00420290|12121950|FG001|NOT COMPLETED|Overall Study||4
10950404|NCT00420303|12121958|FG000|STARTED|Overall Study||12
10950405|NCT00420303|12121959|FG001|STARTED|Overall Study||12
10950406|NCT00420303|12121958|FG000|COMPLETED|Overall Study||11
10950407|NCT00420303|12121959|FG001|COMPLETED|Overall Study||8
10950408|NCT00420303|12121958|FG000|NOT COMPLETED|Overall Study||1
10950409|NCT00420303|12121959|FG001|NOT COMPLETED|Overall Study||4
10950410|NCT00420316|12121967|FG000|STARTED|Overall Study||1082
10950411|NCT00420316|12121968|FG001|STARTED|Overall Study||531
10950412|NCT00420316|12121967|FG000|COMPLETED|Overall Study||1070
10950413|NCT00420316|12121968|FG001|COMPLETED|Overall Study||522
10950414|NCT00420316|12121967|FG000|NOT COMPLETED|Overall Study||12
10950415|NCT00420316|12121968|FG001|NOT COMPLETED|Overall Study||9
10950416|NCT00420342|12121977|FG000|STARTED|Overall Study||30
10950417|NCT00420342|12121978|FG001|STARTED|Overall Study||33
10950418|NCT00420342|12121979|FG002|STARTED|Overall Study||29
10950419|NCT00420342|12121977|FG000|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
10950420|NCT00420342|12121978|FG001|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
10950421|NCT00420342|12121979|FG002|Received Treatment|Overall Study||29
10950422|NCT00420342|12121977|FG000|COMPLETED|Overall Study||29
10950423|NCT00420342|12121978|FG001|COMPLETED|Overall Study||31
10950424|NCT00420342|12121979|FG002|COMPLETED|Overall Study||28
10950425|NCT00420342|12121977|FG000|NOT COMPLETED|Overall Study||1
10950426|NCT00420342|12121978|FG001|NOT COMPLETED|Overall Study||2
10950427|NCT00420342|12121979|FG002|NOT COMPLETED|Overall Study||1
10950428|NCT00420381|12121987|FG000|STARTED|Overall Study||28
10950429|NCT00420381|12121987|FG000|Received at Least One Dose of Study Drug|Overall Study||27
10950430|NCT00420381|12121987|FG000|COMPLETED|Overall Study||27
10950431|NCT00420381|12121987|FG000|NOT COMPLETED|Overall Study||1
10950432|NCT00420407|12121993|FG000|STARTED|Overall Study||41
10950433|NCT00420407|12121994|FG001|STARTED|Overall Study||40
10950434|NCT00420407|12121993|FG000|COMPLETED|Overall Study||37
10950435|NCT00420407|12121994|FG001|COMPLETED|Overall Study||34
10950436|NCT00420407|12121993|FG000|NOT COMPLETED|Overall Study||4
10950437|NCT00420407|12121994|FG001|NOT COMPLETED|Overall Study||6
10950438|NCT00420420|12122003|FG000|STARTED|Overall Study|Number of patients randomized.|73
10950439|NCT00420420|12122004|FG001|STARTED|Overall Study|Number of patients randomized.|71
10950440|NCT00420420|12122003|FG000|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
10950441|NCT00420420|12122004|FG001|COMPLETED|Overall Study||67
10950442|NCT00420420|12122003|FG000|NOT COMPLETED|Overall Study||8
10950443|NCT00420420|12122004|FG001|NOT COMPLETED|Overall Study||4
10950444|NCT00420459|12122010|FG000|STARTED|Overall Study||12
10950445|NCT00420459|12122010|FG000|COMPLETED|Overall Study||12
10950446|NCT00420459|12122010|FG000|NOT COMPLETED|Overall Study||0
10950447|NCT00420511|12122018|FG000|STARTED|Overall Study||10
10950448|NCT00420511|12122019|FG001|STARTED|Overall Study||11
10950449|NCT00420511|12122018|FG000|COMPLETED|Overall Study||8
10950450|NCT00420511|12122019|FG001|COMPLETED|Overall Study||10
10950451|NCT00420511|12122018|FG000|NOT COMPLETED|Overall Study||2
10950452|NCT00420511|12122019|FG001|NOT COMPLETED|Overall Study||1
10950453|NCT00420628|12122029|FG000|STARTED|Overall Study||72
10950454|NCT00420628|12122030|FG001|STARTED|Overall Study||36
10950455|NCT00420628|12122029|FG000|COMPLETED|Overall Study||63
10950456|NCT00420628|12122030|FG001|COMPLETED|Overall Study||32
10950457|NCT00420628|12122029|FG000|NOT COMPLETED|Overall Study||9
10950458|NCT00420628|12122030|FG001|NOT COMPLETED|Overall Study||4
10950459|NCT00420641|12122039|FG000|STARTED|Overall Study||160
10950460|NCT00420641|12122040|FG001|STARTED|Overall Study||172
10950461|NCT00420641|12122041|FG002|STARTED|Overall Study||172
10950462|NCT00420641|12122039|FG000|COMPLETED|Overall Study||115
10950463|NCT00420641|12122040|FG001|COMPLETED|Overall Study||100
10950464|NCT00420641|12122041|FG002|COMPLETED|Overall Study||128
10950465|NCT00420641|12122039|FG000|NOT COMPLETED|Overall Study||45
10950466|NCT00420641|12122040|FG001|NOT COMPLETED|Overall Study||72
10950467|NCT00420641|12122041|FG002|NOT COMPLETED|Overall Study||44
10950468|NCT00420745|12122051|FG000|STARTED|Overall Study||670
10950469|NCT00420745|12122052|FG001|STARTED|Overall Study||339
10950470|NCT00420745|12122051|FG000|COMPLETED|Overall Study||655
10950471|NCT00420745|12122052|FG001|COMPLETED|Overall Study||333
10950472|NCT00420745|12122051|FG000|NOT COMPLETED|Overall Study||15
10950473|NCT00420745|12122052|FG001|NOT COMPLETED|Overall Study||6
10950474|NCT00420771|12122060|FG000|STARTED|Overall Study||8
10950475|NCT00420771|12122061|FG001|STARTED|Overall Study||11
10950476|NCT00420771|12122060|FG000|COMPLETED|Overall Study||5
10950477|NCT00420771|12122061|FG001|COMPLETED|Overall Study||7
10950478|NCT00420771|12122060|FG000|NOT COMPLETED|Overall Study||3
10950479|NCT00420771|12122061|FG001|NOT COMPLETED|Overall Study||4
10950480|NCT00420784|12122071|FG000|STARTED|Overall Study||115
10950481|NCT00420784|12122072|FG001|STARTED|Overall Study||113
10950482|NCT00420784|12122073|FG002|STARTED|Overall Study||111
10950483|NCT00420784|12122074|FG003|STARTED|Overall Study||114
10950484|NCT00420784|12122071|FG000|COMPLETED|Overall Study||86
10950485|NCT00420784|12122072|FG001|COMPLETED|Overall Study||55
10950486|NCT00420784|12122073|FG002|COMPLETED|Overall Study||58
10950487|NCT00420784|12122074|FG003|COMPLETED|Overall Study||36
10950488|NCT00420784|12122071|FG000|NOT COMPLETED|Overall Study||29
10950489|NCT00420784|12122072|FG001|NOT COMPLETED|Overall Study||58
10950490|NCT00420784|12122073|FG002|NOT COMPLETED|Overall Study||53
10950491|NCT00420784|12122074|FG003|NOT COMPLETED|Overall Study||78
10950492|NCT00420849|12122085|FG000|STARTED|Overall Study||587
10950493|NCT00420849|12122085|FG000|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
10950494|NCT00420849|12122085|FG000|NOT COMPLETED|Overall Study||331
10950495|NCT00420927|12122099|FG000|STARTED|Period 1||515
10950496|NCT00420927|12122100|FG001|STARTED|Period 1||517
10950497|NCT00420927|12122101|FG002|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
10950498|NCT00420927|12122102|FG003|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
10950499|NCT00420927|12122103|FG004|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
10950500|NCT00420927|12122104|FG005|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
10950501|NCT00420927|12122105|FG006|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
10950502|NCT00420927|12122099|FG000|COMPLETED|Period 1||466
10950503|NCT00420927|12122100|FG001|COMPLETED|Period 1||460
10950504|NCT00420927|12122101|FG002|COMPLETED|Period 1||0
10950505|NCT00420927|12122102|FG003|COMPLETED|Period 1||0
10950506|NCT00420927|12122103|FG004|COMPLETED|Period 1||0
10950507|NCT00420927|12122104|FG005|COMPLETED|Period 1||0
10950508|NCT00420927|12122105|FG006|COMPLETED|Period 1||0
10950509|NCT00420927|12122099|FG000|NOT COMPLETED|Period 1||49
10950510|NCT00420927|12122100|FG001|NOT COMPLETED|Period 1||57
10950511|NCT00420927|12122101|FG002|NOT COMPLETED|Period 1||0
10950512|NCT00420927|12122102|FG003|NOT COMPLETED|Period 1||0
10950513|NCT00420927|12122103|FG004|NOT COMPLETED|Period 1||0
10950514|NCT00420927|12122104|FG005|NOT COMPLETED|Period 1||0
10950515|NCT00420927|12122105|FG006|NOT COMPLETED|Period 1||0
10950516|NCT00420927|12122099|FG000|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
10950517|NCT00420927|12122100|FG001|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
10950518|NCT00420927|12122101|FG002|STARTED|Period 2||102
10950519|NCT00420927|12122102|FG003|STARTED|Period 2||105
10950520|NCT00420927|12122103|FG004|STARTED|Period 2||259
10950521|NCT00420927|12122104|FG005|STARTED|Period 2||112
10950522|NCT00420927|12122105|FG006|STARTED|Period 2||348
10950523|NCT00420927|12122099|FG000|COMPLETED|Period 2||0
10950524|NCT00420927|12122100|FG001|COMPLETED|Period 2||0
10950525|NCT00420927|12122101|FG002|COMPLETED|Period 2||89
10950526|NCT00420927|12122102|FG003|COMPLETED|Period 2||95
10950527|NCT00420927|12122103|FG004|COMPLETED|Period 2||216
10950528|NCT00420927|12122104|FG005|COMPLETED|Period 2||97
10950529|NCT00420927|12122105|FG006|COMPLETED|Period 2||295
10950530|NCT00420927|12122099|FG000|NOT COMPLETED|Period 2||0
10950531|NCT00420927|12122100|FG001|NOT COMPLETED|Period 2||0
10950532|NCT00420927|12122101|FG002|NOT COMPLETED|Period 2||13
10950533|NCT00420927|12122102|FG003|NOT COMPLETED|Period 2||10
10950534|NCT00420927|12122103|FG004|NOT COMPLETED|Period 2||43
10950535|NCT00420927|12122104|FG005|NOT COMPLETED|Period 2||15
10950536|NCT00420927|12122105|FG006|NOT COMPLETED|Period 2||53
10950537|NCT00420992|12122121|FG000|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
10950538|NCT00420992|12122122|FG001|STARTED|Titration Phase||0
10950539|NCT00420992|12122121|FG000|COMPLETED|Titration Phase||344
10950540|NCT00420992|12122122|FG001|COMPLETED|Titration Phase||0
10950541|NCT00420992|12122121|FG000|NOT COMPLETED|Titration Phase||203
10950542|NCT00420992|12122122|FG001|NOT COMPLETED|Titration Phase||0
10950543|NCT00420992|12122121|FG000|STARTED|Maintenance Phase||171
10950544|NCT00420992|12122122|FG001|STARTED|Maintenance Phase||173
10950545|NCT00420992|12122121|FG000|COMPLETED|Maintenance Phase||110
10950546|NCT00420992|12122122|FG001|COMPLETED|Maintenance Phase||98
10950547|NCT00420992|12122121|FG000|NOT COMPLETED|Maintenance Phase||61
10950548|NCT00420992|12122122|FG001|NOT COMPLETED|Maintenance Phase||75
10950549|NCT00421148|12122149|FG000|STARTED|Overall Study||2
10950550|NCT00421148|12122150|FG001|STARTED|Overall Study||2
10950551|NCT00421148|12122151|FG002|STARTED|Overall Study||2
10950552|NCT00421148|12122152|FG003|STARTED|Overall Study||1
10950553|NCT00421148|12122153|FG004|STARTED|Overall Study||1
10950554|NCT00421148|12122154|FG005|STARTED|Overall Study||5
10950555|NCT00421148|12122155|FG006|STARTED|Overall Study||6
10950556|NCT00421148|12122156|FG007|STARTED|Overall Study||5
10950557|NCT00421148|12122157|FG008|STARTED|Overall Study||5
10950558|NCT00421148|12122158|FG009|STARTED|Overall Study||5
10950559|NCT00421148|12122159|FG010|STARTED|Overall Study||6
10950560|NCT00421148|12122160|FG011|STARTED|Overall Study||6
10950561|NCT00421148|12122161|FG012|STARTED|Overall Study||6
10950562|NCT00421148|12122162|FG013|STARTED|Overall Study||6
10950563|NCT00421148|12122163|FG014|STARTED|Overall Study||6
10950564|NCT00421148|12122164|FG015|STARTED|Overall Study||6
10950565|NCT00421148|12122165|FG016|STARTED|Overall Study||6
10950566|NCT00421148|12122166|FG017|STARTED|Overall Study||6
10950567|NCT00421148|12122167|FG018|STARTED|Overall Study||6
10950568|NCT00421148|12122168|FG019|STARTED|Overall Study||6
10950569|NCT00421148|12122149|FG000|Treated|Overall Study||2
10950570|NCT00421148|12122150|FG001|Treated|Overall Study||2
10950571|NCT00421148|12122151|FG002|Treated|Overall Study||2
10950572|NCT00421148|12122152|FG003|Treated|Overall Study||1
10950573|NCT00421148|12122153|FG004|Treated|Overall Study||1
10950574|NCT00421148|12122154|FG005|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4
10950575|NCT00421148|12122155|FG006|Treated|Overall Study||6
10950576|NCT00421148|12122156|FG007|Treated|Overall Study||5
10950577|NCT00421148|12122157|FG008|Treated|Overall Study||5
10950578|NCT00421148|12122158|FG009|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5
10950579|NCT00421148|12122159|FG010|Treated|Overall Study||6
10950580|NCT00421148|12122160|FG011|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6
10950581|NCT00421148|12122161|FG012|Treated|Overall Study||6
10950582|NCT00421148|12122162|FG013|Treated|Overall Study||6
10950583|NCT00421148|12122163|FG014|Treated|Overall Study||6
10950584|NCT00421148|12122164|FG015|Treated|Overall Study||6
10950585|NCT00421148|12122165|FG016|Treated|Overall Study||6
10950586|NCT00421148|12122166|FG017|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
10950587|NCT00421148|12122167|FG018|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
10950588|NCT00421148|12122168|FG019|Treated|Overall Study||6
10950589|NCT00421148|12122149|FG000|COMPLETED|Overall Study||2
10950590|NCT00421148|12122150|FG001|COMPLETED|Overall Study||2
10950591|NCT00421148|12122151|FG002|COMPLETED|Overall Study||2
10950592|NCT00421148|12122152|FG003|COMPLETED|Overall Study||1
10950593|NCT00421148|12122153|FG004|COMPLETED|Overall Study||1
10950594|NCT00421148|12122154|FG005|COMPLETED|Overall Study||4
10950595|NCT00421148|12122155|FG006|COMPLETED|Overall Study||6
10950596|NCT00421148|12122156|FG007|COMPLETED|Overall Study||5
10950597|NCT00421148|12122157|FG008|COMPLETED|Overall Study||5
10950598|NCT00421148|12122158|FG009|COMPLETED|Overall Study||5
10950599|NCT00421148|12122159|FG010|COMPLETED|Overall Study||6
10950600|NCT00421148|12122160|FG011|COMPLETED|Overall Study||6
10950601|NCT00421148|12122161|FG012|COMPLETED|Overall Study||6
10950602|NCT00421148|12122162|FG013|COMPLETED|Overall Study||6
10950603|NCT00421148|12122163|FG014|COMPLETED|Overall Study||6
10950604|NCT00421148|12122164|FG015|COMPLETED|Overall Study||6
10950605|NCT00421148|12122165|FG016|COMPLETED|Overall Study||6
10950606|NCT00421148|12122166|FG017|COMPLETED|Overall Study||4
10950607|NCT00421148|12122167|FG018|COMPLETED|Overall Study||5
10950608|NCT00421148|12122168|FG019|COMPLETED|Overall Study||6
10950609|NCT00421148|12122149|FG000|NOT COMPLETED|Overall Study||0
10950610|NCT00421148|12122150|FG001|NOT COMPLETED|Overall Study||0
10950611|NCT00421148|12122151|FG002|NOT COMPLETED|Overall Study||0
10950612|NCT00421148|12122152|FG003|NOT COMPLETED|Overall Study||0
10950613|NCT00421148|12122153|FG004|NOT COMPLETED|Overall Study||0
10950614|NCT00421148|12122154|FG005|NOT COMPLETED|Overall Study||1
10950615|NCT00421148|12122155|FG006|NOT COMPLETED|Overall Study||0
10950616|NCT00421148|12122156|FG007|NOT COMPLETED|Overall Study||0
10950617|NCT00421148|12122157|FG008|NOT COMPLETED|Overall Study||0
10950618|NCT00421148|12122158|FG009|NOT COMPLETED|Overall Study||0
10950619|NCT00421148|12122159|FG010|NOT COMPLETED|Overall Study||0
10950620|NCT00421148|12122160|FG011|NOT COMPLETED|Overall Study||0
10950621|NCT00421148|12122161|FG012|NOT COMPLETED|Overall Study||0
10950622|NCT00421148|12122162|FG013|NOT COMPLETED|Overall Study||0
10950623|NCT00421148|12122163|FG014|NOT COMPLETED|Overall Study||0
10950624|NCT00421148|12122164|FG015|NOT COMPLETED|Overall Study||0
10950625|NCT00421148|12122165|FG016|NOT COMPLETED|Overall Study||0
10950626|NCT00421148|12122166|FG017|NOT COMPLETED|Overall Study||2
10950627|NCT00421148|12122167|FG018|NOT COMPLETED|Overall Study||1
10950628|NCT00421148|12122168|FG019|NOT COMPLETED|Overall Study||0
10950629|NCT00421174|12122212|FG000|STARTED|Overall Study||18
10950630|NCT00421174|12122213|FG001|STARTED|Overall Study||19
10950631|NCT00421174|12122212|FG000|COMPLETED|Overall Study||16
10950632|NCT00421174|12122213|FG001|COMPLETED|Overall Study||18
10950633|NCT00421174|12122212|FG000|NOT COMPLETED|Overall Study||2
10950634|NCT00421174|12122213|FG001|NOT COMPLETED|Overall Study||1
10950635|NCT00421304|12122222|FG000|STARTED|Overall Study||40
10950636|NCT00421304|12122223|FG001|STARTED|Overall Study||39
10950637|NCT00421304|12122224|FG002|STARTED|Overall Study||39
10950638|NCT00421304|12122222|FG000|COMPLETED|Overall Study||32
10950639|NCT00421304|12122223|FG001|COMPLETED|Overall Study||35
10950640|NCT00421304|12122224|FG002|COMPLETED|Overall Study||31
10950641|NCT00421304|12122222|FG000|NOT COMPLETED|Overall Study||8
10950642|NCT00421304|12122223|FG001|NOT COMPLETED|Overall Study||4
10950643|NCT00421304|12122224|FG002|NOT COMPLETED|Overall Study||8
10950644|NCT00421343|12122234|FG000|STARTED|Overall Study||29
10950645|NCT00421343|12122234|FG000|COMPLETED|Overall Study||23
10950646|NCT00421343|12122234|FG000|NOT COMPLETED|Overall Study||6
10950647|NCT00421408|12122240|FG000|STARTED|Overall Study||102
10950648|NCT00421408|12122241|FG001|STARTED|Overall Study||106
10950649|NCT00421408|12122240|FG000|COMPLETED|Overall Study||60
10950650|NCT00421408|12122241|FG001|COMPLETED|Overall Study||61
10950651|NCT00421408|12122240|FG000|NOT COMPLETED|Overall Study||42
10950652|NCT00421408|12122241|FG001|NOT COMPLETED|Overall Study||45
10950653|NCT00421603|12122249|FG000|STARTED|Overall Study||39
10950654|NCT00421603|12122250|FG001|STARTED|Overall Study||42
10950655|NCT00421603|12122249|FG000|COMPLETED|Overall Study|Completed all 14 week sof trial|28
10950656|NCT00421603|12122250|FG001|COMPLETED|Overall Study|Completed all 14 week sof trial|30
10950657|NCT00421603|12122249|FG000|NOT COMPLETED|Overall Study||11
10950658|NCT00421603|12122250|FG001|NOT COMPLETED|Overall Study||12
10950659|NCT00421707|12122258|FG000|STARTED|Period 1: Treatment Period 1||67
10950660|NCT00421707|12122259|FG001|STARTED|Period 1: Treatment Period 1||65
10950661|NCT00421707|12122258|FG000|COMPLETED|Period 1: Treatment Period 1||56
10950662|NCT00421707|12122259|FG001|COMPLETED|Period 1: Treatment Period 1||56
10950663|NCT00421707|12122258|FG000|NOT COMPLETED|Period 1: Treatment Period 1||11
10950664|NCT00421707|12122259|FG001|NOT COMPLETED|Period 1: Treatment Period 1||9
10950665|NCT00421707|12122258|FG000|STARTED|Period 2: Washout||56
10950666|NCT00421707|12122259|FG001|STARTED|Period 2: Washout||56
10950667|NCT00421707|12122258|FG000|COMPLETED|Period 2: Washout||55
10950668|NCT00421707|12122259|FG001|COMPLETED|Period 2: Washout||52
10950669|NCT00421707|12122258|FG000|NOT COMPLETED|Period 2: Washout||1
10950670|NCT00421707|12122259|FG001|NOT COMPLETED|Period 2: Washout||4
10950671|NCT00421707|12122258|FG000|STARTED|Period 3:Treatment Period 2||55
10950672|NCT00421707|12122259|FG001|STARTED|Period 3:Treatment Period 2||52
10950673|NCT00421707|12122258|FG000|COMPLETED|Period 3:Treatment Period 2||53
10950674|NCT00421707|12122259|FG001|COMPLETED|Period 3:Treatment Period 2||49
10950675|NCT00421707|12122258|FG000|NOT COMPLETED|Period 3:Treatment Period 2||2
10950676|NCT00421707|12122259|FG001|NOT COMPLETED|Period 3:Treatment Period 2||3
10950677|NCT00421733|12122271|FG000|STARTED|Overall Study||93
10950678|NCT00421733|12122272|FG001|STARTED|Overall Study||95
10950679|NCT00421733|12122273|FG002|STARTED|Overall Study||93
10950680|NCT00421733|12122271|FG000|COMPLETED|Overall Study||78
10950681|NCT00421733|12122272|FG001|COMPLETED|Overall Study||69
10950682|NCT00421733|12122273|FG002|COMPLETED|Overall Study||73
10950683|NCT00421733|12122271|FG000|NOT COMPLETED|Overall Study||15
10950684|NCT00421733|12122272|FG001|NOT COMPLETED|Overall Study||26
10950685|NCT00421733|12122273|FG002|NOT COMPLETED|Overall Study||20
10950686|NCT00421889|12122294|FG000|STARTED|Overall Study||5
10950687|NCT00421889|12122295|FG001|STARTED|Overall Study||5
10950688|NCT00421889|12122296|FG002|STARTED|Overall Study||3
10950689|NCT00421889|12122297|FG003|STARTED|Overall Study||4
10950690|NCT00421889|12122298|FG004|STARTED|Overall Study||6
10950691|NCT00421889|12122299|FG005|STARTED|Overall Study||35
10950692|NCT00421889|12122300|FG006|STARTED|Overall Study||4
10950693|NCT00421889|12122301|FG007|STARTED|Overall Study||3
10950694|NCT00421889|12122302|FG008|STARTED|Overall Study||15
10950695|NCT00421889|12122294|FG000|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
10950696|NCT00421889|12122295|FG001|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
10950697|NCT00421889|12122296|FG002|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
10950698|NCT00421889|12122297|FG003|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
10950699|NCT00421889|12122298|FG004|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
10950700|NCT00421889|12122299|FG005|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
10950701|NCT00421889|12122300|FG006|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
10950702|NCT00421889|12122301|FG007|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
10950703|NCT00421889|12122302|FG008|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
10950704|NCT00421889|12122294|FG000|NOT COMPLETED|Overall Study||5
10950705|NCT00421889|12122295|FG001|NOT COMPLETED|Overall Study||5
10950706|NCT00421889|12122296|FG002|NOT COMPLETED|Overall Study||3
10950707|NCT00421889|12122297|FG003|NOT COMPLETED|Overall Study||4
10950708|NCT00421889|12122298|FG004|NOT COMPLETED|Overall Study||6
10950709|NCT00421889|12122299|FG005|NOT COMPLETED|Overall Study||35
10950710|NCT00421889|12122300|FG006|NOT COMPLETED|Overall Study||4
10950711|NCT00421889|12122301|FG007|NOT COMPLETED|Overall Study||2
10950712|NCT00421889|12122302|FG008|NOT COMPLETED|Overall Study||11
10950713|NCT00421928|12122329|FG000|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
10950714|NCT00421928|12122330|FG001|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
10950715|NCT00421928|12122331|FG002|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
10950716|NCT00421928|12122329|FG000|COMPLETED|Overall Study||181
10950717|NCT00421928|12122330|FG001|COMPLETED|Overall Study||118
10950718|NCT00421928|12122331|FG002|COMPLETED|Overall Study||203
10950719|NCT00421928|12122329|FG000|NOT COMPLETED|Overall Study||163
10950720|NCT00421928|12122330|FG001|NOT COMPLETED|Overall Study||224
10950721|NCT00421928|12122331|FG002|NOT COMPLETED|Overall Study||134
10950722|NCT00421993|12122343|FG000|STARTED|Overall Study||419
10950723|NCT00421993|12122344|FG001|STARTED|Overall Study||418
10950724|NCT00421993|12122345|FG002|STARTED|Overall Study||415
10950725|NCT00421993|12122346|FG003|STARTED|Overall Study||418
10950726|NCT00421993|12122343|FG000|COMPLETED|Overall Study||366
10950727|NCT00421993|12122344|FG001|COMPLETED|Overall Study||369
10950728|NCT00421993|12122345|FG002|COMPLETED|Overall Study||363
10950729|NCT00421993|12122346|FG003|COMPLETED|Overall Study||361
10950730|NCT00421993|12122343|FG000|NOT COMPLETED|Overall Study||53
10950731|NCT00421993|12122344|FG001|NOT COMPLETED|Overall Study||49
10950732|NCT00421993|12122345|FG002|NOT COMPLETED|Overall Study||52
10950733|NCT00421993|12122346|FG003|NOT COMPLETED|Overall Study||57
10950734|NCT00422032|12122358|FG000|STARTED|Overall Study||37
10950735|NCT00422032|12122359|FG001|STARTED|Overall Study||21
10950736|NCT00422032|12122358|FG000|COMPLETED|Overall Study||37
10950737|NCT00422032|12122359|FG001|COMPLETED|Overall Study||21
10950738|NCT00422032|12122358|FG000|NOT COMPLETED|Overall Study||0
10950739|NCT00422032|12122359|FG001|NOT COMPLETED|Overall Study||0
10950740|NCT00422058|12122371|FG000|STARTED|Double-Blind, Week 0-20||98
10950741|NCT00422058|12122372|FG001|STARTED|Double-Blind, Week 0-20||95
10950742|NCT00422058|12122373|FG002|STARTED|Double-Blind, Week 0-20||90
10950743|NCT00422058|12122374|FG003|STARTED|Double-Blind, Week 0-20||93
10950744|NCT00422058|12122375|FG004|STARTED|Double-Blind, Week 0-20||93
10950745|NCT00422058|12122376|FG005|STARTED|Double-Blind, Week 0-20||95
10950746|NCT00422058|12122371|FG000|COMPLETED|Double-Blind, Week 0-20||79
10950747|NCT00422058|12122372|FG001|COMPLETED|Double-Blind, Week 0-20||85
10950748|NCT00422058|12122373|FG002|COMPLETED|Double-Blind, Week 0-20||74
10950749|NCT00422058|12122374|FG003|COMPLETED|Double-Blind, Week 0-20||73
10950750|NCT00422058|12122375|FG004|COMPLETED|Double-Blind, Week 0-20||82
10950751|NCT00422058|12122376|FG005|COMPLETED|Double-Blind, Week 0-20||79
10950752|NCT00422058|12122371|FG000|NOT COMPLETED|Double-Blind, Week 0-20||19
10950753|NCT00422058|12122372|FG001|NOT COMPLETED|Double-Blind, Week 0-20||10
10950754|NCT00422058|12122373|FG002|NOT COMPLETED|Double-Blind, Week 0-20||16
10950755|NCT00422058|12122374|FG003|NOT COMPLETED|Double-Blind, Week 0-20||20
10950756|NCT00422058|12122375|FG004|NOT COMPLETED|Double-Blind, Week 0-20||11
10950757|NCT00422058|12122376|FG005|NOT COMPLETED|Double-Blind, Week 0-20||16
10950758|NCT00422058|12122371|FG000|STARTED|Open-Label Extension, Week 20-104||79
10950759|NCT00422058|12122372|FG001|STARTED|Open-Label Extension, Week 20-104||85
10950760|NCT00422058|12122373|FG002|STARTED|Open-Label Extension, Week 20-104||74
10950761|NCT00422058|12122374|FG003|STARTED|Open-Label Extension, Week 20-104||73
10950762|NCT00422058|12122375|FG004|STARTED|Open-Label Extension, Week 20-104||82
10950763|NCT00422058|12122376|FG005|STARTED|Open-Label Extension, Week 20-104||79
10950764|NCT00422058|12122371|FG000|Enrolled in Extension|Open-Label Extension, Week 20-104||67
10950765|NCT00422058|12122372|FG001|Enrolled in Extension|Open-Label Extension, Week 20-104||68
10950766|NCT00422058|12122373|FG002|Enrolled in Extension|Open-Label Extension, Week 20-104||59
10950767|NCT00422058|12122374|FG003|Enrolled in Extension|Open-Label Extension, Week 20-104||65
10950768|NCT00422058|12122375|FG004|Enrolled in Extension|Open-Label Extension, Week 20-104||72
10950769|NCT00422058|12122376|FG005|Enrolled in Extension|Open-Label Extension, Week 20-104||67
10950770|NCT00422058|12122371|FG000|COMPLETED|Open-Label Extension, Week 20-104||47
10950771|NCT00422058|12122372|FG001|COMPLETED|Open-Label Extension, Week 20-104||46
10950772|NCT00422058|12122373|FG002|COMPLETED|Open-Label Extension, Week 20-104||38
10950773|NCT00422058|12122374|FG003|COMPLETED|Open-Label Extension, Week 20-104||45
10950774|NCT00422058|12122375|FG004|COMPLETED|Open-Label Extension, Week 20-104||47
10950775|NCT00422058|12122376|FG005|COMPLETED|Open-Label Extension, Week 20-104||45
10950776|NCT00422058|12122371|FG000|NOT COMPLETED|Open-Label Extension, Week 20-104||32
10950777|NCT00422058|12122372|FG001|NOT COMPLETED|Open-Label Extension, Week 20-104||39
10950778|NCT00422058|12122373|FG002|NOT COMPLETED|Open-Label Extension, Week 20-104||36
10950779|NCT00422058|12122374|FG003|NOT COMPLETED|Open-Label Extension, Week 20-104||28
10950780|NCT00422058|12122375|FG004|NOT COMPLETED|Open-Label Extension, Week 20-104||35
10950781|NCT00422058|12122376|FG005|NOT COMPLETED|Open-Label Extension, Week 20-104||34
10950782|NCT00422084|12122392|FG000|STARTED|Overall Study||849
10950783|NCT00422084|12122393|FG001|STARTED|Overall Study||423
10950784|NCT00422084|12122392|FG000|COMPLETED|Overall Study||751
10950785|NCT00422084|12122393|FG001|COMPLETED|Overall Study||347
10950786|NCT00422084|12122392|FG000|NOT COMPLETED|Overall Study||98
10950787|NCT00422084|12122393|FG001|NOT COMPLETED|Overall Study||76
10950788|NCT00422097|12122405|FG000|STARTED|Dose Level 1||3
10950789|NCT00422097|12122406|FG001|STARTED|Dose Level 1||0
10950790|NCT00422097|12122407|FG002|STARTED|Dose Level 1||0
10950791|NCT00422097|12122408|FG003|STARTED|Dose Level 1||0
10950792|NCT00422097|12122409|FG004|STARTED|Dose Level 1||0
10950793|NCT00422097|12122410|FG005|STARTED|Dose Level 1||0
10950794|NCT00422097|12122411|FG006|STARTED|Dose Level 1||0
10950795|NCT00422097|12122412|FG007|STARTED|Dose Level 1||0
10950796|NCT00422097|12122405|FG000|COMPLETED|Dose Level 1||3
10950797|NCT00422097|12122406|FG001|COMPLETED|Dose Level 1||0
10950798|NCT00422097|12122407|FG002|COMPLETED|Dose Level 1||0
10950799|NCT00422097|12122408|FG003|COMPLETED|Dose Level 1||0
10950800|NCT00422097|12122409|FG004|COMPLETED|Dose Level 1||0
10950801|NCT00422097|12122410|FG005|COMPLETED|Dose Level 1||0
10950802|NCT00422097|12122411|FG006|COMPLETED|Dose Level 1||0
10950803|NCT00422097|12122412|FG007|COMPLETED|Dose Level 1||0
10950804|NCT00422097|12122405|FG000|NOT COMPLETED|Dose Level 1||0
10950805|NCT00422097|12122406|FG001|NOT COMPLETED|Dose Level 1||0
10950806|NCT00422097|12122407|FG002|NOT COMPLETED|Dose Level 1||0
10950807|NCT00422097|12122408|FG003|NOT COMPLETED|Dose Level 1||0
10950808|NCT00422097|12122409|FG004|NOT COMPLETED|Dose Level 1||0
10950809|NCT00422097|12122410|FG005|NOT COMPLETED|Dose Level 1||0
10950810|NCT00422097|12122411|FG006|NOT COMPLETED|Dose Level 1||0
10950811|NCT00422097|12122412|FG007|NOT COMPLETED|Dose Level 1||0
10950812|NCT00422097|12122405|FG000|STARTED|Dose Level 2||0
10950813|NCT00422097|12122406|FG001|STARTED|Dose Level 2||6
10950814|NCT00422097|12122407|FG002|STARTED|Dose Level 2||0
10950815|NCT00422097|12122408|FG003|STARTED|Dose Level 2||0
10950816|NCT00422097|12122409|FG004|STARTED|Dose Level 2||0
10950817|NCT00422097|12122410|FG005|STARTED|Dose Level 2||0
10950818|NCT00422097|12122411|FG006|STARTED|Dose Level 2||0
10950819|NCT00422097|12122412|FG007|STARTED|Dose Level 2||0
10950820|NCT00422097|12122405|FG000|COMPLETED|Dose Level 2||0
10950821|NCT00422097|12122406|FG001|COMPLETED|Dose Level 2||5
10950822|NCT00422097|12122407|FG002|COMPLETED|Dose Level 2||0
10950823|NCT00422097|12122408|FG003|COMPLETED|Dose Level 2||0
10950824|NCT00422097|12122409|FG004|COMPLETED|Dose Level 2||0
10950825|NCT00422097|12122410|FG005|COMPLETED|Dose Level 2||0
10950826|NCT00422097|12122411|FG006|COMPLETED|Dose Level 2||0
10950827|NCT00422097|12122412|FG007|COMPLETED|Dose Level 2||0
10950828|NCT00422097|12122405|FG000|NOT COMPLETED|Dose Level 2||0
10950829|NCT00422097|12122406|FG001|NOT COMPLETED|Dose Level 2||1
10950830|NCT00422097|12122407|FG002|NOT COMPLETED|Dose Level 2||0
10950831|NCT00422097|12122408|FG003|NOT COMPLETED|Dose Level 2||0
10950832|NCT00422097|12122409|FG004|NOT COMPLETED|Dose Level 2||0
10950833|NCT00422097|12122410|FG005|NOT COMPLETED|Dose Level 2||0
10950834|NCT00422097|12122411|FG006|NOT COMPLETED|Dose Level 2||0
10950835|NCT00422097|12122412|FG007|NOT COMPLETED|Dose Level 2||0
10950836|NCT00422097|12122405|FG000|STARTED|Dose Level 3||0
10950837|NCT00422097|12122406|FG001|STARTED|Dose Level 3||0
10950838|NCT00422097|12122407|FG002|STARTED|Dose Level 3||3
10950839|NCT00422097|12122408|FG003|STARTED|Dose Level 3||0
10950840|NCT00422097|12122409|FG004|STARTED|Dose Level 3||0
10950841|NCT00422097|12122410|FG005|STARTED|Dose Level 3||0
10950842|NCT00422097|12122411|FG006|STARTED|Dose Level 3||0
10950843|NCT00422097|12122412|FG007|STARTED|Dose Level 3||0
10950844|NCT00422097|12122405|FG000|COMPLETED|Dose Level 3||0
10950845|NCT00422097|12122406|FG001|COMPLETED|Dose Level 3||0
10950846|NCT00422097|12122407|FG002|COMPLETED|Dose Level 3||3
10950847|NCT00422097|12122408|FG003|COMPLETED|Dose Level 3||0
10950848|NCT00422097|12122409|FG004|COMPLETED|Dose Level 3||0
10950849|NCT00422097|12122410|FG005|COMPLETED|Dose Level 3||0
10950850|NCT00422097|12122411|FG006|COMPLETED|Dose Level 3||0
10950851|NCT00422097|12122412|FG007|COMPLETED|Dose Level 3||0
10950852|NCT00422097|12122405|FG000|NOT COMPLETED|Dose Level 3||0
10950853|NCT00422097|12122406|FG001|NOT COMPLETED|Dose Level 3||0
10950854|NCT00422097|12122407|FG002|NOT COMPLETED|Dose Level 3||0
10950855|NCT00422097|12122408|FG003|NOT COMPLETED|Dose Level 3||0
10950856|NCT00422097|12122409|FG004|NOT COMPLETED|Dose Level 3||0
10950857|NCT00422097|12122410|FG005|NOT COMPLETED|Dose Level 3||0
10950858|NCT00422097|12122411|FG006|NOT COMPLETED|Dose Level 3||0
10950859|NCT00422097|12122412|FG007|NOT COMPLETED|Dose Level 3||0
10950860|NCT00422097|12122405|FG000|STARTED|Dose Level 4||0
10950861|NCT00422097|12122406|FG001|STARTED|Dose Level 4||0
10950862|NCT00422097|12122407|FG002|STARTED|Dose Level 4||0
10950863|NCT00422097|12122408|FG003|STARTED|Dose Level 4||3
10950864|NCT00422097|12122409|FG004|STARTED|Dose Level 4||0
10950865|NCT00422097|12122410|FG005|STARTED|Dose Level 4||0
10950866|NCT00422097|12122411|FG006|STARTED|Dose Level 4||0
10950867|NCT00422097|12122412|FG007|STARTED|Dose Level 4||0
10950868|NCT00422097|12122405|FG000|COMPLETED|Dose Level 4||0
10950869|NCT00422097|12122406|FG001|COMPLETED|Dose Level 4||0
10950870|NCT00422097|12122407|FG002|COMPLETED|Dose Level 4||0
10950871|NCT00422097|12122408|FG003|COMPLETED|Dose Level 4||3
10950872|NCT00422097|12122409|FG004|COMPLETED|Dose Level 4||0
10950873|NCT00422097|12122410|FG005|COMPLETED|Dose Level 4||0
10950874|NCT00422097|12122411|FG006|COMPLETED|Dose Level 4||0
10950875|NCT00422097|12122412|FG007|COMPLETED|Dose Level 4||0
10950876|NCT00422097|12122405|FG000|NOT COMPLETED|Dose Level 4||0
10950877|NCT00422097|12122406|FG001|NOT COMPLETED|Dose Level 4||0
10950878|NCT00422097|12122407|FG002|NOT COMPLETED|Dose Level 4||0
10950879|NCT00422097|12122408|FG003|NOT COMPLETED|Dose Level 4||0
10950880|NCT00422097|12122409|FG004|NOT COMPLETED|Dose Level 4||0
10950881|NCT00422097|12122410|FG005|NOT COMPLETED|Dose Level 4||0
10950882|NCT00422097|12122411|FG006|NOT COMPLETED|Dose Level 4||0
10950883|NCT00422097|12122412|FG007|NOT COMPLETED|Dose Level 4||0
10950884|NCT00422097|12122405|FG000|STARTED|Dose Level 5||0
10950885|NCT00422097|12122406|FG001|STARTED|Dose Level 5||0
10950886|NCT00422097|12122407|FG002|STARTED|Dose Level 5||0
10950887|NCT00422097|12122408|FG003|STARTED|Dose Level 5||0
10950888|NCT00422097|12122409|FG004|STARTED|Dose Level 5||23
10950889|NCT00422097|12122410|FG005|STARTED|Dose Level 5||0
10950890|NCT00422097|12122411|FG006|STARTED|Dose Level 5||0
10950891|NCT00422097|12122412|FG007|STARTED|Dose Level 5||0
10950892|NCT00422097|12122405|FG000|COMPLETED|Dose Level 5||0
10950893|NCT00422097|12122406|FG001|COMPLETED|Dose Level 5||0
10950894|NCT00422097|12122407|FG002|COMPLETED|Dose Level 5||0
10950895|NCT00422097|12122408|FG003|COMPLETED|Dose Level 5||0
10950896|NCT00422097|12122409|FG004|COMPLETED|Dose Level 5||23
10950897|NCT00422097|12122410|FG005|COMPLETED|Dose Level 5||0
10950898|NCT00422097|12122411|FG006|COMPLETED|Dose Level 5||0
10950899|NCT00422097|12122412|FG007|COMPLETED|Dose Level 5||0
10950900|NCT00422097|12122405|FG000|NOT COMPLETED|Dose Level 5||0
10950901|NCT00422097|12122406|FG001|NOT COMPLETED|Dose Level 5||0
10950902|NCT00422097|12122407|FG002|NOT COMPLETED|Dose Level 5||0
10950903|NCT00422097|12122408|FG003|NOT COMPLETED|Dose Level 5||0
10950904|NCT00422097|12122409|FG004|NOT COMPLETED|Dose Level 5||0
10950905|NCT00422097|12122410|FG005|NOT COMPLETED|Dose Level 5||0
10950906|NCT00422097|12122411|FG006|NOT COMPLETED|Dose Level 5||0
10950907|NCT00422097|12122412|FG007|NOT COMPLETED|Dose Level 5||0
10950908|NCT00422097|12122405|FG000|STARTED|Dose Level 6||0
10950909|NCT00422097|12122406|FG001|STARTED|Dose Level 6||0
10950910|NCT00422097|12122407|FG002|STARTED|Dose Level 6||0
10950911|NCT00422097|12122408|FG003|STARTED|Dose Level 6||0
10950912|NCT00422097|12122409|FG004|STARTED|Dose Level 6||0
10950913|NCT00422097|12122410|FG005|STARTED|Dose Level 6||6
10950914|NCT00422097|12122411|FG006|STARTED|Dose Level 6||0
10950915|NCT00422097|12122412|FG007|STARTED|Dose Level 6||0
10950916|NCT00422097|12122405|FG000|COMPLETED|Dose Level 6||0
10950917|NCT00422097|12122406|FG001|COMPLETED|Dose Level 6||0
10950918|NCT00422097|12122407|FG002|COMPLETED|Dose Level 6||0
10950919|NCT00422097|12122408|FG003|COMPLETED|Dose Level 6||0
10950920|NCT00422097|12122409|FG004|COMPLETED|Dose Level 6||0
10950921|NCT00422097|12122410|FG005|COMPLETED|Dose Level 6||6
10950922|NCT00422097|12122411|FG006|COMPLETED|Dose Level 6||0
10950923|NCT00422097|12122412|FG007|COMPLETED|Dose Level 6||0
10950924|NCT00422097|12122405|FG000|NOT COMPLETED|Dose Level 6||0
10950925|NCT00422097|12122406|FG001|NOT COMPLETED|Dose Level 6||0
10950926|NCT00422097|12122407|FG002|NOT COMPLETED|Dose Level 6||0
10950927|NCT00422097|12122408|FG003|NOT COMPLETED|Dose Level 6||0
10950928|NCT00422097|12122409|FG004|NOT COMPLETED|Dose Level 6||0
10950929|NCT00422097|12122410|FG005|NOT COMPLETED|Dose Level 6||0
10950930|NCT00422097|12122411|FG006|NOT COMPLETED|Dose Level 6||0
10950931|NCT00422097|12122412|FG007|NOT COMPLETED|Dose Level 6||0
10950932|NCT00422097|12122405|FG000|STARTED|Ixabepilone With Famotidine or Food||0
10950933|NCT00422097|12122406|FG001|STARTED|Ixabepilone With Famotidine or Food||0
10950934|NCT00422097|12122407|FG002|STARTED|Ixabepilone With Famotidine or Food||0
10950935|NCT00422097|12122408|FG003|STARTED|Ixabepilone With Famotidine or Food||0
10950936|NCT00422097|12122409|FG004|STARTED|Ixabepilone With Famotidine or Food||0
10950937|NCT00422097|12122410|FG005|STARTED|Ixabepilone With Famotidine or Food||0
10950938|NCT00422097|12122411|FG006|STARTED|Ixabepilone With Famotidine or Food||8
10950939|NCT00422097|12122412|FG007|STARTED|Ixabepilone With Famotidine or Food||7
10950940|NCT00422097|12122405|FG000|COMPLETED|Ixabepilone With Famotidine or Food||0
10950941|NCT00422097|12122406|FG001|COMPLETED|Ixabepilone With Famotidine or Food||0
10950942|NCT00422097|12122407|FG002|COMPLETED|Ixabepilone With Famotidine or Food||0
10950943|NCT00422097|12122408|FG003|COMPLETED|Ixabepilone With Famotidine or Food||0
10950944|NCT00422097|12122409|FG004|COMPLETED|Ixabepilone With Famotidine or Food||0
10950945|NCT00422097|12122410|FG005|COMPLETED|Ixabepilone With Famotidine or Food||0
10950946|NCT00422097|12122411|FG006|COMPLETED|Ixabepilone With Famotidine or Food||8
10950947|NCT00422097|12122412|FG007|COMPLETED|Ixabepilone With Famotidine or Food||7
10950948|NCT00422097|12122405|FG000|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10950949|NCT00422097|12122406|FG001|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10950950|NCT00422097|12122407|FG002|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10950951|NCT00422097|12122408|FG003|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10950952|NCT00422097|12122409|FG004|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10950953|NCT00422097|12122410|FG005|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10950954|NCT00422097|12122411|FG006|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10950955|NCT00422097|12122412|FG007|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
10950956|NCT00422162|12122438|FG000|STARTED|Overall Study||167
10950957|NCT00422162|12122439|FG001|STARTED|Overall Study||172
10950958|NCT00422162|12122438|FG000|Received Treatment|Overall Study||167
10950959|NCT00422162|12122439|FG001|Received Treatment|Overall Study||171
10950960|NCT00422162|12122438|FG000|COMPLETED|Overall Study||143
10950961|NCT00422162|12122439|FG001|COMPLETED|Overall Study||142
10950962|NCT00422162|12122438|FG000|NOT COMPLETED|Overall Study||24
10950963|NCT00422162|12122439|FG001|NOT COMPLETED|Overall Study||30
10950964|NCT00422201|12122455|FG000|STARTED|Overall Study||18
10950965|NCT00422201|12122455|FG000|COMPLETED|Overall Study||7
10950966|NCT00422201|12122455|FG000|NOT COMPLETED|Overall Study||11
10950967|NCT00422227|12122462|FG000|STARTED|Overall Study||197
10950968|NCT00422227|12122463|FG001|STARTED|Overall Study||103
10950969|NCT00422227|12122462|FG000|COMPLETED|Overall Study||193
10950970|NCT00422227|12122463|FG001|COMPLETED|Overall Study||88
10950971|NCT00422227|12122462|FG000|NOT COMPLETED|Overall Study||4
10950972|NCT00422227|12122463|FG001|NOT COMPLETED|Overall Study||15
10950973|NCT00422279|12122471|FG000|STARTED|Overall Study||2
10950974|NCT00422279|12122472|FG001|STARTED|Overall Study||2
10950975|NCT00422279|12122471|FG000|24 Month After Loading Period|Overall Study||2
10950976|NCT00422279|12122472|FG001|24 Month After Loading Period|Overall Study||2
10950977|NCT00422279|12122471|FG000|COMPLETED|Overall Study||2
10950978|NCT00422279|12122472|FG001|COMPLETED|Overall Study||2
10950979|NCT00422279|12122471|FG000|NOT COMPLETED|Overall Study||0
10950980|NCT00422279|12122472|FG001|NOT COMPLETED|Overall Study||0
10950981|NCT00422292|12122484|FG000|STARTED|Overall Study||257
10950982|NCT00422292|12122485|FG001|STARTED|Overall Study||664
10950983|NCT00422292|12122486|FG002|STARTED|Overall Study||246
10950984|NCT00422292|12122487|FG003|STARTED|Overall Study||476
10950985|NCT00422292|12122484|FG000|COMPLETED|Overall Study||239
10950986|NCT00422292|12122485|FG001|COMPLETED|Overall Study||598
10950987|NCT00422292|12122486|FG002|COMPLETED|Overall Study||224
10950988|NCT00422292|12122487|FG003|COMPLETED|Overall Study||452
10950989|NCT00422292|12122484|FG000|NOT COMPLETED|Overall Study||18
10950990|NCT00422292|12122485|FG001|NOT COMPLETED|Overall Study||66
10950991|NCT00422292|12122486|FG002|NOT COMPLETED|Overall Study||22
10950992|NCT00422292|12122487|FG003|NOT COMPLETED|Overall Study||24
10950993|NCT00422383|12122502|FG000|STARTED|Overall Study||134
10950994|NCT00422383|12122503|FG001|STARTED|Overall Study||120
10950995|NCT00422383|12122504|FG002|STARTED|Overall Study||93
10950996|NCT00422383|12122505|FG003|STARTED|Overall Study||6
10950997|NCT00422383|12122506|FG004|STARTED|Overall Study||25
10950998|NCT00422383|12122502|FG000|COMPLETED|Overall Study||119
10950999|NCT00422383|12122503|FG001|COMPLETED|Overall Study||106
10951000|NCT00422383|12122504|FG002|COMPLETED|Overall Study||89
10951001|NCT00422383|12122505|FG003|COMPLETED|Overall Study||4
10951002|NCT00422383|12122506|FG004|COMPLETED|Overall Study||22
10951003|NCT00422383|12122502|FG000|NOT COMPLETED|Overall Study||15
10951004|NCT00422383|12122503|FG001|NOT COMPLETED|Overall Study||14
10951005|NCT00422383|12122504|FG002|NOT COMPLETED|Overall Study||4
10951006|NCT00422383|12122505|FG003|NOT COMPLETED|Overall Study||2
10951007|NCT00422383|12122506|FG004|NOT COMPLETED|Overall Study||3
10951008|NCT00422422|12122524|FG000|STARTED|Overall Study||100
10951009|NCT00422422|12122524|FG000|COMPLETED|Overall Study||90
10951010|NCT00422422|12122524|FG000|NOT COMPLETED|Overall Study||10
10951011|NCT00422448|12122530|FG000|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
10951012|NCT00422448|12122530|FG000|COMPLETED|Overall Study||43
10951013|NCT00422448|12122530|FG000|NOT COMPLETED|Overall Study||0
10951014|NCT00422461|12122538|FG000|STARTED|Overall Study||35
10951015|NCT00422461|12122539|FG001|STARTED|Overall Study||35
10951016|NCT00422461|12122540|FG002|STARTED|Overall Study||32
10951017|NCT00422461|12122541|FG003|STARTED|Overall Study||33
10951018|NCT00422461|12122538|FG000|Treated|Overall Study||34
10951019|NCT00422461|12122539|FG001|Treated|Overall Study||34
10951020|NCT00422461|12122540|FG002|Treated|Overall Study||32
10951021|NCT00422461|12122541|FG003|Treated|Overall Study||33
10951022|NCT00422461|12122538|FG000|Full Analysis Set|Overall Study||34
10951023|NCT00422461|12122539|FG001|Full Analysis Set|Overall Study||34
10951024|NCT00422461|12122540|FG002|Full Analysis Set|Overall Study||31
10951025|NCT00422461|12122541|FG003|Full Analysis Set|Overall Study||33
10951026|NCT00422461|12122538|FG000|COMPLETED|Overall Study||32
10951027|NCT00422461|12122539|FG001|COMPLETED|Overall Study||32
10951028|NCT00422461|12122540|FG002|COMPLETED|Overall Study||31
10951029|NCT00422461|12122541|FG003|COMPLETED|Overall Study||30
10951030|NCT00422461|12122538|FG000|NOT COMPLETED|Overall Study||3
10951031|NCT00422461|12122539|FG001|NOT COMPLETED|Overall Study||3
10951032|NCT00422461|12122540|FG002|NOT COMPLETED|Overall Study||1
10951033|NCT00422461|12122541|FG003|NOT COMPLETED|Overall Study||3
10951034|NCT00422513|12122553|FG000|STARTED|Overall Study||130
10951035|NCT00422513|12122554|FG001|STARTED|Overall Study||130
10951036|NCT00422513|12122553|FG000|COMPLETED|Overall Study||23
10951037|NCT00422513|12122554|FG001|COMPLETED|Overall Study||24
10951038|NCT00422513|12122553|FG000|NOT COMPLETED|Overall Study||107
10951039|NCT00422513|12122554|FG001|NOT COMPLETED|Overall Study||106
10951040|NCT00422591|12122560|FG000|STARTED|Overall Study||175
10951041|NCT00422591|12122560|FG000|COMPLETED|Overall Study||169
10951042|NCT00422591|12122560|FG000|NOT COMPLETED|Overall Study||6
10951043|NCT00422656|12122564|FG000|STARTED|Overall Study||37
10951044|NCT00422656|12122564|FG000|COMPLETED|Overall Study||37
10951045|NCT00422656|12122564|FG000|NOT COMPLETED|Overall Study||0
10951046|NCT00422695|12122570|FG000|STARTED|Overall Study||105
10951047|NCT00422695|12122571|FG001|STARTED|Overall Study||38
10951048|NCT00422695|12122570|FG000|COMPLETED|Overall Study||105
10951049|NCT00422695|12122571|FG001|COMPLETED|Overall Study||38
10951050|NCT00422695|12122570|FG000|NOT COMPLETED|Overall Study||0
10951051|NCT00422695|12122571|FG001|NOT COMPLETED|Overall Study||0
10951052|NCT00422734|12122579|FG000|STARTED|Overall Study||78
10951053|NCT00422734|12122580|FG001|STARTED|Overall Study||264
10951054|NCT00422734|12122579|FG000|COMPLETED|Overall Study||64
10951055|NCT00422734|12122580|FG001|COMPLETED|Overall Study||243
10951056|NCT00422734|12122579|FG000|NOT COMPLETED|Overall Study||14
10951057|NCT00422734|12122580|FG001|NOT COMPLETED|Overall Study||21
10951058|NCT00422799|12122586|FG000|STARTED|Overall Study||63
10951059|NCT00422799|12122586|FG000|COMPLETED|Overall Study||50
10951060|NCT00422799|12122586|FG000|NOT COMPLETED|Overall Study||13
10951061|NCT00422812|12122594|FG000|STARTED|Overall Study||98
10951062|NCT00422812|12122595|FG001|STARTED|Overall Study||104
10951063|NCT00422812|12122596|FG002|STARTED|Overall Study||93
10951064|NCT00422812|12122597|FG003|STARTED|Overall Study||105
10951065|NCT00422812|12122594|FG000|COMPLETED|Overall Study||98
10951066|NCT00422812|12122595|FG001|COMPLETED|Overall Study||103
10951067|NCT00422812|12122596|FG002|COMPLETED|Overall Study||91
10951068|NCT00422812|12122597|FG003|COMPLETED|Overall Study||103
10951069|NCT00422812|12122594|FG000|NOT COMPLETED|Overall Study||0
10951070|NCT00422812|12122595|FG001|NOT COMPLETED|Overall Study||1
10951071|NCT00422812|12122596|FG002|NOT COMPLETED|Overall Study||2
10951072|NCT00422812|12122597|FG003|NOT COMPLETED|Overall Study||2
10951073|NCT00422903|12122609|FG000|STARTED|Overall Study||49
10951074|NCT00422903|12122610|FG001|STARTED|Overall Study||43
10951075|NCT00422903|12122609|FG000|COMPLETED|Overall Study||45
10951076|NCT00422903|12122610|FG001|COMPLETED|Overall Study||38
10951077|NCT00422903|12122609|FG000|NOT COMPLETED|Overall Study||4
10951078|NCT00422903|12122610|FG001|NOT COMPLETED|Overall Study||5
10951079|NCT00423046|12122618|FG000|STARTED|Overall Study||553
10951080|NCT00423046|12122619|FG001|STARTED|Overall Study||553
10951081|NCT00423046|12122618|FG000|COMPLETED|Overall Study|Completed until Month 60|213
10951082|NCT00423046|12122619|FG001|COMPLETED|Overall Study|Completed until Month 60|208
10951083|NCT00423046|12122618|FG000|NOT COMPLETED|Overall Study||340
10951084|NCT00423046|12122619|FG001|NOT COMPLETED|Overall Study||345
10951085|NCT00423085|12122630|FG000|STARTED|24-Week Double-Blind Treatment Phase||288
10951086|NCT00423085|12122631|FG001|STARTED|24-Week Double-Blind Treatment Phase||284
10951087|NCT00423085|12122632|FG002|STARTED|24-Week Double-Blind Treatment Phase||287
10951088|NCT00423085|12122633|FG003|STARTED|24-Week Double-Blind Treatment Phase||0
10951089|NCT00423085|12122630|FG000|COMPLETED|24-Week Double-Blind Treatment Phase||242
10951090|NCT00423085|12122631|FG001|COMPLETED|24-Week Double-Blind Treatment Phase||220
10951091|NCT00423085|12122632|FG002|COMPLETED|24-Week Double-Blind Treatment Phase||228
10951092|NCT00423085|12122633|FG003|COMPLETED|24-Week Double-Blind Treatment Phase||0
10951093|NCT00423085|12122630|FG000|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
10951094|NCT00423085|12122631|FG001|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
10951095|NCT00423085|12122632|FG002|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
10951096|NCT00423085|12122633|FG003|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
10951097|NCT00423085|12122630|FG000|STARTED|52-Week Open-Label Extension Phase||0
10951098|NCT00423085|12122631|FG001|STARTED|52-Week Open-Label Extension Phase||0
10951099|NCT00423085|12122632|FG002|STARTED|52-Week Open-Label Extension Phase||0
10951100|NCT00423085|12122633|FG003|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
10951101|NCT00423085|12122630|FG000|COMPLETED|52-Week Open-Label Extension Phase||0
10951102|NCT00423085|12122631|FG001|COMPLETED|52-Week Open-Label Extension Phase||0
10951103|NCT00423085|12122632|FG002|COMPLETED|52-Week Open-Label Extension Phase||0
10951104|NCT00423085|12122633|FG003|COMPLETED|52-Week Open-Label Extension Phase||474
10951105|NCT00423085|12122630|FG000|NOT COMPLETED|52-Week Open-Label Extension Phase||0
10951106|NCT00423085|12122631|FG001|NOT COMPLETED|52-Week Open-Label Extension Phase||0
10951107|NCT00423085|12122632|FG002|NOT COMPLETED|52-Week Open-Label Extension Phase||0
10951108|NCT00423085|12122633|FG003|NOT COMPLETED|52-Week Open-Label Extension Phase||163
10951109|NCT00423098|12122645|FG000|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
10951110|NCT00423098|12122646|FG001|STARTED|Overall Study||39
10951111|NCT00423098|12122645|FG000|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
10951112|NCT00423098|12122646|FG001|COMPLETED|Overall Study||35
10951113|NCT00423098|12122645|FG000|NOT COMPLETED|Overall Study||3
10951114|NCT00423098|12122646|FG001|NOT COMPLETED|Overall Study||4
10951115|NCT00423137|12122656|FG000|STARTED|Overall Study||11
10951116|NCT00423137|12122657|FG001|STARTED|Overall Study||12
10951117|NCT00423137|12122658|FG002|STARTED|Overall Study||13
10951118|NCT00423137|12122659|FG003|STARTED|Overall Study||12
10951119|NCT00423137|12122656|FG000|COMPLETED|Overall Study||10
10951120|NCT00423137|12122657|FG001|COMPLETED|Overall Study||12
10951121|NCT00423137|12122658|FG002|COMPLETED|Overall Study||7
10951122|NCT00423137|12122659|FG003|COMPLETED|Overall Study||10
10951123|NCT00423137|12122656|FG000|NOT COMPLETED|Overall Study||1
10951124|NCT00423137|12122657|FG001|NOT COMPLETED|Overall Study||0
10951125|NCT00423137|12122658|FG002|NOT COMPLETED|Overall Study||6
10951126|NCT00423137|12122659|FG003|NOT COMPLETED|Overall Study||2
10951127|NCT00423150|12122672|FG000|STARTED|Overall Study||86
10951128|NCT00423150|12122672|FG000|COMPLETED|Overall Study||0
10951129|NCT00423150|12122672|FG000|NOT COMPLETED|Overall Study||86
10951130|NCT00423189|12122679|FG000|STARTED|Overall Study||2
10951131|NCT00423189|12122680|FG001|STARTED|Overall Study||3
10951132|NCT00423189|12122681|FG002|STARTED|Overall Study||2
10951133|NCT00423189|12122679|FG000|COMPLETED|Overall Study||2
10951134|NCT00423189|12122680|FG001|COMPLETED|Overall Study||2
10951135|NCT00423189|12122681|FG002|COMPLETED|Overall Study||2
10951136|NCT00423189|12122679|FG000|NOT COMPLETED|Overall Study||0
10951137|NCT00423189|12122680|FG001|NOT COMPLETED|Overall Study||1
10951138|NCT00423189|12122681|FG002|NOT COMPLETED|Overall Study||0
10951139|NCT00423267|12122696|FG000|STARTED|Period A||9
10951140|NCT00423267|12122697|FG001|STARTED|Period A||7
10951141|NCT00423267|12122696|FG000|COMPLETED|Period A||7
10951142|NCT00423267|12122697|FG001|COMPLETED|Period A||6
10951143|NCT00423267|12122696|FG000|NOT COMPLETED|Period A||2
10951144|NCT00423267|12122697|FG001|NOT COMPLETED|Period A||1
10951145|NCT00423267|12122696|FG000|STARTED|Period B||12
10951146|NCT00423267|12122697|FG001|STARTED|Period B||0
10951147|NCT00423267|12122696|FG000|COMPLETED|Period B||12
10951148|NCT00423267|12122697|FG001|COMPLETED|Period B||0
10951149|NCT00423267|12122696|FG000|NOT COMPLETED|Period B||0
10951150|NCT00423267|12122697|FG001|NOT COMPLETED|Period B||0
10951151|NCT00423293|12122705|FG000|STARTED|Overall Study||63
10951152|NCT00423293|12122705|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
10951153|NCT00423293|12122705|FG000|NOT COMPLETED|Overall Study||11
10951154|NCT00423319|12122711|FG000|STARTED|Overall Study|Randomized|2708
10951155|NCT00423319|12122712|FG001|STARTED|Overall Study|Randomized|2699
10951156|NCT00423319|12122711|FG000|Participants Who Received Treatment|Overall Study||2673
10951157|NCT00423319|12122712|FG001|Participants Who Received Treatment|Overall Study||2659
10951158|NCT00423319|12122711|FG000|COMPLETED|Overall Study||2484
10951159|NCT00423319|12122712|FG001|COMPLETED|Overall Study||2447
10951160|NCT00423319|12122711|FG000|NOT COMPLETED|Overall Study||224
10951161|NCT00423319|12122712|FG001|NOT COMPLETED|Overall Study||252
10951162|NCT00423332|12122721|FG000|STARTED|Overall Study|Randomised|53
10951163|NCT00423332|12122722|FG001|STARTED|Overall Study|Number randomised|18
10951164|NCT00423332|12122721|FG000|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
10951165|NCT00423332|12122722|FG001|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
10951166|NCT00423332|12122721|FG000|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
10951167|NCT00423332|12122722|FG001|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
10951168|NCT00423332|12122721|FG000|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
10951169|NCT00423332|12122722|FG001|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
10951170|NCT00423332|12122721|FG000|NOT COMPLETED|Overall Study||9
10951171|NCT00423332|12122722|FG001|NOT COMPLETED|Overall Study||7
10951172|NCT00423358|12122731|FG000|STARTED|Overall Study||11
10951173|NCT00423358|12122732|FG001|STARTED|Overall Study||11
10951174|NCT00423358|12122731|FG000|COMPLETED|Overall Study||11
10951175|NCT00423358|12122732|FG001|COMPLETED|Overall Study||11
10951176|NCT00423358|12122731|FG000|NOT COMPLETED|Overall Study||0
10951177|NCT00423358|12122732|FG001|NOT COMPLETED|Overall Study||0
10951178|NCT00423436|12122740|FG000|STARTED|Overall Study||35
10951179|NCT00423436|12122741|FG001|STARTED|Overall Study||33
10951180|NCT00423436|12122740|FG000|COMPLETED|Overall Study||35
10951181|NCT00423436|12122741|FG001|COMPLETED|Overall Study||33
10951182|NCT00423436|12122740|FG000|NOT COMPLETED|Overall Study||0
10951183|NCT00423436|12122741|FG001|NOT COMPLETED|Overall Study||0
10951184|NCT00423449|12122747|FG000|STARTED|Overall Study||4
10951185|NCT00423449|12122748|FG001|STARTED|Overall Study||6
10951186|NCT00423449|12122749|FG002|STARTED|Overall Study||17
10951187|NCT00423449|12122750|FG003|STARTED|Overall Study||27
10951188|NCT00423449|12122751|FG004|STARTED|Overall Study||7
10951189|NCT00423449|12122747|FG000|COMPLETED|Overall Study||1
10951190|NCT00423449|12122748|FG001|COMPLETED|Overall Study||2
10951191|NCT00423449|12122749|FG002|COMPLETED|Overall Study||2
10951192|NCT00423449|12122750|FG003|COMPLETED|Overall Study||5
10951193|NCT00423449|12122751|FG004|COMPLETED|Overall Study||0
10951194|NCT00423449|12122747|FG000|NOT COMPLETED|Overall Study||3
10951195|NCT00423449|12122748|FG001|NOT COMPLETED|Overall Study||4
10951196|NCT00423449|12122749|FG002|NOT COMPLETED|Overall Study||15
10951197|NCT00423449|12122750|FG003|NOT COMPLETED|Overall Study||22
10951198|NCT00423449|12122751|FG004|NOT COMPLETED|Overall Study||7
10951199|NCT00423592|12122764|FG000|STARTED|Overall Study|Enrolled|36
10951200|NCT00423592|12122764|FG000|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
10951201|NCT00423592|12122764|FG000|COMPLETED|Overall Study|Completed study|29
10951202|NCT00423592|12122764|FG000|NOT COMPLETED|Overall Study||7
10951203|NCT00423605|12122768|FG000|STARTED|Overall Study||560
10951204|NCT00423605|12122768|FG000|COMPLETED|Overall Study||319
10951205|NCT00423605|12122768|FG000|NOT COMPLETED|Overall Study||241
10951206|NCT00423657|12122774|FG000|STARTED|Overall Study||342
10951207|NCT00423657|12122775|FG001|STARTED|Overall Study||338
10951208|NCT00423657|12122774|FG000|COMPLETED|Overall Study||316
10951209|NCT00423657|12122775|FG001|COMPLETED|Overall Study||313
10951210|NCT00423657|12122774|FG000|NOT COMPLETED|Overall Study||26
10951211|NCT00423657|12122775|FG001|NOT COMPLETED|Overall Study||25
10951212|NCT00423670|12122788|FG000|STARTED|Treatment Period||104
10951213|NCT00423670|12122789|FG001|STARTED|Treatment Period||107
10951214|NCT00423670|12122790|FG002|STARTED|Treatment Period||103
10951215|NCT00423670|12122791|FG003|STARTED|Treatment Period||103
10951216|NCT00423670|12122792|FG004|STARTED|Treatment Period||103
10951217|NCT00423670|12122793|FG005|STARTED|Treatment Period||16
10951218|NCT00423670|12122794|FG006|STARTED|Treatment Period||59
10951219|NCT00423670|12122795|FG007|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
10951220|NCT00423670|12122788|FG000|COMPLETED|Treatment Period||52
10951221|NCT00423670|12122789|FG001|COMPLETED|Treatment Period||77
10951222|NCT00423670|12122790|FG002|COMPLETED|Treatment Period||76
10951223|NCT00423670|12122791|FG003|COMPLETED|Treatment Period||63
10951224|NCT00423670|12122792|FG004|COMPLETED|Treatment Period||76
10951225|NCT00423670|12122793|FG005|COMPLETED|Treatment Period||8
10951226|NCT00423670|12122794|FG006|COMPLETED|Treatment Period||28
10951227|NCT00423670|12122795|FG007|COMPLETED|Treatment Period||15
10951228|NCT00423670|12122788|FG000|NOT COMPLETED|Treatment Period||52
10951229|NCT00423670|12122789|FG001|NOT COMPLETED|Treatment Period||30
10951230|NCT00423670|12122790|FG002|NOT COMPLETED|Treatment Period||27
10951231|NCT00423670|12122791|FG003|NOT COMPLETED|Treatment Period||40
10951232|NCT00423670|12122792|FG004|NOT COMPLETED|Treatment Period||27
10951233|NCT00423670|12122793|FG005|NOT COMPLETED|Treatment Period||8
10951234|NCT00423670|12122794|FG006|NOT COMPLETED|Treatment Period||31
10951235|NCT00423670|12122795|FG007|NOT COMPLETED|Treatment Period||21
10951236|NCT00423670|12122788|FG000|STARTED|Follow-up Period||97
10951237|NCT00423670|12122789|FG001|STARTED|Follow-up Period||100
10951238|NCT00423670|12122790|FG002|STARTED|Follow-up Period||96
10951239|NCT00423670|12122791|FG003|STARTED|Follow-up Period||96
10951240|NCT00423670|12122792|FG004|STARTED|Follow-up Period||91
10951241|NCT00423670|12122793|FG005|STARTED|Follow-up Period||14
10951242|NCT00423670|12122794|FG006|STARTED|Follow-up Period||50
10951243|NCT00423670|12122795|FG007|STARTED|Follow-up Period||35
10951244|NCT00423670|12122788|FG000|COMPLETED|Follow-up Period||94
10951245|NCT00423670|12122789|FG001|COMPLETED|Follow-up Period||84
10951246|NCT00423670|12122790|FG002|COMPLETED|Follow-up Period||85
10951247|NCT00423670|12122791|FG003|COMPLETED|Follow-up Period||91
10951248|NCT00423670|12122792|FG004|COMPLETED|Follow-up Period||89
10951249|NCT00423670|12122793|FG005|COMPLETED|Follow-up Period||14
10951250|NCT00423670|12122794|FG006|COMPLETED|Follow-up Period||41
10951251|NCT00423670|12122795|FG007|COMPLETED|Follow-up Period||32
10951252|NCT00423670|12122788|FG000|NOT COMPLETED|Follow-up Period||3
10951253|NCT00423670|12122789|FG001|NOT COMPLETED|Follow-up Period||16
10951254|NCT00423670|12122790|FG002|NOT COMPLETED|Follow-up Period||11
10951255|NCT00423670|12122791|FG003|NOT COMPLETED|Follow-up Period||5
10951256|NCT00423670|12122792|FG004|NOT COMPLETED|Follow-up Period||2
10951257|NCT00423670|12122793|FG005|NOT COMPLETED|Follow-up Period||0
10951258|NCT00423670|12122794|FG006|NOT COMPLETED|Follow-up Period||9
10951259|NCT00423670|12122795|FG007|NOT COMPLETED|Follow-up Period||3
10951260|NCT00423683|12122818|FG000|STARTED|Overall Study||31
10951261|NCT00423683|12122819|FG001|STARTED|Overall Study||33
10951262|NCT00423683|12122818|FG000|COMPLETED|Overall Study||30
10951263|NCT00423683|12122819|FG001|COMPLETED|Overall Study||33
10951264|NCT00423683|12122818|FG000|NOT COMPLETED|Overall Study||1
10951265|NCT00423683|12122819|FG001|NOT COMPLETED|Overall Study||0
10951266|NCT00423722|12122829|FG000|STARTED|Overall Study||63
10951267|NCT00423722|12122830|FG001|STARTED|Overall Study||66
10951268|NCT00423722|12122829|FG000|COMPLETED|Overall Study||49
10951269|NCT00423722|12122830|FG001|COMPLETED|Overall Study||53
10951270|NCT00423722|12122829|FG000|NOT COMPLETED|Overall Study||14
10951271|NCT00423722|12122830|FG001|NOT COMPLETED|Overall Study||13
10951272|NCT00423735|12122845|FG000|STARTED|Overall Study||29
10951273|NCT00423735|12122846|FG001|STARTED|Overall Study||35
10951274|NCT00423735|12122847|FG002|STARTED|Overall Study||0
10951275|NCT00423735|12122845|FG000|COMPLETED|Overall Study||21
10951276|NCT00423735|12122846|FG001|COMPLETED|Overall Study||29
10951277|NCT00423735|12122847|FG002|COMPLETED|Overall Study||0
10951278|NCT00423735|12122845|FG000|NOT COMPLETED|Overall Study||8
10951279|NCT00423735|12122846|FG001|NOT COMPLETED|Overall Study||6
10951280|NCT00423735|12122847|FG002|NOT COMPLETED|Overall Study||0
10951281|NCT00423800|12122859|FG000|STARTED|Overall Study||3
10951282|NCT00423800|12122860|FG001|STARTED|Overall Study||2
10951283|NCT00423800|12122859|FG000|COMPLETED|Overall Study||3
10951284|NCT00423800|12122860|FG001|COMPLETED|Overall Study||1
10951285|NCT00423800|12122859|FG000|NOT COMPLETED|Overall Study||0
10951286|NCT00423800|12122860|FG001|NOT COMPLETED|Overall Study||1
10951287|NCT00423813|12122870|FG000|STARTED|Overall Study||188
10951288|NCT00423813|12122871|FG001|STARTED|Overall Study||195
10951289|NCT00423813|12122872|FG002|STARTED|Overall Study||190
10951290|NCT00423813|12122870|FG000|Treated|Overall Study||188
10951291|NCT00423813|12122871|FG001|Treated|Overall Study||194
10951292|NCT00423813|12122872|FG002|Treated|Overall Study||189
10951293|NCT00423813|12122870|FG000|COMPLETED|Overall Study||131
10951294|NCT00423813|12122871|FG001|COMPLETED|Overall Study||129
10951295|NCT00423813|12122872|FG002|COMPLETED|Overall Study||116
10951296|NCT00423813|12122870|FG000|NOT COMPLETED|Overall Study||57
10951297|NCT00423813|12122871|FG001|NOT COMPLETED|Overall Study||66
10951298|NCT00423813|12122872|FG002|NOT COMPLETED|Overall Study||74
10951299|NCT00423852|12122880|FG000|STARTED|Overall Study||26
10951300|NCT00423852|12122880|FG000|COMPLETED|Overall Study||23
10951301|NCT00423852|12122880|FG000|NOT COMPLETED|Overall Study||3
10951302|NCT00423878|12122886|FG000|STARTED|Overall Study||109
10951303|NCT00423878|12122887|FG001|STARTED|Overall Study||106
10951304|NCT00423878|12122886|FG000|COMPLETED|Overall Study||89
10951305|NCT00423878|12122887|FG001|COMPLETED|Overall Study||98
10951306|NCT00423878|12122886|FG000|NOT COMPLETED|Overall Study||20
10951307|NCT00423878|12122887|FG001|NOT COMPLETED|Overall Study||8
10951308|NCT00423891|12122896|FG000|STARTED|Enrolled||35
10951309|NCT00423891|12122897|FG001|STARTED|Enrolled||21
10951310|NCT00423891|12122898|FG002|STARTED|Enrolled||8
10951311|NCT00423891|12122896|FG000|COMPLETED|Enrolled||24
10951312|NCT00423891|12122897|FG001|COMPLETED|Enrolled||19
10951313|NCT00423891|12122898|FG002|COMPLETED|Enrolled||5
10951314|NCT00423891|12122896|FG000|NOT COMPLETED|Enrolled||11
10951315|NCT00423891|12122897|FG001|NOT COMPLETED|Enrolled||2
10951316|NCT00423891|12122898|FG002|NOT COMPLETED|Enrolled||3
10951317|NCT00423891|12122896|FG000|STARTED|Treatment||24
10951318|NCT00423891|12122897|FG001|STARTED|Treatment||19
10951319|NCT00423891|12122898|FG002|STARTED|Treatment||5
10951320|NCT00423891|12122896|FG000|COMPLETED|Treatment||22
10951321|NCT00423891|12122897|FG001|COMPLETED|Treatment||19
10951322|NCT00423891|12122898|FG002|COMPLETED|Treatment||5
10951323|NCT00423891|12122896|FG000|NOT COMPLETED|Treatment||2
10951324|NCT00423891|12122897|FG001|NOT COMPLETED|Treatment||0
10951325|NCT00423891|12122898|FG002|NOT COMPLETED|Treatment||0
10951326|NCT00423891|12122896|FG000|STARTED|Post-Dosing Follow Up||22
10951327|NCT00423891|12122897|FG001|STARTED|Post-Dosing Follow Up||18
10951328|NCT00423891|12122898|FG002|STARTED|Post-Dosing Follow Up||5
10951329|NCT00423891|12122896|FG000|COMPLETED|Post-Dosing Follow Up||20
10951330|NCT00423891|12122897|FG001|COMPLETED|Post-Dosing Follow Up||15
10951331|NCT00423891|12122898|FG002|COMPLETED|Post-Dosing Follow Up||3
10951332|NCT00423891|12122896|FG000|NOT COMPLETED|Post-Dosing Follow Up||2
10951333|NCT00423891|12122897|FG001|NOT COMPLETED|Post-Dosing Follow Up||3
10951334|NCT00423891|12122898|FG002|NOT COMPLETED|Post-Dosing Follow Up||2
10951335|NCT00423917|12122908|FG000|STARTED|Overall Study||36
10951336|NCT00423917|12122908|FG000|COMPLETED|Overall Study||33
10951337|NCT00423917|12122908|FG000|NOT COMPLETED|Overall Study||3
10951338|NCT00423930|12122912|FG000|STARTED|Overall Study||44
10951339|NCT00423930|12122912|FG000|COMPLETED|Overall Study||42
10951340|NCT00423930|12122912|FG000|NOT COMPLETED|Overall Study||2
10951341|NCT00423943|12122918|FG000|STARTED|Overall Study||19
10951342|NCT00423943|12122919|FG001|STARTED|Overall Study||14
10951343|NCT00423943|12122918|FG000|COMPLETED|Overall Study||16
10951344|NCT00423943|12122919|FG001|COMPLETED|Overall Study||13
10951345|NCT00423943|12122918|FG000|NOT COMPLETED|Overall Study||3
10951346|NCT00423943|12122919|FG001|NOT COMPLETED|Overall Study||1
10951347|NCT00424021|12122929|FG000|STARTED|NCT00046319 Study Period||16
10951348|NCT00424021|12122930|FG001|STARTED|NCT00046319 Study Period||19
10951349|NCT00424021|12122931|FG002|STARTED|NCT00046319 Study Period||16
10951350|NCT00424021|12122932|FG003|STARTED|NCT00046319 Study Period||13
10951351|NCT00424021|12122929|FG000|COMPLETED|NCT00046319 Study Period||15
10951352|NCT00424021|12122930|FG001|COMPLETED|NCT00046319 Study Period||16
10951353|NCT00424021|12122931|FG002|COMPLETED|NCT00046319 Study Period||15
10951354|NCT00424021|12122932|FG003|COMPLETED|NCT00046319 Study Period||12
10951355|NCT00424021|12122929|FG000|NOT COMPLETED|NCT00046319 Study Period||1
10951356|NCT00424021|12122930|FG001|NOT COMPLETED|NCT00046319 Study Period||3
10951357|NCT00424021|12122931|FG002|NOT COMPLETED|NCT00046319 Study Period||1
10951358|NCT00424021|12122932|FG003|NOT COMPLETED|NCT00046319 Study Period||1
10951359|NCT00424021|12122929|FG000|STARTED|AMB-220-E Study Period||2
10951360|NCT00424021|12122930|FG001|STARTED|AMB-220-E Study Period||7
10951361|NCT00424021|12122931|FG002|STARTED|AMB-220-E Study Period||19
10951362|NCT00424021|12122932|FG003|STARTED|AMB-220-E Study Period||26
10951363|NCT00424021|12122929|FG000|COMPLETED|AMB-220-E Study Period||1
10951364|NCT00424021|12122930|FG001|COMPLETED|AMB-220-E Study Period||5
10951365|NCT00424021|12122931|FG002|COMPLETED|AMB-220-E Study Period||14
10951366|NCT00424021|12122932|FG003|COMPLETED|AMB-220-E Study Period||16
10951367|NCT00424021|12122929|FG000|NOT COMPLETED|AMB-220-E Study Period||1
10951368|NCT00424021|12122930|FG001|NOT COMPLETED|AMB-220-E Study Period||2
10951369|NCT00424021|12122931|FG002|NOT COMPLETED|AMB-220-E Study Period||5
10951370|NCT00424021|12122932|FG003|NOT COMPLETED|AMB-220-E Study Period||10
10951371|NCT00424047|12122951|FG000|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
10951372|NCT00424047|12122952|FG001|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
10951373|NCT00424047|12122951|FG000|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
10951374|NCT00424047|12122952|FG001|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
10951375|NCT00424047|12122951|FG000|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
10951376|NCT00424047|12122952|FG001|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
10951377|NCT00424047|12122951|FG000|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
10951378|NCT00424047|12122952|FG001|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
10951379|NCT00424047|12122951|FG000|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
10951380|NCT00424047|12122952|FG001|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
10951381|NCT00424047|12122951|FG000|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
10951382|NCT00424047|12122952|FG001|STARTED|On Study at Time of Unblinding||175
10951383|NCT00424047|12122951|FG000|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
10951384|NCT00424047|12122952|FG001|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
10951385|NCT00424047|12122951|FG000|NOT COMPLETED|On Study at Time of Unblinding||155
10951386|NCT00424047|12122952|FG001|NOT COMPLETED|On Study at Time of Unblinding||167
10951387|NCT00424047|12122951|FG000|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
10951388|NCT00424047|12122952|FG001|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
10951389|NCT00424047|12122951|FG000|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
10951390|NCT00424047|12122952|FG001|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
10951391|NCT00424047|12122951|FG000|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
10951392|NCT00424047|12122952|FG001|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
10951393|NCT00424177|12122963|FG000|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
10951394|NCT00424177|12122963|FG000|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
10951395|NCT00424177|12122963|FG000|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
10951396|NCT00424177|12122963|FG000|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
10951397|NCT00424177|12122963|FG000|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
10951398|NCT00424177|12122963|FG000|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
10951399|NCT00424177|12122963|FG000|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
10951400|NCT00424177|12122963|FG000|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
10951401|NCT00424177|12122963|FG000|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
10951402|NCT00424190|12122977|FG000|STARTED|Overall Study||351
10951403|NCT00424190|12122978|FG001|STARTED|Overall Study||347
10951404|NCT00424190|12122977|FG000|COMPLETED|Overall Study||329
10951405|NCT00424190|12122978|FG001|COMPLETED|Overall Study||317
10951406|NCT00424190|12122977|FG000|NOT COMPLETED|Overall Study||22
10951407|NCT00424190|12122978|FG001|NOT COMPLETED|Overall Study||30
10951408|NCT00424255|12122986|FG000|STARTED|Overall Study||342
10951409|NCT00424255|12122987|FG001|STARTED|Overall Study||346
10951410|NCT00424255|12122986|FG000|COMPLETED|Overall Study||0
10951411|NCT00424255|12122987|FG001|COMPLETED|Overall Study||0
10951412|NCT00424255|12122986|FG000|NOT COMPLETED|Overall Study||342
10951413|NCT00424255|12122987|FG001|NOT COMPLETED|Overall Study||346
10951414|NCT00424268|12122995|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
10951415|NCT00424268|12122996|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
10951416|NCT00424268|12122995|FG000|COMPLETED|Overall Study||309
10951417|NCT00424268|12122996|FG001|COMPLETED|Overall Study||333
10951418|NCT00424268|12122995|FG000|NOT COMPLETED|Overall Study||62
10951419|NCT00424268|12122996|FG001|NOT COMPLETED|Overall Study||39
10951420|NCT00424294|12123004|FG000|STARTED|Overall Study||36
10951421|NCT00424294|12123005|FG001|STARTED|Overall Study||34
10951422|NCT00424294|12123004|FG000|Treated|Overall Study||35
10951423|NCT00424294|12123005|FG001|Treated|Overall Study||34
10951424|NCT00424294|12123004|FG000|COMPLETED|Overall Study||28
10951425|NCT00424294|12123005|FG001|COMPLETED|Overall Study||19
10951426|NCT00424294|12123004|FG000|NOT COMPLETED|Overall Study||8
10951427|NCT00424294|12123005|FG001|NOT COMPLETED|Overall Study||15
10951428|NCT00424346|12123015|FG000|STARTED|Core Study||71
10951429|NCT00424346|12123016|FG001|STARTED|Core Study||64
10951430|NCT00424346|12123017|FG002|STARTED|Core Study||69
10951431|NCT00424346|12123018|FG003|STARTED|Core Study||70
10951432|NCT00424346|12123015|FG000|COMPLETED|Core Study||62
10951433|NCT00424346|12123016|FG001|COMPLETED|Core Study||56
10951434|NCT00424346|12123017|FG002|COMPLETED|Core Study||65
10951435|NCT00424346|12123018|FG003|COMPLETED|Core Study||63
10951436|NCT00424346|12123015|FG000|NOT COMPLETED|Core Study||9
10951437|NCT00424346|12123016|FG001|NOT COMPLETED|Core Study||8
10951438|NCT00424346|12123017|FG002|NOT COMPLETED|Core Study||4
10951439|NCT00424346|12123018|FG003|NOT COMPLETED|Core Study||7
10951440|NCT00424346|12123015|FG000|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
10951441|NCT00424346|12123016|FG001|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
10951442|NCT00424346|12123017|FG002|STARTED|Extension Phase||59
10951443|NCT00424346|12123018|FG003|STARTED|Extension Phase||58
10951444|NCT00424346|12123015|FG000|COMPLETED|Extension Phase||0
10951445|NCT00424346|12123016|FG001|COMPLETED|Extension Phase||8
10951446|NCT00424346|12123017|FG002|COMPLETED|Extension Phase||4
10951447|NCT00424346|12123018|FG003|COMPLETED|Extension Phase||3
10951448|NCT00424346|12123015|FG000|NOT COMPLETED|Extension Phase||0
10951449|NCT00424346|12123016|FG001|NOT COMPLETED|Extension Phase||102
10951450|NCT00424346|12123017|FG002|NOT COMPLETED|Extension Phase||55
10951451|NCT00424346|12123018|FG003|NOT COMPLETED|Extension Phase||55
10951452|NCT00424372|12123031|FG000|STARTED|Overall Study||126
10951453|NCT00424372|12123031|FG000|COMPLETED|Overall Study||95
10951454|NCT00424372|12123031|FG000|NOT COMPLETED|Overall Study||31
10951455|NCT00424385|12123035|FG000|STARTED|Cohort 0||12
10951456|NCT00424385|12123035|FG000|COMPLETED|Cohort 0||6
10951457|NCT00424385|12123035|FG000|NOT COMPLETED|Cohort 0||6
10951458|NCT00424385|12123035|FG000|STARTED|Cohort 1||5
10951459|NCT00424385|12123035|FG000|COMPLETED|Cohort 1||4
10951460|NCT00424385|12123035|FG000|NOT COMPLETED|Cohort 1||1
10951461|NCT00424398|12123044|FG000|STARTED|Overall Study||35
10951462|NCT00424398|12123045|FG001|STARTED|Overall Study||36
10951463|NCT00424398|12123046|FG002|STARTED|Overall Study||36
10951464|NCT00424398|12123044|FG000|COMPLETED|Overall Study||32
10951465|NCT00424398|12123045|FG001|COMPLETED|Overall Study||35
10951466|NCT00424398|12123046|FG002|COMPLETED|Overall Study||36
10951467|NCT00424398|12123044|FG000|NOT COMPLETED|Overall Study||3
10951468|NCT00424398|12123045|FG001|NOT COMPLETED|Overall Study||1
10951469|NCT00424398|12123046|FG002|NOT COMPLETED|Overall Study||0
10951470|NCT00424463|12123057|FG000|STARTED|Overall Study||45
10951471|NCT00424463|12123058|FG001|STARTED|Overall Study||48
10951472|NCT00424463|12123059|FG002|STARTED|Overall Study||88
10951473|NCT00424463|12123057|FG000|COMPLETED|Overall Study||38
10951474|NCT00424463|12123058|FG001|COMPLETED|Overall Study||34
10951475|NCT00424463|12123059|FG002|COMPLETED|Overall Study||72
10951476|NCT00424463|12123057|FG000|NOT COMPLETED|Overall Study||7
10951477|NCT00424463|12123058|FG001|NOT COMPLETED|Overall Study||14
10951478|NCT00424463|12123059|FG002|NOT COMPLETED|Overall Study||16
10951479|NCT00424476|12123070|FG000|STARTED|Overall Study||287
10951480|NCT00424476|12123071|FG001|STARTED|Overall Study||288
10951481|NCT00424476|12123072|FG002|STARTED|Overall Study||290
10951482|NCT00424476|12123070|FG000|COMPLETED|Overall Study||226
10951483|NCT00424476|12123071|FG001|COMPLETED|Overall Study||240
10951484|NCT00424476|12123072|FG002|COMPLETED|Overall Study||241
10951485|NCT00424476|12123070|FG000|NOT COMPLETED|Overall Study||61
10951486|NCT00424476|12123071|FG001|NOT COMPLETED|Overall Study||48
10951487|NCT00424476|12123072|FG002|NOT COMPLETED|Overall Study||49
10951488|NCT00424489|12123080|FG000|STARTED|Overall Study||9
10951489|NCT00424489|12123080|FG000|COMPLETED|Overall Study||6
10951490|NCT00424489|12123080|FG000|NOT COMPLETED|Overall Study||3
10951491|NCT00424502|12123084|FG000|STARTED|Overall Study||20
10951492|NCT00424502|12123084|FG000|COMPLETED|Overall Study||20
10951493|NCT00424502|12123084|FG000|NOT COMPLETED|Overall Study||0
10951494|NCT00424515|12123090|FG000|STARTED|Overall Study||11
10951495|NCT00424515|12123091|FG001|STARTED|Overall Study||13
10951496|NCT00424515|12123090|FG000|COMPLETED|Overall Study||0
10951497|NCT00424515|12123091|FG001|COMPLETED|Overall Study||0
10951498|NCT00424515|12123090|FG000|NOT COMPLETED|Overall Study||11
10951499|NCT00424515|12123091|FG001|NOT COMPLETED|Overall Study||13
10951500|NCT00424528|12123100|FG000|STARTED|Overall Study||76
10951501|NCT00424528|12123101|FG001|STARTED|Overall Study||80
10951502|NCT00424528|12123102|FG002|STARTED|Overall Study||78
10951503|NCT00424528|12123100|FG000|COMPLETED|Overall Study||71
10951504|NCT00424528|12123101|FG001|COMPLETED|Overall Study||76
10951505|NCT00424528|12123102|FG002|COMPLETED|Overall Study||74
10951506|NCT00424528|12123100|FG000|NOT COMPLETED|Overall Study||5
10951507|NCT00424528|12123101|FG001|NOT COMPLETED|Overall Study||4
10951508|NCT00424528|12123102|FG002|NOT COMPLETED|Overall Study||4
10951509|NCT00424554|12123112|FG000|STARTED|Overall Study||34
10951510|NCT00424554|12123113|FG001|STARTED|Overall Study||6
10951511|NCT00424554|12123112|FG000|COMPLETED|Overall Study||34
10951512|NCT00424554|12123113|FG001|COMPLETED|Overall Study||6
10951513|NCT00424554|12123112|FG000|NOT COMPLETED|Overall Study||0
10951514|NCT00424554|12123113|FG001|NOT COMPLETED|Overall Study||0
10951515|NCT00424593|12123121|FG000|STARTED|Acute Double-Blind Period||115
10951516|NCT00424593|12123122|FG001|STARTED|Acute Double-Blind Period||121
10951517|NCT00424593|12123121|FG000|COMPLETED|Acute Double-Blind Period||84
10951518|NCT00424593|12123122|FG001|COMPLETED|Acute Double-Blind Period||98
10951519|NCT00424593|12123121|FG000|NOT COMPLETED|Acute Double-Blind Period||31
10951520|NCT00424593|12123122|FG001|NOT COMPLETED|Acute Double-Blind Period||23
10951521|NCT00424593|12123121|FG000|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
10951522|NCT00424593|12123122|FG001|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
10951523|NCT00424593|12123121|FG000|COMPLETED|Dose-Blind Extension Period||117
10951524|NCT00424593|12123122|FG001|COMPLETED|Dose-Blind Extension Period||0
10951525|NCT00424593|12123121|FG000|NOT COMPLETED|Dose-Blind Extension Period||64
10951526|NCT00424593|12123122|FG001|NOT COMPLETED|Dose-Blind Extension Period||0
10951527|NCT00424619|12123131|FG000|STARTED|Baseline||22
10951528|NCT00424619|12123132|FG001|STARTED|Baseline||22
10951529|NCT00424619|12123133|FG002|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
10951530|NCT00424619|12123131|FG000|COMPLETED|Baseline||22
10951531|NCT00424619|12123132|FG001|COMPLETED|Baseline||22
10951532|NCT00424619|12123133|FG002|COMPLETED|Baseline||20
10951533|NCT00424619|12123131|FG000|NOT COMPLETED|Baseline||0
10951534|NCT00424619|12123132|FG001|NOT COMPLETED|Baseline||0
10951535|NCT00424619|12123133|FG002|NOT COMPLETED|Baseline||1
10951536|NCT00424619|12123131|FG000|STARTED|4 Week||18
10951537|NCT00424619|12123132|FG001|STARTED|4 Week||17
10951538|NCT00424619|12123133|FG002|STARTED|4 Week||17
10951539|NCT00424619|12123131|FG000|COMPLETED|4 Week||18
10951540|NCT00424619|12123132|FG001|COMPLETED|4 Week||17
10951541|NCT00424619|12123133|FG002|COMPLETED|4 Week||17
10951542|NCT00424619|12123131|FG000|NOT COMPLETED|4 Week||0
10951543|NCT00424619|12123132|FG001|NOT COMPLETED|4 Week||0
10951544|NCT00424619|12123133|FG002|NOT COMPLETED|4 Week||0
10951545|NCT00424619|12123131|FG000|STARTED|3 Month||12
10951546|NCT00424619|12123132|FG001|STARTED|3 Month||18
10951547|NCT00424619|12123133|FG002|STARTED|3 Month||17
10951548|NCT00424619|12123131|FG000|COMPLETED|3 Month||12
10951549|NCT00424619|12123132|FG001|COMPLETED|3 Month||18
10951550|NCT00424619|12123133|FG002|COMPLETED|3 Month||17
10951551|NCT00424619|12123131|FG000|NOT COMPLETED|3 Month||0
10951552|NCT00424619|12123132|FG001|NOT COMPLETED|3 Month||0
10951553|NCT00424619|12123133|FG002|NOT COMPLETED|3 Month||0
10951554|NCT00424632|12123143|FG000|STARTED|Overall Study||1
10951555|NCT00424632|12123144|FG001|STARTED|Overall Study||1
10951556|NCT00424632|12123145|FG002|STARTED|Overall Study||1
10951557|NCT00424632|12123146|FG003|STARTED|Overall Study||4
10951558|NCT00424632|12123147|FG004|STARTED|Overall Study||3
10951559|NCT00424632|12123148|FG005|STARTED|Overall Study||15
10951560|NCT00424632|12123149|FG006|STARTED|Overall Study||7
10951561|NCT00424632|12123150|FG007|STARTED|Overall Study||3
10951562|NCT00424632|12123151|FG008|STARTED|Overall Study||16
10951563|NCT00424632|12123152|FG009|STARTED|Overall Study||6
10951564|NCT00424632|12123143|FG000|COMPLETED|Overall Study||0
10951565|NCT00424632|12123144|FG001|COMPLETED|Overall Study||0
10951566|NCT00424632|12123145|FG002|COMPLETED|Overall Study||0
10951567|NCT00424632|12123146|FG003|COMPLETED|Overall Study||0
10951568|NCT00424632|12123147|FG004|COMPLETED|Overall Study||0
10951569|NCT00424632|12123148|FG005|COMPLETED|Overall Study||0
10951570|NCT00424632|12123149|FG006|COMPLETED|Overall Study||0
10951571|NCT00424632|12123150|FG007|COMPLETED|Overall Study||0
10951572|NCT00424632|12123151|FG008|COMPLETED|Overall Study||0
10951573|NCT00424632|12123152|FG009|COMPLETED|Overall Study||0
10951574|NCT00424632|12123143|FG000|NOT COMPLETED|Overall Study||1
10951575|NCT00424632|12123144|FG001|NOT COMPLETED|Overall Study||1
10951576|NCT00424632|12123145|FG002|NOT COMPLETED|Overall Study||1
10951577|NCT00424632|12123146|FG003|NOT COMPLETED|Overall Study||4
10951578|NCT00424632|12123147|FG004|NOT COMPLETED|Overall Study||3
10951579|NCT00424632|12123148|FG005|NOT COMPLETED|Overall Study||15
10951580|NCT00424632|12123149|FG006|NOT COMPLETED|Overall Study||7
10951581|NCT00424632|12123150|FG007|NOT COMPLETED|Overall Study||3
10951582|NCT00424632|12123151|FG008|NOT COMPLETED|Overall Study||16
10951583|NCT00424632|12123152|FG009|NOT COMPLETED|Overall Study||6
10951584|NCT00424749|12123183|FG000|STARTED|Overall Study||4
10951585|NCT00424749|12123183|FG000|COMPLETED|Overall Study||3
10951586|NCT00424749|12123183|FG000|NOT COMPLETED|Overall Study||1
10951587|NCT00424762|12123189|FG000|STARTED|Overall Study||74
10951588|NCT00424762|12123190|FG001|STARTED|Overall Study||76
10951589|NCT00424762|12123189|FG000|COMPLETED|Overall Study||54
10951590|NCT00424762|12123190|FG001|COMPLETED|Overall Study||54
10951591|NCT00424762|12123189|FG000|NOT COMPLETED|Overall Study||20
10951592|NCT00424762|12123190|FG001|NOT COMPLETED|Overall Study||22
10951593|NCT00424775|12123196|FG000|STARTED|Overall Study||3
10951594|NCT00424775|12123197|FG001|STARTED|Overall Study||0
10951595|NCT00424775|12123196|FG000|COMPLETED|Overall Study||0
10951596|NCT00424775|12123197|FG001|COMPLETED|Overall Study||0
10951597|NCT00424775|12123196|FG000|NOT COMPLETED|Overall Study||3
10951598|NCT00424775|12123197|FG001|NOT COMPLETED|Overall Study||0
10951599|NCT00424827|12123201|FG000|STARTED|Overall Study||11
10951600|NCT00424827|12123201|FG000|COMPLETED|Overall Study||10
10951601|NCT00424827|12123201|FG000|NOT COMPLETED|Overall Study||1
10951602|NCT00424840|12123206|FG000|STARTED|Overall Study||3
10951603|NCT00424840|12123207|FG001|STARTED|Overall Study||4
10951604|NCT00424840|12123208|FG002|STARTED|Overall Study||5
10951605|NCT00424840|12123206|FG000|COMPLETED|Overall Study||3
10951606|NCT00424840|12123207|FG001|COMPLETED|Overall Study||4
10951607|NCT00424840|12123208|FG002|COMPLETED|Overall Study||5
10951608|NCT00424840|12123206|FG000|NOT COMPLETED|Overall Study||0
10951609|NCT00424840|12123207|FG001|NOT COMPLETED|Overall Study||0
10951610|NCT00424840|12123208|FG002|NOT COMPLETED|Overall Study||0
10951611|NCT00425061|12123221|FG000|STARTED|Overall Study||16
10951612|NCT00425061|12123222|FG001|STARTED|Overall Study||17
10951613|NCT00425061|12123223|FG002|STARTED|Overall Study||16
10951614|NCT00425061|12123224|FG003|STARTED|Overall Study||16
10951615|NCT00425061|12123225|FG004|STARTED|Overall Study||45
10951616|NCT00425061|12123226|FG005|STARTED|Overall Study||4
10951617|NCT00425061|12123227|FG006|STARTED|Overall Study||45
10951618|NCT00425061|12123221|FG000|COMPLETED|Overall Study||14
10951619|NCT00425061|12123222|FG001|COMPLETED|Overall Study||15
10951620|NCT00425061|12123223|FG002|COMPLETED|Overall Study||16
10951621|NCT00425061|12123224|FG003|COMPLETED|Overall Study||14
10951622|NCT00425061|12123225|FG004|COMPLETED|Overall Study||19
10951623|NCT00425061|12123226|FG005|COMPLETED|Overall Study||0
10951624|NCT00425061|12123227|FG006|COMPLETED|Overall Study||26
10951625|NCT00425061|12123221|FG000|NOT COMPLETED|Overall Study||2
10951626|NCT00425061|12123222|FG001|NOT COMPLETED|Overall Study||2
10951627|NCT00425061|12123223|FG002|NOT COMPLETED|Overall Study||0
10951628|NCT00425061|12123224|FG003|NOT COMPLETED|Overall Study||2
10951629|NCT00425061|12123225|FG004|NOT COMPLETED|Overall Study||26
10951630|NCT00425061|12123226|FG005|NOT COMPLETED|Overall Study||4
10951631|NCT00425061|12123227|FG006|NOT COMPLETED|Overall Study||19
10951632|NCT00425113|12123247|FG000|STARTED|Overall Study||17
10951633|NCT00425113|12123248|FG001|STARTED|Overall Study||18
10951634|NCT00425113|12123247|FG000|Exposed to Study Drug|Overall Study||16
10951635|NCT00425113|12123248|FG001|Exposed to Study Drug|Overall Study||17
10951636|NCT00425113|12123247|FG000|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
10951637|NCT00425113|12123248|FG001|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
10951638|NCT00425113|12123247|FG000|NOT COMPLETED|Overall Study||2
10951639|NCT00425113|12123248|FG001|NOT COMPLETED|Overall Study||2
10951640|NCT00425269|12123257|FG000|STARTED|Overall Study||101
10951641|NCT00425269|12123258|FG001|STARTED|Overall Study||97
10951642|NCT00425269|12123257|FG000|COMPLETED|Overall Study||82
10951643|NCT00425269|12123258|FG001|COMPLETED|Overall Study||77
10951644|NCT00425269|12123257|FG000|NOT COMPLETED|Overall Study||19
10951645|NCT00425269|12123258|FG001|NOT COMPLETED|Overall Study||20
10951646|NCT00425308|12123266|FG000|STARTED|Overall Study||15
10951647|NCT00425308|12123267|FG001|STARTED|Overall Study||15
10951648|NCT00425308|12123266|FG000|COMPLETED|Overall Study||11
10951649|NCT00425308|12123267|FG001|COMPLETED|Overall Study||14
10951650|NCT00425308|12123266|FG000|NOT COMPLETED|Overall Study||4
10951651|NCT00425308|12123267|FG001|NOT COMPLETED|Overall Study||1
10951652|NCT00425373|12123282|FG000|STARTED|Overall Study||159
10951653|NCT00425373|12123283|FG001|STARTED|Overall Study||167
10951654|NCT00425373|12123284|FG002|STARTED|Overall Study||160
10951655|NCT00425373|12123285|FG003|STARTED|Overall Study||162
10951656|NCT00425373|12123286|FG004|STARTED|Overall Study||169
10951657|NCT00425373|12123287|FG005|STARTED|Overall Study||163
10951658|NCT00425373|12123288|FG006|STARTED|Overall Study||161
10951659|NCT00425373|12123289|FG007|STARTED|Overall Study||161
10951660|NCT00425373|12123290|FG008|STARTED|Overall Study||166
10951661|NCT00425373|12123282|FG000|COMPLETED|Overall Study||154
10951662|NCT00425373|12123283|FG001|COMPLETED|Overall Study||164
10951663|NCT00425373|12123284|FG002|COMPLETED|Overall Study||157
10951664|NCT00425373|12123285|FG003|COMPLETED|Overall Study||160
10951665|NCT00425373|12123286|FG004|COMPLETED|Overall Study||159
10951666|NCT00425373|12123287|FG005|COMPLETED|Overall Study||154
10951667|NCT00425373|12123288|FG006|COMPLETED|Overall Study||154
10951668|NCT00425373|12123289|FG007|COMPLETED|Overall Study||151
10951669|NCT00425373|12123290|FG008|COMPLETED|Overall Study||148
10951670|NCT00425373|12123282|FG000|NOT COMPLETED|Overall Study||5
10951671|NCT00425373|12123283|FG001|NOT COMPLETED|Overall Study||3
10951672|NCT00425373|12123284|FG002|NOT COMPLETED|Overall Study||3
10951673|NCT00425373|12123285|FG003|NOT COMPLETED|Overall Study||2
10951674|NCT00425373|12123286|FG004|NOT COMPLETED|Overall Study||10
10951675|NCT00425373|12123287|FG005|NOT COMPLETED|Overall Study||9
10951676|NCT00425373|12123288|FG006|NOT COMPLETED|Overall Study||7
10951677|NCT00425373|12123289|FG007|NOT COMPLETED|Overall Study||10
10951678|NCT00425373|12123290|FG008|NOT COMPLETED|Overall Study||18
10951679|NCT00425386|12123310|FG000|STARTED|Overall Study||46
10951680|NCT00425386|12123310|FG000|COMPLETED|Overall Study||43
10951681|NCT00425386|12123310|FG000|NOT COMPLETED|Overall Study||3
10951682|NCT00425477|12123314|FG000|STARTED|Overall Study||26
10951683|NCT00425477|12123314|FG000|COMPLETED|Overall Study||13
10951684|NCT00425477|12123314|FG000|NOT COMPLETED|Overall Study||13
10951685|NCT00425503|12123318|FG000|STARTED|Overall Study||40
10951686|NCT00425503|12123318|FG000|COMPLETED|Overall Study||37
10951687|NCT00425503|12123318|FG000|NOT COMPLETED|Overall Study||3
10951688|NCT00425555|12123324|FG000|STARTED|Overall Study||79
10951689|NCT00425555|12123325|FG001|STARTED|Overall Study||60
10951690|NCT00425555|12123324|FG000|COMPLETED|Overall Study||0
10951691|NCT00425555|12123325|FG001|COMPLETED|Overall Study||0
10951692|NCT00425555|12123324|FG000|NOT COMPLETED|Overall Study||79
10951693|NCT00425555|12123325|FG001|NOT COMPLETED|Overall Study||60
10951694|NCT00425607|12123334|FG000|STARTED|Overall Study||29
10951695|NCT00425607|12123334|FG000|Received Treatment|Overall Study||28
10951696|NCT00425607|12123334|FG000|COMPLETED|Overall Study||27
10951697|NCT00425607|12123334|FG000|NOT COMPLETED|Overall Study||2
10951698|NCT00425672|12123338|FG000|STARTED|Overall Study||15
10951699|NCT00425672|12123338|FG000|COMPLETED|Overall Study||14
10951700|NCT00425672|12123338|FG000|NOT COMPLETED|Overall Study||1
10951701|NCT00425698|12123344|FG000|STARTED|Overall Study||44
10951702|NCT00425698|12123345|FG001|STARTED|Overall Study||44
10951703|NCT00425698|12123344|FG000|COMPLETED|Overall Study||41
10951704|NCT00425698|12123345|FG001|COMPLETED|Overall Study||42
10951705|NCT00425698|12123344|FG000|NOT COMPLETED|Overall Study||3
10951706|NCT00425698|12123345|FG001|NOT COMPLETED|Overall Study||2
10951707|NCT00425750|12123351|FG000|STARTED|Overall Study||25
10951708|NCT00425750|12123351|FG000|COMPLETED|Overall Study||0
10951709|NCT00425750|12123351|FG000|NOT COMPLETED|Overall Study||25
10951710|NCT00425802|12123355|FG000|STARTED|Overall Study||61
10951711|NCT00425802|12123355|FG000|COMPLETED|Overall Study||61
10951712|NCT00425802|12123355|FG000|NOT COMPLETED|Overall Study||0
10951713|NCT00425854|12123361|FG000|STARTED|Overall Study|Treated|29
10951714|NCT00425854|12123362|FG001|STARTED|Overall Study|Treated|21
10951715|NCT00425854|12123361|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
10951716|NCT00425854|12123362|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
10951717|NCT00425854|12123361|FG000|NOT COMPLETED|Overall Study||29
10951718|NCT00425854|12123362|FG001|NOT COMPLETED|Overall Study||21
10951719|NCT00425945|12123371|FG000|STARTED|Overall Study||64
10951720|NCT00425945|12123372|FG001|STARTED|Overall Study||66
10951721|NCT00425945|12123371|FG000|COMPLETED|Overall Study||60
10951722|NCT00425945|12123372|FG001|COMPLETED|Overall Study||61
10951723|NCT00425945|12123371|FG000|NOT COMPLETED|Overall Study||4
10951724|NCT00425945|12123372|FG001|NOT COMPLETED|Overall Study||5
10951725|NCT00426127|12123380|FG000|STARTED|Overall Study||2
10951726|NCT00426127|12123380|FG000|COMPLETED|Overall Study||0
10951727|NCT00426127|12123380|FG000|NOT COMPLETED|Overall Study||2
10951728|NCT00426153|12123386|FG000|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
10951729|NCT00426153|12123387|FG001|STARTED|Overall Study||14
10951730|NCT00426153|12123386|FG000|COMPLETED|Overall Study||28
10951731|NCT00426153|12123387|FG001|COMPLETED|Overall Study||14
10951732|NCT00426153|12123386|FG000|NOT COMPLETED|Overall Study||0
10951733|NCT00426153|12123387|FG001|NOT COMPLETED|Overall Study||0
10951734|NCT00426231|12123395|FG000|STARTED|Overall Study||36
10951735|NCT00426231|12123396|FG001|STARTED|Overall Study||37
10951736|NCT00426231|12123395|FG000|COMPLETED|Overall Study|For the 6 month endpoint|27
10951737|NCT00426231|12123396|FG001|COMPLETED|Overall Study|For the 6-month endpoint|25
10951738|NCT00426231|12123395|FG000|NOT COMPLETED|Overall Study||9
10951739|NCT00426231|12123396|FG001|NOT COMPLETED|Overall Study||12
10951740|NCT00426270|12123402|FG000|STARTED|Overall Study||116
10951741|NCT00426270|12123402|FG000|COMPLETED|Overall Study||110
10951742|NCT00426270|12123402|FG000|NOT COMPLETED|Overall Study||6
10951743|NCT00426283|12123408|FG000|STARTED|Overall Study||28
10951744|NCT00426283|12123409|FG001|STARTED|Overall Study||14
10951745|NCT00426283|12123408|FG000|COMPLETED|Overall Study||23
10951746|NCT00426283|12123409|FG001|COMPLETED|Overall Study||13
10951747|NCT00426283|12123408|FG000|NOT COMPLETED|Overall Study||5
10951748|NCT00426283|12123409|FG001|NOT COMPLETED|Overall Study||1
10951749|NCT00426361|12123422|FG000|STARTED|Overall Study||248
10951750|NCT00426361|12123423|FG001|STARTED|Overall Study||255
10951751|NCT00426361|12123424|FG002|STARTED|Overall Study||248
10951752|NCT00426361|12123422|FG000|COMPLETED|Overall Study||244
10951753|NCT00426361|12123423|FG001|COMPLETED|Overall Study||250
10951754|NCT00426361|12123424|FG002|COMPLETED|Overall Study||243
10951755|NCT00426361|12123422|FG000|NOT COMPLETED|Overall Study||4
10951756|NCT00426361|12123423|FG001|NOT COMPLETED|Overall Study||5
10951757|NCT00426361|12123424|FG002|NOT COMPLETED|Overall Study||5
10951758|NCT00426517|12123436|FG000|STARTED|Overall Study||7
10951759|NCT00426517|12123437|FG001|STARTED|Overall Study||36
10951760|NCT00426517|12123438|FG002|STARTED|Overall Study||3
10951761|NCT00426517|12123439|FG003|STARTED|Overall Study||2
10951762|NCT00426517|12123436|FG000|COMPLETED|Overall Study||7
10951763|NCT00426517|12123437|FG001|COMPLETED|Overall Study||36
10951764|NCT00426517|12123438|FG002|COMPLETED|Overall Study||3
10951765|NCT00426517|12123439|FG003|COMPLETED|Overall Study||2
10951766|NCT00426517|12123436|FG000|NOT COMPLETED|Overall Study||0
10951767|NCT00426517|12123437|FG001|NOT COMPLETED|Overall Study||0
10951768|NCT00426517|12123438|FG002|NOT COMPLETED|Overall Study||0
10951769|NCT00426517|12123439|FG003|NOT COMPLETED|Overall Study||0
10951770|NCT00426556|12123453|FG000|STARTED|Phase I - Core Phase||6
10951771|NCT00426556|12123454|FG001|STARTED|Phase I - Core Phase||17
10951772|NCT00426556|12123455|FG002|STARTED|Phase I - Core Phase||10
10951773|NCT00426556|12123456|FG003|STARTED|Phase I - Core Phase||0
10951774|NCT00426556|12123453|FG000|COMPLETED|Phase I - Core Phase||5
10951775|NCT00426556|12123454|FG001|COMPLETED|Phase I - Core Phase||7
10951776|NCT00426556|12123455|FG002|COMPLETED|Phase I - Core Phase||7
10951777|NCT00426556|12123456|FG003|COMPLETED|Phase I - Core Phase||0
10951778|NCT00426556|12123453|FG000|NOT COMPLETED|Phase I - Core Phase||1
10951779|NCT00426556|12123454|FG001|NOT COMPLETED|Phase I - Core Phase||10
10951780|NCT00426556|12123455|FG002|NOT COMPLETED|Phase I - Core Phase||3
10951781|NCT00426556|12123456|FG003|NOT COMPLETED|Phase I - Core Phase||0
10951782|NCT00426556|12123453|FG000|STARTED|Phase I - Extension Phase||5
10951783|NCT00426556|12123454|FG001|STARTED|Phase I - Extension Phase||7
10951784|NCT00426556|12123455|FG002|STARTED|Phase I - Extension Phase||7
10951785|NCT00426556|12123456|FG003|STARTED|Phase I - Extension Phase||0
10951786|NCT00426556|12123453|FG000|COMPLETED|Phase I - Extension Phase||0
10951787|NCT00426556|12123454|FG001|COMPLETED|Phase I - Extension Phase||1
10951788|NCT00426556|12123455|FG002|COMPLETED|Phase I - Extension Phase||0
10951789|NCT00426556|12123456|FG003|COMPLETED|Phase I - Extension Phase||0
10951790|NCT00426556|12123453|FG000|NOT COMPLETED|Phase I - Extension Phase||5
10951791|NCT00426556|12123454|FG001|NOT COMPLETED|Phase I - Extension Phase||6
10951792|NCT00426556|12123455|FG002|NOT COMPLETED|Phase I - Extension Phase||7
10951793|NCT00426556|12123456|FG003|NOT COMPLETED|Phase I - Extension Phase||0
10951794|NCT00426556|12123453|FG000|STARTED|Phase II - Core Phase||0
10951795|NCT00426556|12123454|FG001|STARTED|Phase II - Core Phase||0
10951796|NCT00426556|12123455|FG002|STARTED|Phase II - Core Phase||0
10951797|NCT00426556|12123456|FG003|STARTED|Phase II - Core Phase||55
10951798|NCT00426556|12123453|FG000|COMPLETED|Phase II - Core Phase||0
10951799|NCT00426556|12123454|FG001|COMPLETED|Phase II - Core Phase||0
10951800|NCT00426556|12123455|FG002|COMPLETED|Phase II - Core Phase||0
10951801|NCT00426556|12123456|FG003|COMPLETED|Phase II - Core Phase||28
10951802|NCT00426556|12123453|FG000|NOT COMPLETED|Phase II - Core Phase||0
10951803|NCT00426556|12123454|FG001|NOT COMPLETED|Phase II - Core Phase||0
10951804|NCT00426556|12123455|FG002|NOT COMPLETED|Phase II - Core Phase||0
10951805|NCT00426556|12123456|FG003|NOT COMPLETED|Phase II - Core Phase||27
10951806|NCT00426556|12123453|FG000|STARTED|Phase II - Extension Phase||0
10951807|NCT00426556|12123454|FG001|STARTED|Phase II - Extension Phase||0
10951808|NCT00426556|12123455|FG002|STARTED|Phase II - Extension Phase||0
10951809|NCT00426556|12123456|FG003|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
10951810|NCT00426556|12123453|FG000|COMPLETED|Phase II - Extension Phase||0
10951811|NCT00426556|12123454|FG001|COMPLETED|Phase II - Extension Phase||0
10951812|NCT00426556|12123455|FG002|COMPLETED|Phase II - Extension Phase||0
10951813|NCT00426556|12123456|FG003|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
10951814|NCT00426556|12123453|FG000|NOT COMPLETED|Phase II - Extension Phase||0
10951815|NCT00426556|12123454|FG001|NOT COMPLETED|Phase II - Extension Phase||0
10951816|NCT00426556|12123455|FG002|NOT COMPLETED|Phase II - Extension Phase||0
10951817|NCT00426556|12123456|FG003|NOT COMPLETED|Phase II - Extension Phase||23
10951818|NCT00426660|12123466|FG000|STARTED|Overall Study||1047
10951819|NCT00426660|12123466|FG000|Treated|Overall Study||1032
10951820|NCT00426660|12123466|FG000|Safety Analysis Set|Overall Study||1032
10951821|NCT00426660|12123466|FG000|COMPLETED|Overall Study||916
10951822|NCT00426660|12123466|FG000|NOT COMPLETED|Overall Study||131
10951823|NCT00426751|12123472|FG000|STARTED|Overall Study||226
10951824|NCT00426751|12123473|FG001|STARTED|Overall Study||203
10951825|NCT00426751|12123472|FG000|COMPLETED|Overall Study||204
10951826|NCT00426751|12123473|FG001|COMPLETED|Overall Study||183
10951827|NCT00426751|12123472|FG000|NOT COMPLETED|Overall Study||22
10951828|NCT00426751|12123473|FG001|NOT COMPLETED|Overall Study||20
10951829|NCT00426764|12123479|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
10951830|NCT00426764|12123479|FG000|Discontinued Prior to or During Cycle 6|Overall Study||98
10951831|NCT00426764|12123479|FG000|Discontinued at End of or After Cycle 6|Overall Study||33
10951832|NCT00426764|12123479|FG000|COMPLETED|Overall Study||0
10951833|NCT00426764|12123479|FG000|NOT COMPLETED|Overall Study||131
10951834|NCT00426842|12123489|FG000|STARTED|Overall Study||11
10951835|NCT00426842|12123489|FG000|COMPLETED|Overall Study||10
10951836|NCT00426842|12123489|FG000|NOT COMPLETED|Overall Study||1
10951837|NCT00426855|12123495|FG000|STARTED|Overall Study||12
10951838|NCT00426855|12123495|FG000|COMPLETED|Overall Study||12
10951839|NCT00426855|12123495|FG000|NOT COMPLETED|Overall Study||0
10951840|NCT00427011|12123499|FG000|STARTED|Overall Study||25
10951841|NCT00427011|12123499|FG000|COMPLETED|Overall Study||0
10951842|NCT00427011|12123499|FG000|NOT COMPLETED|Overall Study||25
10951843|NCT00427037|12123506|FG000|STARTED|Overall Study||17
10951844|NCT00427037|12123507|FG001|STARTED|Overall Study||17
10951845|NCT00427037|12123506|FG000|COMPLETED|Overall Study||10
10951846|NCT00427037|12123507|FG001|COMPLETED|Overall Study||10
10951847|NCT00427037|12123506|FG000|NOT COMPLETED|Overall Study||7
10951848|NCT00427037|12123507|FG001|NOT COMPLETED|Overall Study||7
10951849|NCT00427297|12123517|FG000|STARTED|Overall Study||17
10951850|NCT00427297|12123518|FG001|STARTED|Overall Study||17
10951851|NCT00427297|12123517|FG000|COMPLETED|Overall Study||17
10951852|NCT00427297|12123518|FG001|COMPLETED|Overall Study||17
10951853|NCT00427297|12123517|FG000|NOT COMPLETED|Overall Study||0
10951854|NCT00427297|12123518|FG001|NOT COMPLETED|Overall Study||0
10951855|NCT00427336|12123524|FG000|STARTED|Overall Study||9
10951856|NCT00427336|12123524|FG000|COMPLETED|Overall Study||9
10951857|NCT00427336|12123524|FG000|NOT COMPLETED|Overall Study||0
10951858|NCT00427349|12123528|FG000|STARTED|Overall Study||46
10951859|NCT00427349|12123528|FG000|Eligible|Overall Study||45
10951860|NCT00427349|12123528|FG000|Treated|Overall Study||45
10951861|NCT00427349|12123528|FG000|Eligible and Treated|Overall Study||44
10951862|NCT00427349|12123528|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
10951863|NCT00427349|12123528|FG000|NOT COMPLETED|Overall Study||46
10951864|NCT00427557|12123532|FG000|STARTED|Overall Study||30
10951865|NCT00427557|12123532|FG000|COMPLETED|Overall Study||30
10951866|NCT00427557|12123532|FG000|NOT COMPLETED|Overall Study||0
10951867|NCT00427635|12123538|FG000|STARTED|Treatment Phase|Randomised|26
10951868|NCT00427635|12123539|FG001|STARTED|Treatment Phase|Randomised|26
10951869|NCT00427635|12123538|FG000|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
10951870|NCT00427635|12123539|FG001|COMPLETED|Treatment Phase|ITT population|26
10951871|NCT00427635|12123538|FG000|NOT COMPLETED|Treatment Phase||1
10951872|NCT00427635|12123539|FG001|NOT COMPLETED|Treatment Phase||0
10951873|NCT00427635|12123538|FG000|STARTED|Study Completion to Safety Follow-up||25
10951874|NCT00427635|12123539|FG001|STARTED|Study Completion to Safety Follow-up||26
10951875|NCT00427635|12123538|FG000|COMPLETED|Study Completion to Safety Follow-up||25
10951876|NCT00427635|12123539|FG001|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
10951877|NCT00427635|12123538|FG000|NOT COMPLETED|Study Completion to Safety Follow-up||0
10951878|NCT00427635|12123539|FG001|NOT COMPLETED|Study Completion to Safety Follow-up||1
10951879|NCT00427648|12123547|FG000|STARTED|Overall Study||12
10951880|NCT00427648|12123548|FG001|STARTED|Overall Study||10
10951881|NCT00427648|12123547|FG000|COMPLETED|Overall Study||11
10951882|NCT00427648|12123548|FG001|COMPLETED|Overall Study||7
10951883|NCT00427648|12123547|FG000|NOT COMPLETED|Overall Study||1
10951884|NCT00427648|12123548|FG001|NOT COMPLETED|Overall Study||3
10951885|NCT00427661|12123556|FG000|STARTED|Overall Study||8
10951886|NCT00427661|12123556|FG000|COMPLETED|Overall Study||8
10951887|NCT00427661|12123556|FG000|NOT COMPLETED|Overall Study||0
10951888|NCT00427700|12123563|FG000|STARTED|Overall Study||40
10951889|NCT00427700|12123564|FG001|STARTED|Overall Study||42
10951890|NCT00427700|12123563|FG000|COMPLETED|Overall Study||37
10951891|NCT00427700|12123564|FG001|COMPLETED|Overall Study||31
10951892|NCT00427700|12123563|FG000|NOT COMPLETED|Overall Study||3
10951893|NCT00427700|12123564|FG001|NOT COMPLETED|Overall Study||11
10951894|NCT00427765|12123571|FG000|STARTED|Overall Study||164
10951895|NCT00427765|12123571|FG000|COMPLETED|Overall Study||164
10951896|NCT00427765|12123571|FG000|NOT COMPLETED|Overall Study||0
10951897|NCT00427778|12123575|FG000|STARTED|First Intervention (4 Weeks)||14
10951898|NCT00427778|12123576|FG001|STARTED|First Intervention (4 Weeks)||15
10951899|NCT00427778|12123575|FG000|COMPLETED|First Intervention (4 Weeks)||10
10951900|NCT00427778|12123576|FG001|COMPLETED|First Intervention (4 Weeks)||14
10951901|NCT00427778|12123575|FG000|NOT COMPLETED|First Intervention (4 Weeks)||4
10951902|NCT00427778|12123576|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
10951903|NCT00427778|12123575|FG000|STARTED|Wash Out (2 Weeks)||10
10951904|NCT00427778|12123576|FG001|STARTED|Wash Out (2 Weeks)||14
10951905|NCT00427778|12123575|FG000|COMPLETED|Wash Out (2 Weeks)||10
10951906|NCT00427778|12123576|FG001|COMPLETED|Wash Out (2 Weeks)||14
10951907|NCT00427778|12123575|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0
10951908|NCT00427778|12123576|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0
10951909|NCT00427778|12123575|FG000|STARTED|Second Intervention (4 Weeks)||10
10951910|NCT00427778|12123576|FG001|STARTED|Second Intervention (4 Weeks)||14
10951911|NCT00427778|12123575|FG000|COMPLETED|Second Intervention (4 Weeks)||10
10951912|NCT00427778|12123576|FG001|COMPLETED|Second Intervention (4 Weeks)||14
10951913|NCT00427778|12123575|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
10951914|NCT00427778|12123576|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
10951915|NCT00427791|12123597|FG000|STARTED|Overall Study||10
10951916|NCT00427791|12123598|FG001|STARTED|Overall Study||13
10951917|NCT00427791|12123597|FG000|COMPLETED|Overall Study||10
10951918|NCT00427791|12123598|FG001|COMPLETED|Overall Study||13
10951919|NCT00427791|12123597|FG000|NOT COMPLETED|Overall Study||0
10951920|NCT00427791|12123598|FG001|NOT COMPLETED|Overall Study||0
10951921|NCT00427804|12123606|FG000|STARTED|Overall Study||4
10951922|NCT00427804|12123607|FG001|STARTED|Overall Study||5
10951923|NCT00427804|12123606|FG000|COMPLETED|Overall Study||4
10951924|NCT00427804|12123607|FG001|COMPLETED|Overall Study||5
10951925|NCT00427804|12123606|FG000|NOT COMPLETED|Overall Study||0
10951926|NCT00427804|12123607|FG001|NOT COMPLETED|Overall Study||0
10951927|NCT00427895|12123617|FG000|STARTED|Between 6-Month Follow-up - Year 1||411
10951928|NCT00427895|12123618|FG001|STARTED|Between 6-Month Follow-up - Year 1||411
10951929|NCT00427895|12123619|FG002|STARTED|Between 6-Month Follow-up - Year 1||392
10951930|NCT00427895|12123620|FG003|STARTED|Between 6-Month Follow-up - Year 1||854
10951931|NCT00427895|12123621|FG004|STARTED|Between 6-Month Follow-up - Year 1||0
10951932|NCT00427895|12123622|FG005|STARTED|Between 6-Month Follow-up - Year 1||0
10951933|NCT00427895|12123623|FG006|STARTED|Between 6-Month Follow-up - Year 1||0
10951934|NCT00427895|12123624|FG007|STARTED|Between 6-Month Follow-up - Year 1||0
10951935|NCT00427895|12123617|FG000|COMPLETED|Between 6-Month Follow-up - Year 1||411
10951936|NCT00427895|12123618|FG001|COMPLETED|Between 6-Month Follow-up - Year 1||411
10951937|NCT00427895|12123619|FG002|COMPLETED|Between 6-Month Follow-up - Year 1||392
10951938|NCT00427895|12123620|FG003|COMPLETED|Between 6-Month Follow-up - Year 1||502
10951939|NCT00427895|12123621|FG004|COMPLETED|Between 6-Month Follow-up - Year 1||0
10951940|NCT00427895|12123622|FG005|COMPLETED|Between 6-Month Follow-up - Year 1||0
10951941|NCT00427895|12123623|FG006|COMPLETED|Between 6-Month Follow-up - Year 1||0
10951942|NCT00427895|12123624|FG007|COMPLETED|Between 6-Month Follow-up - Year 1||0
10951943|NCT00427895|12123617|FG000|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
10951944|NCT00427895|12123618|FG001|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
10951945|NCT00427895|12123619|FG002|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
10951946|NCT00427895|12123620|FG003|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
10951947|NCT00427895|12123621|FG004|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
10951948|NCT00427895|12123622|FG005|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
10951949|NCT00427895|12123623|FG006|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
10951950|NCT00427895|12123624|FG007|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
10951951|NCT00427895|12123617|FG000|STARTED|Vax 2/Year 3 to 4||0
10951952|NCT00427895|12123618|FG001|STARTED|Vax 2/Year 3 to 4||0
10951953|NCT00427895|12123619|FG002|STARTED|Vax 2/Year 3 to 4||0
10951954|NCT00427895|12123620|FG003|STARTED|Vax 2/Year 3 to 4||0
10951955|NCT00427895|12123621|FG004|STARTED|Vax 2/Year 3 to 4||108
10951956|NCT00427895|12123622|FG005|STARTED|Vax 2/Year 3 to 4||108
10951957|NCT00427895|12123623|FG006|STARTED|Vax 2/Year 3 to 4||189
10951958|NCT00427895|12123624|FG007|STARTED|Vax 2/Year 3 to 4||214
10951959|NCT00427895|12123617|FG000|COMPLETED|Vax 2/Year 3 to 4||0
10951960|NCT00427895|12123618|FG001|COMPLETED|Vax 2/Year 3 to 4||0
10951961|NCT00427895|12123619|FG002|COMPLETED|Vax 2/Year 3 to 4||0
10951962|NCT00427895|12123620|FG003|COMPLETED|Vax 2/Year 3 to 4||0
10951963|NCT00427895|12123621|FG004|COMPLETED|Vax 2/Year 3 to 4||107
10951964|NCT00427895|12123622|FG005|COMPLETED|Vax 2/Year 3 to 4||108
10951965|NCT00427895|12123623|FG006|COMPLETED|Vax 2/Year 3 to 4||189
10951966|NCT00427895|12123624|FG007|COMPLETED|Vax 2/Year 3 to 4||212
10951967|NCT00427895|12123617|FG000|NOT COMPLETED|Vax 2/Year 3 to 4||0
10951968|NCT00427895|12123618|FG001|NOT COMPLETED|Vax 2/Year 3 to 4||0
10951969|NCT00427895|12123619|FG002|NOT COMPLETED|Vax 2/Year 3 to 4||0
10951970|NCT00427895|12123620|FG003|NOT COMPLETED|Vax 2/Year 3 to 4||0
10951971|NCT00427895|12123621|FG004|NOT COMPLETED|Vax 2/Year 3 to 4||1
10951972|NCT00427895|12123622|FG005|NOT COMPLETED|Vax 2/Year 3 to 4||0
10951973|NCT00427895|12123623|FG006|NOT COMPLETED|Vax 2/Year 3 to 4||0
10951974|NCT00427895|12123624|FG007|NOT COMPLETED|Vax 2/Year 3 to 4||2
10951975|NCT00427895|12123617|FG000|STARTED|Vax 1 Baseline/6-Month Follow-up||418
10951976|NCT00427895|12123618|FG001|STARTED|Vax 1 Baseline/6-Month Follow-up||417
10951977|NCT00427895|12123619|FG002|STARTED|Vax 1 Baseline/6-Month Follow-up||406
10951978|NCT00427895|12123620|FG003|STARTED|Vax 1 Baseline/6-Month Follow-up||900
10951979|NCT00427895|12123621|FG004|STARTED|Vax 1 Baseline/6-Month Follow-up||0
10951980|NCT00427895|12123622|FG005|STARTED|Vax 1 Baseline/6-Month Follow-up||0
10951981|NCT00427895|12123623|FG006|STARTED|Vax 1 Baseline/6-Month Follow-up||0
10951982|NCT00427895|12123624|FG007|STARTED|Vax 1 Baseline/6-Month Follow-up||0
10951983|NCT00427895|12123617|FG000|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
10951984|NCT00427895|12123618|FG001|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
10951985|NCT00427895|12123619|FG002|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
10951986|NCT00427895|12123620|FG003|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
10951987|NCT00427895|12123621|FG004|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
10951988|NCT00427895|12123622|FG005|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
10951989|NCT00427895|12123623|FG006|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
10951990|NCT00427895|12123624|FG007|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
10951991|NCT00427895|12123617|FG000|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
10951992|NCT00427895|12123618|FG001|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
10951993|NCT00427895|12123619|FG002|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
10951994|NCT00427895|12123620|FG003|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
10951995|NCT00427895|12123621|FG004|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10951996|NCT00427895|12123622|FG005|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10951997|NCT00427895|12123623|FG006|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10951998|NCT00427895|12123624|FG007|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10951999|NCT00427895|12123617|FG000|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
10952000|NCT00427895|12123618|FG001|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
10952001|NCT00427895|12123619|FG002|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
10952002|NCT00427895|12123620|FG003|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
10952003|NCT00427895|12123621|FG004|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10952004|NCT00427895|12123622|FG005|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10952005|NCT00427895|12123623|FG006|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10952006|NCT00427895|12123624|FG007|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
10952007|NCT00427895|12123617|FG000|STARTED|Vax 1/Year 1 Follow-up||411
10952008|NCT00427895|12123618|FG001|STARTED|Vax 1/Year 1 Follow-up||411
10952009|NCT00427895|12123619|FG002|STARTED|Vax 1/Year 1 Follow-up||392
10952010|NCT00427895|12123620|FG003|STARTED|Vax 1/Year 1 Follow-up||502
10952011|NCT00427895|12123621|FG004|STARTED|Vax 1/Year 1 Follow-up||0
10952012|NCT00427895|12123622|FG005|STARTED|Vax 1/Year 1 Follow-up||0
10952013|NCT00427895|12123623|FG006|STARTED|Vax 1/Year 1 Follow-up||0
10952014|NCT00427895|12123624|FG007|STARTED|Vax 1/Year 1 Follow-up||0
10952015|NCT00427895|12123617|FG000|COMPLETED|Vax 1/Year 1 Follow-up||404
10952016|NCT00427895|12123618|FG001|COMPLETED|Vax 1/Year 1 Follow-up||396
10952017|NCT00427895|12123619|FG002|COMPLETED|Vax 1/Year 1 Follow-up||373
10952018|NCT00427895|12123620|FG003|COMPLETED|Vax 1/Year 1 Follow-up||469
10952019|NCT00427895|12123621|FG004|COMPLETED|Vax 1/Year 1 Follow-up||0
10952020|NCT00427895|12123622|FG005|COMPLETED|Vax 1/Year 1 Follow-up||0
10952021|NCT00427895|12123623|FG006|COMPLETED|Vax 1/Year 1 Follow-up||0
10952022|NCT00427895|12123624|FG007|COMPLETED|Vax 1/Year 1 Follow-up||0
10952023|NCT00427895|12123617|FG000|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
10952024|NCT00427895|12123618|FG001|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
10952025|NCT00427895|12123619|FG002|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
10952026|NCT00427895|12123620|FG003|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
10952027|NCT00427895|12123621|FG004|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
10952028|NCT00427895|12123622|FG005|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
10952029|NCT00427895|12123623|FG006|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
10952030|NCT00427895|12123624|FG007|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
10952031|NCT00427895|12123617|FG000|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
10952032|NCT00427895|12123618|FG001|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
10952033|NCT00427895|12123619|FG002|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
10952034|NCT00427895|12123620|FG003|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
10952035|NCT00427895|12123621|FG004|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
10952036|NCT00427895|12123622|FG005|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
10952037|NCT00427895|12123623|FG006|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
10952038|NCT00427895|12123624|FG007|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
10952039|NCT00427895|12123617|FG000|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
10952040|NCT00427895|12123618|FG001|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
10952041|NCT00427895|12123619|FG002|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
10952042|NCT00427895|12123620|FG003|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10952043|NCT00427895|12123621|FG004|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10952044|NCT00427895|12123622|FG005|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10952045|NCT00427895|12123623|FG006|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10952046|NCT00427895|12123624|FG007|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10952047|NCT00427895|12123617|FG000|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
10952048|NCT00427895|12123618|FG001|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
10952049|NCT00427895|12123619|FG002|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
10952050|NCT00427895|12123620|FG003|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
10952051|NCT00427895|12123621|FG004|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10952052|NCT00427895|12123622|FG005|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10952053|NCT00427895|12123623|FG006|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10952054|NCT00427895|12123624|FG007|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
10952055|NCT00427908|12123667|FG000|STARTED|Primary Phase||229
10952056|NCT00427908|12123668|FG001|STARTED|Primary Phase||231
10952057|NCT00427908|12123669|FG002|STARTED|Primary Phase||75
10952058|NCT00427908|12123670|FG003|STARTED|Primary Phase||78
10952059|NCT00427908|12123667|FG000|COMPLETED|Primary Phase||224
10952060|NCT00427908|12123668|FG001|COMPLETED|Primary Phase||228
10952061|NCT00427908|12123669|FG002|COMPLETED|Primary Phase||72
10952062|NCT00427908|12123670|FG003|COMPLETED|Primary Phase||78
10952063|NCT00427908|12123667|FG000|NOT COMPLETED|Primary Phase||5
10952064|NCT00427908|12123668|FG001|NOT COMPLETED|Primary Phase||3
10952065|NCT00427908|12123669|FG002|NOT COMPLETED|Primary Phase||3
10952066|NCT00427908|12123670|FG003|NOT COMPLETED|Primary Phase||0
10952067|NCT00427908|12123667|FG000|STARTED|Persistence Phase Year 1||222
10952068|NCT00427908|12123668|FG001|STARTED|Persistence Phase Year 1||221
10952069|NCT00427908|12123669|FG002|STARTED|Persistence Phase Year 1||71
10952070|NCT00427908|12123670|FG003|STARTED|Persistence Phase Year 1||78
10952071|NCT00427908|12123667|FG000|COMPLETED|Persistence Phase Year 1||222
10952072|NCT00427908|12123668|FG001|COMPLETED|Persistence Phase Year 1||221
10952073|NCT00427908|12123669|FG002|COMPLETED|Persistence Phase Year 1||71
10952074|NCT00427908|12123670|FG003|COMPLETED|Persistence Phase Year 1||78
10952075|NCT00427908|12123667|FG000|NOT COMPLETED|Persistence Phase Year 1||0
10952076|NCT00427908|12123668|FG001|NOT COMPLETED|Persistence Phase Year 1||0
10952077|NCT00427908|12123669|FG002|NOT COMPLETED|Persistence Phase Year 1||0
10952078|NCT00427908|12123670|FG003|NOT COMPLETED|Persistence Phase Year 1||0
10952079|NCT00427908|12123667|FG000|STARTED|Persistence Phase Year 2||208
10952080|NCT00427908|12123668|FG001|STARTED|Persistence Phase Year 2||215
10952081|NCT00427908|12123669|FG002|STARTED|Persistence Phase Year 2||53
10952082|NCT00427908|12123670|FG003|STARTED|Persistence Phase Year 2||61
10952083|NCT00427908|12123667|FG000|COMPLETED|Persistence Phase Year 2||208
10952084|NCT00427908|12123668|FG001|COMPLETED|Persistence Phase Year 2||215
10952085|NCT00427908|12123669|FG002|COMPLETED|Persistence Phase Year 2||53
10952086|NCT00427908|12123670|FG003|COMPLETED|Persistence Phase Year 2||61
10952087|NCT00427908|12123667|FG000|NOT COMPLETED|Persistence Phase Year 2||0
10952088|NCT00427908|12123668|FG001|NOT COMPLETED|Persistence Phase Year 2||0
10952089|NCT00427908|12123669|FG002|NOT COMPLETED|Persistence Phase Year 2||0
10952090|NCT00427908|12123670|FG003|NOT COMPLETED|Persistence Phase Year 2||0
10952091|NCT00427908|12123667|FG000|STARTED|Persistence Phase Year 3||185
10952092|NCT00427908|12123668|FG001|STARTED|Persistence Phase Year 3||201
10952093|NCT00427908|12123669|FG002|STARTED|Persistence Phase Year 3||38
10952094|NCT00427908|12123670|FG003|STARTED|Persistence Phase Year 3||38
10952095|NCT00427908|12123667|FG000|COMPLETED|Persistence Phase Year 3||185
10952096|NCT00427908|12123668|FG001|COMPLETED|Persistence Phase Year 3||201
10952097|NCT00427908|12123669|FG002|COMPLETED|Persistence Phase Year 3||38
10952098|NCT00427908|12123670|FG003|COMPLETED|Persistence Phase Year 3||38
10952099|NCT00427908|12123667|FG000|NOT COMPLETED|Persistence Phase Year 3||0
10952100|NCT00427908|12123668|FG001|NOT COMPLETED|Persistence Phase Year 3||0
10952101|NCT00427908|12123669|FG002|NOT COMPLETED|Persistence Phase Year 3||0
10952102|NCT00427908|12123670|FG003|NOT COMPLETED|Persistence Phase Year 3||0
10952103|NCT00427908|12123667|FG000|STARTED|Persistence Phase Year 4||165
10952104|NCT00427908|12123668|FG001|STARTED|Persistence Phase Year 4||192
10952105|NCT00427908|12123669|FG002|STARTED|Persistence Phase Year 4||34
10952106|NCT00427908|12123670|FG003|STARTED|Persistence Phase Year 4||32
10952107|NCT00427908|12123667|FG000|COMPLETED|Persistence Phase Year 4||165
10952108|NCT00427908|12123668|FG001|COMPLETED|Persistence Phase Year 4||192
10952109|NCT00427908|12123669|FG002|COMPLETED|Persistence Phase Year 4||34
10952110|NCT00427908|12123670|FG003|COMPLETED|Persistence Phase Year 4||32
10952111|NCT00427908|12123667|FG000|NOT COMPLETED|Persistence Phase Year 4||0
10952112|NCT00427908|12123668|FG001|NOT COMPLETED|Persistence Phase Year 4||0
10952113|NCT00427908|12123669|FG002|NOT COMPLETED|Persistence Phase Year 4||0
10952114|NCT00427908|12123670|FG003|NOT COMPLETED|Persistence Phase Year 4||0
10952115|NCT00427908|12123667|FG000|STARTED|Persistence Phase Year 5||52
10952116|NCT00427908|12123668|FG001|STARTED|Persistence Phase Year 5||99
10952117|NCT00427908|12123669|FG002|STARTED|Persistence Phase Year 5||12
10952118|NCT00427908|12123670|FG003|STARTED|Persistence Phase Year 5||13
10952119|NCT00427908|12123667|FG000|COMPLETED|Persistence Phase Year 5||52
10952120|NCT00427908|12123668|FG001|COMPLETED|Persistence Phase Year 5||99
10952121|NCT00427908|12123669|FG002|COMPLETED|Persistence Phase Year 5||12
10952122|NCT00427908|12123670|FG003|COMPLETED|Persistence Phase Year 5||13
10952123|NCT00427908|12123667|FG000|NOT COMPLETED|Persistence Phase Year 5||0
10952124|NCT00427908|12123668|FG001|NOT COMPLETED|Persistence Phase Year 5||0
10952125|NCT00427908|12123669|FG002|NOT COMPLETED|Persistence Phase Year 5||0
10952126|NCT00427908|12123670|FG003|NOT COMPLETED|Persistence Phase Year 5||0
10952127|NCT00427921|12123705|FG000|STARTED|Overall Study||304
10952128|NCT00427921|12123705|FG000|COMPLETED|Overall Study||254
10952129|NCT00427921|12123705|FG000|NOT COMPLETED|Overall Study||50
10952130|NCT00427934|12123713|FG000|STARTED|Overall Study||8
10952131|NCT00427934|12123714|FG001|STARTED|Overall Study||8
10952132|NCT00427934|12123715|FG002|STARTED|Overall Study||78
10952133|NCT00427934|12123716|FG003|STARTED|Overall Study||34
10952134|NCT00427934|12123713|FG000|Treated|Overall Study||8
10952135|NCT00427934|12123714|FG001|Treated|Overall Study||8
10952136|NCT00427934|12123715|FG002|Treated|Overall Study||77
10952137|NCT00427934|12123716|FG003|Treated|Overall Study||33
10952138|NCT00427934|12123713|FG000|COMPLETED|Overall Study||7
10952139|NCT00427934|12123714|FG001|COMPLETED|Overall Study||8
10952140|NCT00427934|12123715|FG002|COMPLETED|Overall Study||55
10952141|NCT00427934|12123716|FG003|COMPLETED|Overall Study||19
10952142|NCT00427934|12123713|FG000|NOT COMPLETED|Overall Study||1
10952143|NCT00427934|12123714|FG001|NOT COMPLETED|Overall Study||0
10952144|NCT00427934|12123715|FG002|NOT COMPLETED|Overall Study||23
10952145|NCT00427934|12123716|FG003|NOT COMPLETED|Overall Study||15
10952146|NCT00427960|12123730|FG000|STARTED|Overall Study||30
10952147|NCT00427960|12123731|FG001|STARTED|Overall Study||25
10952148|NCT00427960|12123730|FG000|COMPLETED|Overall Study||28
10952149|NCT00427960|12123731|FG001|COMPLETED|Overall Study||21
10952150|NCT00427960|12123730|FG000|NOT COMPLETED|Overall Study||2
10952151|NCT00427960|12123731|FG001|NOT COMPLETED|Overall Study||4
10952152|NCT00427973|12123737|FG000|STARTED|Overall Study||17
10952153|NCT00427973|12123737|FG000|COMPLETED|Overall Study||17
10952154|NCT00427973|12123737|FG000|NOT COMPLETED|Overall Study||0
10952155|NCT00427999|12123741|FG000|STARTED|Overall Study||65
10952156|NCT00427999|12123741|FG000|Intent to Treat (ITT)|Overall Study||61
10952157|NCT00427999|12123741|FG000|Extension Follow-up|Overall Study||19
10952158|NCT00427999|12123741|FG000|COMPLETED|Overall Study||33
10952159|NCT00427999|12123741|FG000|NOT COMPLETED|Overall Study||32
10952160|NCT00428077|12123746|FG000|STARTED|Overall Study||4
10952161|NCT00428077|12123746|FG000|COMPLETED|Overall Study||4
10952162|NCT00428077|12123746|FG000|NOT COMPLETED|Overall Study||0
10952163|NCT00428090|12123754|FG000|STARTED|Overall Study||165
10952164|NCT00428090|12123755|FG001|STARTED|Overall Study||166
10952165|NCT00428090|12123756|FG002|STARTED|Overall Study||165
10952166|NCT00428090|12123757|FG003|STARTED|Overall Study||83
10952167|NCT00428090|12123754|FG000|COMPLETED|Overall Study||131
10952168|NCT00428090|12123755|FG001|COMPLETED|Overall Study||135
10952169|NCT00428090|12123756|FG002|COMPLETED|Overall Study||127
10952170|NCT00428090|12123757|FG003|COMPLETED|Overall Study||55
10952171|NCT00428090|12123754|FG000|NOT COMPLETED|Overall Study||34
10952172|NCT00428090|12123755|FG001|NOT COMPLETED|Overall Study||31
10952173|NCT00428090|12123756|FG002|NOT COMPLETED|Overall Study||38
10952174|NCT00428090|12123757|FG003|NOT COMPLETED|Overall Study||28
10952175|NCT00428116|12123777|FG000|STARTED|Overall Study||21
10952176|NCT00428116|12123778|FG001|STARTED|Overall Study||21
10952177|NCT00428116|12123777|FG000|COMPLETED|Overall Study||18
10952178|NCT00428116|12123778|FG001|COMPLETED|Overall Study||21
10952179|NCT00428116|12123777|FG000|NOT COMPLETED|Overall Study||3
10952180|NCT00428116|12123778|FG001|NOT COMPLETED|Overall Study||0
10952181|NCT00428220|12123785|FG000|STARTED|Overall Study||223
10952182|NCT00428220|12123785|FG000|COMPLETED|Overall Study||0
10952183|NCT00428220|12123785|FG000|NOT COMPLETED|Overall Study||223
10952184|NCT00428246|12123803|FG000|STARTED|Overall Study||8
10952185|NCT00428246|12123804|FG001|STARTED|Overall Study||8
10952186|NCT00428246|12123805|FG002|STARTED|Overall Study||8
10952187|NCT00428246|12123803|FG000|COMPLETED|Overall Study||7
10952188|NCT00428246|12123804|FG001|COMPLETED|Overall Study||8
10952189|NCT00428246|12123805|FG002|COMPLETED|Overall Study||7
10952190|NCT00428246|12123803|FG000|NOT COMPLETED|Overall Study||1
10952191|NCT00428246|12123804|FG001|NOT COMPLETED|Overall Study||0
10952192|NCT00428246|12123805|FG002|NOT COMPLETED|Overall Study||1
10952193|NCT00428298|12123815|FG000|STARTED|Overall Study||30
10952194|NCT00428298|12123816|FG001|STARTED|Overall Study||30
10952195|NCT00428298|12123815|FG000|Second RBANS at Study Exit|Overall Study||3
10952196|NCT00428298|12123816|FG001|Second RBANS at Study Exit|Overall Study||3
10952197|NCT00428298|12123815|FG000|COMPLETED|Overall Study||16
10952198|NCT00428298|12123816|FG001|COMPLETED|Overall Study||19
10952199|NCT00428298|12123815|FG000|NOT COMPLETED|Overall Study||14
10952200|NCT00428298|12123816|FG001|NOT COMPLETED|Overall Study||11
10952201|NCT00428389|12123826|FG000|STARTED|Core Phase||131
10952202|NCT00428389|12123827|FG001|STARTED|Core Phase||131
10952203|NCT00428389|12123826|FG000|Intent-to-treat Population|Core Phase||131
10952204|NCT00428389|12123827|FG001|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
10952205|NCT00428389|12123826|FG000|COMPLETED|Core Phase||120
10952206|NCT00428389|12123827|FG001|COMPLETED|Core Phase||120
10952207|NCT00428389|12123826|FG000|NOT COMPLETED|Core Phase||11
10952208|NCT00428389|12123827|FG001|NOT COMPLETED|Core Phase||11
10952209|NCT00428389|12123826|FG000|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
10952210|NCT00428389|12123827|FG001|STARTED|Extension Phase||117
10952211|NCT00428389|12123826|FG000|COMPLETED|Extension Phase||85
10952212|NCT00428389|12123827|FG001|COMPLETED|Extension Phase||91
10952213|NCT00428389|12123826|FG000|NOT COMPLETED|Extension Phase||32
10952214|NCT00428389|12123827|FG001|NOT COMPLETED|Extension Phase||26
10952215|NCT00428441|12123833|FG000|STARTED|Overall Study||75
10952216|NCT00428441|12123833|FG000|COMPLETED|Overall Study||74
10952217|NCT00428441|12123833|FG000|NOT COMPLETED|Overall Study||1
10952218|NCT00428584|12123839|FG000|STARTED|Comparative Phase||65
10952219|NCT00428584|12123840|FG001|STARTED|Comparative Phase||64
10952220|NCT00428584|12123839|FG000|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
10952221|NCT00428584|12123840|FG001|COMPLETED|Comparative Phase||63
10952222|NCT00428584|12123839|FG000|NOT COMPLETED|Comparative Phase||9
10952223|NCT00428584|12123840|FG001|NOT COMPLETED|Comparative Phase||1
10952224|NCT00428584|12123839|FG000|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
10952225|NCT00428584|12123840|FG001|STARTED|Extension Phase||63
10952226|NCT00428584|12123839|FG000|COMPLETED|Extension Phase||35
10952227|NCT00428584|12123840|FG001|COMPLETED|Extension Phase||34
10952228|NCT00428584|12123839|FG000|NOT COMPLETED|Extension Phase||21
10952229|NCT00428584|12123840|FG001|NOT COMPLETED|Extension Phase||29
10952230|NCT00428597|12123852|FG000|STARTED|Overall Study||86
10952231|NCT00428597|12123853|FG001|STARTED|Overall Study||85
10952232|NCT00428597|12123852|FG000|Received Treatment|Overall Study||83
10952233|NCT00428597|12123853|FG001|Received Treatment|Overall Study||82
10952234|NCT00428597|12123852|FG000|COMPLETED|Overall Study||0
10952235|NCT00428597|12123853|FG001|COMPLETED|Overall Study||0
10952236|NCT00428597|12123852|FG000|NOT COMPLETED|Overall Study||86
10952237|NCT00428597|12123853|FG001|NOT COMPLETED|Overall Study||85
10952238|NCT00428610|12123862|FG000|STARTED|Overall Study||53
10952239|NCT00428610|12123863|FG001|STARTED|Overall Study||18
10952240|NCT00428610|12123864|FG002|STARTED|Overall Study||32
10952241|NCT00428610|12123862|FG000|Received at Least One Dose of Study Drug|Overall Study||53
10952242|NCT00428610|12123863|FG001|Received at Least One Dose of Study Drug|Overall Study||18
10952243|NCT00428610|12123864|FG002|Received at Least One Dose of Study Drug|Overall Study||32
10952244|NCT00428610|12123862|FG000|COMPLETED|Overall Study||0
10952245|NCT00428610|12123863|FG001|COMPLETED|Overall Study||0
10952246|NCT00428610|12123864|FG002|COMPLETED|Overall Study||0
10952247|NCT00428610|12123862|FG000|NOT COMPLETED|Overall Study||53
10952248|NCT00428610|12123863|FG001|NOT COMPLETED|Overall Study||18
10952249|NCT00428610|12123864|FG002|NOT COMPLETED|Overall Study||32
10952250|NCT00428714|12123874|FG000|STARTED|Overall Study||31
10952251|NCT00428714|12123875|FG001|STARTED|Overall Study||42
10952252|NCT00428714|12123874|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
10952253|NCT00428714|12123875|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42
10952254|NCT00428714|12123874|FG000|COMPLETED|Overall Study||0
10952255|NCT00428714|12123875|FG001|COMPLETED|Overall Study||0
10952256|NCT00428714|12123874|FG000|NOT COMPLETED|Overall Study||31
10952257|NCT00428714|12123875|FG001|NOT COMPLETED|Overall Study||42
10952258|NCT00428792|12123884|FG000|STARTED|Overall Study||80
10952259|NCT00428792|12123885|FG001|STARTED|Overall Study||70
10952260|NCT00428792|12123884|FG000|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
10952261|NCT00428792|12123885|FG001|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
10952262|NCT00428792|12123884|FG000|NOT COMPLETED|Overall Study||1
10952263|NCT00428792|12123885|FG001|NOT COMPLETED|Overall Study||4
10952264|NCT00428844|12123894|FG000|STARTED|Completed Study Drug Treatment||25
10952265|NCT00428844|12123895|FG001|STARTED|Completed Study Drug Treatment||24
10952266|NCT00428844|12123896|FG002|STARTED|Completed Study Drug Treatment||26
10952267|NCT00428844|12123894|FG000|Received First Dose|Completed Study Drug Treatment||25
10952268|NCT00428844|12123895|FG001|Received First Dose|Completed Study Drug Treatment||24
10952269|NCT00428844|12123896|FG002|Received First Dose|Completed Study Drug Treatment||25
10952270|NCT00428844|12123894|FG000|COMPLETED|Completed Study Drug Treatment||23
10952271|NCT00428844|12123895|FG001|COMPLETED|Completed Study Drug Treatment||18
10952272|NCT00428844|12123896|FG002|COMPLETED|Completed Study Drug Treatment||19
10952273|NCT00428844|12123894|FG000|NOT COMPLETED|Completed Study Drug Treatment||2
10952274|NCT00428844|12123895|FG001|NOT COMPLETED|Completed Study Drug Treatment||6
10952275|NCT00428844|12123896|FG002|NOT COMPLETED|Completed Study Drug Treatment||7
10952276|NCT00428844|12123894|FG000|STARTED|Completed Test of Cure (TOC) Visit||23
10952277|NCT00428844|12123895|FG001|STARTED|Completed Test of Cure (TOC) Visit||18
10952278|NCT00428844|12123896|FG002|STARTED|Completed Test of Cure (TOC) Visit||19
10952279|NCT00428844|12123894|FG000|COMPLETED|Completed Test of Cure (TOC) Visit||20
10952280|NCT00428844|12123895|FG001|COMPLETED|Completed Test of Cure (TOC) Visit||16
10952281|NCT00428844|12123896|FG002|COMPLETED|Completed Test of Cure (TOC) Visit||17
10952282|NCT00428844|12123894|FG000|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
10952283|NCT00428844|12123895|FG001|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
10952284|NCT00428844|12123896|FG002|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
10952285|NCT00428922|12123904|FG000|STARTED|Overall Study||26
10952286|NCT00428922|12123904|FG000|COMPLETED|Overall Study||26
10952287|NCT00428922|12123904|FG000|NOT COMPLETED|Overall Study||0
10952288|NCT00428948|12123910|FG000|STARTED|Overall Study||961
10952289|NCT00428948|12123911|FG001|STARTED|Overall Study||484
10952290|NCT00428948|12123910|FG000|Received Treatment|Overall Study||961
10952291|NCT00428948|12123911|FG001|Received Treatment|Overall Study||483
10952292|NCT00428948|12123910|FG000|COMPLETED|Overall Study||740
10952293|NCT00428948|12123911|FG001|COMPLETED|Overall Study||417
10952294|NCT00428948|12123910|FG000|NOT COMPLETED|Overall Study||221
10952295|NCT00428948|12123911|FG001|NOT COMPLETED|Overall Study||67
10952296|NCT00428974|12123921|FG000|STARTED|Overall Study|one patient was randomized but never received study treatment|25
10952297|NCT00428974|12123922|FG001|STARTED|Overall Study||17
10952298|NCT00428974|12123923|FG002|STARTED|Overall Study||15
10952299|NCT00428974|12123924|FG003|STARTED|Overall Study||19
10952300|NCT00428974|12123921|FG000|COMPLETED|Overall Study||17
10952301|NCT00428974|12123922|FG001|COMPLETED|Overall Study||17
10952302|NCT00428974|12123923|FG002|COMPLETED|Overall Study||14
10952303|NCT00428974|12123924|FG003|COMPLETED|Overall Study||16
10952304|NCT00428974|12123921|FG000|NOT COMPLETED|Overall Study||8
10952305|NCT00428974|12123922|FG001|NOT COMPLETED|Overall Study||0
10952306|NCT00428974|12123923|FG002|NOT COMPLETED|Overall Study||1
10952307|NCT00428974|12123924|FG003|NOT COMPLETED|Overall Study||3
10952308|NCT00429104|12123935|FG000|STARTED|Overall Study||18
10952309|NCT00429104|12123935|FG000|COMPLETED|Overall Study||17
10952310|NCT00429104|12123935|FG000|NOT COMPLETED|Overall Study||1
10952311|NCT00429143|12123939|FG000|STARTED|Overall Study||27
10952312|NCT00429143|12123939|FG000|COMPLETED|Overall Study||27
10952313|NCT00429143|12123939|FG000|NOT COMPLETED|Overall Study||0
10952314|NCT00429169|12123945|FG000|STARTED|Overall Study||38
10952315|NCT00429169|12123946|FG001|STARTED|Overall Study||40
10952316|NCT00429169|12123945|FG000|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
10952317|NCT00429169|12123946|FG001|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
10952318|NCT00429169|12123945|FG000|NOT COMPLETED|Overall Study||2
10952319|NCT00429169|12123946|FG001|NOT COMPLETED|Overall Study||2
10952320|NCT00429182|12123954|FG000|STARTED|Overall Study||32
10952321|NCT00429182|12123954|FG000|COMPLETED|Overall Study||25
10952322|NCT00429182|12123954|FG000|NOT COMPLETED|Overall Study||7
10952323|NCT00429273|12123961|FG000|STARTED|Overall Study||68
10952324|NCT00429273|12123962|FG001|STARTED|Overall Study||69
10952325|NCT00429273|12123963|FG002|STARTED|Overall Study||70
10952326|NCT00429273|12123961|FG000|COMPLETED|Overall Study||60
10952327|NCT00429273|12123962|FG001|COMPLETED|Overall Study||61
10952328|NCT00429273|12123963|FG002|COMPLETED|Overall Study||61
10952329|NCT00429273|12123961|FG000|NOT COMPLETED|Overall Study||8
10952330|NCT00429273|12123962|FG001|NOT COMPLETED|Overall Study||8
10952331|NCT00429273|12123963|FG002|NOT COMPLETED|Overall Study||9
10952332|NCT00429299|12123974|FG000|STARTED|Overall Study||36
10952333|NCT00429299|12123975|FG001|STARTED|Overall Study||39
10952334|NCT00429299|12123976|FG002|STARTED|Overall Study||46
10952335|NCT00429299|12123974|FG000|COMPLETED|Overall Study||32
10952336|NCT00429299|12123975|FG001|COMPLETED|Overall Study||32
10952337|NCT00429299|12123976|FG002|COMPLETED|Overall Study||42
10952338|NCT00429299|12123974|FG000|NOT COMPLETED|Overall Study||4
10952339|NCT00429299|12123975|FG001|NOT COMPLETED|Overall Study||7
10952340|NCT00429299|12123976|FG002|NOT COMPLETED|Overall Study||4
10952341|NCT00429364|12123986|FG000|STARTED|Overall Study||303
10952342|NCT00429364|12123987|FG001|STARTED|Overall Study||305
10952343|NCT00429364|12123986|FG000|COMPLETED|Overall Study||271
10952344|NCT00429364|12123987|FG001|COMPLETED|Overall Study||272
10952345|NCT00429364|12123986|FG000|NOT COMPLETED|Overall Study||32
10952346|NCT00429364|12123987|FG001|NOT COMPLETED|Overall Study||33
10952347|NCT00429403|12123995|FG000|STARTED|Overall Study||1
10952348|NCT00429403|12123996|FG001|STARTED|Overall Study||0
10952349|NCT00429403|12123995|FG000|COMPLETED|Overall Study||1
10952350|NCT00429403|12123996|FG001|COMPLETED|Overall Study||0
10952351|NCT00429403|12123995|FG000|NOT COMPLETED|Overall Study||0
10952352|NCT00429403|12123996|FG001|NOT COMPLETED|Overall Study||0
10952353|NCT00429416|12124002|FG000|STARTED|Overall Study||14
10952354|NCT00429416|12124002|FG000|COMPLETED|Overall Study||13
10952355|NCT00429416|12124002|FG000|NOT COMPLETED|Overall Study||1
10952356|NCT00429494|12124006|FG000|STARTED|Overall Study||59
10952357|NCT00429494|12124006|FG000|COMPLETED|Overall Study||44
10952358|NCT00429494|12124006|FG000|NOT COMPLETED|Overall Study||15
10952359|NCT00429507|12124010|FG000|STARTED|Overall Study||12
10952360|NCT00429507|12124010|FG000|COMPLETED|Overall Study||12
10952361|NCT00429507|12124010|FG000|NOT COMPLETED|Overall Study||0
10952362|NCT00429572|12124014|FG000|STARTED|Overall Study||19
10952363|NCT00429572|12124014|FG000|COMPLETED|Overall Study||18
10952364|NCT00429572|12124014|FG000|NOT COMPLETED|Overall Study||1
10952365|NCT00429585|12124020|FG000|STARTED|Overall Study||52
10952366|NCT00429585|12124021|FG001|STARTED|Overall Study||47
10952367|NCT00429585|12124020|FG000|COMPLETED|Overall Study||22
10952368|NCT00429585|12124021|FG001|COMPLETED|Overall Study||27
10952369|NCT00429585|12124020|FG000|NOT COMPLETED|Overall Study||30
10952370|NCT00429585|12124021|FG001|NOT COMPLETED|Overall Study||20
10952371|NCT00429663|12124029|FG000|STARTED|Overall Study||76
10952372|NCT00429663|12124030|FG001|STARTED|Overall Study||80
10952373|NCT00429663|12124029|FG000|COMPLETED|Overall Study||40
10952374|NCT00429663|12124030|FG001|COMPLETED|Overall Study||41
10952375|NCT00429663|12124029|FG000|NOT COMPLETED|Overall Study||36
10952376|NCT00429663|12124030|FG001|NOT COMPLETED|Overall Study||39
10952377|NCT00429702|12124038|FG000|STARTED|Overall Study||3
10952378|NCT00429702|12124039|FG001|STARTED|Overall Study||4
10952379|NCT00429702|12124038|FG000|COMPLETED|Overall Study||3
10952380|NCT00429702|12124039|FG001|COMPLETED|Overall Study||4
10952381|NCT00429702|12124038|FG000|NOT COMPLETED|Overall Study||0
10952382|NCT00429702|12124039|FG001|NOT COMPLETED|Overall Study||0
10952383|NCT00429793|12124045|FG000|STARTED|Overall Study||60
10952384|NCT00429793|12124045|FG000|COMPLETED|Overall Study||54
10952385|NCT00429793|12124045|FG000|NOT COMPLETED|Overall Study||6
10952386|NCT00429949|12124054|FG000|STARTED|Overall Study||21
10952387|NCT00429949|12124054|FG000|COMPLETED|Overall Study||21
10952388|NCT00429949|12124054|FG000|NOT COMPLETED|Overall Study||0
10952389|NCT00430183|12124062|FG000|STARTED|Overall Study||391
10952390|NCT00430183|12124063|FG001|STARTED|Overall Study||397
10952391|NCT00430183|12124062|FG000|COMPLETED|Overall Study||391
10952392|NCT00430183|12124063|FG001|COMPLETED|Overall Study||397
10952393|NCT00430183|12124062|FG000|NOT COMPLETED|Overall Study||0
10952394|NCT00430183|12124063|FG001|NOT COMPLETED|Overall Study||0
10952395|NCT00430248|12124072|FG000|STARTED|Overall Study||757
10952396|NCT00430248|12124073|FG001|STARTED|Overall Study||756
10952397|NCT00430248|12124074|FG002|STARTED|Overall Study||756
10952398|NCT00430248|12124072|FG000|COMPLETED|Overall Study||632
10952399|NCT00430248|12124073|FG001|COMPLETED|Overall Study||598
10952400|NCT00430248|12124074|FG002|COMPLETED|Overall Study||621
10952401|NCT00430248|12124072|FG000|NOT COMPLETED|Overall Study||125
10952402|NCT00430248|12124073|FG001|NOT COMPLETED|Overall Study||158
10952403|NCT00430248|12124074|FG002|NOT COMPLETED|Overall Study||135
10952404|NCT00430300|12124086|FG000|STARTED|Overall Study||17
10952405|NCT00430300|12124087|FG001|STARTED|Overall Study||18
10952406|NCT00430300|12124088|FG002|STARTED|Overall Study||35
10952407|NCT00430300|12124089|FG003|STARTED|Overall Study||17
10952408|NCT00430300|12124086|FG000|COMPLETED|Overall Study||15
10952409|NCT00430300|12124087|FG001|COMPLETED|Overall Study||16
10952410|NCT00430300|12124088|FG002|COMPLETED|Overall Study||29
10952411|NCT00430300|12124089|FG003|COMPLETED|Overall Study||15
10952412|NCT00430300|12124086|FG000|NOT COMPLETED|Overall Study||2
10952413|NCT00430300|12124087|FG001|NOT COMPLETED|Overall Study||2
10952414|NCT00430300|12124088|FG002|NOT COMPLETED|Overall Study||6
10952415|NCT00430300|12124089|FG003|NOT COMPLETED|Overall Study||2
10952416|NCT00430352|12124099|FG000|STARTED|Overall Study||545
10952417|NCT00430352|12124099|FG000|COMPLETED|Overall Study||407
10952418|NCT00430352|12124099|FG000|NOT COMPLETED|Overall Study||138
10952419|NCT00430482|12124105|FG000|STARTED|Completed Treatment||41
10952420|NCT00430482|12124106|FG001|STARTED|Completed Treatment||37
10952421|NCT00430482|12124105|FG000|Completed ASI at Midpoint|Completed Treatment||35
10952422|NCT00430482|12124106|FG001|Completed ASI at Midpoint|Completed Treatment||29
10952423|NCT00430482|12124105|FG000|COMPLETED|Completed Treatment||34
10952424|NCT00430482|12124106|FG001|COMPLETED|Completed Treatment||26
10952425|NCT00430482|12124105|FG000|NOT COMPLETED|Completed Treatment||7
10952426|NCT00430482|12124106|FG001|NOT COMPLETED|Completed Treatment||11
10952427|NCT00430482|12124105|FG000|STARTED|Completed 2 Follow-Up Visits||34
10952428|NCT00430482|12124106|FG001|STARTED|Completed 2 Follow-Up Visits||26
10952429|NCT00430482|12124105|FG000|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27
10952430|NCT00430482|12124106|FG001|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20
10952431|NCT00430482|12124105|FG000|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29
10952432|NCT00430482|12124106|FG001|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20
10952433|NCT00430482|12124105|FG000|COMPLETED|Completed 2 Follow-Up Visits||29
10952434|NCT00430482|12124106|FG001|COMPLETED|Completed 2 Follow-Up Visits||20
10952435|NCT00430482|12124105|FG000|NOT COMPLETED|Completed 2 Follow-Up Visits||5
10952436|NCT00430482|12124106|FG001|NOT COMPLETED|Completed 2 Follow-Up Visits||6
10952437|NCT00430495|12124116|FG000|STARTED|Overall Study||64
10952438|NCT00430495|12124117|FG001|STARTED|Overall Study||66
10952439|NCT00430495|12124118|FG002|STARTED|Overall Study||62
10952440|NCT00430495|12124119|FG003|STARTED|Overall Study||64
10952441|NCT00430495|12124116|FG000|Treated|Overall Study||62
10952442|NCT00430495|12124117|FG001|Treated|Overall Study||66
10952443|NCT00430495|12124118|FG002|Treated|Overall Study||62
10952444|NCT00430495|12124119|FG003|Treated|Overall Study||64
10952445|NCT00430495|12124116|FG000|COMPLETED|Overall Study||50
10952446|NCT00430495|12124117|FG001|COMPLETED|Overall Study||59
10952447|NCT00430495|12124118|FG002|COMPLETED|Overall Study||49
10952448|NCT00430495|12124119|FG003|COMPLETED|Overall Study||60
10952449|NCT00430495|12124116|FG000|NOT COMPLETED|Overall Study||14
10952450|NCT00430495|12124117|FG001|NOT COMPLETED|Overall Study||7
10952451|NCT00430495|12124118|FG002|NOT COMPLETED|Overall Study||13
10952452|NCT00430495|12124119|FG003|NOT COMPLETED|Overall Study||4
10952453|NCT00430521|12124137|FG000|STARTED|Overall Study||63
10952454|NCT00430521|12124138|FG001|STARTED|Overall Study||66
10952455|NCT00430521|12124139|FG002|STARTED|Overall Study||64
10952456|NCT00430521|12124140|FG003|STARTED|Overall Study||63
10952457|NCT00430521|12124141|FG004|STARTED|Overall Study||64
10952458|NCT00430521|12124142|FG005|STARTED|Overall Study||64
10952459|NCT00430521|12124143|FG006|STARTED|Overall Study||65
10952460|NCT00430521|12124144|FG007|STARTED|Overall Study||63
10952461|NCT00430521|12124137|FG000|COMPLETED|Overall Study||52
10952462|NCT00430521|12124138|FG001|COMPLETED|Overall Study||57
10952463|NCT00430521|12124139|FG002|COMPLETED|Overall Study||61
10952464|NCT00430521|12124140|FG003|COMPLETED|Overall Study||55
10952465|NCT00430521|12124141|FG004|COMPLETED|Overall Study||59
10952466|NCT00430521|12124142|FG005|COMPLETED|Overall Study||59
10952467|NCT00430521|12124143|FG006|COMPLETED|Overall Study||55
10952468|NCT00430521|12124144|FG007|COMPLETED|Overall Study||51
10952469|NCT00430521|12124137|FG000|NOT COMPLETED|Overall Study||11
10952470|NCT00430521|12124138|FG001|NOT COMPLETED|Overall Study||9
10952471|NCT00430521|12124139|FG002|NOT COMPLETED|Overall Study||3
10952472|NCT00430521|12124140|FG003|NOT COMPLETED|Overall Study||8
10952473|NCT00430521|12124141|FG004|NOT COMPLETED|Overall Study||5
10952474|NCT00430521|12124142|FG005|NOT COMPLETED|Overall Study||5
10952475|NCT00430521|12124143|FG006|NOT COMPLETED|Overall Study||10
10952476|NCT00430521|12124144|FG007|NOT COMPLETED|Overall Study||12
10952477|NCT00430573|12124175|FG000|STARTED|Overall Study||10
10952478|NCT00430573|12124175|FG000|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
10952479|NCT00430573|12124175|FG000|NOT COMPLETED|Overall Study||5
10952480|NCT00430625|12124182|FG000|STARTED|Overall Study||13
10952481|NCT00430625|12124183|FG001|STARTED|Overall Study||12
10952482|NCT00430625|12124182|FG000|COMPLETED|Overall Study||13
10952483|NCT00430625|12124183|FG001|COMPLETED|Overall Study||12
10952484|NCT00430625|12124182|FG000|NOT COMPLETED|Overall Study||0
10952485|NCT00430625|12124183|FG001|NOT COMPLETED|Overall Study||0
10952486|NCT00430638|12124192|FG000|STARTED|Overall Study||138
10952487|NCT00430638|12124193|FG001|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
10952488|NCT00430638|12124192|FG000|COMPLETED|Overall Study||60
10952489|NCT00430638|12124193|FG001|COMPLETED|Overall Study||92
10952490|NCT00430638|12124192|FG000|NOT COMPLETED|Overall Study||78
10952491|NCT00430638|12124193|FG001|NOT COMPLETED|Overall Study||48
10952492|NCT00430677|12124206|FG000|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
10952493|NCT00430677|12124207|FG001|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
10952494|NCT00430677|12124208|FG002|STARTED|Short-term Period||100
10952495|NCT00430677|12124206|FG000|COMPLETED|Short-term Period|Completed the short-term period|76
10952496|NCT00430677|12124207|FG001|COMPLETED|Short-term Period|Completed the short-term period|74
10952497|NCT00430677|12124208|FG002|COMPLETED|Short-term Period|Completed the short-term period|78
10952498|NCT00430677|12124206|FG000|NOT COMPLETED|Short-term Period||23
10952499|NCT00430677|12124207|FG001|NOT COMPLETED|Short-term Period||25
10952500|NCT00430677|12124208|FG002|NOT COMPLETED|Short-term Period||22
10952501|NCT00430677|12124206|FG000|STARTED|Long-term Extension Period||70
10952502|NCT00430677|12124207|FG001|STARTED|Long-term Extension Period||67
10952503|NCT00430677|12124208|FG002|STARTED|Long-term Extension Period||74
10952504|NCT00430677|12124206|FG000|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
10952505|NCT00430677|12124207|FG001|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
10952506|NCT00430677|12124208|FG002|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
10952507|NCT00430677|12124206|FG000|NOT COMPLETED|Long-term Extension Period||60
10952508|NCT00430677|12124207|FG001|NOT COMPLETED|Long-term Extension Period||58
10952509|NCT00430677|12124208|FG002|NOT COMPLETED|Long-term Extension Period||63
10952510|NCT00430716|12124237|FG000|STARTED|Double Blind Phase||42
10952511|NCT00430716|12124238|FG001|STARTED|Double Blind Phase||43
10952512|NCT00430716|12124239|FG002|STARTED|Double Blind Phase||45
10952513|NCT00430716|12124237|FG000|Treated|Double Blind Phase||41
10952514|NCT00430716|12124238|FG001|Treated|Double Blind Phase||43
10952515|NCT00430716|12124239|FG002|Treated|Double Blind Phase||45
10952516|NCT00430716|12124237|FG000|COMPLETED|Double Blind Phase||36
10952517|NCT00430716|12124238|FG001|COMPLETED|Double Blind Phase||38
10952518|NCT00430716|12124239|FG002|COMPLETED|Double Blind Phase||39
10952519|NCT00430716|12124237|FG000|NOT COMPLETED|Double Blind Phase||6
10952520|NCT00430716|12124238|FG001|NOT COMPLETED|Double Blind Phase||5
10952521|NCT00430716|12124239|FG002|NOT COMPLETED|Double Blind Phase||6
10952522|NCT00430716|12124237|FG000|STARTED|Open Label Phase||36
10952523|NCT00430716|12124238|FG001|STARTED|Open Label Phase||38
10952524|NCT00430716|12124239|FG002|STARTED|Open Label Phase||39
10952525|NCT00430716|12124237|FG000|COMPLETED|Open Label Phase||27
10952526|NCT00430716|12124238|FG001|COMPLETED|Open Label Phase||31
10952527|NCT00430716|12124239|FG002|COMPLETED|Open Label Phase||32
10952528|NCT00430716|12124237|FG000|NOT COMPLETED|Open Label Phase||9
10952529|NCT00430716|12124238|FG001|NOT COMPLETED|Open Label Phase||7
10952530|NCT00430716|12124239|FG002|NOT COMPLETED|Open Label Phase||7
10952531|NCT00430755|12124247|FG000|STARTED|Overall Study||98
10952532|NCT00430755|12124247|FG000|COMPLETED|Overall Study||45
10952533|NCT00430755|12124247|FG000|NOT COMPLETED|Overall Study||53
10952534|NCT00430768|12124254|FG000|STARTED|Overall Study||3
10952535|NCT00430768|12124255|FG001|STARTED|Overall Study||3
10952536|NCT00430768|12124256|FG002|STARTED|Overall Study||3
10952537|NCT00430768|12124254|FG000|COMPLETED|Overall Study||3
10952538|NCT00430768|12124255|FG001|COMPLETED|Overall Study||3
10952539|NCT00430768|12124256|FG002|COMPLETED|Overall Study||3
10952540|NCT00430768|12124254|FG000|NOT COMPLETED|Overall Study||0
10952541|NCT00430768|12124255|FG001|NOT COMPLETED|Overall Study||0
10952542|NCT00430768|12124256|FG002|NOT COMPLETED|Overall Study||0
10952543|NCT00430781|12124273|FG000|STARTED|Interim Analysis; 11 February 2008||59
10952544|NCT00430781|12124274|FG001|STARTED|Interim Analysis; 11 February 2008||58
10952545|NCT00430781|12124275|FG002|STARTED|Interim Analysis; 11 February 2008||60
10952546|NCT00430781|12124273|FG000|Ongoing|Interim Analysis; 11 February 2008||23
10952547|NCT00430781|12124274|FG001|Ongoing|Interim Analysis; 11 February 2008||20
10952548|NCT00430781|12124275|FG002|Ongoing|Interim Analysis; 11 February 2008||25
10952549|NCT00430781|12124273|FG000|COMPLETED|Interim Analysis; 11 February 2008||0
10952550|NCT00430781|12124274|FG001|COMPLETED|Interim Analysis; 11 February 2008||0
10952551|NCT00430781|12124275|FG002|COMPLETED|Interim Analysis; 11 February 2008||0
10952552|NCT00430781|12124273|FG000|NOT COMPLETED|Interim Analysis; 11 February 2008||59
10952553|NCT00430781|12124274|FG001|NOT COMPLETED|Interim Analysis; 11 February 2008||58
10952554|NCT00430781|12124275|FG002|NOT COMPLETED|Interim Analysis; 11 February 2008||60
10952555|NCT00430781|12124273|FG000|STARTED|Final Analysis; 31 July 2008||0
10952556|NCT00430781|12124274|FG001|STARTED|Final Analysis; 31 July 2008||78
10952557|NCT00430781|12124275|FG002|STARTED|Final Analysis; 31 July 2008||74
10952558|NCT00430781|12124273|FG000|Ongoing|Final Analysis; 31 July 2008||0
10952559|NCT00430781|12124274|FG001|Ongoing|Final Analysis; 31 July 2008||29
10952560|NCT00430781|12124275|FG002|Ongoing|Final Analysis; 31 July 2008||32
10952561|NCT00430781|12124273|FG000|COMPLETED|Final Analysis; 31 July 2008||0
10952562|NCT00430781|12124274|FG001|COMPLETED|Final Analysis; 31 July 2008||39
10952563|NCT00430781|12124275|FG002|COMPLETED|Final Analysis; 31 July 2008||26
10952564|NCT00430781|12124273|FG000|NOT COMPLETED|Final Analysis; 31 July 2008||0
10952565|NCT00430781|12124274|FG001|NOT COMPLETED|Final Analysis; 31 July 2008||39
10952566|NCT00430781|12124275|FG002|NOT COMPLETED|Final Analysis; 31 July 2008||48
10952567|NCT00430781|12124273|FG000|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
10952568|NCT00430781|12124274|FG001|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
10952569|NCT00430781|12124275|FG002|STARTED|End-of-Study Analysis; 28 July 2011||74
10952570|NCT00430781|12124273|FG000|COMPLETED|End-of-Study Analysis; 28 July 2011||53
10952571|NCT00430781|12124274|FG001|COMPLETED|End-of-Study Analysis; 28 July 2011||59
10952572|NCT00430781|12124275|FG002|COMPLETED|End-of-Study Analysis; 28 July 2011||54
10952573|NCT00430781|12124273|FG000|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
10952574|NCT00430781|12124274|FG001|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
10952575|NCT00430781|12124275|FG002|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
10952576|NCT00430937|12124288|FG000|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
10952577|NCT00430937|12124289|FG001|STARTED|Overall Study||92
10952578|NCT00430937|12124288|FG000|COMPLETED|Overall Study||70
10952579|NCT00430937|12124289|FG001|COMPLETED|Overall Study||64
10952580|NCT00430937|12124288|FG000|NOT COMPLETED|Overall Study||27
10952581|NCT00430937|12124289|FG001|NOT COMPLETED|Overall Study||28
10952582|NCT00430989|12124297|FG000|STARTED|Overall Study||3543
10952583|NCT00430989|12124298|FG001|STARTED|Overall Study||3569
10952584|NCT00430989|12124297|FG000|COMPLETED|Overall Study||3483
10952585|NCT00430989|12124298|FG001|COMPLETED|Overall Study||3509
10952586|NCT00430989|12124297|FG000|NOT COMPLETED|Overall Study||60
10952587|NCT00430989|12124298|FG001|NOT COMPLETED|Overall Study||60
10952588|NCT00431041|12124308|FG000|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
10952589|NCT00431041|12124309|FG001|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
10952590|NCT00431041|12124308|FG000|COMPLETED|Overall Study||52
10952591|NCT00431041|12124309|FG001|COMPLETED|Overall Study||40
10952592|NCT00431041|12124308|FG000|NOT COMPLETED|Overall Study||16
10952593|NCT00431041|12124309|FG001|NOT COMPLETED|Overall Study||24
10952594|NCT00431067|12124315|FG000|STARTED|Overall Study|52 patients screened, 41 treated|41
10952595|NCT00431067|12124315|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
10952596|NCT00431067|12124315|FG000|NOT COMPLETED|Overall Study||41
10952597|NCT00431132|12124319|FG000|STARTED|Overall Study||336
10952598|NCT00431132|12124319|FG000|COMPLETED|Overall Study||292
10952599|NCT00431132|12124319|FG000|NOT COMPLETED|Overall Study||44
10952600|NCT00431184|12124325|FG000|STARTED|1st Intervention (Day 1)||10
10952601|NCT00431184|12124326|FG001|STARTED|1st Intervention (Day 1)||9
10952602|NCT00431184|12124325|FG000|COMPLETED|1st Intervention (Day 1)||10
10952603|NCT00431184|12124326|FG001|COMPLETED|1st Intervention (Day 1)||9
10952604|NCT00431184|12124325|FG000|NOT COMPLETED|1st Intervention (Day 1)||0
10952605|NCT00431184|12124326|FG001|NOT COMPLETED|1st Intervention (Day 1)||0
10952606|NCT00431184|12124325|FG000|STARTED|Second Intervention (Day 2)||10
10952607|NCT00431184|12124326|FG001|STARTED|Second Intervention (Day 2)||9
10952608|NCT00431184|12124325|FG000|COMPLETED|Second Intervention (Day 2)||10
10952609|NCT00431184|12124326|FG001|COMPLETED|Second Intervention (Day 2)||9
10952610|NCT00431184|12124325|FG000|NOT COMPLETED|Second Intervention (Day 2)||0
10952611|NCT00431184|12124326|FG001|NOT COMPLETED|Second Intervention (Day 2)||0
10952612|NCT00431444|12124336|FG000|STARTED|Overall Study||56
10952613|NCT00431444|12124337|FG001|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
10952614|NCT00431444|12124336|FG000|COMPLETED|Overall Study||51
10952615|NCT00431444|12124337|FG001|COMPLETED|Overall Study||46
10952616|NCT00431444|12124336|FG000|NOT COMPLETED|Overall Study||5
10952617|NCT00431444|12124337|FG001|NOT COMPLETED|Overall Study||7
10952618|NCT00431496|12124343|FG000|STARTED|Overall Study||71
10952619|NCT00431496|12124343|FG000|COMPLETED|Overall Study||60
10952620|NCT00431496|12124343|FG000|NOT COMPLETED|Overall Study||11
10952621|NCT00431626|12124349|FG000|STARTED|Overall Study||4
10952622|NCT00431626|12124350|FG001|STARTED|Overall Study||0
10952623|NCT00431626|12124349|FG000|COMPLETED|Overall Study||4
10952624|NCT00431626|12124350|FG001|COMPLETED|Overall Study||0
10952625|NCT00431626|12124349|FG000|NOT COMPLETED|Overall Study||0
10952626|NCT00431626|12124350|FG001|NOT COMPLETED|Overall Study||0
10952627|NCT00431834|12124356|FG000|STARTED|Overall Study||75
10952628|NCT00431834|12124356|FG000|COMPLETED|Overall Study||62
10952629|NCT00431834|12124356|FG000|NOT COMPLETED|Overall Study||13
10952630|NCT00431847|12124367|FG000|STARTED|Overall Study||132
10952631|NCT00431847|12124368|FG001|STARTED|Overall Study||45
10952632|NCT00431847|12124369|FG002|STARTED|Overall Study||24
10952633|NCT00431847|12124370|FG003|STARTED|Overall Study||184
10952634|NCT00431847|12124371|FG004|STARTED|Overall Study||1
10952635|NCT00431847|12124367|FG000|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
10952636|NCT00431847|12124368|FG001|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
10952637|NCT00431847|12124369|FG002|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
10952638|NCT00431847|12124370|FG003|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
10952639|NCT00431847|12124371|FG004|COMPLETED|Overall Study||0
10952640|NCT00431847|12124367|FG000|NOT COMPLETED|Overall Study||6
10952641|NCT00431847|12124368|FG001|NOT COMPLETED|Overall Study||3
10952642|NCT00431847|12124369|FG002|NOT COMPLETED|Overall Study||4
10952643|NCT00431847|12124370|FG003|NOT COMPLETED|Overall Study||14
10952644|NCT00431847|12124371|FG004|NOT COMPLETED|Overall Study||1
10952645|NCT00431951|12124385|FG000|STARTED|Overall Study||8
10952646|NCT00431951|12124386|FG001|STARTED|Overall Study||8
10952647|NCT00431951|12124387|FG002|STARTED|Overall Study||8
10952648|NCT00431951|12124388|FG003|STARTED|Overall Study||6
10952649|NCT00431951|12124385|FG000|COMPLETED|Overall Study||7
10952650|NCT00431951|12124386|FG001|COMPLETED|Overall Study||6
10952651|NCT00431951|12124387|FG002|COMPLETED|Overall Study||6
10952652|NCT00431951|12124388|FG003|COMPLETED|Overall Study||4
10952653|NCT00431951|12124385|FG000|NOT COMPLETED|Overall Study||1
10952654|NCT00431951|12124386|FG001|NOT COMPLETED|Overall Study||2
10952655|NCT00431951|12124387|FG002|NOT COMPLETED|Overall Study||2
10952656|NCT00431951|12124388|FG003|NOT COMPLETED|Overall Study||2
10952657|NCT00431964|12124404|FG000|STARTED|Overall Study||131
10952658|NCT00431964|12124405|FG001|STARTED|Overall Study||132
10952659|NCT00431964|12124404|FG000|Randomized/Received Drug|Overall Study||131
10952660|NCT00431964|12124405|FG001|Randomized/Received Drug|Overall Study||129
10952661|NCT00431964|12124404|FG000|Did Not Receive Drug|Overall Study||0
10952662|NCT00431964|12124405|FG001|Did Not Receive Drug|Overall Study||3
10952663|NCT00431964|12124404|FG000|Withdrew From Study|Overall Study||6
10952664|NCT00431964|12124405|FG001|Withdrew From Study|Overall Study||5
10952665|NCT00431964|12124404|FG000|COMPLETED|Overall Study||125
10952666|NCT00431964|12124405|FG001|COMPLETED|Overall Study||124
10952667|NCT00431964|12124404|FG000|NOT COMPLETED|Overall Study||6
10952668|NCT00431964|12124405|FG001|NOT COMPLETED|Overall Study||8
10952669|NCT00432042|12124414|FG000|STARTED|Overall Study|Number randomized.|479
10952670|NCT00432042|12124415|FG001|STARTED|Overall Study|Number randomized.|235
10952671|NCT00432042|12124416|FG002|STARTED|Overall Study|Number randomized.|241
10952672|NCT00432042|12124414|FG000|Vaccinated|Overall Study||477
10952673|NCT00432042|12124415|FG001|Vaccinated|Overall Study||235
10952674|NCT00432042|12124416|FG002|Vaccinated|Overall Study||240
10952675|NCT00432042|12124414|FG000|COMPLETED|Overall Study||472
10952676|NCT00432042|12124415|FG001|COMPLETED|Overall Study||234
10952677|NCT00432042|12124416|FG002|COMPLETED|Overall Study||239
10952678|NCT00432042|12124414|FG000|NOT COMPLETED|Overall Study||7
10952679|NCT00432042|12124415|FG001|NOT COMPLETED|Overall Study||1
10952680|NCT00432042|12124416|FG002|NOT COMPLETED|Overall Study||2
10952681|NCT00432159|12124429|FG000|STARTED|Overall Study||185
10952682|NCT00432159|12124430|FG001|STARTED|Overall Study||167
10952683|NCT00432159|12124431|FG002|STARTED|Overall Study||39
10952684|NCT00432159|12124432|FG003|STARTED|Overall Study||20
10952685|NCT00432159|12124433|FG004|STARTED|Overall Study||89
10952686|NCT00432159|12124429|FG000|COMPLETED|Overall Study|Actual (Complete efficacy)|163
10952687|NCT00432159|12124430|FG001|COMPLETED|Overall Study|Actual (Complete efficacy)|137
10952688|NCT00432159|12124431|FG002|COMPLETED|Overall Study|Actual (Complete efficacy)|35
10952689|NCT00432159|12124432|FG003|COMPLETED|Overall Study|Actual (Complete efficacy)|15
10952690|NCT00432159|12124433|FG004|COMPLETED|Overall Study|Actual (Complete efficacy)|79
10952691|NCT00432159|12124429|FG000|NOT COMPLETED|Overall Study||22
10952692|NCT00432159|12124430|FG001|NOT COMPLETED|Overall Study||30
10952693|NCT00432159|12124431|FG002|NOT COMPLETED|Overall Study||4
10952694|NCT00432159|12124432|FG003|NOT COMPLETED|Overall Study||5
10952695|NCT00432159|12124433|FG004|NOT COMPLETED|Overall Study||10
10952696|NCT00432172|12124449|FG000|STARTED|Overall Study||47
10952697|NCT00432172|12124450|FG001|STARTED|Overall Study||48
10952698|NCT00432172|12124451|FG002|STARTED|Overall Study||46
10952699|NCT00432172|12124452|FG003|STARTED|Overall Study||48
10952700|NCT00432172|12124449|FG000|COMPLETED|Overall Study||41
10952701|NCT00432172|12124450|FG001|COMPLETED|Overall Study||41
10952702|NCT00432172|12124451|FG002|COMPLETED|Overall Study||35
10952703|NCT00432172|12124452|FG003|COMPLETED|Overall Study||41
10952704|NCT00432172|12124449|FG000|NOT COMPLETED|Overall Study||6
10952705|NCT00432172|12124450|FG001|NOT COMPLETED|Overall Study||7
10952706|NCT00432172|12124451|FG002|NOT COMPLETED|Overall Study||11
10952707|NCT00432172|12124452|FG003|NOT COMPLETED|Overall Study||7
10952708|NCT00432237|12124468|FG000|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
10952709|NCT00432237|12124469|FG001|STARTED|Overall Study||485
10952792|NCT00432679|12124552|FG001|NOT COMPLETED|Overall Study||3
10952710|NCT00432237|12124470|FG002|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
10952711|NCT00432237|12124471|FG003|STARTED|Overall Study||490
10952712|NCT00432237|12124468|FG000|Completed--With Data|Overall Study||176
10952713|NCT00432237|12124469|FG001|Completed--With Data|Overall Study||381
10952714|NCT00432237|12124470|FG002|Completed--With Data|Overall Study||370
10952715|NCT00432237|12124471|FG003|Completed--With Data|Overall Study||365
10952716|NCT00432237|12124468|FG000|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
10952717|NCT00432237|12124469|FG001|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
10952718|NCT00432237|12124470|FG002|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
10952719|NCT00432237|12124471|FG003|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
10952720|NCT00432237|12124468|FG000|COMPLETED|Overall Study||177
10952721|NCT00432237|12124469|FG001|COMPLETED|Overall Study||384
10952722|NCT00432237|12124470|FG002|COMPLETED|Overall Study||375
10952723|NCT00432237|12124471|FG003|COMPLETED|Overall Study||366
10952724|NCT00432237|12124468|FG000|NOT COMPLETED|Overall Study||67
10952725|NCT00432237|12124469|FG001|NOT COMPLETED|Overall Study||101
10952726|NCT00432237|12124470|FG002|NOT COMPLETED|Overall Study||109
10952727|NCT00432237|12124471|FG003|NOT COMPLETED|Overall Study||124
10952728|NCT00432276|12124483|FG000|STARTED|Overall Study||404
10952729|NCT00432276|12124484|FG001|STARTED|Overall Study||399
10952730|NCT00432276|12124483|FG000|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
10952731|NCT00432276|12124484|FG001|Per Protocol Set|Overall Study||306
10952732|NCT00432276|12124483|FG000|COMPLETED|Overall Study||283
10952733|NCT00432276|12124484|FG001|COMPLETED|Overall Study||243
10952734|NCT00432276|12124483|FG000|NOT COMPLETED|Overall Study||121
10952735|NCT00432276|12124484|FG001|NOT COMPLETED|Overall Study||156
10952736|NCT00432341|12124492|FG000|STARTED|Overall Study||24
10952737|NCT00432341|12124493|FG001|STARTED|Overall Study||30
10952738|NCT00432341|12124492|FG000|COMPLETED|Overall Study||24
10952739|NCT00432341|12124493|FG001|COMPLETED|Overall Study||30
10952740|NCT00432341|12124492|FG000|NOT COMPLETED|Overall Study||0
10952741|NCT00432341|12124493|FG001|NOT COMPLETED|Overall Study||0
10952742|NCT00432380|12124502|FG000|STARTED|Overall Study||150
10952743|NCT00432380|12124503|FG001|STARTED|Overall Study||150
10952744|NCT00432380|12124504|FG002|STARTED|Overall Study||75
10952745|NCT00432380|12124502|FG000|COMPLETED|Overall Study||146
10952746|NCT00432380|12124503|FG001|COMPLETED|Overall Study||146
10952747|NCT00432380|12124504|FG002|COMPLETED|Overall Study||74
10952748|NCT00432380|12124502|FG000|NOT COMPLETED|Overall Study||4
10952749|NCT00432380|12124503|FG001|NOT COMPLETED|Overall Study||4
10952750|NCT00432380|12124504|FG002|NOT COMPLETED|Overall Study||1
10952751|NCT00432458|12124515|FG000|STARTED|Overall Study||35
10952752|NCT00432458|12124516|FG001|STARTED|Overall Study||33
10952753|NCT00432458|12124515|FG000|COMPLETED|Overall Study||30
10952754|NCT00432458|12124516|FG001|COMPLETED|Overall Study||32
10952755|NCT00432458|12124515|FG000|NOT COMPLETED|Overall Study||5
10952756|NCT00432458|12124516|FG001|NOT COMPLETED|Overall Study||1
10952757|NCT00432562|12124524|FG000|STARTED|Overall Study||16
10952758|NCT00432562|12124525|FG001|STARTED|Overall Study||15
10952759|NCT00432562|12124524|FG000|COMPLETED|Overall Study||13
10952760|NCT00432562|12124525|FG001|COMPLETED|Overall Study||15
10952761|NCT00432562|12124524|FG000|NOT COMPLETED|Overall Study||3
10952762|NCT00432562|12124525|FG001|NOT COMPLETED|Overall Study||0
10952763|NCT00432601|12124533|FG000|STARTED|Time 1 to Time 2||510
10952764|NCT00432601|12124534|FG001|STARTED|Time 1 to Time 2||512
10952765|NCT00432601|12124533|FG000|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
10952766|NCT00432601|12124534|FG001|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
10952767|NCT00432601|12124533|FG000|NOT COMPLETED|Time 1 to Time 2||369
10952768|NCT00432601|12124534|FG001|NOT COMPLETED|Time 1 to Time 2||368
10952769|NCT00432601|12124533|FG000|STARTED|Time 2 to Time 3||141
10952770|NCT00432601|12124534|FG001|STARTED|Time 2 to Time 3||144
10952771|NCT00432601|12124533|FG000|COMPLETED|Time 2 to Time 3||122
10952772|NCT00432601|12124534|FG001|COMPLETED|Time 2 to Time 3||122
10952773|NCT00432601|12124533|FG000|NOT COMPLETED|Time 2 to Time 3||19
10952774|NCT00432601|12124534|FG001|NOT COMPLETED|Time 2 to Time 3||22
10952775|NCT00432666|12124542|FG000|STARTED|Main Period||73
10952776|NCT00432666|12124543|FG001|STARTED|Main Period||75
10952777|NCT00432666|12124542|FG000|COMPLETED|Main Period||71
10952778|NCT00432666|12124543|FG001|COMPLETED|Main Period||74
10952779|NCT00432666|12124542|FG000|NOT COMPLETED|Main Period||2
10952780|NCT00432666|12124543|FG001|NOT COMPLETED|Main Period||1
10952781|NCT00432666|12124542|FG000|STARTED|Open-Label Extension Period||145
10952782|NCT00432666|12124543|FG001|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
10952783|NCT00432666|12124542|FG000|COMPLETED|Open-Label Extension Period||120
10952784|NCT00432666|12124543|FG001|COMPLETED|Open-Label Extension Period||0
10952785|NCT00432666|12124542|FG000|NOT COMPLETED|Open-Label Extension Period||25
10952786|NCT00432666|12124543|FG001|NOT COMPLETED|Open-Label Extension Period||0
10952787|NCT00432679|12124551|FG000|STARTED|Overall Study||74
10952788|NCT00432679|12124552|FG001|STARTED|Overall Study||75
10952789|NCT00432679|12124551|FG000|COMPLETED|Overall Study||69
10952790|NCT00432679|12124552|FG001|COMPLETED|Overall Study||72
10952791|NCT00432679|12124551|FG000|NOT COMPLETED|Overall Study||5
10952793|NCT00432744|12124560|FG000|STARTED|Months 0-6||12
10952794|NCT00432744|12124561|FG001|STARTED|Months 0-6||12
10952795|NCT00432744|12124560|FG000|COMPLETED|Months 0-6||7
10952796|NCT00432744|12124561|FG001|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
10952797|NCT00432744|12124560|FG000|NOT COMPLETED|Months 0-6||5
10952798|NCT00432744|12124561|FG001|NOT COMPLETED|Months 0-6||4
10952799|NCT00432744|12124560|FG000|STARTED|Months 7 - 12||7
10952800|NCT00432744|12124561|FG001|STARTED|Months 7 - 12||8
10952801|NCT00432744|12124560|FG000|COMPLETED|Months 7 - 12||6
10952802|NCT00432744|12124561|FG001|COMPLETED|Months 7 - 12||7
10952803|NCT00432744|12124560|FG000|NOT COMPLETED|Months 7 - 12||1
10952804|NCT00432744|12124561|FG001|NOT COMPLETED|Months 7 - 12||1
10952805|NCT00432809|12124570|FG000|STARTED|1 Year Follow-up||50
10952806|NCT00432809|12124571|FG001|STARTED|1 Year Follow-up||50
10952807|NCT00432809|12124572|FG002|STARTED|1 Year Follow-up||50
10952808|NCT00432809|12124570|FG000|COMPLETED|1 Year Follow-up||41
10952809|NCT00432809|12124571|FG001|COMPLETED|1 Year Follow-up||50
10952810|NCT00432809|12124572|FG002|COMPLETED|1 Year Follow-up||49
10952811|NCT00432809|12124570|FG000|NOT COMPLETED|1 Year Follow-up||9
10952812|NCT00432809|12124571|FG001|NOT COMPLETED|1 Year Follow-up||0
10952813|NCT00432809|12124572|FG002|NOT COMPLETED|1 Year Follow-up||1
10952814|NCT00432809|12124570|FG000|STARTED|2 Year Sub-study||20
10952815|NCT00432809|12124571|FG001|STARTED|2 Year Sub-study||20
10952816|NCT00432809|12124572|FG002|STARTED|2 Year Sub-study||20
10952817|NCT00432809|12124570|FG000|COMPLETED|2 Year Sub-study||17
10952818|NCT00432809|12124571|FG001|COMPLETED|2 Year Sub-study||18
10952819|NCT00432809|12124572|FG002|COMPLETED|2 Year Sub-study||19
10952820|NCT00432809|12124570|FG000|NOT COMPLETED|2 Year Sub-study||3
10952821|NCT00432809|12124571|FG001|NOT COMPLETED|2 Year Sub-study||2
10952822|NCT00432809|12124572|FG002|NOT COMPLETED|2 Year Sub-study||1
10952823|NCT00432835|12124582|FG000|STARTED|Overall Study||28
10952824|NCT00432835|12124583|FG001|STARTED|Overall Study||30
10952825|NCT00432835|12124582|FG000|Completed 1st Intervention|Overall Study||22
10952826|NCT00432835|12124583|FG001|Completed 1st Intervention|Overall Study||23
10952827|NCT00432835|12124582|FG000|Completed 2nd Intervention|Overall Study||22
10952828|NCT00432835|12124583|FG001|Completed 2nd Intervention|Overall Study||23
10952829|NCT00432835|12124582|FG000|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
10952830|NCT00432835|12124583|FG001|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
10952831|NCT00432835|12124582|FG000|NOT COMPLETED|Overall Study||6
10952832|NCT00432835|12124583|FG001|NOT COMPLETED|Overall Study||7
10952833|NCT00432991|12124591|FG000|STARTED|Overall Study||22
10952834|NCT00432991|12124592|FG001|STARTED|Overall Study||31
10952835|NCT00432991|12124591|FG000|COMPLETED|Overall Study||15
10952836|NCT00432991|12124592|FG001|COMPLETED|Overall Study||19
10952837|NCT00432991|12124591|FG000|NOT COMPLETED|Overall Study||7
10952838|NCT00432991|12124592|FG001|NOT COMPLETED|Overall Study||12
10952839|NCT00433004|12124600|FG000|STARTED|Overall Study||27
10952840|NCT00433004|12124601|FG001|STARTED|Overall Study||23
10952841|NCT00433004|12124600|FG000|COMPLETED|Overall Study||22
10952842|NCT00433004|12124601|FG001|COMPLETED|Overall Study||16
10952843|NCT00433004|12124600|FG000|NOT COMPLETED|Overall Study||5
10952844|NCT00433004|12124601|FG001|NOT COMPLETED|Overall Study||7
10952845|NCT00433017|12124609|FG000|STARTED|Overall Study||122
10952846|NCT00433017|12124610|FG001|STARTED|Overall Study||133
10952847|NCT00433017|12124609|FG000|Completed 12 Month Phase|Overall Study||114
10952848|NCT00433017|12124610|FG001|Completed 12 Month Phase|Overall Study||126
10952849|NCT00433017|12124609|FG000|COMPLETED|Overall Study||26
10952850|NCT00433017|12124610|FG001|COMPLETED|Overall Study||32
10952851|NCT00433017|12124609|FG000|NOT COMPLETED|Overall Study||96
10952852|NCT00433017|12124610|FG001|NOT COMPLETED|Overall Study||101
10952853|NCT00433147|12124620|FG000|STARTED|Overall Study||7
10952854|NCT00433147|12124621|FG001|STARTED|Overall Study||7
10952855|NCT00433147|12124622|FG002|STARTED|Overall Study||9
10952856|NCT00433147|12124623|FG003|STARTED|Overall Study||7
10952857|NCT00433147|12124620|FG000|Safety Population|Overall Study||7
10952858|NCT00433147|12124621|FG001|Safety Population|Overall Study||7
10952859|NCT00433147|12124622|FG002|Safety Population|Overall Study||9
10952860|NCT00433147|12124623|FG003|Safety Population|Overall Study||7
10952861|NCT00433147|12124620|FG000|PD Population|Overall Study||7
10952862|NCT00433147|12124621|FG001|PD Population|Overall Study||6
10952863|NCT00433147|12124622|FG002|PD Population|Overall Study||9
10952864|NCT00433147|12124623|FG003|PD Population|Overall Study||7
10952865|NCT00433147|12124620|FG000|Received at Least One Dose of Study Drug|Overall Study||7
10952866|NCT00433147|12124621|FG001|Received at Least One Dose of Study Drug|Overall Study||7
10952867|NCT00433147|12124622|FG002|Received at Least One Dose of Study Drug|Overall Study||9
10952868|NCT00433147|12124623|FG003|Received at Least One Dose of Study Drug|Overall Study||7
10952869|NCT00433147|12124620|FG000|COMPLETED|Overall Study||7
10952870|NCT00433147|12124621|FG001|COMPLETED|Overall Study||6
10952871|NCT00433147|12124622|FG002|COMPLETED|Overall Study||9
10952872|NCT00433147|12124623|FG003|COMPLETED|Overall Study||7
10952873|NCT00433147|12124620|FG000|NOT COMPLETED|Overall Study||0
10952874|NCT00433147|12124621|FG001|NOT COMPLETED|Overall Study||1
10952875|NCT00433147|12124622|FG002|NOT COMPLETED|Overall Study||0
10952876|NCT00433147|12124623|FG003|NOT COMPLETED|Overall Study||0
10952877|NCT00433160|12124635|FG000|STARTED|52-Week Double-Blind (DB) Period||137
10952878|NCT00433160|12124636|FG001|STARTED|52-Week Double-Blind (DB) Period||70
10952879|NCT00433160|12124635|FG000|Received Treatment|52-Week Double-Blind (DB) Period||136
10952880|NCT00433160|12124636|FG001|Received Treatment|52-Week Double-Blind (DB) Period||68
10952881|NCT00433160|12124635|FG000|COMPLETED|52-Week Double-Blind (DB) Period||120
10952882|NCT00433160|12124636|FG001|COMPLETED|52-Week Double-Blind (DB) Period||60
10952883|NCT00433160|12124635|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
10952884|NCT00433160|12124636|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
10952885|NCT00433160|12124635|FG000|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
10952886|NCT00433160|12124636|FG001|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
10952887|NCT00433160|12124635|FG000|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
10952888|NCT00433160|12124636|FG001|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
10952889|NCT00433160|12124635|FG000|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
10952890|NCT00433160|12124636|FG001|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
10952891|NCT00433160|12124635|FG000|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
10952892|NCT00433160|12124636|FG001|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
10952893|NCT00433160|12124635|FG000|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
10952894|NCT00433160|12124636|FG001|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
10952895|NCT00433160|12124635|FG000|Received Treatment|104 Weeks, 28-Week OL Period||102
10952896|NCT00433160|12124636|FG001|Received Treatment|104 Weeks, 28-Week OL Period||50
10952897|NCT00433160|12124635|FG000|COMPLETED|104 Weeks, 28-Week OL Period||92
10952898|NCT00433160|12124636|FG001|COMPLETED|104 Weeks, 28-Week OL Period||47
10952899|NCT00433160|12124635|FG000|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
10952900|NCT00433160|12124636|FG001|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
10952901|NCT00433199|12124648|FG000|STARTED|Double-Blind Period||40
10952902|NCT00433199|12124649|FG001|STARTED|Double-Blind Period||234
10952903|NCT00433199|12124648|FG000|COMPLETED|Double-Blind Period||28
10952904|NCT00433199|12124649|FG001|COMPLETED|Double-Blind Period||168
10952905|NCT00433199|12124648|FG000|NOT COMPLETED|Double-Blind Period||12
10952906|NCT00433199|12124649|FG001|NOT COMPLETED|Double-Blind Period||66
10952907|NCT00433199|12124648|FG000|STARTED|Open-Label Period||0
10952908|NCT00433199|12124649|FG001|STARTED|Open-Label Period||219
10952909|NCT00433199|12124648|FG000|COMPLETED|Open-Label Period||0
10952910|NCT00433199|12124649|FG001|COMPLETED|Open-Label Period||185
10952911|NCT00433199|12124648|FG000|NOT COMPLETED|Open-Label Period||0
10952912|NCT00433199|12124649|FG001|NOT COMPLETED|Open-Label Period||34
10952913|NCT00433290|12124662|FG000|STARTED|Overall Study||128
10952914|NCT00433290|12124663|FG001|STARTED|Overall Study||128
10952915|NCT00433290|12124662|FG000|COMPLETED|Overall Study||93
10952916|NCT00433290|12124663|FG001|COMPLETED|Overall Study||111
10952917|NCT00433290|12124662|FG000|NOT COMPLETED|Overall Study||35
10952918|NCT00433290|12124663|FG001|NOT COMPLETED|Overall Study||17
10952919|NCT00433329|12124669|FG000|STARTED|Overall Study||100
10952920|NCT00433329|12124669|FG000|COMPLETED|Overall Study||79
10952921|NCT00433329|12124669|FG000|NOT COMPLETED|Overall Study||21
10952922|NCT00433381|12124675|FG000|STARTED|Overall Study||63
10952923|NCT00433381|12124676|FG001|STARTED|Overall Study||60
10952924|NCT00433381|12124675|FG000|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
10952925|NCT00433381|12124676|FG001|COMPLETED|Overall Study||57
10952926|NCT00433381|12124675|FG000|NOT COMPLETED|Overall Study||3
10952927|NCT00433381|12124676|FG001|NOT COMPLETED|Overall Study||3
10952928|NCT00433446|12124690|FG000|STARTED|Overall Study||62
10952929|NCT00433446|12124690|FG000|Eligible|Overall Study||53
10952930|NCT00433446|12124690|FG000|Eligible and Began Protocol Therapy|Overall Study||53
10952931|NCT00433446|12124690|FG000|COMPLETED|Overall Study||1
10952932|NCT00433446|12124690|FG000|NOT COMPLETED|Overall Study||61
10952933|NCT00433537|12124694|FG000|STARTED|Step 1 - VcR-CVAD Induction||45
10952934|NCT00433537|12124695|FG001|STARTED|Step 1 - VcR-CVAD Induction||22
10952935|NCT00433537|12124696|FG002|STARTED|Step 1 - VcR-CVAD Induction||10
10952936|NCT00433537|12124694|FG000|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
10952937|NCT00433537|12124695|FG001|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
10952938|NCT00433537|12124696|FG002|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
10952939|NCT00433537|12124694|FG000|COMPLETED|Step 1 - VcR-CVAD Induction||44
10952940|NCT00433537|12124695|FG001|COMPLETED|Step 1 - VcR-CVAD Induction||22
10952941|NCT00433537|12124696|FG002|COMPLETED|Step 1 - VcR-CVAD Induction||1
10952942|NCT00433537|12124694|FG000|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
10952943|NCT00433537|12124695|FG001|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
10952944|NCT00433537|12124696|FG002|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
10952945|NCT00433537|12124694|FG000|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
10952946|NCT00433537|12124695|FG001|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
10952947|NCT00433537|12124696|FG002|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
10952948|NCT00433537|12124694|FG000|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
10952949|NCT00433537|12124695|FG001|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
10952950|NCT00433537|12124696|FG002|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
10952951|NCT00433537|12124694|FG000|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
10952952|NCT00433537|12124695|FG001|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
10952953|NCT00433537|12124696|FG002|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
10952954|NCT00433537|12124694|FG000|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
10952955|NCT00433537|12124695|FG001|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
10952956|NCT00433537|12124696|FG002|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
10952957|NCT00433550|12124706|FG000|STARTED|Overall Study||17
10952958|NCT00433550|12124707|FG001|STARTED|Overall Study||10
10952959|NCT00433550|12124708|FG002|STARTED|Overall Study||6
10952960|NCT00433550|12124706|FG000|COMPLETED|Overall Study||17
10952961|NCT00433550|12124707|FG001|COMPLETED|Overall Study||10
10952962|NCT00433550|12124708|FG002|COMPLETED|Overall Study||6
10952963|NCT00433550|12124706|FG000|NOT COMPLETED|Overall Study||0
10952964|NCT00433550|12124707|FG001|NOT COMPLETED|Overall Study||0
10952965|NCT00433550|12124708|FG002|NOT COMPLETED|Overall Study||0
10952966|NCT00433654|12124718|FG000|STARTED|Overall Study||258
10952967|NCT00433654|12124719|FG001|STARTED|Overall Study||206
10952968|NCT00433654|12124718|FG000|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
10952969|NCT00433654|12124719|FG001|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
10952970|NCT00433654|12124718|FG000|NOT COMPLETED|Overall Study||15
10952971|NCT00433654|12124719|FG001|NOT COMPLETED|Overall Study||5
10952972|NCT00433745|12124731|FG000|STARTED|Overall Study||4
10952973|NCT00433745|12124731|FG000|COMPLETED|Overall Study||4
10952974|NCT00433745|12124731|FG000|NOT COMPLETED|Overall Study||0
10952975|NCT00433771|12124736|FG000|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
10952976|NCT00433771|12124736|FG000|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
10952977|NCT00433771|12124736|FG000|NOT COMPLETED|Overall Study||19
10952978|NCT00433836|12124742|FG000|STARTED|Overall Study||151
10952979|NCT00433836|12124743|FG001|STARTED|Overall Study||149
10952980|NCT00433836|12124742|FG000|COMPLETED|Overall Study||138
10952981|NCT00433836|12124743|FG001|COMPLETED|Overall Study||143
10952982|NCT00433836|12124742|FG000|NOT COMPLETED|Overall Study||13
10952983|NCT00433836|12124743|FG001|NOT COMPLETED|Overall Study||6
10952984|NCT00433914|12124751|FG000|STARTED|Overall Study||30
10952985|NCT00433914|12124752|FG001|STARTED|Overall Study||30
10952986|NCT00433914|12124751|FG000|COMPLETED|Overall Study||30
10952987|NCT00433914|12124752|FG001|COMPLETED|Overall Study||27
10952988|NCT00433914|12124751|FG000|NOT COMPLETED|Overall Study||0
10952989|NCT00433914|12124752|FG001|NOT COMPLETED|Overall Study||3
10952990|NCT00433966|12124760|FG000|STARTED|Pharmacology Intervention/Randomization||1800
10952991|NCT00433966|12124761|FG001|STARTED|Pharmacology Intervention/Randomization||1802
10952992|NCT00433966|12124762|FG002|STARTED|Pharmacology Intervention/Randomization||0
10952993|NCT00433966|12124763|FG003|STARTED|Pharmacology Intervention/Randomization||0
10952994|NCT00433966|12124760|FG000|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
10952995|NCT00433966|12124761|FG001|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
10952996|NCT00433966|12124762|FG002|30-Day Follow-up|Pharmacology Intervention/Randomization||0
10952997|NCT00433966|12124763|FG003|30-Day Follow-up|Pharmacology Intervention/Randomization||0
10952998|NCT00433966|12124760|FG000|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
10952999|NCT00433966|12124761|FG001|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
10953000|NCT00433966|12124762|FG002|1-Year Follow-up|Pharmacology Intervention/Randomization||0
10953001|NCT00433966|12124763|FG003|1-Year Follow-up|Pharmacology Intervention/Randomization||0
10953002|NCT00433966|12124760|FG000|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
10953003|NCT00433966|12124761|FG001|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
10953004|NCT00433966|12124762|FG002|3-Year Follow-up|Pharmacology Intervention/Randomization||0
10953005|NCT00433966|12124763|FG003|3-Year Follow-up|Pharmacology Intervention/Randomization||0
10953006|NCT00433966|12124760|FG000|COMPLETED|Pharmacology Intervention/Randomization||1634
10953007|NCT00433966|12124761|FG001|COMPLETED|Pharmacology Intervention/Randomization||1628
10953008|NCT00433966|12124762|FG002|COMPLETED|Pharmacology Intervention/Randomization||0
10953009|NCT00433966|12124763|FG003|COMPLETED|Pharmacology Intervention/Randomization||0
10953010|NCT00433966|12124760|FG000|NOT COMPLETED|Pharmacology Intervention/Randomization||166
10953011|NCT00433966|12124761|FG001|NOT COMPLETED|Pharmacology Intervention/Randomization||174
10953012|NCT00433966|12124762|FG002|NOT COMPLETED|Pharmacology Intervention/Randomization||0
10953013|NCT00433966|12124763|FG003|NOT COMPLETED|Pharmacology Intervention/Randomization||0
10953014|NCT00433966|12124760|FG000|STARTED|Stent Intervention/Randomization||0
10953015|NCT00433966|12124761|FG001|STARTED|Stent Intervention/Randomization||0
10953016|NCT00433966|12124762|FG002|STARTED|Stent Intervention/Randomization||2257
10953017|NCT00433966|12124763|FG003|STARTED|Stent Intervention/Randomization||749
10953018|NCT00433966|12124760|FG000|1-Year Follow-up|Stent Intervention/Randomization||0
10953019|NCT00433966|12124761|FG001|1-Year Follow-up|Stent Intervention/Randomization||0
10953020|NCT00433966|12124762|FG002|1-Year Follow-up|Stent Intervention/Randomization||2186
10953021|NCT00433966|12124763|FG003|1-Year Follow-up|Stent Intervention/Randomization||715
10953022|NCT00433966|12124760|FG000|3-Year Follow-up|Stent Intervention/Randomization||0
10953023|NCT00433966|12124761|FG001|3-Year Follow-up|Stent Intervention/Randomization||0
10953024|NCT00433966|12124762|FG002|3-Year Follow-up|Stent Intervention/Randomization||2103
10953025|NCT00433966|12124763|FG003|3-Year Follow-up|Stent Intervention/Randomization||687
10953026|NCT00433966|12124760|FG000|COMPLETED|Stent Intervention/Randomization||0
10953027|NCT00433966|12124761|FG001|COMPLETED|Stent Intervention/Randomization||0
10953028|NCT00433966|12124762|FG002|COMPLETED|Stent Intervention/Randomization||2103
10953029|NCT00433966|12124763|FG003|COMPLETED|Stent Intervention/Randomization||687
10953030|NCT00433966|12124760|FG000|NOT COMPLETED|Stent Intervention/Randomization||0
10953031|NCT00433966|12124761|FG001|NOT COMPLETED|Stent Intervention/Randomization||0
10953032|NCT00433966|12124762|FG002|NOT COMPLETED|Stent Intervention/Randomization||154
10953033|NCT00433966|12124763|FG003|NOT COMPLETED|Stent Intervention/Randomization||62
10953034|NCT00433992|12124775|FG000|STARTED|Overall Study||28
10953035|NCT00433992|12124776|FG001|STARTED|Overall Study||28
10953036|NCT00433992|12124775|FG000|COMPLETED|Overall Study||19
10953037|NCT00433992|12124776|FG001|COMPLETED|Overall Study||20
10953038|NCT00433992|12124775|FG000|NOT COMPLETED|Overall Study||9
10953039|NCT00433992|12124776|FG001|NOT COMPLETED|Overall Study||8
10953040|NCT00434018|12124788|FG000|STARTED|Overall Study||69
10953041|NCT00434018|12124789|FG001|STARTED|Overall Study||69
10953042|NCT00434018|12124788|FG000|COMPLETED|Overall Study||52
10953043|NCT00434018|12124789|FG001|COMPLETED|Overall Study||57
10953044|NCT00434018|12124788|FG000|NOT COMPLETED|Overall Study||17
10953045|NCT00434018|12124789|FG001|NOT COMPLETED|Overall Study||12
10953046|NCT00434057|12124796|FG000|STARTED|Overall Study||1383
10953047|NCT00434057|12124796|FG000|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
10953048|NCT00434057|12124796|FG000|NOT COMPLETED|Overall Study||1
10953049|NCT00434109|12124800|FG000|STARTED|Overall Study||39
10953050|NCT00434109|12124800|FG000|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
10953051|NCT00434109|12124800|FG000|NOT COMPLETED|Overall Study||18
10953052|NCT00434122|12124806|FG000|STARTED|Overall Study|Randomised|42
10953053|NCT00434122|12124807|FG001|STARTED|Overall Study|Randomised|43
10953054|NCT00434122|12124806|FG000|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
10953055|NCT00434122|12124807|FG001|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
10953056|NCT00434122|12124806|FG000|COMPLETED|Overall Study||36
10953057|NCT00434122|12124807|FG001|COMPLETED|Overall Study||36
10953058|NCT00434122|12124806|FG000|NOT COMPLETED|Overall Study||6
10953059|NCT00434122|12124807|FG001|NOT COMPLETED|Overall Study||7
10953060|NCT00434148|12124817|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
10953061|NCT00434148|12124818|FG001|STARTED|Overall Study||80
10953062|NCT00434148|12124817|FG000|Completed Month 12|Overall Study||39
10953063|NCT00434148|12124818|FG001|Completed Month 12|Overall Study||39
10953064|NCT00434148|12124817|FG000|Completed m. 12; Did Not Enter Extension|Overall Study||13
10953065|NCT00434148|12124818|FG001|Completed m. 12; Did Not Enter Extension|Overall Study||7
10953066|NCT00434148|12124817|FG000|Completed Month 12; Entered Extension|Overall Study||26
10953067|NCT00434148|12124818|FG001|Completed Month 12; Entered Extension|Overall Study||32
10953068|NCT00434148|12124817|FG000|COMPLETED|Overall Study||13
10953069|NCT00434148|12124818|FG001|COMPLETED|Overall Study||7
10953070|NCT00434148|12124817|FG000|NOT COMPLETED|Overall Study||69
10953071|NCT00434148|12124818|FG001|NOT COMPLETED|Overall Study||73
10953072|NCT00434161|12124827|FG000|STARTED|Overall Study||109
10953073|NCT00434161|12124828|FG001|STARTED|Overall Study||57
10953074|NCT00434161|12124829|FG002|STARTED|Overall Study||115
10953075|NCT00434161|12124827|FG000|COMPLETED|Overall Study||99
10953076|NCT00434161|12124828|FG001|COMPLETED|Overall Study||54
10953077|NCT00434161|12124829|FG002|COMPLETED|Overall Study||104
10953078|NCT00434161|12124827|FG000|NOT COMPLETED|Overall Study||10
10953079|NCT00434161|12124828|FG001|NOT COMPLETED|Overall Study||3
10953080|NCT00434161|12124829|FG002|NOT COMPLETED|Overall Study||11
10953081|NCT00434213|12124844|FG000|STARTED|Overall Study||309
10953082|NCT00434213|12124844|FG000|COMPLETED|Overall Study||260
10953083|NCT00434213|12124844|FG000|NOT COMPLETED|Overall Study||49
10953084|NCT00434252|12124850|FG000|STARTED|Overall Study||71
10953085|NCT00434252|12124851|FG001|STARTED|Overall Study||143
10953086|NCT00434252|12124850|FG000|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
10953087|NCT00434252|12124851|FG001|Treated|Overall Study||143
10953088|NCT00434252|12124850|FG000|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
10953089|NCT00434252|12124851|FG001|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
10953090|NCT00434252|12124850|FG000|NOT COMPLETED|Overall Study||64
10953091|NCT00434252|12124851|FG001|NOT COMPLETED|Overall Study||131
10953092|NCT00434278|12124859|FG000|STARTED|Overall Study||14
10953093|NCT00434278|12124860|FG001|STARTED|Overall Study||13
10953094|NCT00434278|12124859|FG000|COMPLETED|Overall Study||12
10953095|NCT00434278|12124860|FG001|COMPLETED|Overall Study||13
10953096|NCT00434278|12124859|FG000|NOT COMPLETED|Overall Study||2
10953097|NCT00434278|12124860|FG001|NOT COMPLETED|Overall Study||0
10953098|NCT00434304|12124866|FG000|STARTED|Overall Study||62
10953099|NCT00434304|12124866|FG000|COMPLETED|Overall Study||42
10953100|NCT00434304|12124866|FG000|NOT COMPLETED|Overall Study||20
10953101|NCT00434330|12124877|FG000|STARTED|Overall Study||15
10953102|NCT00434330|12124878|FG001|STARTED|Overall Study||15
10953103|NCT00434330|12124879|FG002|STARTED|Overall Study||16
10953104|NCT00434330|12124880|FG003|STARTED|Overall Study||15
10953105|NCT00434330|12124881|FG004|STARTED|Overall Study||15
10953106|NCT00434330|12124882|FG005|STARTED|Overall Study||15
10953107|NCT00434330|12124877|FG000|COMPLETED|Overall Study||14
10953108|NCT00434330|12124878|FG001|COMPLETED|Overall Study||15
10953109|NCT00434330|12124879|FG002|COMPLETED|Overall Study||13
10953110|NCT00434330|12124880|FG003|COMPLETED|Overall Study||13
10953111|NCT00434330|12124881|FG004|COMPLETED|Overall Study||14
10953112|NCT00434330|12124882|FG005|COMPLETED|Overall Study||14
10953113|NCT00434330|12124877|FG000|NOT COMPLETED|Overall Study||1
10953114|NCT00434330|12124878|FG001|NOT COMPLETED|Overall Study||0
10953115|NCT00434330|12124879|FG002|NOT COMPLETED|Overall Study||3
10953116|NCT00434330|12124880|FG003|NOT COMPLETED|Overall Study||2
10953117|NCT00434330|12124881|FG004|NOT COMPLETED|Overall Study||1
10953118|NCT00434330|12124882|FG005|NOT COMPLETED|Overall Study||1
10953119|NCT00434356|12124898|FG000|STARTED|Overall Study||23
10953120|NCT00434356|12124899|FG001|STARTED|Overall Study||23
10953121|NCT00434356|12124898|FG000|COMPLETED|Overall Study||0
10953122|NCT00434356|12124899|FG001|COMPLETED|Overall Study||0
10953123|NCT00434356|12124898|FG000|NOT COMPLETED|Overall Study||23
10953124|NCT00434356|12124899|FG001|NOT COMPLETED|Overall Study||23
10953125|NCT00434421|12124905|FG000|STARTED|Overall Study||28
10953126|NCT00434421|12124905|FG000|COMPLETED|Overall Study||26
10953127|NCT00434421|12124905|FG000|NOT COMPLETED|Overall Study||2
10953128|NCT00434434|12124912|FG000|STARTED|Overall Study||23
10953129|NCT00434434|12124913|FG001|STARTED|Overall Study||24
10953130|NCT00434434|12124914|FG002|STARTED|Overall Study||14
10953131|NCT00434434|12124912|FG000|COMPLETED|Overall Study||21
10953132|NCT00434434|12124913|FG001|COMPLETED|Overall Study||24
10953133|NCT00434434|12124914|FG002|COMPLETED|Overall Study||13
10953134|NCT00434434|12124912|FG000|NOT COMPLETED|Overall Study||2
10953135|NCT00434434|12124913|FG001|NOT COMPLETED|Overall Study||0
10953136|NCT00434434|12124914|FG002|NOT COMPLETED|Overall Study||1
10953137|NCT00434512|12124928|FG000|STARTED|Overall Study||10
10953138|NCT00434512|12124929|FG001|STARTED|Overall Study||10
10953139|NCT00434512|12124930|FG002|STARTED|Overall Study||10
10953140|NCT00434512|12124931|FG003|STARTED|Overall Study||50
10953141|NCT00434512|12124932|FG004|STARTED|Overall Study||50
10953142|NCT00434512|12124933|FG005|STARTED|Overall Study||50
10953143|NCT00434512|12124928|FG000|COMPLETED|Overall Study||10
10953144|NCT00434512|12124929|FG001|COMPLETED|Overall Study||9
10953145|NCT00434512|12124930|FG002|COMPLETED|Overall Study||10
10953146|NCT00434512|12124931|FG003|COMPLETED|Overall Study||49
10953147|NCT00434512|12124932|FG004|COMPLETED|Overall Study||49
10953148|NCT00434512|12124933|FG005|COMPLETED|Overall Study||49
10953149|NCT00434512|12124928|FG000|NOT COMPLETED|Overall Study||0
10953150|NCT00434512|12124929|FG001|NOT COMPLETED|Overall Study||1
10953151|NCT00434512|12124930|FG002|NOT COMPLETED|Overall Study||0
10953152|NCT00434512|12124931|FG003|NOT COMPLETED|Overall Study||1
10953153|NCT00434512|12124932|FG004|NOT COMPLETED|Overall Study||1
10953154|NCT00434512|12124933|FG005|NOT COMPLETED|Overall Study||1
10953155|NCT00434577|12124956|FG000|STARTED|Months 0-3||164
10953156|NCT00434577|12124957|FG001|STARTED|Months 0-3||166
10953157|NCT00434577|12124958|FG002|STARTED|Months 0-3||165
10953158|NCT00434577|12124959|FG003|STARTED|Months 0-3||165
10953159|NCT00434577|12124960|FG004|STARTED|Months 0-3||54
10953160|NCT00434577|12124956|FG000|COMPLETED|Months 0-3||161
10953161|NCT00434577|12124957|FG001|COMPLETED|Months 0-3||164
10953162|NCT00434577|12124958|FG002|COMPLETED|Months 0-3||161
10953163|NCT00434577|12124959|FG003|COMPLETED|Months 0-3||164
10953164|NCT00434577|12124960|FG004|COMPLETED|Months 0-3||51
10953165|NCT00434577|12124956|FG000|NOT COMPLETED|Months 0-3||3
10953166|NCT00434577|12124957|FG001|NOT COMPLETED|Months 0-3||2
10953167|NCT00434577|12124958|FG002|NOT COMPLETED|Months 0-3||4
10953168|NCT00434577|12124959|FG003|NOT COMPLETED|Months 0-3||1
10953169|NCT00434577|12124960|FG004|NOT COMPLETED|Months 0-3||3
10953170|NCT00434577|12124956|FG000|STARTED|Month 12||156
10953171|NCT00434577|12124957|FG001|STARTED|Month 12||159
10953172|NCT00434577|12124958|FG002|STARTED|Month 12||159
10953173|NCT00434577|12124959|FG003|STARTED|Month 12||161
10953174|NCT00434577|12124960|FG004|STARTED|Month 12||50
10953175|NCT00434577|12124956|FG000|COMPLETED|Month 12||156
10953176|NCT00434577|12124957|FG001|COMPLETED|Month 12||159
10953177|NCT00434577|12124958|FG002|COMPLETED|Month 12||159
10953178|NCT00434577|12124959|FG003|COMPLETED|Month 12||161
10953179|NCT00434577|12124960|FG004|COMPLETED|Month 12||50
10953180|NCT00434577|12124956|FG000|NOT COMPLETED|Month 12||0
10953181|NCT00434577|12124957|FG001|NOT COMPLETED|Month 12||0
10953182|NCT00434577|12124958|FG002|NOT COMPLETED|Month 12||0
10953183|NCT00434577|12124959|FG003|NOT COMPLETED|Month 12||0
10953184|NCT00434577|12124960|FG004|NOT COMPLETED|Month 12||0
10953185|NCT00434577|12124956|FG000|STARTED|Month 24||150
10953186|NCT00434577|12124957|FG001|STARTED|Month 24||155
10953187|NCT00434577|12124958|FG002|STARTED|Month 24||154
10953188|NCT00434577|12124959|FG003|STARTED|Month 24||157
10953189|NCT00434577|12124960|FG004|STARTED|Month 24||49
10953190|NCT00434577|12124956|FG000|COMPLETED|Month 24||150
10953191|NCT00434577|12124957|FG001|COMPLETED|Month 24||155
10953192|NCT00434577|12124958|FG002|COMPLETED|Month 24||154
10953193|NCT00434577|12124959|FG003|COMPLETED|Month 24||157
10953194|NCT00434577|12124960|FG004|COMPLETED|Month 24||49
10953195|NCT00434577|12124956|FG000|NOT COMPLETED|Month 24||0
10953196|NCT00434577|12124957|FG001|NOT COMPLETED|Month 24||0
10953197|NCT00434577|12124958|FG002|NOT COMPLETED|Month 24||0
10953198|NCT00434577|12124959|FG003|NOT COMPLETED|Month 24||0
10953199|NCT00434577|12124960|FG004|NOT COMPLETED|Month 24||0
10953200|NCT00434577|12124956|FG000|STARTED|Month 36||147
10953201|NCT00434577|12124957|FG001|STARTED|Month 36||147
10953202|NCT00434577|12124958|FG002|STARTED|Month 36||150
10953203|NCT00434577|12124959|FG003|STARTED|Month 36||155
10953204|NCT00434577|12124960|FG004|STARTED|Month 36||47
10953205|NCT00434577|12124956|FG000|COMPLETED|Month 36||147
10953206|NCT00434577|12124957|FG001|COMPLETED|Month 36||147
10953207|NCT00434577|12124958|FG002|COMPLETED|Month 36||150
10953208|NCT00434577|12124959|FG003|COMPLETED|Month 36||155
10953209|NCT00434577|12124960|FG004|COMPLETED|Month 36||47
10953210|NCT00434577|12124956|FG000|NOT COMPLETED|Month 36||0
10953211|NCT00434577|12124957|FG001|NOT COMPLETED|Month 36||0
10953212|NCT00434577|12124958|FG002|NOT COMPLETED|Month 36||0
10953213|NCT00434577|12124959|FG003|NOT COMPLETED|Month 36||0
10953214|NCT00434577|12124960|FG004|NOT COMPLETED|Month 36||0
10953215|NCT00434642|12124974|FG000|STARTED|Blinded Treatment Phase||242
10953216|NCT00434642|12124975|FG001|STARTED|Blinded Treatment Phase||242
10953217|NCT00434642|12124974|FG000|COMPLETED|Blinded Treatment Phase||0
10953218|NCT00434642|12124975|FG001|COMPLETED|Blinded Treatment Phase||13
10953219|NCT00434642|12124974|FG000|NOT COMPLETED|Blinded Treatment Phase||242
10953220|NCT00434642|12124975|FG001|NOT COMPLETED|Blinded Treatment Phase||229
10953221|NCT00434642|12124974|FG000|STARTED|Open-label Treatment Phase||0
10953222|NCT00434642|12124975|FG001|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
10953223|NCT00434642|12124974|FG000|COMPLETED|Open-label Treatment Phase||0
10953224|NCT00434642|12124975|FG001|COMPLETED|Open-label Treatment Phase||1
10953225|NCT00434642|12124974|FG000|NOT COMPLETED|Open-label Treatment Phase||0
10953226|NCT00434642|12124975|FG001|NOT COMPLETED|Open-label Treatment Phase||11
10953227|NCT00434759|12124983|FG000|STARTED|Overall Study||46
10953228|NCT00434759|12124984|FG001|STARTED|Overall Study||43
10953229|NCT00434759|12124983|FG000|COMPLETED|Overall Study||22
10953230|NCT00434759|12124984|FG001|COMPLETED|Overall Study||38
10953231|NCT00434759|12124983|FG000|NOT COMPLETED|Overall Study||24
10953232|NCT00434759|12124984|FG001|NOT COMPLETED|Overall Study||5
10953233|NCT00434876|12124994|FG000|STARTED|Overall Study||11
10953234|NCT00434876|12124995|FG001|STARTED|Overall Study||11
10953235|NCT00434876|12124994|FG000|COMPLETED|Overall Study||10
10953236|NCT00434876|12124995|FG001|COMPLETED|Overall Study||10
10953237|NCT00434876|12124994|FG000|NOT COMPLETED|Overall Study||1
10953238|NCT00434876|12124995|FG001|NOT COMPLETED|Overall Study||1
10953239|NCT00434954|12125003|FG000|STARTED|Overall Study||248
10953240|NCT00434954|12125004|FG001|STARTED|Overall Study||246
10953241|NCT00434954|12125003|FG000|Started - Previous Treatment MET Only|Overall Study||182
10953242|NCT00434954|12125004|FG001|Started - Previous Treatment MET Only|Overall Study||181
10953243|NCT00434954|12125003|FG000|Started - Previous Treatment MET + SU|Overall Study||66
10953244|NCT00434954|12125004|FG001|Started - Previous Treatment MET + SU|Overall Study||65
10953245|NCT00434954|12125003|FG000|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
10953246|NCT00434954|12125004|FG001|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
10953247|NCT00434954|12125003|FG000|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
10953248|NCT00434954|12125004|FG001|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
10953249|NCT00434954|12125003|FG000|FAS - Previous Treatment MET + SU|Overall Study||66
10953250|NCT00434954|12125004|FG001|FAS - Previous Treatment MET + SU|Overall Study||60
10953251|NCT00434954|12125003|FG000|Completed - Previous Treatment MET Only|Overall Study||135
10953252|NCT00434954|12125004|FG001|Completed - Previous Treatment MET Only|Overall Study||137
10953253|NCT00434954|12125003|FG000|Completed - Previous Treatment MET + SU|Overall Study||31
10953254|NCT00434954|12125004|FG001|Completed - Previous Treatment MET + SU|Overall Study||38
10953255|NCT00434954|12125003|FG000|COMPLETED|Overall Study||166
10953256|NCT00434954|12125004|FG001|COMPLETED|Overall Study||175
10953257|NCT00434954|12125003|FG000|NOT COMPLETED|Overall Study||82
10953258|NCT00434954|12125004|FG001|NOT COMPLETED|Overall Study||71
10953259|NCT00434967|12125014|FG000|STARTED|Overall Study||97
10953260|NCT00434967|12125015|FG001|STARTED|Overall Study||465
10953261|NCT00434967|12125016|FG002|STARTED|Overall Study||470
10953262|NCT00434967|12125017|FG003|STARTED|Overall Study||492
10953263|NCT00434967|12125014|FG000|COMPLETED|Overall Study||90
10953264|NCT00434967|12125015|FG001|COMPLETED|Overall Study||457
10953265|NCT00434967|12125016|FG002|COMPLETED|Overall Study||461
10953266|NCT00434967|12125017|FG003|COMPLETED|Overall Study||478
10953267|NCT00434967|12125014|FG000|NOT COMPLETED|Overall Study||7
10953268|NCT00434967|12125015|FG001|NOT COMPLETED|Overall Study||8
10953269|NCT00434967|12125016|FG002|NOT COMPLETED|Overall Study||9
10953270|NCT00434967|12125017|FG003|NOT COMPLETED|Overall Study||14
10953271|NCT00434993|12125029|FG000|STARTED|Overall Study||152
10953272|NCT00434993|12125030|FG001|STARTED|Overall Study||130
10953273|NCT00434993|12125029|FG000|COMPLETED|Overall Study||152
10953274|NCT00434993|12125030|FG001|COMPLETED|Overall Study||130
10953275|NCT00434993|12125029|FG000|NOT COMPLETED|Overall Study||0
10953276|NCT00434993|12125030|FG001|NOT COMPLETED|Overall Study||0
10953277|NCT00435019|12125038|FG000|STARTED|Overall Study|Randomised|177
10953278|NCT00435019|12125039|FG001|STARTED|Overall Study|Randomised|171
10953279|NCT00435019|12125038|FG000|Exposed to Study Drug|Overall Study||177
10953280|NCT00435019|12125039|FG001|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
10953281|NCT00435019|12125038|FG000|COMPLETED|Overall Study||164
10953282|NCT00435019|12125039|FG001|COMPLETED|Overall Study||161
10953283|NCT00435019|12125038|FG000|NOT COMPLETED|Overall Study||13
10953284|NCT00435019|12125039|FG001|NOT COMPLETED|Overall Study||10
10953285|NCT00435045|12125047|FG000|STARTED|Weeks 1-8 / 10 mg Dose Level||123
10953286|NCT00435045|12125048|FG001|STARTED|Weeks 1-8 / 10 mg Dose Level||122
10953287|NCT00435045|12125047|FG000|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
10953288|NCT00435045|12125048|FG001|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
10953289|NCT00435045|12125047|FG000|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
10953290|NCT00435045|12125048|FG001|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
10953291|NCT00435045|12125047|FG000|STARTED|Weeks 9-12 / 20mg Dose Level||118
10953292|NCT00435045|12125048|FG001|STARTED|Weeks 9-12 / 20mg Dose Level||118
10953293|NCT00435045|12125047|FG000|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
10953294|NCT00435045|12125048|FG001|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
10953295|NCT00435045|12125047|FG000|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
10953296|NCT00435045|12125048|FG001|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
10953297|NCT00435045|12125047|FG000|STARTED|Weeks 13-16 / 40mg Dose Level||113
10953298|NCT00435045|12125048|FG001|STARTED|Weeks 13-16 / 40mg Dose Level||113
10953299|NCT00435045|12125047|FG000|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
10953300|NCT00435045|12125048|FG001|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
10953301|NCT00435045|12125047|FG000|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
10953302|NCT00435045|12125048|FG001|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
10953303|NCT00435162|12125057|FG000|STARTED|Period 1 (6 Weeks)||15
10953304|NCT00435162|12125058|FG001|STARTED|Period 1 (6 Weeks)||15
10953305|NCT00435162|12125059|FG002|STARTED|Period 1 (6 Weeks)||6
10953306|NCT00435162|12125060|FG003|STARTED|Period 1 (6 Weeks)||8
10953307|NCT00435162|12125061|FG004|STARTED|Period 1 (6 Weeks)||15
10953308|NCT00435162|12125062|FG005|STARTED|Period 1 (6 Weeks)||15
10953309|NCT00435162|12125057|FG000|COMPLETED|Period 1 (6 Weeks)||15
10953310|NCT00435162|12125058|FG001|COMPLETED|Period 1 (6 Weeks)||15
10953311|NCT00435162|12125059|FG002|COMPLETED|Period 1 (6 Weeks)||6
10953312|NCT00435162|12125060|FG003|COMPLETED|Period 1 (6 Weeks)||8
10953313|NCT00435162|12125061|FG004|COMPLETED|Period 1 (6 Weeks)||15
10953314|NCT00435162|12125062|FG005|COMPLETED|Period 1 (6 Weeks)||15
10953315|NCT00435162|12125057|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
10953316|NCT00435162|12125058|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
10953317|NCT00435162|12125059|FG002|NOT COMPLETED|Period 1 (6 Weeks)||0
10953318|NCT00435162|12125060|FG003|NOT COMPLETED|Period 1 (6 Weeks)||0
10953319|NCT00435162|12125061|FG004|NOT COMPLETED|Period 1 (6 Weeks)||0
10953320|NCT00435162|12125062|FG005|NOT COMPLETED|Period 1 (6 Weeks)||0
10953321|NCT00435162|12125057|FG000|STARTED|Period 2 (2 Weeks)||15
10953322|NCT00435162|12125058|FG001|STARTED|Period 2 (2 Weeks)||15
10953323|NCT00435162|12125059|FG002|STARTED|Period 2 (2 Weeks)||6
10953324|NCT00435162|12125060|FG003|STARTED|Period 2 (2 Weeks)||8
10953325|NCT00435162|12125061|FG004|STARTED|Period 2 (2 Weeks)||15
10953326|NCT00435162|12125062|FG005|STARTED|Period 2 (2 Weeks)||15
10953327|NCT00435162|12125057|FG000|COMPLETED|Period 2 (2 Weeks)||15
10953328|NCT00435162|12125058|FG001|COMPLETED|Period 2 (2 Weeks)||14
10953329|NCT00435162|12125059|FG002|COMPLETED|Period 2 (2 Weeks)||6
10953330|NCT00435162|12125060|FG003|COMPLETED|Period 2 (2 Weeks)||8
10953331|NCT00435162|12125061|FG004|COMPLETED|Period 2 (2 Weeks)||15
10953332|NCT00435162|12125062|FG005|COMPLETED|Period 2 (2 Weeks)||15
10953333|NCT00435162|12125057|FG000|NOT COMPLETED|Period 2 (2 Weeks)||0
10953334|NCT00435162|12125058|FG001|NOT COMPLETED|Period 2 (2 Weeks)||1
10953335|NCT00435162|12125059|FG002|NOT COMPLETED|Period 2 (2 Weeks)||0
10953336|NCT00435162|12125060|FG003|NOT COMPLETED|Period 2 (2 Weeks)||0
10953337|NCT00435162|12125061|FG004|NOT COMPLETED|Period 2 (2 Weeks)||0
10953338|NCT00435162|12125062|FG005|NOT COMPLETED|Period 2 (2 Weeks)||0
10953339|NCT00435188|12125077|FG000|STARTED|Overall Study||199
10953340|NCT00435188|12125078|FG001|STARTED|Overall Study||199
10953341|NCT00435188|12125077|FG000|COMPLETED|Overall Study||177
10953342|NCT00435188|12125078|FG001|COMPLETED|Overall Study||176
10953343|NCT00435188|12125077|FG000|NOT COMPLETED|Overall Study||22
10953344|NCT00435188|12125078|FG001|NOT COMPLETED|Overall Study||23
10953345|NCT00435370|12125088|FG000|STARTED|Overall Study||90
10953346|NCT00435370|12125089|FG001|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
10953347|NCT00435370|12125088|FG000|COMPLETED|Overall Study||68
10953348|NCT00435370|12125089|FG001|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
10953349|NCT00435370|12125088|FG000|NOT COMPLETED|Overall Study||22
10953350|NCT00435370|12125089|FG001|NOT COMPLETED|Overall Study||20
10953351|NCT00435409|12125097|FG000|STARTED|Overall Study||221
10953352|NCT00435409|12125098|FG001|STARTED|Overall Study||143
10953353|NCT00435409|12125099|FG002|STARTED|Overall Study||78
10953354|NCT00435409|12125097|FG000|Treated|Overall Study||217
10953355|NCT00435409|12125098|FG001|Treated|Overall Study||139
10953356|NCT00435409|12125099|FG002|Treated|Overall Study||78
10953357|NCT00435409|12125097|FG000|COMPLETED|Overall Study||0
10953358|NCT00435409|12125098|FG001|COMPLETED|Overall Study||0
10953359|NCT00435409|12125099|FG002|COMPLETED|Overall Study||0
10953360|NCT00435409|12125097|FG000|NOT COMPLETED|Overall Study||221
10953361|NCT00435409|12125098|FG001|NOT COMPLETED|Overall Study||143
10953362|NCT00435409|12125099|FG002|NOT COMPLETED|Overall Study||78
10953363|NCT00435461|12125108|FG000|STARTED|Overall Study||313
10953364|NCT00435461|12125109|FG001|STARTED|Overall Study||312
10953365|NCT00435461|12125110|FG002|STARTED|Overall Study||311
10953366|NCT00435461|12125108|FG000|COMPLETED|Overall Study||290
10953367|NCT00435461|12125109|FG001|COMPLETED|Overall Study||298
10953368|NCT00435461|12125110|FG002|COMPLETED|Overall Study||287
10953369|NCT00435461|12125108|FG000|NOT COMPLETED|Overall Study||23
10953370|NCT00435461|12125109|FG001|NOT COMPLETED|Overall Study||14
10953371|NCT00435461|12125110|FG002|NOT COMPLETED|Overall Study||24
10953372|NCT00435487|12125120|FG000|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
10953373|NCT00435487|12125121|FG001|STARTED|Overall Study||86
10953374|NCT00435487|12125120|FG000|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
10953375|NCT00435487|12125121|FG001|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
10953376|NCT00435487|12125120|FG000|COMPLETED|Overall Study||76
10953377|NCT00435487|12125121|FG001|COMPLETED|Overall Study||71
10953378|NCT00435487|12125120|FG000|NOT COMPLETED|Overall Study||12
10953379|NCT00435487|12125121|FG001|NOT COMPLETED|Overall Study||15
10953380|NCT00435539|12125132|FG000|STARTED|Overall Study||12
10953381|NCT00435539|12125133|FG001|STARTED|Overall Study||13
10953382|NCT00435539|12125134|FG002|STARTED|Overall Study||11
10953383|NCT00435539|12125135|FG003|STARTED|Overall Study||12
10953384|NCT00435539|12125136|FG004|STARTED|Overall Study||12
10953385|NCT00435539|12125132|FG000|COMPLETED|Overall Study||12
10953386|NCT00435539|12125133|FG001|COMPLETED|Overall Study||13
10953387|NCT00435539|12125134|FG002|COMPLETED|Overall Study||11
10953388|NCT00435539|12125135|FG003|COMPLETED|Overall Study||12
10953389|NCT00435539|12125136|FG004|COMPLETED|Overall Study||12
10953390|NCT00435539|12125132|FG000|NOT COMPLETED|Overall Study||0
10953391|NCT00435539|12125133|FG001|NOT COMPLETED|Overall Study||0
10953392|NCT00435539|12125134|FG002|NOT COMPLETED|Overall Study||0
10953393|NCT00435539|12125135|FG003|NOT COMPLETED|Overall Study||0
10953394|NCT00435539|12125136|FG004|NOT COMPLETED|Overall Study||0
10953395|NCT00435591|12125151|FG000|STARTED|Overall Study||30
10953396|NCT00435591|12125152|FG001|STARTED|Overall Study||31
10953397|NCT00435591|12125153|FG002|STARTED|Overall Study||30
10953398|NCT00435591|12125154|FG003|STARTED|Overall Study||30
10953399|NCT00435591|12125151|FG000|Safety Analysis Set|Overall Study||28
10953400|NCT00435591|12125152|FG001|Safety Analysis Set|Overall Study||30
10953401|NCT00435591|12125153|FG002|Safety Analysis Set|Overall Study||30
10953402|NCT00435591|12125154|FG003|Safety Analysis Set|Overall Study||29
10953403|NCT00435591|12125151|FG000|Full Analysis Set|Overall Study||28
10953404|NCT00435591|12125152|FG001|Full Analysis Set|Overall Study||29
10953405|NCT00435591|12125153|FG002|Full Analysis Set|Overall Study||30
10953406|NCT00435591|12125154|FG003|Full Analysis Set|Overall Study||29
10953407|NCT00435591|12125151|FG000|End of Treatment|Overall Study||25
10953408|NCT00435591|12125152|FG001|End of Treatment|Overall Study||27
10953409|NCT00435591|12125153|FG002|End of Treatment|Overall Study||27
10953410|NCT00435591|12125154|FG003|End of Treatment|Overall Study||23
10953411|NCT00435591|12125151|FG000|COMPLETED|Overall Study||23
10953412|NCT00435591|12125152|FG001|COMPLETED|Overall Study||27
10953413|NCT00435591|12125153|FG002|COMPLETED|Overall Study||25
10953414|NCT00435591|12125154|FG003|COMPLETED|Overall Study||19
10953415|NCT00435591|12125151|FG000|NOT COMPLETED|Overall Study||7
10953416|NCT00435591|12125152|FG001|NOT COMPLETED|Overall Study||4
10953417|NCT00435591|12125153|FG002|NOT COMPLETED|Overall Study||5
10953418|NCT00435591|12125154|FG003|NOT COMPLETED|Overall Study||11
10953419|NCT00435812|12125169|FG000|STARTED|Overall Study||1820
10953420|NCT00435812|12125170|FG001|STARTED|Overall Study||608
10953421|NCT00435812|12125169|FG000|COMPLETED|Overall Study||1757
10953422|NCT00435812|12125170|FG001|COMPLETED|Overall Study||590
10953423|NCT00435812|12125169|FG000|NOT COMPLETED|Overall Study||63
10953424|NCT00435812|12125170|FG001|NOT COMPLETED|Overall Study||18
10953425|NCT00435825|12125180|FG000|STARTED|Overall Study||141
10953426|NCT00435825|12125181|FG001|STARTED|Overall Study||136
10953427|NCT00435825|12125182|FG002|STARTED|Overall Study||138
10953428|NCT00435825|12125183|FG003|STARTED|Overall Study||136
10953429|NCT00435825|12125180|FG000|Received Study Drug|Overall Study||140
10953430|NCT00435825|12125181|FG001|Received Study Drug|Overall Study||136
10953431|NCT00435825|12125182|FG002|Received Study Drug|Overall Study||136
10953432|NCT00435825|12125183|FG003|Received Study Drug|Overall Study||136
10953433|NCT00435825|12125180|FG000|Entered Follow-up|Overall Study||140
10953434|NCT00435825|12125181|FG001|Entered Follow-up|Overall Study||132
10953435|NCT00435825|12125182|FG002|Entered Follow-up|Overall Study||135
10953436|NCT00435825|12125183|FG003|Entered Follow-up|Overall Study||133
10953437|NCT00435825|12125180|FG000|Completed 24 Weeks Treatment|Overall Study||128
10953438|NCT00435825|12125181|FG001|Completed 24 Weeks Treatment|Overall Study||126
10953439|NCT00435825|12125182|FG002|Completed 24 Weeks Treatment|Overall Study||134
10953440|NCT00435825|12125183|FG003|Completed 24 Weeks Treatment|Overall Study||131
10953441|NCT00435825|12125180|FG000|Completed 48 Weeks Treatment|Overall Study||0
10953442|NCT00435825|12125181|FG001|Completed 48 Weeks Treatment|Overall Study||0
10953443|NCT00435825|12125182|FG002|Completed 48 Weeks Treatment|Overall Study||124
10953444|NCT00435825|12125183|FG003|Completed 48 Weeks Treatment|Overall Study||117
10953445|NCT00435825|12125180|FG000|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
10953446|NCT00435825|12125181|FG001|COMPLETED|Overall Study||124
10953447|NCT00435825|12125182|FG002|COMPLETED|Overall Study||127
10953448|NCT00435825|12125183|FG003|COMPLETED|Overall Study||120
10953449|NCT00435825|12125180|FG000|NOT COMPLETED|Overall Study||18
10953450|NCT00435825|12125181|FG001|NOT COMPLETED|Overall Study||12
10953451|NCT00435825|12125182|FG002|NOT COMPLETED|Overall Study||11
10953452|NCT00435825|12125183|FG003|NOT COMPLETED|Overall Study||16
10953453|NCT00435929|12125195|FG000|STARTED|Overall Study||7
10953454|NCT00435929|12125196|FG001|STARTED|Overall Study||9
10953455|NCT00435929|12125195|FG000|COMPLETED|Overall Study||7
10953456|NCT00435929|12125196|FG001|COMPLETED|Overall Study||9
10953457|NCT00435929|12125195|FG000|NOT COMPLETED|Overall Study||0
10953458|NCT00435929|12125196|FG001|NOT COMPLETED|Overall Study||0
10953459|NCT00435942|12125204|FG000|STARTED|Overall Study||120
10953460|NCT00435942|12125205|FG001|STARTED|Overall Study||60
10953461|NCT00435942|12125204|FG000|COMPLETED|Overall Study||97
10953462|NCT00435942|12125205|FG001|COMPLETED|Overall Study||33
10953463|NCT00435942|12125204|FG000|NOT COMPLETED|Overall Study||23
10953464|NCT00435942|12125205|FG001|NOT COMPLETED|Overall Study||27
10953465|NCT00435994|12125214|FG000|STARTED|Overall Study||22
10953466|NCT00435994|12125215|FG001|STARTED|Overall Study||25
10953467|NCT00435994|12125216|FG002|STARTED|Overall Study||12
10953468|NCT00435994|12125214|FG000|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
10953469|NCT00435994|12125215|FG001|COMPLETED|Overall Study||25
10953470|NCT00435994|12125216|FG002|COMPLETED|Overall Study||12
10953471|NCT00435994|12125214|FG000|NOT COMPLETED|Overall Study||7
10953472|NCT00435994|12125215|FG001|NOT COMPLETED|Overall Study||0
10953473|NCT00435994|12125216|FG002|NOT COMPLETED|Overall Study||0
10953474|NCT00436007|12125228|FG000|STARTED|Overall Study||170
10953475|NCT00436007|12125229|FG001|STARTED|Overall Study||170
10953476|NCT00436007|12125230|FG002|STARTED|Overall Study||171
10953477|NCT00436007|12125228|FG000|COMPLETED|Overall Study||151
10953478|NCT00436007|12125229|FG001|COMPLETED|Overall Study||156
10953479|NCT00436007|12125230|FG002|COMPLETED|Overall Study||148
10953480|NCT00436007|12125228|FG000|NOT COMPLETED|Overall Study||19
10953481|NCT00436007|12125229|FG001|NOT COMPLETED|Overall Study||14
10953482|NCT00436007|12125230|FG002|NOT COMPLETED|Overall Study||23
10953483|NCT00436046|12125246|FG000|STARTED|Overall Study||32
10953484|NCT00436046|12125247|FG001|STARTED|Overall Study||32
10953485|NCT00436046|12125248|FG002|STARTED|Overall Study||31
10953486|NCT00436046|12125246|FG000|COMPLETED|Overall Study||32
10953487|NCT00436046|12125247|FG001|COMPLETED|Overall Study||32
10953488|NCT00436046|12125248|FG002|COMPLETED|Overall Study||31
10953489|NCT00436046|12125246|FG000|NOT COMPLETED|Overall Study||0
10953490|NCT00436046|12125247|FG001|NOT COMPLETED|Overall Study||0
10953491|NCT00436046|12125248|FG002|NOT COMPLETED|Overall Study||0
10953492|NCT00436163|12125256|FG000|STARTED|Overall Study||39
10953493|NCT00436163|12125256|FG000|COMPLETED|Overall Study||36
10953494|NCT00436163|12125256|FG000|NOT COMPLETED|Overall Study||3
10953495|NCT00436215|12125261|FG000|STARTED|Overall Study||55
10953496|NCT00436215|12125261|FG000|COMPLETED|Overall Study||51
10953497|NCT00436215|12125261|FG000|NOT COMPLETED|Overall Study||4
10953498|NCT00436280|12125265|FG000|STARTED|Period 1: Induction||68
10953499|NCT00436280|12125265|FG000|Received at Least 1 Dose of Study Drug|Period 1: Induction||68
10953500|NCT00436280|12125265|FG000|COMPLETED|Period 1: Induction||40
10953501|NCT00436280|12125265|FG000|NOT COMPLETED|Period 1: Induction||28
10953502|NCT00436280|12125265|FG000|STARTED|Period 2: Consolidation||40
10953503|NCT00436280|12125265|FG000|COMPLETED|Period 2: Consolidation||23
10953504|NCT00436280|12125265|FG000|NOT COMPLETED|Period 2: Consolidation||17
10953505|NCT00436280|12125265|FG000|STARTED|Period 3: Maintenance||23
10953506|NCT00436280|12125265|FG000|COMPLETED|Period 3: Maintenance||5
10953507|NCT00436280|12125265|FG000|NOT COMPLETED|Period 3: Maintenance||18
10953508|NCT00436332|12125269|FG000|STARTED|Overall Study||84
10953509|NCT00436332|12125269|FG000|Eligible|Overall Study||82
10953510|NCT00436332|12125269|FG000|Eligible and Began Protocol Therapy|Overall Study||79
10953511|NCT00436332|12125269|FG000|COMPLETED|Overall Study||1
10953512|NCT00436332|12125269|FG000|NOT COMPLETED|Overall Study||83
10953513|NCT00436345|12125275|FG000|STARTED|Overall Study||21
10953514|NCT00436345|12125276|FG001|STARTED|Overall Study||18
10953515|NCT00436345|12125275|FG000|COMPLETED|Overall Study||18
10953516|NCT00436345|12125276|FG001|COMPLETED|Overall Study||18
10953517|NCT00436345|12125275|FG000|NOT COMPLETED|Overall Study||3
10953518|NCT00436345|12125276|FG001|NOT COMPLETED|Overall Study||0
10953519|NCT00436436|12125283|FG000|STARTED|Overall Study||12
10953520|NCT00436436|12125283|FG000|COMPLETED|Overall Study||0
10953521|NCT00436436|12125283|FG000|NOT COMPLETED|Overall Study||12
10953522|NCT00436475|12125291|FG000|STARTED|Overall Study||23
10953523|NCT00436475|12125292|FG001|STARTED|Overall Study||23
10953524|NCT00436475|12125293|FG002|STARTED|Overall Study||22
10953525|NCT00436475|12125294|FG003|STARTED|Overall Study||24
10953526|NCT00436475|12125291|FG000|COMPLETED|Overall Study||23
10953527|NCT00436475|12125292|FG001|COMPLETED|Overall Study||22
10953528|NCT00436475|12125293|FG002|COMPLETED|Overall Study||21
10953529|NCT00436475|12125294|FG003|COMPLETED|Overall Study||22
10953530|NCT00436475|12125291|FG000|NOT COMPLETED|Overall Study||0
10953531|NCT00436475|12125292|FG001|NOT COMPLETED|Overall Study||1
10953532|NCT00436475|12125293|FG002|NOT COMPLETED|Overall Study||1
10953533|NCT00436475|12125294|FG003|NOT COMPLETED|Overall Study||2
10953534|NCT00436501|12125306|FG000|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
10953535|NCT00436501|12125307|FG001|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
10953536|NCT00436501|12125306|FG000|COMPLETED|Complete Study Participation||9
10953537|NCT00436501|12125307|FG001|COMPLETED|Complete Study Participation||49
10953538|NCT00436501|12125306|FG000|NOT COMPLETED|Complete Study Participation||0
10953539|NCT00436501|12125307|FG001|NOT COMPLETED|Complete Study Participation||0
10953540|NCT00436501|12125306|FG000|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
10953541|NCT00436501|12125307|FG001|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
10953542|NCT00436501|12125306|FG000|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
10953543|NCT00436501|12125307|FG001|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
10953544|NCT00436501|12125306|FG000|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
10953545|NCT00436501|12125307|FG001|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
10953546|NCT00436501|12125306|FG000|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
10953547|NCT00436501|12125307|FG001|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
10953548|NCT00436501|12125306|FG000|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
10953549|NCT00436501|12125307|FG001|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
10953550|NCT00436501|12125306|FG000|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
10953551|NCT00436501|12125307|FG001|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
10953552|NCT00436553|12125317|FG000|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
10953553|NCT00436553|12125318|FG001|STARTED|Overall Study||105
10953554|NCT00436553|12125319|FG002|STARTED|Overall Study||112
10953555|NCT00436553|12125317|FG000|COMPLETED|Overall Study|Completed the 12 month study phase.|91
10953556|NCT00436553|12125318|FG001|COMPLETED|Overall Study||93
10953557|NCT00436553|12125319|FG002|COMPLETED|Overall Study||102
10953558|NCT00436553|12125317|FG000|NOT COMPLETED|Overall Study||13
10953559|NCT00436553|12125318|FG001|NOT COMPLETED|Overall Study||12
10953560|NCT00436553|12125319|FG002|NOT COMPLETED|Overall Study||10
10953561|NCT00436605|12125327|FG000|STARTED|Overall Study||39
10953562|NCT00436605|12125327|FG000|COMPLETED|Overall Study||36
10953563|NCT00436605|12125327|FG000|NOT COMPLETED|Overall Study||3
10953564|NCT00436618|12125334|FG000|STARTED|Overall Study||114
10953565|NCT00436618|12125335|FG001|STARTED|Overall Study||55
10953566|NCT00436618|12125336|FG002|STARTED|Overall Study||107
10953567|NCT00436618|12125334|FG000|COMPLETED|Overall Study||84
10953568|NCT00436618|12125335|FG001|COMPLETED|Overall Study||28
10953569|NCT00436618|12125336|FG002|COMPLETED|Overall Study||46
10953570|NCT00436618|12125334|FG000|NOT COMPLETED|Overall Study||30
10953571|NCT00436618|12125335|FG001|NOT COMPLETED|Overall Study||27
10953572|NCT00436618|12125336|FG002|NOT COMPLETED|Overall Study||61
10953573|NCT00436644|12125344|FG000|STARTED|Overall Study||18
10953574|NCT00436644|12125344|FG000|COMPLETED|Overall Study||15
10953575|NCT00436644|12125344|FG000|NOT COMPLETED|Overall Study||3
10953576|NCT00436748|12125350|FG000|STARTED|Overall Study||59
10953577|NCT00436748|12125351|FG001|STARTED|Overall Study||57
10953578|NCT00436748|12125350|FG000|Received Treatment|Overall Study||58
10953579|NCT00436748|12125351|FG001|Received Treatment|Overall Study||56
10953580|NCT00436748|12125350|FG000|COMPLETED|Overall Study||48
10953581|NCT00436748|12125351|FG001|COMPLETED|Overall Study||45
10953582|NCT00436748|12125350|FG000|NOT COMPLETED|Overall Study||11
10953583|NCT00436748|12125351|FG001|NOT COMPLETED|Overall Study||12
10953584|NCT00436852|12125359|FG000|STARTED|Overall Study||45
10953585|NCT00436852|12125360|FG001|STARTED|Overall Study||47
10953586|NCT00436852|12125359|FG000|COMPLETED|Overall Study||10
10953587|NCT00436852|12125360|FG001|COMPLETED|Overall Study||2
10953588|NCT00436852|12125359|FG000|NOT COMPLETED|Overall Study||35
10953589|NCT00436852|12125360|FG001|NOT COMPLETED|Overall Study||45
10953590|NCT00436904|12125369|FG000|STARTED|Overall Study||30
10953591|NCT00436904|12125369|FG000|COMPLETED|Overall Study||30
10953592|NCT00436904|12125369|FG000|NOT COMPLETED|Overall Study||0
10953593|NCT00436917|12125373|FG000|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53
10953594|NCT00436917|12125373|FG000|COMPLETED|Overall Study||32
10953595|NCT00436917|12125373|FG000|NOT COMPLETED|Overall Study||21
10953596|NCT00436956|12125377|FG000|STARTED|Overall Study||36
10953597|NCT00436956|12125378|FG001|STARTED|Overall Study||23
10953598|NCT00436956|12125377|FG000|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
10953599|NCT00436956|12125378|FG001|COMPLETED|Overall Study||23
10953600|NCT00436956|12125377|FG000|NOT COMPLETED|Overall Study||1
10953601|NCT00436956|12125378|FG001|NOT COMPLETED|Overall Study||0
10953602|NCT00436969|12125387|FG000|STARTED|Overall Study||88
10953603|NCT00436969|12125388|FG001|STARTED|Overall Study||186
10953604|NCT00436969|12125387|FG000|Randomized But Not Treated|Overall Study||1
10953605|NCT00436969|12125388|FG001|Randomized But Not Treated|Overall Study||3
10953606|NCT00436969|12125387|FG000|COMPLETED|Overall Study||66
10953607|NCT00436969|12125388|FG001|COMPLETED|Overall Study||134
10953608|NCT00436969|12125387|FG000|NOT COMPLETED|Overall Study||22
10953609|NCT00436969|12125388|FG001|NOT COMPLETED|Overall Study||52
10953610|NCT00436982|12125396|FG000|STARTED|Overall Study||30
10953611|NCT00436982|12125397|FG001|STARTED|Overall Study||30
10953612|NCT00436982|12125396|FG000|COMPLETED|Overall Study||26
10953613|NCT00436982|12125397|FG001|COMPLETED|Overall Study||26
10953614|NCT00436982|12125396|FG000|NOT COMPLETED|Overall Study||4
10953615|NCT00436982|12125397|FG001|NOT COMPLETED|Overall Study||4
10953616|NCT00437034|12125407|FG000|STARTED|Overall Study||6
10953617|NCT00437034|12125407|FG000|COMPLETED|Overall Study||0
10953618|NCT00437034|12125407|FG000|NOT COMPLETED|Overall Study||6
10953619|NCT00437073|12125413|FG000|STARTED|Overall Study||13
10953620|NCT00437073|12125414|FG001|STARTED|Overall Study||9
10953621|NCT00437073|12125413|FG000|COMPLETED|Overall Study||12
10953622|NCT00437073|12125414|FG001|COMPLETED|Overall Study||8
10953623|NCT00437073|12125413|FG000|NOT COMPLETED|Overall Study||1
10953624|NCT00437073|12125414|FG001|NOT COMPLETED|Overall Study||1
10953625|NCT00437125|12125420|FG000|STARTED|Overall Study||151
10953626|NCT00437125|12125420|FG000|COMPLETED|Overall Study||119
10953627|NCT00437125|12125420|FG000|NOT COMPLETED|Overall Study||32
10953628|NCT00437203|12125434|FG000|STARTED|Overall Study||6
10953629|NCT00437203|12125435|FG001|STARTED|Overall Study||8
10953630|NCT00437203|12125436|FG002|STARTED|Overall Study||3
10953631|NCT00437203|12125437|FG003|STARTED|Overall Study||3
10953632|NCT00437203|12125438|FG004|STARTED|Overall Study||3
10953633|NCT00437203|12125439|FG005|STARTED|Overall Study||3
10953634|NCT00437203|12125440|FG006|STARTED|Overall Study||7
10953635|NCT00437203|12125441|FG007|STARTED|Overall Study||3
10953636|NCT00437203|12125442|FG008|STARTED|Overall Study||3
10953637|NCT00437203|12125443|FG009|STARTED|Overall Study||4
10953638|NCT00437203|12125434|FG000|COMPLETED|Overall Study||0
10953639|NCT00437203|12125435|FG001|COMPLETED|Overall Study||0
10953640|NCT00437203|12125436|FG002|COMPLETED|Overall Study||0
10953641|NCT00437203|12125437|FG003|COMPLETED|Overall Study||0
10953642|NCT00437203|12125438|FG004|COMPLETED|Overall Study||0
10953643|NCT00437203|12125439|FG005|COMPLETED|Overall Study||0
10953644|NCT00437203|12125440|FG006|COMPLETED|Overall Study||0
10953645|NCT00437203|12125441|FG007|COMPLETED|Overall Study||0
10953646|NCT00437203|12125442|FG008|COMPLETED|Overall Study||0
10953647|NCT00437203|12125443|FG009|COMPLETED|Overall Study||0
10953648|NCT00437203|12125434|FG000|NOT COMPLETED|Overall Study||6
10953649|NCT00437203|12125435|FG001|NOT COMPLETED|Overall Study||8
10953650|NCT00437203|12125436|FG002|NOT COMPLETED|Overall Study||3
10953651|NCT00437203|12125437|FG003|NOT COMPLETED|Overall Study||3
10953652|NCT00437203|12125438|FG004|NOT COMPLETED|Overall Study||3
10953653|NCT00437203|12125439|FG005|NOT COMPLETED|Overall Study||3
10953654|NCT00437203|12125440|FG006|NOT COMPLETED|Overall Study||7
10953655|NCT00437203|12125441|FG007|NOT COMPLETED|Overall Study||3
10953656|NCT00437203|12125442|FG008|NOT COMPLETED|Overall Study||3
10953657|NCT00437203|12125443|FG009|NOT COMPLETED|Overall Study||4
10953658|NCT00437268|12125476|FG000|STARTED|Overall Study||13
10953659|NCT00437268|12125477|FG001|STARTED|Overall Study||13
10953660|NCT00437268|12125476|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13
10953661|NCT00437268|12125477|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
10953662|NCT00437268|12125476|FG000|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|13
10953663|NCT00437268|12125477|FG001|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|12
10953664|NCT00437268|12125476|FG000|COMPLETED|Overall Study||0
10953665|NCT00437268|12125477|FG001|COMPLETED|Overall Study||0
10953666|NCT00437268|12125476|FG000|NOT COMPLETED|Overall Study||13
10953667|NCT00437268|12125477|FG001|NOT COMPLETED|Overall Study||13
10953668|NCT00437281|12125505|FG000|STARTED|Overall Study||3
10953669|NCT00437281|12125506|FG001|STARTED|Overall Study||3
10953670|NCT00437281|12125507|FG002|STARTED|Overall Study||3
10953671|NCT00437281|12125508|FG003|STARTED|Overall Study||3
10953672|NCT00437281|12125509|FG004|STARTED|Overall Study||4
10953673|NCT00437281|12125510|FG005|STARTED|Overall Study||4
10953674|NCT00437281|12125511|FG006|STARTED|Overall Study||3
10953675|NCT00437281|12125512|FG007|STARTED|Overall Study||3
10953676|NCT00437281|12125513|FG008|STARTED|Overall Study||3
10953677|NCT00437281|12125514|FG009|STARTED|Overall Study||5
10953678|NCT00437281|12125515|FG010|STARTED|Overall Study||3
10953679|NCT00437281|12125516|FG011|STARTED|Overall Study||3
10953680|NCT00437281|12125517|FG012|STARTED|Overall Study||2
10953681|NCT00437281|12125518|FG013|STARTED|Overall Study||3
10953682|NCT00437281|12125519|FG014|STARTED|Overall Study||5
10953683|NCT00437281|12125520|FG015|STARTED|Overall Study||3
10953684|NCT00437281|12125521|FG016|STARTED|Overall Study||3
10953685|NCT00437281|12125522|FG017|STARTED|Overall Study||4
10953686|NCT00437281|12125523|FG018|STARTED|Overall Study||2
10953687|NCT00437281|12125524|FG019|STARTED|Overall Study||3
10953688|NCT00437281|12125505|FG000|COMPLETED|Overall Study||3
10953689|NCT00437281|12125506|FG001|COMPLETED|Overall Study||3
10953690|NCT00437281|12125507|FG002|COMPLETED|Overall Study||3
10953691|NCT00437281|12125508|FG003|COMPLETED|Overall Study||2
10953692|NCT00437281|12125509|FG004|COMPLETED|Overall Study||4
10953693|NCT00437281|12125510|FG005|COMPLETED|Overall Study||3
10953694|NCT00437281|12125511|FG006|COMPLETED|Overall Study||3
10953695|NCT00437281|12125512|FG007|COMPLETED|Overall Study||3
10953696|NCT00437281|12125513|FG008|COMPLETED|Overall Study||3
10953697|NCT00437281|12125514|FG009|COMPLETED|Overall Study||4
10953698|NCT00437281|12125515|FG010|COMPLETED|Overall Study||3
10953699|NCT00437281|12125516|FG011|COMPLETED|Overall Study||3
10953700|NCT00437281|12125517|FG012|COMPLETED|Overall Study||2
10953701|NCT00437281|12125518|FG013|COMPLETED|Overall Study||2
10953702|NCT00437281|12125519|FG014|COMPLETED|Overall Study||4
10953703|NCT00437281|12125520|FG015|COMPLETED|Overall Study||3
10953704|NCT00437281|12125521|FG016|COMPLETED|Overall Study||3
10953705|NCT00437281|12125522|FG017|COMPLETED|Overall Study||4
10953706|NCT00437281|12125523|FG018|COMPLETED|Overall Study||1
10953707|NCT00437281|12125524|FG019|COMPLETED|Overall Study||2
10953708|NCT00437281|12125505|FG000|NOT COMPLETED|Overall Study||0
10953709|NCT00437281|12125506|FG001|NOT COMPLETED|Overall Study||0
10953710|NCT00437281|12125507|FG002|NOT COMPLETED|Overall Study||0
10953711|NCT00437281|12125508|FG003|NOT COMPLETED|Overall Study||1
10953712|NCT00437281|12125509|FG004|NOT COMPLETED|Overall Study||0
10953713|NCT00437281|12125510|FG005|NOT COMPLETED|Overall Study||1
10953714|NCT00437281|12125511|FG006|NOT COMPLETED|Overall Study||0
10953715|NCT00437281|12125512|FG007|NOT COMPLETED|Overall Study||0
10953716|NCT00437281|12125513|FG008|NOT COMPLETED|Overall Study||0
10953717|NCT00437281|12125514|FG009|NOT COMPLETED|Overall Study||1
10953718|NCT00437281|12125515|FG010|NOT COMPLETED|Overall Study||0
10953719|NCT00437281|12125516|FG011|NOT COMPLETED|Overall Study||0
10953720|NCT00437281|12125517|FG012|NOT COMPLETED|Overall Study||0
10953721|NCT00437281|12125518|FG013|NOT COMPLETED|Overall Study||1
10953722|NCT00437281|12125519|FG014|NOT COMPLETED|Overall Study||1
10953723|NCT00437281|12125520|FG015|NOT COMPLETED|Overall Study||0
10953724|NCT00437281|12125521|FG016|NOT COMPLETED|Overall Study||0
10953725|NCT00437281|12125522|FG017|NOT COMPLETED|Overall Study||0
10953726|NCT00437281|12125523|FG018|NOT COMPLETED|Overall Study||1
10953727|NCT00437281|12125524|FG019|NOT COMPLETED|Overall Study||1
10953728|NCT00437294|12125598|FG000|STARTED|Overall Study||43
10953729|NCT00437294|12125599|FG001|STARTED|Overall Study||43
10953730|NCT00437294|12125598|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
10953731|NCT00437294|12125599|FG001|Received at Least 1 Dose of Study Drug|Overall Study||43
10953732|NCT00437294|12125598|FG000|COMPLETED|Overall Study||0
10953733|NCT00437294|12125599|FG001|COMPLETED|Overall Study||0
10953734|NCT00437294|12125598|FG000|NOT COMPLETED|Overall Study||43
10953735|NCT00437294|12125599|FG001|NOT COMPLETED|Overall Study||43
10953736|NCT00437489|12125613|FG000|STARTED|Overall Study||25
10953737|NCT00437489|12125614|FG001|STARTED|Overall Study||24
10953738|NCT00437489|12125613|FG000|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
10953739|NCT00437489|12125614|FG001|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
10953740|NCT00437489|12125613|FG000|NOT COMPLETED|Overall Study||23
10953741|NCT00437489|12125614|FG001|NOT COMPLETED|Overall Study||22
10953742|NCT00437645|12125622|FG000|STARTED|Overall Study||592
10953743|NCT00437645|12125623|FG001|STARTED|Overall Study||591
10953744|NCT00437645|12125622|FG000|COMPLETED|Overall Study||557
10953745|NCT00437645|12125623|FG001|COMPLETED|Overall Study||476
10953746|NCT00437645|12125622|FG000|NOT COMPLETED|Overall Study||35
10953747|NCT00437645|12125623|FG001|NOT COMPLETED|Overall Study||115
10953748|NCT00437658|12125632|FG000|STARTED|Treatment Period (24 Weeks)||84
10953749|NCT00437658|12125633|FG001|STARTED|Treatment Period (24 Weeks)||84
10953750|NCT00437658|12125634|FG002|STARTED|Treatment Period (24 Weeks)||84
10953751|NCT00437658|12125632|FG000|Received Study Drug|Treatment Period (24 Weeks)||84
10953752|NCT00437658|12125633|FG001|Received Study Drug|Treatment Period (24 Weeks)||84
10953753|NCT00437658|12125634|FG002|Received Study Drug|Treatment Period (24 Weeks)||84
10953754|NCT00437658|12125632|FG000|COMPLETED|Treatment Period (24 Weeks)||56
10953755|NCT00437658|12125633|FG001|COMPLETED|Treatment Period (24 Weeks)||62
10953756|NCT00437658|12125634|FG002|COMPLETED|Treatment Period (24 Weeks)||51
10953757|NCT00437658|12125632|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||28
10953758|NCT00437658|12125633|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||22
10953759|NCT00437658|12125634|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||33
10953760|NCT00437658|12125632|FG000|STARTED|Post-treatment Period (24 Weeks)||56
10953761|NCT00437658|12125633|FG001|STARTED|Post-treatment Period (24 Weeks)||62
10953762|NCT00437658|12125634|FG002|STARTED|Post-treatment Period (24 Weeks)||51
10953763|NCT00437658|12125632|FG000|COMPLETED|Post-treatment Period (24 Weeks)||32
10953764|NCT00437658|12125633|FG001|COMPLETED|Post-treatment Period (24 Weeks)||54
10953765|NCT00437658|12125634|FG002|COMPLETED|Post-treatment Period (24 Weeks)||37
10953766|NCT00437658|12125632|FG000|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
10953767|NCT00437658|12125633|FG001|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
10953768|NCT00437658|12125634|FG002|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
10953769|NCT00437983|12125644|FG000|STARTED|Overall Study||79
10953770|NCT00437983|12125645|FG001|STARTED|Overall Study||78
10953771|NCT00437983|12125644|FG000|COMPLETED|Overall Study||66
10953772|NCT00437983|12125645|FG001|COMPLETED|Overall Study||65
10953773|NCT00437983|12125644|FG000|NOT COMPLETED|Overall Study||13
10953774|NCT00437983|12125645|FG001|NOT COMPLETED|Overall Study||13
10953775|NCT00438100|12125653|FG000|STARTED|Overall Study||73
10953776|NCT00438100|12125654|FG001|STARTED|Overall Study||69
10953777|NCT00438100|12125653|FG000|COMPLETED|Overall Study||71
10953778|NCT00438100|12125654|FG001|COMPLETED|Overall Study||65
10953779|NCT00438100|12125653|FG000|NOT COMPLETED|Overall Study||2
10953780|NCT00438100|12125654|FG001|NOT COMPLETED|Overall Study||4
10953781|NCT00438191|12125662|FG000|STARTED|Overall Study||43
10953782|NCT00438191|12125663|FG001|STARTED|Overall Study||40
10953783|NCT00438191|12125662|FG000|COMPLETED|Overall Study||32
10953784|NCT00438191|12125663|FG001|COMPLETED|Overall Study||26
10953785|NCT00438191|12125662|FG000|NOT COMPLETED|Overall Study||11
10953786|NCT00438191|12125663|FG001|NOT COMPLETED|Overall Study||14
10953787|NCT00438204|12125669|FG000|STARTED|Overall Study||39
10953788|NCT00438204|12125669|FG000|COMPLETED|Overall Study||39
10953789|NCT00438204|12125669|FG000|NOT COMPLETED|Overall Study||0
10953790|NCT00438256|12125674|FG000|STARTED|Overall Study||3
10953791|NCT00438256|12125675|FG001|STARTED|Overall Study||3
10953792|NCT00438256|12125676|FG002|STARTED|Overall Study||3
10953793|NCT00438256|12125677|FG003|STARTED|Overall Study||41
10953794|NCT00438256|12125674|FG000|Surgical Resection|Overall Study||1
10953795|NCT00438256|12125675|FG001|Surgical Resection|Overall Study||2
10953796|NCT00438256|12125676|FG002|Surgical Resection|Overall Study||2
10953797|NCT00438256|12125677|FG003|Surgical Resection|Overall Study||34
10953798|NCT00438256|12125674|FG000|COMPLETED|Overall Study||1
10953799|NCT00438256|12125675|FG001|COMPLETED|Overall Study||2
10953800|NCT00438256|12125676|FG002|COMPLETED|Overall Study||2
10953801|NCT00438256|12125677|FG003|COMPLETED|Overall Study||32
10953802|NCT00438256|12125674|FG000|NOT COMPLETED|Overall Study||2
10953803|NCT00438256|12125675|FG001|NOT COMPLETED|Overall Study||1
10953804|NCT00438256|12125676|FG002|NOT COMPLETED|Overall Study||1
10953805|NCT00438256|12125677|FG003|NOT COMPLETED|Overall Study||9
10953806|NCT00438360|12125692|FG000|STARTED|Overall Study|"Started indicates randomized patients."|162
10953807|NCT00438360|12125693|FG001|STARTED|Overall Study||81
10953808|NCT00438360|12125692|FG000|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
10953809|NCT00438360|12125693|FG001|Intention to Treat (ITT) Population|Overall Study||79
10953810|NCT00438360|12125692|FG000|COMPLETED|Overall Study||90
10953811|NCT00438360|12125693|FG001|COMPLETED|Overall Study||38
10953812|NCT00438360|12125692|FG000|NOT COMPLETED|Overall Study||72
10953813|NCT00438360|12125693|FG001|NOT COMPLETED|Overall Study||43
10953814|NCT00438399|12125702|FG000|STARTED|Overall Study||38
10953815|NCT00438399|12125703|FG001|STARTED|Overall Study||40
10953816|NCT00438399|12125704|FG002|STARTED|Overall Study||35
10953817|NCT00438399|12125705|FG003|STARTED|Overall Study||36
10953818|NCT00438399|12125706|FG004|STARTED|Overall Study||33
10953819|NCT00438399|12125707|FG005|STARTED|Overall Study||37
10953820|NCT00438399|12125702|FG000|TREATED & ANALYZED|Overall Study||30
10953821|NCT00438399|12125703|FG001|TREATED & ANALYZED|Overall Study||32
10953822|NCT00438399|12125704|FG002|TREATED & ANALYZED|Overall Study||28
10953823|NCT00438399|12125705|FG003|TREATED & ANALYZED|Overall Study||32
10953824|NCT00438399|12125706|FG004|TREATED & ANALYZED|Overall Study||30
10953825|NCT00438399|12125707|FG005|TREATED & ANALYZED|Overall Study||31
10953826|NCT00438399|12125702|FG000|COMPLETED|Overall Study||30
10953827|NCT00438399|12125703|FG001|COMPLETED|Overall Study||32
10953828|NCT00438399|12125704|FG002|COMPLETED|Overall Study||28
10953829|NCT00438399|12125705|FG003|COMPLETED|Overall Study||32
10953830|NCT00438399|12125706|FG004|COMPLETED|Overall Study||30
10953831|NCT00438399|12125707|FG005|COMPLETED|Overall Study||31
10953832|NCT00438399|12125702|FG000|NOT COMPLETED|Overall Study||8
10953833|NCT00438399|12125703|FG001|NOT COMPLETED|Overall Study||8
10953834|NCT00438399|12125704|FG002|NOT COMPLETED|Overall Study||7
10953835|NCT00438399|12125705|FG003|NOT COMPLETED|Overall Study||4
10953836|NCT00438399|12125706|FG004|NOT COMPLETED|Overall Study||3
10953837|NCT00438399|12125707|FG005|NOT COMPLETED|Overall Study||6
10953838|NCT00438451|12125719|FG000|STARTED|Overall Study||122
10953839|NCT00438451|12125720|FG001|STARTED|Overall Study||121
10953840|NCT00438451|12125721|FG002|STARTED|Overall Study||118
10953841|NCT00438451|12125719|FG000|Safety Population|Overall Study||122
10953842|NCT00438451|12125720|FG001|Safety Population|Overall Study||121
10953843|NCT00438451|12125721|FG002|Safety Population|Overall Study||117
10953844|NCT00438451|12125719|FG000|ITT Population|Overall Study||122
10953845|NCT00438451|12125720|FG001|ITT Population|Overall Study||120
10953846|NCT00438451|12125721|FG002|ITT Population|Overall Study||117
10953847|NCT00438451|12125719|FG000|Maintenance Phase (Week 7-58)|Overall Study||93
10953848|NCT00438451|12125720|FG001|Maintenance Phase (Week 7-58)|Overall Study||89
10953849|NCT00438451|12125721|FG002|Maintenance Phase (Week 7-58)|Overall Study||93
10953850|NCT00438451|12125719|FG000|COMPLETED|Overall Study||75
10953851|NCT00438451|12125720|FG001|COMPLETED|Overall Study||55
10953852|NCT00438451|12125721|FG002|COMPLETED|Overall Study||65
10953853|NCT00438451|12125719|FG000|NOT COMPLETED|Overall Study||47
10953854|NCT00438451|12125720|FG001|NOT COMPLETED|Overall Study||66
10953855|NCT00438451|12125721|FG002|NOT COMPLETED|Overall Study||53
10953856|NCT00438464|12125731|FG000|STARTED|Overall Study||103
10953857|NCT00438464|12125732|FG001|STARTED|Overall Study||101
10953858|NCT00438464|12125731|FG000|Received Assigned Intervention|Overall Study||89
10953859|NCT00438464|12125732|FG001|Received Assigned Intervention|Overall Study||94
10953860|NCT00438464|12125731|FG000|COMPLETED|Overall Study||89
10953861|NCT00438464|12125732|FG001|COMPLETED|Overall Study||94
10953862|NCT00438464|12125731|FG000|NOT COMPLETED|Overall Study||14
10953863|NCT00438464|12125732|FG001|NOT COMPLETED|Overall Study||7
10953864|NCT00438490|12125752|FG000|STARTED|Overall Study||12
10953865|NCT00438490|12125753|FG001|STARTED|Overall Study||9
10953866|NCT00438490|12125752|FG000|COMPLETED|Overall Study||12
10953867|NCT00438490|12125753|FG001|COMPLETED|Overall Study||9
10953868|NCT00438490|12125752|FG000|NOT COMPLETED|Overall Study||0
10953869|NCT00438490|12125753|FG001|NOT COMPLETED|Overall Study||0
10953870|NCT00438633|12125765|FG000|STARTED|Overall Study||32
10953871|NCT00438633|12125766|FG001|STARTED|Overall Study||31
10953872|NCT00438633|12125765|FG000|3-month Follow-up|Overall Study||26
10953873|NCT00438633|12125766|FG001|3-month Follow-up|Overall Study||24
10953874|NCT00438633|12125765|FG000|COMPLETED|Overall Study||16
10953875|NCT00438633|12125766|FG001|COMPLETED|Overall Study||14
10953876|NCT00438633|12125765|FG000|NOT COMPLETED|Overall Study||16
10953877|NCT00438633|12125766|FG001|NOT COMPLETED|Overall Study||17
10953878|NCT00438659|12125774|FG000|STARTED|Overall Study||90
10953879|NCT00438659|12125775|FG001|STARTED|Overall Study||86
10953880|NCT00438659|12125774|FG000|COMPLETED|Overall Study||84
10953881|NCT00438659|12125775|FG001|COMPLETED|Overall Study||82
10953882|NCT00438659|12125774|FG000|NOT COMPLETED|Overall Study||6
10953883|NCT00438659|12125775|FG001|NOT COMPLETED|Overall Study||4
10953884|NCT00438672|12125784|FG000|STARTED|Overall Study||31
10953885|NCT00438672|12125785|FG001|STARTED|Overall Study||33
10953886|NCT00438672|12125784|FG000|COMPLETED|Overall Study||24
10953887|NCT00438672|12125785|FG001|COMPLETED|Overall Study||24
10953888|NCT00438672|12125784|FG000|NOT COMPLETED|Overall Study||7
10953889|NCT00438672|12125785|FG001|NOT COMPLETED|Overall Study||9
10953890|NCT00438750|12125793|FG000|STARTED|Overall Study||48
10953891|NCT00438750|12125794|FG001|STARTED|Overall Study||46
10953892|NCT00438750|12125793|FG000|COMPLETED|Overall Study||39
10953893|NCT00438750|12125794|FG001|COMPLETED|Overall Study||37
10953894|NCT00438750|12125793|FG000|NOT COMPLETED|Overall Study||9
10953895|NCT00438750|12125794|FG001|NOT COMPLETED|Overall Study||9
10953896|NCT00438802|12125803|FG000|STARTED|Overall Study||6
10953897|NCT00438802|12125804|FG001|STARTED|Overall Study||8
10953898|NCT00438802|12125805|FG002|STARTED|Overall Study||9
10953899|NCT00438802|12125803|FG000|COMPLETED|Overall Study||6
10953900|NCT00438802|12125804|FG001|COMPLETED|Overall Study||8
10953901|NCT00438802|12125805|FG002|COMPLETED|Overall Study||9
10953902|NCT00438802|12125803|FG000|NOT COMPLETED|Overall Study||0
10953903|NCT00438802|12125804|FG001|NOT COMPLETED|Overall Study||0
10953904|NCT00438802|12125805|FG002|NOT COMPLETED|Overall Study||0
10953905|NCT00438815|12125815|FG000|STARTED|Overall Study||113
10953906|NCT00438815|12125815|FG000|COMPLETED|Overall Study||43
10953907|NCT00438815|12125815|FG000|NOT COMPLETED|Overall Study||70
10953908|NCT00438854|12125819|FG000|STARTED|Overall Study||15
10953909|NCT00438854|12125819|FG000|COMPLETED|Overall Study||15
10953910|NCT00438854|12125819|FG000|NOT COMPLETED|Overall Study||0
10953911|NCT00438880|12125825|FG000|STARTED|Overall Study||30
10953912|NCT00438880|12125826|FG001|STARTED|Overall Study||8
10953913|NCT00438880|12125825|FG000|COMPLETED|Overall Study||30
10953914|NCT00438880|12125826|FG001|COMPLETED|Overall Study||8
10953915|NCT00438880|12125825|FG000|NOT COMPLETED|Overall Study||0
10953916|NCT00438880|12125826|FG001|NOT COMPLETED|Overall Study||0
10953917|NCT00438932|12125836|FG000|STARTED|Overall Study||4
10953918|NCT00438932|12125837|FG001|STARTED|Overall Study||4
10953919|NCT00438932|12125838|FG002|STARTED|Overall Study||4
10953920|NCT00438932|12125839|FG003|STARTED|Overall Study||4
10953921|NCT00438932|12125836|FG000|COMPLETED|Overall Study||4
10953922|NCT00438932|12125837|FG001|COMPLETED|Overall Study||4
10953923|NCT00438932|12125838|FG002|COMPLETED|Overall Study||4
10953924|NCT00438932|12125839|FG003|COMPLETED|Overall Study||4
10953925|NCT00438932|12125836|FG000|NOT COMPLETED|Overall Study||0
10953926|NCT00438932|12125837|FG001|NOT COMPLETED|Overall Study||0
10953927|NCT00438932|12125838|FG002|NOT COMPLETED|Overall Study||0
10953928|NCT00438932|12125839|FG003|NOT COMPLETED|Overall Study||0
10953929|NCT00438971|12125849|FG000|STARTED|Overall Study||17
10953930|NCT00438971|12125849|FG000|COMPLETED|Overall Study||15
10953931|NCT00438971|12125849|FG000|NOT COMPLETED|Overall Study||2
10953932|NCT00439140|12125857|FG000|STARTED|Treatment Cycle 1||15
10953933|NCT00439140|12125858|FG001|STARTED|Treatment Cycle 1||14
10953934|NCT00439140|12125859|FG002|STARTED|Treatment Cycle 1||12
10953935|NCT00439140|12125857|FG000|COMPLETED|Treatment Cycle 1||14
10953936|NCT00439140|12125858|FG001|COMPLETED|Treatment Cycle 1||10
10953937|NCT00439140|12125859|FG002|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
10953938|NCT00439140|12125857|FG000|NOT COMPLETED|Treatment Cycle 1||1
10953939|NCT00439140|12125858|FG001|NOT COMPLETED|Treatment Cycle 1||4
10953940|NCT00439140|12125859|FG002|NOT COMPLETED|Treatment Cycle 1||1
10953941|NCT00439140|12125857|FG000|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
10953942|NCT00439140|12125858|FG001|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
10953943|NCT00439140|12125859|FG002|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
10953944|NCT00439140|12125857|FG000|COMPLETED|Treatment Cycle 2||11
10953945|NCT00439140|12125858|FG001|COMPLETED|Treatment Cycle 2||6
10953946|NCT00439140|12125859|FG002|COMPLETED|Treatment Cycle 2||0
10953947|NCT00439140|12125857|FG000|NOT COMPLETED|Treatment Cycle 2||2
10953948|NCT00439140|12125858|FG001|NOT COMPLETED|Treatment Cycle 2||1
10953949|NCT00439140|12125859|FG002|NOT COMPLETED|Treatment Cycle 2||0
10953950|NCT00439179|12125871|FG000|STARTED|Overall Study|1 with biliary|3
10953951|NCT00439179|12125872|FG001|STARTED|Overall Study|2 with biliary|13
10953952|NCT00439179|12125873|FG002|STARTED|Overall Study|2 with biliary|6
10953953|NCT00439179|12125874|FG003|STARTED|Overall Study|2 with biliry|5
10953954|NCT00439179|12125871|FG000|COMPLETED|Overall Study||3
10953955|NCT00439179|12125872|FG001|COMPLETED|Overall Study||11
10953956|NCT00439179|12125873|FG002|COMPLETED|Overall Study||6
10953957|NCT00439179|12125874|FG003|COMPLETED|Overall Study||5
10953958|NCT00439179|12125871|FG000|NOT COMPLETED|Overall Study||0
10953959|NCT00439179|12125872|FG001|NOT COMPLETED|Overall Study||2
10953960|NCT00439179|12125873|FG002|NOT COMPLETED|Overall Study||0
10953961|NCT00439179|12125874|FG003|NOT COMPLETED|Overall Study||0
10953962|NCT00439218|12125887|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||4
10953963|NCT00439218|12125887|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
10953964|NCT00439218|12125887|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
10953965|NCT00439218|12125887|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
10953966|NCT00439218|12125887|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
10953967|NCT00439218|12125887|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
10953968|NCT00439231|12125891|FG000|STARTED|Overall Study||33
10953969|NCT00439231|12125891|FG000|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
10953970|NCT00439231|12125891|FG000|NOT COMPLETED|Overall Study||28
10953971|NCT00439244|12125898|FG000|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
10953972|NCT00439244|12125899|FG001|STARTED|Overall Study||137
10953973|NCT00439244|12125900|FG002|STARTED|Overall Study||138
10953974|NCT00439244|12125898|FG000|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
10953975|NCT00439244|12125899|FG001|Safety Population|Overall Study||137
10953976|NCT00439244|12125900|FG002|Safety Population|Overall Study||137
10953977|NCT00439244|12125898|FG000|COMPLETED|Overall Study||126
10953978|NCT00439244|12125899|FG001|COMPLETED|Overall Study||131
10953979|NCT00439244|12125900|FG002|COMPLETED|Overall Study||131
10953980|NCT00439244|12125898|FG000|NOT COMPLETED|Overall Study||11
10953981|NCT00439244|12125899|FG001|NOT COMPLETED|Overall Study||6
10953982|NCT00439244|12125900|FG002|NOT COMPLETED|Overall Study||7
10953983|NCT00439270|12125913|FG000|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
10953984|NCT00439270|12125914|FG001|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
10953985|NCT00439270|12125915|FG002|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
10953986|NCT00439270|12125916|FG003|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
10953987|NCT00439270|12125917|FG004|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
10953988|NCT00439270|12125913|FG000|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
10953989|NCT00439270|12125914|FG001|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
10953990|NCT00439270|12125915|FG002|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
10953991|NCT00439270|12125916|FG003|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
10953992|NCT00439270|12125917|FG004|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
10953993|NCT00439270|12125913|FG000|NOT COMPLETED|Phase 1 (18.1 Months)||3
10953994|NCT00439270|12125914|FG001|NOT COMPLETED|Phase 1 (18.1 Months)||3
10953995|NCT00439270|12125915|FG002|NOT COMPLETED|Phase 1 (18.1 Months)||3
10953996|NCT00439270|12125916|FG003|NOT COMPLETED|Phase 1 (18.1 Months)||0
10953997|NCT00439270|12125917|FG004|NOT COMPLETED|Phase 1 (18.1 Months)||3
10953998|NCT00439270|12125913|FG000|STARTED|Phase 2 (51.6 Months)||0
10953999|NCT00439270|12125914|FG001|STARTED|Phase 2 (51.6 Months)||0
10954000|NCT00439270|12125915|FG002|STARTED|Phase 2 (51.6 Months)||0
10954001|NCT00439270|12125916|FG003|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
10954002|NCT00439270|12125917|FG004|STARTED|Phase 2 (51.6 Months)||0
10954003|NCT00439270|12125913|FG000|COMPLETED|Phase 2 (51.6 Months)||0
10954004|NCT00439270|12125914|FG001|COMPLETED|Phase 2 (51.6 Months)||0
10954005|NCT00439270|12125915|FG002|COMPLETED|Phase 2 (51.6 Months)||0
10954006|NCT00439270|12125916|FG003|COMPLETED|Phase 2 (51.6 Months)||0
10954007|NCT00439270|12125917|FG004|COMPLETED|Phase 2 (51.6 Months)||0
10954008|NCT00439270|12125913|FG000|NOT COMPLETED|Phase 2 (51.6 Months)||0
10954009|NCT00439270|12125914|FG001|NOT COMPLETED|Phase 2 (51.6 Months)||0
10954010|NCT00439270|12125915|FG002|NOT COMPLETED|Phase 2 (51.6 Months)||0
10954011|NCT00439270|12125916|FG003|NOT COMPLETED|Phase 2 (51.6 Months)||34
10954012|NCT00439270|12125917|FG004|NOT COMPLETED|Phase 2 (51.6 Months)||0
10954013|NCT00439296|12125938|FG000|STARTED|Overall Study||5
10954014|NCT00439296|12125939|FG001|STARTED|Overall Study||4
10954015|NCT00439296|12125938|FG000|Treatment Course 1|Overall Study||5
10954016|NCT00439296|12125939|FG001|Treatment Course 1|Overall Study||3
10954017|NCT00439296|12125938|FG000|Treatment Course 2|Overall Study||1
10954018|NCT00439296|12125939|FG001|Treatment Course 2|Overall Study||1
10954019|NCT00439296|12125938|FG000|COMPLETED|Overall Study||5
10954020|NCT00439296|12125939|FG001|COMPLETED|Overall Study||4
10954021|NCT00439296|12125938|FG000|NOT COMPLETED|Overall Study||0
10954022|NCT00439296|12125939|FG001|NOT COMPLETED|Overall Study||0
10954023|NCT00439309|12125947|FG000|STARTED|Treatment||54
10954024|NCT00439309|12125948|FG001|STARTED|Treatment||15
10954025|NCT00439309|12125947|FG000|COMPLETED|Treatment||54
10954026|NCT00439309|12125948|FG001|COMPLETED|Treatment||15
10954027|NCT00439309|12125947|FG000|NOT COMPLETED|Treatment||0
10954028|NCT00439309|12125948|FG001|NOT COMPLETED|Treatment||0
10954029|NCT00439309|12125947|FG000|STARTED|Follow-Up||54
10954030|NCT00439309|12125948|FG001|STARTED|Follow-Up||15
10954031|NCT00439309|12125947|FG000|COMPLETED|Follow-Up||51
10954032|NCT00439309|12125948|FG001|COMPLETED|Follow-Up||13
10954033|NCT00439309|12125947|FG000|NOT COMPLETED|Follow-Up||3
10954034|NCT00439309|12125948|FG001|NOT COMPLETED|Follow-Up||2
10954035|NCT00439335|12125956|FG000|STARTED|Overall Study||113
10954036|NCT00439335|12125957|FG001|STARTED|Overall Study||114
10954037|NCT00439335|12125956|FG000|COMPLETED|Overall Study||111
10954038|NCT00439335|12125957|FG001|COMPLETED|Overall Study||114
10954039|NCT00439335|12125956|FG000|NOT COMPLETED|Overall Study||2
10954040|NCT00439335|12125957|FG001|NOT COMPLETED|Overall Study||0
10954041|NCT00439374|12125965|FG000|STARTED|Overall Study||327
10954042|NCT00439374|12125966|FG001|STARTED|Overall Study||330
10954043|NCT00439374|12125965|FG000|COMPLETED|Overall Study||327
10954044|NCT00439374|12125966|FG001|COMPLETED|Overall Study||330
10954045|NCT00439374|12125965|FG000|NOT COMPLETED|Overall Study||0
10954046|NCT00439374|12125966|FG001|NOT COMPLETED|Overall Study||0
10954047|NCT00439413|12125974|FG000|STARTED|Overall Study||121
10954048|NCT00439413|12125975|FG001|STARTED|Overall Study||125
10954049|NCT00439413|12125974|FG000|COMPLETED|Overall Study||90
10954050|NCT00439413|12125975|FG001|COMPLETED|Overall Study||88
10954051|NCT00439413|12125974|FG000|NOT COMPLETED|Overall Study||31
10954052|NCT00439413|12125975|FG001|NOT COMPLETED|Overall Study||37
10954053|NCT00439465|12125983|FG000|STARTED|Overall Study||23
10954054|NCT00439465|12125983|FG000|COMPLETED|Overall Study||19
10954055|NCT00439465|12125983|FG000|NOT COMPLETED|Overall Study||4
10954056|NCT00439517|12125992|FG000|STARTED|Overall Study||152
10954057|NCT00439517|12125993|FG001|STARTED|Overall Study||150
10954058|NCT00439517|12125992|FG000|COMPLETED|Overall Study||150
10954059|NCT00439517|12125993|FG001|COMPLETED|Overall Study||150
10954060|NCT00439517|12125992|FG000|NOT COMPLETED|Overall Study||2
10954061|NCT00439517|12125993|FG001|NOT COMPLETED|Overall Study||0
10954062|NCT00439556|12126002|FG000|STARTED|Overall Study||36
10954063|NCT00439556|12126003|FG001|STARTED|Overall Study||4
10954064|NCT00439556|12126004|FG002|STARTED|Overall Study||0
10954065|NCT00439556|12126002|FG000|COMPLETED|Overall Study||36
10954066|NCT00439556|12126003|FG001|COMPLETED|Overall Study||3
10954067|NCT00439556|12126004|FG002|COMPLETED|Overall Study||0
10954068|NCT00439556|12126002|FG000|NOT COMPLETED|Overall Study||0
10954069|NCT00439556|12126003|FG001|NOT COMPLETED|Overall Study||1
10954070|NCT00439556|12126004|FG002|NOT COMPLETED|Overall Study||0
10954071|NCT00439608|12126013|FG000|STARTED|Overall Study||60
10954072|NCT00439608|12126013|FG000|COMPLETED|Overall Study||60
10954073|NCT00439608|12126013|FG000|NOT COMPLETED|Overall Study||0
10954074|NCT00439647|12126019|FG000|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
10954075|NCT00439647|12126020|FG001|STARTED|Overall Study||611
10954076|NCT00439647|12126019|FG000|Modified Intent to Treat (mITT)|Overall Study||553
10954077|NCT00439647|12126020|FG001|Modified Intent to Treat (mITT)|Overall Study||574
10954078|NCT00439647|12126019|FG000|COMPLETED|Overall Study||530
10954079|NCT00439647|12126020|FG001|COMPLETED|Overall Study||540
10954080|NCT00439647|12126019|FG000|NOT COMPLETED|Overall Study||58
10954081|NCT00439647|12126020|FG001|NOT COMPLETED|Overall Study||71
10954082|NCT00439673|12126026|FG000|STARTED|Overall Study||62
10954083|NCT00439673|12126026|FG000|COMPLETED|Overall Study||26
10954084|NCT00439673|12126026|FG000|NOT COMPLETED|Overall Study||36
10954085|NCT00439725|12126032|FG000|STARTED|Treatment Period||602
10954086|NCT00439725|12126033|FG001|STARTED|Treatment Period||595
10954087|NCT00439725|12126032|FG000|Participants Received Treatment|Treatment Period|Safety population|598
10954088|NCT00439725|12126033|FG001|Participants Received Treatment|Treatment Period|Safety population|590
10954089|NCT00439725|12126032|FG000|COMPLETED|Treatment Period||366
10954090|NCT00439725|12126033|FG001|COMPLETED|Treatment Period||349
10954091|NCT00439725|12126032|FG000|NOT COMPLETED|Treatment Period||236
10954092|NCT00439725|12126033|FG001|NOT COMPLETED|Treatment Period||246
10954093|NCT00439725|12126032|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
10954094|NCT00439725|12126033|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
10954095|NCT00439725|12126032|FG000|COMPLETED|Observational Period||569
10954096|NCT00439725|12126033|FG001|COMPLETED|Observational Period||553
10954097|NCT00439725|12126032|FG000|NOT COMPLETED|Observational Period||8
10954098|NCT00439725|12126033|FG001|NOT COMPLETED|Observational Period||7
10954099|NCT00439777|12126041|FG000|STARTED|Treatment Period||2420
10954100|NCT00439777|12126042|FG001|STARTED|Treatment Period||2413
10954101|NCT00439777|12126041|FG000|Participants Received Treatment|Treatment Period||2412
10954102|NCT00439777|12126042|FG001|Participants Received Treatment|Treatment Period||2405
10954103|NCT00439777|12126041|FG000|COMPLETED|Treatment Period||2001
10954104|NCT00439777|12126042|FG001|COMPLETED|Treatment Period||1954
10954105|NCT00439777|12126041|FG000|NOT COMPLETED|Treatment Period||419
10954106|NCT00439777|12126042|FG001|NOT COMPLETED|Treatment Period||459
10954107|NCT00439777|12126041|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
10954108|NCT00439777|12126042|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
10954109|NCT00439777|12126041|FG000|COMPLETED|Observational Period||2165
10954110|NCT00439777|12126042|FG001|COMPLETED|Observational Period||2156
10954111|NCT00439777|12126041|FG000|NOT COMPLETED|Observational Period||41
10954112|NCT00439777|12126042|FG001|NOT COMPLETED|Observational Period||41
10954113|NCT00439946|12126048|FG000|STARTED|Overall Study||8
10954114|NCT00439946|12126048|FG000|COMPLETED|Overall Study||8
10954115|NCT00439946|12126048|FG000|NOT COMPLETED|Overall Study||0
10954116|NCT00440011|12126054|FG000|STARTED|Overall Study||131
10954117|NCT00440011|12126055|FG001|STARTED|Overall Study||135
10954118|NCT00440011|12126054|FG000|COMPLETED|Overall Study||127
10954119|NCT00440011|12126055|FG001|COMPLETED|Overall Study||132
10954120|NCT00440011|12126054|FG000|NOT COMPLETED|Overall Study||4
10954121|NCT00440011|12126055|FG001|NOT COMPLETED|Overall Study||3
10954122|NCT00440037|12126061|FG000|STARTED|Overall Study||44
10954123|NCT00440037|12126061|FG000|COMPLETED|Overall Study||35
10954124|NCT00440037|12126061|FG000|NOT COMPLETED|Overall Study||9
10954125|NCT00440050|12126067|FG000|STARTED|Overall Study||164
10954126|NCT00440050|12126068|FG001|STARTED|Overall Study||238
10954127|NCT00440050|12126067|FG000|COMPLETED|Overall Study||124
10954128|NCT00440050|12126068|FG001|COMPLETED|Overall Study||171
10954129|NCT00440050|12126067|FG000|NOT COMPLETED|Overall Study||40
10954130|NCT00440050|12126068|FG001|NOT COMPLETED|Overall Study||67
10954131|NCT00440115|12126077|FG000|STARTED|Overall Study||251
10954132|NCT00440115|12126078|FG001|STARTED|Overall Study||249
10954133|NCT00440115|12126079|FG002|STARTED|Overall Study||250
10954134|NCT00440115|12126077|FG000|COMPLETED|Overall Study||244
10954135|NCT00440115|12126078|FG001|COMPLETED|Overall Study||238
10954136|NCT00440115|12126079|FG002|COMPLETED|Overall Study||244
10954137|NCT00440115|12126077|FG000|NOT COMPLETED|Overall Study||7
10954138|NCT00440115|12126078|FG001|NOT COMPLETED|Overall Study||11
10954139|NCT00440115|12126079|FG002|NOT COMPLETED|Overall Study||6
10954140|NCT00440180|12126089|FG000|STARTED|Overall Study||10
10954141|NCT00440180|12126090|FG001|STARTED|Overall Study||10
10954142|NCT00440180|12126089|FG000|COMPLETED|Overall Study||10
10954143|NCT00440180|12126090|FG001|COMPLETED|Overall Study||10
10954144|NCT00440180|12126089|FG000|NOT COMPLETED|Overall Study||0
10954145|NCT00440180|12126090|FG001|NOT COMPLETED|Overall Study||0
10954146|NCT00440193|12126098|FG000|STARTED|Treatment Period||1731
10954147|NCT00440193|12126099|FG001|STARTED|Treatment Period||1718
10954148|NCT00440193|12126098|FG000|Participants Received Treatment|Treatment Period||1718
10954149|NCT00440193|12126099|FG001|Participants Received Treatment|Treatment Period||1711
10954150|NCT00440193|12126098|FG000|COMPLETED|Treatment Period||1426
10954151|NCT00440193|12126099|FG001|COMPLETED|Treatment Period||1367
10954152|NCT00440193|12126098|FG000|NOT COMPLETED|Treatment Period||305
10954153|NCT00440193|12126099|FG001|NOT COMPLETED|Treatment Period||351
10954154|NCT00440193|12126098|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
10954155|NCT00440193|12126099|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
10954156|NCT00440193|12126098|FG000|COMPLETED|Observational Period||1380
10954157|NCT00440193|12126099|FG001|COMPLETED|Observational Period||1369
10954158|NCT00440193|12126098|FG000|NOT COMPLETED|Observational Period||45
10954159|NCT00440193|12126099|FG001|NOT COMPLETED|Observational Period||38
10954160|NCT00440232|12126107|FG000|STARTED|Overall Study||36
10954161|NCT00440232|12126108|FG001|STARTED|Overall Study||38
10954162|NCT00440232|12126107|FG000|COMPLETED|Overall Study||33
10954163|NCT00440232|12126108|FG001|COMPLETED|Overall Study||34
10954164|NCT00440232|12126107|FG000|NOT COMPLETED|Overall Study||3
10954165|NCT00440232|12126108|FG001|NOT COMPLETED|Overall Study||4
10954166|NCT00440297|12126116|FG000|STARTED|Overall Study||139
10954167|NCT00440297|12126117|FG001|STARTED|Overall Study||138
10954168|NCT00440297|12126116|FG000|Vaccination Visit 1|Overall Study||138
10954169|NCT00440297|12126117|FG001|Vaccination Visit 1|Overall Study||138
10954170|NCT00440297|12126116|FG000|Vaccination Visit 2|Overall Study||136
10954171|NCT00440297|12126117|FG001|Vaccination Visit 2|Overall Study||134
10954172|NCT00440297|12126116|FG000|Vaccination Visit 3|Overall Study||124
10954173|NCT00440297|12126117|FG001|Vaccination Visit 3|Overall Study||125
10954174|NCT00440297|12126116|FG000|Vaccination Visit 4|Overall Study||116
10954175|NCT00440297|12126117|FG001|Vaccination Visit 4|Overall Study||122
10954176|NCT00440297|12126116|FG000|COMPLETED|Overall Study||116
10954177|NCT00440297|12126117|FG001|COMPLETED|Overall Study||120
10954178|NCT00440297|12126116|FG000|NOT COMPLETED|Overall Study||23
10954179|NCT00440297|12126117|FG001|NOT COMPLETED|Overall Study||18
10954180|NCT00440310|12126125|FG000|STARTED|Overall Study||244
10954181|NCT00440310|12126126|FG001|STARTED|Overall Study||239
10954182|NCT00440310|12126125|FG000|Treated|Overall Study||222
10954183|NCT00440310|12126126|FG001|Treated|Overall Study||232
10954184|NCT00440310|12126125|FG000|COMPLETED|Overall Study||216
10954185|NCT00440310|12126126|FG001|COMPLETED|Overall Study||209
10954186|NCT00440310|12126125|FG000|NOT COMPLETED|Overall Study||28
10954187|NCT00440310|12126126|FG001|NOT COMPLETED|Overall Study||30
10954188|NCT00440401|12126134|FG000|STARTED|Overall Study||59
10954189|NCT00440401|12126135|FG001|STARTED|Overall Study||60
10954190|NCT00440401|12126134|FG000|COMPLETED|Overall Study||55
10954191|NCT00440401|12126135|FG001|COMPLETED|Overall Study||54
10954192|NCT00440401|12126134|FG000|NOT COMPLETED|Overall Study||4
10954193|NCT00440401|12126135|FG001|NOT COMPLETED|Overall Study||6
10954194|NCT00440466|12126144|FG000|STARTED|Overall Study||108
10954195|NCT00440466|12126145|FG001|STARTED|Overall Study||107
10954196|NCT00440466|12126146|FG002|STARTED|Overall Study||215
10954197|NCT00440466|12126144|FG000|COMPLETED|Overall Study||95
10954198|NCT00440466|12126145|FG001|COMPLETED|Overall Study||92
10954199|NCT00440466|12126146|FG002|COMPLETED|Overall Study||174
10954200|NCT00440466|12126144|FG000|NOT COMPLETED|Overall Study||13
10954201|NCT00440466|12126145|FG001|NOT COMPLETED|Overall Study||15
10954202|NCT00440466|12126146|FG002|NOT COMPLETED|Overall Study||41
10954203|NCT00440505|12126154|FG000|STARTED|First Intervention||5
10954204|NCT00440505|12126155|FG001|STARTED|First Intervention||2
10954205|NCT00440505|12126156|FG002|STARTED|First Intervention||1
10954206|NCT00440505|12126157|FG003|STARTED|First Intervention||2
10954207|NCT00440505|12126158|FG004|STARTED|First Intervention||5
10954208|NCT00440505|12126159|FG005|STARTED|First Intervention||5
10954209|NCT00440505|12126154|FG000|COMPLETED|First Intervention||5
10954210|NCT00440505|12126155|FG001|COMPLETED|First Intervention||2
10954211|NCT00440505|12126156|FG002|COMPLETED|First Intervention||1
10954212|NCT00440505|12126157|FG003|COMPLETED|First Intervention||2
10954213|NCT00440505|12126158|FG004|COMPLETED|First Intervention||5
10954214|NCT00440505|12126159|FG005|COMPLETED|First Intervention||5
10954215|NCT00440505|12126154|FG000|NOT COMPLETED|First Intervention||0
10954216|NCT00440505|12126155|FG001|NOT COMPLETED|First Intervention||0
10954217|NCT00440505|12126156|FG002|NOT COMPLETED|First Intervention||0
10954218|NCT00440505|12126157|FG003|NOT COMPLETED|First Intervention||0
10954219|NCT00440505|12126158|FG004|NOT COMPLETED|First Intervention||0
10954220|NCT00440505|12126159|FG005|NOT COMPLETED|First Intervention||0
10954221|NCT00440505|12126154|FG000|STARTED|Second Intervention||5
10954222|NCT00440505|12126155|FG001|STARTED|Second Intervention||2
10954223|NCT00440505|12126156|FG002|STARTED|Second Intervention||1
10954224|NCT00440505|12126157|FG003|STARTED|Second Intervention||2
10954225|NCT00440505|12126158|FG004|STARTED|Second Intervention||5
10954226|NCT00440505|12126159|FG005|STARTED|Second Intervention||5
10954227|NCT00440505|12126154|FG000|COMPLETED|Second Intervention||5
10954228|NCT00440505|12126155|FG001|COMPLETED|Second Intervention||2
10954229|NCT00440505|12126156|FG002|COMPLETED|Second Intervention||1
10954230|NCT00440505|12126157|FG003|COMPLETED|Second Intervention||2
10954231|NCT00440505|12126158|FG004|COMPLETED|Second Intervention||5
10954232|NCT00440505|12126159|FG005|COMPLETED|Second Intervention||5
10954233|NCT00440505|12126154|FG000|NOT COMPLETED|Second Intervention||0
10954234|NCT00440505|12126155|FG001|NOT COMPLETED|Second Intervention||0
10954235|NCT00440505|12126156|FG002|NOT COMPLETED|Second Intervention||0
10954236|NCT00440505|12126157|FG003|NOT COMPLETED|Second Intervention||0
10954237|NCT00440505|12126158|FG004|NOT COMPLETED|Second Intervention||0
10954238|NCT00440505|12126159|FG005|NOT COMPLETED|Second Intervention||0
10954239|NCT00440505|12126154|FG000|STARTED|Third Intervention||5
10954240|NCT00440505|12126155|FG001|STARTED|Third Intervention||2
10954241|NCT00440505|12126156|FG002|STARTED|Third Intervention||1
10954242|NCT00440505|12126157|FG003|STARTED|Third Intervention||2
10954243|NCT00440505|12126158|FG004|STARTED|Third Intervention||5
10954244|NCT00440505|12126159|FG005|STARTED|Third Intervention||5
10954245|NCT00440505|12126154|FG000|COMPLETED|Third Intervention||5
10954246|NCT00440505|12126155|FG001|COMPLETED|Third Intervention||2
10954247|NCT00440505|12126156|FG002|COMPLETED|Third Intervention||1
10954248|NCT00440505|12126157|FG003|COMPLETED|Third Intervention||1
10954249|NCT00440505|12126158|FG004|COMPLETED|Third Intervention||5
10954250|NCT00440505|12126159|FG005|COMPLETED|Third Intervention||5
10954251|NCT00440505|12126154|FG000|NOT COMPLETED|Third Intervention||0
10954252|NCT00440505|12126155|FG001|NOT COMPLETED|Third Intervention||0
10954253|NCT00440505|12126156|FG002|NOT COMPLETED|Third Intervention||0
10954254|NCT00440505|12126157|FG003|NOT COMPLETED|Third Intervention||1
10954255|NCT00440505|12126158|FG004|NOT COMPLETED|Third Intervention||0
10954256|NCT00440505|12126159|FG005|NOT COMPLETED|Third Intervention||0
10954257|NCT00440518|12126170|FG000|STARTED|Randomized /Titration Period||72
10954258|NCT00440518|12126171|FG001|STARTED|Randomized /Titration Period||72
10954259|NCT00440518|12126172|FG002|STARTED|Randomized /Titration Period||74
10954260|NCT00440518|12126170|FG000|COMPLETED|Randomized /Titration Period||59
10954261|NCT00440518|12126171|FG001|COMPLETED|Randomized /Titration Period||63
10954262|NCT00440518|12126172|FG002|COMPLETED|Randomized /Titration Period||70
10954263|NCT00440518|12126170|FG000|NOT COMPLETED|Randomized /Titration Period||13
10954264|NCT00440518|12126171|FG001|NOT COMPLETED|Randomized /Titration Period||9
10954265|NCT00440518|12126172|FG002|NOT COMPLETED|Randomized /Titration Period||4
10954266|NCT00440518|12126170|FG000|STARTED|Maintenance and Safety Follow-up Periods||59
10954267|NCT00440518|12126171|FG001|STARTED|Maintenance and Safety Follow-up Periods||63
10954268|NCT00440518|12126172|FG002|STARTED|Maintenance and Safety Follow-up Periods||70
10954269|NCT00440518|12126170|FG000|COMPLETED|Maintenance and Safety Follow-up Periods||52
10954270|NCT00440518|12126171|FG001|COMPLETED|Maintenance and Safety Follow-up Periods||51
10954271|NCT00440518|12126172|FG002|COMPLETED|Maintenance and Safety Follow-up Periods||55
10954272|NCT00440518|12126170|FG000|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
10954273|NCT00440518|12126171|FG001|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
10954274|NCT00440518|12126172|FG002|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
10954275|NCT00440557|12126183|FG000|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
10954276|NCT00440557|12126184|FG001|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
10954277|NCT00440557|12126185|FG002|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
10954278|NCT00440557|12126183|FG000|COMPLETED|Overall Study||98
10954279|NCT00440557|12126184|FG001|COMPLETED|Overall Study||96
10954280|NCT00440557|12126185|FG002|COMPLETED|Overall Study||90
10954281|NCT00440557|12126183|FG000|NOT COMPLETED|Overall Study||25
10954282|NCT00440557|12126184|FG001|NOT COMPLETED|Overall Study||29
10954283|NCT00440557|12126185|FG002|NOT COMPLETED|Overall Study||35
10954284|NCT00440596|12126195|FG000|STARTED|Overall Study||28
10954285|NCT00440596|12126196|FG001|STARTED|Overall Study||28
10954286|NCT00440596|12126195|FG000|COMPLETED|Overall Study||21
10954287|NCT00440596|12126196|FG001|COMPLETED|Overall Study||17
10954288|NCT00440596|12126195|FG000|NOT COMPLETED|Overall Study||7
10954289|NCT00440596|12126196|FG001|NOT COMPLETED|Overall Study||11
10954290|NCT00440700|12126207|FG000|STARTED|Overall Study||122
10954291|NCT00440700|12126208|FG001|STARTED|Overall Study||118
10954292|NCT00440700|12126209|FG002|STARTED|Overall Study||124
10954293|NCT00440700|12126207|FG000|COMPLETED|Overall Study||114
10954294|NCT00440700|12126208|FG001|COMPLETED|Overall Study||110
10954295|NCT00440700|12126209|FG002|COMPLETED|Overall Study||120
10954296|NCT00440700|12126207|FG000|NOT COMPLETED|Overall Study||8
10954297|NCT00440700|12126208|FG001|NOT COMPLETED|Overall Study||8
10954298|NCT00440700|12126209|FG002|NOT COMPLETED|Overall Study||4
10954299|NCT00440726|12126220|FG000|STARTED|Phase 1||4
10954300|NCT00440726|12126221|FG001|STARTED|Phase 1||6
10954301|NCT00440726|12126222|FG002|STARTED|Phase 1||0
10954302|NCT00440726|12126220|FG000|COMPLETED|Phase 1||3
10954303|NCT00440726|12126221|FG001|COMPLETED|Phase 1||5
10954304|NCT00440726|12126222|FG002|COMPLETED|Phase 1||0
10954305|NCT00440726|12126220|FG000|NOT COMPLETED|Phase 1||1
10954306|NCT00440726|12126221|FG001|NOT COMPLETED|Phase 1||1
10954307|NCT00440726|12126222|FG002|NOT COMPLETED|Phase 1||0
10954308|NCT00440726|12126220|FG000|STARTED|Phase 2||0
10954309|NCT00440726|12126221|FG001|STARTED|Phase 2||0
10954310|NCT00440726|12126222|FG002|STARTED|Phase 2||22
10954311|NCT00440726|12126220|FG000|COMPLETED|Phase 2||0
10954312|NCT00440726|12126221|FG001|COMPLETED|Phase 2||0
10954313|NCT00440726|12126222|FG002|COMPLETED|Phase 2||20
10954314|NCT00440726|12126220|FG000|NOT COMPLETED|Phase 2||0
10954315|NCT00440726|12126221|FG001|NOT COMPLETED|Phase 2||0
10954316|NCT00440726|12126222|FG002|NOT COMPLETED|Phase 2||2
10954317|NCT00440830|12126237|FG000|STARTED|Overall Study||20
10954318|NCT00440830|12126238|FG001|STARTED|Overall Study||8
10954319|NCT00440830|12126239|FG002|STARTED|Overall Study||30
10954320|NCT00440830|12126240|FG003|STARTED|Overall Study||10
10954321|NCT00440830|12126237|FG000|COMPLETED|Overall Study||20
10954322|NCT00440830|12126238|FG001|COMPLETED|Overall Study||8
10954323|NCT00440830|12126239|FG002|COMPLETED|Overall Study||30
10954324|NCT00440830|12126240|FG003|COMPLETED|Overall Study||10
10954325|NCT00440830|12126237|FG000|NOT COMPLETED|Overall Study||0
10954326|NCT00440830|12126238|FG001|NOT COMPLETED|Overall Study||0
10954327|NCT00440830|12126239|FG002|NOT COMPLETED|Overall Study||0
10954328|NCT00440830|12126240|FG003|NOT COMPLETED|Overall Study||0
10954329|NCT00440947|12126254|FG000|STARTED|36-Week Induction Phase||515
10954330|NCT00440947|12126255|FG001|STARTED|36-Week Induction Phase||0
10954331|NCT00440947|12126256|FG002|STARTED|36-Week Induction Phase||0
10954332|NCT00440947|12126257|FG003|STARTED|36-Week Induction Phase||0
10954333|NCT00440947|12126258|FG004|STARTED|36-Week Induction Phase||0
10954334|NCT00440947|12126254|FG000|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn't be randomized but weren't withdrawn.|442
10954335|NCT00440947|12126255|FG001|COMPLETED|36-Week Induction Phase||0
10954336|NCT00440947|12126256|FG002|COMPLETED|36-Week Induction Phase||0
10954337|NCT00440947|12126257|FG003|COMPLETED|36-Week Induction Phase||0
10954338|NCT00440947|12126258|FG004|COMPLETED|36-Week Induction Phase||0
10954339|NCT00440947|12126254|FG000|NOT COMPLETED|36-Week Induction Phase||73
10954340|NCT00440947|12126255|FG001|NOT COMPLETED|36-Week Induction Phase||0
10954341|NCT00440947|12126256|FG002|NOT COMPLETED|36-Week Induction Phase||0
10954342|NCT00440947|12126257|FG003|NOT COMPLETED|36-Week Induction Phase||0
10954343|NCT00440947|12126258|FG004|NOT COMPLETED|36-Week Induction Phase||0
10954344|NCT00440947|12126254|FG000|STARTED|48-Week Randomization Phase||0
10954345|NCT00440947|12126255|FG001|STARTED|48-Week Randomization Phase||210
10954346|NCT00440947|12126256|FG002|STARTED|48-Week Randomization Phase||209
10954347|NCT00440947|12126257|FG003|STARTED|48-Week Randomization Phase||0
10954348|NCT00440947|12126258|FG004|STARTED|48-Week Randomization Phase||0
10954349|NCT00440947|12126254|FG000|COMPLETED|48-Week Randomization Phase||0
10954350|NCT00440947|12126255|FG001|COMPLETED|48-Week Randomization Phase||194
10954351|NCT00440947|12126256|FG002|COMPLETED|48-Week Randomization Phase||185
10954352|NCT00440947|12126257|FG003|COMPLETED|48-Week Randomization Phase||0
10954353|NCT00440947|12126258|FG004|COMPLETED|48-Week Randomization Phase||0
10954354|NCT00440947|12126254|FG000|NOT COMPLETED|48-Week Randomization Phase||0
10954355|NCT00440947|12126255|FG001|NOT COMPLETED|48-Week Randomization Phase||16
10954356|NCT00440947|12126256|FG002|NOT COMPLETED|48-Week Randomization Phase||24
10954357|NCT00440947|12126257|FG003|NOT COMPLETED|48-Week Randomization Phase||0
10954358|NCT00440947|12126258|FG004|NOT COMPLETED|48-Week Randomization Phase||0
10954359|NCT00440947|12126254|FG000|STARTED|Optional 60-Week Extension Phase||0
10954360|NCT00440947|12126255|FG001|STARTED|Optional 60-Week Extension Phase||0
10954361|NCT00440947|12126256|FG002|STARTED|Optional 60-Week Extension Phase||0
10954362|NCT00440947|12126257|FG003|STARTED|Optional 60-Week Extension Phase||189
10954363|NCT00440947|12126258|FG004|STARTED|Optional 60-Week Extension Phase||180
10954364|NCT00440947|12126254|FG000|COMPLETED|Optional 60-Week Extension Phase||0
10954365|NCT00440947|12126255|FG001|COMPLETED|Optional 60-Week Extension Phase||0
10954366|NCT00440947|12126256|FG002|COMPLETED|Optional 60-Week Extension Phase||0
10954367|NCT00440947|12126257|FG003|COMPLETED|Optional 60-Week Extension Phase||160
10954368|NCT00440947|12126258|FG004|COMPLETED|Optional 60-Week Extension Phase||154
10954369|NCT00440947|12126254|FG000|NOT COMPLETED|Optional 60-Week Extension Phase||0
10954370|NCT00440947|12126255|FG001|NOT COMPLETED|Optional 60-Week Extension Phase||0
10954371|NCT00440947|12126256|FG002|NOT COMPLETED|Optional 60-Week Extension Phase||0
10954372|NCT00440947|12126257|FG003|NOT COMPLETED|Optional 60-Week Extension Phase||29
10954373|NCT00440947|12126258|FG004|NOT COMPLETED|Optional 60-Week Extension Phase||26
10954374|NCT00440999|12126272|FG000|STARTED|Overall Study||228
10954375|NCT00440999|12126273|FG001|STARTED|Overall Study||228
10954376|NCT00440999|12126272|FG000|COMPLETED|Overall Study||193
10954377|NCT00440999|12126273|FG001|COMPLETED|Overall Study||187
10954378|NCT00440999|12126272|FG000|NOT COMPLETED|Overall Study||35
10954379|NCT00440999|12126273|FG001|NOT COMPLETED|Overall Study||41
10954380|NCT00441012|12126283|FG000|STARTED|Overall Study||270
10954381|NCT00441012|12126284|FG001|STARTED|Overall Study||276
10954382|NCT00441012|12126283|FG000|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
10954383|NCT00441012|12126284|FG001|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
10954384|NCT00441012|12126283|FG000|Vaccination Visit 2|Overall Study||267
10954385|NCT00441012|12126284|FG001|Vaccination Visit 2|Overall Study||272
10954386|NCT00441012|12126283|FG000|Vaccination Visit 3|Overall Study||265
10954387|NCT00441012|12126284|FG001|Vaccination Visit 3|Overall Study||269
10954388|NCT00441012|12126283|FG000|COMPLETED|Overall Study||252
10954389|NCT00441012|12126284|FG001|COMPLETED|Overall Study||263
10954390|NCT00441012|12126283|FG000|NOT COMPLETED|Overall Study||18
10954391|NCT00441012|12126284|FG001|NOT COMPLETED|Overall Study||13
10954392|NCT00441064|12126292|FG000|STARTED|Overall Study||69
10954393|NCT00441064|12126293|FG001|STARTED|Overall Study||63
10954394|NCT00441064|12126292|FG000|Safety Population (SP)|Overall Study||69
10954395|NCT00441064|12126293|FG001|Safety Population (SP)|Overall Study||63
10954396|NCT00441064|12126292|FG000|Intent-to-treat (ITT) Population|Overall Study||61
10954397|NCT00441064|12126293|FG001|Intent-to-treat (ITT) Population|Overall Study||57
10954398|NCT00441064|12126292|FG000|COMPLETED|Overall Study||59
10954399|NCT00441064|12126293|FG001|COMPLETED|Overall Study||56
10954400|NCT00441064|12126292|FG000|NOT COMPLETED|Overall Study||10
10954401|NCT00441064|12126293|FG001|NOT COMPLETED|Overall Study||7
10954402|NCT00441090|12126304|FG000|STARTED|Overall Study||15
10954403|NCT00441090|12126305|FG001|STARTED|Overall Study||15
10954404|NCT00441090|12126306|FG002|STARTED|Overall Study||14
10954405|NCT00441090|12126307|FG003|STARTED|Overall Study||15
10954406|NCT00441090|12126308|FG004|STARTED|Overall Study||5
10954407|NCT00441090|12126304|FG000|COMPLETED|Overall Study||13
10954408|NCT00441090|12126305|FG001|COMPLETED|Overall Study||14
10954409|NCT00441090|12126306|FG002|COMPLETED|Overall Study||12
10954410|NCT00441090|12126307|FG003|COMPLETED|Overall Study||13
10954411|NCT00441090|12126308|FG004|COMPLETED|Overall Study||5
10954412|NCT00441090|12126304|FG000|NOT COMPLETED|Overall Study||2
10954413|NCT00441090|12126305|FG001|NOT COMPLETED|Overall Study||1
10954414|NCT00441090|12126306|FG002|NOT COMPLETED|Overall Study||2
10954415|NCT00441090|12126307|FG003|NOT COMPLETED|Overall Study||2
10954416|NCT00441090|12126308|FG004|NOT COMPLETED|Overall Study||0
10954417|NCT00441103|12126322|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
10954418|NCT00441103|12126323|FG001|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
10954419|NCT00441103|12126322|FG000|COMPLETED|Overall Study||109
10954420|NCT00441103|12126323|FG001|COMPLETED|Overall Study||56
10954421|NCT00441103|12126322|FG000|NOT COMPLETED|Overall Study||11
10954422|NCT00441103|12126323|FG001|NOT COMPLETED|Overall Study||4
10954423|NCT00441116|12126332|FG000|STARTED|Overall Study||76
10954424|NCT00441116|12126333|FG001|STARTED|Overall Study||77
10954425|NCT00441116|12126332|FG000|COMPLETED|Overall Study||73
10954426|NCT00441116|12126333|FG001|COMPLETED|Overall Study||75
10954427|NCT00441116|12126332|FG000|NOT COMPLETED|Overall Study||3
10954428|NCT00441116|12126333|FG001|NOT COMPLETED|Overall Study||2
10954429|NCT00441129|12126341|FG000|STARTED|Overall Study||60
10954430|NCT00441129|12126342|FG001|STARTED|Overall Study||55
10954431|NCT00441129|12126341|FG000|COMPLETED|Overall Study||54
10954432|NCT00441129|12126342|FG001|COMPLETED|Overall Study||41
10954433|NCT00441129|12126341|FG000|NOT COMPLETED|Overall Study||6
10954434|NCT00441129|12126342|FG001|NOT COMPLETED|Overall Study||14
10954435|NCT00441142|12126352|FG000|STARTED|Overall Study||6
10954436|NCT00441142|12126353|FG001|STARTED|Overall Study||7
10954437|NCT00441142|12126354|FG002|STARTED|Overall Study||29
10954438|NCT00441142|12126355|FG003|STARTED|Overall Study||69
10954439|NCT00441142|12126352|FG000|COMPLETED|Overall Study||0
10954440|NCT00441142|12126353|FG001|COMPLETED|Overall Study||0
10954441|NCT00441142|12126354|FG002|COMPLETED|Overall Study||7
10954442|NCT00441142|12126355|FG003|COMPLETED|Overall Study||1
10954443|NCT00441142|12126352|FG000|NOT COMPLETED|Overall Study||6
10954444|NCT00441142|12126353|FG001|NOT COMPLETED|Overall Study||7
10954445|NCT00441142|12126354|FG002|NOT COMPLETED|Overall Study||22
10954446|NCT00441142|12126355|FG003|NOT COMPLETED|Overall Study||68
10954447|NCT00441168|12126369|FG000|STARTED|Treatment Period||17
10954448|NCT00441168|12126370|FG001|STARTED|Treatment Period||13
10954449|NCT00441168|12126369|FG000|TREATED|Treatment Period||16
10954450|NCT00441168|12126370|FG001|TREATED|Treatment Period||13
10954451|NCT00441168|12126369|FG000|COMPLETED|Treatment Period||6
10954452|NCT00441168|12126370|FG001|COMPLETED|Treatment Period||7
10954453|NCT00441168|12126369|FG000|NOT COMPLETED|Treatment Period||11
10954454|NCT00441168|12126370|FG001|NOT COMPLETED|Treatment Period||6
10954455|NCT00441168|12126369|FG000|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
10954456|NCT00441168|12126370|FG001|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
10954457|NCT00441168|12126369|FG000|COMPLETED|Follow-up Period||5
10954458|NCT00441168|12126370|FG001|COMPLETED|Follow-up Period||4
10954459|NCT00441168|12126369|FG000|NOT COMPLETED|Follow-up Period||12
10954460|NCT00441168|12126370|FG001|NOT COMPLETED|Follow-up Period||9
10954461|NCT00441259|12126378|FG000|STARTED|Overall Study||48
10954462|NCT00441259|12126379|FG001|STARTED|Overall Study||48
10954463|NCT00441259|12126378|FG000|COMPLETED|Overall Study||48
10954464|NCT00441259|12126379|FG001|COMPLETED|Overall Study||48
10954465|NCT00441259|12126378|FG000|NOT COMPLETED|Overall Study||0
10954466|NCT00441259|12126379|FG001|NOT COMPLETED|Overall Study||0
10954467|NCT00441285|12126390|FG000|STARTED|Overall Study||16
10954468|NCT00441285|12126391|FG001|STARTED|Overall Study||16
10954469|NCT00441285|12126392|FG002|STARTED|Overall Study||41
10954470|NCT00441285|12126393|FG003|STARTED|Overall Study||40
10954471|NCT00441285|12126394|FG004|STARTED|Overall Study||43
10954472|NCT00441285|12126390|FG000|COMPLETED|Overall Study||16
10954473|NCT00441285|12126391|FG001|COMPLETED|Overall Study||16
10954474|NCT00441285|12126392|FG002|COMPLETED|Overall Study||41
10954475|NCT00441285|12126393|FG003|COMPLETED|Overall Study||40
10954476|NCT00441285|12126394|FG004|COMPLETED|Overall Study||43
10954477|NCT00441285|12126390|FG000|NOT COMPLETED|Overall Study||0
10954478|NCT00441285|12126391|FG001|NOT COMPLETED|Overall Study||0
10954479|NCT00441285|12126392|FG002|NOT COMPLETED|Overall Study||0
10954480|NCT00441285|12126393|FG003|NOT COMPLETED|Overall Study||0
10954481|NCT00441285|12126394|FG004|NOT COMPLETED|Overall Study||0
10954482|NCT00441337|12126410|FG000|STARTED|Overall Study||6
10954483|NCT00441337|12126411|FG001|STARTED|Overall Study||6
10954484|NCT00441337|12126412|FG002|STARTED|Overall Study||6
10954485|NCT00441337|12126413|FG003|STARTED|Overall Study||21
10954486|NCT00441337|12126410|FG000|COMPLETED|Overall Study||0
10954487|NCT00441337|12126411|FG001|COMPLETED|Overall Study||0
10954488|NCT00441337|12126412|FG002|COMPLETED|Overall Study||0
10954489|NCT00441337|12126413|FG003|COMPLETED|Overall Study||0
10954490|NCT00441337|12126410|FG000|NOT COMPLETED|Overall Study||6
10954491|NCT00441337|12126411|FG001|NOT COMPLETED|Overall Study||6
10954492|NCT00441337|12126412|FG002|NOT COMPLETED|Overall Study||6
10954493|NCT00441337|12126413|FG003|NOT COMPLETED|Overall Study||21
10954494|NCT00441350|12126433|FG000|STARTED|Phase A: Randomization to Week 8||285
10954495|NCT00441350|12126434|FG001|STARTED|Phase A: Randomization to Week 8||561
10954496|NCT00441350|12126435|FG002|STARTED|Phase A: Randomization to Week 8||0
10954497|NCT00441350|12126436|FG003|STARTED|Phase A: Randomization to Week 8||0
10954498|NCT00441350|12126437|FG004|STARTED|Phase A: Randomization to Week 8||0
10954499|NCT00441350|12126438|FG005|STARTED|Phase A: Randomization to Week 8||0
10954500|NCT00441350|12126433|FG000|COMPLETED|Phase A: Randomization to Week 8||268
10954501|NCT00441350|12126434|FG001|COMPLETED|Phase A: Randomization to Week 8||524
10954502|NCT00441350|12126435|FG002|COMPLETED|Phase A: Randomization to Week 8||0
10954503|NCT00441350|12126436|FG003|COMPLETED|Phase A: Randomization to Week 8||0
10954504|NCT00441350|12126437|FG004|COMPLETED|Phase A: Randomization to Week 8||0
10954505|NCT00441350|12126438|FG005|COMPLETED|Phase A: Randomization to Week 8||0
10954506|NCT00441350|12126433|FG000|NOT COMPLETED|Phase A: Randomization to Week 8||17
10954507|NCT00441350|12126434|FG001|NOT COMPLETED|Phase A: Randomization to Week 8||37
10954508|NCT00441350|12126435|FG002|NOT COMPLETED|Phase A: Randomization to Week 8||0
10954509|NCT00441350|12126436|FG003|NOT COMPLETED|Phase A: Randomization to Week 8||0
10954510|NCT00441350|12126437|FG004|NOT COMPLETED|Phase A: Randomization to Week 8||0
10954511|NCT00441350|12126438|FG005|NOT COMPLETED|Phase A: Randomization to Week 8||0
10954512|NCT00441350|12126433|FG000|STARTED|Phase B: Week 8 to Week 16||0
10954513|NCT00441350|12126434|FG001|STARTED|Phase B: Week 8 to Week 16||0
10954514|NCT00441350|12126435|FG002|STARTED|Phase B: Week 8 to Week 16||129
10954515|NCT00441350|12126436|FG003|STARTED|Phase B: Week 8 to Week 16||139
10954516|NCT00441350|12126437|FG004|STARTED|Phase B: Week 8 to Week 16||336
10954517|NCT00441350|12126438|FG005|STARTED|Phase B: Week 8 to Week 16||188
10954518|NCT00441350|12126433|FG000|COMPLETED|Phase B: Week 8 to Week 16||0
10954519|NCT00441350|12126434|FG001|COMPLETED|Phase B: Week 8 to Week 16||0
10954520|NCT00441350|12126435|FG002|COMPLETED|Phase B: Week 8 to Week 16||128
10954521|NCT00441350|12126436|FG003|COMPLETED|Phase B: Week 8 to Week 16||137
10954522|NCT00441350|12126437|FG004|COMPLETED|Phase B: Week 8 to Week 16||333
10954523|NCT00441350|12126438|FG005|COMPLETED|Phase B: Week 8 to Week 16||186
10954524|NCT00441350|12126433|FG000|NOT COMPLETED|Phase B: Week 8 to Week 16||0
10954525|NCT00441350|12126434|FG001|NOT COMPLETED|Phase B: Week 8 to Week 16||0
10954526|NCT00441350|12126435|FG002|NOT COMPLETED|Phase B: Week 8 to Week 16||1
10954527|NCT00441350|12126436|FG003|NOT COMPLETED|Phase B: Week 8 to Week 16||2
10954528|NCT00441350|12126437|FG004|NOT COMPLETED|Phase B: Week 8 to Week 16||3
10954529|NCT00441350|12126438|FG005|NOT COMPLETED|Phase B: Week 8 to Week 16||2
10954530|NCT00441363|12126454|FG000|STARTED|Overall Study||32
10954531|NCT00441363|12126455|FG001|STARTED|Overall Study||34
10954532|NCT00441363|12126454|FG000|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
10954533|NCT00441363|12126455|FG001|COMPLETED|Overall Study||19
10954534|NCT00441363|12126454|FG000|NOT COMPLETED|Overall Study||17
10954535|NCT00441363|12126455|FG001|NOT COMPLETED|Overall Study||15
10954536|NCT00441441|12126463|FG000|STARTED|Overall Study||173
10954537|NCT00441441|12126464|FG001|STARTED|Overall Study||177
10954538|NCT00441441|12126463|FG000|COMPLETED|Overall Study||162
10954539|NCT00441441|12126464|FG001|COMPLETED|Overall Study||163
10954540|NCT00441441|12126463|FG000|NOT COMPLETED|Overall Study||11
10954541|NCT00441441|12126464|FG001|NOT COMPLETED|Overall Study||14
10954542|NCT00441467|12126484|FG000|STARTED|Overall Study||22
10954543|NCT00441467|12126484|FG000|2 Cycles|Overall Study||17
10954544|NCT00441467|12126484|FG000|4 Cycles|Overall Study||7
10954545|NCT00441467|12126484|FG000|COMPLETED|Overall Study||4
10954546|NCT00441467|12126484|FG000|NOT COMPLETED|Overall Study||18
10954547|NCT00441480|12126490|FG000|STARTED|Overall Study||46
10954548|NCT00441480|12126491|FG001|STARTED|Overall Study||45
10954549|NCT00441480|12126490|FG000|COMPLETED|Overall Study||43
10954550|NCT00441480|12126491|FG001|COMPLETED|Overall Study||41
10954551|NCT00441480|12126490|FG000|NOT COMPLETED|Overall Study||3
10954552|NCT00441480|12126491|FG001|NOT COMPLETED|Overall Study||4
10954553|NCT00441545|12126497|FG000|STARTED|First Intervention||95
10954554|NCT00441545|12126498|FG001|STARTED|First Intervention||87
10954555|NCT00441545|12126497|FG000|COMPLETED|First Intervention||77
10954556|NCT00441545|12126498|FG001|COMPLETED|First Intervention||75
10954557|NCT00441545|12126497|FG000|NOT COMPLETED|First Intervention||18
10954558|NCT00441545|12126498|FG001|NOT COMPLETED|First Intervention||12
10954559|NCT00441545|12126497|FG000|STARTED|Washout||77
10954560|NCT00441545|12126498|FG001|STARTED|Washout||75
10954561|NCT00441545|12126497|FG000|COMPLETED|Washout||77
10954562|NCT00441545|12126498|FG001|COMPLETED|Washout||75
10954563|NCT00441545|12126497|FG000|NOT COMPLETED|Washout||0
10954564|NCT00441545|12126498|FG001|NOT COMPLETED|Washout||0
10954565|NCT00441545|12126497|FG000|STARTED|Second Intervention||77
10954566|NCT00441545|12126498|FG001|STARTED|Second Intervention||75
10954567|NCT00441545|12126497|FG000|COMPLETED|Second Intervention||65
10954568|NCT00441545|12126498|FG001|COMPLETED|Second Intervention||68
10954569|NCT00441545|12126497|FG000|NOT COMPLETED|Second Intervention||12
10954570|NCT00441545|12126498|FG001|NOT COMPLETED|Second Intervention||7
10954571|NCT00441558|12126504|FG000|STARTED|Overall Study||1723
10954572|NCT00441558|12126504|FG000|COMPLETED|Overall Study||667
10954573|NCT00441558|12126504|FG000|NOT COMPLETED|Overall Study||1056
10954574|NCT00441584|12126508|FG000|STARTED|Overall Study||117
10954575|NCT00441584|12126508|FG000|COMPLETED|Overall Study||12
10954576|NCT00441584|12126508|FG000|NOT COMPLETED|Overall Study||105
10954577|NCT00441701|12126522|FG000|STARTED|Overall Study||22
10954578|NCT00441701|12126523|FG001|STARTED|Overall Study||11
10954579|NCT00441701|12126524|FG002|STARTED|Overall Study||22
10954580|NCT00441701|12126525|FG003|STARTED|Overall Study||11
10954581|NCT00441701|12126526|FG004|STARTED|Overall Study||22
10954582|NCT00441701|12126527|FG005|STARTED|Overall Study||11
10954583|NCT00441701|12126528|FG006|STARTED|Overall Study||0
10954584|NCT00441701|12126529|FG007|STARTED|Overall Study||0
10954585|NCT00441701|12126530|FG008|STARTED|Overall Study||0
10954586|NCT00441701|12126531|FG009|STARTED|Overall Study||0
10954587|NCT00441701|12126522|FG000|COMPLETED|Overall Study||17
10954588|NCT00441701|12126523|FG001|COMPLETED|Overall Study||7
10954589|NCT00441701|12126524|FG002|COMPLETED|Overall Study||18
10954590|NCT00441701|12126525|FG003|COMPLETED|Overall Study||8
10954591|NCT00441701|12126526|FG004|COMPLETED|Overall Study||20
10954592|NCT00441701|12126527|FG005|COMPLETED|Overall Study||8
10954593|NCT00441701|12126528|FG006|COMPLETED|Overall Study||0
10954594|NCT00441701|12126529|FG007|COMPLETED|Overall Study||0
10954595|NCT00441701|12126530|FG008|COMPLETED|Overall Study||0
10954596|NCT00441701|12126531|FG009|COMPLETED|Overall Study||0
10954597|NCT00441701|12126522|FG000|NOT COMPLETED|Overall Study||5
10954598|NCT00441701|12126523|FG001|NOT COMPLETED|Overall Study||4
10954599|NCT00441701|12126524|FG002|NOT COMPLETED|Overall Study||4
10954600|NCT00441701|12126525|FG003|NOT COMPLETED|Overall Study||3
10954601|NCT00441701|12126526|FG004|NOT COMPLETED|Overall Study||2
10954602|NCT00441701|12126527|FG005|NOT COMPLETED|Overall Study||3
10954603|NCT00441701|12126528|FG006|NOT COMPLETED|Overall Study||0
10954604|NCT00441701|12126529|FG007|NOT COMPLETED|Overall Study||0
10954605|NCT00441701|12126530|FG008|NOT COMPLETED|Overall Study||0
10954606|NCT00441701|12126531|FG009|NOT COMPLETED|Overall Study||0
10954607|NCT00441727|12126552|FG000|STARTED|Overall Study|ITT/randomised|817
10954608|NCT00441727|12126553|FG001|STARTED|Overall Study|ITT/randomised|804
10954609|NCT00441727|12126554|FG002|STARTED|Overall Study|ITT/randomised|805
10954610|NCT00441727|12126552|FG000|COMPLETED|Overall Study|ITT/randomised|711
10954611|NCT00441727|12126553|FG001|COMPLETED|Overall Study|ITT/randomised|686
10954612|NCT00441727|12126554|FG002|COMPLETED|Overall Study|ITT/randomised|637
10954613|NCT00441727|12126552|FG000|NOT COMPLETED|Overall Study||106
10954614|NCT00441727|12126553|FG001|NOT COMPLETED|Overall Study||118
10954615|NCT00441727|12126554|FG002|NOT COMPLETED|Overall Study||168
10954616|NCT00441766|12126571|FG000|STARTED|Overall Study||53
10954617|NCT00441766|12126572|FG001|STARTED|Overall Study||53
10954618|NCT00441766|12126573|FG002|STARTED|Overall Study||53
10954619|NCT00441766|12126574|FG003|STARTED|Overall Study||54
10954620|NCT00441766|12126571|FG000|COMPLETED|Overall Study||39
10954621|NCT00441766|12126572|FG001|COMPLETED|Overall Study||46
10954622|NCT00441766|12126573|FG002|COMPLETED|Overall Study||44
10954623|NCT00441766|12126574|FG003|COMPLETED|Overall Study||48
10954624|NCT00441766|12126571|FG000|NOT COMPLETED|Overall Study||14
10954625|NCT00441766|12126572|FG001|NOT COMPLETED|Overall Study||7
10954626|NCT00441766|12126573|FG002|NOT COMPLETED|Overall Study||9
10954627|NCT00441766|12126574|FG003|NOT COMPLETED|Overall Study||6
10954628|NCT00441792|12126586|FG000|STARTED|Overall Study||59
10954629|NCT00441792|12126587|FG001|STARTED|Overall Study||63
10954630|NCT00441792|12126586|FG000|COMPLETED|Overall Study||59
10954631|NCT00441792|12126587|FG001|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
10954632|NCT00441792|12126586|FG000|NOT COMPLETED|Overall Study||0
10954633|NCT00441792|12126587|FG001|NOT COMPLETED|Overall Study||2
10954634|NCT00441883|12126598|FG000|STARTED|Overall Study||43
10954635|NCT00441883|12126599|FG001|STARTED|Overall Study||32
10954636|NCT00441883|12126600|FG002|STARTED|Overall Study||28
10954637|NCT00441883|12126601|FG003|STARTED|Overall Study||28
10954638|NCT00441883|12126602|FG004|STARTED|Overall Study||45
10954639|NCT00441883|12126598|FG000|ITT Population|Overall Study||43
10954640|NCT00441883|12126599|FG001|ITT Population|Overall Study||30
10954641|NCT00441883|12126600|FG002|ITT Population|Overall Study||30
10954642|NCT00441883|12126601|FG003|ITT Population|Overall Study||30
10954643|NCT00441883|12126602|FG004|ITT Population|Overall Study||43
10954644|NCT00441883|12126598|FG000|Per Protocol Population|Overall Study||38
10954645|NCT00441883|12126599|FG001|Per Protocol Population|Overall Study||29
10954646|NCT00441883|12126600|FG002|Per Protocol Population|Overall Study||25
10954647|NCT00441883|12126601|FG003|Per Protocol Population|Overall Study||24
10954648|NCT00441883|12126602|FG004|Per Protocol Population|Overall Study||38
10954649|NCT00441883|12126598|FG000|Safety Population|Overall Study||43
10954650|NCT00441883|12126599|FG001|Safety Population|Overall Study||32
10954651|NCT00441883|12126600|FG002|Safety Population|Overall Study||28
10954652|NCT00441883|12126601|FG003|Safety Population|Overall Study||28
10954653|NCT00441883|12126602|FG004|Safety Population|Overall Study||45
10954654|NCT00441883|12126598|FG000|COMPLETED|Overall Study||42
10954655|NCT00441883|12126599|FG001|COMPLETED|Overall Study||32
10954656|NCT00441883|12126600|FG002|COMPLETED|Overall Study||28
10954657|NCT00441883|12126601|FG003|COMPLETED|Overall Study||28
10954658|NCT00441883|12126602|FG004|COMPLETED|Overall Study||43
10954659|NCT00441883|12126598|FG000|NOT COMPLETED|Overall Study||1
10954660|NCT00441883|12126599|FG001|NOT COMPLETED|Overall Study||0
10954661|NCT00441883|12126600|FG002|NOT COMPLETED|Overall Study||0
10954662|NCT00441883|12126601|FG003|NOT COMPLETED|Overall Study||0
10954663|NCT00441883|12126602|FG004|NOT COMPLETED|Overall Study||2
10954664|NCT00441974|12126614|FG000|STARTED|Overall Study||1470
10954665|NCT00441974|12126614|FG000|COMPLETED|Overall Study||1342
10954666|NCT00441974|12126614|FG000|NOT COMPLETED|Overall Study||128
10954667|NCT00442013|12126623|FG000|STARTED|Overall Study||157
10954668|NCT00442013|12126624|FG001|STARTED|Overall Study||149
10954669|NCT00442013|12126623|FG000|COMPLETED|Overall Study||131
10954670|NCT00442013|12126624|FG001|COMPLETED|Overall Study||132
10954671|NCT00442013|12126623|FG000|NOT COMPLETED|Overall Study||26
10954672|NCT00442013|12126624|FG001|NOT COMPLETED|Overall Study||17
10954673|NCT00442169|12126637|FG000|STARTED|Part 1||17
10954674|NCT00442169|12126638|FG001|STARTED|Part 1||24
10954675|NCT00442169|12126639|FG002|STARTED|Part 1||40
10954676|NCT00442169|12126640|FG003|STARTED|Part 1||31
10954677|NCT00442169|12126641|FG004|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
10954678|NCT00442169|12126642|FG005|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
10954679|NCT00442169|12126637|FG000|COMPLETED|Part 1||17
10954680|NCT00442169|12126638|FG001|COMPLETED|Part 1||24
10954681|NCT00442169|12126639|FG002|COMPLETED|Part 1||40
10954682|NCT00442169|12126640|FG003|COMPLETED|Part 1||31
10954683|NCT00442169|12126641|FG004|COMPLETED|Part 1||0
10954684|NCT00442169|12126642|FG005|COMPLETED|Part 1||0
10954685|NCT00442169|12126637|FG000|NOT COMPLETED|Part 1||0
10954686|NCT00442169|12126638|FG001|NOT COMPLETED|Part 1||0
10954687|NCT00442169|12126639|FG002|NOT COMPLETED|Part 1||0
10954688|NCT00442169|12126640|FG003|NOT COMPLETED|Part 1||0
10954689|NCT00442169|12126641|FG004|NOT COMPLETED|Part 1||0
10954690|NCT00442169|12126642|FG005|NOT COMPLETED|Part 1||0
10954691|NCT00442169|12126637|FG000|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
10954692|NCT00442169|12126638|FG001|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
10954693|NCT00442169|12126639|FG002|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
10954694|NCT00442169|12126640|FG003|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
10954695|NCT00442169|12126641|FG004|STARTED|Part 2||25
10954696|NCT00442169|12126642|FG005|STARTED|Part 2||57
10954697|NCT00442169|12126637|FG000|COMPLETED|Part 2||0
10954698|NCT00442169|12126638|FG001|COMPLETED|Part 2||0
10954699|NCT00442169|12126639|FG002|COMPLETED|Part 2||0
10954700|NCT00442169|12126640|FG003|COMPLETED|Part 2||0
10954701|NCT00442169|12126641|FG004|COMPLETED|Part 2||25
10954702|NCT00442169|12126642|FG005|COMPLETED|Part 2||57
10954703|NCT00442169|12126637|FG000|NOT COMPLETED|Part 2||0
10954704|NCT00442169|12126638|FG001|NOT COMPLETED|Part 2||0
10954705|NCT00442169|12126639|FG002|NOT COMPLETED|Part 2||0
10954706|NCT00442169|12126640|FG003|NOT COMPLETED|Part 2||0
10954707|NCT00442169|12126641|FG004|NOT COMPLETED|Part 2||0
10954708|NCT00442169|12126642|FG005|NOT COMPLETED|Part 2||0
10954709|NCT00442286|12126659|FG000|STARTED|Overall Study||181
10954710|NCT00442286|12126660|FG001|STARTED|Overall Study||84
10954711|NCT00442286|12126659|FG000|6 Months|Overall Study||177
10954712|NCT00442286|12126660|FG001|6 Months|Overall Study||83
10954713|NCT00442286|12126659|FG000|12 Months|Overall Study||174
10954714|NCT00442286|12126660|FG001|12 Months|Overall Study||82
10954715|NCT00442286|12126659|FG000|COMPLETED|Overall Study||174
10954716|NCT00442286|12126660|FG001|COMPLETED|Overall Study||82
10954717|NCT00442286|12126659|FG000|NOT COMPLETED|Overall Study||7
10954718|NCT00442286|12126660|FG001|NOT COMPLETED|Overall Study||2
10954719|NCT00442364|12126668|FG000|STARTED|Overall Study||60
10954720|NCT00442364|12126668|FG000|COMPLETED|Overall Study||60
10954721|NCT00442364|12126668|FG000|NOT COMPLETED|Overall Study||0
10954722|NCT00442416|12126674|FG000|STARTED|Overall Study||39
10954723|NCT00442416|12126675|FG001|STARTED|Overall Study||41
10954724|NCT00442416|12126674|FG000|COMPLETED|Overall Study||2
10954725|NCT00442416|12126675|FG001|COMPLETED|Overall Study||2
10954726|NCT00442416|12126674|FG000|NOT COMPLETED|Overall Study||37
10954727|NCT00442416|12126675|FG001|NOT COMPLETED|Overall Study||39
10954728|NCT00442468|12126681|FG000|STARTED|Overall Study||1283
10954729|NCT00442468|12126681|FG000|COMPLETED|Overall Study||1100
10954730|NCT00442468|12126681|FG000|NOT COMPLETED|Overall Study||183
10954731|NCT00442507|12126685|FG000|STARTED|Overall Study||6
10954732|NCT00442507|12126685|FG000|COMPLETED|Overall Study||6
10954733|NCT00442507|12126685|FG000|NOT COMPLETED|Overall Study||0
10954734|NCT00442572|12126691|FG000|STARTED|Overall Study||17
10954735|NCT00442572|12126692|FG001|STARTED|Overall Study||4
10954736|NCT00442572|12126691|FG000|COMPLETED|Overall Study||9
10954737|NCT00442572|12126692|FG001|COMPLETED|Overall Study||1
10954738|NCT00442572|12126691|FG000|NOT COMPLETED|Overall Study||8
10954739|NCT00442572|12126692|FG001|NOT COMPLETED|Overall Study||3
10954740|NCT00442598|12126702|FG000|STARTED|Overall Study||7
10954741|NCT00442598|12126703|FG001|STARTED|Overall Study||10
10954742|NCT00442598|12126704|FG002|STARTED|Overall Study||0
10954743|NCT00442598|12126702|FG000|Two Cycles|Overall Study||5
10954744|NCT00442598|12126703|FG001|Two Cycles|Overall Study||6
10954745|NCT00442598|12126704|FG002|Two Cycles|Overall Study||0
10954746|NCT00442598|12126702|FG000|COMPLETED|Overall Study||1
10954747|NCT00442598|12126703|FG001|COMPLETED|Overall Study||2
10954748|NCT00442598|12126704|FG002|COMPLETED|Overall Study||0
10954749|NCT00442598|12126702|FG000|NOT COMPLETED|Overall Study||6
10954750|NCT00442598|12126703|FG001|NOT COMPLETED|Overall Study||8
10954751|NCT00442598|12126704|FG002|NOT COMPLETED|Overall Study||0
10954752|NCT00442611|12126713|FG000|STARTED|Overall Study||7
10954753|NCT00442611|12126714|FG001|STARTED|Overall Study||3
10954754|NCT00442611|12126713|FG000|COMPLETED|Overall Study||6
10954755|NCT00442611|12126714|FG001|COMPLETED|Overall Study||3
10954756|NCT00442611|12126713|FG000|NOT COMPLETED|Overall Study||1
10954757|NCT00442611|12126714|FG001|NOT COMPLETED|Overall Study||0
10954758|NCT00442689|12126723|FG000|STARTED|Overall Study||21
10954759|NCT00442689|12126724|FG001|STARTED|Overall Study||24
10954760|NCT00442689|12126725|FG002|STARTED|Overall Study||22
10954761|NCT00442689|12126723|FG000|COMPLETED|Overall Study||11
10954762|NCT00442689|12126724|FG001|COMPLETED|Overall Study||13
10954763|NCT00442689|12126725|FG002|COMPLETED|Overall Study||13
10954764|NCT00442689|12126723|FG000|NOT COMPLETED|Overall Study||10
10954765|NCT00442689|12126724|FG001|NOT COMPLETED|Overall Study||11
10954766|NCT00442689|12126725|FG002|NOT COMPLETED|Overall Study||9
10954767|NCT00442702|12126735|FG000|STARTED|Titration Period||114
10954768|NCT00442702|12126736|FG001|STARTED|Titration Period||114
10954769|NCT00442702|12126735|FG000|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
10954770|NCT00442702|12126736|FG001|Safety Population|Titration Period||113
10954771|NCT00442702|12126735|FG000|COMPLETED|Titration Period||102
10954772|NCT00442702|12126736|FG001|COMPLETED|Titration Period||111
10954773|NCT00442702|12126735|FG000|NOT COMPLETED|Titration Period||12
10954774|NCT00442702|12126736|FG001|NOT COMPLETED|Titration Period||3
10954775|NCT00442702|12126735|FG000|STARTED|Evaluation Period||102
10954776|NCT00442702|12126736|FG001|STARTED|Evaluation Period||111
10954777|NCT00442702|12126735|FG000|COMPLETED|Evaluation Period||97
10954778|NCT00442702|12126736|FG001|COMPLETED|Evaluation Period||107
10954779|NCT00442702|12126735|FG000|NOT COMPLETED|Evaluation Period||5
10954780|NCT00442702|12126736|FG001|NOT COMPLETED|Evaluation Period||4
10954781|NCT00442767|12126742|FG000|STARTED|Overall Study||8
10954782|NCT00442767|12126742|FG000|COMPLETED|Overall Study||8
10954783|NCT00442767|12126742|FG000|NOT COMPLETED|Overall Study||0
10954784|NCT00442936|12126752|FG000|STARTED|Overall Study||333
10954785|NCT00442936|12126753|FG001|STARTED|Overall Study||354
10954786|NCT00442936|12126754|FG002|STARTED|Overall Study||345
10954787|NCT00442936|12126755|FG003|STARTED|Overall Study||348
10954788|NCT00442936|12126752|FG000|COMPLETED|Overall Study||332
10954789|NCT00442936|12126753|FG001|COMPLETED|Overall Study||354
10954790|NCT00442936|12126754|FG002|COMPLETED|Overall Study||344
10954791|NCT00442936|12126755|FG003|COMPLETED|Overall Study||347
10954792|NCT00442936|12126752|FG000|NOT COMPLETED|Overall Study||1
10954793|NCT00442936|12126753|FG001|NOT COMPLETED|Overall Study||0
10954794|NCT00442936|12126754|FG002|NOT COMPLETED|Overall Study||1
10954795|NCT00442936|12126755|FG003|NOT COMPLETED|Overall Study||1
10954796|NCT00442962|12126765|FG000|STARTED|Overall Study||54
10954797|NCT00442962|12126765|FG000|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
10954798|NCT00442962|12126765|FG000|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
10954799|NCT00442962|12126765|FG000|NOT COMPLETED|Overall Study||8
10954800|NCT00443053|12126771|FG000|STARTED|Overall Study||1502
10954801|NCT00443053|12126772|FG001|STARTED|Overall Study||1500
10954802|NCT00443053|12126771|FG000|COMPLETED|Overall Study||1481
10954803|NCT00443053|12126772|FG001|COMPLETED|Overall Study||1467
10954804|NCT00443053|12126771|FG000|NOT COMPLETED|Overall Study||21
10954805|NCT00443053|12126772|FG001|NOT COMPLETED|Overall Study||33
10954806|NCT00443079|12126780|FG000|STARTED|Overall Study||3
10954807|NCT00443079|12126781|FG001|STARTED|Overall Study||3
10954808|NCT00443079|12126780|FG000|COMPLETED|Overall Study||3
10954809|NCT00443079|12126781|FG001|COMPLETED|Overall Study||2
10954810|NCT00443079|12126780|FG000|NOT COMPLETED|Overall Study||0
10954811|NCT00443079|12126781|FG001|NOT COMPLETED|Overall Study||1
10954812|NCT00443118|12126792|FG000|STARTED|Overall Study||515
10954813|NCT00443118|12126793|FG001|STARTED|Overall Study||291
10954814|NCT00443118|12126794|FG002|STARTED|Overall Study||226
10954815|NCT00443118|12126792|FG000|COMPLETED|Overall Study||511
10954816|NCT00443118|12126793|FG001|COMPLETED|Overall Study||290
10954817|NCT00443118|12126794|FG002|COMPLETED|Overall Study||226
10954818|NCT00443118|12126792|FG000|NOT COMPLETED|Overall Study||4
10954819|NCT00443118|12126793|FG001|NOT COMPLETED|Overall Study||1
10954820|NCT00443118|12126794|FG002|NOT COMPLETED|Overall Study||0
10954821|NCT00443209|12126822|FG000|STARTED|Months 1 to 12 Treatment Period||712
10954822|NCT00443209|12126823|FG001|STARTED|Months 1 to 12 Treatment Period||356
10954823|NCT00443209|12126822|FG000|Treated|Months 1 to 12 Treatment Period||641
10954824|NCT00443209|12126823|FG001|Treated|Months 1 to 12 Treatment Period||313
10954825|NCT00443209|12126822|FG000|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
10954826|NCT00443209|12126823|FG001|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
10954827|NCT00443209|12126822|FG000|NOT COMPLETED|Months 1 to 12 Treatment Period||345
10954828|NCT00443209|12126823|FG001|NOT COMPLETED|Months 1 to 12 Treatment Period||154
10954829|NCT00443209|12126822|FG000|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
10954830|NCT00443209|12126823|FG001|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
10954831|NCT00443209|12126822|FG000|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
10954832|NCT00443209|12126823|FG001|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
10954833|NCT00443209|12126822|FG000|NOT COMPLETED|Months 13 to 18 Treatment Period||99
10954834|NCT00443209|12126823|FG001|NOT COMPLETED|Months 13 to 18 Treatment Period||47
10954835|NCT00443261|12126829|FG000|STARTED|Overall Study||1
10954836|NCT00443261|12126829|FG000|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
10954837|NCT00443261|12126829|FG000|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
10954838|NCT00443261|12126829|FG000|NOT COMPLETED|Overall Study||1
10954839|NCT00443352|12126833|FG000|STARTED|Overall Study||27
10954840|NCT00443352|12126833|FG000|COMPLETED|Overall Study||22
10954841|NCT00443352|12126833|FG000|NOT COMPLETED|Overall Study||5
10954842|NCT00443430|12126839|FG000|STARTED|Overall Study||43
10954843|NCT00443430|12126840|FG001|STARTED|Overall Study||42
10954844|NCT00443430|12126839|FG000|COMPLETED|Overall Study||39
10954845|NCT00443430|12126840|FG001|COMPLETED|Overall Study||38
10954846|NCT00443430|12126839|FG000|NOT COMPLETED|Overall Study||4
10954847|NCT00443430|12126840|FG001|NOT COMPLETED|Overall Study||4
10954848|NCT00443456|12126846|FG000|STARTED|Overall Study||134
10954849|NCT00443456|12126846|FG000|COMPLETED|Overall Study||116
10954850|NCT00443456|12126846|FG000|NOT COMPLETED|Overall Study||18
10954851|NCT00443534|12126854|FG000|STARTED|Overall Study||123
10954852|NCT00443534|12126854|FG000|Treated|Overall Study||122
10954853|NCT00443534|12126854|FG000|COMPLETED|Overall Study||0
10954854|NCT00443534|12126854|FG000|NOT COMPLETED|Overall Study||123
10954855|NCT00443547|12126862|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|89
10954856|NCT00443547|12126863|FG001|STARTED|Overall Study|Enrolled and Treated Per Protocol|88
10954857|NCT00443547|12126864|FG002|STARTED|Overall Study|Enrolled and Treated Per Protocol|48
10954858|NCT00443547|12126865|FG003|STARTED|Overall Study|Enrolled and Treated Per Protocol|6
10954859|NCT00443547|12126862|FG000|Evaluated at 12 Months|Overall Study||58
10954860|NCT00443547|12126863|FG001|Evaluated at 12 Months|Overall Study||55
10954861|NCT00443547|12126864|FG002|Evaluated at 12 Months|Overall Study||37
10954862|NCT00443547|12126865|FG003|Evaluated at 12 Months|Overall Study||5
10954863|NCT00443547|12126862|FG000|COMPLETED|Overall Study||44
10954864|NCT00443547|12126863|FG001|COMPLETED|Overall Study||46
10954865|NCT00443547|12126864|FG002|COMPLETED|Overall Study||27
10954866|NCT00443547|12126865|FG003|COMPLETED|Overall Study||4
10954867|NCT00443547|12126862|FG000|NOT COMPLETED|Overall Study||45
10954868|NCT00443547|12126863|FG001|NOT COMPLETED|Overall Study||42
10954869|NCT00443547|12126864|FG002|NOT COMPLETED|Overall Study||21
10954870|NCT00443547|12126865|FG003|NOT COMPLETED|Overall Study||2
10954871|NCT00443560|12126877|FG000|STARTED|Overall Study||1081
10954872|NCT00443560|12126878|FG001|STARTED|Overall Study||1081
10954873|NCT00443560|12126877|FG000|COMPLETED|Overall Study||1021
10954874|NCT00443560|12126878|FG001|COMPLETED|Overall Study||1051
10954875|NCT00443560|12126877|FG000|NOT COMPLETED|Overall Study||60
10954876|NCT00443560|12126878|FG001|NOT COMPLETED|Overall Study||30
10954877|NCT00443651|12126886|FG000|STARTED|Overall Study||401
10954878|NCT00443651|12126887|FG001|STARTED|Overall Study||176
10954879|NCT00443651|12126886|FG000|Week 24|Overall Study||376
10954880|NCT00443651|12126887|FG001|Week 24|Overall Study||160
10954881|NCT00443651|12126886|FG000|Week 48|Overall Study||338
10954882|NCT00443651|12126887|FG001|Week 48|Overall Study||134
10954883|NCT00443651|12126886|FG000|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
10954884|NCT00443651|12126887|FG001|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
10954885|NCT00443651|12126886|FG000|NOT COMPLETED|Overall Study||95
10954886|NCT00443651|12126887|FG001|NOT COMPLETED|Overall Study||58
10954887|NCT00443703|12126895|FG000|STARTED|Overall Study||177
10954888|NCT00443703|12126896|FG001|STARTED|Overall Study||175
10954889|NCT00443703|12126895|FG000|Treated|Overall Study||174
10954890|NCT00443703|12126896|FG001|Treated|Overall Study||174
10954891|NCT00443703|12126895|FG000|COMPLETED|Overall Study||149
10954892|NCT00443703|12126896|FG001|COMPLETED|Overall Study||157
10954893|NCT00443703|12126895|FG000|NOT COMPLETED|Overall Study||28
10954894|NCT00443703|12126896|FG001|NOT COMPLETED|Overall Study||18
10954895|NCT00443729|12126904|FG000|STARTED|Overall Study||176
10954896|NCT00443729|12126905|FG001|STARTED|Overall Study||179
10954897|NCT00443729|12126904|FG000|Treated|Overall Study||176
10954898|NCT00443729|12126905|FG001|Treated|Overall Study||178
10954899|NCT00443729|12126904|FG000|COMPLETED|Overall Study||166
10954900|NCT00443729|12126905|FG001|COMPLETED|Overall Study||172
10954901|NCT00443729|12126904|FG000|NOT COMPLETED|Overall Study||10
10954902|NCT00443729|12126905|FG001|NOT COMPLETED|Overall Study||7
10954903|NCT00443755|12126913|FG000|STARTED|Overall Study||14
10954904|NCT00443755|12126914|FG001|STARTED|Overall Study||14
10954905|NCT00443755|12126913|FG000|COMPLETED|Overall Study||12
10954906|NCT00443755|12126914|FG001|COMPLETED|Overall Study||13
10954907|NCT00443755|12126913|FG000|NOT COMPLETED|Overall Study||2
10954908|NCT00443755|12126914|FG001|NOT COMPLETED|Overall Study||1
10954909|NCT00443781|12126920|FG000|STARTED|Overall Study||62
10954910|NCT00443781|12126920|FG000|COMPLETED|Overall Study||37
10954911|NCT00443781|12126920|FG000|NOT COMPLETED|Overall Study||25
10954912|NCT00443820|12126928|FG000|STARTED|Overall Study||133
10954913|NCT00443820|12126929|FG001|STARTED|Overall Study||130
10954914|NCT00443820|12126930|FG002|STARTED|Overall Study||135
10954915|NCT00443820|12126931|FG003|STARTED|Overall Study||128
10954916|NCT00443820|12126928|FG000|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
10954917|NCT00443820|12126929|FG001|Safety Population|Overall Study||129
10954918|NCT00443820|12126930|FG002|Safety Population|Overall Study||134
10954919|NCT00443820|12126931|FG003|Safety Population|Overall Study||126
10954920|NCT00443820|12126928|FG000|COMPLETED|Overall Study||112
10954921|NCT00443820|12126929|FG001|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
10954922|NCT00443820|12126930|FG002|COMPLETED|Overall Study||117
10954923|NCT00443820|12126931|FG003|COMPLETED|Overall Study||111
10954924|NCT00443820|12126928|FG000|NOT COMPLETED|Overall Study||21
10954925|NCT00443820|12126929|FG001|NOT COMPLETED|Overall Study||19
10954926|NCT00443820|12126930|FG002|NOT COMPLETED|Overall Study||18
10954927|NCT00443820|12126931|FG003|NOT COMPLETED|Overall Study||17
10954928|NCT00443846|12126943|FG000|STARTED|Overall Study||124
10954929|NCT00443846|12126944|FG001|STARTED|Overall Study||123
10954930|NCT00443846|12126943|FG000|Vaccinated|Overall Study||116
10954931|NCT00443846|12126944|FG001|Vaccinated|Overall Study||123
10954932|NCT00443846|12126943|FG000|COMPLETED|Overall Study||113
10954933|NCT00443846|12126944|FG001|COMPLETED|Overall Study||117
10954934|NCT00443846|12126943|FG000|NOT COMPLETED|Overall Study||11
10954935|NCT00443846|12126944|FG001|NOT COMPLETED|Overall Study||6
10954936|NCT00443872|12126950|FG000|STARTED|Overall Study||77
10954937|NCT00443872|12126950|FG000|COMPLETED|Overall Study||60
10954938|NCT00443872|12126950|FG000|NOT COMPLETED|Overall Study||17
10954939|NCT00443898|12126967|FG000|STARTED|Overall Study||126
10954940|NCT00443898|12126968|FG001|STARTED|Overall Study||128
10954941|NCT00443898|12126969|FG002|STARTED|Overall Study||136
10954942|NCT00443898|12126970|FG003|STARTED|Overall Study||128
10954943|NCT00443898|12126967|FG000|COMPLETED|Overall Study||102
10954944|NCT00443898|12126968|FG001|COMPLETED|Overall Study||103
10954945|NCT00443898|12126969|FG002|COMPLETED|Overall Study||107
10954946|NCT00443898|12126970|FG003|COMPLETED|Overall Study||110
10954947|NCT00443898|12126967|FG000|NOT COMPLETED|Overall Study||24
10954948|NCT00443898|12126968|FG001|NOT COMPLETED|Overall Study||25
10954949|NCT00443898|12126969|FG002|NOT COMPLETED|Overall Study||29
10954950|NCT00443898|12126970|FG003|NOT COMPLETED|Overall Study||18
10954951|NCT00444028|12126986|FG000|STARTED|Overall Study||14
10954952|NCT00444028|12126987|FG001|STARTED|Overall Study||7
10954953|NCT00444028|12126988|FG002|STARTED|Overall Study||8
10954954|NCT00444028|12126989|FG003|STARTED|Overall Study||6
10954955|NCT00444028|12126990|FG004|STARTED|Overall Study||7
10954956|NCT00444028|12126991|FG005|STARTED|Overall Study||8
10954957|NCT00444028|12126986|FG000|COMPLETED|Overall Study||14
10954958|NCT00444028|12126987|FG001|COMPLETED|Overall Study||7
10954959|NCT00444028|12126988|FG002|COMPLETED|Overall Study||8
10954960|NCT00444028|12126989|FG003|COMPLETED|Overall Study||6
10954961|NCT00444028|12126990|FG004|COMPLETED|Overall Study||7
10954962|NCT00444028|12126991|FG005|COMPLETED|Overall Study||8
10954963|NCT00444028|12126986|FG000|NOT COMPLETED|Overall Study||0
10954964|NCT00444028|12126987|FG001|NOT COMPLETED|Overall Study||0
10954965|NCT00444028|12126988|FG002|NOT COMPLETED|Overall Study||0
10954966|NCT00444028|12126989|FG003|NOT COMPLETED|Overall Study||0
10954967|NCT00444028|12126990|FG004|NOT COMPLETED|Overall Study||0
10954968|NCT00444028|12126991|FG005|NOT COMPLETED|Overall Study||0
10954969|NCT00444067|12127006|FG000|STARTED|Overall Study||74
10954970|NCT00444067|12127007|FG001|STARTED|Overall Study||24
10954971|NCT00444067|12127006|FG000|COMPLETED|Overall Study||74
10954972|NCT00444067|12127007|FG001|COMPLETED|Overall Study||23
10954973|NCT00444067|12127006|FG000|NOT COMPLETED|Overall Study||0
10954974|NCT00444067|12127007|FG001|NOT COMPLETED|Overall Study||1
10954975|NCT00444080|12127015|FG000|STARTED|Overall Study||61
10954976|NCT00444080|12127016|FG001|STARTED|Overall Study||59
10954977|NCT00444080|12127015|FG000|COMPLETED|Overall Study||61
10954978|NCT00444080|12127016|FG001|COMPLETED|Overall Study||59
10954979|NCT00444080|12127015|FG000|NOT COMPLETED|Overall Study||0
10954980|NCT00444080|12127016|FG001|NOT COMPLETED|Overall Study||0
10954981|NCT00444106|12127028|FG000|STARTED|Overall Study||159
10954982|NCT00444106|12127029|FG001|STARTED|Overall Study||53
10954983|NCT00444106|12127030|FG002|STARTED|Overall Study||53
10954984|NCT00444106|12127028|FG000|Completed Treatment Period|Overall Study||159
10954985|NCT00444106|12127029|FG001|Completed Treatment Period|Overall Study||53
10954986|NCT00444106|12127030|FG002|Completed Treatment Period|Overall Study||53
10954987|NCT00444106|12127028|FG000|COMPLETED|Overall Study||157
10954988|NCT00444106|12127029|FG001|COMPLETED|Overall Study||52
10954989|NCT00444106|12127030|FG002|COMPLETED|Overall Study||52
10954990|NCT00444106|12127028|FG000|NOT COMPLETED|Overall Study||2
10954991|NCT00444106|12127029|FG001|NOT COMPLETED|Overall Study||1
10954992|NCT00444106|12127030|FG002|NOT COMPLETED|Overall Study||1
10954993|NCT00444145|12127041|FG000|STARTED|Overall Study||38
10954994|NCT00444145|12127041|FG000|COMPLETED|Overall Study||19
10954995|NCT00444145|12127041|FG000|NOT COMPLETED|Overall Study||19
10954996|NCT00444275|12127048|FG000|STARTED|Initial Treatment Phase||2156
10954997|NCT00444275|12127049|FG001|STARTED|Initial Treatment Phase||873
10954998|NCT00444275|12127050|FG002|STARTED|Initial Treatment Phase||0
10954999|NCT00444275|12127051|FG003|STARTED|Initial Treatment Phase||0
10955000|NCT00444275|12127052|FG004|STARTED|Initial Treatment Phase||0
10955001|NCT00444275|12127048|FG000|COMPLETED|Initial Treatment Phase||1908
10955002|NCT00444275|12127049|FG001|COMPLETED|Initial Treatment Phase||777
10955003|NCT00444275|12127050|FG002|COMPLETED|Initial Treatment Phase||0
10955004|NCT00444275|12127051|FG003|COMPLETED|Initial Treatment Phase||0
10955005|NCT00444275|12127052|FG004|COMPLETED|Initial Treatment Phase||0
10955006|NCT00444275|12127048|FG000|NOT COMPLETED|Initial Treatment Phase||248
10955007|NCT00444275|12127049|FG001|NOT COMPLETED|Initial Treatment Phase||96
10955008|NCT00444275|12127050|FG002|NOT COMPLETED|Initial Treatment Phase||0
10955009|NCT00444275|12127051|FG003|NOT COMPLETED|Initial Treatment Phase||0
10955010|NCT00444275|12127052|FG004|NOT COMPLETED|Initial Treatment Phase||0
10955011|NCT00444275|12127048|FG000|STARTED|Maintenance Treatment Phase||0
10955012|NCT00444275|12127049|FG001|STARTED|Maintenance Treatment Phase||0
10955013|NCT00444275|12127050|FG002|STARTED|Maintenance Treatment Phase||908
10955014|NCT00444275|12127051|FG003|STARTED|Maintenance Treatment Phase||897
10955015|NCT00444275|12127052|FG004|STARTED|Maintenance Treatment Phase||880
10955016|NCT00444275|12127048|FG000|COMPLETED|Maintenance Treatment Phase||0
10955017|NCT00444275|12127049|FG001|COMPLETED|Maintenance Treatment Phase||0
10955018|NCT00444275|12127050|FG002|COMPLETED|Maintenance Treatment Phase||747
10955019|NCT00444275|12127051|FG003|COMPLETED|Maintenance Treatment Phase||764
10955020|NCT00444275|12127052|FG004|COMPLETED|Maintenance Treatment Phase||701
10955021|NCT00444275|12127048|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
10955022|NCT00444275|12127049|FG001|NOT COMPLETED|Maintenance Treatment Phase||0
10955023|NCT00444275|12127050|FG002|NOT COMPLETED|Maintenance Treatment Phase||161
10955024|NCT00444275|12127051|FG003|NOT COMPLETED|Maintenance Treatment Phase||133
10955025|NCT00444275|12127052|FG004|NOT COMPLETED|Maintenance Treatment Phase||179
10955026|NCT00444457|12127071|FG000|STARTED|Infant Series||489
10955027|NCT00444457|12127072|FG001|STARTED|Infant Series||488
10955028|NCT00444457|12127073|FG002|STARTED|Infant Series||489
10955029|NCT00444457|12127074|FG003|STARTED|Infant Series||246
10955030|NCT00444457|12127071|FG000|Vaccinated Dose 1|Infant Series||486
10955031|NCT00444457|12127072|FG001|Vaccinated Dose 1|Infant Series||484
10955032|NCT00444457|12127073|FG002|Vaccinated Dose 1|Infant Series||485
10955033|NCT00444457|12127074|FG003|Vaccinated Dose 1|Infant Series||244
10955034|NCT00444457|12127071|FG000|Vaccinated Dose 2|Infant Series||455
10955035|NCT00444457|12127072|FG001|Vaccinated Dose 2|Infant Series||447
10955036|NCT00444457|12127073|FG002|Vaccinated Dose 2|Infant Series||455
10955037|NCT00444457|12127074|FG003|Vaccinated Dose 2|Infant Series||228
10955038|NCT00444457|12127071|FG000|Vaccinated Dose 3|Infant Series||442
10955039|NCT00444457|12127072|FG001|Vaccinated Dose 3|Infant Series||435
10955040|NCT00444457|12127073|FG002|Vaccinated Dose 3|Infant Series||438
10955041|NCT00444457|12127074|FG003|Vaccinated Dose 3|Infant Series||225
10955042|NCT00444457|12127071|FG000|COMPLETED|Infant Series||435
10955043|NCT00444457|12127072|FG001|COMPLETED|Infant Series||427
10955044|NCT00444457|12127073|FG002|COMPLETED|Infant Series||428
10955045|NCT00444457|12127074|FG003|COMPLETED|Infant Series||218
10955046|NCT00444457|12127071|FG000|NOT COMPLETED|Infant Series||54
10955047|NCT00444457|12127072|FG001|NOT COMPLETED|Infant Series||61
10955048|NCT00444457|12127073|FG002|NOT COMPLETED|Infant Series||61
10955049|NCT00444457|12127074|FG003|NOT COMPLETED|Infant Series||28
10955050|NCT00444457|12127071|FG000|STARTED|After Infant Series||435
10955051|NCT00444457|12127072|FG001|STARTED|After Infant Series||427
10955052|NCT00444457|12127073|FG002|STARTED|After Infant Series||427
10955053|NCT00444457|12127074|FG003|STARTED|After Infant Series||218
10955054|NCT00444457|12127071|FG000|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
10955055|NCT00444457|12127072|FG001|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
10955056|NCT00444457|12127073|FG002|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
10955057|NCT00444457|12127074|FG003|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
10955058|NCT00444457|12127071|FG000|NOT COMPLETED|After Infant Series||20
10955059|NCT00444457|12127072|FG001|NOT COMPLETED|After Infant Series||30
10955060|NCT00444457|12127073|FG002|NOT COMPLETED|After Infant Series||19
10955061|NCT00444457|12127074|FG003|NOT COMPLETED|After Infant Series||10
10955062|NCT00444457|12127071|FG000|STARTED|Toddler Dose|Vaccinated toddler dose|415
10955063|NCT00444457|12127072|FG001|STARTED|Toddler Dose|Vaccinated toddler dose|397
10955064|NCT00444457|12127073|FG002|STARTED|Toddler Dose|Vaccinated toddler dose|408
10955065|NCT00444457|12127074|FG003|STARTED|Toddler Dose|Vaccinated toddler dose|208
10955066|NCT00444457|12127071|FG000|COMPLETED|Toddler Dose||408
10955067|NCT00444457|12127072|FG001|COMPLETED|Toddler Dose||391
10955068|NCT00444457|12127073|FG002|COMPLETED|Toddler Dose||404
10955069|NCT00444457|12127074|FG003|COMPLETED|Toddler Dose||200
10955070|NCT00444457|12127071|FG000|NOT COMPLETED|Toddler Dose||7
10955071|NCT00444457|12127072|FG001|NOT COMPLETED|Toddler Dose||6
10955072|NCT00444457|12127073|FG002|NOT COMPLETED|Toddler Dose||4
10955073|NCT00444457|12127074|FG003|NOT COMPLETED|Toddler Dose||8
10955074|NCT00444535|12127095|FG000|STARTED|Overall Study||52
10955075|NCT00444535|12127095|FG000|COMPLETED|Overall Study||39
10955076|NCT00444535|12127095|FG000|NOT COMPLETED|Overall Study||13
10955077|NCT00444587|12127101|FG000|STARTED|Overall Study||93
10955078|NCT00444587|12127102|FG001|STARTED|Overall Study||16
10955079|NCT00444587|12127101|FG000|COMPLETED|Overall Study||10
10955080|NCT00444587|12127102|FG001|COMPLETED|Overall Study||1
10955081|NCT00444587|12127101|FG000|NOT COMPLETED|Overall Study||83
10955082|NCT00444587|12127102|FG001|NOT COMPLETED|Overall Study||15
10955083|NCT00444600|12127114|FG000|STARTED|Overall Study|Number of eyes|293
10955084|NCT00444600|12127115|FG001|STARTED|Overall Study|Number of eyes|187
10955085|NCT00444600|12127116|FG002|STARTED|Overall Study|Number of eyes|188
10955086|NCT00444600|12127117|FG003|STARTED|Overall Study|Number of eyes|186
10955087|NCT00444600|12127114|FG000|COMPLETED|Overall Study|Number of eyes|274
10955088|NCT00444600|12127115|FG001|COMPLETED|Overall Study|Number of eyes|171
10955089|NCT00444600|12127116|FG002|COMPLETED|Overall Study|Number of eyes|178
10955090|NCT00444600|12127117|FG003|COMPLETED|Overall Study|Number of eyes|176
10955091|NCT00444600|12127114|FG000|NOT COMPLETED|Overall Study||19
10955092|NCT00444600|12127115|FG001|NOT COMPLETED|Overall Study||16
10955093|NCT00444600|12127116|FG002|NOT COMPLETED|Overall Study||10
10955094|NCT00444600|12127117|FG003|NOT COMPLETED|Overall Study||10
10955095|NCT00444626|12127133|FG000|STARTED|Initial Treatment Period||140
10955096|NCT00444626|12127133|FG000|COMPLETED|Initial Treatment Period||128
10955097|NCT00444626|12127133|FG000|NOT COMPLETED|Initial Treatment Period||12
10955098|NCT00444626|12127133|FG000|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
10955099|NCT00444626|12127133|FG000|COMPLETED|Repeat Treatment Period||105
10955100|NCT00444626|12127133|FG000|NOT COMPLETED|Repeat Treatment Period||0
10955101|NCT00444678|12127146|FG000|STARTED|Overall Study||36
10955102|NCT00444678|12127146|FG000|COMPLETED|Overall Study||5
10955103|NCT00444678|12127146|FG000|NOT COMPLETED|Overall Study||31
10955104|NCT00444795|12127150|FG000|STARTED|Overall Study||620
10955105|NCT00444795|12127150|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
10955106|NCT00444795|12127150|FG000|NOT COMPLETED|Overall Study||3
10955107|NCT00444821|12127156|FG000|STARTED|Overall Study||362
10955108|NCT00444821|12127157|FG001|STARTED|Overall Study||366
10955109|NCT00444821|12127156|FG000|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
10955110|NCT00444821|12127157|FG001|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
10955111|NCT00444821|12127156|FG000|COMPLETED|Overall Study||0
10955112|NCT00444821|12127157|FG001|COMPLETED|Overall Study||0
10955113|NCT00444821|12127156|FG000|NOT COMPLETED|Overall Study||362
10955114|NCT00444821|12127157|FG001|NOT COMPLETED|Overall Study||366
10955115|NCT00444912|12127165|FG000|STARTED|Overall Study||15
10955116|NCT00444912|12127166|FG001|STARTED|Overall Study||15
10955117|NCT00444912|12127165|FG000|Received Plerixafor|Overall Study||15
10955118|NCT00444912|12127166|FG001|Received Plerixafor|Overall Study||15
10955119|NCT00444912|12127165|FG000|Received Transplant|Overall Study||14
10955120|NCT00444912|12127166|FG001|Received Transplant|Overall Study||14
10955121|NCT00444912|12127165|FG000|COMPLETED|Overall Study||12
10955122|NCT00444912|12127166|FG001|COMPLETED|Overall Study||13
10955123|NCT00444912|12127165|FG000|NOT COMPLETED|Overall Study||3
10955124|NCT00444912|12127166|FG001|NOT COMPLETED|Overall Study||2
10955125|NCT00444925|12127175|FG000|STARTED|Single-blind Placebo Run-In Period||2446
10955126|NCT00444925|12127176|FG001|STARTED|Single-blind Placebo Run-In Period||0
10955127|NCT00444925|12127177|FG002|STARTED|Single-blind Placebo Run-In Period||0
10955128|NCT00444925|12127175|FG000|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
10955129|NCT00444925|12127176|FG001|COMPLETED|Single-blind Placebo Run-In Period||0
10955130|NCT00444925|12127177|FG002|COMPLETED|Single-blind Placebo Run-In Period||0
10955131|NCT00444925|12127175|FG000|NOT COMPLETED|Single-blind Placebo Run-In Period||734
10955132|NCT00444925|12127176|FG001|NOT COMPLETED|Single-blind Placebo Run-In Period||0
10955133|NCT00444925|12127177|FG002|NOT COMPLETED|Single-blind Placebo Run-In Period||0
10955134|NCT00444925|12127175|FG000|STARTED|Randomized to Double-blind Treatment||337
10955135|NCT00444925|12127176|FG001|STARTED|Randomized to Double-blind Treatment||690
10955136|NCT00444925|12127177|FG002|STARTED|Randomized to Double-blind Treatment||685
10955137|NCT00444925|12127175|FG000|COMPLETED|Randomized to Double-blind Treatment||334
10955138|NCT00444925|12127176|FG001|COMPLETED|Randomized to Double-blind Treatment||684
10955139|NCT00444925|12127177|FG002|COMPLETED|Randomized to Double-blind Treatment||679
10955140|NCT00444925|12127175|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||3
10955141|NCT00444925|12127176|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||6
10955142|NCT00444925|12127177|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||6
10955143|NCT00444925|12127175|FG000|STARTED|Double-blind Treatment Period||334
10955144|NCT00444925|12127176|FG001|STARTED|Double-blind Treatment Period||684
10955145|NCT00444925|12127177|FG002|STARTED|Double-blind Treatment Period||679
10955146|NCT00444925|12127175|FG000|COMPLETED|Double-blind Treatment Period||304
10955147|NCT00444925|12127176|FG001|COMPLETED|Double-blind Treatment Period||628
10955148|NCT00444925|12127177|FG002|COMPLETED|Double-blind Treatment Period||598
10955149|NCT00444925|12127175|FG000|NOT COMPLETED|Double-blind Treatment Period||30
10955150|NCT00444925|12127176|FG001|NOT COMPLETED|Double-blind Treatment Period||56
10955151|NCT00444925|12127177|FG002|NOT COMPLETED|Double-blind Treatment Period||81
10955152|NCT00444951|12127188|FG000|STARTED|Overall Study||145
10955153|NCT00444951|12127189|FG001|STARTED|Overall Study||142
10955154|NCT00444951|12127190|FG002|STARTED|Overall Study||163
10955155|NCT00444951|12127188|FG000|COMPLETED|Overall Study||140
10955156|NCT00444951|12127189|FG001|COMPLETED|Overall Study||136
10955157|NCT00444951|12127190|FG002|COMPLETED|Overall Study||160
10955158|NCT00444951|12127188|FG000|NOT COMPLETED|Overall Study||5
10955159|NCT00444951|12127189|FG001|NOT COMPLETED|Overall Study||6
10955160|NCT00444951|12127190|FG002|NOT COMPLETED|Overall Study||3
10955161|NCT00444964|12127198|FG000|STARTED|Overall Study||11
10955162|NCT00444964|12127198|FG000|COMPLETED|Overall Study||11
10955163|NCT00444964|12127198|FG000|NOT COMPLETED|Overall Study||0
10955164|NCT00445003|12127205|FG000|STARTED|Overall Study||123
10955165|NCT00445003|12127206|FG001|STARTED|Overall Study||113
10955166|NCT00445003|12127207|FG002|STARTED|Overall Study||109
10955167|NCT00445003|12127205|FG000|COMPLETED|Overall Study||118
10955168|NCT00445003|12127206|FG001|COMPLETED|Overall Study||103
10955169|NCT00445003|12127207|FG002|COMPLETED|Overall Study||105
10955170|NCT00445003|12127205|FG000|NOT COMPLETED|Overall Study||5
10955171|NCT00445003|12127206|FG001|NOT COMPLETED|Overall Study||10
10955172|NCT00445003|12127207|FG002|NOT COMPLETED|Overall Study||4
10955173|NCT00445068|12127215|FG000|STARTED|Overall Study||38
10955174|NCT00445068|12127215|FG000|COMPLETED|Overall Study||2
10955175|NCT00445068|12127215|FG000|NOT COMPLETED|Overall Study||36
10955176|NCT00445146|12127219|FG000|STARTED|Overall Study||192
10955177|NCT00445146|12127219|FG000|COMPLETED|Overall Study||73
10955178|NCT00445146|12127219|FG000|NOT COMPLETED|Overall Study||119
10955179|NCT00445211|12127225|FG000|STARTED|Overall Study||23
10955180|NCT00445211|12127226|FG001|STARTED|Overall Study||23
10955181|NCT00445211|12127225|FG000|COMPLETED|Overall Study||23
10955182|NCT00445211|12127226|FG001|COMPLETED|Overall Study||23
10955183|NCT00445211|12127225|FG000|NOT COMPLETED|Overall Study||0
10955184|NCT00445211|12127226|FG001|NOT COMPLETED|Overall Study||0
10955185|NCT00445224|12127234|FG000|STARTED|Specific Exercises||17
10955186|NCT00445224|12127235|FG001|STARTED|Specific Exercises||16
10955187|NCT00445224|12127234|FG000|Baseline|Specific Exercises||17
10955188|NCT00445224|12127235|FG001|Baseline|Specific Exercises||16
10955189|NCT00445224|12127234|FG000|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
10955190|NCT00445224|12127235|FG001|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
10955191|NCT00445224|12127234|FG000|COMPLETED|Specific Exercises|No adverse event occurred|13
10955192|NCT00445224|12127235|FG001|COMPLETED|Specific Exercises|No adverse event occurred|13
10955193|NCT00445224|12127234|FG000|NOT COMPLETED|Specific Exercises||4
10955194|NCT00445224|12127235|FG001|NOT COMPLETED|Specific Exercises||3
10955195|NCT00445224|12127234|FG000|STARTED|Combined Exercises||13
10955196|NCT00445224|12127235|FG001|STARTED|Combined Exercises||13
10955197|NCT00445224|12127234|FG000|COMPLETED|Combined Exercises||13
10955198|NCT00445224|12127235|FG001|COMPLETED|Combined Exercises||13
10955199|NCT00445224|12127234|FG000|NOT COMPLETED|Combined Exercises||0
10955200|NCT00445224|12127235|FG001|NOT COMPLETED|Combined Exercises||0
10955201|NCT00445263|12127243|FG000|STARTED|Overall Study||83
10955202|NCT00445263|12127244|FG001|STARTED|Overall Study||87
10955203|NCT00445263|12127243|FG000|COMPLETED|Overall Study||83
10955204|NCT00445263|12127244|FG001|COMPLETED|Overall Study||86
10955205|NCT00445263|12127243|FG000|NOT COMPLETED|Overall Study||0
10955206|NCT00445263|12127244|FG001|NOT COMPLETED|Overall Study||1
10955207|NCT00445302|12127254|FG000|STARTED|Overall Study||6
10955208|NCT00445302|12127255|FG001|STARTED|Overall Study||5
10955209|NCT00445302|12127256|FG002|STARTED|Overall Study||6
10955210|NCT00445302|12127257|FG003|STARTED|Overall Study||6
10955211|NCT00445302|12127254|FG000|COMPLETED|Overall Study||6
10955212|NCT00445302|12127255|FG001|COMPLETED|Overall Study||5
10955213|NCT00445302|12127256|FG002|COMPLETED|Overall Study||6
10955214|NCT00445302|12127257|FG003|COMPLETED|Overall Study||6
10955215|NCT00445302|12127254|FG000|NOT COMPLETED|Overall Study||0
10955216|NCT00445302|12127255|FG001|NOT COMPLETED|Overall Study||0
10955217|NCT00445302|12127256|FG002|NOT COMPLETED|Overall Study||0
10955218|NCT00445302|12127257|FG003|NOT COMPLETED|Overall Study||0
10955219|NCT00445315|12127272|FG000|STARTED|Overall Study||6
10955220|NCT00445315|12127273|FG001|STARTED|Overall Study||6
10955221|NCT00445315|12127274|FG002|STARTED|Overall Study||6
10955222|NCT00445315|12127275|FG003|STARTED|Overall Study||6
10955223|NCT00445315|12127276|FG004|STARTED|Overall Study||8
10955224|NCT00445315|12127272|FG000|COMPLETED|Overall Study||6
10955225|NCT00445315|12127273|FG001|COMPLETED|Overall Study||6
10955226|NCT00445315|12127274|FG002|COMPLETED|Overall Study||6
10955227|NCT00445315|12127275|FG003|COMPLETED|Overall Study||6
10955228|NCT00445315|12127276|FG004|COMPLETED|Overall Study||8
10955229|NCT00445315|12127272|FG000|NOT COMPLETED|Overall Study||0
10955230|NCT00445315|12127273|FG001|NOT COMPLETED|Overall Study||0
10955231|NCT00445315|12127274|FG002|NOT COMPLETED|Overall Study||0
10955232|NCT00445315|12127275|FG003|NOT COMPLETED|Overall Study||0
10955233|NCT00445315|12127276|FG004|NOT COMPLETED|Overall Study||0
10955234|NCT00445328|12127291|FG000|STARTED|Overall Study||42
10955235|NCT00445328|12127292|FG001|STARTED|Overall Study||42
10955236|NCT00445328|12127291|FG000|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
10955237|NCT00445328|12127292|FG001|Received Treatment|Overall Study||42
10955238|NCT00445328|12127291|FG000|COMPLETED|Overall Study||39
10955239|NCT00445328|12127292|FG001|COMPLETED|Overall Study||36
10955240|NCT00445328|12127291|FG000|NOT COMPLETED|Overall Study||3
10955241|NCT00445328|12127292|FG001|NOT COMPLETED|Overall Study||6
10955242|NCT00445341|12127298|FG000|STARTED|Overall Study||28
10955243|NCT00445341|12127298|FG000|COMPLETED|Overall Study||26
10955244|NCT00445341|12127298|FG000|NOT COMPLETED|Overall Study||2
10955245|NCT00445432|12127305|FG000|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
10955246|NCT00445432|12127306|FG001|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
10955247|NCT00445432|12127307|FG002|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
10955248|NCT00445432|12127308|FG003|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
10955249|NCT00445432|12127305|FG000|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
10955250|NCT00445432|12127306|FG001|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
10955251|NCT00445432|12127307|FG002|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
10955252|NCT00445432|12127308|FG003|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
10955253|NCT00445432|12127305|FG000|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
10955254|NCT00445432|12127306|FG001|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
10955255|NCT00445432|12127307|FG002|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
10955256|NCT00445432|12127308|FG003|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
10955257|NCT00445432|12127305|FG000|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
10955258|NCT00445432|12127306|FG001|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
10955259|NCT00445432|12127307|FG002|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
10955260|NCT00445432|12127308|FG003|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
10955261|NCT00445432|12127305|FG000|COMPLETED|148 Weeks of Adalimumab Treatment||0
10955262|NCT00445432|12127306|FG001|COMPLETED|148 Weeks of Adalimumab Treatment||0
10955263|NCT00445432|12127307|FG002|COMPLETED|148 Weeks of Adalimumab Treatment||0
10955264|NCT00445432|12127308|FG003|COMPLETED|148 Weeks of Adalimumab Treatment||35
10955265|NCT00445432|12127305|FG000|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
10955266|NCT00445432|12127306|FG001|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
10955267|NCT00445432|12127307|FG002|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
10955268|NCT00445432|12127308|FG003|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
10955269|NCT00445458|12127323|FG000|STARTED|Overall Study||3
10955270|NCT00445458|12127324|FG001|STARTED|Overall Study||5
10955271|NCT00445458|12127325|FG002|STARTED|Overall Study||71
10955272|NCT00445458|12127326|FG003|STARTED|Overall Study||31
10955273|NCT00445458|12127323|FG000|COMPLETED|Overall Study||0
10955274|NCT00445458|12127324|FG001|COMPLETED|Overall Study||0
10955275|NCT00445458|12127325|FG002|COMPLETED|Overall Study||3
10955276|NCT00445458|12127326|FG003|COMPLETED|Overall Study||3
10955277|NCT00445458|12127323|FG000|NOT COMPLETED|Overall Study||3
10955278|NCT00445458|12127324|FG001|NOT COMPLETED|Overall Study||5
10955279|NCT00445458|12127325|FG002|NOT COMPLETED|Overall Study||68
10955280|NCT00445458|12127326|FG003|NOT COMPLETED|Overall Study||28
10955281|NCT00445484|12127341|FG000|STARTED|Overall Study||11
10955282|NCT00445484|12127342|FG001|STARTED|Overall Study||11
10955283|NCT00445484|12127341|FG000|COMPLETED|Overall Study||7
10955284|NCT00445484|12127342|FG001|COMPLETED|Overall Study||10
10955285|NCT00445484|12127341|FG000|NOT COMPLETED|Overall Study||4
10955286|NCT00445484|12127342|FG001|NOT COMPLETED|Overall Study||1
10955287|NCT00445549|12127348|FG000|STARTED|Overall Study||12
10955288|NCT00445549|12127348|FG000|COMPLETED|Overall Study||0
10955289|NCT00445549|12127348|FG000|NOT COMPLETED|Overall Study||12
10955290|NCT00445588|12127352|FG000|STARTED|Overall Study||56
10955291|NCT00445588|12127352|FG000|COMPLETED|Overall Study||56
10955292|NCT00445588|12127352|FG000|NOT COMPLETED|Overall Study||0
10955293|NCT00445601|12127359|FG000|STARTED|Overall Study||201
10955294|NCT00445601|12127360|FG001|STARTED|Overall Study||205
10955295|NCT00445601|12127359|FG000|Received TURBT|Overall Study||190
10955296|NCT00445601|12127360|FG001|Received TURBT|Overall Study||193
10955297|NCT00445601|12127359|FG000|COMPLETED|Overall Study||168
10955298|NCT00445601|12127360|FG001|COMPLETED|Overall Study||177
10955299|NCT00445601|12127359|FG000|NOT COMPLETED|Overall Study||33
10955300|NCT00445601|12127360|FG001|NOT COMPLETED|Overall Study||28
10955301|NCT00445679|12127374|FG000|STARTED|Overall Study||203
10955302|NCT00445679|12127375|FG001|STARTED|Overall Study||203
10955303|NCT00445679|12127376|FG002|STARTED|Overall Study||205
10955304|NCT00445679|12127377|FG003|STARTED|Overall Study||196
10955305|NCT00445679|12127374|FG000|COMPLETED|Overall Study||155
10955306|NCT00445679|12127375|FG001|COMPLETED|Overall Study||157
10955307|NCT00445679|12127376|FG002|COMPLETED|Overall Study||139
10955308|NCT00445679|12127377|FG003|COMPLETED|Overall Study||149
10955309|NCT00445679|12127374|FG000|NOT COMPLETED|Overall Study||48
10955310|NCT00445679|12127375|FG001|NOT COMPLETED|Overall Study||46
10955311|NCT00445679|12127376|FG002|NOT COMPLETED|Overall Study||66
10955312|NCT00445679|12127377|FG003|NOT COMPLETED|Overall Study||47
10955313|NCT00445692|12127387|FG000|STARTED|Overall Study||31
10955314|NCT00445692|12127387|FG000|COMPLETED|Overall Study||15
10955315|NCT00445692|12127387|FG000|NOT COMPLETED|Overall Study||16
10955316|NCT00445705|12127397|FG000|STARTED|Overall Study||53
10955317|NCT00445705|12127398|FG001|STARTED|Overall Study||53
10955318|NCT00445705|12127399|FG002|STARTED|Overall Study||52
10955319|NCT00445705|12127400|FG003|STARTED|Overall Study||53
10955320|NCT00445705|12127397|FG000|COMPLETED|Overall Study||44
10955321|NCT00445705|12127398|FG001|COMPLETED|Overall Study||42
10955322|NCT00445705|12127399|FG002|COMPLETED|Overall Study||41
10955323|NCT00445705|12127400|FG003|COMPLETED|Overall Study||39
10955324|NCT00445705|12127397|FG000|NOT COMPLETED|Overall Study||9
10955325|NCT00445705|12127398|FG001|NOT COMPLETED|Overall Study||11
10955326|NCT00445705|12127399|FG002|NOT COMPLETED|Overall Study||11
10955327|NCT00445705|12127400|FG003|NOT COMPLETED|Overall Study||14
10955328|NCT00445744|12127410|FG000|STARTED|Overall Study||52
10955329|NCT00445744|12127410|FG000|COMPLETED|Overall Study||51
10955330|NCT00445744|12127410|FG000|NOT COMPLETED|Overall Study||1
10955331|NCT00445770|12127417|FG000|STARTED|Overall Study||176
10955332|NCT00445770|12127418|FG001|STARTED|Overall Study||192
10955333|NCT00445770|12127419|FG002|STARTED|Overall Study||182
10955334|NCT00445770|12127417|FG000|COMPLETED|Overall Study||123
10955335|NCT00445770|12127418|FG001|COMPLETED|Overall Study||157
10955336|NCT00445770|12127419|FG002|COMPLETED|Overall Study||151
10955337|NCT00445770|12127417|FG000|NOT COMPLETED|Overall Study||53
10955338|NCT00445770|12127418|FG001|NOT COMPLETED|Overall Study||35
10955339|NCT00445770|12127419|FG002|NOT COMPLETED|Overall Study||31
10955340|NCT00445848|12127429|FG000|STARTED|Overall Study||85
10955341|NCT00445848|12127429|FG000|COMPLETED|Overall Study||0
10955342|NCT00445848|12127429|FG000|NOT COMPLETED|Overall Study||85
10955343|NCT00445887|12127435|FG000|STARTED|Overall Study||33
10955344|NCT00445887|12127436|FG001|STARTED|Overall Study||31
10955345|NCT00445887|12127435|FG000|COMPLETED|Overall Study||33
10955346|NCT00445887|12127436|FG001|COMPLETED|Overall Study||31
10955347|NCT00445887|12127435|FG000|NOT COMPLETED|Overall Study||0
10955348|NCT00445887|12127436|FG001|NOT COMPLETED|Overall Study||0
10955349|NCT00445939|12127455|FG000|STARTED|Period A - Week 0 - Week 4||33
10955350|NCT00445939|12127456|FG001|STARTED|Period A - Week 0 - Week 4||34
10955351|NCT00445939|12127457|FG002|STARTED|Period A - Week 0 - Week 4||23
10955352|NCT00445939|12127458|FG003|STARTED|Period A - Week 0 - Week 4||0
10955353|NCT00445939|12127455|FG000|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
10955354|NCT00445939|12127456|FG001|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
10955355|NCT00445939|12127457|FG002|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
10955356|NCT00445939|12127458|FG003|COMPLETED|Period A - Week 0 - Week 4||0
10955357|NCT00445939|12127455|FG000|NOT COMPLETED|Period A - Week 0 - Week 4||1
10955358|NCT00445939|12127456|FG001|NOT COMPLETED|Period A - Week 0 - Week 4||2
10955359|NCT00445939|12127457|FG002|NOT COMPLETED|Period A - Week 0 - Week 4||0
10955360|NCT00445939|12127458|FG003|NOT COMPLETED|Period A - Week 0 - Week 4||0
10955361|NCT00445939|12127455|FG000|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
10955362|NCT00445939|12127456|FG001|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
10955363|NCT00445939|12127457|FG002|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
10955364|NCT00445939|12127458|FG003|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
10955365|NCT00445939|12127455|FG000|COMPLETED|Period B - Week 4 - Week 8||14
10955366|NCT00445939|12127456|FG001|COMPLETED|Period B - Week 4 - Week 8||0
10955367|NCT00445939|12127457|FG002|COMPLETED|Period B - Week 4 - Week 8||0
10955368|NCT00445939|12127458|FG003|COMPLETED|Period B - Week 4 - Week 8||20
10955369|NCT00445939|12127455|FG000|NOT COMPLETED|Period B - Week 4 - Week 8||2
10955370|NCT00445939|12127456|FG001|NOT COMPLETED|Period B - Week 4 - Week 8||0
10955371|NCT00445939|12127457|FG002|NOT COMPLETED|Period B - Week 4 - Week 8||0
10955372|NCT00445939|12127458|FG003|NOT COMPLETED|Period B - Week 4 - Week 8||1
10955373|NCT00445978|12127478|FG000|STARTED|Week 0 - Week 4 (2.5 mg/kg/Day)||32
10955374|NCT00445978|12127478|FG000|COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||29
10955375|NCT00445978|12127478|FG000|NOT COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||3
10955376|NCT00445978|12127478|FG000|STARTED|Week 4 - Week 8 (5 mg/kg/Day)||29
10955377|NCT00445978|12127478|FG000|Received Escalated Dose|Week 4 - Week 8 (5 mg/kg/Day)||29
10955378|NCT00445978|12127478|FG000|COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||25
10955379|NCT00445978|12127478|FG000|NOT COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||4
10955380|NCT00445978|12127478|FG000|STARTED|Week 8 - Week 12 (10 mg/kg/Day)||25
10955381|NCT00445978|12127478|FG000|Received Escalated Dose|Week 8 - Week 12 (10 mg/kg/Day)||25
10955382|NCT00445978|12127478|FG000|COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||24
10955383|NCT00445978|12127478|FG000|NOT COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||1
10955384|NCT00445978|12127478|FG000|STARTED|Week 12 - Week 16 (20 mg/kg/Day)||24
10955385|NCT00445978|12127478|FG000|Received Escalated Dose|Week 12 - Week 16 (20 mg/kg/Day)||21
10955386|NCT00445978|12127478|FG000|COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||23
10955387|NCT00445978|12127478|FG000|NOT COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||1
10955388|NCT00446030|12127491|FG000|STARTED|TREATMENT (up to 52 Weeks)||93
10955389|NCT00446030|12127492|FG001|STARTED|TREATMENT (up to 52 Weeks)||34
10955390|NCT00446030|12127491|FG000|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
10955391|NCT00446030|12127492|FG001|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
10955392|NCT00446030|12127491|FG000|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
10955393|NCT00446030|12127492|FG001|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
10955394|NCT00446030|12127491|FG000|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
10955395|NCT00446030|12127492|FG001|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
10955396|NCT00446030|12127491|FG000|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
10955397|NCT00446030|12127492|FG001|STARTED|FOLLOW-UP (up to 2-years)||34
10955398|NCT00446030|12127491|FG000|COMPLETED|FOLLOW-UP (up to 2-years)||63
10955399|NCT00446030|12127492|FG001|COMPLETED|FOLLOW-UP (up to 2-years)||25
10955400|NCT00446030|12127491|FG000|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
10955401|NCT00446030|12127492|FG001|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
10955402|NCT00446095|12127503|FG000|STARTED|Phase II (8 Weeks)||23
10955403|NCT00446095|12127504|FG001|STARTED|Phase II (8 Weeks)||21
10955404|NCT00446095|12127505|FG002|STARTED|Phase II (8 Weeks)||24
10955405|NCT00446095|12127506|FG003|STARTED|Phase II (8 Weeks)||0
10955406|NCT00446095|12127507|FG004|STARTED|Phase II (8 Weeks)||0
10955407|NCT00446095|12127503|FG000|COMPLETED|Phase II (8 Weeks)||11
10955408|NCT00446095|12127504|FG001|COMPLETED|Phase II (8 Weeks)||18
10955409|NCT00446095|12127505|FG002|COMPLETED|Phase II (8 Weeks)||21
10955410|NCT00446095|12127506|FG003|COMPLETED|Phase II (8 Weeks)||0
10955411|NCT00446095|12127507|FG004|COMPLETED|Phase II (8 Weeks)||0
10955412|NCT00446095|12127503|FG000|NOT COMPLETED|Phase II (8 Weeks)||12
10955413|NCT00446095|12127504|FG001|NOT COMPLETED|Phase II (8 Weeks)||3
10955414|NCT00446095|12127505|FG002|NOT COMPLETED|Phase II (8 Weeks)||3
10955415|NCT00446095|12127506|FG003|NOT COMPLETED|Phase II (8 Weeks)||0
10955416|NCT00446095|12127507|FG004|NOT COMPLETED|Phase II (8 Weeks)||0
10955417|NCT00446095|12127503|FG000|STARTED|Phase I (28 Days)||0
10955418|NCT00446095|12127504|FG001|STARTED|Phase I (28 Days)||0
10955419|NCT00446095|12127505|FG002|STARTED|Phase I (28 Days)||0
10955420|NCT00446095|12127506|FG003|STARTED|Phase I (28 Days)||6
10955421|NCT00446095|12127507|FG004|STARTED|Phase I (28 Days)||7
10955422|NCT00446095|12127503|FG000|COMPLETED|Phase I (28 Days)||0
10955423|NCT00446095|12127504|FG001|COMPLETED|Phase I (28 Days)||0
10955424|NCT00446095|12127505|FG002|COMPLETED|Phase I (28 Days)||0
10955425|NCT00446095|12127506|FG003|COMPLETED|Phase I (28 Days)||5
10955426|NCT00446095|12127507|FG004|COMPLETED|Phase I (28 Days)||4
10955427|NCT00446095|12127503|FG000|NOT COMPLETED|Phase I (28 Days)||0
10955428|NCT00446095|12127504|FG001|NOT COMPLETED|Phase I (28 Days)||0
10955429|NCT00446095|12127505|FG002|NOT COMPLETED|Phase I (28 Days)||0
10955430|NCT00446095|12127506|FG003|NOT COMPLETED|Phase I (28 Days)||1
10955431|NCT00446095|12127507|FG004|NOT COMPLETED|Phase I (28 Days)||3
10955432|NCT00446134|12127522|FG000|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
10955433|NCT00446134|12127523|FG001|STARTED|Overall Study||70
10955434|NCT00446134|12127524|FG002|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
10955435|NCT00446134|12127525|FG003|STARTED|Overall Study||70
10955436|NCT00446134|12127522|FG000|COMPLETED|Overall Study||35
10955437|NCT00446134|12127523|FG001|COMPLETED|Overall Study||25
10955438|NCT00446134|12127524|FG002|COMPLETED|Overall Study||26
10955439|NCT00446134|12127525|FG003|COMPLETED|Overall Study||25
10955440|NCT00446134|12127522|FG000|NOT COMPLETED|Overall Study||34
10955441|NCT00446134|12127523|FG001|NOT COMPLETED|Overall Study||45
10955442|NCT00446134|12127524|FG002|NOT COMPLETED|Overall Study||43
10955443|NCT00446134|12127525|FG003|NOT COMPLETED|Overall Study||45
10955444|NCT00446147|12127537|FG000|STARTED|Overall Study||195
10955445|NCT00446147|12127538|FG001|STARTED|Overall Study||194
10955446|NCT00446147|12127537|FG000|COMPLETED|Overall Study||180
10955447|NCT00446147|12127538|FG001|COMPLETED|Overall Study||180
10955448|NCT00446147|12127537|FG000|NOT COMPLETED|Overall Study||15
10955449|NCT00446147|12127538|FG001|NOT COMPLETED|Overall Study||14
10955450|NCT00446199|12127548|FG000|STARTED|Overall Study||183
10955451|NCT00446199|12127549|FG001|STARTED|Overall Study||184
10955452|NCT00446199|12127550|FG002|STARTED|Overall Study||185
10955453|NCT00446199|12127551|FG003|STARTED|Overall Study||183
10955454|NCT00446199|12127548|FG000|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
10955455|NCT00446199|12127549|FG001|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
10955456|NCT00446199|12127550|FG002|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
10955457|NCT00446199|12127551|FG003|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
10955458|NCT00446199|12127548|FG000|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
10955459|NCT00446199|12127549|FG001|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
10955460|NCT00446199|12127550|FG002|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
10955461|NCT00446199|12127551|FG003|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
10955462|NCT00446199|12127548|FG000|COMPLETED|Overall Study||160
10955463|NCT00446199|12127549|FG001|COMPLETED|Overall Study||164
10955464|NCT00446199|12127550|FG002|COMPLETED|Overall Study||158
10955465|NCT00446199|12127551|FG003|COMPLETED|Overall Study||153
10955466|NCT00446199|12127548|FG000|NOT COMPLETED|Overall Study||23
10955467|NCT00446199|12127549|FG001|NOT COMPLETED|Overall Study||20
10955468|NCT00446199|12127550|FG002|NOT COMPLETED|Overall Study||27
10955469|NCT00446199|12127551|FG003|NOT COMPLETED|Overall Study||30
10955470|NCT00446251|12127561|FG000|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
10955471|NCT00446251|12127561|FG000|COMPLETED|Overall Study||9
10955472|NCT00446251|12127561|FG000|NOT COMPLETED|Overall Study||5
10955473|NCT00446264|12127565|FG000|STARTED|Overall Study||14
10955474|NCT00446264|12127565|FG000|COMPLETED|Overall Study||14
10955475|NCT00446264|12127565|FG000|NOT COMPLETED|Overall Study||0
10955476|NCT00446290|12127569|FG000|STARTED|Overall Study||22
10955477|NCT00446290|12127569|FG000|COMPLETED|Overall Study||22
10955478|NCT00446290|12127569|FG000|NOT COMPLETED|Overall Study||0
10955479|NCT00446446|12127573|FG000|STARTED|Overall Study||52
10955480|NCT00446446|12127573|FG000|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
10955481|NCT00446446|12127573|FG000|NOT COMPLETED|Overall Study||24
10955482|NCT00446459|12127577|FG000|STARTED|8 Months|34 subjects received any amount of MMF.|34
10955483|NCT00446459|12127577|FG000|COMPLETED|8 Months|22 subjects were on study at month 8.|22
10955484|NCT00446459|12127577|FG000|NOT COMPLETED|8 Months||12
10955485|NCT00446459|12127577|FG000|STARTED|12 Months|22 subjects remained on-study at month 8|22
10955486|NCT00446459|12127577|FG000|COMPLETED|12 Months|4 subjects remained at month 12|4
10955487|NCT00446459|12127577|FG000|NOT COMPLETED|12 Months||18
10955488|NCT00446511|12127585|FG000|STARTED|Overall Study||21
10955489|NCT00446511|12127586|FG001|STARTED|Overall Study||17
10955490|NCT00446511|12127587|FG002|STARTED|Overall Study||103
10955491|NCT00446511|12127588|FG003|STARTED|Overall Study||109
10955492|NCT00446511|12127585|FG000|COMPLETED|Overall Study||11
10955493|NCT00446511|12127586|FG001|COMPLETED|Overall Study||15
10955494|NCT00446511|12127587|FG002|COMPLETED|Overall Study||96
10955495|NCT00446511|12127588|FG003|COMPLETED|Overall Study||103
10955496|NCT00446511|12127585|FG000|NOT COMPLETED|Overall Study||10
10955497|NCT00446511|12127586|FG001|NOT COMPLETED|Overall Study||2
10955498|NCT00446511|12127587|FG002|NOT COMPLETED|Overall Study||7
10955499|NCT00446511|12127588|FG003|NOT COMPLETED|Overall Study||6
10955500|NCT00446550|12127602|FG000|STARTED|Overall Study||11
10955501|NCT00446550|12127603|FG001|STARTED|Overall Study||8
10955502|NCT00446550|12127602|FG000|Safety Population|Overall Study||11
10955503|NCT00446550|12127603|FG001|Safety Population|Overall Study||8
10955504|NCT00446550|12127602|FG000|PD Population|Overall Study||11
10955505|NCT00446550|12127603|FG001|PD Population|Overall Study||8
10955506|NCT00446550|12127602|FG000|COMPLETED|Overall Study||10
10955507|NCT00446550|12127603|FG001|COMPLETED|Overall Study||8
10955508|NCT00446550|12127602|FG000|NOT COMPLETED|Overall Study||1
10955509|NCT00446550|12127603|FG001|NOT COMPLETED|Overall Study||0
10955510|NCT00446563|12127612|FG000|STARTED|Overall Study||43
10955511|NCT00446563|12127613|FG001|STARTED|Overall Study||47
10955512|NCT00446563|12127612|FG000|COMPLETED|Overall Study||36
10955513|NCT00446563|12127613|FG001|COMPLETED|Overall Study||38
10955514|NCT00446563|12127612|FG000|NOT COMPLETED|Overall Study||7
10955515|NCT00446563|12127613|FG001|NOT COMPLETED|Overall Study||9
10955516|NCT00446641|12127621|FG000|STARTED|Overall Study||125
10955517|NCT00446641|12127622|FG001|STARTED|Overall Study||119
10955518|NCT00446641|12127621|FG000|COMPLETED|Overall Study||108
10955519|NCT00446641|12127622|FG001|COMPLETED|Overall Study||109
10955520|NCT00446641|12127621|FG000|NOT COMPLETED|Overall Study||17
10955521|NCT00446641|12127622|FG001|NOT COMPLETED|Overall Study||10
10955522|NCT00446654|12127630|FG000|STARTED|Overall Study||21
10955523|NCT00446654|12127631|FG001|STARTED|Overall Study||22
10955524|NCT00446654|12127630|FG000|COMPLETED|Overall Study||19
10955525|NCT00446654|12127631|FG001|COMPLETED|Overall Study||22
10955526|NCT00446654|12127630|FG000|NOT COMPLETED|Overall Study||2
10955527|NCT00446654|12127631|FG001|NOT COMPLETED|Overall Study||0
10955528|NCT00446797|12127639|FG000|STARTED|Overall Study||141
10955529|NCT00446797|12127640|FG001|STARTED|Overall Study||137
10955530|NCT00446797|12127639|FG000|COMPLETED|Overall Study||133
10955531|NCT00446797|12127640|FG001|COMPLETED|Overall Study||125
10955532|NCT00446797|12127639|FG000|NOT COMPLETED|Overall Study||8
10955533|NCT00446797|12127640|FG001|NOT COMPLETED|Overall Study||12
10955534|NCT00446849|12127646|FG000|STARTED|Acute Phase||138
10955535|NCT00446849|12127646|FG000|COMPLETED|Acute Phase||56
10955536|NCT00446849|12127646|FG000|NOT COMPLETED|Acute Phase||82
10955537|NCT00446849|12127646|FG000|STARTED|Maintenance Phase||208
10955538|NCT00446849|12127646|FG000|COMPLETED|Maintenance Phase||138
10955539|NCT00446849|12127646|FG000|NOT COMPLETED|Maintenance Phase||70
10955540|NCT00446966|12127653|FG000|STARTED|Overall Study||130
10955541|NCT00446966|12127654|FG001|STARTED|Overall Study||130
10955542|NCT00446966|12127653|FG000|COMPLETED|Overall Study||120
10955543|NCT00446966|12127654|FG001|COMPLETED|Overall Study||123
10955544|NCT00446966|12127653|FG000|NOT COMPLETED|Overall Study||10
10955545|NCT00446966|12127654|FG001|NOT COMPLETED|Overall Study||7
10955546|NCT00446992|12127660|FG000|STARTED|Overall Study|Beginning of Intervention|30
10955547|NCT00446992|12127660|FG000|COMPLETED|Overall Study|Intervention Completion|14
10955548|NCT00446992|12127660|FG000|NOT COMPLETED|Overall Study||16
10955549|NCT00447005|12127664|FG000|STARTED|Overall Study||12
10955550|NCT00447005|12127664|FG000|COMPLETED|Overall Study||0
10955551|NCT00447005|12127664|FG000|NOT COMPLETED|Overall Study||12
10955552|NCT00447057|12127672|FG000|STARTED|Overall Study||83
10955553|NCT00447057|12127673|FG001|STARTED|Overall Study||76
10955554|NCT00447057|12127674|FG002|STARTED|Overall Study||19
10955555|NCT00447057|12127675|FG003|STARTED|Overall Study||26
10955556|NCT00447057|12127672|FG000|COMPLETED|Overall Study||0
10955557|NCT00447057|12127673|FG001|COMPLETED|Overall Study||3
10955558|NCT00447057|12127674|FG002|COMPLETED|Overall Study||0
10955559|NCT00447057|12127675|FG003|COMPLETED|Overall Study||0
10955560|NCT00447057|12127672|FG000|NOT COMPLETED|Overall Study||83
10955561|NCT00447057|12127673|FG001|NOT COMPLETED|Overall Study||73
10955562|NCT00447057|12127674|FG002|NOT COMPLETED|Overall Study||19
10955563|NCT00447057|12127675|FG003|NOT COMPLETED|Overall Study||26
10955564|NCT00447083|12127685|FG000|STARTED|Phase I||10
10955565|NCT00447083|12127686|FG001|STARTED|Phase I||9
10955566|NCT00447083|12127687|FG002|STARTED|Phase I||0
10955567|NCT00447083|12127688|FG003|STARTED|Phase I||0
10955568|NCT00447083|12127685|FG000|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
10955569|NCT00447083|12127686|FG001|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
10955570|NCT00447083|12127687|FG002|COMPLETED|Phase I||0
10955571|NCT00447083|12127688|FG003|COMPLETED|Phase I||0
10955572|NCT00447083|12127685|FG000|NOT COMPLETED|Phase I||0
10955573|NCT00447083|12127686|FG001|NOT COMPLETED|Phase I||0
10955574|NCT00447083|12127687|FG002|NOT COMPLETED|Phase I||0
10955575|NCT00447083|12127688|FG003|NOT COMPLETED|Phase I||0
10955576|NCT00447083|12127685|FG000|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
10955577|NCT00447083|12127686|FG001|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
10955578|NCT00447083|12127687|FG002|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
10955579|NCT00447083|12127688|FG003|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
10955580|NCT00447083|12127685|FG000|COMPLETED|Phase II||0
10955581|NCT00447083|12127686|FG001|COMPLETED|Phase II||0
10955582|NCT00447083|12127687|FG002|COMPLETED|Phase II||7
10955583|NCT00447083|12127688|FG003|COMPLETED|Phase II||7
10955584|NCT00447083|12127685|FG000|NOT COMPLETED|Phase II||0
10955585|NCT00447083|12127686|FG001|NOT COMPLETED|Phase II||0
10955586|NCT00447083|12127687|FG002|NOT COMPLETED|Phase II||1
10955587|NCT00447083|12127688|FG003|NOT COMPLETED|Phase II||1
10955588|NCT00447226|12127696|FG000|STARTED|12-Week Open-label Phase||0
10955589|NCT00447226|12127697|FG001|STARTED|12-Week Open-label Phase||32
10955590|NCT00447226|12127696|FG000|COMPLETED|12-Week Open-label Phase||0
10955591|NCT00447226|12127697|FG001|COMPLETED|12-Week Open-label Phase||7
10955592|NCT00447226|12127696|FG000|NOT COMPLETED|12-Week Open-label Phase||0
10955593|NCT00447226|12127697|FG001|NOT COMPLETED|12-Week Open-label Phase||25
10955594|NCT00447226|12127696|FG000|STARTED|Double-blind Phase||4
10955595|NCT00447226|12127697|FG001|STARTED|Double-blind Phase||3
10955596|NCT00447226|12127696|FG000|COMPLETED|Double-blind Phase||0
10955597|NCT00447226|12127697|FG001|COMPLETED|Double-blind Phase||0
10955598|NCT00447226|12127696|FG000|NOT COMPLETED|Double-blind Phase||4
10955599|NCT00447226|12127697|FG001|NOT COMPLETED|Double-blind Phase||3
10955600|NCT00447265|12127712|FG000|STARTED|Overall Study||1
10955601|NCT00447265|12127713|FG001|STARTED|Overall Study||0
10955602|NCT00447265|12127712|FG000|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
10955603|NCT00447265|12127713|FG001|COMPLETED|Overall Study||0
10955604|NCT00447265|12127712|FG000|NOT COMPLETED|Overall Study||1
10955605|NCT00447265|12127713|FG001|NOT COMPLETED|Overall Study||0
10955606|NCT00447278|12127719|FG000|STARTED|Period II (6 Month Open-Label)||199
10955607|NCT00447278|12127720|FG001|STARTED|Period II (6 Month Open-Label)||200
10955608|NCT00447278|12127719|FG000|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
10955609|NCT00447278|12127720|FG001|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
10955610|NCT00447278|12127719|FG000|COMPLETED|Period II (6 Month Open-Label)||157
10955611|NCT00447278|12127720|FG001|COMPLETED|Period II (6 Month Open-Label)||171
10955612|NCT00447278|12127719|FG000|NOT COMPLETED|Period II (6 Month Open-Label)||42
10955613|NCT00447278|12127720|FG001|NOT COMPLETED|Period II (6 Month Open-Label)||29
10955614|NCT00447278|12127719|FG000|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
10955615|NCT00447278|12127720|FG001|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
10955616|NCT00447278|12127719|FG000|COMPLETED|Period III (Optional 6 Month Extension)||109
10955617|NCT00447278|12127720|FG001|COMPLETED|Period III (Optional 6 Month Extension)||140
10955618|NCT00447278|12127719|FG000|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
10955619|NCT00447278|12127720|FG001|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
10955620|NCT00447330|12127727|FG000|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
10955621|NCT00447330|12127727|FG000|COMPLETED|Overall Study||58
10955622|NCT00447330|12127727|FG000|NOT COMPLETED|Overall Study||2
10955623|NCT00447382|12127734|FG000|STARTED|Overall Study||164
10955624|NCT00447382|12127735|FG001|STARTED|Overall Study||166
10955625|NCT00447382|12127734|FG000|COMPLETED|Overall Study||158
10955626|NCT00447382|12127735|FG001|COMPLETED|Overall Study||160
10955627|NCT00447382|12127734|FG000|NOT COMPLETED|Overall Study||6
10955628|NCT00447382|12127735|FG001|NOT COMPLETED|Overall Study||6
10955629|NCT00447499|12127741|FG000|STARTED|Overall Study||59
10955630|NCT00447499|12127741|FG000|COMPLETED|Overall Study||52
10955631|NCT00447499|12127741|FG000|NOT COMPLETED|Overall Study||7
10955632|NCT00447590|12127747|FG000|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
10955633|NCT00447590|12127747|FG000|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
10955634|NCT00447590|12127747|FG000|NOT COMPLETED|Overall Study||60
10955635|NCT00447694|12127751|FG000|STARTED|Overall Study||28
10955636|NCT00447694|12127751|FG000|COMPLETED|Overall Study||22
10955637|NCT00447694|12127751|FG000|NOT COMPLETED|Overall Study||6
10955638|NCT00447772|12127755|FG000|STARTED|Overall Study||516
10955639|NCT00447772|12127755|FG000|COMPLETED|Overall Study||489
10955640|NCT00447772|12127755|FG000|NOT COMPLETED|Overall Study||27
10955641|NCT00447876|12127764|FG000|STARTED|Overall Study||20
10955642|NCT00447876|12127765|FG001|STARTED|Overall Study||20
10955643|NCT00447876|12127764|FG000|COMPLETED|Overall Study||17
10955644|NCT00447876|12127765|FG001|COMPLETED|Overall Study||16
10955645|NCT00447876|12127764|FG000|NOT COMPLETED|Overall Study||3
10955646|NCT00447876|12127765|FG001|NOT COMPLETED|Overall Study||4
10955647|NCT00447902|12127773|FG000|STARTED|Overall Study||5
10955648|NCT00447902|12127774|FG001|STARTED|Overall Study||6
10955649|NCT00447902|12127773|FG000|COMPLETED|Overall Study||1
10955650|NCT00447902|12127774|FG001|COMPLETED|Overall Study||0
10955651|NCT00447902|12127773|FG000|NOT COMPLETED|Overall Study||4
10955652|NCT00447902|12127774|FG001|NOT COMPLETED|Overall Study||6
10955653|NCT00448019|12127780|FG000|STARTED|Overall Study||64
10955654|NCT00448019|12127780|FG000|COMPLETED|Overall Study||57
10955655|NCT00448019|12127780|FG000|NOT COMPLETED|Overall Study||7
10955656|NCT00448123|12127786|FG000|STARTED|Overall Study||62
10955657|NCT00448123|12127787|FG001|STARTED|Overall Study||65
10955658|NCT00448123|12127786|FG000|COMPLETED|Overall Study||47
10955659|NCT00448123|12127787|FG001|COMPLETED|Overall Study||53
10955660|NCT00448123|12127786|FG000|NOT COMPLETED|Overall Study||15
10955661|NCT00448123|12127787|FG001|NOT COMPLETED|Overall Study||12
10955662|NCT00448136|12127798|FG000|STARTED|Overall Study||34
10955663|NCT00448136|12127799|FG001|STARTED|Overall Study||49
10955664|NCT00448136|12127798|FG000|COMPLETED|Overall Study||30
10955665|NCT00448136|12127799|FG001|COMPLETED|Overall Study||41
10955666|NCT00448136|12127798|FG000|NOT COMPLETED|Overall Study||4
10955667|NCT00448136|12127799|FG001|NOT COMPLETED|Overall Study||8
10955668|NCT00448175|12127807|FG000|STARTED|12 Weeks PTNS vs. Drug||50
10955669|NCT00448175|12127808|FG001|STARTED|12 Weeks PTNS vs. Drug||50
10955670|NCT00448175|12127807|FG000|COMPLETED|12 Weeks PTNS vs. Drug||41
10955671|NCT00448175|12127808|FG001|COMPLETED|12 Weeks PTNS vs. Drug||43
10955672|NCT00448175|12127807|FG000|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
10955673|NCT00448175|12127808|FG001|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
10955674|NCT00448175|12127807|FG000|STARTED|Continued PTNS Through 12 Months||35
10955675|NCT00448175|12127808|FG001|STARTED|Continued PTNS Through 12 Months||0
10955676|NCT00448175|12127807|FG000|COMPLETED|Continued PTNS Through 12 Months||25
10955677|NCT00448175|12127808|FG001|COMPLETED|Continued PTNS Through 12 Months||0
10955678|NCT00448175|12127807|FG000|NOT COMPLETED|Continued PTNS Through 12 Months||10
10955679|NCT00448175|12127808|FG001|NOT COMPLETED|Continued PTNS Through 12 Months||0
10955680|NCT00448201|12127814|FG000|STARTED|Overall Study||71
10955681|NCT00448201|12127814|FG000|COMPLETED|Overall Study||71
10955682|NCT00448201|12127814|FG000|NOT COMPLETED|Overall Study||0
10955683|NCT00448227|12127820|FG000|STARTED|Overall Study||18
10955684|NCT00448227|12127820|FG000|COMPLETED|Overall Study||18
10955685|NCT00448227|12127820|FG000|NOT COMPLETED|Overall Study||0
10955686|NCT00448279|12127829|FG000|STARTED|Overall Study||29
10955687|NCT00448279|12127830|FG001|STARTED|Overall Study||29
10955688|NCT00448279|12127829|FG000|COMPLETED|Overall Study||0
10955689|NCT00448279|12127830|FG001|COMPLETED|Overall Study||0
10955690|NCT00448279|12127829|FG000|NOT COMPLETED|Overall Study||29
10955691|NCT00448279|12127830|FG001|NOT COMPLETED|Overall Study||29
10955692|NCT00448344|12127838|FG000|STARTED|Overall Study||235
10955693|NCT00448344|12127839|FG001|STARTED|Overall Study||236
10955694|NCT00448344|12127838|FG000|COMPLETED|Overall Study||205
10955695|NCT00448344|12127839|FG001|COMPLETED|Overall Study||200
10955696|NCT00448344|12127838|FG000|NOT COMPLETED|Overall Study||30
10955697|NCT00448344|12127839|FG001|NOT COMPLETED|Overall Study||36
10955698|NCT00448357|12127845|FG000|STARTED|Overall Study||54
10955699|NCT00448357|12127845|FG000|COMPLETED|Overall Study||54
10955700|NCT00448357|12127845|FG000|NOT COMPLETED|Overall Study||0
10955701|NCT00448435|12127861|FG000|STARTED|Treatment Period I - 4 Weeks||26
10955702|NCT00448435|12127862|FG001|STARTED|Treatment Period I - 4 Weeks||25
10955703|NCT00448435|12127861|FG000|COMPLETED|Treatment Period I - 4 Weeks||26
10955704|NCT00448435|12127862|FG001|COMPLETED|Treatment Period I - 4 Weeks||25
10955705|NCT00448435|12127861|FG000|NOT COMPLETED|Treatment Period I - 4 Weeks||0
10955706|NCT00448435|12127862|FG001|NOT COMPLETED|Treatment Period I - 4 Weeks||0
10955707|NCT00448435|12127861|FG000|STARTED|Washout Period - 2 Weeks||26
10955708|NCT00448435|12127862|FG001|STARTED|Washout Period - 2 Weeks||25
10955709|NCT00448435|12127861|FG000|COMPLETED|Washout Period - 2 Weeks||25
10955710|NCT00448435|12127862|FG001|COMPLETED|Washout Period - 2 Weeks||25
10955711|NCT00448435|12127861|FG000|NOT COMPLETED|Washout Period - 2 Weeks||1
10955712|NCT00448435|12127862|FG001|NOT COMPLETED|Washout Period - 2 Weeks||0
10955713|NCT00448435|12127861|FG000|STARTED|Treatment Period II - 4 Weeks||25
10955714|NCT00448435|12127862|FG001|STARTED|Treatment Period II - 4 Weeks||25
10955715|NCT00448435|12127861|FG000|COMPLETED|Treatment Period II - 4 Weeks||25
10955716|NCT00448435|12127862|FG001|COMPLETED|Treatment Period II - 4 Weeks||25
10955717|NCT00448435|12127861|FG000|NOT COMPLETED|Treatment Period II - 4 Weeks||0
10955718|NCT00448435|12127862|FG001|NOT COMPLETED|Treatment Period II - 4 Weeks||0
10955719|NCT00448435|12127861|FG000|STARTED|Extension Period - 20 Weeks||50
10955720|NCT00448435|12127862|FG001|STARTED|Extension Period - 20 Weeks||0
10955721|NCT00448435|12127861|FG000|COMPLETED|Extension Period - 20 Weeks||50
10955722|NCT00448435|12127862|FG001|COMPLETED|Extension Period - 20 Weeks||0
10955723|NCT00448435|12127861|FG000|NOT COMPLETED|Extension Period - 20 Weeks||0
10955724|NCT00448435|12127862|FG001|NOT COMPLETED|Extension Period - 20 Weeks||0
10955725|NCT00448448|12127873|FG000|STARTED|Overall Study||246
10955726|NCT00448448|12127874|FG001|STARTED|Overall Study||137
10955727|NCT00448448|12127873|FG000|COMPLETED|Overall Study||146
10955728|NCT00448448|12127874|FG001|COMPLETED|Overall Study||96
10955729|NCT00448448|12127873|FG000|NOT COMPLETED|Overall Study||100
10955730|NCT00448448|12127874|FG001|NOT COMPLETED|Overall Study||41
10955731|NCT00448539|12127882|FG000|STARTED|Overall Study||134
10955732|NCT00448539|12127883|FG001|STARTED|Overall Study||152
10955733|NCT00448539|12127882|FG000|COMPLETED|Overall Study||0
10955734|NCT00448539|12127883|FG001|COMPLETED|Overall Study||0
10955735|NCT00448539|12127882|FG000|NOT COMPLETED|Overall Study||134
10955736|NCT00448539|12127883|FG001|NOT COMPLETED|Overall Study||152
10955737|NCT00448591|12127889|FG000|STARTED|Overall Study||2296
10955738|NCT00448591|12127889|FG000|COMPLETED|Overall Study||0
10955739|NCT00448591|12127889|FG000|NOT COMPLETED|Overall Study||2296
10955740|NCT00448669|12127897|FG000|STARTED|Overall Study||611
10955741|NCT00448669|12127898|FG001|STARTED|Overall Study||608
10955742|NCT00448669|12127897|FG000|COMPLETED|Overall Study||393
10955743|NCT00448669|12127898|FG001|COMPLETED|Overall Study||410
10955744|NCT00448669|12127897|FG000|NOT COMPLETED|Overall Study||218
10955745|NCT00448669|12127898|FG001|NOT COMPLETED|Overall Study||198
10955746|NCT00448708|12127908|FG000|STARTED|Overall Study||112
10955747|NCT00448708|12127909|FG001|STARTED|Overall Study||110
10955748|NCT00448708|12127908|FG000|COMPLETED|Overall Study||77
10955749|NCT00448708|12127909|FG001|COMPLETED|Overall Study||79
10955750|NCT00448708|12127908|FG000|NOT COMPLETED|Overall Study||35
10955751|NCT00448708|12127909|FG001|NOT COMPLETED|Overall Study||31
10955752|NCT00448747|12127917|FG000|STARTED|Overall Study||53
10955753|NCT00448747|12127918|FG001|STARTED|Overall Study||48
10955754|NCT00448747|12127917|FG000|Received First Drug Administration|Overall Study||53
10955755|NCT00448747|12127918|FG001|Received First Drug Administration|Overall Study||48
10955756|NCT00448747|12127917|FG000|Received Second Drug Administration|Overall Study||42
10955757|NCT00448747|12127918|FG001|Received Second Drug Administration|Overall Study||10
10955758|NCT00448747|12127917|FG000|Received AEZS-130|Overall Study||52
10955759|NCT00448747|12127918|FG001|Received AEZS-130|Overall Study||48
10955760|NCT00448747|12127917|FG000|Received L-ARG-GHRH|Overall Study||43
10955761|NCT00448747|12127918|FG001|Received L-ARG-GHRH|Overall Study||10
10955762|NCT00448747|12127917|FG000|Received L-ARG-GHRH and AEZS-130|Overall Study||42
10955763|NCT00448747|12127918|FG001|Received L-ARG-GHRH and AEZS-130|Overall Study||10
10955764|NCT00448747|12127917|FG000|Per Protocol Population (PPS)|Overall Study||50
10955765|NCT00448747|12127918|FG001|Per Protocol Population (PPS)|Overall Study||48
10955766|NCT00448747|12127917|FG000|COMPLETED|Overall Study||52
10955767|NCT00448747|12127918|FG001|COMPLETED|Overall Study||48
10955768|NCT00448747|12127917|FG000|NOT COMPLETED|Overall Study||1
10955769|NCT00448747|12127918|FG001|NOT COMPLETED|Overall Study||0
10955770|NCT00448760|12127934|FG000|STARTED|Overall Study||29
10955771|NCT00448760|12127934|FG000|COMPLETED|Overall Study||26
10955772|NCT00448760|12127934|FG000|NOT COMPLETED|Overall Study||3
10955773|NCT00448812|12127940|FG000|STARTED|Year 1||45
10955774|NCT00448812|12127941|FG001|STARTED|Year 1||24
10955775|NCT00448812|12127940|FG000|COMPLETED|Year 1||45
10955776|NCT00448812|12127941|FG001|COMPLETED|Year 1||24
10955777|NCT00448812|12127940|FG000|NOT COMPLETED|Year 1||0
10955778|NCT00448812|12127941|FG001|NOT COMPLETED|Year 1||0
10955779|NCT00448812|12127940|FG000|STARTED|Year 2||45
10955780|NCT00448812|12127941|FG001|STARTED|Year 2||24
10955781|NCT00448812|12127940|FG000|COMPLETED|Year 2||41
10955782|NCT00448812|12127941|FG001|COMPLETED|Year 2||23
10955783|NCT00448812|12127940|FG000|NOT COMPLETED|Year 2||4
10955784|NCT00448812|12127941|FG001|NOT COMPLETED|Year 2||1
10955785|NCT00448812|12127940|FG000|STARTED|Year 3||45
10955786|NCT00448812|12127941|FG001|STARTED|Year 3||24
10955787|NCT00448812|12127940|FG000|COMPLETED|Year 3||41
10955788|NCT00448812|12127941|FG001|COMPLETED|Year 3||21
10955789|NCT00448812|12127940|FG000|NOT COMPLETED|Year 3||4
10955790|NCT00448812|12127941|FG001|NOT COMPLETED|Year 3||3
10955791|NCT00448812|12127940|FG000|STARTED|Year 4||43
10955792|NCT00448812|12127941|FG001|STARTED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
10955793|NCT00448812|12127940|FG000|COMPLETED|Year 4||43
10955794|NCT00448812|12127941|FG001|COMPLETED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
10955795|NCT00448812|12127940|FG000|NOT COMPLETED|Year 4||0
10955796|NCT00448812|12127941|FG001|NOT COMPLETED|Year 4||0
10955797|NCT00448812|12127940|FG000|STARTED|Year 5||43
10955798|NCT00448812|12127941|FG001|STARTED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
10955799|NCT00448812|12127940|FG000|COMPLETED|Year 5||42
10955800|NCT00448812|12127941|FG001|COMPLETED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
10955801|NCT00448812|12127940|FG000|NOT COMPLETED|Year 5||1
10955802|NCT00448812|12127941|FG001|NOT COMPLETED|Year 5||0
10955803|NCT00448864|12127962|FG000|STARTED|Overall Study||27
10955804|NCT00448864|12127963|FG001|STARTED|Overall Study||29
10955805|NCT00448864|12127964|FG002|STARTED|Overall Study||19
10955806|NCT00448864|12127962|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
10955807|NCT00448864|12127963|FG001|Received at Least 1 Dose of Study Drug|Overall Study||25
10955808|NCT00448864|12127964|FG002|Received at Least 1 Dose of Study Drug|Overall Study||18
10955809|NCT00448864|12127962|FG000|Started Post-operative Period|Overall Study||26
10955810|NCT00448864|12127963|FG001|Started Post-operative Period|Overall Study||25
10955811|NCT00448864|12127964|FG002|Started Post-operative Period|Overall Study||18
10955812|NCT00448864|12127962|FG000|Completed Post-operative Period|Overall Study||26
10955813|NCT00448864|12127963|FG001|Completed Post-operative Period|Overall Study||25
10955814|NCT00448864|12127964|FG002|Completed Post-operative Period|Overall Study||18
10955815|NCT00448864|12127962|FG000|COMPLETED|Overall Study||22
10955816|NCT00448864|12127963|FG001|COMPLETED|Overall Study||24
10955817|NCT00448864|12127964|FG002|COMPLETED|Overall Study||18
10955818|NCT00448864|12127962|FG000|NOT COMPLETED|Overall Study||5
10955819|NCT00448864|12127963|FG001|NOT COMPLETED|Overall Study||5
10955820|NCT00448864|12127964|FG002|NOT COMPLETED|Overall Study||1
10955821|NCT00448916|12127978|FG000|STARTED|Overall Study||16
10955822|NCT00448916|12127979|FG001|STARTED|Overall Study||15
10955823|NCT00448916|12127980|FG002|STARTED|Overall Study||12
10955824|NCT00448916|12127981|FG003|STARTED|Overall Study||11
10955825|NCT00448916|12127978|FG000|COMPLETED|Overall Study||9
10955826|NCT00448916|12127979|FG001|COMPLETED|Overall Study||9
10955827|NCT00448916|12127980|FG002|COMPLETED|Overall Study||6
10955828|NCT00448916|12127981|FG003|COMPLETED|Overall Study||5
10955829|NCT00448916|12127978|FG000|NOT COMPLETED|Overall Study||7
10955830|NCT00448916|12127979|FG001|NOT COMPLETED|Overall Study||6
10955831|NCT00448916|12127980|FG002|NOT COMPLETED|Overall Study||6
10955832|NCT00448916|12127981|FG003|NOT COMPLETED|Overall Study||6
10955833|NCT00449007|12127995|FG000|STARTED|Overall Study||2
10955834|NCT00449007|12127996|FG001|STARTED|Overall Study||3
10955835|NCT00449007|12127995|FG000|COMPLETED|Overall Study||2
10955836|NCT00449007|12127996|FG001|COMPLETED|Overall Study||3
10955837|NCT00449007|12127995|FG000|NOT COMPLETED|Overall Study||0
10955838|NCT00449007|12127996|FG001|NOT COMPLETED|Overall Study||0
10955839|NCT00449033|12128006|FG000|STARTED|Treatment Period||452
10955840|NCT00449033|12128007|FG001|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
10955841|NCT00449033|12128006|FG000|Received Treatment|Treatment Period||452
10955842|NCT00449033|12128007|FG001|Received Treatment|Treatment Period||449
10955843|NCT00449033|12128006|FG000|COMPLETED|Treatment Period||0
10955844|NCT00449033|12128007|FG001|COMPLETED|Treatment Period||0
10955845|NCT00449033|12128006|FG000|NOT COMPLETED|Treatment Period||452
10955846|NCT00449033|12128007|FG001|NOT COMPLETED|Treatment Period||452
10955847|NCT00449033|12128006|FG000|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
10955848|NCT00449033|12128007|FG001|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
10955849|NCT00449033|12128006|FG000|COMPLETED|Follow-up Period||0
10955850|NCT00449033|12128007|FG001|COMPLETED|Follow-up Period||0
10955851|NCT00449033|12128006|FG000|NOT COMPLETED|Follow-up Period||425
10955852|NCT00449033|12128007|FG001|NOT COMPLETED|Follow-up Period||434
10955853|NCT00449046|12128013|FG000|STARTED|Overall Study||40
10955854|NCT00449046|12128013|FG000|COMPLETED|Overall Study||40
10955855|NCT00449046|12128013|FG000|NOT COMPLETED|Overall Study||0
10955856|NCT00449072|12128019|FG000|STARTED|Overall Study||148
10955857|NCT00449072|12128020|FG001|STARTED|Overall Study||151
10955858|NCT00449072|12128019|FG000|COMPLETED|Overall Study||107
10955859|NCT00449072|12128020|FG001|COMPLETED|Overall Study||109
10955860|NCT00449072|12128019|FG000|NOT COMPLETED|Overall Study||41
10955861|NCT00449072|12128020|FG001|NOT COMPLETED|Overall Study||42
10955862|NCT00449150|12128029|FG000|STARTED|Overall Study||219
10955863|NCT00449150|12128030|FG001|STARTED|Overall Study||230
10955864|NCT00449150|12128031|FG002|STARTED|Overall Study||218
10955865|NCT00449150|12128029|FG000|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
10955866|NCT00449150|12128030|FG001|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
10955867|NCT00449150|12128031|FG002|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
10955868|NCT00449150|12128029|FG000|NOT COMPLETED|Overall Study||46
10955869|NCT00449150|12128030|FG001|NOT COMPLETED|Overall Study||53
10955870|NCT00449150|12128031|FG002|NOT COMPLETED|Overall Study||47
10955871|NCT00449163|12128042|FG000|STARTED|Overall Study||25
10955872|NCT00449163|12128042|FG000|COMPLETED|Overall Study||22
10955873|NCT00449163|12128042|FG000|NOT COMPLETED|Overall Study||3
10955874|NCT00449176|12128049|FG000|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
10955875|NCT00449176|12128050|FG001|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
10955876|NCT00449176|12128051|FG002|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
10955877|NCT00449176|12128049|FG000|COMPLETED|Overall Study||166
10955878|NCT00449176|12128050|FG001|COMPLETED|Overall Study||133
10955879|NCT00449176|12128051|FG002|COMPLETED|Overall Study||152
10955880|NCT00449176|12128049|FG000|NOT COMPLETED|Overall Study||152
10955881|NCT00449176|12128050|FG001|NOT COMPLETED|Overall Study||195
10955882|NCT00449176|12128051|FG002|NOT COMPLETED|Overall Study||167
10955883|NCT00449540|12128061|FG000|STARTED|Pretreatment Phase||267
10955884|NCT00449540|12128062|FG001|STARTED|Pretreatment Phase||0
10955885|NCT00449540|12128063|FG002|STARTED|Pretreatment Phase||0
10955886|NCT00449540|12128061|FG000|COMPLETED|Pretreatment Phase||201
10955887|NCT00449540|12128062|FG001|COMPLETED|Pretreatment Phase||0
10955888|NCT00449540|12128063|FG002|COMPLETED|Pretreatment Phase||0
10955889|NCT00449540|12128061|FG000|NOT COMPLETED|Pretreatment Phase||66
10955890|NCT00449540|12128062|FG001|NOT COMPLETED|Pretreatment Phase||0
10955891|NCT00449540|12128063|FG002|NOT COMPLETED|Pretreatment Phase||0
10955892|NCT00449540|12128061|FG000|STARTED|Treatment Phase||0
10955893|NCT00449540|12128062|FG001|STARTED|Treatment Phase||102
10955894|NCT00449540|12128063|FG002|STARTED|Treatment Phase||99
10955895|NCT00449540|12128061|FG000|COMPLETED|Treatment Phase||0
10955896|NCT00449540|12128062|FG001|COMPLETED|Treatment Phase||82
10955897|NCT00449540|12128063|FG002|COMPLETED|Treatment Phase||82
10955898|NCT00449540|12128061|FG000|NOT COMPLETED|Treatment Phase||0
10955899|NCT00449540|12128062|FG001|NOT COMPLETED|Treatment Phase||20
10955900|NCT00449540|12128063|FG002|NOT COMPLETED|Treatment Phase||17
10955901|NCT00449644|12128075|FG000|STARTED|Overall Study||23
10955902|NCT00449644|12128076|FG001|STARTED|Overall Study||24
10955903|NCT00449644|12128077|FG002|STARTED|Overall Study||79
10955904|NCT00449644|12128078|FG003|STARTED|Overall Study||81
10955905|NCT00449644|12128075|FG000|Rollover|Overall Study||0
10955906|NCT00449644|12128076|FG001|Rollover|Overall Study||0
10955907|NCT00449644|12128077|FG002|Rollover|Overall Study||0
10955908|NCT00449644|12128078|FG003|Rollover|Overall Study||1
10955909|NCT00449644|12128075|FG000|COMPLETED|Overall Study||13
10955910|NCT00449644|12128076|FG001|COMPLETED|Overall Study||11
10955911|NCT00449644|12128077|FG002|COMPLETED|Overall Study||50
10955912|NCT00449644|12128078|FG003|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
10955913|NCT00449644|12128075|FG000|NOT COMPLETED|Overall Study||10
10955914|NCT00449644|12128076|FG001|NOT COMPLETED|Overall Study||13
10955915|NCT00449644|12128077|FG002|NOT COMPLETED|Overall Study||29
10955916|NCT00449644|12128078|FG003|NOT COMPLETED|Overall Study||32
10955917|NCT00449670|12128093|FG000|STARTED|Primary Phase (Study no.109630)||961
10955918|NCT00449670|12128094|FG001|STARTED|Primary Phase (Study no.109630)||245
10955919|NCT00449670|12128093|FG000|COMPLETED|Primary Phase (Study no.109630)||947
10955920|NCT00449670|12128094|FG001|COMPLETED|Primary Phase (Study no.109630)||243
10955921|NCT00449670|12128093|FG000|NOT COMPLETED|Primary Phase (Study no.109630)||14
10955922|NCT00449670|12128094|FG001|NOT COMPLETED|Primary Phase (Study no.109630)||2
10955923|NCT00449670|12128093|FG000|STARTED|Booster Phase (Study no.109873)||265
10955924|NCT00449670|12128094|FG001|STARTED|Booster Phase (Study no.109873)||236
10955925|NCT00449670|12128093|FG000|COMPLETED|Booster Phase (Study no.109873)||265
10955926|NCT00449670|12128094|FG001|COMPLETED|Booster Phase (Study no.109873)||233
10955927|NCT00449670|12128093|FG000|NOT COMPLETED|Booster Phase (Study no.109873)||0
10955928|NCT00449670|12128094|FG001|NOT COMPLETED|Booster Phase (Study no.109873)||3
10955929|NCT00449696|12128109|FG000|STARTED|Overall Study||251
10955930|NCT00449696|12128110|FG001|STARTED|Overall Study||128
10955931|NCT00449696|12128109|FG000|Received Injection|Overall Study||249
10955932|NCT00449696|12128110|FG001|Received Injection|Overall Study||128
10955933|NCT00449696|12128109|FG000|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
10955934|NCT00449696|12128110|FG001|Analyzed Participants|Overall Study||128
10955935|NCT00449696|12128109|FG000|COMPLETED|Overall Study||231
10955936|NCT00449696|12128110|FG001|COMPLETED|Overall Study||119
10955937|NCT00449696|12128109|FG000|NOT COMPLETED|Overall Study||20
10955938|NCT00449696|12128110|FG001|NOT COMPLETED|Overall Study||9
10955939|NCT00449748|12128116|FG000|STARTED|Overall Study||10
10955940|NCT00449748|12128116|FG000|COMPLETED|Overall Study||10
10955941|NCT00449748|12128116|FG000|NOT COMPLETED|Overall Study||0
10955942|NCT00449761|12128120|FG000|STARTED|Overall Study||27
10955943|NCT00449761|12128120|FG000|COMPLETED|Overall Study||9
10955944|NCT00449761|12128120|FG000|NOT COMPLETED|Overall Study||18
10955945|NCT00449787|12128127|FG000|STARTED|Overall Study||203
10955946|NCT00449787|12128128|FG001|STARTED|Overall Study||198
10955947|NCT00449787|12128127|FG000|COMPLETED|Overall Study||98
10955948|NCT00449787|12128128|FG001|COMPLETED|Overall Study||98
10955949|NCT00449787|12128127|FG000|NOT COMPLETED|Overall Study||105
10955950|NCT00449787|12128128|FG001|NOT COMPLETED|Overall Study||100
10955951|NCT00449865|12128138|FG000|STARTED|Overall Study||867
10955952|NCT00449865|12128139|FG001|STARTED|Overall Study||874
10955953|NCT00449865|12128138|FG000|Completed Year 1|Overall Study|867 Expected at Year 1|802
10955954|NCT00449865|12128139|FG001|Completed Year 1|Overall Study|874 Expected at Year 1|822
10955955|NCT00449865|12128138|FG000|Completed Year 2|Overall Study|867 Expected at Year 2|768
10955956|NCT00449865|12128139|FG001|Completed Year 2|Overall Study|874 Expected at Year 2|766
10955957|NCT00449865|12128138|FG000|Completed Year 3|Overall Study|867 Expected at Year 3|719
10955958|NCT00449865|12128139|FG001|Completed Year 3|Overall Study|874 Expected at Year 3|715
10955959|NCT00449865|12128138|FG000|Completed Year 4|Overall Study|679 Expected at Year 4|521
10955960|NCT00449865|12128139|FG001|Completed Year 4|Overall Study|686 Expected at Year 4|523
10955961|NCT00449865|12128138|FG000|COMPLETED|Overall Study|478 Expected at Year 5|345
10955962|NCT00449865|12128139|FG001|COMPLETED|Overall Study|477 Expected at Year 5|340
10955963|NCT00449865|12128138|FG000|NOT COMPLETED|Overall Study||522
10955964|NCT00449865|12128139|FG001|NOT COMPLETED|Overall Study||534
10955965|NCT00449930|12128147|FG000|STARTED|Overall Study||528
10955966|NCT00449930|12128148|FG001|STARTED|Overall Study||522
10955967|NCT00449930|12128147|FG000|COMPLETED|Overall Study||467
10955968|NCT00449930|12128148|FG001|COMPLETED|Overall Study||447
10955969|NCT00449930|12128147|FG000|NOT COMPLETED|Overall Study||61
10955970|NCT00449930|12128148|FG001|NOT COMPLETED|Overall Study||75
10955971|NCT00449956|12128157|FG000|STARTED|Overall Study||189
10955972|NCT00449956|12128158|FG001|STARTED|Overall Study||92
10955973|NCT00449956|12128159|FG002|STARTED|Overall Study||193
10955974|NCT00449956|12128157|FG000|COMPLETED|Overall Study||179
10955975|NCT00449956|12128158|FG001|COMPLETED|Overall Study||88
10955976|NCT00449956|12128159|FG002|COMPLETED|Overall Study||184
10955977|NCT00449956|12128157|FG000|NOT COMPLETED|Overall Study||10
10955978|NCT00449956|12128158|FG001|NOT COMPLETED|Overall Study||4
10955979|NCT00449956|12128159|FG002|NOT COMPLETED|Overall Study||9
10955980|NCT00450073|12128170|FG000|STARTED|Overall Study||10
10955981|NCT00450073|12128171|FG001|STARTED|Overall Study||10
10955982|NCT00450073|12128172|FG002|STARTED|Overall Study||10
10955983|NCT00450073|12128170|FG000|COMPLETED|Overall Study||9
10955984|NCT00450073|12128171|FG001|COMPLETED|Overall Study||10
10955985|NCT00450073|12128172|FG002|COMPLETED|Overall Study||9
10955986|NCT00450073|12128170|FG000|NOT COMPLETED|Overall Study||1
10955987|NCT00450073|12128171|FG001|NOT COMPLETED|Overall Study||0
10955988|NCT00450073|12128172|FG002|NOT COMPLETED|Overall Study||1
10955989|NCT00450112|12128182|FG000|STARTED|Overall Study||125
10955990|NCT00450112|12128183|FG001|STARTED|Overall Study||77
10955991|NCT00450112|12128182|FG000|Received Injection|Overall Study||125
10955992|NCT00450112|12128183|FG001|Received Injection|Overall Study||74
10955993|NCT00450112|12128182|FG000|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
10955994|NCT00450112|12128183|FG001|Analyzed Participants|Overall Study||74
10955995|NCT00450112|12128182|FG000|COMPLETED|Overall Study||112
10955996|NCT00450112|12128183|FG001|COMPLETED|Overall Study||71
10955997|NCT00450112|12128182|FG000|NOT COMPLETED|Overall Study||13
10955998|NCT00450112|12128183|FG001|NOT COMPLETED|Overall Study||6
10955999|NCT00450177|12128191|FG000|STARTED|Overall Study||97
10956000|NCT00450177|12128192|FG001|STARTED|Overall Study||103
10956001|NCT00450177|12128191|FG000|COMPLETED|Overall Study||88
10956002|NCT00450177|12128192|FG001|COMPLETED|Overall Study||92
10956003|NCT00450177|12128191|FG000|NOT COMPLETED|Overall Study||9
10956004|NCT00450177|12128192|FG001|NOT COMPLETED|Overall Study||11
10956005|NCT00450190|12128198|FG000|STARTED|Overall Study||20
10956006|NCT00450190|12128198|FG000|COMPLETED|Overall Study||18
10956007|NCT00450190|12128198|FG000|NOT COMPLETED|Overall Study||2
10956008|NCT00450216|12128204|FG000|STARTED|Overall Study||607
10956009|NCT00450216|12128205|FG001|STARTED|Overall Study||299
10956010|NCT00450216|12128204|FG000|COMPLETED|Overall Study||433
10956011|NCT00450216|12128205|FG001|COMPLETED|Overall Study||170
10956012|NCT00450216|12128204|FG000|NOT COMPLETED|Overall Study||174
10956013|NCT00450216|12128205|FG001|NOT COMPLETED|Overall Study||129
10956014|NCT00450242|12128213|FG000|STARTED|Overall Study||7
10956015|NCT00450242|12128214|FG001|STARTED|Overall Study||7
10956016|NCT00450242|12128213|FG000|COMPLETED|Overall Study||4
10956017|NCT00450242|12128214|FG001|COMPLETED|Overall Study||6
10956018|NCT00450242|12128213|FG000|NOT COMPLETED|Overall Study||3
10956019|NCT00450242|12128214|FG001|NOT COMPLETED|Overall Study||1
10956020|NCT00450255|12128222|FG000|STARTED|Overall Study||41
10956021|NCT00450255|12128222|FG000|COMPLETED|Overall Study||40
10956022|NCT00450255|12128222|FG000|NOT COMPLETED|Overall Study||1
10956023|NCT00450294|12128227|FG000|STARTED|Overall Study||10
10956024|NCT00450294|12128227|FG000|COMPLETED|Overall Study||10
10956025|NCT00450294|12128227|FG000|NOT COMPLETED|Overall Study||0
10956026|NCT00450372|12128232|FG000|STARTED|Overall Study||38
10956027|NCT00450372|12128232|FG000|COMPLETED|Overall Study||37
10956028|NCT00450372|12128232|FG000|NOT COMPLETED|Overall Study||1
10956029|NCT00450385|12128239|FG000|STARTED|Overall Study||57
10956030|NCT00450385|12128239|FG000|COMPLETED|Overall Study||44
10956031|NCT00450385|12128239|FG000|NOT COMPLETED|Overall Study||13
10956032|NCT00450424|12128246|FG000|STARTED|Overall Study||122
10956033|NCT00450424|12128247|FG001|STARTED|Overall Study||117
10956034|NCT00450424|12128246|FG000|COMPLETED|Overall Study||102
10956035|NCT00450424|12128247|FG001|COMPLETED|Overall Study||106
10956036|NCT00450424|12128246|FG000|NOT COMPLETED|Overall Study||20
10956037|NCT00450424|12128247|FG001|NOT COMPLETED|Overall Study||11
10956038|NCT00450437|12128255|FG000|STARTED|Overall Study||1640
10956039|NCT00450437|12128256|FG001|STARTED|Overall Study||540
10956040|NCT00450437|12128257|FG002|STARTED|Overall Study||1023
10956041|NCT00450437|12128258|FG003|STARTED|Overall Study||336
10956042|NCT00450437|12128255|FG000|COMPLETED|Overall Study||1594
10956043|NCT00450437|12128256|FG001|COMPLETED|Overall Study||524
10956044|NCT00450437|12128257|FG002|COMPLETED|Overall Study||999
10956045|NCT00450437|12128258|FG003|COMPLETED|Overall Study||325
10956046|NCT00450437|12128255|FG000|NOT COMPLETED|Overall Study||46
10956047|NCT00450437|12128256|FG001|NOT COMPLETED|Overall Study||16
10956048|NCT00450437|12128257|FG002|NOT COMPLETED|Overall Study||24
10956049|NCT00450437|12128258|FG003|NOT COMPLETED|Overall Study||11
10956050|NCT00450463|12128274|FG000|STARTED|Initial Drug Administration||33
10956051|NCT00450463|12128275|FG001|STARTED|Initial Drug Administration||31
10956052|NCT00450463|12128274|FG000|COMPLETED|Initial Drug Administration||33
10956053|NCT00450463|12128275|FG001|COMPLETED|Initial Drug Administration||31
10956054|NCT00450463|12128274|FG000|NOT COMPLETED|Initial Drug Administration||0
10956055|NCT00450463|12128275|FG001|NOT COMPLETED|Initial Drug Administration||0
10956056|NCT00450463|12128274|FG000|STARTED|Progressed to Receive Vaccine Alone||11
10956057|NCT00450463|12128275|FG001|STARTED|Progressed to Receive Vaccine Alone||0
10956058|NCT00450463|12128274|FG000|COMPLETED|Progressed to Receive Vaccine Alone||11
10956059|NCT00450463|12128275|FG001|COMPLETED|Progressed to Receive Vaccine Alone||0
10956060|NCT00450463|12128274|FG000|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
10956061|NCT00450463|12128275|FG001|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
10956062|NCT00450580|12128286|FG000|STARTED|Overall Study||106
10956063|NCT00450580|12128287|FG001|STARTED|Overall Study||106
10956064|NCT00450580|12128286|FG000|COMPLETED|Overall Study||90
10956065|NCT00450580|12128287|FG001|COMPLETED|Overall Study||90
10956066|NCT00450580|12128286|FG000|NOT COMPLETED|Overall Study||16
10956067|NCT00450580|12128287|FG001|NOT COMPLETED|Overall Study||16
10956068|NCT00450619|12128295|FG000|STARTED|Overall Study||22
10956069|NCT00450619|12128296|FG001|STARTED|Overall Study||22
10956070|NCT00450619|12128295|FG000|COMPLETED|Overall Study||18
10956071|NCT00450619|12128296|FG001|COMPLETED|Overall Study||21
10956072|NCT00450619|12128295|FG000|NOT COMPLETED|Overall Study||4
10956073|NCT00450619|12128296|FG001|NOT COMPLETED|Overall Study||1
10956074|NCT00450658|12128305|FG000|STARTED|Overall Study||415
10956075|NCT00450658|12128306|FG001|STARTED|Overall Study||212
10956076|NCT00450658|12128305|FG000|COMPLETED|Overall Study||272
10956077|NCT00450658|12128306|FG001|COMPLETED|Overall Study||122
10956078|NCT00450658|12128305|FG000|NOT COMPLETED|Overall Study||143
10956079|NCT00450658|12128306|FG001|NOT COMPLETED|Overall Study||90
10956080|NCT00450723|12128312|FG000|STARTED|Overall Study||39
10956081|NCT00450723|12128312|FG000|COMPLETED|Overall Study||34
10956082|NCT00450723|12128312|FG000|NOT COMPLETED|Overall Study||5
10956083|NCT00450749|12128320|FG000|STARTED|Overall Study||3
10956084|NCT00450749|12128321|FG001|STARTED|Overall Study||3
10956085|NCT00450749|12128322|FG002|STARTED|Overall Study||4
10956086|NCT00450749|12128320|FG000|COMPLETED|Overall Study||3
10956087|NCT00450749|12128321|FG001|COMPLETED|Overall Study||2
10956088|NCT00450749|12128322|FG002|COMPLETED|Overall Study||2
10956089|NCT00450749|12128320|FG000|NOT COMPLETED|Overall Study||0
10956090|NCT00450749|12128321|FG001|NOT COMPLETED|Overall Study||1
10956091|NCT00450749|12128322|FG002|NOT COMPLETED|Overall Study||2
10956092|NCT00450801|12128330|FG000|STARTED|Overall Study||22
10956093|NCT00450801|12128330|FG000|COMPLETED|Overall Study||21
10956094|NCT00450801|12128330|FG000|NOT COMPLETED|Overall Study||1
10956095|NCT00450814|12128349|FG000|STARTED|Overall Study||3
10956096|NCT00450814|12128350|FG001|STARTED|Overall Study||3
10956097|NCT00450814|12128351|FG002|STARTED|Overall Study||3
10956098|NCT00450814|12128352|FG003|STARTED|Overall Study||4
10956099|NCT00450814|12128353|FG004|STARTED|Overall Study||4
10956100|NCT00450814|12128354|FG005|STARTED|Overall Study||7
10956101|NCT00450814|12128355|FG006|STARTED|Overall Study||3
10956102|NCT00450814|12128356|FG007|STARTED|Overall Study||3
10956103|NCT00450814|12128357|FG008|STARTED|Overall Study||2
10956104|NCT00450814|12128358|FG009|STARTED|Overall Study||12
10956105|NCT00450814|12128359|FG010|STARTED|Overall Study||4
10956106|NCT00450814|12128349|FG000|COMPLETED|Overall Study||3
10956107|NCT00450814|12128350|FG001|COMPLETED|Overall Study||3
10956108|NCT00450814|12128351|FG002|COMPLETED|Overall Study||3
10956109|NCT00450814|12128352|FG003|COMPLETED|Overall Study||3
10956110|NCT00450814|12128353|FG004|COMPLETED|Overall Study||3
10956111|NCT00450814|12128354|FG005|COMPLETED|Overall Study||6
10956112|NCT00450814|12128355|FG006|COMPLETED|Overall Study||3
10956113|NCT00450814|12128356|FG007|COMPLETED|Overall Study||3
10956114|NCT00450814|12128357|FG008|COMPLETED|Overall Study||2
10956115|NCT00450814|12128358|FG009|COMPLETED|Overall Study||11
10956116|NCT00450814|12128359|FG010|COMPLETED|Overall Study||4
10956117|NCT00450814|12128349|FG000|NOT COMPLETED|Overall Study||0
10956118|NCT00450814|12128350|FG001|NOT COMPLETED|Overall Study||0
10956119|NCT00450814|12128351|FG002|NOT COMPLETED|Overall Study||0
10956120|NCT00450814|12128352|FG003|NOT COMPLETED|Overall Study||1
10956121|NCT00450814|12128353|FG004|NOT COMPLETED|Overall Study||1
10956122|NCT00450814|12128354|FG005|NOT COMPLETED|Overall Study||1
10956123|NCT00450814|12128355|FG006|NOT COMPLETED|Overall Study||0
10956124|NCT00450814|12128356|FG007|NOT COMPLETED|Overall Study||0
10956125|NCT00450814|12128357|FG008|NOT COMPLETED|Overall Study||0
10956126|NCT00450814|12128358|FG009|NOT COMPLETED|Overall Study||1
10956127|NCT00450814|12128359|FG010|NOT COMPLETED|Overall Study||0
10956128|NCT00450866|12128384|FG000|STARTED|Overall Study||45
10956129|NCT00450866|12128385|FG001|STARTED|Overall Study||10
10956130|NCT00450866|12128384|FG000|COMPLETED|Overall Study||38
10956131|NCT00450866|12128385|FG001|COMPLETED|Overall Study||7
10956132|NCT00450866|12128384|FG000|NOT COMPLETED|Overall Study||7
10956133|NCT00450866|12128385|FG001|NOT COMPLETED|Overall Study||3
10956134|NCT00450983|12128391|FG000|STARTED|Overall Study||1
10956135|NCT00450983|12128391|FG000|COMPLETED|Overall Study||1
10956136|NCT00450983|12128391|FG000|NOT COMPLETED|Overall Study||0
10956137|NCT00451035|12128395|FG000|STARTED|Overall Study||29
10956138|NCT00451035|12128395|FG000|COMPLETED|Overall Study||12
10956139|NCT00451035|12128395|FG000|NOT COMPLETED|Overall Study||17
10956140|NCT00451048|12128400|FG000|STARTED|Overall Study||10
10956141|NCT00451048|12128400|FG000|COMPLETED|Overall Study||10
10956142|NCT00451048|12128400|FG000|NOT COMPLETED|Overall Study||0
10956143|NCT00451178|12128406|FG000|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||58
10956144|NCT00451178|12128407|FG001|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||43
10956145|NCT00451178|12128406|FG000|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||57
10956146|NCT00451178|12128407|FG001|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||43
10956147|NCT00451178|12128406|FG000|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||40
10956148|NCT00451178|12128407|FG001|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||26
10956149|NCT00451178|12128406|FG000|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||18
10956150|NCT00451178|12128407|FG001|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||17
10956151|NCT00451178|12128406|FG000|STARTED|Prior to Maintenance Therapy||40
10956152|NCT00451178|12128407|FG001|STARTED|Prior to Maintenance Therapy|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
10956153|NCT00451178|12128406|FG000|COMPLETED|Prior to Maintenance Therapy||36
10956154|NCT00451178|12128407|FG001|COMPLETED|Prior to Maintenance Therapy||0
10956155|NCT00451178|12128406|FG000|NOT COMPLETED|Prior to Maintenance Therapy||4
10956156|NCT00451178|12128407|FG001|NOT COMPLETED|Prior to Maintenance Therapy||0
10956157|NCT00451178|12128406|FG000|STARTED|Maintenance Therapy (up to 3 Years)||36
10956158|NCT00451178|12128407|FG001|STARTED|Maintenance Therapy (up to 3 Years)|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
10956159|NCT00451178|12128406|FG000|COMPLETED|Maintenance Therapy (up to 3 Years)||6
10956160|NCT00451178|12128407|FG001|COMPLETED|Maintenance Therapy (up to 3 Years)||0
10956161|NCT00451178|12128406|FG000|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||30
10956162|NCT00451178|12128407|FG001|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||0
10956163|NCT00451178|12128406|FG000|STARTED|Long-Term Follow-Up (Up to 2 Years)||6
10956164|NCT00451178|12128407|FG001|STARTED|Long-Term Follow-Up (Up to 2 Years)||26
10956165|NCT00451178|12128406|FG000|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
10956166|NCT00451178|12128407|FG001|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
10956167|NCT00451178|12128406|FG000|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||6
10956168|NCT00451178|12128407|FG001|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||26
10956169|NCT00451191|12128419|FG000|STARTED|Overall Study||68
10956170|NCT00451191|12128420|FG001|STARTED|Overall Study||66
10956171|NCT00451191|12128419|FG000|COMPLETED|Overall Study||53
10956172|NCT00451191|12128420|FG001|COMPLETED|Overall Study||55
10956173|NCT00451191|12128419|FG000|NOT COMPLETED|Overall Study||15
10956174|NCT00451191|12128420|FG001|NOT COMPLETED|Overall Study||11
10956175|NCT00451204|12128428|FG000|STARTED|Overall Study||82
10956176|NCT00451204|12128429|FG001|STARTED|Overall Study||76
10956177|NCT00451204|12128428|FG000|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
10956178|NCT00451204|12128429|FG001|COMPLETED|Overall Study||56
10956179|NCT00451204|12128428|FG000|NOT COMPLETED|Overall Study||22
10956180|NCT00451204|12128429|FG001|NOT COMPLETED|Overall Study||20
10956181|NCT00451217|12128442|FG000|STARTED|Overall Study||49
10956182|NCT00451217|12128443|FG001|STARTED|Overall Study||49
10956183|NCT00451217|12128444|FG002|STARTED|Overall Study||51
10956184|NCT00451217|12128445|FG003|STARTED|Overall Study||49
10956185|NCT00451217|12128442|FG000|Treated|Overall Study||48
10956186|NCT00451217|12128443|FG001|Treated|Overall Study||48
10956187|NCT00451217|12128444|FG002|Treated|Overall Study||48
10956188|NCT00451217|12128445|FG003|Treated|Overall Study||45
10956189|NCT00451217|12128442|FG000|COMPLETED|Overall Study||47
10956190|NCT00451217|12128443|FG001|COMPLETED|Overall Study||47
10956191|NCT00451217|12128444|FG002|COMPLETED|Overall Study||47
10956192|NCT00451217|12128445|FG003|COMPLETED|Overall Study||44
10956193|NCT00451217|12128442|FG000|NOT COMPLETED|Overall Study||2
10956194|NCT00451217|12128443|FG001|NOT COMPLETED|Overall Study||2
10956195|NCT00451217|12128444|FG002|NOT COMPLETED|Overall Study||4
10956196|NCT00451217|12128445|FG003|NOT COMPLETED|Overall Study||5
10956197|NCT00451282|12128457|FG000|STARTED|Overall Study||46
10956198|NCT00451282|12128458|FG001|STARTED|Overall Study||39
10956199|NCT00451282|12128457|FG000|COMPLETED|Overall Study||40
10956200|NCT00451282|12128458|FG001|COMPLETED|Overall Study||34
10956201|NCT00451282|12128457|FG000|NOT COMPLETED|Overall Study||6
10956202|NCT00451282|12128458|FG001|NOT COMPLETED|Overall Study||5
10956203|NCT00451321|12128472|FG000|STARTED|Overall Study||8
10956204|NCT00451321|12128473|FG001|STARTED|Overall Study||15
10956205|NCT00451321|12128474|FG002|STARTED|Overall Study||18
10956206|NCT00451321|12128475|FG003|STARTED|Overall Study||19
10956207|NCT00451321|12128476|FG004|STARTED|Overall Study||7
10956208|NCT00451321|12128477|FG005|STARTED|Overall Study||9
10956209|NCT00451321|12128478|FG006|STARTED|Overall Study||6
10956210|NCT00451321|12128479|FG007|STARTED|Overall Study||6
10956211|NCT00451321|12128472|FG000|COMPLETED|Overall Study||1
10956212|NCT00451321|12128473|FG001|COMPLETED|Overall Study||10
10956213|NCT00451321|12128474|FG002|COMPLETED|Overall Study||0
10956214|NCT00451321|12128475|FG003|COMPLETED|Overall Study||7
10956215|NCT00451321|12128476|FG004|COMPLETED|Overall Study||0
10956216|NCT00451321|12128477|FG005|COMPLETED|Overall Study||0
10956217|NCT00451321|12128478|FG006|COMPLETED|Overall Study||0
10956218|NCT00451321|12128479|FG007|COMPLETED|Overall Study||0
10956219|NCT00451321|12128472|FG000|NOT COMPLETED|Overall Study||7
10956220|NCT00451321|12128473|FG001|NOT COMPLETED|Overall Study||5
10956221|NCT00451321|12128474|FG002|NOT COMPLETED|Overall Study||18
10956222|NCT00451321|12128475|FG003|NOT COMPLETED|Overall Study||12
10956223|NCT00451321|12128476|FG004|NOT COMPLETED|Overall Study||7
10956224|NCT00451321|12128477|FG005|NOT COMPLETED|Overall Study||9
10956225|NCT00451321|12128478|FG006|NOT COMPLETED|Overall Study||6
10956226|NCT00451321|12128479|FG007|NOT COMPLETED|Overall Study||6
10956227|NCT00451451|12128501|FG000|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
10956228|NCT00451451|12128502|FG001|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
10956229|NCT00451451|12128503|FG002|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
10956230|NCT00451451|12128504|FG003|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
10956231|NCT00451451|12128501|FG000|COMPLETED|Overall Study||278
10956232|NCT00451451|12128502|FG001|COMPLETED|Overall Study||284
10956233|NCT00451451|12128503|FG002|COMPLETED|Overall Study||273
10956234|NCT00451451|12128504|FG003|COMPLETED|Overall Study||292
10956235|NCT00451451|12128501|FG000|NOT COMPLETED|Overall Study||85
10956236|NCT00451451|12128502|FG001|NOT COMPLETED|Overall Study||75
10956237|NCT00451451|12128503|FG002|NOT COMPLETED|Overall Study||72
10956238|NCT00451451|12128504|FG003|NOT COMPLETED|Overall Study||58
10956239|NCT00451555|12128519|FG000|STARTED|Overall Study||96
10956240|NCT00451555|12128520|FG001|STARTED|Overall Study||60
10956241|NCT00451555|12128519|FG000|Received at Least One Dose of Study Drug|Overall Study||94
10956242|NCT00451555|12128520|FG001|Received at Least One Dose of Study Drug|Overall Study||58
10956243|NCT00451555|12128519|FG000|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39
10956244|NCT00451555|12128520|FG001|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0
10956245|NCT00451555|12128519|FG000|Enzastaurin Once Daily Dosing (QD)|Overall Study||55
10956246|NCT00451555|12128520|FG001|Enzastaurin Once Daily Dosing (QD)|Overall Study||0
10956247|NCT00451555|12128519|FG000|Progressive Disease|Overall Study||75
10956248|NCT00451555|12128520|FG001|Progressive Disease|Overall Study||54
10956249|NCT00451555|12128519|FG000|Death|Overall Study||2
10956250|NCT00451555|12128520|FG001|Death|Overall Study||0
10956251|NCT00451555|12128519|FG000|COMPLETED|Overall Study||83
10956252|NCT00451555|12128520|FG001|COMPLETED|Overall Study||56
10956253|NCT00451555|12128519|FG000|NOT COMPLETED|Overall Study||13
10956254|NCT00451555|12128520|FG001|NOT COMPLETED|Overall Study||4
10956255|NCT00451698|12128537|FG000|STARTED|Overall Study||3
10956256|NCT00451698|12128538|FG001|STARTED|Overall Study||6
10956257|NCT00451698|12128537|FG000|COMPLETED|Overall Study||3
10956258|NCT00451698|12128538|FG001|COMPLETED|Overall Study||6
10956259|NCT00451698|12128537|FG000|NOT COMPLETED|Overall Study||0
10956260|NCT00451698|12128538|FG001|NOT COMPLETED|Overall Study||0
10956261|NCT00451906|12128546|FG000|STARTED|Overall Study||2252
10956262|NCT00451906|12128546|FG000|COMPLETED|Overall Study||13
10956263|NCT00451906|12128546|FG000|NOT COMPLETED|Overall Study||2239
10956264|NCT00451958|12128554|FG000|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
10956265|NCT00451958|12128555|FG001|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
10956266|NCT00451958|12128556|FG002|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
10956267|NCT00451958|12128557|FG003|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
10956268|NCT00451958|12128558|FG004|STARTED|CS21 (NCT00295750)||204
10956269|NCT00451958|12128554|FG000|COMPLETED|CS21 (NCT00295750)||169
10956270|NCT00451958|12128555|FG001|COMPLETED|CS21 (NCT00295750)||163
10956271|NCT00451958|12128556|FG002|COMPLETED|CS21 (NCT00295750)||0
10956272|NCT00451958|12128557|FG003|COMPLETED|CS21 (NCT00295750)||0
10956273|NCT00451958|12128558|FG004|COMPLETED|CS21 (NCT00295750)||172
10956274|NCT00451958|12128554|FG000|NOT COMPLETED|CS21 (NCT00295750)||41
10956275|NCT00451958|12128555|FG001|NOT COMPLETED|CS21 (NCT00295750)||43
10956276|NCT00451958|12128556|FG002|NOT COMPLETED|CS21 (NCT00295750)||0
10956277|NCT00451958|12128557|FG003|NOT COMPLETED|CS21 (NCT00295750)||0
10956278|NCT00451958|12128558|FG004|NOT COMPLETED|CS21 (NCT00295750)||32
10956279|NCT00451958|12128554|FG000|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
10956280|NCT00451958|12128555|FG001|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
10956281|NCT00451958|12128556|FG002|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
10956282|NCT00451958|12128557|FG003|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
10956283|NCT00451958|12128558|FG004|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
10956284|NCT00451958|12128554|FG000|COMPLETED|CS21A (NCT00451958)||60
10956285|NCT00451958|12128555|FG001|COMPLETED|CS21A (NCT00451958)||49
10956286|NCT00451958|12128556|FG002|COMPLETED|CS21A (NCT00451958)||27
10956287|NCT00451958|12128557|FG003|COMPLETED|CS21A (NCT00451958)||27
10956288|NCT00451958|12128558|FG004|COMPLETED|CS21A (NCT00451958)||0
10956289|NCT00451958|12128554|FG000|NOT COMPLETED|CS21A (NCT00451958)||65
10956290|NCT00451958|12128555|FG001|NOT COMPLETED|CS21A (NCT00451958)||77
10956291|NCT00451958|12128556|FG002|NOT COMPLETED|CS21A (NCT00451958)||42
10956292|NCT00451958|12128557|FG003|NOT COMPLETED|CS21A (NCT00451958)||39
10956293|NCT00451958|12128558|FG004|NOT COMPLETED|CS21A (NCT00451958)||0
10956294|NCT00452114|12128574|FG000|STARTED|Overall Study||15
10956295|NCT00452114|12128575|FG001|STARTED|Overall Study||13
10956296|NCT00452114|12128574|FG000|COMPLETED|Overall Study||12
10956297|NCT00452114|12128575|FG001|COMPLETED|Overall Study||10
10956298|NCT00452114|12128574|FG000|NOT COMPLETED|Overall Study||3
10956299|NCT00452114|12128575|FG001|NOT COMPLETED|Overall Study||3
10956300|NCT00452335|12128584|FG000|STARTED|Overall Study||27
10956301|NCT00452335|12128585|FG001|STARTED|Overall Study||65
10956302|NCT00452335|12128586|FG002|STARTED|Overall Study||32
10956303|NCT00452335|12128584|FG000|COMPLETED|Overall Study||25
10956304|NCT00452335|12128585|FG001|COMPLETED|Overall Study||61
10956305|NCT00452335|12128586|FG002|COMPLETED|Overall Study||23
10956306|NCT00452335|12128584|FG000|NOT COMPLETED|Overall Study||2
10956307|NCT00452335|12128585|FG001|NOT COMPLETED|Overall Study||4
10956308|NCT00452335|12128586|FG002|NOT COMPLETED|Overall Study||9
10956309|NCT00452348|12128599|FG000|STARTED|Overall Study||310
10956310|NCT00452348|12128600|FG001|STARTED|Overall Study||318
10956311|NCT00452348|12128599|FG000|COMPLETED|Overall Study||231
10956312|NCT00452348|12128600|FG001|COMPLETED|Overall Study||234
10956313|NCT00452348|12128599|FG000|NOT COMPLETED|Overall Study||79
10956314|NCT00452348|12128600|FG001|NOT COMPLETED|Overall Study||84
10956315|NCT00452374|12128606|FG000|STARTED|Overall Study||48
10956316|NCT00452374|12128606|FG000|COMPLETED|Overall Study||48
10956317|NCT00452374|12128606|FG000|NOT COMPLETED|Overall Study||0
10956318|NCT00452387|12128610|FG000|STARTED|Overall Study||22
10956319|NCT00452387|12128610|FG000|COMPLETED|Overall Study||22
10956320|NCT00452387|12128610|FG000|NOT COMPLETED|Overall Study||0
10956321|NCT00452400|12128621|FG000|STARTED|Overall Study||79
10956322|NCT00452400|12128622|FG001|STARTED|Overall Study||81
10956323|NCT00452400|12128623|FG002|STARTED|Overall Study||80
10956324|NCT00452400|12128624|FG003|STARTED|Overall Study||86
10956325|NCT00452400|12128625|FG004|STARTED|Overall Study||79
10956326|NCT00452400|12128621|FG000|COMPLETED|Overall Study||74
10956327|NCT00452400|12128622|FG001|COMPLETED|Overall Study||80
10956328|NCT00452400|12128623|FG002|COMPLETED|Overall Study||73
10956329|NCT00452400|12128624|FG003|COMPLETED|Overall Study||85
10956330|NCT00452400|12128625|FG004|COMPLETED|Overall Study||76
10956331|NCT00452400|12128621|FG000|NOT COMPLETED|Overall Study||5
10956332|NCT00452400|12128622|FG001|NOT COMPLETED|Overall Study||1
10956333|NCT00452400|12128623|FG002|NOT COMPLETED|Overall Study||7
10956334|NCT00452400|12128624|FG003|NOT COMPLETED|Overall Study||1
10956335|NCT00452400|12128625|FG004|NOT COMPLETED|Overall Study||3
10956336|NCT00452413|12128640|FG000|STARTED|Overall Study||4
10956337|NCT00452413|12128641|FG001|STARTED|Overall Study||12
10956338|NCT00452413|12128642|FG002|STARTED|Overall Study||49
10956339|NCT00452413|12128640|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
10956340|NCT00452413|12128641|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12
10956341|NCT00452413|12128642|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49
10956342|NCT00452413|12128640|FG000|COMPLETED|Overall Study||0
10956343|NCT00452413|12128641|FG001|COMPLETED|Overall Study||0
10956344|NCT00452413|12128642|FG002|COMPLETED|Overall Study||0
10956345|NCT00452413|12128640|FG000|NOT COMPLETED|Overall Study||4
10956346|NCT00452413|12128641|FG001|NOT COMPLETED|Overall Study||12
10956347|NCT00452413|12128642|FG002|NOT COMPLETED|Overall Study||49
10956348|NCT00452426|12128653|FG000|STARTED|Overall Study||496
10956349|NCT00452426|12128654|FG001|STARTED|Overall Study||504
10956350|NCT00452426|12128653|FG000|COMPLETED|Overall Study||489
10956351|NCT00452426|12128654|FG001|COMPLETED|Overall Study||493
10956352|NCT00452426|12128653|FG000|NOT COMPLETED|Overall Study||7
10956353|NCT00452426|12128654|FG001|NOT COMPLETED|Overall Study||11
10956354|NCT00452439|12128662|FG000|STARTED|Overall Study||36
10956355|NCT00452439|12128663|FG001|STARTED|Overall Study||36
10956356|NCT00452439|12128662|FG000|COMPLETED|Overall Study||22
10956357|NCT00452439|12128663|FG001|COMPLETED|Overall Study||29
10956358|NCT00452439|12128662|FG000|NOT COMPLETED|Overall Study||14
10956359|NCT00452439|12128663|FG001|NOT COMPLETED|Overall Study||7
10956360|NCT00452452|12128672|FG000|STARTED|Overall Study||90
10956361|NCT00452452|12128673|FG001|STARTED|Overall Study||112
10956362|NCT00452452|12128674|FG002|STARTED|Overall Study||153
10956363|NCT00452452|12128672|FG000|Vaccinated Dose 1|Overall Study||90
10956364|NCT00452452|12128673|FG001|Vaccinated Dose 1|Overall Study||112
10956365|NCT00452452|12128674|FG002|Vaccinated Dose 1|Overall Study||152
10956366|NCT00452452|12128672|FG000|Vaccinated Dose 2|Overall Study||90
10956367|NCT00452452|12128673|FG001|Vaccinated Dose 2|Overall Study||112
10956368|NCT00452452|12128674|FG002|Vaccinated Dose 2|Overall Study||0
10956369|NCT00452452|12128672|FG000|Vaccinated Dose 3|Overall Study||89
10956370|NCT00452452|12128673|FG001|Vaccinated Dose 3|Overall Study||0
10956371|NCT00452452|12128674|FG002|Vaccinated Dose 3|Overall Study||0
10956372|NCT00452452|12128672|FG000|COMPLETED|Overall Study||88
10956373|NCT00452452|12128673|FG001|COMPLETED|Overall Study||112
10956374|NCT00452452|12128674|FG002|COMPLETED|Overall Study||152
10956375|NCT00452452|12128672|FG000|NOT COMPLETED|Overall Study||2
10956376|NCT00452452|12128673|FG001|NOT COMPLETED|Overall Study||0
10956377|NCT00452452|12128674|FG002|NOT COMPLETED|Overall Study||1
10956378|NCT00452530|12128690|FG000|STARTED|Overall Study|Randomized|1528
10956379|NCT00452530|12128691|FG001|STARTED|Overall Study|Randomized|1529
10956380|NCT00452530|12128690|FG000|Received Treatment|Overall Study||1501
10956381|NCT00452530|12128691|FG001|Received Treatment|Overall Study||1508
10956382|NCT00452530|12128690|FG000|Evaluable Participants|Overall Study||907
10956383|NCT00452530|12128691|FG001|Evaluable Participants|Overall Study||921
10956384|NCT00452530|12128690|FG000|Primary Participants|Overall Study||976
10956385|NCT00452530|12128691|FG001|Primary Participants|Overall Study||997
10956386|NCT00452530|12128690|FG000|COMPLETED|Overall Study||1392
10956387|NCT00452530|12128691|FG001|COMPLETED|Overall Study||1393
10956388|NCT00452530|12128690|FG000|NOT COMPLETED|Overall Study||136
10956389|NCT00452530|12128691|FG001|NOT COMPLETED|Overall Study||136
10956390|NCT00452543|12128703|FG000|STARTED|Overall Study||12
10956391|NCT00452543|12128704|FG001|STARTED|Overall Study||11
10956392|NCT00452543|12128703|FG000|COMPLETED|Overall Study||7
10956393|NCT00452543|12128704|FG001|COMPLETED|Overall Study||5
10956394|NCT00452543|12128703|FG000|NOT COMPLETED|Overall Study||5
10956395|NCT00452543|12128704|FG001|NOT COMPLETED|Overall Study||6
10956396|NCT00452673|12128714|FG000|STARTED|Dose Escalation Period||7
10956397|NCT00452673|12128715|FG001|STARTED|Dose Escalation Period||9
10956398|NCT00452673|12128716|FG002|STARTED|Dose Escalation Period||6
10956399|NCT00452673|12128717|FG003|STARTED|Dose Escalation Period||9
10956400|NCT00452673|12128718|FG004|STARTED|Dose Escalation Period||0
10956401|NCT00452673|12128714|FG000|COMPLETED|Dose Escalation Period||0
10956402|NCT00452673|12128715|FG001|COMPLETED|Dose Escalation Period||0
10956403|NCT00452673|12128716|FG002|COMPLETED|Dose Escalation Period||0
10956404|NCT00452673|12128717|FG003|COMPLETED|Dose Escalation Period||0
10956405|NCT00452673|12128718|FG004|COMPLETED|Dose Escalation Period||0
10956406|NCT00452673|12128714|FG000|NOT COMPLETED|Dose Escalation Period||7
10956407|NCT00452673|12128715|FG001|NOT COMPLETED|Dose Escalation Period||9
10956408|NCT00452673|12128716|FG002|NOT COMPLETED|Dose Escalation Period||6
10956409|NCT00452673|12128717|FG003|NOT COMPLETED|Dose Escalation Period||9
10956410|NCT00452673|12128718|FG004|NOT COMPLETED|Dose Escalation Period||0
10956411|NCT00452673|12128714|FG000|STARTED|Dose Expansion Period||0
10956412|NCT00452673|12128715|FG001|STARTED|Dose Expansion Period||0
10956413|NCT00452673|12128716|FG002|STARTED|Dose Expansion Period||0
10956414|NCT00452673|12128717|FG003|STARTED|Dose Expansion Period||0
10956415|NCT00452673|12128718|FG004|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
10956416|NCT00452673|12128714|FG000|COMPLETED|Dose Expansion Period||0
10956417|NCT00452673|12128715|FG001|COMPLETED|Dose Expansion Period||0
10956418|NCT00452673|12128716|FG002|COMPLETED|Dose Expansion Period||0
10956419|NCT00452673|12128717|FG003|COMPLETED|Dose Expansion Period||0
10956420|NCT00452673|12128718|FG004|COMPLETED|Dose Expansion Period||0
10956421|NCT00452673|12128714|FG000|NOT COMPLETED|Dose Expansion Period||0
10956422|NCT00452673|12128715|FG001|NOT COMPLETED|Dose Expansion Period||0
10956423|NCT00452673|12128716|FG002|NOT COMPLETED|Dose Expansion Period||0
10956424|NCT00452673|12128717|FG003|NOT COMPLETED|Dose Expansion Period||0
10956425|NCT00452673|12128718|FG004|NOT COMPLETED|Dose Expansion Period||21
10956426|NCT00452699|12128731|FG000|STARTED|Overall Study||306
10956427|NCT00452699|12128732|FG001|STARTED|Overall Study||315
10956428|NCT00452699|12128731|FG000|COMPLETED|Overall Study||225
10956429|NCT00452699|12128732|FG001|COMPLETED|Overall Study||242
10956430|NCT00452699|12128731|FG000|NOT COMPLETED|Overall Study||81
10956431|NCT00452699|12128732|FG001|NOT COMPLETED|Overall Study||73
10956432|NCT00452790|12128740|FG000|STARTED|Infant Series||354
10956433|NCT00452790|12128741|FG001|STARTED|Infant Series||355
10956434|NCT00452790|12128740|FG000|Vaccinated Dose 1|Infant Series||353
10956435|NCT00452790|12128741|FG001|Vaccinated Dose 1|Infant Series||353
10956436|NCT00452790|12128740|FG000|Vaccinated Dose 2|Infant Series||300
10956437|NCT00452790|12128741|FG001|Vaccinated Dose 2|Infant Series||300
10956438|NCT00452790|12128740|FG000|Vaccinated Dose 3|Infant Series||221
10956439|NCT00452790|12128741|FG001|Vaccinated Dose 3|Infant Series||218
10956440|NCT00452790|12128740|FG000|COMPLETED|Infant Series||219
10956441|NCT00452790|12128741|FG001|COMPLETED|Infant Series||214
10956442|NCT00452790|12128740|FG000|NOT COMPLETED|Infant Series||135
10956443|NCT00452790|12128741|FG001|NOT COMPLETED|Infant Series||141
10956444|NCT00452790|12128740|FG000|STARTED|After Infant Series||219
10956445|NCT00452790|12128741|FG001|STARTED|After Infant Series||214
10956446|NCT00452790|12128740|FG000|COMPLETED|After Infant Series||198
10956447|NCT00452790|12128741|FG001|COMPLETED|After Infant Series||200
10956448|NCT00452790|12128740|FG000|NOT COMPLETED|After Infant Series||21
10956449|NCT00452790|12128741|FG001|NOT COMPLETED|After Infant Series||14
10956450|NCT00452790|12128740|FG000|STARTED|Toddler Dose||198
10956451|NCT00452790|12128741|FG001|STARTED|Toddler Dose||200
10956452|NCT00452790|12128740|FG000|COMPLETED|Toddler Dose||198
10956453|NCT00452790|12128741|FG001|COMPLETED|Toddler Dose||198
10956454|NCT00452790|12128740|FG000|NOT COMPLETED|Toddler Dose||0
10956455|NCT00452790|12128741|FG001|NOT COMPLETED|Toddler Dose||2
10956456|NCT00452868|12128751|FG000|STARTED|Overall Study||13
10956457|NCT00452868|12128751|FG000|COMPLETED|Overall Study||11
10956458|NCT00452868|12128751|FG000|NOT COMPLETED|Overall Study||2
10956459|NCT00453102|12128755|FG000|STARTED|Overall Study||18
10956460|NCT00453102|12128755|FG000|COMPLETED|Overall Study||16
10956461|NCT00453102|12128755|FG000|NOT COMPLETED|Overall Study||2
10956462|NCT00453154|12128762|FG000|STARTED|Combination Chemotherapy||12
10956463|NCT00453154|12128763|FG001|STARTED|Combination Chemotherapy||144
10956464|NCT00453154|12128764|FG002|STARTED|Combination Chemotherapy||0
10956465|NCT00453154|12128765|FG003|STARTED|Combination Chemotherapy||0
10956466|NCT00453154|12128762|FG000|COMPLETED|Combination Chemotherapy||12
10956467|NCT00453154|12128763|FG001|COMPLETED|Combination Chemotherapy||95
10956468|NCT00453154|12128764|FG002|COMPLETED|Combination Chemotherapy||0
10956469|NCT00453154|12128765|FG003|COMPLETED|Combination Chemotherapy||0
10956470|NCT00453154|12128762|FG000|NOT COMPLETED|Combination Chemotherapy||0
10956471|NCT00453154|12128763|FG001|NOT COMPLETED|Combination Chemotherapy||49
10956472|NCT00453154|12128764|FG002|NOT COMPLETED|Combination Chemotherapy||0
10956473|NCT00453154|12128765|FG003|NOT COMPLETED|Combination Chemotherapy||0
10956474|NCT00453154|12128762|FG000|STARTED|Double BIind Maintenance||0
10956475|NCT00453154|12128763|FG001|STARTED|Double BIind Maintenance||0
10956476|NCT00453154|12128764|FG002|STARTED|Double BIind Maintenance||46
10956477|NCT00453154|12128765|FG003|STARTED|Double BIind Maintenance||49
10956478|NCT00453154|12128762|FG000|COMPLETED|Double BIind Maintenance||0
10956479|NCT00453154|12128763|FG001|COMPLETED|Double BIind Maintenance||0
10956480|NCT00453154|12128764|FG002|COMPLETED|Double BIind Maintenance||0
10956481|NCT00453154|12128765|FG003|COMPLETED|Double BIind Maintenance||0
10956482|NCT00453154|12128762|FG000|NOT COMPLETED|Double BIind Maintenance||0
10956483|NCT00453154|12128763|FG001|NOT COMPLETED|Double BIind Maintenance||0
10956484|NCT00453154|12128764|FG002|NOT COMPLETED|Double BIind Maintenance||46
10956485|NCT00453154|12128765|FG003|NOT COMPLETED|Double BIind Maintenance||49
10956486|NCT00453154|12128762|FG000|STARTED|Open Label Sunitinib Crossover||0
10956487|NCT00453154|12128763|FG001|STARTED|Open Label Sunitinib Crossover||0
10956488|NCT00453154|12128764|FG002|STARTED|Open Label Sunitinib Crossover||18
10956489|NCT00453154|12128765|FG003|STARTED|Open Label Sunitinib Crossover||0
10956490|NCT00453154|12128762|FG000|COMPLETED|Open Label Sunitinib Crossover||0
10956491|NCT00453154|12128763|FG001|COMPLETED|Open Label Sunitinib Crossover||0
10956492|NCT00453154|12128764|FG002|COMPLETED|Open Label Sunitinib Crossover||18
10956493|NCT00453154|12128765|FG003|COMPLETED|Open Label Sunitinib Crossover||0
10956494|NCT00453154|12128762|FG000|NOT COMPLETED|Open Label Sunitinib Crossover||0
10956495|NCT00453154|12128763|FG001|NOT COMPLETED|Open Label Sunitinib Crossover||0
10956496|NCT00453154|12128764|FG002|NOT COMPLETED|Open Label Sunitinib Crossover||0
10956497|NCT00453154|12128765|FG003|NOT COMPLETED|Open Label Sunitinib Crossover||0
10956498|NCT00453180|12128776|FG000|STARTED|Overall Study||16
10956499|NCT00453180|12128777|FG001|STARTED|Overall Study||15
10956500|NCT00453180|12128776|FG000|COMPLETED|Overall Study||13
10956501|NCT00453180|12128777|FG001|COMPLETED|Overall Study||12
10956502|NCT00453180|12128776|FG000|NOT COMPLETED|Overall Study||3
10956503|NCT00453180|12128777|FG001|NOT COMPLETED|Overall Study||3
10956504|NCT00453193|12128783|FG000|STARTED|Overall Study||24
10956505|NCT00453193|12128783|FG000|COMPLETED|Overall Study||24
10956506|NCT00453193|12128783|FG000|NOT COMPLETED|Overall Study||0
10956507|NCT00453206|12128787|FG000|STARTED|Overall Study||66
10956508|NCT00453206|12128787|FG000|COMPLETED|Overall Study||65
10956509|NCT00453206|12128787|FG000|NOT COMPLETED|Overall Study||1
10956510|NCT00453310|12128791|FG000|STARTED|Overall Study||10
10956511|NCT00453310|12128791|FG000|COMPLETED|Overall Study||0
10956512|NCT00453310|12128791|FG000|NOT COMPLETED|Overall Study||10
10956513|NCT00453336|12128795|FG000|STARTED|Overall Study||45
10956514|NCT00453336|12128795|FG000|COMPLETED|Overall Study||45
10956515|NCT00453336|12128795|FG000|NOT COMPLETED|Overall Study||0
10956516|NCT00453349|12128801|FG000|STARTED|Randomized||228
10956517|NCT00453349|12128802|FG001|STARTED|Randomized||232
10956518|NCT00453349|12128801|FG000|COMPLETED|Randomized||203
10956519|NCT00453349|12128802|FG001|COMPLETED|Randomized||209
10956520|NCT00453349|12128801|FG000|NOT COMPLETED|Randomized||25
10956521|NCT00453349|12128802|FG001|NOT COMPLETED|Randomized||23
10956522|NCT00453349|12128801|FG000|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
10956523|NCT00453349|12128802|FG001|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
10956524|NCT00453349|12128801|FG000|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
10956525|NCT00453349|12128802|FG001|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
10956526|NCT00453349|12128801|FG000|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
10956527|NCT00453349|12128802|FG001|COMPLETED|Reaching of Primary Endpoint (TOC)||219
10956528|NCT00453349|12128801|FG000|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
10956529|NCT00453349|12128802|FG001|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
10956530|NCT00453349|12128801|FG000|STARTED|Completed Study||228
10956531|NCT00453349|12128802|FG001|STARTED|Completed Study||232
10956532|NCT00453349|12128801|FG000|Completed Study Treatment|Completed Study|25 terminated prematurely|203
10956533|NCT00453349|12128802|FG001|Completed Study Treatment|Completed Study|23 terminated prematurely|209
10956534|NCT00453349|12128801|FG000|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
10956535|NCT00453349|12128802|FG001|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
10956536|NCT00453349|12128801|FG000|NOT COMPLETED|Completed Study||27
10956537|NCT00453349|12128802|FG001|NOT COMPLETED|Completed Study||34
10956538|NCT00453362|12128808|FG000|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
10956539|NCT00453362|12128808|FG000|Treated With Erlotinib|Overall Study||74
10956540|NCT00453362|12128808|FG000|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
10956541|NCT00453362|12128808|FG000|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
10956542|NCT00453362|12128808|FG000|COMPLETED|Overall Study||1
10956543|NCT00453362|12128808|FG000|NOT COMPLETED|Overall Study||87
10956544|NCT00453388|12128828|FG000|STARTED|Overall Study||0
10956545|NCT00453388|12128829|FG001|STARTED|Overall Study||5
10956546|NCT00453388|12128830|FG002|STARTED|Overall Study||1
10956547|NCT00453388|12128831|FG003|STARTED|Overall Study||0
10956548|NCT00453388|12128828|FG000|COMPLETED|Overall Study||0
10956549|NCT00453388|12128829|FG001|COMPLETED|Overall Study||5
10956550|NCT00453388|12128830|FG002|COMPLETED|Overall Study||1
10956551|NCT00453388|12128831|FG003|COMPLETED|Overall Study||0
10956552|NCT00453388|12128828|FG000|NOT COMPLETED|Overall Study||0
10956553|NCT00453388|12128829|FG001|NOT COMPLETED|Overall Study||0
10956554|NCT00453388|12128830|FG002|NOT COMPLETED|Overall Study||0
10956555|NCT00453388|12128831|FG003|NOT COMPLETED|Overall Study||0
10956556|NCT00453479|12128844|FG000|STARTED|Overall Study||6
10956557|NCT00453479|12128845|FG001|STARTED|Overall Study||9
10956558|NCT00453479|12128846|FG002|STARTED|Overall Study||8
10956559|NCT00453479|12128844|FG000|COMPLETED|Overall Study||6
10956560|NCT00453479|12128845|FG001|COMPLETED|Overall Study||9
10956561|NCT00453479|12128846|FG002|COMPLETED|Overall Study||8
10956562|NCT00453479|12128844|FG000|NOT COMPLETED|Overall Study||0
10956563|NCT00453479|12128845|FG001|NOT COMPLETED|Overall Study||0
10956564|NCT00453479|12128846|FG002|NOT COMPLETED|Overall Study||0
10956565|NCT00453895|12128856|FG000|STARTED|Overall Study||39
10956566|NCT00453895|12128856|FG000|COMPLETED|Overall Study||39
10956567|NCT00453895|12128856|FG000|NOT COMPLETED|Overall Study||0
10956568|NCT00453921|12128864|FG000|STARTED|Overall Study||19
10956569|NCT00453921|12128865|FG001|STARTED|Overall Study||18
10956570|NCT00453921|12128866|FG002|STARTED|Overall Study||20
10956571|NCT00453921|12128867|FG003|STARTED|Overall Study||19
10956572|NCT00453921|12128864|FG000|COMPLETED|Overall Study||18
10956573|NCT00453921|12128865|FG001|COMPLETED|Overall Study||17
10956574|NCT00453921|12128866|FG002|COMPLETED|Overall Study||18
10956575|NCT00453921|12128867|FG003|COMPLETED|Overall Study||18
10956576|NCT00453921|12128864|FG000|NOT COMPLETED|Overall Study||1
10956577|NCT00453921|12128865|FG001|NOT COMPLETED|Overall Study||1
10956578|NCT00453921|12128866|FG002|NOT COMPLETED|Overall Study||2
10956579|NCT00453921|12128867|FG003|NOT COMPLETED|Overall Study||1
10956580|NCT00453973|12128883|FG000|STARTED|Overall Study||51
10956581|NCT00453973|12128884|FG001|STARTED|Overall Study||63
10956582|NCT00453973|12128883|FG000|COMPLETED|Overall Study||0
10956583|NCT00453973|12128884|FG001|COMPLETED|Overall Study||15
10956584|NCT00453973|12128883|FG000|NOT COMPLETED|Overall Study||51
10956585|NCT00453973|12128884|FG001|NOT COMPLETED|Overall Study||48
10956586|NCT00453986|12128895|FG000|STARTED|Overall Study||311
10956587|NCT00453986|12128896|FG001|STARTED|Overall Study||311
10956588|NCT00453986|12128897|FG002|STARTED|Overall Study||313
10956589|NCT00453986|12128898|FG003|STARTED|Overall Study||312
10956590|NCT00453986|12128899|FG004|STARTED|Overall Study||105
10956591|NCT00453986|12128895|FG000|COMPLETED|Overall Study||305
10956592|NCT00453986|12128896|FG001|COMPLETED|Overall Study||306
10956593|NCT00453986|12128897|FG002|COMPLETED|Overall Study||307
10956594|NCT00453986|12128898|FG003|COMPLETED|Overall Study||310
10956595|NCT00453986|12128899|FG004|COMPLETED|Overall Study||105
10956596|NCT00453986|12128895|FG000|NOT COMPLETED|Overall Study||6
10956597|NCT00453986|12128896|FG001|NOT COMPLETED|Overall Study||5
10956598|NCT00453986|12128897|FG002|NOT COMPLETED|Overall Study||6
10956599|NCT00453986|12128898|FG003|NOT COMPLETED|Overall Study||2
10956600|NCT00453986|12128899|FG004|NOT COMPLETED|Overall Study||0
10956601|NCT00453999|12128918|FG000|STARTED|Overall Study||45
10956602|NCT00453999|12128919|FG001|STARTED|Overall Study||46
10956603|NCT00453999|12128920|FG002|STARTED|Overall Study||46
10956604|NCT00453999|12128918|FG000|COMPLETED|Overall Study||40
10956605|NCT00453999|12128919|FG001|COMPLETED|Overall Study||41
10956606|NCT00453999|12128920|FG002|COMPLETED|Overall Study||43
10956607|NCT00453999|12128918|FG000|NOT COMPLETED|Overall Study||5
10956608|NCT00453999|12128919|FG001|NOT COMPLETED|Overall Study||5
10956609|NCT00453999|12128920|FG002|NOT COMPLETED|Overall Study||3
10956610|NCT00454051|12128931|FG000|STARTED|Overall Study||20
10956611|NCT00454051|12128932|FG001|STARTED|Overall Study||11
10956612|NCT00454051|12128931|FG000|COMPLETED|Overall Study||17
10956613|NCT00454051|12128932|FG001|COMPLETED|Overall Study||8
10956614|NCT00454051|12128931|FG000|NOT COMPLETED|Overall Study||3
10956615|NCT00454051|12128932|FG001|NOT COMPLETED|Overall Study||3
10956616|NCT00454116|12128941|FG000|STARTED|Overall Study|randomised patients|35
10956617|NCT00454116|12128942|FG001|STARTED|Overall Study|randomised patients|36
10956618|NCT00454116|12128943|FG002|STARTED|Overall Study|randomised patients|35
10956619|NCT00454116|12128941|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
10956620|NCT00454116|12128942|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
10956621|NCT00454116|12128943|FG002|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
10956622|NCT00454116|12128941|FG000|NOT COMPLETED|Overall Study||27
10956623|NCT00454116|12128942|FG001|NOT COMPLETED|Overall Study||29
10956624|NCT00454116|12128943|FG002|NOT COMPLETED|Overall Study||28
10956625|NCT00454142|12128951|FG000|STARTED|Overall Study||33
10956626|NCT00454142|12128951|FG000|COMPLETED|Overall Study||32
10956627|NCT00454142|12128951|FG000|NOT COMPLETED|Overall Study||1
10956628|NCT00454181|12128959|FG000|STARTED|Overall Study||45
10956629|NCT00454181|12128960|FG001|STARTED|Overall Study||14
10956630|NCT00454181|12128959|FG000|COMPLETED|Overall Study||30
10956631|NCT00454181|12128960|FG001|COMPLETED|Overall Study||11
10956632|NCT00454181|12128959|FG000|NOT COMPLETED|Overall Study||15
10956633|NCT00454181|12128960|FG001|NOT COMPLETED|Overall Study||3
10956634|NCT00454194|12128968|FG000|STARTED|Overall Study||47
10956635|NCT00454194|12128969|FG001|STARTED|Overall Study||51
10956636|NCT00454194|12128968|FG000|COMPLETED|Overall Study||25
10956637|NCT00454194|12128969|FG001|COMPLETED|Overall Study||37
10956638|NCT00454194|12128968|FG000|NOT COMPLETED|Overall Study||22
10956639|NCT00454194|12128969|FG001|NOT COMPLETED|Overall Study||14
10956640|NCT00454207|12128977|FG000|STARTED|Overall Study||21
10956641|NCT00454207|12128978|FG001|STARTED|Overall Study||23
10956642|NCT00454207|12128977|FG000|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
10956643|NCT00454207|12128978|FG001|COMPLETED|Overall Study||21
10956644|NCT00454207|12128977|FG000|NOT COMPLETED|Overall Study||4
10956645|NCT00454207|12128978|FG001|NOT COMPLETED|Overall Study||2
10956646|NCT00454246|12128999|FG000|STARTED|Overall Study||73
10956647|NCT00454246|12129000|FG001|STARTED|Overall Study||29
10956648|NCT00454246|12129001|FG002|STARTED|Overall Study||9
10956649|NCT00454246|12128999|FG000|COMPLETED|Overall Study||0
10956650|NCT00454246|12129000|FG001|COMPLETED|Overall Study||0
10956651|NCT00454246|12129001|FG002|COMPLETED|Overall Study||0
10956652|NCT00454246|12128999|FG000|NOT COMPLETED|Overall Study||73
10956653|NCT00454246|12129000|FG001|NOT COMPLETED|Overall Study||29
10956654|NCT00454246|12129001|FG002|NOT COMPLETED|Overall Study||9
10956655|NCT00454324|12129011|FG000|STARTED|Overall Study||14
10956656|NCT00454324|12129012|FG001|STARTED|Overall Study||13
10956657|NCT00454324|12129011|FG000|COMPLETED|Overall Study||14
10956658|NCT00454324|12129012|FG001|COMPLETED|Overall Study||13
10956659|NCT00454324|12129011|FG000|NOT COMPLETED|Overall Study||0
10956660|NCT00454324|12129012|FG001|NOT COMPLETED|Overall Study||0
10956661|NCT00454363|12129020|FG000|STARTED|Overall Study||20
10956662|NCT00454363|12129021|FG001|STARTED|Overall Study||31
10956663|NCT00454363|12129020|FG000|COMPLETED|Overall Study||15
10956664|NCT00454363|12129021|FG001|COMPLETED|Overall Study||29
10956665|NCT00454363|12129020|FG000|NOT COMPLETED|Overall Study||5
10956666|NCT00454363|12129021|FG001|NOT COMPLETED|Overall Study||2
10956667|NCT00454532|12129030|FG000|STARTED|Overall Study||11
10956668|NCT00454532|12129031|FG001|STARTED|Overall Study||6
10956669|NCT00454532|12129032|FG002|STARTED|Overall Study||3
10956670|NCT00454532|12129033|FG003|STARTED|Overall Study||7
10956671|NCT00454532|12129030|FG000|COMPLETED|Overall Study||11
10956672|NCT00454532|12129031|FG001|COMPLETED|Overall Study||6
10956673|NCT00454532|12129032|FG002|COMPLETED|Overall Study||3
10956674|NCT00454532|12129033|FG003|COMPLETED|Overall Study||7
10956675|NCT00454532|12129030|FG000|NOT COMPLETED|Overall Study||0
10956676|NCT00454532|12129031|FG001|NOT COMPLETED|Overall Study||0
10956677|NCT00454532|12129032|FG002|NOT COMPLETED|Overall Study||0
10956678|NCT00454532|12129033|FG003|NOT COMPLETED|Overall Study||0
10956679|NCT00454584|12129046|FG000|STARTED|Controlled Period||347
10956680|NCT00454584|12129047|FG001|STARTED|Controlled Period||209
10956681|NCT00454584|12129048|FG002|STARTED|Controlled Period||347
10956682|NCT00454584|12129049|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10956683|NCT00454584|12129050|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10956684|NCT00454584|12129051|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
10956685|NCT00454584|12129046|FG000|COMPLETED|Controlled Period||336
10956686|NCT00454584|12129047|FG001|COMPLETED|Controlled Period||201
10956687|NCT00454584|12129048|FG002|COMPLETED|Controlled Period||342
10956688|NCT00454584|12129049|FG003|COMPLETED|Controlled Period||0
10956689|NCT00454584|12129050|FG004|COMPLETED|Controlled Period||0
10956690|NCT00454584|12129051|FG005|COMPLETED|Controlled Period||0
10956691|NCT00454584|12129046|FG000|NOT COMPLETED|Controlled Period||11
10956692|NCT00454584|12129047|FG001|NOT COMPLETED|Controlled Period||8
10956693|NCT00454584|12129048|FG002|NOT COMPLETED|Controlled Period||5
10956694|NCT00454584|12129049|FG003|NOT COMPLETED|Controlled Period||0
10956695|NCT00454584|12129050|FG004|NOT COMPLETED|Controlled Period||0
10956696|NCT00454584|12129051|FG005|NOT COMPLETED|Controlled Period||0
10956697|NCT00454584|12129046|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10956698|NCT00454584|12129047|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10956699|NCT00454584|12129048|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
10956700|NCT00454584|12129049|FG003|STARTED|After Controlled Period||336
10956701|NCT00454584|12129050|FG004|STARTED|After Controlled Period||201
10956702|NCT00454584|12129051|FG005|STARTED|After Controlled Period||342
10956703|NCT00454584|12129046|FG000|COMPLETED|After Controlled Period||0
10956704|NCT00454584|12129047|FG001|COMPLETED|After Controlled Period||0
10956705|NCT00454584|12129048|FG002|COMPLETED|After Controlled Period||0
10956706|NCT00454584|12129049|FG003|COMPLETED|After Controlled Period||310
10956707|NCT00454584|12129050|FG004|COMPLETED|After Controlled Period||189
10956708|NCT00454584|12129051|FG005|COMPLETED|After Controlled Period||310
10956709|NCT00454584|12129046|FG000|NOT COMPLETED|After Controlled Period||0
10956710|NCT00454584|12129047|FG001|NOT COMPLETED|After Controlled Period||0
10956711|NCT00454584|12129048|FG002|NOT COMPLETED|After Controlled Period||0
10956712|NCT00454584|12129049|FG003|NOT COMPLETED|After Controlled Period||26
10956713|NCT00454584|12129050|FG004|NOT COMPLETED|After Controlled Period||12
10956714|NCT00454584|12129051|FG005|NOT COMPLETED|After Controlled Period||32
10956715|NCT00454636|12129069|FG000|STARTED|Overall Study||41
10956716|NCT00454636|12129070|FG001|STARTED|Overall Study||32
10956717|NCT00454636|12129071|FG002|STARTED|Overall Study||27
10956718|NCT00454636|12129072|FG003|STARTED|Overall Study||58
10956719|NCT00454636|12129069|FG000|COMPLETED|Overall Study||10
10956720|NCT00454636|12129070|FG001|COMPLETED|Overall Study||9
10956721|NCT00454636|12129071|FG002|COMPLETED|Overall Study||7
10956722|NCT00454636|12129072|FG003|COMPLETED|Overall Study||26
10956723|NCT00454636|12129069|FG000|NOT COMPLETED|Overall Study||31
10956724|NCT00454636|12129070|FG001|NOT COMPLETED|Overall Study||23
10956725|NCT00454636|12129071|FG002|NOT COMPLETED|Overall Study||20
10956726|NCT00454636|12129072|FG003|NOT COMPLETED|Overall Study||32
10956727|NCT00454649|12129092|FG000|STARTED|Overall Study||3
10956728|NCT00454649|12129093|FG001|STARTED|Overall Study||5
10956729|NCT00454649|12129094|FG002|STARTED|Overall Study||20
10956730|NCT00454649|12129095|FG003|STARTED|Overall Study||7
10956731|NCT00454649|12129096|FG004|STARTED|Overall Study||1
10956732|NCT00454649|12129097|FG005|STARTED|Overall Study||7
10956733|NCT00454649|12129098|FG006|STARTED|Overall Study||9
10956734|NCT00454649|12129099|FG007|STARTED|Overall Study||19
10956735|NCT00454649|12129100|FG008|STARTED|Overall Study||21
10956736|NCT00454649|12129101|FG009|STARTED|Overall Study||6
10956737|NCT00454649|12129092|FG000|COMPLETED|Overall Study||0
10956738|NCT00454649|12129093|FG001|COMPLETED|Overall Study||1
10956739|NCT00454649|12129094|FG002|COMPLETED|Overall Study||1
10956740|NCT00454649|12129095|FG003|COMPLETED|Overall Study||1
10956741|NCT00454649|12129096|FG004|COMPLETED|Overall Study||0
10956742|NCT00454649|12129097|FG005|COMPLETED|Overall Study||0
10956743|NCT00454649|12129098|FG006|COMPLETED|Overall Study||0
10956744|NCT00454649|12129099|FG007|COMPLETED|Overall Study||0
10956745|NCT00454649|12129100|FG008|COMPLETED|Overall Study||1
10956746|NCT00454649|12129101|FG009|COMPLETED|Overall Study||1
10956747|NCT00454649|12129092|FG000|NOT COMPLETED|Overall Study||3
10956748|NCT00454649|12129093|FG001|NOT COMPLETED|Overall Study||4
10956749|NCT00454649|12129094|FG002|NOT COMPLETED|Overall Study||19
10956750|NCT00454649|12129095|FG003|NOT COMPLETED|Overall Study||6
10956751|NCT00454649|12129096|FG004|NOT COMPLETED|Overall Study||1
10956752|NCT00454649|12129097|FG005|NOT COMPLETED|Overall Study||7
10956753|NCT00454649|12129098|FG006|NOT COMPLETED|Overall Study||9
10956754|NCT00454649|12129099|FG007|NOT COMPLETED|Overall Study||19
10956755|NCT00454649|12129100|FG008|NOT COMPLETED|Overall Study||20
10956756|NCT00454649|12129101|FG009|NOT COMPLETED|Overall Study||5
10956757|NCT00454779|12129144|FG000|STARTED|First-line Treatment Phase||56
10956758|NCT00454779|12129145|FG001|STARTED|First-line Treatment Phase||57
10956759|NCT00454779|12129144|FG000|Received Study Medication|First-line Treatment Phase||56
10956760|NCT00454779|12129145|FG001|Received Study Medication|First-line Treatment Phase||55
10956761|NCT00454779|12129144|FG000|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
10956762|NCT00454779|12129145|FG001|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
10956763|NCT00454779|12129144|FG000|NOT COMPLETED|First-line Treatment Phase||5
10956764|NCT00454779|12129145|FG001|NOT COMPLETED|First-line Treatment Phase||8
10956765|NCT00454779|12129144|FG000|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
10956766|NCT00454779|12129145|FG001|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
10956767|NCT00454779|12129144|FG000|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
10956768|NCT00454779|12129145|FG001|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
10956769|NCT00454779|12129144|FG000|NOT COMPLETED|Second-line Treatment Phase||0
10956770|NCT00454779|12129145|FG001|NOT COMPLETED|Second-line Treatment Phase||3
10956771|NCT00454805|12129153|FG000|STARTED|Overall Study|Randomised|31
10956772|NCT00454805|12129154|FG001|STARTED|Overall Study|Randomised|31
10956773|NCT00454805|12129153|FG000|COMPLETED|Overall Study|Ongoing at data cut-off|5
10956774|NCT00454805|12129154|FG001|COMPLETED|Overall Study|Ongoing at data cut-off|8
10956775|NCT00454805|12129153|FG000|NOT COMPLETED|Overall Study||26
10956776|NCT00454805|12129154|FG001|NOT COMPLETED|Overall Study||23
10956777|NCT00454818|12129168|FG000|STARTED|Phase I: Open-label Dose-escalation||3
10956778|NCT00454818|12129169|FG001|STARTED|Phase I: Open-label Dose-escalation||3
10956779|NCT00454818|12129170|FG002|STARTED|Phase I: Open-label Dose-escalation||3
10956780|NCT00454818|12129171|FG003|STARTED|Phase I: Open-label Dose-escalation||3
10956781|NCT00454818|12129172|FG004|STARTED|Phase I: Open-label Dose-escalation||0
10956782|NCT00454818|12129168|FG000|COMPLETED|Phase I: Open-label Dose-escalation||2
10956783|NCT00454818|12129169|FG001|COMPLETED|Phase I: Open-label Dose-escalation||2
10956784|NCT00454818|12129170|FG002|COMPLETED|Phase I: Open-label Dose-escalation||2
10956785|NCT00454818|12129171|FG003|COMPLETED|Phase I: Open-label Dose-escalation||2
10956786|NCT00454818|12129172|FG004|COMPLETED|Phase I: Open-label Dose-escalation||0
10956787|NCT00454818|12129168|FG000|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
10956788|NCT00454818|12129169|FG001|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
10956789|NCT00454818|12129170|FG002|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
10956790|NCT00454818|12129171|FG003|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
10956791|NCT00454818|12129172|FG004|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
10956792|NCT00454818|12129168|FG000|STARTED|Phase 2: Randomized Double-blind||0
10956793|NCT00454818|12129169|FG001|STARTED|Phase 2: Randomized Double-blind||8
10956794|NCT00454818|12129170|FG002|STARTED|Phase 2: Randomized Double-blind||8
10956795|NCT00454818|12129171|FG003|STARTED|Phase 2: Randomized Double-blind||9
10956796|NCT00454818|12129172|FG004|STARTED|Phase 2: Randomized Double-blind||14
10956797|NCT00454818|12129168|FG000|COMPLETED|Phase 2: Randomized Double-blind||0
10956798|NCT00454818|12129169|FG001|COMPLETED|Phase 2: Randomized Double-blind||6
10956799|NCT00454818|12129170|FG002|COMPLETED|Phase 2: Randomized Double-blind||5
10956800|NCT00454818|12129171|FG003|COMPLETED|Phase 2: Randomized Double-blind||8
10956801|NCT00454818|12129172|FG004|COMPLETED|Phase 2: Randomized Double-blind||10
10956802|NCT00454818|12129168|FG000|NOT COMPLETED|Phase 2: Randomized Double-blind||0
10956803|NCT00454818|12129169|FG001|NOT COMPLETED|Phase 2: Randomized Double-blind||2
10956804|NCT00454818|12129170|FG002|NOT COMPLETED|Phase 2: Randomized Double-blind||3
10956805|NCT00454818|12129171|FG003|NOT COMPLETED|Phase 2: Randomized Double-blind||1
10956806|NCT00454818|12129172|FG004|NOT COMPLETED|Phase 2: Randomized Double-blind||4
10956807|NCT00454857|12129189|FG000|STARTED|Overall Study||326
10956808|NCT00454857|12129189|FG000|Completed Retrospective Chart Review|Overall Study||324
10956809|NCT00454857|12129189|FG000|Completed ≥1 Observational Study Visit|Overall Study||319
10956810|NCT00454857|12129189|FG000|COMPLETED|Overall Study||272
10956811|NCT00454857|12129189|FG000|NOT COMPLETED|Overall Study||54
10956812|NCT00454909|12129196|FG000|STARTED|Overall Study||587
10956813|NCT00454909|12129197|FG001|STARTED|Overall Study||197
10956814|NCT00454909|12129198|FG002|STARTED|Overall Study||88
10956815|NCT00454909|12129196|FG000|COMPLETED|Overall Study||580
10956816|NCT00454909|12129197|FG001|COMPLETED|Overall Study||194
10956817|NCT00454909|12129198|FG002|COMPLETED|Overall Study||86
10956818|NCT00454909|12129196|FG000|NOT COMPLETED|Overall Study||7
10956819|NCT00454909|12129197|FG001|NOT COMPLETED|Overall Study||3
10956820|NCT00454909|12129198|FG002|NOT COMPLETED|Overall Study||2
10956821|NCT00454987|12129210|FG000|STARTED|Booster Period (NCT00258700)||359
10956822|NCT00454987|12129211|FG001|STARTED|Booster Period (NCT00258700)||117
10956823|NCT00454987|12129212|FG002|STARTED|Booster Period (NCT00258700)||0
10956824|NCT00454987|12129210|FG000|COMPLETED|Booster Period (NCT00258700)||357
10956825|NCT00454987|12129211|FG001|COMPLETED|Booster Period (NCT00258700)||116
10956826|NCT00454987|12129212|FG002|COMPLETED|Booster Period (NCT00258700)||0
10956827|NCT00454987|12129210|FG000|NOT COMPLETED|Booster Period (NCT00258700)||2
10956828|NCT00454987|12129211|FG001|NOT COMPLETED|Booster Period (NCT00258700)||1
10956829|NCT00454987|12129212|FG002|NOT COMPLETED|Booster Period (NCT00258700)||0
10956830|NCT00454987|12129210|FG000|STARTED|Year 1 (NCT00454987)||221
10956831|NCT00454987|12129211|FG001|STARTED|Year 1 (NCT00454987)||67
10956832|NCT00454987|12129212|FG002|STARTED|Year 1 (NCT00454987)||0
10956833|NCT00454987|12129210|FG000|COMPLETED|Year 1 (NCT00454987)||221
10956834|NCT00454987|12129211|FG001|COMPLETED|Year 1 (NCT00454987)||67
10956835|NCT00454987|12129212|FG002|COMPLETED|Year 1 (NCT00454987)||0
10956836|NCT00454987|12129210|FG000|NOT COMPLETED|Year 1 (NCT00454987)||0
10956837|NCT00454987|12129211|FG001|NOT COMPLETED|Year 1 (NCT00454987)||0
10956838|NCT00454987|12129212|FG002|NOT COMPLETED|Year 1 (NCT00454987)||0
10956839|NCT00454987|12129210|FG000|STARTED|Year 2 (NCT00454987)||235
10956840|NCT00454987|12129211|FG001|STARTED|Year 2 (NCT00454987)||77
10956841|NCT00454987|12129212|FG002|STARTED|Year 2 (NCT00454987)||74
10956842|NCT00454987|12129210|FG000|COMPLETED|Year 2 (NCT00454987)||235
10956843|NCT00454987|12129211|FG001|COMPLETED|Year 2 (NCT00454987)||77
10956844|NCT00454987|12129212|FG002|COMPLETED|Year 2 (NCT00454987)||74
10956845|NCT00454987|12129210|FG000|NOT COMPLETED|Year 2 (NCT00454987)||0
10956846|NCT00454987|12129211|FG001|NOT COMPLETED|Year 2 (NCT00454987)||0
10956847|NCT00454987|12129212|FG002|NOT COMPLETED|Year 2 (NCT00454987)||0
10956848|NCT00454987|12129210|FG000|STARTED|Year 4 (NCT00454987)||206
10956849|NCT00454987|12129211|FG001|STARTED|Year 4 (NCT00454987)||62
10956850|NCT00454987|12129212|FG002|STARTED|Year 4 (NCT00454987)||0
10956851|NCT00454987|12129210|FG000|COMPLETED|Year 4 (NCT00454987)||206
10956852|NCT00454987|12129211|FG001|COMPLETED|Year 4 (NCT00454987)||62
10956853|NCT00454987|12129212|FG002|COMPLETED|Year 4 (NCT00454987)||0
10956854|NCT00454987|12129210|FG000|NOT COMPLETED|Year 4 (NCT00454987)||0
10956855|NCT00454987|12129211|FG001|NOT COMPLETED|Year 4 (NCT00454987)||0
10956856|NCT00454987|12129212|FG002|NOT COMPLETED|Year 4 (NCT00454987)||0
10956857|NCT00455013|12129224|FG000|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
10956858|NCT00455013|12129225|FG001|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
10956859|NCT00455013|12129226|FG002|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
10956860|NCT00455013|12129224|FG000|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
10956861|NCT00455013|12129225|FG001|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
10956862|NCT00455013|12129226|FG002|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
10956863|NCT00455013|12129224|FG000|NOT COMPLETED|Short Term Period||6
10956864|NCT00455013|12129225|FG001|NOT COMPLETED|Short Term Period||5
10956865|NCT00455013|12129226|FG002|NOT COMPLETED|Short Term Period||2
10956866|NCT00455013|12129224|FG000|STARTED|Long Term Extension (LTE)||27
10956867|NCT00455013|12129225|FG001|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
10956868|NCT00455013|12129226|FG002|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
10956869|NCT00455013|12129224|FG000|COMPLETED|Long Term Extension (LTE)||25
10956870|NCT00455013|12129225|FG001|COMPLETED|Long Term Extension (LTE)||16
10956871|NCT00455013|12129226|FG002|COMPLETED|Long Term Extension (LTE)||20
10956872|NCT00455013|12129224|FG000|NOT COMPLETED|Long Term Extension (LTE)||2
10956873|NCT00455013|12129225|FG001|NOT COMPLETED|Long Term Extension (LTE)||3
10956874|NCT00455013|12129226|FG002|NOT COMPLETED|Long Term Extension (LTE)||7
10956875|NCT00455195|12129236|FG000|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
10956876|NCT00455195|12129237|FG001|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
10956877|NCT00455195|12129236|FG000|COMPLETED|Double-blind Study AGLU02704||55
10956878|NCT00455195|12129237|FG001|COMPLETED|Double-blind Study AGLU02704||26
10956879|NCT00455195|12129236|FG000|NOT COMPLETED|Double-blind Study AGLU02704||5
10956880|NCT00455195|12129237|FG001|NOT COMPLETED|Double-blind Study AGLU02704||4
10956881|NCT00455195|12129236|FG000|STARTED|Extension Study AGLU03206||55
10956882|NCT00455195|12129237|FG001|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
10956883|NCT00455195|12129236|FG000|COMPLETED|Extension Study AGLU03206||55
10956884|NCT00455195|12129237|FG001|COMPLETED|Extension Study AGLU03206||26
10956885|NCT00455195|12129236|FG000|NOT COMPLETED|Extension Study AGLU03206||0
10956886|NCT00455195|12129237|FG001|NOT COMPLETED|Extension Study AGLU03206||0
10956887|NCT00455312|12129245|FG000|STARTED|Overall Study||15
10956888|NCT00455312|12129246|FG001|STARTED|Overall Study||21
10956889|NCT00455312|12129245|FG000|COMPLETED|Overall Study||15
10956890|NCT00455312|12129246|FG001|COMPLETED|Overall Study||20
10956891|NCT00455312|12129245|FG000|NOT COMPLETED|Overall Study||0
10956892|NCT00455312|12129246|FG001|NOT COMPLETED|Overall Study||1
10956893|NCT00455429|12129256|FG000|STARTED|Overall Study||18
10956894|NCT00455429|12129257|FG001|STARTED|Overall Study||15
10956895|NCT00455429|12129258|FG002|STARTED|Overall Study||17
10956896|NCT00455429|12129259|FG003|STARTED|Overall Study||34
10956897|NCT00455429|12129256|FG000|Treated|Overall Study||18
10956898|NCT00455429|12129257|FG001|Treated|Overall Study||15
10956899|NCT00455429|12129258|FG002|Treated|Overall Study||17
10956900|NCT00455429|12129259|FG003|Treated|Overall Study||32
10956901|NCT00455429|12129256|FG000|COMPLETED|Overall Study||16
10956902|NCT00455429|12129257|FG001|COMPLETED|Overall Study||10
10956903|NCT00455429|12129258|FG002|COMPLETED|Overall Study||16
10956904|NCT00455429|12129259|FG003|COMPLETED|Overall Study||20
10956905|NCT00455429|12129256|FG000|NOT COMPLETED|Overall Study||2
10956906|NCT00455429|12129257|FG001|NOT COMPLETED|Overall Study||5
10956907|NCT00455429|12129258|FG002|NOT COMPLETED|Overall Study||1
10956908|NCT00455429|12129259|FG003|NOT COMPLETED|Overall Study||14
10956909|NCT00455455|12129272|FG000|STARTED|Washout||25
10956910|NCT00455455|12129273|FG001|STARTED|Washout||25
10956911|NCT00455455|12129272|FG000|COMPLETED|Washout||25
10956912|NCT00455455|12129273|FG001|COMPLETED|Washout||24
10956913|NCT00455455|12129272|FG000|NOT COMPLETED|Washout||0
10956914|NCT00455455|12129273|FG001|NOT COMPLETED|Washout||1
10956915|NCT00455455|12129272|FG000|STARTED|First Intervention||25
10956916|NCT00455455|12129273|FG001|STARTED|First Intervention||24
10956917|NCT00455455|12129272|FG000|COMPLETED|First Intervention||25
10956918|NCT00455455|12129273|FG001|COMPLETED|First Intervention||24
10956919|NCT00455455|12129272|FG000|NOT COMPLETED|First Intervention||0
10956920|NCT00455455|12129273|FG001|NOT COMPLETED|First Intervention||0
10956921|NCT00455455|12129272|FG000|STARTED|Washout||25
10956922|NCT00455455|12129273|FG001|STARTED|Washout||24
10956923|NCT00455455|12129272|FG000|COMPLETED|Washout||24
10956924|NCT00455455|12129273|FG001|COMPLETED|Washout||24
10956925|NCT00455455|12129272|FG000|NOT COMPLETED|Washout||1
10956926|NCT00455455|12129273|FG001|NOT COMPLETED|Washout||0
10956927|NCT00455455|12129272|FG000|STARTED|Second Intervention||24
10956928|NCT00455455|12129273|FG001|STARTED|Second Intervention||24
10956929|NCT00455455|12129272|FG000|COMPLETED|Second Intervention||24
10956930|NCT00455455|12129273|FG001|COMPLETED|Second Intervention||24
10956931|NCT00455455|12129272|FG000|NOT COMPLETED|Second Intervention||0
10956932|NCT00455455|12129273|FG001|NOT COMPLETED|Second Intervention||0
10956933|NCT00455520|12129284|FG000|STARTED|Open Label Tapentadol Extended Release||591
10956934|NCT00455520|12129285|FG001|STARTED|Open Label Tapentadol Extended Release||0
10956935|NCT00455520|12129284|FG000|COMPLETED|Open Label Tapentadol Extended Release||395
10956936|NCT00455520|12129285|FG001|COMPLETED|Open Label Tapentadol Extended Release||0
10956937|NCT00455520|12129284|FG000|NOT COMPLETED|Open Label Tapentadol Extended Release||196
10956938|NCT00455520|12129285|FG001|NOT COMPLETED|Open Label Tapentadol Extended Release||0
10956939|NCT00455520|12129284|FG000|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
10956940|NCT00455520|12129285|FG001|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
10956941|NCT00455520|12129284|FG000|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
10956942|NCT00455520|12129285|FG001|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
10956943|NCT00455520|12129284|FG000|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
10956944|NCT00455520|12129285|FG001|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
10956945|NCT00455533|12129293|FG000|STARTED|Period One: Initial Chemotherapy||313
10956946|NCT00455533|12129294|FG001|STARTED|Period One: Initial Chemotherapy||0
10956947|NCT00455533|12129295|FG002|STARTED|Period One: Initial Chemotherapy||0
10956948|NCT00455533|12129293|FG000|COMPLETED|Period One: Initial Chemotherapy||295
10956949|NCT00455533|12129294|FG001|COMPLETED|Period One: Initial Chemotherapy||0
10956950|NCT00455533|12129295|FG002|COMPLETED|Period One: Initial Chemotherapy||0
10956951|NCT00455533|12129293|FG000|NOT COMPLETED|Period One: Initial Chemotherapy||18
10956952|NCT00455533|12129294|FG001|NOT COMPLETED|Period One: Initial Chemotherapy||0
10956953|NCT00455533|12129295|FG002|NOT COMPLETED|Period One: Initial Chemotherapy||0
10956954|NCT00455533|12129293|FG000|STARTED|Period Two: Randomized Period||0
10956955|NCT00455533|12129294|FG001|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
10956956|NCT00455533|12129295|FG002|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
10956957|NCT00455533|12129293|FG000|COMPLETED|Period Two: Randomized Period||0
10956958|NCT00455533|12129294|FG001|COMPLETED|Period Two: Randomized Period||139
10956959|NCT00455533|12129295|FG002|COMPLETED|Period Two: Randomized Period||138
10956960|NCT00455533|12129293|FG000|NOT COMPLETED|Period Two: Randomized Period||0
10956961|NCT00455533|12129294|FG001|NOT COMPLETED|Period Two: Randomized Period||6
10956962|NCT00455533|12129295|FG002|NOT COMPLETED|Period Two: Randomized Period||6
10956963|NCT00455650|12129305|FG000|STARTED|Week 1||10
10956964|NCT00455650|12129306|FG001|STARTED|Week 1||10
10956965|NCT00455650|12129307|FG002|STARTED|Week 1||10
10956966|NCT00455650|12129308|FG003|STARTED|Week 1||14
10956967|NCT00455650|12129309|FG004|STARTED|Week 1||14
10956968|NCT00455650|12129310|FG005|STARTED|Week 1||13
10956969|NCT00455650|12129305|FG000|COMPLETED|Week 1||10
10956970|NCT00455650|12129306|FG001|COMPLETED|Week 1||10
10956971|NCT00455650|12129307|FG002|COMPLETED|Week 1||10
10956972|NCT00455650|12129308|FG003|COMPLETED|Week 1||14
10956973|NCT00455650|12129309|FG004|COMPLETED|Week 1||14
10956974|NCT00455650|12129310|FG005|COMPLETED|Week 1||13
10956975|NCT00455650|12129305|FG000|NOT COMPLETED|Week 1||0
10956976|NCT00455650|12129306|FG001|NOT COMPLETED|Week 1||0
10956977|NCT00455650|12129307|FG002|NOT COMPLETED|Week 1||0
10956978|NCT00455650|12129308|FG003|NOT COMPLETED|Week 1||0
10956979|NCT00455650|12129309|FG004|NOT COMPLETED|Week 1||0
10956980|NCT00455650|12129310|FG005|NOT COMPLETED|Week 1||0
10956981|NCT00455650|12129305|FG000|STARTED|Week 2||10
10956982|NCT00455650|12129306|FG001|STARTED|Week 2||10
10956983|NCT00455650|12129307|FG002|STARTED|Week 2||10
10956984|NCT00455650|12129308|FG003|STARTED|Week 2||14
10956985|NCT00455650|12129309|FG004|STARTED|Week 2||14
10956986|NCT00455650|12129310|FG005|STARTED|Week 2||13
10956987|NCT00455650|12129305|FG000|COMPLETED|Week 2||10
10956988|NCT00455650|12129306|FG001|COMPLETED|Week 2||10
10956989|NCT00455650|12129307|FG002|COMPLETED|Week 2||10
10956990|NCT00455650|12129308|FG003|COMPLETED|Week 2||14
10956991|NCT00455650|12129309|FG004|COMPLETED|Week 2||14
10956992|NCT00455650|12129310|FG005|COMPLETED|Week 2||13
10956993|NCT00455650|12129305|FG000|NOT COMPLETED|Week 2||0
10956994|NCT00455650|12129306|FG001|NOT COMPLETED|Week 2||0
10956995|NCT00455650|12129307|FG002|NOT COMPLETED|Week 2||0
10956996|NCT00455650|12129308|FG003|NOT COMPLETED|Week 2||0
10956997|NCT00455650|12129309|FG004|NOT COMPLETED|Week 2||0
10956998|NCT00455650|12129310|FG005|NOT COMPLETED|Week 2||0
10956999|NCT00455650|12129305|FG000|STARTED|Week 3||10
10957000|NCT00455650|12129306|FG001|STARTED|Week 3||10
10957001|NCT00455650|12129307|FG002|STARTED|Week 3||10
10957002|NCT00455650|12129308|FG003|STARTED|Week 3||14
10957003|NCT00455650|12129309|FG004|STARTED|Week 3||14
10957004|NCT00455650|12129310|FG005|STARTED|Week 3||13
10957005|NCT00455650|12129305|FG000|COMPLETED|Week 3||10
10957006|NCT00455650|12129306|FG001|COMPLETED|Week 3||10
10957007|NCT00455650|12129307|FG002|COMPLETED|Week 3||10
10957008|NCT00455650|12129308|FG003|COMPLETED|Week 3||14
10957009|NCT00455650|12129309|FG004|COMPLETED|Week 3||14
10957010|NCT00455650|12129310|FG005|COMPLETED|Week 3||13
10957011|NCT00455650|12129305|FG000|NOT COMPLETED|Week 3||0
10957012|NCT00455650|12129306|FG001|NOT COMPLETED|Week 3||0
10957013|NCT00455650|12129307|FG002|NOT COMPLETED|Week 3||0
10957014|NCT00455650|12129308|FG003|NOT COMPLETED|Week 3||0
10957015|NCT00455650|12129309|FG004|NOT COMPLETED|Week 3||0
10957016|NCT00455650|12129310|FG005|NOT COMPLETED|Week 3||0
10957017|NCT00455663|12129323|FG000|STARTED|Overall Study||37
10957018|NCT00455663|12129324|FG001|STARTED|Overall Study||36
10957019|NCT00455663|12129325|FG002|STARTED|Overall Study||32
10957020|NCT00455663|12129323|FG000|COMPLETED|Overall Study||34
10957021|NCT00455663|12129324|FG001|COMPLETED|Overall Study||32
10957022|NCT00455663|12129325|FG002|COMPLETED|Overall Study||29
10957023|NCT00455663|12129323|FG000|NOT COMPLETED|Overall Study||3
10957024|NCT00455663|12129324|FG001|NOT COMPLETED|Overall Study||4
10957025|NCT00455663|12129325|FG002|NOT COMPLETED|Overall Study||3
10957026|NCT00455689|12129339|FG000|STARTED|Overall Study||14
10957027|NCT00455689|12129340|FG001|STARTED|Overall Study||6
10957028|NCT00455689|12129339|FG000|COMPLETED|Overall Study||14
10957029|NCT00455689|12129340|FG001|COMPLETED|Overall Study||6
10957030|NCT00455689|12129339|FG000|NOT COMPLETED|Overall Study||0
10957031|NCT00455689|12129340|FG001|NOT COMPLETED|Overall Study||0
10957032|NCT00455702|12129347|FG000|STARTED|Overall Study||19
10957033|NCT00455702|12129348|FG001|STARTED|Overall Study||19
10957034|NCT00455702|12129347|FG000|COMPLETED|Overall Study||16
10957035|NCT00455702|12129348|FG001|COMPLETED|Overall Study||16
10957036|NCT00455702|12129347|FG000|NOT COMPLETED|Overall Study||3
10957037|NCT00455702|12129348|FG001|NOT COMPLETED|Overall Study||3
10957038|NCT00455741|12129358|FG000|STARTED|Overall Study||13
10957039|NCT00455741|12129359|FG001|STARTED|Overall Study||12
10957040|NCT00455741|12129358|FG000|COMPLETED|Overall Study||13
10957041|NCT00455741|12129359|FG001|COMPLETED|Overall Study||11
10957042|NCT00455741|12129358|FG000|NOT COMPLETED|Overall Study||0
10957043|NCT00455741|12129359|FG001|NOT COMPLETED|Overall Study||1
10957044|NCT00455858|12129375|FG000|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
10957045|NCT00455858|12129375|FG000|COMPLETED|Overall Study||81
10957046|NCT00455858|12129375|FG000|NOT COMPLETED|Overall Study||6
10957047|NCT00455923|12129381|FG000|STARTED|Overall Study||50
10957048|NCT00455923|12129382|FG001|STARTED|Overall Study||50
10957049|NCT00455923|12129381|FG000|COMPLETED|Overall Study||47
10957050|NCT00455923|12129382|FG001|COMPLETED|Overall Study||47
10957051|NCT00455923|12129381|FG000|NOT COMPLETED|Overall Study||3
10957052|NCT00455923|12129382|FG001|NOT COMPLETED|Overall Study||3
10957053|NCT00455962|12129390|FG000|STARTED|Overall Study||10
10957054|NCT00455962|12129391|FG001|STARTED|Overall Study||13
10957055|NCT00455962|12129390|FG000|COMPLETED|Overall Study||10
10957056|NCT00455962|12129391|FG001|COMPLETED|Overall Study||13
10957057|NCT00455962|12129390|FG000|NOT COMPLETED|Overall Study||0
10957058|NCT00455962|12129391|FG001|NOT COMPLETED|Overall Study||0
10957059|NCT00455975|12129399|FG000|STARTED|Overall Study||58
10957060|NCT00455975|12129400|FG001|STARTED|Overall Study||61
10957061|NCT00455975|12129399|FG000|COMPLETED|Overall Study||40
10957062|NCT00455975|12129400|FG001|COMPLETED|Overall Study||40
10957063|NCT00455975|12129399|FG000|NOT COMPLETED|Overall Study||18
10957064|NCT00455975|12129400|FG001|NOT COMPLETED|Overall Study||21
10957065|NCT00456014|12129406|FG000|STARTED|SSRI Phase||37
10957066|NCT00456014|12129406|FG000|COMPLETED|SSRI Phase||28
10957067|NCT00456014|12129406|FG000|NOT COMPLETED|SSRI Phase||9
10957068|NCT00456014|12129406|FG000|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
10957069|NCT00456014|12129406|FG000|COMPLETED|Tricyclic Phase||1
10957070|NCT00456014|12129406|FG000|NOT COMPLETED|Tricyclic Phase||3
10957071|NCT00456092|12129415|FG000|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46
10957072|NCT00456092|12129416|FG001|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40
10957073|NCT00456092|12129417|FG002|STARTED|Extension Phase||0
10957074|NCT00456092|12129418|FG003|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
10957075|NCT00456092|12129419|FG004|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
10957076|NCT00456092|12129415|FG000|COMPLETED|Extension Phase||35
10957077|NCT00456092|12129416|FG001|COMPLETED|Extension Phase||36
10957078|NCT00456092|12129417|FG002|COMPLETED|Extension Phase||0
10957079|NCT00456092|12129418|FG003|COMPLETED|Extension Phase||19
10957080|NCT00456092|12129419|FG004|COMPLETED|Extension Phase||13
10957081|NCT00456092|12129415|FG000|NOT COMPLETED|Extension Phase||11
10957082|NCT00456092|12129416|FG001|NOT COMPLETED|Extension Phase||4
10957083|NCT00456092|12129417|FG002|NOT COMPLETED|Extension Phase||0
10957084|NCT00456092|12129418|FG003|NOT COMPLETED|Extension Phase||1
10957085|NCT00456092|12129419|FG004|NOT COMPLETED|Extension Phase||7
10957086|NCT00456092|12129415|FG000|STARTED|Treatment Phase (12 Weeks)||67
10957087|NCT00456092|12129416|FG001|STARTED|Treatment Phase (12 Weeks)||69
10957088|NCT00456092|12129417|FG002|STARTED|Treatment Phase (12 Weeks)||68
10957089|NCT00456092|12129418|FG003|STARTED|Treatment Phase (12 Weeks)||0
10957090|NCT00456092|12129419|FG004|STARTED|Treatment Phase (12 Weeks)||0
10957091|NCT00456092|12129415|FG000|COMPLETED|Treatment Phase (12 Weeks)||60
10957092|NCT00456092|12129416|FG001|COMPLETED|Treatment Phase (12 Weeks)||55
10957093|NCT00456092|12129417|FG002|COMPLETED|Treatment Phase (12 Weeks)||50
10957094|NCT00456092|12129418|FG003|COMPLETED|Treatment Phase (12 Weeks)||0
10957095|NCT00456092|12129419|FG004|COMPLETED|Treatment Phase (12 Weeks)||0
10957096|NCT00456092|12129415|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||7
10957097|NCT00456092|12129416|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||14
10957098|NCT00456092|12129417|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||18
10957099|NCT00456092|12129418|FG003|NOT COMPLETED|Treatment Phase (12 Weeks)||0
10957100|NCT00456092|12129419|FG004|NOT COMPLETED|Treatment Phase (12 Weeks)||0
10957101|NCT00456300|12129433|FG000|STARTED|Overall Study||5
10957102|NCT00456300|12129434|FG001|STARTED|Overall Study||4
10957103|NCT00456300|12129433|FG000|COMPLETED|Overall Study||4
10957104|NCT00456300|12129434|FG001|COMPLETED|Overall Study||4
10957105|NCT00456300|12129433|FG000|NOT COMPLETED|Overall Study||1
10957106|NCT00456300|12129434|FG001|NOT COMPLETED|Overall Study||0
10957107|NCT00456365|12129444|FG000|STARTED|Overall Study||56
10957108|NCT00456365|12129445|FG001|STARTED|Overall Study||54
10957109|NCT00456365|12129444|FG000|COMPLETED|Overall Study||49
10957110|NCT00456365|12129445|FG001|COMPLETED|Overall Study||42
10957111|NCT00456365|12129444|FG000|NOT COMPLETED|Overall Study||7
10957112|NCT00456365|12129445|FG001|NOT COMPLETED|Overall Study||12
10957113|NCT00456495|12129453|FG000|STARTED|Overall Study||5
10957114|NCT00456495|12129453|FG000|COMPLETED|Overall Study||3
10957115|NCT00456495|12129453|FG000|NOT COMPLETED|Overall Study||2
10957116|NCT00456508|12129458|FG000|STARTED|Overall Study||147
10957117|NCT00456508|12129458|FG000|COMPLETED|Overall Study||147
10957118|NCT00456508|12129458|FG000|NOT COMPLETED|Overall Study||0
10957119|NCT00456521|12129464|FG000|STARTED|Overall Study||591
10957120|NCT00456521|12129465|FG001|STARTED|Overall Study||202
10957121|NCT00456521|12129464|FG000|COMPLETED|Overall Study||342
10957122|NCT00456521|12129465|FG001|COMPLETED|Overall Study||118
10957123|NCT00456521|12129464|FG000|NOT COMPLETED|Overall Study||249
10957124|NCT00456521|12129465|FG001|NOT COMPLETED|Overall Study||84
10957125|NCT00456547|12129474|FG000|STARTED|Overall Study||12
10957126|NCT00456547|12129475|FG001|STARTED|Overall Study||12
10957127|NCT00456547|12129474|FG000|COMPLETED|Overall Study||12
10957128|NCT00456547|12129475|FG001|COMPLETED|Overall Study||12
10957129|NCT00456547|12129474|FG000|NOT COMPLETED|Overall Study||0
10957130|NCT00456547|12129475|FG001|NOT COMPLETED|Overall Study||0
10957131|NCT00456599|12129481|FG000|STARTED|Overall Study||71
10957132|NCT00456599|12129481|FG000|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
10957133|NCT00456599|12129481|FG000|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
10957134|NCT00456599|12129481|FG000|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
10957135|NCT00456599|12129481|FG000|Completed Resection|Overall Study|43 patients underwent resection.|43
10957136|NCT00456599|12129481|FG000|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
10957137|NCT00456599|12129481|FG000|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
10957138|NCT00456599|12129481|FG000|COMPLETED|Overall Study||68
10957139|NCT00456599|12129481|FG000|NOT COMPLETED|Overall Study||3
10957140|NCT00456625|12129485|FG000|STARTED|Overall Study||76
10957141|NCT00456625|12129485|FG000|COMPLETED|Overall Study||76
10957142|NCT00456625|12129485|FG000|NOT COMPLETED|Overall Study||0
10957143|NCT00456755|12129491|FG000|STARTED|Overall Study||63
10957144|NCT00456755|12129492|FG001|STARTED|Overall Study||63
10957145|NCT00456755|12129491|FG000|COMPLETED|Overall Study||61
10957146|NCT00456755|12129492|FG001|COMPLETED|Overall Study||62
10957147|NCT00456755|12129491|FG000|NOT COMPLETED|Overall Study||2
10957148|NCT00456755|12129492|FG001|NOT COMPLETED|Overall Study||1
10957149|NCT00456807|12129500|FG000|STARTED|Overall Study||53
10957150|NCT00456807|12129501|FG001|STARTED|Overall Study||47
10957151|NCT00456807|12129500|FG000|COMPLETED|Overall Study||52
10957152|NCT00456807|12129501|FG001|COMPLETED|Overall Study||47
10957153|NCT00456807|12129500|FG000|NOT COMPLETED|Overall Study||1
10957154|NCT00456807|12129501|FG001|NOT COMPLETED|Overall Study||0
10957155|NCT00456846|12129509|FG000|STARTED|Overall Study||47
10957156|NCT00456846|12129510|FG001|STARTED|Overall Study||76
10957157|NCT00456846|12129509|FG000|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
10957158|NCT00456846|12129510|FG001|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
10957159|NCT00456846|12129509|FG000|NOT COMPLETED|Overall Study||16
10957160|NCT00456846|12129510|FG001|NOT COMPLETED|Overall Study||28
10957161|NCT00456885|12129516|FG000|STARTED|First Treatment Period, 16 Weeks||24
10957162|NCT00456885|12129517|FG001|STARTED|First Treatment Period, 16 Weeks||17
10957163|NCT00456885|12129516|FG000|COMPLETED|First Treatment Period, 16 Weeks||24
10957164|NCT00456885|12129517|FG001|COMPLETED|First Treatment Period, 16 Weeks||17
10957165|NCT00456885|12129516|FG000|NOT COMPLETED|First Treatment Period, 16 Weeks||0
10957166|NCT00456885|12129517|FG001|NOT COMPLETED|First Treatment Period, 16 Weeks||0
10957167|NCT00456885|12129516|FG000|STARTED|Washout, 3 Weeks||24
10957168|NCT00456885|12129517|FG001|STARTED|Washout, 3 Weeks||17
10957169|NCT00456885|12129516|FG000|COMPLETED|Washout, 3 Weeks||24
10957170|NCT00456885|12129517|FG001|COMPLETED|Washout, 3 Weeks||17
10957171|NCT00456885|12129516|FG000|NOT COMPLETED|Washout, 3 Weeks||0
10957172|NCT00456885|12129517|FG001|NOT COMPLETED|Washout, 3 Weeks||0
10957173|NCT00456885|12129516|FG000|STARTED|Second Treatment Period, 16 Weeks||24
10957174|NCT00456885|12129517|FG001|STARTED|Second Treatment Period, 16 Weeks||17
10957175|NCT00456885|12129516|FG000|COMPLETED|Second Treatment Period, 16 Weeks||23
10957176|NCT00456885|12129517|FG001|COMPLETED|Second Treatment Period, 16 Weeks||17
10957177|NCT00456885|12129516|FG000|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
10957178|NCT00456885|12129517|FG001|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
10957179|NCT00457002|12129524|FG000|STARTED|Overall Study||3255
10957180|NCT00457002|12129525|FG001|STARTED|Overall Study||3273
10957181|NCT00457002|12129524|FG000|COMPLETED|Overall Study||2442
10957182|NCT00457002|12129525|FG001|COMPLETED|Overall Study||2516
10957183|NCT00457002|12129524|FG000|NOT COMPLETED|Overall Study||813
10957184|NCT00457002|12129525|FG001|NOT COMPLETED|Overall Study||757
10957185|NCT00457015|12129533|FG000|STARTED|Overall Study||48
10957186|NCT00457015|12129534|FG001|STARTED|Overall Study||48
10957187|NCT00457015|12129533|FG000|COMPLETED|Overall Study||48
10957188|NCT00457015|12129534|FG001|COMPLETED|Overall Study||47
10957189|NCT00457015|12129533|FG000|NOT COMPLETED|Overall Study||0
10957190|NCT00457015|12129534|FG001|NOT COMPLETED|Overall Study||1
10957191|NCT00457197|12129542|FG000|STARTED|Overall Study||45
10957192|NCT00457197|12129543|FG001|STARTED|Overall Study||45
10957193|NCT00457197|12129542|FG000|COMPLETED|Overall Study||44
10957194|NCT00457197|12129543|FG001|COMPLETED|Overall Study||44
10957195|NCT00457197|12129542|FG000|NOT COMPLETED|Overall Study||1
10957196|NCT00457197|12129543|FG001|NOT COMPLETED|Overall Study||1
10957197|NCT00457249|12129551|FG000|STARTED|Overall Study||1170
10957198|NCT00457249|12129552|FG001|STARTED|Overall Study||391
10957199|NCT00457249|12129551|FG000|COMPLETED|Overall Study||1158
10957200|NCT00457249|12129552|FG001|COMPLETED|Overall Study||389
10957201|NCT00457249|12129551|FG000|NOT COMPLETED|Overall Study||12
10957202|NCT00457249|12129552|FG001|NOT COMPLETED|Overall Study||2
10957203|NCT00457301|12129562|FG000|STARTED|Overall Study||105
10957204|NCT00457301|12129563|FG001|STARTED|Overall Study||108
10957205|NCT00457301|12129562|FG000|COMPLETED|Overall Study||82
10957206|NCT00457301|12129563|FG001|COMPLETED|Overall Study||84
10957207|NCT00457301|12129562|FG000|NOT COMPLETED|Overall Study||23
10957208|NCT00457301|12129563|FG001|NOT COMPLETED|Overall Study||24
10957209|NCT00457366|12129571|FG000|STARTED|Overall Study||40
10957210|NCT00457366|12129572|FG001|STARTED|Overall Study||32
10957211|NCT00457366|12129571|FG000|COMPLETED|Overall Study||40
10957212|NCT00457366|12129572|FG001|COMPLETED|Overall Study||32
10957213|NCT00457366|12129571|FG000|NOT COMPLETED|Overall Study||0
10957214|NCT00457366|12129572|FG001|NOT COMPLETED|Overall Study||0
10957215|NCT00457392|12129580|FG000|STARTED|Overall Study||480
10957216|NCT00457392|12129581|FG001|STARTED|Overall Study||480
10957217|NCT00457392|12129580|FG000|Treated|Overall Study||473
10957218|NCT00457392|12129581|FG001|Treated|Overall Study||477
10957219|NCT00457392|12129580|FG000|COMPLETED|Overall Study||0
10957220|NCT00457392|12129581|FG001|COMPLETED|Overall Study||0
10957221|NCT00457392|12129580|FG000|NOT COMPLETED|Overall Study||480
10957222|NCT00457392|12129581|FG001|NOT COMPLETED|Overall Study||480
10957223|NCT00457418|12129587|FG000|STARTED|Pharmacokinetic (PK) Sampling Phase||32
10957224|NCT00457418|12129587|FG000|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
10957225|NCT00457418|12129587|FG000|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
10957226|NCT00457418|12129587|FG000|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
10957227|NCT00457418|12129587|FG000|COMPLETED|Post PK Maintenance||3
10957228|NCT00457418|12129587|FG000|NOT COMPLETED|Post PK Maintenance||28
10957229|NCT00457626|12129591|FG000|STARTED|Overall Study||66
10957230|NCT00457626|12129591|FG000|COMPLETED|Overall Study||60
10957231|NCT00457626|12129591|FG000|NOT COMPLETED|Overall Study||6
10957232|NCT00457639|12129595|FG000|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9
10957233|NCT00457639|12129596|FG001|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9
10957234|NCT00457639|12129595|FG000|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6
10957235|NCT00457639|12129596|FG001|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7
10957236|NCT00457639|12129595|FG000|NOT COMPLETED|Intervention 1 (6 Months)||3
10957237|NCT00457639|12129596|FG001|NOT COMPLETED|Intervention 1 (6 Months)||2
10957238|NCT00457639|12129595|FG000|STARTED|Intervention 2 (6 Months)||6
10957239|NCT00457639|12129596|FG001|STARTED|Intervention 2 (6 Months)||7
10957240|NCT00457639|12129595|FG000|COMPLETED|Intervention 2 (6 Months)||6
10957241|NCT00457639|12129596|FG001|COMPLETED|Intervention 2 (6 Months)||6
10957242|NCT00457639|12129595|FG000|NOT COMPLETED|Intervention 2 (6 Months)||0
10957243|NCT00457639|12129596|FG001|NOT COMPLETED|Intervention 2 (6 Months)||1
10957244|NCT00457665|12129604|FG000|STARTED|12 Months||28
10957245|NCT00457665|12129605|FG001|STARTED|12 Months||28
10957246|NCT00457665|12129604|FG000|COMPLETED|12 Months||20
10957247|NCT00457665|12129605|FG001|COMPLETED|12 Months||19
10957248|NCT00457665|12129604|FG000|NOT COMPLETED|12 Months||8
10957249|NCT00457665|12129605|FG001|NOT COMPLETED|12 Months||9
10957250|NCT00457665|12129604|FG000|STARTED|24 Months||20
10957251|NCT00457665|12129605|FG001|STARTED|24 Months||19
10957252|NCT00457665|12129604|FG000|COMPLETED|24 Months||15
10957253|NCT00457665|12129605|FG001|COMPLETED|24 Months||11
10957254|NCT00457665|12129604|FG000|NOT COMPLETED|24 Months||5
10957255|NCT00457665|12129605|FG001|NOT COMPLETED|24 Months||8
10957256|NCT00457691|12129613|FG000|STARTED|Overall Study||386
10957257|NCT00457691|12129614|FG001|STARTED|Overall Study||382
10957258|NCT00457691|12129613|FG000|COMPLETED|Overall Study||0
10957259|NCT00457691|12129614|FG001|COMPLETED|Overall Study||0
10957260|NCT00457691|12129613|FG000|NOT COMPLETED|Overall Study||386
10957261|NCT00457691|12129614|FG001|NOT COMPLETED|Overall Study||382
10957262|NCT00457730|12129622|FG000|STARTED|Overall Study||18
10957263|NCT00457730|12129623|FG001|STARTED|Overall Study||20
10957264|NCT00457730|12129622|FG000|COMPLETED|Overall Study||14
10957265|NCT00457730|12129623|FG001|COMPLETED|Overall Study||19
10957266|NCT00457730|12129622|FG000|NOT COMPLETED|Overall Study||4
10957267|NCT00457730|12129623|FG001|NOT COMPLETED|Overall Study||1
10957268|NCT00457743|12129636|FG000|STARTED|Overall Study|Overall study|3
10957269|NCT00457743|12129637|FG001|STARTED|Overall Study|Overall study|30
10957270|NCT00457743|12129638|FG002|STARTED|Overall Study|Overall study|3
10957271|NCT00457743|12129636|FG000|Enrolled in Phase 1|Overall Study||3
10957272|NCT00457743|12129637|FG001|Enrolled in Phase 1|Overall Study||6
10957273|NCT00457743|12129638|FG002|Enrolled in Phase 1|Overall Study||3
10957274|NCT00457743|12129636|FG000|Completed Phase 1|Overall Study||3
10957275|NCT00457743|12129637|FG001|Completed Phase 1|Overall Study||6
10957276|NCT00457743|12129638|FG002|Completed Phase 1|Overall Study||3
10957277|NCT00457743|12129636|FG000|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
10957278|NCT00457743|12129637|FG001|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
10957279|NCT00457743|12129638|FG002|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
10957280|NCT00457743|12129636|FG000|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
10957281|NCT00457743|12129637|FG001|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
10957282|NCT00457743|12129638|FG002|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
10957283|NCT00457743|12129636|FG000|NOT COMPLETED|Overall Study||3
10957284|NCT00457743|12129637|FG001|NOT COMPLETED|Overall Study||27
10957285|NCT00457743|12129638|FG002|NOT COMPLETED|Overall Study||3
10957286|NCT00457795|12129647|FG000|STARTED|Overall Study||15
10957287|NCT00457795|12129647|FG000|COMPLETED|Overall Study||15
10957288|NCT00457795|12129647|FG000|NOT COMPLETED|Overall Study||0
10957289|NCT00457821|12129659|FG000|STARTED|Part 1|Number of subjects randomized|4
10957290|NCT00457821|12129660|FG001|STARTED|Part 1|Number of subjects randomized|4
10957291|NCT00457821|12129661|FG002|STARTED|Part 1|Number of subjects randomized|5
10957292|NCT00457821|12129662|FG003|STARTED|Part 1|Number of subjects randomized|4
10957293|NCT00457821|12129663|FG004|STARTED|Part 1|Number of subjects randomized|4
10957294|NCT00457821|12129664|FG005|STARTED|Part 1|Arm in Part 2 only|0
10957295|NCT00457821|12129665|FG006|STARTED|Part 1|Arm in Part 2 only|0
10957296|NCT00457821|12129666|FG007|STARTED|Part 1|Arm in Part 2 only|0
10957297|NCT00457821|12129659|FG000|COMPLETED|Part 1||4
10957298|NCT00457821|12129660|FG001|COMPLETED|Part 1||4
10957299|NCT00457821|12129661|FG002|COMPLETED|Part 1||4
10957300|NCT00457821|12129662|FG003|COMPLETED|Part 1||4
10957301|NCT00457821|12129663|FG004|COMPLETED|Part 1||4
10957302|NCT00457821|12129664|FG005|COMPLETED|Part 1||0
10957303|NCT00457821|12129665|FG006|COMPLETED|Part 1||0
10957304|NCT00457821|12129666|FG007|COMPLETED|Part 1||0
10957305|NCT00457821|12129659|FG000|NOT COMPLETED|Part 1||0
10957306|NCT00457821|12129660|FG001|NOT COMPLETED|Part 1||0
10957307|NCT00457821|12129661|FG002|NOT COMPLETED|Part 1||1
10957308|NCT00457821|12129662|FG003|NOT COMPLETED|Part 1||0
10957309|NCT00457821|12129663|FG004|NOT COMPLETED|Part 1||0
10957310|NCT00457821|12129664|FG005|NOT COMPLETED|Part 1||0
10957311|NCT00457821|12129665|FG006|NOT COMPLETED|Part 1||0
10957312|NCT00457821|12129666|FG007|NOT COMPLETED|Part 1||0
10957313|NCT00457821|12129659|FG000|STARTED|Part 2|Arm in Part 1 only|0
10957314|NCT00457821|12129660|FG001|STARTED|Part 2|Arm in Part 1 only|0
10957315|NCT00457821|12129661|FG002|STARTED|Part 2|Arm in Part 1 only|0
10957316|NCT00457821|12129662|FG003|STARTED|Part 2|Arm in Part 1 only|0
10957317|NCT00457821|12129663|FG004|STARTED|Part 2|Arm in Part 1 only|0
10957318|NCT00457821|12129664|FG005|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
10957319|NCT00457821|12129665|FG006|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
10957320|NCT00457821|12129666|FG007|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
10957321|NCT00457821|12129659|FG000|Completed Study Drug Treatment|Part 2||0
10957322|NCT00457821|12129660|FG001|Completed Study Drug Treatment|Part 2||0
10957323|NCT00457821|12129661|FG002|Completed Study Drug Treatment|Part 2||0
10957324|NCT00457821|12129662|FG003|Completed Study Drug Treatment|Part 2||0
10957325|NCT00457821|12129663|FG004|Completed Study Drug Treatment|Part 2||0
10957326|NCT00457821|12129664|FG005|Completed Study Drug Treatment|Part 2||8
10957327|NCT00457821|12129665|FG006|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
10957328|NCT00457821|12129666|FG007|Completed Study Drug Treatment|Part 2||4
10957329|NCT00457821|12129659|FG000|COMPLETED|Part 2||0
10957330|NCT00457821|12129660|FG001|COMPLETED|Part 2||0
10957331|NCT00457821|12129661|FG002|COMPLETED|Part 2||0
10957332|NCT00457821|12129662|FG003|COMPLETED|Part 2||0
10957333|NCT00457821|12129663|FG004|COMPLETED|Part 2||0
10957334|NCT00457821|12129664|FG005|COMPLETED|Part 2||8
10957335|NCT00457821|12129665|FG006|COMPLETED|Part 2||7
10957336|NCT00457821|12129666|FG007|COMPLETED|Part 2||4
10957337|NCT00457821|12129659|FG000|NOT COMPLETED|Part 2||0
10957338|NCT00457821|12129660|FG001|NOT COMPLETED|Part 2||0
10957339|NCT00457821|12129661|FG002|NOT COMPLETED|Part 2||0
10957340|NCT00457821|12129662|FG003|NOT COMPLETED|Part 2||0
10957341|NCT00457821|12129663|FG004|NOT COMPLETED|Part 2||0
10957342|NCT00457821|12129664|FG005|NOT COMPLETED|Part 2||0
10957343|NCT00457821|12129665|FG006|NOT COMPLETED|Part 2||0
10957344|NCT00457821|12129666|FG007|NOT COMPLETED|Part 2||1
10957345|NCT00457977|12129685|FG000|STARTED|Overall Study||90
10957346|NCT00457977|12129686|FG001|STARTED|Overall Study||91
10957347|NCT00457977|12129685|FG000|1-Month|Overall Study||88
10957348|NCT00457977|12129686|FG001|1-Month|Overall Study||87
10957349|NCT00457977|12129685|FG000|1-Year|Overall Study||69
10957350|NCT00457977|12129686|FG001|1-Year|Overall Study||76
10957351|NCT00457977|12129685|FG000|2-Year|Overall Study||62
10957352|NCT00457977|12129686|FG001|2-Year|Overall Study||66
10957353|NCT00457977|12129685|FG000|COMPLETED|Overall Study||62
10957354|NCT00457977|12129686|FG001|COMPLETED|Overall Study||66
10957355|NCT00457977|12129685|FG000|NOT COMPLETED|Overall Study||28
10957356|NCT00457977|12129686|FG001|NOT COMPLETED|Overall Study||25
10957357|NCT00458211|12129692|FG000|STARTED|Overall Study||40
10957358|NCT00458211|12129692|FG000|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
10957359|NCT00458211|12129692|FG000|NOT COMPLETED|Overall Study||16
10957360|NCT00458237|12129703|FG000|STARTED|Overall Study||3
10957361|NCT00458237|12129704|FG001|STARTED|Overall Study||3
10957362|NCT00458237|12129705|FG002|STARTED|Overall Study||5
10957363|NCT00458237|12129703|FG000|COMPLETED|Overall Study||3
10957364|NCT00458237|12129704|FG001|COMPLETED|Overall Study||3
10957365|NCT00458237|12129705|FG002|COMPLETED|Overall Study||5
10957366|NCT00458237|12129703|FG000|NOT COMPLETED|Overall Study||0
10957367|NCT00458237|12129704|FG001|NOT COMPLETED|Overall Study||0
10957368|NCT00458237|12129705|FG002|NOT COMPLETED|Overall Study||0
10957369|NCT00458302|12129716|FG000|STARTED|Overall Study||129
10957370|NCT00458302|12129717|FG001|STARTED|Overall Study||127
10957371|NCT00458302|12129716|FG000|COMPLETED|Overall Study||109
10957372|NCT00458302|12129717|FG001|COMPLETED|Overall Study||103
10957373|NCT00458302|12129716|FG000|NOT COMPLETED|Overall Study||20
10957374|NCT00458302|12129717|FG001|NOT COMPLETED|Overall Study||24
10957375|NCT00458341|12129726|FG000|STARTED|Cycle 1||15
10957376|NCT00458341|12129727|FG001|STARTED|Cycle 1||15
10957377|NCT00458341|12129726|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||15
10957378|NCT00458341|12129727|FG001|Received at Least 1 Dose of Study Drug|Cycle 1||15
10957379|NCT00458341|12129726|FG000|COMPLETED|Cycle 1|1 participant did not complete Cycle 1 since all procedures were not performed due to adverse event.|14
10957380|NCT00458341|12129727|FG001|COMPLETED|Cycle 1||15
10957381|NCT00458341|12129726|FG000|NOT COMPLETED|Cycle 1||1
10957382|NCT00458341|12129727|FG001|NOT COMPLETED|Cycle 1||0
10957383|NCT00458341|12129726|FG000|STARTED|Cycle 2|The participant who did not complete Cycle 1 was eligible for Cycle 2 and completed Cycle 2.|15
10957384|NCT00458341|12129727|FG001|STARTED|Cycle 2||15
10957385|NCT00458341|12129726|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||15
10957386|NCT00458341|12129727|FG001|Received at Least 1 Dose of Study Drug|Cycle 2||15
10957387|NCT00458341|12129726|FG000|COMPLETED|Cycle 2||15
10957388|NCT00458341|12129727|FG001|COMPLETED|Cycle 2||15
10957389|NCT00458341|12129726|FG000|NOT COMPLETED|Cycle 2||0
10957390|NCT00458341|12129727|FG001|NOT COMPLETED|Cycle 2||0
10957391|NCT00458393|12129735|FG000|STARTED|Overall Study||1251
10957392|NCT00458393|12129736|FG001|STARTED|Overall Study||1248
10957393|NCT00458393|12129735|FG000|COMPLETED|Overall Study||942
10957394|NCT00458393|12129736|FG001|COMPLETED|Overall Study||953
10957395|NCT00458393|12129735|FG000|NOT COMPLETED|Overall Study||309
10957396|NCT00458393|12129736|FG001|NOT COMPLETED|Overall Study||295
10957397|NCT00458406|12129746|FG000|STARTED|Month 1||43
10957398|NCT00458406|12129747|FG001|STARTED|Month 1||13
10957399|NCT00458406|12129746|FG000|COMPLETED|Month 1||43
10957400|NCT00458406|12129747|FG001|COMPLETED|Month 1||13
10957401|NCT00458406|12129746|FG000|NOT COMPLETED|Month 1||0
10957402|NCT00458406|12129747|FG001|NOT COMPLETED|Month 1||0
10957403|NCT00458406|12129746|FG000|STARTED|Month 3||43
10957404|NCT00458406|12129747|FG001|STARTED|Month 3||13
10957405|NCT00458406|12129746|FG000|COMPLETED|Month 3||43
10957406|NCT00458406|12129747|FG001|COMPLETED|Month 3||13
10957407|NCT00458406|12129746|FG000|NOT COMPLETED|Month 3||0
10957408|NCT00458406|12129747|FG001|NOT COMPLETED|Month 3||0
10957409|NCT00458484|12129767|FG000|STARTED|Overall Study||4
10957410|NCT00458484|12129768|FG001|STARTED|Overall Study||6
10957411|NCT00458484|12129769|FG002|STARTED|Overall Study||3
10957412|NCT00458484|12129770|FG003|STARTED|Overall Study||6
10957413|NCT00458484|12129771|FG004|STARTED|Overall Study||4
10957414|NCT00458484|12129772|FG005|STARTED|Overall Study||5
10957415|NCT00458484|12129773|FG006|STARTED|Overall Study||3
10957416|NCT00458484|12129767|FG000|COMPLETED|Overall Study||4
10957417|NCT00458484|12129768|FG001|COMPLETED|Overall Study||6
10957418|NCT00458484|12129769|FG002|COMPLETED|Overall Study||3
10957419|NCT00458484|12129770|FG003|COMPLETED|Overall Study||6
10957420|NCT00458484|12129771|FG004|COMPLETED|Overall Study||4
10957421|NCT00458484|12129772|FG005|COMPLETED|Overall Study||4
10957422|NCT00458484|12129773|FG006|COMPLETED|Overall Study||3
10957423|NCT00458484|12129767|FG000|NOT COMPLETED|Overall Study||0
10957424|NCT00458484|12129768|FG001|NOT COMPLETED|Overall Study||0
10957425|NCT00458484|12129769|FG002|NOT COMPLETED|Overall Study||0
10957426|NCT00458484|12129770|FG003|NOT COMPLETED|Overall Study||0
10957427|NCT00458484|12129771|FG004|NOT COMPLETED|Overall Study||0
10957428|NCT00458484|12129772|FG005|NOT COMPLETED|Overall Study||1
10957429|NCT00458484|12129773|FG006|NOT COMPLETED|Overall Study||0
10957430|NCT00458705|12129798|FG000|STARTED|Overall Study||45
10957431|NCT00458705|12129798|FG000|COMPLETED|Overall Study||40
10957432|NCT00458705|12129798|FG000|NOT COMPLETED|Overall Study||5
10957433|NCT00458783|12129804|FG000|STARTED|Overall Study||1914
10957434|NCT00458783|12129805|FG001|STARTED|Overall Study||1921
10957435|NCT00458783|12129804|FG000|COMPLETED|Overall Study||686
10957436|NCT00458783|12129805|FG001|COMPLETED|Overall Study||701
10957437|NCT00458783|12129804|FG000|NOT COMPLETED|Overall Study||1228
10957438|NCT00458783|12129805|FG001|NOT COMPLETED|Overall Study||1220
10957439|NCT00458822|12129811|FG000|STARTED|Overall Study||40
10957440|NCT00458822|12129811|FG000|COMPLETED|Overall Study||40
10957441|NCT00458822|12129811|FG000|NOT COMPLETED|Overall Study||0
10957442|NCT00458848|12129815|FG000|STARTED|Overall Study||51
10957443|NCT00458848|12129815|FG000|COMPLETED|Overall Study||51
10957444|NCT00458848|12129815|FG000|NOT COMPLETED|Overall Study||0
10957445|NCT00458952|12129821|FG000|STARTED|Overall Study||7
10957446|NCT00458952|12129822|FG001|STARTED|Overall Study||14
10957447|NCT00458952|12129821|FG000|COMPLETED|Overall Study||5
10957448|NCT00458952|12129822|FG001|COMPLETED|Overall Study||9
10957449|NCT00458952|12129821|FG000|NOT COMPLETED|Overall Study||2
10957450|NCT00458952|12129822|FG001|NOT COMPLETED|Overall Study||5
10957451|NCT00459043|12129828|FG000|STARTED|Overall Study||15
10957452|NCT00459043|12129829|FG001|STARTED|Overall Study||15
10957453|NCT00459043|12129828|FG000|COMPLETED|Overall Study||14
10957454|NCT00459043|12129829|FG001|COMPLETED|Overall Study||15
10957455|NCT00459043|12129828|FG000|NOT COMPLETED|Overall Study||1
10957456|NCT00459043|12129829|FG001|NOT COMPLETED|Overall Study||0
10957457|NCT00459056|12129837|FG000|STARTED|First Intervention (First Three Months)||10
10957458|NCT00459056|12129838|FG001|STARTED|First Intervention (First Three Months)||15
10957459|NCT00459056|12129837|FG000|COMPLETED|First Intervention (First Three Months)||9
10957460|NCT00459056|12129838|FG001|COMPLETED|First Intervention (First Three Months)||14
10957461|NCT00459056|12129837|FG000|NOT COMPLETED|First Intervention (First Three Months)||1
10957462|NCT00459056|12129838|FG001|NOT COMPLETED|First Intervention (First Three Months)||1
10957463|NCT00459056|12129837|FG000|STARTED|Washout (1 Month)||9
10957464|NCT00459056|12129838|FG001|STARTED|Washout (1 Month)||14
10957465|NCT00459056|12129837|FG000|COMPLETED|Washout (1 Month)||9
10957466|NCT00459056|12129838|FG001|COMPLETED|Washout (1 Month)||14
10957467|NCT00459056|12129837|FG000|NOT COMPLETED|Washout (1 Month)||0
10957468|NCT00459056|12129838|FG001|NOT COMPLETED|Washout (1 Month)||0
10957469|NCT00459056|12129837|FG000|STARTED|Second Intervention (Final Three Months)||9
10957470|NCT00459056|12129838|FG001|STARTED|Second Intervention (Final Three Months)||14
10957471|NCT00459056|12129837|FG000|COMPLETED|Second Intervention (Final Three Months)||9
10957472|NCT00459056|12129838|FG001|COMPLETED|Second Intervention (Final Three Months)||14
10957473|NCT00459056|12129837|FG000|NOT COMPLETED|Second Intervention (Final Three Months)||0
10957474|NCT00459056|12129838|FG001|NOT COMPLETED|Second Intervention (Final Three Months)||0
10957475|NCT00459108|12129844|FG000|STARTED|Overall Study||25
10957476|NCT00459108|12129844|FG000|COMPLETED|Overall Study||14
10957477|NCT00459108|12129844|FG000|NOT COMPLETED|Overall Study||11
10957478|NCT00459134|12129851|FG000|STARTED|Overall Study||94
10957479|NCT00459134|12129852|FG001|STARTED|Overall Study||92
10957480|NCT00459134|12129851|FG000|COMPLETED|Overall Study||71
10957481|NCT00459134|12129852|FG001|COMPLETED|Overall Study||67
10957482|NCT00459134|12129851|FG000|NOT COMPLETED|Overall Study||23
10957483|NCT00459134|12129852|FG001|NOT COMPLETED|Overall Study||25
10957484|NCT00459186|12129858|FG000|STARTED|Single Agent RAD001||19
10957485|NCT00459186|12129858|FG000|COMPLETED|Single Agent RAD001||18
10957486|NCT00459186|12129858|FG000|NOT COMPLETED|Single Agent RAD001||1
10957487|NCT00459186|12129858|FG000|STARTED|PET Imaging and Assessment||18
10957488|NCT00459186|12129858|FG000|COMPLETED|PET Imaging and Assessment||15
10957489|NCT00459186|12129858|FG000|NOT COMPLETED|PET Imaging and Assessment||3
10957490|NCT00459186|12129858|FG000|STARTED|Combination RAD001 + Docetaxel||15
10957491|NCT00459186|12129858|FG000|COMPLETED|Combination RAD001 + Docetaxel||15
10957492|NCT00459186|12129858|FG000|NOT COMPLETED|Combination RAD001 + Docetaxel||0
10957493|NCT00459290|12129862|FG000|STARTED|Overall Study||24
10957494|NCT00459290|12129862|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
10957495|NCT00459290|12129862|FG000|NOT COMPLETED|Overall Study||5
10957496|NCT00459303|12129873|FG000|STARTED|Overall Study||20
10957497|NCT00459303|12129873|FG000|COMPLETED|Overall Study||20
10957498|NCT00459303|12129873|FG000|NOT COMPLETED|Overall Study||0
10957499|NCT00459316|12129885|FG000|STARTED|Steps 1 & 2||280
10957500|NCT00459316|12129886|FG001|STARTED|Steps 1 & 2||39
10957501|NCT00459316|12129887|FG002|STARTED|Steps 1 & 2||59
10957502|NCT00459316|12129885|FG000|COMPLETED|Steps 1 & 2||259
10957503|NCT00459316|12129886|FG001|COMPLETED|Steps 1 & 2||32
10957504|NCT00459316|12129887|FG002|COMPLETED|Steps 1 & 2||57
10957505|NCT00459316|12129885|FG000|NOT COMPLETED|Steps 1 & 2||21
10957506|NCT00459316|12129886|FG001|NOT COMPLETED|Steps 1 & 2||7
10957507|NCT00459316|12129887|FG002|NOT COMPLETED|Steps 1 & 2||2
10957508|NCT00459316|12129885|FG000|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
10957509|NCT00459316|12129886|FG001|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
10957510|NCT00459316|12129887|FG002|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
10957511|NCT00459316|12129885|FG000|COMPLETED|Step 3||149
10957512|NCT00459316|12129886|FG001|COMPLETED|Step 3||0
10957513|NCT00459316|12129887|FG002|COMPLETED|Step 3||39
10957514|NCT00459316|12129885|FG000|NOT COMPLETED|Step 3||3
10957515|NCT00459316|12129886|FG001|NOT COMPLETED|Step 3||0
10957516|NCT00459316|12129887|FG002|NOT COMPLETED|Step 3||1
10957517|NCT00459342|12129910|FG000|STARTED|Overall Study||35
10957518|NCT00459342|12129910|FG000|COMPLETED|Overall Study||34
10957519|NCT00459342|12129910|FG000|NOT COMPLETED|Overall Study||1
10957520|NCT00459355|12129916|FG000|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
10957521|NCT00459355|12129917|FG001|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
10957522|NCT00459355|12129916|FG000|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
10957523|NCT00459355|12129917|FG001|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
10957524|NCT00459355|12129916|FG000|NOT COMPLETED|Overall Study||20
10957525|NCT00459355|12129917|FG001|NOT COMPLETED|Overall Study||18
10957526|NCT00459368|12129929|FG000|STARTED|Overall Study||1335
10957527|NCT00459368|12129930|FG001|STARTED|Overall Study||1363
10957528|NCT00459368|12129929|FG000|COMPLETED|Overall Study||1040
10957529|NCT00459368|12129930|FG001|COMPLETED|Overall Study||1034
10957530|NCT00459368|12129929|FG000|NOT COMPLETED|Overall Study||295
10957531|NCT00459368|12129930|FG001|NOT COMPLETED|Overall Study||329
10957532|NCT00459381|12129936|FG000|STARTED|Overall Study||35
10957533|NCT00459381|12129936|FG000|COMPLETED|Overall Study||35
10957534|NCT00459381|12129936|FG000|NOT COMPLETED|Overall Study||0
10957535|NCT00459537|12129942|FG000|STARTED|Overall Study||507
10957536|NCT00459537|12129943|FG001|STARTED|Overall Study||522
10957537|NCT00459537|12129942|FG000|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
10957538|NCT00459537|12129943|FG001|Safety Population|Overall Study||512
10957539|NCT00459537|12129942|FG000|COMPLETED|Overall Study||441
10957540|NCT00459537|12129943|FG001|COMPLETED|Overall Study||446
10957541|NCT00459537|12129942|FG000|NOT COMPLETED|Overall Study||66
10957542|NCT00459537|12129943|FG001|NOT COMPLETED|Overall Study||76
10957543|NCT00459667|12129952|FG000|STARTED|Overall Study||592
10957544|NCT00459667|12129953|FG001|STARTED|Overall Study||647
10957545|NCT00459667|12129954|FG002|STARTED|Overall Study||181
10957546|NCT00459667|12129952|FG000|Study Medication Dispensed|Overall Study||586
10957547|NCT00459667|12129953|FG001|Study Medication Dispensed|Overall Study||645
10957548|NCT00459667|12129954|FG002|Study Medication Dispensed|Overall Study||180
10957549|NCT00459667|12129952|FG000|Started Treatment|Overall Study||586
10957550|NCT00459667|12129953|FG001|Started Treatment|Overall Study||644
10957551|NCT00459667|12129954|FG002|Started Treatment|Overall Study||180
10957552|NCT00459667|12129952|FG000|COMPLETED|Overall Study||554
10957553|NCT00459667|12129953|FG001|COMPLETED|Overall Study||600
10957554|NCT00459667|12129954|FG002|COMPLETED|Overall Study||161
10957555|NCT00459667|12129952|FG000|NOT COMPLETED|Overall Study||38
10957556|NCT00459667|12129953|FG001|NOT COMPLETED|Overall Study||47
10957557|NCT00459667|12129954|FG002|NOT COMPLETED|Overall Study||20
10957558|NCT00459706|12129964|FG000|STARTED|Overall Study||325
10957559|NCT00459706|12129965|FG001|STARTED|Overall Study||315
10957560|NCT00459706|12129964|FG000|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
10957561|NCT00459706|12129965|FG001|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
10957562|NCT00459706|12129964|FG000|COMPLETED|Overall Study||299
10957563|NCT00459706|12129965|FG001|COMPLETED|Overall Study||294
10957564|NCT00459706|12129964|FG000|NOT COMPLETED|Overall Study||26
10957565|NCT00459706|12129965|FG001|NOT COMPLETED|Overall Study||21
10957566|NCT00459732|12129973|FG000|STARTED|Overall Study||23
10957567|NCT00459732|12129974|FG001|STARTED|Overall Study||17
10957568|NCT00459732|12129973|FG000|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
10957569|NCT00459732|12129974|FG001|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
10957570|NCT00459732|12129973|FG000|NOT COMPLETED|Overall Study||4
10957571|NCT00459732|12129974|FG001|NOT COMPLETED|Overall Study||3
10957572|NCT00459810|12129980|FG000|STARTED|Overall Study||21
10957573|NCT00459810|12129980|FG000|COMPLETED|Overall Study||21
10957574|NCT00459810|12129980|FG000|NOT COMPLETED|Overall Study||0
10957575|NCT00459862|12129984|FG000|STARTED|Overall Study||34
10957576|NCT00459862|12129984|FG000|COMPLETED|Overall Study||34
10957577|NCT00459862|12129984|FG000|NOT COMPLETED|Overall Study||0
10957578|NCT00459875|12129988|FG000|STARTED|Overall Study||24
10957579|NCT00459875|12129988|FG000|COMPLETED|Overall Study||21
10957580|NCT00459875|12129988|FG000|NOT COMPLETED|Overall Study||3
10957581|NCT00459953|12129994|FG000|STARTED|Overall Study||72
10957582|NCT00459953|12129995|FG001|STARTED|Overall Study||71
10957583|NCT00459953|12129994|FG000|COMPLETED|Overall Study||71
10957584|NCT00459953|12129995|FG001|COMPLETED|Overall Study||70
10957585|NCT00459953|12129994|FG000|NOT COMPLETED|Overall Study||1
10957586|NCT00459953|12129995|FG001|NOT COMPLETED|Overall Study||1
10957587|NCT00459979|12130001|FG000|STARTED|Overall Study||30
10957588|NCT00459979|12130001|FG000|COMPLETED|Overall Study||28
10957589|NCT00459979|12130001|FG000|NOT COMPLETED|Overall Study||2
10957590|NCT00460031|12130005|FG000|STARTED|Overall Study||34
10957591|NCT00460031|12130005|FG000|COMPLETED|Overall Study||23
10957592|NCT00460031|12130005|FG000|NOT COMPLETED|Overall Study||11
10957593|NCT00460109|12130009|FG000|STARTED|Overall Study||24
10957594|NCT00460109|12130009|FG000|COMPLETED|Overall Study||23
10957595|NCT00460109|12130009|FG000|NOT COMPLETED|Overall Study||1
10957596|NCT00460239|12130013|FG000|STARTED|Overall Study||0
10957597|NCT00460239|12130014|FG001|STARTED|Overall Study||3
10957598|NCT00460239|12130015|FG002|STARTED|Overall Study||1
10957599|NCT00460239|12130016|FG003|STARTED|Overall Study||0
10957600|NCT00460239|12130017|FG004|STARTED|Overall Study||1
10957601|NCT00460239|12130018|FG005|STARTED|Overall Study||4
10957602|NCT00460239|12130019|FG006|STARTED|Overall Study||1
10957603|NCT00460239|12130020|FG007|STARTED|Overall Study||1
10957604|NCT00460239|12130021|FG008|STARTED|Overall Study||1
10957605|NCT00460239|12130013|FG000|COMPLETED|Overall Study||0
10957606|NCT00460239|12130014|FG001|COMPLETED|Overall Study||2
10957607|NCT00460239|12130015|FG002|COMPLETED|Overall Study||1
10957608|NCT00460239|12130016|FG003|COMPLETED|Overall Study||0
10957609|NCT00460239|12130017|FG004|COMPLETED|Overall Study||1
10957610|NCT00460239|12130018|FG005|COMPLETED|Overall Study||1
10957611|NCT00460239|12130019|FG006|COMPLETED|Overall Study||1
10957612|NCT00460239|12130020|FG007|COMPLETED|Overall Study||1
10957613|NCT00460239|12130021|FG008|COMPLETED|Overall Study||1
10957614|NCT00460239|12130013|FG000|NOT COMPLETED|Overall Study||0
10957615|NCT00460239|12130014|FG001|NOT COMPLETED|Overall Study||1
10957616|NCT00460239|12130015|FG002|NOT COMPLETED|Overall Study||0
10957617|NCT00460239|12130016|FG003|NOT COMPLETED|Overall Study||0
10957618|NCT00460239|12130017|FG004|NOT COMPLETED|Overall Study||0
10957619|NCT00460239|12130018|FG005|NOT COMPLETED|Overall Study||3
10957620|NCT00460239|12130019|FG006|NOT COMPLETED|Overall Study||0
10957621|NCT00460239|12130020|FG007|NOT COMPLETED|Overall Study||0
10957622|NCT00460239|12130021|FG008|NOT COMPLETED|Overall Study||0
10957623|NCT00460265|12130036|FG000|STARTED|Overall Study||328
10957624|NCT00460265|12130037|FG001|STARTED|Overall Study||330
10957625|NCT00460265|12130036|FG000|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
10957626|NCT00460265|12130037|FG001|Randomized While Alive|Overall Study||330
10957627|NCT00460265|12130036|FG000|Received Study Medication|Overall Study||325
10957628|NCT00460265|12130037|FG001|Received Study Medication|Overall Study||325
10957629|NCT00460265|12130036|FG000|COMPLETED|Overall Study|Completed study=death|243
10957630|NCT00460265|12130037|FG001|COMPLETED|Overall Study|Completed study=death|241
10957631|NCT00460265|12130036|FG000|NOT COMPLETED|Overall Study||85
10957632|NCT00460265|12130037|FG001|NOT COMPLETED|Overall Study||89
10957633|NCT00460408|12130047|FG000|STARTED|Overall Study||403
10957634|NCT00460408|12130048|FG001|STARTED|Overall Study||16
10957635|NCT00460408|12130049|FG002|STARTED|Overall Study||75
10957636|NCT00460408|12130050|FG003|STARTED|Overall Study||7
10957637|NCT00460408|12130047|FG000|COMPLETED|Overall Study||336
10957638|NCT00460408|12130048|FG001|COMPLETED|Overall Study||13
10957639|NCT00460408|12130049|FG002|COMPLETED|Overall Study||69
10957640|NCT00460408|12130050|FG003|COMPLETED|Overall Study||7
10957641|NCT00460408|12130047|FG000|NOT COMPLETED|Overall Study||67
10957642|NCT00460408|12130048|FG001|NOT COMPLETED|Overall Study||3
10957643|NCT00460408|12130049|FG002|NOT COMPLETED|Overall Study||6
10957644|NCT00460408|12130050|FG003|NOT COMPLETED|Overall Study||0
10957645|NCT00460421|12130063|FG000|STARTED|Overall Study||9
10957646|NCT00460421|12130064|FG001|STARTED|Overall Study||9
10957647|NCT00460421|12130065|FG002|STARTED|Overall Study||9
10957648|NCT00460421|12130063|FG000|COMPLETED|Overall Study||9
10957649|NCT00460421|12130064|FG001|COMPLETED|Overall Study||9
10957650|NCT00460421|12130065|FG002|COMPLETED|Overall Study||9
10957651|NCT00460421|12130063|FG000|NOT COMPLETED|Overall Study||0
10957652|NCT00460421|12130064|FG001|NOT COMPLETED|Overall Study||0
10957653|NCT00460421|12130065|FG002|NOT COMPLETED|Overall Study||0
10957654|NCT00460434|12130074|FG000|STARTED|Overall Study||165
10957655|NCT00460434|12130075|FG001|STARTED|Overall Study||172
10957656|NCT00460434|12130074|FG000|3 Months|Overall Study||163
10957657|NCT00460434|12130075|FG001|3 Months|Overall Study||171
10957658|NCT00460434|12130074|FG000|12 Months|Overall Study||162
10957659|NCT00460434|12130075|FG001|12 Months|Overall Study||165
10957660|NCT00460434|12130074|FG000|COMPLETED|Overall Study||162
10957661|NCT00460434|12130075|FG001|COMPLETED|Overall Study||165
10957662|NCT00460434|12130074|FG000|NOT COMPLETED|Overall Study||3
10957663|NCT00460434|12130075|FG001|NOT COMPLETED|Overall Study||7
10957664|NCT00460525|12130083|FG000|STARTED|Overall Study||201
10957665|NCT00460525|12130084|FG001|STARTED|Overall Study||199
10957666|NCT00460525|12130083|FG000|COMPLETED|Overall Study||190
10957667|NCT00460525|12130084|FG001|COMPLETED|Overall Study||194
10957668|NCT00460525|12130083|FG000|NOT COMPLETED|Overall Study||11
10957669|NCT00460525|12130084|FG001|NOT COMPLETED|Overall Study||5
10957670|NCT00460551|12130090|FG000|STARTED|Overall Study||13
10957671|NCT00460551|12130090|FG000|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
10957672|NCT00460551|12130090|FG000|NOT COMPLETED|Overall Study||0
10957673|NCT00460564|12130098|FG000|STARTED|Double-Blind Phase (12 Weeks)||51
10957674|NCT00460564|12130099|FG001|STARTED|Double-Blind Phase (12 Weeks)||26
10957675|NCT00460564|12130100|FG002|STARTED|Double-Blind Phase (12 Weeks)||21
10957676|NCT00460564|12130101|FG003|STARTED|Double-Blind Phase (12 Weeks)||11
10957677|NCT00460564|12130102|FG004|STARTED|Double-Blind Phase (12 Weeks)||0
10957678|NCT00460564|12130103|FG005|STARTED|Double-Blind Phase (12 Weeks)||0
10957679|NCT00460564|12130104|FG006|STARTED|Double-Blind Phase (12 Weeks)||0
10957680|NCT00460564|12130105|FG007|STARTED|Double-Blind Phase (12 Weeks)||0
10957681|NCT00460564|12130098|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||47
10957682|NCT00460564|12130099|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||25
10957683|NCT00460564|12130100|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||21
10957684|NCT00460564|12130101|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||11
10957685|NCT00460564|12130102|FG004|COMPLETED|Double-Blind Phase (12 Weeks)||0
10957686|NCT00460564|12130103|FG005|COMPLETED|Double-Blind Phase (12 Weeks)||0
10957687|NCT00460564|12130104|FG006|COMPLETED|Double-Blind Phase (12 Weeks)||0
10957688|NCT00460564|12130105|FG007|COMPLETED|Double-Blind Phase (12 Weeks)||0
10957689|NCT00460564|12130098|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
10957690|NCT00460564|12130099|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
10957691|NCT00460564|12130100|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10957692|NCT00460564|12130101|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10957693|NCT00460564|12130102|FG004|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10957694|NCT00460564|12130103|FG005|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10957695|NCT00460564|12130104|FG006|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10957696|NCT00460564|12130105|FG007|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10957697|NCT00460564|12130098|FG000|STARTED|Open-Label Phase (36 Weeks)||0
10957698|NCT00460564|12130099|FG001|STARTED|Open-Label Phase (36 Weeks)||0
10957699|NCT00460564|12130100|FG002|STARTED|Open-Label Phase (36 Weeks)||0
10957700|NCT00460564|12130101|FG003|STARTED|Open-Label Phase (36 Weeks)||0
10957701|NCT00460564|12130102|FG004|STARTED|Open-Label Phase (36 Weeks)||47
10957702|NCT00460564|12130103|FG005|STARTED|Open-Label Phase (36 Weeks)||25
10957703|NCT00460564|12130104|FG006|STARTED|Open-Label Phase (36 Weeks)||21
10957704|NCT00460564|12130105|FG007|STARTED|Open-Label Phase (36 Weeks)||11
10957705|NCT00460564|12130098|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0
10957706|NCT00460564|12130099|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0
10957707|NCT00460564|12130100|FG002|COMPLETED|Open-Label Phase (36 Weeks)||0
10957708|NCT00460564|12130101|FG003|COMPLETED|Open-Label Phase (36 Weeks)||0
10957709|NCT00460564|12130102|FG004|COMPLETED|Open-Label Phase (36 Weeks)||38
10957710|NCT00460564|12130103|FG005|COMPLETED|Open-Label Phase (36 Weeks)||19
10957711|NCT00460564|12130104|FG006|COMPLETED|Open-Label Phase (36 Weeks)||19
10957712|NCT00460564|12130105|FG007|COMPLETED|Open-Label Phase (36 Weeks)||11
10957713|NCT00460564|12130098|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10957714|NCT00460564|12130099|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10957715|NCT00460564|12130100|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10957716|NCT00460564|12130101|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10957717|NCT00460564|12130102|FG004|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
10957718|NCT00460564|12130103|FG005|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
10957719|NCT00460564|12130104|FG006|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
10957720|NCT00460564|12130105|FG007|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10957721|NCT00460577|12130127|FG000|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
10957722|NCT00460577|12130128|FG001|STARTED|Overall Study||30
10957723|NCT00460577|12130127|FG000|COMPLETED|Overall Study||28
10957724|NCT00460577|12130128|FG001|COMPLETED|Overall Study||24
10957725|NCT00460577|12130127|FG000|NOT COMPLETED|Overall Study||2
10957726|NCT00460577|12130128|FG001|NOT COMPLETED|Overall Study||6
10957727|NCT00460603|12130146|FG000|STARTED|Phase 1||6
10957728|NCT00460603|12130147|FG001|STARTED|Phase 1||6
10957729|NCT00460603|12130148|FG002|STARTED|Phase 1||4
10957730|NCT00460603|12130149|FG003|STARTED|Phase 1||8
10957731|NCT00460603|12130150|FG004|STARTED|Phase 1||6
10957732|NCT00460603|12130151|FG005|STARTED|Phase 1||4
10957733|NCT00460603|12130152|FG006|STARTED|Phase 1||6
10957734|NCT00460603|12130153|FG007|STARTED|Phase 1||3
10957735|NCT00460603|12130154|FG008|STARTED|Phase 1||18
10957736|NCT00460603|12130155|FG009|STARTED|Phase 1||0
10957737|NCT00460603|12130156|FG010|STARTED|Phase 1||0
10957738|NCT00460603|12130157|FG011|STARTED|Phase 1||0
10957739|NCT00460603|12130146|FG000|COMPLETED|Phase 1||0
10957740|NCT00460603|12130147|FG001|COMPLETED|Phase 1||0
10957741|NCT00460603|12130148|FG002|COMPLETED|Phase 1||0
10957742|NCT00460603|12130149|FG003|COMPLETED|Phase 1||0
10957743|NCT00460603|12130150|FG004|COMPLETED|Phase 1||0
10957744|NCT00460603|12130151|FG005|COMPLETED|Phase 1||0
10957745|NCT00460603|12130152|FG006|COMPLETED|Phase 1||0
10957746|NCT00460603|12130153|FG007|COMPLETED|Phase 1||0
10957747|NCT00460603|12130154|FG008|COMPLETED|Phase 1||0
10957748|NCT00460603|12130155|FG009|COMPLETED|Phase 1||0
10957749|NCT00460603|12130156|FG010|COMPLETED|Phase 1||0
10957750|NCT00460603|12130157|FG011|COMPLETED|Phase 1||0
10957751|NCT00460603|12130146|FG000|NOT COMPLETED|Phase 1||6
10957752|NCT00460603|12130147|FG001|NOT COMPLETED|Phase 1||6
10957753|NCT00460603|12130148|FG002|NOT COMPLETED|Phase 1||4
10957754|NCT00460603|12130149|FG003|NOT COMPLETED|Phase 1||8
10957755|NCT00460603|12130150|FG004|NOT COMPLETED|Phase 1||6
10957756|NCT00460603|12130151|FG005|NOT COMPLETED|Phase 1||4
10957757|NCT00460603|12130152|FG006|NOT COMPLETED|Phase 1||6
10957758|NCT00460603|12130153|FG007|NOT COMPLETED|Phase 1||3
10957759|NCT00460603|12130154|FG008|NOT COMPLETED|Phase 1||18
10957760|NCT00460603|12130155|FG009|NOT COMPLETED|Phase 1||0
10957761|NCT00460603|12130156|FG010|NOT COMPLETED|Phase 1||0
10957762|NCT00460603|12130157|FG011|NOT COMPLETED|Phase 1||0
10957763|NCT00460603|12130146|FG000|STARTED|Phase 2||0
10957764|NCT00460603|12130147|FG001|STARTED|Phase 2||0
10957765|NCT00460603|12130148|FG002|STARTED|Phase 2||0
10957766|NCT00460603|12130149|FG003|STARTED|Phase 2||0
10957767|NCT00460603|12130150|FG004|STARTED|Phase 2||0
10957768|NCT00460603|12130151|FG005|STARTED|Phase 2||0
10957769|NCT00460603|12130152|FG006|STARTED|Phase 2||0
10957770|NCT00460603|12130153|FG007|STARTED|Phase 2||0
10957771|NCT00460603|12130154|FG008|STARTED|Phase 2||0
10957772|NCT00460603|12130155|FG009|STARTED|Phase 2||42
10957773|NCT00460603|12130156|FG010|STARTED|Phase 2||43
10957774|NCT00460603|12130157|FG011|STARTED|Phase 2||41
10957775|NCT00460603|12130146|FG000|Treated|Phase 2||0
10957776|NCT00460603|12130147|FG001|Treated|Phase 2||0
10957777|NCT00460603|12130148|FG002|Treated|Phase 2||0
10957778|NCT00460603|12130149|FG003|Treated|Phase 2||0
10957779|NCT00460603|12130150|FG004|Treated|Phase 2||0
10957780|NCT00460603|12130151|FG005|Treated|Phase 2||0
10957781|NCT00460603|12130152|FG006|Treated|Phase 2||0
10957782|NCT00460603|12130153|FG007|Treated|Phase 2||0
10957783|NCT00460603|12130154|FG008|Treated|Phase 2||0
10957784|NCT00460603|12130155|FG009|Treated|Phase 2||39
10957785|NCT00460603|12130156|FG010|Treated|Phase 2||43
10957786|NCT00460603|12130157|FG011|Treated|Phase 2||41
10957787|NCT00460603|12130146|FG000|COMPLETED|Phase 2||0
10957788|NCT00460603|12130147|FG001|COMPLETED|Phase 2||0
10957789|NCT00460603|12130148|FG002|COMPLETED|Phase 2||0
10957790|NCT00460603|12130149|FG003|COMPLETED|Phase 2||0
10957791|NCT00460603|12130150|FG004|COMPLETED|Phase 2||0
10957792|NCT00460603|12130151|FG005|COMPLETED|Phase 2||0
10957793|NCT00460603|12130152|FG006|COMPLETED|Phase 2||0
10957794|NCT00460603|12130153|FG007|COMPLETED|Phase 2||0
10957795|NCT00460603|12130154|FG008|COMPLETED|Phase 2||0
10957796|NCT00460603|12130155|FG009|COMPLETED|Phase 2||0
10957797|NCT00460603|12130156|FG010|COMPLETED|Phase 2||0
10957798|NCT00460603|12130157|FG011|COMPLETED|Phase 2||0
10957799|NCT00460603|12130146|FG000|NOT COMPLETED|Phase 2||0
10957800|NCT00460603|12130147|FG001|NOT COMPLETED|Phase 2||0
10957801|NCT00460603|12130148|FG002|NOT COMPLETED|Phase 2||0
10957802|NCT00460603|12130149|FG003|NOT COMPLETED|Phase 2||0
10957803|NCT00460603|12130150|FG004|NOT COMPLETED|Phase 2||0
10957804|NCT00460603|12130151|FG005|NOT COMPLETED|Phase 2||0
10957805|NCT00460603|12130152|FG006|NOT COMPLETED|Phase 2||0
10957806|NCT00460603|12130153|FG007|NOT COMPLETED|Phase 2||0
10957807|NCT00460603|12130154|FG008|NOT COMPLETED|Phase 2||0
10957808|NCT00460603|12130155|FG009|NOT COMPLETED|Phase 2||42
10957809|NCT00460603|12130156|FG010|NOT COMPLETED|Phase 2||43
10957810|NCT00460603|12130157|FG011|NOT COMPLETED|Phase 2||41
10957811|NCT00460655|12130185|FG000|STARTED|Double-Blind Phase (12 Weeks)||58
10957812|NCT00460655|12130186|FG001|STARTED|Double-Blind Phase (12 Weeks)||62
10957813|NCT00460655|12130187|FG002|STARTED|Double-Blind Phase (12 Weeks)||0
10957814|NCT00460655|12130188|FG003|STARTED|Double-Blind Phase (12 Weeks)||0
10957815|NCT00460655|12130185|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||52
10957816|NCT00460655|12130186|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||61
10957817|NCT00460655|12130187|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||0
10957818|NCT00460655|12130188|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||0
10957819|NCT00460655|12130185|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
10957820|NCT00460655|12130186|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
10957821|NCT00460655|12130187|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10957822|NCT00460655|12130188|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
10957823|NCT00460655|12130185|FG000|STARTED|Open-Label Phase (36 Weeks)||0
10957824|NCT00460655|12130186|FG001|STARTED|Open-Label Phase (36 Weeks)||0
10957825|NCT00460655|12130187|FG002|STARTED|Open-Label Phase (36 Weeks)||52
10957826|NCT00460655|12130188|FG003|STARTED|Open-Label Phase (36 Weeks)||61
10957827|NCT00460655|12130185|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0
10957828|NCT00460655|12130186|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0
10957829|NCT00460655|12130187|FG002|COMPLETED|Open-Label Phase (36 Weeks)||45
10957830|NCT00460655|12130188|FG003|COMPLETED|Open-Label Phase (36 Weeks)||52
10957831|NCT00460655|12130185|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10957832|NCT00460655|12130186|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
10957833|NCT00460655|12130187|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
10957834|NCT00460655|12130188|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
10957835|NCT00460746|12130198|FG000|STARTED|Overall Study||10
10957836|NCT00460746|12130198|FG000|COMPLETED|Overall Study||8
10957837|NCT00460746|12130198|FG000|NOT COMPLETED|Overall Study||2
10957838|NCT00460798|12130202|FG000|STARTED|Overall Study||448
10957839|NCT00460798|12130202|FG000|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
10957840|NCT00460798|12130202|FG000|COMPLETED|Overall Study||108
10957841|NCT00460798|12130202|FG000|NOT COMPLETED|Overall Study||340
10957842|NCT00460811|12130211|FG000|STARTED|Overall Study||79
10957843|NCT00460811|12130212|FG001|STARTED|Overall Study||82
10957844|NCT00460811|12130213|FG002|STARTED|Overall Study||85
10957845|NCT00460811|12130214|FG003|STARTED|Overall Study||89
10957846|NCT00460811|12130215|FG004|STARTED|Overall Study||85
10957847|NCT00460811|12130211|FG000|COMPLETED|Overall Study||63
10957848|NCT00460811|12130212|FG001|COMPLETED|Overall Study||67
10957849|NCT00460811|12130213|FG002|COMPLETED|Overall Study||71
10957850|NCT00460811|12130214|FG003|COMPLETED|Overall Study||71
10957851|NCT00460811|12130215|FG004|COMPLETED|Overall Study||65
10957852|NCT00460811|12130211|FG000|NOT COMPLETED|Overall Study||16
10957853|NCT00460811|12130212|FG001|NOT COMPLETED|Overall Study||15
10957854|NCT00460811|12130213|FG002|NOT COMPLETED|Overall Study||14
10957855|NCT00460811|12130214|FG003|NOT COMPLETED|Overall Study||18
10957856|NCT00460811|12130215|FG004|NOT COMPLETED|Overall Study||20
10957857|NCT00460993|12130234|FG000|STARTED|Phase 1 (6 Days)||14
10957858|NCT00460993|12130235|FG001|STARTED|Phase 1 (6 Days)||17
10957859|NCT00460993|12130234|FG000|COMPLETED|Phase 1 (6 Days)||14
10957860|NCT00460993|12130235|FG001|COMPLETED|Phase 1 (6 Days)||17
10957861|NCT00460993|12130234|FG000|NOT COMPLETED|Phase 1 (6 Days)||0
10957862|NCT00460993|12130235|FG001|NOT COMPLETED|Phase 1 (6 Days)||0
10957863|NCT00460993|12130234|FG000|STARTED|Phase 2 (6 Days)||14
10957864|NCT00460993|12130235|FG001|STARTED|Phase 2 (6 Days)||17
10957865|NCT00460993|12130234|FG000|COMPLETED|Phase 2 (6 Days)||14
10957866|NCT00460993|12130235|FG001|COMPLETED|Phase 2 (6 Days)||17
10957867|NCT00460993|12130234|FG000|NOT COMPLETED|Phase 2 (6 Days)||0
10957868|NCT00460993|12130235|FG001|NOT COMPLETED|Phase 2 (6 Days)||0
10957869|NCT00461045|12130241|FG000|STARTED|Overall Study||15
10957870|NCT00461045|12130241|FG000|COMPLETED|Overall Study||15
10957871|NCT00461045|12130241|FG000|NOT COMPLETED|Overall Study||0
10957872|NCT00461097|12130247|FG000|STARTED|Overall Study||40
10957873|NCT00461097|12130248|FG001|STARTED|Overall Study||15
10957874|NCT00461097|12130247|FG000|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
10957875|NCT00461097|12130248|FG001|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
10957876|NCT00461097|12130247|FG000|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
10957877|NCT00461097|12130248|FG001|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
10957878|NCT00461097|12130247|FG000|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
10957879|NCT00461097|12130248|FG001|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
10957880|NCT00461097|12130247|FG000|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
10957881|NCT00461097|12130248|FG001|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
10957882|NCT00461097|12130247|FG000|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
10957883|NCT00461097|12130248|FG001|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
10957884|NCT00461097|12130247|FG000|NOT COMPLETED|Overall Study||0
10957885|NCT00461097|12130248|FG001|NOT COMPLETED|Overall Study||0
10957886|NCT00461123|12130257|FG000|STARTED|Overall Study||25
10957887|NCT00461123|12130258|FG001|STARTED|Overall Study||25
10957888|NCT00461123|12130257|FG000|COMPLETED|Overall Study||19
10957889|NCT00461123|12130258|FG001|COMPLETED|Overall Study||19
10957890|NCT00461123|12130257|FG000|NOT COMPLETED|Overall Study||6
10957891|NCT00461123|12130258|FG001|NOT COMPLETED|Overall Study||6
10957892|NCT00461175|12130266|FG000|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
10957893|NCT00461175|12130267|FG001|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
10957894|NCT00461175|12130266|FG000|COMPLETED|Overall Study||43078
10957895|NCT00461175|12130267|FG001|COMPLETED|Overall Study||18370
10957896|NCT00461175|12130266|FG000|NOT COMPLETED|Overall Study||522
10957897|NCT00461175|12130267|FG001|NOT COMPLETED|Overall Study||365
10957898|NCT00461253|12130275|FG000|STARTED|Overall Study|Identified cases|10093
10957899|NCT00461253|12130276|FG001|STARTED|Overall Study|Identified controls|40250
10957900|NCT00461253|12130275|FG000|COMPLETED|Overall Study|Analyzed cases|5113
10957901|NCT00461253|12130276|FG001|COMPLETED|Overall Study|Analyzed controls|20452
10957902|NCT00461253|12130275|FG000|NOT COMPLETED|Overall Study||4980
10957903|NCT00461253|12130276|FG001|NOT COMPLETED|Overall Study||19798
10957904|NCT00461292|12130285|FG000|STARTED|Treatment Cycle 1||91
10957905|NCT00461292|12130286|FG001|STARTED|Treatment Cycle 1||92
10957906|NCT00461292|12130287|FG002|STARTED|Treatment Cycle 1||92
10957907|NCT00461292|12130285|FG000|COMPLETED|Treatment Cycle 1||76
10957908|NCT00461292|12130286|FG001|COMPLETED|Treatment Cycle 1||80
10957909|NCT00461292|12130287|FG002|COMPLETED|Treatment Cycle 1||81
10957910|NCT00461292|12130285|FG000|NOT COMPLETED|Treatment Cycle 1||15
10957911|NCT00461292|12130286|FG001|NOT COMPLETED|Treatment Cycle 1||12
10957912|NCT00461292|12130287|FG002|NOT COMPLETED|Treatment Cycle 1||11
10957913|NCT00461292|12130285|FG000|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
10957914|NCT00461292|12130286|FG001|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
10957915|NCT00461292|12130287|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
10957916|NCT00461292|12130285|FG000|COMPLETED|Treatment Cycle 2||58
10957917|NCT00461292|12130286|FG001|COMPLETED|Treatment Cycle 2||72
10957918|NCT00461292|12130287|FG002|COMPLETED|Treatment Cycle 2||0
10957919|NCT00461292|12130285|FG000|NOT COMPLETED|Treatment Cycle 2||5
10957920|NCT00461292|12130286|FG001|NOT COMPLETED|Treatment Cycle 2||2
10957921|NCT00461292|12130287|FG002|NOT COMPLETED|Treatment Cycle 2||0
10957922|NCT00461305|12130297|FG000|STARTED|Treatment|Enrolled|355
10957923|NCT00461305|12130298|FG001|STARTED|Treatment|Enrolled|65
10957924|NCT00461305|12130297|FG000|Subjects Dispensed Drugs|Treatment||350
10957925|NCT00461305|12130298|FG001|Subjects Dispensed Drugs|Treatment||65
10957926|NCT00461305|12130297|FG000|Subjects Received Treatment|Treatment|FAS, safety population|349
10957927|NCT00461305|12130298|FG001|Subjects Received Treatment|Treatment|FAS, safety population|65
10957928|NCT00461305|12130297|FG000|COMPLETED|Treatment||254
10957929|NCT00461305|12130298|FG001|COMPLETED|Treatment||56
10957930|NCT00461305|12130297|FG000|NOT COMPLETED|Treatment||101
10957931|NCT00461305|12130298|FG001|NOT COMPLETED|Treatment||9
10957932|NCT00461305|12130297|FG000|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
10957933|NCT00461305|12130298|FG001|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
10957934|NCT00461305|12130297|FG000|COMPLETED|Continued Treatment||254
10957935|NCT00461305|12130298|FG001|COMPLETED|Continued Treatment||0
10957936|NCT00461305|12130297|FG000|NOT COMPLETED|Continued Treatment||95
10957937|NCT00461305|12130298|FG001|NOT COMPLETED|Continued Treatment||0
10957938|NCT00461331|12130305|FG000|STARTED|Intervention 1||10
10957939|NCT00461331|12130306|FG001|STARTED|Intervention 1||10
10957940|NCT00461331|12130305|FG000|COMPLETED|Intervention 1||10
10957941|NCT00461331|12130306|FG001|COMPLETED|Intervention 1||10
10957942|NCT00461331|12130305|FG000|NOT COMPLETED|Intervention 1||0
10957943|NCT00461331|12130306|FG001|NOT COMPLETED|Intervention 1||0
10957944|NCT00461331|12130305|FG000|STARTED|Washout||10
10957945|NCT00461331|12130306|FG001|STARTED|Washout||10
10957946|NCT00461331|12130305|FG000|COMPLETED|Washout||10
10957947|NCT00461331|12130306|FG001|COMPLETED|Washout||10
10957948|NCT00461331|12130305|FG000|NOT COMPLETED|Washout||0
10957949|NCT00461331|12130306|FG001|NOT COMPLETED|Washout||0
10957950|NCT00461331|12130305|FG000|STARTED|Intervention 2||10
10957951|NCT00461331|12130306|FG001|STARTED|Intervention 2||10
10957952|NCT00461331|12130305|FG000|COMPLETED|Intervention 2||10
10957953|NCT00461331|12130306|FG001|COMPLETED|Intervention 2||10
10957954|NCT00461331|12130305|FG000|NOT COMPLETED|Intervention 2||0
10957955|NCT00461331|12130306|FG001|NOT COMPLETED|Intervention 2||0
10957956|NCT00461500|12130315|FG000|STARTED|Overall Study||37
10957957|NCT00461500|12130316|FG001|STARTED|Overall Study||44
10957958|NCT00461500|12130315|FG000|COMPLETED|Overall Study||30
10957959|NCT00461500|12130316|FG001|COMPLETED|Overall Study||38
10957960|NCT00461500|12130315|FG000|NOT COMPLETED|Overall Study||7
10957961|NCT00461500|12130316|FG001|NOT COMPLETED|Overall Study||6
10957962|NCT00461513|12130324|FG000|STARTED|Overall Study|6 patients dropped at time of randomization|187
10957963|NCT00461513|12130325|FG001|STARTED|Overall Study|2 patients dropped at time of randomization|197
10957964|NCT00461513|12130324|FG000|COMPLETED|Overall Study||165
10957965|NCT00461513|12130325|FG001|COMPLETED|Overall Study||172
10957966|NCT00461513|12130324|FG000|NOT COMPLETED|Overall Study||22
10957967|NCT00461513|12130325|FG001|NOT COMPLETED|Overall Study||25
10957968|NCT00461552|12130337|FG000|STARTED|Overall Study||7
10957969|NCT00461552|12130338|FG001|STARTED|Overall Study||7
10957970|NCT00461552|12130337|FG000|COMPLETED|Overall Study||7
10957971|NCT00461552|12130338|FG001|COMPLETED|Overall Study||5
10957972|NCT00461552|12130337|FG000|NOT COMPLETED|Overall Study||0
10957973|NCT00461552|12130338|FG001|NOT COMPLETED|Overall Study||2
10957974|NCT00461591|12130346|FG000|STARTED|Overall Study||406
10957975|NCT00461591|12130347|FG001|STARTED|Overall Study||396
10957976|NCT00461591|12130346|FG000|COMPLETED|Overall Study||317
10957977|NCT00461591|12130347|FG001|COMPLETED|Overall Study||311
10957978|NCT00461591|12130346|FG000|NOT COMPLETED|Overall Study||89
10957979|NCT00461591|12130347|FG001|NOT COMPLETED|Overall Study||85
10957980|NCT00461630|12130355|FG000|STARTED|Overall Study||12838
10957981|NCT00461630|12130356|FG001|STARTED|Overall Study||12835
10957982|NCT00461630|12130355|FG000|COMPLETED|Overall Study||11932
10957983|NCT00461630|12130356|FG001|COMPLETED|Overall Study||12008
10957984|NCT00461630|12130355|FG000|NOT COMPLETED|Overall Study||906
10957985|NCT00461630|12130356|FG001|NOT COMPLETED|Overall Study||827
10957986|NCT00461708|12130364|FG000|STARTED|Overall Study||115
10957987|NCT00461708|12130365|FG001|STARTED|Overall Study||38
10957988|NCT00461708|12130364|FG000|COMPLETED|Overall Study||0
10957989|NCT00461708|12130365|FG001|COMPLETED|Overall Study||0
10957990|NCT00461708|12130364|FG000|NOT COMPLETED|Overall Study||115
10957991|NCT00461708|12130365|FG001|NOT COMPLETED|Overall Study||38
10957992|NCT00461734|12130376|FG000|STARTED|Overall Study||120
10957993|NCT00461734|12130377|FG001|STARTED|Overall Study||120
10957994|NCT00461734|12130376|FG000|COMPLETED|Overall Study||62
10957995|NCT00461734|12130377|FG001|COMPLETED|Overall Study||60
10957996|NCT00461734|12130376|FG000|NOT COMPLETED|Overall Study||58
10957997|NCT00461734|12130377|FG001|NOT COMPLETED|Overall Study||60
10957998|NCT00461773|12130390|FG000|STARTED|Overall Study||3
10957999|NCT00461773|12130391|FG001|STARTED|Overall Study||2
10958000|NCT00461773|12130390|FG000|COMPLETED|Overall Study||3
10958001|NCT00461773|12130391|FG001|COMPLETED|Overall Study||2
10958002|NCT00461773|12130390|FG000|NOT COMPLETED|Overall Study||0
10958003|NCT00461773|12130391|FG001|NOT COMPLETED|Overall Study||0
10958004|NCT00461786|12130397|FG000|STARTED|Overall Study||51
10958005|NCT00461786|12130397|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
10958006|NCT00461786|12130397|FG000|NOT COMPLETED|Overall Study||3
10958007|NCT00461851|12130401|FG000|STARTED|Overall Study||17
10958008|NCT00461851|12130401|FG000|COMPLETED|Overall Study||17
10958009|NCT00461851|12130401|FG000|NOT COMPLETED|Overall Study||0
10958010|NCT00461981|12130407|FG000|STARTED|Overall Study||50
10958011|NCT00461981|12130408|FG001|STARTED|Overall Study||51
10958012|NCT00461981|12130407|FG000|COMPLETED|Overall Study||39
10958013|NCT00461981|12130408|FG001|COMPLETED|Overall Study||42
10958014|NCT00461981|12130407|FG000|NOT COMPLETED|Overall Study||11
10958015|NCT00461981|12130408|FG001|NOT COMPLETED|Overall Study||9
10958016|NCT00462020|12130416|FG000|STARTED|Overall Study||52
10958017|NCT00462020|12130417|FG001|STARTED|Overall Study||50
10958018|NCT00462020|12130416|FG000|COMPLETED|Overall Study||52
10958019|NCT00462020|12130417|FG001|COMPLETED|Overall Study||50
10958020|NCT00462020|12130416|FG000|NOT COMPLETED|Overall Study||0
10958021|NCT00462020|12130417|FG001|NOT COMPLETED|Overall Study||0
10958022|NCT00462072|12130426|FG000|STARTED|Baseline (Week 0)||10
10958023|NCT00462072|12130427|FG001|STARTED|Baseline (Week 0)||12
10958024|NCT00462072|12130428|FG002|STARTED|Baseline (Week 0)||9
10958025|NCT00462072|12130426|FG000|COMPLETED|Baseline (Week 0)||10
10958026|NCT00462072|12130427|FG001|COMPLETED|Baseline (Week 0)||12
10958027|NCT00462072|12130428|FG002|COMPLETED|Baseline (Week 0)||9
10958028|NCT00462072|12130426|FG000|NOT COMPLETED|Baseline (Week 0)||0
10958029|NCT00462072|12130427|FG001|NOT COMPLETED|Baseline (Week 0)||0
10958030|NCT00462072|12130428|FG002|NOT COMPLETED|Baseline (Week 0)||0
10958031|NCT00462072|12130426|FG000|STARTED|Week 10||10
10958032|NCT00462072|12130427|FG001|STARTED|Week 10||12
10958033|NCT00462072|12130428|FG002|STARTED|Week 10||9
10958034|NCT00462072|12130426|FG000|COMPLETED|Week 10||10
10958035|NCT00462072|12130427|FG001|COMPLETED|Week 10||12
10958036|NCT00462072|12130428|FG002|COMPLETED|Week 10||9
10958037|NCT00462072|12130426|FG000|NOT COMPLETED|Week 10||0
10958038|NCT00462072|12130427|FG001|NOT COMPLETED|Week 10||0
10958039|NCT00462072|12130428|FG002|NOT COMPLETED|Week 10||0
10958040|NCT00462124|12130440|FG000|STARTED|Overall Study||7
10958041|NCT00462124|12130440|FG000|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6
10958042|NCT00462124|12130440|FG000|NOT COMPLETED|Overall Study||1
10958043|NCT00462228|12130445|FG000|STARTED|Memantine or Placebo 12 Weeks||11
10958044|NCT00462228|12130445|FG000|COMPLETED|Memantine or Placebo 12 Weeks||11
10958045|NCT00462228|12130445|FG000|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
10958046|NCT00462228|12130445|FG000|STARTED|No Treatment (Washout) 4 Weeks||11
10958047|NCT00462228|12130445|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11
10958048|NCT00462228|12130445|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
10958049|NCT00462228|12130445|FG000|STARTED|Placebo or Memantine 12 Weeks||11
10958050|NCT00462228|12130445|FG000|COMPLETED|Placebo or Memantine 12 Weeks||11
10958051|NCT00462228|12130445|FG000|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
10958052|NCT00462228|12130445|FG000|STARTED|No Treatment (Washout) 4 Weeks||11
10958053|NCT00462228|12130445|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11
10958054|NCT00462228|12130445|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
10958055|NCT00462280|12130456|FG000|STARTED|Overall Study||34
10958056|NCT00462280|12130457|FG001|STARTED|Overall Study||32
10958057|NCT00462280|12130458|FG002|STARTED|Overall Study||7
10958058|NCT00462280|12130459|FG003|STARTED|Overall Study||7
10958059|NCT00462280|12130456|FG000|COMPLETED|Overall Study||24
10958060|NCT00462280|12130457|FG001|COMPLETED|Overall Study||25
10958061|NCT00462280|12130458|FG002|COMPLETED|Overall Study||7
10958062|NCT00462280|12130459|FG003|COMPLETED|Overall Study||4
10958063|NCT00462280|12130456|FG000|NOT COMPLETED|Overall Study||10
10958064|NCT00462280|12130457|FG001|NOT COMPLETED|Overall Study||7
10958065|NCT00462280|12130458|FG002|NOT COMPLETED|Overall Study||0
10958066|NCT00462280|12130459|FG003|NOT COMPLETED|Overall Study||3
10958067|NCT00462306|12130473|FG000|STARTED|Overall Study||4074
10958068|NCT00462306|12130474|FG001|STARTED|Overall Study||503
10958069|NCT00462306|12130473|FG000|COMPLETED|Overall Study||4074
10958070|NCT00462306|12130474|FG001|COMPLETED|Overall Study||490
10958071|NCT00462306|12130473|FG000|NOT COMPLETED|Overall Study||0
10958072|NCT00462306|12130474|FG001|NOT COMPLETED|Overall Study||13
10958073|NCT00462332|12130484|FG000|STARTED|Overall Study||45
10958074|NCT00462332|12130485|FG001|STARTED|Overall Study||41
10958075|NCT00462332|12130484|FG000|COMPLETED|Overall Study||45
10958076|NCT00462332|12130485|FG001|COMPLETED|Overall Study||41
10958077|NCT00462332|12130484|FG000|NOT COMPLETED|Overall Study||0
10958078|NCT00462332|12130485|FG001|NOT COMPLETED|Overall Study||0
10958079|NCT00462345|12130493|FG000|STARTED|Overall Study||40
10958080|NCT00462345|12130493|FG000|Completed First Course|Overall Study||38
10958081|NCT00462345|12130493|FG000|COMPLETED|Overall Study||37
10958082|NCT00462345|12130493|FG000|NOT COMPLETED|Overall Study||3
10958083|NCT00462384|12130497|FG000|STARTED|Overall Study||39
10958084|NCT00462384|12130497|FG000|COMPLETED|Overall Study||30
10958085|NCT00462384|12130497|FG000|NOT COMPLETED|Overall Study||9
10958086|NCT00462423|12130501|FG000|STARTED|Overall Study||50
10958087|NCT00462423|12130501|FG000|COMPLETED|Overall Study||50
10958088|NCT00462423|12130501|FG000|NOT COMPLETED|Overall Study||0
10958089|NCT00462449|12130508|FG000|STARTED|Overall Study||13
10958090|NCT00462449|12130509|FG001|STARTED|Overall Study||10
10958091|NCT00462449|12130508|FG000|COMPLETED|Overall Study||13
10958092|NCT00462449|12130509|FG001|COMPLETED|Overall Study||10
10958093|NCT00462449|12130508|FG000|NOT COMPLETED|Overall Study||0
10958094|NCT00462449|12130509|FG001|NOT COMPLETED|Overall Study||0
10958095|NCT00462462|12130517|FG000|STARTED|Overall Study||17
10958096|NCT00462462|12130518|FG001|STARTED|Overall Study||14
10958097|NCT00462462|12130517|FG000|COMPLETED|Overall Study||17
10958098|NCT00462462|12130518|FG001|COMPLETED|Overall Study||13
10958099|NCT00462462|12130517|FG000|NOT COMPLETED|Overall Study||0
10958100|NCT00462462|12130518|FG001|NOT COMPLETED|Overall Study||1
10958101|NCT00462488|12130528|FG000|STARTED|Overall Study||23
10958102|NCT00462488|12130529|FG001|STARTED|Overall Study||23
10958103|NCT00462488|12130528|FG000|Completed Induction Phase|Overall Study||22
10958104|NCT00462488|12130529|FG001|Completed Induction Phase|Overall Study||23
10958105|NCT00462488|12130528|FG000|Completed Induction 2/Maintenance 1|Overall Study||18
10958106|NCT00462488|12130529|FG001|Completed Induction 2/Maintenance 1|Overall Study||9
10958107|NCT00462488|12130528|FG000|Completed Maintenance 2|Overall Study||7
10958108|NCT00462488|12130529|FG001|Completed Maintenance 2|Overall Study||6
10958109|NCT00462488|12130528|FG000|COMPLETED|Overall Study||3
10958110|NCT00462488|12130529|FG001|COMPLETED|Overall Study||6
10958111|NCT00462488|12130528|FG000|NOT COMPLETED|Overall Study||20
10958112|NCT00462488|12130529|FG001|NOT COMPLETED|Overall Study||17
10958113|NCT00462501|12130535|FG000|STARTED|Overall Study||35
10958114|NCT00462501|12130535|FG000|COMPLETED|Overall Study||30
10958115|NCT00462501|12130535|FG000|NOT COMPLETED|Overall Study||5
10958116|NCT00462605|12130539|FG000|STARTED|Overall Study||24
10958117|NCT00462605|12130539|FG000|COMPLETED|Overall Study||10
10958118|NCT00462605|12130539|FG000|NOT COMPLETED|Overall Study||14
10958119|NCT00462644|12130545|FG000|STARTED|Overall Study||18
10958120|NCT00462644|12130546|FG001|STARTED|Overall Study||12
10958121|NCT00462644|12130545|FG000|COMPLETED|Overall Study||18
10958122|NCT00462644|12130546|FG001|COMPLETED|Overall Study||12
10958123|NCT00462644|12130545|FG000|NOT COMPLETED|Overall Study||0
10958124|NCT00462644|12130546|FG001|NOT COMPLETED|Overall Study||0
10958125|NCT00462670|12130554|FG000|STARTED|Overall Study||57
10958126|NCT00462670|12130555|FG001|STARTED|Overall Study||53
10958127|NCT00462670|12130554|FG000|COMPLETED|Overall Study||52
10958128|NCT00462670|12130555|FG001|COMPLETED|Overall Study||46
10958129|NCT00462670|12130554|FG000|NOT COMPLETED|Overall Study||5
10958130|NCT00462670|12130555|FG001|NOT COMPLETED|Overall Study||7
10958131|NCT00462709|12130561|FG000|STARTED|Overall Study||146
10958132|NCT00462709|12130561|FG000|COMPLETED|Overall Study||79
10958133|NCT00462709|12130561|FG000|NOT COMPLETED|Overall Study||67
10958134|NCT00462722|12130568|FG000|STARTED|Overall Study||50
10958135|NCT00462722|12130569|FG001|STARTED|Overall Study||55
10958136|NCT00462722|12130570|FG002|STARTED|Overall Study||54
10958137|NCT00462722|12130568|FG000|COMPLETED|Overall Study||37
10958138|NCT00462722|12130569|FG001|COMPLETED|Overall Study||51
10958139|NCT00462722|12130570|FG002|COMPLETED|Overall Study||42
10958140|NCT00462722|12130568|FG000|NOT COMPLETED|Overall Study||13
10958141|NCT00462722|12130569|FG001|NOT COMPLETED|Overall Study||4
10958142|NCT00462722|12130570|FG002|NOT COMPLETED|Overall Study||12
10958143|NCT00462735|12130578|FG000|STARTED|Overall Study||33
10958144|NCT00462735|12130578|FG000|COMPLETED|Overall Study||33
10958145|NCT00462735|12130578|FG000|NOT COMPLETED|Overall Study||0
10958146|NCT00462761|12130583|FG000|STARTED|Overall Study||76
10958147|NCT00462761|12130583|FG000|COMPLETED|Overall Study||0
10958148|NCT00462761|12130583|FG000|NOT COMPLETED|Overall Study||76
10958149|NCT00462826|12130615|FG000|STARTED|Overall Study||49
10958150|NCT00462826|12130615|FG000|COMPLETED|Overall Study||44
10958151|NCT00462826|12130615|FG000|NOT COMPLETED|Overall Study||5
10958152|NCT00462839|12130627|FG000|STARTED|Viewed First||53
10958153|NCT00462839|12130628|FG001|STARTED|Viewed First||53
10958154|NCT00462839|12130627|FG000|COMPLETED|Viewed First||53
10958155|NCT00462839|12130628|FG001|COMPLETED|Viewed First||53
10958156|NCT00462839|12130627|FG000|NOT COMPLETED|Viewed First||0
10958157|NCT00462839|12130628|FG001|NOT COMPLETED|Viewed First||0
10958158|NCT00462839|12130627|FG000|STARTED|Viewed Second||53
10958159|NCT00462839|12130628|FG001|STARTED|Viewed Second||53
10958160|NCT00462839|12130627|FG000|COMPLETED|Viewed Second||53
10958161|NCT00462839|12130628|FG001|COMPLETED|Viewed Second||53
10958162|NCT00462839|12130627|FG000|NOT COMPLETED|Viewed Second||0
10958163|NCT00462839|12130628|FG001|NOT COMPLETED|Viewed Second||0
10958164|NCT00462865|12130634|FG000|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
10958165|NCT00462865|12130634|FG000|COMPLETED|Overall Study||17
10958166|NCT00462865|12130634|FG000|NOT COMPLETED|Overall Study||1
10958167|NCT00462917|12130642|FG000|STARTED|Overall Study||72
10958168|NCT00462917|12130643|FG001|STARTED|Overall Study||75
10958169|NCT00462917|12130644|FG002|STARTED|Overall Study||66
10958170|NCT00462917|12130645|FG003|STARTED|Overall Study||77
10958171|NCT00462917|12130642|FG000|Met With Genetic Counselor|Overall Study||66
10958172|NCT00462917|12130643|FG001|Met With Genetic Counselor|Overall Study||71
10958173|NCT00462917|12130644|FG002|Met With Genetic Counselor|Overall Study||56
10958174|NCT00462917|12130645|FG003|Met With Genetic Counselor|Overall Study||71
10958175|NCT00462917|12130642|FG000|Received Risk Information|Overall Study||64
10958176|NCT00462917|12130643|FG001|Received Risk Information|Overall Study||70
10958177|NCT00462917|12130644|FG002|Received Risk Information|Overall Study||55
10958178|NCT00462917|12130645|FG003|Received Risk Information|Overall Study||68
10958179|NCT00462917|12130642|FG000|Completed 6 Week Follow-up|Overall Study||63
10958180|NCT00462917|12130643|FG001|Completed 6 Week Follow-up|Overall Study||70
10958181|NCT00462917|12130644|FG002|Completed 6 Week Follow-up|Overall Study||55
10958182|NCT00462917|12130645|FG003|Completed 6 Week Follow-up|Overall Study||68
10958183|NCT00462917|12130642|FG000|Completed 6 Month Follow-up|Overall Study||63
10958184|NCT00462917|12130643|FG001|Completed 6 Month Follow-up|Overall Study||68
10958185|NCT00462917|12130644|FG002|Completed 6 Month Follow-up|Overall Study||55
10958186|NCT00462917|12130645|FG003|Completed 6 Month Follow-up|Overall Study||66
10958187|NCT00462917|12130642|FG000|COMPLETED|Overall Study||62
10958188|NCT00462917|12130643|FG001|COMPLETED|Overall Study||65
10958189|NCT00462917|12130644|FG002|COMPLETED|Overall Study||54
10958190|NCT00462917|12130645|FG003|COMPLETED|Overall Study||66
10958191|NCT00462917|12130642|FG000|NOT COMPLETED|Overall Study||10
10958192|NCT00462917|12130643|FG001|NOT COMPLETED|Overall Study||10
10958193|NCT00462917|12130644|FG002|NOT COMPLETED|Overall Study||12
10958194|NCT00462917|12130645|FG003|NOT COMPLETED|Overall Study||11
10958195|NCT00462982|12130655|FG000|STARTED|Overall Study||8
10958196|NCT00462982|12130655|FG000|COMPLETED|Overall Study||5
10958197|NCT00462982|12130655|FG000|NOT COMPLETED|Overall Study||3
10958198|NCT00463047|12130659|FG000|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
10958199|NCT00463047|12130660|FG001|STARTED|Titration Period 1||160
10958200|NCT00463047|12130659|FG000|COMPLETED|Titration Period 1||123
10958201|NCT00463047|12130660|FG001|COMPLETED|Titration Period 1||121
10958202|NCT00463047|12130659|FG000|NOT COMPLETED|Titration Period 1||37
10958203|NCT00463047|12130660|FG001|NOT COMPLETED|Titration Period 1||39
10958204|NCT00463047|12130659|FG000|STARTED|Titration Period 2||123
10958205|NCT00463047|12130660|FG001|STARTED|Titration Period 2||121
10958206|NCT00463047|12130659|FG000|COMPLETED|Titration Period 2||93
10958207|NCT00463047|12130660|FG001|COMPLETED|Titration Period 2||98
10958208|NCT00463047|12130659|FG000|NOT COMPLETED|Titration Period 2||30
10958209|NCT00463047|12130660|FG001|NOT COMPLETED|Titration Period 2||23
10958210|NCT00463047|12130659|FG000|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
10958211|NCT00463047|12130660|FG001|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
10958212|NCT00463047|12130659|FG000|COMPLETED|Double-Blind Treatment Period 1||93
10958213|NCT00463047|12130660|FG001|COMPLETED|Double-Blind Treatment Period 1||90
10958214|NCT00463047|12130659|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||3
10958215|NCT00463047|12130660|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||4
10958216|NCT00463047|12130659|FG000|STARTED|Double-Blind Treatment Period 2||93
10958217|NCT00463047|12130660|FG001|STARTED|Double-Blind Treatment Period 2||90
10958218|NCT00463047|12130659|FG000|COMPLETED|Double-Blind Treatment Period 2||92
10958219|NCT00463047|12130660|FG001|COMPLETED|Double-Blind Treatment Period 2||88
10958220|NCT00463047|12130659|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1
10958221|NCT00463047|12130660|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||2
10958222|NCT00463060|12130669|FG000|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
10958223|NCT00463060|12130669|FG000|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
10958224|NCT00463060|12130669|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
10958225|NCT00463060|12130669|FG000|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
10958226|NCT00463060|12130669|FG000|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
10958227|NCT00463060|12130669|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
10958228|NCT00463060|12130669|FG000|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
10958229|NCT00463060|12130669|FG000|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
10958230|NCT00463060|12130669|FG000|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
10958231|NCT00463060|12130669|FG000|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
10958232|NCT00463060|12130669|FG000|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
10958233|NCT00463060|12130669|FG000|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
10958234|NCT00463060|12130669|FG000|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
10958235|NCT00463060|12130669|FG000|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
10958236|NCT00463060|12130669|FG000|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
10958237|NCT00463151|12130682|FG000|STARTED|Overall Study||35
10958238|NCT00463151|12130683|FG001|STARTED|Overall Study||29
10958239|NCT00463151|12130684|FG002|STARTED|Overall Study||29
10958240|NCT00463151|12130685|FG003|STARTED|Overall Study||31
10958241|NCT00463151|12130682|FG000|COMPLETED|Overall Study||33
10958242|NCT00463151|12130683|FG001|COMPLETED|Overall Study||24
10958243|NCT00463151|12130684|FG002|COMPLETED|Overall Study||26
10958244|NCT00463151|12130685|FG003|COMPLETED|Overall Study||24
10958245|NCT00463151|12130682|FG000|NOT COMPLETED|Overall Study||2
10958246|NCT00463151|12130683|FG001|NOT COMPLETED|Overall Study||5
10958247|NCT00463151|12130684|FG002|NOT COMPLETED|Overall Study||3
10958248|NCT00463151|12130685|FG003|NOT COMPLETED|Overall Study||7
10958249|NCT00463229|12130697|FG000|STARTED|Overall Study||52
10958250|NCT00463229|12130698|FG001|STARTED|Overall Study||49
10958251|NCT00463229|12130697|FG000|COMPLETED|Overall Study||43
10958252|NCT00463229|12130698|FG001|COMPLETED|Overall Study||39
10958253|NCT00463229|12130697|FG000|NOT COMPLETED|Overall Study||9
10958254|NCT00463229|12130698|FG001|NOT COMPLETED|Overall Study||10
10958255|NCT00463346|12130707|FG000|STARTED|Overall Study||12
10958256|NCT00463346|12130708|FG001|STARTED|Overall Study||11
10958257|NCT00463346|12130707|FG000|COMPLETED|Overall Study||9
10958258|NCT00463346|12130708|FG001|COMPLETED|Overall Study||8
10958259|NCT00463346|12130707|FG000|NOT COMPLETED|Overall Study||3
10958260|NCT00463346|12130708|FG001|NOT COMPLETED|Overall Study||3
10958261|NCT00463385|12130720|FG000|STARTED|Overall Study||22
10958262|NCT00463385|12130721|FG001|STARTED|Overall Study||22
10958263|NCT00463385|12130722|FG002|STARTED|Overall Study||22
10958264|NCT00463385|12130723|FG003|STARTED|Overall Study||22
10958265|NCT00463385|12130720|FG000|Treated|Overall Study||22
10958266|NCT00463385|12130721|FG001|Treated|Overall Study||22
10958267|NCT00463385|12130722|FG002|Treated|Overall Study||19
10958268|NCT00463385|12130723|FG003|Treated|Overall Study||22
10958269|NCT00463385|12130720|FG000|COMPLETED|Overall Study||0
10958270|NCT00463385|12130721|FG001|COMPLETED|Overall Study||0
10958271|NCT00463385|12130722|FG002|COMPLETED|Overall Study||0
10958272|NCT00463385|12130723|FG003|COMPLETED|Overall Study||0
10958273|NCT00463385|12130720|FG000|NOT COMPLETED|Overall Study||22
10958274|NCT00463385|12130721|FG001|NOT COMPLETED|Overall Study||22
10958275|NCT00463385|12130722|FG002|NOT COMPLETED|Overall Study||22
10958276|NCT00463385|12130723|FG003|NOT COMPLETED|Overall Study||22
10958277|NCT00463437|12130745|FG000|STARTED|Overall Study||359
10958278|NCT00463437|12130746|FG001|STARTED|Overall Study||363
10958279|NCT00463437|12130747|FG002|STARTED|Overall Study||358
10958280|NCT00463437|12130748|FG003|STARTED|Overall Study||357
10958281|NCT00463437|12130745|FG000|COMPLETED|Overall Study||355
10958282|NCT00463437|12130746|FG001|COMPLETED|Overall Study||352
10958283|NCT00463437|12130747|FG002|COMPLETED|Overall Study||352
10958284|NCT00463437|12130748|FG003|COMPLETED|Overall Study||350
10958285|NCT00463437|12130745|FG000|NOT COMPLETED|Overall Study||4
10958286|NCT00463437|12130746|FG001|NOT COMPLETED|Overall Study||11
10958287|NCT00463437|12130747|FG002|NOT COMPLETED|Overall Study||6
10958288|NCT00463437|12130748|FG003|NOT COMPLETED|Overall Study||7
10958289|NCT00463476|12130760|FG000|STARTED|Overall Study||151
10958290|NCT00463476|12130761|FG001|STARTED|Overall Study||154
10958291|NCT00463476|12130760|FG000|COMPLETED|Overall Study||149
10958292|NCT00463476|12130761|FG001|COMPLETED|Overall Study||151
10958293|NCT00463476|12130760|FG000|NOT COMPLETED|Overall Study||2
10958294|NCT00463476|12130761|FG001|NOT COMPLETED|Overall Study||3
10958295|NCT00463567|12130774|FG000|STARTED|Overall Study|Randomized Participants|420
10958296|NCT00463567|12130775|FG001|STARTED|Overall Study||418
10958297|NCT00463567|12130776|FG002|STARTED|Overall Study||420
10958298|NCT00463567|12130777|FG003|STARTED|Overall Study||425
10958299|NCT00463567|12130778|FG004|STARTED|Overall Study||130
10958300|NCT00463567|12130779|FG005|STARTED|Overall Study||123
10958301|NCT00463567|12130780|FG006|STARTED|Overall Study||123
10958302|NCT00463567|12130774|FG000|Safety Population: Received Study Drug|Overall Study||416
10958303|NCT00463567|12130775|FG001|Safety Population: Received Study Drug|Overall Study||416
10958304|NCT00463567|12130776|FG002|Safety Population: Received Study Drug|Overall Study||415
10958305|NCT00463567|12130777|FG003|Safety Population: Received Study Drug|Overall Study||418
10958306|NCT00463567|12130778|FG004|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
10958307|NCT00463567|12130779|FG005|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
10958308|NCT00463567|12130780|FG006|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
10958309|NCT00463567|12130774|FG000|COMPLETED|Overall Study||325
10958310|NCT00463567|12130775|FG001|COMPLETED|Overall Study||341
10958311|NCT00463567|12130776|FG002|COMPLETED|Overall Study||331
10958312|NCT00463567|12130777|FG003|COMPLETED|Overall Study||294
10958313|NCT00463567|12130778|FG004|COMPLETED|Overall Study||107
10958314|NCT00463567|12130779|FG005|COMPLETED|Overall Study||102
10958315|NCT00463567|12130780|FG006|COMPLETED|Overall Study||112
10958316|NCT00463567|12130774|FG000|NOT COMPLETED|Overall Study||95
10958317|NCT00463567|12130775|FG001|NOT COMPLETED|Overall Study||77
10958318|NCT00463567|12130776|FG002|NOT COMPLETED|Overall Study||89
10958319|NCT00463567|12130777|FG003|NOT COMPLETED|Overall Study||131
10958320|NCT00463567|12130778|FG004|NOT COMPLETED|Overall Study||23
10958321|NCT00463567|12130779|FG005|NOT COMPLETED|Overall Study||21
10958322|NCT00463567|12130780|FG006|NOT COMPLETED|Overall Study||11
10958323|NCT00463580|12130804|FG000|STARTED|Overall Study||30
10958324|NCT00463580|12130805|FG001|STARTED|Overall Study||30
10958325|NCT00463580|12130804|FG000|COMPLETED|Overall Study||27
10958326|NCT00463580|12130805|FG001|COMPLETED|Overall Study||28
10958327|NCT00463580|12130804|FG000|NOT COMPLETED|Overall Study||3
10958328|NCT00463580|12130805|FG001|NOT COMPLETED|Overall Study||2
10958329|NCT00463606|12130820|FG000|STARTED|Overall Study||253
10958330|NCT00463606|12130821|FG001|STARTED|Overall Study||254
10958331|NCT00463606|12130822|FG002|STARTED|Overall Study||251
10958332|NCT00463606|12130820|FG000|COMPLETED|Overall Study||212
10958333|NCT00463606|12130821|FG001|COMPLETED|Overall Study||220
10958334|NCT00463606|12130822|FG002|COMPLETED|Overall Study||231
10958335|NCT00463606|12130820|FG000|NOT COMPLETED|Overall Study||41
10958336|NCT00463606|12130821|FG001|NOT COMPLETED|Overall Study||34
10958337|NCT00463606|12130822|FG002|NOT COMPLETED|Overall Study||20
10958338|NCT00463684|12130830|FG000|STARTED|Overall Study||278
10958339|NCT00463684|12130830|FG000|COMPLETED|Overall Study||274
10958340|NCT00463684|12130830|FG000|NOT COMPLETED|Overall Study||4
10958341|NCT00463788|12130836|FG000|STARTED|Overall Study||115
10958342|NCT00463788|12130837|FG001|STARTED|Overall Study||58
10958343|NCT00463788|12130836|FG000|Treated|Overall Study||114
10958344|NCT00463788|12130837|FG001|Treated|Overall Study||57
10958345|NCT00463788|12130836|FG000|COMPLETED|Overall Study||6
10958346|NCT00463788|12130837|FG001|COMPLETED|Overall Study||4
10958347|NCT00463788|12130836|FG000|NOT COMPLETED|Overall Study||109
10958348|NCT00463788|12130837|FG001|NOT COMPLETED|Overall Study||54
10958349|NCT00463801|12130844|FG000|STARTED|Overall Study||52
10958350|NCT00463801|12130844|FG000|COMPLETED|Overall Study||39
10958351|NCT00463801|12130844|FG000|NOT COMPLETED|Overall Study||13
10958352|NCT00463840|12130848|FG000|STARTED|Overall Study||24
10958353|NCT00463840|12130848|FG000|COMPLETED|Overall Study||12
10958354|NCT00463840|12130848|FG000|NOT COMPLETED|Overall Study||12
10958355|NCT00463866|12130854|FG000|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
10958356|NCT00463866|12130855|FG001|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
10958357|NCT00463866|12130854|FG000|COMPLETED|Overall Study||3699
10958358|NCT00463866|12130855|FG001|COMPLETED|Overall Study||3705
10958359|NCT00463866|12130854|FG000|NOT COMPLETED|Overall Study||309
10958360|NCT00463866|12130855|FG001|NOT COMPLETED|Overall Study||340
10958361|NCT00464087|12130864|FG000|STARTED|Overall Study||49
10958362|NCT00464087|12130865|FG001|STARTED|Overall Study||51
10958363|NCT00464087|12130866|FG002|STARTED|Overall Study||29
10958364|NCT00464087|12130864|FG000|COMPLETED|Overall Study||49
10958365|NCT00464087|12130865|FG001|COMPLETED|Overall Study||51
10958366|NCT00464087|12130866|FG002|COMPLETED|Overall Study||0
10958367|NCT00464087|12130864|FG000|NOT COMPLETED|Overall Study||0
10958368|NCT00464087|12130865|FG001|NOT COMPLETED|Overall Study||0
10958369|NCT00464087|12130866|FG002|NOT COMPLETED|Overall Study||29
10958370|NCT00464204|12130876|FG000|STARTED|Overall Study||100
10958371|NCT00464204|12130877|FG001|STARTED|Overall Study||96
10958372|NCT00464204|12130876|FG000|Completed Treatment|Overall Study||81
10958373|NCT00464204|12130877|FG001|Completed Treatment|Overall Study||83
10958374|NCT00464204|12130876|FG000|Day 30 Follow-up Performed|Overall Study||89
10958375|NCT00464204|12130877|FG001|Day 30 Follow-up Performed|Overall Study||83
10958376|NCT00464204|12130876|FG000|Day 90 Follow-up Performed|Overall Study||69
10958377|NCT00464204|12130877|FG001|Day 90 Follow-up Performed|Overall Study||74
10958378|NCT00464204|12130876|FG000|Withdrawal Due to Discharge From ICU|Overall Study||18
10958379|NCT00464204|12130877|FG001|Withdrawal Due to Discharge From ICU|Overall Study||11
10958380|NCT00464204|12130876|FG000|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
10958381|NCT00464204|12130877|FG001|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
10958382|NCT00464204|12130876|FG000|NOT COMPLETED|Overall Study||49
10958383|NCT00464204|12130877|FG001|NOT COMPLETED|Overall Study||32
10958384|NCT00464308|12130888|FG000|STARTED|Overall Study||464
10958385|NCT00464308|12130889|FG001|STARTED|Overall Study||469
10958386|NCT00464308|12130890|FG002|STARTED|Overall Study||459
10958387|NCT00464308|12130888|FG000|COMPLETED|Overall Study||395
10958388|NCT00464308|12130889|FG001|COMPLETED|Overall Study||406
10958389|NCT00464308|12130890|FG002|COMPLETED|Overall Study||400
10958390|NCT00464308|12130888|FG000|NOT COMPLETED|Overall Study||69
10958391|NCT00464308|12130889|FG001|NOT COMPLETED|Overall Study||63
10958392|NCT00464308|12130890|FG002|NOT COMPLETED|Overall Study||59
10958393|NCT00464334|12130909|FG000|STARTED|Overall Study||5
10958394|NCT00464334|12130910|FG001|STARTED|Overall Study||13
10958395|NCT00464334|12130911|FG002|STARTED|Overall Study||8
10958396|NCT00464334|12130912|FG003|STARTED|Overall Study||8
10958397|NCT00464334|12130913|FG004|STARTED|Overall Study||7
10958398|NCT00464334|12130914|FG005|STARTED|Overall Study||7
10958399|NCT00464334|12130915|FG006|STARTED|Overall Study||9
10958400|NCT00464334|12130916|FG007|STARTED|Overall Study||8
10958401|NCT00464334|12130917|FG008|STARTED|Overall Study||8
10958402|NCT00464334|12130918|FG009|STARTED|Overall Study||5
10958403|NCT00464334|12130919|FG010|STARTED|Overall Study||8
10958404|NCT00464334|12130909|FG000|COMPLETED|Overall Study||4
10958405|NCT00464334|12130910|FG001|COMPLETED|Overall Study||5
10958406|NCT00464334|12130911|FG002|COMPLETED|Overall Study||3
10958407|NCT00464334|12130912|FG003|COMPLETED|Overall Study||4
10958408|NCT00464334|12130913|FG004|COMPLETED|Overall Study||3
10958409|NCT00464334|12130914|FG005|COMPLETED|Overall Study||3
10958410|NCT00464334|12130915|FG006|COMPLETED|Overall Study||6
10958411|NCT00464334|12130916|FG007|COMPLETED|Overall Study||7
10958412|NCT00464334|12130917|FG008|COMPLETED|Overall Study||2
10958413|NCT00464334|12130918|FG009|COMPLETED|Overall Study||4
10958414|NCT00464334|12130919|FG010|COMPLETED|Overall Study||4
10958415|NCT00464334|12130909|FG000|NOT COMPLETED|Overall Study||1
10958416|NCT00464334|12130910|FG001|NOT COMPLETED|Overall Study||8
10958417|NCT00464334|12130911|FG002|NOT COMPLETED|Overall Study||5
10958418|NCT00464334|12130912|FG003|NOT COMPLETED|Overall Study||4
10958419|NCT00464334|12130913|FG004|NOT COMPLETED|Overall Study||4
10958420|NCT00464334|12130914|FG005|NOT COMPLETED|Overall Study||4
10958421|NCT00464334|12130915|FG006|NOT COMPLETED|Overall Study||3
10958422|NCT00464334|12130916|FG007|NOT COMPLETED|Overall Study||1
10958423|NCT00464334|12130917|FG008|NOT COMPLETED|Overall Study||6
10958424|NCT00464334|12130918|FG009|NOT COMPLETED|Overall Study||1
10958425|NCT00464334|12130919|FG010|NOT COMPLETED|Overall Study||4
10958426|NCT00464438|12130956|FG000|STARTED|Overall Study||85
10958427|NCT00464438|12130957|FG001|STARTED|Overall Study||86
10958428|NCT00464438|12130956|FG000|COMPLETED|Overall Study||83
10958429|NCT00464438|12130957|FG001|COMPLETED|Overall Study||80
10958430|NCT00464438|12130956|FG000|NOT COMPLETED|Overall Study||2
10958431|NCT00464438|12130957|FG001|NOT COMPLETED|Overall Study||6
10958432|NCT00464464|12130965|FG000|STARTED|Overall Study||41
10958433|NCT00464464|12130966|FG001|STARTED|Overall Study||39
10958434|NCT00464464|12130965|FG000|COMPLETED|Overall Study||36
10958435|NCT00464464|12130966|FG001|COMPLETED|Overall Study||36
10958436|NCT00464464|12130965|FG000|NOT COMPLETED|Overall Study||5
10958437|NCT00464464|12130966|FG001|NOT COMPLETED|Overall Study||3
10958438|NCT00464490|12130974|FG000|STARTED|Overall Study||21
10958439|NCT00464490|12130975|FG001|STARTED|Overall Study||21
10958440|NCT00464490|12130974|FG000|COMPLETED|Overall Study||10
10958441|NCT00464490|12130975|FG001|COMPLETED|Overall Study||10
10958442|NCT00464490|12130974|FG000|NOT COMPLETED|Overall Study||11
10958443|NCT00464490|12130975|FG001|NOT COMPLETED|Overall Study||11
10958444|NCT00464542|12130981|FG000|STARTED|Pre-treatment||12
10958445|NCT00464542|12130981|FG000|COMPLETED|Pre-treatment||10
10958446|NCT00464542|12130981|FG000|NOT COMPLETED|Pre-treatment||2
10958447|NCT00464542|12130981|FG000|STARTED|Post-treatment||10
10958448|NCT00464542|12130981|FG000|COMPLETED|Post-treatment||10
10958449|NCT00464542|12130981|FG000|NOT COMPLETED|Post-treatment||0
10958450|NCT00464568|12130985|FG000|STARTED|Overall Study||32
10958451|NCT00464568|12130985|FG000|COMPLETED|Overall Study||30
10958452|NCT00464568|12130985|FG000|NOT COMPLETED|Overall Study||2
10958453|NCT00464620|12131002|FG000|STARTED|Overall Study||50
10958454|NCT00464620|12131003|FG001|STARTED|Overall Study||200
10958455|NCT00464620|12131004|FG002|STARTED|Overall Study||116
10958456|NCT00464620|12131002|FG000|COMPLETED|Overall Study|48 patients were evaluable.|48
10958457|NCT00464620|12131003|FG001|COMPLETED|Overall Study||198
10958458|NCT00464620|12131004|FG002|COMPLETED|Overall Study||109
10958459|NCT00464620|12131002|FG000|NOT COMPLETED|Overall Study||2
10958460|NCT00464620|12131003|FG001|NOT COMPLETED|Overall Study||2
10958461|NCT00464620|12131004|FG002|NOT COMPLETED|Overall Study||7
10958462|NCT00464646|12131019|FG000|STARTED|Overall Study||76
10958463|NCT00464646|12131020|FG001|STARTED|Overall Study||29
10958464|NCT00464646|12131019|FG000|COMPLETED|Overall Study||76
10958465|NCT00464646|12131020|FG001|COMPLETED|Overall Study||29
10958466|NCT00464646|12131019|FG000|NOT COMPLETED|Overall Study||0
10958467|NCT00464646|12131020|FG001|NOT COMPLETED|Overall Study||0
10958468|NCT00464672|12131029|FG000|STARTED|Overall Study||460
10958469|NCT00464672|12131030|FG001|STARTED|Overall Study||232
10958470|NCT00464672|12131031|FG002|STARTED|Overall Study||400
10958471|NCT00464672|12131032|FG003|STARTED|Overall Study||200
10958472|NCT00464672|12131033|FG004|STARTED|Overall Study||402
10958473|NCT00464672|12131034|FG005|STARTED|Overall Study||199
10958474|NCT00464672|12131029|FG000|COMPLETED|Overall Study||435
10958475|NCT00464672|12131030|FG001|COMPLETED|Overall Study||222
10958476|NCT00464672|12131031|FG002|COMPLETED|Overall Study||400
10958477|NCT00464672|12131032|FG003|COMPLETED|Overall Study||199
10958478|NCT00464672|12131033|FG004|COMPLETED|Overall Study||392
10958479|NCT00464672|12131034|FG005|COMPLETED|Overall Study||195
10958480|NCT00464672|12131029|FG000|NOT COMPLETED|Overall Study||25
10958481|NCT00464672|12131030|FG001|NOT COMPLETED|Overall Study||10
10958482|NCT00464672|12131031|FG002|NOT COMPLETED|Overall Study||0
10958483|NCT00464672|12131032|FG003|NOT COMPLETED|Overall Study||1
10958484|NCT00464672|12131033|FG004|NOT COMPLETED|Overall Study||10
10958485|NCT00464672|12131034|FG005|NOT COMPLETED|Overall Study||4
10958486|NCT00464685|12131064|FG000|STARTED|Overall Study||126
10958487|NCT00464685|12131065|FG001|STARTED|Overall Study||127
10958488|NCT00464685|12131064|FG000|COMPLETED|Overall Study||103
10958489|NCT00464685|12131065|FG001|COMPLETED|Overall Study||94
10958490|NCT00464685|12131064|FG000|NOT COMPLETED|Overall Study||23
10958491|NCT00464685|12131065|FG001|NOT COMPLETED|Overall Study||33
10958492|NCT00464698|12131071|FG000|STARTED|Period 1: 30 mg||20
10958493|NCT00464698|12131071|FG000|COMPLETED|Period 1: 30 mg||17
10958494|NCT00464698|12131071|FG000|NOT COMPLETED|Period 1: 30 mg||3
10958495|NCT00464698|12131071|FG000|STARTED|Period 2: 60 mg||17
10958496|NCT00464698|12131071|FG000|COMPLETED|Period 2: 60 mg||17
10958497|NCT00464698|12131071|FG000|NOT COMPLETED|Period 2: 60 mg||0
10958498|NCT00464698|12131071|FG000|STARTED|Period 3: 120mg||14
10958499|NCT00464698|12131071|FG000|COMPLETED|Period 3: 120mg||12
10958500|NCT00464698|12131071|FG000|NOT COMPLETED|Period 3: 120mg||2
10958501|NCT00464711|12131077|FG000|STARTED|Overall Study||40
10958502|NCT00464711|12131077|FG000|COMPLETED|Overall Study||25
10958503|NCT00464711|12131077|FG000|NOT COMPLETED|Overall Study||15
10958504|NCT00464737|12131084|FG000|STARTED|Overall Study||82
10958505|NCT00464737|12131085|FG001|STARTED|Overall Study||74
10958506|NCT00464737|12131086|FG002|STARTED|Overall Study||74
10958507|NCT00464737|12131084|FG000|COMPLETED|Overall Study||50
10958508|NCT00464737|12131085|FG001|COMPLETED|Overall Study||42
10958509|NCT00464737|12131086|FG002|COMPLETED|Overall Study||19
10958510|NCT00464737|12131084|FG000|NOT COMPLETED|Overall Study||32
10958511|NCT00464737|12131085|FG001|NOT COMPLETED|Overall Study||32
10958512|NCT00464737|12131086|FG002|NOT COMPLETED|Overall Study||55
10958513|NCT00464815|12131096|FG000|STARTED|Overall Study||768
10958514|NCT00464815|12131097|FG001|STARTED|Overall Study||257
10958515|NCT00464815|12131096|FG000|COMPLETED|Overall Study||762
10958516|NCT00464815|12131097|FG001|COMPLETED|Overall Study||254
10958517|NCT00464815|12131096|FG000|NOT COMPLETED|Overall Study||6
10958518|NCT00464815|12131097|FG001|NOT COMPLETED|Overall Study||3
10958519|NCT00464945|12131105|FG000|STARTED|Infant Series||135
10958520|NCT00464945|12131106|FG001|STARTED|Infant Series||134
10958521|NCT00464945|12131105|FG000|Vaccinated Dose 1|Infant Series||134
10958522|NCT00464945|12131106|FG001|Vaccinated Dose 1|Infant Series||134
10958523|NCT00464945|12131105|FG000|Vaccinated Dose 2|Infant Series||132
10958524|NCT00464945|12131106|FG001|Vaccinated Dose 2|Infant Series||133
10958525|NCT00464945|12131105|FG000|Vaccinated Dose 3|Infant Series||132
10958526|NCT00464945|12131106|FG001|Vaccinated Dose 3|Infant Series||133
10958527|NCT00464945|12131105|FG000|COMPLETED|Infant Series||131
10958528|NCT00464945|12131106|FG001|COMPLETED|Infant Series||133
10958529|NCT00464945|12131105|FG000|NOT COMPLETED|Infant Series||4
10958530|NCT00464945|12131106|FG001|NOT COMPLETED|Infant Series||1
10958531|NCT00464945|12131105|FG000|STARTED|After Infant Series||131
10958532|NCT00464945|12131106|FG001|STARTED|After Infant Series||133
10958533|NCT00464945|12131105|FG000|COMPLETED|After Infant Series||131
10958534|NCT00464945|12131106|FG001|COMPLETED|After Infant Series||131
10958535|NCT00464945|12131105|FG000|NOT COMPLETED|After Infant Series||0
10958536|NCT00464945|12131106|FG001|NOT COMPLETED|After Infant Series||2
10958537|NCT00464945|12131105|FG000|STARTED|Toddler Dose||131
10958538|NCT00464945|12131106|FG001|STARTED|Toddler Dose||131
10958539|NCT00464945|12131105|FG000|COMPLETED|Toddler Dose||131
10958540|NCT00464945|12131106|FG001|COMPLETED|Toddler Dose||130
10958541|NCT00464945|12131105|FG000|NOT COMPLETED|Toddler Dose||0
10958542|NCT00464945|12131106|FG001|NOT COMPLETED|Toddler Dose||1
10958543|NCT00465088|12131130|FG000|STARTED|Overall Study|For both arms, started means treated.|114
10958544|NCT00465088|12131131|FG001|STARTED|Overall Study||79
10958545|NCT00465088|12131130|FG000|COMPLETED|Overall Study||82
10958546|NCT00465088|12131131|FG001|COMPLETED|Overall Study||70
10958547|NCT00465088|12131130|FG000|NOT COMPLETED|Overall Study||32
10958548|NCT00465088|12131131|FG001|NOT COMPLETED|Overall Study||9
10958549|NCT00465101|12131137|FG000|STARTED|Overall Study||150
10958550|NCT00465101|12131137|FG000|COMPLETED|Overall Study||91
10958551|NCT00465101|12131137|FG000|NOT COMPLETED|Overall Study||59
10958552|NCT00465179|12131163|FG000|STARTED|Overall Study||57
10958553|NCT00465179|12131163|FG000|COMPLETED|Overall Study||4
10958554|NCT00465179|12131163|FG000|NOT COMPLETED|Overall Study||53
10958555|NCT00465270|12131169|FG000|STARTED|Overall Study||499
10958556|NCT00465270|12131170|FG001|STARTED|Overall Study||481
10958557|NCT00465270|12131169|FG000|COMPLETED|Overall Study||395
10958558|NCT00465270|12131170|FG001|COMPLETED|Overall Study||321
10958559|NCT00465270|12131169|FG000|NOT COMPLETED|Overall Study||104
10958560|NCT00465270|12131170|FG001|NOT COMPLETED|Overall Study||160
10958561|NCT00465361|12131176|FG000|STARTED|Baseline Assessment||7
10958562|NCT00465361|12131176|FG000|COMPLETED|Baseline Assessment||3
10958563|NCT00465361|12131176|FG000|NOT COMPLETED|Baseline Assessment||4
10958564|NCT00465361|12131176|FG000|STARTED|Post-Intervention Assessment||3
10958565|NCT00465361|12131176|FG000|COMPLETED|Post-Intervention Assessment||3
10958566|NCT00465361|12131176|FG000|NOT COMPLETED|Post-Intervention Assessment||0
10958567|NCT00465530|12131182|FG000|STARTED|Overall Study||21
10958568|NCT00465530|12131183|FG001|STARTED|Overall Study||19
10958569|NCT00465530|12131182|FG000|COMPLETED|Overall Study||19
10958570|NCT00465530|12131183|FG001|COMPLETED|Overall Study||15
10958571|NCT00465530|12131182|FG000|NOT COMPLETED|Overall Study||2
10958572|NCT00465530|12131183|FG001|NOT COMPLETED|Overall Study||4
10958573|NCT00465569|12131191|FG000|STARTED|Overall Study||13
10958574|NCT00465569|12131192|FG001|STARTED|Overall Study||7
10958575|NCT00465569|12131191|FG000|COMPLETED|Overall Study||12
10958576|NCT00465569|12131192|FG001|COMPLETED|Overall Study||7
10958577|NCT00465569|12131191|FG000|NOT COMPLETED|Overall Study||1
10958578|NCT00465569|12131192|FG001|NOT COMPLETED|Overall Study||0
10958579|NCT00465595|12131200|FG000|STARTED|Overall Study||27
10958580|NCT00465595|12131201|FG001|STARTED|Overall Study||29
10958581|NCT00465595|12131200|FG000|COMPLETED|Overall Study||22
10958582|NCT00465595|12131201|FG001|COMPLETED|Overall Study||24
10958583|NCT00465595|12131200|FG000|NOT COMPLETED|Overall Study||5
10958584|NCT00465595|12131201|FG001|NOT COMPLETED|Overall Study||5
10958585|NCT00465647|12131217|FG000|STARTED|Overall Study||39
10958586|NCT00465647|12131218|FG001|STARTED|Overall Study||23
10958587|NCT00465647|12131219|FG002|STARTED|Overall Study||29
10958588|NCT00465647|12131220|FG003|STARTED|Overall Study||25
10958589|NCT00465647|12131217|FG000|COMPLETED|Overall Study||26
10958590|NCT00465647|12131218|FG001|COMPLETED|Overall Study||15
10958591|NCT00465647|12131219|FG002|COMPLETED|Overall Study||18
10958592|NCT00465647|12131220|FG003|COMPLETED|Overall Study||12
10958593|NCT00465647|12131217|FG000|NOT COMPLETED|Overall Study||13
10958594|NCT00465647|12131218|FG001|NOT COMPLETED|Overall Study||8
10958595|NCT00465647|12131219|FG002|NOT COMPLETED|Overall Study||11
10958596|NCT00465647|12131220|FG003|NOT COMPLETED|Overall Study||13
10958597|NCT00465738|12131242|FG000|STARTED|Overall Study||97
10958598|NCT00465738|12131243|FG001|STARTED|Overall Study||95
10958599|NCT00465738|12131242|FG000|COMPLETED|Overall Study||91
10958600|NCT00465738|12131243|FG001|COMPLETED|Overall Study||89
10958601|NCT00465738|12131242|FG000|NOT COMPLETED|Overall Study||6
10958602|NCT00465738|12131243|FG001|NOT COMPLETED|Overall Study||6
10958603|NCT00465816|12131252|FG000|STARTED|Overall Study||367
10958604|NCT00465816|12131253|FG001|STARTED|Overall Study||122
10958605|NCT00465816|12131254|FG002|STARTED|Overall Study||122
10958606|NCT00465816|12131252|FG000|COMPLETED|Overall Study||367
10958607|NCT00465816|12131253|FG001|COMPLETED|Overall Study||122
10958608|NCT00465816|12131254|FG002|COMPLETED|Overall Study||120
10958609|NCT00465816|12131252|FG000|NOT COMPLETED|Overall Study||0
10958610|NCT00465816|12131253|FG001|NOT COMPLETED|Overall Study||0
10958611|NCT00465816|12131254|FG002|NOT COMPLETED|Overall Study||2
10958612|NCT00465894|12131265|FG000|STARTED|Treatment For 12 Weeks||30
10958613|NCT00465894|12131266|FG001|STARTED|Treatment For 12 Weeks||28
10958614|NCT00465894|12131265|FG000|COMPLETED|Treatment For 12 Weeks||25
10958615|NCT00465894|12131266|FG001|COMPLETED|Treatment For 12 Weeks||25
10958616|NCT00465894|12131265|FG000|NOT COMPLETED|Treatment For 12 Weeks||5
10958617|NCT00465894|12131266|FG001|NOT COMPLETED|Treatment For 12 Weeks||3
10958618|NCT00465894|12131265|FG000|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
10958619|NCT00465894|12131266|FG001|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
10958620|NCT00465894|12131265|FG000|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
10958621|NCT00465894|12131266|FG001|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
10958622|NCT00465894|12131265|FG000|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
10958623|NCT00465894|12131266|FG001|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
10958624|NCT00465894|12131265|FG000|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
10958625|NCT00465894|12131266|FG001|STARTED|Treatment From 24 Weeks to 52 Weeks||14
10958626|NCT00465894|12131265|FG000|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
10958627|NCT00465894|12131266|FG001|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
10958628|NCT00465894|12131265|FG000|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
10958629|NCT00465894|12131266|FG001|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
10958630|NCT00465972|12131290|FG000|STARTED|Overall Study||20
10958631|NCT00465972|12131291|FG001|STARTED|Overall Study||24
10958632|NCT00465972|12131290|FG000|COMPLETED|Overall Study||18
10958633|NCT00465972|12131291|FG001|COMPLETED|Overall Study||23
10958634|NCT00465972|12131290|FG000|NOT COMPLETED|Overall Study||2
10958635|NCT00465972|12131291|FG001|NOT COMPLETED|Overall Study||1
10958636|NCT00465985|12131299|FG000|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
10958637|NCT00465985|12131300|FG001|STARTED|Part I - Open-label Treatment Period||0
10958638|NCT00465985|12131299|FG000|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
10958639|NCT00465985|12131300|FG001|COMPLETED|Part I - Open-label Treatment Period||0
10958640|NCT00465985|12131299|FG000|NOT COMPLETED|Part I - Open-label Treatment Period||4
10958641|NCT00465985|12131300|FG001|NOT COMPLETED|Part I - Open-label Treatment Period||0
10958642|NCT00465985|12131299|FG000|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
10958643|NCT00465985|12131300|FG001|STARTED|Part II - 1:1 ACZ885:Placebo||16
10958644|NCT00465985|12131299|FG000|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
10958645|NCT00465985|12131300|FG001|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
10958646|NCT00465985|12131299|FG000|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
10958647|NCT00465985|12131300|FG001|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
10958648|NCT00465985|12131299|FG000|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
10958649|NCT00465985|12131300|FG001|STARTED|Part III - Open-label Treatment Period||0
10958650|NCT00465985|12131299|FG000|COMPLETED|Part III - Open-label Treatment Period||29
10958651|NCT00465985|12131300|FG001|COMPLETED|Part III - Open-label Treatment Period||0
10958652|NCT00465985|12131299|FG000|NOT COMPLETED|Part III - Open-label Treatment Period||2
10958653|NCT00465985|12131300|FG001|NOT COMPLETED|Part III - Open-label Treatment Period||0
10958654|NCT00465998|12131309|FG000|STARTED|Overall Study||275
10958655|NCT00465998|12131309|FG000|COMPLETED|Overall Study||275
10958656|NCT00465998|12131309|FG000|NOT COMPLETED|Overall Study||0
10958657|NCT00466167|12131317|FG000|STARTED|Overall Study||165
10958658|NCT00466167|12131318|FG001|STARTED|Overall Study||175
10958659|NCT00466167|12131319|FG002|STARTED|Overall Study||178
10958660|NCT00466167|12131317|FG000|COMPLETED|Overall Study||145
10958661|NCT00466167|12131318|FG001|COMPLETED|Overall Study||163
10958662|NCT00466167|12131319|FG002|COMPLETED|Overall Study||157
10958663|NCT00466167|12131317|FG000|NOT COMPLETED|Overall Study||20
10958664|NCT00466167|12131318|FG001|NOT COMPLETED|Overall Study||12
10958665|NCT00466167|12131319|FG002|NOT COMPLETED|Overall Study||21
10958666|NCT00466193|12131329|FG000|STARTED|Overall Study||150
10958667|NCT00466193|12131330|FG001|STARTED|Overall Study||145
10958668|NCT00466193|12131329|FG000|COMPLETED|Overall Study||138
10958669|NCT00466193|12131330|FG001|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
10958670|NCT00466193|12131329|FG000|NOT COMPLETED|Overall Study||12
10958671|NCT00466193|12131330|FG001|NOT COMPLETED|Overall Study||8
10958672|NCT00466206|12131336|FG000|STARTED|Overall Study||10
10958673|NCT00466206|12131336|FG000|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
10958674|NCT00466206|12131336|FG000|NOT COMPLETED|Overall Study||0
10958675|NCT00466310|12131346|FG000|STARTED|Overall Study||20
10958676|NCT00466310|12131347|FG001|STARTED|Overall Study||20
10958677|NCT00466310|12131348|FG002|STARTED|Overall Study||31
10958678|NCT00466310|12131346|FG000|COMPLETED|Overall Study||20
10958679|NCT00466310|12131347|FG001|COMPLETED|Overall Study||20
10958680|NCT00466310|12131348|FG002|COMPLETED|Overall Study||31
10958681|NCT00466310|12131346|FG000|NOT COMPLETED|Overall Study||0
10958682|NCT00466310|12131347|FG001|NOT COMPLETED|Overall Study||0
10958683|NCT00466310|12131348|FG002|NOT COMPLETED|Overall Study||0
10958684|NCT00466323|12131358|FG000|STARTED|Overall Study||117
10958685|NCT00466323|12131359|FG001|STARTED|Overall Study||115
10958686|NCT00466323|12131358|FG000|COMPLETED|Overall Study||89
10958687|NCT00466323|12131359|FG001|COMPLETED|Overall Study||92
10958688|NCT00466323|12131358|FG000|NOT COMPLETED|Overall Study||28
10958689|NCT00466323|12131359|FG001|NOT COMPLETED|Overall Study||23
10958690|NCT00466440|12131368|FG000|STARTED|Overall Study||14
10958691|NCT00466440|12131369|FG001|STARTED|Overall Study||48
10958692|NCT00466440|12131370|FG002|STARTED|Overall Study||46
10958693|NCT00466440|12131368|FG000|Received at Least One Dose of Study Drug|Overall Study||14
10958694|NCT00466440|12131369|FG001|Received at Least One Dose of Study Drug|Overall Study||47
10958695|NCT00466440|12131370|FG002|Received at Least One Dose of Study Drug|Overall Study||41
10958696|NCT00466440|12131368|FG000|COMPLETED|Overall Study||0
10958697|NCT00466440|12131369|FG001|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|36
10958698|NCT00466440|12131370|FG002|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|34
10958699|NCT00466440|12131368|FG000|NOT COMPLETED|Overall Study||14
10958700|NCT00466440|12131369|FG001|NOT COMPLETED|Overall Study||12
10958701|NCT00466440|12131370|FG002|NOT COMPLETED|Overall Study||12
10958702|NCT00466505|12131387|FG000|STARTED|Overall Study||17
10958703|NCT00466505|12131387|FG000|COMPLETED|Overall Study||0
10958704|NCT00466505|12131387|FG000|NOT COMPLETED|Overall Study||17
10958705|NCT00466661|12131393|FG000|STARTED|Overall Study||16
10958706|NCT00466661|12131394|FG001|STARTED|Overall Study||17
10958707|NCT00466661|12131393|FG000|At Least 1 Postrandomization Visit|Overall Study||14
10958708|NCT00466661|12131394|FG001|At Least 1 Postrandomization Visit|Overall Study||16
10958709|NCT00466661|12131393|FG000|COMPLETED|Overall Study||12
10958710|NCT00466661|12131394|FG001|COMPLETED|Overall Study||11
10958711|NCT00466661|12131393|FG000|NOT COMPLETED|Overall Study||4
10958712|NCT00466661|12131394|FG001|NOT COMPLETED|Overall Study||6
10958713|NCT00466687|12131400|FG000|STARTED|Overall Study||34
10958714|NCT00466687|12131400|FG000|COMPLETED|Overall Study||0
10958715|NCT00466687|12131400|FG000|NOT COMPLETED|Overall Study||34
10958716|NCT00466726|12131406|FG000|STARTED|Overall Study||57
10958717|NCT00466726|12131406|FG000|COMPLETED|Overall Study||43
10958718|NCT00466726|12131406|FG000|NOT COMPLETED|Overall Study||14
10958719|NCT00466752|12131412|FG000|STARTED|Overall Study||5
10958720|NCT00466752|12131413|FG001|STARTED|Overall Study||0
10958721|NCT00466752|12131412|FG000|COMPLETED|Overall Study||5
10958722|NCT00466752|12131413|FG001|COMPLETED|Overall Study||0
10958723|NCT00466752|12131412|FG000|NOT COMPLETED|Overall Study||0
10958724|NCT00466752|12131413|FG001|NOT COMPLETED|Overall Study||0
10958725|NCT00466817|12131421|FG000|STARTED|Overall Study||49
10958726|NCT00466817|12131422|FG001|STARTED|Overall Study||47
10958727|NCT00466817|12131421|FG000|COMPLETED|Overall Study||44
10958728|NCT00466817|12131422|FG001|COMPLETED|Overall Study||43
10958729|NCT00466817|12131421|FG000|NOT COMPLETED|Overall Study||5
10958730|NCT00466817|12131422|FG001|NOT COMPLETED|Overall Study||4
10958731|NCT00466921|12131437|FG000|STARTED|First 3 Cycles of Treatment|One patient completed only a few days of treatment|33
10958732|NCT00466921|12131437|FG000|Completed 1 Cycle|First 3 Cycles of Treatment||32
10958733|NCT00466921|12131437|FG000|Started Cycle 2|First 3 Cycles of Treatment||31
10958734|NCT00466921|12131437|FG000|Completed 3 Cycles|First 3 Cycles of Treatment||26
10958735|NCT00466921|12131437|FG000|COMPLETED|First 3 Cycles of Treatment||26
10958736|NCT00466921|12131437|FG000|NOT COMPLETED|First 3 Cycles of Treatment||7
10958737|NCT00466921|12131437|FG000|STARTED|Completed 4 Cycles/Reached 1st Response||26
10958738|NCT00466921|12131437|FG000|Completed 4 Cycles/1st Response|Completed 4 Cycles/Reached 1st Response||21
10958739|NCT00466921|12131437|FG000|COMPLETED|Completed 4 Cycles/Reached 1st Response||21
10958740|NCT00466921|12131437|FG000|NOT COMPLETED|Completed 4 Cycles/Reached 1st Response||5
10958741|NCT00466921|12131437|FG000|STARTED|Continued Treatment||21
10958742|NCT00466921|12131437|FG000|COMPLETED|Continued Treatment||21
10958743|NCT00466921|12131437|FG000|NOT COMPLETED|Continued Treatment||0
10958744|NCT00466921|12131437|FG000|STARTED|Follow up for a Minimum of 1 Year||33
10958745|NCT00466921|12131437|FG000|COMPLETED|Follow up for a Minimum of 1 Year||27
10958746|NCT00466921|12131437|FG000|NOT COMPLETED|Follow up for a Minimum of 1 Year||6
10958747|NCT00466947|12131443|FG000|STARTED|Primary Outcome Analysis Period||11875
10958748|NCT00466947|12131444|FG001|STARTED|Primary Outcome Analysis Period||11863
10958749|NCT00466947|12131443|FG000|Ongoing|Primary Outcome Analysis Period||11875
10958750|NCT00466947|12131444|FG001|Ongoing|Primary Outcome Analysis Period||11863
10958751|NCT00466947|12131443|FG000|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
10958752|NCT00466947|12131444|FG001|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
10958753|NCT00466947|12131443|FG000|NOT COMPLETED|Primary Outcome Analysis Period||11875
10958754|NCT00466947|12131444|FG001|NOT COMPLETED|Primary Outcome Analysis Period||11863
10958755|NCT00466947|12131443|FG000|STARTED|Study End Analysis Period||11798
10958756|NCT00466947|12131444|FG001|STARTED|Study End Analysis Period||11799
10958757|NCT00466947|12131443|FG000|COMPLETED|Study End Analysis Period||9302
10958758|NCT00466947|12131444|FG001|COMPLETED|Study End Analysis Period||9265
10958759|NCT00466947|12131443|FG000|NOT COMPLETED|Study End Analysis Period||2496
10958760|NCT00466947|12131444|FG001|NOT COMPLETED|Study End Analysis Period||2534
10958761|NCT00466960|12131451|FG000|STARTED|Overall Study||21
10958762|NCT00466960|12131451|FG000|COMPLETED|Overall Study||21
10958763|NCT00466960|12131451|FG000|NOT COMPLETED|Overall Study||0
10958764|NCT00467038|12131457|FG000|STARTED|Overall Study||11
10958765|NCT00467038|12131458|FG001|STARTED|Overall Study||11
10958766|NCT00467038|12131457|FG000|COMPLETED|Overall Study||11
10958767|NCT00467038|12131458|FG001|COMPLETED|Overall Study||11
10958768|NCT00467038|12131457|FG000|NOT COMPLETED|Overall Study||0
10958769|NCT00467038|12131458|FG001|NOT COMPLETED|Overall Study||0
10958770|NCT00467051|12131465|FG000|STARTED|Overall Study||20
10958771|NCT00467051|12131465|FG000|COMPLETED|Overall Study||18
10958772|NCT00467051|12131465|FG000|NOT COMPLETED|Overall Study||2
10958773|NCT00467077|12131470|FG000|STARTED|Overall Study||21
10958774|NCT00467077|12131470|FG000|COMPLETED|Overall Study||21
10958775|NCT00467077|12131470|FG000|NOT COMPLETED|Overall Study||0
10958776|NCT00467259|12131476|FG000|STARTED|Overall Study||251
10958777|NCT00467259|12131477|FG001|STARTED|Overall Study||1020
10958778|NCT00467259|12131476|FG000|ITT Population|Overall Study||251
10958779|NCT00467259|12131477|FG001|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
10958780|NCT00467259|12131476|FG000|COMPLETED|Overall Study||176
10958781|NCT00467259|12131477|FG001|COMPLETED|Overall Study||778
10958782|NCT00467259|12131476|FG000|NOT COMPLETED|Overall Study||75
10958783|NCT00467259|12131477|FG001|NOT COMPLETED|Overall Study||242
10958784|NCT00467272|12131483|FG000|STARTED|Overall Study||41
10958785|NCT00467272|12131483|FG000|COMPLETED|Overall Study||38
10958786|NCT00467272|12131483|FG000|NOT COMPLETED|Overall Study||3
10958787|NCT00467285|12131489|FG000|STARTED|Overall Study||32
10958788|NCT00467285|12131490|FG001|STARTED|Overall Study||64
10958789|NCT00467285|12131489|FG000|COMPLETED|Overall Study||28
10958790|NCT00467285|12131490|FG001|COMPLETED|Overall Study||60
10958791|NCT00467285|12131489|FG000|NOT COMPLETED|Overall Study||4
10958792|NCT00467285|12131490|FG001|NOT COMPLETED|Overall Study||4
10958793|NCT00467298|12131500|FG000|STARTED|Overall Study||46
10958794|NCT00467298|12131501|FG001|STARTED|Overall Study||44
10958795|NCT00467298|12131500|FG000|COMPLETED|Overall Study||42
10958796|NCT00467298|12131501|FG001|COMPLETED|Overall Study||38
10958797|NCT00467298|12131500|FG000|NOT COMPLETED|Overall Study||4
10958798|NCT00467298|12131501|FG001|NOT COMPLETED|Overall Study||6
10958799|NCT00467350|12131509|FG000|STARTED|Overall Study||41
10958800|NCT00467350|12131510|FG001|STARTED|Overall Study||39
10958801|NCT00467350|12131509|FG000|COMPLETED|Overall Study||40
10958802|NCT00467350|12131510|FG001|COMPLETED|Overall Study||39
10958803|NCT00467350|12131509|FG000|NOT COMPLETED|Overall Study||1
10958804|NCT00467350|12131510|FG001|NOT COMPLETED|Overall Study||0
10958805|NCT00467363|12131518|FG000|STARTED|Overall Study||615
10958806|NCT00467363|12131519|FG001|STARTED|Overall Study||613
10958807|NCT00467363|12131518|FG000|COMPLETED|Overall Study||535
10958808|NCT00467363|12131519|FG001|COMPLETED|Overall Study||543
10958809|NCT00467363|12131518|FG000|NOT COMPLETED|Overall Study||80
10958810|NCT00467363|12131519|FG001|NOT COMPLETED|Overall Study||70
10958811|NCT00467389|12131525|FG000|STARTED|Overall Study||6
10958812|NCT00467389|12131526|FG001|STARTED|Overall Study||6
10958813|NCT00467389|12131525|FG000|COMPLETED|Overall Study||6
10958814|NCT00467389|12131526|FG001|COMPLETED|Overall Study||6
10958815|NCT00467389|12131525|FG000|NOT COMPLETED|Overall Study||0
10958816|NCT00467389|12131526|FG001|NOT COMPLETED|Overall Study||0
10958817|NCT00467519|12131534|FG000|STARTED|Overall Study||531
10958818|NCT00467519|12131535|FG001|STARTED|Overall Study||511
10958819|NCT00467519|12131534|FG000|COMPLETED|Overall Study||517
10958820|NCT00467519|12131535|FG001|COMPLETED|Overall Study||488
10958821|NCT00467519|12131534|FG000|NOT COMPLETED|Overall Study||14
10958822|NCT00467519|12131535|FG001|NOT COMPLETED|Overall Study||23
10958823|NCT00467558|12131543|FG000|STARTED|Overall Study||4
10958824|NCT00467558|12131544|FG001|STARTED|Overall Study||3
10958825|NCT00467558|12131543|FG000|COMPLETED|Overall Study||2
10958826|NCT00467558|12131544|FG001|COMPLETED|Overall Study||3
10958827|NCT00467558|12131543|FG000|NOT COMPLETED|Overall Study||2
10958828|NCT00467558|12131544|FG001|NOT COMPLETED|Overall Study||0
10958829|NCT00467584|12131553|FG000|STARTED|Overall Study||21
10958830|NCT00467584|12131554|FG001|STARTED|Overall Study||20
10958831|NCT00467584|12131555|FG002|STARTED|Overall Study||21
10958832|NCT00467584|12131553|FG000|COMPLETED|Overall Study||17
10958833|NCT00467584|12131554|FG001|COMPLETED|Overall Study||15
10958834|NCT00467584|12131555|FG002|COMPLETED|Overall Study||20
10958835|NCT00467584|12131553|FG000|NOT COMPLETED|Overall Study||4
10958836|NCT00467584|12131554|FG001|NOT COMPLETED|Overall Study||5
10958837|NCT00467584|12131555|FG002|NOT COMPLETED|Overall Study||1
10958838|NCT00467597|12131567|FG000|STARTED|Overall Study||26
10958839|NCT00467597|12131568|FG001|STARTED|Overall Study||6
10958840|NCT00467597|12131567|FG000|COMPLETED|Overall Study||24
10958841|NCT00467597|12131568|FG001|COMPLETED|Overall Study||6
10958842|NCT00467597|12131567|FG000|NOT COMPLETED|Overall Study||2
10958843|NCT00467597|12131568|FG001|NOT COMPLETED|Overall Study||0
10958844|NCT00467610|12131578|FG000|STARTED|Overall Study||6
10958845|NCT00467610|12131578|FG000|COMPLETED|Overall Study||5
10958846|NCT00467610|12131578|FG000|NOT COMPLETED|Overall Study||1
10958847|NCT00467649|12131584|FG000|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
10958848|NCT00467649|12131585|FG001|STARTED|Phase 1 (Randomized Population)||56
10958849|NCT00467649|12131586|FG002|STARTED|Phase 1 (Randomized Population)||0
10958850|NCT00467649|12131587|FG003|STARTED|Phase 1 (Randomized Population)||0
10958851|NCT00467649|12131588|FG004|STARTED|Phase 1 (Randomized Population)||0
10958852|NCT00467649|12131589|FG005|STARTED|Phase 1 (Randomized Population)||0
10958853|NCT00467649|12131584|FG000|Intent to Treat|Phase 1 (Randomized Population)||56
10958854|NCT00467649|12131585|FG001|Intent to Treat|Phase 1 (Randomized Population)||56
10958855|NCT00467649|12131586|FG002|Intent to Treat|Phase 1 (Randomized Population)||0
10958856|NCT00467649|12131587|FG003|Intent to Treat|Phase 1 (Randomized Population)||0
10958857|NCT00467649|12131588|FG004|Intent to Treat|Phase 1 (Randomized Population)||0
10958858|NCT00467649|12131589|FG005|Intent to Treat|Phase 1 (Randomized Population)||0
10958859|NCT00467649|12131584|FG000|COMPLETED|Phase 1 (Randomized Population)||48
10958860|NCT00467649|12131585|FG001|COMPLETED|Phase 1 (Randomized Population)||50
10958861|NCT00467649|12131586|FG002|COMPLETED|Phase 1 (Randomized Population)||0
10958862|NCT00467649|12131587|FG003|COMPLETED|Phase 1 (Randomized Population)||0
10958863|NCT00467649|12131588|FG004|COMPLETED|Phase 1 (Randomized Population)||0
10958864|NCT00467649|12131589|FG005|COMPLETED|Phase 1 (Randomized Population)||0
10958865|NCT00467649|12131584|FG000|NOT COMPLETED|Phase 1 (Randomized Population)||9
10958866|NCT00467649|12131585|FG001|NOT COMPLETED|Phase 1 (Randomized Population)||6
10958867|NCT00467649|12131586|FG002|NOT COMPLETED|Phase 1 (Randomized Population)||0
10958868|NCT00467649|12131587|FG003|NOT COMPLETED|Phase 1 (Randomized Population)||0
10958869|NCT00467649|12131588|FG004|NOT COMPLETED|Phase 1 (Randomized Population)||0
10958870|NCT00467649|12131589|FG005|NOT COMPLETED|Phase 1 (Randomized Population)||0
10958871|NCT00467649|12131584|FG000|STARTED|Phase 2 (Intent-to-Treat Population)||0
10958872|NCT00467649|12131585|FG001|STARTED|Phase 2 (Intent-to-Treat Population)||0
10958873|NCT00467649|12131586|FG002|STARTED|Phase 2 (Intent-to-Treat Population)||17
10958874|NCT00467649|12131587|FG003|STARTED|Phase 2 (Intent-to-Treat Population)||31
10958875|NCT00467649|12131588|FG004|STARTED|Phase 2 (Intent-to-Treat Population)||14
10958876|NCT00467649|12131589|FG005|STARTED|Phase 2 (Intent-to-Treat Population)||36
10958877|NCT00467649|12131584|FG000|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
10958878|NCT00467649|12131585|FG001|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
10958879|NCT00467649|12131586|FG002|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
10958880|NCT00467649|12131587|FG003|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
10958881|NCT00467649|12131588|FG004|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
10958882|NCT00467649|12131589|FG005|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
10958883|NCT00467649|12131584|FG000|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
10958884|NCT00467649|12131585|FG001|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
10958885|NCT00467649|12131586|FG002|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
10958886|NCT00467649|12131587|FG003|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
10958887|NCT00467649|12131588|FG004|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
10958888|NCT00467649|12131589|FG005|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
10958889|NCT00467740|12131612|FG000|STARTED|Overall Study||54
10958890|NCT00467740|12131613|FG001|STARTED|Overall Study||61
10958891|NCT00467740|12131614|FG002|STARTED|Overall Study||60
10958892|NCT00467740|12131615|FG003|STARTED|Overall Study||60
10958893|NCT00467740|12131616|FG004|STARTED|Overall Study||61
10958894|NCT00467740|12131612|FG000|COMPLETED|Overall Study||53
10958895|NCT00467740|12131613|FG001|COMPLETED|Overall Study||58
10958896|NCT00467740|12131614|FG002|COMPLETED|Overall Study||58
10958897|NCT00467740|12131615|FG003|COMPLETED|Overall Study||59
10958898|NCT00467740|12131616|FG004|COMPLETED|Overall Study||61
10958899|NCT00467740|12131612|FG000|NOT COMPLETED|Overall Study||1
10958900|NCT00467740|12131613|FG001|NOT COMPLETED|Overall Study||3
10958901|NCT00467740|12131614|FG002|NOT COMPLETED|Overall Study||2
10958902|NCT00467740|12131615|FG003|NOT COMPLETED|Overall Study||1
10958903|NCT00467740|12131616|FG004|NOT COMPLETED|Overall Study||0
10958904|NCT00467779|12131643|FG000|STARTED|Stage 1||4
10958905|NCT00467779|12131644|FG001|STARTED|Stage 1||3
10958906|NCT00467779|12131645|FG002|STARTED|Stage 1||3
10958907|NCT00467779|12131646|FG003|STARTED|Stage 1||3
10958908|NCT00467779|12131647|FG004|STARTED|Stage 1||3
10958909|NCT00467779|12131648|FG005|STARTED|Stage 1||6
10958910|NCT00467779|12131649|FG006|STARTED|Stage 1||7
10958911|NCT00467779|12131650|FG007|STARTED|Stage 1||7
10958912|NCT00467779|12131651|FG008|STARTED|Stage 1||0
10958913|NCT00467779|12131652|FG009|STARTED|Stage 1||0
10958914|NCT00467779|12131653|FG010|STARTED|Stage 1||0
10958915|NCT00467779|12131654|FG011|STARTED|Stage 1||0
10958916|NCT00467779|12131655|FG012|STARTED|Stage 1||0
10958917|NCT00467779|12131656|FG013|STARTED|Stage 1||0
10958918|NCT00467779|12131657|FG014|STARTED|Stage 1||0
10958919|NCT00467779|12131643|FG000|COMPLETED|Stage 1||0
10958920|NCT00467779|12131644|FG001|COMPLETED|Stage 1||0
10958921|NCT00467779|12131645|FG002|COMPLETED|Stage 1||0
10958922|NCT00467779|12131646|FG003|COMPLETED|Stage 1||0
10958923|NCT00467779|12131647|FG004|COMPLETED|Stage 1||0
10958924|NCT00467779|12131648|FG005|COMPLETED|Stage 1||1
10958925|NCT00467779|12131649|FG006|COMPLETED|Stage 1||0
10958926|NCT00467779|12131650|FG007|COMPLETED|Stage 1||0
10958927|NCT00467779|12131651|FG008|COMPLETED|Stage 1||0
10958928|NCT00467779|12131652|FG009|COMPLETED|Stage 1||0
10958929|NCT00467779|12131653|FG010|COMPLETED|Stage 1||0
10958930|NCT00467779|12131654|FG011|COMPLETED|Stage 1||0
10958931|NCT00467779|12131655|FG012|COMPLETED|Stage 1||0
10958932|NCT00467779|12131656|FG013|COMPLETED|Stage 1||0
10958933|NCT00467779|12131657|FG014|COMPLETED|Stage 1||0
10958934|NCT00467779|12131643|FG000|NOT COMPLETED|Stage 1||4
10958935|NCT00467779|12131644|FG001|NOT COMPLETED|Stage 1||3
10958936|NCT00467779|12131645|FG002|NOT COMPLETED|Stage 1||3
10958937|NCT00467779|12131646|FG003|NOT COMPLETED|Stage 1||3
10958938|NCT00467779|12131647|FG004|NOT COMPLETED|Stage 1||3
10958939|NCT00467779|12131648|FG005|NOT COMPLETED|Stage 1||5
10958940|NCT00467779|12131649|FG006|NOT COMPLETED|Stage 1||7
10958941|NCT00467779|12131650|FG007|NOT COMPLETED|Stage 1||7
10958942|NCT00467779|12131651|FG008|NOT COMPLETED|Stage 1||0
10958943|NCT00467779|12131652|FG009|NOT COMPLETED|Stage 1||0
10958944|NCT00467779|12131653|FG010|NOT COMPLETED|Stage 1||0
10958945|NCT00467779|12131654|FG011|NOT COMPLETED|Stage 1||0
10958946|NCT00467779|12131655|FG012|NOT COMPLETED|Stage 1||0
10958947|NCT00467779|12131656|FG013|NOT COMPLETED|Stage 1||0
10958948|NCT00467779|12131657|FG014|NOT COMPLETED|Stage 1||0
10958949|NCT00467779|12131643|FG000|STARTED|Stage 1A||0
10958950|NCT00467779|12131644|FG001|STARTED|Stage 1A||0
10958951|NCT00467779|12131645|FG002|STARTED|Stage 1A||0
10958952|NCT00467779|12131646|FG003|STARTED|Stage 1A||0
10958953|NCT00467779|12131647|FG004|STARTED|Stage 1A||0
10958954|NCT00467779|12131648|FG005|STARTED|Stage 1A||0
10958955|NCT00467779|12131649|FG006|STARTED|Stage 1A||0
10958956|NCT00467779|12131650|FG007|STARTED|Stage 1A||0
10958957|NCT00467779|12131651|FG008|STARTED|Stage 1A||0
10958958|NCT00467779|12131652|FG009|STARTED|Stage 1A||3
10958959|NCT00467779|12131653|FG010|STARTED|Stage 1A||3
10958960|NCT00467779|12131654|FG011|STARTED|Stage 1A||8
10958961|NCT00467779|12131655|FG012|STARTED|Stage 1A||6
10958962|NCT00467779|12131656|FG013|STARTED|Stage 1A||0
10958963|NCT00467779|12131657|FG014|STARTED|Stage 1A||0
10958964|NCT00467779|12131643|FG000|COMPLETED|Stage 1A||0
10958965|NCT00467779|12131644|FG001|COMPLETED|Stage 1A||0
10958966|NCT00467779|12131645|FG002|COMPLETED|Stage 1A||0
10958967|NCT00467779|12131646|FG003|COMPLETED|Stage 1A||0
10958968|NCT00467779|12131647|FG004|COMPLETED|Stage 1A||0
10958969|NCT00467779|12131648|FG005|COMPLETED|Stage 1A||0
10958970|NCT00467779|12131649|FG006|COMPLETED|Stage 1A||0
10958971|NCT00467779|12131650|FG007|COMPLETED|Stage 1A||0
10958972|NCT00467779|12131651|FG008|COMPLETED|Stage 1A||0
10958973|NCT00467779|12131652|FG009|COMPLETED|Stage 1A||0
10958974|NCT00467779|12131653|FG010|COMPLETED|Stage 1A||0
10958975|NCT00467779|12131654|FG011|COMPLETED|Stage 1A||0
10958976|NCT00467779|12131655|FG012|COMPLETED|Stage 1A||0
10958977|NCT00467779|12131656|FG013|COMPLETED|Stage 1A||0
10958978|NCT00467779|12131657|FG014|COMPLETED|Stage 1A||0
10958979|NCT00467779|12131643|FG000|NOT COMPLETED|Stage 1A||0
10958980|NCT00467779|12131644|FG001|NOT COMPLETED|Stage 1A||0
10958981|NCT00467779|12131645|FG002|NOT COMPLETED|Stage 1A||0
10958982|NCT00467779|12131646|FG003|NOT COMPLETED|Stage 1A||0
10958983|NCT00467779|12131647|FG004|NOT COMPLETED|Stage 1A||0
10958984|NCT00467779|12131648|FG005|NOT COMPLETED|Stage 1A||0
10958985|NCT00467779|12131649|FG006|NOT COMPLETED|Stage 1A||0
10958986|NCT00467779|12131650|FG007|NOT COMPLETED|Stage 1A||0
10958987|NCT00467779|12131651|FG008|NOT COMPLETED|Stage 1A||0
10958988|NCT00467779|12131652|FG009|NOT COMPLETED|Stage 1A||3
10958989|NCT00467779|12131653|FG010|NOT COMPLETED|Stage 1A||3
10958990|NCT00467779|12131654|FG011|NOT COMPLETED|Stage 1A||8
10958991|NCT00467779|12131655|FG012|NOT COMPLETED|Stage 1A||6
10958992|NCT00467779|12131656|FG013|NOT COMPLETED|Stage 1A||0
10958993|NCT00467779|12131657|FG014|NOT COMPLETED|Stage 1A||0
10958994|NCT00467779|12131643|FG000|STARTED|Stage 2||0
10958995|NCT00467779|12131644|FG001|STARTED|Stage 2||0
10958996|NCT00467779|12131645|FG002|STARTED|Stage 2||0
10958997|NCT00467779|12131646|FG003|STARTED|Stage 2||0
10958998|NCT00467779|12131647|FG004|STARTED|Stage 2||0
10958999|NCT00467779|12131648|FG005|STARTED|Stage 2||0
10959000|NCT00467779|12131649|FG006|STARTED|Stage 2||0
10959001|NCT00467779|12131650|FG007|STARTED|Stage 2||0
10959002|NCT00467779|12131651|FG008|STARTED|Stage 2||21
10959003|NCT00467779|12131652|FG009|STARTED|Stage 2||0
10959004|NCT00467779|12131653|FG010|STARTED|Stage 2||0
10959005|NCT00467779|12131654|FG011|STARTED|Stage 2||0
10959006|NCT00467779|12131655|FG012|STARTED|Stage 2||0
10959007|NCT00467779|12131656|FG013|STARTED|Stage 2||0
10959008|NCT00467779|12131657|FG014|STARTED|Stage 2||0
10959009|NCT00467779|12131643|FG000|COMPLETED|Stage 2||0
10959010|NCT00467779|12131644|FG001|COMPLETED|Stage 2||0
10959011|NCT00467779|12131645|FG002|COMPLETED|Stage 2||0
10959012|NCT00467779|12131646|FG003|COMPLETED|Stage 2||0
10959013|NCT00467779|12131647|FG004|COMPLETED|Stage 2||0
10959014|NCT00467779|12131648|FG005|COMPLETED|Stage 2||0
10959015|NCT00467779|12131649|FG006|COMPLETED|Stage 2||0
10959016|NCT00467779|12131650|FG007|COMPLETED|Stage 2||0
10959017|NCT00467779|12131651|FG008|COMPLETED|Stage 2||0
10959018|NCT00467779|12131652|FG009|COMPLETED|Stage 2||0
10959019|NCT00467779|12131653|FG010|COMPLETED|Stage 2||0
10959020|NCT00467779|12131654|FG011|COMPLETED|Stage 2||0
10959021|NCT00467779|12131655|FG012|COMPLETED|Stage 2||0
10959022|NCT00467779|12131656|FG013|COMPLETED|Stage 2||0
10959023|NCT00467779|12131657|FG014|COMPLETED|Stage 2||0
10959024|NCT00467779|12131643|FG000|NOT COMPLETED|Stage 2||0
10959025|NCT00467779|12131644|FG001|NOT COMPLETED|Stage 2||0
10959026|NCT00467779|12131645|FG002|NOT COMPLETED|Stage 2||0
10959027|NCT00467779|12131646|FG003|NOT COMPLETED|Stage 2||0
10959028|NCT00467779|12131647|FG004|NOT COMPLETED|Stage 2||0
10959029|NCT00467779|12131648|FG005|NOT COMPLETED|Stage 2||0
10959030|NCT00467779|12131649|FG006|NOT COMPLETED|Stage 2||0
10959031|NCT00467779|12131650|FG007|NOT COMPLETED|Stage 2||0
10959032|NCT00467779|12131651|FG008|NOT COMPLETED|Stage 2||21
10959033|NCT00467779|12131652|FG009|NOT COMPLETED|Stage 2||0
10959034|NCT00467779|12131653|FG010|NOT COMPLETED|Stage 2||0
10959035|NCT00467779|12131654|FG011|NOT COMPLETED|Stage 2||0
10959036|NCT00467779|12131655|FG012|NOT COMPLETED|Stage 2||0
10959037|NCT00467779|12131656|FG013|NOT COMPLETED|Stage 2||0
10959038|NCT00467779|12131657|FG014|NOT COMPLETED|Stage 2||0
10959039|NCT00467779|12131643|FG000|STARTED|Stage 2A||0
10959040|NCT00467779|12131644|FG001|STARTED|Stage 2A||0
10959041|NCT00467779|12131645|FG002|STARTED|Stage 2A||0
10959042|NCT00467779|12131646|FG003|STARTED|Stage 2A||0
10959043|NCT00467779|12131647|FG004|STARTED|Stage 2A||0
10959044|NCT00467779|12131648|FG005|STARTED|Stage 2A||0
10959045|NCT00467779|12131649|FG006|STARTED|Stage 2A||0
10959046|NCT00467779|12131650|FG007|STARTED|Stage 2A||0
10959047|NCT00467779|12131651|FG008|STARTED|Stage 2A||0
10959048|NCT00467779|12131652|FG009|STARTED|Stage 2A||0
10959049|NCT00467779|12131653|FG010|STARTED|Stage 2A||0
10959050|NCT00467779|12131654|FG011|STARTED|Stage 2A||0
10959051|NCT00467779|12131655|FG012|STARTED|Stage 2A||0
10959052|NCT00467779|12131656|FG013|STARTED|Stage 2A||22
10959053|NCT00467779|12131657|FG014|STARTED|Stage 2A||0
10959054|NCT00467779|12131643|FG000|COMPLETED|Stage 2A||0
10959055|NCT00467779|12131644|FG001|COMPLETED|Stage 2A||0
10959056|NCT00467779|12131645|FG002|COMPLETED|Stage 2A||0
10959057|NCT00467779|12131646|FG003|COMPLETED|Stage 2A||0
10959058|NCT00467779|12131647|FG004|COMPLETED|Stage 2A||0
10959059|NCT00467779|12131648|FG005|COMPLETED|Stage 2A||0
10959060|NCT00467779|12131649|FG006|COMPLETED|Stage 2A||0
10959061|NCT00467779|12131650|FG007|COMPLETED|Stage 2A||0
10959062|NCT00467779|12131651|FG008|COMPLETED|Stage 2A||0
10959063|NCT00467779|12131652|FG009|COMPLETED|Stage 2A||0
10959064|NCT00467779|12131653|FG010|COMPLETED|Stage 2A||0
10959065|NCT00467779|12131654|FG011|COMPLETED|Stage 2A||0
10959066|NCT00467779|12131655|FG012|COMPLETED|Stage 2A||0
10959067|NCT00467779|12131656|FG013|COMPLETED|Stage 2A||1
10959068|NCT00467779|12131657|FG014|COMPLETED|Stage 2A||0
10959069|NCT00467779|12131643|FG000|NOT COMPLETED|Stage 2A||0
10959070|NCT00467779|12131644|FG001|NOT COMPLETED|Stage 2A||0
10959071|NCT00467779|12131645|FG002|NOT COMPLETED|Stage 2A||0
10959072|NCT00467779|12131646|FG003|NOT COMPLETED|Stage 2A||0
10959073|NCT00467779|12131647|FG004|NOT COMPLETED|Stage 2A||0
10959074|NCT00467779|12131648|FG005|NOT COMPLETED|Stage 2A||0
10959075|NCT00467779|12131649|FG006|NOT COMPLETED|Stage 2A||0
10959076|NCT00467779|12131650|FG007|NOT COMPLETED|Stage 2A||0
10959077|NCT00467779|12131651|FG008|NOT COMPLETED|Stage 2A||0
10959078|NCT00467779|12131652|FG009|NOT COMPLETED|Stage 2A||0
10959079|NCT00467779|12131653|FG010|NOT COMPLETED|Stage 2A||0
10959080|NCT00467779|12131654|FG011|NOT COMPLETED|Stage 2A||0
10959081|NCT00467779|12131655|FG012|NOT COMPLETED|Stage 2A||0
10959082|NCT00467779|12131656|FG013|NOT COMPLETED|Stage 2A||21
10959083|NCT00467779|12131657|FG014|NOT COMPLETED|Stage 2A||0
10959084|NCT00467779|12131643|FG000|STARTED|Stage 3||0
10959085|NCT00467779|12131644|FG001|STARTED|Stage 3||0
10959086|NCT00467779|12131645|FG002|STARTED|Stage 3||0
10959087|NCT00467779|12131646|FG003|STARTED|Stage 3||0
10959088|NCT00467779|12131647|FG004|STARTED|Stage 3||0
10959089|NCT00467779|12131648|FG005|STARTED|Stage 3||0
10959090|NCT00467779|12131649|FG006|STARTED|Stage 3||0
10959091|NCT00467779|12131650|FG007|STARTED|Stage 3||0
10959092|NCT00467779|12131651|FG008|STARTED|Stage 3||0
10959093|NCT00467779|12131652|FG009|STARTED|Stage 3||0
10959094|NCT00467779|12131653|FG010|STARTED|Stage 3||0
10959095|NCT00467779|12131654|FG011|STARTED|Stage 3||0
10959096|NCT00467779|12131655|FG012|STARTED|Stage 3||0
10959097|NCT00467779|12131656|FG013|STARTED|Stage 3||0
10959098|NCT00467779|12131657|FG014|STARTED|Stage 3||20
10959099|NCT00467779|12131643|FG000|COMPLETED|Stage 3||0
10959100|NCT00467779|12131644|FG001|COMPLETED|Stage 3||0
10959101|NCT00467779|12131645|FG002|COMPLETED|Stage 3||0
10959102|NCT00467779|12131646|FG003|COMPLETED|Stage 3||0
10959103|NCT00467779|12131647|FG004|COMPLETED|Stage 3||0
10959104|NCT00467779|12131648|FG005|COMPLETED|Stage 3||0
10959105|NCT00467779|12131649|FG006|COMPLETED|Stage 3||0
10959106|NCT00467779|12131650|FG007|COMPLETED|Stage 3||0
10959107|NCT00467779|12131651|FG008|COMPLETED|Stage 3||0
10959108|NCT00467779|12131652|FG009|COMPLETED|Stage 3||0
10959109|NCT00467779|12131653|FG010|COMPLETED|Stage 3||0
10959110|NCT00467779|12131654|FG011|COMPLETED|Stage 3||0
10959111|NCT00467779|12131655|FG012|COMPLETED|Stage 3||0
10959112|NCT00467779|12131656|FG013|COMPLETED|Stage 3||0
10959113|NCT00467779|12131657|FG014|COMPLETED|Stage 3||3
10959114|NCT00467779|12131643|FG000|NOT COMPLETED|Stage 3||0
10959115|NCT00467779|12131644|FG001|NOT COMPLETED|Stage 3||0
10959116|NCT00467779|12131645|FG002|NOT COMPLETED|Stage 3||0
10959117|NCT00467779|12131646|FG003|NOT COMPLETED|Stage 3||0
10959118|NCT00467779|12131647|FG004|NOT COMPLETED|Stage 3||0
10959119|NCT00467779|12131648|FG005|NOT COMPLETED|Stage 3||0
10959120|NCT00467779|12131649|FG006|NOT COMPLETED|Stage 3||0
10959121|NCT00467779|12131650|FG007|NOT COMPLETED|Stage 3||0
10959122|NCT00467779|12131651|FG008|NOT COMPLETED|Stage 3||0
10959123|NCT00467779|12131652|FG009|NOT COMPLETED|Stage 3||0
10959124|NCT00467779|12131653|FG010|NOT COMPLETED|Stage 3||0
10959125|NCT00467779|12131654|FG011|NOT COMPLETED|Stage 3||0
10959126|NCT00467779|12131655|FG012|NOT COMPLETED|Stage 3||0
10959127|NCT00467779|12131656|FG013|NOT COMPLETED|Stage 3||0
10959128|NCT00467779|12131657|FG014|NOT COMPLETED|Stage 3||17
10959129|NCT00467818|12131697|FG000|STARTED|Overall Study||9
10959130|NCT00467818|12131698|FG001|STARTED|Overall Study||8
10959131|NCT00467818|12131697|FG000|COMPLETED|Overall Study||6
10959132|NCT00467818|12131698|FG001|COMPLETED|Overall Study||6
10959133|NCT00467818|12131697|FG000|NOT COMPLETED|Overall Study||3
10959134|NCT00467818|12131698|FG001|NOT COMPLETED|Overall Study||2
10959135|NCT00467831|12131706|FG000|STARTED|Overall Study||3
10959136|NCT00467831|12131706|FG000|COMPLETED|Overall Study||0
10959137|NCT00467831|12131706|FG000|NOT COMPLETED|Overall Study||3
10959138|NCT00467844|12131713|FG000|STARTED|Overall Study||53
10959139|NCT00467844|12131714|FG001|STARTED|Overall Study||54
10959140|NCT00467844|12131715|FG002|STARTED|Overall Study||52
10959141|NCT00467844|12131713|FG000|COMPLETED|Overall Study||34
10959142|NCT00467844|12131714|FG001|COMPLETED|Overall Study||34
10959143|NCT00467844|12131715|FG002|COMPLETED|Overall Study||38
10959144|NCT00467844|12131713|FG000|NOT COMPLETED|Overall Study||19
10959145|NCT00467844|12131714|FG001|NOT COMPLETED|Overall Study||20
10959146|NCT00467844|12131715|FG002|NOT COMPLETED|Overall Study||14
10959147|NCT00467857|12131728|FG000|STARTED|Overall Study||146
10959148|NCT00467857|12131729|FG001|STARTED|Overall Study||147
10959149|NCT00467857|12131728|FG000|COMPLETED|Overall Study||143
10959150|NCT00467857|12131729|FG001|COMPLETED|Overall Study||139
10959151|NCT00467857|12131728|FG000|NOT COMPLETED|Overall Study||3
10959152|NCT00467857|12131729|FG001|NOT COMPLETED|Overall Study||8
10959153|NCT00467870|12131741|FG000|STARTED|Overall Study||120
10959154|NCT00467870|12131742|FG001|STARTED|Overall Study||117
10959155|NCT00467870|12131743|FG002|STARTED|Overall Study||22
10959156|NCT00467870|12131744|FG003|STARTED|Overall Study||112
10959157|NCT00467870|12131745|FG004|STARTED|Overall Study||130
10959158|NCT00467870|12131746|FG005|STARTED|Overall Study||23
10959159|NCT00467870|12131741|FG000|COMPLETED|Overall Study||75
10959160|NCT00467870|12131742|FG001|COMPLETED|Overall Study||74
10959161|NCT00467870|12131743|FG002|COMPLETED|Overall Study||18
10959162|NCT00467870|12131744|FG003|COMPLETED|Overall Study||79
10959163|NCT00467870|12131745|FG004|COMPLETED|Overall Study||93
10959164|NCT00467870|12131746|FG005|COMPLETED|Overall Study||21
10959165|NCT00467870|12131741|FG000|NOT COMPLETED|Overall Study||45
10959166|NCT00467870|12131742|FG001|NOT COMPLETED|Overall Study||43
10959167|NCT00467870|12131743|FG002|NOT COMPLETED|Overall Study||4
10959168|NCT00467870|12131744|FG003|NOT COMPLETED|Overall Study||33
10959169|NCT00467870|12131745|FG004|NOT COMPLETED|Overall Study||37
10959170|NCT00467870|12131746|FG005|NOT COMPLETED|Overall Study||2
10959171|NCT00467896|12131756|FG000|STARTED|Overall Study||62
10959172|NCT00467896|12131756|FG000|COMPLETED|Overall Study||11
10959173|NCT00467896|12131756|FG000|NOT COMPLETED|Overall Study||51
10959174|NCT00467961|12131762|FG000|STARTED|Overall Study||31
10959175|NCT00467961|12131762|FG000|COMPLETED|Overall Study||24
10959176|NCT00467961|12131762|FG000|NOT COMPLETED|Overall Study||7
10959177|NCT00468052|12131768|FG000|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
10959178|NCT00468052|12131769|FG001|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
10959179|NCT00468052|12131768|FG000|Target Enrollment|Overall Study||70
10959180|NCT00468052|12131769|FG001|Target Enrollment|Overall Study||70
10959181|NCT00468052|12131768|FG000|COMPLETED|Overall Study||61
10959182|NCT00468052|12131769|FG001|COMPLETED|Overall Study||61
10959183|NCT00468052|12131768|FG000|NOT COMPLETED|Overall Study||7
10959184|NCT00468052|12131769|FG001|NOT COMPLETED|Overall Study||8
10959185|NCT00468104|12131777|FG000|STARTED|First Intervention||54
10959186|NCT00468104|12131778|FG001|STARTED|First Intervention||46
10959187|NCT00468104|12131777|FG000|COMPLETED|First Intervention||45
10959188|NCT00468104|12131778|FG001|COMPLETED|First Intervention||45
10959189|NCT00468104|12131777|FG000|NOT COMPLETED|First Intervention||9
10959190|NCT00468104|12131778|FG001|NOT COMPLETED|First Intervention||1
10959191|NCT00468104|12131777|FG000|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
10959192|NCT00468104|12131778|FG001|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
10959193|NCT00468104|12131777|FG000|COMPLETED|Second Intervention||3
10959194|NCT00468104|12131778|FG001|COMPLETED|Second Intervention||37
10959195|NCT00468104|12131777|FG000|NOT COMPLETED|Second Intervention||5
10959196|NCT00468104|12131778|FG001|NOT COMPLETED|Second Intervention||4
10959197|NCT00468143|12131787|FG000|STARTED|First Intervention (3 Weeks)||31
10959198|NCT00468143|12131788|FG001|STARTED|First Intervention (3 Weeks)||31
10959199|NCT00468143|12131787|FG000|COMPLETED|First Intervention (3 Weeks)||28
10959200|NCT00468143|12131788|FG001|COMPLETED|First Intervention (3 Weeks)||27
10959201|NCT00468143|12131787|FG000|NOT COMPLETED|First Intervention (3 Weeks)||3
10959202|NCT00468143|12131788|FG001|NOT COMPLETED|First Intervention (3 Weeks)||4
10959203|NCT00468143|12131787|FG000|STARTED|Second Intervention (3 Weeks)||28
10959204|NCT00468143|12131788|FG001|STARTED|Second Intervention (3 Weeks)||27
10959205|NCT00468143|12131787|FG000|COMPLETED|Second Intervention (3 Weeks)||25
10959206|NCT00468143|12131788|FG001|COMPLETED|Second Intervention (3 Weeks)||24
10959207|NCT00468143|12131787|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||3
10959208|NCT00468143|12131788|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||3
10959209|NCT00468169|12131796|FG000|STARTED|Overall Study||57
10959210|NCT00468169|12131797|FG001|STARTED|Overall Study||53
10959211|NCT00468169|12131796|FG000|COMPLETED|Overall Study||56
10959212|NCT00468169|12131797|FG001|COMPLETED|Overall Study||53
10959213|NCT00468169|12131796|FG000|NOT COMPLETED|Overall Study||1
10959214|NCT00468169|12131797|FG001|NOT COMPLETED|Overall Study||0
10959215|NCT00468208|12131805|FG000|STARTED|Overall Study||20
10959216|NCT00468208|12131805|FG000|COMPLETED|Overall Study|All patients reached common closing or early termination|20
10959217|NCT00468208|12131805|FG000|NOT COMPLETED|Overall Study||0
10959218|NCT00468286|12131811|FG000|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
10959219|NCT00468286|12131812|FG001|STARTED|Overall Study||66
10959220|NCT00468286|12131811|FG000|COMPLETED|Overall Study||60
10959221|NCT00468286|12131812|FG001|COMPLETED|Overall Study||54
10959222|NCT00468286|12131811|FG000|NOT COMPLETED|Overall Study||7
10959223|NCT00468286|12131812|FG001|NOT COMPLETED|Overall Study||12
10959224|NCT00468299|12131820|FG000|STARTED|Overall Study||9
10959225|NCT00468299|12131821|FG001|STARTED|Overall Study||8
10959226|NCT00468299|12131820|FG000|COMPLETED|Overall Study||9
10959227|NCT00468299|12131821|FG001|COMPLETED|Overall Study||7
10959228|NCT00468299|12131820|FG000|NOT COMPLETED|Overall Study||0
10959229|NCT00468299|12131821|FG001|NOT COMPLETED|Overall Study||1
10959230|NCT00468481|12131831|FG000|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
10959231|NCT00468481|12131832|FG001|STARTED|Overall Study||94
10959232|NCT00468481|12131831|FG000|Subjects Treated|Overall Study||285
10959233|NCT00468481|12131832|FG001|Subjects Treated|Overall Study||94
10959234|NCT00468481|12131831|FG000|COMPLETED|Overall Study||203
10959235|NCT00468481|12131832|FG001|COMPLETED|Overall Study||70
10959236|NCT00468481|12131831|FG000|NOT COMPLETED|Overall Study||88
10959237|NCT00468481|12131832|FG001|NOT COMPLETED|Overall Study||24
10959238|NCT00468546|12131840|FG000|STARTED|Week 24 Analysis||208
10959239|NCT00468546|12131841|FG001|STARTED|Week 24 Analysis||308
10959240|NCT00468546|12131840|FG000|COMPLETED|Week 24 Analysis||111
10959241|NCT00468546|12131841|FG001|COMPLETED|Week 24 Analysis||253
10959242|NCT00468546|12131840|FG000|NOT COMPLETED|Week 24 Analysis||97
10959243|NCT00468546|12131841|FG001|NOT COMPLETED|Week 24 Analysis||55
10959244|NCT00468546|12131840|FG000|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
10959245|NCT00468546|12131841|FG001|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
10959246|NCT00468546|12131840|FG000|COMPLETED|Week 24 to Week 104 Analysis||103
10959247|NCT00468546|12131841|FG001|COMPLETED|Week 24 to Week 104 Analysis||83
10959248|NCT00468546|12131840|FG000|NOT COMPLETED|Week 24 to Week 104 Analysis||105
10959249|NCT00468546|12131841|FG001|NOT COMPLETED|Week 24 to Week 104 Analysis||225
10959250|NCT00468559|12131849|FG000|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
10959251|NCT00468559|12131850|FG001|STARTED|Open-label Treatment Phase||0
10959252|NCT00468559|12131851|FG002|STARTED|Open-label Treatment Phase||0
10959253|NCT00468559|12131849|FG000|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
10959254|NCT00468559|12131850|FG001|COMPLETED|Open-label Treatment Phase||0
10959255|NCT00468559|12131851|FG002|COMPLETED|Open-label Treatment Phase||0
10959256|NCT00468559|12131849|FG000|NOT COMPLETED|Open-label Treatment Phase||18
10959257|NCT00468559|12131850|FG001|NOT COMPLETED|Open-label Treatment Phase||0
10959258|NCT00468559|12131851|FG002|NOT COMPLETED|Open-label Treatment Phase||0
10959259|NCT00468559|12131849|FG000|STARTED|Double-blind, Treatment-withdrawal Phase||0
10959260|NCT00468559|12131850|FG001|STARTED|Double-blind, Treatment-withdrawal Phase||39
10959261|NCT00468559|12131851|FG002|STARTED|Double-blind, Treatment-withdrawal Phase||41
10959262|NCT00468559|12131849|FG000|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
10959263|NCT00468559|12131850|FG001|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
10959264|NCT00468559|12131851|FG002|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
10959265|NCT00468559|12131849|FG000|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
10959266|NCT00468559|12131850|FG001|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
10959267|NCT00468559|12131851|FG002|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
10959268|NCT00468585|12131863|FG000|STARTED|Overall Study||4
10959269|NCT00468585|12131864|FG001|STARTED|Overall Study||3
10959270|NCT00468585|12131865|FG002|STARTED|Overall Study||50
10959271|NCT00468585|12131866|FG003|STARTED|Overall Study||6
10959272|NCT00468585|12131863|FG000|COMPLETED|Overall Study||3
10959273|NCT00468585|12131864|FG001|COMPLETED|Overall Study||3
10959274|NCT00468585|12131865|FG002|COMPLETED|Overall Study||45
10959275|NCT00468585|12131866|FG003|COMPLETED|Overall Study||5
10959276|NCT00468585|12131863|FG000|NOT COMPLETED|Overall Study||1
10959277|NCT00468585|12131864|FG001|NOT COMPLETED|Overall Study||0
10959278|NCT00468585|12131865|FG002|NOT COMPLETED|Overall Study||5
10959279|NCT00468585|12131866|FG003|NOT COMPLETED|Overall Study||1
10959280|NCT00468650|12131876|FG000|STARTED|Overall Study||117
10959281|NCT00468650|12131876|FG000|COMPLETED|Overall Study||110
10959282|NCT00468650|12131876|FG000|NOT COMPLETED|Overall Study||7
10959283|NCT00468676|12131883|FG000|STARTED|Overall Study||108
10959284|NCT00468676|12131884|FG001|STARTED|Overall Study||106
10959285|NCT00468676|12131883|FG000|COMPLETED|Overall Study||92
10959286|NCT00468676|12131884|FG001|COMPLETED|Overall Study||94
10959287|NCT00468676|12131883|FG000|NOT COMPLETED|Overall Study||16
10959288|NCT00468676|12131884|FG001|NOT COMPLETED|Overall Study||12
10959289|NCT00468728|12131894|FG000|STARTED|Enrollment||264
10959290|NCT00468728|12131895|FG001|STARTED|Enrollment||271
10959291|NCT00468728|12131894|FG000|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
10959292|NCT00468728|12131895|FG001|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
10959293|NCT00468728|12131894|FG000|NOT COMPLETED|Enrollment||4
10959294|NCT00468728|12131895|FG001|NOT COMPLETED|Enrollment||7
10959295|NCT00468728|12131894|FG000|STARTED|Treatment||260
10959296|NCT00468728|12131895|FG001|STARTED|Treatment||264
10959297|NCT00468728|12131894|FG000|COMPLETED|Treatment||256
10959298|NCT00468728|12131895|FG001|COMPLETED|Treatment||253
10959299|NCT00468728|12131894|FG000|NOT COMPLETED|Treatment||4
10959300|NCT00468728|12131895|FG001|NOT COMPLETED|Treatment||11
10959301|NCT00468728|12131894|FG000|STARTED|Follow-up||256
10959302|NCT00468728|12131895|FG001|STARTED|Follow-up||253
10959303|NCT00468728|12131894|FG000|COMPLETED|Follow-up||222
10959304|NCT00468728|12131895|FG001|COMPLETED|Follow-up||222
10959305|NCT00468728|12131894|FG000|NOT COMPLETED|Follow-up||34
10959306|NCT00468728|12131895|FG001|NOT COMPLETED|Follow-up||31
10959307|NCT00468819|12131906|FG000|STARTED|Overall Study|Enrolled participants|48
10959308|NCT00468819|12131907|FG001|STARTED|Overall Study|Enrolled participants|44
10959309|NCT00468819|12131908|FG002|STARTED|Overall Study|Enrolled participants|48
10959310|NCT00468819|12131906|FG000|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
10959311|NCT00468819|12131907|FG001|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
10959312|NCT00468819|12131908|FG002|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
10959313|NCT00468819|12131906|FG000|COMPLETED|Overall Study||42
10959314|NCT00468819|12131907|FG001|COMPLETED|Overall Study||44
10959315|NCT00468819|12131908|FG002|COMPLETED|Overall Study||46
10959316|NCT00468819|12131906|FG000|NOT COMPLETED|Overall Study||6
10959317|NCT00468819|12131907|FG001|NOT COMPLETED|Overall Study||0
10959318|NCT00468819|12131908|FG002|NOT COMPLETED|Overall Study||2
10959319|NCT00468845|12131921|FG000|STARTED|Overall Study||162
10959320|NCT00468845|12131922|FG001|STARTED|Overall Study||170
10959321|NCT00468845|12131923|FG002|STARTED|Overall Study||169
10959322|NCT00468845|12131921|FG000|Received Treatment|Overall Study||161
10959323|NCT00468845|12131922|FG001|Received Treatment|Overall Study||166
10959324|NCT00468845|12131923|FG002|Received Treatment|Overall Study||167
10959325|NCT00468845|12131921|FG000|COMPLETED|Overall Study||141
10959326|NCT00468845|12131922|FG001|COMPLETED|Overall Study||136
10959327|NCT00468845|12131923|FG002|COMPLETED|Overall Study||139
10959328|NCT00468845|12131921|FG000|NOT COMPLETED|Overall Study||21
10959329|NCT00468845|12131922|FG001|NOT COMPLETED|Overall Study||34
10959330|NCT00468845|12131923|FG002|NOT COMPLETED|Overall Study||30
10959331|NCT00468858|12131934|FG000|STARTED|Overall Study||211
10959332|NCT00468858|12131935|FG001|STARTED|Overall Study||212
10959333|NCT00468858|12131936|FG002|STARTED|Overall Study||213
10959334|NCT00468858|12131934|FG000|COMPLETED|Overall Study||202
10959335|NCT00468858|12131935|FG001|COMPLETED|Overall Study||202
10959336|NCT00468858|12131936|FG002|COMPLETED|Overall Study||199
10959337|NCT00468858|12131934|FG000|NOT COMPLETED|Overall Study||9
10959338|NCT00468858|12131935|FG001|NOT COMPLETED|Overall Study||10
10959339|NCT00468858|12131936|FG002|NOT COMPLETED|Overall Study||14
10959340|NCT00468910|12132000|FG000|STARTED|Overall Study||40
10959341|NCT00468910|12132001|FG001|STARTED|Overall Study||39
10959342|NCT00468910|12132000|FG000|Randomization|Overall Study||40
10959343|NCT00468910|12132001|FG001|Randomization|Overall Study||39
10959344|NCT00468910|12132000|FG000|Treatment|Overall Study||36
10959345|NCT00468910|12132001|FG001|Treatment|Overall Study||36
10959346|NCT00468910|12132000|FG000|Post-Treatment Biopsy|Overall Study||36
10959347|NCT00468910|12132001|FG001|Post-Treatment Biopsy|Overall Study||36
10959348|NCT00468910|12132000|FG000|Follow-up|Overall Study||36
10959349|NCT00468910|12132001|FG001|Follow-up|Overall Study||36
10959350|NCT00468910|12132000|FG000|COMPLETED|Overall Study||36
10959351|NCT00468910|12132001|FG001|COMPLETED|Overall Study||36
10959352|NCT00468910|12132000|FG000|NOT COMPLETED|Overall Study||4
10959353|NCT00468910|12132001|FG001|NOT COMPLETED|Overall Study||3
10959354|NCT00469014|12132012|FG000|STARTED|Initial Phase Randomization||5
10959355|NCT00469014|12132013|FG001|STARTED|Initial Phase Randomization||4
10959356|NCT00469014|12132014|FG002|STARTED|Initial Phase Randomization||5
10959357|NCT00469014|12132015|FG003|STARTED|Initial Phase Randomization||6
10959358|NCT00469014|12132012|FG000|COMPLETED|Initial Phase Randomization||4
10959359|NCT00469014|12132013|FG001|COMPLETED|Initial Phase Randomization||3
10959360|NCT00469014|12132014|FG002|COMPLETED|Initial Phase Randomization||4
10959361|NCT00469014|12132015|FG003|COMPLETED|Initial Phase Randomization||5
10959362|NCT00469014|12132012|FG000|NOT COMPLETED|Initial Phase Randomization||1
10959363|NCT00469014|12132013|FG001|NOT COMPLETED|Initial Phase Randomization||1
10959364|NCT00469014|12132014|FG002|NOT COMPLETED|Initial Phase Randomization||1
10959365|NCT00469014|12132015|FG003|NOT COMPLETED|Initial Phase Randomization||1
10959366|NCT00469014|12132012|FG000|STARTED|Adaptive Randomization||13
10959367|NCT00469014|12132013|FG001|STARTED|Adaptive Randomization||3
10959368|NCT00469014|12132014|FG002|STARTED|Adaptive Randomization||24
10959369|NCT00469014|12132015|FG003|STARTED|Adaptive Randomization||11
10959370|NCT00469014|12132012|FG000|COMPLETED|Adaptive Randomization||12
10959371|NCT00469014|12132013|FG001|COMPLETED|Adaptive Randomization||2
10959372|NCT00469014|12132014|FG002|COMPLETED|Adaptive Randomization||23
10959373|NCT00469014|12132015|FG003|COMPLETED|Adaptive Randomization||10
10959374|NCT00469014|12132012|FG000|NOT COMPLETED|Adaptive Randomization||1
10959375|NCT00469014|12132013|FG001|NOT COMPLETED|Adaptive Randomization||1
10959376|NCT00469014|12132014|FG002|NOT COMPLETED|Adaptive Randomization||1
10959377|NCT00469014|12132015|FG003|NOT COMPLETED|Adaptive Randomization||1
10959378|NCT00469079|12132028|FG000|STARTED|Overall Study||27
10959379|NCT00469079|12132029|FG001|STARTED|Overall Study||52
10959380|NCT00469079|12132030|FG002|STARTED|Overall Study||51
10959381|NCT00469079|12132028|FG000|COMPLETED|Overall Study||18
10959382|NCT00469079|12132029|FG001|COMPLETED|Overall Study||30
10959383|NCT00469079|12132030|FG002|COMPLETED|Overall Study||32
10959384|NCT00469079|12132028|FG000|NOT COMPLETED|Overall Study||9
10959385|NCT00469079|12132029|FG001|NOT COMPLETED|Overall Study||22
10959386|NCT00469079|12132030|FG002|NOT COMPLETED|Overall Study||19
10959387|NCT00469092|12132046|FG000|STARTED|Overall Study||239
10959388|NCT00469092|12132047|FG001|STARTED|Overall Study||241
10959389|NCT00469092|12132046|FG000|Exposed to Study Drug|Overall Study||231
10959390|NCT00469092|12132047|FG001|Exposed to Study Drug|Overall Study||238
10959391|NCT00469092|12132046|FG000|COMPLETED|Overall Study||213
10959392|NCT00469092|12132047|FG001|COMPLETED|Overall Study||220
10959393|NCT00469092|12132046|FG000|NOT COMPLETED|Overall Study||26
10959394|NCT00469092|12132047|FG001|NOT COMPLETED|Overall Study||21
10959395|NCT00469144|12132055|FG000|STARTED|Overall Study|Eight assigned to Fixed Dose without randomization.|114
10959396|NCT00469144|12132056|FG001|STARTED|Overall Study||111
10959397|NCT00469144|12132055|FG000|COMPLETED|Overall Study||108
10959398|NCT00469144|12132056|FG001|COMPLETED|Overall Study||105
10959399|NCT00469144|12132055|FG000|NOT COMPLETED|Overall Study||6
10959400|NCT00469144|12132056|FG001|NOT COMPLETED|Overall Study||6
10959401|NCT00469209|12132069|FG000|STARTED|Overall Study||20
10959402|NCT00469209|12132070|FG001|STARTED|Overall Study||20
10959403|NCT00469209|12132071|FG002|STARTED|Overall Study||20
10959404|NCT00469209|12132069|FG000|COMPLETED|Overall Study||19
10959405|NCT00469209|12132070|FG001|COMPLETED|Overall Study||20
10959406|NCT00469209|12132071|FG002|COMPLETED|Overall Study||19
10959407|NCT00469209|12132069|FG000|NOT COMPLETED|Overall Study||1
10959408|NCT00469209|12132070|FG001|NOT COMPLETED|Overall Study||0
10959409|NCT00469209|12132071|FG002|NOT COMPLETED|Overall Study||1
10959410|NCT00469274|12132081|FG000|STARTED|Overall Study||44
10959411|NCT00469274|12132082|FG001|STARTED|Overall Study||42
10959412|NCT00469274|12132081|FG000|COMPLETED|Overall Study||44
10959413|NCT00469274|12132082|FG001|COMPLETED|Overall Study||42
10959414|NCT00469274|12132081|FG000|NOT COMPLETED|Overall Study||0
10959415|NCT00469274|12132082|FG001|NOT COMPLETED|Overall Study||0
10959416|NCT00469391|12132090|FG000|STARTED|Overall Study||27
10959417|NCT00469391|12132091|FG001|STARTED|Overall Study||29
10959418|NCT00469391|12132090|FG000|Discontinued Prior to Procedure|Overall Study||2
10959419|NCT00469391|12132091|FG001|Discontinued Prior to Procedure|Overall Study||3
10959420|NCT00469391|12132090|FG000|Unsuccessful Implant Procedure|Overall Study||4
10959421|NCT00469391|12132091|FG001|Unsuccessful Implant Procedure|Overall Study||0
10959422|NCT00469391|12132090|FG000|Adverse Event|Overall Study||8
10959423|NCT00469391|12132091|FG001|Adverse Event|Overall Study||0
10959424|NCT00469391|12132090|FG000|Lost to Follow up|Overall Study||0
10959425|NCT00469391|12132091|FG001|Lost to Follow up|Overall Study||1
10959426|NCT00469391|12132090|FG000|Patient Preference|Overall Study||0
10959427|NCT00469391|12132091|FG001|Patient Preference|Overall Study||1
10959428|NCT00469391|12132090|FG000|COMPLETED|Overall Study||13
10959429|NCT00469391|12132091|FG001|COMPLETED|Overall Study||24
10959430|NCT00469391|12132090|FG000|NOT COMPLETED|Overall Study||14
10959431|NCT00469391|12132091|FG001|NOT COMPLETED|Overall Study||5
10959432|NCT00469456|12132099|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
10959433|NCT00469456|12132100|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
10959434|NCT00469456|12132099|FG000|COMPLETED|Overall Study||120
10959435|NCT00469456|12132100|FG001|COMPLETED|Overall Study||131
10959436|NCT00469456|12132099|FG000|NOT COMPLETED|Overall Study||9
10959437|NCT00469456|12132100|FG001|NOT COMPLETED|Overall Study||4
10959438|NCT00469508|12132108|FG000|STARTED|Overall Study||34
10959439|NCT00469508|12132109|FG001|STARTED|Overall Study||37
10959440|NCT00469508|12132108|FG000|COMPLETED|Overall Study||14
10959441|NCT00469508|12132109|FG001|COMPLETED|Overall Study||13
10959442|NCT00469508|12132108|FG000|NOT COMPLETED|Overall Study||20
10959443|NCT00469508|12132109|FG001|NOT COMPLETED|Overall Study||24
10959444|NCT00469833|12132115|FG000|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
10959445|NCT00469833|12132115|FG000|COMPLETED|Overall Study||15
10959446|NCT00469833|12132115|FG000|NOT COMPLETED|Overall Study||2
10959447|NCT00469859|12132127|FG000|STARTED|Overall Study||6
10959448|NCT00469859|12132128|FG001|STARTED|Overall Study||8
10959449|NCT00469859|12132127|FG000|COMPLETED|Overall Study||6
10959450|NCT00469859|12132128|FG001|COMPLETED|Overall Study||6
10959451|NCT00469859|12132127|FG000|NOT COMPLETED|Overall Study||0
10959452|NCT00469859|12132128|FG001|NOT COMPLETED|Overall Study||2
10959453|NCT00469898|12132134|FG000|STARTED|Overall Study||50
10959454|NCT00469898|12132134|FG000|COMPLETED|Overall Study||25
10959455|NCT00469898|12132134|FG000|NOT COMPLETED|Overall Study||25
10959456|NCT00469911|12132140|FG000|STARTED|Overall Study||8
10959457|NCT00469911|12132141|FG001|STARTED|Overall Study||10
10959458|NCT00469911|12132140|FG000|COMPLETED|Overall Study||8
10959459|NCT00469911|12132141|FG001|COMPLETED|Overall Study||10
10959460|NCT00469911|12132140|FG000|NOT COMPLETED|Overall Study||0
10959461|NCT00469911|12132141|FG001|NOT COMPLETED|Overall Study||0
10959462|NCT00470054|12132146|FG000|STARTED|Overall Study||44
10959463|NCT00470054|12132146|FG000|COMPLETED|Overall Study||43
10959464|NCT00470054|12132146|FG000|NOT COMPLETED|Overall Study||1
10959465|NCT00470093|12132150|FG000|STARTED|Overall Study||2
10959466|NCT00470093|12132150|FG000|COMPLETED|Overall Study||0
10959467|NCT00470093|12132150|FG000|NOT COMPLETED|Overall Study||2
10959468|NCT00470106|12132158|FG000|STARTED|Overall Study||19
10959469|NCT00470106|12132159|FG001|STARTED|Overall Study||24
10959470|NCT00470106|12132160|FG002|STARTED|Overall Study||21
10959471|NCT00470106|12132161|FG003|STARTED|Overall Study||21
10959472|NCT00470106|12132158|FG000|COMPLETED|Overall Study||16
10959473|NCT00470106|12132159|FG001|COMPLETED|Overall Study||19
10959474|NCT00470106|12132160|FG002|COMPLETED|Overall Study||14
10959475|NCT00470106|12132161|FG003|COMPLETED|Overall Study||19
10959476|NCT00470106|12132158|FG000|NOT COMPLETED|Overall Study||3
10959477|NCT00470106|12132159|FG001|NOT COMPLETED|Overall Study||5
10959478|NCT00470106|12132160|FG002|NOT COMPLETED|Overall Study||7
10959479|NCT00470106|12132161|FG003|NOT COMPLETED|Overall Study||2
10959480|NCT00470158|12132180|FG000|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
10959481|NCT00470158|12132181|FG001|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
10959482|NCT00470158|12132182|FG002|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
10959483|NCT00470158|12132183|FG003|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
10959484|NCT00470158|12132184|FG004|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
10959485|NCT00470158|12132180|FG000|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
10959486|NCT00470158|12132181|FG001|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
10959487|NCT00470158|12132182|FG002|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
10959488|NCT00470158|12132183|FG003|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
10959489|NCT00470158|12132184|FG004|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
10959490|NCT00470158|12132180|FG000|NOT COMPLETED|Overall Study||8
10959491|NCT00470158|12132181|FG001|NOT COMPLETED|Overall Study||8
10959492|NCT00470158|12132182|FG002|NOT COMPLETED|Overall Study||8
10959493|NCT00470158|12132183|FG003|NOT COMPLETED|Overall Study||5
10959494|NCT00470158|12132184|FG004|NOT COMPLETED|Overall Study||6
10959495|NCT00470184|12132196|FG000|STARTED|Overall Study||41
10959496|NCT00470184|12132196|FG000|Treated With Study Therapy|Overall Study||36
10959497|NCT00470184|12132196|FG000|COMPLETED|Overall Study||19
10959498|NCT00470184|12132196|FG000|NOT COMPLETED|Overall Study||22
10959499|NCT00470262|12132203|FG000|STARTED|Overall Study||15
10959500|NCT00470262|12132204|FG001|STARTED|Overall Study||12
10959501|NCT00470262|12132203|FG000|COMPLETED|Overall Study||13
10959502|NCT00470262|12132204|FG001|COMPLETED|Overall Study||12
10959503|NCT00470262|12132203|FG000|NOT COMPLETED|Overall Study||2
10959504|NCT00470262|12132204|FG001|NOT COMPLETED|Overall Study||0
10959505|NCT00470275|12132211|FG000|STARTED|Overall Study||10
10959506|NCT00470275|12132211|FG000|COMPLETED|Overall Study||0
10959507|NCT00470275|12132211|FG000|NOT COMPLETED|Overall Study||10
10959508|NCT00470301|12132215|FG000|STARTED|Overall Study||60
10959509|NCT00470301|12132215|FG000|COMPLETED|Overall Study||55
10959510|NCT00470301|12132215|FG000|NOT COMPLETED|Overall Study||5
10959511|NCT00470366|12132220|FG000|STARTED|Overall Study||60
10959512|NCT00470366|12132220|FG000|COMPLETED|Overall Study||56
10959513|NCT00470366|12132220|FG000|NOT COMPLETED|Overall Study||4
10959514|NCT00470392|12132226|FG000|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
10959515|NCT00470392|12132227|FG001|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
10959516|NCT00470392|12132226|FG000|COMPLETED|Overall Study||7
10959517|NCT00470392|12132227|FG001|COMPLETED|Overall Study||2
10959518|NCT00470392|12132226|FG000|NOT COMPLETED|Overall Study||0
10959519|NCT00470392|12132227|FG001|NOT COMPLETED|Overall Study||0
10959520|NCT00470418|12132236|FG000|STARTED|Overall Study||7
10959521|NCT00470418|12132237|FG001|STARTED|Overall Study||3
10959522|NCT00470418|12132236|FG000|COMPLETED|Overall Study||6
10959523|NCT00470418|12132237|FG001|COMPLETED|Overall Study||3
10959524|NCT00470418|12132236|FG000|NOT COMPLETED|Overall Study||1
10959525|NCT00470418|12132237|FG001|NOT COMPLETED|Overall Study||0
10959526|NCT00470470|12132243|FG000|STARTED|Overall Study||30
10959527|NCT00470470|12132243|FG000|COMPLETED|Overall Study||25
10959528|NCT00470470|12132243|FG000|NOT COMPLETED|Overall Study||5
10959529|NCT00470535|12132247|FG000|STARTED|Overall Study||18
10959530|NCT00470535|12132247|FG000|COMPLETED|Overall Study||0
10959531|NCT00470535|12132247|FG000|NOT COMPLETED|Overall Study||18
10959532|NCT00470548|12132253|FG000|STARTED|Overall Study||3
10959533|NCT00470548|12132254|FG001|STARTED|Overall Study||3
10959534|NCT00470548|12132255|FG002|STARTED|Overall Study||6
10959535|NCT00470548|12132256|FG003|STARTED|Overall Study||37
10959536|NCT00470548|12132253|FG000|COMPLETED|Overall Study||3
10959537|NCT00470548|12132254|FG001|COMPLETED|Overall Study||3
10959538|NCT00470548|12132255|FG002|COMPLETED|Overall Study||6
10959539|NCT00470548|12132256|FG003|COMPLETED|Overall Study||37
10959540|NCT00470548|12132253|FG000|NOT COMPLETED|Overall Study||0
10959541|NCT00470548|12132254|FG001|NOT COMPLETED|Overall Study||0
10959542|NCT00470548|12132255|FG002|NOT COMPLETED|Overall Study||0
10959543|NCT00470548|12132256|FG003|NOT COMPLETED|Overall Study||0
10959544|NCT00470600|12132268|FG000|STARTED|Overall Study||86
10959545|NCT00470600|12132269|FG001|STARTED|Overall Study||99
10959546|NCT00470600|12132268|FG000|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
10959547|NCT00470600|12132269|FG001|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
10959548|NCT00470600|12132268|FG000|NOT COMPLETED|Overall Study||0
10959549|NCT00470600|12132269|FG001|NOT COMPLETED|Overall Study||0
10959550|NCT00470626|12132275|FG000|STARTED|Overall Study||129
10959551|NCT00470626|12132275|FG000|COMPLETED|Overall Study||112
10959552|NCT00470626|12132275|FG000|NOT COMPLETED|Overall Study||17
10959553|NCT00470717|12132279|FG000|STARTED|Overall Study|Each participant could be called up to 4 times weekly for 13 weeks (38x4x13)|38
10959554|NCT00470717|12132279|FG000|COMPLETED|Overall Study||38
10959555|NCT00470717|12132279|FG000|NOT COMPLETED|Overall Study||0
10959556|NCT00470834|12132285|FG000|STARTED|Treatment Period (18 Months)||65
10959557|NCT00470834|12132286|FG001|STARTED|Treatment Period (18 Months)||62
10959558|NCT00470834|12132285|FG000|COMPLETED|Treatment Period (18 Months)||27
10959559|NCT00470834|12132286|FG001|COMPLETED|Treatment Period (18 Months)||31
10959560|NCT00470834|12132285|FG000|NOT COMPLETED|Treatment Period (18 Months)||38
10959561|NCT00470834|12132286|FG001|NOT COMPLETED|Treatment Period (18 Months)||31
10959562|NCT00470834|12132285|FG000|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
10959563|NCT00470834|12132286|FG001|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
10959564|NCT00470834|12132285|FG000|COMPLETED|Extension Period (24 Months)||11
10959565|NCT00470834|12132286|FG001|COMPLETED|Extension Period (24 Months)||7
10959566|NCT00470834|12132285|FG000|NOT COMPLETED|Extension Period (24 Months)||15
10959567|NCT00470834|12132286|FG001|NOT COMPLETED|Extension Period (24 Months)||23
10959568|NCT00470847|12132292|FG000|STARTED|Overall Study||35
10959569|NCT00470847|12132292|FG000|COMPLETED|Overall Study||34
10959570|NCT00470847|12132292|FG000|NOT COMPLETED|Overall Study||1
10959571|NCT00471068|12132300|FG000|STARTED|Overall Study||21
10959572|NCT00471068|12132301|FG001|STARTED|Overall Study||25
10959573|NCT00471068|12132300|FG000|COMPLETED|Overall Study||20
10959574|NCT00471068|12132301|FG001|COMPLETED|Overall Study||24
10959575|NCT00471068|12132300|FG000|NOT COMPLETED|Overall Study||1
10959576|NCT00471068|12132301|FG001|NOT COMPLETED|Overall Study||1
10959577|NCT00471081|12132309|FG000|STARTED|Active Phase||160
10959578|NCT00471081|12132310|FG001|STARTED|Active Phase||189
10959579|NCT00471081|12132309|FG000|COMPLETED|Active Phase||158
10959580|NCT00471081|12132310|FG001|COMPLETED|Active Phase||176
10959581|NCT00471081|12132309|FG000|NOT COMPLETED|Active Phase||2
10959582|NCT00471081|12132310|FG001|NOT COMPLETED|Active Phase||13
10959583|NCT00471081|12132309|FG000|STARTED|Extended Safety Follow-Up||160
10959584|NCT00471081|12132310|FG001|STARTED|Extended Safety Follow-Up||189
10959585|NCT00471081|12132309|FG000|COMPLETED|Extended Safety Follow-Up||158
10959586|NCT00471081|12132310|FG001|COMPLETED|Extended Safety Follow-Up||176
10959587|NCT00471081|12132309|FG000|NOT COMPLETED|Extended Safety Follow-Up||2
10959588|NCT00471081|12132310|FG001|NOT COMPLETED|Extended Safety Follow-Up||13
10959589|NCT00471107|12132320|FG000|STARTED|Overall Study||15
10959590|NCT00471107|12132321|FG001|STARTED|Overall Study||15
10959591|NCT00471107|12132322|FG002|STARTED|Overall Study||15
10959592|NCT00471107|12132320|FG000|COMPLETED|Overall Study||12
10959593|NCT00471107|12132321|FG001|COMPLETED|Overall Study||14
10959594|NCT00471107|12132322|FG002|COMPLETED|Overall Study||12
10959595|NCT00471107|12132320|FG000|NOT COMPLETED|Overall Study||3
10959596|NCT00471107|12132321|FG001|NOT COMPLETED|Overall Study||1
10959597|NCT00471107|12132322|FG002|NOT COMPLETED|Overall Study||3
10959598|NCT00471146|12132332|FG000|STARTED|Overall Study||314
10959599|NCT00471146|12132333|FG001|STARTED|Overall Study||316
10959600|NCT00471146|12132332|FG000|Treated|Overall Study||305
10959601|NCT00471146|12132333|FG001|Treated|Overall Study||308
10959602|NCT00471146|12132332|FG000|COMPLETED|Overall Study||142
10959603|NCT00471146|12132333|FG001|COMPLETED|Overall Study||142
10959604|NCT00471146|12132332|FG000|NOT COMPLETED|Overall Study||172
10959605|NCT00471146|12132333|FG001|NOT COMPLETED|Overall Study||174
10959606|NCT00471237|12132346|FG000|STARTED|Overall Study||90
10959607|NCT00471237|12132347|FG001|STARTED|Overall Study||87
10959608|NCT00471237|12132348|FG002|STARTED|Overall Study||82
10959609|NCT00471237|12132349|FG003|STARTED|Overall Study||88
10959610|NCT00471237|12132350|FG004|STARTED|Overall Study||87
10959611|NCT00471237|12132351|FG005|STARTED|Overall Study||89
10959612|NCT00471237|12132352|FG006|STARTED|Overall Study||41
10959613|NCT00471237|12132346|FG000|COMPLETED|Overall Study||49
10959614|NCT00471237|12132347|FG001|COMPLETED|Overall Study||45
10959615|NCT00471237|12132348|FG002|COMPLETED|Overall Study||48
10959616|NCT00471237|12132349|FG003|COMPLETED|Overall Study||43
10959617|NCT00471237|12132350|FG004|COMPLETED|Overall Study||46
10959618|NCT00471237|12132351|FG005|COMPLETED|Overall Study||50
10959619|NCT00471237|12132352|FG006|COMPLETED|Overall Study||38
10959620|NCT00471237|12132346|FG000|NOT COMPLETED|Overall Study||41
10959621|NCT00471237|12132347|FG001|NOT COMPLETED|Overall Study||42
10959622|NCT00471237|12132348|FG002|NOT COMPLETED|Overall Study||34
10959623|NCT00471237|12132349|FG003|NOT COMPLETED|Overall Study||45
10959624|NCT00471237|12132350|FG004|NOT COMPLETED|Overall Study||41
10959625|NCT00471237|12132351|FG005|NOT COMPLETED|Overall Study||39
10959626|NCT00471237|12132352|FG006|NOT COMPLETED|Overall Study||3
10959627|NCT00471276|12132372|FG000|STARTED|Overall Study||83
10959628|NCT00471276|12132372|FG000|COMPLETED|Overall Study||0
10959629|NCT00471276|12132372|FG000|NOT COMPLETED|Overall Study||83
10959630|NCT00471315|12132376|FG000|STARTED|Overall Study||18
10959631|NCT00471315|12132376|FG000|COMPLETED|Overall Study||10
10959632|NCT00471315|12132376|FG000|NOT COMPLETED|Overall Study||8
10959633|NCT00471328|12132382|FG000|STARTED|Core Phase||165
10959634|NCT00471328|12132383|FG001|STARTED|Core Phase||83
10959635|NCT00471328|12132382|FG000|Crossover to Nilotinib:Started Extension|Core Phase||0
10959636|NCT00471328|12132383|FG001|Crossover to Nilotinib:Started Extension|Core Phase||53
10959637|NCT00471328|12132382|FG000|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
10959638|NCT00471328|12132383|FG001|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
10959639|NCT00471328|12132382|FG000|NOT COMPLETED|Core Phase||107
10959640|NCT00471328|12132383|FG001|NOT COMPLETED|Core Phase||67
10959641|NCT00471328|12132382|FG000|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
10959642|NCT00471328|12132383|FG001|STARTED|Extension Phase||67
10959643|NCT00471328|12132382|FG000|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
10959644|NCT00471328|12132383|FG001|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
10959645|NCT00471328|12132382|FG000|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
10959646|NCT00471328|12132383|FG001|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
10959647|NCT00471328|12132382|FG000|Started:CrossOver During Extension|Extension Phase||0
10959648|NCT00471328|12132383|FG001|Started:CrossOver During Extension|Extension Phase||10
10959649|NCT00471328|12132382|FG000|COMPLETED|Extension Phase||0
10959650|NCT00471328|12132383|FG001|COMPLETED|Extension Phase||0
10959651|NCT00471328|12132382|FG000|NOT COMPLETED|Extension Phase||41
10959652|NCT00471328|12132383|FG001|NOT COMPLETED|Extension Phase||67
10959653|NCT00471354|12132391|FG000|STARTED|Overall Study||228
10959654|NCT00471354|12132391|FG000|COMPLETED|Overall Study||176
10959655|NCT00471354|12132391|FG000|NOT COMPLETED|Overall Study||52
10959656|NCT00471380|12132395|FG000|STARTED|First Intervention||22
10959657|NCT00471380|12132396|FG001|STARTED|First Intervention||24
10959658|NCT00471380|12132395|FG000|COMPLETED|First Intervention||18
10959659|NCT00471380|12132396|FG001|COMPLETED|First Intervention||20
10959660|NCT00471380|12132395|FG000|NOT COMPLETED|First Intervention||4
10959661|NCT00471380|12132396|FG001|NOT COMPLETED|First Intervention||4
10959662|NCT00471380|12132395|FG000|STARTED|Second Intervention||18
10959663|NCT00471380|12132396|FG001|STARTED|Second Intervention||20
10959664|NCT00471380|12132395|FG000|COMPLETED|Second Intervention||18
10959665|NCT00471380|12132396|FG001|COMPLETED|Second Intervention||16
10959666|NCT00471380|12132395|FG000|NOT COMPLETED|Second Intervention||0
10959667|NCT00471380|12132396|FG001|NOT COMPLETED|Second Intervention||4
10959668|NCT00471380|12132395|FG000|STARTED|Third Intervention||18
10959669|NCT00471380|12132396|FG001|STARTED|Third Intervention||16
10959670|NCT00471380|12132395|FG000|COMPLETED|Third Intervention||17
10959671|NCT00471380|12132396|FG001|COMPLETED|Third Intervention||14
10959672|NCT00471380|12132395|FG000|NOT COMPLETED|Third Intervention||1
10959673|NCT00471380|12132396|FG001|NOT COMPLETED|Third Intervention||2
10959674|NCT00471445|12132404|FG000|STARTED|Overall Study||229
10959675|NCT00471445|12132405|FG001|STARTED|Overall Study||233
10959676|NCT00471445|12132404|FG000|COMPLETED|Overall Study||227
10959677|NCT00471445|12132405|FG001|COMPLETED|Overall Study||231
10959678|NCT00471445|12132404|FG000|NOT COMPLETED|Overall Study||2
10959679|NCT00471445|12132405|FG001|NOT COMPLETED|Overall Study||2
10959680|NCT00471497|12132414|FG000|STARTED|Core Treatment Phase||283
10959681|NCT00471497|12132415|FG001|STARTED|Core Treatment Phase||282
10959682|NCT00471497|12132416|FG002|STARTED|Core Treatment Phase||281
10959683|NCT00471497|12132414|FG000|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|280
10959684|NCT00471497|12132415|FG001|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|279
10959685|NCT00471497|12132416|FG002|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|277
10959686|NCT00471497|12132414|FG000|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||235
10959687|NCT00471497|12132415|FG001|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||256
10959688|NCT00471497|12132416|FG002|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||278
10959689|NCT00471497|12132414|FG000|Discontinued Core/Entered Ext.|Core Treatment Phase||48
10959690|NCT00471497|12132415|FG001|Discontinued Core/Entered Ext.|Core Treatment Phase||26
10959691|NCT00471497|12132416|FG002|Discontinued Core/Entered Ext.|Core Treatment Phase||3
10959692|NCT00471497|12132414|FG000|COMPLETED|Core Treatment Phase||99
10959693|NCT00471497|12132415|FG001|COMPLETED|Core Treatment Phase||107
10959694|NCT00471497|12132416|FG002|COMPLETED|Core Treatment Phase||99
10959695|NCT00471497|12132414|FG000|NOT COMPLETED|Core Treatment Phase||184
10959696|NCT00471497|12132415|FG001|NOT COMPLETED|Core Treatment Phase||175
10959697|NCT00471497|12132416|FG002|NOT COMPLETED|Core Treatment Phase||182
10959698|NCT00471497|12132414|FG000|STARTED|Extension Phase||48
10959699|NCT00471497|12132415|FG001|STARTED|Extension Phase||26
10959700|NCT00471497|12132416|FG002|STARTED|Extension Phase||3
10959701|NCT00471497|12132414|FG000|COMPLETED|Extension Phase||21
10959702|NCT00471497|12132415|FG001|COMPLETED|Extension Phase||12
10959703|NCT00471497|12132416|FG002|COMPLETED|Extension Phase||2
10959704|NCT00471497|12132414|FG000|NOT COMPLETED|Extension Phase||27
10959705|NCT00471497|12132415|FG001|NOT COMPLETED|Extension Phase||14
10959706|NCT00471497|12132416|FG002|NOT COMPLETED|Extension Phase||1
10959707|NCT00471536|12132427|FG000|STARTED|Overall Study||19
10959708|NCT00471536|12132427|FG000|COMPLETED|Overall Study||18
10959709|NCT00471536|12132427|FG000|NOT COMPLETED|Overall Study||1
10959710|NCT00471705|12132434|FG000|STARTED|Overall Study||145
10959711|NCT00471705|12132435|FG001|STARTED|Overall Study||143
10959712|NCT00471705|12132436|FG002|STARTED|Overall Study||149
10959713|NCT00471705|12132434|FG000|COMPLETED|Overall Study||121
10959714|NCT00471705|12132435|FG001|COMPLETED|Overall Study||121
10959715|NCT00471705|12132436|FG002|COMPLETED|Overall Study||134
10959716|NCT00471705|12132434|FG000|NOT COMPLETED|Overall Study||24
10959717|NCT00471705|12132435|FG001|NOT COMPLETED|Overall Study||22
10959718|NCT00471705|12132436|FG002|NOT COMPLETED|Overall Study||15
10959719|NCT00471718|12132444|FG000|STARTED|Overall Study||27
10959720|NCT00471718|12132444|FG000|COMPLETED|Overall Study||0
10959721|NCT00471718|12132444|FG000|NOT COMPLETED|Overall Study||27
10959722|NCT00471822|12132452|FG000|STARTED|Overall Study||9707
10959723|NCT00471822|12132452|FG000|Treated|Overall Study||9705
10959724|NCT00471822|12132452|FG000|COMPLETED|Overall Study||9705
10959725|NCT00471822|12132452|FG000|NOT COMPLETED|Overall Study||2
10959726|NCT00471848|12132456|FG000|STARTED|Overall Study||35
10959727|NCT00471848|12132456|FG000|COMPLETED|Overall Study|35 registered patients received the full 5-day Rabbit Antithymocyte Globuline (RATG) treatment|35
10959728|NCT00471848|12132456|FG000|NOT COMPLETED|Overall Study||0
10959729|NCT00471887|12132460|FG000|STARTED|Overall Study||32
10959730|NCT00471887|12132460|FG000|COMPLETED|Overall Study||23
10959731|NCT00471887|12132460|FG000|NOT COMPLETED|Overall Study||9
10959732|NCT00472030|12132466|FG000|STARTED|Overall Study||2
10959733|NCT00472030|12132467|FG001|STARTED|Overall Study||0
10959734|NCT00472030|12132466|FG000|COMPLETED|Overall Study||1
10959735|NCT00472030|12132467|FG001|COMPLETED|Overall Study||0
10959736|NCT00472030|12132466|FG000|NOT COMPLETED|Overall Study||1
10959737|NCT00472030|12132467|FG001|NOT COMPLETED|Overall Study||0
10959738|NCT00472056|12132481|FG000|STARTED|Overall Study||25
10959739|NCT00472056|12132482|FG001|STARTED|Overall Study||19
10959740|NCT00472056|12132483|FG002|STARTED|Overall Study||32
10959741|NCT00472056|12132484|FG003|STARTED|Overall Study||17
10959742|NCT00472056|12132481|FG000|COMPLETED|Overall Study||25
10959743|NCT00472056|12132482|FG001|COMPLETED|Overall Study||19
10959744|NCT00472056|12132483|FG002|COMPLETED|Overall Study||32
10959745|NCT00472056|12132484|FG003|COMPLETED|Overall Study||17
10959746|NCT00472056|12132481|FG000|NOT COMPLETED|Overall Study||0
10959747|NCT00472056|12132482|FG001|NOT COMPLETED|Overall Study||0
10959748|NCT00472056|12132483|FG002|NOT COMPLETED|Overall Study||0
10959749|NCT00472056|12132484|FG003|NOT COMPLETED|Overall Study||0
10959750|NCT00472199|12132494|FG000|STARTED|Overall Study||166
10959751|NCT00472199|12132495|FG001|STARTED|Overall Study||163
10959752|NCT00472199|12132494|FG000|COMPLETED|Overall Study||131
10959753|NCT00472199|12132495|FG001|COMPLETED|Overall Study||103
10959754|NCT00472199|12132494|FG000|NOT COMPLETED|Overall Study||35
10959755|NCT00472199|12132495|FG001|NOT COMPLETED|Overall Study||60
10959756|NCT00472290|12132501|FG000|STARTED|Overall Study||72
10959757|NCT00472290|12132501|FG000|COMPLETED|Overall Study||0
10959758|NCT00472290|12132501|FG000|NOT COMPLETED|Overall Study||72
10959759|NCT00472303|12132507|FG000|STARTED|Titration Phase||338
10959760|NCT00472303|12132508|FG001|STARTED|Titration Phase||158
10959761|NCT00472303|12132509|FG002|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
10959762|NCT00472303|12132507|FG000|COMPLETED|Titration Phase||279
10959763|NCT00472303|12132508|FG001|COMPLETED|Titration Phase||129
10959764|NCT00472303|12132509|FG002|COMPLETED|Titration Phase||0
10959765|NCT00472303|12132507|FG000|NOT COMPLETED|Titration Phase||59
10959766|NCT00472303|12132508|FG001|NOT COMPLETED|Titration Phase||29
10959767|NCT00472303|12132509|FG002|NOT COMPLETED|Titration Phase||0
10959768|NCT00472303|12132507|FG000|STARTED|Discontinuations After Titration Phase||279
10959769|NCT00472303|12132508|FG001|STARTED|Discontinuations After Titration Phase||129
10959770|NCT00472303|12132509|FG002|STARTED|Discontinuations After Titration Phase||0
10959771|NCT00472303|12132507|FG000|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
10959772|NCT00472303|12132508|FG001|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
10959773|NCT00472303|12132509|FG002|COMPLETED|Discontinuations After Titration Phase||0
10959774|NCT00472303|12132507|FG000|NOT COMPLETED|Discontinuations After Titration Phase||61
10959775|NCT00472303|12132508|FG001|NOT COMPLETED|Discontinuations After Titration Phase||20
10959776|NCT00472303|12132509|FG002|NOT COMPLETED|Discontinuations After Titration Phase||0
10959777|NCT00472303|12132507|FG000|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
10959778|NCT00472303|12132508|FG001|STARTED|Maintenance Phase||109
10959779|NCT00472303|12132509|FG002|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
10959780|NCT00472303|12132507|FG000|COMPLETED|Maintenance Phase||89
10959781|NCT00472303|12132508|FG001|COMPLETED|Maintenance Phase||93
10959782|NCT00472303|12132509|FG002|COMPLETED|Maintenance Phase||95
10959783|NCT00472303|12132507|FG000|NOT COMPLETED|Maintenance Phase||17
10959784|NCT00472303|12132508|FG001|NOT COMPLETED|Maintenance Phase||16
10959785|NCT00472303|12132509|FG002|NOT COMPLETED|Maintenance Phase||17
10959786|NCT00472420|12132537|FG000|STARTED|Induction Treatment Period||48
10959787|NCT00472420|12132537|FG000|COMPLETED|Induction Treatment Period||32
10959788|NCT00472420|12132537|FG000|NOT COMPLETED|Induction Treatment Period||16
10959789|NCT00472420|12132537|FG000|STARTED|Follow-up Period||32
10959790|NCT00472420|12132537|FG000|COMPLETED|Follow-up Period||15
10959791|NCT00472420|12132537|FG000|NOT COMPLETED|Follow-up Period||17
10959792|NCT00472446|12132545|FG000|STARTED|Overall Study||46
10959793|NCT00472446|12132546|FG001|STARTED|Overall Study||47
10959794|NCT00472446|12132547|FG002|STARTED|Overall Study||45
10959795|NCT00472446|12132548|FG003|STARTED|Overall Study||45
10959796|NCT00472446|12132545|FG000|COMPLETED|Overall Study||41
10959797|NCT00472446|12132546|FG001|COMPLETED|Overall Study||41
10959798|NCT00472446|12132547|FG002|COMPLETED|Overall Study||38
10959799|NCT00472446|12132548|FG003|COMPLETED|Overall Study||39
10959800|NCT00472446|12132545|FG000|NOT COMPLETED|Overall Study||5
10959801|NCT00472446|12132546|FG001|NOT COMPLETED|Overall Study||6
10959802|NCT00472446|12132547|FG002|NOT COMPLETED|Overall Study||7
10959803|NCT00472446|12132548|FG003|NOT COMPLETED|Overall Study||6
10959804|NCT00472576|12132560|FG000|STARTED|First Intervention||2
10959805|NCT00472576|12132561|FG001|STARTED|First Intervention||3
10959806|NCT00472576|12132560|FG000|COMPLETED|First Intervention||2
10959807|NCT00472576|12132561|FG001|COMPLETED|First Intervention||3
10959808|NCT00472576|12132560|FG000|NOT COMPLETED|First Intervention||0
10959809|NCT00472576|12132561|FG001|NOT COMPLETED|First Intervention||0
10959810|NCT00472576|12132560|FG000|STARTED|Second Intervention||2
10959811|NCT00472576|12132561|FG001|STARTED|Second Intervention||3
10959812|NCT00472576|12132560|FG000|COMPLETED|Second Intervention||2
10959813|NCT00472576|12132561|FG001|COMPLETED|Second Intervention||3
10959814|NCT00472576|12132560|FG000|NOT COMPLETED|Second Intervention||0
10959815|NCT00472576|12132561|FG001|NOT COMPLETED|Second Intervention||0
10959816|NCT00472641|12132567|FG000|STARTED|Overall Study||25
10959817|NCT00472641|12132567|FG000|COMPLETED|Overall Study||18
10959818|NCT00472641|12132567|FG000|NOT COMPLETED|Overall Study||7
10959819|NCT00472732|12132573|FG000|STARTED|Overall Study||24
10959820|NCT00472732|12132574|FG001|STARTED|Overall Study||22
10959821|NCT00472732|12132573|FG000|COMPLETED|Overall Study||24
10959822|NCT00472732|12132574|FG001|COMPLETED|Overall Study||22
10959823|NCT00472732|12132573|FG000|NOT COMPLETED|Overall Study||0
10959824|NCT00472732|12132574|FG001|NOT COMPLETED|Overall Study||0
10959825|NCT00472797|12132582|FG000|STARTED|Overall Study||119
10959826|NCT00472797|12132583|FG001|STARTED|Overall Study||113
10959827|NCT00472797|12132582|FG000|COMPLETED|Overall Study||115
10959828|NCT00472797|12132583|FG001|COMPLETED|Overall Study||112
10959829|NCT00472797|12132582|FG000|NOT COMPLETED|Overall Study||4
10959830|NCT00472797|12132583|FG001|NOT COMPLETED|Overall Study||1
10959831|NCT00472849|12132594|FG000|STARTED|Overall Study||12
10959832|NCT00472849|12132595|FG001|STARTED|Overall Study||78
10959833|NCT00472849|12132594|FG000|COMPLETED|Overall Study||12
10959834|NCT00472849|12132595|FG001|COMPLETED|Overall Study||78
10959835|NCT00472849|12132594|FG000|NOT COMPLETED|Overall Study||0
10959836|NCT00472849|12132595|FG001|NOT COMPLETED|Overall Study||0
10959837|NCT00473083|12132604|FG000|STARTED|Overall Study||50
10959838|NCT00473083|12132605|FG001|STARTED|Overall Study||50
10959839|NCT00473083|12132606|FG002|STARTED|Overall Study||50
10959840|NCT00473083|12132604|FG000|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
10959841|NCT00473083|12132605|FG001|COMPLETED|Overall Study||50
10959842|NCT00473083|12132606|FG002|COMPLETED|Overall Study||50
10959843|NCT00473083|12132604|FG000|NOT COMPLETED|Overall Study||1
10959844|NCT00473083|12132605|FG001|NOT COMPLETED|Overall Study||0
10959845|NCT00473083|12132606|FG002|NOT COMPLETED|Overall Study||0
10959846|NCT00473265|12132617|FG000|STARTED|Overall Study||68
10959847|NCT00473265|12132617|FG000|COMPLETED|Overall Study||48
10959848|NCT00473265|12132617|FG000|NOT COMPLETED|Overall Study||20
10959849|NCT00473330|12132624|FG000|STARTED|Core Study||125
10959850|NCT00473330|12132625|FG001|STARTED|Core Study||125
10959851|NCT00473330|12132626|FG002|STARTED|Core Study||127
10959852|NCT00473330|12132624|FG000|COMPLETED|Core Study||98
10959853|NCT00473330|12132625|FG001|COMPLETED|Core Study||100
10959854|NCT00473330|12132626|FG002|COMPLETED|Core Study||86
10959855|NCT00473330|12132624|FG000|NOT COMPLETED|Core Study||27
10959856|NCT00473330|12132625|FG001|NOT COMPLETED|Core Study||25
10959857|NCT00473330|12132626|FG002|NOT COMPLETED|Core Study||41
10959858|NCT00473330|12132624|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
10959859|NCT00473330|12132625|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
10959860|NCT00473330|12132626|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
10959861|NCT00473330|12132624|FG000|COMPLETED|Open-label Extension Through Month 48||63
10959862|NCT00473330|12132625|FG001|COMPLETED|Open-label Extension Through Month 48||59
10959863|NCT00473330|12132626|FG002|COMPLETED|Open-label Extension Through Month 48||50
10959864|NCT00473330|12132624|FG000|NOT COMPLETED|Open-label Extension Through Month 48||26
10959865|NCT00473330|12132625|FG001|NOT COMPLETED|Open-label Extension Through Month 48||20
10959866|NCT00473330|12132626|FG002|NOT COMPLETED|Open-label Extension Through Month 48||27
10959867|NCT00473330|12132624|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
10959868|NCT00473330|12132625|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
10959869|NCT00473330|12132626|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
10959870|NCT00473330|12132624|FG000|COMPLETED|Open-label Extension Through Month 60||1
10959871|NCT00473330|12132625|FG001|COMPLETED|Open-label Extension Through Month 60||1
10959872|NCT00473330|12132626|FG002|COMPLETED|Open-label Extension Through Month 60||0
10959873|NCT00473330|12132624|FG000|NOT COMPLETED|Open-label Extension Through Month 60||88
10959874|NCT00473330|12132625|FG001|NOT COMPLETED|Open-label Extension Through Month 60||78
10959875|NCT00473330|12132626|FG002|NOT COMPLETED|Open-label Extension Through Month 60||77
10959876|NCT00473382|12132657|FG000|STARTED|Core Study||130
10959877|NCT00473382|12132658|FG001|STARTED|Core Study||125
10959878|NCT00473382|12132659|FG002|STARTED|Core Study||127
10959879|NCT00473382|12132657|FG000|COMPLETED|Core Study||102
10959880|NCT00473382|12132658|FG001|COMPLETED|Core Study||98
10959881|NCT00473382|12132659|FG002|COMPLETED|Core Study||98
10959882|NCT00473382|12132657|FG000|NOT COMPLETED|Core Study||28
10959883|NCT00473382|12132658|FG001|NOT COMPLETED|Core Study||27
10959884|NCT00473382|12132659|FG002|NOT COMPLETED|Core Study||29
10959885|NCT00473382|12132657|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
10959886|NCT00473382|12132658|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
10959887|NCT00473382|12132659|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
10959888|NCT00473382|12132657|FG000|COMPLETED|Open-label Extension Through Month 48||38
10959889|NCT00473382|12132658|FG001|COMPLETED|Open-label Extension Through Month 48||42
10959890|NCT00473382|12132659|FG002|COMPLETED|Open-label Extension Through Month 48||37
10959891|NCT00473382|12132657|FG000|NOT COMPLETED|Open-label Extension Through Month 48||50
10959892|NCT00473382|12132658|FG001|NOT COMPLETED|Open-label Extension Through Month 48||41
10959893|NCT00473382|12132659|FG002|NOT COMPLETED|Open-label Extension Through Month 48||47
10959894|NCT00473382|12132657|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
10959895|NCT00473382|12132658|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
10959896|NCT00473382|12132659|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
10959897|NCT00473382|12132657|FG000|COMPLETED|Open-label Extension Through Month 60||2
10959898|NCT00473382|12132658|FG001|COMPLETED|Open-label Extension Through Month 60||1
10959899|NCT00473382|12132659|FG002|COMPLETED|Open-label Extension Through Month 60||2
10959900|NCT00473382|12132657|FG000|NOT COMPLETED|Open-label Extension Through Month 60||86
10959901|NCT00473382|12132658|FG001|NOT COMPLETED|Open-label Extension Through Month 60||82
10959902|NCT00473382|12132659|FG002|NOT COMPLETED|Open-label Extension Through Month 60||82
10959903|NCT00473434|12132685|FG000|STARTED|Overall Study||64
10959904|NCT00473434|12132685|FG000|COMPLETED|Overall Study||32
10959905|NCT00473434|12132685|FG000|NOT COMPLETED|Overall Study||32
10959906|NCT00473512|12132707|FG000|STARTED|Period 1 (Phase 1)||3
10959907|NCT00473512|12132708|FG001|STARTED|Period 1 (Phase 1)||3
10959908|NCT00473512|12132709|FG002|STARTED|Period 1 (Phase 1)||3
10959909|NCT00473512|12132710|FG003|STARTED|Period 1 (Phase 1)||42
10959910|NCT00473512|12132711|FG004|STARTED|Period 1 (Phase 1)||3
10959911|NCT00473512|12132707|FG000|COMPLETED|Period 1 (Phase 1)||2
10959912|NCT00473512|12132708|FG001|COMPLETED|Period 1 (Phase 1)||2
10959913|NCT00473512|12132709|FG002|COMPLETED|Period 1 (Phase 1)||3
10959914|NCT00473512|12132710|FG003|COMPLETED|Period 1 (Phase 1)||25
10959915|NCT00473512|12132711|FG004|COMPLETED|Period 1 (Phase 1)||2
10959916|NCT00473512|12132707|FG000|NOT COMPLETED|Period 1 (Phase 1)||1
10959917|NCT00473512|12132708|FG001|NOT COMPLETED|Period 1 (Phase 1)||1
10959918|NCT00473512|12132709|FG002|NOT COMPLETED|Period 1 (Phase 1)||0
10959919|NCT00473512|12132710|FG003|NOT COMPLETED|Period 1 (Phase 1)||17
10959920|NCT00473512|12132711|FG004|NOT COMPLETED|Period 1 (Phase 1)||1
10959921|NCT00473512|12132707|FG000|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
10959922|NCT00473512|12132708|FG001|STARTED|Period 2 (Phase 2)||2
10959923|NCT00473512|12132709|FG002|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
10959924|NCT00473512|12132710|FG003|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
10959925|NCT00473512|12132711|FG004|STARTED|Period 2 (Phase 2)||2
10959926|NCT00473512|12132707|FG000|COMPLETED|Period 2 (Phase 2)||0
10959927|NCT00473512|12132708|FG001|COMPLETED|Period 2 (Phase 2)||0
10959928|NCT00473512|12132709|FG002|COMPLETED|Period 2 (Phase 2)||0
10959929|NCT00473512|12132710|FG003|COMPLETED|Period 2 (Phase 2)||0
10959930|NCT00473512|12132711|FG004|COMPLETED|Period 2 (Phase 2)||0
10959931|NCT00473512|12132707|FG000|NOT COMPLETED|Period 2 (Phase 2)||1
10959932|NCT00473512|12132708|FG001|NOT COMPLETED|Period 2 (Phase 2)||2
10959933|NCT00473512|12132709|FG002|NOT COMPLETED|Period 2 (Phase 2)||2
10959934|NCT00473512|12132710|FG003|NOT COMPLETED|Period 2 (Phase 2)||23
10959935|NCT00473512|12132711|FG004|NOT COMPLETED|Period 2 (Phase 2)||2
10959936|NCT00473564|12132731|FG000|STARTED|Overall Study||170
10959937|NCT00473564|12132731|FG000|COMPLETED|Overall Study||147
10959938|NCT00473564|12132731|FG000|NOT COMPLETED|Overall Study||23
10959939|NCT00473590|12132737|FG000|STARTED|Overall Study||53
10959940|NCT00473590|12132738|FG001|STARTED|Overall Study||49
10959941|NCT00473590|12132737|FG000|Treated|Overall Study||52
10959942|NCT00473590|12132738|FG001|Treated|Overall Study||48
10959943|NCT00473590|12132737|FG000|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
10959944|NCT00473590|12132738|FG001|Safety Population|Overall Study||50
10959945|NCT00473590|12132737|FG000|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
10959946|NCT00473590|12132738|FG001|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
10959947|NCT00473590|12132737|FG000|NOT COMPLETED|Overall Study||45
10959948|NCT00473590|12132738|FG001|NOT COMPLETED|Overall Study||38
10959949|NCT00473642|12132747|FG000|STARTED|Overall Study||10
10959950|NCT00473642|12132748|FG001|STARTED|Overall Study||11
10959951|NCT00473642|12132749|FG002|STARTED|Overall Study||10
10959952|NCT00473642|12132747|FG000|COMPLETED|Overall Study||8
10959953|NCT00473642|12132748|FG001|COMPLETED|Overall Study||10
10959954|NCT00473642|12132749|FG002|COMPLETED|Overall Study||8
10959955|NCT00473642|12132747|FG000|NOT COMPLETED|Overall Study||2
10959956|NCT00473642|12132748|FG001|NOT COMPLETED|Overall Study||1
10959957|NCT00473642|12132749|FG002|NOT COMPLETED|Overall Study||2
10959958|NCT00473655|12132763|FG000|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
10959959|NCT00473655|12132764|FG001|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
10959960|NCT00473655|12132765|FG002|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
10959961|NCT00473655|12132763|FG000|COMPLETED|Overall Study|9 participants were lost of follow up|102
10959962|NCT00473655|12132764|FG001|COMPLETED|Overall Study|5 participants were lost of follow up|107
10959963|NCT00473655|12132765|FG002|COMPLETED|Overall Study|8 participants were lost of follow up|103
10959964|NCT00473655|12132763|FG000|NOT COMPLETED|Overall Study||9
10959965|NCT00473655|12132764|FG001|NOT COMPLETED|Overall Study||5
10959966|NCT00473655|12132765|FG002|NOT COMPLETED|Overall Study||8
10959967|NCT00473668|12132776|FG000|STARTED|Overall Study||100
10959968|NCT00473668|12132777|FG001|STARTED|Overall Study||100
10959969|NCT00473668|12132778|FG002|STARTED|Overall Study||99
10959970|NCT00473668|12132776|FG000|COMPLETED|Overall Study||95
10959971|NCT00473668|12132777|FG001|COMPLETED|Overall Study||89
10959972|NCT00473668|12132778|FG002|COMPLETED|Overall Study||89
10959973|NCT00473668|12132776|FG000|NOT COMPLETED|Overall Study||5
10959974|NCT00473668|12132777|FG001|NOT COMPLETED|Overall Study||11
10959975|NCT00473668|12132778|FG002|NOT COMPLETED|Overall Study||10
10959976|NCT00473694|12132790|FG000|STARTED|Overall Study||48
10959977|NCT00473694|12132791|FG001|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41
10959978|NCT00473694|12132792|FG002|STARTED|Overall Study||51
10959979|NCT00473694|12132793|FG003|STARTED|Overall Study||42
10959980|NCT00473694|12132790|FG000|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37
10959981|NCT00473694|12132791|FG001|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38
10959982|NCT00473694|12132792|FG002|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46
10959983|NCT00473694|12132793|FG003|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36
10959984|NCT00473694|12132790|FG000|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
10959985|NCT00473694|12132791|FG001|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
10959986|NCT00473694|12132792|FG002|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46
10959987|NCT00473694|12132793|FG003|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35
10959988|NCT00473694|12132790|FG000|NOT COMPLETED|Overall Study||11
10959989|NCT00473694|12132791|FG001|NOT COMPLETED|Overall Study||4
10959990|NCT00473694|12132792|FG002|NOT COMPLETED|Overall Study||5
10959991|NCT00473694|12132793|FG003|NOT COMPLETED|Overall Study||7
10959992|NCT00473746|12132811|FG000|STARTED|Period 1 (Phase 1)||6
10959993|NCT00473746|12132812|FG001|STARTED|Period 1 (Phase 1)||9
10959994|NCT00473746|12132813|FG002|STARTED|Period 1 (Phase 1)||6
10959995|NCT00473746|12132814|FG003|STARTED|Period 1 (Phase 1)||12
10959996|NCT00473746|12132815|FG004|STARTED|Period 1 (Phase 1)||0
10959997|NCT00473746|12132811|FG000|COMPLETED|Period 1 (Phase 1)||0
10959998|NCT00473746|12132812|FG001|COMPLETED|Period 1 (Phase 1)||0
10959999|NCT00473746|12132813|FG002|COMPLETED|Period 1 (Phase 1)||0
10960000|NCT00473746|12132814|FG003|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
10960001|NCT00473746|12132815|FG004|COMPLETED|Period 1 (Phase 1)||0
10960002|NCT00473746|12132811|FG000|NOT COMPLETED|Period 1 (Phase 1)||6
10960003|NCT00473746|12132812|FG001|NOT COMPLETED|Period 1 (Phase 1)||9
10960004|NCT00473746|12132813|FG002|NOT COMPLETED|Period 1 (Phase 1)||6
10960005|NCT00473746|12132814|FG003|NOT COMPLETED|Period 1 (Phase 1)||10
10960006|NCT00473746|12132815|FG004|NOT COMPLETED|Period 1 (Phase 1)||0
10960007|NCT00473746|12132811|FG000|STARTED|Period 2 (Phase 2)||0
10960008|NCT00473746|12132812|FG001|STARTED|Period 2 (Phase 2)||0
10960009|NCT00473746|12132813|FG002|STARTED|Period 2 (Phase 2)||0
10960010|NCT00473746|12132814|FG003|STARTED|Period 2 (Phase 2)||0
10960011|NCT00473746|12132815|FG004|STARTED|Period 2 (Phase 2)||33
10960012|NCT00473746|12132811|FG000|COMPLETED|Period 2 (Phase 2)||0
10960013|NCT00473746|12132812|FG001|COMPLETED|Period 2 (Phase 2)||0
10960014|NCT00473746|12132813|FG002|COMPLETED|Period 2 (Phase 2)||0
10960015|NCT00473746|12132814|FG003|COMPLETED|Period 2 (Phase 2)||0
10960016|NCT00473746|12132815|FG004|COMPLETED|Period 2 (Phase 2)||6
10960017|NCT00473746|12132811|FG000|NOT COMPLETED|Period 2 (Phase 2)||0
10960018|NCT00473746|12132812|FG001|NOT COMPLETED|Period 2 (Phase 2)||0
10960019|NCT00473746|12132813|FG002|NOT COMPLETED|Period 2 (Phase 2)||0
10960020|NCT00473746|12132814|FG003|NOT COMPLETED|Period 2 (Phase 2)||0
10960021|NCT00473746|12132815|FG004|NOT COMPLETED|Period 2 (Phase 2)||27
10960022|NCT00473824|12132831|FG000|STARTED|Overall Study||5
10960023|NCT00473824|12132832|FG001|STARTED|Overall Study||2
10960024|NCT00473824|12132831|FG000|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
10960025|NCT00473824|12132832|FG001|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
10960026|NCT00473824|12132831|FG000|NOT COMPLETED|Overall Study||5
10960027|NCT00473824|12132832|FG001|NOT COMPLETED|Overall Study||0
10960028|NCT00473837|12132840|FG000|STARTED|Overall Study||50
10960029|NCT00473837|12132841|FG001|STARTED|Overall Study||46
10960030|NCT00473837|12132840|FG000|COMPLETED|Overall Study||49
10960031|NCT00473837|12132841|FG001|COMPLETED|Overall Study||43
10960032|NCT00473837|12132840|FG000|NOT COMPLETED|Overall Study||1
10960033|NCT00473837|12132841|FG001|NOT COMPLETED|Overall Study||3
10960034|NCT00473876|12132849|FG000|STARTED|Overall Study||39
10960035|NCT00473876|12132850|FG001|STARTED|Overall Study||23
10960036|NCT00473876|12132849|FG000|COMPLETED|Overall Study||36
10960037|NCT00473876|12132850|FG001|COMPLETED|Overall Study||22
10960038|NCT00473876|12132849|FG000|NOT COMPLETED|Overall Study||3
10960039|NCT00473876|12132850|FG001|NOT COMPLETED|Overall Study||1
10960040|NCT00473889|12132860|FG000|STARTED|Overall Study||126
10960041|NCT00473889|12132861|FG001|STARTED|Overall Study||127
10960042|NCT00473889|12132860|FG000|COMPLETED|Overall Study||43
10960043|NCT00473889|12132861|FG001|COMPLETED|Overall Study||63
10960044|NCT00473889|12132860|FG000|NOT COMPLETED|Overall Study||83
10960045|NCT00473889|12132861|FG001|NOT COMPLETED|Overall Study||64
10960046|NCT00474045|12132869|FG000|STARTED|Overall Study||233
10960047|NCT00474045|12132870|FG001|STARTED|Overall Study||237
10960048|NCT00474045|12132869|FG000|Exposed-All Subjects|Overall Study||233
10960049|NCT00474045|12132870|FG001|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
10960050|NCT00474045|12132869|FG000|Exposed-Pregnant Subjects|Overall Study||152
10960051|NCT00474045|12132870|FG001|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
10960052|NCT00474045|12132869|FG000|Pregnancies (for Exposed-pregnant)|Overall Study||152
10960053|NCT00474045|12132870|FG001|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
10960054|NCT00474045|12132869|FG000|COMPLETED|Overall Study||127
10960055|NCT00474045|12132870|FG001|COMPLETED|Overall Study||136
10960056|NCT00474045|12132869|FG000|NOT COMPLETED|Overall Study||106
10960057|NCT00474045|12132870|FG001|NOT COMPLETED|Overall Study||101
10960058|NCT00474058|12132878|FG000|STARTED|Overall Study||190
10960059|NCT00474058|12132879|FG001|STARTED|Overall Study||97
10960060|NCT00474058|12132878|FG000|COMPLETED|Overall Study||166
10960061|NCT00474058|12132879|FG001|COMPLETED|Overall Study||80
10960062|NCT00474058|12132878|FG000|NOT COMPLETED|Overall Study||24
10960063|NCT00474058|12132879|FG001|NOT COMPLETED|Overall Study||17
10960064|NCT00474123|12132887|FG000|STARTED|Overall Study||38
10960065|NCT00474123|12132888|FG001|STARTED|Overall Study||40
10960066|NCT00474123|12132887|FG000|COMPLETED|Overall Study||38
10960067|NCT00474123|12132888|FG001|COMPLETED|Overall Study||40
10960068|NCT00474123|12132887|FG000|NOT COMPLETED|Overall Study||0
10960069|NCT00474123|12132888|FG001|NOT COMPLETED|Overall Study||0
10960070|NCT00474175|12132897|FG000|STARTED|Overall Study||115
10960071|NCT00474175|12132898|FG001|STARTED|Overall Study||233
10960072|NCT00474175|12132899|FG002|STARTED|Overall Study||229
10960073|NCT00474175|12132897|FG000|Treated|Overall Study||115
10960074|NCT00474175|12132898|FG001|Treated|Overall Study||233
10960075|NCT00474175|12132899|FG002|Treated|Overall Study||228
10960076|NCT00474175|12132897|FG000|COMPLETED|Overall Study||114
10960077|NCT00474175|12132898|FG001|COMPLETED|Overall Study||226
10960078|NCT00474175|12132899|FG002|COMPLETED|Overall Study||225
10960079|NCT00474175|12132897|FG000|NOT COMPLETED|Overall Study||1
10960080|NCT00474175|12132898|FG001|NOT COMPLETED|Overall Study||7
10960081|NCT00474175|12132899|FG002|NOT COMPLETED|Overall Study||4
10960082|NCT00474201|12132907|FG000|STARTED|Overall Study||15
10960083|NCT00474201|12132907|FG000|COMPLETED|Overall Study||15
10960084|NCT00474201|12132907|FG000|NOT COMPLETED|Overall Study||0
10960085|NCT00474240|12132918|FG000|STARTED|Overall Study||27
10960086|NCT00474240|12132919|FG001|STARTED|Overall Study||26
10960087|NCT00474240|12132920|FG002|STARTED|Overall Study||26
10960088|NCT00474240|12132921|FG003|STARTED|Overall Study||26
10960089|NCT00474240|12132922|FG004|STARTED|Overall Study||26
10960090|NCT00474240|12132923|FG005|STARTED|Overall Study||26
10960091|NCT00474240|12132918|FG000|COMPLETED|Overall Study||26
10960092|NCT00474240|12132919|FG001|COMPLETED|Overall Study||25
10960093|NCT00474240|12132920|FG002|COMPLETED|Overall Study||17
10960094|NCT00474240|12132921|FG003|COMPLETED|Overall Study||10
10960095|NCT00474240|12132922|FG004|COMPLETED|Overall Study||18
10960096|NCT00474240|12132923|FG005|COMPLETED|Overall Study||8
10960097|NCT00474240|12132918|FG000|NOT COMPLETED|Overall Study||1
10960098|NCT00474240|12132919|FG001|NOT COMPLETED|Overall Study||1
10960099|NCT00474240|12132920|FG002|NOT COMPLETED|Overall Study||9
10960100|NCT00474240|12132921|FG003|NOT COMPLETED|Overall Study||16
10960101|NCT00474240|12132922|FG004|NOT COMPLETED|Overall Study||8
10960102|NCT00474240|12132923|FG005|NOT COMPLETED|Overall Study||18
10960103|NCT00474253|12132939|FG000|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58
10960104|NCT00474253|12132940|FG001|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57
10960105|NCT00474253|12132939|FG000|Treated|Overall Study|Based on actual treatment received.|56
10960106|NCT00474253|12132940|FG001|Treated|Overall Study|Based on actual treatment received.|54
10960107|NCT00474253|12132939|FG000|COMPLETED|Overall Study|Based on actual treatment received.|55
10960108|NCT00474253|12132940|FG001|COMPLETED|Overall Study|Based on actual treatment received.|53
10960109|NCT00474253|12132939|FG000|NOT COMPLETED|Overall Study||3
10960110|NCT00474253|12132940|FG001|NOT COMPLETED|Overall Study||4
10960111|NCT00474266|12132950|FG000|STARTED|Overall Study||375
10960112|NCT00474266|12132951|FG001|STARTED|Overall Study||374
10960113|NCT00474266|12132952|FG002|STARTED|Overall Study||126
10960114|NCT00474266|12132953|FG003|STARTED|Overall Study||125
10960115|NCT00474266|12132950|FG000|COMPLETED|Overall Study||368
10960116|NCT00474266|12132951|FG001|COMPLETED|Overall Study||354
10960117|NCT00474266|12132952|FG002|COMPLETED|Overall Study||122
10960118|NCT00474266|12132953|FG003|COMPLETED|Overall Study||118
10960119|NCT00474266|12132950|FG000|NOT COMPLETED|Overall Study||7
10960120|NCT00474266|12132951|FG001|NOT COMPLETED|Overall Study||20
10960121|NCT00474266|12132952|FG002|NOT COMPLETED|Overall Study||4
10960122|NCT00474266|12132953|FG003|NOT COMPLETED|Overall Study||7
10960123|NCT00474383|12132966|FG000|STARTED|Main Study||47
10960124|NCT00474383|12132967|FG001|STARTED|Main Study||0
10960125|NCT00474383|12132966|FG000|COMPLETED|Main Study||11
10960126|NCT00474383|12132967|FG001|COMPLETED|Main Study||0
10960127|NCT00474383|12132966|FG000|NOT COMPLETED|Main Study||36
10960128|NCT00474383|12132967|FG001|NOT COMPLETED|Main Study||0
10960129|NCT00474383|12132966|FG000|STARTED|Between Main Study and Extension||11
10960130|NCT00474383|12132967|FG001|STARTED|Between Main Study and Extension||0
10960131|NCT00474383|12132966|FG000|COMPLETED|Between Main Study and Extension||5
10960132|NCT00474383|12132967|FG001|COMPLETED|Between Main Study and Extension||0
10960133|NCT00474383|12132966|FG000|NOT COMPLETED|Between Main Study and Extension||6
10960134|NCT00474383|12132967|FG001|NOT COMPLETED|Between Main Study and Extension||0
10960135|NCT00474383|12132966|FG000|STARTED|Extension||0
10960136|NCT00474383|12132967|FG001|STARTED|Extension||5
10960137|NCT00474383|12132966|FG000|COMPLETED|Extension||0
10960138|NCT00474383|12132967|FG001|COMPLETED|Extension||0
10960139|NCT00474383|12132966|FG000|NOT COMPLETED|Extension||0
10960140|NCT00474383|12132967|FG001|NOT COMPLETED|Extension||5
10960141|NCT00474487|12132975|FG000|STARTED|Overall Study||1606
10960142|NCT00474487|12132976|FG001|STARTED|Overall Study||217
10960143|NCT00474487|12132977|FG002|STARTED|Overall Study||899
10960144|NCT00474487|12132978|FG003|STARTED|Overall Study||109
10960145|NCT00474487|12132975|FG000|COMPLETED|Overall Study||1576
10960146|NCT00474487|12132976|FG001|COMPLETED|Overall Study||215
10960147|NCT00474487|12132977|FG002|COMPLETED|Overall Study||885
10960148|NCT00474487|12132978|FG003|COMPLETED|Overall Study||109
10960149|NCT00474487|12132975|FG000|NOT COMPLETED|Overall Study||30
10960150|NCT00474487|12132976|FG001|NOT COMPLETED|Overall Study||2
10960151|NCT00474487|12132977|FG002|NOT COMPLETED|Overall Study||14
10960152|NCT00474487|12132978|FG003|NOT COMPLETED|Overall Study||0
10960153|NCT00474526|12133005|FG000|STARTED|Overall Study||154
10960154|NCT00474526|12133006|FG001|STARTED|Overall Study||166
10960155|NCT00474526|12133007|FG002|STARTED|Overall Study||159
10960156|NCT00474526|12133008|FG003|STARTED|Overall Study||680
10960157|NCT00474526|12133009|FG004|STARTED|Overall Study||76
10960158|NCT00474526|12133010|FG005|STARTED|Overall Study||70
10960159|NCT00474526|12133011|FG006|STARTED|Overall Study||203
10960160|NCT00474526|12133012|FG007|STARTED|Overall Study||151
10960161|NCT00474526|12133013|FG008|STARTED|Overall Study||150
10960162|NCT00474526|12133014|FG009|STARTED|Overall Study||148
10960163|NCT00474526|12133015|FG010|STARTED|Overall Study||151
10960164|NCT00474526|12133016|FG011|STARTED|Overall Study||150
10960165|NCT00474526|12133017|FG012|STARTED|Overall Study||150
10960166|NCT00474526|12133018|FG013|STARTED|Overall Study||1426
10960167|NCT00474526|12133019|FG014|STARTED|Overall Study||358
10960168|NCT00474526|12133020|FG015|STARTED|Overall Study||170
10960169|NCT00474526|12133021|FG016|STARTED|Overall Study||183
10960170|NCT00474526|12133005|FG000|COMPLETED|Overall Study||121
10960171|NCT00474526|12133006|FG001|COMPLETED|Overall Study||120
10960172|NCT00474526|12133007|FG002|COMPLETED|Overall Study||110
10960173|NCT00474526|12133008|FG003|COMPLETED|Overall Study||561
10960174|NCT00474526|12133009|FG004|COMPLETED|Overall Study||8
10960175|NCT00474526|12133010|FG005|COMPLETED|Overall Study||54
10960176|NCT00474526|12133011|FG006|COMPLETED|Overall Study||178
10960177|NCT00474526|12133012|FG007|COMPLETED|Overall Study||145
10960178|NCT00474526|12133013|FG008|COMPLETED|Overall Study||144
10960179|NCT00474526|12133014|FG009|COMPLETED|Overall Study||121
10960180|NCT00474526|12133015|FG010|COMPLETED|Overall Study||141
10960181|NCT00474526|12133016|FG011|COMPLETED|Overall Study||139
10960182|NCT00474526|12133017|FG012|COMPLETED|Overall Study||135
10960183|NCT00474526|12133018|FG013|COMPLETED|Overall Study||1270
10960184|NCT00474526|12133019|FG014|COMPLETED|Overall Study||281
10960185|NCT00474526|12133020|FG015|COMPLETED|Overall Study||152
10960186|NCT00474526|12133021|FG016|COMPLETED|Overall Study||174
10960187|NCT00474526|12133005|FG000|NOT COMPLETED|Overall Study||33
10960188|NCT00474526|12133006|FG001|NOT COMPLETED|Overall Study||46
10960189|NCT00474526|12133007|FG002|NOT COMPLETED|Overall Study||49
10960190|NCT00474526|12133008|FG003|NOT COMPLETED|Overall Study||119
10960191|NCT00474526|12133009|FG004|NOT COMPLETED|Overall Study||68
10960192|NCT00474526|12133010|FG005|NOT COMPLETED|Overall Study||16
10960193|NCT00474526|12133011|FG006|NOT COMPLETED|Overall Study||25
10960194|NCT00474526|12133012|FG007|NOT COMPLETED|Overall Study||6
10960195|NCT00474526|12133013|FG008|NOT COMPLETED|Overall Study||6
10960196|NCT00474526|12133014|FG009|NOT COMPLETED|Overall Study||27
10960197|NCT00474526|12133015|FG010|NOT COMPLETED|Overall Study||10
10960198|NCT00474526|12133016|FG011|NOT COMPLETED|Overall Study||11
10960199|NCT00474526|12133017|FG012|NOT COMPLETED|Overall Study||15
10960200|NCT00474526|12133018|FG013|NOT COMPLETED|Overall Study||156
10960201|NCT00474526|12133019|FG014|NOT COMPLETED|Overall Study||77
10960202|NCT00474526|12133020|FG015|NOT COMPLETED|Overall Study||18
10960203|NCT00474526|12133021|FG016|NOT COMPLETED|Overall Study||9
10960204|NCT00474539|12133109|FG000|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
10960205|NCT00474539|12133110|FG001|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
10960206|NCT00474539|12133109|FG000|Vaccinated Dose 1|Infant Series||218
10960207|NCT00474539|12133110|FG001|Vaccinated Dose 1|Infant Series||226
10960208|NCT00474539|12133109|FG000|Vaccinated Dose 2|Infant Series||217
10960209|NCT00474539|12133110|FG001|Vaccinated Dose 2|Infant Series||222
10960210|NCT00474539|12133109|FG000|Vaccinated Dose 3|Infant Series||214
10960211|NCT00474539|12133110|FG001|Vaccinated Dose 3|Infant Series||221
10960212|NCT00474539|12133109|FG000|COMPLETED|Infant Series||213
10960213|NCT00474539|12133110|FG001|COMPLETED|Infant Series||220
10960214|NCT00474539|12133109|FG000|NOT COMPLETED|Infant Series||10
10960215|NCT00474539|12133110|FG001|NOT COMPLETED|Infant Series||6
10960216|NCT00474539|12133109|FG000|STARTED|After Infant Series||213
10960217|NCT00474539|12133110|FG001|STARTED|After Infant Series||220
10960218|NCT00474539|12133109|FG000|COMPLETED|After Infant Series||209
10960219|NCT00474539|12133110|FG001|COMPLETED|After Infant Series||220
10960220|NCT00474539|12133109|FG000|NOT COMPLETED|After Infant Series||4
10960221|NCT00474539|12133110|FG001|NOT COMPLETED|After Infant Series||0
10960222|NCT00474539|12133109|FG000|STARTED|Toddler Dose||209
10960223|NCT00474539|12133110|FG001|STARTED|Toddler Dose||220
10960224|NCT00474539|12133109|FG000|COMPLETED|Toddler Dose||208
10960225|NCT00474539|12133110|FG001|COMPLETED|Toddler Dose||220
10960226|NCT00474539|12133109|FG000|NOT COMPLETED|Toddler Dose||1
10960227|NCT00474539|12133110|FG001|NOT COMPLETED|Toddler Dose||0
10960228|NCT00474617|12133144|FG000|STARTED|Overall Study||56
10960229|NCT00474617|12133145|FG001|STARTED|Overall Study||64
10960230|NCT00474617|12133146|FG002|STARTED|Overall Study||42
10960231|NCT00474617|12133144|FG000|Treated|Overall Study||48
10960232|NCT00474617|12133145|FG001|Treated|Overall Study||62
10960233|NCT00474617|12133146|FG002|Treated|Overall Study||40
10960234|NCT00474617|12133144|FG000|COMPLETED|Overall Study||48
10960235|NCT00474617|12133145|FG001|COMPLETED|Overall Study||61
10960236|NCT00474617|12133146|FG002|COMPLETED|Overall Study||40
10960237|NCT00474617|12133144|FG000|NOT COMPLETED|Overall Study||8
10960238|NCT00474617|12133145|FG001|NOT COMPLETED|Overall Study||3
10960239|NCT00474617|12133146|FG002|NOT COMPLETED|Overall Study||2
10960240|NCT00474630|12133156|FG000|STARTED|Overall Study||335
10960241|NCT00474630|12133157|FG001|STARTED|Overall Study||170
10960242|NCT00474630|12133156|FG000|COMPLETED|Overall Study||175
10960243|NCT00474630|12133157|FG001|COMPLETED|Overall Study||100
10960244|NCT00474630|12133156|FG000|NOT COMPLETED|Overall Study||160
10960245|NCT00474630|12133157|FG001|NOT COMPLETED|Overall Study||70
10960246|NCT00474708|12133166|FG000|STARTED|Overall Study||791
10960247|NCT00474708|12133167|FG001|STARTED|Overall Study||367
10960248|NCT00474708|12133166|FG000|COMPLETED|Overall Study||734
10960249|NCT00474708|12133167|FG001|COMPLETED|Overall Study||342
10960250|NCT00474708|12133166|FG000|NOT COMPLETED|Overall Study||57
10960251|NCT00474708|12133167|FG001|NOT COMPLETED|Overall Study||25
10960252|NCT00474760|12133180|FG000|STARTED|Overall Study||3
10960253|NCT00474760|12133181|FG001|STARTED|Overall Study||3
10960254|NCT00474760|12133182|FG002|STARTED|Overall Study||3
10960255|NCT00474760|12133183|FG003|STARTED|Overall Study||3
10960256|NCT00474760|12133184|FG004|STARTED|Overall Study||13
10960257|NCT00474760|12133185|FG005|STARTED|Overall Study||29
10960258|NCT00474760|12133186|FG006|STARTED|Overall Study||11
10960259|NCT00474760|12133180|FG000|COMPLETED|Overall Study||0
10960260|NCT00474760|12133181|FG001|COMPLETED|Overall Study||0
10960261|NCT00474760|12133182|FG002|COMPLETED|Overall Study||0
10960262|NCT00474760|12133183|FG003|COMPLETED|Overall Study||0
10960263|NCT00474760|12133184|FG004|COMPLETED|Overall Study||1
10960264|NCT00474760|12133185|FG005|COMPLETED|Overall Study||0
10960265|NCT00474760|12133186|FG006|COMPLETED|Overall Study||1
10960266|NCT00474760|12133180|FG000|NOT COMPLETED|Overall Study||3
10960267|NCT00474760|12133181|FG001|NOT COMPLETED|Overall Study||3
10960268|NCT00474760|12133182|FG002|NOT COMPLETED|Overall Study||3
10960269|NCT00474760|12133183|FG003|NOT COMPLETED|Overall Study||3
10960270|NCT00474760|12133184|FG004|NOT COMPLETED|Overall Study||12
10960271|NCT00474760|12133185|FG005|NOT COMPLETED|Overall Study||29
10960272|NCT00474760|12133186|FG006|NOT COMPLETED|Overall Study||10
10960273|NCT00474786|12133211|FG000|STARTED|Overall Study||259
10960274|NCT00474786|12133212|FG001|STARTED|Overall Study||253
10960275|NCT00474786|12133211|FG000|COMPLETED|Overall Study||0
10960276|NCT00474786|12133212|FG001|COMPLETED|Overall Study||0
10960277|NCT00474786|12133211|FG000|NOT COMPLETED|Overall Study||259
10960278|NCT00474786|12133212|FG001|NOT COMPLETED|Overall Study||253
10960279|NCT00474812|12133218|FG000|STARTED|Overall Study||51
10960280|NCT00474812|12133218|FG000|COMPLETED|Overall Study||44
10960281|NCT00474812|12133218|FG000|NOT COMPLETED|Overall Study||7
10960282|NCT00474851|12133224|FG000|STARTED|Overall Study||26
10960283|NCT00474851|12133225|FG001|STARTED|Overall Study||27
10960284|NCT00474851|12133224|FG000|Completed Baseline|Overall Study||25
10960285|NCT00474851|12133225|FG001|Completed Baseline|Overall Study||26
10960286|NCT00474851|12133224|FG000|COMPLETED|Overall Study||18
10960287|NCT00474851|12133225|FG001|COMPLETED|Overall Study||16
10960288|NCT00474851|12133224|FG000|NOT COMPLETED|Overall Study||8
10960289|NCT00474851|12133225|FG001|NOT COMPLETED|Overall Study||11
10960290|NCT00474903|12133235|FG000|STARTED|Overall Study||30
10960291|NCT00474903|12133236|FG001|STARTED|Overall Study||47
10960292|NCT00474903|12133237|FG002|STARTED|Overall Study||45
10960293|NCT00474903|12133235|FG000|COMPLETED|Overall Study||29
10960294|NCT00474903|12133236|FG001|COMPLETED|Overall Study||42
10960295|NCT00474903|12133237|FG002|COMPLETED|Overall Study||43
10960296|NCT00474903|12133235|FG000|NOT COMPLETED|Overall Study||1
10960297|NCT00474903|12133236|FG001|NOT COMPLETED|Overall Study||5
10960298|NCT00474903|12133237|FG002|NOT COMPLETED|Overall Study||2
10960299|NCT00474929|12133250|FG000|STARTED|Overall Study||6
10960300|NCT00474929|12133251|FG001|STARTED|Overall Study||6
10960301|NCT00474929|12133252|FG002|STARTED|Overall Study||7
10960302|NCT00474929|12133253|FG003|STARTED|Overall Study||7
10960303|NCT00474929|12133254|FG004|STARTED|Overall Study||77
10960304|NCT00474929|12133250|FG000|COMPLETED|Overall Study||6
10960305|NCT00474929|12133251|FG001|COMPLETED|Overall Study||5
10960306|NCT00474929|12133252|FG002|COMPLETED|Overall Study||5
10960307|NCT00474929|12133253|FG003|COMPLETED|Overall Study||5
10960308|NCT00474929|12133254|FG004|COMPLETED|Overall Study||77
10960309|NCT00474929|12133250|FG000|NOT COMPLETED|Overall Study||0
10960310|NCT00474929|12133251|FG001|NOT COMPLETED|Overall Study||1
10960311|NCT00474929|12133252|FG002|NOT COMPLETED|Overall Study||2
10960312|NCT00474929|12133253|FG003|NOT COMPLETED|Overall Study||2
10960313|NCT00474929|12133254|FG004|NOT COMPLETED|Overall Study||0
10960314|NCT00474955|12133267|FG000|STARTED|Overall Study||27
10960315|NCT00474955|12133267|FG000|COMPLETED|Overall Study||19
10960316|NCT00474955|12133267|FG000|NOT COMPLETED|Overall Study||8
10960317|NCT00474968|12133273|FG000|STARTED|Overall Study||366
10960318|NCT00474968|12133274|FG001|STARTED|Overall Study||371
10960319|NCT00474968|12133273|FG000|COMPLETED|Overall Study||348
10960320|NCT00474968|12133274|FG001|COMPLETED|Overall Study||355
10960321|NCT00474968|12133273|FG000|NOT COMPLETED|Overall Study||18
10960322|NCT00474968|12133274|FG001|NOT COMPLETED|Overall Study||16
10960323|NCT00474994|12133280|FG000|STARTED|Overall Study||53
10960324|NCT00474994|12133280|FG000|COMPLETED|Overall Study||48
10960325|NCT00474994|12133280|FG000|NOT COMPLETED|Overall Study||5
10960326|NCT00475020|12133284|FG000|STARTED|Overall Study||63
10960327|NCT00475020|12133284|FG000|COMPLETED|Overall Study||58
10960328|NCT00475020|12133284|FG000|NOT COMPLETED|Overall Study||5
10960329|NCT00475033|12133290|FG000|STARTED|Infant Series||300
10960330|NCT00475033|12133291|FG001|STARTED|Infant Series||303
10960331|NCT00475033|12133290|FG000|Vaccinated Dose 1|Infant Series||300
10960332|NCT00475033|12133291|FG001|Vaccinated Dose 1|Infant Series||303
10960333|NCT00475033|12133290|FG000|Vaccinated Dose 2|Infant Series||297
10960334|NCT00475033|12133291|FG001|Vaccinated Dose 2|Infant Series||296
10960335|NCT00475033|12133290|FG000|Vaccinated Dose 3|Infant Series||293
10960336|NCT00475033|12133291|FG001|Vaccinated Dose 3|Infant Series||294
10960337|NCT00475033|12133290|FG000|COMPLETED|Infant Series||293
10960338|NCT00475033|12133291|FG001|COMPLETED|Infant Series||290
10960339|NCT00475033|12133290|FG000|NOT COMPLETED|Infant Series||7
10960340|NCT00475033|12133291|FG001|NOT COMPLETED|Infant Series||13
10960341|NCT00475033|12133290|FG000|STARTED|After the Infant Series||293
10960342|NCT00475033|12133291|FG001|STARTED|After the Infant Series||290
10960343|NCT00475033|12133290|FG000|Withdrawn After Infant Series|After the Infant Series||6
10960344|NCT00475033|12133291|FG001|Withdrawn After Infant Series|After the Infant Series||8
10960345|NCT00475033|12133290|FG000|COMPLETED|After the Infant Series||287
10960346|NCT00475033|12133291|FG001|COMPLETED|After the Infant Series||282
10960347|NCT00475033|12133290|FG000|NOT COMPLETED|After the Infant Series||6
10960348|NCT00475033|12133291|FG001|NOT COMPLETED|After the Infant Series||8
10960349|NCT00475033|12133290|FG000|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
10960350|NCT00475033|12133291|FG001|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
10960351|NCT00475033|12133290|FG000|COMPLETED|Toddler Dose||283
10960352|NCT00475033|12133291|FG001|COMPLETED|Toddler Dose||282
10960353|NCT00475033|12133290|FG000|NOT COMPLETED|Toddler Dose||4
10960354|NCT00475033|12133291|FG001|NOT COMPLETED|Toddler Dose||0
10960355|NCT00475085|12133308|FG000|STARTED|Overall Study||253
10960356|NCT00475085|12133309|FG001|STARTED|Overall Study||254
10960357|NCT00475085|12133310|FG002|STARTED|Overall Study||260
10960358|NCT00475085|12133311|FG003|STARTED|Overall Study||254
10960359|NCT00475085|12133308|FG000|COMPLETED|Overall Study||235
10960360|NCT00475085|12133309|FG001|COMPLETED|Overall Study||234
10960361|NCT00475085|12133310|FG002|COMPLETED|Overall Study||241
10960362|NCT00475085|12133311|FG003|COMPLETED|Overall Study||234
10960363|NCT00475085|12133308|FG000|NOT COMPLETED|Overall Study||18
10960364|NCT00475085|12133309|FG001|NOT COMPLETED|Overall Study||20
10960365|NCT00475085|12133310|FG002|NOT COMPLETED|Overall Study||19
10960366|NCT00475085|12133311|FG003|NOT COMPLETED|Overall Study||20
10960367|NCT00475150|12133323|FG000|STARTED|Overall Study||23
10960368|NCT00475150|12133324|FG001|STARTED|Overall Study||16
10960369|NCT00475150|12133323|FG000|COMPLETED|Overall Study||23
10960370|NCT00475150|12133324|FG001|COMPLETED|Overall Study||16
10960371|NCT00475150|12133323|FG000|NOT COMPLETED|Overall Study||0
10960372|NCT00475150|12133324|FG001|NOT COMPLETED|Overall Study||0
10960373|NCT00475176|12133329|FG000|STARTED|Overall Study||24
10960374|NCT00475176|12133329|FG000|COMPLETED|Overall Study||20
10960375|NCT00475176|12133329|FG000|NOT COMPLETED|Overall Study||4
10960376|NCT00475215|12133335|FG000|STARTED|Overall Study||44
10960377|NCT00475215|12133336|FG001|STARTED|Overall Study||42
10960378|NCT00475215|12133335|FG000|Treated|Overall Study||39
10960379|NCT00475215|12133336|FG001|Treated|Overall Study||38
10960380|NCT00475215|12133335|FG000|COMPLETED|Overall Study||39
10960381|NCT00475215|12133336|FG001|COMPLETED|Overall Study||38
10960382|NCT00475215|12133335|FG000|NOT COMPLETED|Overall Study||5
10960383|NCT00475215|12133336|FG001|NOT COMPLETED|Overall Study||4
10960384|NCT00475228|12133344|FG000|STARTED|Overall Study||44
10960385|NCT00475228|12133345|FG001|STARTED|Overall Study||44
10960386|NCT00475228|12133344|FG000|COMPLETED|Overall Study||27
10960387|NCT00475228|12133345|FG001|COMPLETED|Overall Study||27
10960388|NCT00475228|12133344|FG000|NOT COMPLETED|Overall Study||17
10960389|NCT00475228|12133345|FG001|NOT COMPLETED|Overall Study||17
10960390|NCT00475241|12133357|FG000|STARTED|Overall Study||18
10960391|NCT00475241|12133358|FG001|STARTED|Overall Study||18
10960392|NCT00475241|12133357|FG000|COMPLETED|Overall Study||11
10960393|NCT00475241|12133358|FG001|COMPLETED|Overall Study||15
10960394|NCT00475241|12133357|FG000|NOT COMPLETED|Overall Study||7
10960395|NCT00475241|12133358|FG001|NOT COMPLETED|Overall Study||3
10960396|NCT00475306|12133369|FG000|STARTED|Overall Study||73
10960397|NCT00475306|12133370|FG001|STARTED|Overall Study||72
10960398|NCT00475306|12133371|FG002|STARTED|Overall Study||72
10960399|NCT00475306|12133372|FG003|STARTED|Overall Study||72
10960484|NCT00475735|12133485|FG002|NOT COMPLETED|Treatment Washout||0
10960400|NCT00475306|12133369|FG000|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
10960401|NCT00475306|12133370|FG001|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
10960402|NCT00475306|12133371|FG002|COMPLETED|Overall Study||72
10960403|NCT00475306|12133372|FG003|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
10960404|NCT00475306|12133369|FG000|NOT COMPLETED|Overall Study||1
10960405|NCT00475306|12133370|FG001|NOT COMPLETED|Overall Study||1
10960406|NCT00475306|12133371|FG002|NOT COMPLETED|Overall Study||0
10960407|NCT00475306|12133372|FG003|NOT COMPLETED|Overall Study||1
10960408|NCT00475319|12133385|FG000|STARTED|Overall Study||103
10960409|NCT00475319|12133386|FG001|STARTED|Overall Study||102
10960410|NCT00475319|12133387|FG002|STARTED|Overall Study||103
10960411|NCT00475319|12133385|FG000|COMPLETED|Overall Study||101
10960412|NCT00475319|12133386|FG001|COMPLETED|Overall Study||101
10960413|NCT00475319|12133387|FG002|COMPLETED|Overall Study||99
10960414|NCT00475319|12133385|FG000|NOT COMPLETED|Overall Study||2
10960415|NCT00475319|12133386|FG001|NOT COMPLETED|Overall Study||1
10960416|NCT00475319|12133387|FG002|NOT COMPLETED|Overall Study||4
10960417|NCT00475423|12133398|FG000|STARTED|Overall Study||122
10960418|NCT00475423|12133398|FG000|COMPLETED|Overall Study||90
10960419|NCT00475423|12133398|FG000|NOT COMPLETED|Overall Study||32
10960420|NCT00475501|12133406|FG000|STARTED|Overall Study||14
10960421|NCT00475501|12133407|FG001|STARTED|Overall Study||13
10960422|NCT00475501|12133408|FG002|STARTED|Overall Study||17
10960423|NCT00475501|12133409|FG003|STARTED|Overall Study||16
10960424|NCT00475501|12133406|FG000|COMPLETED|Overall Study||7
10960425|NCT00475501|12133407|FG001|COMPLETED|Overall Study||8
10960426|NCT00475501|12133408|FG002|COMPLETED|Overall Study||13
10960427|NCT00475501|12133409|FG003|COMPLETED|Overall Study||12
10960428|NCT00475501|12133406|FG000|NOT COMPLETED|Overall Study||7
10960429|NCT00475501|12133407|FG001|NOT COMPLETED|Overall Study||5
10960430|NCT00475501|12133408|FG002|NOT COMPLETED|Overall Study||4
10960431|NCT00475501|12133409|FG003|NOT COMPLETED|Overall Study||4
10960432|NCT00475644|12133451|FG000|STARTED|Overall Study||66
10960433|NCT00475644|12133451|FG000|Received at Least One Dose of Study Drug|Overall Study||66
10960434|NCT00475644|12133451|FG000|COMPLETED|Overall Study||53
10960435|NCT00475644|12133451|FG000|NOT COMPLETED|Overall Study||13
10960436|NCT00475670|12133457|FG000|STARTED|Overall Study||3
10960437|NCT00475670|12133458|FG001|STARTED|Overall Study||41
10960438|NCT00475670|12133457|FG000|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
10960439|NCT00475670|12133458|FG001|COMPLETED|Overall Study||0
10960440|NCT00475670|12133457|FG000|NOT COMPLETED|Overall Study||3
10960441|NCT00475670|12133458|FG001|NOT COMPLETED|Overall Study||41
10960442|NCT00475709|12133464|FG000|STARTED|Overall Study||1022
10960443|NCT00475709|12133464|FG000|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
10960444|NCT00475709|12133464|FG000|COMPLETED|Overall Study||946
10960445|NCT00475709|12133464|FG000|NOT COMPLETED|Overall Study||76
10960446|NCT00475722|12133470|FG000|STARTED|Overall Study||61
10960447|NCT00475722|12133471|FG001|STARTED|Overall Study||59
10960448|NCT00475722|12133470|FG000|COMPLETED|Overall Study||46
10960449|NCT00475722|12133471|FG001|COMPLETED|Overall Study||47
10960450|NCT00475722|12133470|FG000|NOT COMPLETED|Overall Study||15
10960451|NCT00475722|12133471|FG001|NOT COMPLETED|Overall Study||12
10960452|NCT00475735|12133483|FG000|STARTED|Treatment Period 1||14
10960453|NCT00475735|12133484|FG001|STARTED|Treatment Period 1||13
10960454|NCT00475735|12133485|FG002|STARTED|Treatment Period 1||7
10960455|NCT00475735|12133486|FG003|STARTED|Treatment Period 1||7
10960456|NCT00475735|12133487|FG004|STARTED|Treatment Period 1||16
10960457|NCT00475735|12133488|FG005|STARTED|Treatment Period 1||15
10960458|NCT00475735|12133483|FG000|COMPLETED|Treatment Period 1||10
10960459|NCT00475735|12133484|FG001|COMPLETED|Treatment Period 1||11
10960460|NCT00475735|12133485|FG002|COMPLETED|Treatment Period 1||7
10960461|NCT00475735|12133486|FG003|COMPLETED|Treatment Period 1||5
10960462|NCT00475735|12133487|FG004|COMPLETED|Treatment Period 1||14
10960463|NCT00475735|12133488|FG005|COMPLETED|Treatment Period 1||12
10960464|NCT00475735|12133483|FG000|NOT COMPLETED|Treatment Period 1||4
10960465|NCT00475735|12133484|FG001|NOT COMPLETED|Treatment Period 1||2
10960466|NCT00475735|12133485|FG002|NOT COMPLETED|Treatment Period 1||0
10960467|NCT00475735|12133486|FG003|NOT COMPLETED|Treatment Period 1||2
10960468|NCT00475735|12133487|FG004|NOT COMPLETED|Treatment Period 1||2
10960469|NCT00475735|12133488|FG005|NOT COMPLETED|Treatment Period 1||3
10960470|NCT00475735|12133483|FG000|STARTED|Treatment Washout||10
10960471|NCT00475735|12133484|FG001|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
10960472|NCT00475735|12133485|FG002|STARTED|Treatment Washout||7
10960473|NCT00475735|12133486|FG003|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
10960474|NCT00475735|12133487|FG004|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
10960475|NCT00475735|12133488|FG005|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
10960476|NCT00475735|12133483|FG000|COMPLETED|Treatment Washout||10
10960477|NCT00475735|12133484|FG001|COMPLETED|Treatment Washout||10
10960478|NCT00475735|12133485|FG002|COMPLETED|Treatment Washout||7
10960479|NCT00475735|12133486|FG003|COMPLETED|Treatment Washout||6
10960480|NCT00475735|12133487|FG004|COMPLETED|Treatment Washout||16
10960481|NCT00475735|12133488|FG005|COMPLETED|Treatment Washout||14
10960482|NCT00475735|12133483|FG000|NOT COMPLETED|Treatment Washout||0
10960483|NCT00475735|12133484|FG001|NOT COMPLETED|Treatment Washout||2
10960485|NCT00475735|12133486|FG003|NOT COMPLETED|Treatment Washout||0
10960486|NCT00475735|12133487|FG004|NOT COMPLETED|Treatment Washout||0
10960487|NCT00475735|12133488|FG005|NOT COMPLETED|Treatment Washout||0
10960488|NCT00475735|12133483|FG000|STARTED|Treatment Period 2||10
10960489|NCT00475735|12133484|FG001|STARTED|Treatment Period 2||10
10960490|NCT00475735|12133485|FG002|STARTED|Treatment Period 2||7
10960491|NCT00475735|12133486|FG003|STARTED|Treatment Period 2||6
10960492|NCT00475735|12133487|FG004|STARTED|Treatment Period 2||16
10960493|NCT00475735|12133488|FG005|STARTED|Treatment Period 2||14
10960494|NCT00475735|12133483|FG000|COMPLETED|Treatment Period 2||10
10960495|NCT00475735|12133484|FG001|COMPLETED|Treatment Period 2||9
10960496|NCT00475735|12133485|FG002|COMPLETED|Treatment Period 2||7
10960497|NCT00475735|12133486|FG003|COMPLETED|Treatment Period 2||4
10960498|NCT00475735|12133487|FG004|COMPLETED|Treatment Period 2||15
10960499|NCT00475735|12133488|FG005|COMPLETED|Treatment Period 2||13
10960500|NCT00475735|12133483|FG000|NOT COMPLETED|Treatment Period 2||0
10960501|NCT00475735|12133484|FG001|NOT COMPLETED|Treatment Period 2||1
10960502|NCT00475735|12133485|FG002|NOT COMPLETED|Treatment Period 2||0
10960503|NCT00475735|12133486|FG003|NOT COMPLETED|Treatment Period 2||2
10960504|NCT00475735|12133487|FG004|NOT COMPLETED|Treatment Period 2||1
10960505|NCT00475735|12133488|FG005|NOT COMPLETED|Treatment Period 2||1
10960506|NCT00475787|12133498|FG000|STARTED|Overall Study||69
10960507|NCT00475787|12133499|FG001|STARTED|Overall Study||67
10960508|NCT00475787|12133498|FG000|COMPLETED|Overall Study||61
10960509|NCT00475787|12133499|FG001|COMPLETED|Overall Study||60
10960510|NCT00475787|12133498|FG000|NOT COMPLETED|Overall Study||8
10960511|NCT00475787|12133499|FG001|NOT COMPLETED|Overall Study||7
10960512|NCT00475852|12133509|FG000|STARTED|Overall Study||3564
10960513|NCT00475852|12133510|FG001|STARTED|Overall Study||3577
10960514|NCT00475852|12133509|FG000|COMPLETED|Overall Study||3047
10960515|NCT00475852|12133510|FG001|COMPLETED|Overall Study||3029
10960516|NCT00475852|12133509|FG000|NOT COMPLETED|Overall Study||517
10960517|NCT00475852|12133510|FG001|NOT COMPLETED|Overall Study||548
10960518|NCT00475865|12133519|FG000|STARTED|Overall Study|randomized|41
10960519|NCT00475865|12133520|FG001|STARTED|Overall Study|randomized|42
10960520|NCT00475865|12133521|FG002|STARTED|Overall Study|randomized|40
10960521|NCT00475865|12133519|FG000|Treated|Overall Study|completed treatment period|41
10960522|NCT00475865|12133520|FG001|Treated|Overall Study||42
10960523|NCT00475865|12133521|FG002|Treated|Overall Study||40
10960524|NCT00475865|12133519|FG000|COMPLETED|Overall Study||39
10960525|NCT00475865|12133520|FG001|COMPLETED|Overall Study|completed treatment period|37
10960526|NCT00475865|12133521|FG002|COMPLETED|Overall Study|completed treatment period|34
10960527|NCT00475865|12133519|FG000|NOT COMPLETED|Overall Study||2
10960528|NCT00475865|12133520|FG001|NOT COMPLETED|Overall Study||5
10960529|NCT00475865|12133521|FG002|NOT COMPLETED|Overall Study||6
10960530|NCT00475878|12133533|FG000|STARTED|Overall Study||75
10960531|NCT00475878|12133534|FG001|STARTED|Overall Study||72
10960532|NCT00475878|12133533|FG000|COMPLETED|Overall Study||75
10960533|NCT00475878|12133534|FG001|COMPLETED|Overall Study||72
10960534|NCT00475878|12133533|FG000|NOT COMPLETED|Overall Study||0
10960535|NCT00475878|12133534|FG001|NOT COMPLETED|Overall Study||0
10960536|NCT00475904|12133545|FG000|STARTED|Overall Study||140
10960537|NCT00475904|12133546|FG001|STARTED|Overall Study||144
10960538|NCT00475904|12133547|FG002|STARTED|Overall Study||76
10960539|NCT00475904|12133545|FG000|COMPLETED|Overall Study||125
10960540|NCT00475904|12133546|FG001|COMPLETED|Overall Study||131
10960541|NCT00475904|12133547|FG002|COMPLETED|Overall Study||72
10960542|NCT00475904|12133545|FG000|NOT COMPLETED|Overall Study||15
10960543|NCT00475904|12133546|FG001|NOT COMPLETED|Overall Study||13
10960544|NCT00475904|12133547|FG002|NOT COMPLETED|Overall Study||4
10960545|NCT00475982|12133557|FG000|STARTED|Overall Study||23
10960546|NCT00475982|12133558|FG001|STARTED|Overall Study||21
10960547|NCT00475982|12133557|FG000|COMPLETED|Overall Study||16
10960548|NCT00475982|12133558|FG001|COMPLETED|Overall Study||18
10960549|NCT00475982|12133557|FG000|NOT COMPLETED|Overall Study||7
10960550|NCT00475982|12133558|FG001|NOT COMPLETED|Overall Study||3
10960551|NCT00476008|12133566|FG000|STARTED|Overall Study||22
10960552|NCT00476008|12133567|FG001|STARTED|Overall Study||21
10960553|NCT00476008|12133566|FG000|6 Month Testing|Overall Study||15
10960554|NCT00476008|12133567|FG001|6 Month Testing|Overall Study||14
10960555|NCT00476008|12133566|FG000|COMPLETED|Overall Study||13
10960556|NCT00476008|12133567|FG001|COMPLETED|Overall Study||13
10960557|NCT00476008|12133566|FG000|NOT COMPLETED|Overall Study||9
10960558|NCT00476008|12133567|FG001|NOT COMPLETED|Overall Study||8
10960559|NCT00476021|12133579|FG000|STARTED|Overall Study||51
10960560|NCT00476021|12133580|FG001|STARTED|Overall Study||51
10960561|NCT00476021|12133579|FG000|COMPLETED|Overall Study||51
10960562|NCT00476021|12133580|FG001|COMPLETED|Overall Study||51
10960563|NCT00476021|12133579|FG000|NOT COMPLETED|Overall Study||0
10960564|NCT00476021|12133580|FG001|NOT COMPLETED|Overall Study||0
10960565|NCT00476047|12133592|FG000|STARTED|Overall Study||16
10960566|NCT00476047|12133592|FG000|Completed Treatment|Overall Study||16
10960567|NCT00476047|12133592|FG000|COMPLETED|Overall Study||15
10960568|NCT00476047|12133592|FG000|NOT COMPLETED|Overall Study||1
10960569|NCT00476086|12133598|FG000|STARTED|Overall Study||20
10960570|NCT00476086|12133598|FG000|Received Chemotherapy|Overall Study||19
10960571|NCT00476086|12133598|FG000|Received Radiation|Overall Study||15
10960572|NCT00476086|12133598|FG000|COMPLETED|Overall Study||15
10960573|NCT00476086|12133598|FG000|NOT COMPLETED|Overall Study||5
10960574|NCT00476151|12133606|FG000|STARTED|Overall Study||112
10960575|NCT00476151|12133607|FG001|STARTED|Overall Study||114
10960576|NCT00476151|12133606|FG000|COMPLETED|Overall Study||109
10960577|NCT00476151|12133607|FG001|COMPLETED|Overall Study||107
10960578|NCT00476151|12133606|FG000|NOT COMPLETED|Overall Study||3
10960579|NCT00476151|12133607|FG001|NOT COMPLETED|Overall Study||7
10960580|NCT00476229|12133613|FG000|STARTED|Overall Study||20
10960581|NCT00476229|12133613|FG000|COMPLETED|Overall Study||19
10960582|NCT00476229|12133613|FG000|NOT COMPLETED|Overall Study||1
10960583|NCT00476242|12133619|FG000|STARTED|Overall Study||27
10960584|NCT00476242|12133620|FG001|STARTED|Overall Study||28
10960585|NCT00476242|12133619|FG000|COMPLETED|Overall Study||19
10960586|NCT00476242|12133620|FG001|COMPLETED|Overall Study||12
10960587|NCT00476242|12133619|FG000|NOT COMPLETED|Overall Study||8
10960588|NCT00476242|12133620|FG001|NOT COMPLETED|Overall Study||16
10960589|NCT00476476|12133630|FG000|STARTED|Overall Study||17
10960590|NCT00476476|12133631|FG001|STARTED|Overall Study||24
10960591|NCT00476476|12133630|FG000|Response Evaluable|Overall Study||17
10960592|NCT00476476|12133631|FG001|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
10960593|NCT00476476|12133630|FG000|COMPLETED|Overall Study||15
10960594|NCT00476476|12133631|FG001|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
10960595|NCT00476476|12133630|FG000|NOT COMPLETED|Overall Study||2
10960596|NCT00476476|12133631|FG001|NOT COMPLETED|Overall Study||24
10960597|NCT00476593|12133640|FG000|STARTED|Overall Study||32
10960598|NCT00476593|12133641|FG001|STARTED|Overall Study||19
10960599|NCT00476593|12133642|FG002|STARTED|Overall Study||38
10960600|NCT00476593|12133643|FG003|STARTED|Overall Study||129
10960601|NCT00476593|12133640|FG000|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
10960602|NCT00476593|12133641|FG001|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
10960603|NCT00476593|12133642|FG002|COMPLETED|Overall Study||30
10960604|NCT00476593|12133643|FG003|COMPLETED|Overall Study||107
10960605|NCT00476593|12133640|FG000|NOT COMPLETED|Overall Study||10
10960606|NCT00476593|12133641|FG001|NOT COMPLETED|Overall Study||2
10960607|NCT00476593|12133642|FG002|NOT COMPLETED|Overall Study||8
10960608|NCT00476593|12133643|FG003|NOT COMPLETED|Overall Study||22
10960609|NCT00476645|12133653|FG000|STARTED|Overall Study||10
10960610|NCT00476645|12133653|FG000|COMPLETED|Overall Study||10
10960611|NCT00476645|12133653|FG000|NOT COMPLETED|Overall Study||0
10960612|NCT00476788|12133657|FG000|STARTED|Overall Study||14
10960613|NCT00476788|12133657|FG000|COMPLETED|Overall Study||11
10960614|NCT00476788|12133657|FG000|NOT COMPLETED|Overall Study||3
10960615|NCT00476957|12133663|FG000|STARTED|Overall Study||4357
10960616|NCT00476957|12133664|FG001|STARTED|Overall Study||4352
10960617|NCT00476957|12133663|FG000|COMPLETED|Overall Study||4181
10960618|NCT00476957|12133664|FG001|COMPLETED|Overall Study||4159
10960619|NCT00476957|12133663|FG000|NOT COMPLETED|Overall Study||176
10960620|NCT00476957|12133664|FG001|NOT COMPLETED|Overall Study||193
10960621|NCT00476996|12133673|FG000|STARTED|Blinded Treatment Phase (up to Week 48)||277
10960622|NCT00476996|12133674|FG001|STARTED|Blinded Treatment Phase (up to Week 48)||277
10960623|NCT00476996|12133675|FG002|STARTED|Blinded Treatment Phase (up to Week 48)||282
10960624|NCT00476996|12133676|FG003|STARTED|Blinded Treatment Phase (up to Week 48)||0
10960625|NCT00476996|12133673|FG000|COMPLETED|Blinded Treatment Phase (up to Week 48)||205
10960626|NCT00476996|12133674|FG001|COMPLETED|Blinded Treatment Phase (up to Week 48)||222
10960627|NCT00476996|12133675|FG002|COMPLETED|Blinded Treatment Phase (up to Week 48)||237
10960628|NCT00476996|12133676|FG003|COMPLETED|Blinded Treatment Phase (up to Week 48)||0
10960629|NCT00476996|12133673|FG000|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72
10960630|NCT00476996|12133674|FG001|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55
10960631|NCT00476996|12133675|FG002|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45
10960632|NCT00476996|12133676|FG003|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0
10960633|NCT00476996|12133673|FG000|STARTED|OLE Phase (From Week 48)||0
10960634|NCT00476996|12133674|FG001|STARTED|OLE Phase (From Week 48)||0
10960635|NCT00476996|12133675|FG002|STARTED|OLE Phase (From Week 48)||0
10960636|NCT00476996|12133676|FG003|STARTED|OLE Phase (From Week 48)||664
10960637|NCT00476996|12133673|FG000|COMPLETED|OLE Phase (From Week 48)||0
10960638|NCT00476996|12133674|FG001|COMPLETED|OLE Phase (From Week 48)||0
10960639|NCT00476996|12133675|FG002|COMPLETED|OLE Phase (From Week 48)||0
10960640|NCT00476996|12133676|FG003|COMPLETED|OLE Phase (From Week 48)||0
10960641|NCT00476996|12133673|FG000|NOT COMPLETED|OLE Phase (From Week 48)||0
10960642|NCT00476996|12133674|FG001|NOT COMPLETED|OLE Phase (From Week 48)||0
10960643|NCT00476996|12133675|FG002|NOT COMPLETED|OLE Phase (From Week 48)||0
10960644|NCT00476996|12133676|FG003|NOT COMPLETED|OLE Phase (From Week 48)||664
10960645|NCT00477087|12133685|FG000|STARTED|Overall Study||10
10960646|NCT00477087|12133685|FG000|COMPLETED|Overall Study||10
10960647|NCT00477087|12133685|FG000|NOT COMPLETED|Overall Study||0
10960648|NCT00477152|12133689|FG000|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
10960649|NCT00477152|12133689|FG000|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
10960650|NCT00477152|12133689|FG000|NOT COMPLETED|Overall Study||3
10960651|NCT00477165|12133695|FG000|STARTED|Overall Study||27
10960652|NCT00477165|12133696|FG001|STARTED|Overall Study||27
10960653|NCT00477165|12133695|FG000|COMPLETED|Overall Study||20
10960654|NCT00477165|12133696|FG001|COMPLETED|Overall Study||25
10960655|NCT00477165|12133695|FG000|NOT COMPLETED|Overall Study||7
10960656|NCT00477165|12133696|FG001|NOT COMPLETED|Overall Study||2
10960657|NCT00477191|12133702|FG000|STARTED|Overall Study||18
10960658|NCT00477191|12133702|FG000|COMPLETED|Overall Study||13
10960659|NCT00477191|12133702|FG000|NOT COMPLETED|Overall Study||5
10960660|NCT00477204|12133708|FG000|STARTED|Overall Study||4
10960661|NCT00477204|12133709|FG001|STARTED|Overall Study||5
10960662|NCT00477204|12133708|FG000|COMPLETED|Overall Study||4
10960663|NCT00477204|12133709|FG001|COMPLETED|Overall Study||5
10960664|NCT00477204|12133708|FG000|NOT COMPLETED|Overall Study||0
10960665|NCT00477204|12133709|FG001|NOT COMPLETED|Overall Study||0
10960666|NCT00477269|12133717|FG000|STARTED|Core Study||28
10960667|NCT00477269|12133718|FG001|STARTED|Core Study||31
10960668|NCT00477269|12133719|FG002|STARTED|Core Study||0
10960669|NCT00477269|12133717|FG000|COMPLETED|Core Study||19
10960670|NCT00477269|12133718|FG001|COMPLETED|Core Study||23
10960671|NCT00477269|12133719|FG002|COMPLETED|Core Study||0
10960672|NCT00477269|12133717|FG000|NOT COMPLETED|Core Study||9
10960673|NCT00477269|12133718|FG001|NOT COMPLETED|Core Study||8
10960674|NCT00477269|12133719|FG002|NOT COMPLETED|Core Study||0
10960675|NCT00477269|12133717|FG000|STARTED|Open Label Extension|Arm in the Core study not extension|0
10960676|NCT00477269|12133718|FG001|STARTED|Open Label Extension|Arm in the Core study not extension|0
10960677|NCT00477269|12133719|FG002|STARTED|Open Label Extension||22
10960678|NCT00477269|12133717|FG000|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
10960679|NCT00477269|12133718|FG001|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
10960680|NCT00477269|12133719|FG002|COMPLETED|Open Label Extension||9
10960681|NCT00477269|12133717|FG000|NOT COMPLETED|Open Label Extension||0
10960682|NCT00477269|12133718|FG001|NOT COMPLETED|Open Label Extension||0
10960683|NCT00477269|12133719|FG002|NOT COMPLETED|Open Label Extension||13
10960684|NCT00477295|12133729|FG000|STARTED|Overall Study||282
10960685|NCT00477295|12133730|FG001|STARTED|Overall Study||301
10960686|NCT00477295|12133729|FG000|COMPLETED|Overall Study||161
10960687|NCT00477295|12133730|FG001|COMPLETED|Overall Study||192
10960688|NCT00477295|12133729|FG000|NOT COMPLETED|Overall Study||121
10960689|NCT00477295|12133730|FG001|NOT COMPLETED|Overall Study||109
10960690|NCT00477334|12133740|FG000|STARTED|Overall Study||312
10960691|NCT00477334|12133741|FG001|STARTED|Overall Study||151
10960692|NCT00477334|12133740|FG000|Randomized and Took Study Drug|Overall Study||206
10960693|NCT00477334|12133741|FG001|Randomized and Took Study Drug|Overall Study||98
10960694|NCT00477334|12133740|FG000|Intent to Treat Population|Overall Study||201
10960695|NCT00477334|12133741|FG001|Intent to Treat Population|Overall Study||98
10960696|NCT00477334|12133740|FG000|Participants Completing First Recurrence|Overall Study||187
10960697|NCT00477334|12133741|FG001|Participants Completing First Recurrence|Overall Study||92
10960698|NCT00477334|12133740|FG000|Modified Intent to Treat Population|Overall Study||152
10960699|NCT00477334|12133741|FG001|Modified Intent to Treat Population|Overall Study||78
10960700|NCT00477334|12133740|FG000|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
10960701|NCT00477334|12133741|FG001|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
10960702|NCT00477334|12133740|FG000|NOT COMPLETED|Overall Study||170
10960703|NCT00477334|12133741|FG001|NOT COMPLETED|Overall Study||76
10960704|NCT00477386|12133753|FG000|STARTED|Overall Study||11
10960705|NCT00477386|12133754|FG001|STARTED|Overall Study||17
10960706|NCT00477386|12133753|FG000|COMPLETED|Overall Study||0
10960707|NCT00477386|12133754|FG001|COMPLETED|Overall Study||0
10960708|NCT00477386|12133753|FG000|NOT COMPLETED|Overall Study||11
10960709|NCT00477386|12133754|FG001|NOT COMPLETED|Overall Study||17
10960710|NCT00477451|12133764|FG000|STARTED|Overall Study||20
10960711|NCT00477451|12133765|FG001|STARTED|Overall Study||20
10960712|NCT00477451|12133766|FG002|STARTED|Overall Study||7
10960713|NCT00477451|12133767|FG003|STARTED|Overall Study||2
10960714|NCT00477451|12133764|FG000|COMPLETED|Overall Study||20
10960715|NCT00477451|12133765|FG001|COMPLETED|Overall Study||20
10960716|NCT00477451|12133766|FG002|COMPLETED|Overall Study||7
10960717|NCT00477451|12133767|FG003|COMPLETED|Overall Study||2
10960718|NCT00477451|12133764|FG000|NOT COMPLETED|Overall Study||0
10960719|NCT00477451|12133765|FG001|NOT COMPLETED|Overall Study||0
10960720|NCT00477451|12133766|FG002|NOT COMPLETED|Overall Study||0
10960721|NCT00477451|12133767|FG003|NOT COMPLETED|Overall Study||0
10960722|NCT00477464|12133775|FG000|STARTED|Overall Study||51
10960723|NCT00477464|12133775|FG000|COMPLETED|Overall Study||0
10960724|NCT00477464|12133775|FG000|NOT COMPLETED|Overall Study||51
10960725|NCT00477490|12133786|FG000|STARTED|Part I: 4 Week Efficacy||160
10960726|NCT00477490|12133787|FG001|STARTED|Part I: 4 Week Efficacy||163
10960727|NCT00477490|12133788|FG002|STARTED|Part I: 4 Week Efficacy||158
10960728|NCT00477490|12133789|FG003|STARTED|Part I: 4 Week Efficacy||158
10960729|NCT00477490|12133790|FG004|STARTED|Part I: 4 Week Efficacy||160
10960730|NCT00477490|12133791|FG005|STARTED|Part I: 4 Week Efficacy||0
10960731|NCT00477490|12133792|FG006|STARTED|Part I: 4 Week Efficacy||0
10960732|NCT00477490|12133793|FG007|STARTED|Part I: 4 Week Efficacy||0
10960733|NCT00477490|12133794|FG008|STARTED|Part I: 4 Week Efficacy||0
10960734|NCT00477490|12133786|FG000|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
10960735|NCT00477490|12133787|FG001|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
10960736|NCT00477490|12133788|FG002|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
10960737|NCT00477490|12133789|FG003|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
10960738|NCT00477490|12133790|FG004|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
10960739|NCT00477490|12133791|FG005|ITT Population|Part I: 4 Week Efficacy||0
10960740|NCT00477490|12133792|FG006|ITT Population|Part I: 4 Week Efficacy||0
10960741|NCT00477490|12133793|FG007|ITT Population|Part I: 4 Week Efficacy||0
10960742|NCT00477490|12133794|FG008|ITT Population|Part I: 4 Week Efficacy||0
10960743|NCT00477490|12133786|FG000|COMPLETED|Part I: 4 Week Efficacy||145
10960744|NCT00477490|12133787|FG001|COMPLETED|Part I: 4 Week Efficacy||144
10960745|NCT00477490|12133788|FG002|COMPLETED|Part I: 4 Week Efficacy||148
10960746|NCT00477490|12133789|FG003|COMPLETED|Part I: 4 Week Efficacy||138
10960747|NCT00477490|12133790|FG004|COMPLETED|Part I: 4 Week Efficacy||135
10960748|NCT00477490|12133791|FG005|COMPLETED|Part I: 4 Week Efficacy||0
10960749|NCT00477490|12133792|FG006|COMPLETED|Part I: 4 Week Efficacy||0
10960750|NCT00477490|12133793|FG007|COMPLETED|Part I: 4 Week Efficacy||0
10960751|NCT00477490|12133794|FG008|COMPLETED|Part I: 4 Week Efficacy||0
10960752|NCT00477490|12133786|FG000|NOT COMPLETED|Part I: 4 Week Efficacy||15
10960753|NCT00477490|12133787|FG001|NOT COMPLETED|Part I: 4 Week Efficacy||19
10960754|NCT00477490|12133788|FG002|NOT COMPLETED|Part I: 4 Week Efficacy||10
10960755|NCT00477490|12133789|FG003|NOT COMPLETED|Part I: 4 Week Efficacy||20
10960756|NCT00477490|12133790|FG004|NOT COMPLETED|Part I: 4 Week Efficacy||25
10960757|NCT00477490|12133791|FG005|NOT COMPLETED|Part I: 4 Week Efficacy||0
10960758|NCT00477490|12133792|FG006|NOT COMPLETED|Part I: 4 Week Efficacy||0
10960759|NCT00477490|12133793|FG007|NOT COMPLETED|Part I: 4 Week Efficacy||0
10960760|NCT00477490|12133794|FG008|NOT COMPLETED|Part I: 4 Week Efficacy||0
10960761|NCT00477490|12133786|FG000|STARTED|Part II: Extension Week 5 up to Day 169||0
10960762|NCT00477490|12133787|FG001|STARTED|Part II: Extension Week 5 up to Day 169||135
10960763|NCT00477490|12133788|FG002|STARTED|Part II: Extension Week 5 up to Day 169||135
10960764|NCT00477490|12133789|FG003|STARTED|Part II: Extension Week 5 up to Day 169||132
10960765|NCT00477490|12133790|FG004|STARTED|Part II: Extension Week 5 up to Day 169||127
10960766|NCT00477490|12133791|FG005|STARTED|Part II: Extension Week 5 up to Day 169||31
10960767|NCT00477490|12133792|FG006|STARTED|Part II: Extension Week 5 up to Day 169||37
10960768|NCT00477490|12133793|FG007|STARTED|Part II: Extension Week 5 up to Day 169||34
10960769|NCT00477490|12133794|FG008|STARTED|Part II: Extension Week 5 up to Day 169||34
10960770|NCT00477490|12133786|FG000|COMPLETED|Part II: Extension Week 5 up to Day 169||0
10960771|NCT00477490|12133787|FG001|COMPLETED|Part II: Extension Week 5 up to Day 169||107
10960772|NCT00477490|12133788|FG002|COMPLETED|Part II: Extension Week 5 up to Day 169||120
10960773|NCT00477490|12133789|FG003|COMPLETED|Part II: Extension Week 5 up to Day 169||120
10960774|NCT00477490|12133790|FG004|COMPLETED|Part II: Extension Week 5 up to Day 169||107
10960775|NCT00477490|12133791|FG005|COMPLETED|Part II: Extension Week 5 up to Day 169||25
10960776|NCT00477490|12133792|FG006|COMPLETED|Part II: Extension Week 5 up to Day 169||32
10960777|NCT00477490|12133793|FG007|COMPLETED|Part II: Extension Week 5 up to Day 169||29
10960778|NCT00477490|12133794|FG008|COMPLETED|Part II: Extension Week 5 up to Day 169||26
10960779|NCT00477490|12133786|FG000|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
10960780|NCT00477490|12133787|FG001|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
10960781|NCT00477490|12133788|FG002|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
10960782|NCT00477490|12133789|FG003|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
10960783|NCT00477490|12133790|FG004|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
10960784|NCT00477490|12133791|FG005|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
10960785|NCT00477490|12133792|FG006|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
10960786|NCT00477490|12133793|FG007|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
10960787|NCT00477490|12133794|FG008|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
10960788|NCT00477594|12133824|FG000|STARTED|Year 1 and Year 2||16
10960789|NCT00477594|12133825|FG001|STARTED|Year 1 and Year 2||5
10960790|NCT00477594|12133824|FG000|COMPLETED|Year 1 and Year 2||7
10960791|NCT00477594|12133825|FG001|COMPLETED|Year 1 and Year 2||1
10960792|NCT00477594|12133824|FG000|NOT COMPLETED|Year 1 and Year 2||9
10960793|NCT00477594|12133825|FG001|NOT COMPLETED|Year 1 and Year 2||4
10960794|NCT00477594|12133824|FG000|STARTED|Year 3||4
10960795|NCT00477594|12133825|FG001|STARTED|Year 3||0
10960796|NCT00477594|12133824|FG000|COMPLETED|Year 3||2
10960797|NCT00477594|12133825|FG001|COMPLETED|Year 3||0
10960798|NCT00477594|12133824|FG000|NOT COMPLETED|Year 3||2
10960799|NCT00477594|12133825|FG001|NOT COMPLETED|Year 3||0
10960800|NCT00477594|12133824|FG000|STARTED|Follow-up Period||16
10960801|NCT00477594|12133825|FG001|STARTED|Follow-up Period||5
10960802|NCT00477594|12133824|FG000|COMPLETED|Follow-up Period||13
10960803|NCT00477594|12133825|FG001|COMPLETED|Follow-up Period||4
10960804|NCT00477594|12133824|FG000|NOT COMPLETED|Follow-up Period||3
10960805|NCT00477594|12133825|FG001|NOT COMPLETED|Follow-up Period||1
10960806|NCT00477607|12133833|FG000|STARTED|Overall Study||19
10960807|NCT00477607|12133834|FG001|STARTED|Overall Study||20
10960808|NCT00477607|12133833|FG000|COMPLETED|Overall Study||12
10960809|NCT00477607|12133834|FG001|COMPLETED|Overall Study||13
10960810|NCT00477607|12133833|FG000|NOT COMPLETED|Overall Study||7
10960811|NCT00477607|12133834|FG001|NOT COMPLETED|Overall Study||7
10960812|NCT00477633|12133840|FG000|STARTED|Overall Study||1700
10960813|NCT00477633|12133840|FG000|COMPLETED|Overall Study||991
10960814|NCT00477633|12133840|FG000|NOT COMPLETED|Overall Study||709
10960815|NCT00477659|12133844|FG000|STARTED|Overall Study||14
10960816|NCT00477659|12133844|FG000|COMPLETED|Overall Study||14
10960817|NCT00477659|12133844|FG000|NOT COMPLETED|Overall Study||0
10960818|NCT00477672|12133851|FG000|STARTED|Overall Study||98
10960819|NCT00477672|12133852|FG001|STARTED|Overall Study||101
10960820|NCT00477672|12133853|FG002|STARTED|Overall Study||99
10960821|NCT00477672|12133851|FG000|COMPLETED|Overall Study||91
10960822|NCT00477672|12133852|FG001|COMPLETED|Overall Study||85
10960823|NCT00477672|12133853|FG002|COMPLETED|Overall Study||83
10960824|NCT00477672|12133851|FG000|NOT COMPLETED|Overall Study||7
10960825|NCT00477672|12133852|FG001|NOT COMPLETED|Overall Study||16
10960826|NCT00477672|12133853|FG002|NOT COMPLETED|Overall Study||16
10960827|NCT00477685|12133861|FG000|STARTED|Overall Study||10
10960828|NCT00477685|12133861|FG000|COMPLETED|Overall Study||10
10960829|NCT00477685|12133861|FG000|NOT COMPLETED|Overall Study||0
10960830|NCT00477750|12133865|FG000|STARTED|Overall Study||26
10960831|NCT00477750|12133865|FG000|COMPLETED|Overall Study||15
10960832|NCT00477750|12133865|FG000|NOT COMPLETED|Overall Study||11
10960833|NCT00477971|12133873|FG000|STARTED|Overall Study||34
10960834|NCT00477971|12133874|FG001|STARTED|Overall Study||55
10960835|NCT00477971|12133873|FG000|COMPLETED|Overall Study||17
10960836|NCT00477971|12133874|FG001|COMPLETED|Overall Study||49
10960837|NCT00477971|12133873|FG000|NOT COMPLETED|Overall Study||17
10960838|NCT00477971|12133874|FG001|NOT COMPLETED|Overall Study||6
10960839|NCT00478023|12133885|FG000|STARTED|Overall Study||170
10960840|NCT00478023|12133886|FG001|STARTED|Overall Study||168
10960841|NCT00478023|12133887|FG002|STARTED|Overall Study||171
10960842|NCT00478023|12133888|FG003|STARTED|Overall Study||176
10960843|NCT00478023|12133889|FG004|STARTED|Overall Study||169
10960844|NCT00478023|12133885|FG000|COMPLETED|Overall Study||135
10960845|NCT00478023|12133886|FG001|COMPLETED|Overall Study||144
10960846|NCT00478023|12133887|FG002|COMPLETED|Overall Study||151
10960847|NCT00478023|12133888|FG003|COMPLETED|Overall Study||146
10960848|NCT00478023|12133889|FG004|COMPLETED|Overall Study||114
10960849|NCT00478023|12133885|FG000|NOT COMPLETED|Overall Study||35
10960850|NCT00478023|12133886|FG001|NOT COMPLETED|Overall Study||24
10960851|NCT00478023|12133887|FG002|NOT COMPLETED|Overall Study||20
10960852|NCT00478023|12133888|FG003|NOT COMPLETED|Overall Study||30
10960853|NCT00478023|12133889|FG004|NOT COMPLETED|Overall Study||55
10960854|NCT00478036|12133904|FG000|STARTED|Overall Study||10
10960855|NCT00478036|12133905|FG001|STARTED|Overall Study||7
10960856|NCT00478036|12133906|FG002|STARTED|Overall Study||14
10960857|NCT00478036|12133904|FG000|COMPLETED|Overall Study||10
10960858|NCT00478036|12133905|FG001|COMPLETED|Overall Study||7
10960859|NCT00478036|12133906|FG002|COMPLETED|Overall Study||14
10960860|NCT00478036|12133904|FG000|NOT COMPLETED|Overall Study||0
10960861|NCT00478036|12133905|FG001|NOT COMPLETED|Overall Study||0
10960862|NCT00478036|12133906|FG002|NOT COMPLETED|Overall Study||0
10960863|NCT00478140|12133914|FG000|STARTED|Overall Study||4
10960864|NCT00478140|12133914|FG000|COMPLETED|Overall Study||3
10960865|NCT00478140|12133914|FG000|NOT COMPLETED|Overall Study||1
10960866|NCT00478192|12133921|FG000|STARTED|Overall Study||20
10960867|NCT00478192|12133922|FG001|STARTED|Overall Study||20
10960868|NCT00478192|12133923|FG002|STARTED|Overall Study||10
10960869|NCT00478192|12133921|FG000|Full Analysis Set / Safety Analysis Set|Overall Study||20
10960870|NCT00478192|12133922|FG001|Full Analysis Set / Safety Analysis Set|Overall Study||20
10960871|NCT00478192|12133923|FG002|Full Analysis Set / Safety Analysis Set|Overall Study||9
10960872|NCT00478192|12133921|FG000|End of Treatment|Overall Study||18
10960873|NCT00478192|12133922|FG001|End of Treatment|Overall Study||16
10960874|NCT00478192|12133923|FG002|End of Treatment|Overall Study||8
10960875|NCT00478192|12133921|FG000|COMPLETED|Overall Study||16
10960876|NCT00478192|12133922|FG001|COMPLETED|Overall Study||15
10960877|NCT00478192|12133923|FG002|COMPLETED|Overall Study||8
10960878|NCT00478192|12133921|FG000|NOT COMPLETED|Overall Study||4
10960879|NCT00478192|12133922|FG001|NOT COMPLETED|Overall Study||5
10960880|NCT00478192|12133923|FG002|NOT COMPLETED|Overall Study||2
10960881|NCT00478205|12133934|FG000|STARTED|Overall Study||981
10960882|NCT00478205|12133935|FG001|STARTED|Overall Study||486
10960883|NCT00478205|12133934|FG000|COMPLETED|Overall Study||685
10960884|NCT00478205|12133935|FG001|COMPLETED|Overall Study||399
10960885|NCT00478205|12133934|FG000|NOT COMPLETED|Overall Study||296
10960886|NCT00478205|12133935|FG001|NOT COMPLETED|Overall Study||87
10960887|NCT00478218|12133943|FG000|STARTED|Overall Study||34
10960888|NCT00478218|12133944|FG001|STARTED|Overall Study||19
10960889|NCT00478218|12133943|FG000|COMPLETED|Overall Study||34
10960890|NCT00478218|12133944|FG001|COMPLETED|Overall Study||19
10960891|NCT00478218|12133943|FG000|NOT COMPLETED|Overall Study||0
10960892|NCT00478218|12133944|FG001|NOT COMPLETED|Overall Study||0
10960893|NCT00478231|12133950|FG000|STARTED|Overall Study||209
10960894|NCT00478231|12133950|FG000|Treated|Overall Study||206
10960895|NCT00478231|12133950|FG000|COMPLETED|Overall Study||125
10960896|NCT00478231|12133950|FG000|NOT COMPLETED|Overall Study||84
10960897|NCT00478244|12133954|FG000|STARTED|Overall Study||7
10960898|NCT00478244|12133954|FG000|COMPLETED|Overall Study||6
10960899|NCT00478244|12133954|FG000|NOT COMPLETED|Overall Study||1
10960900|NCT00478257|12133960|FG000|STARTED|Overall Study||23
10960901|NCT00478257|12133961|FG001|STARTED|Overall Study||16
10960902|NCT00478257|12133960|FG000|COMPLETED|Overall Study||15
10960903|NCT00478257|12133961|FG001|COMPLETED|Overall Study||13
10960904|NCT00478257|12133960|FG000|NOT COMPLETED|Overall Study||8
10960905|NCT00478257|12133961|FG001|NOT COMPLETED|Overall Study||3
10960906|NCT00478335|12133969|FG000|STARTED|Period 1 (4 Days)||2
10960907|NCT00478335|12133970|FG001|STARTED|Period 1 (4 Days)||2
10960908|NCT00478335|12133969|FG000|COMPLETED|Period 1 (4 Days)||2
10960909|NCT00478335|12133970|FG001|COMPLETED|Period 1 (4 Days)||2
10960910|NCT00478335|12133969|FG000|NOT COMPLETED|Period 1 (4 Days)||0
10960911|NCT00478335|12133970|FG001|NOT COMPLETED|Period 1 (4 Days)||0
10960912|NCT00478335|12133969|FG000|STARTED|Period 2 (4 Days)||2
10960913|NCT00478335|12133970|FG001|STARTED|Period 2 (4 Days)||2
10960914|NCT00478335|12133969|FG000|COMPLETED|Period 2 (4 Days)||2
10960915|NCT00478335|12133970|FG001|COMPLETED|Period 2 (4 Days)||2
10960916|NCT00478335|12133969|FG000|NOT COMPLETED|Period 2 (4 Days)||0
10960917|NCT00478335|12133970|FG001|NOT COMPLETED|Period 2 (4 Days)||0
10960918|NCT00478361|12133976|FG000|STARTED|Overall Study||39
10960919|NCT00478361|12133976|FG000|COMPLETED|Overall Study||39
10960920|NCT00478361|12133976|FG000|NOT COMPLETED|Overall Study||0
10960921|NCT00478426|12133980|FG000|STARTED|Overall Study||34
10960922|NCT00478426|12133980|FG000|COMPLETED|Overall Study||33
10960923|NCT00478426|12133980|FG000|NOT COMPLETED|Overall Study||1
10960924|NCT00478556|12133986|FG000|STARTED|Overall Study||151
10960925|NCT00478556|12133987|FG001|STARTED|Overall Study||149
10960926|NCT00478556|12133986|FG000|COMPLETED|Overall Study||151
10960927|NCT00478556|12133987|FG001|COMPLETED|Overall Study||149
10960928|NCT00478556|12133986|FG000|NOT COMPLETED|Overall Study||0
10960929|NCT00478556|12133987|FG001|NOT COMPLETED|Overall Study||0
10960930|NCT00478569|12133993|FG000|STARTED|Overall Study||1170
10960931|NCT00478569|12133993|FG000|COMPLETED|Overall Study||761
10960932|NCT00478569|12133993|FG000|NOT COMPLETED|Overall Study||409
10960933|NCT00478608|12134005|FG000|STARTED|Overall Study||79
10960934|NCT00478608|12134005|FG000|COMPLETED|Overall Study||59
10960935|NCT00478608|12134005|FG000|NOT COMPLETED|Overall Study||20
10960936|NCT00478647|12134009|FG000|STARTED|Overall Study||40
10960937|NCT00478647|12134009|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
10960938|NCT00478647|12134009|FG000|NOT COMPLETED|Overall Study||2
10960939|NCT00478673|12134013|FG000|STARTED|30-Days Post-Procedure||298
10960940|NCT00478673|12134013|FG000|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
10960941|NCT00478673|12134013|FG000|NOT COMPLETED|30-Days Post-Procedure||10
10960942|NCT00478673|12134013|FG000|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
10960943|NCT00478673|12134013|FG000|COMPLETED|12-Months Post-Procedure||231
10960944|NCT00478673|12134013|FG000|NOT COMPLETED|12-Months Post-Procedure||64
10960945|NCT00478777|12134017|FG000|STARTED|Overall Study||150
10960946|NCT00478777|12134017|FG000|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
10960947|NCT00478777|12134017|FG000|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
10960948|NCT00478777|12134017|FG000|NOT COMPLETED|Overall Study||77
10960949|NCT00478881|12134023|FG000|STARTED|Overall Study||199
10960950|NCT00478881|12134024|FG001|STARTED|Overall Study||198
10960951|NCT00478881|12134023|FG000|Received Medication|Overall Study||198
10960952|NCT00478881|12134024|FG001|Received Medication|Overall Study||198
10960953|NCT00478881|12134023|FG000|COMPLETED|Overall Study||160
10960954|NCT00478881|12134024|FG001|COMPLETED|Overall Study||176
10960955|NCT00478881|12134023|FG000|NOT COMPLETED|Overall Study||39
10960956|NCT00478881|12134024|FG001|NOT COMPLETED|Overall Study||22
10960957|NCT00478933|12134030|FG000|STARTED|Overall Study||1223
10960958|NCT00478933|12134030|FG000|COMPLETED|Overall Study||1145
10960959|NCT00478933|12134030|FG000|NOT COMPLETED|Overall Study||78
10960960|NCT00479037|12134056|FG000|STARTED|Overall Study||41
10960961|NCT00479037|12134057|FG001|STARTED|Overall Study||40
10960962|NCT00479037|12134056|FG000|COMPLETED|Overall Study||38
10960963|NCT00479037|12134057|FG001|COMPLETED|Overall Study||34
10960964|NCT00479037|12134056|FG000|NOT COMPLETED|Overall Study||3
10960965|NCT00479037|12134057|FG001|NOT COMPLETED|Overall Study||6
10960966|NCT00479089|12134065|FG000|STARTED|Overall Study||25
10960967|NCT00479089|12134066|FG001|STARTED|Overall Study||25
10960968|NCT00479089|12134065|FG000|COMPLETED|Overall Study||25
10960969|NCT00479089|12134066|FG001|COMPLETED|Overall Study||25
10960970|NCT00479089|12134065|FG000|NOT COMPLETED|Overall Study||0
10960971|NCT00479089|12134066|FG001|NOT COMPLETED|Overall Study||0
10960972|NCT00479115|12134072|FG000|STARTED|Overall Study||1
10960973|NCT00479115|12134072|FG000|COMPLETED|Overall Study||1
10960974|NCT00479115|12134072|FG000|NOT COMPLETED|Overall Study||0
10960975|NCT00479154|12134078|FG000|STARTED|Overall Study||3
10960976|NCT00479154|12134079|FG001|STARTED|Overall Study||3
10960977|NCT00479154|12134078|FG000|COMPLETED|Overall Study||3
10960978|NCT00479154|12134079|FG001|COMPLETED|Overall Study||3
10960979|NCT00479154|12134078|FG000|NOT COMPLETED|Overall Study||0
10960980|NCT00479154|12134079|FG001|NOT COMPLETED|Overall Study||0
10960981|NCT00479232|12134087|FG000|STARTED|Overall Study||3
10960982|NCT00479232|12134088|FG001|STARTED|Overall Study||3
10960983|NCT00479232|12134089|FG002|STARTED|Overall Study||28
10960984|NCT00479232|12134090|FG003|STARTED|Overall Study||3
10960985|NCT00479232|12134091|FG004|STARTED|Overall Study||4
10960986|NCT00479232|12134092|FG005|STARTED|Overall Study||30
10960987|NCT00479232|12134087|FG000|COMPLETED|Overall Study||0
10960988|NCT00479232|12134088|FG001|COMPLETED|Overall Study||0
10960989|NCT00479232|12134089|FG002|COMPLETED|Overall Study||0
10960990|NCT00479232|12134090|FG003|COMPLETED|Overall Study||0
10960991|NCT00479232|12134091|FG004|COMPLETED|Overall Study||0
10960992|NCT00479232|12134092|FG005|COMPLETED|Overall Study||0
10960993|NCT00479232|12134087|FG000|NOT COMPLETED|Overall Study||3
10960994|NCT00479232|12134088|FG001|NOT COMPLETED|Overall Study||3
10960995|NCT00479232|12134089|FG002|NOT COMPLETED|Overall Study||28
10960996|NCT00479232|12134090|FG003|NOT COMPLETED|Overall Study||3
10960997|NCT00479232|12134091|FG004|NOT COMPLETED|Overall Study||4
10960998|NCT00479232|12134092|FG005|NOT COMPLETED|Overall Study||30
10960999|NCT00479336|12134114|FG000|STARTED|Overall Study||27
10961000|NCT00479336|12134115|FG001|STARTED|Overall Study||26
10961001|NCT00479336|12134116|FG002|STARTED|Overall Study||25
10961002|NCT00479336|12134117|FG003|STARTED|Overall Study||26
10961003|NCT00479336|12134114|FG000|COMPLETED|Overall Study||23
10961004|NCT00479336|12134115|FG001|COMPLETED|Overall Study||20
10961005|NCT00479336|12134116|FG002|COMPLETED|Overall Study||24
10961006|NCT00479336|12134117|FG003|COMPLETED|Overall Study||21
10961007|NCT00479336|12134114|FG000|NOT COMPLETED|Overall Study||4
10961008|NCT00479336|12134115|FG001|NOT COMPLETED|Overall Study||6
10961009|NCT00479336|12134116|FG002|NOT COMPLETED|Overall Study||1
10961010|NCT00479336|12134117|FG003|NOT COMPLETED|Overall Study||5
10961011|NCT00479388|12134129|FG000|STARTED|Overall Study||606
10961012|NCT00479388|12134130|FG001|STARTED|Overall Study||610
10961013|NCT00479388|12134129|FG000|COMPLETED|Overall Study||474
10961014|NCT00479388|12134130|FG001|COMPLETED|Overall Study||537
10961015|NCT00479388|12134129|FG000|NOT COMPLETED|Overall Study||132
10961016|NCT00479388|12134130|FG001|NOT COMPLETED|Overall Study||73
10961017|NCT00479401|12134139|FG000|STARTED|Overall Study||223
10961018|NCT00479401|12134140|FG001|STARTED|Overall Study||213
10961019|NCT00479401|12134141|FG002|STARTED|Overall Study||103
10961020|NCT00479401|12134139|FG000|COMPLETED|Overall Study||174
10961021|NCT00479401|12134140|FG001|COMPLETED|Overall Study||176
10961022|NCT00479401|12134141|FG002|COMPLETED|Overall Study||91
10961023|NCT00479401|12134139|FG000|NOT COMPLETED|Overall Study||49
10961024|NCT00479401|12134140|FG001|NOT COMPLETED|Overall Study||37
10961025|NCT00479401|12134141|FG002|NOT COMPLETED|Overall Study||12
10961026|NCT00479466|12134155|FG000|STARTED|Overall Study||57
10961027|NCT00479466|12134156|FG001|STARTED|Overall Study||57
10961028|NCT00479466|12134157|FG002|STARTED|Overall Study||57
10961029|NCT00479466|12134158|FG003|STARTED|Overall Study||58
10961030|NCT00479466|12134159|FG004|STARTED|Overall Study||56
10961031|NCT00479466|12134160|FG005|STARTED|Overall Study||57
10961032|NCT00479466|12134155|FG000|COMPLETED|Overall Study||44
10961033|NCT00479466|12134156|FG001|COMPLETED|Overall Study||49
10961034|NCT00479466|12134157|FG002|COMPLETED|Overall Study||54
10961035|NCT00479466|12134158|FG003|COMPLETED|Overall Study||55
10961036|NCT00479466|12134159|FG004|COMPLETED|Overall Study||48
10961037|NCT00479466|12134160|FG005|COMPLETED|Overall Study||53
10961038|NCT00479466|12134155|FG000|NOT COMPLETED|Overall Study||13
10961039|NCT00479466|12134156|FG001|NOT COMPLETED|Overall Study||8
10961040|NCT00479466|12134157|FG002|NOT COMPLETED|Overall Study||3
10961041|NCT00479466|12134158|FG003|NOT COMPLETED|Overall Study||3
10961042|NCT00479466|12134159|FG004|NOT COMPLETED|Overall Study||8
10961043|NCT00479466|12134160|FG005|NOT COMPLETED|Overall Study||4
10961044|NCT00479557|12134181|FG000|STARTED|Overall Study||36
10961045|NCT00479557|12134182|FG001|STARTED|Overall Study||61
10961046|NCT00479557|12134183|FG002|STARTED|Overall Study||40
10961047|NCT00479557|12134184|FG003|STARTED|Overall Study||35
10961048|NCT00479557|12134185|FG004|STARTED|Overall Study||12
10961049|NCT00479557|12134186|FG005|STARTED|Overall Study||44
10961050|NCT00479557|12134187|FG006|STARTED|Overall Study||17
10961051|NCT00479557|12134181|FG000|Treated|Overall Study||36
10961052|NCT00479557|12134182|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
10961053|NCT00479557|12134183|FG002|Treated|Overall Study||40
10961054|NCT00479557|12134184|FG003|Treated|Overall Study||35
10961055|NCT00479557|12134185|FG004|Treated|Overall Study||12
10961056|NCT00479557|12134186|FG005|Treated|Overall Study||44
10961057|NCT00479557|12134187|FG006|Treated|Overall Study||17
10961058|NCT00479557|12134181|FG000|COMPLETED|Overall Study||26
10961059|NCT00479557|12134182|FG001|COMPLETED|Overall Study||51
10961060|NCT00479557|12134183|FG002|COMPLETED|Overall Study||32
10961061|NCT00479557|12134184|FG003|COMPLETED|Overall Study||30
10961062|NCT00479557|12134185|FG004|COMPLETED|Overall Study||8
10961063|NCT00479557|12134186|FG005|COMPLETED|Overall Study||31
10961064|NCT00479557|12134187|FG006|COMPLETED|Overall Study||15
10961065|NCT00479557|12134181|FG000|NOT COMPLETED|Overall Study||10
10961066|NCT00479557|12134182|FG001|NOT COMPLETED|Overall Study||10
10961067|NCT00479557|12134183|FG002|NOT COMPLETED|Overall Study||8
10961068|NCT00479557|12134184|FG003|NOT COMPLETED|Overall Study||5
10961069|NCT00479557|12134185|FG004|NOT COMPLETED|Overall Study||4
10961070|NCT00479557|12134186|FG005|NOT COMPLETED|Overall Study||13
10961071|NCT00479557|12134187|FG006|NOT COMPLETED|Overall Study||2
10961072|NCT00479674|12134209|FG000|STARTED|Overall Study||41
10961073|NCT00479674|12134209|FG000|COMPLETED|Overall Study||0
10961074|NCT00479674|12134209|FG000|NOT COMPLETED|Overall Study||41
10961075|NCT00479687|12134215|FG000|STARTED|Ph 1: Blinded, Randomized, Controlled||150
10961076|NCT00479687|12134216|FG001|STARTED|Ph 1: Blinded, Randomized, Controlled||150
10961077|NCT00479687|12134217|FG002|STARTED|Ph 1: Blinded, Randomized, Controlled||0
10961078|NCT00479687|12134215|FG000|COMPLETED|Ph 1: Blinded, Randomized, Controlled||125
10961079|NCT00479687|12134216|FG001|COMPLETED|Ph 1: Blinded, Randomized, Controlled||131
10961080|NCT00479687|12134217|FG002|COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
10961081|NCT00479687|12134215|FG000|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||25
10961082|NCT00479687|12134216|FG001|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||19
10961083|NCT00479687|12134217|FG002|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
10961084|NCT00479687|12134215|FG000|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
10961085|NCT00479687|12134216|FG001|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
10961086|NCT00479687|12134217|FG002|STARTED|Ph 2: Open Label, Single (Supartz) Arm|Four did not continue to Ph2; 224 received at least 1 inj. and 28 received no trt. (only follow-up)|224
10961087|NCT00479687|12134215|FG000|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
10961088|NCT00479687|12134216|FG001|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
10961089|NCT00479687|12134217|FG002|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||215
10961090|NCT00479687|12134215|FG000|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
10961091|NCT00479687|12134216|FG001|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
10961092|NCT00479687|12134217|FG002|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||9
10961093|NCT00479856|12134224|FG000|STARTED|Overall Study||9
10961094|NCT00479856|12134224|FG000|COMPLETED|Overall Study||6
10961095|NCT00479856|12134224|FG000|NOT COMPLETED|Overall Study||3
10961096|NCT00479882|12134232|FG000|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
10961097|NCT00479882|12134233|FG001|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
10961098|NCT00479882|12134234|FG002|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
10961099|NCT00479882|12134235|FG003|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
10961100|NCT00479882|12134232|FG000|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
10961101|NCT00479882|12134233|FG001|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
10961102|NCT00479882|12134234|FG002|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
10961103|NCT00479882|12134235|FG003|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
10961104|NCT00479882|12134232|FG000|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
10961105|NCT00479882|12134233|FG001|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
10961106|NCT00479882|12134234|FG002|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
10961107|NCT00479882|12134235|FG003|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
10961108|NCT00479882|12134232|FG000|STARTED|Crossover: Period III (Weeks 13-20)||472
10961109|NCT00479882|12134233|FG001|STARTED|Crossover: Period III (Weeks 13-20)||440
10961110|NCT00479882|12134234|FG002|STARTED|Crossover: Period III (Weeks 13-20)||440
10961111|NCT00479882|12134235|FG003|STARTED|Crossover: Period III (Weeks 13-20)||465
10961112|NCT00479882|12134232|FG000|COMPLETED|Crossover: Period III (Weeks 13-20)||447
10961113|NCT00479882|12134233|FG001|COMPLETED|Crossover: Period III (Weeks 13-20)||419
10961114|NCT00479882|12134234|FG002|COMPLETED|Crossover: Period III (Weeks 13-20)||420
10961115|NCT00479882|12134235|FG003|COMPLETED|Crossover: Period III (Weeks 13-20)||447
10961116|NCT00479882|12134232|FG000|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
10961117|NCT00479882|12134233|FG001|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
10961118|NCT00479882|12134234|FG002|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
10961119|NCT00479882|12134235|FG003|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
10961120|NCT00480025|12134263|FG000|STARTED|Overall Study||1515
10961121|NCT00480025|12134264|FG001|STARTED|Overall Study||757
10961122|NCT00480025|12134263|FG000|COMPLETED|Overall Study||763
10961123|NCT00480025|12134264|FG001|COMPLETED|Overall Study||388
10961124|NCT00480025|12134263|FG000|NOT COMPLETED|Overall Study||752
10961125|NCT00480025|12134264|FG001|NOT COMPLETED|Overall Study||369
10961126|NCT00480077|12134278|FG000|STARTED|Overall Study||168
10961127|NCT00480077|12134279|FG001|STARTED|Overall Study||167
10961128|NCT00480077|12134278|FG000|COMPLETED|Overall Study||137
10961129|NCT00480077|12134279|FG001|COMPLETED|Overall Study||141
10961130|NCT00480077|12134278|FG000|NOT COMPLETED|Overall Study||31
10961131|NCT00480077|12134279|FG001|NOT COMPLETED|Overall Study||26
10961132|NCT00480324|12134287|FG000|STARTED|Overall Study||508
10961133|NCT00480324|12134288|FG001|STARTED|Overall Study||257
10961134|NCT00480324|12134287|FG000|COMPLETED|Overall Study||476
10961135|NCT00480324|12134288|FG001|COMPLETED|Overall Study||241
10961136|NCT00480324|12134287|FG000|NOT COMPLETED|Overall Study||32
10961137|NCT00480324|12134288|FG001|NOT COMPLETED|Overall Study||16
10961138|NCT00480441|12134296|FG000|STARTED|Screening||61
10961139|NCT00480441|12134297|FG001|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
10961140|NCT00480441|12134298|FG002|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
10961141|NCT00480441|12134296|FG000|COMPLETED|Screening||24
10961142|NCT00480441|12134297|FG001|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
10961143|NCT00480441|12134298|FG002|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
10961144|NCT00480441|12134296|FG000|NOT COMPLETED|Screening||37
10961145|NCT00480441|12134297|FG001|NOT COMPLETED|Screening||0
10961146|NCT00480441|12134298|FG002|NOT COMPLETED|Screening||0
10961147|NCT00480441|12134296|FG000|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24
10961148|NCT00480441|12134297|FG001|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
10961149|NCT00480441|12134298|FG002|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
10961150|NCT00480441|12134296|FG000|COMPLETED|Baseline Functional MRI||12
10961151|NCT00480441|12134297|FG001|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
10961152|NCT00480441|12134298|FG002|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
10961153|NCT00480441|12134296|FG000|NOT COMPLETED|Baseline Functional MRI||12
10961154|NCT00480441|12134297|FG001|NOT COMPLETED|Baseline Functional MRI||0
10961155|NCT00480441|12134298|FG002|NOT COMPLETED|Baseline Functional MRI||0
10961156|NCT00480441|12134296|FG000|STARTED|Randomization||0
10961157|NCT00480441|12134297|FG001|STARTED|Randomization||13
10961158|NCT00480441|12134298|FG002|STARTED|Randomization||11
10961159|NCT00480441|12134296|FG000|COMPLETED|Randomization||0
10961160|NCT00480441|12134297|FG001|COMPLETED|Randomization||6
10961161|NCT00480441|12134298|FG002|COMPLETED|Randomization||9
10961162|NCT00480441|12134296|FG000|NOT COMPLETED|Randomization||0
10961163|NCT00480441|12134297|FG001|NOT COMPLETED|Randomization||7
10961164|NCT00480441|12134298|FG002|NOT COMPLETED|Randomization||2
10961165|NCT00480493|12134307|FG000|STARTED|Overall Study||32
10961166|NCT00480493|12134308|FG001|STARTED|Overall Study||28
10961167|NCT00480493|12134307|FG000|Randomized|Overall Study||32
10961168|NCT00480493|12134308|FG001|Randomized|Overall Study||28
10961169|NCT00480493|12134307|FG000|COMPLETED|Overall Study||30
10961170|NCT00480493|12134308|FG001|COMPLETED|Overall Study||21
10961171|NCT00480493|12134307|FG000|NOT COMPLETED|Overall Study||2
10961172|NCT00480493|12134308|FG001|NOT COMPLETED|Overall Study||7
10961173|NCT00480532|12134320|FG000|STARTED|Overall Study||33
10961174|NCT00480532|12134321|FG001|STARTED|Overall Study||33
10961175|NCT00480532|12134322|FG002|STARTED|Overall Study||33
10961176|NCT00480532|12134323|FG003|STARTED|Overall Study||32
10961177|NCT00480532|12134320|FG000|COMPLETED|Overall Study||31
10961178|NCT00480532|12134321|FG001|COMPLETED|Overall Study||29
10961179|NCT00480532|12134322|FG002|COMPLETED|Overall Study||29
10961180|NCT00480532|12134323|FG003|COMPLETED|Overall Study||31
10961181|NCT00480532|12134320|FG000|NOT COMPLETED|Overall Study||2
10961182|NCT00480532|12134321|FG001|NOT COMPLETED|Overall Study||4
10961183|NCT00480532|12134322|FG002|NOT COMPLETED|Overall Study||4
10961184|NCT00480532|12134323|FG003|NOT COMPLETED|Overall Study||1
10961185|NCT00480636|12134333|FG000|STARTED|Overall Study||102
10961186|NCT00480636|12134333|FG000|COMPLETED|Overall Study||83
10961187|NCT00480636|12134333|FG000|NOT COMPLETED|Overall Study||19
10961188|NCT00480740|12134340|FG000|STARTED|Overall Study||26
10961189|NCT00480740|12134341|FG001|STARTED|Overall Study||9
10961190|NCT00480740|12134342|FG002|STARTED|Overall Study||6
10961191|NCT00480740|12134340|FG000|COMPLETED|Overall Study||26
10961192|NCT00480740|12134341|FG001|COMPLETED|Overall Study||9
10961193|NCT00480740|12134342|FG002|COMPLETED|Overall Study||6
10961194|NCT00480740|12134340|FG000|NOT COMPLETED|Overall Study||0
10961195|NCT00480740|12134341|FG001|NOT COMPLETED|Overall Study||0
10961196|NCT00480740|12134342|FG002|NOT COMPLETED|Overall Study||0
10961197|NCT00480779|12134352|FG000|STARTED|Overall Study||26
10961198|NCT00480779|12134353|FG001|STARTED|Overall Study||22
10961199|NCT00480779|12134352|FG000|COMPLETED|Overall Study||24
10961200|NCT00480779|12134353|FG001|COMPLETED|Overall Study||19
10961201|NCT00480779|12134352|FG000|NOT COMPLETED|Overall Study||2
10961202|NCT00480779|12134353|FG001|NOT COMPLETED|Overall Study||3
10961203|NCT00480857|12134359|FG000|STARTED|Overall Study||19
10961204|NCT00480857|12134359|FG000|COMPLETED|Overall Study||17
10961205|NCT00480857|12134359|FG000|NOT COMPLETED|Overall Study||2
10961206|NCT00480987|12134363|FG000|STARTED|Overall Study||27
10961207|NCT00480987|12134363|FG000|COMPLETED|Overall Study||27
10961208|NCT00480987|12134363|FG000|NOT COMPLETED|Overall Study||0
10961209|NCT00481065|12134375|FG000|STARTED|Overall Study||51
10961210|NCT00481065|12134376|FG001|STARTED|Overall Study||50
10961211|NCT00481065|12134377|FG002|STARTED|Overall Study||51
10961212|NCT00481065|12134378|FG003|STARTED|Overall Study||52
10961213|NCT00481065|12134379|FG004|STARTED|Overall Study||51
10961214|NCT00481065|12134380|FG005|STARTED|Overall Study||51
10961215|NCT00481065|12134381|FG006|STARTED|Overall Study||50
10961216|NCT00481065|12134382|FG007|STARTED|Overall Study||49
10961217|NCT00481065|12134375|FG000|COMPLETED|Overall Study||29
10961218|NCT00481065|12134376|FG001|COMPLETED|Overall Study||33
10961219|NCT00481065|12134377|FG002|COMPLETED|Overall Study||32
10961220|NCT00481065|12134378|FG003|COMPLETED|Overall Study||37
10961221|NCT00481065|12134379|FG004|COMPLETED|Overall Study||28
10961222|NCT00481065|12134380|FG005|COMPLETED|Overall Study||27
10961223|NCT00481065|12134381|FG006|COMPLETED|Overall Study||34
10961224|NCT00481065|12134382|FG007|COMPLETED|Overall Study||30
10961225|NCT00481065|12134375|FG000|NOT COMPLETED|Overall Study||22
10961226|NCT00481065|12134376|FG001|NOT COMPLETED|Overall Study||17
10961227|NCT00481065|12134377|FG002|NOT COMPLETED|Overall Study||19
10961228|NCT00481065|12134378|FG003|NOT COMPLETED|Overall Study||15
10961229|NCT00481065|12134379|FG004|NOT COMPLETED|Overall Study||23
10961230|NCT00481065|12134380|FG005|NOT COMPLETED|Overall Study||24
10961231|NCT00481065|12134381|FG006|NOT COMPLETED|Overall Study||16
10961232|NCT00481065|12134382|FG007|NOT COMPLETED|Overall Study||19
10961233|NCT00481078|12134404|FG000|STARTED|Overall Study||62
10961234|NCT00481078|12134405|FG001|STARTED|Overall Study||32
10961235|NCT00481078|12134404|FG000|COMPLETED|Overall Study||20
10961236|NCT00481078|12134405|FG001|COMPLETED|Overall Study||12
10961237|NCT00481078|12134404|FG000|NOT COMPLETED|Overall Study||42
10961238|NCT00481078|12134405|FG001|NOT COMPLETED|Overall Study||20
10961239|NCT00481195|12134413|FG000|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
10961240|NCT00481195|12134414|FG001|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
10961241|NCT00481195|12134413|FG000|COMPLETED|Overall Study||89
10961242|NCT00481195|12134414|FG001|COMPLETED|Overall Study||90
10961243|NCT00481195|12134413|FG000|NOT COMPLETED|Overall Study||39
10961244|NCT00481195|12134414|FG001|NOT COMPLETED|Overall Study||39
10961245|NCT00481247|12134422|FG000|STARTED|Overall Study|Randomized|259
10961246|NCT00481247|12134423|FG001|STARTED|Overall Study|Randomized|260
10961247|NCT00481247|12134422|FG000|Received Treatment|Overall Study||258
10961248|NCT00481247|12134423|FG001|Received Treatment|Overall Study||258
10961249|NCT00481247|12134422|FG000|COMPLETED|Overall Study||0
10961250|NCT00481247|12134423|FG001|COMPLETED|Overall Study||0
10961251|NCT00481247|12134422|FG000|NOT COMPLETED|Overall Study||259
10961252|NCT00481247|12134423|FG001|NOT COMPLETED|Overall Study||260
10961253|NCT00481351|12134431|FG000|STARTED|Overall Study||13
10961254|NCT00481351|12134432|FG001|STARTED|Overall Study||12
10961255|NCT00481351|12134431|FG000|COMPLETED|Overall Study||13
10961256|NCT00481351|12134432|FG001|COMPLETED|Overall Study||12
10961257|NCT00481351|12134431|FG000|NOT COMPLETED|Overall Study||0
10961258|NCT00481351|12134432|FG001|NOT COMPLETED|Overall Study||0
10961259|NCT00481507|12134440|FG000|STARTED|Overall Study||64
10961260|NCT00481507|12134441|FG001|STARTED|Overall Study||61
10961261|NCT00481507|12134440|FG000|COMPLETED|Overall Study||64
10961262|NCT00481507|12134441|FG001|COMPLETED|Overall Study||61
10961263|NCT00481507|12134440|FG000|NOT COMPLETED|Overall Study||0
10961264|NCT00481507|12134441|FG001|NOT COMPLETED|Overall Study||0
10961265|NCT00481676|12134449|FG000|STARTED|Overall Study||27
10961266|NCT00481676|12134450|FG001|STARTED|Overall Study||22
10961267|NCT00481676|12134449|FG000|COMPLETED|Overall Study||25
10961268|NCT00481676|12134450|FG001|COMPLETED|Overall Study||17
10961269|NCT00481676|12134449|FG000|NOT COMPLETED|Overall Study||2
10961270|NCT00481676|12134450|FG001|NOT COMPLETED|Overall Study||5
10961271|NCT00481767|12134458|FG000|STARTED|Overall Study||450
10961272|NCT00481767|12134459|FG001|STARTED|Overall Study||226
10961273|NCT00481767|12134458|FG000|COMPLETED|Overall Study||418
10961274|NCT00481767|12134459|FG001|COMPLETED|Overall Study||205
10961275|NCT00481767|12134458|FG000|NOT COMPLETED|Overall Study||32
10961276|NCT00481767|12134459|FG001|NOT COMPLETED|Overall Study||21
10961277|NCT00481832|12134465|FG000|STARTED|Enrollment||50
10961278|NCT00481832|12134465|FG000|COMPLETED|Enrollment||40
10961279|NCT00481832|12134465|FG000|NOT COMPLETED|Enrollment||10
10961280|NCT00481832|12134465|FG000|STARTED|Autologous Hematopoietic Cell Transplant||40
10961281|NCT00481832|12134465|FG000|COMPLETED|Autologous Hematopoietic Cell Transplant||40
10961282|NCT00481832|12134465|FG000|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
10961283|NCT00481832|12134465|FG000|STARTED|Inter-transplant Period||40
10961284|NCT00481832|12134465|FG000|COMPLETED|Inter-transplant Period||13
10961285|NCT00481832|12134465|FG000|NOT COMPLETED|Inter-transplant Period||27
10961286|NCT00481832|12134465|FG000|STARTED|Allogenic Hematopoietic Cell Transplant||13
10961287|NCT00481832|12134465|FG000|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
10961288|NCT00481832|12134465|FG000|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
10961289|NCT00481845|12134471|FG000|STARTED|Overall Study||1
10961290|NCT00481845|12134472|FG001|STARTED|Overall Study||0
10961291|NCT00481845|12134471|FG000|COMPLETED|Overall Study||1
10961292|NCT00481845|12134472|FG001|COMPLETED|Overall Study||0
10961293|NCT00481845|12134471|FG000|NOT COMPLETED|Overall Study||0
10961294|NCT00481845|12134472|FG001|NOT COMPLETED|Overall Study||0
10961295|NCT00481871|12134483|FG000|STARTED|Overall Study||7
10961296|NCT00481871|12134484|FG001|STARTED|Overall Study||10
10961297|NCT00481871|12134485|FG002|STARTED|Overall Study||18
10961298|NCT00481871|12134486|FG003|STARTED|Overall Study||38
10961299|NCT00481871|12134487|FG004|STARTED|Overall Study||34
10961300|NCT00481871|12134483|FG000|COMPLETED|Overall Study||7
10961301|NCT00481871|12134484|FG001|COMPLETED|Overall Study||10
10961302|NCT00481871|12134485|FG002|COMPLETED|Overall Study||17
10961303|NCT00481871|12134486|FG003|COMPLETED|Overall Study||38
10961304|NCT00481871|12134487|FG004|COMPLETED|Overall Study||34
10961305|NCT00481871|12134483|FG000|NOT COMPLETED|Overall Study||0
10961306|NCT00481871|12134484|FG001|NOT COMPLETED|Overall Study||0
10961307|NCT00481871|12134485|FG002|NOT COMPLETED|Overall Study||1
10961308|NCT00481871|12134486|FG003|NOT COMPLETED|Overall Study||0
10961309|NCT00481871|12134487|FG004|NOT COMPLETED|Overall Study||0
10961310|NCT00481988|12134497|FG000|STARTED|Overall Study||12
10961311|NCT00481988|12134498|FG001|STARTED|Overall Study|one patient was dropped from the study before randomization|9
10961312|NCT00481988|12134497|FG000|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
10961313|NCT00481988|12134498|FG001|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
10961314|NCT00481988|12134497|FG000|COMPLETED|Overall Study||11
10961315|NCT00481988|12134498|FG001|COMPLETED|Overall Study||8
10961316|NCT00481988|12134497|FG000|NOT COMPLETED|Overall Study||1
10961317|NCT00481988|12134498|FG001|NOT COMPLETED|Overall Study||1
10961318|NCT00482001|12134506|FG000|STARTED|Overall Study||11
10961319|NCT00482001|12134507|FG001|STARTED|Overall Study||11
10961320|NCT00482001|12134506|FG000|COMPLETED|Overall Study||10
10961321|NCT00482001|12134507|FG001|COMPLETED|Overall Study||10
10961322|NCT00482001|12134506|FG000|NOT COMPLETED|Overall Study||1
10961323|NCT00482001|12134507|FG001|NOT COMPLETED|Overall Study||1
10961324|NCT00482014|12134519|FG000|STARTED|Overall Study||9
10961325|NCT00482014|12134520|FG001|STARTED|Overall Study||13
10961326|NCT00482014|12134521|FG002|STARTED|Overall Study||46
10961327|NCT00482014|12134522|FG003|STARTED|Overall Study||52
10961328|NCT00482014|12134519|FG000|COMPLETED|Overall Study||2
10961329|NCT00482014|12134520|FG001|COMPLETED|Overall Study||7
10961330|NCT00482014|12134521|FG002|COMPLETED|Overall Study||35
10961331|NCT00482014|12134522|FG003|COMPLETED|Overall Study||29
10961332|NCT00482014|12134519|FG000|NOT COMPLETED|Overall Study||7
10961333|NCT00482014|12134520|FG001|NOT COMPLETED|Overall Study||6
10961334|NCT00482014|12134521|FG002|NOT COMPLETED|Overall Study||11
10961335|NCT00482014|12134522|FG003|NOT COMPLETED|Overall Study||23
10961336|NCT00482053|12134534|FG000|STARTED|Autologous Peripheral Stem Cells||3
10961337|NCT00482053|12134534|FG000|COMPLETED|Autologous Peripheral Stem Cells||3
10961338|NCT00482053|12134534|FG000|NOT COMPLETED|Autologous Peripheral Stem Cells||0
10961339|NCT00482053|12134534|FG000|STARTED|Inter-treatment Period||3
10961340|NCT00482053|12134534|FG000|COMPLETED|Inter-treatment Period||2
10961341|NCT00482053|12134534|FG000|NOT COMPLETED|Inter-treatment Period||1
10961342|NCT00482053|12134534|FG000|STARTED|Allogeneic Peripheral Stem Cells||2
10961343|NCT00482053|12134534|FG000|COMPLETED|Allogeneic Peripheral Stem Cells||2
10961344|NCT00482053|12134534|FG000|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
10961345|NCT00482170|12134540|FG000|STARTED|Overall Study||207
10961346|NCT00482170|12134541|FG001|STARTED|Overall Study||214
10961347|NCT00482170|12134540|FG000|Treated|Overall Study||207
10961348|NCT00482170|12134541|FG001|Treated|Overall Study||211
10961349|NCT00482170|12134540|FG000|COMPLETED|Overall Study||192
10961350|NCT00482170|12134541|FG001|COMPLETED|Overall Study||194
10961351|NCT00482170|12134540|FG000|NOT COMPLETED|Overall Study||15
10961352|NCT00482170|12134541|FG001|NOT COMPLETED|Overall Study||20
10961353|NCT00482274|12134547|FG000|STARTED|Overall Study||3
10961354|NCT00482274|12134547|FG000|COMPLETED|Overall Study||2
10961355|NCT00482274|12134547|FG000|NOT COMPLETED|Overall Study||1
10961356|NCT00482391|12134551|FG000|STARTED|Overall Study||95
10961357|NCT00482391|12134551|FG000|COMPLETED|Overall Study||92
10961358|NCT00482391|12134551|FG000|NOT COMPLETED|Overall Study||3
10961359|NCT00482547|12134558|FG000|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
10961360|NCT00482547|12134559|FG001|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
10961361|NCT00482547|12134558|FG000|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
10961362|NCT00482547|12134559|FG001|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
10961363|NCT00482547|12134558|FG000|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
10961364|NCT00482547|12134559|FG001|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
10961365|NCT00482547|12134558|FG000|COMPLETED|Overall Study||426
10961366|NCT00482547|12134559|FG001|COMPLETED|Overall Study||428
10961367|NCT00482547|12134558|FG000|NOT COMPLETED|Overall Study||173
10961368|NCT00482547|12134559|FG001|NOT COMPLETED|Overall Study||161
10961369|NCT00482612|12134569|FG000|STARTED|In-treatment Period||137
10961370|NCT00482612|12134570|FG001|STARTED|In-treatment Period||125
10961371|NCT00482612|12134571|FG002|STARTED|In-treatment Period||129
10961372|NCT00482612|12134572|FG003|STARTED|In-treatment Period||135
10961373|NCT00482612|12134569|FG000|Treated|In-treatment Period||137
10961374|NCT00482612|12134570|FG001|Treated|In-treatment Period||125
10961375|NCT00482612|12134571|FG002|Treated|In-treatment Period||128
10961376|NCT00482612|12134572|FG003|Treated|In-treatment Period||135
10961377|NCT00482612|12134569|FG000|COMPLETED|In-treatment Period||137
10961378|NCT00482612|12134570|FG001|COMPLETED|In-treatment Period||125
10961379|NCT00482612|12134571|FG002|COMPLETED|In-treatment Period||128
10961380|NCT00482612|12134572|FG003|COMPLETED|In-treatment Period||135
10961381|NCT00482612|12134569|FG000|NOT COMPLETED|In-treatment Period||0
10961382|NCT00482612|12134570|FG001|NOT COMPLETED|In-treatment Period||0
10961383|NCT00482612|12134571|FG002|NOT COMPLETED|In-treatment Period||1
10961384|NCT00482612|12134572|FG003|NOT COMPLETED|In-treatment Period||0
10961385|NCT00482612|12134569|FG000|STARTED|Follow-up Period||137
10961386|NCT00482612|12134570|FG001|STARTED|Follow-up Period||125
10961387|NCT00482612|12134571|FG002|STARTED|Follow-up Period||128
10961388|NCT00482612|12134572|FG003|STARTED|Follow-up Period||135
10961389|NCT00482612|12134569|FG000|COMPLETED|Follow-up Period||123
10961390|NCT00482612|12134570|FG001|COMPLETED|Follow-up Period||107
10961391|NCT00482612|12134571|FG002|COMPLETED|Follow-up Period||106
10961392|NCT00482612|12134572|FG003|COMPLETED|Follow-up Period||127
10961393|NCT00482612|12134569|FG000|NOT COMPLETED|Follow-up Period||14
10961394|NCT00482612|12134570|FG001|NOT COMPLETED|Follow-up Period||18
10961395|NCT00482612|12134571|FG002|NOT COMPLETED|Follow-up Period||22
10961396|NCT00482612|12134572|FG003|NOT COMPLETED|Follow-up Period||8
10961397|NCT00482625|12134586|FG000|STARTED|Overall Study||6
10961398|NCT00482625|12134586|FG000|COMPLETED|Overall Study||6
10961399|NCT00482625|12134586|FG000|NOT COMPLETED|Overall Study||0
10961400|NCT00482677|12134592|FG000|STARTED|Overall Study||281
10961401|NCT00482677|12134593|FG001|STARTED|Overall Study||281
10961402|NCT00482677|12134592|FG000|COMPLETED|Overall Study||281
10961403|NCT00482677|12134593|FG001|COMPLETED|Overall Study||281
10961404|NCT00482677|12134592|FG000|NOT COMPLETED|Overall Study||0
10961405|NCT00482677|12134593|FG001|NOT COMPLETED|Overall Study||0
10961406|NCT00482703|12134601|FG000|STARTED|Overall Study|number enrolled, randomized and treated|11
10961407|NCT00482703|12134602|FG001|STARTED|Overall Study|number enrolled, randomized and treated|12
10961408|NCT00482703|12134601|FG000|COMPLETED|Overall Study||10
10961409|NCT00482703|12134602|FG001|COMPLETED|Overall Study||12
10961410|NCT00482703|12134601|FG000|NOT COMPLETED|Overall Study||1
10961411|NCT00482703|12134602|FG001|NOT COMPLETED|Overall Study||0
10961412|NCT00482729|12134617|FG000|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
10961413|NCT00482729|12134618|FG001|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
10961414|NCT00482729|12134617|FG000|Completed Phase A|Overall Study||484
10961415|NCT00482729|12134618|FG001|Completed Phase A|Overall Study||482
10961416|NCT00482729|12134617|FG000|Completed Phase B|Overall Study||409
10961417|NCT00482729|12134618|FG001|Completed Phase B|Overall Study||406
10961418|NCT00482729|12134617|FG000|COMPLETED|Overall Study||409
10961419|NCT00482729|12134618|FG001|COMPLETED|Overall Study||406
10961420|NCT00482729|12134617|FG000|NOT COMPLETED|Overall Study||217
10961421|NCT00482729|12134618|FG001|NOT COMPLETED|Overall Study||218
10961422|NCT00482911|12134626|FG000|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
10961423|NCT00482911|12134627|FG001|STARTED|Dosing Schedule 1: Len & Cyc||0
10961424|NCT00482911|12134626|FG000|COMPLETED|Dosing Schedule 1: Len & Cyc||3
10961425|NCT00482911|12134627|FG001|COMPLETED|Dosing Schedule 1: Len & Cyc||0
10961426|NCT00482911|12134626|FG000|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
10961427|NCT00482911|12134627|FG001|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
10961428|NCT00482911|12134626|FG000|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
10961512|NCT00483652|12134739|FG000|NOT COMPLETED|Double-blind Treatment Period||7
10961429|NCT00482911|12134627|FG001|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
10961430|NCT00482911|12134626|FG000|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
10961431|NCT00482911|12134627|FG001|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
10961432|NCT00482911|12134626|FG000|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
10961433|NCT00482911|12134627|FG001|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
10961434|NCT00482911|12134626|FG000|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
10961435|NCT00482911|12134627|FG001|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
10961436|NCT00482911|12134626|FG000|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
10961437|NCT00482911|12134627|FG001|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
10961438|NCT00482911|12134626|FG000|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
10961439|NCT00482911|12134627|FG001|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
10961440|NCT00483002|12134633|FG000|STARTED|Overall Study||3719
10961441|NCT00483002|12134633|FG000|COMPLETED|Overall Study||1165
10961442|NCT00483002|12134633|FG000|NOT COMPLETED|Overall Study||2554
10961443|NCT00483041|12134639|FG000|STARTED|Overall Study||5
10961444|NCT00483041|12134640|FG001|STARTED|Overall Study||6
10961445|NCT00483041|12134639|FG000|COMPLETED|Overall Study||5
10961446|NCT00483041|12134640|FG001|COMPLETED|Overall Study||5
10961447|NCT00483041|12134639|FG000|NOT COMPLETED|Overall Study||0
10961448|NCT00483041|12134640|FG001|NOT COMPLETED|Overall Study||1
10961449|NCT00483184|12134649|FG000|STARTED|Overall Study||27
10961450|NCT00483184|12134650|FG001|STARTED|Overall Study||31
10961451|NCT00483184|12134651|FG002|STARTED|Overall Study||26
10961452|NCT00483184|12134649|FG000|COMPLETED|Overall Study||22
10961453|NCT00483184|12134650|FG001|COMPLETED|Overall Study||27
10961454|NCT00483184|12134651|FG002|COMPLETED|Overall Study||23
10961455|NCT00483184|12134649|FG000|NOT COMPLETED|Overall Study||5
10961456|NCT00483184|12134650|FG001|NOT COMPLETED|Overall Study||4
10961457|NCT00483184|12134651|FG002|NOT COMPLETED|Overall Study||3
10961458|NCT00483223|12134659|FG000|STARTED|Overall Study||86
10961459|NCT00483223|12134659|FG000|COMPLETED|Overall Study||86
10961460|NCT00483223|12134659|FG000|NOT COMPLETED|Overall Study||0
10961461|NCT00483262|12134665|FG000|STARTED|Overall Study||20
10961462|NCT00483262|12134666|FG001|STARTED|Overall Study||43
10961463|NCT00483262|12134665|FG000|COMPLETED|Overall Study||20
10961464|NCT00483262|12134666|FG001|COMPLETED|Overall Study||43
10961465|NCT00483262|12134665|FG000|NOT COMPLETED|Overall Study||0
10961466|NCT00483262|12134666|FG001|NOT COMPLETED|Overall Study||0
10961467|NCT00483327|12134676|FG000|STARTED|Overall Study||30
10961468|NCT00483327|12134676|FG000|COMPLETED|Overall Study||20
10961469|NCT00483327|12134676|FG000|NOT COMPLETED|Overall Study||10
10961470|NCT00483379|12134684|FG000|STARTED|Treatment Period||6
10961471|NCT00483379|12134685|FG001|STARTED|Treatment Period||7
10961472|NCT00483379|12134684|FG000|COMPLETED|Treatment Period||4
10961473|NCT00483379|12134685|FG001|COMPLETED|Treatment Period||7
10961474|NCT00483379|12134684|FG000|NOT COMPLETED|Treatment Period||2
10961475|NCT00483379|12134685|FG001|NOT COMPLETED|Treatment Period||0
10961476|NCT00483379|12134684|FG000|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
10961477|NCT00483379|12134685|FG001|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
10961478|NCT00483379|12134684|FG000|COMPLETED|Extension Period||1
10961479|NCT00483379|12134685|FG001|COMPLETED|Extension Period||2
10961480|NCT00483379|12134684|FG000|NOT COMPLETED|Extension Period||0
10961481|NCT00483379|12134685|FG001|NOT COMPLETED|Extension Period||0
10961482|NCT00483405|12134693|FG000|STARTED|Overall Study||28
10961483|NCT00483405|12134693|FG000|COMPLETED|Overall Study||0
10961484|NCT00483405|12134693|FG000|NOT COMPLETED|Overall Study||28
10961485|NCT00483496|12134697|FG000|STARTED|Overall Study||16
10961486|NCT00483496|12134697|FG000|COMPLETED|Overall Study||15
10961487|NCT00483496|12134697|FG000|NOT COMPLETED|Overall Study||1
10961488|NCT00483509|12134709|FG000|STARTED|Overall Study||28
10961489|NCT00483509|12134709|FG000|COMPLETED|Overall Study||28
10961490|NCT00483509|12134709|FG000|NOT COMPLETED|Overall Study||0
10961491|NCT00483548|12134715|FG000|STARTED|Overall Study||148
10961492|NCT00483548|12134716|FG001|STARTED|Overall Study||150
10961493|NCT00483548|12134715|FG000|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
10961494|NCT00483548|12134716|FG001|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
10961495|NCT00483548|12134715|FG000|COMPLETED|Overall Study||88
10961496|NCT00483548|12134716|FG001|COMPLETED|Overall Study||104
10961497|NCT00483548|12134715|FG000|NOT COMPLETED|Overall Study||60
10961498|NCT00483548|12134716|FG001|NOT COMPLETED|Overall Study||46
10961499|NCT00483561|12134722|FG000|STARTED|Overall Study||26
10961500|NCT00483561|12134722|FG000|COMPLETED|Overall Study||15
10961501|NCT00483561|12134722|FG000|NOT COMPLETED|Overall Study||11
10961502|NCT00483574|12134728|FG000|STARTED|Overall Study||1053
10961503|NCT00483574|12134729|FG001|STARTED|Overall Study||321
10961504|NCT00483574|12134728|FG000|COMPLETED|Overall Study||951
10961505|NCT00483574|12134729|FG001|COMPLETED|Overall Study||308
10961506|NCT00483574|12134728|FG000|NOT COMPLETED|Overall Study||102
10961507|NCT00483574|12134729|FG001|NOT COMPLETED|Overall Study||13
10961508|NCT00483652|12134739|FG000|STARTED|Double-blind Treatment Period||120
10961509|NCT00483652|12134740|FG001|STARTED|Double-blind Treatment Period||119
10961510|NCT00483652|12134739|FG000|COMPLETED|Double-blind Treatment Period||113
10961511|NCT00483652|12134740|FG001|COMPLETED|Double-blind Treatment Period||114
10961513|NCT00483652|12134740|FG001|NOT COMPLETED|Double-blind Treatment Period||5
10961514|NCT00483652|12134739|FG000|STARTED|Post-study Follow-up||113
10961515|NCT00483652|12134740|FG001|STARTED|Post-study Follow-up||114
10961516|NCT00483652|12134739|FG000|COMPLETED|Post-study Follow-up||113
10961517|NCT00483652|12134740|FG001|COMPLETED|Post-study Follow-up||114
10961518|NCT00483652|12134739|FG000|NOT COMPLETED|Post-study Follow-up||0
10961519|NCT00483652|12134740|FG001|NOT COMPLETED|Post-study Follow-up||0
10961520|NCT00483704|12134749|FG000|STARTED|Randomization||644
10961521|NCT00483704|12134750|FG001|STARTED|Randomization||645
10961522|NCT00483704|12134751|FG002|STARTED|Randomization||646
10961523|NCT00483704|12134749|FG000|COMPLETED|Randomization||573
10961524|NCT00483704|12134750|FG001|COMPLETED|Randomization||549
10961525|NCT00483704|12134751|FG002|COMPLETED|Randomization||555
10961526|NCT00483704|12134749|FG000|NOT COMPLETED|Randomization||71
10961527|NCT00483704|12134750|FG001|NOT COMPLETED|Randomization||96
10961528|NCT00483704|12134751|FG002|NOT COMPLETED|Randomization||91
10961529|NCT00483704|12134749|FG000|STARTED|Treatment||573
10961530|NCT00483704|12134750|FG001|STARTED|Treatment||549
10961531|NCT00483704|12134751|FG002|STARTED|Treatment||555
10961532|NCT00483704|12134749|FG000|COMPLETED|Treatment||444
10961533|NCT00483704|12134750|FG001|COMPLETED|Treatment||420
10961534|NCT00483704|12134751|FG002|COMPLETED|Treatment||399
10961535|NCT00483704|12134749|FG000|NOT COMPLETED|Treatment||129
10961536|NCT00483704|12134750|FG001|NOT COMPLETED|Treatment||129
10961537|NCT00483704|12134751|FG002|NOT COMPLETED|Treatment||156
10961538|NCT00483717|12134764|FG000|STARTED|Overall Study||87
10961539|NCT00483717|12134765|FG001|STARTED|Overall Study||86
10961540|NCT00483717|12134764|FG000|COMPLETED|Overall Study||63
10961541|NCT00483717|12134765|FG001|COMPLETED|Overall Study||65
10961542|NCT00483717|12134764|FG000|NOT COMPLETED|Overall Study||24
10961543|NCT00483717|12134765|FG001|NOT COMPLETED|Overall Study||21
10961544|NCT00483756|12134774|FG000|STARTED|Overall Study||110
10961545|NCT00483756|12134775|FG001|STARTED|Overall Study||110
10961546|NCT00483756|12134776|FG002|STARTED|Overall Study||111
10961547|NCT00483756|12134774|FG000|Treated|Overall Study||109
10961548|NCT00483756|12134775|FG001|Treated|Overall Study||106
10961549|NCT00483756|12134776|FG002|Treated|Overall Study||107
10961550|NCT00483756|12134774|FG000|COMPLETED|Overall Study||77
10961551|NCT00483756|12134775|FG001|COMPLETED|Overall Study||60
10961552|NCT00483756|12134776|FG002|COMPLETED|Overall Study||59
10961553|NCT00483756|12134774|FG000|NOT COMPLETED|Overall Study||33
10961554|NCT00483756|12134775|FG001|NOT COMPLETED|Overall Study||50
10961555|NCT00483756|12134776|FG002|NOT COMPLETED|Overall Study||52
10961556|NCT00483938|12134791|FG000|STARTED|Overall Study||41
10961557|NCT00483938|12134792|FG001|STARTED|Overall Study||43
10961558|NCT00483938|12134793|FG002|STARTED|Overall Study||30
10961559|NCT00483938|12134794|FG003|STARTED|Overall Study||31
10961560|NCT00483938|12134795|FG004|STARTED|Overall Study||25
10961561|NCT00483938|12134796|FG005|STARTED|Overall Study||26
10961562|NCT00483938|12134797|FG006|STARTED|Overall Study||40
10961563|NCT00483938|12134791|FG000|COMPLETED|Overall Study||36
10961564|NCT00483938|12134792|FG001|COMPLETED|Overall Study||24
10961565|NCT00483938|12134793|FG002|COMPLETED|Overall Study||30
10961566|NCT00483938|12134794|FG003|COMPLETED|Overall Study||25
10961567|NCT00483938|12134795|FG004|COMPLETED|Overall Study||23
10961568|NCT00483938|12134796|FG005|COMPLETED|Overall Study||18
10961569|NCT00483938|12134797|FG006|COMPLETED|Overall Study||0
10961570|NCT00483938|12134791|FG000|NOT COMPLETED|Overall Study||5
10961571|NCT00483938|12134792|FG001|NOT COMPLETED|Overall Study||19
10961572|NCT00483938|12134793|FG002|NOT COMPLETED|Overall Study||0
10961573|NCT00483938|12134794|FG003|NOT COMPLETED|Overall Study||6
10961574|NCT00483938|12134795|FG004|NOT COMPLETED|Overall Study||2
10961575|NCT00483938|12134796|FG005|NOT COMPLETED|Overall Study||8
10961576|NCT00483938|12134797|FG006|NOT COMPLETED|Overall Study||40
10961577|NCT00484094|12134816|FG000|STARTED|Overall Study||209
10961578|NCT00484094|12134816|FG000|COMPLETED|Overall Study||167
10961579|NCT00484094|12134816|FG000|NOT COMPLETED|Overall Study||42
10961580|NCT00484159|12134823|FG000|STARTED|Overall Study||50
10961581|NCT00484159|12134824|FG001|STARTED|Overall Study||50
10961582|NCT00484159|12134825|FG002|STARTED|Overall Study||51
10961583|NCT00484159|12134823|FG000|COMPLETED|Overall Study||49
10961584|NCT00484159|12134824|FG001|COMPLETED|Overall Study||49
10961585|NCT00484159|12134825|FG002|COMPLETED|Overall Study||51
10961586|NCT00484159|12134823|FG000|NOT COMPLETED|Overall Study||1
10961587|NCT00484159|12134824|FG001|NOT COMPLETED|Overall Study||1
10961588|NCT00484159|12134825|FG002|NOT COMPLETED|Overall Study||0
10961589|NCT00484185|12134833|FG000|STARTED|Overall Study||183
10961590|NCT00484185|12134833|FG000|Treated|Overall Study||178
10961591|NCT00484185|12134833|FG000|COMPLETED|Overall Study||112
10961592|NCT00484185|12134833|FG000|NOT COMPLETED|Overall Study||71
10961593|NCT00484198|12134841|FG000|STARTED|Overall Study||137
10961594|NCT00484198|12134842|FG001|STARTED|Overall Study||274
10961595|NCT00484198|12134843|FG002|STARTED|Overall Study||750
10961596|NCT00484198|12134844|FG003|STARTED|Overall Study||751
10961597|NCT00484198|12134841|FG000|COMPLETED|Overall Study||96
10961598|NCT00484198|12134842|FG001|COMPLETED|Overall Study||208
10961599|NCT00484198|12134843|FG002|COMPLETED|Overall Study||599
10961600|NCT00484198|12134844|FG003|COMPLETED|Overall Study||579
10961601|NCT00484198|12134841|FG000|NOT COMPLETED|Overall Study||41
10961602|NCT00484198|12134842|FG001|NOT COMPLETED|Overall Study||66
10961603|NCT00484198|12134843|FG002|NOT COMPLETED|Overall Study||151
10961604|NCT00484198|12134844|FG003|NOT COMPLETED|Overall Study||172
10961605|NCT00484289|12134862|FG000|STARTED|Long Term Phase||13
10961606|NCT00484289|12134863|FG001|STARTED|Long Term Phase||178
10961607|NCT00484289|12134864|FG002|STARTED|Long Term Phase||26
10961608|NCT00484289|12134862|FG000|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
10961609|NCT00484289|12134863|FG001|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
10961610|NCT00484289|12134864|FG002|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
10961611|NCT00484289|12134862|FG000|NOT COMPLETED|Long Term Phase||3
10961612|NCT00484289|12134863|FG001|NOT COMPLETED|Long Term Phase||36
10961613|NCT00484289|12134864|FG002|NOT COMPLETED|Long Term Phase||16
10961614|NCT00484289|12134862|FG000|STARTED|Post Marketing Phase||10
10961615|NCT00484289|12134863|FG001|STARTED|Post Marketing Phase||142
10961616|NCT00484289|12134864|FG002|STARTED|Post Marketing Phase||10
10961617|NCT00484289|12134862|FG000|COMPLETED|Post Marketing Phase||10
10961618|NCT00484289|12134863|FG001|COMPLETED|Post Marketing Phase||141
10961619|NCT00484289|12134864|FG002|COMPLETED|Post Marketing Phase||10
10961620|NCT00484289|12134862|FG000|NOT COMPLETED|Post Marketing Phase||0
10961621|NCT00484289|12134863|FG001|NOT COMPLETED|Post Marketing Phase||1
10961622|NCT00484289|12134864|FG002|NOT COMPLETED|Post Marketing Phase||0
10961623|NCT00484315|12134875|FG000|STARTED|12-Month Clinical Follow-up||942
10961624|NCT00484315|12134876|FG001|STARTED|12-Month Clinical Follow-up||320
10961625|NCT00484315|12134875|FG000|COMPLETED|12-Month Clinical Follow-up||914
10961626|NCT00484315|12134876|FG001|COMPLETED|12-Month Clinical Follow-up||311
10961627|NCT00484315|12134875|FG000|NOT COMPLETED|12-Month Clinical Follow-up||28
10961628|NCT00484315|12134876|FG001|NOT COMPLETED|12-Month Clinical Follow-up||9
10961629|NCT00484315|12134875|FG000|STARTED|9-Month Angiographic Follow-up||256
10961630|NCT00484315|12134876|FG001|STARTED|9-Month Angiographic Follow-up||74
10961631|NCT00484315|12134875|FG000|COMPLETED|9-Month Angiographic Follow-up||228
10961632|NCT00484315|12134876|FG001|COMPLETED|9-Month Angiographic Follow-up||61
10961633|NCT00484315|12134875|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||28
10961634|NCT00484315|12134876|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||13
10961635|NCT00484354|12134884|FG000|STARTED|Overall Study||64
10961636|NCT00484354|12134885|FG001|STARTED|Overall Study||59
10961637|NCT00484354|12134884|FG000|COMPLETED|Overall Study||63
10961638|NCT00484354|12134885|FG001|COMPLETED|Overall Study||57
10961639|NCT00484354|12134884|FG000|NOT COMPLETED|Overall Study||1
10961640|NCT00484354|12134885|FG001|NOT COMPLETED|Overall Study||2
10961641|NCT00484393|12134893|FG000|STARTED|Overall Study||4
10961642|NCT00484393|12134894|FG001|STARTED|Overall Study||3
10961643|NCT00484393|12134893|FG000|COMPLETED|Overall Study||4
10961644|NCT00484393|12134894|FG001|COMPLETED|Overall Study||3
10961645|NCT00484393|12134893|FG000|NOT COMPLETED|Overall Study||0
10961646|NCT00484393|12134894|FG001|NOT COMPLETED|Overall Study||0
10961647|NCT00484679|12134900|FG000|STARTED|Overall Study||18
10961648|NCT00484679|12134900|FG000|COMPLETED|Overall Study||15
10961649|NCT00484679|12134900|FG000|NOT COMPLETED|Overall Study||3
10961650|NCT00484874|12134904|FG000|STARTED|Overall Study||12
10961651|NCT00484874|12134904|FG000|COMPLETED|Overall Study||12
10961652|NCT00484874|12134904|FG000|NOT COMPLETED|Overall Study||0
10961653|NCT00484939|12134913|FG000|STARTED|Overall Study||140
10961654|NCT00484939|12134914|FG001|STARTED|Overall Study||140
10961655|NCT00484939|12134913|FG000|COMPLETED|Overall Study||0
10961656|NCT00484939|12134914|FG001|COMPLETED|Overall Study||0
10961657|NCT00484939|12134913|FG000|NOT COMPLETED|Overall Study||140
10961658|NCT00484939|12134914|FG001|NOT COMPLETED|Overall Study||140
10961659|NCT00485069|12134922|FG000|STARTED|Overall Study||65
10961660|NCT00485069|12134923|FG001|STARTED|Overall Study||58
10961661|NCT00485069|12134922|FG000|COMPLETED|Overall Study||47
10961662|NCT00485069|12134923|FG001|COMPLETED|Overall Study||46
10961663|NCT00485069|12134922|FG000|NOT COMPLETED|Overall Study||18
10961664|NCT00485069|12134923|FG001|NOT COMPLETED|Overall Study||12
10961665|NCT00485134|12134944|FG000|STARTED|Overall Study||12
10961666|NCT00485134|12134945|FG001|STARTED|Overall Study||12
10961667|NCT00485134|12134946|FG002|STARTED|Overall Study||12
10961668|NCT00485134|12134947|FG003|STARTED|Overall Study||8
10961669|NCT00485134|12134948|FG004|STARTED|Overall Study||10
10961670|NCT00485134|12134949|FG005|STARTED|Overall Study||7
10961671|NCT00485134|12134950|FG006|STARTED|Overall Study||31
10961672|NCT00485134|12134951|FG007|STARTED|Overall Study||21
10961673|NCT00485134|12134944|FG000|COMPLETED|Overall Study||11
10961674|NCT00485134|12134945|FG001|COMPLETED|Overall Study||10
10961675|NCT00485134|12134946|FG002|COMPLETED|Overall Study||9
10961676|NCT00485134|12134947|FG003|COMPLETED|Overall Study||7
10961677|NCT00485134|12134948|FG004|COMPLETED|Overall Study||7
10961678|NCT00485134|12134949|FG005|COMPLETED|Overall Study||3
10961679|NCT00485134|12134950|FG006|COMPLETED|Overall Study||28
10961680|NCT00485134|12134951|FG007|COMPLETED|Overall Study||20
10961681|NCT00485134|12134944|FG000|NOT COMPLETED|Overall Study||1
10961682|NCT00485134|12134945|FG001|NOT COMPLETED|Overall Study||2
10961683|NCT00485134|12134946|FG002|NOT COMPLETED|Overall Study||3
10961684|NCT00485134|12134947|FG003|NOT COMPLETED|Overall Study||1
10961685|NCT00485134|12134948|FG004|NOT COMPLETED|Overall Study||3
10961686|NCT00485134|12134949|FG005|NOT COMPLETED|Overall Study||4
10961687|NCT00485134|12134950|FG006|NOT COMPLETED|Overall Study||3
10961688|NCT00485134|12134951|FG007|NOT COMPLETED|Overall Study||1
10961689|NCT00485173|12134965|FG000|STARTED|Overall Study||224
10961690|NCT00485173|12134966|FG001|STARTED|Overall Study||486
10961691|NCT00485173|12134965|FG000|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
10961692|NCT00485173|12134966|FG001|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
10961693|NCT00485173|12134965|FG000|NOT COMPLETED|Overall Study||36
10961694|NCT00485173|12134966|FG001|NOT COMPLETED|Overall Study||64
10961695|NCT00485264|12134978|FG000|STARTED|Overall Study||71
10961696|NCT00485264|12134979|FG001|STARTED|Overall Study||16
10961697|NCT00485264|12134980|FG002|STARTED|Overall Study||18
10961698|NCT00485264|12134981|FG003|STARTED|Overall Study||21
10961699|NCT00485264|12134982|FG004|STARTED|Overall Study||15
10961700|NCT00485264|12134983|FG005|STARTED|Overall Study||12
10961701|NCT00485264|12134978|FG000|Completed Week 24|Overall Study||67
10961702|NCT00485264|12134979|FG001|Completed Week 24|Overall Study||16
10961703|NCT00485264|12134980|FG002|Completed Week 24|Overall Study||18
10961704|NCT00485264|12134981|FG003|Completed Week 24|Overall Study||21
10961705|NCT00485264|12134982|FG004|Completed Week 24|Overall Study||14
10961706|NCT00485264|12134983|FG005|Completed Week 24|Overall Study||11
10961707|NCT00485264|12134978|FG000|COMPLETED|Overall Study||35
10961708|NCT00485264|12134979|FG001|COMPLETED|Overall Study||9
10961709|NCT00485264|12134980|FG002|COMPLETED|Overall Study||12
10961710|NCT00485264|12134981|FG003|COMPLETED|Overall Study||17
10961711|NCT00485264|12134982|FG004|COMPLETED|Overall Study||9
10961712|NCT00485264|12134983|FG005|COMPLETED|Overall Study||5
10961713|NCT00485264|12134978|FG000|NOT COMPLETED|Overall Study||36
10961714|NCT00485264|12134979|FG001|NOT COMPLETED|Overall Study||7
10961715|NCT00485264|12134980|FG002|NOT COMPLETED|Overall Study||6
10961716|NCT00485264|12134981|FG003|NOT COMPLETED|Overall Study||4
10961717|NCT00485264|12134982|FG004|NOT COMPLETED|Overall Study||6
10961718|NCT00485264|12134983|FG005|NOT COMPLETED|Overall Study||7
10961719|NCT00485303|12135002|FG000|STARTED|Overall Study||58
10961720|NCT00485303|12135002|FG000|COMPLETED|Overall Study||2
10961721|NCT00485303|12135002|FG000|NOT COMPLETED|Overall Study||56
10961722|NCT00485433|12135010|FG000|STARTED|Overall Study||24
10961723|NCT00485433|12135011|FG001|STARTED|Overall Study||25
10961724|NCT00485433|12135012|FG002|STARTED|Overall Study||24
10961725|NCT00485433|12135013|FG003|STARTED|Overall Study||25
10961726|NCT00485433|12135010|FG000|COMPLETED|Overall Study||24
10961727|NCT00485433|12135011|FG001|COMPLETED|Overall Study||25
10961728|NCT00485433|12135012|FG002|COMPLETED|Overall Study||24
10961729|NCT00485433|12135013|FG003|COMPLETED|Overall Study||25
10961730|NCT00485433|12135010|FG000|NOT COMPLETED|Overall Study||0
10961731|NCT00485433|12135011|FG001|NOT COMPLETED|Overall Study||0
10961732|NCT00485433|12135012|FG002|NOT COMPLETED|Overall Study||0
10961733|NCT00485433|12135013|FG003|NOT COMPLETED|Overall Study||0
10961734|NCT00485472|12135023|FG000|STARTED|Overall Study||73
10961735|NCT00485472|12135024|FG001|STARTED|Overall Study||76
10961736|NCT00485472|12135023|FG000|Entered Maintenance Phase|Overall Study||65
10961737|NCT00485472|12135024|FG001|Entered Maintenance Phase|Overall Study||67
10961738|NCT00485472|12135023|FG000|COMPLETED|Overall Study||57
10961739|NCT00485472|12135024|FG001|COMPLETED|Overall Study||64
10961740|NCT00485472|12135023|FG000|NOT COMPLETED|Overall Study||16
10961741|NCT00485472|12135024|FG001|NOT COMPLETED|Overall Study||12
10961742|NCT00485485|12135030|FG000|STARTED|Overall Study||7
10961743|NCT00485485|12135030|FG000|COMPLETED|Overall Study||7
10961744|NCT00485485|12135030|FG000|NOT COMPLETED|Overall Study||0
10961745|NCT00485589|12135037|FG000|STARTED|Overall Study||210
10961746|NCT00485589|12135038|FG001|STARTED|Overall Study||200
10961747|NCT00485589|12135039|FG002|STARTED|Overall Study||203
10961748|NCT00485589|12135037|FG000|COMPLETED|Overall Study||183
10961749|NCT00485589|12135038|FG001|COMPLETED|Overall Study||180
10961750|NCT00485589|12135039|FG002|COMPLETED|Overall Study||185
10961751|NCT00485589|12135037|FG000|NOT COMPLETED|Overall Study||27
10961752|NCT00485589|12135038|FG001|NOT COMPLETED|Overall Study||20
10961753|NCT00485589|12135039|FG002|NOT COMPLETED|Overall Study||18
10961754|NCT00485732|12135058|FG000|STARTED|Overall Study||149
10961755|NCT00485732|12135059|FG001|STARTED|Overall Study||76
10961756|NCT00485732|12135058|FG000|COMPLETED|Overall Study||141
10961757|NCT00485732|12135059|FG001|COMPLETED|Overall Study||67
10961758|NCT00485732|12135058|FG000|NOT COMPLETED|Overall Study||8
10961759|NCT00485732|12135059|FG001|NOT COMPLETED|Overall Study||9
10961760|NCT00485758|12135067|FG000|STARTED|Overall Study||454
10961761|NCT00485758|12135068|FG001|STARTED|Overall Study||342
10961762|NCT00485758|12135067|FG000|COMPLETED|Overall Study||298
10961763|NCT00485758|12135068|FG001|COMPLETED|Overall Study||277
10961764|NCT00485758|12135067|FG000|NOT COMPLETED|Overall Study||156
10961765|NCT00485758|12135068|FG001|NOT COMPLETED|Overall Study||65
10961766|NCT00485836|12135077|FG000|STARTED|Overall Study||130
10961767|NCT00485836|12135078|FG001|STARTED|Overall Study||132
10961768|NCT00485836|12135079|FG002|STARTED|Overall Study||130
10961769|NCT00485836|12135077|FG000|Received Study Drug (Safety Population)|Overall Study||129
10961770|NCT00485836|12135078|FG001|Received Study Drug (Safety Population)|Overall Study||132
10961771|NCT00485836|12135079|FG002|Received Study Drug (Safety Population)|Overall Study||129
10961772|NCT00485836|12135077|FG000|COMPLETED|Overall Study||115
10961773|NCT00485836|12135078|FG001|COMPLETED|Overall Study||129
10961774|NCT00485836|12135079|FG002|COMPLETED|Overall Study||119
10961775|NCT00485836|12135077|FG000|NOT COMPLETED|Overall Study||15
10961776|NCT00485836|12135078|FG001|NOT COMPLETED|Overall Study||3
10961777|NCT00485836|12135079|FG002|NOT COMPLETED|Overall Study||11
10961778|NCT00485953|12135089|FG000|STARTED|Overall Study||55
10961779|NCT00485953|12135090|FG001|STARTED|Overall Study||54
10961780|NCT00485953|12135089|FG000|COMPLETED|Overall Study||48
10961781|NCT00485953|12135090|FG001|COMPLETED|Overall Study||47
10961782|NCT00485953|12135089|FG000|NOT COMPLETED|Overall Study||7
10961783|NCT00485953|12135090|FG001|NOT COMPLETED|Overall Study||7
10961784|NCT00486018|12135101|FG000|STARTED|Overall Study||132
10961785|NCT00486018|12135102|FG001|STARTED|Overall Study||134
10961786|NCT00486018|12135103|FG002|STARTED|Overall Study||131
10961787|NCT00486018|12135101|FG000|Received Drug (Safety Population)|Overall Study||131
10961788|NCT00486018|12135102|FG001|Received Drug (Safety Population)|Overall Study||134
10961789|NCT00486018|12135103|FG002|Received Drug (Safety Population)|Overall Study||130
10961790|NCT00486018|12135101|FG000|COMPLETED|Overall Study||123
10961791|NCT00486018|12135102|FG001|COMPLETED|Overall Study||128
10961792|NCT00486018|12135103|FG002|COMPLETED|Overall Study||125
10961793|NCT00486018|12135101|FG000|NOT COMPLETED|Overall Study||9
10961794|NCT00486018|12135102|FG001|NOT COMPLETED|Overall Study||6
10961795|NCT00486018|12135103|FG002|NOT COMPLETED|Overall Study||6
10961796|NCT00486031|12135111|FG000|STARTED|Overall Study||443
10961797|NCT00486031|12135111|FG000|COMPLETED|Overall Study||440
10961798|NCT00486031|12135111|FG000|NOT COMPLETED|Overall Study||3
10961799|NCT00486044|12135118|FG000|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
10961800|NCT00486044|12135119|FG001|STARTED|Overall Study|23 in MRI sub-study|49
10961801|NCT00486044|12135118|FG000|COMPLETED|Overall Study|27 completed MRI sub-study|49
10961802|NCT00486044|12135119|FG001|COMPLETED|Overall Study|21 completed MRI sub-study|46
10961803|NCT00486044|12135118|FG000|NOT COMPLETED|Overall Study||2
10961804|NCT00486044|12135119|FG001|NOT COMPLETED|Overall Study||3
10961805|NCT00486226|12135125|FG000|STARTED|Overall Study||105
10961806|NCT00486226|12135125|FG000|COMPLETED|Overall Study||92
10961807|NCT00486226|12135125|FG000|NOT COMPLETED|Overall Study||13
10961808|NCT00486252|12135132|FG000|STARTED|Overall Study||996
10961809|NCT00486252|12135132|FG000|COMPLETED|Overall Study||938
10961810|NCT00486252|12135132|FG000|NOT COMPLETED|Overall Study||58
10961811|NCT00486265|12135138|FG000|STARTED|Overall Study|Partipants dosed on day 1.|9
10961812|NCT00486265|12135138|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
10961813|NCT00486265|12135138|FG000|NOT COMPLETED|Overall Study||9
10961814|NCT00486278|12135142|FG000|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
10961815|NCT00486278|12135142|FG000|COMPLETED|Overall Study||42
10961816|NCT00486278|12135142|FG000|NOT COMPLETED|Overall Study||9
10961817|NCT00486291|12135158|FG000|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
10961818|NCT00486291|12135159|FG001|STARTED|Overall Study|1 subject discontinued prior to first dose|105
10961819|NCT00486291|12135158|FG000|COMPLETED|Overall Study||89
10961820|NCT00486291|12135159|FG001|COMPLETED|Overall Study||76
10961821|NCT00486291|12135158|FG000|NOT COMPLETED|Overall Study||16
10961822|NCT00486291|12135159|FG001|NOT COMPLETED|Overall Study||29
10961823|NCT00486330|12135165|FG000|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
10961824|NCT00486330|12135165|FG000|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
10961825|NCT00486330|12135165|FG000|NOT COMPLETED|Overall Study||2
10961826|NCT00486434|12135171|FG000|STARTED|Overall Study||588
10961827|NCT00486434|12135172|FG001|STARTED|Overall Study||588
10961828|NCT00486434|12135171|FG000|COMPLETED|Overall Study||394
10961829|NCT00486434|12135172|FG001|COMPLETED|Overall Study||454
10961830|NCT00486434|12135171|FG000|NOT COMPLETED|Overall Study||194
10961831|NCT00486434|12135172|FG001|NOT COMPLETED|Overall Study||134
10961832|NCT00486447|12135179|FG000|STARTED|Overall Study||249
10961833|NCT00486447|12135179|FG000|COMPLETED|Overall Study||249
10961834|NCT00486447|12135179|FG000|NOT COMPLETED|Overall Study||0
10961835|NCT00486525|12135186|FG000|STARTED|Overall Study||100
10961836|NCT00486525|12135187|FG001|STARTED|Overall Study||100
10961837|NCT00486525|12135186|FG000|COMPLETED|Overall Study||94
10961838|NCT00486525|12135187|FG001|COMPLETED|Overall Study||87
10961839|NCT00486525|12135186|FG000|NOT COMPLETED|Overall Study||6
10961840|NCT00486525|12135187|FG001|NOT COMPLETED|Overall Study||13
10961841|NCT00486603|12135195|FG000|STARTED|Overall Study||3
10961842|NCT00486603|12135196|FG001|STARTED|Overall Study||7
10961843|NCT00486603|12135197|FG002|STARTED|Overall Study||3
10961844|NCT00486603|12135198|FG003|STARTED|Overall Study||3
10961845|NCT00486603|12135199|FG004|STARTED|Overall Study||76
10961846|NCT00486603|12135195|FG000|COMPLETED|Overall Study||2
10961847|NCT00486603|12135196|FG001|COMPLETED|Overall Study||6
10961848|NCT00486603|12135197|FG002|COMPLETED|Overall Study||3
10961849|NCT00486603|12135198|FG003|COMPLETED|Overall Study||3
10961850|NCT00486603|12135199|FG004|COMPLETED|Overall Study||76
10961851|NCT00486603|12135195|FG000|NOT COMPLETED|Overall Study||1
10961852|NCT00486603|12135196|FG001|NOT COMPLETED|Overall Study||1
10961853|NCT00486603|12135197|FG002|NOT COMPLETED|Overall Study||0
10961854|NCT00486603|12135198|FG003|NOT COMPLETED|Overall Study||0
10961855|NCT00486603|12135199|FG004|NOT COMPLETED|Overall Study||0
10961856|NCT00486642|12135216|FG000|STARTED|Overall Study||10
10961857|NCT00486642|12135217|FG001|STARTED|Overall Study||13
10961858|NCT00486642|12135216|FG000|COMPLETED|Overall Study||10
10961859|NCT00486642|12135217|FG001|COMPLETED|Overall Study||13
10961860|NCT00486642|12135216|FG000|NOT COMPLETED|Overall Study||0
10961861|NCT00486642|12135217|FG001|NOT COMPLETED|Overall Study||0
10961862|NCT00486720|12135227|FG000|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
10961863|NCT00486720|12135228|FG001|STARTED|Overall Study||12
10961864|NCT00486720|12135227|FG000|COMPLETED|Overall Study||0
10961865|NCT00486720|12135228|FG001|COMPLETED|Overall Study||0
10961866|NCT00486720|12135227|FG000|NOT COMPLETED|Overall Study||10
10961867|NCT00486720|12135228|FG001|NOT COMPLETED|Overall Study||12
10961868|NCT00486759|12135236|FG000|STARTED|Treatment||390
10961869|NCT00486759|12135237|FG001|STARTED|Treatment||397
10961870|NCT00486759|12135236|FG000|COMPLETED|Treatment||203
10961871|NCT00486759|12135237|FG001|COMPLETED|Treatment||260
10961872|NCT00486759|12135236|FG000|NOT COMPLETED|Treatment||187
10961873|NCT00486759|12135237|FG001|NOT COMPLETED|Treatment||137
10961874|NCT00486759|12135236|FG000|STARTED|Safety Follow-up||203
10961875|NCT00486759|12135237|FG001|STARTED|Safety Follow-up||260
10961876|NCT00486759|12135236|FG000|COMPLETED|Safety Follow-up||64
10961877|NCT00486759|12135237|FG001|COMPLETED|Safety Follow-up||142
10961878|NCT00486759|12135236|FG000|NOT COMPLETED|Safety Follow-up||139
10961879|NCT00486759|12135237|FG001|NOT COMPLETED|Safety Follow-up||118
10961880|NCT00486811|12135246|FG000|STARTED|Overall Study||337
10961881|NCT00486811|12135247|FG001|STARTED|Overall Study|One participant was not eligible to be dosed.|320
10961882|NCT00486811|12135248|FG002|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
10961883|NCT00486811|12135246|FG000|COMPLETED|Overall Study||215
10961884|NCT00486811|12135247|FG001|COMPLETED|Overall Study||179
10961885|NCT00486811|12135248|FG002|COMPLETED|Overall Study||119
10961886|NCT00486811|12135246|FG000|NOT COMPLETED|Overall Study||122
10961887|NCT00486811|12135247|FG001|NOT COMPLETED|Overall Study||141
10961888|NCT00486811|12135248|FG002|NOT COMPLETED|Overall Study||214
10961889|NCT00486824|12135258|FG000|STARTED|Overall Study||5
10961890|NCT00486824|12135259|FG001|STARTED|Overall Study||5
10961891|NCT00486824|12135258|FG000|COMPLETED|Overall Study||3
10961892|NCT00486824|12135259|FG001|COMPLETED|Overall Study||3
10961893|NCT00486824|12135258|FG000|NOT COMPLETED|Overall Study||2
10961894|NCT00486824|12135259|FG001|NOT COMPLETED|Overall Study||2
10961895|NCT00486837|12135267|FG000|STARTED|Overall Study||37
10961896|NCT00486837|12135268|FG001|STARTED|Overall Study||35
10961897|NCT00486837|12135267|FG000|COMPLETED|Overall Study||28
10961898|NCT00486837|12135268|FG001|COMPLETED|Overall Study||28
10961899|NCT00486837|12135267|FG000|NOT COMPLETED|Overall Study||9
10961900|NCT00486837|12135268|FG001|NOT COMPLETED|Overall Study||7
10961901|NCT00486863|12135278|FG000|STARTED|Overall Study||184
10961902|NCT00486863|12135279|FG001|STARTED|Overall Study||186
10961903|NCT00486863|12135278|FG000|COMPLETED|Overall Study||183
10961904|NCT00486863|12135279|FG001|COMPLETED|Overall Study||183
10961905|NCT00486863|12135278|FG000|NOT COMPLETED|Overall Study||1
10961906|NCT00486863|12135279|FG001|NOT COMPLETED|Overall Study||3
10961907|NCT00486902|12135288|FG000|STARTED|Overall Study||94
10961908|NCT00486902|12135289|FG001|STARTED|Overall Study||94
10961909|NCT00486902|12135288|FG000|COMPLETED|Overall Study||85
10961910|NCT00486902|12135289|FG001|COMPLETED|Overall Study||89
10961911|NCT00486902|12135288|FG000|NOT COMPLETED|Overall Study||9
10961912|NCT00486902|12135289|FG001|NOT COMPLETED|Overall Study||5
10961913|NCT00486954|12135299|FG000|STARTED|Pilot Part||6
10961914|NCT00486954|12135300|FG001|STARTED|Pilot Part||0
10961915|NCT00486954|12135301|FG002|STARTED|Pilot Part||6
10961916|NCT00486954|12135302|FG003|STARTED|Pilot Part||0
10961917|NCT00486954|12135303|FG004|STARTED|Pilot Part||0
10961918|NCT00486954|12135299|FG000|COMPLETED|Pilot Part||0
10961919|NCT00486954|12135300|FG001|COMPLETED|Pilot Part||0
10961920|NCT00486954|12135301|FG002|COMPLETED|Pilot Part||0
10961921|NCT00486954|12135302|FG003|COMPLETED|Pilot Part||0
10961922|NCT00486954|12135303|FG004|COMPLETED|Pilot Part||0
10961923|NCT00486954|12135299|FG000|NOT COMPLETED|Pilot Part||6
10961924|NCT00486954|12135300|FG001|NOT COMPLETED|Pilot Part||0
10961925|NCT00486954|12135301|FG002|NOT COMPLETED|Pilot Part||6
10961926|NCT00486954|12135302|FG003|NOT COMPLETED|Pilot Part||0
10961927|NCT00486954|12135303|FG004|NOT COMPLETED|Pilot Part||0
10961928|NCT00486954|12135299|FG000|STARTED|Randomized Part||0
10961929|NCT00486954|12135300|FG001|STARTED|Randomized Part||0
10961930|NCT00486954|12135301|FG002|STARTED|Randomized Part||0
10961931|NCT00486954|12135302|FG003|STARTED|Randomized Part||132
10961932|NCT00486954|12135303|FG004|STARTED|Randomized Part||129
10961933|NCT00486954|12135299|FG000|COMPLETED|Randomized Part||0
10961934|NCT00486954|12135300|FG001|COMPLETED|Randomized Part||0
10961935|NCT00486954|12135301|FG002|COMPLETED|Randomized Part||0
10961936|NCT00486954|12135302|FG003|COMPLETED|Randomized Part||112
10961937|NCT00486954|12135303|FG004|COMPLETED|Randomized Part||115
10961938|NCT00486954|12135299|FG000|NOT COMPLETED|Randomized Part||0
10961939|NCT00486954|12135300|FG001|NOT COMPLETED|Randomized Part||0
10961940|NCT00486954|12135301|FG002|NOT COMPLETED|Randomized Part||0
10961941|NCT00486954|12135302|FG003|NOT COMPLETED|Randomized Part||20
10961942|NCT00486954|12135303|FG004|NOT COMPLETED|Randomized Part||14
10961943|NCT00487084|12135316|FG000|STARTED|Overall Study||33
10961944|NCT00487084|12135317|FG001|STARTED|Overall Study||33
10961945|NCT00487084|12135318|FG002|STARTED|Overall Study||33
10961946|NCT00487084|12135316|FG000|COMPLETED|Overall Study||29
10961947|NCT00487084|12135317|FG001|COMPLETED|Overall Study||30
10961948|NCT00487084|12135318|FG002|COMPLETED|Overall Study||28
10961949|NCT00487084|12135316|FG000|NOT COMPLETED|Overall Study||4
10961950|NCT00487084|12135317|FG001|NOT COMPLETED|Overall Study||3
10961951|NCT00487084|12135318|FG002|NOT COMPLETED|Overall Study||5
10961952|NCT00487188|12135328|FG000|STARTED|Induction Phase||31
10961953|NCT00487188|12135329|FG001|STARTED|Induction Phase||16
10961954|NCT00487188|12135330|FG002|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
10961955|NCT00487188|12135328|FG000|Safety Population|Induction Phase||29
10961956|NCT00487188|12135329|FG001|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
10961957|NCT00487188|12135330|FG002|Safety Population|Induction Phase||0
10961958|NCT00487188|12135328|FG000|COMPLETED|Induction Phase||22
10961959|NCT00487188|12135329|FG001|COMPLETED|Induction Phase||9
10961960|NCT00487188|12135330|FG002|COMPLETED|Induction Phase||0
10961961|NCT00487188|12135328|FG000|NOT COMPLETED|Induction Phase||9
10961962|NCT00487188|12135329|FG001|NOT COMPLETED|Induction Phase||7
10961963|NCT00487188|12135330|FG002|NOT COMPLETED|Induction Phase||0
10961964|NCT00487188|12135328|FG000|STARTED|Maintenance Phase||10
10961965|NCT00487188|12135329|FG001|STARTED|Maintenance Phase||8
10961966|NCT00487188|12135330|FG002|STARTED|Maintenance Phase||9
10961967|NCT00487188|12135328|FG000|COMPLETED|Maintenance Phase||7
10961968|NCT00487188|12135329|FG001|COMPLETED|Maintenance Phase||8
10961969|NCT00487188|12135330|FG002|COMPLETED|Maintenance Phase||8
10961970|NCT00487188|12135328|FG000|NOT COMPLETED|Maintenance Phase||3
10961971|NCT00487188|12135329|FG001|NOT COMPLETED|Maintenance Phase||0
10961972|NCT00487188|12135330|FG002|NOT COMPLETED|Maintenance Phase||1
10961973|NCT00487240|12135348|FG000|STARTED|Overall Study||195
10961974|NCT00487240|12135349|FG001|STARTED|Overall Study||192
10961975|NCT00487240|12135348|FG000|Full Analysis Set (ITT Population)|Overall Study||192
10961976|NCT00487240|12135349|FG001|Full Analysis Set (ITT Population)|Overall Study||189
10961977|NCT00487240|12135348|FG000|COMPLETED|Overall Study||164
10961978|NCT00487240|12135349|FG001|COMPLETED|Overall Study||166
10961979|NCT00487240|12135348|FG000|NOT COMPLETED|Overall Study||31
10961980|NCT00487240|12135349|FG001|NOT COMPLETED|Overall Study||26
10961981|NCT00487279|12135357|FG000|STARTED|Overall Study||44
10961982|NCT00487279|12135358|FG001|STARTED|Overall Study||37
10961983|NCT00487279|12135357|FG000|COMPLETED|Overall Study||43
10961984|NCT00487279|12135358|FG001|COMPLETED|Overall Study||35
10961985|NCT00487279|12135357|FG000|NOT COMPLETED|Overall Study||1
10961986|NCT00487279|12135358|FG001|NOT COMPLETED|Overall Study||2
10961987|NCT00487396|12135364|FG000|STARTED|Overall Study||98
10961988|NCT00487396|12135364|FG000|COMPLETED|Overall Study||95
10961989|NCT00487396|12135364|FG000|NOT COMPLETED|Overall Study||3
10961990|NCT00487435|12135373|FG000|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
10961991|NCT00487435|12135373|FG000|COMPLETED|Overall Study||669
10961992|NCT00487435|12135373|FG000|NOT COMPLETED|Overall Study||485
10961993|NCT00487539|12135381|FG000|STARTED|Overall Study||331
10961994|NCT00487539|12135382|FG001|STARTED|Overall Study||72
10961995|NCT00487539|12135383|FG002|STARTED|Overall Study||331
10961996|NCT00487539|12135384|FG003|STARTED|Overall Study||331
10961997|NCT00487539|12135381|FG000|COMPLETED|Overall Study||324
10961998|NCT00487539|12135382|FG001|COMPLETED|Overall Study||69
10961999|NCT00487539|12135383|FG002|COMPLETED|Overall Study||328
10962000|NCT00487539|12135384|FG003|COMPLETED|Overall Study||327
10962001|NCT00487539|12135381|FG000|NOT COMPLETED|Overall Study||7
10962002|NCT00487539|12135382|FG001|NOT COMPLETED|Overall Study||3
10962003|NCT00487539|12135383|FG002|NOT COMPLETED|Overall Study||3
10962004|NCT00487539|12135384|FG003|NOT COMPLETED|Overall Study||4
10962005|NCT00487552|12135393|FG000|STARTED|Overall Study||18
10962006|NCT00487552|12135393|FG000|COMPLETED|Overall Study||12
10962007|NCT00487552|12135393|FG000|NOT COMPLETED|Overall Study||6
10962008|NCT00487565|12135398|FG000|STARTED|Overall Study||210
10962009|NCT00487565|12135398|FG000|COMPLETED|Overall Study||182
10962010|NCT00487565|12135398|FG000|NOT COMPLETED|Overall Study||28
10962011|NCT00487669|12135402|FG000|STARTED|Overall Study||12
10962012|NCT00487669|12135402|FG000|COMPLETED|Overall Study||12
10962013|NCT00487669|12135402|FG000|NOT COMPLETED|Overall Study||0
10962014|NCT00487695|12135408|FG000|STARTED|First Procedure||23
10962015|NCT00487695|12135409|FG001|STARTED|First Procedure||23
10962016|NCT00487695|12135408|FG000|COMPLETED|First Procedure||20
10962017|NCT00487695|12135409|FG001|COMPLETED|First Procedure||23
10962018|NCT00487695|12135408|FG000|NOT COMPLETED|First Procedure||3
10962019|NCT00487695|12135409|FG001|NOT COMPLETED|First Procedure||0
10962020|NCT00487695|12135408|FG000|STARTED|Second Procedure||20
10962021|NCT00487695|12135409|FG001|STARTED|Second Procedure||23
10962022|NCT00487695|12135408|FG000|COMPLETED|Second Procedure||19
10962023|NCT00487695|12135409|FG001|COMPLETED|Second Procedure||20
10962024|NCT00487695|12135408|FG000|NOT COMPLETED|Second Procedure||1
10962025|NCT00487695|12135409|FG001|NOT COMPLETED|Second Procedure||3
10962026|NCT00487721|12135417|FG000|STARTED|Overall Study||6
10962027|NCT00487721|12135418|FG001|STARTED|Overall Study||6
10962028|NCT00487721|12135417|FG000|COMPLETED|Overall Study||6
10962029|NCT00487721|12135418|FG001|COMPLETED|Overall Study||6
10962030|NCT00487721|12135417|FG000|NOT COMPLETED|Overall Study||0
10962031|NCT00487721|12135418|FG001|NOT COMPLETED|Overall Study||0
10962032|NCT00487747|12135423|FG000|STARTED|Overall Study||18
10962033|NCT00487747|12135423|FG000|COMPLETED|Overall Study||7
10962034|NCT00487747|12135423|FG000|NOT COMPLETED|Overall Study||11
10962035|NCT00487825|12135429|FG000|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
10962036|NCT00487825|12135430|FG001|STARTED|Overall Study||26
10962037|NCT00487825|12135429|FG000|COMPLETED|Overall Study||46
10962038|NCT00487825|12135430|FG001|COMPLETED|Overall Study||21
10962039|NCT00487825|12135429|FG000|NOT COMPLETED|Overall Study||6
10962040|NCT00487825|12135430|FG001|NOT COMPLETED|Overall Study||5
10962041|NCT00487942|12135440|FG000|STARTED|Overall Study||15
10962042|NCT00487942|12135441|FG001|STARTED|Overall Study||15
10962043|NCT00487942|12135442|FG002|STARTED|Overall Study||15
10962044|NCT00487942|12135443|FG003|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
10962045|NCT00487942|12135440|FG000|COMPLETED|Overall Study||12
10962046|NCT00487942|12135441|FG001|COMPLETED|Overall Study||12
10962047|NCT00487942|12135442|FG002|COMPLETED|Overall Study||12
10962048|NCT00487942|12135443|FG003|COMPLETED|Overall Study||13
10962049|NCT00487942|12135440|FG000|NOT COMPLETED|Overall Study||3
10962050|NCT00487942|12135441|FG001|NOT COMPLETED|Overall Study||3
10962051|NCT00487942|12135442|FG002|NOT COMPLETED|Overall Study||3
10962052|NCT00487942|12135443|FG003|NOT COMPLETED|Overall Study||2
10962053|NCT00488033|12135455|FG000|STARTED|Overall Study||448
10962054|NCT00488033|12135456|FG001|STARTED|Overall Study||452
10962055|NCT00488033|12135455|FG000|COMPLETED|Overall Study||447
10962056|NCT00488033|12135456|FG001|COMPLETED|Overall Study||452
10962057|NCT00488033|12135455|FG000|NOT COMPLETED|Overall Study||1
10962058|NCT00488033|12135456|FG001|NOT COMPLETED|Overall Study||0
10962059|NCT00488059|12135462|FG000|STARTED|Phase I: ENF 90mg SC BID||29
10962060|NCT00488059|12135463|FG001|STARTED|Phase I: ENF 90mg SC BID||0
10962061|NCT00488059|12135464|FG002|STARTED|Phase I: ENF 90mg SC BID||0
10962062|NCT00488059|12135462|FG000|COMPLETED|Phase I: ENF 90mg SC BID||14
10962063|NCT00488059|12135463|FG001|COMPLETED|Phase I: ENF 90mg SC BID||0
10962064|NCT00488059|12135464|FG002|COMPLETED|Phase I: ENF 90mg SC BID||0
10962065|NCT00488059|12135462|FG000|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
10962066|NCT00488059|12135463|FG001|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
10962067|NCT00488059|12135464|FG002|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
10962068|NCT00488059|12135462|FG000|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
10962069|NCT00488059|12135463|FG001|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
10962070|NCT00488059|12135464|FG002|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
10962071|NCT00488059|12135462|FG000|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
10962072|NCT00488059|12135463|FG001|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
10962073|NCT00488059|12135464|FG002|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
10962074|NCT00488059|12135462|FG000|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
10962075|NCT00488059|12135463|FG001|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
10962076|NCT00488059|12135464|FG002|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
10962077|NCT00488059|12135462|FG000|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
10962078|NCT00488059|12135463|FG001|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
10962079|NCT00488059|12135464|FG002|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
10962080|NCT00488059|12135462|FG000|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
10962081|NCT00488059|12135463|FG001|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
10962082|NCT00488059|12135464|FG002|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
10962083|NCT00488059|12135462|FG000|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
10962084|NCT00488059|12135463|FG001|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
10962085|NCT00488059|12135464|FG002|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
10962086|NCT00488293|12135479|FG000|STARTED|Overall Study||196
10962087|NCT00488293|12135480|FG001|STARTED|Overall Study||196
10962088|NCT00488293|12135479|FG000|COMPLETED|Overall Study||160
10962089|NCT00488293|12135480|FG001|COMPLETED|Overall Study||166
10962090|NCT00488293|12135479|FG000|NOT COMPLETED|Overall Study||36
10962091|NCT00488293|12135480|FG001|NOT COMPLETED|Overall Study||30
10962092|NCT00488319|12135489|FG000|STARTED|Overall Study||39
10962093|NCT00488319|12135490|FG001|STARTED|Overall Study||118
10962094|NCT00488319|12135491|FG002|STARTED|Overall Study||243
10962095|NCT00488319|12135489|FG000|COMPLETED|Overall Study||24
10962096|NCT00488319|12135490|FG001|COMPLETED|Overall Study||75
10962097|NCT00488319|12135491|FG002|COMPLETED|Overall Study||121
10962098|NCT00488319|12135489|FG000|NOT COMPLETED|Overall Study||15
10962099|NCT00488319|12135490|FG001|NOT COMPLETED|Overall Study||43
10962100|NCT00488319|12135491|FG002|NOT COMPLETED|Overall Study||122
10962101|NCT00488345|12135503|FG000|STARTED|Overall Study||17
10962102|NCT00488345|12135504|FG001|STARTED|Overall Study||21
10962103|NCT00488345|12135505|FG002|STARTED|Overall Study||20
10962104|NCT00488345|12135503|FG000|COMPLETED|Overall Study||17
10962105|NCT00488345|12135504|FG001|COMPLETED|Overall Study||17
10962106|NCT00488345|12135505|FG002|COMPLETED|Overall Study||17
10962107|NCT00488345|12135503|FG000|NOT COMPLETED|Overall Study||0
10962108|NCT00488345|12135504|FG001|NOT COMPLETED|Overall Study||4
10962109|NCT00488345|12135505|FG002|NOT COMPLETED|Overall Study||3
10962110|NCT00488475|12135514|FG000|STARTED|Overall Study||4945
10962111|NCT00488475|12135514|FG000|COMPLETED|Overall Study||3191
10962112|NCT00488475|12135514|FG000|NOT COMPLETED|Overall Study||1754
10962113|NCT00488488|12135518|FG000|STARTED|Overall Study||1028
10962114|NCT00488488|12135518|FG000|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
10962115|NCT00488488|12135518|FG000|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
10962116|NCT00488488|12135518|FG000|NOT COMPLETED|Overall Study||268
10962117|NCT00488514|12135522|FG000|STARTED|Overall Study||656
10962118|NCT00488514|12135522|FG000|COMPLETED|Overall Study||363
10962119|NCT00488514|12135522|FG000|NOT COMPLETED|Overall Study||293
10962120|NCT00488592|12135543|FG000|STARTED|Overall Study|10 subjects were accrued|10
10962121|NCT00488592|12135543|FG000|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
10962122|NCT00488592|12135543|FG000|NOT COMPLETED|Overall Study||3
10962123|NCT00488618|12135549|FG000|STARTED|Overall Study||120
10962124|NCT00488618|12135550|FG001|STARTED|Overall Study||118
10962125|NCT00488618|12135549|FG000|Safety Population: Received Study Drug|Overall Study||118
10962126|NCT00488618|12135550|FG001|Safety Population: Received Study Drug|Overall Study||118
10962127|NCT00488618|12135549|FG000|COMPLETED|Overall Study||73
10962128|NCT00488618|12135550|FG001|COMPLETED|Overall Study||75
10962129|NCT00488618|12135549|FG000|NOT COMPLETED|Overall Study||47
10962130|NCT00488618|12135550|FG001|NOT COMPLETED|Overall Study||43
10962131|NCT00488631|12135562|FG000|STARTED|Double Blind Period (Week 0-54)||156
10962132|NCT00488631|12135563|FG001|STARTED|Double Blind Period (Week 0-54)||154
10962133|NCT00488631|12135564|FG002|STARTED|Double Blind Period (Week 0-54)||154
10962134|NCT00488631|12135565|FG003|STARTED|Double Blind Period (Week 0-54)||129
10962135|NCT00488631|12135566|FG004|STARTED|Double Blind Period (Week 0-54)||230
10962136|NCT00488631|12135567|FG005|STARTED|Double Blind Period (Week 0-54)||405
10962137|NCT00488631|12135568|FG006|STARTED|Double Blind Period (Week 0-54)||0
10962138|NCT00488631|12135569|FG007|STARTED|Double Blind Period (Week 0-54)||0
10962139|NCT00488631|12135570|FG008|STARTED|Double Blind Period (Week 0-54)||0
10962140|NCT00488631|12135571|FG009|STARTED|Double Blind Period (Week 0-54)||0
10962141|NCT00488631|12135562|FG000|COMPLETED|Double Blind Period (Week 0-54)||113
10962142|NCT00488631|12135563|FG001|COMPLETED|Double Blind Period (Week 0-54)||111
10962143|NCT00488631|12135564|FG002|COMPLETED|Double Blind Period (Week 0-54)||109
10962144|NCT00488631|12135565|FG003|COMPLETED|Double Blind Period (Week 0-54)||88
10962145|NCT00488631|12135566|FG004|COMPLETED|Double Blind Period (Week 0-54)||127
10962146|NCT00488631|12135567|FG005|COMPLETED|Double Blind Period (Week 0-54)||189
10962147|NCT00488631|12135568|FG006|COMPLETED|Double Blind Period (Week 0-54)||0
10962148|NCT00488631|12135569|FG007|COMPLETED|Double Blind Period (Week 0-54)||0
10962149|NCT00488631|12135570|FG008|COMPLETED|Double Blind Period (Week 0-54)||0
10962150|NCT00488631|12135571|FG009|COMPLETED|Double Blind Period (Week 0-54)||0
10962151|NCT00488631|12135562|FG000|NOT COMPLETED|Double Blind Period (Week 0-54)||43
10962152|NCT00488631|12135563|FG001|NOT COMPLETED|Double Blind Period (Week 0-54)||43
10962153|NCT00488631|12135564|FG002|NOT COMPLETED|Double Blind Period (Week 0-54)||45
10962154|NCT00488631|12135565|FG003|NOT COMPLETED|Double Blind Period (Week 0-54)||41
10962155|NCT00488631|12135566|FG004|NOT COMPLETED|Double Blind Period (Week 0-54)||103
10962156|NCT00488631|12135567|FG005|NOT COMPLETED|Double Blind Period (Week 0-54)||216
10962157|NCT00488631|12135568|FG006|NOT COMPLETED|Double Blind Period (Week 0-54)||0
10962158|NCT00488631|12135569|FG007|NOT COMPLETED|Double Blind Period (Week 0-54)||0
10962159|NCT00488631|12135570|FG008|NOT COMPLETED|Double Blind Period (Week 0-54)||0
10962160|NCT00488631|12135571|FG009|NOT COMPLETED|Double Blind Period (Week 0-54)||0
10962161|NCT00488631|12135562|FG000|STARTED|Open Label Study Extension (Week 54-228)||0
10962162|NCT00488631|12135563|FG001|STARTED|Open Label Study Extension (Week 54-228)||0
10962163|NCT00488631|12135564|FG002|STARTED|Open Label Study Extension (Week 54-228)||0
10962164|NCT00488631|12135565|FG003|STARTED|Open Label Study Extension (Week 54-228)||0
10962165|NCT00488631|12135566|FG004|STARTED|Open Label Study Extension (Week 54-228)||0
10962166|NCT00488631|12135567|FG005|STARTED|Open Label Study Extension (Week 54-228)||0
10962167|NCT00488631|12135568|FG006|STARTED|Open Label Study Extension (Week 54-228)||96
10962168|NCT00488631|12135569|FG007|STARTED|Open Label Study Extension (Week 54-228)||93
10962169|NCT00488631|12135570|FG008|STARTED|Open Label Study Extension (Week 54-228)||470
10962170|NCT00488631|12135571|FG009|STARTED|Open Label Study Extension (Week 54-228)||7
10962171|NCT00488631|12135562|FG000|COMPLETED|Open Label Study Extension (Week 54-228)||0
10962172|NCT00488631|12135563|FG001|COMPLETED|Open Label Study Extension (Week 54-228)||0
10962173|NCT00488631|12135564|FG002|COMPLETED|Open Label Study Extension (Week 54-228)||0
10962174|NCT00488631|12135565|FG003|COMPLETED|Open Label Study Extension (Week 54-228)||0
10962175|NCT00488631|12135566|FG004|COMPLETED|Open Label Study Extension (Week 54-228)||0
10962176|NCT00488631|12135567|FG005|COMPLETED|Open Label Study Extension (Week 54-228)||0
10962177|NCT00488631|12135568|FG006|COMPLETED|Open Label Study Extension (Week 54-228)||16
10962178|NCT00488631|12135569|FG007|COMPLETED|Open Label Study Extension (Week 54-228)||66
10962179|NCT00488631|12135570|FG008|COMPLETED|Open Label Study Extension (Week 54-228)||288
10962180|NCT00488631|12135571|FG009|COMPLETED|Open Label Study Extension (Week 54-228)||4
10962181|NCT00488631|12135562|FG000|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
10962182|NCT00488631|12135563|FG001|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
10962183|NCT00488631|12135564|FG002|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
10962184|NCT00488631|12135565|FG003|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
10962185|NCT00488631|12135566|FG004|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
10962186|NCT00488631|12135567|FG005|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
10962187|NCT00488631|12135568|FG006|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
10962188|NCT00488631|12135569|FG007|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
10962189|NCT00488631|12135570|FG008|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
10962190|NCT00488631|12135571|FG009|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
10962191|NCT00488644|12135594|FG000|STARTED|Overall Study||12
10962192|NCT00488644|12135594|FG000|COMPLETED|Overall Study||10
10962193|NCT00488644|12135594|FG000|NOT COMPLETED|Overall Study||2
10962194|NCT00488683|12135601|FG000|STARTED|Overall Study||108
10962195|NCT00488683|12135602|FG001|STARTED|Overall Study||54
10962196|NCT00488683|12135603|FG002|STARTED|Overall Study||54
10962197|NCT00488683|12135601|FG000|COMPLETED|Overall Study||96
10962198|NCT00488683|12135602|FG001|COMPLETED|Overall Study||48
10962199|NCT00488683|12135603|FG002|COMPLETED|Overall Study||52
10962200|NCT00488683|12135601|FG000|NOT COMPLETED|Overall Study||12
10962201|NCT00488683|12135602|FG001|NOT COMPLETED|Overall Study||6
10962202|NCT00488683|12135603|FG002|NOT COMPLETED|Overall Study||2
10962203|NCT00488774|12135619|FG000|STARTED|Overall Study||77
10962204|NCT00488774|12135620|FG001|STARTED|Overall Study||62
10962205|NCT00488774|12135621|FG002|STARTED|Overall Study||75
10962206|NCT00488774|12135622|FG003|STARTED|Overall Study||77
10962207|NCT00488774|12135619|FG000|COMPLETED|Overall Study||69
10962208|NCT00488774|12135620|FG001|COMPLETED|Overall Study||57
10962209|NCT00488774|12135621|FG002|COMPLETED|Overall Study||70
10962210|NCT00488774|12135622|FG003|COMPLETED|Overall Study||74
10962211|NCT00488774|12135619|FG000|NOT COMPLETED|Overall Study||8
10962212|NCT00488774|12135620|FG001|NOT COMPLETED|Overall Study||5
10962213|NCT00488774|12135621|FG002|NOT COMPLETED|Overall Study||5
10962214|NCT00488774|12135622|FG003|NOT COMPLETED|Overall Study||3
10962215|NCT00488826|12135636|FG000|STARTED|Overall Study||300
10962216|NCT00488826|12135637|FG001|STARTED|Overall Study||296
10962217|NCT00488826|12135638|FG002|STARTED|Overall Study||204
10962218|NCT00488826|12135636|FG000|COMPLETED|Overall Study||244
10962219|NCT00488826|12135637|FG001|COMPLETED|Overall Study||244
10962220|NCT00488826|12135638|FG002|COMPLETED|Overall Study||178
10962221|NCT00488826|12135636|FG000|NOT COMPLETED|Overall Study||56
10962222|NCT00488826|12135637|FG001|NOT COMPLETED|Overall Study||52
10962223|NCT00488826|12135638|FG002|NOT COMPLETED|Overall Study||26
10962224|NCT00488865|12135646|FG000|STARTED|Overall Study||100
10962225|NCT00488865|12135646|FG000|COMPLETED|Overall Study||100
10962226|NCT00488865|12135646|FG000|NOT COMPLETED|Overall Study||0
10962227|NCT00488982|12135650|FG000|STARTED|Induction Chemotherapy||125
10962228|NCT00488982|12135651|FG001|STARTED|Induction Chemotherapy||0
10962229|NCT00488982|12135652|FG002|STARTED|Induction Chemotherapy||0
10962230|NCT00488982|12135650|FG000|6 Cycles Completed|Induction Chemotherapy||94
10962231|NCT00488982|12135651|FG001|6 Cycles Completed|Induction Chemotherapy||0
10962232|NCT00488982|12135652|FG002|6 Cycles Completed|Induction Chemotherapy||0
10962233|NCT00488982|12135650|FG000|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52
10962234|NCT00488982|12135651|FG001|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
10962235|NCT00488982|12135652|FG002|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
10962236|NCT00488982|12135650|FG000|COMPLETED|Induction Chemotherapy||52
10962237|NCT00488982|12135651|FG001|COMPLETED|Induction Chemotherapy||0
10962238|NCT00488982|12135652|FG002|COMPLETED|Induction Chemotherapy||0
10962239|NCT00488982|12135650|FG000|NOT COMPLETED|Induction Chemotherapy||73
10962240|NCT00488982|12135651|FG001|NOT COMPLETED|Induction Chemotherapy||0
10962241|NCT00488982|12135652|FG002|NOT COMPLETED|Induction Chemotherapy||0
10962242|NCT00488982|12135650|FG000|STARTED|Course 1||0
10962243|NCT00488982|12135651|FG001|STARTED|Course 1||25
10962244|NCT00488982|12135652|FG002|STARTED|Course 1||27
10962245|NCT00488982|12135650|FG000|COMPLETED|Course 1||0
10962246|NCT00488982|12135651|FG001|COMPLETED|Course 1||13
10962247|NCT00488982|12135652|FG002|COMPLETED|Course 1||13
10962248|NCT00488982|12135650|FG000|NOT COMPLETED|Course 1||0
10962249|NCT00488982|12135651|FG001|NOT COMPLETED|Course 1||12
10962250|NCT00488982|12135652|FG002|NOT COMPLETED|Course 1||14
10962251|NCT00488982|12135650|FG000|STARTED|Course 2||0
10962252|NCT00488982|12135651|FG001|STARTED|Course 2||13
10962253|NCT00488982|12135652|FG002|STARTED|Course 2||13
10962254|NCT00488982|12135650|FG000|COMPLETED|Course 2||0
10962255|NCT00488982|12135651|FG001|COMPLETED|Course 2||4
10962256|NCT00488982|12135652|FG002|COMPLETED|Course 2||8
10962257|NCT00488982|12135650|FG000|NOT COMPLETED|Course 2||0
10962258|NCT00488982|12135651|FG001|NOT COMPLETED|Course 2||9
10962259|NCT00488982|12135652|FG002|NOT COMPLETED|Course 2||5
10962260|NCT00488982|12135650|FG000|STARTED|Course 3||0
10962261|NCT00488982|12135651|FG001|STARTED|Course 3||4
10962262|NCT00488982|12135652|FG002|STARTED|Course 3||8
10962263|NCT00488982|12135650|FG000|COMPLETED|Course 3||0
10962264|NCT00488982|12135651|FG001|COMPLETED|Course 3||2
10962265|NCT00488982|12135652|FG002|COMPLETED|Course 3||3
10962266|NCT00488982|12135650|FG000|NOT COMPLETED|Course 3||0
10962267|NCT00488982|12135651|FG001|NOT COMPLETED|Course 3||2
10962268|NCT00488982|12135652|FG002|NOT COMPLETED|Course 3||5
10962269|NCT00488982|12135650|FG000|STARTED|Response to Course 3||0
10962270|NCT00488982|12135651|FG001|STARTED|Response to Course 3||2
10962271|NCT00488982|12135652|FG002|STARTED|Response to Course 3||3
10962272|NCT00488982|12135650|FG000|COMPLETED|Response to Course 3||0
10962273|NCT00488982|12135651|FG001|COMPLETED|Response to Course 3||1
10962274|NCT00488982|12135652|FG002|COMPLETED|Response to Course 3||0
10962275|NCT00488982|12135650|FG000|NOT COMPLETED|Response to Course 3||0
10962276|NCT00488982|12135651|FG001|NOT COMPLETED|Response to Course 3||1
10962277|NCT00488982|12135652|FG002|NOT COMPLETED|Response to Course 3||3
10962278|NCT00489086|12135666|FG000|STARTED|Overall Study||36
10962279|NCT00489086|12135666|FG000|Completed 18 Months|Overall Study||23
10962280|NCT00489086|12135666|FG000|COMPLETED|Overall Study||13
10962281|NCT00489086|12135666|FG000|NOT COMPLETED|Overall Study||23
10962282|NCT00489216|12135670|FG000|STARTED|Overall Study||2
10962283|NCT00489216|12135670|FG000|COMPLETED|Overall Study||1
10962284|NCT00489216|12135670|FG000|NOT COMPLETED|Overall Study||1
10962285|NCT00489255|12135676|FG000|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
10962286|NCT00489255|12135677|FG001|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
10962287|NCT00489255|12135676|FG000|COMPLETED|Screening and Initial Randomization||136
10962288|NCT00489255|12135677|FG001|COMPLETED|Screening and Initial Randomization||46
10962289|NCT00489255|12135676|FG000|NOT COMPLETED|Screening and Initial Randomization||9
10962290|NCT00489255|12135677|FG001|NOT COMPLETED|Screening and Initial Randomization||3
10962291|NCT00489255|12135676|FG000|STARTED|Period 1: Days 1 to 28||136
10962292|NCT00489255|12135677|FG001|STARTED|Period 1: Days 1 to 28||46
10962293|NCT00489255|12135676|FG000|Completed and Follow Period 2|Period 1: Days 1 to 28||94
10962294|NCT00489255|12135677|FG001|Completed and Follow Period 2|Period 1: Days 1 to 28||29
10962295|NCT00489255|12135676|FG000|Completed But Discontinued Study|Period 1: Days 1 to 28||13
10962296|NCT00489255|12135677|FG001|Completed But Discontinued Study|Period 1: Days 1 to 28||5
10962297|NCT00489255|12135676|FG000|COMPLETED|Period 1: Days 1 to 28||107
10962298|NCT00489255|12135677|FG001|COMPLETED|Period 1: Days 1 to 28||34
10962299|NCT00489255|12135676|FG000|NOT COMPLETED|Period 1: Days 1 to 28||29
10962300|NCT00489255|12135677|FG001|NOT COMPLETED|Period 1: Days 1 to 28||12
10962301|NCT00489255|12135676|FG000|STARTED|Period 2: Days 29 to 56||64
10962302|NCT00489255|12135677|FG001|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
10962303|NCT00489255|12135676|FG000|Completed and Follow Period 3|Period 2: Days 29 to 56||58
10962304|NCT00489255|12135677|FG001|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
10962305|NCT00489255|12135676|FG000|Completed But Discontinued Study|Period 2: Days 29 to 56||3
10962306|NCT00489255|12135677|FG001|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
10962307|NCT00489255|12135676|FG000|COMPLETED|Period 2: Days 29 to 56||61
10962308|NCT00489255|12135677|FG001|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
10962309|NCT00489255|12135676|FG000|NOT COMPLETED|Period 2: Days 29 to 56||3
10962310|NCT00489255|12135677|FG001|NOT COMPLETED|Period 2: Days 29 to 56||4
10962311|NCT00489255|12135676|FG000|STARTED|Period 3: Days 57 to 84||28
10962312|NCT00489255|12135677|FG001|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
10962313|NCT00489255|12135676|FG000|COMPLETED|Period 3: Days 57 to 84||24
10962314|NCT00489255|12135677|FG001|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
10962315|NCT00489255|12135676|FG000|NOT COMPLETED|Period 3: Days 57 to 84||4
10962316|NCT00489255|12135677|FG001|NOT COMPLETED|Period 3: Days 57 to 84||4
10962317|NCT00489268|12135688|FG000|STARTED|Overall Study||1
10962318|NCT00489268|12135689|FG001|STARTED|Overall Study||10
10962319|NCT00489268|12135690|FG002|STARTED|Overall Study||10
10962320|NCT00489268|12135691|FG003|STARTED|Overall Study||11
10962321|NCT00489268|12135692|FG004|STARTED|Overall Study||70
10962322|NCT00489268|12135688|FG000|COMPLETED|Overall Study||1
10962323|NCT00489268|12135689|FG001|COMPLETED|Overall Study||10
10962324|NCT00489268|12135690|FG002|COMPLETED|Overall Study||9
10962325|NCT00489268|12135691|FG003|COMPLETED|Overall Study||11
10962326|NCT00489268|12135692|FG004|COMPLETED|Overall Study||50
10962327|NCT00489268|12135688|FG000|NOT COMPLETED|Overall Study||0
10962328|NCT00489268|12135689|FG001|NOT COMPLETED|Overall Study||0
10962329|NCT00489268|12135690|FG002|NOT COMPLETED|Overall Study||1
10962330|NCT00489268|12135691|FG003|NOT COMPLETED|Overall Study||0
10962331|NCT00489268|12135692|FG004|NOT COMPLETED|Overall Study||20
10962332|NCT00489281|12135706|FG000|STARTED|Overall Study||29
10962333|NCT00489281|12135707|FG001|STARTED|Overall Study||13
10962334|NCT00489281|12135706|FG000|COMPLETED|Overall Study||29
10962335|NCT00489281|12135707|FG001|COMPLETED|Overall Study||13
10962336|NCT00489281|12135706|FG000|NOT COMPLETED|Overall Study||0
10962337|NCT00489281|12135707|FG001|NOT COMPLETED|Overall Study||0
10962338|NCT00489359|12135715|FG000|STARTED|Overall Study||20
10962339|NCT00489359|12135716|FG001|STARTED|Overall Study||66
10962340|NCT00489359|12135715|FG000|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
10962341|NCT00489359|12135716|FG001|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
10962342|NCT00489359|12135715|FG000|NOT COMPLETED|Overall Study||7
10962343|NCT00489359|12135716|FG001|NOT COMPLETED|Overall Study||29
10962344|NCT00489411|12135729|FG000|STARTED|Initial Treatment Period (Weeks 1-5)||115
10962345|NCT00489411|12135730|FG001|STARTED|Initial Treatment Period (Weeks 1-5)||116
10962346|NCT00489411|12135729|FG000|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
10962347|NCT00489411|12135730|FG001|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
10962348|NCT00489411|12135729|FG000|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
10962349|NCT00489411|12135730|FG001|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
10962350|NCT00489411|12135729|FG000|STARTED|Washout Period (Weeks 6-7)||87
10962351|NCT00489411|12135730|FG001|STARTED|Washout Period (Weeks 6-7)||94
10962352|NCT00489411|12135729|FG000|COMPLETED|Washout Period (Weeks 6-7)||85
10962353|NCT00489411|12135730|FG001|COMPLETED|Washout Period (Weeks 6-7)||93
10962354|NCT00489411|12135729|FG000|NOT COMPLETED|Washout Period (Weeks 6-7)||2
10962355|NCT00489411|12135730|FG001|NOT COMPLETED|Washout Period (Weeks 6-7)||1
10962356|NCT00489411|12135729|FG000|STARTED|Crossover Treatment Period (Weeks 8-12)||85
10962357|NCT00489411|12135730|FG001|STARTED|Crossover Treatment Period (Weeks 8-12)||93
10962358|NCT00489411|12135729|FG000|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
10962359|NCT00489411|12135730|FG001|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
10962360|NCT00489411|12135729|FG000|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
10962361|NCT00489411|12135730|FG001|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
10962362|NCT00489424|12135739|FG000|STARTED|Overall Study||267
10962363|NCT00489424|12135740|FG001|STARTED|Overall Study||264
10962364|NCT00489424|12135741|FG002|STARTED|Overall Study||262
10962365|NCT00489424|12135739|FG000|COMPLETED|Overall Study||263
10962366|NCT00489424|12135740|FG001|COMPLETED|Overall Study||259
10962367|NCT00489424|12135741|FG002|COMPLETED|Overall Study||257
10962368|NCT00489424|12135739|FG000|NOT COMPLETED|Overall Study||4
10962369|NCT00489424|12135740|FG001|NOT COMPLETED|Overall Study||5
10962370|NCT00489424|12135741|FG002|NOT COMPLETED|Overall Study||5
10962371|NCT00489476|12135753|FG000|STARTED|Overall Study||39
10962372|NCT00489476|12135754|FG001|STARTED|Overall Study||43
10962373|NCT00489476|12135755|FG002|STARTED|Overall Study||43
10962374|NCT00489476|12135756|FG003|STARTED|Overall Study||43
10962375|NCT00489476|12135753|FG000|COMPLETED|Overall Study||39
10962376|NCT00489476|12135754|FG001|COMPLETED|Overall Study||42
10962377|NCT00489476|12135755|FG002|COMPLETED|Overall Study||43
10962378|NCT00489476|12135756|FG003|COMPLETED|Overall Study||43
10962379|NCT00489476|12135753|FG000|NOT COMPLETED|Overall Study||0
10962380|NCT00489476|12135754|FG001|NOT COMPLETED|Overall Study||1
10962381|NCT00489476|12135755|FG002|NOT COMPLETED|Overall Study||0
10962382|NCT00489476|12135756|FG003|NOT COMPLETED|Overall Study||0
10962383|NCT00489489|12135769|FG000|STARTED|Overall Study|randomized|41
10962384|NCT00489489|12135770|FG001|STARTED|Overall Study|randomized|37
10962385|NCT00489489|12135771|FG002|STARTED|Overall Study|randomized|40
10962386|NCT00489489|12135769|FG000|Treated|Overall Study||41
10962387|NCT00489489|12135770|FG001|Treated|Overall Study||36
10962388|NCT00489489|12135771|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
10962389|NCT00489489|12135769|FG000|COMPLETED|Overall Study|completed treatment period|38
10962390|NCT00489489|12135770|FG001|COMPLETED|Overall Study|completed treatment period|32
10962391|NCT00489489|12135771|FG002|COMPLETED|Overall Study|completed treatment period|37
10962392|NCT00489489|12135769|FG000|NOT COMPLETED|Overall Study||3
10962393|NCT00489489|12135770|FG001|NOT COMPLETED|Overall Study||5
10962394|NCT00489489|12135771|FG002|NOT COMPLETED|Overall Study||3
10962395|NCT00489541|12135783|FG000|STARTED|12-Month Clinical Follow-up||224
10962396|NCT00489541|12135784|FG001|STARTED|12-Month Clinical Follow-up||125
10962397|NCT00489541|12135783|FG000|COMPLETED|12-Month Clinical Follow-up||215
10962398|NCT00489541|12135784|FG001|COMPLETED|12-Month Clinical Follow-up||120
10962399|NCT00489541|12135783|FG000|NOT COMPLETED|12-Month Clinical Follow-up||9
10962400|NCT00489541|12135784|FG001|NOT COMPLETED|12-Month Clinical Follow-up||5
10962401|NCT00489541|12135783|FG000|STARTED|9-Month Angiographic Follow-up||224
10962402|NCT00489541|12135784|FG001|STARTED|9-Month Angiographic Follow-up||125
10962403|NCT00489541|12135783|FG000|COMPLETED|9-Month Angiographic Follow-up||197
10962404|NCT00489541|12135784|FG001|COMPLETED|9-Month Angiographic Follow-up||108
10962405|NCT00489541|12135783|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||27
10962406|NCT00489541|12135784|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||17
10962407|NCT00489554|12135790|FG000|STARTED|Overall Study||230
10962408|NCT00489554|12135790|FG000|COMPLETED|Overall Study||226
10962409|NCT00489554|12135790|FG000|NOT COMPLETED|Overall Study||4
10962410|NCT00489736|12135796|FG000|STARTED|Overall Study|Randomized and treated patients|249
10962411|NCT00489736|12135797|FG001|STARTED|Overall Study|Randomized and treated patients|255
10962412|NCT00489736|12135796|FG000|COMPLETED|Overall Study|completed study drug period|153
10962413|NCT00489736|12135797|FG001|COMPLETED|Overall Study|completed study drug period|186
10962414|NCT00489736|12135796|FG000|NOT COMPLETED|Overall Study||96
10962415|NCT00489736|12135797|FG001|NOT COMPLETED|Overall Study||69
10962416|NCT00489853|12135803|FG000|STARTED|Treatment Period 1||36
10962417|NCT00489853|12135804|FG001|STARTED|Treatment Period 1||37
10962418|NCT00489853|12135805|FG002|STARTED|Treatment Period 1||38
10962419|NCT00489853|12135803|FG000|COMPLETED|Treatment Period 1||36
10962420|NCT00489853|12135804|FG001|COMPLETED|Treatment Period 1||37
10962421|NCT00489853|12135805|FG002|COMPLETED|Treatment Period 1||38
10962422|NCT00489853|12135803|FG000|NOT COMPLETED|Treatment Period 1||0
10962423|NCT00489853|12135804|FG001|NOT COMPLETED|Treatment Period 1||0
10962424|NCT00489853|12135805|FG002|NOT COMPLETED|Treatment Period 1||0
10962425|NCT00489853|12135803|FG000|STARTED|Wash-out Period 1||36
10962426|NCT00489853|12135804|FG001|STARTED|Wash-out Period 1||37
10962427|NCT00489853|12135805|FG002|STARTED|Wash-out Period 1||38
10962428|NCT00489853|12135803|FG000|COMPLETED|Wash-out Period 1||35
10962429|NCT00489853|12135804|FG001|COMPLETED|Wash-out Period 1||34
10962430|NCT00489853|12135805|FG002|COMPLETED|Wash-out Period 1||32
10962431|NCT00489853|12135803|FG000|NOT COMPLETED|Wash-out Period 1||1
10962432|NCT00489853|12135804|FG001|NOT COMPLETED|Wash-out Period 1||3
10962433|NCT00489853|12135805|FG002|NOT COMPLETED|Wash-out Period 1||6
10962434|NCT00489853|12135803|FG000|STARTED|Treatment Period 2||33
10962435|NCT00489853|12135804|FG001|STARTED|Treatment Period 2||35
10962436|NCT00489853|12135805|FG002|STARTED|Treatment Period 2||33
10962437|NCT00489853|12135803|FG000|COMPLETED|Treatment Period 2||33
10962438|NCT00489853|12135804|FG001|COMPLETED|Treatment Period 2||35
10962439|NCT00489853|12135805|FG002|COMPLETED|Treatment Period 2||33
10962440|NCT00489853|12135803|FG000|NOT COMPLETED|Treatment Period 2||0
10962441|NCT00489853|12135804|FG001|NOT COMPLETED|Treatment Period 2||0
10962442|NCT00489853|12135805|FG002|NOT COMPLETED|Treatment Period 2||0
10962443|NCT00489853|12135803|FG000|STARTED|Wash-out Period 2||33
10962444|NCT00489853|12135804|FG001|STARTED|Wash-out Period 2||35
10962445|NCT00489853|12135805|FG002|STARTED|Wash-out Period 2||33
10962446|NCT00489853|12135803|FG000|COMPLETED|Wash-out Period 2||29
10962447|NCT00489853|12135804|FG001|COMPLETED|Wash-out Period 2||32
10962448|NCT00489853|12135805|FG002|COMPLETED|Wash-out Period 2||31
10962449|NCT00489853|12135803|FG000|NOT COMPLETED|Wash-out Period 2||4
10962450|NCT00489853|12135804|FG001|NOT COMPLETED|Wash-out Period 2||3
10962451|NCT00489853|12135805|FG002|NOT COMPLETED|Wash-out Period 2||2
10962452|NCT00489853|12135803|FG000|STARTED|Treatment Period 3||29
10962453|NCT00489853|12135804|FG001|STARTED|Treatment Period 3||30
10962454|NCT00489853|12135805|FG002|STARTED|Treatment Period 3||33
10962455|NCT00489853|12135803|FG000|COMPLETED|Treatment Period 3||29
10962456|NCT00489853|12135804|FG001|COMPLETED|Treatment Period 3||29
10962457|NCT00489853|12135805|FG002|COMPLETED|Treatment Period 3||33
10962458|NCT00489853|12135803|FG000|NOT COMPLETED|Treatment Period 3||0
10962459|NCT00489853|12135804|FG001|NOT COMPLETED|Treatment Period 3||1
10962460|NCT00489853|12135805|FG002|NOT COMPLETED|Treatment Period 3||0
10962461|NCT00489853|12135803|FG000|STARTED|Follow-up Period||29
10962462|NCT00489853|12135804|FG001|STARTED|Follow-up Period||29
10962463|NCT00489853|12135805|FG002|STARTED|Follow-up Period||33
10962464|NCT00489853|12135803|FG000|COMPLETED|Follow-up Period||29
10962465|NCT00489853|12135804|FG001|COMPLETED|Follow-up Period||29
10962466|NCT00489853|12135805|FG002|COMPLETED|Follow-up Period||33
10962467|NCT00489853|12135803|FG000|NOT COMPLETED|Follow-up Period||0
10962468|NCT00489853|12135804|FG001|NOT COMPLETED|Follow-up Period||0
10962469|NCT00489853|12135805|FG002|NOT COMPLETED|Follow-up Period||0
10962470|NCT00489866|12135815|FG000|STARTED|Overall Study||7
10962471|NCT00489866|12135816|FG001|STARTED|Overall Study||7
10962472|NCT00489866|12135815|FG000|COMPLETED|Overall Study||5
10962473|NCT00489866|12135816|FG001|COMPLETED|Overall Study||7
10962474|NCT00489866|12135815|FG000|NOT COMPLETED|Overall Study||2
10962475|NCT00489866|12135816|FG001|NOT COMPLETED|Overall Study||0
10962476|NCT00489918|12135835|FG000|STARTED|Overall Study||33
10962477|NCT00489918|12135836|FG001|STARTED|Overall Study||34
10962478|NCT00489918|12135837|FG002|STARTED|Overall Study||32
10962479|NCT00489918|12135838|FG003|STARTED|Overall Study||33
10962480|NCT00489918|12135839|FG004|STARTED|Overall Study||33
10962481|NCT00489918|12135835|FG000|COMPLETED|Overall Study||31
10962482|NCT00489918|12135836|FG001|COMPLETED|Overall Study||32
10962483|NCT00489918|12135837|FG002|COMPLETED|Overall Study||28
10962484|NCT00489918|12135838|FG003|COMPLETED|Overall Study||32
10962485|NCT00489918|12135839|FG004|COMPLETED|Overall Study||32
10962486|NCT00489918|12135835|FG000|NOT COMPLETED|Overall Study||2
10962487|NCT00489918|12135836|FG001|NOT COMPLETED|Overall Study||2
10962488|NCT00489918|12135837|FG002|NOT COMPLETED|Overall Study||4
10962489|NCT00489918|12135838|FG003|NOT COMPLETED|Overall Study||1
10962490|NCT00489918|12135839|FG004|NOT COMPLETED|Overall Study||1
10962491|NCT00489970|12135854|FG000|STARTED|Persistence Year 1||1069
10962492|NCT00489970|12135855|FG001|STARTED|Persistence Year 1||523
10962493|NCT00489970|12135856|FG002|STARTED|Persistence Year 1||0
10962494|NCT00489970|12135854|FG000|COMPLETED|Persistence Year 1||1069
10962495|NCT00489970|12135855|FG001|COMPLETED|Persistence Year 1||523
10962496|NCT00489970|12135856|FG002|COMPLETED|Persistence Year 1||0
10962497|NCT00489970|12135854|FG000|NOT COMPLETED|Persistence Year 1||0
10962498|NCT00489970|12135855|FG001|NOT COMPLETED|Persistence Year 1||0
10962499|NCT00489970|12135856|FG002|NOT COMPLETED|Persistence Year 1||0
10962500|NCT00489970|12135854|FG000|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
10962501|NCT00489970|12135855|FG001|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
10962502|NCT00489970|12135856|FG002|STARTED|Persistence Year 3||0
10962503|NCT00489970|12135854|FG000|COMPLETED|Persistence Year 3||1019
10962504|NCT00489970|12135855|FG001|COMPLETED|Persistence Year 3||486
10962505|NCT00489970|12135856|FG002|COMPLETED|Persistence Year 3||0
10962506|NCT00489970|12135854|FG000|NOT COMPLETED|Persistence Year 3||0
10962507|NCT00489970|12135855|FG001|NOT COMPLETED|Persistence Year 3||0
10962508|NCT00489970|12135856|FG002|NOT COMPLETED|Persistence Year 3||0
10962509|NCT00489970|12135854|FG000|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
10962510|NCT00489970|12135855|FG001|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
10962511|NCT00489970|12135856|FG002|STARTED|Persistence Year 5||0
10962512|NCT00489970|12135854|FG000|COMPLETED|Persistence Year 5||856
10962513|NCT00489970|12135855|FG001|COMPLETED|Persistence Year 5||401
10962514|NCT00489970|12135856|FG002|COMPLETED|Persistence Year 5||0
10962515|NCT00489970|12135854|FG000|NOT COMPLETED|Persistence Year 5||0
10962516|NCT00489970|12135855|FG001|NOT COMPLETED|Persistence Year 5||0
10962517|NCT00489970|12135856|FG002|NOT COMPLETED|Persistence Year 5||0
10962518|NCT00489970|12135854|FG000|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309
10962519|NCT00489970|12135855|FG001|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138
10962520|NCT00489970|12135856|FG002|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362
10962521|NCT00489970|12135854|FG000|COMPLETED|Persistence Year 9||306
10962522|NCT00489970|12135855|FG001|COMPLETED|Persistence Year 9||136
10962523|NCT00489970|12135856|FG002|COMPLETED|Persistence Year 9||357
10962524|NCT00489970|12135854|FG000|NOT COMPLETED|Persistence Year 9||3
10962525|NCT00489970|12135855|FG001|NOT COMPLETED|Persistence Year 9||2
10962526|NCT00489970|12135856|FG002|NOT COMPLETED|Persistence Year 9||5
10962527|NCT00490009|12135867|FG000|STARTED|Overall Study||9
10962528|NCT00490009|12135867|FG000|COMPLETED|Overall Study||9
10962529|NCT00490009|12135867|FG000|NOT COMPLETED|Overall Study||0
10962530|NCT00490022|12135874|FG000|STARTED|Overall Study||16
10962531|NCT00490022|12135875|FG001|STARTED|Overall Study||15
10962532|NCT00490022|12135874|FG000|COMPLETED|Overall Study||15
10962533|NCT00490022|12135875|FG001|COMPLETED|Overall Study||12
10962534|NCT00490022|12135874|FG000|NOT COMPLETED|Overall Study||1
10962535|NCT00490022|12135875|FG001|NOT COMPLETED|Overall Study||3
10962536|NCT00490061|12135881|FG000|STARTED|Overall Study||17
10962537|NCT00490061|12135881|FG000|COMPLETED|Overall Study||16
10962538|NCT00490061|12135881|FG000|NOT COMPLETED|Overall Study||1
10962539|NCT00490100|12135885|FG000|STARTED|Overall Study||6
10962540|NCT00490100|12135885|FG000|COMPLETED|Overall Study||3
10962541|NCT00490100|12135885|FG000|NOT COMPLETED|Overall Study||3
10962542|NCT00490139|12135894|FG000|STARTED|Overall Study||2093
10962543|NCT00490139|12135895|FG001|STARTED|Overall Study||2091
10962544|NCT00490139|12135896|FG002|STARTED|Overall Study||2100
10962545|NCT00490139|12135897|FG003|STARTED|Overall Study||2097
10962546|NCT00490139|12135894|FG000|COMPLETED|Overall Study||1785
10962547|NCT00490139|12135895|FG001|COMPLETED|Overall Study||1816
10962548|NCT00490139|12135896|FG002|COMPLETED|Overall Study||1666
10962549|NCT00490139|12135897|FG003|COMPLETED|Overall Study||1790
10962550|NCT00490139|12135894|FG000|NOT COMPLETED|Overall Study||308
10962551|NCT00490139|12135895|FG001|NOT COMPLETED|Overall Study||275
10962552|NCT00490139|12135896|FG002|NOT COMPLETED|Overall Study||434
10962553|NCT00490139|12135897|FG003|NOT COMPLETED|Overall Study||307
10962554|NCT00490256|12135911|FG000|STARTED|Overall Study||7
10962555|NCT00490256|12135912|FG001|STARTED|Overall Study||7
10962556|NCT00490256|12135911|FG000|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
10962557|NCT00490256|12135912|FG001|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
10962558|NCT00490256|12135911|FG000|COMPLETED|Overall Study||7
10962559|NCT00490256|12135912|FG001|COMPLETED|Overall Study||7
10962560|NCT00490256|12135911|FG000|NOT COMPLETED|Overall Study||0
10962561|NCT00490256|12135912|FG001|NOT COMPLETED|Overall Study||0
10962562|NCT00490269|12135920|FG000|STARTED|Dronabinol Then Placebo||6
10962563|NCT00490269|12135921|FG001|STARTED|Dronabinol Then Placebo||6
10962564|NCT00490269|12135920|FG000|COMPLETED|Dronabinol Then Placebo||6
10962565|NCT00490269|12135921|FG001|COMPLETED|Dronabinol Then Placebo||6
10962566|NCT00490269|12135920|FG000|NOT COMPLETED|Dronabinol Then Placebo||0
10962567|NCT00490269|12135921|FG001|NOT COMPLETED|Dronabinol Then Placebo||0
10962568|NCT00490269|12135920|FG000|STARTED|Placebo Then Dronabinol||6
10962569|NCT00490269|12135921|FG001|STARTED|Placebo Then Dronabinol||6
10962570|NCT00490269|12135920|FG000|COMPLETED|Placebo Then Dronabinol||6
10962571|NCT00490269|12135921|FG001|COMPLETED|Placebo Then Dronabinol||6
10962572|NCT00490269|12135920|FG000|NOT COMPLETED|Placebo Then Dronabinol||0
10962573|NCT00490269|12135921|FG001|NOT COMPLETED|Placebo Then Dronabinol||0
10962574|NCT00490282|12135927|FG000|STARTED|Overall Study||25
10962575|NCT00490282|12135927|FG000|COMPLETED|Overall Study||22
10962576|NCT00490282|12135927|FG000|NOT COMPLETED|Overall Study||3
10962577|NCT00490451|12135934|FG000|STARTED|Overall Study||63
10962578|NCT00490451|12135935|FG001|STARTED|Overall Study||38
10962579|NCT00490451|12135934|FG000|COMPLETED|Overall Study||0
10962580|NCT00490451|12135935|FG001|COMPLETED|Overall Study||0
10962581|NCT00490451|12135934|FG000|NOT COMPLETED|Overall Study||63
10962582|NCT00490451|12135935|FG001|NOT COMPLETED|Overall Study||38
10962583|NCT00490477|12135943|FG000|STARTED|Overall Study||8
10962584|NCT00490477|12135944|FG001|STARTED|Overall Study||8
10962585|NCT00490477|12135943|FG000|COMPLETED|Overall Study||8
10962586|NCT00490477|12135944|FG001|COMPLETED|Overall Study||8
10962587|NCT00490477|12135943|FG000|NOT COMPLETED|Overall Study||0
10962588|NCT00490477|12135944|FG001|NOT COMPLETED|Overall Study||0
10962589|NCT00490490|12135950|FG000|STARTED|Completed Assessment for CR||8
10962590|NCT00490490|12135950|FG000|COMPLETED|Completed Assessment for CR||8
10962591|NCT00490490|12135950|FG000|NOT COMPLETED|Completed Assessment for CR||0
10962592|NCT00490490|12135950|FG000|STARTED|Completed Assessment for TTP||8
10962593|NCT00490490|12135950|FG000|COMPLETED|Completed Assessment for TTP||5
10962594|NCT00490490|12135950|FG000|NOT COMPLETED|Completed Assessment for TTP||3
10962595|NCT00490529|12135954|FG000|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59
10962596|NCT00490529|12135954|FG000|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48
10962597|NCT00490529|12135954|FG000|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11
10962598|NCT00490529|12135954|FG000|STARTED|Treatment With CpG-MCL Vaccine||48
10962599|NCT00490529|12135954|FG000|COMPLETED|Treatment With CpG-MCL Vaccine||47
10962600|NCT00490529|12135954|FG000|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1
10962601|NCT00490542|12135960|FG000|STARTED|Overall Study||38
10962602|NCT00490542|12135961|FG001|STARTED|Overall Study||35
10962603|NCT00490542|12135960|FG000|COMPLETED|Overall Study||31
10962604|NCT00490542|12135961|FG001|COMPLETED|Overall Study||31
10962605|NCT00490542|12135960|FG000|NOT COMPLETED|Overall Study||7
10962606|NCT00490542|12135961|FG001|NOT COMPLETED|Overall Study||4
10962607|NCT00490555|12135971|FG000|STARTED|Overall Study||8
10962608|NCT00490555|12135972|FG001|STARTED|Overall Study||8
10962609|NCT00490555|12135973|FG002|STARTED|Overall Study||9
10962610|NCT00490555|12135974|FG003|STARTED|Overall Study||7
10962611|NCT00490555|12135971|FG000|COMPLETED|Overall Study||8
10962612|NCT00490555|12135972|FG001|COMPLETED|Overall Study||8
10962613|NCT00490555|12135973|FG002|COMPLETED|Overall Study||7
10962614|NCT00490555|12135974|FG003|COMPLETED|Overall Study||7
10962615|NCT00490555|12135971|FG000|NOT COMPLETED|Overall Study||0
10962616|NCT00490555|12135972|FG001|NOT COMPLETED|Overall Study||0
10962617|NCT00490555|12135973|FG002|NOT COMPLETED|Overall Study||2
10962618|NCT00490555|12135974|FG003|NOT COMPLETED|Overall Study||0
10962619|NCT00490568|12135984|FG000|STARTED|Overall Study||1461
10962620|NCT00490568|12135984|FG000|COMPLETED|Overall Study||97
10962621|NCT00490568|12135984|FG000|NOT COMPLETED|Overall Study||1364
10962622|NCT00490646|12135991|FG000|STARTED|Overall Study||25
10962623|NCT00490646|12135992|FG001|STARTED|Overall Study||25
10962624|NCT00490646|12135991|FG000|Treated|Overall Study||24
10962625|NCT00490646|12135992|FG001|Treated|Overall Study||24
10962626|NCT00490646|12135991|FG000|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
10962627|NCT00490646|12135992|FG001|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
10962628|NCT00490646|12135991|FG000|NOT COMPLETED|Overall Study||2
10962629|NCT00490646|12135992|FG001|NOT COMPLETED|Overall Study||2
10962630|NCT00490698|12135998|FG000|STARTED|Overall Study||11
10962631|NCT00490698|12135998|FG000|COMPLETED|Overall Study||1
10962632|NCT00490698|12135998|FG000|NOT COMPLETED|Overall Study||10
10962633|NCT00490724|12136005|FG000|STARTED|Period I||21
10962634|NCT00490724|12136006|FG001|STARTED|Period I||20
10962635|NCT00490724|12136007|FG002|STARTED|Period I||20
10962636|NCT00490724|12136005|FG000|COMPLETED|Period I||21
10962637|NCT00490724|12136006|FG001|COMPLETED|Period I||20
10962638|NCT00490724|12136007|FG002|COMPLETED|Period I||19
10962639|NCT00490724|12136005|FG000|NOT COMPLETED|Period I||0
10962640|NCT00490724|12136006|FG001|NOT COMPLETED|Period I||0
10962641|NCT00490724|12136007|FG002|NOT COMPLETED|Period I||1
10962642|NCT00490724|12136005|FG000|STARTED|Period II||21
10962643|NCT00490724|12136006|FG001|STARTED|Period II||20
10962644|NCT00490724|12136007|FG002|STARTED|Period II||19
10962645|NCT00490724|12136005|FG000|COMPLETED|Period II||18
10962646|NCT00490724|12136006|FG001|COMPLETED|Period II||19
10962647|NCT00490724|12136007|FG002|COMPLETED|Period II||16
10962648|NCT00490724|12136005|FG000|NOT COMPLETED|Period II||3
10962649|NCT00490724|12136006|FG001|NOT COMPLETED|Period II||1
10962650|NCT00490724|12136007|FG002|NOT COMPLETED|Period II||3
10962651|NCT00490802|12136017|FG000|STARTED|Overall Study||10
10962652|NCT00490802|12136018|FG001|STARTED|Overall Study||9
10962653|NCT00490802|12136017|FG000|COMPLETED|Overall Study||9
10962654|NCT00490802|12136018|FG001|COMPLETED|Overall Study||7
10962655|NCT00490802|12136017|FG000|NOT COMPLETED|Overall Study||1
10962656|NCT00490802|12136018|FG001|NOT COMPLETED|Overall Study||2
10962657|NCT00490815|12136027|FG000|STARTED|Overall Study||20
10962658|NCT00490815|12136028|FG001|STARTED|Overall Study||17
10962659|NCT00490815|12136027|FG000|COMPLETED|Overall Study||12
10962660|NCT00490815|12136028|FG001|COMPLETED|Overall Study||8
10962661|NCT00490815|12136027|FG000|NOT COMPLETED|Overall Study||8
10962662|NCT00490815|12136028|FG001|NOT COMPLETED|Overall Study||9
10962663|NCT00490841|12136034|FG000|STARTED|Overall Study||202
10962664|NCT00490841|12136034|FG000|COMPLETED|Overall Study||189
10962665|NCT00490841|12136034|FG000|NOT COMPLETED|Overall Study||13
10962666|NCT00490919|12136041|FG000|STARTED|Open-label Run-in Period||1024
10962667|NCT00490919|12136042|FG001|STARTED|Open-label Run-in Period||0
10962668|NCT00490919|12136043|FG002|STARTED|Open-label Run-in Period||0
10962669|NCT00490919|12136041|FG000|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
10962670|NCT00490919|12136042|FG001|COMPLETED|Open-label Run-in Period||0
10962671|NCT00490919|12136043|FG002|COMPLETED|Open-label Run-in Period||0
10962672|NCT00490919|12136041|FG000|NOT COMPLETED|Open-label Run-in Period||483
10962673|NCT00490919|12136042|FG001|NOT COMPLETED|Open-label Run-in Period||0
10962674|NCT00490919|12136043|FG002|NOT COMPLETED|Open-label Run-in Period||0
10962675|NCT00490919|12136041|FG000|STARTED|Double-blind Phase||0
10962676|NCT00490919|12136042|FG001|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
10962677|NCT00490919|12136043|FG002|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
10962678|NCT00490919|12136041|FG000|COMPLETED|Double-blind Phase||0
10962679|NCT00490919|12136042|FG001|COMPLETED|Double-blind Phase||170
10962680|NCT00490919|12136043|FG002|COMPLETED|Double-blind Phase||199
10962681|NCT00490919|12136041|FG000|NOT COMPLETED|Double-blind Phase||0
10962682|NCT00490919|12136042|FG001|NOT COMPLETED|Double-blind Phase||86
10962683|NCT00490919|12136043|FG002|NOT COMPLETED|Double-blind Phase||84
10962684|NCT00490945|12136055|FG000|STARTED|Overall Study||8
10962685|NCT00490945|12136056|FG001|STARTED|Overall Study||9
10962686|NCT00490945|12136057|FG002|STARTED|Overall Study||8
10962687|NCT00490945|12136058|FG003|STARTED|Overall Study||7
10962688|NCT00490945|12136059|FG004|STARTED|Overall Study||7
10962689|NCT00490945|12136055|FG000|COMPLETED|Overall Study||8
10962690|NCT00490945|12136056|FG001|COMPLETED|Overall Study||8
10962691|NCT00490945|12136057|FG002|COMPLETED|Overall Study||8
10962692|NCT00490945|12136058|FG003|COMPLETED|Overall Study||7
10962693|NCT00490945|12136059|FG004|COMPLETED|Overall Study||7
10962694|NCT00490945|12136055|FG000|NOT COMPLETED|Overall Study||0
10962695|NCT00490945|12136056|FG001|NOT COMPLETED|Overall Study||1
10962696|NCT00490945|12136057|FG002|NOT COMPLETED|Overall Study||0
10962697|NCT00490945|12136058|FG003|NOT COMPLETED|Overall Study||0
10962698|NCT00490945|12136059|FG004|NOT COMPLETED|Overall Study||0
10962699|NCT00490971|12136079|FG000|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
10962700|NCT00490971|12136080|FG001|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
10962701|NCT00490971|12136081|FG002|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
10962702|NCT00490971|12136082|FG003|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
10962703|NCT00490971|12136083|FG004|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
10962704|NCT00490971|12136079|FG000|COMPLETED|Acute/Continuation||308
10962705|NCT00490971|12136080|FG001|COMPLETED|Acute/Continuation||86
10962706|NCT00490971|12136081|FG002|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
10962707|NCT00490971|12136082|FG003|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
10962708|NCT00490971|12136083|FG004|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
10962709|NCT00490971|12136079|FG000|NOT COMPLETED|Acute/Continuation||306
10962710|NCT00490971|12136080|FG001|NOT COMPLETED|Acute/Continuation||62
10962711|NCT00490971|12136081|FG002|NOT COMPLETED|Acute/Continuation||0
10962712|NCT00490971|12136082|FG003|NOT COMPLETED|Acute/Continuation||0
10962713|NCT00490971|12136083|FG004|NOT COMPLETED|Acute/Continuation||0
10962714|NCT00490971|12136079|FG000|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
10962715|NCT00490971|12136080|FG001|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
10962716|NCT00490971|12136081|FG002|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
10962717|NCT00490971|12136082|FG003|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
10962718|NCT00490971|12136083|FG004|STARTED|Maintenance||83
10962807|NCT00491764|12136195|FG004|COMPLETED|Overall Study||33
10962719|NCT00490971|12136079|FG000|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
10962720|NCT00490971|12136080|FG001|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
10962721|NCT00490971|12136081|FG002|COMPLETED|Maintenance||96
10962722|NCT00490971|12136082|FG003|COMPLETED|Maintenance||96
10962723|NCT00490971|12136083|FG004|COMPLETED|Maintenance||44
10962724|NCT00490971|12136079|FG000|NOT COMPLETED|Maintenance||0
10962725|NCT00490971|12136080|FG001|NOT COMPLETED|Maintenance||0
10962726|NCT00490971|12136081|FG002|NOT COMPLETED|Maintenance||51
10962727|NCT00490971|12136082|FG003|NOT COMPLETED|Maintenance||53
10962728|NCT00490971|12136083|FG004|NOT COMPLETED|Maintenance||39
10962729|NCT00491075|12136095|FG000|STARTED|Overall Study||16
10962730|NCT00491075|12136095|FG000|COMPLETED|Overall Study||14
10962731|NCT00491075|12136095|FG000|NOT COMPLETED|Overall Study||2
10962732|NCT00491179|12136101|FG000|STARTED|Overall Study||25
10962733|NCT00491179|12136102|FG001|STARTED|Overall Study||10
10962734|NCT00491179|12136101|FG000|COMPLETED|Overall Study||18
10962735|NCT00491179|12136102|FG001|COMPLETED|Overall Study||8
10962736|NCT00491179|12136101|FG000|NOT COMPLETED|Overall Study||7
10962737|NCT00491179|12136102|FG001|NOT COMPLETED|Overall Study||2
10962738|NCT00491244|12136110|FG000|STARTED|Overall Study||189
10962739|NCT00491244|12136111|FG001|STARTED|Overall Study||188
10962740|NCT00491244|12136110|FG000|COMPLETED|Overall Study||162
10962741|NCT00491244|12136111|FG001|COMPLETED|Overall Study||168
10962742|NCT00491244|12136110|FG000|NOT COMPLETED|Overall Study||27
10962743|NCT00491244|12136111|FG001|NOT COMPLETED|Overall Study||20
10962744|NCT00491322|12136119|FG000|STARTED|Overall Study||41
10962745|NCT00491322|12136120|FG001|STARTED|Overall Study||51
10962746|NCT00491322|12136119|FG000|COMPLETED|Overall Study||40
10962747|NCT00491322|12136120|FG001|COMPLETED|Overall Study||50
10962748|NCT00491322|12136119|FG000|NOT COMPLETED|Overall Study||1
10962749|NCT00491322|12136120|FG001|NOT COMPLETED|Overall Study||1
10962750|NCT00491374|12136128|FG000|STARTED|Overall Study||0
10962751|NCT00491374|12136129|FG001|STARTED|Overall Study||0
10962752|NCT00491374|12136128|FG000|COMPLETED|Overall Study||0
10962753|NCT00491374|12136129|FG001|COMPLETED|Overall Study||0
10962754|NCT00491374|12136128|FG000|NOT COMPLETED|Overall Study||0
10962755|NCT00491374|12136129|FG001|NOT COMPLETED|Overall Study||0
10962756|NCT00491491|12136137|FG000|STARTED|Overall Study||22
10962757|NCT00491491|12136138|FG001|STARTED|Overall Study||21
10962758|NCT00491491|12136137|FG000|COMPLETED|Overall Study||22
10962759|NCT00491491|12136138|FG001|COMPLETED|Overall Study||21
10962760|NCT00491491|12136137|FG000|NOT COMPLETED|Overall Study||0
10962761|NCT00491491|12136138|FG001|NOT COMPLETED|Overall Study||0
10962762|NCT00491530|12136147|FG000|STARTED|Overall Study||174
10962763|NCT00491530|12136148|FG001|STARTED|Overall Study||50
10962764|NCT00491530|12136149|FG002|STARTED|Overall Study||86
10962765|NCT00491530|12136147|FG000|COMPLETED|Overall Study||162
10962766|NCT00491530|12136148|FG001|COMPLETED|Overall Study||44
10962767|NCT00491530|12136149|FG002|COMPLETED|Overall Study||81
10962768|NCT00491530|12136147|FG000|NOT COMPLETED|Overall Study||12
10962769|NCT00491530|12136148|FG001|NOT COMPLETED|Overall Study||6
10962770|NCT00491530|12136149|FG002|NOT COMPLETED|Overall Study||5
10962771|NCT00491556|12136159|FG000|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
10962772|NCT00491556|12136160|FG001|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
10962773|NCT00491556|12136159|FG000|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
10962774|NCT00491556|12136160|FG001|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
10962775|NCT00491556|12136159|FG000|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
10962776|NCT00491556|12136160|FG001|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
10962777|NCT00491556|12136159|FG000|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
10962778|NCT00491556|12136160|FG001|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
10962779|NCT00491556|12136159|FG000|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
10962780|NCT00491556|12136160|FG001|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
10962781|NCT00491556|12136159|FG000|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
10962782|NCT00491556|12136160|FG001|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
10962783|NCT00491556|12136159|FG000|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
10962784|NCT00491556|12136160|FG001|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
10962785|NCT00491608|12136166|FG000|STARTED|Overall Study|Participants who received treatment|209
10962786|NCT00491608|12136166|FG000|COMPLETED|Overall Study||206
10962787|NCT00491608|12136166|FG000|NOT COMPLETED|Overall Study||3
10962788|NCT00491751|12136173|FG000|STARTED|Overall Study||22
10962789|NCT00491751|12136174|FG001|STARTED|Overall Study||44
10962790|NCT00491751|12136175|FG002|STARTED|Overall Study||42
10962791|NCT00491751|12136173|FG000|COMPLETED|Overall Study||22
10962792|NCT00491751|12136174|FG001|COMPLETED|Overall Study||44
10962793|NCT00491751|12136175|FG002|COMPLETED|Overall Study||42
10962794|NCT00491751|12136173|FG000|NOT COMPLETED|Overall Study||0
10962795|NCT00491751|12136174|FG001|NOT COMPLETED|Overall Study||0
10962796|NCT00491751|12136175|FG002|NOT COMPLETED|Overall Study||0
10962797|NCT00491764|12136191|FG000|STARTED|Overall Study||37
10962798|NCT00491764|12136192|FG001|STARTED|Overall Study||37
10962799|NCT00491764|12136193|FG002|STARTED|Overall Study||36
10962800|NCT00491764|12136194|FG003|STARTED|Overall Study||36
10962801|NCT00491764|12136195|FG004|STARTED|Overall Study||36
10962802|NCT00491764|12136196|FG005|STARTED|Overall Study||36
10962803|NCT00491764|12136191|FG000|COMPLETED|Overall Study||32
10962804|NCT00491764|12136192|FG001|COMPLETED|Overall Study||30
10962805|NCT00491764|12136193|FG002|COMPLETED|Overall Study||28
10962806|NCT00491764|12136194|FG003|COMPLETED|Overall Study||28
10962808|NCT00491764|12136196|FG005|COMPLETED|Overall Study||27
10962809|NCT00491764|12136191|FG000|NOT COMPLETED|Overall Study||5
10962810|NCT00491764|12136192|FG001|NOT COMPLETED|Overall Study||7
10962811|NCT00491764|12136193|FG002|NOT COMPLETED|Overall Study||8
10962812|NCT00491764|12136194|FG003|NOT COMPLETED|Overall Study||8
10962813|NCT00491764|12136195|FG004|NOT COMPLETED|Overall Study||3
10962814|NCT00491764|12136196|FG005|NOT COMPLETED|Overall Study||9
10962815|NCT00491829|12136213|FG000|STARTED|Overall Study||311
10962816|NCT00491829|12136214|FG001|STARTED|Overall Study||316
10962817|NCT00491829|12136215|FG002|STARTED|Overall Study||318
10962818|NCT00491829|12136213|FG000|COMPLETED|Overall Study||216
10962819|NCT00491829|12136214|FG001|COMPLETED|Overall Study||202
10962820|NCT00491829|12136215|FG002|COMPLETED|Overall Study||243
10962821|NCT00491829|12136213|FG000|NOT COMPLETED|Overall Study||95
10962822|NCT00491829|12136214|FG001|NOT COMPLETED|Overall Study||114
10962823|NCT00491829|12136215|FG002|NOT COMPLETED|Overall Study||75
10962824|NCT00491894|12136223|FG000|STARTED|Overall Study||137
10962825|NCT00491894|12136223|FG000|COMPLETED|Overall Study||103
10962826|NCT00491894|12136223|FG000|NOT COMPLETED|Overall Study||34
10962827|NCT00492024|12136229|FG000|STARTED|Treatment||251
10962828|NCT00492024|12136230|FG001|STARTED|Treatment||123
10962829|NCT00492024|12136229|FG000|COMPLETED|Treatment||222
10962830|NCT00492024|12136230|FG001|COMPLETED|Treatment||101
10962831|NCT00492024|12136229|FG000|NOT COMPLETED|Treatment||29
10962832|NCT00492024|12136230|FG001|NOT COMPLETED|Treatment||22
10962833|NCT00492024|12136229|FG000|STARTED|Follow up||222
10962834|NCT00492024|12136230|FG001|STARTED|Follow up||101
10962835|NCT00492024|12136229|FG000|COMPLETED|Follow up||221
10962836|NCT00492024|12136230|FG001|COMPLETED|Follow up||99
10962837|NCT00492024|12136229|FG000|NOT COMPLETED|Follow up||1
10962838|NCT00492024|12136230|FG001|NOT COMPLETED|Follow up||2
10962839|NCT00492063|12136240|FG000|STARTED|Overall Study||652
10962840|NCT00492063|12136241|FG001|STARTED|Overall Study||648
10962841|NCT00492063|12136242|FG002|STARTED|Overall Study||678
10962842|NCT00492063|12136243|FG003|STARTED|Overall Study||676
10962843|NCT00492063|12136240|FG000|COMPLETED|Overall Study||642
10962844|NCT00492063|12136241|FG001|COMPLETED|Overall Study||634
10962845|NCT00492063|12136242|FG002|COMPLETED|Overall Study||667
10962846|NCT00492063|12136243|FG003|COMPLETED|Overall Study||666
10962847|NCT00492063|12136240|FG000|NOT COMPLETED|Overall Study||10
10962848|NCT00492063|12136241|FG001|NOT COMPLETED|Overall Study||14
10962849|NCT00492063|12136242|FG002|NOT COMPLETED|Overall Study||11
10962850|NCT00492063|12136243|FG003|NOT COMPLETED|Overall Study||10
10962851|NCT00492089|12136255|FG000|STARTED|First Intervention (6 Weeks)||5
10962852|NCT00492089|12136256|FG001|STARTED|First Intervention (6 Weeks)||6
10962853|NCT00492089|12136255|FG000|COMPLETED|First Intervention (6 Weeks)||5
10962854|NCT00492089|12136256|FG001|COMPLETED|First Intervention (6 Weeks)||6
10962855|NCT00492089|12136255|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
10962856|NCT00492089|12136256|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10962857|NCT00492089|12136255|FG000|STARTED|Second Intervention (6 Weeks)||5
10962858|NCT00492089|12136256|FG001|STARTED|Second Intervention (6 Weeks)||6
10962859|NCT00492089|12136255|FG000|COMPLETED|Second Intervention (6 Weeks)||5
10962860|NCT00492089|12136256|FG001|COMPLETED|Second Intervention (6 Weeks)||6
10962861|NCT00492089|12136255|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10962862|NCT00492089|12136256|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10962863|NCT00492115|12136264|FG000|STARTED|Overall Study||19
10962864|NCT00492115|12136265|FG001|STARTED|Overall Study||19
10962865|NCT00492115|12136264|FG000|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
10962866|NCT00492115|12136265|FG001|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
10962867|NCT00492115|12136264|FG000|NOT COMPLETED|Overall Study||3
10962868|NCT00492115|12136265|FG001|NOT COMPLETED|Overall Study||4
10962869|NCT00492206|12136271|FG000|STARTED|Overall Study||40
10962870|NCT00492206|12136271|FG000|COMPLETED|Overall Study||40
10962871|NCT00492206|12136271|FG000|NOT COMPLETED|Overall Study||0
10962872|NCT00492232|12136279|FG000|STARTED|Placebo Run-in||0
10962873|NCT00492232|12136280|FG001|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
10962874|NCT00492232|12136279|FG000|COMPLETED|Placebo Run-in||0
10962875|NCT00492232|12136280|FG001|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
10962876|NCT00492232|12136279|FG000|NOT COMPLETED|Placebo Run-in||0
10962877|NCT00492232|12136280|FG001|NOT COMPLETED|Placebo Run-in||70
10962878|NCT00492232|12136279|FG000|STARTED|Double-Blind Treatment||65
10962879|NCT00492232|12136280|FG001|STARTED|Double-Blind Treatment||70
10962880|NCT00492232|12136279|FG000|COMPLETED|Double-Blind Treatment||47
10962881|NCT00492232|12136280|FG001|COMPLETED|Double-Blind Treatment||45
10962882|NCT00492232|12136279|FG000|NOT COMPLETED|Double-Blind Treatment||18
10962883|NCT00492232|12136280|FG001|NOT COMPLETED|Double-Blind Treatment||25
10962884|NCT00492232|12136279|FG000|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
10962885|NCT00492232|12136280|FG001|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
10962886|NCT00492232|12136279|FG000|COMPLETED|Open-Label Treatment||88
10962887|NCT00492232|12136280|FG001|COMPLETED|Open-Label Treatment||0
10962888|NCT00492232|12136279|FG000|NOT COMPLETED|Open-Label Treatment||1
10962889|NCT00492232|12136280|FG001|NOT COMPLETED|Open-Label Treatment||0
10962890|NCT00492284|12136290|FG000|STARTED|Overall Study||39
10962891|NCT00492284|12136291|FG001|STARTED|Overall Study||39
10962892|NCT00492284|12136292|FG002|STARTED|Overall Study||43
10962893|NCT00492284|12136293|FG003|STARTED|Overall Study||41
10962894|NCT00492284|12136290|FG000|COMPLETED|Overall Study||38
10962895|NCT00492284|12136291|FG001|COMPLETED|Overall Study||35
10962896|NCT00492284|12136292|FG002|COMPLETED|Overall Study||37
10962897|NCT00492284|12136293|FG003|COMPLETED|Overall Study||31
10962898|NCT00492284|12136290|FG000|NOT COMPLETED|Overall Study||1
10962899|NCT00492284|12136291|FG001|NOT COMPLETED|Overall Study||4
10962900|NCT00492284|12136292|FG002|NOT COMPLETED|Overall Study||6
10962901|NCT00492284|12136293|FG003|NOT COMPLETED|Overall Study||10
10962902|NCT00492297|12136303|FG000|STARTED|Treatment||83
10962903|NCT00492297|12136303|FG000|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
10962904|NCT00492297|12136303|FG000|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
10962905|NCT00492297|12136303|FG000|COMPLETED|Treatment||78
10962906|NCT00492297|12136303|FG000|NOT COMPLETED|Treatment||5
10962907|NCT00492297|12136303|FG000|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
10962908|NCT00492297|12136303|FG000|COMPLETED|Active Follow-up 30(+4) Days Duration||59
10962909|NCT00492297|12136303|FG000|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
10962910|NCT00492297|12136303|FG000|STARTED|Survival Only Follow-up||59
10962911|NCT00492297|12136303|FG000|COMPLETED|Survival Only Follow-up||0
10962912|NCT00492297|12136303|FG000|NOT COMPLETED|Survival Only Follow-up||59
10962913|NCT00492336|12136309|FG000|STARTED|Overall Study||28
10962914|NCT00492336|12136310|FG001|STARTED|Overall Study||29
10962915|NCT00492336|12136309|FG000|COMPLETED|Overall Study||26
10962916|NCT00492336|12136310|FG001|COMPLETED|Overall Study||23
10962917|NCT00492336|12136309|FG000|NOT COMPLETED|Overall Study||2
10962918|NCT00492336|12136310|FG001|NOT COMPLETED|Overall Study||6
10962919|NCT00492401|12136316|FG000|STARTED|Overall Study||55
10962920|NCT00492401|12136316|FG000|COMPLETED|Overall Study||55
10962921|NCT00492401|12136316|FG000|NOT COMPLETED|Overall Study||0
10962922|NCT00492531|12136324|FG000|STARTED|Overall Study||37
10962923|NCT00492531|12136325|FG001|STARTED|Overall Study||37
10962924|NCT00492531|12136324|FG000|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
10962925|NCT00492531|12136325|FG001|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
10962926|NCT00492531|12136324|FG000|NOT COMPLETED|Overall Study||22
10962927|NCT00492531|12136325|FG001|NOT COMPLETED|Overall Study||23
10962928|NCT00492544|12136331|FG000|STARTED|Overall Study||100
10962929|NCT00492544|12136331|FG000|COMPLETED|Overall Study||100
10962930|NCT00492544|12136331|FG000|NOT COMPLETED|Overall Study||0
10962931|NCT00492557|12136337|FG000|STARTED|Overall Study||580
10962932|NCT00492557|12136338|FG001|STARTED|Overall Study||580
10962933|NCT00492557|12136337|FG000|Vaccinated Dose 1|Overall Study||577
10962934|NCT00492557|12136338|FG001|Vaccinated Dose 1|Overall Study||575
10962935|NCT00492557|12136337|FG000|Vaccinated Dose 2|Overall Study||560
10962936|NCT00492557|12136338|FG001|Vaccinated Dose 2|Overall Study||558
10962937|NCT00492557|12136337|FG000|COMPLETED|Overall Study||556
10962938|NCT00492557|12136338|FG001|COMPLETED|Overall Study||557
10962939|NCT00492557|12136337|FG000|NOT COMPLETED|Overall Study||24
10962940|NCT00492557|12136338|FG001|NOT COMPLETED|Overall Study||23
10962941|NCT00492583|12136349|FG000|STARTED|Overall Study||95
10962942|NCT00492583|12136350|FG001|STARTED|Overall Study||87
10962943|NCT00492583|12136349|FG000|COMPLETED|Overall Study||95
10962944|NCT00492583|12136350|FG001|COMPLETED|Overall Study||87
10962945|NCT00492583|12136349|FG000|NOT COMPLETED|Overall Study||0
10962946|NCT00492583|12136350|FG001|NOT COMPLETED|Overall Study||0
10962947|NCT00492622|12136356|FG000|STARTED|Overall Study|all subjects received the immediate release formulation|12
10962948|NCT00492622|12136356|FG000|COMPLETED|Overall Study||12
10962949|NCT00492622|12136356|FG000|NOT COMPLETED|Overall Study||0
10962950|NCT00492648|12136366|FG000|STARTED|Month 30 (109671 Study)||4
10962951|NCT00492648|12136367|FG001|STARTED|Month 30 (109671 Study)||30
10962952|NCT00492648|12136366|FG000|COMPLETED|Month 30 (109671 Study)||4
10962953|NCT00492648|12136367|FG001|COMPLETED|Month 30 (109671 Study)||29
10962954|NCT00492648|12136366|FG000|NOT COMPLETED|Month 30 (109671 Study)||0
10962955|NCT00492648|12136367|FG001|NOT COMPLETED|Month 30 (109671 Study)||1
10962956|NCT00492648|12136366|FG000|STARTED|Month 42 (109674 Study)||3
10962957|NCT00492648|12136367|FG001|STARTED|Month 42 (109674 Study)||20
10962958|NCT00492648|12136366|FG000|COMPLETED|Month 42 (109674 Study)||3
10962959|NCT00492648|12136367|FG001|COMPLETED|Month 42 (109674 Study)||20
10962960|NCT00492648|12136366|FG000|NOT COMPLETED|Month 42 (109674 Study)||0
10962961|NCT00492648|12136367|FG001|NOT COMPLETED|Month 42 (109674 Study)||0
10962962|NCT00492726|12136375|FG000|STARTED|Overall Study||410
10962963|NCT00492726|12136376|FG001|STARTED|Overall Study||394
10962964|NCT00492726|12136375|FG000|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
10962965|NCT00492726|12136376|FG001|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
10962966|NCT00492726|12136375|FG000|End of Study|Overall Study||360
10962967|NCT00492726|12136376|FG001|End of Study|Overall Study||358
10962968|NCT00492726|12136375|FG000|COMPLETED|Overall Study||360
10962969|NCT00492726|12136376|FG001|COMPLETED|Overall Study||358
10962970|NCT00492726|12136375|FG000|NOT COMPLETED|Overall Study||50
10962971|NCT00492726|12136376|FG001|NOT COMPLETED|Overall Study||36
10962972|NCT00492752|12136384|FG000|STARTED|Double Blind Treatment||134
10962973|NCT00492752|12136385|FG001|STARTED|Double Blind Treatment||16
10962974|NCT00492752|12136386|FG002|STARTED|Double Blind Treatment||70
10962975|NCT00492752|12136387|FG003|STARTED|Double Blind Treatment||6
10962976|NCT00492752|12136384|FG000|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
10963142|NCT00493220|12136465|FG005|NOT COMPLETED|Second Intervention||0
10962977|NCT00492752|12136385|FG001|Received Treatment|Double Blind Treatment|Safety Population|16
10962978|NCT00492752|12136386|FG002|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
10962979|NCT00492752|12136387|FG003|Received Treatment|Double Blind Treatment|Safety Population|6
10962980|NCT00492752|12136384|FG000|COMPLETED|Double Blind Treatment||120
10962981|NCT00492752|12136385|FG001|COMPLETED|Double Blind Treatment||16
10962982|NCT00492752|12136386|FG002|COMPLETED|Double Blind Treatment||67
10962983|NCT00492752|12136387|FG003|COMPLETED|Double Blind Treatment||6
10962984|NCT00492752|12136384|FG000|NOT COMPLETED|Double Blind Treatment||14
10962985|NCT00492752|12136385|FG001|NOT COMPLETED|Double Blind Treatment||0
10962986|NCT00492752|12136386|FG002|NOT COMPLETED|Double Blind Treatment||3
10962987|NCT00492752|12136387|FG003|NOT COMPLETED|Double Blind Treatment||0
10962988|NCT00492752|12136384|FG000|STARTED|Follow-up and/or Open Label Sorafenib||120
10962989|NCT00492752|12136385|FG001|STARTED|Follow-up and/or Open Label Sorafenib||16
10962990|NCT00492752|12136386|FG002|STARTED|Follow-up and/or Open Label Sorafenib||67
10962991|NCT00492752|12136387|FG003|STARTED|Follow-up and/or Open Label Sorafenib||6
10962992|NCT00492752|12136384|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
10962993|NCT00492752|12136385|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
10962994|NCT00492752|12136386|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
10962995|NCT00492752|12136387|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
10962996|NCT00492752|12136384|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
10962997|NCT00492752|12136385|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
10962998|NCT00492752|12136386|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
10962999|NCT00492752|12136387|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
10963000|NCT00492752|12136384|FG000|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
10963001|NCT00492752|12136385|FG001|COMPLETED|Follow-up and/or Open Label Sorafenib||0
10963002|NCT00492752|12136386|FG002|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
10963003|NCT00492752|12136387|FG003|COMPLETED|Follow-up and/or Open Label Sorafenib||0
10963004|NCT00492752|12136384|FG000|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
10963005|NCT00492752|12136385|FG001|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
10963006|NCT00492752|12136386|FG002|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
10963007|NCT00492752|12136387|FG003|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
10963008|NCT00492856|12136394|FG000|STARTED|Induction||105
10963009|NCT00492856|12136395|FG001|STARTED|Induction||0
10963010|NCT00492856|12136396|FG002|STARTED|Induction||0
10963011|NCT00492856|12136397|FG003|STARTED|Induction||0
10963012|NCT00492856|12136394|FG000|COMPLETED|Induction||99
10963013|NCT00492856|12136395|FG001|COMPLETED|Induction||0
10963014|NCT00492856|12136396|FG002|COMPLETED|Induction||0
10963015|NCT00492856|12136397|FG003|COMPLETED|Induction||0
10963016|NCT00492856|12136394|FG000|NOT COMPLETED|Induction||6
10963017|NCT00492856|12136395|FG001|NOT COMPLETED|Induction||0
10963018|NCT00492856|12136396|FG002|NOT COMPLETED|Induction||0
10963019|NCT00492856|12136397|FG003|NOT COMPLETED|Induction||0
10963020|NCT00492856|12136394|FG000|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
10963021|NCT00492856|12136395|FG001|STARTED|Consolidation||0
10963022|NCT00492856|12136396|FG002|STARTED|Consolidation||0
10963023|NCT00492856|12136397|FG003|STARTED|Consolidation||0
10963024|NCT00492856|12136394|FG000|COMPLETED|Consolidation||83
10963025|NCT00492856|12136395|FG001|COMPLETED|Consolidation||0
10963026|NCT00492856|12136396|FG002|COMPLETED|Consolidation||0
10963027|NCT00492856|12136397|FG003|COMPLETED|Consolidation||0
10963028|NCT00492856|12136394|FG000|NOT COMPLETED|Consolidation||9
10963029|NCT00492856|12136395|FG001|NOT COMPLETED|Consolidation||0
10963030|NCT00492856|12136396|FG002|NOT COMPLETED|Consolidation||0
10963031|NCT00492856|12136397|FG003|NOT COMPLETED|Consolidation||0
10963032|NCT00492856|12136394|FG000|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
10963033|NCT00492856|12136395|FG001|STARTED|Post-consolidation||41
10963034|NCT00492856|12136396|FG002|STARTED|Post-consolidation||27
10963035|NCT00492856|12136397|FG003|STARTED|Post-consolidation||1
10963036|NCT00492856|12136394|FG000|COMPLETED|Post-consolidation||0
10963037|NCT00492856|12136395|FG001|COMPLETED|Post-consolidation||29
10963038|NCT00492856|12136396|FG002|COMPLETED|Post-consolidation||0
10963039|NCT00492856|12136397|FG003|COMPLETED|Post-consolidation||0
10963040|NCT00492856|12136394|FG000|NOT COMPLETED|Post-consolidation||0
10963041|NCT00492856|12136395|FG001|NOT COMPLETED|Post-consolidation||12
10963042|NCT00492856|12136396|FG002|NOT COMPLETED|Post-consolidation||27
10963043|NCT00492856|12136397|FG003|NOT COMPLETED|Post-consolidation||1
10963044|NCT00492921|12136409|FG000|STARTED|Overall Study||5
10963045|NCT00492921|12136410|FG001|STARTED|Overall Study||4
10963046|NCT00492921|12136411|FG002|STARTED|Overall Study||3
10963047|NCT00492921|12136409|FG000|COMPLETED|Overall Study||4
10963048|NCT00492921|12136410|FG001|COMPLETED|Overall Study||4
10963049|NCT00492921|12136411|FG002|COMPLETED|Overall Study||2
10963050|NCT00492921|12136409|FG000|NOT COMPLETED|Overall Study||1
10963051|NCT00492921|12136410|FG001|NOT COMPLETED|Overall Study||0
10963052|NCT00492921|12136411|FG002|NOT COMPLETED|Overall Study||1
10963053|NCT00492973|12136421|FG000|STARTED|Overall Study||37
10963054|NCT00492973|12136422|FG001|STARTED|Overall Study||39
10963055|NCT00492973|12136421|FG000|COMPLETED|Overall Study||37
10963056|NCT00492973|12136422|FG001|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
10963057|NCT00492973|12136421|FG000|NOT COMPLETED|Overall Study||0
10963058|NCT00492973|12136422|FG001|NOT COMPLETED|Overall Study||1
10963059|NCT00493012|12136430|FG000|STARTED|Overall Study||100
10963060|NCT00493012|12136431|FG001|STARTED|Overall Study||100
10963061|NCT00493012|12136430|FG000|COMPLETED|Overall Study||82
10963062|NCT00493012|12136431|FG001|COMPLETED|Overall Study||83
10963063|NCT00493012|12136430|FG000|NOT COMPLETED|Overall Study||18
10963064|NCT00493012|12136431|FG001|NOT COMPLETED|Overall Study||17
10963065|NCT00493038|12136439|FG000|STARTED|Treatment||147
10963066|NCT00493038|12136440|FG001|STARTED|Treatment||146
10963067|NCT00493038|12136439|FG000|Randomization|Treatment||147
10963068|NCT00493038|12136440|FG001|Randomization|Treatment||146
10963069|NCT00493038|12136439|FG000|Treated With Study Medication|Treatment||145
10963070|NCT00493038|12136440|FG001|Treated With Study Medication|Treatment||142
10963071|NCT00493038|12136439|FG000|Test-of-Cure Visit|Treatment||123
10963072|NCT00493038|12136440|FG001|Test-of-Cure Visit|Treatment||126
10963073|NCT00493038|12136439|FG000|COMPLETED|Treatment||123
10963074|NCT00493038|12136440|FG001|COMPLETED|Treatment||126
10963075|NCT00493038|12136439|FG000|NOT COMPLETED|Treatment||24
10963076|NCT00493038|12136440|FG001|NOT COMPLETED|Treatment||20
10963077|NCT00493038|12136439|FG000|STARTED|Follow-up||123
10963078|NCT00493038|12136440|FG001|STARTED|Follow-up||126
10963079|NCT00493038|12136439|FG000|COMPLETED|Follow-up||122
10963080|NCT00493038|12136440|FG001|COMPLETED|Follow-up||126
10963081|NCT00493038|12136439|FG000|NOT COMPLETED|Follow-up||1
10963082|NCT00493038|12136440|FG001|NOT COMPLETED|Follow-up||0
10963083|NCT00493064|12136446|FG000|STARTED|Overall Study||63
10963084|NCT00493064|12136446|FG000|COMPLETED|Overall Study||52
10963085|NCT00493064|12136446|FG000|NOT COMPLETED|Overall Study||11
10963086|NCT00493181|12136450|FG000|STARTED|Overall Study||8
10963087|NCT00493181|12136450|FG000|COMPLETED|Overall Study||8
10963088|NCT00493181|12136450|FG000|NOT COMPLETED|Overall Study||0
10963089|NCT00493220|12136460|FG000|STARTED|First Intervention||5
10963090|NCT00493220|12136461|FG001|STARTED|First Intervention||5
10963091|NCT00493220|12136462|FG002|STARTED|First Intervention||5
10963092|NCT00493220|12136463|FG003|STARTED|First Intervention||5
10963093|NCT00493220|12136464|FG004|STARTED|First Intervention||5
10963094|NCT00493220|12136465|FG005|STARTED|First Intervention||5
10963095|NCT00493220|12136460|FG000|COMPLETED|First Intervention||5
10963096|NCT00493220|12136461|FG001|COMPLETED|First Intervention||5
10963097|NCT00493220|12136462|FG002|COMPLETED|First Intervention||5
10963098|NCT00493220|12136463|FG003|COMPLETED|First Intervention||5
10963099|NCT00493220|12136464|FG004|COMPLETED|First Intervention||5
10963100|NCT00493220|12136465|FG005|COMPLETED|First Intervention||5
10963101|NCT00493220|12136460|FG000|NOT COMPLETED|First Intervention||0
10963102|NCT00493220|12136461|FG001|NOT COMPLETED|First Intervention||0
10963103|NCT00493220|12136462|FG002|NOT COMPLETED|First Intervention||0
10963104|NCT00493220|12136463|FG003|NOT COMPLETED|First Intervention||0
10963105|NCT00493220|12136464|FG004|NOT COMPLETED|First Intervention||0
10963106|NCT00493220|12136465|FG005|NOT COMPLETED|First Intervention||0
10963107|NCT00493220|12136460|FG000|STARTED|First 7-Day Washout & Safety Follow-up||5
10963108|NCT00493220|12136461|FG001|STARTED|First 7-Day Washout & Safety Follow-up||5
10963109|NCT00493220|12136462|FG002|STARTED|First 7-Day Washout & Safety Follow-up||5
10963110|NCT00493220|12136463|FG003|STARTED|First 7-Day Washout & Safety Follow-up||5
10963111|NCT00493220|12136464|FG004|STARTED|First 7-Day Washout & Safety Follow-up||5
10963112|NCT00493220|12136465|FG005|STARTED|First 7-Day Washout & Safety Follow-up||5
10963113|NCT00493220|12136460|FG000|COMPLETED|First 7-Day Washout & Safety Follow-up||5
10963114|NCT00493220|12136461|FG001|COMPLETED|First 7-Day Washout & Safety Follow-up||5
10963115|NCT00493220|12136462|FG002|COMPLETED|First 7-Day Washout & Safety Follow-up||5
10963116|NCT00493220|12136463|FG003|COMPLETED|First 7-Day Washout & Safety Follow-up||5
10963117|NCT00493220|12136464|FG004|COMPLETED|First 7-Day Washout & Safety Follow-up||5
10963118|NCT00493220|12136465|FG005|COMPLETED|First 7-Day Washout & Safety Follow-up||5
10963119|NCT00493220|12136460|FG000|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
10963120|NCT00493220|12136461|FG001|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
10963121|NCT00493220|12136462|FG002|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
10963122|NCT00493220|12136463|FG003|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
10963123|NCT00493220|12136464|FG004|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
10963124|NCT00493220|12136465|FG005|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
10963125|NCT00493220|12136460|FG000|STARTED|Second Intervention||5
10963126|NCT00493220|12136461|FG001|STARTED|Second Intervention||5
10963127|NCT00493220|12136462|FG002|STARTED|Second Intervention||5
10963128|NCT00493220|12136463|FG003|STARTED|Second Intervention||5
10963129|NCT00493220|12136464|FG004|STARTED|Second Intervention||5
10963130|NCT00493220|12136465|FG005|STARTED|Second Intervention||5
10963131|NCT00493220|12136460|FG000|COMPLETED|Second Intervention||5
10963132|NCT00493220|12136461|FG001|COMPLETED|Second Intervention||5
10963133|NCT00493220|12136462|FG002|COMPLETED|Second Intervention||5
10963134|NCT00493220|12136463|FG003|COMPLETED|Second Intervention||5
10963135|NCT00493220|12136464|FG004|COMPLETED|Second Intervention||5
10963136|NCT00493220|12136465|FG005|COMPLETED|Second Intervention||5
10963137|NCT00493220|12136460|FG000|NOT COMPLETED|Second Intervention||0
10963138|NCT00493220|12136461|FG001|NOT COMPLETED|Second Intervention||0
10963139|NCT00493220|12136462|FG002|NOT COMPLETED|Second Intervention||0
10963140|NCT00493220|12136463|FG003|NOT COMPLETED|Second Intervention||0
10963141|NCT00493220|12136464|FG004|NOT COMPLETED|Second Intervention||0
10963143|NCT00493220|12136460|FG000|STARTED|Second 7-Day Washout & Safety Follow-up||5
10963144|NCT00493220|12136461|FG001|STARTED|Second 7-Day Washout & Safety Follow-up||5
10963145|NCT00493220|12136462|FG002|STARTED|Second 7-Day Washout & Safety Follow-up||5
10963146|NCT00493220|12136463|FG003|STARTED|Second 7-Day Washout & Safety Follow-up||5
10963147|NCT00493220|12136464|FG004|STARTED|Second 7-Day Washout & Safety Follow-up||5
10963148|NCT00493220|12136465|FG005|STARTED|Second 7-Day Washout & Safety Follow-up||5
10963149|NCT00493220|12136460|FG000|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
10963150|NCT00493220|12136461|FG001|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
10963151|NCT00493220|12136462|FG002|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
10963152|NCT00493220|12136463|FG003|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
10963153|NCT00493220|12136464|FG004|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
10963154|NCT00493220|12136465|FG005|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
10963155|NCT00493220|12136460|FG000|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
10963156|NCT00493220|12136461|FG001|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
10963157|NCT00493220|12136462|FG002|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
10963158|NCT00493220|12136463|FG003|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
10963159|NCT00493220|12136464|FG004|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
10963160|NCT00493220|12136465|FG005|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
10963161|NCT00493220|12136460|FG000|STARTED|Third Intervention||5
10963162|NCT00493220|12136461|FG001|STARTED|Third Intervention||5
10963163|NCT00493220|12136462|FG002|STARTED|Third Intervention||5
10963164|NCT00493220|12136463|FG003|STARTED|Third Intervention||5
10963165|NCT00493220|12136464|FG004|STARTED|Third Intervention||5
10963166|NCT00493220|12136465|FG005|STARTED|Third Intervention||5
10963167|NCT00493220|12136460|FG000|COMPLETED|Third Intervention||4
10963168|NCT00493220|12136461|FG001|COMPLETED|Third Intervention||5
10963169|NCT00493220|12136462|FG002|COMPLETED|Third Intervention||5
10963170|NCT00493220|12136463|FG003|COMPLETED|Third Intervention||5
10963171|NCT00493220|12136464|FG004|COMPLETED|Third Intervention||5
10963172|NCT00493220|12136465|FG005|COMPLETED|Third Intervention||5
10963173|NCT00493220|12136460|FG000|NOT COMPLETED|Third Intervention||1
10963174|NCT00493220|12136461|FG001|NOT COMPLETED|Third Intervention||0
10963175|NCT00493220|12136462|FG002|NOT COMPLETED|Third Intervention||0
10963176|NCT00493220|12136463|FG003|NOT COMPLETED|Third Intervention||0
10963177|NCT00493220|12136464|FG004|NOT COMPLETED|Third Intervention||0
10963178|NCT00493220|12136465|FG005|NOT COMPLETED|Third Intervention||0
10963179|NCT00493220|12136460|FG000|STARTED|Final 7-Day Safety Follow-up||4
10963180|NCT00493220|12136461|FG001|STARTED|Final 7-Day Safety Follow-up||5
10963181|NCT00493220|12136462|FG002|STARTED|Final 7-Day Safety Follow-up||5
10963182|NCT00493220|12136463|FG003|STARTED|Final 7-Day Safety Follow-up||5
10963183|NCT00493220|12136464|FG004|STARTED|Final 7-Day Safety Follow-up||5
10963184|NCT00493220|12136465|FG005|STARTED|Final 7-Day Safety Follow-up||5
10963185|NCT00493220|12136460|FG000|COMPLETED|Final 7-Day Safety Follow-up||4
10963186|NCT00493220|12136461|FG001|COMPLETED|Final 7-Day Safety Follow-up||5
10963187|NCT00493220|12136462|FG002|COMPLETED|Final 7-Day Safety Follow-up||5
10963188|NCT00493220|12136463|FG003|COMPLETED|Final 7-Day Safety Follow-up||5
10963189|NCT00493220|12136464|FG004|COMPLETED|Final 7-Day Safety Follow-up||5
10963190|NCT00493220|12136465|FG005|COMPLETED|Final 7-Day Safety Follow-up||5
10963191|NCT00493220|12136460|FG000|NOT COMPLETED|Final 7-Day Safety Follow-up||0
10963192|NCT00493220|12136461|FG001|NOT COMPLETED|Final 7-Day Safety Follow-up||0
10963193|NCT00493220|12136462|FG002|NOT COMPLETED|Final 7-Day Safety Follow-up||0
10963194|NCT00493220|12136463|FG003|NOT COMPLETED|Final 7-Day Safety Follow-up||0
10963195|NCT00493220|12136464|FG004|NOT COMPLETED|Final 7-Day Safety Follow-up||0
10963196|NCT00493220|12136465|FG005|NOT COMPLETED|Final 7-Day Safety Follow-up||0
10963197|NCT00493246|12136483|FG000|STARTED|Overall Study||2
10963198|NCT00493246|12136484|FG001|STARTED|Overall Study||1
10963199|NCT00493246|12136485|FG002|STARTED|Overall Study||12
10963200|NCT00493246|12136486|FG003|STARTED|Overall Study||13
10963201|NCT00493246|12136487|FG004|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
10963202|NCT00493246|12136488|FG005|STARTED|Overall Study|All subjects who were randomized.|16
10963203|NCT00493246|12136489|FG006|STARTED|Overall Study|All subjects who were randomized.|12
10963204|NCT00493246|12136490|FG007|STARTED|Overall Study|All subjects who were randomized.|10
10963205|NCT00493246|12136483|FG000|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
10963206|NCT00493246|12136484|FG001|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
10963207|NCT00493246|12136485|FG002|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
10963208|NCT00493246|12136486|FG003|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
10963209|NCT00493246|12136487|FG004|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
10963210|NCT00493246|12136488|FG005|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
10963211|NCT00493246|12136489|FG006|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
10963212|NCT00493246|12136490|FG007|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
10963213|NCT00493246|12136483|FG000|NOT COMPLETED|Overall Study||0
10963214|NCT00493246|12136484|FG001|NOT COMPLETED|Overall Study||0
10963215|NCT00493246|12136485|FG002|NOT COMPLETED|Overall Study||0
10963216|NCT00493246|12136486|FG003|NOT COMPLETED|Overall Study||0
10963217|NCT00493246|12136487|FG004|NOT COMPLETED|Overall Study||1
10963218|NCT00493246|12136488|FG005|NOT COMPLETED|Overall Study||1
10963219|NCT00493246|12136489|FG006|NOT COMPLETED|Overall Study||1
10963220|NCT00493246|12136490|FG007|NOT COMPLETED|Overall Study||0
10963221|NCT00493285|12136514|FG000|STARTED|Overall Study||13
10963222|NCT00493285|12136515|FG001|STARTED|Overall Study||6
10963223|NCT00493285|12136516|FG002|STARTED|Overall Study||9
10963224|NCT00493285|12136517|FG003|STARTED|Overall Study||6
10963225|NCT00493285|12136518|FG004|STARTED|Overall Study||10
10963226|NCT00493285|12136519|FG005|STARTED|Overall Study||5
10963227|NCT00493285|12136514|FG000|COMPLETED|Overall Study||13
10963228|NCT00493285|12136515|FG001|COMPLETED|Overall Study||6
10963229|NCT00493285|12136516|FG002|COMPLETED|Overall Study||9
10963230|NCT00493285|12136517|FG003|COMPLETED|Overall Study||6
10963231|NCT00493285|12136518|FG004|COMPLETED|Overall Study||9
10963232|NCT00493285|12136519|FG005|COMPLETED|Overall Study||5
10963233|NCT00493285|12136514|FG000|NOT COMPLETED|Overall Study||0
10963234|NCT00493285|12136515|FG001|NOT COMPLETED|Overall Study||0
10963235|NCT00493285|12136516|FG002|NOT COMPLETED|Overall Study||0
10963236|NCT00493285|12136517|FG003|NOT COMPLETED|Overall Study||0
10963237|NCT00493285|12136518|FG004|NOT COMPLETED|Overall Study||1
10963238|NCT00493285|12136519|FG005|NOT COMPLETED|Overall Study||0
10963239|NCT00493311|12136535|FG000|STARTED|Overall Study||29
10963240|NCT00493311|12136536|FG001|STARTED|Overall Study||31
10963241|NCT00493311|12136535|FG000|COMPLETED|Overall Study||27
10963242|NCT00493311|12136536|FG001|COMPLETED|Overall Study||29
10963243|NCT00493311|12136535|FG000|NOT COMPLETED|Overall Study||2
10963244|NCT00493311|12136536|FG001|NOT COMPLETED|Overall Study||2
10963245|NCT00493454|12136542|FG000|STARTED|Overall Study||6
10963246|NCT00493454|12136542|FG000|COMPLETED|Overall Study||5
10963247|NCT00493454|12136542|FG000|NOT COMPLETED|Overall Study||1
10963248|NCT00493636|12136548|FG000|STARTED|Overall Study||81
10963249|NCT00493636|12136549|FG001|STARTED|Overall Study||79
10963250|NCT00493636|12136548|FG000|COMPLETED|Overall Study||79
10963251|NCT00493636|12136549|FG001|COMPLETED|Overall Study||77
10963252|NCT00493636|12136548|FG000|NOT COMPLETED|Overall Study||2
10963253|NCT00493636|12136549|FG001|NOT COMPLETED|Overall Study||2
10963254|NCT00493649|12136555|FG000|STARTED|Overall Study||493
10963255|NCT00493649|12136555|FG000|COMPLETED|Overall Study||411
10963256|NCT00493649|12136555|FG000|NOT COMPLETED|Overall Study||82
10963257|NCT00493779|12136562|FG000|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
10963258|NCT00493779|12136562|FG000|COMPLETED|Overall Study|Completed follow-up phase|97
10963259|NCT00493779|12136562|FG000|NOT COMPLETED|Overall Study||1
10963260|NCT00493805|12136567|FG000|STARTED|Overall Study||17
10963261|NCT00493805|12136568|FG001|STARTED|Overall Study||42
10963262|NCT00493805|12136567|FG000|COMPLETED|Overall Study||17
10963263|NCT00493805|12136568|FG001|COMPLETED|Overall Study||42
10963264|NCT00493805|12136567|FG000|NOT COMPLETED|Overall Study||0
10963265|NCT00493805|12136568|FG001|NOT COMPLETED|Overall Study||0
10963266|NCT00493974|12136576|FG000|STARTED|Overall Study||60
10963267|NCT00493974|12136577|FG001|STARTED|Overall Study||59
10963268|NCT00493974|12136576|FG000|COMPLETED|Overall Study||47
10963269|NCT00493974|12136577|FG001|COMPLETED|Overall Study||45
10963270|NCT00493974|12136576|FG000|NOT COMPLETED|Overall Study||13
10963271|NCT00493974|12136577|FG001|NOT COMPLETED|Overall Study||14
10963272|NCT00494013|12136585|FG000|STARTED|Overall Study||223
10963273|NCT00494013|12136586|FG001|STARTED|Overall Study||219
10963274|NCT00494013|12136585|FG000|Full Analysis Set (Intent to Treat)|Overall Study||219
10963275|NCT00494013|12136586|FG001|Full Analysis Set (Intent to Treat)|Overall Study||210
10963276|NCT00494013|12136585|FG000|COMPLETED|Overall Study||193
10963277|NCT00494013|12136586|FG001|COMPLETED|Overall Study||183
10963278|NCT00494013|12136585|FG000|NOT COMPLETED|Overall Study||30
10963279|NCT00494013|12136586|FG001|NOT COMPLETED|Overall Study||36
10963280|NCT00494026|12136592|FG000|STARTED|Overall Study||4
10963281|NCT00494026|12136592|FG000|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
10963282|NCT00494026|12136592|FG000|NOT COMPLETED|Overall Study||4
10963283|NCT00494091|12136598|FG000|STARTED|Overall Study||6
10963284|NCT00494091|12136599|FG001|STARTED|Overall Study||76
10963285|NCT00494091|12136598|FG000|COMPLETED|Overall Study||0
10963286|NCT00494091|12136599|FG001|COMPLETED|Overall Study||0
10963287|NCT00494091|12136598|FG000|NOT COMPLETED|Overall Study||6
10963288|NCT00494091|12136599|FG001|NOT COMPLETED|Overall Study||76
10963289|NCT00494143|12136606|FG000|STARTED|Overall Study||1
10963290|NCT00494143|12136607|FG001|STARTED|Overall Study||2
10963291|NCT00494143|12136608|FG002|STARTED|Overall Study||3
10963292|NCT00494143|12136609|FG003|STARTED|Overall Study||0
10963293|NCT00494143|12136610|FG004|STARTED|Overall Study||1
10963294|NCT00494143|12136611|FG005|STARTED|Overall Study||0
10963295|NCT00494143|12136606|FG000|COMPLETED|Overall Study||1
10963296|NCT00494143|12136607|FG001|COMPLETED|Overall Study||2
10963297|NCT00494143|12136608|FG002|COMPLETED|Overall Study||3
10963298|NCT00494143|12136609|FG003|COMPLETED|Overall Study||0
10963299|NCT00494143|12136610|FG004|COMPLETED|Overall Study||1
10963300|NCT00494143|12136611|FG005|COMPLETED|Overall Study||0
10963301|NCT00494143|12136606|FG000|NOT COMPLETED|Overall Study||0
10963302|NCT00494143|12136607|FG001|NOT COMPLETED|Overall Study||0
10963303|NCT00494143|12136608|FG002|NOT COMPLETED|Overall Study||0
10963304|NCT00494143|12136609|FG003|NOT COMPLETED|Overall Study||0
10963305|NCT00494143|12136610|FG004|NOT COMPLETED|Overall Study||0
10963306|NCT00494143|12136611|FG005|NOT COMPLETED|Overall Study||0
10963307|NCT00494221|12136626|FG000|STARTED|Overall Study||58
10963308|NCT00494221|12136627|FG001|STARTED|Overall Study||56
10963309|NCT00494221|12136628|FG002|STARTED|Overall Study||58
10963310|NCT00494221|12136626|FG000|COMPLETED|Overall Study||42
10963311|NCT00494221|12136627|FG001|COMPLETED|Overall Study||45
10963312|NCT00494221|12136628|FG002|COMPLETED|Overall Study||44
10963313|NCT00494221|12136626|FG000|NOT COMPLETED|Overall Study||16
10963314|NCT00494221|12136627|FG001|NOT COMPLETED|Overall Study||11
10963315|NCT00494221|12136628|FG002|NOT COMPLETED|Overall Study||14
10963316|NCT00494299|12136638|FG000|STARTED|Overall Study||229
10963317|NCT00494299|12136639|FG001|STARTED|Overall Study||229
10963318|NCT00494299|12136638|FG000|Received Treatment|Overall Study||229
10963319|NCT00494299|12136639|FG001|Received Treatment|Overall Study||227
10963320|NCT00494299|12136638|FG000|COMPLETED|Overall Study||0
10963321|NCT00494299|12136639|FG001|COMPLETED|Overall Study||0
10963322|NCT00494299|12136638|FG000|NOT COMPLETED|Overall Study||229
10963323|NCT00494299|12136639|FG001|NOT COMPLETED|Overall Study||229
10963324|NCT00494442|12136647|FG000|STARTED|Overall Study|Patients received treatment|24
10963325|NCT00494442|12136648|FG001|STARTED|Overall Study|Patients received treatment|33
10963326|NCT00494442|12136647|FG000|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
10963327|NCT00494442|12136648|FG001|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
10963328|NCT00494442|12136647|FG000|NOT COMPLETED|Overall Study||17
10963329|NCT00494442|12136648|FG001|NOT COMPLETED|Overall Study||16
10963330|NCT00494481|12136656|FG000|STARTED|Overall Study|randomised patients|35
10963331|NCT00494481|12136657|FG001|STARTED|Overall Study|randomised patients|29
10963332|NCT00494481|12136656|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
10963333|NCT00494481|12136657|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
10963334|NCT00494481|12136656|FG000|NOT COMPLETED|Overall Study||29
10963335|NCT00494481|12136657|FG001|NOT COMPLETED|Overall Study||24
10963336|NCT00494494|12136665|FG000|STARTED|Overall Study||40
10963337|NCT00494494|12136666|FG001|STARTED|Overall Study||39
10963338|NCT00494494|12136665|FG000|COMPLETED|Overall Study||40
10963339|NCT00494494|12136666|FG001|COMPLETED|Overall Study||39
10963340|NCT00494494|12136665|FG000|NOT COMPLETED|Overall Study||0
10963341|NCT00494494|12136666|FG001|NOT COMPLETED|Overall Study||0
10963342|NCT00494507|12136676|FG000|STARTED|Double-Blind Phase||12
10963343|NCT00494507|12136677|FG001|STARTED|Double-Blind Phase||9
10963344|NCT00494507|12136678|FG002|STARTED|Double-Blind Phase||24
10963345|NCT00494507|12136679|FG003|STARTED|Double-Blind Phase||20
10963346|NCT00494507|12136676|FG000|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
10963347|NCT00494507|12136677|FG001|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
10963348|NCT00494507|12136678|FG002|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
10963349|NCT00494507|12136679|FG003|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
10963350|NCT00494507|12136676|FG000|COMPLETED|Double-Blind Phase||9
10963351|NCT00494507|12136677|FG001|COMPLETED|Double-Blind Phase||9
10963352|NCT00494507|12136678|FG002|COMPLETED|Double-Blind Phase||22
10963353|NCT00494507|12136679|FG003|COMPLETED|Double-Blind Phase||19
10963354|NCT00494507|12136676|FG000|NOT COMPLETED|Double-Blind Phase||3
10963355|NCT00494507|12136677|FG001|NOT COMPLETED|Double-Blind Phase||0
10963356|NCT00494507|12136678|FG002|NOT COMPLETED|Double-Blind Phase||2
10963357|NCT00494507|12136679|FG003|NOT COMPLETED|Double-Blind Phase||1
10963358|NCT00494507|12136676|FG000|STARTED|Open-Label Phase||9
10963359|NCT00494507|12136677|FG001|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
10963360|NCT00494507|12136678|FG002|STARTED|Open-Label Phase||22
10963361|NCT00494507|12136679|FG003|STARTED|Open-Label Phase||19
10963362|NCT00494507|12136676|FG000|COMPLETED|Open-Label Phase||9
10963363|NCT00494507|12136677|FG001|COMPLETED|Open-Label Phase||7
10963364|NCT00494507|12136678|FG002|COMPLETED|Open-Label Phase||17
10963365|NCT00494507|12136679|FG003|COMPLETED|Open-Label Phase||14
10963366|NCT00494507|12136676|FG000|NOT COMPLETED|Open-Label Phase||0
10963367|NCT00494507|12136677|FG001|NOT COMPLETED|Open-Label Phase||1
10963368|NCT00494507|12136678|FG002|NOT COMPLETED|Open-Label Phase||5
10963369|NCT00494507|12136679|FG003|NOT COMPLETED|Open-Label Phase||5
10963370|NCT00494585|12136699|FG000|STARTED|Overall Study||22
10963371|NCT00494585|12136699|FG000|COMPLETED|Overall Study||22
10963372|NCT00494585|12136699|FG000|NOT COMPLETED|Overall Study||0
10963373|NCT00494676|12136703|FG000|STARTED|Allocation||37
10963374|NCT00494676|12136704|FG001|STARTED|Allocation||36
10963375|NCT00494676|12136703|FG000|COMPLETED|Allocation||35
10963376|NCT00494676|12136704|FG001|COMPLETED|Allocation||32
10963377|NCT00494676|12136703|FG000|NOT COMPLETED|Allocation||2
10963378|NCT00494676|12136704|FG001|NOT COMPLETED|Allocation||4
10963379|NCT00494676|12136703|FG000|STARTED|First Intervention||35
10963380|NCT00494676|12136704|FG001|STARTED|First Intervention||32
10963381|NCT00494676|12136703|FG000|COMPLETED|First Intervention||34
10963382|NCT00494676|12136704|FG001|COMPLETED|First Intervention||29
10963383|NCT00494676|12136703|FG000|NOT COMPLETED|First Intervention||1
10963384|NCT00494676|12136704|FG001|NOT COMPLETED|First Intervention||3
10963385|NCT00494676|12136703|FG000|STARTED|Second Intervention||34
10963386|NCT00494676|12136704|FG001|STARTED|Second Intervention||29
10963387|NCT00494676|12136703|FG000|COMPLETED|Second Intervention||33
10963388|NCT00494676|12136704|FG001|COMPLETED|Second Intervention||28
10963389|NCT00494676|12136703|FG000|NOT COMPLETED|Second Intervention||1
10963390|NCT00494676|12136704|FG001|NOT COMPLETED|Second Intervention||1
10963391|NCT00494780|12136712|FG000|STARTED|Overall Study||29
10963392|NCT00494780|12136713|FG001|STARTED|Overall Study||30
10963393|NCT00494780|12136712|FG000|COMPLETED|Overall Study||18
10963394|NCT00494780|12136713|FG001|COMPLETED|Overall Study||17
10963395|NCT00494780|12136712|FG000|NOT COMPLETED|Overall Study||11
10963396|NCT00494780|12136713|FG001|NOT COMPLETED|Overall Study||13
10963397|NCT00494806|12136723|FG000|STARTED|Overall Study||34
10963398|NCT00494806|12136724|FG001|STARTED|Overall Study||32
10963399|NCT00494806|12136723|FG000|COMPLETED|Overall Study||34
10963400|NCT00494806|12136724|FG001|COMPLETED|Overall Study||32
10963401|NCT00494806|12136723|FG000|NOT COMPLETED|Overall Study||0
10963402|NCT00494806|12136724|FG001|NOT COMPLETED|Overall Study||0
10963403|NCT00494871|12136732|FG000|STARTED|Double-blind (DB) Treatment Period||640
10963404|NCT00494871|12136733|FG001|STARTED|Double-blind (DB) Treatment Period||640
10963405|NCT00494871|12136732|FG000|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
10963406|NCT00494871|12136733|FG001|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
10963407|NCT00494871|12136732|FG000|COMPLETED|Double-blind (DB) Treatment Period||480
10963408|NCT00494871|12136733|FG001|COMPLETED|Double-blind (DB) Treatment Period||468
10963409|NCT00494871|12136732|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||160
10963410|NCT00494871|12136733|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||172
10963411|NCT00494871|12136732|FG000|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
10963412|NCT00494871|12136733|FG001|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
10963413|NCT00494871|12136732|FG000|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
10963414|NCT00494871|12136733|FG001|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
10963415|NCT00494871|12136732|FG000|COMPLETED|Follow-up (FU) Period||610
10963416|NCT00494871|12136733|FG001|COMPLETED|Follow-up (FU) Period||616
10963417|NCT00494871|12136732|FG000|NOT COMPLETED|Follow-up (FU) Period||29
10963418|NCT00494871|12136733|FG001|NOT COMPLETED|Follow-up (FU) Period||23
10963419|NCT00494975|12136743|FG000|STARTED|Overall Study||10
10963420|NCT00494975|12136744|FG001|STARTED|Overall Study||11
10963421|NCT00494975|12136743|FG000|COMPLETED|Overall Study||8
10963422|NCT00494975|12136744|FG001|COMPLETED|Overall Study||10
10963423|NCT00494975|12136743|FG000|NOT COMPLETED|Overall Study||2
10963424|NCT00494975|12136744|FG001|NOT COMPLETED|Overall Study||1
10963425|NCT00495040|12136750|FG000|STARTED|Overall Study||38
10963426|NCT00495040|12136750|FG000|COMPLETED|Overall Study||35
10963427|NCT00495040|12136750|FG000|NOT COMPLETED|Overall Study||3
10963428|NCT00495079|12136754|FG000|STARTED|Overall Study||65
10963429|NCT00495079|12136754|FG000|COMPLETED|Overall Study||65
10963430|NCT00495079|12136754|FG000|NOT COMPLETED|Overall Study||0
10963431|NCT00495157|12136764|FG000|STARTED|Overall Study||113
10963432|NCT00495157|12136765|FG001|STARTED|Overall Study||115
10963433|NCT00495157|12136766|FG002|STARTED|Overall Study||114
10963434|NCT00495157|12136764|FG000|COMPLETED|Overall Study||97
10963435|NCT00495157|12136765|FG001|COMPLETED|Overall Study||92
10963436|NCT00495157|12136766|FG002|COMPLETED|Overall Study||101
10963437|NCT00495157|12136764|FG000|NOT COMPLETED|Overall Study||16
10963438|NCT00495157|12136765|FG001|NOT COMPLETED|Overall Study||23
10963439|NCT00495157|12136766|FG002|NOT COMPLETED|Overall Study||13
10963440|NCT00495170|12136774|FG000|STARTED|Overall Study||84
10963441|NCT00495170|12136774|FG000|COMPLETED|Overall Study||64
10963442|NCT00495170|12136774|FG000|NOT COMPLETED|Overall Study||20
10963443|NCT00495391|12136780|FG000|STARTED|Overall Study||42
10963444|NCT00495391|12136781|FG001|STARTED|Overall Study||22
10963445|NCT00495391|12136780|FG000|From Baseline to Week 8|Overall Study||31
10963446|NCT00495391|12136781|FG001|From Baseline to Week 8|Overall Study||20
10963447|NCT00495391|12136780|FG000|From Baseline to Week 16|Overall Study||24
10963448|NCT00495391|12136781|FG001|From Baseline to Week 16|Overall Study||11
10963449|NCT00495391|12136780|FG000|From Baseline to End of Treatment|Overall Study||6
10963450|NCT00495391|12136781|FG001|From Baseline to End of Treatment|Overall Study||1
10963451|NCT00495391|12136780|FG000|From Baseline to End of Follow up|Overall Study||6
10963452|NCT00495391|12136781|FG001|From Baseline to End of Follow up|Overall Study||1
10963453|NCT00495391|12136780|FG000|COMPLETED|Overall Study||6
10963454|NCT00495391|12136781|FG001|COMPLETED|Overall Study||1
10963455|NCT00495391|12136780|FG000|NOT COMPLETED|Overall Study||36
10963456|NCT00495391|12136781|FG001|NOT COMPLETED|Overall Study||21
10963457|NCT00495469|12136794|FG000|STARTED|Overall Study||36
10963458|NCT00495469|12136795|FG001|STARTED|Overall Study||37
10963459|NCT00495469|12136796|FG002|STARTED|Overall Study||34
10963460|NCT00495469|12136797|FG003|STARTED|Overall Study||36
10963461|NCT00495469|12136798|FG004|STARTED|Overall Study||36
10963462|NCT00495469|12136799|FG005|STARTED|Overall Study||36
10963463|NCT00495469|12136800|FG006|STARTED|Overall Study||35
10963464|NCT00495469|12136794|FG000|COMPLETED|Overall Study||30
10963465|NCT00495469|12136795|FG001|COMPLETED|Overall Study||30
10963466|NCT00495469|12136796|FG002|COMPLETED|Overall Study||27
10963467|NCT00495469|12136797|FG003|COMPLETED|Overall Study||32
10963468|NCT00495469|12136798|FG004|COMPLETED|Overall Study||31
10963469|NCT00495469|12136799|FG005|COMPLETED|Overall Study||31
10963470|NCT00495469|12136800|FG006|COMPLETED|Overall Study||30
10963471|NCT00495469|12136794|FG000|NOT COMPLETED|Overall Study||6
10963472|NCT00495469|12136795|FG001|NOT COMPLETED|Overall Study||7
10963473|NCT00495469|12136796|FG002|NOT COMPLETED|Overall Study||7
10963474|NCT00495469|12136797|FG003|NOT COMPLETED|Overall Study||4
10963475|NCT00495469|12136798|FG004|NOT COMPLETED|Overall Study||5
10963476|NCT00495469|12136799|FG005|NOT COMPLETED|Overall Study||5
10963477|NCT00495469|12136800|FG006|NOT COMPLETED|Overall Study||5
10963478|NCT00495495|12136823|FG000|STARTED|Overall Study||394
10963479|NCT00495495|12136823|FG000|COMPLETED|Overall Study||295
10963480|NCT00495495|12136823|FG000|NOT COMPLETED|Overall Study||99
10963481|NCT00495521|12136830|FG000|STARTED|Overall Study||1
10963482|NCT00495521|12136831|FG001|STARTED|Overall Study||1
10963483|NCT00495521|12136830|FG000|COMPLETED|Overall Study||1
10963484|NCT00495521|12136831|FG001|COMPLETED|Overall Study||0
10963485|NCT00495521|12136830|FG000|NOT COMPLETED|Overall Study||0
10963486|NCT00495521|12136831|FG001|NOT COMPLETED|Overall Study||1
10963487|NCT00495586|12136839|FG000|STARTED|Overall Study||156
10963488|NCT00495586|12136840|FG001|STARTED|Overall Study||162
10963489|NCT00495586|12136839|FG000|COMPLETED|Overall Study||152
10963490|NCT00495586|12136840|FG001|COMPLETED|Overall Study||158
10963491|NCT00495586|12136839|FG000|NOT COMPLETED|Overall Study||4
10963492|NCT00495586|12136840|FG001|NOT COMPLETED|Overall Study||4
10963493|NCT00495612|12136850|FG000|STARTED|Overall Study||36
10963494|NCT00495612|12136851|FG001|STARTED|Overall Study||33
10963495|NCT00495612|12136850|FG000|COMPLETED|Overall Study||32
10963496|NCT00495612|12136851|FG001|COMPLETED|Overall Study||33
10963497|NCT00495612|12136850|FG000|NOT COMPLETED|Overall Study||4
10963498|NCT00495612|12136851|FG001|NOT COMPLETED|Overall Study||0
10963499|NCT00495625|12136857|FG000|STARTED|Overall Study||33
10963500|NCT00495625|12136857|FG000|COMPLETED|Overall Study||23
10963501|NCT00495625|12136857|FG000|NOT COMPLETED|Overall Study||10
10963502|NCT00495677|12136868|FG000|STARTED|Stage 1 (25 Days)||2
10963503|NCT00495677|12136869|FG001|STARTED|Stage 1 (25 Days)||6
10963504|NCT00495677|12136870|FG002|STARTED|Stage 1 (25 Days)||6
10963505|NCT00495677|12136871|FG003|STARTED|Stage 1 (25 Days)||6
10963506|NCT00495677|12136872|FG004|STARTED|Stage 1 (25 Days)||0
10963507|NCT00495677|12136873|FG005|STARTED|Stage 1 (25 Days)||0
10963508|NCT00495677|12136874|FG006|STARTED|Stage 1 (25 Days)||0
10963509|NCT00495677|12136868|FG000|COMPLETED|Stage 1 (25 Days)||2
10963510|NCT00495677|12136869|FG001|COMPLETED|Stage 1 (25 Days)||6
10963511|NCT00495677|12136870|FG002|COMPLETED|Stage 1 (25 Days)||5
10963512|NCT00495677|12136871|FG003|COMPLETED|Stage 1 (25 Days)||6
10963513|NCT00495677|12136872|FG004|COMPLETED|Stage 1 (25 Days)||0
10963514|NCT00495677|12136873|FG005|COMPLETED|Stage 1 (25 Days)||0
10963515|NCT00495677|12136874|FG006|COMPLETED|Stage 1 (25 Days)||0
10963516|NCT00495677|12136868|FG000|NOT COMPLETED|Stage 1 (25 Days)||0
10963517|NCT00495677|12136869|FG001|NOT COMPLETED|Stage 1 (25 Days)||0
10963518|NCT00495677|12136870|FG002|NOT COMPLETED|Stage 1 (25 Days)||1
10963519|NCT00495677|12136871|FG003|NOT COMPLETED|Stage 1 (25 Days)||0
10963520|NCT00495677|12136872|FG004|NOT COMPLETED|Stage 1 (25 Days)||0
10963521|NCT00495677|12136873|FG005|NOT COMPLETED|Stage 1 (25 Days)||0
10963522|NCT00495677|12136874|FG006|NOT COMPLETED|Stage 1 (25 Days)||0
10963523|NCT00495677|12136868|FG000|STARTED|Stage 2 (25 Days)||0
10963524|NCT00495677|12136869|FG001|STARTED|Stage 2 (25 Days)||0
10963525|NCT00495677|12136870|FG002|STARTED|Stage 2 (25 Days)||0
10963526|NCT00495677|12136871|FG003|STARTED|Stage 2 (25 Days)||0
10963527|NCT00495677|12136872|FG004|STARTED|Stage 2 (25 Days)||8
10963528|NCT00495677|12136873|FG005|STARTED|Stage 2 (25 Days)||8
10963529|NCT00495677|12136874|FG006|STARTED|Stage 2 (25 Days)||7
10963530|NCT00495677|12136868|FG000|COMPLETED|Stage 2 (25 Days)||0
10963531|NCT00495677|12136869|FG001|COMPLETED|Stage 2 (25 Days)||0
10963532|NCT00495677|12136870|FG002|COMPLETED|Stage 2 (25 Days)||0
10963533|NCT00495677|12136871|FG003|COMPLETED|Stage 2 (25 Days)||0
10963534|NCT00495677|12136872|FG004|COMPLETED|Stage 2 (25 Days)||8
10963535|NCT00495677|12136873|FG005|COMPLETED|Stage 2 (25 Days)||8
10963536|NCT00495677|12136874|FG006|COMPLETED|Stage 2 (25 Days)||7
10963537|NCT00495677|12136868|FG000|NOT COMPLETED|Stage 2 (25 Days)||0
10963538|NCT00495677|12136869|FG001|NOT COMPLETED|Stage 2 (25 Days)||0
10963539|NCT00495677|12136870|FG002|NOT COMPLETED|Stage 2 (25 Days)||0
10963540|NCT00495677|12136871|FG003|NOT COMPLETED|Stage 2 (25 Days)||0
10963541|NCT00495677|12136872|FG004|NOT COMPLETED|Stage 2 (25 Days)||0
10963542|NCT00495677|12136873|FG005|NOT COMPLETED|Stage 2 (25 Days)||0
10963543|NCT00495677|12136874|FG006|NOT COMPLETED|Stage 2 (25 Days)||0
10963544|NCT00495755|12136890|FG000|STARTED|Overall Study||13
10963545|NCT00495755|12136890|FG000|COMPLETED|Overall Study||10
10963546|NCT00495755|12136890|FG000|NOT COMPLETED|Overall Study||3
10963547|NCT00495794|12136897|FG000|STARTED|Overall Study||2319
10963548|NCT00495794|12136898|FG001|STARTED|Overall Study||2303
10963549|NCT00495794|12136897|FG000|COMPLETED|Overall Study||1797
10963550|NCT00495794|12136898|FG001|COMPLETED|Overall Study||2303
10963551|NCT00495794|12136897|FG000|NOT COMPLETED|Overall Study||522
10963552|NCT00495794|12136898|FG001|NOT COMPLETED|Overall Study||0
10963553|NCT00495820|12136906|FG000|STARTED|Overall Study||30
10963554|NCT00495820|12136907|FG001|STARTED|Overall Study||30
10963555|NCT00495820|12136906|FG000|COMPLETED|Overall Study||29
10963556|NCT00495820|12136907|FG001|COMPLETED|Overall Study||29
10963557|NCT00495820|12136906|FG000|NOT COMPLETED|Overall Study||1
10963558|NCT00495820|12136907|FG001|NOT COMPLETED|Overall Study||1
10963559|NCT00496015|12136918|FG000|STARTED|Overall Study||178
10963560|NCT00496015|12136919|FG001|STARTED|Overall Study||27
10963561|NCT00496015|12136920|FG002|STARTED|Overall Study||172
10963562|NCT00496015|12136921|FG003|STARTED|Overall Study||37
10963563|NCT00496015|12136922|FG004|STARTED|Overall Study||336
10963564|NCT00496015|12136918|FG000|COMPLETED|Overall Study||177
10963565|NCT00496015|12136919|FG001|COMPLETED|Overall Study||27
10963566|NCT00496015|12136920|FG002|COMPLETED|Overall Study||172
10963567|NCT00496015|12136921|FG003|COMPLETED|Overall Study||36
10963568|NCT00496015|12136922|FG004|COMPLETED|Overall Study||336
10963569|NCT00496015|12136918|FG000|NOT COMPLETED|Overall Study||1
10963570|NCT00496015|12136919|FG001|NOT COMPLETED|Overall Study||0
10963571|NCT00496015|12136920|FG002|NOT COMPLETED|Overall Study||0
10963572|NCT00496015|12136921|FG003|NOT COMPLETED|Overall Study||1
10963573|NCT00496015|12136922|FG004|NOT COMPLETED|Overall Study||0
10963574|NCT00496054|12136942|FG000|STARTED|Overall Study||110
10963575|NCT00496054|12136942|FG000|COMPLETED|Overall Study||102
10963576|NCT00496054|12136942|FG000|NOT COMPLETED|Overall Study||8
10963577|NCT00496080|12136946|FG000|STARTED|Overall Study||87
10963578|NCT00496080|12136946|FG000|COMPLETED|Overall Study||60
10963579|NCT00496080|12136946|FG000|NOT COMPLETED|Overall Study||27
10963580|NCT00496197|12136951|FG000|STARTED|Overall Study||282
10963581|NCT00496197|12136951|FG000|COMPLETED|Overall Study||160
10963582|NCT00496197|12136951|FG000|NOT COMPLETED|Overall Study||122
10963583|NCT00496262|12136955|FG000|STARTED|Overall Study||15
10963584|NCT00496262|12136955|FG000|COMPLETED|Overall Study||15
10963585|NCT00496262|12136955|FG000|NOT COMPLETED|Overall Study||0
10963586|NCT00496340|12136961|FG000|STARTED|Overall Study||42
10963587|NCT00496340|12136961|FG000|COMPLETED|Overall Study||42
10963588|NCT00496340|12136961|FG000|NOT COMPLETED|Overall Study||0
10963589|NCT00496366|12136965|FG000|STARTED|Overall Study||11
10963590|NCT00496366|12136965|FG000|COMPLETED|Overall Study||10
10963591|NCT00496366|12136965|FG000|NOT COMPLETED|Overall Study||1
10963592|NCT00496379|12136969|FG000|STARTED|Overall Study||15
10963593|NCT00496379|12136969|FG000|COMPLETED|Overall Study||15
10963594|NCT00496379|12136969|FG000|NOT COMPLETED|Overall Study||0
10963595|NCT00496470|12136975|FG000|STARTED|Overall Study||329
10963596|NCT00496470|12136976|FG001|STARTED|Overall Study||331
10963597|NCT00496470|12136975|FG000|Received Study Medication|Overall Study||329
10963598|NCT00496470|12136976|FG001|Received Study Medication|Overall Study||330
10963599|NCT00496470|12136975|FG000|COMPLETED|Overall Study||303
10963600|NCT00496470|12136976|FG001|COMPLETED|Overall Study||302
10963601|NCT00496470|12136975|FG000|NOT COMPLETED|Overall Study||26
10963602|NCT00496470|12136976|FG001|NOT COMPLETED|Overall Study||29
10963603|NCT00496483|12136982|FG000|STARTED|Overall Study||60
10963604|NCT00496483|12136982|FG000|Dosed|Overall Study||51
10963605|NCT00496483|12136982|FG000|COMPLETED|Overall Study||48
10963606|NCT00496483|12136982|FG000|NOT COMPLETED|Overall Study||12
10963607|NCT00496587|12136989|FG000|STARTED|Overall Study||34
10963608|NCT00496587|12136989|FG000|COMPLETED|Overall Study||3
10963609|NCT00496587|12136989|FG000|NOT COMPLETED|Overall Study||31
10963610|NCT00496626|12136995|FG000|STARTED|Overall Study||302
10963611|NCT00496626|12136996|FG001|STARTED|Overall Study||298
10963612|NCT00496626|12136995|FG000|COMPLETED|Overall Study||296
10963613|NCT00496626|12136996|FG001|COMPLETED|Overall Study||292
10963614|NCT00496626|12136995|FG000|NOT COMPLETED|Overall Study||6
10963615|NCT00496626|12136996|FG001|NOT COMPLETED|Overall Study||6
10963616|NCT00496769|12137008|FG000|STARTED|Double Blind|Randomized|2807
10963617|NCT00496769|12137009|FG001|STARTED|Double Blind|Randomized|2791
10963618|NCT00496769|12137010|FG002|STARTED|Double Blind||0
10963619|NCT00496769|12137008|FG000|Received Treatment|Double Blind||2798
10963620|NCT00496769|12137009|FG001|Received Treatment|Double Blind||2708
10963621|NCT00496769|12137010|FG002|Received Treatment|Double Blind||0
10963622|NCT00496769|12137008|FG000|COMPLETED|Double Blind||2249
10963623|NCT00496769|12137009|FG001|COMPLETED|Double Blind||2142
10963624|NCT00496769|12137010|FG002|COMPLETED|Double Blind||0
10963625|NCT00496769|12137008|FG000|NOT COMPLETED|Double Blind||558
10963626|NCT00496769|12137009|FG001|NOT COMPLETED|Double Blind||649
10963627|NCT00496769|12137010|FG002|NOT COMPLETED|Double Blind||0
10963628|NCT00496769|12137008|FG000|STARTED|Open Label||0
10963629|NCT00496769|12137009|FG001|STARTED|Open Label||0
10963630|NCT00496769|12137010|FG002|STARTED|Open Label||3275
10963631|NCT00496769|12137008|FG000|COMPLETED|Open Label||0
10963632|NCT00496769|12137009|FG001|COMPLETED|Open Label||0
10963633|NCT00496769|12137010|FG002|COMPLETED|Open Label||2264
10963634|NCT00496769|12137008|FG000|NOT COMPLETED|Open Label||0
10963635|NCT00496769|12137009|FG001|NOT COMPLETED|Open Label||0
10963636|NCT00496769|12137010|FG002|NOT COMPLETED|Open Label||1011
10963637|NCT00496808|12137019|FG000|STARTED|Overall Study||69
10963638|NCT00496808|12137019|FG000|COMPLETED|Overall Study||69
10963639|NCT00496808|12137019|FG000|NOT COMPLETED|Overall Study||0
10963640|NCT00496860|12137026|FG000|STARTED|Overall Study||4
10963641|NCT00496860|12137027|FG001|STARTED|Overall Study||16
10963642|NCT00496860|12137028|FG002|STARTED|Overall Study||6
10963643|NCT00496860|12137026|FG000|COMPLETED|Overall Study||3
10963644|NCT00496860|12137027|FG001|COMPLETED|Overall Study||15
10963645|NCT00496860|12137028|FG002|COMPLETED|Overall Study||6
10963646|NCT00496860|12137026|FG000|NOT COMPLETED|Overall Study||1
10963647|NCT00496860|12137027|FG001|NOT COMPLETED|Overall Study||1
10963648|NCT00496860|12137028|FG002|NOT COMPLETED|Overall Study||0
10963649|NCT00496873|12137036|FG000|STARTED|Overall Study||85
10963650|NCT00496873|12137036|FG000|COMPLETED|Overall Study||78
10963651|NCT00496873|12137036|FG000|NOT COMPLETED|Overall Study||7
10963652|NCT00496964|12137042|FG000|STARTED|Overall Study||1
10963653|NCT00496964|12137043|FG001|STARTED|Overall Study||4
10963654|NCT00496964|12137042|FG000|COMPLETED|Overall Study||1
10963655|NCT00496964|12137043|FG001|COMPLETED|Overall Study||3
10963656|NCT00496964|12137042|FG000|NOT COMPLETED|Overall Study||0
10963657|NCT00496964|12137043|FG001|NOT COMPLETED|Overall Study||1
10963658|NCT00497055|12137053|FG000|STARTED|Overall Study||45
10963659|NCT00497055|12137054|FG001|STARTED|Overall Study||45
10963660|NCT00497055|12137053|FG000|COMPLETED|Overall Study||35
10963661|NCT00497055|12137054|FG001|COMPLETED|Overall Study||40
10963662|NCT00497055|12137053|FG000|NOT COMPLETED|Overall Study||10
10963663|NCT00497055|12137054|FG001|NOT COMPLETED|Overall Study||5
10963664|NCT00497081|12137062|FG000|STARTED|Overall Study||30
10963665|NCT00497081|12137063|FG001|STARTED|Overall Study||30
10963666|NCT00497081|12137062|FG000|COMPLETED|Overall Study||28
10963667|NCT00497081|12137063|FG001|COMPLETED|Overall Study||28
10963668|NCT00497081|12137062|FG000|NOT COMPLETED|Overall Study||2
10963669|NCT00497081|12137063|FG001|NOT COMPLETED|Overall Study||2
10963670|NCT00497146|12137071|FG000|STARTED|Treatment Period||115
10963671|NCT00497146|12137072|FG001|STARTED|Treatment Period||112
10963672|NCT00497146|12137071|FG000|COMPLETED|Treatment Period||88
10963673|NCT00497146|12137072|FG001|COMPLETED|Treatment Period||91
10963674|NCT00497146|12137071|FG000|NOT COMPLETED|Treatment Period||27
10963675|NCT00497146|12137072|FG001|NOT COMPLETED|Treatment Period||21
10963676|NCT00497146|12137071|FG000|STARTED|Long-term Follow-up Period||65
10963677|NCT00497146|12137072|FG001|STARTED|Long-term Follow-up Period||72
10963678|NCT00497146|12137071|FG000|COMPLETED|Long-term Follow-up Period||50
10963679|NCT00497146|12137072|FG001|COMPLETED|Long-term Follow-up Period||66
10963680|NCT00497146|12137071|FG000|NOT COMPLETED|Long-term Follow-up Period||15
10963681|NCT00497146|12137072|FG001|NOT COMPLETED|Long-term Follow-up Period||6
10963682|NCT00497198|12137082|FG000|STARTED|Overall Study||92
10963683|NCT00497198|12137083|FG001|STARTED|Overall Study||91
10963684|NCT00497198|12137082|FG000|COMPLETED|Overall Study||87
10963685|NCT00497198|12137083|FG001|COMPLETED|Overall Study||86
10963686|NCT00497198|12137082|FG000|NOT COMPLETED|Overall Study||5
10963687|NCT00497198|12137083|FG001|NOT COMPLETED|Overall Study||5
10963688|NCT00497289|12137091|FG000|STARTED|Overall Study||24
10963689|NCT00497289|12137092|FG001|STARTED|Overall Study||24
10963690|NCT00497289|12137091|FG000|COMPLETED|Overall Study||19
10963691|NCT00497289|12137092|FG001|COMPLETED|Overall Study||18
10963692|NCT00497289|12137091|FG000|NOT COMPLETED|Overall Study||5
10963693|NCT00497289|12137092|FG001|NOT COMPLETED|Overall Study||6
10963694|NCT00497770|12137104|FG000|STARTED|Overall Study||304
10963695|NCT00497770|12137105|FG001|STARTED|Overall Study||65
10963696|NCT00497770|12137106|FG002|STARTED|Overall Study||37
10963697|NCT00497770|12137107|FG003|STARTED|Overall Study||28
10963698|NCT00497770|12137104|FG000|COMPLETED|Overall Study||304
10963699|NCT00497770|12137105|FG001|COMPLETED|Overall Study||65
10963700|NCT00497770|12137106|FG002|COMPLETED|Overall Study||37
10963701|NCT00497770|12137107|FG003|COMPLETED|Overall Study||28
10963702|NCT00497770|12137104|FG000|NOT COMPLETED|Overall Study||0
10963703|NCT00497770|12137105|FG001|NOT COMPLETED|Overall Study||0
10963704|NCT00497770|12137106|FG002|NOT COMPLETED|Overall Study||0
10963705|NCT00497770|12137107|FG003|NOT COMPLETED|Overall Study||0
10963706|NCT00497796|12137120|FG000|STARTED|Overall Study||147
10963707|NCT00497796|12137121|FG001|STARTED|Overall Study||160
10963708|NCT00497796|12137120|FG000|COMPLETED|Overall Study||62
10963709|NCT00497796|12137121|FG001|COMPLETED|Overall Study||101
10963710|NCT00497796|12137120|FG000|NOT COMPLETED|Overall Study||85
10963711|NCT00497796|12137121|FG001|NOT COMPLETED|Overall Study||59
10963712|NCT00497874|12137129|FG000|STARTED|Overall Study||443
10963713|NCT00497874|12137130|FG001|STARTED|Overall Study||459
10963714|NCT00497874|12137129|FG000|COMPLETED|Overall Study||296
10963715|NCT00497874|12137130|FG001|COMPLETED|Overall Study||343
10963716|NCT00497874|12137129|FG000|NOT COMPLETED|Overall Study||147
10963717|NCT00497874|12137130|FG001|NOT COMPLETED|Overall Study||116
10963718|NCT00498173|12137140|FG000|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
10963719|NCT00498173|12137141|FG001|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
10963720|NCT00498173|12137142|FG002|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
10963721|NCT00498173|12137140|FG000|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
10963722|NCT00498173|12137141|FG001|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
10963723|NCT00498173|12137142|FG002|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
10963724|NCT00498173|12137140|FG000|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
10963725|NCT00498173|12137141|FG001|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
10963726|NCT00498173|12137142|FG002|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
10963727|NCT00498173|12137140|FG000|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
10963728|NCT00498173|12137141|FG001|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
10963729|NCT00498173|12137142|FG002|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
10963730|NCT00498173|12137140|FG000|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
10963731|NCT00498173|12137141|FG001|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
10963732|NCT00498173|12137142|FG002|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
10963733|NCT00498173|12137140|FG000|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
10963734|NCT00498173|12137141|FG001|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
10963735|NCT00498173|12137142|FG002|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
10963736|NCT00498186|12137150|FG000|STARTED|Overall Study||295
10963737|NCT00498186|12137150|FG000|COMPLETED|Overall Study||122
10963738|NCT00498186|12137150|FG000|NOT COMPLETED|Overall Study||173
10963739|NCT00498355|12137154|FG000|STARTED|Overall Study||7
10963740|NCT00498355|12137154|FG000|COMPLETED|Overall Study||6
10963741|NCT00498355|12137154|FG000|NOT COMPLETED|Overall Study||1
10963742|NCT00498368|12137161|FG000|STARTED|Overall Study||17
10963743|NCT00498368|12137162|FG001|STARTED|Overall Study||17
10963744|NCT00498368|12137161|FG000|COMPLETED|Overall Study||14
10963745|NCT00498368|12137162|FG001|COMPLETED|Overall Study||15
10963746|NCT00498368|12137161|FG000|NOT COMPLETED|Overall Study||3
10963747|NCT00498368|12137162|FG001|NOT COMPLETED|Overall Study||2
10963748|NCT00498433|12137171|FG000|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
10963749|NCT00498433|12137172|FG001|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
10963750|NCT00498433|12137173|FG002|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
10963751|NCT00498433|12137171|FG000|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
10963752|NCT00498433|12137172|FG001|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
10963753|NCT00498433|12137173|FG002|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
10963754|NCT00498433|12137171|FG000|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
10963755|NCT00498433|12137172|FG001|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
10963756|NCT00498433|12137173|FG002|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
10963757|NCT00498433|12137171|FG000|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
10963758|NCT00498433|12137172|FG001|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
10963759|NCT00498433|12137173|FG002|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
10963760|NCT00498433|12137171|FG000|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
10963761|NCT00498433|12137172|FG001|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
10963762|NCT00498433|12137173|FG002|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
10963763|NCT00498433|12137171|FG000|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
10963764|NCT00498433|12137172|FG001|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
10963765|NCT00498433|12137173|FG002|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
10963766|NCT00498433|12137171|FG000|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
10963767|NCT00498433|12137172|FG001|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
10963768|NCT00498433|12137173|FG002|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
10963769|NCT00498433|12137171|FG000|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
10963770|NCT00498433|12137172|FG001|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
10963771|NCT00498433|12137173|FG002|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
10963772|NCT00498433|12137171|FG000|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
10963773|NCT00498433|12137172|FG001|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
10963774|NCT00498433|12137173|FG002|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
10963775|NCT00498433|12137171|FG000|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
10963776|NCT00498433|12137172|FG001|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
10963777|NCT00498433|12137173|FG002|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
10963778|NCT00498433|12137171|FG000|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
10963779|NCT00498433|12137172|FG001|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
10963780|NCT00498433|12137173|FG002|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
10963781|NCT00498433|12137171|FG000|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
10963782|NCT00498433|12137172|FG001|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
10963783|NCT00498433|12137173|FG002|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
10963784|NCT00498433|12137171|FG000|STARTED|Part 2: Double Blind (12 Weeks)||0
10963785|NCT00498433|12137172|FG001|STARTED|Part 2: Double Blind (12 Weeks)||8
10963786|NCT00498433|12137173|FG002|STARTED|Part 2: Double Blind (12 Weeks)||8
10963787|NCT00498433|12137171|FG000|COMPLETED|Part 2: Double Blind (12 Weeks)||0
10963788|NCT00498433|12137172|FG001|COMPLETED|Part 2: Double Blind (12 Weeks)||8
10963789|NCT00498433|12137173|FG002|COMPLETED|Part 2: Double Blind (12 Weeks)||8
10963790|NCT00498433|12137171|FG000|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
10963791|NCT00498433|12137172|FG001|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
10963792|NCT00498433|12137173|FG002|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
10963793|NCT00498485|12137192|FG000|STARTED|Overall Study||7
10963794|NCT00498485|12137193|FG001|STARTED|Overall Study||10
10963795|NCT00498485|12137192|FG000|COMPLETED|Overall Study||6
10963796|NCT00498485|12137193|FG001|COMPLETED|Overall Study||5
10963797|NCT00498485|12137192|FG000|NOT COMPLETED|Overall Study||1
10963798|NCT00498485|12137193|FG001|NOT COMPLETED|Overall Study||5
10963799|NCT00498550|12137203|FG000|STARTED|Overall Study||15
10963800|NCT00498550|12137204|FG001|STARTED|Overall Study||16
10963801|NCT00498550|12137203|FG000|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
10963802|NCT00498550|12137204|FG001|COMPLETED|Overall Study||15
10963803|NCT00498550|12137203|FG000|NOT COMPLETED|Overall Study||0
10963804|NCT00498550|12137204|FG001|NOT COMPLETED|Overall Study||1
10963805|NCT00498602|12137217|FG000|STARTED|Overall Study||36
10963806|NCT00498602|12137218|FG001|STARTED|Overall Study||61
10963807|NCT00498602|12137219|FG002|STARTED|Overall Study||40
10963808|NCT00498602|12137220|FG003|STARTED|Overall Study||35
10963809|NCT00498602|12137221|FG004|STARTED|Overall Study||12
10963810|NCT00498602|12137222|FG005|STARTED|Overall Study||44
10963811|NCT00498602|12137223|FG006|STARTED|Overall Study||17
10963812|NCT00498602|12137217|FG000|Treated|Overall Study||36
10963813|NCT00498602|12137218|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
10963814|NCT00498602|12137219|FG002|Treated|Overall Study||40
10963815|NCT00498602|12137220|FG003|Treated|Overall Study||35
10963816|NCT00498602|12137221|FG004|Treated|Overall Study||12
10963817|NCT00498602|12137222|FG005|Treated|Overall Study||44
10963818|NCT00498602|12137223|FG006|Treated|Overall Study||17
10963819|NCT00498602|12137217|FG000|COMPLETED|Overall Study||26
10963820|NCT00498602|12137218|FG001|COMPLETED|Overall Study||51
10963821|NCT00498602|12137219|FG002|COMPLETED|Overall Study||32
10963822|NCT00498602|12137220|FG003|COMPLETED|Overall Study||30
10963823|NCT00498602|12137221|FG004|COMPLETED|Overall Study||8
10963824|NCT00498602|12137222|FG005|COMPLETED|Overall Study||31
10963825|NCT00498602|12137223|FG006|COMPLETED|Overall Study||15
10963826|NCT00498602|12137217|FG000|NOT COMPLETED|Overall Study||10
10963827|NCT00498602|12137218|FG001|NOT COMPLETED|Overall Study||10
10963828|NCT00498602|12137219|FG002|NOT COMPLETED|Overall Study||8
10963829|NCT00498602|12137220|FG003|NOT COMPLETED|Overall Study||5
10963830|NCT00498602|12137221|FG004|NOT COMPLETED|Overall Study||4
10963831|NCT00498602|12137222|FG005|NOT COMPLETED|Overall Study||13
10963832|NCT00498602|12137223|FG006|NOT COMPLETED|Overall Study||2
10963833|NCT00498615|12137239|FG000|STARTED|Fasudil 80mg||2
10963834|NCT00498615|12137240|FG001|STARTED|Fasudil 80mg||4
10963835|NCT00498615|12137241|FG002|STARTED|Fasudil 80mg||3
10963836|NCT00498615|12137242|FG003|STARTED|Fasudil 80mg||2
10963837|NCT00498615|12137243|FG004|STARTED|Fasudil 80mg||3
10963838|NCT00498615|12137244|FG005|STARTED|Fasudil 80mg||3
10963839|NCT00498615|12137239|FG000|COMPLETED|Fasudil 80mg||2
10963840|NCT00498615|12137240|FG001|COMPLETED|Fasudil 80mg||4
10963841|NCT00498615|12137241|FG002|COMPLETED|Fasudil 80mg||3
10963842|NCT00498615|12137242|FG003|COMPLETED|Fasudil 80mg||2
10963843|NCT00498615|12137243|FG004|COMPLETED|Fasudil 80mg||3
10963844|NCT00498615|12137244|FG005|COMPLETED|Fasudil 80mg||3
10963845|NCT00498615|12137239|FG000|NOT COMPLETED|Fasudil 80mg||0
10963846|NCT00498615|12137240|FG001|NOT COMPLETED|Fasudil 80mg||0
10963847|NCT00498615|12137241|FG002|NOT COMPLETED|Fasudil 80mg||0
10963848|NCT00498615|12137242|FG003|NOT COMPLETED|Fasudil 80mg||0
10963849|NCT00498615|12137243|FG004|NOT COMPLETED|Fasudil 80mg||0
10963850|NCT00498615|12137244|FG005|NOT COMPLETED|Fasudil 80mg||0
10963851|NCT00498615|12137239|FG000|STARTED|Fasudil 40mg||2
10963852|NCT00498615|12137240|FG001|STARTED|Fasudil 40mg||4
10963853|NCT00498615|12137241|FG002|STARTED|Fasudil 40mg||3
10963854|NCT00498615|12137242|FG003|STARTED|Fasudil 40mg||2
10963855|NCT00498615|12137243|FG004|STARTED|Fasudil 40mg||3
10963856|NCT00498615|12137244|FG005|STARTED|Fasudil 40mg||3
10963857|NCT00498615|12137239|FG000|COMPLETED|Fasudil 40mg||2
10963858|NCT00498615|12137240|FG001|COMPLETED|Fasudil 40mg||4
10963859|NCT00498615|12137241|FG002|COMPLETED|Fasudil 40mg||3
10963860|NCT00498615|12137242|FG003|COMPLETED|Fasudil 40mg||2
10963861|NCT00498615|12137243|FG004|COMPLETED|Fasudil 40mg||3
10963862|NCT00498615|12137244|FG005|COMPLETED|Fasudil 40mg||3
10963863|NCT00498615|12137239|FG000|NOT COMPLETED|Fasudil 40mg||0
10963864|NCT00498615|12137240|FG001|NOT COMPLETED|Fasudil 40mg||0
10963865|NCT00498615|12137241|FG002|NOT COMPLETED|Fasudil 40mg||0
10963866|NCT00498615|12137242|FG003|NOT COMPLETED|Fasudil 40mg||0
10963867|NCT00498615|12137243|FG004|NOT COMPLETED|Fasudil 40mg||0
10963868|NCT00498615|12137244|FG005|NOT COMPLETED|Fasudil 40mg||0
10963869|NCT00498615|12137239|FG000|STARTED|Placebo||2
10963870|NCT00498615|12137240|FG001|STARTED|Placebo||4
10963871|NCT00498615|12137241|FG002|STARTED|Placebo||3
10963872|NCT00498615|12137242|FG003|STARTED|Placebo||2
10963873|NCT00498615|12137243|FG004|STARTED|Placebo||3
10963874|NCT00498615|12137244|FG005|STARTED|Placebo||3
10963875|NCT00498615|12137239|FG000|COMPLETED|Placebo||2
10963876|NCT00498615|12137240|FG001|COMPLETED|Placebo||4
10963877|NCT00498615|12137241|FG002|COMPLETED|Placebo||3
10963878|NCT00498615|12137242|FG003|COMPLETED|Placebo||2
10963879|NCT00498615|12137243|FG004|COMPLETED|Placebo||3
10963880|NCT00498615|12137244|FG005|COMPLETED|Placebo||3
10963881|NCT00498615|12137239|FG000|NOT COMPLETED|Placebo||0
10963882|NCT00498615|12137240|FG001|NOT COMPLETED|Placebo||0
10963883|NCT00498615|12137241|FG002|NOT COMPLETED|Placebo||0
10963884|NCT00498615|12137242|FG003|NOT COMPLETED|Placebo||0
10963885|NCT00498615|12137243|FG004|NOT COMPLETED|Placebo||0
10963886|NCT00498615|12137244|FG005|NOT COMPLETED|Placebo||0
10963887|NCT00498628|12137260|FG000|STARTED|Overall Study||105
10963888|NCT00498628|12137261|FG001|STARTED|Overall Study||113
10963889|NCT00498628|12137260|FG000|COMPLETED|Overall Study||90
10963890|NCT00498628|12137261|FG001|COMPLETED|Overall Study||92
10963891|NCT00498628|12137260|FG000|NOT COMPLETED|Overall Study||15
10963892|NCT00498628|12137261|FG001|NOT COMPLETED|Overall Study||21
10963893|NCT00498706|12137271|FG000|STARTED|Overall Study||163
10963894|NCT00498706|12137272|FG001|STARTED|Overall Study||162
10963895|NCT00498706|12137271|FG000|Post Treatment Week 18|Overall Study||163
10963896|NCT00498706|12137272|FG001|Post Treatment Week 18|Overall Study||162
10963897|NCT00498706|12137271|FG000|COMPLETED|Overall Study||163
10963898|NCT00498706|12137272|FG001|COMPLETED|Overall Study||162
10963899|NCT00498706|12137271|FG000|NOT COMPLETED|Overall Study||0
10963900|NCT00498706|12137272|FG001|NOT COMPLETED|Overall Study||0
10963901|NCT00498797|12137282|FG000|STARTED|Overall Study|randomised patients|43
10963902|NCT00498797|12137283|FG001|STARTED|Overall Study|randomised patients|43
10963903|NCT00498797|12137282|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
10963904|NCT00498797|12137283|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
10963905|NCT00498797|12137282|FG000|NOT COMPLETED|Overall Study||38
10963906|NCT00498797|12137283|FG001|NOT COMPLETED|Overall Study||29
10963907|NCT00498927|12137289|FG000|STARTED|Overall Study||47
10963908|NCT00498927|12137289|FG000|COMPLETED|Overall Study||47
10963909|NCT00498927|12137289|FG000|NOT COMPLETED|Overall Study||0
10963910|NCT00498940|12137295|FG000|STARTED|Overall Study||30
10963911|NCT00498940|12137296|FG001|STARTED|Overall Study||31
10963912|NCT00498940|12137295|FG000|COMPLETED|Overall Study||30
10963913|NCT00498940|12137296|FG001|COMPLETED|Overall Study||31
10963914|NCT00498940|12137295|FG000|NOT COMPLETED|Overall Study||0
10963915|NCT00498940|12137296|FG001|NOT COMPLETED|Overall Study||0
10963916|NCT00499031|12137302|FG000|STARTED|Overall Study|Total number participants enrolled on study|38
10963917|NCT00499031|12137302|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
10963918|NCT00499031|12137302|FG000|NOT COMPLETED|Overall Study||3
10963919|NCT00499083|12137306|FG000|STARTED|Overall Study||17
10963920|NCT00499083|12137306|FG000|Participants at UNMC|Overall Study||3
10963921|NCT00499083|12137306|FG000|Participants at Moffitt Cancer Center|Overall Study||14
10963922|NCT00499083|12137306|FG000|COMPLETED|Overall Study||14
10963923|NCT00499083|12137306|FG000|NOT COMPLETED|Overall Study||3
10963924|NCT00499096|12137312|FG000|STARTED|Overall Study||58
10963925|NCT00499096|12137313|FG001|STARTED|Overall Study||60
10963926|NCT00499096|12137312|FG000|COMPLETED|Overall Study||35
10963927|NCT00499096|12137313|FG001|COMPLETED|Overall Study||40
10963928|NCT00499096|12137312|FG000|NOT COMPLETED|Overall Study||23
10963929|NCT00499096|12137313|FG001|NOT COMPLETED|Overall Study||20
10963930|NCT00499109|12137323|FG000|STARTED|Overall Study||183
10963931|NCT00499109|12137324|FG001|STARTED|Overall Study||92
10963932|NCT00499109|12137323|FG000|COMPLETED|Overall Study||165
10963933|NCT00499109|12137324|FG001|COMPLETED|Overall Study||85
10963934|NCT00499109|12137323|FG000|NOT COMPLETED|Overall Study||18
10963935|NCT00499109|12137324|FG001|NOT COMPLETED|Overall Study||7
10963936|NCT00499122|12137333|FG000|STARTED|Overall Study||41
10963937|NCT00499122|12137333|FG000|COMPLETED|Overall Study||39
10963938|NCT00499122|12137333|FG000|NOT COMPLETED|Overall Study||2
10963939|NCT00499174|12137340|FG000|STARTED|Overall Study||78
10963940|NCT00499174|12137341|FG001|STARTED|Overall Study||102
10963941|NCT00499174|12137340|FG000|COMPLETED|Overall Study||0
10963942|NCT00499174|12137341|FG001|COMPLETED|Overall Study||93
10963943|NCT00499174|12137340|FG000|NOT COMPLETED|Overall Study||78
10963944|NCT00499174|12137341|FG001|NOT COMPLETED|Overall Study||9
10963945|NCT00499252|12137349|FG000|STARTED|Overall Study||51
10963946|NCT00499252|12137349|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
10963947|NCT00499252|12137349|FG000|NOT COMPLETED|Overall Study||12
10963948|NCT00499343|12137359|FG000|STARTED|Overall Study||41
10963949|NCT00499343|12137360|FG001|STARTED|Overall Study||43
10963950|NCT00499343|12137359|FG000|COMPLETED|Overall Study||41
10963951|NCT00499343|12137360|FG001|COMPLETED|Overall Study||43
10963952|NCT00499343|12137359|FG000|NOT COMPLETED|Overall Study||0
10963953|NCT00499343|12137360|FG001|NOT COMPLETED|Overall Study||0
10963954|NCT00499369|12137371|FG000|STARTED|Overall Study||16
10963955|NCT00499369|12137372|FG001|STARTED|Overall Study||18
10963956|NCT00499369|12137373|FG002|STARTED|Overall Study||17
10963957|NCT00499369|12137374|FG003|STARTED|Overall Study||9
10963958|NCT00499369|12137375|FG004|STARTED|Overall Study||12
10963959|NCT00499369|12137371|FG000|Eligible|Overall Study||14
10963960|NCT00499369|12137372|FG001|Eligible|Overall Study||16
10963961|NCT00499369|12137373|FG002|Eligible|Overall Study||16
10963962|NCT00499369|12137374|FG003|Eligible|Overall Study||8
10963963|NCT00499369|12137375|FG004|Eligible|Overall Study||12
10963964|NCT00499369|12137371|FG000|COMPLETED|Overall Study||0
10963965|NCT00499369|12137372|FG001|COMPLETED|Overall Study||0
10963966|NCT00499369|12137373|FG002|COMPLETED|Overall Study||0
10963967|NCT00499369|12137374|FG003|COMPLETED|Overall Study||0
10963968|NCT00499369|12137375|FG004|COMPLETED|Overall Study||0
10963969|NCT00499369|12137371|FG000|NOT COMPLETED|Overall Study||16
10963970|NCT00499369|12137372|FG001|NOT COMPLETED|Overall Study||18
10963971|NCT00499369|12137373|FG002|NOT COMPLETED|Overall Study||17
10963972|NCT00499369|12137374|FG003|NOT COMPLETED|Overall Study||9
10963973|NCT00499369|12137375|FG004|NOT COMPLETED|Overall Study||12
10963974|NCT00499408|12137387|FG000|STARTED|Overall Study||26
10963975|NCT00499408|12137387|FG000|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
10963976|NCT00499408|12137387|FG000|NOT COMPLETED|Overall Study||0
10963977|NCT00499447|12137391|FG000|STARTED|Overall Study||13
10963978|NCT00499447|12137391|FG000|COMPLETED|Overall Study||13
10963979|NCT00499447|12137391|FG000|NOT COMPLETED|Overall Study||0
10963980|NCT00499460|12137397|FG000|STARTED|Intervention 1 (30 Days)||8
10963981|NCT00499460|12137398|FG001|STARTED|Intervention 1 (30 Days)||7
10963982|NCT00499460|12137397|FG000|COMPLETED|Intervention 1 (30 Days)||6
10963983|NCT00499460|12137398|FG001|COMPLETED|Intervention 1 (30 Days)||7
10963984|NCT00499460|12137397|FG000|NOT COMPLETED|Intervention 1 (30 Days)||2
10963985|NCT00499460|12137398|FG001|NOT COMPLETED|Intervention 1 (30 Days)||0
10963986|NCT00499460|12137397|FG000|STARTED|Intervention 2 (30 Days)||6
10963987|NCT00499460|12137398|FG001|STARTED|Intervention 2 (30 Days)||7
10963988|NCT00499460|12137397|FG000|COMPLETED|Intervention 2 (30 Days)||6
10963989|NCT00499460|12137398|FG001|COMPLETED|Intervention 2 (30 Days)||6
10963990|NCT00499460|12137397|FG000|NOT COMPLETED|Intervention 2 (30 Days)||0
10963991|NCT00499460|12137398|FG001|NOT COMPLETED|Intervention 2 (30 Days)||1
10963992|NCT00499473|12137416|FG000|STARTED|Overall Study||27
10963993|NCT00499473|12137417|FG001|STARTED|Overall Study||4
10963994|NCT00499473|12137416|FG000|COMPLETED|Overall Study|Patients evaluable|21
10963995|NCT00499473|12137417|FG001|COMPLETED|Overall Study||4
10963996|NCT00499473|12137416|FG000|NOT COMPLETED|Overall Study||6
10963997|NCT00499473|12137417|FG001|NOT COMPLETED|Overall Study||0
10963998|NCT00499486|12137423|FG000|STARTED|Overall Study||47
10963999|NCT00499486|12137423|FG000|COMPLETED|Overall Study||31
10964000|NCT00499486|12137423|FG000|NOT COMPLETED|Overall Study||16
10964001|NCT00499603|12137429|FG000|STARTED|Overall Study||27
10964002|NCT00499603|12137430|FG001|STARTED|Overall Study||23
10964003|NCT00499603|12137429|FG000|COMPLETED|Overall Study||27
10964004|NCT00499603|12137430|FG001|COMPLETED|Overall Study||22
10964005|NCT00499603|12137429|FG000|NOT COMPLETED|Overall Study||0
10964006|NCT00499603|12137430|FG001|NOT COMPLETED|Overall Study||1
10964007|NCT00499616|12137442|FG000|STARTED|Overall Study||176
10964008|NCT00499616|12137443|FG001|STARTED|Overall Study||142
10964009|NCT00499616|12137444|FG002|STARTED|Overall Study||89
10964010|NCT00499616|12137445|FG003|STARTED|Overall Study||57
10964011|NCT00499616|12137442|FG000|COMPLETED|Overall Study||161
10964012|NCT00499616|12137443|FG001|COMPLETED|Overall Study||114
10964013|NCT00499616|12137444|FG002|COMPLETED|Overall Study||53
10964014|NCT00499616|12137445|FG003|COMPLETED|Overall Study||0
10964015|NCT00499616|12137442|FG000|NOT COMPLETED|Overall Study||15
10964016|NCT00499616|12137443|FG001|NOT COMPLETED|Overall Study||28
10964017|NCT00499616|12137444|FG002|NOT COMPLETED|Overall Study||36
10964018|NCT00499616|12137445|FG003|NOT COMPLETED|Overall Study||57
10964019|NCT00499655|12137460|FG000|STARTED|Overall Study||53
10964020|NCT00499655|12137461|FG001|STARTED|Overall Study||54
10964021|NCT00499655|12137460|FG000|COMPLETED|Overall Study||53
10964022|NCT00499655|12137461|FG001|COMPLETED|Overall Study||54
10964023|NCT00499655|12137460|FG000|NOT COMPLETED|Overall Study||0
10964024|NCT00499655|12137461|FG001|NOT COMPLETED|Overall Study||0
10964025|NCT00499681|12137470|FG000|STARTED|Overall Study||4
10964026|NCT00499681|12137471|FG001|STARTED|Overall Study||2
10964027|NCT00499681|12137470|FG000|COMPLETED|Overall Study||4
10964028|NCT00499681|12137471|FG001|COMPLETED|Overall Study||0
10964029|NCT00499681|12137470|FG000|NOT COMPLETED|Overall Study||0
10964030|NCT00499681|12137471|FG001|NOT COMPLETED|Overall Study||2
10964031|NCT00499694|12137477|FG000|STARTED|Overall Study||31
10964032|NCT00499694|12137477|FG000|COMPLETED|Overall Study||30
10964033|NCT00499694|12137477|FG000|NOT COMPLETED|Overall Study||1
10964034|NCT00499746|12137482|FG000|STARTED|Phase 1(6-9 One Day Sessions)||20
10964035|NCT00499746|12137482|FG000|COMPLETED|Phase 1(6-9 One Day Sessions)||8
10964036|NCT00499746|12137482|FG000|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
10964037|NCT00499746|12137482|FG000|STARTED|Phase 2 (6-9 One Day Sessions)||8
10964038|NCT00499746|12137482|FG000|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
10964039|NCT00499746|12137482|FG000|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
10964040|NCT00499746|12137482|FG000|STARTED|Phase 3 (9-14 One Day Sessions)||8
10964041|NCT00499746|12137482|FG000|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
10964042|NCT00499746|12137482|FG000|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
10964043|NCT00499863|12137498|FG000|STARTED|Overall Study||145
10964044|NCT00499863|12137499|FG001|STARTED|Overall Study||72
10964045|NCT00499863|12137498|FG000|COMPLETED|Overall Study||95
10964046|NCT00499863|12137499|FG001|COMPLETED|Overall Study||29
10964047|NCT00499863|12137498|FG000|NOT COMPLETED|Overall Study||50
10964048|NCT00499863|12137499|FG001|NOT COMPLETED|Overall Study||43
10964049|NCT00499889|12137505|FG000|STARTED|Overall Study||42
10964050|NCT00499889|12137505|FG000|COMPLETED|Overall Study||41
10964051|NCT00499889|12137505|FG000|NOT COMPLETED|Overall Study||1
10964052|NCT00499915|12137511|FG000|STARTED|Overall Study||83
10964053|NCT00499915|12137512|FG001|STARTED|Overall Study||82
10964054|NCT00499915|12137511|FG000|COMPLETED|Overall Study||68
10964055|NCT00499915|12137512|FG001|COMPLETED|Overall Study||76
10964056|NCT00499915|12137511|FG000|NOT COMPLETED|Overall Study||15
10964057|NCT00499915|12137512|FG001|NOT COMPLETED|Overall Study||6
10964058|NCT00500110|12137518|FG000|STARTED|Overall Study||39
10964059|NCT00500110|12137518|FG000|COMPLETED|Overall Study||36
10964060|NCT00500110|12137518|FG000|NOT COMPLETED|Overall Study||3
10964061|NCT00500149|12137522|FG000|STARTED|Enrolled (Dose-optimization Phase)||129
10964062|NCT00500149|12137523|FG001|STARTED|Enrolled (Dose-optimization Phase)||0
10964063|NCT00500149|12137522|FG000|COMPLETED|Enrolled (Dose-optimization Phase)||117
10964064|NCT00500149|12137523|FG001|COMPLETED|Enrolled (Dose-optimization Phase)||0
10964065|NCT00500149|12137522|FG000|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
10964066|NCT00500149|12137523|FG001|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
10964067|NCT00500149|12137522|FG000|STARTED|First Intervention (Cross-over Phase)||58
10964068|NCT00500149|12137523|FG001|STARTED|First Intervention (Cross-over Phase)||59
10964069|NCT00500149|12137522|FG000|COMPLETED|First Intervention (Cross-over Phase)||56
10964070|NCT00500149|12137523|FG001|COMPLETED|First Intervention (Cross-over Phase)||57
10964071|NCT00500149|12137522|FG000|NOT COMPLETED|First Intervention (Cross-over Phase)||2
10964072|NCT00500149|12137523|FG001|NOT COMPLETED|First Intervention (Cross-over Phase)||2
10964073|NCT00500149|12137522|FG000|STARTED|Second Intervention (Cross-over Phase)||56
10964074|NCT00500149|12137523|FG001|STARTED|Second Intervention (Cross-over Phase)||57
10964075|NCT00500149|12137522|FG000|COMPLETED|Second Intervention (Cross-over Phase)||54
10964076|NCT00500149|12137523|FG001|COMPLETED|Second Intervention (Cross-over Phase)||57
10964077|NCT00500149|12137522|FG000|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
10964078|NCT00500149|12137523|FG001|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
10964079|NCT00500240|12137531|FG000|STARTED|Overall Study||25
10964080|NCT00500240|12137532|FG001|STARTED|Overall Study||26
10964081|NCT00500240|12137531|FG000|COMPLETED|Overall Study||25
10964082|NCT00500240|12137532|FG001|COMPLETED|Overall Study||26
10964083|NCT00500240|12137531|FG000|NOT COMPLETED|Overall Study||0
10964084|NCT00500240|12137532|FG001|NOT COMPLETED|Overall Study||0
10964085|NCT00500266|12137540|FG000|STARTED|Overall Study||1053
10964086|NCT00500266|12137540|FG000|Treated|Overall Study||1049
10964087|NCT00500266|12137540|FG000|COMPLETED|Overall Study||1040
10964088|NCT00500266|12137540|FG000|NOT COMPLETED|Overall Study||13
10964089|NCT00500292|12137548|FG000|STARTED|Overall Study|randomised patients|32
10964090|NCT00500292|12137549|FG001|STARTED|Overall Study|randomised patients|35
10964091|NCT00500292|12137550|FG002|STARTED|Overall Study|randomised patients|37
10964092|NCT00500292|12137548|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
10964093|NCT00500292|12137549|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
10964094|NCT00500292|12137550|FG002|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
10964095|NCT00500292|12137548|FG000|NOT COMPLETED|Overall Study||25
10964096|NCT00500292|12137549|FG001|NOT COMPLETED|Overall Study||31
10964097|NCT00500292|12137550|FG002|NOT COMPLETED|Overall Study||27
10964098|NCT00500318|12137560|FG000|STARTED|Overall Study||86
10964099|NCT00500318|12137561|FG001|STARTED|Overall Study||95
10964100|NCT00500318|12137560|FG000|COMPLETED|Overall Study||81
10964101|NCT00500318|12137561|FG001|COMPLETED|Overall Study||78
10964102|NCT00500318|12137560|FG000|NOT COMPLETED|Overall Study||5
10964103|NCT00500318|12137561|FG001|NOT COMPLETED|Overall Study||17
10964104|NCT00500331|12137574|FG000|STARTED|Overall Study||48
10964105|NCT00500331|12137575|FG001|STARTED|Overall Study||47
10964106|NCT00500331|12137576|FG002|STARTED|Overall Study||48
10964107|NCT00500331|12137577|FG003|STARTED|Overall Study||48
10964108|NCT00500331|12137578|FG004|STARTED|Overall Study||48
10964109|NCT00500331|12137579|FG005|STARTED|Overall Study||47
10964110|NCT00500331|12137580|FG006|STARTED|Overall Study||48
10964111|NCT00500331|12137574|FG000|COMPLETED|Overall Study||33
10964112|NCT00500331|12137575|FG001|COMPLETED|Overall Study||42
10964113|NCT00500331|12137576|FG002|COMPLETED|Overall Study||43
10964114|NCT00500331|12137577|FG003|COMPLETED|Overall Study||38
10964115|NCT00500331|12137578|FG004|COMPLETED|Overall Study||44
10964116|NCT00500331|12137579|FG005|COMPLETED|Overall Study||42
10964117|NCT00500331|12137580|FG006|COMPLETED|Overall Study||46
10964118|NCT00500331|12137574|FG000|NOT COMPLETED|Overall Study||15
10964119|NCT00500331|12137575|FG001|NOT COMPLETED|Overall Study||5
10964120|NCT00500331|12137576|FG002|NOT COMPLETED|Overall Study||5
10964121|NCT00500331|12137577|FG003|NOT COMPLETED|Overall Study||10
10964122|NCT00500331|12137578|FG004|NOT COMPLETED|Overall Study||4
10964123|NCT00500331|12137579|FG005|NOT COMPLETED|Overall Study||5
10964124|NCT00500331|12137580|FG006|NOT COMPLETED|Overall Study||2
10964125|NCT00500357|12137597|FG000|STARTED|Overall Study||105
10964126|NCT00500357|12137597|FG000|Received 13vPnC (Vax 3)|Overall Study||105
10964127|NCT00500357|12137597|FG000|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
10964128|NCT00500357|12137597|FG000|COMPLETED|Overall Study||104
10964129|NCT00500357|12137597|FG000|NOT COMPLETED|Overall Study||1
10964130|NCT00500370|12137614|FG000|STARTED|Overall Study||80
10964131|NCT00500370|12137615|FG001|STARTED|Overall Study||83
10964132|NCT00500370|12137614|FG000|Treatment Start-Baseline (Week 0)|Overall Study||73
10964133|NCT00500370|12137615|FG001|Treatment Start-Baseline (Week 0)|Overall Study||79
10964134|NCT00500370|12137614|FG000|Treatment Complete (Week 24)|Overall Study||48
10964135|NCT00500370|12137615|FG001|Treatment Complete (Week 24)|Overall Study||54
10964136|NCT00500370|12137614|FG000|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
10964137|NCT00500370|12137615|FG001|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
10964138|NCT00500370|12137614|FG000|NOT COMPLETED|Overall Study||33
10964139|NCT00500370|12137615|FG001|NOT COMPLETED|Overall Study||34
10964140|NCT00500448|12137623|FG000|STARTED|Overall Study||14
10964141|NCT00500448|12137624|FG001|STARTED|Overall Study||16
10964142|NCT00500448|12137623|FG000|COMPLETED|Overall Study||14
10964143|NCT00500448|12137624|FG001|COMPLETED|Overall Study||16
10964144|NCT00500448|12137623|FG000|NOT COMPLETED|Overall Study||0
10964145|NCT00500448|12137624|FG001|NOT COMPLETED|Overall Study||0
10964146|NCT00500539|12137630|FG000|STARTED|Treatment Period (24 Weeks)||155
10964147|NCT00500539|12137630|FG000|COMPLETED|Treatment Period (24 Weeks)||140
10964148|NCT00500539|12137630|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||15
10964149|NCT00500539|12137630|FG000|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
10964150|NCT00500539|12137630|FG000|COMPLETED|Follow-up Period (16 Weeks)||136
10964151|NCT00500539|12137630|FG000|NOT COMPLETED|Follow-up Period (16 Weeks)||12
10964152|NCT00500578|12137639|FG000|STARTED|Overall Study||18
10964153|NCT00500578|12137640|FG001|STARTED|Overall Study||32
10964154|NCT00500578|12137639|FG000|COMPLETED|Overall Study|All completed|18
10964155|NCT00500578|12137640|FG001|COMPLETED|Overall Study|All completed|32
10964156|NCT00500578|12137639|FG000|NOT COMPLETED|Overall Study||0
10964157|NCT00500578|12137640|FG001|NOT COMPLETED|Overall Study||0
10964158|NCT00500656|12137650|FG000|STARTED|Controlled Phase||36
10964159|NCT00500656|12137651|FG001|STARTED|Controlled Phase||38
10964160|NCT00500656|12137652|FG002|STARTED|Controlled Phase||3
10964161|NCT00500656|12137653|FG003|STARTED|Controlled Phase||8
10964162|NCT00500656|12137650|FG000|COMPLETED|Controlled Phase||26
10964163|NCT00500656|12137651|FG001|COMPLETED|Controlled Phase||28
10964164|NCT00500656|12137652|FG002|COMPLETED|Controlled Phase||2
10964165|NCT00500656|12137653|FG003|COMPLETED|Controlled Phase||0
10964166|NCT00500656|12137650|FG000|NOT COMPLETED|Controlled Phase||10
10964167|NCT00500656|12137651|FG001|NOT COMPLETED|Controlled Phase||10
10964168|NCT00500656|12137652|FG002|NOT COMPLETED|Controlled Phase||1
10964169|NCT00500656|12137653|FG003|NOT COMPLETED|Controlled Phase||8
10964170|NCT00500656|12137650|FG000|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
10964171|NCT00500656|12137651|FG001|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
10964172|NCT00500656|12137652|FG002|STARTED|Open Label Extension (OLE) Phase||2
10964173|NCT00500656|12137653|FG003|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
10964174|NCT00500656|12137650|FG000|COMPLETED|Open Label Extension (OLE) Phase||16
10964175|NCT00500656|12137651|FG001|COMPLETED|Open Label Extension (OLE) Phase||9
10964176|NCT00500656|12137652|FG002|COMPLETED|Open Label Extension (OLE) Phase||1
10964177|NCT00500656|12137653|FG003|COMPLETED|Open Label Extension (OLE) Phase||6
10964178|NCT00500656|12137650|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||7
10964179|NCT00500656|12137651|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||12
10964180|NCT00500656|12137652|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||1
10964181|NCT00500656|12137653|FG003|NOT COMPLETED|Open Label Extension (OLE) Phase||2
10964182|NCT00500760|12137665|FG000|STARTED|Overall Study||89
10964183|NCT00500760|12137666|FG001|STARTED|Overall Study||64
10964184|NCT00500760|12137665|FG000|Received Treatment|Overall Study||87
10964185|NCT00500760|12137666|FG001|Received Treatment|Overall Study||63
10964186|NCT00500760|12137665|FG000|COMPLETED|Overall Study||46
10964187|NCT00500760|12137666|FG001|COMPLETED|Overall Study||40
10964188|NCT00500760|12137665|FG000|NOT COMPLETED|Overall Study||43
10964189|NCT00500760|12137666|FG001|NOT COMPLETED|Overall Study||24
10964190|NCT00500903|12137675|FG000|STARTED|Overall Study||65
10964191|NCT00500903|12137676|FG001|STARTED|Overall Study||2
10964192|NCT00500903|12137677|FG002|STARTED|Overall Study||20
10964193|NCT00500903|12137675|FG000|COMPLETED|Overall Study||0
10964194|NCT00500903|12137676|FG001|COMPLETED|Overall Study||0
10964195|NCT00500903|12137677|FG002|COMPLETED|Overall Study||0
10964196|NCT00500903|12137675|FG000|NOT COMPLETED|Overall Study||65
10964197|NCT00500903|12137676|FG001|NOT COMPLETED|Overall Study||2
10964198|NCT00500903|12137677|FG002|NOT COMPLETED|Overall Study||20
10964199|NCT00501007|12137715|FG000|STARTED|Overall Study||100
10964200|NCT00501007|12137716|FG001|STARTED|Overall Study||103
10964201|NCT00501007|12137715|FG000|COMPLETED|Overall Study||71
10964202|NCT00501007|12137716|FG001|COMPLETED|Overall Study||78
10964203|NCT00501007|12137715|FG000|NOT COMPLETED|Overall Study||29
10964204|NCT00501007|12137716|FG001|NOT COMPLETED|Overall Study||25
10964205|NCT00501059|12137724|FG000|STARTED|Overall Study||6270
10964206|NCT00501059|12137725|FG001|STARTED|Overall Study||6276
10964207|NCT00501059|12137724|FG000|COMPLETED|Overall Study||4402
10964208|NCT00501059|12137725|FG001|COMPLETED|Overall Study||4384
10964209|NCT00501059|12137724|FG000|NOT COMPLETED|Overall Study||1868
10964210|NCT00501059|12137725|FG001|NOT COMPLETED|Overall Study||1892
10964211|NCT00501085|12137733|FG000|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
10964212|NCT00501085|12137733|FG000|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
10964213|NCT00501085|12137733|FG000|NOT COMPLETED|Overall Study||432
10964214|NCT00501293|12137739|FG000|STARTED|Optimization Period||110
10964215|NCT00501293|12137740|FG001|STARTED|Optimization Period||53
10964216|NCT00501293|12137739|FG000|COMPLETED|Optimization Period||109
10964217|NCT00501293|12137740|FG001|COMPLETED|Optimization Period||53
10964218|NCT00501293|12137739|FG000|NOT COMPLETED|Optimization Period||1
10964219|NCT00501293|12137740|FG001|NOT COMPLETED|Optimization Period||0
10964220|NCT00501293|12137739|FG000|STARTED|Maintenance Period||109
10964221|NCT00501293|12137740|FG001|STARTED|Maintenance Period||53
10964222|NCT00501293|12137739|FG000|COMPLETED|Maintenance Period||63
10964223|NCT00501293|12137740|FG001|COMPLETED|Maintenance Period||25
10964224|NCT00501293|12137739|FG000|NOT COMPLETED|Maintenance Period||46
10964225|NCT00501293|12137740|FG001|NOT COMPLETED|Maintenance Period||28
10964226|NCT00501540|12137747|FG000|STARTED|Overall Study||15
10964227|NCT00501540|12137747|FG000|COMPLETED|Overall Study||10
10964228|NCT00501540|12137747|FG000|NOT COMPLETED|Overall Study||5
10964229|NCT00501592|12137754|FG000|STARTED|Overall Study||20
10964230|NCT00501592|12137755|FG001|STARTED|Overall Study||21
10964231|NCT00501592|12137756|FG002|STARTED|Overall Study||23
10964232|NCT00501592|12137754|FG000|COMPLETED|Overall Study||20
10964233|NCT00501592|12137755|FG001|COMPLETED|Overall Study||16
10964234|NCT00501592|12137756|FG002|COMPLETED|Overall Study||20
10964235|NCT00501592|12137754|FG000|NOT COMPLETED|Overall Study||0
10964236|NCT00501592|12137755|FG001|NOT COMPLETED|Overall Study||5
10964237|NCT00501592|12137756|FG002|NOT COMPLETED|Overall Study||3
10964238|NCT00501631|12137766|FG000|STARTED|Part A (Double-blind Period)||152
10964239|NCT00501631|12137767|FG001|STARTED|Part A (Double-blind Period)||148
10964240|NCT00501631|12137766|FG000|COMPLETED|Part A (Double-blind Period)||90
10964241|NCT00501631|12137767|FG001|COMPLETED|Part A (Double-blind Period)||99
10964242|NCT00501631|12137766|FG000|NOT COMPLETED|Part A (Double-blind Period)||62
10964243|NCT00501631|12137767|FG001|NOT COMPLETED|Part A (Double-blind Period)||49
10964244|NCT00501631|12137766|FG000|STARTED|Part B (Open-label Period)||90
10964245|NCT00501631|12137767|FG001|STARTED|Part B (Open-label Period)||99
10964246|NCT00501631|12137766|FG000|COMPLETED|Part B (Open-label Period)||37
10964247|NCT00501631|12137767|FG001|COMPLETED|Part B (Open-label Period)||48
10964248|NCT00501631|12137766|FG000|NOT COMPLETED|Part B (Open-label Period)||53
10964249|NCT00501631|12137767|FG001|NOT COMPLETED|Part B (Open-label Period)||51
10964250|NCT00501644|12137773|FG000|STARTED|Overall Study||59
10964251|NCT00501644|12137773|FG000|COMPLETED|Overall Study||54
10964252|NCT00501644|12137773|FG000|NOT COMPLETED|Overall Study||5
10964253|NCT00501852|12137777|FG000|STARTED|Overall Study||83
10964254|NCT00501852|12137777|FG000|NVA237 12.5µg|Overall Study||55
10964255|NCT00501852|12137777|FG000|NVA237 25µg|Overall Study||51
10964256|NCT00501852|12137777|FG000|NVA237 50µg|Overall Study||53
10964257|NCT00501852|12137777|FG000|NVA237 100µg|Overall Study||54
10964258|NCT00501852|12137777|FG000|Placebo|Overall Study||55
10964259|NCT00501852|12137777|FG000|Tiotropium|Overall Study||55
10964260|NCT00501852|12137777|FG000|COMPLETED|Overall Study||78
10964261|NCT00501852|12137777|FG000|NOT COMPLETED|Overall Study||5
10964262|NCT00501891|12137791|FG000|STARTED|Overall Study||32
10964263|NCT00501891|12137791|FG000|COMPLETED|Overall Study||32
10964264|NCT00501891|12137791|FG000|NOT COMPLETED|Overall Study||0
10964265|NCT00501943|12137798|FG000|STARTED|Overall Study||22
10964266|NCT00501943|12137799|FG001|STARTED|Overall Study||21
10964267|NCT00501943|12137798|FG000|COMPLETED|Overall Study||20
10964268|NCT00501943|12137799|FG001|COMPLETED|Overall Study||18
10964269|NCT00501943|12137798|FG000|NOT COMPLETED|Overall Study||2
10964270|NCT00501943|12137799|FG001|NOT COMPLETED|Overall Study||3
10964271|NCT00501969|12137807|FG000|STARTED|Overall Study||395
10964272|NCT00501969|12137807|FG000|COMPLETED|Overall Study||189
10964273|NCT00501969|12137807|FG000|NOT COMPLETED|Overall Study||206
10964274|NCT00501995|12137811|FG000|STARTED|Overall Study||6
10964275|NCT00501995|12137811|FG000|COMPLETED|Overall Study||5
10964276|NCT00501995|12137811|FG000|NOT COMPLETED|Overall Study||1
10964277|NCT00502203|12137815|FG000|STARTED|Overall Study||23
10964278|NCT00502203|12137815|FG000|COMPLETED|Overall Study||22
10964279|NCT00502203|12137815|FG000|NOT COMPLETED|Overall Study||1
10964280|NCT00502216|12137821|FG000|STARTED|Overall Study||21
10964281|NCT00502216|12137822|FG001|STARTED|Overall Study||19
10964282|NCT00502216|12137821|FG000|COMPLETED|Overall Study||21
10964283|NCT00502216|12137822|FG001|COMPLETED|Overall Study||19
10964284|NCT00502216|12137821|FG000|NOT COMPLETED|Overall Study||0
10964285|NCT00502216|12137822|FG001|NOT COMPLETED|Overall Study||0
10964286|NCT00502242|12137830|FG000|STARTED|Overall Study||155
10964287|NCT00502242|12137831|FG001|STARTED|Overall Study||140
10964288|NCT00502242|12137830|FG000|COMPLETED|Overall Study||104
10964289|NCT00502242|12137831|FG001|COMPLETED|Overall Study||84
10964290|NCT00502242|12137830|FG000|NOT COMPLETED|Overall Study||51
10964291|NCT00502242|12137831|FG001|NOT COMPLETED|Overall Study||56
10964292|NCT00502307|12137837|FG000|STARTED|Open Label Period (16 Weeks)||272
10964293|NCT00502307|12137838|FG001|STARTED|Open Label Period (16 Weeks)||0
10964294|NCT00502307|12137839|FG002|STARTED|Open Label Period (16 Weeks)||0
10964295|NCT00502307|12137837|FG000|COMPLETED|Open Label Period (16 Weeks)||196
10964296|NCT00502307|12137838|FG001|COMPLETED|Open Label Period (16 Weeks)||0
10964297|NCT00502307|12137839|FG002|COMPLETED|Open Label Period (16 Weeks)||0
10964298|NCT00502307|12137837|FG000|NOT COMPLETED|Open Label Period (16 Weeks)||76
10964299|NCT00502307|12137838|FG001|NOT COMPLETED|Open Label Period (16 Weeks)||0
10964300|NCT00502307|12137839|FG002|NOT COMPLETED|Open Label Period (16 Weeks)||0
10964301|NCT00502307|12137837|FG000|STARTED|Double-Blind Period (12 Weeks)||0
10964302|NCT00502307|12137838|FG001|STARTED|Double-Blind Period (12 Weeks)||61
10964303|NCT00502307|12137839|FG002|STARTED|Double-Blind Period (12 Weeks)||57
10964304|NCT00502307|12137837|FG000|COMPLETED|Double-Blind Period (12 Weeks)||0
10964305|NCT00502307|12137838|FG001|COMPLETED|Double-Blind Period (12 Weeks)||35
10964306|NCT00502307|12137839|FG002|COMPLETED|Double-Blind Period (12 Weeks)||48
10964307|NCT00502307|12137837|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
10964308|NCT00502307|12137838|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||26
10964309|NCT00502307|12137839|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||9
10964310|NCT00502307|12137837|FG000|STARTED|Maintenance Period||148
10964311|NCT00502307|12137838|FG001|STARTED|Maintenance Period||0
10964312|NCT00502307|12137839|FG002|STARTED|Maintenance Period||0
10964313|NCT00502307|12137837|FG000|COMPLETED|Maintenance Period||0
10964314|NCT00502307|12137838|FG001|COMPLETED|Maintenance Period||0
10964315|NCT00502307|12137839|FG002|COMPLETED|Maintenance Period||0
10964316|NCT00502307|12137837|FG000|NOT COMPLETED|Maintenance Period||148
10964317|NCT00502307|12137838|FG001|NOT COMPLETED|Maintenance Period||0
10964318|NCT00502307|12137839|FG002|NOT COMPLETED|Maintenance Period||0
10964319|NCT00502320|12137858|FG000|STARTED|Overall Study||25
10964320|NCT00502320|12137859|FG001|STARTED|Overall Study||25
10964321|NCT00502320|12137858|FG000|Screening Visit|Overall Study||25
10964322|NCT00502320|12137859|FG001|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
10964323|NCT00502320|12137858|FG000|COMPLETED|Overall Study||19
10964324|NCT00502320|12137859|FG001|COMPLETED|Overall Study||18
10964325|NCT00502320|12137858|FG000|NOT COMPLETED|Overall Study||6
10964326|NCT00502320|12137859|FG001|NOT COMPLETED|Overall Study||7
10964327|NCT00502593|12137877|FG000|STARTED|Overall Study||51
10964328|NCT00502593|12137878|FG001|STARTED|Overall Study||18
10964329|NCT00502593|12137879|FG002|STARTED|Overall Study||51
10964330|NCT00502593|12137880|FG003|STARTED|Overall Study||18
10964331|NCT00502593|12137881|FG004|STARTED|Overall Study||51
10964332|NCT00502593|12137882|FG005|STARTED|Overall Study||17
10964333|NCT00502593|12137883|FG006|STARTED|Overall Study||49
10964334|NCT00502593|12137884|FG007|STARTED|Overall Study||17
10964335|NCT00502593|12137885|FG008|STARTED|Overall Study||49
10964336|NCT00502593|12137886|FG009|STARTED|Overall Study||17
10964337|NCT00502593|12137887|FG010|STARTED|Overall Study||49
10964338|NCT00502593|12137888|FG011|STARTED|Overall Study||18
10964339|NCT00502593|12137877|FG000|COMPLETED|Overall Study||48
10964340|NCT00502593|12137878|FG001|COMPLETED|Overall Study||16
10964341|NCT00502593|12137879|FG002|COMPLETED|Overall Study||41
10964342|NCT00502593|12137880|FG003|COMPLETED|Overall Study||14
10964343|NCT00502593|12137881|FG004|COMPLETED|Overall Study||47
10964344|NCT00502593|12137882|FG005|COMPLETED|Overall Study||17
10964345|NCT00502593|12137883|FG006|COMPLETED|Overall Study||44
10964346|NCT00502593|12137884|FG007|COMPLETED|Overall Study||17
10964347|NCT00502593|12137885|FG008|COMPLETED|Overall Study||43
10964348|NCT00502593|12137886|FG009|COMPLETED|Overall Study||17
10964349|NCT00502593|12137887|FG010|COMPLETED|Overall Study||47
10964350|NCT00502593|12137888|FG011|COMPLETED|Overall Study||18
10964351|NCT00502593|12137877|FG000|NOT COMPLETED|Overall Study||3
10964352|NCT00502593|12137878|FG001|NOT COMPLETED|Overall Study||2
10964353|NCT00502593|12137879|FG002|NOT COMPLETED|Overall Study||10
10964354|NCT00502593|12137880|FG003|NOT COMPLETED|Overall Study||4
10964355|NCT00502593|12137881|FG004|NOT COMPLETED|Overall Study||4
10964356|NCT00502593|12137882|FG005|NOT COMPLETED|Overall Study||0
10964357|NCT00502593|12137883|FG006|NOT COMPLETED|Overall Study||5
10964358|NCT00502593|12137884|FG007|NOT COMPLETED|Overall Study||0
10964359|NCT00502593|12137885|FG008|NOT COMPLETED|Overall Study||6
10964360|NCT00502593|12137886|FG009|NOT COMPLETED|Overall Study||0
10964361|NCT00502593|12137887|FG010|NOT COMPLETED|Overall Study||2
10964362|NCT00502593|12137888|FG011|NOT COMPLETED|Overall Study||0
10964363|NCT00502671|12137937|FG000|STARTED|Overall Study||228
10964364|NCT00502671|12137937|FG000|COMPLETED|Overall Study||151
10964365|NCT00502671|12137937|FG000|NOT COMPLETED|Overall Study||77
10964366|NCT00502697|12137943|FG000|STARTED|Overall Study||122
10964367|NCT00502697|12137944|FG001|STARTED|Overall Study||114
10964368|NCT00502697|12137943|FG000|COMPLETED|Overall Study||109
10964369|NCT00502697|12137944|FG001|COMPLETED|Overall Study||102
10964370|NCT00502697|12137943|FG000|NOT COMPLETED|Overall Study||13
10964371|NCT00502697|12137944|FG001|NOT COMPLETED|Overall Study||12
10964372|NCT00502775|12137953|FG000|STARTED|Overall Study||229
10964373|NCT00502775|12137954|FG001|STARTED|Overall Study||224
10964374|NCT00502775|12137955|FG002|STARTED|Overall Study||227
10964375|NCT00502775|12137953|FG000|COMPLETED|Overall Study||219
10964376|NCT00502775|12137954|FG001|COMPLETED|Overall Study||209
10964377|NCT00502775|12137955|FG002|COMPLETED|Overall Study||214
10964378|NCT00502775|12137953|FG000|NOT COMPLETED|Overall Study||10
10964379|NCT00502775|12137954|FG001|NOT COMPLETED|Overall Study||15
10964380|NCT00502775|12137955|FG002|NOT COMPLETED|Overall Study||13
10964381|NCT00502801|12137963|FG000|STARTED|Treatment Period||183
10964382|NCT00502801|12137963|FG000|COMPLETED|Treatment Period||129
10964383|NCT00502801|12137963|FG000|NOT COMPLETED|Treatment Period||54
10964384|NCT00502801|12137963|FG000|STARTED|End of Therapy to Test of Cure||129
10964385|NCT00502801|12137963|FG000|COMPLETED|End of Therapy to Test of Cure||121
10964386|NCT00502801|12137963|FG000|NOT COMPLETED|End of Therapy to Test of Cure||8
10964387|NCT00502840|12137967|FG000|STARTED|Overall Study||193
10964388|NCT00502840|12137967|FG000|COMPLETED|Overall Study||93
10964389|NCT00502840|12137967|FG000|NOT COMPLETED|Overall Study||100
10964390|NCT00502853|12137972|FG000|STARTED|Overall Study||10
10964391|NCT00502853|12137972|FG000|COMPLETED|Overall Study||10
10964392|NCT00502853|12137972|FG000|NOT COMPLETED|Overall Study||0
10964393|NCT00502905|12137977|FG000|STARTED|Overall Study||196
10964394|NCT00502905|12137977|FG000|COMPLETED|Overall Study||196
10964395|NCT00502905|12137977|FG000|NOT COMPLETED|Overall Study||0
10964396|NCT00502944|12137983|FG000|STARTED|Overall Study||2446
10964397|NCT00502944|12137984|FG001|STARTED|Overall Study||2409
10964398|NCT00502944|12137983|FG000|COMPLETED|Overall Study||1382
10964399|NCT00502944|12137984|FG001|COMPLETED|Overall Study||643
10964400|NCT00502944|12137983|FG000|NOT COMPLETED|Overall Study||1064
10964401|NCT00502944|12137984|FG001|NOT COMPLETED|Overall Study||1766
10964402|NCT00502996|12137990|FG000|STARTED|Overall Study||232
10964403|NCT00502996|12137990|FG000|COMPLETED|Overall Study||188
10964404|NCT00502996|12137990|FG000|NOT COMPLETED|Overall Study||44
10964405|NCT00503113|12137997|FG000|STARTED|Overall Study||268
10964406|NCT00503113|12137998|FG001|STARTED|Overall Study||264
10964407|NCT00503113|12137999|FG002|STARTED|Overall Study||269
10964408|NCT00503113|12137997|FG000|Intent to Treat Population (ITT)|Overall Study||262
10964409|NCT00503113|12137998|FG001|Intent to Treat Population (ITT)|Overall Study||261
10964410|NCT00503113|12137999|FG002|Intent to Treat Population (ITT)|Overall Study||268
10964411|NCT00503113|12137997|FG000|Per Protocol Population (PP)|Overall Study||246
10964412|NCT00503113|12137998|FG001|Per Protocol Population (PP)|Overall Study||243
10964413|NCT00503113|12137999|FG002|Per Protocol Population (PP)|Overall Study||241
10964414|NCT00503113|12137997|FG000|Safety Population|Overall Study||263
10964415|NCT00503113|12137998|FG001|Safety Population|Overall Study||263
10964416|NCT00503113|12137999|FG002|Safety Population|Overall Study||267
10964417|NCT00503113|12137997|FG000|COMPLETED|Overall Study||235
10964418|NCT00503113|12137998|FG001|COMPLETED|Overall Study||236
10964419|NCT00503113|12137999|FG002|COMPLETED|Overall Study||241
10964420|NCT00503113|12137997|FG000|NOT COMPLETED|Overall Study||33
10964421|NCT00503113|12137998|FG001|NOT COMPLETED|Overall Study||28
10964422|NCT00503113|12137999|FG002|NOT COMPLETED|Overall Study||28
10964423|NCT00503139|12138007|FG000|STARTED|Overall Study||684
10964424|NCT00503139|12138007|FG000|COMPLETED|Overall Study||676
10964425|NCT00503139|12138007|FG000|NOT COMPLETED|Overall Study||8
10964426|NCT00503308|12138013|FG000|STARTED|Overall Study||146
10964427|NCT00503308|12138014|FG001|STARTED|Overall Study||135
10964428|NCT00503308|12138013|FG000|COMPLETED|Overall Study||144
10964429|NCT00503308|12138014|FG001|COMPLETED|Overall Study||134
10964430|NCT00503308|12138013|FG000|NOT COMPLETED|Overall Study||2
10964431|NCT00503308|12138014|FG001|NOT COMPLETED|Overall Study||1
10964432|NCT00503399|12138022|FG000|STARTED|Overall Study||45
10964433|NCT00503399|12138023|FG001|STARTED|Overall Study||47
10964434|NCT00503399|12138022|FG000|COMPLETED|Overall Study||38
10964435|NCT00503399|12138023|FG001|COMPLETED|Overall Study||39
10964436|NCT00503399|12138022|FG000|NOT COMPLETED|Overall Study||7
10964437|NCT00503399|12138023|FG001|NOT COMPLETED|Overall Study||8
10964438|NCT00503425|12138029|FG000|STARTED|Overall Study||215
10964439|NCT00503425|12138029|FG000|COMPLETED|Overall Study||161
10964440|NCT00503425|12138029|FG000|NOT COMPLETED|Overall Study||54
10964441|NCT00503685|12138037|FG000|STARTED|Overall Study||23
10964442|NCT00503685|12138038|FG001|STARTED|Overall Study||22
10964443|NCT00503685|12138039|FG002|STARTED|Overall Study||20
10964444|NCT00503685|12138037|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
10964445|NCT00503685|12138038|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21
10964446|NCT00503685|12138039|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
10964447|NCT00503685|12138037|FG000|COMPLETED|Overall Study||23
10964448|NCT00503685|12138038|FG001|COMPLETED|Overall Study||19
10964449|NCT00503685|12138039|FG002|COMPLETED|Overall Study||18
10964450|NCT00503685|12138037|FG000|NOT COMPLETED|Overall Study||0
10964451|NCT00503685|12138038|FG001|NOT COMPLETED|Overall Study||3
10964452|NCT00503685|12138039|FG002|NOT COMPLETED|Overall Study||2
10964453|NCT00503698|12138050|FG000|STARTED|Overall Study|Randomised|357
10964454|NCT00503698|12138051|FG001|STARTED|Overall Study|Randomised|355
10964455|NCT00503698|12138050|FG000|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
10964456|NCT00503698|12138051|FG001|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
10964457|NCT00503698|12138050|FG000|COMPLETED|Overall Study|Trial prematurely terminated|0
10964458|NCT00503698|12138051|FG001|COMPLETED|Overall Study|Trial prematurely terminated|0
10964459|NCT00503698|12138050|FG000|NOT COMPLETED|Overall Study||357
10964460|NCT00503698|12138051|FG001|NOT COMPLETED|Overall Study||355
10964461|NCT00503750|12138057|FG000|STARTED|Overall Study||27
10964462|NCT00503750|12138057|FG000|COMPLETED|Overall Study||27
10964463|NCT00503750|12138057|FG000|NOT COMPLETED|Overall Study||0
10964464|NCT00503776|12138065|FG000|STARTED|Overall Study||8
10964465|NCT00503776|12138066|FG001|STARTED|Overall Study||12
10964466|NCT00503776|12138067|FG002|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
10964467|NCT00503776|12138068|FG003|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
10964468|NCT00503776|12138065|FG000|COMPLETED|Overall Study||7
10964469|NCT00503776|12138066|FG001|COMPLETED|Overall Study||12
10964470|NCT00503776|12138067|FG002|COMPLETED|Overall Study||10
10964471|NCT00503776|12138068|FG003|COMPLETED|Overall Study||8
10964472|NCT00503776|12138065|FG000|NOT COMPLETED|Overall Study||1
10964473|NCT00503776|12138066|FG001|NOT COMPLETED|Overall Study||0
10964474|NCT00503776|12138067|FG002|NOT COMPLETED|Overall Study||2
10964475|NCT00503776|12138068|FG003|NOT COMPLETED|Overall Study||2
10964476|NCT00503867|12138083|FG000|STARTED|Overall Study||10
10964477|NCT00503867|12138083|FG000|COMPLETED|Overall Study||8
10964478|NCT00503867|12138083|FG000|NOT COMPLETED|Overall Study||2
10964479|NCT00503906|12138087|FG000|STARTED|Overall Study||30
10964480|NCT00503906|12138087|FG000|COMPLETED|Overall Study||29
10964481|NCT00503906|12138087|FG000|NOT COMPLETED|Overall Study||1
10964482|NCT00503984|12138094|FG000|STARTED|Overall Study||3
10964483|NCT00503984|12138095|FG001|STARTED|Overall Study||3
10964484|NCT00503984|12138096|FG002|STARTED|Overall Study||3
10964485|NCT00503984|12138097|FG003|STARTED|Overall Study||6
10964486|NCT00503984|12138098|FG004|STARTED|Overall Study||6
10964487|NCT00503984|12138099|FG005|STARTED|Overall Study||1
10964488|NCT00503984|12138094|FG000|COMPLETED|Overall Study||3
10964489|NCT00503984|12138095|FG001|COMPLETED|Overall Study||1
10964490|NCT00503984|12138096|FG002|COMPLETED|Overall Study||3
10964491|NCT00503984|12138097|FG003|COMPLETED|Overall Study||6
10964492|NCT00503984|12138098|FG004|COMPLETED|Overall Study||5
10964493|NCT00503984|12138099|FG005|COMPLETED|Overall Study||1
10964494|NCT00503984|12138094|FG000|NOT COMPLETED|Overall Study||0
10964495|NCT00503984|12138095|FG001|NOT COMPLETED|Overall Study||2
10964496|NCT00503984|12138096|FG002|NOT COMPLETED|Overall Study||0
10964497|NCT00503984|12138097|FG003|NOT COMPLETED|Overall Study||0
10964498|NCT00503984|12138098|FG004|NOT COMPLETED|Overall Study||1
10964499|NCT00503984|12138099|FG005|NOT COMPLETED|Overall Study||0
10964500|NCT00503997|12138123|FG000|STARTED|Overall Study||42
10964501|NCT00503997|12138123|FG000|COMPLETED|Overall Study||34
10964502|NCT00503997|12138123|FG000|NOT COMPLETED|Overall Study||8
10964503|NCT00504023|12138127|FG000|STARTED|Overall Study||8
10964504|NCT00504023|12138127|FG000|COMPLETED|Overall Study||8
10964505|NCT00504023|12138127|FG000|NOT COMPLETED|Overall Study||0
10964506|NCT00504075|12138131|FG000|STARTED|Overall Study||35
10964507|NCT00504075|12138131|FG000|COMPLETED|Overall Study||27
10964508|NCT00504075|12138131|FG000|NOT COMPLETED|Overall Study||8
10964509|NCT00504153|12138136|FG000|STARTED|Overall Study||19
10964510|NCT00504153|12138136|FG000|COMPLETED|Overall Study||13
10964511|NCT00504153|12138136|FG000|NOT COMPLETED|Overall Study||6
10964512|NCT00504166|12138142|FG000|STARTED|Overall Study||26
10964513|NCT00504166|12138143|FG001|STARTED|Overall Study||27
10964514|NCT00504166|12138142|FG000|COMPLETED|Overall Study||20
10964515|NCT00504166|12138143|FG001|COMPLETED|Overall Study||13
10964516|NCT00504166|12138142|FG000|NOT COMPLETED|Overall Study||6
10964517|NCT00504166|12138143|FG001|NOT COMPLETED|Overall Study||14
10964518|NCT00504231|12138153|FG000|STARTED|Overall Study||65
10964519|NCT00504231|12138154|FG001|STARTED|Overall Study||64
10964520|NCT00504231|12138155|FG002|STARTED|Overall Study||64
10964521|NCT00504231|12138156|FG003|STARTED|Overall Study||65
10964522|NCT00504231|12138153|FG000|COMPLETED|Overall Study||65
10964523|NCT00504231|12138154|FG001|COMPLETED|Overall Study||64
10964524|NCT00504231|12138155|FG002|COMPLETED|Overall Study||63
10964525|NCT00504231|12138156|FG003|COMPLETED|Overall Study||65
10964526|NCT00504231|12138153|FG000|NOT COMPLETED|Overall Study||0
10964527|NCT00504231|12138154|FG001|NOT COMPLETED|Overall Study||0
10964528|NCT00504231|12138155|FG002|NOT COMPLETED|Overall Study||1
10964529|NCT00504231|12138156|FG003|NOT COMPLETED|Overall Study||0
10964530|NCT00504257|12138170|FG000|STARTED|Overall Study||45
10964531|NCT00504257|12138170|FG000|COMPLETED|Overall Study||41
10964532|NCT00504257|12138170|FG000|NOT COMPLETED|Overall Study||4
10964533|NCT00504309|12138180|FG000|STARTED|Overall Study||7
10964534|NCT00504309|12138181|FG001|STARTED|Overall Study||5
10964535|NCT00504309|12138182|FG002|STARTED|Overall Study||2
10964536|NCT00504309|12138183|FG003|STARTED|Overall Study||3
10964537|NCT00504309|12138184|FG004|STARTED|Overall Study||8
10964538|NCT00504309|12138185|FG005|STARTED|Overall Study||3
10964539|NCT00504309|12138180|FG000|COMPLETED|Overall Study||7
10964540|NCT00504309|12138181|FG001|COMPLETED|Overall Study||5
10964541|NCT00504309|12138182|FG002|COMPLETED|Overall Study|Participant dropped out during second period|1
10964542|NCT00504309|12138183|FG003|COMPLETED|Overall Study||3
10964543|NCT00504309|12138184|FG004|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
10964544|NCT00504309|12138185|FG005|COMPLETED|Overall Study||3
10964545|NCT00504309|12138180|FG000|NOT COMPLETED|Overall Study||0
10964546|NCT00504309|12138181|FG001|NOT COMPLETED|Overall Study||0
10964547|NCT00504309|12138182|FG002|NOT COMPLETED|Overall Study||1
10964548|NCT00504309|12138183|FG003|NOT COMPLETED|Overall Study||0
10964549|NCT00504309|12138184|FG004|NOT COMPLETED|Overall Study||1
10964550|NCT00504309|12138185|FG005|NOT COMPLETED|Overall Study||0
10964551|NCT00504348|12138197|FG000|STARTED|Overall Study||25
10964552|NCT00504348|12138197|FG000|COMPLETED|Overall Study||17
10964553|NCT00504348|12138197|FG000|NOT COMPLETED|Overall Study||8
10964554|NCT00504426|12138205|FG000|STARTED|Overall Study||32
10964555|NCT00504426|12138206|FG001|STARTED|Overall Study||23
10964556|NCT00504426|12138207|FG002|STARTED|Overall Study||22
10964557|NCT00504426|12138208|FG003|STARTED|Overall Study||24
10964558|NCT00504426|12138205|FG000|COMPLETED|Overall Study||29
10964559|NCT00504426|12138206|FG001|COMPLETED|Overall Study||22
10964560|NCT00504426|12138207|FG002|COMPLETED|Overall Study||18
10964561|NCT00504426|12138208|FG003|COMPLETED|Overall Study||24
10964562|NCT00504426|12138205|FG000|NOT COMPLETED|Overall Study||3
10964563|NCT00504426|12138206|FG001|NOT COMPLETED|Overall Study||1
10964564|NCT00504426|12138207|FG002|NOT COMPLETED|Overall Study||4
10964565|NCT00504426|12138208|FG003|NOT COMPLETED|Overall Study||0
10964566|NCT00504504|12138221|FG000|STARTED|Overall Study||82
10964567|NCT00504504|12138221|FG000|COMPLETED|Overall Study||82
10964568|NCT00504504|12138221|FG000|NOT COMPLETED|Overall Study||0
10964569|NCT00504556|12138230|FG000|STARTED|Overall Study||235
10964570|NCT00504556|12138231|FG001|STARTED|Overall Study||245
10964571|NCT00504556|12138232|FG002|STARTED|Overall Study||235
10964572|NCT00504556|12138233|FG003|STARTED|Overall Study||180
10964573|NCT00504556|12138234|FG004|STARTED|Overall Study||251
10964574|NCT00504556|12138230|FG000|Safety Analysis Set|Overall Study||235
10964575|NCT00504556|12138231|FG001|Safety Analysis Set|Overall Study||244
10964576|NCT00504556|12138232|FG002|Safety Analysis Set|Overall Study||234
10964577|NCT00504556|12138233|FG003|Safety Analysis Set|Overall Study||180
10964578|NCT00504556|12138234|FG004|Safety Analysis Set|Overall Study||250
10964579|NCT00504556|12138230|FG000|Per Protocol Analysis Set|Overall Study||235
10964580|NCT00504556|12138231|FG001|Per Protocol Analysis Set|Overall Study||243
10964581|NCT00504556|12138232|FG002|Per Protocol Analysis Set|Overall Study||234
10964582|NCT00504556|12138233|FG003|Per Protocol Analysis Set|Overall Study||180
10964583|NCT00504556|12138234|FG004|Per Protocol Analysis Set|Overall Study||250
10964584|NCT00504556|12138230|FG000|Pharmacodynamic Analysis Set|Overall Study||230
10964585|NCT00504556|12138231|FG001|Pharmacodynamic Analysis Set|Overall Study||236
10964586|NCT00504556|12138232|FG002|Pharmacodynamic Analysis Set|Overall Study||228
10964587|NCT00504556|12138233|FG003|Pharmacodynamic Analysis Set|Overall Study||170
10964588|NCT00504556|12138234|FG004|Pharmacodynamic Analysis Set|Overall Study||244
10964589|NCT00504556|12138230|FG000|COMPLETED|Overall Study||200
10964590|NCT00504556|12138231|FG001|COMPLETED|Overall Study||207
10964591|NCT00504556|12138232|FG002|COMPLETED|Overall Study||204
10964592|NCT00504556|12138233|FG003|COMPLETED|Overall Study||52
10964593|NCT00504556|12138234|FG004|COMPLETED|Overall Study||226
10964594|NCT00504556|12138230|FG000|NOT COMPLETED|Overall Study||35
10964595|NCT00504556|12138231|FG001|NOT COMPLETED|Overall Study||38
10964596|NCT00504556|12138232|FG002|NOT COMPLETED|Overall Study||31
10964597|NCT00504556|12138233|FG003|NOT COMPLETED|Overall Study||128
10964598|NCT00504556|12138234|FG004|NOT COMPLETED|Overall Study||25
10964599|NCT00504595|12138250|FG000|STARTED|Overall Study||50
10964600|NCT00504595|12138251|FG001|STARTED|Overall Study||10
10964601|NCT00504595|12138252|FG002|STARTED|Overall Study||10
10964602|NCT00504595|12138253|FG003|STARTED|Overall Study||10
10964603|NCT00504595|12138250|FG000|COMPLETED|Overall Study||49
10964604|NCT00504595|12138251|FG001|COMPLETED|Overall Study||10
10964605|NCT00504595|12138252|FG002|COMPLETED|Overall Study||8
10964606|NCT00504595|12138253|FG003|COMPLETED|Overall Study||10
10964607|NCT00504595|12138250|FG000|NOT COMPLETED|Overall Study||1
10964608|NCT00504595|12138251|FG001|NOT COMPLETED|Overall Study||0
10964609|NCT00504595|12138252|FG002|NOT COMPLETED|Overall Study||2
10964610|NCT00504595|12138253|FG003|NOT COMPLETED|Overall Study||0
10964611|NCT00504660|12138265|FG000|STARTED|Overall Study||31
10964612|NCT00504660|12138266|FG001|STARTED|Overall Study||43
10964613|NCT00504660|12138265|FG000|COMPLETED|Overall Study||31
10964614|NCT00504660|12138266|FG001|COMPLETED|Overall Study||43
10964615|NCT00504660|12138265|FG000|NOT COMPLETED|Overall Study||0
10964616|NCT00504660|12138266|FG001|NOT COMPLETED|Overall Study||0
10964617|NCT00504725|12138274|FG000|STARTED|Overall Study||21
10964618|NCT00504725|12138275|FG001|STARTED|Overall Study||20
10964619|NCT00504725|12138274|FG000|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
10964620|NCT00504725|12138275|FG001|COMPLETED|Overall Study||20
10964621|NCT00504725|12138274|FG000|NOT COMPLETED|Overall Study||1
10964622|NCT00504725|12138275|FG001|NOT COMPLETED|Overall Study||0
10964623|NCT00504751|12138281|FG000|STARTED|Overall Study||15
10964624|NCT00504751|12138281|FG000|COMPLETED|Overall Study||15
10964625|NCT00504751|12138281|FG000|NOT COMPLETED|Overall Study||0
10964626|NCT00504777|12138285|FG000|STARTED|Overall Study||36
10964627|NCT00504777|12138285|FG000|COMPLETED|Overall Study||35
10964628|NCT00504777|12138285|FG000|NOT COMPLETED|Overall Study||1
10964629|NCT00504829|12138292|FG000|STARTED|Overall Study||73
10964630|NCT00504829|12138293|FG001|STARTED|Overall Study||74
10964631|NCT00504829|12138294|FG002|STARTED|Overall Study||73
10964632|NCT00504829|12138292|FG000|COMPLETED|Overall Study||67
10964633|NCT00504829|12138293|FG001|COMPLETED|Overall Study||70
10964634|NCT00504829|12138294|FG002|COMPLETED|Overall Study||63
10964635|NCT00504829|12138292|FG000|NOT COMPLETED|Overall Study||6
10964636|NCT00504829|12138293|FG001|NOT COMPLETED|Overall Study||4
10964637|NCT00504829|12138294|FG002|NOT COMPLETED|Overall Study||10
10964638|NCT00504881|12138304|FG000|STARTED|Overall Study||121
10964639|NCT00504881|12138305|FG001|STARTED|Overall Study||359
10964640|NCT00504881|12138304|FG000|COMPLETED|Overall Study||111
10964641|NCT00504881|12138305|FG001|COMPLETED|Overall Study||323
10964642|NCT00504881|12138304|FG000|NOT COMPLETED|Overall Study||10
10964643|NCT00504881|12138305|FG001|NOT COMPLETED|Overall Study||36
10964644|NCT00504894|12138316|FG000|STARTED|Overall Study||20
10964645|NCT00504894|12138317|FG001|STARTED|Overall Study||21
10964646|NCT00504894|12138318|FG002|STARTED|Overall Study||19
10964647|NCT00504894|12138316|FG000|COMPLETED|Overall Study||17
10964648|NCT00504894|12138317|FG001|COMPLETED|Overall Study||18
10964649|NCT00504894|12138318|FG002|COMPLETED|Overall Study||19
10964650|NCT00504894|12138316|FG000|NOT COMPLETED|Overall Study||3
10964651|NCT00504894|12138317|FG001|NOT COMPLETED|Overall Study||3
10964652|NCT00504894|12138318|FG002|NOT COMPLETED|Overall Study||0
10964653|NCT00505076|12138329|FG000|STARTED|Overall Study||22
10964654|NCT00505076|12138330|FG001|STARTED|Overall Study||19
10964655|NCT00505076|12138331|FG002|STARTED|Overall Study||22
10964656|NCT00505076|12138329|FG000|COMPLETED|Overall Study||19
10964657|NCT00505076|12138330|FG001|COMPLETED|Overall Study||17
10964658|NCT00505076|12138331|FG002|COMPLETED|Overall Study||17
10964659|NCT00505076|12138329|FG000|NOT COMPLETED|Overall Study||3
10964660|NCT00505076|12138330|FG001|NOT COMPLETED|Overall Study||2
10964661|NCT00505076|12138331|FG002|NOT COMPLETED|Overall Study||5
10964662|NCT00505284|12138344|FG000|STARTED|Overall Study||73
10964663|NCT00505284|12138345|FG001|STARTED|Overall Study||72
10964664|NCT00505284|12138346|FG002|STARTED|Overall Study||69
10964665|NCT00505284|12138347|FG003|STARTED|Overall Study||68
10964666|NCT00505284|12138348|FG004|STARTED|Overall Study||70
10964667|NCT00505284|12138344|FG000|COMPLETED|Overall Study||63
10964668|NCT00505284|12138345|FG001|COMPLETED|Overall Study||56
10964669|NCT00505284|12138346|FG002|COMPLETED|Overall Study||57
10964670|NCT00505284|12138347|FG003|COMPLETED|Overall Study||49
10964671|NCT00505284|12138348|FG004|COMPLETED|Overall Study||37
10964672|NCT00505284|12138344|FG000|NOT COMPLETED|Overall Study||10
10964673|NCT00505284|12138345|FG001|NOT COMPLETED|Overall Study||16
10964674|NCT00505284|12138346|FG002|NOT COMPLETED|Overall Study||12
10964675|NCT00505284|12138347|FG003|NOT COMPLETED|Overall Study||19
10964676|NCT00505284|12138348|FG004|NOT COMPLETED|Overall Study||33
10964677|NCT00505362|12138362|FG000|STARTED|Overall Study||35
10964678|NCT00505362|12138363|FG001|STARTED|Overall Study||28
10964679|NCT00505362|12138362|FG000|COMPLETED|Overall Study||35
10964680|NCT00505362|12138363|FG001|COMPLETED|Overall Study||28
10964681|NCT00505362|12138362|FG000|NOT COMPLETED|Overall Study||0
10964682|NCT00505362|12138363|FG001|NOT COMPLETED|Overall Study||0
10964683|NCT00505375|12138371|FG000|STARTED|Overall Study||77
10964684|NCT00505375|12138372|FG001|STARTED|Overall Study||35
10964685|NCT00505375|12138371|FG000|COMPLETED|Overall Study||73
10964686|NCT00505375|12138372|FG001|COMPLETED|Overall Study||30
10964687|NCT00505375|12138371|FG000|NOT COMPLETED|Overall Study||4
10964688|NCT00505375|12138372|FG001|NOT COMPLETED|Overall Study||5
10964689|NCT00505414|12138380|FG000|STARTED|Titration Phase||0
10964690|NCT00505414|12138381|FG001|STARTED|Titration Phase||0
10964691|NCT00505414|12138382|FG002|STARTED|Titration Phase||0
10964692|NCT00505414|12138383|FG003|STARTED|Titration Phase||62
10964693|NCT00505414|12138384|FG004|STARTED|Titration Phase||31
10964694|NCT00505414|12138380|FG000|COMPLETED|Titration Phase||0
10964695|NCT00505414|12138381|FG001|COMPLETED|Titration Phase||0
10964696|NCT00505414|12138382|FG002|COMPLETED|Titration Phase||0
10964697|NCT00505414|12138383|FG003|COMPLETED|Titration Phase||32
10964698|NCT00505414|12138384|FG004|COMPLETED|Titration Phase||19
10964699|NCT00505414|12138380|FG000|NOT COMPLETED|Titration Phase||0
10964700|NCT00505414|12138381|FG001|NOT COMPLETED|Titration Phase||0
10964701|NCT00505414|12138382|FG002|NOT COMPLETED|Titration Phase||0
10964702|NCT00505414|12138383|FG003|NOT COMPLETED|Titration Phase||30
10964703|NCT00505414|12138384|FG004|NOT COMPLETED|Titration Phase||12
10964704|NCT00505414|12138380|FG000|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
10964705|NCT00505414|12138381|FG001|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
10964706|NCT00505414|12138382|FG002|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
10964707|NCT00505414|12138383|FG003|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
10964708|NCT00505414|12138384|FG004|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
10964709|NCT00505414|12138380|FG000|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
10964710|NCT00505414|12138381|FG001|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
10964711|NCT00505414|12138382|FG002|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
10964712|NCT00505414|12138383|FG003|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
10964713|NCT00505414|12138384|FG004|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
10964714|NCT00505414|12138380|FG000|COMPLETED|Maintenance Phase||12
10964715|NCT00505414|12138381|FG001|COMPLETED|Maintenance Phase||10
10964716|NCT00505414|12138382|FG002|COMPLETED|Maintenance Phase||6
10964717|NCT00505414|12138383|FG003|COMPLETED|Maintenance Phase||0
10964718|NCT00505414|12138384|FG004|COMPLETED|Maintenance Phase||0
10964719|NCT00505414|12138380|FG000|NOT COMPLETED|Maintenance Phase||6
10964720|NCT00505414|12138381|FG001|NOT COMPLETED|Maintenance Phase||5
10964721|NCT00505414|12138382|FG002|NOT COMPLETED|Maintenance Phase||8
10964722|NCT00505414|12138383|FG003|NOT COMPLETED|Maintenance Phase||0
10964723|NCT00505414|12138384|FG004|NOT COMPLETED|Maintenance Phase||0
10964724|NCT00505518|12138396|FG000|STARTED|Overall Study||9
10964725|NCT00505518|12138396|FG000|COMPLETED|Overall Study||9
10964726|NCT00505518|12138396|FG000|NOT COMPLETED|Overall Study||0
10964727|NCT00505622|12138403|FG000|STARTED|Overall Study||121
10964728|NCT00505622|12138404|FG001|STARTED|Overall Study||108
10964729|NCT00505622|12138405|FG002|STARTED|Overall Study||96
10964730|NCT00505622|12138403|FG000|COMPLETED|Overall Study||0
10964731|NCT00505622|12138404|FG001|COMPLETED|Overall Study||0
10964732|NCT00505622|12138405|FG002|COMPLETED|Overall Study||0
10964733|NCT00505622|12138403|FG000|NOT COMPLETED|Overall Study||121
10964734|NCT00505622|12138404|FG001|NOT COMPLETED|Overall Study||108
10964735|NCT00505622|12138405|FG002|NOT COMPLETED|Overall Study||96
10964736|NCT00505635|12138413|FG000|STARTED|Overall Study||5
10964737|NCT00505635|12138413|FG000|COMPLETED|Overall Study||5
10964738|NCT00505635|12138413|FG000|NOT COMPLETED|Overall Study||0
10964739|NCT00505661|12138417|FG000|STARTED|Overall Study||16
10964740|NCT00505661|12138417|FG000|COMPLETED|Overall Study||12
10964741|NCT00505661|12138417|FG000|NOT COMPLETED|Overall Study||4
10964742|NCT00505687|12138421|FG000|STARTED|Overall Study||186
10964743|NCT00505687|12138421|FG000|COMPLETED|Overall Study||91
10964744|NCT00505687|12138421|FG000|NOT COMPLETED|Overall Study||95
10964745|NCT00505752|12138429|FG000|STARTED|Overall Study||132
10964746|NCT00505752|12138430|FG001|STARTED|Overall Study||128
10964747|NCT00505752|12138431|FG002|STARTED|Overall Study||128
10964748|NCT00505752|12138432|FG003|STARTED|Overall Study||132
10964749|NCT00505752|12138429|FG000|COMPLETED|Overall Study||126
10964750|NCT00505752|12138430|FG001|COMPLETED|Overall Study||119
10964751|NCT00505752|12138431|FG002|COMPLETED|Overall Study||120
10964752|NCT00505752|12138432|FG003|COMPLETED|Overall Study||126
10964753|NCT00505752|12138429|FG000|NOT COMPLETED|Overall Study||6
10964754|NCT00505752|12138430|FG001|NOT COMPLETED|Overall Study||9
10964755|NCT00505752|12138431|FG002|NOT COMPLETED|Overall Study||8
10964756|NCT00505752|12138432|FG003|NOT COMPLETED|Overall Study||6
10964757|NCT00505765|12138445|FG000|STARTED|Overall Study||21
10964758|NCT00505765|12138446|FG001|STARTED|Overall Study||20
10964759|NCT00505765|12138447|FG002|STARTED|Overall Study||22
10964760|NCT00505765|12138445|FG000|Mid-Point Assessment|Overall Study||20
10964761|NCT00505765|12138446|FG001|Mid-Point Assessment|Overall Study||19
10964762|NCT00505765|12138447|FG002|Mid-Point Assessment|Overall Study||21
10964763|NCT00505765|12138445|FG000|COMPLETED|Overall Study||19
10964764|NCT00505765|12138446|FG001|COMPLETED|Overall Study||17
10964765|NCT00505765|12138447|FG002|COMPLETED|Overall Study||19
10964766|NCT00505765|12138445|FG000|NOT COMPLETED|Overall Study||2
10964767|NCT00505765|12138446|FG001|NOT COMPLETED|Overall Study||3
10964768|NCT00505765|12138447|FG002|NOT COMPLETED|Overall Study||3
10964769|NCT00505778|12138457|FG000|STARTED|Overall Study||514
10964770|NCT00505778|12138458|FG001|STARTED|Overall Study||513
10964771|NCT00505778|12138457|FG000|Intent to Treat (ITT) Population|Overall Study||512
10964772|NCT00505778|12138458|FG001|Intent to Treat (ITT) Population|Overall Study||511
10964773|NCT00505778|12138457|FG000|COMPLETED|Overall Study||380
10964774|NCT00505778|12138458|FG001|COMPLETED|Overall Study||378
10964775|NCT00505778|12138457|FG000|NOT COMPLETED|Overall Study||134
10964776|NCT00505778|12138458|FG001|NOT COMPLETED|Overall Study||135
10964777|NCT00505895|12138466|FG000|STARTED|Overall Study||27
10964778|NCT00505895|12138467|FG001|STARTED|Overall Study||23
10964779|NCT00505895|12138466|FG000|COMPLETED|Overall Study||27
10964780|NCT00505895|12138467|FG001|COMPLETED|Overall Study||23
10964781|NCT00505895|12138466|FG000|NOT COMPLETED|Overall Study||0
10964782|NCT00505895|12138467|FG001|NOT COMPLETED|Overall Study||0
10964783|NCT00505921|12138473|FG000|STARTED|Overall Study||27
10964784|NCT00505921|12138473|FG000|COMPLETED|Overall Study||18
10964785|NCT00505921|12138473|FG000|NOT COMPLETED|Overall Study||9
10964786|NCT00505934|12138477|FG000|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
10964787|NCT00505934|12138477|FG000|COMPLETED|Overall Study||16
10964788|NCT00505934|12138477|FG000|NOT COMPLETED|Overall Study||3
10964789|NCT00506025|12138484|FG000|STARTED|Overall Study||10
10964790|NCT00506025|12138485|FG001|STARTED|Overall Study||9
10964791|NCT00506025|12138486|FG002|STARTED|Overall Study||8
10964792|NCT00506025|12138484|FG000|COMPLETED|Overall Study||10
10964793|NCT00506025|12138485|FG001|COMPLETED|Overall Study||9
10964794|NCT00506025|12138486|FG002|COMPLETED|Overall Study||8
10964795|NCT00506025|12138484|FG000|NOT COMPLETED|Overall Study||0
10964796|NCT00506025|12138485|FG001|NOT COMPLETED|Overall Study||0
10964797|NCT00506025|12138486|FG002|NOT COMPLETED|Overall Study||0
10964798|NCT00506077|12138496|FG000|STARTED|Treatment Period 1||28
10964799|NCT00506077|12138497|FG001|STARTED|Treatment Period 1||27
10964800|NCT00506077|12138496|FG000|COMPLETED|Treatment Period 1||24
10964801|NCT00506077|12138497|FG001|COMPLETED|Treatment Period 1||24
10964802|NCT00506077|12138496|FG000|NOT COMPLETED|Treatment Period 1||4
10964803|NCT00506077|12138497|FG001|NOT COMPLETED|Treatment Period 1||3
10964804|NCT00506077|12138496|FG000|STARTED|Washout||24
10964805|NCT00506077|12138497|FG001|STARTED|Washout||24
10964806|NCT00506077|12138496|FG000|COMPLETED|Washout||24
10964807|NCT00506077|12138497|FG001|COMPLETED|Washout||24
10964808|NCT00506077|12138496|FG000|NOT COMPLETED|Washout||0
10964809|NCT00506077|12138497|FG001|NOT COMPLETED|Washout||0
10964810|NCT00506077|12138496|FG000|STARTED|Treatment Period 2||24
10964811|NCT00506077|12138497|FG001|STARTED|Treatment Period 2||24
10964812|NCT00506077|12138496|FG000|COMPLETED|Treatment Period 2||23
10964813|NCT00506077|12138497|FG001|COMPLETED|Treatment Period 2||23
10964814|NCT00506077|12138496|FG000|NOT COMPLETED|Treatment Period 2||1
10964815|NCT00506077|12138497|FG001|NOT COMPLETED|Treatment Period 2||1
10964816|NCT00506129|12138503|FG000|STARTED|Overall Study||33
10964817|NCT00506129|12138503|FG000|COMPLETED|Overall Study||11
10964818|NCT00506129|12138503|FG000|NOT COMPLETED|Overall Study||22
10964819|NCT00506142|12138509|FG000|STARTED|Overall Study||35
10964820|NCT00506142|12138510|FG001|STARTED|Overall Study||19
10964821|NCT00506142|12138509|FG000|COMPLETED|Overall Study||0
10964822|NCT00506142|12138510|FG001|COMPLETED|Overall Study||0
10964823|NCT00506142|12138509|FG000|NOT COMPLETED|Overall Study||35
10964824|NCT00506142|12138510|FG001|NOT COMPLETED|Overall Study||19
10964825|NCT00506155|12138516|FG000|STARTED|Overall Study||60
10964826|NCT00506155|12138516|FG000|COMPLETED|Overall Study||60
10964827|NCT00506155|12138516|FG000|NOT COMPLETED|Overall Study||0
10964828|NCT00506285|12138522|FG000|STARTED|3 Week Screening Phase||46
10964829|NCT00506285|12138523|FG001|STARTED|3 Week Screening Phase||46
10964830|NCT00506285|12138522|FG000|COMPLETED|3 Week Screening Phase||29
10964831|NCT00506285|12138523|FG001|COMPLETED|3 Week Screening Phase||36
10964832|NCT00506285|12138522|FG000|NOT COMPLETED|3 Week Screening Phase||17
10964833|NCT00506285|12138523|FG001|NOT COMPLETED|3 Week Screening Phase||10
10964834|NCT00506285|12138522|FG000|STARTED|Double Blind Cross-Over Phase||29
10964835|NCT00506285|12138523|FG001|STARTED|Double Blind Cross-Over Phase||36
10964836|NCT00506285|12138522|FG000|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
10964837|NCT00506285|12138523|FG001|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
10964838|NCT00506285|12138522|FG000|COMPLETED|Double Blind Cross-Over Phase||20
10964839|NCT00506285|12138523|FG001|COMPLETED|Double Blind Cross-Over Phase||31
10964840|NCT00506285|12138522|FG000|NOT COMPLETED|Double Blind Cross-Over Phase||9
10964841|NCT00506285|12138523|FG001|NOT COMPLETED|Double Blind Cross-Over Phase||5
10964842|NCT00506285|12138522|FG000|STARTED|6-month Open Label Phase||20
10964843|NCT00506285|12138523|FG001|STARTED|6-month Open Label Phase||31
10964844|NCT00506285|12138522|FG000|COMPLETED|6-month Open Label Phase||10
10964845|NCT00506285|12138523|FG001|COMPLETED|6-month Open Label Phase||19
10964846|NCT00506285|12138522|FG000|NOT COMPLETED|6-month Open Label Phase||10
10964847|NCT00506285|12138523|FG001|NOT COMPLETED|6-month Open Label Phase||12
10964848|NCT00506350|12138540|FG000|STARTED|Overall Study||36
10964849|NCT00506350|12138541|FG001|STARTED|Overall Study||40
10964850|NCT00506350|12138542|FG002|STARTED|Overall Study||37
10964851|NCT00506350|12138543|FG003|STARTED|Overall Study||36
10964852|NCT00506350|12138544|FG004|STARTED|Overall Study||50
10964853|NCT00506350|12138545|FG005|STARTED|Overall Study||40
10964854|NCT00506350|12138546|FG006|STARTED|Overall Study||35
10964855|NCT00506350|12138547|FG007|STARTED|Overall Study||41
10964856|NCT00506350|12138548|FG008|STARTED|Overall Study||35
10964857|NCT00506350|12138540|FG000|COMPLETED|Overall Study||33
10964858|NCT00506350|12138541|FG001|COMPLETED|Overall Study||37
10964859|NCT00506350|12138542|FG002|COMPLETED|Overall Study||31
10964860|NCT00506350|12138543|FG003|COMPLETED|Overall Study||34
10964861|NCT00506350|12138544|FG004|COMPLETED|Overall Study||40
10964862|NCT00506350|12138545|FG005|COMPLETED|Overall Study||38
10964863|NCT00506350|12138546|FG006|COMPLETED|Overall Study||33
10964864|NCT00506350|12138547|FG007|COMPLETED|Overall Study||36
10964865|NCT00506350|12138548|FG008|COMPLETED|Overall Study||30
10964866|NCT00506350|12138540|FG000|NOT COMPLETED|Overall Study||3
10964867|NCT00506350|12138541|FG001|NOT COMPLETED|Overall Study||3
10964868|NCT00506350|12138542|FG002|NOT COMPLETED|Overall Study||6
10964869|NCT00506350|12138543|FG003|NOT COMPLETED|Overall Study||2
10964870|NCT00506350|12138544|FG004|NOT COMPLETED|Overall Study||10
10964871|NCT00506350|12138545|FG005|NOT COMPLETED|Overall Study||2
10964872|NCT00506350|12138546|FG006|NOT COMPLETED|Overall Study||2
10964873|NCT00506350|12138547|FG007|NOT COMPLETED|Overall Study||5
10964874|NCT00506350|12138548|FG008|NOT COMPLETED|Overall Study||5
10964875|NCT00506389|12138578|FG000|STARTED|In-treatment Period||143
10964876|NCT00506389|12138579|FG001|STARTED|In-treatment Period||139
10964877|NCT00506389|12138580|FG002|STARTED|In-treatment Period||137
10964878|NCT00506389|12138578|FG000|All Participants Treated|In-treatment Period||139
10964879|NCT00506389|12138579|FG001|All Participants Treated|In-treatment Period||138
10964880|NCT00506389|12138580|FG002|All Participants Treated|In-treatment Period||136
10964881|NCT00506389|12138578|FG000|COMPLETED|In-treatment Period||117
10964882|NCT00506389|12138579|FG001|COMPLETED|In-treatment Period||124
10964883|NCT00506389|12138580|FG002|COMPLETED|In-treatment Period||125
10964884|NCT00506389|12138578|FG000|NOT COMPLETED|In-treatment Period||26
10964885|NCT00506389|12138579|FG001|NOT COMPLETED|In-treatment Period||15
10964886|NCT00506389|12138580|FG002|NOT COMPLETED|In-treatment Period||12
10964887|NCT00506389|12138578|FG000|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
10964888|NCT00506389|12138579|FG001|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
10964889|NCT00506389|12138580|FG002|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
10964890|NCT00506389|12138578|FG000|COMPLETED|Follow-up Period||139
10964891|NCT00506389|12138579|FG001|COMPLETED|Follow-up Period||138
10964892|NCT00506389|12138580|FG002|COMPLETED|Follow-up Period||136
10964893|NCT00506389|12138578|FG000|NOT COMPLETED|Follow-up Period||0
10964894|NCT00506389|12138579|FG001|NOT COMPLETED|Follow-up Period||0
10964895|NCT00506389|12138580|FG002|NOT COMPLETED|Follow-up Period||0
10964896|NCT00506415|12138591|FG000|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
10964897|NCT00506415|12138592|FG001|STARTED|Initial Open Label (Maximum 48 Weeks)||0
10964898|NCT00506415|12138593|FG002|STARTED|Initial Open Label (Maximum 48 Weeks)||0
10964899|NCT00506415|12138594|FG003|STARTED|Initial Open Label (Maximum 48 Weeks)||0
10964900|NCT00506415|12138591|FG000|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
10964901|NCT00506415|12138592|FG001|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
10964902|NCT00506415|12138593|FG002|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
10964903|NCT00506415|12138594|FG003|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
10964904|NCT00506415|12138591|FG000|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
10964905|NCT00506415|12138592|FG001|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
10964906|NCT00506415|12138593|FG002|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
10964907|NCT00506415|12138594|FG003|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
10964908|NCT00506415|12138591|FG000|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
10964909|NCT00506415|12138592|FG001|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
10964910|NCT00506415|12138593|FG002|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
10964911|NCT00506415|12138594|FG003|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
10964912|NCT00506415|12138591|FG000|STARTED|Double Blind (Maximum 48 Weeks )||0
10964913|NCT00506415|12138592|FG001|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
10964914|NCT00506415|12138593|FG002|STARTED|Double Blind (Maximum 48 Weeks )||280
10964915|NCT00506415|12138594|FG003|STARTED|Double Blind (Maximum 48 Weeks )||0
10964916|NCT00506415|12138591|FG000|COMPLETED|Double Blind (Maximum 48 Weeks )||0
10964917|NCT00506415|12138592|FG001|COMPLETED|Double Blind (Maximum 48 Weeks )||203
10964918|NCT00506415|12138593|FG002|COMPLETED|Double Blind (Maximum 48 Weeks )||207
10964919|NCT00506415|12138594|FG003|COMPLETED|Double Blind (Maximum 48 Weeks )||0
10964920|NCT00506415|12138591|FG000|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
10964921|NCT00506415|12138592|FG001|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
10964922|NCT00506415|12138593|FG002|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
10964923|NCT00506415|12138594|FG003|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
10964924|NCT00506415|12138591|FG000|STARTED|Extended Open Label (Maximum 48 Weeks)||0
10964925|NCT00506415|12138592|FG001|STARTED|Extended Open Label (Maximum 48 Weeks)||0
10964926|NCT00506415|12138593|FG002|STARTED|Extended Open Label (Maximum 48 Weeks)||0
10964927|NCT00506415|12138594|FG003|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
10964928|NCT00506415|12138591|FG000|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
10964929|NCT00506415|12138592|FG001|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
10964930|NCT00506415|12138593|FG002|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
10964931|NCT00506415|12138594|FG003|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
10964932|NCT00506415|12138591|FG000|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
10964933|NCT00506415|12138592|FG001|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
10964934|NCT00506415|12138593|FG002|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
10964935|NCT00506415|12138594|FG003|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
10964936|NCT00506441|12138607|FG000|STARTED|Period 1; Open-label Period||245
10964937|NCT00506441|12138608|FG001|STARTED|Period 1; Open-label Period||0
10964938|NCT00506441|12138607|FG000|COMPLETED|Period 1; Open-label Period||169
10964939|NCT00506441|12138608|FG001|COMPLETED|Period 1; Open-label Period||0
10964940|NCT00506441|12138607|FG000|NOT COMPLETED|Period 1; Open-label Period||76
10964941|NCT00506441|12138608|FG001|NOT COMPLETED|Period 1; Open-label Period||0
10964942|NCT00506441|12138607|FG000|STARTED|Period 2; Double-blind Period||85
10964943|NCT00506441|12138608|FG001|STARTED|Period 2; Double-blind Period||84
10964944|NCT00506441|12138607|FG000|COMPLETED|Period 2; Double-blind Period||82
10964945|NCT00506441|12138608|FG001|COMPLETED|Period 2; Double-blind Period||79
10964946|NCT00506441|12138607|FG000|NOT COMPLETED|Period 2; Double-blind Period||3
10964947|NCT00506441|12138608|FG001|NOT COMPLETED|Period 2; Double-blind Period||5
10964948|NCT00506454|12138618|FG000|STARTED|Overall Study||11
10964949|NCT00506454|12138619|FG001|STARTED|Overall Study||11
10964950|NCT00506454|12138618|FG000|COMPLETED|Overall Study||10
10964951|NCT00506454|12138619|FG001|COMPLETED|Overall Study||10
10964952|NCT00506454|12138618|FG000|NOT COMPLETED|Overall Study||1
10964953|NCT00506454|12138619|FG001|NOT COMPLETED|Overall Study||1
10964954|NCT00506493|12138625|FG000|STARTED|Overall Study||75
10964955|NCT00506493|12138625|FG000|COMPLETED|Overall Study||64
10964956|NCT00506493|12138625|FG000|NOT COMPLETED|Overall Study||11
10964957|NCT00506519|12138634|FG000|STARTED|Overall Study||10
10964958|NCT00506519|12138635|FG001|STARTED|Overall Study||10
10964959|NCT00506519|12138636|FG002|STARTED|Overall Study||5
10964960|NCT00506519|12138634|FG000|Completed Treatment (Day 5)|Overall Study||8
10964961|NCT00506519|12138635|FG001|Completed Treatment (Day 5)|Overall Study||7
10964962|NCT00506519|12138636|FG002|Completed Treatment (Day 5)|Overall Study||5
10964963|NCT00506519|12138634|FG000|Day 28 Follow up|Overall Study||8
10964964|NCT00506519|12138635|FG001|Day 28 Follow up|Overall Study||6
10964965|NCT00506519|12138636|FG002|Day 28 Follow up|Overall Study||5
10964966|NCT00506519|12138634|FG000|COMPLETED|Overall Study||5
10964967|NCT00506519|12138635|FG001|COMPLETED|Overall Study||4
10964968|NCT00506519|12138636|FG002|COMPLETED|Overall Study||5
10964969|NCT00506519|12138634|FG000|NOT COMPLETED|Overall Study||5
10964970|NCT00506519|12138635|FG001|NOT COMPLETED|Overall Study||6
10964971|NCT00506519|12138636|FG002|NOT COMPLETED|Overall Study||0
10964972|NCT00506597|12138647|FG000|STARTED|Overall Study||33
10964973|NCT00506597|12138647|FG000|COMPLETED|Overall Study||33
10964974|NCT00506597|12138647|FG000|NOT COMPLETED|Overall Study||0
10964975|NCT00506662|12138653|FG000|STARTED|Overall Study||38
10964976|NCT00506662|12138654|FG001|STARTED|Overall Study||48
10964977|NCT00506662|12138653|FG000|COMPLETED|Overall Study||21
10964978|NCT00506662|12138654|FG001|COMPLETED|Overall Study||20
10964979|NCT00506662|12138653|FG000|NOT COMPLETED|Overall Study||17
10964980|NCT00506662|12138654|FG001|NOT COMPLETED|Overall Study||28
10964981|NCT00506675|12138662|FG000|STARTED|Overall Study||27
10964982|NCT00506675|12138663|FG001|STARTED|Overall Study||28
10964983|NCT00506675|12138662|FG000|COMPLETED|Overall Study||27
10964984|NCT00506675|12138663|FG001|COMPLETED|Overall Study||28
10964985|NCT00506675|12138662|FG000|NOT COMPLETED|Overall Study||0
10964986|NCT00506675|12138663|FG001|NOT COMPLETED|Overall Study||0
10964987|NCT00506714|12138671|FG000|STARTED|Overall Study||13
10964988|NCT00506714|12138672|FG001|STARTED|Overall Study||13
10964989|NCT00506714|12138671|FG000|COMPLETED|Overall Study||13
10964990|NCT00506714|12138672|FG001|COMPLETED|Overall Study||13
10964991|NCT00506714|12138671|FG000|NOT COMPLETED|Overall Study||0
10964992|NCT00506714|12138672|FG001|NOT COMPLETED|Overall Study||0
10964993|NCT00506753|12138682|FG000|STARTED|Overall Study||100
10964994|NCT00506753|12138683|FG001|STARTED|Overall Study||99
10964995|NCT00506753|12138682|FG000|COMPLETED|Overall Study||79
10964996|NCT00506753|12138683|FG001|COMPLETED|Overall Study||84
10964997|NCT00506753|12138682|FG000|NOT COMPLETED|Overall Study||21
10964998|NCT00506753|12138683|FG001|NOT COMPLETED|Overall Study||15
10964999|NCT00506779|12138691|FG000|STARTED|Overall Study||4
10965000|NCT00506779|12138692|FG001|STARTED|Overall Study||6
10965001|NCT00506779|12138693|FG002|STARTED|Overall Study||2
10965002|NCT00506779|12138694|FG003|STARTED|Overall Study||5
10965003|NCT00506779|12138691|FG000|COMPLETED|Overall Study||3
10965004|NCT00506779|12138692|FG001|COMPLETED|Overall Study||5
10965005|NCT00506779|12138693|FG002|COMPLETED|Overall Study||0
10965006|NCT00506779|12138694|FG003|COMPLETED|Overall Study||4
10965007|NCT00506779|12138691|FG000|NOT COMPLETED|Overall Study||1
10965008|NCT00506779|12138692|FG001|NOT COMPLETED|Overall Study||1
10965009|NCT00506779|12138693|FG002|NOT COMPLETED|Overall Study||2
10965010|NCT00506779|12138694|FG003|NOT COMPLETED|Overall Study||1
10965011|NCT00506831|12138705|FG000|STARTED|Overall Study||9
10965012|NCT00506831|12138705|FG000|COMPLETED|Overall Study||7
10965013|NCT00506831|12138705|FG000|NOT COMPLETED|Overall Study||2
10965014|NCT00506857|12138709|FG000|STARTED|Overall Study||80
10965015|NCT00506857|12138709|FG000|COMPLETED|Overall Study||80
10965016|NCT00506857|12138709|FG000|NOT COMPLETED|Overall Study||0
10965017|NCT00506883|12138717|FG000|STARTED|Overall Study||52
10965018|NCT00506883|12138718|FG001|STARTED|Overall Study||74
10965019|NCT00506883|12138719|FG002|STARTED|Overall Study||59
10965020|NCT00506883|12138717|FG000|COMPLETED|Overall Study||45
10965021|NCT00506883|12138718|FG001|COMPLETED|Overall Study||71
10965022|NCT00506883|12138719|FG002|COMPLETED|Overall Study||55
10965023|NCT00506883|12138717|FG000|NOT COMPLETED|Overall Study||7
10965024|NCT00506883|12138718|FG001|NOT COMPLETED|Overall Study||3
10965025|NCT00506883|12138719|FG002|NOT COMPLETED|Overall Study||4
10965026|NCT00506922|12138732|FG000|STARTED|Overall Study||37
10965027|NCT00506922|12138733|FG001|STARTED|Overall Study||10
10965028|NCT00506922|12138734|FG002|STARTED|Overall Study||29
10965029|NCT00506922|12138735|FG003|STARTED|Overall Study||63
10965030|NCT00506922|12138736|FG004|STARTED|Overall Study||11
10965031|NCT00506922|12138732|FG000|COMPLETED|Overall Study||37
10965032|NCT00506922|12138733|FG001|COMPLETED|Overall Study||10
10965033|NCT00506922|12138734|FG002|COMPLETED|Overall Study||29
10965034|NCT00506922|12138735|FG003|COMPLETED|Overall Study||61
10965035|NCT00506922|12138736|FG004|COMPLETED|Overall Study||10
10965036|NCT00506922|12138732|FG000|NOT COMPLETED|Overall Study||0
10965037|NCT00506922|12138733|FG001|NOT COMPLETED|Overall Study||0
10965038|NCT00506922|12138734|FG002|NOT COMPLETED|Overall Study||0
10965039|NCT00506922|12138735|FG003|NOT COMPLETED|Overall Study||2
10965040|NCT00506922|12138736|FG004|NOT COMPLETED|Overall Study||1
10965041|NCT00506948|12138744|FG000|STARTED|Overall Study||10
10965042|NCT00506948|12138744|FG000|COMPLETED|Overall Study||0
10965043|NCT00506948|12138744|FG000|NOT COMPLETED|Overall Study||10
10965044|NCT00507026|12138751|FG000|STARTED|Overall Study||145
10965045|NCT00507026|12138752|FG001|STARTED|Overall Study||60
10965046|NCT00507026|12138753|FG002|STARTED|Overall Study||72
10965047|NCT00507026|12138751|FG000|COMPLETED|Overall Study||132
10965048|NCT00507026|12138752|FG001|COMPLETED|Overall Study||56
10965049|NCT00507026|12138753|FG002|COMPLETED|Overall Study||51
10965050|NCT00507026|12138751|FG000|NOT COMPLETED|Overall Study||13
10965051|NCT00507026|12138752|FG001|NOT COMPLETED|Overall Study||4
10965052|NCT00507026|12138753|FG002|NOT COMPLETED|Overall Study||21
10965053|NCT00507130|12138765|FG000|STARTED|Overall Study||9
10965054|NCT00507130|12138766|FG001|STARTED|Overall Study||9
10965055|NCT00507130|12138767|FG002|STARTED|Overall Study||9
10965056|NCT00507130|12138768|FG003|STARTED|Overall Study||9
10965057|NCT00507130|12138765|FG000|COMPLETED|Overall Study||8
10965058|NCT00507130|12138766|FG001|COMPLETED|Overall Study||9
10965059|NCT00507130|12138767|FG002|COMPLETED|Overall Study||8
10965060|NCT00507130|12138768|FG003|COMPLETED|Overall Study||8
10965061|NCT00507130|12138765|FG000|NOT COMPLETED|Overall Study||1
10965062|NCT00507130|12138766|FG001|NOT COMPLETED|Overall Study||0
10965063|NCT00507130|12138767|FG002|NOT COMPLETED|Overall Study||1
10965064|NCT00507130|12138768|FG003|NOT COMPLETED|Overall Study||1
10965065|NCT00507208|12138780|FG000|STARTED|Overall Study||27
10965066|NCT00507208|12138781|FG001|STARTED|Overall Study||26
10965067|NCT00507208|12138780|FG000|Received Dynasplint in Crossover|Overall Study||0
10965068|NCT00507208|12138781|FG001|Received Dynasplint in Crossover|Overall Study||3
10965069|NCT00507208|12138780|FG000|COMPLETED|Overall Study||27
10965070|NCT00507208|12138781|FG001|COMPLETED|Overall Study||26
10965071|NCT00507208|12138780|FG000|NOT COMPLETED|Overall Study||0
10965072|NCT00507208|12138781|FG001|NOT COMPLETED|Overall Study||0
10965073|NCT00507416|12138790|FG000|STARTED|Overall Study||168
10965074|NCT00507416|12138791|FG001|STARTED|Overall Study||167
10965075|NCT00507416|12138792|FG002|STARTED|Overall Study||167
10965076|NCT00507416|12138790|FG000|Treated (Safety Population)|Overall Study||165
10965077|NCT00507416|12138791|FG001|Treated (Safety Population)|Overall Study||158
10965078|NCT00507416|12138792|FG002|Treated (Safety Population)|Overall Study||163
10965079|NCT00507416|12138790|FG000|Completed 8 Treatment Cycles|Overall Study||82
10965080|NCT00507416|12138791|FG001|Completed 8 Treatment Cycles|Overall Study||60
10965081|NCT00507416|12138792|FG002|Completed 8 Treatment Cycles|Overall Study||69
10965082|NCT00507416|12138790|FG000|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
10965083|NCT00507416|12138791|FG001|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
10965084|NCT00507416|12138792|FG002|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
10965085|NCT00507416|12138790|FG000|NOT COMPLETED|Overall Study||118
10965086|NCT00507416|12138791|FG001|NOT COMPLETED|Overall Study||125
10965087|NCT00507416|12138792|FG002|NOT COMPLETED|Overall Study||114
10965088|NCT00507429|12138802|FG000|STARTED|Treatment Phase|Randomized|55
10965089|NCT00507429|12138803|FG001|STARTED|Treatment Phase|Randomized|25
10965090|NCT00507429|12138802|FG000|COMPLETED|Treatment Phase||18
10965091|NCT00507429|12138803|FG001|COMPLETED|Treatment Phase||7
10965092|NCT00507429|12138802|FG000|NOT COMPLETED|Treatment Phase||37
10965093|NCT00507429|12138803|FG001|NOT COMPLETED|Treatment Phase||18
10965094|NCT00507429|12138802|FG000|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
10965095|NCT00507429|12138803|FG001|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
10965096|NCT00507429|12138802|FG000|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
10965097|NCT00507429|12138803|FG001|COMPLETED|Maintenance Phase||0
10965098|NCT00507429|12138802|FG000|NOT COMPLETED|Maintenance Phase||14
10965099|NCT00507429|12138803|FG001|NOT COMPLETED|Maintenance Phase||0
10965100|NCT00507442|12138815|FG000|STARTED|Overall Study||42
10965101|NCT00507442|12138816|FG001|STARTED|Overall Study||66
10965102|NCT00507442|12138817|FG002|STARTED|Overall Study||33
10965103|NCT00507442|12138818|FG003|STARTED|Overall Study||17
10965104|NCT00507442|12138815|FG000|COMPLETED|Overall Study||26
10965105|NCT00507442|12138816|FG001|COMPLETED|Overall Study||39
10965106|NCT00507442|12138817|FG002|COMPLETED|Overall Study||18
10965107|NCT00507442|12138818|FG003|COMPLETED|Overall Study||12
10965108|NCT00507442|12138815|FG000|NOT COMPLETED|Overall Study||16
10965109|NCT00507442|12138816|FG001|NOT COMPLETED|Overall Study||27
10965110|NCT00507442|12138817|FG002|NOT COMPLETED|Overall Study||15
10965111|NCT00507442|12138818|FG003|NOT COMPLETED|Overall Study||5
10965112|NCT00507455|12138835|FG000|STARTED|Overall Study||74
10965113|NCT00507455|12138836|FG001|STARTED|Overall Study||74
10965114|NCT00507455|12138837|FG002|STARTED|Overall Study||74
10965115|NCT00507455|12138835|FG000|COMPLETED|Overall Study||62
10965116|NCT00507455|12138836|FG001|COMPLETED|Overall Study||68
10965117|NCT00507455|12138837|FG002|COMPLETED|Overall Study||62
10965118|NCT00507455|12138835|FG000|NOT COMPLETED|Overall Study||12
10965119|NCT00507455|12138836|FG001|NOT COMPLETED|Overall Study||6
10965120|NCT00507455|12138837|FG002|NOT COMPLETED|Overall Study||12
10965121|NCT00507507|12138847|FG000|STARTED|Treatment Period||64
10965122|NCT00507507|12138848|FG001|STARTED|Treatment Period||62
10965123|NCT00507507|12138847|FG000|Completed 192 Weeks of Treatment|Treatment Period||52
10965124|NCT00507507|12138848|FG001|Completed 192 Weeks of Treatment|Treatment Period||52
10965125|NCT00507507|12138847|FG000|COMPLETED|Treatment Period||12
10965126|NCT00507507|12138848|FG001|COMPLETED|Treatment Period||9
10965127|NCT00507507|12138847|FG000|NOT COMPLETED|Treatment Period||52
10965128|NCT00507507|12138848|FG001|NOT COMPLETED|Treatment Period||53
10965129|NCT00507507|12138847|FG000|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
10965130|NCT00507507|12138848|FG001|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
10965131|NCT00507507|12138847|FG000|COMPLETED|24-week Treatment-free Follow-up Period||16
10965132|NCT00507507|12138848|FG001|COMPLETED|24-week Treatment-free Follow-up Period||12
10965133|NCT00507507|12138847|FG000|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
10965134|NCT00507507|12138848|FG001|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
10965135|NCT00507546|12138858|FG000|STARTED|Overall Study||4
10965136|NCT00507546|12138859|FG001|STARTED|Overall Study||4
10965137|NCT00507546|12138858|FG000|COMPLETED|Overall Study||2
10965138|NCT00507546|12138859|FG001|COMPLETED|Overall Study||3
10965139|NCT00507546|12138858|FG000|NOT COMPLETED|Overall Study||2
10965140|NCT00507546|12138859|FG001|NOT COMPLETED|Overall Study||1
10965141|NCT00507559|12138867|FG000|STARTED|Overall Study||155
10965142|NCT00507559|12138867|FG000|COMPLETED|Overall Study||84
10965143|NCT00507559|12138867|FG000|NOT COMPLETED|Overall Study||71
10965144|NCT00507689|12138874|FG000|STARTED|Pre-Randomization Period||40
10965145|NCT00507689|12138875|FG001|STARTED|Pre-Randomization Period||0
10965146|NCT00507689|12138874|FG000|COMPLETED|Pre-Randomization Period||37
10965147|NCT00507689|12138875|FG001|COMPLETED|Pre-Randomization Period||0
10965148|NCT00507689|12138874|FG000|NOT COMPLETED|Pre-Randomization Period||3
10965149|NCT00507689|12138875|FG001|NOT COMPLETED|Pre-Randomization Period||0
10965150|NCT00507689|12138874|FG000|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
10965151|NCT00507689|12138875|FG001|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
10965152|NCT00507689|12138874|FG000|COMPLETED|Randomized Period||18
10965153|NCT00507689|12138875|FG001|COMPLETED|Randomized Period||16
10965154|NCT00507689|12138874|FG000|NOT COMPLETED|Randomized Period||1
10965155|NCT00507689|12138875|FG001|NOT COMPLETED|Randomized Period||2
10965156|NCT00507728|12138885|FG000|STARTED|Randomization to Month 3||75
10965157|NCT00507728|12138886|FG001|STARTED|Randomization to Month 3||89
10965158|NCT00507728|12138887|FG002|STARTED|Randomization to Month 3||90
10965159|NCT00507728|12138885|FG000|COMPLETED|Randomization to Month 3||60
10965160|NCT00507728|12138886|FG001|COMPLETED|Randomization to Month 3||75
10965161|NCT00507728|12138887|FG002|COMPLETED|Randomization to Month 3||70
10965162|NCT00507728|12138885|FG000|NOT COMPLETED|Randomization to Month 3||15
10965163|NCT00507728|12138886|FG001|NOT COMPLETED|Randomization to Month 3||14
10965164|NCT00507728|12138887|FG002|NOT COMPLETED|Randomization to Month 3||20
10965165|NCT00507728|12138885|FG000|STARTED|From 3 Months to 6 Months||60
10965166|NCT00507728|12138886|FG001|STARTED|From 3 Months to 6 Months||75
10965167|NCT00507728|12138887|FG002|STARTED|From 3 Months to 6 Months||70
10965168|NCT00507728|12138885|FG000|COMPLETED|From 3 Months to 6 Months||54
10965169|NCT00507728|12138886|FG001|COMPLETED|From 3 Months to 6 Months||65
10965170|NCT00507728|12138887|FG002|COMPLETED|From 3 Months to 6 Months||61
10965171|NCT00507728|12138885|FG000|NOT COMPLETED|From 3 Months to 6 Months||6
10965172|NCT00507728|12138886|FG001|NOT COMPLETED|From 3 Months to 6 Months||10
10965173|NCT00507728|12138887|FG002|NOT COMPLETED|From 3 Months to 6 Months||9
10965174|NCT00507767|12138901|FG000|STARTED|Overall Study||15
10965175|NCT00507767|12138901|FG000|COMPLETED|Overall Study||15
10965176|NCT00507767|12138901|FG000|NOT COMPLETED|Overall Study||0
10965177|NCT00507819|12138905|FG000|STARTED|First Intervention (6 Weeks)||14
10965178|NCT00507819|12138906|FG001|STARTED|First Intervention (6 Weeks)||14
10965179|NCT00507819|12138905|FG000|COMPLETED|First Intervention (6 Weeks)||14
10965180|NCT00507819|12138906|FG001|COMPLETED|First Intervention (6 Weeks)||14
10965181|NCT00507819|12138905|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
10965182|NCT00507819|12138906|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
10965183|NCT00507819|12138905|FG000|STARTED|Washout (6 Weeks)||14
10965184|NCT00507819|12138906|FG001|STARTED|Washout (6 Weeks)||14
10965185|NCT00507819|12138905|FG000|COMPLETED|Washout (6 Weeks)||13
10965186|NCT00507819|12138906|FG001|COMPLETED|Washout (6 Weeks)||14
10965187|NCT00507819|12138905|FG000|NOT COMPLETED|Washout (6 Weeks)||1
10965188|NCT00507819|12138906|FG001|NOT COMPLETED|Washout (6 Weeks)||0
10965189|NCT00507819|12138905|FG000|STARTED|Second Intervention (6 Weeks)||13
10965190|NCT00507819|12138906|FG001|STARTED|Second Intervention (6 Weeks)||14
10965191|NCT00507819|12138905|FG000|COMPLETED|Second Intervention (6 Weeks)||13
10965192|NCT00507819|12138906|FG001|COMPLETED|Second Intervention (6 Weeks)||14
10965193|NCT00507819|12138905|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10965194|NCT00507819|12138906|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
10965195|NCT00508001|12138915|FG000|STARTED|Overall Study||19
10965196|NCT00508001|12138916|FG001|STARTED|Overall Study||25
10965197|NCT00508001|12138917|FG002|STARTED|Overall Study||23
10965198|NCT00508001|12138915|FG000|Secondary Treatment Phase|Overall Study||0
10965199|NCT00508001|12138916|FG001|Secondary Treatment Phase|Overall Study||13
10965200|NCT00508001|12138917|FG002|Secondary Treatment Phase|Overall Study||16
10965201|NCT00508001|12138915|FG000|COMPLETED|Overall Study||0
10965202|NCT00508001|12138916|FG001|COMPLETED|Overall Study||13
10965203|NCT00508001|12138917|FG002|COMPLETED|Overall Study||16
10965204|NCT00508001|12138915|FG000|NOT COMPLETED|Overall Study||19
10965205|NCT00508001|12138916|FG001|NOT COMPLETED|Overall Study||12
10965206|NCT00508001|12138917|FG002|NOT COMPLETED|Overall Study||7
10965207|NCT00508027|12138925|FG000|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
10965208|NCT00508027|12138925|FG000|COMPLETED|Dose Level 1||12
10965209|NCT00508027|12138925|FG000|NOT COMPLETED|Dose Level 1||8
10965210|NCT00508027|12138925|FG000|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
10965211|NCT00508027|12138925|FG000|COMPLETED|Dose Level 2||16
10965212|NCT00508027|12138925|FG000|NOT COMPLETED|Dose Level 2||4
10965213|NCT00508027|12138925|FG000|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
10965214|NCT00508027|12138925|FG000|COMPLETED|Dose Level 3||2
10965215|NCT00508027|12138925|FG000|NOT COMPLETED|Dose Level 3||0
10965216|NCT00508105|12138940|FG000|STARTED|Overall Study||44
10965217|NCT00508105|12138941|FG001|STARTED|Overall Study||43
10965218|NCT00508105|12138940|FG000|COMPLETED|Overall Study||40
10965219|NCT00508105|12138941|FG001|COMPLETED|Overall Study||37
10965220|NCT00508105|12138940|FG000|NOT COMPLETED|Overall Study||4
10965221|NCT00508105|12138941|FG001|NOT COMPLETED|Overall Study||6
10965222|NCT00508118|12138950|FG000|STARTED|Overall Study||3
10965223|NCT00508118|12138951|FG001|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
10965224|NCT00508118|12138950|FG000|COMPLETED|Overall Study||3
10965225|NCT00508118|12138951|FG001|COMPLETED|Overall Study||4
10965226|NCT00508118|12138950|FG000|NOT COMPLETED|Overall Study||0
10965227|NCT00508118|12138951|FG001|NOT COMPLETED|Overall Study||0
10965228|NCT00508144|12138958|FG000|STARTED|Overall Study||64
10965229|NCT00508144|12138958|FG000|COMPLETED|Overall Study||53
10965230|NCT00508144|12138958|FG000|NOT COMPLETED|Overall Study||11
10965231|NCT00508157|12138964|FG000|STARTED|Overall Study||26
10965232|NCT00508157|12138965|FG001|STARTED|Overall Study||26
10965233|NCT00508157|12138964|FG000|Randomized Sample|Overall Study||26
10965234|NCT00508157|12138965|FG001|Randomized Sample|Overall Study||26
10965235|NCT00508157|12138964|FG000|Safety Sample|Overall Study||26
10965236|NCT00508157|12138965|FG001|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
10965237|NCT00508157|12138964|FG000|COMPLETED|Overall Study||24
10965238|NCT00508157|12138965|FG001|COMPLETED|Overall Study||23
10965239|NCT00508157|12138964|FG000|NOT COMPLETED|Overall Study||2
10965240|NCT00508157|12138965|FG001|NOT COMPLETED|Overall Study||3
10965241|NCT00508183|12138973|FG000|STARTED|Overall Study||48
10965242|NCT00508183|12138974|FG001|STARTED|Overall Study||42
10965243|NCT00508183|12138973|FG000|COMPLETED|Overall Study||39
10965244|NCT00508183|12138974|FG001|COMPLETED|Overall Study||34
10965245|NCT00508183|12138973|FG000|NOT COMPLETED|Overall Study||9
10965246|NCT00508183|12138974|FG001|NOT COMPLETED|Overall Study||8
10965247|NCT00508196|12138980|FG000|STARTED|Overall Study||11
10965248|NCT00508196|12138981|FG001|STARTED|Overall Study||11
10965249|NCT00508196|12138980|FG000|COMPLETED|Overall Study||11
10965250|NCT00508196|12138981|FG001|COMPLETED|Overall Study||11
10965251|NCT00508196|12138980|FG000|NOT COMPLETED|Overall Study||0
10965252|NCT00508196|12138981|FG001|NOT COMPLETED|Overall Study||0
10965253|NCT00508261|12138991|FG000|STARTED|Overall Study||222
10965254|NCT00508261|12138992|FG001|STARTED|Overall Study||220
10965255|NCT00508261|12138993|FG002|STARTED|Overall Study||224
10965256|NCT00508261|12138994|FG003|STARTED|Overall Study||127
10965257|NCT00508261|12138991|FG000|COMPLETED|Overall Study||219
10965258|NCT00508261|12138992|FG001|COMPLETED|Overall Study||212
10965259|NCT00508261|12138993|FG002|COMPLETED|Overall Study||218
10965260|NCT00508261|12138994|FG003|COMPLETED|Overall Study||126
10965261|NCT00508261|12138991|FG000|NOT COMPLETED|Overall Study||3
10965262|NCT00508261|12138992|FG001|NOT COMPLETED|Overall Study||8
10965263|NCT00508261|12138993|FG002|NOT COMPLETED|Overall Study||6
10965264|NCT00508261|12138994|FG003|NOT COMPLETED|Overall Study||1
10965265|NCT00508274|12139008|FG000|STARTED|Overall Study||52
10965266|NCT00508274|12139008|FG000|COMPLETED|Overall Study||2
10965267|NCT00508274|12139008|FG000|NOT COMPLETED|Overall Study||50
10965268|NCT00508300|12139014|FG000|STARTED|Overall Study||67
10965269|NCT00508300|12139015|FG001|STARTED|Overall Study||61
10965270|NCT00508300|12139014|FG000|COMPLETED|Overall Study||65
10965271|NCT00508300|12139015|FG001|COMPLETED|Overall Study||57
10965272|NCT00508300|12139014|FG000|NOT COMPLETED|Overall Study||2
10965273|NCT00508300|12139015|FG001|NOT COMPLETED|Overall Study||4
10965274|NCT00508391|12139023|FG000|STARTED|First Treatment||60
10965275|NCT00508391|12139024|FG001|STARTED|First Treatment||62
10965276|NCT00508391|12139023|FG000|COMPLETED|First Treatment||54
10965277|NCT00508391|12139024|FG001|COMPLETED|First Treatment||59
10965278|NCT00508391|12139023|FG000|NOT COMPLETED|First Treatment||6
10965279|NCT00508391|12139024|FG001|NOT COMPLETED|First Treatment||3
10965280|NCT00508391|12139023|FG000|STARTED|Second Treatment||54
10965281|NCT00508391|12139024|FG001|STARTED|Second Treatment||59
10965282|NCT00508391|12139023|FG000|COMPLETED|Second Treatment||52
10965283|NCT00508391|12139024|FG001|COMPLETED|Second Treatment||59
10965284|NCT00508391|12139023|FG000|NOT COMPLETED|Second Treatment||2
10965285|NCT00508391|12139024|FG001|NOT COMPLETED|Second Treatment||0
10965286|NCT00508404|12139032|FG000|STARTED|Overall Study||154
10965287|NCT00508404|12139032|FG000|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
10965288|NCT00508404|12139032|FG000|NOT COMPLETED|Overall Study||42
10965289|NCT00508469|12139039|FG000|STARTED|Overall Study||52
10965290|NCT00508469|12139040|FG001|STARTED|Overall Study||50
10965291|NCT00508469|12139039|FG000|COMPLETED|Overall Study||35
10965292|NCT00508469|12139040|FG001|COMPLETED|Overall Study||40
10965293|NCT00508469|12139039|FG000|NOT COMPLETED|Overall Study||17
10965294|NCT00508469|12139040|FG001|NOT COMPLETED|Overall Study||10
10965295|NCT00508482|12139049|FG000|STARTED|Over 4 Weeks of Treatment||237
10965296|NCT00508482|12139050|FG001|STARTED|Over 4 Weeks of Treatment||119
10965297|NCT00508482|12139051|FG002|STARTED|Over 4 Weeks of Treatment||119
10965298|NCT00508482|12139049|FG000|COMPLETED|Over 4 Weeks of Treatment||216
10965299|NCT00508482|12139050|FG001|COMPLETED|Over 4 Weeks of Treatment||102
10965300|NCT00508482|12139051|FG002|COMPLETED|Over 4 Weeks of Treatment||99
10965301|NCT00508482|12139049|FG000|NOT COMPLETED|Over 4 Weeks of Treatment||21
10965302|NCT00508482|12139050|FG001|NOT COMPLETED|Over 4 Weeks of Treatment||17
10965303|NCT00508482|12139051|FG002|NOT COMPLETED|Over 4 Weeks of Treatment||20
10965304|NCT00508482|12139049|FG000|STARTED|at the 4th Week of Follow-up||216
10965305|NCT00508482|12139050|FG001|STARTED|at the 4th Week of Follow-up||102
10965306|NCT00508482|12139051|FG002|STARTED|at the 4th Week of Follow-up||99
10965307|NCT00508482|12139049|FG000|COMPLETED|at the 4th Week of Follow-up||196
10965308|NCT00508482|12139050|FG001|COMPLETED|at the 4th Week of Follow-up||96
10965309|NCT00508482|12139051|FG002|COMPLETED|at the 4th Week of Follow-up||98
10965310|NCT00508482|12139049|FG000|NOT COMPLETED|at the 4th Week of Follow-up||20
10965311|NCT00508482|12139050|FG001|NOT COMPLETED|at the 4th Week of Follow-up||6
10965312|NCT00508482|12139051|FG002|NOT COMPLETED|at the 4th Week of Follow-up||1
10965313|NCT00508482|12139049|FG000|STARTED|at the 12th Week of Follow-up||196
10965314|NCT00508482|12139050|FG001|STARTED|at the 12th Week of Follow-up||96
10965315|NCT00508482|12139051|FG002|STARTED|at the 12th Week of Follow-up||98
10965316|NCT00508482|12139049|FG000|COMPLETED|at the 12th Week of Follow-up||196
10965317|NCT00508482|12139050|FG001|COMPLETED|at the 12th Week of Follow-up||96
10965318|NCT00508482|12139051|FG002|COMPLETED|at the 12th Week of Follow-up||98
10965319|NCT00508482|12139049|FG000|NOT COMPLETED|at the 12th Week of Follow-up||0
10965320|NCT00508482|12139050|FG001|NOT COMPLETED|at the 12th Week of Follow-up||0
10965321|NCT00508482|12139051|FG002|NOT COMPLETED|at the 12th Week of Follow-up||0
10965322|NCT00508521|12139060|FG000|STARTED|Overall Study||4
10965323|NCT00508521|12139060|FG000|COMPLETED|Overall Study||4
10965324|NCT00508521|12139060|FG000|NOT COMPLETED|Overall Study||0
10965325|NCT00508651|12139066|FG000|STARTED|Overall Study||20
10965326|NCT00508651|12139067|FG001|STARTED|Overall Study||10
10965327|NCT00508651|12139066|FG000|COMPLETED|Overall Study||16
10965328|NCT00508651|12139067|FG001|COMPLETED|Overall Study||8
10965329|NCT00508651|12139066|FG000|NOT COMPLETED|Overall Study||4
10965330|NCT00508651|12139067|FG001|NOT COMPLETED|Overall Study||2
10965331|NCT00508716|12139075|FG000|STARTED|Overall Study||61
10965332|NCT00508716|12139076|FG001|STARTED|Overall Study||63
10965333|NCT00508716|12139075|FG000|COMPLETED|Overall Study||61
10965334|NCT00508716|12139076|FG001|COMPLETED|Overall Study||63
10965335|NCT00508716|12139075|FG000|NOT COMPLETED|Overall Study||0
10965336|NCT00508716|12139076|FG001|NOT COMPLETED|Overall Study||0
10965337|NCT00508742|12139084|FG000|STARTED|Period 1: Infant Series||932
10965338|NCT00508742|12139085|FG001|STARTED|Period 1: Infant Series||934
10965339|NCT00508742|12139084|FG000|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
10965340|NCT00508742|12139085|FG001|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
10965341|NCT00508742|12139084|FG000|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
10965342|NCT00508742|12139085|FG001|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
10965343|NCT00508742|12139084|FG000|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
10965344|NCT00508742|12139085|FG001|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
10965345|NCT00508742|12139084|FG000|COMPLETED|Period 1: Infant Series||890
10965346|NCT00508742|12139085|FG001|COMPLETED|Period 1: Infant Series||889
10965347|NCT00508742|12139084|FG000|NOT COMPLETED|Period 1: Infant Series||42
10965348|NCT00508742|12139085|FG001|NOT COMPLETED|Period 1: Infant Series||45
10965349|NCT00508742|12139084|FG000|STARTED|Period 2: After Infant Series||890
10965350|NCT00508742|12139085|FG001|STARTED|Period 2: After Infant Series||889
10965351|NCT00508742|12139084|FG000|COMPLETED|Period 2: After Infant Series||883
10965352|NCT00508742|12139085|FG001|COMPLETED|Period 2: After Infant Series||878
10965353|NCT00508742|12139084|FG000|NOT COMPLETED|Period 2: After Infant Series||7
10965354|NCT00508742|12139085|FG001|NOT COMPLETED|Period 2: After Infant Series||11
10965355|NCT00508742|12139084|FG000|STARTED|Period 3: Toddler Dose||883
10965356|NCT00508742|12139085|FG001|STARTED|Period 3: Toddler Dose||878
10965357|NCT00508742|12139084|FG000|COMPLETED|Period 3: Toddler Dose||858
10965358|NCT00508742|12139085|FG001|COMPLETED|Period 3: Toddler Dose||863
10965359|NCT00508742|12139084|FG000|NOT COMPLETED|Period 3: Toddler Dose||25
10965360|NCT00508742|12139085|FG001|NOT COMPLETED|Period 3: Toddler Dose||15
10965361|NCT00508755|12139097|FG000|STARTED|Overall Study||6
10965362|NCT00508755|12139097|FG000|COMPLETED|Overall Study||5
10965363|NCT00508755|12139097|FG000|NOT COMPLETED|Overall Study||1
10965364|NCT00508924|12139107|FG000|STARTED|Overall Study||36
10965365|NCT00508924|12139108|FG001|STARTED|Overall Study||38
10965366|NCT00508924|12139109|FG002|STARTED|Overall Study||32
10965367|NCT00508924|12139110|FG003|STARTED|Overall Study||34
10965368|NCT00508924|12139107|FG000|COMPLETED|Overall Study||36
10965369|NCT00508924|12139108|FG001|COMPLETED|Overall Study||38
10965370|NCT00508924|12139109|FG002|COMPLETED|Overall Study||31
10965371|NCT00508924|12139110|FG003|COMPLETED|Overall Study||33
10965372|NCT00508924|12139107|FG000|NOT COMPLETED|Overall Study||0
10965373|NCT00508924|12139108|FG001|NOT COMPLETED|Overall Study||0
10965374|NCT00508924|12139109|FG002|NOT COMPLETED|Overall Study||1
10965375|NCT00508924|12139110|FG003|NOT COMPLETED|Overall Study||1
10965376|NCT00509002|12139120|FG000|STARTED|Overall Study||37
10965377|NCT00509002|12139120|FG000|COMPLETED|Overall Study||37
10965378|NCT00509002|12139120|FG000|NOT COMPLETED|Overall Study||0
10965379|NCT00509028|12139126|FG000|STARTED|Overall Study||121
10965380|NCT00509028|12139127|FG001|STARTED|Overall Study||120
10965381|NCT00509028|12139126|FG000|COMPLETED|Overall Study||109
10965382|NCT00509028|12139127|FG001|COMPLETED|Overall Study||113
10965383|NCT00509028|12139126|FG000|NOT COMPLETED|Overall Study||12
10965384|NCT00509028|12139127|FG001|NOT COMPLETED|Overall Study||7
10965385|NCT00509041|12139133|FG000|STARTED|Overall Study||43
10965386|NCT00509041|12139133|FG000|COMPLETED|Overall Study||43
10965387|NCT00509041|12139133|FG000|NOT COMPLETED|Overall Study||0
10965388|NCT00509067|12139139|FG000|STARTED|Overall Study||19
10965389|NCT00509067|12139140|FG001|STARTED|Overall Study||24
10965390|NCT00509067|12139139|FG000|COMPLETED|Overall Study||15
10965391|NCT00509067|12139140|FG001|COMPLETED|Overall Study||19
10965392|NCT00509067|12139139|FG000|NOT COMPLETED|Overall Study||4
10965393|NCT00509067|12139140|FG001|NOT COMPLETED|Overall Study||5
10965394|NCT00509093|12139150|FG000|STARTED|Overall Study||32
10965395|NCT00509093|12139150|FG000|COMPLETED|Overall Study||8
10965396|NCT00509093|12139150|FG000|NOT COMPLETED|Overall Study||24
10965397|NCT00509106|12139156|FG000|STARTED|Overall Study||315
10965398|NCT00509106|12139157|FG001|STARTED|Overall Study||307
10965399|NCT00509106|12139156|FG000|COMPLETED|Overall Study||284
10965400|NCT00509106|12139157|FG001|COMPLETED|Overall Study||278
10965401|NCT00509106|12139156|FG000|NOT COMPLETED|Overall Study||31
10965402|NCT00509106|12139157|FG001|NOT COMPLETED|Overall Study||29
10965403|NCT00509145|12139165|FG000|STARTED|Overall Study||550
10965404|NCT00509145|12139166|FG001|STARTED|Overall Study||556
10965405|NCT00509145|12139165|FG000|COMPLETED|Overall Study||437
10965406|NCT00509145|12139166|FG001|COMPLETED|Overall Study||427
10965407|NCT00509145|12139165|FG000|NOT COMPLETED|Overall Study||113
10965408|NCT00509145|12139166|FG001|NOT COMPLETED|Overall Study||129
10965409|NCT00509171|12139174|FG000|STARTED|Overall Study||11
10965410|NCT00509171|12139175|FG001|STARTED|Overall Study||11
10965411|NCT00509171|12139174|FG000|COMPLETED|Overall Study||11
10965412|NCT00509171|12139175|FG001|COMPLETED|Overall Study||11
10965413|NCT00509171|12139174|FG000|NOT COMPLETED|Overall Study||0
10965414|NCT00509171|12139175|FG001|NOT COMPLETED|Overall Study||0
10965415|NCT00509197|12139183|FG000|STARTED|Overall Study||6
10965416|NCT00509197|12139184|FG001|STARTED|Overall Study||6
10965417|NCT00509197|12139183|FG000|COMPLETED|Overall Study||6
10965418|NCT00509197|12139184|FG001|COMPLETED|Overall Study||6
10965419|NCT00509197|12139183|FG000|NOT COMPLETED|Overall Study||0
10965420|NCT00509197|12139184|FG001|NOT COMPLETED|Overall Study||0
10965421|NCT00509223|12139194|FG000|STARTED|Overall Study||207
10965422|NCT00509223|12139195|FG001|STARTED|Overall Study||209
10965423|NCT00509223|12139194|FG000|COMPLETED|Overall Study||119
10965424|NCT00509223|12139195|FG001|COMPLETED|Overall Study||137
10965425|NCT00509223|12139194|FG000|NOT COMPLETED|Overall Study||88
10965426|NCT00509223|12139195|FG001|NOT COMPLETED|Overall Study||72
10965427|NCT00509236|12139203|FG000|STARTED|Overall Study||64
10965428|NCT00509236|12139204|FG001|STARTED|Overall Study||65
10965429|NCT00509236|12139203|FG000|COMPLETED|Overall Study||47
10965430|NCT00509236|12139204|FG001|COMPLETED|Overall Study||45
10965431|NCT00509236|12139203|FG000|NOT COMPLETED|Overall Study||17
10965432|NCT00509236|12139204|FG001|NOT COMPLETED|Overall Study||20
10965433|NCT00509249|12139210|FG000|STARTED|Overall Study||18
10965434|NCT00509249|12139210|FG000|COMPLETED|Overall Study||18
10965435|NCT00509249|12139210|FG000|NOT COMPLETED|Overall Study||0
10965436|NCT00509262|12139216|FG000|STARTED|Overall Study||211
10965437|NCT00509262|12139217|FG001|STARTED|Overall Study||212
10965438|NCT00509262|12139216|FG000|COMPLETED|Overall Study||164
10965439|NCT00509262|12139217|FG001|COMPLETED|Overall Study||170
10965440|NCT00509262|12139216|FG000|NOT COMPLETED|Overall Study||47
10965441|NCT00509262|12139217|FG001|NOT COMPLETED|Overall Study||42
10965442|NCT00509288|12139225|FG000|STARTED|Overall Study||21
10965443|NCT00509288|12139226|FG001|STARTED|Overall Study||3
10965444|NCT00509288|12139225|FG000|COMPLETED|Overall Study||21
10965445|NCT00509288|12139226|FG001|COMPLETED|Overall Study||3
10965446|NCT00509288|12139225|FG000|NOT COMPLETED|Overall Study||0
10965447|NCT00509288|12139226|FG001|NOT COMPLETED|Overall Study||0
10965448|NCT00509366|12139237|FG000|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
10965449|NCT00509366|12139238|FG001|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
10965450|NCT00509366|12139239|FG002|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
10965451|NCT00509366|12139240|FG003|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
10965452|NCT00509366|12139241|FG004|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
10965453|NCT00509366|12139237|FG000|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
10965454|NCT00509366|12139238|FG001|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
10965455|NCT00509366|12139239|FG002|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
10965456|NCT00509366|12139240|FG003|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
10965457|NCT00509366|12139241|FG004|Assigned Treatment|Overall Study||0
10965458|NCT00509366|12139237|FG000|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
10965459|NCT00509366|12139238|FG001|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
10965460|NCT00509366|12139239|FG002|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
10965461|NCT00509366|12139240|FG003|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
10965462|NCT00509366|12139241|FG004|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
10965463|NCT00509366|12139237|FG000|NOT COMPLETED|Overall Study||1
10965464|NCT00509366|12139238|FG001|NOT COMPLETED|Overall Study||1
10965465|NCT00509366|12139239|FG002|NOT COMPLETED|Overall Study||1
10965466|NCT00509366|12139240|FG003|NOT COMPLETED|Overall Study||0
10965467|NCT00509366|12139241|FG004|NOT COMPLETED|Overall Study||0
10965468|NCT00509392|12139253|FG000|STARTED|Overall Study||32
10965469|NCT00509392|12139254|FG001|STARTED|Overall Study||33
10965470|NCT00509392|12139255|FG002|STARTED|Overall Study||4
10965471|NCT00509392|12139253|FG000|COMPLETED|Overall Study||32
10965472|NCT00509392|12139254|FG001|COMPLETED|Overall Study||33
10965473|NCT00509392|12139255|FG002|COMPLETED|Overall Study||4
10965474|NCT00509392|12139253|FG000|NOT COMPLETED|Overall Study||0
10965475|NCT00509392|12139254|FG001|NOT COMPLETED|Overall Study||0
10965476|NCT00509392|12139255|FG002|NOT COMPLETED|Overall Study||0
10965477|NCT00509496|12139263|FG000|STARTED|Overall Study||19
10965478|NCT00509496|12139264|FG001|STARTED|Overall Study||2
10965479|NCT00509496|12139263|FG000|COMPLETED|Overall Study||19
10965480|NCT00509496|12139264|FG001|COMPLETED|Overall Study||2
10965481|NCT00509496|12139263|FG000|NOT COMPLETED|Overall Study||0
10965482|NCT00509496|12139264|FG001|NOT COMPLETED|Overall Study||0
10965483|NCT00509587|12139270|FG000|STARTED|Overall Study||21
10965484|NCT00509587|12139270|FG000|COMPLETED|Overall Study||21
10965485|NCT00509587|12139270|FG000|NOT COMPLETED|Overall Study||0
10965486|NCT00509665|12139274|FG000|STARTED|Overall Study||18
10965487|NCT00509665|12139274|FG000|COMPLETED|Overall Study||18
10965488|NCT00509665|12139274|FG000|NOT COMPLETED|Overall Study||0
10965489|NCT00509769|12139278|FG000|STARTED|Overall Study||112
10965490|NCT00509769|12139278|FG000|COMPLETED|Overall Study||21
10965491|NCT00509769|12139278|FG000|NOT COMPLETED|Overall Study||91
10965492|NCT00509795|12139286|FG000|STARTED|Overall Study||306
10965493|NCT00509795|12139287|FG001|STARTED|Overall Study||304
10965494|NCT00509795|12139288|FG002|STARTED|Overall Study||304
10965495|NCT00509795|12139289|FG003|STARTED|Overall Study||303
10965496|NCT00509795|12139286|FG000|Patients Received Treatment (SAF)|Overall Study||304
10965497|NCT00509795|12139287|FG001|Patients Received Treatment (SAF)|Overall Study||304
10965498|NCT00509795|12139288|FG002|Patients Received Treatment (SAF)|Overall Study||304
10965499|NCT00509795|12139289|FG003|Patients Received Treatment (SAF)|Overall Study||303
10965500|NCT00509795|12139286|FG000|Full Analysis Set (FAS) Population|Overall Study||304
10965501|NCT00509795|12139287|FG001|Full Analysis Set (FAS) Population|Overall Study||304
10965502|NCT00509795|12139288|FG002|Full Analysis Set (FAS) Population|Overall Study||301
10965503|NCT00509795|12139289|FG003|Full Analysis Set (FAS) Population|Overall Study||301
10965504|NCT00509795|12139286|FG000|Per Protocol Set (PPS) Population|Overall Study||269
10965505|NCT00509795|12139287|FG001|Per Protocol Set (PPS) Population|Overall Study||285
10965506|NCT00509795|12139288|FG002|Per Protocol Set (PPS) Population|Overall Study||270
10965507|NCT00509795|12139289|FG003|Per Protocol Set (PPS) Population|Overall Study||265
10965508|NCT00509795|12139286|FG000|COMPLETED|Overall Study||284
10965509|NCT00509795|12139287|FG001|COMPLETED|Overall Study||293
10965510|NCT00509795|12139288|FG002|COMPLETED|Overall Study||277
10965511|NCT00509795|12139289|FG003|COMPLETED|Overall Study||276
10965512|NCT00509795|12139286|FG000|NOT COMPLETED|Overall Study||22
10965513|NCT00509795|12139287|FG001|NOT COMPLETED|Overall Study||11
10965514|NCT00509795|12139288|FG002|NOT COMPLETED|Overall Study||27
10965515|NCT00509795|12139289|FG003|NOT COMPLETED|Overall Study||27
10965516|NCT00509821|12139302|FG000|STARTED|Study Period 1 (Induction)||3
10965517|NCT00509821|12139303|FG001|STARTED|Study Period 1 (Induction)||57
10965518|NCT00509821|12139302|FG000|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3
10965519|NCT00509821|12139303|FG001|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57
10965520|NCT00509821|12139302|FG000|COMPLETED|Study Period 1 (Induction)||3
10965521|NCT00509821|12139303|FG001|COMPLETED|Study Period 1 (Induction)||53
10965522|NCT00509821|12139302|FG000|NOT COMPLETED|Study Period 1 (Induction)||0
10965523|NCT00509821|12139303|FG001|NOT COMPLETED|Study Period 1 (Induction)||4
10965524|NCT00509821|12139302|FG000|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3
10965525|NCT00509821|12139303|FG001|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53
10965526|NCT00509821|12139302|FG000|COMPLETED|Study Period 2 (Radiation)||3
10965527|NCT00509821|12139303|FG001|COMPLETED|Study Period 2 (Radiation)||0
10965528|NCT00509821|12139302|FG000|NOT COMPLETED|Study Period 2 (Radiation)||0
10965529|NCT00509821|12139303|FG001|NOT COMPLETED|Study Period 2 (Radiation)||53
10965530|NCT00509821|12139302|FG000|STARTED|Study Period 3 (Maintenance)||3
10965531|NCT00509821|12139303|FG001|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49
10965532|NCT00509821|12139302|FG000|COMPLETED|Study Period 3 (Maintenance)||3
10965533|NCT00509821|12139303|FG001|COMPLETED|Study Period 3 (Maintenance)||0
10965534|NCT00509821|12139302|FG000|NOT COMPLETED|Study Period 3 (Maintenance)||0
10965535|NCT00509821|12139303|FG001|NOT COMPLETED|Study Period 3 (Maintenance)||49
10965536|NCT00509821|12139302|FG000|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2
10965537|NCT00509821|12139303|FG001|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50
10965538|NCT00509821|12139302|FG000|COMPLETED|Study Period 4 (Follow Up)||2
10965539|NCT00509821|12139303|FG001|COMPLETED|Study Period 4 (Follow Up)||50
10965540|NCT00509821|12139302|FG000|NOT COMPLETED|Study Period 4 (Follow Up)||0
10965541|NCT00509821|12139303|FG001|NOT COMPLETED|Study Period 4 (Follow Up)||0
10965542|NCT00509873|12139316|FG000|STARTED|Overall Study||287
10965543|NCT00509873|12139317|FG001|STARTED|Overall Study||291
10965544|NCT00509873|12139316|FG000|COMPLETED|Overall Study||276
10965545|NCT00509873|12139317|FG001|COMPLETED|Overall Study||276
10965546|NCT00509873|12139316|FG000|NOT COMPLETED|Overall Study||11
10965547|NCT00509873|12139317|FG001|NOT COMPLETED|Overall Study||15
10965548|NCT00509899|12139331|FG000|STARTED|Overall Study||30
10965549|NCT00509899|12139332|FG001|STARTED|Overall Study||35
10965550|NCT00509899|12139333|FG002|STARTED|Overall Study||47
10965551|NCT00509899|12139334|FG003|STARTED|Overall Study||5
10965552|NCT00509899|12139335|FG004|STARTED|Overall Study||6
10965553|NCT00509899|12139336|FG005|STARTED|Overall Study||22
10965554|NCT00509899|12139337|FG006|STARTED|Overall Study||6
10965555|NCT00509899|12139338|FG007|STARTED|Overall Study||3
10965556|NCT00509899|12139331|FG000|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
10965557|NCT00509899|12139332|FG001|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
10965558|NCT00509899|12139333|FG002|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
10965559|NCT00509899|12139334|FG003|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
10965640|NCT00510484|12139426|FG000|COMPLETED|Wash-out Period||16
10965560|NCT00509899|12139335|FG004|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
10965561|NCT00509899|12139336|FG005|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
10965562|NCT00509899|12139337|FG006|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
10965563|NCT00509899|12139338|FG007|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
10965564|NCT00509899|12139331|FG000|NOT COMPLETED|Overall Study||16
10965565|NCT00509899|12139332|FG001|NOT COMPLETED|Overall Study||9
10965566|NCT00509899|12139333|FG002|NOT COMPLETED|Overall Study||20
10965567|NCT00509899|12139334|FG003|NOT COMPLETED|Overall Study||4
10965568|NCT00509899|12139335|FG004|NOT COMPLETED|Overall Study||5
10965569|NCT00509899|12139336|FG005|NOT COMPLETED|Overall Study||10
10965570|NCT00509899|12139337|FG006|NOT COMPLETED|Overall Study||1
10965571|NCT00509899|12139338|FG007|NOT COMPLETED|Overall Study||1
10965572|NCT00509925|12139352|FG000|STARTED|Overall Study||12
10965573|NCT00509925|12139353|FG001|STARTED|Overall Study||11
10965574|NCT00509925|12139352|FG000|COMPLETED|Overall Study||12
10965575|NCT00509925|12139353|FG001|COMPLETED|Overall Study||10
10965576|NCT00509925|12139352|FG000|NOT COMPLETED|Overall Study||0
10965577|NCT00509925|12139353|FG001|NOT COMPLETED|Overall Study||1
10965578|NCT00510068|12139363|FG000|STARTED|Double-blind Period||207
10965579|NCT00510068|12139364|FG001|STARTED|Double-blind Period||203
10965580|NCT00510068|12139363|FG000|Safety Population|Double-blind Period||204
10965581|NCT00510068|12139364|FG001|Safety Population|Double-blind Period||203
10965582|NCT00510068|12139363|FG000|COMPLETED|Double-blind Period||0
10965583|NCT00510068|12139364|FG001|COMPLETED|Double-blind Period||0
10965584|NCT00510068|12139363|FG000|NOT COMPLETED|Double-blind Period||207
10965585|NCT00510068|12139364|FG001|NOT COMPLETED|Double-blind Period||203
10965586|NCT00510068|12139363|FG000|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
10965587|NCT00510068|12139364|FG001|STARTED|Open-label Period||0
10965588|NCT00510068|12139363|FG000|COMPLETED|Open-label Period||0
10965589|NCT00510068|12139364|FG001|COMPLETED|Open-label Period||0
10965590|NCT00510068|12139363|FG000|NOT COMPLETED|Open-label Period||225
10965591|NCT00510068|12139364|FG001|NOT COMPLETED|Open-label Period||0
10965592|NCT00510146|12139374|FG000|STARTED|Double-Blind Treatment||343
10965593|NCT00510146|12139375|FG001|STARTED|Double-Blind Treatment||171
10965594|NCT00510146|12139374|FG000|COMPLETED|Double-Blind Treatment||267
10965595|NCT00510146|12139375|FG001|COMPLETED|Double-Blind Treatment||122
10965596|NCT00510146|12139374|FG000|NOT COMPLETED|Double-Blind Treatment||76
10965597|NCT00510146|12139375|FG001|NOT COMPLETED|Double-Blind Treatment||49
10965598|NCT00510146|12139374|FG000|STARTED|Open-Label Treatment||267
10965599|NCT00510146|12139375|FG001|STARTED|Open-Label Treatment||122
10965600|NCT00510146|12139374|FG000|COMPLETED|Open-Label Treatment||196
10965601|NCT00510146|12139375|FG001|COMPLETED|Open-Label Treatment||96
10965602|NCT00510146|12139374|FG000|NOT COMPLETED|Open-Label Treatment||71
10965603|NCT00510146|12139375|FG001|NOT COMPLETED|Open-Label Treatment||26
10965604|NCT00510198|12139385|FG000|STARTED|Overall Study||59
10965605|NCT00510198|12139386|FG001|STARTED|Overall Study||58
10965606|NCT00510198|12139385|FG000|COMPLETED|Overall Study||54
10965607|NCT00510198|12139386|FG001|COMPLETED|Overall Study||54
10965608|NCT00510198|12139385|FG000|NOT COMPLETED|Overall Study||5
10965609|NCT00510198|12139386|FG001|NOT COMPLETED|Overall Study||4
10965610|NCT00510224|12139394|FG000|STARTED|Overall Study||13
10965611|NCT00510224|12139394|FG000|COMPLETED|Overall Study||10
10965612|NCT00510224|12139394|FG000|NOT COMPLETED|Overall Study||3
10965613|NCT00510276|12139400|FG000|STARTED|Acute Double-Blind Phase||220
10965614|NCT00510276|12139401|FG001|STARTED|Acute Double-Blind Phase||225
10965615|NCT00510276|12139400|FG000|COMPLETED|Acute Double-Blind Phase||115
10965616|NCT00510276|12139401|FG001|COMPLETED|Acute Double-Blind Phase||130
10965617|NCT00510276|12139400|FG000|NOT COMPLETED|Acute Double-Blind Phase||105
10965618|NCT00510276|12139401|FG001|NOT COMPLETED|Acute Double-Blind Phase||95
10965619|NCT00510276|12139400|FG000|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
10965620|NCT00510276|12139401|FG001|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
10965621|NCT00510276|12139400|FG000|COMPLETED|Extension Open-Label Phase||78
10965622|NCT00510276|12139401|FG001|COMPLETED|Extension Open-Label Phase||81
10965623|NCT00510276|12139400|FG000|NOT COMPLETED|Extension Open-Label Phase||33
10965624|NCT00510276|12139401|FG001|NOT COMPLETED|Extension Open-Label Phase||48
10965625|NCT00510289|12139414|FG000|STARTED|Overall Study|All patients who consented|19
10965626|NCT00510289|12139414|FG000|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
10965627|NCT00510289|12139414|FG000|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
10965628|NCT00510289|12139414|FG000|NOT COMPLETED|Overall Study||12
10965629|NCT00510458|12139419|FG000|STARTED|Overall Study||74
10965630|NCT00510458|12139419|FG000|COMPLETED|Overall Study||27
10965631|NCT00510458|12139419|FG000|NOT COMPLETED|Overall Study||47
10965632|NCT00510484|12139426|FG000|STARTED|Period 1||16
10965633|NCT00510484|12139427|FG001|STARTED|Period 1||16
10965634|NCT00510484|12139426|FG000|COMPLETED|Period 1||16
10965635|NCT00510484|12139427|FG001|COMPLETED|Period 1||16
10965636|NCT00510484|12139426|FG000|NOT COMPLETED|Period 1||0
10965637|NCT00510484|12139427|FG001|NOT COMPLETED|Period 1||0
10965638|NCT00510484|12139426|FG000|STARTED|Wash-out Period||16
10965639|NCT00510484|12139427|FG001|STARTED|Wash-out Period||16
10965641|NCT00510484|12139427|FG001|COMPLETED|Wash-out Period||15
10965642|NCT00510484|12139426|FG000|NOT COMPLETED|Wash-out Period||0
10965643|NCT00510484|12139427|FG001|NOT COMPLETED|Wash-out Period||1
10965644|NCT00510484|12139426|FG000|STARTED|Period 2||16
10965645|NCT00510484|12139427|FG001|STARTED|Period 2||15
10965646|NCT00510484|12139426|FG000|COMPLETED|Period 2||16
10965647|NCT00510484|12139427|FG001|COMPLETED|Period 2||15
10965648|NCT00510484|12139426|FG000|NOT COMPLETED|Period 2||0
10965649|NCT00510484|12139427|FG001|NOT COMPLETED|Period 2||0
10965650|NCT00510497|12139433|FG000|STARTED|Overall Study||11
10965651|NCT00510497|12139433|FG000|COMPLETED|Overall Study||8
10965652|NCT00510497|12139433|FG000|NOT COMPLETED|Overall Study||3
10965653|NCT00510510|12139440|FG000|STARTED|Overall Study||92
10965654|NCT00510510|12139441|FG001|STARTED|Overall Study||98
10965655|NCT00510510|12139442|FG002|STARTED|Overall Study||91
10965656|NCT00510510|12139440|FG000|COMPLETED|Overall Study||87
10965657|NCT00510510|12139441|FG001|COMPLETED|Overall Study||89
10965658|NCT00510510|12139442|FG002|COMPLETED|Overall Study||74
10965659|NCT00510510|12139440|FG000|NOT COMPLETED|Overall Study||5
10965660|NCT00510510|12139441|FG001|NOT COMPLETED|Overall Study||9
10965661|NCT00510510|12139442|FG002|NOT COMPLETED|Overall Study||17
10965662|NCT00510653|12139450|FG000|STARTED|Overall Study||24
10965663|NCT00510653|12139450|FG000|COMPLETED|Overall Study||13
10965664|NCT00510653|12139450|FG000|NOT COMPLETED|Overall Study||11
10965665|NCT00510692|12139456|FG000|STARTED|Overall Study||29
10965666|NCT00510692|12139457|FG001|STARTED|Overall Study||29
10965667|NCT00510692|12139456|FG000|COMPLETED|Overall Study||27
10965668|NCT00510692|12139457|FG001|COMPLETED|Overall Study||26
10965669|NCT00510692|12139456|FG000|NOT COMPLETED|Overall Study||2
10965670|NCT00510692|12139457|FG001|NOT COMPLETED|Overall Study||3
10965671|NCT00510718|12139472|FG000|STARTED|Single Dose Period: 1 Week||15
10965672|NCT00510718|12139473|FG001|STARTED|Single Dose Period: 1 Week||12
10965673|NCT00510718|12139472|FG000|30 mg/Day|Single Dose Period: 1 Week||3
10965674|NCT00510718|12139473|FG001|30 mg/Day|Single Dose Period: 1 Week||0
10965675|NCT00510718|12139472|FG000|60 mg/Day|Single Dose Period: 1 Week||3
10965676|NCT00510718|12139473|FG001|60 mg/Day|Single Dose Period: 1 Week||0
10965677|NCT00510718|12139472|FG000|150/160 mg/Day|Single Dose Period: 1 Week||2
10965678|NCT00510718|12139473|FG001|150/160 mg/Day|Single Dose Period: 1 Week||1
10965679|NCT00510718|12139472|FG000|240 mg/Day|Single Dose Period: 1 Week||3
10965680|NCT00510718|12139473|FG001|240 mg/Day|Single Dose Period: 1 Week||0
10965681|NCT00510718|12139472|FG000|360 mg/Day|Single Dose Period: 1 Week||4
10965682|NCT00510718|12139473|FG001|360 mg/Day|Single Dose Period: 1 Week||2
10965683|NCT00510718|12139472|FG000|480 mg/Day|Single Dose Period: 1 Week||0
10965684|NCT00510718|12139473|FG001|480 mg/Day|Single Dose Period: 1 Week||6
10965685|NCT00510718|12139472|FG000|600 mg/Day|Single Dose Period: 1 Week||0
10965686|NCT00510718|12139473|FG001|600 mg/Day|Single Dose Period: 1 Week||3
10965687|NCT00510718|12139472|FG000|COMPLETED|Single Dose Period: 1 Week||15
10965688|NCT00510718|12139473|FG001|COMPLETED|Single Dose Period: 1 Week||12
10965689|NCT00510718|12139472|FG000|NOT COMPLETED|Single Dose Period: 1 Week||0
10965690|NCT00510718|12139473|FG001|NOT COMPLETED|Single Dose Period: 1 Week||0
10965691|NCT00510718|12139472|FG000|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65
10965692|NCT00510718|12139473|FG001|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75
10965693|NCT00510718|12139472|FG000|30 mg/Day|Multiple Dose Period: 12 Weeks||3
10965694|NCT00510718|12139473|FG001|30 mg/Day|Multiple Dose Period: 12 Weeks||0
10965695|NCT00510718|12139472|FG000|60 mg/Day|Multiple Dose Period: 12 Weeks||15
10965696|NCT00510718|12139473|FG001|60 mg/Day|Multiple Dose Period: 12 Weeks||12
10965697|NCT00510718|12139472|FG000|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15
10965698|NCT00510718|12139473|FG001|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13
10965699|NCT00510718|12139472|FG000|240 mg/Day|Multiple Dose Period: 12 Weeks||17
10965700|NCT00510718|12139473|FG001|240 mg/Day|Multiple Dose Period: 12 Weeks||12
10965701|NCT00510718|12139472|FG000|360 mg/Day|Multiple Dose Period: 12 Weeks||15
10965702|NCT00510718|12139473|FG001|360 mg/Day|Multiple Dose Period: 12 Weeks||13
10965703|NCT00510718|12139472|FG000|480 mg/Day|Multiple Dose Period: 12 Weeks||0
10965704|NCT00510718|12139473|FG001|480 mg/Day|Multiple Dose Period: 12 Weeks||22
10965705|NCT00510718|12139472|FG000|600 mg/Day|Multiple Dose Period: 12 Weeks||0
10965706|NCT00510718|12139473|FG001|600 mg/Day|Multiple Dose Period: 12 Weeks||3
10965707|NCT00510718|12139472|FG000|COMPLETED|Multiple Dose Period: 12 Weeks||50
10965708|NCT00510718|12139473|FG001|COMPLETED|Multiple Dose Period: 12 Weeks||43
10965709|NCT00510718|12139472|FG000|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15
10965710|NCT00510718|12139473|FG001|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32
10965711|NCT00510744|12139492|FG000|STARTED|Overall Study||5
10965712|NCT00510744|12139492|FG000|COMPLETED|Overall Study||5
10965713|NCT00510744|12139492|FG000|NOT COMPLETED|Overall Study||0
10965714|NCT00510783|12139498|FG000|STARTED|Overall Study||82
10965715|NCT00510783|12139499|FG001|STARTED|Overall Study||76
10965716|NCT00510783|12139498|FG000|COMPLETED|Overall Study||51
10965717|NCT00510783|12139499|FG001|COMPLETED|Overall Study||47
10965718|NCT00510783|12139498|FG000|NOT COMPLETED|Overall Study||31
10965719|NCT00510783|12139499|FG001|NOT COMPLETED|Overall Study||29
10965720|NCT00510809|12139508|FG000|STARTED|Overall Study||18
10965721|NCT00510809|12139509|FG001|STARTED|Overall Study||18
10965722|NCT00510809|12139510|FG002|STARTED|Overall Study||18
10965723|NCT00510809|12139508|FG000|COMPLETED|Overall Study||18
10965724|NCT00510809|12139509|FG001|COMPLETED|Overall Study||18
10965725|NCT00510809|12139510|FG002|COMPLETED|Overall Study||18
10965726|NCT00510809|12139508|FG000|NOT COMPLETED|Overall Study||0
10965727|NCT00510809|12139509|FG001|NOT COMPLETED|Overall Study||0
10965728|NCT00510809|12139510|FG002|NOT COMPLETED|Overall Study||0
10965729|NCT00510835|12139521|FG000|STARTED|Overall Study||445
10965730|NCT00510835|12139522|FG001|STARTED|Overall Study||448
10965731|NCT00510835|12139523|FG002|STARTED|Overall Study||458
10965732|NCT00510835|12139521|FG000|COMPLETED|Overall Study||439
10965733|NCT00510835|12139522|FG001|COMPLETED|Overall Study||446
10965734|NCT00510835|12139523|FG002|COMPLETED|Overall Study||456
10965735|NCT00510835|12139521|FG000|NOT COMPLETED|Overall Study||6
10965736|NCT00510835|12139522|FG001|NOT COMPLETED|Overall Study||2
10965737|NCT00510835|12139523|FG002|NOT COMPLETED|Overall Study||2
10965738|NCT00510874|12139538|FG000|STARTED|Overall Study||78
10965739|NCT00510874|12139539|FG001|STARTED|Overall Study||152
10965740|NCT00510874|12139540|FG002|STARTED|Overall Study||151
10965741|NCT00510874|12139541|FG003|STARTED|Overall Study||151
10965742|NCT00510874|12139542|FG004|STARTED|Overall Study||148
10965743|NCT00510874|12139543|FG005|STARTED|Overall Study||50
10965744|NCT00510874|12139544|FG006|STARTED|Overall Study||50
10965745|NCT00510874|12139538|FG000|COMPLETED|Overall Study|Upto Day 182|75
10965746|NCT00510874|12139539|FG001|COMPLETED|Overall Study|Upto Day 182|148
10965747|NCT00510874|12139540|FG002|COMPLETED|Overall Study|Upto Day 182|150
10965748|NCT00510874|12139541|FG003|COMPLETED|Overall Study|Upto Day 182|148
10965749|NCT00510874|12139542|FG004|COMPLETED|Overall Study|Upto Day 182|141
10965750|NCT00510874|12139543|FG005|COMPLETED|Overall Study|Upto Day 182|50
10965751|NCT00510874|12139544|FG006|COMPLETED|Overall Study|Upto Day 182|49
10965752|NCT00510874|12139538|FG000|NOT COMPLETED|Overall Study||3
10965753|NCT00510874|12139539|FG001|NOT COMPLETED|Overall Study||4
10965754|NCT00510874|12139540|FG002|NOT COMPLETED|Overall Study||1
10965755|NCT00510874|12139541|FG003|NOT COMPLETED|Overall Study||3
10965756|NCT00510874|12139542|FG004|NOT COMPLETED|Overall Study||7
10965757|NCT00510874|12139543|FG005|NOT COMPLETED|Overall Study||0
10965758|NCT00510874|12139544|FG006|NOT COMPLETED|Overall Study||1
10965759|NCT00510887|12139561|FG000|STARTED|Overall Study||12
10965760|NCT00510887|12139561|FG000|COMPLETED|Overall Study||11
10965761|NCT00510887|12139561|FG000|NOT COMPLETED|Overall Study||1
10965762|NCT00510952|12139567|FG000|STARTED|Overall Study||235
10965763|NCT00510952|12139568|FG001|STARTED|Overall Study||236
10965764|NCT00510952|12139567|FG000|Full Analysis Set (Intent to Treat)|Overall Study||229
10965765|NCT00510952|12139568|FG001|Full Analysis Set (Intent to Treat)|Overall Study||229
10965766|NCT00510952|12139567|FG000|COMPLETED|Overall Study||209
10965767|NCT00510952|12139568|FG001|COMPLETED|Overall Study||220
10965768|NCT00510952|12139567|FG000|NOT COMPLETED|Overall Study||26
10965769|NCT00510952|12139568|FG001|NOT COMPLETED|Overall Study||16
10965770|NCT00511004|12139577|FG000|STARTED|Overall Study||13
10965771|NCT00511004|12139578|FG001|STARTED|Overall Study||13
10965772|NCT00511004|12139579|FG002|STARTED|Overall Study||14
10965773|NCT00511004|12139577|FG000|COMPLETED|Overall Study||13
10965774|NCT00511004|12139578|FG001|COMPLETED|Overall Study||13
10965775|NCT00511004|12139579|FG002|COMPLETED|Overall Study||10
10965776|NCT00511004|12139577|FG000|NOT COMPLETED|Overall Study||0
10965777|NCT00511004|12139578|FG001|NOT COMPLETED|Overall Study||0
10965778|NCT00511004|12139579|FG002|NOT COMPLETED|Overall Study||4
10965779|NCT00511095|12139590|FG000|STARTED|Overall Study||207
10965780|NCT00511095|12139590|FG000|COMPLETED|Overall Study||196
10965781|NCT00511095|12139590|FG000|NOT COMPLETED|Overall Study||11
10965782|NCT00511108|12139604|FG000|STARTED|Overall Study||52
10965783|NCT00511108|12139605|FG001|STARTED|Overall Study||54
10965784|NCT00511108|12139606|FG002|STARTED|Overall Study||52
10965785|NCT00511108|12139607|FG003|STARTED|Overall Study||53
10965786|NCT00511108|12139604|FG000|COMPLETED|Overall Study||46
10965787|NCT00511108|12139605|FG001|COMPLETED|Overall Study||52
10965788|NCT00511108|12139606|FG002|COMPLETED|Overall Study||47
10965789|NCT00511108|12139607|FG003|COMPLETED|Overall Study||48
10965790|NCT00511108|12139604|FG000|NOT COMPLETED|Overall Study||6
10965791|NCT00511108|12139605|FG001|NOT COMPLETED|Overall Study||2
10965792|NCT00511108|12139606|FG002|NOT COMPLETED|Overall Study||5
10965793|NCT00511108|12139607|FG003|NOT COMPLETED|Overall Study||5
10965794|NCT00511147|12139617|FG000|STARTED|Overall Study||64
10965795|NCT00511147|12139617|FG000|COMPLETED|Overall Study||57
10965796|NCT00511147|12139617|FG000|NOT COMPLETED|Overall Study||7
10965797|NCT00511173|12139621|FG000|STARTED|Overall Study||102
10965798|NCT00511173|12139621|FG000|COMPLETED|Overall Study||102
10965799|NCT00511173|12139621|FG000|NOT COMPLETED|Overall Study||0
10965800|NCT00511238|12139628|FG000|STARTED|Overall Study||46
10965801|NCT00511238|12139629|FG001|STARTED|Overall Study||266
10965802|NCT00511238|12139628|FG000|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
10965803|NCT00511238|12139629|FG001|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
10965804|NCT00511238|12139628|FG000|NOT COMPLETED|Overall Study||42
10965805|NCT00511238|12139629|FG001|NOT COMPLETED|Overall Study||226
10965806|NCT00511472|12139647|FG000|STARTED|Overall Study||47
10965807|NCT00511472|12139648|FG001|STARTED|Overall Study||23
10965808|NCT00511472|12139647|FG000|COMPLETED|Overall Study||44
10965809|NCT00511472|12139648|FG001|COMPLETED|Overall Study||17
10965810|NCT00511472|12139647|FG000|NOT COMPLETED|Overall Study||3
10965811|NCT00511472|12139648|FG001|NOT COMPLETED|Overall Study||6
10965812|NCT00511667|12139665|FG000|STARTED|Overall Study||52
10965813|NCT00511667|12139666|FG001|STARTED|Overall Study||18
10965814|NCT00511667|12139665|FG000|COMPLETED|Overall Study||40
10965815|NCT00511667|12139666|FG001|COMPLETED|Overall Study||15
10965816|NCT00511667|12139665|FG000|NOT COMPLETED|Overall Study||12
10965817|NCT00511667|12139666|FG001|NOT COMPLETED|Overall Study||3
10965818|NCT00511706|12139680|FG000|STARTED|Overall Study||123
10965819|NCT00511706|12139681|FG001|STARTED|Overall Study||120
10965820|NCT00511706|12139680|FG000|COMPLETED|Overall Study||115
10965821|NCT00511706|12139681|FG001|COMPLETED|Overall Study||115
10965822|NCT00511706|12139680|FG000|NOT COMPLETED|Overall Study||8
10965823|NCT00511706|12139681|FG001|NOT COMPLETED|Overall Study||5
10965824|NCT00511797|12139691|FG000|STARTED|Overall Study||62
10965825|NCT00511797|12139692|FG001|STARTED|Overall Study||63
10965826|NCT00511797|12139693|FG002|STARTED|Overall Study||62
10965827|NCT00511797|12139694|FG003|STARTED|Overall Study||62
10965828|NCT00511797|12139691|FG000|Subjects Dispensed Drugs|Overall Study||61
10965829|NCT00511797|12139692|FG001|Subjects Dispensed Drugs|Overall Study||63
10965830|NCT00511797|12139693|FG002|Subjects Dispensed Drugs|Overall Study||61
10965831|NCT00511797|12139694|FG003|Subjects Dispensed Drugs|Overall Study||59
10965832|NCT00511797|12139691|FG000|Subjects Received Treatment|Overall Study|FAS|61
10965833|NCT00511797|12139692|FG001|Subjects Received Treatment|Overall Study|FAS|62
10965834|NCT00511797|12139693|FG002|Subjects Received Treatment|Overall Study|FAS|61
10965835|NCT00511797|12139694|FG003|Subjects Received Treatment|Overall Study|FAS|58
10965836|NCT00511797|12139691|FG000|COMPLETED|Overall Study||55
10965837|NCT00511797|12139692|FG001|COMPLETED|Overall Study||55
10965838|NCT00511797|12139693|FG002|COMPLETED|Overall Study||51
10965839|NCT00511797|12139694|FG003|COMPLETED|Overall Study||47
10965840|NCT00511797|12139691|FG000|NOT COMPLETED|Overall Study||7
10965841|NCT00511797|12139692|FG001|NOT COMPLETED|Overall Study||8
10965842|NCT00511797|12139693|FG002|NOT COMPLETED|Overall Study||11
10965843|NCT00511797|12139694|FG003|NOT COMPLETED|Overall Study||15
10965844|NCT00511810|12139706|FG000|STARTED|Overall Study||8
10965845|NCT00511810|12139707|FG001|STARTED|Overall Study||12
10965846|NCT00511810|12139706|FG000|COMPLETED|Overall Study||7
10965847|NCT00511810|12139707|FG001|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
10965848|NCT00511810|12139706|FG000|NOT COMPLETED|Overall Study||1
10965849|NCT00511810|12139707|FG001|NOT COMPLETED|Overall Study||5
10965850|NCT00511836|12139715|FG000|STARTED|Double-blind Period||16
10965851|NCT00511836|12139716|FG001|STARTED|Double-blind Period||15
10965852|NCT00511836|12139715|FG000|COMPLETED|Double-blind Period||15
10965853|NCT00511836|12139716|FG001|COMPLETED|Double-blind Period||15
10965854|NCT00511836|12139715|FG000|NOT COMPLETED|Double-blind Period||1
10965855|NCT00511836|12139716|FG001|NOT COMPLETED|Double-blind Period||0
10965856|NCT00511836|12139715|FG000|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
10965857|NCT00511836|12139716|FG001|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
10965858|NCT00511836|12139715|FG000|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
10965859|NCT00511836|12139716|FG001|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
10965860|NCT00511836|12139715|FG000|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
10965861|NCT00511836|12139716|FG001|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
10965862|NCT00511862|12139726|FG000|STARTED|Overall Study||61
10965863|NCT00511862|12139727|FG001|STARTED|Overall Study||43
10965864|NCT00511862|12139728|FG002|STARTED|Overall Study||47
10965865|NCT00511862|12139726|FG000|COMPLETED|Overall Study||61
10965866|NCT00511862|12139727|FG001|COMPLETED|Overall Study||43
10965867|NCT00511862|12139728|FG002|COMPLETED|Overall Study||47
10965868|NCT00511862|12139726|FG000|NOT COMPLETED|Overall Study||0
10965869|NCT00511862|12139727|FG001|NOT COMPLETED|Overall Study||0
10965870|NCT00511862|12139728|FG002|NOT COMPLETED|Overall Study||0
10965871|NCT00511875|12139740|FG000|STARTED|Overall Study||15
10965872|NCT00511875|12139741|FG001|STARTED|Overall Study||15
10965873|NCT00511875|12139740|FG000|COMPLETED|Overall Study||10
10965874|NCT00511875|12139741|FG001|COMPLETED|Overall Study||15
10965875|NCT00511875|12139740|FG000|NOT COMPLETED|Overall Study||5
10965876|NCT00511875|12139741|FG001|NOT COMPLETED|Overall Study||0
10965877|NCT00511901|12139749|FG000|STARTED|Overall Study||11
10965878|NCT00511901|12139750|FG001|STARTED|Overall Study||11
10965879|NCT00511901|12139749|FG000|COMPLETED|Overall Study||10
10965880|NCT00511901|12139750|FG001|COMPLETED|Overall Study||8
10965881|NCT00511901|12139749|FG000|NOT COMPLETED|Overall Study||1
10965882|NCT00511901|12139750|FG001|NOT COMPLETED|Overall Study||3
10965883|NCT00511914|12139758|FG000|STARTED|Overall Study||68
10965884|NCT00511914|12139759|FG001|STARTED|Overall Study||67
10965885|NCT00511914|12139758|FG000|COMPLETED|Overall Study||68
10965886|NCT00511914|12139759|FG001|COMPLETED|Overall Study||67
10965887|NCT00511914|12139758|FG000|NOT COMPLETED|Overall Study||0
10965888|NCT00511914|12139759|FG001|NOT COMPLETED|Overall Study||0
10965889|NCT00511992|12139765|FG000|STARTED|Overall Study||20
10965890|NCT00511992|12139765|FG000|COMPLETED|Overall Study||13
10965891|NCT00511992|12139765|FG000|NOT COMPLETED|Overall Study||7
10965892|NCT00512096|12139769|FG000|STARTED|Overall Study||30
10965893|NCT00512096|12139769|FG000|COMPLETED|Overall Study||23
10965894|NCT00512096|12139769|FG000|NOT COMPLETED|Overall Study||7
10965895|NCT00512135|12139773|FG000|STARTED|Overall Study||801
10965896|NCT00512135|12139773|FG000|Treated|Overall Study||796
10965897|NCT00512135|12139773|FG000|COMPLETED|Overall Study||717
10965898|NCT00512135|12139773|FG000|NOT COMPLETED|Overall Study||84
10965899|NCT00512148|12139778|FG000|STARTED|Primay Study Period||7
10965900|NCT00512148|12139778|FG000|COMPLETED|Primay Study Period||6
10965901|NCT00512148|12139778|FG000|NOT COMPLETED|Primay Study Period||1
10965902|NCT00512148|12139778|FG000|STARTED|Long Term Follow Up Period||6
10965903|NCT00512148|12139778|FG000|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
10965904|NCT00512148|12139778|FG000|NOT COMPLETED|Long Term Follow Up Period||6
10965905|NCT00512252|12139787|FG000|STARTED|Overall Study||3
10965906|NCT00512252|12139788|FG001|STARTED|Overall Study||3
10965907|NCT00512252|12139789|FG002|STARTED|Overall Study||46
10965908|NCT00512252|12139787|FG000|COMPLETED|Overall Study||3
10965909|NCT00512252|12139788|FG001|COMPLETED|Overall Study||3
10965910|NCT00512252|12139789|FG002|COMPLETED|Overall Study||43
10965911|NCT00512252|12139787|FG000|NOT COMPLETED|Overall Study||0
10965912|NCT00512252|12139788|FG001|NOT COMPLETED|Overall Study||0
10965913|NCT00512252|12139789|FG002|NOT COMPLETED|Overall Study||3
10965914|NCT00512278|12139806|FG000|STARTED|Overall Study||73
10965915|NCT00512278|12139807|FG001|STARTED|Overall Study||73
10965916|NCT00512278|12139806|FG000|COMPLETED|Overall Study||45
10965917|NCT00512278|12139807|FG001|COMPLETED|Overall Study||56
10965918|NCT00512278|12139806|FG000|NOT COMPLETED|Overall Study||28
10965919|NCT00512278|12139807|FG001|NOT COMPLETED|Overall Study||17
10965920|NCT00512707|12139817|FG000|STARTED|Overall Study||70
10965921|NCT00512707|12139818|FG001|STARTED|Overall Study||70
10965922|NCT00512707|12139817|FG000|COMPLETED|Overall Study||60
10965923|NCT00512707|12139818|FG001|COMPLETED|Overall Study||58
10965924|NCT00512707|12139817|FG000|NOT COMPLETED|Overall Study||10
10965925|NCT00512707|12139818|FG001|NOT COMPLETED|Overall Study||12
10965926|NCT00512798|12139826|FG000|STARTED|Overall Study||19
10965927|NCT00512798|12139827|FG001|STARTED|Overall Study||28
10965928|NCT00512798|12139826|FG000|COMPLETED|Overall Study||0
10965929|NCT00512798|12139827|FG001|COMPLETED|Overall Study||1
10965930|NCT00512798|12139826|FG000|NOT COMPLETED|Overall Study||19
10965931|NCT00512798|12139827|FG001|NOT COMPLETED|Overall Study||27
10965932|NCT00512876|12139834|FG000|STARTED|Overall Study||24
10965933|NCT00512876|12139834|FG000|COMPLETED|Overall Study||20
10965934|NCT00512876|12139834|FG000|NOT COMPLETED|Overall Study||4
10965935|NCT00512902|12139838|FG000|STARTED|Overall Study||20
10965936|NCT00512902|12139838|FG000|COMPLETED|Overall Study||12
10965937|NCT00512902|12139838|FG000|NOT COMPLETED|Overall Study||8
10965938|NCT00513019|12139844|FG000|STARTED|Overall Study||17
10965939|NCT00513019|12139845|FG001|STARTED|Overall Study||18
10965940|NCT00513019|12139844|FG000|COMPLETED|Overall Study||12
10965941|NCT00513019|12139845|FG001|COMPLETED|Overall Study||13
10965942|NCT00513019|12139844|FG000|NOT COMPLETED|Overall Study||5
10965943|NCT00513019|12139845|FG001|NOT COMPLETED|Overall Study||5
10965944|NCT00513071|12139851|FG000|STARTED|Overall Study||28
10965945|NCT00513071|12139851|FG000|COMPLETED|Overall Study||23
10965946|NCT00513071|12139851|FG000|NOT COMPLETED|Overall Study||5
10965947|NCT00513240|12139857|FG000|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
10965948|NCT00513240|12139858|FG001|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
10965949|NCT00513240|12139857|FG000|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
10965950|NCT00513240|12139858|FG001|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
10965951|NCT00513240|12139857|FG000|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
10965952|NCT00513240|12139858|FG001|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
10965953|NCT00513240|12139857|FG000|NOT COMPLETED|Overall Study||13
10965954|NCT00513240|12139858|FG001|NOT COMPLETED|Overall Study||7
10965955|NCT00513292|12139869|FG000|STARTED|Overall Study||138
10965956|NCT00513292|12139870|FG001|STARTED|Overall Study||142
10965957|NCT00513292|12139869|FG000|COMPLETED|Overall Study||138
10965958|NCT00513292|12139870|FG001|COMPLETED|Overall Study||142
10965959|NCT00513292|12139869|FG000|NOT COMPLETED|Overall Study||0
10965960|NCT00513292|12139870|FG001|NOT COMPLETED|Overall Study||0
10965961|NCT00513305|12139878|FG000|STARTED|Overall Study||33
10965962|NCT00513305|12139879|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
10965963|NCT00513305|12139878|FG000|COMPLETED|Overall Study||5
10965964|NCT00513305|12139879|FG001|COMPLETED|Overall Study||7
10965965|NCT00513305|12139878|FG000|NOT COMPLETED|Overall Study||28
10965966|NCT00513305|12139879|FG001|NOT COMPLETED|Overall Study||27
10965967|NCT00513344|12139885|FG000|STARTED|Diet Restriction (3 Days)||5
10965968|NCT00513344|12139885|FG000|COMPLETED|Diet Restriction (3 Days)||5
10965969|NCT00513344|12139885|FG000|NOT COMPLETED|Diet Restriction (3 Days)||0
10965970|NCT00513344|12139885|FG000|STARTED|1st Intervention 1 Day||5
10965971|NCT00513344|12139885|FG000|COMPLETED|1st Intervention 1 Day||5
10965972|NCT00513344|12139885|FG000|NOT COMPLETED|1st Intervention 1 Day||0
10965973|NCT00513344|12139885|FG000|STARTED|Washout Period 3 Days||5
10965974|NCT00513344|12139885|FG000|COMPLETED|Washout Period 3 Days||5
10965975|NCT00513344|12139885|FG000|NOT COMPLETED|Washout Period 3 Days||0
10965976|NCT00513344|12139885|FG000|STARTED|2nd Intervention 1 Day||5
10965977|NCT00513344|12139885|FG000|COMPLETED|2nd Intervention 1 Day||5
10965978|NCT00513344|12139885|FG000|NOT COMPLETED|2nd Intervention 1 Day||0
10965979|NCT00513344|12139885|FG000|STARTED|Washout Period 3 Days||5
10965980|NCT00513344|12139885|FG000|COMPLETED|Washout Period 3 Days||5
10965981|NCT00513344|12139885|FG000|NOT COMPLETED|Washout Period 3 Days||0
10965982|NCT00513344|12139885|FG000|STARTED|3rd Intervention 1 Day||5
10965983|NCT00513344|12139885|FG000|COMPLETED|3rd Intervention 1 Day||5
10965984|NCT00513344|12139885|FG000|NOT COMPLETED|3rd Intervention 1 Day||0
10965985|NCT00513357|12139895|FG000|STARTED|Overall Study||38
10965986|NCT00513357|12139896|FG001|STARTED|Overall Study||35
10965987|NCT00513357|12139895|FG000|COMPLETED|Overall Study||23
10965988|NCT00513357|12139896|FG001|COMPLETED|Overall Study||25
10965989|NCT00513357|12139895|FG000|NOT COMPLETED|Overall Study||15
10965990|NCT00513357|12139896|FG001|NOT COMPLETED|Overall Study||10
10965991|NCT00513370|12139902|FG000|STARTED|Overall Study||203
10965992|NCT00513370|12139902|FG000|COMPLETED|Overall Study||179
10965993|NCT00513370|12139902|FG000|NOT COMPLETED|Overall Study||24
10965994|NCT00513409|12139910|FG000|STARTED|Overall Study||84
10965995|NCT00513409|12139911|FG001|STARTED|Overall Study||79
10965996|NCT00513409|12139910|FG000|COMPLETED|Overall Study||82
10965997|NCT00513409|12139911|FG001|COMPLETED|Overall Study||73
10965998|NCT00513409|12139910|FG000|NOT COMPLETED|Overall Study||2
10965999|NCT00513409|12139911|FG001|NOT COMPLETED|Overall Study||6
10966000|NCT00513435|12139917|FG000|STARTED|Overall Study||9
10966001|NCT00513435|12139917|FG000|COMPLETED|Overall Study||9
10966002|NCT00513435|12139917|FG000|NOT COMPLETED|Overall Study||0
10966003|NCT00513461|12139923|FG000|STARTED|Overall Study||57
10966004|NCT00513461|12139924|FG001|STARTED|Overall Study||53
10966005|NCT00513461|12139923|FG000|COMPLETED|Overall Study||44
10966006|NCT00513461|12139924|FG001|COMPLETED|Overall Study||43
10966007|NCT00513461|12139923|FG000|NOT COMPLETED|Overall Study||13
10966008|NCT00513461|12139924|FG001|NOT COMPLETED|Overall Study||10
10966009|NCT00513474|12139932|FG000|STARTED|Overall Study||25
10966010|NCT00513474|12139933|FG001|STARTED|Overall Study||21
10966011|NCT00513474|12139932|FG000|Received Rasburicase Per Protocol|Overall Study||24
10966012|NCT00513474|12139933|FG001|Received Rasburicase Per Protocol|Overall Study||0
10966013|NCT00513474|12139932|FG000|COMPLETED|Overall Study||18
10966014|NCT00513474|12139933|FG001|COMPLETED|Overall Study||12
10966015|NCT00513474|12139932|FG000|NOT COMPLETED|Overall Study||7
10966016|NCT00513474|12139933|FG001|NOT COMPLETED|Overall Study||9
10966017|NCT00513500|12139941|FG000|STARTED|Overall Study||1017
10966018|NCT00513500|12139942|FG001|STARTED|Overall Study||2108
10966019|NCT00513500|12139941|FG000|COMPLETED|Overall Study||976
10966020|NCT00513500|12139942|FG001|COMPLETED|Overall Study||2054
10966021|NCT00513500|12139941|FG000|NOT COMPLETED|Overall Study||41
10966022|NCT00513500|12139942|FG001|NOT COMPLETED|Overall Study||54
10966023|NCT00513526|12139948|FG000|STARTED|Overall Study||109
10966024|NCT00513526|12139948|FG000|COMPLETED|Overall Study||92
10966025|NCT00513526|12139948|FG000|NOT COMPLETED|Overall Study||17
10966026|NCT00513604|12139959|FG000|STARTED|Overall Study|Cohort 1 = unselected TIL|26
10966027|NCT00513604|12139960|FG001|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
10966028|NCT00513604|12139961|FG002|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
10966029|NCT00513604|12139962|FG003|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
10966030|NCT00513604|12139963|FG004|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
10966031|NCT00513604|12139959|FG000|COMPLETED|Overall Study||24
10966032|NCT00513604|12139960|FG001|COMPLETED|Overall Study||36
10966033|NCT00513604|12139961|FG002|COMPLETED|Overall Study||21
10966034|NCT00513604|12139962|FG003|COMPLETED|Overall Study||34
10966035|NCT00513604|12139963|FG004|COMPLETED|Overall Study||35
10966036|NCT00513604|12139959|FG000|NOT COMPLETED|Overall Study||2
10966037|NCT00513604|12139960|FG001|NOT COMPLETED|Overall Study||3
10966038|NCT00513604|12139961|FG002|NOT COMPLETED|Overall Study||3
10966039|NCT00513604|12139962|FG003|NOT COMPLETED|Overall Study||0
10966040|NCT00513604|12139963|FG004|NOT COMPLETED|Overall Study||0
10966041|NCT00513682|12139975|FG000|STARTED|Screening Phase||9
10966042|NCT00513682|12139975|FG000|COMPLETED|Screening Phase||9
10966043|NCT00513682|12139975|FG000|NOT COMPLETED|Screening Phase||0
10966044|NCT00513682|12139975|FG000|STARTED|Washout Phase||9
10966045|NCT00513682|12139975|FG000|COMPLETED|Washout Phase||7
10966046|NCT00513682|12139975|FG000|NOT COMPLETED|Washout Phase||2
10966047|NCT00513682|12139975|FG000|STARTED|Treatment Phase||7
10966048|NCT00513682|12139975|FG000|COMPLETED|Treatment Phase||7
10966049|NCT00513682|12139975|FG000|NOT COMPLETED|Treatment Phase||0
10966050|NCT00513695|12139982|FG000|STARTED|Overall Study||68
10966051|NCT00513695|12139982|FG000|COMPLETED|Overall Study||63
10966052|NCT00513695|12139982|FG000|NOT COMPLETED|Overall Study||5
10966053|NCT00513708|12139989|FG000|STARTED|Overall Study||50
10966054|NCT00513708|12139990|FG001|STARTED|Overall Study||50
10966055|NCT00513708|12139991|FG002|STARTED|Overall Study||50
10966056|NCT00513708|12139989|FG000|COMPLETED|Overall Study||46
10966057|NCT00513708|12139990|FG001|COMPLETED|Overall Study||46
10966058|NCT00513708|12139991|FG002|COMPLETED|Overall Study||46
10966059|NCT00513708|12139989|FG000|NOT COMPLETED|Overall Study||4
10966060|NCT00513708|12139990|FG001|NOT COMPLETED|Overall Study||4
10966061|NCT00513708|12139991|FG002|NOT COMPLETED|Overall Study||4
10966062|NCT00513747|12140002|FG000|STARTED|Overall Study||17
10966063|NCT00513747|12140003|FG001|STARTED|Overall Study||11
10966064|NCT00513747|12140004|FG002|STARTED|Overall Study||55
10966065|NCT00513747|12140002|FG000|Received at Least One Dose of Treatment|Overall Study||9
10966066|NCT00513747|12140003|FG001|Received at Least One Dose of Treatment|Overall Study||11
10966067|NCT00513747|12140004|FG002|Received at Least One Dose of Treatment|Overall Study||40
10966068|NCT00513747|12140002|FG000|COMPLETED|Overall Study||17
10966069|NCT00513747|12140003|FG001|COMPLETED|Overall Study||11
10966070|NCT00513747|12140004|FG002|COMPLETED|Overall Study||55
10966071|NCT00513747|12140002|FG000|NOT COMPLETED|Overall Study||0
10966072|NCT00513747|12140003|FG001|NOT COMPLETED|Overall Study||0
10966073|NCT00513747|12140004|FG002|NOT COMPLETED|Overall Study||0
10966074|NCT00513799|12140018|FG000|STARTED|One-Month Follow-Up||75
10966075|NCT00513799|12140019|FG001|STARTED|One-Month Follow-Up||75
10966076|NCT00513799|12140020|FG002|STARTED|One-Month Follow-Up||75
10966077|NCT00513799|12140021|FG003|STARTED|One-Month Follow-Up||75
10966078|NCT00513799|12140018|FG000|COMPLETED|One-Month Follow-Up||64
10966079|NCT00513799|12140019|FG001|COMPLETED|One-Month Follow-Up||62
10966080|NCT00513799|12140020|FG002|COMPLETED|One-Month Follow-Up||64
10966081|NCT00513799|12140021|FG003|COMPLETED|One-Month Follow-Up||54
10966082|NCT00513799|12140018|FG000|NOT COMPLETED|One-Month Follow-Up||11
10966083|NCT00513799|12140019|FG001|NOT COMPLETED|One-Month Follow-Up||13
10966084|NCT00513799|12140020|FG002|NOT COMPLETED|One-Month Follow-Up||11
10966085|NCT00513799|12140021|FG003|NOT COMPLETED|One-Month Follow-Up||21
10966086|NCT00513799|12140018|FG000|STARTED|Four-Month Follow-Up||64
10966087|NCT00513799|12140019|FG001|STARTED|Four-Month Follow-Up||62
10966088|NCT00513799|12140020|FG002|STARTED|Four-Month Follow-Up||64
10966089|NCT00513799|12140021|FG003|STARTED|Four-Month Follow-Up||54
10966090|NCT00513799|12140018|FG000|COMPLETED|Four-Month Follow-Up||64
10966091|NCT00513799|12140019|FG001|COMPLETED|Four-Month Follow-Up||57
10966092|NCT00513799|12140020|FG002|COMPLETED|Four-Month Follow-Up||57
10966093|NCT00513799|12140021|FG003|COMPLETED|Four-Month Follow-Up||51
10966094|NCT00513799|12140018|FG000|NOT COMPLETED|Four-Month Follow-Up||0
10966095|NCT00513799|12140019|FG001|NOT COMPLETED|Four-Month Follow-Up||5
10966096|NCT00513799|12140020|FG002|NOT COMPLETED|Four-Month Follow-Up||7
10966097|NCT00513799|12140021|FG003|NOT COMPLETED|Four-Month Follow-Up||3
10966098|NCT00514020|12140035|FG000|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
10966099|NCT00514020|12140035|FG000|COMPLETED|Overall Study||5
10966100|NCT00514020|12140035|FG000|NOT COMPLETED|Overall Study||28
10966101|NCT00514046|12140048|FG000|STARTED|Overall Study||5
10966102|NCT00514046|12140049|FG001|STARTED|Overall Study||1
10966103|NCT00514046|12140050|FG002|STARTED|Overall Study||5
10966104|NCT00514046|12140051|FG003|STARTED|Overall Study||1
10966105|NCT00514046|12140052|FG004|STARTED|Overall Study||1
10966106|NCT00514046|12140053|FG005|STARTED|Overall Study||1
10966107|NCT00514046|12140054|FG006|STARTED|Overall Study||1
10966108|NCT00514046|12140055|FG007|STARTED|Overall Study||1
10966109|NCT00514046|12140056|FG008|STARTED|Overall Study||1
10966110|NCT00514046|12140048|FG000|COMPLETED|Overall Study||2
10966111|NCT00514046|12140049|FG001|COMPLETED|Overall Study||0
10966112|NCT00514046|12140050|FG002|COMPLETED|Overall Study||0
10966113|NCT00514046|12140051|FG003|COMPLETED|Overall Study||1
10966114|NCT00514046|12140052|FG004|COMPLETED|Overall Study||0
10966115|NCT00514046|12140053|FG005|COMPLETED|Overall Study||0
10966116|NCT00514046|12140054|FG006|COMPLETED|Overall Study||1
10966117|NCT00514046|12140055|FG007|COMPLETED|Overall Study||0
10966118|NCT00514046|12140056|FG008|COMPLETED|Overall Study||0
10966119|NCT00514046|12140048|FG000|NOT COMPLETED|Overall Study||3
10966120|NCT00514046|12140049|FG001|NOT COMPLETED|Overall Study||1
10966121|NCT00514046|12140050|FG002|NOT COMPLETED|Overall Study||5
10966122|NCT00514046|12140051|FG003|NOT COMPLETED|Overall Study||0
10966123|NCT00514046|12140052|FG004|NOT COMPLETED|Overall Study||1
10966124|NCT00514046|12140053|FG005|NOT COMPLETED|Overall Study||1
10966125|NCT00514046|12140054|FG006|NOT COMPLETED|Overall Study||0
10966126|NCT00514046|12140055|FG007|NOT COMPLETED|Overall Study||1
10966127|NCT00514046|12140056|FG008|NOT COMPLETED|Overall Study||1
10966128|NCT00514137|12140078|FG000|STARTED|Overall Study||13
10966129|NCT00514137|12140078|FG000|COMPLETED|Overall Study||13
10966130|NCT00514137|12140078|FG000|NOT COMPLETED|Overall Study||0
10966131|NCT00514215|12140082|FG000|STARTED|Overall Study||8
10966132|NCT00514215|12140082|FG000|COMPLETED|Overall Study||8
10966133|NCT00514215|12140082|FG000|NOT COMPLETED|Overall Study||0
10966134|NCT00514449|12140088|FG000|STARTED|Overall Study||12
10966135|NCT00514449|12140089|FG001|STARTED|Overall Study||12
10966136|NCT00514449|12140088|FG000|COMPLETED|Overall Study||9
10966137|NCT00514449|12140089|FG001|COMPLETED|Overall Study||8
10966138|NCT00514449|12140088|FG000|NOT COMPLETED|Overall Study||3
10966139|NCT00514449|12140089|FG001|NOT COMPLETED|Overall Study||4
10966140|NCT00514501|12140098|FG000|STARTED|Overall Study||510
10966141|NCT00514501|12140098|FG000|COMPLETED|Overall Study||507
10966142|NCT00514501|12140098|FG000|NOT COMPLETED|Overall Study||3
10966143|NCT00514514|12140105|FG000|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
10966144|NCT00514514|12140106|FG001|STARTED|Pre-phase||0
10966145|NCT00514514|12140107|FG002|STARTED|Pre-phase||0
10966146|NCT00514514|12140105|FG000|COMPLETED|Pre-phase||499
10966147|NCT00514514|12140106|FG001|COMPLETED|Pre-phase||0
10966148|NCT00514514|12140107|FG002|COMPLETED|Pre-phase||0
10966149|NCT00514514|12140105|FG000|NOT COMPLETED|Pre-phase||303
10966150|NCT00514514|12140106|FG001|NOT COMPLETED|Pre-phase||0
10966151|NCT00514514|12140107|FG002|NOT COMPLETED|Pre-phase||0
10966152|NCT00514514|12140105|FG000|STARTED|Randomized - 9 Month||166
10966153|NCT00514514|12140106|FG001|STARTED|Randomized - 9 Month||171
10966154|NCT00514514|12140107|FG002|STARTED|Randomized - 9 Month||162
10966155|NCT00514514|12140105|FG000|Randomized - Received Treatment|Randomized - 9 Month||165
10966156|NCT00514514|12140106|FG001|Randomized - Received Treatment|Randomized - 9 Month||171
10966157|NCT00514514|12140107|FG002|Randomized - Received Treatment|Randomized - 9 Month||161
10966158|NCT00514514|12140105|FG000|COMPLETED|Randomized - 9 Month||127
10966159|NCT00514514|12140106|FG001|COMPLETED|Randomized - 9 Month||110
10966160|NCT00514514|12140107|FG002|COMPLETED|Randomized - 9 Month||124
10966161|NCT00514514|12140105|FG000|NOT COMPLETED|Randomized - 9 Month||39
10966162|NCT00514514|12140106|FG001|NOT COMPLETED|Randomized - 9 Month||61
10966163|NCT00514514|12140107|FG002|NOT COMPLETED|Randomized - 9 Month||38
10966164|NCT00514514|12140105|FG000|STARTED|Extension - 4 Years||145
10966165|NCT00514514|12140106|FG001|STARTED|Extension - 4 Years||139
10966166|NCT00514514|12140107|FG002|STARTED|Extension - 4 Years||134
10966167|NCT00514514|12140105|FG000|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
10966168|NCT00514514|12140106|FG001|Non-randomized (Followed)|Extension - 4 Years||0
10966169|NCT00514514|12140107|FG002|Non-randomized (Followed)|Extension - 4 Years||0
10966170|NCT00514514|12140105|FG000|COMPLETED|Extension - 4 Years||108
10966171|NCT00514514|12140106|FG001|COMPLETED|Extension - 4 Years||117
10966172|NCT00514514|12140107|FG002|COMPLETED|Extension - 4 Years||113
10966173|NCT00514514|12140105|FG000|NOT COMPLETED|Extension - 4 Years||37
10966174|NCT00514514|12140106|FG001|NOT COMPLETED|Extension - 4 Years||22
10966175|NCT00514514|12140107|FG002|NOT COMPLETED|Extension - 4 Years||21
10966176|NCT00514540|12140115|FG000|STARTED|First-Line Chemo||113
10966177|NCT00514540|12140115|FG000|COMPLETED|First-Line Chemo||105
10966178|NCT00514540|12140115|FG000|NOT COMPLETED|First-Line Chemo||8
10966179|NCT00514540|12140115|FG000|STARTED|Second-Line||105
10966180|NCT00514540|12140115|FG000|COMPLETED|Second-Line||74
10966181|NCT00514540|12140115|FG000|NOT COMPLETED|Second-Line||31
10966182|NCT00514592|12140123|FG000|STARTED|Overall Study||230
10966183|NCT00514592|12140123|FG000|COMPLETED|Overall Study||230
10966184|NCT00514592|12140123|FG000|NOT COMPLETED|Overall Study||0
10966185|NCT00514683|12140132|FG000|STARTED|Overall Study|Randomised|87
10966186|NCT00514683|12140133|FG001|STARTED|Overall Study|Randomised|87
10966187|NCT00514683|12140134|FG002|STARTED|Overall Study|Randomised|86
10966188|NCT00514683|12140135|FG003|STARTED|Overall Study|Randomised|86
10966189|NCT00514683|12140136|FG004|STARTED|Overall Study|Randomised|86
10966190|NCT00514683|12140132|FG000|COMPLETED|Overall Study||61
10966191|NCT00514683|12140133|FG001|COMPLETED|Overall Study||62
10966192|NCT00514683|12140134|FG002|COMPLETED|Overall Study||68
10966193|NCT00514683|12140135|FG003|COMPLETED|Overall Study||72
10966194|NCT00514683|12140136|FG004|COMPLETED|Overall Study||53
10966195|NCT00514683|12140132|FG000|NOT COMPLETED|Overall Study||26
10966196|NCT00514683|12140133|FG001|NOT COMPLETED|Overall Study||25
10966197|NCT00514683|12140134|FG002|NOT COMPLETED|Overall Study||18
10966198|NCT00514683|12140135|FG003|NOT COMPLETED|Overall Study||14
10966199|NCT00514683|12140136|FG004|NOT COMPLETED|Overall Study||33
10966200|NCT00514709|12140154|FG000|STARTED|Overall Study||1230
10966201|NCT00514709|12140155|FG001|STARTED|Overall Study||613
10966202|NCT00514709|12140154|FG000|COMPLETED|Overall Study||1230
10966203|NCT00514709|12140155|FG001|COMPLETED|Overall Study||613
10966204|NCT00514709|12140154|FG000|NOT COMPLETED|Overall Study||0
10966205|NCT00514709|12140155|FG001|NOT COMPLETED|Overall Study||0
10966206|NCT00514735|12140165|FG000|STARTED|Overall Study||138
10966207|NCT00514735|12140166|FG001|STARTED|Overall Study||72
10966208|NCT00514735|12140165|FG000|COMPLETED|Overall Study||124
10966209|NCT00514735|12140166|FG001|COMPLETED|Overall Study||66
10966210|NCT00514735|12140165|FG000|NOT COMPLETED|Overall Study||14
10966211|NCT00514735|12140166|FG001|NOT COMPLETED|Overall Study||6
10966212|NCT00514852|12140176|FG000|STARTED|Overall Study||157
10966213|NCT00514852|12140177|FG001|STARTED|Overall Study||159
10966214|NCT00514852|12140176|FG000|COMPLETED|Overall Study||152
10966215|NCT00514852|12140177|FG001|COMPLETED|Overall Study||154
10966216|NCT00514852|12140176|FG000|NOT COMPLETED|Overall Study||5
10966217|NCT00514852|12140177|FG001|NOT COMPLETED|Overall Study||5
10966218|NCT00514904|12140185|FG000|STARTED|Overall Study||1125
10966219|NCT00514904|12140186|FG001|STARTED|Overall Study||376
10966220|NCT00514904|12140185|FG000|COMPLETED|Overall Study||1101
10966221|NCT00514904|12140186|FG001|COMPLETED|Overall Study||371
10966222|NCT00514904|12140185|FG000|NOT COMPLETED|Overall Study||24
10966223|NCT00514904|12140186|FG001|NOT COMPLETED|Overall Study||5
10966224|NCT00514917|12140194|FG000|STARTED|Overall Study||207
10966225|NCT00514917|12140195|FG001|STARTED|Overall Study||206
10966226|NCT00514917|12140194|FG000|Treated|Overall Study||196
10966227|NCT00514917|12140195|FG001|Treated|Overall Study||204
10966228|NCT00514917|12140194|FG000|Completed Study Treatment|Overall Study||170
10966229|NCT00514917|12140195|FG001|Completed Study Treatment|Overall Study||182
10966230|NCT00514917|12140194|FG000|Testosterone-Specific Evaluable|Overall Study||122
10966231|NCT00514917|12140195|FG001|Testosterone-Specific Evaluable|Overall Study||124
10966232|NCT00514917|12140194|FG000|COMPLETED|Overall Study||81
10966233|NCT00514917|12140195|FG001|COMPLETED|Overall Study||91
10966234|NCT00514917|12140194|FG000|NOT COMPLETED|Overall Study||126
10966235|NCT00514917|12140195|FG001|NOT COMPLETED|Overall Study||115
10966236|NCT00514943|12140205|FG000|STARTED|Stage 1|1 randomized patient was not treated|62
10966237|NCT00514943|12140206|FG001|STARTED|Stage 1|2 randomized patients were not treated|62
10966238|NCT00514943|12140205|FG000|COMPLETED|Stage 1||32
10966239|NCT00514943|12140206|FG001|COMPLETED|Stage 1||36
10966240|NCT00514943|12140205|FG000|NOT COMPLETED|Stage 1||30
10966241|NCT00514943|12140206|FG001|NOT COMPLETED|Stage 1||26
10966242|NCT00514943|12140205|FG000|STARTED|Stage 2||32
10966243|NCT00514943|12140206|FG001|STARTED|Stage 2||36
10966244|NCT00514943|12140205|FG000|COMPLETED|Stage 2||0
10966245|NCT00514943|12140206|FG001|COMPLETED|Stage 2||0
10966246|NCT00514943|12140205|FG000|NOT COMPLETED|Stage 2||32
10966247|NCT00514943|12140206|FG001|NOT COMPLETED|Stage 2||36
10966248|NCT00515008|12140229|FG000|STARTED|Overall Study||33
10966249|NCT00515008|12140230|FG001|STARTED|Overall Study||33
10966250|NCT00515008|12140229|FG000|Completed 12 Week Evaluation|Overall Study||32
10966251|NCT00515008|12140230|FG001|Completed 12 Week Evaluation|Overall Study||29
10966252|NCT00515008|12140229|FG000|COMPLETED|Overall Study||30
10966253|NCT00515008|12140230|FG001|COMPLETED|Overall Study||29
10966254|NCT00515008|12140229|FG000|NOT COMPLETED|Overall Study||3
10966255|NCT00515008|12140230|FG001|NOT COMPLETED|Overall Study||4
10966256|NCT00515021|12140241|FG000|STARTED|Overall Study||9
10966257|NCT00515021|12140242|FG001|STARTED|Overall Study||11
10966258|NCT00515021|12140241|FG000|COMPLETED|Overall Study||9
10966259|NCT00515021|12140242|FG001|COMPLETED|Overall Study||11
10966260|NCT00515021|12140241|FG000|NOT COMPLETED|Overall Study||0
10966261|NCT00515021|12140242|FG001|NOT COMPLETED|Overall Study||0
10966262|NCT00515034|12140254|FG000|STARTED|Overall Study||49
10966263|NCT00515034|12140255|FG001|STARTED|Overall Study||15
10966264|NCT00515034|12140256|FG002|STARTED|Overall Study||62
10966265|NCT00515034|12140257|FG003|STARTED|Overall Study||20
10966266|NCT00515034|12140254|FG000|TREATED|Overall Study||48
10966267|NCT00515034|12140255|FG001|TREATED|Overall Study||15
10966268|NCT00515034|12140256|FG002|TREATED|Overall Study||61
10966269|NCT00515034|12140257|FG003|TREATED|Overall Study||19
10966270|NCT00515034|12140254|FG000|COMPLETED|Overall Study||41
10966271|NCT00515034|12140255|FG001|COMPLETED|Overall Study||13
10966272|NCT00515034|12140256|FG002|COMPLETED|Overall Study||54
10966273|NCT00515034|12140257|FG003|COMPLETED|Overall Study||15
10966274|NCT00515034|12140254|FG000|NOT COMPLETED|Overall Study||8
10966275|NCT00515034|12140255|FG001|NOT COMPLETED|Overall Study||2
10966276|NCT00515034|12140256|FG002|NOT COMPLETED|Overall Study||8
10966277|NCT00515034|12140257|FG003|NOT COMPLETED|Overall Study||5
10966278|NCT00515073|12140267|FG000|STARTED|Overall Study||30
10966279|NCT00515073|12140267|FG000|COMPLETED|Overall Study||28
10966280|NCT00515073|12140267|FG000|NOT COMPLETED|Overall Study||2
10966281|NCT00515086|12140275|FG000|STARTED|Overall Study||24
10966282|NCT00515086|12140276|FG001|STARTED|Overall Study||6
10966283|NCT00515086|12140277|FG002|STARTED|Overall Study||5
10966284|NCT00515086|12140278|FG003|STARTED|Overall Study||6
10966285|NCT00515086|12140275|FG000|COMPLETED|Overall Study||0
10966286|NCT00515086|12140276|FG001|COMPLETED|Overall Study||0
10966287|NCT00515086|12140277|FG002|COMPLETED|Overall Study||0
10966288|NCT00515086|12140278|FG003|COMPLETED|Overall Study||0
10966289|NCT00515086|12140275|FG000|NOT COMPLETED|Overall Study||24
10966290|NCT00515086|12140276|FG001|NOT COMPLETED|Overall Study||6
10966291|NCT00515086|12140277|FG002|NOT COMPLETED|Overall Study||5
10966292|NCT00515086|12140278|FG003|NOT COMPLETED|Overall Study||6
10966293|NCT00515099|12140296|FG000|STARTED|Overall Study||38
10966294|NCT00515099|12140297|FG001|STARTED|Overall Study||20
10966295|NCT00515099|12140296|FG000|COMPLETED|Overall Study||35
10966296|NCT00515099|12140297|FG001|COMPLETED|Overall Study||16
10966297|NCT00515099|12140296|FG000|NOT COMPLETED|Overall Study||3
10966298|NCT00515099|12140297|FG001|NOT COMPLETED|Overall Study||4
10966299|NCT00515177|12140305|FG000|STARTED|Overall Study||20
10966300|NCT00515177|12140306|FG001|STARTED|Overall Study||10
10966301|NCT00515177|12140305|FG000|COMPLETED|Overall Study||18
10966302|NCT00515177|12140306|FG001|COMPLETED|Overall Study||9
10966303|NCT00515177|12140305|FG000|NOT COMPLETED|Overall Study||2
10966304|NCT00515177|12140306|FG001|NOT COMPLETED|Overall Study||1
10966305|NCT00515203|12140315|FG000|STARTED|Overall Study||17
10966306|NCT00515203|12140316|FG001|STARTED|Overall Study||5
10966307|NCT00515203|12140315|FG000|COMPLETED|Overall Study||17
10966308|NCT00515203|12140316|FG001|COMPLETED|Overall Study||5
10966309|NCT00515203|12140315|FG000|NOT COMPLETED|Overall Study||0
10966310|NCT00515203|12140316|FG001|NOT COMPLETED|Overall Study||0
10966311|NCT00515216|12140322|FG000|STARTED|Overall Study||26
10966312|NCT00515216|12140322|FG000|COMPLETED|Overall Study||25
10966313|NCT00515216|12140322|FG000|NOT COMPLETED|Overall Study||1
10966314|NCT00515294|12140331|FG000|STARTED|Overall Study||38
10966315|NCT00515294|12140332|FG001|STARTED|Overall Study||39
10966316|NCT00515294|12140333|FG002|STARTED|Overall Study||38
10966317|NCT00515294|12140334|FG003|STARTED|Overall Study||39
10966318|NCT00515294|12140331|FG000|COMPLETED|Overall Study||29
10966319|NCT00515294|12140332|FG001|COMPLETED|Overall Study||36
10966320|NCT00515294|12140333|FG002|COMPLETED|Overall Study||27
10966321|NCT00515294|12140334|FG003|COMPLETED|Overall Study||35
10966322|NCT00515294|12140331|FG000|NOT COMPLETED|Overall Study||9
10966323|NCT00515294|12140332|FG001|NOT COMPLETED|Overall Study||3
10966324|NCT00515294|12140333|FG002|NOT COMPLETED|Overall Study||11
10966325|NCT00515294|12140334|FG003|NOT COMPLETED|Overall Study||4
10966326|NCT00515411|12140347|FG000|STARTED|Overall Study||54
10966327|NCT00515411|12140348|FG001|STARTED|Overall Study||31
10966328|NCT00515411|12140349|FG002|STARTED|Overall Study||26
10966329|NCT00515411|12140347|FG000|COMPLETED|Overall Study||54
10966330|NCT00515411|12140348|FG001|COMPLETED|Overall Study||31
10966331|NCT00515411|12140349|FG002|COMPLETED|Overall Study||26
10966332|NCT00515411|12140347|FG000|NOT COMPLETED|Overall Study||0
10966333|NCT00515411|12140348|FG001|NOT COMPLETED|Overall Study||0
10966334|NCT00515411|12140349|FG002|NOT COMPLETED|Overall Study||0
10966335|NCT00515437|12140361|FG000|STARTED|Overall Study||14
10966336|NCT00515437|12140362|FG001|STARTED|Overall Study||12
10966337|NCT00515437|12140363|FG002|STARTED|Overall Study||13
10966338|NCT00515437|12140364|FG003|STARTED|Overall Study||15
10966339|NCT00515437|12140361|FG000|COMPLETED|Overall Study||14
10966340|NCT00515437|12140362|FG001|COMPLETED|Overall Study||12
10966341|NCT00515437|12140363|FG002|COMPLETED|Overall Study||13
10966342|NCT00515437|12140364|FG003|COMPLETED|Overall Study||14
10966343|NCT00515437|12140361|FG000|NOT COMPLETED|Overall Study||0
10966344|NCT00515437|12140362|FG001|NOT COMPLETED|Overall Study||0
10966345|NCT00515437|12140363|FG002|NOT COMPLETED|Overall Study||0
10966346|NCT00515437|12140364|FG003|NOT COMPLETED|Overall Study||1
10966347|NCT00515463|12140376|FG000|STARTED|Overall Study||155
10966348|NCT00515463|12140377|FG001|STARTED|Overall Study||156
10966349|NCT00515463|12140376|FG000|Received Study Medication|Overall Study||154
10966350|NCT00515463|12140377|FG001|Received Study Medication|Overall Study||156
10966351|NCT00515463|12140376|FG000|COMPLETED|Overall Study||141
10966352|NCT00515463|12140377|FG001|COMPLETED|Overall Study||142
10966353|NCT00515463|12140376|FG000|NOT COMPLETED|Overall Study||14
10966354|NCT00515463|12140377|FG001|NOT COMPLETED|Overall Study||14
10966355|NCT00515502|12140384|FG000|STARTED|Treatment Period 1||1
10966356|NCT00515502|12140385|FG001|STARTED|Treatment Period 1||4
10966357|NCT00515502|12140386|FG002|STARTED|Treatment Period 1||4
10966358|NCT00515502|12140387|FG003|STARTED|Treatment Period 1||3
10966359|NCT00515502|12140388|FG004|STARTED|Treatment Period 1||3
10966360|NCT00515502|12140389|FG005|STARTED|Treatment Period 1||1
10966361|NCT00515502|12140390|FG006|STARTED|Treatment Period 1||2
10966362|NCT00515502|12140391|FG007|STARTED|Treatment Period 1||1
10966363|NCT00515502|12140392|FG008|STARTED|Treatment Period 1||1
10966364|NCT00515502|12140393|FG009|STARTED|Treatment Period 1||2
10966365|NCT00515502|12140394|FG010|STARTED|Treatment Period 1||1
10966366|NCT00515502|12140395|FG011|STARTED|Treatment Period 1||1
10966367|NCT00515502|12140384|FG000|COMPLETED|Treatment Period 1||1
10966368|NCT00515502|12140385|FG001|COMPLETED|Treatment Period 1||4
10966369|NCT00515502|12140386|FG002|COMPLETED|Treatment Period 1||4
10966370|NCT00515502|12140387|FG003|COMPLETED|Treatment Period 1||3
10966371|NCT00515502|12140388|FG004|COMPLETED|Treatment Period 1||3
10966372|NCT00515502|12140389|FG005|COMPLETED|Treatment Period 1||1
10966373|NCT00515502|12140390|FG006|COMPLETED|Treatment Period 1||1
10966374|NCT00515502|12140391|FG007|COMPLETED|Treatment Period 1||1
10966375|NCT00515502|12140392|FG008|COMPLETED|Treatment Period 1||0
10966376|NCT00515502|12140393|FG009|COMPLETED|Treatment Period 1||2
10966377|NCT00515502|12140394|FG010|COMPLETED|Treatment Period 1||1
10966378|NCT00515502|12140395|FG011|COMPLETED|Treatment Period 1||0
10966379|NCT00515502|12140384|FG000|NOT COMPLETED|Treatment Period 1||0
10966380|NCT00515502|12140385|FG001|NOT COMPLETED|Treatment Period 1||0
10966381|NCT00515502|12140386|FG002|NOT COMPLETED|Treatment Period 1||0
10966382|NCT00515502|12140387|FG003|NOT COMPLETED|Treatment Period 1||0
10966383|NCT00515502|12140388|FG004|NOT COMPLETED|Treatment Period 1||0
10966384|NCT00515502|12140389|FG005|NOT COMPLETED|Treatment Period 1||0
10966385|NCT00515502|12140390|FG006|NOT COMPLETED|Treatment Period 1||1
10966386|NCT00515502|12140391|FG007|NOT COMPLETED|Treatment Period 1||0
10966387|NCT00515502|12140392|FG008|NOT COMPLETED|Treatment Period 1||1
10966388|NCT00515502|12140393|FG009|NOT COMPLETED|Treatment Period 1||0
10966389|NCT00515502|12140394|FG010|NOT COMPLETED|Treatment Period 1||0
10966390|NCT00515502|12140395|FG011|NOT COMPLETED|Treatment Period 1||1
10966391|NCT00515502|12140384|FG000|STARTED|Washout Period 1||1
10966392|NCT00515502|12140385|FG001|STARTED|Washout Period 1||4
10966393|NCT00515502|12140386|FG002|STARTED|Washout Period 1||4
10966394|NCT00515502|12140387|FG003|STARTED|Washout Period 1||3
10966395|NCT00515502|12140388|FG004|STARTED|Washout Period 1||3
10966396|NCT00515502|12140389|FG005|STARTED|Washout Period 1||1
10966397|NCT00515502|12140390|FG006|STARTED|Washout Period 1||1
10966398|NCT00515502|12140391|FG007|STARTED|Washout Period 1||1
10966399|NCT00515502|12140392|FG008|STARTED|Washout Period 1||0
10966400|NCT00515502|12140393|FG009|STARTED|Washout Period 1||2
10966401|NCT00515502|12140394|FG010|STARTED|Washout Period 1||1
10966402|NCT00515502|12140395|FG011|STARTED|Washout Period 1||0
10966403|NCT00515502|12140384|FG000|COMPLETED|Washout Period 1||1
10966404|NCT00515502|12140385|FG001|COMPLETED|Washout Period 1||4
10966405|NCT00515502|12140386|FG002|COMPLETED|Washout Period 1||4
10966406|NCT00515502|12140387|FG003|COMPLETED|Washout Period 1||3
10966407|NCT00515502|12140388|FG004|COMPLETED|Washout Period 1||3
10966408|NCT00515502|12140389|FG005|COMPLETED|Washout Period 1||1
10966409|NCT00515502|12140390|FG006|COMPLETED|Washout Period 1||1
10966410|NCT00515502|12140391|FG007|COMPLETED|Washout Period 1||1
10966411|NCT00515502|12140392|FG008|COMPLETED|Washout Period 1||0
10966412|NCT00515502|12140393|FG009|COMPLETED|Washout Period 1||2
10966413|NCT00515502|12140394|FG010|COMPLETED|Washout Period 1||1
10966414|NCT00515502|12140395|FG011|COMPLETED|Washout Period 1||0
10966415|NCT00515502|12140384|FG000|NOT COMPLETED|Washout Period 1||0
10966416|NCT00515502|12140385|FG001|NOT COMPLETED|Washout Period 1||0
10966417|NCT00515502|12140386|FG002|NOT COMPLETED|Washout Period 1||0
10966418|NCT00515502|12140387|FG003|NOT COMPLETED|Washout Period 1||0
10966419|NCT00515502|12140388|FG004|NOT COMPLETED|Washout Period 1||0
10966420|NCT00515502|12140389|FG005|NOT COMPLETED|Washout Period 1||0
10966421|NCT00515502|12140390|FG006|NOT COMPLETED|Washout Period 1||0
10966422|NCT00515502|12140391|FG007|NOT COMPLETED|Washout Period 1||0
10966423|NCT00515502|12140392|FG008|NOT COMPLETED|Washout Period 1||0
10966424|NCT00515502|12140393|FG009|NOT COMPLETED|Washout Period 1||0
10966425|NCT00515502|12140394|FG010|NOT COMPLETED|Washout Period 1||0
10966426|NCT00515502|12140395|FG011|NOT COMPLETED|Washout Period 1||0
10966427|NCT00515502|12140384|FG000|STARTED|Treatment Period 2||1
10966428|NCT00515502|12140385|FG001|STARTED|Treatment Period 2||4
10966429|NCT00515502|12140386|FG002|STARTED|Treatment Period 2||4
10966430|NCT00515502|12140387|FG003|STARTED|Treatment Period 2||3
10966431|NCT00515502|12140388|FG004|STARTED|Treatment Period 2||3
10966432|NCT00515502|12140389|FG005|STARTED|Treatment Period 2||1
10966433|NCT00515502|12140390|FG006|STARTED|Treatment Period 2||1
10966434|NCT00515502|12140391|FG007|STARTED|Treatment Period 2||1
10966435|NCT00515502|12140392|FG008|STARTED|Treatment Period 2||0
10966436|NCT00515502|12140393|FG009|STARTED|Treatment Period 2||2
10966437|NCT00515502|12140394|FG010|STARTED|Treatment Period 2||1
10966438|NCT00515502|12140395|FG011|STARTED|Treatment Period 2||0
10966439|NCT00515502|12140384|FG000|COMPLETED|Treatment Period 2||1
10966440|NCT00515502|12140385|FG001|COMPLETED|Treatment Period 2||3
10966441|NCT00515502|12140386|FG002|COMPLETED|Treatment Period 2||4
10966442|NCT00515502|12140387|FG003|COMPLETED|Treatment Period 2||3
10966443|NCT00515502|12140388|FG004|COMPLETED|Treatment Period 2||3
10966444|NCT00515502|12140389|FG005|COMPLETED|Treatment Period 2||1
10966445|NCT00515502|12140390|FG006|COMPLETED|Treatment Period 2||1
10966446|NCT00515502|12140391|FG007|COMPLETED|Treatment Period 2||1
10966447|NCT00515502|12140392|FG008|COMPLETED|Treatment Period 2||0
10966448|NCT00515502|12140393|FG009|COMPLETED|Treatment Period 2||2
10966449|NCT00515502|12140394|FG010|COMPLETED|Treatment Period 2||1
10966450|NCT00515502|12140395|FG011|COMPLETED|Treatment Period 2||0
10966451|NCT00515502|12140384|FG000|NOT COMPLETED|Treatment Period 2||0
10966452|NCT00515502|12140385|FG001|NOT COMPLETED|Treatment Period 2||1
10966453|NCT00515502|12140386|FG002|NOT COMPLETED|Treatment Period 2||0
10966454|NCT00515502|12140387|FG003|NOT COMPLETED|Treatment Period 2||0
10966455|NCT00515502|12140388|FG004|NOT COMPLETED|Treatment Period 2||0
10966456|NCT00515502|12140389|FG005|NOT COMPLETED|Treatment Period 2||0
10966457|NCT00515502|12140390|FG006|NOT COMPLETED|Treatment Period 2||0
10966458|NCT00515502|12140391|FG007|NOT COMPLETED|Treatment Period 2||0
10966459|NCT00515502|12140392|FG008|NOT COMPLETED|Treatment Period 2||0
10966460|NCT00515502|12140393|FG009|NOT COMPLETED|Treatment Period 2||0
10966461|NCT00515502|12140394|FG010|NOT COMPLETED|Treatment Period 2||0
10966462|NCT00515502|12140395|FG011|NOT COMPLETED|Treatment Period 2||0
10966463|NCT00515502|12140384|FG000|STARTED|Washout Period 2||1
10966464|NCT00515502|12140385|FG001|STARTED|Washout Period 2||3
10966465|NCT00515502|12140386|FG002|STARTED|Washout Period 2||4
10966466|NCT00515502|12140387|FG003|STARTED|Washout Period 2||3
10966467|NCT00515502|12140388|FG004|STARTED|Washout Period 2||3
10966468|NCT00515502|12140389|FG005|STARTED|Washout Period 2||1
10966469|NCT00515502|12140390|FG006|STARTED|Washout Period 2||1
10966470|NCT00515502|12140391|FG007|STARTED|Washout Period 2||1
10966471|NCT00515502|12140392|FG008|STARTED|Washout Period 2||0
10966472|NCT00515502|12140393|FG009|STARTED|Washout Period 2||2
10966473|NCT00515502|12140394|FG010|STARTED|Washout Period 2||1
10966474|NCT00515502|12140395|FG011|STARTED|Washout Period 2||0
10966475|NCT00515502|12140384|FG000|COMPLETED|Washout Period 2||1
10966476|NCT00515502|12140385|FG001|COMPLETED|Washout Period 2||3
10966477|NCT00515502|12140386|FG002|COMPLETED|Washout Period 2||4
10966478|NCT00515502|12140387|FG003|COMPLETED|Washout Period 2||3
10966479|NCT00515502|12140388|FG004|COMPLETED|Washout Period 2||3
10966480|NCT00515502|12140389|FG005|COMPLETED|Washout Period 2||1
10966481|NCT00515502|12140390|FG006|COMPLETED|Washout Period 2||1
10966482|NCT00515502|12140391|FG007|COMPLETED|Washout Period 2||1
10966483|NCT00515502|12140392|FG008|COMPLETED|Washout Period 2||0
10966484|NCT00515502|12140393|FG009|COMPLETED|Washout Period 2||2
10966485|NCT00515502|12140394|FG010|COMPLETED|Washout Period 2||1
10966486|NCT00515502|12140395|FG011|COMPLETED|Washout Period 2||0
10966487|NCT00515502|12140384|FG000|NOT COMPLETED|Washout Period 2||0
10966488|NCT00515502|12140385|FG001|NOT COMPLETED|Washout Period 2||0
10966489|NCT00515502|12140386|FG002|NOT COMPLETED|Washout Period 2||0
10966490|NCT00515502|12140387|FG003|NOT COMPLETED|Washout Period 2||0
10966491|NCT00515502|12140388|FG004|NOT COMPLETED|Washout Period 2||0
10966492|NCT00515502|12140389|FG005|NOT COMPLETED|Washout Period 2||0
10966493|NCT00515502|12140390|FG006|NOT COMPLETED|Washout Period 2||0
10966494|NCT00515502|12140391|FG007|NOT COMPLETED|Washout Period 2||0
10966495|NCT00515502|12140392|FG008|NOT COMPLETED|Washout Period 2||0
10966496|NCT00515502|12140393|FG009|NOT COMPLETED|Washout Period 2||0
10966497|NCT00515502|12140394|FG010|NOT COMPLETED|Washout Period 2||0
10966498|NCT00515502|12140395|FG011|NOT COMPLETED|Washout Period 2||0
10966499|NCT00515502|12140384|FG000|STARTED|Treatment Period 3||1
10966500|NCT00515502|12140385|FG001|STARTED|Treatment Period 3||3
10966501|NCT00515502|12140386|FG002|STARTED|Treatment Period 3||4
10966502|NCT00515502|12140387|FG003|STARTED|Treatment Period 3||3
10966503|NCT00515502|12140388|FG004|STARTED|Treatment Period 3||3
10966504|NCT00515502|12140389|FG005|STARTED|Treatment Period 3||1
10966505|NCT00515502|12140390|FG006|STARTED|Treatment Period 3||1
10966506|NCT00515502|12140391|FG007|STARTED|Treatment Period 3||1
10966507|NCT00515502|12140392|FG008|STARTED|Treatment Period 3||0
10966508|NCT00515502|12140393|FG009|STARTED|Treatment Period 3||2
10966509|NCT00515502|12140394|FG010|STARTED|Treatment Period 3||1
10966510|NCT00515502|12140395|FG011|STARTED|Treatment Period 3||0
10966511|NCT00515502|12140384|FG000|COMPLETED|Treatment Period 3||1
10966512|NCT00515502|12140385|FG001|COMPLETED|Treatment Period 3||3
10966513|NCT00515502|12140386|FG002|COMPLETED|Treatment Period 3||4
10966514|NCT00515502|12140387|FG003|COMPLETED|Treatment Period 3||3
10966515|NCT00515502|12140388|FG004|COMPLETED|Treatment Period 3||3
10966516|NCT00515502|12140389|FG005|COMPLETED|Treatment Period 3||1
10966517|NCT00515502|12140390|FG006|COMPLETED|Treatment Period 3||1
10966518|NCT00515502|12140391|FG007|COMPLETED|Treatment Period 3||1
10966519|NCT00515502|12140392|FG008|COMPLETED|Treatment Period 3||0
10966520|NCT00515502|12140393|FG009|COMPLETED|Treatment Period 3||2
10966521|NCT00515502|12140394|FG010|COMPLETED|Treatment Period 3||1
10966522|NCT00515502|12140395|FG011|COMPLETED|Treatment Period 3||0
10966523|NCT00515502|12140384|FG000|NOT COMPLETED|Treatment Period 3||0
10966524|NCT00515502|12140385|FG001|NOT COMPLETED|Treatment Period 3||0
10966525|NCT00515502|12140386|FG002|NOT COMPLETED|Treatment Period 3||0
10966526|NCT00515502|12140387|FG003|NOT COMPLETED|Treatment Period 3||0
10966527|NCT00515502|12140388|FG004|NOT COMPLETED|Treatment Period 3||0
10966528|NCT00515502|12140389|FG005|NOT COMPLETED|Treatment Period 3||0
10966529|NCT00515502|12140390|FG006|NOT COMPLETED|Treatment Period 3||0
10966530|NCT00515502|12140391|FG007|NOT COMPLETED|Treatment Period 3||0
10966531|NCT00515502|12140392|FG008|NOT COMPLETED|Treatment Period 3||0
10966532|NCT00515502|12140393|FG009|NOT COMPLETED|Treatment Period 3||0
10966533|NCT00515502|12140394|FG010|NOT COMPLETED|Treatment Period 3||0
10966534|NCT00515502|12140395|FG011|NOT COMPLETED|Treatment Period 3||0
10966535|NCT00515502|12140384|FG000|STARTED|Washout Period 3||1
10966536|NCT00515502|12140385|FG001|STARTED|Washout Period 3||3
10966537|NCT00515502|12140386|FG002|STARTED|Washout Period 3||4
10966538|NCT00515502|12140387|FG003|STARTED|Washout Period 3||3
10966539|NCT00515502|12140388|FG004|STARTED|Washout Period 3||3
10966540|NCT00515502|12140389|FG005|STARTED|Washout Period 3||1
10966541|NCT00515502|12140390|FG006|STARTED|Washout Period 3||1
10966542|NCT00515502|12140391|FG007|STARTED|Washout Period 3||1
10966543|NCT00515502|12140392|FG008|STARTED|Washout Period 3||0
10966544|NCT00515502|12140393|FG009|STARTED|Washout Period 3||2
10966545|NCT00515502|12140394|FG010|STARTED|Washout Period 3||1
10966546|NCT00515502|12140395|FG011|STARTED|Washout Period 3||0
10966547|NCT00515502|12140384|FG000|COMPLETED|Washout Period 3||1
10966548|NCT00515502|12140385|FG001|COMPLETED|Washout Period 3||3
10966549|NCT00515502|12140386|FG002|COMPLETED|Washout Period 3||4
10966550|NCT00515502|12140387|FG003|COMPLETED|Washout Period 3||3
10966551|NCT00515502|12140388|FG004|COMPLETED|Washout Period 3||3
10966552|NCT00515502|12140389|FG005|COMPLETED|Washout Period 3||1
10966553|NCT00515502|12140390|FG006|COMPLETED|Washout Period 3||1
10966554|NCT00515502|12140391|FG007|COMPLETED|Washout Period 3||1
10966555|NCT00515502|12140392|FG008|COMPLETED|Washout Period 3||0
10966556|NCT00515502|12140393|FG009|COMPLETED|Washout Period 3||2
10966557|NCT00515502|12140394|FG010|COMPLETED|Washout Period 3||1
10966558|NCT00515502|12140395|FG011|COMPLETED|Washout Period 3||0
10966559|NCT00515502|12140384|FG000|NOT COMPLETED|Washout Period 3||0
10966560|NCT00515502|12140385|FG001|NOT COMPLETED|Washout Period 3||0
10966561|NCT00515502|12140386|FG002|NOT COMPLETED|Washout Period 3||0
10966562|NCT00515502|12140387|FG003|NOT COMPLETED|Washout Period 3||0
10966563|NCT00515502|12140388|FG004|NOT COMPLETED|Washout Period 3||0
10966564|NCT00515502|12140389|FG005|NOT COMPLETED|Washout Period 3||0
10966565|NCT00515502|12140390|FG006|NOT COMPLETED|Washout Period 3||0
10966566|NCT00515502|12140391|FG007|NOT COMPLETED|Washout Period 3||0
10966567|NCT00515502|12140392|FG008|NOT COMPLETED|Washout Period 3||0
10966568|NCT00515502|12140393|FG009|NOT COMPLETED|Washout Period 3||0
10966569|NCT00515502|12140394|FG010|NOT COMPLETED|Washout Period 3||0
10966570|NCT00515502|12140395|FG011|NOT COMPLETED|Washout Period 3||0
10966571|NCT00515502|12140384|FG000|STARTED|Treatment Period 4||1
10966572|NCT00515502|12140385|FG001|STARTED|Treatment Period 4||3
10966573|NCT00515502|12140386|FG002|STARTED|Treatment Period 4||4
10966574|NCT00515502|12140387|FG003|STARTED|Treatment Period 4||3
10966575|NCT00515502|12140388|FG004|STARTED|Treatment Period 4||3
10966576|NCT00515502|12140389|FG005|STARTED|Treatment Period 4||1
10966577|NCT00515502|12140390|FG006|STARTED|Treatment Period 4||1
10966578|NCT00515502|12140391|FG007|STARTED|Treatment Period 4||1
10966579|NCT00515502|12140392|FG008|STARTED|Treatment Period 4||0
10966580|NCT00515502|12140393|FG009|STARTED|Treatment Period 4||2
10966581|NCT00515502|12140394|FG010|STARTED|Treatment Period 4||1
10966582|NCT00515502|12140395|FG011|STARTED|Treatment Period 4||0
10966583|NCT00515502|12140384|FG000|COMPLETED|Treatment Period 4||1
10966584|NCT00515502|12140385|FG001|COMPLETED|Treatment Period 4||3
10966585|NCT00515502|12140386|FG002|COMPLETED|Treatment Period 4||4
10966586|NCT00515502|12140387|FG003|COMPLETED|Treatment Period 4||3
10966587|NCT00515502|12140388|FG004|COMPLETED|Treatment Period 4||3
10966588|NCT00515502|12140389|FG005|COMPLETED|Treatment Period 4||1
10966589|NCT00515502|12140390|FG006|COMPLETED|Treatment Period 4||1
10966590|NCT00515502|12140391|FG007|COMPLETED|Treatment Period 4||1
10966591|NCT00515502|12140392|FG008|COMPLETED|Treatment Period 4||0
10966592|NCT00515502|12140393|FG009|COMPLETED|Treatment Period 4||2
10966593|NCT00515502|12140394|FG010|COMPLETED|Treatment Period 4||1
10966594|NCT00515502|12140395|FG011|COMPLETED|Treatment Period 4||0
10966595|NCT00515502|12140384|FG000|NOT COMPLETED|Treatment Period 4||0
10966596|NCT00515502|12140385|FG001|NOT COMPLETED|Treatment Period 4||0
10966597|NCT00515502|12140386|FG002|NOT COMPLETED|Treatment Period 4||0
10966598|NCT00515502|12140387|FG003|NOT COMPLETED|Treatment Period 4||0
10966599|NCT00515502|12140388|FG004|NOT COMPLETED|Treatment Period 4||0
10966600|NCT00515502|12140389|FG005|NOT COMPLETED|Treatment Period 4||0
10966601|NCT00515502|12140390|FG006|NOT COMPLETED|Treatment Period 4||0
10966602|NCT00515502|12140391|FG007|NOT COMPLETED|Treatment Period 4||0
10966603|NCT00515502|12140392|FG008|NOT COMPLETED|Treatment Period 4||0
10966604|NCT00515502|12140393|FG009|NOT COMPLETED|Treatment Period 4||0
10966605|NCT00515502|12140394|FG010|NOT COMPLETED|Treatment Period 4||0
10966606|NCT00515502|12140395|FG011|NOT COMPLETED|Treatment Period 4||0
10966607|NCT00515528|12140414|FG000|STARTED|Overall Study||10
10966608|NCT00515528|12140415|FG001|STARTED|Overall Study||7
10966609|NCT00515528|12140414|FG000|COMPLETED|Overall Study||10
10966610|NCT00515528|12140415|FG001|COMPLETED|Overall Study||7
10966611|NCT00515528|12140414|FG000|NOT COMPLETED|Overall Study||0
10966612|NCT00515528|12140415|FG001|NOT COMPLETED|Overall Study||0
10966613|NCT00515541|12140425|FG000|STARTED|Overall Study||10
10966614|NCT00515541|12140426|FG001|STARTED|Overall Study||12
10966615|NCT00515541|12140427|FG002|STARTED|Overall Study||10
10966616|NCT00515541|12140428|FG003|STARTED|Overall Study||11
10966617|NCT00515541|12140425|FG000|6 Weeks (1 gm Lovaza)|Overall Study||10
10966618|NCT00515541|12140426|FG001|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
10966619|NCT00515541|12140427|FG002|6 Weeks (1 gm Lovaza)|Overall Study||10
10966620|NCT00515541|12140428|FG003|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
10966621|NCT00515541|12140425|FG000|12 Weeks (2 gm Lovaza)|Overall Study||10
10966622|NCT00515541|12140426|FG001|12 Weeks (2 gm Lovaza)|Overall Study||10
10966623|NCT00515541|12140427|FG002|12 Weeks (2 gm Lovaza)|Overall Study||10
10966624|NCT00515541|12140428|FG003|12 Weeks (2 gm Lovaza)|Overall Study||10
10966625|NCT00515541|12140425|FG000|18 Weeks (4 gm Lovaza)|Overall Study||10
10966626|NCT00515541|12140426|FG001|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
10966627|NCT00515541|12140427|FG002|18 Weeks (4 gm Lovaza)|Overall Study||10
10966628|NCT00515541|12140428|FG003|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
10966629|NCT00515541|12140425|FG000|24 Weeks (8 gm Lovaza)|Overall Study||10
10966630|NCT00515541|12140426|FG001|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
10966631|NCT00515541|12140427|FG002|24 Weeks (8 gm Lovaza)|Overall Study||10
10966632|NCT00515541|12140428|FG003|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
10966633|NCT00515541|12140425|FG000|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
10966634|NCT00515541|12140426|FG001|COMPLETED|Overall Study||7
10966635|NCT00515541|12140427|FG002|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
10966636|NCT00515541|12140428|FG003|COMPLETED|Overall Study||6
10966637|NCT00515541|12140425|FG000|NOT COMPLETED|Overall Study||0
10966638|NCT00515541|12140426|FG001|NOT COMPLETED|Overall Study||5
10966639|NCT00515541|12140427|FG002|NOT COMPLETED|Overall Study||0
10966640|NCT00515541|12140428|FG003|NOT COMPLETED|Overall Study||5
10966641|NCT00515619|12140438|FG000|STARTED|Overall Study||376
10966642|NCT00515619|12140438|FG000|Safety Set|Overall Study||376
10966643|NCT00515619|12140438|FG000|COMPLETED|Overall Study||160
10966644|NCT00515619|12140438|FG000|NOT COMPLETED|Overall Study||216
10966645|NCT00515697|12140442|FG000|STARTED|Overall Study||39
10966646|NCT00515697|12140442|FG000|Received at Least 1 Dose of Study Drug|Overall Study||39
10966647|NCT00515697|12140442|FG000|COMPLETED|Overall Study||39
10966648|NCT00515697|12140442|FG000|NOT COMPLETED|Overall Study||0
10966649|NCT00515723|12140450|FG000|STARTED|Overall Study||25
10966650|NCT00515723|12140451|FG001|STARTED|Overall Study||22
10966651|NCT00515723|12140452|FG002|STARTED|Overall Study||22
10966652|NCT00515723|12140453|FG003|STARTED|Overall Study||27
10966653|NCT00515723|12140450|FG000|COMPLETED|Overall Study||20
10966654|NCT00515723|12140451|FG001|COMPLETED|Overall Study||21
10966655|NCT00515723|12140452|FG002|COMPLETED|Overall Study||21
10966656|NCT00515723|12140453|FG003|COMPLETED|Overall Study||21
10966657|NCT00515723|12140450|FG000|NOT COMPLETED|Overall Study||5
10966658|NCT00515723|12140451|FG001|NOT COMPLETED|Overall Study||1
10966659|NCT00515723|12140452|FG002|NOT COMPLETED|Overall Study||1
10966660|NCT00515723|12140453|FG003|NOT COMPLETED|Overall Study||6
10966661|NCT00515827|12140466|FG000|STARTED|First Intervention (12 Weeks)||27
10966662|NCT00515827|12140467|FG001|STARTED|First Intervention (12 Weeks)||26
10966663|NCT00515827|12140466|FG000|COMPLETED|First Intervention (12 Weeks)||26
10966664|NCT00515827|12140467|FG001|COMPLETED|First Intervention (12 Weeks)||25
10966665|NCT00515827|12140466|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
10966666|NCT00515827|12140467|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
10966667|NCT00515827|12140466|FG000|STARTED|Second Intervention (12 Weeks)||26
10966668|NCT00515827|12140467|FG001|STARTED|Second Intervention (12 Weeks)||25
10966669|NCT00515827|12140466|FG000|COMPLETED|Second Intervention (12 Weeks)||25
10966670|NCT00515827|12140467|FG001|COMPLETED|Second Intervention (12 Weeks)||25
10966671|NCT00515827|12140466|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1
10966672|NCT00515827|12140467|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
10966673|NCT00515879|12140477|FG000|STARTED|Overall Study||87
10966674|NCT00515879|12140478|FG001|STARTED|Overall Study||82
10966675|NCT00515879|12140477|FG000|COMPLETED|Overall Study||62
10966676|NCT00515879|12140478|FG001|COMPLETED|Overall Study||62
10966677|NCT00515879|12140477|FG000|NOT COMPLETED|Overall Study||25
10966678|NCT00515879|12140478|FG001|NOT COMPLETED|Overall Study||20
10966679|NCT00516048|12140488|FG000|STARTED|Overall Study||15
10966680|NCT00516048|12140489|FG001|STARTED|Overall Study||42
10966681|NCT00516048|12140490|FG002|STARTED|Overall Study||1
10966682|NCT00516048|12140488|FG000|COMPLETED|Overall Study||15
10966683|NCT00516048|12140489|FG001|COMPLETED|Overall Study||40
10966684|NCT00516048|12140490|FG002|COMPLETED|Overall Study||0
10966685|NCT00516048|12140488|FG000|NOT COMPLETED|Overall Study||0
10966686|NCT00516048|12140489|FG001|NOT COMPLETED|Overall Study||2
10966687|NCT00516048|12140490|FG002|NOT COMPLETED|Overall Study||1
10966688|NCT00516074|12140500|FG000|STARTED|Overall Study||28
10966689|NCT00516074|12140501|FG001|STARTED|Overall Study||26
10966690|NCT00516074|12140500|FG000|COMPLETED|Overall Study||22
10966691|NCT00516074|12140501|FG001|COMPLETED|Overall Study||23
10966692|NCT00516074|12140500|FG000|NOT COMPLETED|Overall Study||6
10966693|NCT00516074|12140501|FG001|NOT COMPLETED|Overall Study||3
10966694|NCT00516139|12140507|FG000|STARTED|Overall Study||122
10966695|NCT00516139|12140507|FG000|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
10966696|NCT00516139|12140507|FG000|NOT COMPLETED|Overall Study||38
10966697|NCT00516165|12140515|FG000|STARTED|Overall Study||28
10966698|NCT00516165|12140515|FG000|COMPLETED|Overall Study||28
10966699|NCT00516165|12140515|FG000|NOT COMPLETED|Overall Study||0
10966700|NCT00516217|12140519|FG000|STARTED|Overall Study||29
10966701|NCT00516217|12140519|FG000|COMPLETED|Overall Study||29
10966702|NCT00516217|12140519|FG000|NOT COMPLETED|Overall Study||0
10966703|NCT00516269|12140525|FG000|STARTED|Overall Study||19
10966704|NCT00516269|12140526|FG001|STARTED|Overall Study||19
10966705|NCT00516269|12140525|FG000|COMPLETED|Overall Study|2 patients had an early termination|17
10966706|NCT00516269|12140526|FG001|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
10966707|NCT00516269|12140525|FG000|NOT COMPLETED|Overall Study||2
10966708|NCT00516269|12140526|FG001|NOT COMPLETED|Overall Study||3
10966709|NCT00516295|12140535|FG000|STARTED|Overall Study||7
10966710|NCT00516295|12140536|FG001|STARTED|Overall Study||0
10966711|NCT00516295|12140537|FG002|STARTED|Overall Study||0
10966712|NCT00516295|12140535|FG000|COMPLETED|Overall Study||4
10966713|NCT00516295|12140536|FG001|COMPLETED|Overall Study||0
10966714|NCT00516295|12140537|FG002|COMPLETED|Overall Study||0
10966715|NCT00516295|12140535|FG000|NOT COMPLETED|Overall Study||3
10966716|NCT00516295|12140536|FG001|NOT COMPLETED|Overall Study||0
10966717|NCT00516295|12140537|FG002|NOT COMPLETED|Overall Study||0
10966718|NCT00516321|12140547|FG000|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
10966719|NCT00516321|12140548|FG001|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
10966720|NCT00516321|12140549|FG002|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
10966721|NCT00516321|12140547|FG000|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
10966722|NCT00516321|12140548|FG001|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
10966723|NCT00516321|12140549|FG002|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
10966724|NCT00516321|12140547|FG000|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
10966725|NCT00516321|12140548|FG001|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
10966726|NCT00516321|12140549|FG002|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
10966727|NCT00516321|12140547|FG000|STARTED|Double-blind (DB) Antiviral Treatment||0
10966728|NCT00516321|12140548|FG001|STARTED|Double-blind (DB) Antiviral Treatment||232
10966729|NCT00516321|12140549|FG002|STARTED|Double-blind (DB) Antiviral Treatment||450
10966730|NCT00516321|12140547|FG000|COMPLETED|Double-blind (DB) Antiviral Treatment||0
10966731|NCT00516321|12140548|FG001|COMPLETED|Double-blind (DB) Antiviral Treatment||197
10966732|NCT00516321|12140549|FG002|COMPLETED|Double-blind (DB) Antiviral Treatment||396
10966733|NCT00516321|12140547|FG000|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
10966734|NCT00516321|12140548|FG001|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
10966735|NCT00516321|12140549|FG002|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
10966736|NCT00516386|12140557|FG000|STARTED|Overall Study||16
10966737|NCT00516386|12140557|FG000|COMPLETED|Overall Study||10
10966738|NCT00516386|12140557|FG000|NOT COMPLETED|Overall Study||6
10966739|NCT00516503|12140563|FG000|STARTED|Overall Study||101
10966740|NCT00516503|12140564|FG001|STARTED|Overall Study||102
10966741|NCT00516503|12140563|FG000|COMPLETED|Overall Study||101
10966742|NCT00516503|12140564|FG001|COMPLETED|Overall Study||102
10966743|NCT00516503|12140563|FG000|NOT COMPLETED|Overall Study||0
10966744|NCT00516503|12140564|FG001|NOT COMPLETED|Overall Study||0
10966745|NCT00516893|12140570|FG000|STARTED|Overall Study||113
10966746|NCT00516893|12140570|FG000|Received Study Treatment|Overall Study||112
10966747|NCT00516893|12140570|FG000|COMPLETED|Overall Study||92
10966748|NCT00516893|12140570|FG000|NOT COMPLETED|Overall Study||21
10966749|NCT00516906|12140576|FG000|STARTED|Overall Study||36
10966750|NCT00516906|12140577|FG001|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
10966751|NCT00516906|12140576|FG000|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
10966752|NCT00516906|12140577|FG001|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
10966753|NCT00516906|12140576|FG000|NOT COMPLETED|Overall Study||6
10966754|NCT00516906|12140577|FG001|NOT COMPLETED|Overall Study||2
10966755|NCT00516919|12140583|FG000|STARTED|Overall Study||40
10966756|NCT00516919|12140584|FG001|STARTED|Overall Study||39
10966757|NCT00516919|12140583|FG000|COMPLETED|Overall Study||30
10966758|NCT00516919|12140584|FG001|COMPLETED|Overall Study||32
10966759|NCT00516919|12140583|FG000|NOT COMPLETED|Overall Study||10
10966760|NCT00516919|12140584|FG001|NOT COMPLETED|Overall Study||7
10966761|NCT00517010|12140590|FG000|STARTED|Overall Study||6
10966762|NCT00517010|12140590|FG000|COMPLETED|Overall Study||5
10966763|NCT00517010|12140590|FG000|NOT COMPLETED|Overall Study||1
10966764|NCT00517296|12140596|FG000|STARTED|Overall Study||10
10966765|NCT00517296|12140597|FG001|STARTED|Overall Study||11
10966766|NCT00517296|12140596|FG000|COMPLETED|Overall Study||9
10966767|NCT00517296|12140597|FG001|COMPLETED|Overall Study||11
10966768|NCT00517296|12140596|FG000|NOT COMPLETED|Overall Study||1
10966769|NCT00517296|12140597|FG001|NOT COMPLETED|Overall Study||0
10966770|NCT00517413|12140603|FG000|STARTED|Overall Study||163
10966771|NCT00517413|12140603|FG000|COMPLETED|Overall Study||102
10966772|NCT00517413|12140603|FG000|NOT COMPLETED|Overall Study||61
10966773|NCT00517530|12140614|FG000|STARTED|Overall Study||21
10966774|NCT00517530|12140615|FG001|STARTED|Overall Study||13
10966775|NCT00517530|12140616|FG002|STARTED|Overall Study||18
10966776|NCT00517530|12140617|FG003|STARTED|Overall Study||22
10966777|NCT00517530|12140618|FG004|STARTED|Overall Study||21
10966778|NCT00517530|12140619|FG005|STARTED|Overall Study||19
10966779|NCT00517530|12140620|FG006|STARTED|Overall Study||20
10966780|NCT00517530|12140614|FG000|Completed Treatment|Overall Study||11
10966781|NCT00517530|12140615|FG001|Completed Treatment|Overall Study||13
10966782|NCT00517530|12140616|FG002|Completed Treatment|Overall Study||13
10966783|NCT00517530|12140617|FG003|Completed Treatment|Overall Study||18
10966784|NCT00517530|12140618|FG004|Completed Treatment|Overall Study||9
10966785|NCT00517530|12140619|FG005|Completed Treatment|Overall Study||9
10966786|NCT00517530|12140620|FG006|Completed Treatment|Overall Study||13
10966787|NCT00517530|12140614|FG000|Started Follow-up|Overall Study||20
10966788|NCT00517530|12140615|FG001|Started Follow-up|Overall Study||13
10966789|NCT00517530|12140616|FG002|Started Follow-up|Overall Study||17
10966790|NCT00517530|12140617|FG003|Started Follow-up|Overall Study||21
10966791|NCT00517530|12140618|FG004|Started Follow-up|Overall Study||17
10966792|NCT00517530|12140619|FG005|Started Follow-up|Overall Study||16
10966793|NCT00517530|12140620|FG006|Started Follow-up|Overall Study||19
10966794|NCT00517530|12140614|FG000|Completed Follow-up|Overall Study||2
10966795|NCT00517530|12140615|FG001|Completed Follow-up|Overall Study||0
10966796|NCT00517530|12140616|FG002|Completed Follow-up|Overall Study||0
10966797|NCT00517530|12140617|FG003|Completed Follow-up|Overall Study||1
10966798|NCT00517530|12140618|FG004|Completed Follow-up|Overall Study||0
10966799|NCT00517530|12140619|FG005|Completed Follow-up|Overall Study||0
10966800|NCT00517530|12140620|FG006|Completed Follow-up|Overall Study||1
10966801|NCT00517530|12140614|FG000|Retreated Population|Overall Study||2
10966802|NCT00517530|12140615|FG001|Retreated Population|Overall Study||2
10966803|NCT00517530|12140616|FG002|Retreated Population|Overall Study||1
10966804|NCT00517530|12140617|FG003|Retreated Population|Overall Study||4
10966805|NCT00517530|12140618|FG004|Retreated Population|Overall Study||2
10966806|NCT00517530|12140619|FG005|Retreated Population|Overall Study||2
10966807|NCT00517530|12140620|FG006|Retreated Population|Overall Study||0
10966808|NCT00517530|12140614|FG000|COMPLETED|Overall Study||2
10966809|NCT00517530|12140615|FG001|COMPLETED|Overall Study||0
10966810|NCT00517530|12140616|FG002|COMPLETED|Overall Study||0
10966811|NCT00517530|12140617|FG003|COMPLETED|Overall Study||1
10966812|NCT00517530|12140618|FG004|COMPLETED|Overall Study||1
10966813|NCT00517530|12140619|FG005|COMPLETED|Overall Study||0
10966814|NCT00517530|12140620|FG006|COMPLETED|Overall Study||1
10966815|NCT00517530|12140614|FG000|NOT COMPLETED|Overall Study||19
10966816|NCT00517530|12140615|FG001|NOT COMPLETED|Overall Study||13
10966817|NCT00517530|12140616|FG002|NOT COMPLETED|Overall Study||18
10966818|NCT00517530|12140617|FG003|NOT COMPLETED|Overall Study||21
10966819|NCT00517530|12140618|FG004|NOT COMPLETED|Overall Study||20
10966820|NCT00517530|12140619|FG005|NOT COMPLETED|Overall Study||19
10966821|NCT00517530|12140620|FG006|NOT COMPLETED|Overall Study||19
10966822|NCT00517556|12140653|FG000|STARTED|Overall Study||19
10966823|NCT00517556|12140654|FG001|STARTED|Overall Study||19
10966824|NCT00517556|12140653|FG000|COMPLETED|Overall Study||15
10966825|NCT00517556|12140654|FG001|COMPLETED|Overall Study||14
10966826|NCT00517556|12140653|FG000|NOT COMPLETED|Overall Study||4
10966827|NCT00517556|12140654|FG001|NOT COMPLETED|Overall Study||5
10966828|NCT00517595|12140660|FG000|STARTED|Overall Study||48
10966829|NCT00517595|12140660|FG000|COMPLETED|Overall Study||48
10966830|NCT00517595|12140660|FG000|NOT COMPLETED|Overall Study||0
10966831|NCT00517634|12140664|FG000|STARTED|First Treatment Period||4
10966832|NCT00517634|12140665|FG001|STARTED|First Treatment Period||4
10966833|NCT00517634|12140666|FG002|STARTED|First Treatment Period||4
10966834|NCT00517634|12140667|FG003|STARTED|First Treatment Period||3
10966835|NCT00517634|12140668|FG004|STARTED|First Treatment Period||4
10966836|NCT00517634|12140669|FG005|STARTED|First Treatment Period||4
10966837|NCT00517634|12140664|FG000|COMPLETED|First Treatment Period||4
10966838|NCT00517634|12140665|FG001|COMPLETED|First Treatment Period||4
10966839|NCT00517634|12140666|FG002|COMPLETED|First Treatment Period||4
10966840|NCT00517634|12140667|FG003|COMPLETED|First Treatment Period||3
10966841|NCT00517634|12140668|FG004|COMPLETED|First Treatment Period||4
10966842|NCT00517634|12140669|FG005|COMPLETED|First Treatment Period||4
10966843|NCT00517634|12140664|FG000|NOT COMPLETED|First Treatment Period||0
10966844|NCT00517634|12140665|FG001|NOT COMPLETED|First Treatment Period||0
10966845|NCT00517634|12140666|FG002|NOT COMPLETED|First Treatment Period||0
10966846|NCT00517634|12140667|FG003|NOT COMPLETED|First Treatment Period||0
10966847|NCT00517634|12140668|FG004|NOT COMPLETED|First Treatment Period||0
10966848|NCT00517634|12140669|FG005|NOT COMPLETED|First Treatment Period||0
10966849|NCT00517634|12140664|FG000|STARTED|Second Treatment Period||4
10966850|NCT00517634|12140665|FG001|STARTED|Second Treatment Period||4
10966851|NCT00517634|12140666|FG002|STARTED|Second Treatment Period||4
10966852|NCT00517634|12140667|FG003|STARTED|Second Treatment Period||3
10966853|NCT00517634|12140668|FG004|STARTED|Second Treatment Period||4
10966854|NCT00517634|12140669|FG005|STARTED|Second Treatment Period||4
10966855|NCT00517634|12140664|FG000|COMPLETED|Second Treatment Period||4
10966856|NCT00517634|12140665|FG001|COMPLETED|Second Treatment Period||4
10966857|NCT00517634|12140666|FG002|COMPLETED|Second Treatment Period||4
10966858|NCT00517634|12140667|FG003|COMPLETED|Second Treatment Period||3
10966859|NCT00517634|12140668|FG004|COMPLETED|Second Treatment Period||3
10966860|NCT00517634|12140669|FG005|COMPLETED|Second Treatment Period||4
10966861|NCT00517634|12140664|FG000|NOT COMPLETED|Second Treatment Period||0
10966862|NCT00517634|12140665|FG001|NOT COMPLETED|Second Treatment Period||0
10966863|NCT00517634|12140666|FG002|NOT COMPLETED|Second Treatment Period||0
10966864|NCT00517634|12140667|FG003|NOT COMPLETED|Second Treatment Period||0
10966865|NCT00517634|12140668|FG004|NOT COMPLETED|Second Treatment Period||1
10966866|NCT00517634|12140669|FG005|NOT COMPLETED|Second Treatment Period||0
10966867|NCT00517634|12140664|FG000|STARTED|Third Treatment Period||4
10966868|NCT00517634|12140665|FG001|STARTED|Third Treatment Period||4
10966869|NCT00517634|12140666|FG002|STARTED|Third Treatment Period||4
10966870|NCT00517634|12140667|FG003|STARTED|Third Treatment Period||3
10966871|NCT00517634|12140668|FG004|STARTED|Third Treatment Period||3
10966872|NCT00517634|12140669|FG005|STARTED|Third Treatment Period||4
10966873|NCT00517634|12140664|FG000|COMPLETED|Third Treatment Period||4
10966874|NCT00517634|12140665|FG001|COMPLETED|Third Treatment Period||4
10966875|NCT00517634|12140666|FG002|COMPLETED|Third Treatment Period||4
10966876|NCT00517634|12140667|FG003|COMPLETED|Third Treatment Period||3
10966877|NCT00517634|12140668|FG004|COMPLETED|Third Treatment Period||3
10966878|NCT00517634|12140669|FG005|COMPLETED|Third Treatment Period||4
10966879|NCT00517634|12140664|FG000|NOT COMPLETED|Third Treatment Period||0
10966880|NCT00517634|12140665|FG001|NOT COMPLETED|Third Treatment Period||0
10966881|NCT00517634|12140666|FG002|NOT COMPLETED|Third Treatment Period||0
10966882|NCT00517634|12140667|FG003|NOT COMPLETED|Third Treatment Period||0
10966883|NCT00517634|12140668|FG004|NOT COMPLETED|Third Treatment Period||0
10966884|NCT00517634|12140669|FG005|NOT COMPLETED|Third Treatment Period||0
10966885|NCT00517751|12140677|FG000|STARTED|Overall Study||162
10966886|NCT00517751|12140677|FG000|COMPLETED|Overall Study||33
10966887|NCT00517751|12140677|FG000|NOT COMPLETED|Overall Study||129
10966888|NCT00517829|12140683|FG000|STARTED|Overall Study||75
10966889|NCT00517829|12140684|FG001|STARTED|Overall Study||75
10966890|NCT00517829|12140683|FG000|COMPLETED|Overall Study||0
10966891|NCT00517829|12140684|FG001|COMPLETED|Overall Study||0
10966892|NCT00517829|12140683|FG000|NOT COMPLETED|Overall Study||75
10966893|NCT00517829|12140684|FG001|NOT COMPLETED|Overall Study||75
10966894|NCT00517881|12140690|FG000|STARTED|Overall Study||29
10966895|NCT00517881|12140690|FG000|COMPLETED|Overall Study||24
10966896|NCT00517881|12140690|FG000|NOT COMPLETED|Overall Study||5
10966897|NCT00517933|12140696|FG000|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
10966898|NCT00517933|12140697|FG001|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
10966899|NCT00517933|12140696|FG000|COMPLETED|Period 1||81
10966900|NCT00517933|12140697|FG001|COMPLETED|Period 1||85
10966901|NCT00517933|12140696|FG000|NOT COMPLETED|Period 1||8
10966902|NCT00517933|12140697|FG001|NOT COMPLETED|Period 1||6
10966903|NCT00517933|12140696|FG000|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
10966904|NCT00517933|12140697|FG001|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
10966905|NCT00517933|12140696|FG000|COMPLETED|Period 2||73
10966906|NCT00517933|12140697|FG001|COMPLETED|Period 2||70
10966907|NCT00517933|12140696|FG000|NOT COMPLETED|Period 2||6
10966908|NCT00517933|12140697|FG001|NOT COMPLETED|Period 2||13
10966909|NCT00518011|12140708|FG000|STARTED|Overall Study||9
10966910|NCT00518011|12140709|FG001|STARTED|Overall Study||8
10966911|NCT00518011|12140708|FG000|COMPLETED|Overall Study||0
10966912|NCT00518011|12140709|FG001|COMPLETED|Overall Study||0
10966913|NCT00518011|12140708|FG000|NOT COMPLETED|Overall Study||9
10966914|NCT00518011|12140709|FG001|NOT COMPLETED|Overall Study||8
10966915|NCT00518089|12140718|FG000|STARTED|Overall Study||430
10966916|NCT00518089|12140719|FG001|STARTED|Overall Study||429
10966917|NCT00518089|12140718|FG000|COMPLETED|Overall Study||402
10966918|NCT00518089|12140719|FG001|COMPLETED|Overall Study||398
10966919|NCT00518089|12140718|FG000|NOT COMPLETED|Overall Study||28
10966920|NCT00518089|12140719|FG001|NOT COMPLETED|Overall Study||31
10966921|NCT00518115|12140735|FG000|STARTED|Overall Study||52
10966922|NCT00518115|12140736|FG001|STARTED|Overall Study||35
10966923|NCT00518115|12140737|FG002|STARTED|Overall Study||36
10966924|NCT00518115|12140738|FG003|STARTED|Overall Study||35
10966925|NCT00518115|12140739|FG004|STARTED|Overall Study||31
10966926|NCT00518115|12140740|FG005|STARTED|Overall Study||34
10966927|NCT00518115|12140741|FG006|STARTED|Overall Study||33
10966928|NCT00518115|12140742|FG007|STARTED|Overall Study||35
10966929|NCT00518115|12140743|FG008|STARTED|Overall Study||35
10966930|NCT00518115|12140744|FG009|STARTED|Overall Study||35
10966931|NCT00518115|12140735|FG000|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
10966932|NCT00518115|12140736|FG001|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
10966933|NCT00518115|12140737|FG002|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
10966934|NCT00518115|12140738|FG003|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
10966935|NCT00518115|12140739|FG004|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
10966936|NCT00518115|12140740|FG005|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
10966937|NCT00518115|12140741|FG006|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
10966938|NCT00518115|12140742|FG007|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
10966939|NCT00518115|12140743|FG008|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
10966940|NCT00518115|12140744|FG009|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
10966941|NCT00518115|12140735|FG000|COMPLETED|Overall Study||40
10966942|NCT00518115|12140736|FG001|COMPLETED|Overall Study||29
10966943|NCT00518115|12140737|FG002|COMPLETED|Overall Study||19
10966944|NCT00518115|12140738|FG003|COMPLETED|Overall Study||24
10966945|NCT00518115|12140739|FG004|COMPLETED|Overall Study||21
10966946|NCT00518115|12140740|FG005|COMPLETED|Overall Study||19
10966947|NCT00518115|12140741|FG006|COMPLETED|Overall Study||25
10966948|NCT00518115|12140742|FG007|COMPLETED|Overall Study||20
10966949|NCT00518115|12140743|FG008|COMPLETED|Overall Study||30
10966950|NCT00518115|12140744|FG009|COMPLETED|Overall Study||20
10966951|NCT00518115|12140735|FG000|NOT COMPLETED|Overall Study||12
10966952|NCT00518115|12140736|FG001|NOT COMPLETED|Overall Study||6
10966953|NCT00518115|12140737|FG002|NOT COMPLETED|Overall Study||17
10966954|NCT00518115|12140738|FG003|NOT COMPLETED|Overall Study||11
10966955|NCT00518115|12140739|FG004|NOT COMPLETED|Overall Study||10
10966956|NCT00518115|12140740|FG005|NOT COMPLETED|Overall Study||15
10966957|NCT00518115|12140741|FG006|NOT COMPLETED|Overall Study||8
10966958|NCT00518115|12140742|FG007|NOT COMPLETED|Overall Study||15
10966959|NCT00518115|12140743|FG008|NOT COMPLETED|Overall Study||5
10966960|NCT00518115|12140744|FG009|NOT COMPLETED|Overall Study||15
10966961|NCT00518154|12140767|FG000|STARTED|Overall Study||7
10966962|NCT00518154|12140767|FG000|COMPLETED|Overall Study||7
10966963|NCT00518154|12140767|FG000|NOT COMPLETED|Overall Study||0
10966964|NCT00518180|12140774|FG000|STARTED|Overall Study||540
10966965|NCT00518180|12140775|FG001|STARTED|Overall Study||541
10966966|NCT00518180|12140776|FG002|STARTED|Overall Study||539
10966967|NCT00518180|12140774|FG000|COMPLETED|Overall Study||475
10966968|NCT00518180|12140775|FG001|COMPLETED|Overall Study||472
10966969|NCT00518180|12140776|FG002|COMPLETED|Overall Study||457
10966970|NCT00518180|12140774|FG000|NOT COMPLETED|Overall Study||65
10966971|NCT00518180|12140775|FG001|NOT COMPLETED|Overall Study||69
10966972|NCT00518180|12140776|FG002|NOT COMPLETED|Overall Study||82
10966973|NCT00518206|12140795|FG000|STARTED|Overall Study||27
10966974|NCT00518206|12140796|FG001|STARTED|Overall Study||19
10966975|NCT00518206|12140795|FG000|COMPLETED|Overall Study||16
10966976|NCT00518206|12140796|FG001|COMPLETED|Overall Study||13
10966977|NCT00518206|12140795|FG000|NOT COMPLETED|Overall Study||11
10966978|NCT00518206|12140796|FG001|NOT COMPLETED|Overall Study||6
10966979|NCT00518284|12140806|FG000|STARTED|Overall Study||0
10966980|NCT00518284|12140807|FG001|STARTED|Overall Study||3
10966981|NCT00518284|12140808|FG002|STARTED|Overall Study||1
10966982|NCT00518284|12140809|FG003|STARTED|Overall Study||2
10966983|NCT00518284|12140806|FG000|COMPLETED|Overall Study||0
10966984|NCT00518284|12140807|FG001|COMPLETED|Overall Study||0
10966985|NCT00518284|12140808|FG002|COMPLETED|Overall Study||0
10966986|NCT00518284|12140809|FG003|COMPLETED|Overall Study||0
10966987|NCT00518284|12140806|FG000|NOT COMPLETED|Overall Study||0
10966988|NCT00518284|12140807|FG001|NOT COMPLETED|Overall Study||3
10966989|NCT00518284|12140808|FG002|NOT COMPLETED|Overall Study||1
10966990|NCT00518284|12140809|FG003|NOT COMPLETED|Overall Study||2
10966991|NCT00518323|12140823|FG000|STARTED|Overall Study||54
10966992|NCT00518323|12140824|FG001|STARTED|Overall Study||48
10966993|NCT00518323|12140825|FG002|STARTED|Overall Study||48
10966994|NCT00518323|12140826|FG003|STARTED|Overall Study||51
10966995|NCT00518323|12140823|FG000|COMPLETED|Overall Study||35
10966996|NCT00518323|12140824|FG001|COMPLETED|Overall Study||40
10966997|NCT00518323|12140825|FG002|COMPLETED|Overall Study||37
10966998|NCT00518323|12140826|FG003|COMPLETED|Overall Study||26
10966999|NCT00518323|12140823|FG000|NOT COMPLETED|Overall Study||19
10967000|NCT00518323|12140824|FG001|NOT COMPLETED|Overall Study||8
10967001|NCT00518323|12140825|FG002|NOT COMPLETED|Overall Study||11
10967002|NCT00518323|12140826|FG003|NOT COMPLETED|Overall Study||25
10967003|NCT00518336|12140838|FG000|STARTED|Year 7||222
10967004|NCT00518336|12140839|FG001|STARTED|Year 7||211
10967005|NCT00518336|12140838|FG000|COMPLETED|Year 7||220
10967006|NCT00518336|12140839|FG001|COMPLETED|Year 7||208
10967007|NCT00518336|12140838|FG000|NOT COMPLETED|Year 7||2
10967008|NCT00518336|12140839|FG001|NOT COMPLETED|Year 7||3
10967009|NCT00518336|12140838|FG000|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
10967010|NCT00518336|12140839|FG001|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
10967011|NCT00518336|12140838|FG000|COMPLETED|Year 8||222
10967012|NCT00518336|12140839|FG001|COMPLETED|Year 8||211
10967013|NCT00518336|12140838|FG000|NOT COMPLETED|Year 8||1
10967014|NCT00518336|12140839|FG001|NOT COMPLETED|Year 8||2
10967015|NCT00518336|12140838|FG000|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
10967016|NCT00518336|12140839|FG001|STARTED|Year 9||213
10967017|NCT00518336|12140838|FG000|COMPLETED|Year 9||219
10967018|NCT00518336|12140839|FG001|COMPLETED|Year 9||212
10967019|NCT00518336|12140838|FG000|NOT COMPLETED|Year 9||5
10967020|NCT00518336|12140839|FG001|NOT COMPLETED|Year 9||1
10967021|NCT00518349|12140847|FG000|STARTED|Overall Study||60
10967022|NCT00518349|12140848|FG001|STARTED|Overall Study||60
10967023|NCT00518349|12140847|FG000|COMPLETED|Overall Study||60
10967024|NCT00518349|12140848|FG001|COMPLETED|Overall Study||60
10967025|NCT00518349|12140847|FG000|NOT COMPLETED|Overall Study||0
10967026|NCT00518349|12140848|FG001|NOT COMPLETED|Overall Study||0
10967027|NCT00518531|12140856|FG000|STARTED|Treatment Period 1||124
10967028|NCT00518531|12140857|FG001|STARTED|Treatment Period 1||126
10967029|NCT00518531|12140856|FG000|Received Treatment|Treatment Period 1||119
10967030|NCT00518531|12140857|FG001|Received Treatment|Treatment Period 1||124
10967031|NCT00518531|12140856|FG000|COMPLETED|Treatment Period 1||106
10967032|NCT00518531|12140857|FG001|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
10967033|NCT00518531|12140856|FG000|NOT COMPLETED|Treatment Period 1||18
10967034|NCT00518531|12140857|FG001|NOT COMPLETED|Treatment Period 1||12
10967035|NCT00518531|12140856|FG000|STARTED|Treatment Period 2||106
10967036|NCT00518531|12140857|FG001|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
10967037|NCT00518531|12140856|FG000|Received Treatment|Treatment Period 2||106
10967038|NCT00518531|12140857|FG001|Received Treatment|Treatment Period 2||110
10967039|NCT00518531|12140856|FG000|COMPLETED|Treatment Period 2||103
10967040|NCT00518531|12140857|FG001|COMPLETED|Treatment Period 2||95
10967041|NCT00518531|12140856|FG000|NOT COMPLETED|Treatment Period 2||3
10967042|NCT00518531|12140857|FG001|NOT COMPLETED|Treatment Period 2||20
10967043|NCT00518622|12140873|FG000|STARTED|Overall Study||3
10967044|NCT00518622|12140874|FG001|STARTED|Overall Study||6
10967045|NCT00518622|12140875|FG002|STARTED|Overall Study||6
10967046|NCT00518622|12140876|FG003|STARTED|Overall Study||5
10967047|NCT00518622|12140877|FG004|STARTED|Overall Study||6
10967048|NCT00518622|12140878|FG005|STARTED|Overall Study||5
10967049|NCT00518622|12140879|FG006|STARTED|Overall Study||4
10967050|NCT00518622|12140880|FG007|STARTED|Overall Study||5
10967051|NCT00518622|12140873|FG000|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
10967052|NCT00518622|12140874|FG001|Completed Therapy|Overall Study||5
10967053|NCT00518622|12140875|FG002|Completed Therapy|Overall Study||6
10967054|NCT00518622|12140876|FG003|Completed Therapy|Overall Study||5
10967055|NCT00518622|12140877|FG004|Completed Therapy|Overall Study||6
10967056|NCT00518622|12140878|FG005|Completed Therapy|Overall Study||5
10967057|NCT00518622|12140879|FG006|Completed Therapy|Overall Study||4
10967058|NCT00518622|12140880|FG007|Completed Therapy|Overall Study||5
10967059|NCT00518622|12140873|FG000|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
10967060|NCT00518622|12140874|FG001|Discontinued Therapy|Overall Study||1
10967061|NCT00518622|12140875|FG002|Discontinued Therapy|Overall Study||0
10967062|NCT00518622|12140876|FG003|Discontinued Therapy|Overall Study||0
10967063|NCT00518622|12140877|FG004|Discontinued Therapy|Overall Study||0
10967064|NCT00518622|12140878|FG005|Discontinued Therapy|Overall Study||0
10967065|NCT00518622|12140879|FG006|Discontinued Therapy|Overall Study||0
10967066|NCT00518622|12140880|FG007|Discontinued Therapy|Overall Study||0
10967067|NCT00518622|12140873|FG000|COMPLETED|Overall Study||3
10967068|NCT00518622|12140874|FG001|COMPLETED|Overall Study||5
10967069|NCT00518622|12140875|FG002|COMPLETED|Overall Study||5
10967070|NCT00518622|12140876|FG003|COMPLETED|Overall Study||5
10967071|NCT00518622|12140877|FG004|COMPLETED|Overall Study||6
10967072|NCT00518622|12140878|FG005|COMPLETED|Overall Study||5
10967073|NCT00518622|12140879|FG006|COMPLETED|Overall Study||4
10967074|NCT00518622|12140880|FG007|COMPLETED|Overall Study||5
10967075|NCT00518622|12140873|FG000|NOT COMPLETED|Overall Study||0
10967076|NCT00518622|12140874|FG001|NOT COMPLETED|Overall Study||1
10967077|NCT00518622|12140875|FG002|NOT COMPLETED|Overall Study||1
10967078|NCT00518622|12140876|FG003|NOT COMPLETED|Overall Study||0
10967079|NCT00518622|12140877|FG004|NOT COMPLETED|Overall Study||0
10967080|NCT00518622|12140878|FG005|NOT COMPLETED|Overall Study||0
10967081|NCT00518622|12140879|FG006|NOT COMPLETED|Overall Study||0
10967082|NCT00518622|12140880|FG007|NOT COMPLETED|Overall Study||0
10967083|NCT00518687|12140900|FG000|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
10967084|NCT00518687|12140901|FG001|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
10967085|NCT00518687|12140900|FG000|Vaccinated|Overall Study||3981
10967086|NCT00518687|12140901|FG001|Vaccinated|Overall Study||3982
10967087|NCT00518687|12140900|FG000|COMPLETED|Overall Study||2568
10967088|NCT00518687|12140901|FG001|COMPLETED|Overall Study||2585
10967089|NCT00518687|12140900|FG000|NOT COMPLETED|Overall Study||1437
10967090|NCT00518687|12140901|FG001|NOT COMPLETED|Overall Study||1420
10967091|NCT00518713|12140911|FG000|STARTED|Overall Study||58
10967092|NCT00518713|12140912|FG001|STARTED|Overall Study||62
10967093|NCT00518713|12140913|FG002|STARTED|Overall Study||59
10967094|NCT00518713|12140914|FG003|STARTED|Overall Study||59
10967095|NCT00518713|12140911|FG000|Modified Intent-to-Treat Population|Overall Study||53
10967096|NCT00518713|12140912|FG001|Modified Intent-to-Treat Population|Overall Study||58
10967097|NCT00518713|12140913|FG002|Modified Intent-to-Treat Population|Overall Study||49
10967098|NCT00518713|12140914|FG003|Modified Intent-to-Treat Population|Overall Study||57
10967099|NCT00518713|12140911|FG000|COMPLETED|Overall Study||50
10967100|NCT00518713|12140912|FG001|COMPLETED|Overall Study||45
10967101|NCT00518713|12140913|FG002|COMPLETED|Overall Study||41
10967102|NCT00518713|12140914|FG003|COMPLETED|Overall Study||41
10967103|NCT00518713|12140911|FG000|NOT COMPLETED|Overall Study||8
10967104|NCT00518713|12140912|FG001|NOT COMPLETED|Overall Study||17
10967105|NCT00518713|12140913|FG002|NOT COMPLETED|Overall Study||18
10967106|NCT00518713|12140914|FG003|NOT COMPLETED|Overall Study||18
10967107|NCT00518882|12140926|FG000|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
10967108|NCT00518882|12140927|FG001|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
10967109|NCT00518882|12140926|FG000|Randomised|Double-Blind, Week 0-26||233
10967110|NCT00518882|12140927|FG001|Randomised|Double-Blind, Week 0-26||231
10967111|NCT00518882|12140926|FG000|COMPLETED|Double-Blind, Week 0-26||202
10967112|NCT00518882|12140927|FG001|COMPLETED|Double-Blind, Week 0-26||187
10967113|NCT00518882|12140926|FG000|NOT COMPLETED|Double-Blind, Week 0-26||33
10967114|NCT00518882|12140927|FG001|NOT COMPLETED|Double-Blind, Week 0-26||45
10967115|NCT00518882|12140926|FG000|STARTED|Open-Label Extension, Week 26-78||202
10967116|NCT00518882|12140927|FG001|STARTED|Open-Label Extension, Week 26-78||187
10967117|NCT00518882|12140926|FG000|COMPLETED|Open-Label Extension, Week 26-78||161
10967118|NCT00518882|12140927|FG001|COMPLETED|Open-Label Extension, Week 26-78||138
10967119|NCT00518882|12140926|FG000|NOT COMPLETED|Open-Label Extension, Week 26-78||41
10967120|NCT00518882|12140927|FG001|NOT COMPLETED|Open-Label Extension, Week 26-78||49
10967121|NCT00518973|12140935|FG000|STARTED|Overall Study||9
10967122|NCT00518973|12140936|FG001|STARTED|Overall Study||6
10967123|NCT00518973|12140935|FG000|COMPLETED|Overall Study||6
10967124|NCT00518973|12140936|FG001|COMPLETED|Overall Study||4
10967125|NCT00518973|12140935|FG000|NOT COMPLETED|Overall Study||3
10967126|NCT00518973|12140936|FG001|NOT COMPLETED|Overall Study||2
10967127|NCT00518986|12140944|FG000|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
10967128|NCT00518986|12140945|FG001|STARTED|Overall Study||124
10967129|NCT00518986|12140944|FG000|COMPLETED|Overall Study||99
10967130|NCT00518986|12140945|FG001|COMPLETED|Overall Study||98
10967131|NCT00518986|12140944|FG000|NOT COMPLETED|Overall Study||26
10967132|NCT00518986|12140945|FG001|NOT COMPLETED|Overall Study||26
10967133|NCT00519077|12140951|FG000|STARTED|Overall Study||44
10967134|NCT00519077|12140951|FG000|COMPLETED|Overall Study||36
10967135|NCT00519077|12140951|FG000|NOT COMPLETED|Overall Study||8
10967136|NCT00519194|12140955|FG000|STARTED|Overall Study||112
10967137|NCT00519194|12140955|FG000|COMPLETED|Overall Study||91
10967138|NCT00519194|12140955|FG000|NOT COMPLETED|Overall Study||21
10967139|NCT00519285|12140961|FG000|STARTED|Overall Study|Randomized|612
10967140|NCT00519285|12140962|FG001|STARTED|Overall Study|Randomized|612
10967141|NCT00519285|12140961|FG000|TREATED|Overall Study|Received at least part of one dose of placebo|604
10967142|NCT00519285|12140962|FG001|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
10967143|NCT00519285|12140961|FG000|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
10967144|NCT00519285|12140962|FG001|Still Treated at Cut-off Date|Overall Study||2
10967145|NCT00519285|12140961|FG000|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
10967146|NCT00519285|12140962|FG001|COMPLETED|Overall Study||0
10967147|NCT00519285|12140961|FG000|NOT COMPLETED|Overall Study||612
10967148|NCT00519285|12140962|FG001|NOT COMPLETED|Overall Study||612
10967149|NCT00519376|12140968|FG000|STARTED|Treatment Period 1||2
10967150|NCT00519376|12140969|FG001|STARTED|Treatment Period 1||2
10967151|NCT00519376|12140970|FG002|STARTED|Treatment Period 1||2
10967152|NCT00519376|12140971|FG003|STARTED|Treatment Period 1||2
10967153|NCT00519376|12140972|FG004|STARTED|Treatment Period 1||1
10967154|NCT00519376|12140973|FG005|STARTED|Treatment Period 1||1
10967155|NCT00519376|12140974|FG006|STARTED|Treatment Period 1||1
10967156|NCT00519376|12140975|FG007|STARTED|Treatment Period 1||1
10967157|NCT00519376|12140976|FG008|STARTED|Treatment Period 1||1
10967158|NCT00519376|12140977|FG009|STARTED|Treatment Period 1||1
10967159|NCT00519376|12140978|FG010|STARTED|Treatment Period 1||1
10967160|NCT00519376|12140979|FG011|STARTED|Treatment Period 1||1
10967161|NCT00519376|12140980|FG012|STARTED|Treatment Period 1||1
10967162|NCT00519376|12140981|FG013|STARTED|Treatment Period 1||1
10967163|NCT00519376|12140982|FG014|STARTED|Treatment Period 1||1
10967164|NCT00519376|12140983|FG015|STARTED|Treatment Period 1||1
10967165|NCT00519376|12140968|FG000|COMPLETED|Treatment Period 1||2
10967166|NCT00519376|12140969|FG001|COMPLETED|Treatment Period 1||2
10967167|NCT00519376|12140970|FG002|COMPLETED|Treatment Period 1||2
10967168|NCT00519376|12140971|FG003|COMPLETED|Treatment Period 1||2
10967169|NCT00519376|12140972|FG004|COMPLETED|Treatment Period 1||1
10967170|NCT00519376|12140973|FG005|COMPLETED|Treatment Period 1||1
10967171|NCT00519376|12140974|FG006|COMPLETED|Treatment Period 1||1
10967172|NCT00519376|12140975|FG007|COMPLETED|Treatment Period 1||1
10967173|NCT00519376|12140976|FG008|COMPLETED|Treatment Period 1||1
10967174|NCT00519376|12140977|FG009|COMPLETED|Treatment Period 1||1
10967175|NCT00519376|12140978|FG010|COMPLETED|Treatment Period 1||1
10967176|NCT00519376|12140979|FG011|COMPLETED|Treatment Period 1||1
10967177|NCT00519376|12140980|FG012|COMPLETED|Treatment Period 1||1
10967178|NCT00519376|12140981|FG013|COMPLETED|Treatment Period 1||1
10967179|NCT00519376|12140982|FG014|COMPLETED|Treatment Period 1||1
10967180|NCT00519376|12140983|FG015|COMPLETED|Treatment Period 1||1
10967181|NCT00519376|12140968|FG000|NOT COMPLETED|Treatment Period 1||0
10967182|NCT00519376|12140969|FG001|NOT COMPLETED|Treatment Period 1||0
10967183|NCT00519376|12140970|FG002|NOT COMPLETED|Treatment Period 1||0
10967184|NCT00519376|12140971|FG003|NOT COMPLETED|Treatment Period 1||0
10967185|NCT00519376|12140972|FG004|NOT COMPLETED|Treatment Period 1||0
10967186|NCT00519376|12140973|FG005|NOT COMPLETED|Treatment Period 1||0
10967187|NCT00519376|12140974|FG006|NOT COMPLETED|Treatment Period 1||0
10967188|NCT00519376|12140975|FG007|NOT COMPLETED|Treatment Period 1||0
10967189|NCT00519376|12140976|FG008|NOT COMPLETED|Treatment Period 1||0
10967190|NCT00519376|12140977|FG009|NOT COMPLETED|Treatment Period 1||0
10967191|NCT00519376|12140978|FG010|NOT COMPLETED|Treatment Period 1||0
10967192|NCT00519376|12140979|FG011|NOT COMPLETED|Treatment Period 1||0
10967193|NCT00519376|12140980|FG012|NOT COMPLETED|Treatment Period 1||0
10967194|NCT00519376|12140981|FG013|NOT COMPLETED|Treatment Period 1||0
10967195|NCT00519376|12140982|FG014|NOT COMPLETED|Treatment Period 1||0
10967196|NCT00519376|12140983|FG015|NOT COMPLETED|Treatment Period 1||0
10967197|NCT00519376|12140968|FG000|STARTED|Washout Period 1||2
10967198|NCT00519376|12140969|FG001|STARTED|Washout Period 1||2
10967199|NCT00519376|12140970|FG002|STARTED|Washout Period 1||2
10967200|NCT00519376|12140971|FG003|STARTED|Washout Period 1||2
10967201|NCT00519376|12140972|FG004|STARTED|Washout Period 1||1
10967202|NCT00519376|12140973|FG005|STARTED|Washout Period 1||1
10967203|NCT00519376|12140974|FG006|STARTED|Washout Period 1||1
10967204|NCT00519376|12140975|FG007|STARTED|Washout Period 1||1
10967205|NCT00519376|12140976|FG008|STARTED|Washout Period 1||1
10967206|NCT00519376|12140977|FG009|STARTED|Washout Period 1||1
10967207|NCT00519376|12140978|FG010|STARTED|Washout Period 1||1
10967208|NCT00519376|12140979|FG011|STARTED|Washout Period 1||1
10967209|NCT00519376|12140980|FG012|STARTED|Washout Period 1||1
10967210|NCT00519376|12140981|FG013|STARTED|Washout Period 1||1
10967211|NCT00519376|12140982|FG014|STARTED|Washout Period 1||1
10967212|NCT00519376|12140983|FG015|STARTED|Washout Period 1||1
10967213|NCT00519376|12140968|FG000|COMPLETED|Washout Period 1||2
10967214|NCT00519376|12140969|FG001|COMPLETED|Washout Period 1||2
10967215|NCT00519376|12140970|FG002|COMPLETED|Washout Period 1||2
10967216|NCT00519376|12140971|FG003|COMPLETED|Washout Period 1||2
10967217|NCT00519376|12140972|FG004|COMPLETED|Washout Period 1||1
10967218|NCT00519376|12140973|FG005|COMPLETED|Washout Period 1||1
10967219|NCT00519376|12140974|FG006|COMPLETED|Washout Period 1||1
10967220|NCT00519376|12140975|FG007|COMPLETED|Washout Period 1||1
10967221|NCT00519376|12140976|FG008|COMPLETED|Washout Period 1||1
10967222|NCT00519376|12140977|FG009|COMPLETED|Washout Period 1||1
10967223|NCT00519376|12140978|FG010|COMPLETED|Washout Period 1||1
10967224|NCT00519376|12140979|FG011|COMPLETED|Washout Period 1||1
10967225|NCT00519376|12140980|FG012|COMPLETED|Washout Period 1||1
10967226|NCT00519376|12140981|FG013|COMPLETED|Washout Period 1||1
10967227|NCT00519376|12140982|FG014|COMPLETED|Washout Period 1||1
10967228|NCT00519376|12140983|FG015|COMPLETED|Washout Period 1||1
10967229|NCT00519376|12140968|FG000|NOT COMPLETED|Washout Period 1||0
10967230|NCT00519376|12140969|FG001|NOT COMPLETED|Washout Period 1||0
10967231|NCT00519376|12140970|FG002|NOT COMPLETED|Washout Period 1||0
10967232|NCT00519376|12140971|FG003|NOT COMPLETED|Washout Period 1||0
10967233|NCT00519376|12140972|FG004|NOT COMPLETED|Washout Period 1||0
10967234|NCT00519376|12140973|FG005|NOT COMPLETED|Washout Period 1||0
10967235|NCT00519376|12140974|FG006|NOT COMPLETED|Washout Period 1||0
10967236|NCT00519376|12140975|FG007|NOT COMPLETED|Washout Period 1||0
10967237|NCT00519376|12140976|FG008|NOT COMPLETED|Washout Period 1||0
10967238|NCT00519376|12140977|FG009|NOT COMPLETED|Washout Period 1||0
10967239|NCT00519376|12140978|FG010|NOT COMPLETED|Washout Period 1||0
10967240|NCT00519376|12140979|FG011|NOT COMPLETED|Washout Period 1||0
10967241|NCT00519376|12140980|FG012|NOT COMPLETED|Washout Period 1||0
10967242|NCT00519376|12140981|FG013|NOT COMPLETED|Washout Period 1||0
10967243|NCT00519376|12140982|FG014|NOT COMPLETED|Washout Period 1||0
10967244|NCT00519376|12140983|FG015|NOT COMPLETED|Washout Period 1||0
10967245|NCT00519376|12140968|FG000|STARTED|Treatment Period 2||2
10967246|NCT00519376|12140969|FG001|STARTED|Treatment Period 2||2
10967247|NCT00519376|12140970|FG002|STARTED|Treatment Period 2||2
10967248|NCT00519376|12140971|FG003|STARTED|Treatment Period 2||2
10967249|NCT00519376|12140972|FG004|STARTED|Treatment Period 2||1
10967250|NCT00519376|12140973|FG005|STARTED|Treatment Period 2||1
10967251|NCT00519376|12140974|FG006|STARTED|Treatment Period 2||1
10967252|NCT00519376|12140975|FG007|STARTED|Treatment Period 2||1
10967253|NCT00519376|12140976|FG008|STARTED|Treatment Period 2||1
10967254|NCT00519376|12140977|FG009|STARTED|Treatment Period 2||1
10967255|NCT00519376|12140978|FG010|STARTED|Treatment Period 2||1
10967256|NCT00519376|12140979|FG011|STARTED|Treatment Period 2||1
10967257|NCT00519376|12140980|FG012|STARTED|Treatment Period 2||1
10967258|NCT00519376|12140981|FG013|STARTED|Treatment Period 2||1
10967259|NCT00519376|12140982|FG014|STARTED|Treatment Period 2||1
10967260|NCT00519376|12140983|FG015|STARTED|Treatment Period 2||1
10967261|NCT00519376|12140968|FG000|COMPLETED|Treatment Period 2||2
10967262|NCT00519376|12140969|FG001|COMPLETED|Treatment Period 2||2
10967263|NCT00519376|12140970|FG002|COMPLETED|Treatment Period 2||2
10967264|NCT00519376|12140971|FG003|COMPLETED|Treatment Period 2||2
10967265|NCT00519376|12140972|FG004|COMPLETED|Treatment Period 2||1
10967266|NCT00519376|12140973|FG005|COMPLETED|Treatment Period 2||1
10967267|NCT00519376|12140974|FG006|COMPLETED|Treatment Period 2||1
10967268|NCT00519376|12140975|FG007|COMPLETED|Treatment Period 2||1
10967269|NCT00519376|12140976|FG008|COMPLETED|Treatment Period 2||1
10967270|NCT00519376|12140977|FG009|COMPLETED|Treatment Period 2||1
10967271|NCT00519376|12140978|FG010|COMPLETED|Treatment Period 2||1
10967272|NCT00519376|12140979|FG011|COMPLETED|Treatment Period 2||1
10967273|NCT00519376|12140980|FG012|COMPLETED|Treatment Period 2||0
10967274|NCT00519376|12140981|FG013|COMPLETED|Treatment Period 2||1
10967275|NCT00519376|12140982|FG014|COMPLETED|Treatment Period 2||1
10967276|NCT00519376|12140983|FG015|COMPLETED|Treatment Period 2||1
10967277|NCT00519376|12140968|FG000|NOT COMPLETED|Treatment Period 2||0
10967278|NCT00519376|12140969|FG001|NOT COMPLETED|Treatment Period 2||0
10967279|NCT00519376|12140970|FG002|NOT COMPLETED|Treatment Period 2||0
10967280|NCT00519376|12140971|FG003|NOT COMPLETED|Treatment Period 2||0
10967281|NCT00519376|12140972|FG004|NOT COMPLETED|Treatment Period 2||0
10967282|NCT00519376|12140973|FG005|NOT COMPLETED|Treatment Period 2||0
10967283|NCT00519376|12140974|FG006|NOT COMPLETED|Treatment Period 2||0
10967284|NCT00519376|12140975|FG007|NOT COMPLETED|Treatment Period 2||0
10967285|NCT00519376|12140976|FG008|NOT COMPLETED|Treatment Period 2||0
10967286|NCT00519376|12140977|FG009|NOT COMPLETED|Treatment Period 2||0
10967287|NCT00519376|12140978|FG010|NOT COMPLETED|Treatment Period 2||0
10967288|NCT00519376|12140979|FG011|NOT COMPLETED|Treatment Period 2||0
10967289|NCT00519376|12140980|FG012|NOT COMPLETED|Treatment Period 2||1
10967290|NCT00519376|12140981|FG013|NOT COMPLETED|Treatment Period 2||0
10967291|NCT00519376|12140982|FG014|NOT COMPLETED|Treatment Period 2||0
10967292|NCT00519376|12140983|FG015|NOT COMPLETED|Treatment Period 2||0
10967293|NCT00519376|12140968|FG000|STARTED|Washout Period 2||2
10967294|NCT00519376|12140969|FG001|STARTED|Washout Period 2||2
10967295|NCT00519376|12140970|FG002|STARTED|Washout Period 2||2
10967296|NCT00519376|12140971|FG003|STARTED|Washout Period 2||2
10967297|NCT00519376|12140972|FG004|STARTED|Washout Period 2||1
10967298|NCT00519376|12140973|FG005|STARTED|Washout Period 2||1
10967299|NCT00519376|12140974|FG006|STARTED|Washout Period 2||1
10967300|NCT00519376|12140975|FG007|STARTED|Washout Period 2||1
10967301|NCT00519376|12140976|FG008|STARTED|Washout Period 2||1
10967302|NCT00519376|12140977|FG009|STARTED|Washout Period 2||1
10967303|NCT00519376|12140978|FG010|STARTED|Washout Period 2||1
10967304|NCT00519376|12140979|FG011|STARTED|Washout Period 2||1
10967305|NCT00519376|12140980|FG012|STARTED|Washout Period 2||0
10967306|NCT00519376|12140981|FG013|STARTED|Washout Period 2||1
10967307|NCT00519376|12140982|FG014|STARTED|Washout Period 2||1
10967308|NCT00519376|12140983|FG015|STARTED|Washout Period 2||1
10967309|NCT00519376|12140968|FG000|COMPLETED|Washout Period 2||2
10967310|NCT00519376|12140969|FG001|COMPLETED|Washout Period 2||2
10967311|NCT00519376|12140970|FG002|COMPLETED|Washout Period 2||2
10967312|NCT00519376|12140971|FG003|COMPLETED|Washout Period 2||2
10967313|NCT00519376|12140972|FG004|COMPLETED|Washout Period 2||1
10967314|NCT00519376|12140973|FG005|COMPLETED|Washout Period 2||1
10967315|NCT00519376|12140974|FG006|COMPLETED|Washout Period 2||1
10967316|NCT00519376|12140975|FG007|COMPLETED|Washout Period 2||1
10967317|NCT00519376|12140976|FG008|COMPLETED|Washout Period 2||1
10967318|NCT00519376|12140977|FG009|COMPLETED|Washout Period 2||1
10967319|NCT00519376|12140978|FG010|COMPLETED|Washout Period 2||1
10967320|NCT00519376|12140979|FG011|COMPLETED|Washout Period 2||1
10967321|NCT00519376|12140980|FG012|COMPLETED|Washout Period 2||0
10967322|NCT00519376|12140981|FG013|COMPLETED|Washout Period 2||1
10967323|NCT00519376|12140982|FG014|COMPLETED|Washout Period 2||1
10967324|NCT00519376|12140983|FG015|COMPLETED|Washout Period 2||1
10967325|NCT00519376|12140968|FG000|NOT COMPLETED|Washout Period 2||0
10967326|NCT00519376|12140969|FG001|NOT COMPLETED|Washout Period 2||0
10967327|NCT00519376|12140970|FG002|NOT COMPLETED|Washout Period 2||0
10967328|NCT00519376|12140971|FG003|NOT COMPLETED|Washout Period 2||0
10967329|NCT00519376|12140972|FG004|NOT COMPLETED|Washout Period 2||0
10967330|NCT00519376|12140973|FG005|NOT COMPLETED|Washout Period 2||0
10967331|NCT00519376|12140974|FG006|NOT COMPLETED|Washout Period 2||0
10967332|NCT00519376|12140975|FG007|NOT COMPLETED|Washout Period 2||0
10967333|NCT00519376|12140976|FG008|NOT COMPLETED|Washout Period 2||0
10967334|NCT00519376|12140977|FG009|NOT COMPLETED|Washout Period 2||0
10967335|NCT00519376|12140978|FG010|NOT COMPLETED|Washout Period 2||0
10967336|NCT00519376|12140979|FG011|NOT COMPLETED|Washout Period 2||0
10967337|NCT00519376|12140980|FG012|NOT COMPLETED|Washout Period 2||0
10967338|NCT00519376|12140981|FG013|NOT COMPLETED|Washout Period 2||0
10967339|NCT00519376|12140982|FG014|NOT COMPLETED|Washout Period 2||0
10967340|NCT00519376|12140983|FG015|NOT COMPLETED|Washout Period 2||0
10967341|NCT00519376|12140968|FG000|STARTED|Treatment Period 3||2
10967342|NCT00519376|12140969|FG001|STARTED|Treatment Period 3||2
10967343|NCT00519376|12140970|FG002|STARTED|Treatment Period 3||2
10967344|NCT00519376|12140971|FG003|STARTED|Treatment Period 3||2
10967345|NCT00519376|12140972|FG004|STARTED|Treatment Period 3||1
10967346|NCT00519376|12140973|FG005|STARTED|Treatment Period 3||1
10967347|NCT00519376|12140974|FG006|STARTED|Treatment Period 3||1
10967348|NCT00519376|12140975|FG007|STARTED|Treatment Period 3||1
10967349|NCT00519376|12140976|FG008|STARTED|Treatment Period 3||1
10967350|NCT00519376|12140977|FG009|STARTED|Treatment Period 3||1
10967351|NCT00519376|12140978|FG010|STARTED|Treatment Period 3||1
10967352|NCT00519376|12140979|FG011|STARTED|Treatment Period 3||1
10967353|NCT00519376|12140980|FG012|STARTED|Treatment Period 3||0
10967354|NCT00519376|12140981|FG013|STARTED|Treatment Period 3||1
10967355|NCT00519376|12140982|FG014|STARTED|Treatment Period 3||1
10967356|NCT00519376|12140983|FG015|STARTED|Treatment Period 3||1
10967357|NCT00519376|12140968|FG000|COMPLETED|Treatment Period 3||2
10967358|NCT00519376|12140969|FG001|COMPLETED|Treatment Period 3||2
10967359|NCT00519376|12140970|FG002|COMPLETED|Treatment Period 3||2
10967360|NCT00519376|12140971|FG003|COMPLETED|Treatment Period 3||2
10967361|NCT00519376|12140972|FG004|COMPLETED|Treatment Period 3||1
10967362|NCT00519376|12140973|FG005|COMPLETED|Treatment Period 3||1
10967363|NCT00519376|12140974|FG006|COMPLETED|Treatment Period 3||1
10967364|NCT00519376|12140975|FG007|COMPLETED|Treatment Period 3||1
10967365|NCT00519376|12140976|FG008|COMPLETED|Treatment Period 3||1
10967366|NCT00519376|12140977|FG009|COMPLETED|Treatment Period 3||1
10967367|NCT00519376|12140978|FG010|COMPLETED|Treatment Period 3||1
10967368|NCT00519376|12140979|FG011|COMPLETED|Treatment Period 3||1
10967369|NCT00519376|12140980|FG012|COMPLETED|Treatment Period 3||0
10967370|NCT00519376|12140981|FG013|COMPLETED|Treatment Period 3||1
10967371|NCT00519376|12140982|FG014|COMPLETED|Treatment Period 3||1
10967372|NCT00519376|12140983|FG015|COMPLETED|Treatment Period 3||1
10967373|NCT00519376|12140968|FG000|NOT COMPLETED|Treatment Period 3||0
10967374|NCT00519376|12140969|FG001|NOT COMPLETED|Treatment Period 3||0
10967375|NCT00519376|12140970|FG002|NOT COMPLETED|Treatment Period 3||0
10967376|NCT00519376|12140971|FG003|NOT COMPLETED|Treatment Period 3||0
10967377|NCT00519376|12140972|FG004|NOT COMPLETED|Treatment Period 3||0
10967378|NCT00519376|12140973|FG005|NOT COMPLETED|Treatment Period 3||0
10967379|NCT00519376|12140974|FG006|NOT COMPLETED|Treatment Period 3||0
10967380|NCT00519376|12140975|FG007|NOT COMPLETED|Treatment Period 3||0
10967381|NCT00519376|12140976|FG008|NOT COMPLETED|Treatment Period 3||0
10967382|NCT00519376|12140977|FG009|NOT COMPLETED|Treatment Period 3||0
10967383|NCT00519376|12140978|FG010|NOT COMPLETED|Treatment Period 3||0
10967384|NCT00519376|12140979|FG011|NOT COMPLETED|Treatment Period 3||0
10967385|NCT00519376|12140980|FG012|NOT COMPLETED|Treatment Period 3||0
10967386|NCT00519376|12140981|FG013|NOT COMPLETED|Treatment Period 3||0
10967387|NCT00519376|12140982|FG014|NOT COMPLETED|Treatment Period 3||0
10967388|NCT00519376|12140983|FG015|NOT COMPLETED|Treatment Period 3||0
10967389|NCT00519376|12140968|FG000|STARTED|Washout Period 3||2
10967390|NCT00519376|12140969|FG001|STARTED|Washout Period 3||2
10967391|NCT00519376|12140970|FG002|STARTED|Washout Period 3||2
10967392|NCT00519376|12140971|FG003|STARTED|Washout Period 3||2
10967393|NCT00519376|12140972|FG004|STARTED|Washout Period 3||1
10967394|NCT00519376|12140973|FG005|STARTED|Washout Period 3||1
10967395|NCT00519376|12140974|FG006|STARTED|Washout Period 3||1
10967396|NCT00519376|12140975|FG007|STARTED|Washout Period 3||1
10967397|NCT00519376|12140976|FG008|STARTED|Washout Period 3||1
10967398|NCT00519376|12140977|FG009|STARTED|Washout Period 3||1
10967399|NCT00519376|12140978|FG010|STARTED|Washout Period 3||1
10967400|NCT00519376|12140979|FG011|STARTED|Washout Period 3||1
10967401|NCT00519376|12140980|FG012|STARTED|Washout Period 3||0
10967402|NCT00519376|12140981|FG013|STARTED|Washout Period 3||1
10967403|NCT00519376|12140982|FG014|STARTED|Washout Period 3||1
10967404|NCT00519376|12140983|FG015|STARTED|Washout Period 3||1
10967405|NCT00519376|12140968|FG000|COMPLETED|Washout Period 3||2
10967406|NCT00519376|12140969|FG001|COMPLETED|Washout Period 3||2
10967407|NCT00519376|12140970|FG002|COMPLETED|Washout Period 3||2
10967408|NCT00519376|12140971|FG003|COMPLETED|Washout Period 3||2
10967409|NCT00519376|12140972|FG004|COMPLETED|Washout Period 3||1
10967410|NCT00519376|12140973|FG005|COMPLETED|Washout Period 3||1
10967411|NCT00519376|12140974|FG006|COMPLETED|Washout Period 3||1
10967412|NCT00519376|12140975|FG007|COMPLETED|Washout Period 3||1
10967413|NCT00519376|12140976|FG008|COMPLETED|Washout Period 3||1
10967414|NCT00519376|12140977|FG009|COMPLETED|Washout Period 3||1
10967415|NCT00519376|12140978|FG010|COMPLETED|Washout Period 3||1
10967416|NCT00519376|12140979|FG011|COMPLETED|Washout Period 3||1
10967417|NCT00519376|12140980|FG012|COMPLETED|Washout Period 3||0
10967418|NCT00519376|12140981|FG013|COMPLETED|Washout Period 3||1
10967419|NCT00519376|12140982|FG014|COMPLETED|Washout Period 3||1
10967420|NCT00519376|12140983|FG015|COMPLETED|Washout Period 3||1
10967421|NCT00519376|12140968|FG000|NOT COMPLETED|Washout Period 3||0
10967422|NCT00519376|12140969|FG001|NOT COMPLETED|Washout Period 3||0
10967423|NCT00519376|12140970|FG002|NOT COMPLETED|Washout Period 3||0
10967424|NCT00519376|12140971|FG003|NOT COMPLETED|Washout Period 3||0
10967425|NCT00519376|12140972|FG004|NOT COMPLETED|Washout Period 3||0
10967426|NCT00519376|12140973|FG005|NOT COMPLETED|Washout Period 3||0
10967427|NCT00519376|12140974|FG006|NOT COMPLETED|Washout Period 3||0
10967428|NCT00519376|12140975|FG007|NOT COMPLETED|Washout Period 3||0
10967429|NCT00519376|12140976|FG008|NOT COMPLETED|Washout Period 3||0
10967430|NCT00519376|12140977|FG009|NOT COMPLETED|Washout Period 3||0
10967431|NCT00519376|12140978|FG010|NOT COMPLETED|Washout Period 3||0
10967432|NCT00519376|12140979|FG011|NOT COMPLETED|Washout Period 3||0
10967433|NCT00519376|12140980|FG012|NOT COMPLETED|Washout Period 3||0
10967434|NCT00519376|12140981|FG013|NOT COMPLETED|Washout Period 3||0
10967435|NCT00519376|12140982|FG014|NOT COMPLETED|Washout Period 3||0
10967436|NCT00519376|12140983|FG015|NOT COMPLETED|Washout Period 3||0
10967437|NCT00519376|12140968|FG000|STARTED|Treatment Period 4||2
10967438|NCT00519376|12140969|FG001|STARTED|Treatment Period 4||2
10967439|NCT00519376|12140970|FG002|STARTED|Treatment Period 4||2
10967440|NCT00519376|12140971|FG003|STARTED|Treatment Period 4||2
10967441|NCT00519376|12140972|FG004|STARTED|Treatment Period 4||1
10967442|NCT00519376|12140973|FG005|STARTED|Treatment Period 4||1
10967443|NCT00519376|12140974|FG006|STARTED|Treatment Period 4||1
10967444|NCT00519376|12140975|FG007|STARTED|Treatment Period 4||1
10967445|NCT00519376|12140976|FG008|STARTED|Treatment Period 4||1
10967446|NCT00519376|12140977|FG009|STARTED|Treatment Period 4||1
10967447|NCT00519376|12140978|FG010|STARTED|Treatment Period 4||1
10967448|NCT00519376|12140979|FG011|STARTED|Treatment Period 4||1
10967449|NCT00519376|12140980|FG012|STARTED|Treatment Period 4||0
10967450|NCT00519376|12140981|FG013|STARTED|Treatment Period 4||1
10967451|NCT00519376|12140982|FG014|STARTED|Treatment Period 4||1
10967452|NCT00519376|12140983|FG015|STARTED|Treatment Period 4||1
10967453|NCT00519376|12140968|FG000|COMPLETED|Treatment Period 4||2
10967454|NCT00519376|12140969|FG001|COMPLETED|Treatment Period 4||2
10967455|NCT00519376|12140970|FG002|COMPLETED|Treatment Period 4||1
10967456|NCT00519376|12140971|FG003|COMPLETED|Treatment Period 4||2
10967457|NCT00519376|12140972|FG004|COMPLETED|Treatment Period 4||1
10967458|NCT00519376|12140973|FG005|COMPLETED|Treatment Period 4||1
10967459|NCT00519376|12140974|FG006|COMPLETED|Treatment Period 4||1
10967460|NCT00519376|12140975|FG007|COMPLETED|Treatment Period 4||1
10967461|NCT00519376|12140976|FG008|COMPLETED|Treatment Period 4||1
10967462|NCT00519376|12140977|FG009|COMPLETED|Treatment Period 4||1
10967463|NCT00519376|12140978|FG010|COMPLETED|Treatment Period 4||1
10967464|NCT00519376|12140979|FG011|COMPLETED|Treatment Period 4||1
10967465|NCT00519376|12140980|FG012|COMPLETED|Treatment Period 4||0
10967466|NCT00519376|12140981|FG013|COMPLETED|Treatment Period 4||1
10967467|NCT00519376|12140982|FG014|COMPLETED|Treatment Period 4||1
10967468|NCT00519376|12140983|FG015|COMPLETED|Treatment Period 4||1
10967469|NCT00519376|12140968|FG000|NOT COMPLETED|Treatment Period 4||0
10967470|NCT00519376|12140969|FG001|NOT COMPLETED|Treatment Period 4||0
10967471|NCT00519376|12140970|FG002|NOT COMPLETED|Treatment Period 4||1
10967472|NCT00519376|12140971|FG003|NOT COMPLETED|Treatment Period 4||0
10967473|NCT00519376|12140972|FG004|NOT COMPLETED|Treatment Period 4||0
10967474|NCT00519376|12140973|FG005|NOT COMPLETED|Treatment Period 4||0
10967475|NCT00519376|12140974|FG006|NOT COMPLETED|Treatment Period 4||0
10967476|NCT00519376|12140975|FG007|NOT COMPLETED|Treatment Period 4||0
10967477|NCT00519376|12140976|FG008|NOT COMPLETED|Treatment Period 4||0
10967478|NCT00519376|12140977|FG009|NOT COMPLETED|Treatment Period 4||0
10967479|NCT00519376|12140978|FG010|NOT COMPLETED|Treatment Period 4||0
10967480|NCT00519376|12140979|FG011|NOT COMPLETED|Treatment Period 4||0
10967481|NCT00519376|12140980|FG012|NOT COMPLETED|Treatment Period 4||0
10967482|NCT00519376|12140981|FG013|NOT COMPLETED|Treatment Period 4||0
10967483|NCT00519376|12140982|FG014|NOT COMPLETED|Treatment Period 4||0
10967484|NCT00519376|12140983|FG015|NOT COMPLETED|Treatment Period 4||0
10967485|NCT00519428|12140998|FG000|STARTED|Overall Study||78
10967486|NCT00519428|12140999|FG001|STARTED|Overall Study||84
10967487|NCT00519428|12141000|FG002|STARTED|Overall Study||83
10967488|NCT00519428|12140998|FG000|COMPLETED|Overall Study||57
10967489|NCT00519428|12140999|FG001|COMPLETED|Overall Study||69
10967490|NCT00519428|12141000|FG002|COMPLETED|Overall Study||58
10967491|NCT00519428|12140998|FG000|NOT COMPLETED|Overall Study||21
10967492|NCT00519428|12140999|FG001|NOT COMPLETED|Overall Study||15
10967493|NCT00519428|12141000|FG002|NOT COMPLETED|Overall Study||25
10967494|NCT00519532|12141011|FG000|STARTED|Overall Study||84
10967495|NCT00519532|12141011|FG000|COMPLETED|Overall Study||66
10967496|NCT00519532|12141011|FG000|NOT COMPLETED|Overall Study||18
10967497|NCT00519584|12141019|FG000|STARTED|Overall Study||54
10967498|NCT00519584|12141020|FG001|STARTED|Overall Study||54
10967499|NCT00519584|12141021|FG002|STARTED|Overall Study||54
10967500|NCT00519584|12141022|FG003|STARTED|Overall Study||56
10967501|NCT00519584|12141019|FG000|COMPLETED|Overall Study||54
10967502|NCT00519584|12141020|FG001|COMPLETED|Overall Study||54
10967503|NCT00519584|12141021|FG002|COMPLETED|Overall Study||54
10967504|NCT00519584|12141022|FG003|COMPLETED|Overall Study||56
10967505|NCT00519584|12141019|FG000|NOT COMPLETED|Overall Study||0
10967506|NCT00519584|12141020|FG001|NOT COMPLETED|Overall Study||0
10967507|NCT00519584|12141021|FG002|NOT COMPLETED|Overall Study||0
10967508|NCT00519584|12141022|FG003|NOT COMPLETED|Overall Study||0
10967509|NCT00519623|12141032|FG000|STARTED|Overall Study||9
10967510|NCT00519623|12141032|FG000|COMPLETED|Overall Study||8
10967511|NCT00519623|12141032|FG000|NOT COMPLETED|Overall Study||1
10967512|NCT00519636|12141040|FG000|STARTED|Treatment Period 1||91
10967513|NCT00519636|12141041|FG001|STARTED|Treatment Period 1||86
10967514|NCT00519636|12141042|FG002|STARTED|Treatment Period 1||90
10967515|NCT00519636|12141043|FG003|STARTED|Treatment Period 1||93
10967516|NCT00519636|12141040|FG000|COMPLETED|Treatment Period 1||89
10967517|NCT00519636|12141041|FG001|COMPLETED|Treatment Period 1||86
10967518|NCT00519636|12141042|FG002|COMPLETED|Treatment Period 1||89
10967519|NCT00519636|12141043|FG003|COMPLETED|Treatment Period 1||93
10967520|NCT00519636|12141040|FG000|NOT COMPLETED|Treatment Period 1||2
10967521|NCT00519636|12141041|FG001|NOT COMPLETED|Treatment Period 1||0
10967522|NCT00519636|12141042|FG002|NOT COMPLETED|Treatment Period 1||1
10967523|NCT00519636|12141043|FG003|NOT COMPLETED|Treatment Period 1||0
10967524|NCT00519636|12141040|FG000|STARTED|Washout Period||89
10967525|NCT00519636|12141041|FG001|STARTED|Washout Period||86
10967526|NCT00519636|12141042|FG002|STARTED|Washout Period||89
10967527|NCT00519636|12141043|FG003|STARTED|Washout Period||93
10967528|NCT00519636|12141040|FG000|COMPLETED|Washout Period||69
10967529|NCT00519636|12141041|FG001|COMPLETED|Washout Period||72
10967530|NCT00519636|12141042|FG002|COMPLETED|Washout Period||75
10967531|NCT00519636|12141043|FG003|COMPLETED|Washout Period||88
10967532|NCT00519636|12141040|FG000|NOT COMPLETED|Washout Period||20
10967533|NCT00519636|12141041|FG001|NOT COMPLETED|Washout Period||14
10967534|NCT00519636|12141042|FG002|NOT COMPLETED|Washout Period||14
10967535|NCT00519636|12141043|FG003|NOT COMPLETED|Washout Period||5
10967536|NCT00519636|12141040|FG000|STARTED|Treatment Period 2||69
10967537|NCT00519636|12141041|FG001|STARTED|Treatment Period 2||72
10967538|NCT00519636|12141042|FG002|STARTED|Treatment Period 2||75
10967539|NCT00519636|12141043|FG003|STARTED|Treatment Period 2||88
10967540|NCT00519636|12141040|FG000|COMPLETED|Treatment Period 2||69
10967541|NCT00519636|12141041|FG001|COMPLETED|Treatment Period 2||71
10967542|NCT00519636|12141042|FG002|COMPLETED|Treatment Period 2||74
10967543|NCT00519636|12141043|FG003|COMPLETED|Treatment Period 2||86
10967544|NCT00519636|12141040|FG000|NOT COMPLETED|Treatment Period 2||0
10967545|NCT00519636|12141041|FG001|NOT COMPLETED|Treatment Period 2||1
10967546|NCT00519636|12141042|FG002|NOT COMPLETED|Treatment Period 2||1
10967547|NCT00519636|12141043|FG003|NOT COMPLETED|Treatment Period 2||2
10967548|NCT00519636|12141040|FG000|STARTED|Post Study Period||69
10967549|NCT00519636|12141041|FG001|STARTED|Post Study Period||71
10967550|NCT00519636|12141042|FG002|STARTED|Post Study Period||74
10967551|NCT00519636|12141043|FG003|STARTED|Post Study Period||86
10967552|NCT00519636|12141040|FG000|COMPLETED|Post Study Period||69
10967553|NCT00519636|12141041|FG001|COMPLETED|Post Study Period||71
10967554|NCT00519636|12141042|FG002|COMPLETED|Post Study Period||74
10967555|NCT00519636|12141043|FG003|COMPLETED|Post Study Period||85
10967556|NCT00519636|12141040|FG000|NOT COMPLETED|Post Study Period||0
10967557|NCT00519636|12141041|FG001|NOT COMPLETED|Post Study Period||0
10967558|NCT00519636|12141042|FG002|NOT COMPLETED|Post Study Period||0
10967559|NCT00519636|12141043|FG003|NOT COMPLETED|Post Study Period||1
10967560|NCT00519649|12141057|FG000|STARTED|Overall Study||300
10967561|NCT00519649|12141057|FG000|COMPLETED|Overall Study||299
10967562|NCT00519649|12141057|FG000|NOT COMPLETED|Overall Study||1
10967563|NCT00519779|12141063|FG000|STARTED|Overall Study||34
10967564|NCT00519779|12141064|FG001|STARTED|Overall Study||34
10967565|NCT00519779|12141063|FG000|COMPLETED|Overall Study||34
10967566|NCT00519779|12141064|FG001|COMPLETED|Overall Study||33
10967567|NCT00519779|12141063|FG000|NOT COMPLETED|Overall Study||0
10967568|NCT00519779|12141064|FG001|NOT COMPLETED|Overall Study||1
10967569|NCT00519831|12141070|FG000|STARTED|Overall Study||16
10967570|NCT00519831|12141070|FG000|COMPLETED|Overall Study||13
10967571|NCT00519831|12141070|FG000|NOT COMPLETED|Overall Study||3
10967572|NCT00519896|12141074|FG000|STARTED|Overall Study||35
10967573|NCT00519896|12141074|FG000|COMPLETED|Overall Study||33
10967574|NCT00519896|12141074|FG000|NOT COMPLETED|Overall Study||2
10967575|NCT00520013|12141081|FG000|STARTED|Overall Study||23
10967576|NCT00520013|12141082|FG001|STARTED|Overall Study||25
10967577|NCT00520013|12141083|FG002|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
10967578|NCT00520013|12141081|FG000|Treated|Overall Study||23
10967579|NCT00520013|12141082|FG001|Treated|Overall Study||25
10967580|NCT00520013|12141083|FG002|Treated|Overall Study||11
10967581|NCT00520013|12141081|FG000|COMPLETED|Overall Study||11
10967582|NCT00520013|12141082|FG001|COMPLETED|Overall Study||10
10967583|NCT00520013|12141083|FG002|COMPLETED|Overall Study||0
10967584|NCT00520013|12141081|FG000|NOT COMPLETED|Overall Study||12
10967585|NCT00520013|12141082|FG001|NOT COMPLETED|Overall Study||15
10967586|NCT00520013|12141083|FG002|NOT COMPLETED|Overall Study||11
10967587|NCT00520039|12141091|FG000|STARTED|Overall Study||28
10967588|NCT00520039|12141092|FG001|STARTED|Overall Study||24
10967589|NCT00520039|12141091|FG000|COMPLETED|Overall Study||21
10967590|NCT00520039|12141092|FG001|COMPLETED|Overall Study||19
10967591|NCT00520039|12141091|FG000|NOT COMPLETED|Overall Study||7
10967592|NCT00520039|12141092|FG001|NOT COMPLETED|Overall Study||5
10967593|NCT00520130|12141102|FG000|STARTED|Overall Study||44
10967594|NCT00520130|12141103|FG001|STARTED|Overall Study||45
10967595|NCT00520130|12141102|FG000|COMPLETED|Overall Study||39
10967596|NCT00520130|12141103|FG001|COMPLETED|Overall Study||44
10967597|NCT00520130|12141102|FG000|NOT COMPLETED|Overall Study||5
10967598|NCT00520130|12141103|FG001|NOT COMPLETED|Overall Study||1
10967599|NCT00520234|12141115|FG000|STARTED|Overall Study||118
10967600|NCT00520234|12141116|FG001|STARTED|Overall Study||104
10967601|NCT00520234|12141115|FG000|COMPLETED|Overall Study||117
10967602|NCT00520234|12141116|FG001|COMPLETED|Overall Study||102
10967603|NCT00520234|12141115|FG000|NOT COMPLETED|Overall Study||1
10967604|NCT00520234|12141116|FG001|NOT COMPLETED|Overall Study||2
10967605|NCT00520286|12141125|FG000|STARTED|Overall Study||142
10967606|NCT00520286|12141126|FG001|STARTED|Overall Study||68
10967607|NCT00520286|12141125|FG000|COMPLETED|Overall Study||76
10967608|NCT00520286|12141126|FG001|COMPLETED|Overall Study||36
10967609|NCT00520286|12141125|FG000|NOT COMPLETED|Overall Study||66
10967610|NCT00520286|12141126|FG001|NOT COMPLETED|Overall Study||32
10967611|NCT00520299|12141135|FG000|STARTED|Overall Study||6
10967612|NCT00520299|12141136|FG001|STARTED|Overall Study||6
10967613|NCT00520299|12141137|FG002|STARTED|Overall Study||19
10967614|NCT00520299|12141135|FG000|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
10967615|NCT00520299|12141136|FG001|COMPLETED|Overall Study||3
10967616|NCT00520299|12141137|FG002|COMPLETED|Overall Study||13
10967617|NCT00520299|12141135|FG000|NOT COMPLETED|Overall Study||0
10967618|NCT00520299|12141136|FG001|NOT COMPLETED|Overall Study||3
10967619|NCT00520299|12141137|FG002|NOT COMPLETED|Overall Study||6
10967620|NCT00520351|12141147|FG000|STARTED|First Intervention|Start date is Sep.06, 2007|15
10967621|NCT00520351|12141148|FG001|STARTED|First Intervention|Start date is Sep.06, 2007|15
10967622|NCT00520351|12141147|FG000|COMPLETED|First Intervention|End date is Feb.25, 2008|14
10967623|NCT00520351|12141148|FG001|COMPLETED|First Intervention|End date is Feb.25, 2008|14
10967624|NCT00520351|12141147|FG000|NOT COMPLETED|First Intervention||1
10967625|NCT00520351|12141148|FG001|NOT COMPLETED|First Intervention||1
10967626|NCT00520351|12141147|FG000|STARTED|Second Intervention||14
10967627|NCT00520351|12141148|FG001|STARTED|Second Intervention||14
10967628|NCT00520351|12141147|FG000|COMPLETED|Second Intervention||14
10967629|NCT00520351|12141148|FG001|COMPLETED|Second Intervention||14
10967630|NCT00520351|12141147|FG000|NOT COMPLETED|Second Intervention||0
10967631|NCT00520351|12141148|FG001|NOT COMPLETED|Second Intervention||0
10967632|NCT00520403|12141154|FG000|STARTED|Bevacizumab + IFN/Vinblastine||25
10967633|NCT00520403|12141154|FG000|COMPLETED|Bevacizumab + IFN/Vinblastine||7
10967634|NCT00520403|12141154|FG000|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
10967635|NCT00520403|12141154|FG000|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
10967636|NCT00520403|12141154|FG000|COMPLETED|Bevacizumab Monotherapy||0
10967637|NCT00520403|12141154|FG000|NOT COMPLETED|Bevacizumab Monotherapy||2
10967638|NCT00520468|12141158|FG000|STARTED|Overall Study||14
10967639|NCT00520468|12141158|FG000|COMPLETED|Overall Study||14
10967640|NCT00520468|12141158|FG000|NOT COMPLETED|Overall Study||0
10967641|NCT00520481|12141164|FG000|STARTED|Overall Study||31
10967642|NCT00520481|12141165|FG001|STARTED|Overall Study||10
10967643|NCT00520481|12141164|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
10967644|NCT00520481|12141165|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
10967645|NCT00520481|12141164|FG000|COMPLETED|Overall Study||24
10967646|NCT00520481|12141165|FG001|COMPLETED|Overall Study||9
10967647|NCT00520481|12141164|FG000|NOT COMPLETED|Overall Study||7
10967648|NCT00520481|12141165|FG001|NOT COMPLETED|Overall Study||1
10967649|NCT00520494|12141173|FG000|STARTED|Overall Study||18
10967650|NCT00520494|12141173|FG000|COMPLETED|Overall Study||17
10967651|NCT00520494|12141173|FG000|NOT COMPLETED|Overall Study||1
10967652|NCT00520533|12141177|FG000|STARTED|Overall Study||8
10967653|NCT00520533|12141177|FG000|COMPLETED|Overall Study||4
10967654|NCT00520533|12141177|FG000|NOT COMPLETED|Overall Study||4
10967655|NCT00520546|12141182|FG000|STARTED|Overall Study||44
10967656|NCT00520546|12141182|FG000|COMPLETED|Overall Study||38
10967657|NCT00520546|12141182|FG000|NOT COMPLETED|Overall Study||6
10967658|NCT00520572|12141197|FG000|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
10967659|NCT00520572|12141198|FG001|STARTED|Overall Study|Participants randomised.|64
10967660|NCT00520572|12141199|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
10967661|NCT00520572|12141200|FG003|STARTED|Overall Study|Participants randomised.|64
10967662|NCT00520572|12141201|FG004|STARTED|Overall Study|Participants randomised.|65
10967663|NCT00520572|12141202|FG005|STARTED|Overall Study|Participants randomised.|64
10967664|NCT00520572|12141197|FG000|COMPLETED|Overall Study|Participants completed the study.|52
10967665|NCT00520572|12141198|FG001|COMPLETED|Overall Study|Participants completed the study.|50
10967666|NCT00520572|12141199|FG002|COMPLETED|Overall Study|Participants completed the study.|49
10967667|NCT00520572|12141200|FG003|COMPLETED|Overall Study|Participants completed the study.|50
10967668|NCT00520572|12141201|FG004|COMPLETED|Overall Study|Participants completed the study.|53
10967669|NCT00520572|12141202|FG005|COMPLETED|Overall Study|Participants completed the study.|62
10967670|NCT00520572|12141197|FG000|NOT COMPLETED|Overall Study||12
10967671|NCT00520572|12141198|FG001|NOT COMPLETED|Overall Study||14
10967672|NCT00520572|12141199|FG002|NOT COMPLETED|Overall Study||15
10967673|NCT00520572|12141200|FG003|NOT COMPLETED|Overall Study||14
10967674|NCT00520572|12141201|FG004|NOT COMPLETED|Overall Study||12
10967675|NCT00520572|12141202|FG005|NOT COMPLETED|Overall Study||2
10967676|NCT00520676|12141218|FG000|STARTED|Overall Study||128
10967677|NCT00520676|12141219|FG001|STARTED|Overall Study||132
10967678|NCT00520676|12141218|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118
10967679|NCT00520676|12141219|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127
10967680|NCT00520676|12141218|FG000|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
10967681|NCT00520676|12141219|FG001|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
10967682|NCT00520676|12141218|FG000|COMPLETED|Overall Study||27
10967683|NCT00520676|12141219|FG001|COMPLETED|Overall Study||29
10967684|NCT00520676|12141218|FG000|NOT COMPLETED|Overall Study||101
10967685|NCT00520676|12141219|FG001|NOT COMPLETED|Overall Study||103
10967686|NCT00520741|12141227|FG000|STARTED|Overall Study||106
10967687|NCT00520741|12141228|FG001|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
10967688|NCT00520741|12141227|FG000|COMPLETED|Overall Study||69
10967689|NCT00520741|12141228|FG001|COMPLETED|Overall Study||194
10967690|NCT00520741|12141227|FG000|NOT COMPLETED|Overall Study||37
10967691|NCT00520741|12141228|FG001|NOT COMPLETED|Overall Study||125
10967692|NCT00520845|12141236|FG000|STARTED|Overall Study||23
10967693|NCT00520845|12141236|FG000|COMPLETED|Overall Study||1
10967694|NCT00520845|12141236|FG000|NOT COMPLETED|Overall Study||22
10967695|NCT00520884|12141242|FG000|STARTED|Overall Study||3
10967696|NCT00520884|12141243|FG001|STARTED|Overall Study||2
10967697|NCT00520884|12141244|FG002|STARTED|Overall Study||2
10967698|NCT00520884|12141245|FG003|STARTED|Overall Study||3
10967699|NCT00520884|12141242|FG000|COMPLETED|Overall Study||3
10967700|NCT00520884|12141243|FG001|COMPLETED|Overall Study||2
10967701|NCT00520884|12141244|FG002|COMPLETED|Overall Study||2
10967702|NCT00520884|12141245|FG003|COMPLETED|Overall Study||3
10967703|NCT00520884|12141242|FG000|NOT COMPLETED|Overall Study||0
10967704|NCT00520884|12141243|FG001|NOT COMPLETED|Overall Study||0
10967705|NCT00520884|12141244|FG002|NOT COMPLETED|Overall Study||0
10967706|NCT00520884|12141245|FG003|NOT COMPLETED|Overall Study||0
10967707|NCT00520910|12141254|FG000|STARTED|Overall Study||5
10967708|NCT00520910|12141255|FG001|STARTED|Overall Study||5
10967709|NCT00520910|12141254|FG000|COMPLETED|Overall Study||5
10967710|NCT00520910|12141255|FG001|COMPLETED|Overall Study||5
10967711|NCT00520910|12141254|FG000|NOT COMPLETED|Overall Study||0
10967712|NCT00520910|12141255|FG001|NOT COMPLETED|Overall Study||0
10967713|NCT00520936|12141269|FG000|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
10967714|NCT00520936|12141270|FG001|STARTED|Overall Study||11
10967715|NCT00520936|12141271|FG002|STARTED|Overall Study||9
10967716|NCT00520936|12141272|FG003|STARTED|Overall Study||5
10967717|NCT00520936|12141273|FG004|STARTED|Overall Study||6
10967718|NCT00520936|12141274|FG005|STARTED|Overall Study||10
10967719|NCT00520936|12141275|FG006|STARTED|Overall Study||11
10967720|NCT00520936|12141276|FG007|STARTED|Overall Study||10
10967721|NCT00520936|12141269|FG000|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
10967722|NCT00520936|12141270|FG001|COMPLETED|Overall Study||7
10967723|NCT00520936|12141271|FG002|COMPLETED|Overall Study||7
10967724|NCT00520936|12141272|FG003|COMPLETED|Overall Study||5
10967725|NCT00520936|12141273|FG004|COMPLETED|Overall Study||5
10967726|NCT00520936|12141274|FG005|COMPLETED|Overall Study||10
10967727|NCT00520936|12141275|FG006|COMPLETED|Overall Study||7
10967728|NCT00520936|12141276|FG007|COMPLETED|Overall Study||9
10967729|NCT00520936|12141269|FG000|NOT COMPLETED|Overall Study||0
10967730|NCT00520936|12141270|FG001|NOT COMPLETED|Overall Study||4
10967731|NCT00520936|12141271|FG002|NOT COMPLETED|Overall Study||2
10967732|NCT00520936|12141272|FG003|NOT COMPLETED|Overall Study||0
10967733|NCT00520936|12141273|FG004|NOT COMPLETED|Overall Study||1
10967734|NCT00520936|12141274|FG005|NOT COMPLETED|Overall Study||0
10967735|NCT00520936|12141275|FG006|NOT COMPLETED|Overall Study||4
10967736|NCT00520936|12141276|FG007|NOT COMPLETED|Overall Study||1
10967737|NCT00520975|12141289|FG000|STARTED|Overall Study||48
10967738|NCT00520975|12141290|FG001|STARTED|Overall Study||48
10967739|NCT00520975|12141289|FG000|Treated and Reported Adverse Events Data|Overall Study||47
10967740|NCT00520975|12141290|FG001|Treated and Reported Adverse Events Data|Overall Study||45
10967741|NCT00520975|12141289|FG000|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
10967742|NCT00520975|12141290|FG001|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
10967743|NCT00520975|12141289|FG000|NOT COMPLETED|Overall Study||48
10967744|NCT00520975|12141290|FG001|NOT COMPLETED|Overall Study||48
10967745|NCT00521001|12141296|FG000|STARTED|Overall Study||49
10967746|NCT00521001|12141296|FG000|COMPLETED|Overall Study||48
10967747|NCT00521001|12141296|FG000|NOT COMPLETED|Overall Study||1
10967748|NCT00521014|12141300|FG000|STARTED|Overall Study||14
10967749|NCT00521014|12141300|FG000|COMPLETED|Overall Study||13
10967750|NCT00521014|12141300|FG000|NOT COMPLETED|Overall Study||1
10967751|NCT00521053|12141304|FG000|STARTED|Treatment Phase||80
10967752|NCT00521053|12141304|FG000|Received 1 Cycle of PV-10|Treatment Phase||35
10967753|NCT00521053|12141304|FG000|Received 2 Cycles of PV-10|Treatment Phase||26
10967754|NCT00521053|12141304|FG000|Received 3 Cycles of PV-10|Treatment Phase||16
10967755|NCT00521053|12141304|FG000|Received 4 Cycles of PV-10|Treatment Phase||3
10967756|NCT00521053|12141304|FG000|COMPLETED|Treatment Phase||80
10967757|NCT00521053|12141304|FG000|NOT COMPLETED|Treatment Phase||0
10967758|NCT00521053|12141304|FG000|STARTED|Observation Phase||80
10967759|NCT00521053|12141304|FG000|COMPLETED|Observation Phase||12
10967760|NCT00521053|12141304|FG000|NOT COMPLETED|Observation Phase||68
10967761|NCT00521079|12141313|FG000|STARTED|Overall Study||192
10967762|NCT00521079|12141314|FG001|STARTED|Overall Study||102
10967763|NCT00521079|12141313|FG000|Surgical Roll-In|Overall Study||9
10967764|NCT00521079|12141314|FG001|Surgical Roll-In|Overall Study||5
10967765|NCT00521079|12141313|FG000|COMPLETED|Overall Study||178
10967766|NCT00521079|12141314|FG001|COMPLETED|Overall Study||97
10967767|NCT00521079|12141313|FG000|NOT COMPLETED|Overall Study||14
10967768|NCT00521079|12141314|FG001|NOT COMPLETED|Overall Study||5
10967769|NCT00521144|12141325|FG000|STARTED|Overall Study||6
10967770|NCT00521144|12141326|FG001|STARTED|Overall Study||5
10967771|NCT00521144|12141327|FG002|STARTED|Overall Study||3
10967772|NCT00521144|12141328|FG003|STARTED|Overall Study||1
10967773|NCT00521144|12141329|FG004|STARTED|Overall Study||7
10967774|NCT00521144|12141325|FG000|COMPLETED|Overall Study||2
10967775|NCT00521144|12141326|FG001|COMPLETED|Overall Study||2
10967776|NCT00521144|12141327|FG002|COMPLETED|Overall Study||1
10967777|NCT00521144|12141328|FG003|COMPLETED|Overall Study||0
10967778|NCT00521144|12141329|FG004|COMPLETED|Overall Study||0
10967779|NCT00521144|12141325|FG000|NOT COMPLETED|Overall Study||4
10967780|NCT00521144|12141326|FG001|NOT COMPLETED|Overall Study||3
10967781|NCT00521144|12141327|FG002|NOT COMPLETED|Overall Study||2
10967782|NCT00521144|12141328|FG003|NOT COMPLETED|Overall Study||1
10967783|NCT00521144|12141329|FG004|NOT COMPLETED|Overall Study||7
10967784|NCT00521339|12141341|FG000|STARTED|Treatment Phase||31
10967785|NCT00521339|12141342|FG001|STARTED|Treatment Phase||0
10967786|NCT00521339|12141343|FG002|STARTED|Treatment Phase||0
10967787|NCT00521339|12141341|FG000|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
10967788|NCT00521339|12141342|FG001|Received Apremilast|Treatment Phase||0
10967789|NCT00521339|12141343|FG002|Received Apremilast|Treatment Phase||0
10967790|NCT00521339|12141341|FG000|COMPLETED|Treatment Phase||19
10967791|NCT00521339|12141342|FG001|COMPLETED|Treatment Phase||0
10967792|NCT00521339|12141343|FG002|COMPLETED|Treatment Phase||0
10967793|NCT00521339|12141341|FG000|NOT COMPLETED|Treatment Phase||12
10967794|NCT00521339|12141342|FG001|NOT COMPLETED|Treatment Phase||0
10967795|NCT00521339|12141343|FG002|NOT COMPLETED|Treatment Phase||0
10967796|NCT00521339|12141341|FG000|STARTED|Treatment Extension Phase||0
10967797|NCT00521339|12141342|FG001|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
10967798|NCT00521339|12141343|FG002|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
10967799|NCT00521339|12141341|FG000|COMPLETED|Treatment Extension Phase||0
10967800|NCT00521339|12141342|FG001|COMPLETED|Treatment Extension Phase||4
10967801|NCT00521339|12141343|FG002|COMPLETED|Treatment Extension Phase||4
10967802|NCT00521339|12141341|FG000|NOT COMPLETED|Treatment Extension Phase||0
10967803|NCT00521339|12141342|FG001|NOT COMPLETED|Treatment Extension Phase||0
10967804|NCT00521339|12141343|FG002|NOT COMPLETED|Treatment Extension Phase||3
10967805|NCT00521339|12141341|FG000|STARTED|Observational Follow Up Phase||14
10967806|NCT00521339|12141342|FG001|STARTED|Observational Follow Up Phase||4
10967807|NCT00521339|12141343|FG002|STARTED|Observational Follow Up Phase||4
10967808|NCT00521339|12141341|FG000|COMPLETED|Observational Follow Up Phase||14
10967809|NCT00521339|12141342|FG001|COMPLETED|Observational Follow Up Phase||4
10967810|NCT00521339|12141343|FG002|COMPLETED|Observational Follow Up Phase||4
10967811|NCT00521339|12141341|FG000|NOT COMPLETED|Observational Follow Up Phase||0
10967812|NCT00521339|12141342|FG001|NOT COMPLETED|Observational Follow Up Phase||0
10967813|NCT00521339|12141343|FG002|NOT COMPLETED|Observational Follow Up Phase||0
10967814|NCT00521352|12141366|FG000|STARTED|Overall Study||12
10967815|NCT00521352|12141367|FG001|STARTED|Overall Study||13
10967816|NCT00521352|12141366|FG000|COMPLETED|Overall Study||11
10967817|NCT00521352|12141367|FG001|COMPLETED|Overall Study||10
10967818|NCT00521352|12141366|FG000|NOT COMPLETED|Overall Study||1
10967819|NCT00521352|12141367|FG001|NOT COMPLETED|Overall Study||3
10967820|NCT00521365|12141373|FG000|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
10967821|NCT00521365|12141373|FG000|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
10967822|NCT00521365|12141373|FG000|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
10967823|NCT00521365|12141373|FG000|Safety Analysis Set|Overall Study|All participants who received study treatment|88
10967824|NCT00521365|12141373|FG000|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
10967825|NCT00521365|12141373|FG000|NOT COMPLETED|Overall Study||20
10967826|NCT00521404|12141377|FG000|STARTED|Overall Study||62
10967827|NCT00521404|12141377|FG000|COMPLETED|Overall Study||0
10967828|NCT00521404|12141377|FG000|NOT COMPLETED|Overall Study||62
10967829|NCT00521456|12141383|FG000|STARTED|Overall Study||176
10967830|NCT00521456|12141384|FG001|STARTED|Overall Study||87
10967831|NCT00521456|12141383|FG000|COMPLETED|Overall Study||163
10967832|NCT00521456|12141384|FG001|COMPLETED|Overall Study||59
10967833|NCT00521456|12141383|FG000|NOT COMPLETED|Overall Study||13
10967834|NCT00521456|12141384|FG001|NOT COMPLETED|Overall Study||28
10967835|NCT00521586|12141392|FG000|STARTED|Initial Vaccination (Year 0)||554
10967836|NCT00521586|12141393|FG001|STARTED|Initial Vaccination (Year 0)||562
10967837|NCT00521586|12141392|FG000|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
10967838|NCT00521586|12141393|FG001|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
10967839|NCT00521586|12141392|FG000|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
10967840|NCT00521586|12141393|FG001|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
10967841|NCT00521586|12141392|FG000|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
10967842|NCT00521586|12141393|FG001|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
10967843|NCT00521586|12141392|FG000|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
10967844|NCT00521586|12141393|FG001|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
10967845|NCT00521586|12141392|FG000|NOT COMPLETED|Initial Vaccination (Year 0)||21
10967846|NCT00521586|12141393|FG001|NOT COMPLETED|Initial Vaccination (Year 0)||29
10967847|NCT00521586|12141392|FG000|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
10967848|NCT00521586|12141393|FG001|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
10967849|NCT00521586|12141392|FG000|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
10967850|NCT00521586|12141393|FG001|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
10967851|NCT00521586|12141392|FG000|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
10967852|NCT00521586|12141393|FG001|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
10967853|NCT00521586|12141392|FG000|STARTED|Revaccination With 13vPnC (Year 5)||364
10967854|NCT00521586|12141393|FG001|STARTED|Revaccination With 13vPnC (Year 5)||363
10967855|NCT00521586|12141392|FG000|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
10967856|NCT00521586|12141393|FG001|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
10967857|NCT00521586|12141392|FG000|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
10967858|NCT00521586|12141393|FG001|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
10967859|NCT00521586|12141392|FG000|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
10967860|NCT00521586|12141393|FG001|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
10967861|NCT00521586|12141392|FG000|COMPLETED|Revaccination With 13vPnC (Year 5)||361
10967862|NCT00521586|12141393|FG001|COMPLETED|Revaccination With 13vPnC (Year 5)||351
10967863|NCT00521586|12141392|FG000|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
10967864|NCT00521586|12141393|FG001|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
10967865|NCT00521976|12141411|FG000|STARTED|Overall Study||871
10967866|NCT00521976|12141411|FG000|COMPLETED|Overall Study||871
10967867|NCT00521976|12141411|FG000|NOT COMPLETED|Overall Study||0
10967868|NCT00521989|12141420|FG000|STARTED|Overall Study||56
10967869|NCT00521989|12141421|FG001|STARTED|Overall Study||54
10967870|NCT00521989|12141422|FG002|STARTED|Overall Study||57
10967871|NCT00521989|12141423|FG003|STARTED|Overall Study||54
10967872|NCT00521989|12141424|FG004|STARTED|Overall Study||58
10967873|NCT00521989|12141420|FG000|COMPLETED|Overall Study||36
10967874|NCT00521989|12141421|FG001|COMPLETED|Overall Study||37
10967875|NCT00521989|12141422|FG002|COMPLETED|Overall Study||41
10967876|NCT00521989|12141423|FG003|COMPLETED|Overall Study||42
10967877|NCT00521989|12141424|FG004|COMPLETED|Overall Study||35
10967878|NCT00521989|12141420|FG000|NOT COMPLETED|Overall Study||20
10967879|NCT00521989|12141421|FG001|NOT COMPLETED|Overall Study||17
10967880|NCT00521989|12141422|FG002|NOT COMPLETED|Overall Study||16
10967881|NCT00521989|12141423|FG003|NOT COMPLETED|Overall Study||12
10967882|NCT00521989|12141424|FG004|NOT COMPLETED|Overall Study||23
10967883|NCT00522041|12141438|FG000|STARTED|Overall Study||123
10967884|NCT00522041|12141439|FG001|STARTED|Overall Study||125
10967885|NCT00522041|12141438|FG000|Received Treatment|Overall Study||123
10967886|NCT00522041|12141439|FG001|Received Treatment|Overall Study||124
10967887|NCT00522041|12141438|FG000|COMPLETED|Overall Study||106
10967888|NCT00522041|12141439|FG001|COMPLETED|Overall Study||113
10967889|NCT00522041|12141438|FG000|NOT COMPLETED|Overall Study||17
10967890|NCT00522041|12141439|FG001|NOT COMPLETED|Overall Study||12
10967891|NCT00522171|12141448|FG000|STARTED|Overall Study||15
10967892|NCT00522171|12141449|FG001|STARTED|Overall Study||15
10967893|NCT00522171|12141448|FG000|COMPLETED|Overall Study||15
10967894|NCT00522171|12141449|FG001|COMPLETED|Overall Study||15
10967895|NCT00522171|12141448|FG000|NOT COMPLETED|Overall Study||0
10967896|NCT00522171|12141449|FG001|NOT COMPLETED|Overall Study||0
10967897|NCT00522275|12141455|FG000|STARTED|Overall Study||308
10967898|NCT00522275|12141455|FG000|COMPLETED|Overall Study||138
10967899|NCT00522275|12141455|FG000|NOT COMPLETED|Overall Study||170
10967900|NCT00522379|12141464|FG000|STARTED|Overall Study||101
10967901|NCT00522379|12141465|FG001|STARTED|Overall Study||107
10967902|NCT00522379|12141466|FG002|STARTED|Overall Study||104
10967903|NCT00522379|12141467|FG003|STARTED|Overall Study||94
10967904|NCT00522379|12141468|FG004|STARTED|Overall Study||108
10967905|NCT00522379|12141464|FG000|COMPLETED|Overall Study||79
10967906|NCT00522379|12141465|FG001|COMPLETED|Overall Study||84
10967907|NCT00522379|12141466|FG002|COMPLETED|Overall Study||82
10967908|NCT00522379|12141467|FG003|COMPLETED|Overall Study||80
10967909|NCT00522379|12141468|FG004|COMPLETED|Overall Study||81
10967910|NCT00522379|12141464|FG000|NOT COMPLETED|Overall Study||22
10967911|NCT00522379|12141465|FG001|NOT COMPLETED|Overall Study||23
10967912|NCT00522379|12141466|FG002|NOT COMPLETED|Overall Study||22
10967913|NCT00522379|12141467|FG003|NOT COMPLETED|Overall Study||14
10967914|NCT00522379|12141468|FG004|NOT COMPLETED|Overall Study||27
10967915|NCT00522392|12141482|FG000|STARTED|Overall Study||23
10967916|NCT00522392|12141483|FG001|STARTED|Overall Study||25
10967917|NCT00522392|12141482|FG000|Pts w/ Measurable Disease at Baseline|Overall Study||16
10967918|NCT00522392|12141483|FG001|Pts w/ Measurable Disease at Baseline|Overall Study||16
10967919|NCT00522392|12141482|FG000|Pts w/ QOL Assessments Complete|Overall Study||12
10967920|NCT00522392|12141483|FG001|Pts w/ QOL Assessments Complete|Overall Study||8
10967921|NCT00522392|12141482|FG000|COMPLETED|Overall Study||15
10967922|NCT00522392|12141483|FG001|COMPLETED|Overall Study||12
10967923|NCT00522392|12141482|FG000|NOT COMPLETED|Overall Study||8
10967924|NCT00522392|12141483|FG001|NOT COMPLETED|Overall Study||13
10967925|NCT00522418|12141491|FG000|STARTED|Overall Study||59
10967926|NCT00522418|12141492|FG001|STARTED|Overall Study||63
10967927|NCT00522418|12141491|FG000|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|54
10967928|NCT00522418|12141492|FG001|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|58
10967929|NCT00522418|12141491|FG000|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
10967930|NCT00522418|12141492|FG001|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
10967931|NCT00522418|12141491|FG000|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
10967932|NCT00522418|12141492|FG001|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
10967933|NCT00522418|12141491|FG000|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
10967934|NCT00522418|12141492|FG001|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
10967935|NCT00522418|12141491|FG000|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
10967936|NCT00522418|12141492|FG001|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
10967937|NCT00522418|12141491|FG000|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
10967938|NCT00522418|12141492|FG001|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
10967939|NCT00522418|12141491|FG000|COMPLETED|Overall Study|Completed 2-year follow-up|2
10967940|NCT00522418|12141492|FG001|COMPLETED|Overall Study|Completed 2-year follow-up|5
10967941|NCT00522418|12141491|FG000|NOT COMPLETED|Overall Study||57
10967942|NCT00522418|12141492|FG001|NOT COMPLETED|Overall Study||58
10967943|NCT00522431|12141500|FG000|STARTED|Overall Study||149
10967944|NCT00522431|12141500|FG000|COMPLETED|Overall Study||138
10967945|NCT00522431|12141500|FG000|NOT COMPLETED|Overall Study||11
10967946|NCT00522548|12141506|FG000|STARTED|Overall Study||18
10967947|NCT00522548|12141507|FG001|STARTED|Overall Study||19
10967948|NCT00522548|12141506|FG000|Consented to Pharmacokinetic Study|Overall Study||11
10967949|NCT00522548|12141507|FG001|Consented to Pharmacokinetic Study|Overall Study||10
10967950|NCT00522548|12141506|FG000|Completed 0/2 PK Visits|Overall Study||3
10967951|NCT00522548|12141507|FG001|Completed 0/2 PK Visits|Overall Study||4
10967952|NCT00522548|12141506|FG000|Completed 1/2 PK Visits|Overall Study||1
10967953|NCT00522548|12141507|FG001|Completed 1/2 PK Visits|Overall Study||1
10967954|NCT00522548|12141506|FG000|Completed 2/2 PK Visits|Overall Study||7
10967955|NCT00522548|12141507|FG001|Completed 2/2 PK Visits|Overall Study||5
10967956|NCT00522548|12141506|FG000|COMPLETED|Overall Study||16
10967957|NCT00522548|12141507|FG001|COMPLETED|Overall Study||15
10967958|NCT00522548|12141506|FG000|NOT COMPLETED|Overall Study||2
10967959|NCT00522548|12141507|FG001|NOT COMPLETED|Overall Study||4
10967960|NCT00522626|12141513|FG000|STARTED|Overall Study||19
10967961|NCT00522626|12141513|FG000|COMPLETED|Overall Study||12
10967962|NCT00522626|12141513|FG000|NOT COMPLETED|Overall Study||7
10967963|NCT00522795|12141517|FG000|STARTED|Overall Study||40
10967964|NCT00522795|12141517|FG000|COMPLETED|Overall Study||40
10967965|NCT00522795|12141517|FG000|NOT COMPLETED|Overall Study||0
10967966|NCT00522873|12141523|FG000|STARTED|Overall Study||490
10967967|NCT00522873|12141524|FG001|STARTED|Overall Study||172
10967968|NCT00522873|12141523|FG000|Received Treatment|Overall Study||489
10967969|NCT00522873|12141524|FG001|Received Treatment|Overall Study||172
10967970|NCT00522873|12141523|FG000|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
10967971|NCT00522873|12141524|FG001|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
10967972|NCT00522873|12141523|FG000|NOT COMPLETED|Overall Study||96
10967973|NCT00522873|12141524|FG001|NOT COMPLETED|Overall Study||44
10967974|NCT00522925|12141533|FG000|STARTED|Overall Study||36
10967975|NCT00522925|12141534|FG001|STARTED|Overall Study||39
10967976|NCT00522925|12141535|FG002|STARTED|Overall Study||38
10967977|NCT00522925|12141533|FG000|COMPLETED|Overall Study||28
10967978|NCT00522925|12141534|FG001|COMPLETED|Overall Study||38
10967979|NCT00522925|12141535|FG002|COMPLETED|Overall Study||36
10967980|NCT00522925|12141533|FG000|NOT COMPLETED|Overall Study||8
10967981|NCT00522925|12141534|FG001|NOT COMPLETED|Overall Study||1
10967982|NCT00522925|12141535|FG002|NOT COMPLETED|Overall Study||2
10967983|NCT00522951|12141543|FG000|STARTED|Period 1||86
10967984|NCT00522951|12141544|FG001|STARTED|Period 1||79
10967985|NCT00522951|12141543|FG000|Received Treatment|Period 1||86
10967986|NCT00522951|12141544|FG001|Received Treatment|Period 1||78
10967987|NCT00522951|12141543|FG000|COMPLETED|Period 1||86
10967988|NCT00522951|12141544|FG001|COMPLETED|Period 1||78
10967989|NCT00522951|12141543|FG000|NOT COMPLETED|Period 1||0
10967990|NCT00522951|12141544|FG001|NOT COMPLETED|Period 1||1
10967991|NCT00522951|12141543|FG000|STARTED|Washout Period||86
10967992|NCT00522951|12141544|FG001|STARTED|Washout Period||78
10967993|NCT00522951|12141543|FG000|COMPLETED|Washout Period||86
10967994|NCT00522951|12141544|FG001|COMPLETED|Washout Period||76
10967995|NCT00522951|12141543|FG000|NOT COMPLETED|Washout Period||0
10967996|NCT00522951|12141544|FG001|NOT COMPLETED|Washout Period||2
10967997|NCT00522951|12141543|FG000|STARTED|Period 2||86
10967998|NCT00522951|12141544|FG001|STARTED|Period 2||76
10967999|NCT00522951|12141543|FG000|Subjects Received Treatment|Period 2||84
10968000|NCT00522951|12141544|FG001|Subjects Received Treatment|Period 2||75
10968001|NCT00522951|12141543|FG000|COMPLETED|Period 2||84
10968002|NCT00522951|12141544|FG001|COMPLETED|Period 2||75
10968003|NCT00522951|12141543|FG000|NOT COMPLETED|Period 2||2
10968004|NCT00522951|12141544|FG001|NOT COMPLETED|Period 2||1
10968005|NCT00523237|12141554|FG000|STARTED|Overall Study||14
10968006|NCT00523237|12141554|FG000|COMPLETED|Overall Study||14
10968007|NCT00523237|12141554|FG000|NOT COMPLETED|Overall Study||0
10968008|NCT00523302|12141560|FG000|STARTED|Overall Study||10
10968009|NCT00523302|12141561|FG001|STARTED|Overall Study||10
10968010|NCT00523302|12141560|FG000|COMPLETED|Overall Study||10
10968011|NCT00523302|12141561|FG001|COMPLETED|Overall Study||10
10968012|NCT00523302|12141560|FG000|NOT COMPLETED|Overall Study||0
10968013|NCT00523302|12141561|FG001|NOT COMPLETED|Overall Study||0
10968014|NCT00523367|12141567|FG000|STARTED|Overall Study||25
10968015|NCT00523367|12141567|FG000|COMPLETED|Overall Study||2
10968016|NCT00523367|12141567|FG000|NOT COMPLETED|Overall Study||23
10968017|NCT00523419|12141571|FG000|STARTED|Overall Study||32
10968018|NCT00523419|12141571|FG000|COMPLETED|Overall Study||0
10968019|NCT00523419|12141571|FG000|NOT COMPLETED|Overall Study||32
10968020|NCT00523549|12141577|FG000|STARTED|Overall Study||114
10968021|NCT00523549|12141578|FG001|STARTED|Overall Study||115
10968022|NCT00523549|12141577|FG000|COMPLETED|Overall Study||95
10968023|NCT00523549|12141578|FG001|COMPLETED|Overall Study||99
10968024|NCT00523549|12141577|FG000|NOT COMPLETED|Overall Study||19
10968025|NCT00523549|12141578|FG001|NOT COMPLETED|Overall Study||16
10968026|NCT00523614|12141586|FG000|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
10968027|NCT00523614|12141587|FG001|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
10968028|NCT00523614|12141586|FG000|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
10968029|NCT00523614|12141587|FG001|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
10968030|NCT00523614|12141586|FG000|NOT COMPLETED|Overall Study||0
10968031|NCT00523614|12141587|FG001|NOT COMPLETED|Overall Study||0
10968032|NCT00523640|12141593|FG000|STARTED|Overall Study||30
10968033|NCT00523640|12141593|FG000|COMPLETED|Overall Study|1 patient died before starting treatment|29
10968034|NCT00523640|12141593|FG000|NOT COMPLETED|Overall Study||1
10968035|NCT00523705|12141599|FG000|STARTED|Overall Study||7
10968036|NCT00523705|12141600|FG001|STARTED|Overall Study||4
10968037|NCT00523705|12141599|FG000|COMPLETED|Overall Study||7
10968038|NCT00523705|12141600|FG001|COMPLETED|Overall Study|1 withdrew due to no time|3
10968039|NCT00523705|12141599|FG000|NOT COMPLETED|Overall Study||0
10968040|NCT00523705|12141600|FG001|NOT COMPLETED|Overall Study||1
10968041|NCT00523718|12141608|FG000|STARTED|Overall Study||20
10968042|NCT00523718|12141609|FG001|STARTED|Overall Study||18
10968043|NCT00523718|12141608|FG000|COMPLETED|Overall Study||17
10968044|NCT00523718|12141609|FG001|COMPLETED|Overall Study||18
10968045|NCT00523718|12141608|FG000|NOT COMPLETED|Overall Study||3
10968046|NCT00523718|12141609|FG001|NOT COMPLETED|Overall Study||0
10968047|NCT00523744|12141615|FG000|STARTED|Phase 1 - Amlodipine+Olmesartan||257
10968048|NCT00523744|12141615|FG000|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
10968049|NCT00523744|12141615|FG000|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
10968050|NCT00523744|12141615|FG000|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
10968051|NCT00523744|12141615|FG000|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
10968052|NCT00523744|12141615|FG000|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
10968053|NCT00523744|12141615|FG000|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
10968054|NCT00523744|12141615|FG000|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
10968055|NCT00523744|12141615|FG000|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
10968056|NCT00523848|12141622|FG000|STARTED|Overall Study||46
10968057|NCT00523848|12141622|FG000|Treated With Study Therapy|Overall Study||44
10968058|NCT00523848|12141622|FG000|COMPLETED|Overall Study||22
10968059|NCT00523848|12141622|FG000|NOT COMPLETED|Overall Study||24
10968060|NCT00523978|12141628|FG000|STARTED|Overall Study||171
10968061|NCT00523978|12141629|FG001|STARTED|Overall Study||87
10968062|NCT00523978|12141628|FG000|COMPLETED|Overall Study||162
10968063|NCT00523978|12141629|FG001|COMPLETED|Overall Study||79
10968064|NCT00523978|12141628|FG000|NOT COMPLETED|Overall Study||9
10968065|NCT00523978|12141629|FG001|NOT COMPLETED|Overall Study||8
10968066|NCT00523991|12141638|FG000|STARTED|Overall Study||219
10968067|NCT00523991|12141639|FG001|STARTED|Overall Study||238
10968068|NCT00523991|12141638|FG000|COMPLETED|Overall Study||198
10968069|NCT00523991|12141639|FG001|COMPLETED|Overall Study||211
10968070|NCT00523991|12141638|FG000|NOT COMPLETED|Overall Study||21
10968071|NCT00523991|12141639|FG001|NOT COMPLETED|Overall Study||27
10968072|NCT00524017|12141647|FG000|STARTED|Overall Study||13
10968073|NCT00524017|12141648|FG001|STARTED|Overall Study||6
10968074|NCT00524017|12141647|FG000|COMPLETED|Overall Study||13
10968075|NCT00524017|12141648|FG001|COMPLETED|Overall Study||5
10968076|NCT00524017|12141647|FG000|NOT COMPLETED|Overall Study||0
10968077|NCT00524017|12141648|FG001|NOT COMPLETED|Overall Study||1
10968078|NCT00524030|12141656|FG000|STARTED|Overall Study||32
10968079|NCT00524030|12141657|FG001|STARTED|Overall Study||129
10968080|NCT00524030|12141656|FG000|Completed Double-Blind Treatment Phase|Overall Study||15
10968081|NCT00524030|12141657|FG001|Completed Double-Blind Treatment Phase|Overall Study||70
10968082|NCT00524030|12141656|FG000|Completed Taper/Titration Phase|Overall Study||15
10968083|NCT00524030|12141657|FG001|Completed Taper/Titration Phase|Overall Study||70
10968084|NCT00524030|12141656|FG000|COMPLETED|Overall Study||15
10968085|NCT00524030|12141657|FG001|COMPLETED|Overall Study||70
10968086|NCT00524030|12141656|FG000|NOT COMPLETED|Overall Study||17
10968087|NCT00524030|12141657|FG001|NOT COMPLETED|Overall Study||59
10968088|NCT00524043|12141667|FG000|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
10968089|NCT00524043|12141668|FG001|STARTED|Overall Study||70
10968090|NCT00524043|12141669|FG002|STARTED|Overall Study||66
10968091|NCT00524043|12141667|FG000|COMPLETED|Overall Study||34
10968092|NCT00524043|12141668|FG001|COMPLETED|Overall Study||42
10968093|NCT00524043|12141669|FG002|COMPLETED|Overall Study||35
10968094|NCT00524043|12141667|FG000|NOT COMPLETED|Overall Study||30
10968095|NCT00524043|12141668|FG001|NOT COMPLETED|Overall Study||28
10968096|NCT00524043|12141669|FG002|NOT COMPLETED|Overall Study||31
10968097|NCT00524121|12141677|FG000|STARTED|Overall Study||22
10968098|NCT00524121|12141677|FG000|COMPLETED|Overall Study||3
10968099|NCT00524121|12141677|FG000|NOT COMPLETED|Overall Study||19
10968100|NCT00524173|12141694|FG000|STARTED|Overall Study||17
10968101|NCT00524173|12141695|FG001|STARTED|Overall Study||15
10968102|NCT00524173|12141694|FG000|COMPLETED|Overall Study||12
10968103|NCT00524173|12141695|FG001|COMPLETED|Overall Study||13
10968104|NCT00524173|12141694|FG000|NOT COMPLETED|Overall Study||5
10968105|NCT00524173|12141695|FG001|NOT COMPLETED|Overall Study||2
10968106|NCT00524225|12141701|FG000|STARTED|Overall Study||3
10968107|NCT00524225|12141701|FG000|COMPLETED|Overall Study||3
10968108|NCT00524225|12141701|FG000|NOT COMPLETED|Overall Study||0
10968109|NCT00524264|12141708|FG000|STARTED|Overall Study||164
10968110|NCT00524264|12141709|FG001|STARTED|Overall Study||84
10968111|NCT00524264|12141708|FG000|COMPLETED|Overall Study||144
10968112|NCT00524264|12141709|FG001|COMPLETED|Overall Study||57
10968113|NCT00524264|12141708|FG000|NOT COMPLETED|Overall Study||20
10968114|NCT00524264|12141709|FG001|NOT COMPLETED|Overall Study||27
10968115|NCT00524303|12141718|FG000|STARTED|Overall Study||33
10968116|NCT00524303|12141719|FG001|STARTED|Overall Study||34
10968117|NCT00524303|12141720|FG002|STARTED|Overall Study||33
10968118|NCT00524303|12141718|FG000|COMPLETED|Overall Study||21
10968119|NCT00524303|12141719|FG001|COMPLETED|Overall Study||24
10968120|NCT00524303|12141720|FG002|COMPLETED|Overall Study||15
10968121|NCT00524303|12141718|FG000|NOT COMPLETED|Overall Study||12
10968122|NCT00524303|12141719|FG001|NOT COMPLETED|Overall Study||10
10968123|NCT00524303|12141720|FG002|NOT COMPLETED|Overall Study||18
10968124|NCT00524316|12141731|FG000|STARTED|Overall Study||16
10968125|NCT00524316|12141731|FG000|COMPLETED|Overall Study||0
10968126|NCT00524316|12141731|FG000|NOT COMPLETED|Overall Study||16
10968127|NCT00524342|12141735|FG000|STARTED|Overall Study||7
10968128|NCT00524342|12141735|FG000|COMPLETED|Overall Study||7
10968129|NCT00524342|12141735|FG000|NOT COMPLETED|Overall Study||0
10968130|NCT00524368|12141741|FG000|STARTED|Overall Study||294
10968131|NCT00524368|12141742|FG001|STARTED|Overall Study||296
10968132|NCT00524368|12141741|FG000|COMPLETED|Overall Study||253
10968133|NCT00524368|12141742|FG001|COMPLETED|Overall Study||248
10968134|NCT00524368|12141741|FG000|NOT COMPLETED|Overall Study||41
10968135|NCT00524368|12141742|FG001|NOT COMPLETED|Overall Study||48
10968136|NCT00524420|12141750|FG000|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
10968137|NCT00524420|12141751|FG001|STARTED|Overall Study||11
10968138|NCT00524420|12141750|FG000|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
10968139|NCT00524420|12141751|FG001|COMPLETED|Overall Study||11
10968140|NCT00524420|12141750|FG000|NOT COMPLETED|Overall Study||1
10968141|NCT00524420|12141751|FG001|NOT COMPLETED|Overall Study||0
10968142|NCT00524472|12141761|FG000|STARTED|Overall Study||709
10968143|NCT00524472|12141762|FG001|STARTED|Overall Study||730
10968144|NCT00524472|12141761|FG000|COMPLETED|Overall Study||709
10968145|NCT00524472|12141762|FG001|COMPLETED|Overall Study||730
10968146|NCT00524472|12141761|FG000|NOT COMPLETED|Overall Study||0
10968147|NCT00524472|12141762|FG001|NOT COMPLETED|Overall Study||0
10968148|NCT00524537|12141768|FG000|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
10968149|NCT00524537|12141768|FG000|Discontinued|Overall Study|Discontinued from study|2811
10968150|NCT00524537|12141768|FG000|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
10968151|NCT00524537|12141768|FG000|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
10968152|NCT00524537|12141768|FG000|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
10968153|NCT00524537|12141768|FG000|NOT COMPLETED|Overall Study||2574
10968154|NCT00524576|12141774|FG000|STARTED|Overall Study||97
10968155|NCT00524576|12141775|FG001|STARTED|Overall Study||47
10968156|NCT00524576|12141774|FG000|COMPLETED|Overall Study||97
10968157|NCT00524576|12141775|FG001|COMPLETED|Overall Study||47
10968158|NCT00524576|12141774|FG000|NOT COMPLETED|Overall Study||0
10968159|NCT00524576|12141775|FG001|NOT COMPLETED|Overall Study||0
10968160|NCT00524589|12141781|FG000|STARTED|Overall Study||18
10968161|NCT00524589|12141781|FG000|COMPLETED|Overall Study||0
10968162|NCT00524589|12141781|FG000|NOT COMPLETED|Overall Study||18
10968163|NCT00524680|12141789|FG000|STARTED|Overall Study||37
10968164|NCT00524680|12141790|FG001|STARTED|Overall Study||35
10968165|NCT00524680|12141791|FG002|STARTED|Overall Study||36
10968166|NCT00524680|12141792|FG003|STARTED|Overall Study||40
10968167|NCT00524680|12141789|FG000|COMPLETED|Overall Study||34
10968168|NCT00524680|12141790|FG001|COMPLETED|Overall Study||34
10968169|NCT00524680|12141791|FG002|COMPLETED|Overall Study||33
10968170|NCT00524680|12141792|FG003|COMPLETED|Overall Study||34
10968171|NCT00524680|12141789|FG000|NOT COMPLETED|Overall Study||3
10968172|NCT00524680|12141790|FG001|NOT COMPLETED|Overall Study||1
10968173|NCT00524680|12141791|FG002|NOT COMPLETED|Overall Study||3
10968174|NCT00524680|12141792|FG003|NOT COMPLETED|Overall Study||6
10968175|NCT00524745|12141806|FG000|STARTED|Overall Study||229
10968176|NCT00524745|12141807|FG001|STARTED|Overall Study||206
10968177|NCT00524745|12141808|FG002|STARTED|Overall Study||241
10968178|NCT00524745|12141809|FG003|STARTED|Overall Study||227
10968179|NCT00524745|12141806|FG000|COMPLETED|Overall Study||195
10968180|NCT00524745|12141807|FG001|COMPLETED|Overall Study||193
10968181|NCT00524745|12141808|FG002|COMPLETED|Overall Study||212
10968182|NCT00524745|12141809|FG003|COMPLETED|Overall Study||205
10968183|NCT00524745|12141806|FG000|NOT COMPLETED|Overall Study||34
10968184|NCT00524745|12141807|FG001|NOT COMPLETED|Overall Study||13
10968185|NCT00524745|12141808|FG002|NOT COMPLETED|Overall Study||29
10968186|NCT00524745|12141809|FG003|NOT COMPLETED|Overall Study||22
10968187|NCT00524771|12141821|FG000|STARTED|Overall Study||17084
10968188|NCT00524771|12141822|FG001|STARTED|Overall Study||17016
10968189|NCT00524771|12141821|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
10968190|NCT00524771|12141822|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
10968191|NCT00524771|12141821|FG000|NOT COMPLETED|Overall Study||220
10968192|NCT00524771|12141822|FG001|NOT COMPLETED|Overall Study||585
10968193|NCT00524940|12141829|FG000|STARTED|Overall Study||124
10968194|NCT00524940|12141829|FG000|COMPLETED|Overall Study||124
10968195|NCT00524940|12141829|FG000|NOT COMPLETED|Overall Study||0
10968196|NCT00525031|12141835|FG000|STARTED|Overall Study||27
10968197|NCT00525031|12141836|FG001|STARTED|Overall Study||25
10968198|NCT00525031|12141835|FG000|COMPLETED|Overall Study||26
10968199|NCT00525031|12141836|FG001|COMPLETED|Overall Study||24
10968200|NCT00525031|12141835|FG000|NOT COMPLETED|Overall Study||1
10968201|NCT00525031|12141836|FG001|NOT COMPLETED|Overall Study||1
10968202|NCT00525044|12141845|FG000|STARTED|Overall Study||124
10968203|NCT00525044|12141846|FG001|STARTED|Overall Study||125
10968204|NCT00525044|12141845|FG000|COMPLETED|Overall Study||124
10968205|NCT00525044|12141846|FG001|COMPLETED|Overall Study||124
10968206|NCT00525044|12141845|FG000|NOT COMPLETED|Overall Study||0
10968207|NCT00525044|12141846|FG001|NOT COMPLETED|Overall Study||1
10968208|NCT00525057|12141854|FG000|STARTED|Overall Study||25
10968209|NCT00525057|12141855|FG001|STARTED|Overall Study||25
10968210|NCT00525057|12141854|FG000|COMPLETED|Overall Study||25
10968211|NCT00525057|12141855|FG001|COMPLETED|Overall Study||25
10968212|NCT00525057|12141854|FG000|NOT COMPLETED|Overall Study||0
10968213|NCT00525057|12141855|FG001|NOT COMPLETED|Overall Study||0
10968214|NCT00525135|12141861|FG000|STARTED|Overall Study||5
10968215|NCT00525135|12141861|FG000|COMPLETED|Overall Study||5
10968216|NCT00525135|12141861|FG000|NOT COMPLETED|Overall Study||0
10968217|NCT00525148|12141869|FG000|STARTED|Overall Study|entered and treated|23
10968218|NCT00525148|12141870|FG001|STARTED|Overall Study|entered and treated|38
10968219|NCT00525148|12141871|FG002|STARTED|Overall Study|entered and treated|7
10968220|NCT00525148|12141872|FG003|STARTED|Overall Study|entered and treated|61
10968221|NCT00525148|12141869|FG000|COMPLETED|Overall Study||0
10968222|NCT00525148|12141870|FG001|COMPLETED|Overall Study||0
10968223|NCT00525148|12141871|FG002|COMPLETED|Overall Study||0
10968224|NCT00525148|12141872|FG003|COMPLETED|Overall Study||0
10968225|NCT00525148|12141869|FG000|NOT COMPLETED|Overall Study||23
10968226|NCT00525148|12141870|FG001|NOT COMPLETED|Overall Study||38
10968227|NCT00525148|12141871|FG002|NOT COMPLETED|Overall Study||7
10968228|NCT00525148|12141872|FG003|NOT COMPLETED|Overall Study||61
10968229|NCT00525161|12141882|FG000|STARTED|Overall Study||11
10968230|NCT00525161|12141882|FG000|COMPLETED|Overall Study||10
10968231|NCT00525161|12141882|FG000|NOT COMPLETED|Overall Study||1
10968232|NCT00525174|12141888|FG000|STARTED|Overall Study||97
10968233|NCT00525174|12141889|FG001|STARTED|Overall Study||89
10968234|NCT00525174|12141888|FG000|COMPLETED|Overall Study||88
10968235|NCT00525174|12141889|FG001|COMPLETED|Overall Study||81
10968236|NCT00525174|12141888|FG000|NOT COMPLETED|Overall Study||9
10968237|NCT00525174|12141889|FG001|NOT COMPLETED|Overall Study||8
10968238|NCT00525265|12141897|FG000|STARTED|Overall Study||10
10968239|NCT00525265|12141898|FG001|STARTED|Overall Study||10
10968240|NCT00525265|12141897|FG000|COMPLETED|Overall Study||9
10968241|NCT00525265|12141898|FG001|COMPLETED|Overall Study||10
10968242|NCT00525265|12141897|FG000|NOT COMPLETED|Overall Study||1
10968243|NCT00525265|12141898|FG001|NOT COMPLETED|Overall Study||0
10968244|NCT00525421|12141906|FG000|STARTED|Overall Study|Enrollment started october 2007|10
10968245|NCT00525421|12141907|FG001|STARTED|Overall Study||10
10968246|NCT00525421|12141906|FG000|COMPLETED|Overall Study||10
10968247|NCT00525421|12141907|FG001|COMPLETED|Overall Study||10
10968248|NCT00525421|12141906|FG000|NOT COMPLETED|Overall Study||0
10968249|NCT00525421|12141907|FG001|NOT COMPLETED|Overall Study||0
10968250|NCT00525499|12141917|FG000|STARTED|Overall Study||47
10968251|NCT00525499|12141918|FG001|STARTED|Overall Study||46
10968252|NCT00525499|12141919|FG002|STARTED|Overall Study||47
10968253|NCT00525499|12141920|FG003|STARTED|Overall Study||46
10968254|NCT00525499|12141917|FG000|COMPLETED|Overall Study||40
10968255|NCT00525499|12141918|FG001|COMPLETED|Overall Study||39
10968256|NCT00525499|12141919|FG002|COMPLETED|Overall Study||40
10968257|NCT00525499|12141920|FG003|COMPLETED|Overall Study||39
10968258|NCT00525499|12141917|FG000|NOT COMPLETED|Overall Study||7
10968259|NCT00525499|12141918|FG001|NOT COMPLETED|Overall Study||7
10968260|NCT00525499|12141919|FG002|NOT COMPLETED|Overall Study||7
10968261|NCT00525499|12141920|FG003|NOT COMPLETED|Overall Study||7
10968262|NCT00525512|12141932|FG000|STARTED|Double-Blind Phase||259
10968263|NCT00525512|12141933|FG001|STARTED|Double-Blind Phase||260
10968264|NCT00525512|12141934|FG002|STARTED|Double-Blind Phase||0
10968265|NCT00525512|12141935|FG003|STARTED|Double-Blind Phase||0
10968266|NCT00525512|12141932|FG000|COMPLETED|Double-Blind Phase||163
10968267|NCT00525512|12141933|FG001|COMPLETED|Double-Blind Phase||194
10968268|NCT00525512|12141934|FG002|COMPLETED|Double-Blind Phase||0
10968269|NCT00525512|12141935|FG003|COMPLETED|Double-Blind Phase||0
10968270|NCT00525512|12141932|FG000|NOT COMPLETED|Double-Blind Phase||96
10968271|NCT00525512|12141933|FG001|NOT COMPLETED|Double-Blind Phase||66
10968272|NCT00525512|12141934|FG002|NOT COMPLETED|Double-Blind Phase||0
10968273|NCT00525512|12141935|FG003|NOT COMPLETED|Double-Blind Phase||0
10968274|NCT00525512|12141932|FG000|STARTED|Open-Label Phase||0
10968275|NCT00525512|12141933|FG001|STARTED|Open-Label Phase||0
10968276|NCT00525512|12141934|FG002|STARTED|Open-Label Phase||164
10968277|NCT00525512|12141935|FG003|STARTED|Open-Label Phase||194
10968278|NCT00525512|12141932|FG000|COMPLETED|Open-Label Phase||0
10968279|NCT00525512|12141933|FG001|COMPLETED|Open-Label Phase||0
10968280|NCT00525512|12141934|FG002|COMPLETED|Open-Label Phase||158
10968281|NCT00525512|12141935|FG003|COMPLETED|Open-Label Phase||189
10968282|NCT00525512|12141932|FG000|NOT COMPLETED|Open-Label Phase||0
10968283|NCT00525512|12141933|FG001|NOT COMPLETED|Open-Label Phase||0
10968284|NCT00525512|12141934|FG002|NOT COMPLETED|Open-Label Phase||6
10968285|NCT00525512|12141935|FG003|NOT COMPLETED|Open-Label Phase||5
10968286|NCT00525525|12141949|FG000|STARTED|Overall Study||59
10968287|NCT00525525|12141950|FG001|STARTED|Overall Study||15
10968288|NCT00525525|12141949|FG000|COMPLETED|Overall Study||59
10968289|NCT00525525|12141950|FG001|COMPLETED|Overall Study||15
10968290|NCT00525525|12141949|FG000|NOT COMPLETED|Overall Study||0
10968291|NCT00525525|12141950|FG001|NOT COMPLETED|Overall Study||0
10968292|NCT00525590|12141956|FG000|STARTED|Overall Study||59
10968293|NCT00525590|12141956|FG000|COMPLETED|Overall Study||14
10968294|NCT00525590|12141956|FG000|NOT COMPLETED|Overall Study||45
10968295|NCT00525603|12141960|FG000|STARTED|Overall Study||60
10968296|NCT00525603|12141960|FG000|COMPLETED|Overall Study||60
10968297|NCT00525603|12141960|FG000|NOT COMPLETED|Overall Study||0
10968298|NCT00525629|12141964|FG000|STARTED|First Intervention||20
10968299|NCT00525629|12141965|FG001|STARTED|First Intervention||20
10968300|NCT00525629|12141964|FG000|COMPLETED|First Intervention||15
10968301|NCT00525629|12141965|FG001|COMPLETED|First Intervention||15
10968302|NCT00525629|12141964|FG000|NOT COMPLETED|First Intervention||5
10968303|NCT00525629|12141965|FG001|NOT COMPLETED|First Intervention||5
10968304|NCT00525629|12141964|FG000|STARTED|Washout||15
10968305|NCT00525629|12141965|FG001|STARTED|Washout||15
10968306|NCT00525629|12141964|FG000|COMPLETED|Washout||15
10968307|NCT00525629|12141965|FG001|COMPLETED|Washout||15
10968308|NCT00525629|12141964|FG000|NOT COMPLETED|Washout||0
10968309|NCT00525629|12141965|FG001|NOT COMPLETED|Washout||0
10968310|NCT00525629|12141964|FG000|STARTED|Second Intervention||15
10968311|NCT00525629|12141965|FG001|STARTED|Second Intervention||15
10968312|NCT00525629|12141964|FG000|COMPLETED|Second Intervention||0
10968313|NCT00525629|12141965|FG001|COMPLETED|Second Intervention||0
10968314|NCT00525629|12141964|FG000|NOT COMPLETED|Second Intervention||15
10968315|NCT00525629|12141965|FG001|NOT COMPLETED|Second Intervention||15
10968316|NCT00525733|12141973|FG000|STARTED|Overall Study||14
10968317|NCT00525733|12141974|FG001|STARTED|Overall Study||26
10968318|NCT00525733|12141973|FG000|COMPLETED|Overall Study||11
10968319|NCT00525733|12141974|FG001|COMPLETED|Overall Study||23
10968320|NCT00525733|12141973|FG000|NOT COMPLETED|Overall Study||3
10968321|NCT00525733|12141974|FG001|NOT COMPLETED|Overall Study||3
10968322|NCT00525785|12141980|FG000|STARTED|Overall Study||58
10968323|NCT00525785|12141980|FG000|COMPLETED|Overall Study||55
10968324|NCT00525785|12141980|FG000|NOT COMPLETED|Overall Study||3
10968325|NCT00525798|12141986|FG000|STARTED|Overall Study||2334
10968326|NCT00525798|12141987|FG001|STARTED|Overall Study||2331
10968327|NCT00525798|12141986|FG000|COMPLETED|Overall Study||1578
10968328|NCT00525798|12141987|FG001|COMPLETED|Overall Study||1732
10968329|NCT00525798|12141986|FG000|NOT COMPLETED|Overall Study||756
10968330|NCT00525798|12141987|FG001|NOT COMPLETED|Overall Study||599
10968331|NCT00525824|12141997|FG000|STARTED|Overall Study|Randomized population|214
10968332|NCT00525824|12141998|FG001|STARTED|Overall Study|Randomized population|214
10968333|NCT00525824|12141999|FG002|STARTED|Overall Study|Randomized population|202
10968334|NCT00525824|12142000|FG003|STARTED|Overall Study|Randomized population|203
10968335|NCT00525824|12141997|FG000|COMPLETED|Overall Study||195
10968336|NCT00525824|12141998|FG001|COMPLETED|Overall Study||186
10968337|NCT00525824|12141999|FG002|COMPLETED|Overall Study||183
10968338|NCT00525824|12142000|FG003|COMPLETED|Overall Study||188
10968339|NCT00525824|12141997|FG000|NOT COMPLETED|Overall Study||19
10968340|NCT00525824|12141998|FG001|NOT COMPLETED|Overall Study||28
10968341|NCT00525824|12141999|FG002|NOT COMPLETED|Overall Study||19
10968342|NCT00525824|12142000|FG003|NOT COMPLETED|Overall Study||15
10968343|NCT00525837|12142014|FG000|STARTED|Overall Study||18
10968344|NCT00525837|12142014|FG000|COMPLETED|Overall Study||14
10968345|NCT00525837|12142014|FG000|NOT COMPLETED|Overall Study||4
10968346|NCT00525876|12142021|FG000|STARTED|Overall Study||16
10968347|NCT00525876|12142022|FG001|STARTED|Overall Study||20
10968348|NCT00525876|12142021|FG000|COMPLETED|Overall Study||16
10968349|NCT00525876|12142022|FG001|COMPLETED|Overall Study||20
10968350|NCT00525876|12142021|FG000|NOT COMPLETED|Overall Study||0
10968351|NCT00525876|12142022|FG001|NOT COMPLETED|Overall Study||0
10968352|NCT00525902|12142028|FG000|STARTED|Overall Study||31
10968353|NCT00525902|12142028|FG000|10 Weeks|Overall Study||30
10968354|NCT00525902|12142028|FG000|50 Weeks|Overall Study||12
10968355|NCT00525902|12142028|FG000|COMPLETED|Overall Study||30
10968356|NCT00525902|12142028|FG000|NOT COMPLETED|Overall Study||1
10968357|NCT00525915|12142034|FG000|STARTED|Overall Study||63
10968358|NCT00525915|12142035|FG001|STARTED|Overall Study||63
10968359|NCT00525915|12142034|FG000|COMPLETED|Overall Study|Participants who underwent surgery.|55
10968360|NCT00525915|12142035|FG001|COMPLETED|Overall Study||54
10968361|NCT00525915|12142034|FG000|NOT COMPLETED|Overall Study||8
10968362|NCT00525915|12142035|FG001|NOT COMPLETED|Overall Study||9
10968363|NCT00526058|12142043|FG000|STARTED|Period: First Intervention||9
10968364|NCT00526058|12142044|FG001|STARTED|Period: First Intervention||9
10968365|NCT00526058|12142043|FG000|COMPLETED|Period: First Intervention||9
10968366|NCT00526058|12142044|FG001|COMPLETED|Period: First Intervention||9
10968367|NCT00526058|12142043|FG000|NOT COMPLETED|Period: First Intervention||0
10968368|NCT00526058|12142044|FG001|NOT COMPLETED|Period: First Intervention||0
10968369|NCT00526058|12142043|FG000|STARTED|Period: Second Intervention||9
10968370|NCT00526058|12142044|FG001|STARTED|Period: Second Intervention||9
10968371|NCT00526058|12142043|FG000|COMPLETED|Period: Second Intervention||9
10968372|NCT00526058|12142044|FG001|COMPLETED|Period: Second Intervention||9
10968373|NCT00526058|12142043|FG000|NOT COMPLETED|Period: Second Intervention||0
10968374|NCT00526058|12142044|FG001|NOT COMPLETED|Period: Second Intervention||0
10968375|NCT00526071|12142050|FG000|STARTED|Overall Study||23
10968376|NCT00526071|12142050|FG000|Safety Population|Overall Study||23
10968377|NCT00526071|12142050|FG000|Pharmacodynamic (PD) Population|Overall Study||23
10968378|NCT00526071|12142050|FG000|Amenable Population; Men|Overall Study||11
10968379|NCT00526071|12142050|FG000|Amenable Population; Women|Overall Study||5
10968380|NCT00526071|12142050|FG000|Non-amenable Population; Men|Overall Study||3
10968381|NCT00526071|12142050|FG000|Non-amenable Population; Women|Overall Study||4
10968382|NCT00526071|12142050|FG000|COMPLETED|Overall Study||17
10968383|NCT00526071|12142050|FG000|NOT COMPLETED|Overall Study||6
10968384|NCT00526097|12142060|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
10968385|NCT00526097|12142061|FG001|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
10968386|NCT00526097|12142060|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
10968387|NCT00526097|12142061|FG001|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
10968388|NCT00526097|12142060|FG000|NOT COMPLETED|Overall Study||15
10968389|NCT00526097|12142061|FG001|NOT COMPLETED|Overall Study||56
10968390|NCT00526110|12142069|FG000|STARTED|Overall Study||53
10968391|NCT00526110|12142070|FG001|STARTED|Overall Study||45
10968392|NCT00526110|12142069|FG000|COMPLETED|Overall Study||51
10968393|NCT00526110|12142070|FG001|COMPLETED|Overall Study||4
10968394|NCT00526110|12142069|FG000|NOT COMPLETED|Overall Study||2
10968395|NCT00526110|12142070|FG001|NOT COMPLETED|Overall Study||41
10968396|NCT00526123|12142078|FG000|STARTED|Overall Study|Intent-to-Treat population|303
10968397|NCT00526123|12142079|FG001|STARTED|Overall Study|Intent-to-Treat population|296
10968398|NCT00526123|12142078|FG000|COMPLETED|Overall Study||39
10968399|NCT00526123|12142079|FG001|COMPLETED|Overall Study||50
10968400|NCT00526123|12142078|FG000|NOT COMPLETED|Overall Study||264
10968401|NCT00526123|12142079|FG001|NOT COMPLETED|Overall Study||246
10968402|NCT00526162|12142085|FG000|STARTED|Overall Study||83
10968403|NCT00526162|12142085|FG000|COMPLETED|Overall Study||80
10968404|NCT00526162|12142085|FG000|NOT COMPLETED|Overall Study||3
10968405|NCT00526188|12142093|FG000|STARTED|Overall Study||234
10968406|NCT00526188|12142093|FG000|COMPLETED|Overall Study||234
10968407|NCT00526188|12142093|FG000|NOT COMPLETED|Overall Study||0
10968408|NCT00526292|12142097|FG000|STARTED|Overall Study||6
10968409|NCT00526292|12142097|FG000|COMPLETED|Overall Study||6
10968410|NCT00526292|12142097|FG000|NOT COMPLETED|Overall Study||0
10968411|NCT00526474|12142103|FG000|STARTED|Overall Study||13224
10968412|NCT00526474|12142104|FG001|STARTED|Overall Study||13225
10968413|NCT00526474|12142103|FG000|Received Study Drug|Overall Study||13166
10968414|NCT00526474|12142104|FG001|Received Study Drug|Overall Study||13186
10968415|NCT00526474|12142103|FG000|COMPLETED|Overall Study||12932
10968416|NCT00526474|12142104|FG001|COMPLETED|Overall Study||12953
10968417|NCT00526474|12142103|FG000|NOT COMPLETED|Overall Study||292
10968418|NCT00526474|12142104|FG001|NOT COMPLETED|Overall Study||272
10968419|NCT00526591|12142112|FG000|STARTED|Overall Study||8
10968420|NCT00526591|12142113|FG001|STARTED|Overall Study||9
10968421|NCT00526591|12142112|FG000|COMPLETED|Overall Study||8
10968422|NCT00526591|12142113|FG001|COMPLETED|Overall Study||9
10968423|NCT00526591|12142112|FG000|NOT COMPLETED|Overall Study||0
10968424|NCT00526591|12142113|FG001|NOT COMPLETED|Overall Study||0
10968425|NCT00526630|12142121|FG000|STARTED|First Intervention Period - 12 Weeks||12
10968426|NCT00526630|12142122|FG001|STARTED|First Intervention Period - 12 Weeks||11
10968427|NCT00526630|12142121|FG000|COMPLETED|First Intervention Period - 12 Weeks||12
10968428|NCT00526630|12142122|FG001|COMPLETED|First Intervention Period - 12 Weeks||8
10968429|NCT00526630|12142121|FG000|NOT COMPLETED|First Intervention Period - 12 Weeks||0
10968430|NCT00526630|12142122|FG001|NOT COMPLETED|First Intervention Period - 12 Weeks||3
10968431|NCT00526630|12142121|FG000|STARTED|Second Intervention Period - 12 Weeks||12
10968432|NCT00526630|12142122|FG001|STARTED|Second Intervention Period - 12 Weeks||8
10968433|NCT00526630|12142121|FG000|COMPLETED|Second Intervention Period - 12 Weeks||10
10968434|NCT00526630|12142122|FG001|COMPLETED|Second Intervention Period - 12 Weeks||7
10968435|NCT00526630|12142121|FG000|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
10968436|NCT00526630|12142122|FG001|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
10968437|NCT00526656|12142130|FG000|STARTED|Overall Study||9
10968438|NCT00526656|12142130|FG000|COMPLETED|Overall Study||7
10968439|NCT00526656|12142130|FG000|NOT COMPLETED|Overall Study||2
10968440|NCT00526669|12142135|FG000|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
10968441|NCT00526669|12142136|FG001|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
10968442|NCT00526669|12142135|FG000|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
10968443|NCT00526669|12142136|FG001|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
10968444|NCT00526669|12142135|FG000|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
10968445|NCT00526669|12142136|FG001|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
10968446|NCT00526669|12142135|FG000|STARTED|Combined Treatment Phase||0
10968447|NCT00526669|12142136|FG001|STARTED|Combined Treatment Phase||67
10968448|NCT00526669|12142135|FG000|COMPLETED|Combined Treatment Phase||0
10968449|NCT00526669|12142136|FG001|COMPLETED|Combined Treatment Phase||59
10968450|NCT00526669|12142135|FG000|NOT COMPLETED|Combined Treatment Phase||0
10968451|NCT00526669|12142136|FG001|NOT COMPLETED|Combined Treatment Phase||8
10968452|NCT00526799|12142144|FG000|STARTED|Overall Study||16
10968453|NCT00526799|12142145|FG001|STARTED|Overall Study||14
10968454|NCT00526799|12142144|FG000|COMPLETED|Overall Study||15
10968455|NCT00526799|12142145|FG001|COMPLETED|Overall Study||13
10968456|NCT00526799|12142144|FG000|NOT COMPLETED|Overall Study||1
10968457|NCT00526799|12142145|FG001|NOT COMPLETED|Overall Study||1
10968458|NCT00526890|12142151|FG000|STARTED|Overall Study||16
10968459|NCT00526890|12142151|FG000|COMPLETED|Overall Study||14
10968460|NCT00526890|12142151|FG000|NOT COMPLETED|Overall Study||2
10968461|NCT00526994|12142158|FG000|STARTED|Overall Study||909
10968462|NCT00526994|12142159|FG001|STARTED|Overall Study||893
10968463|NCT00526994|12142160|FG002|STARTED|Overall Study||898
10968464|NCT00526994|12142158|FG000|COMPLETED|Overall Study||801
10968465|NCT00526994|12142159|FG001|COMPLETED|Overall Study||772
10968466|NCT00526994|12142160|FG002|COMPLETED|Overall Study||791
10968467|NCT00526994|12142158|FG000|NOT COMPLETED|Overall Study||108
10968468|NCT00526994|12142159|FG001|NOT COMPLETED|Overall Study||121
10968469|NCT00526994|12142160|FG002|NOT COMPLETED|Overall Study||107
10968470|NCT00527072|12142168|FG000|STARTED|Overall Study||215
10968471|NCT00527072|12142168|FG000|COMPLETED|Overall Study||179
10968472|NCT00527072|12142168|FG000|NOT COMPLETED|Overall Study||36
10968473|NCT00527098|12142175|FG000|STARTED|Overall Study||36
10968474|NCT00527098|12142176|FG001|STARTED|Overall Study||83
10968475|NCT00527098|12142175|FG000|COMPLETED|Overall Study||36
10968476|NCT00527098|12142176|FG001|COMPLETED|Overall Study||83
10968477|NCT00527098|12142175|FG000|NOT COMPLETED|Overall Study||0
10968478|NCT00527098|12142176|FG001|NOT COMPLETED|Overall Study||0
10968479|NCT00527111|12142183|FG000|STARTED|Overall Study||70
10968480|NCT00527111|12142184|FG001|STARTED|Overall Study||69
10968481|NCT00527111|12142183|FG000|COMPLETED|Overall Study||50
10968482|NCT00527111|12142184|FG001|COMPLETED|Overall Study||47
10968483|NCT00527111|12142183|FG000|NOT COMPLETED|Overall Study||20
10968484|NCT00527111|12142184|FG001|NOT COMPLETED|Overall Study||22
10968485|NCT00527124|12142192|FG000|STARTED|Overall Study||29
10968486|NCT00527124|12142193|FG001|STARTED|Overall Study||28
10968487|NCT00527124|12142192|FG000|COMPLETED|Overall Study||29
10968488|NCT00527124|12142193|FG001|COMPLETED|Overall Study||28
10968489|NCT00527124|12142192|FG000|NOT COMPLETED|Overall Study||0
10968490|NCT00527124|12142193|FG001|NOT COMPLETED|Overall Study||0
10968491|NCT00527319|12142202|FG000|STARTED|Overall Study||12
10968492|NCT00527319|12142203|FG001|STARTED|Overall Study||12
10968493|NCT00527319|12142204|FG002|STARTED|Overall Study||13
10968494|NCT00527319|12142202|FG000|COMPLETED|Overall Study||6
10968495|NCT00527319|12142203|FG001|COMPLETED|Overall Study||8
10968496|NCT00527319|12142204|FG002|COMPLETED|Overall Study||7
10968497|NCT00527319|12142202|FG000|NOT COMPLETED|Overall Study||6
10968498|NCT00527319|12142203|FG001|NOT COMPLETED|Overall Study||4
10968499|NCT00527319|12142204|FG002|NOT COMPLETED|Overall Study||6
10968500|NCT00527332|12142214|FG000|STARTED|Overall Study||91
10968501|NCT00527332|12142215|FG001|STARTED|Overall Study||89
10968502|NCT00527332|12142214|FG000|COMPLETED|Overall Study||82
10968503|NCT00527332|12142215|FG001|COMPLETED|Overall Study||80
10968504|NCT00527332|12142214|FG000|NOT COMPLETED|Overall Study||9
10968505|NCT00527332|12142215|FG001|NOT COMPLETED|Overall Study||9
10968506|NCT00527397|12142221|FG000|STARTED|Overall Study||24
10968507|NCT00527397|12142221|FG000|COMPLETED|Overall Study||0
10968508|NCT00527397|12142221|FG000|NOT COMPLETED|Overall Study||24
10968509|NCT00527423|12142228|FG000|STARTED|Overall Study||157
10968510|NCT00527423|12142228|FG000|COMPLETED|Overall Study||120
10968511|NCT00527423|12142228|FG000|NOT COMPLETED|Overall Study||37
10968512|NCT00527475|12142236|FG000|STARTED|Overall Study||30
10968513|NCT00527475|12142237|FG001|STARTED|Overall Study||30
10968514|NCT00527475|12142236|FG000|COMPLETED|Overall Study||27
10968515|NCT00527475|12142237|FG001|COMPLETED|Overall Study||29
10968516|NCT00527475|12142236|FG000|NOT COMPLETED|Overall Study||3
10968517|NCT00527475|12142237|FG001|NOT COMPLETED|Overall Study||1
10968518|NCT00527488|12142247|FG000|STARTED|Overall Study||13
10968519|NCT00527488|12142248|FG001|STARTED|Overall Study||13
10968520|NCT00527488|12142249|FG002|STARTED|Overall Study||13
10968521|NCT00527488|12142250|FG003|STARTED|Overall Study||13
10968522|NCT00527488|12142247|FG000|COMPLETED|Overall Study||13
10968523|NCT00527488|12142248|FG001|COMPLETED|Overall Study||12
10968524|NCT00527488|12142249|FG002|COMPLETED|Overall Study||12
10968525|NCT00527488|12142250|FG003|COMPLETED|Overall Study||13
10968526|NCT00527488|12142247|FG000|NOT COMPLETED|Overall Study||0
10968527|NCT00527488|12142248|FG001|NOT COMPLETED|Overall Study||1
10968528|NCT00527488|12142249|FG002|NOT COMPLETED|Overall Study||1
10968529|NCT00527488|12142250|FG003|NOT COMPLETED|Overall Study||0
10968530|NCT00527514|12142260|FG000|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
10968531|NCT00527514|12142260|FG000|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
10968532|NCT00527514|12142260|FG000|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
10968533|NCT00527514|12142260|FG000|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
10968534|NCT00527514|12142260|FG000|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
10968535|NCT00527514|12142260|FG000|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
10968536|NCT00527514|12142260|FG000|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
10968537|NCT00527514|12142260|FG000|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
10968538|NCT00527514|12142260|FG000|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
10968539|NCT00527514|12142260|FG000|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
10968540|NCT00527514|12142260|FG000|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
10968541|NCT00527514|12142260|FG000|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
10968542|NCT00527566|12142271|FG000|STARTED|Overall Study||10
10968543|NCT00527566|12142271|FG000|COMPLETED|Overall Study||10
10968544|NCT00527566|12142271|FG000|NOT COMPLETED|Overall Study||0
10968545|NCT00527592|12142277|FG000|STARTED|Overall Study||54
10968546|NCT00527592|12142277|FG000|COMPLETED|Overall Study||54
10968547|NCT00527592|12142277|FG000|NOT COMPLETED|Overall Study||0
10968548|NCT00527605|12142285|FG000|STARTED|Overall Study||126
10968549|NCT00527605|12142286|FG001|STARTED|Overall Study||127
10968550|NCT00527605|12142285|FG000|COMPLETED|Overall Study||113
10968551|NCT00527605|12142286|FG001|COMPLETED|Overall Study||116
10968552|NCT00527605|12142285|FG000|NOT COMPLETED|Overall Study||13
10968553|NCT00527605|12142286|FG001|NOT COMPLETED|Overall Study||11
10968554|NCT00527618|12142292|FG000|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
10968555|NCT00527618|12142293|FG001|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
10968556|NCT00527618|12142292|FG000|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
10968557|NCT00527618|12142293|FG001|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
10968558|NCT00527618|12142292|FG000|NOT COMPLETED|Week 1-12 (First Intervention)||3
10968559|NCT00527618|12142293|FG001|NOT COMPLETED|Week 1-12 (First Intervention)||2
10968560|NCT00527618|12142292|FG000|STARTED|Week 13-14 (Washout)||13
10968561|NCT00527618|12142293|FG001|STARTED|Week 13-14 (Washout)||16
10968562|NCT00527618|12142292|FG000|COMPLETED|Week 13-14 (Washout)||12
10968563|NCT00527618|12142293|FG001|COMPLETED|Week 13-14 (Washout)||16
10968564|NCT00527618|12142292|FG000|NOT COMPLETED|Week 13-14 (Washout)||1
10968565|NCT00527618|12142293|FG001|NOT COMPLETED|Week 13-14 (Washout)||0
10968566|NCT00527618|12142292|FG000|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
10968567|NCT00527618|12142293|FG001|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
10968568|NCT00527618|12142292|FG000|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
10968569|NCT00527618|12142293|FG001|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
10968570|NCT00527618|12142292|FG000|NOT COMPLETED|Week 15-18 (Second Intervention)||0
10968571|NCT00527618|12142293|FG001|NOT COMPLETED|Week 15-18 (Second Intervention)||3
10968572|NCT00527644|12142300|FG000|STARTED|Overall Study||14
10968573|NCT00527644|12142300|FG000|COMPLETED|Overall Study||14
10968574|NCT00527644|12142300|FG000|NOT COMPLETED|Overall Study||0
10968575|NCT00527722|12142306|FG000|STARTED|Overall Study||22
10968576|NCT00527722|12142307|FG001|STARTED|Overall Study||25
10968577|NCT00527722|12142306|FG000|COMPLETED|Overall Study||22
10968578|NCT00527722|12142307|FG001|COMPLETED|Overall Study||25
10968579|NCT00527722|12142306|FG000|NOT COMPLETED|Overall Study||0
10968580|NCT00527722|12142307|FG001|NOT COMPLETED|Overall Study||0
10968581|NCT00527735|12142316|FG000|STARTED|Overall Study|Treated|113
10968582|NCT00527735|12142317|FG001|STARTED|Overall Study|Treated|109
10968583|NCT00527735|12142318|FG002|STARTED|Overall Study|Treated|109
10968584|NCT00527735|12142316|FG000|COMPLETED|Overall Study|Still on treatment|5
10968585|NCT00527735|12142317|FG001|COMPLETED|Overall Study|Still on treatment|2
10968586|NCT00527735|12142318|FG002|COMPLETED|Overall Study|Still on treatment|2
10968587|NCT00527735|12142316|FG000|NOT COMPLETED|Overall Study||108
10968588|NCT00527735|12142317|FG001|NOT COMPLETED|Overall Study||107
10968589|NCT00527735|12142318|FG002|NOT COMPLETED|Overall Study||107
10968590|NCT00527787|12142340|FG000|STARTED|Overall Study||218
10968591|NCT00527787|12142341|FG001|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
10968592|NCT00527787|12142340|FG000|COMPLETED|Overall Study||180
10968593|NCT00527787|12142341|FG001|COMPLETED|Overall Study||153
10968594|NCT00527787|12142340|FG000|NOT COMPLETED|Overall Study||38
10968595|NCT00527787|12142341|FG001|NOT COMPLETED|Overall Study||63
10968596|NCT00527826|12142349|FG000|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
10968597|NCT00527826|12142350|FG001|STARTED|Overall Study||106
10968598|NCT00527826|12142349|FG000|COMPLETED|Overall Study||87
10968599|NCT00527826|12142350|FG001|COMPLETED|Overall Study||80
10968600|NCT00527826|12142349|FG000|NOT COMPLETED|Overall Study||21
10968601|NCT00527826|12142350|FG001|NOT COMPLETED|Overall Study||26
10968602|NCT00527878|12142359|FG000|STARTED|Intervention 1||7
10968603|NCT00527878|12142360|FG001|STARTED|Intervention 1||7
10968604|NCT00527878|12142359|FG000|COMPLETED|Intervention 1||5
10968605|NCT00527878|12142360|FG001|COMPLETED|Intervention 1||4
10968606|NCT00527878|12142359|FG000|NOT COMPLETED|Intervention 1||2
10968607|NCT00527878|12142360|FG001|NOT COMPLETED|Intervention 1||3
10968608|NCT00527878|12142359|FG000|STARTED|Intervention 2||5
10968609|NCT00527878|12142360|FG001|STARTED|Intervention 2||4
10968610|NCT00527878|12142359|FG000|COMPLETED|Intervention 2||5
10968611|NCT00527878|12142360|FG001|COMPLETED|Intervention 2||4
10968612|NCT00527878|12142359|FG000|NOT COMPLETED|Intervention 2||0
10968613|NCT00527878|12142360|FG001|NOT COMPLETED|Intervention 2||0
10968614|NCT00527904|12142366|FG000|STARTED|Overall Study||239
10968615|NCT00527904|12142366|FG000|COMPLETED|Overall Study||143
10968616|NCT00527904|12142366|FG000|NOT COMPLETED|Overall Study||96
10968617|NCT00527943|12142372|FG000|STARTED|Overall Study||6471
10968618|NCT00527943|12142373|FG001|STARTED|Overall Study||6473
10968619|NCT00527943|12142372|FG000|Received Treatment|Overall Study||6441
10968620|NCT00527943|12142373|FG001|Received Treatment|Overall Study||6446
10968621|NCT00527943|12142372|FG000|COMPLETED|Overall Study||6311
10968622|NCT00527943|12142373|FG001|COMPLETED|Overall Study||6327
10968623|NCT00527943|12142372|FG000|NOT COMPLETED|Overall Study||160
10968624|NCT00527943|12142373|FG001|NOT COMPLETED|Overall Study||146
10968625|NCT00528112|12142381|FG000|STARTED|Treatment up to 3 Years||1432
10968626|NCT00528112|12142382|FG001|STARTED|Treatment up to 3 Years||1453
10968627|NCT00528112|12142381|FG000|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
10968628|NCT00528112|12142382|FG001|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
10968629|NCT00528112|12142381|FG000|COMPLETED|Treatment up to 3 Years||819
10968630|NCT00528112|12142382|FG001|COMPLETED|Treatment up to 3 Years||870
10968631|NCT00528112|12142381|FG000|NOT COMPLETED|Treatment up to 3 Years||613
10968632|NCT00528112|12142382|FG001|NOT COMPLETED|Treatment up to 3 Years||583
10968633|NCT00528112|12142381|FG000|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
10968634|NCT00528112|12142382|FG001|STARTED|Extension Phase||707
10968635|NCT00528112|12142381|FG000|COMPLETED|Extension Phase||0
10968636|NCT00528112|12142382|FG001|COMPLETED|Extension Phase||550
10968637|NCT00528112|12142381|FG000|NOT COMPLETED|Extension Phase||0
10968638|NCT00528112|12142382|FG001|NOT COMPLETED|Extension Phase||157
10968639|NCT00528190|12142392|FG000|STARTED|Overall Study||18
10968640|NCT00528190|12142393|FG001|STARTED|Overall Study||17
10968641|NCT00528190|12142392|FG000|COMPLETED|Overall Study||18
10968642|NCT00528190|12142393|FG001|COMPLETED|Overall Study||16
10968643|NCT00528190|12142392|FG000|NOT COMPLETED|Overall Study||0
10968644|NCT00528190|12142393|FG001|NOT COMPLETED|Overall Study||1
10968645|NCT00528268|12142401|FG000|STARTED|Overall Study||6
10968646|NCT00528268|12142402|FG001|STARTED|Overall Study||8
10968647|NCT00528268|12142401|FG000|COMPLETED|Overall Study||5
10968648|NCT00528268|12142402|FG001|COMPLETED|Overall Study||7
10968649|NCT00528268|12142401|FG000|NOT COMPLETED|Overall Study||1
10968650|NCT00528268|12142402|FG001|NOT COMPLETED|Overall Study||1
10968651|NCT00528372|12142417|FG000|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
10968652|NCT00528372|12142418|FG001|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
10968653|NCT00528372|12142419|FG002|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
10968654|NCT00528372|12142420|FG003|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
10968655|NCT00528372|12142421|FG004|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
10968656|NCT00528372|12142422|FG005|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
10968657|NCT00528372|12142423|FG006|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
10968658|NCT00528372|12142424|FG007|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
10968659|NCT00528372|12142425|FG008|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
10968660|NCT00528372|12142417|FG000|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
10968661|NCT00528372|12142418|FG001|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
10968662|NCT00528372|12142419|FG002|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
10968663|NCT00528372|12142420|FG003|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
10968664|NCT00528372|12142421|FG004|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
10968665|NCT00528372|12142422|FG005|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
10968666|NCT00528372|12142423|FG006|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
10968667|NCT00528372|12142424|FG007|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
10968668|NCT00528372|12142425|FG008|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
10968669|NCT00528372|12142417|FG000|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
10968670|NCT00528372|12142418|FG001|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
10968671|NCT00528372|12142419|FG002|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
10968672|NCT00528372|12142420|FG003|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
10968673|NCT00528372|12142421|FG004|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
10968674|NCT00528372|12142422|FG005|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
10968675|NCT00528372|12142423|FG006|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
10968676|NCT00528372|12142424|FG007|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
10968677|NCT00528372|12142425|FG008|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
10968678|NCT00528372|12142417|FG000|STARTED|Long-term (LT) Period (Weeks 24-102)||62
10968679|NCT00528372|12142418|FG001|STARTED|Long-term (LT) Period (Weeks 24-102)||59
10968680|NCT00528372|12142419|FG002|STARTED|Long-term (LT) Period (Weeks 24-102)||51
10968681|NCT00528372|12142420|FG003|STARTED|Long-term (LT) Period (Weeks 24-102)||56
10968682|NCT00528372|12142421|FG004|STARTED|Long-term (LT) Period (Weeks 24-102)||58
10968683|NCT00528372|12142422|FG005|STARTED|Long-term (LT) Period (Weeks 24-102)||57
10968684|NCT00528372|12142423|FG006|STARTED|Long-term (LT) Period (Weeks 24-102)||65
10968685|NCT00528372|12142424|FG007|STARTED|Long-term (LT) Period (Weeks 24-102)||28
10968686|NCT00528372|12142425|FG008|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
10968687|NCT00528372|12142417|FG000|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
10968688|NCT00528372|12142418|FG001|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
10968689|NCT00528372|12142419|FG002|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
10968690|NCT00528372|12142420|FG003|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
10968691|NCT00528372|12142421|FG004|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
10968692|NCT00528372|12142422|FG005|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
10968693|NCT00528372|12142423|FG006|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
10968694|NCT00528372|12142424|FG007|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
10968695|NCT00528372|12142425|FG008|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
10968696|NCT00528372|12142417|FG000|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
10968697|NCT00528372|12142418|FG001|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
10968698|NCT00528372|12142419|FG002|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
10968699|NCT00528372|12142420|FG003|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
10968700|NCT00528372|12142421|FG004|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
10968701|NCT00528372|12142422|FG005|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
10968702|NCT00528372|12142423|FG006|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
10968703|NCT00528372|12142424|FG007|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
10968704|NCT00528372|12142425|FG008|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
10968705|NCT00528398|12142471|FG000|STARTED|Overall Study||111
10968706|NCT00528398|12142471|FG000|COMPLETED|Overall Study||111
10968707|NCT00528398|12142471|FG000|NOT COMPLETED|Overall Study||0
10968708|NCT00528411|12142478|FG000|STARTED|Overall Study||57
10968709|NCT00528411|12142479|FG001|STARTED|Overall Study||54
10968710|NCT00528411|12142480|FG002|STARTED|Overall Study||12
10968711|NCT00528411|12142478|FG000|COMPLETED|Overall Study||52
10968712|NCT00528411|12142479|FG001|COMPLETED|Overall Study||51
10968713|NCT00528411|12142480|FG002|COMPLETED|Overall Study||11
10968714|NCT00528411|12142478|FG000|NOT COMPLETED|Overall Study||5
10968715|NCT00528411|12142479|FG001|NOT COMPLETED|Overall Study||3
10968716|NCT00528411|12142480|FG002|NOT COMPLETED|Overall Study||1
10968717|NCT00528424|12142488|FG000|STARTED|Overall Study||286
10968718|NCT00528424|12142488|FG000|COMPLETED|Overall Study||257
10968719|NCT00528424|12142488|FG000|NOT COMPLETED|Overall Study||29
10968720|NCT00528450|12142492|FG000|STARTED|Overall Study||1
10968721|NCT00528450|12142492|FG000|COMPLETED|Overall Study||1
10968722|NCT00528450|12142492|FG000|NOT COMPLETED|Overall Study||0
10968723|NCT00528528|12142500|FG000|STARTED|Overall Study||40
10968724|NCT00528528|12142501|FG001|STARTED|Overall Study||42
10968725|NCT00528528|12142502|FG002|STARTED|Overall Study||40
10968726|NCT00528528|12142503|FG003|STARTED|Overall Study||39
10968727|NCT00528528|12142500|FG000|Ongoing at Time of Cut-off|Overall Study||0
10968728|NCT00528528|12142501|FG001|Ongoing at Time of Cut-off|Overall Study||0
10968729|NCT00528528|12142502|FG002|Ongoing at Time of Cut-off|Overall Study||1
10968730|NCT00528528|12142503|FG003|Ongoing at Time of Cut-off|Overall Study||0
10968731|NCT00528528|12142500|FG000|COMPLETED|Overall Study||37
10968732|NCT00528528|12142501|FG001|COMPLETED|Overall Study||39
10968733|NCT00528528|12142502|FG002|COMPLETED|Overall Study||37
10968734|NCT00528528|12142503|FG003|COMPLETED|Overall Study||36
10968735|NCT00528528|12142500|FG000|NOT COMPLETED|Overall Study||3
10968736|NCT00528528|12142501|FG001|NOT COMPLETED|Overall Study||3
10968737|NCT00528528|12142502|FG002|NOT COMPLETED|Overall Study||3
10968738|NCT00528528|12142503|FG003|NOT COMPLETED|Overall Study||3
10968739|NCT00528541|12142517|FG000|STARTED|Overall Study||75
10968740|NCT00528541|12142518|FG001|STARTED|Overall Study||70
10968741|NCT00528541|12142517|FG000|COMPLETED|Overall Study||73
10968742|NCT00528541|12142518|FG001|COMPLETED|Overall Study||69
10968743|NCT00528541|12142517|FG000|NOT COMPLETED|Overall Study||2
10968744|NCT00528541|12142518|FG001|NOT COMPLETED|Overall Study||1
10968745|NCT00528567|12142526|FG000|STARTED|Overall Study||1301
10968746|NCT00528567|12142527|FG001|STARTED|Overall Study||1290
10968747|NCT00528567|12142526|FG000|Intention to Treat|Overall Study||1301
10968748|NCT00528567|12142527|FG001|Intention to Treat|Overall Study||1290
10968749|NCT00528567|12142526|FG000|Safety Population|Overall Study||1288
10968750|NCT00528567|12142527|FG001|Safety Population|Overall Study||1271
10968751|NCT00528567|12142526|FG000|COMPLETED|Overall Study||870
10968752|NCT00528567|12142527|FG001|COMPLETED|Overall Study||982
10968753|NCT00528567|12142526|FG000|NOT COMPLETED|Overall Study||431
10968754|NCT00528567|12142527|FG001|NOT COMPLETED|Overall Study||308
10968755|NCT00528580|12142542|FG000|STARTED|Overall Study||34
10968756|NCT00528580|12142543|FG001|STARTED|Overall Study||34
10968757|NCT00528580|12142542|FG000|COMPLETED|Overall Study||34
10968758|NCT00528580|12142543|FG001|COMPLETED|Overall Study||34
10968759|NCT00528580|12142542|FG000|NOT COMPLETED|Overall Study||0
10968760|NCT00528580|12142543|FG001|NOT COMPLETED|Overall Study||0
10968761|NCT00528606|12142551|FG000|STARTED|Overall Study||204
10968762|NCT00528606|12142552|FG001|STARTED|Overall Study||104
10968763|NCT00528606|12142551|FG000|COMPLETED|Overall Study||191
10968764|NCT00528606|12142552|FG001|COMPLETED|Overall Study||100
10968765|NCT00528606|12142551|FG000|NOT COMPLETED|Overall Study||13
10968766|NCT00528606|12142552|FG001|NOT COMPLETED|Overall Study||4
10968767|NCT00528645|12142558|FG000|STARTED|Overall Study||23
10968768|NCT00528645|12142558|FG000|COMPLETED|Overall Study||20
10968769|NCT00528645|12142558|FG000|NOT COMPLETED|Overall Study||3
10968770|NCT00528788|12142563|FG000|STARTED|Overall Study||24
10968771|NCT00528788|12142563|FG000|COMPLETED|Overall Study||20
10968772|NCT00528788|12142563|FG000|NOT COMPLETED|Overall Study||4
10968773|NCT00528801|12142569|FG000|STARTED|Overall Study||160
10968774|NCT00528801|12142570|FG001|STARTED|Overall Study||52
10968775|NCT00528801|12142569|FG000|COMPLETED|Overall Study||133
10968776|NCT00528801|12142570|FG001|COMPLETED|Overall Study||41
10968777|NCT00528801|12142569|FG000|NOT COMPLETED|Overall Study||27
10968778|NCT00528801|12142570|FG001|NOT COMPLETED|Overall Study||11
10968779|NCT00528840|12142576|FG000|STARTED|Overall Study||201
10968780|NCT00528840|12142576|FG000|COMPLETED|Overall Study||168
10968781|NCT00528840|12142576|FG000|NOT COMPLETED|Overall Study||33
10968782|NCT00528866|12142580|FG000|STARTED|Overall Study||80
10968783|NCT00528866|12142580|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
10968784|NCT00528866|12142580|FG000|NOT COMPLETED|Overall Study||6
10968785|NCT00528879|12142589|FG000|STARTED|Short-term Period (Day 1 to Week 24)||137
10968786|NCT00528879|12142590|FG001|STARTED|Short-term Period (Day 1 to Week 24)||137
10968787|NCT00528879|12142591|FG002|STARTED|Short-term Period (Day 1 to Week 24)||137
10968788|NCT00528879|12142592|FG003|STARTED|Short-term Period (Day 1 to Week 24)||135
10968789|NCT00528879|12142589|FG000|Completed the Period|Short-term Period (Day 1 to Week 24)||119
10968790|NCT00528879|12142590|FG001|Completed the Period|Short-term Period (Day 1 to Week 24)||121
10968791|NCT00528879|12142591|FG002|Completed the Period|Short-term Period (Day 1 to Week 24)||122
10968792|NCT00528879|12142592|FG003|Completed the Period|Short-term Period (Day 1 to Week 24)||121
10968793|NCT00528879|12142589|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
10968794|NCT00528879|12142590|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
10968795|NCT00528879|12142591|FG002|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
10968796|NCT00528879|12142592|FG003|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
10968797|NCT00528879|12142589|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
10968798|NCT00528879|12142590|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
10968799|NCT00528879|12142591|FG002|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
10968800|NCT00528879|12142592|FG003|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
10968801|NCT00528879|12142589|FG000|STARTED|Long-term Period (Weeks 24 to 102)||115
10968802|NCT00528879|12142590|FG001|STARTED|Long-term Period (Weeks 24 to 102)||120
10968803|NCT00528879|12142591|FG002|STARTED|Long-term Period (Weeks 24 to 102)||122
10968804|NCT00528879|12142592|FG003|STARTED|Long-term Period (Weeks 24 to 102)||119
10968805|NCT00528879|12142589|FG000|COMPLETED|Long-term Period (Weeks 24 to 102)||73
10968806|NCT00528879|12142590|FG001|COMPLETED|Long-term Period (Weeks 24 to 102)||82
10968807|NCT00528879|12142591|FG002|COMPLETED|Long-term Period (Weeks 24 to 102)||89
10968808|NCT00528879|12142592|FG003|COMPLETED|Long-term Period (Weeks 24 to 102)||95
10968809|NCT00528879|12142589|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
10968810|NCT00528879|12142590|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
10968811|NCT00528879|12142591|FG002|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
10968812|NCT00528879|12142592|FG003|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
10968813|NCT00528931|12142602|FG000|STARTED|Overall Study||16
10968814|NCT00528931|12142602|FG000|COMPLETED|Overall Study||15
10968815|NCT00528931|12142602|FG000|NOT COMPLETED|Overall Study||1
10968816|NCT00528957|12142609|FG000|STARTED|Randomized Phase (Baseline to Week 48)||48
10968817|NCT00528957|12142610|FG001|STARTED|Randomized Phase (Baseline to Week 48)||49
10968818|NCT00528957|12142609|FG000|COMPLETED|Randomized Phase (Baseline to Week 48)||44
10968819|NCT00528957|12142610|FG001|COMPLETED|Randomized Phase (Baseline to Week 48)||48
10968820|NCT00528957|12142609|FG000|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
10968821|NCT00528957|12142610|FG001|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
10968822|NCT00528957|12142609|FG000|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
10968823|NCT00528957|12142610|FG001|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
10968824|NCT00528957|12142609|FG000|COMPLETED|First Extension (Week 48 to Week 144)||35
10968825|NCT00528957|12142610|FG001|COMPLETED|First Extension (Week 48 to Week 144)||40
10968826|NCT00528957|12142609|FG000|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
10968827|NCT00528957|12142610|FG001|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
10968828|NCT00528957|12142609|FG000|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
10968829|NCT00528957|12142610|FG001|STARTED|Second Extension (Week 144 to Week 240)||40
10968830|NCT00528957|12142609|FG000|COMPLETED|Second Extension (Week 144 to Week 240)||27
10968831|NCT00528957|12142610|FG001|COMPLETED|Second Extension (Week 144 to Week 240)||37
10968832|NCT00528957|12142609|FG000|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
10968833|NCT00528957|12142610|FG001|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
10968834|NCT00528957|12142609|FG000|STARTED|Third Extension (Week 240 to Week 336)||27
10968835|NCT00528957|12142610|FG001|STARTED|Third Extension (Week 240 to Week 336)||37
10968836|NCT00528957|12142609|FG000|COMPLETED|Third Extension (Week 240 to Week 336)||21
10968837|NCT00528957|12142610|FG001|COMPLETED|Third Extension (Week 240 to Week 336)||27
10968838|NCT00528957|12142609|FG000|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
10968839|NCT00528957|12142610|FG001|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
10968840|NCT00528957|12142609|FG000|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
10968841|NCT00528957|12142610|FG001|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
10968842|NCT00528957|12142609|FG000|COMPLETED|Long-Term Extension (Week 336 and On)||9
10968843|NCT00528957|12142610|FG001|COMPLETED|Long-Term Extension (Week 336 and On)||8
10968844|NCT00528957|12142609|FG000|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
10968845|NCT00528957|12142610|FG001|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
10968846|NCT00528970|12142629|FG000|STARTED|Overall Study||124
10968847|NCT00528970|12142630|FG001|STARTED|Overall Study||125
10968848|NCT00528970|12142631|FG002|STARTED|Overall Study||125
10968849|NCT00528970|12142629|FG000|Received at Least 1 Dose of Study Drug|Overall Study||124
10968850|NCT00528970|12142630|FG001|Received at Least 1 Dose of Study Drug|Overall Study||125
10968851|NCT00528970|12142631|FG002|Received at Least 1 Dose of Study Drug|Overall Study||124
10968852|NCT00528970|12142629|FG000|COMPLETED|Overall Study||110
10968853|NCT00528970|12142630|FG001|COMPLETED|Overall Study||110
10968854|NCT00528970|12142631|FG002|COMPLETED|Overall Study||105
10968855|NCT00528970|12142629|FG000|NOT COMPLETED|Overall Study||14
10968856|NCT00528970|12142630|FG001|NOT COMPLETED|Overall Study||15
10968857|NCT00528970|12142631|FG002|NOT COMPLETED|Overall Study||20
10968858|NCT00528996|12142644|FG000|STARTED|Overall Study||429
10968859|NCT00528996|12142645|FG001|STARTED|Overall Study||419
10968860|NCT00528996|12142646|FG002|STARTED|Overall Study||415
10968861|NCT00528996|12142647|FG003|STARTED|Overall Study||390
10968862|NCT00528996|12142648|FG004|STARTED|Overall Study||427
10968863|NCT00528996|12142644|FG000|COMPLETED|Overall Study||365
10968864|NCT00528996|12142645|FG001|COMPLETED|Overall Study||395
10968865|NCT00528996|12142646|FG002|COMPLETED|Overall Study||372
10968866|NCT00528996|12142647|FG003|COMPLETED|Overall Study||340
10968867|NCT00528996|12142648|FG004|COMPLETED|Overall Study||390
10968868|NCT00528996|12142644|FG000|NOT COMPLETED|Overall Study||64
10968869|NCT00528996|12142645|FG001|NOT COMPLETED|Overall Study||24
10968870|NCT00528996|12142646|FG002|NOT COMPLETED|Overall Study||43
10968871|NCT00528996|12142647|FG003|NOT COMPLETED|Overall Study||50
10968872|NCT00528996|12142648|FG004|NOT COMPLETED|Overall Study||37
10968873|NCT00529035|12142663|FG000|STARTED|Overall Study|29 enrolled|29
10968874|NCT00529035|12142663|FG000|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
10968875|NCT00529035|12142663|FG000|NOT COMPLETED|Overall Study||1
10968876|NCT00529087|12142677|FG000|STARTED|Overall Study||150
10968877|NCT00529087|12142678|FG001|STARTED|Overall Study||148
10968878|NCT00529087|12142679|FG002|STARTED|Overall Study||162
10968879|NCT00529087|12142677|FG000|COMPLETED|Overall Study||122
10968880|NCT00529087|12142678|FG001|COMPLETED|Overall Study||120
10968881|NCT00529087|12142679|FG002|COMPLETED|Overall Study||146
10968882|NCT00529087|12142677|FG000|NOT COMPLETED|Overall Study||28
10968883|NCT00529087|12142678|FG001|NOT COMPLETED|Overall Study||28
10968884|NCT00529087|12142679|FG002|NOT COMPLETED|Overall Study||16
10968885|NCT00529100|12142700|FG000|STARTED|Overall Study||16
10968886|NCT00529100|12142701|FG001|STARTED|Overall Study||33
10968887|NCT00529100|12142700|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16
10968888|NCT00529100|12142701|FG001|Received at Least 1 Dose of Study Drug|Overall Study||33
10968889|NCT00529100|12142700|FG000|COMPLETED|Overall Study||16
10968890|NCT00529100|12142701|FG001|COMPLETED|Overall Study||24
10968891|NCT00529100|12142700|FG000|NOT COMPLETED|Overall Study||0
10968892|NCT00529100|12142701|FG001|NOT COMPLETED|Overall Study||9
10968893|NCT00529126|12142715|FG000|STARTED|Overall Study||25
10968894|NCT00529126|12142716|FG001|STARTED|Overall Study||25
10968895|NCT00529126|12142717|FG002|STARTED|Overall Study||24
10968896|NCT00529126|12142718|FG003|STARTED|Overall Study||26
10968897|NCT00529126|12142715|FG000|COMPLETED|Overall Study||25
10968898|NCT00529126|12142716|FG001|COMPLETED|Overall Study||25
10968899|NCT00529126|12142717|FG002|COMPLETED|Overall Study||24
10968900|NCT00529126|12142718|FG003|COMPLETED|Overall Study||26
10968901|NCT00529126|12142715|FG000|NOT COMPLETED|Overall Study||0
10968902|NCT00529126|12142716|FG001|NOT COMPLETED|Overall Study||0
10968903|NCT00529126|12142717|FG002|NOT COMPLETED|Overall Study||0
10968904|NCT00529126|12142718|FG003|NOT COMPLETED|Overall Study||0
10968905|NCT00529191|12142730|FG000|STARTED|Overall Study||27
10968906|NCT00529191|12142731|FG001|STARTED|Overall Study||13
10968907|NCT00529191|12142730|FG000|COMPLETED|Overall Study||24
10968908|NCT00529191|12142731|FG001|COMPLETED|Overall Study||13
10968909|NCT00529191|12142730|FG000|NOT COMPLETED|Overall Study||3
10968910|NCT00529191|12142731|FG001|NOT COMPLETED|Overall Study||0
10968911|NCT00529204|12142746|FG000|STARTED|Overall Study||1
10968912|NCT00529204|12142746|FG000|COMPLETED|Overall Study||1
10968913|NCT00529204|12142746|FG000|NOT COMPLETED|Overall Study||0
10968914|NCT00529217|12142750|FG000|STARTED|Overall Study||12
10968915|NCT00529217|12142750|FG000|COMPLETED|Overall Study||8
10968916|NCT00529217|12142750|FG000|NOT COMPLETED|Overall Study||4
10968917|NCT00529243|12142755|FG000|STARTED|Overall Study||52
10968918|NCT00529243|12142755|FG000|COMPLETED|Overall Study||49
10968919|NCT00529243|12142755|FG000|NOT COMPLETED|Overall Study||3
10968920|NCT00529308|12142761|FG000|STARTED|Overall Study||9
10968921|NCT00529308|12142762|FG001|STARTED|Overall Study||11
10968922|NCT00529308|12142761|FG000|COMPLETED|Overall Study||8
10968923|NCT00529308|12142762|FG001|COMPLETED|Overall Study||10
10968924|NCT00529308|12142761|FG000|NOT COMPLETED|Overall Study||1
10968925|NCT00529308|12142762|FG001|NOT COMPLETED|Overall Study||1
10968926|NCT00529373|12142770|FG000|STARTED|Base Study||8043
10968927|NCT00529373|12142771|FG001|STARTED|Base Study||8028
10968928|NCT00529373|12142770|FG000|COMPLETED|Base Study||4297
10968929|NCT00529373|12142771|FG001|COMPLETED|Base Study||3960
10968930|NCT00529373|12142770|FG000|NOT COMPLETED|Base Study||3746
10968931|NCT00529373|12142771|FG001|NOT COMPLETED|Base Study||4068
10968932|NCT00529373|12142770|FG000|STARTED|First Extension Study||4297
10968933|NCT00529373|12142771|FG001|STARTED|First Extension Study||3960
10968934|NCT00529373|12142770|FG000|COMPLETED|First Extension Study||3144
10968935|NCT00529373|12142771|FG001|COMPLETED|First Extension Study||2309
10968936|NCT00529373|12142770|FG000|NOT COMPLETED|First Extension Study||1153
10968937|NCT00529373|12142771|FG001|NOT COMPLETED|First Extension Study||1651
10968938|NCT00529373|12142770|FG000|STARTED|Second Extension Study||3144
10968939|NCT00529373|12142771|FG001|STARTED|Second Extension Study||2309
10968940|NCT00529373|12142770|FG000|COMPLETED|Second Extension Study||2844
10968941|NCT00529373|12142771|FG001|COMPLETED|Second Extension Study||2112
10968942|NCT00529373|12142770|FG000|NOT COMPLETED|Second Extension Study||300
10968943|NCT00529373|12142771|FG001|NOT COMPLETED|Second Extension Study||197
10968944|NCT00529386|12142785|FG000|STARTED|Overall Study|Study has been discontinued|7
10968945|NCT00529386|12142785|FG000|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6
10968946|NCT00529386|12142785|FG000|NOT COMPLETED|Overall Study||1
10968947|NCT00529399|12142792|FG000|STARTED|Overall Study||48
10968948|NCT00529399|12142793|FG001|STARTED|Overall Study||49
10968949|NCT00529399|12142794|FG002|STARTED|Overall Study||48
10968950|NCT00529399|12142792|FG000|COMPLETED|Overall Study||46
10968951|NCT00529399|12142793|FG001|COMPLETED|Overall Study||48
10968952|NCT00529399|12142794|FG002|COMPLETED|Overall Study||46
10968953|NCT00529399|12142792|FG000|NOT COMPLETED|Overall Study||2
10968954|NCT00529399|12142793|FG001|NOT COMPLETED|Overall Study||1
10968955|NCT00529399|12142794|FG002|NOT COMPLETED|Overall Study||2
10968956|NCT00529451|12142806|FG000|STARTED|Overall Study||331
10968957|NCT00529451|12142807|FG001|STARTED|Overall Study||323
10968958|NCT00529451|12142808|FG002|STARTED|Overall Study||332
10968959|NCT00529451|12142809|FG003|STARTED|Overall Study||330
10968960|NCT00529451|12142806|FG000|COMPLETED|Overall Study||294
10968961|NCT00529451|12142807|FG001|COMPLETED|Overall Study||275
10968962|NCT00529451|12142808|FG002|COMPLETED|Overall Study||292
10968963|NCT00529451|12142809|FG003|COMPLETED|Overall Study||299
10968964|NCT00529451|12142806|FG000|NOT COMPLETED|Overall Study||37
10968965|NCT00529451|12142807|FG001|NOT COMPLETED|Overall Study||48
10968966|NCT00529451|12142808|FG002|NOT COMPLETED|Overall Study||40
10968967|NCT00529451|12142809|FG003|NOT COMPLETED|Overall Study||31
10968968|NCT00529516|12142825|FG000|STARTED|Overall Study||475
10968969|NCT00529516|12142826|FG001|STARTED|Overall Study||488
10968970|NCT00529516|12142827|FG002|STARTED|Overall Study||289
10968971|NCT00529516|12142825|FG000|COMPLETED|Overall Study||472
10968972|NCT00529516|12142826|FG001|COMPLETED|Overall Study||486
10968973|NCT00529516|12142827|FG002|COMPLETED|Overall Study||288
10968974|NCT00529516|12142825|FG000|NOT COMPLETED|Overall Study||3
10968975|NCT00529516|12142826|FG001|NOT COMPLETED|Overall Study||2
10968976|NCT00529516|12142827|FG002|NOT COMPLETED|Overall Study||1
10968977|NCT00529529|12142838|FG000|STARTED|Overall Study||268
10968978|NCT00529529|12142839|FG001|STARTED|Overall Study||268
10968979|NCT00529529|12142840|FG002|STARTED|Overall Study||269
10968980|NCT00529529|12142838|FG000|COMPLETED|Overall Study||225
10968981|NCT00529529|12142839|FG001|COMPLETED|Overall Study||225
10968982|NCT00529529|12142840|FG002|COMPLETED|Overall Study||238
10968983|NCT00529529|12142838|FG000|NOT COMPLETED|Overall Study||43
10968984|NCT00529529|12142839|FG001|NOT COMPLETED|Overall Study||43
10968985|NCT00529529|12142840|FG002|NOT COMPLETED|Overall Study||31
10968986|NCT00529542|12142850|FG000|STARTED|Overall Study||9
10968987|NCT00529542|12142851|FG001|STARTED|Overall Study||11
10968988|NCT00529542|12142850|FG000|COMPLETED|Overall Study||8
10968989|NCT00529542|12142851|FG001|COMPLETED|Overall Study||10
10968990|NCT00529542|12142850|FG000|NOT COMPLETED|Overall Study||1
10968991|NCT00529542|12142851|FG001|NOT COMPLETED|Overall Study||1
10968992|NCT00529555|12142860|FG000|STARTED|Overall Study||200
10968993|NCT00529555|12142861|FG001|STARTED|Overall Study||202
10968994|NCT00529555|12142862|FG002|STARTED|Overall Study||200
10968995|NCT00529555|12142860|FG000|COMPLETED|Overall Study||171
10968996|NCT00529555|12142861|FG001|COMPLETED|Overall Study||172
10968997|NCT00529555|12142862|FG002|COMPLETED|Overall Study||174
10968998|NCT00529555|12142860|FG000|NOT COMPLETED|Overall Study||29
10968999|NCT00529555|12142861|FG001|NOT COMPLETED|Overall Study||30
10969000|NCT00529555|12142862|FG002|NOT COMPLETED|Overall Study||26
10969001|NCT00529568|12142872|FG000|STARTED|Open-label Pre-Antiviral Treatment Phase||805
10969002|NCT00529568|12142873|FG001|STARTED|Open-label Pre-Antiviral Treatment Phase||0
10969003|NCT00529568|12142874|FG002|STARTED|Open-label Pre-Antiviral Treatment Phase||0
10969004|NCT00529568|12142872|FG000|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
10969005|NCT00529568|12142873|FG001|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
10969006|NCT00529568|12142874|FG002|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
10969007|NCT00529568|12142872|FG000|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
10969008|NCT00529568|12142873|FG001|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
10969009|NCT00529568|12142874|FG002|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
10969010|NCT00529568|12142872|FG000|STARTED|Double-bilnd Antiviral Treatment Phase||0
10969011|NCT00529568|12142873|FG001|STARTED|Double-bilnd Antiviral Treatment Phase||253
10969012|NCT00529568|12142874|FG002|STARTED|Double-bilnd Antiviral Treatment Phase||506
10969013|NCT00529568|12142872|FG000|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
10969014|NCT00529568|12142873|FG001|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
10969015|NCT00529568|12142874|FG002|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
10969016|NCT00529568|12142872|FG000|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
10969017|NCT00529568|12142873|FG001|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
10969018|NCT00529568|12142874|FG002|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
10969019|NCT00529633|12142885|FG000|STARTED|Overall Study||2
10969020|NCT00529633|12142886|FG001|STARTED|Overall Study||2
10969021|NCT00529633|12142885|FG000|COMPLETED|Overall Study||1
10969022|NCT00529633|12142886|FG001|COMPLETED|Overall Study||1
10969023|NCT00529633|12142885|FG000|NOT COMPLETED|Overall Study||1
10969024|NCT00529633|12142886|FG001|NOT COMPLETED|Overall Study||1
10969025|NCT00529659|12142894|FG000|STARTED|Overall Study||81
10969026|NCT00529659|12142895|FG001|STARTED|Overall Study||89
10969027|NCT00529659|12142894|FG000|COMPLETED|Overall Study||70
10969028|NCT00529659|12142895|FG001|COMPLETED|Overall Study||66
10969029|NCT00529659|12142894|FG000|NOT COMPLETED|Overall Study||11
10969030|NCT00529659|12142895|FG001|NOT COMPLETED|Overall Study||23
10969031|NCT00529789|12142901|FG000|STARTED|Study Period II/III||72
10969032|NCT00529789|12142901|FG000|COMPLETED|Study Period II/III||48
10969033|NCT00529789|12142901|FG000|NOT COMPLETED|Study Period II/III||24
10969034|NCT00529789|12142901|FG000|STARTED|Study Period IV||48
10969035|NCT00529789|12142901|FG000|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
10969036|NCT00529789|12142901|FG000|NOT COMPLETED|Study Period IV||6
10969037|NCT00529802|12142911|FG000|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
10969038|NCT00529802|12142911|FG000|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
10969039|NCT00529802|12142911|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||10
10969040|NCT00529802|12142911|FG000|STARTED|Evaluable for Secondary Endpoint||50
10969041|NCT00529802|12142911|FG000|COMPLETED|Evaluable for Secondary Endpoint||48
10969042|NCT00529802|12142911|FG000|NOT COMPLETED|Evaluable for Secondary Endpoint||2
10969043|NCT00529958|12142920|FG000|STARTED|2-Year Follow-up||110
10969044|NCT00529958|12142921|FG001|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110
10969045|NCT00529958|12142922|FG002|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110
10969046|NCT00529958|12142920|FG000|COMPLETED|2-Year Follow-up||106
10969047|NCT00529958|12142921|FG001|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108
10969048|NCT00529958|12142922|FG002|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108
10969049|NCT00529958|12142920|FG000|NOT COMPLETED|2-Year Follow-up||4
10969050|NCT00529958|12142921|FG001|NOT COMPLETED|2-Year Follow-up||2
10969051|NCT00529958|12142922|FG002|NOT COMPLETED|2-Year Follow-up||2
10969052|NCT00529958|12142920|FG000|STARTED|5-Year Follow-up||106
10969053|NCT00529958|12142921|FG001|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108
10969054|NCT00529958|12142922|FG002|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108
10969055|NCT00529958|12142920|FG000|COMPLETED|5-Year Follow-up||103
10969056|NCT00529958|12142921|FG001|COMPLETED|5-Year Follow-up||105
10969057|NCT00529958|12142922|FG002|COMPLETED|5-Year Follow-up||107
10969058|NCT00529958|12142920|FG000|NOT COMPLETED|5-Year Follow-up||3
10969059|NCT00529958|12142921|FG001|NOT COMPLETED|5-Year Follow-up||3
10969060|NCT00529958|12142922|FG002|NOT COMPLETED|5-Year Follow-up||1
10969061|NCT00530023|12142932|FG000|STARTED|Overall Study||14
10969062|NCT00530023|12142933|FG001|STARTED|Overall Study||15
10969063|NCT00530023|12142932|FG000|COMPLETED|Overall Study||14
10969064|NCT00530023|12142933|FG001|COMPLETED|Overall Study||14
10969065|NCT00530023|12142932|FG000|NOT COMPLETED|Overall Study||0
10969066|NCT00530023|12142933|FG001|NOT COMPLETED|Overall Study||1
10969067|NCT00530075|12142939|FG000|STARTED|Overall Study||45
10969068|NCT00530075|12142939|FG000|COMPLETED|Overall Study||38
10969069|NCT00530075|12142939|FG000|NOT COMPLETED|Overall Study||7
10969070|NCT00530088|12142943|FG000|STARTED|Overall Study||30
10969071|NCT00530088|12142943|FG000|COMPLETED|Overall Study||20
10969072|NCT00530088|12142943|FG000|NOT COMPLETED|Overall Study||10
10969073|NCT00530218|12142947|FG000|STARTED|Overall Study||61
10969074|NCT00530218|12142947|FG000|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
10969075|NCT00530218|12142947|FG000|NOT COMPLETED|Overall Study||25
10969076|NCT00530257|12142954|FG000|STARTED|Overall Study||31
10969077|NCT00530257|12142954|FG000|COMPLETED|Overall Study||30
10969078|NCT00530257|12142954|FG000|NOT COMPLETED|Overall Study||1
10969079|NCT00530270|12142963|FG000|STARTED|Overall Study||6
10969080|NCT00530270|12142964|FG001|STARTED|Overall Study||6
10969081|NCT00530270|12142963|FG000|COMPLETED|Overall Study||5
10969082|NCT00530270|12142964|FG001|COMPLETED|Overall Study||6
10969083|NCT00530270|12142963|FG000|NOT COMPLETED|Overall Study||1
10969084|NCT00530270|12142964|FG001|NOT COMPLETED|Overall Study||0
10969085|NCT00530335|12142970|FG000|STARTED|Overall Study||45
10969086|NCT00530335|12142970|FG000|COMPLETED|Overall Study||39
10969087|NCT00530335|12142970|FG000|NOT COMPLETED|Overall Study||6
10969088|NCT00530348|12142976|FG000|STARTED|Overall Study|Randomized.|195
10969089|NCT00530348|12142977|FG001|STARTED|Overall Study|Randomized.|386
10969090|NCT00530348|12142976|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
10969091|NCT00530348|12142977|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
10969092|NCT00530348|12142976|FG000|COMPLETED|Overall Study||173
10969093|NCT00530348|12142977|FG001|COMPLETED|Overall Study||367
10969094|NCT00530348|12142976|FG000|NOT COMPLETED|Overall Study||22
10969095|NCT00530348|12142977|FG001|NOT COMPLETED|Overall Study||19
10969096|NCT00530439|12142985|FG000|STARTED|Overall Study||180
10969097|NCT00530439|12142986|FG001|STARTED|Overall Study||180
10969098|NCT00530439|12142985|FG000|COMPLETED|Overall Study||150
10969099|NCT00530439|12142986|FG001|COMPLETED|Overall Study||154
10969100|NCT00530439|12142985|FG000|NOT COMPLETED|Overall Study||30
10969101|NCT00530439|12142986|FG001|NOT COMPLETED|Overall Study||26
10969102|NCT00530504|12142992|FG000|STARTED|Overall Study||1500
10969103|NCT00530504|12142992|FG000|COMPLETED|Overall Study||1348
10969104|NCT00530504|12142992|FG000|NOT COMPLETED|Overall Study||152
10969105|NCT00530621|12142998|FG000|STARTED|Overall Study||80
10969106|NCT00530621|12142999|FG001|STARTED|Overall Study||80
10969107|NCT00530621|12142998|FG000|Received at Least 1 Dose of Study Drug|Overall Study||79
10969108|NCT00530621|12142999|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80
10969109|NCT00530621|12142998|FG000|COMPLETED|Overall Study||0
10969110|NCT00530621|12142999|FG001|COMPLETED|Overall Study||0
10969111|NCT00530621|12142998|FG000|NOT COMPLETED|Overall Study||80
10969112|NCT00530621|12142999|FG001|NOT COMPLETED|Overall Study||80
10969113|NCT00530634|12143009|FG000|STARTED|Overall Study||3
10969114|NCT00530634|12143009|FG000|COMPLETED|Overall Study||3
10969115|NCT00530634|12143009|FG000|NOT COMPLETED|Overall Study||0
10969116|NCT00530712|12143013|FG000|STARTED|Enrollment|Total Enrolled Subjects|287
10969117|NCT00530712|12143013|FG000|COMPLETED|Enrollment|Subjects Available at Discharge|287
10969118|NCT00530712|12143013|FG000|NOT COMPLETED|Enrollment||0
10969119|NCT00530712|12143013|FG000|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
10969120|NCT00530712|12143013|FG000|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
10969121|NCT00530712|12143013|FG000|NOT COMPLETED|30 Day Follow-up Visit||7
10969122|NCT00530712|12143013|FG000|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
10969123|NCT00530712|12143013|FG000|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
10969124|NCT00530712|12143013|FG000|NOT COMPLETED|6 Month Follow-up Visit||12
10969125|NCT00530712|12143013|FG000|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
10969126|NCT00530712|12143013|FG000|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
10969127|NCT00530712|12143013|FG000|NOT COMPLETED|12 Month Follow-up Visit||24
10969128|NCT00530764|12143022|FG000|STARTED|Overall Study||90
10969129|NCT00530764|12143023|FG001|STARTED|Overall Study||88
10969130|NCT00530764|12143024|FG002|STARTED|Overall Study||91
10969131|NCT00530764|12143025|FG003|STARTED|Overall Study||91
10969132|NCT00530764|12143022|FG000|COMPLETED|Overall Study||59
10969133|NCT00530764|12143023|FG001|COMPLETED|Overall Study||67
10969134|NCT00530764|12143024|FG002|COMPLETED|Overall Study||71
10969135|NCT00530764|12143025|FG003|COMPLETED|Overall Study||66
10969136|NCT00530764|12143022|FG000|NOT COMPLETED|Overall Study||31
10969137|NCT00530764|12143023|FG001|NOT COMPLETED|Overall Study||21
10969138|NCT00530764|12143024|FG002|NOT COMPLETED|Overall Study||20
10969139|NCT00530764|12143025|FG003|NOT COMPLETED|Overall Study||25
10969140|NCT00530777|12143040|FG000|STARTED|Overall Study||74
10969141|NCT00530777|12143041|FG001|STARTED|Overall Study||74
10969142|NCT00530777|12143040|FG000|COMPLETED|Overall Study||67
10969143|NCT00530777|12143041|FG001|COMPLETED|Overall Study||69
10969144|NCT00530777|12143040|FG000|NOT COMPLETED|Overall Study||7
10969145|NCT00530777|12143041|FG001|NOT COMPLETED|Overall Study||5
10969146|NCT00530790|12143047|FG000|STARTED|Overall Study||35
10969147|NCT00530790|12143047|FG000|COMPLETED|Overall Study||30
10969148|NCT00530790|12143047|FG000|NOT COMPLETED|Overall Study||5
10969149|NCT00530803|12143053|FG000|STARTED|Overall Study||50
10969150|NCT00530803|12143054|FG001|STARTED|Overall Study||50
10969151|NCT00530803|12143053|FG000|COMPLETED|Overall Study||50
10969152|NCT00530803|12143054|FG001|COMPLETED|Overall Study||50
10969153|NCT00530803|12143053|FG000|NOT COMPLETED|Overall Study||0
10969154|NCT00530803|12143054|FG001|NOT COMPLETED|Overall Study||0
10969155|NCT00530816|12143063|FG000|STARTED|Overall Study||35
10969156|NCT00530816|12143064|FG001|STARTED|Overall Study||59
10969157|NCT00530816|12143065|FG002|STARTED|Overall Study||70
10969158|NCT00530816|12143063|FG000|COMPLETED|Overall Study||9
10969159|NCT00530816|12143064|FG001|COMPLETED|Overall Study||17
10969160|NCT00530816|12143065|FG002|COMPLETED|Overall Study||29
10969161|NCT00530816|12143063|FG000|NOT COMPLETED|Overall Study||26
10969162|NCT00530816|12143064|FG001|NOT COMPLETED|Overall Study||42
10969163|NCT00530816|12143065|FG002|NOT COMPLETED|Overall Study||41
10969164|NCT00530842|12143075|FG000|STARTED|Overall Study||172
10969165|NCT00530842|12143076|FG001|STARTED|Overall Study||172
10969166|NCT00530842|12143075|FG000|COMPLETED|Overall Study||149
10969167|NCT00530842|12143076|FG001|COMPLETED|Overall Study||151
10969168|NCT00530842|12143075|FG000|NOT COMPLETED|Overall Study||23
10969169|NCT00530842|12143076|FG001|NOT COMPLETED|Overall Study||21
10969170|NCT00530842|12143075|FG000|STARTED|Period 1||172
10969171|NCT00530842|12143076|FG001|STARTED|Period 1||172
10969172|NCT00530842|12143075|FG000|COMPLETED|Period 1||158
10969173|NCT00530842|12143076|FG001|COMPLETED|Period 1||161
10969174|NCT00530842|12143075|FG000|NOT COMPLETED|Period 1||14
10969175|NCT00530842|12143076|FG001|NOT COMPLETED|Period 1||11
10969176|NCT00530842|12143075|FG000|STARTED|Period 2||157
10969177|NCT00530842|12143076|FG001|STARTED|Period 2||160
10969178|NCT00530842|12143075|FG000|COMPLETED|Period 2||149
10969179|NCT00530842|12143076|FG001|COMPLETED|Period 2||151
10969180|NCT00530842|12143075|FG000|NOT COMPLETED|Period 2||8
10969181|NCT00530842|12143076|FG001|NOT COMPLETED|Period 2||9
10969182|NCT00530855|12143084|FG000|STARTED|Overall Study||322
10969183|NCT00530855|12143084|FG000|COMPLETED|Overall Study||210
10969184|NCT00530855|12143084|FG000|NOT COMPLETED|Overall Study||112
10969185|NCT00530894|12143092|FG000|STARTED|Overall Study||348
10969186|NCT00530894|12143093|FG001|STARTED|Overall Study||351
10969187|NCT00530894|12143094|FG002|STARTED|Overall Study||179
10969188|NCT00530894|12143095|FG003|STARTED|Overall Study||179
10969189|NCT00530894|12143092|FG000|COMPLETED|Overall Study||260
10969190|NCT00530894|12143093|FG001|COMPLETED|Overall Study||236
10969191|NCT00530894|12143094|FG002|COMPLETED|Overall Study||124
10969192|NCT00530894|12143095|FG003|COMPLETED|Overall Study||85
10969193|NCT00530894|12143092|FG000|NOT COMPLETED|Overall Study||88
10969194|NCT00530894|12143093|FG001|NOT COMPLETED|Overall Study||115
10969195|NCT00530894|12143094|FG002|NOT COMPLETED|Overall Study||55
10969196|NCT00530894|12143095|FG003|NOT COMPLETED|Overall Study||94
10969197|NCT00530920|12143110|FG000|STARTED|Overall Study||30
10969198|NCT00530920|12143111|FG001|STARTED|Overall Study||27
10969199|NCT00530920|12143112|FG002|STARTED|Overall Study||28
10969200|NCT00530920|12143110|FG000|COMPLETED|Overall Study||30
10969201|NCT00530920|12143111|FG001|COMPLETED|Overall Study||25
10969202|NCT00530920|12143112|FG002|COMPLETED|Overall Study||24
10969203|NCT00530920|12143110|FG000|NOT COMPLETED|Overall Study||0
10969204|NCT00530920|12143111|FG001|NOT COMPLETED|Overall Study||2
10969205|NCT00530920|12143112|FG002|NOT COMPLETED|Overall Study||4
10969206|NCT00530946|12143125|FG000|STARTED|Overall Study||43
10969207|NCT00530946|12143126|FG001|STARTED|Overall Study||41
10969208|NCT00530946|12143127|FG002|STARTED|Overall Study||41
10969209|NCT00530946|12143128|FG003|STARTED|Overall Study||40
10969210|NCT00530946|12143125|FG000|COMPLETED|Overall Study||41
10969211|NCT00530946|12143126|FG001|COMPLETED|Overall Study||39
10969212|NCT00530946|12143127|FG002|COMPLETED|Overall Study||40
10969213|NCT00530946|12143128|FG003|COMPLETED|Overall Study||38
10969214|NCT00530946|12143125|FG000|NOT COMPLETED|Overall Study||2
10969215|NCT00530946|12143126|FG001|NOT COMPLETED|Overall Study||2
10969216|NCT00530946|12143127|FG002|NOT COMPLETED|Overall Study||1
10969217|NCT00530946|12143128|FG003|NOT COMPLETED|Overall Study||2
10969218|NCT00531011|12143140|FG000|STARTED|Overall Study||103
10969219|NCT00531011|12143141|FG001|STARTED|Overall Study||97
10969220|NCT00531011|12143140|FG000|COMPLETED|Overall Study||99
10969221|NCT00531011|12143141|FG001|COMPLETED|Overall Study||90
10969222|NCT00531011|12143140|FG000|NOT COMPLETED|Overall Study||4
10969223|NCT00531011|12143141|FG001|NOT COMPLETED|Overall Study||7
10969224|NCT00531050|12143153|FG000|STARTED|Part 1: Period 1||4
10969225|NCT00531050|12143154|FG001|STARTED|Part 1: Period 1||5
10969226|NCT00531050|12143155|FG002|STARTED|Part 1: Period 1||4
10969227|NCT00531050|12143156|FG003|STARTED|Part 1: Period 1||5
10969228|NCT00531050|12143157|FG004|STARTED|Part 1: Period 1||4
10969229|NCT00531050|12143158|FG005|STARTED|Part 1: Period 1||5
10969230|NCT00531050|12143153|FG000|COMPLETED|Part 1: Period 1||4
10969231|NCT00531050|12143154|FG001|COMPLETED|Part 1: Period 1||4
10969232|NCT00531050|12143155|FG002|COMPLETED|Part 1: Period 1||4
10969233|NCT00531050|12143156|FG003|COMPLETED|Part 1: Period 1||4
10969234|NCT00531050|12143157|FG004|COMPLETED|Part 1: Period 1||4
10969235|NCT00531050|12143158|FG005|COMPLETED|Part 1: Period 1||5
10969236|NCT00531050|12143153|FG000|NOT COMPLETED|Part 1: Period 1||0
10969237|NCT00531050|12143154|FG001|NOT COMPLETED|Part 1: Period 1||1
10969238|NCT00531050|12143155|FG002|NOT COMPLETED|Part 1: Period 1||0
10969239|NCT00531050|12143156|FG003|NOT COMPLETED|Part 1: Period 1||1
10969240|NCT00531050|12143157|FG004|NOT COMPLETED|Part 1: Period 1||0
10969241|NCT00531050|12143158|FG005|NOT COMPLETED|Part 1: Period 1||0
10969242|NCT00531050|12143153|FG000|STARTED|Part 1: Period 2||4
10969243|NCT00531050|12143154|FG001|STARTED|Part 1: Period 2||4
10969244|NCT00531050|12143155|FG002|STARTED|Part 1: Period 2||4
10969245|NCT00531050|12143156|FG003|STARTED|Part 1: Period 2||4
10969246|NCT00531050|12143157|FG004|STARTED|Part 1: Period 2||4
10969247|NCT00531050|12143158|FG005|STARTED|Part 1: Period 2||5
10969248|NCT00531050|12143153|FG000|COMPLETED|Part 1: Period 2||4
10969249|NCT00531050|12143154|FG001|COMPLETED|Part 1: Period 2||4
10969250|NCT00531050|12143155|FG002|COMPLETED|Part 1: Period 2||4
10969251|NCT00531050|12143156|FG003|COMPLETED|Part 1: Period 2||4
10969252|NCT00531050|12143157|FG004|COMPLETED|Part 1: Period 2||4
10969253|NCT00531050|12143158|FG005|COMPLETED|Part 1: Period 2||5
10969254|NCT00531050|12143153|FG000|NOT COMPLETED|Part 1: Period 2||0
10969255|NCT00531050|12143154|FG001|NOT COMPLETED|Part 1: Period 2||0
10969256|NCT00531050|12143155|FG002|NOT COMPLETED|Part 1: Period 2||0
10969257|NCT00531050|12143156|FG003|NOT COMPLETED|Part 1: Period 2||0
10969258|NCT00531050|12143157|FG004|NOT COMPLETED|Part 1: Period 2||0
10969259|NCT00531050|12143158|FG005|NOT COMPLETED|Part 1: Period 2||0
10969260|NCT00531050|12143153|FG000|STARTED|Part 1: Period 3||4
10969261|NCT00531050|12143154|FG001|STARTED|Part 1: Period 3||4
10969262|NCT00531050|12143155|FG002|STARTED|Part 1: Period 3||4
10969263|NCT00531050|12143156|FG003|STARTED|Part 1: Period 3||4
10969264|NCT00531050|12143157|FG004|STARTED|Part 1: Period 3||4
10969265|NCT00531050|12143158|FG005|STARTED|Part 1: Period 3||5
10969266|NCT00531050|12143153|FG000|COMPLETED|Part 1: Period 3||3
10969267|NCT00531050|12143154|FG001|COMPLETED|Part 1: Period 3||4
10969268|NCT00531050|12143155|FG002|COMPLETED|Part 1: Period 3||4
10969269|NCT00531050|12143156|FG003|COMPLETED|Part 1: Period 3||4
10969270|NCT00531050|12143157|FG004|COMPLETED|Part 1: Period 3||4
10969271|NCT00531050|12143158|FG005|COMPLETED|Part 1: Period 3||5
10969272|NCT00531050|12143153|FG000|NOT COMPLETED|Part 1: Period 3||1
10969273|NCT00531050|12143154|FG001|NOT COMPLETED|Part 1: Period 3||0
10969274|NCT00531050|12143155|FG002|NOT COMPLETED|Part 1: Period 3||0
10969275|NCT00531050|12143156|FG003|NOT COMPLETED|Part 1: Period 3||0
10969276|NCT00531050|12143157|FG004|NOT COMPLETED|Part 1: Period 3||0
10969277|NCT00531050|12143158|FG005|NOT COMPLETED|Part 1: Period 3||0
10969278|NCT00531050|12143153|FG000|STARTED|Part 2: Period 1||3
10969279|NCT00531050|12143154|FG001|STARTED|Part 2: Period 1||4
10969280|NCT00531050|12143155|FG002|STARTED|Part 2: Period 1||4
10969281|NCT00531050|12143156|FG003|STARTED|Part 2: Period 1||4
10969282|NCT00531050|12143157|FG004|STARTED|Part 2: Period 1||4
10969283|NCT00531050|12143158|FG005|STARTED|Part 2: Period 1||5
10969284|NCT00531050|12143153|FG000|COMPLETED|Part 2: Period 1||3
10969285|NCT00531050|12143154|FG001|COMPLETED|Part 2: Period 1||4
10969286|NCT00531050|12143155|FG002|COMPLETED|Part 2: Period 1||4
10969287|NCT00531050|12143156|FG003|COMPLETED|Part 2: Period 1||4
10969288|NCT00531050|12143157|FG004|COMPLETED|Part 2: Period 1||4
10969289|NCT00531050|12143158|FG005|COMPLETED|Part 2: Period 1||4
10969290|NCT00531050|12143153|FG000|NOT COMPLETED|Part 2: Period 1||0
10969291|NCT00531050|12143154|FG001|NOT COMPLETED|Part 2: Period 1||0
10969292|NCT00531050|12143155|FG002|NOT COMPLETED|Part 2: Period 1||0
10969293|NCT00531050|12143156|FG003|NOT COMPLETED|Part 2: Period 1||0
10969294|NCT00531050|12143157|FG004|NOT COMPLETED|Part 2: Period 1||0
10969295|NCT00531050|12143158|FG005|NOT COMPLETED|Part 2: Period 1||1
10969296|NCT00531050|12143153|FG000|STARTED|Part 2: Period 2||3
10969297|NCT00531050|12143154|FG001|STARTED|Part 2: Period 2||4
10969298|NCT00531050|12143155|FG002|STARTED|Part 2: Period 2||4
10969299|NCT00531050|12143156|FG003|STARTED|Part 2: Period 2||4
10969300|NCT00531050|12143157|FG004|STARTED|Part 2: Period 2||4
10969301|NCT00531050|12143158|FG005|STARTED|Part 2: Period 2||4
10969302|NCT00531050|12143153|FG000|COMPLETED|Part 2: Period 2||3
10969303|NCT00531050|12143154|FG001|COMPLETED|Part 2: Period 2||4
10969304|NCT00531050|12143155|FG002|COMPLETED|Part 2: Period 2||4
10969305|NCT00531050|12143156|FG003|COMPLETED|Part 2: Period 2||4
10969306|NCT00531050|12143157|FG004|COMPLETED|Part 2: Period 2||4
10969307|NCT00531050|12143158|FG005|COMPLETED|Part 2: Period 2||4
10969308|NCT00531050|12143153|FG000|NOT COMPLETED|Part 2: Period 2||0
10969309|NCT00531050|12143154|FG001|NOT COMPLETED|Part 2: Period 2||0
10969310|NCT00531050|12143155|FG002|NOT COMPLETED|Part 2: Period 2||0
10969311|NCT00531050|12143156|FG003|NOT COMPLETED|Part 2: Period 2||0
10969312|NCT00531050|12143157|FG004|NOT COMPLETED|Part 2: Period 2||0
10969313|NCT00531050|12143158|FG005|NOT COMPLETED|Part 2: Period 2||0
10969314|NCT00531050|12143153|FG000|STARTED|Part 2: Period 3||3
10969315|NCT00531050|12143154|FG001|STARTED|Part 2: Period 3||4
10969316|NCT00531050|12143155|FG002|STARTED|Part 2: Period 3||4
10969317|NCT00531050|12143156|FG003|STARTED|Part 2: Period 3||4
10969318|NCT00531050|12143157|FG004|STARTED|Part 2: Period 3||4
10969319|NCT00531050|12143158|FG005|STARTED|Part 2: Period 3||4
10969320|NCT00531050|12143153|FG000|COMPLETED|Part 2: Period 3||2
10969321|NCT00531050|12143154|FG001|COMPLETED|Part 2: Period 3||4
10969322|NCT00531050|12143155|FG002|COMPLETED|Part 2: Period 3||4
10969323|NCT00531050|12143156|FG003|COMPLETED|Part 2: Period 3||4
10969324|NCT00531050|12143157|FG004|COMPLETED|Part 2: Period 3||4
10969325|NCT00531050|12143158|FG005|COMPLETED|Part 2: Period 3||3
10969326|NCT00531050|12143153|FG000|NOT COMPLETED|Part 2: Period 3||1
10969327|NCT00531050|12143154|FG001|NOT COMPLETED|Part 2: Period 3||0
10969328|NCT00531050|12143155|FG002|NOT COMPLETED|Part 2: Period 3||0
10969329|NCT00531050|12143156|FG003|NOT COMPLETED|Part 2: Period 3||0
10969330|NCT00531050|12143157|FG004|NOT COMPLETED|Part 2: Period 3||0
10969331|NCT00531050|12143158|FG005|NOT COMPLETED|Part 2: Period 3||1
10969332|NCT00531206|12143175|FG000|STARTED|Overall Study||65
10969333|NCT00531206|12143175|FG000|COMPLETED|Overall Study||45
10969334|NCT00531206|12143175|FG000|NOT COMPLETED|Overall Study||20
10969335|NCT00531284|12143196|FG000|STARTED|Overall Study||3
10969336|NCT00531284|12143197|FG001|STARTED|Overall Study||4
10969337|NCT00531284|12143198|FG002|STARTED|Overall Study||7
10969338|NCT00531284|12143199|FG003|STARTED|Overall Study||65
10969339|NCT00531284|12143200|FG004|STARTED|Overall Study||6
10969340|NCT00531284|12143201|FG005|STARTED|Overall Study||7
10969341|NCT00531284|12143202|FG006|STARTED|Overall Study||6
10969342|NCT00531284|12143203|FG007|STARTED|Overall Study||10
10969343|NCT00531284|12143204|FG008|STARTED|Overall Study||11
10969344|NCT00531284|12143205|FG009|STARTED|Overall Study||4
10969345|NCT00531284|12143206|FG010|STARTED|Overall Study||3
10969346|NCT00531284|12143207|FG011|STARTED|Overall Study||24
10969347|NCT00531284|12143208|FG012|STARTED|Overall Study||2
10969348|NCT00531284|12143209|FG013|STARTED|Overall Study||3
10969349|NCT00531284|12143210|FG014|STARTED|Overall Study||7
10969350|NCT00531284|12143211|FG015|STARTED|Overall Study||14
10969351|NCT00531284|12143212|FG016|STARTED|Overall Study||8
10969352|NCT00531284|12143196|FG000|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
10969353|NCT00531284|12143197|FG001|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
10969354|NCT00531284|12143198|FG002|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
10969355|NCT00531284|12143199|FG003|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
10969356|NCT00531284|12143200|FG004|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10969357|NCT00531284|12143201|FG005|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10969358|NCT00531284|12143202|FG006|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10969359|NCT00531284|12143203|FG007|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10969360|NCT00531284|12143204|FG008|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10969361|NCT00531284|12143205|FG009|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10969362|NCT00531284|12143206|FG010|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10969363|NCT00531284|12143207|FG011|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10969364|NCT00531284|12143208|FG012|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10969365|NCT00531284|12143209|FG013|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10969366|NCT00531284|12143210|FG014|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
10969367|NCT00531284|12143211|FG015|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
10969368|NCT00531284|12143212|FG016|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
10969369|NCT00531284|12143196|FG000|NOT COMPLETED|Overall Study||3
10969370|NCT00531284|12143197|FG001|NOT COMPLETED|Overall Study||4
10969371|NCT00531284|12143198|FG002|NOT COMPLETED|Overall Study||6
10969372|NCT00531284|12143199|FG003|NOT COMPLETED|Overall Study||63
10969373|NCT00531284|12143200|FG004|NOT COMPLETED|Overall Study||6
10969374|NCT00531284|12143201|FG005|NOT COMPLETED|Overall Study||7
10969375|NCT00531284|12143202|FG006|NOT COMPLETED|Overall Study||6
10969376|NCT00531284|12143203|FG007|NOT COMPLETED|Overall Study||10
10969377|NCT00531284|12143204|FG008|NOT COMPLETED|Overall Study||11
10969378|NCT00531284|12143205|FG009|NOT COMPLETED|Overall Study||4
10969379|NCT00531284|12143206|FG010|NOT COMPLETED|Overall Study||3
10969380|NCT00531284|12143207|FG011|NOT COMPLETED|Overall Study||24
10969381|NCT00531284|12143208|FG012|NOT COMPLETED|Overall Study||2
10969382|NCT00531284|12143209|FG013|NOT COMPLETED|Overall Study||3
10969383|NCT00531284|12143210|FG014|NOT COMPLETED|Overall Study||4
10969384|NCT00531284|12143211|FG015|NOT COMPLETED|Overall Study||12
10969385|NCT00531284|12143212|FG016|NOT COMPLETED|Overall Study||8
10969386|NCT00531427|12143270|FG000|STARTED|Overall Study||282
10969387|NCT00531427|12143271|FG001|STARTED|Overall Study||285
10969388|NCT00531427|12143270|FG000|COMPLETED|Overall Study||209
10969389|NCT00531427|12143271|FG001|COMPLETED|Overall Study||191
10969390|NCT00531427|12143270|FG000|NOT COMPLETED|Overall Study||73
10969391|NCT00531427|12143271|FG001|NOT COMPLETED|Overall Study||94
10969392|NCT00531453|12143280|FG000|STARTED|Overall Study|02 October 2007|49
10969393|NCT00531453|12143281|FG001|STARTED|Overall Study|02 October 2007|49
10969394|NCT00531453|12143280|FG000|COMPLETED|Overall Study|10 April 2009|49
10969395|NCT00531453|12143281|FG001|COMPLETED|Overall Study|10 April 2009|49
10969396|NCT00531453|12143280|FG000|NOT COMPLETED|Overall Study||0
10969397|NCT00531453|12143281|FG001|NOT COMPLETED|Overall Study||0
10969398|NCT00531479|12143289|FG000|STARTED|Overall Study||230
10969399|NCT00531479|12143290|FG001|STARTED|Overall Study||229
10969400|NCT00531479|12143289|FG000|Treated|Overall Study||228
10969401|NCT00531479|12143290|FG001|Treated|Overall Study||226
10969402|NCT00531479|12143289|FG000|COMPLETED|Overall Study||154
10969403|NCT00531479|12143290|FG001|COMPLETED|Overall Study||146
10969404|NCT00531479|12143289|FG000|NOT COMPLETED|Overall Study||76
10969405|NCT00531479|12143290|FG001|NOT COMPLETED|Overall Study||83
10969406|NCT00531518|12143298|FG000|STARTED|Overall Study||87
10969407|NCT00531518|12143299|FG001|STARTED|Overall Study||205
10969408|NCT00531518|12143298|FG000|COMPLETED|Overall Study||55
10969409|NCT00531518|12143299|FG001|COMPLETED|Overall Study||134
10969410|NCT00531518|12143298|FG000|NOT COMPLETED|Overall Study||32
10969411|NCT00531518|12143299|FG001|NOT COMPLETED|Overall Study||71
10969412|NCT00531661|12143307|FG000|STARTED|6 Months||270
10969413|NCT00531661|12143308|FG001|STARTED|6 Months||280
10969414|NCT00531661|12143307|FG000|COMPLETED|6 Months||244
10969415|NCT00531661|12143308|FG001|COMPLETED|6 Months||254
10969416|NCT00531661|12143307|FG000|NOT COMPLETED|6 Months||26
10969417|NCT00531661|12143308|FG001|NOT COMPLETED|6 Months||26
10969418|NCT00531661|12143307|FG000|STARTED|Study Duration: 15 Months Avg. Follow-up||244
10969419|NCT00531661|12143308|FG001|STARTED|Study Duration: 15 Months Avg. Follow-up||254
10969420|NCT00531661|12143307|FG000|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
10969421|NCT00531661|12143308|FG001|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
10969422|NCT00531661|12143307|FG000|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
10969423|NCT00531661|12143308|FG001|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
10969424|NCT00531752|12143321|FG000|STARTED|First Double-blind Intervention Period||17
10969425|NCT00531752|12143322|FG001|STARTED|First Double-blind Intervention Period||17
10969426|NCT00531752|12143323|FG002|STARTED|First Double-blind Intervention Period||16
10969427|NCT00531752|12143324|FG003|STARTED|First Double-blind Intervention Period||16
10969428|NCT00531752|12143321|FG000|Treated|First Double-blind Intervention Period||16
10969429|NCT00531752|12143322|FG001|Treated|First Double-blind Intervention Period||17
10969430|NCT00531752|12143323|FG002|Treated|First Double-blind Intervention Period||16
10969431|NCT00531752|12143324|FG003|Treated|First Double-blind Intervention Period||16
10969432|NCT00531752|12143321|FG000|COMPLETED|First Double-blind Intervention Period||11
10969433|NCT00531752|12143322|FG001|COMPLETED|First Double-blind Intervention Period||13
10969434|NCT00531752|12143323|FG002|COMPLETED|First Double-blind Intervention Period||9
10969435|NCT00531752|12143324|FG003|COMPLETED|First Double-blind Intervention Period||13
10969436|NCT00531752|12143321|FG000|NOT COMPLETED|First Double-blind Intervention Period||6
10969437|NCT00531752|12143322|FG001|NOT COMPLETED|First Double-blind Intervention Period||4
10969438|NCT00531752|12143323|FG002|NOT COMPLETED|First Double-blind Intervention Period||7
10969439|NCT00531752|12143324|FG003|NOT COMPLETED|First Double-blind Intervention Period||3
10969440|NCT00531752|12143321|FG000|STARTED|Wash-out Period (at Least 7 Days)||11
10969441|NCT00531752|12143322|FG001|STARTED|Wash-out Period (at Least 7 Days)||13
10969442|NCT00531752|12143323|FG002|STARTED|Wash-out Period (at Least 7 Days)||9
10969443|NCT00531752|12143324|FG003|STARTED|Wash-out Period (at Least 7 Days)||13
10969444|NCT00531752|12143321|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||11
10969445|NCT00531752|12143322|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||13
10969446|NCT00531752|12143323|FG002|COMPLETED|Wash-out Period (at Least 7 Days)||9
10969447|NCT00531752|12143324|FG003|COMPLETED|Wash-out Period (at Least 7 Days)||13
10969448|NCT00531752|12143321|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
10969449|NCT00531752|12143322|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
10969450|NCT00531752|12143323|FG002|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
10969451|NCT00531752|12143324|FG003|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
10969452|NCT00531752|12143321|FG000|STARTED|Second Double-blind Intervention Period||11
10969453|NCT00531752|12143322|FG001|STARTED|Second Double-blind Intervention Period||13
10969454|NCT00531752|12143323|FG002|STARTED|Second Double-blind Intervention Period||9
10969455|NCT00531752|12143324|FG003|STARTED|Second Double-blind Intervention Period||13
10969456|NCT00531752|12143321|FG000|COMPLETED|Second Double-blind Intervention Period||9
10969457|NCT00531752|12143322|FG001|COMPLETED|Second Double-blind Intervention Period||11
10969458|NCT00531752|12143323|FG002|COMPLETED|Second Double-blind Intervention Period||9
10969459|NCT00531752|12143324|FG003|COMPLETED|Second Double-blind Intervention Period||11
10969460|NCT00531752|12143321|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2
10969461|NCT00531752|12143322|FG001|NOT COMPLETED|Second Double-blind Intervention Period||2
10969462|NCT00531752|12143323|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0
10969463|NCT00531752|12143324|FG003|NOT COMPLETED|Second Double-blind Intervention Period||2
10969464|NCT00531817|12143334|FG000|STARTED|Randomized||412
10969465|NCT00531817|12143335|FG001|STARTED|Randomized||207
10969466|NCT00531817|12143334|FG000|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
10969467|NCT00531817|12143335|FG001|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
10969468|NCT00531817|12143334|FG000|COMPLETED|Randomized||353
10969469|NCT00531817|12143335|FG001|COMPLETED|Randomized||173
10969470|NCT00531817|12143334|FG000|NOT COMPLETED|Randomized||59
10969471|NCT00531817|12143335|FG001|NOT COMPLETED|Randomized||34
10969472|NCT00531817|12143334|FG000|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|343
10969473|NCT00531817|12143335|FG001|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|170
10969474|NCT00531817|12143334|FG000|COMPLETED|Entered Extended Treatment Period||206
10969475|NCT00531817|12143335|FG001|COMPLETED|Entered Extended Treatment Period||113
10969476|NCT00531817|12143334|FG000|NOT COMPLETED|Entered Extended Treatment Period||137
10969477|NCT00531817|12143335|FG001|NOT COMPLETED|Entered Extended Treatment Period||57
10969478|NCT00531843|12143344|FG000|STARTED|Overall Study||81
10969479|NCT00531843|12143345|FG001|STARTED|Overall Study||6
10969480|NCT00531843|12143344|FG000|COMPLETED|Overall Study||81
10969481|NCT00531843|12143345|FG001|COMPLETED|Overall Study||6
10969482|NCT00531843|12143344|FG000|NOT COMPLETED|Overall Study||0
10969483|NCT00531843|12143345|FG001|NOT COMPLETED|Overall Study||0
10969484|NCT00531882|12143354|FG000|STARTED|Overall Study||10
10969485|NCT00531882|12143355|FG001|STARTED|Overall Study||10
10969486|NCT00531882|12143356|FG002|STARTED|Overall Study||5
10969487|NCT00531882|12143354|FG000|COMPLETED|Overall Study||10
10969488|NCT00531882|12143355|FG001|COMPLETED|Overall Study||10
10969489|NCT00531882|12143356|FG002|COMPLETED|Overall Study||5
10969490|NCT00531882|12143354|FG000|NOT COMPLETED|Overall Study||0
10969491|NCT00531882|12143355|FG001|NOT COMPLETED|Overall Study||0
10969492|NCT00531882|12143356|FG002|NOT COMPLETED|Overall Study||0
10969493|NCT00531934|12143366|FG000|STARTED|Overall Study||73
10969494|NCT00531934|12143367|FG001|STARTED|Overall Study||74
10969495|NCT00531934|12143366|FG000|COMPLETED|Overall Study||7
10969496|NCT00531934|12143367|FG001|COMPLETED|Overall Study||11
10969497|NCT00531934|12143366|FG000|NOT COMPLETED|Overall Study||66
10969498|NCT00531934|12143367|FG001|NOT COMPLETED|Overall Study||63
10969499|NCT00531947|12143375|FG000|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
10969500|NCT00531947|12143376|FG001|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
10969501|NCT00531947|12143375|FG000|COMPLETED|Overall Study||114
10969502|NCT00531947|12143376|FG001|COMPLETED|Overall Study||101
10969503|NCT00531947|12143375|FG000|NOT COMPLETED|Overall Study||42
10969504|NCT00531947|12143376|FG001|NOT COMPLETED|Overall Study||51
10969505|NCT00531960|12143384|FG000|STARTED|Overall Study||61
10969506|NCT00531960|12143385|FG001|STARTED|Overall Study||63
10969507|NCT00531960|12143384|FG000|COMPLETED|Overall Study||0
10969508|NCT00531960|12143385|FG001|COMPLETED|Overall Study||0
10969509|NCT00531960|12143384|FG000|NOT COMPLETED|Overall Study||61
10969510|NCT00531960|12143385|FG001|NOT COMPLETED|Overall Study||63
10969511|NCT00532129|12143391|FG000|STARTED|Treatment Period||100
10969512|NCT00532129|12143391|FG000|COMPLETED|Treatment Period||51
10969513|NCT00532129|12143391|FG000|NOT COMPLETED|Treatment Period||49
10969514|NCT00532129|12143391|FG000|STARTED|Follow-up Period||98
10969515|NCT00532129|12143391|FG000|COMPLETED|Follow-up Period||33
10969516|NCT00532129|12143391|FG000|NOT COMPLETED|Follow-up Period||65
10969517|NCT00532155|12143397|FG000|STARTED|Overall Study||457
10969518|NCT00532155|12143398|FG001|STARTED|Overall Study||456
10969519|NCT00532155|12143397|FG000|SAFETY POPULATION|Overall Study||455
10969520|NCT00532155|12143398|FG001|SAFETY POPULATION|Overall Study||450
10969521|NCT00532155|12143397|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
10969522|NCT00532155|12143398|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
10969523|NCT00532155|12143397|FG000|NOT COMPLETED|Overall Study||457
10969524|NCT00532155|12143398|FG001|NOT COMPLETED|Overall Study||456
10969525|NCT00532259|12143404|FG000|STARTED|Overall Study||72
10969526|NCT00532259|12143404|FG000|COMPLETED|Overall Study||40
10969527|NCT00532259|12143404|FG000|NOT COMPLETED|Overall Study||32
10969528|NCT00532298|12143415|FG000|STARTED|Overall Study||269
10969529|NCT00532298|12143416|FG001|STARTED|Overall Study||266
10969530|NCT00532298|12143417|FG002|STARTED|Overall Study||264
10969531|NCT00532298|12143418|FG003|STARTED|Overall Study||264
10969532|NCT00532298|12143419|FG004|STARTED|Overall Study||268
10969533|NCT00532298|12143420|FG005|STARTED|Overall Study||263
10969534|NCT00532298|12143415|FG000|COMPLETED|Overall Study||267
10969535|NCT00532298|12143416|FG001|COMPLETED|Overall Study||265
10969536|NCT00532298|12143417|FG002|COMPLETED|Overall Study||263
10969537|NCT00532298|12143418|FG003|COMPLETED|Overall Study||264
10969538|NCT00532298|12143419|FG004|COMPLETED|Overall Study||267
10969539|NCT00532298|12143420|FG005|COMPLETED|Overall Study||261
10969540|NCT00532298|12143415|FG000|NOT COMPLETED|Overall Study||2
10969541|NCT00532298|12143416|FG001|NOT COMPLETED|Overall Study||1
10969542|NCT00532298|12143417|FG002|NOT COMPLETED|Overall Study||1
10969543|NCT00532298|12143418|FG003|NOT COMPLETED|Overall Study||0
10969544|NCT00532298|12143419|FG004|NOT COMPLETED|Overall Study||1
10969545|NCT00532298|12143420|FG005|NOT COMPLETED|Overall Study||2
10969546|NCT00532441|12143434|FG000|STARTED|Overall Study||14
10969547|NCT00532441|12143435|FG001|STARTED|Overall Study||11
10969548|NCT00532441|12143434|FG000|COMPLETED|Overall Study||13
10969549|NCT00532441|12143435|FG001|COMPLETED|Overall Study||11
10969550|NCT00532441|12143434|FG000|NOT COMPLETED|Overall Study||1
10969551|NCT00532441|12143435|FG001|NOT COMPLETED|Overall Study||0
10969552|NCT00532480|12143444|FG000|STARTED|Overall Study||10
10969553|NCT00532480|12143444|FG000|COMPLETED|Overall Study||7
10969554|NCT00532480|12143444|FG000|NOT COMPLETED|Overall Study||3
10969555|NCT00532493|12143450|FG000|STARTED|Overall Study||152
10969556|NCT00532493|12143451|FG001|STARTED|Overall Study||152
10969557|NCT00532493|12143450|FG000|COMPLETED|Overall Study||122
10969558|NCT00532493|12143451|FG001|COMPLETED|Overall Study||123
10969559|NCT00532493|12143450|FG000|NOT COMPLETED|Overall Study||30
10969560|NCT00532493|12143451|FG001|NOT COMPLETED|Overall Study||29
10969561|NCT00532779|12143462|FG000|STARTED|Overall Study||578
10969562|NCT00532779|12143463|FG001|STARTED|Overall Study||583
10969563|NCT00532779|12143464|FG002|STARTED|Overall Study||581
10969564|NCT00532779|12143462|FG000|COMPLETED|Overall Study||284
10969565|NCT00532779|12143463|FG001|COMPLETED|Overall Study||296
10969566|NCT00532779|12143464|FG002|COMPLETED|Overall Study||290
10969567|NCT00532779|12143462|FG000|NOT COMPLETED|Overall Study||294
10969568|NCT00532779|12143463|FG001|NOT COMPLETED|Overall Study||287
10969569|NCT00532779|12143464|FG002|NOT COMPLETED|Overall Study||291
10969570|NCT00532844|12143474|FG000|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
10969571|NCT00532844|12143475|FG001|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
10969572|NCT00532844|12143474|FG000|COMPLETED|Treatment Period - Day 1 to Day 14||24
10969573|NCT00532844|12143475|FG001|COMPLETED|Treatment Period - Day 1 to Day 14||23
10969574|NCT00532844|12143474|FG000|NOT COMPLETED|Treatment Period - Day 1 to Day 14||0
10969575|NCT00532844|12143475|FG001|NOT COMPLETED|Treatment Period - Day 1 to Day 14||1
10969576|NCT00532844|12143474|FG000|STARTED|Washout (1 Day)||24
10969577|NCT00532844|12143475|FG001|STARTED|Washout (1 Day)||23
10969578|NCT00532844|12143474|FG000|COMPLETED|Washout (1 Day)||24
10969579|NCT00532844|12143475|FG001|COMPLETED|Washout (1 Day)||23
10969580|NCT00532844|12143474|FG000|NOT COMPLETED|Washout (1 Day)||0
10969581|NCT00532844|12143475|FG001|NOT COMPLETED|Washout (1 Day)||0
10969582|NCT00532844|12143474|FG000|STARTED|Treatment Period - Day 15 to Day 28||24
10969583|NCT00532844|12143475|FG001|STARTED|Treatment Period - Day 15 to Day 28||23
10969584|NCT00532844|12143474|FG000|COMPLETED|Treatment Period - Day 15 to Day 28||20
10969585|NCT00532844|12143475|FG001|COMPLETED|Treatment Period - Day 15 to Day 28||23
10969586|NCT00532844|12143474|FG000|NOT COMPLETED|Treatment Period - Day 15 to Day 28||4
10969587|NCT00532844|12143475|FG001|NOT COMPLETED|Treatment Period - Day 15 to Day 28||0
10969588|NCT00532883|12143498|FG000|STARTED|Overall Study||11
10969589|NCT00532883|12143499|FG001|STARTED|Overall Study||12
10969590|NCT00532883|12143500|FG002|STARTED|Overall Study||10
10969591|NCT00532883|12143501|FG003|STARTED|Overall Study||11
10969592|NCT00532883|12143498|FG000|COMPLETED|Overall Study|Study terminated early.|5
10969593|NCT00532883|12143499|FG001|COMPLETED|Overall Study|Study terminated early.|5
10969594|NCT00532883|12143500|FG002|COMPLETED|Overall Study|Study terminated early.|6
10969595|NCT00532883|12143501|FG003|COMPLETED|Overall Study|Study terminated early.|6
10969596|NCT00532883|12143498|FG000|NOT COMPLETED|Overall Study||6
10969597|NCT00532883|12143499|FG001|NOT COMPLETED|Overall Study||7
10969598|NCT00532883|12143500|FG002|NOT COMPLETED|Overall Study||4
10969599|NCT00532883|12143501|FG003|NOT COMPLETED|Overall Study||5
10969600|NCT00532935|12143513|FG000|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
10969601|NCT00532935|12143514|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
10969602|NCT00532935|12143513|FG000|COMPLETED|Overall Study||210
10969603|NCT00532935|12143514|FG001|COMPLETED|Overall Study||204
10969604|NCT00532935|12143513|FG000|NOT COMPLETED|Overall Study||51
10969605|NCT00532935|12143514|FG001|NOT COMPLETED|Overall Study||52
10969606|NCT00532948|12143523|FG000|STARTED|Overall Study||4
10969607|NCT00532948|12143524|FG001|STARTED|Overall Study||14
10969608|NCT00532948|12143525|FG002|STARTED|Overall Study||6
10969609|NCT00532948|12143523|FG000|COMPLETED|Overall Study||0
10969610|NCT00532948|12143524|FG001|COMPLETED|Overall Study||9
10969611|NCT00532948|12143525|FG002|COMPLETED|Overall Study||2
10969612|NCT00532948|12143523|FG000|NOT COMPLETED|Overall Study||4
10969613|NCT00532948|12143524|FG001|NOT COMPLETED|Overall Study||5
10969614|NCT00532948|12143525|FG002|NOT COMPLETED|Overall Study||4
10969615|NCT00533117|12143541|FG000|STARTED|Overall Study||18
10969616|NCT00533117|12143542|FG001|STARTED|Overall Study||19
10969617|NCT00533117|12143543|FG002|STARTED|Overall Study||20
10969618|NCT00533117|12143544|FG003|STARTED|Overall Study||18
10969619|NCT00533117|12143541|FG000|COMPLETED|Overall Study||14
10969620|NCT00533117|12143542|FG001|COMPLETED|Overall Study||14
10969621|NCT00533117|12143543|FG002|COMPLETED|Overall Study||14
10969622|NCT00533117|12143544|FG003|COMPLETED|Overall Study||13
10969623|NCT00533117|12143541|FG000|NOT COMPLETED|Overall Study||4
10969624|NCT00533117|12143542|FG001|NOT COMPLETED|Overall Study||5
10969625|NCT00533117|12143543|FG002|NOT COMPLETED|Overall Study||6
10969626|NCT00533117|12143544|FG003|NOT COMPLETED|Overall Study||5
10969627|NCT00533273|12143556|FG000|STARTED|Double-blind||45
10969628|NCT00533273|12143557|FG001|STARTED|Double-blind||21
10969629|NCT00533273|12143556|FG000|COMPLETED|Double-blind||45
10969630|NCT00533273|12143557|FG001|COMPLETED|Double-blind||19
10969631|NCT00533273|12143556|FG000|NOT COMPLETED|Double-blind||0
10969632|NCT00533273|12143557|FG001|NOT COMPLETED|Double-blind||2
10969633|NCT00533273|12143556|FG000|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
10969634|NCT00533273|12143557|FG001|STARTED|Open-label|no placebo - this phase was open label|0
10969635|NCT00533273|12143556|FG000|COMPLETED|Open-label||58
10969636|NCT00533273|12143557|FG001|COMPLETED|Open-label||0
10969637|NCT00533273|12143556|FG000|NOT COMPLETED|Open-label||6
10969638|NCT00533273|12143557|FG001|NOT COMPLETED|Open-label||0
10969639|NCT00533429|12143565|FG000|STARTED|Overall Study||20
10969640|NCT00533429|12143566|FG001|STARTED|Overall Study||20
10969641|NCT00533429|12143565|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
10969642|NCT00533429|12143566|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
10969643|NCT00533429|12143565|FG000|Entered Maintenance|Overall Study||8
10969644|NCT00533429|12143566|FG001|Entered Maintenance|Overall Study||10
10969645|NCT00533429|12143565|FG000|COMPLETED|Overall Study||1
10969646|NCT00533429|12143566|FG001|COMPLETED|Overall Study||4
10969647|NCT00533429|12143565|FG000|NOT COMPLETED|Overall Study||19
10969648|NCT00533429|12143566|FG001|NOT COMPLETED|Overall Study||16
10969649|NCT00533442|12143576|FG000|STARTED|Allocation and Intent to Treat Analysis||86
10969650|NCT00533442|12143577|FG001|STARTED|Allocation and Intent to Treat Analysis||84
10969651|NCT00533442|12143576|FG000|COMPLETED|Allocation and Intent to Treat Analysis||86
10969652|NCT00533442|12143577|FG001|COMPLETED|Allocation and Intent to Treat Analysis||84
10969653|NCT00533442|12143576|FG000|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
10969654|NCT00533442|12143577|FG001|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
10969655|NCT00533442|12143576|FG000|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
10969656|NCT00533442|12143577|FG001|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
10969657|NCT00533442|12143576|FG000|COMPLETED|Follow-up||77
10969658|NCT00533442|12143577|FG001|COMPLETED|Follow-up||74
10969659|NCT00533442|12143576|FG000|NOT COMPLETED|Follow-up||9
10969660|NCT00533442|12143577|FG001|NOT COMPLETED|Follow-up||10
10969661|NCT00533507|12143585|FG000|STARTED|Overall Study||230
10969662|NCT00533507|12143585|FG000|COMPLETED|Overall Study||229
10969663|NCT00533507|12143585|FG000|NOT COMPLETED|Overall Study||1
10969664|NCT00533546|12143589|FG000|STARTED|Overall Study||12
10969665|NCT00533546|12143589|FG000|COMPLETED|Overall Study||12
10969666|NCT00533546|12143589|FG000|NOT COMPLETED|Overall Study||0
10969667|NCT00533702|12143596|FG000|STARTED|Overall Study||54
10969668|NCT00533702|12143597|FG001|STARTED|Overall Study||52
10969669|NCT00533702|12143596|FG000|Received Any Quantity of Study Drug|Overall Study||52
10969670|NCT00533702|12143597|FG001|Received Any Quantity of Study Drug|Overall Study||50
10969671|NCT00533702|12143596|FG000|COMPLETED|Overall Study||49
10969672|NCT00533702|12143597|FG001|COMPLETED|Overall Study||50
10969673|NCT00533702|12143596|FG000|NOT COMPLETED|Overall Study||5
10969674|NCT00533702|12143597|FG001|NOT COMPLETED|Overall Study||2
10969675|NCT00533845|12143605|FG000|STARTED|Overall Study||15
10969676|NCT00533845|12143606|FG001|STARTED|Overall Study||15
10969677|NCT00533845|12143605|FG000|COMPLETED|Overall Study||14
10969678|NCT00533845|12143606|FG001|COMPLETED|Overall Study||15
10969679|NCT00533845|12143605|FG000|NOT COMPLETED|Overall Study||1
10969680|NCT00533845|12143606|FG001|NOT COMPLETED|Overall Study||0
10969681|NCT00533897|12143615|FG000|STARTED|Lead-in (LI) Period 1||167
10969682|NCT00533897|12143616|FG001|STARTED|Lead-in (LI) Period 1||0
10969683|NCT00533897|12143617|FG002|STARTED|Lead-in (LI) Period 1||0
10969684|NCT00533897|12143618|FG003|STARTED|Lead-in (LI) Period 1||0
10969685|NCT00533897|12143619|FG004|STARTED|Lead-in (LI) Period 1||0
10969686|NCT00533897|12143620|FG005|STARTED|Lead-in (LI) Period 1||0
10969687|NCT00533897|12143621|FG006|STARTED|Lead-in (LI) Period 1||0
10969688|NCT00533897|12143622|FG007|STARTED|Lead-in (LI) Period 1||0
10969689|NCT00533897|12143615|FG000|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
10969690|NCT00533897|12143616|FG001|COMPLETED|Lead-in (LI) Period 1||0
10969691|NCT00533897|12143617|FG002|COMPLETED|Lead-in (LI) Period 1||0
10969692|NCT00533897|12143618|FG003|COMPLETED|Lead-in (LI) Period 1||0
10969693|NCT00533897|12143619|FG004|COMPLETED|Lead-in (LI) Period 1||0
10969694|NCT00533897|12143620|FG005|COMPLETED|Lead-in (LI) Period 1||0
10969695|NCT00533897|12143621|FG006|COMPLETED|Lead-in (LI) Period 1||0
10969696|NCT00533897|12143622|FG007|COMPLETED|Lead-in (LI) Period 1||0
10969697|NCT00533897|12143615|FG000|NOT COMPLETED|Lead-in (LI) Period 1||10
10969698|NCT00533897|12143616|FG001|NOT COMPLETED|Lead-in (LI) Period 1||0
10969699|NCT00533897|12143617|FG002|NOT COMPLETED|Lead-in (LI) Period 1||0
10969700|NCT00533897|12143618|FG003|NOT COMPLETED|Lead-in (LI) Period 1||0
10969701|NCT00533897|12143619|FG004|NOT COMPLETED|Lead-in (LI) Period 1||0
10969702|NCT00533897|12143620|FG005|NOT COMPLETED|Lead-in (LI) Period 1||0
10969703|NCT00533897|12143621|FG006|NOT COMPLETED|Lead-in (LI) Period 1||0
10969704|NCT00533897|12143622|FG007|NOT COMPLETED|Lead-in (LI) Period 1||0
10969705|NCT00533897|12143615|FG000|STARTED|Double-blind Withdrawal (DBW) Period 2||0
10969706|NCT00533897|12143616|FG001|STARTED|Double-blind Withdrawal (DBW) Period 2||40
10969707|NCT00533897|12143617|FG002|STARTED|Double-blind Withdrawal (DBW) Period 2||80
10969708|NCT00533897|12143618|FG003|STARTED|Double-blind Withdrawal (DBW) Period 2||0
10969709|NCT00533897|12143619|FG004|STARTED|Double-blind Withdrawal (DBW) Period 2||0
10969710|NCT00533897|12143620|FG005|STARTED|Double-blind Withdrawal (DBW) Period 2||0
10969711|NCT00533897|12143621|FG006|STARTED|Double-blind Withdrawal (DBW) Period 2||0
10969712|NCT00533897|12143622|FG007|STARTED|Double-blind Withdrawal (DBW) Period 2||0
10969713|NCT00533897|12143615|FG000|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10969714|NCT00533897|12143616|FG001|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
10969715|NCT00533897|12143617|FG002|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
10969716|NCT00533897|12143618|FG003|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10969717|NCT00533897|12143619|FG004|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10969718|NCT00533897|12143620|FG005|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10969719|NCT00533897|12143621|FG006|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10969720|NCT00533897|12143622|FG007|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10969721|NCT00533897|12143615|FG000|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10969722|NCT00533897|12143616|FG001|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
10969723|NCT00533897|12143617|FG002|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
10969724|NCT00533897|12143618|FG003|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10969725|NCT00533897|12143619|FG004|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10969726|NCT00533897|12143620|FG005|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10969727|NCT00533897|12143621|FG006|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10969728|NCT00533897|12143622|FG007|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
10969729|NCT00533897|12143615|FG000|STARTED|Re-introduction (RI) Period 3||0
10969730|NCT00533897|12143616|FG001|STARTED|Re-introduction (RI) Period 3||0
10969731|NCT00533897|12143617|FG002|STARTED|Re-introduction (RI) Period 3||0
10969732|NCT00533897|12143618|FG003|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
10969733|NCT00533897|12143619|FG004|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
10969734|NCT00533897|12143620|FG005|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
10969735|NCT00533897|12143621|FG006|STARTED|Re-introduction (RI) Period 3||0
10969736|NCT00533897|12143622|FG007|STARTED|Re-introduction (RI) Period 3||0
10969737|NCT00533897|12143615|FG000|COMPLETED|Re-introduction (RI) Period 3||0
10969738|NCT00533897|12143616|FG001|COMPLETED|Re-introduction (RI) Period 3||0
10969739|NCT00533897|12143617|FG002|COMPLETED|Re-introduction (RI) Period 3||0
10969740|NCT00533897|12143618|FG003|COMPLETED|Re-introduction (RI) Period 3||40
10969741|NCT00533897|12143619|FG004|COMPLETED|Re-introduction (RI) Period 3||35
10969742|NCT00533897|12143620|FG005|COMPLETED|Re-introduction (RI) Period 3||42
10969743|NCT00533897|12143621|FG006|COMPLETED|Re-introduction (RI) Period 3||0
10969744|NCT00533897|12143622|FG007|COMPLETED|Re-introduction (RI) Period 3||0
10969745|NCT00533897|12143615|FG000|NOT COMPLETED|Re-introduction (RI) Period 3||0
10969746|NCT00533897|12143616|FG001|NOT COMPLETED|Re-introduction (RI) Period 3||0
10969747|NCT00533897|12143617|FG002|NOT COMPLETED|Re-introduction (RI) Period 3||0
10969748|NCT00533897|12143618|FG003|NOT COMPLETED|Re-introduction (RI) Period 3||0
10969749|NCT00533897|12143619|FG004|NOT COMPLETED|Re-introduction (RI) Period 3||0
10969750|NCT00533897|12143620|FG005|NOT COMPLETED|Re-introduction (RI) Period 3||2
10969751|NCT00533897|12143621|FG006|NOT COMPLETED|Re-introduction (RI) Period 3||0
10969752|NCT00533897|12143622|FG007|NOT COMPLETED|Re-introduction (RI) Period 3||0
10969753|NCT00533897|12143615|FG000|STARTED|Long Term Extension (LTE)||0
10969754|NCT00533897|12143616|FG001|STARTED|Long Term Extension (LTE)||0
10969755|NCT00533897|12143617|FG002|STARTED|Long Term Extension (LTE)||0
10969756|NCT00533897|12143618|FG003|STARTED|Long Term Extension (LTE)||0
10969757|NCT00533897|12143619|FG004|STARTED|Long Term Extension (LTE)||0
10969758|NCT00533897|12143620|FG005|STARTED|Long Term Extension (LTE)||0
10969759|NCT00533897|12143621|FG006|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
10969760|NCT00533897|12143622|FG007|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
10969761|NCT00533897|12143615|FG000|COMPLETED|Long Term Extension (LTE)||0
10969762|NCT00533897|12143616|FG001|COMPLETED|Long Term Extension (LTE)||0
10969763|NCT00533897|12143617|FG002|COMPLETED|Long Term Extension (LTE)||0
10969764|NCT00533897|12143618|FG003|COMPLETED|Long Term Extension (LTE)||0
10969765|NCT00533897|12143619|FG004|COMPLETED|Long Term Extension (LTE)||0
10969766|NCT00533897|12143620|FG005|COMPLETED|Long Term Extension (LTE)||0
10969767|NCT00533897|12143621|FG006|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
10969768|NCT00533897|12143622|FG007|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
10969769|NCT00533897|12143615|FG000|NOT COMPLETED|Long Term Extension (LTE)||0
10969770|NCT00533897|12143616|FG001|NOT COMPLETED|Long Term Extension (LTE)||0
10969771|NCT00533897|12143617|FG002|NOT COMPLETED|Long Term Extension (LTE)||0
10969772|NCT00533897|12143618|FG003|NOT COMPLETED|Long Term Extension (LTE)||0
10969773|NCT00533897|12143619|FG004|NOT COMPLETED|Long Term Extension (LTE)||0
10969774|NCT00533897|12143620|FG005|NOT COMPLETED|Long Term Extension (LTE)||0
10969775|NCT00533897|12143621|FG006|NOT COMPLETED|Long Term Extension (LTE)||13
10969776|NCT00533897|12143622|FG007|NOT COMPLETED|Long Term Extension (LTE)||25
10969777|NCT00533910|12143655|FG000|STARTED|Overall Study||21
10969778|NCT00533910|12143656|FG001|STARTED|Overall Study||21
10969779|NCT00533910|12143655|FG000|COMPLETED|Overall Study||21
10969780|NCT00533910|12143656|FG001|COMPLETED|Overall Study||21
10969781|NCT00533910|12143655|FG000|NOT COMPLETED|Overall Study||0
10969782|NCT00533910|12143656|FG001|NOT COMPLETED|Overall Study||0
10969783|NCT00534001|12143664|FG000|STARTED|Overall Study||48
10969784|NCT00534001|12143665|FG001|STARTED|Overall Study||47
10969785|NCT00534001|12143664|FG000|COMPLETED|Overall Study||43
10969786|NCT00534001|12143665|FG001|COMPLETED|Overall Study||43
10969787|NCT00534001|12143664|FG000|NOT COMPLETED|Overall Study||5
10969788|NCT00534001|12143665|FG001|NOT COMPLETED|Overall Study||4
10969789|NCT00534092|12143673|FG000|STARTED|Overall Study||55
10969790|NCT00534092|12143674|FG001|STARTED|Overall Study||14
10969791|NCT00534092|12143673|FG000|COMPLETED|Overall Study||53
10969792|NCT00534092|12143674|FG001|COMPLETED|Overall Study||14
10969793|NCT00534092|12143673|FG000|NOT COMPLETED|Overall Study||2
10969794|NCT00534092|12143674|FG001|NOT COMPLETED|Overall Study||0
10969795|NCT00534105|12143684|FG000|STARTED|Overall Study||47
10969796|NCT00534105|12143685|FG001|STARTED|Overall Study||59
10969797|NCT00534105|12143684|FG000|COMPLETED|Overall Study||24
10969798|NCT00534105|12143685|FG001|COMPLETED|Overall Study||20
10969799|NCT00534105|12143684|FG000|NOT COMPLETED|Overall Study||23
10969800|NCT00534105|12143685|FG001|NOT COMPLETED|Overall Study||39
10969801|NCT00534118|12143693|FG000|STARTED|Overall Study||17
10969802|NCT00534118|12143694|FG001|STARTED|Overall Study||22
10969803|NCT00534118|12143693|FG000|COMPLETED|Overall Study||17
10969804|NCT00534118|12143694|FG001|COMPLETED|Overall Study||22
10969805|NCT00534118|12143693|FG000|NOT COMPLETED|Overall Study||0
10969806|NCT00534118|12143694|FG001|NOT COMPLETED|Overall Study||0
10969807|NCT00534209|12143702|FG000|STARTED|Overall Study||1
10969808|NCT00534209|12143702|FG000|COMPLETED|Overall Study||1
10969809|NCT00534209|12143702|FG000|NOT COMPLETED|Overall Study||0
10969810|NCT00534235|12143710|FG000|STARTED|Overall Study||107
10969811|NCT00534235|12143711|FG001|STARTED|Overall Study||215
10969812|NCT00534235|12143710|FG000|COMPLETED|Overall Study||91
10969813|NCT00534235|12143711|FG001|COMPLETED|Overall Study||192
10969814|NCT00534235|12143710|FG000|NOT COMPLETED|Overall Study||16
10969815|NCT00534235|12143711|FG001|NOT COMPLETED|Overall Study||23
10969816|NCT00534248|12143720|FG000|STARTED|Overall Study||11211
10969817|NCT00534248|12143721|FG001|STARTED|Overall Study||11228
10969818|NCT00534248|12143720|FG000|VACCINATED|Overall Study||11186
10969819|NCT00534248|12143721|FG001|VACCINATED|Overall Study||11210
10969820|NCT00534248|12143720|FG000|COMPLETED|Overall Study||10550
10969821|NCT00534248|12143721|FG001|COMPLETED|Overall Study||10555
10969822|NCT00534248|12143720|FG000|NOT COMPLETED|Overall Study||661
10969823|NCT00534248|12143721|FG001|NOT COMPLETED|Overall Study||673
10969824|NCT00534313|12143731|FG000|STARTED|Short-term Period||43
10969825|NCT00534313|12143732|FG001|STARTED|Short-term Period||40
10969826|NCT00534313|12143733|FG002|STARTED|Short-term Period||45
10969827|NCT00534313|12143734|FG003|STARTED|Short-term Period||42
10969828|NCT00534313|12143731|FG000|COMPLETED|Short-term Period|Completed the short-term study|37
10969829|NCT00534313|12143732|FG001|COMPLETED|Short-term Period|Completed the short-term study|34
10969830|NCT00534313|12143733|FG002|COMPLETED|Short-term Period|Completed the short-term study|43
10969831|NCT00534313|12143734|FG003|COMPLETED|Short-term Period|Completed the short-term study|33
10969832|NCT00534313|12143731|FG000|NOT COMPLETED|Short-term Period||6
10969833|NCT00534313|12143732|FG001|NOT COMPLETED|Short-term Period||6
10969834|NCT00534313|12143733|FG002|NOT COMPLETED|Short-term Period||2
10969835|NCT00534313|12143734|FG003|NOT COMPLETED|Short-term Period||9
10969836|NCT00534313|12143731|FG000|STARTED|Long-term Period||37
10969837|NCT00534313|12143732|FG001|STARTED|Long-term Period||34
10969838|NCT00534313|12143733|FG002|STARTED|Long-term Period||43
10969839|NCT00534313|12143734|FG003|STARTED|Long-term Period||33
10969840|NCT00534313|12143731|FG000|COMPLETED|Long-term Period||0
10969841|NCT00534313|12143732|FG001|COMPLETED|Long-term Period||0
10969842|NCT00534313|12143733|FG002|COMPLETED|Long-term Period||0
10969843|NCT00534313|12143734|FG003|COMPLETED|Long-term Period||0
10969844|NCT00534313|12143731|FG000|NOT COMPLETED|Long-term Period||37
10969845|NCT00534313|12143732|FG001|NOT COMPLETED|Long-term Period||34
10969846|NCT00534313|12143733|FG002|NOT COMPLETED|Long-term Period||43
10969847|NCT00534313|12143734|FG003|NOT COMPLETED|Long-term Period||33
10969848|NCT00534352|12143779|FG000|STARTED|Treatment A: TMC125 + TDF/FTC||23
10969849|NCT00534352|12143779|FG000|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
10969850|NCT00534352|12143779|FG000|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
10969851|NCT00534352|12143779|FG000|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
10969852|NCT00534352|12143779|FG000|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
10969853|NCT00534352|12143779|FG000|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
10969854|NCT00534352|12143779|FG000|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
10969855|NCT00534352|12143779|FG000|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
10969856|NCT00534352|12143779|FG000|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
10969857|NCT00534352|12143779|FG000|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
10969858|NCT00534352|12143779|FG000|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
10969859|NCT00534352|12143779|FG000|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
10969860|NCT00534365|12143794|FG000|STARTED|Overall Study||127
10969861|NCT00534365|12143795|FG001|STARTED|Overall Study||136
10969862|NCT00534365|12143794|FG000|Received Procedure|Overall Study||127
10969863|NCT00534365|12143795|FG001|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
10969864|NCT00534365|12143794|FG000|Any Follow up|Overall Study||126
10969865|NCT00534365|12143795|FG001|Any Follow up|Overall Study||135
10969866|NCT00534365|12143794|FG000|Follow up at 12 Months or More|Overall Study||119
10969867|NCT00534365|12143795|FG001|Follow up at 12 Months or More|Overall Study||128
10969868|NCT00534365|12143794|FG000|Included in Intent to Treat Analysis|Overall Study||127
10969869|NCT00534365|12143795|FG001|Included in Intent to Treat Analysis|Overall Study||136
10969870|NCT00534365|12143794|FG000|COMPLETED|Overall Study||127
10969871|NCT00534365|12143795|FG001|COMPLETED|Overall Study||129
10969872|NCT00534365|12143794|FG000|NOT COMPLETED|Overall Study||0
10969873|NCT00534365|12143795|FG001|NOT COMPLETED|Overall Study||7
10969874|NCT00534404|12143806|FG000|STARTED|Overall Study||827
10969875|NCT00534404|12143807|FG001|STARTED|Overall Study||830
10969876|NCT00534404|12143808|FG002|STARTED|Overall Study||828
10969877|NCT00534404|12143806|FG000|Completed at Least 1 Online Session|Overall Study||781
10969878|NCT00534404|12143807|FG001|Completed at Least 1 Online Session|Overall Study||813
10969879|NCT00534404|12143808|FG002|Completed at Least 1 Online Session|Overall Study||658
10969880|NCT00534404|12143806|FG000|Completed First NRT Order|Overall Study||765
10969881|NCT00534404|12143807|FG001|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
10969882|NCT00534404|12143808|FG002|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
10969883|NCT00534404|12143806|FG000|Completed Second NRT Order|Overall Study||640
10969884|NCT00534404|12143807|FG001|Completed Second NRT Order|Overall Study||789
10969885|NCT00534404|12143808|FG002|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
10969886|NCT00534404|12143806|FG000|Completed at Least 1 Counseling Call|Overall Study||813
10969887|NCT00534404|12143807|FG001|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
10969888|NCT00534404|12143808|FG002|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
10969889|NCT00534404|12143806|FG000|1-month Follow up Completed|Overall Study||742
10969890|NCT00534404|12143807|FG001|1-month Follow up Completed|Overall Study||781
10969891|NCT00534404|12143808|FG002|1-month Follow up Completed|Overall Study||626
10969892|NCT00534404|12143806|FG000|3-month Follow up Completed|Overall Study||682
10969893|NCT00534404|12143807|FG001|3-month Follow up Completed|Overall Study||731
10969894|NCT00534404|12143808|FG002|3-month Follow up Completed|Overall Study||593
10969895|NCT00534404|12143806|FG000|COMPLETED|Overall Study||647
10969896|NCT00534404|12143807|FG001|COMPLETED|Overall Study||687
10969897|NCT00534404|12143808|FG002|COMPLETED|Overall Study||586
10969898|NCT00534404|12143806|FG000|NOT COMPLETED|Overall Study||180
10969899|NCT00534404|12143807|FG001|NOT COMPLETED|Overall Study||143
10969900|NCT00534404|12143808|FG002|NOT COMPLETED|Overall Study||242
10969901|NCT00534417|12143816|FG000|STARTED|Overall Study||41
10969902|NCT00534417|12143816|FG000|COMPLETED|Overall Study||41
10969903|NCT00534417|12143816|FG000|NOT COMPLETED|Overall Study||0
10969904|NCT00534495|12143822|FG000|STARTED|Double Blind Placebo Phase Week 0-4||36
10969905|NCT00534495|12143823|FG001|STARTED|Double Blind Placebo Phase Week 0-4||35
10969906|NCT00534495|12143824|FG002|STARTED|Double Blind Placebo Phase Week 0-4||0
10969907|NCT00534495|12143822|FG000|COMPLETED|Double Blind Placebo Phase Week 0-4||36
10969908|NCT00534495|12143823|FG001|COMPLETED|Double Blind Placebo Phase Week 0-4||34
10969909|NCT00534495|12143824|FG002|COMPLETED|Double Blind Placebo Phase Week 0-4||0
10969910|NCT00534495|12143822|FG000|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
10969911|NCT00534495|12143823|FG001|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
10969912|NCT00534495|12143824|FG002|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
10969913|NCT00534495|12143822|FG000|STARTED|All Active Treatment Phase Week 4-24||36
10969914|NCT00534495|12143823|FG001|STARTED|All Active Treatment Phase Week 4-24||34
10969915|NCT00534495|12143824|FG002|STARTED|All Active Treatment Phase Week 4-24||0
10969916|NCT00534495|12143822|FG000|COMPLETED|All Active Treatment Phase Week 4-24||32
10969917|NCT00534495|12143823|FG001|COMPLETED|All Active Treatment Phase Week 4-24||25
10969918|NCT00534495|12143824|FG002|COMPLETED|All Active Treatment Phase Week 4-24||0
10969919|NCT00534495|12143822|FG000|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
10969920|NCT00534495|12143823|FG001|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
10969921|NCT00534495|12143824|FG002|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
10969922|NCT00534495|12143822|FG000|STARTED|Long Term Ext. Phase Week 24-month 21||0
10969923|NCT00534495|12143823|FG001|STARTED|Long Term Ext. Phase Week 24-month 21||0
10969924|NCT00534495|12143824|FG002|STARTED|Long Term Ext. Phase Week 24-month 21||40
10969925|NCT00534495|12143822|FG000|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
10969926|NCT00534495|12143823|FG001|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
10969927|NCT00534495|12143824|FG002|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
10969928|NCT00534495|12143822|FG000|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
10969929|NCT00534495|12143823|FG001|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
10969930|NCT00534495|12143824|FG002|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
10969931|NCT00534599|12143837|FG000|STARTED|Overall Study|Randomized|209
10969932|NCT00534599|12143838|FG001|STARTED|Overall Study|Randomized|200
10969933|NCT00534599|12143837|FG000|COMPLETED|Overall Study||152
10969934|NCT00534599|12143838|FG001|COMPLETED|Overall Study||168
10969935|NCT00534599|12143837|FG000|NOT COMPLETED|Overall Study||57
10969936|NCT00534599|12143838|FG001|NOT COMPLETED|Overall Study||32
10969937|NCT00534638|12143846|FG000|STARTED|Overall Study||14837
10969938|NCT00534638|12143847|FG001|STARTED|Overall Study||17338
10969939|NCT00534638|12143846|FG000|COMPLETED|Overall Study||8346
10969940|NCT00534638|12143847|FG001|COMPLETED|Overall Study||5547
10969941|NCT00534638|12143846|FG000|NOT COMPLETED|Overall Study||6491
10969942|NCT00534638|12143847|FG001|NOT COMPLETED|Overall Study||11791
10969943|NCT00534703|12143860|FG000|STARTED|Overall Study||4
10969944|NCT00534703|12143861|FG001|STARTED|Overall Study||1
10969945|NCT00534703|12143860|FG000|COMPLETED|Overall Study||4
10969946|NCT00534703|12143861|FG001|COMPLETED|Overall Study||1
10969947|NCT00534703|12143860|FG000|NOT COMPLETED|Overall Study||0
10969948|NCT00534703|12143861|FG001|NOT COMPLETED|Overall Study||0
10969949|NCT00534794|12143871|FG000|STARTED|Overall Study||40
10969950|NCT00534794|12143872|FG001|STARTED|Overall Study||39
10969951|NCT00534794|12143871|FG000|COMPLETED|Overall Study||40
10969952|NCT00534794|12143872|FG001|COMPLETED|Overall Study||39
10969953|NCT00534794|12143871|FG000|NOT COMPLETED|Overall Study||0
10969954|NCT00534794|12143872|FG001|NOT COMPLETED|Overall Study||0
10969955|NCT00534833|12143880|FG000|STARTED|Overall Study||182
10969956|NCT00534833|12143881|FG001|STARTED|Overall Study||180
10969957|NCT00534833|12143880|FG000|COMPLETED|Overall Study||182
10969958|NCT00534833|12143881|FG001|COMPLETED|Overall Study||180
10969959|NCT00534833|12143880|FG000|NOT COMPLETED|Overall Study||0
10969960|NCT00534833|12143881|FG001|NOT COMPLETED|Overall Study||0
10969961|NCT00534937|12143891|FG000|STARTED|Overall Study||42
10969962|NCT00534937|12143892|FG001|STARTED|Overall Study||47
10969963|NCT00534937|12143891|FG000|COMPLETED|Overall Study||34
10969964|NCT00534937|12143892|FG001|COMPLETED|Overall Study||35
10969965|NCT00534937|12143891|FG000|NOT COMPLETED|Overall Study||8
10969966|NCT00534937|12143892|FG001|NOT COMPLETED|Overall Study||12
10969967|NCT00535002|12143908|FG000|STARTED|Overall Study||19
10969968|NCT00535002|12143909|FG001|STARTED|Overall Study||12
10969969|NCT00535002|12143910|FG002|STARTED|Overall Study||13
10969970|NCT00535002|12143911|FG003|STARTED|Overall Study||14
10969971|NCT00535002|12143912|FG004|STARTED|Overall Study||9
10969972|NCT00535002|12143913|FG005|STARTED|Overall Study||17
10969973|NCT00535002|12143914|FG006|STARTED|Overall Study||12
10969974|NCT00535002|12143915|FG007|STARTED|Overall Study||16
10969975|NCT00535002|12143908|FG000|COMPLETED|Overall Study||19
10969976|NCT00535002|12143909|FG001|COMPLETED|Overall Study||12
10969977|NCT00535002|12143910|FG002|COMPLETED|Overall Study||13
10969978|NCT00535002|12143911|FG003|COMPLETED|Overall Study||14
10969979|NCT00535002|12143912|FG004|COMPLETED|Overall Study||9
10969980|NCT00535002|12143913|FG005|COMPLETED|Overall Study||17
10969981|NCT00535002|12143914|FG006|COMPLETED|Overall Study||12
10969982|NCT00535002|12143915|FG007|COMPLETED|Overall Study||16
10969983|NCT00535002|12143908|FG000|NOT COMPLETED|Overall Study||0
10969984|NCT00535002|12143909|FG001|NOT COMPLETED|Overall Study||0
10969985|NCT00535002|12143910|FG002|NOT COMPLETED|Overall Study||0
10969986|NCT00535002|12143911|FG003|NOT COMPLETED|Overall Study||0
10969987|NCT00535002|12143912|FG004|NOT COMPLETED|Overall Study||0
10969988|NCT00535002|12143913|FG005|NOT COMPLETED|Overall Study||0
10969989|NCT00535002|12143914|FG006|NOT COMPLETED|Overall Study||0
10969990|NCT00535002|12143915|FG007|NOT COMPLETED|Overall Study||0
10969991|NCT00535132|12143931|FG000|STARTED|Randomized Population|Number of Subjects Randomized|100
10969992|NCT00535132|12143932|FG001|STARTED|Randomized Population|Number of Subjects Randomized|101
10969993|NCT00535132|12143931|FG000|COMPLETED|Randomized Population||100
10969994|NCT00535132|12143932|FG001|COMPLETED|Randomized Population||101
10969995|NCT00535132|12143931|FG000|NOT COMPLETED|Randomized Population||0
10969996|NCT00535132|12143932|FG001|NOT COMPLETED|Randomized Population||0
10969997|NCT00535132|12143931|FG000|STARTED|Safety Analysis Set||100
10969998|NCT00535132|12143932|FG001|STARTED|Safety Analysis Set||101
10969999|NCT00535132|12143931|FG000|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
10970000|NCT00535132|12143932|FG001|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
10970001|NCT00535132|12143931|FG000|NOT COMPLETED|Safety Analysis Set||2
10970002|NCT00535132|12143932|FG001|NOT COMPLETED|Safety Analysis Set||2
10970003|NCT00535132|12143931|FG000|STARTED|Intent-to-Treat (ITT) Analysis Set||98
10970004|NCT00535132|12143932|FG001|STARTED|Intent-to-Treat (ITT) Analysis Set||99
10970005|NCT00535132|12143931|FG000|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
10970006|NCT00535132|12143932|FG001|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
10970007|NCT00535132|12143931|FG000|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
10970008|NCT00535132|12143932|FG001|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
10970009|NCT00535145|12143940|FG000|STARTED|Phase I||114
10970010|NCT00535145|12143940|FG000|COMPLETED|Phase I||85
10970011|NCT00535145|12143940|FG000|NOT COMPLETED|Phase I||29
10970012|NCT00535145|12143940|FG000|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
10970013|NCT00535145|12143940|FG000|COMPLETED|Phase II||69
10970014|NCT00535145|12143940|FG000|NOT COMPLETED|Phase II||15
10970015|NCT00535223|12143950|FG000|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
10970016|NCT00535223|12143951|FG001|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
10970017|NCT00535223|12143950|FG000|COMPLETED|Overall Study||37
10970018|NCT00535223|12143951|FG001|COMPLETED|Overall Study||39
10970019|NCT00535223|12143950|FG000|NOT COMPLETED|Overall Study||4
10970020|NCT00535223|12143951|FG001|NOT COMPLETED|Overall Study||1
10970021|NCT00535236|12143967|FG000|STARTED|Overall Study||40
10970022|NCT00535236|12143968|FG001|STARTED|Overall Study||10
10970023|NCT00535236|12143969|FG002|STARTED|Overall Study||41
10970024|NCT00535236|12143970|FG003|STARTED|Overall Study||10
10970025|NCT00535236|12143971|FG004|STARTED|Overall Study||59
10970026|NCT00535236|12143972|FG005|STARTED|Overall Study||20
10970027|NCT00535236|12143973|FG006|STARTED|Overall Study||62
10970028|NCT00535236|12143974|FG007|STARTED|Overall Study||19
10970029|NCT00535236|12143975|FG008|STARTED|Overall Study||60
10970030|NCT00535236|12143976|FG009|STARTED|Overall Study||20
10970031|NCT00535236|12143967|FG000|Vaccination 1|Overall Study||40
10970032|NCT00535236|12143968|FG001|Vaccination 1|Overall Study||10
10970033|NCT00535236|12143969|FG002|Vaccination 1|Overall Study||40
10970034|NCT00535236|12143970|FG003|Vaccination 1|Overall Study||10
10970035|NCT00535236|12143971|FG004|Vaccination 1|Overall Study||58
10970036|NCT00535236|12143972|FG005|Vaccination 1|Overall Study||19
10970037|NCT00535236|12143973|FG006|Vaccination 1|Overall Study||61
10970038|NCT00535236|12143974|FG007|Vaccination 1|Overall Study||19
10970039|NCT00535236|12143975|FG008|Vaccination 1|Overall Study||60
10970040|NCT00535236|12143976|FG009|Vaccination 1|Overall Study||20
10970041|NCT00535236|12143967|FG000|Vaccination 2|Overall Study||35
10970042|NCT00535236|12143968|FG001|Vaccination 2|Overall Study||10
10970043|NCT00535236|12143969|FG002|Vaccination 2|Overall Study||37
10970044|NCT00535236|12143970|FG003|Vaccination 2|Overall Study||8
10970045|NCT00535236|12143971|FG004|Vaccination 2|Overall Study||52
10970046|NCT00535236|12143972|FG005|Vaccination 2|Overall Study||19
10970047|NCT00535236|12143973|FG006|Vaccination 2|Overall Study||58
10970048|NCT00535236|12143974|FG007|Vaccination 2|Overall Study||19
10970049|NCT00535236|12143975|FG008|Vaccination 2|Overall Study||57
10970050|NCT00535236|12143976|FG009|Vaccination 2|Overall Study||19
10970051|NCT00535236|12143967|FG000|Vaccination 3|Overall Study||34
10970052|NCT00535236|12143968|FG001|Vaccination 3|Overall Study||10
10970053|NCT00535236|12143969|FG002|Vaccination 3|Overall Study||35
10970054|NCT00535236|12143970|FG003|Vaccination 3|Overall Study||8
10970055|NCT00535236|12143971|FG004|Vaccination 3|Overall Study||48
10970056|NCT00535236|12143972|FG005|Vaccination 3|Overall Study||19
10970057|NCT00535236|12143973|FG006|Vaccination 3|Overall Study||51
10970058|NCT00535236|12143974|FG007|Vaccination 3|Overall Study||18
10970059|NCT00535236|12143975|FG008|Vaccination 3|Overall Study||53
10970060|NCT00535236|12143976|FG009|Vaccination 3|Overall Study||18
10970061|NCT00535236|12143967|FG000|Vaccination 4|Overall Study||34
10970062|NCT00535236|12143968|FG001|Vaccination 4|Overall Study||10
10970063|NCT00535236|12143969|FG002|Vaccination 4|Overall Study||32
10970064|NCT00535236|12143970|FG003|Vaccination 4|Overall Study||6
10970065|NCT00535236|12143971|FG004|Vaccination 4|Overall Study||47
10970066|NCT00535236|12143972|FG005|Vaccination 4|Overall Study||19
10970067|NCT00535236|12143973|FG006|Vaccination 4|Overall Study||51
10970068|NCT00535236|12143974|FG007|Vaccination 4|Overall Study||18
10970069|NCT00535236|12143975|FG008|Vaccination 4|Overall Study||50
10970070|NCT00535236|12143976|FG009|Vaccination 4|Overall Study||17
10970071|NCT00535236|12143967|FG000|COMPLETED|Overall Study||33
10970072|NCT00535236|12143968|FG001|COMPLETED|Overall Study||8
10970073|NCT00535236|12143969|FG002|COMPLETED|Overall Study||29
10970074|NCT00535236|12143970|FG003|COMPLETED|Overall Study||6
10970075|NCT00535236|12143971|FG004|COMPLETED|Overall Study||47
10970076|NCT00535236|12143972|FG005|COMPLETED|Overall Study||19
10970077|NCT00535236|12143973|FG006|COMPLETED|Overall Study||51
10970078|NCT00535236|12143974|FG007|COMPLETED|Overall Study||18
10970079|NCT00535236|12143975|FG008|COMPLETED|Overall Study||47
10970080|NCT00535236|12143976|FG009|COMPLETED|Overall Study||16
10970081|NCT00535236|12143967|FG000|NOT COMPLETED|Overall Study||7
10970082|NCT00535236|12143968|FG001|NOT COMPLETED|Overall Study||2
10970083|NCT00535236|12143969|FG002|NOT COMPLETED|Overall Study||12
10970084|NCT00535236|12143970|FG003|NOT COMPLETED|Overall Study||4
10970085|NCT00535236|12143971|FG004|NOT COMPLETED|Overall Study||12
10970086|NCT00535236|12143972|FG005|NOT COMPLETED|Overall Study||1
10970087|NCT00535236|12143973|FG006|NOT COMPLETED|Overall Study||11
10970088|NCT00535236|12143974|FG007|NOT COMPLETED|Overall Study||1
10970089|NCT00535236|12143975|FG008|NOT COMPLETED|Overall Study||13
10970090|NCT00535236|12143976|FG009|NOT COMPLETED|Overall Study||4
10970091|NCT00535288|12144006|FG000|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
10970092|NCT00535288|12144007|FG001|STARTED|Overall Study||162
10970093|NCT00535288|12144008|FG002|STARTED|Overall Study||160
10970094|NCT00535288|12144009|FG003|STARTED|Overall Study||151
10970095|NCT00535288|12144010|FG004|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
10970096|NCT00535288|12144006|FG000|COMPLETED|Overall Study||260
10970097|NCT00535288|12144007|FG001|COMPLETED|Overall Study||130
10970098|NCT00535288|12144008|FG002|COMPLETED|Overall Study||127
10970099|NCT00535288|12144009|FG003|COMPLETED|Overall Study||122
10970100|NCT00535288|12144010|FG004|COMPLETED|Overall Study||116
10970101|NCT00535288|12144006|FG000|NOT COMPLETED|Overall Study||54
10970102|NCT00535288|12144007|FG001|NOT COMPLETED|Overall Study||32
10970103|NCT00535288|12144008|FG002|NOT COMPLETED|Overall Study||33
10970104|NCT00535288|12144009|FG003|NOT COMPLETED|Overall Study||29
10970105|NCT00535288|12144010|FG004|NOT COMPLETED|Overall Study||42
10970106|NCT00535301|12144029|FG000|STARTED|Overall Study||38
10970107|NCT00535301|12144030|FG001|STARTED|Overall Study||38
10970108|NCT00535301|12144029|FG000|COMPLETED|Overall Study||33
10970109|NCT00535301|12144030|FG001|COMPLETED|Overall Study||33
10970110|NCT00535301|12144029|FG000|NOT COMPLETED|Overall Study||5
10970111|NCT00535301|12144030|FG001|NOT COMPLETED|Overall Study||5
10970112|NCT00535392|12144038|FG000|STARTED|Overall Study||33
10970113|NCT00535392|12144038|FG000|COMPLETED|Overall Study||33
10970114|NCT00535392|12144038|FG000|NOT COMPLETED|Overall Study||0
10970115|NCT00535496|12144044|FG000|STARTED|Overall Study||15
10970116|NCT00535496|12144045|FG001|STARTED|Overall Study||15
10970117|NCT00535496|12144046|FG002|STARTED|Overall Study||30
10970118|NCT00535496|12144047|FG003|STARTED|Overall Study||31
10970119|NCT00535496|12144044|FG000|All-Subjects-Treated (AST) Group|Overall Study||15
10970120|NCT00535496|12144045|FG001|All-Subjects-Treated (AST) Group|Overall Study||14
10970121|NCT00535496|12144046|FG002|All-Subjects-Treated (AST) Group|Overall Study||30
10970122|NCT00535496|12144047|FG003|All-Subjects-Treated (AST) Group|Overall Study||31
10970123|NCT00535496|12144044|FG000|COMPLETED|Overall Study||15
10970124|NCT00535496|12144045|FG001|COMPLETED|Overall Study||13
10970125|NCT00535496|12144046|FG002|COMPLETED|Overall Study||30
10970126|NCT00535496|12144047|FG003|COMPLETED|Overall Study||31
10970127|NCT00535496|12144044|FG000|NOT COMPLETED|Overall Study||0
10970128|NCT00535496|12144045|FG001|NOT COMPLETED|Overall Study||2
10970129|NCT00535496|12144046|FG002|NOT COMPLETED|Overall Study||0
10970130|NCT00535496|12144047|FG003|NOT COMPLETED|Overall Study||0
10970131|NCT00535587|12144058|FG000|STARTED|Overall Study||53
10970132|NCT00535587|12144059|FG001|STARTED|Overall Study||53
10970133|NCT00535587|12144060|FG002|STARTED|Overall Study||47
10970134|NCT00535587|12144061|FG003|STARTED|Overall Study||54
10970135|NCT00535587|12144058|FG000|COMPLETED|Overall Study||43
10970136|NCT00535587|12144059|FG001|COMPLETED|Overall Study||42
10970137|NCT00535587|12144060|FG002|COMPLETED|Overall Study||39
10970138|NCT00535587|12144061|FG003|COMPLETED|Overall Study||41
10970139|NCT00535587|12144058|FG000|NOT COMPLETED|Overall Study||10
10970140|NCT00535587|12144059|FG001|NOT COMPLETED|Overall Study||11
10970141|NCT00535587|12144060|FG002|NOT COMPLETED|Overall Study||8
10970142|NCT00535587|12144061|FG003|NOT COMPLETED|Overall Study||13
10970143|NCT00535613|12144071|FG000|STARTED|Overall Study||49
10970144|NCT00535613|12144072|FG001|STARTED|Overall Study||50
10970145|NCT00535613|12144071|FG000|COMPLETED|Overall Study||49
10970146|NCT00535613|12144072|FG001|COMPLETED|Overall Study||50
10970147|NCT00535613|12144071|FG000|NOT COMPLETED|Overall Study||0
10970148|NCT00535613|12144072|FG001|NOT COMPLETED|Overall Study||0
10970149|NCT00535626|12144078|FG000|STARTED|Overall Study||190
10970150|NCT00535626|12144078|FG000|COMPLETED|Overall Study||85
10970151|NCT00535626|12144078|FG000|NOT COMPLETED|Overall Study||105
10970152|NCT00535652|12144083|FG000|STARTED|Overall Study||23
10970153|NCT00535652|12144083|FG000|COMPLETED|Overall Study||20
10970154|NCT00535652|12144083|FG000|NOT COMPLETED|Overall Study||3
10970155|NCT00535730|12144089|FG000|STARTED|Overall Study||236
10970156|NCT00535730|12144090|FG001|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
10970157|NCT00535730|12144089|FG000|COMPLETED|Overall Study||234
10970158|NCT00535730|12144090|FG001|COMPLETED|Overall Study||230
10970159|NCT00535730|12144089|FG000|NOT COMPLETED|Overall Study||2
10970160|NCT00535730|12144090|FG001|NOT COMPLETED|Overall Study||7
10970161|NCT00535743|12144121|FG000|STARTED|Overall Study||5
10970162|NCT00535743|12144122|FG001|STARTED|Overall Study||11
10970163|NCT00535743|12144123|FG002|STARTED|Overall Study||11
10970164|NCT00535743|12144124|FG003|STARTED|Overall Study||11
10970165|NCT00535743|12144125|FG004|STARTED|Overall Study||11
10970166|NCT00535743|12144126|FG005|STARTED|Overall Study||10
10970167|NCT00535743|12144127|FG006|STARTED|Overall Study||3
10970168|NCT00535743|12144128|FG007|STARTED|Overall Study||5
10970169|NCT00535743|12144129|FG008|STARTED|Overall Study||5
10970170|NCT00535743|12144130|FG009|STARTED|Overall Study||5
10970171|NCT00535743|12144131|FG010|STARTED|Overall Study||5
10970172|NCT00535743|12144132|FG011|STARTED|Overall Study||5
10970173|NCT00535743|12144133|FG012|STARTED|Overall Study||5
10970174|NCT00535743|12144134|FG013|STARTED|Overall Study||10
10970175|NCT00535743|12144135|FG014|STARTED|Overall Study||9
10970265|NCT00535782|12144208|FG002|STARTED|Part 1: 24-Week Double-blind Period||0
10970176|NCT00535743|12144136|FG015|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13
10970177|NCT00535743|12144137|FG016|STARTED|Overall Study||10
10970178|NCT00535743|12144138|FG017|STARTED|Overall Study||11
10970179|NCT00535743|12144139|FG018|STARTED|Overall Study||3
10970180|NCT00535743|12144140|FG019|STARTED|Overall Study||5
10970181|NCT00535743|12144141|FG020|STARTED|Overall Study||5
10970182|NCT00535743|12144142|FG021|STARTED|Overall Study||5
10970183|NCT00535743|12144143|FG022|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6
10970184|NCT00535743|12144144|FG023|STARTED|Overall Study||5
10970185|NCT00535743|12144121|FG000|Treated|Overall Study||5
10970186|NCT00535743|12144122|FG001|Treated|Overall Study||11
10970187|NCT00535743|12144123|FG002|Treated|Overall Study||11
10970188|NCT00535743|12144124|FG003|Treated|Overall Study||11
10970189|NCT00535743|12144125|FG004|Treated|Overall Study||11
10970190|NCT00535743|12144126|FG005|Treated|Overall Study||10
10970191|NCT00535743|12144127|FG006|Treated|Overall Study||3
10970192|NCT00535743|12144128|FG007|Treated|Overall Study||5
10970193|NCT00535743|12144129|FG008|Treated|Overall Study||4
10970194|NCT00535743|12144130|FG009|Treated|Overall Study||5
10970195|NCT00535743|12144131|FG010|Treated|Overall Study||5
10970196|NCT00535743|12144132|FG011|Treated|Overall Study||5
10970197|NCT00535743|12144133|FG012|Treated|Overall Study||5
10970198|NCT00535743|12144134|FG013|Treated|Overall Study||10
10970199|NCT00535743|12144135|FG014|Treated|Overall Study||9
10970200|NCT00535743|12144136|FG015|Treated|Overall Study|N=2 (randomized to Arm O) rec'd 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13
10970201|NCT00535743|12144137|FG016|Treated|Overall Study||10
10970202|NCT00535743|12144138|FG017|Treated|Overall Study||11
10970203|NCT00535743|12144139|FG018|Treated|Overall Study||3
10970204|NCT00535743|12144140|FG019|Treated|Overall Study||5
10970205|NCT00535743|12144141|FG020|Treated|Overall Study||5
10970206|NCT00535743|12144142|FG021|Treated|Overall Study||5
10970207|NCT00535743|12144143|FG022|Treated|Overall Study|N=1 (randomized to Arm Q) rec'd 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6
10970208|NCT00535743|12144144|FG023|Treated|Overall Study||5
10970209|NCT00535743|12144121|FG000|COMPLETED|Overall Study||5
10970210|NCT00535743|12144122|FG001|COMPLETED|Overall Study||11
10970211|NCT00535743|12144123|FG002|COMPLETED|Overall Study||11
10970212|NCT00535743|12144124|FG003|COMPLETED|Overall Study||11
10970213|NCT00535743|12144125|FG004|COMPLETED|Overall Study||11
10970214|NCT00535743|12144126|FG005|COMPLETED|Overall Study||10
10970215|NCT00535743|12144127|FG006|COMPLETED|Overall Study||3
10970216|NCT00535743|12144128|FG007|COMPLETED|Overall Study||5
10970217|NCT00535743|12144129|FG008|COMPLETED|Overall Study||4
10970218|NCT00535743|12144130|FG009|COMPLETED|Overall Study||4
10970219|NCT00535743|12144131|FG010|COMPLETED|Overall Study||5
10970220|NCT00535743|12144132|FG011|COMPLETED|Overall Study||5
10970221|NCT00535743|12144133|FG012|COMPLETED|Overall Study||5
10970222|NCT00535743|12144134|FG013|COMPLETED|Overall Study||10
10970223|NCT00535743|12144135|FG014|COMPLETED|Overall Study||9
10970224|NCT00535743|12144136|FG015|COMPLETED|Overall Study||13
10970225|NCT00535743|12144137|FG016|COMPLETED|Overall Study||10
10970226|NCT00535743|12144138|FG017|COMPLETED|Overall Study||11
10970227|NCT00535743|12144139|FG018|COMPLETED|Overall Study||3
10970228|NCT00535743|12144140|FG019|COMPLETED|Overall Study||5
10970229|NCT00535743|12144141|FG020|COMPLETED|Overall Study||5
10970230|NCT00535743|12144142|FG021|COMPLETED|Overall Study||4
10970231|NCT00535743|12144143|FG022|COMPLETED|Overall Study||6
10970232|NCT00535743|12144144|FG023|COMPLETED|Overall Study||5
10970233|NCT00535743|12144121|FG000|NOT COMPLETED|Overall Study||0
10970234|NCT00535743|12144122|FG001|NOT COMPLETED|Overall Study||0
10970235|NCT00535743|12144123|FG002|NOT COMPLETED|Overall Study||0
10970236|NCT00535743|12144124|FG003|NOT COMPLETED|Overall Study||0
10970237|NCT00535743|12144125|FG004|NOT COMPLETED|Overall Study||0
10970238|NCT00535743|12144126|FG005|NOT COMPLETED|Overall Study||0
10970239|NCT00535743|12144127|FG006|NOT COMPLETED|Overall Study||0
10970240|NCT00535743|12144128|FG007|NOT COMPLETED|Overall Study||0
10970241|NCT00535743|12144129|FG008|NOT COMPLETED|Overall Study||1
10970242|NCT00535743|12144130|FG009|NOT COMPLETED|Overall Study||1
10970243|NCT00535743|12144131|FG010|NOT COMPLETED|Overall Study||0
10970244|NCT00535743|12144132|FG011|NOT COMPLETED|Overall Study||0
10970245|NCT00535743|12144133|FG012|NOT COMPLETED|Overall Study||0
10970246|NCT00535743|12144134|FG013|NOT COMPLETED|Overall Study||0
10970247|NCT00535743|12144135|FG014|NOT COMPLETED|Overall Study||0
10970248|NCT00535743|12144136|FG015|NOT COMPLETED|Overall Study||0
10970249|NCT00535743|12144137|FG016|NOT COMPLETED|Overall Study||0
10970250|NCT00535743|12144138|FG017|NOT COMPLETED|Overall Study||0
10970251|NCT00535743|12144139|FG018|NOT COMPLETED|Overall Study||0
10970252|NCT00535743|12144140|FG019|NOT COMPLETED|Overall Study||0
10970253|NCT00535743|12144141|FG020|NOT COMPLETED|Overall Study||0
10970254|NCT00535743|12144142|FG021|NOT COMPLETED|Overall Study||1
10970255|NCT00535743|12144143|FG022|NOT COMPLETED|Overall Study||0
10970256|NCT00535743|12144144|FG023|NOT COMPLETED|Overall Study||0
10970257|NCT00535769|12144196|FG000|STARTED|Overall Study||35
10970258|NCT00535769|12144197|FG001|STARTED|Overall Study||35
10970259|NCT00535769|12144196|FG000|COMPLETED|Overall Study||35
10970260|NCT00535769|12144197|FG001|COMPLETED|Overall Study||35
10970261|NCT00535769|12144196|FG000|NOT COMPLETED|Overall Study||0
10970262|NCT00535769|12144197|FG001|NOT COMPLETED|Overall Study||0
10970263|NCT00535782|12144206|FG000|STARTED|Part 1: 24-Week Double-blind Period||69
10970264|NCT00535782|12144207|FG001|STARTED|Part 1: 24-Week Double-blind Period||63
10970266|NCT00535782|12144206|FG000|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
10970267|NCT00535782|12144207|FG001|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
10970268|NCT00535782|12144208|FG002|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
10970269|NCT00535782|12144206|FG000|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
10970270|NCT00535782|12144207|FG001|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
10970271|NCT00535782|12144208|FG002|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
10970272|NCT00535782|12144206|FG000|COMPLETED|Part 1: 24-Week Double-blind Period||65
10970273|NCT00535782|12144207|FG001|COMPLETED|Part 1: 24-Week Double-blind Period||59
10970274|NCT00535782|12144208|FG002|COMPLETED|Part 1: 24-Week Double-blind Period||0
10970275|NCT00535782|12144206|FG000|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
10970276|NCT00535782|12144207|FG001|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
10970277|NCT00535782|12144208|FG002|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
10970278|NCT00535782|12144206|FG000|STARTED|Part 2: 80-Week Open-label Period||0
10970279|NCT00535782|12144207|FG001|STARTED|Part 2: 80-Week Open-label Period||0
10970280|NCT00535782|12144208|FG002|STARTED|Part 2: 80-Week Open-label Period||124
10970281|NCT00535782|12144206|FG000|COMPLETED|Part 2: 80-Week Open-label Period||0
10970282|NCT00535782|12144207|FG001|COMPLETED|Part 2: 80-Week Open-label Period||0
10970283|NCT00535782|12144208|FG002|COMPLETED|Part 2: 80-Week Open-label Period||98
10970284|NCT00535782|12144206|FG000|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
10970285|NCT00535782|12144207|FG001|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
10970286|NCT00535782|12144208|FG002|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
10970287|NCT00535821|12144217|FG000|STARTED|Overall Study||2
10970288|NCT00535821|12144218|FG001|STARTED|Overall Study||3
10970289|NCT00535821|12144217|FG000|COMPLETED|Overall Study||2
10970290|NCT00535821|12144218|FG001|COMPLETED|Overall Study||3
10970291|NCT00535821|12144217|FG000|NOT COMPLETED|Overall Study||0
10970292|NCT00535821|12144218|FG001|NOT COMPLETED|Overall Study||0
10970293|NCT00535847|12144227|FG000|STARTED|Overall Study||81
10970294|NCT00535847|12144228|FG001|STARTED|Overall Study||34
10970295|NCT00535847|12144229|FG002|STARTED|Overall Study||2
10970296|NCT00535847|12144227|FG000|COMPLETED|Overall Study||59
10970297|NCT00535847|12144228|FG001|COMPLETED|Overall Study||20
10970298|NCT00535847|12144229|FG002|COMPLETED|Overall Study||0
10970299|NCT00535847|12144227|FG000|NOT COMPLETED|Overall Study||22
10970300|NCT00535847|12144228|FG001|NOT COMPLETED|Overall Study||14
10970301|NCT00535847|12144229|FG002|NOT COMPLETED|Overall Study||2
10970302|NCT00535873|12144241|FG000|STARTED|Overall Study||60
10970303|NCT00535873|12144241|FG000|COMPLETED|Overall Study||60
10970304|NCT00535873|12144241|FG000|NOT COMPLETED|Overall Study||0
10970305|NCT00535925|12144247|FG000|STARTED|Overall Study||188
10970306|NCT00535925|12144248|FG001|STARTED|Overall Study||207
10970307|NCT00535925|12144247|FG000|COMPLETED|Overall Study||169
10970308|NCT00535925|12144248|FG001|COMPLETED|Overall Study||199
10970309|NCT00535925|12144247|FG000|NOT COMPLETED|Overall Study||19
10970310|NCT00535925|12144248|FG001|NOT COMPLETED|Overall Study||8
10970311|NCT00535938|12144258|FG000|STARTED|Overall Study||506
10970312|NCT00535938|12144259|FG001|STARTED|Overall Study||866
10970313|NCT00535938|12144258|FG000|COMPLETED|Overall Study||115
10970314|NCT00535938|12144259|FG001|COMPLETED|Overall Study||404
10970315|NCT00535938|12144258|FG000|NOT COMPLETED|Overall Study||391
10970316|NCT00535938|12144259|FG001|NOT COMPLETED|Overall Study||462
10970317|NCT00536107|12144267|FG000|STARTED|Overall Study||8
10970318|NCT00536107|12144268|FG001|STARTED|Overall Study||6
10970319|NCT00536107|12144267|FG000|COMPLETED|Overall Study||0
10970320|NCT00536107|12144268|FG001|COMPLETED|Overall Study||0
10970321|NCT00536107|12144267|FG000|NOT COMPLETED|Overall Study||8
10970322|NCT00536107|12144268|FG001|NOT COMPLETED|Overall Study||6
10970323|NCT00536120|12144276|FG000|STARTED|Overall Study||30
10970324|NCT00536120|12144277|FG001|STARTED|Overall Study||30
10970325|NCT00536120|12144276|FG000|COMPLETED|Overall Study||24
10970326|NCT00536120|12144277|FG001|COMPLETED|Overall Study||27
10970327|NCT00536120|12144276|FG000|NOT COMPLETED|Overall Study||6
10970328|NCT00536120|12144277|FG001|NOT COMPLETED|Overall Study||3
10970329|NCT00536172|12144285|FG000|STARTED|Overall Study||74
10970330|NCT00536172|12144286|FG001|STARTED|Overall Study||74
10970331|NCT00536172|12144285|FG000|COMPLETED|Overall Study||60
10970332|NCT00536172|12144286|FG001|COMPLETED|Overall Study||65
10970333|NCT00536172|12144285|FG000|NOT COMPLETED|Overall Study||14
10970334|NCT00536172|12144286|FG001|NOT COMPLETED|Overall Study||9
10970335|NCT00536198|12144294|FG000|STARTED|Overall Study||125
10970336|NCT00536198|12144295|FG001|STARTED|Overall Study||127
10970337|NCT00536198|12144294|FG000|Cycle 1|Overall Study||110
10970338|NCT00536198|12144295|FG001|Cycle 1|Overall Study||123
10970339|NCT00536198|12144294|FG000|Cycle 2|Overall Study||104
10970340|NCT00536198|12144295|FG001|Cycle 2|Overall Study||112
10970341|NCT00536198|12144294|FG000|Cycle 3|Overall Study||100
10970342|NCT00536198|12144295|FG001|Cycle 3|Overall Study||101
10970343|NCT00536198|12144294|FG000|Cycle 4|Overall Study||95
10970344|NCT00536198|12144295|FG001|Cycle 4|Overall Study||98
10970345|NCT00536198|12144294|FG000|Cycle 5|Overall Study||88
10970346|NCT00536198|12144295|FG001|Cycle 5|Overall Study||85
10970347|NCT00536198|12144294|FG000|Cycle 6|Overall Study||88
10970348|NCT00536198|12144295|FG001|Cycle 6|Overall Study||88
10970349|NCT00536198|12144294|FG000|COMPLETED|Overall Study||88
10970350|NCT00536198|12144295|FG001|COMPLETED|Overall Study||88
10970351|NCT00536198|12144294|FG000|NOT COMPLETED|Overall Study||37
10970352|NCT00536198|12144295|FG001|NOT COMPLETED|Overall Study||39
10970353|NCT00536263|12144306|FG000|STARTED|Overall Study||225
10970354|NCT00536263|12144307|FG001|STARTED|Overall Study||221
10970355|NCT00536263|12144308|FG002|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
10970356|NCT00536263|12144306|FG000|COMPLETED|Overall Study||214
10970357|NCT00536263|12144307|FG001|COMPLETED|Overall Study||207
10970358|NCT00536263|12144308|FG002|COMPLETED|Overall Study||204
10970359|NCT00536263|12144306|FG000|NOT COMPLETED|Overall Study||11
10970360|NCT00536263|12144307|FG001|NOT COMPLETED|Overall Study||14
10970361|NCT00536263|12144308|FG002|NOT COMPLETED|Overall Study||21
10970362|NCT00536341|12144318|FG000|STARTED|Overall Study||10
10970363|NCT00536341|12144319|FG001|STARTED|Overall Study||54
10970364|NCT00536341|12144318|FG000|COMPLETED|Overall Study||5
10970365|NCT00536341|12144319|FG001|COMPLETED|Overall Study||43
10970366|NCT00536341|12144318|FG000|NOT COMPLETED|Overall Study||5
10970367|NCT00536341|12144319|FG001|NOT COMPLETED|Overall Study||11
10970368|NCT00536471|12144330|FG000|STARTED|Overall Study||257
10970369|NCT00536471|12144331|FG001|STARTED|Overall Study||127
10970370|NCT00536471|12144332|FG002|STARTED|Overall Study||261
10970371|NCT00536471|12144333|FG003|STARTED|Overall Study||131
10970372|NCT00536471|12144330|FG000|COMPLETED|Overall Study||101
10970373|NCT00536471|12144331|FG001|COMPLETED|Overall Study||43
10970374|NCT00536471|12144332|FG002|COMPLETED|Overall Study||122
10970375|NCT00536471|12144333|FG003|COMPLETED|Overall Study||57
10970376|NCT00536471|12144330|FG000|NOT COMPLETED|Overall Study||156
10970377|NCT00536471|12144331|FG001|NOT COMPLETED|Overall Study||84
10970378|NCT00536471|12144332|FG002|NOT COMPLETED|Overall Study||139
10970379|NCT00536471|12144333|FG003|NOT COMPLETED|Overall Study||74
10970380|NCT00536484|12144352|FG000|STARTED|Overall Study|448 participants randomised; 3 not treated|445
10970381|NCT00536484|12144353|FG001|STARTED|Overall Study|448 participants randomised; 10 not treated|438
10970382|NCT00536484|12144352|FG000|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
10970383|NCT00536484|12144353|FG001|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
10970384|NCT00536484|12144352|FG000|NOT COMPLETED|Overall Study||60
10970385|NCT00536484|12144353|FG001|NOT COMPLETED|Overall Study||56
10970386|NCT00536510|12144361|FG000|STARTED|Overall Study||322
10970387|NCT00536510|12144362|FG001|STARTED|Overall Study||324
10970388|NCT00536510|12144361|FG000|COMPLETED|Overall Study||240
10970389|NCT00536510|12144362|FG001|COMPLETED|Overall Study||295
10970390|NCT00536510|12144361|FG000|NOT COMPLETED|Overall Study||82
10970391|NCT00536510|12144362|FG001|NOT COMPLETED|Overall Study||29
10970392|NCT00536575|12144368|FG000|STARTED|Overall Study||13
10970393|NCT00536575|12144368|FG000|COMPLETED|Overall Study||11
10970394|NCT00536575|12144368|FG000|NOT COMPLETED|Overall Study||2
10970395|NCT00536601|12144377|FG000|STARTED|Overall Study||6
10970396|NCT00536601|12144378|FG001|STARTED|Overall Study||21
10970397|NCT00536601|12144379|FG002|STARTED|Overall Study||71
10970398|NCT00536601|12144380|FG003|STARTED|Overall Study||65
10970399|NCT00536601|12144381|FG004|STARTED|Overall Study||11
10970400|NCT00536601|12144377|FG000|COMPLETED|Overall Study||6
10970401|NCT00536601|12144378|FG001|COMPLETED|Overall Study||21
10970402|NCT00536601|12144379|FG002|COMPLETED|Overall Study||71
10970403|NCT00536601|12144380|FG003|COMPLETED|Overall Study||65
10970404|NCT00536601|12144381|FG004|COMPLETED|Overall Study||11
10970405|NCT00536601|12144377|FG000|NOT COMPLETED|Overall Study||0
10970406|NCT00536601|12144378|FG001|NOT COMPLETED|Overall Study||0
10970407|NCT00536601|12144379|FG002|NOT COMPLETED|Overall Study||0
10970408|NCT00536601|12144380|FG003|NOT COMPLETED|Overall Study||0
10970409|NCT00536601|12144381|FG004|NOT COMPLETED|Overall Study||0
10970410|NCT00536731|12144396|FG000|STARTED|Overall Study||253
10970411|NCT00536731|12144397|FG001|STARTED|Overall Study||246
10970412|NCT00536731|12144398|FG002|STARTED|Overall Study||243
10970413|NCT00536731|12144396|FG000|COMPLETED|Overall Study||249
10970414|NCT00536731|12144397|FG001|COMPLETED|Overall Study||241
10970415|NCT00536731|12144398|FG002|COMPLETED|Overall Study||238
10970416|NCT00536731|12144396|FG000|NOT COMPLETED|Overall Study||4
10970417|NCT00536731|12144397|FG001|NOT COMPLETED|Overall Study||5
10970418|NCT00536731|12144398|FG002|NOT COMPLETED|Overall Study||5
10970419|NCT00536744|12144408|FG000|STARTED|Overall Study||107
10970420|NCT00536744|12144409|FG001|STARTED|Overall Study||99
10970421|NCT00536744|12144408|FG000|COMPLETED|Overall Study||78
10970422|NCT00536744|12144409|FG001|COMPLETED|Overall Study||71
10970423|NCT00536744|12144408|FG000|NOT COMPLETED|Overall Study||29
10970424|NCT00536744|12144409|FG001|NOT COMPLETED|Overall Study||28
10970425|NCT00536809|12144415|FG000|STARTED|Phase I (Dose-finding Phase)||10
10970426|NCT00536809|12144415|FG000|COMPLETED|Phase I (Dose-finding Phase)||10
10970427|NCT00536809|12144415|FG000|NOT COMPLETED|Phase I (Dose-finding Phase)||0
10970428|NCT00536809|12144415|FG000|STARTED|Phase II||2
10970429|NCT00536809|12144415|FG000|COMPLETED|Phase II||0
10970430|NCT00536809|12144415|FG000|NOT COMPLETED|Phase II||2
10970431|NCT00536874|12144419|FG000|STARTED|Overall Study||39
10970432|NCT00536874|12144419|FG000|COMPLETED|Overall Study||35
10970433|NCT00536874|12144419|FG000|NOT COMPLETED|Overall Study||4
10970434|NCT00536913|12144425|FG000|STARTED|Overall Study||55
10970435|NCT00536913|12144426|FG001|STARTED|Overall Study||52
10970436|NCT00536913|12144425|FG000|COMPLETED|Overall Study||55
10970437|NCT00536913|12144426|FG001|COMPLETED|Overall Study||52
10970438|NCT00536913|12144425|FG000|NOT COMPLETED|Overall Study||0
10970439|NCT00536913|12144426|FG001|NOT COMPLETED|Overall Study||0
10970440|NCT00536939|12144432|FG000|STARTED|Overall Study||2
10970441|NCT00536939|12144433|FG001|STARTED|Overall Study||0
10970442|NCT00536939|12144432|FG000|Entered Safety lead-in|Overall Study||2
10970443|NCT00536939|12144433|FG001|Entered Safety lead-in|Overall Study||0
10970444|NCT00536939|12144432|FG000|Randomized|Overall Study||0
10970445|NCT00536939|12144433|FG001|Randomized|Overall Study||0
10970446|NCT00536939|12144432|FG000|COMPLETED|Overall Study||0
10970447|NCT00536939|12144433|FG001|COMPLETED|Overall Study||0
10970448|NCT00536939|12144432|FG000|NOT COMPLETED|Overall Study||2
10970449|NCT00536939|12144433|FG001|NOT COMPLETED|Overall Study||0
10970450|NCT00536991|12144438|FG000|STARTED|Overall Study||51
10970451|NCT00536991|12144438|FG000|COMPLETED|Overall Study||38
10970452|NCT00536991|12144438|FG000|NOT COMPLETED|Overall Study||13
10970453|NCT00537017|12144443|FG000|STARTED|Treatment Phase||140
10970454|NCT00537017|12144443|FG000|COMPLETED|Treatment Phase||106
10970455|NCT00537017|12144443|FG000|NOT COMPLETED|Treatment Phase||34
10970456|NCT00537017|12144443|FG000|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
10970457|NCT00537017|12144443|FG000|COMPLETED|Follow-up Phase||126
10970458|NCT00537017|12144443|FG000|NOT COMPLETED|Follow-up Phase||9
10970459|NCT00537030|12144447|FG000|STARTED|Overall Study||59
10970460|NCT00537030|12144447|FG000|COMPLETED|Overall Study||43
10970461|NCT00537030|12144447|FG000|NOT COMPLETED|Overall Study||16
10970462|NCT00537056|12144451|FG000|STARTED|Baseline PET/CT||17
10970463|NCT00537056|12144451|FG000|COMPLETED|Baseline PET/CT||17
10970464|NCT00537056|12144451|FG000|NOT COMPLETED|Baseline PET/CT||0
10970465|NCT00537056|12144451|FG000|STARTED|Interim PET/CT||17
10970466|NCT00537056|12144451|FG000|COMPLETED|Interim PET/CT||12
10970467|NCT00537056|12144451|FG000|NOT COMPLETED|Interim PET/CT||5
10970468|NCT00537056|12144451|FG000|STARTED|12-month Follow-up||17
10970469|NCT00537056|12144451|FG000|COMPLETED|12-month Follow-up||17
10970470|NCT00537056|12144451|FG000|NOT COMPLETED|12-month Follow-up||0
10970471|NCT00537082|12144460|FG000|STARTED|Overall Study||57
10970472|NCT00537082|12144461|FG001|STARTED|Overall Study||57
10970473|NCT00537082|12144462|FG002|STARTED|Overall Study||57
10970474|NCT00537082|12144460|FG000|COMPLETED|Overall Study||48
10970475|NCT00537082|12144461|FG001|COMPLETED|Overall Study||48
10970476|NCT00537082|12144462|FG002|COMPLETED|Overall Study||51
10970477|NCT00537082|12144460|FG000|NOT COMPLETED|Overall Study||9
10970478|NCT00537082|12144461|FG001|NOT COMPLETED|Overall Study||9
10970479|NCT00537082|12144462|FG002|NOT COMPLETED|Overall Study||6
10970480|NCT00537095|12144472|FG000|STARTED|Overall Study||72
10970481|NCT00537095|12144473|FG001|STARTED|Overall Study||73
10970482|NCT00537095|12144472|FG000|COMPLETED|Overall Study||21
10970483|NCT00537095|12144473|FG001|COMPLETED|Overall Study||16
10970484|NCT00537095|12144472|FG000|NOT COMPLETED|Overall Study||51
10970485|NCT00537095|12144473|FG001|NOT COMPLETED|Overall Study||57
10970486|NCT00537238|12144481|FG000|STARTED|Overall Study||254
10970487|NCT00537238|12144482|FG001|STARTED|Overall Study||255
10970488|NCT00537238|12144481|FG000|Completed Titration Phase|Overall Study||226
10970489|NCT00537238|12144482|FG001|Completed Titration Phase|Overall Study||236
10970490|NCT00537238|12144481|FG000|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
10970491|NCT00537238|12144482|FG001|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
10970492|NCT00537238|12144481|FG000|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
10970493|NCT00537238|12144482|FG001|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
10970494|NCT00537238|12144481|FG000|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
10970495|NCT00537238|12144482|FG001|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
10970496|NCT00537238|12144481|FG000|NOT COMPLETED|Overall Study||174
10970497|NCT00537238|12144482|FG001|NOT COMPLETED|Overall Study||173
10970498|NCT00537277|12144488|FG000|STARTED|Overall Study||161
10970499|NCT00537277|12144488|FG000|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
10970500|NCT00537277|12144488|FG000|COMPLETED|Overall Study||112
10970501|NCT00537277|12144488|FG000|NOT COMPLETED|Overall Study||49
10970502|NCT00537290|12144492|FG000|STARTED|Overall Study||19
10970503|NCT00537290|12144492|FG000|COMPLETED|Overall Study||19
10970504|NCT00537290|12144492|FG000|NOT COMPLETED|Overall Study||0
10970505|NCT00537303|12144498|FG000|STARTED|Overall Study||146
10970506|NCT00537303|12144499|FG001|STARTED|Overall Study||150
10970507|NCT00537303|12144498|FG000|COMPLETED|Overall Study||120
10970508|NCT00537303|12144499|FG001|COMPLETED|Overall Study||125
10970509|NCT00537303|12144498|FG000|NOT COMPLETED|Overall Study||26
10970510|NCT00537303|12144499|FG001|NOT COMPLETED|Overall Study||25
10970511|NCT00537316|12144511|FG000|STARTED|Part 1||79
10970512|NCT00537316|12144512|FG001|STARTED|Part 1||80
10970513|NCT00537316|12144513|FG002|STARTED|Part 1||80
10970514|NCT00537316|12144514|FG003|STARTED|Part 1||0
10970515|NCT00537316|12144515|FG004|STARTED|Part 1||0
10970516|NCT00537316|12144516|FG005|STARTED|Part 1||0
10970517|NCT00537316|12144517|FG006|STARTED|Part 1||0
10970518|NCT00537316|12144511|FG000|COMPLETED|Part 1||65
10970519|NCT00537316|12144512|FG001|COMPLETED|Part 1||53
10970520|NCT00537316|12144513|FG002|COMPLETED|Part 1||63
10970521|NCT00537316|12144514|FG003|COMPLETED|Part 1||0
10970522|NCT00537316|12144515|FG004|COMPLETED|Part 1||0
10970523|NCT00537316|12144516|FG005|COMPLETED|Part 1||0
10970524|NCT00537316|12144517|FG006|COMPLETED|Part 1||0
10970525|NCT00537316|12144511|FG000|NOT COMPLETED|Part 1||14
10970526|NCT00537316|12144512|FG001|NOT COMPLETED|Part 1||27
10970527|NCT00537316|12144513|FG002|NOT COMPLETED|Part 1||17
10970528|NCT00537316|12144514|FG003|NOT COMPLETED|Part 1||0
10970529|NCT00537316|12144515|FG004|NOT COMPLETED|Part 1||0
10970530|NCT00537316|12144516|FG005|NOT COMPLETED|Part 1||0
10970531|NCT00537316|12144517|FG006|NOT COMPLETED|Part 1||0
10970532|NCT00537316|12144511|FG000|STARTED|Part 2||37
10970533|NCT00537316|12144512|FG001|STARTED|Part 2||10
10970534|NCT00537316|12144513|FG002|STARTED|Part 2||48
10970535|NCT00537316|12144514|FG003|STARTED|Part 2||5
10970536|NCT00537316|12144515|FG004|STARTED|Part 2||2
10970537|NCT00537316|12144516|FG005|STARTED|Part 2||4
10970538|NCT00537316|12144517|FG006|STARTED|Part 2||2
10970539|NCT00537316|12144511|FG000|COMPLETED|Part 2||11
10970540|NCT00537316|12144512|FG001|COMPLETED|Part 2||1
10970541|NCT00537316|12144513|FG002|COMPLETED|Part 2||16
10970542|NCT00537316|12144514|FG003|COMPLETED|Part 2||2
10970543|NCT00537316|12144515|FG004|COMPLETED|Part 2||1
10970544|NCT00537316|12144516|FG005|COMPLETED|Part 2||0
10970545|NCT00537316|12144517|FG006|COMPLETED|Part 2||0
10970546|NCT00537316|12144511|FG000|NOT COMPLETED|Part 2||26
10970547|NCT00537316|12144512|FG001|NOT COMPLETED|Part 2||9
10970548|NCT00537316|12144513|FG002|NOT COMPLETED|Part 2||32
10970549|NCT00537316|12144514|FG003|NOT COMPLETED|Part 2||3
10970550|NCT00537316|12144515|FG004|NOT COMPLETED|Part 2||1
10970551|NCT00537316|12144516|FG005|NOT COMPLETED|Part 2||4
10970552|NCT00537316|12144517|FG006|NOT COMPLETED|Part 2||2
10970553|NCT00537329|12144536|FG000|STARTED|Overall Study||43
10970554|NCT00537329|12144536|FG000|COMPLETED|Overall Study||17
10970555|NCT00537329|12144536|FG000|NOT COMPLETED|Overall Study||26
10970556|NCT00537381|12144542|FG000|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
10970557|NCT00537381|12144543|FG001|STARTED|Overall Study||66
10970558|NCT00537381|12144542|FG000|COMPLETED|Overall Study||9
10970559|NCT00537381|12144543|FG001|COMPLETED|Overall Study||4
10970560|NCT00537381|12144542|FG000|NOT COMPLETED|Overall Study||56
10970561|NCT00537381|12144543|FG001|NOT COMPLETED|Overall Study||62
10970562|NCT00537394|12144554|FG000|STARTED|First Year of Follow-up||181
10970563|NCT00537394|12144555|FG001|STARTED|First Year of Follow-up||179
10970564|NCT00537394|12144556|FG002|STARTED|First Year of Follow-up||53
10970565|NCT00537394|12144554|FG000|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
10970566|NCT00537394|12144555|FG001|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
10970567|NCT00537394|12144556|FG002|COMPLETED|First Year of Follow-up||50
10970568|NCT00537394|12144554|FG000|NOT COMPLETED|First Year of Follow-up||12
10970569|NCT00537394|12144555|FG001|NOT COMPLETED|First Year of Follow-up||11
10970570|NCT00537394|12144556|FG002|NOT COMPLETED|First Year of Follow-up||3
10970571|NCT00537394|12144554|FG000|STARTED|2nd Year of Follow-up||169
10970572|NCT00537394|12144555|FG001|STARTED|2nd Year of Follow-up||168
10970573|NCT00537394|12144556|FG002|STARTED|2nd Year of Follow-up||50
10970574|NCT00537394|12144554|FG000|COMPLETED|2nd Year of Follow-up||158
10970575|NCT00537394|12144555|FG001|COMPLETED|2nd Year of Follow-up||159
10970576|NCT00537394|12144556|FG002|COMPLETED|2nd Year of Follow-up||44
10970577|NCT00537394|12144554|FG000|NOT COMPLETED|2nd Year of Follow-up||11
10970578|NCT00537394|12144555|FG001|NOT COMPLETED|2nd Year of Follow-up||9
10970579|NCT00537394|12144556|FG002|NOT COMPLETED|2nd Year of Follow-up||6
10970580|NCT00537407|12144567|FG000|STARTED|Part 1 Weeks 1-4||10
10970581|NCT00537407|12144568|FG001|STARTED|Part 1 Weeks 1-4||9
10970582|NCT00537407|12144569|FG002|STARTED|Part 1 Weeks 1-4||11
10970583|NCT00537407|12144570|FG003|STARTED|Part 1 Weeks 1-4||10
10970584|NCT00537407|12144571|FG004|STARTED|Part 1 Weeks 1-4||10
10970585|NCT00537407|12144567|FG000|COMPLETED|Part 1 Weeks 1-4||10
10970586|NCT00537407|12144568|FG001|COMPLETED|Part 1 Weeks 1-4||9
10970587|NCT00537407|12144569|FG002|COMPLETED|Part 1 Weeks 1-4||11
10970588|NCT00537407|12144570|FG003|COMPLETED|Part 1 Weeks 1-4||10
10970589|NCT00537407|12144571|FG004|COMPLETED|Part 1 Weeks 1-4||10
10970590|NCT00537407|12144567|FG000|NOT COMPLETED|Part 1 Weeks 1-4||0
10970591|NCT00537407|12144568|FG001|NOT COMPLETED|Part 1 Weeks 1-4||0
10970592|NCT00537407|12144569|FG002|NOT COMPLETED|Part 1 Weeks 1-4||0
10970593|NCT00537407|12144570|FG003|NOT COMPLETED|Part 1 Weeks 1-4||0
10970594|NCT00537407|12144571|FG004|NOT COMPLETED|Part 1 Weeks 1-4||0
10970595|NCT00537407|12144567|FG000|STARTED|Part 2 Weeks 5-48 or 72||10
10970596|NCT00537407|12144568|FG001|STARTED|Part 2 Weeks 5-48 or 72||9
10970597|NCT00537407|12144569|FG002|STARTED|Part 2 Weeks 5-48 or 72||11
10970598|NCT00537407|12144570|FG003|STARTED|Part 2 Weeks 5-48 or 72||10
10970599|NCT00537407|12144571|FG004|STARTED|Part 2 Weeks 5-48 or 72||10
10970600|NCT00537407|12144567|FG000|COMPLETED|Part 2 Weeks 5-48 or 72||2
10970601|NCT00537407|12144568|FG001|COMPLETED|Part 2 Weeks 5-48 or 72||1
10970602|NCT00537407|12144569|FG002|COMPLETED|Part 2 Weeks 5-48 or 72||2
10970603|NCT00537407|12144570|FG003|COMPLETED|Part 2 Weeks 5-48 or 72||4
10970604|NCT00537407|12144571|FG004|COMPLETED|Part 2 Weeks 5-48 or 72||3
10970605|NCT00537407|12144567|FG000|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
10970606|NCT00537407|12144568|FG001|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
10970607|NCT00537407|12144569|FG002|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
10970608|NCT00537407|12144570|FG003|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
10970609|NCT00537407|12144571|FG004|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
10970610|NCT00537485|12144589|FG000|STARTED|Overall Study||90
10970611|NCT00537485|12144590|FG001|STARTED|Overall Study||90
10970612|NCT00537485|12144589|FG000|COMPLETED|Overall Study||75
10970613|NCT00537485|12144590|FG001|COMPLETED|Overall Study||80
10970614|NCT00537485|12144589|FG000|NOT COMPLETED|Overall Study||15
10970615|NCT00537485|12144590|FG001|NOT COMPLETED|Overall Study||10
10970616|NCT00537511|12144596|FG000|STARTED|Treatment Period (Combination)||22
10970704|NCT00538213|12144715|FG001|STARTED|Overall Study||40
10970705|NCT00538213|12144716|FG002|STARTED|Overall Study||38
10970617|NCT00537511|12144596|FG000|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
10970618|NCT00537511|12144596|FG000|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
10970619|NCT00537511|12144596|FG000|COMPLETED|Treatment Period (Combination)||17
10970620|NCT00537511|12144596|FG000|NOT COMPLETED|Treatment Period (Combination)||5
10970621|NCT00537511|12144596|FG000|STARTED|Extension Period (Combination)||17
10970622|NCT00537511|12144596|FG000|COMPLETED|Extension Period (Combination)||11
10970623|NCT00537511|12144596|FG000|NOT COMPLETED|Extension Period (Combination)||6
10970624|NCT00537511|12144596|FG000|STARTED|Recovery Period (Monotherapy)||11
10970625|NCT00537511|12144596|FG000|COMPLETED|Recovery Period (Monotherapy)||3
10970626|NCT00537511|12144596|FG000|NOT COMPLETED|Recovery Period (Monotherapy)||8
10970627|NCT00537511|12144596|FG000|STARTED|Maintenance Phase (Monotherapy)||8
10970628|NCT00537511|12144596|FG000|COMPLETED|Maintenance Phase (Monotherapy)||0
10970629|NCT00537511|12144596|FG000|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
10970630|NCT00537576|12144619|FG000|STARTED|Overall Study||3
10970631|NCT00537576|12144620|FG001|STARTED|Overall Study||3
10970632|NCT00537576|12144621|FG002|STARTED|Overall Study||3
10970633|NCT00537576|12144622|FG003|STARTED|Overall Study||1
10970634|NCT00537576|12144623|FG004|STARTED|Overall Study||1
10970635|NCT00537576|12144624|FG005|STARTED|Overall Study||1
10970636|NCT00537576|12144619|FG000|COMPLETED|Overall Study||3
10970637|NCT00537576|12144620|FG001|COMPLETED|Overall Study||3
10970638|NCT00537576|12144621|FG002|COMPLETED|Overall Study||3
10970639|NCT00537576|12144622|FG003|COMPLETED|Overall Study||1
10970640|NCT00537576|12144623|FG004|COMPLETED|Overall Study||1
10970641|NCT00537576|12144624|FG005|COMPLETED|Overall Study||1
10970642|NCT00537576|12144619|FG000|NOT COMPLETED|Overall Study||0
10970643|NCT00537576|12144620|FG001|NOT COMPLETED|Overall Study||0
10970644|NCT00537576|12144621|FG002|NOT COMPLETED|Overall Study||0
10970645|NCT00537576|12144622|FG003|NOT COMPLETED|Overall Study||0
10970646|NCT00537576|12144623|FG004|NOT COMPLETED|Overall Study||0
10970647|NCT00537576|12144624|FG005|NOT COMPLETED|Overall Study||0
10970648|NCT00537680|12144641|FG000|STARTED|Overall Study||22
10970649|NCT00537680|12144642|FG001|STARTED|Overall Study||24
10970650|NCT00537680|12144643|FG002|STARTED|Overall Study||24
10970651|NCT00537680|12144641|FG000|COMPLETED|Overall Study||22
10970652|NCT00537680|12144642|FG001|COMPLETED|Overall Study||22
10970653|NCT00537680|12144643|FG002|COMPLETED|Overall Study||24
10970654|NCT00537680|12144641|FG000|NOT COMPLETED|Overall Study||0
10970655|NCT00537680|12144642|FG001|NOT COMPLETED|Overall Study||2
10970656|NCT00537680|12144643|FG002|NOT COMPLETED|Overall Study||0
10970657|NCT00537745|12144651|FG000|STARTED|Overall Study|There were three screen fails and two early terminations.|14
10970658|NCT00537745|12144651|FG000|Began Intervention|Overall Study||11
10970659|NCT00537745|12144651|FG000|COMPLETED|Overall Study||9
10970660|NCT00537745|12144651|FG000|NOT COMPLETED|Overall Study||5
10970661|NCT00537771|12144658|FG000|STARTED|Overall Study||178
10970662|NCT00537771|12144659|FG001|STARTED|Overall Study||175
10970663|NCT00537771|12144658|FG000|COMPLETED|Overall Study||149
10970664|NCT00537771|12144659|FG001|COMPLETED|Overall Study||114
10970665|NCT00537771|12144658|FG000|NOT COMPLETED|Overall Study||29
10970666|NCT00537771|12144659|FG001|NOT COMPLETED|Overall Study||61
10970667|NCT00537810|12144669|FG000|STARTED|Overall Study||26
10970668|NCT00537810|12144670|FG001|STARTED|Overall Study||27
10970669|NCT00537810|12144671|FG002|STARTED|Overall Study||25
10970670|NCT00537810|12144672|FG003|STARTED|Overall Study||26
10970671|NCT00537810|12144669|FG000|COMPLETED|Overall Study||20
10970672|NCT00537810|12144670|FG001|COMPLETED|Overall Study||14
10970673|NCT00537810|12144671|FG002|COMPLETED|Overall Study||21
10970674|NCT00537810|12144672|FG003|COMPLETED|Overall Study||22
10970675|NCT00537810|12144669|FG000|NOT COMPLETED|Overall Study||6
10970676|NCT00537810|12144670|FG001|NOT COMPLETED|Overall Study||13
10970677|NCT00537810|12144671|FG002|NOT COMPLETED|Overall Study||4
10970678|NCT00537810|12144672|FG003|NOT COMPLETED|Overall Study||4
10970679|NCT00537823|12144684|FG000|STARTED|Overall Study||7
10970680|NCT00537823|12144685|FG001|STARTED|Overall Study||2
10970681|NCT00537823|12144684|FG000|COMPLETED|Overall Study||5
10970682|NCT00537823|12144685|FG001|COMPLETED|Overall Study||2
10970683|NCT00537823|12144684|FG000|NOT COMPLETED|Overall Study||2
10970684|NCT00537823|12144685|FG001|NOT COMPLETED|Overall Study||0
10970685|NCT00537940|12144694|FG000|STARTED|Overall Study||241
10970686|NCT00537940|12144695|FG001|STARTED|Overall Study||241
10970687|NCT00537940|12144694|FG000|Completed Titration Phase|Overall Study||213
10970688|NCT00537940|12144695|FG001|Completed Titration Phase|Overall Study||210
10970689|NCT00537940|12144694|FG000|Completed Maintenance Phase|Overall Study||187
10970690|NCT00537940|12144695|FG001|Completed Maintenance Phase|Overall Study||172
10970691|NCT00537940|12144694|FG000|Entered Opt Blinded Continuation Phase|Overall Study||140
10970692|NCT00537940|12144695|FG001|Entered Opt Blinded Continuation Phase|Overall Study||139
10970693|NCT00537940|12144694|FG000|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
10970694|NCT00537940|12144695|FG001|COMPLETED|Overall Study||62
10970695|NCT00537940|12144694|FG000|NOT COMPLETED|Overall Study||183
10970696|NCT00537940|12144695|FG001|NOT COMPLETED|Overall Study||179
10970697|NCT00537979|12144703|FG000|STARTED|Overall Study||38
10970698|NCT00537979|12144704|FG001|STARTED|Overall Study||109
10970699|NCT00537979|12144703|FG000|COMPLETED|Overall Study||32
10970700|NCT00537979|12144704|FG001|COMPLETED|Overall Study||89
10970701|NCT00537979|12144703|FG000|NOT COMPLETED|Overall Study||6
10970702|NCT00537979|12144704|FG001|NOT COMPLETED|Overall Study||20
10970703|NCT00538213|12144714|FG000|STARTED|Overall Study||55
10970706|NCT00538213|12144714|FG000|COMPLETED|Overall Study||55
10970707|NCT00538213|12144715|FG001|COMPLETED|Overall Study||40
10970708|NCT00538213|12144716|FG002|COMPLETED|Overall Study||38
10970709|NCT00538213|12144714|FG000|NOT COMPLETED|Overall Study||0
10970710|NCT00538213|12144715|FG001|NOT COMPLETED|Overall Study||0
10970711|NCT00538213|12144716|FG002|NOT COMPLETED|Overall Study||0
10970712|NCT00538291|12144725|FG000|STARTED|Overall Study||13
10970713|NCT00538291|12144725|FG000|COMPLETED|Overall Study||10
10970714|NCT00538291|12144725|FG000|NOT COMPLETED|Overall Study||3
10970715|NCT00538304|12144731|FG000|STARTED|Overall Study||151
10970716|NCT00538304|12144732|FG001|STARTED|Overall Study||71
10970717|NCT00538304|12144731|FG000|COMPLETED|Overall Study||144
10970718|NCT00538304|12144732|FG001|COMPLETED|Overall Study||66
10970719|NCT00538304|12144731|FG000|NOT COMPLETED|Overall Study||7
10970720|NCT00538304|12144732|FG001|NOT COMPLETED|Overall Study||5
10970721|NCT00538434|12144742|FG000|STARTED|Overall Study||56
10970722|NCT00538434|12144743|FG001|STARTED|Overall Study||57
10970723|NCT00538434|12144744|FG002|STARTED|Overall Study||57
10970724|NCT00538434|12144745|FG003|STARTED|Overall Study||57
10970725|NCT00538434|12144742|FG000|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
10970726|NCT00538434|12144743|FG001|Intent-to-treat (ITT) Population|Overall Study||57
10970727|NCT00538434|12144744|FG002|Intent-to-treat (ITT) Population|Overall Study||57
10970728|NCT00538434|12144745|FG003|Intent-to-treat (ITT) Population|Overall Study||57
10970729|NCT00538434|12144742|FG000|COMPLETED|Overall Study|Completed all scheduled study visits|47
10970730|NCT00538434|12144743|FG001|COMPLETED|Overall Study|Completed all scheduled study visits|46
10970731|NCT00538434|12144744|FG002|COMPLETED|Overall Study|Completed all scheduled study visits|50
10970732|NCT00538434|12144745|FG003|COMPLETED|Overall Study|Completed all scheduled study visits|51
10970733|NCT00538434|12144742|FG000|NOT COMPLETED|Overall Study||9
10970734|NCT00538434|12144743|FG001|NOT COMPLETED|Overall Study||11
10970735|NCT00538434|12144744|FG002|NOT COMPLETED|Overall Study||7
10970736|NCT00538434|12144745|FG003|NOT COMPLETED|Overall Study||6
10970737|NCT00538473|12144758|FG000|STARTED|Overall Study||33
10970738|NCT00538473|12144759|FG001|STARTED|Overall Study||35
10970739|NCT00538473|12144758|FG000|COMPLETED|Overall Study||32
10970740|NCT00538473|12144759|FG001|COMPLETED|Overall Study||35
10970741|NCT00538473|12144758|FG000|NOT COMPLETED|Overall Study||1
10970742|NCT00538473|12144759|FG001|NOT COMPLETED|Overall Study||0
10970743|NCT00538512|12144768|FG000|STARTED|Overall Study||814
10970744|NCT00538512|12144769|FG001|STARTED|Overall Study||813
10970745|NCT00538512|12144770|FG002|STARTED|Overall Study||325
10970746|NCT00538512|12144768|FG000|COMPLETED|Overall Study||787
10970747|NCT00538512|12144769|FG001|COMPLETED|Overall Study||783
10970748|NCT00538512|12144770|FG002|COMPLETED|Overall Study||312
10970749|NCT00538512|12144768|FG000|NOT COMPLETED|Overall Study||27
10970750|NCT00538512|12144769|FG001|NOT COMPLETED|Overall Study||30
10970751|NCT00538512|12144770|FG002|NOT COMPLETED|Overall Study||13
10970752|NCT00538590|12144780|FG000|STARTED|Overall Study||10
10970753|NCT00538590|12144781|FG001|STARTED|Overall Study||10
10970754|NCT00538590|12144780|FG000|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
10970755|NCT00538590|12144781|FG001|COMPLETED|Overall Study||10
10970756|NCT00538590|12144780|FG000|NOT COMPLETED|Overall Study||1
10970757|NCT00538590|12144781|FG001|NOT COMPLETED|Overall Study||0
10970758|NCT00538616|12144789|FG000|STARTED|Overall Study||5
10970759|NCT00538616|12144790|FG001|STARTED|Overall Study||3
10970760|NCT00538616|12144789|FG000|COMPLETED|Overall Study||5
10970761|NCT00538616|12144790|FG001|COMPLETED|Overall Study||3
10970762|NCT00538616|12144789|FG000|NOT COMPLETED|Overall Study||0
10970763|NCT00538616|12144790|FG001|NOT COMPLETED|Overall Study||0
10970764|NCT00538629|12144796|FG000|STARTED|Overall Study||471
10970765|NCT00538629|12144796|FG000|COMPLETED|Overall Study||449
10970766|NCT00538629|12144796|FG000|NOT COMPLETED|Overall Study||22
10970767|NCT00538642|12144802|FG000|STARTED|Overall Study||10
10970768|NCT00538642|12144803|FG001|STARTED|Overall Study||14
10970769|NCT00538642|12144802|FG000|COMPLETED|Overall Study||9
10970770|NCT00538642|12144803|FG001|COMPLETED|Overall Study||9
10970771|NCT00538642|12144802|FG000|NOT COMPLETED|Overall Study||1
10970772|NCT00538642|12144803|FG001|NOT COMPLETED|Overall Study||5
10970773|NCT00538681|12144814|FG000|STARTED|Overall Study||9
10970774|NCT00538681|12144815|FG001|STARTED|Overall Study||4
10970775|NCT00538681|12144816|FG002|STARTED|Overall Study||11
10970776|NCT00538681|12144817|FG003|STARTED|Overall Study|One (1) participant received pemetrexed and cisplatin only before the study was closed.|11
10970777|NCT00538681|12144814|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||9
10970778|NCT00538681|12144815|FG001|Received ≥1 Dose of Any Study Drug|Overall Study||4
10970779|NCT00538681|12144816|FG002|Received ≥1 Dose of Any Study Drug|Overall Study||11
10970780|NCT00538681|12144817|FG003|Received ≥1 Dose of Any Study Drug|Overall Study||11
10970781|NCT00538681|12144814|FG000|COMPLETED|Overall Study||0
10970782|NCT00538681|12144815|FG001|COMPLETED|Overall Study||0
10970783|NCT00538681|12144816|FG002|COMPLETED|Overall Study||0
10970784|NCT00538681|12144817|FG003|COMPLETED|Overall Study||0
10970785|NCT00538681|12144814|FG000|NOT COMPLETED|Overall Study||9
10970786|NCT00538681|12144815|FG001|NOT COMPLETED|Overall Study||4
10970787|NCT00538681|12144816|FG002|NOT COMPLETED|Overall Study||11
10970788|NCT00538681|12144817|FG003|NOT COMPLETED|Overall Study||11
10970789|NCT00538733|12144828|FG000|STARTED|Overall Study||26
10970790|NCT00538733|12144828|FG000|Removed Due to Progression of Disease|Overall Study||1
10970791|NCT00538733|12144828|FG000|Removed to Pursue a Stem Cell Transplant|Overall Study||11
10970792|NCT00538733|12144828|FG000|Removed to Pursue Alternative Theray|Overall Study||2
10970793|NCT00538733|12144828|FG000|COMPLETED|Overall Study||14
10970794|NCT00538733|12144828|FG000|NOT COMPLETED|Overall Study||12
10970795|NCT00538759|12144837|FG000|STARTED|Overall Study||13
10970796|NCT00538759|12144838|FG001|STARTED|Overall Study||8
10970797|NCT00538759|12144837|FG000|COMPLETED|Overall Study||13
10970798|NCT00538759|12144838|FG001|COMPLETED|Overall Study||8
10970799|NCT00538759|12144837|FG000|NOT COMPLETED|Overall Study||0
10970800|NCT00538759|12144838|FG001|NOT COMPLETED|Overall Study||0
10970801|NCT00538785|12144846|FG000|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
10970802|NCT00538785|12144847|FG001|STARTED|Overall Study||612
10970803|NCT00538785|12144846|FG000|COMPLETED|Overall Study||604
10970804|NCT00538785|12144847|FG001|COMPLETED|Overall Study||595
10970805|NCT00538785|12144846|FG000|NOT COMPLETED|Overall Study||19
10970806|NCT00538785|12144847|FG001|NOT COMPLETED|Overall Study||17
10970807|NCT00538824|12144853|FG000|STARTED|Overall Study||5
10970808|NCT00538824|12144853|FG000|Progression of Disease|Overall Study||2
10970809|NCT00538824|12144853|FG000|COMPLETED|Overall Study||5
10970810|NCT00538824|12144853|FG000|NOT COMPLETED|Overall Study||0
10970811|NCT00538850|12144857|FG000|STARTED|Titration Period||130
10970812|NCT00538850|12144858|FG001|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
10970813|NCT00538850|12144859|FG002|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
10970814|NCT00538850|12144857|FG000|COMPLETED|Titration Period||98
10970815|NCT00538850|12144858|FG001|COMPLETED|Titration Period||0
10970816|NCT00538850|12144859|FG002|COMPLETED|Titration Period||0
10970817|NCT00538850|12144857|FG000|NOT COMPLETED|Titration Period||32
10970818|NCT00538850|12144858|FG001|NOT COMPLETED|Titration Period||0
10970819|NCT00538850|12144859|FG002|NOT COMPLETED|Titration Period||0
10970820|NCT00538850|12144857|FG000|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
10970821|NCT00538850|12144858|FG001|STARTED|Fentanyl Sublingual Spray - Double-blind||98
10970822|NCT00538850|12144859|FG002|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
10970823|NCT00538850|12144857|FG000|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
10970824|NCT00538850|12144858|FG001|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
10970825|NCT00538850|12144859|FG002|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
10970826|NCT00538850|12144857|FG000|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
10970827|NCT00538850|12144858|FG001|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
10970828|NCT00538850|12144859|FG002|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
10970829|NCT00538850|12144857|FG000|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
10970830|NCT00538850|12144858|FG001|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
10970831|NCT00538850|12144859|FG002|STARTED|Placebo - Double-blind||98
10970832|NCT00538850|12144857|FG000|COMPLETED|Placebo - Double-blind||0
10970833|NCT00538850|12144858|FG001|COMPLETED|Placebo - Double-blind||0
10970834|NCT00538850|12144859|FG002|COMPLETED|Placebo - Double-blind||95
10970835|NCT00538850|12144857|FG000|NOT COMPLETED|Placebo - Double-blind||0
10970836|NCT00538850|12144858|FG001|NOT COMPLETED|Placebo - Double-blind||0
10970837|NCT00538850|12144859|FG002|NOT COMPLETED|Placebo - Double-blind||3
10970838|NCT00538863|12144865|FG000|STARTED|Open-label Titration||229
10970839|NCT00538863|12144865|FG000|COMPLETED|Open-label Titration||184
10970840|NCT00538863|12144865|FG000|NOT COMPLETED|Open-label Titration||45
10970841|NCT00538863|12144865|FG000|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
10970842|NCT00538863|12144865|FG000|COMPLETED|Open-label Maintenance||163
10970843|NCT00538863|12144865|FG000|NOT COMPLETED|Open-label Maintenance||106
10970844|NCT00538902|12144874|FG000|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
10970845|NCT00538902|12144875|FG001|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
10970846|NCT00538902|12144876|FG002|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
10970847|NCT00538902|12144874|FG000|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
10970848|NCT00538902|12144875|FG001|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
10970849|NCT00538902|12144876|FG002|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
10970850|NCT00538902|12144874|FG000|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
10970851|NCT00538902|12144875|FG001|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
10970852|NCT00538902|12144876|FG002|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
10970853|NCT00538902|12144874|FG000|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
10970854|NCT00538902|12144875|FG001|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
10970855|NCT00538902|12144876|FG002|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
10970856|NCT00538902|12144874|FG000|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
10970857|NCT00538902|12144875|FG001|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
10970858|NCT00538902|12144876|FG002|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
10970859|NCT00538902|12144874|FG000|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
10970860|NCT00538902|12144875|FG001|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
10970861|NCT00538902|12144876|FG002|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
10970862|NCT00538915|12144886|FG000|STARTED|Overall Study||63
10970863|NCT00538915|12144886|FG000|COMPLETED|Overall Study||52
10970864|NCT00538915|12144886|FG000|NOT COMPLETED|Overall Study||11
10970865|NCT00539006|12144894|FG000|STARTED|Pre-treatment||96
10970866|NCT00539006|12144895|FG001|STARTED|Pre-treatment||95
10970867|NCT00539006|12144896|FG002|STARTED|Pre-treatment||95
10970868|NCT00539006|12144897|FG003|STARTED|Pre-treatment||91
10970869|NCT00539006|12144894|FG000|COMPLETED|Pre-treatment||96
10970870|NCT00539006|12144895|FG001|COMPLETED|Pre-treatment||94
10970871|NCT00539006|12144896|FG002|COMPLETED|Pre-treatment||95
10970872|NCT00539006|12144897|FG003|COMPLETED|Pre-treatment||91
10970873|NCT00539006|12144894|FG000|NOT COMPLETED|Pre-treatment||0
10970874|NCT00539006|12144895|FG001|NOT COMPLETED|Pre-treatment||1
10970875|NCT00539006|12144896|FG002|NOT COMPLETED|Pre-treatment||0
10970876|NCT00539006|12144897|FG003|NOT COMPLETED|Pre-treatment||0
10970877|NCT00539006|12144894|FG000|STARTED|Treatment Period 1||96
10970878|NCT00539006|12144895|FG001|STARTED|Treatment Period 1||94
10970879|NCT00539006|12144896|FG002|STARTED|Treatment Period 1||95
10970880|NCT00539006|12144897|FG003|STARTED|Treatment Period 1||91
10970881|NCT00539006|12144894|FG000|COMPLETED|Treatment Period 1||96
10970882|NCT00539006|12144895|FG001|COMPLETED|Treatment Period 1||94
10970883|NCT00539006|12144896|FG002|COMPLETED|Treatment Period 1||93
10970884|NCT00539006|12144897|FG003|COMPLETED|Treatment Period 1||90
10970885|NCT00539006|12144894|FG000|NOT COMPLETED|Treatment Period 1||0
10970886|NCT00539006|12144895|FG001|NOT COMPLETED|Treatment Period 1||0
10970887|NCT00539006|12144896|FG002|NOT COMPLETED|Treatment Period 1||2
10970888|NCT00539006|12144897|FG003|NOT COMPLETED|Treatment Period 1||1
10970889|NCT00539006|12144894|FG000|STARTED|Washout||96
10970890|NCT00539006|12144895|FG001|STARTED|Washout||94
10970891|NCT00539006|12144896|FG002|STARTED|Washout||93
10970892|NCT00539006|12144897|FG003|STARTED|Washout||90
10970893|NCT00539006|12144894|FG000|COMPLETED|Washout||76
10970894|NCT00539006|12144895|FG001|COMPLETED|Washout||84
10970895|NCT00539006|12144896|FG002|COMPLETED|Washout||77
10970896|NCT00539006|12144897|FG003|COMPLETED|Washout||81
10970897|NCT00539006|12144894|FG000|NOT COMPLETED|Washout||20
10970898|NCT00539006|12144895|FG001|NOT COMPLETED|Washout||10
10970899|NCT00539006|12144896|FG002|NOT COMPLETED|Washout||16
10970900|NCT00539006|12144897|FG003|NOT COMPLETED|Washout||9
10970901|NCT00539006|12144894|FG000|STARTED|Treatment Period 2||76
10970902|NCT00539006|12144895|FG001|STARTED|Treatment Period 2||84
10970903|NCT00539006|12144896|FG002|STARTED|Treatment Period 2||77
10970904|NCT00539006|12144897|FG003|STARTED|Treatment Period 2||81
10970905|NCT00539006|12144894|FG000|COMPLETED|Treatment Period 2||75
10970906|NCT00539006|12144895|FG001|COMPLETED|Treatment Period 2||83
10970907|NCT00539006|12144896|FG002|COMPLETED|Treatment Period 2||77
10970908|NCT00539006|12144897|FG003|COMPLETED|Treatment Period 2||81
10970909|NCT00539006|12144894|FG000|NOT COMPLETED|Treatment Period 2||1
10970910|NCT00539006|12144895|FG001|NOT COMPLETED|Treatment Period 2||1
10970911|NCT00539006|12144896|FG002|NOT COMPLETED|Treatment Period 2||0
10970912|NCT00539006|12144897|FG003|NOT COMPLETED|Treatment Period 2||0
10970913|NCT00539006|12144894|FG000|STARTED|Post-Study||75
10970914|NCT00539006|12144895|FG001|STARTED|Post-Study||83
10970915|NCT00539006|12144896|FG002|STARTED|Post-Study||77
10970916|NCT00539006|12144897|FG003|STARTED|Post-Study||81
10970917|NCT00539006|12144894|FG000|COMPLETED|Post-Study||75
10970918|NCT00539006|12144895|FG001|COMPLETED|Post-Study||83
10970919|NCT00539006|12144896|FG002|COMPLETED|Post-Study||77
10970920|NCT00539006|12144897|FG003|COMPLETED|Post-Study||81
10970921|NCT00539006|12144894|FG000|NOT COMPLETED|Post-Study||0
10970922|NCT00539006|12144895|FG001|NOT COMPLETED|Post-Study||0
10970923|NCT00539006|12144896|FG002|NOT COMPLETED|Post-Study||0
10970924|NCT00539006|12144897|FG003|NOT COMPLETED|Post-Study||0
10970925|NCT00539032|12144915|FG000|STARTED|Overall Study||153
10970926|NCT00539032|12144916|FG001|STARTED|Overall Study||85
10970927|NCT00539032|12144915|FG000|COMPLETED|Overall Study||151
10970928|NCT00539032|12144916|FG001|COMPLETED|Overall Study||84
10970929|NCT00539032|12144915|FG000|NOT COMPLETED|Overall Study||2
10970930|NCT00539032|12144916|FG001|NOT COMPLETED|Overall Study||1
10970931|NCT00539110|12144924|FG000|STARTED|Overall Study||5
10970932|NCT00539110|12144925|FG001|STARTED|Overall Study||5
10970933|NCT00539110|12144924|FG000|COMPLETED|Overall Study||5
10970934|NCT00539110|12144925|FG001|COMPLETED|Overall Study||5
10970935|NCT00539110|12144924|FG000|NOT COMPLETED|Overall Study||0
10970936|NCT00539110|12144925|FG001|NOT COMPLETED|Overall Study||0
10970937|NCT00539188|12144933|FG000|STARTED|Overall Study||4
10970938|NCT00539188|12144934|FG001|STARTED|Overall Study||2
10970939|NCT00539188|12144933|FG000|Received Allocated Intervention|Overall Study||3
10970940|NCT00539188|12144934|FG001|Received Allocated Intervention|Overall Study||2
10970941|NCT00539188|12144933|FG000|COMPLETED|Overall Study||1
10970942|NCT00539188|12144934|FG001|COMPLETED|Overall Study||1
10970943|NCT00539188|12144933|FG000|NOT COMPLETED|Overall Study||3
10970944|NCT00539188|12144934|FG001|NOT COMPLETED|Overall Study||1
10970945|NCT00539240|12144943|FG000|STARTED|Overall Study||59
10970946|NCT00539240|12144944|FG001|STARTED|Overall Study||55
10970947|NCT00539240|12144945|FG002|STARTED|Overall Study||54
10970948|NCT00539240|12144943|FG000|COMPLETED|Overall Study||53
10970949|NCT00539240|12144944|FG001|COMPLETED|Overall Study||48
10970950|NCT00539240|12144945|FG002|COMPLETED|Overall Study||39
10970951|NCT00539240|12144943|FG000|NOT COMPLETED|Overall Study||6
10970952|NCT00539240|12144944|FG001|NOT COMPLETED|Overall Study||7
10970953|NCT00539240|12144945|FG002|NOT COMPLETED|Overall Study||15
10970954|NCT00539253|12144953|FG000|STARTED|Overall Study||45
10970955|NCT00539253|12144953|FG000|COMPLETED|Overall Study||19
10970956|NCT00539253|12144953|FG000|NOT COMPLETED|Overall Study||26
10970957|NCT00539279|12144959|FG000|STARTED|Treatment||41
10970958|NCT00539279|12144960|FG001|STARTED|Treatment||46
10970959|NCT00539279|12144959|FG000|COMPLETED|Treatment||30
10970960|NCT00539279|12144960|FG001|COMPLETED|Treatment||38
10970961|NCT00539279|12144959|FG000|NOT COMPLETED|Treatment||11
10970962|NCT00539279|12144960|FG001|NOT COMPLETED|Treatment||8
10970963|NCT00539279|12144959|FG000|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
10970964|NCT00539279|12144960|FG001|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
10970965|NCT00539279|12144959|FG000|COMPLETED|Post-Treatment Assessment||18
10970966|NCT00539279|12144960|FG001|COMPLETED|Post-Treatment Assessment||29
10970967|NCT00539279|12144959|FG000|NOT COMPLETED|Post-Treatment Assessment||12
10970968|NCT00539279|12144960|FG001|NOT COMPLETED|Post-Treatment Assessment||9
10970969|NCT00539279|12144959|FG000|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
10970970|NCT00539279|12144960|FG001|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
10970971|NCT00539279|12144959|FG000|COMPLETED|6-Month Follow-Up Assessment||17
10970972|NCT00539279|12144960|FG001|COMPLETED|6-Month Follow-Up Assessment||22
10970973|NCT00539279|12144959|FG000|NOT COMPLETED|6-Month Follow-Up Assessment||1
10970974|NCT00539279|12144960|FG001|NOT COMPLETED|6-Month Follow-Up Assessment||7
10970975|NCT00539305|12144968|FG000|STARTED|Overall Study||10
10970976|NCT00539305|12144969|FG001|STARTED|Overall Study||12
10970977|NCT00539305|12144968|FG000|COMPLETED|Overall Study||9
10970978|NCT00539305|12144969|FG001|COMPLETED|Overall Study||10
10970979|NCT00539305|12144968|FG000|NOT COMPLETED|Overall Study||1
10970980|NCT00539305|12144969|FG001|NOT COMPLETED|Overall Study||2
10970981|NCT00539500|12144975|FG000|STARTED|Overall Study||3
10970982|NCT00539500|12144975|FG000|COMPLETED|Overall Study||0
10970983|NCT00539500|12144975|FG000|NOT COMPLETED|Overall Study||3
10970984|NCT00539513|12144981|FG000|STARTED|Overall Study||5
10970985|NCT00539513|12144982|FG001|STARTED|Overall Study||5
10970986|NCT00539513|12144981|FG000|Received Allocated Intervention|Overall Study||3
10970987|NCT00539513|12144982|FG001|Received Allocated Intervention|Overall Study||4
10970988|NCT00539513|12144981|FG000|COMPLETED|Overall Study||3
10970989|NCT00539513|12144982|FG001|COMPLETED|Overall Study||3
10970990|NCT00539513|12144981|FG000|NOT COMPLETED|Overall Study||2
10970991|NCT00539513|12144982|FG001|NOT COMPLETED|Overall Study||2
10970992|NCT00539526|12144991|FG000|STARTED|Overall Study||35
10970993|NCT00539526|12144992|FG001|STARTED|Overall Study||33
10970994|NCT00539526|12144993|FG002|STARTED|Overall Study||38
10970995|NCT00539526|12144991|FG000|COMPLETED|Overall Study||32
10970996|NCT00539526|12144992|FG001|COMPLETED|Overall Study||31
10970997|NCT00539526|12144993|FG002|COMPLETED|Overall Study||36
10970998|NCT00539526|12144991|FG000|NOT COMPLETED|Overall Study||3
10970999|NCT00539526|12144992|FG001|NOT COMPLETED|Overall Study||2
10971000|NCT00539526|12144993|FG002|NOT COMPLETED|Overall Study||2
10971001|NCT00539539|12145003|FG000|STARTED|Overall Study||815
10971002|NCT00539539|12145004|FG001|STARTED|Overall Study||771
10971003|NCT00539539|12145003|FG000|COMPLETED|Overall Study||815
10971004|NCT00539539|12145004|FG001|COMPLETED|Overall Study||771
10971005|NCT00539539|12145003|FG000|NOT COMPLETED|Overall Study||0
10971006|NCT00539539|12145004|FG001|NOT COMPLETED|Overall Study||0
10971007|NCT00539656|12145010|FG000|STARTED|Overall Study||3
10971008|NCT00539656|12145010|FG000|COMPLETED|Overall Study||3
10971009|NCT00539656|12145010|FG000|NOT COMPLETED|Overall Study||0
10971010|NCT00539695|12145014|FG000|STARTED|Overall Study||25
10971011|NCT00539695|12145014|FG000|Evaluable Patients|Overall Study|Patients who received IL-2.|22
10971012|NCT00539695|12145014|FG000|COMPLETED|Overall Study||12
10971013|NCT00539695|12145014|FG000|NOT COMPLETED|Overall Study||13
10971014|NCT00539734|12145018|FG000|STARTED|Overall Study||26
10971015|NCT00539734|12145018|FG000|COMPLETED|Overall Study||25
10971016|NCT00539734|12145018|FG000|NOT COMPLETED|Overall Study||1
10971017|NCT00539864|12145024|FG000|STARTED|Overall Study||300
10971018|NCT00539864|12145025|FG001|STARTED|Overall Study||302
10971019|NCT00539864|12145024|FG000|COMPLETED|Overall Study||299
10971020|NCT00539864|12145025|FG001|COMPLETED|Overall Study||300
10971021|NCT00539864|12145024|FG000|NOT COMPLETED|Overall Study||1
10971022|NCT00539864|12145025|FG001|NOT COMPLETED|Overall Study||2
10971023|NCT00539942|12145033|FG000|STARTED|Overall Study||4
10971024|NCT00539942|12145034|FG001|STARTED|Overall Study||3
10971025|NCT00539942|12145033|FG000|COMPLETED|Overall Study||4
10971026|NCT00539942|12145034|FG001|COMPLETED|Overall Study||3
10971027|NCT00539942|12145033|FG000|NOT COMPLETED|Overall Study||0
10971028|NCT00539942|12145034|FG001|NOT COMPLETED|Overall Study||0
10971029|NCT00539994|12145043|FG000|STARTED|Overall Study||23
10971030|NCT00539994|12145044|FG001|STARTED|Overall Study||19
10971031|NCT00539994|12145045|FG002|STARTED|Overall Study||15
10971032|NCT00539994|12145043|FG000|COMPLETED|Overall Study||20
10971033|NCT00539994|12145044|FG001|COMPLETED|Overall Study||18
10971034|NCT00539994|12145045|FG002|COMPLETED|Overall Study||13
10971035|NCT00539994|12145043|FG000|NOT COMPLETED|Overall Study||3
10971036|NCT00539994|12145044|FG001|NOT COMPLETED|Overall Study||1
10971037|NCT00539994|12145045|FG002|NOT COMPLETED|Overall Study||2
10971038|NCT00540007|12145062|FG000|STARTED|Overall Study||38
10971039|NCT00540007|12145063|FG001|STARTED|Overall Study||42
10971040|NCT00540007|12145062|FG000|COMPLETED|Overall Study||38
10971041|NCT00540007|12145063|FG001|COMPLETED|Overall Study||42
10971042|NCT00540007|12145062|FG000|NOT COMPLETED|Overall Study||0
10971043|NCT00540007|12145063|FG001|NOT COMPLETED|Overall Study||0
10971044|NCT00540046|12145072|FG000|STARTED|Overall Study||104
10971045|NCT00540046|12145073|FG001|STARTED|Overall Study||111
10971046|NCT00540046|12145072|FG000|COMPLETED|Overall Study||71
10971047|NCT00540046|12145073|FG001|COMPLETED|Overall Study||88
10971048|NCT00540046|12145072|FG000|NOT COMPLETED|Overall Study||33
10971049|NCT00540046|12145073|FG001|NOT COMPLETED|Overall Study||23
10971050|NCT00540124|12145084|FG000|STARTED|Overall Study||51
10971051|NCT00540124|12145085|FG001|STARTED|Overall Study||51
10971052|NCT00540124|12145086|FG002|STARTED|Overall Study||49
10971053|NCT00540124|12145084|FG000|COMPLETED|Overall Study||47
10971054|NCT00540124|12145085|FG001|COMPLETED|Overall Study||48
10971055|NCT00540124|12145086|FG002|COMPLETED|Overall Study||48
10971056|NCT00540124|12145084|FG000|NOT COMPLETED|Overall Study||4
10971057|NCT00540124|12145085|FG001|NOT COMPLETED|Overall Study||3
10971058|NCT00540124|12145086|FG002|NOT COMPLETED|Overall Study||1
10971059|NCT00540228|12145099|FG000|STARTED|Overall Study||200
10971060|NCT00540228|12145100|FG001|STARTED|Overall Study||198
10971061|NCT00540228|12145101|FG002|STARTED|Overall Study||204
10971062|NCT00540228|12145102|FG003|STARTED|Overall Study||202
10971063|NCT00540228|12145103|FG004|STARTED|Overall Study||202
10971064|NCT00540228|12145099|FG000|COMPLETED|Overall Study||197
10971065|NCT00540228|12145100|FG001|COMPLETED|Overall Study||197
10971066|NCT00540228|12145101|FG002|COMPLETED|Overall Study||204
10971067|NCT00540228|12145102|FG003|COMPLETED|Overall Study||202
10971068|NCT00540228|12145103|FG004|COMPLETED|Overall Study||202
10971069|NCT00540228|12145099|FG000|NOT COMPLETED|Overall Study||3
10971070|NCT00540228|12145100|FG001|NOT COMPLETED|Overall Study||1
10971071|NCT00540228|12145101|FG002|NOT COMPLETED|Overall Study||0
10971072|NCT00540228|12145102|FG003|NOT COMPLETED|Overall Study||0
10971073|NCT00540228|12145103|FG004|NOT COMPLETED|Overall Study||0
10971074|NCT00540293|12145115|FG000|STARTED|Overall Study||425
10971075|NCT00540293|12145115|FG000|COMPLETED|Overall Study||390
10971076|NCT00540293|12145115|FG000|NOT COMPLETED|Overall Study||35
10971077|NCT00540423|12145127|FG000|STARTED|Double-Blind Treatment Period||8
10971078|NCT00540423|12145128|FG001|STARTED|Double-Blind Treatment Period||15
10971079|NCT00540423|12145129|FG002|STARTED|Double-Blind Treatment Period||0
10971080|NCT00540423|12145127|FG000|COMPLETED|Double-Blind Treatment Period||8
10971081|NCT00540423|12145128|FG001|COMPLETED|Double-Blind Treatment Period||14
10971082|NCT00540423|12145129|FG002|COMPLETED|Double-Blind Treatment Period||0
10971083|NCT00540423|12145127|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10971084|NCT00540423|12145128|FG001|NOT COMPLETED|Double-Blind Treatment Period||1
10971085|NCT00540423|12145129|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
10971086|NCT00540423|12145127|FG000|STARTED|Open-Label Treatment Period||0
10971087|NCT00540423|12145128|FG001|STARTED|Open-Label Treatment Period||0
10971088|NCT00540423|12145129|FG002|STARTED|Open-Label Treatment Period||22
10971089|NCT00540423|12145127|FG000|COMPLETED|Open-Label Treatment Period||0
10971090|NCT00540423|12145128|FG001|COMPLETED|Open-Label Treatment Period||0
10971091|NCT00540423|12145129|FG002|COMPLETED|Open-Label Treatment Period||20
10971092|NCT00540423|12145127|FG000|NOT COMPLETED|Open-Label Treatment Period||0
10971093|NCT00540423|12145128|FG001|NOT COMPLETED|Open-Label Treatment Period||0
10971094|NCT00540423|12145129|FG002|NOT COMPLETED|Open-Label Treatment Period||2
10971095|NCT00540436|12145147|FG000|STARTED|First 12-Week Treatment Period||25
10971096|NCT00540436|12145147|FG000|COMPLETED|First 12-Week Treatment Period||22
10971097|NCT00540436|12145147|FG000|NOT COMPLETED|First 12-Week Treatment Period||3
10971098|NCT00540436|12145147|FG000|STARTED|Second 12-Week Treatment Period||22
10971099|NCT00540436|12145147|FG000|COMPLETED|Second 12-Week Treatment Period||21
10971100|NCT00540436|12145147|FG000|NOT COMPLETED|Second 12-Week Treatment Period||1
10971101|NCT00540449|12145153|FG000|STARTED|Overall Study||346
10971102|NCT00540449|12145154|FG001|STARTED|Overall Study||344
10971103|NCT00540449|12145153|FG000|COMPLETED|Overall Study||262
10971104|NCT00540449|12145154|FG001|COMPLETED|Overall Study||266
10971105|NCT00540449|12145153|FG000|NOT COMPLETED|Overall Study||84
10971106|NCT00540449|12145154|FG001|NOT COMPLETED|Overall Study||78
10971107|NCT00540514|12145162|FG000|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
10971108|NCT00540514|12145163|FG001|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
10971109|NCT00540514|12145162|FG000|Treated|Overall Study||514
10971110|NCT00540514|12145163|FG001|Treated|Overall Study||524
10971111|NCT00540514|12145162|FG000|Biomarker Population|Overall Study||35
10971112|NCT00540514|12145163|FG001|Biomarker Population|Overall Study||36
10971113|NCT00540514|12145162|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
10971114|NCT00540514|12145163|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
10971115|NCT00540514|12145162|FG000|NOT COMPLETED|Overall Study||246
10971116|NCT00540514|12145163|FG001|NOT COMPLETED|Overall Study||266
10971117|NCT00540579|12145170|FG000|STARTED|Overall Study||23
10971118|NCT00540579|12145170|FG000|COMPLETED|Overall Study||23
10971119|NCT00540579|12145170|FG000|NOT COMPLETED|Overall Study||0
10971120|NCT00540592|12145184|FG000|STARTED|Overall Study||204
10971121|NCT00540592|12145185|FG001|STARTED|Overall Study||202
10971122|NCT00540592|12145186|FG002|STARTED|Overall Study||202
10971123|NCT00540592|12145187|FG003|STARTED|Overall Study||202
10971124|NCT00540592|12145188|FG004|STARTED|Overall Study||199
10971125|NCT00540592|12145189|FG005|STARTED|Overall Study||198
10971126|NCT00540592|12145190|FG006|STARTED|Overall Study||198
10971127|NCT00540592|12145191|FG007|STARTED|Overall Study||199
10971128|NCT00540592|12145192|FG008|STARTED|Overall Study||200
10971129|NCT00540592|12145193|FG009|STARTED|Overall Study||203
10971130|NCT00540592|12145184|FG000|Completed at Day 180|Overall Study||200
10971131|NCT00540592|12145185|FG001|Completed at Day 180|Overall Study||201
10971132|NCT00540592|12145186|FG002|Completed at Day 180|Overall Study||197
10971133|NCT00540592|12145187|FG003|Completed at Day 180|Overall Study||197
10971134|NCT00540592|12145188|FG004|Completed at Day 180|Overall Study||195
10971135|NCT00540592|12145189|FG005|Completed at Day 180|Overall Study||198
10971136|NCT00540592|12145190|FG006|Completed at Day 180|Overall Study||196
10971137|NCT00540592|12145191|FG007|Completed at Day 180|Overall Study||193
10971138|NCT00540592|12145192|FG008|Completed at Day 180|Overall Study||198
10971139|NCT00540592|12145193|FG009|Completed at Day 180|Overall Study||189
10971140|NCT00540592|12145184|FG000|COMPLETED|Overall Study||202
10971141|NCT00540592|12145185|FG001|COMPLETED|Overall Study||201
10971142|NCT00540592|12145186|FG002|COMPLETED|Overall Study||201
10971143|NCT00540592|12145187|FG003|COMPLETED|Overall Study||201
10971144|NCT00540592|12145188|FG004|COMPLETED|Overall Study||198
10971145|NCT00540592|12145189|FG005|COMPLETED|Overall Study||198
10971146|NCT00540592|12145190|FG006|COMPLETED|Overall Study||198
10971147|NCT00540592|12145191|FG007|COMPLETED|Overall Study||198
10971148|NCT00540592|12145192|FG008|COMPLETED|Overall Study||199
10971149|NCT00540592|12145193|FG009|COMPLETED|Overall Study||201
10971150|NCT00540592|12145184|FG000|NOT COMPLETED|Overall Study||2
10971151|NCT00540592|12145185|FG001|NOT COMPLETED|Overall Study||1
10971152|NCT00540592|12145186|FG002|NOT COMPLETED|Overall Study||1
10971153|NCT00540592|12145187|FG003|NOT COMPLETED|Overall Study||1
10971154|NCT00540592|12145188|FG004|NOT COMPLETED|Overall Study||1
10971155|NCT00540592|12145189|FG005|NOT COMPLETED|Overall Study||0
10971156|NCT00540592|12145190|FG006|NOT COMPLETED|Overall Study||0
10971157|NCT00540592|12145191|FG007|NOT COMPLETED|Overall Study||1
10971158|NCT00540592|12145192|FG008|NOT COMPLETED|Overall Study||1
10971159|NCT00540592|12145193|FG009|NOT COMPLETED|Overall Study||2
10971160|NCT00540644|12145217|FG000|STARTED|Overall Study||48
10971161|NCT00540644|12145218|FG001|STARTED|Overall Study||22
10971162|NCT00540644|12145217|FG000|COMPLETED|Overall Study||39
10971163|NCT00540644|12145218|FG001|COMPLETED|Overall Study||13
10971164|NCT00540644|12145217|FG000|NOT COMPLETED|Overall Study||9
10971165|NCT00540644|12145218|FG001|NOT COMPLETED|Overall Study||9
10971166|NCT00540722|12145224|FG000|STARTED|Overall Study||56
10971167|NCT00540722|12145224|FG000|COMPLETED|Overall Study||56
10971168|NCT00540722|12145224|FG000|NOT COMPLETED|Overall Study||0
10971169|NCT00540982|12145229|FG000|STARTED|Overall Study||47
10971170|NCT00540982|12145229|FG000|Normal Liver Function|Overall Study||11
10971171|NCT00540982|12145229|FG000|Mild Liver Dysfunction|Overall Study||6
10971172|NCT00540982|12145229|FG000|Moderate Liver Dysfunction|Overall Study||18
10971173|NCT00540982|12145229|FG000|Severe Liver Dysfunction|Overall Study||12
10971174|NCT00540982|12145229|FG000|COMPLETED|Overall Study||47
10971175|NCT00540982|12145229|FG000|NOT COMPLETED|Overall Study||0
10971176|NCT00541034|12145251|FG000|STARTED|Overall Study||49
10971177|NCT00541034|12145251|FG000|COMPLETED|Overall Study||46
10971178|NCT00541034|12145251|FG000|NOT COMPLETED|Overall Study||3
10971179|NCT00541099|12145255|FG000|STARTED|Overall Study||11
10971180|NCT00541099|12145255|FG000|COMPLETED|Overall Study||8
10971181|NCT00541099|12145255|FG000|NOT COMPLETED|Overall Study||3
10971182|NCT00541190|12145261|FG000|STARTED|Overall Study||10
10971183|NCT00541190|12145262|FG001|STARTED|Overall Study||11
10971184|NCT00541190|12145261|FG000|COMPLETED|Overall Study||10
10971185|NCT00541190|12145262|FG001|COMPLETED|Overall Study||11
10971186|NCT00541190|12145261|FG000|NOT COMPLETED|Overall Study||0
10971187|NCT00541190|12145262|FG001|NOT COMPLETED|Overall Study||0
10971188|NCT00541229|12145276|FG000|STARTED|Treatment Period I (Week 1)||17
10971189|NCT00541229|12145277|FG001|STARTED|Treatment Period I (Week 1)||16
10971190|NCT00541229|12145278|FG002|STARTED|Treatment Period I (Week 1)||20
10971191|NCT00541229|12145279|FG003|STARTED|Treatment Period I (Week 1)||18
10971192|NCT00541229|12145280|FG004|STARTED|Treatment Period I (Week 1)||14
10971193|NCT00541229|12145281|FG005|STARTED|Treatment Period I (Week 1)||18
10971194|NCT00541229|12145276|FG000|COMPLETED|Treatment Period I (Week 1)||17
10971195|NCT00541229|12145277|FG001|COMPLETED|Treatment Period I (Week 1)||15
10971196|NCT00541229|12145278|FG002|COMPLETED|Treatment Period I (Week 1)||17
10971197|NCT00541229|12145279|FG003|COMPLETED|Treatment Period I (Week 1)||17
10971198|NCT00541229|12145280|FG004|COMPLETED|Treatment Period I (Week 1)||14
10971199|NCT00541229|12145281|FG005|COMPLETED|Treatment Period I (Week 1)||16
10971200|NCT00541229|12145276|FG000|NOT COMPLETED|Treatment Period I (Week 1)||0
10971201|NCT00541229|12145277|FG001|NOT COMPLETED|Treatment Period I (Week 1)||1
10971202|NCT00541229|12145278|FG002|NOT COMPLETED|Treatment Period I (Week 1)||3
10971203|NCT00541229|12145279|FG003|NOT COMPLETED|Treatment Period I (Week 1)||1
10971204|NCT00541229|12145280|FG004|NOT COMPLETED|Treatment Period I (Week 1)||0
10971205|NCT00541229|12145281|FG005|NOT COMPLETED|Treatment Period I (Week 1)||2
10971206|NCT00541229|12145276|FG000|STARTED|Washout Period I (Week 2-5)||17
10971207|NCT00541229|12145277|FG001|STARTED|Washout Period I (Week 2-5)||15
10971208|NCT00541229|12145278|FG002|STARTED|Washout Period I (Week 2-5)||17
10971209|NCT00541229|12145279|FG003|STARTED|Washout Period I (Week 2-5)||17
10971210|NCT00541229|12145280|FG004|STARTED|Washout Period I (Week 2-5)||14
10971211|NCT00541229|12145281|FG005|STARTED|Washout Period I (Week 2-5)||16
10971212|NCT00541229|12145276|FG000|COMPLETED|Washout Period I (Week 2-5)||13
10971213|NCT00541229|12145277|FG001|COMPLETED|Washout Period I (Week 2-5)||13
10971214|NCT00541229|12145278|FG002|COMPLETED|Washout Period I (Week 2-5)||13
10971215|NCT00541229|12145279|FG003|COMPLETED|Washout Period I (Week 2-5)||13
10971216|NCT00541229|12145280|FG004|COMPLETED|Washout Period I (Week 2-5)||13
10971217|NCT00541229|12145281|FG005|COMPLETED|Washout Period I (Week 2-5)||11
10971218|NCT00541229|12145276|FG000|NOT COMPLETED|Washout Period I (Week 2-5)||4
10971219|NCT00541229|12145277|FG001|NOT COMPLETED|Washout Period I (Week 2-5)||2
10971220|NCT00541229|12145278|FG002|NOT COMPLETED|Washout Period I (Week 2-5)||4
10971221|NCT00541229|12145279|FG003|NOT COMPLETED|Washout Period I (Week 2-5)||4
10971222|NCT00541229|12145280|FG004|NOT COMPLETED|Washout Period I (Week 2-5)||1
10971223|NCT00541229|12145281|FG005|NOT COMPLETED|Washout Period I (Week 2-5)||5
10971224|NCT00541229|12145276|FG000|STARTED|Treatment Period II (Week 6)||13
10971225|NCT00541229|12145277|FG001|STARTED|Treatment Period II (Week 6)||13
10971226|NCT00541229|12145278|FG002|STARTED|Treatment Period II (Week 6)||13
10971227|NCT00541229|12145279|FG003|STARTED|Treatment Period II (Week 6)||13
10971228|NCT00541229|12145280|FG004|STARTED|Treatment Period II (Week 6)||13
10971229|NCT00541229|12145281|FG005|STARTED|Treatment Period II (Week 6)||11
10971230|NCT00541229|12145276|FG000|COMPLETED|Treatment Period II (Week 6)||11
10971231|NCT00541229|12145277|FG001|COMPLETED|Treatment Period II (Week 6)||12
10971232|NCT00541229|12145278|FG002|COMPLETED|Treatment Period II (Week 6)||12
10971233|NCT00541229|12145279|FG003|COMPLETED|Treatment Period II (Week 6)||12
10971234|NCT00541229|12145280|FG004|COMPLETED|Treatment Period II (Week 6)||11
10971235|NCT00541229|12145281|FG005|COMPLETED|Treatment Period II (Week 6)||8
10971236|NCT00541229|12145276|FG000|NOT COMPLETED|Treatment Period II (Week 6)||2
10971237|NCT00541229|12145277|FG001|NOT COMPLETED|Treatment Period II (Week 6)||1
10971238|NCT00541229|12145278|FG002|NOT COMPLETED|Treatment Period II (Week 6)||1
10971239|NCT00541229|12145279|FG003|NOT COMPLETED|Treatment Period II (Week 6)||1
10971240|NCT00541229|12145280|FG004|NOT COMPLETED|Treatment Period II (Week 6)||2
10971241|NCT00541229|12145281|FG005|NOT COMPLETED|Treatment Period II (Week 6)||3
10971242|NCT00541229|12145276|FG000|STARTED|Washout Period II (Week 7-10)||11
10971243|NCT00541229|12145277|FG001|STARTED|Washout Period II (Week 7-10)||12
10971244|NCT00541229|12145278|FG002|STARTED|Washout Period II (Week 7-10)||12
10971245|NCT00541229|12145279|FG003|STARTED|Washout Period II (Week 7-10)||12
10971246|NCT00541229|12145280|FG004|STARTED|Washout Period II (Week 7-10)||11
10971247|NCT00541229|12145281|FG005|STARTED|Washout Period II (Week 7-10)||8
10971248|NCT00541229|12145276|FG000|COMPLETED|Washout Period II (Week 7-10)||7
10971249|NCT00541229|12145277|FG001|COMPLETED|Washout Period II (Week 7-10)||8
10971250|NCT00541229|12145278|FG002|COMPLETED|Washout Period II (Week 7-10)||10
10971251|NCT00541229|12145279|FG003|COMPLETED|Washout Period II (Week 7-10)||8
10971252|NCT00541229|12145280|FG004|COMPLETED|Washout Period II (Week 7-10)||7
10971253|NCT00541229|12145281|FG005|COMPLETED|Washout Period II (Week 7-10)||5
10971254|NCT00541229|12145276|FG000|NOT COMPLETED|Washout Period II (Week 7-10)||4
10971255|NCT00541229|12145277|FG001|NOT COMPLETED|Washout Period II (Week 7-10)||4
10971256|NCT00541229|12145278|FG002|NOT COMPLETED|Washout Period II (Week 7-10)||2
10971257|NCT00541229|12145279|FG003|NOT COMPLETED|Washout Period II (Week 7-10)||4
10971258|NCT00541229|12145280|FG004|NOT COMPLETED|Washout Period II (Week 7-10)||4
10971259|NCT00541229|12145281|FG005|NOT COMPLETED|Washout Period II (Week 7-10)||3
10971260|NCT00541229|12145276|FG000|STARTED|Treatment Period III (Week 11)||7
10971261|NCT00541229|12145277|FG001|STARTED|Treatment Period III (Week 11)||8
10971262|NCT00541229|12145278|FG002|STARTED|Treatment Period III (Week 11)||10
10971263|NCT00541229|12145279|FG003|STARTED|Treatment Period III (Week 11)||8
10971264|NCT00541229|12145280|FG004|STARTED|Treatment Period III (Week 11)||7
10971265|NCT00541229|12145281|FG005|STARTED|Treatment Period III (Week 11)||5
10971266|NCT00541229|12145276|FG000|COMPLETED|Treatment Period III (Week 11)||7
10971267|NCT00541229|12145277|FG001|COMPLETED|Treatment Period III (Week 11)||8
10971268|NCT00541229|12145278|FG002|COMPLETED|Treatment Period III (Week 11)||9
10971269|NCT00541229|12145279|FG003|COMPLETED|Treatment Period III (Week 11)||8
10971270|NCT00541229|12145280|FG004|COMPLETED|Treatment Period III (Week 11)||6
10971271|NCT00541229|12145281|FG005|COMPLETED|Treatment Period III (Week 11)||4
10971272|NCT00541229|12145276|FG000|NOT COMPLETED|Treatment Period III (Week 11)||0
10971273|NCT00541229|12145277|FG001|NOT COMPLETED|Treatment Period III (Week 11)||0
10971274|NCT00541229|12145278|FG002|NOT COMPLETED|Treatment Period III (Week 11)||1
10971275|NCT00541229|12145279|FG003|NOT COMPLETED|Treatment Period III (Week 11)||0
10971276|NCT00541229|12145280|FG004|NOT COMPLETED|Treatment Period III (Week 11)||1
10971277|NCT00541229|12145281|FG005|NOT COMPLETED|Treatment Period III (Week 11)||1
10971278|NCT00541242|12145291|FG000|STARTED|Treatment Period 1||0
10971279|NCT00541242|12145292|FG001|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
10971280|NCT00541242|12145291|FG000|COMPLETED|Treatment Period 1||0
10971281|NCT00541242|12145292|FG001|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
10971282|NCT00541242|12145291|FG000|NOT COMPLETED|Treatment Period 1||0
10971283|NCT00541242|12145292|FG001|NOT COMPLETED|Treatment Period 1||0
10971284|NCT00541242|12145291|FG000|STARTED|Treatment Period 2||270
10971285|NCT00541242|12145292|FG001|STARTED|Treatment Period 2||273
10971286|NCT00541242|12145291|FG000|COMPLETED|Treatment Period 2||261
10971287|NCT00541242|12145292|FG001|COMPLETED|Treatment Period 2||266
10971288|NCT00541242|12145291|FG000|NOT COMPLETED|Treatment Period 2||9
10971289|NCT00541242|12145292|FG001|NOT COMPLETED|Treatment Period 2||7
10971290|NCT00541307|12145298|FG000|STARTED|Overall Study||119
10971291|NCT00541307|12145298|FG000|COMPLETED|Overall Study||95
10971292|NCT00541307|12145298|FG000|NOT COMPLETED|Overall Study||24
10971293|NCT00541346|12145302|FG000|STARTED|Baseline||16
10971294|NCT00541346|12145302|FG000|COMPLETED|Baseline||16
10971295|NCT00541346|12145302|FG000|NOT COMPLETED|Baseline||0
10971296|NCT00541346|12145302|FG000|STARTED|Follow-up||16
10971297|NCT00541346|12145302|FG000|COMPLETED|Follow-up||15
10971298|NCT00541346|12145302|FG000|NOT COMPLETED|Follow-up||1
10971299|NCT00541385|12145308|FG000|STARTED|Overall Study||355
10971300|NCT00541385|12145309|FG001|STARTED|Overall Study||180
10971301|NCT00541385|12145308|FG000|COMPLETED|Overall Study||274
10971302|NCT00541385|12145309|FG001|COMPLETED|Overall Study||142
10971303|NCT00541385|12145308|FG000|NOT COMPLETED|Overall Study||81
10971304|NCT00541385|12145309|FG001|NOT COMPLETED|Overall Study||38
10971305|NCT00541450|12145317|FG000|STARTED|Phase A||244
10971306|NCT00541450|12145318|FG001|STARTED|Phase A||248
10971307|NCT00541450|12145317|FG000|COMPLETED|Phase A||224
10971308|NCT00541450|12145318|FG001|COMPLETED|Phase A||231
10971309|NCT00541450|12145317|FG000|NOT COMPLETED|Phase A||20
10971310|NCT00541450|12145318|FG001|NOT COMPLETED|Phase A||17
10971311|NCT00541450|12145317|FG000|STARTED|Phase B||224
10971312|NCT00541450|12145318|FG001|STARTED|Phase B||231
10971313|NCT00541450|12145317|FG000|COMPLETED|Phase B||187
10971314|NCT00541450|12145318|FG001|COMPLETED|Phase B||200
10971315|NCT00541450|12145317|FG000|NOT COMPLETED|Phase B||37
10971316|NCT00541450|12145318|FG001|NOT COMPLETED|Phase B||31
10971317|NCT00541593|12145328|FG000|STARTED|Overall Study||5
10971318|NCT00541593|12145328|FG000|COMPLETED|Overall Study||5
10971319|NCT00541593|12145328|FG000|NOT COMPLETED|Overall Study||0
10971320|NCT00541658|12145335|FG000|STARTED|Overall Study||308
10971321|NCT00541658|12145336|FG001|STARTED|Overall Study||307
10971322|NCT00541658|12145337|FG002|STARTED|Overall Study||308
10971323|NCT00541658|12145335|FG000|ITT Population|Overall Study||307
10971324|NCT00541658|12145336|FG001|ITT Population|Overall Study||307
10971325|NCT00541658|12145337|FG002|ITT Population|Overall Study||308
10971326|NCT00541658|12145335|FG000|COMPLETED|Overall Study||248
10971327|NCT00541658|12145336|FG001|COMPLETED|Overall Study||234
10971328|NCT00541658|12145337|FG002|COMPLETED|Overall Study||240
10971329|NCT00541658|12145335|FG000|NOT COMPLETED|Overall Study||60
10971330|NCT00541658|12145336|FG001|NOT COMPLETED|Overall Study||73
10971331|NCT00541658|12145337|FG002|NOT COMPLETED|Overall Study||68
10971332|NCT00541671|12145349|FG000|STARTED|Overall Study||13
10971333|NCT00541671|12145350|FG001|STARTED|Overall Study||12
10971334|NCT00541671|12145349|FG000|COMPLETED|Overall Study||13
10971335|NCT00541671|12145350|FG001|COMPLETED|Overall Study||12
10971336|NCT00541671|12145349|FG000|NOT COMPLETED|Overall Study||0
10971337|NCT00541671|12145350|FG001|NOT COMPLETED|Overall Study||0
10971338|NCT00541775|12145359|FG000|STARTED|Overall Study||94
10971339|NCT00541775|12145360|FG001|STARTED|Overall Study||87
10971340|NCT00541775|12145361|FG002|STARTED|Overall Study||92
10971341|NCT00541775|12145359|FG000|COMPLETED|Overall Study||85
10971342|NCT00541775|12145360|FG001|COMPLETED|Overall Study||85
10971343|NCT00541775|12145361|FG002|COMPLETED|Overall Study||84
10971344|NCT00541775|12145359|FG000|NOT COMPLETED|Overall Study||9
10971345|NCT00541775|12145360|FG001|NOT COMPLETED|Overall Study||2
10971346|NCT00541775|12145361|FG002|NOT COMPLETED|Overall Study||8
10971347|NCT00541866|12145374|FG000|STARTED|Overall Study|41 started, but only 39 treated|41
10971348|NCT00541866|12145375|FG001|STARTED|Overall Study||18
10971349|NCT00541866|12145376|FG002|STARTED|Overall Study||17
10971350|NCT00541866|12145377|FG003|STARTED|Overall Study||16
10971351|NCT00541866|12145378|FG004|STARTED|Overall Study||18
10971352|NCT00541866|12145374|FG000|COMPLETED|Overall Study||7
10971353|NCT00541866|12145375|FG001|COMPLETED|Overall Study||0
10971354|NCT00541866|12145376|FG002|COMPLETED|Overall Study||2
10971355|NCT00541866|12145377|FG003|COMPLETED|Overall Study||0
10971356|NCT00541866|12145378|FG004|COMPLETED|Overall Study||3
10971357|NCT00541866|12145374|FG000|NOT COMPLETED|Overall Study||34
10971358|NCT00541866|12145375|FG001|NOT COMPLETED|Overall Study||18
10971359|NCT00541866|12145376|FG002|NOT COMPLETED|Overall Study||15
10971360|NCT00541866|12145377|FG003|NOT COMPLETED|Overall Study||16
10971361|NCT00541866|12145378|FG004|NOT COMPLETED|Overall Study||15
10971362|NCT00541931|12145408|FG000|STARTED|Overall Study||22
10971363|NCT00541931|12145409|FG001|STARTED|Overall Study||15
10971364|NCT00541931|12145408|FG000|COMPLETED|Overall Study||17
10971365|NCT00541931|12145409|FG001|COMPLETED|Overall Study||11
10971366|NCT00541931|12145408|FG000|NOT COMPLETED|Overall Study||5
10971367|NCT00541931|12145409|FG001|NOT COMPLETED|Overall Study||4
10971368|NCT00541970|12145421|FG000|STARTED|Month 7||240
10971369|NCT00541970|12145422|FG001|STARTED|Month 7||241
10971370|NCT00541970|12145423|FG002|STARTED|Month 7||240
10971371|NCT00541970|12145424|FG003|STARTED|Month 7||239
10971372|NCT00541970|12145421|FG000|COMPLETED|Month 7||231
10971373|NCT00541970|12145422|FG001|COMPLETED|Month 7||228
10971374|NCT00541970|12145423|FG002|COMPLETED|Month 7||229
10971375|NCT00541970|12145424|FG003|COMPLETED|Month 7||234
10971376|NCT00541970|12145421|FG000|NOT COMPLETED|Month 7||9
10971377|NCT00541970|12145422|FG001|NOT COMPLETED|Month 7||13
10971378|NCT00541970|12145423|FG002|NOT COMPLETED|Month 7||11
10971379|NCT00541970|12145424|FG003|NOT COMPLETED|Month 7||5
10971380|NCT00541970|12145421|FG000|STARTED|Month 12||240
10971381|NCT00541970|12145422|FG001|STARTED|Month 12||241
10971382|NCT00541970|12145423|FG002|STARTED|Month 12||240
10971383|NCT00541970|12145424|FG003|STARTED|Month 12||239
10971384|NCT00541970|12145421|FG000|COMPLETED|Month 12||228
10971385|NCT00541970|12145422|FG001|COMPLETED|Month 12||219
10971386|NCT00541970|12145423|FG002|COMPLETED|Month 12||219
10971387|NCT00541970|12145424|FG003|COMPLETED|Month 12||223
10971388|NCT00541970|12145421|FG000|NOT COMPLETED|Month 12||12
10971389|NCT00541970|12145422|FG001|NOT COMPLETED|Month 12||22
10971390|NCT00541970|12145423|FG002|NOT COMPLETED|Month 12||21
10971391|NCT00541970|12145424|FG003|NOT COMPLETED|Month 12||16
10971392|NCT00541970|12145421|FG000|STARTED|Month 18||240
10971393|NCT00541970|12145422|FG001|STARTED|Month 18||241
10971394|NCT00541970|12145423|FG002|STARTED|Month 18||240
10971395|NCT00541970|12145424|FG003|STARTED|Month 18||239
10971396|NCT00541970|12145421|FG000|COMPLETED|Month 18||226
10971397|NCT00541970|12145422|FG001|COMPLETED|Month 18||217
10971398|NCT00541970|12145423|FG002|COMPLETED|Month 18||215
10971399|NCT00541970|12145424|FG003|COMPLETED|Month 18||222
10971400|NCT00541970|12145421|FG000|NOT COMPLETED|Month 18||14
10971401|NCT00541970|12145422|FG001|NOT COMPLETED|Month 18||24
10971402|NCT00541970|12145423|FG002|NOT COMPLETED|Month 18||25
10971403|NCT00541970|12145424|FG003|NOT COMPLETED|Month 18||17
10971404|NCT00541970|12145421|FG000|STARTED|Month 24||240
10971405|NCT00541970|12145422|FG001|STARTED|Month 24||241
10971406|NCT00541970|12145423|FG002|STARTED|Month 24||240
10971407|NCT00541970|12145424|FG003|STARTED|Month 24||239
10971408|NCT00541970|12145421|FG000|COMPLETED|Month 24||211
10971409|NCT00541970|12145422|FG001|COMPLETED|Month 24||209
10971410|NCT00541970|12145423|FG002|COMPLETED|Month 24||208
10971411|NCT00541970|12145424|FG003|COMPLETED|Month 24||217
10971412|NCT00541970|12145421|FG000|NOT COMPLETED|Month 24||29
10971413|NCT00541970|12145422|FG001|NOT COMPLETED|Month 24||32
10971414|NCT00541970|12145423|FG002|NOT COMPLETED|Month 24||32
10971415|NCT00541970|12145424|FG003|NOT COMPLETED|Month 24||22
10971416|NCT00541970|12145421|FG000|STARTED|Month 36||240
10971417|NCT00541970|12145422|FG001|STARTED|Month 36||241
10971418|NCT00541970|12145423|FG002|STARTED|Month 36||240
10971419|NCT00541970|12145424|FG003|STARTED|Month 36||239
10971420|NCT00541970|12145421|FG000|COMPLETED|Month 36||179
10971421|NCT00541970|12145422|FG001|COMPLETED|Month 36||175
10971422|NCT00541970|12145423|FG002|COMPLETED|Month 36||174
10971423|NCT00541970|12145424|FG003|COMPLETED|Month 36||179
10971424|NCT00541970|12145421|FG000|NOT COMPLETED|Month 36||61
10971425|NCT00541970|12145422|FG001|NOT COMPLETED|Month 36||66
10971426|NCT00541970|12145423|FG002|NOT COMPLETED|Month 36||66
10971427|NCT00541970|12145424|FG003|NOT COMPLETED|Month 36||60
10971428|NCT00541970|12145421|FG000|STARTED|Month 48||240
10971429|NCT00541970|12145422|FG001|STARTED|Month 48||241
10971430|NCT00541970|12145423|FG002|STARTED|Month 48||240
10971431|NCT00541970|12145424|FG003|STARTED|Month 48||239
10971432|NCT00541970|12145421|FG000|COMPLETED|Month 48||169
10971433|NCT00541970|12145422|FG001|COMPLETED|Month 48||168
10971434|NCT00541970|12145423|FG002|COMPLETED|Month 48||167
10971435|NCT00541970|12145424|FG003|COMPLETED|Month 48||164
10971436|NCT00541970|12145421|FG000|NOT COMPLETED|Month 48||71
10971437|NCT00541970|12145422|FG001|NOT COMPLETED|Month 48||73
10971438|NCT00541970|12145423|FG002|NOT COMPLETED|Month 48||73
10971439|NCT00541970|12145424|FG003|NOT COMPLETED|Month 48||75
10971440|NCT00541970|12145421|FG000|STARTED|Month 60||240
10971441|NCT00541970|12145422|FG001|STARTED|Month 60||241
10971442|NCT00541970|12145423|FG002|STARTED|Month 60||240
10971443|NCT00541970|12145424|FG003|STARTED|Month 60||239
10971444|NCT00541970|12145421|FG000|COMPLETED|Month 60||162
10971445|NCT00541970|12145422|FG001|COMPLETED|Month 60||164
10971446|NCT00541970|12145423|FG002|COMPLETED|Month 60||158
10971447|NCT00541970|12145424|FG003|COMPLETED|Month 60||167
10971448|NCT00541970|12145421|FG000|NOT COMPLETED|Month 60||78
10971449|NCT00541970|12145422|FG001|NOT COMPLETED|Month 60||77
10971450|NCT00541970|12145423|FG002|NOT COMPLETED|Month 60||82
10971451|NCT00541970|12145424|FG003|NOT COMPLETED|Month 60||72
10971452|NCT00542178|12145440|FG000|STARTED|Overall Study||390
10971453|NCT00542178|12145441|FG001|STARTED|Overall Study||412
10971454|NCT00542178|12145442|FG002|STARTED|Overall Study||382
10971455|NCT00542178|12145443|FG003|STARTED|Overall Study||370
10971456|NCT00542178|12145444|FG004|STARTED|Overall Study||464
10971457|NCT00542178|12145445|FG005|STARTED|Overall Study||495
10971458|NCT00542178|12145446|FG006|STARTED|Overall Study||493
10971459|NCT00542178|12145447|FG007|STARTED|Overall Study||466
10971460|NCT00542178|12145440|FG000|COMPLETED|Overall Study||315
10971461|NCT00542178|12145441|FG001|COMPLETED|Overall Study||332
10971462|NCT00542178|12145442|FG002|COMPLETED|Overall Study||308
10971463|NCT00542178|12145443|FG003|COMPLETED|Overall Study||308
10971464|NCT00542178|12145444|FG004|COMPLETED|Overall Study||400
10971465|NCT00542178|12145445|FG005|COMPLETED|Overall Study||406
10971466|NCT00542178|12145446|FG006|COMPLETED|Overall Study||406
10971467|NCT00542178|12145447|FG007|COMPLETED|Overall Study||381
10971468|NCT00542178|12145440|FG000|NOT COMPLETED|Overall Study||75
10971469|NCT00542178|12145441|FG001|NOT COMPLETED|Overall Study||80
10971470|NCT00542178|12145442|FG002|NOT COMPLETED|Overall Study||74
10971471|NCT00542178|12145443|FG003|NOT COMPLETED|Overall Study||62
10971472|NCT00542178|12145444|FG004|NOT COMPLETED|Overall Study||64
10971473|NCT00542178|12145445|FG005|NOT COMPLETED|Overall Study||89
10971474|NCT00542178|12145446|FG006|NOT COMPLETED|Overall Study||87
10971475|NCT00542178|12145447|FG007|NOT COMPLETED|Overall Study||85
10971476|NCT00542191|12145461|FG000|STARTED|Overall Study||21
10971477|NCT00542191|12145461|FG000|COMPLETED|Overall Study||18
10971478|NCT00542191|12145461|FG000|NOT COMPLETED|Overall Study||3
10971479|NCT00542269|12145468|FG000|STARTED|Overall Study||61
10971480|NCT00542269|12145469|FG001|STARTED|Overall Study||60
10971481|NCT00542269|12145470|FG002|STARTED|Overall Study||57
10971482|NCT00542269|12145468|FG000|COMPLETED|Overall Study||48
10971483|NCT00542269|12145469|FG001|COMPLETED|Overall Study||54
10971484|NCT00542269|12145470|FG002|COMPLETED|Overall Study||51
10971485|NCT00542269|12145468|FG000|NOT COMPLETED|Overall Study||13
10971486|NCT00542269|12145469|FG001|NOT COMPLETED|Overall Study||6
10971487|NCT00542269|12145470|FG002|NOT COMPLETED|Overall Study||6
10971488|NCT00542308|12145480|FG000|STARTED|Overall Study||90
10971489|NCT00542308|12145480|FG000|COMPLETED|Overall Study||90
10971490|NCT00542308|12145480|FG000|NOT COMPLETED|Overall Study||0
10971491|NCT00542321|12145486|FG000|STARTED|Overall Study||8
10971492|NCT00542321|12145487|FG001|STARTED|Overall Study||8
10971493|NCT00542321|12145486|FG000|COMPLETED|Overall Study||8
10971494|NCT00542321|12145487|FG001|COMPLETED|Overall Study||7
10971495|NCT00542321|12145486|FG000|NOT COMPLETED|Overall Study||0
10971496|NCT00542321|12145487|FG001|NOT COMPLETED|Overall Study||1
10971497|NCT00542386|12145499|FG000|STARTED|Overall Study||104
10971498|NCT00542386|12145500|FG001|STARTED|Overall Study||102
10971499|NCT00542386|12145501|FG002|STARTED|Overall Study||99
10971500|NCT00542386|12145502|FG003|STARTED|Overall Study||103
10971501|NCT00542386|12145503|FG004|STARTED|Overall Study||102
10971502|NCT00542386|12145504|FG005|STARTED|Overall Study||132
10971503|NCT00542386|12145499|FG000|COMPLETED|Overall Study||61
10971504|NCT00542386|12145500|FG001|COMPLETED|Overall Study||74
10971505|NCT00542386|12145501|FG002|COMPLETED|Overall Study||66
10971506|NCT00542386|12145502|FG003|COMPLETED|Overall Study||65
10971507|NCT00542386|12145503|FG004|COMPLETED|Overall Study||62
10971508|NCT00542386|12145504|FG005|COMPLETED|Overall Study||82
10971509|NCT00542386|12145499|FG000|NOT COMPLETED|Overall Study||43
10971510|NCT00542386|12145500|FG001|NOT COMPLETED|Overall Study||28
10971511|NCT00542386|12145501|FG002|NOT COMPLETED|Overall Study||33
10971512|NCT00542386|12145502|FG003|NOT COMPLETED|Overall Study||38
10971513|NCT00542386|12145503|FG004|NOT COMPLETED|Overall Study||40
10971514|NCT00542386|12145504|FG005|NOT COMPLETED|Overall Study||50
10971515|NCT00542425|12145523|FG000|STARTED|Initial 24 Weeks||46
10971516|NCT00542425|12145524|FG001|STARTED|Initial 24 Weeks||43
10971517|NCT00542425|12145525|FG002|STARTED|Initial 24 Weeks||43
10971518|NCT00542425|12145526|FG003|STARTED|Initial 24 Weeks||45
10971519|NCT00542425|12145527|FG004|STARTED|Initial 24 Weeks||45
10971520|NCT00542425|12145523|FG000|COMPLETED|Initial 24 Weeks||42
10971521|NCT00542425|12145524|FG001|COMPLETED|Initial 24 Weeks||33
10971522|NCT00542425|12145525|FG002|COMPLETED|Initial 24 Weeks||36
10971523|NCT00542425|12145526|FG003|COMPLETED|Initial 24 Weeks||34
10971524|NCT00542425|12145527|FG004|COMPLETED|Initial 24 Weeks||39
10971525|NCT00542425|12145523|FG000|NOT COMPLETED|Initial 24 Weeks||4
10971526|NCT00542425|12145524|FG001|NOT COMPLETED|Initial 24 Weeks||10
10971527|NCT00542425|12145525|FG002|NOT COMPLETED|Initial 24 Weeks||7
10971528|NCT00542425|12145526|FG003|NOT COMPLETED|Initial 24 Weeks||11
10971529|NCT00542425|12145527|FG004|NOT COMPLETED|Initial 24 Weeks||6
10971530|NCT00542425|12145523|FG000|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
10971531|NCT00542425|12145524|FG001|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
10971532|NCT00542425|12145525|FG002|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
10971533|NCT00542425|12145526|FG003|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
10971534|NCT00542425|12145527|FG004|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
10971535|NCT00542425|12145523|FG000|COMPLETED|Extended 24 Weeks of Treatment||10
10971536|NCT00542425|12145524|FG001|COMPLETED|Extended 24 Weeks of Treatment||11
10971537|NCT00542425|12145525|FG002|COMPLETED|Extended 24 Weeks of Treatment||8
10971538|NCT00542425|12145526|FG003|COMPLETED|Extended 24 Weeks of Treatment||6
10971539|NCT00542425|12145527|FG004|COMPLETED|Extended 24 Weeks of Treatment||13
10971540|NCT00542425|12145523|FG000|NOT COMPLETED|Extended 24 Weeks of Treatment||1
10971541|NCT00542425|12145524|FG001|NOT COMPLETED|Extended 24 Weeks of Treatment||2
10971542|NCT00542425|12145525|FG002|NOT COMPLETED|Extended 24 Weeks of Treatment||2
10971543|NCT00542425|12145526|FG003|NOT COMPLETED|Extended 24 Weeks of Treatment||1
10971544|NCT00542425|12145527|FG004|NOT COMPLETED|Extended 24 Weeks of Treatment||1
10971545|NCT00542490|12145539|FG000|STARTED|Overall Study||23
10971546|NCT00542490|12145539|FG000|COMPLETED|Overall Study||21
10971547|NCT00542490|12145539|FG000|NOT COMPLETED|Overall Study||2
10971548|NCT00542620|12145545|FG000|STARTED|Overall Study||13
10971549|NCT00542620|12145546|FG001|STARTED|Overall Study||12
10971550|NCT00542620|12145545|FG000|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
10971551|NCT00542620|12145546|FG001|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
10971552|NCT00542620|12145545|FG000|COMPLETED|Overall Study||13
10971553|NCT00542620|12145546|FG001|COMPLETED|Overall Study||12
10971554|NCT00542620|12145545|FG000|NOT COMPLETED|Overall Study||0
10971555|NCT00542620|12145546|FG001|NOT COMPLETED|Overall Study||0
10971556|NCT00542750|12145552|FG000|STARTED|Overall Study||24
10971557|NCT00542750|12145552|FG000|COMPLETED|Overall Study||24
10971558|NCT00542750|12145552|FG000|NOT COMPLETED|Overall Study||0
10971559|NCT00542789|12145558|FG000|STARTED|Overall Study|Randomised|175
10971560|NCT00542789|12145559|FG001|STARTED|Overall Study|Randomised|168
10971561|NCT00542789|12145558|FG000|COMPLETED|Overall Study||134
10971562|NCT00542789|12145559|FG001|COMPLETED|Overall Study||90
10971563|NCT00542789|12145558|FG000|NOT COMPLETED|Overall Study||41
10971564|NCT00542789|12145559|FG001|NOT COMPLETED|Overall Study||78
10971565|NCT00542815|12145568|FG000|STARTED|Overall Study||432
10971566|NCT00542815|12145569|FG001|STARTED|Overall Study||76
10971567|NCT00542815|12145570|FG002|STARTED|Overall Study||124
10971568|NCT00542815|12145568|FG000|COMPLETED|Overall Study||326
10971569|NCT00542815|12145569|FG001|COMPLETED|Overall Study||44
10971570|NCT00542815|12145570|FG002|COMPLETED|Overall Study||92
10971571|NCT00542815|12145568|FG000|NOT COMPLETED|Overall Study||106
10971572|NCT00542815|12145569|FG001|NOT COMPLETED|Overall Study||32
10971573|NCT00542815|12145570|FG002|NOT COMPLETED|Overall Study||32
10971574|NCT00542828|12145578|FG000|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
10971575|NCT00542828|12145578|FG000|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
10971576|NCT00542828|12145578|FG000|NOT COMPLETED|Overall Study||13
10971577|NCT00542880|12145584|FG000|STARTED|Period 1|This was a cross-over study|217
10971578|NCT00542880|12145585|FG001|STARTED|Period 1||225
10971579|NCT00542880|12145584|FG000|COMPLETED|Period 1||211
10971580|NCT00542880|12145585|FG001|COMPLETED|Period 1||213
10971581|NCT00542880|12145584|FG000|NOT COMPLETED|Period 1||6
10971582|NCT00542880|12145585|FG001|NOT COMPLETED|Period 1||12
10971583|NCT00542880|12145584|FG000|STARTED|Period 2||211
10971584|NCT00542880|12145585|FG001|STARTED|Period 2||213
10971585|NCT00542880|12145584|FG000|COMPLETED|Period 2||204
10971586|NCT00542880|12145585|FG001|COMPLETED|Period 2||203
10971587|NCT00542880|12145584|FG000|NOT COMPLETED|Period 2||7
10971588|NCT00542880|12145585|FG001|NOT COMPLETED|Period 2||10
10971589|NCT00542880|12145584|FG000|STARTED|Period 3||204
10971590|NCT00542880|12145585|FG001|STARTED|Period 3||203
10971591|NCT00542880|12145584|FG000|COMPLETED|Period 3||204
10971592|NCT00542880|12145585|FG001|COMPLETED|Period 3||201
10971593|NCT00542880|12145584|FG000|NOT COMPLETED|Period 3||0
10971594|NCT00542880|12145585|FG001|NOT COMPLETED|Period 3||2
10971595|NCT00542919|12145595|FG000|STARTED|Overall Study||23
10971596|NCT00542919|12145596|FG001|STARTED|Overall Study||19
10971597|NCT00542919|12145597|FG002|STARTED|Overall Study||15
10971598|NCT00542919|12145595|FG000|Received At Least One Dose of Study Drug|Overall Study||23
10971599|NCT00542919|12145596|FG001|Received At Least One Dose of Study Drug|Overall Study||19
10971600|NCT00542919|12145597|FG002|Received At Least One Dose of Study Drug|Overall Study||15
10971601|NCT00542919|12145595|FG000|Progressive Disease|Overall Study||15
10971602|NCT00542919|12145596|FG001|Progressive Disease|Overall Study||11
10971603|NCT00542919|12145597|FG002|Progressive Disease|Overall Study||7
10971604|NCT00542919|12145595|FG000|Death|Overall Study||1
10971605|NCT00542919|12145596|FG001|Death|Overall Study||1
10971606|NCT00542919|12145597|FG002|Death|Overall Study||2
10971607|NCT00542919|12145595|FG000|COMPLETED|Overall Study||16
10971608|NCT00542919|12145596|FG001|COMPLETED|Overall Study||12
10971609|NCT00542919|12145597|FG002|COMPLETED|Overall Study||9
10971610|NCT00542919|12145595|FG000|NOT COMPLETED|Overall Study||7
10971611|NCT00542919|12145596|FG001|NOT COMPLETED|Overall Study||7
10971612|NCT00542919|12145597|FG002|NOT COMPLETED|Overall Study||6
10971613|NCT00542971|12145620|FG000|STARTED|Overall Study||75
10971614|NCT00542971|12145620|FG000|COMPLETED|Overall Study||75
10971615|NCT00542971|12145620|FG000|NOT COMPLETED|Overall Study||0
10971616|NCT00542997|12145624|FG000|STARTED|Wash in / Wash Out Period||51
10971617|NCT00542997|12145624|FG000|COMPLETED|Wash in / Wash Out Period||46
10971618|NCT00542997|12145624|FG000|NOT COMPLETED|Wash in / Wash Out Period||5
10971619|NCT00542997|12145624|FG000|STARTED|Efficacy Period||46
10971620|NCT00542997|12145624|FG000|COMPLETED|Efficacy Period||43
10971621|NCT00542997|12145624|FG000|NOT COMPLETED|Efficacy Period||3
10971622|NCT00543062|12145631|FG000|STARTED|Overall Study||12
10971623|NCT00543062|12145632|FG001|STARTED|Overall Study||12
10971624|NCT00543062|12145633|FG002|STARTED|Overall Study||12
10971625|NCT00543062|12145634|FG003|STARTED|Overall Study||12
10971626|NCT00543062|12145631|FG000|COMPLETED|Overall Study||10
10971627|NCT00543062|12145632|FG001|COMPLETED|Overall Study||11
10971628|NCT00543062|12145633|FG002|COMPLETED|Overall Study||9
10971629|NCT00543062|12145634|FG003|COMPLETED|Overall Study||11
10971630|NCT00543062|12145631|FG000|NOT COMPLETED|Overall Study||2
10971631|NCT00543062|12145632|FG001|NOT COMPLETED|Overall Study||1
10971632|NCT00543062|12145633|FG002|NOT COMPLETED|Overall Study||3
10971633|NCT00543062|12145634|FG003|NOT COMPLETED|Overall Study||1
10971634|NCT00543101|12145654|FG000|STARTED|Overall Study||12
10971635|NCT00543101|12145655|FG001|STARTED|Overall Study||12
10971636|NCT00543101|12145654|FG000|COMPLETED|Overall Study||12
10971637|NCT00543101|12145655|FG001|COMPLETED|Overall Study||12
10971638|NCT00543101|12145654|FG000|NOT COMPLETED|Overall Study||0
10971639|NCT00543101|12145655|FG001|NOT COMPLETED|Overall Study||0
10971640|NCT00543127|12145664|FG000|STARTED|Overall Study||433
10971641|NCT00543127|12145665|FG001|STARTED|Overall Study||437
10971642|NCT00543127|12145664|FG000|COMPLETED|Overall Study||303
10971643|NCT00543127|12145665|FG001|COMPLETED|Overall Study||350
10971644|NCT00543127|12145664|FG000|NOT COMPLETED|Overall Study||130
10971645|NCT00543127|12145665|FG001|NOT COMPLETED|Overall Study||87
10971646|NCT00543140|12145671|FG000|STARTED|Overall Study||303
10971647|NCT00543140|12145671|FG000|COMPLETED|Overall Study||231
10971648|NCT00543140|12145671|FG000|NOT COMPLETED|Overall Study||72
10971649|NCT00543296|12145675|FG000|STARTED|Overall Study||21
10971650|NCT00543296|12145675|FG000|COMPLETED|Overall Study||14
10971651|NCT00543296|12145675|FG000|NOT COMPLETED|Overall Study||7
10971652|NCT00543309|12145682|FG000|STARTED|Overall Study||35
10971653|NCT00543309|12145683|FG001|STARTED|Overall Study||36
10971654|NCT00543309|12145684|FG002|STARTED|Overall Study||35
10971655|NCT00543309|12145682|FG000|COMPLETED|Overall Study||35
10971656|NCT00543309|12145683|FG001|COMPLETED|Overall Study||35
10971657|NCT00543309|12145684|FG002|COMPLETED|Overall Study||35
10971658|NCT00543309|12145682|FG000|NOT COMPLETED|Overall Study||0
10971659|NCT00543309|12145683|FG001|NOT COMPLETED|Overall Study||1
10971660|NCT00543309|12145684|FG002|NOT COMPLETED|Overall Study||0
10971661|NCT00543387|12145702|FG000|STARTED|Panel 1 + Panel 2||3
10971662|NCT00543387|12145703|FG001|STARTED|Panel 1 + Panel 2||3
10971663|NCT00543387|12145704|FG002|STARTED|Panel 1 + Panel 2||3
10971664|NCT00543387|12145705|FG003|STARTED|Panel 1 + Panel 2||3
10971665|NCT00543387|12145706|FG004|STARTED|Panel 1 + Panel 2||3
10971666|NCT00543387|12145707|FG005|STARTED|Panel 1 + Panel 2||3
10971667|NCT00543387|12145708|FG006|STARTED|Panel 1 + Panel 2||6
10971668|NCT00543387|12145709|FG007|STARTED|Panel 1 + Panel 2||6
10971669|NCT00543387|12145710|FG008|STARTED|Panel 1 + Panel 2||5
10971670|NCT00543387|12145711|FG009|STARTED|Panel 1 + Panel 2||0
10971671|NCT00543387|12145712|FG010|STARTED|Panel 1 + Panel 2||0
10971672|NCT00543387|12145702|FG000|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10971673|NCT00543387|12145703|FG001|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
10971674|NCT00543387|12145704|FG002|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10971675|NCT00543387|12145705|FG003|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10971676|NCT00543387|12145706|FG004|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
10971677|NCT00543387|12145707|FG005|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
10971678|NCT00543387|12145708|FG006|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10971679|NCT00543387|12145709|FG007|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10971680|NCT00543387|12145710|FG008|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10971681|NCT00543387|12145711|FG009|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10971682|NCT00543387|12145712|FG010|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
10971683|NCT00543387|12145702|FG000|COMPLETED|Panel 1 + Panel 2||0
10971684|NCT00543387|12145703|FG001|COMPLETED|Panel 1 + Panel 2||0
10971685|NCT00543387|12145704|FG002|COMPLETED|Panel 1 + Panel 2||0
10971686|NCT00543387|12145705|FG003|COMPLETED|Panel 1 + Panel 2||0
10971687|NCT00543387|12145706|FG004|COMPLETED|Panel 1 + Panel 2||0
10971688|NCT00543387|12145707|FG005|COMPLETED|Panel 1 + Panel 2||0
10971689|NCT00543387|12145708|FG006|COMPLETED|Panel 1 + Panel 2||0
10971690|NCT00543387|12145709|FG007|COMPLETED|Panel 1 + Panel 2||0
10971691|NCT00543387|12145710|FG008|COMPLETED|Panel 1 + Panel 2||0
10971692|NCT00543387|12145711|FG009|COMPLETED|Panel 1 + Panel 2||0
10971693|NCT00543387|12145712|FG010|COMPLETED|Panel 1 + Panel 2||0
10971694|NCT00543387|12145702|FG000|NOT COMPLETED|Panel 1 + Panel 2||3
10971695|NCT00543387|12145703|FG001|NOT COMPLETED|Panel 1 + Panel 2||3
10971696|NCT00543387|12145704|FG002|NOT COMPLETED|Panel 1 + Panel 2||3
10971697|NCT00543387|12145705|FG003|NOT COMPLETED|Panel 1 + Panel 2||3
10971698|NCT00543387|12145706|FG004|NOT COMPLETED|Panel 1 + Panel 2||3
10971699|NCT00543387|12145707|FG005|NOT COMPLETED|Panel 1 + Panel 2||3
10971700|NCT00543387|12145708|FG006|NOT COMPLETED|Panel 1 + Panel 2||6
10971701|NCT00543387|12145709|FG007|NOT COMPLETED|Panel 1 + Panel 2||6
10971702|NCT00543387|12145710|FG008|NOT COMPLETED|Panel 1 + Panel 2||5
10971703|NCT00543387|12145711|FG009|NOT COMPLETED|Panel 1 + Panel 2||0
10971704|NCT00543387|12145712|FG010|NOT COMPLETED|Panel 1 + Panel 2||0
10971705|NCT00543387|12145702|FG000|STARTED|Crossover Participants||0
10971706|NCT00543387|12145703|FG001|STARTED|Crossover Participants||0
10971707|NCT00543387|12145704|FG002|STARTED|Crossover Participants||0
10971708|NCT00543387|12145705|FG003|STARTED|Crossover Participants||0
10971709|NCT00543387|12145706|FG004|STARTED|Crossover Participants||0
10971710|NCT00543387|12145707|FG005|STARTED|Crossover Participants||0
10971711|NCT00543387|12145708|FG006|STARTED|Crossover Participants||0
10971712|NCT00543387|12145709|FG007|STARTED|Crossover Participants||0
10971713|NCT00543387|12145710|FG008|STARTED|Crossover Participants||0
10971714|NCT00543387|12145711|FG009|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
10971715|NCT00543387|12145712|FG010|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
10971716|NCT00543387|12145702|FG000|COMPLETED|Crossover Participants||0
10971717|NCT00543387|12145703|FG001|COMPLETED|Crossover Participants||0
10971718|NCT00543387|12145704|FG002|COMPLETED|Crossover Participants||0
10971719|NCT00543387|12145705|FG003|COMPLETED|Crossover Participants||0
10971720|NCT00543387|12145706|FG004|COMPLETED|Crossover Participants||0
10971721|NCT00543387|12145707|FG005|COMPLETED|Crossover Participants||0
10971722|NCT00543387|12145708|FG006|COMPLETED|Crossover Participants||0
10971723|NCT00543387|12145709|FG007|COMPLETED|Crossover Participants||0
10971724|NCT00543387|12145710|FG008|COMPLETED|Crossover Participants||0
10971725|NCT00543387|12145711|FG009|COMPLETED|Crossover Participants||0
10971726|NCT00543387|12145712|FG010|COMPLETED|Crossover Participants||0
10971727|NCT00543387|12145702|FG000|NOT COMPLETED|Crossover Participants||0
10971728|NCT00543387|12145703|FG001|NOT COMPLETED|Crossover Participants||0
10971729|NCT00543387|12145704|FG002|NOT COMPLETED|Crossover Participants||0
10971730|NCT00543387|12145705|FG003|NOT COMPLETED|Crossover Participants||0
10971731|NCT00543387|12145706|FG004|NOT COMPLETED|Crossover Participants||0
10971732|NCT00543387|12145707|FG005|NOT COMPLETED|Crossover Participants||0
10971733|NCT00543387|12145708|FG006|NOT COMPLETED|Crossover Participants||0
10971734|NCT00543387|12145709|FG007|NOT COMPLETED|Crossover Participants||0
10971735|NCT00543387|12145710|FG008|NOT COMPLETED|Crossover Participants||0
10971736|NCT00543387|12145711|FG009|NOT COMPLETED|Crossover Participants||1
10971737|NCT00543387|12145712|FG010|NOT COMPLETED|Crossover Participants||3
10971738|NCT00543400|12145740|FG000|STARTED|Overall Study||151
10971739|NCT00543400|12145741|FG001|STARTED|Overall Study||44
10971740|NCT00543400|12145742|FG002|STARTED|Overall Study||152
10971741|NCT00543400|12145743|FG003|STARTED|Overall Study||156
10971742|NCT00543400|12145740|FG000|COMPLETED|Overall Study||146
10971743|NCT00543400|12145741|FG001|COMPLETED|Overall Study||43
10971744|NCT00543400|12145742|FG002|COMPLETED|Overall Study||148
10971745|NCT00543400|12145743|FG003|COMPLETED|Overall Study||151
10971746|NCT00543400|12145740|FG000|NOT COMPLETED|Overall Study||5
10971747|NCT00543400|12145741|FG001|NOT COMPLETED|Overall Study||1
10971748|NCT00543400|12145742|FG002|NOT COMPLETED|Overall Study||4
10971749|NCT00543400|12145743|FG003|NOT COMPLETED|Overall Study||5
10971750|NCT00543439|12145756|FG000|STARTED|Period 1||10
10971751|NCT00543439|12145757|FG001|STARTED|Period 1||29
10971752|NCT00543439|12145758|FG002|STARTED|Period 1||27
10971753|NCT00543439|12145756|FG000|Treated|Period 1||9
10971754|NCT00543439|12145757|FG001|Treated|Period 1||29
10971755|NCT00543439|12145758|FG002|Treated|Period 1||27
10971756|NCT00543439|12145756|FG000|COMPLETED|Period 1||9
10971757|NCT00543439|12145757|FG001|COMPLETED|Period 1||26
10971758|NCT00543439|12145758|FG002|COMPLETED|Period 1||25
10971759|NCT00543439|12145756|FG000|NOT COMPLETED|Period 1||1
10971760|NCT00543439|12145757|FG001|NOT COMPLETED|Period 1||3
10971761|NCT00543439|12145758|FG002|NOT COMPLETED|Period 1||2
10971762|NCT00543439|12145756|FG000|STARTED|Period 2||9
10971763|NCT00543439|12145757|FG001|STARTED|Period 2||26
10971764|NCT00543439|12145758|FG002|STARTED|Period 2||25
10971765|NCT00543439|12145756|FG000|COMPLETED|Period 2||8
10971766|NCT00543439|12145757|FG001|COMPLETED|Period 2||25
10971767|NCT00543439|12145758|FG002|COMPLETED|Period 2||23
10971768|NCT00543439|12145756|FG000|NOT COMPLETED|Period 2||1
10971769|NCT00543439|12145757|FG001|NOT COMPLETED|Period 2||1
10971770|NCT00543439|12145758|FG002|NOT COMPLETED|Period 2||2
10971771|NCT00543543|12145779|FG000|STARTED|Base Study||315
10971772|NCT00543543|12145780|FG001|STARTED|Base Study||7106
10971773|NCT00543543|12145781|FG002|STARTED|Base Study||310
10971774|NCT00543543|12145782|FG003|STARTED|Base Study||7109
10971775|NCT00543543|12145779|FG000|Completed 3 Vaccinations|Base Study||300
10971776|NCT00543543|12145780|FG001|Completed 3 Vaccinations|Base Study||6928
10971777|NCT00543543|12145781|FG002|Completed 3 Vaccinations|Base Study||297
10971778|NCT00543543|12145782|FG003|Completed 3 Vaccinations|Base Study||6934
10971779|NCT00543543|12145779|FG000|COMPLETED|Base Study|Follow-up was up to 7 months|295
10971780|NCT00543543|12145780|FG001|COMPLETED|Base Study|Follow-up was up to 54 months|5854
10971781|NCT00543543|12145781|FG002|COMPLETED|Base Study|Follow-up was up to 7 months|296
10971782|NCT00543543|12145782|FG003|COMPLETED|Base Study|Follow-up was up to 54 months|5887
10971783|NCT00543543|12145779|FG000|NOT COMPLETED|Base Study||20
10971784|NCT00543543|12145780|FG001|NOT COMPLETED|Base Study||1252
10971785|NCT00543543|12145781|FG002|NOT COMPLETED|Base Study||14
10971786|NCT00543543|12145782|FG003|NOT COMPLETED|Base Study||1222
10971787|NCT00543543|12145779|FG000|STARTED|Extension Study|This group did not participate in the Extension Study|0
10971788|NCT00543543|12145780|FG001|STARTED|Extension Study|Cohort 1|150
10971789|NCT00543543|12145781|FG002|STARTED|Extension Study|This group did not participate in the Extension Study|0
10971790|NCT00543543|12145782|FG003|STARTED|Extension Study|Cohort 2|3050
10971791|NCT00543543|12145779|FG000|COMPLETED|Extension Study||0
10971792|NCT00543543|12145780|FG001|COMPLETED|Extension Study||150
10971793|NCT00543543|12145781|FG002|COMPLETED|Extension Study||0
10971794|NCT00543543|12145782|FG003|COMPLETED|Extension Study||2824
10971795|NCT00543543|12145779|FG000|NOT COMPLETED|Extension Study||0
10971796|NCT00543543|12145780|FG001|NOT COMPLETED|Extension Study||0
10971797|NCT00543543|12145781|FG002|NOT COMPLETED|Extension Study||0
10971798|NCT00543543|12145782|FG003|NOT COMPLETED|Extension Study||226
10971799|NCT00543569|12145801|FG000|STARTED|Overall Study||82
10971800|NCT00543569|12145802|FG001|STARTED|Overall Study||80
10971801|NCT00543569|12145803|FG002|STARTED|Overall Study||80
10971802|NCT00543569|12145804|FG003|STARTED|Overall Study||81
10971803|NCT00543569|12145801|FG000|Received Treatment|Overall Study||79
10971804|NCT00543569|12145802|FG001|Received Treatment|Overall Study||77
10971805|NCT00543569|12145803|FG002|Received Treatment|Overall Study||75
10971806|NCT00543569|12145804|FG003|Received Treatment|Overall Study||78
10971807|NCT00543569|12145801|FG000|COMPLETED|Overall Study||70
10971808|NCT00543569|12145802|FG001|COMPLETED|Overall Study||72
10971809|NCT00543569|12145803|FG002|COMPLETED|Overall Study||60
10971810|NCT00543569|12145804|FG003|COMPLETED|Overall Study||72
10971811|NCT00543569|12145801|FG000|NOT COMPLETED|Overall Study||12
10971812|NCT00543569|12145802|FG001|NOT COMPLETED|Overall Study||8
10971813|NCT00543569|12145803|FG002|NOT COMPLETED|Overall Study||20
10971814|NCT00543569|12145804|FG003|NOT COMPLETED|Overall Study||9
10971815|NCT00543725|12145816|FG000|STARTED|Overall Study||340
10971816|NCT00543725|12145817|FG001|STARTED|Overall Study||338
10971817|NCT00543725|12145816|FG000|COMPLETED|Overall Study||272
10971818|NCT00543725|12145817|FG001|COMPLETED|Overall Study||264
10971819|NCT00543725|12145816|FG000|NOT COMPLETED|Overall Study||68
10971820|NCT00543725|12145817|FG001|NOT COMPLETED|Overall Study||74
10971821|NCT00543764|12145825|FG000|STARTED|Overall Study||100
10971822|NCT00543764|12145826|FG001|STARTED|Overall Study||50
10971823|NCT00543764|12145825|FG000|COMPLETED|Overall Study||100
10971824|NCT00543764|12145826|FG001|COMPLETED|Overall Study||50
10971825|NCT00543764|12145825|FG000|NOT COMPLETED|Overall Study||0
10971826|NCT00543764|12145826|FG001|NOT COMPLETED|Overall Study||0
10971827|NCT00543777|12145832|FG000|STARTED|Overall Study||44
10971828|NCT00543777|12145832|FG000|COMPLETED|Overall Study||44
10971829|NCT00543777|12145832|FG000|NOT COMPLETED|Overall Study||0
10971830|NCT00543803|12145836|FG000|STARTED|Overall Study||334
10971831|NCT00543803|12145836|FG000|COMPLETED|Overall Study||192
10971832|NCT00543803|12145836|FG000|NOT COMPLETED|Overall Study||142
10971833|NCT00543855|12145846|FG000|STARTED|Overall Study||35
10971834|NCT00543855|12145847|FG001|STARTED|Overall Study||33
10971835|NCT00543855|12145848|FG002|STARTED|Overall Study||37
10971836|NCT00543855|12145849|FG003|STARTED|Overall Study||34
10971837|NCT00543855|12145846|FG000|COMPLETED|Overall Study||31
10971838|NCT00543855|12145847|FG001|COMPLETED|Overall Study||31
10971839|NCT00543855|12145848|FG002|COMPLETED|Overall Study||31
10971840|NCT00543855|12145849|FG003|COMPLETED|Overall Study||30
10971841|NCT00543855|12145846|FG000|NOT COMPLETED|Overall Study||4
10971842|NCT00543855|12145847|FG001|NOT COMPLETED|Overall Study||2
10971843|NCT00543855|12145848|FG002|NOT COMPLETED|Overall Study||6
10971844|NCT00543855|12145849|FG003|NOT COMPLETED|Overall Study||4
10971845|NCT00543985|12145859|FG000|STARTED|Overall Study||36
10971846|NCT00543985|12145859|FG000|COMPLETED|Overall Study||32
10971847|NCT00543985|12145859|FG000|NOT COMPLETED|Overall Study||4
10971848|NCT00544076|12145869|FG000|STARTED|Overall Study||34
10971849|NCT00544076|12145870|FG001|STARTED|Overall Study||35
10971850|NCT00544076|12145871|FG002|STARTED|Overall Study||31
10971851|NCT00544076|12145869|FG000|COMPLETED|Overall Study||17
10971852|NCT00544076|12145870|FG001|COMPLETED|Overall Study||19
10971853|NCT00544076|12145871|FG002|COMPLETED|Overall Study||20
10971854|NCT00544076|12145869|FG000|NOT COMPLETED|Overall Study||17
10971855|NCT00544076|12145870|FG001|NOT COMPLETED|Overall Study||16
10971856|NCT00544076|12145871|FG002|NOT COMPLETED|Overall Study||11
10971857|NCT00544167|12145880|FG000|STARTED|Overall Study||45
10971858|NCT00544167|12145880|FG000|COMPLETED|Overall Study||16
10971859|NCT00544167|12145880|FG000|NOT COMPLETED|Overall Study||29
10971860|NCT00544440|12145884|FG000|STARTED|Overall Study||57
10971861|NCT00544440|12145884|FG000|COMPLETED|Overall Study||0
10971862|NCT00544440|12145884|FG000|NOT COMPLETED|Overall Study||57
10971863|NCT00544544|12145888|FG000|STARTED|Overall Study||14
10971864|NCT00544544|12145888|FG000|COMPLETED|Overall Study||11
10971865|NCT00544544|12145888|FG000|NOT COMPLETED|Overall Study||3
10971866|NCT00544557|12145892|FG000|STARTED|Overall Study||1685
10971867|NCT00544557|12145892|FG000|COMPLETED|Overall Study||1251
10971868|NCT00544557|12145892|FG000|NOT COMPLETED|Overall Study||434
10971869|NCT00544648|12145898|FG000|STARTED|Overall Study||11
10971870|NCT00544648|12145899|FG001|STARTED|Overall Study||2
10971871|NCT00544648|12145898|FG000|COMPLETED|Overall Study||8
10971872|NCT00544648|12145899|FG001|COMPLETED|Overall Study||1
10971873|NCT00544648|12145898|FG000|NOT COMPLETED|Overall Study||3
10971874|NCT00544648|12145899|FG001|NOT COMPLETED|Overall Study||1
10971875|NCT00544674|12145907|FG000|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
10971876|NCT00544674|12145907|FG000|COMPLETED|Overall Study||4
10971877|NCT00544674|12145907|FG000|NOT COMPLETED|Overall Study||1
10971878|NCT00544713|12145913|FG000|STARTED|Overall Study||114
10971879|NCT00544713|12145914|FG001|STARTED|Overall Study||114
10971880|NCT00544713|12145913|FG000|COMPLETED|Overall Study||111
10971881|NCT00544713|12145914|FG001|COMPLETED|Overall Study||109
10971882|NCT00544713|12145913|FG000|NOT COMPLETED|Overall Study||3
10971883|NCT00544713|12145914|FG001|NOT COMPLETED|Overall Study||5
10971884|NCT00544778|12145920|FG000|STARTED|Overall Study||7
10971885|NCT00544778|12145920|FG000|COMPLETED|Overall Study||7
10971886|NCT00544778|12145920|FG000|NOT COMPLETED|Overall Study||0
10971887|NCT00544817|12145924|FG000|STARTED|Combined Modality||47
10971888|NCT00544817|12145924|FG000|COMPLETED|Combined Modality||40
10971889|NCT00544817|12145924|FG000|NOT COMPLETED|Combined Modality||7
10971890|NCT00544817|12145924|FG000|STARTED|No Treatment Interval||40
10971891|NCT00544817|12145924|FG000|COMPLETED|No Treatment Interval||28
10971892|NCT00544817|12145924|FG000|NOT COMPLETED|No Treatment Interval||12
10971893|NCT00544817|12145924|FG000|STARTED|Follow-up Systemic Therapy||28
10971894|NCT00544817|12145924|FG000|COMPLETED|Follow-up Systemic Therapy||9
10971895|NCT00544817|12145924|FG000|NOT COMPLETED|Follow-up Systemic Therapy||19
10971896|NCT00544869|12145931|FG000|STARTED|Overall Study||36
10971897|NCT00544869|12145932|FG001|STARTED|Overall Study||14
10971898|NCT00544869|12145933|FG002|STARTED|Overall Study||2
10971899|NCT00544869|12145931|FG000|COMPLETED|Overall Study||24
10971900|NCT00544869|12145932|FG001|COMPLETED|Overall Study||12
10971901|NCT00544869|12145933|FG002|COMPLETED|Overall Study||2
10971902|NCT00544869|12145931|FG000|NOT COMPLETED|Overall Study||12
10971903|NCT00544869|12145932|FG001|NOT COMPLETED|Overall Study||2
10971904|NCT00544869|12145933|FG002|NOT COMPLETED|Overall Study||0
10971905|NCT00544882|12145943|FG000|STARTED|Cycle 1: Run-in Cycle||61
10971906|NCT00544882|12145944|FG001|STARTED|Cycle 1: Run-in Cycle||0
10971907|NCT00544882|12145945|FG002|STARTED|Cycle 1: Run-in Cycle||0
10971908|NCT00544882|12145943|FG000|COMPLETED|Cycle 1: Run-in Cycle||58
10971909|NCT00544882|12145944|FG001|COMPLETED|Cycle 1: Run-in Cycle||0
10971910|NCT00544882|12145945|FG002|COMPLETED|Cycle 1: Run-in Cycle||0
10971911|NCT00544882|12145943|FG000|NOT COMPLETED|Cycle 1: Run-in Cycle||3
10971912|NCT00544882|12145944|FG001|NOT COMPLETED|Cycle 1: Run-in Cycle||0
10971913|NCT00544882|12145945|FG002|NOT COMPLETED|Cycle 1: Run-in Cycle||0
10971914|NCT00544882|12145943|FG000|STARTED|Cycle 2: Randomized Treatment Cycle||0
10971915|NCT00544882|12145944|FG001|STARTED|Cycle 2: Randomized Treatment Cycle||29
10971916|NCT00544882|12145945|FG002|STARTED|Cycle 2: Randomized Treatment Cycle||29
10971917|NCT00544882|12145943|FG000|Treated|Cycle 2: Randomized Treatment Cycle||0
10971918|NCT00544882|12145944|FG001|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
10971919|NCT00544882|12145945|FG002|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
10971920|NCT00544882|12145943|FG000|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
10971921|NCT00544882|12145944|FG001|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
10971922|NCT00544882|12145945|FG002|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
10971923|NCT00544882|12145943|FG000|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
10971924|NCT00544882|12145944|FG001|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
10971925|NCT00544882|12145945|FG002|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
10971926|NCT00544882|12145943|FG000|STARTED|Cycle 3: Follow-up||0
10971927|NCT00544882|12145944|FG001|STARTED|Cycle 3: Follow-up||28
10971928|NCT00544882|12145945|FG002|STARTED|Cycle 3: Follow-up||28
10971929|NCT00544882|12145943|FG000|COMPLETED|Cycle 3: Follow-up||0
10971930|NCT00544882|12145944|FG001|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
10971931|NCT00544882|12145945|FG002|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
10971932|NCT00544882|12145943|FG000|NOT COMPLETED|Cycle 3: Follow-up||0
10971933|NCT00544882|12145944|FG001|NOT COMPLETED|Cycle 3: Follow-up||2
10971934|NCT00544882|12145945|FG002|NOT COMPLETED|Cycle 3: Follow-up||0
10971935|NCT00544908|12145951|FG000|STARTED|Overall Study||7
10971936|NCT00544908|12145951|FG000|COMPLETED|Overall Study||7
10971937|NCT00544908|12145951|FG000|NOT COMPLETED|Overall Study||0
10971938|NCT00545025|12145957|FG000|STARTED|Overall Study||160
10971939|NCT00545025|12145958|FG001|STARTED|Overall Study||83
10971940|NCT00545025|12145957|FG000|COMPLETED|Overall Study||160
10971941|NCT00545025|12145958|FG001|COMPLETED|Overall Study||83
10971942|NCT00545025|12145957|FG000|NOT COMPLETED|Overall Study||0
10971943|NCT00545025|12145958|FG001|NOT COMPLETED|Overall Study||0
10971944|NCT00545051|12145966|FG000|STARTED|Overall Study||68
10971945|NCT00545051|12145967|FG001|STARTED|Overall Study||72
10971946|NCT00545051|12145966|FG000|COMPLETED|Overall Study||59
10971947|NCT00545051|12145967|FG001|COMPLETED|Overall Study||65
10971948|NCT00545051|12145966|FG000|NOT COMPLETED|Overall Study||9
10971949|NCT00545051|12145967|FG001|NOT COMPLETED|Overall Study||7
10971950|NCT00545064|12145973|FG000|STARTED|Overall Study||178
10971951|NCT00545064|12145973|FG000|Visit 1 (Baseline)|Overall Study||178
10971952|NCT00545064|12145973|FG000|Visit 2 (Week 4)|Overall Study||169
10971953|NCT00545064|12145973|FG000|Visit 3 (Week 8)|Overall Study|8 patients didn't complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
10971954|NCT00545064|12145973|FG000|COMPLETED|Overall Study||170
10971955|NCT00545064|12145973|FG000|NOT COMPLETED|Overall Study||8
10971956|NCT00545077|12145981|FG000|STARTED|Overall Study||189
10971957|NCT00545077|12145982|FG001|STARTED|Overall Study||191
10971958|NCT00545077|12145981|FG000|COMPLETED|Overall Study||41
10971959|NCT00545077|12145982|FG001|COMPLETED|Overall Study||36
10971960|NCT00545077|12145981|FG000|NOT COMPLETED|Overall Study||148
10971961|NCT00545077|12145982|FG001|NOT COMPLETED|Overall Study||155
10971962|NCT00545103|12145992|FG000|STARTED|Overall Study||148
10971963|NCT00545103|12145993|FG001|STARTED|Overall Study||148
10971964|NCT00545103|12145994|FG002|STARTED|Overall Study||150
10971965|NCT00545103|12145995|FG003|STARTED|Overall Study||146
10971966|NCT00545103|12145992|FG000|COMPLETED|Overall Study||73
10971967|NCT00545103|12145993|FG001|COMPLETED|Overall Study||70
10971968|NCT00545103|12145994|FG002|COMPLETED|Overall Study||74
10971969|NCT00545103|12145995|FG003|COMPLETED|Overall Study||76
10971970|NCT00545103|12145992|FG000|NOT COMPLETED|Overall Study||75
10971971|NCT00545103|12145993|FG001|NOT COMPLETED|Overall Study||78
10971972|NCT00545103|12145994|FG002|NOT COMPLETED|Overall Study||76
10971973|NCT00545103|12145995|FG003|NOT COMPLETED|Overall Study||70
10971974|NCT00545155|12146005|FG000|STARTED|Overall Study||187
10971975|NCT00545155|12146005|FG000|COMPLETED|Overall Study||187
10971976|NCT00545155|12146005|FG000|NOT COMPLETED|Overall Study||0
10971977|NCT00545168|12146012|FG000|STARTED|Overall Study||203
10971978|NCT00545168|12146013|FG001|STARTED|Overall Study||63
10971979|NCT00545168|12146014|FG002|STARTED|Overall Study||214
10971980|NCT00545168|12146012|FG000|COMPLETED|Overall Study||187
10971981|NCT00545168|12146013|FG001|COMPLETED|Overall Study||58
10971982|NCT00545168|12146014|FG002|COMPLETED|Overall Study||193
10971983|NCT00545168|12146012|FG000|NOT COMPLETED|Overall Study||16
10971984|NCT00545168|12146013|FG001|NOT COMPLETED|Overall Study||5
10971985|NCT00545168|12146014|FG002|NOT COMPLETED|Overall Study||21
10971986|NCT00545181|12146025|FG000|STARTED|Overall Study||29
10971987|NCT00545181|12146026|FG001|STARTED|Overall Study||25
10971988|NCT00545181|12146025|FG000|COMPLETED|Overall Study||29
10971989|NCT00545181|12146026|FG001|COMPLETED|Overall Study||25
10971990|NCT00545181|12146025|FG000|NOT COMPLETED|Overall Study||0
10971991|NCT00545181|12146026|FG001|NOT COMPLETED|Overall Study||0
10971992|NCT00545233|12146034|FG000|STARTED|Overall Study||79
10971993|NCT00545233|12146035|FG001|STARTED|Overall Study||76
10971994|NCT00545233|12146034|FG000|Safety Set|Overall Study||77
10971995|NCT00545233|12146035|FG001|Safety Set|Overall Study||75
10971996|NCT00545233|12146034|FG000|Intent-to-Treat (ITT)|Overall Study||77
10971997|NCT00545233|12146035|FG001|Intent-to-Treat (ITT)|Overall Study||73
10971998|NCT00545233|12146034|FG000|COMPLETED|Overall Study||33
10971999|NCT00545233|12146035|FG001|COMPLETED|Overall Study||41
10972000|NCT00545233|12146034|FG000|NOT COMPLETED|Overall Study||46
10972001|NCT00545233|12146035|FG001|NOT COMPLETED|Overall Study||35
10972002|NCT00545272|12146048|FG000|STARTED|Overall Study||61
10972003|NCT00545272|12146049|FG001|STARTED|Overall Study||68
10972004|NCT00545272|12146050|FG002|STARTED|Overall Study||65
10972005|NCT00545272|12146051|FG003|STARTED|Overall Study||72
10972006|NCT00545272|12146052|FG004|STARTED|Overall Study||64
10972007|NCT00545272|12146053|FG005|STARTED|Overall Study||62
10972008|NCT00545272|12146048|FG000|COMPLETED|Overall Study||61
10972009|NCT00545272|12146049|FG001|COMPLETED|Overall Study||67
10972010|NCT00545272|12146050|FG002|COMPLETED|Overall Study||64
10972011|NCT00545272|12146051|FG003|COMPLETED|Overall Study||71
10972012|NCT00545272|12146052|FG004|COMPLETED|Overall Study||62
10972013|NCT00545272|12146053|FG005|COMPLETED|Overall Study||59
10972014|NCT00545272|12146048|FG000|NOT COMPLETED|Overall Study||0
10972015|NCT00545272|12146049|FG001|NOT COMPLETED|Overall Study||1
10972016|NCT00545272|12146050|FG002|NOT COMPLETED|Overall Study||1
10972017|NCT00545272|12146051|FG003|NOT COMPLETED|Overall Study||1
10972018|NCT00545272|12146052|FG004|NOT COMPLETED|Overall Study||2
10972019|NCT00545272|12146053|FG005|NOT COMPLETED|Overall Study||3
10972020|NCT00545298|12146070|FG000|STARTED|Overall Study||2
10972021|NCT00545298|12146071|FG001|STARTED|Overall Study||1
10972022|NCT00545298|12146072|FG002|STARTED|Overall Study||1
10972023|NCT00545298|12146070|FG000|COMPLETED|Overall Study||0
10972024|NCT00545298|12146071|FG001|COMPLETED|Overall Study||1
10972025|NCT00545298|12146072|FG002|COMPLETED|Overall Study||0
10972026|NCT00545298|12146070|FG000|NOT COMPLETED|Overall Study||2
10972027|NCT00545298|12146071|FG001|NOT COMPLETED|Overall Study||0
10972028|NCT00545298|12146072|FG002|NOT COMPLETED|Overall Study||1
10972029|NCT00545363|12146085|FG000|STARTED|Overall Study||358
10972030|NCT00545363|12146086|FG001|STARTED|Overall Study||358
10972031|NCT00545363|12146085|FG000|Treated|Overall Study||354
10972032|NCT00545363|12146086|FG001|Treated|Overall Study||357
10972033|NCT00545363|12146085|FG000|COMPLETED|Overall Study||339
10972034|NCT00545363|12146086|FG001|COMPLETED|Overall Study||343
10972035|NCT00545363|12146085|FG000|NOT COMPLETED|Overall Study||19
10972036|NCT00545363|12146086|FG001|NOT COMPLETED|Overall Study||15
10972037|NCT00545402|12146094|FG000|STARTED|Overall Study||90
10972038|NCT00545402|12146095|FG001|STARTED|Overall Study||90
10972039|NCT00545402|12146094|FG000|COMPLETED|Overall Study||56
10972040|NCT00545402|12146095|FG001|COMPLETED|Overall Study||61
10972041|NCT00545402|12146094|FG000|NOT COMPLETED|Overall Study||34
10972042|NCT00545402|12146095|FG001|NOT COMPLETED|Overall Study||29
10972043|NCT00545441|12146103|FG000|STARTED|Overall Study||44
10972044|NCT00545441|12146104|FG001|STARTED|Overall Study||42
10972045|NCT00545441|12146103|FG000|COMPLETED|Overall Study||26
10972046|NCT00545441|12146104|FG001|COMPLETED|Overall Study||26
10972047|NCT00545441|12146103|FG000|NOT COMPLETED|Overall Study||18
10972048|NCT00545441|12146104|FG001|NOT COMPLETED|Overall Study||16
10972049|NCT00545532|12146112|FG000|STARTED|Overall Study||105
10972050|NCT00545532|12146113|FG001|STARTED|Overall Study||110
10972051|NCT00545532|12146112|FG000|COMPLETED|Overall Study||99
10972052|NCT00545532|12146113|FG001|COMPLETED|Overall Study||100
10972053|NCT00545532|12146112|FG000|NOT COMPLETED|Overall Study||6
10972054|NCT00545532|12146113|FG001|NOT COMPLETED|Overall Study||10
10972055|NCT00545571|12146121|FG000|STARTED|Overall Study||120
10972056|NCT00545571|12146121|FG000|COMPLETED|Overall Study||53
10972057|NCT00545571|12146121|FG000|NOT COMPLETED|Overall Study||67
10972058|NCT00545584|12146128|FG000|STARTED|Overall Study||412
10972059|NCT00545584|12146129|FG001|STARTED|Overall Study||414
10972060|NCT00545584|12146130|FG002|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
10972061|NCT00545584|12146128|FG000|COMPLETED|Overall Study||333
10972062|NCT00545584|12146129|FG001|COMPLETED|Overall Study||334
10972063|NCT00545584|12146130|FG002|COMPLETED|Overall Study||250
10972064|NCT00545584|12146128|FG000|NOT COMPLETED|Overall Study||79
10972065|NCT00545584|12146129|FG001|NOT COMPLETED|Overall Study||80
10972066|NCT00545584|12146130|FG002|NOT COMPLETED|Overall Study||56
10972067|NCT00545623|12146142|FG000|STARTED|Overall Study||32
10972068|NCT00545623|12146143|FG001|STARTED|Overall Study||31
10972069|NCT00545623|12146144|FG002|STARTED|Overall Study||33
10972070|NCT00545623|12146145|FG003|STARTED|Overall Study||34
10972071|NCT00545623|12146142|FG000|COMPLETED|Overall Study||25
10972072|NCT00545623|12146143|FG001|COMPLETED|Overall Study||21
10972073|NCT00545623|12146144|FG002|COMPLETED|Overall Study||20
10972074|NCT00545623|12146145|FG003|COMPLETED|Overall Study||23
10972075|NCT00545623|12146142|FG000|NOT COMPLETED|Overall Study||7
10972076|NCT00545623|12146143|FG001|NOT COMPLETED|Overall Study||10
10972077|NCT00545623|12146144|FG002|NOT COMPLETED|Overall Study||13
10972078|NCT00545623|12146145|FG003|NOT COMPLETED|Overall Study||11
10972079|NCT00545662|12146157|FG000|STARTED|Overall Study||606
10972080|NCT00545662|12146158|FG001|STARTED|Overall Study||607
10972081|NCT00545662|12146157|FG000|COMPLETED|Overall Study||521
10972082|NCT00545662|12146158|FG001|COMPLETED|Overall Study||528
10972083|NCT00545662|12146157|FG000|NOT COMPLETED|Overall Study||85
10972084|NCT00545662|12146158|FG001|NOT COMPLETED|Overall Study||79
10972085|NCT00545688|12146168|FG000|STARTED|Neo-Adjuvant Treatment Period||107
10972086|NCT00545688|12146169|FG001|STARTED|Neo-Adjuvant Treatment Period||107
10972087|NCT00545688|12146170|FG002|STARTED|Neo-Adjuvant Treatment Period||108
10972088|NCT00545688|12146171|FG003|STARTED|Neo-Adjuvant Treatment Period||94
10972089|NCT00545688|12146168|FG000|COMPLETED|Neo-Adjuvant Treatment Period||103
10972090|NCT00545688|12146169|FG001|COMPLETED|Neo-Adjuvant Treatment Period||102
10972091|NCT00545688|12146170|FG002|COMPLETED|Neo-Adjuvant Treatment Period||94
10972092|NCT00545688|12146171|FG003|COMPLETED|Neo-Adjuvant Treatment Period||88
10972093|NCT00545688|12146168|FG000|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
10972094|NCT00545688|12146169|FG001|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
10972095|NCT00545688|12146170|FG002|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
10972096|NCT00545688|12146171|FG003|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
10972097|NCT00545688|12146168|FG000|STARTED|Adjuvant Treatment Period||103
10972098|NCT00545688|12146169|FG001|STARTED|Adjuvant Treatment Period||102
10972099|NCT00545688|12146170|FG002|STARTED|Adjuvant Treatment Period||94
10972100|NCT00545688|12146171|FG003|STARTED|Adjuvant Treatment Period||88
10972101|NCT00545688|12146168|FG000|COMPLETED|Adjuvant Treatment Period||98
10972102|NCT00545688|12146169|FG001|COMPLETED|Adjuvant Treatment Period||94
10972103|NCT00545688|12146170|FG002|COMPLETED|Adjuvant Treatment Period||90
10972104|NCT00545688|12146171|FG003|COMPLETED|Adjuvant Treatment Period||74
10972105|NCT00545688|12146168|FG000|NOT COMPLETED|Adjuvant Treatment Period||5
10972106|NCT00545688|12146169|FG001|NOT COMPLETED|Adjuvant Treatment Period||8
10972107|NCT00545688|12146170|FG002|NOT COMPLETED|Adjuvant Treatment Period||4
10972108|NCT00545688|12146171|FG003|NOT COMPLETED|Adjuvant Treatment Period||14
10972109|NCT00545688|12146168|FG000|STARTED|Follow-Up Period||98
10972110|NCT00545688|12146169|FG001|STARTED|Follow-Up Period||102
10972111|NCT00545688|12146170|FG002|STARTED|Follow-Up Period||98
10972112|NCT00545688|12146171|FG003|STARTED|Follow-Up Period||87
10972113|NCT00545688|12146168|FG000|COMPLETED|Follow-Up Period||77
10972114|NCT00545688|12146169|FG001|COMPLETED|Follow-Up Period||83
10972115|NCT00545688|12146170|FG002|COMPLETED|Follow-Up Period||78
10972116|NCT00545688|12146171|FG003|COMPLETED|Follow-Up Period||60
10972117|NCT00545688|12146168|FG000|NOT COMPLETED|Follow-Up Period||21
10972118|NCT00545688|12146169|FG001|NOT COMPLETED|Follow-Up Period||19
10972119|NCT00545688|12146170|FG002|NOT COMPLETED|Follow-Up Period||20
10972120|NCT00545688|12146171|FG003|NOT COMPLETED|Follow-Up Period||27
10972121|NCT00545714|12146184|FG000|STARTED|Induction Phase (6 Months)||86
10972122|NCT00545714|12146184|FG000|Safety Population|Induction Phase (6 Months)||86
10972123|NCT00545714|12146184|FG000|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84
10972124|NCT00545714|12146184|FG000|COMPLETED|Induction Phase (6 Months)||74
10972125|NCT00545714|12146184|FG000|NOT COMPLETED|Induction Phase (6 Months)||12
10972126|NCT00545714|12146184|FG000|STARTED|Maintenance Phase (36 Months)||74
10972127|NCT00545714|12146184|FG000|COMPLETED|Maintenance Phase (36 Months)||42
10972128|NCT00545714|12146184|FG000|NOT COMPLETED|Maintenance Phase (36 Months)||32
10972129|NCT00545740|12146192|FG000|STARTED|Overall Study||145
10972130|NCT00545740|12146193|FG001|STARTED|Overall Study||145
10972131|NCT00545740|12146194|FG002|STARTED|Overall Study||151
10972132|NCT00545740|12146195|FG003|STARTED|Overall Study||149
10972133|NCT00545740|12146192|FG000|COMPLETED|Overall Study||70
10972134|NCT00545740|12146193|FG001|COMPLETED|Overall Study||62
10972135|NCT00545740|12146194|FG002|COMPLETED|Overall Study||55
10972136|NCT00545740|12146195|FG003|COMPLETED|Overall Study||78
10972137|NCT00545740|12146192|FG000|NOT COMPLETED|Overall Study||75
10972138|NCT00545740|12146193|FG001|NOT COMPLETED|Overall Study||83
10972139|NCT00545740|12146194|FG002|NOT COMPLETED|Overall Study||96
10972140|NCT00545740|12146195|FG003|NOT COMPLETED|Overall Study||71
10972141|NCT00545753|12146208|FG000|STARTED|Overall Study||243
10972142|NCT00545753|12146209|FG001|STARTED|Overall Study||59
10972143|NCT00545753|12146210|FG002|STARTED|Overall Study||256
10972144|NCT00545753|12146208|FG000|COMPLETED|Overall Study||227
10972145|NCT00545753|12146209|FG001|COMPLETED|Overall Study||54
10972146|NCT00545753|12146210|FG002|COMPLETED|Overall Study||230
10972147|NCT00545753|12146208|FG000|NOT COMPLETED|Overall Study||16
10972148|NCT00545753|12146209|FG001|NOT COMPLETED|Overall Study||5
10972149|NCT00545753|12146210|FG002|NOT COMPLETED|Overall Study||26
10972150|NCT00545779|12146219|FG000|STARTED|Overall Study||677
10972151|NCT00545779|12146219|FG000|COMPLETED|Overall Study||633
10972152|NCT00545779|12146219|FG000|NOT COMPLETED|Overall Study||44
10972153|NCT00545792|12146223|FG000|STARTED|Overall Study||21
10972154|NCT00545792|12146223|FG000|COMPLETED|Overall Study||20
10972155|NCT00545792|12146223|FG000|NOT COMPLETED|Overall Study||1
10972156|NCT00545818|12146229|FG000|STARTED|Overall Study||49
10972157|NCT00545818|12146230|FG001|STARTED|Overall Study||46
10972158|NCT00545818|12146229|FG000|COMPLETED|Overall Study||46
10972159|NCT00545818|12146230|FG001|COMPLETED|Overall Study||39
10972160|NCT00545818|12146229|FG000|NOT COMPLETED|Overall Study||3
10972161|NCT00545818|12146230|FG001|NOT COMPLETED|Overall Study||7
10972162|NCT00545948|12146239|FG000|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
10972163|NCT00545948|12146240|FG001|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
10972164|NCT00545948|12146241|FG002|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
10972165|NCT00545948|12146239|FG000|Assigned Treatment|Overall Study||9
10972166|NCT00545948|12146240|FG001|Assigned Treatment|Overall Study||15
10972167|NCT00545948|12146241|FG002|Assigned Treatment|Overall Study||0
10972168|NCT00545948|12146239|FG000|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
10972169|NCT00545948|12146240|FG001|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
10972170|NCT00545948|12146241|FG002|COMPLETED|Overall Study||0
10972171|NCT00545948|12146239|FG000|NOT COMPLETED|Overall Study||1
10972172|NCT00545948|12146240|FG001|NOT COMPLETED|Overall Study||1
10972173|NCT00545948|12146241|FG002|NOT COMPLETED|Overall Study||7
10972174|NCT00545974|12146252|FG000|STARTED|Overall Study|subjects randomized to memantine cohort|39
10972175|NCT00545974|12146253|FG001|STARTED|Overall Study|subjects randomized to placebo cohort|42
10972176|NCT00545974|12146252|FG000|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
10972177|NCT00545974|12146253|FG001|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
10972178|NCT00545974|12146252|FG000|NOT COMPLETED|Overall Study||2
10972179|NCT00545974|12146253|FG001|NOT COMPLETED|Overall Study||3
10972180|NCT00546000|12146259|FG000|STARTED|Overall Study||56
10972181|NCT00546000|12146259|FG000|COMPLETED|Overall Study||52
10972182|NCT00546000|12146259|FG000|NOT COMPLETED|Overall Study||4
10972183|NCT00546078|12146265|FG000|STARTED|Overall Study||65
10972184|NCT00546078|12146266|FG001|STARTED|Overall Study||50
10972185|NCT00546078|12146265|FG000|Month 18|Overall Study||61
10972186|NCT00546078|12146266|FG001|Month 18|Overall Study||45
10972187|NCT00546078|12146265|FG000|COMPLETED|Overall Study||61
10972188|NCT00546078|12146266|FG001|COMPLETED|Overall Study||43
10972189|NCT00546078|12146265|FG000|NOT COMPLETED|Overall Study||4
10972190|NCT00546078|12146266|FG001|NOT COMPLETED|Overall Study||7
10972191|NCT00546104|12146272|FG000|STARTED|Overall Study||31
10972192|NCT00546104|12146272|FG000|COMPLETED|Overall Study||31
10972193|NCT00546104|12146272|FG000|NOT COMPLETED|Overall Study||0
10972194|NCT00546117|12146278|FG000|STARTED|Overall Study||9
10972195|NCT00546117|12146279|FG001|STARTED|Overall Study||7
10972196|NCT00546117|12146278|FG000|COMPLETED|Overall Study||5
10972197|NCT00546117|12146279|FG001|COMPLETED|Overall Study||7
10972198|NCT00546117|12146278|FG000|NOT COMPLETED|Overall Study||4
10972199|NCT00546117|12146279|FG001|NOT COMPLETED|Overall Study||0
10972200|NCT00546156|12146289|FG000|STARTED|Overall Study||84
10972201|NCT00546156|12146290|FG001|STARTED|Overall Study||20
10972202|NCT00546156|12146289|FG000|COMPLETED|Overall Study||70
10972203|NCT00546156|12146290|FG001|COMPLETED|Overall Study||19
10972204|NCT00546156|12146289|FG000|NOT COMPLETED|Overall Study||14
10972205|NCT00546156|12146290|FG001|NOT COMPLETED|Overall Study||1
10972206|NCT00546260|12146297|FG000|STARTED|Overall Study||36
10972207|NCT00546260|12146298|FG001|STARTED|Overall Study||34
10972208|NCT00546260|12146297|FG000|COMPLETED|Overall Study||28
10972209|NCT00546260|12146298|FG001|COMPLETED|Overall Study||32
10972210|NCT00546260|12146297|FG000|NOT COMPLETED|Overall Study||8
10972211|NCT00546260|12146298|FG001|NOT COMPLETED|Overall Study||2
10972212|NCT00546351|12146304|FG000|STARTED|Overall Study||621
10972213|NCT00546351|12146304|FG000|COMPLETED|Overall Study||385
10972214|NCT00546351|12146304|FG000|NOT COMPLETED|Overall Study||236
10972215|NCT00546364|12146311|FG000|STARTED|Overall Study||20
10972216|NCT00546364|12146312|FG001|STARTED|Overall Study||22
10972217|NCT00546364|12146313|FG002|STARTED|Overall Study||20
10972218|NCT00546364|12146311|FG000|Never Treated|Overall Study||0
10972219|NCT00546364|12146312|FG001|Never Treated|Overall Study||0
10972220|NCT00546364|12146313|FG002|Never Treated|Overall Study||0
10972221|NCT00546364|12146311|FG000|COMPLETED|Overall Study|Still on treatment|3
10972222|NCT00546364|12146312|FG001|COMPLETED|Overall Study|Still on treatment|4
10972223|NCT00546364|12146313|FG002|COMPLETED|Overall Study|Still on treatment|3
10972224|NCT00546364|12146311|FG000|NOT COMPLETED|Overall Study||17
10972225|NCT00546364|12146312|FG001|NOT COMPLETED|Overall Study||18
10972226|NCT00546364|12146313|FG002|NOT COMPLETED|Overall Study||17
10972227|NCT00546377|12146321|FG000|STARTED|Overall Study||50
10972228|NCT00546377|12146321|FG000|COMPLETED|Overall Study||43
10972229|NCT00546377|12146321|FG000|NOT COMPLETED|Overall Study||7
10972230|NCT00546390|12146327|FG000|STARTED|Overall Study||27
10972231|NCT00546390|12146328|FG001|STARTED|Overall Study||28
10972232|NCT00546390|12146327|FG000|COMPLETED|Overall Study||27
10972233|NCT00546390|12146328|FG001|COMPLETED|Overall Study||28
10972234|NCT00546390|12146327|FG000|NOT COMPLETED|Overall Study||0
10972235|NCT00546390|12146328|FG001|NOT COMPLETED|Overall Study||0
10972236|NCT00546429|12146335|FG000|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
10972237|NCT00546429|12146335|FG000|COMPLETED|Overall Study||32
10972238|NCT00546429|12146335|FG000|NOT COMPLETED|Overall Study||30
10972239|NCT00546481|12146341|FG000|STARTED|Correction Phase (CERA or Epoetin Beta)||39
10972240|NCT00546481|12146342|FG001|STARTED|Correction Phase (CERA or Epoetin Beta)||41
10972241|NCT00546481|12146343|FG002|STARTED|Correction Phase (CERA or Epoetin Beta)||0
10972242|NCT00546481|12146341|FG000|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
10972243|NCT00546481|12146342|FG001|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
10972244|NCT00546481|12146343|FG002|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
10972245|NCT00546481|12146341|FG000|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
10972246|NCT00546481|12146342|FG001|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
10972247|NCT00546481|12146343|FG002|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
10972248|NCT00546481|12146341|FG000|STARTED|Maintenance Phase (CERA)||0
10972249|NCT00546481|12146342|FG001|STARTED|Maintenance Phase (CERA)||0
10972250|NCT00546481|12146343|FG002|STARTED|Maintenance Phase (CERA)||54
10972251|NCT00546481|12146341|FG000|COMPLETED|Maintenance Phase (CERA)||0
10972252|NCT00546481|12146342|FG001|COMPLETED|Maintenance Phase (CERA)||0
10972253|NCT00546481|12146343|FG002|COMPLETED|Maintenance Phase (CERA)||50
10972254|NCT00546481|12146341|FG000|NOT COMPLETED|Maintenance Phase (CERA)||0
10972255|NCT00546481|12146342|FG001|NOT COMPLETED|Maintenance Phase (CERA)||0
10972256|NCT00546481|12146343|FG002|NOT COMPLETED|Maintenance Phase (CERA)||4
10972257|NCT00546572|12146353|FG000|STARTED|Vax 1 / Year 0||464
10972258|NCT00546572|12146354|FG001|STARTED|Vax 1 / Year 0||474
10972259|NCT00546572|12146353|FG000|Received Vax 1|Vax 1 / Year 0||463
10972260|NCT00546572|12146354|FG001|Received Vax 1|Vax 1 / Year 0||473
10972261|NCT00546572|12146353|FG000|COMPLETED|Vax 1 / Year 0||391
10972262|NCT00546572|12146354|FG001|COMPLETED|Vax 1 / Year 0||404
10972263|NCT00546572|12146353|FG000|NOT COMPLETED|Vax 1 / Year 0||73
10972264|NCT00546572|12146354|FG001|NOT COMPLETED|Vax 1 / Year 0||70
10972265|NCT00546572|12146353|FG000|STARTED|Vax 2 / Year 1||391
10972266|NCT00546572|12146354|FG001|STARTED|Vax 2 / Year 1||404
10972267|NCT00546572|12146353|FG000|Received Vax 2|Vax 2 / Year 1||391
10972268|NCT00546572|12146354|FG001|Received Vax 2|Vax 2 / Year 1||404
10972269|NCT00546572|12146353|FG000|COMPLETED|Vax 2 / Year 1||387
10972270|NCT00546572|12146354|FG001|COMPLETED|Vax 2 / Year 1||402
10972271|NCT00546572|12146353|FG000|NOT COMPLETED|Vax 2 / Year 1||4
10972272|NCT00546572|12146354|FG001|NOT COMPLETED|Vax 2 / Year 1||2
10972273|NCT00546637|12146373|FG000|STARTED|Overall Study||474
10972274|NCT00546637|12146374|FG001|STARTED|Overall Study||473
10972275|NCT00546637|12146373|FG000|Received Treatment|Overall Study||471
10972276|NCT00546637|12146374|FG001|Received Treatment|Overall Study||472
10972277|NCT00546637|12146373|FG000|COMPLETED|Overall Study||401
10972278|NCT00546637|12146374|FG001|COMPLETED|Overall Study||424
10972279|NCT00546637|12146373|FG000|NOT COMPLETED|Overall Study||73
10972280|NCT00546637|12146374|FG001|NOT COMPLETED|Overall Study||49
10972281|NCT00546715|12146384|FG000|STARTED|Overall Study||6
10972282|NCT00546715|12146385|FG001|STARTED|Overall Study||5
10972283|NCT00546715|12146386|FG002|STARTED|Overall Study||5
10972284|NCT00546715|12146387|FG003|STARTED|Overall Study||2
10972285|NCT00546715|12146384|FG000|COMPLETED|Overall Study||6
10972286|NCT00546715|12146385|FG001|COMPLETED|Overall Study||4
10972287|NCT00546715|12146386|FG002|COMPLETED|Overall Study||5
10972288|NCT00546715|12146387|FG003|COMPLETED|Overall Study||2
10972289|NCT00546715|12146384|FG000|NOT COMPLETED|Overall Study||0
10972290|NCT00546715|12146385|FG001|NOT COMPLETED|Overall Study||1
10972291|NCT00546715|12146386|FG002|NOT COMPLETED|Overall Study||0
10972292|NCT00546715|12146387|FG003|NOT COMPLETED|Overall Study||0
10972293|NCT00546728|12146399|FG000|STARTED|Overall Study||25
10972294|NCT00546728|12146400|FG001|STARTED|Overall Study||25
10972295|NCT00546728|12146399|FG000|COMPLETED|Overall Study||25
10972296|NCT00546728|12146400|FG001|COMPLETED|Overall Study||25
10972297|NCT00546728|12146399|FG000|NOT COMPLETED|Overall Study||0
10972298|NCT00546728|12146400|FG001|NOT COMPLETED|Overall Study||0
10972299|NCT00546819|12146408|FG000|STARTED|Overall Study||207
10972300|NCT00546819|12146409|FG001|STARTED|Overall Study||102
10972301|NCT00546819|12146408|FG000|VACCINATED|Overall Study||206
10972302|NCT00546819|12146409|FG001|VACCINATED|Overall Study||100
10972303|NCT00546819|12146408|FG000|COMPLETED|Overall Study||199
10972304|NCT00546819|12146409|FG001|COMPLETED|Overall Study||96
10972305|NCT00546819|12146408|FG000|NOT COMPLETED|Overall Study||8
10972306|NCT00546819|12146409|FG001|NOT COMPLETED|Overall Study||6
10972307|NCT00546871|12146415|FG000|STARTED|Part 1 - IV Infusions of IGIV, PK||14
10972308|NCT00546871|12146416|FG001|STARTED|Part 1 - IV Infusions of IGIV, PK||35
10972309|NCT00546871|12146415|FG000|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
10972310|NCT00546871|12146416|FG001|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
10972311|NCT00546871|12146415|FG000|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
10972312|NCT00546871|12146416|FG001|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
10972313|NCT00546871|12146415|FG000|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
10972314|NCT00546871|12146416|FG001|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
10972315|NCT00546871|12146415|FG000|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
10972316|NCT00546871|12146416|FG001|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
10972317|NCT00546871|12146415|FG000|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
10972318|NCT00546871|12146416|FG001|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
10972319|NCT00546871|12146415|FG000|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
10972320|NCT00546871|12146416|FG001|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
10972321|NCT00546871|12146415|FG000|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
10972322|NCT00546871|12146416|FG001|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
10972323|NCT00546871|12146415|FG000|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
10972324|NCT00546871|12146416|FG001|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
10972325|NCT00546871|12146415|FG000|STARTED|Part 3b - SC IGIV 12 Weeks||12
10972326|NCT00546871|12146416|FG001|STARTED|Part 3b - SC IGIV 12 Weeks||32
10972327|NCT00546871|12146415|FG000|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
10972328|NCT00546871|12146416|FG001|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
10972329|NCT00546871|12146415|FG000|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
10972330|NCT00546871|12146416|FG001|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
10972331|NCT00546871|12146415|FG000|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
10972332|NCT00546871|12146416|FG001|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
10972333|NCT00546871|12146415|FG000|COMPLETED|Study Extension Period||9
10972334|NCT00546871|12146416|FG001|COMPLETED|Study Extension Period||25
10972335|NCT00546871|12146415|FG000|NOT COMPLETED|Study Extension Period||1
10972336|NCT00546871|12146416|FG001|NOT COMPLETED|Study Extension Period||1
10972337|NCT00546884|12146447|FG000|STARTED|Overall Study||145
10972338|NCT00546884|12146448|FG001|STARTED|Overall Study||117
10972339|NCT00546884|12146447|FG000|COMPLETED|Overall Study||145
10972340|NCT00546884|12146448|FG001|COMPLETED|Overall Study||117
10972341|NCT00546884|12146447|FG000|NOT COMPLETED|Overall Study||0
10972342|NCT00546884|12146448|FG001|NOT COMPLETED|Overall Study||0
10972343|NCT00546897|12146456|FG000|STARTED|Overall Study||15
10972344|NCT00546897|12146457|FG001|STARTED|Overall Study||33
10972345|NCT00546897|12146456|FG000|COMPLETED|Overall Study||15
10972346|NCT00546897|12146457|FG001|COMPLETED|Overall Study||33
10972347|NCT00546897|12146456|FG000|NOT COMPLETED|Overall Study||0
10972348|NCT00546897|12146457|FG001|NOT COMPLETED|Overall Study||0
10972349|NCT00546910|12146465|FG000|STARTED|Overall Study||63
10972350|NCT00546910|12146466|FG001|STARTED|Overall Study||62
10972351|NCT00546910|12146465|FG000|COMPLETED|Overall Study||54
10972352|NCT00546910|12146466|FG001|COMPLETED|Overall Study||51
10972353|NCT00546910|12146465|FG000|NOT COMPLETED|Overall Study||9
10972354|NCT00546910|12146466|FG001|NOT COMPLETED|Overall Study||11
10972355|NCT00547105|12146472|FG000|STARTED|Overall Study||24
10972356|NCT00547105|12146472|FG000|COMPLETED|Overall Study||24
10972357|NCT00547105|12146472|FG000|NOT COMPLETED|Overall Study||0
10972358|NCT00547118|12146478|FG000|STARTED|Overall Study||8
10972359|NCT00547118|12146479|FG001|STARTED|Overall Study||9
10972360|NCT00547118|12146478|FG000|COMPLETED|Overall Study||0
10972361|NCT00547118|12146479|FG001|COMPLETED|Overall Study||0
10972362|NCT00547118|12146478|FG000|NOT COMPLETED|Overall Study||8
10972363|NCT00547118|12146479|FG001|NOT COMPLETED|Overall Study||9
10972364|NCT00547157|12146489|FG000|STARTED|Overall Study||90
10972365|NCT00547157|12146490|FG001|STARTED|Overall Study||62
10972366|NCT00547157|12146489|FG000|COMPLETED|Overall Study||41
10972367|NCT00547157|12146490|FG001|COMPLETED|Overall Study||39
10972368|NCT00547157|12146489|FG000|NOT COMPLETED|Overall Study||49
10972369|NCT00547157|12146490|FG001|NOT COMPLETED|Overall Study||23
10972370|NCT00547248|12146500|FG000|STARTED|Overall Study||280
10972371|NCT00547248|12146501|FG001|STARTED|Overall Study||93
10972372|NCT00547248|12146502|FG002|STARTED|Overall Study||285
10972373|NCT00547248|12146503|FG003|STARTED|Overall Study||98
10972374|NCT00547248|12146500|FG000|COMPLETED|Overall Study||280
10972375|NCT00547248|12146501|FG001|COMPLETED|Overall Study||93
10972376|NCT00547248|12146502|FG002|COMPLETED|Overall Study||275
10972377|NCT00547248|12146503|FG003|COMPLETED|Overall Study||96
10972378|NCT00547248|12146500|FG000|NOT COMPLETED|Overall Study||0
10972379|NCT00547248|12146501|FG001|NOT COMPLETED|Overall Study||0
10972380|NCT00547248|12146502|FG002|NOT COMPLETED|Overall Study||10
10972381|NCT00547248|12146503|FG003|NOT COMPLETED|Overall Study||2
10972382|NCT00547365|12146516|FG000|STARTED|Overall Study||10
10972383|NCT00547365|12146516|FG000|COMPLETED|Overall Study||2
10972384|NCT00547365|12146516|FG000|NOT COMPLETED|Overall Study||8
10972385|NCT00547378|12146524|FG000|STARTED|Randomized Cohort||70
10972386|NCT00547378|12146525|FG001|STARTED|Randomized Cohort||77
10972387|NCT00547378|12146526|FG002|STARTED|Randomized Cohort||0
10972388|NCT00547378|12146524|FG000|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
10972389|NCT00547378|12146525|FG001|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
10972390|NCT00547378|12146526|FG002|Month 3|Randomized Cohort||0
10972391|NCT00547378|12146524|FG000|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
10972392|NCT00547378|12146525|FG001|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
10972393|NCT00547378|12146526|FG002|Month 6|Randomized Cohort||0
10972394|NCT00547378|12146524|FG000|COMPLETED|Randomized Cohort||59
10972395|NCT00547378|12146525|FG001|COMPLETED|Randomized Cohort||71
10972396|NCT00547378|12146526|FG002|COMPLETED|Randomized Cohort||0
10972397|NCT00547378|12146524|FG000|NOT COMPLETED|Randomized Cohort||11
10972398|NCT00547378|12146525|FG001|NOT COMPLETED|Randomized Cohort||6
10972399|NCT00547378|12146526|FG002|NOT COMPLETED|Randomized Cohort||0
10972400|NCT00547378|12146524|FG000|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
10972401|NCT00547378|12146525|FG001|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
10972402|NCT00547378|12146526|FG002|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
10972403|NCT00547378|12146524|FG000|Month 3|All Implanted Cohort||51
10972404|NCT00547378|12146525|FG001|Month 3|All Implanted Cohort||39
10972405|NCT00547378|12146526|FG002|Month 3|All Implanted Cohort||178
10972406|NCT00547378|12146524|FG000|Month 6|All Implanted Cohort||50
10972407|NCT00547378|12146525|FG001|Month 6|All Implanted Cohort||36
10972408|NCT00547378|12146526|FG002|Month 6|All Implanted Cohort||178
10972409|NCT00547378|12146524|FG000|Month 12|All Implanted Cohort||48
10972410|NCT00547378|12146525|FG001|Month 12|All Implanted Cohort||32
10972411|NCT00547378|12146526|FG002|Month 12|All Implanted Cohort||175
10972412|NCT00547378|12146524|FG000|Month 24|All Implanted Cohort||42
10972413|NCT00547378|12146525|FG001|Month 24|All Implanted Cohort||30
10972414|NCT00547378|12146526|FG002|Month 24|All Implanted Cohort||161
10972415|NCT00547378|12146524|FG000|Month 36|All Implanted Cohort||42
10972416|NCT00547378|12146525|FG001|Month 36|All Implanted Cohort||29
10972417|NCT00547378|12146526|FG002|Month 36|All Implanted Cohort||146
10972418|NCT00547378|12146524|FG000|Month 48|All Implanted Cohort||38
10972419|NCT00547378|12146525|FG001|Month 48|All Implanted Cohort||27
10972420|NCT00547378|12146526|FG002|Month 48|All Implanted Cohort||136
10972421|NCT00547378|12146524|FG000|Month 60|All Implanted Cohort||36
10972422|NCT00547378|12146525|FG001|Month 60|All Implanted Cohort||23
10972423|NCT00547378|12146526|FG002|Month 60|All Implanted Cohort||114
10972424|NCT00547378|12146524|FG000|COMPLETED|All Implanted Cohort||36
10972425|NCT00547378|12146525|FG001|COMPLETED|All Implanted Cohort||22
10972426|NCT00547378|12146526|FG002|COMPLETED|All Implanted Cohort||111
10972427|NCT00547378|12146524|FG000|NOT COMPLETED|All Implanted Cohort||15
10972428|NCT00547378|12146525|FG001|NOT COMPLETED|All Implanted Cohort||18
10972429|NCT00547378|12146526|FG002|NOT COMPLETED|All Implanted Cohort||70
10972430|NCT00547521|12146536|FG000|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
10972431|NCT00547521|12146537|FG001|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
10972432|NCT00547521|12146536|FG000|COMPLETED|Short Term Study (4 Months)||50
10972433|NCT00547521|12146537|FG001|COMPLETED|Short Term Study (4 Months)||45
10972434|NCT00547521|12146536|FG000|NOT COMPLETED|Short Term Study (4 Months)||1
10972435|NCT00547521|12146537|FG001|NOT COMPLETED|Short Term Study (4 Months)||4
10972436|NCT00547521|12146536|FG000|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
10972437|NCT00547521|12146537|FG001|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
10972438|NCT00547521|12146536|FG000|COMPLETED|Long Term Extension (LTE) Study||0
10972439|NCT00547521|12146537|FG001|COMPLETED|Long Term Extension (LTE) Study||59
10972440|NCT00547521|12146536|FG000|NOT COMPLETED|Long Term Extension (LTE) Study||0
10972441|NCT00547521|12146537|FG001|NOT COMPLETED|Long Term Extension (LTE) Study||31
10972442|NCT00547534|12146550|FG000|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
10972443|NCT00547534|12146550|FG000|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
10972444|NCT00547534|12146550|FG000|NOT COMPLETED|Overall Study||11
10972445|NCT00547586|12146560|FG000|STARTED|Overall Study||33
10972446|NCT00547586|12146561|FG001|STARTED|Overall Study||7
10972447|NCT00547586|12146562|FG002|STARTED|Overall Study||14
10972448|NCT00547586|12146563|FG003|STARTED|Overall Study||33
10972449|NCT00547586|12146564|FG004|STARTED|Overall Study||35
10972450|NCT00547586|12146560|FG000|COMPLETED|Overall Study||28
10972451|NCT00547586|12146561|FG001|COMPLETED|Overall Study||6
10972452|NCT00547586|12146562|FG002|COMPLETED|Overall Study||13
10972453|NCT00547586|12146563|FG003|COMPLETED|Overall Study||27
10972454|NCT00547586|12146564|FG004|COMPLETED|Overall Study||32
10972455|NCT00547586|12146560|FG000|NOT COMPLETED|Overall Study||5
10972456|NCT00547586|12146561|FG001|NOT COMPLETED|Overall Study||1
10972457|NCT00547586|12146562|FG002|NOT COMPLETED|Overall Study||1
10972458|NCT00547586|12146563|FG003|NOT COMPLETED|Overall Study||6
10972459|NCT00547586|12146564|FG004|NOT COMPLETED|Overall Study||3
10972460|NCT00547638|12146578|FG000|STARTED|Overall Study||143
10972461|NCT00547638|12146579|FG001|STARTED|Overall Study||73
10972462|NCT00547638|12146578|FG000|COMPLETED|Overall Study||119
10972463|NCT00547638|12146579|FG001|COMPLETED|Overall Study||59
10972464|NCT00547638|12146578|FG000|NOT COMPLETED|Overall Study||24
10972465|NCT00547638|12146579|FG001|NOT COMPLETED|Overall Study||14
10972466|NCT00547703|12146587|FG000|STARTED|Overall Study||4
10972467|NCT00547703|12146588|FG001|STARTED|Overall Study||1
10972468|NCT00547703|12146587|FG000|COMPLETED|Overall Study||3
10972469|NCT00547703|12146588|FG001|COMPLETED|Overall Study||1
10972470|NCT00547703|12146587|FG000|NOT COMPLETED|Overall Study||1
10972471|NCT00547703|12146588|FG001|NOT COMPLETED|Overall Study||0
10972472|NCT00547729|12146594|FG000|STARTED|Overall Study||71
10972473|NCT00547729|12146594|FG000|COMPLETED|Overall Study||71
10972474|NCT00547729|12146594|FG000|NOT COMPLETED|Overall Study||0
10972475|NCT00547898|12146602|FG000|STARTED|Overall Study||138
10972476|NCT00547898|12146603|FG001|STARTED|Overall Study||136
10972477|NCT00547898|12146604|FG002|STARTED|Overall Study||54
10972478|NCT00547898|12146605|FG003|STARTED|Overall Study||46
10972479|NCT00547898|12146602|FG000|COMPLETED|Overall Study||129
10972480|NCT00547898|12146603|FG001|COMPLETED|Overall Study||126
10972481|NCT00547898|12146604|FG002|COMPLETED|Overall Study||54
10972482|NCT00547898|12146605|FG003|COMPLETED|Overall Study||40
10972483|NCT00547898|12146602|FG000|NOT COMPLETED|Overall Study||9
10972484|NCT00547898|12146603|FG001|NOT COMPLETED|Overall Study||10
10972485|NCT00547898|12146604|FG002|NOT COMPLETED|Overall Study||0
10972486|NCT00547898|12146605|FG003|NOT COMPLETED|Overall Study||6
10972487|NCT00547911|12146621|FG000|STARTED|Overall Study||2
10972488|NCT00547911|12146622|FG001|STARTED|Overall Study||2
10972489|NCT00547911|12146623|FG002|STARTED|Overall Study||2
10972490|NCT00547911|12146624|FG003|STARTED|Overall Study||2
10972491|NCT00547911|12146625|FG004|STARTED|Overall Study||3
10972492|NCT00547911|12146626|FG005|STARTED|Overall Study||3
10972493|NCT00547911|12146621|FG000|COMPLETED|Overall Study||2
10972494|NCT00547911|12146622|FG001|COMPLETED|Overall Study||2
10972495|NCT00547911|12146623|FG002|COMPLETED|Overall Study||2
10972496|NCT00547911|12146624|FG003|COMPLETED|Overall Study||1
10972497|NCT00547911|12146625|FG004|COMPLETED|Overall Study||3
10972498|NCT00547911|12146626|FG005|COMPLETED|Overall Study||3
10972499|NCT00547911|12146621|FG000|NOT COMPLETED|Overall Study||0
10972500|NCT00547911|12146622|FG001|NOT COMPLETED|Overall Study||0
10972501|NCT00547911|12146623|FG002|NOT COMPLETED|Overall Study||0
10972502|NCT00547911|12146624|FG003|NOT COMPLETED|Overall Study||1
10972503|NCT00547911|12146625|FG004|NOT COMPLETED|Overall Study||0
10972504|NCT00547911|12146626|FG005|NOT COMPLETED|Overall Study||0
10972505|NCT00548041|12146639|FG000|STARTED|Overall Study||100
10972506|NCT00548041|12146639|FG000|COMPLETED|Overall Study||100
10972507|NCT00548041|12146639|FG000|NOT COMPLETED|Overall Study||0
10972508|NCT00548132|12146645|FG000|STARTED|Overall Study||534
10972509|NCT00548132|12146646|FG001|STARTED|Overall Study||554
10972510|NCT00548132|12146645|FG000|Consented to Study|Overall Study||534
10972511|NCT00548132|12146646|FG001|Consented to Study|Overall Study||554
10972512|NCT00548132|12146645|FG000|COMPLETED|Overall Study||534
10972513|NCT00548132|12146646|FG001|COMPLETED|Overall Study||554
10972514|NCT00548132|12146645|FG000|NOT COMPLETED|Overall Study||0
10972515|NCT00548132|12146646|FG001|NOT COMPLETED|Overall Study||0
10972516|NCT00548145|12146656|FG000|STARTED|Overall Study||18
10972517|NCT00548145|12146657|FG001|STARTED|Overall Study||20
10972518|NCT00548145|12146656|FG000|COMPLETED|Overall Study||17
10972519|NCT00548145|12146657|FG001|COMPLETED|Overall Study||16
10972520|NCT00548145|12146656|FG000|NOT COMPLETED|Overall Study||1
10972521|NCT00548145|12146657|FG001|NOT COMPLETED|Overall Study||4
10972522|NCT00548171|12146665|FG000|STARTED|Overall Study||164
10972523|NCT00548171|12146666|FG001|STARTED|Overall Study||39
10972524|NCT00548171|12146665|FG000|COMPLETED|Overall Study||164
10972525|NCT00548171|12146666|FG001|COMPLETED|Overall Study||39
10972526|NCT00548171|12146665|FG000|NOT COMPLETED|Overall Study||0
10972527|NCT00548171|12146666|FG001|NOT COMPLETED|Overall Study||0
10972528|NCT00548184|12146672|FG000|STARTED|Overall Study||65
10972529|NCT00548184|12146672|FG000|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
10972530|NCT00548184|12146672|FG000|NOT COMPLETED|Overall Study||5
10972531|NCT00548197|12146678|FG000|STARTED|Overall Study||18
10972532|NCT00548197|12146679|FG001|STARTED|Overall Study||22
10972533|NCT00548197|12146678|FG000|COMPLETED|Overall Study||18
10972534|NCT00548197|12146679|FG001|COMPLETED|Overall Study||22
10972535|NCT00548197|12146678|FG000|NOT COMPLETED|Overall Study||0
10972536|NCT00548197|12146679|FG001|NOT COMPLETED|Overall Study||0
10972537|NCT00548249|12146692|FG000|STARTED|Overall Study||26
10972538|NCT00548249|12146693|FG001|STARTED|Overall Study||26
10972539|NCT00548249|12146694|FG002|STARTED|Overall Study||29
10972540|NCT00548249|12146695|FG003|STARTED|Overall Study||22
10972541|NCT00548249|12146696|FG004|STARTED|Overall Study||28
10972542|NCT00548249|12146692|FG000|COMPLETED|Overall Study||10
10972543|NCT00548249|12146693|FG001|COMPLETED|Overall Study||13
10972544|NCT00548249|12146694|FG002|COMPLETED|Overall Study||9
10972545|NCT00548249|12146695|FG003|COMPLETED|Overall Study||9
10972546|NCT00548249|12146696|FG004|COMPLETED|Overall Study||7
10972547|NCT00548249|12146692|FG000|NOT COMPLETED|Overall Study||16
10972548|NCT00548249|12146693|FG001|NOT COMPLETED|Overall Study||13
10972549|NCT00548249|12146694|FG002|NOT COMPLETED|Overall Study||20
10972550|NCT00548249|12146695|FG003|NOT COMPLETED|Overall Study||13
10972551|NCT00548249|12146696|FG004|NOT COMPLETED|Overall Study||21
10972552|NCT00548262|12146708|FG000|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
10972553|NCT00548262|12146708|FG000|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
10972554|NCT00548262|12146708|FG000|NOT COMPLETED|Overall Study||32
10972555|NCT00548340|12146715|FG000|STARTED|Overall Study||109
10972556|NCT00548340|12146716|FG001|STARTED|Overall Study||109
10972557|NCT00548340|12146717|FG002|STARTED|Overall Study||104
10972558|NCT00548340|12146715|FG000|COMPLETED|Overall Study||101
10972559|NCT00548340|12146716|FG001|COMPLETED|Overall Study||98
10972560|NCT00548340|12146717|FG002|COMPLETED|Overall Study||95
10972561|NCT00548340|12146715|FG000|NOT COMPLETED|Overall Study||8
10972562|NCT00548340|12146716|FG001|NOT COMPLETED|Overall Study||11
10972563|NCT00548340|12146717|FG002|NOT COMPLETED|Overall Study||9
10972564|NCT00548405|12146728|FG000|STARTED|Overall Study|Randomized.|231
10972565|NCT00548405|12146729|FG001|STARTED|Overall Study|Randomized.|436
10972566|NCT00548405|12146730|FG002|STARTED|Overall Study|Randomized.|173
10972567|NCT00548405|12146728|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
10972568|NCT00548405|12146729|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
10972569|NCT00548405|12146730|FG002|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
10972570|NCT00548405|12146728|FG000|COMPLETED|Overall Study||175
10972571|NCT00548405|12146729|FG001|COMPLETED|Overall Study||416
10972572|NCT00548405|12146730|FG002|COMPLETED|Overall Study||164
10972573|NCT00548405|12146728|FG000|NOT COMPLETED|Overall Study||56
10972574|NCT00548405|12146729|FG001|NOT COMPLETED|Overall Study||20
10972575|NCT00548405|12146730|FG002|NOT COMPLETED|Overall Study||9
10972576|NCT00548418|12146739|FG000|STARTED|Overall Study||27
10972577|NCT00548418|12146739|FG000|COMPLETED|Overall Study||27
10972578|NCT00548418|12146739|FG000|NOT COMPLETED|Overall Study||0
10972579|NCT00548431|12146743|FG000|STARTED|Overall Study||38
10972580|NCT00548431|12146743|FG000|COMPLETED|Overall Study||38
10972581|NCT00548431|12146743|FG000|NOT COMPLETED|Overall Study||0
10972582|NCT00548470|12146747|FG000|STARTED|Overall Study||14
10972583|NCT00548470|12146747|FG000|COMPLETED|Overall Study||12
10972584|NCT00548470|12146747|FG000|NOT COMPLETED|Overall Study||2
10972585|NCT00548548|12146753|FG000|STARTED|Overall Study||387
10972586|NCT00548548|12146754|FG001|STARTED|Overall Study||387
10972587|NCT00548548|12146753|FG000|Treated|Overall Study||383
10972588|NCT00548548|12146754|FG001|Treated|Overall Study||384
10972589|NCT00548548|12146753|FG000|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
10972590|NCT00548548|12146754|FG001|Safety Population|Overall Study||381
10972591|NCT00548548|12146753|FG000|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
10972592|NCT00548548|12146754|FG001|COMPLETED|Overall Study||21
10972593|NCT00548548|12146753|FG000|NOT COMPLETED|Overall Study||362
10972594|NCT00548548|12146754|FG001|NOT COMPLETED|Overall Study||366
10972595|NCT00548652|12146763|FG000|STARTED|Overall Study||18
10972596|NCT00548652|12146764|FG001|STARTED|Overall Study||38
10972597|NCT00548652|12146765|FG002|STARTED|Overall Study||45
10972598|NCT00548652|12146763|FG000|COMPLETED|Overall Study||16
10972599|NCT00548652|12146764|FG001|COMPLETED|Overall Study||29
10972600|NCT00548652|12146765|FG002|COMPLETED|Overall Study||34
10972601|NCT00548652|12146763|FG000|NOT COMPLETED|Overall Study||2
10972602|NCT00548652|12146764|FG001|NOT COMPLETED|Overall Study||9
10972603|NCT00548652|12146765|FG002|NOT COMPLETED|Overall Study||11
10972604|NCT00548691|12146775|FG000|STARTED|Overall Study||258
10972605|NCT00548691|12146776|FG001|STARTED|Overall Study||259
10972606|NCT00548691|12146775|FG000|COMPLETED|Overall Study||251
10972607|NCT00548691|12146776|FG001|COMPLETED|Overall Study||250
10972608|NCT00548691|12146775|FG000|NOT COMPLETED|Overall Study||7
10972609|NCT00548691|12146776|FG001|NOT COMPLETED|Overall Study||9
10972610|NCT00548717|12146784|FG000|STARTED|Overall Study||13
10972611|NCT00548717|12146785|FG001|STARTED|Overall Study||2
10972612|NCT00548717|12146784|FG000|COMPLETED|Overall Study||4
10972613|NCT00548717|12146785|FG001|COMPLETED|Overall Study||0
10972614|NCT00548717|12146784|FG000|NOT COMPLETED|Overall Study||9
10972615|NCT00548717|12146785|FG001|NOT COMPLETED|Overall Study||2
10972616|NCT00548808|12146796|FG000|STARTED|Overall Study||214
10972617|NCT00548808|12146797|FG001|STARTED|Overall Study||212
10972618|NCT00548808|12146796|FG000|Full Analysis Set|Overall Study||211
10972619|NCT00548808|12146797|FG001|Full Analysis Set|Overall Study||212
10972620|NCT00548808|12146796|FG000|Per-Protocol Set|Overall Study||177
10972621|NCT00548808|12146797|FG001|Per-Protocol Set|Overall Study||184
10972622|NCT00548808|12146796|FG000|COMPLETED|Overall Study||172
10972623|NCT00548808|12146797|FG001|COMPLETED|Overall Study||186
10972624|NCT00548808|12146796|FG000|NOT COMPLETED|Overall Study||42
10972625|NCT00548808|12146797|FG001|NOT COMPLETED|Overall Study||26
10972626|NCT00548847|12146803|FG000|STARTED|Overall Study||15
10972627|NCT00548847|12146803|FG000|COMPLETED|Overall Study||8
10972628|NCT00548847|12146803|FG000|NOT COMPLETED|Overall Study||7
10972629|NCT00548860|12146809|FG000|STARTED|Overall Study||996
10972630|NCT00548860|12146810|FG001|STARTED|Overall Study||1022
10972631|NCT00548860|12146809|FG000|COMPLETED|Overall Study||860
10972632|NCT00548860|12146810|FG001|COMPLETED|Overall Study||847
10972633|NCT00548860|12146809|FG000|NOT COMPLETED|Overall Study||136
10972634|NCT00548860|12146810|FG001|NOT COMPLETED|Overall Study||175
10972635|NCT00549042|12146818|FG000|STARTED|Conversion and Titration Phase||459
10972636|NCT00549042|12146819|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
10972637|NCT00549042|12146818|FG000|COMPLETED|Conversion and Titration Phase||268
10972638|NCT00549042|12146819|FG001|COMPLETED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
10972639|NCT00549042|12146818|FG000|NOT COMPLETED|Conversion and Titration Phase||191
10972640|NCT00549042|12146819|FG001|NOT COMPLETED|Conversion and Titration Phase||0
10972641|NCT00549042|12146818|FG000|STARTED|Double-blind Phase||134
10972642|NCT00549042|12146819|FG001|STARTED|Double-blind Phase||134
10972643|NCT00549042|12146818|FG000|COMPLETED|Double-blind Phase||66
10972644|NCT00549042|12146819|FG001|COMPLETED|Double-blind Phase||44
10972645|NCT00549042|12146818|FG000|NOT COMPLETED|Double-blind Phase||68
10972646|NCT00549042|12146819|FG001|NOT COMPLETED|Double-blind Phase||90
10972647|NCT00549055|12146826|FG000|STARTED|Overall Study||38
10972648|NCT00549055|12146826|FG000|COMPLETED|Overall Study||3
10972649|NCT00549055|12146826|FG000|NOT COMPLETED|Overall Study||35
10972650|NCT00549172|12146832|FG000|STARTED|Overall Study||70
10972651|NCT00549172|12146833|FG001|STARTED|Overall Study||76
10972652|NCT00549172|12146832|FG000|COMPLETED|Overall Study||70
10972653|NCT00549172|12146833|FG001|COMPLETED|Overall Study||76
10972654|NCT00549172|12146832|FG000|NOT COMPLETED|Overall Study||0
10972655|NCT00549172|12146833|FG001|NOT COMPLETED|Overall Study||0
10972656|NCT00549198|12146841|FG000|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
10972657|NCT00549198|12146842|FG001|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
10972658|NCT00549198|12146841|FG000|COMPLETED|Overall Study||115
10972659|NCT00549198|12146842|FG001|COMPLETED|Overall Study||134
10972660|NCT00549198|12146841|FG000|NOT COMPLETED|Overall Study||80
10972661|NCT00549198|12146842|FG001|NOT COMPLETED|Overall Study||63
10972662|NCT00549302|12146850|FG000|STARTED|Double-Blind||63
10972663|NCT00549302|12146851|FG001|STARTED|Double-Blind||294
10972664|NCT00549302|12146852|FG002|STARTED|Double-Blind||0
10972665|NCT00549302|12146850|FG000|Received at Least One Dose of Study Drug|Double-Blind||63
10972666|NCT00549302|12146851|FG001|Received at Least One Dose of Study Drug|Double-Blind||294
10972667|NCT00549302|12146852|FG002|Received at Least One Dose of Study Drug|Double-Blind||0
10972668|NCT00549302|12146850|FG000|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
10972669|NCT00549302|12146851|FG001|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
10972670|NCT00549302|12146852|FG002|COMPLETED|Double-Blind||0
10972671|NCT00549302|12146850|FG000|NOT COMPLETED|Double-Blind||11
10972672|NCT00549302|12146851|FG001|NOT COMPLETED|Double-Blind||53
10972673|NCT00549302|12146852|FG002|NOT COMPLETED|Double-Blind||0
10972674|NCT00549302|12146850|FG000|STARTED|Open-Label||0
10972675|NCT00549302|12146851|FG001|STARTED|Open-Label||0
10972676|NCT00549302|12146852|FG002|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
10972677|NCT00549302|12146850|FG000|COMPLETED|Open-Label||0
10972678|NCT00549302|12146851|FG001|COMPLETED|Open-Label||0
10972679|NCT00549302|12146852|FG002|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
10972680|NCT00549302|12146850|FG000|NOT COMPLETED|Open-Label||0
10972681|NCT00549302|12146851|FG001|NOT COMPLETED|Open-Label||0
10972682|NCT00549302|12146852|FG002|NOT COMPLETED|Open-Label||69
10972683|NCT00549393|12146862|FG000|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
10972684|NCT00549393|12146863|FG001|STARTED|Period 1 (6 Months)|ITT|1199
10972685|NCT00549393|12146862|FG000|Per Protocol|Period 1 (6 Months)||880
10972686|NCT00549393|12146863|FG001|Per Protocol|Period 1 (6 Months)||1199
10972687|NCT00549393|12146862|FG000|COMPLETED|Period 1 (6 Months)||1319
10972688|NCT00549393|12146863|FG001|COMPLETED|Period 1 (6 Months)||1199
10972689|NCT00549393|12146862|FG000|NOT COMPLETED|Period 1 (6 Months)||0
10972690|NCT00549393|12146863|FG001|NOT COMPLETED|Period 1 (6 Months)||0
10972691|NCT00549393|12146862|FG000|STARTED|Period 2 Washout (2 Weeks)||0
10972692|NCT00549393|12146863|FG001|STARTED|Period 2 Washout (2 Weeks)||0
10972693|NCT00549393|12146862|FG000|COMPLETED|Period 2 Washout (2 Weeks)||0
10972694|NCT00549393|12146863|FG001|COMPLETED|Period 2 Washout (2 Weeks)||0
10972695|NCT00549393|12146862|FG000|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
10972696|NCT00549393|12146863|FG001|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
10972697|NCT00549393|12146862|FG000|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
10972698|NCT00549393|12146863|FG001|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
10972699|NCT00549393|12146862|FG000|Per Protocol|Period 3 (6 Months)||667
10972700|NCT00549393|12146863|FG001|Per Protocol|Period 3 (6 Months)||1326
10972701|NCT00549393|12146862|FG000|COMPLETED|Period 3 (6 Months)||1103
10972702|NCT00549393|12146863|FG001|COMPLETED|Period 3 (6 Months)||1326
10972703|NCT00549393|12146862|FG000|NOT COMPLETED|Period 3 (6 Months)||0
10972704|NCT00549393|12146863|FG001|NOT COMPLETED|Period 3 (6 Months)||0
10972705|NCT00549445|12146873|FG000|STARTED|Overall Study||23
10972706|NCT00549445|12146874|FG001|STARTED|Overall Study||30
10972707|NCT00549445|12146873|FG000|COMPLETED|Overall Study||8
10972708|NCT00549445|12146874|FG001|COMPLETED|Overall Study||13
10972709|NCT00549445|12146873|FG000|NOT COMPLETED|Overall Study||15
10972710|NCT00549445|12146874|FG001|NOT COMPLETED|Overall Study||17
10972711|NCT00549549|12146884|FG000|STARTED|Overall Study||101
10972712|NCT00549549|12146885|FG001|STARTED|Overall Study||99
10972713|NCT00549549|12146886|FG002|STARTED|Overall Study||99
10972714|NCT00549549|12146887|FG003|STARTED|Overall Study||103
10972715|NCT00549549|12146884|FG000|Treated|Overall Study||101
10972716|NCT00549549|12146885|FG001|Treated|Overall Study||99
10972717|NCT00549549|12146886|FG002|Treated|Overall Study||98
10972718|NCT00549549|12146887|FG003|Treated|Overall Study||102
10972719|NCT00549549|12146884|FG000|COMPLETED|Overall Study||77
10972720|NCT00549549|12146885|FG001|COMPLETED|Overall Study||77
10972721|NCT00549549|12146886|FG002|COMPLETED|Overall Study||82
10972722|NCT00549549|12146887|FG003|COMPLETED|Overall Study||78
10972723|NCT00549549|12146884|FG000|NOT COMPLETED|Overall Study||24
10972724|NCT00549549|12146885|FG001|NOT COMPLETED|Overall Study||22
10972725|NCT00549549|12146886|FG002|NOT COMPLETED|Overall Study||17
10972726|NCT00549549|12146887|FG003|NOT COMPLETED|Overall Study||25
10972727|NCT00549562|12146897|FG000|STARTED|Overall Study||25
10972728|NCT00549562|12146897|FG000|COMPLETED|Overall Study||23
10972729|NCT00549562|12146897|FG000|NOT COMPLETED|Overall Study||2
10972730|NCT00549601|12146904|FG000|STARTED|Randomized||43
10972731|NCT00549601|12146905|FG001|STARTED|Randomized||48
10972732|NCT00549601|12146906|FG002|STARTED|Randomized||51
10972733|NCT00549601|12146904|FG000|COMPLETED|Randomized||43
10972734|NCT00549601|12146905|FG001|COMPLETED|Randomized||47
10972735|NCT00549601|12146906|FG002|COMPLETED|Randomized||49
10972736|NCT00549601|12146904|FG000|NOT COMPLETED|Randomized||0
10972737|NCT00549601|12146905|FG001|NOT COMPLETED|Randomized||1
10972738|NCT00549601|12146906|FG002|NOT COMPLETED|Randomized||2
10972739|NCT00549601|12146904|FG000|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
10972740|NCT00549601|12146905|FG001|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
10972741|NCT00549601|12146906|FG002|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
10972742|NCT00549601|12146904|FG000|COMPLETED|Received Study Drug||36
10972743|NCT00549601|12146905|FG001|COMPLETED|Received Study Drug||36
10972744|NCT00549601|12146906|FG002|COMPLETED|Received Study Drug||45
10972745|NCT00549601|12146904|FG000|NOT COMPLETED|Received Study Drug||7
10972746|NCT00549601|12146905|FG001|NOT COMPLETED|Received Study Drug||11
10972747|NCT00549601|12146906|FG002|NOT COMPLETED|Received Study Drug||4
10972748|NCT00549640|12146918|FG000|STARTED|Overall Study||40
10972749|NCT00549640|12146919|FG001|STARTED|Overall Study||40
10972750|NCT00549640|12146918|FG000|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
10972751|NCT00549640|12146919|FG001|COMPLETED|Overall Study||24
10972752|NCT00549640|12146918|FG000|NOT COMPLETED|Overall Study||18
10972753|NCT00549640|12146919|FG001|NOT COMPLETED|Overall Study||16
10972754|NCT00549718|12146929|FG000|STARTED|Overall Study||125
10972755|NCT00549718|12146930|FG001|STARTED|Overall Study||123
10972756|NCT00549718|12146931|FG002|STARTED|Overall Study||124
10972757|NCT00549718|12146932|FG003|STARTED|Overall Study||128
10972758|NCT00549718|12146929|FG000|COMPLETED|Overall Study||84
10972759|NCT00549718|12146930|FG001|COMPLETED|Overall Study||86
10972760|NCT00549718|12146931|FG002|COMPLETED|Overall Study||85
10972761|NCT00549718|12146932|FG003|COMPLETED|Overall Study||73
10972762|NCT00549718|12146929|FG000|NOT COMPLETED|Overall Study||41
10972763|NCT00549718|12146930|FG001|NOT COMPLETED|Overall Study||37
10972764|NCT00549718|12146931|FG002|NOT COMPLETED|Overall Study||39
10972765|NCT00549718|12146932|FG003|NOT COMPLETED|Overall Study||55
10972766|NCT00549757|12146944|FG000|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
10972767|NCT00549757|12146945|FG001|STARTED|Active Treatment Phase: Max. 50 Months||4310
10972768|NCT00549757|12146944|FG000|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
10972769|NCT00549757|12146945|FG001|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
10972770|NCT00549757|12146944|FG000|Safety Set|Active Treatment Phase: Max. 50 Months||4272
10972771|NCT00549757|12146945|FG001|Safety Set|Active Treatment Phase: Max. 50 Months||4285
10972772|NCT00549757|12146944|FG000|COMPLETED|Active Treatment Phase: Max. 50 Months||0
10972773|NCT00549757|12146945|FG001|COMPLETED|Active Treatment Phase: Max. 50 Months||0
10972774|NCT00549757|12146944|FG000|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
10972775|NCT00549757|12146945|FG001|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
10972776|NCT00549757|12146944|FG000|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
10972777|NCT00549757|12146945|FG001|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
10972778|NCT00549757|12146944|FG000|COMPLETED|Extension Period (in Average 9 Months)||3148
10972779|NCT00549757|12146945|FG001|COMPLETED|Extension Period (in Average 9 Months)||3182
10972780|NCT00549757|12146944|FG000|NOT COMPLETED|Extension Period (in Average 9 Months)||625
10972781|NCT00549757|12146945|FG001|NOT COMPLETED|Extension Period (in Average 9 Months)||635
10972782|NCT00549770|12146965|FG000|STARTED|Overall Study||156
10972783|NCT00549770|12146966|FG001|STARTED|Overall Study||169
10972784|NCT00549770|12146967|FG002|STARTED|Overall Study||172
10972785|NCT00549770|12146968|FG003|STARTED|Overall Study||163
10972786|NCT00549770|12146969|FG004|STARTED|Overall Study||166
10972787|NCT00549770|12146970|FG005|STARTED|Overall Study||164
10972788|NCT00549770|12146971|FG006|STARTED|Overall Study||165
10972789|NCT00549770|12146972|FG007|STARTED|Overall Study||173
10972790|NCT00549770|12146965|FG000|Intent-to-treat Population|Overall Study||154
10972791|NCT00549770|12146966|FG001|Intent-to-treat Population|Overall Study||168
10972792|NCT00549770|12146967|FG002|Intent-to-treat Population|Overall Study||170
10972793|NCT00549770|12146968|FG003|Intent-to-treat Population|Overall Study||163
10972794|NCT00549770|12146969|FG004|Intent-to-treat Population|Overall Study||163
10972795|NCT00549770|12146970|FG005|Intent-to-treat Population|Overall Study||163
10972796|NCT00549770|12146971|FG006|Intent-to-treat Population|Overall Study||164
10972797|NCT00549770|12146972|FG007|Intent-to-treat Population|Overall Study||172
10972798|NCT00549770|12146965|FG000|Ambulatory Blood Pressure Monitoring|Overall Study||48
10972799|NCT00549770|12146966|FG001|Ambulatory Blood Pressure Monitoring|Overall Study||61
10972800|NCT00549770|12146967|FG002|Ambulatory Blood Pressure Monitoring|Overall Study||53
10972801|NCT00549770|12146968|FG003|Ambulatory Blood Pressure Monitoring|Overall Study||55
10972802|NCT00549770|12146969|FG004|Ambulatory Blood Pressure Monitoring|Overall Study||49
10972803|NCT00549770|12146970|FG005|Ambulatory Blood Pressure Monitoring|Overall Study||54
10972804|NCT00549770|12146971|FG006|Ambulatory Blood Pressure Monitoring|Overall Study||50
10972805|NCT00549770|12146972|FG007|Ambulatory Blood Pressure Monitoring|Overall Study||57
10972806|NCT00549770|12146965|FG000|COMPLETED|Overall Study||149
10972807|NCT00549770|12146966|FG001|COMPLETED|Overall Study||158
10972808|NCT00549770|12146967|FG002|COMPLETED|Overall Study||162
10972809|NCT00549770|12146968|FG003|COMPLETED|Overall Study||147
10972810|NCT00549770|12146969|FG004|COMPLETED|Overall Study||149
10972811|NCT00549770|12146970|FG005|COMPLETED|Overall Study||151
10972812|NCT00549770|12146971|FG006|COMPLETED|Overall Study||151
10972813|NCT00549770|12146972|FG007|COMPLETED|Overall Study||148
10972814|NCT00549770|12146965|FG000|NOT COMPLETED|Overall Study||7
10972815|NCT00549770|12146966|FG001|NOT COMPLETED|Overall Study||11
10972816|NCT00549770|12146967|FG002|NOT COMPLETED|Overall Study||10
10972817|NCT00549770|12146968|FG003|NOT COMPLETED|Overall Study||16
10972818|NCT00549770|12146969|FG004|NOT COMPLETED|Overall Study||17
10972819|NCT00549770|12146970|FG005|NOT COMPLETED|Overall Study||13
10972820|NCT00549770|12146971|FG006|NOT COMPLETED|Overall Study||14
10972821|NCT00549770|12146972|FG007|NOT COMPLETED|Overall Study||25
10972822|NCT00549783|12146992|FG000|STARTED|Overall Study||139
10972823|NCT00549783|12146993|FG001|STARTED|Overall Study||135
10972824|NCT00549783|12146992|FG000|COMPLETED|Overall Study||131
10972825|NCT00549783|12146993|FG001|COMPLETED|Overall Study||122
10972826|NCT00549783|12146992|FG000|NOT COMPLETED|Overall Study||8
10972827|NCT00549783|12146993|FG001|NOT COMPLETED|Overall Study||13
10972828|NCT00549822|12146999|FG000|STARTED|Overall Study||3
10972829|NCT00549822|12146999|FG000|COMPLETED|Overall Study||3
10972830|NCT00549822|12146999|FG000|NOT COMPLETED|Overall Study||0
10972831|NCT00549900|12147003|FG000|STARTED|Overall Study||30
10972832|NCT00549900|12147003|FG000|COMPLETED|Overall Study||29
10972833|NCT00549900|12147003|FG000|NOT COMPLETED|Overall Study||1
10972834|NCT00549939|12147010|FG000|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
10972835|NCT00549939|12147011|FG001|STARTED|12-week Double Blind Treatment Period||57
10972836|NCT00549939|12147012|FG002|STARTED|12-week Double Blind Treatment Period||58
10972837|NCT00549939|12147010|FG000|COMPLETED|12-week Double Blind Treatment Period||56
10972838|NCT00549939|12147011|FG001|COMPLETED|12-week Double Blind Treatment Period||55
10972839|NCT00549939|12147012|FG002|COMPLETED|12-week Double Blind Treatment Period||56
10972840|NCT00549939|12147010|FG000|NOT COMPLETED|12-week Double Blind Treatment Period||1
10972841|NCT00549939|12147011|FG001|NOT COMPLETED|12-week Double Blind Treatment Period||2
10972842|NCT00549939|12147012|FG002|NOT COMPLETED|12-week Double Blind Treatment Period||2
10972843|NCT00549939|12147010|FG000|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
10972844|NCT00549939|12147011|FG001|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
10972845|NCT00549939|12147012|FG002|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
10972846|NCT00549939|12147010|FG000|COMPLETED|40-week Open Label Treatment Period||0
10972847|NCT00549939|12147011|FG001|COMPLETED|40-week Open Label Treatment Period||75
10972848|NCT00549939|12147012|FG002|COMPLETED|40-week Open Label Treatment Period||78
10972849|NCT00549939|12147010|FG000|NOT COMPLETED|40-week Open Label Treatment Period||0
10972850|NCT00549939|12147011|FG001|NOT COMPLETED|40-week Open Label Treatment Period||5
10972851|NCT00549939|12147012|FG002|NOT COMPLETED|40-week Open Label Treatment Period||5
10972852|NCT00550043|12147027|FG000|STARTED|Overall Study||9
10972853|NCT00550043|12147028|FG001|STARTED|Overall Study||12
10972854|NCT00550043|12147029|FG002|STARTED|Overall Study||9
10972855|NCT00550043|12147030|FG003|STARTED|Overall Study||10
10972856|NCT00550043|12147031|FG004|STARTED|Overall Study||10
10972857|NCT00550043|12147027|FG000|COMPLETED|Overall Study||9
10972858|NCT00550043|12147028|FG001|COMPLETED|Overall Study||9
10972859|NCT00550043|12147029|FG002|COMPLETED|Overall Study||8
10972860|NCT00550043|12147030|FG003|COMPLETED|Overall Study||8
10972861|NCT00550043|12147031|FG004|COMPLETED|Overall Study||9
10972862|NCT00550043|12147027|FG000|NOT COMPLETED|Overall Study||0
10972863|NCT00550043|12147028|FG001|NOT COMPLETED|Overall Study||3
10972864|NCT00550043|12147029|FG002|NOT COMPLETED|Overall Study||1
10972865|NCT00550043|12147030|FG003|NOT COMPLETED|Overall Study||2
10972866|NCT00550043|12147031|FG004|NOT COMPLETED|Overall Study||1
10972867|NCT00550147|12147043|FG000|STARTED|OROS Methylphenidate Monotherapy||30
10972868|NCT00550147|12147043|FG000|COMPLETED|OROS Methylphenidate Monotherapy||24
10972869|NCT00550147|12147043|FG000|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
10972870|NCT00550147|12147043|FG000|STARTED|Quetiapine Addition Treatment Period||24
10972871|NCT00550147|12147043|FG000|COMPLETED|Quetiapine Addition Treatment Period||18
10972872|NCT00550147|12147043|FG000|NOT COMPLETED|Quetiapine Addition Treatment Period||6
10972873|NCT00550173|12147059|FG000|STARTED|Overall Study||81
10972874|NCT00550173|12147060|FG001|STARTED|Overall Study||82
10972875|NCT00550173|12147061|FG002|STARTED|Overall Study||84
10972876|NCT00550173|12147059|FG000|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
10972877|NCT00550173|12147060|FG001|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
10972878|NCT00550173|12147061|FG002|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
10972879|NCT00550173|12147059|FG000|Not Discontinued at 18 Months|Overall Study||9
10972880|NCT00550173|12147060|FG001|Not Discontinued at 18 Months|Overall Study||19
10972881|NCT00550173|12147061|FG002|Not Discontinued at 18 Months|Overall Study||11
10972882|NCT00550173|12147059|FG000|COMPLETED|Overall Study||9
10972883|NCT00550173|12147060|FG001|COMPLETED|Overall Study||19
10972884|NCT00550173|12147061|FG002|COMPLETED|Overall Study||11
10972885|NCT00550173|12147059|FG000|NOT COMPLETED|Overall Study||72
10972886|NCT00550173|12147060|FG001|NOT COMPLETED|Overall Study||63
10972887|NCT00550173|12147061|FG002|NOT COMPLETED|Overall Study||73
10972888|NCT00550238|12147070|FG000|STARTED|Overall Study||459
10972889|NCT00550238|12147070|FG000|COMPLETED|Overall Study||0
10972890|NCT00550238|12147070|FG000|NOT COMPLETED|Overall Study||459
10972891|NCT00550277|12147074|FG000|STARTED|Overall Study||20
10972892|NCT00550277|12147074|FG000|COMPLETED|Overall Study||11
10972893|NCT00550277|12147074|FG000|NOT COMPLETED|Overall Study||9
10972894|NCT00550290|12147080|FG000|STARTED|Overall Study||10
10972895|NCT00550290|12147081|FG001|STARTED|Overall Study||8
10972896|NCT00550290|12147080|FG000|COMPLETED|Overall Study||10
10972897|NCT00550290|12147081|FG001|COMPLETED|Overall Study||8
10972898|NCT00550290|12147080|FG000|NOT COMPLETED|Overall Study||0
10972899|NCT00550290|12147081|FG001|NOT COMPLETED|Overall Study||0
10972900|NCT00550368|12147089|FG000|STARTED|Overall Study||26
10972901|NCT00550368|12147090|FG001|STARTED|Overall Study||19
10972902|NCT00550368|12147089|FG000|COMPLETED|Overall Study||26
10972903|NCT00550368|12147090|FG001|COMPLETED|Overall Study||19
10972904|NCT00550368|12147089|FG000|NOT COMPLETED|Overall Study||0
10972905|NCT00550368|12147090|FG001|NOT COMPLETED|Overall Study||0
10972906|NCT00550394|12147098|FG000|STARTED|Overall Study||21
10972907|NCT00550394|12147099|FG001|STARTED|Overall Study||18
10972908|NCT00550394|12147098|FG000|COMPLETED|Overall Study||9
10972909|NCT00550394|12147099|FG001|COMPLETED|Overall Study||5
10972910|NCT00550394|12147098|FG000|NOT COMPLETED|Overall Study||12
10972911|NCT00550394|12147099|FG001|NOT COMPLETED|Overall Study||13
10972912|NCT00550407|12147109|FG000|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
10972913|NCT00550407|12147110|FG001|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
10972914|NCT00550407|12147111|FG002|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
10972915|NCT00550407|12147109|FG000|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
10972916|NCT00550407|12147110|FG001|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
10972917|NCT00550407|12147111|FG002|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
10972918|NCT00550407|12147109|FG000|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
10972919|NCT00550407|12147110|FG001|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
10972920|NCT00550407|12147111|FG002|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
10972921|NCT00550407|12147109|FG000|STARTED|26-Week Randomized Phase||0
10972922|NCT00550407|12147110|FG001|STARTED|26-Week Randomized Phase||58
10972923|NCT00550407|12147111|FG002|STARTED|26-Week Randomized Phase||45
10972924|NCT00550407|12147109|FG000|COMPLETED|26-Week Randomized Phase||0
10972925|NCT00550407|12147110|FG001|COMPLETED|26-Week Randomized Phase||15
10972926|NCT00550407|12147111|FG002|COMPLETED|26-Week Randomized Phase||21
10972927|NCT00550407|12147109|FG000|NOT COMPLETED|26-Week Randomized Phase||0
10972928|NCT00550407|12147110|FG001|NOT COMPLETED|26-Week Randomized Phase||43
10972929|NCT00550407|12147111|FG002|NOT COMPLETED|26-Week Randomized Phase||24
10972930|NCT00550420|12147119|FG000|STARTED|Overall Study||331
10972931|NCT00550420|12147119|FG000|COMPLETED|Overall Study||26
10972932|NCT00550420|12147119|FG000|NOT COMPLETED|Overall Study||305
10972933|NCT00550446|12147132|FG000|STARTED|Up To Week 12||54
10972934|NCT00550446|12147133|FG001|STARTED|Up To Week 12||52
10972935|NCT00550446|12147134|FG002|STARTED|Up To Week 12||50
10972936|NCT00550446|12147135|FG003|STARTED|Up To Week 12||61
10972937|NCT00550446|12147136|FG004|STARTED|Up To Week 12||57
10972938|NCT00550446|12147137|FG005|STARTED|Up To Week 12||53
10972939|NCT00550446|12147138|FG006|STARTED|Up To Week 12||59
10972940|NCT00550446|12147139|FG007|STARTED|Up To Week 12||0
10972941|NCT00550446|12147140|FG008|STARTED|Up To Week 12||0
10972942|NCT00550446|12147141|FG009|STARTED|Up To Week 12||0
10972943|NCT00550446|12147142|FG010|STARTED|Up To Week 12||0
10972944|NCT00550446|12147132|FG000|Treated|Up To Week 12||54
10972945|NCT00550446|12147133|FG001|Treated|Up To Week 12||51
10972946|NCT00550446|12147134|FG002|Treated|Up To Week 12||49
10972947|NCT00550446|12147135|FG003|Treated|Up To Week 12||61
10972948|NCT00550446|12147136|FG004|Treated|Up To Week 12||57
10972949|NCT00550446|12147137|FG005|Treated|Up To Week 12||53
10972950|NCT00550446|12147138|FG006|Treated|Up To Week 12||59
10972951|NCT00550446|12147139|FG007|Treated|Up To Week 12||0
10972952|NCT00550446|12147140|FG008|Treated|Up To Week 12||0
10972953|NCT00550446|12147141|FG009|Treated|Up To Week 12||0
10972954|NCT00550446|12147142|FG010|Treated|Up To Week 12||0
10972955|NCT00550446|12147132|FG000|COMPLETED|Up To Week 12||44
10972956|NCT00550446|12147133|FG001|COMPLETED|Up To Week 12||47
10972957|NCT00550446|12147134|FG002|COMPLETED|Up To Week 12||46
10972958|NCT00550446|12147135|FG003|COMPLETED|Up To Week 12||58
10972959|NCT00550446|12147136|FG004|COMPLETED|Up To Week 12||54
10972960|NCT00550446|12147137|FG005|COMPLETED|Up To Week 12||45
10972961|NCT00550446|12147138|FG006|COMPLETED|Up To Week 12||46
10972962|NCT00550446|12147139|FG007|COMPLETED|Up To Week 12||0
10972963|NCT00550446|12147140|FG008|COMPLETED|Up To Week 12||0
10972964|NCT00550446|12147141|FG009|COMPLETED|Up To Week 12||0
10972965|NCT00550446|12147142|FG010|COMPLETED|Up To Week 12||0
10972966|NCT00550446|12147132|FG000|NOT COMPLETED|Up To Week 12||10
10972967|NCT00550446|12147133|FG001|NOT COMPLETED|Up To Week 12||5
10972968|NCT00550446|12147134|FG002|NOT COMPLETED|Up To Week 12||4
10972969|NCT00550446|12147135|FG003|NOT COMPLETED|Up To Week 12||3
10972970|NCT00550446|12147136|FG004|NOT COMPLETED|Up To Week 12||3
10972971|NCT00550446|12147137|FG005|NOT COMPLETED|Up To Week 12||8
10972972|NCT00550446|12147138|FG006|NOT COMPLETED|Up To Week 12||13
10972973|NCT00550446|12147139|FG007|NOT COMPLETED|Up To Week 12||0
10972974|NCT00550446|12147140|FG008|NOT COMPLETED|Up To Week 12||0
10972975|NCT00550446|12147141|FG009|NOT COMPLETED|Up To Week 12||0
10972976|NCT00550446|12147142|FG010|NOT COMPLETED|Up To Week 12||0
10972977|NCT00550446|12147132|FG000|STARTED|Post Week 12||27
10972978|NCT00550446|12147133|FG001|STARTED|Post Week 12||30
10972979|NCT00550446|12147134|FG002|STARTED|Post Week 12||46
10972980|NCT00550446|12147135|FG003|STARTED|Post Week 12||58
10972981|NCT00550446|12147136|FG004|STARTED|Post Week 12||54
10972982|NCT00550446|12147137|FG005|STARTED|Post Week 12||1
10972983|NCT00550446|12147138|FG006|STARTED|Post Week 12||21
10972984|NCT00550446|12147139|FG007|STARTED|Post Week 12||17
10972985|NCT00550446|12147140|FG008|STARTED|Post Week 12||17
10972986|NCT00550446|12147141|FG009|STARTED|Post Week 12||44
10972987|NCT00550446|12147142|FG010|STARTED|Post Week 12||25
10972988|NCT00550446|12147132|FG000|COMPLETED|Post Week 12||24
10972989|NCT00550446|12147133|FG001|COMPLETED|Post Week 12||28
10972990|NCT00550446|12147134|FG002|COMPLETED|Post Week 12||43
10972991|NCT00550446|12147135|FG003|COMPLETED|Post Week 12||55
10972992|NCT00550446|12147136|FG004|COMPLETED|Post Week 12||52
10972993|NCT00550446|12147137|FG005|COMPLETED|Post Week 12||0
10972994|NCT00550446|12147138|FG006|COMPLETED|Post Week 12||19
10972995|NCT00550446|12147139|FG007|COMPLETED|Post Week 12||16
10972996|NCT00550446|12147140|FG008|COMPLETED|Post Week 12||15
10972997|NCT00550446|12147141|FG009|COMPLETED|Post Week 12||37
10972998|NCT00550446|12147142|FG010|COMPLETED|Post Week 12||24
10972999|NCT00550446|12147132|FG000|NOT COMPLETED|Post Week 12||3
10973000|NCT00550446|12147133|FG001|NOT COMPLETED|Post Week 12||2
10973001|NCT00550446|12147134|FG002|NOT COMPLETED|Post Week 12||3
10973002|NCT00550446|12147135|FG003|NOT COMPLETED|Post Week 12||3
10973003|NCT00550446|12147136|FG004|NOT COMPLETED|Post Week 12||2
10973004|NCT00550446|12147137|FG005|NOT COMPLETED|Post Week 12||1
10973005|NCT00550446|12147138|FG006|NOT COMPLETED|Post Week 12||2
10973006|NCT00550446|12147139|FG007|NOT COMPLETED|Post Week 12||1
10973007|NCT00550446|12147140|FG008|NOT COMPLETED|Post Week 12||2
10973008|NCT00550446|12147141|FG009|NOT COMPLETED|Post Week 12||7
10973009|NCT00550446|12147142|FG010|NOT COMPLETED|Post Week 12||1
10973010|NCT00550459|12147182|FG000|STARTED|Overall Study||28
10973011|NCT00550459|12147183|FG001|STARTED|Overall Study||29
10973012|NCT00550459|12147182|FG000|COMPLETED|Overall Study||27
10973013|NCT00550459|12147183|FG001|COMPLETED|Overall Study||26
10973014|NCT00550459|12147182|FG000|NOT COMPLETED|Overall Study||1
10973015|NCT00550459|12147183|FG001|NOT COMPLETED|Overall Study||3
10973016|NCT00550537|12147189|FG000|STARTED|Overall Study||116
10973017|NCT00550537|12147189|FG000|COMPLETED|Overall Study||12
10973018|NCT00550537|12147189|FG000|NOT COMPLETED|Overall Study||104
10973019|NCT00550550|12147200|FG000|STARTED|Overall Study||176
10973020|NCT00550550|12147201|FG001|STARTED|Overall Study||169
10973021|NCT00550550|12147200|FG000|Number Treated|Overall Study||175
10973022|NCT00550550|12147201|FG001|Number Treated|Overall Study||169
10973023|NCT00550550|12147200|FG000|COMPLETED|Overall Study||142
10973024|NCT00550550|12147201|FG001|COMPLETED|Overall Study||140
10973025|NCT00550550|12147200|FG000|NOT COMPLETED|Overall Study||34
10973026|NCT00550550|12147201|FG001|NOT COMPLETED|Overall Study||29
10973027|NCT00550589|12147207|FG000|STARTED|Overall Study||33
10973028|NCT00550589|12147207|FG000|COMPLETED|Overall Study||33
10973029|NCT00550589|12147207|FG000|NOT COMPLETED|Overall Study||0
10973030|NCT00550615|12147215|FG000|STARTED|Overall Study||3
10973031|NCT00550615|12147216|FG001|STARTED|Overall Study||3
10973032|NCT00550615|12147217|FG002|STARTED|Overall Study||10
10973033|NCT00550615|12147218|FG003|STARTED|Overall Study||22
10973034|NCT00550615|12147215|FG000|COMPLETED|Overall Study||3
10973035|NCT00550615|12147216|FG001|COMPLETED|Overall Study||3
10973036|NCT00550615|12147217|FG002|COMPLETED|Overall Study||6
10973037|NCT00550615|12147218|FG003|COMPLETED|Overall Study||12
10973038|NCT00550615|12147215|FG000|NOT COMPLETED|Overall Study||0
10973039|NCT00550615|12147216|FG001|NOT COMPLETED|Overall Study||0
10973040|NCT00550615|12147217|FG002|NOT COMPLETED|Overall Study||4
10973041|NCT00550615|12147218|FG003|NOT COMPLETED|Overall Study||10
10973042|NCT00550654|12147224|FG000|STARTED|Overall Study||1
10973043|NCT00550654|12147224|FG000|COMPLETED|Overall Study||1
10973044|NCT00550654|12147224|FG000|NOT COMPLETED|Overall Study||0
10973045|NCT00550680|12147228|FG000|STARTED|Overall Study||208
10973046|NCT00550680|12147228|FG000|COMPLETED|Overall Study||152
10973047|NCT00550680|12147228|FG000|NOT COMPLETED|Overall Study||56
10973048|NCT00550732|12147232|FG000|STARTED|Overall Study||40
10973049|NCT00550732|12147232|FG000|COMPLETED|Overall Study||29
10973050|NCT00550732|12147232|FG000|NOT COMPLETED|Overall Study||11
10973051|NCT00550745|12147239|FG000|STARTED|Overall Study||6000
10973052|NCT00550745|12147240|FG001|STARTED|Overall Study||5999
10973053|NCT00550745|12147239|FG000|COMPLETED|Overall Study||5913
10973054|NCT00550745|12147240|FG001|COMPLETED|Overall Study||5939
10973055|NCT00550745|12147239|FG000|NOT COMPLETED|Overall Study||87
10973056|NCT00550745|12147240|FG001|NOT COMPLETED|Overall Study||60
10973057|NCT00550771|12147248|FG000|STARTED|Overall Study||121
10973058|NCT00550771|12147249|FG001|STARTED|Overall Study||60
10973059|NCT00550771|12147248|FG000|COMPLETED|Overall Study||104
10973060|NCT00550771|12147249|FG001|COMPLETED|Overall Study||50
10973061|NCT00550771|12147248|FG000|NOT COMPLETED|Overall Study||17
10973062|NCT00550771|12147249|FG001|NOT COMPLETED|Overall Study||10
10973063|NCT00550836|12147257|FG000|STARTED|Overall Study||49
10973064|NCT00550836|12147258|FG001|STARTED|Overall Study||55
10973065|NCT00550836|12147257|FG000|COMPLETED|Overall Study||46
10973066|NCT00550836|12147258|FG001|COMPLETED|Overall Study||46
10973067|NCT00550836|12147257|FG000|NOT COMPLETED|Overall Study||3
10973068|NCT00550836|12147258|FG001|NOT COMPLETED|Overall Study||9
10973069|NCT00550862|12147268|FG000|STARTED|Overall Study||38
10973070|NCT00550862|12147269|FG001|STARTED|Overall Study||48
10973071|NCT00550862|12147270|FG002|STARTED|Overall Study||41
10973072|NCT00550862|12147271|FG003|STARTED|Overall Study||38
10973073|NCT00550862|12147268|FG000|COMPLETED|Overall Study||32
10973074|NCT00550862|12147269|FG001|COMPLETED|Overall Study||42
10973075|NCT00550862|12147270|FG002|COMPLETED|Overall Study||25
10973076|NCT00550862|12147271|FG003|COMPLETED|Overall Study||37
10973077|NCT00550862|12147268|FG000|NOT COMPLETED|Overall Study||6
10973078|NCT00550862|12147269|FG001|NOT COMPLETED|Overall Study||6
10973079|NCT00550862|12147270|FG002|NOT COMPLETED|Overall Study||16
10973080|NCT00550862|12147271|FG003|NOT COMPLETED|Overall Study||1
10973081|NCT00550953|12147283|FG000|STARTED|Overall Study||156
10973082|NCT00550953|12147284|FG001|STARTED|Overall Study||158
10973083|NCT00550953|12147283|FG000|COMPLETED|Overall Study||150
10973084|NCT00550953|12147284|FG001|COMPLETED|Overall Study||152
10973085|NCT00550953|12147283|FG000|NOT COMPLETED|Overall Study||6
10973086|NCT00550953|12147284|FG001|NOT COMPLETED|Overall Study||6
10973087|NCT00551031|12147295|FG000|STARTED|Overall Study||637
10973088|NCT00551031|12147296|FG001|STARTED|Overall Study||636
10973089|NCT00551031|12147297|FG002|STARTED|Overall Study||319
10973090|NCT00551031|12147298|FG003|STARTED|Overall Study||320
10973091|NCT00551031|12147299|FG004|STARTED|Overall Study||186
10973092|NCT00551031|12147295|FG000|COMPLETED|Overall Study||635
10973093|NCT00551031|12147296|FG001|COMPLETED|Overall Study||625
10973094|NCT00551031|12147297|FG002|COMPLETED|Overall Study||317
10973095|NCT00551031|12147298|FG003|COMPLETED|Overall Study||317
10973096|NCT00551031|12147299|FG004|COMPLETED|Overall Study||185
10973097|NCT00551031|12147295|FG000|NOT COMPLETED|Overall Study||2
10973098|NCT00551031|12147296|FG001|NOT COMPLETED|Overall Study||11
10973099|NCT00551031|12147297|FG002|NOT COMPLETED|Overall Study||2
10973100|NCT00551031|12147298|FG003|NOT COMPLETED|Overall Study||3
10973101|NCT00551031|12147299|FG004|NOT COMPLETED|Overall Study||1
10973102|NCT00551070|12147311|FG000|STARTED|Overall Study||52
10973103|NCT00551070|12147311|FG000|COMPLETED|Overall Study||52
10973104|NCT00551070|12147311|FG000|NOT COMPLETED|Overall Study||0
10973105|NCT00551135|12147319|FG000|STARTED|Overall Study||108
10973106|NCT00551135|12147320|FG001|STARTED|Overall Study||106
10973107|NCT00551135|12147321|FG002|STARTED|Overall Study||103
10973108|NCT00551135|12147322|FG003|STARTED|Overall Study||108
10973109|NCT00551135|12147319|FG000|COMPLETED|Overall Study||103
10973110|NCT00551135|12147320|FG001|COMPLETED|Overall Study||104
10973111|NCT00551135|12147321|FG002|COMPLETED|Overall Study||98
10973112|NCT00551135|12147322|FG003|COMPLETED|Overall Study||103
10973113|NCT00551135|12147319|FG000|NOT COMPLETED|Overall Study||5
10973114|NCT00551135|12147320|FG001|NOT COMPLETED|Overall Study||2
10973115|NCT00551135|12147321|FG002|NOT COMPLETED|Overall Study||5
10973116|NCT00551135|12147322|FG003|NOT COMPLETED|Overall Study||5
10973117|NCT00551161|12147332|FG000|STARTED|Overall Study||12
10973118|NCT00551161|12147332|FG000|COMPLETED|Overall Study||11
10973119|NCT00551161|12147332|FG000|NOT COMPLETED|Overall Study||1
10973120|NCT00551174|12147338|FG000|STARTED|Overall Study||381
10973121|NCT00551174|12147339|FG001|STARTED|Overall Study||400
10973122|NCT00551174|12147338|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
10973123|NCT00551174|12147339|FG001|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
10973124|NCT00551174|12147338|FG000|NOT COMPLETED|Overall Study||19
10973125|NCT00551174|12147339|FG001|NOT COMPLETED|Overall Study||6
10973126|NCT00551200|12147345|FG000|STARTED|Overall Study||14
10973127|NCT00551200|12147345|FG000|COMPLETED|Overall Study||10
10973128|NCT00551200|12147345|FG000|NOT COMPLETED|Overall Study||4
10973129|NCT00551213|12147357|FG000|STARTED|Overall Study||50
10973130|NCT00551213|12147358|FG001|STARTED|Overall Study||17
10973131|NCT00551213|12147357|FG000|Treated|Overall Study||49
10973132|NCT00551213|12147358|FG001|Treated|Overall Study||15
10973133|NCT00551213|12147357|FG000|COMPLETED|Overall Study||0
10973134|NCT00551213|12147358|FG001|COMPLETED|Overall Study||0
10973135|NCT00551213|12147357|FG000|NOT COMPLETED|Overall Study||50
10973136|NCT00551213|12147358|FG001|NOT COMPLETED|Overall Study||17
10973137|NCT00551291|12147364|FG000|STARTED|Overall Study||10
10973138|NCT00551291|12147364|FG000|COMPLETED|Overall Study||9
10973139|NCT00551291|12147364|FG000|NOT COMPLETED|Overall Study||1
10973140|NCT00551369|12147368|FG000|STARTED|Overall Study||33
10973141|NCT00551369|12147368|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
10973142|NCT00551369|12147368|FG000|NOT COMPLETED|Overall Study||7
10973143|NCT00551421|12147372|FG000|STARTED|Original Protocol, Dose Level 1||3
10973144|NCT00551421|12147372|FG000|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
10973145|NCT00551421|12147372|FG000|NOT COMPLETED|Original Protocol, Dose Level 1||0
10973146|NCT00551421|12147372|FG000|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
10973147|NCT00551421|12147372|FG000|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
10973148|NCT00551421|12147372|FG000|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
10973149|NCT00551460|12147377|FG000|STARTED|Overall Study||78
10973150|NCT00551460|12147377|FG000|COMPLETED|Overall Study||60
10973151|NCT00551460|12147377|FG000|NOT COMPLETED|Overall Study||18
10973152|NCT00551525|12147381|FG000|STARTED|Overall Study||67
10973153|NCT00551525|12147381|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
10973154|NCT00551525|12147381|FG000|NOT COMPLETED|Overall Study||5
10973155|NCT00551642|12147387|FG000|STARTED|Treatment Period||399
10973156|NCT00551642|12147388|FG001|STARTED|Treatment Period||401
10973157|NCT00551642|12147387|FG000|Safety Population|Treatment Period||395
10973158|NCT00551642|12147388|FG001|Safety Population|Treatment Period||397
10973159|NCT00551642|12147387|FG000|COMPLETED|Treatment Period||338
10973160|NCT00551642|12147388|FG001|COMPLETED|Treatment Period||338
10973161|NCT00551642|12147387|FG000|NOT COMPLETED|Treatment Period||61
10973162|NCT00551642|12147388|FG001|NOT COMPLETED|Treatment Period||63
10973163|NCT00551642|12147387|FG000|STARTED|7-Year Follow-up||152
10973164|NCT00551642|12147388|FG001|STARTED|7-Year Follow-up||153
10973165|NCT00551642|12147387|FG000|COMPLETED|7-Year Follow-up||152
10973166|NCT00551642|12147388|FG001|COMPLETED|7-Year Follow-up||153
10973167|NCT00551642|12147387|FG000|NOT COMPLETED|7-Year Follow-up||0
10973168|NCT00551642|12147388|FG001|NOT COMPLETED|7-Year Follow-up||0
10973169|NCT00551707|12147399|FG000|STARTED|Overall Study||4
10973170|NCT00551707|12147400|FG001|STARTED|Overall Study||22
10973171|NCT00551707|12147401|FG002|STARTED|Overall Study||13
10973172|NCT00551707|12147402|FG003|STARTED|Overall Study||8
10973173|NCT00551707|12147403|FG004|STARTED|Overall Study||4
10973174|NCT00551707|12147399|FG000|COMPLETED|Overall Study||4
10973175|NCT00551707|12147400|FG001|COMPLETED|Overall Study||16
10973176|NCT00551707|12147401|FG002|COMPLETED|Overall Study||10
10973177|NCT00551707|12147402|FG003|COMPLETED|Overall Study||4
10973178|NCT00551707|12147403|FG004|COMPLETED|Overall Study||3
10973179|NCT00551707|12147399|FG000|NOT COMPLETED|Overall Study||0
10973180|NCT00551707|12147400|FG001|NOT COMPLETED|Overall Study||6
10973181|NCT00551707|12147401|FG002|NOT COMPLETED|Overall Study||3
10973182|NCT00551707|12147402|FG003|NOT COMPLETED|Overall Study||4
10973183|NCT00551707|12147403|FG004|NOT COMPLETED|Overall Study||1
10973184|NCT00551746|12147419|FG000|STARTED|Overall Study||36
10973185|NCT00551746|12147420|FG001|STARTED|Overall Study||34
10973186|NCT00551746|12147419|FG000|COMPLETED|Overall Study||25
10973187|NCT00551746|12147420|FG001|COMPLETED|Overall Study||26
10973188|NCT00551746|12147419|FG000|NOT COMPLETED|Overall Study||11
10973189|NCT00551746|12147420|FG001|NOT COMPLETED|Overall Study||8
10973190|NCT00551759|12147426|FG000|STARTED|Overall Study||22
10973191|NCT00551759|12147426|FG000|Eligible and Began Treatment|Overall Study||21
10973192|NCT00551759|12147426|FG000|Underwent Surgery|Overall Study||17
10973193|NCT00551759|12147426|FG000|Received Adjuvant Therapy|Overall Study||12
10973194|NCT00551759|12147426|FG000|COMPLETED|Overall Study||9
10973195|NCT00551759|12147426|FG000|NOT COMPLETED|Overall Study||13
10973196|NCT00552058|12147432|FG000|STARTED|Overall Study||223
10973197|NCT00552058|12147433|FG001|STARTED|Overall Study||216
10973198|NCT00552058|12147432|FG000|COMPLETED|Overall Study||207
10973199|NCT00552058|12147433|FG001|COMPLETED|Overall Study||192
10973200|NCT00552058|12147432|FG000|NOT COMPLETED|Overall Study||16
10973201|NCT00552058|12147433|FG001|NOT COMPLETED|Overall Study||24
10973202|NCT00552071|12147441|FG000|STARTED|Overall Study||10
10973203|NCT00552071|12147442|FG001|STARTED|Overall Study||11
10973204|NCT00552071|12147441|FG000|COMPLETED|Overall Study||6
10973205|NCT00552071|12147442|FG001|COMPLETED|Overall Study||9
10973206|NCT00552071|12147441|FG000|NOT COMPLETED|Overall Study||4
10973207|NCT00552071|12147442|FG001|NOT COMPLETED|Overall Study||2
10973208|NCT00552084|12147452|FG000|STARTED|Overall Study||126
10973209|NCT00552084|12147453|FG001|STARTED|Overall Study||64
10973210|NCT00552084|12147452|FG000|COMPLETED|Overall Study||118
10973211|NCT00552084|12147453|FG001|COMPLETED|Overall Study||55
10973212|NCT00552084|12147452|FG000|NOT COMPLETED|Overall Study||8
10973213|NCT00552084|12147453|FG001|NOT COMPLETED|Overall Study||9
10973214|NCT00552110|12147464|FG000|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
10973215|NCT00552110|12147465|FG001|STARTED|Overall Study||139
10973216|NCT00552110|12147466|FG002|STARTED|Overall Study||139
10973217|NCT00552110|12147467|FG003|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
10973218|NCT00552110|12147468|FG004|STARTED|Overall Study||142
10973219|NCT00552110|12147464|FG000|COMPLETED|Overall Study||142
10973220|NCT00552110|12147465|FG001|COMPLETED|Overall Study||134
10973221|NCT00552110|12147466|FG002|COMPLETED|Overall Study||137
10973222|NCT00552110|12147467|FG003|COMPLETED|Overall Study||133
10973223|NCT00552110|12147468|FG004|COMPLETED|Overall Study||133
10973224|NCT00552110|12147464|FG000|NOT COMPLETED|Overall Study||4
10973225|NCT00552110|12147465|FG001|NOT COMPLETED|Overall Study||5
10973226|NCT00552110|12147466|FG002|NOT COMPLETED|Overall Study||2
10973227|NCT00552110|12147467|FG003|NOT COMPLETED|Overall Study||8
10973228|NCT00552110|12147468|FG004|NOT COMPLETED|Overall Study||9
10973229|NCT00552175|12147483|FG000|STARTED|Overall Study||167
10973230|NCT00552175|12147484|FG001|STARTED|Overall Study||86
10973231|NCT00552175|12147485|FG002|STARTED|Overall Study||86
10973232|NCT00552175|12147483|FG000|Full Analysis Set Population|Overall Study||167
10973233|NCT00552175|12147484|FG001|Full Analysis Set Population|Overall Study||85
10973234|NCT00552175|12147485|FG002|Full Analysis Set Population|Overall Study||86
10973235|NCT00552175|12147483|FG000|COMPLETED|Overall Study||150
10973236|NCT00552175|12147484|FG001|COMPLETED|Overall Study||73
10973237|NCT00552175|12147485|FG002|COMPLETED|Overall Study||72
10973238|NCT00552175|12147483|FG000|NOT COMPLETED|Overall Study||17
10973239|NCT00552175|12147484|FG001|NOT COMPLETED|Overall Study||13
10973240|NCT00552175|12147485|FG002|NOT COMPLETED|Overall Study||14
10973241|NCT00552188|12147496|FG000|STARTED|Overall Study||26
10973242|NCT00552188|12147497|FG001|STARTED|Overall Study||26
10973243|NCT00552188|12147496|FG000|COMPLETED|Overall Study||24
10973244|NCT00552188|12147497|FG001|COMPLETED|Overall Study||21
10973245|NCT00552188|12147496|FG000|NOT COMPLETED|Overall Study||2
10973246|NCT00552188|12147497|FG001|NOT COMPLETED|Overall Study||5
10973247|NCT00552240|12147505|FG000|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
10973248|NCT00552240|12147506|FG001|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
10973249|NCT00552240|12147505|FG000|COMPLETED|Overall Study||51
10973250|NCT00552240|12147506|FG001|COMPLETED|Overall Study||59
10973251|NCT00552240|12147505|FG000|NOT COMPLETED|Overall Study||24
10973252|NCT00552240|12147506|FG001|NOT COMPLETED|Overall Study||18
10973253|NCT00552279|12147514|FG000|STARTED|Overall Study||403
10973254|NCT00552279|12147515|FG001|STARTED|Overall Study||401
10973255|NCT00552279|12147514|FG000|COMPLETED|Overall Study||389
10973256|NCT00552279|12147515|FG001|COMPLETED|Overall Study||398
10973257|NCT00552279|12147514|FG000|NOT COMPLETED|Overall Study||14
10973258|NCT00552279|12147515|FG001|NOT COMPLETED|Overall Study||3
10973259|NCT00552305|12147521|FG000|STARTED|Overall Study||370
10973260|NCT00552305|12147521|FG000|COMPLETED|Overall Study||120
10973261|NCT00552305|12147521|FG000|NOT COMPLETED|Overall Study||250
10973262|NCT00552344|12147525|FG000|STARTED|Overall Study||402
10973263|NCT00552344|12147525|FG000|COMPLETED|Overall Study||87
10973264|NCT00552344|12147525|FG000|NOT COMPLETED|Overall Study||315
10973265|NCT00552396|12147537|FG000|STARTED|Overall Study||4
10973266|NCT00552396|12147538|FG001|STARTED|Overall Study||3
10973267|NCT00552396|12147539|FG002|STARTED|Overall Study||3
10973268|NCT00552396|12147540|FG003|STARTED|Overall Study||6
10973269|NCT00552396|12147541|FG004|STARTED|Overall Study||3
10973270|NCT00552396|12147542|FG005|STARTED|Overall Study||3
10973271|NCT00552396|12147543|FG006|STARTED|Overall Study||10
10973272|NCT00552396|12147537|FG000|COMPLETED|Overall Study||1
10973273|NCT00552396|12147538|FG001|COMPLETED|Overall Study||0
10973274|NCT00552396|12147539|FG002|COMPLETED|Overall Study||0
10973275|NCT00552396|12147540|FG003|COMPLETED|Overall Study||0
10973276|NCT00552396|12147541|FG004|COMPLETED|Overall Study||0
10973277|NCT00552396|12147542|FG005|COMPLETED|Overall Study||0
10973278|NCT00552396|12147543|FG006|COMPLETED|Overall Study||1
10973279|NCT00552396|12147537|FG000|NOT COMPLETED|Overall Study||3
10973280|NCT00552396|12147538|FG001|NOT COMPLETED|Overall Study||3
10973281|NCT00552396|12147539|FG002|NOT COMPLETED|Overall Study||3
10973282|NCT00552396|12147540|FG003|NOT COMPLETED|Overall Study||6
10973283|NCT00552396|12147541|FG004|NOT COMPLETED|Overall Study||3
10973284|NCT00552396|12147542|FG005|NOT COMPLETED|Overall Study||3
10973285|NCT00552396|12147543|FG006|NOT COMPLETED|Overall Study||9
10973286|NCT00552409|12147579|FG000|STARTED|Overall Study||11
10973287|NCT00552409|12147580|FG001|STARTED|Overall Study||11
10973288|NCT00552409|12147579|FG000|COMPLETED|Overall Study||10
10973289|NCT00552409|12147580|FG001|COMPLETED|Overall Study||9
10973290|NCT00552409|12147579|FG000|NOT COMPLETED|Overall Study||1
10973291|NCT00552409|12147580|FG001|NOT COMPLETED|Overall Study||2
10973292|NCT00552422|12147586|FG000|STARTED|Overall Study||6
10973293|NCT00552422|12147586|FG000|COMPLETED|Overall Study||6
10973294|NCT00552422|12147586|FG000|NOT COMPLETED|Overall Study||0
10973295|NCT00552448|12147592|FG000|STARTED|Overall Study||20
10973296|NCT00552448|12147593|FG001|STARTED|Overall Study||16
10973297|NCT00552448|12147592|FG000|COMPLETED|Overall Study||19
10973298|NCT00552448|12147593|FG001|COMPLETED|Overall Study||16
10973299|NCT00552448|12147592|FG000|NOT COMPLETED|Overall Study||1
10973300|NCT00552448|12147593|FG001|NOT COMPLETED|Overall Study||0
10973301|NCT00552578|12147601|FG000|STARTED|Overall Study||6
10973302|NCT00552578|12147602|FG001|STARTED|Overall Study||6
10973303|NCT00552578|12147601|FG000|COMPLETED|Overall Study||5
10973304|NCT00552578|12147602|FG001|COMPLETED|Overall Study||5
10973305|NCT00552578|12147601|FG000|NOT COMPLETED|Overall Study||1
10973306|NCT00552578|12147602|FG001|NOT COMPLETED|Overall Study||1
10973307|NCT00552617|12147618|FG000|STARTED|Overall Study||10
10973308|NCT00552617|12147619|FG001|STARTED|Overall Study||10
10973309|NCT00552617|12147620|FG002|STARTED|Overall Study||10
10973310|NCT00552617|12147621|FG003|STARTED|Overall Study||10
10973311|NCT00552617|12147622|FG004|STARTED|Overall Study||10
10973312|NCT00552617|12147623|FG005|STARTED|Overall Study||10
10973313|NCT00552617|12147624|FG006|STARTED|Overall Study||10
10973314|NCT00552617|12147625|FG007|STARTED|Overall Study||10
10973315|NCT00552617|12147626|FG008|STARTED|Overall Study||10
10973316|NCT00552617|12147627|FG009|STARTED|Overall Study||10
10973317|NCT00552617|12147618|FG000|Treated|Overall Study||10
10973318|NCT00552617|12147619|FG001|Treated|Overall Study||10
10973319|NCT00552617|12147620|FG002|Treated|Overall Study||9
10973320|NCT00552617|12147621|FG003|Treated|Overall Study||10
10973321|NCT00552617|12147622|FG004|Treated|Overall Study||10
10973322|NCT00552617|12147623|FG005|Treated|Overall Study||10
10973323|NCT00552617|12147624|FG006|Treated|Overall Study||10
10973324|NCT00552617|12147625|FG007|Treated|Overall Study||10
10973325|NCT00552617|12147626|FG008|Treated|Overall Study||10
10973326|NCT00552617|12147627|FG009|Treated|Overall Study||9
10973327|NCT00552617|12147618|FG000|COMPLETED|Overall Study||10
10973328|NCT00552617|12147619|FG001|COMPLETED|Overall Study||10
10973329|NCT00552617|12147620|FG002|COMPLETED|Overall Study||9
10973330|NCT00552617|12147621|FG003|COMPLETED|Overall Study||9
10973331|NCT00552617|12147622|FG004|COMPLETED|Overall Study||10
10973332|NCT00552617|12147623|FG005|COMPLETED|Overall Study||8
10973333|NCT00552617|12147624|FG006|COMPLETED|Overall Study||10
10973334|NCT00552617|12147625|FG007|COMPLETED|Overall Study||10
10973335|NCT00552617|12147626|FG008|COMPLETED|Overall Study||8
10973336|NCT00552617|12147627|FG009|COMPLETED|Overall Study||9
10973337|NCT00552617|12147618|FG000|NOT COMPLETED|Overall Study||0
10973338|NCT00552617|12147619|FG001|NOT COMPLETED|Overall Study||0
10973339|NCT00552617|12147620|FG002|NOT COMPLETED|Overall Study||1
10973340|NCT00552617|12147621|FG003|NOT COMPLETED|Overall Study||1
10973341|NCT00552617|12147622|FG004|NOT COMPLETED|Overall Study||0
10973342|NCT00552617|12147623|FG005|NOT COMPLETED|Overall Study||2
10973343|NCT00552617|12147624|FG006|NOT COMPLETED|Overall Study||0
10973344|NCT00552617|12147625|FG007|NOT COMPLETED|Overall Study||0
10973345|NCT00552617|12147626|FG008|NOT COMPLETED|Overall Study||2
10973346|NCT00552617|12147627|FG009|NOT COMPLETED|Overall Study||1
10973347|NCT00552669|12147651|FG000|STARTED|Overall Study|patients|100
10973348|NCT00552669|12147652|FG001|STARTED|Overall Study|patients|100
10973349|NCT00552669|12147651|FG000|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
10973350|NCT00552669|12147652|FG001|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
10973351|NCT00552669|12147651|FG000|NOT COMPLETED|Overall Study||3
10973352|NCT00552669|12147652|FG001|NOT COMPLETED|Overall Study||7
10973353|NCT00552695|12147660|FG000|STARTED|Overall Study|August 2007|22
10973354|NCT00552695|12147661|FG001|STARTED|Overall Study|August 2007|23
10973355|NCT00552695|12147660|FG000|COMPLETED|Overall Study|September 2007|22
10973356|NCT00552695|12147661|FG001|COMPLETED|Overall Study|September 2007|23
10973357|NCT00552695|12147660|FG000|NOT COMPLETED|Overall Study||0
10973358|NCT00552695|12147661|FG001|NOT COMPLETED|Overall Study||0
10973359|NCT00552760|12147669|FG000|STARTED|Overall Study||42
10973360|NCT00552760|12147670|FG001|STARTED|Overall Study||41
10973361|NCT00552760|12147669|FG000|COMPLETED|Overall Study||16
10973362|NCT00552760|12147670|FG001|COMPLETED|Overall Study||8
10973363|NCT00552760|12147669|FG000|NOT COMPLETED|Overall Study||26
10973364|NCT00552760|12147670|FG001|NOT COMPLETED|Overall Study||33
10973365|NCT00552786|12147678|FG000|STARTED|First Intervention||25
10973366|NCT00552786|12147679|FG001|STARTED|First Intervention||28
10973367|NCT00552786|12147678|FG000|Medication and Hearing Evaluation|First Intervention||25
10973368|NCT00552786|12147679|FG001|Medication and Hearing Evaluation|First Intervention||28
10973369|NCT00552786|12147678|FG000|COMPLETED|First Intervention||25
10973370|NCT00552786|12147679|FG001|COMPLETED|First Intervention||28
10973371|NCT00552786|12147678|FG000|NOT COMPLETED|First Intervention||0
10973372|NCT00552786|12147679|FG001|NOT COMPLETED|First Intervention||0
10973373|NCT00552786|12147678|FG000|STARTED|Washout Period of 2 Weeks||25
10973374|NCT00552786|12147679|FG001|STARTED|Washout Period of 2 Weeks||28
10973375|NCT00552786|12147678|FG000|COMPLETED|Washout Period of 2 Weeks||25
10973376|NCT00552786|12147679|FG001|COMPLETED|Washout Period of 2 Weeks||28
10973377|NCT00552786|12147678|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10973378|NCT00552786|12147679|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10973379|NCT00552786|12147678|FG000|STARTED|Second Intervention||25
10973380|NCT00552786|12147679|FG001|STARTED|Second Intervention||28
10973381|NCT00552786|12147678|FG000|COMPLETED|Second Intervention||25
10973382|NCT00552786|12147679|FG001|COMPLETED|Second Intervention||28
10973383|NCT00552786|12147678|FG000|NOT COMPLETED|Second Intervention||0
10973384|NCT00552786|12147679|FG001|NOT COMPLETED|Second Intervention||0
10973385|NCT00552812|12147685|FG000|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
10973386|NCT00552812|12147685|FG000|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
10973387|NCT00552812|12147685|FG000|NOT COMPLETED|Overall Study||20
10973388|NCT00552929|12147699|FG000|STARTED|Overall Study||9
10973389|NCT00552929|12147700|FG001|STARTED|Overall Study||10
10973390|NCT00552929|12147701|FG002|STARTED|Overall Study||10
10973391|NCT00552929|12147702|FG003|STARTED|Overall Study||11
10973392|NCT00552929|12147703|FG004|STARTED|Overall Study||10
10973393|NCT00552929|12147704|FG005|STARTED|Overall Study||10
10973394|NCT00552929|12147705|FG006|STARTED|Overall Study||10
10973395|NCT00552929|12147706|FG007|STARTED|Overall Study||11
10973396|NCT00552929|12147707|FG008|STARTED|Overall Study||10
10973397|NCT00552929|12147708|FG009|STARTED|Overall Study||11
10973398|NCT00552929|12147699|FG000|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9
10973399|NCT00552929|12147700|FG001|Participants as Treated|Overall Study||10
10973400|NCT00552929|12147701|FG002|Participants as Treated|Overall Study||10
10973401|NCT00552929|12147702|FG003|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11
10973402|NCT00552929|12147703|FG004|Participants as Treated|Overall Study||10
10973403|NCT00552929|12147704|FG005|Participants as Treated|Overall Study||9
10973404|NCT00552929|12147705|FG006|Participants as Treated|Overall Study||10
10973405|NCT00552929|12147706|FG007|Participants as Treated|Overall Study||11
10973406|NCT00552929|12147707|FG008|Participants as Treated|Overall Study||10
10973407|NCT00552929|12147708|FG009|Participants as Treated|Overall Study||11
10973408|NCT00552929|12147699|FG000|COMPLETED|Overall Study||9
10973409|NCT00552929|12147700|FG001|COMPLETED|Overall Study||10
10973410|NCT00552929|12147701|FG002|COMPLETED|Overall Study||10
10973411|NCT00552929|12147702|FG003|COMPLETED|Overall Study||11
10973412|NCT00552929|12147703|FG004|COMPLETED|Overall Study||10
10973413|NCT00552929|12147704|FG005|COMPLETED|Overall Study||9
10973414|NCT00552929|12147705|FG006|COMPLETED|Overall Study||10
10973415|NCT00552929|12147706|FG007|COMPLETED|Overall Study||11
10973416|NCT00552929|12147707|FG008|COMPLETED|Overall Study||9
10973417|NCT00552929|12147708|FG009|COMPLETED|Overall Study||11
10973418|NCT00552929|12147699|FG000|NOT COMPLETED|Overall Study||0
10973419|NCT00552929|12147700|FG001|NOT COMPLETED|Overall Study||0
10973420|NCT00552929|12147701|FG002|NOT COMPLETED|Overall Study||0
10973421|NCT00552929|12147702|FG003|NOT COMPLETED|Overall Study||0
10973422|NCT00552929|12147703|FG004|NOT COMPLETED|Overall Study||0
10973423|NCT00552929|12147704|FG005|NOT COMPLETED|Overall Study||1
10973424|NCT00552929|12147705|FG006|NOT COMPLETED|Overall Study||0
10973425|NCT00552929|12147706|FG007|NOT COMPLETED|Overall Study||0
10973426|NCT00552929|12147707|FG008|NOT COMPLETED|Overall Study||1
10973427|NCT00552929|12147708|FG009|NOT COMPLETED|Overall Study||0
10973428|NCT00553059|12147732|FG000|STARTED|Overall Study||31
10973429|NCT00553059|12147733|FG001|STARTED|Overall Study||31
10973430|NCT00553059|12147732|FG000|COMPLETED|Overall Study||30
10973431|NCT00553059|12147733|FG001|COMPLETED|Overall Study||29
10973432|NCT00553059|12147732|FG000|NOT COMPLETED|Overall Study||1
10973433|NCT00553059|12147733|FG001|NOT COMPLETED|Overall Study||2
10973434|NCT00553098|12147739|FG000|STARTED|Overall Study||29
10973435|NCT00553098|12147739|FG000|COMPLETED|Overall Study||28
10973436|NCT00553098|12147739|FG000|NOT COMPLETED|Overall Study||1
10973437|NCT00553150|12147749|FG000|STARTED|Overall Study||6
10973438|NCT00553150|12147750|FG001|STARTED|Overall Study||6
10973439|NCT00553150|12147751|FG002|STARTED|Overall Study||6
10973440|NCT00553150|12147752|FG003|STARTED|Overall Study||104
10973441|NCT00553150|12147749|FG000|COMPLETED|Overall Study||6
10973442|NCT00553150|12147750|FG001|COMPLETED|Overall Study||6
10973443|NCT00553150|12147751|FG002|COMPLETED|Overall Study||6
10973444|NCT00553150|12147752|FG003|COMPLETED|Overall Study||100
10973445|NCT00553150|12147749|FG000|NOT COMPLETED|Overall Study||0
10973446|NCT00553150|12147750|FG001|NOT COMPLETED|Overall Study||0
10973447|NCT00553150|12147751|FG002|NOT COMPLETED|Overall Study||0
10973448|NCT00553150|12147752|FG003|NOT COMPLETED|Overall Study||4
10973449|NCT00553163|12147762|FG000|STARTED|Overall Study||16
10973450|NCT00553163|12147763|FG001|STARTED|Overall Study||10
10973451|NCT00553163|12147762|FG000|COMPLETED|Overall Study||16
10973452|NCT00553163|12147763|FG001|COMPLETED|Overall Study||10
10973453|NCT00553163|12147762|FG000|NOT COMPLETED|Overall Study||0
10973454|NCT00553163|12147763|FG001|NOT COMPLETED|Overall Study||0
10973455|NCT00553202|12147774|FG000|STARTED|Overall Study||158
10973456|NCT00553202|12147774|FG000|COMPLETED|Overall Study||90
10973457|NCT00553202|12147774|FG000|NOT COMPLETED|Overall Study||68
10973458|NCT00553254|12147781|FG000|STARTED|Overall Study||6
10973459|NCT00553254|12147782|FG001|STARTED|Overall Study||6
10973460|NCT00553254|12147783|FG002|STARTED|Overall Study||43
10973461|NCT00553254|12147781|FG000|COMPLETED|Overall Study||0
10973462|NCT00553254|12147782|FG001|COMPLETED|Overall Study||0
10973463|NCT00553254|12147783|FG002|COMPLETED|Overall Study||0
10973464|NCT00553254|12147781|FG000|NOT COMPLETED|Overall Study||6
10973465|NCT00553254|12147782|FG001|NOT COMPLETED|Overall Study||6
10973466|NCT00553254|12147783|FG002|NOT COMPLETED|Overall Study||43
10973467|NCT00553267|12147798|FG000|STARTED|Overall Study||315
10973468|NCT00553267|12147799|FG001|STARTED|Overall Study||315
10973469|NCT00553267|12147800|FG002|STARTED|Overall Study||317
10973470|NCT00553267|12147798|FG000|COMPLETED|Overall Study||301
10973471|NCT00553267|12147799|FG001|COMPLETED|Overall Study||297
10973472|NCT00553267|12147800|FG002|COMPLETED|Overall Study||307
10973473|NCT00553267|12147798|FG000|NOT COMPLETED|Overall Study||14
10973474|NCT00553267|12147799|FG001|NOT COMPLETED|Overall Study||18
10973475|NCT00553267|12147800|FG002|NOT COMPLETED|Overall Study||10
10973476|NCT00553280|12147808|FG000|STARTED|Overall Study||123
10973477|NCT00553280|12147808|FG000|COMPLETED|Overall Study||97
10973478|NCT00553280|12147808|FG000|NOT COMPLETED|Overall Study||26
10973479|NCT00553319|12147815|FG000|STARTED|Overall Study||43
10973480|NCT00553319|12147816|FG001|STARTED|Overall Study||40
10973481|NCT00553319|12147817|FG002|STARTED|Overall Study||43
10973482|NCT00553319|12147815|FG000|COMPLETED|Overall Study||29
10973483|NCT00553319|12147816|FG001|COMPLETED|Overall Study||30
10973484|NCT00553319|12147817|FG002|COMPLETED|Overall Study||34
10973485|NCT00553319|12147815|FG000|NOT COMPLETED|Overall Study||14
10973486|NCT00553319|12147816|FG001|NOT COMPLETED|Overall Study||10
10973487|NCT00553319|12147817|FG002|NOT COMPLETED|Overall Study||9
10973488|NCT00553332|12147825|FG000|STARTED|Overall Study||29
10973489|NCT00553332|12147825|FG000|COMPLETED|Overall Study|evaluable for response|28
10973490|NCT00553332|12147825|FG000|NOT COMPLETED|Overall Study||1
10973491|NCT00553358|12147832|FG000|STARTED|Overall Study||152
10973492|NCT00553358|12147833|FG001|STARTED|Overall Study||154
10973493|NCT00553358|12147834|FG002|STARTED|Overall Study||149
10973494|NCT00553358|12147832|FG000|COMPLETED|Overall Study||73
10973495|NCT00553358|12147833|FG001|COMPLETED|Overall Study||58
10973496|NCT00553358|12147834|FG002|COMPLETED|Overall Study||61
10973497|NCT00553358|12147832|FG000|NOT COMPLETED|Overall Study||79
10973498|NCT00553358|12147833|FG001|NOT COMPLETED|Overall Study||96
10973499|NCT00553358|12147834|FG002|NOT COMPLETED|Overall Study||88
10973500|NCT00553410|12147850|FG000|STARTED|Overall Study||2441
10973501|NCT00553410|12147851|FG001|STARTED|Overall Study||2443
10973502|NCT00553410|12147850|FG000|COMPLETED|Overall Study||2426
10973503|NCT00553410|12147851|FG001|COMPLETED|Overall Study||2425
10973504|NCT00553410|12147850|FG000|NOT COMPLETED|Overall Study||15
10973505|NCT00553410|12147851|FG001|NOT COMPLETED|Overall Study||18
10973506|NCT00553436|12147857|FG000|STARTED|Overall Study|20 August 2007|7
10973507|NCT00553436|12147857|FG000|COMPLETED|Overall Study|09 April 2009|6
10973508|NCT00553436|12147857|FG000|NOT COMPLETED|Overall Study||1
10973509|NCT00553462|12147861|FG000|STARTED|Overall Study||75
10973510|NCT00553462|12147861|FG000|COMPLETED|Overall Study||61
10973511|NCT00553462|12147861|FG000|NOT COMPLETED|Overall Study||14
10973512|NCT00553475|12147868|FG000|STARTED|Overall Study||135
10973513|NCT00553475|12147869|FG001|STARTED|Overall Study||134
10973514|NCT00553475|12147870|FG002|STARTED|Overall Study||45
10973515|NCT00553475|12147868|FG000|COMPLETED|Overall Study||119
10973516|NCT00553475|12147869|FG001|COMPLETED|Overall Study||114
10973517|NCT00553475|12147870|FG002|COMPLETED|Overall Study||32
10973518|NCT00553475|12147868|FG000|NOT COMPLETED|Overall Study||16
10973519|NCT00553475|12147869|FG001|NOT COMPLETED|Overall Study||20
10973520|NCT00553475|12147870|FG002|NOT COMPLETED|Overall Study||13
10973521|NCT00553501|12147880|FG000|STARTED|Overall Study||59
10973522|NCT00553501|12147880|FG000|COMPLETED|Overall Study||55
10973523|NCT00553501|12147880|FG000|NOT COMPLETED|Overall Study||4
10973524|NCT00553514|12147889|FG000|STARTED|Overall Study||14
10973525|NCT00553514|12147890|FG001|STARTED|Overall Study||14
10973526|NCT00553514|12147891|FG002|STARTED|Overall Study||15
10973527|NCT00553514|12147892|FG003|STARTED|Overall Study||13
10973528|NCT00553514|12147893|FG004|STARTED|Overall Study||15
10973529|NCT00553514|12147889|FG000|COMPLETED|Overall Study||6
10973530|NCT00553514|12147890|FG001|COMPLETED|Overall Study||6
10973531|NCT00553514|12147891|FG002|COMPLETED|Overall Study||9
10973532|NCT00553514|12147892|FG003|COMPLETED|Overall Study||6
10973533|NCT00553514|12147893|FG004|COMPLETED|Overall Study||8
10973534|NCT00553514|12147889|FG000|NOT COMPLETED|Overall Study||8
10973535|NCT00553514|12147890|FG001|NOT COMPLETED|Overall Study||8
10973536|NCT00553514|12147891|FG002|NOT COMPLETED|Overall Study||6
10973537|NCT00553514|12147892|FG003|NOT COMPLETED|Overall Study||7
10973538|NCT00553514|12147893|FG004|NOT COMPLETED|Overall Study||7
10973539|NCT00553540|12147907|FG000|STARTED|Overall Study||25
10973540|NCT00553540|12147908|FG001|STARTED|Overall Study||25
10973541|NCT00553540|12147907|FG000|COMPLETED|Overall Study||23
10973542|NCT00553540|12147908|FG001|COMPLETED|Overall Study||20
10973543|NCT00553540|12147907|FG000|NOT COMPLETED|Overall Study||2
10973544|NCT00553540|12147908|FG001|NOT COMPLETED|Overall Study||5
10973545|NCT00553605|12147916|FG000|STARTED|Overall Study||176
10973546|NCT00553605|12147917|FG001|STARTED|Overall Study||164
10973547|NCT00553605|12147916|FG000|Treated|Overall Study||174
10973548|NCT00553605|12147917|FG001|Treated|Overall Study||164
10973549|NCT00553605|12147916|FG000|COMPLETED|Overall Study||172
10973550|NCT00553605|12147917|FG001|COMPLETED|Overall Study||161
10973551|NCT00553605|12147916|FG000|NOT COMPLETED|Overall Study||4
10973552|NCT00553605|12147917|FG001|NOT COMPLETED|Overall Study||3
10973553|NCT00553631|12147925|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|17
10973554|NCT00553631|12147926|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|17
10973555|NCT00553631|12147925|FG000|COMPLETED|Overall Study||16
10973556|NCT00553631|12147926|FG001|COMPLETED|Overall Study||16
10973557|NCT00553631|12147925|FG000|NOT COMPLETED|Overall Study||1
10973558|NCT00553631|12147926|FG001|NOT COMPLETED|Overall Study||1
10973559|NCT00553644|12147932|FG000|STARTED|Overall Study||53
10973560|NCT00553644|12147932|FG000|COMPLETED|Overall Study||25
10973561|NCT00553644|12147932|FG000|NOT COMPLETED|Overall Study||28
10973562|NCT00553696|12147940|FG000|STARTED|Overall Study||4
10973563|NCT00553696|12147941|FG001|STARTED|Overall Study||16
10973564|NCT00553696|12147942|FG002|STARTED|Overall Study||6
10973565|NCT00553696|12147943|FG003|STARTED|Overall Study||1
10973566|NCT00553696|12147940|FG000|COMPLETED|Overall Study||0
10973567|NCT00553696|12147941|FG001|COMPLETED|Overall Study||0
10973568|NCT00553696|12147942|FG002|COMPLETED|Overall Study||0
10973569|NCT00553696|12147943|FG003|COMPLETED|Overall Study||0
10973570|NCT00553696|12147940|FG000|NOT COMPLETED|Overall Study||4
10973571|NCT00553696|12147941|FG001|NOT COMPLETED|Overall Study||16
10973572|NCT00553696|12147942|FG002|NOT COMPLETED|Overall Study||6
10973573|NCT00553696|12147943|FG003|NOT COMPLETED|Overall Study||1
10973574|NCT00553735|12147956|FG000|STARTED|Overall Study||8
10973575|NCT00553735|12147956|FG000|COMPLETED|Overall Study||1
10973576|NCT00553735|12147956|FG000|NOT COMPLETED|Overall Study||7
10973577|NCT00553787|12147966|FG000|STARTED|Overall Study||994
10973578|NCT00553787|12147967|FG001|STARTED|Overall Study||498
10973579|NCT00553787|12147968|FG002|STARTED|Overall Study||995
10973580|NCT00553787|12147966|FG000|COMPLETED|Overall Study||616
10973581|NCT00553787|12147967|FG001|COMPLETED|Overall Study||374
10973582|NCT00553787|12147968|FG002|COMPLETED|Overall Study||733
10973583|NCT00553787|12147966|FG000|NOT COMPLETED|Overall Study||378
10973584|NCT00553787|12147967|FG001|NOT COMPLETED|Overall Study||124
10973585|NCT00553787|12147968|FG002|NOT COMPLETED|Overall Study||262
10973586|NCT00553839|12147976|FG000|STARTED|Overall Study||21
10973587|NCT00553839|12147976|FG000|COMPLETED|Overall Study||21
10973588|NCT00553839|12147976|FG000|NOT COMPLETED|Overall Study||0
10973589|NCT00553969|12147984|FG000|STARTED|Overall Study||31
10973590|NCT00553969|12147985|FG001|STARTED|Overall Study||24
10973591|NCT00553969|12147986|FG002|STARTED|Overall Study||22
10973592|NCT00553969|12147987|FG003|STARTED|Overall Study||24
10973593|NCT00553969|12147984|FG000|COMPLETED|Overall Study||23
10973594|NCT00553969|12147985|FG001|COMPLETED|Overall Study||24
10973595|NCT00553969|12147986|FG002|COMPLETED|Overall Study||21
10973596|NCT00553969|12147987|FG003|COMPLETED|Overall Study||23
10973597|NCT00553969|12147984|FG000|NOT COMPLETED|Overall Study||8
10973598|NCT00553969|12147985|FG001|NOT COMPLETED|Overall Study||0
10973599|NCT00553969|12147986|FG002|NOT COMPLETED|Overall Study||1
10973600|NCT00553969|12147987|FG003|NOT COMPLETED|Overall Study||1
10973601|NCT00554099|12148000|FG000|STARTED|Treatment Period (12 Weeks)||41
10973602|NCT00554099|12148001|FG001|STARTED|Treatment Period (12 Weeks)||40
10973603|NCT00554099|12148002|FG002|STARTED|Treatment Period (12 Weeks)||36
10973604|NCT00554099|12148000|FG000|COMPLETED|Treatment Period (12 Weeks)||29
10973605|NCT00554099|12148001|FG001|COMPLETED|Treatment Period (12 Weeks)||32
10973606|NCT00554099|12148002|FG002|COMPLETED|Treatment Period (12 Weeks)||27
10973607|NCT00554099|12148000|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||12
10973608|NCT00554099|12148001|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||8
10973609|NCT00554099|12148002|FG002|NOT COMPLETED|Treatment Period (12 Weeks)||9
10973610|NCT00554099|12148000|FG000|STARTED|Non-Treatment Phase (9 Months)||29
10973611|NCT00554099|12148001|FG001|STARTED|Non-Treatment Phase (9 Months)||32
10973612|NCT00554099|12148002|FG002|STARTED|Non-Treatment Phase (9 Months)||27
10973613|NCT00554099|12148000|FG000|COMPLETED|Non-Treatment Phase (9 Months)||22
10973614|NCT00554099|12148001|FG001|COMPLETED|Non-Treatment Phase (9 Months)||27
10973615|NCT00554099|12148002|FG002|COMPLETED|Non-Treatment Phase (9 Months)||24
10973616|NCT00554099|12148000|FG000|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
10973617|NCT00554099|12148001|FG001|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
10973618|NCT00554099|12148002|FG002|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
10973619|NCT00554216|12148013|FG000|STARTED|Overall Study||514
10973620|NCT00554216|12148014|FG001|STARTED|Overall Study||241
10973621|NCT00554216|12148015|FG002|STARTED|Overall Study||512
10973622|NCT00554216|12148013|FG000|COMPLETED|Overall Study||272
10973623|NCT00554216|12148014|FG001|COMPLETED|Overall Study||147
10973624|NCT00554216|12148015|FG002|COMPLETED|Overall Study||340
10973625|NCT00554216|12148013|FG000|NOT COMPLETED|Overall Study||242
10973626|NCT00554216|12148014|FG001|NOT COMPLETED|Overall Study||94
10973627|NCT00554216|12148015|FG002|NOT COMPLETED|Overall Study||172
10973628|NCT00554229|12148025|FG000|STARTED|Overall Study||299
10973629|NCT00554229|12148026|FG001|STARTED|Overall Study||295
10973630|NCT00554229|12148025|FG000|Patients Who Received Treatment|Overall Study||298
10973631|NCT00554229|12148026|FG001|Patients Who Received Treatment|Overall Study||295
10973632|NCT00554229|12148025|FG000|COMPLETED|Overall Study||73
10973633|NCT00554229|12148026|FG001|COMPLETED|Overall Study||70
10973634|NCT00554229|12148025|FG000|NOT COMPLETED|Overall Study||226
10973635|NCT00554229|12148026|FG001|NOT COMPLETED|Overall Study||225
10973636|NCT00554372|12148034|FG000|STARTED|Overall Study||14
10973637|NCT00554372|12148035|FG001|STARTED|Overall Study||16
10973638|NCT00554372|12148034|FG000|COMPLETED|Overall Study||14
10973639|NCT00554372|12148035|FG001|COMPLETED|Overall Study||16
10973640|NCT00554372|12148034|FG000|NOT COMPLETED|Overall Study||0
10973641|NCT00554372|12148035|FG001|NOT COMPLETED|Overall Study||0
10973642|NCT00554463|12148043|FG000|STARTED|Overall Study||5
10973643|NCT00554463|12148043|FG000|COMPLETED|Overall Study||5
10973644|NCT00554463|12148043|FG000|NOT COMPLETED|Overall Study||0
10973645|NCT00554619|12148047|FG000|STARTED|Overall Study||21
10973646|NCT00554619|12148047|FG000|COMPLETED|Overall Study||18
10973647|NCT00554619|12148047|FG000|NOT COMPLETED|Overall Study||3
10973648|NCT00554671|12148053|FG000|STARTED|Overall Study||117
10973649|NCT00554671|12148054|FG001|STARTED|Overall Study||133
10973650|NCT00554671|12148053|FG000|COMPLETED|Overall Study||97
10973651|NCT00554671|12148054|FG001|COMPLETED|Overall Study||117
10973652|NCT00554671|12148053|FG000|NOT COMPLETED|Overall Study||20
10973653|NCT00554671|12148054|FG001|NOT COMPLETED|Overall Study||16
10973654|NCT00554749|12148061|FG000|STARTED|Overall Study||7
10973655|NCT00554749|12148061|FG000|COMPLETED|Overall Study||7
10973656|NCT00554749|12148061|FG000|NOT COMPLETED|Overall Study||0
10973657|NCT00554801|12148067|FG000|STARTED|Overall Study||55
10973658|NCT00554801|12148068|FG001|STARTED|Overall Study||29
10973659|NCT00554801|12148067|FG000|COMPLETED|Overall Study||36
10973660|NCT00554801|12148068|FG001|COMPLETED|Overall Study||29
10973661|NCT00554801|12148067|FG000|NOT COMPLETED|Overall Study||19
10973662|NCT00554801|12148068|FG001|NOT COMPLETED|Overall Study||0
10973663|NCT00554853|12148078|FG000|STARTED|First Arm of Study||72
10973664|NCT00554853|12148079|FG001|STARTED|First Arm of Study||71
10973665|NCT00554853|12148078|FG000|COMPLETED|First Arm of Study||56
10973666|NCT00554853|12148079|FG001|COMPLETED|First Arm of Study||64
10973667|NCT00554853|12148078|FG000|NOT COMPLETED|First Arm of Study||16
10973668|NCT00554853|12148079|FG001|NOT COMPLETED|First Arm of Study||7
10973669|NCT00554853|12148078|FG000|STARTED|Washout Period (2 Weeks)||56
10973670|NCT00554853|12148079|FG001|STARTED|Washout Period (2 Weeks)||64
10973671|NCT00554853|12148078|FG000|COMPLETED|Washout Period (2 Weeks)||56
10973672|NCT00554853|12148079|FG001|COMPLETED|Washout Period (2 Weeks)||57
10973673|NCT00554853|12148078|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
10973674|NCT00554853|12148079|FG001|NOT COMPLETED|Washout Period (2 Weeks)||7
10973675|NCT00554853|12148078|FG000|STARTED|Crossover Arm (3 Months)||56
10973676|NCT00554853|12148079|FG001|STARTED|Crossover Arm (3 Months)||57
10973677|NCT00554853|12148078|FG000|COMPLETED|Crossover Arm (3 Months)||53
10973678|NCT00554853|12148079|FG001|COMPLETED|Crossover Arm (3 Months)||55
10973679|NCT00554853|12148078|FG000|NOT COMPLETED|Crossover Arm (3 Months)||3
10973680|NCT00554853|12148079|FG001|NOT COMPLETED|Crossover Arm (3 Months)||2
10973681|NCT00554970|12148095|FG000|STARTED|Period 1||8
10973682|NCT00554970|12148096|FG001|STARTED|Period 1||8
10973683|NCT00554970|12148097|FG002|STARTED|Period 1||8
10973684|NCT00554970|12148098|FG003|STARTED|Period 1||8
10973685|NCT00554970|12148095|FG000|COMPLETED|Period 1||7
10973686|NCT00554970|12148096|FG001|COMPLETED|Period 1||8
10973687|NCT00554970|12148097|FG002|COMPLETED|Period 1||8
10973688|NCT00554970|12148098|FG003|COMPLETED|Period 1||8
10973689|NCT00554970|12148095|FG000|NOT COMPLETED|Period 1||1
10973690|NCT00554970|12148096|FG001|NOT COMPLETED|Period 1||0
10973691|NCT00554970|12148097|FG002|NOT COMPLETED|Period 1||0
10973692|NCT00554970|12148098|FG003|NOT COMPLETED|Period 1||0
10973693|NCT00554970|12148095|FG000|STARTED|Period 2||7
10973694|NCT00554970|12148096|FG001|STARTED|Period 2||8
10973695|NCT00554970|12148097|FG002|STARTED|Period 2||8
10973696|NCT00554970|12148098|FG003|STARTED|Period 2||8
10973697|NCT00554970|12148095|FG000|COMPLETED|Period 2||7
10973698|NCT00554970|12148096|FG001|COMPLETED|Period 2||8
10973699|NCT00554970|12148097|FG002|COMPLETED|Period 2||7
10973700|NCT00554970|12148098|FG003|COMPLETED|Period 2||8
10973701|NCT00554970|12148095|FG000|NOT COMPLETED|Period 2||0
10973702|NCT00554970|12148096|FG001|NOT COMPLETED|Period 2||0
10973703|NCT00554970|12148097|FG002|NOT COMPLETED|Period 2||1
10973704|NCT00554970|12148098|FG003|NOT COMPLETED|Period 2||0
10973705|NCT00554996|12148108|FG000|STARTED|Overall Study||10
10973706|NCT00554996|12148108|FG000|COMPLETED|Overall Study||10
10973707|NCT00554996|12148108|FG000|NOT COMPLETED|Overall Study||0
10973708|NCT00555048|12148112|FG000|STARTED|Overall Study||1
10973709|NCT00555048|12148112|FG000|COMPLETED|Overall Study||1
10973710|NCT00555048|12148112|FG000|NOT COMPLETED|Overall Study||0
10973711|NCT00555061|12148116|FG000|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
10973712|NCT00555061|12148116|FG000|COMPLETED|Overall Study||78
10973713|NCT00555061|12148116|FG000|NOT COMPLETED|Overall Study||9
10973714|NCT00555152|12148124|FG000|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
10973715|NCT00555152|12148125|FG001|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
10973716|NCT00555152|12148126|FG002|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
10973717|NCT00555152|12148127|FG003|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
10973718|NCT00555152|12148124|FG000|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
10973719|NCT00555152|12148125|FG001|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
10973720|NCT00555152|12148126|FG002|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
10973721|NCT00555152|12148127|FG003|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
10973722|NCT00555152|12148124|FG000|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
10973723|NCT00555152|12148125|FG001|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
10973724|NCT00555152|12148126|FG002|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
10973725|NCT00555152|12148127|FG003|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
10973726|NCT00555152|12148124|FG000|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
10973727|NCT00555152|12148125|FG001|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
10973728|NCT00555152|12148126|FG002|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
10973729|NCT00555152|12148127|FG003|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
10973730|NCT00555152|12148124|FG000|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
10973731|NCT00555152|12148125|FG001|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
10973732|NCT00555152|12148126|FG002|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
10973733|NCT00555152|12148127|FG003|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
10973734|NCT00555152|12148124|FG000|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
10973735|NCT00555152|12148125|FG001|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
10973736|NCT00555152|12148126|FG002|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
10973737|NCT00555152|12148127|FG003|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
10973738|NCT00555217|12148139|FG000|STARTED|Overall Study||724
10973739|NCT00555217|12148140|FG001|STARTED|Overall Study||724
10973740|NCT00555217|12148139|FG000|COMPLETED|Overall Study||649
10973741|NCT00555217|12148140|FG001|COMPLETED|Overall Study||656
10973742|NCT00555217|12148139|FG000|NOT COMPLETED|Overall Study||75
10973743|NCT00555217|12148140|FG001|NOT COMPLETED|Overall Study||68
10973744|NCT00555321|12148151|FG000|STARTED|Treatment Phase up to 12-months||52
10973745|NCT00555321|12148152|FG001|STARTED|Treatment Phase up to 12-months||51
10973746|NCT00555321|12148153|FG002|STARTED|Treatment Phase up to 12-months||50
10973747|NCT00555321|12148154|FG003|STARTED|Treatment Phase up to 12-months||53
10973748|NCT00555321|12148155|FG004|STARTED|Treatment Phase up to 12-months||54
10973749|NCT00555321|12148151|FG000|Received Transplant and Treated|Treatment Phase up to 12-months||50
10973750|NCT00555321|12148152|FG001|Received Transplant and Treated|Treatment Phase up to 12-months||48
10973751|NCT00555321|12148153|FG002|Received Transplant and Treated|Treatment Phase up to 12-months||49
10973752|NCT00555321|12148154|FG003|Received Transplant and Treated|Treatment Phase up to 12-months||53
10973753|NCT00555321|12148155|FG004|Received Transplant and Treated|Treatment Phase up to 12-months||50
10973754|NCT00555321|12148151|FG000|COMPLETED|Treatment Phase up to 12-months||31
10973755|NCT00555321|12148152|FG001|COMPLETED|Treatment Phase up to 12-months||29
10973756|NCT00555321|12148153|FG002|COMPLETED|Treatment Phase up to 12-months||26
10973757|NCT00555321|12148154|FG003|COMPLETED|Treatment Phase up to 12-months||46
10973758|NCT00555321|12148155|FG004|COMPLETED|Treatment Phase up to 12-months||32
10973759|NCT00555321|12148151|FG000|NOT COMPLETED|Treatment Phase up to 12-months||21
10973760|NCT00555321|12148152|FG001|NOT COMPLETED|Treatment Phase up to 12-months||22
10973761|NCT00555321|12148153|FG002|NOT COMPLETED|Treatment Phase up to 12-months||24
10973762|NCT00555321|12148154|FG003|NOT COMPLETED|Treatment Phase up to 12-months||7
10973763|NCT00555321|12148155|FG004|NOT COMPLETED|Treatment Phase up to 12-months||22
10973764|NCT00555321|12148151|FG000|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
10973765|NCT00555321|12148152|FG001|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
10973766|NCT00555321|12148153|FG002|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
10973767|NCT00555321|12148154|FG003|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
10973768|NCT00555321|12148155|FG004|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
10973769|NCT00555321|12148151|FG000|COMPLETED|Long-term Extension Phase||0
10973770|NCT00555321|12148152|FG001|COMPLETED|Long-term Extension Phase||0
10973771|NCT00555321|12148153|FG002|COMPLETED|Long-term Extension Phase||0
10973772|NCT00555321|12148154|FG003|COMPLETED|Long-term Extension Phase||0
10973773|NCT00555321|12148155|FG004|COMPLETED|Long-term Extension Phase||0
10973774|NCT00555321|12148151|FG000|NOT COMPLETED|Long-term Extension Phase||30
10973775|NCT00555321|12148152|FG001|NOT COMPLETED|Long-term Extension Phase||27
10973776|NCT00555321|12148153|FG002|NOT COMPLETED|Long-term Extension Phase||24
10973777|NCT00555321|12148154|FG003|NOT COMPLETED|Long-term Extension Phase||38
10973778|NCT00555321|12148155|FG004|NOT COMPLETED|Long-term Extension Phase||26
10973779|NCT00555360|12148174|FG000|STARTED|Overall Study||183
10973780|NCT00555360|12148175|FG001|STARTED|Overall Study||189
10973781|NCT00555360|12148174|FG000|COMPLETED|Overall Study||156
10973782|NCT00555360|12148175|FG001|COMPLETED|Overall Study||153
10973783|NCT00555360|12148174|FG000|NOT COMPLETED|Overall Study||27
10973784|NCT00555360|12148175|FG001|NOT COMPLETED|Overall Study||36
10973785|NCT00555425|12148184|FG000|STARTED|Overall Study||57
10973786|NCT00555425|12148185|FG001|STARTED|Overall Study||56
10973787|NCT00555425|12148184|FG000|COMPLETED|Overall Study||6
10973788|NCT00555425|12148185|FG001|COMPLETED|Overall Study||37
10973789|NCT00555425|12148184|FG000|NOT COMPLETED|Overall Study||51
10973790|NCT00555425|12148185|FG001|NOT COMPLETED|Overall Study||19
10973791|NCT00555438|12148191|FG000|STARTED|10 Days Post-operative||442
10973792|NCT00555438|12148191|FG000|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
10973793|NCT00555438|12148191|FG000|NOT COMPLETED|10 Days Post-operative||4
10973794|NCT00555438|12148191|FG000|STARTED|Between 10 Days and 30 Days Postoperativ||438
10973795|NCT00555438|12148191|FG000|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
10973796|NCT00555438|12148191|FG000|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
10973797|NCT00555464|12148197|FG000|STARTED|Overall Study||4
10973798|NCT00555464|12148198|FG001|STARTED|Overall Study||4
10973799|NCT00555464|12148197|FG000|COMPLETED|Overall Study||4
10973800|NCT00555464|12148198|FG001|COMPLETED|Overall Study||1
10973801|NCT00555464|12148197|FG000|NOT COMPLETED|Overall Study||0
10973802|NCT00555464|12148198|FG001|NOT COMPLETED|Overall Study||3
10973803|NCT00555477|12148206|FG000|STARTED|Overall Study||14
10973804|NCT00555477|12148207|FG001|STARTED|Overall Study||45
10973805|NCT00555477|12148206|FG000|COMPLETED|Overall Study||12
10973806|NCT00555477|12148207|FG001|COMPLETED|Overall Study||32
10973807|NCT00555477|12148206|FG000|NOT COMPLETED|Overall Study||2
10973808|NCT00555477|12148207|FG001|NOT COMPLETED|Overall Study||13
10973809|NCT00555568|12148215|FG000|STARTED|Overall Study||100
10973810|NCT00555568|12148216|FG001|STARTED|Overall Study||98
10973811|NCT00555568|12148217|FG002|STARTED|Overall Study||100
10973812|NCT00555568|12148215|FG000|COMPLETED|Overall Study||74
10973813|NCT00555568|12148216|FG001|COMPLETED|Overall Study||82
10973814|NCT00555568|12148217|FG002|COMPLETED|Overall Study||84
10973815|NCT00555568|12148215|FG000|NOT COMPLETED|Overall Study||26
10973816|NCT00555568|12148216|FG001|NOT COMPLETED|Overall Study||16
10973817|NCT00555568|12148217|FG002|NOT COMPLETED|Overall Study||16
10973818|NCT00555581|12148225|FG000|STARTED|Overall Study||30
10973819|NCT00555581|12148225|FG000|COMPLETED|Overall Study||24
10973820|NCT00555581|12148225|FG000|NOT COMPLETED|Overall Study||6
10973821|NCT00555620|12148235|FG000|STARTED|Overall Study||6
10973822|NCT00555620|12148236|FG001|STARTED|Overall Study||7
10973823|NCT00555620|12148237|FG002|STARTED|Overall Study||15
10973824|NCT00555620|12148238|FG003|STARTED|Overall Study||23
10973825|NCT00555620|12148239|FG004|STARTED|Overall Study||3
10973826|NCT00555620|12148240|FG005|STARTED|Overall Study||22
10973827|NCT00555620|12148235|FG000|COMPLETED|Overall Study||0
10973828|NCT00555620|12148236|FG001|COMPLETED|Overall Study||0
10973829|NCT00555620|12148237|FG002|COMPLETED|Overall Study||0
10973830|NCT00555620|12148238|FG003|COMPLETED|Overall Study||0
10973831|NCT00555620|12148239|FG004|COMPLETED|Overall Study||0
10973832|NCT00555620|12148240|FG005|COMPLETED|Overall Study||0
10973833|NCT00555620|12148235|FG000|NOT COMPLETED|Overall Study||6
10973834|NCT00555620|12148236|FG001|NOT COMPLETED|Overall Study||7
10973835|NCT00555620|12148237|FG002|NOT COMPLETED|Overall Study||15
10973836|NCT00555620|12148238|FG003|NOT COMPLETED|Overall Study||23
10973837|NCT00555620|12148239|FG004|NOT COMPLETED|Overall Study||3
10973838|NCT00555620|12148240|FG005|NOT COMPLETED|Overall Study||22
10973839|NCT00555672|12148260|FG000|STARTED|Overall Study||24
10973840|NCT00555672|12148261|FG001|STARTED|Overall Study||10
10973841|NCT00555672|12148260|FG000|COMPLETED|Overall Study||0
10973842|NCT00555672|12148261|FG001|COMPLETED|Overall Study||0
10973843|NCT00555672|12148260|FG000|NOT COMPLETED|Overall Study||24
10973844|NCT00555672|12148261|FG001|NOT COMPLETED|Overall Study||10
10973845|NCT00555750|12148269|FG000|STARTED|Overall Study||10
10973846|NCT00555750|12148270|FG001|STARTED|Overall Study||10
10973847|NCT00555750|12148269|FG000|COMPLETED|Overall Study||10
10973848|NCT00555750|12148270|FG001|COMPLETED|Overall Study||10
10973849|NCT00555750|12148269|FG000|NOT COMPLETED|Overall Study||0
10973850|NCT00555750|12148270|FG001|NOT COMPLETED|Overall Study||0
10973851|NCT00555880|12148278|FG000|STARTED|Treatment Period 1 (1 Day)||13
10973852|NCT00555880|12148279|FG001|STARTED|Treatment Period 1 (1 Day)||11
10973853|NCT00555880|12148278|FG000|COMPLETED|Treatment Period 1 (1 Day)||13
10973854|NCT00555880|12148279|FG001|COMPLETED|Treatment Period 1 (1 Day)||11
10973855|NCT00555880|12148278|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10973856|NCT00555880|12148279|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
10973857|NCT00555880|12148278|FG000|STARTED|Washout (1 Day)||13
10973858|NCT00555880|12148279|FG001|STARTED|Washout (1 Day)||11
10973859|NCT00555880|12148278|FG000|COMPLETED|Washout (1 Day)||13
10973860|NCT00555880|12148279|FG001|COMPLETED|Washout (1 Day)||11
10973861|NCT00555880|12148278|FG000|NOT COMPLETED|Washout (1 Day)||0
10973862|NCT00555880|12148279|FG001|NOT COMPLETED|Washout (1 Day)||0
10973863|NCT00555880|12148278|FG000|STARTED|Treatment Period 2 (1 Day)||13
10973864|NCT00555880|12148279|FG001|STARTED|Treatment Period 2 (1 Day)||11
10973865|NCT00555880|12148278|FG000|COMPLETED|Treatment Period 2 (1 Day)||13
10973866|NCT00555880|12148279|FG001|COMPLETED|Treatment Period 2 (1 Day)||11
10973867|NCT00555880|12148278|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10973868|NCT00555880|12148279|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
10973869|NCT00555893|12148288|FG000|STARTED|Overall Study||130
10973870|NCT00555893|12148289|FG001|STARTED|Overall Study||63
10973871|NCT00555893|12148288|FG000|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
10973872|NCT00555893|12148289|FG001|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
10973873|NCT00555893|12148288|FG000|COMPLETED|Overall Study||130
10973874|NCT00555893|12148289|FG001|COMPLETED|Overall Study||63
10973875|NCT00555893|12148288|FG000|NOT COMPLETED|Overall Study||0
10973876|NCT00555893|12148289|FG001|NOT COMPLETED|Overall Study||0
10973877|NCT00555906|12148298|FG000|STARTED|Phase 1||3
10973878|NCT00555906|12148299|FG001|STARTED|Phase 1||6
10973879|NCT00555906|12148300|FG002|STARTED|Phase 1||7
10973880|NCT00555906|12148301|FG003|STARTED|Phase 1||5
10973881|NCT00555906|12148302|FG004|STARTED|Phase 1||0
10973882|NCT00555906|12148298|FG000|COMPLETED|Phase 1||0
10973883|NCT00555906|12148299|FG001|COMPLETED|Phase 1||0
10973884|NCT00555906|12148300|FG002|COMPLETED|Phase 1||0
10973885|NCT00555906|12148301|FG003|COMPLETED|Phase 1||0
10973886|NCT00555906|12148302|FG004|COMPLETED|Phase 1||0
10973887|NCT00555906|12148298|FG000|NOT COMPLETED|Phase 1||3
10973888|NCT00555906|12148299|FG001|NOT COMPLETED|Phase 1||6
10973889|NCT00555906|12148300|FG002|NOT COMPLETED|Phase 1||7
10973890|NCT00555906|12148301|FG003|NOT COMPLETED|Phase 1||5
10973891|NCT00555906|12148302|FG004|NOT COMPLETED|Phase 1||0
10973892|NCT00555906|12148298|FG000|STARTED|Phase 2||0
10973893|NCT00555906|12148299|FG001|STARTED|Phase 2||0
10973894|NCT00555906|12148300|FG002|STARTED|Phase 2||0
10973895|NCT00555906|12148301|FG003|STARTED|Phase 2||0
10973896|NCT00555906|12148302|FG004|STARTED|Phase 2||32
10973897|NCT00555906|12148298|FG000|Treated|Phase 2||0
10973898|NCT00555906|12148299|FG001|Treated|Phase 2||0
10973899|NCT00555906|12148300|FG002|Treated|Phase 2||0
10973900|NCT00555906|12148301|FG003|Treated|Phase 2||0
10973901|NCT00555906|12148302|FG004|Treated|Phase 2||30
10973902|NCT00555906|12148298|FG000|COMPLETED|Phase 2||0
10973903|NCT00555906|12148299|FG001|COMPLETED|Phase 2||0
10973904|NCT00555906|12148300|FG002|COMPLETED|Phase 2||0
10973905|NCT00555906|12148301|FG003|COMPLETED|Phase 2||0
10973906|NCT00555906|12148302|FG004|COMPLETED|Phase 2||0
10973907|NCT00555906|12148298|FG000|NOT COMPLETED|Phase 2||0
10973908|NCT00555906|12148299|FG001|NOT COMPLETED|Phase 2||0
10973909|NCT00555906|12148300|FG002|NOT COMPLETED|Phase 2||0
10973910|NCT00555906|12148301|FG003|NOT COMPLETED|Phase 2||0
10973911|NCT00555906|12148302|FG004|NOT COMPLETED|Phase 2||32
10973912|NCT00555971|12148319|FG000|STARTED|Overall Study||5
10973913|NCT00555971|12148320|FG001|STARTED|Overall Study||8
10973914|NCT00555971|12148319|FG000|COMPLETED|Overall Study||4
10973915|NCT00555971|12148320|FG001|COMPLETED|Overall Study||7
10973916|NCT00555971|12148319|FG000|NOT COMPLETED|Overall Study||1
10973917|NCT00555971|12148320|FG001|NOT COMPLETED|Overall Study||1
10973918|NCT00555997|12148329|FG000|STARTED|Phase 1 SPCD||29
10973919|NCT00555997|12148330|FG001|STARTED|Phase 1 SPCD||91
10973920|NCT00555997|12148331|FG002|STARTED|Phase 1 SPCD||0
10973921|NCT00555997|12148332|FG003|STARTED|Phase 1 SPCD||0
10973922|NCT00555997|12148329|FG000|COMPLETED|Phase 1 SPCD||17
10973923|NCT00555997|12148330|FG001|COMPLETED|Phase 1 SPCD||76
10973924|NCT00555997|12148331|FG002|COMPLETED|Phase 1 SPCD||0
10973925|NCT00555997|12148332|FG003|COMPLETED|Phase 1 SPCD||0
10973926|NCT00555997|12148329|FG000|NOT COMPLETED|Phase 1 SPCD||12
10973927|NCT00555997|12148330|FG001|NOT COMPLETED|Phase 1 SPCD||15
10973928|NCT00555997|12148331|FG002|NOT COMPLETED|Phase 1 SPCD||0
10973929|NCT00555997|12148332|FG003|NOT COMPLETED|Phase 1 SPCD||0
10973930|NCT00555997|12148329|FG000|STARTED|Phase 2 SPCD||0
10973931|NCT00555997|12148330|FG001|STARTED|Phase 2 SPCD||0
10973932|NCT00555997|12148331|FG002|STARTED|Phase 2 SPCD||38
10973933|NCT00555997|12148332|FG003|STARTED|Phase 2 SPCD||25
10973934|NCT00555997|12148329|FG000|COMPLETED|Phase 2 SPCD||0
10973935|NCT00555997|12148330|FG001|COMPLETED|Phase 2 SPCD||0
10973936|NCT00555997|12148331|FG002|COMPLETED|Phase 2 SPCD||31
10973937|NCT00555997|12148332|FG003|COMPLETED|Phase 2 SPCD||22
10973938|NCT00555997|12148329|FG000|NOT COMPLETED|Phase 2 SPCD||0
10973939|NCT00555997|12148330|FG001|NOT COMPLETED|Phase 2 SPCD||0
10973940|NCT00555997|12148331|FG002|NOT COMPLETED|Phase 2 SPCD||7
10973941|NCT00555997|12148332|FG003|NOT COMPLETED|Phase 2 SPCD||3
10973942|NCT00556049|12148344|FG000|STARTED|Overall Study||72
10973943|NCT00556049|12148344|FG000|COMPLETED|Overall Study||72
10973944|NCT00556049|12148344|FG000|NOT COMPLETED|Overall Study||0
10973945|NCT00556140|12148348|FG000|STARTED|Overall Study||16
10973946|NCT00556140|12148348|FG000|COMPLETED|Overall Study||13
10973947|NCT00556140|12148348|FG000|NOT COMPLETED|Overall Study||3
10973948|NCT00556322|12148354|FG000|STARTED|Overall Study||221
10973949|NCT00556322|12148355|FG001|STARTED|Overall Study||203
10973950|NCT00556322|12148354|FG000|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
10973951|NCT00556322|12148355|FG001|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
10973952|NCT00556322|12148354|FG000|NOT COMPLETED|Overall Study||221
10973953|NCT00556322|12148355|FG001|NOT COMPLETED|Overall Study||203
10973954|NCT00556426|12148364|FG000|STARTED|Overall Study||100
10973955|NCT00556426|12148364|FG000|COMPLETED|Overall Study||91
10973956|NCT00556426|12148364|FG000|NOT COMPLETED|Overall Study||9
10973957|NCT00556439|12148373|FG000|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
10973958|NCT00556439|12148374|FG001|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
10973959|NCT00556439|12148375|FG002|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
10973960|NCT00556439|12148376|FG003|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
10973961|NCT00556439|12148373|FG000|COMPLETED|Study Entry to Week 12||41
10973962|NCT00556439|12148374|FG001|COMPLETED|Study Entry to Week 12||0
10973963|NCT00556439|12148375|FG002|COMPLETED|Study Entry to Week 12||26
10973964|NCT00556439|12148376|FG003|COMPLETED|Study Entry to Week 12||0
10973965|NCT00556439|12148373|FG000|NOT COMPLETED|Study Entry to Week 12||8
10973966|NCT00556439|12148374|FG001|NOT COMPLETED|Study Entry to Week 12||0
10973967|NCT00556439|12148375|FG002|NOT COMPLETED|Study Entry to Week 12||8
10973968|NCT00556439|12148376|FG003|NOT COMPLETED|Study Entry to Week 12||0
10973969|NCT00556439|12148373|FG000|STARTED|After Week 12 (Randomized Study Period)||20
10973970|NCT00556439|12148374|FG001|STARTED|After Week 12 (Randomized Study Period)||21
10973971|NCT00556439|12148375|FG002|STARTED|After Week 12 (Randomized Study Period)||11
10973972|NCT00556439|12148376|FG003|STARTED|After Week 12 (Randomized Study Period)||15
10973973|NCT00556439|12148373|FG000|COMPLETED|After Week 12 (Randomized Study Period)||17
10973974|NCT00556439|12148374|FG001|COMPLETED|After Week 12 (Randomized Study Period)||17
10973975|NCT00556439|12148375|FG002|COMPLETED|After Week 12 (Randomized Study Period)||11
10973976|NCT00556439|12148376|FG003|COMPLETED|After Week 12 (Randomized Study Period)||14
10973977|NCT00556439|12148373|FG000|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
10973978|NCT00556439|12148374|FG001|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
10973979|NCT00556439|12148375|FG002|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
10973980|NCT00556439|12148376|FG003|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
10973981|NCT00556452|12148389|FG000|STARTED|Overall Study||6
10973982|NCT00556452|12148390|FG001|STARTED|Overall Study||21
10973983|NCT00556452|12148391|FG002|STARTED|Overall Study||19
10973984|NCT00556452|12148389|FG000|COMPLETED|Overall Study||6
10973985|NCT00556452|12148390|FG001|COMPLETED|Overall Study||21
10973986|NCT00556452|12148391|FG002|COMPLETED|Overall Study||19
10973987|NCT00556452|12148389|FG000|NOT COMPLETED|Overall Study||0
10973988|NCT00556452|12148390|FG001|NOT COMPLETED|Overall Study||0
10973989|NCT00556452|12148391|FG002|NOT COMPLETED|Overall Study||0
10973990|NCT00556478|12148398|FG000|STARTED|Double-blind Phase||171
10973991|NCT00556478|12148399|FG001|STARTED|Double-blind Phase||85
10973992|NCT00556478|12148398|FG000|ITT|Double-blind Phase||167
10973993|NCT00556478|12148399|FG001|ITT|Double-blind Phase||82
10973994|NCT00556478|12148398|FG000|COMPLETED|Double-blind Phase||150
10973995|NCT00556478|12148399|FG001|COMPLETED|Double-blind Phase||77
10973996|NCT00556478|12148398|FG000|NOT COMPLETED|Double-blind Phase||21
10973997|NCT00556478|12148399|FG001|NOT COMPLETED|Double-blind Phase||8
10973998|NCT00556478|12148398|FG000|STARTED|Open-Label Phase||146
10973999|NCT00556478|12148399|FG001|STARTED|Open-Label Phase||77
10974000|NCT00556478|12148398|FG000|Treated in Open-label|Open-Label Phase||142
10974001|NCT00556478|12148399|FG001|Treated in Open-label|Open-Label Phase||71
10974002|NCT00556478|12148398|FG000|COMPLETED|Open-Label Phase||132
10974003|NCT00556478|12148399|FG001|COMPLETED|Open-Label Phase||67
10974004|NCT00556478|12148398|FG000|NOT COMPLETED|Open-Label Phase||14
10974005|NCT00556478|12148399|FG001|NOT COMPLETED|Open-Label Phase||10
10974006|NCT00556491|12148410|FG000|STARTED|Overall Study|January 2008|20
10974007|NCT00556491|12148411|FG001|STARTED|Overall Study||20
10974008|NCT00556491|12148410|FG000|COMPLETED|Overall Study||19
10974009|NCT00556491|12148411|FG001|COMPLETED|Overall Study||19
10974010|NCT00556491|12148410|FG000|NOT COMPLETED|Overall Study||1
10974011|NCT00556491|12148411|FG001|NOT COMPLETED|Overall Study||1
10974012|NCT00556504|12148429|FG000|STARTED|Overall Study||42
10974013|NCT00556504|12148430|FG001|STARTED|Overall Study||42
10974014|NCT00556504|12148429|FG000|Intend-to Treat Population|Overall Study||42
10974015|NCT00556504|12148430|FG001|Intend-to Treat Population|Overall Study||42
10974016|NCT00556504|12148429|FG000|Safety Population|Overall Study||41
10974017|NCT00556504|12148430|FG001|Safety Population|Overall Study||42
10974018|NCT00556504|12148429|FG000|COMPLETED|Overall Study||34
10974019|NCT00556504|12148430|FG001|COMPLETED|Overall Study||33
10974020|NCT00556504|12148429|FG000|NOT COMPLETED|Overall Study||8
10974021|NCT00556504|12148430|FG001|NOT COMPLETED|Overall Study||9
10974022|NCT00556543|12148436|FG000|STARTED|Overall Study||10
10974023|NCT00556543|12148436|FG000|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
10974024|NCT00556543|12148436|FG000|NOT COMPLETED|Overall Study||0
10974025|NCT00556673|12148445|FG000|STARTED|Overall Study||16
10974026|NCT00556673|12148446|FG001|STARTED|Overall Study||15
10974027|NCT00556673|12148445|FG000|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
10974028|NCT00556673|12148446|FG001|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
10974029|NCT00556673|12148445|FG000|COMPLETED|Overall Study||13
10974030|NCT00556673|12148446|FG001|COMPLETED|Overall Study||13
10974031|NCT00556673|12148445|FG000|NOT COMPLETED|Overall Study||3
10974032|NCT00556673|12148446|FG001|NOT COMPLETED|Overall Study||2
10974033|NCT00556712|12148456|FG000|STARTED|Overall Study||451
10974034|NCT00556712|12148457|FG001|STARTED|Overall Study||438
10974035|NCT00556712|12148456|FG000|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
10974036|NCT00556712|12148457|FG001|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
10974037|NCT00556712|12148456|FG000|NOT COMPLETED|Overall Study||451
10974038|NCT00556712|12148457|FG001|NOT COMPLETED|Overall Study||438
10974039|NCT00556842|12148465|FG000|STARTED|Overall Study||749
10974040|NCT00556842|12148466|FG001|STARTED|Overall Study||746
10974041|NCT00556842|12148465|FG000|COMPLETED|Overall Study||718
10974042|NCT00556842|12148466|FG001|COMPLETED|Overall Study||723
10974043|NCT00556842|12148465|FG000|NOT COMPLETED|Overall Study||31
10974044|NCT00556842|12148466|FG001|NOT COMPLETED|Overall Study||23
10974045|NCT00556894|12148483|FG000|STARTED|Overall Study||82
10974046|NCT00556894|12148484|FG001|STARTED|Overall Study||87
10974047|NCT00556894|12148485|FG002|STARTED|Overall Study||84
10974048|NCT00556894|12148483|FG000|COMPLETED|Overall Study||66
10974049|NCT00556894|12148484|FG001|COMPLETED|Overall Study||68
10974050|NCT00556894|12148485|FG002|COMPLETED|Overall Study||65
10974051|NCT00556894|12148483|FG000|NOT COMPLETED|Overall Study||16
10974052|NCT00556894|12148484|FG001|NOT COMPLETED|Overall Study||19
10974053|NCT00556894|12148485|FG002|NOT COMPLETED|Overall Study||19
10974054|NCT00556933|12148497|FG000|STARTED|Single vs. Divided-dose rATG Induction||45
10974055|NCT00556933|12148498|FG001|STARTED|Single vs. Divided-dose rATG Induction||45
10974056|NCT00556933|12148499|FG002|STARTED|Single vs. Divided-dose rATG Induction||45
10974057|NCT00556933|12148500|FG003|STARTED|Single vs. Divided-dose rATG Induction||45
10974058|NCT00556933|12148497|FG000|COMPLETED|Single vs. Divided-dose rATG Induction||43
10974059|NCT00556933|12148498|FG001|COMPLETED|Single vs. Divided-dose rATG Induction||37
10974060|NCT00556933|12148499|FG002|COMPLETED|Single vs. Divided-dose rATG Induction||39
10974061|NCT00556933|12148500|FG003|COMPLETED|Single vs. Divided-dose rATG Induction||43
10974062|NCT00556933|12148497|FG000|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
10974063|NCT00556933|12148498|FG001|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
10974064|NCT00556933|12148499|FG002|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
10974065|NCT00556933|12148500|FG003|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
10974066|NCT00556933|12148497|FG000|STARTED|CNI Withdrawal vs. Minimization||43
10974067|NCT00556933|12148498|FG001|STARTED|CNI Withdrawal vs. Minimization||37
10974068|NCT00556933|12148499|FG002|STARTED|CNI Withdrawal vs. Minimization||39
10974069|NCT00556933|12148500|FG003|STARTED|CNI Withdrawal vs. Minimization||43
10974070|NCT00556933|12148497|FG000|COMPLETED|CNI Withdrawal vs. Minimization||42
10974071|NCT00556933|12148498|FG001|COMPLETED|CNI Withdrawal vs. Minimization||33
10974072|NCT00556933|12148499|FG002|COMPLETED|CNI Withdrawal vs. Minimization||36
10974073|NCT00556933|12148500|FG003|COMPLETED|CNI Withdrawal vs. Minimization||41
10974074|NCT00556933|12148497|FG000|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
10974075|NCT00556933|12148498|FG001|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
10974076|NCT00556933|12148499|FG002|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
10974077|NCT00556933|12148500|FG003|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
10974078|NCT00556946|12148519|FG000|STARTED|Overall Study||17
10974079|NCT00556946|12148519|FG000|COMPLETED|Overall Study||16
10974080|NCT00556946|12148519|FG000|NOT COMPLETED|Overall Study||1
10974081|NCT00556972|12148523|FG000|STARTED|Overall Study||4
10974082|NCT00556972|12148523|FG000|COMPLETED|Overall Study||4
10974083|NCT00556972|12148523|FG000|NOT COMPLETED|Overall Study||0
10974084|NCT00556998|12148527|FG000|STARTED|Voriconazole Intravenous (IV)||26
10974085|NCT00556998|12148527|FG000|Treated|Voriconazole Intravenous (IV)||26
10974086|NCT00556998|12148527|FG000|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
10974087|NCT00556998|12148527|FG000|NOT COMPLETED|Voriconazole Intravenous (IV)||5
10974088|NCT00556998|12148527|FG000|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
10974089|NCT00556998|12148527|FG000|COMPLETED|Voriconazole Oral||20
10974090|NCT00556998|12148527|FG000|NOT COMPLETED|Voriconazole Oral||2
10974091|NCT00557076|12148537|FG000|STARTED|Overall Study||8
10974092|NCT00557076|12148538|FG001|STARTED|Overall Study||8
10974093|NCT00557076|12148537|FG000|COMPLETED|Overall Study||8
10974094|NCT00557076|12148538|FG001|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
10974095|NCT00557076|12148537|FG000|NOT COMPLETED|Overall Study||0
10974096|NCT00557076|12148538|FG001|NOT COMPLETED|Overall Study||1
10974097|NCT00557245|12148547|FG000|STARTED|Overall Study||1589
10974098|NCT00557245|12148548|FG001|STARTED|Overall Study||1583
10974099|NCT00557245|12148549|FG002|STARTED|Overall Study||1586
10974100|NCT00557245|12148547|FG000|COMPLETED|Overall Study||1577
10974101|NCT00557245|12148548|FG001|COMPLETED|Overall Study||1571
10974102|NCT00557245|12148549|FG002|COMPLETED|Overall Study||1574
10974103|NCT00557245|12148547|FG000|NOT COMPLETED|Overall Study||12
10974104|NCT00557245|12148548|FG001|NOT COMPLETED|Overall Study||12
10974105|NCT00557245|12148549|FG002|NOT COMPLETED|Overall Study||12
10974106|NCT00557284|12148562|FG000|STARTED|Overall Study||9
10974107|NCT00557284|12148563|FG001|STARTED|Overall Study||11
10974108|NCT00557284|12148562|FG000|COMPLETED|Overall Study||9
10974109|NCT00557284|12148563|FG001|COMPLETED|Overall Study||11
10974110|NCT00557284|12148562|FG000|NOT COMPLETED|Overall Study||0
10974111|NCT00557284|12148563|FG001|NOT COMPLETED|Overall Study||0
10974112|NCT00557310|12148569|FG000|STARTED|Main Study (0 - 18 Months)||35
10974113|NCT00557310|12148569|FG000|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
10974114|NCT00557310|12148569|FG000|NOT COMPLETED|Main Study (0 - 18 Months)||5
10974115|NCT00557310|12148569|FG000|STARTED|Extension Phase (18 - 24 Months)||30
10974116|NCT00557310|12148569|FG000|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
10974117|NCT00557310|12148569|FG000|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
10974118|NCT00557323|12148573|FG000|STARTED|Overall Study||34
10974119|NCT00557323|12148573|FG000|COMPLETED|Overall Study||27
10974120|NCT00557323|12148573|FG000|NOT COMPLETED|Overall Study||7
10974121|NCT00557349|12148579|FG000|STARTED|Overall Study|omeprazole/bicarb|22
10974122|NCT00557349|12148580|FG001|STARTED|Overall Study||18
10974123|NCT00557349|12148579|FG000|COMPLETED|Overall Study||17
10974124|NCT00557349|12148580|FG001|COMPLETED|Overall Study||13
10974125|NCT00557349|12148579|FG000|NOT COMPLETED|Overall Study||5
10974126|NCT00557349|12148580|FG001|NOT COMPLETED|Overall Study||5
10974127|NCT00557362|12148590|FG000|STARTED|Overall Study||30
10974128|NCT00557362|12148591|FG001|STARTED|Overall Study||30
10974129|NCT00557362|12148592|FG002|STARTED|Overall Study||30
10974130|NCT00557362|12148593|FG003|STARTED|Overall Study||30
10974131|NCT00557362|12148590|FG000|COMPLETED|Overall Study||28
10974132|NCT00557362|12148591|FG001|COMPLETED|Overall Study||28
10974133|NCT00557362|12148592|FG002|COMPLETED|Overall Study||26
10974134|NCT00557362|12148593|FG003|COMPLETED|Overall Study||27
10974135|NCT00557362|12148590|FG000|NOT COMPLETED|Overall Study||2
10974136|NCT00557362|12148591|FG001|NOT COMPLETED|Overall Study||2
10974137|NCT00557362|12148592|FG002|NOT COMPLETED|Overall Study||4
10974138|NCT00557362|12148593|FG003|NOT COMPLETED|Overall Study||3
10974139|NCT00557440|12148609|FG000|STARTED|Treatment Period 1||12
10974140|NCT00557440|12148610|FG001|STARTED|Treatment Period 1||12
10974141|NCT00557440|12148611|FG002|STARTED|Treatment Period 1||13
10974142|NCT00557440|12148609|FG000|COMPLETED|Treatment Period 1||12
10974143|NCT00557440|12148610|FG001|COMPLETED|Treatment Period 1||12
10974144|NCT00557440|12148611|FG002|COMPLETED|Treatment Period 1||12
10974145|NCT00557440|12148609|FG000|NOT COMPLETED|Treatment Period 1||0
10974146|NCT00557440|12148610|FG001|NOT COMPLETED|Treatment Period 1||0
10974147|NCT00557440|12148611|FG002|NOT COMPLETED|Treatment Period 1||1
10974148|NCT00557440|12148609|FG000|STARTED|Treatment Period 2||12
10974149|NCT00557440|12148610|FG001|STARTED|Treatment Period 2||12
10974150|NCT00557440|12148611|FG002|STARTED|Treatment Period 2||12
10974151|NCT00557440|12148609|FG000|COMPLETED|Treatment Period 2||12
10974152|NCT00557440|12148610|FG001|COMPLETED|Treatment Period 2||12
10974153|NCT00557440|12148611|FG002|COMPLETED|Treatment Period 2||12
10974154|NCT00557440|12148609|FG000|NOT COMPLETED|Treatment Period 2||0
10974155|NCT00557440|12148610|FG001|NOT COMPLETED|Treatment Period 2||0
10974156|NCT00557440|12148611|FG002|NOT COMPLETED|Treatment Period 2||0
10974157|NCT00557440|12148609|FG000|STARTED|Treatment Period 3||12
10974158|NCT00557440|12148610|FG001|STARTED|Treatment Period 3||12
10974159|NCT00557440|12148611|FG002|STARTED|Treatment Period 3||12
10974160|NCT00557440|12148609|FG000|COMPLETED|Treatment Period 3||12
10974161|NCT00557440|12148610|FG001|COMPLETED|Treatment Period 3||12
10974162|NCT00557440|12148611|FG002|COMPLETED|Treatment Period 3||12
10974163|NCT00557440|12148609|FG000|NOT COMPLETED|Treatment Period 3||0
10974164|NCT00557440|12148610|FG001|NOT COMPLETED|Treatment Period 3||0
10974165|NCT00557440|12148611|FG002|NOT COMPLETED|Treatment Period 3||0
10974166|NCT00557466|12148625|FG000|STARTED|Overall Study||98
10974167|NCT00557466|12148626|FG001|STARTED|Overall Study||92
10974168|NCT00557466|12148627|FG002|STARTED|Overall Study||101
10974169|NCT00557466|12148628|FG003|STARTED|Overall Study||96
10974170|NCT00557466|12148629|FG004|STARTED|Overall Study||90
10974171|NCT00557466|12148630|FG005|STARTED|Overall Study||91
10974172|NCT00557466|12148625|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
10974173|NCT00557466|12148626|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
10974174|NCT00557466|12148627|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
10974175|NCT00557466|12148628|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
10974176|NCT00557466|12148629|FG004|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
10974177|NCT00557466|12148630|FG005|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
10974178|NCT00557466|12148625|FG000|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
10974179|NCT00557466|12148626|FG001|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
10974180|NCT00557466|12148627|FG002|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
10974181|NCT00557466|12148628|FG003|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
10974182|NCT00557466|12148629|FG004|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
10974183|NCT00557466|12148630|FG005|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
10974184|NCT00557466|12148625|FG000|COMPLETED|Overall Study||94
10974185|NCT00557466|12148626|FG001|COMPLETED|Overall Study||87
10974186|NCT00557466|12148627|FG002|COMPLETED|Overall Study||95
10974187|NCT00557466|12148628|FG003|COMPLETED|Overall Study||92
10974188|NCT00557466|12148629|FG004|COMPLETED|Overall Study||87
10974189|NCT00557466|12148630|FG005|COMPLETED|Overall Study||85
10974190|NCT00557466|12148625|FG000|NOT COMPLETED|Overall Study||4
10974191|NCT00557466|12148626|FG001|NOT COMPLETED|Overall Study||5
10974192|NCT00557466|12148627|FG002|NOT COMPLETED|Overall Study||6
10974193|NCT00557466|12148628|FG003|NOT COMPLETED|Overall Study||4
10974194|NCT00557466|12148629|FG004|NOT COMPLETED|Overall Study||3
10974195|NCT00557466|12148630|FG005|NOT COMPLETED|Overall Study||6
10974196|NCT00557492|12148644|FG000|STARTED|Overall Study||59
10974197|NCT00557492|12148644|FG000|COMPLETED|Overall Study|Evaluable for outcomes|58
10974198|NCT00557492|12148644|FG000|NOT COMPLETED|Overall Study||1
10974199|NCT00557505|12148657|FG000|STARTED|Overall Study||3
10974200|NCT00557505|12148658|FG001|STARTED|Overall Study||3
10974201|NCT00557505|12148659|FG002|STARTED|Overall Study||4
10974202|NCT00557505|12148660|FG003|STARTED|Overall Study||3
10974203|NCT00557505|12148661|FG004|STARTED|Overall Study||2
10974204|NCT00557505|12148662|FG005|STARTED|Overall Study||3
10974205|NCT00557505|12148663|FG006|STARTED|Overall Study||3
10974206|NCT00557505|12148664|FG007|STARTED|Overall Study||5
10974207|NCT00557505|12148665|FG008|STARTED|Overall Study||17
10974208|NCT00557505|12148657|FG000|COMPLETED|Overall Study||0
10974209|NCT00557505|12148658|FG001|COMPLETED|Overall Study||0
10974210|NCT00557505|12148659|FG002|COMPLETED|Overall Study||0
10974211|NCT00557505|12148660|FG003|COMPLETED|Overall Study||0
10974212|NCT00557505|12148661|FG004|COMPLETED|Overall Study||0
10974213|NCT00557505|12148662|FG005|COMPLETED|Overall Study||0
10974214|NCT00557505|12148663|FG006|COMPLETED|Overall Study||0
10974215|NCT00557505|12148664|FG007|COMPLETED|Overall Study||0
10974216|NCT00557505|12148665|FG008|COMPLETED|Overall Study||0
10974217|NCT00557505|12148657|FG000|NOT COMPLETED|Overall Study||3
10974218|NCT00557505|12148658|FG001|NOT COMPLETED|Overall Study||3
10974219|NCT00557505|12148659|FG002|NOT COMPLETED|Overall Study||4
10974220|NCT00557505|12148660|FG003|NOT COMPLETED|Overall Study||3
10974221|NCT00557505|12148661|FG004|NOT COMPLETED|Overall Study||2
10974222|NCT00557505|12148662|FG005|NOT COMPLETED|Overall Study||3
10974223|NCT00557505|12148663|FG006|NOT COMPLETED|Overall Study||3
10974224|NCT00557505|12148664|FG007|NOT COMPLETED|Overall Study||5
10974225|NCT00557505|12148665|FG008|NOT COMPLETED|Overall Study||17
10974226|NCT00557622|12148690|FG000|STARTED|4-Week Run-in Phase||5
10974227|NCT00557622|12148691|FG001|STARTED|4-Week Run-in Phase||0
10974228|NCT00557622|12148690|FG000|COMPLETED|4-Week Run-in Phase||3
10974229|NCT00557622|12148691|FG001|COMPLETED|4-Week Run-in Phase||0
10974230|NCT00557622|12148690|FG000|NOT COMPLETED|4-Week Run-in Phase||2
10974231|NCT00557622|12148691|FG001|NOT COMPLETED|4-Week Run-in Phase||0
10974232|NCT00557622|12148690|FG000|STARTED|12-Week Treatment Phase||1
10974233|NCT00557622|12148691|FG001|STARTED|12-Week Treatment Phase||2
10974234|NCT00557622|12148690|FG000|COMPLETED|12-Week Treatment Phase||1
10974235|NCT00557622|12148691|FG001|COMPLETED|12-Week Treatment Phase||1
10974236|NCT00557622|12148690|FG000|NOT COMPLETED|12-Week Treatment Phase||0
10974237|NCT00557622|12148691|FG001|NOT COMPLETED|12-Week Treatment Phase||1
10974238|NCT00557830|12148700|FG000|STARTED|Screening Treatment Phase||12
10974239|NCT00557830|12148701|FG001|STARTED|Screening Treatment Phase||0
10974240|NCT00557830|12148702|FG002|STARTED|Screening Treatment Phase||0
10974241|NCT00557830|12148700|FG000|COMPLETED|Screening Treatment Phase||6
10974242|NCT00557830|12148701|FG001|COMPLETED|Screening Treatment Phase||0
10974243|NCT00557830|12148702|FG002|COMPLETED|Screening Treatment Phase||0
10974244|NCT00557830|12148700|FG000|NOT COMPLETED|Screening Treatment Phase||6
10974245|NCT00557830|12148701|FG001|NOT COMPLETED|Screening Treatment Phase||0
10974246|NCT00557830|12148702|FG002|NOT COMPLETED|Screening Treatment Phase||0
10974247|NCT00557830|12148700|FG000|STARTED|Treatment Phase||0
10974248|NCT00557830|12148701|FG001|STARTED|Treatment Phase||4
10974249|NCT00557830|12148702|FG002|STARTED|Treatment Phase||2
10974250|NCT00557830|12148700|FG000|COMPLETED|Treatment Phase||0
10974251|NCT00557830|12148701|FG001|COMPLETED|Treatment Phase||4
10974252|NCT00557830|12148702|FG002|COMPLETED|Treatment Phase||2
10974253|NCT00557830|12148700|FG000|NOT COMPLETED|Treatment Phase||0
10974254|NCT00557830|12148701|FG001|NOT COMPLETED|Treatment Phase||0
10974255|NCT00557830|12148702|FG002|NOT COMPLETED|Treatment Phase||0
10974256|NCT00557856|12148710|FG000|STARTED|Part 1: Dose Escalation Phase||7
10974257|NCT00557856|12148711|FG001|STARTED|Part 1: Dose Escalation Phase||5
10974258|NCT00557856|12148712|FG002|STARTED|Part 1: Dose Escalation Phase||6
10974259|NCT00557856|12148713|FG003|STARTED|Part 1: Dose Escalation Phase||3
10974260|NCT00557856|12148714|FG004|STARTED|Part 1: Dose Escalation Phase||4
10974261|NCT00557856|12148715|FG005|STARTED|Part 1: Dose Escalation Phase||8
10974262|NCT00557856|12148716|FG006|STARTED|Part 1: Dose Escalation Phase||7
10974263|NCT00557856|12148717|FG007|STARTED|Part 1: Dose Escalation Phase||6
10974264|NCT00557856|12148718|FG008|STARTED|Part 1: Dose Escalation Phase||0
10974265|NCT00557856|12148710|FG000|Treated|Part 1: Dose Escalation Phase||5
10974266|NCT00557856|12148711|FG001|Treated|Part 1: Dose Escalation Phase||5
10974267|NCT00557856|12148712|FG002|Treated|Part 1: Dose Escalation Phase||6
10974268|NCT00557856|12148713|FG003|Treated|Part 1: Dose Escalation Phase||3
10974269|NCT00557856|12148714|FG004|Treated|Part 1: Dose Escalation Phase||4
10974270|NCT00557856|12148715|FG005|Treated|Part 1: Dose Escalation Phase||8
10974271|NCT00557856|12148716|FG006|Treated|Part 1: Dose Escalation Phase||7
10974272|NCT00557856|12148717|FG007|Treated|Part 1: Dose Escalation Phase||6
10974273|NCT00557856|12148718|FG008|Treated|Part 1: Dose Escalation Phase||0
10974274|NCT00557856|12148710|FG000|COMPLETED|Part 1: Dose Escalation Phase||0
10974275|NCT00557856|12148711|FG001|COMPLETED|Part 1: Dose Escalation Phase||0
10974276|NCT00557856|12148712|FG002|COMPLETED|Part 1: Dose Escalation Phase||0
10974277|NCT00557856|12148713|FG003|COMPLETED|Part 1: Dose Escalation Phase||0
10974278|NCT00557856|12148714|FG004|COMPLETED|Part 1: Dose Escalation Phase||0
10974279|NCT00557856|12148715|FG005|COMPLETED|Part 1: Dose Escalation Phase||0
10974280|NCT00557856|12148716|FG006|COMPLETED|Part 1: Dose Escalation Phase||0
10974281|NCT00557856|12148717|FG007|COMPLETED|Part 1: Dose Escalation Phase||0
10974282|NCT00557856|12148718|FG008|COMPLETED|Part 1: Dose Escalation Phase||0
10974283|NCT00557856|12148710|FG000|NOT COMPLETED|Part 1: Dose Escalation Phase||7
10974284|NCT00557856|12148711|FG001|NOT COMPLETED|Part 1: Dose Escalation Phase||5
10974285|NCT00557856|12148712|FG002|NOT COMPLETED|Part 1: Dose Escalation Phase||6
10974286|NCT00557856|12148713|FG003|NOT COMPLETED|Part 1: Dose Escalation Phase||3
10974287|NCT00557856|12148714|FG004|NOT COMPLETED|Part 1: Dose Escalation Phase||4
10974288|NCT00557856|12148715|FG005|NOT COMPLETED|Part 1: Dose Escalation Phase||8
10974289|NCT00557856|12148716|FG006|NOT COMPLETED|Part 1: Dose Escalation Phase||7
10974290|NCT00557856|12148717|FG007|NOT COMPLETED|Part 1: Dose Escalation Phase||6
10974291|NCT00557856|12148718|FG008|NOT COMPLETED|Part 1: Dose Escalation Phase||0
10974292|NCT00557856|12148710|FG000|STARTED|Part 2: Exploratory Phase||0
10974293|NCT00557856|12148711|FG001|STARTED|Part 2: Exploratory Phase||0
10974294|NCT00557856|12148712|FG002|STARTED|Part 2: Exploratory Phase||0
10974295|NCT00557856|12148713|FG003|STARTED|Part 2: Exploratory Phase||0
10974296|NCT00557856|12148714|FG004|STARTED|Part 2: Exploratory Phase||0
10974297|NCT00557856|12148715|FG005|STARTED|Part 2: Exploratory Phase||0
10974298|NCT00557856|12148716|FG006|STARTED|Part 2: Exploratory Phase||0
10974299|NCT00557856|12148717|FG007|STARTED|Part 2: Exploratory Phase||0
10974300|NCT00557856|12148718|FG008|STARTED|Part 2: Exploratory Phase||24
10974301|NCT00557856|12148710|FG000|COMPLETED|Part 2: Exploratory Phase||0
10974302|NCT00557856|12148711|FG001|COMPLETED|Part 2: Exploratory Phase||0
10974303|NCT00557856|12148712|FG002|COMPLETED|Part 2: Exploratory Phase||0
10974304|NCT00557856|12148713|FG003|COMPLETED|Part 2: Exploratory Phase||0
10974305|NCT00557856|12148714|FG004|COMPLETED|Part 2: Exploratory Phase||0
10974306|NCT00557856|12148715|FG005|COMPLETED|Part 2: Exploratory Phase||0
10974307|NCT00557856|12148716|FG006|COMPLETED|Part 2: Exploratory Phase||0
10974308|NCT00557856|12148717|FG007|COMPLETED|Part 2: Exploratory Phase||0
10974309|NCT00557856|12148718|FG008|COMPLETED|Part 2: Exploratory Phase||0
10974310|NCT00557856|12148710|FG000|NOT COMPLETED|Part 2: Exploratory Phase||0
10974311|NCT00557856|12148711|FG001|NOT COMPLETED|Part 2: Exploratory Phase||0
10974312|NCT00557856|12148712|FG002|NOT COMPLETED|Part 2: Exploratory Phase||0
10974313|NCT00557856|12148713|FG003|NOT COMPLETED|Part 2: Exploratory Phase||0
10974314|NCT00557856|12148714|FG004|NOT COMPLETED|Part 2: Exploratory Phase||0
10974315|NCT00557856|12148715|FG005|NOT COMPLETED|Part 2: Exploratory Phase||0
10974316|NCT00557856|12148716|FG006|NOT COMPLETED|Part 2: Exploratory Phase||0
10974317|NCT00557856|12148717|FG007|NOT COMPLETED|Part 2: Exploratory Phase||0
10974318|NCT00557856|12148718|FG008|NOT COMPLETED|Part 2: Exploratory Phase||24
10974319|NCT00557882|12148735|FG000|STARTED|Overall Study||32
10974320|NCT00557882|12148736|FG001|STARTED|Overall Study||33
10974321|NCT00557882|12148735|FG000|COMPLETED|Overall Study||27
10974322|NCT00557882|12148736|FG001|COMPLETED|Overall Study||33
10974323|NCT00557882|12148735|FG000|NOT COMPLETED|Overall Study||5
10974324|NCT00557882|12148736|FG001|NOT COMPLETED|Overall Study||0
10974325|NCT00557947|12148742|FG000|STARTED|Overall Study||83
10974326|NCT00557947|12148742|FG000|COMPLETED|Overall Study||83
10974327|NCT00557947|12148742|FG000|NOT COMPLETED|Overall Study||0
10974328|NCT00558012|12148752|FG000|STARTED|Overall Study||89
10974329|NCT00558012|12148753|FG001|STARTED|Overall Study||92
10974330|NCT00558012|12148752|FG000|COMPLETED|Overall Study||64
10974331|NCT00558012|12148753|FG001|COMPLETED|Overall Study||74
10974332|NCT00558012|12148752|FG000|NOT COMPLETED|Overall Study||25
10974333|NCT00558012|12148753|FG001|NOT COMPLETED|Overall Study||18
10974334|NCT00558025|12148761|FG000|STARTED|Overall Study||104
10974335|NCT00558025|12148762|FG001|STARTED|Overall Study||52
10974336|NCT00558025|12148761|FG000|COMPLETED|Overall Study||100
10974337|NCT00558025|12148762|FG001|COMPLETED|Overall Study||49
10974338|NCT00558025|12148761|FG000|NOT COMPLETED|Overall Study||4
10974339|NCT00558025|12148762|FG001|NOT COMPLETED|Overall Study||3
10974340|NCT00558064|12148770|FG000|STARTED|Overall Study||269
10974341|NCT00558064|12148771|FG001|STARTED|Overall Study||262
10974342|NCT00558064|12148770|FG000|COMPLETED|Overall Study||264
10974343|NCT00558064|12148771|FG001|COMPLETED|Overall Study||257
10974344|NCT00558064|12148770|FG000|NOT COMPLETED|Overall Study||5
10974345|NCT00558064|12148771|FG001|NOT COMPLETED|Overall Study||5
10974346|NCT00558103|12148782|FG000|STARTED|Randomized Treatment Phase||38
10974347|NCT00558103|12148783|FG001|STARTED|Randomized Treatment Phase||38
10974348|NCT00558103|12148784|FG002|STARTED|Randomized Treatment Phase||36
10974349|NCT00558103|12148785|FG003|STARTED|Randomized Treatment Phase||13
10974350|NCT00558103|12148786|FG004|STARTED|Randomized Treatment Phase||38
10974351|NCT00558103|12148787|FG005|STARTED|Randomized Treatment Phase||0
10974352|NCT00558103|12148782|FG000|COMPLETED|Randomized Treatment Phase||33
10974353|NCT00558103|12148783|FG001|COMPLETED|Randomized Treatment Phase||34
10974354|NCT00558103|12148784|FG002|COMPLETED|Randomized Treatment Phase||33
10974355|NCT00558103|12148785|FG003|COMPLETED|Randomized Treatment Phase||11
10974356|NCT00558103|12148786|FG004|COMPLETED|Randomized Treatment Phase||33
10974357|NCT00558103|12148787|FG005|COMPLETED|Randomized Treatment Phase||0
10974358|NCT00558103|12148782|FG000|NOT COMPLETED|Randomized Treatment Phase||5
10974359|NCT00558103|12148783|FG001|NOT COMPLETED|Randomized Treatment Phase||4
10974360|NCT00558103|12148784|FG002|NOT COMPLETED|Randomized Treatment Phase||3
10974361|NCT00558103|12148785|FG003|NOT COMPLETED|Randomized Treatment Phase||2
10974362|NCT00558103|12148786|FG004|NOT COMPLETED|Randomized Treatment Phase||5
10974363|NCT00558103|12148787|FG005|NOT COMPLETED|Randomized Treatment Phase||0
10974364|NCT00558103|12148782|FG000|STARTED|Monotherapy Extension Phase||0
10974365|NCT00558103|12148783|FG001|STARTED|Monotherapy Extension Phase||0
10974366|NCT00558103|12148784|FG002|STARTED|Monotherapy Extension Phase||0
10974367|NCT00558103|12148785|FG003|STARTED|Monotherapy Extension Phase||0
10974368|NCT00558103|12148786|FG004|STARTED|Monotherapy Extension Phase||0
10974369|NCT00558103|12148787|FG005|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
10974370|NCT00558103|12148782|FG000|COMPLETED|Monotherapy Extension Phase||0
10974371|NCT00558103|12148783|FG001|COMPLETED|Monotherapy Extension Phase||0
10974372|NCT00558103|12148784|FG002|COMPLETED|Monotherapy Extension Phase||0
10974373|NCT00558103|12148785|FG003|COMPLETED|Monotherapy Extension Phase||0
10974374|NCT00558103|12148786|FG004|COMPLETED|Monotherapy Extension Phase||0
10974375|NCT00558103|12148787|FG005|COMPLETED|Monotherapy Extension Phase||0
10974376|NCT00558103|12148782|FG000|NOT COMPLETED|Monotherapy Extension Phase||0
10974377|NCT00558103|12148783|FG001|NOT COMPLETED|Monotherapy Extension Phase||0
10974378|NCT00558103|12148784|FG002|NOT COMPLETED|Monotherapy Extension Phase||0
10974379|NCT00558103|12148785|FG003|NOT COMPLETED|Monotherapy Extension Phase||0
10974380|NCT00558103|12148786|FG004|NOT COMPLETED|Monotherapy Extension Phase||0
10974381|NCT00558103|12148787|FG005|NOT COMPLETED|Monotherapy Extension Phase||9
10974382|NCT00558246|12148800|FG000|STARTED|Overall Study||79
10974383|NCT00558246|12148800|FG000|COMPLETED|Overall Study||79
10974384|NCT00558246|12148800|FG000|NOT COMPLETED|Overall Study||0
10974385|NCT00558259|12148809|FG000|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
10974386|NCT00558259|12148810|FG001|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
10974387|NCT00558259|12148809|FG000|COMPLETED|Overall Study|Completed treatment.|610
10974388|NCT00558259|12148810|FG001|COMPLETED|Overall Study|Completed treatment.|563
10974389|NCT00558259|12148809|FG000|NOT COMPLETED|Overall Study||71
10974390|NCT00558259|12148810|FG001|NOT COMPLETED|Overall Study||99
10974391|NCT00558272|12148818|FG000|STARTED|Overall Study|Randomised|69
10974392|NCT00558272|12148819|FG001|STARTED|Overall Study|Randomised|70
10974393|NCT00558272|12148818|FG000|30 Days Follow-up|Overall Study|30 days after last dose|41
10974394|NCT00558272|12148819|FG001|30 Days Follow-up|Overall Study|30 days after last dose|67
10974395|NCT00558272|12148818|FG000|COMPLETED|Overall Study|4-week treatment period|56
10974396|NCT00558272|12148819|FG001|COMPLETED|Overall Study|4-week treatment period|68
10974397|NCT00558272|12148818|FG000|NOT COMPLETED|Overall Study||13
10974398|NCT00558272|12148819|FG001|NOT COMPLETED|Overall Study||2
10974399|NCT00558285|12148830|FG000|STARTED|Overall Study||50
10974400|NCT00558285|12148831|FG001|STARTED|Overall Study||51
10974401|NCT00558285|12148832|FG002|STARTED|Overall Study||51
10974402|NCT00558285|12148833|FG003|STARTED|Overall Study||52
10974403|NCT00558285|12148834|FG004|STARTED|Overall Study||53
10974404|NCT00558285|12148830|FG000|Safety: Received Study Drug|Overall Study||49
10974405|NCT00558285|12148831|FG001|Safety: Received Study Drug|Overall Study||51
10974406|NCT00558285|12148832|FG002|Safety: Received Study Drug|Overall Study||51
10974407|NCT00558285|12148833|FG003|Safety: Received Study Drug|Overall Study||51
10974408|NCT00558285|12148834|FG004|Safety: Received Study Drug|Overall Study||53
10974409|NCT00558285|12148830|FG000|COMPLETED|Overall Study||44
10974410|NCT00558285|12148831|FG001|COMPLETED|Overall Study||48
10974411|NCT00558285|12148832|FG002|COMPLETED|Overall Study||46
10974412|NCT00558285|12148833|FG003|COMPLETED|Overall Study||48
10974413|NCT00558285|12148834|FG004|COMPLETED|Overall Study||49
10974414|NCT00558285|12148830|FG000|NOT COMPLETED|Overall Study||6
10974415|NCT00558285|12148831|FG001|NOT COMPLETED|Overall Study||3
10974416|NCT00558285|12148832|FG002|NOT COMPLETED|Overall Study||5
10974417|NCT00558285|12148833|FG003|NOT COMPLETED|Overall Study||4
10974418|NCT00558285|12148834|FG004|NOT COMPLETED|Overall Study||4
10974419|NCT00558363|12148848|FG000|STARTED|Overall Study||147
10974420|NCT00558363|12148849|FG001|STARTED|Overall Study||147
10974421|NCT00558363|12148848|FG000|COMPLETED|Overall Study||76
10974422|NCT00558363|12148849|FG001|COMPLETED|Overall Study||111
10974423|NCT00558363|12148848|FG000|NOT COMPLETED|Overall Study||71
10974424|NCT00558363|12148849|FG001|NOT COMPLETED|Overall Study||36
10974425|NCT00558428|12148859|FG000|STARTED|Overall Study||267
10974426|NCT00558428|12148860|FG001|STARTED|Overall Study||276
10974427|NCT00558428|12148861|FG002|STARTED|Overall Study||277
10974428|NCT00558428|12148862|FG003|STARTED|Overall Study||277
10974429|NCT00558428|12148859|FG000|COMPLETED|Overall Study||255
10974430|NCT00558428|12148860|FG001|COMPLETED|Overall Study||252
10974431|NCT00558428|12148861|FG002|COMPLETED|Overall Study||273
10974432|NCT00558428|12148862|FG003|COMPLETED|Overall Study||266
10974433|NCT00558428|12148859|FG000|NOT COMPLETED|Overall Study||12
10974434|NCT00558428|12148860|FG001|NOT COMPLETED|Overall Study||24
10974435|NCT00558428|12148861|FG002|NOT COMPLETED|Overall Study||4
10974436|NCT00558428|12148862|FG003|NOT COMPLETED|Overall Study||11
10974437|NCT00558467|12148874|FG000|STARTED|Overall Study||20
10974438|NCT00558467|12148875|FG001|STARTED|Overall Study||43
10974439|NCT00558467|12148874|FG000|COMPLETED|Overall Study||19
10974440|NCT00558467|12148875|FG001|COMPLETED|Overall Study||39
10974441|NCT00558467|12148874|FG000|NOT COMPLETED|Overall Study||1
10974442|NCT00558467|12148875|FG001|NOT COMPLETED|Overall Study||4
10974443|NCT00558519|12148881|FG000|STARTED|Overall Study||318
10974444|NCT00558519|12148881|FG000|COMPLETED|Overall Study||295
10974445|NCT00558519|12148881|FG000|NOT COMPLETED|Overall Study||23
10974446|NCT00558571|12148889|FG000|STARTED|Overall Study||16
10974447|NCT00558571|12148890|FG001|STARTED|Overall Study||16
10974448|NCT00558571|12148891|FG002|STARTED|Overall Study||16
10974449|NCT00558571|12148892|FG003|STARTED|Overall Study||30
10974450|NCT00558571|12148889|FG000|COMPLETED|Overall Study||16
10974451|NCT00558571|12148890|FG001|COMPLETED|Overall Study||16
10974452|NCT00558571|12148891|FG002|COMPLETED|Overall Study||16
10974453|NCT00558571|12148892|FG003|COMPLETED|Overall Study||30
10974454|NCT00558571|12148889|FG000|NOT COMPLETED|Overall Study||0
10974455|NCT00558571|12148890|FG001|NOT COMPLETED|Overall Study||0
10974456|NCT00558571|12148891|FG002|NOT COMPLETED|Overall Study||0
10974457|NCT00558571|12148892|FG003|NOT COMPLETED|Overall Study||0
10974458|NCT00558636|12148915|FG000|STARTED|Treatment|up to 6 cycles of combination therapy|47
10974459|NCT00558636|12148916|FG001|STARTED|Treatment||44
10974460|NCT00558636|12148915|FG000|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
10974461|NCT00558636|12148916|FG001|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
10974462|NCT00558636|12148915|FG000|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
10974463|NCT00558636|12148916|FG001|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
10974464|NCT00558636|12148915|FG000|NOT COMPLETED|Treatment||47
10974465|NCT00558636|12148916|FG001|NOT COMPLETED|Treatment||44
10974466|NCT00558636|12148915|FG000|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
10974467|NCT00558636|12148916|FG001|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
10974468|NCT00558636|12148915|FG000|COMPLETED|Follow-up|Study was prematurely terminated|0
10974469|NCT00558636|12148916|FG001|COMPLETED|Follow-up|Study was prematurely terminated|0
10974470|NCT00558636|12148915|FG000|NOT COMPLETED|Follow-up||12
10974471|NCT00558636|12148916|FG001|NOT COMPLETED|Follow-up||7
10974472|NCT00558701|12148924|FG000|STARTED|Overall Study||15
10974473|NCT00558701|12148925|FG001|STARTED|Overall Study||15
10974474|NCT00558701|12148924|FG000|COMPLETED|Overall Study||14
10974475|NCT00558701|12148925|FG001|COMPLETED|Overall Study||11
10974476|NCT00558701|12148924|FG000|NOT COMPLETED|Overall Study||1
10974477|NCT00558701|12148925|FG001|NOT COMPLETED|Overall Study||4
10974478|NCT00558753|12148933|FG000|STARTED|Overall Study||120
10974479|NCT00558753|12148934|FG001|STARTED|Overall Study||120
10974480|NCT00558753|12148933|FG000|COMPLETED|Overall Study||115
10974481|NCT00558753|12148934|FG001|COMPLETED|Overall Study||113
10974482|NCT00558753|12148933|FG000|NOT COMPLETED|Overall Study||5
10974483|NCT00558753|12148934|FG001|NOT COMPLETED|Overall Study||7
10974484|NCT00558792|12148943|FG000|STARTED|Overall Study||68
10974485|NCT00558792|12148944|FG001|STARTED|Overall Study||63
10974486|NCT00558792|12148945|FG002|STARTED|Overall Study||60
10974487|NCT00558792|12148943|FG000|COMPLETED|Overall Study||68
10974488|NCT00558792|12148944|FG001|COMPLETED|Overall Study||63
10974489|NCT00558792|12148945|FG002|COMPLETED|Overall Study||60
10974490|NCT00558792|12148943|FG000|NOT COMPLETED|Overall Study||0
10974491|NCT00558792|12148944|FG001|NOT COMPLETED|Overall Study||0
10974492|NCT00558792|12148945|FG002|NOT COMPLETED|Overall Study||0
10974493|NCT00558831|12148956|FG000|STARTED|Overall Study||11
10974494|NCT00558831|12148956|FG000|COMPLETED|Overall Study||10
10974495|NCT00558831|12148956|FG000|NOT COMPLETED|Overall Study||1
10974496|NCT00558844|12148967|FG000|STARTED|Overall Study||15
10974497|NCT00558844|12148968|FG001|STARTED|Overall Study||7
10974498|NCT00558844|12148969|FG002|STARTED|Overall Study||7
10974499|NCT00558844|12148970|FG003|STARTED|Overall Study||5
10974500|NCT00558844|12148971|FG004|STARTED|Overall Study||7
10974501|NCT00558844|12148967|FG000|COMPLETED|Overall Study||12
10974502|NCT00558844|12148968|FG001|COMPLETED|Overall Study||7
10974503|NCT00558844|12148969|FG002|COMPLETED|Overall Study||6
10974504|NCT00558844|12148970|FG003|COMPLETED|Overall Study||5
10974505|NCT00558844|12148971|FG004|COMPLETED|Overall Study||6
10974506|NCT00558844|12148967|FG000|NOT COMPLETED|Overall Study||3
10974507|NCT00558844|12148968|FG001|NOT COMPLETED|Overall Study||0
10974508|NCT00558844|12148969|FG002|NOT COMPLETED|Overall Study||1
10974509|NCT00558844|12148970|FG003|NOT COMPLETED|Overall Study||0
10974510|NCT00558844|12148971|FG004|NOT COMPLETED|Overall Study||1
10974511|NCT00558896|12148991|FG000|STARTED|Overall Study||60
10974512|NCT00558896|12148992|FG001|STARTED|Overall Study||34
10974513|NCT00558896|12148993|FG002|STARTED|Overall Study||35
10974514|NCT00558896|12148994|FG003|STARTED|Overall Study||35
10974515|NCT00558896|12148995|FG004|STARTED|Overall Study||60
10974516|NCT00558896|12148996|FG005|STARTED|Overall Study||120
10974517|NCT00558896|12148997|FG006|STARTED|Overall Study||33
10974518|NCT00558896|12148991|FG000|COMPLETED|Overall Study||39
10974519|NCT00558896|12148992|FG001|COMPLETED|Overall Study||27
10974520|NCT00558896|12148993|FG002|COMPLETED|Overall Study||30
10974521|NCT00558896|12148994|FG003|COMPLETED|Overall Study||23
10974522|NCT00558896|12148995|FG004|COMPLETED|Overall Study||37
10974523|NCT00558896|12148996|FG005|COMPLETED|Overall Study||68
10974524|NCT00558896|12148997|FG006|COMPLETED|Overall Study||9
10974525|NCT00558896|12148991|FG000|NOT COMPLETED|Overall Study||21
10974526|NCT00558896|12148992|FG001|NOT COMPLETED|Overall Study||7
10974527|NCT00558896|12148993|FG002|NOT COMPLETED|Overall Study||5
10974528|NCT00558896|12148994|FG003|NOT COMPLETED|Overall Study||12
10974529|NCT00558896|12148995|FG004|NOT COMPLETED|Overall Study||23
10974530|NCT00558896|12148996|FG005|NOT COMPLETED|Overall Study||52
10974531|NCT00558896|12148997|FG006|NOT COMPLETED|Overall Study||24
10974532|NCT00559013|12149013|FG000|STARTED|Overall Study||38
10974533|NCT00559013|12149013|FG000|COMPLETED|Overall Study||38
10974534|NCT00559013|12149013|FG000|NOT COMPLETED|Overall Study||0
10974535|NCT00559104|12149019|FG000|STARTED|Overall Study||55
10974536|NCT00559104|12149020|FG001|STARTED|Overall Study||5
10974537|NCT00559104|12149019|FG000|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
10974538|NCT00559104|12149020|FG001|COMPLETED|Overall Study||5
10974539|NCT00559104|12149019|FG000|NOT COMPLETED|Overall Study||9
10974540|NCT00559104|12149020|FG001|NOT COMPLETED|Overall Study||0
10974541|NCT00559273|12149028|FG000|STARTED|Correction Period (20 Weeks)||153
10974542|NCT00559273|12149029|FG001|STARTED|Correction Period (20 Weeks)||154
10974543|NCT00559273|12149028|FG000|Treated|Correction Period (20 Weeks)||151
10974544|NCT00559273|12149029|FG001|Treated|Correction Period (20 Weeks)||154
10974545|NCT00559273|12149028|FG000|COMPLETED|Correction Period (20 Weeks)||144
10974546|NCT00559273|12149029|FG001|COMPLETED|Correction Period (20 Weeks)||142
10974547|NCT00559273|12149028|FG000|NOT COMPLETED|Correction Period (20 Weeks)||9
10974548|NCT00559273|12149029|FG001|NOT COMPLETED|Correction Period (20 Weeks)||12
10974549|NCT00559273|12149028|FG000|STARTED|Evaluation Period (8 Weeks)||144
10974550|NCT00559273|12149029|FG001|STARTED|Evaluation Period (8 Weeks)||142
10974551|NCT00559273|12149028|FG000|COMPLETED|Evaluation Period (8 Weeks)||141
10974552|NCT00559273|12149029|FG001|COMPLETED|Evaluation Period (8 Weeks)||137
10974553|NCT00559273|12149028|FG000|NOT COMPLETED|Evaluation Period (8 Weeks)||3
10974554|NCT00559273|12149029|FG001|NOT COMPLETED|Evaluation Period (8 Weeks)||5
10974555|NCT00559364|12149037|FG000|STARTED|Overall Study||30
10974556|NCT00559364|12149038|FG001|STARTED|Overall Study||20
10974557|NCT00559364|12149037|FG000|COMPLETED|Overall Study||29
10974558|NCT00559364|12149038|FG001|COMPLETED|Overall Study||20
10974559|NCT00559364|12149037|FG000|NOT COMPLETED|Overall Study||1
10974560|NCT00559364|12149038|FG001|NOT COMPLETED|Overall Study||0
10974561|NCT00559377|12149044|FG000|STARTED|Overall Study||16
10974562|NCT00559377|12149044|FG000|COMPLETED|Overall Study||7
10974563|NCT00559377|12149044|FG000|NOT COMPLETED|Overall Study||9
10974564|NCT00559468|12149053|FG000|STARTED|Overall Study||26
10974565|NCT00559468|12149054|FG001|STARTED|Overall Study||26
10974566|NCT00559468|12149053|FG000|Treated|Overall Study||26
10974567|NCT00559468|12149054|FG001|Treated|Overall Study||25
10974568|NCT00559468|12149053|FG000|COMPLETED|Overall Study||26
10974569|NCT00559468|12149054|FG001|COMPLETED|Overall Study||25
10974570|NCT00559468|12149053|FG000|NOT COMPLETED|Overall Study||0
10974571|NCT00559468|12149054|FG001|NOT COMPLETED|Overall Study||1
10974572|NCT00559507|12149060|FG000|STARTED|Overall Study||12
10974573|NCT00559507|12149060|FG000|COMPLETED|Overall Study||9
10974574|NCT00559507|12149060|FG000|NOT COMPLETED|Overall Study||3
10974575|NCT00559585|12149066|FG000|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
10974576|NCT00559585|12149067|FG001|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
10974577|NCT00559585|12149066|FG000|COMPLETED|Double Blind ST Period Main Study||693
10974578|NCT00559585|12149067|FG001|COMPLETED|Double Blind ST Period Main Study||676
10974579|NCT00559585|12149066|FG000|NOT COMPLETED|Double Blind ST Period Main Study||43
10974580|NCT00559585|12149067|FG001|NOT COMPLETED|Double Blind ST Period Main Study||45
10974581|NCT00559585|12149066|FG000|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
10974582|NCT00559585|12149067|FG001|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
10974583|NCT00559585|12149066|FG000|COMPLETED|Anti-TNF Sub-Study in ST Period||7
10974584|NCT00559585|12149067|FG001|COMPLETED|Anti-TNF Sub-Study in ST Period||9
10974585|NCT00559585|12149066|FG000|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
10974586|NCT00559585|12149067|FG001|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
10974587|NCT00559585|12149066|FG000|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
10974588|NCT00559585|12149067|FG001|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
10974589|NCT00559585|12149066|FG000|COMPLETED|Open Label LT Period Main + Sub-Study||945
10974590|NCT00559585|12149067|FG001|COMPLETED|Open Label LT Period Main + Sub-Study||0
10974591|NCT00559585|12149066|FG000|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
10974592|NCT00559585|12149067|FG001|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
10974593|NCT00559637|12149084|FG000|STARTED|Overall Study||184
10974594|NCT00559637|12149084|FG000|COMPLETED|Overall Study||130
10974595|NCT00559637|12149084|FG000|NOT COMPLETED|Overall Study||54
10974596|NCT00559754|12149088|FG000|STARTED|Overall Study||72
10974597|NCT00559754|12149088|FG000|COMPLETED|Overall Study||61
10974598|NCT00559754|12149088|FG000|NOT COMPLETED|Overall Study||11
10974599|NCT00559845|12149092|FG000|STARTED|Overall Study||56
10974600|NCT00559845|12149092|FG000|COMPLETED|Overall Study||49
10974601|NCT00559845|12149092|FG000|NOT COMPLETED|Overall Study||7
10974602|NCT00559949|12149096|FG000|STARTED|Overall Study||39
10974603|NCT00559949|12149096|FG000|COMPLETED|Overall Study||32
10974604|NCT00559949|12149096|FG000|NOT COMPLETED|Overall Study||7
10974605|NCT00559962|12149108|FG000|STARTED|Overall Study||33
10974606|NCT00559962|12149109|FG001|STARTED|Overall Study||34
10974607|NCT00559962|12149110|FG002|STARTED|Overall Study||34
10974608|NCT00559962|12149111|FG003|STARTED|Overall Study||34
10974609|NCT00559962|12149112|FG004|STARTED|Overall Study||35
10974610|NCT00559962|12149113|FG005|STARTED|Overall Study||28
10974611|NCT00559962|12149114|FG006|STARTED|Overall Study||33
10974612|NCT00559962|12149115|FG007|STARTED|Overall Study||29
10974613|NCT00559962|12149108|FG000|COMPLETED|Overall Study||31
10974614|NCT00559962|12149109|FG001|COMPLETED|Overall Study||25
10974615|NCT00559962|12149110|FG002|COMPLETED|Overall Study||24
10974616|NCT00559962|12149111|FG003|COMPLETED|Overall Study||29
10974617|NCT00559962|12149112|FG004|COMPLETED|Overall Study||21
10974618|NCT00559962|12149113|FG005|COMPLETED|Overall Study||23
10974619|NCT00559962|12149114|FG006|COMPLETED|Overall Study||28
10974620|NCT00559962|12149115|FG007|COMPLETED|Overall Study||25
10974621|NCT00559962|12149108|FG000|NOT COMPLETED|Overall Study||2
10974622|NCT00559962|12149109|FG001|NOT COMPLETED|Overall Study||9
10974623|NCT00559962|12149110|FG002|NOT COMPLETED|Overall Study||10
10974624|NCT00559962|12149111|FG003|NOT COMPLETED|Overall Study||5
10974625|NCT00559962|12149112|FG004|NOT COMPLETED|Overall Study||14
10974626|NCT00559962|12149113|FG005|NOT COMPLETED|Overall Study||5
10974627|NCT00559962|12149114|FG006|NOT COMPLETED|Overall Study||5
10974628|NCT00559962|12149115|FG007|NOT COMPLETED|Overall Study||4
10974629|NCT00559988|12149136|FG000|STARTED|Overall Study||1357
10974630|NCT00559988|12149137|FG001|STARTED|Overall Study||1361
10974631|NCT00559988|12149136|FG000|COMPLETED|Overall Study||1006
10974632|NCT00559988|12149137|FG001|COMPLETED|Overall Study||1009
10974633|NCT00559988|12149136|FG000|NOT COMPLETED|Overall Study||351
10974634|NCT00559988|12149137|FG001|NOT COMPLETED|Overall Study||352
10974635|NCT00560066|12149145|FG000|STARTED|Overall Study||396
10974636|NCT00560066|12149146|FG001|STARTED|Overall Study||1002
10974637|NCT00560066|12149145|FG000|COMPLETED|Overall Study||390
10974638|NCT00560066|12149146|FG001|COMPLETED|Overall Study||980
10974639|NCT00560066|12149145|FG000|NOT COMPLETED|Overall Study||6
10974640|NCT00560066|12149146|FG001|NOT COMPLETED|Overall Study||22
10974641|NCT00560105|12149159|FG000|STARTED|Overall Study||20
10974642|NCT00560105|12149160|FG001|STARTED|Overall Study||20
10974643|NCT00560105|12149159|FG000|COMPLETED|Overall Study||19
10974644|NCT00560105|12149160|FG001|COMPLETED|Overall Study||18
10974645|NCT00560105|12149159|FG000|NOT COMPLETED|Overall Study||1
10974646|NCT00560105|12149160|FG001|NOT COMPLETED|Overall Study||2
10974647|NCT00560235|12149169|FG000|STARTED|Phase 1||10
10974648|NCT00560235|12149170|FG001|STARTED|Phase 1||0
10974649|NCT00560235|12149171|FG002|STARTED|Phase 1||0
10974650|NCT00560235|12149169|FG000|COMPLETED|Phase 1||2
10974651|NCT00560235|12149170|FG001|COMPLETED|Phase 1||0
10974652|NCT00560235|12149171|FG002|COMPLETED|Phase 1||0
10974653|NCT00560235|12149169|FG000|NOT COMPLETED|Phase 1||8
10974654|NCT00560235|12149170|FG001|NOT COMPLETED|Phase 1||0
10974655|NCT00560235|12149171|FG002|NOT COMPLETED|Phase 1||0
10974656|NCT00560235|12149169|FG000|STARTED|Phase 1B||0
10974657|NCT00560235|12149170|FG001|STARTED|Phase 1B||21
10974658|NCT00560235|12149171|FG002|STARTED|Phase 1B||0
10974659|NCT00560235|12149169|FG000|COMPLETED|Phase 1B||0
10974660|NCT00560235|12149170|FG001|COMPLETED|Phase 1B||2
10974661|NCT00560235|12149171|FG002|COMPLETED|Phase 1B||0
10974662|NCT00560235|12149169|FG000|NOT COMPLETED|Phase 1B||0
10974663|NCT00560235|12149170|FG001|NOT COMPLETED|Phase 1B||19
10974664|NCT00560235|12149171|FG002|NOT COMPLETED|Phase 1B||0
10974665|NCT00560235|12149169|FG000|STARTED|Phase 2||0
10974666|NCT00560235|12149170|FG001|STARTED|Phase 2||0
10974667|NCT00560235|12149171|FG002|STARTED|Phase 2||107
10974668|NCT00560235|12149169|FG000|COMPLETED|Phase 2||0
10974669|NCT00560235|12149170|FG001|COMPLETED|Phase 2||0
10974670|NCT00560235|12149171|FG002|COMPLETED|Phase 2||10
10974671|NCT00560235|12149169|FG000|NOT COMPLETED|Phase 2||0
10974672|NCT00560235|12149170|FG001|NOT COMPLETED|Phase 2||0
10974673|NCT00560235|12149171|FG002|NOT COMPLETED|Phase 2||97
10974674|NCT00560313|12149189|FG000|STARTED|Overall Study||54
10974675|NCT00560313|12149189|FG000|COMPLETED|Overall Study||48
10974676|NCT00560313|12149189|FG000|NOT COMPLETED|Overall Study||6
10974677|NCT00560352|12149211|FG000|STARTED|Overall Study||7
10974678|NCT00560352|12149212|FG001|STARTED|Overall Study||3
10974679|NCT00560352|12149213|FG002|STARTED|Overall Study||4
10974680|NCT00560352|12149211|FG000|COMPLETED|Overall Study||0
10974681|NCT00560352|12149212|FG001|COMPLETED|Overall Study||0
10974682|NCT00560352|12149213|FG002|COMPLETED|Overall Study||0
10974683|NCT00560352|12149211|FG000|NOT COMPLETED|Overall Study||7
10974684|NCT00560352|12149212|FG001|NOT COMPLETED|Overall Study||3
10974685|NCT00560352|12149213|FG002|NOT COMPLETED|Overall Study||4
10974686|NCT00560391|12149230|FG000|STARTED|Overall Study|Participants who received treatment|6
10974687|NCT00560391|12149231|FG001|STARTED|Overall Study|Participants who received treatment|3
10974688|NCT00560391|12149232|FG002|STARTED|Overall Study|Participants who received treatment|3
10974689|NCT00560391|12149233|FG003|STARTED|Overall Study|Participants who received treatment|6
10974690|NCT00560391|12149234|FG004|STARTED|Overall Study|Participants who received treatment|17
10974691|NCT00560391|12149230|FG000|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
10974692|NCT00560391|12149231|FG001|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
10974693|NCT00560391|12149232|FG002|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
10974694|NCT00560391|12149233|FG003|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
10974695|NCT00560391|12149234|FG004|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
10974696|NCT00560391|12149230|FG000|NOT COMPLETED|Overall Study||0
10974697|NCT00560391|12149231|FG001|NOT COMPLETED|Overall Study||0
10974698|NCT00560391|12149232|FG002|NOT COMPLETED|Overall Study||0
10974699|NCT00560391|12149233|FG003|NOT COMPLETED|Overall Study||1
10974700|NCT00560391|12149234|FG004|NOT COMPLETED|Overall Study||2
10974701|NCT00560404|12149249|FG000|STARTED|Overall Study||112
10974702|NCT00560404|12149250|FG001|STARTED|Overall Study||121
10974703|NCT00560404|12149249|FG000|COMPLETED|Overall Study||76
10974704|NCT00560404|12149250|FG001|COMPLETED|Overall Study||100
10974705|NCT00560404|12149249|FG000|NOT COMPLETED|Overall Study||36
10974706|NCT00560404|12149250|FG001|NOT COMPLETED|Overall Study||21
10974707|NCT00560417|12149258|FG000|STARTED|Overall Study||171
10974708|NCT00560417|12149259|FG001|STARTED|Overall Study||168
10974709|NCT00560417|12149258|FG000|Intention to Treat (ITT) Population|Overall Study||170
10974710|NCT00560417|12149259|FG001|Intention to Treat (ITT) Population|Overall Study||167
10974711|NCT00560417|12149258|FG000|COMPLETED|Overall Study||154
10974712|NCT00560417|12149259|FG001|COMPLETED|Overall Study||151
10974713|NCT00560417|12149258|FG000|NOT COMPLETED|Overall Study||17
10974714|NCT00560417|12149259|FG001|NOT COMPLETED|Overall Study||17
10974715|NCT00560508|12149267|FG000|STARTED|12 Week Double-blind Period||56
10974716|NCT00560508|12149268|FG001|STARTED|12 Week Double-blind Period||56
10974717|NCT00560508|12149267|FG000|COMPLETED|12 Week Double-blind Period||51
10974718|NCT00560508|12149268|FG001|COMPLETED|12 Week Double-blind Period||53
10974719|NCT00560508|12149267|FG000|NOT COMPLETED|12 Week Double-blind Period||5
10974720|NCT00560508|12149268|FG001|NOT COMPLETED|12 Week Double-blind Period||3
10974721|NCT00560508|12149267|FG000|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
10974722|NCT00560508|12149268|FG001|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
10974723|NCT00560508|12149267|FG000|COMPLETED|52-week Open-label Period Pramipexole ER||43
10974724|NCT00560508|12149268|FG001|COMPLETED|52-week Open-label Period Pramipexole ER||42
10974725|NCT00560508|12149267|FG000|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
10974726|NCT00560508|12149268|FG001|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
10974727|NCT00560560|12149281|FG000|STARTED|Overall Study||85
10974728|NCT00560560|12149282|FG001|STARTED|Overall Study||83
10974729|NCT00560560|12149281|FG000|COMPLETED|Overall Study||0
10974730|NCT00560560|12149282|FG001|COMPLETED|Overall Study||0
10974731|NCT00560560|12149281|FG000|NOT COMPLETED|Overall Study||85
10974732|NCT00560560|12149282|FG001|NOT COMPLETED|Overall Study||83
10974733|NCT00560573|12149288|FG000|STARTED|Overall Study||6
10974734|NCT00560573|12149289|FG001|STARTED|Overall Study||3
10974735|NCT00560573|12149290|FG002|STARTED|Overall Study||6
10974736|NCT00560573|12149291|FG003|STARTED|Overall Study||10
10974737|NCT00560573|12149292|FG004|STARTED|Overall Study||8
10974738|NCT00560573|12149293|FG005|STARTED|Overall Study||13
10974739|NCT00560573|12149288|FG000|Treated|Overall Study||6
10974740|NCT00560573|12149289|FG001|Treated|Overall Study||3
10974741|NCT00560573|12149290|FG002|Treated|Overall Study||6
10974742|NCT00560573|12149291|FG003|Treated|Overall Study||10
10974743|NCT00560573|12149292|FG004|Treated|Overall Study||7
10974744|NCT00560573|12149293|FG005|Treated|Overall Study||13
10974745|NCT00560573|12149288|FG000|COMPLETED|Overall Study||0
10974746|NCT00560573|12149289|FG001|COMPLETED|Overall Study||0
10974747|NCT00560573|12149290|FG002|COMPLETED|Overall Study||0
10974748|NCT00560573|12149291|FG003|COMPLETED|Overall Study||0
10974749|NCT00560573|12149292|FG004|COMPLETED|Overall Study||1
10974750|NCT00560573|12149293|FG005|COMPLETED|Overall Study||0
10974751|NCT00560573|12149288|FG000|NOT COMPLETED|Overall Study||6
10974752|NCT00560573|12149289|FG001|NOT COMPLETED|Overall Study||3
10974753|NCT00560573|12149290|FG002|NOT COMPLETED|Overall Study||6
10974754|NCT00560573|12149291|FG003|NOT COMPLETED|Overall Study||10
10974755|NCT00560573|12149292|FG004|NOT COMPLETED|Overall Study||7
10974756|NCT00560573|12149293|FG005|NOT COMPLETED|Overall Study||13
10974757|NCT00560612|12149325|FG000|STARTED|Overall Study||5
10974758|NCT00560612|12149326|FG001|STARTED|Overall Study||7
10974759|NCT00560612|12149325|FG000|COMPLETED|Overall Study||5
10974760|NCT00560612|12149326|FG001|COMPLETED|Overall Study||7
10974761|NCT00560612|12149325|FG000|NOT COMPLETED|Overall Study||0
10974762|NCT00560612|12149326|FG001|NOT COMPLETED|Overall Study||0
10974763|NCT00560703|12149334|FG000|STARTED|Overall Study||46
10974764|NCT00560703|12149335|FG001|STARTED|Overall Study||24
10974765|NCT00560703|12149334|FG000|COMPLETED|Overall Study||46
10974766|NCT00560703|12149335|FG001|COMPLETED|Overall Study||18
10974767|NCT00560703|12149334|FG000|NOT COMPLETED|Overall Study||0
10974768|NCT00560703|12149335|FG001|NOT COMPLETED|Overall Study||6
10974769|NCT00560755|12149341|FG000|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
10974770|NCT00560755|12149341|FG000|ProQuad® Dose 1 and Dose 2|Overall Study||3346
10974771|NCT00560755|12149341|FG000|COMPLETED|Overall Study||3328
10974772|NCT00560755|12149341|FG000|NOT COMPLETED|Overall Study||60
10974773|NCT00560794|12149346|FG000|STARTED|Overall Study||21
10974774|NCT00560794|12149346|FG000|Completed 1 Treatment Cycle|Overall Study||20
10974775|NCT00560794|12149346|FG000|COMPLETED|Overall Study||10
10974776|NCT00560794|12149346|FG000|NOT COMPLETED|Overall Study||11
10974777|NCT00560833|12149357|FG000|STARTED|Overall Study||317
10974778|NCT00560833|12149358|FG001|STARTED|Overall Study||155
10974779|NCT00560833|12149359|FG002|STARTED|Overall Study||160
10974780|NCT00560833|12149360|FG003|STARTED|Overall Study||155
10974781|NCT00560833|12149361|FG004|STARTED|Overall Study||156
10974782|NCT00560833|12149357|FG000|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
10974783|NCT00560833|12149358|FG001|Treated|Overall Study|One participant was randomized but not treated|154
10974784|NCT00560833|12149359|FG002|Treated|Overall Study||160
10974785|NCT00560833|12149360|FG003|Treated|Overall Study||155
10974786|NCT00560833|12149361|FG004|Treated|Overall Study|One participant was randomized but not treated|155
10974787|NCT00560833|12149357|FG000|COMPLETED|Overall Study||273
10974788|NCT00560833|12149358|FG001|COMPLETED|Overall Study||129
10974789|NCT00560833|12149359|FG002|COMPLETED|Overall Study||121
10974790|NCT00560833|12149360|FG003|COMPLETED|Overall Study||124
10974791|NCT00560833|12149361|FG004|COMPLETED|Overall Study||114
10974792|NCT00560833|12149357|FG000|NOT COMPLETED|Overall Study||44
10974793|NCT00560833|12149358|FG001|NOT COMPLETED|Overall Study||26
10974794|NCT00560833|12149359|FG002|NOT COMPLETED|Overall Study||39
10974795|NCT00560833|12149360|FG003|NOT COMPLETED|Overall Study||31
10974796|NCT00560833|12149361|FG004|NOT COMPLETED|Overall Study||42
10974797|NCT00560859|12149375|FG000|STARTED|Overall Study||226
10974798|NCT00560859|12149376|FG001|STARTED|Overall Study||227
10974799|NCT00560859|12149375|FG000|COMPLETED|Overall Study||194
10974800|NCT00560859|12149376|FG001|COMPLETED|Overall Study||203
10974801|NCT00560859|12149375|FG000|NOT COMPLETED|Overall Study||32
10974802|NCT00560859|12149376|FG001|NOT COMPLETED|Overall Study||24
10974803|NCT00560885|12149383|FG000|STARTED|Overall Study||55
10974804|NCT00560885|12149383|FG000|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
10974805|NCT00560885|12149383|FG000|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
10974806|NCT00560885|12149383|FG000|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
10974807|NCT00560885|12149383|FG000|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
10974808|NCT00560885|12149383|FG000|2 Year Follow-up|Overall Study||47
10974809|NCT00560885|12149383|FG000|COMPLETED|Overall Study||47
10974810|NCT00560885|12149383|FG000|NOT COMPLETED|Overall Study||8
10974811|NCT00560937|12149389|FG000|STARTED|Overall Study||10
10974812|NCT00560937|12149390|FG001|STARTED|Overall Study||11
10974813|NCT00560937|12149389|FG000|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
10974814|NCT00560937|12149390|FG001|COMPLETED|Overall Study||9
10974815|NCT00560937|12149389|FG000|NOT COMPLETED|Overall Study||1
10974816|NCT00560937|12149390|FG001|NOT COMPLETED|Overall Study||2
10974817|NCT00560950|12149398|FG000|STARTED|Overall Study||72
10974818|NCT00560950|12149399|FG001|STARTED|Overall Study||71
10974819|NCT00560950|12149398|FG000|COMPLETED|Overall Study||71
10974820|NCT00560950|12149399|FG001|COMPLETED|Overall Study||71
10974821|NCT00560950|12149398|FG000|NOT COMPLETED|Overall Study||1
10974822|NCT00560950|12149399|FG001|NOT COMPLETED|Overall Study||0
10974823|NCT00561002|12149409|FG000|STARTED|Overall Study||23
10974824|NCT00561002|12149410|FG001|STARTED|Overall Study||9
10974825|NCT00561002|12149409|FG000|COMPLETED|Overall Study||23
10974826|NCT00561002|12149410|FG001|COMPLETED|Overall Study||9
10974827|NCT00561002|12149409|FG000|NOT COMPLETED|Overall Study||0
10974828|NCT00561002|12149410|FG001|NOT COMPLETED|Overall Study||0
10974829|NCT00561015|12149422|FG000|STARTED|Overall Study||9
10974830|NCT00561015|12149423|FG001|STARTED|Overall Study||5
10974831|NCT00561015|12149424|FG002|STARTED|Overall Study||9
10974832|NCT00561015|12149425|FG003|STARTED|Overall Study||8
10974833|NCT00561015|12149426|FG004|STARTED|Overall Study||9
10974834|NCT00561015|12149427|FG005|STARTED|Overall Study||9
10974835|NCT00561015|12149422|FG000|COMPLETED|Overall Study||5
10974836|NCT00561015|12149423|FG001|COMPLETED|Overall Study||5
10974837|NCT00561015|12149424|FG002|COMPLETED|Overall Study||9
10974838|NCT00561015|12149425|FG003|COMPLETED|Overall Study||7
10974839|NCT00561015|12149426|FG004|COMPLETED|Overall Study||8
10974840|NCT00561015|12149427|FG005|COMPLETED|Overall Study||6
10974841|NCT00561015|12149422|FG000|NOT COMPLETED|Overall Study||4
10974842|NCT00561015|12149423|FG001|NOT COMPLETED|Overall Study||0
10974843|NCT00561015|12149424|FG002|NOT COMPLETED|Overall Study||0
10974844|NCT00561015|12149425|FG003|NOT COMPLETED|Overall Study||1
10974845|NCT00561015|12149426|FG004|NOT COMPLETED|Overall Study||1
10974846|NCT00561015|12149427|FG005|NOT COMPLETED|Overall Study||3
10974847|NCT00561080|12149448|FG000|STARTED|Vaccination Period (up to Month 4)||253
10974848|NCT00561080|12149449|FG001|STARTED|Vaccination Period (up to Month 4)||255
10974849|NCT00561080|12149450|FG002|STARTED|Vaccination Period (up to Month 4)||251
10974850|NCT00561080|12149448|FG000|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
10974851|NCT00561080|12149449|FG001|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
10974852|NCT00561080|12149450|FG002|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
10974853|NCT00561080|12149448|FG000|COMPLETED|Vaccination Period (up to Month 4)||250
10974854|NCT00561080|12149449|FG001|COMPLETED|Vaccination Period (up to Month 4)||229
10974855|NCT00561080|12149450|FG002|COMPLETED|Vaccination Period (up to Month 4)||225
10974856|NCT00561080|12149448|FG000|NOT COMPLETED|Vaccination Period (up to Month 4)||3
10974857|NCT00561080|12149449|FG001|NOT COMPLETED|Vaccination Period (up to Month 4)||26
10974858|NCT00561080|12149450|FG002|NOT COMPLETED|Vaccination Period (up to Month 4)||26
10974859|NCT00561080|12149448|FG000|STARTED|12-month Post Last Dose Follow-up||250
10974860|NCT00561080|12149449|FG001|STARTED|12-month Post Last Dose Follow-up||229
10974861|NCT00561080|12149450|FG002|STARTED|12-month Post Last Dose Follow-up||225
10974862|NCT00561080|12149448|FG000|COMPLETED|12-month Post Last Dose Follow-up||243
10974863|NCT00561080|12149449|FG001|COMPLETED|12-month Post Last Dose Follow-up||220
10974864|NCT00561080|12149450|FG002|COMPLETED|12-month Post Last Dose Follow-up||215
10974865|NCT00561080|12149448|FG000|NOT COMPLETED|12-month Post Last Dose Follow-up||7
10974866|NCT00561080|12149449|FG001|NOT COMPLETED|12-month Post Last Dose Follow-up||9
10974867|NCT00561080|12149450|FG002|NOT COMPLETED|12-month Post Last Dose Follow-up||10
10974868|NCT00561080|12149448|FG000|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
10974869|NCT00561080|12149449|FG001|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
10975038|NCT00561925|12149661|FG002|COMPLETED|Open-Label Extension Period||0
10974870|NCT00561080|12149450|FG002|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
10974871|NCT00561080|12149448|FG000|COMPLETED|24-month Post Last Dose Follow-up||0
10974872|NCT00561080|12149449|FG001|COMPLETED|24-month Post Last Dose Follow-up||0
10974873|NCT00561080|12149450|FG002|COMPLETED|24-month Post Last Dose Follow-up||0
10974874|NCT00561080|12149448|FG000|NOT COMPLETED|24-month Post Last Dose Follow-up||0
10974875|NCT00561080|12149449|FG001|NOT COMPLETED|24-month Post Last Dose Follow-up||0
10974876|NCT00561080|12149450|FG002|NOT COMPLETED|24-month Post Last Dose Follow-up||0
10974877|NCT00561080|12149448|FG000|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
10974878|NCT00561080|12149449|FG001|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
10974879|NCT00561080|12149450|FG002|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
10974880|NCT00561080|12149448|FG000|COMPLETED|36 Month Post Last Dose Follow-up||0
10974881|NCT00561080|12149449|FG001|COMPLETED|36 Month Post Last Dose Follow-up||0
10974882|NCT00561080|12149450|FG002|COMPLETED|36 Month Post Last Dose Follow-up||0
10974883|NCT00561080|12149448|FG000|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
10974884|NCT00561080|12149449|FG001|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
10974885|NCT00561080|12149450|FG002|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
10974886|NCT00561145|12149462|FG000|STARTED|Overall Study||15
10974887|NCT00561145|12149463|FG001|STARTED|Overall Study||17
10974888|NCT00561145|12149462|FG000|COMPLETED|Overall Study||15
10974889|NCT00561145|12149463|FG001|COMPLETED|Overall Study||17
10974890|NCT00561145|12149462|FG000|NOT COMPLETED|Overall Study||0
10974891|NCT00561145|12149463|FG001|NOT COMPLETED|Overall Study||0
10974892|NCT00561340|12149471|FG000|STARTED|Overall Study||13
10974893|NCT00561340|12149472|FG001|STARTED|Overall Study||16
10974894|NCT00561340|12149471|FG000|COMPLETED|Overall Study||7
10974895|NCT00561340|12149472|FG001|COMPLETED|Overall Study||16
10974896|NCT00561340|12149471|FG000|NOT COMPLETED|Overall Study||6
10974897|NCT00561340|12149472|FG001|NOT COMPLETED|Overall Study||0
10974898|NCT00561353|12149488|FG000|STARTED|Overall Study||18
10974899|NCT00561353|12149489|FG001|STARTED|Overall Study||19
10974900|NCT00561353|12149490|FG002|STARTED|Overall Study||13
10974901|NCT00561353|12149491|FG003|STARTED|Overall Study||18
10974902|NCT00561353|12149492|FG004|STARTED|Overall Study||6
10974903|NCT00561353|12149493|FG005|STARTED|Overall Study||9
10974904|NCT00561353|12149494|FG006|STARTED|Overall Study||9
10974905|NCT00561353|12149495|FG007|STARTED|Overall Study||10
10974906|NCT00561353|12149496|FG008|STARTED|Overall Study||9
10974907|NCT00561353|12149497|FG009|STARTED|Overall Study||5
10974908|NCT00561353|12149488|FG000|COMPLETED|Overall Study||13
10974909|NCT00561353|12149489|FG001|COMPLETED|Overall Study||16
10974910|NCT00561353|12149490|FG002|COMPLETED|Overall Study||10
10974911|NCT00561353|12149491|FG003|COMPLETED|Overall Study||12
10974912|NCT00561353|12149492|FG004|COMPLETED|Overall Study||5
10974913|NCT00561353|12149493|FG005|COMPLETED|Overall Study||3
10974914|NCT00561353|12149494|FG006|COMPLETED|Overall Study||3
10974915|NCT00561353|12149495|FG007|COMPLETED|Overall Study||6
10974916|NCT00561353|12149496|FG008|COMPLETED|Overall Study||2
10974917|NCT00561353|12149497|FG009|COMPLETED|Overall Study||3
10974918|NCT00561353|12149488|FG000|NOT COMPLETED|Overall Study||5
10974919|NCT00561353|12149489|FG001|NOT COMPLETED|Overall Study||3
10974920|NCT00561353|12149490|FG002|NOT COMPLETED|Overall Study||3
10974921|NCT00561353|12149491|FG003|NOT COMPLETED|Overall Study||6
10974922|NCT00561353|12149492|FG004|NOT COMPLETED|Overall Study||1
10974923|NCT00561353|12149493|FG005|NOT COMPLETED|Overall Study||6
10974924|NCT00561353|12149494|FG006|NOT COMPLETED|Overall Study||6
10974925|NCT00561353|12149495|FG007|NOT COMPLETED|Overall Study||4
10974926|NCT00561353|12149496|FG008|NOT COMPLETED|Overall Study||7
10974927|NCT00561353|12149497|FG009|NOT COMPLETED|Overall Study||2
10974928|NCT00561392|12149559|FG000|STARTED|Overall Study||208
10974929|NCT00561392|12149559|FG000|COMPLETED|Overall Study||155
10974930|NCT00561392|12149559|FG000|NOT COMPLETED|Overall Study||53
10974931|NCT00561418|12149563|FG000|STARTED|Overall Study||23
10974932|NCT00561418|12149563|FG000|COMPLETED|Overall Study||23
10974933|NCT00561418|12149563|FG000|NOT COMPLETED|Overall Study||0
10974934|NCT00561431|12149569|FG000|STARTED|Overall Study||100
10974935|NCT00561431|12149570|FG001|STARTED|Overall Study||100
10974936|NCT00561431|12149569|FG000|COMPLETED|Overall Study||100
10974937|NCT00561431|12149570|FG001|COMPLETED|Overall Study||100
10974938|NCT00561431|12149569|FG000|NOT COMPLETED|Overall Study||0
10974939|NCT00561431|12149570|FG001|NOT COMPLETED|Overall Study||0
10974940|NCT00561457|12149576|FG000|STARTED|Overall Study||134
10974941|NCT00561457|12149576|FG000|COMPLETED|Overall Study||110
10974942|NCT00561457|12149576|FG000|NOT COMPLETED|Overall Study||24
10974943|NCT00561470|12149582|FG000|STARTED|Overall Study||614
10974944|NCT00561470|12149583|FG001|STARTED|Overall Study||612
10974945|NCT00561470|12149582|FG000|TREATED|Overall Study||609
10974946|NCT00561470|12149583|FG001|TREATED|Overall Study||607
10974947|NCT00561470|12149582|FG000|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
10974948|NCT00561470|12149583|FG001|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
10974949|NCT00561470|12149582|FG000|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
10974950|NCT00561470|12149583|FG001|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
10974951|NCT00561470|12149582|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
10975039|NCT00561925|12149662|FG003|COMPLETED|Open-Label Extension Period||315
10974952|NCT00561470|12149583|FG001|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
10974953|NCT00561470|12149582|FG000|NOT COMPLETED|Overall Study||614
10974954|NCT00561470|12149583|FG001|NOT COMPLETED|Overall Study||612
10974955|NCT00561574|12149593|FG000|STARTED|Overall Study||128
10974956|NCT00561574|12149594|FG001|STARTED|Overall Study||131
10974957|NCT00561574|12149593|FG000|COMPLETED|Overall Study||80
10974958|NCT00561574|12149594|FG001|COMPLETED|Overall Study||73
10974959|NCT00561574|12149593|FG000|NOT COMPLETED|Overall Study||48
10974960|NCT00561574|12149594|FG001|NOT COMPLETED|Overall Study||58
10974961|NCT00561600|12149602|FG000|STARTED|Overall Study||130
10974962|NCT00561600|12149603|FG001|STARTED|Overall Study||135
10974963|NCT00561600|12149602|FG000|COMPLETED|Overall Study||112
10974964|NCT00561600|12149603|FG001|COMPLETED|Overall Study||119
10974965|NCT00561600|12149602|FG000|NOT COMPLETED|Overall Study||18
10974966|NCT00561600|12149603|FG001|NOT COMPLETED|Overall Study||16
10974967|NCT00561652|12149613|FG000|STARTED|Overall Study||10
10974968|NCT00561652|12149614|FG001|STARTED|Overall Study||20
10974969|NCT00561652|12149613|FG000|COMPLETED|Overall Study||10
10974970|NCT00561652|12149614|FG001|COMPLETED|Overall Study||19
10974971|NCT00561652|12149613|FG000|NOT COMPLETED|Overall Study||0
10974972|NCT00561652|12149614|FG001|NOT COMPLETED|Overall Study||1
10974973|NCT00561678|12149622|FG000|STARTED|Overall Study||197
10974974|NCT00561678|12149623|FG001|STARTED|Overall Study||207
10974975|NCT00561678|12149622|FG000|COMPLETED|Overall Study||189
10974976|NCT00561678|12149623|FG001|COMPLETED|Overall Study||201
10974977|NCT00561678|12149622|FG000|NOT COMPLETED|Overall Study||8
10974978|NCT00561678|12149623|FG001|NOT COMPLETED|Overall Study||6
10974979|NCT00561730|12149629|FG000|STARTED|Overall Study||1995
10974980|NCT00561730|12149629|FG000|COMPLETED|Overall Study||1986
10974981|NCT00561730|12149629|FG000|NOT COMPLETED|Overall Study||9
10974982|NCT00561821|12149639|FG000|STARTED|Overall Study||132
10974983|NCT00561821|12149640|FG001|STARTED|Overall Study||136
10974984|NCT00561821|12149641|FG002|STARTED|Overall Study||134
10974985|NCT00561821|12149642|FG003|STARTED|Overall Study||136
10974986|NCT00561821|12149639|FG000|Treated|Overall Study||132
10974987|NCT00561821|12149640|FG001|Treated|Overall Study||136
10974988|NCT00561821|12149641|FG002|Treated|Overall Study||133
10974989|NCT00561821|12149642|FG003|Treated|Overall Study||136
10974990|NCT00561821|12149639|FG000|COMPLETED|Overall Study||127
10974991|NCT00561821|12149640|FG001|COMPLETED|Overall Study||130
10974992|NCT00561821|12149641|FG002|COMPLETED|Overall Study||132
10974993|NCT00561821|12149642|FG003|COMPLETED|Overall Study||133
10974994|NCT00561821|12149639|FG000|NOT COMPLETED|Overall Study||5
10974995|NCT00561821|12149640|FG001|NOT COMPLETED|Overall Study||6
10974996|NCT00561821|12149641|FG002|NOT COMPLETED|Overall Study||2
10974997|NCT00561821|12149642|FG003|NOT COMPLETED|Overall Study||3
10974998|NCT00561834|12149652|FG000|STARTED|Overall Study||2
10974999|NCT00561834|12149652|FG000|COMPLETED|Overall Study||2
10975000|NCT00561834|12149652|FG000|NOT COMPLETED|Overall Study||0
10975001|NCT00561925|12149659|FG000|STARTED|14 Day Lead-In Period||1068
10975002|NCT00561925|12149660|FG001|STARTED|14 Day Lead-In Period||0
10975003|NCT00561925|12149661|FG002|STARTED|14 Day Lead-In Period||0
10975004|NCT00561925|12149662|FG003|STARTED|14 Day Lead-In Period||0
10975005|NCT00561925|12149663|FG004|STARTED|14 Day Lead-In Period||0
10975006|NCT00561925|12149659|FG000|COMPLETED|14 Day Lead-In Period||1013
10975007|NCT00561925|12149660|FG001|COMPLETED|14 Day Lead-In Period||0
10975008|NCT00561925|12149661|FG002|COMPLETED|14 Day Lead-In Period||0
10975009|NCT00561925|12149662|FG003|COMPLETED|14 Day Lead-In Period||0
10975010|NCT00561925|12149663|FG004|COMPLETED|14 Day Lead-In Period||0
10975011|NCT00561925|12149659|FG000|NOT COMPLETED|14 Day Lead-In Period||55
10975012|NCT00561925|12149660|FG001|NOT COMPLETED|14 Day Lead-In Period||0
10975013|NCT00561925|12149661|FG002|NOT COMPLETED|14 Day Lead-In Period||0
10975014|NCT00561925|12149662|FG003|NOT COMPLETED|14 Day Lead-In Period||0
10975015|NCT00561925|12149663|FG004|NOT COMPLETED|14 Day Lead-In Period||0
10975016|NCT00561925|12149659|FG000|STARTED|144-week Double-blind, Double-dummy||0
10975017|NCT00561925|12149660|FG001|STARTED|144-week Double-blind, Double-dummy||508
10975018|NCT00561925|12149661|FG002|STARTED|144-week Double-blind, Double-dummy||505
10975019|NCT00561925|12149662|FG003|STARTED|144-week Double-blind, Double-dummy||0
10975020|NCT00561925|12149663|FG004|STARTED|144-week Double-blind, Double-dummy||0
10975021|NCT00561925|12149659|FG000|COMPLETED|144-week Double-blind, Double-dummy||0
10975022|NCT00561925|12149660|FG001|COMPLETED|144-week Double-blind, Double-dummy||358
10975023|NCT00561925|12149661|FG002|COMPLETED|144-week Double-blind, Double-dummy||378
10975024|NCT00561925|12149662|FG003|COMPLETED|144-week Double-blind, Double-dummy||0
10975025|NCT00561925|12149663|FG004|COMPLETED|144-week Double-blind, Double-dummy||0
10975026|NCT00561925|12149659|FG000|NOT COMPLETED|144-week Double-blind, Double-dummy||0
10975027|NCT00561925|12149660|FG001|NOT COMPLETED|144-week Double-blind, Double-dummy||150
10975028|NCT00561925|12149661|FG002|NOT COMPLETED|144-week Double-blind, Double-dummy||127
10975029|NCT00561925|12149662|FG003|NOT COMPLETED|144-week Double-blind, Double-dummy||0
10975030|NCT00561925|12149663|FG004|NOT COMPLETED|144-week Double-blind, Double-dummy||0
10975031|NCT00561925|12149659|FG000|STARTED|Open-Label Extension Period||0
10975032|NCT00561925|12149660|FG001|STARTED|Open-Label Extension Period||1
10975033|NCT00561925|12149661|FG002|STARTED|Open-Label Extension Period||0
10975034|NCT00561925|12149662|FG003|STARTED|Open-Label Extension Period||358
10975035|NCT00561925|12149663|FG004|STARTED|Open-Label Extension Period||378
10975036|NCT00561925|12149659|FG000|COMPLETED|Open-Label Extension Period||0
10975037|NCT00561925|12149660|FG001|COMPLETED|Open-Label Extension Period||1
10975040|NCT00561925|12149663|FG004|COMPLETED|Open-Label Extension Period||328
10975041|NCT00561925|12149659|FG000|NOT COMPLETED|Open-Label Extension Period||0
10975042|NCT00561925|12149660|FG001|NOT COMPLETED|Open-Label Extension Period||0
10975043|NCT00561925|12149661|FG002|NOT COMPLETED|Open-Label Extension Period||0
10975044|NCT00561925|12149662|FG003|NOT COMPLETED|Open-Label Extension Period||43
10975045|NCT00561925|12149663|FG004|NOT COMPLETED|Open-Label Extension Period||50
10975046|NCT00561951|12149684|FG000|STARTED|Overall Study||318
10975047|NCT00561951|12149685|FG001|STARTED|Overall Study||320
10975048|NCT00561951|12149686|FG002|STARTED|Overall Study||313
10975049|NCT00561951|12149684|FG000|COMPLETED|Overall Study||285
10975050|NCT00561951|12149685|FG001|COMPLETED|Overall Study||286
10975051|NCT00561951|12149686|FG002|COMPLETED|Overall Study||281
10975052|NCT00561951|12149684|FG000|NOT COMPLETED|Overall Study||33
10975053|NCT00561951|12149685|FG001|NOT COMPLETED|Overall Study||34
10975054|NCT00561951|12149686|FG002|NOT COMPLETED|Overall Study||32
10975055|NCT00561977|12149697|FG000|STARTED|Overall Study||12
10975056|NCT00561977|12149698|FG001|STARTED|Overall Study||12
10975057|NCT00561977|12149699|FG002|STARTED|Overall Study||12
10975058|NCT00561977|12149697|FG000|COMPLETED|Overall Study||12
10975059|NCT00561977|12149698|FG001|COMPLETED|Overall Study||9
10975060|NCT00561977|12149699|FG002|COMPLETED|Overall Study||10
10975061|NCT00561977|12149697|FG000|NOT COMPLETED|Overall Study||0
10975062|NCT00561977|12149698|FG001|NOT COMPLETED|Overall Study||3
10975063|NCT00561977|12149699|FG002|NOT COMPLETED|Overall Study||2
10975064|NCT00562094|12149707|FG000|STARTED|Overall Study||8616
10975065|NCT00562094|12149707|FG000|COMPLETED|Overall Study||8554
10975066|NCT00562094|12149707|FG000|NOT COMPLETED|Overall Study||62
10975067|NCT00562120|12149715|FG000|STARTED|First Intervention Period||6
10975068|NCT00562120|12149716|FG001|STARTED|First Intervention Period||5
10975069|NCT00562120|12149717|FG002|STARTED|First Intervention Period||5
10975070|NCT00562120|12149718|FG003|STARTED|First Intervention Period||5
10975071|NCT00562120|12149715|FG000|Treated|First Intervention Period||5
10975072|NCT00562120|12149716|FG001|Treated|First Intervention Period||5
10975073|NCT00562120|12149717|FG002|Treated|First Intervention Period||5
10975074|NCT00562120|12149718|FG003|Treated|First Intervention Period||5
10975075|NCT00562120|12149715|FG000|COMPLETED|First Intervention Period||4
10975076|NCT00562120|12149716|FG001|COMPLETED|First Intervention Period||5
10975077|NCT00562120|12149717|FG002|COMPLETED|First Intervention Period||5
10975078|NCT00562120|12149718|FG003|COMPLETED|First Intervention Period||5
10975079|NCT00562120|12149715|FG000|NOT COMPLETED|First Intervention Period||2
10975080|NCT00562120|12149716|FG001|NOT COMPLETED|First Intervention Period||0
10975081|NCT00562120|12149717|FG002|NOT COMPLETED|First Intervention Period||0
10975082|NCT00562120|12149718|FG003|NOT COMPLETED|First Intervention Period||0
10975083|NCT00562120|12149715|FG000|STARTED|Washout Period 1 (At Least 14 Days)||4
10975084|NCT00562120|12149716|FG001|STARTED|Washout Period 1 (At Least 14 Days)||5
10975085|NCT00562120|12149717|FG002|STARTED|Washout Period 1 (At Least 14 Days)||5
10975086|NCT00562120|12149718|FG003|STARTED|Washout Period 1 (At Least 14 Days)||5
10975087|NCT00562120|12149715|FG000|COMPLETED|Washout Period 1 (At Least 14 Days)||4
10975088|NCT00562120|12149716|FG001|COMPLETED|Washout Period 1 (At Least 14 Days)||5
10975089|NCT00562120|12149717|FG002|COMPLETED|Washout Period 1 (At Least 14 Days)||5
10975090|NCT00562120|12149718|FG003|COMPLETED|Washout Period 1 (At Least 14 Days)||5
10975091|NCT00562120|12149715|FG000|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
10975092|NCT00562120|12149716|FG001|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
10975093|NCT00562120|12149717|FG002|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
10975094|NCT00562120|12149718|FG003|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
10975095|NCT00562120|12149715|FG000|STARTED|Second Intervention Period||4
10975096|NCT00562120|12149716|FG001|STARTED|Second Intervention Period||5
10975097|NCT00562120|12149717|FG002|STARTED|Second Intervention Period||5
10975098|NCT00562120|12149718|FG003|STARTED|Second Intervention Period||5
10975099|NCT00562120|12149715|FG000|COMPLETED|Second Intervention Period||4
10975100|NCT00562120|12149716|FG001|COMPLETED|Second Intervention Period||5
10975101|NCT00562120|12149717|FG002|COMPLETED|Second Intervention Period||5
10975102|NCT00562120|12149718|FG003|COMPLETED|Second Intervention Period||5
10975103|NCT00562120|12149715|FG000|NOT COMPLETED|Second Intervention Period||0
10975104|NCT00562120|12149716|FG001|NOT COMPLETED|Second Intervention Period||0
10975105|NCT00562120|12149717|FG002|NOT COMPLETED|Second Intervention Period||0
10975106|NCT00562120|12149718|FG003|NOT COMPLETED|Second Intervention Period||0
10975107|NCT00562120|12149715|FG000|STARTED|Washout Period 2 (At Least 14 Days)||4
10975108|NCT00562120|12149716|FG001|STARTED|Washout Period 2 (At Least 14 Days)||5
10975109|NCT00562120|12149717|FG002|STARTED|Washout Period 2 (At Least 14 Days)||5
10975110|NCT00562120|12149718|FG003|STARTED|Washout Period 2 (At Least 14 Days)||5
10975111|NCT00562120|12149715|FG000|COMPLETED|Washout Period 2 (At Least 14 Days)||4
10975112|NCT00562120|12149716|FG001|COMPLETED|Washout Period 2 (At Least 14 Days)||5
10975113|NCT00562120|12149717|FG002|COMPLETED|Washout Period 2 (At Least 14 Days)||5
10975114|NCT00562120|12149718|FG003|COMPLETED|Washout Period 2 (At Least 14 Days)||5
10975115|NCT00562120|12149715|FG000|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
10975116|NCT00562120|12149716|FG001|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
10975117|NCT00562120|12149717|FG002|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
10975118|NCT00562120|12149718|FG003|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
10975119|NCT00562120|12149715|FG000|STARTED|Third Intervention Period||4
10975120|NCT00562120|12149716|FG001|STARTED|Third Intervention Period||5
10975121|NCT00562120|12149717|FG002|STARTED|Third Intervention Period||5
10975122|NCT00562120|12149718|FG003|STARTED|Third Intervention Period||5
10975123|NCT00562120|12149715|FG000|COMPLETED|Third Intervention Period||4
10975124|NCT00562120|12149716|FG001|COMPLETED|Third Intervention Period||5
10975125|NCT00562120|12149717|FG002|COMPLETED|Third Intervention Period||5
10975126|NCT00562120|12149718|FG003|COMPLETED|Third Intervention Period||5
10975127|NCT00562120|12149715|FG000|NOT COMPLETED|Third Intervention Period||0
10975128|NCT00562120|12149716|FG001|NOT COMPLETED|Third Intervention Period||0
10975129|NCT00562120|12149717|FG002|NOT COMPLETED|Third Intervention Period||0
10975130|NCT00562120|12149718|FG003|NOT COMPLETED|Third Intervention Period||0
10975131|NCT00562120|12149715|FG000|STARTED|Washout Period 3 (At Least 14 Days)||4
10975132|NCT00562120|12149716|FG001|STARTED|Washout Period 3 (At Least 14 Days)||5
10975133|NCT00562120|12149717|FG002|STARTED|Washout Period 3 (At Least 14 Days)||5
10975134|NCT00562120|12149718|FG003|STARTED|Washout Period 3 (At Least 14 Days)||5
10975135|NCT00562120|12149715|FG000|COMPLETED|Washout Period 3 (At Least 14 Days)||4
10975136|NCT00562120|12149716|FG001|COMPLETED|Washout Period 3 (At Least 14 Days)||5
10975137|NCT00562120|12149717|FG002|COMPLETED|Washout Period 3 (At Least 14 Days)||5
10975138|NCT00562120|12149718|FG003|COMPLETED|Washout Period 3 (At Least 14 Days)||5
10975139|NCT00562120|12149715|FG000|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
10975140|NCT00562120|12149716|FG001|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
10975141|NCT00562120|12149717|FG002|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
10975142|NCT00562120|12149718|FG003|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
10975143|NCT00562120|12149715|FG000|STARTED|Fourth Intervention Period||4
10975144|NCT00562120|12149716|FG001|STARTED|Fourth Intervention Period||5
10975145|NCT00562120|12149717|FG002|STARTED|Fourth Intervention Period||5
10975146|NCT00562120|12149718|FG003|STARTED|Fourth Intervention Period||5
10975147|NCT00562120|12149715|FG000|COMPLETED|Fourth Intervention Period||4
10975148|NCT00562120|12149716|FG001|COMPLETED|Fourth Intervention Period||5
10975149|NCT00562120|12149717|FG002|COMPLETED|Fourth Intervention Period||5
10975150|NCT00562120|12149718|FG003|COMPLETED|Fourth Intervention Period||5
10975151|NCT00562120|12149715|FG000|NOT COMPLETED|Fourth Intervention Period||0
10975152|NCT00562120|12149716|FG001|NOT COMPLETED|Fourth Intervention Period||0
10975153|NCT00562120|12149717|FG002|NOT COMPLETED|Fourth Intervention Period||0
10975154|NCT00562120|12149718|FG003|NOT COMPLETED|Fourth Intervention Period||0
10975155|NCT00562159|12149730|FG000|STARTED|Overall Study||213
10975156|NCT00562159|12149731|FG001|STARTED|Overall Study||225
10975157|NCT00562159|12149730|FG000|COMPLETED|Overall Study||175
10975158|NCT00562159|12149731|FG001|COMPLETED|Overall Study||192
10975159|NCT00562159|12149730|FG000|NOT COMPLETED|Overall Study||38
10975160|NCT00562159|12149731|FG001|NOT COMPLETED|Overall Study||33
10975161|NCT00562302|12149740|FG000|STARTED|Overall Study||170
10975162|NCT00562302|12149741|FG001|STARTED|Overall Study||169
10975163|NCT00562302|12149740|FG000|COMPLETED|Overall Study||150
10975164|NCT00562302|12149741|FG001|COMPLETED|Overall Study||137
10975165|NCT00562302|12149740|FG000|NOT COMPLETED|Overall Study||20
10975166|NCT00562302|12149741|FG001|NOT COMPLETED|Overall Study||32
10975167|NCT00562315|12149747|FG000|STARTED|Overall Study||93
10975168|NCT00562315|12149747|FG000|COMPLETED|Overall Study||93
10975169|NCT00562315|12149747|FG000|NOT COMPLETED|Overall Study||0
10975170|NCT00562328|12149753|FG000|STARTED|Overall Study||33
10975171|NCT00562328|12149753|FG000|COMPLETED|Overall Study||33
10975172|NCT00562328|12149753|FG000|NOT COMPLETED|Overall Study||0
10975173|NCT00562354|12149759|FG000|STARTED|Overall Study||134
10975174|NCT00562354|12149760|FG001|STARTED|Overall Study||137
10975175|NCT00562354|12149759|FG000|Received Study Treatment|Overall Study||134
10975176|NCT00562354|12149760|FG001|Received Study Treatment|Overall Study||136
10975177|NCT00562354|12149759|FG000|Evaluable Immunogenicity Population|Overall Study||134
10975178|NCT00562354|12149760|FG001|Evaluable Immunogenicity Population|Overall Study||134
10975179|NCT00562354|12149759|FG000|COMPLETED|Overall Study||134
10975180|NCT00562354|12149760|FG001|COMPLETED|Overall Study||135
10975181|NCT00562354|12149759|FG000|NOT COMPLETED|Overall Study||0
10975182|NCT00562354|12149760|FG001|NOT COMPLETED|Overall Study||2
10975183|NCT00562484|12149770|FG000|STARTED|Overall Study||10033
10975184|NCT00562484|12149771|FG001|STARTED|Overall Study||5011
10975185|NCT00562484|12149770|FG000|COMPLETED|Overall Study||9827
10975186|NCT00562484|12149771|FG001|COMPLETED|Overall Study||4907
10975187|NCT00562484|12149770|FG000|NOT COMPLETED|Overall Study||206
10975188|NCT00562484|12149771|FG001|NOT COMPLETED|Overall Study||104
10975189|NCT00562588|12149779|FG000|STARTED|Overall Study||260
10975190|NCT00562588|12149780|FG001|STARTED|Overall Study||283
10975191|NCT00562588|12149779|FG000|COMPLETED|Overall Study||168
10975192|NCT00562588|12149780|FG001|COMPLETED|Overall Study||184
10975193|NCT00562588|12149779|FG000|NOT COMPLETED|Overall Study||92
10975194|NCT00562588|12149780|FG001|NOT COMPLETED|Overall Study||99
10975195|NCT00562627|12149789|FG000|STARTED|Overall Study||34
10975196|NCT00562627|12149790|FG001|STARTED|Overall Study||34
10975197|NCT00562627|12149791|FG002|STARTED|Overall Study||34
10975198|NCT00562627|12149789|FG000|COMPLETED|Overall Study||33
10975199|NCT00562627|12149790|FG001|COMPLETED|Overall Study||33
10975200|NCT00562627|12149791|FG002|COMPLETED|Overall Study||33
10975201|NCT00562627|12149789|FG000|NOT COMPLETED|Overall Study||1
10975202|NCT00562627|12149790|FG001|NOT COMPLETED|Overall Study||1
10975203|NCT00562627|12149791|FG002|NOT COMPLETED|Overall Study||1
10975204|NCT00562718|12149799|FG000|STARTED|Overall Study||50
10975205|NCT00562718|12149799|FG000|COMPLETED|Overall Study||39
10975206|NCT00562718|12149799|FG000|NOT COMPLETED|Overall Study||11
10975207|NCT00562861|12149805|FG000|STARTED|Overall Study||60
10975208|NCT00562861|12149806|FG001|STARTED|Overall Study||59
10975209|NCT00562861|12149805|FG000|COMPLETED|Overall Study||40
10975210|NCT00562861|12149806|FG001|COMPLETED|Overall Study||48
10975211|NCT00562861|12149805|FG000|NOT COMPLETED|Overall Study||20
10975212|NCT00562861|12149806|FG001|NOT COMPLETED|Overall Study||11
10975213|NCT00562965|12149814|FG000|STARTED|Overall Study||15
10975214|NCT00562965|12149815|FG001|STARTED|Overall Study||14
10975215|NCT00562965|12149814|FG000|Treated|Overall Study||15
10975216|NCT00562965|12149815|FG001|Treated|Overall Study||13
10975217|NCT00562965|12149814|FG000|COMPLETED|Overall Study||12
10975218|NCT00562965|12149815|FG001|COMPLETED|Overall Study||8
10975219|NCT00562965|12149814|FG000|NOT COMPLETED|Overall Study||3
10975220|NCT00562965|12149815|FG001|NOT COMPLETED|Overall Study||6
10975221|NCT00562978|12149823|FG000|STARTED|Overall Study||6
10975222|NCT00562978|12149824|FG001|STARTED|Overall Study||48
10975223|NCT00562978|12149823|FG000|COMPLETED|Overall Study||5
10975224|NCT00562978|12149824|FG001|COMPLETED|Overall Study||37
10975225|NCT00562978|12149823|FG000|NOT COMPLETED|Overall Study||1
10975226|NCT00562978|12149824|FG001|NOT COMPLETED|Overall Study||11
10975227|NCT00563186|12149832|FG000|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
10975228|NCT00563186|12149833|FG001|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
10975229|NCT00563186|12149832|FG000|COMPLETED|Overall Study||910
10975230|NCT00563186|12149833|FG001|COMPLETED|Overall Study||604
10975231|NCT00563186|12149832|FG000|NOT COMPLETED|Overall Study||98
10975232|NCT00563186|12149833|FG001|NOT COMPLETED|Overall Study||75
10975233|NCT00563290|12149844|FG000|STARTED|Overall Study||3
10975234|NCT00563290|12149845|FG001|STARTED|Overall Study||4
10975235|NCT00563290|12149844|FG000|COMPLETED|Overall Study||3
10975236|NCT00563290|12149845|FG001|COMPLETED|Overall Study||4
10975237|NCT00563290|12149844|FG000|NOT COMPLETED|Overall Study||0
10975238|NCT00563290|12149845|FG001|NOT COMPLETED|Overall Study||0
10975239|NCT00563316|12149853|FG000|STARTED|Overall Study||28
10975240|NCT00563316|12149853|FG000|Received Investigational Product|Overall Study||27
10975241|NCT00563316|12149853|FG000|COMPLETED|Overall Study||16
10975242|NCT00563316|12149853|FG000|NOT COMPLETED|Overall Study||12
10975243|NCT00563368|12149868|FG000|STARTED|Overall Study||109
10975244|NCT00563368|12149869|FG001|STARTED|Overall Study||109
10975245|NCT00563368|12149870|FG002|STARTED|Overall Study||108
10975246|NCT00563368|12149871|FG003|STARTED|Overall Study||107
10975247|NCT00563368|12149872|FG004|STARTED|Overall Study||108
10975248|NCT00563368|12149873|FG005|STARTED|Overall Study||107
10975249|NCT00563368|12149874|FG006|STARTED|Overall Study||108
10975250|NCT00563368|12149868|FG000|COMPLETED|Overall Study||74
10975251|NCT00563368|12149869|FG001|COMPLETED|Overall Study||79
10975252|NCT00563368|12149870|FG002|COMPLETED|Overall Study||78
10975253|NCT00563368|12149871|FG003|COMPLETED|Overall Study||78
10975254|NCT00563368|12149872|FG004|COMPLETED|Overall Study||80
10975255|NCT00563368|12149873|FG005|COMPLETED|Overall Study||77
10975256|NCT00563368|12149874|FG006|COMPLETED|Overall Study||75
10975257|NCT00563368|12149868|FG000|NOT COMPLETED|Overall Study||35
10975258|NCT00563368|12149869|FG001|NOT COMPLETED|Overall Study||30
10975259|NCT00563368|12149870|FG002|NOT COMPLETED|Overall Study||30
10975260|NCT00563368|12149871|FG003|NOT COMPLETED|Overall Study||29
10975261|NCT00563368|12149872|FG004|NOT COMPLETED|Overall Study||28
10975262|NCT00563368|12149873|FG005|NOT COMPLETED|Overall Study||30
10975263|NCT00563368|12149874|FG006|NOT COMPLETED|Overall Study||33
10975264|NCT00563381|12149892|FG000|STARTED|Overall Study|Started treatment|3707
10975265|NCT00563381|12149893|FG001|STARTED|Overall Study|Started treatment|3669
10975266|NCT00563381|12149892|FG000|COMPLETED|Overall Study|Completed treatment|3122
10975267|NCT00563381|12149893|FG001|COMPLETED|Overall Study|Completed treatment|3021
10975268|NCT00563381|12149892|FG000|NOT COMPLETED|Overall Study||585
10975269|NCT00563381|12149893|FG001|NOT COMPLETED|Overall Study||648
10975270|NCT00563706|12149908|FG000|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
10975271|NCT00563706|12149909|FG001|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
10975272|NCT00563706|12149910|FG002|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
10975273|NCT00563706|12149911|FG003|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
10975274|NCT00563706|12149912|FG004|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
10975275|NCT00563706|12149913|FG005|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
10975276|NCT00563706|12149914|FG006|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
10975277|NCT00563706|12149915|FG007|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
10975278|NCT00563706|12149916|FG008|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
10975279|NCT00563706|12149908|FG000|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
10975280|NCT00563706|12149909|FG001|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
10975281|NCT00563706|12149910|FG002|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
10975282|NCT00563706|12149911|FG003|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
10975283|NCT00563706|12149912|FG004|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
10975284|NCT00563706|12149913|FG005|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
10975285|NCT00563706|12149914|FG006|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
10975286|NCT00563706|12149915|FG007|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
10975287|NCT00563706|12149916|FG008|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
10975288|NCT00563706|12149908|FG000|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
10975289|NCT00563706|12149909|FG001|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
10975290|NCT00563706|12149910|FG002|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
10975291|NCT00563706|12149911|FG003|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
10975292|NCT00563706|12149912|FG004|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
10975293|NCT00563706|12149913|FG005|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
10975294|NCT00563706|12149914|FG006|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
10975295|NCT00563706|12149915|FG007|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
10975296|NCT00563706|12149916|FG008|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
10975297|NCT00563706|12149908|FG000|STARTED|Taper Phase (Day 29 up to Day 35)||20
10975298|NCT00563706|12149909|FG001|STARTED|Taper Phase (Day 29 up to Day 35)||13
10975299|NCT00563706|12149910|FG002|STARTED|Taper Phase (Day 29 up to Day 35)||3
10975300|NCT00563706|12149911|FG003|STARTED|Taper Phase (Day 29 up to Day 35)||9
10975301|NCT00563706|12149912|FG004|STARTED|Taper Phase (Day 29 up to Day 35)||11
10975302|NCT00563706|12149913|FG005|STARTED|Taper Phase (Day 29 up to Day 35)||14
10975303|NCT00563706|12149914|FG006|STARTED|Taper Phase (Day 29 up to Day 35)||9
10975304|NCT00563706|12149915|FG007|STARTED|Taper Phase (Day 29 up to Day 35)||16
10975305|NCT00563706|12149916|FG008|STARTED|Taper Phase (Day 29 up to Day 35)||32
10975306|NCT00563706|12149908|FG000|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
10975307|NCT00563706|12149909|FG001|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
10975308|NCT00563706|12149910|FG002|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
10975309|NCT00563706|12149911|FG003|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
10975310|NCT00563706|12149912|FG004|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
10975311|NCT00563706|12149913|FG005|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
10975312|NCT00563706|12149914|FG006|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
10975313|NCT00563706|12149915|FG007|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
10975314|NCT00563706|12149916|FG008|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
10975315|NCT00563706|12149908|FG000|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10975316|NCT00563706|12149909|FG001|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10975317|NCT00563706|12149910|FG002|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10975318|NCT00563706|12149911|FG003|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10975319|NCT00563706|12149912|FG004|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10975320|NCT00563706|12149913|FG005|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10975321|NCT00563706|12149914|FG006|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10975322|NCT00563706|12149915|FG007|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10975323|NCT00563706|12149916|FG008|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
10975324|NCT00563784|12149936|FG000|STARTED|Overall Study||68
10975325|NCT00563784|12149936|FG000|COMPLETED|Overall Study||46
10975326|NCT00563784|12149936|FG000|NOT COMPLETED|Overall Study||22
10975327|NCT00563797|12149942|FG000|STARTED|Overall Study||11
10975328|NCT00563797|12149943|FG001|STARTED|Overall Study||10
10975329|NCT00563797|12149942|FG000|Received Allocated Intervention|Overall Study||11
10975330|NCT00563797|12149943|FG001|Received Allocated Intervention|Overall Study||10
10975331|NCT00563797|12149942|FG000|Follow-Up|Overall Study||11
10975332|NCT00563797|12149943|FG001|Follow-Up|Overall Study||10
10975333|NCT00563797|12149942|FG000|COMPLETED|Overall Study||4
10975334|NCT00563797|12149943|FG001|COMPLETED|Overall Study||8
10975335|NCT00563797|12149942|FG000|NOT COMPLETED|Overall Study||7
10975336|NCT00563797|12149943|FG001|NOT COMPLETED|Overall Study||2
10975337|NCT00564018|12149954|FG000|STARTED|Overall Study||11
10975338|NCT00564018|12149955|FG001|STARTED|Overall Study||10
10975339|NCT00564018|12149956|FG002|STARTED|Overall Study||12
10975340|NCT00564018|12149954|FG000|COMPLETED|Overall Study||9
10975341|NCT00564018|12149955|FG001|COMPLETED|Overall Study||7
10975342|NCT00564018|12149956|FG002|COMPLETED|Overall Study||11
10975343|NCT00564018|12149954|FG000|NOT COMPLETED|Overall Study||2
10975344|NCT00564018|12149955|FG001|NOT COMPLETED|Overall Study||3
10975345|NCT00564018|12149956|FG002|NOT COMPLETED|Overall Study||1
10975346|NCT00564070|12149966|FG000|STARTED|Overall Study||42
10975347|NCT00564070|12149967|FG001|STARTED|Overall Study||45
10975348|NCT00564070|12149966|FG000|COMPLETED|Overall Study||30
10975349|NCT00564070|12149967|FG001|COMPLETED|Overall Study||38
10975350|NCT00564070|12149966|FG000|NOT COMPLETED|Overall Study||12
10975351|NCT00564070|12149967|FG001|NOT COMPLETED|Overall Study||7
10975352|NCT00564265|12149973|FG000|STARTED|Overall Study||24
10975353|NCT00564265|12149973|FG000|COMPLETED|Overall Study||24
10975354|NCT00564265|12149973|FG000|NOT COMPLETED|Overall Study||0
10975355|NCT05085665|12149977|FG000|STARTED|Overall Study||41
10975356|NCT05085665|12149977|FG000|COMPLETED|Overall Study||39
10975357|NCT05085665|12149977|FG000|NOT COMPLETED|Overall Study||2
10975358|NCT04148872|12149983|FG000|STARTED|Overall Study||7
10975359|NCT04148872|12149984|FG001|STARTED|Overall Study|8 participants were consented and assigned to this arm; however, 1 never attended clinic visits and therefore no data was collected from or about this participant.|8
10975360|NCT04148872|12149983|FG000|COMPLETED|Overall Study||5
10975361|NCT04148872|12149984|FG001|COMPLETED|Overall Study||7
10975362|NCT04148872|12149983|FG000|NOT COMPLETED|Overall Study||2
10975363|NCT04148872|12149984|FG001|NOT COMPLETED|Overall Study||1
10975364|NCT04111185|12149992|FG000|STARTED|Overall Study||17
10975365|NCT04111185|12149993|FG001|STARTED|Overall Study||14
10975366|NCT04111185|12149992|FG000|COMPLETED|Overall Study||17
10975367|NCT04111185|12149993|FG001|COMPLETED|Overall Study||14
10975368|NCT04111185|12149992|FG000|NOT COMPLETED|Overall Study||0
10975369|NCT04111185|12149993|FG001|NOT COMPLETED|Overall Study||0
10975370|NCT04080752|12150001|FG000|STARTED|Overall Study||112
10975371|NCT04080752|12150002|FG001|STARTED|Overall Study||110
10975372|NCT04080752|12150001|FG000|COMPLETED|Overall Study||99
10975373|NCT04080752|12150002|FG001|COMPLETED|Overall Study||104
10975374|NCT04080752|12150001|FG000|NOT COMPLETED|Overall Study||13
10975375|NCT04080752|12150002|FG001|NOT COMPLETED|Overall Study||6
10975376|NCT04053387|12150009|FG000|STARTED|Overall Study||763
10975377|NCT04053387|12150009|FG000|COMPLETED|Overall Study||531
10975378|NCT04053387|12150009|FG000|NOT COMPLETED|Overall Study||232
10975379|NCT03799627|12150023|FG000|STARTED|Overall Study||35
10975380|NCT03799627|12150024|FG001|STARTED|Overall Study||34
10975381|NCT03799627|12150025|FG002|STARTED|Overall Study||23
10975382|NCT03799627|12150026|FG003|STARTED|Overall Study||18
10975383|NCT03799627|12150027|FG004|STARTED|Overall Study||21
10975384|NCT03799627|12150028|FG005|STARTED|Overall Study||21
10975385|NCT03799627|12150029|FG006|STARTED|Overall Study||13
10975386|NCT03799627|12150030|FG007|STARTED|Overall Study||5
10975387|NCT03799627|12150031|FG008|STARTED|Overall Study||5
10975388|NCT03799627|12150023|FG000|COMPLETED|Overall Study||27
10975389|NCT03799627|12150024|FG001|COMPLETED|Overall Study||23
10975390|NCT03799627|12150025|FG002|COMPLETED|Overall Study||22
10975391|NCT03799627|12150026|FG003|COMPLETED|Overall Study||8
10975392|NCT03799627|12150027|FG004|COMPLETED|Overall Study||12
10975393|NCT03799627|12150028|FG005|COMPLETED|Overall Study||8
10975394|NCT03799627|12150029|FG006|COMPLETED|Overall Study||10
10975395|NCT03799627|12150030|FG007|COMPLETED|Overall Study||3
10975396|NCT03799627|12150031|FG008|COMPLETED|Overall Study||2
10975397|NCT03799627|12150023|FG000|NOT COMPLETED|Overall Study||8
10975398|NCT03799627|12150024|FG001|NOT COMPLETED|Overall Study||11
10975399|NCT03799627|12150025|FG002|NOT COMPLETED|Overall Study||1
10975400|NCT03799627|12150026|FG003|NOT COMPLETED|Overall Study||10
10975401|NCT03799627|12150027|FG004|NOT COMPLETED|Overall Study||9
10975402|NCT03799627|12150028|FG005|NOT COMPLETED|Overall Study||13
10975403|NCT03799627|12150029|FG006|NOT COMPLETED|Overall Study||3
10975404|NCT03799627|12150030|FG007|NOT COMPLETED|Overall Study||2
10975405|NCT03799627|12150031|FG008|NOT COMPLETED|Overall Study||3
10975406|NCT03735498|12150070|FG000|STARTED|Overall Study|Total subjects who provided consent and were eligible to participate.|14
10975407|NCT03735498|12150070|FG000|Started Intervention|Overall Study||10
10975408|NCT03735498|12150070|FG000|COMPLETED|Overall Study|Subjects who completed all 6 sessions.|8
10975409|NCT03735498|12150070|FG000|NOT COMPLETED|Overall Study||6
10975410|NCT03734679|12150074|FG000|STARTED|Overall Study||12
10975411|NCT03734679|12150074|FG000|COMPLETED|Overall Study||11
10975412|NCT03734679|12150074|FG000|NOT COMPLETED|Overall Study||1
10975413|NCT03707587|12150080|FG000|STARTED|Overall Study||7
10975414|NCT03707587|12150081|FG001|STARTED|Overall Study||2
10975415|NCT03707587|12150080|FG000|COMPLETED|Overall Study||7
10975416|NCT03707587|12150081|FG001|COMPLETED|Overall Study||1
10975417|NCT03707587|12150080|FG000|NOT COMPLETED|Overall Study||0
10975418|NCT03707587|12150081|FG001|NOT COMPLETED|Overall Study||1
10975419|NCT03659136|12150089|FG000|STARTED|Overall Study||52
10975420|NCT03659136|12150090|FG001|STARTED|Overall Study||51
10975421|NCT03659136|12150089|FG000|Treated|Overall Study||50
10975422|NCT03659136|12150090|FG001|Treated|Overall Study||51
10975423|NCT03659136|12150089|FG000|COMPLETED|Overall Study||9
10975424|NCT03659136|12150090|FG001|COMPLETED|Overall Study||12
10975425|NCT03659136|12150089|FG000|NOT COMPLETED|Overall Study||43
10975426|NCT03659136|12150090|FG001|NOT COMPLETED|Overall Study||39
10975427|NCT03628976|12150099|FG000|STARTED|Overall Study||12
10975428|NCT03628976|12150100|FG001|STARTED|Overall Study||12
10975429|NCT03628976|12150099|FG000|COMPLETED|Overall Study||12
10975430|NCT03628976|12150100|FG001|COMPLETED|Overall Study||12
10975431|NCT03628976|12150099|FG000|NOT COMPLETED|Overall Study||0
10975432|NCT03628976|12150100|FG001|NOT COMPLETED|Overall Study||0
10975433|NCT03595332|12150108|FG000|STARTED|Overall Study||92
10975434|NCT03595332|12150109|FG001|STARTED|Overall Study||130
10975435|NCT03595332|12150108|FG000|COMPLETED|Overall Study||76
10975436|NCT03595332|12150109|FG001|COMPLETED|Overall Study||106
10975437|NCT03595332|12150108|FG000|NOT COMPLETED|Overall Study||16
10975438|NCT03595332|12150109|FG001|NOT COMPLETED|Overall Study||24
10975439|NCT02928224|12150122|FG000|STARTED|Overall Study||37
10975440|NCT02928224|12150123|FG001|STARTED|Overall Study||224
10975441|NCT02928224|12150124|FG002|STARTED|Overall Study||220
10975442|NCT02928224|12150125|FG003|STARTED|Overall Study||221
10975443|NCT02928224|12150122|FG000|COMPLETED|Overall Study||0
10975444|NCT02928224|12150123|FG001|COMPLETED|Overall Study||0
10975445|NCT02928224|12150124|FG002|COMPLETED|Overall Study||0
10975446|NCT02928224|12150125|FG003|COMPLETED|Overall Study||0
10975447|NCT02928224|12150122|FG000|NOT COMPLETED|Overall Study||37
10975448|NCT02928224|12150123|FG001|NOT COMPLETED|Overall Study||224
10975449|NCT02928224|12150124|FG002|NOT COMPLETED|Overall Study||220
10975450|NCT02928224|12150125|FG003|NOT COMPLETED|Overall Study||221
10975451|NCT02702401|12150142|FG000|STARTED|Overall Study||278
10975452|NCT02702401|12150143|FG001|STARTED|Overall Study||135
10975453|NCT02702401|12150142|FG000|Treated|Overall Study||278
10975454|NCT02702401|12150143|FG001|Treated|Overall Study||135
10975455|NCT02702401|12150142|FG000|Received Second Course|Overall Study||7
10975456|NCT02702401|12150143|FG001|Received Second Course|Overall Study||0
10975457|NCT02702401|12150142|FG000|COMPLETED|Overall Study||0
10975458|NCT02702401|12150143|FG001|COMPLETED|Overall Study||0
10975459|NCT02702401|12150142|FG000|NOT COMPLETED|Overall Study||278
10975460|NCT02702401|12150143|FG001|NOT COMPLETED|Overall Study||135
10975461|NCT02646982|12150152|FG000|STARTED|Overall Study||38
10975462|NCT02646982|12150153|FG001|STARTED|Overall Study||39
10975463|NCT02646982|12150152|FG000|COMPLETED|Overall Study||35
10975464|NCT02646982|12150153|FG001|COMPLETED|Overall Study||37
10975465|NCT02646982|12150152|FG000|NOT COMPLETED|Overall Study||3
10975466|NCT02646982|12150153|FG001|NOT COMPLETED|Overall Study||2
10975467|NCT02592551|12150162|FG000|STARTED|Overall Study||9
10975468|NCT02592551|12150163|FG001|STARTED|Overall Study||11
10975469|NCT02592551|12150164|FG002|STARTED|Overall Study||4
10975560|NCT02123108|12150242|FG001|NOT COMPLETED|Overall Study||3
10975470|NCT02592551|12150162|FG000|COMPLETED|Overall Study|One participant completed all study procedures and got the tumor sample for analysis. However, the sample was too small to analyze in the lab and so that it was not evaluable for primary and secondary analysis.|8
10975471|NCT02592551|12150163|FG001|COMPLETED|Overall Study||8
10975472|NCT02592551|12150164|FG002|COMPLETED|Overall Study||4
10975473|NCT02592551|12150162|FG000|NOT COMPLETED|Overall Study||1
10975474|NCT02592551|12150163|FG001|NOT COMPLETED|Overall Study||3
10975475|NCT02592551|12150164|FG002|NOT COMPLETED|Overall Study||0
10975476|NCT02481830|12150175|FG000|STARTED|Overall Study||284
10975477|NCT02481830|12150176|FG001|STARTED|Overall Study||285
10975478|NCT02481830|12150175|FG000|COMPLETED|Overall Study||282
10975479|NCT02481830|12150176|FG001|COMPLETED|Overall Study||265
10975480|NCT02481830|12150175|FG000|NOT COMPLETED|Overall Study||2
10975481|NCT02481830|12150176|FG001|NOT COMPLETED|Overall Study||20
10975482|NCT02425904|12150184|FG000|STARTED|Overall Study||20
10975483|NCT02425904|12150185|FG001|STARTED|Overall Study||5
10975484|NCT02425904|12150184|FG000|Efficacy Analysis|Overall Study||20
10975485|NCT02425904|12150185|FG001|Efficacy Analysis|Overall Study|1 patient was incorrectly assigned to LCH-related disorders cohort but it is actually LCH patients, so excluded from efficacy analysis.|4
10975486|NCT02425904|12150184|FG000|COMPLETED|Overall Study||17
10975487|NCT02425904|12150185|FG001|COMPLETED|Overall Study||2
10975488|NCT02425904|12150184|FG000|NOT COMPLETED|Overall Study||3
10975489|NCT02425904|12150185|FG001|NOT COMPLETED|Overall Study||3
10975490|NCT02367040|12150194|FG000|STARTED|Overall Study||307
10975491|NCT02367040|12150195|FG001|STARTED|Overall Study||151
10975492|NCT02367040|12150194|FG000|Received Treatment|Overall Study||304
10975493|NCT02367040|12150195|FG001|Received Treatment|Overall Study||149
10975494|NCT02367040|12150194|FG000|COMPLETED|Overall Study||70
10975495|NCT02367040|12150195|FG001|COMPLETED|Overall Study||29
10975496|NCT02367040|12150194|FG000|NOT COMPLETED|Overall Study||237
10975497|NCT02367040|12150195|FG001|NOT COMPLETED|Overall Study||122
10975498|NCT02346526|12150201|FG000|STARTED|Overall Study||22
10975499|NCT02346526|12150201|FG000|COMPLETED|Overall Study||22
10975500|NCT02346526|12150201|FG000|NOT COMPLETED|Overall Study||0
10975501|NCT02230891|12150214|FG000|STARTED|Baseline||21
10975502|NCT02230891|12150215|FG001|STARTED|Baseline||18
10975503|NCT02230891|12150216|FG002|STARTED|Baseline||19
10975504|NCT02230891|12150214|FG000|COMPLETED|Baseline||21
10975505|NCT02230891|12150215|FG001|COMPLETED|Baseline||17
10975506|NCT02230891|12150216|FG002|COMPLETED|Baseline||18
10975507|NCT02230891|12150214|FG000|NOT COMPLETED|Baseline||0
10975508|NCT02230891|12150215|FG001|NOT COMPLETED|Baseline||1
10975509|NCT02230891|12150216|FG002|NOT COMPLETED|Baseline||1
10975510|NCT02230891|12150214|FG000|STARTED|2 Week||21
10975511|NCT02230891|12150215|FG001|STARTED|2 Week||17
10975512|NCT02230891|12150216|FG002|STARTED|2 Week|No week 2 for subjects in usual care|0
10975513|NCT02230891|12150214|FG000|COMPLETED|2 Week||18
10975514|NCT02230891|12150215|FG001|COMPLETED|2 Week||15
10975515|NCT02230891|12150216|FG002|COMPLETED|2 Week|No week 2 for subjects in usual care|0
10975516|NCT02230891|12150214|FG000|NOT COMPLETED|2 Week||3
10975517|NCT02230891|12150215|FG001|NOT COMPLETED|2 Week||2
10975518|NCT02230891|12150216|FG002|NOT COMPLETED|2 Week||0
10975519|NCT02230891|12150214|FG000|STARTED|6 Month||18
10975520|NCT02230891|12150215|FG001|STARTED|6 Month||15
10975521|NCT02230891|12150216|FG002|STARTED|6 Month||18
10975522|NCT02230891|12150214|FG000|COMPLETED|6 Month||17
10975523|NCT02230891|12150215|FG001|COMPLETED|6 Month||12
10975524|NCT02230891|12150216|FG002|COMPLETED|6 Month||17
10975525|NCT02230891|12150214|FG000|NOT COMPLETED|6 Month||1
10975526|NCT02230891|12150215|FG001|NOT COMPLETED|6 Month||3
10975527|NCT02230891|12150216|FG002|NOT COMPLETED|6 Month||1
10975528|NCT02230891|12150214|FG000|STARTED|12 Month||17
10975529|NCT02230891|12150215|FG001|STARTED|12 Month||12
10975530|NCT02230891|12150216|FG002|STARTED|12 Month||17
10975531|NCT02230891|12150214|FG000|COMPLETED|12 Month||16
10975532|NCT02230891|12150215|FG001|COMPLETED|12 Month||9
10975533|NCT02230891|12150216|FG002|COMPLETED|12 Month||17
10975534|NCT02230891|12150214|FG000|NOT COMPLETED|12 Month||1
10975535|NCT02230891|12150215|FG001|NOT COMPLETED|12 Month||3
10975536|NCT02230891|12150216|FG002|NOT COMPLETED|12 Month||0
10975537|NCT02230891|12150214|FG000|STARTED|18 Month End of Study||16
10975538|NCT02230891|12150215|FG001|STARTED|18 Month End of Study||9
10975539|NCT02230891|12150216|FG002|STARTED|18 Month End of Study||17
10975540|NCT02230891|12150214|FG000|COMPLETED|18 Month End of Study||15
10975541|NCT02230891|12150215|FG001|COMPLETED|18 Month End of Study||9
10975542|NCT02230891|12150216|FG002|COMPLETED|18 Month End of Study||16
10975543|NCT02230891|12150214|FG000|NOT COMPLETED|18 Month End of Study||1
10975544|NCT02230891|12150215|FG001|NOT COMPLETED|18 Month End of Study||0
10975545|NCT02230891|12150216|FG002|NOT COMPLETED|18 Month End of Study||1
10975546|NCT02225925|12150226|FG000|STARTED|Overall Study||45
10975547|NCT02225925|12150226|FG000|COMPLETED|Overall Study||45
10975548|NCT02225925|12150226|FG000|NOT COMPLETED|Overall Study||0
10975549|NCT02148263|12150232|FG000|STARTED|Overall Study||12
10975550|NCT02148263|12150233|FG001|STARTED|Overall Study||13
10975551|NCT02148263|12150232|FG000|COMPLETED|Overall Study||9
10975552|NCT02148263|12150233|FG001|COMPLETED|Overall Study||11
10975553|NCT02148263|12150232|FG000|NOT COMPLETED|Overall Study||3
10975554|NCT02148263|12150233|FG001|NOT COMPLETED|Overall Study||2
10975555|NCT02123108|12150241|FG000|STARTED|Overall Study||30
10975556|NCT02123108|12150242|FG001|STARTED|Overall Study||29
10975557|NCT02123108|12150241|FG000|COMPLETED|Overall Study||28
10975558|NCT02123108|12150242|FG001|COMPLETED|Overall Study||26
10975559|NCT02123108|12150241|FG000|NOT COMPLETED|Overall Study||2
10975561|NCT02032810|12150250|FG000|STARTED|Overall Study||6
10975562|NCT02032810|12150251|FG001|STARTED|Overall Study||11
10975563|NCT02032810|12150250|FG000|COMPLETED|Overall Study||6
10975564|NCT02032810|12150251|FG001|COMPLETED|Overall Study||11
10975565|NCT02032810|12150250|FG000|NOT COMPLETED|Overall Study||0
10975566|NCT02032810|12150251|FG001|NOT COMPLETED|Overall Study||0
10975567|NCT01962948|12150265|FG000|STARTED|Overall Study||3
10975568|NCT01962948|12150266|FG001|STARTED|Overall Study||3
10975569|NCT01962948|12150267|FG002|STARTED|Overall Study||6
10975570|NCT01962948|12150268|FG003|STARTED|Overall Study||0
10975571|NCT01962948|12150265|FG000|COMPLETED|Overall Study||0
10975572|NCT01962948|12150266|FG001|COMPLETED|Overall Study||0
10975573|NCT01962948|12150267|FG002|COMPLETED|Overall Study||0
10975574|NCT01962948|12150268|FG003|COMPLETED|Overall Study||0
10975575|NCT01962948|12150265|FG000|NOT COMPLETED|Overall Study||3
10975576|NCT01962948|12150266|FG001|NOT COMPLETED|Overall Study||3
10975577|NCT01962948|12150267|FG002|NOT COMPLETED|Overall Study||6
10975578|NCT01962948|12150268|FG003|NOT COMPLETED|Overall Study||0
10975579|NCT01910402|12150277|FG000|STARTED|Randomized Phase||248
10975580|NCT01910402|12150278|FG001|STARTED|Randomized Phase||247
10975581|NCT01910402|12150277|FG000|COMPLETED|Randomized Phase||206
10975582|NCT01910402|12150278|FG001|COMPLETED|Randomized Phase||192
10975583|NCT01910402|12150277|FG000|NOT COMPLETED|Randomized Phase||42
10975584|NCT01910402|12150278|FG001|NOT COMPLETED|Randomized Phase||55
10975585|NCT01910402|12150277|FG000|STARTED|Continuation Phase||120
10975586|NCT01910402|12150278|FG001|STARTED|Continuation Phase||0
10975587|NCT01910402|12150277|FG000|COMPLETED|Continuation Phase||30
10975588|NCT01910402|12150278|FG001|COMPLETED|Continuation Phase||0
10975589|NCT01910402|12150277|FG000|NOT COMPLETED|Continuation Phase||90
10975590|NCT01910402|12150278|FG001|NOT COMPLETED|Continuation Phase||0
10975591|NCT01815580|12150288|FG000|STARTED|Overall Study||110
10975592|NCT01815580|12150289|FG001|STARTED|Overall Study||115
10975593|NCT01815580|12150288|FG000|COMPLETED|Overall Study||98
10975594|NCT01815580|12150289|FG001|COMPLETED|Overall Study||100
10975595|NCT01815580|12150288|FG000|NOT COMPLETED|Overall Study||12
10975596|NCT01815580|12150289|FG001|NOT COMPLETED|Overall Study||15
10975597|NCT01696773|12150302|FG000|STARTED|Days 1-13, Washout||6
10975598|NCT01696773|12150303|FG001|STARTED|Days 1-13, Washout||6
10975599|NCT01696773|12150302|FG000|COMPLETED|Days 1-13, Washout||6
10975600|NCT01696773|12150303|FG001|COMPLETED|Days 1-13, Washout||6
10975601|NCT01696773|12150302|FG000|NOT COMPLETED|Days 1-13, Washout||0
10975602|NCT01696773|12150303|FG001|NOT COMPLETED|Days 1-13, Washout||0
10975603|NCT01696773|12150302|FG000|STARTED|Day 14, First Intervention||6
10975604|NCT01696773|12150303|FG001|STARTED|Day 14, First Intervention||6
10975605|NCT01696773|12150302|FG000|COMPLETED|Day 14, First Intervention||6
10975606|NCT01696773|12150303|FG001|COMPLETED|Day 14, First Intervention||6
10975607|NCT01696773|12150302|FG000|NOT COMPLETED|Day 14, First Intervention||0
10975608|NCT01696773|12150303|FG001|NOT COMPLETED|Day 14, First Intervention||0
10975609|NCT01696773|12150302|FG000|STARTED|Days 15-27, Washout||6
10975610|NCT01696773|12150303|FG001|STARTED|Days 15-27, Washout||6
10975611|NCT01696773|12150302|FG000|COMPLETED|Days 15-27, Washout||5
10975612|NCT01696773|12150303|FG001|COMPLETED|Days 15-27, Washout||6
10975613|NCT01696773|12150302|FG000|NOT COMPLETED|Days 15-27, Washout||1
10975614|NCT01696773|12150303|FG001|NOT COMPLETED|Days 15-27, Washout||0
10975615|NCT01696773|12150302|FG000|STARTED|Day 28, Second Intervention||5
10975616|NCT01696773|12150303|FG001|STARTED|Day 28, Second Intervention||6
10975617|NCT01696773|12150302|FG000|COMPLETED|Day 28, Second Intervention||5
10975618|NCT01696773|12150303|FG001|COMPLETED|Day 28, Second Intervention||6
10975619|NCT01696773|12150302|FG000|NOT COMPLETED|Day 28, Second Intervention||0
10975620|NCT01696773|12150303|FG001|NOT COMPLETED|Day 28, Second Intervention||0
10975621|NCT01659151|12150309|FG000|STARTED|Overall Study||17
10975622|NCT01659151|12150309|FG000|COMPLETED|Overall Study||16
10975623|NCT01659151|12150309|FG000|NOT COMPLETED|Overall Study||1
10975624|NCT01137604|12150317|FG000|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
10975625|NCT01137604|12150318|FG001|STARTED|Overall Study||42
10975626|NCT01137604|12150319|FG002|STARTED|Overall Study||39
10975627|NCT01137604|12150320|FG003|STARTED|Overall Study||32
10975628|NCT01137604|12150317|FG000|Treatment Discontinued Due to Disease Progression|Overall Study||34
10975629|NCT01137604|12150318|FG001|Treatment Discontinued Due to Disease Progression|Overall Study||32
10975630|NCT01137604|12150319|FG002|Treatment Discontinued Due to Disease Progression|Overall Study||26
10975631|NCT01137604|12150320|FG003|Treatment Discontinued Due to Disease Progression|Overall Study||21
10975632|NCT01137604|12150317|FG000|COMPLETED|Overall Study||34
10975633|NCT01137604|12150318|FG001|COMPLETED|Overall Study||32
10975634|NCT01137604|12150319|FG002|COMPLETED|Overall Study||26
10975635|NCT01137604|12150320|FG003|COMPLETED|Overall Study||21
10975636|NCT01137604|12150317|FG000|NOT COMPLETED|Overall Study||4
10975637|NCT01137604|12150318|FG001|NOT COMPLETED|Overall Study||10
10975638|NCT01137604|12150319|FG002|NOT COMPLETED|Overall Study||13
10975639|NCT01137604|12150320|FG003|NOT COMPLETED|Overall Study||11
10975640|NCT00754208|12150330|FG000|STARTED|Overall Study||7
10975641|NCT00754208|12150330|FG000|COMPLETED|Overall Study||7
10975642|NCT00754208|12150330|FG000|NOT COMPLETED|Overall Study||0
10975643|NCT00634166|12150337|FG000|STARTED|Overall Study||82
10975644|NCT00634166|12150338|FG001|STARTED|Overall Study||138
10975645|NCT00634166|12150337|FG000|COMPLETED|Overall Study||22
10975646|NCT00634166|12150338|FG001|COMPLETED|Overall Study||78
10975647|NCT00634166|12150337|FG000|NOT COMPLETED|Overall Study||60
10975648|NCT00634166|12150338|FG001|NOT COMPLETED|Overall Study||60
10975649|NCT00564278|12150348|FG000|STARTED|Overall Study||97
10975650|NCT00564278|12150349|FG001|STARTED|Overall Study||98
10975651|NCT00564278|12150348|FG000|COMPLETED|Overall Study||50
10975652|NCT00564278|12150349|FG001|COMPLETED|Overall Study||56
10975653|NCT00564278|12150348|FG000|NOT COMPLETED|Overall Study||47
10975654|NCT00564278|12150349|FG001|NOT COMPLETED|Overall Study||42
10975655|NCT00564395|12150355|FG000|STARTED|First Intervention (10 Days)||9
10975656|NCT00564395|12150356|FG001|STARTED|First Intervention (10 Days)||9
10975657|NCT00564395|12150355|FG000|Received Intervention|First Intervention (10 Days)||7
10975658|NCT00564395|12150356|FG001|Received Intervention|First Intervention (10 Days)||7
10975659|NCT00564395|12150355|FG000|COMPLETED|First Intervention (10 Days)||7
10975660|NCT00564395|12150356|FG001|COMPLETED|First Intervention (10 Days)||7
10975661|NCT00564395|12150355|FG000|NOT COMPLETED|First Intervention (10 Days)||2
10975662|NCT00564395|12150356|FG001|NOT COMPLETED|First Intervention (10 Days)||2
10975663|NCT00564395|12150355|FG000|STARTED|Second Intervention (10 Days)||7
10975664|NCT00564395|12150356|FG001|STARTED|Second Intervention (10 Days)||7
10975665|NCT00564395|12150355|FG000|COMPLETED|Second Intervention (10 Days)||7
10975666|NCT00564395|12150356|FG001|COMPLETED|Second Intervention (10 Days)||7
10975667|NCT00564395|12150355|FG000|NOT COMPLETED|Second Intervention (10 Days)||0
10975668|NCT00564395|12150356|FG001|NOT COMPLETED|Second Intervention (10 Days)||0
10975669|NCT00564447|12150370|FG000|STARTED|Overall Study||6
10975670|NCT00564447|12150371|FG001|STARTED|Overall Study||6
10975671|NCT00564447|12150372|FG002|STARTED|Overall Study||6
10975672|NCT00564447|12150373|FG003|STARTED|Overall Study||6
10975673|NCT00564447|12150374|FG004|STARTED|Overall Study||6
10975674|NCT00564447|12150375|FG005|STARTED|Overall Study||6
10975675|NCT00564447|12150376|FG006|STARTED|Overall Study||6
10975676|NCT00564447|12150377|FG007|STARTED|Overall Study||6
10975677|NCT00564447|12150370|FG000|COMPLETED|Overall Study||6
10975678|NCT00564447|12150371|FG001|COMPLETED|Overall Study||6
10975679|NCT00564447|12150372|FG002|COMPLETED|Overall Study||6
10975680|NCT00564447|12150373|FG003|COMPLETED|Overall Study||6
10975681|NCT00564447|12150374|FG004|COMPLETED|Overall Study||6
10975682|NCT00564447|12150375|FG005|COMPLETED|Overall Study||6
10975683|NCT00564447|12150376|FG006|COMPLETED|Overall Study||6
10975684|NCT00564447|12150377|FG007|COMPLETED|Overall Study||6
10975685|NCT00564447|12150370|FG000|NOT COMPLETED|Overall Study||0
10975686|NCT00564447|12150371|FG001|NOT COMPLETED|Overall Study||0
10975687|NCT00564447|12150372|FG002|NOT COMPLETED|Overall Study||0
10975688|NCT00564447|12150373|FG003|NOT COMPLETED|Overall Study||0
10975689|NCT00564447|12150374|FG004|NOT COMPLETED|Overall Study||0
10975690|NCT00564447|12150375|FG005|NOT COMPLETED|Overall Study||0
10975691|NCT00564447|12150376|FG006|NOT COMPLETED|Overall Study||0
10975692|NCT00564447|12150377|FG007|NOT COMPLETED|Overall Study||0
10975693|NCT00564486|12150398|FG000|STARTED|Overall Study||43
10975694|NCT00564486|12150399|FG001|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
10975695|NCT00564486|12150400|FG002|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
10975696|NCT00564486|12150401|FG003|STARTED|Overall Study||67
10975697|NCT00564486|12150398|FG000|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
10975698|NCT00564486|12150399|FG001|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
10975699|NCT00564486|12150400|FG002|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
10975700|NCT00564486|12150401|FG003|COMPLETED|Overall Study||60
10975701|NCT00564486|12150398|FG000|NOT COMPLETED|Overall Study||7
10975702|NCT00564486|12150399|FG001|NOT COMPLETED|Overall Study||1
10975703|NCT00564486|12150400|FG002|NOT COMPLETED|Overall Study||3
10975704|NCT00564486|12150401|FG003|NOT COMPLETED|Overall Study||7
10975705|NCT00564629|12150417|FG000|STARTED|Overall Study||51
10975706|NCT00564629|12150418|FG001|STARTED|Overall Study||54
10975707|NCT00564629|12150417|FG000|COMPLETED|Overall Study||36
10975708|NCT00564629|12150418|FG001|COMPLETED|Overall Study||45
10975709|NCT00564629|12150417|FG000|NOT COMPLETED|Overall Study||15
10975710|NCT00564629|12150418|FG001|NOT COMPLETED|Overall Study||9
10975711|NCT00564681|12150428|FG000|STARTED|Overall Study||117
10975712|NCT00564681|12150429|FG001|STARTED|Overall Study||61
10975713|NCT00564681|12150430|FG002|STARTED|Overall Study||43
10975714|NCT00564681|12150431|FG003|STARTED|Overall Study||21
10975715|NCT00564681|12150428|FG000|COMPLETED|Overall Study||106
10975716|NCT00564681|12150429|FG001|COMPLETED|Overall Study||58
10975717|NCT00564681|12150430|FG002|COMPLETED|Overall Study||40
10975718|NCT00564681|12150431|FG003|COMPLETED|Overall Study||19
10975719|NCT00564681|12150428|FG000|NOT COMPLETED|Overall Study||11
10975720|NCT00564681|12150429|FG001|NOT COMPLETED|Overall Study||3
10975721|NCT00564681|12150430|FG002|NOT COMPLETED|Overall Study||3
10975722|NCT00564681|12150431|FG003|NOT COMPLETED|Overall Study||2
10975723|NCT00564733|12150440|FG000|STARTED|Overall Study||55
10975724|NCT00564733|12150440|FG000|COMPLETED|Overall Study||46
10975725|NCT00564733|12150440|FG000|NOT COMPLETED|Overall Study||9
10975726|NCT00564850|12150444|FG000|STARTED|Overall Study||37
10975727|NCT00564850|12150444|FG000|COMPLETED|Overall Study||35
10975728|NCT00564850|12150444|FG000|NOT COMPLETED|Overall Study||2
10975729|NCT00564889|12150448|FG000|STARTED|Overall Study||35
10975730|NCT00564889|12150448|FG000|COMPLETED|Overall Study||6
10975731|NCT00564889|12150448|FG000|NOT COMPLETED|Overall Study||29
10975732|NCT00564902|12150455|FG000|STARTED|Overall Study||10
10975733|NCT00564902|12150456|FG001|STARTED|Overall Study||25
10975734|NCT00564902|12150457|FG002|STARTED|Overall Study||25
10975735|NCT00564902|12150455|FG000|4 Months|Overall Study||9
10975736|NCT00564902|12150456|FG001|4 Months|Overall Study||24
10975737|NCT00564902|12150457|FG002|4 Months|Overall Study||23
10975738|NCT00564902|12150455|FG000|8 Months|Overall Study||9
10975739|NCT00564902|12150456|FG001|8 Months|Overall Study||22
10975740|NCT00564902|12150457|FG002|8 Months|Overall Study||21
10975741|NCT00564902|12150455|FG000|12 Months|Overall Study||9
10975742|NCT00564902|12150456|FG001|12 Months|Overall Study||21
10975743|NCT00564902|12150457|FG002|12 Months|Overall Study||21
10975744|NCT00564902|12150455|FG000|COMPLETED|Overall Study||9
10975745|NCT00564902|12150456|FG001|COMPLETED|Overall Study||21
10975746|NCT00564902|12150457|FG002|COMPLETED|Overall Study||21
10975747|NCT00564902|12150455|FG000|NOT COMPLETED|Overall Study||1
10975748|NCT00564902|12150456|FG001|NOT COMPLETED|Overall Study||4
10975749|NCT00564902|12150457|FG002|NOT COMPLETED|Overall Study||4
10975750|NCT00564954|12150467|FG000|STARTED|Period 1- 1 Week||44
10975751|NCT00564954|12150468|FG001|STARTED|Period 1- 1 Week||42
10975752|NCT00564954|12150467|FG000|COMPLETED|Period 1- 1 Week||44
10975753|NCT00564954|12150468|FG001|COMPLETED|Period 1- 1 Week||42
10975754|NCT00564954|12150467|FG000|NOT COMPLETED|Period 1- 1 Week||0
10975755|NCT00564954|12150468|FG001|NOT COMPLETED|Period 1- 1 Week||0
10975756|NCT00564954|12150467|FG000|STARTED|Period 2- 1 Week||44
10975757|NCT00564954|12150468|FG001|STARTED|Period 2- 1 Week||42
10975758|NCT00564954|12150467|FG000|COMPLETED|Period 2- 1 Week||44
10975759|NCT00564954|12150468|FG001|COMPLETED|Period 2- 1 Week||42
10975760|NCT00564954|12150467|FG000|NOT COMPLETED|Period 2- 1 Week||0
10975761|NCT00564954|12150468|FG001|NOT COMPLETED|Period 2- 1 Week||0
10975762|NCT00565045|12150476|FG000|STARTED|Overall Study||10
10975763|NCT00565045|12150477|FG001|STARTED|Overall Study||11
10975764|NCT00565045|12150476|FG000|COMPLETED|Overall Study||9
10975765|NCT00565045|12150477|FG001|COMPLETED|Overall Study||8
10975766|NCT00565045|12150476|FG000|NOT COMPLETED|Overall Study||1
10975767|NCT00565045|12150477|FG001|NOT COMPLETED|Overall Study||3
10975768|NCT00565058|12150485|FG000|STARTED|Overall Study||10
10975769|NCT00565058|12150486|FG001|STARTED|Overall Study||15
10975770|NCT00565058|12150485|FG000|COMPLETED|Overall Study||9
10975771|NCT00565058|12150486|FG001|COMPLETED|Overall Study||15
10975772|NCT00565058|12150485|FG000|NOT COMPLETED|Overall Study||1
10975773|NCT00565058|12150486|FG001|NOT COMPLETED|Overall Study||0
10975774|NCT00565084|12150492|FG000|STARTED|First Treatment Period||11
10975775|NCT00565084|12150493|FG001|STARTED|First Treatment Period||11
10975776|NCT00565084|12150494|FG002|STARTED|First Treatment Period||11
10975777|NCT00565084|12150492|FG000|COMPLETED|First Treatment Period||11
10975778|NCT00565084|12150493|FG001|COMPLETED|First Treatment Period||11
10975779|NCT00565084|12150494|FG002|COMPLETED|First Treatment Period||11
10975780|NCT00565084|12150492|FG000|NOT COMPLETED|First Treatment Period||0
10975781|NCT00565084|12150493|FG001|NOT COMPLETED|First Treatment Period||0
10975782|NCT00565084|12150494|FG002|NOT COMPLETED|First Treatment Period||0
10975783|NCT00565084|12150492|FG000|STARTED|Second Treatment Period||11
10975784|NCT00565084|12150493|FG001|STARTED|Second Treatment Period||11
10975785|NCT00565084|12150494|FG002|STARTED|Second Treatment Period||11
10975786|NCT00565084|12150492|FG000|COMPLETED|Second Treatment Period||11
10975787|NCT00565084|12150493|FG001|COMPLETED|Second Treatment Period||11
10975788|NCT00565084|12150494|FG002|COMPLETED|Second Treatment Period||11
10975789|NCT00565084|12150492|FG000|NOT COMPLETED|Second Treatment Period||0
10975790|NCT00565084|12150493|FG001|NOT COMPLETED|Second Treatment Period||0
10975791|NCT00565084|12150494|FG002|NOT COMPLETED|Second Treatment Period||0
10975792|NCT00565084|12150492|FG000|STARTED|Third Treatment Period||11
10975793|NCT00565084|12150493|FG001|STARTED|Third Treatment Period||11
10975794|NCT00565084|12150494|FG002|STARTED|Third Treatment Period||11
10975795|NCT00565084|12150492|FG000|COMPLETED|Third Treatment Period||11
10975796|NCT00565084|12150493|FG001|COMPLETED|Third Treatment Period||11
10975797|NCT00565084|12150494|FG002|COMPLETED|Third Treatment Period||11
10975798|NCT00565084|12150492|FG000|NOT COMPLETED|Third Treatment Period||0
10975799|NCT00565084|12150493|FG001|NOT COMPLETED|Third Treatment Period||0
10975800|NCT00565084|12150494|FG002|NOT COMPLETED|Third Treatment Period||0
10975801|NCT00565110|12150504|FG000|STARTED|Overall Study||230
10975802|NCT00565110|12150505|FG001|STARTED|Overall Study||242
10975803|NCT00565110|12150504|FG000|12-Month|Overall Study||114
10975804|NCT00565110|12150505|FG001|12-Month|Overall Study||144
10975805|NCT00565110|12150504|FG000|COMPLETED|Overall Study||99
10975806|NCT00565110|12150505|FG001|COMPLETED|Overall Study||111
10975807|NCT00565110|12150504|FG000|NOT COMPLETED|Overall Study||131
10975808|NCT00565110|12150505|FG001|NOT COMPLETED|Overall Study||131
10975809|NCT00565136|12150511|FG000|STARTED|Overall Study||29
10975810|NCT00565136|12150511|FG000|COMPLETED|Overall Study||26
10975811|NCT00565136|12150511|FG000|NOT COMPLETED|Overall Study||3
10975812|NCT00565266|12150515|FG000|STARTED|Overall Study||210
10975813|NCT00565266|12150515|FG000|COMPLETED|Overall Study||174
10975814|NCT00565266|12150515|FG000|NOT COMPLETED|Overall Study||36
10975815|NCT00565370|12150523|FG000|STARTED|Overall Study||21
10975816|NCT00565370|12150523|FG000|COMPLETED|Overall Study||21
10975817|NCT00565370|12150523|FG000|NOT COMPLETED|Overall Study||0
10975818|NCT00565409|12150527|FG000|STARTED|Period 1 Open Label||834
10975819|NCT00565409|12150528|FG001|STARTED|Period 1 Open Label||0
10975820|NCT00565409|12150529|FG002|STARTED|Period 1 Open Label||0
10975821|NCT00565409|12150530|FG003|STARTED|Period 1 Open Label||0
10975822|NCT00565409|12150527|FG000|COMPLETED|Period 1 Open Label||756
10975823|NCT00565409|12150528|FG001|COMPLETED|Period 1 Open Label||0
10975824|NCT00565409|12150529|FG002|COMPLETED|Period 1 Open Label||0
10975825|NCT00565409|12150530|FG003|COMPLETED|Period 1 Open Label||0
10975826|NCT00565409|12150527|FG000|NOT COMPLETED|Period 1 Open Label||78
10975827|NCT00565409|12150528|FG001|NOT COMPLETED|Period 1 Open Label||0
10975828|NCT00565409|12150529|FG002|NOT COMPLETED|Period 1 Open Label||0
10975829|NCT00565409|12150530|FG003|NOT COMPLETED|Period 1 Open Label||0
10975830|NCT00565409|12150527|FG000|STARTED|After Period 1, Prior to Period 2||756
10975831|NCT00565409|12150528|FG001|STARTED|After Period 1, Prior to Period 2||0
10975832|NCT00565409|12150529|FG002|STARTED|After Period 1, Prior to Period 2||0
10975833|NCT00565409|12150530|FG003|STARTED|After Period 1, Prior to Period 2||0
10975834|NCT00565409|12150527|FG000|COMPLETED|After Period 1, Prior to Period 2||604
10975835|NCT00565409|12150528|FG001|COMPLETED|After Period 1, Prior to Period 2||0
10975836|NCT00565409|12150529|FG002|COMPLETED|After Period 1, Prior to Period 2||0
10975837|NCT00565409|12150530|FG003|COMPLETED|After Period 1, Prior to Period 2||0
10975838|NCT00565409|12150527|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||152
10975839|NCT00565409|12150528|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0
10975840|NCT00565409|12150529|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||0
10975841|NCT00565409|12150530|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0
10975842|NCT00565409|12150527|FG000|STARTED|Period 2 Double-Blind||0
10975843|NCT00565409|12150528|FG001|STARTED|Period 2 Double-Blind||202
10975844|NCT00565409|12150529|FG002|STARTED|Period 2 Double-Blind||202
10975845|NCT00565409|12150530|FG003|STARTED|Period 2 Double-Blind||200
10975846|NCT00565409|12150527|FG000|COMPLETED|Period 2 Double-Blind||0
10975847|NCT00565409|12150528|FG001|COMPLETED|Period 2 Double-Blind||181
10975848|NCT00565409|12150529|FG002|COMPLETED|Period 2 Double-Blind||175
10975849|NCT00565409|12150530|FG003|COMPLETED|Period 2 Double-Blind||141
10975850|NCT00565409|12150527|FG000|NOT COMPLETED|Period 2 Double-Blind||0
10975851|NCT00565409|12150528|FG001|NOT COMPLETED|Period 2 Double-Blind||21
10975852|NCT00565409|12150529|FG002|NOT COMPLETED|Period 2 Double-Blind||27
10975853|NCT00565409|12150530|FG003|NOT COMPLETED|Period 2 Double-Blind||59
10975854|NCT00565448|12150542|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
10975855|NCT00565448|12150543|FG001|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
10975856|NCT00565448|12150542|FG000|COMPLETED|Overall Study|Completed induction period as per protocol.|47
10975857|NCT00565448|12150543|FG001|COMPLETED|Overall Study|Completed induction period as per protocol.|23
10975858|NCT00565448|12150542|FG000|NOT COMPLETED|Overall Study||3
10975859|NCT00565448|12150543|FG001|NOT COMPLETED|Overall Study||2
10975860|NCT00565604|12150552|FG000|STARTED|Overall Study||43
10975861|NCT00565604|12150552|FG000|7 Day|Overall Study||41
10975862|NCT00565604|12150552|FG000|2 Week|Overall Study||41
10975863|NCT00565604|12150552|FG000|6 Week|Overall Study||39
10975864|NCT00565604|12150552|FG000|6 Month|Overall Study||39
10975865|NCT00565604|12150552|FG000|COMPLETED|Overall Study||39
10975866|NCT00565604|12150552|FG000|NOT COMPLETED|Overall Study||4
10975867|NCT00565643|12150558|FG000|STARTED|Overall Study||380
10975868|NCT00565643|12150559|FG001|STARTED|Overall Study||373
10975869|NCT00565643|12150558|FG000|Safety Data|Overall Study||380
10975870|NCT00565643|12150559|FG001|Safety Data|Overall Study||373
10975871|NCT00565643|12150558|FG000|Primary Outcome (Subsequent Cesarean)|Overall Study||80
10975872|NCT00565643|12150559|FG001|Primary Outcome (Subsequent Cesarean)|Overall Study||92
10975873|NCT00565643|12150558|FG000|COMPLETED|Overall Study||380
10975874|NCT00565643|12150559|FG001|COMPLETED|Overall Study||373
10975875|NCT00565643|12150558|FG000|NOT COMPLETED|Overall Study||0
10975876|NCT00565643|12150559|FG001|NOT COMPLETED|Overall Study||0
10975877|NCT00565669|12150568|FG000|STARTED|Overall Study||11
10975878|NCT00565669|12150569|FG001|STARTED|Overall Study||9
10975879|NCT00565669|12150568|FG000|COMPLETED|Overall Study||11
10975880|NCT00565669|12150569|FG001|COMPLETED|Overall Study||9
10975881|NCT00565669|12150568|FG000|NOT COMPLETED|Overall Study||0
10975882|NCT00565669|12150569|FG001|NOT COMPLETED|Overall Study||0
10975883|NCT00565721|12150575|FG000|STARTED|Overall Study||33
10975884|NCT00565721|12150575|FG000|COMPLETED|Overall Study||16
10975885|NCT00565721|12150575|FG000|NOT COMPLETED|Overall Study||17
10975886|NCT00565747|12150596|FG000|STARTED|Overall Study||654
10975887|NCT00565747|12150597|FG001|STARTED|Overall Study||678
10975888|NCT00565747|12150596|FG000|COMPLETED|Overall Study|Completed with an embryo transfer|587
10975889|NCT00565747|12150597|FG001|COMPLETED|Overall Study|Completed with an embryo transfer|605
10975890|NCT00565747|12150596|FG000|NOT COMPLETED|Overall Study||67
10975891|NCT00565747|12150597|FG001|NOT COMPLETED|Overall Study||73
10975892|NCT00565773|12150603|FG000|STARTED|Overall Study||40
10975893|NCT00565773|12150603|FG000|COMPLETED|Overall Study||38
10975894|NCT00565773|12150603|FG000|NOT COMPLETED|Overall Study||2
10975895|NCT00565812|12150610|FG000|STARTED|Overall Study||485
10975896|NCT00565812|12150611|FG001|STARTED|Overall Study||486
10975897|NCT00565812|12150612|FG002|STARTED|Overall Study||486
10975898|NCT00565812|12150610|FG000|COMPLETED|Overall Study||341
10975899|NCT00565812|12150611|FG001|COMPLETED|Overall Study||351
10975900|NCT00565812|12150612|FG002|COMPLETED|Overall Study||356
10975901|NCT00565812|12150610|FG000|NOT COMPLETED|Overall Study||144
10975902|NCT00565812|12150611|FG001|NOT COMPLETED|Overall Study||135
10975903|NCT00565812|12150612|FG002|NOT COMPLETED|Overall Study||130
10975904|NCT00565864|12150623|FG000|STARTED|Overall Study||58
10975905|NCT00565864|12150624|FG001|STARTED|Overall Study||59
10975906|NCT00565864|12150625|FG002|STARTED|Overall Study||56
10975907|NCT00565864|12150623|FG000|COMPLETED|Overall Study||46
10975908|NCT00565864|12150624|FG001|COMPLETED|Overall Study||47
10975909|NCT00565864|12150625|FG002|COMPLETED|Overall Study||45
10975910|NCT00565864|12150623|FG000|NOT COMPLETED|Overall Study||12
10975911|NCT00565864|12150624|FG001|NOT COMPLETED|Overall Study||12
10975912|NCT00565864|12150625|FG002|NOT COMPLETED|Overall Study||11
10975913|NCT00565916|12150637|FG000|STARTED|Overall Study||11
10975914|NCT00565916|12150638|FG001|STARTED|Overall Study||11
10975915|NCT00565916|12150637|FG000|COMPLETED|Overall Study||11
10975916|NCT00565916|12150638|FG001|COMPLETED|Overall Study||11
10975917|NCT00565916|12150637|FG000|NOT COMPLETED|Overall Study||0
10975918|NCT00565916|12150638|FG001|NOT COMPLETED|Overall Study||0
10975919|NCT00566020|12150644|FG000|STARTED|6-week Dosage Adjustment Phase||92
10975920|NCT00566020|12150645|FG001|STARTED|6-week Dosage Adjustment Phase||0
10975921|NCT00566020|12150644|FG000|COMPLETED|6-week Dosage Adjustment Phase||85
10975922|NCT00566020|12150645|FG001|COMPLETED|6-week Dosage Adjustment Phase||0
10975923|NCT00566020|12150644|FG000|NOT COMPLETED|6-week Dosage Adjustment Phase||7
10975924|NCT00566020|12150645|FG001|NOT COMPLETED|6-week Dosage Adjustment Phase||0
10975925|NCT00566020|12150644|FG000|STARTED|46-week Long-term Administration Phase||0
10975926|NCT00566020|12150645|FG001|STARTED|46-week Long-term Administration Phase||85
10975927|NCT00566020|12150644|FG000|COMPLETED|46-week Long-term Administration Phase||0
10975928|NCT00566020|12150645|FG001|COMPLETED|46-week Long-term Administration Phase||68
10975929|NCT00566020|12150644|FG000|NOT COMPLETED|46-week Long-term Administration Phase||0
10975930|NCT00566020|12150645|FG001|NOT COMPLETED|46-week Long-term Administration Phase||17
10975931|NCT00566098|12150650|FG000|STARTED|Collection of MILs||25
10975932|NCT00566098|12150650|FG000|COMPLETED|Collection of MILs||23
10975933|NCT00566098|12150650|FG000|NOT COMPLETED|Collection of MILs||2
10975934|NCT00566098|12150650|FG000|STARTED|Generation of MILs Product||23
10975935|NCT00566098|12150650|FG000|COMPLETED|Generation of MILs Product||22
10975936|NCT00566098|12150650|FG000|NOT COMPLETED|Generation of MILs Product||1
10975937|NCT00566098|12150650|FG000|STARTED|Administration of ASCT+MILs||22
10975938|NCT00566098|12150650|FG000|COMPLETED|Administration of ASCT+MILs||4
10975939|NCT00566098|12150650|FG000|NOT COMPLETED|Administration of ASCT+MILs||18
10975940|NCT00566111|12150657|FG000|STARTED|Overall Study||2
10975941|NCT00566111|12150658|FG001|STARTED|Overall Study||3
10975942|NCT00566111|12150657|FG000|COMPLETED|Overall Study||2
10975943|NCT00566111|12150658|FG001|COMPLETED|Overall Study||1
10975944|NCT00566111|12150657|FG000|NOT COMPLETED|Overall Study||0
10975945|NCT00566111|12150658|FG001|NOT COMPLETED|Overall Study||2
10975946|NCT00566150|12150666|FG000|STARTED|Overall Study||19
10975947|NCT00566150|12150667|FG001|STARTED|Overall Study||16
10975948|NCT00566150|12150666|FG000|COMPLETED|Overall Study||10
10975949|NCT00566150|12150667|FG001|COMPLETED|Overall Study||11
10975950|NCT00566150|12150666|FG000|NOT COMPLETED|Overall Study||9
10975951|NCT00566150|12150667|FG001|NOT COMPLETED|Overall Study||5
10975952|NCT00566228|12150675|FG000|STARTED|Overall Study||62
10975953|NCT00566228|12150676|FG001|STARTED|Overall Study||60
10975954|NCT00566228|12150675|FG000|COMPLETED|Overall Study||56
10975955|NCT00566228|12150676|FG001|COMPLETED|Overall Study||55
10975956|NCT00566228|12150675|FG000|NOT COMPLETED|Overall Study||6
10975957|NCT00566228|12150676|FG001|NOT COMPLETED|Overall Study||5
10975958|NCT00566254|12150684|FG000|STARTED|Overall Study||100
10975959|NCT00566254|12150685|FG001|STARTED|Overall Study||107
10975960|NCT00566254|12150684|FG000|COMPLETED|Overall Study||90
10975961|NCT00566254|12150685|FG001|COMPLETED|Overall Study||93
10975962|NCT00566254|12150684|FG000|NOT COMPLETED|Overall Study||10
10975963|NCT00566254|12150685|FG001|NOT COMPLETED|Overall Study||14
10975964|NCT00566501|12150693|FG000|STARTED|Overall Study||570
10975965|NCT00566501|12150694|FG001|STARTED|Overall Study||332
10975966|NCT00566501|12150693|FG000|COMPLETED|Overall Study||423
10975967|NCT00566501|12150694|FG001|COMPLETED|Overall Study||210
10975968|NCT00566501|12150693|FG000|NOT COMPLETED|Overall Study||147
10975969|NCT00566501|12150694|FG001|NOT COMPLETED|Overall Study||122
10975970|NCT00566527|12150703|FG000|STARTED|Overall Study|Number randomized.|541
10975971|NCT00566527|12150704|FG001|STARTED|Overall Study|Number randomized.|540
10975972|NCT00566527|12150705|FG002|STARTED|Overall Study|Number randomized.|539
10975973|NCT00566527|12150703|FG000|Received ProQuad® Dose 1|Overall Study||529
10975974|NCT00566527|12150704|FG001|Received ProQuad® Dose 1|Overall Study||484
10975975|NCT00566527|12150705|FG002|Received ProQuad® Dose 1|Overall Study||470
10975976|NCT00566527|12150703|FG000|Received ProQuad® Dose 2|Overall Study||525
10975977|NCT00566527|12150704|FG001|Received ProQuad® Dose 2|Overall Study||478
10975978|NCT00566527|12150705|FG002|Received ProQuad® Dose 2|Overall Study||462
10975979|NCT00566527|12150703|FG000|COMPLETED|Overall Study||524
10975980|NCT00566527|12150704|FG001|COMPLETED|Overall Study||474
10975981|NCT00566527|12150705|FG002|COMPLETED|Overall Study||461
10975982|NCT00566527|12150703|FG000|NOT COMPLETED|Overall Study||17
10975983|NCT00566527|12150704|FG001|NOT COMPLETED|Overall Study||66
10975984|NCT00566527|12150705|FG002|NOT COMPLETED|Overall Study||78
10975985|NCT00566540|12150715|FG000|STARTED|Overall Study||11
10975986|NCT00566540|12150715|FG000|COMPLETED|Overall Study||11
10975987|NCT00566540|12150715|FG000|NOT COMPLETED|Overall Study||0
10975988|NCT00566579|12150721|FG000|STARTED|Overall Study||29
10975989|NCT00566579|12150722|FG001|STARTED|Overall Study||31
10975990|NCT00566579|12150721|FG000|COMPLETED|Overall Study||29
10975991|NCT00566579|12150722|FG001|COMPLETED|Overall Study||31
10975992|NCT00566579|12150721|FG000|NOT COMPLETED|Overall Study||0
10975993|NCT00566579|12150722|FG001|NOT COMPLETED|Overall Study||0
10975994|NCT00566631|12150728|FG000|STARTED|Part 1: Core Treatment Phase||294
10975995|NCT00566631|12150728|FG000|COMPLETED|Part 1: Core Treatment Phase||234
10975996|NCT00566631|12150728|FG000|NOT COMPLETED|Part 1: Core Treatment Phase||60
10975997|NCT00566631|12150728|FG000|STARTED|Between Treatment and Extension Phase||234
10975998|NCT00566631|12150728|FG000|COMPLETED|Between Treatment and Extension Phase||139
10975999|NCT00566631|12150728|FG000|NOT COMPLETED|Between Treatment and Extension Phase||95
10976000|NCT00566631|12150728|FG000|STARTED|Part 2: Extension Phase||139
10976001|NCT00566631|12150728|FG000|COMPLETED|Part 2: Extension Phase||57
10976002|NCT00566631|12150728|FG000|NOT COMPLETED|Part 2: Extension Phase||82
10976003|NCT00566696|12150732|FG000|STARTED|Overall Study||73
10976004|NCT00566696|12150732|FG000|COMPLETED|Overall Study||31
10976005|NCT00566696|12150732|FG000|NOT COMPLETED|Overall Study||42
10976006|NCT00566709|12150738|FG000|STARTED|Overall Study||51
10976007|NCT00566709|12150739|FG001|STARTED|Overall Study||51
10976008|NCT00566709|12150738|FG000|COMPLETED|Overall Study||46
10976009|NCT00566709|12150739|FG001|COMPLETED|Overall Study||51
10976010|NCT00566709|12150738|FG000|NOT COMPLETED|Overall Study||5
10976011|NCT00566709|12150739|FG001|NOT COMPLETED|Overall Study||0
10976012|NCT00566722|12150748|FG000|STARTED|Overall Study||41
10976013|NCT00566722|12150749|FG001|STARTED|Overall Study||29
10976014|NCT00566722|12150750|FG002|STARTED|Overall Study||82
10976015|NCT00566722|12150748|FG000|COMPLETED|Overall Study||39
10976016|NCT00566722|12150749|FG001|COMPLETED|Overall Study||24
10976017|NCT00566722|12150750|FG002|COMPLETED|Overall Study||73
10976018|NCT00566722|12150748|FG000|NOT COMPLETED|Overall Study||2
10976019|NCT00566722|12150749|FG001|NOT COMPLETED|Overall Study||5
10976020|NCT00566722|12150750|FG002|NOT COMPLETED|Overall Study||9
10976021|NCT00566735|12150763|FG000|STARTED|Overall Study||20
10976022|NCT00566735|12150764|FG001|STARTED|Overall Study||19
10976023|NCT00566735|12150763|FG000|Withdrew Before Baseline Measures|Overall Study||2
10976024|NCT00566735|12150764|FG001|Withdrew Before Baseline Measures|Overall Study||7
10976025|NCT00566735|12150763|FG000|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
10976026|NCT00566735|12150764|FG001|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
10976027|NCT00566735|12150763|FG000|NOT COMPLETED|Overall Study||2
10976028|NCT00566735|12150764|FG001|NOT COMPLETED|Overall Study||7
10976029|NCT00566813|12150772|FG000|STARTED|Overall Study||4
10976030|NCT00566813|12150773|FG001|STARTED|Overall Study||6
10976031|NCT00566813|12150772|FG000|COMPLETED|Overall Study||4
10976032|NCT00566813|12150773|FG001|COMPLETED|Overall Study||6
10976033|NCT00566813|12150772|FG000|NOT COMPLETED|Overall Study||0
10976034|NCT00566813|12150773|FG001|NOT COMPLETED|Overall Study||0
10976035|NCT00566852|12150781|FG000|STARTED|Overall Study||278
10976036|NCT00566852|12150782|FG001|STARTED|Overall Study||276
10976037|NCT00566852|12150781|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
10976038|NCT00566852|12150782|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
10976039|NCT00566852|12150781|FG000|NOT COMPLETED|Overall Study||207
10976040|NCT00566852|12150782|FG001|NOT COMPLETED|Overall Study||198
10976041|NCT00566930|12150791|FG000|STARTED|Overall Study||29
10976042|NCT00566930|12150792|FG001|STARTED|Overall Study||36
10976043|NCT00566930|12150793|FG002|STARTED|Overall Study||33
10976044|NCT00566930|12150791|FG000|COMPLETED|Overall Study||27
10976045|NCT00566930|12150792|FG001|COMPLETED|Overall Study||32
10976046|NCT00566930|12150793|FG002|COMPLETED|Overall Study||32
10976047|NCT00566930|12150791|FG000|NOT COMPLETED|Overall Study||2
10976048|NCT00566930|12150792|FG001|NOT COMPLETED|Overall Study||4
10976049|NCT00566930|12150793|FG002|NOT COMPLETED|Overall Study||1
10976050|NCT00566943|12150803|FG000|STARTED|Overall Study||52
10976051|NCT00566943|12150804|FG001|STARTED|Overall Study||49
10976052|NCT00566943|12150803|FG000|COMPLETED|Overall Study||52
10976053|NCT00566943|12150804|FG001|COMPLETED|Overall Study||49
10976054|NCT00566943|12150803|FG000|NOT COMPLETED|Overall Study||0
10976055|NCT00566943|12150804|FG001|NOT COMPLETED|Overall Study||0
10976056|NCT00566969|12150819|FG000|STARTED|Overall Study||34
10976057|NCT00566969|12150820|FG001|STARTED|Overall Study||37
10976058|NCT00566969|12150821|FG002|STARTED|Overall Study||35
10976059|NCT00566969|12150819|FG000|COMPLETED|Overall Study||19
10976060|NCT00566969|12150820|FG001|COMPLETED|Overall Study||28
10976061|NCT00566969|12150821|FG002|COMPLETED|Overall Study||23
10976062|NCT00566969|12150819|FG000|NOT COMPLETED|Overall Study||15
10976063|NCT00566969|12150820|FG001|NOT COMPLETED|Overall Study||9
10976064|NCT00566969|12150821|FG002|NOT COMPLETED|Overall Study||12
10976065|NCT00566982|12150831|FG000|STARTED|Overall Study||63
10976066|NCT00566982|12150832|FG001|STARTED|Overall Study||363
10976067|NCT00566982|12150831|FG000|COMPLETED|Overall Study||55
10976068|NCT00566982|12150832|FG001|COMPLETED|Overall Study||294
10976069|NCT00566982|12150831|FG000|NOT COMPLETED|Overall Study||8
10976070|NCT00566982|12150832|FG001|NOT COMPLETED|Overall Study||69
10976071|NCT00567008|12150843|FG000|STARTED|Overall Study||18
10976072|NCT00567008|12150844|FG001|STARTED|Overall Study||19
10976073|NCT00567008|12150843|FG000|COMPLETED|Overall Study||17
10976074|NCT00567008|12150844|FG001|COMPLETED|Overall Study||18
10976075|NCT00567008|12150843|FG000|NOT COMPLETED|Overall Study||1
10976076|NCT00567008|12150844|FG001|NOT COMPLETED|Overall Study||1
10976077|NCT00567112|12150850|FG000|STARTED|Treatment Period 1 (3 Days)||7
10976078|NCT00567112|12150851|FG001|STARTED|Treatment Period 1 (3 Days)||8
10976079|NCT00567112|12150852|FG002|STARTED|Treatment Period 1 (3 Days)||0
10976080|NCT00567112|12150850|FG000|COMPLETED|Treatment Period 1 (3 Days)||7
10976081|NCT00567112|12150851|FG001|COMPLETED|Treatment Period 1 (3 Days)||8
10976082|NCT00567112|12150852|FG002|COMPLETED|Treatment Period 1 (3 Days)||0
10976083|NCT00567112|12150850|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10976084|NCT00567112|12150851|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10976085|NCT00567112|12150852|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0
10976086|NCT00567112|12150850|FG000|STARTED|Washout Period 1 (3 Days)||7
10976087|NCT00567112|12150851|FG001|STARTED|Washout Period 1 (3 Days)||8
10976088|NCT00567112|12150852|FG002|STARTED|Washout Period 1 (3 Days)||0
10976089|NCT00567112|12150850|FG000|COMPLETED|Washout Period 1 (3 Days)||7
10976090|NCT00567112|12150851|FG001|COMPLETED|Washout Period 1 (3 Days)||8
10976091|NCT00567112|12150852|FG002|COMPLETED|Washout Period 1 (3 Days)||0
10976092|NCT00567112|12150850|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0
10976093|NCT00567112|12150851|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0
10976094|NCT00567112|12150852|FG002|NOT COMPLETED|Washout Period 1 (3 Days)||0
10976095|NCT00567112|12150850|FG000|STARTED|Treatment Period 2 (3 Days)||7
10976096|NCT00567112|12150851|FG001|STARTED|Treatment Period 2 (3 Days)||8
10976097|NCT00567112|12150852|FG002|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
10976098|NCT00567112|12150850|FG000|COMPLETED|Treatment Period 2 (3 Days)||7
10976099|NCT00567112|12150851|FG001|COMPLETED|Treatment Period 2 (3 Days)||7
10976100|NCT00567112|12150852|FG002|COMPLETED|Treatment Period 2 (3 Days)||3
10976101|NCT00567112|12150850|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10976102|NCT00567112|12150851|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||1
10976103|NCT00567112|12150852|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0
10976104|NCT00567112|12150850|FG000|STARTED|Washout Period 2 (3 Days)||7
10976105|NCT00567112|12150851|FG001|STARTED|Washout Period 2 (3 Days)||7
10976106|NCT00567112|12150852|FG002|STARTED|Washout Period 2 (3 Days)||3
10976107|NCT00567112|12150850|FG000|COMPLETED|Washout Period 2 (3 Days)||7
10976108|NCT00567112|12150851|FG001|COMPLETED|Washout Period 2 (3 Days)||7
10976109|NCT00567112|12150852|FG002|COMPLETED|Washout Period 2 (3 Days)||3
10976110|NCT00567112|12150850|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
10976111|NCT00567112|12150851|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
10976112|NCT00567112|12150852|FG002|NOT COMPLETED|Washout Period 2 (3 Days)||0
10976113|NCT00567112|12150850|FG000|STARTED|Treatment Period 3 (3 Days)||7
10976114|NCT00567112|12150851|FG001|STARTED|Treatment Period 3 (3 Days)||7
10976115|NCT00567112|12150852|FG002|STARTED|Treatment Period 3 (3 Days)||3
10976116|NCT00567112|12150850|FG000|COMPLETED|Treatment Period 3 (3 Days)||7
10976117|NCT00567112|12150851|FG001|COMPLETED|Treatment Period 3 (3 Days)||7
10976118|NCT00567112|12150852|FG002|COMPLETED|Treatment Period 3 (3 Days)||3
10976119|NCT00567112|12150850|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10976120|NCT00567112|12150851|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10976121|NCT00567112|12150852|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
10976122|NCT00567112|12150850|FG000|STARTED|Washout Period 3 (3 Days)||7
10976123|NCT00567112|12150851|FG001|STARTED|Washout Period 3 (3 Days)||7
10976124|NCT00567112|12150852|FG002|STARTED|Washout Period 3 (3 Days)||3
10976125|NCT00567112|12150850|FG000|COMPLETED|Washout Period 3 (3 Days)||4
10976126|NCT00567112|12150851|FG001|COMPLETED|Washout Period 3 (3 Days)||7
10976127|NCT00567112|12150852|FG002|COMPLETED|Washout Period 3 (3 Days)||3
10976128|NCT00567112|12150850|FG000|NOT COMPLETED|Washout Period 3 (3 Days)||3
10976129|NCT00567112|12150851|FG001|NOT COMPLETED|Washout Period 3 (3 Days)||0
10976130|NCT00567112|12150852|FG002|NOT COMPLETED|Washout Period 3 (3 Days)||0
10976131|NCT00567112|12150850|FG000|STARTED|Treatment Period 4 (3 Days)||4
10976132|NCT00567112|12150851|FG001|STARTED|Treatment Period 4 (3 Days)||7
10976133|NCT00567112|12150852|FG002|STARTED|Treatment Period 4 (3 Days)||3
10976134|NCT00567112|12150850|FG000|COMPLETED|Treatment Period 4 (3 Days)||4
10976135|NCT00567112|12150851|FG001|COMPLETED|Treatment Period 4 (3 Days)||7
10976136|NCT00567112|12150852|FG002|COMPLETED|Treatment Period 4 (3 Days)||3
10976137|NCT00567112|12150850|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0
10976138|NCT00567112|12150851|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0
10976139|NCT00567112|12150852|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0
10976140|NCT00567164|12150864|FG000|STARTED|Overall Study||1421
10976141|NCT00567164|12150865|FG001|STARTED|Overall Study||234
10976142|NCT00567164|12150866|FG002|STARTED|Overall Study||232
10976143|NCT00567164|12150864|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
10976144|NCT00567164|12150865|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set|232
10976145|NCT00567164|12150866|FG002|Subjects Received Treatment|Overall Study|Full Analysis Set|226
10976146|NCT00567164|12150864|FG000|COMPLETED|Overall Study||875
10976147|NCT00567164|12150865|FG001|COMPLETED|Overall Study||161
10976148|NCT00567164|12150866|FG002|COMPLETED|Overall Study||160
10976149|NCT00567164|12150864|FG000|NOT COMPLETED|Overall Study||546
10976150|NCT00567164|12150865|FG001|NOT COMPLETED|Overall Study||73
10976151|NCT00567164|12150866|FG002|NOT COMPLETED|Overall Study||72
10976152|NCT00567190|12150880|FG000|STARTED|Overall Study||402
10976153|NCT00567190|12150881|FG001|STARTED|Overall Study||406
10976154|NCT00567190|12150880|FG000|Did Not Receive Any Study Treatment|Overall Study||2
10976155|NCT00567190|12150881|FG001|Did Not Receive Any Study Treatment|Overall Study||2
10976156|NCT00567190|12150880|FG000|Received at Least One Dose of Pertuzumab|Overall Study||399
10976157|NCT00567190|12150881|FG001|Received at Least One Dose of Pertuzumab|Overall Study|9 participants randomized to the Placebo arm actually received at least one dose of pertuzumab.|9
10976158|NCT00567190|12150880|FG000|Received at Least One Dose of Placebo|Overall Study|1 participant randomized to the Pertuzumab arm actually received placebo at every treatment cycle.|1
10976159|NCT00567190|12150881|FG001|Received at Least One Dose of Placebo|Overall Study||395
10976160|NCT00567190|12150880|FG000|Crossover From Placebo to Pertuzumab|Overall Study||0
10976161|NCT00567190|12150881|FG001|Crossover From Placebo to Pertuzumab|Overall Study|From July 2012, 50 participants randomized to Placebo arm crossed over to open-label pertuzumab.|50
10976162|NCT00567190|12150880|FG000|COMPLETED|Overall Study||119
10976163|NCT00567190|12150881|FG001|COMPLETED|Overall Study||73
10976164|NCT00567190|12150880|FG000|NOT COMPLETED|Overall Study||283
10976165|NCT00567190|12150881|FG001|NOT COMPLETED|Overall Study||333
10976166|NCT00567229|12150892|FG000|STARTED|Overall Study||3
10976167|NCT00567229|12150892|FG000|COMPLETED|Overall Study||3
10976168|NCT00567229|12150892|FG000|NOT COMPLETED|Overall Study||0
10976169|NCT00567242|12150898|FG000|STARTED|Overall Study||7
10976170|NCT00567242|12150899|FG001|STARTED|Overall Study||7
10976171|NCT00567242|12150898|FG000|COMPLETED|Overall Study||7
10976172|NCT00567242|12150899|FG001|COMPLETED|Overall Study||7
10976173|NCT00567242|12150898|FG000|NOT COMPLETED|Overall Study||0
10976174|NCT00567242|12150899|FG001|NOT COMPLETED|Overall Study||0
10976175|NCT00567255|12150907|FG000|STARTED|Overall Study||1001
10976176|NCT00567255|12150908|FG001|STARTED|Overall Study||495
10976177|NCT00567255|12150907|FG000|COMPLETED|Overall Study||538
10976178|NCT00567255|12150908|FG001|COMPLETED|Overall Study||267
10976179|NCT00567255|12150907|FG000|NOT COMPLETED|Overall Study||463
10976180|NCT00567255|12150908|FG001|NOT COMPLETED|Overall Study||228
10976181|NCT00567268|12150914|FG000|STARTED|Overall Study||1194
10976182|NCT00567268|12150914|FG000|COMPLETED|Overall Study||1144
10976183|NCT00567268|12150914|FG000|NOT COMPLETED|Overall Study||50
10976184|NCT00567307|12150955|FG000|STARTED|Overall Study||111
10976185|NCT00567307|12150956|FG001|STARTED|Overall Study||105
10976186|NCT00567307|12150955|FG000|COMPLETED|Overall Study||99
10976187|NCT00567307|12150956|FG001|COMPLETED|Overall Study||104
10976188|NCT00567307|12150955|FG000|NOT COMPLETED|Overall Study||12
10976189|NCT00567307|12150956|FG001|NOT COMPLETED|Overall Study||1
10976190|NCT00567320|12150964|FG000|STARTED|Overall Study||13
10976191|NCT00567320|12150965|FG001|STARTED|Overall Study||18
10976192|NCT00567320|12150964|FG000|COMPLETED|Overall Study||13
10976193|NCT00567320|12150965|FG001|COMPLETED|Overall Study||18
10976194|NCT00567320|12150964|FG000|NOT COMPLETED|Overall Study||0
10976195|NCT00567320|12150965|FG001|NOT COMPLETED|Overall Study||0
10976196|NCT00567359|12150971|FG000|STARTED|Overall Study||100
10976197|NCT00567359|12150971|FG000|COMPLETED|Overall Study||99
10976198|NCT00567359|12150971|FG000|NOT COMPLETED|Overall Study||1
10976199|NCT00567398|12150977|FG000|STARTED|Overall Study||127
10976200|NCT00567398|12150978|FG001|STARTED|Overall Study||124
10976201|NCT00567398|12150977|FG000|COMPLETED|Overall Study||120
10976202|NCT00567398|12150978|FG001|COMPLETED|Overall Study||101
10976203|NCT00567398|12150977|FG000|NOT COMPLETED|Overall Study||7
10976204|NCT00567398|12150978|FG001|NOT COMPLETED|Overall Study||23
10976205|NCT00567476|12150986|FG000|STARTED|Overall Study||78
10976206|NCT00567476|12150987|FG001|STARTED|Overall Study||38
10976207|NCT00567476|12150986|FG000|COMPLETED|Overall Study||70
10976208|NCT00567476|12150987|FG001|COMPLETED|Overall Study||34
10976209|NCT00567476|12150986|FG000|NOT COMPLETED|Overall Study||8
10976210|NCT00567476|12150987|FG001|NOT COMPLETED|Overall Study||4
10976211|NCT00567489|12150995|FG000|STARTED|Overall Study||127
10976212|NCT00567489|12150996|FG001|STARTED|Overall Study||124
10976213|NCT00567489|12150995|FG000|COMPLETED|Overall Study||120
10976214|NCT00567489|12150996|FG001|COMPLETED|Overall Study||101
10976215|NCT00567489|12150995|FG000|NOT COMPLETED|Overall Study||7
10976216|NCT00567489|12150996|FG001|NOT COMPLETED|Overall Study||23
10976217|NCT00567502|12151006|FG000|STARTED|Overall Study||804
10976218|NCT00567502|12151007|FG001|STARTED|Overall Study||141
10976219|NCT00567502|12151008|FG002|STARTED|Overall Study||2666
10976220|NCT00567502|12151009|FG003|STARTED|Overall Study||110
10976221|NCT00567502|12151006|FG000|Initiated Treatment|Overall Study||804
10976222|NCT00567502|12151007|FG001|Initiated Treatment|Overall Study||141
10976223|NCT00567502|12151008|FG002|Initiated Treatment|Overall Study||2666
10976224|NCT00567502|12151009|FG003|Initiated Treatment|Overall Study||38
10976225|NCT00567502|12151006|FG000|COMPLETED|Overall Study||563
10976226|NCT00567502|12151007|FG001|COMPLETED|Overall Study||108
10976227|NCT00567502|12151008|FG002|COMPLETED|Overall Study||1758
10976228|NCT00567502|12151009|FG003|COMPLETED|Overall Study||23
10976229|NCT00567502|12151006|FG000|NOT COMPLETED|Overall Study||241
10976230|NCT00567502|12151007|FG001|NOT COMPLETED|Overall Study||33
10976231|NCT00567502|12151008|FG002|NOT COMPLETED|Overall Study||908
10976232|NCT00567502|12151009|FG003|NOT COMPLETED|Overall Study||87
10976233|NCT00567541|12151032|FG000|STARTED|Overall Study||7
10976234|NCT00567541|12151033|FG001|STARTED|Overall Study||9
10976235|NCT00567541|12151032|FG000|COMPLETED|Overall Study||7
10976236|NCT00567541|12151033|FG001|COMPLETED|Overall Study||8
10976237|NCT00567541|12151032|FG000|NOT COMPLETED|Overall Study||0
10976238|NCT00567541|12151033|FG001|NOT COMPLETED|Overall Study||1
10976239|NCT00567593|12151039|FG000|STARTED|Overall Study||12
10976240|NCT00567593|12151039|FG000|COMPLETED|Overall Study||10
10976241|NCT00567593|12151039|FG000|NOT COMPLETED|Overall Study||2
10976242|NCT00567840|12151048|FG000|STARTED|Overall Study||15
10976243|NCT00567840|12151049|FG001|STARTED|Overall Study||15
10976244|NCT00567840|12151050|FG002|STARTED|Overall Study||16
10976245|NCT00567840|12151051|FG003|STARTED|Overall Study||15
10976246|NCT00567840|12151052|FG004|STARTED|Overall Study||8
10976247|NCT00567840|12151048|FG000|COMPLETED|Overall Study||13
10976248|NCT00567840|12151049|FG001|COMPLETED|Overall Study||15
10976249|NCT00567840|12151050|FG002|COMPLETED|Overall Study||15
10976250|NCT00567840|12151051|FG003|COMPLETED|Overall Study||14
10976251|NCT00567840|12151052|FG004|COMPLETED|Overall Study||8
10976252|NCT00567840|12151048|FG000|NOT COMPLETED|Overall Study||2
10976253|NCT00567840|12151049|FG001|NOT COMPLETED|Overall Study||0
10976254|NCT00567840|12151050|FG002|NOT COMPLETED|Overall Study||1
10976255|NCT00567840|12151051|FG003|NOT COMPLETED|Overall Study||1
10976256|NCT00567840|12151052|FG004|NOT COMPLETED|Overall Study||0
10976257|NCT00567879|12151070|FG000|STARTED|Overall Study||7
10976258|NCT00567879|12151071|FG001|STARTED|Overall Study||7
10976259|NCT00567879|12151072|FG002|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
10976260|NCT00567879|12151073|FG003|STARTED|Overall Study||6
10976261|NCT00567879|12151074|FG004|STARTED|Overall Study||12
10976262|NCT00567879|12151075|FG005|STARTED|Overall Study||3
10976263|NCT00567879|12151070|FG000|Maximum Tolerated Dose Determining Set|Overall Study||5
10976264|NCT00567879|12151071|FG001|Maximum Tolerated Dose Determining Set|Overall Study||7
10976265|NCT00567879|12151072|FG002|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
10976266|NCT00567879|12151073|FG003|Maximum Tolerated Dose Determining Set|Overall Study||6
10976267|NCT00567879|12151074|FG004|Maximum Tolerated Dose Determining Set|Overall Study||12
10976268|NCT00567879|12151075|FG005|Maximum Tolerated Dose Determining Set|Overall Study||3
10976269|NCT00567879|12151070|FG000|COMPLETED|Overall Study||0
10976270|NCT00567879|12151071|FG001|COMPLETED|Overall Study||0
10976271|NCT00567879|12151072|FG002|COMPLETED|Overall Study||0
10976272|NCT00567879|12151073|FG003|COMPLETED|Overall Study||0
10976273|NCT00567879|12151074|FG004|COMPLETED|Overall Study||0
10976274|NCT00567879|12151075|FG005|COMPLETED|Overall Study||0
10976275|NCT00567879|12151070|FG000|NOT COMPLETED|Overall Study||7
10976276|NCT00567879|12151071|FG001|NOT COMPLETED|Overall Study||7
10976277|NCT00567879|12151072|FG002|NOT COMPLETED|Overall Study||21
10976278|NCT00567879|12151073|FG003|NOT COMPLETED|Overall Study||6
10976279|NCT00567879|12151074|FG004|NOT COMPLETED|Overall Study||12
10976280|NCT00567879|12151075|FG005|NOT COMPLETED|Overall Study||3
10976281|NCT00567892|12151095|FG000|STARTED|First Treatment (2 or 4 Weeks)||7
10976282|NCT00567892|12151096|FG001|STARTED|First Treatment (2 or 4 Weeks)||7
10976283|NCT00567892|12151097|FG002|STARTED|First Treatment (2 or 4 Weeks)||10
10976284|NCT00567892|12151098|FG003|STARTED|First Treatment (2 or 4 Weeks)||10
10976285|NCT00567892|12151095|FG000|COMPLETED|First Treatment (2 or 4 Weeks)||7
10976286|NCT00567892|12151096|FG001|COMPLETED|First Treatment (2 or 4 Weeks)||7
10976287|NCT00567892|12151097|FG002|COMPLETED|First Treatment (2 or 4 Weeks)||9
10976288|NCT00567892|12151098|FG003|COMPLETED|First Treatment (2 or 4 Weeks)||6
10976289|NCT00567892|12151095|FG000|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
10976290|NCT00567892|12151096|FG001|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
10976291|NCT00567892|12151097|FG002|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
10976292|NCT00567892|12151098|FG003|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
10976293|NCT00567892|12151095|FG000|STARTED|Washout (2 Weeks)||7
10976294|NCT00567892|12151096|FG001|STARTED|Washout (2 Weeks)||7
10976295|NCT00567892|12151097|FG002|STARTED|Washout (2 Weeks)||9
10976296|NCT00567892|12151098|FG003|STARTED|Washout (2 Weeks)||6
10976297|NCT00567892|12151095|FG000|COMPLETED|Washout (2 Weeks)||7
10976298|NCT00567892|12151096|FG001|COMPLETED|Washout (2 Weeks)||7
10976299|NCT00567892|12151097|FG002|COMPLETED|Washout (2 Weeks)||9
10976300|NCT00567892|12151098|FG003|COMPLETED|Washout (2 Weeks)||6
10976301|NCT00567892|12151095|FG000|NOT COMPLETED|Washout (2 Weeks)||0
10976302|NCT00567892|12151096|FG001|NOT COMPLETED|Washout (2 Weeks)||0
10976303|NCT00567892|12151097|FG002|NOT COMPLETED|Washout (2 Weeks)||0
10976304|NCT00567892|12151098|FG003|NOT COMPLETED|Washout (2 Weeks)||0
10976305|NCT00567892|12151095|FG000|STARTED|Second Treatment (2 or 4 Weeks)||7
10976306|NCT00567892|12151096|FG001|STARTED|Second Treatment (2 or 4 Weeks)||7
10976307|NCT00567892|12151097|FG002|STARTED|Second Treatment (2 or 4 Weeks)||9
10976308|NCT00567892|12151098|FG003|STARTED|Second Treatment (2 or 4 Weeks)||6
10976309|NCT00567892|12151095|FG000|COMPLETED|Second Treatment (2 or 4 Weeks)||7
10976310|NCT00567892|12151096|FG001|COMPLETED|Second Treatment (2 or 4 Weeks)||7
10976311|NCT00567892|12151097|FG002|COMPLETED|Second Treatment (2 or 4 Weeks)||9
10976312|NCT00567892|12151098|FG003|COMPLETED|Second Treatment (2 or 4 Weeks)||5
10976313|NCT00567892|12151095|FG000|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
10976314|NCT00567892|12151096|FG001|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
10976315|NCT00567892|12151097|FG002|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
10976316|NCT00567892|12151098|FG003|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
10976317|NCT00567996|12151113|FG000|STARTED|Overall Study|Randomized participants|333
10976318|NCT00567996|12151114|FG001|STARTED|Overall Study||334
10976319|NCT00567996|12151115|FG002|STARTED|Overall Study||335
10976320|NCT00567996|12151113|FG000|Intent-to-treat: Received Study Drug|Overall Study||330
10976321|NCT00567996|12151114|FG001|Intent-to-treat: Received Study Drug|Overall Study||333
10976322|NCT00567996|12151115|FG002|Intent-to-treat: Received Study Drug|Overall Study||335
10976323|NCT00567996|12151113|FG000|COMPLETED|Overall Study||289
10976324|NCT00567996|12151114|FG001|COMPLETED|Overall Study||284
10976325|NCT00567996|12151115|FG002|COMPLETED|Overall Study||265
10976326|NCT00567996|12151113|FG000|NOT COMPLETED|Overall Study||44
10976327|NCT00567996|12151114|FG001|NOT COMPLETED|Overall Study||50
10976328|NCT00567996|12151115|FG002|NOT COMPLETED|Overall Study||70
10976329|NCT00568022|12151126|FG000|STARTED|Overall Study||3
10976330|NCT00568022|12151127|FG001|STARTED|Overall Study||3
10976331|NCT00568022|12151128|FG002|STARTED|Overall Study||3
10976332|NCT00568022|12151126|FG000|COMPLETED|Overall Study||3
10976333|NCT00568022|12151127|FG001|COMPLETED|Overall Study||3
10976334|NCT00568022|12151128|FG002|COMPLETED|Overall Study||3
10976335|NCT00568022|12151126|FG000|NOT COMPLETED|Overall Study||0
10976336|NCT00568022|12151127|FG001|NOT COMPLETED|Overall Study||0
10976337|NCT00568022|12151128|FG002|NOT COMPLETED|Overall Study||0
10976338|NCT00568061|12151139|FG000|STARTED|Overall Study||13
10976339|NCT00568061|12151140|FG001|STARTED|Overall Study||16
10976340|NCT00568061|12151139|FG000|COMPLETED|Overall Study||8
10976341|NCT00568061|12151140|FG001|COMPLETED|Overall Study||14
10976342|NCT00568061|12151139|FG000|NOT COMPLETED|Overall Study||5
10976343|NCT00568061|12151140|FG001|NOT COMPLETED|Overall Study||2
10976344|NCT00568087|12151149|FG000|STARTED|Overall Study||22
10976345|NCT00568087|12151150|FG001|STARTED|Overall Study||24
10976346|NCT00568087|12151149|FG000|Received Intervention|Overall Study||21
10976347|NCT00568087|12151150|FG001|Received Intervention|Overall Study||23
10976348|NCT00568087|12151149|FG000|COMPLETED|Overall Study||15
10976349|NCT00568087|12151150|FG001|COMPLETED|Overall Study||17
10976350|NCT00568087|12151149|FG000|NOT COMPLETED|Overall Study||7
10976351|NCT00568087|12151150|FG001|NOT COMPLETED|Overall Study||7
10976352|NCT00568126|12151158|FG000|STARTED|Overall Study||24
10976353|NCT00568126|12151159|FG001|STARTED|Overall Study||21
10976354|NCT00568126|12151158|FG000|COMPLETED|Overall Study||13
10976355|NCT00568126|12151159|FG001|COMPLETED|Overall Study||12
10976356|NCT00568126|12151158|FG000|NOT COMPLETED|Overall Study||11
10976357|NCT00568126|12151159|FG001|NOT COMPLETED|Overall Study||9
10976358|NCT00568321|12151168|FG000|STARTED|Overall Study||33
10976359|NCT00568321|12151169|FG001|STARTED|Overall Study||33
10976360|NCT00568321|12151170|FG002|STARTED|Overall Study||33
10976361|NCT00568321|12151168|FG000|Treated|Overall Study||31
10976362|NCT00568321|12151169|FG001|Treated|Overall Study||33
10976363|NCT00568321|12151170|FG002|Treated|Overall Study||32
10976364|NCT00568321|12151168|FG000|COMPLETED|Overall Study||20
10976365|NCT00568321|12151169|FG001|COMPLETED|Overall Study||28
10976366|NCT00568321|12151170|FG002|COMPLETED|Overall Study||24
10976367|NCT00568321|12151168|FG000|NOT COMPLETED|Overall Study||13
10976368|NCT00568321|12151169|FG001|NOT COMPLETED|Overall Study||5
10976369|NCT00568321|12151170|FG002|NOT COMPLETED|Overall Study||9
10976370|NCT00568334|12151182|FG000|STARTED|Overall Study||122
10976371|NCT00568334|12151183|FG001|STARTED|Overall Study||122
10976372|NCT00568334|12151182|FG000|COMPLETED|Overall Study||121
10976373|NCT00568334|12151183|FG001|COMPLETED|Overall Study||121
10976374|NCT00568334|12151182|FG000|NOT COMPLETED|Overall Study||1
10976375|NCT00568334|12151183|FG001|NOT COMPLETED|Overall Study||1
10976376|NCT00568386|12151191|FG000|STARTED|Overall Study||20
10976377|NCT00568386|12151192|FG001|STARTED|Overall Study||20
10976378|NCT00568386|12151191|FG000|COMPLETED|Overall Study||20
10976379|NCT00568386|12151192|FG001|COMPLETED|Overall Study||20
10976380|NCT00568386|12151191|FG000|NOT COMPLETED|Overall Study||0
10976381|NCT00568386|12151192|FG001|NOT COMPLETED|Overall Study||0
10976382|NCT00568399|12151198|FG000|STARTED|Overall Study||37
10976383|NCT00568399|12151198|FG000|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
10976384|NCT00568399|12151198|FG000|NOT COMPLETED|Overall Study||15
10976385|NCT00568451|12151206|FG000|STARTED|Overall Study||0
10976386|NCT00568451|12151207|FG001|STARTED|Overall Study||0
10976387|NCT00568451|12151208|FG002|STARTED|Overall Study||2
10976388|NCT00568451|12151209|FG003|STARTED|Overall Study||9
10976389|NCT00568451|12151206|FG000|COMPLETED|Overall Study||0
10976390|NCT00568451|12151207|FG001|COMPLETED|Overall Study||0
10976391|NCT00568451|12151208|FG002|COMPLETED|Overall Study||0
10976392|NCT00568451|12151209|FG003|COMPLETED|Overall Study||2
10976393|NCT00568451|12151206|FG000|NOT COMPLETED|Overall Study||0
10976394|NCT00568451|12151207|FG001|NOT COMPLETED|Overall Study||0
10976395|NCT00568451|12151208|FG002|NOT COMPLETED|Overall Study||2
10976396|NCT00568451|12151209|FG003|NOT COMPLETED|Overall Study||7
10976397|NCT00568555|12151222|FG000|STARTED|Overall Study||16
10976398|NCT00568555|12151223|FG001|STARTED|Overall Study||15
10976399|NCT00568555|12151222|FG000|COMPLETED|Overall Study||15
10976400|NCT00568555|12151223|FG001|COMPLETED|Overall Study||14
10976401|NCT00568555|12151222|FG000|NOT COMPLETED|Overall Study||1
10976402|NCT00568555|12151223|FG001|NOT COMPLETED|Overall Study||1
10976403|NCT00568633|12151233|FG000|STARTED|Overall Study||25
10976404|NCT00568633|12151234|FG001|STARTED|Overall Study||33
10976405|NCT00568633|12151233|FG000|COMPLETED|Overall Study||25
10976406|NCT00568633|12151234|FG001|COMPLETED|Overall Study||33
10976407|NCT00568633|12151233|FG000|NOT COMPLETED|Overall Study||0
10976408|NCT00568633|12151234|FG001|NOT COMPLETED|Overall Study||0
10976409|NCT00568685|12151243|FG000|STARTED|Overall Study||51
10976410|NCT00568685|12151244|FG001|STARTED|Overall Study||51
10976411|NCT00568685|12151245|FG002|STARTED|Overall Study||51
10976412|NCT00568685|12151243|FG000|COMPLETED|Overall Study||41
10976413|NCT00568685|12151244|FG001|COMPLETED|Overall Study||46
10976414|NCT00568685|12151245|FG002|COMPLETED|Overall Study||46
10976415|NCT00568685|12151243|FG000|NOT COMPLETED|Overall Study||10
10976416|NCT00568685|12151244|FG001|NOT COMPLETED|Overall Study||5
10976417|NCT00568685|12151245|FG002|NOT COMPLETED|Overall Study||5
10976418|NCT00568776|12151261|FG000|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
10976419|NCT00568776|12151262|FG001|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
10976420|NCT00568776|12151263|FG002|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
10976421|NCT00568776|12151264|FG003|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
10976422|NCT00568776|12151261|FG000|COMPLETED|Overall Study||53
10976423|NCT00568776|12151262|FG001|COMPLETED|Overall Study||52
10976424|NCT00568776|12151263|FG002|COMPLETED|Overall Study||15
10976425|NCT00568776|12151264|FG003|COMPLETED|Overall Study||19
10976426|NCT00568776|12151261|FG000|NOT COMPLETED|Overall Study||30
10976427|NCT00568776|12151262|FG001|NOT COMPLETED|Overall Study||36
10976428|NCT00568776|12151263|FG002|NOT COMPLETED|Overall Study||74
10976429|NCT00568776|12151264|FG003|NOT COMPLETED|Overall Study||72
10976430|NCT04274192|12151276|FG000|STARTED|Overall Study||1
10976431|NCT04274192|12151277|FG001|STARTED|Overall Study||0
10976432|NCT04274192|12151276|FG000|COMPLETED|Overall Study||0
10976433|NCT04274192|12151277|FG001|COMPLETED|Overall Study||0
10976434|NCT04274192|12151276|FG000|NOT COMPLETED|Overall Study||1
10976435|NCT04274192|12151277|FG001|NOT COMPLETED|Overall Study||0
10976436|NCT04200833|12151285|FG000|STARTED|Overall Study||10
10976437|NCT04200833|12151285|FG000|COMPLETED|Overall Study||10
10976438|NCT04200833|12151285|FG000|NOT COMPLETED|Overall Study||0
10976439|NCT04110314|12151295|FG000|STARTED|Overall Study||71781
10976440|NCT04110314|12151296|FG001|STARTED|Overall Study||71492
10976441|NCT04110314|12151297|FG002|STARTED|Overall Study||72177
10976442|NCT04110314|12151298|FG003|STARTED|Overall Study||71512
10976443|NCT04110314|12151299|FG004|STARTED|Overall Study||71536
10976444|NCT04110314|12151300|FG005|STARTED|Overall Study||72138
10976445|NCT04110314|12151295|FG000|Patients Who Met Inclusion|Overall Study||36526
10976446|NCT04110314|12151296|FG001|Patients Who Met Inclusion|Overall Study||36388
10976447|NCT04110314|12151297|FG002|Patients Who Met Inclusion|Overall Study||36541
10976448|NCT04110314|12151298|FG003|Patients Who Met Inclusion|Overall Study||36377
10976449|NCT04110314|12151299|FG004|Patients Who Met Inclusion|Overall Study||36289
10976450|NCT04110314|12151300|FG005|Patients Who Met Inclusion|Overall Study||36411
10976451|NCT04110314|12151295|FG000|COMPLETED|Overall Study||36526
10976452|NCT04110314|12151296|FG001|COMPLETED|Overall Study||36388
10976453|NCT04110314|12151297|FG002|COMPLETED|Overall Study||36541
10976454|NCT04110314|12151298|FG003|COMPLETED|Overall Study||36377
10976455|NCT04110314|12151299|FG004|COMPLETED|Overall Study||36289
10976456|NCT04110314|12151300|FG005|COMPLETED|Overall Study||36411
10976457|NCT04110314|12151295|FG000|NOT COMPLETED|Overall Study||35255
10976458|NCT04110314|12151296|FG001|NOT COMPLETED|Overall Study||35104
10976459|NCT04110314|12151297|FG002|NOT COMPLETED|Overall Study||35636
10976460|NCT04110314|12151298|FG003|NOT COMPLETED|Overall Study||35135
10976461|NCT04110314|12151299|FG004|NOT COMPLETED|Overall Study||35247
10976462|NCT04110314|12151300|FG005|NOT COMPLETED|Overall Study||35727
10976463|NCT04084288|12151312|FG000|STARTED|Overall Study||41
10976464|NCT04084288|12151312|FG000|COMPLETED|Overall Study||41
10976465|NCT04084288|12151312|FG000|NOT COMPLETED|Overall Study||0
10976466|NCT03961204|12151321|FG000|STARTED|Overall Study||662
10976467|NCT03961204|12151321|FG000|COMPLETED|Overall Study||655
10976468|NCT03961204|12151321|FG000|NOT COMPLETED|Overall Study||7
10976469|NCT03895840|12151325|FG000|STARTED|Overall Study||70
10976470|NCT03895840|12151325|FG000|6-Week Follow-Up|Overall Study||70
10976471|NCT03895840|12151325|FG000|12-Week Follow-Up|Overall Study||65
10976472|NCT03895840|12151325|FG000|24-Week Follow-Up|Overall Study||49
10976473|NCT03895840|12151325|FG000|COMPLETED|Overall Study||49
10976474|NCT03895840|12151325|FG000|NOT COMPLETED|Overall Study||21
10976475|NCT03818399|12151329|FG000|STARTED|Overall Study||19
10976476|NCT03818399|12151329|FG000|COMPLETED|Overall Study||5
10976477|NCT03818399|12151329|FG000|NOT COMPLETED|Overall Study||14
10976478|NCT03603496|12151335|FG000|STARTED|Overall Study||706
10976479|NCT03603496|12151336|FG001|STARTED|Overall Study||703
10976480|NCT03603496|12151335|FG000|COMPLETED|Overall Study||520
10976481|NCT03603496|12151336|FG001|COMPLETED|Overall Study||518
10976482|NCT03603496|12151335|FG000|NOT COMPLETED|Overall Study||186
10976483|NCT03603496|12151336|FG001|NOT COMPLETED|Overall Study||185
10976484|NCT03480802|12151344|FG000|STARTED|Overall Study||152
10976485|NCT03480802|12151345|FG001|STARTED|Overall Study||150
10976486|NCT03480802|12151344|FG000|Week 8|Overall Study||150
10976487|NCT03480802|12151345|FG001|Week 8|Overall Study||148
10976488|NCT03480802|12151344|FG000|COMPLETED|Overall Study||145
10976489|NCT03480802|12151345|FG001|COMPLETED|Overall Study||147
10976490|NCT03480802|12151344|FG000|NOT COMPLETED|Overall Study||7
10976491|NCT03480802|12151345|FG001|NOT COMPLETED|Overall Study||3
10976492|NCT03472521|12151355|FG000|STARTED|Overall Study||41
10976493|NCT03472521|12151356|FG001|STARTED|Overall Study||37
10976494|NCT03472521|12151355|FG000|Received Allocated Intervention|Overall Study||41
10976495|NCT03472521|12151356|FG001|Received Allocated Intervention|Overall Study||37
10976496|NCT03472521|12151355|FG000|COMPLETED|Overall Study||35
10976497|NCT03472521|12151356|FG001|COMPLETED|Overall Study||34
10976498|NCT03472521|12151355|FG000|NOT COMPLETED|Overall Study||6
10976499|NCT03472521|12151356|FG001|NOT COMPLETED|Overall Study||3
10976500|NCT03303950|12151362|FG000|STARTED|Overall Study||6
10976501|NCT03303950|12151362|FG000|COMPLETED|Overall Study||6
10976502|NCT03303950|12151362|FG000|NOT COMPLETED|Overall Study||0
10976503|NCT02673203|12151369|FG000|STARTED|Overall Study||16
10976504|NCT02673203|12151370|FG001|STARTED|Overall Study||15
10976505|NCT02673203|12151369|FG000|COMPLETED|Overall Study||16
10976506|NCT02673203|12151370|FG001|COMPLETED|Overall Study||15
10976507|NCT02673203|12151369|FG000|NOT COMPLETED|Overall Study||0
10976508|NCT02673203|12151370|FG001|NOT COMPLETED|Overall Study||0
10976509|NCT02664441|12151378|FG000|STARTED|Randomization||23
10976510|NCT02664441|12151379|FG001|STARTED|Randomization||19
10976511|NCT02664441|12151378|FG000|COMPLETED|Randomization||23
10976512|NCT02664441|12151379|FG001|COMPLETED|Randomization||18
10976513|NCT02664441|12151378|FG000|NOT COMPLETED|Randomization||0
10976514|NCT02664441|12151379|FG001|NOT COMPLETED|Randomization||1
10976515|NCT02664441|12151378|FG000|STARTED|36-week Randomized Trial||23
10976516|NCT02664441|12151379|FG001|STARTED|36-week Randomized Trial||18
10976517|NCT02664441|12151378|FG000|COMPLETED|36-week Randomized Trial||20
10976518|NCT02664441|12151379|FG001|COMPLETED|36-week Randomized Trial||15
10976519|NCT02664441|12151378|FG000|NOT COMPLETED|36-week Randomized Trial||3
10976520|NCT02664441|12151379|FG001|NOT COMPLETED|36-week Randomized Trial||3
10976521|NCT02664441|12151378|FG000|STARTED|18-week Open Label Extension||20
10976522|NCT02664441|12151379|FG001|STARTED|18-week Open Label Extension||15
10976523|NCT02664441|12151378|FG000|COMPLETED|18-week Open Label Extension||17
10976524|NCT02664441|12151379|FG001|COMPLETED|18-week Open Label Extension||14
10976525|NCT02664441|12151378|FG000|NOT COMPLETED|18-week Open Label Extension||3
10976526|NCT02664441|12151379|FG001|NOT COMPLETED|18-week Open Label Extension||1
10976527|NCT02527187|12151388|FG000|STARTED|Overall Study||75
10976528|NCT02527187|12151389|FG001|STARTED|Overall Study||126
10976529|NCT02527187|12151388|FG000|COMPLETED|Overall Study||75
10976530|NCT02527187|12151389|FG001|COMPLETED|Overall Study||126
10976531|NCT02527187|12151388|FG000|NOT COMPLETED|Overall Study||0
10976532|NCT02527187|12151389|FG001|NOT COMPLETED|Overall Study||0
10976533|NCT02513472|12151399|FG000|STARTED|Overall Study||66
10976534|NCT02513472|12151400|FG001|STARTED|Overall Study||101
10976535|NCT02513472|12151399|FG000|Phase 1b Safety run-in|Overall Study||3
10976536|NCT02513472|12151400|FG001|Phase 1b Safety run-in|Overall Study||4
10976537|NCT02513472|12151399|FG000|Phase 2|Overall Study||63
10976538|NCT02513472|12151400|FG001|Phase 2|Overall Study||97
10976539|NCT02513472|12151399|FG000|COMPLETED|Overall Study||0
10976540|NCT02513472|12151400|FG001|COMPLETED|Overall Study||0
10976541|NCT02513472|12151399|FG000|NOT COMPLETED|Overall Study||66
10976542|NCT02513472|12151400|FG001|NOT COMPLETED|Overall Study||101
10976543|NCT02476409|12151410|FG000|STARTED|Overall Study||19
10976544|NCT02476409|12151411|FG001|STARTED|Overall Study||21
10976545|NCT02476409|12151410|FG000|COMPLETED|Overall Study||19
10976546|NCT02476409|12151411|FG001|COMPLETED|Overall Study||21
10976547|NCT02476409|12151410|FG000|NOT COMPLETED|Overall Study||0
10976548|NCT02476409|12151411|FG001|NOT COMPLETED|Overall Study||0
10976549|NCT02132650|12151423|FG000|STARTED|Overall Study||20
10976550|NCT02132650|12151424|FG001|STARTED|Overall Study||18
10976551|NCT02132650|12151423|FG000|Post-Intervention Assessment|Overall Study||19
10976552|NCT02132650|12151424|FG001|Post-Intervention Assessment|Overall Study||17
10976553|NCT02132650|12151423|FG000|COMPLETED|Overall Study||17
10976554|NCT02132650|12151424|FG001|COMPLETED|Overall Study||14
10976555|NCT02132650|12151423|FG000|NOT COMPLETED|Overall Study||3
10976556|NCT02132650|12151424|FG001|NOT COMPLETED|Overall Study||4
10976557|NCT01980355|12151432|FG000|STARTED|Overall Study||39
10976558|NCT01980355|12151433|FG001|STARTED|Overall Study||37
10976559|NCT01980355|12151432|FG000|COMPLETED|Overall Study||39
10976560|NCT01980355|12151433|FG001|COMPLETED|Overall Study||37
10976561|NCT01980355|12151432|FG000|NOT COMPLETED|Overall Study||0
10976562|NCT01980355|12151433|FG001|NOT COMPLETED|Overall Study||0
10976563|NCT01559935|12151439|FG000|STARTED|Car Phase||72
10976564|NCT01559935|12151439|FG000|COMPLETED|Car Phase||58
10976565|NCT01559935|12151439|FG000|NOT COMPLETED|Car Phase||14
10976566|NCT01559935|12151439|FG000|STARTED|BiRD Phase||58
10976567|NCT01559935|12151439|FG000|COMPLETED|BiRD Phase||54
10976568|NCT01559935|12151439|FG000|NOT COMPLETED|BiRD Phase||4
10976569|NCT01559935|12151439|FG000|STARTED|Maintenance Phase||54
10976570|NCT01559935|12151439|FG000|COMPLETED|Maintenance Phase||0
10976571|NCT01559935|12151439|FG000|NOT COMPLETED|Maintenance Phase||54
10976572|NCT01285362|12151445|FG000|STARTED|Overall Study||4
10976573|NCT01285362|12151446|FG001|STARTED|Overall Study||4
10976574|NCT01285362|12151445|FG000|COMPLETED|Overall Study||4
10976575|NCT01285362|12151446|FG001|COMPLETED|Overall Study||4
10976576|NCT01285362|12151445|FG000|NOT COMPLETED|Overall Study||0
10976577|NCT01285362|12151446|FG001|NOT COMPLETED|Overall Study||0
10976578|NCT01067144|12151454|FG000|STARTED|Treatment||207
10976579|NCT01067144|12151455|FG001|STARTED|Treatment||215
10976580|NCT01067144|12151454|FG000|COMPLETED|Treatment||203
10976581|NCT01067144|12151455|FG001|COMPLETED|Treatment||208
10976582|NCT01067144|12151454|FG000|NOT COMPLETED|Treatment||4
10976583|NCT01067144|12151455|FG001|NOT COMPLETED|Treatment||7
10976584|NCT01067144|12151454|FG000|STARTED|Follow-up||203
10976585|NCT01067144|12151455|FG001|STARTED|Follow-up||208
10976586|NCT01067144|12151454|FG000|Intention-to-Treat Analysis Set|Follow-up||202
10976587|NCT01067144|12151455|FG001|Intention-to-Treat Analysis Set|Follow-up||208
10976588|NCT01067144|12151454|FG000|COMPLETED|Follow-up||144
10976589|NCT01067144|12151455|FG001|COMPLETED|Follow-up||152
10976590|NCT01067144|12151454|FG000|NOT COMPLETED|Follow-up||59
10976591|NCT01067144|12151455|FG001|NOT COMPLETED|Follow-up||56
10976592|NCT00600483|12151463|FG000|STARTED|Overall Study||753
10976593|NCT00600483|12151464|FG001|STARTED|Overall Study||749
10976594|NCT00600483|12151463|FG000|COMPLETED|Overall Study||717
10976595|NCT00600483|12151464|FG001|COMPLETED|Overall Study||702
10976596|NCT00600483|12151463|FG000|NOT COMPLETED|Overall Study||36
10976597|NCT00600483|12151464|FG001|NOT COMPLETED|Overall Study||47
10976598|NCT00568854|12151472|FG000|STARTED|Overall Study||6
10976599|NCT00568854|12151473|FG001|STARTED|Overall Study||4
10976600|NCT00568854|12151472|FG000|COMPLETED|Overall Study||6
10976601|NCT00568854|12151473|FG001|COMPLETED|Overall Study||4
10976602|NCT00568854|12151472|FG000|NOT COMPLETED|Overall Study||0
10976603|NCT00568854|12151473|FG001|NOT COMPLETED|Overall Study||0
10976604|NCT00568958|12151481|FG000|STARTED|Allocation||70
10976605|NCT00568958|12151482|FG001|STARTED|Allocation||70
10976606|NCT00568958|12151481|FG000|COMPLETED|Allocation||61
10976607|NCT00568958|12151482|FG001|COMPLETED|Allocation||67
10976608|NCT00568958|12151481|FG000|NOT COMPLETED|Allocation||9
10976609|NCT00568958|12151482|FG001|NOT COMPLETED|Allocation||3
10976610|NCT00568958|12151481|FG000|STARTED|Follow-Up||61
10976611|NCT00568958|12151482|FG001|STARTED|Follow-Up||67
10976612|NCT00568958|12151481|FG000|COMPLETED|Follow-Up||52
10976613|NCT00568958|12151482|FG001|COMPLETED|Follow-Up||60
10976614|NCT00568958|12151481|FG000|NOT COMPLETED|Follow-Up||9
10976615|NCT00568958|12151482|FG001|NOT COMPLETED|Follow-Up||7
10976616|NCT00569010|12151492|FG000|STARTED|Overall Study||6
10976617|NCT00569010|12151493|FG001|STARTED|Overall Study||6
10976618|NCT00569010|12151494|FG002|STARTED|Overall Study||11
10976619|NCT00569010|12151495|FG003|STARTED|Overall Study||11
10976620|NCT00569010|12151492|FG000|COMPLETED|Overall Study||6
10976621|NCT00569010|12151493|FG001|COMPLETED|Overall Study||6
10976622|NCT00569010|12151494|FG002|COMPLETED|Overall Study||11
10976623|NCT00569010|12151495|FG003|COMPLETED|Overall Study||11
10976624|NCT00569010|12151492|FG000|NOT COMPLETED|Overall Study||0
10976625|NCT00569010|12151493|FG001|NOT COMPLETED|Overall Study||0
10976626|NCT00569010|12151494|FG002|NOT COMPLETED|Overall Study||0
10976627|NCT00569010|12151495|FG003|NOT COMPLETED|Overall Study||0
10976628|NCT00569166|12151508|FG000|STARTED|Overall Study||30
10976629|NCT00569166|12151509|FG001|STARTED|Overall Study||31
10976630|NCT00569166|12151510|FG002|STARTED|Overall Study||31
10976631|NCT00569166|12151508|FG000|COMPLETED|Overall Study||21
10976632|NCT00569166|12151509|FG001|COMPLETED|Overall Study||25
10976633|NCT00569166|12151510|FG002|COMPLETED|Overall Study||27
10976634|NCT00569166|12151508|FG000|NOT COMPLETED|Overall Study||9
10976635|NCT00569166|12151509|FG001|NOT COMPLETED|Overall Study||6
10976636|NCT00569166|12151510|FG002|NOT COMPLETED|Overall Study||4
10976637|NCT00569192|12151521|FG000|STARTED|Overall Study||111
10976638|NCT00569192|12151522|FG001|STARTED|Overall Study||125
10976639|NCT00569192|12151523|FG002|STARTED|Overall Study||124
10976640|NCT00569192|12151521|FG000|COMPLETED|Overall Study||88
10976641|NCT00569192|12151522|FG001|COMPLETED|Overall Study||105
10976642|NCT00569192|12151523|FG002|COMPLETED|Overall Study||99
10976643|NCT00569192|12151521|FG000|NOT COMPLETED|Overall Study||23
10976644|NCT00569192|12151522|FG001|NOT COMPLETED|Overall Study||20
10976645|NCT00569192|12151523|FG002|NOT COMPLETED|Overall Study||25
10976646|NCT00569231|12151531|FG000|STARTED|Overall Study||18
10976647|NCT00569231|12151531|FG000|COMPLETED|Overall Study||11
10976648|NCT00569231|12151531|FG000|NOT COMPLETED|Overall Study||7
10976649|NCT00569270|12151535|FG000|STARTED|Period: First Intervention|randomized cross over study|15
10976650|NCT00569270|12151536|FG001|STARTED|Period: First Intervention||15
10976651|NCT00569270|12151535|FG000|COMPLETED|Period: First Intervention||15
10976652|NCT00569270|12151536|FG001|COMPLETED|Period: First Intervention||14
10976653|NCT00569270|12151535|FG000|NOT COMPLETED|Period: First Intervention||0
10976654|NCT00569270|12151536|FG001|NOT COMPLETED|Period: First Intervention||1
10976655|NCT00569270|12151535|FG000|STARTED|Period: Second Intervention||15
10976656|NCT00569270|12151536|FG001|STARTED|Period: Second Intervention||14
10976657|NCT00569270|12151535|FG000|29 Days|Period: Second Intervention||15
10976658|NCT00569270|12151536|FG001|29 Days|Period: Second Intervention||14
10976659|NCT00569270|12151535|FG000|COMPLETED|Period: Second Intervention||15
10976660|NCT00569270|12151536|FG001|COMPLETED|Period: Second Intervention||14
10976661|NCT00569270|12151535|FG000|NOT COMPLETED|Period: Second Intervention||0
10976662|NCT00569270|12151536|FG001|NOT COMPLETED|Period: Second Intervention||0
10976663|NCT00569309|12151551|FG000|STARTED|Overall Study||30
10976664|NCT00569309|12151551|FG000|COMPLETED|Overall Study||30
10976665|NCT00569309|12151551|FG000|NOT COMPLETED|Overall Study||0
10976666|NCT00569374|12151555|FG000|STARTED|Overall Study||8
10976667|NCT00569374|12151555|FG000|COMPLETED|Overall Study||4
10976668|NCT00569374|12151555|FG000|NOT COMPLETED|Overall Study||4
10976669|NCT00569530|12151561|FG000|STARTED|Overall Study||43
10976670|NCT00569530|12151562|FG001|STARTED|Overall Study||42
10976671|NCT00569530|12151561|FG000|COMPLETED|Overall Study||43
10976672|NCT00569530|12151562|FG001|COMPLETED|Overall Study||42
10976673|NCT00569530|12151561|FG000|NOT COMPLETED|Overall Study||0
10976674|NCT00569530|12151562|FG001|NOT COMPLETED|Overall Study||0
10976675|NCT00569582|12151568|FG000|STARTED|Overall Study||50
10976676|NCT00569582|12151568|FG000|COMPLETED|Overall Study||34
10976677|NCT00569582|12151568|FG000|NOT COMPLETED|Overall Study||16
10976678|NCT00569660|12151572|FG000|STARTED|Overall Study||34
10976679|NCT00569660|12151572|FG000|COMPLETED|Overall Study||34
10976680|NCT00569660|12151572|FG000|NOT COMPLETED|Overall Study||0
10976681|NCT00569673|12151576|FG000|STARTED|Overall Study|Total number participants enrolled on study|71
10976682|NCT00569673|12151576|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
10976683|NCT00569673|12151576|FG000|NOT COMPLETED|Overall Study||0
10976684|NCT00569777|12151582|FG000|STARTED|Overall Study||206
10976685|NCT00569777|12151583|FG001|STARTED|Overall Study||104
10976686|NCT00569777|12151582|FG000|COMPLETED|Overall Study||196
10976687|NCT00569777|12151583|FG001|COMPLETED|Overall Study||101
10976688|NCT00569777|12151582|FG000|NOT COMPLETED|Overall Study||10
10976689|NCT00569777|12151583|FG001|NOT COMPLETED|Overall Study||3
10976690|NCT00569803|12151597|FG000|STARTED|Overall Study||5
10976691|NCT00569803|12151598|FG001|STARTED|Overall Study||5
10976692|NCT00569803|12151599|FG002|STARTED|Overall Study||5
10976693|NCT00569803|12151600|FG003|STARTED|Overall Study||6
10976694|NCT00569803|12151601|FG004|STARTED|Overall Study||5
10976695|NCT00569803|12151602|FG005|STARTED|Overall Study||5
10976696|NCT00569803|12151603|FG006|STARTED|Overall Study||10
10976697|NCT00569803|12151604|FG007|STARTED|Overall Study||6
10976698|NCT00569803|12151597|FG000|COMPLETED|Overall Study||4
10976699|NCT00569803|12151598|FG001|COMPLETED|Overall Study||5
10976700|NCT00569803|12151599|FG002|COMPLETED|Overall Study||5
10976701|NCT00569803|12151600|FG003|COMPLETED|Overall Study||5
10976702|NCT00569803|12151601|FG004|COMPLETED|Overall Study||5
10976703|NCT00569803|12151602|FG005|COMPLETED|Overall Study||5
10976704|NCT00569803|12151603|FG006|COMPLETED|Overall Study||10
10976705|NCT00569803|12151604|FG007|COMPLETED|Overall Study||5
10976706|NCT00569803|12151597|FG000|NOT COMPLETED|Overall Study||1
10976707|NCT00569803|12151598|FG001|NOT COMPLETED|Overall Study||0
10976708|NCT00569803|12151599|FG002|NOT COMPLETED|Overall Study||0
10976709|NCT00569803|12151600|FG003|NOT COMPLETED|Overall Study||1
10976710|NCT00569803|12151601|FG004|NOT COMPLETED|Overall Study||0
10976711|NCT00569803|12151602|FG005|NOT COMPLETED|Overall Study||0
10976712|NCT00569803|12151603|FG006|NOT COMPLETED|Overall Study||0
10976713|NCT00569803|12151604|FG007|NOT COMPLETED|Overall Study||1
10976714|NCT00569855|12151626|FG000|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
10976715|NCT00569855|12151626|FG000|COMPLETED|Overall Study|785 subjects treated with study drug|785
10976716|NCT00569855|12151626|FG000|NOT COMPLETED|Overall Study||0
10976717|NCT00569946|12151630|FG000|STARTED|Overall Study||64
10976718|NCT00569946|12151630|FG000|COMPLETED|Overall Study||5
10976719|NCT00569946|12151630|FG000|NOT COMPLETED|Overall Study||59
10976720|NCT00570037|12151636|FG000|STARTED|Overall Study||238
10976721|NCT00570037|12151637|FG001|STARTED|Overall Study||306
10976722|NCT00570037|12151636|FG000|COMPLETED|Overall Study||194
10976723|NCT00570037|12151637|FG001|COMPLETED|Overall Study||237
10976724|NCT00570037|12151636|FG000|NOT COMPLETED|Overall Study||44
10976725|NCT00570037|12151637|FG001|NOT COMPLETED|Overall Study||69
10976726|NCT00570063|12151645|FG000|STARTED|Overall Study||24
10976727|NCT00570063|12151646|FG001|STARTED|Overall Study||11
10976728|NCT00570063|12151645|FG000|COMPLETED|Overall Study||9
10976729|NCT00570063|12151646|FG001|COMPLETED|Overall Study||3
10976730|NCT00570063|12151645|FG000|NOT COMPLETED|Overall Study||15
10976731|NCT00570063|12151646|FG001|NOT COMPLETED|Overall Study||8
10976732|NCT00570089|12151652|FG000|STARTED|Period 1||10
10976733|NCT00570089|12151653|FG001|STARTED|Period 1||10
10976734|NCT00570089|12151652|FG000|COMPLETED|Period 1||10
10976735|NCT00570089|12151653|FG001|COMPLETED|Period 1||10
10976736|NCT00570089|12151652|FG000|NOT COMPLETED|Period 1||0
10976737|NCT00570089|12151653|FG001|NOT COMPLETED|Period 1||0
10976738|NCT00570089|12151652|FG000|STARTED|Perod 2||10
10976739|NCT00570089|12151653|FG001|STARTED|Perod 2||10
10976740|NCT00570089|12151652|FG000|COMPLETED|Perod 2||10
10976741|NCT00570089|12151653|FG001|COMPLETED|Perod 2||10
10976742|NCT00570089|12151652|FG000|NOT COMPLETED|Perod 2||0
10976743|NCT00570089|12151653|FG001|NOT COMPLETED|Perod 2||0
10976744|NCT00570128|12151663|FG000|STARTED|Overall Study||64
10976745|NCT00570128|12151664|FG001|STARTED|Overall Study||65
10976746|NCT00570128|12151663|FG000|Intent to Treat (ITT) Population|Overall Study||62
10976747|NCT00570128|12151664|FG001|Intent to Treat (ITT) Population|Overall Study||65
10976748|NCT00570128|12151663|FG000|COMPLETED|Overall Study||60
10976749|NCT00570128|12151664|FG001|COMPLETED|Overall Study||65
10976750|NCT00570128|12151663|FG000|NOT COMPLETED|Overall Study||4
10976751|NCT00570128|12151664|FG001|NOT COMPLETED|Overall Study||0
10976752|NCT00570141|12151670|FG000|STARTED|Overall Study||13
10976753|NCT00570141|12151670|FG000|COMPLETED|Overall Study||10
10976754|NCT00570141|12151670|FG000|NOT COMPLETED|Overall Study||3
10976755|NCT00570232|12151674|FG000|STARTED|Overall Study||31
10976756|NCT00570232|12151674|FG000|COMPLETED|Overall Study||8
10976757|NCT00570232|12151674|FG000|NOT COMPLETED|Overall Study||23
10976758|NCT00570310|12151680|FG000|STARTED|Overall Study||53
10976759|NCT00570310|12151681|FG001|STARTED|Overall Study||51
10976760|NCT00570310|12151680|FG000|COMPLETED|Overall Study||51
10976761|NCT00570310|12151681|FG001|COMPLETED|Overall Study||45
10976762|NCT00570310|12151680|FG000|NOT COMPLETED|Overall Study||2
10976763|NCT00570310|12151681|FG001|NOT COMPLETED|Overall Study||6
10976764|NCT00570323|12151689|FG000|STARTED|Started Treatment After Randomization||36
10976765|NCT00570323|12151690|FG001|STARTED|Started Treatment After Randomization||36
10976766|NCT00570323|12151689|FG000|COMPLETED|Started Treatment After Randomization||34
10976767|NCT00570323|12151690|FG001|COMPLETED|Started Treatment After Randomization||35
10976768|NCT00570323|12151689|FG000|NOT COMPLETED|Started Treatment After Randomization||2
10976769|NCT00570323|12151690|FG001|NOT COMPLETED|Started Treatment After Randomization||1
10976770|NCT00570323|12151689|FG000|STARTED|Complete Study After Start||34
10976771|NCT00570323|12151690|FG001|STARTED|Complete Study After Start||35
10976772|NCT00570323|12151689|FG000|COMPLETED|Complete Study After Start||31
10976773|NCT00570323|12151690|FG001|COMPLETED|Complete Study After Start||34
10976774|NCT00570323|12151689|FG000|NOT COMPLETED|Complete Study After Start||3
10976775|NCT00570323|12151690|FG001|NOT COMPLETED|Complete Study After Start||1
10976776|NCT00570349|12151701|FG000|STARTED|Overall Study||6
10976777|NCT00570349|12151702|FG001|STARTED|Overall Study||6
10976778|NCT00570349|12151703|FG002|STARTED|Overall Study||6
10976779|NCT00570349|12151701|FG000|COMPLETED|Overall Study||6
10976780|NCT00570349|12151702|FG001|COMPLETED|Overall Study||6
10976781|NCT00570349|12151703|FG002|COMPLETED|Overall Study||6
10976782|NCT00570349|12151701|FG000|NOT COMPLETED|Overall Study||0
10976783|NCT00570349|12151702|FG001|NOT COMPLETED|Overall Study||0
10976784|NCT00570349|12151703|FG002|NOT COMPLETED|Overall Study||0
10976785|NCT00570362|12151713|FG000|STARTED|Overall Study||19
10976786|NCT00570362|12151714|FG001|STARTED|Overall Study||30
10976787|NCT00570362|12151713|FG000|COMPLETED|Overall Study||19
10976788|NCT00570362|12151714|FG001|COMPLETED|Overall Study||30
10976789|NCT00570362|12151713|FG000|NOT COMPLETED|Overall Study||0
10976790|NCT00570362|12151714|FG001|NOT COMPLETED|Overall Study||0
10976791|NCT00570401|12151720|FG000|STARTED|Overall Study||21
10976792|NCT00570401|12151720|FG000|COMPLETED|Overall Study||19
10976793|NCT00570401|12151720|FG000|NOT COMPLETED|Overall Study||2
10976794|NCT00570492|12151726|FG000|STARTED|16-week Single-blind Baseline Period||910
10976795|NCT00570492|12151727|FG001|STARTED|16-week Single-blind Baseline Period||0
10976796|NCT00570492|12151728|FG002|STARTED|16-week Single-blind Baseline Period||0
10976797|NCT00570492|12151726|FG000|COMPLETED|16-week Single-blind Baseline Period||474
10976798|NCT00570492|12151727|FG001|COMPLETED|16-week Single-blind Baseline Period||0
10976799|NCT00570492|12151728|FG002|COMPLETED|16-week Single-blind Baseline Period||0
10976800|NCT00570492|12151726|FG000|NOT COMPLETED|16-week Single-blind Baseline Period||436
10976801|NCT00570492|12151727|FG001|NOT COMPLETED|16-week Single-blind Baseline Period||0
10976802|NCT00570492|12151728|FG002|NOT COMPLETED|16-week Single-blind Baseline Period||0
10976803|NCT00570492|12151726|FG000|STARTED|52-week Double-blind Treatment Period||0
10976804|NCT00570492|12151727|FG001|STARTED|52-week Double-blind Treatment Period||237
10976805|NCT00570492|12151728|FG002|STARTED|52-week Double-blind Treatment Period||237
10976806|NCT00570492|12151726|FG000|COMPLETED|52-week Double-blind Treatment Period||0
10976807|NCT00570492|12151727|FG001|COMPLETED|52-week Double-blind Treatment Period||187
10976808|NCT00570492|12151728|FG002|COMPLETED|52-week Double-blind Treatment Period||186
10976809|NCT00570492|12151726|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0
10976810|NCT00570492|12151727|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||50
10976811|NCT00570492|12151728|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||51
10976812|NCT00570505|12151734|FG000|STARTED|Overall Study||149
10976813|NCT00570505|12151734|FG000|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
10976814|NCT00570505|12151734|FG000|NOT COMPLETED|Overall Study||41
10976815|NCT00570661|12151738|FG000|STARTED|Overall Study||17
10976816|NCT00570661|12151738|FG000|COMPLETED|Overall Study||10
10976817|NCT00570661|12151738|FG000|NOT COMPLETED|Overall Study||7
10976818|NCT00570674|12151743|FG000|STARTED|Overall Study||6
10976819|NCT00570674|12151744|FG001|STARTED|Overall Study||3
10976820|NCT00570674|12151745|FG002|STARTED|Overall Study||4
10976821|NCT00570674|12151746|FG003|STARTED|Overall Study||3
10976822|NCT00570674|12151747|FG004|STARTED|Overall Study||3
10976823|NCT00570674|12151748|FG005|STARTED|Overall Study||10
10976824|NCT00570674|12151749|FG006|STARTED|Overall Study|The study did not continue beyond phase I.|0
10976825|NCT00570674|12151743|FG000|Treated|Overall Study||6
10976826|NCT00570674|12151744|FG001|Treated|Overall Study||3
10976827|NCT00570674|12151745|FG002|Treated|Overall Study||3
10976828|NCT00570674|12151746|FG003|Treated|Overall Study||3
10976829|NCT00570674|12151747|FG004|Treated|Overall Study||3
10976830|NCT00570674|12151748|FG005|Treated|Overall Study||10
10976831|NCT00570674|12151749|FG006|Treated|Overall Study||0
10976832|NCT00570674|12151743|FG000|PEG Evaluable|Overall Study||6
10976833|NCT00570674|12151744|FG001|PEG Evaluable|Overall Study||3
10976834|NCT00570674|12151745|FG002|PEG Evaluable|Overall Study||3
10976835|NCT00570674|12151746|FG003|PEG Evaluable|Overall Study||3
10976836|NCT00570674|12151747|FG004|PEG Evaluable|Overall Study||2
10976837|NCT00570674|12151748|FG005|PEG Evaluable|Overall Study||10
10976838|NCT00570674|12151749|FG006|PEG Evaluable|Overall Study||0
10976839|NCT00570674|12151743|FG000|COMPLETED|Overall Study||6
10976840|NCT00570674|12151744|FG001|COMPLETED|Overall Study||3
10976841|NCT00570674|12151745|FG002|COMPLETED|Overall Study||3
10976842|NCT00570674|12151746|FG003|COMPLETED|Overall Study||3
10976843|NCT00570674|12151747|FG004|COMPLETED|Overall Study||3
10976844|NCT00570674|12151748|FG005|COMPLETED|Overall Study||10
10976845|NCT00570674|12151749|FG006|COMPLETED|Overall Study||0
10976846|NCT00570674|12151743|FG000|NOT COMPLETED|Overall Study||0
10976847|NCT00570674|12151744|FG001|NOT COMPLETED|Overall Study||0
10976848|NCT00570674|12151745|FG002|NOT COMPLETED|Overall Study||1
10976849|NCT00570674|12151746|FG003|NOT COMPLETED|Overall Study||0
10976850|NCT00570674|12151747|FG004|NOT COMPLETED|Overall Study||0
10976851|NCT00570674|12151748|FG005|NOT COMPLETED|Overall Study||0
10976852|NCT00570674|12151749|FG006|NOT COMPLETED|Overall Study||0
10976853|NCT00570687|12151762|FG000|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976854|NCT00570687|12151763|FG001|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976855|NCT00570687|12151764|FG002|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976856|NCT00570687|12151765|FG003|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976857|NCT00570687|12151766|FG004|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10976858|NCT00570687|12151767|FG005|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10976859|NCT00570687|12151768|FG006|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10976860|NCT00570687|12151769|FG007|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10976861|NCT00570687|12151770|FG008|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10976862|NCT00570687|12151771|FG009|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10976863|NCT00570687|12151762|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976864|NCT00570687|12151763|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976865|NCT00570687|12151764|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976866|NCT00570687|12151765|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976867|NCT00570687|12151766|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10976868|NCT00570687|12151767|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10976869|NCT00570687|12151768|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10976870|NCT00570687|12151769|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10976871|NCT00570687|12151770|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10976872|NCT00570687|12151771|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
10976873|NCT00570687|12151762|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976874|NCT00570687|12151763|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976875|NCT00570687|12151764|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976876|NCT00570687|12151765|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976877|NCT00570687|12151766|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976878|NCT00570687|12151767|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976879|NCT00570687|12151768|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976880|NCT00570687|12151769|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976881|NCT00570687|12151770|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976882|NCT00570687|12151771|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
10976883|NCT00570687|12151762|FG000|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
10976884|NCT00570687|12151763|FG001|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
10976885|NCT00570687|12151764|FG002|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
10976886|NCT00570687|12151765|FG003|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
10976887|NCT00570687|12151766|FG004|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
10976888|NCT00570687|12151767|FG005|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
10976889|NCT00570687|12151768|FG006|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
10976890|NCT00570687|12151769|FG007|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
10976891|NCT00570687|12151770|FG008|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
10976892|NCT00570687|12151771|FG009|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
10976893|NCT00570687|12151762|FG000|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10976894|NCT00570687|12151763|FG001|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10976895|NCT00570687|12151764|FG002|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10976896|NCT00570687|12151765|FG003|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10976897|NCT00570687|12151766|FG004|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
10976898|NCT00570687|12151767|FG005|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
10976899|NCT00570687|12151768|FG006|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
10976900|NCT00570687|12151769|FG007|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
10976901|NCT00570687|12151770|FG008|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
10976902|NCT00570687|12151771|FG009|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
10976903|NCT00570687|12151762|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10976904|NCT00570687|12151763|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10976905|NCT00570687|12151764|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10976906|NCT00570687|12151765|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10976907|NCT00570687|12151766|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10976908|NCT00570687|12151767|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10976909|NCT00570687|12151768|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10976910|NCT00570687|12151769|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10976911|NCT00570687|12151770|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10976912|NCT00570687|12151771|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
10976913|NCT00570687|12151762|FG000|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976914|NCT00570687|12151763|FG001|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976915|NCT00570687|12151764|FG002|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976916|NCT00570687|12151765|FG003|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976917|NCT00570687|12151766|FG004|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10976918|NCT00570687|12151767|FG005|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10976919|NCT00570687|12151768|FG006|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10976920|NCT00570687|12151769|FG007|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10976921|NCT00570687|12151770|FG008|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10976922|NCT00570687|12151771|FG009|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10976923|NCT00570687|12151762|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976924|NCT00570687|12151763|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976925|NCT00570687|12151764|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976926|NCT00570687|12151765|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976927|NCT00570687|12151766|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10976928|NCT00570687|12151767|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10976929|NCT00570687|12151768|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10976930|NCT00570687|12151769|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10976931|NCT00570687|12151770|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10976932|NCT00570687|12151771|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
10976933|NCT00570687|12151762|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976934|NCT00570687|12151763|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976935|NCT00570687|12151764|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976936|NCT00570687|12151765|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976937|NCT00570687|12151766|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976938|NCT00570687|12151767|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976939|NCT00570687|12151768|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976940|NCT00570687|12151769|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976941|NCT00570687|12151770|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976942|NCT00570687|12151771|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
10976943|NCT00570687|12151762|FG000|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
10976944|NCT00570687|12151763|FG001|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
10976945|NCT00570687|12151764|FG002|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
10976946|NCT00570687|12151765|FG003|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
10976947|NCT00570687|12151766|FG004|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
10976948|NCT00570687|12151767|FG005|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
10976949|NCT00570687|12151768|FG006|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
10976950|NCT00570687|12151769|FG007|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
10976951|NCT00570687|12151770|FG008|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
10976952|NCT00570687|12151771|FG009|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
10976953|NCT00570687|12151762|FG000|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10976954|NCT00570687|12151763|FG001|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10976955|NCT00570687|12151764|FG002|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10976956|NCT00570687|12151765|FG003|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10976957|NCT00570687|12151766|FG004|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
10976958|NCT00570687|12151767|FG005|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
10976959|NCT00570687|12151768|FG006|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
10976960|NCT00570687|12151769|FG007|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
10976961|NCT00570687|12151770|FG008|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
10976962|NCT00570687|12151771|FG009|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
10976963|NCT00570687|12151762|FG000|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10976964|NCT00570687|12151763|FG001|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10976965|NCT00570687|12151764|FG002|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10976966|NCT00570687|12151765|FG003|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10976967|NCT00570687|12151766|FG004|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10976968|NCT00570687|12151767|FG005|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10976969|NCT00570687|12151768|FG006|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10976970|NCT00570687|12151769|FG007|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10976971|NCT00570687|12151770|FG008|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10976972|NCT00570687|12151771|FG009|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
10976973|NCT00570687|12151762|FG000|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10976974|NCT00570687|12151763|FG001|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10976975|NCT00570687|12151764|FG002|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10976976|NCT00570687|12151765|FG003|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10976977|NCT00570687|12151766|FG004|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10976978|NCT00570687|12151767|FG005|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10976979|NCT00570687|12151768|FG006|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10976980|NCT00570687|12151769|FG007|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10976981|NCT00570687|12151770|FG008|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10976982|NCT00570687|12151771|FG009|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10976983|NCT00570687|12151762|FG000|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10976984|NCT00570687|12151763|FG001|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10976985|NCT00570687|12151764|FG002|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10976986|NCT00570687|12151765|FG003|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10976987|NCT00570687|12151766|FG004|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10976988|NCT00570687|12151767|FG005|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10976989|NCT00570687|12151768|FG006|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10976990|NCT00570687|12151769|FG007|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10976991|NCT00570687|12151770|FG008|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10976992|NCT00570687|12151771|FG009|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
10976993|NCT00570687|12151762|FG000|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10976994|NCT00570687|12151763|FG001|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10976995|NCT00570687|12151764|FG002|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10976996|NCT00570687|12151765|FG003|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10976997|NCT00570687|12151766|FG004|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10976998|NCT00570687|12151767|FG005|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10976999|NCT00570687|12151768|FG006|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10977000|NCT00570687|12151769|FG007|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10977001|NCT00570687|12151770|FG008|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10977002|NCT00570687|12151771|FG009|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
10977003|NCT00570687|12151762|FG000|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
10977004|NCT00570687|12151763|FG001|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
10977005|NCT00570687|12151764|FG002|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
10977006|NCT00570687|12151765|FG003|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
10977007|NCT00570687|12151766|FG004|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
10977008|NCT00570687|12151767|FG005|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
10977009|NCT00570687|12151768|FG006|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
10977010|NCT00570687|12151769|FG007|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
10977011|NCT00570687|12151770|FG008|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
10977012|NCT00570687|12151771|FG009|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
10977013|NCT00570687|12151762|FG000|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10977014|NCT00570687|12151763|FG001|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10977015|NCT00570687|12151764|FG002|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10977016|NCT00570687|12151765|FG003|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10977017|NCT00570687|12151766|FG004|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10977018|NCT00570687|12151767|FG005|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10977019|NCT00570687|12151768|FG006|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
10977020|NCT00570687|12151769|FG007|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10977021|NCT00570687|12151770|FG008|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
10977022|NCT00570687|12151771|FG009|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10977023|NCT00570687|12151762|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10977024|NCT00570687|12151763|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10977025|NCT00570687|12151764|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10977026|NCT00570687|12151765|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
10977027|NCT00570687|12151766|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
10977028|NCT00570687|12151767|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
10977029|NCT00570687|12151768|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
10977030|NCT00570687|12151769|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
10977031|NCT00570687|12151770|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
10977032|NCT00570687|12151771|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
10977033|NCT00570687|12151762|FG000|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10977034|NCT00570687|12151763|FG001|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10977035|NCT00570687|12151764|FG002|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10977036|NCT00570687|12151765|FG003|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10977037|NCT00570687|12151766|FG004|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10977038|NCT00570687|12151767|FG005|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10977039|NCT00570687|12151768|FG006|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
10977040|NCT00570687|12151769|FG007|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10977041|NCT00570687|12151770|FG008|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
10977042|NCT00570687|12151771|FG009|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
10977043|NCT00570687|12151762|FG000|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977044|NCT00570687|12151763|FG001|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977045|NCT00570687|12151764|FG002|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977046|NCT00570687|12151765|FG003|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977047|NCT00570687|12151766|FG004|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977048|NCT00570687|12151767|FG005|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977049|NCT00570687|12151768|FG006|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
10977050|NCT00570687|12151769|FG007|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977051|NCT00570687|12151770|FG008|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
10977052|NCT00570687|12151771|FG009|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977053|NCT00570687|12151762|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977054|NCT00570687|12151763|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977055|NCT00570687|12151764|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977056|NCT00570687|12151765|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977057|NCT00570687|12151766|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977058|NCT00570687|12151767|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977059|NCT00570687|12151768|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977060|NCT00570687|12151769|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977061|NCT00570687|12151770|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977062|NCT00570687|12151771|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
10977063|NCT00570687|12151762|FG000|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10977064|NCT00570687|12151763|FG001|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10977065|NCT00570687|12151764|FG002|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10977066|NCT00570687|12151765|FG003|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10977067|NCT00570687|12151766|FG004|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10977068|NCT00570687|12151767|FG005|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10977069|NCT00570687|12151768|FG006|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
10977070|NCT00570687|12151769|FG007|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10977071|NCT00570687|12151770|FG008|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
10977072|NCT00570687|12151771|FG009|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
10977073|NCT00570687|12151762|FG000|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977074|NCT00570687|12151763|FG001|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977075|NCT00570687|12151764|FG002|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977076|NCT00570687|12151765|FG003|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977077|NCT00570687|12151766|FG004|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977078|NCT00570687|12151767|FG005|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977079|NCT00570687|12151768|FG006|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
10977080|NCT00570687|12151769|FG007|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977081|NCT00570687|12151770|FG008|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977082|NCT00570687|12151771|FG009|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977083|NCT00570687|12151762|FG000|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977084|NCT00570687|12151763|FG001|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977085|NCT00570687|12151764|FG002|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977086|NCT00570687|12151765|FG003|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977087|NCT00570687|12151766|FG004|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977088|NCT00570687|12151767|FG005|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977089|NCT00570687|12151768|FG006|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977090|NCT00570687|12151769|FG007|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977091|NCT00570687|12151770|FG008|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
10977092|NCT00570687|12151771|FG009|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
10977093|NCT00570687|12151762|FG000|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10977094|NCT00570687|12151763|FG001|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10977095|NCT00570687|12151764|FG002|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10977096|NCT00570687|12151765|FG003|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10977097|NCT00570687|12151766|FG004|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10977098|NCT00570687|12151767|FG005|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10977099|NCT00570687|12151768|FG006|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
10977100|NCT00570687|12151769|FG007|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10977101|NCT00570687|12151770|FG008|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10977102|NCT00570687|12151771|FG009|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
10977103|NCT00570687|12151762|FG000|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977104|NCT00570687|12151763|FG001|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977105|NCT00570687|12151764|FG002|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977106|NCT00570687|12151765|FG003|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977107|NCT00570687|12151766|FG004|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977108|NCT00570687|12151767|FG005|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977109|NCT00570687|12151768|FG006|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
10977110|NCT00570687|12151769|FG007|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977111|NCT00570687|12151770|FG008|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977112|NCT00570687|12151771|FG009|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977113|NCT00570687|12151762|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977114|NCT00570687|12151763|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977115|NCT00570687|12151764|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977116|NCT00570687|12151765|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977117|NCT00570687|12151766|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977118|NCT00570687|12151767|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977119|NCT00570687|12151768|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977120|NCT00570687|12151769|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977121|NCT00570687|12151770|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977122|NCT00570687|12151771|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
10977123|NCT00570687|12151762|FG000|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10977124|NCT00570687|12151763|FG001|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10977125|NCT00570687|12151764|FG002|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10977126|NCT00570687|12151765|FG003|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10977127|NCT00570687|12151766|FG004|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10977128|NCT00570687|12151767|FG005|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10977129|NCT00570687|12151768|FG006|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
10977130|NCT00570687|12151769|FG007|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10977131|NCT00570687|12151770|FG008|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10977132|NCT00570687|12151771|FG009|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
10977133|NCT00570687|12151762|FG000|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977134|NCT00570687|12151763|FG001|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977135|NCT00570687|12151764|FG002|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977136|NCT00570687|12151765|FG003|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977137|NCT00570687|12151766|FG004|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977138|NCT00570687|12151767|FG005|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977139|NCT00570687|12151768|FG006|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977140|NCT00570687|12151769|FG007|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977141|NCT00570687|12151770|FG008|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977142|NCT00570687|12151771|FG009|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977143|NCT00570687|12151762|FG000|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977144|NCT00570687|12151763|FG001|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977145|NCT00570687|12151764|FG002|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977146|NCT00570687|12151765|FG003|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977147|NCT00570687|12151766|FG004|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977148|NCT00570687|12151767|FG005|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977149|NCT00570687|12151768|FG006|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
10977150|NCT00570687|12151769|FG007|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977151|NCT00570687|12151770|FG008|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977152|NCT00570687|12151771|FG009|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
10977153|NCT00570687|12151762|FG000|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
10977154|NCT00570687|12151763|FG001|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
10977155|NCT00570687|12151764|FG002|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
10977156|NCT00570687|12151765|FG003|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
10977157|NCT00570687|12151766|FG004|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977158|NCT00570687|12151767|FG005|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977159|NCT00570687|12151768|FG006|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977160|NCT00570687|12151769|FG007|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977161|NCT00570687|12151770|FG008|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977162|NCT00570687|12151771|FG009|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977163|NCT00570687|12151762|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
10977164|NCT00570687|12151763|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
10977165|NCT00570687|12151764|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
10977166|NCT00570687|12151765|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
10977167|NCT00570687|12151766|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977168|NCT00570687|12151767|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977169|NCT00570687|12151768|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977170|NCT00570687|12151769|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977171|NCT00570687|12151770|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977172|NCT00570687|12151771|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977173|NCT00570687|12151762|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977174|NCT00570687|12151763|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977175|NCT00570687|12151764|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977176|NCT00570687|12151765|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977177|NCT00570687|12151766|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977178|NCT00570687|12151767|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977179|NCT00570687|12151768|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977180|NCT00570687|12151769|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977181|NCT00570687|12151770|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977182|NCT00570687|12151771|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
10977183|NCT00570687|12151762|FG000|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
10977184|NCT00570687|12151763|FG001|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
10977185|NCT00570687|12151764|FG002|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
10977186|NCT00570687|12151765|FG003|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
10977187|NCT00570687|12151766|FG004|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
10977188|NCT00570687|12151767|FG005|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
10977189|NCT00570687|12151768|FG006|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
10977190|NCT00570687|12151769|FG007|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
10977191|NCT00570687|12151770|FG008|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
10977192|NCT00570687|12151771|FG009|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
10977193|NCT00570687|12151762|FG000|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
10977194|NCT00570687|12151763|FG001|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
10977195|NCT00570687|12151764|FG002|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
10977196|NCT00570687|12151765|FG003|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
10977197|NCT00570687|12151766|FG004|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977198|NCT00570687|12151767|FG005|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977199|NCT00570687|12151768|FG006|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977200|NCT00570687|12151769|FG007|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977201|NCT00570687|12151770|FG008|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977202|NCT00570687|12151771|FG009|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977203|NCT00570687|12151762|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977204|NCT00570687|12151763|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977205|NCT00570687|12151764|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977206|NCT00570687|12151765|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977207|NCT00570687|12151766|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977208|NCT00570687|12151767|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977209|NCT00570687|12151768|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977210|NCT00570687|12151769|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977211|NCT00570687|12151770|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977212|NCT00570687|12151771|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
10977213|NCT00570687|12151762|FG000|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
10977214|NCT00570687|12151763|FG001|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
10977215|NCT00570687|12151764|FG002|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
10977216|NCT00570687|12151765|FG003|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
10977217|NCT00570687|12151766|FG004|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977218|NCT00570687|12151767|FG005|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977219|NCT00570687|12151768|FG006|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977220|NCT00570687|12151769|FG007|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977221|NCT00570687|12151770|FG008|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977222|NCT00570687|12151771|FG009|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977223|NCT00570687|12151762|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
10977224|NCT00570687|12151763|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
10977225|NCT00570687|12151764|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
10977226|NCT00570687|12151765|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
10977227|NCT00570687|12151766|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977228|NCT00570687|12151767|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977229|NCT00570687|12151768|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977230|NCT00570687|12151769|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977231|NCT00570687|12151770|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977232|NCT00570687|12151771|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977233|NCT00570687|12151762|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977234|NCT00570687|12151763|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977235|NCT00570687|12151764|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977236|NCT00570687|12151765|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977237|NCT00570687|12151766|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977238|NCT00570687|12151767|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977239|NCT00570687|12151768|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977240|NCT00570687|12151769|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977241|NCT00570687|12151770|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977242|NCT00570687|12151771|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
10977243|NCT00570687|12151762|FG000|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
10977244|NCT00570687|12151763|FG001|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
10977245|NCT00570687|12151764|FG002|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
10977246|NCT00570687|12151765|FG003|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
10977247|NCT00570687|12151766|FG004|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
10977248|NCT00570687|12151767|FG005|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
10977249|NCT00570687|12151768|FG006|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
10977250|NCT00570687|12151769|FG007|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
10977251|NCT00570687|12151770|FG008|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
10977252|NCT00570687|12151771|FG009|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
10977253|NCT00570687|12151762|FG000|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
10977254|NCT00570687|12151763|FG001|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
10977255|NCT00570687|12151764|FG002|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
10977256|NCT00570687|12151765|FG003|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
10977257|NCT00570687|12151766|FG004|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977258|NCT00570687|12151767|FG005|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977259|NCT00570687|12151768|FG006|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977260|NCT00570687|12151769|FG007|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977261|NCT00570687|12151770|FG008|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977262|NCT00570687|12151771|FG009|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977263|NCT00570687|12151762|FG000|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977264|NCT00570687|12151763|FG001|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977265|NCT00570687|12151764|FG002|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977266|NCT00570687|12151765|FG003|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977267|NCT00570687|12151766|FG004|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977268|NCT00570687|12151767|FG005|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977269|NCT00570687|12151768|FG006|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977270|NCT00570687|12151769|FG007|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977271|NCT00570687|12151770|FG008|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977272|NCT00570687|12151771|FG009|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
10977273|NCT00570687|12151762|FG000|STARTED|Clamp 1 (1 Day) - Amendment 1||4
10977274|NCT00570687|12151763|FG001|STARTED|Clamp 1 (1 Day) - Amendment 1||2
10977275|NCT00570687|12151764|FG002|STARTED|Clamp 1 (1 Day) - Amendment 1||2
10977276|NCT00570687|12151765|FG003|STARTED|Clamp 1 (1 Day) - Amendment 1||4
10977277|NCT00570687|12151766|FG004|STARTED|Clamp 1 (1 Day) - Amendment 1||0
10977278|NCT00570687|12151767|FG005|STARTED|Clamp 1 (1 Day) - Amendment 1||0
10977279|NCT00570687|12151768|FG006|STARTED|Clamp 1 (1 Day) - Amendment 1||0
10977280|NCT00570687|12151769|FG007|STARTED|Clamp 1 (1 Day) - Amendment 1||0
10977281|NCT00570687|12151770|FG008|STARTED|Clamp 1 (1 Day) - Amendment 1||0
10977282|NCT00570687|12151771|FG009|STARTED|Clamp 1 (1 Day) - Amendment 1||0
10977283|NCT00570687|12151762|FG000|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
10977284|NCT00570687|12151763|FG001|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
10977285|NCT00570687|12151764|FG002|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
10977286|NCT00570687|12151765|FG003|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
10977287|NCT00570687|12151766|FG004|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977288|NCT00570687|12151767|FG005|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977289|NCT00570687|12151768|FG006|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977290|NCT00570687|12151769|FG007|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977291|NCT00570687|12151770|FG008|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977292|NCT00570687|12151771|FG009|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977293|NCT00570687|12151762|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977294|NCT00570687|12151763|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977295|NCT00570687|12151764|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977296|NCT00570687|12151765|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977297|NCT00570687|12151766|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977298|NCT00570687|12151767|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977299|NCT00570687|12151768|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977300|NCT00570687|12151769|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977301|NCT00570687|12151770|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977302|NCT00570687|12151771|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
10977303|NCT00570687|12151762|FG000|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
10977304|NCT00570687|12151763|FG001|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
10977305|NCT00570687|12151764|FG002|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
10977306|NCT00570687|12151765|FG003|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
10977307|NCT00570687|12151766|FG004|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
10977308|NCT00570687|12151767|FG005|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
10977309|NCT00570687|12151768|FG006|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
10977310|NCT00570687|12151769|FG007|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
10977311|NCT00570687|12151770|FG008|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
10977312|NCT00570687|12151771|FG009|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
10977313|NCT00570687|12151762|FG000|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
10977314|NCT00570687|12151763|FG001|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
10977315|NCT00570687|12151764|FG002|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
10977316|NCT00570687|12151765|FG003|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
10977317|NCT00570687|12151766|FG004|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977318|NCT00570687|12151767|FG005|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977319|NCT00570687|12151768|FG006|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977320|NCT00570687|12151769|FG007|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977321|NCT00570687|12151770|FG008|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977322|NCT00570687|12151771|FG009|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977323|NCT00570687|12151762|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977324|NCT00570687|12151763|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977325|NCT00570687|12151764|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977326|NCT00570687|12151765|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977327|NCT00570687|12151766|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977328|NCT00570687|12151767|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977329|NCT00570687|12151768|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977330|NCT00570687|12151769|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977331|NCT00570687|12151770|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977332|NCT00570687|12151771|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
10977333|NCT00570687|12151762|FG000|STARTED|Clamp 2 (1 Day) - Amendment 1||4
10977334|NCT00570687|12151763|FG001|STARTED|Clamp 2 (1 Day) - Amendment 1||2
10977335|NCT00570687|12151764|FG002|STARTED|Clamp 2 (1 Day) - Amendment 1||2
10977336|NCT00570687|12151765|FG003|STARTED|Clamp 2 (1 Day) - Amendment 1||4
10977337|NCT00570687|12151766|FG004|STARTED|Clamp 2 (1 Day) - Amendment 1||0
10977338|NCT00570687|12151767|FG005|STARTED|Clamp 2 (1 Day) - Amendment 1||0
10977339|NCT00570687|12151768|FG006|STARTED|Clamp 2 (1 Day) - Amendment 1||0
10977340|NCT00570687|12151769|FG007|STARTED|Clamp 2 (1 Day) - Amendment 1||0
10977341|NCT00570687|12151770|FG008|STARTED|Clamp 2 (1 Day) - Amendment 1||0
10977342|NCT00570687|12151771|FG009|STARTED|Clamp 2 (1 Day) - Amendment 1||0
10977343|NCT00570687|12151762|FG000|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
10977344|NCT00570687|12151763|FG001|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
10977345|NCT00570687|12151764|FG002|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
10977346|NCT00570687|12151765|FG003|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
10977347|NCT00570687|12151766|FG004|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977348|NCT00570687|12151767|FG005|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977349|NCT00570687|12151768|FG006|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977350|NCT00570687|12151769|FG007|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977351|NCT00570687|12151770|FG008|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977352|NCT00570687|12151771|FG009|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977353|NCT00570687|12151762|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977354|NCT00570687|12151763|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977355|NCT00570687|12151764|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977356|NCT00570687|12151765|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977357|NCT00570687|12151766|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977358|NCT00570687|12151767|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977359|NCT00570687|12151768|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977360|NCT00570687|12151769|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977361|NCT00570687|12151770|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977362|NCT00570687|12151771|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
10977363|NCT00570700|12151785|FG000|STARTED|Overall Study||38
10977364|NCT00570700|12151785|FG000|COMPLETED|Overall Study||27
10977365|NCT00570700|12151785|FG000|NOT COMPLETED|Overall Study||11
10977366|NCT00570713|12151791|FG000|STARTED|Overall Study||78
10977367|NCT00570713|12151792|FG001|STARTED|Overall Study||77
10977368|NCT00570713|12151791|FG000|COMPLETED|Overall Study||0
10977369|NCT00570713|12151792|FG001|COMPLETED|Overall Study||0
10977370|NCT00570713|12151791|FG000|NOT COMPLETED|Overall Study||78
10977371|NCT00570713|12151792|FG001|NOT COMPLETED|Overall Study||77
10977372|NCT00570739|12151802|FG000|STARTED|Overall Study||141
10977373|NCT00570739|12151803|FG001|STARTED|Overall Study||145
10977374|NCT00570739|12151804|FG002|STARTED|Overall Study||108
10977375|NCT00570739|12151805|FG003|STARTED|Overall Study||108
10977376|NCT00570739|12151802|FG000|COMPLETED|Overall Study||120
10977377|NCT00570739|12151803|FG001|COMPLETED|Overall Study||124
10977378|NCT00570739|12151804|FG002|COMPLETED|Overall Study||92
10977379|NCT00570739|12151805|FG003|COMPLETED|Overall Study||96
10977380|NCT00570739|12151802|FG000|NOT COMPLETED|Overall Study||21
10977381|NCT00570739|12151803|FG001|NOT COMPLETED|Overall Study||21
10977382|NCT00570739|12151804|FG002|NOT COMPLETED|Overall Study||16
10977383|NCT00570739|12151805|FG003|NOT COMPLETED|Overall Study||12
10977384|NCT00570765|12151838|FG000|STARTED|DB Phase||20
10977385|NCT00570765|12151839|FG001|STARTED|DB Phase||16
10977386|NCT00570765|12151840|FG002|STARTED|DB Phase||24
10977387|NCT00570765|12151841|FG003|STARTED|DB Phase||0
10977388|NCT00570765|12151838|FG000|Received at Least 1 Dose of Study Drug|DB Phase||20
10977389|NCT00570765|12151839|FG001|Received at Least 1 Dose of Study Drug|DB Phase||16
10977390|NCT00570765|12151840|FG002|Received at Least 1 Dose of Study Drug|DB Phase||23
10977391|NCT00570765|12151841|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0
10977392|NCT00570765|12151838|FG000|Safety Population|DB Phase||20
10977393|NCT00570765|12151839|FG001|Safety Population|DB Phase||16
10977394|NCT00570765|12151840|FG002|Safety Population|DB Phase||23
10977395|NCT00570765|12151841|FG003|Safety Population|DB Phase||0
10977396|NCT00570765|12151838|FG000|COMPLETED|DB Phase||16
10977397|NCT00570765|12151839|FG001|COMPLETED|DB Phase||9
10977398|NCT00570765|12151840|FG002|COMPLETED|DB Phase||23
10977399|NCT00570765|12151841|FG003|COMPLETED|DB Phase||0
10977400|NCT00570765|12151838|FG000|NOT COMPLETED|DB Phase||4
10977401|NCT00570765|12151839|FG001|NOT COMPLETED|DB Phase||7
10977402|NCT00570765|12151840|FG002|NOT COMPLETED|DB Phase||1
10977403|NCT00570765|12151841|FG003|NOT COMPLETED|DB Phase||0
10977404|NCT00570765|12151838|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
10977405|NCT00570765|12151839|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
10977489|NCT00571324|12151912|FG001|NOT COMPLETED|Intervention 2 (7 Hours)||0
10977406|NCT00570765|12151840|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
10977407|NCT00570765|12151841|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|28
10977408|NCT00570765|12151838|FG000|Received at Least 1 Dose of Study Drug|LTSE Phase||0
10977409|NCT00570765|12151839|FG001|Received at Least 1 Dose of Study Drug|LTSE Phase||0
10977410|NCT00570765|12151840|FG002|Received at Least 1 Dose of Study Drug|LTSE Phase||0
10977411|NCT00570765|12151841|FG003|Received at Least 1 Dose of Study Drug|LTSE Phase||28
10977412|NCT00570765|12151838|FG000|Safety Population|LTSE Phase||0
10977413|NCT00570765|12151839|FG001|Safety Population|LTSE Phase||0
10977414|NCT00570765|12151840|FG002|Safety Population|LTSE Phase||0
10977415|NCT00570765|12151841|FG003|Safety Population|LTSE Phase||28
10977416|NCT00570765|12151838|FG000|COMPLETED|LTSE Phase||0
10977417|NCT00570765|12151839|FG001|COMPLETED|LTSE Phase||0
10977418|NCT00570765|12151840|FG002|COMPLETED|LTSE Phase||0
10977419|NCT00570765|12151841|FG003|COMPLETED|LTSE Phase||16
10977420|NCT00570765|12151838|FG000|NOT COMPLETED|LTSE Phase||0
10977421|NCT00570765|12151839|FG001|NOT COMPLETED|LTSE Phase||0
10977422|NCT00570765|12151840|FG002|NOT COMPLETED|LTSE Phase||0
10977423|NCT00570765|12151841|FG003|NOT COMPLETED|LTSE Phase||12
10977424|NCT00570778|12151852|FG000|STARTED|Overall Study||41
10977425|NCT00570778|12151853|FG001|STARTED|Overall Study||38
10977426|NCT00570778|12151854|FG002|STARTED|Overall Study||37
10977427|NCT00570778|12151855|FG003|STARTED|Overall Study||38
10977428|NCT00570778|12151852|FG000|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
10977429|NCT00570778|12151853|FG001|Safety Population: Received Study Drug|Overall Study||38
10977430|NCT00570778|12151854|FG002|Safety Population: Received Study Drug|Overall Study||36
10977431|NCT00570778|12151855|FG003|Safety Population: Received Study Drug|Overall Study||38
10977432|NCT00570778|12151852|FG000|Modified Intent-to-treat Population|Overall Study||40
10977433|NCT00570778|12151853|FG001|Modified Intent-to-treat Population|Overall Study||37
10977434|NCT00570778|12151854|FG002|Modified Intent-to-treat Population|Overall Study||35
10977435|NCT00570778|12151855|FG003|Modified Intent-to-treat Population|Overall Study||37
10977436|NCT00570778|12151852|FG000|COMPLETED|Overall Study||37
10977437|NCT00570778|12151853|FG001|COMPLETED|Overall Study||34
10977438|NCT00570778|12151854|FG002|COMPLETED|Overall Study||30
10977439|NCT00570778|12151855|FG003|COMPLETED|Overall Study||34
10977440|NCT00570778|12151852|FG000|NOT COMPLETED|Overall Study||4
10977441|NCT00570778|12151853|FG001|NOT COMPLETED|Overall Study||4
10977442|NCT00570778|12151854|FG002|NOT COMPLETED|Overall Study||7
10977443|NCT00570778|12151855|FG003|NOT COMPLETED|Overall Study||4
10977444|NCT00570908|12151865|FG000|STARTED|Overall Study||12
10977445|NCT00570908|12151865|FG000|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
10977446|NCT00570908|12151865|FG000|NOT COMPLETED|Overall Study||7
10977447|NCT00570921|12151869|FG000|STARTED|Overall Study||33
10977448|NCT00570921|12151869|FG000|COMPLETED|Overall Study||31
10977449|NCT00570921|12151869|FG000|NOT COMPLETED|Overall Study||2
10977450|NCT00570960|12151875|FG000|STARTED|Overall Study||4
10977451|NCT00570960|12151876|FG001|STARTED|Overall Study||4
10977452|NCT00570960|12151875|FG000|COMPLETED|Overall Study||4
10977453|NCT00570960|12151876|FG001|COMPLETED|Overall Study||4
10977454|NCT00570960|12151875|FG000|NOT COMPLETED|Overall Study||0
10977455|NCT00570960|12151876|FG001|NOT COMPLETED|Overall Study||0
10977456|NCT00571038|12151884|FG000|STARTED|Overall Study||219
10977457|NCT00571038|12151885|FG001|STARTED|Overall Study||185
10977458|NCT00571038|12151884|FG000|6 Month Follow up|Overall Study||208
10977459|NCT00571038|12151885|FG001|6 Month Follow up|Overall Study||176
10977460|NCT00571038|12151884|FG000|18 Month Survey Only|Overall Study||199
10977461|NCT00571038|12151885|FG001|18 Month Survey Only|Overall Study||163
10977462|NCT00571038|12151884|FG000|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
10977463|NCT00571038|12151885|FG001|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
10977464|NCT00571038|12151884|FG000|NOT COMPLETED|Overall Study||11
10977465|NCT00571038|12151885|FG001|NOT COMPLETED|Overall Study||14
10977466|NCT00571064|12151891|FG000|STARTED|Overall Study||97
10977467|NCT00571064|12151891|FG000|COMPLETED|Overall Study||76
10977468|NCT00571064|12151891|FG000|NOT COMPLETED|Overall Study||21
10977469|NCT00571103|12151896|FG000|STARTED|Overall Study||28
10977470|NCT00571103|12151896|FG000|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
10977471|NCT00571103|12151896|FG000|NOT COMPLETED|Overall Study||2
10977472|NCT00571259|12151902|FG000|STARTED|Overall Study||148
10977473|NCT00571259|12151903|FG001|STARTED|Overall Study||155
10977474|NCT00571259|12151902|FG000|COMPLETED|Overall Study||4
10977475|NCT00571259|12151903|FG001|COMPLETED|Overall Study||14
10977476|NCT00571259|12151902|FG000|NOT COMPLETED|Overall Study||144
10977477|NCT00571259|12151903|FG001|NOT COMPLETED|Overall Study||141
10977478|NCT00571324|12151911|FG000|STARTED|Intervention 1 (7 Hours)||5
10977479|NCT00571324|12151912|FG001|STARTED|Intervention 1 (7 Hours)||4
10977480|NCT00571324|12151911|FG000|COMPLETED|Intervention 1 (7 Hours)||5
10977481|NCT00571324|12151912|FG001|COMPLETED|Intervention 1 (7 Hours)||4
10977482|NCT00571324|12151911|FG000|NOT COMPLETED|Intervention 1 (7 Hours)||0
10977483|NCT00571324|12151912|FG001|NOT COMPLETED|Intervention 1 (7 Hours)||0
10977484|NCT00571324|12151911|FG000|STARTED|Intervention 2 (7 Hours)||5
10977485|NCT00571324|12151912|FG001|STARTED|Intervention 2 (7 Hours)||4
10977486|NCT00571324|12151911|FG000|COMPLETED|Intervention 2 (7 Hours)||5
10977487|NCT00571324|12151912|FG001|COMPLETED|Intervention 2 (7 Hours)||4
10977488|NCT00571324|12151911|FG000|NOT COMPLETED|Intervention 2 (7 Hours)||0
10977490|NCT00571428|12151920|FG000|STARTED|Overall Study||15
10977491|NCT00571428|12151921|FG001|STARTED|Overall Study||18
10977492|NCT00571428|12151920|FG000|COMPLETED|Overall Study||15
10977493|NCT00571428|12151921|FG001|COMPLETED|Overall Study||18
10977494|NCT00571428|12151920|FG000|NOT COMPLETED|Overall Study||0
10977495|NCT00571428|12151921|FG001|NOT COMPLETED|Overall Study||0
10977496|NCT00571493|12151927|FG000|STARTED|Overall Study||3
10977497|NCT00571493|12151928|FG001|STARTED|Overall Study||4
10977498|NCT00571493|12151929|FG002|STARTED|Overall Study||3
10977499|NCT00571493|12151930|FG003|STARTED|Overall Study||3
10977500|NCT00571493|12151931|FG004|STARTED|Overall Study||11
10977501|NCT00571493|12151932|FG005|STARTED|Overall Study||12
10977502|NCT00571493|12151933|FG006|STARTED|Overall Study||6
10977503|NCT00571493|12151927|FG000|COMPLETED|Overall Study||3
10977504|NCT00571493|12151928|FG001|COMPLETED|Overall Study||4
10977505|NCT00571493|12151929|FG002|COMPLETED|Overall Study||3
10977506|NCT00571493|12151930|FG003|COMPLETED|Overall Study||3
10977507|NCT00571493|12151931|FG004|COMPLETED|Overall Study||11
10977508|NCT00571493|12151932|FG005|COMPLETED|Overall Study||12
10977509|NCT00571493|12151933|FG006|COMPLETED|Overall Study||6
10977510|NCT00571493|12151927|FG000|NOT COMPLETED|Overall Study||0
10977511|NCT00571493|12151928|FG001|NOT COMPLETED|Overall Study||0
10977512|NCT00571493|12151929|FG002|NOT COMPLETED|Overall Study||0
10977513|NCT00571493|12151930|FG003|NOT COMPLETED|Overall Study||0
10977514|NCT00571493|12151931|FG004|NOT COMPLETED|Overall Study||0
10977515|NCT00571493|12151932|FG005|NOT COMPLETED|Overall Study||0
10977516|NCT00571493|12151933|FG006|NOT COMPLETED|Overall Study||0
10977517|NCT00571519|12151948|FG000|STARTED|Overall Study||3
10977518|NCT00571519|12151949|FG001|STARTED|Overall Study||9
10977519|NCT00571519|12151950|FG002|STARTED|Overall Study||12
10977520|NCT00571519|12151951|FG003|STARTED|Overall Study||27
10977521|NCT00571519|12151952|FG004|STARTED|Overall Study||9
10977522|NCT00571519|12151953|FG005|STARTED|Overall Study||10
10977523|NCT00571519|12151954|FG006|STARTED|Overall Study||24
10977524|NCT00571519|12151948|FG000|COMPLETED|Overall Study||0
10977525|NCT00571519|12151949|FG001|COMPLETED|Overall Study||0
10977526|NCT00571519|12151950|FG002|COMPLETED|Overall Study||0
10977527|NCT00571519|12151951|FG003|COMPLETED|Overall Study||0
10977528|NCT00571519|12151952|FG004|COMPLETED|Overall Study||0
10977529|NCT00571519|12151953|FG005|COMPLETED|Overall Study||0
10977530|NCT00571519|12151954|FG006|COMPLETED|Overall Study||0
10977531|NCT00571519|12151948|FG000|NOT COMPLETED|Overall Study||3
10977532|NCT00571519|12151949|FG001|NOT COMPLETED|Overall Study||9
10977533|NCT00571519|12151950|FG002|NOT COMPLETED|Overall Study||12
10977534|NCT00571519|12151951|FG003|NOT COMPLETED|Overall Study||27
10977535|NCT00571519|12151952|FG004|NOT COMPLETED|Overall Study||9
10977536|NCT00571519|12151953|FG005|NOT COMPLETED|Overall Study||10
10977537|NCT00571519|12151954|FG006|NOT COMPLETED|Overall Study||24
10977538|NCT00571649|12151972|FG000|STARTED|Treatment Period||4050
10977539|NCT00571649|12151973|FG001|STARTED|Treatment Period||4051
10977540|NCT00571649|12151972|FG000|Participants Received Treatment|Treatment Period||3997
10977541|NCT00571649|12151973|FG001|Participants Received Treatment|Treatment Period||4001
10977542|NCT00571649|12151972|FG000|Day 10|Treatment Period||3454
10977543|NCT00571649|12151973|FG001|Day 10|Treatment Period||3499
10977544|NCT00571649|12151972|FG000|Day 35|Treatment Period||3033
10977545|NCT00571649|12151973|FG001|Day 35|Treatment Period||3115
10977546|NCT00571649|12151972|FG000|COMPLETED|Treatment Period||2958
10977547|NCT00571649|12151973|FG001|COMPLETED|Treatment Period||3047
10977548|NCT00571649|12151972|FG000|NOT COMPLETED|Treatment Period||1092
10977549|NCT00571649|12151973|FG001|NOT COMPLETED|Treatment Period||1004
10977550|NCT00571649|12151972|FG000|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
10977551|NCT00571649|12151973|FG001|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
10977552|NCT00571649|12151972|FG000|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
10977553|NCT00571649|12151973|FG001|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
10977554|NCT00571649|12151972|FG000|NOT COMPLETED|Follow-up Period||545
10977555|NCT00571649|12151973|FG001|NOT COMPLETED|Follow-up Period||528
10977556|NCT00571662|12151979|FG000|STARTED|Overall Study||76
10977557|NCT00571662|12151979|FG000|COMPLETED|Overall Study||68
10977558|NCT00571662|12151979|FG000|NOT COMPLETED|Overall Study||8
10977559|NCT00571688|12151987|FG000|STARTED|Overall Study||25
10977560|NCT00571688|12151988|FG001|STARTED|Overall Study||25
10977561|NCT00571688|12151987|FG000|COMPLETED|Overall Study||20
10977562|NCT00571688|12151988|FG001|COMPLETED|Overall Study||19
10977563|NCT00571688|12151987|FG000|NOT COMPLETED|Overall Study||5
10977564|NCT00571688|12151988|FG001|NOT COMPLETED|Overall Study||6
10977565|NCT00571701|12151996|FG000|STARTED|First Intervention 12 Months||19
10977566|NCT00571701|12151997|FG001|STARTED|First Intervention 12 Months||22
10977567|NCT00571701|12151996|FG000|COMPLETED|First Intervention 12 Months||16
10977568|NCT00571701|12151997|FG001|COMPLETED|First Intervention 12 Months||21
10977569|NCT00571701|12151996|FG000|NOT COMPLETED|First Intervention 12 Months||3
10977570|NCT00571701|12151997|FG001|NOT COMPLETED|First Intervention 12 Months||1
10977571|NCT00571701|12151996|FG000|STARTED|Second Intervention 12 Months||16
10977572|NCT00571701|12151997|FG001|STARTED|Second Intervention 12 Months||21
10977573|NCT00571701|12151996|FG000|COMPLETED|Second Intervention 12 Months||13
10977574|NCT00571701|12151997|FG001|COMPLETED|Second Intervention 12 Months||20
10977575|NCT00571701|12151996|FG000|NOT COMPLETED|Second Intervention 12 Months||3
10977576|NCT00571701|12151997|FG001|NOT COMPLETED|Second Intervention 12 Months||1
10977577|NCT00571948|12152023|FG000|STARTED|Overall Study||66
10977578|NCT00571948|12152024|FG001|STARTED|Overall Study||66
10977579|NCT00571948|12152023|FG000|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
10977580|NCT00571948|12152024|FG001|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
10977581|NCT00571948|12152023|FG000|NOT COMPLETED|Overall Study||11
10977582|NCT00571948|12152024|FG001|NOT COMPLETED|Overall Study||14
10977583|NCT00571961|12152030|FG000|STARTED|Overall Study||12
10977584|NCT00571961|12152030|FG000|COMPLETED|Overall Study||12
10977585|NCT00571961|12152030|FG000|NOT COMPLETED|Overall Study||0
10977586|NCT00571974|12152036|FG000|STARTED|Phase I||9
10977587|NCT00571974|12152037|FG001|STARTED|Phase I||0
10977588|NCT00571974|12152036|FG000|COMPLETED|Phase I||9
10977589|NCT00571974|12152037|FG001|COMPLETED|Phase I||0
10977590|NCT00571974|12152036|FG000|NOT COMPLETED|Phase I||0
10977591|NCT00571974|12152037|FG001|NOT COMPLETED|Phase I||0
10977592|NCT00571974|12152036|FG000|STARTED|Phase II||0
10977593|NCT00571974|12152037|FG001|STARTED|Phase II|3 participants are from phase I|21
10977594|NCT00571974|12152036|FG000|COMPLETED|Phase II||0
10977595|NCT00571974|12152037|FG001|COMPLETED|Phase II||17
10977596|NCT00571974|12152036|FG000|NOT COMPLETED|Phase II||0
10977597|NCT00571974|12152037|FG001|NOT COMPLETED|Phase II||4
10977598|NCT00571987|12152043|FG000|STARTED|Overall Study||107
10977599|NCT00571987|12152043|FG000|COMPLETED|Overall Study||100
10977600|NCT00571987|12152043|FG000|NOT COMPLETED|Overall Study||7
10977601|NCT00572039|12152050|FG000|STARTED|Overall Study||121
10977602|NCT00572039|12152051|FG001|STARTED|Overall Study||120
10977603|NCT00572039|12152050|FG000|COMPLETED|Overall Study||105
10977604|NCT00572039|12152051|FG001|COMPLETED|Overall Study||110
10977605|NCT00572039|12152050|FG000|NOT COMPLETED|Overall Study||16
10977606|NCT00572039|12152051|FG001|NOT COMPLETED|Overall Study||10
10977607|NCT00572117|12152061|FG000|STARTED|Overall Study||5
10977608|NCT00572117|12152062|FG001|STARTED|Overall Study||7
10977609|NCT00572117|12152061|FG000|COMPLETED|Overall Study||3
10977610|NCT00572117|12152062|FG001|COMPLETED|Overall Study||5
10977611|NCT00572117|12152061|FG000|NOT COMPLETED|Overall Study||2
10977612|NCT00572117|12152062|FG001|NOT COMPLETED|Overall Study||2
10977613|NCT00572156|12152074|FG000|STARTED|Overall Study||26
10977614|NCT00572156|12152075|FG001|STARTED|Overall Study||27
10977615|NCT00572156|12152076|FG002|STARTED|Overall Study||27
10977616|NCT00572156|12152077|FG003|STARTED|Overall Study||26
10977617|NCT00572156|12152074|FG000|COMPLETED|Overall Study||0
10977618|NCT00572156|12152075|FG001|COMPLETED|Overall Study||1
10977619|NCT00572156|12152076|FG002|COMPLETED|Overall Study||0
10977620|NCT00572156|12152077|FG003|COMPLETED|Overall Study||1
10977621|NCT00572156|12152074|FG000|NOT COMPLETED|Overall Study||26
10977622|NCT00572156|12152075|FG001|NOT COMPLETED|Overall Study||26
10977623|NCT00572156|12152076|FG002|NOT COMPLETED|Overall Study||27
10977624|NCT00572156|12152077|FG003|NOT COMPLETED|Overall Study||25
10977625|NCT00572195|12152087|FG000|STARTED|Overall Study||230
10977626|NCT00572195|12152087|FG000|COMPLETED|Overall Study||162
10977627|NCT00572195|12152087|FG000|NOT COMPLETED|Overall Study||68
10977628|NCT00572234|12152093|FG000|STARTED|Overall Study||19
10977629|NCT00572234|12152094|FG001|STARTED|Overall Study||21
10977630|NCT00572234|12152093|FG000|COMPLETED|Overall Study||18
10977631|NCT00572234|12152094|FG001|COMPLETED|Overall Study||16
10977632|NCT00572234|12152093|FG000|NOT COMPLETED|Overall Study||1
10977633|NCT00572234|12152094|FG001|NOT COMPLETED|Overall Study||5
10977634|NCT00572455|12152114|FG000|STARTED|Stage I (14 Days)||9
10977635|NCT00572455|12152115|FG001|STARTED|Stage I (14 Days)||9
10977636|NCT00572455|12152116|FG002|STARTED|Stage I (14 Days)||9
10977637|NCT00572455|12152117|FG003|STARTED|Stage I (14 Days)||10
10977638|NCT00572455|12152118|FG004|STARTED|Stage I (14 Days)||9
10977639|NCT00572455|12152119|FG005|STARTED|Stage I (14 Days)||9
10977640|NCT00572455|12152120|FG006|STARTED|Stage I (14 Days)||12
10977641|NCT00572455|12152121|FG007|STARTED|Stage I (14 Days)||0
10977642|NCT00572455|12152122|FG008|STARTED|Stage I (14 Days)||0
10977643|NCT00572455|12152123|FG009|STARTED|Stage I (14 Days)||0
10977644|NCT00572455|12152124|FG010|STARTED|Stage I (14 Days)||0
10977645|NCT00572455|12152125|FG011|STARTED|Stage I (14 Days)||0
10977646|NCT00572455|12152126|FG012|STARTED|Stage I (14 Days)||0
10977647|NCT00572455|12152127|FG013|STARTED|Stage I (14 Days)||0
10977648|NCT00572455|12152114|FG000|COMPLETED|Stage I (14 Days)||9
10977649|NCT00572455|12152115|FG001|COMPLETED|Stage I (14 Days)||9
10977650|NCT00572455|12152116|FG002|COMPLETED|Stage I (14 Days)||9
10977651|NCT00572455|12152117|FG003|COMPLETED|Stage I (14 Days)||10
10977652|NCT00572455|12152118|FG004|COMPLETED|Stage I (14 Days)||8
10977653|NCT00572455|12152119|FG005|COMPLETED|Stage I (14 Days)||6
10977654|NCT00572455|12152120|FG006|COMPLETED|Stage I (14 Days)||12
10977655|NCT00572455|12152121|FG007|COMPLETED|Stage I (14 Days)||0
10977656|NCT00572455|12152122|FG008|COMPLETED|Stage I (14 Days)||0
10977657|NCT00572455|12152123|FG009|COMPLETED|Stage I (14 Days)||0
10977658|NCT00572455|12152124|FG010|COMPLETED|Stage I (14 Days)||0
10977659|NCT00572455|12152125|FG011|COMPLETED|Stage I (14 Days)||0
10977660|NCT00572455|12152126|FG012|COMPLETED|Stage I (14 Days)||0
10977661|NCT00572455|12152127|FG013|COMPLETED|Stage I (14 Days)||0
10977662|NCT00572455|12152114|FG000|NOT COMPLETED|Stage I (14 Days)||0
10977663|NCT00572455|12152115|FG001|NOT COMPLETED|Stage I (14 Days)||0
10977664|NCT00572455|12152116|FG002|NOT COMPLETED|Stage I (14 Days)||0
10977665|NCT00572455|12152117|FG003|NOT COMPLETED|Stage I (14 Days)||0
10977666|NCT00572455|12152118|FG004|NOT COMPLETED|Stage I (14 Days)||1
10977667|NCT00572455|12152119|FG005|NOT COMPLETED|Stage I (14 Days)||3
10977668|NCT00572455|12152120|FG006|NOT COMPLETED|Stage I (14 Days)||0
10977669|NCT00572455|12152121|FG007|NOT COMPLETED|Stage I (14 Days)||0
10977670|NCT00572455|12152122|FG008|NOT COMPLETED|Stage I (14 Days)||0
10977671|NCT00572455|12152123|FG009|NOT COMPLETED|Stage I (14 Days)||0
10977672|NCT00572455|12152124|FG010|NOT COMPLETED|Stage I (14 Days)||0
10977673|NCT00572455|12152125|FG011|NOT COMPLETED|Stage I (14 Days)||0
10977674|NCT00572455|12152126|FG012|NOT COMPLETED|Stage I (14 Days)||0
10977675|NCT00572455|12152127|FG013|NOT COMPLETED|Stage I (14 Days)||0
10977676|NCT00572455|12152114|FG000|STARTED|Stage II (28 Days)||0
10977677|NCT00572455|12152115|FG001|STARTED|Stage II (28 Days)||0
10977678|NCT00572455|12152116|FG002|STARTED|Stage II (28 Days)||0
10977679|NCT00572455|12152117|FG003|STARTED|Stage II (28 Days)||0
10977680|NCT00572455|12152118|FG004|STARTED|Stage II (28 Days)||0
10977681|NCT00572455|12152119|FG005|STARTED|Stage II (28 Days)||0
10977682|NCT00572455|12152120|FG006|STARTED|Stage II (28 Days)||0
10977683|NCT00572455|12152121|FG007|STARTED|Stage II (28 Days)||35
10977684|NCT00572455|12152122|FG008|STARTED|Stage II (28 Days)||36
10977685|NCT00572455|12152123|FG009|STARTED|Stage II (28 Days)||36
10977686|NCT00572455|12152124|FG010|STARTED|Stage II (28 Days)||36
10977687|NCT00572455|12152125|FG011|STARTED|Stage II (28 Days)||36
10977688|NCT00572455|12152126|FG012|STARTED|Stage II (28 Days)||36
10977689|NCT00572455|12152127|FG013|STARTED|Stage II (28 Days)||36
10977690|NCT00572455|12152114|FG000|Treated|Stage II (28 Days)||0
10977691|NCT00572455|12152115|FG001|Treated|Stage II (28 Days)||0
10977692|NCT00572455|12152116|FG002|Treated|Stage II (28 Days)||0
10977693|NCT00572455|12152117|FG003|Treated|Stage II (28 Days)||0
10977694|NCT00572455|12152118|FG004|Treated|Stage II (28 Days)||0
10977695|NCT00572455|12152119|FG005|Treated|Stage II (28 Days)||0
10977696|NCT00572455|12152120|FG006|Treated|Stage II (28 Days)||0
10977697|NCT00572455|12152121|FG007|Treated|Stage II (28 Days)||35
10977698|NCT00572455|12152122|FG008|Treated|Stage II (28 Days)||36
10977699|NCT00572455|12152123|FG009|Treated|Stage II (28 Days)||36
10977700|NCT00572455|12152124|FG010|Treated|Stage II (28 Days)||36
10977701|NCT00572455|12152125|FG011|Treated|Stage II (28 Days)||36
10977702|NCT00572455|12152126|FG012|Treated|Stage II (28 Days)||36
10977703|NCT00572455|12152127|FG013|Treated|Stage II (28 Days)||35
10977704|NCT00572455|12152114|FG000|COMPLETED|Stage II (28 Days)||0
10977705|NCT00572455|12152115|FG001|COMPLETED|Stage II (28 Days)||0
10977706|NCT00572455|12152116|FG002|COMPLETED|Stage II (28 Days)||0
10977707|NCT00572455|12152117|FG003|COMPLETED|Stage II (28 Days)||0
10977708|NCT00572455|12152118|FG004|COMPLETED|Stage II (28 Days)||0
10977709|NCT00572455|12152119|FG005|COMPLETED|Stage II (28 Days)||0
10977710|NCT00572455|12152120|FG006|COMPLETED|Stage II (28 Days)||0
10977711|NCT00572455|12152121|FG007|COMPLETED|Stage II (28 Days)||34
10977712|NCT00572455|12152122|FG008|COMPLETED|Stage II (28 Days)||33
10977713|NCT00572455|12152123|FG009|COMPLETED|Stage II (28 Days)||33
10977714|NCT00572455|12152124|FG010|COMPLETED|Stage II (28 Days)||31
10977715|NCT00572455|12152125|FG011|COMPLETED|Stage II (28 Days)||32
10977716|NCT00572455|12152126|FG012|COMPLETED|Stage II (28 Days)||31
10977717|NCT00572455|12152127|FG013|COMPLETED|Stage II (28 Days)||34
10977718|NCT00572455|12152114|FG000|NOT COMPLETED|Stage II (28 Days)||0
10977719|NCT00572455|12152115|FG001|NOT COMPLETED|Stage II (28 Days)||0
10977720|NCT00572455|12152116|FG002|NOT COMPLETED|Stage II (28 Days)||0
10977721|NCT00572455|12152117|FG003|NOT COMPLETED|Stage II (28 Days)||0
10977722|NCT00572455|12152118|FG004|NOT COMPLETED|Stage II (28 Days)||0
10977723|NCT00572455|12152119|FG005|NOT COMPLETED|Stage II (28 Days)||0
10977724|NCT00572455|12152120|FG006|NOT COMPLETED|Stage II (28 Days)||0
10977725|NCT00572455|12152121|FG007|NOT COMPLETED|Stage II (28 Days)||1
10977726|NCT00572455|12152122|FG008|NOT COMPLETED|Stage II (28 Days)||3
10977727|NCT00572455|12152123|FG009|NOT COMPLETED|Stage II (28 Days)||3
10977728|NCT00572455|12152124|FG010|NOT COMPLETED|Stage II (28 Days)||5
10977729|NCT00572455|12152125|FG011|NOT COMPLETED|Stage II (28 Days)||4
10977730|NCT00572455|12152126|FG012|NOT COMPLETED|Stage II (28 Days)||5
10977731|NCT00572455|12152127|FG013|NOT COMPLETED|Stage II (28 Days)||2
10977732|NCT00572468|12152159|FG000|STARTED|Overall Study||22
10977733|NCT00572468|12152160|FG001|STARTED|Overall Study||20
10977734|NCT00572468|12152159|FG000|COMPLETED|Overall Study||20
10977735|NCT00572468|12152160|FG001|COMPLETED|Overall Study||16
10977736|NCT00572468|12152159|FG000|NOT COMPLETED|Overall Study||2
10977737|NCT00572468|12152160|FG001|NOT COMPLETED|Overall Study||4
10977738|NCT00572533|12152168|FG000|STARTED|Overall Study||31
10977739|NCT00572533|12152169|FG001|STARTED|Overall Study||31
10977740|NCT00572533|12152168|FG000|COMPLETED|Overall Study||24
10977741|NCT00572533|12152169|FG001|COMPLETED|Overall Study||28
10977742|NCT00572533|12152168|FG000|NOT COMPLETED|Overall Study||7
10977743|NCT00572533|12152169|FG001|NOT COMPLETED|Overall Study||3
10977744|NCT00572572|12152177|FG000|STARTED|Overall Study||35
10977745|NCT00572572|12152178|FG001|STARTED|Overall Study||34
10977746|NCT00572572|12152177|FG000|COMPLETED|Overall Study||32
10977747|NCT00572572|12152178|FG001|COMPLETED|Overall Study||28
10977748|NCT00572572|12152177|FG000|NOT COMPLETED|Overall Study||3
10977749|NCT00572572|12152178|FG001|NOT COMPLETED|Overall Study||6
10977750|NCT00572624|12152186|FG000|STARTED|Overall Study||37
10977751|NCT00572624|12152187|FG001|STARTED|Overall Study||14
10977752|NCT00572624|12152186|FG000|COMPLETED|Overall Study||20
10977753|NCT00572624|12152187|FG001|COMPLETED|Overall Study||10
10977754|NCT00572624|12152186|FG000|NOT COMPLETED|Overall Study||17
10977755|NCT00572624|12152187|FG001|NOT COMPLETED|Overall Study||4
10977756|NCT00572728|12152193|FG000|STARTED|Overall Study|Registered|90
10977757|NCT00572728|12152193|FG000|Eligible|Overall Study||87
10977758|NCT00572728|12152193|FG000|Enrolled Under Amendment 5 or Later|Overall Study||82
10977759|NCT00572728|12152193|FG000|Did Not Withdraw|Overall Study||72
10977760|NCT00572728|12152193|FG000|On Study|Overall Study||71
10977761|NCT00572728|12152193|FG000|Completed FLT1 Scan|Overall Study||67
10977762|NCT00572728|12152193|FG000|First Therapy Initiated|Overall Study||65
10977763|NCT00572728|12152193|FG000|Completed FLT2 Scan|Overall Study||60
10977764|NCT00572728|12152193|FG000|Second Chemotherapy Initiated|Overall Study||59
10977765|NCT00572728|12152193|FG000|Second Chemotherapy Initiated After FLT2|Overall Study||52
10977766|NCT00572728|12152193|FG000|Pathology Complete|Overall Study||51
10977767|NCT00572728|12152193|FG000|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
10977768|NCT00572728|12152193|FG000|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
10977769|NCT00572728|12152193|FG000|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
10977770|NCT00572728|12152193|FG000|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
10977771|NCT00572728|12152193|FG000|NOT COMPLETED|Overall Study||39
10977772|NCT00572832|12152201|FG000|STARTED|Overall Study||100
10977773|NCT00572832|12152202|FG001|STARTED|Overall Study||100
10977774|NCT00572832|12152201|FG000|COMPLETED|Overall Study||100
10977775|NCT00572832|12152202|FG001|COMPLETED|Overall Study||88
10977776|NCT00572832|12152201|FG000|NOT COMPLETED|Overall Study||0
10977777|NCT00572832|12152202|FG001|NOT COMPLETED|Overall Study||12
10977778|NCT00572897|12152210|FG000|STARTED|Overall Study||32
10977779|NCT00572897|12152211|FG001|STARTED|Overall Study||34
10977780|NCT00572897|12152210|FG000|COMPLETED|Overall Study||32
10977781|NCT00572897|12152211|FG001|COMPLETED|Overall Study||34
10977782|NCT00572897|12152210|FG000|NOT COMPLETED|Overall Study||0
10977783|NCT00572897|12152211|FG001|NOT COMPLETED|Overall Study||0
10977784|NCT00572910|12152223|FG000|STARTED|Overall Study||19
10977785|NCT00572910|12152224|FG001|STARTED|Overall Study||18
10977786|NCT00572910|12152225|FG002|STARTED|Overall Study||19
10977787|NCT00572910|12152226|FG003|STARTED|Overall Study||18
10977788|NCT00572910|12152227|FG004|STARTED|Overall Study||19
10977789|NCT00572910|12152228|FG005|STARTED|Overall Study||19
10977790|NCT00572910|12152229|FG006|STARTED|Overall Study||19
10977791|NCT00572910|12152230|FG007|STARTED|Overall Study||19
10977792|NCT00572910|12152231|FG008|STARTED|Overall Study||19
10977793|NCT00572910|12152232|FG009|STARTED|Overall Study||19
10977794|NCT00572910|12152233|FG010|STARTED|Overall Study||18
10977795|NCT00572910|12152223|FG000|COMPLETED|Overall Study||15
10977796|NCT00572910|12152224|FG001|COMPLETED|Overall Study||15
10977797|NCT00572910|12152225|FG002|COMPLETED|Overall Study||17
10977798|NCT00572910|12152226|FG003|COMPLETED|Overall Study||14
10977799|NCT00572910|12152227|FG004|COMPLETED|Overall Study||17
10977800|NCT00572910|12152228|FG005|COMPLETED|Overall Study||16
10977801|NCT00572910|12152229|FG006|COMPLETED|Overall Study||15
10977802|NCT00572910|12152230|FG007|COMPLETED|Overall Study||15
10977803|NCT00572910|12152231|FG008|COMPLETED|Overall Study||16
10977804|NCT00572910|12152232|FG009|COMPLETED|Overall Study||13
10977805|NCT00572910|12152233|FG010|COMPLETED|Overall Study||15
10977806|NCT00572910|12152223|FG000|NOT COMPLETED|Overall Study||4
10977807|NCT00572910|12152224|FG001|NOT COMPLETED|Overall Study||3
10977808|NCT00572910|12152225|FG002|NOT COMPLETED|Overall Study||2
10977809|NCT00572910|12152226|FG003|NOT COMPLETED|Overall Study||4
10977810|NCT00572910|12152227|FG004|NOT COMPLETED|Overall Study||2
10977811|NCT00572910|12152228|FG005|NOT COMPLETED|Overall Study||3
10977812|NCT00572910|12152229|FG006|NOT COMPLETED|Overall Study||4
10977813|NCT00572910|12152230|FG007|NOT COMPLETED|Overall Study||4
10977814|NCT00572910|12152231|FG008|NOT COMPLETED|Overall Study||3
10977815|NCT00572910|12152232|FG009|NOT COMPLETED|Overall Study||6
10977816|NCT00572910|12152233|FG010|NOT COMPLETED|Overall Study||3
10977817|NCT00572936|12152268|FG000|STARTED|First Intervention||4
10977818|NCT00572936|12152269|FG001|STARTED|First Intervention||4
10977819|NCT00572936|12152270|FG002|STARTED|First Intervention||5
10977820|NCT00572936|12152271|FG003|STARTED|First Intervention||5
10977821|NCT00572936|12152272|FG004|STARTED|First Intervention||5
10977822|NCT00572936|12152273|FG005|STARTED|First Intervention||5
10977823|NCT00572936|12152268|FG000|COMPLETED|First Intervention||4
10977824|NCT00572936|12152269|FG001|COMPLETED|First Intervention||4
10977825|NCT00572936|12152270|FG002|COMPLETED|First Intervention||5
10977826|NCT00572936|12152271|FG003|COMPLETED|First Intervention||5
10977827|NCT00572936|12152272|FG004|COMPLETED|First Intervention||5
10977828|NCT00572936|12152273|FG005|COMPLETED|First Intervention||5
10977829|NCT00572936|12152268|FG000|NOT COMPLETED|First Intervention||0
10977830|NCT00572936|12152269|FG001|NOT COMPLETED|First Intervention||0
10977831|NCT00572936|12152270|FG002|NOT COMPLETED|First Intervention||0
10977832|NCT00572936|12152271|FG003|NOT COMPLETED|First Intervention||0
10977833|NCT00572936|12152272|FG004|NOT COMPLETED|First Intervention||0
10977834|NCT00572936|12152273|FG005|NOT COMPLETED|First Intervention||0
10977835|NCT00572936|12152268|FG000|STARTED|Second Intervention||4
10977836|NCT00572936|12152269|FG001|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
10977837|NCT00572936|12152270|FG002|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
10977838|NCT00572936|12152271|FG003|STARTED|Second Intervention||5
10977839|NCT00572936|12152272|FG004|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
10977840|NCT00572936|12152273|FG005|STARTED|Second Intervention||5
10977841|NCT00572936|12152268|FG000|COMPLETED|Second Intervention||4
10977842|NCT00572936|12152269|FG001|COMPLETED|Second Intervention||3
10977843|NCT00572936|12152270|FG002|COMPLETED|Second Intervention||4
10977844|NCT00572936|12152271|FG003|COMPLETED|Second Intervention||5
10977845|NCT00572936|12152272|FG004|COMPLETED|Second Intervention||4
10977846|NCT00572936|12152273|FG005|COMPLETED|Second Intervention||5
10977847|NCT00572936|12152268|FG000|NOT COMPLETED|Second Intervention||0
10977848|NCT00572936|12152269|FG001|NOT COMPLETED|Second Intervention||0
10977849|NCT00572936|12152270|FG002|NOT COMPLETED|Second Intervention||0
10977850|NCT00572936|12152271|FG003|NOT COMPLETED|Second Intervention||0
10977851|NCT00572936|12152272|FG004|NOT COMPLETED|Second Intervention||0
10977852|NCT00572936|12152273|FG005|NOT COMPLETED|Second Intervention||0
10977853|NCT00572936|12152268|FG000|STARTED|Third Intervention||4
10977854|NCT00572936|12152269|FG001|STARTED|Third Intervention||3
10977855|NCT00572936|12152270|FG002|STARTED|Third Intervention||4
10977856|NCT00572936|12152271|FG003|STARTED|Third Intervention||5
10977857|NCT00572936|12152272|FG004|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
10977858|NCT00572936|12152273|FG005|STARTED|Third Intervention||5
10977859|NCT00572936|12152268|FG000|COMPLETED|Third Intervention||4
10977860|NCT00572936|12152269|FG001|COMPLETED|Third Intervention||3
10977861|NCT00572936|12152270|FG002|COMPLETED|Third Intervention||4
10977862|NCT00572936|12152271|FG003|COMPLETED|Third Intervention||5
10977863|NCT00572936|12152272|FG004|COMPLETED|Third Intervention||3
10977864|NCT00572936|12152273|FG005|COMPLETED|Third Intervention||5
10977865|NCT00572936|12152268|FG000|NOT COMPLETED|Third Intervention||0
10977866|NCT00572936|12152269|FG001|NOT COMPLETED|Third Intervention||0
10977867|NCT00572936|12152270|FG002|NOT COMPLETED|Third Intervention||0
10977868|NCT00572936|12152271|FG003|NOT COMPLETED|Third Intervention||0
10977869|NCT00572936|12152272|FG004|NOT COMPLETED|Third Intervention||0
10977870|NCT00572936|12152273|FG005|NOT COMPLETED|Third Intervention||0
10977871|NCT00573066|12152281|FG000|STARTED|Overall Study||56
10977872|NCT00573066|12152281|FG000|COMPLETED|Overall Study||36
10977873|NCT00573066|12152281|FG000|NOT COMPLETED|Overall Study||20
10977874|NCT00573144|12152287|FG000|STARTED|Overall Study||30
10977875|NCT00573144|12152288|FG001|STARTED|Overall Study||28
10977876|NCT00573144|12152287|FG000|COMPLETED|Overall Study||28
10977877|NCT00573144|12152288|FG001|COMPLETED|Overall Study||25
10977878|NCT00573144|12152287|FG000|NOT COMPLETED|Overall Study||2
10977879|NCT00573144|12152288|FG001|NOT COMPLETED|Overall Study||3
10977880|NCT00573170|12152294|FG000|STARTED|First Treatment Period||64
10977881|NCT00573170|12152295|FG001|STARTED|First Treatment Period||60
10977882|NCT00573170|12152296|FG002|STARTED|First Treatment Period||60
10977883|NCT00573170|12152297|FG003|STARTED|First Treatment Period||66
10977884|NCT00573170|12152298|FG004|STARTED|First Treatment Period||63
10977885|NCT00573170|12152299|FG005|STARTED|First Treatment Period||62
10977886|NCT00573170|12152294|FG000|COMPLETED|First Treatment Period||64
10977887|NCT00573170|12152295|FG001|COMPLETED|First Treatment Period||60
10977888|NCT00573170|12152296|FG002|COMPLETED|First Treatment Period||60
10977889|NCT00573170|12152297|FG003|COMPLETED|First Treatment Period||66
10977890|NCT00573170|12152298|FG004|COMPLETED|First Treatment Period||62
10977891|NCT00573170|12152299|FG005|COMPLETED|First Treatment Period||62
10977892|NCT00573170|12152294|FG000|NOT COMPLETED|First Treatment Period||0
10977893|NCT00573170|12152295|FG001|NOT COMPLETED|First Treatment Period||0
10977894|NCT00573170|12152296|FG002|NOT COMPLETED|First Treatment Period||0
10977895|NCT00573170|12152297|FG003|NOT COMPLETED|First Treatment Period||0
10977896|NCT00573170|12152298|FG004|NOT COMPLETED|First Treatment Period||1
10977897|NCT00573170|12152299|FG005|NOT COMPLETED|First Treatment Period||0
10977898|NCT00573170|12152294|FG000|STARTED|First Washout Period||64
10977899|NCT00573170|12152295|FG001|STARTED|First Washout Period||60
10977900|NCT00573170|12152296|FG002|STARTED|First Washout Period||60
10977901|NCT00573170|12152297|FG003|STARTED|First Washout Period||66
10977902|NCT00573170|12152298|FG004|STARTED|First Washout Period||62
10977903|NCT00573170|12152299|FG005|STARTED|First Washout Period||62
10977904|NCT00573170|12152294|FG000|COMPLETED|First Washout Period||56
10977905|NCT00573170|12152295|FG001|COMPLETED|First Washout Period||58
10977906|NCT00573170|12152296|FG002|COMPLETED|First Washout Period||59
10977907|NCT00573170|12152297|FG003|COMPLETED|First Washout Period||61
10977908|NCT00573170|12152298|FG004|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
10977909|NCT00573170|12152299|FG005|COMPLETED|First Washout Period||55
10977910|NCT00573170|12152294|FG000|NOT COMPLETED|First Washout Period||8
10977911|NCT00573170|12152295|FG001|NOT COMPLETED|First Washout Period||2
10977912|NCT00573170|12152296|FG002|NOT COMPLETED|First Washout Period||1
10977913|NCT00573170|12152297|FG003|NOT COMPLETED|First Washout Period||5
10977914|NCT00573170|12152298|FG004|NOT COMPLETED|First Washout Period||3
10977915|NCT00573170|12152299|FG005|NOT COMPLETED|First Washout Period||7
10977916|NCT00573170|12152294|FG000|STARTED|Second Treatment Period||56
10977917|NCT00573170|12152295|FG001|STARTED|Second Treatment Period||58
10977918|NCT00573170|12152296|FG002|STARTED|Second Treatment Period||59
10977919|NCT00573170|12152297|FG003|STARTED|Second Treatment Period||61
10977920|NCT00573170|12152298|FG004|STARTED|Second Treatment Period||59
10977921|NCT00573170|12152299|FG005|STARTED|Second Treatment Period||55
10977922|NCT00573170|12152294|FG000|COMPLETED|Second Treatment Period||56
10977923|NCT00573170|12152295|FG001|COMPLETED|Second Treatment Period||58
10977924|NCT00573170|12152296|FG002|COMPLETED|Second Treatment Period||59
10977925|NCT00573170|12152297|FG003|COMPLETED|Second Treatment Period||61
10977926|NCT00573170|12152298|FG004|COMPLETED|Second Treatment Period||59
10977927|NCT00573170|12152299|FG005|COMPLETED|Second Treatment Period||55
10977928|NCT00573170|12152294|FG000|NOT COMPLETED|Second Treatment Period||0
10977929|NCT00573170|12152295|FG001|NOT COMPLETED|Second Treatment Period||0
10977930|NCT00573170|12152296|FG002|NOT COMPLETED|Second Treatment Period||0
10977931|NCT00573170|12152297|FG003|NOT COMPLETED|Second Treatment Period||0
10977932|NCT00573170|12152298|FG004|NOT COMPLETED|Second Treatment Period||0
10977933|NCT00573170|12152299|FG005|NOT COMPLETED|Second Treatment Period||0
10977934|NCT00573170|12152294|FG000|STARTED|Second Washout Period||56
10977935|NCT00573170|12152295|FG001|STARTED|Second Washout Period||58
10977936|NCT00573170|12152296|FG002|STARTED|Second Washout Period||59
10977937|NCT00573170|12152297|FG003|STARTED|Second Washout Period||61
10977938|NCT00573170|12152298|FG004|STARTED|Second Washout Period||59
10977939|NCT00573170|12152299|FG005|STARTED|Second Washout Period||55
10977940|NCT00573170|12152294|FG000|COMPLETED|Second Washout Period||51
10977941|NCT00573170|12152295|FG001|COMPLETED|Second Washout Period||54
10977942|NCT00573170|12152296|FG002|COMPLETED|Second Washout Period||55
10977943|NCT00573170|12152297|FG003|COMPLETED|Second Washout Period||56
10977944|NCT00573170|12152298|FG004|COMPLETED|Second Washout Period||51
10977945|NCT00573170|12152299|FG005|COMPLETED|Second Washout Period||53
10977946|NCT00573170|12152294|FG000|NOT COMPLETED|Second Washout Period||5
10977947|NCT00573170|12152295|FG001|NOT COMPLETED|Second Washout Period||4
10977948|NCT00573170|12152296|FG002|NOT COMPLETED|Second Washout Period||4
10977949|NCT00573170|12152297|FG003|NOT COMPLETED|Second Washout Period||5
10977950|NCT00573170|12152298|FG004|NOT COMPLETED|Second Washout Period||8
10977951|NCT00573170|12152299|FG005|NOT COMPLETED|Second Washout Period||2
10977952|NCT00573170|12152294|FG000|STARTED|Third Treatment Period||51
10977953|NCT00573170|12152295|FG001|STARTED|Third Treatment Period||54
10977954|NCT00573170|12152296|FG002|STARTED|Third Treatment Period||55
10977955|NCT00573170|12152297|FG003|STARTED|Third Treatment Period||56
10977956|NCT00573170|12152298|FG004|STARTED|Third Treatment Period||51
10977957|NCT00573170|12152299|FG005|STARTED|Third Treatment Period||53
10977958|NCT00573170|12152294|FG000|COMPLETED|Third Treatment Period||50
10977959|NCT00573170|12152295|FG001|COMPLETED|Third Treatment Period||54
10977960|NCT00573170|12152296|FG002|COMPLETED|Third Treatment Period||55
10977961|NCT00573170|12152297|FG003|COMPLETED|Third Treatment Period||56
10977962|NCT00573170|12152298|FG004|COMPLETED|Third Treatment Period||51
10977963|NCT00573170|12152299|FG005|COMPLETED|Third Treatment Period||51
10977964|NCT00573170|12152294|FG000|NOT COMPLETED|Third Treatment Period||1
10977965|NCT00573170|12152295|FG001|NOT COMPLETED|Third Treatment Period||0
10977966|NCT00573170|12152296|FG002|NOT COMPLETED|Third Treatment Period||0
10977967|NCT00573170|12152297|FG003|NOT COMPLETED|Third Treatment Period||0
10977968|NCT00573170|12152298|FG004|NOT COMPLETED|Third Treatment Period||0
10977969|NCT00573170|12152299|FG005|NOT COMPLETED|Third Treatment Period||2
10977970|NCT00573183|12152318|FG000|STARTED|Overall Study||234
10977971|NCT00573183|12152319|FG001|STARTED|Overall Study||237
10977972|NCT00573183|12152318|FG000|COMPLETED|Overall Study||162
10977973|NCT00573183|12152319|FG001|COMPLETED|Overall Study||174
10977974|NCT00573183|12152318|FG000|NOT COMPLETED|Overall Study||72
10977975|NCT00573183|12152319|FG001|NOT COMPLETED|Overall Study||63
10977976|NCT00573248|12152329|FG000|STARTED|Overall Study||40
10977977|NCT00573248|12152330|FG001|STARTED|Overall Study||38
10977978|NCT00573248|12152329|FG000|Nicotine Patches and Placebo Patches|Overall Study||25
10977979|NCT00573248|12152330|FG001|Nicotine Patches and Placebo Patches|Overall Study||27
10977980|NCT00573248|12152329|FG000|COMPLETED|Overall Study||25
10977981|NCT00573248|12152330|FG001|COMPLETED|Overall Study||27
10977982|NCT00573248|12152329|FG000|NOT COMPLETED|Overall Study||15
10977983|NCT00573248|12152330|FG001|NOT COMPLETED|Overall Study||11
10977984|NCT00573261|12152338|FG000|STARTED|Overall Study||20
10977985|NCT00573261|12152339|FG001|STARTED|Overall Study||20
10977986|NCT00573261|12152338|FG000|COMPLETED|Overall Study||14
10977987|NCT00573261|12152339|FG001|COMPLETED|Overall Study||15
10977988|NCT00573261|12152338|FG000|NOT COMPLETED|Overall Study||6
10977989|NCT00573261|12152339|FG001|NOT COMPLETED|Overall Study||5
10977990|NCT00573287|12152349|FG000|STARTED|Overall Study||7
10977991|NCT00573287|12152350|FG001|STARTED|Overall Study||7
10977992|NCT00573287|12152349|FG000|COMPLETED|Overall Study||3
10977993|NCT00573287|12152350|FG001|COMPLETED|Overall Study||4
10977994|NCT00573287|12152349|FG000|NOT COMPLETED|Overall Study||4
10977995|NCT00573287|12152350|FG001|NOT COMPLETED|Overall Study||3
10977996|NCT00573313|12152360|FG000|STARTED|Overall Study|Eighteen participants recruited to start.|18
10977997|NCT00573313|12152361|FG001|STARTED|Overall Study||28
10977998|NCT00573313|12152362|FG002|STARTED|Overall Study|Nineteen recruited to start.|19
10977999|NCT00573313|12152363|FG003|STARTED|Overall Study||26
10978000|NCT00573313|12152360|FG000|COMPLETED|Overall Study||13
10978001|NCT00573313|12152361|FG001|COMPLETED|Overall Study||28
10978002|NCT00573313|12152362|FG002|COMPLETED|Overall Study||13
10978003|NCT00573313|12152363|FG003|COMPLETED|Overall Study||26
10978004|NCT00573313|12152360|FG000|NOT COMPLETED|Overall Study||5
10978005|NCT00573313|12152361|FG001|NOT COMPLETED|Overall Study||0
10978006|NCT00573313|12152362|FG002|NOT COMPLETED|Overall Study||6
10978007|NCT00573313|12152363|FG003|NOT COMPLETED|Overall Study||0
10978008|NCT00573430|12152373|FG000|STARTED|Overall Study|randomized|40
10978009|NCT00573430|12152374|FG001|STARTED|Overall Study|randomized|45
10978010|NCT00573430|12152375|FG002|STARTED|Overall Study|randomized|43
10978011|NCT00573430|12152373|FG000|COMPLETED|Overall Study||39
10978012|NCT00573430|12152374|FG001|COMPLETED|Overall Study||40
10978013|NCT00573430|12152375|FG002|COMPLETED|Overall Study||33
10978014|NCT00573430|12152373|FG000|NOT COMPLETED|Overall Study||1
10978015|NCT00573430|12152374|FG001|NOT COMPLETED|Overall Study||5
10978016|NCT00573430|12152375|FG002|NOT COMPLETED|Overall Study||10
10978017|NCT00573443|12152386|FG000|STARTED|Double-Blind Phase||110
10978018|NCT00573443|12152387|FG001|STARTED|Double-Blind Phase||107
10978019|NCT00573443|12152388|FG002|STARTED|Double-Blind Phase||109
10978020|NCT00573443|12152386|FG000|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
10978021|NCT00573443|12152387|FG001|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
10978022|NCT00573443|12152388|FG002|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
10978023|NCT00573443|12152386|FG000|Subjects With PBA Secondary to MS|Double-Blind Phase||45
10978024|NCT00573443|12152387|FG001|Subjects With PBA Secondary to MS|Double-Blind Phase||39
10978025|NCT00573443|12152388|FG002|Subjects With PBA Secondary to MS|Double-Blind Phase||45
10978026|NCT00573443|12152386|FG000|COMPLETED|Double-Blind Phase||101
10978027|NCT00573443|12152387|FG001|COMPLETED|Double-Blind Phase||88
10978028|NCT00573443|12152388|FG002|COMPLETED|Double-Blind Phase||94
10978029|NCT00573443|12152386|FG000|NOT COMPLETED|Double-Blind Phase||9
10978030|NCT00573443|12152387|FG001|NOT COMPLETED|Double-Blind Phase||19
10978031|NCT00573443|12152388|FG002|NOT COMPLETED|Double-Blind Phase||15
10978032|NCT00573443|12152386|FG000|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
10978033|NCT00573443|12152387|FG001|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10978034|NCT00573443|12152388|FG002|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10978035|NCT00573443|12152386|FG000|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
10978036|NCT00573443|12152387|FG001|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10978037|NCT00573443|12152388|FG002|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10978038|NCT00573443|12152386|FG000|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
10978039|NCT00573443|12152387|FG001|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10978040|NCT00573443|12152388|FG002|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10978041|NCT00573443|12152386|FG000|COMPLETED|Open-Label Extension Phase||235
10978042|NCT00573443|12152387|FG001|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10978043|NCT00573443|12152388|FG002|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
10978044|NCT00573443|12152386|FG000|NOT COMPLETED|Open-Label Extension Phase||18
10978045|NCT00573443|12152387|FG001|NOT COMPLETED|Open-Label Extension Phase||0
10978046|NCT00573443|12152388|FG002|NOT COMPLETED|Open-Label Extension Phase||0
10978047|NCT00573469|12152400|FG000|STARTED|Overall Study||26
10978048|NCT00573469|12152401|FG001|STARTED|Overall Study||25
10978049|NCT00573469|12152402|FG002|STARTED|Overall Study||26
10978050|NCT00573469|12152400|FG000|COMPLETED|Overall Study||20
10978051|NCT00573469|12152401|FG001|COMPLETED|Overall Study||21
10978052|NCT00573469|12152402|FG002|COMPLETED|Overall Study||22
10978053|NCT00573469|12152400|FG000|NOT COMPLETED|Overall Study||6
10978054|NCT00573469|12152401|FG001|NOT COMPLETED|Overall Study||4
10978055|NCT00573469|12152402|FG002|NOT COMPLETED|Overall Study||4
10978056|NCT00573508|12152412|FG000|STARTED|Overall Study||382
10978057|NCT00573508|12152413|FG001|STARTED|Overall Study||386
10978058|NCT00573508|12152412|FG000|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
10978059|NCT00573508|12152413|FG001|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
10978060|NCT00573508|12152412|FG000|COMPLETED|Overall Study||318
10978061|NCT00573508|12152413|FG001|COMPLETED|Overall Study||345
10978062|NCT00573508|12152412|FG000|NOT COMPLETED|Overall Study||64
10978063|NCT00573508|12152413|FG001|NOT COMPLETED|Overall Study||41
10978064|NCT00573534|12152419|FG000|STARTED|Overall Study||8
10978065|NCT00573534|12152419|FG000|COMPLETED|Overall Study||5
10978066|NCT00573534|12152419|FG000|NOT COMPLETED|Overall Study||3
10978067|NCT00573755|12152426|FG000|STARTED|Overall Study||2
10978068|NCT00573755|12152427|FG001|STARTED|Overall Study||2
10978069|NCT00573755|12152426|FG000|COMPLETED|Overall Study||1
10978070|NCT00573755|12152427|FG001|COMPLETED|Overall Study||2
10978071|NCT00573755|12152426|FG000|NOT COMPLETED|Overall Study||1
10978072|NCT00573755|12152427|FG001|NOT COMPLETED|Overall Study||0
10978073|NCT00573768|12152436|FG000|STARTED|Overall Study||89
10978074|NCT00573768|12152437|FG001|STARTED|Overall Study||91
10978075|NCT00573768|12152438|FG002|STARTED|Overall Study||91
10978076|NCT00573768|12152436|FG000|COMPLETED|Overall Study||87
10978077|NCT00573768|12152437|FG001|COMPLETED|Overall Study||89
10978078|NCT00573768|12152438|FG002|COMPLETED|Overall Study||87
10978079|NCT00573768|12152436|FG000|NOT COMPLETED|Overall Study||2
10978080|NCT00573768|12152437|FG001|NOT COMPLETED|Overall Study||2
10978081|NCT00573768|12152438|FG002|NOT COMPLETED|Overall Study||4
10978082|NCT00573794|12152446|FG000|STARTED|Overall Study||585
10978083|NCT00573794|12152446|FG000|COMPLETED|Overall Study||255
10978084|NCT00573794|12152446|FG000|NOT COMPLETED|Overall Study||330
10978085|NCT00573833|12152450|FG000|STARTED|Overall Study||23
10978086|NCT00573833|12152450|FG000|COMPLETED|Overall Study||21
10978087|NCT00573833|12152450|FG000|NOT COMPLETED|Overall Study||2
10978088|NCT00573859|12152454|FG000|STARTED|Medication Versus Placebo||27
10978089|NCT00573859|12152454|FG000|COMPLETED|Medication Versus Placebo||15
10978090|NCT00573859|12152454|FG000|NOT COMPLETED|Medication Versus Placebo||12
10978091|NCT00573859|12152454|FG000|STARTED|Smoking Versus Abstinence||27
10978092|NCT00573859|12152454|FG000|COMPLETED|Smoking Versus Abstinence||15
10978093|NCT00573859|12152454|FG000|NOT COMPLETED|Smoking Versus Abstinence||12
10978094|NCT00573872|12152458|FG000|STARTED|Overall Study|# of patients that signed consent|43
10978095|NCT00573872|12152458|FG000|COMPLETED|Overall Study|# of patients that completed treatment|32
10978096|NCT00573872|12152458|FG000|NOT COMPLETED|Overall Study||11
10978097|NCT00573989|12152462|FG000|STARTED|Erlotinib Phase I||4
10978098|NCT00573989|12152463|FG001|STARTED|Erlotinib Phase I||6
10978099|NCT00573989|12152464|FG002|STARTED|Erlotinib Phase I||5
10978100|NCT00573989|12152465|FG003|STARTED|Erlotinib Phase I||0
10978101|NCT00573989|12152462|FG000|COMPLETED|Erlotinib Phase I||4
10978102|NCT00573989|12152463|FG001|COMPLETED|Erlotinib Phase I||6
10978103|NCT00573989|12152464|FG002|COMPLETED|Erlotinib Phase I||5
10978104|NCT00573989|12152465|FG003|COMPLETED|Erlotinib Phase I||0
10978105|NCT00573989|12152462|FG000|NOT COMPLETED|Erlotinib Phase I||0
10978106|NCT00573989|12152463|FG001|NOT COMPLETED|Erlotinib Phase I||0
10978107|NCT00573989|12152464|FG002|NOT COMPLETED|Erlotinib Phase I||0
10978108|NCT00573989|12152465|FG003|NOT COMPLETED|Erlotinib Phase I||0
10978109|NCT00573989|12152462|FG000|STARTED|Erlotinib 125mg- Phase II||0
10978110|NCT00573989|12152463|FG001|STARTED|Erlotinib 125mg- Phase II||0
10978111|NCT00573989|12152464|FG002|STARTED|Erlotinib 125mg- Phase II||0
10978112|NCT00573989|12152465|FG003|STARTED|Erlotinib 125mg- Phase II||12
10978113|NCT00573989|12152462|FG000|COMPLETED|Erlotinib 125mg- Phase II||0
10978114|NCT00573989|12152463|FG001|COMPLETED|Erlotinib 125mg- Phase II||0
10978115|NCT00573989|12152464|FG002|COMPLETED|Erlotinib 125mg- Phase II||0
10978116|NCT00573989|12152465|FG003|COMPLETED|Erlotinib 125mg- Phase II||12
10978117|NCT00573989|12152462|FG000|NOT COMPLETED|Erlotinib 125mg- Phase II||0
10978118|NCT00573989|12152463|FG001|NOT COMPLETED|Erlotinib 125mg- Phase II||0
10978119|NCT00573989|12152464|FG002|NOT COMPLETED|Erlotinib 125mg- Phase II||0
10978120|NCT00573989|12152465|FG003|NOT COMPLETED|Erlotinib 125mg- Phase II||0
10978121|NCT00574067|12152476|FG000|STARTED|Overall Study||53
10978122|NCT00574067|12152477|FG001|STARTED|Overall Study||53
10978123|NCT00574067|12152478|FG002|STARTED|Overall Study||54
10978124|NCT00574067|12152479|FG003|STARTED|Overall Study||53
10978125|NCT00574067|12152476|FG000|COMPLETED|Overall Study||52
10978126|NCT00574067|12152477|FG001|COMPLETED|Overall Study||52
10978127|NCT00574067|12152478|FG002|COMPLETED|Overall Study||54
10978128|NCT00574067|12152479|FG003|COMPLETED|Overall Study||53
10978129|NCT00574067|12152476|FG000|NOT COMPLETED|Overall Study||1
10978130|NCT00574067|12152477|FG001|NOT COMPLETED|Overall Study||1
10978131|NCT00574067|12152478|FG002|NOT COMPLETED|Overall Study||0
10978132|NCT00574067|12152479|FG003|NOT COMPLETED|Overall Study||0
10978133|NCT00574119|12152493|FG000|STARTED|Overall Study||16
10978134|NCT00574119|12152493|FG000|COMPLETED|Overall Study||12
10978135|NCT00574119|12152493|FG000|NOT COMPLETED|Overall Study||4
10978136|NCT00574145|12152499|FG000|STARTED|Overall Study||22
10978137|NCT00574145|12152500|FG001|STARTED|Overall Study||22
10978138|NCT00574145|12152499|FG000|COMPLETED|Overall Study||20
10978139|NCT00574145|12152500|FG001|COMPLETED|Overall Study||21
10978140|NCT00574145|12152499|FG000|NOT COMPLETED|Overall Study||2
10978141|NCT00574145|12152500|FG001|NOT COMPLETED|Overall Study||1
10978142|NCT00574171|12152506|FG000|STARTED|Overall Study||29
10978143|NCT00574171|12152506|FG000|COMPLETED|Overall Study||29
10978144|NCT00574171|12152506|FG000|NOT COMPLETED|Overall Study||0
10978145|NCT00574197|12152510|FG000|STARTED|Overall Study||11
10978146|NCT00574197|12152510|FG000|COMPLETED|Overall Study||6
10978147|NCT00574197|12152510|FG000|NOT COMPLETED|Overall Study||5
10978148|NCT00574236|12152514|FG000|STARTED|Overall Study||4
10978149|NCT00574236|12152514|FG000|COMPLETED|Overall Study||4
10978150|NCT00574236|12152514|FG000|NOT COMPLETED|Overall Study||0
10978151|NCT00574249|12152520|FG000|STARTED|Overall Study||364
10978152|NCT00574249|12152521|FG001|STARTED|Overall Study||366
10978153|NCT00574249|12152520|FG000|COMPLETED|Overall Study||338
10978154|NCT00574249|12152521|FG001|COMPLETED|Overall Study||338
10978155|NCT00574249|12152520|FG000|NOT COMPLETED|Overall Study||26
10978156|NCT00574249|12152521|FG001|NOT COMPLETED|Overall Study||28
10978157|NCT00574275|12152529|FG000|STARTED|Overall Study||275
10978158|NCT00574275|12152530|FG001|STARTED|Overall Study||271
10978159|NCT00574275|12152529|FG000|TREATED|Overall Study||273
10978160|NCT00574275|12152530|FG001|TREATED|Overall Study||268
10978161|NCT00574275|12152529|FG000|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
10978162|NCT00574275|12152530|FG001|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
10978163|NCT00574275|12152529|FG000|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
10978164|NCT00574275|12152530|FG001|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
10978165|NCT00574275|12152529|FG000|NOT COMPLETED|Overall Study||275
10978166|NCT00574275|12152530|FG001|NOT COMPLETED|Overall Study||271
10978167|NCT00574288|12152543|FG000|STARTED|Overall Study||20
10978168|NCT00574288|12152544|FG001|STARTED|Overall Study||3
10978169|NCT00574288|12152545|FG002|STARTED|Overall Study||3
10978170|NCT00574288|12152546|FG003|STARTED|Overall Study||3
10978171|NCT00574288|12152547|FG004|STARTED|Overall Study||3
10978172|NCT00574288|12152548|FG005|STARTED|Overall Study||30
10978173|NCT00574288|12152549|FG006|STARTED|Overall Study||42
10978174|NCT00574288|12152543|FG000|COMPLETED|Overall Study||0
10978175|NCT00574288|12152544|FG001|COMPLETED|Overall Study||0
10978176|NCT00574288|12152545|FG002|COMPLETED|Overall Study||0
10978177|NCT00574288|12152546|FG003|COMPLETED|Overall Study||1
10978178|NCT00574288|12152547|FG004|COMPLETED|Overall Study||1
10978179|NCT00574288|12152548|FG005|COMPLETED|Overall Study||4
10978180|NCT00574288|12152549|FG006|COMPLETED|Overall Study||14
10978181|NCT00574288|12152543|FG000|NOT COMPLETED|Overall Study||20
10978182|NCT00574288|12152544|FG001|NOT COMPLETED|Overall Study||3
10978183|NCT00574288|12152545|FG002|NOT COMPLETED|Overall Study||3
10978184|NCT00574288|12152546|FG003|NOT COMPLETED|Overall Study||2
10978185|NCT00574288|12152547|FG004|NOT COMPLETED|Overall Study||2
10978186|NCT00574288|12152548|FG005|NOT COMPLETED|Overall Study||26
10978187|NCT00574288|12152549|FG006|NOT COMPLETED|Overall Study||28
10978188|NCT00574340|12152575|FG000|STARTED|Study 1 (2 Days)||10
10978189|NCT00574340|12152576|FG001|STARTED|Study 1 (2 Days)||10
10978190|NCT00574340|12152575|FG000|COMPLETED|Study 1 (2 Days)||10
10978191|NCT00574340|12152576|FG001|COMPLETED|Study 1 (2 Days)||10
10978192|NCT00574340|12152575|FG000|NOT COMPLETED|Study 1 (2 Days)||0
10978193|NCT00574340|12152576|FG001|NOT COMPLETED|Study 1 (2 Days)||0
10978194|NCT00574340|12152575|FG000|STARTED|Study 2 (2 Days)||6
10978195|NCT00574340|12152576|FG001|STARTED|Study 2 (2 Days)||6
10978196|NCT00574340|12152575|FG000|COMPLETED|Study 2 (2 Days)||6
10978197|NCT00574340|12152576|FG001|COMPLETED|Study 2 (2 Days)||6
10978198|NCT00574340|12152575|FG000|NOT COMPLETED|Study 2 (2 Days)||0
10978199|NCT00574340|12152576|FG001|NOT COMPLETED|Study 2 (2 Days)||0
10978200|NCT00574405|12152584|FG000|STARTED|Overall Study||12
10978201|NCT00574405|12152585|FG001|STARTED|Overall Study||12
10978202|NCT00574405|12152584|FG000|COMPLETED|Overall Study||9
10978203|NCT00574405|12152585|FG001|COMPLETED|Overall Study||10
10978204|NCT00574405|12152584|FG000|NOT COMPLETED|Overall Study||3
10978205|NCT00574405|12152585|FG001|NOT COMPLETED|Overall Study||2
10978206|NCT00574548|12152593|FG000|STARTED|Overall Study||482
10978207|NCT00574548|12152594|FG001|STARTED|Overall Study||238
10978208|NCT00574548|12152593|FG000|Received Vaccination 1 (Vax 1)|Overall Study||478
10978209|NCT00574548|12152594|FG001|Received Vaccination 1 (Vax 1)|Overall Study||237
10978210|NCT00574548|12152593|FG000|Completed Vax 1 (6 Month Contact)|Overall Study||468
10978211|NCT00574548|12152594|FG001|Completed Vax 1 (6 Month Contact)|Overall Study||234
10978212|NCT00574548|12152593|FG000|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
10978213|NCT00574548|12152594|FG001|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
10978214|NCT00574548|12152593|FG000|Withdrawn Before Vax 2|Overall Study||41
10978215|NCT00574548|12152594|FG001|Withdrawn Before Vax 2|Overall Study||11
10978216|NCT00574548|12152593|FG000|Received Vax 2|Overall Study||427
10978217|NCT00574548|12152594|FG001|Received Vax 2|Overall Study||223
10978218|NCT00574548|12152593|FG000|Completed Vax 2 (6 Month Contact)|Overall Study||421
10978219|NCT00574548|12152594|FG001|Completed Vax 2 (6 Month Contact)|Overall Study||222
10978220|NCT00574548|12152593|FG000|COMPLETED|Overall Study||421
10978221|NCT00574548|12152594|FG001|COMPLETED|Overall Study||222
10978222|NCT00574548|12152593|FG000|NOT COMPLETED|Overall Study||61
10978223|NCT00574548|12152594|FG001|NOT COMPLETED|Overall Study||16
10978224|NCT00574587|12152622|FG000|STARTED|Overall Study||3
10978225|NCT00574587|12152623|FG001|STARTED|Overall Study||23
10978226|NCT00574587|12152624|FG002|STARTED|Overall Study||16
10978227|NCT00574587|12152625|FG003|STARTED|Overall Study||13
10978228|NCT00574587|12152622|FG000|COMPLETED|Overall Study||3
10978229|NCT00574587|12152623|FG001|COMPLETED|Overall Study||23
10978230|NCT00574587|12152624|FG002|COMPLETED|Overall Study||16
10978231|NCT00574587|12152625|FG003|COMPLETED|Overall Study||13
10978232|NCT00574587|12152622|FG000|NOT COMPLETED|Overall Study||0
10978233|NCT00574587|12152623|FG001|NOT COMPLETED|Overall Study||0
10978234|NCT00574587|12152624|FG002|NOT COMPLETED|Overall Study||0
10978235|NCT00574587|12152625|FG003|NOT COMPLETED|Overall Study||0
10978236|NCT00574704|12152640|FG000|STARTED|Overall Study||10
10978237|NCT00574704|12152641|FG001|STARTED|Overall Study||10
10978238|NCT00574704|12152642|FG002|STARTED|Overall Study||10
10978239|NCT00574704|12152643|FG003|STARTED|Overall Study||10
10978240|NCT00574704|12152640|FG000|COMPLETED|Overall Study||10
10978241|NCT00574704|12152641|FG001|COMPLETED|Overall Study||10
10978242|NCT00574704|12152642|FG002|COMPLETED|Overall Study||9
10978243|NCT00574704|12152643|FG003|COMPLETED|Overall Study||10
10978244|NCT00574704|12152640|FG000|NOT COMPLETED|Overall Study||0
10978245|NCT00574704|12152641|FG001|NOT COMPLETED|Overall Study||0
10978246|NCT00574704|12152642|FG002|NOT COMPLETED|Overall Study||1
10978247|NCT00574704|12152643|FG003|NOT COMPLETED|Overall Study||0
10978248|NCT00574795|12152653|FG000|STARTED|Infant Series||193
10978249|NCT00574795|12152653|FG000|Vaccinated Dose 1|Infant Series||193
10978250|NCT00574795|12152653|FG000|Vaccinated Dose 2|Infant Series||190
10978251|NCT00574795|12152653|FG000|Vaccinated Dose 3|Infant Series||190
10978252|NCT00574795|12152653|FG000|COMPLETED|Infant Series||188
10978253|NCT00574795|12152653|FG000|NOT COMPLETED|Infant Series||5
10978254|NCT00574795|12152653|FG000|STARTED|After Infant Series||188
10978255|NCT00574795|12152653|FG000|COMPLETED|After Infant Series||185
10978256|NCT00574795|12152653|FG000|NOT COMPLETED|After Infant Series||3
10978257|NCT00574795|12152653|FG000|STARTED|Toddler Dose||185
10978258|NCT00574795|12152653|FG000|COMPLETED|Toddler Dose||184
10978259|NCT00574795|12152653|FG000|NOT COMPLETED|Toddler Dose||1
10978260|NCT00574834|12152671|FG000|STARTED|Overall Study||9
10978261|NCT00574834|12152672|FG001|STARTED|Overall Study||4
10978262|NCT00574834|12152673|FG002|STARTED|Overall Study||4
10978263|NCT00574834|12152671|FG000|COMPLETED|Overall Study||9
10978264|NCT00574834|12152672|FG001|COMPLETED|Overall Study||4
10978265|NCT00574834|12152673|FG002|COMPLETED|Overall Study||4
10978266|NCT00574834|12152671|FG000|NOT COMPLETED|Overall Study||0
10978267|NCT00574834|12152672|FG001|NOT COMPLETED|Overall Study||0
10978268|NCT00574834|12152673|FG002|NOT COMPLETED|Overall Study||0
10978269|NCT00574847|12152683|FG000|STARTED|Overall Study||64
10978270|NCT00574847|12152684|FG001|STARTED|Overall Study||63
10978271|NCT00574847|12152683|FG000|COMPLETED|Overall Study||56
10978272|NCT00574847|12152684|FG001|COMPLETED|Overall Study||56
10978273|NCT00574847|12152683|FG000|NOT COMPLETED|Overall Study||8
10978274|NCT00574847|12152684|FG001|NOT COMPLETED|Overall Study||7
10978275|NCT00574873|12152692|FG000|STARTED|Overall Study||250
10978276|NCT00574873|12152693|FG001|STARTED|Overall Study||252
10978277|NCT00574873|12152692|FG000|Treated|Overall Study||248
10978278|NCT00574873|12152693|FG001|Treated|Overall Study||251
10978279|NCT00574873|12152692|FG000|COMPLETED|Overall Study||12
10978280|NCT00574873|12152693|FG001|COMPLETED|Overall Study||1
10978281|NCT00574873|12152692|FG000|NOT COMPLETED|Overall Study||238
10978282|NCT00574873|12152693|FG001|NOT COMPLETED|Overall Study||251
10978283|NCT00574912|12152699|FG000|STARTED|Overall Study||20
10978284|NCT00574912|12152699|FG000|Completed Placebo|Overall Study|12 original participants started the trial.|12
10978285|NCT00574912|12152699|FG000|Completed 0.5|Overall Study||12
10978286|NCT00574912|12152699|FG000|Completed 1.0|Overall Study||12
10978287|NCT00574912|12152699|FG000|Completed 1.5|Overall Study||12
10978288|NCT00574912|12152699|FG000|Completed 2.0|Overall Study||12
10978289|NCT00574912|12152699|FG000|COMPLETED|Overall Study||12
10978290|NCT00574912|12152699|FG000|NOT COMPLETED|Overall Study||8
10978291|NCT00574951|12152711|FG000|STARTED|Overall Study||23
10978292|NCT00574951|12152711|FG000|COMPLETED|Overall Study||22
10978293|NCT00574951|12152711|FG000|NOT COMPLETED|Overall Study||1
10978294|NCT00574990|12152718|FG000|STARTED|Overall Study||12
10978295|NCT00574990|12152719|FG001|STARTED|Overall Study||19
10978296|NCT00574990|12152720|FG002|STARTED|Overall Study||8
10978297|NCT00574990|12152718|FG000|COMPLETED|Overall Study||12
10978298|NCT00574990|12152719|FG001|COMPLETED|Overall Study||19
10978299|NCT00574990|12152720|FG002|COMPLETED|Overall Study||8
10978300|NCT00574990|12152718|FG000|NOT COMPLETED|Overall Study||0
10978301|NCT00574990|12152719|FG001|NOT COMPLETED|Overall Study||0
10978302|NCT00574990|12152720|FG002|NOT COMPLETED|Overall Study||0
10978303|NCT00575016|12152735|FG000|STARTED|Treatment Cycle 1||17
10978304|NCT00575016|12152736|FG001|STARTED|Treatment Cycle 1||21
10978305|NCT00575016|12152737|FG002|STARTED|Treatment Cycle 1||19
10978306|NCT00575016|12152738|FG003|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
10978307|NCT00575016|12152735|FG000|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
10978308|NCT00575016|12152736|FG001|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
10978309|NCT00575016|12152737|FG002|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
10978310|NCT00575016|12152738|FG003|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
10978311|NCT00575016|12152735|FG000|NOT COMPLETED|Treatment Cycle 1||9
10978312|NCT00575016|12152736|FG001|NOT COMPLETED|Treatment Cycle 1||5
10978313|NCT00575016|12152737|FG002|NOT COMPLETED|Treatment Cycle 1||4
10978314|NCT00575016|12152738|FG003|NOT COMPLETED|Treatment Cycle 1||5
10978315|NCT00575016|12152735|FG000|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
10978316|NCT00575016|12152736|FG001|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
10978317|NCT00575016|12152737|FG002|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
10978318|NCT00575016|12152738|FG003|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
10978319|NCT00575016|12152735|FG000|COMPLETED|Treatment Cycle 2||30
10978320|NCT00575016|12152736|FG001|COMPLETED|Treatment Cycle 2||0
10978321|NCT00575016|12152737|FG002|COMPLETED|Treatment Cycle 2||0
10978322|NCT00575016|12152738|FG003|COMPLETED|Treatment Cycle 2||0
10978323|NCT00575016|12152735|FG000|NOT COMPLETED|Treatment Cycle 2||1
10978324|NCT00575016|12152736|FG001|NOT COMPLETED|Treatment Cycle 2||0
10978325|NCT00575016|12152737|FG002|NOT COMPLETED|Treatment Cycle 2||0
10978326|NCT00575016|12152738|FG003|NOT COMPLETED|Treatment Cycle 2||0
10978327|NCT00575029|12152748|FG000|STARTED|Overall Study||7
10978328|NCT00575029|12152748|FG000|COMPLETED|Overall Study||7
10978329|NCT00575029|12152748|FG000|NOT COMPLETED|Overall Study||0
10978330|NCT00575042|12152752|FG000|STARTED|Overall Study||20
10978331|NCT00575042|12152752|FG000|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
10978332|NCT00575042|12152752|FG000|NOT COMPLETED|Overall Study||3
10978333|NCT00575094|12152757|FG000|STARTED|Overall Study||9
10978334|NCT00575094|12152757|FG000|COMPLETED|Overall Study||6
10978335|NCT00575094|12152757|FG000|NOT COMPLETED|Overall Study||3
10978336|NCT00575146|12152761|FG000|STARTED|Overall Study||20
10978337|NCT00575146|12152761|FG000|COMPLETED|Overall Study||17
10978338|NCT00575146|12152761|FG000|NOT COMPLETED|Overall Study||3
10978339|NCT00575159|12152765|FG000|STARTED|Overall Study||10
10978340|NCT00575159|12152765|FG000|COMPLETED|Overall Study||10
10978341|NCT00575159|12152765|FG000|NOT COMPLETED|Overall Study||0
10978342|NCT00575185|12152783|FG000|STARTED|Overall Study||12
10978343|NCT00575185|12152784|FG001|STARTED|Overall Study||11
10978344|NCT00575185|12152783|FG000|COMPLETED|Overall Study||12
10978345|NCT00575185|12152784|FG001|COMPLETED|Overall Study||11
10978346|NCT00575185|12152783|FG000|NOT COMPLETED|Overall Study||0
10978347|NCT00575185|12152784|FG001|NOT COMPLETED|Overall Study||0
10978348|NCT00575328|12152794|FG000|STARTED|Overall Study||4
10978349|NCT00575328|12152795|FG001|STARTED|Overall Study||4
10978350|NCT00575328|12152794|FG000|COMPLETED|Overall Study||1
10978351|NCT00575328|12152795|FG001|COMPLETED|Overall Study||2
10978352|NCT00575328|12152794|FG000|NOT COMPLETED|Overall Study||3
10978353|NCT00575328|12152795|FG001|NOT COMPLETED|Overall Study||2
10978354|NCT00575367|12152803|FG000|STARTED|Overall Study||19
10978355|NCT00575367|12152804|FG001|STARTED|Overall Study||18
10978356|NCT00575367|12152803|FG000|COMPLETED|Overall Study||19
10978357|NCT00575367|12152804|FG001|COMPLETED|Overall Study||18
10978358|NCT00575367|12152803|FG000|NOT COMPLETED|Overall Study||0
10978359|NCT00575367|12152804|FG001|NOT COMPLETED|Overall Study||0
10978360|NCT00575380|12152812|FG000|STARTED|Overall Study||58
10978361|NCT00575380|12152813|FG001|STARTED|Overall Study||58
10978362|NCT00575380|12152812|FG000|COMPLETED|Overall Study||57
10978363|NCT00575380|12152813|FG001|COMPLETED|Overall Study||55
10978364|NCT00575380|12152812|FG000|NOT COMPLETED|Overall Study||1
10978365|NCT00575380|12152813|FG001|NOT COMPLETED|Overall Study||3
10978366|NCT00575510|12152822|FG000|STARTED|Overall Study||114
10978367|NCT00575510|12152823|FG001|STARTED|Overall Study||114
10978368|NCT00575510|12152824|FG002|STARTED|Overall Study||113
10978369|NCT00575510|12152822|FG000|COMPLETED|Overall Study||102
10978370|NCT00575510|12152823|FG001|COMPLETED|Overall Study||101
10978371|NCT00575510|12152824|FG002|COMPLETED|Overall Study||96
10978372|NCT00575510|12152822|FG000|NOT COMPLETED|Overall Study||12
10978373|NCT00575510|12152823|FG001|NOT COMPLETED|Overall Study||13
10978374|NCT00575510|12152824|FG002|NOT COMPLETED|Overall Study||17
10978375|NCT00575588|12152835|FG000|STARTED|Overall Study|Randomized and treated|428
10978376|NCT00575588|12152836|FG001|STARTED|Overall Study|Randomized and treated|430
10978377|NCT00575588|12152835|FG000|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
10978378|NCT00575588|12152836|FG001|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
10978379|NCT00575588|12152835|FG000|NOT COMPLETED|Overall Study||263
10978380|NCT00575588|12152836|FG001|NOT COMPLETED|Overall Study||283
10978381|NCT00575666|12152844|FG000|STARTED|Overall Study||21
10978382|NCT00575666|12152845|FG001|STARTED|Overall Study||24
10978383|NCT00575666|12152844|FG000|COMPLETED|Overall Study||17
10978384|NCT00575666|12152845|FG001|COMPLETED|Overall Study||21
10978385|NCT00575666|12152844|FG000|NOT COMPLETED|Overall Study||4
10978386|NCT00575666|12152845|FG001|NOT COMPLETED|Overall Study||3
10978387|NCT00575887|12152851|FG000|STARTED|Overall Study||25
10978388|NCT00575887|12152851|FG000|COMPLETED|Overall Study||25
10978389|NCT00575887|12152851|FG000|NOT COMPLETED|Overall Study||0
10978390|NCT00575965|12152855|FG000|STARTED|Overall Study||18
10978391|NCT00575965|12152855|FG000|COMPLETED|Overall Study||18
10978392|NCT00575965|12152855|FG000|NOT COMPLETED|Overall Study||0
10978393|NCT00576056|12152859|FG000|STARTED|Overall Study||19
10978394|NCT00576056|12152859|FG000|COMPLETED|Overall Study||5
10978395|NCT00576056|12152859|FG000|NOT COMPLETED|Overall Study||14
10978396|NCT00576147|12152863|FG000|STARTED|Overall Study||431
10978397|NCT00576147|12152863|FG000|COMPLETED|Overall Study||431
10978398|NCT00576147|12152863|FG000|NOT COMPLETED|Overall Study||0
10978399|NCT00576199|12152867|FG000|STARTED|Overall Study||30
10978400|NCT00576199|12152867|FG000|COMPLETED|Overall Study||0
10978401|NCT00576199|12152867|FG000|NOT COMPLETED|Overall Study||30
10978402|NCT00576251|12152873|FG000|STARTED|Overall Study||109
10978403|NCT00576251|12152874|FG001|STARTED|Overall Study||112
10978404|NCT00576251|12152873|FG000|COMPLETED|Overall Study||108
10978405|NCT00576251|12152874|FG001|COMPLETED|Overall Study||111
10978406|NCT00576251|12152873|FG000|NOT COMPLETED|Overall Study||1
10978407|NCT00576251|12152874|FG001|NOT COMPLETED|Overall Study||1
10978408|NCT00576303|12152880|FG000|STARTED|Dose Titration Period||200
10978409|NCT00576303|12152880|FG000|COMPLETED|Dose Titration Period||183
10978410|NCT00576303|12152880|FG000|NOT COMPLETED|Dose Titration Period||17
10978411|NCT00576303|12152880|FG000|STARTED|Efficacy Evaluation Period||183
10978412|NCT00576303|12152880|FG000|COMPLETED|Efficacy Evaluation Period||178
10978413|NCT00576303|12152880|FG000|NOT COMPLETED|Efficacy Evaluation Period||5
10978414|NCT00576303|12152880|FG000|STARTED|Long Term Safety Period||178
10978415|NCT00576303|12152880|FG000|COMPLETED|Long Term Safety Period||162
10978416|NCT00576303|12152880|FG000|NOT COMPLETED|Long Term Safety Period||16
10978417|NCT00576316|12152884|FG000|STARTED|Overall Study|Number of patients recruited|201
10978418|NCT00576316|12152884|FG000|COMPLETED|Overall Study|Number of patients who completed study|181
10978419|NCT00576316|12152884|FG000|NOT COMPLETED|Overall Study||20
10978420|NCT00576381|12152888|FG000|STARTED|Overall Study||30
10978421|NCT00576381|12152888|FG000|COMPLETED|Overall Study||23
10978422|NCT00576381|12152888|FG000|NOT COMPLETED|Overall Study||7
10978423|NCT00576420|12152895|FG000|STARTED|Overall Study||26
10978424|NCT00576420|12152896|FG001|STARTED|Overall Study||24
10978425|NCT00576420|12152897|FG002|STARTED|Overall Study||23
10978426|NCT00576420|12152895|FG000|COMPLETED|Overall Study||26
10978427|NCT00576420|12152896|FG001|COMPLETED|Overall Study||24
10978428|NCT00576420|12152897|FG002|COMPLETED|Overall Study||22
10978429|NCT00576420|12152895|FG000|NOT COMPLETED|Overall Study||0
10978430|NCT00576420|12152896|FG001|NOT COMPLETED|Overall Study||0
10978431|NCT00576420|12152897|FG002|NOT COMPLETED|Overall Study||1
10978432|NCT00576472|12152961|FG000|STARTED|Initial Screening||230
10978433|NCT00576472|12152962|FG001|STARTED|Initial Screening||40
10978434|NCT00576472|12152963|FG002|STARTED|Initial Screening||199
10978435|NCT00576472|12152964|FG003|STARTED|Initial Screening||0
10978436|NCT00576472|12152965|FG004|STARTED|Initial Screening||0
10978437|NCT00576472|12152966|FG005|STARTED|Initial Screening||0
10978438|NCT00576472|12152967|FG006|STARTED|Initial Screening||0
10978439|NCT00576472|12152968|FG007|STARTED|Initial Screening||0
10978440|NCT00576472|12152969|FG008|STARTED|Initial Screening||0
10978441|NCT00576472|12152970|FG009|STARTED|Initial Screening||0
10978442|NCT00576472|12152971|FG010|STARTED|Initial Screening||0
10978443|NCT00576472|12152972|FG011|STARTED|Initial Screening||0
10978444|NCT00576472|12152973|FG012|STARTED|Initial Screening||0
10978445|NCT00576472|12152974|FG013|STARTED|Initial Screening||0
10978446|NCT00576472|12152975|FG014|STARTED|Initial Screening||0
10978447|NCT00576472|12152961|FG000|COMPLETED|Initial Screening||230
10978448|NCT00576472|12152962|FG001|COMPLETED|Initial Screening||40
10978449|NCT00576472|12152963|FG002|COMPLETED|Initial Screening||199
10978450|NCT00576472|12152964|FG003|COMPLETED|Initial Screening||0
10978451|NCT00576472|12152965|FG004|COMPLETED|Initial Screening||0
10978452|NCT00576472|12152966|FG005|COMPLETED|Initial Screening||0
10978453|NCT00576472|12152967|FG006|COMPLETED|Initial Screening||0
10978454|NCT00576472|12152968|FG007|COMPLETED|Initial Screening||0
10978455|NCT00576472|12152969|FG008|COMPLETED|Initial Screening||0
10978456|NCT00576472|12152970|FG009|COMPLETED|Initial Screening||0
10978457|NCT00576472|12152971|FG010|COMPLETED|Initial Screening||0
10978458|NCT00576472|12152972|FG011|COMPLETED|Initial Screening||0
10978459|NCT00576472|12152973|FG012|COMPLETED|Initial Screening||0
10978460|NCT00576472|12152974|FG013|COMPLETED|Initial Screening||0
10978461|NCT00576472|12152975|FG014|COMPLETED|Initial Screening||0
10978462|NCT00576472|12152961|FG000|NOT COMPLETED|Initial Screening||0
10978463|NCT00576472|12152962|FG001|NOT COMPLETED|Initial Screening||0
10978464|NCT00576472|12152963|FG002|NOT COMPLETED|Initial Screening||0
10978465|NCT00576472|12152964|FG003|NOT COMPLETED|Initial Screening||0
10978466|NCT00576472|12152965|FG004|NOT COMPLETED|Initial Screening||0
10978467|NCT00576472|12152966|FG005|NOT COMPLETED|Initial Screening||0
10978468|NCT00576472|12152967|FG006|NOT COMPLETED|Initial Screening||0
10978469|NCT00576472|12152968|FG007|NOT COMPLETED|Initial Screening||0
10978470|NCT00576472|12152969|FG008|NOT COMPLETED|Initial Screening||0
10978471|NCT00576472|12152970|FG009|NOT COMPLETED|Initial Screening||0
10978472|NCT00576472|12152971|FG010|NOT COMPLETED|Initial Screening||0
10978473|NCT00576472|12152972|FG011|NOT COMPLETED|Initial Screening||0
10978474|NCT00576472|12152973|FG012|NOT COMPLETED|Initial Screening||0
10978475|NCT00576472|12152974|FG013|NOT COMPLETED|Initial Screening||0
10978476|NCT00576472|12152975|FG014|NOT COMPLETED|Initial Screening||0
10978477|NCT00576472|12152961|FG000|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
10978478|NCT00576472|12152962|FG001|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
10978479|NCT00576472|12152963|FG002|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
10978480|NCT00576472|12152964|FG003|STARTED|MPH In-Lab Phase||335
10978481|NCT00576472|12152965|FG004|STARTED|MPH In-Lab Phase||67
10978482|NCT00576472|12152966|FG005|STARTED|MPH In-Lab Phase||67
10978483|NCT00576472|12152967|FG006|STARTED|MPH In-Lab Phase||0
10978484|NCT00576472|12152968|FG007|STARTED|MPH In-Lab Phase||0
10978485|NCT00576472|12152969|FG008|STARTED|MPH In-Lab Phase||0
10978486|NCT00576472|12152970|FG009|STARTED|MPH In-Lab Phase||0
10978487|NCT00576472|12152971|FG010|STARTED|MPH In-Lab Phase||0
10978488|NCT00576472|12152972|FG011|STARTED|MPH In-Lab Phase||0
10978489|NCT00576472|12152973|FG012|STARTED|MPH In-Lab Phase||0
10978490|NCT00576472|12152974|FG013|STARTED|MPH In-Lab Phase||0
10978491|NCT00576472|12152975|FG014|STARTED|MPH In-Lab Phase||0
10978492|NCT00576472|12152961|FG000|COMPLETED|MPH In-Lab Phase||0
10978493|NCT00576472|12152962|FG001|COMPLETED|MPH In-Lab Phase||0
10978494|NCT00576472|12152963|FG002|COMPLETED|MPH In-Lab Phase||0
10978495|NCT00576472|12152964|FG003|COMPLETED|MPH In-Lab Phase||0
10978496|NCT00576472|12152965|FG004|COMPLETED|MPH In-Lab Phase||67
10978497|NCT00576472|12152966|FG005|COMPLETED|MPH In-Lab Phase||67
10978498|NCT00576472|12152967|FG006|COMPLETED|MPH In-Lab Phase||0
10978499|NCT00576472|12152968|FG007|COMPLETED|MPH In-Lab Phase||0
10978500|NCT00576472|12152969|FG008|COMPLETED|MPH In-Lab Phase||0
10978501|NCT00576472|12152970|FG009|COMPLETED|MPH In-Lab Phase||0
10978502|NCT00576472|12152971|FG010|COMPLETED|MPH In-Lab Phase||0
10978503|NCT00576472|12152972|FG011|COMPLETED|MPH In-Lab Phase||0
10978504|NCT00576472|12152973|FG012|COMPLETED|MPH In-Lab Phase||0
10978505|NCT00576472|12152974|FG013|COMPLETED|MPH In-Lab Phase||0
10978506|NCT00576472|12152975|FG014|COMPLETED|MPH In-Lab Phase||0
10978507|NCT00576472|12152961|FG000|NOT COMPLETED|MPH In-Lab Phase||0
10978508|NCT00576472|12152962|FG001|NOT COMPLETED|MPH In-Lab Phase||0
10978509|NCT00576472|12152963|FG002|NOT COMPLETED|MPH In-Lab Phase||0
10978510|NCT00576472|12152964|FG003|NOT COMPLETED|MPH In-Lab Phase||335
10978511|NCT00576472|12152965|FG004|NOT COMPLETED|MPH In-Lab Phase||0
10978512|NCT00576472|12152966|FG005|NOT COMPLETED|MPH In-Lab Phase||0
10978513|NCT00576472|12152967|FG006|NOT COMPLETED|MPH In-Lab Phase||0
10978514|NCT00576472|12152968|FG007|NOT COMPLETED|MPH In-Lab Phase||0
10978515|NCT00576472|12152969|FG008|NOT COMPLETED|MPH In-Lab Phase||0
10978516|NCT00576472|12152970|FG009|NOT COMPLETED|MPH In-Lab Phase||0
10978517|NCT00576472|12152971|FG010|NOT COMPLETED|MPH In-Lab Phase||0
10978518|NCT00576472|12152972|FG011|NOT COMPLETED|MPH In-Lab Phase||0
10978519|NCT00576472|12152973|FG012|NOT COMPLETED|MPH In-Lab Phase||0
10978520|NCT00576472|12152974|FG013|NOT COMPLETED|MPH In-Lab Phase||0
10978521|NCT00576472|12152975|FG014|NOT COMPLETED|MPH In-Lab Phase||0
10978522|NCT00576472|12152961|FG000|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
10978523|NCT00576472|12152962|FG001|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
10978524|NCT00576472|12152963|FG002|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
10978525|NCT00576472|12152964|FG003|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
10978526|NCT00576472|12152965|FG004|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
10978527|NCT00576472|12152966|FG005|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
10978528|NCT00576472|12152967|FG006|STARTED|MPH Cross Over Phase||12
10978529|NCT00576472|12152968|FG007|STARTED|MPH Cross Over Phase||20
10978530|NCT00576472|12152969|FG008|STARTED|MPH Cross Over Phase||18
10978531|NCT00576472|12152970|FG009|STARTED|MPH Cross Over Phase||22
10978532|NCT00576472|12152971|FG010|STARTED|MPH Cross Over Phase||23
10978533|NCT00576472|12152972|FG011|STARTED|MPH Cross Over Phase||18
10978534|NCT00576472|12152973|FG012|STARTED|MPH Cross Over Phase||21
10978535|NCT00576472|12152974|FG013|STARTED|MPH Cross Over Phase||0
10978536|NCT00576472|12152975|FG014|STARTED|MPH Cross Over Phase||0
10978537|NCT00576472|12152961|FG000|COMPLETED|MPH Cross Over Phase||0
10978538|NCT00576472|12152962|FG001|COMPLETED|MPH Cross Over Phase||0
10978539|NCT00576472|12152963|FG002|COMPLETED|MPH Cross Over Phase||0
10978540|NCT00576472|12152964|FG003|COMPLETED|MPH Cross Over Phase||0
10978541|NCT00576472|12152965|FG004|COMPLETED|MPH Cross Over Phase||0
10978542|NCT00576472|12152966|FG005|COMPLETED|MPH Cross Over Phase||0
10978543|NCT00576472|12152967|FG006|COMPLETED|MPH Cross Over Phase||0
10978544|NCT00576472|12152968|FG007|COMPLETED|MPH Cross Over Phase||20
10978545|NCT00576472|12152969|FG008|COMPLETED|MPH Cross Over Phase||16
10978546|NCT00576472|12152970|FG009|COMPLETED|MPH Cross Over Phase||22
10978547|NCT00576472|12152971|FG010|COMPLETED|MPH Cross Over Phase||22
10978548|NCT00576472|12152972|FG011|COMPLETED|MPH Cross Over Phase||17
10978549|NCT00576472|12152973|FG012|COMPLETED|MPH Cross Over Phase||21
10978550|NCT00576472|12152974|FG013|COMPLETED|MPH Cross Over Phase||0
10978551|NCT00576472|12152975|FG014|COMPLETED|MPH Cross Over Phase||0
10978552|NCT00576472|12152961|FG000|NOT COMPLETED|MPH Cross Over Phase||0
10978553|NCT00576472|12152962|FG001|NOT COMPLETED|MPH Cross Over Phase||0
10978554|NCT00576472|12152963|FG002|NOT COMPLETED|MPH Cross Over Phase||0
10978555|NCT00576472|12152964|FG003|NOT COMPLETED|MPH Cross Over Phase||0
10978556|NCT00576472|12152965|FG004|NOT COMPLETED|MPH Cross Over Phase||0
10978557|NCT00576472|12152966|FG005|NOT COMPLETED|MPH Cross Over Phase||0
10978558|NCT00576472|12152967|FG006|NOT COMPLETED|MPH Cross Over Phase||12
10978559|NCT00576472|12152968|FG007|NOT COMPLETED|MPH Cross Over Phase||0
10978560|NCT00576472|12152969|FG008|NOT COMPLETED|MPH Cross Over Phase||2
10978561|NCT00576472|12152970|FG009|NOT COMPLETED|MPH Cross Over Phase||0
10978562|NCT00576472|12152971|FG010|NOT COMPLETED|MPH Cross Over Phase||1
10978563|NCT00576472|12152972|FG011|NOT COMPLETED|MPH Cross Over Phase||1
10978564|NCT00576472|12152973|FG012|NOT COMPLETED|MPH Cross Over Phase||0
10978565|NCT00576472|12152974|FG013|NOT COMPLETED|MPH Cross Over Phase||0
10978566|NCT00576472|12152975|FG014|NOT COMPLETED|MPH Cross Over Phase||0
10978567|NCT00576472|12152961|FG000|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10978568|NCT00576472|12152962|FG001|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10978569|NCT00576472|12152963|FG002|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10978570|NCT00576472|12152964|FG003|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10978571|NCT00576472|12152965|FG004|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10978572|NCT00576472|12152966|FG005|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10978573|NCT00576472|12152967|FG006|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10978574|NCT00576472|12152968|FG007|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10978575|NCT00576472|12152969|FG008|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10978576|NCT00576472|12152970|FG009|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10978577|NCT00576472|12152971|FG010|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10978578|NCT00576472|12152972|FG011|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10978579|NCT00576472|12152973|FG012|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
10978580|NCT00576472|12152974|FG013|STARTED|MPH Home Maintenance Phase||27
10978581|NCT00576472|12152975|FG014|STARTED|MPH Home Maintenance Phase||91
10978582|NCT00576472|12152961|FG000|COMPLETED|MPH Home Maintenance Phase||0
10978583|NCT00576472|12152962|FG001|COMPLETED|MPH Home Maintenance Phase||0
10978584|NCT00576472|12152963|FG002|COMPLETED|MPH Home Maintenance Phase||0
10978585|NCT00576472|12152964|FG003|COMPLETED|MPH Home Maintenance Phase||0
10978586|NCT00576472|12152965|FG004|COMPLETED|MPH Home Maintenance Phase||0
10978587|NCT00576472|12152966|FG005|COMPLETED|MPH Home Maintenance Phase||0
10978588|NCT00576472|12152967|FG006|COMPLETED|MPH Home Maintenance Phase||0
10978589|NCT00576472|12152968|FG007|COMPLETED|MPH Home Maintenance Phase||0
10978590|NCT00576472|12152969|FG008|COMPLETED|MPH Home Maintenance Phase||0
10978591|NCT00576472|12152970|FG009|COMPLETED|MPH Home Maintenance Phase||0
10978592|NCT00576472|12152971|FG010|COMPLETED|MPH Home Maintenance Phase||0
10978593|NCT00576472|12152972|FG011|COMPLETED|MPH Home Maintenance Phase||0
10978594|NCT00576472|12152973|FG012|COMPLETED|MPH Home Maintenance Phase||0
10978595|NCT00576472|12152974|FG013|COMPLETED|MPH Home Maintenance Phase||0
10978596|NCT00576472|12152975|FG014|COMPLETED|MPH Home Maintenance Phase||68
10978597|NCT00576472|12152961|FG000|NOT COMPLETED|MPH Home Maintenance Phase||0
10978598|NCT00576472|12152962|FG001|NOT COMPLETED|MPH Home Maintenance Phase||0
10978599|NCT00576472|12152963|FG002|NOT COMPLETED|MPH Home Maintenance Phase||0
10978600|NCT00576472|12152964|FG003|NOT COMPLETED|MPH Home Maintenance Phase||0
10978601|NCT00576472|12152965|FG004|NOT COMPLETED|MPH Home Maintenance Phase||0
10978602|NCT00576472|12152966|FG005|NOT COMPLETED|MPH Home Maintenance Phase||0
10978603|NCT00576472|12152967|FG006|NOT COMPLETED|MPH Home Maintenance Phase||0
10978604|NCT00576472|12152968|FG007|NOT COMPLETED|MPH Home Maintenance Phase||0
10978605|NCT00576472|12152969|FG008|NOT COMPLETED|MPH Home Maintenance Phase||0
10978606|NCT00576472|12152970|FG009|NOT COMPLETED|MPH Home Maintenance Phase||0
10978607|NCT00576472|12152971|FG010|NOT COMPLETED|MPH Home Maintenance Phase||0
10978608|NCT00576472|12152972|FG011|NOT COMPLETED|MPH Home Maintenance Phase||0
10978609|NCT00576472|12152973|FG012|NOT COMPLETED|MPH Home Maintenance Phase||0
10978610|NCT00576472|12152974|FG013|NOT COMPLETED|MPH Home Maintenance Phase||27
10978611|NCT00576472|12152975|FG014|NOT COMPLETED|MPH Home Maintenance Phase||23
10978612|NCT00576576|12153006|FG000|STARTED|Overall Study||27
10978613|NCT00576576|12153006|FG000|COMPLETED|Overall Study||20
10978614|NCT00576576|12153006|FG000|NOT COMPLETED|Overall Study||7
10978615|NCT00576628|12153010|FG000|STARTED|Overall Study||125
10978616|NCT00576628|12153010|FG000|COMPLETED|Overall Study||82
10978617|NCT00576628|12153010|FG000|NOT COMPLETED|Overall Study||43
10978618|NCT00576680|12153015|FG000|STARTED|Overall Study||43
10978619|NCT00576680|12153015|FG000|COMPLETED|Overall Study||43
10978620|NCT00576680|12153015|FG000|NOT COMPLETED|Overall Study||0
10978621|NCT00576693|12153021|FG000|STARTED|Overall Study||224
10978622|NCT00576693|12153022|FG001|STARTED|Overall Study||227
10978623|NCT00576693|12153021|FG000|COMPLETED|Overall Study||214
10978624|NCT00576693|12153022|FG001|COMPLETED|Overall Study||203
10978625|NCT00576693|12153021|FG000|NOT COMPLETED|Overall Study||10
10978626|NCT00576693|12153022|FG001|NOT COMPLETED|Overall Study||24
10978627|NCT00576732|12153031|FG000|STARTED|DOUBLE BLIND||35
10978628|NCT00576732|12153032|FG001|STARTED|DOUBLE BLIND||30
10978629|NCT00576732|12153033|FG002|STARTED|DOUBLE BLIND||31
10978630|NCT00576732|12153034|FG003|STARTED|DOUBLE BLIND||0
10978631|NCT00576732|12153035|FG004|STARTED|DOUBLE BLIND||0
10978632|NCT00576732|12153036|FG005|STARTED|DOUBLE BLIND||0
10978633|NCT00576732|12153031|FG000|COMPLETED|DOUBLE BLIND||27
10978634|NCT00576732|12153032|FG001|COMPLETED|DOUBLE BLIND||25
10978635|NCT00576732|12153033|FG002|COMPLETED|DOUBLE BLIND||25
10978636|NCT00576732|12153034|FG003|COMPLETED|DOUBLE BLIND||0
10978637|NCT00576732|12153035|FG004|COMPLETED|DOUBLE BLIND||0
10978638|NCT00576732|12153036|FG005|COMPLETED|DOUBLE BLIND||0
10978639|NCT00576732|12153031|FG000|NOT COMPLETED|DOUBLE BLIND||8
10978640|NCT00576732|12153032|FG001|NOT COMPLETED|DOUBLE BLIND||5
10978641|NCT00576732|12153033|FG002|NOT COMPLETED|DOUBLE BLIND||6
10978642|NCT00576732|12153034|FG003|NOT COMPLETED|DOUBLE BLIND||0
10978643|NCT00576732|12153035|FG004|NOT COMPLETED|DOUBLE BLIND||0
10978644|NCT00576732|12153036|FG005|NOT COMPLETED|DOUBLE BLIND||0
10978645|NCT00576732|12153031|FG000|STARTED|OPEN LABEL||0
10978646|NCT00576732|12153032|FG001|STARTED|OPEN LABEL||0
10978647|NCT00576732|12153033|FG002|STARTED|OPEN LABEL||0
10978648|NCT00576732|12153034|FG003|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
10978649|NCT00576732|12153035|FG004|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
10978650|NCT00576732|12153036|FG005|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
10978651|NCT00576732|12153031|FG000|COMPLETED|OPEN LABEL||0
10978652|NCT00576732|12153032|FG001|COMPLETED|OPEN LABEL||0
10978653|NCT00576732|12153033|FG002|COMPLETED|OPEN LABEL||0
10978654|NCT00576732|12153034|FG003|COMPLETED|OPEN LABEL||19
10978655|NCT00576732|12153035|FG004|COMPLETED|OPEN LABEL||20
10978656|NCT00576732|12153036|FG005|COMPLETED|OPEN LABEL||17
10978657|NCT00576732|12153031|FG000|NOT COMPLETED|OPEN LABEL||0
10978658|NCT00576732|12153032|FG001|NOT COMPLETED|OPEN LABEL||0
10978659|NCT00576732|12153033|FG002|NOT COMPLETED|OPEN LABEL||0
10978660|NCT00576732|12153034|FG003|NOT COMPLETED|OPEN LABEL||11
10978661|NCT00576732|12153035|FG004|NOT COMPLETED|OPEN LABEL||4
10978662|NCT00576732|12153036|FG005|NOT COMPLETED|OPEN LABEL||8
10978663|NCT00576758|12153050|FG000|STARTED|Induction Treatment Period||87
10978664|NCT00576758|12153051|FG001|STARTED|Induction Treatment Period||88
10978665|NCT00576758|12153050|FG000|Received Treatment|Induction Treatment Period||86
10978666|NCT00576758|12153051|FG001|Received Treatment|Induction Treatment Period||87
10978667|NCT00576758|12153050|FG000|COMPLETED|Induction Treatment Period||79
10978668|NCT00576758|12153051|FG001|COMPLETED|Induction Treatment Period||83
10978669|NCT00576758|12153050|FG000|NOT COMPLETED|Induction Treatment Period||8
10978670|NCT00576758|12153051|FG001|NOT COMPLETED|Induction Treatment Period||5
10978671|NCT00576758|12153050|FG000|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
10978672|NCT00576758|12153051|FG001|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
10978673|NCT00576758|12153050|FG000|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
10978674|NCT00576758|12153051|FG001|COMPLETED|Extension Treatment Period||30
10978675|NCT00576758|12153050|FG000|NOT COMPLETED|Extension Treatment Period||42
10978676|NCT00576758|12153051|FG001|NOT COMPLETED|Extension Treatment Period||43
10978677|NCT00576758|12153050|FG000|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
10978678|NCT00576758|12153051|FG001|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
10978679|NCT00576758|12153050|FG000|COMPLETED|Follow-up Period||28
10978680|NCT00576758|12153051|FG001|COMPLETED|Follow-up Period||34
10978681|NCT00576758|12153050|FG000|NOT COMPLETED|Follow-up Period||27
10978682|NCT00576758|12153051|FG001|NOT COMPLETED|Follow-up Period||17
10978683|NCT00576823|12153061|FG000|STARTED|12-week Efficacy Phase||12
10978684|NCT00576823|12153062|FG001|STARTED|12-week Efficacy Phase||6
10978685|NCT00576823|12153063|FG002|STARTED|12-week Efficacy Phase||7
10978686|NCT00576823|12153061|FG000|COMPLETED|12-week Efficacy Phase||11
10978687|NCT00576823|12153062|FG001|COMPLETED|12-week Efficacy Phase||6
10978688|NCT00576823|12153063|FG002|COMPLETED|12-week Efficacy Phase||7
10978689|NCT00576823|12153061|FG000|NOT COMPLETED|12-week Efficacy Phase||1
10978690|NCT00576823|12153062|FG001|NOT COMPLETED|12-week Efficacy Phase||0
10978691|NCT00576823|12153063|FG002|NOT COMPLETED|12-week Efficacy Phase||0
10978692|NCT00576823|12153061|FG000|STARTED|40-week Safety Extension Phase||11
10978693|NCT00576823|12153062|FG001|STARTED|40-week Safety Extension Phase||6
10978694|NCT00576823|12153063|FG002|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
10978695|NCT00576823|12153061|FG000|COMPLETED|40-week Safety Extension Phase||10
10978696|NCT00576823|12153062|FG001|COMPLETED|40-week Safety Extension Phase||6
10978697|NCT00576823|12153063|FG002|COMPLETED|40-week Safety Extension Phase||6
10978698|NCT00576823|12153061|FG000|NOT COMPLETED|40-week Safety Extension Phase||1
10978699|NCT00576823|12153062|FG001|NOT COMPLETED|40-week Safety Extension Phase||0
10978700|NCT00576823|12153063|FG002|NOT COMPLETED|40-week Safety Extension Phase||0
10978701|NCT00576901|12153074|FG000|STARTED|Overall Study||23
10978702|NCT00576901|12153074|FG000|COMPLETED|Overall Study||20
10978703|NCT00576901|12153074|FG000|NOT COMPLETED|Overall Study||3
10978704|NCT00576927|12153080|FG000|STARTED|Clinical Assessment||79
10978705|NCT00576927|12153080|FG000|COMPLETED|Clinical Assessment||43
10978706|NCT00576927|12153080|FG000|NOT COMPLETED|Clinical Assessment||36
10978707|NCT00576927|12153080|FG000|STARTED|Baseline||43
10978708|NCT00576927|12153080|FG000|COMPLETED|Baseline||30
10978709|NCT00576927|12153080|FG000|NOT COMPLETED|Baseline||13
10978710|NCT00576927|12153080|FG000|STARTED|Sleep Hygiene Behavioral Intervention||30
10978711|NCT00576927|12153080|FG000|COMPLETED|Sleep Hygiene Behavioral Intervention||23
10978712|NCT00576927|12153080|FG000|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
10978713|NCT00576927|12153080|FG000|STARTED|Sleep Hygiene With the Placebo||23
10978714|NCT00576927|12153080|FG000|COMPLETED|Sleep Hygiene With the Placebo||22
10978715|NCT00576927|12153080|FG000|NOT COMPLETED|Sleep Hygiene With the Placebo||1
10978716|NCT00576927|12153080|FG000|STARTED|Sleep Hygiene With Study Drug||22
10978717|NCT00576927|12153080|FG000|COMPLETED|Sleep Hygiene With Study Drug||22
10978718|NCT00576927|12153080|FG000|NOT COMPLETED|Sleep Hygiene With Study Drug||0
10978719|NCT00576927|12153080|FG000|STARTED|Randomization 1:1 Placebo or Active Drug||22
10978720|NCT00576927|12153080|FG000|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
10978721|NCT00576927|12153080|FG000|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
10978722|NCT00577005|12153088|FG000|STARTED|Overall Study||16
10978723|NCT00577005|12153089|FG001|STARTED|Overall Study||12
10978724|NCT00577005|12153088|FG000|COMPLETED|Overall Study||11
10978725|NCT00577005|12153089|FG001|COMPLETED|Overall Study||9
10978726|NCT00577005|12153088|FG000|NOT COMPLETED|Overall Study||5
10978727|NCT00577005|12153089|FG001|NOT COMPLETED|Overall Study||3
10978728|NCT00577031|12153098|FG000|STARTED|Overall Study||205
10978729|NCT00577031|12153098|FG000|COMPLETED|Overall Study||0
10978730|NCT00577031|12153098|FG000|NOT COMPLETED|Overall Study||205
10978731|NCT00577083|12153107|FG000|STARTED|First Intervention (14 Days)||48
10978732|NCT00577083|12153108|FG001|STARTED|First Intervention (14 Days)||52
10978733|NCT00577083|12153107|FG000|COMPLETED|First Intervention (14 Days)||48
10978734|NCT00577083|12153108|FG001|COMPLETED|First Intervention (14 Days)||52
10978735|NCT00577083|12153107|FG000|NOT COMPLETED|First Intervention (14 Days)||0
10978736|NCT00577083|12153108|FG001|NOT COMPLETED|First Intervention (14 Days)||0
10978737|NCT00577083|12153107|FG000|STARTED|Washout (14 Days)||48
10978738|NCT00577083|12153108|FG001|STARTED|Washout (14 Days)||52
10978739|NCT00577083|12153107|FG000|COMPLETED|Washout (14 Days)||48
10978740|NCT00577083|12153108|FG001|COMPLETED|Washout (14 Days)||52
10978741|NCT00577083|12153107|FG000|NOT COMPLETED|Washout (14 Days)||0
10978742|NCT00577083|12153108|FG001|NOT COMPLETED|Washout (14 Days)||0
10978743|NCT00577083|12153107|FG000|STARTED|Second Intervention (14days)||48
10978744|NCT00577083|12153108|FG001|STARTED|Second Intervention (14days)||52
10978745|NCT00577083|12153107|FG000|COMPLETED|Second Intervention (14days)||48
10978746|NCT00577083|12153108|FG001|COMPLETED|Second Intervention (14days)||52
10978747|NCT00577083|12153107|FG000|NOT COMPLETED|Second Intervention (14days)||0
10978748|NCT00577083|12153108|FG001|NOT COMPLETED|Second Intervention (14days)||0
10978749|NCT00577096|12153122|FG000|STARTED|Short Term Participation||69
10978750|NCT00577096|12153123|FG001|STARTED|Short Term Participation||66
10978751|NCT00577096|12153122|FG000|COMPLETED|Short Term Participation||62
10978752|NCT00577096|12153123|FG001|COMPLETED|Short Term Participation||58
10978753|NCT00577096|12153122|FG000|NOT COMPLETED|Short Term Participation||7
10978754|NCT00577096|12153123|FG001|NOT COMPLETED|Short Term Participation||8
10978755|NCT00577096|12153122|FG000|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
10978756|NCT00577096|12153123|FG001|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
10978757|NCT00577096|12153122|FG000|COMPLETED|Long Term Participation||34
10978758|NCT00577096|12153123|FG001|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
10978759|NCT00577096|12153122|FG000|NOT COMPLETED|Long Term Participation||0
10978760|NCT00577096|12153123|FG001|NOT COMPLETED|Long Term Participation||0
10978761|NCT00577122|12153131|FG000|STARTED|Overall Study||14
10978762|NCT00577122|12153132|FG001|STARTED|Overall Study||16
10978763|NCT00577122|12153131|FG000|COMPLETED|Overall Study||0
10978764|NCT00577122|12153132|FG001|COMPLETED|Overall Study||0
10978765|NCT00577122|12153131|FG000|NOT COMPLETED|Overall Study||14
10978766|NCT00577122|12153132|FG001|NOT COMPLETED|Overall Study||16
10978767|NCT00577135|12153143|FG000|STARTED|Overall Study||74
10978768|NCT00577135|12153144|FG001|STARTED|Overall Study||82
10978769|NCT00577135|12153145|FG002|STARTED|Overall Study||77
10978770|NCT00577135|12153146|FG003|STARTED|Overall Study||75
10978771|NCT00577135|12153143|FG000|COMPLETED|Overall Study||74
10978772|NCT00577135|12153144|FG001|COMPLETED|Overall Study||82
10978773|NCT00577135|12153145|FG002|COMPLETED|Overall Study||77
10978774|NCT00577135|12153146|FG003|COMPLETED|Overall Study||75
10978775|NCT00577135|12153143|FG000|NOT COMPLETED|Overall Study||0
10978776|NCT00577135|12153144|FG001|NOT COMPLETED|Overall Study||0
10978777|NCT00577135|12153145|FG002|NOT COMPLETED|Overall Study||0
10978778|NCT00577135|12153146|FG003|NOT COMPLETED|Overall Study||0
10978779|NCT00577382|12153158|FG000|STARTED|Overall Study||21
10978780|NCT00577382|12153159|FG001|STARTED|Overall Study||31
10978781|NCT00577382|12153158|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
10978782|NCT00577382|12153159|FG001|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
10978783|NCT00577382|12153158|FG000|NOT COMPLETED|Overall Study||21
10978784|NCT00577382|12153159|FG001|NOT COMPLETED|Overall Study||31
10978785|NCT00577408|12153167|FG000|STARTED|Overall Study||28
10978786|NCT00577408|12153168|FG001|STARTED|Overall Study||32
10978787|NCT00577408|12153167|FG000|COMPLETED|Overall Study||16
10978788|NCT00577408|12153168|FG001|COMPLETED|Overall Study||9
10978789|NCT00577408|12153167|FG000|NOT COMPLETED|Overall Study||12
10978790|NCT00577408|12153168|FG001|NOT COMPLETED|Overall Study||23
10978791|NCT00577460|12153177|FG000|STARTED|Overall Study||129
10978792|NCT00577460|12153178|FG001|STARTED|Overall Study||123
10978793|NCT00577460|12153179|FG002|STARTED|Overall Study||139
10978794|NCT00577460|12153177|FG000|COMPLETED|Overall Study||113
10978795|NCT00577460|12153178|FG001|COMPLETED|Overall Study||104
10978796|NCT00577460|12153179|FG002|COMPLETED|Overall Study||112
10978797|NCT00577460|12153177|FG000|NOT COMPLETED|Overall Study||16
10978798|NCT00577460|12153178|FG001|NOT COMPLETED|Overall Study||19
10978799|NCT00577460|12153179|FG002|NOT COMPLETED|Overall Study||27
10978800|NCT00577473|12153196|FG000|STARTED|Overall Study||154
10978801|NCT00577473|12153197|FG001|STARTED|Overall Study||147
10978802|NCT00577473|12153196|FG000|ITT Population|Overall Study||150
10978803|NCT00577473|12153197|FG001|ITT Population|Overall Study||136
10978804|NCT00577473|12153196|FG000|COMPLETED|Overall Study||133
10978805|NCT00577473|12153197|FG001|COMPLETED|Overall Study||123
10978806|NCT00577473|12153196|FG000|NOT COMPLETED|Overall Study||21
10978807|NCT00577473|12153197|FG001|NOT COMPLETED|Overall Study||24
10978808|NCT00577512|12153203|FG000|STARTED|Overall Study||4
10978809|NCT00577512|12153203|FG000|COMPLETED|Overall Study||0
10978810|NCT00577512|12153203|FG000|NOT COMPLETED|Overall Study||4
10978811|NCT00577590|12153210|FG000|STARTED|Overall Study||28
10978812|NCT00577590|12153211|FG001|STARTED|Overall Study||27
10978813|NCT00577590|12153212|FG002|STARTED|Overall Study||23
10978814|NCT00577590|12153210|FG000|COMPLETED|Overall Study||28
10978815|NCT00577590|12153211|FG001|COMPLETED|Overall Study||27
10978816|NCT00577590|12153212|FG002|COMPLETED|Overall Study||23
10978817|NCT00577590|12153210|FG000|NOT COMPLETED|Overall Study||0
10978818|NCT00577590|12153211|FG001|NOT COMPLETED|Overall Study||0
10978819|NCT00577590|12153212|FG002|NOT COMPLETED|Overall Study||0
10978820|NCT00577629|12153220|FG000|STARTED|Treatment Period||39
10978821|NCT00577629|12153220|FG000|COMPLETED|Treatment Period||38
10978822|NCT00577629|12153220|FG000|NOT COMPLETED|Treatment Period||1
10978823|NCT00577629|12153220|FG000|STARTED|Long Term Follow-Up||38
10978824|NCT00577629|12153220|FG000|COMPLETED|Long Term Follow-Up||13
10978825|NCT00577629|12153220|FG000|NOT COMPLETED|Long Term Follow-Up||25
10978826|NCT00577642|12153226|FG000|STARTED|Overall Study||29
10978827|NCT00577642|12153226|FG000|COMPLETED|Overall Study||28
10978828|NCT00577642|12153226|FG000|NOT COMPLETED|Overall Study||1
10978829|NCT00577655|12153232|FG000|STARTED|Overall Study|This number represents the number of participants randomized.|52
10978830|NCT00577655|12153233|FG001|STARTED|Overall Study|This number represents the number of participants randomized.|51
10978831|NCT00577655|12153232|FG000|COMPLETED|Overall Study||51
10978832|NCT00577655|12153233|FG001|COMPLETED|Overall Study||47
10978833|NCT00577655|12153232|FG000|NOT COMPLETED|Overall Study||1
10978834|NCT00577655|12153233|FG001|NOT COMPLETED|Overall Study||4
10978835|NCT00577707|12153240|FG000|STARTED|Overall Study||9
10978836|NCT00577707|12153240|FG000|COMPLETED|Overall Study||6
10978837|NCT00577707|12153240|FG000|NOT COMPLETED|Overall Study||3
10978838|NCT00577720|12153248|FG000|STARTED|Overall Study||37
10978839|NCT00577720|12153249|FG001|STARTED|Overall Study||36
10978840|NCT00577720|12153250|FG002|STARTED|Overall Study||36
10978841|NCT00577720|12153251|FG003|STARTED|Overall Study||72
10978842|NCT00577720|12153248|FG000|ITT (Intent to Treat) Population|Overall Study||34
10978843|NCT00577720|12153249|FG001|ITT (Intent to Treat) Population|Overall Study||35
10978844|NCT00577720|12153250|FG002|ITT (Intent to Treat) Population|Overall Study||35
10978845|NCT00577720|12153251|FG003|ITT (Intent to Treat) Population|Overall Study||65
10978846|NCT00577720|12153248|FG000|COMPLETED|Overall Study||33
10978847|NCT00577720|12153249|FG001|COMPLETED|Overall Study||35
10978848|NCT00577720|12153250|FG002|COMPLETED|Overall Study||35
10978849|NCT00577720|12153251|FG003|COMPLETED|Overall Study||65
10978850|NCT00577720|12153248|FG000|NOT COMPLETED|Overall Study||4
10978851|NCT00577720|12153249|FG001|NOT COMPLETED|Overall Study||1
10978852|NCT00577720|12153250|FG002|NOT COMPLETED|Overall Study||1
10978853|NCT00577720|12153251|FG003|NOT COMPLETED|Overall Study||7
10978854|NCT00577824|12153264|FG000|STARTED|Overall Study|Started=Randomized|72
10978855|NCT00577824|12153265|FG001|STARTED|Overall Study||73
10978856|NCT00577824|12153266|FG002|STARTED|Overall Study||36
10978857|NCT00577824|12153264|FG000|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
10978858|NCT00577824|12153265|FG001|Full Analysis Set|Overall Study||72
10978859|NCT00577824|12153266|FG002|Full Analysis Set|Overall Study||35
10978860|NCT00577824|12153264|FG000|COMPLETED|Overall Study||65
10978861|NCT00577824|12153265|FG001|COMPLETED|Overall Study||53
10978862|NCT00577824|12153266|FG002|COMPLETED|Overall Study||34
10978863|NCT00577824|12153264|FG000|NOT COMPLETED|Overall Study||7
10978864|NCT00577824|12153265|FG001|NOT COMPLETED|Overall Study||20
10978865|NCT00577824|12153266|FG002|NOT COMPLETED|Overall Study||2
10978866|NCT00577863|12153276|FG000|STARTED|Overall Study||92
10978867|NCT00577863|12153277|FG001|STARTED|Overall Study||108
10978868|NCT00577863|12153276|FG000|Received at Least One Injection|Overall Study||92
10978869|NCT00577863|12153277|FG001|Received at Least One Injection|Overall Study||107
10978870|NCT00577863|12153276|FG000|COMPLETED|Overall Study||82
10978871|NCT00577863|12153277|FG001|COMPLETED|Overall Study||94
10978872|NCT00577863|12153276|FG000|NOT COMPLETED|Overall Study||10
10978873|NCT00577863|12153277|FG001|NOT COMPLETED|Overall Study||14
10978874|NCT00577889|12153286|FG000|STARTED|Overall Study||9
10978875|NCT00577889|12153287|FG001|STARTED|Overall Study||6
10978876|NCT00577889|12153288|FG002|STARTED|Overall Study||6
10978877|NCT00577889|12153286|FG000|COMPLETED|Overall Study||8
10978878|NCT00577889|12153287|FG001|COMPLETED|Overall Study||6
10978879|NCT00577889|12153288|FG002|COMPLETED|Overall Study||6
10978880|NCT00577889|12153286|FG000|NOT COMPLETED|Overall Study||1
10978881|NCT00577889|12153287|FG001|NOT COMPLETED|Overall Study||0
10978882|NCT00577889|12153288|FG002|NOT COMPLETED|Overall Study||0
10978883|NCT00577993|12153299|FG000|STARTED|Overall Study||85
10978884|NCT00577993|12153300|FG001|STARTED|Overall Study||90
10978885|NCT00577993|12153301|FG002|STARTED|Overall Study||35
10978886|NCT00577993|12153299|FG000|COMPLETED|Overall Study||78
10978887|NCT00577993|12153300|FG001|COMPLETED|Overall Study||80
10978888|NCT00577993|12153301|FG002|COMPLETED|Overall Study||32
10978889|NCT00577993|12153299|FG000|NOT COMPLETED|Overall Study||7
10978890|NCT00577993|12153300|FG001|NOT COMPLETED|Overall Study||10
10978891|NCT00577993|12153301|FG002|NOT COMPLETED|Overall Study||3
10978892|NCT00578071|12153307|FG000|STARTED|Overall Study||29
10978893|NCT00578071|12153307|FG000|COMPLETED|Overall Study||29
10978894|NCT00578071|12153307|FG000|NOT COMPLETED|Overall Study||0
10978895|NCT00578136|12153314|FG000|STARTED|Overall Study||27
10978896|NCT00578136|12153315|FG001|STARTED|Overall Study||27
10978897|NCT00578136|12153314|FG000|COMPLETED|Overall Study||26
10978898|NCT00578136|12153315|FG001|COMPLETED|Overall Study||26
10978899|NCT00578136|12153314|FG000|NOT COMPLETED|Overall Study||1
10978900|NCT00578136|12153315|FG001|NOT COMPLETED|Overall Study||1
10978901|NCT00578175|12153324|FG000|STARTED|Overall Study||705
10978902|NCT00578175|12153325|FG001|STARTED|Overall Study||689
10978903|NCT00578175|12153326|FG002|STARTED|Overall Study||389
10978904|NCT00578175|12153324|FG000|COMPLETED|Overall Study||635
10978905|NCT00578175|12153325|FG001|COMPLETED|Overall Study||646
10978906|NCT00578175|12153326|FG002|COMPLETED|Overall Study||365
10978907|NCT00578175|12153324|FG000|NOT COMPLETED|Overall Study||70
10978908|NCT00578175|12153325|FG001|NOT COMPLETED|Overall Study||43
10978909|NCT00578175|12153326|FG002|NOT COMPLETED|Overall Study||24
10978910|NCT00578214|12153339|FG000|STARTED|Overall Study||22
10978911|NCT00578214|12153340|FG001|STARTED|Overall Study||22
10978912|NCT00578214|12153341|FG002|STARTED|Overall Study||31
10978913|NCT00578214|12153339|FG000|COMPLETED|Overall Study||22
10978914|NCT00578214|12153340|FG001|COMPLETED|Overall Study||22
10978915|NCT00578214|12153341|FG002|COMPLETED|Overall Study||31
10978916|NCT00578214|12153339|FG000|NOT COMPLETED|Overall Study||0
10978917|NCT00578214|12153340|FG001|NOT COMPLETED|Overall Study||0
10978918|NCT00578214|12153341|FG002|NOT COMPLETED|Overall Study||0
10978919|NCT00578227|12153352|FG000|STARTED|Overall Study||272
10978920|NCT00578227|12153353|FG001|STARTED|Overall Study||270
10978921|NCT00578227|12153354|FG002|STARTED|Overall Study||271
10978922|NCT00578227|12153352|FG000|COMPLETED|Overall Study||267
10978923|NCT00578227|12153353|FG001|COMPLETED|Overall Study||268
10978924|NCT00578227|12153354|FG002|COMPLETED|Overall Study||267
10978925|NCT00578227|12153352|FG000|NOT COMPLETED|Overall Study||5
10978926|NCT00578227|12153353|FG001|NOT COMPLETED|Overall Study||2
10978927|NCT00578227|12153354|FG002|NOT COMPLETED|Overall Study||4
10978928|NCT00578279|12153366|FG000|STARTED|Overall Study||10
10978929|NCT00578279|12153367|FG001|STARTED|Overall Study||10
10978930|NCT00578279|12153366|FG000|COMPLETED|Overall Study||10
10978931|NCT00578279|12153367|FG001|COMPLETED|Overall Study||10
10978932|NCT00578279|12153366|FG000|NOT COMPLETED|Overall Study||0
10978933|NCT00578279|12153367|FG001|NOT COMPLETED|Overall Study||0
10978934|NCT00578292|12153373|FG000|STARTED|Overall Study||10
10978935|NCT00578292|12153373|FG000|COMPLETED|Overall Study||7
10978936|NCT00578292|12153373|FG000|NOT COMPLETED|Overall Study||3
10978937|NCT00578305|12153380|FG000|STARTED|Double-blind Treatment Phase||62
10978938|NCT00578305|12153381|FG001|STARTED|Double-blind Treatment Phase||60
10978939|NCT00578305|12153382|FG002|STARTED|Double-blind Treatment Phase||63
10978940|NCT00578305|12153380|FG000|Treated|Double-blind Treatment Phase||62
10978941|NCT00578305|12153381|FG001|Treated|Double-blind Treatment Phase||60
10978942|NCT00578305|12153382|FG002|Treated|Double-blind Treatment Phase||63
10978943|NCT00578305|12153380|FG000|COMPLETED|Double-blind Treatment Phase||59
10978944|NCT00578305|12153381|FG001|COMPLETED|Double-blind Treatment Phase||56
10978945|NCT00578305|12153382|FG002|COMPLETED|Double-blind Treatment Phase||49
10978946|NCT00578305|12153380|FG000|NOT COMPLETED|Double-blind Treatment Phase||3
10978947|NCT00578305|12153381|FG001|NOT COMPLETED|Double-blind Treatment Phase||4
10978948|NCT00578305|12153382|FG002|NOT COMPLETED|Double-blind Treatment Phase||14
10978949|NCT00578305|12153380|FG000|STARTED|Extension Phase||53
10978950|NCT00578305|12153381|FG001|STARTED|Extension Phase||50
10978951|NCT00578305|12153382|FG002|STARTED|Extension Phase||43
10978952|NCT00578305|12153380|FG000|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
10978953|NCT00578305|12153381|FG001|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
10978954|NCT00578305|12153382|FG002|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
10978955|NCT00578305|12153380|FG000|NOT COMPLETED|Extension Phase||4
10978956|NCT00578305|12153381|FG001|NOT COMPLETED|Extension Phase||1
10978957|NCT00578305|12153382|FG002|NOT COMPLETED|Extension Phase||3
10978958|NCT00578305|12153380|FG000|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
10978959|NCT00578305|12153381|FG001|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
10978960|NCT00578305|12153382|FG002|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
10978961|NCT00578305|12153380|FG000|COMPLETED|Safety Follow-up Phase||11
10978962|NCT00578305|12153381|FG001|COMPLETED|Safety Follow-up Phase||9
10978963|NCT00578305|12153382|FG002|COMPLETED|Safety Follow-up Phase||8
10978964|NCT00578305|12153380|FG000|NOT COMPLETED|Safety Follow-up Phase||46
10978965|NCT00578305|12153381|FG001|NOT COMPLETED|Safety Follow-up Phase||45
10978966|NCT00578305|12153382|FG002|NOT COMPLETED|Safety Follow-up Phase||46
10978967|NCT00578318|12153398|FG000|STARTED|Overall Study||8
10978968|NCT00578318|12153399|FG001|STARTED|Overall Study||8
10978969|NCT00578318|12153398|FG000|COMPLETED|Overall Study||5
10978970|NCT00578318|12153399|FG001|COMPLETED|Overall Study||8
10978971|NCT00578318|12153398|FG000|NOT COMPLETED|Overall Study||3
10978972|NCT00578318|12153399|FG001|NOT COMPLETED|Overall Study||0
10978973|NCT00578331|12153407|FG000|STARTED|Overall Study||445
10978974|NCT00578331|12153408|FG001|STARTED|Overall Study||445
10978975|NCT00578331|12153407|FG000|COMPLETED|Overall Study||329
10978976|NCT00578331|12153408|FG001|COMPLETED|Overall Study||320
10978977|NCT00578331|12153407|FG000|NOT COMPLETED|Overall Study||116
10978978|NCT00578331|12153408|FG001|NOT COMPLETED|Overall Study||125
10978979|NCT00578344|12153414|FG000|STARTED|Overall Study||8
10978980|NCT00578344|12153414|FG000|COMPLETED|Overall Study||6
10978981|NCT00578344|12153414|FG000|NOT COMPLETED|Overall Study||2
10978982|NCT00578383|12153422|FG000|STARTED|Overall Study||37
10978983|NCT00578383|12153423|FG001|STARTED|Overall Study||36
10978984|NCT00578383|12153424|FG002|STARTED|Overall Study||19
10978985|NCT00578383|12153425|FG003|STARTED|Overall Study||15
10978986|NCT00578383|12153422|FG000|COMPLETED|Overall Study||21
10978987|NCT00578383|12153423|FG001|COMPLETED|Overall Study||20
10978988|NCT00578383|12153424|FG002|COMPLETED|Overall Study||13
10978989|NCT00578383|12153425|FG003|COMPLETED|Overall Study||9
10978990|NCT00578383|12153422|FG000|NOT COMPLETED|Overall Study||16
10978991|NCT00578383|12153423|FG001|NOT COMPLETED|Overall Study||16
10978992|NCT00578383|12153424|FG002|NOT COMPLETED|Overall Study||6
10978993|NCT00578383|12153425|FG003|NOT COMPLETED|Overall Study||6
10978994|NCT00578448|12153439|FG000|STARTED|Day 1 up to 3 Years of Planned Study||12
10978995|NCT00578448|12153439|FG000|COMPLETED|Day 1 up to 3 Years of Planned Study||9
10978996|NCT00578448|12153439|FG000|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
10978997|NCT00578448|12153439|FG000|STARTED|1 Year Long Term Extension (LTE)||9
10978998|NCT00578448|12153439|FG000|COMPLETED|1 Year Long Term Extension (LTE)||8
10978999|NCT00578448|12153439|FG000|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
10979000|NCT00578461|12153445|FG000|STARTED|Overall Study||26
10979001|NCT00578461|12153445|FG000|COMPLETED|Overall Study||26
10979002|NCT00578461|12153445|FG000|NOT COMPLETED|Overall Study||0
10979003|NCT00578539|12153449|FG000|STARTED|Overall Study||24
10979004|NCT00578539|12153449|FG000|COMPLETED|Overall Study||24
10979005|NCT00578539|12153449|FG000|NOT COMPLETED|Overall Study||0
10979006|NCT00578552|12153456|FG000|STARTED|Overall Study||27
10979007|NCT00578552|12153457|FG001|STARTED|Overall Study||27
10979008|NCT00578552|12153458|FG002|STARTED|Overall Study||26
10979009|NCT00578552|12153456|FG000|COMPLETED|Overall Study||12
10979010|NCT00578552|12153457|FG001|COMPLETED|Overall Study||13
10979011|NCT00578552|12153458|FG002|COMPLETED|Overall Study||11
10979012|NCT00578552|12153456|FG000|NOT COMPLETED|Overall Study||15
10979013|NCT00578552|12153457|FG001|NOT COMPLETED|Overall Study||14
10979014|NCT00578552|12153458|FG002|NOT COMPLETED|Overall Study||15
10979015|NCT00578565|12153466|FG000|STARTED|Overall Study||10
10979016|NCT00578565|12153466|FG000|COMPLETED|Overall Study||7
10979017|NCT00578565|12153466|FG000|NOT COMPLETED|Overall Study||3
10979018|NCT00578617|12153473|FG000|STARTED|Overall Study||31
10979019|NCT00578617|12153474|FG001|STARTED|Overall Study||29
10979020|NCT00578617|12153473|FG000|COMPLETED|Overall Study||31
10979021|NCT00578617|12153474|FG001|COMPLETED|Overall Study||29
10979022|NCT00578617|12153473|FG000|NOT COMPLETED|Overall Study||0
10979023|NCT00578617|12153474|FG001|NOT COMPLETED|Overall Study||0
10979024|NCT00578643|12153480|FG000|STARTED|Overall Study||15
10979025|NCT00578643|12153480|FG000|COMPLETED|Overall Study||13
10979026|NCT00578643|12153480|FG000|NOT COMPLETED|Overall Study||2
10979027|NCT00578669|12153486|FG000|STARTED|Overall Study||107
10979028|NCT00578669|12153487|FG001|STARTED|Overall Study||99
10979029|NCT00578669|12153486|FG000|COMPLETED|Overall Study||107
10979030|NCT00578669|12153487|FG001|COMPLETED|Overall Study||99
10979031|NCT00578669|12153486|FG000|NOT COMPLETED|Overall Study||0
10979032|NCT00578669|12153487|FG001|NOT COMPLETED|Overall Study||0
10979033|NCT00578734|12153495|FG000|STARTED|Overall Study||84
10979034|NCT00578734|12153496|FG001|STARTED|Overall Study||81
10979035|NCT00578734|12153495|FG000|COMPLETED|Overall Study||84
10979036|NCT00578734|12153496|FG001|COMPLETED|Overall Study||81
10979037|NCT00578734|12153495|FG000|NOT COMPLETED|Overall Study||0
10979038|NCT00578734|12153496|FG001|NOT COMPLETED|Overall Study||0
10979039|NCT00578786|12153505|FG000|STARTED|Overall Study||96
10979040|NCT00578786|12153506|FG001|STARTED|Overall Study||190
10979041|NCT00578786|12153507|FG002|STARTED|Overall Study||97
10979042|NCT00578786|12153505|FG000|COMPLETED|Overall Study||57
10979043|NCT00578786|12153506|FG001|COMPLETED|Overall Study||124
10979044|NCT00578786|12153507|FG002|COMPLETED|Overall Study||67
10979045|NCT00578786|12153505|FG000|NOT COMPLETED|Overall Study||39
10979046|NCT00578786|12153506|FG001|NOT COMPLETED|Overall Study||66
10979047|NCT00578786|12153507|FG002|NOT COMPLETED|Overall Study||30
10979048|NCT00578812|12153527|FG000|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
10979049|NCT00578812|12153528|FG001|STARTED|Overall Study||192
10979050|NCT00578812|12153527|FG000|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
10979051|NCT00578812|12153528|FG001|COMPLETED|Overall Study||185
10979052|NCT00578812|12153527|FG000|NOT COMPLETED|Overall Study||6
10979053|NCT00578812|12153528|FG001|NOT COMPLETED|Overall Study||7
10979054|NCT00578864|12153537|FG000|STARTED|Overall Study||7
10979055|NCT00578864|12153538|FG001|STARTED|Overall Study||6
10979056|NCT00578864|12153537|FG000|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
10979057|NCT00578864|12153538|FG001|COMPLETED|Overall Study||6
10979058|NCT00578864|12153537|FG000|NOT COMPLETED|Overall Study||1
10979059|NCT00578864|12153538|FG001|NOT COMPLETED|Overall Study||0
10979060|NCT00578877|12153546|FG000|STARTED|Overall Study||150
10979061|NCT00578877|12153547|FG001|STARTED|Overall Study||300
10979062|NCT00578877|12153546|FG000|COMPLETED|Overall Study||69
10979063|NCT00578877|12153547|FG001|COMPLETED|Overall Study||172
10979064|NCT00578877|12153546|FG000|NOT COMPLETED|Overall Study||81
10979065|NCT00578877|12153547|FG001|NOT COMPLETED|Overall Study||128
10979066|NCT00578903|12153553|FG000|STARTED|Overall Study||22
10979067|NCT00578903|12153553|FG000|COMPLETED|Overall Study||22
10979068|NCT00578903|12153553|FG000|NOT COMPLETED|Overall Study||0
10979069|NCT00578929|12153561|FG000|STARTED|Vehicle Run-In Period||0
10979070|NCT00578929|12153562|FG001|STARTED|Vehicle Run-In Period||2388
10979071|NCT00578929|12153563|FG002|STARTED|Vehicle Run-In Period||0
10979072|NCT00578929|12153564|FG003|STARTED|Vehicle Run-In Period||0
10979073|NCT00578929|12153561|FG000|COMPLETED|Vehicle Run-In Period||0
10979074|NCT00578929|12153562|FG001|COMPLETED|Vehicle Run-In Period||2388
10979075|NCT00578929|12153563|FG002|COMPLETED|Vehicle Run-In Period||0
10979076|NCT00578929|12153564|FG003|COMPLETED|Vehicle Run-In Period||0
10979077|NCT00578929|12153561|FG000|NOT COMPLETED|Vehicle Run-In Period||0
10979078|NCT00578929|12153562|FG001|NOT COMPLETED|Vehicle Run-In Period||0
10979079|NCT00578929|12153563|FG002|NOT COMPLETED|Vehicle Run-In Period||0
10979080|NCT00578929|12153564|FG003|NOT COMPLETED|Vehicle Run-In Period||0
10979081|NCT00578929|12153561|FG000|STARTED|Randomized Period||298
10979082|NCT00578929|12153562|FG001|STARTED|Randomized Period||297
10979083|NCT00578929|12153563|FG002|STARTED|Randomized Period||296
10979084|NCT00578929|12153564|FG003|STARTED|Randomized Period||297
10979085|NCT00578929|12153561|FG000|COMPLETED|Randomized Period||281
10979086|NCT00578929|12153562|FG001|COMPLETED|Randomized Period||283
10979087|NCT00578929|12153563|FG002|COMPLETED|Randomized Period||288
10979088|NCT00578929|12153564|FG003|COMPLETED|Randomized Period||283
10979089|NCT00578929|12153561|FG000|NOT COMPLETED|Randomized Period||17
10979090|NCT00578929|12153562|FG001|NOT COMPLETED|Randomized Period||14
10979091|NCT00578929|12153563|FG002|NOT COMPLETED|Randomized Period||8
10979092|NCT00578929|12153564|FG003|NOT COMPLETED|Randomized Period||14
10979093|NCT00578942|12153575|FG000|STARTED|Overall Study||48
10979094|NCT00578942|12153575|FG000|COMPLETED|Overall Study||47
10979095|NCT00578942|12153575|FG000|NOT COMPLETED|Overall Study||1
10979096|NCT00578968|12153582|FG000|STARTED|Baseline (Prior to Intervention)||12
10979097|NCT00578968|12153583|FG001|STARTED|Baseline (Prior to Intervention)||12
10979098|NCT00578968|12153584|FG002|STARTED|Baseline (Prior to Intervention)||12
10979099|NCT00578968|12153582|FG000|COMPLETED|Baseline (Prior to Intervention)||12
10979100|NCT00578968|12153583|FG001|COMPLETED|Baseline (Prior to Intervention)||12
10979101|NCT00578968|12153584|FG002|COMPLETED|Baseline (Prior to Intervention)||12
10979102|NCT00578968|12153582|FG000|NOT COMPLETED|Baseline (Prior to Intervention)||0
10979103|NCT00578968|12153583|FG001|NOT COMPLETED|Baseline (Prior to Intervention)||0
10979104|NCT00578968|12153584|FG002|NOT COMPLETED|Baseline (Prior to Intervention)||0
10979105|NCT00578968|12153582|FG000|STARTED|Intervention||12
10979106|NCT00578968|12153583|FG001|STARTED|Intervention||12
10979107|NCT00578968|12153584|FG002|STARTED|Intervention||0
10979108|NCT00578968|12153582|FG000|COMPLETED|Intervention||12
10979109|NCT00578968|12153583|FG001|COMPLETED|Intervention||12
10979110|NCT00578968|12153584|FG002|COMPLETED|Intervention||0
10979111|NCT00578968|12153582|FG000|NOT COMPLETED|Intervention||0
10979112|NCT00578968|12153583|FG001|NOT COMPLETED|Intervention||0
10979113|NCT00578968|12153584|FG002|NOT COMPLETED|Intervention||0
10979114|NCT00579059|12153595|FG000|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
10979115|NCT00579059|12153596|FG001|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
10979116|NCT00579059|12153595|FG000|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
10979117|NCT00579059|12153596|FG001|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
10979118|NCT00579059|12153595|FG000|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
10979119|NCT00579059|12153596|FG001|6 Months|Overall Study|6 patients didn't return for follow-up.|4
10979120|NCT00579059|12153595|FG000|1 Year|Overall Study|13 patients didn't return for follow-up.|8
10979121|NCT00579059|12153596|FG001|1 Year|Overall Study|7 patients didn't return for follow-up.|3
10979122|NCT00579059|12153595|FG000|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
10979123|NCT00579059|12153596|FG001|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
10979124|NCT00579059|12153595|FG000|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
10979125|NCT00579059|12153596|FG001|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
10979126|NCT00579059|12153595|FG000|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
10979127|NCT00579059|12153596|FG001|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
10979128|NCT00579059|12153595|FG000|NOT COMPLETED|Overall Study||21
10979129|NCT00579059|12153596|FG001|NOT COMPLETED|Overall Study||10
10979130|NCT00579098|12153604|FG000|STARTED|Overall Study||62
10979131|NCT00579098|12153605|FG001|STARTED|Overall Study||63
10979132|NCT00579098|12153604|FG000|COMPLETED|Overall Study||53
10979133|NCT00579098|12153605|FG001|COMPLETED|Overall Study||55
10979134|NCT00579098|12153604|FG000|NOT COMPLETED|Overall Study||9
10979135|NCT00579098|12153605|FG001|NOT COMPLETED|Overall Study||8
10979136|NCT00579111|12153613|FG000|STARTED|Overall Study||3
10979137|NCT00579111|12153614|FG001|STARTED|Overall Study||1
10979138|NCT00579111|12153613|FG000|COMPLETED|Overall Study||1
10979139|NCT00579111|12153614|FG001|COMPLETED|Overall Study||0
10979140|NCT00579111|12153613|FG000|NOT COMPLETED|Overall Study||2
10979141|NCT00579111|12153614|FG001|NOT COMPLETED|Overall Study||1
10979142|NCT00579137|12153620|FG000|STARTED|Overall Study||3
10979143|NCT00579137|12153620|FG000|COMPLETED|Overall Study||3
10979144|NCT00579137|12153620|FG000|NOT COMPLETED|Overall Study||0
10979145|NCT00579280|12153627|FG000|STARTED|Overall Study||49
10979146|NCT00579280|12153628|FG001|STARTED|Overall Study||49
10979147|NCT00579280|12153629|FG002|STARTED|Overall Study||51
10979148|NCT00579280|12153627|FG000|COMPLETED|Overall Study|LOCF evaluable sample|47
10979149|NCT00579280|12153628|FG001|COMPLETED|Overall Study|LOCF evaluable sample|46
10979150|NCT00579280|12153629|FG002|COMPLETED|Overall Study|LOCF evaluable sample|51
10979151|NCT00579280|12153627|FG000|NOT COMPLETED|Overall Study||2
10979152|NCT00579280|12153628|FG001|NOT COMPLETED|Overall Study||3
10979153|NCT00579280|12153629|FG002|NOT COMPLETED|Overall Study||0
10979154|NCT00579345|12153645|FG000|STARTED|Overall Study||549
10979155|NCT00579345|12153646|FG001|STARTED|Overall Study||169
10979156|NCT00579345|12153647|FG002|STARTED|Overall Study||391
10979157|NCT00579345|12153648|FG003|STARTED|Overall Study||144
10979158|NCT00579345|12153649|FG004|STARTED|Overall Study||90
10979159|NCT00579345|12153650|FG005|STARTED|Overall Study||78
10979160|NCT00579345|12153651|FG006|STARTED|Overall Study||57
10979161|NCT00579345|12153652|FG007|STARTED|Overall Study||44
10979162|NCT00579345|12153645|FG000|COMPLETED|Overall Study||544
10979163|NCT00579345|12153646|FG001|COMPLETED|Overall Study||168
10979164|NCT00579345|12153647|FG002|COMPLETED|Overall Study||389
10979165|NCT00579345|12153648|FG003|COMPLETED|Overall Study||143
10979166|NCT00579345|12153649|FG004|COMPLETED|Overall Study||90
10979167|NCT00579345|12153650|FG005|COMPLETED|Overall Study||78
10979168|NCT00579345|12153651|FG006|COMPLETED|Overall Study||57
10979169|NCT00579345|12153652|FG007|COMPLETED|Overall Study||42
10979170|NCT00579345|12153645|FG000|NOT COMPLETED|Overall Study||5
10979171|NCT00579345|12153646|FG001|NOT COMPLETED|Overall Study||1
10979172|NCT00579345|12153647|FG002|NOT COMPLETED|Overall Study||2
10979173|NCT00579345|12153648|FG003|NOT COMPLETED|Overall Study||1
10979174|NCT00579345|12153649|FG004|NOT COMPLETED|Overall Study||0
10979175|NCT00579345|12153650|FG005|NOT COMPLETED|Overall Study||0
10979176|NCT00579345|12153651|FG006|NOT COMPLETED|Overall Study||0
10979177|NCT00579345|12153652|FG007|NOT COMPLETED|Overall Study||2
10979178|NCT00579436|12153682|FG000|STARTED|Overall Study||19
10979179|NCT00579436|12153683|FG001|STARTED|Overall Study||14
10979180|NCT00579436|12153682|FG000|COMPLETED|Overall Study||19
10979181|NCT00579436|12153683|FG001|COMPLETED|Overall Study||14
10979182|NCT00579436|12153682|FG000|NOT COMPLETED|Overall Study||0
10979183|NCT00579436|12153683|FG001|NOT COMPLETED|Overall Study||0
10979184|NCT00579501|12153689|FG000|STARTED|Overall Study||29
10979185|NCT00579501|12153689|FG000|COMPLETED|Overall Study||0
10979186|NCT00579501|12153689|FG000|NOT COMPLETED|Overall Study||29
10979187|NCT00579553|12153695|FG000|STARTED|Overall Study||82
10979188|NCT00579553|12153696|FG001|STARTED|Overall Study||92
10979189|NCT00579553|12153695|FG000|COMPLETED|Overall Study||66
10979190|NCT00579553|12153696|FG001|COMPLETED|Overall Study||79
10979191|NCT00579553|12153695|FG000|NOT COMPLETED|Overall Study||16
10979192|NCT00579553|12153696|FG001|NOT COMPLETED|Overall Study||13
10979193|NCT00579670|12153707|FG000|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
10979194|NCT00579670|12153708|FG001|STARTED|Overall Study||57
10979195|NCT00579670|12153709|FG002|STARTED|Overall Study||88
10979196|NCT00579670|12153710|FG003|STARTED|Overall Study||285
10979197|NCT00579670|12153711|FG004|STARTED|Overall Study||5
10979198|NCT00579670|12153707|FG000|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
10979199|NCT00579670|12153708|FG001|Population: Within SmPC (Started)|Overall Study||56
10979200|NCT00579670|12153709|FG002|Population: Within SmPC (Started)|Overall Study||83
10979201|NCT00579670|12153710|FG003|Population: Within SmPC (Started)|Overall Study||159
10979202|NCT00579670|12153711|FG004|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
10979203|NCT00579670|12153707|FG000|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
10979204|NCT00579670|12153708|FG001|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
10979205|NCT00579670|12153709|FG002|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
10979206|NCT00579670|12153710|FG003|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
10979207|NCT00579670|12153711|FG004|Population: Within SmPC (Completed)|Overall Study||0
10979208|NCT00579670|12153707|FG000|COMPLETED|Overall Study||13
10979209|NCT00579670|12153708|FG001|COMPLETED|Overall Study||56
10979210|NCT00579670|12153709|FG002|COMPLETED|Overall Study||84
10979211|NCT00579670|12153710|FG003|COMPLETED|Overall Study||263
10979212|NCT00579670|12153711|FG004|COMPLETED|Overall Study||5
10979213|NCT00579670|12153707|FG000|NOT COMPLETED|Overall Study||2
10979214|NCT00579670|12153708|FG001|NOT COMPLETED|Overall Study||1
10979215|NCT00579670|12153709|FG002|NOT COMPLETED|Overall Study||4
10979216|NCT00579670|12153710|FG003|NOT COMPLETED|Overall Study||22
10979217|NCT00579670|12153711|FG004|NOT COMPLETED|Overall Study||0
10979218|NCT00579813|12153737|FG000|STARTED|Overall Study||60
10979219|NCT00579813|12153738|FG001|STARTED|Overall Study||10
10979220|NCT00579813|12153737|FG000|COMPLETED|Overall Study||60
10979221|NCT00579813|12153738|FG001|COMPLETED|Overall Study||10
10979222|NCT00579813|12153737|FG000|NOT COMPLETED|Overall Study||0
10979223|NCT00579813|12153738|FG001|NOT COMPLETED|Overall Study||0
10979224|NCT00579878|12153748|FG000|STARTED|Overall Study||22
10979225|NCT00579878|12153749|FG001|STARTED|Overall Study||23
10979226|NCT00579878|12153750|FG002|STARTED|Overall Study||24
10979227|NCT00579878|12153748|FG000|COMPLETED|Overall Study||15
10979228|NCT00579878|12153749|FG001|COMPLETED|Overall Study||20
10979229|NCT00579878|12153750|FG002|COMPLETED|Overall Study||14
10979230|NCT00579878|12153748|FG000|NOT COMPLETED|Overall Study||7
10979231|NCT00579878|12153749|FG001|NOT COMPLETED|Overall Study||3
10979232|NCT00579878|12153750|FG002|NOT COMPLETED|Overall Study||10
10979233|NCT00579982|12153758|FG000|STARTED|Overall Study||97
10979234|NCT00579982|12153758|FG000|COMPLETED|Overall Study||89
10979235|NCT00579982|12153758|FG000|NOT COMPLETED|Overall Study||8
10979236|NCT00580034|12153762|FG000|STARTED|Overall Study||88
10979237|NCT00580034|12153763|FG001|STARTED|Overall Study||88
10979238|NCT00580034|12153762|FG000|COMPLETED|Overall Study||78
10979239|NCT00580034|12153763|FG001|COMPLETED|Overall Study||88
10979240|NCT00580034|12153762|FG000|NOT COMPLETED|Overall Study||10
10979241|NCT00580034|12153763|FG001|NOT COMPLETED|Overall Study||0
10979242|NCT00580047|12153770|FG000|STARTED|Overall Study||24
10979243|NCT00580047|12153771|FG001|STARTED|Overall Study||23
10979244|NCT00580047|12153772|FG002|STARTED|Overall Study||12
10979245|NCT00580047|12153770|FG000|COMPLETED|Overall Study||21
10979246|NCT00580047|12153771|FG001|COMPLETED|Overall Study||21
10979247|NCT00580047|12153772|FG002|COMPLETED|Overall Study||10
10979248|NCT00580047|12153770|FG000|NOT COMPLETED|Overall Study||3
10979249|NCT00580047|12153771|FG001|NOT COMPLETED|Overall Study||2
10979250|NCT00580047|12153772|FG002|NOT COMPLETED|Overall Study||2
10979251|NCT00580073|12153783|FG000|STARTED|Overall Study||6
10979252|NCT00580073|12153783|FG000|COMPLETED|Overall Study||6
10979253|NCT00580073|12153783|FG000|NOT COMPLETED|Overall Study||0
10979254|NCT00580138|12153787|FG000|STARTED|Overall Study||30
10979255|NCT00580138|12153787|FG000|COMPLETED|Overall Study||30
10979256|NCT00580138|12153787|FG000|NOT COMPLETED|Overall Study||0
10979257|NCT00580151|12153793|FG000|STARTED|Overall Study||9
10979258|NCT00580151|12153794|FG001|STARTED|Overall Study||0
10979259|NCT00580151|12153793|FG000|COMPLETED|Overall Study||9
10979260|NCT00580151|12153794|FG001|COMPLETED|Overall Study||0
10979261|NCT00580151|12153793|FG000|NOT COMPLETED|Overall Study||0
10979262|NCT00580151|12153794|FG001|NOT COMPLETED|Overall Study||0
10979263|NCT00580229|12153800|FG000|STARTED|Overall Study||50
10979264|NCT00580229|12153800|FG000|COMPLETED|Overall Study||50
10979265|NCT00580229|12153800|FG000|NOT COMPLETED|Overall Study||0
10979266|NCT00580294|12153804|FG000|STARTED|Overall Study||12
10979267|NCT00580294|12153804|FG000|COMPLETED|Overall Study||12
10979268|NCT00580294|12153804|FG000|NOT COMPLETED|Overall Study||0
10979269|NCT00580333|12153808|FG000|STARTED|Overall Study||51
10979270|NCT00580333|12153808|FG000|COMPLETED|Overall Study||51
10979271|NCT00580333|12153808|FG000|NOT COMPLETED|Overall Study||0
10979272|NCT00580372|12153813|FG000|STARTED|Overall Study||231
10979273|NCT00580372|12153813|FG000|COMPLETED|Overall Study||231
10979274|NCT00580372|12153813|FG000|NOT COMPLETED|Overall Study||0
10979275|NCT00580398|12153819|FG000|STARTED|Overall Study||17
10979276|NCT00580398|12153820|FG001|STARTED|Overall Study||32
10979277|NCT00580398|12153819|FG000|COMPLETED|Overall Study||17
10979278|NCT00580398|12153820|FG001|COMPLETED|Overall Study||32
10979279|NCT00580398|12153819|FG000|NOT COMPLETED|Overall Study||0
10979280|NCT00580398|12153820|FG001|NOT COMPLETED|Overall Study||0
10979281|NCT00580502|12153826|FG000|STARTED|Overall Study||50
10979282|NCT00580502|12153826|FG000|COMPLETED|Overall Study||50
10979283|NCT00580502|12153826|FG000|NOT COMPLETED|Overall Study||0
10979284|NCT00580606|12153832|FG000|STARTED|Double Blind (DB)||20
10979285|NCT00580606|12153833|FG001|STARTED|Double Blind (DB)||20
10979286|NCT00580606|12153832|FG000|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
10979287|NCT00580606|12153833|FG001|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
10979288|NCT00580606|12153832|FG000|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
10979289|NCT00580606|12153833|FG001|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
10979290|NCT00580606|12153832|FG000|NOT COMPLETED|Double Blind (DB)||0
10979291|NCT00580606|12153833|FG001|NOT COMPLETED|Double Blind (DB)||0
10979292|NCT00580606|12153832|FG000|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
10979293|NCT00580606|12153833|FG001|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
10979294|NCT00580606|12153832|FG000|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
10979295|NCT00580606|12153833|FG001|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
10979296|NCT00580606|12153832|FG000|Had Week 68 Oral Food Challenge|Open Label (OL)||15
10979297|NCT00580606|12153833|FG001|Had Week 68 Oral Food Challenge|Open Label (OL)||12
10979298|NCT00580606|12153832|FG000|Had Week 116 Oral Food Challenge|Open Label (OL)||13
10979299|NCT00580606|12153833|FG001|Had Week 116 Oral Food Challenge|Open Label (OL)||6
10979300|NCT00580606|12153832|FG000|Had Week 164 Oral Food Challenge|Open Label (OL)||9
10979301|NCT00580606|12153833|FG001|Had Week 164 Oral Food Challenge|Open Label (OL)||5
10979302|NCT00580606|12153832|FG000|Had Week 172 Oral Food Challenge|Open Label (OL)||2
10979303|NCT00580606|12153833|FG001|Had Week 172 Oral Food Challenge|Open Label (OL)||2
10979304|NCT00580606|12153832|FG000|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
10979305|NCT00580606|12153833|FG001|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
10979306|NCT00580606|12153832|FG000|NOT COMPLETED|Open Label (OL)||9
10979307|NCT00580606|12153833|FG001|NOT COMPLETED|Open Label (OL)||12
10979308|NCT00580645|12153850|FG000|STARTED|Overall Study||20
10979309|NCT00580645|12153851|FG001|STARTED|Overall Study||20
10979310|NCT00580645|12153852|FG002|STARTED|Overall Study||20
10979311|NCT00580645|12153850|FG000|COMPLETED|Overall Study||20
10979312|NCT00580645|12153851|FG001|COMPLETED|Overall Study||20
10979313|NCT00580645|12153852|FG002|COMPLETED|Overall Study||20
10979314|NCT00580645|12153850|FG000|NOT COMPLETED|Overall Study||0
10979315|NCT00580645|12153851|FG001|NOT COMPLETED|Overall Study||0
10979316|NCT00580645|12153852|FG002|NOT COMPLETED|Overall Study||0
10979317|NCT00580671|12153863|FG000|STARTED|Overall Study||51
10979318|NCT00580671|12153864|FG001|STARTED|Overall Study||51
10979319|NCT00580671|12153865|FG002|STARTED|Overall Study||51
10979320|NCT00580671|12153863|FG000|COMPLETED|Overall Study||35
10979321|NCT00580671|12153864|FG001|COMPLETED|Overall Study||35
10979322|NCT00580671|12153865|FG002|COMPLETED|Overall Study||34
10979323|NCT00580671|12153863|FG000|NOT COMPLETED|Overall Study||16
10979324|NCT00580671|12153864|FG001|NOT COMPLETED|Overall Study||16
10979325|NCT00580671|12153865|FG002|NOT COMPLETED|Overall Study||17
10979326|NCT00580723|12153873|FG000|STARTED|Overall Study||24
10979327|NCT00580723|12153873|FG000|COMPLETED|Overall Study||16
10979328|NCT00580723|12153873|FG000|NOT COMPLETED|Overall Study||8
10979329|NCT00580788|12153881|FG000|STARTED|Overall Study||3
10979330|NCT00580788|12153882|FG001|STARTED|Overall Study||6
10979331|NCT00580788|12153883|FG002|STARTED|Overall Study||3
10979332|NCT00580788|12153884|FG003|STARTED|Overall Study||2
10979333|NCT00580788|12153881|FG000|COMPLETED|Overall Study||3
10979334|NCT00580788|12153882|FG001|COMPLETED|Overall Study||6
10979335|NCT00580788|12153883|FG002|COMPLETED|Overall Study||3
10979336|NCT00580788|12153884|FG003|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
10979337|NCT00580788|12153881|FG000|NOT COMPLETED|Overall Study||0
10979338|NCT00580788|12153882|FG001|NOT COMPLETED|Overall Study||0
10979339|NCT00580788|12153883|FG002|NOT COMPLETED|Overall Study||0
10979340|NCT00580788|12153884|FG003|NOT COMPLETED|Overall Study||1
10979341|NCT00580801|12153904|FG000|STARTED|Overall Study||8
10979342|NCT00580801|12153905|FG001|STARTED|Overall Study||8
10979343|NCT00580801|12153906|FG002|STARTED|Overall Study||8
10979344|NCT00580801|12153904|FG000|COMPLETED|Overall Study||2
10979345|NCT00580801|12153905|FG001|COMPLETED|Overall Study||7
10979346|NCT00580801|12153906|FG002|COMPLETED|Overall Study||5
10979347|NCT00580801|12153904|FG000|NOT COMPLETED|Overall Study||6
10979348|NCT00580801|12153905|FG001|NOT COMPLETED|Overall Study||1
10979349|NCT00580801|12153906|FG002|NOT COMPLETED|Overall Study||3
10979350|NCT00580840|12153914|FG000|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
10979351|NCT00580840|12153915|FG001|STARTED|Run-in||0
10979352|NCT00580840|12153916|FG002|STARTED|Run-in||0
10979353|NCT00580840|12153917|FG003|STARTED|Run-in||0
10979354|NCT00580840|12153914|FG000|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
10979355|NCT00580840|12153915|FG001|COMPLETED|Run-in||0
10979356|NCT00580840|12153916|FG002|COMPLETED|Run-in||0
10979357|NCT00580840|12153917|FG003|COMPLETED|Run-in||0
10979358|NCT00580840|12153914|FG000|NOT COMPLETED|Run-in||124
10979359|NCT00580840|12153915|FG001|NOT COMPLETED|Run-in||0
10979360|NCT00580840|12153916|FG002|NOT COMPLETED|Run-in||0
10979361|NCT00580840|12153917|FG003|NOT COMPLETED|Run-in||0
10979362|NCT00580840|12153914|FG000|STARTED|Double-Blind||0
10979363|NCT00580840|12153915|FG001|STARTED|Double-Blind||70
10979364|NCT00580840|12153916|FG002|STARTED|Double-Blind||70
10979365|NCT00580840|12153917|FG003|STARTED|Double-Blind||69
10979366|NCT00580840|12153914|FG000|COMPLETED|Double-Blind||0
10979367|NCT00580840|12153915|FG001|COMPLETED|Double-Blind||63
10979368|NCT00580840|12153916|FG002|COMPLETED|Double-Blind||61
10979369|NCT00580840|12153917|FG003|COMPLETED|Double-Blind||54
10979370|NCT00580840|12153914|FG000|NOT COMPLETED|Double-Blind||0
10979371|NCT00580840|12153915|FG001|NOT COMPLETED|Double-Blind||7
10979372|NCT00580840|12153916|FG002|NOT COMPLETED|Double-Blind||9
10979373|NCT00580840|12153917|FG003|NOT COMPLETED|Double-Blind||15
10979374|NCT00580853|12153930|FG000|STARTED|Overall Study||20
10979375|NCT00580853|12153931|FG001|STARTED|Overall Study||21
10979376|NCT00580853|12153932|FG002|STARTED|Overall Study||21
10979377|NCT00580853|12153930|FG000|COMPLETED|Overall Study||20
10979378|NCT00580853|12153931|FG001|COMPLETED|Overall Study||21
10979379|NCT00580853|12153932|FG002|COMPLETED|Overall Study||21
10979380|NCT00580853|12153930|FG000|NOT COMPLETED|Overall Study||0
10979381|NCT00580853|12153931|FG001|NOT COMPLETED|Overall Study||0
10979382|NCT00580853|12153932|FG002|NOT COMPLETED|Overall Study||0
10979383|NCT00580866|12153942|FG000|STARTED|Overall Study||10
10979384|NCT00580866|12153943|FG001|STARTED|Overall Study||7
10979385|NCT00580866|12153942|FG000|COMPLETED|Overall Study||8
10979386|NCT00580866|12153943|FG001|COMPLETED|Overall Study||5
10979387|NCT00580866|12153942|FG000|NOT COMPLETED|Overall Study||2
10979388|NCT00580866|12153943|FG001|NOT COMPLETED|Overall Study||2
10979389|NCT00580957|12153951|FG000|STARTED|Overall Study||28
10979390|NCT00580957|12153952|FG001|STARTED|Overall Study||28
10979391|NCT00580957|12153951|FG000|COMPLETED|Overall Study||21
10979392|NCT00580957|12153952|FG001|COMPLETED|Overall Study||21
10979393|NCT00580957|12153951|FG000|NOT COMPLETED|Overall Study||7
10979394|NCT00580957|12153952|FG001|NOT COMPLETED|Overall Study||7
10979395|NCT00580970|12153960|FG000|STARTED|Pre-treatment||73
10979396|NCT00580970|12153960|FG000|COMPLETED|Pre-treatment||72
10979397|NCT00580970|12153960|FG000|NOT COMPLETED|Pre-treatment||1
10979398|NCT00580970|12153960|FG000|STARTED|Treatment (Lovastatin)||72
10979399|NCT00580970|12153960|FG000|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
10979400|NCT00580970|12153960|FG000|COMPLETED|Treatment (Lovastatin)||53
10979401|NCT00580970|12153960|FG000|NOT COMPLETED|Treatment (Lovastatin)||19
10979402|NCT00580983|12153964|FG000|STARTED|Overall Study||80
10979403|NCT00580983|12153964|FG000|COMPLETED|Overall Study||73
10979404|NCT00580983|12153964|FG000|NOT COMPLETED|Overall Study||7
10979405|NCT00581048|12153968|FG000|STARTED|Overall Study||33
10979406|NCT00581048|12153968|FG000|COMPLETED|Overall Study||33
10979407|NCT00581048|12153968|FG000|NOT COMPLETED|Overall Study||0
10979408|NCT00581061|12153973|FG000|STARTED|Overall Study||13
10979409|NCT00581061|12153973|FG000|COMPLETED|Overall Study||13
10979410|NCT00581061|12153973|FG000|NOT COMPLETED|Overall Study||0
10979411|NCT00581100|12153981|FG000|STARTED|Overall Study||38
10979412|NCT00581100|12153982|FG001|STARTED|Overall Study||34
10979413|NCT00581100|12153981|FG000|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
10979414|NCT00581100|12153982|FG001|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
10979415|NCT00581100|12153981|FG000|COMPLETED|Overall Study||31
10979416|NCT00581100|12153982|FG001|COMPLETED|Overall Study||29
10979417|NCT00581100|12153981|FG000|NOT COMPLETED|Overall Study||7
10979418|NCT00581100|12153982|FG001|NOT COMPLETED|Overall Study||5
10979419|NCT00581230|12153988|FG000|STARTED|Overall Study||51
10979420|NCT00581230|12153988|FG000|Laryngoscopy Without RAMP|Overall Study||51
10979421|NCT00581230|12153988|FG000|Laryngoscopy With RAMP|Overall Study||51
10979422|NCT00581230|12153988|FG000|COMPLETED|Overall Study||51
10979423|NCT00581230|12153988|FG000|NOT COMPLETED|Overall Study||0
10979424|NCT00581256|12153997|FG000|STARTED|Overall Study||28
10979425|NCT00581256|12153998|FG001|STARTED|Overall Study||26
10979426|NCT00581256|12153997|FG000|COMPLETED|Overall Study||28
10979427|NCT00581256|12153998|FG001|COMPLETED|Overall Study||26
10979428|NCT00581256|12153997|FG000|NOT COMPLETED|Overall Study||0
10979429|NCT00581256|12153998|FG001|NOT COMPLETED|Overall Study||0
10979430|NCT00581308|12154004|FG000|STARTED|Pre Discharge||215
10979431|NCT00581308|12154004|FG000|COMPLETED|Pre Discharge||213
10979432|NCT00581308|12154004|FG000|NOT COMPLETED|Pre Discharge||2
10979433|NCT00581308|12154004|FG000|STARTED|Month 1||213
10979434|NCT00581308|12154004|FG000|COMPLETED|Month 1||205
10979435|NCT00581308|12154004|FG000|NOT COMPLETED|Month 1||8
10979436|NCT00581308|12154004|FG000|STARTED|Month 6||205
10979437|NCT00581308|12154004|FG000|COMPLETED|Month 6||202
10979438|NCT00581308|12154004|FG000|NOT COMPLETED|Month 6||3
10979439|NCT00581308|12154004|FG000|STARTED|Month 12||202
10979440|NCT00581308|12154004|FG000|COMPLETED|Month 12||182
10979441|NCT00581308|12154004|FG000|NOT COMPLETED|Month 12||20
10979442|NCT00581308|12154004|FG000|STARTED|24 Months||182
10979443|NCT00581308|12154004|FG000|COMPLETED|24 Months||176
10979444|NCT00581308|12154004|FG000|NOT COMPLETED|24 Months||6
10979445|NCT00581308|12154004|FG000|STARTED|36 Months||176
10979446|NCT00581308|12154004|FG000|COMPLETED|36 Months||170
10979447|NCT00581308|12154004|FG000|NOT COMPLETED|36 Months||6
10979448|NCT00581308|12154004|FG000|STARTED|48 Months||170
10979449|NCT00581308|12154004|FG000|COMPLETED|48 Months||161
10979450|NCT00581308|12154004|FG000|NOT COMPLETED|48 Months||9
10979451|NCT00581308|12154004|FG000|STARTED|60 Months||161
10979452|NCT00581308|12154004|FG000|COMPLETED|60 Months||158
10979453|NCT00581308|12154004|FG000|NOT COMPLETED|60 Months||3
10979454|NCT00581347|12154013|FG000|STARTED|Overall Study||3839
10979455|NCT00581347|12154014|FG001|STARTED|Overall Study||3707
10979456|NCT00581347|12154013|FG000|COMPLETED|Overall Study||3839
10979457|NCT00581347|12154014|FG001|COMPLETED|Overall Study||3707
10979458|NCT00581347|12154013|FG000|NOT COMPLETED|Overall Study||0
10979459|NCT00581347|12154014|FG001|NOT COMPLETED|Overall Study||0
10979460|NCT00581360|12154020|FG000|STARTED|Overall Study||10
10979461|NCT00581360|12154020|FG000|COMPLETED|Overall Study||9
10979462|NCT00581360|12154020|FG000|NOT COMPLETED|Overall Study||1
10979463|NCT00581386|12154027|FG000|STARTED|Overall Study|05/30/2007|73
10979464|NCT00581386|12154028|FG001|STARTED|Overall Study|05/30/2007|73
10979465|NCT00581386|12154029|FG002|STARTED|Overall Study|05/30/2007|72
10979466|NCT00581386|12154027|FG000|COMPLETED|Overall Study|04/15/2009|73
10979467|NCT00581386|12154028|FG001|COMPLETED|Overall Study|04/15/2009|73
10979468|NCT00581386|12154029|FG002|COMPLETED|Overall Study|04/15/2009|72
10979469|NCT00581386|12154027|FG000|NOT COMPLETED|Overall Study||0
10979470|NCT00581386|12154028|FG001|NOT COMPLETED|Overall Study||0
10979471|NCT00581386|12154029|FG002|NOT COMPLETED|Overall Study||0
10979472|NCT00581399|12154039|FG000|STARTED|Overall Study||46
10979473|NCT00581399|12154040|FG001|STARTED|Overall Study||48
10979474|NCT00581399|12154039|FG000|COMPLETED|Overall Study||46
10979475|NCT00581399|12154040|FG001|COMPLETED|Overall Study||48
10979476|NCT00581399|12154039|FG000|NOT COMPLETED|Overall Study||0
10979477|NCT00581399|12154040|FG001|NOT COMPLETED|Overall Study||0
10979478|NCT00581529|12154046|FG000|STARTED|Overall Study||34
10979479|NCT00581529|12154046|FG000|COMPLETED|Overall Study||34
10979480|NCT00581529|12154046|FG000|NOT COMPLETED|Overall Study||0
10979481|NCT00581542|12154052|FG000|STARTED|Overall Study||62
10979482|NCT00581542|12154053|FG001|STARTED|Overall Study||62
10979483|NCT00581542|12154052|FG000|COMPLETED|Overall Study||51
10979484|NCT00581542|12154053|FG001|COMPLETED|Overall Study||39
10979485|NCT00581542|12154052|FG000|NOT COMPLETED|Overall Study||11
10979486|NCT00581542|12154053|FG001|NOT COMPLETED|Overall Study||23
10979487|NCT00581555|12154063|FG000|STARTED|Overall Study||62
10979488|NCT00581555|12154064|FG001|STARTED|Overall Study||58
10979489|NCT00581555|12154063|FG000|COMPLETED|Overall Study||19
10979490|NCT00581555|12154064|FG001|COMPLETED|Overall Study||38
10979491|NCT00581555|12154063|FG000|NOT COMPLETED|Overall Study||43
10979492|NCT00581555|12154064|FG001|NOT COMPLETED|Overall Study||20
10979493|NCT00581581|12154072|FG000|STARTED|Overall Study||32
10979494|NCT00581581|12154073|FG001|STARTED|Overall Study||30
10979495|NCT00581581|12154072|FG000|COMPLETED|Overall Study||32
10979496|NCT00581581|12154073|FG001|COMPLETED|Overall Study||30
10979497|NCT00581581|12154072|FG000|NOT COMPLETED|Overall Study||0
10979498|NCT00581581|12154073|FG001|NOT COMPLETED|Overall Study||0
10979499|NCT00581776|12154079|FG000|STARTED|Overall Study||30
10979500|NCT00581776|12154079|FG000|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
10979501|NCT00581776|12154079|FG000|NOT COMPLETED|Overall Study||3
10979502|NCT00581828|12154083|FG000|STARTED|Overall Study||19
10979503|NCT00581828|12154083|FG000|COMPLETED|Overall Study||18
10979504|NCT00581828|12154083|FG000|NOT COMPLETED|Overall Study||1
10979505|NCT00581854|12154087|FG000|STARTED|Overall Study||22
10979506|NCT00581854|12154087|FG000|COMPLETED|Overall Study||22
10979507|NCT00581854|12154087|FG000|NOT COMPLETED|Overall Study||0
10979508|NCT00581867|12154091|FG000|STARTED|First Intervention||16
10979509|NCT00581867|12154092|FG001|STARTED|First Intervention||15
10979510|NCT00581867|12154091|FG000|COMPLETED|First Intervention||16
10979511|NCT00581867|12154092|FG001|COMPLETED|First Intervention||15
10979512|NCT00581867|12154091|FG000|NOT COMPLETED|First Intervention||0
10979513|NCT00581867|12154092|FG001|NOT COMPLETED|First Intervention||0
10979514|NCT00581867|12154091|FG000|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
10979515|NCT00581867|12154092|FG001|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
10979516|NCT00581867|12154091|FG000|COMPLETED|Second Intervention||15
10979517|NCT00581867|12154092|FG001|COMPLETED|Second Intervention||14
10979518|NCT00581867|12154091|FG000|NOT COMPLETED|Second Intervention||0
10979519|NCT00581867|12154092|FG001|NOT COMPLETED|Second Intervention||0
10979520|NCT00581893|12154098|FG000|STARTED|First Intervention (1 Month)||10
10979521|NCT00581893|12154099|FG001|STARTED|First Intervention (1 Month)||10
10979522|NCT00581893|12154098|FG000|COMPLETED|First Intervention (1 Month)||10
10979523|NCT00581893|12154099|FG001|COMPLETED|First Intervention (1 Month)||10
10979524|NCT00581893|12154098|FG000|NOT COMPLETED|First Intervention (1 Month)||0
10979525|NCT00581893|12154099|FG001|NOT COMPLETED|First Intervention (1 Month)||0
10979526|NCT00581893|12154098|FG000|STARTED|Washout (14 Days)||10
10979527|NCT00581893|12154099|FG001|STARTED|Washout (14 Days)||10
10979528|NCT00581893|12154098|FG000|COMPLETED|Washout (14 Days)||10
10979529|NCT00581893|12154099|FG001|COMPLETED|Washout (14 Days)||10
10979530|NCT00581893|12154098|FG000|NOT COMPLETED|Washout (14 Days)||0
10979531|NCT00581893|12154099|FG001|NOT COMPLETED|Washout (14 Days)||0
10979532|NCT00581893|12154098|FG000|STARTED|Second Intervention (1 Month)||10
10979533|NCT00581893|12154099|FG001|STARTED|Second Intervention (1 Month)||10
10979534|NCT00581893|12154098|FG000|COMPLETED|Second Intervention (1 Month)||7
10979535|NCT00581893|12154099|FG001|COMPLETED|Second Intervention (1 Month)||8
10979536|NCT00581893|12154098|FG000|NOT COMPLETED|Second Intervention (1 Month)||3
10979537|NCT00581893|12154099|FG001|NOT COMPLETED|Second Intervention (1 Month)||2
10979538|NCT00581919|12154105|FG000|STARTED|Overall Study||32
10979539|NCT00581919|12154105|FG000|COMPLETED|Overall Study||8
10979540|NCT00581919|12154105|FG000|NOT COMPLETED|Overall Study||24
10979541|NCT00581945|12154112|FG000|STARTED|Overall Study||74
10979542|NCT00581945|12154113|FG001|STARTED|Overall Study||73
10979543|NCT00581945|12154112|FG000|COMPLETED|Overall Study||65
10979544|NCT00581945|12154113|FG001|COMPLETED|Overall Study||63
10979545|NCT00581945|12154112|FG000|NOT COMPLETED|Overall Study||9
10979546|NCT00581945|12154113|FG001|NOT COMPLETED|Overall Study||10
10979547|NCT00581971|12154119|FG000|STARTED|Overall Study||30
10979548|NCT00581971|12154119|FG000|COMPLETED|Overall Study||30
10979549|NCT00581971|12154119|FG000|NOT COMPLETED|Overall Study||0
10979550|NCT00582010|12154126|FG000|STARTED|Overall Study||40
10979551|NCT00582010|12154127|FG001|STARTED|Overall Study||40
10979552|NCT00582010|12154126|FG000|COMPLETED|Overall Study||40
10979553|NCT00582010|12154127|FG001|COMPLETED|Overall Study||39
10979554|NCT00582010|12154126|FG000|NOT COMPLETED|Overall Study||0
10979555|NCT00582010|12154127|FG001|NOT COMPLETED|Overall Study||1
10979556|NCT00582075|12154133|FG000|STARTED|Overall Study||25
10979557|NCT00582075|12154133|FG000|COMPLETED|Overall Study||25
10979558|NCT00582075|12154133|FG000|NOT COMPLETED|Overall Study||0
10979559|NCT00582114|12154139|FG000|STARTED|Overall Study||100
10979560|NCT00582114|12154140|FG001|STARTED|Overall Study||100
10979561|NCT00582114|12154139|FG000|COMPLETED|Overall Study||58
10979562|NCT00582114|12154140|FG001|COMPLETED|Overall Study||46
10979563|NCT00582114|12154139|FG000|NOT COMPLETED|Overall Study||42
10979564|NCT00582114|12154140|FG001|NOT COMPLETED|Overall Study||54
10979565|NCT00582166|12154146|FG000|STARTED|Overall Study||18
10979566|NCT00582166|12154146|FG000|COMPLETED|Overall Study||16
10979567|NCT00582166|12154146|FG000|NOT COMPLETED|Overall Study||2
10979568|NCT00582205|12154150|FG000|STARTED|Overall Study||21
10979569|NCT00582205|12154150|FG000|COMPLETED|Overall Study||11
10979570|NCT00582205|12154150|FG000|NOT COMPLETED|Overall Study||10
10979571|NCT00582309|12154157|FG000|STARTED|Overall Study||56
10979572|NCT00582309|12154158|FG001|STARTED|Overall Study||49
10979573|NCT00582309|12154159|FG002|STARTED|Overall Study||46
10979574|NCT00582309|12154157|FG000|COMPLETED|Overall Study||56
10979575|NCT00582309|12154158|FG001|COMPLETED|Overall Study||49
10979576|NCT00582309|12154159|FG002|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
10979577|NCT00582309|12154157|FG000|NOT COMPLETED|Overall Study||0
10979578|NCT00582309|12154158|FG001|NOT COMPLETED|Overall Study||0
10979579|NCT00582309|12154159|FG002|NOT COMPLETED|Overall Study||2
10979580|NCT00582361|12154169|FG000|STARTED|Overall Study||25
10979581|NCT00582361|12154170|FG001|STARTED|Overall Study||38
10979582|NCT00582361|12154169|FG000|COMPLETED|Overall Study||25
10979583|NCT00582361|12154170|FG001|COMPLETED|Overall Study||38
10979584|NCT00582361|12154169|FG000|NOT COMPLETED|Overall Study||0
10979585|NCT00582361|12154170|FG001|NOT COMPLETED|Overall Study||0
10979586|NCT00582400|12154176|FG000|STARTED|Overall Study||9
10979587|NCT00582400|12154176|FG000|COMPLETED|Overall Study||6
10979588|NCT00582400|12154176|FG000|NOT COMPLETED|Overall Study||3
10979589|NCT00582426|12154182|FG000|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
10979590|NCT00582426|12154183|FG001|STARTED|Overall Study||71
10979591|NCT00582426|12154182|FG000|COMPLETED|Overall Study||48
10979592|NCT00582426|12154183|FG001|COMPLETED|Overall Study||58
10979593|NCT00582426|12154182|FG000|NOT COMPLETED|Overall Study||20
10979594|NCT00582426|12154183|FG001|NOT COMPLETED|Overall Study||13
10979595|NCT00582491|12154191|FG000|STARTED|Overall Study||11
10979596|NCT00582491|12154192|FG001|STARTED|Overall Study||10
10979597|NCT00582491|12154191|FG000|COMPLETED|Overall Study||10
10979598|NCT00582491|12154192|FG001|COMPLETED|Overall Study||10
10979599|NCT00582491|12154191|FG000|NOT COMPLETED|Overall Study||1
10979600|NCT00582491|12154192|FG001|NOT COMPLETED|Overall Study||0
10979601|NCT00582517|12154200|FG000|STARTED|Overall Study||45
10979602|NCT00582517|12154201|FG001|STARTED|Overall Study||55
10979603|NCT00582517|12154200|FG000|COMPLETED|Overall Study||45
10979604|NCT00582517|12154201|FG001|COMPLETED|Overall Study||55
10979605|NCT00582517|12154200|FG000|NOT COMPLETED|Overall Study||0
10979606|NCT00582517|12154201|FG001|NOT COMPLETED|Overall Study||0
10979607|NCT00582556|12154210|FG000|STARTED|Overall Study||14
10979608|NCT00582556|12154211|FG001|STARTED|Overall Study||15
10979609|NCT00582556|12154212|FG002|STARTED|Overall Study||14
10979610|NCT00582556|12154210|FG000|COMPLETED|Overall Study||14
10979611|NCT00582556|12154211|FG001|COMPLETED|Overall Study||14
10979612|NCT00582556|12154212|FG002|COMPLETED|Overall Study||12
10979613|NCT00582556|12154210|FG000|NOT COMPLETED|Overall Study||0
10979614|NCT00582556|12154211|FG001|NOT COMPLETED|Overall Study||1
10979615|NCT00582556|12154212|FG002|NOT COMPLETED|Overall Study||2
10979616|NCT00582608|12154221|FG000|STARTED|Overall Study||12
10979617|NCT00582608|12154221|FG000|COMPLETED|Overall Study||0
10979618|NCT00582608|12154221|FG000|NOT COMPLETED|Overall Study||12
10979619|NCT00582660|12154227|FG000|STARTED|Overall Study||20
10979620|NCT00582660|12154228|FG001|STARTED|Overall Study||20
10979621|NCT00582660|12154227|FG000|COMPLETED|Overall Study||20
10979622|NCT00582660|12154228|FG001|COMPLETED|Overall Study||20
10979623|NCT00582660|12154227|FG000|NOT COMPLETED|Overall Study||0
10979624|NCT00582660|12154228|FG001|NOT COMPLETED|Overall Study||0
10979625|NCT00582738|12154236|FG000|STARTED|Overall Study||21
10979626|NCT00582738|12154237|FG001|STARTED|Overall Study||22
10979627|NCT00582738|12154236|FG000|COMPLETED|Overall Study||12
10979628|NCT00582738|12154237|FG001|COMPLETED|Overall Study||4
10979629|NCT00582738|12154236|FG000|NOT COMPLETED|Overall Study||9
10979630|NCT00582738|12154237|FG001|NOT COMPLETED|Overall Study||18
10979631|NCT00582790|12154249|FG000|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
10979632|NCT00582790|12154249|FG000|COMPLETED|Overall Study||11
10979633|NCT00582790|12154249|FG000|NOT COMPLETED|Overall Study||1
10979634|NCT00582816|12154254|FG000|STARTED|Overall Study||9
10979635|NCT00582816|12154254|FG000|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
10979636|NCT00582816|12154254|FG000|NOT COMPLETED|Overall Study||3
10979637|NCT00582894|12154258|FG000|STARTED|Overall Study||17
10979638|NCT00582894|12154258|FG000|Day 100 Post Transplant|Overall Study||17
10979639|NCT00582894|12154258|FG000|COMPLETED|Overall Study||17
10979640|NCT00582894|12154258|FG000|NOT COMPLETED|Overall Study||0
10979641|NCT00582907|12154262|FG000|STARTED|1st Course||4
10979642|NCT00582907|12154263|FG001|STARTED|1st Course||3
10979643|NCT00582907|12154264|FG002|STARTED|1st Course||3
10979644|NCT00582907|12154265|FG003|STARTED|1st Course||4
10979645|NCT00582907|12154262|FG000|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
10979646|NCT00582907|12154263|FG001|COMPLETED|1st Course||3
10979647|NCT00582907|12154264|FG002|COMPLETED|1st Course||3
10979648|NCT00582907|12154265|FG003|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
10979649|NCT00582907|12154262|FG000|NOT COMPLETED|1st Course||1
10979650|NCT00582907|12154263|FG001|NOT COMPLETED|1st Course||0
10979651|NCT00582907|12154264|FG002|NOT COMPLETED|1st Course||0
10979652|NCT00582907|12154265|FG003|NOT COMPLETED|1st Course||1
10979653|NCT00582907|12154262|FG000|STARTED|2nd Course||3
10979654|NCT00582907|12154263|FG001|STARTED|2nd Course||3
10979655|NCT00582907|12154264|FG002|STARTED|2nd Course||3
10979656|NCT00582907|12154265|FG003|STARTED|2nd Course||3
10979657|NCT00582907|12154262|FG000|COMPLETED|2nd Course||2
10979658|NCT00582907|12154263|FG001|COMPLETED|2nd Course||3
10979659|NCT00582907|12154264|FG002|COMPLETED|2nd Course||3
10979660|NCT00582907|12154265|FG003|COMPLETED|2nd Course||3
10979661|NCT00582907|12154262|FG000|NOT COMPLETED|2nd Course||1
10979662|NCT00582907|12154263|FG001|NOT COMPLETED|2nd Course||0
10979663|NCT00582907|12154264|FG002|NOT COMPLETED|2nd Course||0
10979664|NCT00582907|12154265|FG003|NOT COMPLETED|2nd Course||0
10979665|NCT00582907|12154262|FG000|STARTED|3rd Course||2
10979666|NCT00582907|12154263|FG001|STARTED|3rd Course||3
10979667|NCT00582907|12154264|FG002|STARTED|3rd Course||3
10979668|NCT00582907|12154265|FG003|STARTED|3rd Course||3
10979669|NCT00582907|12154262|FG000|COMPLETED|3rd Course||2
10979670|NCT00582907|12154263|FG001|COMPLETED|3rd Course||3
10979671|NCT00582907|12154264|FG002|COMPLETED|3rd Course||3
10979672|NCT00582907|12154265|FG003|COMPLETED|3rd Course||3
10979673|NCT00582907|12154262|FG000|NOT COMPLETED|3rd Course||0
10979674|NCT00582907|12154263|FG001|NOT COMPLETED|3rd Course||0
10979675|NCT00582907|12154264|FG002|NOT COMPLETED|3rd Course||0
10979676|NCT00582907|12154265|FG003|NOT COMPLETED|3rd Course||0
10979677|NCT00582907|12154262|FG000|STARTED|4th Course||2
10979678|NCT00582907|12154263|FG001|STARTED|4th Course||3
10979679|NCT00582907|12154264|FG002|STARTED|4th Course||3
10979680|NCT00582907|12154265|FG003|STARTED|4th Course||3
10979681|NCT00582907|12154262|FG000|COMPLETED|4th Course||2
10979682|NCT00582907|12154263|FG001|COMPLETED|4th Course||3
10979683|NCT00582907|12154264|FG002|COMPLETED|4th Course||3
10979684|NCT00582907|12154265|FG003|COMPLETED|4th Course||3
10979685|NCT00582907|12154262|FG000|NOT COMPLETED|4th Course||0
10979686|NCT00582907|12154263|FG001|NOT COMPLETED|4th Course||0
10979687|NCT00582907|12154264|FG002|NOT COMPLETED|4th Course||0
10979688|NCT00582907|12154265|FG003|NOT COMPLETED|4th Course||0
10979689|NCT00582933|12154271|FG000|STARTED|Overall Study||95
10979690|NCT00582933|12154271|FG000|COMPLETED|Overall Study||92
10979691|NCT00582933|12154271|FG000|NOT COMPLETED|Overall Study||3
10979692|NCT00582946|12154275|FG000|STARTED|Overall Study||16
10979693|NCT00582946|12154275|FG000|COMPLETED|Overall Study||16
10979694|NCT00582946|12154275|FG000|NOT COMPLETED|Overall Study||0
10979695|NCT00582972|12154279|FG000|STARTED|Overall Study||23
10979696|NCT00582972|12154279|FG000|COMPLETED|Overall Study||21
10979697|NCT00582972|12154279|FG000|NOT COMPLETED|Overall Study||2
10979698|NCT00582998|12154286|FG000|STARTED|Overall Study||119
10979699|NCT00582998|12154287|FG001|STARTED|Overall Study||130
10979700|NCT00582998|12154286|FG000|COMPLETED|Overall Study||119
10979701|NCT00582998|12154287|FG001|COMPLETED|Overall Study||130
10979702|NCT00582998|12154286|FG000|NOT COMPLETED|Overall Study||0
10979703|NCT00582998|12154287|FG001|NOT COMPLETED|Overall Study||0
10979704|NCT00583011|12154295|FG000|STARTED|Overall Study||36
10979705|NCT00583011|12154296|FG001|STARTED|Overall Study||40
10979706|NCT00583011|12154295|FG000|COMPLETED|Overall Study||36
10979707|NCT00583011|12154296|FG001|COMPLETED|Overall Study||40
10979708|NCT00583011|12154295|FG000|NOT COMPLETED|Overall Study||0
10979709|NCT00583011|12154296|FG001|NOT COMPLETED|Overall Study||0
10979710|NCT00583050|12154303|FG000|STARTED|Overall Study||1366
10979711|NCT00583050|12154303|FG000|COMPLETED|Overall Study||1366
10979712|NCT00583050|12154303|FG000|NOT COMPLETED|Overall Study||0
10979713|NCT00583102|12154307|FG000|STARTED|Overall Study||23
10979714|NCT00583102|12154307|FG000|COMPLETED|Overall Study||20
10979715|NCT00583102|12154307|FG000|NOT COMPLETED|Overall Study||3
10979716|NCT00583219|12154311|FG000|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
10979717|NCT00583219|12154311|FG000|COMPLETED|Phase 1||9
10979718|NCT00583219|12154311|FG000|NOT COMPLETED|Phase 1||0
10979719|NCT00583219|12154311|FG000|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
10979720|NCT00583219|12154311|FG000|COMPLETED|Phase 2||21
10979721|NCT00583219|12154311|FG000|NOT COMPLETED|Phase 2||1
10979722|NCT00583362|12154315|FG000|STARTED|Overall Study||298
10979723|NCT00583362|12154315|FG000|COMPLETED|Overall Study||96
10979724|NCT00583362|12154315|FG000|NOT COMPLETED|Overall Study||202
10979725|NCT00583375|12154321|FG000|STARTED|Overall Study||142
10979726|NCT00583375|12154322|FG001|STARTED|Overall Study||272
10979727|NCT00583375|12154321|FG000|COMPLETED|Overall Study||142
10979728|NCT00583375|12154322|FG001|COMPLETED|Overall Study||272
10979729|NCT00583375|12154321|FG000|NOT COMPLETED|Overall Study||0
10979730|NCT00583375|12154322|FG001|NOT COMPLETED|Overall Study||0
10979731|NCT00583414|12154328|FG000|STARTED|Overall Study||401
10979732|NCT00583414|12154328|FG000|COMPLETED|Overall Study||401
10979733|NCT00583414|12154328|FG000|NOT COMPLETED|Overall Study||0
10979734|NCT00583453|12154334|FG000|STARTED|Overall Study||9
10979735|NCT00583453|12154335|FG001|STARTED|Overall Study||8
10979736|NCT00583453|12154334|FG000|COMPLETED|Overall Study||9
10979737|NCT00583453|12154335|FG001|COMPLETED|Overall Study||6
10979738|NCT00583453|12154334|FG000|NOT COMPLETED|Overall Study||0
10979739|NCT00583453|12154335|FG001|NOT COMPLETED|Overall Study||2
10979740|NCT00583492|12154345|FG000|STARTED|Overall Study||21
10979741|NCT00583492|12154346|FG001|STARTED|Overall Study||23
10979742|NCT00583492|12154345|FG000|COMPLETED|Overall Study||21
10979743|NCT00583492|12154346|FG001|COMPLETED|Overall Study||23
10979744|NCT00583492|12154345|FG000|NOT COMPLETED|Overall Study||0
10979745|NCT00583492|12154346|FG001|NOT COMPLETED|Overall Study||0
10979746|NCT00583557|12154352|FG000|STARTED|Overall Study||155
10979747|NCT00583557|12154352|FG000|Received at Least 1 Dose Belimumab|Overall Study||153
10979748|NCT00583557|12154352|FG000|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
10979749|NCT00583557|12154352|FG000|NOT COMPLETED|Overall Study||70
10979750|NCT00583596|12154356|FG000|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
10979751|NCT00583596|12154356|FG000|COMPLETED|Overall Study||152
10979752|NCT00583596|12154356|FG000|NOT COMPLETED|Overall Study||284
10979753|NCT00583622|12154361|FG000|STARTED|Overall Study||12
10979754|NCT00583622|12154361|FG000|COMPLETED|Overall Study||12
10979755|NCT00583622|12154361|FG000|NOT COMPLETED|Overall Study||0
10979756|NCT00583661|12154365|FG000|STARTED|Overall Study||48
10979757|NCT00583661|12154365|FG000|COMPLETED|Overall Study||48
10979758|NCT00583661|12154365|FG000|NOT COMPLETED|Overall Study||0
10979759|NCT00583700|12154372|FG000|STARTED|Overall Study||27
10979760|NCT00583700|12154373|FG001|STARTED|Overall Study||27
10979761|NCT00583700|12154372|FG000|COMPLETED|Overall Study||24
10979762|NCT00583700|12154373|FG001|COMPLETED|Overall Study||23
10979763|NCT00583700|12154372|FG000|NOT COMPLETED|Overall Study||3
10979764|NCT00583700|12154373|FG001|NOT COMPLETED|Overall Study||4
10979765|NCT00583713|12154382|FG000|STARTED|Overall Study||6
10979766|NCT00583713|12154383|FG001|STARTED|Overall Study||6
10979767|NCT00583713|12154384|FG002|STARTED|Overall Study||6
10979768|NCT00583713|12154382|FG000|COMPLETED|Overall Study||6
10979769|NCT00583713|12154383|FG001|COMPLETED|Overall Study||6
10979770|NCT00583713|12154384|FG002|COMPLETED|Overall Study||6
10979771|NCT00583713|12154382|FG000|NOT COMPLETED|Overall Study||0
10979772|NCT00583713|12154383|FG001|NOT COMPLETED|Overall Study||0
10979773|NCT00583713|12154384|FG002|NOT COMPLETED|Overall Study||0
10979774|NCT00583791|12154392|FG000|STARTED|Overall Study||91
10979775|NCT00583791|12154392|FG000|COMPLETED|Overall Study||18
10979776|NCT00583791|12154392|FG000|NOT COMPLETED|Overall Study||73
10979777|NCT00583908|12154396|FG000|STARTED|Period 1 - First Intervention||1
10979778|NCT00583908|12154397|FG001|STARTED|Period 1 - First Intervention||2
10979779|NCT00583908|12154398|FG002|STARTED|Period 1 - First Intervention||1
10979780|NCT00583908|12154399|FG003|STARTED|Period 1 - First Intervention||1
10979781|NCT00583908|12154400|FG004|STARTED|Period 1 - First Intervention||2
10979782|NCT00583908|12154401|FG005|STARTED|Period 1 - First Intervention||1
10979783|NCT00583908|12154402|FG006|STARTED|Period 1 - First Intervention||1
10979784|NCT00583908|12154403|FG007|STARTED|Period 1 - First Intervention||1
10979785|NCT00583908|12154404|FG008|STARTED|Period 1 - First Intervention||1
10979786|NCT00583908|12154405|FG009|STARTED|Period 1 - First Intervention||1
10979787|NCT00583908|12154406|FG010|STARTED|Period 1 - First Intervention||1
10979788|NCT00583908|12154407|FG011|STARTED|Period 1 - First Intervention||1
10979789|NCT00583908|12154396|FG000|COMPLETED|Period 1 - First Intervention||1
10979790|NCT00583908|12154397|FG001|COMPLETED|Period 1 - First Intervention||2
10979791|NCT00583908|12154398|FG002|COMPLETED|Period 1 - First Intervention||1
10979792|NCT00583908|12154399|FG003|COMPLETED|Period 1 - First Intervention||1
10979793|NCT00583908|12154400|FG004|COMPLETED|Period 1 - First Intervention||2
10979794|NCT00583908|12154401|FG005|COMPLETED|Period 1 - First Intervention||1
10979795|NCT00583908|12154402|FG006|COMPLETED|Period 1 - First Intervention||1
10979796|NCT00583908|12154403|FG007|COMPLETED|Period 1 - First Intervention||1
10979797|NCT00583908|12154404|FG008|COMPLETED|Period 1 - First Intervention||1
10979798|NCT00583908|12154405|FG009|COMPLETED|Period 1 - First Intervention||1
10979799|NCT00583908|12154406|FG010|COMPLETED|Period 1 - First Intervention||1
10979800|NCT00583908|12154407|FG011|COMPLETED|Period 1 - First Intervention||1
10979801|NCT00583908|12154396|FG000|NOT COMPLETED|Period 1 - First Intervention||0
10979802|NCT00583908|12154397|FG001|NOT COMPLETED|Period 1 - First Intervention||0
10979803|NCT00583908|12154398|FG002|NOT COMPLETED|Period 1 - First Intervention||0
10979804|NCT00583908|12154399|FG003|NOT COMPLETED|Period 1 - First Intervention||0
10979805|NCT00583908|12154400|FG004|NOT COMPLETED|Period 1 - First Intervention||0
10979806|NCT00583908|12154401|FG005|NOT COMPLETED|Period 1 - First Intervention||0
10979807|NCT00583908|12154402|FG006|NOT COMPLETED|Period 1 - First Intervention||0
10979808|NCT00583908|12154403|FG007|NOT COMPLETED|Period 1 - First Intervention||0
10979809|NCT00583908|12154404|FG008|NOT COMPLETED|Period 1 - First Intervention||0
10979810|NCT00583908|12154405|FG009|NOT COMPLETED|Period 1 - First Intervention||0
10979811|NCT00583908|12154406|FG010|NOT COMPLETED|Period 1 - First Intervention||0
10979812|NCT00583908|12154407|FG011|NOT COMPLETED|Period 1 - First Intervention||0
10979813|NCT00583908|12154396|FG000|STARTED|Period 2 - Second Intervention||1
10979814|NCT00583908|12154397|FG001|STARTED|Period 2 - Second Intervention||2
10979815|NCT00583908|12154398|FG002|STARTED|Period 2 - Second Intervention||1
10979816|NCT00583908|12154399|FG003|STARTED|Period 2 - Second Intervention||1
10979817|NCT00583908|12154400|FG004|STARTED|Period 2 - Second Intervention||2
10979818|NCT00583908|12154401|FG005|STARTED|Period 2 - Second Intervention||1
10979819|NCT00583908|12154402|FG006|STARTED|Period 2 - Second Intervention||1
10979820|NCT00583908|12154403|FG007|STARTED|Period 2 - Second Intervention||1
10979821|NCT00583908|12154404|FG008|STARTED|Period 2 - Second Intervention||1
10979822|NCT00583908|12154405|FG009|STARTED|Period 2 - Second Intervention||1
10979823|NCT00583908|12154406|FG010|STARTED|Period 2 - Second Intervention||1
10979824|NCT00583908|12154407|FG011|STARTED|Period 2 - Second Intervention||1
10979825|NCT00583908|12154396|FG000|COMPLETED|Period 2 - Second Intervention||1
10979826|NCT00583908|12154397|FG001|COMPLETED|Period 2 - Second Intervention||2
10979827|NCT00583908|12154398|FG002|COMPLETED|Period 2 - Second Intervention||1
10979828|NCT00583908|12154399|FG003|COMPLETED|Period 2 - Second Intervention||1
10979829|NCT00583908|12154400|FG004|COMPLETED|Period 2 - Second Intervention||2
10979830|NCT00583908|12154401|FG005|COMPLETED|Period 2 - Second Intervention||1
10979831|NCT00583908|12154402|FG006|COMPLETED|Period 2 - Second Intervention||1
10979832|NCT00583908|12154403|FG007|COMPLETED|Period 2 - Second Intervention||1
10979833|NCT00583908|12154404|FG008|COMPLETED|Period 2 - Second Intervention||1
10979834|NCT00583908|12154405|FG009|COMPLETED|Period 2 - Second Intervention||1
10979835|NCT00583908|12154406|FG010|COMPLETED|Period 2 - Second Intervention||1
10979836|NCT00583908|12154407|FG011|COMPLETED|Period 2 - Second Intervention||1
10979837|NCT00583908|12154396|FG000|NOT COMPLETED|Period 2 - Second Intervention||0
10979838|NCT00583908|12154397|FG001|NOT COMPLETED|Period 2 - Second Intervention||0
10979839|NCT00583908|12154398|FG002|NOT COMPLETED|Period 2 - Second Intervention||0
10979840|NCT00583908|12154399|FG003|NOT COMPLETED|Period 2 - Second Intervention||0
10979841|NCT00583908|12154400|FG004|NOT COMPLETED|Period 2 - Second Intervention||0
10979842|NCT00583908|12154401|FG005|NOT COMPLETED|Period 2 - Second Intervention||0
10979843|NCT00583908|12154402|FG006|NOT COMPLETED|Period 2 - Second Intervention||0
10979844|NCT00583908|12154403|FG007|NOT COMPLETED|Period 2 - Second Intervention||0
10979845|NCT00583908|12154404|FG008|NOT COMPLETED|Period 2 - Second Intervention||0
10979846|NCT00583908|12154405|FG009|NOT COMPLETED|Period 2 - Second Intervention||0
10979847|NCT00583908|12154406|FG010|NOT COMPLETED|Period 2 - Second Intervention||0
10979848|NCT00583908|12154407|FG011|NOT COMPLETED|Period 2 - Second Intervention||0
10979849|NCT00583908|12154396|FG000|STARTED|Period 3 - Third Intervention||1
10979850|NCT00583908|12154397|FG001|STARTED|Period 3 - Third Intervention||2
10979851|NCT00583908|12154398|FG002|STARTED|Period 3 - Third Intervention||1
10979852|NCT00583908|12154399|FG003|STARTED|Period 3 - Third Intervention||1
10979853|NCT00583908|12154400|FG004|STARTED|Period 3 - Third Intervention||2
10979854|NCT00583908|12154401|FG005|STARTED|Period 3 - Third Intervention||1
10979855|NCT00583908|12154402|FG006|STARTED|Period 3 - Third Intervention||1
10979856|NCT00583908|12154403|FG007|STARTED|Period 3 - Third Intervention||1
10979857|NCT00583908|12154404|FG008|STARTED|Period 3 - Third Intervention||1
10979858|NCT00583908|12154405|FG009|STARTED|Period 3 - Third Intervention||1
10979859|NCT00583908|12154406|FG010|STARTED|Period 3 - Third Intervention||1
10979860|NCT00583908|12154407|FG011|STARTED|Period 3 - Third Intervention||1
10979861|NCT00583908|12154396|FG000|COMPLETED|Period 3 - Third Intervention||1
10979862|NCT00583908|12154397|FG001|COMPLETED|Period 3 - Third Intervention||2
10979863|NCT00583908|12154398|FG002|COMPLETED|Period 3 - Third Intervention||1
10979864|NCT00583908|12154399|FG003|COMPLETED|Period 3 - Third Intervention||1
10979865|NCT00583908|12154400|FG004|COMPLETED|Period 3 - Third Intervention||2
10979866|NCT00583908|12154401|FG005|COMPLETED|Period 3 - Third Intervention||1
10979867|NCT00583908|12154402|FG006|COMPLETED|Period 3 - Third Intervention||1
10979868|NCT00583908|12154403|FG007|COMPLETED|Period 3 - Third Intervention||1
10979869|NCT00583908|12154404|FG008|COMPLETED|Period 3 - Third Intervention||1
10979870|NCT00583908|12154405|FG009|COMPLETED|Period 3 - Third Intervention||1
10979871|NCT00583908|12154406|FG010|COMPLETED|Period 3 - Third Intervention||1
10979872|NCT00583908|12154407|FG011|COMPLETED|Period 3 - Third Intervention||1
10979873|NCT00583908|12154396|FG000|NOT COMPLETED|Period 3 - Third Intervention||0
10979874|NCT00583908|12154397|FG001|NOT COMPLETED|Period 3 - Third Intervention||0
10979875|NCT00583908|12154398|FG002|NOT COMPLETED|Period 3 - Third Intervention||0
10979876|NCT00583908|12154399|FG003|NOT COMPLETED|Period 3 - Third Intervention||0
10979877|NCT00583908|12154400|FG004|NOT COMPLETED|Period 3 - Third Intervention||0
10979878|NCT00583908|12154401|FG005|NOT COMPLETED|Period 3 - Third Intervention||0
10979879|NCT00583908|12154402|FG006|NOT COMPLETED|Period 3 - Third Intervention||0
10979880|NCT00583908|12154403|FG007|NOT COMPLETED|Period 3 - Third Intervention||0
10979881|NCT00583908|12154404|FG008|NOT COMPLETED|Period 3 - Third Intervention||0
10979882|NCT00583908|12154405|FG009|NOT COMPLETED|Period 3 - Third Intervention||0
10979883|NCT00583908|12154406|FG010|NOT COMPLETED|Period 3 - Third Intervention||0
10979884|NCT00583908|12154407|FG011|NOT COMPLETED|Period 3 - Third Intervention||0
10979885|NCT00583908|12154396|FG000|STARTED|Period 4 - Fourth Intervention||1
10979886|NCT00583908|12154397|FG001|STARTED|Period 4 - Fourth Intervention||2
10979887|NCT00583908|12154398|FG002|STARTED|Period 4 - Fourth Intervention||1
10979888|NCT00583908|12154399|FG003|STARTED|Period 4 - Fourth Intervention||1
10979889|NCT00583908|12154400|FG004|STARTED|Period 4 - Fourth Intervention||2
10979890|NCT00583908|12154401|FG005|STARTED|Period 4 - Fourth Intervention||1
10979891|NCT00583908|12154402|FG006|STARTED|Period 4 - Fourth Intervention||1
10979892|NCT00583908|12154403|FG007|STARTED|Period 4 - Fourth Intervention||1
10979893|NCT00583908|12154404|FG008|STARTED|Period 4 - Fourth Intervention||1
10979894|NCT00583908|12154405|FG009|STARTED|Period 4 - Fourth Intervention||1
10979895|NCT00583908|12154406|FG010|STARTED|Period 4 - Fourth Intervention||1
10979896|NCT00583908|12154407|FG011|STARTED|Period 4 - Fourth Intervention||1
10979897|NCT00583908|12154396|FG000|COMPLETED|Period 4 - Fourth Intervention||1
10979898|NCT00583908|12154397|FG001|COMPLETED|Period 4 - Fourth Intervention||2
10979899|NCT00583908|12154398|FG002|COMPLETED|Period 4 - Fourth Intervention||1
10979900|NCT00583908|12154399|FG003|COMPLETED|Period 4 - Fourth Intervention||1
10979901|NCT00583908|12154400|FG004|COMPLETED|Period 4 - Fourth Intervention||2
10979902|NCT00583908|12154401|FG005|COMPLETED|Period 4 - Fourth Intervention||1
10979903|NCT00583908|12154402|FG006|COMPLETED|Period 4 - Fourth Intervention||1
10979904|NCT00583908|12154403|FG007|COMPLETED|Period 4 - Fourth Intervention||1
10979905|NCT00583908|12154404|FG008|COMPLETED|Period 4 - Fourth Intervention||1
10979906|NCT00583908|12154405|FG009|COMPLETED|Period 4 - Fourth Intervention||1
10979907|NCT00583908|12154406|FG010|COMPLETED|Period 4 - Fourth Intervention||1
10979908|NCT00583908|12154407|FG011|COMPLETED|Period 4 - Fourth Intervention||1
10979909|NCT00583908|12154396|FG000|NOT COMPLETED|Period 4 - Fourth Intervention||0
10979910|NCT00583908|12154397|FG001|NOT COMPLETED|Period 4 - Fourth Intervention||0
10979911|NCT00583908|12154398|FG002|NOT COMPLETED|Period 4 - Fourth Intervention||0
10979912|NCT00583908|12154399|FG003|NOT COMPLETED|Period 4 - Fourth Intervention||0
10979913|NCT00583908|12154400|FG004|NOT COMPLETED|Period 4 - Fourth Intervention||0
10979914|NCT00583908|12154401|FG005|NOT COMPLETED|Period 4 - Fourth Intervention||0
10979915|NCT00583908|12154402|FG006|NOT COMPLETED|Period 4 - Fourth Intervention||0
10979916|NCT00583908|12154403|FG007|NOT COMPLETED|Period 4 - Fourth Intervention||0
10979917|NCT00583908|12154404|FG008|NOT COMPLETED|Period 4 - Fourth Intervention||0
10979918|NCT00583908|12154405|FG009|NOT COMPLETED|Period 4 - Fourth Intervention||0
10979919|NCT00583908|12154406|FG010|NOT COMPLETED|Period 4 - Fourth Intervention||0
10979920|NCT00583908|12154407|FG011|NOT COMPLETED|Period 4 - Fourth Intervention||0
10979921|NCT00583947|12154427|FG000|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
10979922|NCT00583947|12154428|FG001|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
10979923|NCT00583947|12154427|FG000|COMPLETED|Cross-over Period||22
10979924|NCT00583947|12154428|FG001|COMPLETED|Cross-over Period||24
10979925|NCT00583947|12154427|FG000|NOT COMPLETED|Cross-over Period||5
10979926|NCT00583947|12154428|FG001|NOT COMPLETED|Cross-over Period||2
10979927|NCT00583947|12154427|FG000|STARTED|Washout||22
10979928|NCT00583947|12154428|FG001|STARTED|Washout||24
10979929|NCT00583947|12154427|FG000|COMPLETED|Washout||22
10979930|NCT00583947|12154428|FG001|COMPLETED|Washout||24
10979931|NCT00583947|12154427|FG000|NOT COMPLETED|Washout||0
10979932|NCT00583947|12154428|FG001|NOT COMPLETED|Washout||0
10979933|NCT00583947|12154427|FG000|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
10979934|NCT00583947|12154428|FG001|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
10979935|NCT00583947|12154427|FG000|COMPLETED|Open Label Period||22
10979936|NCT00583947|12154428|FG001|COMPLETED|Open Label Period||24
10979937|NCT00583947|12154427|FG000|NOT COMPLETED|Open Label Period||0
10979938|NCT00583947|12154428|FG001|NOT COMPLETED|Open Label Period||0
10979939|NCT00584077|12154436|FG000|STARTED|Overall Study||15
10979940|NCT00584077|12154436|FG000|COMPLETED|Overall Study||15
10979941|NCT00584077|12154436|FG000|NOT COMPLETED|Overall Study||0
10979942|NCT00584194|12154441|FG000|STARTED|Overall Study||278
10979943|NCT00584194|12154441|FG000|COMPLETED|Overall Study||143
10979944|NCT00584194|12154441|FG000|NOT COMPLETED|Overall Study||135
10979945|NCT00584220|12154445|FG000|STARTED|First Period||48
10979946|NCT00584220|12154446|FG001|STARTED|First Period||39
10979947|NCT00584220|12154445|FG000|COMPLETED|First Period||48
10979948|NCT00584220|12154446|FG001|COMPLETED|First Period||39
10979949|NCT00584220|12154445|FG000|NOT COMPLETED|First Period||0
10979950|NCT00584220|12154446|FG001|NOT COMPLETED|First Period||0
10979951|NCT00584220|12154445|FG000|STARTED|Second Period||48
10979952|NCT00584220|12154446|FG001|STARTED|Second Period||39
10979953|NCT00584220|12154445|FG000|COMPLETED|Second Period||48
10979954|NCT00584220|12154446|FG001|COMPLETED|Second Period||39
10979955|NCT00584220|12154445|FG000|NOT COMPLETED|Second Period||0
10979956|NCT00584220|12154446|FG001|NOT COMPLETED|Second Period||0
10979957|NCT00584285|12154452|FG000|STARTED|Overall Study||18
10979958|NCT00584285|12154452|FG000|COMPLETED|Overall Study||18
10979959|NCT00584285|12154452|FG000|NOT COMPLETED|Overall Study||0
10979960|NCT00584402|12154456|FG000|STARTED|Overall Study||8
10979961|NCT00584402|12154456|FG000|COMPLETED|Overall Study||8
10979962|NCT00584402|12154456|FG000|NOT COMPLETED|Overall Study||0
10979963|NCT00584415|12154460|FG000|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
10979964|NCT00584415|12154460|FG000|COMPLETED|Overall Study||112
10979965|NCT00584415|12154460|FG000|NOT COMPLETED|Overall Study||7
10979966|NCT00584454|12154465|FG000|STARTED|Overall Study||10
10979967|NCT00584454|12154465|FG000|COMPLETED|Overall Study||6
10979968|NCT00584454|12154465|FG000|NOT COMPLETED|Overall Study||4
10979969|NCT00584480|12154469|FG000|STARTED|First 8 Weeks (40 Treatments)||10
10979970|NCT00584480|12154469|FG000|COMPLETED|First 8 Weeks (40 Treatments)||10
10979971|NCT00584480|12154469|FG000|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
10979972|NCT00584480|12154469|FG000|STARTED|4-Week Break From Treatment||10
10979973|NCT00584480|12154469|FG000|COMPLETED|4-Week Break From Treatment||10
10979974|NCT00584480|12154469|FG000|NOT COMPLETED|4-Week Break From Treatment||0
10979975|NCT00584480|12154469|FG000|STARTED|Second 8 Weeks (40 Treatments)||10
10979976|NCT00584480|12154469|FG000|COMPLETED|Second 8 Weeks (40 Treatments)||10
10979977|NCT00584480|12154469|FG000|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
10979978|NCT00584558|12154473|FG000|STARTED|Overall Study||2420
10979979|NCT00584558|12154473|FG000|COMPLETED|Overall Study||2420
10979980|NCT00584558|12154473|FG000|NOT COMPLETED|Overall Study||0
10979981|NCT00584701|12154478|FG000|STARTED|Active Risperidone||49
10979982|NCT00584701|12154478|FG000|COMPLETED|Active Risperidone||46
10979983|NCT00584701|12154478|FG000|NOT COMPLETED|Active Risperidone||3
10979984|NCT00584701|12154478|FG000|STARTED|Follow-up||46
10979985|NCT00584701|12154478|FG000|COMPLETED|Follow-up||34
10979986|NCT00584701|12154478|FG000|NOT COMPLETED|Follow-up||12
10979987|NCT00584727|12154483|FG000|STARTED|First Intervention||17
10979988|NCT00584727|12154484|FG001|STARTED|First Intervention||17
10979989|NCT00584727|12154485|FG002|STARTED|First Intervention||16
10979990|NCT00584727|12154486|FG003|STARTED|First Intervention||14
10979991|NCT00584727|12154487|FG004|STARTED|First Intervention||16
10979992|NCT00584727|12154488|FG005|STARTED|First Intervention||16
10979993|NCT00584727|12154483|FG000|COMPLETED|First Intervention||17
10979994|NCT00584727|12154484|FG001|COMPLETED|First Intervention||17
10979995|NCT00584727|12154485|FG002|COMPLETED|First Intervention||15
10979996|NCT00584727|12154486|FG003|COMPLETED|First Intervention||14
10979997|NCT00584727|12154487|FG004|COMPLETED|First Intervention||16
10979998|NCT00584727|12154488|FG005|COMPLETED|First Intervention||16
10979999|NCT00584727|12154483|FG000|NOT COMPLETED|First Intervention||0
10980000|NCT00584727|12154484|FG001|NOT COMPLETED|First Intervention||0
10980001|NCT00584727|12154485|FG002|NOT COMPLETED|First Intervention||1
10980002|NCT00584727|12154486|FG003|NOT COMPLETED|First Intervention||0
10980003|NCT00584727|12154487|FG004|NOT COMPLETED|First Intervention||0
10980004|NCT00584727|12154488|FG005|NOT COMPLETED|First Intervention||0
10980005|NCT00584727|12154483|FG000|STARTED|Second Intervention||17
10980006|NCT00584727|12154484|FG001|STARTED|Second Intervention||17
10980007|NCT00584727|12154485|FG002|STARTED|Second Intervention||15
10980008|NCT00584727|12154486|FG003|STARTED|Second Intervention||14
10980009|NCT00584727|12154487|FG004|STARTED|Second Intervention||16
10980010|NCT00584727|12154488|FG005|STARTED|Second Intervention||16
10980011|NCT00584727|12154483|FG000|COMPLETED|Second Intervention||17
10980012|NCT00584727|12154484|FG001|COMPLETED|Second Intervention||17
10980013|NCT00584727|12154485|FG002|COMPLETED|Second Intervention||15
10980014|NCT00584727|12154486|FG003|COMPLETED|Second Intervention||14
10980015|NCT00584727|12154487|FG004|COMPLETED|Second Intervention||16
10980016|NCT00584727|12154488|FG005|COMPLETED|Second Intervention||16
10980017|NCT00584727|12154483|FG000|NOT COMPLETED|Second Intervention||0
10980018|NCT00584727|12154484|FG001|NOT COMPLETED|Second Intervention||0
10980019|NCT00584727|12154485|FG002|NOT COMPLETED|Second Intervention||0
10980020|NCT00584727|12154486|FG003|NOT COMPLETED|Second Intervention||0
10980021|NCT00584727|12154487|FG004|NOT COMPLETED|Second Intervention||0
10980022|NCT00584727|12154488|FG005|NOT COMPLETED|Second Intervention||0
10980023|NCT00584727|12154483|FG000|STARTED|Third Intervention||17
10980024|NCT00584727|12154484|FG001|STARTED|Third Intervention||17
10980025|NCT00584727|12154485|FG002|STARTED|Third Intervention||15
10980026|NCT00584727|12154486|FG003|STARTED|Third Intervention||14
10980027|NCT00584727|12154487|FG004|STARTED|Third Intervention||16
10980028|NCT00584727|12154488|FG005|STARTED|Third Intervention||16
10980029|NCT00584727|12154483|FG000|COMPLETED|Third Intervention||17
10980030|NCT00584727|12154484|FG001|COMPLETED|Third Intervention||17
10980031|NCT00584727|12154485|FG002|COMPLETED|Third Intervention||14
10980032|NCT00584727|12154486|FG003|COMPLETED|Third Intervention||14
10980033|NCT00584727|12154487|FG004|COMPLETED|Third Intervention||12
10980034|NCT00584727|12154488|FG005|COMPLETED|Third Intervention||14
10980035|NCT00584727|12154483|FG000|NOT COMPLETED|Third Intervention||0
10980036|NCT00584727|12154484|FG001|NOT COMPLETED|Third Intervention||0
10980037|NCT00584727|12154485|FG002|NOT COMPLETED|Third Intervention||1
10980038|NCT00584727|12154486|FG003|NOT COMPLETED|Third Intervention||0
10980039|NCT00584727|12154487|FG004|NOT COMPLETED|Third Intervention||4
10980040|NCT00584727|12154488|FG005|NOT COMPLETED|Third Intervention||2
10980041|NCT00584740|12154501|FG000|STARTED|Overall Study||39
10980042|NCT00584740|12154502|FG001|STARTED|Overall Study||20
10980043|NCT00584740|12154501|FG000|COMPLETED|Overall Study||27
10980044|NCT00584740|12154502|FG001|COMPLETED|Overall Study||14
10980045|NCT00584740|12154501|FG000|NOT COMPLETED|Overall Study||12
10980046|NCT00584740|12154502|FG001|NOT COMPLETED|Overall Study||6
10980047|NCT00584805|12154508|FG000|STARTED|Overall Study||138
10980048|NCT00584805|12154508|FG000|COMPLETED|Overall Study||39
10980049|NCT00584805|12154508|FG000|NOT COMPLETED|Overall Study||99
10980050|NCT00584831|12154514|FG000|STARTED|Intervention 1||1
10980051|NCT00584831|12154515|FG001|STARTED|Intervention 1||3
10980052|NCT00584831|12154516|FG002|STARTED|Intervention 1||2
10980053|NCT00584831|12154517|FG003|STARTED|Intervention 1||1
10980054|NCT00584831|12154518|FG004|STARTED|Intervention 1||2
10980055|NCT00584831|12154519|FG005|STARTED|Intervention 1||1
10980056|NCT00584831|12154520|FG006|STARTED|Intervention 1||6
10980057|NCT00584831|12154521|FG007|STARTED|Intervention 1||2
10980058|NCT00584831|12154522|FG008|STARTED|Intervention 1||4
10980059|NCT00584831|12154523|FG009|STARTED|Intervention 1||2
10980060|NCT00584831|12154524|FG010|STARTED|Intervention 1||2
10980061|NCT00584831|12154525|FG011|STARTED|Intervention 1||1
10980062|NCT00584831|12154526|FG012|STARTED|Intervention 1||2
10980063|NCT00584831|12154527|FG013|STARTED|Intervention 1||1
10980064|NCT00584831|12154528|FG014|STARTED|Intervention 1||3
10980065|NCT00584831|12154529|FG015|STARTED|Intervention 1||1
10980066|NCT00584831|12154530|FG016|STARTED|Intervention 1||4
10980067|NCT00584831|12154531|FG017|STARTED|Intervention 1||1
10980068|NCT00584831|12154532|FG018|STARTED|Intervention 1||1
10980069|NCT00584831|12154514|FG000|COMPLETED|Intervention 1||1
10980070|NCT00584831|12154515|FG001|COMPLETED|Intervention 1||3
10980071|NCT00584831|12154516|FG002|COMPLETED|Intervention 1||2
10980072|NCT00584831|12154517|FG003|COMPLETED|Intervention 1||1
10980073|NCT00584831|12154518|FG004|COMPLETED|Intervention 1||2
10980074|NCT00584831|12154519|FG005|COMPLETED|Intervention 1||1
10980075|NCT00584831|12154520|FG006|COMPLETED|Intervention 1||6
10980076|NCT00584831|12154521|FG007|COMPLETED|Intervention 1||2
10980077|NCT00584831|12154522|FG008|COMPLETED|Intervention 1||4
10980078|NCT00584831|12154523|FG009|COMPLETED|Intervention 1||2
10980079|NCT00584831|12154524|FG010|COMPLETED|Intervention 1||2
10980080|NCT00584831|12154525|FG011|COMPLETED|Intervention 1||1
10980081|NCT00584831|12154526|FG012|COMPLETED|Intervention 1||2
10980082|NCT00584831|12154527|FG013|COMPLETED|Intervention 1||1
10980083|NCT00584831|12154528|FG014|COMPLETED|Intervention 1||3
10980084|NCT00584831|12154529|FG015|COMPLETED|Intervention 1||1
10980085|NCT00584831|12154530|FG016|COMPLETED|Intervention 1||4
10980086|NCT00584831|12154531|FG017|COMPLETED|Intervention 1||1
10980087|NCT00584831|12154532|FG018|COMPLETED|Intervention 1||1
10980088|NCT00584831|12154514|FG000|NOT COMPLETED|Intervention 1||0
10980089|NCT00584831|12154515|FG001|NOT COMPLETED|Intervention 1||0
10980090|NCT00584831|12154516|FG002|NOT COMPLETED|Intervention 1||0
10980091|NCT00584831|12154517|FG003|NOT COMPLETED|Intervention 1||0
10980092|NCT00584831|12154518|FG004|NOT COMPLETED|Intervention 1||0
10980093|NCT00584831|12154519|FG005|NOT COMPLETED|Intervention 1||0
10980094|NCT00584831|12154520|FG006|NOT COMPLETED|Intervention 1||0
10980095|NCT00584831|12154521|FG007|NOT COMPLETED|Intervention 1||0
10980096|NCT00584831|12154522|FG008|NOT COMPLETED|Intervention 1||0
10980097|NCT00584831|12154523|FG009|NOT COMPLETED|Intervention 1||0
10980098|NCT00584831|12154524|FG010|NOT COMPLETED|Intervention 1||0
10980099|NCT00584831|12154525|FG011|NOT COMPLETED|Intervention 1||0
10980100|NCT00584831|12154526|FG012|NOT COMPLETED|Intervention 1||0
10980101|NCT00584831|12154527|FG013|NOT COMPLETED|Intervention 1||0
10980102|NCT00584831|12154528|FG014|NOT COMPLETED|Intervention 1||0
10980103|NCT00584831|12154529|FG015|NOT COMPLETED|Intervention 1||0
10980104|NCT00584831|12154530|FG016|NOT COMPLETED|Intervention 1||0
10980105|NCT00584831|12154531|FG017|NOT COMPLETED|Intervention 1||0
10980106|NCT00584831|12154532|FG018|NOT COMPLETED|Intervention 1||0
10980107|NCT00584831|12154514|FG000|STARTED|Intervention 2||1
10980108|NCT00584831|12154515|FG001|STARTED|Intervention 2||3
10980109|NCT00584831|12154516|FG002|STARTED|Intervention 2||2
10980110|NCT00584831|12154517|FG003|STARTED|Intervention 2||1
10980111|NCT00584831|12154518|FG004|STARTED|Intervention 2||2
10980112|NCT00584831|12154519|FG005|STARTED|Intervention 2||1
10980113|NCT00584831|12154520|FG006|STARTED|Intervention 2||6
10980114|NCT00584831|12154521|FG007|STARTED|Intervention 2||2
10980115|NCT00584831|12154522|FG008|STARTED|Intervention 2||4
10980116|NCT00584831|12154523|FG009|STARTED|Intervention 2||2
10980117|NCT00584831|12154524|FG010|STARTED|Intervention 2||2
10980118|NCT00584831|12154525|FG011|STARTED|Intervention 2||1
10980119|NCT00584831|12154526|FG012|STARTED|Intervention 2||2
10980120|NCT00584831|12154527|FG013|STARTED|Intervention 2||1
10980121|NCT00584831|12154528|FG014|STARTED|Intervention 2||3
10980122|NCT00584831|12154529|FG015|STARTED|Intervention 2||1
10980123|NCT00584831|12154530|FG016|STARTED|Intervention 2||4
10980124|NCT00584831|12154531|FG017|STARTED|Intervention 2||1
10980125|NCT00584831|12154532|FG018|STARTED|Intervention 2||1
10980126|NCT00584831|12154514|FG000|COMPLETED|Intervention 2||1
10980127|NCT00584831|12154515|FG001|COMPLETED|Intervention 2||3
10980128|NCT00584831|12154516|FG002|COMPLETED|Intervention 2||2
10980129|NCT00584831|12154517|FG003|COMPLETED|Intervention 2||1
10980130|NCT00584831|12154518|FG004|COMPLETED|Intervention 2||2
10980131|NCT00584831|12154519|FG005|COMPLETED|Intervention 2||1
10980132|NCT00584831|12154520|FG006|COMPLETED|Intervention 2||6
10980133|NCT00584831|12154521|FG007|COMPLETED|Intervention 2||2
10980134|NCT00584831|12154522|FG008|COMPLETED|Intervention 2||4
10980135|NCT00584831|12154523|FG009|COMPLETED|Intervention 2||2
10980136|NCT00584831|12154524|FG010|COMPLETED|Intervention 2||2
10980137|NCT00584831|12154525|FG011|COMPLETED|Intervention 2||1
10980138|NCT00584831|12154526|FG012|COMPLETED|Intervention 2||2
10980139|NCT00584831|12154527|FG013|COMPLETED|Intervention 2||1
10980140|NCT00584831|12154528|FG014|COMPLETED|Intervention 2||3
10980141|NCT00584831|12154529|FG015|COMPLETED|Intervention 2||1
10980142|NCT00584831|12154530|FG016|COMPLETED|Intervention 2||4
10980143|NCT00584831|12154531|FG017|COMPLETED|Intervention 2||1
10980144|NCT00584831|12154532|FG018|COMPLETED|Intervention 2||1
10980145|NCT00584831|12154514|FG000|NOT COMPLETED|Intervention 2||0
10980146|NCT00584831|12154515|FG001|NOT COMPLETED|Intervention 2||0
10980147|NCT00584831|12154516|FG002|NOT COMPLETED|Intervention 2||0
10980148|NCT00584831|12154517|FG003|NOT COMPLETED|Intervention 2||0
10980149|NCT00584831|12154518|FG004|NOT COMPLETED|Intervention 2||0
10980150|NCT00584831|12154519|FG005|NOT COMPLETED|Intervention 2||0
10980151|NCT00584831|12154520|FG006|NOT COMPLETED|Intervention 2||0
10980152|NCT00584831|12154521|FG007|NOT COMPLETED|Intervention 2||0
10980153|NCT00584831|12154522|FG008|NOT COMPLETED|Intervention 2||0
10980154|NCT00584831|12154523|FG009|NOT COMPLETED|Intervention 2||0
10980155|NCT00584831|12154524|FG010|NOT COMPLETED|Intervention 2||0
10980156|NCT00584831|12154525|FG011|NOT COMPLETED|Intervention 2||0
10980157|NCT00584831|12154526|FG012|NOT COMPLETED|Intervention 2||0
10980158|NCT00584831|12154527|FG013|NOT COMPLETED|Intervention 2||0
10980159|NCT00584831|12154528|FG014|NOT COMPLETED|Intervention 2||0
10980160|NCT00584831|12154529|FG015|NOT COMPLETED|Intervention 2||0
10980161|NCT00584831|12154530|FG016|NOT COMPLETED|Intervention 2||0
10980162|NCT00584831|12154531|FG017|NOT COMPLETED|Intervention 2||0
10980163|NCT00584831|12154532|FG018|NOT COMPLETED|Intervention 2||0
10980164|NCT00584831|12154514|FG000|STARTED|Intervention 3||1
10980165|NCT00584831|12154515|FG001|STARTED|Intervention 3||3
10980166|NCT00584831|12154516|FG002|STARTED|Intervention 3||2
10980167|NCT00584831|12154517|FG003|STARTED|Intervention 3||1
10980168|NCT00584831|12154518|FG004|STARTED|Intervention 3||2
10980169|NCT00584831|12154519|FG005|STARTED|Intervention 3||1
10980170|NCT00584831|12154520|FG006|STARTED|Intervention 3||6
10980171|NCT00584831|12154521|FG007|STARTED|Intervention 3||2
10980172|NCT00584831|12154522|FG008|STARTED|Intervention 3||4
10980173|NCT00584831|12154523|FG009|STARTED|Intervention 3||2
10980174|NCT00584831|12154524|FG010|STARTED|Intervention 3||2
10980175|NCT00584831|12154525|FG011|STARTED|Intervention 3||1
10980176|NCT00584831|12154526|FG012|STARTED|Intervention 3||2
10980177|NCT00584831|12154527|FG013|STARTED|Intervention 3||1
10980178|NCT00584831|12154528|FG014|STARTED|Intervention 3||3
10980179|NCT00584831|12154529|FG015|STARTED|Intervention 3||1
10980180|NCT00584831|12154530|FG016|STARTED|Intervention 3||4
10980181|NCT00584831|12154531|FG017|STARTED|Intervention 3||1
10980182|NCT00584831|12154532|FG018|STARTED|Intervention 3||1
10980183|NCT00584831|12154514|FG000|COMPLETED|Intervention 3||1
10980184|NCT00584831|12154515|FG001|COMPLETED|Intervention 3||3
10980185|NCT00584831|12154516|FG002|COMPLETED|Intervention 3||2
10980186|NCT00584831|12154517|FG003|COMPLETED|Intervention 3||1
10980187|NCT00584831|12154518|FG004|COMPLETED|Intervention 3||2
10980188|NCT00584831|12154519|FG005|COMPLETED|Intervention 3||1
10980189|NCT00584831|12154520|FG006|COMPLETED|Intervention 3||6
10980190|NCT00584831|12154521|FG007|COMPLETED|Intervention 3||2
10980191|NCT00584831|12154522|FG008|COMPLETED|Intervention 3||4
10980192|NCT00584831|12154523|FG009|COMPLETED|Intervention 3||2
10980193|NCT00584831|12154524|FG010|COMPLETED|Intervention 3||2
10980194|NCT00584831|12154525|FG011|COMPLETED|Intervention 3||1
10980195|NCT00584831|12154526|FG012|COMPLETED|Intervention 3||2
10980196|NCT00584831|12154527|FG013|COMPLETED|Intervention 3||1
10980197|NCT00584831|12154528|FG014|COMPLETED|Intervention 3||3
10980198|NCT00584831|12154529|FG015|COMPLETED|Intervention 3||1
10980199|NCT00584831|12154530|FG016|COMPLETED|Intervention 3||4
10980200|NCT00584831|12154531|FG017|COMPLETED|Intervention 3||1
10980201|NCT00584831|12154532|FG018|COMPLETED|Intervention 3||1
10980202|NCT00584831|12154514|FG000|NOT COMPLETED|Intervention 3||0
10980203|NCT00584831|12154515|FG001|NOT COMPLETED|Intervention 3||0
10980204|NCT00584831|12154516|FG002|NOT COMPLETED|Intervention 3||0
10980205|NCT00584831|12154517|FG003|NOT COMPLETED|Intervention 3||0
10980206|NCT00584831|12154518|FG004|NOT COMPLETED|Intervention 3||0
10980207|NCT00584831|12154519|FG005|NOT COMPLETED|Intervention 3||0
10980208|NCT00584831|12154520|FG006|NOT COMPLETED|Intervention 3||0
10980209|NCT00584831|12154521|FG007|NOT COMPLETED|Intervention 3||0
10980210|NCT00584831|12154522|FG008|NOT COMPLETED|Intervention 3||0
10980211|NCT00584831|12154523|FG009|NOT COMPLETED|Intervention 3||0
10980212|NCT00584831|12154524|FG010|NOT COMPLETED|Intervention 3||0
10980213|NCT00584831|12154525|FG011|NOT COMPLETED|Intervention 3||0
10980214|NCT00584831|12154526|FG012|NOT COMPLETED|Intervention 3||0
10980215|NCT00584831|12154527|FG013|NOT COMPLETED|Intervention 3||0
10980216|NCT00584831|12154528|FG014|NOT COMPLETED|Intervention 3||0
10980217|NCT00584831|12154529|FG015|NOT COMPLETED|Intervention 3||0
10980218|NCT00584831|12154530|FG016|NOT COMPLETED|Intervention 3||0
10980219|NCT00584831|12154531|FG017|NOT COMPLETED|Intervention 3||0
10980220|NCT00584831|12154532|FG018|NOT COMPLETED|Intervention 3||0
10980221|NCT00584831|12154514|FG000|STARTED|Intervention 4||1
10980222|NCT00584831|12154515|FG001|STARTED|Intervention 4||3
10980223|NCT00584831|12154516|FG002|STARTED|Intervention 4||2
10980224|NCT00584831|12154517|FG003|STARTED|Intervention 4||1
10980225|NCT00584831|12154518|FG004|STARTED|Intervention 4||2
10980226|NCT00584831|12154519|FG005|STARTED|Intervention 4||1
10980227|NCT00584831|12154520|FG006|STARTED|Intervention 4||6
10980228|NCT00584831|12154521|FG007|STARTED|Intervention 4||2
10980229|NCT00584831|12154522|FG008|STARTED|Intervention 4||3
10980230|NCT00584831|12154523|FG009|STARTED|Intervention 4||2
10980231|NCT00584831|12154524|FG010|STARTED|Intervention 4||2
10980232|NCT00584831|12154525|FG011|STARTED|Intervention 4||1
10980233|NCT00584831|12154526|FG012|STARTED|Intervention 4||2
10980234|NCT00584831|12154527|FG013|STARTED|Intervention 4||1
10980235|NCT00584831|12154528|FG014|STARTED|Intervention 4||2
10980236|NCT00584831|12154529|FG015|STARTED|Intervention 4||1
10980237|NCT00584831|12154530|FG016|STARTED|Intervention 4||4
10980238|NCT00584831|12154531|FG017|STARTED|Intervention 4||1
10980239|NCT00584831|12154532|FG018|STARTED|Intervention 4||1
10980240|NCT00584831|12154514|FG000|COMPLETED|Intervention 4||1
10980241|NCT00584831|12154515|FG001|COMPLETED|Intervention 4||3
10980242|NCT00584831|12154516|FG002|COMPLETED|Intervention 4||2
10980243|NCT00584831|12154517|FG003|COMPLETED|Intervention 4||1
10980244|NCT00584831|12154518|FG004|COMPLETED|Intervention 4||2
10980245|NCT00584831|12154519|FG005|COMPLETED|Intervention 4||1
10980246|NCT00584831|12154520|FG006|COMPLETED|Intervention 4||6
10980247|NCT00584831|12154521|FG007|COMPLETED|Intervention 4||2
10980248|NCT00584831|12154522|FG008|COMPLETED|Intervention 4||3
10980249|NCT00584831|12154523|FG009|COMPLETED|Intervention 4||2
10980250|NCT00584831|12154524|FG010|COMPLETED|Intervention 4||2
10980251|NCT00584831|12154525|FG011|COMPLETED|Intervention 4||1
10980252|NCT00584831|12154526|FG012|COMPLETED|Intervention 4||2
10980253|NCT00584831|12154527|FG013|COMPLETED|Intervention 4||1
10980254|NCT00584831|12154528|FG014|COMPLETED|Intervention 4||2
10980255|NCT00584831|12154529|FG015|COMPLETED|Intervention 4||1
10980256|NCT00584831|12154530|FG016|COMPLETED|Intervention 4||4
10980257|NCT00584831|12154531|FG017|COMPLETED|Intervention 4||1
10980258|NCT00584831|12154532|FG018|COMPLETED|Intervention 4||1
10980259|NCT00584831|12154514|FG000|NOT COMPLETED|Intervention 4||0
10980260|NCT00584831|12154515|FG001|NOT COMPLETED|Intervention 4||0
10980261|NCT00584831|12154516|FG002|NOT COMPLETED|Intervention 4||0
10980262|NCT00584831|12154517|FG003|NOT COMPLETED|Intervention 4||0
10980263|NCT00584831|12154518|FG004|NOT COMPLETED|Intervention 4||0
10980264|NCT00584831|12154519|FG005|NOT COMPLETED|Intervention 4||0
10980265|NCT00584831|12154520|FG006|NOT COMPLETED|Intervention 4||0
10980266|NCT00584831|12154521|FG007|NOT COMPLETED|Intervention 4||0
10980267|NCT00584831|12154522|FG008|NOT COMPLETED|Intervention 4||0
10980268|NCT00584831|12154523|FG009|NOT COMPLETED|Intervention 4||0
10980269|NCT00584831|12154524|FG010|NOT COMPLETED|Intervention 4||0
10980270|NCT00584831|12154525|FG011|NOT COMPLETED|Intervention 4||0
10980271|NCT00584831|12154526|FG012|NOT COMPLETED|Intervention 4||0
10980272|NCT00584831|12154527|FG013|NOT COMPLETED|Intervention 4||0
10980273|NCT00584831|12154528|FG014|NOT COMPLETED|Intervention 4||0
10980274|NCT00584831|12154529|FG015|NOT COMPLETED|Intervention 4||0
10980275|NCT00584831|12154530|FG016|NOT COMPLETED|Intervention 4||0
10980276|NCT00584831|12154531|FG017|NOT COMPLETED|Intervention 4||0
10980277|NCT00584831|12154532|FG018|NOT COMPLETED|Intervention 4||0
10980278|NCT00584844|12154542|FG000|STARTED|Overall Study||484
10980279|NCT00584844|12154542|FG000|COMPLETED|Overall Study||405
10980280|NCT00584844|12154542|FG000|NOT COMPLETED|Overall Study||79
10980281|NCT00584857|12154550|FG000|STARTED|Overall Study||30
10980282|NCT00584857|12154550|FG000|COMPLETED|Overall Study||30
10980283|NCT00584857|12154550|FG000|NOT COMPLETED|Overall Study||0
10980284|NCT00584870|12154557|FG000|STARTED|Overall Study||88
10980285|NCT00584870|12154558|FG001|STARTED|Overall Study||89
10980286|NCT00584870|12154559|FG002|STARTED|Overall Study||43
10980287|NCT00584870|12154557|FG000|Treated|Overall Study||88
10980288|NCT00584870|12154558|FG001|Treated|Overall Study||88
10980289|NCT00584870|12154559|FG002|Treated|Overall Study||41
10980290|NCT00584870|12154557|FG000|COMPLETED|Overall Study||59
10980291|NCT00584870|12154558|FG001|COMPLETED|Overall Study||64
10980292|NCT00584870|12154559|FG002|COMPLETED|Overall Study||25
10980293|NCT00584870|12154557|FG000|NOT COMPLETED|Overall Study||29
10980294|NCT00584870|12154558|FG001|NOT COMPLETED|Overall Study||25
10980295|NCT00584870|12154559|FG002|NOT COMPLETED|Overall Study||18
10980296|NCT00584909|12154567|FG000|STARTED|Overall Study||13
10980297|NCT00584909|12154567|FG000|COMPLETED|Overall Study||9
10980298|NCT00584909|12154567|FG000|NOT COMPLETED|Overall Study||4
10980299|NCT00584922|12154571|FG000|STARTED|Overall Study||175
10980300|NCT00584922|12154571|FG000|COMPLETED|Overall Study||175
10980301|NCT00584922|12154571|FG000|NOT COMPLETED|Overall Study||0
10980302|NCT00584948|12154577|FG000|STARTED|Overall Study||47
10980303|NCT00584948|12154578|FG001|STARTED|Overall Study||47
10980304|NCT00584948|12154577|FG000|COMPLETED|Overall Study||34
10980305|NCT00584948|12154578|FG001|COMPLETED|Overall Study||36
10980306|NCT00584948|12154577|FG000|NOT COMPLETED|Overall Study||13
10980307|NCT00584948|12154578|FG001|NOT COMPLETED|Overall Study||11
10980308|NCT00584987|12154588|FG000|STARTED|Overall Study||15
10980309|NCT00584987|12154589|FG001|STARTED|Overall Study||16
10980310|NCT00584987|12154590|FG002|STARTED|Overall Study||17
10980311|NCT00584987|12154591|FG003|STARTED|Overall Study||16
10980312|NCT00584987|12154588|FG000|COMPLETED|Overall Study||14
10980313|NCT00584987|12154589|FG001|COMPLETED|Overall Study||15
10980314|NCT00584987|12154590|FG002|COMPLETED|Overall Study||16
10980315|NCT00584987|12154591|FG003|COMPLETED|Overall Study||15
10980316|NCT00584987|12154588|FG000|NOT COMPLETED|Overall Study||1
10980317|NCT00584987|12154589|FG001|NOT COMPLETED|Overall Study||1
10980318|NCT00584987|12154590|FG002|NOT COMPLETED|Overall Study||1
10980319|NCT00584987|12154591|FG003|NOT COMPLETED|Overall Study||1
10980320|NCT00585013|12154603|FG000|STARTED|Overall Study||8
10980321|NCT00585013|12154604|FG001|STARTED|Overall Study||8
10980322|NCT00585013|12154603|FG000|COMPLETED|Overall Study||8
10980323|NCT00585013|12154604|FG001|COMPLETED|Overall Study||8
10980324|NCT00585013|12154603|FG000|NOT COMPLETED|Overall Study||0
10980325|NCT00585013|12154604|FG001|NOT COMPLETED|Overall Study||0
10980326|NCT00585039|12154614|FG000|STARTED|Overall Study||57
10980327|NCT00585039|12154615|FG001|STARTED|Overall Study||44
10980328|NCT00585039|12154614|FG000|COMPLETED|Overall Study||55
10980329|NCT00585039|12154615|FG001|COMPLETED|Overall Study||44
10980330|NCT00585039|12154614|FG000|NOT COMPLETED|Overall Study||2
10980331|NCT00585039|12154615|FG001|NOT COMPLETED|Overall Study||0
10980332|NCT00585052|12154623|FG000|STARTED|Overall Study||11
10980333|NCT00585052|12154623|FG000|COMPLETED|Overall Study||10
10980334|NCT00585052|12154623|FG000|NOT COMPLETED|Overall Study||1
10980335|NCT00585078|12154627|FG000|STARTED|Overall Study||40
10980336|NCT00585078|12154627|FG000|Treated|Overall Study||37
10980337|NCT00585078|12154627|FG000|Toxicity Evaluable|Overall Study||36
10980338|NCT00585078|12154627|FG000|Response Evaluable|Overall Study||24
10980339|NCT00585078|12154627|FG000|COMPLETED|Overall Study||0
10980340|NCT00585078|12154627|FG000|NOT COMPLETED|Overall Study||40
10980341|NCT00585104|12154631|FG000|STARTED|Overall Study||10
10980342|NCT00585104|12154631|FG000|COMPLETED|Overall Study||6
10980343|NCT00585104|12154631|FG000|NOT COMPLETED|Overall Study||4
10980344|NCT00585169|12154635|FG000|STARTED|Overall Study||29
10980345|NCT00585169|12154635|FG000|COMPLETED|Overall Study||28
10980346|NCT00585169|12154635|FG000|NOT COMPLETED|Overall Study||1
10980347|NCT00585182|12154641|FG000|STARTED|Overall Study||28
10980348|NCT00585182|12154641|FG000|COMPLETED|Overall Study||28
10980349|NCT00585182|12154641|FG000|NOT COMPLETED|Overall Study||0
10980350|NCT00585247|12154647|FG000|STARTED|Overall Study||14
10980351|NCT00585247|12154648|FG001|STARTED|Overall Study||13
10980352|NCT00585247|12154647|FG000|COMPLETED|Overall Study||14
10980353|NCT00585247|12154648|FG001|COMPLETED|Overall Study||13
10980354|NCT00585247|12154647|FG000|NOT COMPLETED|Overall Study||0
10980355|NCT00585247|12154648|FG001|NOT COMPLETED|Overall Study||0
10980356|NCT00585286|12154654|FG000|STARTED|Overall Study||15
10980357|NCT00585286|12154654|FG000|COMPLETED|Overall Study||14
10980358|NCT00585286|12154654|FG000|NOT COMPLETED|Overall Study||1
10980359|NCT00585312|12154660|FG000|STARTED|Overall Study|STARTED=Randomized|55
10980360|NCT00585312|12154661|FG001|STARTED|Overall Study|STARTED=Randomized|51
10980361|NCT00585312|12154660|FG000|Treated|Overall Study||53
10980362|NCT00585312|12154661|FG001|Treated|Overall Study||48
10980363|NCT00585312|12154660|FG000|COMPLETED|Overall Study||4
10980364|NCT00585312|12154661|FG001|COMPLETED|Overall Study||7
10980365|NCT00585312|12154660|FG000|NOT COMPLETED|Overall Study||51
10980366|NCT00585312|12154661|FG001|NOT COMPLETED|Overall Study||44
10980367|NCT00585325|12154669|FG000|STARTED|Overall Study||10
10980368|NCT00585325|12154670|FG001|STARTED|Overall Study||13
10980369|NCT00585325|12154669|FG000|COMPLETED|Overall Study||9
10980370|NCT00585325|12154670|FG001|COMPLETED|Overall Study||12
10980371|NCT00585325|12154669|FG000|NOT COMPLETED|Overall Study||1
10980372|NCT00585325|12154670|FG001|NOT COMPLETED|Overall Study||1
10980373|NCT00585351|12154682|FG000|STARTED|Notification Period (Informed Consent)||50
10980374|NCT00585351|12154683|FG001|STARTED|Notification Period (Informed Consent)||50
10980375|NCT00585351|12154684|FG002|STARTED|Notification Period (Informed Consent)||0
10980376|NCT00585351|12154685|FG003|STARTED|Notification Period (Informed Consent)||0
10980377|NCT00585351|12154686|FG004|STARTED|Notification Period (Informed Consent)||0
10980378|NCT00585351|12154687|FG005|STARTED|Notification Period (Informed Consent)||0
10980379|NCT00585351|12154688|FG006|STARTED|Notification Period (Informed Consent)||0
10980380|NCT00585351|12154689|FG007|STARTED|Notification Period (Informed Consent)||0
10980381|NCT00585351|12154682|FG000|COMPLETED|Notification Period (Informed Consent)||27
10980382|NCT00585351|12154683|FG001|COMPLETED|Notification Period (Informed Consent)||25
10980383|NCT00585351|12154684|FG002|COMPLETED|Notification Period (Informed Consent)||0
10980384|NCT00585351|12154685|FG003|COMPLETED|Notification Period (Informed Consent)||0
10980385|NCT00585351|12154686|FG004|COMPLETED|Notification Period (Informed Consent)||0
10980386|NCT00585351|12154687|FG005|COMPLETED|Notification Period (Informed Consent)||0
10980387|NCT00585351|12154688|FG006|COMPLETED|Notification Period (Informed Consent)||0
10980388|NCT00585351|12154689|FG007|COMPLETED|Notification Period (Informed Consent)||0
10980389|NCT00585351|12154682|FG000|NOT COMPLETED|Notification Period (Informed Consent)||23
10980390|NCT00585351|12154683|FG001|NOT COMPLETED|Notification Period (Informed Consent)||25
10980391|NCT00585351|12154684|FG002|NOT COMPLETED|Notification Period (Informed Consent)||0
10980392|NCT00585351|12154685|FG003|NOT COMPLETED|Notification Period (Informed Consent)||0
10980393|NCT00585351|12154686|FG004|NOT COMPLETED|Notification Period (Informed Consent)||0
10980394|NCT00585351|12154687|FG005|NOT COMPLETED|Notification Period (Informed Consent)||0
10980395|NCT00585351|12154688|FG006|NOT COMPLETED|Notification Period (Informed Consent)||0
10980396|NCT00585351|12154689|FG007|NOT COMPLETED|Notification Period (Informed Consent)||0
10980397|NCT00585351|12154682|FG000|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
10980398|NCT00585351|12154683|FG001|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
10980399|NCT00585351|12154684|FG002|STARTED|Enrollment Period (Intervention)||15
10980400|NCT00585351|12154685|FG003|STARTED|Enrollment Period (Intervention)||15
10980401|NCT00585351|12154686|FG004|STARTED|Enrollment Period (Intervention)||5
10980402|NCT00585351|12154687|FG005|STARTED|Enrollment Period (Intervention)||7
10980403|NCT00585351|12154688|FG006|STARTED|Enrollment Period (Intervention)||7
10980404|NCT00585351|12154689|FG007|STARTED|Enrollment Period (Intervention)||3
10980405|NCT00585351|12154682|FG000|COMPLETED|Enrollment Period (Intervention)||0
10980406|NCT00585351|12154683|FG001|COMPLETED|Enrollment Period (Intervention)||0
10980407|NCT00585351|12154684|FG002|COMPLETED|Enrollment Period (Intervention)||15
10980408|NCT00585351|12154685|FG003|COMPLETED|Enrollment Period (Intervention)||15
10980409|NCT00585351|12154686|FG004|COMPLETED|Enrollment Period (Intervention)||3
10980410|NCT00585351|12154687|FG005|COMPLETED|Enrollment Period (Intervention)||5
10980411|NCT00585351|12154688|FG006|COMPLETED|Enrollment Period (Intervention)||5
10980412|NCT00585351|12154689|FG007|COMPLETED|Enrollment Period (Intervention)||2
10980413|NCT00585351|12154682|FG000|NOT COMPLETED|Enrollment Period (Intervention)||0
10980414|NCT00585351|12154683|FG001|NOT COMPLETED|Enrollment Period (Intervention)||0
10980415|NCT00585351|12154684|FG002|NOT COMPLETED|Enrollment Period (Intervention)||0
10980416|NCT00585351|12154685|FG003|NOT COMPLETED|Enrollment Period (Intervention)||0
10980417|NCT00585351|12154686|FG004|NOT COMPLETED|Enrollment Period (Intervention)||2
10980418|NCT00585351|12154687|FG005|NOT COMPLETED|Enrollment Period (Intervention)||2
10980419|NCT00585351|12154688|FG006|NOT COMPLETED|Enrollment Period (Intervention)||2
10980420|NCT00585351|12154689|FG007|NOT COMPLETED|Enrollment Period (Intervention)||1
10980421|NCT00585377|12154703|FG000|STARTED|Overall Study||50
10980422|NCT00585377|12154703|FG000|COMPLETED|Overall Study||50
10980423|NCT00585377|12154703|FG000|NOT COMPLETED|Overall Study||0
10980424|NCT00585468|12154707|FG000|STARTED|First Intervention||10
10980425|NCT00585468|12154708|FG001|STARTED|First Intervention||11
10980426|NCT00585468|12154707|FG000|COMPLETED|First Intervention||9
10980427|NCT00585468|12154708|FG001|COMPLETED|First Intervention||10
10980428|NCT00585468|12154707|FG000|NOT COMPLETED|First Intervention||1
10980429|NCT00585468|12154708|FG001|NOT COMPLETED|First Intervention||1
10980430|NCT00585468|12154707|FG000|STARTED|Second Intervention||9
10980431|NCT00585468|12154708|FG001|STARTED|Second Intervention||10
10980432|NCT00585468|12154707|FG000|COMPLETED|Second Intervention||9
10980433|NCT00585468|12154708|FG001|COMPLETED|Second Intervention||10
10980434|NCT00585468|12154707|FG000|NOT COMPLETED|Second Intervention||0
10980435|NCT00585468|12154708|FG001|NOT COMPLETED|Second Intervention||0
10980436|NCT00585494|12154716|FG000|STARTED|Overall Study||300
10980437|NCT00585494|12154716|FG000|COMPLETED|Overall Study||244
10980438|NCT00585494|12154716|FG000|NOT COMPLETED|Overall Study||56
10980439|NCT00585533|12154720|FG000|STARTED|Overall Study||40
10980440|NCT00585533|12154720|FG000|COMPLETED|Overall Study||31
10980441|NCT00585533|12154720|FG000|NOT COMPLETED|Overall Study||9
10980442|NCT00585546|12154724|FG000|STARTED|LVAD Implantation Required for 4 Months||18
10980443|NCT00585546|12154724|FG000|COMPLETED|LVAD Implantation Required for 4 Months||13
10980444|NCT00585546|12154724|FG000|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
10980445|NCT00585546|12154724|FG000|STARTED|Clenbuterol Treatment - up to 12 Months||13
10980446|NCT00585546|12154724|FG000|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
10980447|NCT00585546|12154724|FG000|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
10980448|NCT00585637|12154732|FG000|STARTED|Baseline||81
10980449|NCT00585637|12154733|FG001|STARTED|Baseline||81
10980450|NCT00585637|12154734|FG002|STARTED|Baseline||83
10980451|NCT00585637|12154735|FG003|STARTED|Baseline||83
10980452|NCT00585637|12154732|FG000|COMPLETED|Baseline||81
10980453|NCT00585637|12154733|FG001|COMPLETED|Baseline||81
10980454|NCT00585637|12154734|FG002|COMPLETED|Baseline||83
10980455|NCT00585637|12154735|FG003|COMPLETED|Baseline||83
10980456|NCT00585637|12154732|FG000|NOT COMPLETED|Baseline||0
10980457|NCT00585637|12154733|FG001|NOT COMPLETED|Baseline||0
10980458|NCT00585637|12154734|FG002|NOT COMPLETED|Baseline||0
10980459|NCT00585637|12154735|FG003|NOT COMPLETED|Baseline||0
10980460|NCT00585637|12154732|FG000|STARTED|3-month Time Point||81
10980461|NCT00585637|12154733|FG001|STARTED|3-month Time Point||81
10980462|NCT00585637|12154734|FG002|STARTED|3-month Time Point||83
10980463|NCT00585637|12154735|FG003|STARTED|3-month Time Point||83
10980464|NCT00585637|12154732|FG000|COMPLETED|3-month Time Point||71
10980465|NCT00585637|12154733|FG001|COMPLETED|3-month Time Point||67
10980466|NCT00585637|12154734|FG002|COMPLETED|3-month Time Point||76
10980467|NCT00585637|12154735|FG003|COMPLETED|3-month Time Point||78
10980468|NCT00585637|12154732|FG000|NOT COMPLETED|3-month Time Point||10
10980469|NCT00585637|12154733|FG001|NOT COMPLETED|3-month Time Point||14
10980470|NCT00585637|12154734|FG002|NOT COMPLETED|3-month Time Point||7
10980471|NCT00585637|12154735|FG003|NOT COMPLETED|3-month Time Point||5
10980472|NCT00585637|12154732|FG000|STARTED|6-month Time Point||81
10980473|NCT00585637|12154733|FG001|STARTED|6-month Time Point||81
10980474|NCT00585637|12154734|FG002|STARTED|6-month Time Point||83
10980475|NCT00585637|12154735|FG003|STARTED|6-month Time Point||83
10980476|NCT00585637|12154732|FG000|COMPLETED|6-month Time Point||75
10980477|NCT00585637|12154733|FG001|COMPLETED|6-month Time Point||68
10980478|NCT00585637|12154734|FG002|COMPLETED|6-month Time Point||72
10980479|NCT00585637|12154735|FG003|COMPLETED|6-month Time Point||77
10980480|NCT00585637|12154732|FG000|NOT COMPLETED|6-month Time Point||6
10980481|NCT00585637|12154733|FG001|NOT COMPLETED|6-month Time Point||13
10980482|NCT00585637|12154734|FG002|NOT COMPLETED|6-month Time Point||11
10980483|NCT00585637|12154735|FG003|NOT COMPLETED|6-month Time Point||6
10980484|NCT00585650|12154747|FG000|STARTED|Overall Study||8
10980485|NCT00585650|12154748|FG001|STARTED|Overall Study||12
10980486|NCT00585650|12154747|FG000|COMPLETED|Overall Study||8
10980487|NCT00585650|12154748|FG001|COMPLETED|Overall Study||12
10980488|NCT00585650|12154747|FG000|NOT COMPLETED|Overall Study||0
10980489|NCT00585650|12154748|FG001|NOT COMPLETED|Overall Study||0
10980490|NCT00585689|12154754|FG000|STARTED|Overall Study||29
10980491|NCT00585689|12154754|FG000|COMPLETED|Overall Study||22
10980492|NCT00585689|12154754|FG000|NOT COMPLETED|Overall Study||7
10980493|NCT00585715|12154760|FG000|STARTED|Overall Study||11
10980494|NCT00585715|12154761|FG001|STARTED|Overall Study||11
10980495|NCT00585715|12154760|FG000|COMPLETED|Overall Study||8
10980496|NCT00585715|12154761|FG001|COMPLETED|Overall Study||11
10980497|NCT00585715|12154760|FG000|NOT COMPLETED|Overall Study||3
10980498|NCT00585715|12154761|FG001|NOT COMPLETED|Overall Study||0
10980499|NCT00585780|12154771|FG000|STARTED|Overall Study||21
10980500|NCT00585780|12154772|FG001|STARTED|Overall Study||23
10980501|NCT00585780|12154773|FG002|STARTED|Overall Study||34
10980502|NCT00585780|12154774|FG003|STARTED|Overall Study||22
10980503|NCT00585780|12154771|FG000|COMPLETED|Overall Study||13
10980504|NCT00585780|12154772|FG001|COMPLETED|Overall Study||14
10980505|NCT00585780|12154773|FG002|COMPLETED|Overall Study||21
10980506|NCT00585780|12154774|FG003|COMPLETED|Overall Study||14
10980507|NCT00585780|12154771|FG000|NOT COMPLETED|Overall Study||8
10980508|NCT00585780|12154772|FG001|NOT COMPLETED|Overall Study||9
10980509|NCT00585780|12154773|FG002|NOT COMPLETED|Overall Study||13
10980510|NCT00585780|12154774|FG003|NOT COMPLETED|Overall Study||8
10980511|NCT00585910|12154788|FG000|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
10980512|NCT00585910|12154788|FG000|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
10980513|NCT00585910|12154788|FG000|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
10980514|NCT00585910|12154788|FG000|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
10980515|NCT00585910|12154788|FG000|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
10980516|NCT00585910|12154788|FG000|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
10980517|NCT00585923|12154795|FG000|STARTED|Overall Study||56
10980518|NCT00585923|12154796|FG001|STARTED|Overall Study||59
10980519|NCT00585923|12154795|FG000|COMPLETED|Overall Study||25
10980520|NCT00585923|12154796|FG001|COMPLETED|Overall Study||26
10980521|NCT00585923|12154795|FG000|NOT COMPLETED|Overall Study||31
10980522|NCT00585923|12154796|FG001|NOT COMPLETED|Overall Study||33
10980523|NCT00585975|12154804|FG000|STARTED|Overall Study||277
10980524|NCT00585975|12154805|FG001|STARTED|Overall Study||291
10980525|NCT00585975|12154804|FG000|COMPLETED|Overall Study||262
10980526|NCT00585975|12154805|FG001|COMPLETED|Overall Study||278
10980527|NCT00585975|12154804|FG000|NOT COMPLETED|Overall Study||15
10980528|NCT00585975|12154805|FG001|NOT COMPLETED|Overall Study||13
10980529|NCT00586001|12154813|FG000|STARTED|Overall Study||26
10980530|NCT00586001|12154814|FG001|STARTED|Overall Study||11
10980531|NCT00586001|12154813|FG000|COMPLETED|Overall Study||22
10980532|NCT00586001|12154814|FG001|COMPLETED|Overall Study||10
10980533|NCT00586001|12154813|FG000|NOT COMPLETED|Overall Study||4
10980534|NCT00586001|12154814|FG001|NOT COMPLETED|Overall Study||1
10980535|NCT00586066|12154823|FG000|STARTED|Overall Study||48
10980536|NCT00586066|12154824|FG001|STARTED|Overall Study||24
10980537|NCT00586066|12154823|FG000|COMPLETED|Overall Study||30
10980538|NCT00586066|12154824|FG001|COMPLETED|Overall Study||14
10980539|NCT00586066|12154823|FG000|NOT COMPLETED|Overall Study||18
10980540|NCT00586066|12154824|FG001|NOT COMPLETED|Overall Study||10
10980541|NCT00586105|12154830|FG000|STARTED|Overall Study||39
10980542|NCT00586105|12154830|FG000|COMPLETED|Overall Study||0
10980543|NCT00586105|12154830|FG000|NOT COMPLETED|Overall Study||39
10980544|NCT00586157|12154834|FG000|STARTED|First Intervention||15
10980545|NCT00586157|12154835|FG001|STARTED|First Intervention||15
10980546|NCT00586157|12154834|FG000|COMPLETED|First Intervention||14
10980547|NCT00586157|12154835|FG001|COMPLETED|First Intervention||15
10980548|NCT00586157|12154834|FG000|NOT COMPLETED|First Intervention||1
10980549|NCT00586157|12154835|FG001|NOT COMPLETED|First Intervention||0
10980550|NCT00586157|12154834|FG000|STARTED|Second Intervention||14
10980551|NCT00586157|12154835|FG001|STARTED|Second Intervention||15
10980552|NCT00586157|12154834|FG000|COMPLETED|Second Intervention||12
10980553|NCT00586157|12154835|FG001|COMPLETED|Second Intervention||14
10980554|NCT00586157|12154834|FG000|NOT COMPLETED|Second Intervention||2
10980555|NCT00586157|12154835|FG001|NOT COMPLETED|Second Intervention||1
10980556|NCT00586170|12154843|FG000|STARTED|Overall Study||5
10980557|NCT00586170|12154844|FG001|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
10980558|NCT00586170|12154843|FG000|COMPLETED|Overall Study||5
10980559|NCT00586170|12154844|FG001|COMPLETED|Overall Study||3
10980560|NCT00586170|12154843|FG000|NOT COMPLETED|Overall Study||0
10980561|NCT00586170|12154844|FG001|NOT COMPLETED|Overall Study||0
10980562|NCT00586196|12154852|FG000|STARTED|Overall Study||7
10980563|NCT00586196|12154853|FG001|STARTED|Overall Study||9
10980564|NCT00586196|12154852|FG000|COMPLETED|Overall Study||7
10980565|NCT00586196|12154853|FG001|COMPLETED|Overall Study||9
10980566|NCT00586196|12154852|FG000|NOT COMPLETED|Overall Study||0
10980567|NCT00586196|12154853|FG001|NOT COMPLETED|Overall Study||0
10980568|NCT00586261|12154861|FG000|STARTED|Overall Study||17
10980569|NCT00586261|12154862|FG001|STARTED|Overall Study||19
10980570|NCT00586261|12154861|FG000|COMPLETED|Overall Study||17
10980571|NCT00586261|12154862|FG001|COMPLETED|Overall Study||19
10980572|NCT00586261|12154861|FG000|NOT COMPLETED|Overall Study||0
10980573|NCT00586261|12154862|FG001|NOT COMPLETED|Overall Study||0
10980574|NCT00586313|12154868|FG000|STARTED|Overall Study||21
10980575|NCT00586313|12154868|FG000|COMPLETED|Overall Study||19
10980576|NCT00586313|12154868|FG000|NOT COMPLETED|Overall Study||2
10980577|NCT00586326|12154872|FG000|STARTED|Enrollment to Device Placement-Enrolled||133
10980578|NCT00586326|12154872|FG000|COMPLETED|Enrollment to Device Placement-Enrolled||118
10980579|NCT00586326|12154872|FG000|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
10980580|NCT00586326|12154872|FG000|STARTED|Device Placed toTreatment-ITT||118
10980581|NCT00586326|12154872|FG000|COMPLETED|Device Placed toTreatment-ITT||100
10980582|NCT00586326|12154872|FG000|NOT COMPLETED|Device Placed toTreatment-ITT||18
10980583|NCT00586326|12154872|FG000|STARTED|Treated Through 5-yr Follow Up-Treated||100
10980584|NCT00586326|12154872|FG000|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
10980585|NCT00586326|12154872|FG000|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
10980586|NCT00586339|12154883|FG000|STARTED|Overall Study||61
10980587|NCT00586339|12154884|FG001|STARTED|Overall Study||59
10980588|NCT00586339|12154885|FG002|STARTED|Overall Study||30
10980589|NCT00586339|12154883|FG000|COMPLETED|Overall Study||54
10980590|NCT00586339|12154884|FG001|COMPLETED|Overall Study||52
10980591|NCT00586339|12154885|FG002|COMPLETED|Overall Study||24
10980592|NCT00586339|12154883|FG000|NOT COMPLETED|Overall Study||7
10980593|NCT00586339|12154884|FG001|NOT COMPLETED|Overall Study||7
10980594|NCT00586339|12154885|FG002|NOT COMPLETED|Overall Study||6
10980595|NCT00586469|12154895|FG000|STARTED|Overall Study||500
10980596|NCT00586469|12154896|FG001|STARTED|Overall Study||500
10980597|NCT00586469|12154895|FG000|COMPLETED|Overall Study||500
10980598|NCT00586469|12154896|FG001|COMPLETED|Overall Study||499
10980599|NCT00586469|12154895|FG000|NOT COMPLETED|Overall Study||0
10980600|NCT00586469|12154896|FG001|NOT COMPLETED|Overall Study||1
10980601|NCT00586482|12154904|FG000|STARTED|Overall Study||22
10980602|NCT00586482|12154905|FG001|STARTED|Overall Study||24
10980603|NCT00586482|12154904|FG000|COMPLETED|Overall Study||22
10980604|NCT00586482|12154905|FG001|COMPLETED|Overall Study||24
10980605|NCT00586482|12154904|FG000|NOT COMPLETED|Overall Study||0
10980606|NCT00586482|12154905|FG001|NOT COMPLETED|Overall Study||0
10980607|NCT00586495|12154911|FG000|STARTED|Treatment Period||95
10980608|NCT00586495|12154911|FG000|COMPLETED|Treatment Period||0
10980609|NCT00586495|12154911|FG000|NOT COMPLETED|Treatment Period||95
10980610|NCT00586495|12154911|FG000|STARTED|Follow-up||92
10980611|NCT00586495|12154911|FG000|COMPLETED|Follow-up||0
10980612|NCT00586495|12154911|FG000|NOT COMPLETED|Follow-up||92
10980613|NCT00586508|12154917|FG000|STARTED|Overall Study||68
10980614|NCT00586508|12154918|FG001|STARTED|Overall Study||13
10980615|NCT00586508|12154917|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
10980616|NCT00586508|12154918|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
10980617|NCT00586508|12154917|FG000|COMPLETED|Overall Study||0
10980618|NCT00586508|12154918|FG001|COMPLETED|Overall Study||0
10980619|NCT00586508|12154917|FG000|NOT COMPLETED|Overall Study||68
10980620|NCT00586508|12154918|FG001|NOT COMPLETED|Overall Study||13
10980621|NCT00586521|12154924|FG000|STARTED|On Demand Treatment (Months 1-6)||20
10980622|NCT00586521|12154924|FG000|COMPLETED|On Demand Treatment (Months 1-6)||19
10980623|NCT00586521|12154924|FG000|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
10980624|NCT00586521|12154924|FG000|STARTED|Prophylactic Treatment (Months 8-13)||19
10980625|NCT00586521|12154924|FG000|COMPLETED|Prophylactic Treatment (Months 8-13)||19
10980626|NCT00586521|12154924|FG000|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
10980627|NCT00586573|12154928|FG000|STARTED|Overall Study||34
10980628|NCT00586573|12154928|FG000|COMPLETED|Overall Study||28
10980629|NCT00586573|12154928|FG000|NOT COMPLETED|Overall Study||6
10980630|NCT00586612|12154934|FG000|STARTED|Primary Phase||163
10980631|NCT00586612|12154935|FG001|STARTED|Primary Phase||150
10980632|NCT00586612|12154934|FG000|COMPLETED|Primary Phase||162
10980633|NCT00586612|12154935|FG001|COMPLETED|Primary Phase||147
10980634|NCT00586612|12154934|FG000|NOT COMPLETED|Primary Phase||1
10980635|NCT00586612|12154935|FG001|NOT COMPLETED|Primary Phase||3
10980636|NCT00586612|12154934|FG000|STARTED|Booster Phase||154
10980637|NCT00586612|12154935|FG001|STARTED|Booster Phase||144
10980638|NCT00586612|12154934|FG000|COMPLETED|Booster Phase||151
10980639|NCT00586612|12154935|FG001|COMPLETED|Booster Phase||143
10980640|NCT00586612|12154934|FG000|NOT COMPLETED|Booster Phase||3
10980641|NCT00586612|12154935|FG001|NOT COMPLETED|Booster Phase||1
10980642|NCT00586625|12154943|FG000|STARTED|Overall Study||575
10980643|NCT00586625|12154944|FG001|STARTED|Overall Study||286
10980644|NCT00586625|12154943|FG000|COMPLETED|Overall Study||532
10980645|NCT00586625|12154944|FG001|COMPLETED|Overall Study||269
10980646|NCT00586625|12154943|FG000|NOT COMPLETED|Overall Study||43
10980647|NCT00586625|12154944|FG001|NOT COMPLETED|Overall Study||17
10980648|NCT00586664|12154953|FG000|STARTED|Overall Study||43
10980649|NCT00586664|12154954|FG001|STARTED|Overall Study||43
10980650|NCT00586664|12154955|FG002|STARTED|Overall Study||44
10980651|NCT00586664|12154953|FG000|COMPLETED|Overall Study||38
10980652|NCT00586664|12154954|FG001|COMPLETED|Overall Study||36
10980653|NCT00586664|12154955|FG002|COMPLETED|Overall Study||43
10980654|NCT00586664|12154953|FG000|NOT COMPLETED|Overall Study||5
10980655|NCT00586664|12154954|FG001|NOT COMPLETED|Overall Study||7
10980656|NCT00586664|12154955|FG002|NOT COMPLETED|Overall Study||1
10980657|NCT00586690|12154965|FG000|STARTED|Overall Study|Four consented subjects were screen failures.|21
10980658|NCT00586690|12154966|FG001|STARTED|Overall Study||22
10980659|NCT00586690|12154965|FG000|COMPLETED|Overall Study||5
10980660|NCT00586690|12154966|FG001|COMPLETED|Overall Study||22
10980661|NCT00586690|12154965|FG000|NOT COMPLETED|Overall Study||16
10980662|NCT00586690|12154966|FG001|NOT COMPLETED|Overall Study||0
10980663|NCT00586703|12154971|FG000|STARTED|Overall Study||16
10980664|NCT00586703|12154971|FG000|COMPLETED|Overall Study||4
10980665|NCT00586703|12154971|FG000|NOT COMPLETED|Overall Study||12
10980666|NCT00586729|12154977|FG000|STARTED|Overall Study||14
10980667|NCT00586729|12154978|FG001|STARTED|Overall Study||9
10980668|NCT00586729|12154977|FG000|COMPLETED|Overall Study||11
10980669|NCT00586729|12154978|FG001|COMPLETED|Overall Study||8
10980670|NCT00586729|12154977|FG000|NOT COMPLETED|Overall Study||3
10980671|NCT00586729|12154978|FG001|NOT COMPLETED|Overall Study||1
10980672|NCT00586820|12154986|FG000|STARTED|Overall Study||12
10980673|NCT00586820|12154987|FG001|STARTED|Overall Study||11
10980674|NCT00586820|12154986|FG000|COMPLETED|Overall Study||11
10980675|NCT00586820|12154987|FG001|COMPLETED|Overall Study||11
10980676|NCT00586820|12154986|FG000|NOT COMPLETED|Overall Study||1
10980677|NCT00586820|12154987|FG001|NOT COMPLETED|Overall Study||0
10980678|NCT00586846|12154993|FG000|STARTED|Overall Study||40
10980679|NCT00586846|12154993|FG000|COMPLETED|Overall Study||34
10980680|NCT00586846|12154993|FG000|NOT COMPLETED|Overall Study||6
10980681|NCT00586898|12154997|FG000|STARTED|Overall Study||36
10980682|NCT00586898|12154997|FG000|COMPLETED|Overall Study||29
10980683|NCT00586898|12154997|FG000|NOT COMPLETED|Overall Study||7
10980684|NCT00587041|12155004|FG000|STARTED|Overall Study||12
10980685|NCT00587041|12155005|FG001|STARTED|Overall Study||14
10980686|NCT00587041|12155006|FG002|STARTED|Overall Study||14
10980687|NCT00587041|12155004|FG000|COMPLETED|Overall Study||12
10980688|NCT00587041|12155005|FG001|COMPLETED|Overall Study||14
10980689|NCT00587041|12155006|FG002|COMPLETED|Overall Study||14
10980690|NCT00587041|12155004|FG000|NOT COMPLETED|Overall Study||0
10980691|NCT00587041|12155005|FG001|NOT COMPLETED|Overall Study||0
10980692|NCT00587041|12155006|FG002|NOT COMPLETED|Overall Study||0
10980693|NCT00587054|12155014|FG000|STARTED|Overall Study||129
10980694|NCT00587054|12155014|FG000|COMPLETED|Overall Study||120
10980695|NCT00587054|12155014|FG000|NOT COMPLETED|Overall Study||9
10980696|NCT00587067|12155018|FG000|STARTED|Overall Study||34
10980697|NCT00587067|12155018|FG000|COMPLETED|Overall Study||34
10980698|NCT00587067|12155018|FG000|NOT COMPLETED|Overall Study||0
10980699|NCT00587132|12155026|FG000|STARTED|Overall Study||4
10980700|NCT00587132|12155027|FG001|STARTED|Overall Study||0
10980701|NCT00587132|12155028|FG002|STARTED|Overall Study||0
10980702|NCT00587132|12155029|FG003|STARTED|Overall Study||0
10980703|NCT00587132|12155026|FG000|COMPLETED|Overall Study||4
10980704|NCT00587132|12155027|FG001|COMPLETED|Overall Study||0
10980705|NCT00587132|12155028|FG002|COMPLETED|Overall Study||0
10980706|NCT00587132|12155029|FG003|COMPLETED|Overall Study||0
10980707|NCT00587132|12155026|FG000|NOT COMPLETED|Overall Study||0
10980708|NCT00587132|12155027|FG001|NOT COMPLETED|Overall Study||0
10980709|NCT00587132|12155028|FG002|NOT COMPLETED|Overall Study||0
10980710|NCT00587132|12155029|FG003|NOT COMPLETED|Overall Study||0
10980711|NCT00587158|12155041|FG000|STARTED|Overall Study||49
10980712|NCT00587158|12155042|FG001|STARTED|Overall Study||51
10980713|NCT00587158|12155041|FG000|Continued in Study|Overall Study||45
10980714|NCT00587158|12155042|FG001|Continued in Study|Overall Study||46
10980715|NCT00587158|12155041|FG000|COMPLETED|Overall Study||44
10980716|NCT00587158|12155042|FG001|COMPLETED|Overall Study||43
10980717|NCT00587158|12155041|FG000|NOT COMPLETED|Overall Study||5
10980718|NCT00587158|12155042|FG001|NOT COMPLETED|Overall Study||8
10980719|NCT00587171|12155050|FG000|STARTED|Overall Study||9
10980720|NCT00587171|12155051|FG001|STARTED|Overall Study||10
10980721|NCT00587171|12155050|FG000|COMPLETED|Overall Study||8
10980722|NCT00587171|12155051|FG001|COMPLETED|Overall Study||9
10980723|NCT00587171|12155050|FG000|NOT COMPLETED|Overall Study||1
10980724|NCT00587171|12155051|FG001|NOT COMPLETED|Overall Study||1
10980725|NCT00587288|12155059|FG000|STARTED|Overall Study||53
10980726|NCT00587288|12155060|FG001|STARTED|Overall Study||53
10980727|NCT00587288|12155059|FG000|COMPLETED|Overall Study||50
10980728|NCT00587288|12155060|FG001|COMPLETED|Overall Study||44
10980729|NCT00587288|12155059|FG000|NOT COMPLETED|Overall Study||3
10980730|NCT00587288|12155060|FG001|NOT COMPLETED|Overall Study||9
10980731|NCT00587431|12155070|FG000|STARTED|Overall Study||63
10980732|NCT00587431|12155071|FG001|STARTED|Overall Study||39
10980733|NCT00587431|12155070|FG000|COMPLETED|Overall Study||62
10980734|NCT00587431|12155071|FG001|COMPLETED|Overall Study||38
10980735|NCT00587431|12155070|FG000|NOT COMPLETED|Overall Study||1
10980736|NCT00587431|12155071|FG001|NOT COMPLETED|Overall Study||1
10980737|NCT00587457|12155083|FG000|STARTED|Overall Study||3
10980738|NCT00587457|12155084|FG001|STARTED|Overall Study||3
10980739|NCT00587457|12155085|FG002|STARTED|Overall Study||5
10980740|NCT00587457|12155083|FG000|COMPLETED|Overall Study||0
10980741|NCT00587457|12155084|FG001|COMPLETED|Overall Study||0
10980742|NCT00587457|12155085|FG002|COMPLETED|Overall Study||0
10980743|NCT00587457|12155083|FG000|NOT COMPLETED|Overall Study||3
10980744|NCT00587457|12155084|FG001|NOT COMPLETED|Overall Study||3
10980745|NCT00587457|12155085|FG002|NOT COMPLETED|Overall Study||5
10980746|NCT00587483|12155096|FG000|STARTED|Overall Study||115
10980747|NCT00587483|12155097|FG001|STARTED|Overall Study||115
10980748|NCT00587483|12155098|FG002|STARTED|Overall Study||112
10980749|NCT00587483|12155096|FG000|COMPLETED|Overall Study||115
10980750|NCT00587483|12155097|FG001|COMPLETED|Overall Study||115
10980751|NCT00587483|12155098|FG002|COMPLETED|Overall Study||112
10980752|NCT00587483|12155096|FG000|NOT COMPLETED|Overall Study||0
10980753|NCT00587483|12155097|FG001|NOT COMPLETED|Overall Study||0
10980754|NCT00587483|12155098|FG002|NOT COMPLETED|Overall Study||0
10980755|NCT00587587|12155108|FG000|STARTED|Overall Study||17
10980756|NCT00587587|12155109|FG001|STARTED|Overall Study||13
10980757|NCT00587587|12155108|FG000|COMPLETED|Overall Study||11
10980758|NCT00587587|12155109|FG001|COMPLETED|Overall Study||12
10980759|NCT00587587|12155108|FG000|NOT COMPLETED|Overall Study||6
10980760|NCT00587587|12155109|FG001|NOT COMPLETED|Overall Study||1
10980761|NCT00587639|12155117|FG000|STARTED|Overall Study||8
10980762|NCT00587639|12155117|FG000|COMPLETED|Overall Study||7
10980763|NCT00587639|12155117|FG000|NOT COMPLETED|Overall Study||1
10980764|NCT00587678|12155124|FG000|STARTED|Overall Study||22
10980765|NCT00587678|12155125|FG001|STARTED|Overall Study||22
10980766|NCT00587678|12155126|FG002|STARTED|Overall Study||41
10980767|NCT00587678|12155124|FG000|COMPLETED|Overall Study||16
10980768|NCT00587678|12155125|FG001|COMPLETED|Overall Study||18
10980769|NCT00587678|12155126|FG002|COMPLETED|Overall Study||33
10980770|NCT00587678|12155124|FG000|NOT COMPLETED|Overall Study||6
10980771|NCT00587678|12155125|FG001|NOT COMPLETED|Overall Study||4
10980772|NCT00587678|12155126|FG002|NOT COMPLETED|Overall Study||8
10980773|NCT00587769|12155134|FG000|STARTED|Overall Study||38
10980774|NCT00587769|12155134|FG000|COMPLETED|Overall Study||38
10980775|NCT00587769|12155134|FG000|NOT COMPLETED|Overall Study||0
10980776|NCT00587834|12155138|FG000|STARTED|Overall Study||96
10980777|NCT00587834|12155138|FG000|COMPLETED|Overall Study||96
10980778|NCT00587834|12155138|FG000|NOT COMPLETED|Overall Study||0
10980779|NCT00587847|12155153|FG000|STARTED|Overall Study||12
10980780|NCT00587847|12155153|FG000|COMPLETED|Overall Study||5
10980781|NCT00587847|12155153|FG000|NOT COMPLETED|Overall Study||7
10980782|NCT04545008|12155158|FG000|STARTED|Overall Study||2
10980783|NCT04545008|12155158|FG000|COMPLETED|Overall Study||2
10980784|NCT04545008|12155158|FG000|NOT COMPLETED|Overall Study||0
10980785|NCT04411680|12155164|FG000|STARTED|Treatment Period||78
10980786|NCT04411680|12155165|FG001|STARTED|Treatment Period||44
10980787|NCT04411680|12155164|FG000|COMPLETED|Treatment Period||49
10980788|NCT04411680|12155165|FG001|COMPLETED|Treatment Period||36
10980789|NCT04411680|12155164|FG000|NOT COMPLETED|Treatment Period||29
10980790|NCT04411680|12155165|FG001|NOT COMPLETED|Treatment Period||8
10980791|NCT04411680|12155164|FG000|STARTED|Follow up Period||78
10980792|NCT04411680|12155165|FG001|STARTED|Follow up Period||44
10980793|NCT04411680|12155164|FG000|COMPLETED|Follow up Period||60
10980794|NCT04411680|12155165|FG001|COMPLETED|Follow up Period||30
10980795|NCT04411680|12155164|FG000|NOT COMPLETED|Follow up Period||18
10980796|NCT04411680|12155165|FG001|NOT COMPLETED|Follow up Period||14
10980797|NCT04364984|12155174|FG000|STARTED|Overall Study||37
10980798|NCT04364984|12155175|FG001|STARTED|Overall Study||44
10980799|NCT04364984|12155176|FG002|STARTED|Overall Study||31
10980800|NCT04364984|12155174|FG000|COMPLETED|Overall Study||35
10980801|NCT04364984|12155175|FG001|COMPLETED|Overall Study||42
10980802|NCT04364984|12155176|FG002|COMPLETED|Overall Study||31
10980803|NCT04364984|12155174|FG000|NOT COMPLETED|Overall Study||2
10980804|NCT04364984|12155175|FG001|NOT COMPLETED|Overall Study||2
10980805|NCT04364984|12155176|FG002|NOT COMPLETED|Overall Study||0
10980806|NCT04363437|12155186|FG000|STARTED|Overall Study||10
10980807|NCT04363437|12155187|FG001|STARTED|Overall Study||11
10980808|NCT04363437|12155186|FG000|COMPLETED|Overall Study||10
10980809|NCT04363437|12155187|FG001|COMPLETED|Overall Study||11
10980810|NCT04363437|12155186|FG000|NOT COMPLETED|Overall Study||0
10980811|NCT04363437|12155187|FG001|NOT COMPLETED|Overall Study||0
10980812|NCT04033991|12155193|FG000|STARTED|Overall Study||684
10980813|NCT04033991|12155193|FG000|Participants Who Took First-line Sunitinib Therapy|Overall Study||622
10980814|NCT04033991|12155193|FG000|Participants Who Took Second-line Axitinib Therapy|Overall Study||121
10980815|NCT04033991|12155193|FG000|Participants Who Took First-line Sunitinib Therapy and Then Second-line Axitinib Therapy|Overall Study||59
10980816|NCT04033991|12155193|FG000|Participants Who Took Drugs Other Than Sunitinib as First-line and Then Second-line Axitinib Therapy|Overall Study||62
10980817|NCT04033991|12155193|FG000|COMPLETED|Overall Study||684
10980818|NCT04033991|12155193|FG000|NOT COMPLETED|Overall Study||0
10980819|NCT03930849|12155202|FG000|STARTED|Overall Study||17
10980820|NCT03930849|12155203|FG001|STARTED|Overall Study||18
10980821|NCT03930849|12155204|FG002|STARTED|Overall Study||18
10980822|NCT03930849|12155202|FG000|COMPLETED|Overall Study||13
10980823|NCT03930849|12155203|FG001|COMPLETED|Overall Study||18
10980824|NCT03930849|12155204|FG002|COMPLETED|Overall Study||14
10980825|NCT03930849|12155202|FG000|NOT COMPLETED|Overall Study||4
10980826|NCT03930849|12155203|FG001|NOT COMPLETED|Overall Study||0
10980827|NCT03930849|12155204|FG002|NOT COMPLETED|Overall Study||4
10980828|NCT03793439|12155212|FG000|STARTED|Overall Study||5
10980829|NCT03793439|12155212|FG000|COMPLETED|Overall Study||3
10980830|NCT03793439|12155212|FG000|NOT COMPLETED|Overall Study||2
10980831|NCT03711266|12155216|FG000|STARTED|Overall Study||30
10980832|NCT03711266|12155216|FG000|COMPLETED|Overall Study||20
10980833|NCT03711266|12155216|FG000|NOT COMPLETED|Overall Study||10
10980834|NCT03630393|12155222|FG000|STARTED|Overall Study||68
10980835|NCT03630393|12155223|FG001|STARTED|Overall Study||71
10980836|NCT03630393|12155222|FG000|COMPLETED|Overall Study||67
10980837|NCT03630393|12155223|FG001|COMPLETED|Overall Study||71
10980838|NCT03630393|12155222|FG000|NOT COMPLETED|Overall Study||1
10980839|NCT03630393|12155223|FG001|NOT COMPLETED|Overall Study||0
10980840|NCT03531788|12155231|FG000|STARTED|Overall Study||12
10980841|NCT03531788|12155232|FG001|STARTED|Overall Study||6
10980842|NCT03531788|12155231|FG000|COMPLETED|Overall Study||11
10980843|NCT03531788|12155232|FG001|COMPLETED|Overall Study||6
10980844|NCT03531788|12155231|FG000|NOT COMPLETED|Overall Study||1
10980845|NCT03531788|12155232|FG001|NOT COMPLETED|Overall Study||0
10980846|NCT03359811|12155240|FG000|STARTED|Overall Study||35
10980847|NCT03359811|12155241|FG001|STARTED|Overall Study||35
10980848|NCT03359811|12155240|FG000|COMPLETED|Overall Study||33
10980849|NCT03359811|12155241|FG001|COMPLETED|Overall Study||35
10980850|NCT03359811|12155240|FG000|NOT COMPLETED|Overall Study||2
10980851|NCT03359811|12155241|FG001|NOT COMPLETED|Overall Study||0
10980852|NCT03241589|12155250|FG000|STARTED|Overall Study||109
10980853|NCT03241589|12155251|FG001|STARTED|Overall Study||357
10980854|NCT03241589|12155250|FG000|COMPLETED|Overall Study||109
10980855|NCT03241589|12155251|FG001|COMPLETED|Overall Study||357
10980856|NCT03241589|12155250|FG000|NOT COMPLETED|Overall Study||0
10980857|NCT03241589|12155251|FG001|NOT COMPLETED|Overall Study||0
10980858|NCT02959775|12155262|FG000|STARTED|Overall Study||160
10980859|NCT02959775|12155263|FG001|STARTED|Overall Study||160
10980860|NCT02959775|12155264|FG002|STARTED|Overall Study||160
10980861|NCT02959775|12155262|FG000|COMPLETED|Overall Study||133
10980862|NCT02959775|12155263|FG001|COMPLETED|Overall Study||133
10980863|NCT02959775|12155264|FG002|COMPLETED|Overall Study||124
10980864|NCT02959775|12155262|FG000|NOT COMPLETED|Overall Study||27
10980865|NCT02959775|12155263|FG001|NOT COMPLETED|Overall Study||27
10980866|NCT02959775|12155264|FG002|NOT COMPLETED|Overall Study||36
10980867|NCT02954406|12155283|FG000|STARTED|Overall Study||3
10980868|NCT02954406|12155284|FG001|STARTED|Overall Study||6
10980869|NCT02954406|12155285|FG002|STARTED|Overall Study||6
10980870|NCT02954406|12155286|FG003|STARTED|Overall Study||6
10980871|NCT02954406|12155287|FG004|STARTED|Overall Study||7
10980872|NCT02954406|12155288|FG005|STARTED|Overall Study||3
10980873|NCT02954406|12155289|FG006|STARTED|Overall Study||3
10980874|NCT02954406|12155290|FG007|STARTED|Overall Study||2
10980875|NCT02954406|12155291|FG008|STARTED|Overall Study||4
10980876|NCT02954406|12155292|FG009|STARTED|Overall Study||3
10980877|NCT02954406|12155293|FG010|STARTED|Overall Study||0
10980878|NCT02954406|12155283|FG000|COMPLETED|Overall Study||0
10980879|NCT02954406|12155284|FG001|COMPLETED|Overall Study||0
10980880|NCT02954406|12155285|FG002|COMPLETED|Overall Study||0
10980881|NCT02954406|12155286|FG003|COMPLETED|Overall Study||0
10980882|NCT02954406|12155287|FG004|COMPLETED|Overall Study||0
10980883|NCT02954406|12155288|FG005|COMPLETED|Overall Study||0
10980884|NCT02954406|12155289|FG006|COMPLETED|Overall Study||0
10980885|NCT02954406|12155290|FG007|COMPLETED|Overall Study||0
10980886|NCT02954406|12155291|FG008|COMPLETED|Overall Study||0
10980887|NCT02954406|12155292|FG009|COMPLETED|Overall Study||0
10980888|NCT02954406|12155293|FG010|COMPLETED|Overall Study||0
10980889|NCT02954406|12155283|FG000|NOT COMPLETED|Overall Study||3
10980890|NCT02954406|12155284|FG001|NOT COMPLETED|Overall Study||6
10980891|NCT02954406|12155285|FG002|NOT COMPLETED|Overall Study||6
10980892|NCT02954406|12155286|FG003|NOT COMPLETED|Overall Study||6
10980893|NCT02954406|12155287|FG004|NOT COMPLETED|Overall Study||7
10980894|NCT02954406|12155288|FG005|NOT COMPLETED|Overall Study||3
10980895|NCT02954406|12155289|FG006|NOT COMPLETED|Overall Study||3
10980896|NCT02954406|12155290|FG007|NOT COMPLETED|Overall Study||2
10980897|NCT02954406|12155291|FG008|NOT COMPLETED|Overall Study||4
10980898|NCT02954406|12155292|FG009|NOT COMPLETED|Overall Study||3
10980899|NCT02954406|12155293|FG010|NOT COMPLETED|Overall Study||0
10980900|NCT02927145|12155328|FG000|STARTED|Initial Recruitment||12
10980901|NCT02927145|12155329|FG001|STARTED|Initial Recruitment||12
10980902|NCT02927145|12155330|FG002|STARTED|Initial Recruitment||12
10980903|NCT02927145|12155331|FG003|STARTED|Initial Recruitment||14
10980904|NCT02927145|12155332|FG004|STARTED|Initial Recruitment||17
10980905|NCT02927145|12155333|FG005|STARTED|Initial Recruitment||15
10980906|NCT02927145|12155334|FG006|STARTED|Initial Recruitment||0
10980907|NCT02927145|12155335|FG007|STARTED|Initial Recruitment||0
10980908|NCT02927145|12155336|FG008|STARTED|Initial Recruitment||6
10980909|NCT02927145|12155328|FG000|COMPLETED|Initial Recruitment||12
10980910|NCT02927145|12155329|FG001|COMPLETED|Initial Recruitment||11
10980911|NCT02927145|12155330|FG002|COMPLETED|Initial Recruitment||11
10980912|NCT02927145|12155331|FG003|COMPLETED|Initial Recruitment||10
10980913|NCT02927145|12155332|FG004|COMPLETED|Initial Recruitment||14
10980914|NCT02927145|12155333|FG005|COMPLETED|Initial Recruitment||14
10980915|NCT02927145|12155334|FG006|COMPLETED|Initial Recruitment||0
10980916|NCT02927145|12155335|FG007|COMPLETED|Initial Recruitment||0
10980917|NCT02927145|12155336|FG008|COMPLETED|Initial Recruitment||4
10980918|NCT02927145|12155328|FG000|NOT COMPLETED|Initial Recruitment||0
10980919|NCT02927145|12155329|FG001|NOT COMPLETED|Initial Recruitment||1
10980920|NCT02927145|12155330|FG002|NOT COMPLETED|Initial Recruitment||1
10980921|NCT02927145|12155331|FG003|NOT COMPLETED|Initial Recruitment||4
10980922|NCT02927145|12155332|FG004|NOT COMPLETED|Initial Recruitment||3
10980923|NCT02927145|12155333|FG005|NOT COMPLETED|Initial Recruitment||1
10980924|NCT02927145|12155334|FG006|NOT COMPLETED|Initial Recruitment||0
10980925|NCT02927145|12155335|FG007|NOT COMPLETED|Initial Recruitment||0
10980926|NCT02927145|12155336|FG008|NOT COMPLETED|Initial Recruitment||2
10980927|NCT02927145|12155328|FG000|STARTED|Invitation for Additional Challenge||0
10980928|NCT02927145|12155329|FG001|STARTED|Invitation for Additional Challenge||0
10980929|NCT02927145|12155330|FG002|STARTED|Invitation for Additional Challenge||0
10980930|NCT02927145|12155331|FG003|STARTED|Invitation for Additional Challenge||0
10980931|NCT02927145|12155332|FG004|STARTED|Invitation for Additional Challenge||0
10980932|NCT02927145|12155333|FG005|STARTED|Invitation for Additional Challenge||0
10980933|NCT02927145|12155334|FG006|STARTED|Invitation for Additional Challenge||9
10980934|NCT02927145|12155335|FG007|STARTED|Invitation for Additional Challenge||8
10980935|NCT02927145|12155336|FG008|STARTED|Invitation for Additional Challenge||0
10980936|NCT02927145|12155328|FG000|COMPLETED|Invitation for Additional Challenge||0
10980937|NCT02927145|12155329|FG001|COMPLETED|Invitation for Additional Challenge||0
10980938|NCT02927145|12155330|FG002|COMPLETED|Invitation for Additional Challenge||0
10980939|NCT02927145|12155331|FG003|COMPLETED|Invitation for Additional Challenge||0
10980940|NCT02927145|12155332|FG004|COMPLETED|Invitation for Additional Challenge||0
10980941|NCT02927145|12155333|FG005|COMPLETED|Invitation for Additional Challenge||0
10980942|NCT02927145|12155334|FG006|COMPLETED|Invitation for Additional Challenge||8
10980943|NCT02927145|12155335|FG007|COMPLETED|Invitation for Additional Challenge||8
10980944|NCT02927145|12155336|FG008|COMPLETED|Invitation for Additional Challenge||0
10980945|NCT02927145|12155328|FG000|NOT COMPLETED|Invitation for Additional Challenge||0
10980946|NCT02927145|12155329|FG001|NOT COMPLETED|Invitation for Additional Challenge||0
10980947|NCT02927145|12155330|FG002|NOT COMPLETED|Invitation for Additional Challenge||0
10980948|NCT02927145|12155331|FG003|NOT COMPLETED|Invitation for Additional Challenge||0
10980949|NCT02927145|12155332|FG004|NOT COMPLETED|Invitation for Additional Challenge||0
10980950|NCT02927145|12155333|FG005|NOT COMPLETED|Invitation for Additional Challenge||0
10980951|NCT02927145|12155334|FG006|NOT COMPLETED|Invitation for Additional Challenge||1
10980952|NCT02927145|12155335|FG007|NOT COMPLETED|Invitation for Additional Challenge||0
10980953|NCT02927145|12155336|FG008|NOT COMPLETED|Invitation for Additional Challenge||0
10980954|NCT02910583|12155359|FG000|STARTED|Overall Study||159
10980955|NCT02910583|12155360|FG001|STARTED|Overall Study||164
10980956|NCT02910583|12155359|FG000|MRD Cohort/ Not Randomized|Overall Study|Not applicable to this cohort.|0
10980957|NCT02910583|12155360|FG001|MRD Cohort/ Not Randomized|Overall Study||15
10980958|NCT02910583|12155359|FG000|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study|Not applicable to this cohort.|0
10980959|NCT02910583|12155360|FG001|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study||43
10980960|NCT02910583|12155359|FG000|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study|Not applicable to this cohort.|0
10980961|NCT02910583|12155360|FG001|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study||43
10980962|NCT02910583|12155359|FG000|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study|Not applicable to this cohort.|0
10980963|NCT02910583|12155360|FG001|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study||31
10980964|NCT02910583|12155359|FG000|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study|Not applicable to this cohort.|0
10980965|NCT02910583|12155360|FG001|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study||32
10980966|NCT02910583|12155359|FG000|COMPLETED|Overall Study||152
10980967|NCT02910583|12155360|FG001|COMPLETED|Overall Study||157
10980968|NCT02910583|12155359|FG000|NOT COMPLETED|Overall Study||7
10980969|NCT02910583|12155360|FG001|NOT COMPLETED|Overall Study||7
10980970|NCT02699060|12155397|FG000|STARTED|Overall Study||68
10980971|NCT02699060|12155397|FG000|COMPLETED|Overall Study||68
10980972|NCT02699060|12155397|FG000|NOT COMPLETED|Overall Study||0
10980973|NCT02598388|12155417|FG000|STARTED|Overall Study||40
10980974|NCT02598388|12155418|FG001|STARTED|Overall Study||10
10980975|NCT02598388|12155419|FG002|STARTED|Overall Study||20
10980976|NCT02598388|12155420|FG003|STARTED|Overall Study||5
10980977|NCT02598388|12155421|FG004|STARTED|Overall Study||161
10980978|NCT02598388|12155422|FG005|STARTED|Overall Study||39
10980979|NCT02598388|12155423|FG006|STARTED|Overall Study||161
10980980|NCT02598388|12155424|FG007|STARTED|Overall Study||39
10980981|NCT02598388|12155425|FG008|STARTED|Overall Study||39
10980982|NCT02598388|12155426|FG009|STARTED|Overall Study||10
10980983|NCT02598388|12155427|FG010|STARTED|Overall Study||40
10980984|NCT02598388|12155428|FG011|STARTED|Overall Study||10
10980985|NCT02598388|12155417|FG000|COMPLETED|Overall Study||39
10980986|NCT02598388|12155418|FG001|COMPLETED|Overall Study||10
10980987|NCT02598388|12155419|FG002|COMPLETED|Overall Study||18
10980988|NCT02598388|12155420|FG003|COMPLETED|Overall Study||5
10980989|NCT02598388|12155421|FG004|COMPLETED|Overall Study||151
10980990|NCT02598388|12155422|FG005|COMPLETED|Overall Study||38
10980991|NCT02598388|12155423|FG006|COMPLETED|Overall Study||156
10980992|NCT02598388|12155424|FG007|COMPLETED|Overall Study||38
10980993|NCT02598388|12155425|FG008|COMPLETED|Overall Study||39
10980994|NCT02598388|12155426|FG009|COMPLETED|Overall Study||9
10980995|NCT02598388|12155427|FG010|COMPLETED|Overall Study||39
10980996|NCT02598388|12155428|FG011|COMPLETED|Overall Study||10
10980997|NCT02598388|12155417|FG000|NOT COMPLETED|Overall Study||1
10980998|NCT02598388|12155418|FG001|NOT COMPLETED|Overall Study||0
10980999|NCT02598388|12155419|FG002|NOT COMPLETED|Overall Study||2
10981000|NCT02598388|12155420|FG003|NOT COMPLETED|Overall Study||0
10981001|NCT02598388|12155421|FG004|NOT COMPLETED|Overall Study||10
10981002|NCT02598388|12155422|FG005|NOT COMPLETED|Overall Study||1
10981003|NCT02598388|12155423|FG006|NOT COMPLETED|Overall Study||5
10981004|NCT02598388|12155424|FG007|NOT COMPLETED|Overall Study||1
10981005|NCT02598388|12155425|FG008|NOT COMPLETED|Overall Study||0
10981006|NCT02598388|12155426|FG009|NOT COMPLETED|Overall Study||1
10981007|NCT02598388|12155427|FG010|NOT COMPLETED|Overall Study||1
10981008|NCT02598388|12155428|FG011|NOT COMPLETED|Overall Study||0
10981009|NCT02493751|12155461|FG000|STARTED|Overall Study||16
10981010|NCT02493751|12155462|FG001|STARTED|Overall Study||39
10981011|NCT02493751|12155461|FG000|COMPLETED|Overall Study||0
10981012|NCT02493751|12155462|FG001|COMPLETED|Overall Study||0
10981013|NCT02493751|12155461|FG000|NOT COMPLETED|Overall Study||16
10981014|NCT02493751|12155462|FG001|NOT COMPLETED|Overall Study||39
10981015|NCT02285166|12155469|FG000|STARTED|Overall Study||15330
10981016|NCT02285166|12155469|FG000|COMPLETED|Overall Study||14364
10981017|NCT02285166|12155469|FG000|NOT COMPLETED|Overall Study||966
10981018|NCT02075593|12155475|FG000|STARTED|Overall Study||4
10981019|NCT02075593|12155475|FG000|Infants Born to Pregnant Women Who Received at Least One Dose of Study Treatment|Overall Study||4
10981020|NCT02075593|12155475|FG000|COMPLETED|Overall Study||1
10981021|NCT02075593|12155475|FG000|NOT COMPLETED|Overall Study||3
10981022|NCT00587860|12155483|FG000|STARTED|Overall Study||35
10981023|NCT00587860|12155484|FG001|STARTED|Overall Study||35
10981024|NCT00587860|12155483|FG000|COMPLETED|Overall Study||30
10981025|NCT00587860|12155484|FG001|COMPLETED|Overall Study||30
10981026|NCT00587860|12155483|FG000|NOT COMPLETED|Overall Study||5
10981027|NCT00587860|12155484|FG001|NOT COMPLETED|Overall Study||5
10981028|NCT00587964|12155490|FG000|STARTED|Overall Study||51
10981029|NCT00587964|12155490|FG000|COMPLETED|Overall Study||39
10981030|NCT00587964|12155490|FG000|NOT COMPLETED|Overall Study||12
10981031|NCT00587990|12155497|FG000|STARTED|Overall Study||2
10981032|NCT00587990|12155498|FG001|STARTED|Overall Study||4
10981033|NCT00587990|12155499|FG002|STARTED|Overall Study||3
10981034|NCT00587990|12155497|FG000|COMPLETED|Overall Study||2
10981035|NCT00587990|12155498|FG001|COMPLETED|Overall Study||4
10981036|NCT00587990|12155499|FG002|COMPLETED|Overall Study||2
10981037|NCT00587990|12155497|FG000|NOT COMPLETED|Overall Study||0
10981038|NCT00587990|12155498|FG001|NOT COMPLETED|Overall Study||0
10981039|NCT00587990|12155499|FG002|NOT COMPLETED|Overall Study||1
10981040|NCT00588094|12155507|FG000|STARTED|Overall Study||20
10981041|NCT00588094|12155507|FG000|COMPLETED|Overall Study||15
10981042|NCT00588094|12155507|FG000|NOT COMPLETED|Overall Study||5
10981043|NCT00588159|12155513|FG000|STARTED|Overall Study||72
10981044|NCT00588159|12155514|FG001|STARTED|Overall Study||74
10981045|NCT00588159|12155513|FG000|COMPLETED|Overall Study||57
10981046|NCT00588159|12155514|FG001|COMPLETED|Overall Study||63
10981047|NCT00588159|12155513|FG000|NOT COMPLETED|Overall Study||15
10981048|NCT00588159|12155514|FG001|NOT COMPLETED|Overall Study||11
10981049|NCT00588237|12155520|FG000|STARTED|Overall Study||42
10981050|NCT00588237|12155520|FG000|COMPLETED|Overall Study||38
10981051|NCT00588237|12155520|FG000|NOT COMPLETED|Overall Study||4
10981052|NCT00588341|12155524|FG000|STARTED|Overall Study||24
10981053|NCT00588341|12155524|FG000|COMPLETED|Overall Study||19
10981054|NCT00588341|12155524|FG000|NOT COMPLETED|Overall Study||5
10981055|NCT00588354|12155530|FG000|STARTED|Baseline to 2 Weeks||11
10981056|NCT00588354|12155531|FG001|STARTED|Baseline to 2 Weeks||15
10981057|NCT00588354|12155530|FG000|COMPLETED|Baseline to 2 Weeks||9
10981058|NCT00588354|12155531|FG001|COMPLETED|Baseline to 2 Weeks||15
10981059|NCT00588354|12155530|FG000|NOT COMPLETED|Baseline to 2 Weeks||2
10981060|NCT00588354|12155531|FG001|NOT COMPLETED|Baseline to 2 Weeks||0
10981061|NCT00588354|12155530|FG000|STARTED|Baseline to 4 Weeks||9
10981062|NCT00588354|12155531|FG001|STARTED|Baseline to 4 Weeks||15
10981063|NCT00588354|12155530|FG000|COMPLETED|Baseline to 4 Weeks||9
10981064|NCT00588354|12155531|FG001|COMPLETED|Baseline to 4 Weeks||14
10981065|NCT00588354|12155530|FG000|NOT COMPLETED|Baseline to 4 Weeks||0
10981066|NCT00588354|12155531|FG001|NOT COMPLETED|Baseline to 4 Weeks||1
10981067|NCT00588380|12155538|FG000|STARTED|Overall Study||88
10981068|NCT00588380|12155538|FG000|COMPLETED|Overall Study||88
10981069|NCT00588380|12155538|FG000|NOT COMPLETED|Overall Study||0
10981070|NCT00588406|12155545|FG000|STARTED|Overall Study||46
10981071|NCT00588406|12155546|FG001|STARTED|Overall Study||49
10981072|NCT00588406|12155545|FG000|COMPLETED|Overall Study||46
10981073|NCT00588406|12155546|FG001|COMPLETED|Overall Study||49
10981074|NCT00588406|12155545|FG000|NOT COMPLETED|Overall Study||0
10981075|NCT00588406|12155546|FG001|NOT COMPLETED|Overall Study||0
10981076|NCT00588445|12155552|FG000|STARTED|Overall Study||65
10981077|NCT00588445|12155552|FG000|COMPLETED|Overall Study||50
10981078|NCT00588445|12155552|FG000|NOT COMPLETED|Overall Study||15
10981079|NCT00588536|12155558|FG000|STARTED|Overall Study||5
10981080|NCT00588536|12155558|FG000|COMPLETED|Overall Study||5
10981081|NCT00588536|12155558|FG000|NOT COMPLETED|Overall Study||0
10981082|NCT00588640|12155562|FG000|STARTED|Overall Study||10
10981083|NCT00588640|12155562|FG000|COMPLETED|Overall Study||8
10981084|NCT00588640|12155562|FG000|NOT COMPLETED|Overall Study||2
10981085|NCT00588666|12155566|FG000|STARTED|Overall Study||51
10981086|NCT00588666|12155566|FG000|COMPLETED|Overall Study||47
10981087|NCT00588666|12155566|FG000|NOT COMPLETED|Overall Study||4
10981088|NCT00588692|12155572|FG000|STARTED|Overall Study||30
10981089|NCT00588692|12155573|FG001|STARTED|Overall Study||30
10981090|NCT00588692|12155572|FG000|COMPLETED|Overall Study||23
10981091|NCT00588692|12155573|FG001|COMPLETED|Overall Study||27
10981092|NCT00588692|12155572|FG000|NOT COMPLETED|Overall Study||7
10981093|NCT00588692|12155573|FG001|NOT COMPLETED|Overall Study||3
10981094|NCT00588731|12155583|FG000|STARTED|Overall Study||21
10981095|NCT00588731|12155584|FG001|STARTED|Overall Study||20
10981096|NCT00588731|12155583|FG000|COMPLETED|Overall Study||18
10981097|NCT00588731|12155584|FG001|COMPLETED|Overall Study||18
10981098|NCT00588731|12155583|FG000|NOT COMPLETED|Overall Study||3
10981099|NCT00588731|12155584|FG001|NOT COMPLETED|Overall Study||2
10981100|NCT00588809|12155590|FG000|STARTED|Overall Study||47
10981101|NCT00588809|12155590|FG000|COMPLETED|Overall Study||47
10981102|NCT00588809|12155590|FG000|NOT COMPLETED|Overall Study||0
10981103|NCT00588822|12155594|FG000|STARTED|Overall Study||21
10981104|NCT00588822|12155594|FG000|COMPLETED|Overall Study||13
10981105|NCT00588822|12155594|FG000|NOT COMPLETED|Overall Study||8
10981106|NCT00588848|12155600|FG000|STARTED|Overall Study||3
10981107|NCT00588848|12155601|FG001|STARTED|Overall Study||8
10981108|NCT00588848|12155600|FG000|COMPLETED|Overall Study||3
10981109|NCT00588848|12155601|FG001|COMPLETED|Overall Study||5
10981110|NCT00588848|12155600|FG000|NOT COMPLETED|Overall Study||0
10981111|NCT00588848|12155601|FG001|NOT COMPLETED|Overall Study||3
10981112|NCT00588900|12155609|FG000|STARTED|Overall Study||5
10981113|NCT00588900|12155609|FG000|COMPLETED|Overall Study||5
10981114|NCT00588900|12155609|FG000|NOT COMPLETED|Overall Study||0
10981115|NCT00588952|12155615|FG000|STARTED|Overall Study||29
10981116|NCT00588952|12155616|FG001|STARTED|Overall Study||70
10981117|NCT00588952|12155615|FG000|COMPLETED|Overall Study||26
10981118|NCT00588952|12155616|FG001|COMPLETED|Overall Study||63
10981119|NCT00588952|12155615|FG000|NOT COMPLETED|Overall Study||3
10981120|NCT00588952|12155616|FG001|NOT COMPLETED|Overall Study||7
10981121|NCT00588965|12155622|FG000|STARTED|Overall Study||35
10981122|NCT00588965|12155622|FG000|COMPLETED|Overall Study||35
10981123|NCT00588965|12155622|FG000|NOT COMPLETED|Overall Study||0
10981124|NCT00589056|12155628|FG000|STARTED|Overall Study||55
10981125|NCT00589056|12155628|FG000|COMPLETED|Overall Study||52
10981126|NCT00589056|12155628|FG000|NOT COMPLETED|Overall Study||3
10981127|NCT00589108|12155635|FG000|STARTED|Overall Study||80
10981128|NCT00589108|12155636|FG001|STARTED|Overall Study||80
10981129|NCT00589108|12155637|FG002|STARTED|Overall Study||80
10981130|NCT00589108|12155635|FG000|COMPLETED|Overall Study||76
10981131|NCT00589108|12155636|FG001|COMPLETED|Overall Study||76
10981132|NCT00589108|12155637|FG002|COMPLETED|Overall Study||75
10981133|NCT00589108|12155635|FG000|NOT COMPLETED|Overall Study||4
10981134|NCT00589108|12155636|FG001|NOT COMPLETED|Overall Study||4
10981135|NCT00589108|12155637|FG002|NOT COMPLETED|Overall Study||5
10981136|NCT00589121|12155647|FG000|STARTED|Overall Study||12
10981137|NCT00589121|12155648|FG001|STARTED|Overall Study||86
10981138|NCT00589121|12155647|FG000|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
10981139|NCT00589121|12155648|FG001|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
10981140|NCT00589121|12155647|FG000|NOT COMPLETED|Overall Study||2
10981141|NCT00589121|12155648|FG001|NOT COMPLETED|Overall Study||7
10981142|NCT00589277|12155659|FG000|STARTED|Overall Study||1222
10981143|NCT00589277|12155660|FG001|STARTED|Overall Study||810
10981144|NCT00589277|12155659|FG000|Completed 2 Week Follow Up|Overall Study||603
10981145|NCT00589277|12155660|FG001|Completed 2 Week Follow Up|Overall Study||424
10981146|NCT00589277|12155659|FG000|Completed 3 Month Follow Up|Overall Study||762
10981147|NCT00589277|12155660|FG001|Completed 3 Month Follow Up|Overall Study||524
10981148|NCT00589277|12155659|FG000|COMPLETED|Overall Study||762
10981149|NCT00589277|12155660|FG001|COMPLETED|Overall Study||524
10981150|NCT00589277|12155659|FG000|NOT COMPLETED|Overall Study||460
10981151|NCT00589277|12155660|FG001|NOT COMPLETED|Overall Study||286
10981152|NCT00589290|12155666|FG000|STARTED|Overall Study||41
10981153|NCT00589290|12155666|FG000|COMPLETED|Overall Study||40
10981154|NCT00589290|12155666|FG000|NOT COMPLETED|Overall Study||1
10981155|NCT00589303|12155674|FG000|STARTED|Overall Study||14
10981156|NCT00589303|12155675|FG001|STARTED|Overall Study||13
10981157|NCT00589303|12155674|FG000|COMPLETED|Overall Study||12
10981158|NCT00589303|12155675|FG001|COMPLETED|Overall Study||12
10981159|NCT00589303|12155674|FG000|NOT COMPLETED|Overall Study||2
10981160|NCT00589303|12155675|FG001|NOT COMPLETED|Overall Study||1
10981161|NCT00589329|12155683|FG000|STARTED|Overall Study||10
10981162|NCT00589329|12155684|FG001|STARTED|Overall Study||10
10981163|NCT00589329|12155683|FG000|COMPLETED|Overall Study||10
10981164|NCT00589329|12155684|FG001|COMPLETED|Overall Study||10
10981165|NCT00589329|12155683|FG000|NOT COMPLETED|Overall Study||0
10981166|NCT00589329|12155684|FG001|NOT COMPLETED|Overall Study||0
10981167|NCT00589472|12155691|FG000|STARTED|Overall Study||19
10981168|NCT00589472|12155691|FG000|COMPLETED|Overall Study||18
10981169|NCT00589472|12155691|FG000|NOT COMPLETED|Overall Study||1
10981170|NCT00589563|12155695|FG000|STARTED|Overall Study||32
10981171|NCT00589563|12155695|FG000|COMPLETED|Overall Study||32
10981172|NCT00589563|12155695|FG000|NOT COMPLETED|Overall Study||0
10981173|NCT00589602|12155699|FG000|STARTED|Overall Study||13
10981174|NCT00589602|12155699|FG000|COMPLETED|Overall Study||12
10981175|NCT00589602|12155699|FG000|NOT COMPLETED|Overall Study||1
10981176|NCT00589628|12155707|FG000|STARTED|Overall Study||7
10981177|NCT00589628|12155708|FG001|STARTED|Overall Study||6
10981178|NCT00589628|12155707|FG000|COMPLETED|Overall Study||7
10981179|NCT00589628|12155708|FG001|COMPLETED|Overall Study||5
10981180|NCT00589628|12155707|FG000|NOT COMPLETED|Overall Study||0
10981181|NCT00589628|12155708|FG001|NOT COMPLETED|Overall Study||1
10981182|NCT00589667|12155714|FG000|STARTED|Overall Study||26
10981183|NCT00589667|12155714|FG000|COMPLETED|Overall Study||23
10981184|NCT00589667|12155714|FG000|NOT COMPLETED|Overall Study||3
10981185|NCT00589693|12155720|FG000|STARTED|Overall Study||115
10981186|NCT00589693|12155721|FG001|STARTED|Overall Study||112
10981187|NCT00589693|12155720|FG000|COMPLETED|Overall Study||71
10981188|NCT00589693|12155721|FG001|COMPLETED|Overall Study||83
10981189|NCT00589693|12155720|FG000|NOT COMPLETED|Overall Study||44
10981190|NCT00589693|12155721|FG001|NOT COMPLETED|Overall Study||29
10981191|NCT00589784|12155729|FG000|STARTED|Overall Study||36
10981192|NCT00589784|12155730|FG001|STARTED|Overall Study||14
10981193|NCT00589784|12155729|FG000|COMPLETED|Overall Study||35
10981194|NCT00589784|12155730|FG001|COMPLETED|Overall Study||4
10981195|NCT00589784|12155729|FG000|NOT COMPLETED|Overall Study||1
10981196|NCT00589784|12155730|FG001|NOT COMPLETED|Overall Study||10
10981197|NCT00589797|12155737|FG000|STARTED|Overall Study||264
10981198|NCT00589797|12155738|FG001|STARTED|Overall Study||112
10981199|NCT00589797|12155737|FG000|Baseline|Overall Study||218
10981200|NCT00589797|12155738|FG001|Baseline|Overall Study||106
10981201|NCT00589797|12155737|FG000|24 Months|Overall Study||191
10981202|NCT00589797|12155738|FG001|24 Months|Overall Study||89
10981203|NCT00589797|12155737|FG000|COMPLETED|Overall Study||191
10981204|NCT00589797|12155738|FG001|COMPLETED|Overall Study||89
10981205|NCT00589797|12155737|FG000|NOT COMPLETED|Overall Study||73
10981206|NCT00589797|12155738|FG001|NOT COMPLETED|Overall Study||23
10981207|NCT00589836|12155744|FG000|STARTED|Overall Study||20
10981208|NCT00589836|12155744|FG000|COMPLETED|Overall Study||20
10981209|NCT00589836|12155744|FG000|NOT COMPLETED|Overall Study||0
10981210|NCT00589849|12155748|FG000|STARTED|Overall Study||32
10981211|NCT00589849|12155748|FG000|COMPLETED|Overall Study||32
10981212|NCT00589849|12155748|FG000|NOT COMPLETED|Overall Study||0
10981213|NCT00589888|12155752|FG000|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
10981214|NCT00589888|12155753|FG001|STARTED|Normal Saline @ 40cc/Hour||0
10981215|NCT00589888|12155754|FG002|STARTED|Normal Saline @ 40cc/Hour||0
10981216|NCT00589888|12155755|FG003|STARTED|Normal Saline @ 40cc/Hour||0
10981217|NCT00589888|12155756|FG004|STARTED|Normal Saline @ 40cc/Hour||0
10981218|NCT00589888|12155752|FG000|COMPLETED|Normal Saline @ 40cc/Hour||13
10981219|NCT00589888|12155753|FG001|COMPLETED|Normal Saline @ 40cc/Hour||0
10981220|NCT00589888|12155754|FG002|COMPLETED|Normal Saline @ 40cc/Hour||0
10981221|NCT00589888|12155755|FG003|COMPLETED|Normal Saline @ 40cc/Hour||0
10981222|NCT00589888|12155756|FG004|COMPLETED|Normal Saline @ 40cc/Hour||0
10981223|NCT00589888|12155752|FG000|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
10981224|NCT00589888|12155753|FG001|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
10981225|NCT00589888|12155754|FG002|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
10981226|NCT00589888|12155755|FG003|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
10981227|NCT00589888|12155756|FG004|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
10981228|NCT00589888|12155752|FG000|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
10981229|NCT00589888|12155753|FG001|STARTED|Intralipid 20% @ 20cc/hr||13
10981230|NCT00589888|12155754|FG002|STARTED|Intralipid 20% @ 20cc/hr||0
10981231|NCT00589888|12155755|FG003|STARTED|Intralipid 20% @ 20cc/hr||0
10981232|NCT00589888|12155756|FG004|STARTED|Intralipid 20% @ 20cc/hr||0
10981233|NCT00589888|12155752|FG000|COMPLETED|Intralipid 20% @ 20cc/hr||0
10981234|NCT00589888|12155753|FG001|COMPLETED|Intralipid 20% @ 20cc/hr||13
10981235|NCT00589888|12155754|FG002|COMPLETED|Intralipid 20% @ 20cc/hr||0
10981236|NCT00589888|12155755|FG003|COMPLETED|Intralipid 20% @ 20cc/hr||0
10981237|NCT00589888|12155756|FG004|COMPLETED|Intralipid 20% @ 20cc/hr||0
10981238|NCT00589888|12155752|FG000|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
10981239|NCT00589888|12155753|FG001|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
10981240|NCT00589888|12155754|FG002|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
10981241|NCT00589888|12155755|FG003|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
10981242|NCT00589888|12155756|FG004|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
10981243|NCT00589888|12155752|FG000|STARTED|Intralipid 20% @ 40cc/Hour||0
10981244|NCT00589888|12155753|FG001|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
10981245|NCT00589888|12155754|FG002|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
10981246|NCT00589888|12155755|FG003|STARTED|Intralipid 20% @ 40cc/Hour||0
10981247|NCT00589888|12155756|FG004|STARTED|Intralipid 20% @ 40cc/Hour||0
10981248|NCT00589888|12155752|FG000|COMPLETED|Intralipid 20% @ 40cc/Hour||0
10981249|NCT00589888|12155753|FG001|COMPLETED|Intralipid 20% @ 40cc/Hour||0
10981250|NCT00589888|12155754|FG002|COMPLETED|Intralipid 20% @ 40cc/Hour||13
10981251|NCT00589888|12155755|FG003|COMPLETED|Intralipid 20% @ 40cc/Hour||0
10981252|NCT00589888|12155756|FG004|COMPLETED|Intralipid 20% @ 40cc/Hour||0
10981253|NCT00589888|12155752|FG000|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
10981254|NCT00589888|12155753|FG001|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
10981255|NCT00589888|12155754|FG002|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
10981256|NCT00589888|12155755|FG003|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
10981257|NCT00589888|12155756|FG004|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
10981258|NCT00589888|12155752|FG000|STARTED|32-gram Oral Fat Load||0
10981259|NCT00589888|12155753|FG001|STARTED|32-gram Oral Fat Load||0
10981260|NCT00589888|12155754|FG002|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
10981261|NCT00589888|12155755|FG003|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
10981262|NCT00589888|12155756|FG004|STARTED|32-gram Oral Fat Load||0
10981263|NCT00589888|12155752|FG000|COMPLETED|32-gram Oral Fat Load||0
10981264|NCT00589888|12155753|FG001|COMPLETED|32-gram Oral Fat Load||0
10981265|NCT00589888|12155754|FG002|COMPLETED|32-gram Oral Fat Load||0
10981266|NCT00589888|12155755|FG003|COMPLETED|32-gram Oral Fat Load||13
10981267|NCT00589888|12155756|FG004|COMPLETED|32-gram Oral Fat Load||0
10981268|NCT00589888|12155752|FG000|NOT COMPLETED|32-gram Oral Fat Load||0
10981269|NCT00589888|12155753|FG001|NOT COMPLETED|32-gram Oral Fat Load||0
10981270|NCT00589888|12155754|FG002|NOT COMPLETED|32-gram Oral Fat Load||0
10981271|NCT00589888|12155755|FG003|NOT COMPLETED|32-gram Oral Fat Load||0
10981272|NCT00589888|12155756|FG004|NOT COMPLETED|32-gram Oral Fat Load||0
10981273|NCT00589888|12155752|FG000|STARTED|64-gram Oral Fat Load||0
10981274|NCT00589888|12155753|FG001|STARTED|64-gram Oral Fat Load||0
10981275|NCT00589888|12155754|FG002|STARTED|64-gram Oral Fat Load||0
10981276|NCT00589888|12155755|FG003|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
10981277|NCT00589888|12155756|FG004|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
10981278|NCT00589888|12155752|FG000|COMPLETED|64-gram Oral Fat Load||0
10981279|NCT00589888|12155753|FG001|COMPLETED|64-gram Oral Fat Load||0
10981280|NCT00589888|12155754|FG002|COMPLETED|64-gram Oral Fat Load||0
10981281|NCT00589888|12155755|FG003|COMPLETED|64-gram Oral Fat Load||0
10981282|NCT00589888|12155756|FG004|COMPLETED|64-gram Oral Fat Load||13
10981283|NCT00589888|12155752|FG000|NOT COMPLETED|64-gram Oral Fat Load||0
10981284|NCT00589888|12155753|FG001|NOT COMPLETED|64-gram Oral Fat Load||0
10981285|NCT00589888|12155754|FG002|NOT COMPLETED|64-gram Oral Fat Load||0
10981286|NCT00589888|12155755|FG003|NOT COMPLETED|64-gram Oral Fat Load||0
10981287|NCT00589888|12155756|FG004|NOT COMPLETED|64-gram Oral Fat Load||0
10981288|NCT00589914|12155775|FG000|STARTED|Overall Study||606
10981289|NCT00589914|12155776|FG001|STARTED|Overall Study||608
10981290|NCT00589914|12155775|FG000|COMPLETED|Overall Study||456
10981291|NCT00589914|12155776|FG001|COMPLETED|Overall Study||471
10981292|NCT00589914|12155775|FG000|NOT COMPLETED|Overall Study||150
10981293|NCT00589914|12155776|FG001|NOT COMPLETED|Overall Study||137
10981294|NCT00589979|12155784|FG000|STARTED|Run-In Period||169
10981295|NCT00589979|12155785|FG001|STARTED|Run-In Period||0
10981296|NCT00589979|12155786|FG002|STARTED|Run-In Period||0
10981297|NCT00589979|12155784|FG000|COMPLETED|Run-In Period||93
10981298|NCT00589979|12155785|FG001|COMPLETED|Run-In Period||0
10981299|NCT00589979|12155786|FG002|COMPLETED|Run-In Period||0
10981300|NCT00589979|12155784|FG000|NOT COMPLETED|Run-In Period||76
10981301|NCT00589979|12155785|FG001|NOT COMPLETED|Run-In Period||0
10981302|NCT00589979|12155786|FG002|NOT COMPLETED|Run-In Period||0
10981303|NCT00589979|12155784|FG000|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
10981304|NCT00589979|12155785|FG001|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
10981305|NCT00589979|12155786|FG002|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
10981306|NCT00589979|12155784|FG000|COMPLETED|Double-Blind Treatment Period 1||0
10981307|NCT00589979|12155785|FG001|COMPLETED|Double-Blind Treatment Period 1||48
10981308|NCT00589979|12155786|FG002|COMPLETED|Double-Blind Treatment Period 1||41
10981309|NCT00589979|12155784|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||0
10981310|NCT00589979|12155785|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||2
10981311|NCT00589979|12155786|FG002|NOT COMPLETED|Double-Blind Treatment Period 1||2
10981312|NCT00589979|12155784|FG000|STARTED|Double-Blind Treatment Period 2||0
10981313|NCT00589979|12155785|FG001|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
10981314|NCT00589979|12155786|FG002|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
10981315|NCT00589979|12155784|FG000|COMPLETED|Double-Blind Treatment Period 2||0
10981316|NCT00589979|12155785|FG001|COMPLETED|Double-Blind Treatment Period 2||47
10981317|NCT00589979|12155786|FG002|COMPLETED|Double-Blind Treatment Period 2||39
10981318|NCT00589979|12155784|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||0
10981319|NCT00589979|12155785|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||1
10981320|NCT00589979|12155786|FG002|NOT COMPLETED|Double-Blind Treatment Period 2||2
10981321|NCT00589979|12155784|FG000|STARTED|Double-Blind Treatment Period 3||0
10981322|NCT00589979|12155785|FG001|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
10981323|NCT00589979|12155786|FG002|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
10981324|NCT00589979|12155784|FG000|COMPLETED|Double-Blind Treatment Period 3||0
10981325|NCT00589979|12155785|FG001|COMPLETED|Double-Blind Treatment Period 3||46
10981326|NCT00589979|12155786|FG002|COMPLETED|Double-Blind Treatment Period 3||38
10981327|NCT00589979|12155784|FG000|NOT COMPLETED|Double-Blind Treatment Period 3||0
10981328|NCT00589979|12155785|FG001|NOT COMPLETED|Double-Blind Treatment Period 3||1
10981329|NCT00589979|12155786|FG002|NOT COMPLETED|Double-Blind Treatment Period 3||1
10981330|NCT00590005|12155798|FG000|STARTED|Overall Study||106
10981331|NCT00590005|12155799|FG001|STARTED|Overall Study||119
10981332|NCT00590005|12155798|FG000|COMPLETED|Overall Study||106
10981333|NCT00590005|12155799|FG001|COMPLETED|Overall Study||119
10981334|NCT00590005|12155798|FG000|NOT COMPLETED|Overall Study||0
10981335|NCT00590005|12155799|FG001|NOT COMPLETED|Overall Study||0
10981336|NCT00590018|12155807|FG000|STARTED|Overall Study||9
10981337|NCT00590018|12155808|FG001|STARTED|Overall Study||9
10981338|NCT00590018|12155807|FG000|COMPLETED|Overall Study||9
10981339|NCT00590018|12155808|FG001|COMPLETED|Overall Study||9
10981340|NCT00590018|12155807|FG000|NOT COMPLETED|Overall Study||0
10981341|NCT00590018|12155808|FG001|NOT COMPLETED|Overall Study||0
10981342|NCT00590031|12155814|FG000|STARTED|Overall Study||61
10981343|NCT00590031|12155814|FG000|COMPLETED|Overall Study||55
10981344|NCT00590031|12155814|FG000|NOT COMPLETED|Overall Study||6
10981345|NCT00590044|12155820|FG000|STARTED|Overall Study||38
10981346|NCT00590044|12155821|FG001|STARTED|Overall Study||36
10981347|NCT00590044|12155820|FG000|COMPLETED|Overall Study||34
10981348|NCT00590044|12155821|FG001|COMPLETED|Overall Study||34
10981349|NCT00590044|12155820|FG000|NOT COMPLETED|Overall Study||4
10981350|NCT00590044|12155821|FG001|NOT COMPLETED|Overall Study||2
10981351|NCT00590161|12155832|FG000|STARTED|Overall Study||26
10981352|NCT00590161|12155833|FG001|STARTED|Overall Study||29
10981353|NCT00590161|12155832|FG000|COMPLETED|Overall Study||23
10981354|NCT00590161|12155833|FG001|COMPLETED|Overall Study||26
10981355|NCT00590161|12155832|FG000|NOT COMPLETED|Overall Study||3
10981356|NCT00590161|12155833|FG001|NOT COMPLETED|Overall Study||3
10981357|NCT00590226|12155841|FG000|STARTED|Overall Study||67
10981358|NCT00590226|12155842|FG001|STARTED|Overall Study||63
10981359|NCT00590226|12155841|FG000|COMPLETED|Overall Study||67
10981360|NCT00590226|12155842|FG001|COMPLETED|Overall Study||63
10981361|NCT00590226|12155841|FG000|NOT COMPLETED|Overall Study||0
10981362|NCT00590226|12155842|FG001|NOT COMPLETED|Overall Study||0
10981363|NCT00590317|12155850|FG000|STARTED|Overall Study||32
10981364|NCT00590317|12155851|FG001|STARTED|Overall Study||32
10981365|NCT00590317|12155850|FG000|COMPLETED|Overall Study||31
10981366|NCT00590317|12155851|FG001|COMPLETED|Overall Study||27
10981367|NCT00590317|12155850|FG000|NOT COMPLETED|Overall Study||1
10981368|NCT00590317|12155851|FG001|NOT COMPLETED|Overall Study||5
10981369|NCT00590369|12155860|FG000|STARTED|Overall Study||6
10981370|NCT00590369|12155861|FG001|STARTED|Overall Study||5
10981371|NCT00590369|12155860|FG000|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
10981372|NCT00590369|12155861|FG001|COMPLETED|Overall Study||5
10981373|NCT00590369|12155860|FG000|NOT COMPLETED|Overall Study||0
10981374|NCT00590369|12155861|FG001|NOT COMPLETED|Overall Study||0
10981375|NCT00590395|12155867|FG000|STARTED|Overall Study||19
10981376|NCT00590395|12155867|FG000|COMPLETED|Overall Study||19
10981377|NCT00590395|12155867|FG000|NOT COMPLETED|Overall Study||0
10981378|NCT00590460|12155871|FG000|STARTED|Overall Study||5
10981379|NCT00590460|12155871|FG000|COMPLETED|Overall Study||5
10981380|NCT00590460|12155871|FG000|NOT COMPLETED|Overall Study||0
10981381|NCT00590564|12155879|FG000|STARTED|Overall Study||42
10981382|NCT00590564|12155879|FG000|COMPLETED|Overall Study||24
10981383|NCT00590564|12155879|FG000|NOT COMPLETED|Overall Study||18
10981384|NCT00590577|12155887|FG000|STARTED|Overall Study||160
10981385|NCT00590577|12155888|FG001|STARTED|Overall Study||165
10981386|NCT00590577|12155889|FG002|STARTED|Overall Study||163
10981387|NCT00590577|12155890|FG003|STARTED|Overall Study||164
10981388|NCT00590577|12155887|FG000|COMPLETED|Overall Study||83
10981389|NCT00590577|12155888|FG001|COMPLETED|Overall Study||89
10981390|NCT00590577|12155889|FG002|COMPLETED|Overall Study||90
10981391|NCT00590577|12155890|FG003|COMPLETED|Overall Study||71
10981392|NCT00590577|12155887|FG000|NOT COMPLETED|Overall Study||77
10981393|NCT00590577|12155888|FG001|NOT COMPLETED|Overall Study||76
10981394|NCT00590577|12155889|FG002|NOT COMPLETED|Overall Study||73
10981395|NCT00590577|12155890|FG003|NOT COMPLETED|Overall Study||93
10981396|NCT00590590|12155903|FG000|STARTED|Overall Study||39
10981397|NCT00590590|12155904|FG001|STARTED|Overall Study||39
10981398|NCT00590590|12155905|FG002|STARTED|Overall Study||27
10981399|NCT00590590|12155903|FG000|COMPLETED|Overall Study||32
10981400|NCT00590590|12155904|FG001|COMPLETED|Overall Study||33
10981401|NCT00590590|12155905|FG002|COMPLETED|Overall Study||21
10981402|NCT00590590|12155903|FG000|NOT COMPLETED|Overall Study||7
10981403|NCT00590590|12155904|FG001|NOT COMPLETED|Overall Study||6
10981404|NCT00590590|12155905|FG002|NOT COMPLETED|Overall Study||6
10981405|NCT00590681|12155913|FG000|STARTED|Overall Study||62
10981406|NCT00590681|12155913|FG000|COMPLETED|Overall Study|The forty-two participants who did proceed to the post-RT phase|42
10981407|NCT00590681|12155913|FG000|NOT COMPLETED|Overall Study||20
10981408|NCT00590707|12155919|FG000|STARTED|Overall Study||100
10981409|NCT00590707|12155920|FG001|STARTED|Overall Study||100
10981410|NCT00590707|12155919|FG000|COMPLETED|Overall Study||100
10981411|NCT00590707|12155920|FG001|COMPLETED|Overall Study||100
10981412|NCT00590707|12155919|FG000|NOT COMPLETED|Overall Study||0
10981413|NCT00590707|12155920|FG001|NOT COMPLETED|Overall Study||0
10981414|NCT00590720|12155928|FG000|STARTED|Overall Study||4
10981415|NCT00590720|12155929|FG001|STARTED|Overall Study||7
10981416|NCT00590720|12155928|FG000|COMPLETED|Overall Study||3
10981417|NCT00590720|12155929|FG001|COMPLETED|Overall Study||6
10981418|NCT00590720|12155928|FG000|NOT COMPLETED|Overall Study||1
10981419|NCT00590720|12155929|FG001|NOT COMPLETED|Overall Study||1
10981420|NCT00590759|12155935|FG000|STARTED|Overall Study||150
10981421|NCT00590759|12155935|FG000|COMPLETED|Overall Study||70
10981422|NCT00590759|12155935|FG000|NOT COMPLETED|Overall Study||80
10981423|NCT00590772|12155939|FG000|STARTED|Overall Study||31
10981424|NCT00590772|12155939|FG000|COMPLETED|Overall Study||31
10981425|NCT00590772|12155939|FG000|NOT COMPLETED|Overall Study||0
10981426|NCT00590824|12155949|FG000|STARTED|Overall Study||11
10981427|NCT00590824|12155950|FG001|STARTED|Overall Study||9
10981428|NCT00590824|12155951|FG002|STARTED|Overall Study||2
10981429|NCT00590824|12155952|FG003|STARTED|Overall Study||1
10981430|NCT00590824|12155949|FG000|COMPLETED|Overall Study||11
10981431|NCT00590824|12155950|FG001|COMPLETED|Overall Study||7
10981432|NCT00590824|12155951|FG002|COMPLETED|Overall Study||1
10981433|NCT00590824|12155952|FG003|COMPLETED|Overall Study||0
10981434|NCT00590824|12155949|FG000|NOT COMPLETED|Overall Study||0
10981435|NCT00590824|12155950|FG001|NOT COMPLETED|Overall Study||2
10981436|NCT00590824|12155951|FG002|NOT COMPLETED|Overall Study||1
10981437|NCT00590824|12155952|FG003|NOT COMPLETED|Overall Study||1
10981438|NCT00590863|12155965|FG000|STARTED|Overall Study||221
10981439|NCT00590863|12155966|FG001|STARTED|Overall Study||220
10981440|NCT00590863|12155967|FG002|STARTED|Overall Study||224
10981441|NCT00590863|12155965|FG000|COMPLETED|Overall Study||137
10981442|NCT00590863|12155966|FG001|COMPLETED|Overall Study||138
10981443|NCT00590863|12155967|FG002|COMPLETED|Overall Study||146
10981444|NCT00590863|12155965|FG000|NOT COMPLETED|Overall Study||84
10981445|NCT00590863|12155966|FG001|NOT COMPLETED|Overall Study||82
10981446|NCT00590863|12155967|FG002|NOT COMPLETED|Overall Study||78
10981447|NCT00590889|12155978|FG000|STARTED|Overall Study||404
10981448|NCT00590889|12155979|FG001|STARTED|Overall Study||403
10981449|NCT00590889|12155978|FG000|COMPLETED|Overall Study||118
10981450|NCT00590889|12155979|FG001|COMPLETED|Overall Study||104
10981451|NCT00590889|12155978|FG000|NOT COMPLETED|Overall Study||286
10981452|NCT00590889|12155979|FG001|NOT COMPLETED|Overall Study||299
10981453|NCT00590902|12155985|FG000|STARTED|Overall Study||81
10981454|NCT00590902|12155985|FG000|COMPLETED|Overall Study||80
10981455|NCT00590902|12155985|FG000|NOT COMPLETED|Overall Study||1
10981456|NCT00590954|12155989|FG000|STARTED|Overall Study||32
10981457|NCT00590954|12155989|FG000|COMPLETED|Overall Study||30
10981458|NCT00590954|12155989|FG000|NOT COMPLETED|Overall Study||2
10981459|NCT00590967|12155997|FG000|STARTED|Overall Study||44
10981460|NCT00590967|12155998|FG001|STARTED|Overall Study||25
10981461|NCT00590967|12155997|FG000|COMPLETED|Overall Study||41
10981462|NCT00590967|12155998|FG001|COMPLETED|Overall Study||20
10981463|NCT00590967|12155997|FG000|NOT COMPLETED|Overall Study||3
10981464|NCT00590967|12155998|FG001|NOT COMPLETED|Overall Study||5
10981465|NCT00590980|12156004|FG000|STARTED|Overall Study||82
10981466|NCT00590980|12156004|FG000|COMPLETED|Overall Study||72
10981467|NCT00590980|12156004|FG000|NOT COMPLETED|Overall Study||10
10981468|NCT00591006|12156008|FG000|STARTED|Overall Study||1
10981469|NCT00591006|12156009|FG001|STARTED|Overall Study||0
10981470|NCT00591006|12156010|FG002|STARTED|Overall Study||1
10981471|NCT00591006|12156011|FG003|STARTED|Overall Study||1
10981472|NCT00591006|12156012|FG004|STARTED|Overall Study||1
10981473|NCT00591006|12156013|FG005|STARTED|Overall Study||0
10981474|NCT00591006|12156014|FG006|STARTED|Overall Study||1
10981475|NCT00591006|12156015|FG007|STARTED|Overall Study||0
10981476|NCT00591006|12156016|FG008|STARTED|Overall Study||1
10981477|NCT00591006|12156017|FG009|STARTED|Overall Study||1
10981478|NCT00591006|12156018|FG010|STARTED|Overall Study||0
10981479|NCT00591006|12156019|FG011|STARTED|Overall Study||1
10981480|NCT00591006|12156020|FG012|STARTED|Overall Study||1
10981481|NCT00591006|12156021|FG013|STARTED|Overall Study||2
10981482|NCT00591006|12156022|FG014|STARTED|Overall Study||0
10981483|NCT00591006|12156023|FG015|STARTED|Overall Study||1
10981484|NCT00591006|12156024|FG016|STARTED|Overall Study||0
10981485|NCT00591006|12156025|FG017|STARTED|Overall Study||1
10981486|NCT00591006|12156026|FG018|STARTED|Overall Study||0
10981487|NCT00591006|12156027|FG019|STARTED|Overall Study||1
10981488|NCT00591006|12156028|FG020|STARTED|Overall Study||0
10981489|NCT00591006|12156029|FG021|STARTED|Overall Study||1
10981490|NCT00591006|12156030|FG022|STARTED|Overall Study||1
10981491|NCT00591006|12156031|FG023|STARTED|Overall Study||1
10981492|NCT00591006|12156008|FG000|Treatment #2|Overall Study||1
10981493|NCT00591006|12156009|FG001|Treatment #2|Overall Study||0
10981494|NCT00591006|12156010|FG002|Treatment #2|Overall Study||1
10981495|NCT00591006|12156011|FG003|Treatment #2|Overall Study||1
10981496|NCT00591006|12156012|FG004|Treatment #2|Overall Study||1
10981497|NCT00591006|12156013|FG005|Treatment #2|Overall Study||0
10981498|NCT00591006|12156014|FG006|Treatment #2|Overall Study||1
10981499|NCT00591006|12156015|FG007|Treatment #2|Overall Study||0
10981500|NCT00591006|12156016|FG008|Treatment #2|Overall Study||1
10981501|NCT00591006|12156017|FG009|Treatment #2|Overall Study||1
10981502|NCT00591006|12156018|FG010|Treatment #2|Overall Study||0
10981503|NCT00591006|12156019|FG011|Treatment #2|Overall Study||1
10981504|NCT00591006|12156020|FG012|Treatment #2|Overall Study||1
10981505|NCT00591006|12156021|FG013|Treatment #2|Overall Study||2
10981506|NCT00591006|12156022|FG014|Treatment #2|Overall Study||0
10981507|NCT00591006|12156023|FG015|Treatment #2|Overall Study||0
10981508|NCT00591006|12156024|FG016|Treatment #2|Overall Study||0
10981509|NCT00591006|12156025|FG017|Treatment #2|Overall Study||1
10981510|NCT00591006|12156026|FG018|Treatment #2|Overall Study||0
10981511|NCT00591006|12156027|FG019|Treatment #2|Overall Study||1
10981512|NCT00591006|12156028|FG020|Treatment #2|Overall Study||0
10981513|NCT00591006|12156029|FG021|Treatment #2|Overall Study||1
10981514|NCT00591006|12156030|FG022|Treatment #2|Overall Study||1
10981515|NCT00591006|12156031|FG023|Treatment #2|Overall Study||1
10981516|NCT00591006|12156008|FG000|Treatment #3|Overall Study||1
10981517|NCT00591006|12156009|FG001|Treatment #3|Overall Study||0
10981518|NCT00591006|12156010|FG002|Treatment #3|Overall Study||1
10981519|NCT00591006|12156011|FG003|Treatment #3|Overall Study||1
10981520|NCT00591006|12156012|FG004|Treatment #3|Overall Study||1
10981521|NCT00591006|12156013|FG005|Treatment #3|Overall Study||0
10981522|NCT00591006|12156014|FG006|Treatment #3|Overall Study||1
10981523|NCT00591006|12156015|FG007|Treatment #3|Overall Study||0
10981524|NCT00591006|12156016|FG008|Treatment #3|Overall Study||1
10981525|NCT00591006|12156017|FG009|Treatment #3|Overall Study||1
10981526|NCT00591006|12156018|FG010|Treatment #3|Overall Study||0
10981527|NCT00591006|12156019|FG011|Treatment #3|Overall Study||1
10981528|NCT00591006|12156020|FG012|Treatment #3|Overall Study||1
10981529|NCT00591006|12156021|FG013|Treatment #3|Overall Study||2
10981530|NCT00591006|12156022|FG014|Treatment #3|Overall Study||0
10981531|NCT00591006|12156023|FG015|Treatment #3|Overall Study||0
10981532|NCT00591006|12156024|FG016|Treatment #3|Overall Study||0
10981533|NCT00591006|12156025|FG017|Treatment #3|Overall Study||1
10981534|NCT00591006|12156026|FG018|Treatment #3|Overall Study||0
10981535|NCT00591006|12156027|FG019|Treatment #3|Overall Study||1
10981536|NCT00591006|12156028|FG020|Treatment #3|Overall Study||0
10981537|NCT00591006|12156029|FG021|Treatment #3|Overall Study||1
10981538|NCT00591006|12156030|FG022|Treatment #3|Overall Study||1
10981539|NCT00591006|12156031|FG023|Treatment #3|Overall Study||1
10981540|NCT00591006|12156008|FG000|Treatment #4|Overall Study||1
10981541|NCT00591006|12156009|FG001|Treatment #4|Overall Study||0
10981542|NCT00591006|12156010|FG002|Treatment #4|Overall Study||1
10981543|NCT00591006|12156011|FG003|Treatment #4|Overall Study||1
10981544|NCT00591006|12156012|FG004|Treatment #4|Overall Study||1
10981545|NCT00591006|12156013|FG005|Treatment #4|Overall Study||0
10981546|NCT00591006|12156014|FG006|Treatment #4|Overall Study||1
10981547|NCT00591006|12156015|FG007|Treatment #4|Overall Study||0
10981548|NCT00591006|12156016|FG008|Treatment #4|Overall Study||1
10981549|NCT00591006|12156017|FG009|Treatment #4|Overall Study||1
10981550|NCT00591006|12156018|FG010|Treatment #4|Overall Study||0
10981551|NCT00591006|12156019|FG011|Treatment #4|Overall Study||1
10981552|NCT00591006|12156020|FG012|Treatment #4|Overall Study||1
10981553|NCT00591006|12156021|FG013|Treatment #4|Overall Study||2
10981554|NCT00591006|12156022|FG014|Treatment #4|Overall Study||0
10981555|NCT00591006|12156023|FG015|Treatment #4|Overall Study||0
10981556|NCT00591006|12156024|FG016|Treatment #4|Overall Study||0
10981557|NCT00591006|12156025|FG017|Treatment #4|Overall Study||1
10981558|NCT00591006|12156026|FG018|Treatment #4|Overall Study||0
10981559|NCT00591006|12156027|FG019|Treatment #4|Overall Study||1
10981560|NCT00591006|12156028|FG020|Treatment #4|Overall Study||0
10981561|NCT00591006|12156029|FG021|Treatment #4|Overall Study||1
10981562|NCT00591006|12156030|FG022|Treatment #4|Overall Study||0
10981563|NCT00591006|12156031|FG023|Treatment #4|Overall Study||0
10981564|NCT00591006|12156008|FG000|COMPLETED|Overall Study||1
10981565|NCT00591006|12156009|FG001|COMPLETED|Overall Study||0
10981566|NCT00591006|12156010|FG002|COMPLETED|Overall Study||1
10981567|NCT00591006|12156011|FG003|COMPLETED|Overall Study||1
10981568|NCT00591006|12156012|FG004|COMPLETED|Overall Study||1
10981569|NCT00591006|12156013|FG005|COMPLETED|Overall Study||0
10981570|NCT00591006|12156014|FG006|COMPLETED|Overall Study||1
10981571|NCT00591006|12156015|FG007|COMPLETED|Overall Study||0
10981572|NCT00591006|12156016|FG008|COMPLETED|Overall Study||1
10981573|NCT00591006|12156017|FG009|COMPLETED|Overall Study||1
10981574|NCT00591006|12156018|FG010|COMPLETED|Overall Study||0
10981575|NCT00591006|12156019|FG011|COMPLETED|Overall Study||1
10981576|NCT00591006|12156020|FG012|COMPLETED|Overall Study||1
10981577|NCT00591006|12156021|FG013|COMPLETED|Overall Study||2
10981578|NCT00591006|12156022|FG014|COMPLETED|Overall Study||0
10981579|NCT00591006|12156023|FG015|COMPLETED|Overall Study||0
10981580|NCT00591006|12156024|FG016|COMPLETED|Overall Study||0
10981581|NCT00591006|12156025|FG017|COMPLETED|Overall Study||1
10981582|NCT00591006|12156026|FG018|COMPLETED|Overall Study||0
10981583|NCT00591006|12156027|FG019|COMPLETED|Overall Study||1
10981584|NCT00591006|12156028|FG020|COMPLETED|Overall Study||0
10981585|NCT00591006|12156029|FG021|COMPLETED|Overall Study||1
10981586|NCT00591006|12156030|FG022|COMPLETED|Overall Study||0
10981587|NCT00591006|12156031|FG023|COMPLETED|Overall Study||0
10981588|NCT00591006|12156008|FG000|NOT COMPLETED|Overall Study||0
10981589|NCT00591006|12156009|FG001|NOT COMPLETED|Overall Study||0
10981590|NCT00591006|12156010|FG002|NOT COMPLETED|Overall Study||0
10981591|NCT00591006|12156011|FG003|NOT COMPLETED|Overall Study||0
10981592|NCT00591006|12156012|FG004|NOT COMPLETED|Overall Study||0
10981593|NCT00591006|12156013|FG005|NOT COMPLETED|Overall Study||0
10981594|NCT00591006|12156014|FG006|NOT COMPLETED|Overall Study||0
10981595|NCT00591006|12156015|FG007|NOT COMPLETED|Overall Study||0
10981596|NCT00591006|12156016|FG008|NOT COMPLETED|Overall Study||0
10981597|NCT00591006|12156017|FG009|NOT COMPLETED|Overall Study||0
10981598|NCT00591006|12156018|FG010|NOT COMPLETED|Overall Study||0
10981599|NCT00591006|12156019|FG011|NOT COMPLETED|Overall Study||0
10981600|NCT00591006|12156020|FG012|NOT COMPLETED|Overall Study||0
10981601|NCT00591006|12156021|FG013|NOT COMPLETED|Overall Study||0
10981602|NCT00591006|12156022|FG014|NOT COMPLETED|Overall Study||0
10981603|NCT00591006|12156023|FG015|NOT COMPLETED|Overall Study||1
10981604|NCT00591006|12156024|FG016|NOT COMPLETED|Overall Study||0
10981605|NCT00591006|12156025|FG017|NOT COMPLETED|Overall Study||0
10981606|NCT00591006|12156026|FG018|NOT COMPLETED|Overall Study||0
10981607|NCT00591006|12156027|FG019|NOT COMPLETED|Overall Study||0
10981608|NCT00591006|12156028|FG020|NOT COMPLETED|Overall Study||0
10981609|NCT00591006|12156029|FG021|NOT COMPLETED|Overall Study||0
10981610|NCT00591006|12156030|FG022|NOT COMPLETED|Overall Study||1
10981611|NCT00591006|12156031|FG023|NOT COMPLETED|Overall Study||1
10981612|NCT00591019|12156048|FG000|STARTED|Baseline (1 Day)||3
10981613|NCT00591019|12156049|FG001|STARTED|Baseline (1 Day)||4
10981614|NCT00591019|12156048|FG000|COMPLETED|Baseline (1 Day)||3
10981615|NCT00591019|12156049|FG001|COMPLETED|Baseline (1 Day)||4
10981616|NCT00591019|12156048|FG000|NOT COMPLETED|Baseline (1 Day)||0
10981617|NCT00591019|12156049|FG001|NOT COMPLETED|Baseline (1 Day)||0
10981618|NCT00591019|12156048|FG000|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
10981619|NCT00591019|12156049|FG001|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
10981620|NCT00591019|12156048|FG000|COMPLETED|Intervention 1 (14 Days)||2
10981621|NCT00591019|12156049|FG001|COMPLETED|Intervention 1 (14 Days)||3
10981622|NCT00591019|12156048|FG000|NOT COMPLETED|Intervention 1 (14 Days)||0
10981623|NCT00591019|12156049|FG001|NOT COMPLETED|Intervention 1 (14 Days)||0
10981624|NCT00591019|12156048|FG000|STARTED|Intevention 2 (14 Days)||2
10981625|NCT00591019|12156049|FG001|STARTED|Intevention 2 (14 Days)||3
10981626|NCT00591019|12156048|FG000|COMPLETED|Intevention 2 (14 Days)||2
10981627|NCT00591019|12156049|FG001|COMPLETED|Intevention 2 (14 Days)||3
10981628|NCT00591019|12156048|FG000|NOT COMPLETED|Intevention 2 (14 Days)||0
10981629|NCT00591019|12156049|FG001|NOT COMPLETED|Intevention 2 (14 Days)||0
10981630|NCT00591123|12156057|FG000|STARTED|Overall Study||38
10981631|NCT00591123|12156057|FG000|COMPLETED|Overall Study|38 were analyzed for safety, 33 were included for efficacy.|38
10981632|NCT00591123|12156057|FG000|NOT COMPLETED|Overall Study||0
10981633|NCT00591149|12156061|FG000|STARTED|Overall Study||16
10981634|NCT00591149|12156061|FG000|COMPLETED|Overall Study||11
10981635|NCT00591149|12156061|FG000|NOT COMPLETED|Overall Study||5
10981636|NCT00591214|12156065|FG000|STARTED|Overall Study||10
10981637|NCT00591214|12156065|FG000|COMPLETED|Overall Study||2
10981638|NCT00591214|12156065|FG000|NOT COMPLETED|Overall Study||8
10981639|NCT00591240|12156071|FG000|STARTED|Overall Study||116
10981640|NCT00591240|12156072|FG001|STARTED|Overall Study||222
10981641|NCT00591240|12156071|FG000|COMPLETED|Overall Study||116
10981642|NCT00591240|12156072|FG001|COMPLETED|Overall Study||222
10981643|NCT00591240|12156071|FG000|NOT COMPLETED|Overall Study||0
10981644|NCT00591240|12156072|FG001|NOT COMPLETED|Overall Study||0
10981645|NCT00591253|12156081|FG000|STARTED|Overall Study|Randomized or Treated|140
10981646|NCT00591253|12156082|FG001|STARTED|Overall Study|Randomized or Treated|137
10981647|NCT00591253|12156083|FG002|STARTED|Overall Study|Randomized or Treated|138
10981648|NCT00591253|12156081|FG000|COMPLETED|Overall Study||126
10981649|NCT00591253|12156082|FG001|COMPLETED|Overall Study||116
10981650|NCT00591253|12156083|FG002|COMPLETED|Overall Study||123
10981651|NCT00591253|12156081|FG000|NOT COMPLETED|Overall Study||14
10981652|NCT00591253|12156082|FG001|NOT COMPLETED|Overall Study||21
10981653|NCT00591253|12156083|FG002|NOT COMPLETED|Overall Study||15
10981654|NCT00591266|12156094|FG000|STARTED|Overall Study|Randomized only|189
10981655|NCT00591266|12156095|FG001|STARTED|Overall Study|Randomized only|188
10981656|NCT00591266|12156096|FG002|STARTED|Overall Study|Randomized only|189
10981657|NCT00591266|12156094|FG000|COMPLETED|Overall Study||180
10981658|NCT00591266|12156095|FG001|COMPLETED|Overall Study||177
10981659|NCT00591266|12156096|FG002|COMPLETED|Overall Study||175
10981660|NCT00591266|12156094|FG000|NOT COMPLETED|Overall Study||9
10981661|NCT00591266|12156095|FG001|NOT COMPLETED|Overall Study||11
10981662|NCT00591266|12156096|FG002|NOT COMPLETED|Overall Study||14
10981663|NCT00591305|12156106|FG000|STARTED|Overall Study||1
10981664|NCT00591305|12156107|FG001|STARTED|Overall Study||0
10981665|NCT00591305|12156106|FG000|1st Follow-up in 2 Wks After Surgery|Overall Study||1
10981666|NCT00591305|12156107|FG001|1st Follow-up in 2 Wks After Surgery|Overall Study||0
10981667|NCT00591305|12156106|FG000|COMPLETED|Overall Study||1
10981668|NCT00591305|12156107|FG001|COMPLETED|Overall Study||0
10981669|NCT00591305|12156106|FG000|NOT COMPLETED|Overall Study||0
10981670|NCT00591305|12156107|FG001|NOT COMPLETED|Overall Study||0
10981671|NCT00591344|12156116|FG000|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
10981672|NCT00591344|12156117|FG001|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
10981673|NCT00591344|12156116|FG000|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
10981674|NCT00591344|12156117|FG001|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
10981675|NCT00591344|12156116|FG000|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
10981676|NCT00591344|12156117|FG001|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
10981677|NCT00591344|12156116|FG000|NOT COMPLETED|Overall Study||5
10981678|NCT00591344|12156117|FG001|NOT COMPLETED|Overall Study||8
10981679|NCT00591370|12156127|FG000|STARTED|Overall Study||51
10981680|NCT00591370|12156127|FG000|COMPLETED|Overall Study||49
10981681|NCT00591370|12156127|FG000|NOT COMPLETED|Overall Study||2
10981682|NCT00591409|12156141|FG000|STARTED|Overall Study||10
10981683|NCT00591409|12156142|FG001|STARTED|Overall Study||10
10981684|NCT00591409|12156143|FG002|STARTED|Overall Study||10
10981685|NCT00591409|12156144|FG003|STARTED|Overall Study||10
10981686|NCT00591409|12156145|FG004|STARTED|Overall Study||10
10981687|NCT00591409|12156146|FG005|STARTED|Overall Study||10
10981688|NCT00591409|12156147|FG006|STARTED|Overall Study||10
10981689|NCT00591409|12156148|FG007|STARTED|Overall Study||10
10981690|NCT00591409|12156149|FG008|STARTED|Overall Study||9
10981691|NCT00591409|12156150|FG009|STARTED|Overall Study||11
10981692|NCT00591409|12156141|FG000|Treated|Overall Study||10
10981693|NCT00591409|12156142|FG001|Treated|Overall Study||10
10981694|NCT00591409|12156143|FG002|Treated|Overall Study||10
10981695|NCT00591409|12156144|FG003|Treated|Overall Study||10
10981696|NCT00591409|12156145|FG004|Treated|Overall Study||9
10981697|NCT00591409|12156146|FG005|Treated|Overall Study||10
10981698|NCT00591409|12156147|FG006|Treated|Overall Study||10
10981699|NCT00591409|12156148|FG007|Treated|Overall Study||10
10981700|NCT00591409|12156149|FG008|Treated|Overall Study||9
10981701|NCT00591409|12156150|FG009|Treated|Overall Study||10
10981702|NCT00591409|12156141|FG000|COMPLETED|Overall Study||10
10981703|NCT00591409|12156142|FG001|COMPLETED|Overall Study||10
10981704|NCT00591409|12156143|FG002|COMPLETED|Overall Study||10
10981705|NCT00591409|12156144|FG003|COMPLETED|Overall Study||10
10981706|NCT00591409|12156145|FG004|COMPLETED|Overall Study||9
10981707|NCT00591409|12156146|FG005|COMPLETED|Overall Study||10
10981708|NCT00591409|12156147|FG006|COMPLETED|Overall Study||10
10981709|NCT00591409|12156148|FG007|COMPLETED|Overall Study||10
10981710|NCT00591409|12156149|FG008|COMPLETED|Overall Study||9
10981711|NCT00591409|12156150|FG009|COMPLETED|Overall Study||10
10981712|NCT00591409|12156141|FG000|NOT COMPLETED|Overall Study||0
10981713|NCT00591409|12156142|FG001|NOT COMPLETED|Overall Study||0
10981714|NCT00591409|12156143|FG002|NOT COMPLETED|Overall Study||0
10981715|NCT00591409|12156144|FG003|NOT COMPLETED|Overall Study||0
10981716|NCT00591409|12156145|FG004|NOT COMPLETED|Overall Study||1
10981717|NCT00591409|12156146|FG005|NOT COMPLETED|Overall Study||0
10981718|NCT00591409|12156147|FG006|NOT COMPLETED|Overall Study||0
10981719|NCT00591409|12156148|FG007|NOT COMPLETED|Overall Study||0
10981720|NCT00591409|12156149|FG008|NOT COMPLETED|Overall Study||0
10981721|NCT00591409|12156150|FG009|NOT COMPLETED|Overall Study||1
10981722|NCT00591565|12156172|FG000|STARTED|Overall Study||13
10981723|NCT00591565|12156172|FG000|COMPLETED|Overall Study||8
10981724|NCT00591565|12156172|FG000|NOT COMPLETED|Overall Study||5
10981725|NCT00591578|12156179|FG000|STARTED|Double-Blind Treatment Phase||327
10981726|NCT00591578|12156180|FG001|STARTED|Double-Blind Treatment Phase||329
10981727|NCT00591578|12156181|FG002|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
10981728|NCT00591578|12156179|FG000|COMPLETED|Double-Blind Treatment Phase||249
10981729|NCT00591578|12156180|FG001|COMPLETED|Double-Blind Treatment Phase||249
10981730|NCT00591578|12156181|FG002|COMPLETED|Double-Blind Treatment Phase||244
10981731|NCT00591578|12156179|FG000|NOT COMPLETED|Double-Blind Treatment Phase||78
10981732|NCT00591578|12156180|FG001|NOT COMPLETED|Double-Blind Treatment Phase||80
10981733|NCT00591578|12156181|FG002|NOT COMPLETED|Double-Blind Treatment Phase||84
10981734|NCT00591578|12156179|FG000|STARTED|Open-Label Extension Phase||55
10981735|NCT00591578|12156180|FG001|STARTED|Open-Label Extension Phase||115
10981736|NCT00591578|12156181|FG002|STARTED|Open-Label Extension Phase||0
10981737|NCT00591578|12156179|FG000|COMPLETED|Open-Label Extension Phase||49
10981738|NCT00591578|12156180|FG001|COMPLETED|Open-Label Extension Phase||105
10981739|NCT00591578|12156181|FG002|COMPLETED|Open-Label Extension Phase||0
10981740|NCT00591578|12156179|FG000|NOT COMPLETED|Open-Label Extension Phase||6
10981741|NCT00591578|12156180|FG001|NOT COMPLETED|Open-Label Extension Phase||10
10981742|NCT00591578|12156181|FG002|NOT COMPLETED|Open-Label Extension Phase||0
10981743|NCT00591591|12156192|FG000|STARTED|Overall Study||176
10981744|NCT00591591|12156193|FG001|STARTED|Overall Study||133
10981745|NCT00591591|12156192|FG000|COMPLETED|Overall Study||165
10981746|NCT00591591|12156193|FG001|COMPLETED|Overall Study||94
10981747|NCT00591591|12156192|FG000|NOT COMPLETED|Overall Study||11
10981748|NCT00591591|12156193|FG001|NOT COMPLETED|Overall Study||39
10981749|NCT00591630|12156203|FG000|STARTED|Overall Study||6
10981750|NCT00591630|12156204|FG001|STARTED|Overall Study||8
10981751|NCT00591630|12156205|FG002|STARTED|Overall Study||10
10981752|NCT00591630|12156206|FG003|STARTED|Overall Study||6
10981753|NCT00591630|12156203|FG000|COMPLETED|Overall Study||6
10981754|NCT00591630|12156204|FG001|COMPLETED|Overall Study||8
10981755|NCT00591630|12156205|FG002|COMPLETED|Overall Study||9
10981756|NCT00591630|12156206|FG003|COMPLETED|Overall Study||6
10981757|NCT00591630|12156203|FG000|NOT COMPLETED|Overall Study||0
10981758|NCT00591630|12156204|FG001|NOT COMPLETED|Overall Study||0
10981759|NCT00591630|12156205|FG002|NOT COMPLETED|Overall Study||1
10981760|NCT00591630|12156206|FG003|NOT COMPLETED|Overall Study||0
10981761|NCT00591721|12156218|FG000|STARTED|Overall Study||89
10981762|NCT00591721|12156219|FG001|STARTED|Overall Study||92
10981763|NCT00591721|12156218|FG000|COMPLETED|Overall Study||68
10981764|NCT00591721|12156219|FG001|COMPLETED|Overall Study||70
10981765|NCT00591721|12156218|FG000|NOT COMPLETED|Overall Study||21
10981766|NCT00591721|12156219|FG001|NOT COMPLETED|Overall Study||22
10981767|NCT00591734|12156225|FG000|STARTED|Overall Study||57
10981768|NCT00591734|12156225|FG000|COMPLETED|Overall Study||4
10981769|NCT00591734|12156225|FG000|NOT COMPLETED|Overall Study||53
10981770|NCT00591760|12156231|FG000|STARTED|Overall Study||28
10981771|NCT00591760|12156232|FG001|STARTED|Overall Study||28
10981772|NCT00591760|12156231|FG000|COMPLETED|Overall Study||28
10981773|NCT00591760|12156232|FG001|COMPLETED|Overall Study||28
10981774|NCT00591760|12156231|FG000|NOT COMPLETED|Overall Study||0
10981775|NCT00591760|12156232|FG001|NOT COMPLETED|Overall Study||0
10981776|NCT00591773|12156241|FG000|STARTED|Overall Study||185
10981777|NCT00591773|12156242|FG001|STARTED|Overall Study||182
10981778|NCT00591773|12156243|FG002|STARTED|Overall Study||184
10981779|NCT00591773|12156241|FG000|COMPLETED|Overall Study||169
10981780|NCT00591773|12156242|FG001|COMPLETED|Overall Study||158
10981781|NCT00591773|12156243|FG002|COMPLETED|Overall Study||168
10981782|NCT00591773|12156241|FG000|NOT COMPLETED|Overall Study||16
10981783|NCT00591773|12156242|FG001|NOT COMPLETED|Overall Study||24
10981784|NCT00591773|12156243|FG002|NOT COMPLETED|Overall Study||16
10981785|NCT00591786|12156261|FG000|STARTED|Overall Study||9
10981786|NCT00591786|12156262|FG001|STARTED|Overall Study||9
10981787|NCT00591786|12156263|FG002|STARTED|Overall Study||11
10981788|NCT00591786|12156264|FG003|STARTED|Overall Study||11
10981789|NCT00591786|12156265|FG004|STARTED|Overall Study||10
10981790|NCT00591786|12156266|FG005|STARTED|Overall Study||10
10981791|NCT00591786|12156267|FG006|STARTED|Overall Study||10
10981792|NCT00591786|12156268|FG007|STARTED|Overall Study||10
10981793|NCT00591786|12156269|FG008|STARTED|Overall Study||10
10981794|NCT00591786|12156270|FG009|STARTED|Overall Study||10
10981795|NCT00591786|12156261|FG000|Treated Participants|Overall Study||9
10981796|NCT00591786|12156262|FG001|Treated Participants|Overall Study||9
10981797|NCT00591786|12156263|FG002|Treated Participants|Overall Study||10
10981798|NCT00591786|12156264|FG003|Treated Participants|Overall Study||11
10981799|NCT00591786|12156265|FG004|Treated Participants|Overall Study||10
10981800|NCT00591786|12156266|FG005|Treated Participants|Overall Study||10
10981801|NCT00591786|12156267|FG006|Treated Participants|Overall Study||10
10981802|NCT00591786|12156268|FG007|Treated Participants|Overall Study||10
10981803|NCT00591786|12156269|FG008|Treated Participants|Overall Study||10
10981804|NCT00591786|12156270|FG009|Treated Participants|Overall Study||10
10981805|NCT00591786|12156261|FG000|COMPLETED|Overall Study||9
10981806|NCT00591786|12156262|FG001|COMPLETED|Overall Study||9
10981807|NCT00591786|12156263|FG002|COMPLETED|Overall Study||10
10981808|NCT00591786|12156264|FG003|COMPLETED|Overall Study||11
10981809|NCT00591786|12156265|FG004|COMPLETED|Overall Study||10
10981810|NCT00591786|12156266|FG005|COMPLETED|Overall Study||10
10981811|NCT00591786|12156267|FG006|COMPLETED|Overall Study||10
10981812|NCT00591786|12156268|FG007|COMPLETED|Overall Study||10
10981813|NCT00591786|12156269|FG008|COMPLETED|Overall Study||10
10981814|NCT00591786|12156270|FG009|COMPLETED|Overall Study||10
10981815|NCT00591786|12156261|FG000|NOT COMPLETED|Overall Study||0
10981816|NCT00591786|12156262|FG001|NOT COMPLETED|Overall Study||0
10981817|NCT00591786|12156263|FG002|NOT COMPLETED|Overall Study||1
10981818|NCT00591786|12156264|FG003|NOT COMPLETED|Overall Study||0
10981819|NCT00591786|12156265|FG004|NOT COMPLETED|Overall Study||0
10981820|NCT00591786|12156266|FG005|NOT COMPLETED|Overall Study||0
10981821|NCT00591786|12156267|FG006|NOT COMPLETED|Overall Study||0
10981822|NCT00591786|12156268|FG007|NOT COMPLETED|Overall Study||0
10981823|NCT00591786|12156269|FG008|NOT COMPLETED|Overall Study||0
10981824|NCT00591786|12156270|FG009|NOT COMPLETED|Overall Study||0
10981825|NCT00591825|12156296|FG000|STARTED|Overall Study||14
10981826|NCT00591825|12156297|FG001|STARTED|Overall Study||13
10981827|NCT00591825|12156298|FG002|STARTED|Overall Study||13
10981828|NCT00591825|12156299|FG003|STARTED|Overall Study||14
10981829|NCT00591825|12156296|FG000|COMPLETED|Overall Study||14
10981830|NCT00591825|12156297|FG001|COMPLETED|Overall Study||13
10981831|NCT00591825|12156298|FG002|COMPLETED|Overall Study||13
10981832|NCT00591825|12156299|FG003|COMPLETED|Overall Study||14
10981833|NCT00591825|12156296|FG000|NOT COMPLETED|Overall Study||0
10981834|NCT00591825|12156297|FG001|NOT COMPLETED|Overall Study||0
10981835|NCT00591825|12156298|FG002|NOT COMPLETED|Overall Study||0
10981836|NCT00591825|12156299|FG003|NOT COMPLETED|Overall Study||0
10981837|NCT00591838|12156324|FG000|STARTED|Overall Study||5
10981838|NCT00591838|12156325|FG001|STARTED|Overall Study||6
10981839|NCT00591838|12156326|FG002|STARTED|Overall Study||6
10981840|NCT00591838|12156327|FG003|STARTED|Overall Study||6
10981841|NCT00591838|12156328|FG004|STARTED|Overall Study||51
10981842|NCT00591838|12156324|FG000|COMPLETED|Overall Study||5
10981843|NCT00591838|12156325|FG001|COMPLETED|Overall Study||6
10981844|NCT00591838|12156326|FG002|COMPLETED|Overall Study||6
10981845|NCT00591838|12156327|FG003|COMPLETED|Overall Study||5
10981846|NCT00591838|12156328|FG004|COMPLETED|Overall Study||51
10981847|NCT00591838|12156324|FG000|NOT COMPLETED|Overall Study||0
10981848|NCT00591838|12156325|FG001|NOT COMPLETED|Overall Study||0
10981849|NCT00591838|12156326|FG002|NOT COMPLETED|Overall Study||0
10981850|NCT00591838|12156327|FG003|NOT COMPLETED|Overall Study||1
10981851|NCT00591838|12156328|FG004|NOT COMPLETED|Overall Study||0
10981852|NCT00591851|12156341|FG000|STARTED|Overall Study||70
10981853|NCT00591851|12156341|FG000|COMPLETED|Overall Study||64
10981854|NCT00591851|12156341|FG000|NOT COMPLETED|Overall Study||6
10981855|NCT00591864|12156345|FG000|STARTED|Overall Study||89
10981856|NCT00591864|12156345|FG000|COMPLETED|Overall Study||84
10981857|NCT00591864|12156345|FG000|NOT COMPLETED|Overall Study||5
10981858|NCT00591942|12156350|FG000|STARTED|Overall Study||36
10981859|NCT00591942|12156351|FG001|STARTED|Overall Study||36
10981860|NCT00591942|12156350|FG000|COMPLETED|Overall Study||36
10981861|NCT00591942|12156351|FG001|COMPLETED|Overall Study||36
10981862|NCT00591942|12156350|FG000|NOT COMPLETED|Overall Study||0
10981863|NCT00591942|12156351|FG001|NOT COMPLETED|Overall Study||0
10981864|NCT00592072|12156357|FG000|STARTED|First Sequence||6
10981865|NCT00592072|12156358|FG001|STARTED|First Sequence||6
10981866|NCT00592072|12156357|FG000|COMPLETED|First Sequence||6
10981867|NCT00592072|12156358|FG001|COMPLETED|First Sequence||6
10981868|NCT00592072|12156357|FG000|NOT COMPLETED|First Sequence||0
10981869|NCT00592072|12156358|FG001|NOT COMPLETED|First Sequence||0
10981870|NCT00592072|12156357|FG000|STARTED|Wash Out Period||6
10981871|NCT00592072|12156358|FG001|STARTED|Wash Out Period||6
10981872|NCT00592072|12156357|FG000|COMPLETED|Wash Out Period||5
10981873|NCT00592072|12156358|FG001|COMPLETED|Wash Out Period||5
10981874|NCT00592072|12156357|FG000|NOT COMPLETED|Wash Out Period||1
10981875|NCT00592072|12156358|FG001|NOT COMPLETED|Wash Out Period||1
10981876|NCT00592072|12156357|FG000|STARTED|Second Sequence||5
10981877|NCT00592072|12156358|FG001|STARTED|Second Sequence||5
10981878|NCT00592072|12156357|FG000|COMPLETED|Second Sequence||5
10981879|NCT00592072|12156358|FG001|COMPLETED|Second Sequence||5
10981880|NCT00592072|12156357|FG000|NOT COMPLETED|Second Sequence||0
10981881|NCT00592072|12156358|FG001|NOT COMPLETED|Second Sequence||0
10981882|NCT00592124|12156370|FG000|STARTED|Overall Study||28
10981883|NCT00592124|12156371|FG001|STARTED|Overall Study||29
10981884|NCT00592124|12156372|FG002|STARTED|Overall Study||30
10981885|NCT00592124|12156373|FG003|STARTED|Overall Study||27
10981886|NCT00592124|12156374|FG004|STARTED|Overall Study||27
10981887|NCT00592124|12156375|FG005|STARTED|Overall Study||27
10981888|NCT00592124|12156370|FG000|COMPLETED|Overall Study||24
10981889|NCT00592124|12156371|FG001|COMPLETED|Overall Study||24
10981890|NCT00592124|12156372|FG002|COMPLETED|Overall Study||24
10981891|NCT00592124|12156373|FG003|COMPLETED|Overall Study||24
10981892|NCT00592124|12156374|FG004|COMPLETED|Overall Study||24
10981893|NCT00592124|12156375|FG005|COMPLETED|Overall Study||24
10981894|NCT00592124|12156370|FG000|NOT COMPLETED|Overall Study||4
10981895|NCT00592124|12156371|FG001|NOT COMPLETED|Overall Study||5
10981896|NCT00592124|12156372|FG002|NOT COMPLETED|Overall Study||6
10981897|NCT00592124|12156373|FG003|NOT COMPLETED|Overall Study||3
10981898|NCT00592124|12156374|FG004|NOT COMPLETED|Overall Study||3
10981899|NCT00592124|12156375|FG005|NOT COMPLETED|Overall Study||3
10981900|NCT00592176|12156385|FG000|STARTED|Overall Study||5
10981901|NCT00592176|12156385|FG000|COMPLETED|Overall Study||5
10981902|NCT00592176|12156385|FG000|NOT COMPLETED|Overall Study||0
10981903|NCT00592319|12156391|FG000|STARTED|Overall Study||2
10981904|NCT00592319|12156392|FG001|STARTED|Overall Study||8
10981905|NCT00592319|12156391|FG000|COMPLETED|Overall Study||2
10981906|NCT00592319|12156392|FG001|COMPLETED|Overall Study||5
10981907|NCT00592319|12156391|FG000|NOT COMPLETED|Overall Study||0
10981908|NCT00592319|12156392|FG001|NOT COMPLETED|Overall Study||3
10981909|NCT00592358|12156400|FG000|STARTED|Overall Study||17
10981910|NCT00592358|12156400|FG000|COMPLETED|Overall Study||11
10981911|NCT00592358|12156400|FG000|NOT COMPLETED|Overall Study||6
10981912|NCT00592384|12156406|FG000|STARTED|Overall Study||64
10981913|NCT00592384|12156407|FG001|STARTED|Overall Study||69
10981914|NCT00592384|12156406|FG000|COMPLETED|Overall Study||59
10981915|NCT00592384|12156407|FG001|COMPLETED|Overall Study||63
10981916|NCT00592384|12156406|FG000|NOT COMPLETED|Overall Study||5
10981917|NCT00592384|12156407|FG001|NOT COMPLETED|Overall Study||6
10981918|NCT00592475|12156416|FG000|STARTED|Overall Study||6
10981919|NCT00592475|12156417|FG001|STARTED|Overall Study||9
10981920|NCT00592475|12156418|FG002|STARTED|Overall Study||5
10981921|NCT00592475|12156416|FG000|COMPLETED|Overall Study||6
10981922|NCT00592475|12156417|FG001|COMPLETED|Overall Study||9
10981923|NCT00592475|12156418|FG002|COMPLETED|Overall Study||5
10981924|NCT00592475|12156416|FG000|NOT COMPLETED|Overall Study||0
10981925|NCT00592475|12156417|FG001|NOT COMPLETED|Overall Study||0
10981926|NCT00592475|12156418|FG002|NOT COMPLETED|Overall Study||0
10981927|NCT00592488|12156428|FG000|STARTED|Overall Study||6
10981928|NCT00592488|12156429|FG001|STARTED|Overall Study||7
10981929|NCT00592488|12156428|FG000|COMPLETED|Overall Study||6
10981930|NCT00592488|12156429|FG001|COMPLETED|Overall Study||7
10981931|NCT00592488|12156428|FG000|NOT COMPLETED|Overall Study||0
10981932|NCT00592488|12156429|FG001|NOT COMPLETED|Overall Study||0
10981933|NCT00592501|12156437|FG000|STARTED|Overall Study||25
10981934|NCT00592501|12156437|FG000|COMPLETED|Overall Study||23
10981935|NCT00592501|12156437|FG000|NOT COMPLETED|Overall Study||2
10981936|NCT00592553|12156444|FG000|STARTED|Overall Study||60
10981937|NCT00592553|12156445|FG001|STARTED|Overall Study||57
10981938|NCT00592553|12156446|FG002|STARTED|Overall Study||57
10981939|NCT00592553|12156444|FG000|As-treated Population|Overall Study||60
10981940|NCT00592553|12156445|FG001|As-treated Population|Overall Study||57
10981941|NCT00592553|12156446|FG002|As-treated Population|Overall Study||57
10981942|NCT00592553|12156444|FG000|ITT Population|Overall Study||60
10981943|NCT00592553|12156445|FG001|ITT Population|Overall Study||57
10981944|NCT00592553|12156446|FG002|ITT Population|Overall Study||57
10981945|NCT00592553|12156444|FG000|COMPLETED|Overall Study||59
10981946|NCT00592553|12156445|FG001|COMPLETED|Overall Study||57
10981947|NCT00592553|12156446|FG002|COMPLETED|Overall Study||57
10981948|NCT00592553|12156444|FG000|NOT COMPLETED|Overall Study||1
10981949|NCT00592553|12156445|FG001|NOT COMPLETED|Overall Study||0
10981950|NCT00592553|12156446|FG002|NOT COMPLETED|Overall Study||0
10981951|NCT00592631|12156456|FG000|STARTED|Overall Study||16
10981952|NCT00592631|12156457|FG001|STARTED|Overall Study||11
10981953|NCT00592631|12156456|FG000|COMPLETED|Overall Study||16
10981954|NCT00592631|12156457|FG001|COMPLETED|Overall Study||9
10981955|NCT00592631|12156456|FG000|NOT COMPLETED|Overall Study||0
10981956|NCT00592631|12156457|FG001|NOT COMPLETED|Overall Study||2
10981957|NCT00592683|12156465|FG000|STARTED|Overall Study||10
10981958|NCT00592683|12156466|FG001|STARTED|Overall Study||10
10981959|NCT00592683|12156465|FG000|COMPLETED|Overall Study||6
10981960|NCT00592683|12156466|FG001|COMPLETED|Overall Study||6
10981961|NCT00592683|12156465|FG000|NOT COMPLETED|Overall Study||4
10981962|NCT00592683|12156466|FG001|NOT COMPLETED|Overall Study||4
10981963|NCT00592761|12156472|FG000|STARTED|First Intervention (2 Weeks)||9
10981964|NCT00592761|12156473|FG001|STARTED|First Intervention (2 Weeks)||9
10981965|NCT00592761|12156472|FG000|COMPLETED|First Intervention (2 Weeks)||9
10981966|NCT00592761|12156473|FG001|COMPLETED|First Intervention (2 Weeks)||9
10981967|NCT00592761|12156472|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
10981968|NCT00592761|12156473|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
10981969|NCT00592761|12156472|FG000|STARTED|Second Intervention (2 Weeks)||9
10981970|NCT00592761|12156473|FG001|STARTED|Second Intervention (2 Weeks)||9
10981971|NCT00592761|12156472|FG000|COMPLETED|Second Intervention (2 Weeks)||9
10981972|NCT00592761|12156473|FG001|COMPLETED|Second Intervention (2 Weeks)||9
10981973|NCT00592761|12156472|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
10981974|NCT00592761|12156473|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
10981975|NCT00592774|12156484|FG000|STARTED|Overall Study||26
10981976|NCT00592774|12156485|FG001|STARTED|Overall Study||53
10981977|NCT00592774|12156486|FG002|STARTED|Overall Study||22
10981978|NCT00592774|12156487|FG003|STARTED|Overall Study||22
10981979|NCT00592774|12156488|FG004|STARTED|Overall Study||23
10981980|NCT00592774|12156484|FG000|COMPLETED|Overall Study||15
10981981|NCT00592774|12156485|FG001|COMPLETED|Overall Study||21
10981982|NCT00592774|12156486|FG002|COMPLETED|Overall Study||18
10981983|NCT00592774|12156487|FG003|COMPLETED|Overall Study||8
10981984|NCT00592774|12156488|FG004|COMPLETED|Overall Study||9
10981985|NCT00592774|12156484|FG000|NOT COMPLETED|Overall Study||11
10981986|NCT00592774|12156485|FG001|NOT COMPLETED|Overall Study||32
10981987|NCT00592774|12156486|FG002|NOT COMPLETED|Overall Study||4
10981988|NCT00592774|12156487|FG003|NOT COMPLETED|Overall Study||14
10981989|NCT00592774|12156488|FG004|NOT COMPLETED|Overall Study||14
10981990|NCT00592839|12156503|FG000|STARTED|Overall Study||53
10981991|NCT00592839|12156504|FG001|STARTED|Overall Study||52
10981992|NCT00592839|12156505|FG002|STARTED|Overall Study||52
10981993|NCT00592839|12156503|FG000|COMPLETED|Overall Study||51
10981994|NCT00592839|12156504|FG001|COMPLETED|Overall Study||48
10981995|NCT00592839|12156505|FG002|COMPLETED|Overall Study||46
10981996|NCT00592839|12156503|FG000|NOT COMPLETED|Overall Study||2
10981997|NCT00592839|12156504|FG001|NOT COMPLETED|Overall Study||4
10981998|NCT00592839|12156505|FG002|NOT COMPLETED|Overall Study||6
10981999|NCT00592852|12156513|FG000|STARTED|Overall Study||13
10982000|NCT00592852|12156513|FG000|COMPLETED|Overall Study||7
10982001|NCT00592852|12156513|FG000|NOT COMPLETED|Overall Study||6
10982002|NCT00592904|12156521|FG000|STARTED|Overall Study||57
10982003|NCT00592904|12156522|FG001|STARTED|Overall Study||148
10982004|NCT00592904|12156523|FG002|STARTED|Overall Study||27
10982005|NCT00592904|12156524|FG003|STARTED|Overall Study||30
10982006|NCT00592904|12156521|FG000|COMPLETED|Overall Study||32
10982007|NCT00592904|12156522|FG001|COMPLETED|Overall Study||93
10982008|NCT00592904|12156523|FG002|COMPLETED|Overall Study||10
10982009|NCT00592904|12156524|FG003|COMPLETED|Overall Study||19
10982010|NCT00592904|12156521|FG000|NOT COMPLETED|Overall Study||25
10982011|NCT00592904|12156522|FG001|NOT COMPLETED|Overall Study||55
10982012|NCT00592904|12156523|FG002|NOT COMPLETED|Overall Study||17
10982013|NCT00592904|12156524|FG003|NOT COMPLETED|Overall Study||11
10982014|NCT00592943|12156536|FG000|STARTED|Overall Study||6
10982015|NCT00592943|12156537|FG001|STARTED|Overall Study||6
10982016|NCT00592943|12156536|FG000|COMPLETED|Overall Study||6
10982017|NCT00592943|12156537|FG001|COMPLETED|Overall Study||6
10982018|NCT00592943|12156536|FG000|NOT COMPLETED|Overall Study||0
10982019|NCT00592943|12156537|FG001|NOT COMPLETED|Overall Study||0
10982020|NCT00593112|12156545|FG000|STARTED|Overall Study||27
10982021|NCT00593112|12156546|FG001|STARTED|Overall Study||12
10982022|NCT00593112|12156545|FG000|COMPLETED|Overall Study||17
10982023|NCT00593112|12156546|FG001|COMPLETED|Overall Study||12
10982024|NCT00593112|12156545|FG000|NOT COMPLETED|Overall Study||10
10982025|NCT00593112|12156546|FG001|NOT COMPLETED|Overall Study||0
10982026|NCT00593333|12156554|FG000|STARTED|Overall Study||54
10982027|NCT00593333|12156555|FG001|STARTED|Overall Study||56
10982028|NCT00593333|12156554|FG000|COMPLETED|Overall Study||44
10982029|NCT00593333|12156555|FG001|COMPLETED|Overall Study||45
10982030|NCT00593333|12156554|FG000|NOT COMPLETED|Overall Study||10
10982031|NCT00593333|12156555|FG001|NOT COMPLETED|Overall Study||11
10982032|NCT00593346|12156561|FG000|STARTED|Overall Study||151
10982033|NCT00593346|12156561|FG000|COMPLETED|Overall Study||151
10982034|NCT00593346|12156561|FG000|NOT COMPLETED|Overall Study||0
10982035|NCT00593372|12156568|FG000|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
10982036|NCT00593372|12156569|FG001|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
10982037|NCT00593372|12156568|FG000|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
10982038|NCT00593372|12156569|FG001|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
10982039|NCT00593372|12156568|FG000|NOT COMPLETED|Overall Study||0
10982040|NCT00593372|12156569|FG001|NOT COMPLETED|Overall Study||0
10982041|NCT00593385|12156575|FG000|STARTED|Overall Study||165
10982042|NCT00593385|12156575|FG000|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
10982043|NCT00593385|12156575|FG000|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
10982044|NCT00593385|12156575|FG000|NOT COMPLETED|Overall Study||40
10982045|NCT00593450|12156585|FG000|STARTED|Overall Study||301
10982046|NCT00593450|12156586|FG001|STARTED|Overall Study||286
10982047|NCT00593450|12156587|FG002|STARTED|Overall Study||298
10982048|NCT00593450|12156588|FG003|STARTED|Overall Study||300
10982049|NCT00593450|12156585|FG000|COMPLETED|Overall Study||284
10982050|NCT00593450|12156586|FG001|COMPLETED|Overall Study||265
10982051|NCT00593450|12156587|FG002|COMPLETED|Overall Study||285
10982052|NCT00593450|12156588|FG003|COMPLETED|Overall Study||271
10982053|NCT00593450|12156585|FG000|NOT COMPLETED|Overall Study||17
10982054|NCT00593450|12156586|FG001|NOT COMPLETED|Overall Study||21
10982055|NCT00593450|12156587|FG002|NOT COMPLETED|Overall Study||13
10982056|NCT00593450|12156588|FG003|NOT COMPLETED|Overall Study||29
10982057|NCT00593489|12156600|FG000|STARTED|Allocation|allocated to intervention group to receive the intervention|75
10982058|NCT00593489|12156601|FG001|STARTED|Allocation|allocated to usual care group|79
10982059|NCT00593489|12156600|FG000|COMPLETED|Allocation||73
10982060|NCT00593489|12156601|FG001|COMPLETED|Allocation||78
10982061|NCT00593489|12156600|FG000|NOT COMPLETED|Allocation||2
10982062|NCT00593489|12156601|FG001|NOT COMPLETED|Allocation||1
10982063|NCT00593489|12156600|FG000|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|73
10982064|NCT00593489|12156601|FG001|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|78
10982065|NCT00593489|12156600|FG000|COMPLETED|Analysis||73
10982066|NCT00593489|12156601|FG001|COMPLETED|Analysis||78
10982067|NCT00593489|12156600|FG000|NOT COMPLETED|Analysis||0
10982068|NCT00593489|12156601|FG001|NOT COMPLETED|Analysis||0
10982069|NCT00593554|12156611|FG000|STARTED|Overall Study||3
10982070|NCT00593554|12156612|FG001|STARTED|Overall Study||5
10982071|NCT00593554|12156611|FG000|COMPLETED|Overall Study||0
10982072|NCT00593554|12156612|FG001|COMPLETED|Overall Study||0
10982073|NCT00593554|12156611|FG000|NOT COMPLETED|Overall Study||3
10982074|NCT00593554|12156612|FG001|NOT COMPLETED|Overall Study||5
10982075|NCT00593606|12156618|FG000|STARTED|Overall Study||124
10982076|NCT00593606|12156618|FG000|Start of Treatment - Safety Set|Overall Study||116
10982077|NCT00593606|12156618|FG000|Full Analysis Set|Overall Study||114
10982078|NCT00593606|12156618|FG000|Treatment Period Completed|Overall Study||99
10982079|NCT00593606|12156618|FG000|COMPLETED|Overall Study||97
10982080|NCT00593606|12156618|FG000|NOT COMPLETED|Overall Study||27
10982081|NCT00593645|12156622|FG000|STARTED|Overall Study||7
10982082|NCT00593645|12156622|FG000|COMPLETED|Overall Study||7
10982083|NCT00593645|12156622|FG000|NOT COMPLETED|Overall Study||0
10982084|NCT00593684|12156628|FG000|STARTED|Overall Study||25
10982085|NCT00593684|12156629|FG001|STARTED|Overall Study||25
10982086|NCT00593684|12156628|FG000|COMPLETED|Overall Study||23
10982087|NCT00593684|12156629|FG001|COMPLETED|Overall Study||24
10982088|NCT00593684|12156628|FG000|NOT COMPLETED|Overall Study||2
10982089|NCT00593684|12156629|FG001|NOT COMPLETED|Overall Study||1
10982090|NCT00593736|12156639|FG000|STARTED|Screening Period and Placebo Run-in||0
10982091|NCT00593736|12156640|FG001|STARTED|Screening Period and Placebo Run-in||0
10982092|NCT00593736|12156641|FG002|STARTED|Screening Period and Placebo Run-in||0
10982093|NCT00593736|12156642|FG003|STARTED|Screening Period and Placebo Run-in||549
10982094|NCT00593736|12156639|FG000|COMPLETED|Screening Period and Placebo Run-in||0
10982095|NCT00593736|12156640|FG001|COMPLETED|Screening Period and Placebo Run-in||0
10982096|NCT00593736|12156641|FG002|COMPLETED|Screening Period and Placebo Run-in||0
10982097|NCT00593736|12156642|FG003|COMPLETED|Screening Period and Placebo Run-in||132
10982098|NCT00593736|12156639|FG000|NOT COMPLETED|Screening Period and Placebo Run-in||0
10982099|NCT00593736|12156640|FG001|NOT COMPLETED|Screening Period and Placebo Run-in||0
10982100|NCT00593736|12156641|FG002|NOT COMPLETED|Screening Period and Placebo Run-in||0
10982101|NCT00593736|12156642|FG003|NOT COMPLETED|Screening Period and Placebo Run-in||417
10982102|NCT00593736|12156639|FG000|STARTED|Treatment Period and Placebo Run-out||32
10982103|NCT00593736|12156640|FG001|STARTED|Treatment Period and Placebo Run-out||33
10982104|NCT00593736|12156641|FG002|STARTED|Treatment Period and Placebo Run-out||35
10982105|NCT00593736|12156642|FG003|STARTED|Treatment Period and Placebo Run-out||32
10982106|NCT00593736|12156639|FG000|COMPLETED|Treatment Period and Placebo Run-out||29
10982107|NCT00593736|12156640|FG001|COMPLETED|Treatment Period and Placebo Run-out||31
10982108|NCT00593736|12156641|FG002|COMPLETED|Treatment Period and Placebo Run-out||30
10982109|NCT00593736|12156642|FG003|COMPLETED|Treatment Period and Placebo Run-out||28
10982110|NCT00593736|12156639|FG000|NOT COMPLETED|Treatment Period and Placebo Run-out||3
10982111|NCT00593736|12156640|FG001|NOT COMPLETED|Treatment Period and Placebo Run-out||2
10982112|NCT00593736|12156641|FG002|NOT COMPLETED|Treatment Period and Placebo Run-out||5
10982113|NCT00593736|12156642|FG003|NOT COMPLETED|Treatment Period and Placebo Run-out||4
10982114|NCT00593814|12156654|FG000|STARTED|Overall Study||139
10982115|NCT00593814|12156655|FG001|STARTED|Overall Study||120
10982116|NCT00593814|12156654|FG000|COMPLETED|Overall Study||115
10982117|NCT00593814|12156655|FG001|COMPLETED|Overall Study||120
10982118|NCT00593814|12156654|FG000|NOT COMPLETED|Overall Study||24
10982119|NCT00593814|12156655|FG001|NOT COMPLETED|Overall Study||0
10982120|NCT00593827|12156663|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
10982121|NCT00593827|12156664|FG001|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
10982122|NCT00593827|12156663|FG000|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
10982123|NCT00593827|12156664|FG001|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
10982124|NCT00593827|12156663|FG000|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
10982125|NCT00593827|12156664|FG001|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
10982126|NCT00593827|12156663|FG000|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
10982127|NCT00593827|12156664|FG001|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
10982128|NCT00593827|12156663|FG000|NOT COMPLETED|Overall Study||0
10982129|NCT00593827|12156664|FG001|NOT COMPLETED|Overall Study||2
10982130|NCT00593866|12156670|FG000|STARTED|Overall Study||50
10982131|NCT00593866|12156670|FG000|COMPLETED|Overall Study||50
10982132|NCT00593866|12156670|FG000|NOT COMPLETED|Overall Study||0
10982133|NCT00593918|12156676|FG000|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
10982134|NCT00593918|12156677|FG001|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
10982135|NCT00593918|12156676|FG000|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
10982136|NCT00593918|12156677|FG001|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
10982137|NCT00593918|12156676|FG000|NOT COMPLETED|Overall Study||5
10982138|NCT00593918|12156677|FG001|NOT COMPLETED|Overall Study||24
10982139|NCT00593957|12156686|FG000|STARTED|Overall Study||13
10982140|NCT00593957|12156687|FG001|STARTED|Overall Study||13
10982141|NCT00593957|12156688|FG002|STARTED|Overall Study||12
10982142|NCT00593957|12156686|FG000|COMPLETED|Overall Study||13
10982143|NCT00593957|12156687|FG001|COMPLETED|Overall Study||12
10982144|NCT00593957|12156688|FG002|COMPLETED|Overall Study||10
10982145|NCT00593957|12156686|FG000|NOT COMPLETED|Overall Study||0
10982146|NCT00593957|12156687|FG001|NOT COMPLETED|Overall Study||1
10982147|NCT00593957|12156688|FG002|NOT COMPLETED|Overall Study||2
10982148|NCT00594009|12156710|FG000|STARTED|Overall Study||1
10982149|NCT00594009|12156710|FG000|COMPLETED|Overall Study||1
10982150|NCT00594009|12156710|FG000|NOT COMPLETED|Overall Study||0
10982151|NCT00594022|12156716|FG000|STARTED|Overall Study||176
10982152|NCT00594022|12156717|FG001|STARTED|Overall Study||173
10982153|NCT00594022|12156716|FG000|COMPLETED|Overall Study||176
10982154|NCT00594022|12156717|FG001|COMPLETED|Overall Study||173
10982155|NCT00594022|12156716|FG000|NOT COMPLETED|Overall Study||0
10982156|NCT00594022|12156717|FG001|NOT COMPLETED|Overall Study||0
10982157|NCT00594035|12156725|FG000|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
10982158|NCT00594035|12156726|FG001|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
10982159|NCT00594035|12156725|FG000|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
10982160|NCT00594035|12156726|FG001|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
10982161|NCT00594035|12156725|FG000|NOT COMPLETED|Overall Study||2
10982162|NCT00594035|12156726|FG001|NOT COMPLETED|Overall Study||3
10982163|NCT00594061|12156732|FG000|STARTED|Overall Study||9
10982164|NCT00594061|12156732|FG000|COMPLETED|Overall Study||9
10982165|NCT00594061|12156732|FG000|NOT COMPLETED|Overall Study||0
10982166|NCT00594100|12156736|FG000|STARTED|Procedure||245
10982167|NCT00594100|12156736|FG000|COMPLETED|Procedure||236
10982168|NCT00594100|12156736|FG000|NOT COMPLETED|Procedure||9
10982169|NCT00594100|12156736|FG000|STARTED|Follow-up Through 30 Days Post Procedure||236
10982170|NCT00594100|12156736|FG000|COMPLETED|Follow-up Through 30 Days Post Procedure||224
10982171|NCT00594100|12156736|FG000|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
10982172|NCT00594165|12156740|FG000|STARTED|Overall Study||217
10982173|NCT00594165|12156740|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
10982174|NCT00594165|12156740|FG000|NOT COMPLETED|Overall Study||217
10982175|NCT00594178|12156744|FG000|STARTED|Overall Study||17
10982176|NCT00594178|12156744|FG000|COMPLETED|Overall Study||12
10982177|NCT00594178|12156744|FG000|NOT COMPLETED|Overall Study||5
10982178|NCT00594204|12156750|FG000|STARTED|Overall Study||394
10982179|NCT00594204|12156751|FG001|STARTED|Overall Study||199
10982180|NCT00594204|12156750|FG000|Received Treatment|Overall Study||390
10982181|NCT00594204|12156751|FG001|Received Treatment|Overall Study||198
10982182|NCT00594204|12156750|FG000|COMPLETED|Overall Study||336
10982183|NCT00594204|12156751|FG001|COMPLETED|Overall Study||154
10982184|NCT00594204|12156750|FG000|NOT COMPLETED|Overall Study||58
10982185|NCT00594204|12156751|FG001|NOT COMPLETED|Overall Study||45
10982186|NCT00594230|12156759|FG000|STARTED|Overall Study||16
10982187|NCT00594230|12156760|FG001|STARTED|Overall Study||10
10982188|NCT00594230|12156759|FG000|COMPLETED|Overall Study||1
10982189|NCT00594230|12156760|FG001|COMPLETED|Overall Study||1
10982190|NCT00594230|12156759|FG000|NOT COMPLETED|Overall Study||15
10982191|NCT00594230|12156760|FG001|NOT COMPLETED|Overall Study||9
10982192|NCT00594256|12156766|FG000|STARTED|Overall Study||8
10982193|NCT00594256|12156766|FG000|COMPLETED|Overall Study||8
10982194|NCT00594256|12156766|FG000|NOT COMPLETED|Overall Study||0
10982195|NCT00594308|12156771|FG000|STARTED|Overall Study||10
10982196|NCT00594308|12156771|FG000|COMPLETED|Overall Study||10
10982197|NCT00594308|12156771|FG000|NOT COMPLETED|Overall Study||0
10982198|NCT00594399|12156777|FG000|STARTED|Initial 3 Month Counseling||180
10982199|NCT00594399|12156778|FG001|STARTED|Initial 3 Month Counseling||122
10982200|NCT00594399|12156779|FG002|STARTED|Initial 3 Month Counseling||0
10982201|NCT00594399|12156777|FG000|COMPLETED|Initial 3 Month Counseling||163
10982202|NCT00594399|12156778|FG001|COMPLETED|Initial 3 Month Counseling||118
10982203|NCT00594399|12156779|FG002|COMPLETED|Initial 3 Month Counseling||0
10982204|NCT00594399|12156777|FG000|NOT COMPLETED|Initial 3 Month Counseling||17
10982205|NCT00594399|12156778|FG001|NOT COMPLETED|Initial 3 Month Counseling||4
10982206|NCT00594399|12156779|FG002|NOT COMPLETED|Initial 3 Month Counseling||0
10982207|NCT00594399|12156777|FG000|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
10982208|NCT00594399|12156778|FG001|STARTED|Rerandomization Arm 1 Only||118
10982209|NCT00594399|12156779|FG002|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
10982210|NCT00594399|12156777|FG000|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
10982211|NCT00594399|12156778|FG001|Rerandomization|Rerandomization Arm 1 Only||114
10982212|NCT00594399|12156779|FG002|Rerandomization|Rerandomization Arm 1 Only||82
10982213|NCT00594399|12156777|FG000|COMPLETED|Rerandomization Arm 1 Only||79
10982214|NCT00594399|12156778|FG001|COMPLETED|Rerandomization Arm 1 Only||114
10982215|NCT00594399|12156779|FG002|COMPLETED|Rerandomization Arm 1 Only||82
10982216|NCT00594399|12156777|FG000|NOT COMPLETED|Rerandomization Arm 1 Only||2
10982217|NCT00594399|12156778|FG001|NOT COMPLETED|Rerandomization Arm 1 Only||4
10982218|NCT00594399|12156779|FG002|NOT COMPLETED|Rerandomization Arm 1 Only||0
10982219|NCT00594425|12156788|FG000|STARTED|Overall Study||50
10982220|NCT00594425|12156789|FG001|STARTED|Overall Study||48
10982221|NCT00594425|12156790|FG002|STARTED|Overall Study||52
10982222|NCT00594425|12156788|FG000|COMPLETED|Overall Study||43
10982223|NCT00594425|12156789|FG001|COMPLETED|Overall Study||34
10982224|NCT00594425|12156790|FG002|COMPLETED|Overall Study||42
10982225|NCT00594425|12156788|FG000|NOT COMPLETED|Overall Study||7
10982226|NCT00594425|12156789|FG001|NOT COMPLETED|Overall Study||14
10982227|NCT00594425|12156790|FG002|NOT COMPLETED|Overall Study||10
10982228|NCT00594464|12156798|FG000|STARTED|Overall Study||14
10982229|NCT00594464|12156798|FG000|COMPLETED|Overall Study||11
10982230|NCT00594464|12156798|FG000|NOT COMPLETED|Overall Study||3
10982231|NCT00594516|12156808|FG000|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
10982232|NCT00594516|12156809|FG001|STARTED|Open Label (OL): Tapentadol IR||0
10982233|NCT00594516|12156810|FG002|STARTED|Open Label (OL): Tapentadol IR||0
10982234|NCT00594516|12156808|FG000|COMPLETED|Open Label (OL): Tapentadol IR||87
10982235|NCT00594516|12156809|FG001|COMPLETED|Open Label (OL): Tapentadol IR||0
10982236|NCT00594516|12156810|FG002|COMPLETED|Open Label (OL): Tapentadol IR||0
10982237|NCT00594516|12156808|FG000|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
10982238|NCT00594516|12156809|FG001|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
10982239|NCT00594516|12156810|FG002|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
10982240|NCT00594516|12156808|FG000|STARTED|DB: Tapentadol IR to ER & ER to IR||0
10982241|NCT00594516|12156809|FG001|STARTED|DB: Tapentadol IR to ER & ER to IR||44
10982242|NCT00594516|12156810|FG002|STARTED|DB: Tapentadol IR to ER & ER to IR||43
10982243|NCT00594516|12156808|FG000|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
10982244|NCT00594516|12156809|FG001|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
10982245|NCT00594516|12156810|FG002|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
10982246|NCT00594516|12156808|FG000|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
10982247|NCT00594516|12156809|FG001|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
10982248|NCT00594516|12156810|FG002|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
10982249|NCT00594568|12156817|FG000|STARTED|Initial Treatment||501
10982250|NCT00594568|12156818|FG001|STARTED|Initial Treatment||507
10982251|NCT00594568|12156819|FG002|STARTED|Initial Treatment||529
10982252|NCT00594568|12156817|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
10982253|NCT00594568|12156818|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
10982254|NCT00594568|12156819|FG002|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
10982255|NCT00594568|12156817|FG000|COMPLETED|Initial Treatment||189
10982256|NCT00594568|12156818|FG001|COMPLETED|Initial Treatment||153
10982257|NCT00594568|12156819|FG002|COMPLETED|Initial Treatment||121
10982258|NCT00594568|12156817|FG000|NOT COMPLETED|Initial Treatment||312
10982259|NCT00594568|12156818|FG001|NOT COMPLETED|Initial Treatment||354
10982260|NCT00594568|12156819|FG002|NOT COMPLETED|Initial Treatment||408
10982261|NCT00594568|12156817|FG000|STARTED|Delayed Start||189
10982262|NCT00594568|12156818|FG001|STARTED|Delayed Start||153
10982263|NCT00594568|12156819|FG002|STARTED|Delayed Start||121
10982264|NCT00594568|12156817|FG000|COMPLETED|Delayed Start||91
10982265|NCT00594568|12156818|FG001|COMPLETED|Delayed Start||76
10982266|NCT00594568|12156819|FG002|COMPLETED|Delayed Start||55
10982267|NCT00594568|12156817|FG000|NOT COMPLETED|Delayed Start||98
10982268|NCT00594568|12156818|FG001|NOT COMPLETED|Delayed Start||77
10982269|NCT00594568|12156819|FG002|NOT COMPLETED|Delayed Start||66
10982270|NCT00594568|12156817|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
10982271|NCT00594568|12156818|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
10982272|NCT00594568|12156819|FG002|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
10982273|NCT00594568|12156817|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||229
10982274|NCT00594568|12156818|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||168
10982275|NCT00594568|12156819|FG002|COMPLETED|Safety Follow Up (SFU)-Optional||172
10982276|NCT00594568|12156817|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
10982277|NCT00594568|12156818|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
10982278|NCT00594568|12156819|FG002|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
10982279|NCT00594646|12156835|FG000|STARTED|Overall Study||100
10982280|NCT00594646|12156835|FG000|COMPLETED|Overall Study||84
10982281|NCT00594646|12156835|FG000|NOT COMPLETED|Overall Study||16
10982282|NCT00594659|12156843|FG000|STARTED|Overall Study||29
10982283|NCT00594659|12156844|FG001|STARTED|Overall Study||30
10982284|NCT00594659|12156845|FG002|STARTED|Overall Study||16
10982285|NCT00594659|12156843|FG000|COMPLETED|Overall Study||16
10982286|NCT00594659|12156844|FG001|COMPLETED|Overall Study||21
10982287|NCT00594659|12156845|FG002|COMPLETED|Overall Study||9
10982288|NCT00594659|12156843|FG000|NOT COMPLETED|Overall Study||13
10982289|NCT00594659|12156844|FG001|NOT COMPLETED|Overall Study||9
10982290|NCT00594659|12156845|FG002|NOT COMPLETED|Overall Study||7
10982291|NCT00594685|12156853|FG000|STARTED|Overall Study||10
10982292|NCT00594685|12156853|FG000|COMPLETED|Overall Study||10
10982293|NCT00594685|12156853|FG000|NOT COMPLETED|Overall Study||0
10982294|NCT00594815|12156857|FG000|STARTED|Overall Study||52
10982295|NCT00594815|12156857|FG000|COMPLETED|Overall Study||43
10982296|NCT00594815|12156857|FG000|NOT COMPLETED|Overall Study||9
10982297|NCT00594854|12156863|FG000|STARTED|Overall Study||9
10982298|NCT00594854|12156864|FG001|STARTED|Overall Study||11
10982299|NCT00594854|12156863|FG000|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
10982300|NCT00594854|12156864|FG001|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
10982301|NCT00594854|12156863|FG000|NOT COMPLETED|Overall Study||7
10982302|NCT00594854|12156864|FG001|NOT COMPLETED|Overall Study||10
10982303|NCT00594880|12156872|FG000|STARTED|Overall Study||12
10982304|NCT00594880|12156873|FG001|STARTED|Overall Study||11
10982305|NCT00594880|12156872|FG000|COMPLETED|Overall Study||10
10982306|NCT00594880|12156873|FG001|COMPLETED|Overall Study||10
10982307|NCT00594880|12156872|FG000|NOT COMPLETED|Overall Study||2
10982308|NCT00594880|12156873|FG001|NOT COMPLETED|Overall Study||1
10982309|NCT00594906|12156885|FG000|STARTED|Overall Study||7
10982310|NCT00594906|12156886|FG001|STARTED|Overall Study||3
10982311|NCT00594906|12156885|FG000|COMPLETED|Overall Study||6
10982312|NCT00594906|12156886|FG001|COMPLETED|Overall Study||1
10982313|NCT00594906|12156885|FG000|NOT COMPLETED|Overall Study||1
10982314|NCT00594906|12156886|FG001|NOT COMPLETED|Overall Study||2
10982315|NCT00594932|12156894|FG000|STARTED|First 3 Months||13
10982316|NCT00594932|12156895|FG001|STARTED|First 3 Months||14
10982317|NCT00594932|12156894|FG000|COMPLETED|First 3 Months||12
10982318|NCT00594932|12156895|FG001|COMPLETED|First 3 Months||11
10982319|NCT00594932|12156894|FG000|NOT COMPLETED|First 3 Months||1
10982320|NCT00594932|12156895|FG001|NOT COMPLETED|First 3 Months||3
10982321|NCT00594932|12156894|FG000|STARTED|Final 3 Months||12
10982322|NCT00594932|12156895|FG001|STARTED|Final 3 Months||11
10982323|NCT00594932|12156894|FG000|COMPLETED|Final 3 Months||8
10982324|NCT00594932|12156895|FG001|COMPLETED|Final 3 Months||8
10982325|NCT00594932|12156894|FG000|NOT COMPLETED|Final 3 Months||4
10982326|NCT00594932|12156895|FG001|NOT COMPLETED|Final 3 Months||3
10982327|NCT00594945|12156904|FG000|STARTED|Cohort 1 / Treatment Period 1||4
10982328|NCT00594945|12156905|FG001|STARTED|Cohort 1 / Treatment Period 1||0
10982329|NCT00594945|12156906|FG002|STARTED|Cohort 1 / Treatment Period 1||2
10982330|NCT00594945|12156904|FG000|COMPLETED|Cohort 1 / Treatment Period 1||4
10982331|NCT00594945|12156905|FG001|COMPLETED|Cohort 1 / Treatment Period 1||0
10982332|NCT00594945|12156906|FG002|COMPLETED|Cohort 1 / Treatment Period 1||2
10982333|NCT00594945|12156904|FG000|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
10982334|NCT00594945|12156905|FG001|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
10982335|NCT00594945|12156906|FG002|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
10982336|NCT00594945|12156904|FG000|STARTED|Cohort 2 / Treatment Period 2||0
10982337|NCT00594945|12156905|FG001|STARTED|Cohort 2 / Treatment Period 2||3
10982338|NCT00594945|12156906|FG002|STARTED|Cohort 2 / Treatment Period 2||2
10982339|NCT00594945|12156904|FG000|COMPLETED|Cohort 2 / Treatment Period 2||0
10982340|NCT00594945|12156905|FG001|COMPLETED|Cohort 2 / Treatment Period 2||3
10982341|NCT00594945|12156906|FG002|COMPLETED|Cohort 2 / Treatment Period 2||2
10982342|NCT00594945|12156904|FG000|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
10982343|NCT00594945|12156905|FG001|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
10982344|NCT00594945|12156906|FG002|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
10982345|NCT00594958|12156915|FG000|STARTED|Overall Study||214
10982346|NCT00594958|12156916|FG001|STARTED|Overall Study||213
10982347|NCT00594958|12156917|FG002|STARTED|Overall Study||212
10982348|NCT00594958|12156915|FG000|Randomized and at Least 1 Vaccination|Overall Study||212
10982349|NCT00594958|12156916|FG001|Randomized and at Least 1 Vaccination|Overall Study||213
10982350|NCT00594958|12156917|FG002|Randomized and at Least 1 Vaccination|Overall Study||211
10982351|NCT00594958|12156915|FG000|COMPLETED|Overall Study||200
10982352|NCT00594958|12156916|FG001|COMPLETED|Overall Study||210
10982353|NCT00594958|12156917|FG002|COMPLETED|Overall Study||202
10982354|NCT00594958|12156915|FG000|NOT COMPLETED|Overall Study||14
10982355|NCT00594958|12156916|FG001|NOT COMPLETED|Overall Study||3
10982356|NCT00594958|12156917|FG002|NOT COMPLETED|Overall Study||10
10982357|NCT00594997|12156927|FG000|STARTED|Overall Study||1562
10982358|NCT00594997|12156928|FG001|STARTED|Overall Study||2008
10982359|NCT00594997|12156927|FG000|COMPLETED|Overall Study||1562
10982360|NCT00594997|12156928|FG001|COMPLETED|Overall Study||2008
10982361|NCT00594997|12156927|FG000|NOT COMPLETED|Overall Study||0
10982362|NCT00594997|12156928|FG001|NOT COMPLETED|Overall Study||0
10982363|NCT00595075|12156938|FG000|STARTED|Overall Study||6
10982364|NCT00595075|12156939|FG001|STARTED|Overall Study||5
10982365|NCT00595075|12156938|FG000|COMPLETED|Overall Study||5
10982366|NCT00595075|12156939|FG001|COMPLETED|Overall Study||5
10982367|NCT00595075|12156938|FG000|NOT COMPLETED|Overall Study||1
10982368|NCT00595075|12156939|FG001|NOT COMPLETED|Overall Study||0
10982369|NCT00595088|12156945|FG000|STARTED|Overall Study||47
10982370|NCT00595088|12156945|FG000|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
10982371|NCT00595088|12156945|FG000|NOT COMPLETED|Overall Study||40
10982372|NCT00595101|12156953|FG000|STARTED|Overall Study||29
10982373|NCT00595101|12156954|FG001|STARTED|Overall Study||29
10982374|NCT00595101|12156955|FG002|STARTED|Overall Study||29
10982375|NCT00595101|12156956|FG003|STARTED|Overall Study||30
10982376|NCT00595101|12156953|FG000|COMPLETED|Overall Study||29
10982377|NCT00595101|12156954|FG001|COMPLETED|Overall Study||28
10982378|NCT00595101|12156955|FG002|COMPLETED|Overall Study||29
10982379|NCT00595101|12156956|FG003|COMPLETED|Overall Study||30
10982380|NCT00595101|12156953|FG000|NOT COMPLETED|Overall Study||0
10982381|NCT00595101|12156954|FG001|NOT COMPLETED|Overall Study||1
10982382|NCT00595101|12156955|FG002|NOT COMPLETED|Overall Study||0
10982383|NCT00595101|12156956|FG003|NOT COMPLETED|Overall Study||0
10982384|NCT00595114|12156968|FG000|STARTED|Overall Study||24
10982385|NCT00595114|12156969|FG001|STARTED|Overall Study||19
10982386|NCT00595114|12156968|FG000|COMPLETED|Overall Study||24
10982387|NCT00595114|12156969|FG001|COMPLETED|Overall Study||19
10982388|NCT00595114|12156968|FG000|NOT COMPLETED|Overall Study||0
10982389|NCT00595114|12156969|FG001|NOT COMPLETED|Overall Study||0
10982390|NCT00595127|12156975|FG000|STARTED|Overall Study||21
10982391|NCT00595127|12156975|FG000|COMPLETED|Overall Study||11
10982392|NCT00595127|12156975|FG000|NOT COMPLETED|Overall Study||10
10982393|NCT00595153|12156982|FG000|STARTED|Overall Study||24
10982394|NCT00595153|12156983|FG001|STARTED|Overall Study||42
10982395|NCT00595153|12156984|FG002|STARTED|Overall Study||61
10982396|NCT00595153|12156982|FG000|COMPLETED|Overall Study||20
10982397|NCT00595153|12156983|FG001|COMPLETED|Overall Study||26
10982398|NCT00595153|12156984|FG002|COMPLETED|Overall Study||36
10982399|NCT00595153|12156982|FG000|NOT COMPLETED|Overall Study||4
10982400|NCT00595153|12156983|FG001|NOT COMPLETED|Overall Study||16
10982401|NCT00595153|12156984|FG002|NOT COMPLETED|Overall Study||25
10982402|NCT00595231|12156994|FG000|STARTED|Overall Study||120
10982403|NCT00595231|12156995|FG001|STARTED|Overall Study||119
10982404|NCT00595231|12156994|FG000|COMPLETED|Overall Study||115
10982405|NCT00595231|12156995|FG001|COMPLETED|Overall Study||114
10982406|NCT00595231|12156994|FG000|NOT COMPLETED|Overall Study||5
10982407|NCT00595231|12156995|FG001|NOT COMPLETED|Overall Study||5
10982408|NCT00595270|12157004|FG000|STARTED|Overall Study||116
10982409|NCT00595270|12157005|FG001|STARTED|Overall Study||117
10982410|NCT00595270|12157006|FG002|STARTED|Overall Study||116
10982411|NCT00595270|12157004|FG000|COMPLETED|Overall Study||110
10982412|NCT00595270|12157005|FG001|COMPLETED|Overall Study||107
10982413|NCT00595270|12157006|FG002|COMPLETED|Overall Study||108
10982414|NCT00595270|12157004|FG000|NOT COMPLETED|Overall Study||6
10982415|NCT00595270|12157005|FG001|NOT COMPLETED|Overall Study||10
10982416|NCT00595270|12157006|FG002|NOT COMPLETED|Overall Study||8
10982417|NCT00595309|12157014|FG000|STARTED|Overall Study||198
10982418|NCT00595309|12157014|FG000|COMPLETED|Overall Study||194
10982419|NCT00595309|12157014|FG000|NOT COMPLETED|Overall Study||4
10982420|NCT00595335|12157020|FG000|STARTED|Baseline to Six Months||13
10982421|NCT00595335|12157021|FG001|STARTED|Baseline to Six Months||12
10982422|NCT00595335|12157020|FG000|COMPLETED|Baseline to Six Months||11
10982423|NCT00595335|12157021|FG001|COMPLETED|Baseline to Six Months||10
10982424|NCT00595335|12157020|FG000|NOT COMPLETED|Baseline to Six Months||2
10982425|NCT00595335|12157021|FG001|NOT COMPLETED|Baseline to Six Months||2
10982426|NCT00595335|12157020|FG000|STARTED|Six Months to Twelve Months||11
10982427|NCT00595335|12157021|FG001|STARTED|Six Months to Twelve Months||10
10982428|NCT00595335|12157020|FG000|COMPLETED|Six Months to Twelve Months||10
10982429|NCT00595335|12157021|FG001|COMPLETED|Six Months to Twelve Months||9
10982430|NCT00595335|12157020|FG000|NOT COMPLETED|Six Months to Twelve Months||1
10982431|NCT00595335|12157021|FG001|NOT COMPLETED|Six Months to Twelve Months||1
10982432|NCT00595361|12157033|FG000|STARTED|Overall Study||12
10982433|NCT00595361|12157034|FG001|STARTED|Overall Study||18
10982434|NCT00595361|12157033|FG000|COMPLETED|Overall Study||12
10982435|NCT00595361|12157034|FG001|COMPLETED|Overall Study||18
10982436|NCT00595361|12157033|FG000|NOT COMPLETED|Overall Study||0
10982437|NCT00595361|12157034|FG001|NOT COMPLETED|Overall Study||0
10982438|NCT00595413|12157044|FG000|STARTED|Overall Study||76
10982439|NCT00595413|12157045|FG001|STARTED|Overall Study||78
10982440|NCT00595413|12157046|FG002|STARTED|Overall Study||78
10982441|NCT00595413|12157047|FG003|STARTED|Overall Study||79
10982442|NCT00595413|12157044|FG000|COMPLETED|Overall Study||69
10982443|NCT00595413|12157045|FG001|COMPLETED|Overall Study||73
10982444|NCT00595413|12157046|FG002|COMPLETED|Overall Study||70
10982445|NCT00595413|12157047|FG003|COMPLETED|Overall Study||75
10982446|NCT00595413|12157044|FG000|NOT COMPLETED|Overall Study||7
10982447|NCT00595413|12157045|FG001|NOT COMPLETED|Overall Study||5
10982448|NCT00595413|12157046|FG002|NOT COMPLETED|Overall Study||8
10982449|NCT00595413|12157047|FG003|NOT COMPLETED|Overall Study||4
10982450|NCT00595465|12157060|FG000|STARTED|Overall Study||130
10982451|NCT00595465|12157061|FG001|STARTED|Overall Study||129
10982452|NCT00595465|12157062|FG002|STARTED|Overall Study||128
10982453|NCT00595465|12157060|FG000|COMPLETED|Overall Study||124
10982454|NCT00595465|12157061|FG001|COMPLETED|Overall Study||125
10982455|NCT00595465|12157062|FG002|COMPLETED|Overall Study||121
10982456|NCT00595465|12157060|FG000|NOT COMPLETED|Overall Study||6
10982457|NCT00595465|12157061|FG001|NOT COMPLETED|Overall Study||4
10982458|NCT00595465|12157062|FG002|NOT COMPLETED|Overall Study||7
10982459|NCT00595478|12157072|FG000|STARTED|Treatment||37
10982460|NCT00595478|12157073|FG001|STARTED|Treatment||38
10982461|NCT00595478|12157072|FG000|COMPLETED|Treatment||37
10982462|NCT00595478|12157073|FG001|COMPLETED|Treatment||38
10982463|NCT00595478|12157072|FG000|NOT COMPLETED|Treatment||0
10982464|NCT00595478|12157073|FG001|NOT COMPLETED|Treatment||0
10982465|NCT00595478|12157072|FG000|STARTED|36-week Follow-up Period||37
10982466|NCT00595478|12157073|FG001|STARTED|36-week Follow-up Period||38
10982467|NCT00595478|12157072|FG000|COMPLETED|36-week Follow-up Period||28
10982468|NCT00595478|12157073|FG001|COMPLETED|36-week Follow-up Period||30
10982469|NCT00595478|12157072|FG000|NOT COMPLETED|36-week Follow-up Period||9
10982470|NCT00595478|12157073|FG001|NOT COMPLETED|36-week Follow-up Period||8
10982471|NCT00595504|12157081|FG000|STARTED|Overall Study||16
10982472|NCT00595504|12157082|FG001|STARTED|Overall Study||9
10982473|NCT00595504|12157081|FG000|COMPLETED|Overall Study||14
10982474|NCT00595504|12157082|FG001|COMPLETED|Overall Study||6
10982475|NCT00595504|12157081|FG000|NOT COMPLETED|Overall Study||2
10982476|NCT00595504|12157082|FG001|NOT COMPLETED|Overall Study||3
10982477|NCT00595517|12157088|FG000|STARTED|Overall Study||130
10982478|NCT00595517|12157088|FG000|COMPLETED|Overall Study||111
10982479|NCT00595517|12157088|FG000|NOT COMPLETED|Overall Study||19
10982480|NCT00595530|12157092|FG000|STARTED|Overall Study||3
10982481|NCT00595530|12157092|FG000|COMPLETED|Overall Study||3
10982482|NCT00595530|12157092|FG000|NOT COMPLETED|Overall Study||0
10982483|NCT00595556|12157099|FG000|STARTED|Overall Study||20
10982484|NCT00595556|12157100|FG001|STARTED|Overall Study||20
10982485|NCT00595556|12157099|FG000|COMPLETED|Overall Study||17
10982486|NCT00595556|12157100|FG001|COMPLETED|Overall Study||19
10982487|NCT00595556|12157099|FG000|NOT COMPLETED|Overall Study||3
10982488|NCT00595556|12157100|FG001|NOT COMPLETED|Overall Study||1
10982489|NCT00595621|12157108|FG000|STARTED|Open Label Run in||22
10982490|NCT00595621|12157109|FG001|STARTED|Open Label Run in||0
10982491|NCT00595621|12157108|FG000|COMPLETED|Open Label Run in||19
10982492|NCT00595621|12157109|FG001|COMPLETED|Open Label Run in||0
10982493|NCT00595621|12157108|FG000|NOT COMPLETED|Open Label Run in||3
10982494|NCT00595621|12157109|FG001|NOT COMPLETED|Open Label Run in||0
10982495|NCT00595621|12157108|FG000|STARTED|Randomization and Study||10
10982496|NCT00595621|12157109|FG001|STARTED|Randomization and Study||9
10982497|NCT00595621|12157108|FG000|COMPLETED|Randomization and Study||8
10982498|NCT00595621|12157109|FG001|COMPLETED|Randomization and Study||8
10982499|NCT00595621|12157108|FG000|NOT COMPLETED|Randomization and Study||2
10982500|NCT00595621|12157109|FG001|NOT COMPLETED|Randomization and Study||1
10982501|NCT00595764|12157118|FG000|STARTED|Overall Study||71
10982502|NCT00595764|12157119|FG001|STARTED|Overall Study||70
10982503|NCT00595764|12157118|FG000|COMPLETED|Overall Study||32
10982504|NCT00595764|12157119|FG001|COMPLETED|Overall Study||27
10982505|NCT00595764|12157118|FG000|NOT COMPLETED|Overall Study||39
10982506|NCT00595764|12157119|FG001|NOT COMPLETED|Overall Study||43
10982507|NCT00595790|12157128|FG000|STARTED|Overall Study||125
10982508|NCT00595790|12157129|FG001|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
10982509|NCT00595790|12157130|FG002|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
10982510|NCT00595790|12157128|FG000|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
10982511|NCT00595790|12157129|FG001|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
10982512|NCT00595790|12157130|FG002|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
10982513|NCT00595790|12157128|FG000|NOT COMPLETED|Overall Study||2
10982514|NCT00595790|12157129|FG001|NOT COMPLETED|Overall Study||1
10982515|NCT00595790|12157130|FG002|NOT COMPLETED|Overall Study||3
10982516|NCT00595868|12157140|FG000|STARTED|Overall Study||107
10982517|NCT00595868|12157141|FG001|STARTED|Overall Study||111
10982518|NCT00595868|12157140|FG000|COMPLETED|Overall Study||62
10982519|NCT00595868|12157141|FG001|COMPLETED|Overall Study||61
10982520|NCT00595868|12157140|FG000|NOT COMPLETED|Overall Study||45
10982521|NCT00595868|12157141|FG001|NOT COMPLETED|Overall Study||50
10982522|NCT00595881|12157147|FG000|STARTED|Overall Study||420
10982523|NCT00595881|12157147|FG000|COMPLETED|Overall Study||420
10982524|NCT00595881|12157147|FG000|NOT COMPLETED|Overall Study||0
10982525|NCT00595946|12157154|FG000|STARTED|Overall Study||218
10982526|NCT00595946|12157155|FG001|STARTED|Overall Study||221
10982527|NCT00595946|12157154|FG000|COMPLETED|Overall Study||154
10982528|NCT00595946|12157155|FG001|COMPLETED|Overall Study||152
10982529|NCT00595946|12157154|FG000|NOT COMPLETED|Overall Study||64
10982530|NCT00595946|12157155|FG001|NOT COMPLETED|Overall Study||69
10982531|NCT00595959|12157161|FG000|STARTED|Overall Study||65
10982532|NCT00595959|12157161|FG000|COMPLETED|Overall Study||63
10982533|NCT00595959|12157161|FG000|NOT COMPLETED|Overall Study||2
10982534|NCT00596011|12157167|FG000|STARTED|Overall Study||49
10982535|NCT00596011|12157168|FG001|STARTED|Overall Study||48
10982536|NCT00596011|12157167|FG000|COMPLETED|Overall Study||36
10982537|NCT00596011|12157168|FG001|COMPLETED|Overall Study||38
10982538|NCT00596011|12157167|FG000|NOT COMPLETED|Overall Study||13
10982539|NCT00596011|12157168|FG001|NOT COMPLETED|Overall Study||10
10982540|NCT00596102|12157177|FG000|STARTED|Up to Month 6||2283
10982541|NCT00596102|12157178|FG001|STARTED|Up to Month 6||338
10982542|NCT00596102|12157179|FG002|STARTED|Up to Month 6||637
10982543|NCT00596102|12157177|FG000|COMPLETED|Up to Month 6||2283
10982544|NCT00596102|12157178|FG001|COMPLETED|Up to Month 6||338
10982545|NCT00596102|12157179|FG002|COMPLETED|Up to Month 6||637
10982546|NCT00596102|12157177|FG000|NOT COMPLETED|Up to Month 6||0
10982547|NCT00596102|12157178|FG001|NOT COMPLETED|Up to Month 6||0
10982548|NCT00596102|12157179|FG002|NOT COMPLETED|Up to Month 6||0
10982549|NCT00596102|12157177|FG000|STARTED|Up to Month 60||2283
10982550|NCT00596102|12157178|FG001|STARTED|Up to Month 60||338
10982551|NCT00596102|12157179|FG002|STARTED|Up to Month 60||637
10982552|NCT00596102|12157177|FG000|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
10982553|NCT00596102|12157178|FG001|COMPLETED|Up to Month 60||0
10982554|NCT00596102|12157179|FG002|COMPLETED|Up to Month 60||0
10982555|NCT00596102|12157177|FG000|NOT COMPLETED|Up to Month 60||2181
10982556|NCT00596102|12157178|FG001|NOT COMPLETED|Up to Month 60||338
10982557|NCT00596102|12157179|FG002|NOT COMPLETED|Up to Month 60||637
10982558|NCT00596167|12157186|FG000|STARTED|Overall Study|All recruited subjects completed the study.|6
10982559|NCT00596167|12157186|FG000|COMPLETED|Overall Study||6
10982560|NCT00596167|12157186|FG000|NOT COMPLETED|Overall Study||0
10982561|NCT00596271|12157193|FG000|STARTED|Overall Study||65
10982562|NCT00596271|12157194|FG001|STARTED|Overall Study||65
10982563|NCT00596271|12157195|FG002|STARTED|Overall Study||62
10982564|NCT00596271|12157193|FG000|COMPLETED|Overall Study||60
10982565|NCT00596271|12157194|FG001|COMPLETED|Overall Study||59
10982566|NCT00596271|12157195|FG002|COMPLETED|Overall Study||61
10982567|NCT00596271|12157193|FG000|NOT COMPLETED|Overall Study||5
10982568|NCT00596271|12157194|FG001|NOT COMPLETED|Overall Study||6
10982569|NCT00596271|12157195|FG002|NOT COMPLETED|Overall Study||1
10982570|NCT00596362|12157204|FG000|STARTED|Overall Study||1
10982571|NCT00596362|12157204|FG000|COMPLETED|Overall Study||0
10982572|NCT00596362|12157204|FG000|NOT COMPLETED|Overall Study||1
10982573|NCT00596427|12157210|FG000|STARTED|Overall Study||30
10982574|NCT00596427|12157211|FG001|STARTED|Overall Study||30
10982575|NCT00596427|12157210|FG000|COMPLETED|Overall Study||26
10982576|NCT00596427|12157211|FG001|COMPLETED|Overall Study||28
10982577|NCT00596427|12157210|FG000|NOT COMPLETED|Overall Study||4
10982578|NCT00596427|12157211|FG001|NOT COMPLETED|Overall Study||2
10982579|NCT00596440|12157220|FG000|STARTED|Overall Study||113
10982580|NCT00596440|12157221|FG001|STARTED|Overall Study||121
10982581|NCT00596440|12157220|FG000|Showed to Eligibility Visit|Overall Study||85
10982582|NCT00596440|12157221|FG001|Showed to Eligibility Visit|Overall Study||72
10982583|NCT00596440|12157220|FG000|Showed to First Treatment Session|Overall Study||61
10982584|NCT00596440|12157221|FG001|Showed to First Treatment Session|Overall Study||52
10982585|NCT00596440|12157220|FG000|COMPLETED|Overall Study||48
10982586|NCT00596440|12157221|FG001|COMPLETED|Overall Study||41
10982587|NCT00596440|12157220|FG000|NOT COMPLETED|Overall Study||65
10982588|NCT00596440|12157221|FG001|NOT COMPLETED|Overall Study||80
10982589|NCT00596453|12157229|FG000|STARTED|Overall Study||13
10982590|NCT00596453|12157230|FG001|STARTED|Overall Study||15
10982591|NCT00596453|12157229|FG000|COMPLETED|Overall Study||12
10982592|NCT00596453|12157230|FG001|COMPLETED|Overall Study||12
10982593|NCT00596453|12157229|FG000|NOT COMPLETED|Overall Study||1
10982594|NCT00596453|12157230|FG001|NOT COMPLETED|Overall Study||3
10982595|NCT00596466|12157236|FG000|STARTED|Overall Study||75
10982596|NCT00596466|12157236|FG000|Enrolled, Treated|Overall Study||73
10982597|NCT00596466|12157236|FG000|COMPLETED|Overall Study||58
10982598|NCT00596466|12157236|FG000|NOT COMPLETED|Overall Study||17
10982599|NCT00596622|12157243|FG000|STARTED|Overall Study||46
10982600|NCT00596622|12157243|FG000|COMPLETED|Overall Study||33
10982601|NCT00596622|12157243|FG000|NOT COMPLETED|Overall Study||13
10982602|NCT00596635|12157255|FG000|STARTED|Overall Study||17
10982603|NCT00596635|12157256|FG001|STARTED|Overall Study||20
10982604|NCT00596635|12157257|FG002|STARTED|Overall Study||19
10982605|NCT00596635|12157255|FG000|COMPLETED|Overall Study||10
10982606|NCT00596635|12157256|FG001|COMPLETED|Overall Study||7
10982607|NCT00596635|12157257|FG002|COMPLETED|Overall Study||11
10982608|NCT00596635|12157255|FG000|NOT COMPLETED|Overall Study||7
10982609|NCT00596635|12157256|FG001|NOT COMPLETED|Overall Study||13
10982610|NCT00596635|12157257|FG002|NOT COMPLETED|Overall Study||8
10982611|NCT00596687|12157267|FG000|STARTED|Overall Study||118
10982612|NCT00596687|12157268|FG001|STARTED|Overall Study||116
10982613|NCT00596687|12157267|FG000|COMPLETED|Overall Study||104
10982614|NCT00596687|12157268|FG001|COMPLETED|Overall Study||107
10982615|NCT00596687|12157267|FG000|NOT COMPLETED|Overall Study||14
10982616|NCT00596687|12157268|FG001|NOT COMPLETED|Overall Study||9
10982617|NCT00596752|12157276|FG000|STARTED|Overall Study||415
10982618|NCT00596752|12157277|FG001|STARTED|Overall Study||425
10982619|NCT00596752|12157276|FG000|Randomized and Treated|Overall Study||415
10982620|NCT00596752|12157277|FG001|Randomized and Treated|Overall Study||424
10982621|NCT00596752|12157276|FG000|COMPLETED|Overall Study||289
10982622|NCT00596752|12157277|FG001|COMPLETED|Overall Study||282
10982623|NCT00596752|12157276|FG000|NOT COMPLETED|Overall Study||126
10982624|NCT00596752|12157277|FG001|NOT COMPLETED|Overall Study||143
10982625|NCT00594386|12157283|FG000|STARTED|Overall Study||258
10982626|NCT00594386|12157283|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
10982627|NCT00594386|12157283|FG000|NOT COMPLETED|Overall Study||258
10982628|NCT00596817|12157290|FG000|STARTED|Open-label Period||0
10982629|NCT00596817|12157291|FG001|STARTED|Open-label Period||639
10982630|NCT00596817|12157290|FG000|COMPLETED|Open-label Period||0
10982631|NCT00596817|12157291|FG001|COMPLETED|Open-label Period||492
10982632|NCT00596817|12157290|FG000|NOT COMPLETED|Open-label Period||0
10982633|NCT00596817|12157291|FG001|NOT COMPLETED|Open-label Period||147
10982634|NCT00596817|12157290|FG000|STARTED|Open-label Period to Double-blind Period||0
10982635|NCT00596817|12157291|FG001|STARTED|Open-label Period to Double-blind Period||492
10982636|NCT00596817|12157290|FG000|COMPLETED|Open-label Period to Double-blind Period||0
10982637|NCT00596817|12157291|FG001|COMPLETED|Open-label Period to Double-blind Period||400
10982638|NCT00596817|12157290|FG000|NOT COMPLETED|Open-label Period to Double-blind Period||0
10982639|NCT00596817|12157291|FG001|NOT COMPLETED|Open-label Period to Double-blind Period||92
10982640|NCT00596817|12157290|FG000|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
10982641|NCT00596817|12157291|FG001|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
10982642|NCT00596817|12157290|FG000|COMPLETED|Double-blind Period||104
10982643|NCT00596817|12157291|FG001|COMPLETED|Double-blind Period||125
10982644|NCT00596817|12157290|FG000|NOT COMPLETED|Double-blind Period||88
10982645|NCT00596817|12157291|FG001|NOT COMPLETED|Double-blind Period||79
10982646|NCT00596830|12157300|FG000|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
10982647|NCT00596830|12157301|FG001|STARTED|Overall Study||339
10982648|NCT00596830|12157300|FG000|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
10982649|NCT00596830|12157301|FG001|Treated|Overall Study||332
10982650|NCT00596830|12157300|FG000|COMPLETED|Overall Study||0
10982651|NCT00596830|12157301|FG001|COMPLETED|Overall Study||0
10982652|NCT00596830|12157300|FG000|NOT COMPLETED|Overall Study||342
10982653|NCT00596830|12157301|FG001|NOT COMPLETED|Overall Study||339
10982654|NCT00596934|12157307|FG000|STARTED|Overall Study||9
10982655|NCT00596934|12157307|FG000|COMPLETED|Overall Study||7
10982656|NCT00596934|12157307|FG000|NOT COMPLETED|Overall Study||2
10982657|NCT00596960|12157315|FG000|STARTED|Overall Study||70
10982658|NCT00596960|12157316|FG001|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
10982659|NCT00596960|12157315|FG000|COMPLETED|Overall Study||59
10982660|NCT00596960|12157316|FG001|COMPLETED|Overall Study||60
10982661|NCT00596960|12157315|FG000|NOT COMPLETED|Overall Study||11
10982662|NCT00596960|12157316|FG001|NOT COMPLETED|Overall Study||9
10982663|NCT00597038|12157324|FG000|STARTED|Overall Study||16
10982664|NCT00597038|12157325|FG001|STARTED|Overall Study||34
10982665|NCT00597038|12157324|FG000|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
10982666|NCT00597038|12157325|FG001|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
10982667|NCT00597038|12157324|FG000|NOT COMPLETED|Overall Study||2
10982668|NCT00597038|12157325|FG001|NOT COMPLETED|Overall Study||4
10982669|NCT00597116|12157335|FG000|STARTED|Overall Study||14
10982670|NCT00597116|12157336|FG001|STARTED|Overall Study||11
10982671|NCT00597116|12157335|FG000|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
10982672|NCT00597116|12157336|FG001|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
10982673|NCT00597116|12157335|FG000|NOT COMPLETED|Overall Study||14
10982674|NCT00597116|12157336|FG001|NOT COMPLETED|Overall Study||11
10982675|NCT00597207|12157344|FG000|STARTED|Overall Study||2099
10982676|NCT00597207|12157345|FG001|STARTED|Overall Study||2132
10982677|NCT00597207|12157344|FG000|COMPLETED|Overall Study||2094
10982678|NCT00597207|12157345|FG001|COMPLETED|Overall Study||2125
10982679|NCT00597207|12157344|FG000|NOT COMPLETED|Overall Study||5
10982680|NCT00597207|12157345|FG001|NOT COMPLETED|Overall Study||7
10982681|NCT00597246|12157351|FG000|STARTED|Overall Study||30
10982682|NCT00597246|12157351|FG000|COMPLETED|Overall Study||30
10982683|NCT00597246|12157351|FG000|NOT COMPLETED|Overall Study||0
10982684|NCT00597272|12157362|FG000|STARTED|Overall Study||1
10982685|NCT00597272|12157363|FG001|STARTED|Overall Study||1
10982686|NCT00597272|12157364|FG002|STARTED|Overall Study||10
10982687|NCT00597272|12157365|FG003|STARTED|Overall Study||1
10982688|NCT00597272|12157366|FG004|STARTED|Overall Study||1
10982689|NCT00597272|12157367|FG005|STARTED|Overall Study||10
10982690|NCT00597272|12157368|FG006|STARTED|Overall Study||10
10982691|NCT00597272|12157362|FG000|COMPLETED|Overall Study||1
10982692|NCT00597272|12157363|FG001|COMPLETED|Overall Study||1
10982693|NCT00597272|12157364|FG002|COMPLETED|Overall Study||10
10982694|NCT00597272|12157365|FG003|COMPLETED|Overall Study||1
10982695|NCT00597272|12157366|FG004|COMPLETED|Overall Study||1
10982696|NCT00597272|12157367|FG005|COMPLETED|Overall Study||10
10982697|NCT00597272|12157368|FG006|COMPLETED|Overall Study||10
10982698|NCT00597272|12157362|FG000|NOT COMPLETED|Overall Study||0
10982699|NCT00597272|12157363|FG001|NOT COMPLETED|Overall Study||0
10982700|NCT00597272|12157364|FG002|NOT COMPLETED|Overall Study||0
10982701|NCT00597272|12157365|FG003|NOT COMPLETED|Overall Study||0
10982702|NCT00597272|12157366|FG004|NOT COMPLETED|Overall Study||0
10982703|NCT00597272|12157367|FG005|NOT COMPLETED|Overall Study||0
10982704|NCT00597272|12157368|FG006|NOT COMPLETED|Overall Study||0
10982705|NCT00597376|12157386|FG000|STARTED|Overall Study||51
10982706|NCT00597376|12157387|FG001|STARTED|Overall Study||53
10982707|NCT00597376|12157386|FG000|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
10982708|NCT00597376|12157387|FG001|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
10982709|NCT00597376|12157386|FG000|NOT COMPLETED|Overall Study||8
10982710|NCT00597376|12157387|FG001|NOT COMPLETED|Overall Study||4
10982711|NCT00597402|12157393|FG000|STARTED|Overall Study||125
10982712|NCT00597402|12157393|FG000|COMPLETED|Overall Study||125
10982713|NCT00597402|12157393|FG000|NOT COMPLETED|Overall Study||0
10982714|NCT00597428|12157399|FG000|STARTED|Overall Study||214
10982715|NCT00597428|12157400|FG001|STARTED|Overall Study||223
10982716|NCT00597428|12157399|FG000|COMPLETED|Overall Study||153
10982717|NCT00597428|12157400|FG001|COMPLETED|Overall Study||152
10982718|NCT00597428|12157399|FG000|NOT COMPLETED|Overall Study||61
10982719|NCT00597428|12157400|FG001|NOT COMPLETED|Overall Study||71
10982720|NCT00597493|12157406|FG000|STARTED|Overall Study||32
10982721|NCT00597493|12157406|FG000|COMPLETED|Overall Study||32
10982722|NCT00597493|12157406|FG000|NOT COMPLETED|Overall Study||0
10982723|NCT00597506|12157414|FG000|STARTED|Overall Study||50
10982724|NCT00597506|12157414|FG000|COMPLETED|Overall Study||49
10982725|NCT00597506|12157414|FG000|NOT COMPLETED|Overall Study||1
10982726|NCT00597519|12157418|FG000|STARTED|Overall Study||28
10982727|NCT00597519|12157418|FG000|COMPLETED|Overall Study||27
10982728|NCT00597519|12157418|FG000|NOT COMPLETED|Overall Study||1
10982729|NCT00597545|12157424|FG000|STARTED|Overall Study||4
10982730|NCT00597545|12157425|FG001|STARTED|Overall Study||6
10982731|NCT00597545|12157424|FG000|COMPLETED|Overall Study||4
10982732|NCT00597545|12157425|FG001|COMPLETED|Overall Study||6
10982733|NCT00597545|12157424|FG000|NOT COMPLETED|Overall Study||0
10982734|NCT00597545|12157425|FG001|NOT COMPLETED|Overall Study||0
10982735|NCT00597558|12157431|FG000|STARTED|Overall Study||13
10982736|NCT00597558|12157431|FG000|COMPLETED|Overall Study||9
10982737|NCT00597558|12157431|FG000|NOT COMPLETED|Overall Study||4
10982738|NCT00597584|12157437|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
10982739|NCT00597584|12157438|FG001|STARTED|Overall Study||274
10982740|NCT00597584|12157437|FG000|COMPLETED|Overall Study||421
10982741|NCT00597584|12157438|FG001|COMPLETED|Overall Study||211
10982742|NCT00597584|12157437|FG000|NOT COMPLETED|Overall Study||128
10982743|NCT00597584|12157438|FG001|NOT COMPLETED|Overall Study||63
10982744|NCT00597675|12157446|FG000|STARTED|Blinded Phase||4
10982745|NCT00597675|12157447|FG001|STARTED|Blinded Phase||6
10982746|NCT00597675|12157446|FG000|COMPLETED|Blinded Phase||2
10982747|NCT00597675|12157447|FG001|COMPLETED|Blinded Phase||5
10982748|NCT00597675|12157446|FG000|NOT COMPLETED|Blinded Phase||2
10982749|NCT00597675|12157447|FG001|NOT COMPLETED|Blinded Phase||1
10982750|NCT00597675|12157446|FG000|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
10982751|NCT00597675|12157447|FG001|STARTED|Open Label Phase||5
10982752|NCT00597675|12157446|FG000|COMPLETED|Open Label Phase||2
10982753|NCT00597675|12157447|FG001|COMPLETED|Open Label Phase||5
10982754|NCT00597675|12157446|FG000|NOT COMPLETED|Open Label Phase||0
10982755|NCT00597675|12157447|FG001|NOT COMPLETED|Open Label Phase||0
10982756|NCT00597701|12157457|FG000|STARTED|Overall Study||25
10982757|NCT00597701|12157458|FG001|STARTED|Overall Study||21
10982758|NCT00597701|12157457|FG000|COMPLETED|Overall Study||18
10982759|NCT00597701|12157458|FG001|COMPLETED|Overall Study||13
10982760|NCT00597701|12157457|FG000|NOT COMPLETED|Overall Study||7
10982761|NCT00597701|12157458|FG001|NOT COMPLETED|Overall Study||8
10982762|NCT00597714|12157466|FG000|STARTED|Overall Study||80
10982763|NCT00597714|12157467|FG001|STARTED|Overall Study||57
10982764|NCT00597714|12157468|FG002|STARTED|Overall Study||94
10982765|NCT00597714|12157466|FG000|COMPLETED|Overall Study||24
10982766|NCT00597714|12157467|FG001|COMPLETED|Overall Study||11
10982767|NCT00597714|12157468|FG002|COMPLETED|Overall Study||84
10982768|NCT00597714|12157466|FG000|NOT COMPLETED|Overall Study||56
10982769|NCT00597714|12157467|FG001|NOT COMPLETED|Overall Study||46
10982770|NCT00597714|12157468|FG002|NOT COMPLETED|Overall Study||10
10982771|NCT00597727|12157481|FG000|STARTED|12 Month Blinded Phase||14
10982772|NCT00597727|12157482|FG001|STARTED|12 Month Blinded Phase||15
10982773|NCT00597727|12157483|FG002|STARTED|12 Month Blinded Phase||0
10982774|NCT00597727|12157484|FG003|STARTED|12 Month Blinded Phase||27
10982775|NCT00597727|12157485|FG004|STARTED|12 Month Blinded Phase||4
10982776|NCT00597727|12157481|FG000|COMPLETED|12 Month Blinded Phase||14
10982777|NCT00597727|12157482|FG001|COMPLETED|12 Month Blinded Phase||15
10982778|NCT00597727|12157483|FG002|COMPLETED|12 Month Blinded Phase||0
10982779|NCT00597727|12157484|FG003|COMPLETED|12 Month Blinded Phase||17
10982780|NCT00597727|12157485|FG004|COMPLETED|12 Month Blinded Phase||3
10982781|NCT00597727|12157481|FG000|NOT COMPLETED|12 Month Blinded Phase||0
10982782|NCT00597727|12157482|FG001|NOT COMPLETED|12 Month Blinded Phase||0
10982783|NCT00597727|12157483|FG002|NOT COMPLETED|12 Month Blinded Phase||0
10982784|NCT00597727|12157484|FG003|NOT COMPLETED|12 Month Blinded Phase||10
10982785|NCT00597727|12157485|FG004|NOT COMPLETED|12 Month Blinded Phase||1
10982786|NCT00597727|12157481|FG000|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
10982870|NCT00597935|12157553|FG001|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
10982787|NCT00597727|12157482|FG001|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
10982788|NCT00597727|12157483|FG002|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
10982789|NCT00597727|12157484|FG003|STARTED|Open-label Extended Maintenance Phase||17
10982790|NCT00597727|12157485|FG004|STARTED|Open-label Extended Maintenance Phase||3
10982791|NCT00597727|12157481|FG000|COMPLETED|Open-label Extended Maintenance Phase||0
10982792|NCT00597727|12157482|FG001|COMPLETED|Open-label Extended Maintenance Phase||0
10982793|NCT00597727|12157483|FG002|COMPLETED|Open-label Extended Maintenance Phase||23
10982794|NCT00597727|12157484|FG003|COMPLETED|Open-label Extended Maintenance Phase||14
10982795|NCT00597727|12157485|FG004|COMPLETED|Open-label Extended Maintenance Phase||1
10982796|NCT00597727|12157481|FG000|NOT COMPLETED|Open-label Extended Maintenance Phase||0
10982797|NCT00597727|12157482|FG001|NOT COMPLETED|Open-label Extended Maintenance Phase||0
10982798|NCT00597727|12157483|FG002|NOT COMPLETED|Open-label Extended Maintenance Phase||6
10982799|NCT00597727|12157484|FG003|NOT COMPLETED|Open-label Extended Maintenance Phase||3
10982800|NCT00597727|12157485|FG004|NOT COMPLETED|Open-label Extended Maintenance Phase||2
10982801|NCT00597753|12157501|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
10982802|NCT00597753|12157502|FG001|STARTED|Overall Study||271
10982803|NCT00597753|12157501|FG000|COMPLETED|Overall Study||366
10982804|NCT00597753|12157502|FG001|COMPLETED|Overall Study||202
10982805|NCT00597753|12157501|FG000|NOT COMPLETED|Overall Study||166
10982806|NCT00597753|12157502|FG001|NOT COMPLETED|Overall Study||69
10982807|NCT00597766|12157511|FG000|STARTED|Enrolled||9
10982808|NCT00597766|12157512|FG001|STARTED|Enrolled||9
10982809|NCT00597766|12157513|FG002|STARTED|Enrolled||10
10982810|NCT00597766|12157511|FG000|COMPLETED|Enrolled||9
10982811|NCT00597766|12157512|FG001|COMPLETED|Enrolled||9
10982812|NCT00597766|12157513|FG002|COMPLETED|Enrolled||10
10982813|NCT00597766|12157511|FG000|NOT COMPLETED|Enrolled||0
10982814|NCT00597766|12157512|FG001|NOT COMPLETED|Enrolled||0
10982815|NCT00597766|12157513|FG002|NOT COMPLETED|Enrolled||0
10982816|NCT00597766|12157511|FG000|STARTED|Follow-up 1, Week 4||9
10982817|NCT00597766|12157512|FG001|STARTED|Follow-up 1, Week 4||9
10982818|NCT00597766|12157513|FG002|STARTED|Follow-up 1, Week 4||10
10982819|NCT00597766|12157511|FG000|COMPLETED|Follow-up 1, Week 4||8
10982820|NCT00597766|12157512|FG001|COMPLETED|Follow-up 1, Week 4||9
10982821|NCT00597766|12157513|FG002|COMPLETED|Follow-up 1, Week 4||10
10982822|NCT00597766|12157511|FG000|NOT COMPLETED|Follow-up 1, Week 4||1
10982823|NCT00597766|12157512|FG001|NOT COMPLETED|Follow-up 1, Week 4||0
10982824|NCT00597766|12157513|FG002|NOT COMPLETED|Follow-up 1, Week 4||0
10982825|NCT00597766|12157511|FG000|STARTED|Follow-up 2, Week 8||8
10982826|NCT00597766|12157512|FG001|STARTED|Follow-up 2, Week 8||9
10982827|NCT00597766|12157513|FG002|STARTED|Follow-up 2, Week 8||10
10982828|NCT00597766|12157511|FG000|COMPLETED|Follow-up 2, Week 8||8
10982829|NCT00597766|12157512|FG001|COMPLETED|Follow-up 2, Week 8||9
10982830|NCT00597766|12157513|FG002|COMPLETED|Follow-up 2, Week 8||9
10982831|NCT00597766|12157511|FG000|NOT COMPLETED|Follow-up 2, Week 8||0
10982832|NCT00597766|12157512|FG001|NOT COMPLETED|Follow-up 2, Week 8||0
10982833|NCT00597766|12157513|FG002|NOT COMPLETED|Follow-up 2, Week 8||1
10982834|NCT00597766|12157511|FG000|STARTED|Follow-up 3, Week 12||8
10982835|NCT00597766|12157512|FG001|STARTED|Follow-up 3, Week 12||9
10982836|NCT00597766|12157513|FG002|STARTED|Follow-up 3, Week 12||9
10982837|NCT00597766|12157511|FG000|COMPLETED|Follow-up 3, Week 12||8
10982838|NCT00597766|12157512|FG001|COMPLETED|Follow-up 3, Week 12||9
10982839|NCT00597766|12157513|FG002|COMPLETED|Follow-up 3, Week 12||9
10982840|NCT00597766|12157511|FG000|NOT COMPLETED|Follow-up 3, Week 12||0
10982841|NCT00597766|12157512|FG001|NOT COMPLETED|Follow-up 3, Week 12||0
10982842|NCT00597766|12157513|FG002|NOT COMPLETED|Follow-up 3, Week 12||0
10982843|NCT00597818|12157525|FG000|STARTED|Overall Study||30
10982844|NCT00597818|12157526|FG001|STARTED|Overall Study||30
10982845|NCT00597818|12157527|FG002|STARTED|Overall Study||31
10982846|NCT00597818|12157528|FG003|STARTED|Overall Study||30
10982847|NCT00597818|12157525|FG000|COMPLETED|Overall Study||12
10982848|NCT00597818|12157526|FG001|COMPLETED|Overall Study||14
10982849|NCT00597818|12157527|FG002|COMPLETED|Overall Study||12
10982850|NCT00597818|12157528|FG003|COMPLETED|Overall Study||20
10982851|NCT00597818|12157525|FG000|NOT COMPLETED|Overall Study||18
10982852|NCT00597818|12157526|FG001|NOT COMPLETED|Overall Study||16
10982853|NCT00597818|12157527|FG002|NOT COMPLETED|Overall Study||19
10982854|NCT00597818|12157528|FG003|NOT COMPLETED|Overall Study||10
10982855|NCT00597896|12157540|FG000|STARTED|Overall Study||24
10982856|NCT00597896|12157541|FG001|STARTED|Overall Study||26
10982857|NCT00597896|12157540|FG000|COMPLETED|Overall Study||21
10982858|NCT00597896|12157541|FG001|COMPLETED|Overall Study||24
10982859|NCT00597896|12157540|FG000|NOT COMPLETED|Overall Study||3
10982860|NCT00597896|12157541|FG001|NOT COMPLETED|Overall Study||2
10982861|NCT00597935|12157552|FG000|STARTED|Randomized to Surgical and BPMT Arms||95
10982862|NCT00597935|12157553|FG001|STARTED|Randomized to Surgical and BPMT Arms||91
10982863|NCT00597935|12157554|FG002|STARTED|Randomized to Surgical and BPMT Arms||91
10982864|NCT00597935|12157555|FG003|STARTED|Randomized to Surgical and BPMT Arms||97
10982865|NCT00597935|12157552|FG000|COMPLETED|Randomized to Surgical and BPMT Arms||95
10982866|NCT00597935|12157553|FG001|COMPLETED|Randomized to Surgical and BPMT Arms||91
10982867|NCT00597935|12157554|FG002|COMPLETED|Randomized to Surgical and BPMT Arms||91
10982868|NCT00597935|12157555|FG003|COMPLETED|Randomized to Surgical and BPMT Arms||97
10982869|NCT00597935|12157552|FG000|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
10982871|NCT00597935|12157554|FG002|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
10982872|NCT00597935|12157555|FG003|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
10982873|NCT00597935|12157552|FG000|STARTED|Baseline to 6-Months||95
10982874|NCT00597935|12157553|FG001|STARTED|Baseline to 6-Months||91
10982875|NCT00597935|12157554|FG002|STARTED|Baseline to 6-Months||91
10982876|NCT00597935|12157555|FG003|STARTED|Baseline to 6-Months||97
10982877|NCT00597935|12157552|FG000|COMPLETED|Baseline to 6-Months||93
10982878|NCT00597935|12157553|FG001|COMPLETED|Baseline to 6-Months||87
10982879|NCT00597935|12157554|FG002|COMPLETED|Baseline to 6-Months||87
10982880|NCT00597935|12157555|FG003|COMPLETED|Baseline to 6-Months||93
10982881|NCT00597935|12157552|FG000|NOT COMPLETED|Baseline to 6-Months||2
10982882|NCT00597935|12157553|FG001|NOT COMPLETED|Baseline to 6-Months||4
10982883|NCT00597935|12157554|FG002|NOT COMPLETED|Baseline to 6-Months||4
10982884|NCT00597935|12157555|FG003|NOT COMPLETED|Baseline to 6-Months||4
10982885|NCT00597935|12157552|FG000|STARTED|6-Months to 24-Months||93
10982886|NCT00597935|12157553|FG001|STARTED|6-Months to 24-Months||87
10982887|NCT00597935|12157554|FG002|STARTED|6-Months to 24-Months||87
10982888|NCT00597935|12157555|FG003|STARTED|6-Months to 24-Months||93
10982889|NCT00597935|12157552|FG000|COMPLETED|6-Months to 24-Months||76
10982890|NCT00597935|12157553|FG001|COMPLETED|6-Months to 24-Months||79
10982891|NCT00597935|12157554|FG002|COMPLETED|6-Months to 24-Months||77
10982892|NCT00597935|12157555|FG003|COMPLETED|6-Months to 24-Months||85
10982893|NCT00597935|12157552|FG000|NOT COMPLETED|6-Months to 24-Months||17
10982894|NCT00597935|12157553|FG001|NOT COMPLETED|6-Months to 24-Months||8
10982895|NCT00597935|12157554|FG002|NOT COMPLETED|6-Months to 24-Months||10
10982896|NCT00597935|12157555|FG003|NOT COMPLETED|6-Months to 24-Months||8
10982897|NCT00598078|12157565|FG000|STARTED|Period 1 (Day 1)||10
10982898|NCT00598078|12157566|FG001|STARTED|Period 1 (Day 1)||10
10982899|NCT00598078|12157565|FG000|COMPLETED|Period 1 (Day 1)||10
10982900|NCT00598078|12157566|FG001|COMPLETED|Period 1 (Day 1)||10
10982901|NCT00598078|12157565|FG000|NOT COMPLETED|Period 1 (Day 1)||0
10982902|NCT00598078|12157566|FG001|NOT COMPLETED|Period 1 (Day 1)||0
10982903|NCT00598078|12157565|FG000|STARTED|Period 2 (Day 2)||10
10982904|NCT00598078|12157566|FG001|STARTED|Period 2 (Day 2)||10
10982905|NCT00598078|12157565|FG000|COMPLETED|Period 2 (Day 2)||9
10982906|NCT00598078|12157566|FG001|COMPLETED|Period 2 (Day 2)||10
10982907|NCT00598078|12157565|FG000|NOT COMPLETED|Period 2 (Day 2)||1
10982908|NCT00598078|12157566|FG001|NOT COMPLETED|Period 2 (Day 2)||0
10982909|NCT00598078|12157565|FG000|STARTED|Period 3 (Day 3)||9
10982910|NCT00598078|12157566|FG001|STARTED|Period 3 (Day 3)||10
10982911|NCT00598078|12157565|FG000|COMPLETED|Period 3 (Day 3)||9
10982912|NCT00598078|12157566|FG001|COMPLETED|Period 3 (Day 3)||10
10982913|NCT00598078|12157565|FG000|NOT COMPLETED|Period 3 (Day 3)||0
10982914|NCT00598078|12157566|FG001|NOT COMPLETED|Period 3 (Day 3)||0
10982915|NCT00598273|12157577|FG000|STARTED|Overall Study||161
10982916|NCT00598273|12157578|FG001|STARTED|Overall Study||165
10982917|NCT00598273|12157579|FG002|STARTED|Overall Study||164
10982918|NCT00598273|12157577|FG000|COMPLETED|Overall Study||120
10982919|NCT00598273|12157578|FG001|COMPLETED|Overall Study||127
10982920|NCT00598273|12157579|FG002|COMPLETED|Overall Study||125
10982921|NCT00598273|12157577|FG000|NOT COMPLETED|Overall Study||41
10982922|NCT00598273|12157578|FG001|NOT COMPLETED|Overall Study||38
10982923|NCT00598273|12157579|FG002|NOT COMPLETED|Overall Study||39
10982924|NCT00598442|12157590|FG000|STARTED|Overall Study||167
10982925|NCT00598442|12157591|FG001|STARTED|Overall Study||163
10982926|NCT00598442|12157592|FG002|STARTED|Overall Study||163
10982927|NCT00598442|12157590|FG000|COMPLETED|Overall Study||124
10982928|NCT00598442|12157591|FG001|COMPLETED|Overall Study||124
10982929|NCT00598442|12157592|FG002|COMPLETED|Overall Study||139
10982930|NCT00598442|12157590|FG000|NOT COMPLETED|Overall Study||43
10982931|NCT00598442|12157591|FG001|NOT COMPLETED|Overall Study||39
10982932|NCT00598442|12157592|FG002|NOT COMPLETED|Overall Study||24
10982933|NCT00598481|12157600|FG000|STARTED|Baseline||12
10982934|NCT00598481|12157600|FG000|COMPLETED|Baseline||12
10982935|NCT00598481|12157600|FG000|NOT COMPLETED|Baseline||0
10982936|NCT00598481|12157600|FG000|STARTED|Treatment||12
10982937|NCT00598481|12157600|FG000|COMPLETED|Treatment||11
10982938|NCT00598481|12157600|FG000|NOT COMPLETED|Treatment||1
10982939|NCT00598507|12157607|FG000|STARTED|Overall Study||35
10982940|NCT00598507|12157607|FG000|COMPLETED|Overall Study||35
10982941|NCT00598507|12157607|FG000|NOT COMPLETED|Overall Study||0
10982942|NCT00598559|12157614|FG000|STARTED|Overall Study||92
10982943|NCT00598559|12157615|FG001|STARTED|Overall Study||91
10982944|NCT00598559|12157616|FG002|STARTED|Overall Study||30
10982945|NCT00598559|12157614|FG000|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
10982946|NCT00598559|12157615|FG001|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
10982947|NCT00598559|12157616|FG002|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
10982948|NCT00598559|12157614|FG000|NOT COMPLETED|Overall Study||27
10982949|NCT00598559|12157615|FG001|NOT COMPLETED|Overall Study||28
10982950|NCT00598559|12157616|FG002|NOT COMPLETED|Overall Study||3
10982951|NCT00598585|12157626|FG000|STARTED|Overall Study||6
10982952|NCT00598585|12157627|FG001|STARTED|Overall Study||6
10982953|NCT00598585|12157626|FG000|COMPLETED|Overall Study||5
10982954|NCT00598585|12157627|FG001|COMPLETED|Overall Study||6
10982955|NCT00598585|12157626|FG000|NOT COMPLETED|Overall Study||1
10982956|NCT00598585|12157627|FG001|NOT COMPLETED|Overall Study||0
10982957|NCT00598650|12157633|FG000|STARTED|Overall Study||108
10982958|NCT00598650|12157633|FG000|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
10982959|NCT00598650|12157633|FG000|NOT COMPLETED|Overall Study||27
10982960|NCT00598663|12157640|FG000|STARTED|First Intervention (6 Months)||76
10982961|NCT00598663|12157641|FG001|STARTED|First Intervention (6 Months)||77
10982962|NCT00598663|12157640|FG000|COMPLETED|First Intervention (6 Months)||73
10982963|NCT00598663|12157641|FG001|COMPLETED|First Intervention (6 Months)||71
10982964|NCT00598663|12157640|FG000|NOT COMPLETED|First Intervention (6 Months)||3
10982965|NCT00598663|12157641|FG001|NOT COMPLETED|First Intervention (6 Months)||6
10982966|NCT00598663|12157640|FG000|STARTED|Washout (4 Months)||73
10982967|NCT00598663|12157641|FG001|STARTED|Washout (4 Months)||71
10982968|NCT00598663|12157640|FG000|COMPLETED|Washout (4 Months)||73
10982969|NCT00598663|12157641|FG001|COMPLETED|Washout (4 Months)||70
10982970|NCT00598663|12157640|FG000|NOT COMPLETED|Washout (4 Months)||0
10982971|NCT00598663|12157641|FG001|NOT COMPLETED|Washout (4 Months)||1
10982972|NCT00598663|12157640|FG000|STARTED|Second Intervention (6 Months)||73
10982973|NCT00598663|12157641|FG001|STARTED|Second Intervention (6 Months)||70
10982974|NCT00598663|12157640|FG000|COMPLETED|Second Intervention (6 Months)||69
10982975|NCT00598663|12157641|FG001|COMPLETED|Second Intervention (6 Months)||69
10982976|NCT00598663|12157640|FG000|NOT COMPLETED|Second Intervention (6 Months)||4
10982977|NCT00598663|12157641|FG001|NOT COMPLETED|Second Intervention (6 Months)||1
10982978|NCT00598689|12157652|FG000|STARTED|Overall Study||40
10982979|NCT00598689|12157653|FG001|STARTED|Overall Study||40
10982980|NCT00598689|12157652|FG000|COMPLETED|Overall Study||40
10982981|NCT00598689|12157653|FG001|COMPLETED|Overall Study||40
10982982|NCT00598689|12157652|FG000|NOT COMPLETED|Overall Study||0
10982983|NCT00598689|12157653|FG001|NOT COMPLETED|Overall Study||0
10982984|NCT00598702|12157667|FG000|STARTED|Overall Study||1
10982985|NCT00598702|12157668|FG001|STARTED|Overall Study||3
10982986|NCT00598702|12157669|FG002|STARTED|Overall Study||7
10982987|NCT00598702|12157670|FG003|STARTED|Overall Study||33
10982988|NCT00598702|12157671|FG004|STARTED|Overall Study||9
10982989|NCT00598702|12157672|FG005|STARTED|Overall Study||42
10982990|NCT00598702|12157673|FG006|STARTED|Overall Study||1
10982991|NCT00598702|12157674|FG007|STARTED|Overall Study||4
10982992|NCT00598702|12157667|FG000|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
10982993|NCT00598702|12157668|FG001|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
10982994|NCT00598702|12157669|FG002|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
10982995|NCT00598702|12157670|FG003|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
10982996|NCT00598702|12157671|FG004|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
10982997|NCT00598702|12157672|FG005|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
10982998|NCT00598702|12157673|FG006|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
10982999|NCT00598702|12157674|FG007|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
10983000|NCT00598702|12157667|FG000|NOT COMPLETED|Overall Study||0
10983001|NCT00598702|12157668|FG001|NOT COMPLETED|Overall Study||2
10983002|NCT00598702|12157669|FG002|NOT COMPLETED|Overall Study||2
10983003|NCT00598702|12157670|FG003|NOT COMPLETED|Overall Study||8
10983004|NCT00598702|12157671|FG004|NOT COMPLETED|Overall Study||3
10983005|NCT00598702|12157672|FG005|NOT COMPLETED|Overall Study||12
10983006|NCT00598702|12157673|FG006|NOT COMPLETED|Overall Study||1
10983007|NCT00598702|12157674|FG007|NOT COMPLETED|Overall Study||0
10983008|NCT00598806|12157694|FG000|STARTED|Overall Study||402
10983009|NCT00598806|12157695|FG001|STARTED|Overall Study||410
10983010|NCT00598806|12157694|FG000|COMPLETED|Overall Study||329
10983011|NCT00598806|12157695|FG001|COMPLETED|Overall Study||346
10983012|NCT00598806|12157694|FG000|NOT COMPLETED|Overall Study||73
10983013|NCT00598806|12157695|FG001|NOT COMPLETED|Overall Study||64
10983014|NCT00598819|12157701|FG000|STARTED|Overall Study||14
10983015|NCT00598819|12157701|FG000|COMPLETED|Overall Study||14
10983016|NCT00598819|12157701|FG000|NOT COMPLETED|Overall Study||0
10983017|NCT00598832|12157707|FG000|STARTED|Overall Study||533
10983018|NCT00598832|12157708|FG001|STARTED|Overall Study||542
10983019|NCT00598832|12157707|FG000|COMPLETED|Overall Study||471
10983020|NCT00598832|12157708|FG001|COMPLETED|Overall Study||460
10983021|NCT00598832|12157707|FG000|NOT COMPLETED|Overall Study||62
10983022|NCT00598832|12157708|FG001|NOT COMPLETED|Overall Study||82
10983023|NCT00598871|12157716|FG000|STARTED|Overall Study||3
10983024|NCT00598871|12157717|FG001|STARTED|Overall Study||9
10983025|NCT00598871|12157716|FG000|COMPLETED|Overall Study||3
10983026|NCT00598871|12157717|FG001|COMPLETED|Overall Study||8
10983027|NCT00598871|12157716|FG000|NOT COMPLETED|Overall Study||0
10983028|NCT00598871|12157717|FG001|NOT COMPLETED|Overall Study||1
10983029|NCT00598975|12157725|FG000|STARTED|Overall Study||12
10983030|NCT00598975|12157726|FG001|STARTED|Overall Study||6
10983031|NCT00598975|12157725|FG000|Completed Cycle 1|Overall Study||12
10983032|NCT00598975|12157726|FG001|Completed Cycle 1|Overall Study||6
10983033|NCT00598975|12157725|FG000|COMPLETED|Overall Study||0
10983034|NCT00598975|12157726|FG001|COMPLETED|Overall Study||0
10983035|NCT00598975|12157725|FG000|NOT COMPLETED|Overall Study||12
10983036|NCT00598975|12157726|FG001|NOT COMPLETED|Overall Study||6
10983037|NCT00599014|12157734|FG000|STARTED|Overall Study||335
10983038|NCT00599014|12157734|FG000|COMPLETED|Overall Study||335
10983039|NCT00599014|12157734|FG000|NOT COMPLETED|Overall Study||0
10983040|NCT00599053|12157740|FG000|STARTED|Overall Study||5
10983041|NCT00599053|12157741|FG001|STARTED|Overall Study||2
10983042|NCT00599053|12157740|FG000|COMPLETED|Overall Study||5
10983043|NCT00599053|12157741|FG001|COMPLETED|Overall Study||2
10983044|NCT00599053|12157740|FG000|NOT COMPLETED|Overall Study||0
10983045|NCT00599053|12157741|FG001|NOT COMPLETED|Overall Study||0
10983046|NCT00599196|12157747|FG000|STARTED|Overall Study||381
10983047|NCT00599196|12157747|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
10983048|NCT00599196|12157747|FG000|NOT COMPLETED|Overall Study||381
10983049|NCT00599248|12157753|FG000|STARTED|Overall Study||3
10983050|NCT00599248|12157754|FG001|STARTED|Overall Study||3
10983051|NCT00599248|12157755|FG002|STARTED|Overall Study||3
10983052|NCT00599248|12157756|FG003|STARTED|Overall Study||3
10983053|NCT00599248|12157753|FG000|COMPLETED|Overall Study||3
10983054|NCT00599248|12157754|FG001|COMPLETED|Overall Study||3
10983055|NCT00599248|12157755|FG002|COMPLETED|Overall Study||3
10983056|NCT00599248|12157756|FG003|COMPLETED|Overall Study||3
10983057|NCT00599248|12157753|FG000|NOT COMPLETED|Overall Study||0
10983058|NCT00599248|12157754|FG001|NOT COMPLETED|Overall Study||0
10983059|NCT00599248|12157755|FG002|NOT COMPLETED|Overall Study||0
10983060|NCT00599248|12157756|FG003|NOT COMPLETED|Overall Study||0
10983061|NCT00599313|12157765|FG000|STARTED|Overall Study||36
10983062|NCT00599313|12157765|FG000|COMPLETED|Overall Study||0
10983063|NCT00599313|12157765|FG000|NOT COMPLETED|Overall Study||36
10983064|NCT00599326|12157769|FG000|STARTED|Overall Study||10
10983065|NCT00599326|12157769|FG000|COMPLETED|Overall Study||8
10983066|NCT00599326|12157769|FG000|NOT COMPLETED|Overall Study||2
10983067|NCT00599339|12157773|FG000|STARTED|Overall Study||2195
10983068|NCT00599339|12157773|FG000|Safety Set|Overall Study||2179
10983069|NCT00599339|12157773|FG000|COMPLETED|Overall Study||1531
10983070|NCT00599339|12157773|FG000|NOT COMPLETED|Overall Study||664
10983071|NCT00599521|12157797|FG000|STARTED|Overall Study||535
10983072|NCT00599521|12157798|FG001|STARTED|Overall Study||531
10983073|NCT00599521|12157797|FG000|COMPLETED|Overall Study||475
10983074|NCT00599521|12157798|FG001|COMPLETED|Overall Study||462
10983075|NCT00599521|12157797|FG000|NOT COMPLETED|Overall Study||60
10983076|NCT00599521|12157798|FG001|NOT COMPLETED|Overall Study||69
10983077|NCT00599638|12157808|FG000|STARTED|First Intervention Period (2 Weeks)||16
10983078|NCT00599638|12157809|FG001|STARTED|First Intervention Period (2 Weeks)||14
10983079|NCT00599638|12157810|FG002|STARTED|First Intervention Period (2 Weeks)||20
10983080|NCT00599638|12157811|FG003|STARTED|First Intervention Period (2 Weeks)||22
10983081|NCT00599638|12157808|FG000|Treated|First Intervention Period (2 Weeks)||16
10983082|NCT00599638|12157809|FG001|Treated|First Intervention Period (2 Weeks)||13
10983083|NCT00599638|12157810|FG002|Treated|First Intervention Period (2 Weeks)||20
10983084|NCT00599638|12157811|FG003|Treated|First Intervention Period (2 Weeks)||21
10983085|NCT00599638|12157808|FG000|COMPLETED|First Intervention Period (2 Weeks)||14
10983086|NCT00599638|12157809|FG001|COMPLETED|First Intervention Period (2 Weeks)||12
10983087|NCT00599638|12157810|FG002|COMPLETED|First Intervention Period (2 Weeks)||17
10983088|NCT00599638|12157811|FG003|COMPLETED|First Intervention Period (2 Weeks)||17
10983089|NCT00599638|12157808|FG000|NOT COMPLETED|First Intervention Period (2 Weeks)||2
10983090|NCT00599638|12157809|FG001|NOT COMPLETED|First Intervention Period (2 Weeks)||2
10983091|NCT00599638|12157810|FG002|NOT COMPLETED|First Intervention Period (2 Weeks)||3
10983092|NCT00599638|12157811|FG003|NOT COMPLETED|First Intervention Period (2 Weeks)||5
10983093|NCT00599638|12157808|FG000|STARTED|Washout Period (2 Weeks)||14
10983094|NCT00599638|12157809|FG001|STARTED|Washout Period (2 Weeks)||12
10983095|NCT00599638|12157810|FG002|STARTED|Washout Period (2 Weeks)||17
10983096|NCT00599638|12157811|FG003|STARTED|Washout Period (2 Weeks)||17
10983097|NCT00599638|12157808|FG000|COMPLETED|Washout Period (2 Weeks)||13
10983098|NCT00599638|12157809|FG001|COMPLETED|Washout Period (2 Weeks)||11
10983099|NCT00599638|12157810|FG002|COMPLETED|Washout Period (2 Weeks)||17
10983100|NCT00599638|12157811|FG003|COMPLETED|Washout Period (2 Weeks)||14
10983101|NCT00599638|12157808|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
10983102|NCT00599638|12157809|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1
10983103|NCT00599638|12157810|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
10983104|NCT00599638|12157811|FG003|NOT COMPLETED|Washout Period (2 Weeks)||3
10983105|NCT00599638|12157808|FG000|STARTED|Second Intervention Period (2 Weeks)||13
10983106|NCT00599638|12157809|FG001|STARTED|Second Intervention Period (2 Weeks)||11
10983107|NCT00599638|12157810|FG002|STARTED|Second Intervention Period (2 Weeks)||17
10983108|NCT00599638|12157811|FG003|STARTED|Second Intervention Period (2 Weeks)||14
10983109|NCT00599638|12157808|FG000|COMPLETED|Second Intervention Period (2 Weeks)||12
10983110|NCT00599638|12157809|FG001|COMPLETED|Second Intervention Period (2 Weeks)||11
10983111|NCT00599638|12157810|FG002|COMPLETED|Second Intervention Period (2 Weeks)||17
10983112|NCT00599638|12157811|FG003|COMPLETED|Second Intervention Period (2 Weeks)||14
10983113|NCT00599638|12157808|FG000|NOT COMPLETED|Second Intervention Period (2 Weeks)||1
10983114|NCT00599638|12157809|FG001|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
10983115|NCT00599638|12157810|FG002|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
10983116|NCT00599638|12157811|FG003|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
10983117|NCT00599755|12157819|FG000|STARTED|Overall Study||68
10983118|NCT00599755|12157819|FG000|COMPLETED|Overall Study||49
10983119|NCT00599755|12157819|FG000|NOT COMPLETED|Overall Study||19
10983120|NCT00599872|12157825|FG000|STARTED|Overall Study||216
10983121|NCT00599872|12157826|FG001|STARTED|Overall Study||214
10983122|NCT00599872|12157825|FG000|COMPLETED|Overall Study||167
10983123|NCT00599872|12157826|FG001|COMPLETED|Overall Study||181
10983124|NCT00599872|12157825|FG000|NOT COMPLETED|Overall Study||49
10983125|NCT00599872|12157826|FG001|NOT COMPLETED|Overall Study||33
10983126|NCT00599924|12157843|FG000|STARTED|Overall Study||4
10983127|NCT00599924|12157844|FG001|STARTED|Overall Study||9
10983128|NCT00599924|12157845|FG002|STARTED|Overall Study||5
10983129|NCT00599924|12157846|FG003|STARTED|Overall Study||12
10983130|NCT00599924|12157847|FG004|STARTED|Overall Study||9
10983131|NCT00599924|12157848|FG005|STARTED|Overall Study||6
10983132|NCT00599924|12157849|FG006|STARTED|Overall Study||8
10983133|NCT00599924|12157843|FG000|COMPLETED|Overall Study||1
10983134|NCT00599924|12157844|FG001|COMPLETED|Overall Study||4
10983135|NCT00599924|12157845|FG002|COMPLETED|Overall Study||3
10983136|NCT00599924|12157846|FG003|COMPLETED|Overall Study||4
10983137|NCT00599924|12157847|FG004|COMPLETED|Overall Study||3
10983138|NCT00599924|12157848|FG005|COMPLETED|Overall Study||2
10983139|NCT00599924|12157849|FG006|COMPLETED|Overall Study||3
10983140|NCT00599924|12157843|FG000|NOT COMPLETED|Overall Study||3
10983141|NCT00599924|12157844|FG001|NOT COMPLETED|Overall Study||5
10983142|NCT00599924|12157845|FG002|NOT COMPLETED|Overall Study||2
10983143|NCT00599924|12157846|FG003|NOT COMPLETED|Overall Study||8
10983144|NCT00599924|12157847|FG004|NOT COMPLETED|Overall Study||6
10983145|NCT00599924|12157848|FG005|NOT COMPLETED|Overall Study||4
10983146|NCT00599924|12157849|FG006|NOT COMPLETED|Overall Study||5
10983147|NCT00600028|12157872|FG000|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
10983148|NCT00600028|12157873|FG001|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
10983149|NCT00600028|12157872|FG000|COMPLETED|First Intervention (12 Weeks)||12
10983150|NCT00600028|12157873|FG001|COMPLETED|First Intervention (12 Weeks)||10
10983151|NCT00600028|12157872|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
10983152|NCT00600028|12157873|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
10983153|NCT00600028|12157872|FG000|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
10983154|NCT00600028|12157873|FG001|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
10983155|NCT00600028|12157872|FG000|COMPLETED|Second Intervention (12 Weeks)||12
10983156|NCT00600028|12157873|FG001|COMPLETED|Second Intervention (12 Weeks)||8
10983157|NCT00600028|12157872|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
10983158|NCT00600028|12157873|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||2
10983159|NCT00600067|12157884|FG000|STARTED|Overall Study||55
10983160|NCT00600067|12157885|FG001|STARTED|Overall Study||75
10983161|NCT00600067|12157884|FG000|COMPLETED|Overall Study||52
10983162|NCT00600067|12157885|FG001|COMPLETED|Overall Study||68
10983163|NCT00600067|12157884|FG000|NOT COMPLETED|Overall Study||3
10983164|NCT00600067|12157885|FG001|NOT COMPLETED|Overall Study||7
10983165|NCT00600080|12157892|FG000|STARTED|Period 1: Baseline to One-week||28
10983166|NCT00600080|12157893|FG001|STARTED|Period 1: Baseline to One-week||32
10983167|NCT00600080|12157892|FG000|COMPLETED|Period 1: Baseline to One-week||28
10983168|NCT00600080|12157893|FG001|COMPLETED|Period 1: Baseline to One-week||32
10983169|NCT00600080|12157892|FG000|NOT COMPLETED|Period 1: Baseline to One-week||0
10983170|NCT00600080|12157893|FG001|NOT COMPLETED|Period 1: Baseline to One-week||0
10983171|NCT00600080|12157892|FG000|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
10983172|NCT00600080|12157893|FG001|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
10983173|NCT00600080|12157892|FG000|COMPLETED|Period 2: One-week to Two-weeks||28
10983174|NCT00600080|12157893|FG001|COMPLETED|Period 2: One-week to Two-weeks||32
10983175|NCT00600080|12157892|FG000|NOT COMPLETED|Period 2: One-week to Two-weeks||0
10983176|NCT00600080|12157893|FG001|NOT COMPLETED|Period 2: One-week to Two-weeks||0
10983177|NCT00600106|12157901|FG000|STARTED|Overall Study||18
10983178|NCT00600106|12157902|FG001|STARTED|Overall Study||19
10983179|NCT00600106|12157901|FG000|COMPLETED|Overall Study||17
10983180|NCT00600106|12157902|FG001|COMPLETED|Overall Study||18
10983181|NCT00600106|12157901|FG000|NOT COMPLETED|Overall Study||1
10983182|NCT00600106|12157902|FG001|NOT COMPLETED|Overall Study||1
10983183|NCT00600119|12157914|FG000|STARTED|Single-blind Placebo run-in Period||36
10983184|NCT00600119|12157915|FG001|STARTED|Single-blind Placebo run-in Period||35
10983185|NCT00600119|12157916|FG002|STARTED|Single-blind Placebo run-in Period||29
10983186|NCT00600119|12157917|FG003|STARTED|Single-blind Placebo run-in Period||31
10983187|NCT00600119|12157918|FG004|STARTED|Single-blind Placebo run-in Period||39
10983188|NCT00600119|12157919|FG005|STARTED|Single-blind Placebo run-in Period||37
10983189|NCT00600119|12157914|FG000|COMPLETED|Single-blind Placebo run-in Period||32
10983190|NCT00600119|12157915|FG001|COMPLETED|Single-blind Placebo run-in Period||33
10983191|NCT00600119|12157916|FG002|COMPLETED|Single-blind Placebo run-in Period||27
10983192|NCT00600119|12157917|FG003|COMPLETED|Single-blind Placebo run-in Period||30
10983193|NCT00600119|12157918|FG004|COMPLETED|Single-blind Placebo run-in Period||37
10983194|NCT00600119|12157919|FG005|COMPLETED|Single-blind Placebo run-in Period||35
10983195|NCT00600119|12157914|FG000|NOT COMPLETED|Single-blind Placebo run-in Period||4
10983196|NCT00600119|12157915|FG001|NOT COMPLETED|Single-blind Placebo run-in Period||2
10983197|NCT00600119|12157916|FG002|NOT COMPLETED|Single-blind Placebo run-in Period||2
10983198|NCT00600119|12157917|FG003|NOT COMPLETED|Single-blind Placebo run-in Period||1
10983199|NCT00600119|12157918|FG004|NOT COMPLETED|Single-blind Placebo run-in Period||2
10983200|NCT00600119|12157919|FG005|NOT COMPLETED|Single-blind Placebo run-in Period||2
10983201|NCT00600119|12157914|FG000|STARTED|Double-blind Treatment Period||32
10983202|NCT00600119|12157915|FG001|STARTED|Double-blind Treatment Period||33
10983203|NCT00600119|12157916|FG002|STARTED|Double-blind Treatment Period||27
10983204|NCT00600119|12157917|FG003|STARTED|Double-blind Treatment Period||30
10983205|NCT00600119|12157918|FG004|STARTED|Double-blind Treatment Period||37
10983206|NCT00600119|12157919|FG005|STARTED|Double-blind Treatment Period||35
10983207|NCT00600119|12157914|FG000|COMPLETED|Double-blind Treatment Period||27
10983208|NCT00600119|12157915|FG001|COMPLETED|Double-blind Treatment Period||28
10983209|NCT00600119|12157916|FG002|COMPLETED|Double-blind Treatment Period||27
10983210|NCT00600119|12157917|FG003|COMPLETED|Double-blind Treatment Period||28
10983211|NCT00600119|12157918|FG004|COMPLETED|Double-blind Treatment Period||31
10983212|NCT00600119|12157919|FG005|COMPLETED|Double-blind Treatment Period||21
10983213|NCT00600119|12157914|FG000|NOT COMPLETED|Double-blind Treatment Period||5
10983214|NCT00600119|12157915|FG001|NOT COMPLETED|Double-blind Treatment Period||5
10983215|NCT00600119|12157916|FG002|NOT COMPLETED|Double-blind Treatment Period||0
10983216|NCT00600119|12157917|FG003|NOT COMPLETED|Double-blind Treatment Period||2
10983217|NCT00600119|12157918|FG004|NOT COMPLETED|Double-blind Treatment Period||6
10983218|NCT00600119|12157919|FG005|NOT COMPLETED|Double-blind Treatment Period||14
10983219|NCT00600119|12157914|FG000|STARTED|Follow-up Period||27
10983220|NCT00600119|12157915|FG001|STARTED|Follow-up Period||28
10983221|NCT00600119|12157916|FG002|STARTED|Follow-up Period||27
10983222|NCT00600119|12157917|FG003|STARTED|Follow-up Period||28
10983223|NCT00600119|12157918|FG004|STARTED|Follow-up Period||31
10983224|NCT00600119|12157919|FG005|STARTED|Follow-up Period||21
10983225|NCT00600119|12157914|FG000|COMPLETED|Follow-up Period||26
10983226|NCT00600119|12157915|FG001|COMPLETED|Follow-up Period||28
10983227|NCT00600119|12157916|FG002|COMPLETED|Follow-up Period||27
10983228|NCT00600119|12157917|FG003|COMPLETED|Follow-up Period||28
10983229|NCT00600119|12157918|FG004|COMPLETED|Follow-up Period||31
10983230|NCT00600119|12157919|FG005|COMPLETED|Follow-up Period||20
10983231|NCT00600119|12157914|FG000|NOT COMPLETED|Follow-up Period||1
10983232|NCT00600119|12157915|FG001|NOT COMPLETED|Follow-up Period||0
10983233|NCT00600119|12157916|FG002|NOT COMPLETED|Follow-up Period||0
10983234|NCT00600119|12157917|FG003|NOT COMPLETED|Follow-up Period||0
10983235|NCT00600119|12157918|FG004|NOT COMPLETED|Follow-up Period||0
10983236|NCT00600119|12157919|FG005|NOT COMPLETED|Follow-up Period||1
10983237|NCT00600171|12157939|FG000|STARTED|Overall Study||102
10983238|NCT00600171|12157940|FG001|STARTED|Overall Study||101
10983239|NCT00600171|12157941|FG002|STARTED|Overall Study||101
10983240|NCT00600171|12157942|FG003|STARTED|Overall Study||100
10983241|NCT00600171|12157943|FG004|STARTED|Overall Study||101
10983242|NCT00600171|12157944|FG005|STARTED|Overall Study||102
10983243|NCT00600171|12157939|FG000|COMPLETED|Overall Study||86
10983244|NCT00600171|12157940|FG001|COMPLETED|Overall Study||84
10983245|NCT00600171|12157941|FG002|COMPLETED|Overall Study||91
10983246|NCT00600171|12157942|FG003|COMPLETED|Overall Study||88
10983247|NCT00600171|12157943|FG004|COMPLETED|Overall Study||93
10983248|NCT00600171|12157944|FG005|COMPLETED|Overall Study||97
10983249|NCT00600171|12157939|FG000|NOT COMPLETED|Overall Study||16
10983250|NCT00600171|12157940|FG001|NOT COMPLETED|Overall Study||17
10983251|NCT00600171|12157941|FG002|NOT COMPLETED|Overall Study||10
10983252|NCT00600171|12157942|FG003|NOT COMPLETED|Overall Study||12
10983253|NCT00600171|12157943|FG004|NOT COMPLETED|Overall Study||8
10983254|NCT00600171|12157944|FG005|NOT COMPLETED|Overall Study||5
10983255|NCT00600340|12157962|FG000|STARTED|Overall Study||285
10983256|NCT00600340|12157963|FG001|STARTED|Overall Study||279
10983257|NCT00600340|12157962|FG000|COMPLETED|Overall Study||285
10983258|NCT00600340|12157963|FG001|COMPLETED|Overall Study||279
10983259|NCT00600340|12157962|FG000|NOT COMPLETED|Overall Study||0
10983260|NCT00600340|12157963|FG001|NOT COMPLETED|Overall Study||0
10983261|NCT00600353|12157971|FG000|STARTED|Overall Study||10
10983262|NCT00600353|12157972|FG001|STARTED|Overall Study||10
10983263|NCT00600353|12157971|FG000|COMPLETED|Overall Study||9
10983264|NCT00600353|12157972|FG001|COMPLETED|Overall Study||9
10983265|NCT00600353|12157971|FG000|NOT COMPLETED|Overall Study||1
10983266|NCT00600353|12157972|FG001|NOT COMPLETED|Overall Study||1
10983267|NCT00600613|12157978|FG000|STARTED|Overall Study||6
10983268|NCT00600613|12157978|FG000|COMPLETED|Overall Study||5
10983269|NCT00600613|12157978|FG000|NOT COMPLETED|Overall Study||1
10983270|NCT00600704|12157984|FG000|STARTED|Overall Study||100
10983271|NCT00600704|12157985|FG001|STARTED|Overall Study||92
10983272|NCT00600704|12157984|FG000|COMPLETED|Overall Study||100
10983273|NCT00600704|12157985|FG001|COMPLETED|Overall Study||92
10983274|NCT00600704|12157984|FG000|NOT COMPLETED|Overall Study||0
10983275|NCT00600704|12157985|FG001|NOT COMPLETED|Overall Study||0
10983276|NCT00600743|12157995|FG000|STARTED|Overall Study||4
10983277|NCT00600743|12157996|FG001|STARTED|Overall Study||4
10983278|NCT00600743|12157997|FG002|STARTED|Overall Study||8
10983279|NCT00600743|12157998|FG003|STARTED|Overall Study||7
10983280|NCT00600743|12157995|FG000|COMPLETED|Overall Study||4
10983281|NCT00600743|12157996|FG001|COMPLETED|Overall Study||4
10983282|NCT00600743|12157997|FG002|COMPLETED|Overall Study||8
10983283|NCT00600743|12157998|FG003|COMPLETED|Overall Study||7
10983284|NCT00600743|12157995|FG000|NOT COMPLETED|Overall Study||0
10983285|NCT00600743|12157996|FG001|NOT COMPLETED|Overall Study||0
10983286|NCT00600743|12157997|FG002|NOT COMPLETED|Overall Study||0
10983287|NCT00600743|12157998|FG003|NOT COMPLETED|Overall Study||0
10983288|NCT00600756|12158019|FG000|STARTED|Analysis After 6 Months||395
10983289|NCT00600756|12158020|FG001|STARTED|Analysis After 6 Months||403
10983290|NCT00600756|12158019|FG000|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
10983291|NCT00600756|12158020|FG001|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
10983292|NCT00600756|12158019|FG000|NOT COMPLETED|Analysis After 6 Months||131
10983293|NCT00600756|12158020|FG001|NOT COMPLETED|Analysis After 6 Months||120
10983294|NCT00600756|12158019|FG000|STARTED|Overall Study Analysis After 12 Months||395
10983295|NCT00600756|12158020|FG001|STARTED|Overall Study Analysis After 12 Months||403
10983296|NCT00600756|12158019|FG000|Randomized Analysis|Overall Study Analysis After 12 Months||395
10983297|NCT00600756|12158020|FG001|Randomized Analysis|Overall Study Analysis After 12 Months||403
10983298|NCT00600756|12158019|FG000|Safety Analysis|Overall Study Analysis After 12 Months||391
10983299|NCT00600756|12158020|FG001|Safety Analysis|Overall Study Analysis After 12 Months||402
10983300|NCT00600756|12158019|FG000|ITT Analysis|Overall Study Analysis After 12 Months||379
10983301|NCT00600756|12158020|FG001|ITT Analysis|Overall Study Analysis After 12 Months||392
10983302|NCT00600756|12158019|FG000|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
10983303|NCT00600756|12158020|FG001|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
10983304|NCT00600756|12158019|FG000|NOT COMPLETED|Overall Study Analysis After 12 Months||183
10983305|NCT00600756|12158020|FG001|NOT COMPLETED|Overall Study Analysis After 12 Months||176
10983306|NCT00600821|12158028|FG000|STARTED|Overall Study||58
10983307|NCT00600821|12158029|FG001|STARTED|Overall Study||60
10983308|NCT00600821|12158028|FG000|Treated|Overall Study||58
10983309|NCT00600821|12158029|FG001|Treated|Overall Study||59
10983310|NCT00600821|12158028|FG000|COMPLETED|Overall Study||0
10983311|NCT00600821|12158029|FG001|COMPLETED|Overall Study||0
10983312|NCT00600821|12158028|FG000|NOT COMPLETED|Overall Study||58
10983313|NCT00600821|12158029|FG001|NOT COMPLETED|Overall Study||60
10983314|NCT00600886|12158039|FG000|STARTED|Core Phase - Full Analysis Set (FAS)||176
10983315|NCT00600886|12158040|FG001|STARTED|Core Phase - Full Analysis Set (FAS)||182
10983316|NCT00600886|12158039|FG000|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
10983317|NCT00600886|12158040|FG001|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
10983318|NCT00600886|12158039|FG000|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
10983319|NCT00600886|12158040|FG001|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
10983320|NCT00600886|12158039|FG000|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
10983321|NCT00600886|12158040|FG001|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
10983322|NCT00600886|12158039|FG000|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
10983323|NCT00600886|12158040|FG001|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
10983324|NCT00600886|12158039|FG000|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
10983325|NCT00600886|12158040|FG001|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
10983326|NCT00600886|12158039|FG000|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
10983327|NCT00600886|12158040|FG001|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
10983328|NCT00600886|12158039|FG000|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
10983329|NCT00600886|12158040|FG001|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
10983330|NCT00600886|12158039|FG000|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
10983331|NCT00600886|12158040|FG001|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
10983332|NCT00600886|12158039|FG000|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
10983333|NCT00600886|12158040|FG001|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
10983334|NCT00600886|12158039|FG000|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
10983335|NCT00600886|12158040|FG001|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
10983336|NCT00600886|12158039|FG000|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
10983337|NCT00600886|12158040|FG001|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
10983338|NCT00600886|12158039|FG000|NOT COMPLETED|Extension - Same Treatment (FAS)||46
10983339|NCT00600886|12158040|FG001|NOT COMPLETED|Extension - Same Treatment (FAS)||11
10983340|NCT00600886|12158039|FG000|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
10983341|NCT00600886|12158040|FG001|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
10983342|NCT00600886|12158039|FG000|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
10983343|NCT00600886|12158040|FG001|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
10983344|NCT00600886|12158039|FG000|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
10983345|NCT00600886|12158040|FG001|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
10983346|NCT00600886|12158039|FG000|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
10983347|NCT00600886|12158040|FG001|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
10983348|NCT00600886|12158039|FG000|Discontinued After M26|Extension - After Crossover (CAS)||31
10983349|NCT00600886|12158040|FG001|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
10983350|NCT00600886|12158039|FG000|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
10983351|NCT00600886|12158040|FG001|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
10983352|NCT00600886|12158039|FG000|NOT COMPLETED|Extension - After Crossover (CAS)||62
10983353|NCT00600886|12158040|FG001|NOT COMPLETED|Extension - After Crossover (CAS)||13
10983354|NCT00600925|12158062|FG000|STARTED|Overall Study||300
10983355|NCT00600925|12158063|FG001|STARTED|Overall Study||302
10983356|NCT00600925|12158062|FG000|COMPLETED|Overall Study||300
10983357|NCT00600925|12158063|FG001|COMPLETED|Overall Study||302
10983358|NCT00600925|12158062|FG000|NOT COMPLETED|Overall Study||0
10983359|NCT00600925|12158063|FG001|NOT COMPLETED|Overall Study||0
10983360|NCT00600938|12158071|FG000|STARTED|Core Study||98
10983361|NCT00600938|12158072|FG001|STARTED|Core Study||99
10983362|NCT00600938|12158073|FG002|STARTED|Core Study||0
10983363|NCT00600938|12158074|FG003|STARTED|Core Study||0
10983364|NCT00600938|12158071|FG000|Core Safety Set|Core Study||96
10983365|NCT00600938|12158072|FG001|Core Safety Set|Core Study||91
10983366|NCT00600938|12158073|FG002|Core Safety Set|Core Study||0
10983367|NCT00600938|12158074|FG003|Core Safety Set|Core Study||0
10983368|NCT00600938|12158071|FG000|Per Protocol Set (PPS)|Core Study||91
10983369|NCT00600938|12158072|FG001|Per Protocol Set (PPS)|Core Study||81
10983370|NCT00600938|12158073|FG002|Per Protocol Set (PPS)|Core Study||0
10983371|NCT00600938|12158074|FG003|Per Protocol Set (PPS)|Core Study||0
10983372|NCT00600938|12158071|FG000|COMPLETED|Core Study||82
10983373|NCT00600938|12158072|FG001|COMPLETED|Core Study||78
10983374|NCT00600938|12158073|FG002|COMPLETED|Core Study||0
10983375|NCT00600938|12158074|FG003|COMPLETED|Core Study||0
10983376|NCT00600938|12158071|FG000|NOT COMPLETED|Core Study||16
10983377|NCT00600938|12158072|FG001|NOT COMPLETED|Core Study||21
10983378|NCT00600938|12158073|FG002|NOT COMPLETED|Core Study||0
10983379|NCT00600938|12158074|FG003|NOT COMPLETED|Core Study||0
10983380|NCT00600938|12158071|FG000|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
10983381|NCT00600938|12158072|FG001|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
10983382|NCT00600938|12158073|FG002|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
10983383|NCT00600938|12158074|FG003|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
10983384|NCT00600938|12158071|FG000|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
10983385|NCT00600938|12158072|FG001|Extension Safety Set|Extension Study||29
10983386|NCT00600938|12158073|FG002|Extension Safety Set|Extension Study||42
10983387|NCT00600938|12158074|FG003|Extension Safety Set|Extension Study||1
10983388|NCT00600938|12158071|FG000|COMPLETED|Extension Study||65
10983389|NCT00600938|12158072|FG001|COMPLETED|Extension Study||24
10983390|NCT00600938|12158073|FG002|COMPLETED|Extension Study||33
10983391|NCT00600938|12158074|FG003|COMPLETED|Extension Study||0
10983392|NCT00600938|12158071|FG000|NOT COMPLETED|Extension Study||9
10983393|NCT00600938|12158072|FG001|NOT COMPLETED|Extension Study||5
10983394|NCT00600938|12158073|FG002|NOT COMPLETED|Extension Study||9
10983395|NCT00600938|12158074|FG003|NOT COMPLETED|Extension Study||1
10983396|NCT00601107|12158103|FG000|STARTED|Overall Study|Randomized.|27
10983397|NCT00601107|12158104|FG001|STARTED|Overall Study||31
10983398|NCT00601107|12158105|FG002|STARTED|Overall Study||28
10983399|NCT00601107|12158106|FG003|STARTED|Overall Study||25
10983400|NCT00601107|12158103|FG000|Treated|Overall Study||27
10983401|NCT00601107|12158104|FG001|Treated|Overall Study||31
10983402|NCT00601107|12158105|FG002|Treated|Overall Study||28
10983403|NCT00601107|12158106|FG003|Treated|Overall Study||25
10983404|NCT00601107|12158103|FG000|COMPLETED|Overall Study||14
10983405|NCT00601107|12158104|FG001|COMPLETED|Overall Study||22
10983406|NCT00601107|12158105|FG002|COMPLETED|Overall Study||16
10983407|NCT00601107|12158106|FG003|COMPLETED|Overall Study||13
10983408|NCT00601107|12158103|FG000|NOT COMPLETED|Overall Study||13
10983409|NCT00601107|12158104|FG001|NOT COMPLETED|Overall Study||9
10983410|NCT00601107|12158105|FG002|NOT COMPLETED|Overall Study||12
10983411|NCT00601107|12158106|FG003|NOT COMPLETED|Overall Study||12
10983412|NCT00601146|12158116|FG000|STARTED|Overall Study||39
10983413|NCT00601146|12158116|FG000|COMPLETED|Overall Study||39
10983414|NCT00601146|12158116|FG000|NOT COMPLETED|Overall Study||0
10983415|NCT00601172|12158122|FG000|STARTED|Overall Study||355
10983416|NCT00601172|12158123|FG001|STARTED|Overall Study||355
10983417|NCT00601172|12158122|FG000|COMPLETED|Overall Study||214
10983418|NCT00601172|12158123|FG001|COMPLETED|Overall Study||228
10983419|NCT00601172|12158122|FG000|NOT COMPLETED|Overall Study||141
10983420|NCT00601172|12158123|FG001|NOT COMPLETED|Overall Study||127
10983421|NCT00601250|12158132|FG000|STARTED|Overall Study|number who started treatment|177
10983422|NCT00601250|12158133|FG001|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
10983423|NCT00601250|12158132|FG000|COMPLETED|Overall Study|number who completed treatment|163
10983424|NCT00601250|12158133|FG001|COMPLETED|Overall Study|number who completed treatment|484
10983425|NCT00601250|12158132|FG000|NOT COMPLETED|Overall Study||14
10983426|NCT00601250|12158133|FG001|NOT COMPLETED|Overall Study||39
10983427|NCT00601354|12158141|FG000|STARTED|Overall Study||8
10983428|NCT00601354|12158142|FG001|STARTED|Overall Study||9
10983429|NCT00601354|12158141|FG000|COMPLETED|Overall Study||4
10983430|NCT00601354|12158142|FG001|COMPLETED|Overall Study||4
10983431|NCT00601354|12158141|FG000|NOT COMPLETED|Overall Study||4
10983432|NCT00601354|12158142|FG001|NOT COMPLETED|Overall Study||5
10983433|NCT00601367|12158148|FG000|STARTED|Overall Study||480
10983434|NCT00601367|12158148|FG000|COMPLETED|Overall Study||293
10983435|NCT00601367|12158148|FG000|NOT COMPLETED|Overall Study||187
10983436|NCT00601419|12158152|FG000|STARTED|Overall Study||230
10983437|NCT00601419|12158152|FG000|COMPLETED|Overall Study||226
10983438|NCT00601419|12158152|FG000|NOT COMPLETED|Overall Study||4
10983439|NCT00601458|12158175|FG000|STARTED|Overall Study||36
10983440|NCT00601458|12158176|FG001|STARTED|Overall Study||34
10983441|NCT00601458|12158177|FG002|STARTED|Overall Study||30
10983442|NCT00601458|12158175|FG000|COMPLETED|Overall Study||32
10983443|NCT00601458|12158176|FG001|COMPLETED|Overall Study||29
10983444|NCT00601458|12158177|FG002|COMPLETED|Overall Study||28
10983445|NCT00601458|12158175|FG000|NOT COMPLETED|Overall Study||4
10983446|NCT00601458|12158176|FG001|NOT COMPLETED|Overall Study||5
10983447|NCT00601458|12158177|FG002|NOT COMPLETED|Overall Study||2
10983448|NCT00601484|12158187|FG000|STARTED|Overall Study||34
10983449|NCT00601484|12158188|FG001|STARTED|Overall Study||31
10983450|NCT00601484|12158187|FG000|Treated|Overall Study||34
10983451|NCT00601484|12158188|FG001|Treated|Overall Study||30
10983452|NCT00601484|12158187|FG000|COMPLETED|Overall Study||29
10983453|NCT00601484|12158188|FG001|COMPLETED|Overall Study||23
10983454|NCT00601484|12158187|FG000|NOT COMPLETED|Overall Study||5
10983455|NCT00601484|12158188|FG001|NOT COMPLETED|Overall Study||8
10983456|NCT00601523|12158196|FG000|STARTED|Overall Study||368
10983457|NCT00601523|12158197|FG001|STARTED|Overall Study||143
10983458|NCT00601523|12158196|FG000|COMPLETED|Overall Study||291
10983459|NCT00601523|12158197|FG001|COMPLETED|Overall Study||117
10983460|NCT00601523|12158196|FG000|NOT COMPLETED|Overall Study||77
10983461|NCT00601523|12158197|FG001|NOT COMPLETED|Overall Study||26
10983462|NCT00601627|12158203|FG000|STARTED|Overall Study||51
10983463|NCT00601627|12158203|FG000|COMPLETED|Overall Study||51
10983464|NCT00601627|12158203|FG000|NOT COMPLETED|Overall Study||0
10983465|NCT00601640|12158210|FG000|STARTED|Overall Study||52
10983466|NCT00601640|12158211|FG001|STARTED|Overall Study||52
10983467|NCT00601640|12158212|FG002|STARTED|Overall Study||52
10983468|NCT00601640|12158210|FG000|COMPLETED|Overall Study||47
10983469|NCT00601640|12158211|FG001|COMPLETED|Overall Study||47
10983470|NCT00601640|12158212|FG002|COMPLETED|Overall Study||42
10983471|NCT00601640|12158210|FG000|NOT COMPLETED|Overall Study||5
10983472|NCT00601640|12158211|FG001|NOT COMPLETED|Overall Study||5
10983473|NCT00601640|12158212|FG002|NOT COMPLETED|Overall Study||10
10983474|NCT00601705|12158222|FG000|STARTED|Overall Study||61
10983475|NCT00601705|12158222|FG000|COMPLETED|Overall Study||60
10983476|NCT00601705|12158222|FG000|NOT COMPLETED|Overall Study||1
10983477|NCT00601718|12158227|FG000|STARTED|Overall Study||29
10983478|NCT00601718|12158227|FG000|COMPLETED|Overall Study||29
10983479|NCT00601718|12158227|FG000|NOT COMPLETED|Overall Study||0
10983480|NCT00601731|12158243|FG000|STARTED|Overall Study||143
10983481|NCT00601731|12158244|FG001|STARTED|Overall Study||43
10983482|NCT00601731|12158245|FG002|STARTED|Overall Study||166
10983483|NCT00601731|12158246|FG003|STARTED|Overall Study||30
10983484|NCT00601731|12158243|FG000|COMPLETED|Overall Study||120
10983485|NCT00601731|12158244|FG001|COMPLETED|Overall Study||43
10983486|NCT00601731|12158245|FG002|COMPLETED|Overall Study||151
10983487|NCT00601731|12158246|FG003|COMPLETED|Overall Study||29
10983488|NCT00601731|12158243|FG000|NOT COMPLETED|Overall Study||23
10983489|NCT00601731|12158244|FG001|NOT COMPLETED|Overall Study||0
10983490|NCT00601731|12158245|FG002|NOT COMPLETED|Overall Study||15
10983491|NCT00601731|12158246|FG003|NOT COMPLETED|Overall Study||1
10983492|NCT00601796|12158272|FG000|STARTED|Overall Study||24
10983493|NCT00601796|12158272|FG000|COMPLETED|Overall Study||24
10983494|NCT00601796|12158272|FG000|NOT COMPLETED|Overall Study||0
10983495|NCT00601835|12158278|FG000|STARTED|Overall Study||2950
10983496|NCT00601835|12158279|FG001|STARTED|Overall Study||700
10983497|NCT00601835|12158278|FG000|COMPLETED|Overall Study||2890
10983498|NCT00601835|12158279|FG001|COMPLETED|Overall Study||686
10983499|NCT00601835|12158278|FG000|NOT COMPLETED|Overall Study||60
10983500|NCT00601835|12158279|FG001|NOT COMPLETED|Overall Study||14
10983501|NCT00601926|12158285|FG000|STARTED|Overall Study||5
10983502|NCT00601926|12158285|FG000|COMPLETED|Overall Study||5
10983503|NCT00601926|12158285|FG000|NOT COMPLETED|Overall Study||0
10983504|NCT00601952|12158291|FG000|STARTED|Overall Study||14
10983505|NCT00601952|12158292|FG001|STARTED|Overall Study||17
10983506|NCT00601952|12158291|FG000|COMPLETED|Overall Study||12
10983507|NCT00601952|12158292|FG001|COMPLETED|Overall Study||17
10983508|NCT00601952|12158291|FG000|NOT COMPLETED|Overall Study||2
10983509|NCT00601952|12158292|FG001|NOT COMPLETED|Overall Study||0
10983510|NCT00601965|12158302|FG000|STARTED|Overall Study||18
10983511|NCT00601965|12158303|FG001|STARTED|Overall Study||18
10983512|NCT00601965|12158304|FG002|STARTED|Overall Study||19
10983513|NCT00601965|12158305|FG003|STARTED|Overall Study||18
10983514|NCT00601965|12158302|FG000|COMPLETED|Overall Study||18
10983515|NCT00601965|12158303|FG001|COMPLETED|Overall Study||16
10983516|NCT00601965|12158304|FG002|COMPLETED|Overall Study||19
10983517|NCT00601965|12158305|FG003|COMPLETED|Overall Study||17
10983518|NCT00601965|12158302|FG000|NOT COMPLETED|Overall Study||0
10983519|NCT00601965|12158303|FG001|NOT COMPLETED|Overall Study||2
10983520|NCT00601965|12158304|FG002|NOT COMPLETED|Overall Study||0
10983521|NCT00601965|12158305|FG003|NOT COMPLETED|Overall Study||1
10983522|NCT00602043|12158315|FG000|STARTED|Overall Study||20
10983523|NCT00602043|12158315|FG000|COMPLETED|Overall Study||15
10983524|NCT00602043|12158315|FG000|NOT COMPLETED|Overall Study||5
10983525|NCT00602225|12158322|FG000|STARTED|Overall Study||50
10983526|NCT00602225|12158322|FG000|COMPLETED|Overall Study||50
10983527|NCT00602225|12158322|FG000|NOT COMPLETED|Overall Study||0
10983528|NCT00602290|12158330|FG000|STARTED|Overall Study||48
10983529|NCT00602290|12158331|FG001|STARTED|Overall Study||48
10983530|NCT00602290|12158332|FG002|STARTED|Overall Study||47
10983531|NCT00602290|12158330|FG000|COMPLETED|Overall Study||46
10983532|NCT00602290|12158331|FG001|COMPLETED|Overall Study||46
10983533|NCT00602290|12158332|FG002|COMPLETED|Overall Study||46
10983534|NCT00602290|12158330|FG000|NOT COMPLETED|Overall Study||2
10983535|NCT00602290|12158331|FG001|NOT COMPLETED|Overall Study||2
10983536|NCT00602290|12158332|FG002|NOT COMPLETED|Overall Study||1
10983537|NCT00602355|12158343|FG000|STARTED|Overall Study||53
10983538|NCT00602355|12158344|FG001|STARTED|Overall Study||56
10983539|NCT00602355|12158345|FG002|STARTED|Overall Study||53
10983540|NCT00602355|12158343|FG000|COMPLETED|Overall Study||44
10983541|NCT00602355|12158344|FG001|COMPLETED|Overall Study||38
10983542|NCT00602355|12158345|FG002|COMPLETED|Overall Study||43
10983543|NCT00602355|12158343|FG000|NOT COMPLETED|Overall Study||9
10983544|NCT00602355|12158344|FG001|NOT COMPLETED|Overall Study||18
10983545|NCT00602355|12158345|FG002|NOT COMPLETED|Overall Study||10
10983546|NCT00602420|12158355|FG000|STARTED|Overall Study||257
10983547|NCT00602420|12158356|FG001|STARTED|Overall Study||253
10983548|NCT00602420|12158355|FG000|COMPLETED|Overall Study||232
10983549|NCT00602420|12158356|FG001|COMPLETED|Overall Study||229
10983550|NCT00602420|12158355|FG000|NOT COMPLETED|Overall Study||25
10983551|NCT00602420|12158356|FG001|NOT COMPLETED|Overall Study||24
10983552|NCT00602446|12158362|FG000|STARTED|Overall Study||3
10983553|NCT00602446|12158362|FG000|COMPLETED|Overall Study||3
10983554|NCT00602446|12158362|FG000|NOT COMPLETED|Overall Study||0
10983555|NCT00602472|12158368|FG000|STARTED|Overall Study|3 randomised patients never took medication.|263
10983556|NCT00602472|12158369|FG001|STARTED|Overall Study|3 randomised patients never took medication.|792
10983557|NCT00602472|12158368|FG000|COMPLETED|Overall Study|number who completed treatment|242
10983558|NCT00602472|12158369|FG001|COMPLETED|Overall Study|number who completed treatment|734
10983559|NCT00602472|12158368|FG000|NOT COMPLETED|Overall Study||21
10983560|NCT00602472|12158369|FG001|NOT COMPLETED|Overall Study||58
10983561|NCT00602537|12158377|FG000|STARTED|12 Week Double Blind Comparison||65
10983562|NCT00602537|12158378|FG001|STARTED|12 Week Double Blind Comparison||64
10983563|NCT00602537|12158377|FG000|Responded|12 Week Double Blind Comparison||44
10983564|NCT00602537|12158378|FG001|Responded|12 Week Double Blind Comparison||22
10983565|NCT00602537|12158377|FG000|COMPLETED|12 Week Double Blind Comparison||42
10983566|NCT00602537|12158378|FG001|COMPLETED|12 Week Double Blind Comparison||17
10983567|NCT00602537|12158377|FG000|NOT COMPLETED|12 Week Double Blind Comparison||23
10983568|NCT00602537|12158378|FG001|NOT COMPLETED|12 Week Double Blind Comparison||47
10983569|NCT00602537|12158377|FG000|STARTED|Follow Up Study Comparison||42
10983570|NCT00602537|12158378|FG001|STARTED|Follow Up Study Comparison||17
10983571|NCT00602537|12158377|FG000|COMPLETED|Follow Up Study Comparison||31
10983572|NCT00602537|12158378|FG001|COMPLETED|Follow Up Study Comparison||14
10983573|NCT00602537|12158377|FG000|NOT COMPLETED|Follow Up Study Comparison||11
10983574|NCT00602537|12158378|FG001|NOT COMPLETED|Follow Up Study Comparison||3
10983575|NCT00602771|12158386|FG000|STARTED|Overall Study||63
10983576|NCT00602771|12158387|FG001|STARTED|Overall Study||21
10983577|NCT00602771|12158386|FG000|COMPLETED|Overall Study||62
10983578|NCT00602771|12158387|FG001|COMPLETED|Overall Study||21
10983579|NCT00602771|12158386|FG000|NOT COMPLETED|Overall Study||1
10983580|NCT00602771|12158387|FG001|NOT COMPLETED|Overall Study||0
10983581|NCT00602797|12158393|FG000|STARTED|Overall Study||20
10983582|NCT00602797|12158393|FG000|COMPLETED|Overall Study||19
10983583|NCT00602797|12158393|FG000|NOT COMPLETED|Overall Study||1
10983584|NCT00602836|12158398|FG000|STARTED|Overall Study||44
10983585|NCT00602836|12158398|FG000|COMPLETED|Overall Study||39
10983586|NCT00602836|12158398|FG000|NOT COMPLETED|Overall Study||5
10983587|NCT00602927|12158404|FG000|STARTED|Period 1: 13 Days||19
10983588|NCT00602927|12158405|FG001|STARTED|Period 1: 13 Days||19
10983589|NCT00602927|12158404|FG000|COMPLETED|Period 1: 13 Days||15
10983590|NCT00602927|12158405|FG001|COMPLETED|Period 1: 13 Days||14
10983591|NCT00602927|12158404|FG000|NOT COMPLETED|Period 1: 13 Days||4
10983592|NCT00602927|12158405|FG001|NOT COMPLETED|Period 1: 13 Days||5
10983593|NCT00602927|12158404|FG000|STARTED|Period 2: 14 Days||15
10983594|NCT00602927|12158405|FG001|STARTED|Period 2: 14 Days||14
10983595|NCT00602927|12158404|FG000|COMPLETED|Period 2: 14 Days||15
10983596|NCT00602927|12158405|FG001|COMPLETED|Period 2: 14 Days||12
10983597|NCT00602927|12158404|FG000|NOT COMPLETED|Period 2: 14 Days||0
10983598|NCT00602927|12158405|FG001|NOT COMPLETED|Period 2: 14 Days||2
10983599|NCT00602927|12158404|FG000|STARTED|Period 3: 13 Days||15
10983600|NCT00602927|12158405|FG001|STARTED|Period 3: 13 Days||12
10983601|NCT00602927|12158404|FG000|COMPLETED|Period 3: 13 Days||13
10983602|NCT00602927|12158405|FG001|COMPLETED|Period 3: 13 Days||9
10983603|NCT00602927|12158404|FG000|NOT COMPLETED|Period 3: 13 Days||2
10983604|NCT00602927|12158405|FG001|NOT COMPLETED|Period 3: 13 Days||3
10983605|NCT00602953|12158416|FG000|STARTED|Overall Study||15
10983606|NCT00602953|12158417|FG001|STARTED|Overall Study||26
10983607|NCT00602953|12158418|FG002|STARTED|Overall Study||47
10983608|NCT00602953|12158419|FG003|STARTED|Overall Study||13
10983609|NCT00602953|12158420|FG004|STARTED|Overall Study||0
10983610|NCT00602953|12158416|FG000|COMPLETED|Overall Study||15
10983611|NCT00602953|12158417|FG001|COMPLETED|Overall Study||26
10983612|NCT00602953|12158418|FG002|COMPLETED|Overall Study||47
10983613|NCT00602953|12158419|FG003|COMPLETED|Overall Study||13
10983614|NCT00602953|12158420|FG004|COMPLETED|Overall Study||0
10983615|NCT00602953|12158416|FG000|NOT COMPLETED|Overall Study||0
10983616|NCT00602953|12158417|FG001|NOT COMPLETED|Overall Study||0
10983617|NCT00602953|12158418|FG002|NOT COMPLETED|Overall Study||0
10983618|NCT00602953|12158419|FG003|NOT COMPLETED|Overall Study||0
10983619|NCT00602953|12158420|FG004|NOT COMPLETED|Overall Study||0
10983620|NCT00602979|12158437|FG000|STARTED|Overall Study||48
10983621|NCT00602979|12158438|FG001|STARTED|Overall Study||48
10983622|NCT00602979|12158439|FG002|STARTED|Overall Study||48
10983623|NCT00602979|12158440|FG003|STARTED|Overall Study||48
10983624|NCT00602979|12158441|FG004|STARTED|Overall Study||48
10983625|NCT00602979|12158437|FG000|COMPLETED|Overall Study||45
10983626|NCT00602979|12158438|FG001|COMPLETED|Overall Study||45
10983627|NCT00602979|12158439|FG002|COMPLETED|Overall Study||45
10983628|NCT00602979|12158440|FG003|COMPLETED|Overall Study||45
10983629|NCT00602979|12158441|FG004|COMPLETED|Overall Study||45
10983630|NCT00602979|12158437|FG000|NOT COMPLETED|Overall Study||3
10983631|NCT00602979|12158438|FG001|NOT COMPLETED|Overall Study||3
10983632|NCT00602979|12158439|FG002|NOT COMPLETED|Overall Study||3
10983633|NCT00602979|12158440|FG003|NOT COMPLETED|Overall Study||3
10983634|NCT00602979|12158441|FG004|NOT COMPLETED|Overall Study||3
10983635|NCT00603018|12158453|FG000|STARTED|Overall Study||23
10983636|NCT00603018|12158453|FG000|COMPLETED|Overall Study||23
10983637|NCT00603018|12158453|FG000|NOT COMPLETED|Overall Study||0
10983638|NCT00603044|12158460|FG000|STARTED|Overall Study||11
10983639|NCT00603044|12158461|FG001|STARTED|Overall Study||13
10983640|NCT00603044|12158460|FG000|COMPLETED|Overall Study||11
10983641|NCT00603044|12158461|FG001|COMPLETED|Overall Study||13
10983642|NCT00603044|12158460|FG000|NOT COMPLETED|Overall Study||0
10983643|NCT00603044|12158461|FG001|NOT COMPLETED|Overall Study||0
10983644|NCT00603187|12158467|FG000|STARTED|Overall Study||4
10983645|NCT00603187|12158467|FG000|COMPLETED|Overall Study||4
10983646|NCT00603187|12158467|FG000|NOT COMPLETED|Overall Study||0
10983647|NCT00603239|12158473|FG000|STARTED|Overall Study||111
10983648|NCT00603239|12158474|FG001|STARTED|Overall Study||54
10983649|NCT00603239|12158473|FG000|COMPLETED|Overall Study||96
10983650|NCT00603239|12158474|FG001|COMPLETED|Overall Study||50
10983651|NCT00603239|12158473|FG000|NOT COMPLETED|Overall Study||15
10983652|NCT00603239|12158474|FG001|NOT COMPLETED|Overall Study||4
10983653|NCT00603265|12158483|FG000|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
10983654|NCT00603265|12158484|FG001|STARTED|Overall Study||78
10983655|NCT00603265|12158485|FG002|STARTED|Overall Study||72
10983656|NCT00603265|12158483|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75
10983657|NCT00603265|12158484|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78
10983658|NCT00603265|12158485|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72
10983659|NCT00603265|12158483|FG000|COMPLETED|Overall Study||69
10983660|NCT00603265|12158484|FG001|COMPLETED|Overall Study||62
10983661|NCT00603265|12158485|FG002|COMPLETED|Overall Study||67
10983662|NCT00603265|12158483|FG000|NOT COMPLETED|Overall Study||7
10983663|NCT00603265|12158484|FG001|NOT COMPLETED|Overall Study||16
10983664|NCT00603265|12158485|FG002|NOT COMPLETED|Overall Study||5
10983665|NCT00603278|12158499|FG000|STARTED|Overall Study||107
10983666|NCT00603278|12158500|FG001|STARTED|Overall Study||105
10983667|NCT00603278|12158501|FG002|STARTED|Overall Study||101
10983668|NCT00603278|12158502|FG003|STARTED|Overall Study||103
10983669|NCT00603278|12158503|FG004|STARTED|Overall Study||99
10983670|NCT00603278|12158504|FG005|STARTED|Overall Study||100
10983671|NCT00603278|12158499|FG000|COMPLETED|Overall Study||66
10983672|NCT00603278|12158500|FG001|COMPLETED|Overall Study||88
10983673|NCT00603278|12158501|FG002|COMPLETED|Overall Study||87
10983674|NCT00603278|12158502|FG003|COMPLETED|Overall Study||92
10983675|NCT00603278|12158503|FG004|COMPLETED|Overall Study||86
10983676|NCT00603278|12158504|FG005|COMPLETED|Overall Study||81
10983677|NCT00603278|12158499|FG000|NOT COMPLETED|Overall Study||41
10983678|NCT00603278|12158500|FG001|NOT COMPLETED|Overall Study||17
10983679|NCT00603278|12158501|FG002|NOT COMPLETED|Overall Study||14
10983680|NCT00603278|12158502|FG003|NOT COMPLETED|Overall Study||11
10983681|NCT00603278|12158503|FG004|NOT COMPLETED|Overall Study||13
10983682|NCT00603278|12158504|FG005|NOT COMPLETED|Overall Study||19
10983683|NCT00603291|12158521|FG000|STARTED|Overall Study||95
10983684|NCT00603291|12158522|FG001|STARTED|Overall Study||256
10983685|NCT00603291|12158523|FG002|STARTED|Overall Study||253
10983686|NCT00603291|12158521|FG000|COMPLETED|Overall Study||75
10983687|NCT00603291|12158522|FG001|COMPLETED|Overall Study||169
10983688|NCT00603291|12158523|FG002|COMPLETED|Overall Study||157
10983689|NCT00603291|12158521|FG000|NOT COMPLETED|Overall Study||20
10983690|NCT00603291|12158522|FG001|NOT COMPLETED|Overall Study||87
10983691|NCT00603291|12158523|FG002|NOT COMPLETED|Overall Study||96
10983692|NCT00603304|12158533|FG000|STARTED|Overall Study||183
10983693|NCT00603304|12158534|FG001|STARTED|Overall Study||186
10983694|NCT00603304|12158533|FG000|COMPLETED|Overall Study||151
10983695|NCT00603304|12158534|FG001|COMPLETED|Overall Study||155
10983696|NCT00603304|12158533|FG000|NOT COMPLETED|Overall Study||32
10983697|NCT00603304|12158534|FG001|NOT COMPLETED|Overall Study||31
10983698|NCT00603382|12158548|FG000|STARTED|Overall Study||94
10983699|NCT00603382|12158549|FG001|STARTED|Overall Study||97
10983700|NCT00603382|12158550|FG002|STARTED|Overall Study||100
10983701|NCT00603382|12158551|FG003|STARTED|Overall Study||110
10983702|NCT00603382|12158552|FG004|STARTED|Overall Study||95
10983703|NCT00603382|12158553|FG005|STARTED|Overall Study||102
10983704|NCT00603382|12158548|FG000|COMPLETED|Overall Study||76
10983705|NCT00603382|12158549|FG001|COMPLETED|Overall Study||83
10983706|NCT00603382|12158550|FG002|COMPLETED|Overall Study||91
10983707|NCT00603382|12158551|FG003|COMPLETED|Overall Study||98
10983708|NCT00603382|12158552|FG004|COMPLETED|Overall Study||86
10983709|NCT00603382|12158553|FG005|COMPLETED|Overall Study||84
10983710|NCT00603382|12158548|FG000|NOT COMPLETED|Overall Study||18
10983711|NCT00603382|12158549|FG001|NOT COMPLETED|Overall Study||14
10983712|NCT00603382|12158550|FG002|NOT COMPLETED|Overall Study||9
10983713|NCT00603382|12158551|FG003|NOT COMPLETED|Overall Study||12
10983714|NCT00603382|12158552|FG004|NOT COMPLETED|Overall Study||9
10983715|NCT00603382|12158553|FG005|NOT COMPLETED|Overall Study||18
10983716|NCT00603408|12158567|FG000|STARTED|Overall Study||5
10983717|NCT00603408|12158567|FG000|COMPLETED|Overall Study||5
10983718|NCT00603408|12158567|FG000|NOT COMPLETED|Overall Study||0
10983719|NCT00603447|12158579|FG000|STARTED|Overall Study||6
10983720|NCT00603447|12158580|FG001|STARTED|Overall Study||6
10983721|NCT00603447|12158581|FG002|STARTED|Overall Study||8
10983722|NCT00603447|12158582|FG003|STARTED|Overall Study||6
10983723|NCT00603447|12158583|FG004|STARTED|Overall Study||6
10983724|NCT00603447|12158584|FG005|STARTED|Overall Study||8
10983725|NCT00603447|12158585|FG006|STARTED|Overall Study||44
10983726|NCT00603447|12158579|FG000|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
10983727|NCT00603447|12158580|FG001|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
10983728|NCT00603447|12158581|FG002|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
10983729|NCT00603447|12158582|FG003|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
10983730|NCT00603447|12158583|FG004|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
10983731|NCT00603447|12158584|FG005|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
10983732|NCT00603447|12158585|FG006|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
10983733|NCT00603447|12158579|FG000|NOT COMPLETED|Overall Study||0
10983734|NCT00603447|12158580|FG001|NOT COMPLETED|Overall Study||3
10983735|NCT00603447|12158581|FG002|NOT COMPLETED|Overall Study||2
10983736|NCT00603447|12158582|FG003|NOT COMPLETED|Overall Study||2
10983737|NCT00603447|12158583|FG004|NOT COMPLETED|Overall Study||5
10983738|NCT00603447|12158584|FG005|NOT COMPLETED|Overall Study||2
10983739|NCT00603447|12158585|FG006|NOT COMPLETED|Overall Study||24
10983740|NCT00603473|12158601|FG000|STARTED|Overall Study||89
10983741|NCT00603473|12158601|FG000|COMPLETED|Overall Study||80
10983742|NCT00603473|12158601|FG000|NOT COMPLETED|Overall Study||9
10983743|NCT00603512|12158610|FG000|STARTED|Overall Study||28
10983744|NCT00603512|12158611|FG001|STARTED|Overall Study||28
10983745|NCT00603512|12158612|FG002|STARTED|Overall Study||28
10983746|NCT00603512|12158613|FG003|STARTED|Overall Study||28
10983747|NCT00603512|12158614|FG004|STARTED|Overall Study||28
10983748|NCT00603512|12158610|FG000|Treated|Overall Study||28
10983749|NCT00603512|12158611|FG001|Treated|Overall Study||27
10983750|NCT00603512|12158612|FG002|Treated|Overall Study||27
10983751|NCT00603512|12158613|FG003|Treated|Overall Study||26
10983752|NCT00603512|12158614|FG004|Treated|Overall Study||28
10983753|NCT00603512|12158610|FG000|COMPLETED|Overall Study||26
10983754|NCT00603512|12158611|FG001|COMPLETED|Overall Study||23
10983755|NCT00603512|12158612|FG002|COMPLETED|Overall Study||23
10983756|NCT00603512|12158613|FG003|COMPLETED|Overall Study||21
10983757|NCT00603512|12158614|FG004|COMPLETED|Overall Study||23
10983758|NCT00603512|12158610|FG000|NOT COMPLETED|Overall Study||2
10983759|NCT00603512|12158611|FG001|NOT COMPLETED|Overall Study||5
10983760|NCT00603512|12158612|FG002|NOT COMPLETED|Overall Study||5
10983761|NCT00603512|12158613|FG003|NOT COMPLETED|Overall Study||7
10983762|NCT00603512|12158614|FG004|NOT COMPLETED|Overall Study||5
10983763|NCT00603525|12158628|FG000|STARTED|DB Treatment Period (24 Weeks)||84
10983764|NCT00603525|12158629|FG001|STARTED|DB Treatment Period (24 Weeks)||85
10983765|NCT00603525|12158630|FG002|STARTED|DB Treatment Period (24 Weeks)||0
10983766|NCT00603525|12158628|FG000|COMPLETED|DB Treatment Period (24 Weeks)||67
10983767|NCT00603525|12158629|FG001|COMPLETED|DB Treatment Period (24 Weeks)||63
10983768|NCT00603525|12158630|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0
10983769|NCT00603525|12158628|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
10983770|NCT00603525|12158629|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
10983771|NCT00603525|12158630|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
10983772|NCT00603525|12158628|FG000|STARTED|OL Treatment Period (120 Weeks)||0
10983773|NCT00603525|12158629|FG001|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
10983774|NCT00603525|12158630|FG002|STARTED|OL Treatment Period (120 Weeks)||0
10983775|NCT00603525|12158628|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0
10983776|NCT00603525|12158629|FG001|COMPLETED|OL Treatment Period (120 Weeks)||13
10983777|NCT00603525|12158630|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0
10983778|NCT00603525|12158628|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
10983779|NCT00603525|12158629|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
10983780|NCT00603525|12158630|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
10983781|NCT00603525|12158628|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0
10983782|NCT00603525|12158629|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0
10983783|NCT00603525|12158630|FG002|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
10983784|NCT00603525|12158628|FG000|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
10983785|NCT00603525|12158629|FG001|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
10983786|NCT00603525|12158630|FG002|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
10983787|NCT00603525|12158628|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0
10983788|NCT00603525|12158629|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0
10983789|NCT00603525|12158630|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||13
10983790|NCT00603525|12158628|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
10983791|NCT00603525|12158629|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
10983792|NCT00603525|12158630|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
10983793|NCT00603538|12158644|FG000|STARTED|Overall Study||6
10983794|NCT00603538|12158645|FG001|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
10983795|NCT00603538|12158646|FG002|STARTED|Overall Study||6
10983796|NCT00603538|12158644|FG000|COMPLETED|Overall Study||3
10983797|NCT00603538|12158645|FG001|COMPLETED|Overall Study||3
10983798|NCT00603538|12158646|FG002|COMPLETED|Overall Study||4
10983799|NCT00603538|12158644|FG000|NOT COMPLETED|Overall Study||3
10983800|NCT00603538|12158645|FG001|NOT COMPLETED|Overall Study||4
10983801|NCT00603538|12158646|FG002|NOT COMPLETED|Overall Study||2
10983802|NCT00603564|12158659|FG000|STARTED|Overall Study|January 2006|20
10983803|NCT00603564|12158660|FG001|STARTED|Overall Study|January 2006|27
10983804|NCT00603564|12158659|FG000|COMPLETED|Overall Study|February 2008|20
10983805|NCT00603564|12158660|FG001|COMPLETED|Overall Study|February 2008|27
10983806|NCT00603564|12158659|FG000|NOT COMPLETED|Overall Study||0
10983807|NCT00603564|12158660|FG001|NOT COMPLETED|Overall Study||0
10983808|NCT00603590|12158668|FG000|STARTED|Overall Study||241
10983809|NCT00603590|12158669|FG001|STARTED|Overall Study||234
10983810|NCT00603590|12158668|FG000|One Month|Overall Study||204
10983811|NCT00603590|12158669|FG001|One Month|Overall Study||212
10983812|NCT00603590|12158668|FG000|Four Months|Overall Study||187
10983813|NCT00603590|12158669|FG001|Four Months|Overall Study||200
10983814|NCT00603590|12158668|FG000|Eight Months|Overall Study||178
10983815|NCT00603590|12158669|FG001|Eight Months|Overall Study||194
10983816|NCT00603590|12158668|FG000|COMPLETED|Overall Study||165
10983817|NCT00603590|12158669|FG001|COMPLETED|Overall Study||183
10983818|NCT00603590|12158668|FG000|NOT COMPLETED|Overall Study||76
10983819|NCT00603590|12158669|FG001|NOT COMPLETED|Overall Study||51
10983820|NCT00603642|12158677|FG000|STARTED|Overall Study||12
10983821|NCT00603642|12158678|FG001|STARTED|Overall Study||22
10983822|NCT00603642|12158677|FG000|COMPLETED|Overall Study||12
10983823|NCT00603642|12158678|FG001|COMPLETED|Overall Study||22
10983824|NCT00603642|12158677|FG000|NOT COMPLETED|Overall Study||0
10983825|NCT00603642|12158678|FG001|NOT COMPLETED|Overall Study||0
10983826|NCT00603720|12158689|FG000|STARTED|Overall Study||10
10983827|NCT00603720|12158690|FG001|STARTED|Overall Study||10
10983828|NCT00603720|12158691|FG002|STARTED|Overall Study||12
10983829|NCT00603720|12158692|FG003|STARTED|Overall Study||10
10983830|NCT00603720|12158693|FG004|STARTED|Overall Study||12
10983831|NCT00603720|12158689|FG000|COMPLETED|Overall Study||10
10983832|NCT00603720|12158690|FG001|COMPLETED|Overall Study||10
10983833|NCT00603720|12158691|FG002|COMPLETED|Overall Study||12
10983834|NCT00603720|12158692|FG003|COMPLETED|Overall Study||10
10983835|NCT00603720|12158693|FG004|COMPLETED|Overall Study||12
10983836|NCT00603720|12158689|FG000|NOT COMPLETED|Overall Study||0
10983837|NCT00603720|12158690|FG001|NOT COMPLETED|Overall Study||0
10983838|NCT00603720|12158691|FG002|NOT COMPLETED|Overall Study||0
10983839|NCT00603720|12158692|FG003|NOT COMPLETED|Overall Study||0
10983840|NCT00603720|12158693|FG004|NOT COMPLETED|Overall Study||0
10983841|NCT00603733|12158707|FG000|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
10983842|NCT00603733|12158708|FG001|STARTED|Active Phase ITT||95
10983843|NCT00603733|12158707|FG000|COMPLETED|Active Phase ITT||84
10983844|NCT00603733|12158708|FG001|COMPLETED|Active Phase ITT||78
10983845|NCT00603733|12158707|FG000|NOT COMPLETED|Active Phase ITT||11
10983846|NCT00603733|12158708|FG001|NOT COMPLETED|Active Phase ITT||17
10983847|NCT00603733|12158707|FG000|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
10983848|NCT00603733|12158708|FG001|STARTED|Run-In Phase - 4 Weeks||49
10983849|NCT00603733|12158707|FG000|COMPLETED|Run-In Phase - 4 Weeks||35
10983850|NCT00603733|12158708|FG001|COMPLETED|Run-In Phase - 4 Weeks||36
10983851|NCT00603733|12158707|FG000|NOT COMPLETED|Run-In Phase - 4 Weeks||14
10983852|NCT00603733|12158708|FG001|NOT COMPLETED|Run-In Phase - 4 Weeks||13
10983853|NCT00603733|12158707|FG000|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
10983854|NCT00603733|12158708|FG001|STARTED|Maintenance Phase ITT||82
10983855|NCT00603733|12158707|FG000|COMPLETED|Maintenance Phase ITT||61
10983856|NCT00603733|12158708|FG001|COMPLETED|Maintenance Phase ITT||66
10983857|NCT00603733|12158707|FG000|NOT COMPLETED|Maintenance Phase ITT||10
10983858|NCT00603733|12158708|FG001|NOT COMPLETED|Maintenance Phase ITT||16
10983859|NCT00603746|12158720|FG000|STARTED|Overall Study||103
10983860|NCT00603746|12158721|FG001|STARTED|Overall Study||99
10983861|NCT00603746|12158722|FG002|STARTED|Overall Study||101
10983862|NCT00603746|12158723|FG003|STARTED|Overall Study||107
10983863|NCT00603746|12158724|FG004|STARTED|Overall Study||102
10983864|NCT00603746|12158725|FG005|STARTED|Overall Study||110
10983865|NCT00603746|12158720|FG000|COMPLETED|Overall Study||65
10983866|NCT00603746|12158721|FG001|COMPLETED|Overall Study||81
10983867|NCT00603746|12158722|FG002|COMPLETED|Overall Study||93
10983868|NCT00603746|12158723|FG003|COMPLETED|Overall Study||94
10983869|NCT00603746|12158724|FG004|COMPLETED|Overall Study||85
10983870|NCT00603746|12158725|FG005|COMPLETED|Overall Study||97
10983871|NCT00603746|12158720|FG000|NOT COMPLETED|Overall Study||38
10983872|NCT00603746|12158721|FG001|NOT COMPLETED|Overall Study||18
10983873|NCT00603746|12158722|FG002|NOT COMPLETED|Overall Study||8
10983874|NCT00603746|12158723|FG003|NOT COMPLETED|Overall Study||13
10983875|NCT00603746|12158724|FG004|NOT COMPLETED|Overall Study||17
10983876|NCT00603746|12158725|FG005|NOT COMPLETED|Overall Study||13
10983877|NCT00603798|12158742|FG000|STARTED|Overall Study||162
10983878|NCT00603798|12158743|FG001|STARTED|Overall Study||164
10983879|NCT00603798|12158744|FG002|STARTED|Overall Study||164
10983880|NCT00603798|12158742|FG000|COMPLETED|Overall Study||152
10983881|NCT00603798|12158743|FG001|COMPLETED|Overall Study||157
10983882|NCT00603798|12158744|FG002|COMPLETED|Overall Study||154
10983883|NCT00603798|12158742|FG000|NOT COMPLETED|Overall Study||10
10983884|NCT00603798|12158743|FG001|NOT COMPLETED|Overall Study||7
10983885|NCT00603798|12158744|FG002|NOT COMPLETED|Overall Study||10
10983886|NCT00603837|12158754|FG000|STARTED|Overall Study||20
10983887|NCT00603837|12158755|FG001|STARTED|Overall Study||19
10983888|NCT00603837|12158754|FG000|COMPLETED|Overall Study||17
10983889|NCT00603837|12158755|FG001|COMPLETED|Overall Study||19
10983890|NCT00603837|12158754|FG000|NOT COMPLETED|Overall Study||3
10983891|NCT00603837|12158755|FG001|NOT COMPLETED|Overall Study||0
10983892|NCT00603889|12158761|FG000|STARTED|Overall Study||12
10983893|NCT00603889|12158761|FG000|COMPLETED|Overall Study||12
10983894|NCT00603889|12158761|FG000|NOT COMPLETED|Overall Study||0
10983895|NCT00603902|12158768|FG000|STARTED|Overall Study||802
10983896|NCT00603902|12158769|FG001|STARTED|Overall Study||1603
10983897|NCT00603902|12158770|FG002|STARTED|Overall Study||1603
10983898|NCT00603902|12158768|FG000|COMPLETED|Overall Study||473
10983899|NCT00603902|12158769|FG001|COMPLETED|Overall Study||917
10983900|NCT00603902|12158770|FG002|COMPLETED|Overall Study||834
10983901|NCT00603902|12158768|FG000|NOT COMPLETED|Overall Study||329
10983902|NCT00603902|12158769|FG001|NOT COMPLETED|Overall Study||686
10983903|NCT00603902|12158770|FG002|NOT COMPLETED|Overall Study||769
10983904|NCT00603915|12158778|FG000|STARTED|Overall Study||20
10983905|NCT00603915|12158778|FG000|COMPLETED|Overall Study||19
10983906|NCT00603915|12158778|FG000|NOT COMPLETED|Overall Study||1
10983907|NCT00603941|12158785|FG000|STARTED|Overall Study||7
10983908|NCT00603941|12158786|FG001|STARTED|Overall Study||10
10983909|NCT00603941|12158787|FG002|STARTED|Overall Study||2
10983910|NCT00603941|12158785|FG000|COMPLETED|Overall Study||0
10983911|NCT00603941|12158786|FG001|COMPLETED|Overall Study||0
10983912|NCT00603941|12158787|FG002|COMPLETED|Overall Study||0
10983913|NCT00603941|12158785|FG000|NOT COMPLETED|Overall Study||7
10983914|NCT00603941|12158786|FG001|NOT COMPLETED|Overall Study||10
10983915|NCT00603941|12158787|FG002|NOT COMPLETED|Overall Study||2
10983916|NCT00603980|12158796|FG000|STARTED|Study Qualification||31
10983917|NCT00603980|12158796|FG000|COMPLETED|Study Qualification||15
10983918|NCT00603980|12158796|FG000|NOT COMPLETED|Study Qualification||16
10983919|NCT00603980|12158796|FG000|STARTED|Main Study||15
10983920|NCT00603980|12158796|FG000|COMPLETED|Main Study||14
10983921|NCT00603980|12158796|FG000|NOT COMPLETED|Main Study||1
10983922|NCT00603993|12158816|FG000|STARTED|Overall Study||88
10983923|NCT00603993|12158816|FG000|COMPLETED|Overall Study||68
10983924|NCT00603993|12158816|FG000|NOT COMPLETED|Overall Study||20
10983925|NCT00604019|12158822|FG000|STARTED|Overall Study||134
10983926|NCT00604019|12158823|FG001|STARTED|Overall Study||118
10983927|NCT00604019|12158822|FG000|COMPLETED|Overall Study||134
10983928|NCT00604019|12158823|FG001|COMPLETED|Overall Study||118
10983929|NCT00604019|12158822|FG000|NOT COMPLETED|Overall Study||0
10983930|NCT00604019|12158823|FG001|NOT COMPLETED|Overall Study||0
10983931|NCT00604045|12158831|FG000|STARTED|Overall Study||15
10983932|NCT00604045|12158832|FG001|STARTED|Overall Study||10
10983933|NCT00604045|12158831|FG000|COMPLETED|Overall Study||14
10983934|NCT00604045|12158832|FG001|COMPLETED|Overall Study||9
10983935|NCT00604045|12158831|FG000|NOT COMPLETED|Overall Study||1
10983936|NCT00604045|12158832|FG001|NOT COMPLETED|Overall Study||1
10983937|NCT00604162|12158838|FG000|STARTED|Overall Study||332
10983938|NCT00604162|12158838|FG000|COMPLETED|Overall Study||328
10983939|NCT00604162|12158838|FG000|NOT COMPLETED|Overall Study||4
10983940|NCT00604175|12158848|FG000|STARTED|Entry Through Week 28||130
10983941|NCT00604175|12158849|FG001|STARTED|Entry Through Week 28||95
10983942|NCT00604175|12158850|FG002|STARTED|Entry Through Week 28||94
10983943|NCT00604175|12158848|FG000|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
10983944|NCT00604175|12158849|FG001|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
10983945|NCT00604175|12158850|FG002|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
10983946|NCT00604175|12158848|FG000|NOT COMPLETED|Entry Through Week 28||10
10983947|NCT00604175|12158849|FG001|NOT COMPLETED|Entry Through Week 28||3
10983948|NCT00604175|12158850|FG002|NOT COMPLETED|Entry Through Week 28||1
10983949|NCT00604175|12158848|FG000|STARTED|Week 29 Through Week 72||120
10983950|NCT00604175|12158849|FG001|STARTED|Week 29 Through Week 72||92
10983951|NCT00604175|12158850|FG002|STARTED|Week 29 Through Week 72||93
10983952|NCT00604175|12158848|FG000|COMPLETED|Week 29 Through Week 72||108
10983953|NCT00604175|12158849|FG001|COMPLETED|Week 29 Through Week 72||85
10983954|NCT00604175|12158850|FG002|COMPLETED|Week 29 Through Week 72||89
10983955|NCT00604175|12158848|FG000|NOT COMPLETED|Week 29 Through Week 72||12
10983956|NCT00604175|12158849|FG001|NOT COMPLETED|Week 29 Through Week 72||7
10983957|NCT00604175|12158850|FG002|NOT COMPLETED|Week 29 Through Week 72||4
10983958|NCT00604188|12158884|FG000|STARTED|Overall Study||93
10983959|NCT00604188|12158885|FG001|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
10983960|NCT00604188|12158884|FG000|COMPLETED|Overall Study||66
10983961|NCT00604188|12158885|FG001|COMPLETED|Overall Study||70
10983962|NCT00604188|12158884|FG000|NOT COMPLETED|Overall Study||27
10983963|NCT00604188|12158885|FG001|NOT COMPLETED|Overall Study||25
10983964|NCT00604214|12158893|FG000|STARTED|Baseline to Day 28||851
10983965|NCT00604214|12158894|FG001|STARTED|Baseline to Day 28||845
10983966|NCT00604214|12158893|FG000|Received Study Drug|Baseline to Day 28||833
10983967|NCT00604214|12158894|FG001|Received Study Drug|Baseline to Day 28||833
10983968|NCT00604214|12158893|FG000|COMPLETED|Baseline to Day 28||623
10983969|NCT00604214|12158894|FG001|COMPLETED|Baseline to Day 28||632
10983970|NCT00604214|12158893|FG000|NOT COMPLETED|Baseline to Day 28||228
10983971|NCT00604214|12158894|FG001|NOT COMPLETED|Baseline to Day 28||213
10983972|NCT00604214|12158893|FG000|STARTED|Day 29 to Day 90||623
10983973|NCT00604214|12158894|FG001|STARTED|Day 29 to Day 90||632
10983974|NCT00604214|12158893|FG000|COMPLETED|Day 29 to Day 90||555
10983975|NCT00604214|12158894|FG001|COMPLETED|Day 29 to Day 90||553
10983976|NCT00604214|12158893|FG000|NOT COMPLETED|Day 29 to Day 90||68
10983977|NCT00604214|12158894|FG001|NOT COMPLETED|Day 29 to Day 90||79
10983978|NCT00604214|12158893|FG000|STARTED|Day 91 to Day 180||555
10983979|NCT00604214|12158894|FG001|STARTED|Day 91 to Day 180||553
10983980|NCT00604214|12158893|FG000|COMPLETED|Day 91 to Day 180||529
10983981|NCT00604214|12158894|FG001|COMPLETED|Day 91 to Day 180||521
10983982|NCT00604214|12158893|FG000|NOT COMPLETED|Day 91 to Day 180||26
10983983|NCT00604214|12158894|FG001|NOT COMPLETED|Day 91 to Day 180||32
10983984|NCT00604279|12158902|FG000|STARTED|Overall Study||229
10983985|NCT00604279|12158903|FG001|STARTED|Overall Study||223
10983986|NCT00604279|12158902|FG000|COMPLETED|Overall Study||165
10983987|NCT00604279|12158903|FG001|COMPLETED|Overall Study||185
10983988|NCT00604279|12158902|FG000|NOT COMPLETED|Overall Study||64
10983989|NCT00604279|12158903|FG001|NOT COMPLETED|Overall Study||38
10983990|NCT00604383|12158911|FG000|STARTED|Overall Study||345
10983991|NCT00604383|12158912|FG001|STARTED|Overall Study||340
10983992|NCT00604383|12158911|FG000|Received at Least 1 Dose of Study Drug|Overall Study||345
10983993|NCT00604383|12158912|FG001|Received at Least 1 Dose of Study Drug|Overall Study||340
10983994|NCT00604383|12158911|FG000|Received Extended Treatment|Overall Study||136
10983995|NCT00604383|12158912|FG001|Received Extended Treatment|Overall Study||141
10983996|NCT00604383|12158911|FG000|COMPLETED|Overall Study||258
10983997|NCT00604383|12158912|FG001|COMPLETED|Overall Study||256
10983998|NCT00604383|12158911|FG000|NOT COMPLETED|Overall Study||87
10983999|NCT00604383|12158912|FG001|NOT COMPLETED|Overall Study||84
10984000|NCT00604461|12158918|FG000|STARTED|Overall Study||13
10984001|NCT00604461|12158918|FG000|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
10984002|NCT00604461|12158918|FG000|NOT COMPLETED|Overall Study||1
10984003|NCT00604552|12158924|FG000|STARTED|Overall Study||189
10984004|NCT00604552|12158925|FG001|STARTED|Overall Study||160
10984005|NCT00604552|12158924|FG000|COMPLETED|Overall Study||189
10984006|NCT00604552|12158925|FG001|COMPLETED|Overall Study||160
10984007|NCT00604552|12158924|FG000|NOT COMPLETED|Overall Study||0
10984008|NCT00604552|12158925|FG001|NOT COMPLETED|Overall Study||0
10984009|NCT00604565|12158935|FG000|STARTED|Overall Study||4
10984010|NCT00604565|12158936|FG001|STARTED|Overall Study||7
10984011|NCT00604565|12158935|FG000|COMPLETED|Overall Study||4
10984012|NCT00604565|12158936|FG001|COMPLETED|Overall Study||4
10984013|NCT00604565|12158935|FG000|NOT COMPLETED|Overall Study||0
10984014|NCT00604565|12158936|FG001|NOT COMPLETED|Overall Study||3
10984015|NCT00604669|12158942|FG000|STARTED|Overall Study||170
10984016|NCT00604669|12158942|FG000|COMPLETED|Overall Study||163
10984017|NCT00604669|12158942|FG000|NOT COMPLETED|Overall Study||7
10984018|NCT00604695|12158948|FG000|STARTED|Overall Study||20
10984019|NCT00604695|12158949|FG001|STARTED|Overall Study||20
10984020|NCT00604695|12158948|FG000|COMPLETED|Overall Study||20
10984021|NCT00604695|12158949|FG001|COMPLETED|Overall Study||16
10984022|NCT00604695|12158948|FG000|NOT COMPLETED|Overall Study||0
10984023|NCT00604695|12158949|FG001|NOT COMPLETED|Overall Study||4
10984024|NCT00604708|12158957|FG000|STARTED|Overall Study||430
10984025|NCT00604708|12158958|FG001|STARTED|Overall Study||437
10984026|NCT00604708|12158957|FG000|COMPLETED|Overall Study||399
10984027|NCT00604708|12158958|FG001|COMPLETED|Overall Study||397
10984028|NCT00604708|12158957|FG000|NOT COMPLETED|Overall Study||31
10984029|NCT00604708|12158958|FG001|NOT COMPLETED|Overall Study||40
10984030|NCT00604721|12158964|FG000|STARTED|Overall Study||19
10984031|NCT00604721|12158964|FG000|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
10984032|NCT00604721|12158964|FG000|NOT COMPLETED|Overall Study||2
10984033|NCT00604786|12158971|FG000|STARTED|Overall Study||14
10984034|NCT00604786|12158972|FG001|STARTED|Overall Study||4
10984035|NCT00604786|12158971|FG000|COMPLETED|Overall Study||12
10984036|NCT00604786|12158972|FG001|COMPLETED|Overall Study||4
10984037|NCT00604786|12158971|FG000|NOT COMPLETED|Overall Study||2
10984038|NCT00604786|12158972|FG001|NOT COMPLETED|Overall Study||0
10984039|NCT00604825|12158982|FG000|STARTED|Overall Study||90
10984040|NCT00604825|12158983|FG001|STARTED|Overall Study||87
10984041|NCT00604825|12158984|FG002|STARTED|Overall Study||89
10984042|NCT00604825|12158985|FG003|STARTED|Overall Study||90
10984043|NCT00604825|12158982|FG000|COMPLETED|Overall Study||81
10984044|NCT00604825|12158983|FG001|COMPLETED|Overall Study||72
10984045|NCT00604825|12158984|FG002|COMPLETED|Overall Study||73
10984046|NCT00604825|12158985|FG003|COMPLETED|Overall Study||79
10984047|NCT00604825|12158982|FG000|NOT COMPLETED|Overall Study||9
10984048|NCT00604825|12158983|FG001|NOT COMPLETED|Overall Study||15
10984049|NCT00604825|12158984|FG002|NOT COMPLETED|Overall Study||16
10984050|NCT00604825|12158985|FG003|NOT COMPLETED|Overall Study||11
10984051|NCT00604890|12158999|FG000|STARTED|Overall Study||47
10984052|NCT00604890|12159000|FG001|STARTED|Overall Study||45
10984053|NCT00604890|12159001|FG002|STARTED|Overall Study||48
10984054|NCT00604890|12159002|FG003|STARTED|Overall Study||46
10984055|NCT00604890|12158999|FG000|COMPLETED|Overall Study||44
10984056|NCT00604890|12159000|FG001|COMPLETED|Overall Study||45
10984057|NCT00604890|12159001|FG002|COMPLETED|Overall Study||47
10984058|NCT00604890|12159002|FG003|COMPLETED|Overall Study||42
10984059|NCT00604890|12158999|FG000|NOT COMPLETED|Overall Study||3
10984060|NCT00604890|12159000|FG001|NOT COMPLETED|Overall Study||0
10984061|NCT00604890|12159001|FG002|NOT COMPLETED|Overall Study||1
10984062|NCT00604890|12159002|FG003|NOT COMPLETED|Overall Study||4
10984063|NCT00604968|12159013|FG000|STARTED|Overall Study||25
10984064|NCT00604968|12159013|FG000|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
10984065|NCT00604968|12159013|FG000|NOT COMPLETED|Overall Study||0
10984066|NCT00605033|12159019|FG000|STARTED|Overall Study||143
10984067|NCT00605033|12159020|FG001|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
10984068|NCT00605033|12159019|FG000|COMPLETED|Overall Study||136
10984069|NCT00605033|12159020|FG001|COMPLETED|Overall Study||90
10984070|NCT00605033|12159019|FG000|NOT COMPLETED|Overall Study||7
10984071|NCT00605033|12159020|FG001|NOT COMPLETED|Overall Study||8
10984072|NCT00605072|12159029|FG000|STARTED|Overall Study||18
10984073|NCT00605072|12159030|FG001|STARTED|Overall Study||20
10984074|NCT00605072|12159031|FG002|STARTED|Overall Study||15
10984075|NCT00605072|12159029|FG000|COMPLETED|Overall Study||11
10984076|NCT00605072|12159030|FG001|COMPLETED|Overall Study||9
10984077|NCT00605072|12159031|FG002|COMPLETED|Overall Study||11
10984078|NCT00605072|12159029|FG000|NOT COMPLETED|Overall Study||7
10984079|NCT00605072|12159030|FG001|NOT COMPLETED|Overall Study||11
10984080|NCT00605072|12159031|FG002|NOT COMPLETED|Overall Study||4
10984081|NCT00605085|12159041|FG000|STARTED|Overall Study||2012
10984082|NCT00605085|12159042|FG001|STARTED|Overall Study||663
10984083|NCT00605085|12159041|FG000|COMPLETED|Overall Study||1962
10984084|NCT00605085|12159042|FG001|COMPLETED|Overall Study||638
10984085|NCT00605085|12159041|FG000|NOT COMPLETED|Overall Study||50
10984086|NCT00605085|12159042|FG001|NOT COMPLETED|Overall Study||25
10984087|NCT00605176|12159051|FG000|STARTED|Overall Study||160
10984088|NCT00605176|12159052|FG001|STARTED|Overall Study||160
10984089|NCT00605176|12159053|FG002|STARTED|Overall Study||159
10984090|NCT00605176|12159051|FG000|COMPLETED|Overall Study||149
10984091|NCT00605176|12159052|FG001|COMPLETED|Overall Study||154
10984092|NCT00605176|12159053|FG002|COMPLETED|Overall Study||150
10984093|NCT00605176|12159051|FG000|NOT COMPLETED|Overall Study||11
10984094|NCT00605176|12159052|FG001|NOT COMPLETED|Overall Study||6
10984095|NCT00605176|12159053|FG002|NOT COMPLETED|Overall Study||9
10984096|NCT00605202|12159061|FG000|STARTED|First Intervention||5
10984097|NCT00605202|12159062|FG001|STARTED|First Intervention||5
10984098|NCT00605202|12159061|FG000|COMPLETED|First Intervention||5
10984099|NCT00605202|12159062|FG001|COMPLETED|First Intervention||5
10984100|NCT00605202|12159061|FG000|NOT COMPLETED|First Intervention||0
10984101|NCT00605202|12159062|FG001|NOT COMPLETED|First Intervention||0
10984102|NCT00605202|12159061|FG000|STARTED|Washout Period of 3 Weeks||5
10984103|NCT00605202|12159062|FG001|STARTED|Washout Period of 3 Weeks||5
10984104|NCT00605202|12159061|FG000|COMPLETED|Washout Period of 3 Weeks||5
10984105|NCT00605202|12159062|FG001|COMPLETED|Washout Period of 3 Weeks||5
10984106|NCT00605202|12159061|FG000|NOT COMPLETED|Washout Period of 3 Weeks||0
10984107|NCT00605202|12159062|FG001|NOT COMPLETED|Washout Period of 3 Weeks||0
10984108|NCT00605202|12159061|FG000|STARTED|Second Intervention||5
10984109|NCT00605202|12159062|FG001|STARTED|Second Intervention||5
10984110|NCT00605202|12159061|FG000|COMPLETED|Second Intervention||5
10984111|NCT00605202|12159062|FG001|COMPLETED|Second Intervention||5
10984112|NCT00605202|12159061|FG000|NOT COMPLETED|Second Intervention||0
10984113|NCT00605202|12159062|FG001|NOT COMPLETED|Second Intervention||0
10984114|NCT00605267|12159070|FG000|STARTED|Overall Study||98
10984115|NCT00605267|12159071|FG001|STARTED|Overall Study||99
10984116|NCT00605267|12159070|FG000|COMPLETED|Overall Study|Breast surgery performed|95
10984117|NCT00605267|12159071|FG001|COMPLETED|Overall Study|Breast surgery performed|90
10984118|NCT00605267|12159070|FG000|NOT COMPLETED|Overall Study||3
10984119|NCT00605267|12159071|FG001|NOT COMPLETED|Overall Study||9
10984120|NCT00605280|12159081|FG000|STARTED|Year 1||145
10984121|NCT00605280|12159082|FG001|STARTED|Year 1||22
10984122|NCT00605280|12159083|FG002|STARTED|Year 1||7
10984123|NCT00605280|12159084|FG003|STARTED|Year 1||143
10984124|NCT00605280|12159081|FG000|Received 0.3 mg Treatment|Year 1||144
10984125|NCT00605280|12159082|FG001|Received 0.3 mg Treatment|Year 1||13
10984126|NCT00605280|12159083|FG002|Received 0.3 mg Treatment|Year 1||3
10984127|NCT00605280|12159084|FG003|Received 0.3 mg Treatment|Year 1||0
10984128|NCT00605280|12159081|FG000|COMPLETED|Year 1||126
10984129|NCT00605280|12159082|FG001|COMPLETED|Year 1||11
10984130|NCT00605280|12159083|FG002|COMPLETED|Year 1||6
10984131|NCT00605280|12159084|FG003|COMPLETED|Year 1||124
10984132|NCT00605280|12159081|FG000|NOT COMPLETED|Year 1||19
10984133|NCT00605280|12159082|FG001|NOT COMPLETED|Year 1||11
10984134|NCT00605280|12159083|FG002|NOT COMPLETED|Year 1||1
10984135|NCT00605280|12159084|FG003|NOT COMPLETED|Year 1||19
10984136|NCT00605280|12159081|FG000|STARTED|Year 2||126
10984137|NCT00605280|12159082|FG001|STARTED|Year 2||11
10984138|NCT00605280|12159083|FG002|STARTED|Year 2||6
10984139|NCT00605280|12159084|FG003|STARTED|Year 2||124
10984140|NCT00605280|12159081|FG000|Received 0.3 mg Treatment|Year 2||126
10984141|NCT00605280|12159082|FG001|Received 0.3 mg Treatment|Year 2||3
10984142|NCT00605280|12159083|FG002|Received 0.3 mg Treatment|Year 2||2
10984143|NCT00605280|12159084|FG003|Received 0.3 mg Treatment|Year 2||0
10984144|NCT00605280|12159081|FG000|COMPLETED|Year 2||102
10984145|NCT00605280|12159082|FG001|COMPLETED|Year 2||5
10984146|NCT00605280|12159083|FG002|COMPLETED|Year 2||0
10984147|NCT00605280|12159084|FG003|COMPLETED|Year 2||102
10984148|NCT00605280|12159081|FG000|NOT COMPLETED|Year 2||24
10984149|NCT00605280|12159082|FG001|NOT COMPLETED|Year 2||6
10984150|NCT00605280|12159083|FG002|NOT COMPLETED|Year 2||6
10984151|NCT00605280|12159084|FG003|NOT COMPLETED|Year 2||22
10984152|NCT00605280|12159081|FG000|STARTED|Year 3 Extension||46
10984153|NCT00605280|12159082|FG001|STARTED|Year 3 Extension||0
10984154|NCT00605280|12159083|FG002|STARTED|Year 3 Extension||0
10984155|NCT00605280|12159084|FG003|STARTED|Year 3 Extension||54
10984156|NCT00605280|12159081|FG000|Received 0.3 mg Treatment|Year 3 Extension||46
10984157|NCT00605280|12159082|FG001|Received 0.3 mg Treatment|Year 3 Extension||0
10984158|NCT00605280|12159083|FG002|Received 0.3 mg Treatment|Year 3 Extension||0
10984159|NCT00605280|12159084|FG003|Received 0.3 mg Treatment|Year 3 Extension||54
10984160|NCT00605280|12159081|FG000|COMPLETED|Year 3 Extension||38
10984161|NCT00605280|12159082|FG001|COMPLETED|Year 3 Extension||0
10984162|NCT00605280|12159083|FG002|COMPLETED|Year 3 Extension||0
10984163|NCT00605280|12159084|FG003|COMPLETED|Year 3 Extension||45
10984164|NCT00605280|12159081|FG000|NOT COMPLETED|Year 3 Extension||8
10984165|NCT00605280|12159082|FG001|NOT COMPLETED|Year 3 Extension||0
10984166|NCT00605280|12159083|FG002|NOT COMPLETED|Year 3 Extension||0
10984167|NCT00605280|12159084|FG003|NOT COMPLETED|Year 3 Extension||9
10984168|NCT00605293|12159096|FG000|STARTED|Overall Study||65
10984169|NCT00605293|12159097|FG001|STARTED|Overall Study||36
10984170|NCT00605293|12159096|FG000|COMPLETED|Overall Study||48
10984171|NCT00605293|12159097|FG001|COMPLETED|Overall Study||31
10984172|NCT00605293|12159096|FG000|NOT COMPLETED|Overall Study||17
10984173|NCT00605293|12159097|FG001|NOT COMPLETED|Overall Study||5
10984174|NCT00605306|12159105|FG000|STARTED|Overall Study||14
10984175|NCT00605306|12159106|FG001|STARTED|Overall Study||14
10984176|NCT00605306|12159105|FG000|COMPLETED|Overall Study||14
10984177|NCT00605306|12159106|FG001|COMPLETED|Overall Study||13
10984178|NCT00605306|12159105|FG000|NOT COMPLETED|Overall Study||0
10984179|NCT00605306|12159106|FG001|NOT COMPLETED|Overall Study||1
10984180|NCT00605319|12159112|FG000|STARTED|Overall Study||17
10984181|NCT00605319|12159112|FG000|COMPLETED|Overall Study||11
10984182|NCT00605319|12159112|FG000|NOT COMPLETED|Overall Study||6
10984183|NCT00605345|12159124|FG000|STARTED|Overall Study||46
10984184|NCT00605345|12159125|FG001|STARTED|Overall Study||25
10984185|NCT00605345|12159124|FG000|COMPLETED|Overall Study||45
10984186|NCT00605345|12159125|FG001|COMPLETED|Overall Study||22
10984187|NCT00605345|12159124|FG000|NOT COMPLETED|Overall Study||1
10984188|NCT00605345|12159125|FG001|NOT COMPLETED|Overall Study||3
10984189|NCT00605358|12159133|FG000|STARTED|Overall Study||81
10984190|NCT00605358|12159134|FG001|STARTED|Overall Study||80
10984191|NCT00605358|12159133|FG000|COMPLETED|Overall Study||81
10984192|NCT00605358|12159134|FG001|COMPLETED|Overall Study||80
10984193|NCT00605358|12159133|FG000|NOT COMPLETED|Overall Study||0
10984194|NCT00605358|12159134|FG001|NOT COMPLETED|Overall Study||0
10984195|NCT00605384|12159142|FG000|STARTED|Overall Study||1
10984196|NCT00605384|12159143|FG001|STARTED|Overall Study||1
10984197|NCT00605384|12159142|FG000|COMPLETED|Overall Study|study terminated early|0
10984198|NCT00605384|12159143|FG001|COMPLETED|Overall Study|study terminated early|0
10984199|NCT00605384|12159142|FG000|NOT COMPLETED|Overall Study||1
10984200|NCT00605384|12159143|FG001|NOT COMPLETED|Overall Study||1
10984201|NCT00605423|12159151|FG000|STARTED|Overall Study||4
10984202|NCT00605423|12159152|FG001|STARTED|Overall Study||2
10984203|NCT00605423|12159151|FG000|COMPLETED|Overall Study||4
10984204|NCT00605423|12159152|FG001|COMPLETED|Overall Study||2
10984205|NCT00605423|12159151|FG000|NOT COMPLETED|Overall Study||0
10984206|NCT00605423|12159152|FG001|NOT COMPLETED|Overall Study||0
10984207|NCT00605475|12159168|FG000|STARTED|Overall Study||10
10984208|NCT00605475|12159169|FG001|STARTED|Overall Study||5
10984209|NCT00605475|12159170|FG002|STARTED|Overall Study||45
10984210|NCT00605475|12159171|FG003|STARTED|Overall Study||45
10984211|NCT00605475|12159172|FG004|STARTED|Overall Study||25
10984212|NCT00605475|12159173|FG005|STARTED|Overall Study||24
10984213|NCT00605475|12159174|FG006|STARTED|Overall Study||23
10984214|NCT00605475|12159175|FG007|STARTED|Overall Study||24
10984215|NCT00605475|12159176|FG008|STARTED|Overall Study||20
10984216|NCT00605475|12159177|FG009|STARTED|Overall Study||10
10984217|NCT00605475|12159168|FG000|COMPLETED|Overall Study||10
10984218|NCT00605475|12159169|FG001|COMPLETED|Overall Study||5
10984219|NCT00605475|12159170|FG002|COMPLETED|Overall Study||45
10984220|NCT00605475|12159171|FG003|COMPLETED|Overall Study||45
10984221|NCT00605475|12159172|FG004|COMPLETED|Overall Study||24
10984222|NCT00605475|12159173|FG005|COMPLETED|Overall Study||22
10984223|NCT00605475|12159174|FG006|COMPLETED|Overall Study||22
10984224|NCT00605475|12159175|FG007|COMPLETED|Overall Study||24
10984225|NCT00605475|12159176|FG008|COMPLETED|Overall Study||18
10984226|NCT00605475|12159177|FG009|COMPLETED|Overall Study||8
10984227|NCT00605475|12159168|FG000|NOT COMPLETED|Overall Study||0
10984228|NCT00605475|12159169|FG001|NOT COMPLETED|Overall Study||0
10984229|NCT00605475|12159170|FG002|NOT COMPLETED|Overall Study||0
10984230|NCT00605475|12159171|FG003|NOT COMPLETED|Overall Study||0
10984231|NCT00605475|12159172|FG004|NOT COMPLETED|Overall Study||1
10984232|NCT00605475|12159173|FG005|NOT COMPLETED|Overall Study||2
10984233|NCT00605475|12159174|FG006|NOT COMPLETED|Overall Study||1
10984234|NCT00605475|12159175|FG007|NOT COMPLETED|Overall Study||0
10984235|NCT00605475|12159176|FG008|NOT COMPLETED|Overall Study||2
10984236|NCT00605475|12159177|FG009|NOT COMPLETED|Overall Study||2
10984237|NCT00605540|12159220|FG000|STARTED|Overall Study||133
10984238|NCT00605540|12159220|FG000|COMPLETED|Overall Study||95
10984239|NCT00605540|12159220|FG000|NOT COMPLETED|Overall Study||38
10984240|NCT00605566|12159224|FG000|STARTED|Overall Study||22
10984241|NCT00605566|12159224|FG000|COMPLETED|Overall Study||19
10984242|NCT00605566|12159224|FG000|NOT COMPLETED|Overall Study||3
10984243|NCT00605644|12159233|FG000|STARTED|Overall Study||29
10984244|NCT00605644|12159234|FG001|STARTED|Overall Study||19
10984245|NCT00605644|12159235|FG002|STARTED|Overall Study||20
10984246|NCT00605644|12159236|FG003|STARTED|Overall Study||30
10984247|NCT00605644|12159237|FG004|STARTED|Overall Study||30
10984248|NCT00605644|12159233|FG000|COMPLETED|Overall Study||28
10984249|NCT00605644|12159234|FG001|COMPLETED|Overall Study||18
10984250|NCT00605644|12159235|FG002|COMPLETED|Overall Study||18
10984251|NCT00605644|12159236|FG003|COMPLETED|Overall Study||25
10984252|NCT00605644|12159237|FG004|COMPLETED|Overall Study||22
10984253|NCT00605644|12159233|FG000|NOT COMPLETED|Overall Study||1
10984254|NCT00605644|12159234|FG001|NOT COMPLETED|Overall Study||1
10984255|NCT00605644|12159235|FG002|NOT COMPLETED|Overall Study||2
10984256|NCT00605644|12159236|FG003|NOT COMPLETED|Overall Study||5
10984257|NCT00605644|12159237|FG004|NOT COMPLETED|Overall Study||8
10984258|NCT00605657|12159249|FG000|STARTED|Overall Study||5
10984259|NCT00605657|12159249|FG000|COMPLETED|Overall Study||3
10984260|NCT00605657|12159249|FG000|NOT COMPLETED|Overall Study||2
10984261|NCT00605696|12159255|FG000|STARTED|Overall Study||7
10984262|NCT00605696|12159256|FG001|STARTED|Overall Study||11
10984263|NCT00605696|12159255|FG000|COMPLETED|Overall Study||7
10984264|NCT00605696|12159256|FG001|COMPLETED|Overall Study||11
10984265|NCT00605696|12159255|FG000|NOT COMPLETED|Overall Study||0
10984266|NCT00605696|12159256|FG001|NOT COMPLETED|Overall Study||0
10984267|NCT00605722|12159262|FG000|STARTED|Overall Study||51
10984268|NCT00605722|12159262|FG000|COMPLETED|Overall Study|Completed=Completed Treatment.|0
10984269|NCT00605722|12159262|FG000|NOT COMPLETED|Overall Study||51
10984270|NCT00605813|12159266|FG000|STARTED|Overall Study||542
10984271|NCT00605813|12159266|FG000|COMPLETED|Overall Study||517
10984272|NCT00605813|12159266|FG000|NOT COMPLETED|Overall Study||25
10984273|NCT00605826|12159281|FG000|STARTED|Overall Study||136
10984274|NCT00605826|12159282|FG001|STARTED|Overall Study||70
10984275|NCT00605826|12159281|FG000|COMPLETED|Overall Study||129
10984276|NCT00605826|12159282|FG001|COMPLETED|Overall Study||60
10984277|NCT00605826|12159281|FG000|NOT COMPLETED|Overall Study||7
10984278|NCT00605826|12159282|FG001|NOT COMPLETED|Overall Study||10
10984279|NCT00605839|12159291|FG000|STARTED|Overall Study||40
10984280|NCT00605839|12159292|FG001|STARTED|Overall Study||37
10984281|NCT00605839|12159293|FG002|STARTED|Overall Study||28
10984282|NCT00605839|12159291|FG000|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
10984283|NCT00605839|12159292|FG001|COMPLETED|Overall Study||37
10984284|NCT00605839|12159293|FG002|COMPLETED|Overall Study||28
10984285|NCT00605839|12159291|FG000|NOT COMPLETED|Overall Study||1
10984286|NCT00605839|12159292|FG001|NOT COMPLETED|Overall Study||0
10984287|NCT00605839|12159293|FG002|NOT COMPLETED|Overall Study||0
10984288|NCT00605865|12159301|FG000|STARTED|Overall Study||2272
10984289|NCT00605865|12159301|FG000|COMPLETED|Overall Study||2157
10984290|NCT00605865|12159301|FG000|NOT COMPLETED|Overall Study||115
10984291|NCT00605904|12159335|FG000|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
10984292|NCT00605904|12159336|FG001|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
10984293|NCT00605904|12159335|FG000|COMPLETED|Baseline Data Collection and Dosing||13
10984294|NCT00605904|12159336|FG001|COMPLETED|Baseline Data Collection and Dosing||16
10984295|NCT00605904|12159335|FG000|NOT COMPLETED|Baseline Data Collection and Dosing||0
10984296|NCT00605904|12159336|FG001|NOT COMPLETED|Baseline Data Collection and Dosing||5
10984297|NCT00605904|12159335|FG000|STARTED|Infusion Sessions||13
10984298|NCT00605904|12159336|FG001|STARTED|Infusion Sessions||16
10984299|NCT00605904|12159335|FG000|Saline Infusion|Infusion Sessions||13
10984300|NCT00605904|12159336|FG001|Saline Infusion|Infusion Sessions||14
10984301|NCT00605904|12159335|FG000|mCPP Infusion|Infusion Sessions||12
10984302|NCT00605904|12159336|FG001|mCPP Infusion|Infusion Sessions||13
10984303|NCT00605904|12159335|FG000|Yohimbine Infusion|Infusion Sessions||12
10984304|NCT00605904|12159336|FG001|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
10984305|NCT00605904|12159335|FG000|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
10984306|NCT00605904|12159336|FG001|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
10984307|NCT00605904|12159335|FG000|NOT COMPLETED|Infusion Sessions||1
10984308|NCT00605904|12159336|FG001|NOT COMPLETED|Infusion Sessions||3
10984309|NCT00605917|12159342|FG000|STARTED|Overall Study||987
10984310|NCT00605917|12159342|FG000|COMPLETED|Overall Study||908
10984311|NCT00605917|12159342|FG000|NOT COMPLETED|Overall Study||79
10984312|NCT00606008|12159377|FG000|STARTED|Overall Study||30
10984313|NCT00606008|12159377|FG000|COMPLETED|Overall Study||25
10984314|NCT00606008|12159377|FG000|NOT COMPLETED|Overall Study||5
10984315|NCT00606021|12159387|FG000|STARTED|Induction Phase||106
10984316|NCT00606021|12159388|FG001|STARTED|Induction Phase||0
10984317|NCT00606021|12159389|FG002|STARTED|Induction Phase||0
10984318|NCT00606021|12159387|FG000|COMPLETED|Induction Phase||19
10984319|NCT00606021|12159388|FG001|COMPLETED|Induction Phase||0
10984320|NCT00606021|12159389|FG002|COMPLETED|Induction Phase||0
10984321|NCT00606021|12159387|FG000|NOT COMPLETED|Induction Phase||87
10984322|NCT00606021|12159388|FG001|NOT COMPLETED|Induction Phase||0
10984323|NCT00606021|12159389|FG002|NOT COMPLETED|Induction Phase||0
10984324|NCT00606021|12159387|FG000|STARTED|Maintenance Phase||0
10984325|NCT00606021|12159388|FG001|STARTED|Maintenance Phase||28
10984326|NCT00606021|12159389|FG002|STARTED|Maintenance Phase||27
10984327|NCT00606021|12159387|FG000|COMPLETED|Maintenance Phase||0
10984328|NCT00606021|12159388|FG001|COMPLETED|Maintenance Phase||5
10984329|NCT00606021|12159389|FG002|COMPLETED|Maintenance Phase||10
10984330|NCT00606021|12159387|FG000|NOT COMPLETED|Maintenance Phase||0
10984331|NCT00606021|12159388|FG001|NOT COMPLETED|Maintenance Phase||23
10984332|NCT00606021|12159389|FG002|NOT COMPLETED|Maintenance Phase||17
10984333|NCT00606034|12159397|FG000|STARTED|Overall Study||21
10984334|NCT00606034|12159397|FG000|COMPLETED|Overall Study||20
10984335|NCT00606034|12159397|FG000|NOT COMPLETED|Overall Study||1
10984336|NCT00606047|12159403|FG000|STARTED|Overall Study||200
10984337|NCT00606047|12159403|FG000|COMPLETED|Overall Study||200
10984338|NCT00606047|12159403|FG000|NOT COMPLETED|Overall Study||0
10984339|NCT00606086|12159409|FG000|STARTED|Overall Study||72
10984340|NCT00606086|12159410|FG001|STARTED|Overall Study||68
10984341|NCT00606086|12159409|FG000|COMPLETED|Overall Study||60
10984342|NCT00606086|12159410|FG001|COMPLETED|Overall Study||53
10984343|NCT00606086|12159409|FG000|NOT COMPLETED|Overall Study||12
10984344|NCT00606086|12159410|FG001|NOT COMPLETED|Overall Study||15
10984345|NCT00606138|12159418|FG000|STARTED|Overall Study||6
10984346|NCT00606138|12159419|FG001|STARTED|Overall Study||2
10984347|NCT00606138|12159418|FG000|COMPLETED|Overall Study||6
10984348|NCT00606138|12159419|FG001|COMPLETED|Overall Study||2
10984349|NCT00606138|12159418|FG000|NOT COMPLETED|Overall Study||0
10984350|NCT00606138|12159419|FG001|NOT COMPLETED|Overall Study||0
10984351|NCT00606177|12159427|FG000|STARTED|Overall Study||55
10984352|NCT00606177|12159428|FG001|STARTED|Overall Study||44
10984353|NCT00606177|12159427|FG000|COMPLETED|Overall Study||28
10984354|NCT00606177|12159428|FG001|COMPLETED|Overall Study||19
10984355|NCT00606177|12159427|FG000|NOT COMPLETED|Overall Study||27
10984356|NCT00606177|12159428|FG001|NOT COMPLETED|Overall Study||25
10984357|NCT00606229|12159434|FG000|STARTED|Overall Study||41
10984358|NCT00606229|12159434|FG000|COMPLETED|Overall Study||19
10984359|NCT00606229|12159434|FG000|NOT COMPLETED|Overall Study||22
10984360|NCT00606281|12159440|FG000|STARTED|Overall Study||128
10984361|NCT00606281|12159441|FG001|STARTED|Overall Study||130
10984362|NCT00606281|12159440|FG000|COMPLETED|Overall Study||72
10984363|NCT00606281|12159441|FG001|COMPLETED|Overall Study||64
10984364|NCT00606281|12159440|FG000|NOT COMPLETED|Overall Study||56
10984365|NCT00606281|12159441|FG001|NOT COMPLETED|Overall Study||66
10984366|NCT00606307|12159447|FG000|STARTED|Overall Study||29
10984367|NCT00606307|12159447|FG000|COMPLETED|Overall Study||18
10984368|NCT00606307|12159447|FG000|NOT COMPLETED|Overall Study||11
10984369|NCT00606320|12159451|FG000|STARTED|Overall Study||59
10984370|NCT00606320|12159451|FG000|COMPLETED|Overall Study||22
10984371|NCT00606320|12159451|FG000|NOT COMPLETED|Overall Study||37
10984372|NCT00606489|12159457|FG000|STARTED|Overall Study||21
10984373|NCT00606489|12159458|FG001|STARTED|Overall Study||40
10984374|NCT00606489|12159457|FG000|COMPLETED|Overall Study||21
10984375|NCT00606489|12159458|FG001|COMPLETED|Overall Study||40
10984376|NCT00606489|12159457|FG000|NOT COMPLETED|Overall Study||0
10984377|NCT00606489|12159458|FG001|NOT COMPLETED|Overall Study||0
10984378|NCT00606502|12159466|FG000|STARTED|Randomization||100
10984379|NCT00606502|12159467|FG001|STARTED|Randomization||101
10984380|NCT00606502|12159466|FG000|COMPLETED|Randomization||97
10984381|NCT00606502|12159467|FG001|COMPLETED|Randomization||101
10984382|NCT00606502|12159466|FG000|NOT COMPLETED|Randomization||3
10984383|NCT00606502|12159467|FG001|NOT COMPLETED|Randomization||0
10984384|NCT00606502|12159466|FG000|STARTED|Treatment||97
10984385|NCT00606502|12159467|FG001|STARTED|Treatment||101
10984386|NCT00606502|12159466|FG000|COMPLETED|Treatment||97
10984387|NCT00606502|12159467|FG001|COMPLETED|Treatment||98
10984388|NCT00606502|12159466|FG000|NOT COMPLETED|Treatment||0
10984389|NCT00606502|12159467|FG001|NOT COMPLETED|Treatment||3
10984390|NCT00606554|12159475|FG000|STARTED|Overall Study||15
10984391|NCT00606554|12159476|FG001|STARTED|Overall Study||18
10984392|NCT00606554|12159475|FG000|COMPLETED|Overall Study||15
10984393|NCT00606554|12159476|FG001|COMPLETED|Overall Study||18
10984394|NCT00606554|12159475|FG000|NOT COMPLETED|Overall Study||0
10984395|NCT00606554|12159476|FG001|NOT COMPLETED|Overall Study||0
10984396|NCT00606580|12159489|FG000|STARTED|Overall Study||125
10984397|NCT00606580|12159490|FG001|STARTED|Overall Study||125
10984398|NCT00606580|12159491|FG002|STARTED|Overall Study||125
10984399|NCT00606580|12159489|FG000|COMPLETED|Overall Study||123
10984400|NCT00606580|12159490|FG001|COMPLETED|Overall Study||122
10984401|NCT00606580|12159491|FG002|COMPLETED|Overall Study||103
10984402|NCT00606580|12159489|FG000|NOT COMPLETED|Overall Study||2
10984403|NCT00606580|12159490|FG001|NOT COMPLETED|Overall Study||3
10984404|NCT00606580|12159491|FG002|NOT COMPLETED|Overall Study||22
10984405|NCT00606593|12159499|FG000|STARTED|Overall Study|Randomized participants|11
10984406|NCT00606593|12159500|FG001|STARTED|Overall Study|Randomized participants|11
10984407|NCT00606593|12159501|FG002|STARTED|Overall Study|Randomized participants|11
10984408|NCT00606593|12159502|FG003|STARTED|Overall Study|Randomized participants|11
10984409|NCT00606593|12159503|FG004|STARTED|Overall Study|Randomized participants|12
10984410|NCT00606593|12159504|FG005|STARTED|Overall Study|Randomized participants|11
10984411|NCT00606593|12159505|FG006|STARTED|Overall Study|Randomized participants|11
10984412|NCT00606593|12159506|FG007|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
10984413|NCT00606593|12159507|FG008|STARTED|Overall Study|Randomized participants|12
10984414|NCT00606593|12159508|FG009|STARTED|Overall Study|Randomized participants|11
10984415|NCT00606593|12159499|FG000|1st Double-blind Treatment|Overall Study||11
10984416|NCT00606593|12159500|FG001|1st Double-blind Treatment|Overall Study||11
10984417|NCT00606593|12159501|FG002|1st Double-blind Treatment|Overall Study||11
10984418|NCT00606593|12159502|FG003|1st Double-blind Treatment|Overall Study||11
10984419|NCT00606593|12159503|FG004|1st Double-blind Treatment|Overall Study||12
10984420|NCT00606593|12159504|FG005|1st Double-blind Treatment|Overall Study||11
10984421|NCT00606593|12159505|FG006|1st Double-blind Treatment|Overall Study||11
10984422|NCT00606593|12159506|FG007|1st Double-blind Treatment|Overall Study||11
10984423|NCT00606593|12159507|FG008|1st Double-blind Treatment|Overall Study||12
10984424|NCT00606593|12159508|FG009|1st Double-blind Treatment|Overall Study||11
10984425|NCT00606593|12159499|FG000|2nd Double-blind Treatment|Overall Study||11
10984426|NCT00606593|12159500|FG001|2nd Double-blind Treatment|Overall Study||11
10984427|NCT00606593|12159501|FG002|2nd Double-blind Treatment|Overall Study||11
10984428|NCT00606593|12159502|FG003|2nd Double-blind Treatment|Overall Study||10
10984429|NCT00606593|12159503|FG004|2nd Double-blind Treatment|Overall Study||12
10984430|NCT00606593|12159504|FG005|2nd Double-blind Treatment|Overall Study||11
10984431|NCT00606593|12159505|FG006|2nd Double-blind Treatment|Overall Study||10
10984432|NCT00606593|12159506|FG007|2nd Double-blind Treatment|Overall Study||9
10984433|NCT00606593|12159507|FG008|2nd Double-blind Treatment|Overall Study||12
10984434|NCT00606593|12159508|FG009|2nd Double-blind Treatment|Overall Study||11
10984435|NCT00606593|12159499|FG000|3rd Double-blind Treatment|Overall Study||11
10984436|NCT00606593|12159500|FG001|3rd Double-blind Treatment|Overall Study||11
10984437|NCT00606593|12159501|FG002|3rd Double-blind Treatment|Overall Study||10
10984438|NCT00606593|12159502|FG003|3rd Double-blind Treatment|Overall Study||10
10984439|NCT00606593|12159503|FG004|3rd Double-blind Treatment|Overall Study||11
10984440|NCT00606593|12159504|FG005|3rd Double-blind Treatment|Overall Study||11
10984441|NCT00606593|12159505|FG006|3rd Double-blind Treatment|Overall Study||10
10984442|NCT00606593|12159506|FG007|3rd Double-blind Treatment|Overall Study||9
10984443|NCT00606593|12159507|FG008|3rd Double-blind Treatment|Overall Study||12
10984444|NCT00606593|12159508|FG009|3rd Double-blind Treatment|Overall Study||11
10984445|NCT00606593|12159499|FG000|4th Double-blind Treatment|Overall Study||10
10984446|NCT00606593|12159500|FG001|4th Double-blind Treatment|Overall Study||11
10984447|NCT00606593|12159501|FG002|4th Double-blind Treatment|Overall Study||10
10984448|NCT00606593|12159502|FG003|4th Double-blind Treatment|Overall Study||10
10984449|NCT00606593|12159503|FG004|4th Double-blind Treatment|Overall Study||11
10984450|NCT00606593|12159504|FG005|4th Double-blind Treatment|Overall Study||11
10984451|NCT00606593|12159505|FG006|4th Double-blind Treatment|Overall Study||10
10984452|NCT00606593|12159506|FG007|4th Double-blind Treatment|Overall Study||9
10984453|NCT00606593|12159507|FG008|4th Double-blind Treatment|Overall Study||11
10984454|NCT00606593|12159508|FG009|4th Double-blind Treatment|Overall Study||11
10984455|NCT00606593|12159499|FG000|5th Double-blind Treatment|Overall Study||10
10984456|NCT00606593|12159500|FG001|5th Double-blind Treatment|Overall Study||11
10984457|NCT00606593|12159501|FG002|5th Double-blind Treatment|Overall Study||9
10984458|NCT00606593|12159502|FG003|5th Double-blind Treatment|Overall Study||10
10984459|NCT00606593|12159503|FG004|5th Double-blind Treatment|Overall Study||11
10984460|NCT00606593|12159504|FG005|5th Double-blind Treatment|Overall Study||11
10984461|NCT00606593|12159505|FG006|5th Double-blind Treatment|Overall Study||10
10984462|NCT00606593|12159506|FG007|5th Double-blind Treatment|Overall Study||9
10984463|NCT00606593|12159507|FG008|5th Double-blind Treatment|Overall Study||11
10984464|NCT00606593|12159508|FG009|5th Double-blind Treatment|Overall Study||11
10984465|NCT00606593|12159499|FG000|COMPLETED|Overall Study||10
10984466|NCT00606593|12159500|FG001|COMPLETED|Overall Study||11
10984467|NCT00606593|12159501|FG002|COMPLETED|Overall Study||9
10984468|NCT00606593|12159502|FG003|COMPLETED|Overall Study||10
10984469|NCT00606593|12159503|FG004|COMPLETED|Overall Study||11
10984470|NCT00606593|12159504|FG005|COMPLETED|Overall Study||11
10984471|NCT00606593|12159505|FG006|COMPLETED|Overall Study||10
10984472|NCT00606593|12159506|FG007|COMPLETED|Overall Study||9
10984473|NCT00606593|12159507|FG008|COMPLETED|Overall Study||11
10984474|NCT00606593|12159508|FG009|COMPLETED|Overall Study||11
10984475|NCT00606593|12159499|FG000|NOT COMPLETED|Overall Study||1
10984476|NCT00606593|12159500|FG001|NOT COMPLETED|Overall Study||0
10984477|NCT00606593|12159501|FG002|NOT COMPLETED|Overall Study||2
10984478|NCT00606593|12159502|FG003|NOT COMPLETED|Overall Study||1
10984479|NCT00606593|12159503|FG004|NOT COMPLETED|Overall Study||1
10984480|NCT00606593|12159504|FG005|NOT COMPLETED|Overall Study||0
10984481|NCT00606593|12159505|FG006|NOT COMPLETED|Overall Study||1
10984482|NCT00606593|12159506|FG007|NOT COMPLETED|Overall Study||2
10984483|NCT00606593|12159507|FG008|NOT COMPLETED|Overall Study||1
10984484|NCT00606593|12159508|FG009|NOT COMPLETED|Overall Study||0
10984485|NCT00606632|12159521|FG000|STARTED|Overall Study||226
10984486|NCT00606632|12159521|FG000|COMPLETED|Overall Study||204
10984487|NCT00606632|12159521|FG000|NOT COMPLETED|Overall Study||22
10984488|NCT00606684|12159536|FG000|STARTED|2-week Single-Blind Run-in Period||851
10984489|NCT00606684|12159537|FG001|STARTED|2-week Single-Blind Run-in Period||0
10984490|NCT00606684|12159538|FG002|STARTED|2-week Single-Blind Run-in Period||0
10984491|NCT00606684|12159539|FG003|STARTED|2-week Single-Blind Run-in Period||0
10984492|NCT00606684|12159540|FG004|STARTED|2-week Single-Blind Run-in Period||0
10984493|NCT00606684|12159541|FG005|STARTED|2-week Single-Blind Run-in Period||0
10984494|NCT00606684|12159542|FG006|STARTED|2-week Single-Blind Run-in Period||0
10984495|NCT00606684|12159536|FG000|COMPLETED|2-week Single-Blind Run-in Period||605
10984496|NCT00606684|12159537|FG001|COMPLETED|2-week Single-Blind Run-in Period||0
10984497|NCT00606684|12159538|FG002|COMPLETED|2-week Single-Blind Run-in Period||0
10984498|NCT00606684|12159539|FG003|COMPLETED|2-week Single-Blind Run-in Period||0
10984499|NCT00606684|12159540|FG004|COMPLETED|2-week Single-Blind Run-in Period||0
10984500|NCT00606684|12159541|FG005|COMPLETED|2-week Single-Blind Run-in Period||0
10984501|NCT00606684|12159542|FG006|COMPLETED|2-week Single-Blind Run-in Period||0
10984502|NCT00606684|12159536|FG000|NOT COMPLETED|2-week Single-Blind Run-in Period||246
10984503|NCT00606684|12159537|FG001|NOT COMPLETED|2-week Single-Blind Run-in Period||0
10984504|NCT00606684|12159538|FG002|NOT COMPLETED|2-week Single-Blind Run-in Period||0
10984505|NCT00606684|12159539|FG003|NOT COMPLETED|2-week Single-Blind Run-in Period||0
10984506|NCT00606684|12159540|FG004|NOT COMPLETED|2-week Single-Blind Run-in Period||0
10984507|NCT00606684|12159541|FG005|NOT COMPLETED|2-week Single-Blind Run-in Period||0
10984508|NCT00606684|12159542|FG006|NOT COMPLETED|2-week Single-Blind Run-in Period||0
10984509|NCT00606684|12159536|FG000|STARTED|Double-Blind Treatment Period||0
10984510|NCT00606684|12159537|FG001|STARTED|Double-Blind Treatment Period||101
10984511|NCT00606684|12159538|FG002|STARTED|Double-Blind Treatment Period||99
10984512|NCT00606684|12159539|FG003|STARTED|Double-Blind Treatment Period||101
10984513|NCT00606684|12159540|FG004|STARTED|Double-Blind Treatment Period||101
10984514|NCT00606684|12159541|FG005|STARTED|Double-Blind Treatment Period||101
10984515|NCT00606684|12159542|FG006|STARTED|Double-Blind Treatment Period||99
10984516|NCT00606684|12159536|FG000|COMPLETED|Double-Blind Treatment Period||0
10984517|NCT00606684|12159537|FG001|COMPLETED|Double-Blind Treatment Period||85
10984518|NCT00606684|12159538|FG002|COMPLETED|Double-Blind Treatment Period||88
10984519|NCT00606684|12159539|FG003|COMPLETED|Double-Blind Treatment Period||91
10984520|NCT00606684|12159540|FG004|COMPLETED|Double-Blind Treatment Period||92
10984521|NCT00606684|12159541|FG005|COMPLETED|Double-Blind Treatment Period||92
10984522|NCT00606684|12159542|FG006|COMPLETED|Double-Blind Treatment Period||91
10984523|NCT00606684|12159536|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
10984524|NCT00606684|12159537|FG001|NOT COMPLETED|Double-Blind Treatment Period||16
10984525|NCT00606684|12159538|FG002|NOT COMPLETED|Double-Blind Treatment Period||11
10984526|NCT00606684|12159539|FG003|NOT COMPLETED|Double-Blind Treatment Period||10
10984527|NCT00606684|12159540|FG004|NOT COMPLETED|Double-Blind Treatment Period||9
10984528|NCT00606684|12159541|FG005|NOT COMPLETED|Double-Blind Treatment Period||9
10984529|NCT00606684|12159542|FG006|NOT COMPLETED|Double-Blind Treatment Period||8
10984530|NCT00606801|12159558|FG000|STARTED|Adaptation||17
10984531|NCT00606801|12159559|FG001|STARTED|Adaptation||17
10984532|NCT00606801|12159558|FG000|COMPLETED|Adaptation||17
10984533|NCT00606801|12159559|FG001|COMPLETED|Adaptation||17
10984534|NCT00606801|12159558|FG000|NOT COMPLETED|Adaptation||0
10984535|NCT00606801|12159559|FG001|NOT COMPLETED|Adaptation||0
10984536|NCT00606801|12159558|FG000|STARTED|Intervention||17
10984537|NCT00606801|12159559|FG001|STARTED|Intervention||17
10984538|NCT00606801|12159558|FG000|COMPLETED|Intervention||14
10984539|NCT00606801|12159559|FG001|COMPLETED|Intervention||14
10984540|NCT00606801|12159558|FG000|NOT COMPLETED|Intervention||3
10984541|NCT00606801|12159559|FG001|NOT COMPLETED|Intervention||3
10984542|NCT00606892|12159569|FG000|STARTED|Adaptation||9
10984543|NCT00606892|12159570|FG001|STARTED|Adaptation||8
10984544|NCT00606892|12159569|FG000|COMPLETED|Adaptation||9
10984545|NCT00606892|12159570|FG001|COMPLETED|Adaptation||8
10984546|NCT00606892|12159569|FG000|NOT COMPLETED|Adaptation||0
10984547|NCT00606892|12159570|FG001|NOT COMPLETED|Adaptation||0
10984548|NCT00606892|12159569|FG000|STARTED|First Intervention||9
10984549|NCT00606892|12159570|FG001|STARTED|First Intervention||8
10984550|NCT00606892|12159569|FG000|COMPLETED|First Intervention||8
10984551|NCT00606892|12159570|FG001|COMPLETED|First Intervention||4
10984552|NCT00606892|12159569|FG000|NOT COMPLETED|First Intervention||1
10984553|NCT00606892|12159570|FG001|NOT COMPLETED|First Intervention||4
10984554|NCT00606892|12159569|FG000|STARTED|Washout Period||8
10984555|NCT00606892|12159570|FG001|STARTED|Washout Period||4
10984556|NCT00606892|12159569|FG000|COMPLETED|Washout Period||8
10984557|NCT00606892|12159570|FG001|COMPLETED|Washout Period||4
10984558|NCT00606892|12159569|FG000|NOT COMPLETED|Washout Period||0
10984559|NCT00606892|12159570|FG001|NOT COMPLETED|Washout Period||0
10984560|NCT00606892|12159569|FG000|STARTED|Second Intervention||8
10984561|NCT00606892|12159570|FG001|STARTED|Second Intervention||4
10984562|NCT00606892|12159569|FG000|COMPLETED|Second Intervention||8
10984563|NCT00606892|12159570|FG001|COMPLETED|Second Intervention||4
10984564|NCT00606892|12159569|FG000|NOT COMPLETED|Second Intervention||0
10984565|NCT00606892|12159570|FG001|NOT COMPLETED|Second Intervention||0
10984566|NCT00606905|12159604|FG000|STARTED|Overall Study||38
10984567|NCT00606905|12159605|FG001|STARTED|Overall Study||39
10984568|NCT00606905|12159604|FG000|Pregnancy|Overall Study||29
10984569|NCT00606905|12159605|FG001|Pregnancy|Overall Study||33
10984570|NCT00606905|12159604|FG000|COMPLETED|Overall Study||23
10984571|NCT00606905|12159605|FG001|COMPLETED|Overall Study||24
10984572|NCT00606905|12159604|FG000|NOT COMPLETED|Overall Study||15
10984573|NCT00606905|12159605|FG001|NOT COMPLETED|Overall Study||15
10984574|NCT00606931|12159611|FG000|STARTED|Overall Study||22
10984575|NCT00606931|12159611|FG000|COMPLETED|Overall Study||19
10984576|NCT00606931|12159611|FG000|NOT COMPLETED|Overall Study||3
10984577|NCT00606944|12159617|FG000|STARTED|Overall Study||98
10984578|NCT00606944|12159618|FG001|STARTED|Overall Study||100
10984579|NCT00606944|12159617|FG000|COMPLETED|Overall Study||98
10984580|NCT00606944|12159618|FG001|COMPLETED|Overall Study||100
10984581|NCT00606944|12159617|FG000|NOT COMPLETED|Overall Study||0
10984582|NCT00606944|12159618|FG001|NOT COMPLETED|Overall Study||0
10984583|NCT00607022|12159627|FG000|STARTED|Overall Study||7
10984584|NCT00607022|12159628|FG001|STARTED|Overall Study||15
10984585|NCT00607022|12159629|FG002|STARTED|Overall Study||19
10984586|NCT00607022|12159627|FG000|COMPLETED|Overall Study||6
10984587|NCT00607022|12159628|FG001|COMPLETED|Overall Study||15
10984588|NCT00607022|12159629|FG002|COMPLETED|Overall Study||19
10984589|NCT00607022|12159627|FG000|NOT COMPLETED|Overall Study||1
10984590|NCT00607022|12159628|FG001|NOT COMPLETED|Overall Study||0
10984591|NCT00607022|12159629|FG002|NOT COMPLETED|Overall Study||0
10984592|NCT00607048|12159639|FG000|STARTED|Overall Study||3
10984593|NCT00607048|12159640|FG001|STARTED|Overall Study||6
10984594|NCT00607048|12159641|FG002|STARTED|Overall Study||7
10984595|NCT00607048|12159642|FG003|STARTED|Overall Study||3
10984596|NCT00607048|12159643|FG004|STARTED|Overall Study||6
10984597|NCT00607048|12159644|FG005|STARTED|Overall Study||7
10984598|NCT00607048|12159639|FG000|COMPLETED|Overall Study||0
10984599|NCT00607048|12159640|FG001|COMPLETED|Overall Study||2
10984600|NCT00607048|12159641|FG002|COMPLETED|Overall Study||3
10984601|NCT00607048|12159642|FG003|COMPLETED|Overall Study||0
10984602|NCT00607048|12159643|FG004|COMPLETED|Overall Study||0
10984603|NCT00607048|12159644|FG005|COMPLETED|Overall Study||2
10984604|NCT00607048|12159639|FG000|NOT COMPLETED|Overall Study||3
10984605|NCT00607048|12159640|FG001|NOT COMPLETED|Overall Study||4
10984606|NCT00607048|12159641|FG002|NOT COMPLETED|Overall Study||4
10984607|NCT00607048|12159642|FG003|NOT COMPLETED|Overall Study||3
10984608|NCT00607048|12159643|FG004|NOT COMPLETED|Overall Study||6
10984609|NCT00607048|12159644|FG005|NOT COMPLETED|Overall Study||5
10984610|NCT00607087|12159663|FG000|STARTED|Overall Study||99
10984611|NCT00607087|12159664|FG001|STARTED|Overall Study||95
10984612|NCT00607087|12159665|FG002|STARTED|Overall Study||94
10984613|NCT00607087|12159663|FG000|COMPLETED|Overall Study||84
10984614|NCT00607087|12159664|FG001|COMPLETED|Overall Study||84
10984615|NCT00607087|12159665|FG002|COMPLETED|Overall Study||84
10984616|NCT00607087|12159663|FG000|NOT COMPLETED|Overall Study||15
10984617|NCT00607087|12159664|FG001|NOT COMPLETED|Overall Study||11
10984618|NCT00607087|12159665|FG002|NOT COMPLETED|Overall Study||10
10984619|NCT00607087|12159663|FG000|STARTED|Period 1||99
10984620|NCT00607087|12159664|FG001|STARTED|Period 1||95
10984621|NCT00607087|12159665|FG002|STARTED|Period 1||94
10984622|NCT00607087|12159663|FG000|COMPLETED|Period 1||87
10984623|NCT00607087|12159664|FG001|COMPLETED|Period 1||89
10984624|NCT00607087|12159665|FG002|COMPLETED|Period 1||89
10984625|NCT00607087|12159663|FG000|NOT COMPLETED|Period 1||12
10984626|NCT00607087|12159664|FG001|NOT COMPLETED|Period 1||6
10984627|NCT00607087|12159665|FG002|NOT COMPLETED|Period 1||5
10984628|NCT00607087|12159663|FG000|STARTED|Period 2||87
10984629|NCT00607087|12159664|FG001|STARTED|Period 2||89
10984630|NCT00607087|12159665|FG002|STARTED|Period 2||89
10984631|NCT00607087|12159663|FG000|COMPLETED|Period 2||86
10984632|NCT00607087|12159664|FG001|COMPLETED|Period 2||86
10984633|NCT00607087|12159665|FG002|COMPLETED|Period 2||84
10984634|NCT00607087|12159663|FG000|NOT COMPLETED|Period 2||1
10984635|NCT00607087|12159664|FG001|NOT COMPLETED|Period 2||3
10984636|NCT00607087|12159665|FG002|NOT COMPLETED|Period 2||5
10984637|NCT00607087|12159663|FG000|STARTED|Period 3||86
10984638|NCT00607087|12159664|FG001|STARTED|Period 3||86
10984639|NCT00607087|12159665|FG002|STARTED|Period 3||84
10984640|NCT00607087|12159663|FG000|COMPLETED|Period 3||84
10984641|NCT00607087|12159664|FG001|COMPLETED|Period 3||84
10984642|NCT00607087|12159665|FG002|COMPLETED|Period 3||84
10984643|NCT00607087|12159663|FG000|NOT COMPLETED|Period 3||2
10984644|NCT00607087|12159664|FG001|NOT COMPLETED|Period 3||2
10984645|NCT00607087|12159665|FG002|NOT COMPLETED|Period 3||0
10984646|NCT00607113|12159675|FG000|STARTED|Overall Study||19
10984647|NCT00607113|12159676|FG001|STARTED|Overall Study||20
10984648|NCT00607113|12159675|FG000|COMPLETED|Overall Study||19
10984649|NCT00607113|12159676|FG001|COMPLETED|Overall Study||20
10984650|NCT00607113|12159675|FG000|NOT COMPLETED|Overall Study||0
10984651|NCT00607113|12159676|FG001|NOT COMPLETED|Overall Study||0
10984652|NCT00607126|12159683|FG000|STARTED|Overall Study||17
10984653|NCT00607126|12159684|FG001|STARTED|Overall Study||19
10984654|NCT00607126|12159683|FG000|COMPLETED|Overall Study||17
10984655|NCT00607126|12159684|FG001|COMPLETED|Overall Study||19
10984656|NCT00607126|12159683|FG000|NOT COMPLETED|Overall Study||0
10984657|NCT00607126|12159684|FG001|NOT COMPLETED|Overall Study||0
10984658|NCT00607243|12159692|FG000|STARTED|Initial Post-vaccination Period||82
10984659|NCT00607243|12159693|FG001|STARTED|Initial Post-vaccination Period||41
10984660|NCT00607243|12159692|FG000|COMPLETED|Initial Post-vaccination Period||82
10984661|NCT00607243|12159693|FG001|COMPLETED|Initial Post-vaccination Period||41
10984662|NCT00607243|12159692|FG000|NOT COMPLETED|Initial Post-vaccination Period||0
10984663|NCT00607243|12159693|FG001|NOT COMPLETED|Initial Post-vaccination Period||0
10984664|NCT00607243|12159692|FG000|STARTED|Telephone Safety Assessment Period||82
10984665|NCT00607243|12159693|FG001|STARTED|Telephone Safety Assessment Period||41
10984666|NCT00607243|12159692|FG000|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
10984667|NCT00607243|12159693|FG001|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
10984668|NCT00607243|12159692|FG000|NOT COMPLETED|Telephone Safety Assessment Period||5
10984669|NCT00607243|12159693|FG001|NOT COMPLETED|Telephone Safety Assessment Period||2
10984670|NCT00607269|12159701|FG000|STARTED|Overall Study||67
10984671|NCT00607269|12159702|FG001|STARTED|Overall Study||64
10984672|NCT00607269|12159701|FG000|COMPLETED|Overall Study||67
10984673|NCT00607269|12159702|FG001|COMPLETED|Overall Study||64
10984674|NCT00607269|12159701|FG000|NOT COMPLETED|Overall Study||0
10984675|NCT00607269|12159702|FG001|NOT COMPLETED|Overall Study||0
10984676|NCT00607321|12159708|FG000|STARTED|Overall Study||60
10984677|NCT00607321|12159708|FG000|COMPLETED|Overall Study||60
10984678|NCT00607321|12159708|FG000|NOT COMPLETED|Overall Study||0
10984679|NCT00607373|12159716|FG000|STARTED|Treatment Period||17
10984680|NCT00607373|12159717|FG001|STARTED|Treatment Period||34
10984681|NCT00607373|12159716|FG000|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
10984682|NCT00607373|12159717|FG001|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
10984683|NCT00607373|12159716|FG000|NOT COMPLETED|Treatment Period||0
10984684|NCT00607373|12159717|FG001|NOT COMPLETED|Treatment Period||6
10984685|NCT00607373|12159716|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
10984686|NCT00607373|12159717|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
10984687|NCT00607373|12159716|FG000|COMPLETED|Follow-up Period||0
10984688|NCT00607373|12159717|FG001|COMPLETED|Follow-up Period||6
10984689|NCT00607373|12159716|FG000|NOT COMPLETED|Follow-up Period||1
10984690|NCT00607373|12159717|FG001|NOT COMPLETED|Follow-up Period||5
10984691|NCT00607386|12159723|FG000|STARTED|Overall Study||28
10984692|NCT00607386|12159723|FG000|COMPLETED|Overall Study||27
10984693|NCT00607386|12159723|FG000|NOT COMPLETED|Overall Study||1
10984694|NCT00607594|12159727|FG000|STARTED|Overall Study||21
10984695|NCT00607594|12159727|FG000|COMPLETED|Overall Study||21
10984696|NCT00607594|12159727|FG000|NOT COMPLETED|Overall Study||0
10984697|NCT00607620|12159735|FG000|STARTED|Overall Study||409
10984698|NCT00607620|12159736|FG001|STARTED|Overall Study||469
10984699|NCT00607620|12159735|FG000|COMPLETED|Overall Study||409
10984700|NCT00607620|12159736|FG001|COMPLETED|Overall Study||469
10984701|NCT00607620|12159735|FG000|NOT COMPLETED|Overall Study||0
10984702|NCT00607620|12159736|FG001|NOT COMPLETED|Overall Study||0
10984703|NCT00607672|12159745|FG000|STARTED|Overall Study||32
10984704|NCT00607672|12159746|FG001|STARTED|Overall Study||27
10984705|NCT00607672|12159747|FG002|STARTED|Overall Study||27
10984706|NCT00607672|12159745|FG000|COMPLETED|Overall Study||28
10984707|NCT00607672|12159746|FG001|COMPLETED|Overall Study||24
10984708|NCT00607672|12159747|FG002|COMPLETED|Overall Study||22
10984709|NCT00607672|12159745|FG000|NOT COMPLETED|Overall Study||4
10984710|NCT00607672|12159746|FG001|NOT COMPLETED|Overall Study||3
10984711|NCT00607672|12159747|FG002|NOT COMPLETED|Overall Study||5
10984712|NCT00607724|12159765|FG000|STARTED|Stage 1: Dose Escalation||7
10984713|NCT00607724|12159766|FG001|STARTED|Stage 1: Dose Escalation||9
10984714|NCT00607724|12159767|FG002|STARTED|Stage 1: Dose Escalation||4
10984715|NCT00607724|12159768|FG003|STARTED|Stage 1: Dose Escalation||0
10984716|NCT00607724|12159769|FG004|STARTED|Stage 1: Dose Escalation||0
10984717|NCT00607724|12159770|FG005|STARTED|Stage 1: Dose Escalation||0
10984718|NCT00607724|12159771|FG006|STARTED|Stage 1: Dose Escalation||0
10984719|NCT00607724|12159765|FG000|COMPLETED|Stage 1: Dose Escalation||0
10984720|NCT00607724|12159766|FG001|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered 'completers'.|1
10984721|NCT00607724|12159767|FG002|COMPLETED|Stage 1: Dose Escalation||0
10984722|NCT00607724|12159768|FG003|COMPLETED|Stage 1: Dose Escalation||0
10984723|NCT00607724|12159769|FG004|COMPLETED|Stage 1: Dose Escalation||0
10984724|NCT00607724|12159770|FG005|COMPLETED|Stage 1: Dose Escalation||0
10984725|NCT00607724|12159771|FG006|COMPLETED|Stage 1: Dose Escalation||0
10984726|NCT00607724|12159765|FG000|NOT COMPLETED|Stage 1: Dose Escalation||7
10984727|NCT00607724|12159766|FG001|NOT COMPLETED|Stage 1: Dose Escalation||8
10984728|NCT00607724|12159767|FG002|NOT COMPLETED|Stage 1: Dose Escalation||4
10984729|NCT00607724|12159768|FG003|NOT COMPLETED|Stage 1: Dose Escalation||0
10984730|NCT00607724|12159769|FG004|NOT COMPLETED|Stage 1: Dose Escalation||0
10984731|NCT00607724|12159770|FG005|NOT COMPLETED|Stage 1: Dose Escalation||0
10984732|NCT00607724|12159771|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0
10984733|NCT00607724|12159765|FG000|STARTED|Stage 2: Expanded Cohort||0
10984734|NCT00607724|12159766|FG001|STARTED|Stage 2: Expanded Cohort||0
10984735|NCT00607724|12159767|FG002|STARTED|Stage 2: Expanded Cohort||0
10984736|NCT00607724|12159768|FG003|STARTED|Stage 2: Expanded Cohort||6
10984737|NCT00607724|12159769|FG004|STARTED|Stage 2: Expanded Cohort||14
10984738|NCT00607724|12159770|FG005|STARTED|Stage 2: Expanded Cohort||12
10984739|NCT00607724|12159771|FG006|STARTED|Stage 2: Expanded Cohort||16
10984740|NCT00607724|12159765|FG000|COMPLETED|Stage 2: Expanded Cohort||0
10984741|NCT00607724|12159766|FG001|COMPLETED|Stage 2: Expanded Cohort||0
10984742|NCT00607724|12159767|FG002|COMPLETED|Stage 2: Expanded Cohort||0
10984743|NCT00607724|12159768|FG003|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|1
10984744|NCT00607724|12159769|FG004|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
10984745|NCT00607724|12159770|FG005|COMPLETED|Stage 2: Expanded Cohort||0
10984746|NCT00607724|12159771|FG006|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
10984747|NCT00607724|12159765|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0
10984748|NCT00607724|12159766|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0
10984749|NCT00607724|12159767|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0
10984750|NCT00607724|12159768|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||5
10984751|NCT00607724|12159769|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||9
10984752|NCT00607724|12159770|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||12
10984753|NCT00607724|12159771|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||11
10984754|NCT00607789|12159797|FG000|STARTED|Overall Study|20 participants were randomized in each group|20
10984755|NCT00607789|12159798|FG001|STARTED|Overall Study||20
10984756|NCT00607789|12159797|FG000|COMPLETED|Overall Study||13
10984757|NCT00607789|12159798|FG001|COMPLETED|Overall Study||14
10984758|NCT00607789|12159797|FG000|NOT COMPLETED|Overall Study||7
10984759|NCT00607789|12159798|FG001|NOT COMPLETED|Overall Study||6
10984760|NCT00607815|12159806|FG000|STARTED|Overall Study||43
10984761|NCT00607815|12159807|FG001|STARTED|Overall Study||36
10984762|NCT00607815|12159806|FG000|COMPLETED|Overall Study||20
10984763|NCT00607815|12159807|FG001|COMPLETED|Overall Study||25
10984764|NCT00607815|12159806|FG000|NOT COMPLETED|Overall Study||23
10984765|NCT00607815|12159807|FG001|NOT COMPLETED|Overall Study||11
10984766|NCT00607867|12159817|FG000|STARTED|Overall Study||7
10984767|NCT00607867|12159818|FG001|STARTED|Overall Study||7
10984768|NCT00607867|12159817|FG000|COMPLETED|Overall Study||7
10984769|NCT00607867|12159818|FG001|COMPLETED|Overall Study||7
10984770|NCT00607867|12159817|FG000|NOT COMPLETED|Overall Study||0
10984771|NCT00607867|12159818|FG001|NOT COMPLETED|Overall Study||0
10984772|NCT00607880|12159826|FG000|STARTED|Overall Study||50
10984773|NCT00607880|12159827|FG001|STARTED|Overall Study||50
10984774|NCT00607880|12159826|FG000|COMPLETED|Overall Study||49
10984775|NCT00607880|12159827|FG001|COMPLETED|Overall Study||50
10984776|NCT00607880|12159826|FG000|NOT COMPLETED|Overall Study||1
10984777|NCT00607880|12159827|FG001|NOT COMPLETED|Overall Study||0
10984778|NCT00607893|12159835|FG000|STARTED|Overall Study||77
10984779|NCT00607893|12159836|FG001|STARTED|Overall Study||76
10984780|NCT00607893|12159835|FG000|Completed Baseline Visit|Overall Study||74
10984781|NCT00607893|12159836|FG001|Completed Baseline Visit|Overall Study||75
10984782|NCT00607893|12159835|FG000|Completed 8 Week Visit|Overall Study||71
10984783|NCT00607893|12159836|FG001|Completed 8 Week Visit|Overall Study||72
10984784|NCT00607893|12159835|FG000|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
10984785|NCT00607893|12159836|FG001|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
10984786|NCT00607893|12159835|FG000|COMPLETED|Overall Study||71
10984787|NCT00607893|12159836|FG001|COMPLETED|Overall Study||72
10984788|NCT00607893|12159835|FG000|NOT COMPLETED|Overall Study||6
10984789|NCT00607893|12159836|FG001|NOT COMPLETED|Overall Study||4
10984790|NCT00607919|12159846|FG000|STARTED|Acute Phase||120
10984791|NCT00607919|12159847|FG001|STARTED|Acute Phase||89
10984792|NCT00607919|12159846|FG000|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
10984793|NCT00607919|12159847|FG001|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
10984794|NCT00607919|12159846|FG000|NOT COMPLETED|Acute Phase||34
10984795|NCT00607919|12159847|FG001|NOT COMPLETED|Acute Phase||16
10984796|NCT00607919|12159846|FG000|STARTED|Open-Label Phase||84
10984797|NCT00607919|12159847|FG001|STARTED|Open-Label Phase||71
10984798|NCT00607919|12159846|FG000|COMPLETED|Open-Label Phase||74
10984799|NCT00607919|12159847|FG001|COMPLETED|Open-Label Phase||59
10984800|NCT00607919|12159846|FG000|NOT COMPLETED|Open-Label Phase||10
10984801|NCT00607919|12159847|FG001|NOT COMPLETED|Open-Label Phase||12
10984802|NCT00607997|12159859|FG000|STARTED|Overall Study||29
10984803|NCT00607997|12159860|FG001|STARTED|Overall Study||35
10984804|NCT00607997|12159861|FG002|STARTED|Overall Study||29
10984805|NCT00607997|12159862|FG003|STARTED|Overall Study||20
10984806|NCT00607997|12159859|FG000|COMPLETED|Overall Study||2
10984807|NCT00607997|12159860|FG001|COMPLETED|Overall Study||8
10984808|NCT00607997|12159861|FG002|COMPLETED|Overall Study||5
10984809|NCT00607997|12159862|FG003|COMPLETED|Overall Study||4
10984810|NCT00607997|12159859|FG000|NOT COMPLETED|Overall Study||27
10984811|NCT00607997|12159860|FG001|NOT COMPLETED|Overall Study||27
10984812|NCT00607997|12159861|FG002|NOT COMPLETED|Overall Study||24
10984813|NCT00607997|12159862|FG003|NOT COMPLETED|Overall Study||16
10984814|NCT00608062|12159883|FG000|STARTED|Overall Study|25 women completed baseline testing, 4 women withdrew prior to randomization|12
10984815|NCT00608062|12159884|FG001|STARTED|Overall Study||12
10984816|NCT00608062|12159885|FG002|STARTED|Overall Study|43 women completed baseline testing, 3 women withdrew prior to randomization|19
10984817|NCT00608062|12159886|FG003|STARTED|Overall Study||21
10984818|NCT00608062|12159887|FG004|STARTED|Overall Study||13
10984819|NCT00608062|12159888|FG005|STARTED|Overall Study||15
10984820|NCT00608062|12159883|FG000|COMPLETED|Overall Study||12
10984821|NCT00608062|12159884|FG001|COMPLETED|Overall Study||12
10984822|NCT00608062|12159885|FG002|COMPLETED|Overall Study||19
10984823|NCT00608062|12159886|FG003|COMPLETED|Overall Study||21
10984824|NCT00608062|12159887|FG004|COMPLETED|Overall Study||13
10984825|NCT00608062|12159888|FG005|COMPLETED|Overall Study||15
10984826|NCT00608062|12159883|FG000|NOT COMPLETED|Overall Study||0
10984827|NCT00608062|12159884|FG001|NOT COMPLETED|Overall Study||0
10984828|NCT00608062|12159885|FG002|NOT COMPLETED|Overall Study||0
10984829|NCT00608062|12159886|FG003|NOT COMPLETED|Overall Study||0
10984830|NCT00608062|12159887|FG004|NOT COMPLETED|Overall Study||0
10984831|NCT00608062|12159888|FG005|NOT COMPLETED|Overall Study||0
10984832|NCT00608140|12159906|FG000|STARTED|Overall Study||1
10984833|NCT00608140|12159907|FG001|STARTED|Overall Study||1
10984834|NCT00608140|12159906|FG000|COMPLETED|Overall Study|Study ended early due to low enrollment|0
10984835|NCT00608140|12159907|FG001|COMPLETED|Overall Study|Study ended early due to low enrollment|0
10984836|NCT00608140|12159906|FG000|NOT COMPLETED|Overall Study||1
10984837|NCT00608140|12159907|FG001|NOT COMPLETED|Overall Study||1
10984838|NCT00608205|12159924|FG000|STARTED|Overall Study||35
10984839|NCT00608205|12159925|FG001|STARTED|Overall Study||34
10984840|NCT00608205|12159924|FG000|COMPLETED|Overall Study||32
10984841|NCT00608205|12159925|FG001|COMPLETED|Overall Study||31
10984842|NCT00608205|12159924|FG000|NOT COMPLETED|Overall Study||3
10984843|NCT00608205|12159925|FG001|NOT COMPLETED|Overall Study||3
10984844|NCT00608244|12159933|FG000|STARTED|Overall Study||59
10984845|NCT00608244|12159933|FG000|COMPLETED|Overall Study||57
10984846|NCT00608244|12159933|FG000|NOT COMPLETED|Overall Study||2
10984847|NCT00608322|12159941|FG000|STARTED|Overall Study||26
10984848|NCT00608322|12159942|FG001|STARTED|Overall Study||23
10984849|NCT00608322|12159941|FG000|COMPLETED|Overall Study||24
10984850|NCT00608322|12159942|FG001|COMPLETED|Overall Study||22
10984851|NCT00608322|12159941|FG000|NOT COMPLETED|Overall Study||2
10984852|NCT00608322|12159942|FG001|NOT COMPLETED|Overall Study||1
10984853|NCT00608426|12159950|FG000|STARTED|Overall Study||2604
10984854|NCT00608426|12159951|FG001|STARTED|Overall Study||2519
10984855|NCT00608426|12159950|FG000|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
10984856|NCT00608426|12159951|FG001|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
10984857|NCT00608426|12159950|FG000|NOT COMPLETED|Overall Study||836
10984858|NCT00608426|12159951|FG001|NOT COMPLETED|Overall Study||905
10984859|NCT00608491|12159959|FG000|STARTED|Overall Study||94
10984860|NCT00608491|12159960|FG001|STARTED|Overall Study||94
10984861|NCT00608491|12159959|FG000|COMPLETED|Overall Study||73
10984862|NCT00608491|12159960|FG001|COMPLETED|Overall Study||72
10984863|NCT00608491|12159959|FG000|NOT COMPLETED|Overall Study||21
10984864|NCT00608491|12159960|FG001|NOT COMPLETED|Overall Study||22
10984865|NCT00608517|12159969|FG000|STARTED|Overall Study||2
10984866|NCT00608517|12159970|FG001|STARTED|Overall Study||3
10984867|NCT00608517|12159971|FG002|STARTED|Overall Study||1
10984868|NCT00608517|12159969|FG000|COMPLETED|Overall Study||1
10984869|NCT00608517|12159970|FG001|COMPLETED|Overall Study||3
10984870|NCT00608517|12159971|FG002|COMPLETED|Overall Study||1
10984871|NCT00608517|12159969|FG000|NOT COMPLETED|Overall Study||1
10984872|NCT00608517|12159970|FG001|NOT COMPLETED|Overall Study||0
10984873|NCT00608517|12159971|FG002|NOT COMPLETED|Overall Study||0
10984874|NCT00608530|12159984|FG000|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
10984875|NCT00608530|12159985|FG001|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
10984876|NCT00608530|12159986|FG002|STARTED|Study 1 Psychologist-delivered Treatment||0
10984877|NCT00608530|12159987|FG003|STARTED|Study 1 Psychologist-delivered Treatment||0
10984878|NCT00608530|12159984|FG000|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
10984879|NCT00608530|12159985|FG001|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
10984880|NCT00608530|12159986|FG002|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
10984881|NCT00608530|12159987|FG003|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
10984882|NCT00608530|12159984|FG000|COMPLETED|Study 1 Psychologist-delivered Treatment||22
10984883|NCT00608530|12159985|FG001|COMPLETED|Study 1 Psychologist-delivered Treatment||28
10984884|NCT00608530|12159986|FG002|COMPLETED|Study 1 Psychologist-delivered Treatment||0
10984885|NCT00608530|12159987|FG003|COMPLETED|Study 1 Psychologist-delivered Treatment||0
10984886|NCT00608530|12159984|FG000|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
10984887|NCT00608530|12159985|FG001|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
10984888|NCT00608530|12159986|FG002|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
10984889|NCT00608530|12159987|FG003|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
10984890|NCT00608530|12159984|FG000|STARTED|Study 2 Nurse-delivered Treatments||0
10984891|NCT00608530|12159985|FG001|STARTED|Study 2 Nurse-delivered Treatments||0
10984892|NCT00608530|12159986|FG002|STARTED|Study 2 Nurse-delivered Treatments||33
10984893|NCT00608530|12159987|FG003|STARTED|Study 2 Nurse-delivered Treatments||34
10984894|NCT00608530|12159984|FG000|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
10984895|NCT00608530|12159985|FG001|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
10984896|NCT00608530|12159986|FG002|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
10984897|NCT00608530|12159987|FG003|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
10984898|NCT00608530|12159984|FG000|COMPLETED|Study 2 Nurse-delivered Treatments||0
10984899|NCT00608530|12159985|FG001|COMPLETED|Study 2 Nurse-delivered Treatments||0
10984900|NCT00608530|12159986|FG002|COMPLETED|Study 2 Nurse-delivered Treatments||21
10984901|NCT00608530|12159987|FG003|COMPLETED|Study 2 Nurse-delivered Treatments||27
10984902|NCT00608530|12159984|FG000|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
10984903|NCT00608530|12159985|FG001|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
10984904|NCT00608530|12159986|FG002|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
10984905|NCT00608530|12159987|FG003|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
10984906|NCT00608543|12160002|FG000|STARTED|Overall Study||17
10984907|NCT00608543|12160002|FG000|COMPLETED|Overall Study||13
10984908|NCT00608543|12160002|FG000|NOT COMPLETED|Overall Study||4
10984909|NCT00608569|12160009|FG000|STARTED|Overall Study||129
10984910|NCT00608569|12160010|FG001|STARTED|Overall Study||128
10984911|NCT00608569|12160009|FG000|COMPLETED|Overall Study||119
10984912|NCT00608569|12160010|FG001|COMPLETED|Overall Study||119
10984913|NCT00608569|12160009|FG000|NOT COMPLETED|Overall Study||10
10984914|NCT00608569|12160010|FG001|NOT COMPLETED|Overall Study||9
10984915|NCT00608582|12160018|FG000|STARTED|Overall Study||14
10984916|NCT00608582|12160019|FG001|STARTED|Overall Study||11
10984917|NCT00608582|12160018|FG000|COMPLETED|Overall Study||10
10984918|NCT00608582|12160019|FG001|COMPLETED|Overall Study||7
10984919|NCT00608582|12160018|FG000|NOT COMPLETED|Overall Study||4
10984920|NCT00608582|12160019|FG001|NOT COMPLETED|Overall Study||4
10984921|NCT00608634|12160030|FG000|STARTED|Overall Study||28
10984922|NCT00608634|12160031|FG001|STARTED|Overall Study||27
10984923|NCT00608634|12160032|FG002|STARTED|Overall Study||28
10984924|NCT00608634|12160030|FG000|COMPLETED|Overall Study||26
10984925|NCT00608634|12160031|FG001|COMPLETED|Overall Study||26
10984926|NCT00608634|12160032|FG002|COMPLETED|Overall Study||27
10984927|NCT00608634|12160030|FG000|NOT COMPLETED|Overall Study||2
10984928|NCT00608634|12160031|FG001|NOT COMPLETED|Overall Study||1
10984929|NCT00608634|12160032|FG002|NOT COMPLETED|Overall Study||1
10984930|NCT00608829|12160042|FG000|STARTED|Overall Study||23
10984931|NCT00608829|12160042|FG000|COMPLETED|Overall Study||8
10984932|NCT00608829|12160042|FG000|NOT COMPLETED|Overall Study||15
10984933|NCT00608842|12160050|FG000|STARTED|Overall Study||15
10984934|NCT00608842|12160051|FG001|STARTED|Overall Study||15
10984935|NCT00608842|12160052|FG002|STARTED|Overall Study||15
10984936|NCT00608842|12160053|FG003|STARTED|Overall Study||17
10984937|NCT00608842|12160050|FG000|COMPLETED|Overall Study||14
10984938|NCT00608842|12160051|FG001|COMPLETED|Overall Study||14
10984939|NCT00608842|12160052|FG002|COMPLETED|Overall Study||13
10984940|NCT00608842|12160053|FG003|COMPLETED|Overall Study||16
10984941|NCT00608842|12160050|FG000|NOT COMPLETED|Overall Study||1
10984942|NCT00608842|12160051|FG001|NOT COMPLETED|Overall Study||1
10984943|NCT00608842|12160052|FG002|NOT COMPLETED|Overall Study||2
10984944|NCT00608842|12160053|FG003|NOT COMPLETED|Overall Study||1
10984945|NCT00608868|12160063|FG000|STARTED|Overall Study||156
10984946|NCT00608868|12160063|FG000|Enrolled|Overall Study||156
10984947|NCT00608868|12160063|FG000|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
10984948|NCT00608868|12160063|FG000|Treatment Completed|Overall Study||141
10984949|NCT00608868|12160063|FG000|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
10984950|NCT00608868|12160063|FG000|Per Protocol (PP) Population|Overall Study||121
10984951|NCT00608868|12160063|FG000|COMPLETED|Overall Study||141
10984952|NCT00608868|12160063|FG000|NOT COMPLETED|Overall Study||15
10984953|NCT00608881|12160069|FG000|STARTED|Overall Study||303
10984954|NCT00608881|12160070|FG001|STARTED|Overall Study||306
10984955|NCT00608881|12160069|FG000|COMPLETED|Overall Study||224
10984956|NCT00608881|12160070|FG001|COMPLETED|Overall Study||240
10984957|NCT00608881|12160069|FG000|NOT COMPLETED|Overall Study||79
10984958|NCT00608881|12160070|FG001|NOT COMPLETED|Overall Study||66
10984959|NCT00608894|12160078|FG000|STARTED|Overall Study||7
10984960|NCT00608894|12160079|FG001|STARTED|Overall Study||6
10984961|NCT00608894|12160078|FG000|COMPLETED|Overall Study||7
10984962|NCT00608894|12160079|FG001|COMPLETED|Overall Study|One patient was granted permission to crossover to LCP-Tacro due to treatment intolerance|4
10984963|NCT00608894|12160078|FG000|NOT COMPLETED|Overall Study||0
10984964|NCT00608894|12160079|FG001|NOT COMPLETED|Overall Study||2
10984965|NCT00608907|12160090|FG000|STARTED|Overall Study||30
10984966|NCT00608907|12160091|FG001|STARTED|Overall Study||13
10984967|NCT00608907|12160092|FG002|STARTED|Overall Study||18
10984968|NCT00608907|12160090|FG000|COMPLETED|Overall Study||18
10984969|NCT00608907|12160091|FG001|COMPLETED|Overall Study||13
10984970|NCT00608907|12160092|FG002|COMPLETED|Overall Study||17
10984971|NCT00608907|12160090|FG000|NOT COMPLETED|Overall Study||12
10984972|NCT00608907|12160091|FG001|NOT COMPLETED|Overall Study||0
10984973|NCT00608907|12160092|FG002|NOT COMPLETED|Overall Study||1
10984974|NCT00608959|12160102|FG000|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
10984975|NCT00608959|12160102|FG000|COMPLETED|Part 1||24
10984976|NCT00608959|12160102|FG000|NOT COMPLETED|Part 1||1
10984977|NCT00608959|12160102|FG000|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
10984978|NCT00608959|12160102|FG000|COMPLETED|Part 2||25
10984979|NCT00608959|12160102|FG000|NOT COMPLETED|Part 2||0
10984980|NCT00608985|12160116|FG000|STARTED|Overall Study|Randomized and started double-blind treatment|177
10984981|NCT00608985|12160117|FG001|STARTED|Overall Study|Randomized and started double-blind treatment|186
10984982|NCT00608985|12160118|FG002|STARTED|Overall Study|Randomized and started double-blind treatment|176
10984983|NCT00608985|12160119|FG003|STARTED|Overall Study|Randomized and started double-blind treatment|168
10984984|NCT00608985|12160116|FG000|Completed Double-blind Treatment|Overall Study||163
10984985|NCT00608985|12160117|FG001|Completed Double-blind Treatment|Overall Study||174
10984986|NCT00608985|12160118|FG002|Completed Double-blind Treatment|Overall Study||171
10984987|NCT00608985|12160119|FG003|Completed Double-blind Treatment|Overall Study||161
10984988|NCT00608985|12160116|FG000|COMPLETED|Overall Study|Completed follow-up|161
10984989|NCT00608985|12160117|FG001|COMPLETED|Overall Study|Completed follow-up|173
10984990|NCT00608985|12160118|FG002|COMPLETED|Overall Study|Completed follow-up|170
10984991|NCT00608985|12160119|FG003|COMPLETED|Overall Study|Completed follow-up|159
10984992|NCT00608985|12160116|FG000|NOT COMPLETED|Overall Study||16
10984993|NCT00608985|12160117|FG001|NOT COMPLETED|Overall Study||13
10984994|NCT00608985|12160118|FG002|NOT COMPLETED|Overall Study||6
10984995|NCT00608985|12160119|FG003|NOT COMPLETED|Overall Study||9
10984996|NCT00609128|12160129|FG000|STARTED|Overall Study||21
10984997|NCT00609128|12160129|FG000|COMPLETED|Overall Study||21
10984998|NCT00609128|12160129|FG000|NOT COMPLETED|Overall Study||0
10984999|NCT00609167|12160136|FG000|STARTED|Overall Study||33
10985000|NCT00609167|12160137|FG001|STARTED|Overall Study||30
10985001|NCT00609167|12160136|FG000|COMPLETED|Overall Study||25
10985002|NCT00609167|12160137|FG001|COMPLETED|Overall Study||23
10985003|NCT00609167|12160136|FG000|NOT COMPLETED|Overall Study||8
10985004|NCT00609167|12160137|FG001|NOT COMPLETED|Overall Study||7
10985005|NCT00609245|12160143|FG000|STARTED|Overall Study||13
10985006|NCT00609245|12160143|FG000|COMPLETED|Overall Study||12
10985007|NCT00609245|12160143|FG000|NOT COMPLETED|Overall Study||1
10985008|NCT00609271|12160151|FG000|STARTED|Overall Study||75
10985009|NCT00609271|12160152|FG001|STARTED|Overall Study||73
10985010|NCT00609271|12160151|FG000|COMPLETED|Overall Study||59
10985011|NCT00609271|12160152|FG001|COMPLETED|Overall Study||60
10985012|NCT00609271|12160151|FG000|NOT COMPLETED|Overall Study||16
10985013|NCT00609271|12160152|FG001|NOT COMPLETED|Overall Study||13
10985014|NCT00609336|12160158|FG000|STARTED|Overall Study||35
10985015|NCT00609336|12160158|FG000|Surgery|Overall Study||22
10985016|NCT00609336|12160158|FG000|COMPLETED|Overall Study||22
10985017|NCT00609336|12160158|FG000|NOT COMPLETED|Overall Study||13
10985018|NCT00609362|12160165|FG000|STARTED|Overall Study||29
10985019|NCT00609362|12160166|FG001|STARTED|Overall Study||28
10985020|NCT00609362|12160165|FG000|COMPLETED|Overall Study||26
10985021|NCT00609362|12160166|FG001|COMPLETED|Overall Study||27
10985022|NCT00609362|12160165|FG000|NOT COMPLETED|Overall Study||3
10985023|NCT00609362|12160166|FG001|NOT COMPLETED|Overall Study||1
10985024|NCT00609466|12160175|FG000|STARTED|Overall Study||96
10985025|NCT00609466|12160176|FG001|STARTED|Overall Study||96
10985026|NCT00609466|12160177|FG002|STARTED|Overall Study||99
10985027|NCT00609466|12160175|FG000|COMPLETED|Overall Study||94
10985028|NCT00609466|12160176|FG001|COMPLETED|Overall Study||90
10985029|NCT00609466|12160177|FG002|COMPLETED|Overall Study||95
10985030|NCT00609466|12160175|FG000|NOT COMPLETED|Overall Study||2
10985031|NCT00609466|12160176|FG001|NOT COMPLETED|Overall Study||6
10985032|NCT00609466|12160177|FG002|NOT COMPLETED|Overall Study||4
10985033|NCT00609492|12160188|FG000|STARTED|Overall Study||44
10985034|NCT00609492|12160189|FG001|STARTED|Overall Study||72
10985035|NCT00609492|12160190|FG002|STARTED|Overall Study||129
10985036|NCT00609492|12160188|FG000|COMPLETED|Overall Study||43
10985037|NCT00609492|12160189|FG001|COMPLETED|Overall Study||69
10985038|NCT00609492|12160190|FG002|COMPLETED|Overall Study||122
10985039|NCT00609492|12160188|FG000|NOT COMPLETED|Overall Study||1
10985040|NCT00609492|12160189|FG001|NOT COMPLETED|Overall Study||3
10985041|NCT00609492|12160190|FG002|NOT COMPLETED|Overall Study||7
10985042|NCT00609518|12160202|FG000|STARTED|Overall Study||54
10985043|NCT00609518|12160203|FG001|STARTED|Overall Study||57
10985044|NCT00609518|12160202|FG000|Completed 6 Treatment Cycles|Overall Study||19
10985045|NCT00609518|12160203|FG001|Completed 6 Treatment Cycles|Overall Study||22
10985046|NCT00609518|12160202|FG000|COMPLETED|Overall Study||11
10985047|NCT00609518|12160203|FG001|COMPLETED|Overall Study||17
10985048|NCT00609518|12160202|FG000|NOT COMPLETED|Overall Study||43
10985049|NCT00609518|12160203|FG001|NOT COMPLETED|Overall Study||40
10985050|NCT00609609|12160211|FG000|STARTED|Overall Study||30
10985051|NCT00609609|12160212|FG001|STARTED|Overall Study||51
10985052|NCT00609609|12160211|FG000|COMPLETED|Overall Study||24
10985053|NCT00609609|12160212|FG001|COMPLETED|Overall Study||49
10985054|NCT00609609|12160211|FG000|NOT COMPLETED|Overall Study||6
10985055|NCT00609609|12160212|FG001|NOT COMPLETED|Overall Study||2
10985056|NCT00609622|12160220|FG000|STARTED|Overall Study||96
10985057|NCT00609622|12160221|FG001|STARTED|Overall Study||95
10985058|NCT00609622|12160220|FG000|COMPLETED|Overall Study||0
10985059|NCT00609622|12160221|FG001|COMPLETED|Overall Study||0
10985060|NCT00609622|12160220|FG000|NOT COMPLETED|Overall Study||96
10985061|NCT00609622|12160221|FG001|NOT COMPLETED|Overall Study||95
10985062|NCT00609674|12160229|FG000|STARTED|Overall Study||155
10985063|NCT00609674|12160230|FG001|STARTED|Overall Study||160
10985064|NCT00609674|12160229|FG000|COMPLETED|Overall Study||148
10985065|NCT00609674|12160230|FG001|COMPLETED|Overall Study||153
10985066|NCT00609674|12160229|FG000|NOT COMPLETED|Overall Study||7
10985067|NCT00609674|12160230|FG001|NOT COMPLETED|Overall Study||7
10985068|NCT00609739|12160236|FG000|STARTED|Overall Study||1
10985069|NCT00609739|12160236|FG000|COMPLETED|Overall Study||1
10985070|NCT00609739|12160236|FG000|NOT COMPLETED|Overall Study||0
10985071|NCT00609804|12160242|FG000|STARTED|Overall Study||25
10985072|NCT00609804|12160243|FG001|STARTED|Overall Study||28
10985073|NCT00609804|12160242|FG000|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
10985074|NCT00609804|12160243|FG001|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
10985075|NCT00609804|12160242|FG000|NOT COMPLETED|Overall Study||25
10985076|NCT00609804|12160243|FG001|NOT COMPLETED|Overall Study||28
10985077|NCT00609869|12160252|FG000|STARTED|Overall Study||29
10985078|NCT00609869|12160252|FG000|COMPLETED|Overall Study||18
10985079|NCT00609869|12160252|FG000|NOT COMPLETED|Overall Study||11
10985080|NCT00609947|12160256|FG000|STARTED|Overall Study||241
10985081|NCT00609947|12160256|FG000|COMPLETED|Overall Study|One death due to automobile accident.|240
10985082|NCT00609947|12160256|FG000|NOT COMPLETED|Overall Study||1
10985083|NCT00609973|12160263|FG000|STARTED|Overall Study||17
10985084|NCT00609973|12160264|FG001|STARTED|Overall Study||16
10985085|NCT00609973|12160263|FG000|COMPLETED|Overall Study||9
10985086|NCT00609973|12160264|FG001|COMPLETED|Overall Study||10
10985087|NCT00609973|12160263|FG000|NOT COMPLETED|Overall Study||8
10985088|NCT00609973|12160264|FG001|NOT COMPLETED|Overall Study||6
10985089|NCT00609986|12160272|FG000|STARTED|Overall Study||52
10985090|NCT00609986|12160273|FG001|STARTED|Overall Study||52
10985091|NCT00609986|12160272|FG000|Received Transplant|Overall Study||44
10985092|NCT00609986|12160273|FG001|Received Transplant|Overall Study||49
10985093|NCT00609986|12160272|FG000|COMPLETED|Overall Study||44
10985094|NCT00609986|12160273|FG001|COMPLETED|Overall Study||49
10985095|NCT00609986|12160272|FG000|NOT COMPLETED|Overall Study||8
10985096|NCT00609986|12160273|FG001|NOT COMPLETED|Overall Study||3
10985097|NCT00610116|12160279|FG000|STARTED|Overall Study||305
10985098|NCT00610116|12160279|FG000|COMPLETED|Overall Study|Number of analyzable patients|292
10985099|NCT00610116|12160279|FG000|NOT COMPLETED|Overall Study||13
10985100|NCT00610129|12160283|FG000|STARTED|Overall Study||28
10985101|NCT00610129|12160283|FG000|COMPLETED|Overall Study||25
10985102|NCT00610129|12160283|FG000|NOT COMPLETED|Overall Study||3
10985103|NCT00610155|12160287|FG000|STARTED|Period 1||4
10985104|NCT00610155|12160288|FG001|STARTED|Period 1||3
10985105|NCT00610155|12160289|FG002|STARTED|Period 1||4
10985106|NCT00610155|12160290|FG003|STARTED|Period 1||3
10985107|NCT00610155|12160291|FG004|STARTED|Period 1||3
10985108|NCT00610155|12160292|FG005|STARTED|Period 1||1
10985109|NCT00610155|12160287|FG000|COMPLETED|Period 1||4
10985110|NCT00610155|12160288|FG001|COMPLETED|Period 1||3
10985111|NCT00610155|12160289|FG002|COMPLETED|Period 1||3
10985112|NCT00610155|12160290|FG003|COMPLETED|Period 1||3
10985113|NCT00610155|12160291|FG004|COMPLETED|Period 1||3
10985114|NCT00610155|12160292|FG005|COMPLETED|Period 1||1
10985115|NCT00610155|12160287|FG000|NOT COMPLETED|Period 1||0
10985116|NCT00610155|12160288|FG001|NOT COMPLETED|Period 1||0
10985117|NCT00610155|12160289|FG002|NOT COMPLETED|Period 1||1
10985118|NCT00610155|12160290|FG003|NOT COMPLETED|Period 1||0
10985119|NCT00610155|12160291|FG004|NOT COMPLETED|Period 1||0
10985120|NCT00610155|12160292|FG005|NOT COMPLETED|Period 1||0
10985121|NCT00610155|12160287|FG000|STARTED|Washout Period 1 (7 Days)||4
10985122|NCT00610155|12160288|FG001|STARTED|Washout Period 1 (7 Days)||3
10985123|NCT00610155|12160289|FG002|STARTED|Washout Period 1 (7 Days)||3
10985124|NCT00610155|12160290|FG003|STARTED|Washout Period 1 (7 Days)||3
10985125|NCT00610155|12160291|FG004|STARTED|Washout Period 1 (7 Days)||3
10985126|NCT00610155|12160292|FG005|STARTED|Washout Period 1 (7 Days)||1
10985127|NCT00610155|12160287|FG000|COMPLETED|Washout Period 1 (7 Days)||4
10985128|NCT00610155|12160288|FG001|COMPLETED|Washout Period 1 (7 Days)||3
10985129|NCT00610155|12160289|FG002|COMPLETED|Washout Period 1 (7 Days)||3
10985130|NCT00610155|12160290|FG003|COMPLETED|Washout Period 1 (7 Days)||3
10985131|NCT00610155|12160291|FG004|COMPLETED|Washout Period 1 (7 Days)||3
10985132|NCT00610155|12160292|FG005|COMPLETED|Washout Period 1 (7 Days)||1
10985133|NCT00610155|12160287|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
10985134|NCT00610155|12160288|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
10985135|NCT00610155|12160289|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
10985136|NCT00610155|12160290|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
10985137|NCT00610155|12160291|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
10985138|NCT00610155|12160292|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
10985139|NCT00610155|12160287|FG000|STARTED|Period 2||4
10985140|NCT00610155|12160288|FG001|STARTED|Period 2||3
10985141|NCT00610155|12160289|FG002|STARTED|Period 2||3
10985142|NCT00610155|12160290|FG003|STARTED|Period 2||3
10985143|NCT00610155|12160291|FG004|STARTED|Period 2||3
10985144|NCT00610155|12160292|FG005|STARTED|Period 2||1
10985145|NCT00610155|12160287|FG000|COMPLETED|Period 2||4
10985146|NCT00610155|12160288|FG001|COMPLETED|Period 2||3
10985147|NCT00610155|12160289|FG002|COMPLETED|Period 2||3
10985148|NCT00610155|12160290|FG003|COMPLETED|Period 2||3
10985149|NCT00610155|12160291|FG004|COMPLETED|Period 2||3
10985150|NCT00610155|12160292|FG005|COMPLETED|Period 2||1
10985151|NCT00610155|12160287|FG000|NOT COMPLETED|Period 2||0
10985152|NCT00610155|12160288|FG001|NOT COMPLETED|Period 2||0
10985153|NCT00610155|12160289|FG002|NOT COMPLETED|Period 2||0
10985154|NCT00610155|12160290|FG003|NOT COMPLETED|Period 2||0
10985155|NCT00610155|12160291|FG004|NOT COMPLETED|Period 2||0
10985156|NCT00610155|12160292|FG005|NOT COMPLETED|Period 2||0
10985157|NCT00610155|12160287|FG000|STARTED|Washout Period 2 (7 Days)||4
10985158|NCT00610155|12160288|FG001|STARTED|Washout Period 2 (7 Days)||3
10985159|NCT00610155|12160289|FG002|STARTED|Washout Period 2 (7 Days)||3
10985160|NCT00610155|12160290|FG003|STARTED|Washout Period 2 (7 Days)||3
10985161|NCT00610155|12160291|FG004|STARTED|Washout Period 2 (7 Days)||3
10985162|NCT00610155|12160292|FG005|STARTED|Washout Period 2 (7 Days)||1
10985163|NCT00610155|12160287|FG000|COMPLETED|Washout Period 2 (7 Days)||4
10985164|NCT00610155|12160288|FG001|COMPLETED|Washout Period 2 (7 Days)||3
10985165|NCT00610155|12160289|FG002|COMPLETED|Washout Period 2 (7 Days)||3
10985166|NCT00610155|12160290|FG003|COMPLETED|Washout Period 2 (7 Days)||3
10985167|NCT00610155|12160291|FG004|COMPLETED|Washout Period 2 (7 Days)||3
10985168|NCT00610155|12160292|FG005|COMPLETED|Washout Period 2 (7 Days)||1
10985169|NCT00610155|12160287|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
10985170|NCT00610155|12160288|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
10985171|NCT00610155|12160289|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
10985172|NCT00610155|12160290|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
10985173|NCT00610155|12160291|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
10985174|NCT00610155|12160292|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
10985175|NCT00610155|12160287|FG000|STARTED|Period 3||4
10985176|NCT00610155|12160288|FG001|STARTED|Period 3||3
10985177|NCT00610155|12160289|FG002|STARTED|Period 3||3
10985178|NCT00610155|12160290|FG003|STARTED|Period 3||3
10985179|NCT00610155|12160291|FG004|STARTED|Period 3||3
10985180|NCT00610155|12160292|FG005|STARTED|Period 3||1
10985181|NCT00610155|12160287|FG000|COMPLETED|Period 3||3
10985182|NCT00610155|12160288|FG001|COMPLETED|Period 3||3
10985183|NCT00610155|12160289|FG002|COMPLETED|Period 3||3
10985184|NCT00610155|12160290|FG003|COMPLETED|Period 3||3
10985185|NCT00610155|12160291|FG004|COMPLETED|Period 3||3
10985186|NCT00610155|12160292|FG005|COMPLETED|Period 3||1
10985187|NCT00610155|12160287|FG000|NOT COMPLETED|Period 3||1
10985188|NCT00610155|12160288|FG001|NOT COMPLETED|Period 3||0
10985189|NCT00610155|12160289|FG002|NOT COMPLETED|Period 3||0
10985190|NCT00610155|12160290|FG003|NOT COMPLETED|Period 3||0
10985191|NCT00610155|12160291|FG004|NOT COMPLETED|Period 3||0
10985192|NCT00610155|12160292|FG005|NOT COMPLETED|Period 3||0
10985193|NCT00610168|12160302|FG000|STARTED|Overall Study||75
10985194|NCT00610168|12160303|FG001|STARTED|Overall Study||7
10985195|NCT00610168|12160302|FG000|COMPLETED|Overall Study||73
10985196|NCT00610168|12160303|FG001|COMPLETED|Overall Study||7
10985197|NCT00610168|12160302|FG000|NOT COMPLETED|Overall Study||2
10985198|NCT00610168|12160303|FG001|NOT COMPLETED|Overall Study||0
10985199|NCT00610207|12160309|FG000|STARTED|Overall Study||21
10985200|NCT00610207|12160309|FG000|COMPLETED|Overall Study||18
10985201|NCT00610207|12160309|FG000|NOT COMPLETED|Overall Study||3
10985202|NCT00610311|12160313|FG000|STARTED|Overall Study||3
10985203|NCT00610311|12160313|FG000|COMPLETED|Overall Study||3
10985204|NCT00610311|12160313|FG000|NOT COMPLETED|Overall Study||0
10985205|NCT00610363|12160319|FG000|STARTED|Overall Study||42
10985206|NCT00610363|12160320|FG001|STARTED|Overall Study||41
10985207|NCT00610363|12160319|FG000|COMPLETED|Overall Study||31
10985208|NCT00610363|12160320|FG001|COMPLETED|Overall Study||38
10985209|NCT00610363|12160319|FG000|NOT COMPLETED|Overall Study||11
10985210|NCT00610363|12160320|FG001|NOT COMPLETED|Overall Study||3
10985211|NCT00610428|12160330|FG000|STARTED|Overall Study||24
10985212|NCT00610428|12160331|FG001|STARTED|Overall Study||24
10985213|NCT00610428|12160332|FG002|STARTED|Overall Study||27
10985214|NCT00610428|12160330|FG000|COMPLETED|Overall Study||24
10985215|NCT00610428|12160331|FG001|COMPLETED|Overall Study||23
10985216|NCT00610428|12160332|FG002|COMPLETED|Overall Study||25
10985217|NCT00610428|12160330|FG000|NOT COMPLETED|Overall Study||0
10985218|NCT00610428|12160331|FG001|NOT COMPLETED|Overall Study||1
10985219|NCT00610428|12160332|FG002|NOT COMPLETED|Overall Study||2
10985220|NCT00610441|12160344|FG000|STARTED|Treatment Period 1 - 3 Weeks||15
10985221|NCT00610441|12160345|FG001|STARTED|Treatment Period 1 - 3 Weeks||16
10985222|NCT00610441|12160346|FG002|STARTED|Treatment Period 1 - 3 Weeks||18
10985223|NCT00610441|12160347|FG003|STARTED|Treatment Period 1 - 3 Weeks||18
10985224|NCT00610441|12160344|FG000|COMPLETED|Treatment Period 1 - 3 Weeks||12
10985225|NCT00610441|12160345|FG001|COMPLETED|Treatment Period 1 - 3 Weeks||14
10985226|NCT00610441|12160346|FG002|COMPLETED|Treatment Period 1 - 3 Weeks||11
10985227|NCT00610441|12160347|FG003|COMPLETED|Treatment Period 1 - 3 Weeks||16
10985228|NCT00610441|12160344|FG000|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
10985229|NCT00610441|12160345|FG001|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
10985230|NCT00610441|12160346|FG002|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
10985231|NCT00610441|12160347|FG003|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
10985232|NCT00610441|12160344|FG000|STARTED|Placebo Washout Period - 2 Weeks||12
10985233|NCT00610441|12160345|FG001|STARTED|Placebo Washout Period - 2 Weeks||14
10985234|NCT00610441|12160346|FG002|STARTED|Placebo Washout Period - 2 Weeks||11
10985235|NCT00610441|12160347|FG003|STARTED|Placebo Washout Period - 2 Weeks||16
10985236|NCT00610441|12160344|FG000|COMPLETED|Placebo Washout Period - 2 Weeks||12
10985237|NCT00610441|12160345|FG001|COMPLETED|Placebo Washout Period - 2 Weeks||13
10985238|NCT00610441|12160346|FG002|COMPLETED|Placebo Washout Period - 2 Weeks||9
10985239|NCT00610441|12160347|FG003|COMPLETED|Placebo Washout Period - 2 Weeks||16
10985240|NCT00610441|12160344|FG000|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
10985241|NCT00610441|12160345|FG001|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
10985242|NCT00610441|12160346|FG002|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
10985243|NCT00610441|12160347|FG003|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
10985244|NCT00610441|12160344|FG000|STARTED|Treatment Period 2 - 3 Weeks||12
10985245|NCT00610441|12160345|FG001|STARTED|Treatment Period 2 - 3 Weeks||13
10985246|NCT00610441|12160346|FG002|STARTED|Treatment Period 2 - 3 Weeks||9
10985247|NCT00610441|12160347|FG003|STARTED|Treatment Period 2 - 3 Weeks||16
10985248|NCT00610441|12160344|FG000|COMPLETED|Treatment Period 2 - 3 Weeks||10
10985249|NCT00610441|12160345|FG001|COMPLETED|Treatment Period 2 - 3 Weeks||12
10985250|NCT00610441|12160346|FG002|COMPLETED|Treatment Period 2 - 3 Weeks||9
10985251|NCT00610441|12160347|FG003|COMPLETED|Treatment Period 2 - 3 Weeks||14
10985252|NCT00610441|12160344|FG000|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
10985253|NCT00610441|12160345|FG001|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
10985254|NCT00610441|12160346|FG002|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
10985255|NCT00610441|12160347|FG003|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
10985256|NCT00610480|12160361|FG000|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
10985257|NCT00610480|12160362|FG001|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
10985258|NCT00610480|12160361|FG000|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
10985259|NCT00610480|12160362|FG001|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
10985260|NCT00610480|12160361|FG000|NOT COMPLETED|Overall Study||0
10985261|NCT00610480|12160362|FG001|NOT COMPLETED|Overall Study||0
10985262|NCT00610649|12160379|FG000|STARTED|Overall Study||4
10985263|NCT00610649|12160380|FG001|STARTED|Overall Study||2
10985264|NCT00610649|12160381|FG002|STARTED|Overall Study||4
10985265|NCT00610649|12160382|FG003|STARTED|Overall Study||2
10985266|NCT00610649|12160383|FG004|STARTED|Overall Study||4
10985267|NCT00610649|12160384|FG005|STARTED|Overall Study||2
10985268|NCT00610649|12160385|FG006|STARTED|Overall Study||4
10985269|NCT00610649|12160386|FG007|STARTED|Overall Study||2
10985270|NCT00610649|12160387|FG008|STARTED|Overall Study||10
10985271|NCT00610649|12160388|FG009|STARTED|Overall Study||10
10985272|NCT00610649|12160389|FG010|STARTED|Overall Study||10
10985273|NCT00610649|12160379|FG000|COMPLETED|Overall Study||3
10985274|NCT00610649|12160380|FG001|COMPLETED|Overall Study||1
10985275|NCT00610649|12160381|FG002|COMPLETED|Overall Study||4
10985276|NCT00610649|12160382|FG003|COMPLETED|Overall Study||2
10985277|NCT00610649|12160383|FG004|COMPLETED|Overall Study||4
10985278|NCT00610649|12160384|FG005|COMPLETED|Overall Study||2
10985279|NCT00610649|12160385|FG006|COMPLETED|Overall Study||4
10985280|NCT00610649|12160386|FG007|COMPLETED|Overall Study||2
10985281|NCT00610649|12160387|FG008|COMPLETED|Overall Study||10
10985282|NCT00610649|12160388|FG009|COMPLETED|Overall Study||9
10985283|NCT00610649|12160389|FG010|COMPLETED|Overall Study||9
10985284|NCT00610649|12160379|FG000|NOT COMPLETED|Overall Study||1
10985285|NCT00610649|12160380|FG001|NOT COMPLETED|Overall Study||1
10985286|NCT00610649|12160381|FG002|NOT COMPLETED|Overall Study||0
10985287|NCT00610649|12160382|FG003|NOT COMPLETED|Overall Study||0
10985288|NCT00610649|12160383|FG004|NOT COMPLETED|Overall Study||0
10985289|NCT00610649|12160384|FG005|NOT COMPLETED|Overall Study||0
10985290|NCT00610649|12160385|FG006|NOT COMPLETED|Overall Study||0
10985291|NCT00610649|12160386|FG007|NOT COMPLETED|Overall Study||0
10985292|NCT00610649|12160387|FG008|NOT COMPLETED|Overall Study||0
10985293|NCT00610649|12160388|FG009|NOT COMPLETED|Overall Study||1
10985294|NCT00610649|12160389|FG010|NOT COMPLETED|Overall Study||1
10985295|NCT00610675|12160413|FG000|STARTED|Overall Study||346
10985296|NCT00610675|12160413|FG000|Treated|Overall Study||342
10985297|NCT00610675|12160413|FG000|COMPLETED|Overall Study||126
10985298|NCT00610675|12160413|FG000|NOT COMPLETED|Overall Study||220
10985299|NCT00610688|12160420|FG000|STARTED|Overall Study||64
10985300|NCT00610688|12160421|FG001|STARTED|Overall Study||65
10985301|NCT00610688|12160422|FG002|STARTED|Overall Study||63
10985302|NCT00610688|12160420|FG000|COMPLETED|Overall Study||55
10985303|NCT00610688|12160421|FG001|COMPLETED|Overall Study||52
10985304|NCT00610688|12160422|FG002|COMPLETED|Overall Study||55
10985305|NCT00610688|12160420|FG000|NOT COMPLETED|Overall Study||9
10985306|NCT00610688|12160421|FG001|NOT COMPLETED|Overall Study||13
10985307|NCT00610688|12160422|FG002|NOT COMPLETED|Overall Study||8
10985308|NCT00610701|12160432|FG000|STARTED|Overall Study||15
10985309|NCT00610701|12160433|FG001|STARTED|Overall Study||20
10985310|NCT00610701|12160432|FG000|COMPLETED|Overall Study||5
10985311|NCT00610701|12160433|FG001|COMPLETED|Overall Study||9
10985312|NCT00610701|12160432|FG000|NOT COMPLETED|Overall Study||10
10985313|NCT00610701|12160433|FG001|NOT COMPLETED|Overall Study||11
10985314|NCT00610714|12160441|FG000|STARTED|Overall Study||105
10985315|NCT00610714|12160442|FG001|STARTED|Overall Study||106
10985316|NCT00610714|12160441|FG000|COMPLETED|Overall Study||79
10985317|NCT00610714|12160442|FG001|COMPLETED|Overall Study||82
10985318|NCT00610714|12160441|FG000|NOT COMPLETED|Overall Study||26
10985319|NCT00610714|12160442|FG001|NOT COMPLETED|Overall Study||24
10985320|NCT00610727|12160454|FG000|STARTED|Overall Study||14
10985321|NCT00610727|12160455|FG001|STARTED|Overall Study||8
10985322|NCT00610727|12160456|FG002|STARTED|Overall Study||8
10985323|NCT00610727|12160457|FG003|STARTED|Overall Study||8
10985324|NCT00610727|12160458|FG004|STARTED|Overall Study||8
10985325|NCT00610727|12160459|FG005|STARTED|Overall Study||8
10985326|NCT00610727|12160454|FG000|COMPLETED|Overall Study||14
10985327|NCT00610727|12160455|FG001|COMPLETED|Overall Study||8
10985328|NCT00610727|12160456|FG002|COMPLETED|Overall Study||8
10985329|NCT00610727|12160457|FG003|COMPLETED|Overall Study||8
10985330|NCT00610727|12160458|FG004|COMPLETED|Overall Study||8
10985331|NCT00610727|12160459|FG005|COMPLETED|Overall Study||8
10985332|NCT00610727|12160454|FG000|NOT COMPLETED|Overall Study||0
10985333|NCT00610727|12160455|FG001|NOT COMPLETED|Overall Study||0
10985334|NCT00610727|12160456|FG002|NOT COMPLETED|Overall Study||0
10985335|NCT00610727|12160457|FG003|NOT COMPLETED|Overall Study||0
10985336|NCT00610727|12160458|FG004|NOT COMPLETED|Overall Study||0
10985337|NCT00610727|12160459|FG005|NOT COMPLETED|Overall Study||0
10985338|NCT00610740|12160477|FG000|STARTED|Overall Study||18
10985339|NCT00610740|12160477|FG000|COMPLETED|Overall Study||18
10985340|NCT00610740|12160477|FG000|NOT COMPLETED|Overall Study||0
10985341|NCT00610857|12160481|FG000|STARTED|Overall Study||37
10985342|NCT00610857|12160481|FG000|COMPLETED|Overall Study||35
10985343|NCT00610857|12160481|FG000|NOT COMPLETED|Overall Study||2
10985344|NCT00610883|12160485|FG000|STARTED|Overall Study||17
10985345|NCT00610883|12160485|FG000|COMPLETED|Overall Study||17
10985346|NCT00610883|12160485|FG000|NOT COMPLETED|Overall Study||0
10985347|NCT00610935|12160491|FG000|STARTED|Overall Study||25
10985348|NCT00610935|12160492|FG001|STARTED|Overall Study||57
10985349|NCT00610935|12160491|FG000|ITTI Population|Overall Study||25
10985350|NCT00610935|12160492|FG001|ITTI Population|Overall Study||55
10985351|NCT00610935|12160491|FG000|ITT Population|Overall Study||25
10985352|NCT00610935|12160492|FG001|ITT Population|Overall Study||57
10985353|NCT00610935|12160491|FG000|COMPLETED|Overall Study||24
10985354|NCT00610935|12160492|FG001|COMPLETED|Overall Study||54
10985355|NCT00610935|12160491|FG000|NOT COMPLETED|Overall Study||1
10985356|NCT00610935|12160492|FG001|NOT COMPLETED|Overall Study||3
10985357|NCT00610987|12160500|FG000|STARTED|Overall Study||75
10985358|NCT00610987|12160501|FG001|STARTED|Overall Study||71
10985359|NCT00610987|12160500|FG000|COMPLETED|Overall Study||75
10985360|NCT00610987|12160501|FG001|COMPLETED|Overall Study||71
10985361|NCT00610987|12160500|FG000|NOT COMPLETED|Overall Study||0
10985362|NCT00610987|12160501|FG001|NOT COMPLETED|Overall Study||0
10985363|NCT00611026|12160510|FG000|STARTED|Randomized to Double-blind Treatment||480
10985364|NCT00611026|12160511|FG001|STARTED|Randomized to Double-blind Treatment||974
10985365|NCT00611026|12160512|FG002|STARTED|Randomized to Double-blind Treatment||963
10985366|NCT00611026|12160510|FG000|COMPLETED|Randomized to Double-blind Treatment||478
10985367|NCT00611026|12160511|FG001|COMPLETED|Randomized to Double-blind Treatment||973
10985368|NCT00611026|12160512|FG002|COMPLETED|Randomized to Double-blind Treatment||960
10985369|NCT00611026|12160510|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||2
10985370|NCT00611026|12160511|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1
10985371|NCT00611026|12160512|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||3
10985372|NCT00611026|12160510|FG000|STARTED|Double-blind Treatment Period||478
10985373|NCT00611026|12160511|FG001|STARTED|Double-blind Treatment Period||973
10985374|NCT00611026|12160512|FG002|STARTED|Double-blind Treatment Period||960
10985375|NCT00611026|12160510|FG000|COMPLETED|Double-blind Treatment Period||431
10985376|NCT00611026|12160511|FG001|COMPLETED|Double-blind Treatment Period||885
10985377|NCT00611026|12160512|FG002|COMPLETED|Double-blind Treatment Period||862
10985378|NCT00611026|12160510|FG000|NOT COMPLETED|Double-blind Treatment Period||47
10985379|NCT00611026|12160511|FG001|NOT COMPLETED|Double-blind Treatment Period||88
10985380|NCT00611026|12160512|FG002|NOT COMPLETED|Double-blind Treatment Period||98
10985381|NCT00611130|12160524|FG000|STARTED|Overall Study||92
10985382|NCT00611130|12160525|FG001|STARTED|Overall Study||94
10985383|NCT00611130|12160524|FG000|Completed 12 Week Treatment Phase|Overall Study||61
10985384|NCT00611130|12160525|FG001|Completed 12 Week Treatment Phase|Overall Study||64
10985385|NCT00611130|12160524|FG000|COMPLETED|Overall Study||43
10985386|NCT00611130|12160525|FG001|COMPLETED|Overall Study||47
10985387|NCT00611130|12160524|FG000|NOT COMPLETED|Overall Study||49
10985388|NCT00611130|12160525|FG001|NOT COMPLETED|Overall Study||47
10985389|NCT00611247|12160534|FG000|STARTED|Overall Study||5
10985390|NCT00611247|12160535|FG001|STARTED|Overall Study||31
10985391|NCT00611247|12160534|FG000|COMPLETED|Overall Study||3
10985392|NCT00611247|12160535|FG001|COMPLETED|Overall Study||10
10985393|NCT00611247|12160534|FG000|NOT COMPLETED|Overall Study||2
10985394|NCT00611247|12160535|FG001|NOT COMPLETED|Overall Study||21
10985395|NCT00611325|12160544|FG000|STARTED|Overall Study||28
10985396|NCT00611325|12160545|FG001|STARTED|Overall Study||28
10985397|NCT00611325|12160544|FG000|COMPLETED|Overall Study||28
10985398|NCT00611325|12160545|FG001|COMPLETED|Overall Study||28
10985399|NCT00611325|12160544|FG000|NOT COMPLETED|Overall Study||0
10985400|NCT00611325|12160545|FG001|NOT COMPLETED|Overall Study||0
10985401|NCT00611351|12160551|FG000|STARTED|Overall Study||5
10985402|NCT00611351|12160551|FG000|COMPLETED|Overall Study||3
10985403|NCT00611351|12160551|FG000|NOT COMPLETED|Overall Study||2
10985404|NCT00611403|12160557|FG000|STARTED|Treatment Phase||68
10985405|NCT00611403|12160558|FG001|STARTED|Treatment Phase||69
10985406|NCT00611403|12160557|FG000|COMPLETED|Treatment Phase||62
10985407|NCT00611403|12160558|FG001|COMPLETED|Treatment Phase||58
10985408|NCT00611403|12160557|FG000|NOT COMPLETED|Treatment Phase||6
10985409|NCT00611403|12160558|FG001|NOT COMPLETED|Treatment Phase||11
10985410|NCT00611403|12160557|FG000|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
10985411|NCT00611403|12160558|FG001|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
10985412|NCT00611403|12160557|FG000|COMPLETED|Post Treatment Extension Phase||22
10985413|NCT00611403|12160558|FG001|COMPLETED|Post Treatment Extension Phase||24
10985414|NCT00611403|12160557|FG000|NOT COMPLETED|Post Treatment Extension Phase||4
10985415|NCT00611403|12160558|FG001|NOT COMPLETED|Post Treatment Extension Phase||1
10985416|NCT00611442|12160566|FG000|STARTED|Overall Study||95
10985417|NCT00611442|12160567|FG001|STARTED|Overall Study||96
10985418|NCT00611442|12160566|FG000|COMPLETED|Overall Study||94
10985419|NCT00611442|12160567|FG001|COMPLETED|Overall Study||94
10985420|NCT00611442|12160566|FG000|NOT COMPLETED|Overall Study||1
10985421|NCT00611442|12160567|FG001|NOT COMPLETED|Overall Study||2
10985422|NCT00611455|12160575|FG000|STARTED|DB Treatment Period (24 Weeks)||134
10985423|NCT00611455|12160576|FG001|STARTED|DB Treatment Period (24 Weeks)||131
10985424|NCT00611455|12160577|FG002|STARTED|DB Treatment Period (24 Weeks)||0
10985425|NCT00611455|12160575|FG000|COMPLETED|DB Treatment Period (24 Weeks)||121
10985426|NCT00611455|12160576|FG001|COMPLETED|DB Treatment Period (24 Weeks)||117
10985427|NCT00611455|12160577|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0
10985428|NCT00611455|12160575|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
10985429|NCT00611455|12160576|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
10985430|NCT00611455|12160577|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
10985431|NCT00611455|12160575|FG000|STARTED|OL Treatment Period (120 Weeks)||0
10985432|NCT00611455|12160576|FG001|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
10985433|NCT00611455|12160577|FG002|STARTED|OL Treatment Period (120 Weeks)||0
10985434|NCT00611455|12160575|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0
10985435|NCT00611455|12160576|FG001|COMPLETED|OL Treatment Period (120 Weeks)||52
10985436|NCT00611455|12160577|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0
10985437|NCT00611455|12160575|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
10985438|NCT00611455|12160576|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
10985439|NCT00611455|12160577|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
10985440|NCT00611455|12160575|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0
10985441|NCT00611455|12160576|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0
10985442|NCT00611455|12160577|FG002|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
10985443|NCT00611455|12160575|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0
10985444|NCT00611455|12160576|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0
10985445|NCT00611455|12160577|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||49
10985446|NCT00611455|12160575|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
10985447|NCT00611455|12160576|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
10985448|NCT00611455|12160577|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
10985449|NCT00611468|12160587|FG000|STARTED|Overall Study||3
10985450|NCT00611468|12160588|FG001|STARTED|Overall Study||7
10985451|NCT00611468|12160589|FG002|STARTED|Overall Study||6
10985452|NCT00611468|12160590|FG003|STARTED|Overall Study||13
10985453|NCT00611468|12160587|FG000|COMPLETED|Overall Study||3
10985454|NCT00611468|12160588|FG001|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
10985455|NCT00611468|12160589|FG002|COMPLETED|Overall Study||6
10985456|NCT00611468|12160590|FG003|COMPLETED|Overall Study||13
10985457|NCT00611468|12160587|FG000|NOT COMPLETED|Overall Study||0
10985458|NCT00611468|12160588|FG001|NOT COMPLETED|Overall Study||1
10985459|NCT00611468|12160589|FG002|NOT COMPLETED|Overall Study||0
10985460|NCT00611468|12160590|FG003|NOT COMPLETED|Overall Study||0
10985461|NCT00611533|12160594|FG000|STARTED|First Intervention (6 Weeks)||8
10985462|NCT00611533|12160595|FG001|STARTED|First Intervention (6 Weeks)||8
10985463|NCT00611533|12160594|FG000|COMPLETED|First Intervention (6 Weeks)||8
10985464|NCT00611533|12160595|FG001|COMPLETED|First Intervention (6 Weeks)||6
10985465|NCT00611533|12160594|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
10985466|NCT00611533|12160595|FG001|NOT COMPLETED|First Intervention (6 Weeks)||2
10985467|NCT00611533|12160594|FG000|STARTED|Second Intervention (6 Weeks)||8
10985468|NCT00611533|12160595|FG001|STARTED|Second Intervention (6 Weeks)||6
10985469|NCT00611533|12160594|FG000|COMPLETED|Second Intervention (6 Weeks)||8
10985470|NCT00611533|12160595|FG001|COMPLETED|Second Intervention (6 Weeks)||4
10985471|NCT00611533|12160594|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
10985472|NCT00611533|12160595|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||2
10985473|NCT00611559|12160605|FG000|STARTED|Overall Study||111
10985474|NCT00611559|12160606|FG001|STARTED|Overall Study||115
10985475|NCT00611559|12160607|FG002|STARTED|Overall Study||57
10985476|NCT00611559|12160605|FG000|COMPLETED|Overall Study||110
10985477|NCT00611559|12160606|FG001|COMPLETED|Overall Study||114
10985478|NCT00611559|12160607|FG002|COMPLETED|Overall Study||56
10985479|NCT00611559|12160605|FG000|NOT COMPLETED|Overall Study||1
10985480|NCT00611559|12160606|FG001|NOT COMPLETED|Overall Study||1
10985481|NCT00611559|12160607|FG002|NOT COMPLETED|Overall Study||1
10985482|NCT00611624|12160615|FG000|STARTED|Overall Study||28
10985483|NCT00611624|12160615|FG000|COMPLETED|Overall Study||28
10985484|NCT00611624|12160615|FG000|NOT COMPLETED|Overall Study||0
10985485|NCT00611715|12160622|FG000|STARTED|Overall Study||42
10985486|NCT00611715|12160623|FG001|STARTED|Overall Study||6
10985487|NCT00611715|12160622|FG000|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
10985488|NCT00611715|12160623|FG001|COMPLETED|Overall Study||0
10985489|NCT00611715|12160622|FG000|NOT COMPLETED|Overall Study||41
10985490|NCT00611715|12160623|FG001|NOT COMPLETED|Overall Study||6
10985491|NCT00611767|12160637|FG000|STARTED|Overall Study||49
10985492|NCT00611767|12160638|FG001|STARTED|Overall Study||24
10985493|NCT00611767|12160637|FG000|Thiopental Test Day|Overall Study||3
10985494|NCT00611767|12160638|FG001|Thiopental Test Day|Overall Study||1
10985495|NCT00611767|12160637|FG000|Placebo Test Day|Overall Study||6
10985496|NCT00611767|12160638|FG001|Placebo Test Day|Overall Study||1
10985497|NCT00611767|12160637|FG000|COMPLETED|Overall Study||40
10985498|NCT00611767|12160638|FG001|COMPLETED|Overall Study||22
10985499|NCT00611767|12160637|FG000|NOT COMPLETED|Overall Study||9
10985500|NCT00611767|12160638|FG001|NOT COMPLETED|Overall Study||2
10985501|NCT00611806|12160646|FG000|STARTED|Overall Study||94
10985502|NCT00611806|12160647|FG001|STARTED|Overall Study||46
10985503|NCT00611806|12160646|FG000|COMPLETED|Overall Study||78
10985504|NCT00611806|12160647|FG001|COMPLETED|Overall Study||43
10985505|NCT00611806|12160646|FG000|NOT COMPLETED|Overall Study||16
10985506|NCT00611806|12160647|FG001|NOT COMPLETED|Overall Study||3
10985507|NCT00611858|12160653|FG000|STARTED|Overall Study||13
10985508|NCT00611858|12160653|FG000|COMPLETED|Overall Study||9
10985509|NCT00611858|12160653|FG000|NOT COMPLETED|Overall Study||4
10985510|NCT00611884|12160663|FG000|STARTED|Overall Study||61
10985511|NCT00611884|12160664|FG001|STARTED|Overall Study||60
10985512|NCT00611884|12160665|FG002|STARTED|Overall Study||62
10985513|NCT00611884|12160666|FG003|STARTED|Overall Study||62
10985514|NCT00611884|12160663|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
10985515|NCT00611884|12160664|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
10985516|NCT00611884|12160665|FG002|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
10985517|NCT00611884|12160666|FG003|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
10985518|NCT00611884|12160663|FG000|COMPLETED|Overall Study||52
10985519|NCT00611884|12160664|FG001|COMPLETED|Overall Study||51
10985520|NCT00611884|12160665|FG002|COMPLETED|Overall Study||58
10985521|NCT00611884|12160666|FG003|COMPLETED|Overall Study||56
10985522|NCT00611884|12160663|FG000|NOT COMPLETED|Overall Study||9
10985523|NCT00611884|12160664|FG001|NOT COMPLETED|Overall Study||9
10985524|NCT00611884|12160665|FG002|NOT COMPLETED|Overall Study||4
10985525|NCT00611884|12160666|FG003|NOT COMPLETED|Overall Study||6
10985526|NCT00611897|12160676|FG000|STARTED|Day 1: Initial Treatment||8
10985527|NCT00611897|12160677|FG001|STARTED|Day 1: Initial Treatment||8
10985528|NCT00611897|12160676|FG000|COMPLETED|Day 1: Initial Treatment||8
10985529|NCT00611897|12160677|FG001|COMPLETED|Day 1: Initial Treatment||8
10985530|NCT00611897|12160676|FG000|NOT COMPLETED|Day 1: Initial Treatment||0
10985531|NCT00611897|12160677|FG001|NOT COMPLETED|Day 1: Initial Treatment||0
10985532|NCT00611897|12160676|FG000|STARTED|Day 2: Crossover Treatment||8
10985533|NCT00611897|12160677|FG001|STARTED|Day 2: Crossover Treatment||8
10985534|NCT00611897|12160676|FG000|COMPLETED|Day 2: Crossover Treatment||8
10985535|NCT00611897|12160677|FG001|COMPLETED|Day 2: Crossover Treatment||8
10985536|NCT00611897|12160676|FG000|NOT COMPLETED|Day 2: Crossover Treatment||0
10985537|NCT00611897|12160677|FG001|NOT COMPLETED|Day 2: Crossover Treatment||0
10985538|NCT00611923|12160687|FG000|STARTED|Overall Study||12
10985539|NCT00611923|12160688|FG001|STARTED|Overall Study||13
10985540|NCT00611923|12160687|FG000|COMPLETED|Overall Study||10
10985541|NCT00611923|12160688|FG001|COMPLETED|Overall Study||11
10985542|NCT00611923|12160687|FG000|NOT COMPLETED|Overall Study||2
10985543|NCT00611923|12160688|FG001|NOT COMPLETED|Overall Study||2
10985544|NCT00611975|12160698|FG000|STARTED|Overall Study||45
10985545|NCT00611975|12160699|FG001|STARTED|Overall Study||38
10985546|NCT00611975|12160698|FG000|COMPLETED|Overall Study||40
10985547|NCT00611975|12160699|FG001|COMPLETED|Overall Study||30
10985548|NCT00611975|12160698|FG000|NOT COMPLETED|Overall Study||5
10985549|NCT00611975|12160699|FG001|NOT COMPLETED|Overall Study||8
10985550|NCT00612040|12160708|FG000|STARTED|Overall Study||60
10985551|NCT00612040|12160709|FG001|STARTED|Overall Study||59
10985552|NCT00612040|12160710|FG002|STARTED|Overall Study||59
10985553|NCT00612040|12160708|FG000|Exposed|Overall Study||60
10985554|NCT00612040|12160709|FG001|Exposed|Overall Study||59
10985555|NCT00612040|12160710|FG002|Exposed|Overall Study||59
10985556|NCT00612040|12160708|FG000|COMPLETED|Overall Study||55
10985557|NCT00612040|12160709|FG001|COMPLETED|Overall Study||52
10985558|NCT00612040|12160710|FG002|COMPLETED|Overall Study||52
10985559|NCT00612040|12160708|FG000|NOT COMPLETED|Overall Study||5
10985560|NCT00612040|12160709|FG001|NOT COMPLETED|Overall Study||7
10985561|NCT00612040|12160710|FG002|NOT COMPLETED|Overall Study||7
10985562|NCT00612066|12160718|FG000|STARTED|Overall Study||2
10985563|NCT00612066|12160718|FG000|COMPLETED|Overall Study||1
10985564|NCT00612066|12160718|FG000|NOT COMPLETED|Overall Study||1
10985565|NCT00612105|12160724|FG000|STARTED|Period Title 1: 6-Week Titration Phase||125
10985566|NCT00612105|12160725|FG001|STARTED|Period Title 1: 6-Week Titration Phase||62
10985567|NCT00612105|12160724|FG000|COMPLETED|Period Title 1: 6-Week Titration Phase||89
10985568|NCT00612105|12160725|FG001|COMPLETED|Period Title 1: 6-Week Titration Phase||57
10985569|NCT00612105|12160724|FG000|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
10985570|NCT00612105|12160725|FG001|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
10985571|NCT00612105|12160724|FG000|STARTED|Period Title 2: 4-Week Maintenance Phase||89
10985572|NCT00612105|12160725|FG001|STARTED|Period Title 2: 4-Week Maintenance Phase||57
10985573|NCT00612105|12160724|FG000|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
10985574|NCT00612105|12160725|FG001|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
10985575|NCT00612105|12160724|FG000|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
10985576|NCT00612105|12160725|FG001|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
10985577|NCT00612105|12160724|FG000|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
10985578|NCT00612105|12160725|FG001|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
10985579|NCT00612105|12160724|FG000|COMPLETED|Period Title 3: 3-Week Taper Phase||85
10985580|NCT00612105|12160725|FG001|COMPLETED|Period Title 3: 3-Week Taper Phase||58
10985581|NCT00612105|12160724|FG000|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
10985582|NCT00612105|12160725|FG001|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
10985583|NCT00612222|12160731|FG000|STARTED|Overall Study||4
10985584|NCT00612222|12160731|FG000|COMPLETED|Overall Study||4
10985585|NCT00612222|12160731|FG000|NOT COMPLETED|Overall Study||0
10985586|NCT00612235|12160739|FG000|STARTED|Overall Study||20
10985587|NCT00612235|12160740|FG001|STARTED|Overall Study||20
10985588|NCT00612235|12160741|FG002|STARTED|Overall Study||20
10985589|NCT00612235|12160742|FG003|STARTED|Overall Study||20
10985590|NCT00612235|12160739|FG000|COMPLETED|Overall Study||20
10985591|NCT00612235|12160740|FG001|COMPLETED|Overall Study||20
10985592|NCT00612235|12160741|FG002|COMPLETED|Overall Study||20
10985593|NCT00612235|12160742|FG003|COMPLETED|Overall Study||20
10985594|NCT00612235|12160739|FG000|NOT COMPLETED|Overall Study||0
10985595|NCT00612235|12160740|FG001|NOT COMPLETED|Overall Study||0
10985596|NCT00612235|12160741|FG002|NOT COMPLETED|Overall Study||0
10985597|NCT00612235|12160742|FG003|NOT COMPLETED|Overall Study||0
10985598|NCT00612313|12160755|FG000|STARTED|Overall Study||69
10985599|NCT00612313|12160756|FG001|STARTED|Overall Study||75
10985600|NCT00612313|12160755|FG000|COMPLETED|Overall Study||52
10985601|NCT00612313|12160756|FG001|COMPLETED|Overall Study||62
10985602|NCT00612313|12160755|FG000|NOT COMPLETED|Overall Study||17
10985603|NCT00612313|12160756|FG001|NOT COMPLETED|Overall Study||13
10985604|NCT00612339|12160768|FG000|STARTED|Overall Study||41
10985605|NCT00612339|12160768|FG000|COMPLETED|Overall Study||41
10985606|NCT00612339|12160768|FG000|NOT COMPLETED|Overall Study||0
10985607|NCT00612352|12160774|FG000|STARTED|Overall Study||65
10985608|NCT00612352|12160775|FG001|STARTED|Overall Study||115
10985609|NCT00612352|12160774|FG000|40%mg & 100%mg|Overall Study||1
10985610|NCT00612352|12160775|FG001|40%mg & 100%mg|Overall Study||1
10985611|NCT00612352|12160774|FG000|Placebo & 100%mg|Overall Study||1
10985612|NCT00612352|12160775|FG001|Placebo & 100%mg|Overall Study||0
10985613|NCT00612352|12160774|FG000|100%mg|Overall Study||2
10985614|NCT00612352|12160775|FG001|100%mg|Overall Study||1
10985615|NCT00612352|12160774|FG000|40%mg|Overall Study||1
10985616|NCT00612352|12160775|FG001|40%mg|Overall Study||0
10985617|NCT00612352|12160774|FG000|Placebo|Overall Study||4
10985618|NCT00612352|12160775|FG001|Placebo|Overall Study||4
10985619|NCT00612352|12160774|FG000|COMPLETED|Overall Study||56
10985620|NCT00612352|12160775|FG001|COMPLETED|Overall Study||109
10985621|NCT00612352|12160774|FG000|NOT COMPLETED|Overall Study||9
10985622|NCT00612352|12160775|FG001|NOT COMPLETED|Overall Study||6
10985623|NCT00612430|12160783|FG000|STARTED|Overall Study||32
10985624|NCT00612430|12160784|FG001|STARTED|Overall Study||27
10985625|NCT00612430|12160783|FG000|COMPLETED|Overall Study||32
10985626|NCT00612430|12160784|FG001|COMPLETED|Overall Study||27
10985627|NCT00612430|12160783|FG000|NOT COMPLETED|Overall Study||0
10985628|NCT00612430|12160784|FG001|NOT COMPLETED|Overall Study||0
10985629|NCT00612456|12160795|FG000|STARTED|Overall Study||27
10985630|NCT00612456|12160796|FG001|STARTED|Overall Study||27
10985631|NCT00612456|12160797|FG002|STARTED|Overall Study||16
10985632|NCT00612456|12160795|FG000|COMPLETED|Overall Study||25
10985633|NCT00612456|12160796|FG001|COMPLETED|Overall Study||25
10985634|NCT00612456|12160797|FG002|COMPLETED|Overall Study||16
10985635|NCT00612456|12160795|FG000|NOT COMPLETED|Overall Study||2
10985636|NCT00612456|12160796|FG001|NOT COMPLETED|Overall Study||2
10985637|NCT00612456|12160797|FG002|NOT COMPLETED|Overall Study||0
10985638|NCT00612508|12160809|FG000|STARTED|Overall Study||7
10985639|NCT00612508|12160810|FG001|STARTED|Overall Study||7
10985640|NCT00612508|12160809|FG000|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
10985641|NCT00612508|12160810|FG001|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
10985642|NCT00612508|12160809|FG000|NOT COMPLETED|Overall Study||3
10985643|NCT00612508|12160810|FG001|NOT COMPLETED|Overall Study||4
10985644|NCT00612534|12160822|FG000|STARTED|Overall Study||24
10985645|NCT00612534|12160823|FG001|STARTED|Overall Study||26
10985646|NCT00612534|12160824|FG002|STARTED|Overall Study||20
10985647|NCT00612534|12160825|FG003|STARTED|Overall Study||24
10985648|NCT00612534|12160822|FG000|COMPLETED|Overall Study||11
10985649|NCT00612534|12160823|FG001|COMPLETED|Overall Study||9
10985650|NCT00612534|12160824|FG002|COMPLETED|Overall Study||13
10985651|NCT00612534|12160825|FG003|COMPLETED|Overall Study||7
10985652|NCT00612534|12160822|FG000|NOT COMPLETED|Overall Study||13
10985653|NCT00612534|12160823|FG001|NOT COMPLETED|Overall Study||17
10985654|NCT00612534|12160824|FG002|NOT COMPLETED|Overall Study||7
10985655|NCT00612534|12160825|FG003|NOT COMPLETED|Overall Study||17
10985656|NCT00612560|12160839|FG000|STARTED|Overall Study||7
10985657|NCT00612560|12160840|FG001|STARTED|Overall Study||7
10985658|NCT00612560|12160841|FG002|STARTED|Overall Study||8
10985659|NCT00612560|12160842|FG003|STARTED|Overall Study||6
10985660|NCT00612560|12160839|FG000|COMPLETED|Overall Study||7
10985661|NCT00612560|12160840|FG001|COMPLETED|Overall Study||7
10985662|NCT00612560|12160841|FG002|COMPLETED|Overall Study||8
10985663|NCT00612560|12160842|FG003|COMPLETED|Overall Study||6
10985664|NCT00612560|12160839|FG000|NOT COMPLETED|Overall Study||0
10985665|NCT00612560|12160840|FG001|NOT COMPLETED|Overall Study||0
10985666|NCT00612560|12160841|FG002|NOT COMPLETED|Overall Study||0
10985667|NCT00612560|12160842|FG003|NOT COMPLETED|Overall Study||0
10985668|NCT00612573|12160856|FG000|STARTED|Overall Study||64
10985669|NCT00612573|12160857|FG001|STARTED|Overall Study||65
10985670|NCT00612573|12160858|FG002|STARTED|Overall Study||61
10985671|NCT00612573|12160859|FG003|STARTED|Overall Study||67
10985672|NCT00612573|12160856|FG000|COMPLETED|Overall Study||52
10985673|NCT00612573|12160857|FG001|COMPLETED|Overall Study||51
10985674|NCT00612573|12160858|FG002|COMPLETED|Overall Study||52
10985675|NCT00612573|12160859|FG003|COMPLETED|Overall Study||54
10985676|NCT00612573|12160856|FG000|NOT COMPLETED|Overall Study||12
10985677|NCT00612573|12160857|FG001|NOT COMPLETED|Overall Study||14
10985678|NCT00612573|12160858|FG002|NOT COMPLETED|Overall Study||9
10985679|NCT00612573|12160859|FG003|NOT COMPLETED|Overall Study||13
10985680|NCT00612586|12160871|FG000|STARTED|Overall Study||58
10985681|NCT00612586|12160872|FG001|STARTED|Overall Study||59
10985682|NCT00612586|12160871|FG000|Received at Least 1 Dose|Overall Study||57
10985683|NCT00612586|12160872|FG001|Received at Least 1 Dose|Overall Study||58
10985684|NCT00612586|12160871|FG000|COMPLETED|Overall Study||15
10985685|NCT00612586|12160872|FG001|COMPLETED|Overall Study||18
10985686|NCT00612586|12160871|FG000|NOT COMPLETED|Overall Study||43
10985687|NCT00612586|12160872|FG001|NOT COMPLETED|Overall Study||41
10985688|NCT00612690|12160881|FG000|STARTED|Overall Study||275
10985689|NCT00612690|12160882|FG001|STARTED|Overall Study||207
10985690|NCT00612690|12160881|FG000|COMPLETED|Overall Study||160
10985691|NCT00612690|12160882|FG001|COMPLETED|Overall Study||89
10985692|NCT00612690|12160881|FG000|NOT COMPLETED|Overall Study||115
10985693|NCT00612690|12160882|FG001|NOT COMPLETED|Overall Study||118
10985694|NCT00612716|12160890|FG000|STARTED|Overall Study||6
10985695|NCT00612716|12160890|FG000|COMPLETED|Overall Study||6
10985696|NCT00612716|12160890|FG000|NOT COMPLETED|Overall Study||0
10985697|NCT00612768|12160894|FG000|STARTED|Overall Study||50
10985698|NCT00612768|12160894|FG000|COMPLETED|Overall Study||50
10985699|NCT00612768|12160894|FG000|NOT COMPLETED|Overall Study||0
10985700|NCT00612807|12160921|FG000|STARTED|Overall Study||14
10985701|NCT00612807|12160922|FG001|STARTED|Overall Study||28
10985702|NCT00612807|12160921|FG000|COMPLETED|Overall Study||12
10985703|NCT00612807|12160922|FG001|COMPLETED|Overall Study||28
10985704|NCT00612807|12160921|FG000|NOT COMPLETED|Overall Study||2
10985705|NCT00612807|12160922|FG001|NOT COMPLETED|Overall Study||0
10985706|NCT00612924|12160930|FG000|STARTED|Overall Study||101
10985707|NCT00612924|12160931|FG001|STARTED|Overall Study||94
10985708|NCT00612924|12160930|FG000|COMPLETED|Overall Study||94
10985709|NCT00612924|12160931|FG001|COMPLETED|Overall Study||85
10985710|NCT00612924|12160930|FG000|NOT COMPLETED|Overall Study||7
10985711|NCT00612924|12160931|FG001|NOT COMPLETED|Overall Study||9
10985712|NCT00613015|12160944|FG000|STARTED|Overall Study||13
10985713|NCT00613015|12160945|FG001|STARTED|Overall Study||12
10985714|NCT00613015|12160946|FG002|STARTED|Overall Study||26
10985715|NCT00613015|12160947|FG003|STARTED|Overall Study||24
10985716|NCT00613015|12160948|FG004|STARTED|Overall Study||15
10985717|NCT00613015|12160949|FG005|STARTED|Overall Study||19
10985718|NCT00613015|12160944|FG000|COMPLETED|Overall Study||13
10985719|NCT00613015|12160945|FG001|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
10985720|NCT00613015|12160946|FG002|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
10985721|NCT00613015|12160947|FG003|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
10985722|NCT00613015|12160948|FG004|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
10985723|NCT00613015|12160949|FG005|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
10985724|NCT00613015|12160944|FG000|NOT COMPLETED|Overall Study||0
10985725|NCT00613015|12160945|FG001|NOT COMPLETED|Overall Study||1
10985726|NCT00613015|12160946|FG002|NOT COMPLETED|Overall Study||3
10985727|NCT00613015|12160947|FG003|NOT COMPLETED|Overall Study||3
10985728|NCT00613015|12160948|FG004|NOT COMPLETED|Overall Study||2
10985729|NCT00613015|12160949|FG005|NOT COMPLETED|Overall Study||3
10985730|NCT00613028|12160965|FG000|STARTED|Overall Study||10
10985731|NCT00613028|12160966|FG001|STARTED|Overall Study||13
10985732|NCT00613028|12160965|FG000|COMPLETED|Overall Study||10
10985733|NCT00613028|12160966|FG001|COMPLETED|Overall Study||12
10985734|NCT00613028|12160965|FG000|NOT COMPLETED|Overall Study||0
10985735|NCT00613028|12160966|FG001|NOT COMPLETED|Overall Study||1
10985736|NCT00613080|12160972|FG000|STARTED|Overall Study||79
10985737|NCT00613080|12160972|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
10985738|NCT00613080|12160972|FG000|NOT COMPLETED|Overall Study||11
10985739|NCT00613106|12160978|FG000|STARTED|Overall Study||132
10985740|NCT00613106|12160979|FG001|STARTED|Overall Study||47
10985741|NCT00613106|12160978|FG000|COMPLETED|Overall Study||112
10985742|NCT00613106|12160979|FG001|COMPLETED|Overall Study||38
10985743|NCT00613106|12160978|FG000|NOT COMPLETED|Overall Study||20
10985744|NCT00613106|12160979|FG001|NOT COMPLETED|Overall Study||9
10985745|NCT00613171|12160985|FG000|STARTED|Overall Study||27
10985746|NCT00613171|12160985|FG000|COMPLETED|Overall Study||13
10985747|NCT00613171|12160985|FG000|NOT COMPLETED|Overall Study||14
10985748|NCT00613301|12160990|FG000|STARTED|Overall Study||416
10985749|NCT00613301|12160990|FG000|COMPLETED|Overall Study||188
10985750|NCT00613301|12160990|FG000|NOT COMPLETED|Overall Study||228
10985751|NCT00613314|12160995|FG000|STARTED|Overall Study||15268
10985752|NCT00613314|12160995|FG000|COMPLETED|Overall Study||15113
10985753|NCT00613314|12160995|FG000|NOT COMPLETED|Overall Study||155
10985754|NCT00613327|12160999|FG000|STARTED|Overall Study||345
10985755|NCT00613327|12160999|FG000|COMPLETED|Overall Study||244
10985756|NCT00613327|12160999|FG000|NOT COMPLETED|Overall Study||101
10985757|NCT00613366|12161005|FG000|STARTED|Overall Study||20
10985758|NCT00613366|12161006|FG001|STARTED|Overall Study||20
10985759|NCT00613366|12161005|FG000|COMPLETED|Overall Study||17
10985760|NCT00613366|12161006|FG001|COMPLETED|Overall Study||18
10985761|NCT00613366|12161005|FG000|NOT COMPLETED|Overall Study||3
10985762|NCT00613366|12161006|FG001|NOT COMPLETED|Overall Study||2
10985763|NCT00613379|12161015|FG000|STARTED|Overall Study||10
10985764|NCT00613379|12161016|FG001|STARTED|Overall Study||10
10985765|NCT00613379|12161017|FG002|STARTED|Overall Study||11
10985766|NCT00613379|12161015|FG000|COMPLETED|Overall Study||10
10985767|NCT00613379|12161016|FG001|COMPLETED|Overall Study||10
10985768|NCT00613379|12161017|FG002|COMPLETED|Overall Study||11
10985769|NCT00613379|12161015|FG000|NOT COMPLETED|Overall Study||0
10985770|NCT00613379|12161016|FG001|NOT COMPLETED|Overall Study||0
10985771|NCT00613379|12161017|FG002|NOT COMPLETED|Overall Study||0
10985772|NCT00613405|12161027|FG000|STARTED|Overall Study||45
10985773|NCT00613405|12161028|FG001|STARTED|Overall Study||42
10985774|NCT00613405|12161027|FG000|COMPLETED|Overall Study||45
10985775|NCT00613405|12161028|FG001|COMPLETED|Overall Study||42
10985776|NCT00613405|12161027|FG000|NOT COMPLETED|Overall Study||0
10985777|NCT00613405|12161028|FG001|NOT COMPLETED|Overall Study||0
10985778|NCT00613509|12161036|FG000|STARTED|Cycle 1||11
10985779|NCT00613509|12161037|FG001|STARTED|Cycle 1||12
10985780|NCT00613509|12161036|FG000|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
10985781|NCT00613509|12161037|FG001|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
10985782|NCT00613509|12161036|FG000|NOT COMPLETED|Cycle 1||5
10985783|NCT00613509|12161037|FG001|NOT COMPLETED|Cycle 1||8
10985784|NCT00613509|12161036|FG000|STARTED|Cycle 2 (Group 2 = Crossover)||11
10985785|NCT00613509|12161037|FG001|STARTED|Cycle 2 (Group 2 = Crossover)||4
10985786|NCT00613509|12161036|FG000|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
10985787|NCT00613509|12161037|FG001|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
10985788|NCT00613509|12161036|FG000|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
10985789|NCT00613509|12161037|FG001|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
10985790|NCT00613574|12161043|FG000|STARTED|Overall Study||407
10985791|NCT00613574|12161043|FG000|COMPLETED|Overall Study||401
10985792|NCT00613574|12161043|FG000|NOT COMPLETED|Overall Study||6
10985793|NCT00613626|12161050|FG000|STARTED|Overall Study||33
10985794|NCT00613626|12161051|FG001|STARTED|Overall Study||34
10985795|NCT00613626|12161052|FG002|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
10985796|NCT00613626|12161050|FG000|1st Dose ZD6474|Overall Study||33
10985797|NCT00613626|12161051|FG001|1st Dose ZD6474|Overall Study||34
10985798|NCT00613626|12161052|FG002|1st Dose ZD6474|Overall Study||7
10985799|NCT00613626|12161050|FG000|COMPLETED|Overall Study||33
10985800|NCT00613626|12161051|FG001|COMPLETED|Overall Study||33
10985801|NCT00613626|12161052|FG002|COMPLETED|Overall Study||7
10985802|NCT00613626|12161050|FG000|NOT COMPLETED|Overall Study||0
10985803|NCT00613626|12161051|FG001|NOT COMPLETED|Overall Study||1
10985804|NCT00613626|12161052|FG002|NOT COMPLETED|Overall Study||0
10985805|NCT00613821|12161061|FG000|STARTED|Overall Study||40
10985806|NCT00613821|12161062|FG001|STARTED|Overall Study||40
10985807|NCT00613821|12161061|FG000|COMPLETED|Overall Study||38
10985808|NCT00613821|12161062|FG001|COMPLETED|Overall Study||39
10985809|NCT00613821|12161061|FG000|NOT COMPLETED|Overall Study||2
10985810|NCT00613821|12161062|FG001|NOT COMPLETED|Overall Study||1
10985811|NCT00613834|12161070|FG000|STARTED|Overall Study||29
10985812|NCT00613834|12161071|FG001|STARTED|Overall Study||29
10985813|NCT00613834|12161070|FG000|COMPLETED|Overall Study||29
10985814|NCT00613834|12161071|FG001|COMPLETED|Overall Study||26
10985815|NCT00613834|12161070|FG000|NOT COMPLETED|Overall Study||0
10985816|NCT00613834|12161071|FG001|NOT COMPLETED|Overall Study||3
10985817|NCT00613925|12161081|FG000|STARTED|Overall Study||37
10985818|NCT00613925|12161082|FG001|STARTED|Overall Study||33
10985819|NCT00613925|12161081|FG000|COMPLETED|Overall Study||37
10985820|NCT00613925|12161082|FG001|COMPLETED|Overall Study||32
10985821|NCT00613925|12161081|FG000|NOT COMPLETED|Overall Study||0
10985822|NCT00613925|12161082|FG001|NOT COMPLETED|Overall Study||1
10985823|NCT00613938|12161092|FG000|STARTED|Overall Study||69
10985824|NCT00613938|12161093|FG001|STARTED|Overall Study||275
10985825|NCT00613938|12161094|FG002|STARTED|Overall Study||278
10985826|NCT00613938|12161095|FG003|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
10985827|NCT00613938|12161092|FG000|COMPLETED|Overall Study||49
10985828|NCT00613938|12161093|FG001|COMPLETED|Overall Study||247
10985829|NCT00613938|12161094|FG002|COMPLETED|Overall Study||255
10985830|NCT00613938|12161095|FG003|COMPLETED|Overall Study||253
10985831|NCT00613938|12161092|FG000|NOT COMPLETED|Overall Study||20
10985832|NCT00613938|12161093|FG001|NOT COMPLETED|Overall Study||28
10985833|NCT00613938|12161094|FG002|NOT COMPLETED|Overall Study||23
10985834|NCT00613938|12161095|FG003|NOT COMPLETED|Overall Study||26
10985835|NCT00613951|12161108|FG000|STARTED|Overall Study||61
10985836|NCT00613951|12161109|FG001|STARTED|Overall Study||59
10985837|NCT00613951|12161110|FG002|STARTED|Overall Study||62
10985838|NCT00613951|12161108|FG000|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
10985839|NCT00613951|12161109|FG001|Exposed|Overall Study||59
10985840|NCT00613951|12161110|FG002|Exposed|Overall Study||62
10985841|NCT00613951|12161108|FG000|COMPLETED|Overall Study||54
10985842|NCT00613951|12161109|FG001|COMPLETED|Overall Study||54
10985843|NCT00613951|12161110|FG002|COMPLETED|Overall Study||57
10985844|NCT00613951|12161108|FG000|NOT COMPLETED|Overall Study||7
10985845|NCT00613951|12161109|FG001|NOT COMPLETED|Overall Study||5
10985846|NCT00613951|12161110|FG002|NOT COMPLETED|Overall Study||5
10985847|NCT00614055|12161124|FG000|STARTED|Overall Study||59
10985848|NCT00614055|12161125|FG001|STARTED|Overall Study||59
10985849|NCT00614055|12161126|FG002|STARTED|Overall Study||60
10985850|NCT00614055|12161124|FG000|Exposed|Overall Study||59
10985851|NCT00614055|12161125|FG001|Exposed|Overall Study||59
10985852|NCT00614055|12161126|FG002|Exposed|Overall Study||60
10985853|NCT00614055|12161124|FG000|COMPLETED|Overall Study||55
10985854|NCT00614055|12161125|FG001|COMPLETED|Overall Study||53
10985855|NCT00614055|12161126|FG002|COMPLETED|Overall Study||55
10985856|NCT00614055|12161124|FG000|NOT COMPLETED|Overall Study||4
10985857|NCT00614055|12161125|FG001|NOT COMPLETED|Overall Study||6
10985858|NCT00614055|12161126|FG002|NOT COMPLETED|Overall Study||5
10985859|NCT00614120|12161141|FG000|STARTED|Overall Study|Randomised|231
10985860|NCT00614120|12161142|FG001|STARTED|Overall Study|Randomised|233
10985861|NCT00614120|12161143|FG002|STARTED|Overall Study|Randomised|234
10985862|NCT00614120|12161144|FG003|STARTED|Overall Study|Randomised|231
10985863|NCT00614120|12161141|FG000|Exposed to Study Drug|Overall Study||231
10985864|NCT00614120|12161142|FG001|Exposed to Study Drug|Overall Study||233
10985865|NCT00614120|12161143|FG002|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
10985866|NCT00614120|12161144|FG003|Exposed to Study Drug|Overall Study||231
10985867|NCT00614120|12161141|FG000|COMPLETED|Overall Study||202
10985868|NCT00614120|12161142|FG001|COMPLETED|Overall Study||187
10985869|NCT00614120|12161143|FG002|COMPLETED|Overall Study||175
10985870|NCT00614120|12161144|FG003|COMPLETED|Overall Study||215
10985871|NCT00614120|12161141|FG000|NOT COMPLETED|Overall Study||29
10985872|NCT00614120|12161142|FG001|NOT COMPLETED|Overall Study||46
10985873|NCT00614120|12161143|FG002|NOT COMPLETED|Overall Study||59
10985874|NCT00614120|12161144|FG003|NOT COMPLETED|Overall Study||16
10985875|NCT00614198|12161156|FG000|STARTED|Stage 1||38
10985876|NCT00614198|12161157|FG001|STARTED|Stage 1||34
10985877|NCT00614198|12161156|FG000|COMPLETED|Stage 1||26
10985878|NCT00614198|12161157|FG001|COMPLETED|Stage 1||29
10985879|NCT00614198|12161156|FG000|NOT COMPLETED|Stage 1||12
10985880|NCT00614198|12161157|FG001|NOT COMPLETED|Stage 1||5
10985881|NCT00614198|12161156|FG000|STARTED|Stage 2||26
10985882|NCT00614198|12161157|FG001|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
10985883|NCT00614198|12161156|FG000|COMPLETED|Stage 2||18
10985884|NCT00614198|12161157|FG001|COMPLETED|Stage 2||17
10985885|NCT00614198|12161156|FG000|NOT COMPLETED|Stage 2||8
10985886|NCT00614198|12161157|FG001|NOT COMPLETED|Stage 2||12
10985887|NCT00614315|12161163|FG000|STARTED|Overall Study||30
10985888|NCT00614315|12161163|FG000|COMPLETED|Overall Study||30
10985889|NCT00614315|12161163|FG000|NOT COMPLETED|Overall Study||0
10985890|NCT00614380|12161171|FG000|STARTED|Overall Study||564
10985891|NCT00614380|12161172|FG001|STARTED|Overall Study||206
10985892|NCT00614380|12161173|FG002|STARTED|Overall Study||25
10985893|NCT00614380|12161174|FG003|STARTED|Overall Study||181
10985894|NCT00614380|12161171|FG000|COMPLETED|Overall Study||529
10985895|NCT00614380|12161172|FG001|COMPLETED|Overall Study||198
10985896|NCT00614380|12161173|FG002|COMPLETED|Overall Study||24
10985897|NCT00614380|12161174|FG003|COMPLETED|Overall Study||179
10985898|NCT00614380|12161171|FG000|NOT COMPLETED|Overall Study||35
10985899|NCT00614380|12161172|FG001|NOT COMPLETED|Overall Study||8
10985900|NCT00614380|12161173|FG002|NOT COMPLETED|Overall Study||1
10985901|NCT00614380|12161174|FG003|NOT COMPLETED|Overall Study||2
10985902|NCT00614393|12161194|FG000|STARTED|Overall Study||180
10985903|NCT00614393|12161195|FG001|STARTED|Overall Study||8
10985904|NCT00614393|12161196|FG002|STARTED|Overall Study||10
10985905|NCT00614393|12161197|FG003|STARTED|Overall Study||180
10985906|NCT00614393|12161198|FG004|STARTED|Overall Study||180
10985907|NCT00614393|12161194|FG000|Treated|Overall Study||180
10985908|NCT00614393|12161195|FG001|Treated|Overall Study||8
10985909|NCT00614393|12161196|FG002|Treated|Overall Study||10
10985910|NCT00614393|12161197|FG003|Treated|Overall Study||180
10985911|NCT00614393|12161198|FG004|Treated|Overall Study||178
10985912|NCT00614393|12161194|FG000|COMPLETED|Overall Study||0
10985913|NCT00614393|12161195|FG001|COMPLETED|Overall Study||0
10985914|NCT00614393|12161196|FG002|COMPLETED|Overall Study||0
10985915|NCT00614393|12161197|FG003|COMPLETED|Overall Study||0
10985916|NCT00614393|12161198|FG004|COMPLETED|Overall Study||0
10985917|NCT00614393|12161194|FG000|NOT COMPLETED|Overall Study||180
10985918|NCT00614393|12161195|FG001|NOT COMPLETED|Overall Study||8
10985919|NCT00614393|12161196|FG002|NOT COMPLETED|Overall Study||10
10985920|NCT00614393|12161197|FG003|NOT COMPLETED|Overall Study||180
10985921|NCT00614393|12161198|FG004|NOT COMPLETED|Overall Study||180
10985922|NCT00614406|12161212|FG000|STARTED|Overall Study||7
10985923|NCT00614406|12161213|FG001|STARTED|Overall Study||4
10985924|NCT00614406|12161212|FG000|COMPLETED|Overall Study||7
10985925|NCT00614406|12161213|FG001|COMPLETED|Overall Study||4
10985926|NCT00614406|12161212|FG000|NOT COMPLETED|Overall Study||0
10985927|NCT00614406|12161213|FG001|NOT COMPLETED|Overall Study||0
10985928|NCT00614445|12161221|FG000|STARTED|Overall Study||140
10985929|NCT00614445|12161222|FG001|STARTED|Overall Study||140
10985930|NCT00614445|12161221|FG000|COMPLETED|Overall Study||112
10985931|NCT00614445|12161222|FG001|COMPLETED|Overall Study||91
10985932|NCT00614445|12161221|FG000|NOT COMPLETED|Overall Study||28
10985933|NCT00614445|12161222|FG001|NOT COMPLETED|Overall Study||49
10985934|NCT00614458|12161228|FG000|STARTED|Overall Study||6
10985935|NCT00614458|12161228|FG000|COMPLETED|Overall Study||6
10985936|NCT00614458|12161228|FG000|NOT COMPLETED|Overall Study||0
10985937|NCT00614484|12161232|FG000|STARTED|Overall Study||28
10985938|NCT00614484|12161232|FG000|COMPLETED|Overall Study||28
10985939|NCT00614484|12161232|FG000|NOT COMPLETED|Overall Study||0
10985940|NCT00614523|12161239|FG000|STARTED|Overall Study||83
10985941|NCT00614523|12161240|FG001|STARTED|Overall Study||167
10985942|NCT00614523|12161239|FG000|COMPLETED|Overall Study||20
10985943|NCT00614523|12161240|FG001|COMPLETED|Overall Study||36
10985944|NCT00614523|12161239|FG000|NOT COMPLETED|Overall Study||63
10985945|NCT00614523|12161240|FG001|NOT COMPLETED|Overall Study||131
10985946|NCT00614575|12161246|FG000|STARTED|Overall Study|The number of patients enrolled.|1089
10985947|NCT00614575|12161246|FG000|COMPLETED|Overall Study||861
10985948|NCT00614575|12161246|FG000|NOT COMPLETED|Overall Study||228
10985949|NCT00614614|12161252|FG000|STARTED|Primary Vaccination Phase||1272
10985950|NCT00614614|12161253|FG001|STARTED|Primary Vaccination Phase||282
10985951|NCT00614614|12161254|FG002|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
10985952|NCT00614614|12161255|FG003|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
10985953|NCT00614614|12161256|FG004|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
10985954|NCT00614614|12161252|FG000|COMPLETED|Primary Vaccination Phase||1182
10985955|NCT00614614|12161253|FG001|COMPLETED|Primary Vaccination Phase||265
10985956|NCT00614614|12161254|FG002|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
10985957|NCT00614614|12161255|FG003|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
10985958|NCT00614614|12161256|FG004|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
10985959|NCT00614614|12161252|FG000|NOT COMPLETED|Primary Vaccination Phase||90
10985960|NCT00614614|12161253|FG001|NOT COMPLETED|Primary Vaccination Phase||17
10985961|NCT00614614|12161254|FG002|NOT COMPLETED|Primary Vaccination Phase||0
10985962|NCT00614614|12161255|FG003|NOT COMPLETED|Primary Vaccination Phase||0
10985963|NCT00614614|12161256|FG004|NOT COMPLETED|Primary Vaccination Phase||0
10985964|NCT00614614|12161252|FG000|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
10985965|NCT00614614|12161253|FG001|STARTED|Booster Vaccination Phase||233
10985966|NCT00614614|12161254|FG002|STARTED|Booster Vaccination Phase||432
10985967|NCT00614614|12161255|FG003|STARTED|Booster Vaccination Phase||229
10985968|NCT00614614|12161256|FG004|STARTED|Booster Vaccination Phase||409
10985969|NCT00614614|12161252|FG000|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
10985970|NCT00614614|12161253|FG001|COMPLETED|Booster Vaccination Phase||227
10985971|NCT00614614|12161254|FG002|COMPLETED|Booster Vaccination Phase||405
10985972|NCT00614614|12161255|FG003|COMPLETED|Booster Vaccination Phase||210
10985973|NCT00614614|12161256|FG004|COMPLETED|Booster Vaccination Phase||396
10985974|NCT00614614|12161252|FG000|NOT COMPLETED|Booster Vaccination Phase||0
10985975|NCT00614614|12161253|FG001|NOT COMPLETED|Booster Vaccination Phase||6
10985976|NCT00614614|12161254|FG002|NOT COMPLETED|Booster Vaccination Phase||27
10985977|NCT00614614|12161255|FG003|NOT COMPLETED|Booster Vaccination Phase||19
10985978|NCT00614614|12161256|FG004|NOT COMPLETED|Booster Vaccination Phase||13
10985979|NCT00614744|12161273|FG000|STARTED|Overall Study||83
10985980|NCT00614744|12161274|FG001|STARTED|Overall Study||85
10985981|NCT00614744|12161273|FG000|COMPLETED|Overall Study||78
10985982|NCT00614744|12161274|FG001|COMPLETED|Overall Study||79
10985983|NCT00614744|12161273|FG000|NOT COMPLETED|Overall Study||5
10985984|NCT00614744|12161274|FG001|NOT COMPLETED|Overall Study||6
10985985|NCT00614822|12161280|FG000|STARTED|Overall Study||50
10985986|NCT00614822|12161280|FG000|COMPLETED|Overall Study||47
10985987|NCT00614822|12161280|FG000|NOT COMPLETED|Overall Study||3
10985988|NCT00614874|12161285|FG000|STARTED|Overall Study||16
10985989|NCT00614874|12161285|FG000|COMPLETED|Overall Study||14
10985990|NCT00614874|12161285|FG000|NOT COMPLETED|Overall Study||2
10985991|NCT00614913|12161289|FG000|STARTED|Overall Study||76
10985992|NCT00614913|12161289|FG000|COMPLETED|Overall Study||76
10985993|NCT00614913|12161289|FG000|NOT COMPLETED|Overall Study||0
10985994|NCT00614926|12161295|FG000|STARTED|Overall Study||25
10985995|NCT00614926|12161296|FG001|STARTED|Overall Study||7
10985996|NCT00614926|12161295|FG000|COMPLETED|Overall Study||21
10985997|NCT00614926|12161296|FG001|COMPLETED|Overall Study||7
10985998|NCT00614926|12161295|FG000|NOT COMPLETED|Overall Study||4
10985999|NCT00614926|12161296|FG001|NOT COMPLETED|Overall Study||0
10986000|NCT00614939|12161304|FG000|STARTED|Overall Study|Randomized and treated|85
10986001|NCT00614939|12161305|FG001|STARTED|Overall Study|Randomized and treated|85
10986002|NCT00614939|12161304|FG000|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
10986003|NCT00614939|12161305|FG001|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
10986004|NCT00614939|12161304|FG000|NOT COMPLETED|Overall Study||35
10986005|NCT00614939|12161305|FG001|NOT COMPLETED|Overall Study||43
10986006|NCT00614991|12161317|FG000|STARTED|Overall Study||8
10986007|NCT00614991|12161318|FG001|STARTED|Overall Study||9
10986008|NCT00614991|12161319|FG002|STARTED|Overall Study||7
10986009|NCT00614991|12161320|FG003|STARTED|Overall Study||7
10986010|NCT00614991|12161321|FG004|STARTED|Overall Study||7
10986011|NCT00614991|12161322|FG005|STARTED|Overall Study||6
10986012|NCT00614991|12161317|FG000|COMPLETED|Overall Study||5
10986013|NCT00614991|12161318|FG001|COMPLETED|Overall Study||6
10986014|NCT00614991|12161319|FG002|COMPLETED|Overall Study||7
10986015|NCT00614991|12161320|FG003|COMPLETED|Overall Study||7
10986016|NCT00614991|12161321|FG004|COMPLETED|Overall Study||6
10986017|NCT00614991|12161322|FG005|COMPLETED|Overall Study||6
10986018|NCT00614991|12161317|FG000|NOT COMPLETED|Overall Study||3
10986019|NCT00614991|12161318|FG001|NOT COMPLETED|Overall Study||3
10986020|NCT00614991|12161319|FG002|NOT COMPLETED|Overall Study||0
10986021|NCT00614991|12161320|FG003|NOT COMPLETED|Overall Study||0
10986022|NCT00614991|12161321|FG004|NOT COMPLETED|Overall Study||1
10986023|NCT00614991|12161322|FG005|NOT COMPLETED|Overall Study||0
10986024|NCT00615017|12161347|FG000|STARTED|Overall Study|Patients received treatment|8
10986025|NCT00615017|12161348|FG001|STARTED|Overall Study|Patients received treatment|9
10986026|NCT00615017|12161349|FG002|STARTED|Overall Study|Patients received treatment|12
10986027|NCT00615017|12161350|FG003|STARTED|Overall Study|Patients received treatment|10
10986028|NCT00615017|12161351|FG004|STARTED|Overall Study|Patients received treatment|8
10986029|NCT00615017|12161352|FG005|STARTED|Overall Study|Patients received treatment|23
10986030|NCT00615017|12161347|FG000|COMPLETED|Overall Study|Patient completed the study drug|8
10986031|NCT00615017|12161348|FG001|COMPLETED|Overall Study|Patient completed the study drug|8
10986032|NCT00615017|12161349|FG002|COMPLETED|Overall Study|Patient completed the study drug|7
10986033|NCT00615017|12161350|FG003|COMPLETED|Overall Study|Patient completed the study drug|9
10986034|NCT00615017|12161351|FG004|COMPLETED|Overall Study|Patient completed the study drug|7
10986035|NCT00615017|12161352|FG005|COMPLETED|Overall Study|Patient completed the study drug|20
10986036|NCT00615017|12161347|FG000|NOT COMPLETED|Overall Study||0
10986037|NCT00615017|12161348|FG001|NOT COMPLETED|Overall Study||1
10986038|NCT00615017|12161349|FG002|NOT COMPLETED|Overall Study||5
10986039|NCT00615017|12161350|FG003|NOT COMPLETED|Overall Study||1
10986040|NCT00615017|12161351|FG004|NOT COMPLETED|Overall Study||1
10986041|NCT00615017|12161352|FG005|NOT COMPLETED|Overall Study||3
10986042|NCT00615030|12161366|FG000|STARTED|Period I||9
10986043|NCT00615030|12161367|FG001|STARTED|Period I||8
10986044|NCT00615030|12161368|FG002|STARTED|Period I||9
10986045|NCT00615030|12161369|FG003|STARTED|Period I||8
10986046|NCT00615030|12161370|FG004|STARTED|Period I||9
10986047|NCT00615030|12161371|FG005|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
10986048|NCT00615030|12161372|FG006|STARTED|Period I||7
10986049|NCT00615030|12161373|FG007|STARTED|Period I||7
10986050|NCT00615030|12161374|FG008|STARTED|Period I||9
10986051|NCT00615030|12161375|FG009|STARTED|Period I||8
10986052|NCT00615030|12161376|FG010|STARTED|Period I||8
10986053|NCT00615030|12161377|FG011|STARTED|Period I||7
10986054|NCT00615030|12161366|FG000|COMPLETED|Period I||8
10986055|NCT00615030|12161367|FG001|COMPLETED|Period I||8
10986056|NCT00615030|12161368|FG002|COMPLETED|Period I||9
10986057|NCT00615030|12161369|FG003|COMPLETED|Period I||8
10986058|NCT00615030|12161370|FG004|COMPLETED|Period I||8
10986059|NCT00615030|12161371|FG005|COMPLETED|Period I||5
10986060|NCT00615030|12161372|FG006|COMPLETED|Period I||7
10986061|NCT00615030|12161373|FG007|COMPLETED|Period I||7
10986062|NCT00615030|12161374|FG008|COMPLETED|Period I||8
10986063|NCT00615030|12161375|FG009|COMPLETED|Period I||8
10986064|NCT00615030|12161376|FG010|COMPLETED|Period I||7
10986065|NCT00615030|12161377|FG011|COMPLETED|Period I||6
10986066|NCT00615030|12161366|FG000|NOT COMPLETED|Period I||1
10986067|NCT00615030|12161367|FG001|NOT COMPLETED|Period I||0
10986068|NCT00615030|12161368|FG002|NOT COMPLETED|Period I||0
10986069|NCT00615030|12161369|FG003|NOT COMPLETED|Period I||0
10986070|NCT00615030|12161370|FG004|NOT COMPLETED|Period I||1
10986071|NCT00615030|12161371|FG005|NOT COMPLETED|Period I||1
10986072|NCT00615030|12161372|FG006|NOT COMPLETED|Period I||0
10986073|NCT00615030|12161373|FG007|NOT COMPLETED|Period I||0
10986074|NCT00615030|12161374|FG008|NOT COMPLETED|Period I||1
10986075|NCT00615030|12161375|FG009|NOT COMPLETED|Period I||0
10986076|NCT00615030|12161376|FG010|NOT COMPLETED|Period I||1
10986077|NCT00615030|12161377|FG011|NOT COMPLETED|Period I||1
10986078|NCT00615030|12161366|FG000|STARTED|Period II||8
10986079|NCT00615030|12161367|FG001|STARTED|Period II||8
10986080|NCT00615030|12161368|FG002|STARTED|Period II||9
10986081|NCT00615030|12161369|FG003|STARTED|Period II||8
10986082|NCT00615030|12161370|FG004|STARTED|Period II||8
10986083|NCT00615030|12161371|FG005|STARTED|Period II||5
10986084|NCT00615030|12161372|FG006|STARTED|Period II||7
10986085|NCT00615030|12161373|FG007|STARTED|Period II||7
10986086|NCT00615030|12161374|FG008|STARTED|Period II||8
10986087|NCT00615030|12161375|FG009|STARTED|Period II||8
10986088|NCT00615030|12161376|FG010|STARTED|Period II||7
10986089|NCT00615030|12161377|FG011|STARTED|Period II||6
10986090|NCT00615030|12161366|FG000|COMPLETED|Period II||8
10986091|NCT00615030|12161367|FG001|COMPLETED|Period II||8
10986092|NCT00615030|12161368|FG002|COMPLETED|Period II||8
10986093|NCT00615030|12161369|FG003|COMPLETED|Period II||7
10986094|NCT00615030|12161370|FG004|COMPLETED|Period II||8
10986095|NCT00615030|12161371|FG005|COMPLETED|Period II||5
10986096|NCT00615030|12161372|FG006|COMPLETED|Period II||6
10986097|NCT00615030|12161373|FG007|COMPLETED|Period II||7
10986098|NCT00615030|12161374|FG008|COMPLETED|Period II||7
10986099|NCT00615030|12161375|FG009|COMPLETED|Period II||8
10986100|NCT00615030|12161376|FG010|COMPLETED|Period II||7
10986101|NCT00615030|12161377|FG011|COMPLETED|Period II||6
10986102|NCT00615030|12161366|FG000|NOT COMPLETED|Period II||0
10986103|NCT00615030|12161367|FG001|NOT COMPLETED|Period II||0
10986104|NCT00615030|12161368|FG002|NOT COMPLETED|Period II||1
10986105|NCT00615030|12161369|FG003|NOT COMPLETED|Period II||1
10986106|NCT00615030|12161370|FG004|NOT COMPLETED|Period II||0
10986107|NCT00615030|12161371|FG005|NOT COMPLETED|Period II||0
10986108|NCT00615030|12161372|FG006|NOT COMPLETED|Period II||1
10986109|NCT00615030|12161373|FG007|NOT COMPLETED|Period II||0
10986110|NCT00615030|12161374|FG008|NOT COMPLETED|Period II||1
10986111|NCT00615030|12161375|FG009|NOT COMPLETED|Period II||0
10986112|NCT00615030|12161376|FG010|NOT COMPLETED|Period II||0
10986113|NCT00615030|12161377|FG011|NOT COMPLETED|Period II||0
10986114|NCT00615030|12161366|FG000|STARTED|Period III||8
10986115|NCT00615030|12161367|FG001|STARTED|Period III||8
10986116|NCT00615030|12161368|FG002|STARTED|Period III||8
10986117|NCT00615030|12161369|FG003|STARTED|Period III||7
10986118|NCT00615030|12161370|FG004|STARTED|Period III||8
10986119|NCT00615030|12161371|FG005|STARTED|Period III||5
10986120|NCT00615030|12161372|FG006|STARTED|Period III||6
10986121|NCT00615030|12161373|FG007|STARTED|Period III||7
10986122|NCT00615030|12161374|FG008|STARTED|Period III||7
10986123|NCT00615030|12161375|FG009|STARTED|Period III||8
10986124|NCT00615030|12161376|FG010|STARTED|Period III||7
10986125|NCT00615030|12161377|FG011|STARTED|Period III||6
10986126|NCT00615030|12161366|FG000|COMPLETED|Period III||7
10986127|NCT00615030|12161367|FG001|COMPLETED|Period III||8
10986128|NCT00615030|12161368|FG002|COMPLETED|Period III||8
10986129|NCT00615030|12161369|FG003|COMPLETED|Period III||6
10986130|NCT00615030|12161370|FG004|COMPLETED|Period III||8
10986131|NCT00615030|12161371|FG005|COMPLETED|Period III||5
10986132|NCT00615030|12161372|FG006|COMPLETED|Period III||6
10986133|NCT00615030|12161373|FG007|COMPLETED|Period III||7
10986134|NCT00615030|12161374|FG008|COMPLETED|Period III||7
10986135|NCT00615030|12161375|FG009|COMPLETED|Period III||8
10986136|NCT00615030|12161376|FG010|COMPLETED|Period III||7
10986137|NCT00615030|12161377|FG011|COMPLETED|Period III||6
10986138|NCT00615030|12161366|FG000|NOT COMPLETED|Period III||1
10986139|NCT00615030|12161367|FG001|NOT COMPLETED|Period III||0
10986140|NCT00615030|12161368|FG002|NOT COMPLETED|Period III||0
10986141|NCT00615030|12161369|FG003|NOT COMPLETED|Period III||1
10986142|NCT00615030|12161370|FG004|NOT COMPLETED|Period III||0
10986143|NCT00615030|12161371|FG005|NOT COMPLETED|Period III||0
10986144|NCT00615030|12161372|FG006|NOT COMPLETED|Period III||0
10986145|NCT00615030|12161373|FG007|NOT COMPLETED|Period III||0
10986146|NCT00615030|12161374|FG008|NOT COMPLETED|Period III||0
10986147|NCT00615030|12161375|FG009|NOT COMPLETED|Period III||0
10986148|NCT00615030|12161376|FG010|NOT COMPLETED|Period III||0
10986149|NCT00615030|12161377|FG011|NOT COMPLETED|Period III||0
10986150|NCT00615056|12161395|FG000|STARTED|Overall Study||49
10986151|NCT00615056|12161396|FG001|STARTED|Overall Study||51
10986152|NCT00615056|12161397|FG002|STARTED|Overall Study||36
10986153|NCT00615056|12161398|FG003|STARTED|Overall Study||35
10986154|NCT00615056|12161395|FG000|Treated|Overall Study||46
10986155|NCT00615056|12161396|FG001|Treated|Overall Study||51
10986156|NCT00615056|12161397|FG002|Treated|Overall Study||36
10986157|NCT00615056|12161398|FG003|Treated|Overall Study||35
10986158|NCT00615056|12161395|FG000|COMPLETED|Overall Study||0
10986159|NCT00615056|12161396|FG001|COMPLETED|Overall Study||0
10986160|NCT00615056|12161397|FG002|COMPLETED|Overall Study||0
10986161|NCT00615056|12161398|FG003|COMPLETED|Overall Study||0
10986162|NCT00615056|12161395|FG000|NOT COMPLETED|Overall Study||49
10986163|NCT00615056|12161396|FG001|NOT COMPLETED|Overall Study||51
10986164|NCT00615056|12161397|FG002|NOT COMPLETED|Overall Study||36
10986165|NCT00615056|12161398|FG003|NOT COMPLETED|Overall Study||35
10986166|NCT00615069|12161408|FG000|STARTED|Overall Study||35
10986167|NCT00615069|12161408|FG000|COMPLETED|Overall Study||19
10986168|NCT00615069|12161408|FG000|NOT COMPLETED|Overall Study||16
10986169|NCT00615108|12161412|FG000|STARTED|Overall Study||3148
10986170|NCT00615108|12161412|FG000|COMPLETED|Overall Study||2641
10986171|NCT00615108|12161412|FG000|NOT COMPLETED|Overall Study||507
10986172|NCT00615199|12161422|FG000|STARTED|Overall Study||34
10986173|NCT00615199|12161423|FG001|STARTED|Overall Study||36
10986174|NCT00615199|12161424|FG002|STARTED|Overall Study||34
10986175|NCT00615199|12161425|FG003|STARTED|Overall Study||35
10986176|NCT00615199|12161422|FG000|COMPLETED|Overall Study||26
10986177|NCT00615199|12161423|FG001|COMPLETED|Overall Study||34
10986178|NCT00615199|12161424|FG002|COMPLETED|Overall Study||33
10986179|NCT00615199|12161425|FG003|COMPLETED|Overall Study||33
10986180|NCT00615199|12161422|FG000|NOT COMPLETED|Overall Study||8
10986181|NCT00615199|12161423|FG001|NOT COMPLETED|Overall Study||2
10986182|NCT00615199|12161424|FG002|NOT COMPLETED|Overall Study||1
10986183|NCT00615199|12161425|FG003|NOT COMPLETED|Overall Study||2
10986184|NCT00615264|12161437|FG000|STARTED|Overall Study||225
10986185|NCT00615264|12161438|FG001|STARTED|Overall Study||232
10986186|NCT00615264|12161437|FG000|Received at Least One Dose (ITT)|Overall Study||225
10986187|NCT00615264|12161438|FG001|Received at Least One Dose (ITT)|Overall Study||231
10986188|NCT00615264|12161437|FG000|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
10986189|NCT00615264|12161438|FG001|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
10986190|NCT00615264|12161437|FG000|COMPLETED|Overall Study||175
10986191|NCT00615264|12161438|FG001|COMPLETED|Overall Study||180
10986192|NCT00615264|12161437|FG000|NOT COMPLETED|Overall Study||50
10986193|NCT00615264|12161438|FG001|NOT COMPLETED|Overall Study||52
10986194|NCT00615290|12161444|FG000|STARTED|Overall Study||42
10986195|NCT00615290|12161444|FG000|COMPLETED|Overall Study||34
10986196|NCT00615290|12161444|FG000|NOT COMPLETED|Overall Study||8
10986197|NCT00615420|12161450|FG000|STARTED|Overall Study||54
10986198|NCT00615420|12161451|FG001|STARTED|Overall Study||52
10986199|NCT00615420|12161450|FG000|COMPLETED|Overall Study||23
10986200|NCT00615420|12161451|FG001|COMPLETED|Overall Study||25
10986201|NCT00615420|12161450|FG000|NOT COMPLETED|Overall Study||31
10986202|NCT00615420|12161451|FG001|NOT COMPLETED|Overall Study||27
10986203|NCT00615433|12161461|FG000|STARTED|Overall Study||120
10986204|NCT00615433|12161462|FG001|STARTED|Overall Study||119
10986205|NCT00615433|12161463|FG002|STARTED|Overall Study||123
10986206|NCT00615433|12161464|FG003|STARTED|Overall Study||116
10986207|NCT00615433|12161461|FG000|COMPLETED|Overall Study||77
10986208|NCT00615433|12161462|FG001|COMPLETED|Overall Study||66
10986209|NCT00615433|12161463|FG002|COMPLETED|Overall Study||84
10986210|NCT00615433|12161464|FG003|COMPLETED|Overall Study||71
10986211|NCT00615433|12161461|FG000|NOT COMPLETED|Overall Study||43
10986212|NCT00615433|12161462|FG001|NOT COMPLETED|Overall Study||53
10986213|NCT00615433|12161463|FG002|NOT COMPLETED|Overall Study||39
10986214|NCT00615433|12161464|FG003|NOT COMPLETED|Overall Study||45
10986215|NCT00615459|12161475|FG000|STARTED|Period I||41
10986216|NCT00615459|12161476|FG001|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
10986217|NCT00615459|12161477|FG002|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
10986218|NCT00615459|12161478|FG003|STARTED|Period I||43
10986219|NCT00615459|12161475|FG000|COMPLETED|Period I||37
10986220|NCT00615459|12161476|FG001|COMPLETED|Period I||40
10986221|NCT00615459|12161477|FG002|COMPLETED|Period I||40
10986222|NCT00615459|12161478|FG003|COMPLETED|Period I||42
10986223|NCT00615459|12161475|FG000|NOT COMPLETED|Period I||4
10986224|NCT00615459|12161476|FG001|NOT COMPLETED|Period I||1
10986225|NCT00615459|12161477|FG002|NOT COMPLETED|Period I||2
10986226|NCT00615459|12161478|FG003|NOT COMPLETED|Period I||1
10986227|NCT00615459|12161475|FG000|STARTED|Period II||37
10986228|NCT00615459|12161476|FG001|STARTED|Period II||40
10986229|NCT00615459|12161477|FG002|STARTED|Period II||40
10986230|NCT00615459|12161478|FG003|STARTED|Period II||42
10986231|NCT00615459|12161475|FG000|COMPLETED|Period II||36
10986232|NCT00615459|12161476|FG001|COMPLETED|Period II||40
10986233|NCT00615459|12161477|FG002|COMPLETED|Period II||40
10986234|NCT00615459|12161478|FG003|COMPLETED|Period II||41
10986235|NCT00615459|12161475|FG000|NOT COMPLETED|Period II||1
10986236|NCT00615459|12161476|FG001|NOT COMPLETED|Period II||0
10986237|NCT00615459|12161477|FG002|NOT COMPLETED|Period II||0
10986238|NCT00615459|12161478|FG003|NOT COMPLETED|Period II||1
10986239|NCT00615459|12161475|FG000|STARTED|Period III||36
10986240|NCT00615459|12161476|FG001|STARTED|Period III||40
10986241|NCT00615459|12161477|FG002|STARTED|Period III||40
10986242|NCT00615459|12161478|FG003|STARTED|Period III||41
10986243|NCT00615459|12161475|FG000|COMPLETED|Period III||36
10986244|NCT00615459|12161476|FG001|COMPLETED|Period III||37
10986245|NCT00615459|12161477|FG002|COMPLETED|Period III||39
10986246|NCT00615459|12161478|FG003|COMPLETED|Period III||41
10986247|NCT00615459|12161475|FG000|NOT COMPLETED|Period III||0
10986248|NCT00615459|12161476|FG001|NOT COMPLETED|Period III||3
10986249|NCT00615459|12161477|FG002|NOT COMPLETED|Period III||1
10986250|NCT00615459|12161478|FG003|NOT COMPLETED|Period III||0
10986251|NCT00615472|12161490|FG000|STARTED|Overall Study||30
10986252|NCT00615472|12161491|FG001|STARTED|Overall Study||28
10986253|NCT00615472|12161490|FG000|COMPLETED|Overall Study||30
10986254|NCT00615472|12161491|FG001|COMPLETED|Overall Study||28
10986255|NCT00615472|12161490|FG000|NOT COMPLETED|Overall Study||0
10986256|NCT00615472|12161491|FG001|NOT COMPLETED|Overall Study||0
10986257|NCT00615550|12161499|FG000|STARTED|Overall Study||229
10986258|NCT00615550|12161500|FG001|STARTED|Overall Study||236
10986259|NCT00615550|12161499|FG000|COMPLETED|Overall Study||223
10986260|NCT00615550|12161500|FG001|COMPLETED|Overall Study||235
10986261|NCT00615550|12161499|FG000|NOT COMPLETED|Overall Study||6
10986262|NCT00615550|12161500|FG001|NOT COMPLETED|Overall Study||1
10986263|NCT00615589|12161506|FG000|STARTED|Overall Study||22
10986264|NCT00615589|12161506|FG000|COMPLETED|Overall Study||22
10986265|NCT00615589|12161506|FG000|NOT COMPLETED|Overall Study||0
10986266|NCT00615719|12161511|FG000|STARTED|Overall Study||35
10986267|NCT00615719|12161511|FG000|COMPLETED|Overall Study||30
10986268|NCT00615719|12161511|FG000|NOT COMPLETED|Overall Study||5
10986269|NCT00615784|12161515|FG000|STARTED|Overall Study||24
10986270|NCT00615784|12161515|FG000|COMPLETED|Overall Study||24
10986271|NCT00615784|12161515|FG000|NOT COMPLETED|Overall Study||0
10986272|NCT00615836|12161523|FG000|STARTED|Part I of Core Study (FE992026 CS29)||163
10986273|NCT00615836|12161524|FG001|STARTED|Part I of Core Study (FE992026 CS29)||158
10986274|NCT00615836|12161525|FG002|STARTED|Part I of Core Study (FE992026 CS29)||158
10986275|NCT00615836|12161526|FG003|STARTED|Part I of Core Study (FE992026 CS29)||160
10986276|NCT00615836|12161527|FG004|STARTED|Part I of Core Study (FE992026 CS29)||160
10986277|NCT00615836|12161523|FG000|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
10986278|NCT00615836|12161524|FG001|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
10986279|NCT00615836|12161525|FG002|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
10986280|NCT00615836|12161526|FG003|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
10986281|NCT00615836|12161527|FG004|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
10986282|NCT00615836|12161523|FG000|COMPLETED|Part I of Core Study (FE992026 CS29)||144
10986283|NCT00615836|12161524|FG001|COMPLETED|Part I of Core Study (FE992026 CS29)||148
10986284|NCT00615836|12161525|FG002|COMPLETED|Part I of Core Study (FE992026 CS29)||138
10986285|NCT00615836|12161526|FG003|COMPLETED|Part I of Core Study (FE992026 CS29)||135
10986286|NCT00615836|12161527|FG004|COMPLETED|Part I of Core Study (FE992026 CS29)||145
10986287|NCT00615836|12161523|FG000|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
10986288|NCT00615836|12161524|FG001|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
10986289|NCT00615836|12161525|FG002|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
10986290|NCT00615836|12161526|FG003|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
10986291|NCT00615836|12161527|FG004|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
10986292|NCT00615836|12161523|FG000|STARTED|Extension Study (FE992026 CS31)||141
10986293|NCT00615836|12161524|FG001|STARTED|Extension Study (FE992026 CS31)||144
10986294|NCT00615836|12161525|FG002|STARTED|Extension Study (FE992026 CS31)||132
10986295|NCT00615836|12161526|FG003|STARTED|Extension Study (FE992026 CS31)||137
10986296|NCT00615836|12161527|FG004|STARTED|Extension Study (FE992026 CS31)||0
10986297|NCT00615836|12161523|FG000|COMPLETED|Extension Study (FE992026 CS31)||0
10986298|NCT00615836|12161524|FG001|COMPLETED|Extension Study (FE992026 CS31)||58
10986299|NCT00615836|12161525|FG002|COMPLETED|Extension Study (FE992026 CS31)||59
10986300|NCT00615836|12161526|FG003|COMPLETED|Extension Study (FE992026 CS31)||53
10986301|NCT00615836|12161527|FG004|COMPLETED|Extension Study (FE992026 CS31)||0
10986302|NCT00615836|12161523|FG000|NOT COMPLETED|Extension Study (FE992026 CS31)||141
10986303|NCT00615836|12161524|FG001|NOT COMPLETED|Extension Study (FE992026 CS31)||86
10986304|NCT00615836|12161525|FG002|NOT COMPLETED|Extension Study (FE992026 CS31)||73
10986305|NCT00615836|12161526|FG003|NOT COMPLETED|Extension Study (FE992026 CS31)||84
10986306|NCT00615836|12161527|FG004|NOT COMPLETED|Extension Study (FE992026 CS31)||0
10986307|NCT00615901|12161543|FG000|STARTED|Overall Study||38
10986308|NCT00615901|12161543|FG000|COMPLETED|Overall Study||29
10986309|NCT00615901|12161543|FG000|NOT COMPLETED|Overall Study||9
10986310|NCT00615914|12161547|FG000|STARTED|Overall Study|The number of patients enrolled|1645
10986311|NCT00615914|12161547|FG000|COMPLETED|Overall Study||1008
10986312|NCT00615914|12161547|FG000|NOT COMPLETED|Overall Study||637
10986313|NCT00615927|12161554|FG000|STARTED|Overall Study||32
10986314|NCT00615927|12161555|FG001|STARTED|Overall Study||32
10986315|NCT00615927|12161554|FG000|COMPLETED|Overall Study||32
10986316|NCT00615927|12161555|FG001|COMPLETED|Overall Study||32
10986317|NCT00615927|12161554|FG000|NOT COMPLETED|Overall Study||0
10986318|NCT00615927|12161555|FG001|NOT COMPLETED|Overall Study||0
10986319|NCT00615992|12161561|FG000|STARTED|Overall Study||754
10986320|NCT00615992|12161561|FG000|COMPLETED|Overall Study||687
10986321|NCT00615992|12161561|FG000|NOT COMPLETED|Overall Study||67
10986322|NCT00616018|12161565|FG000|STARTED|Overall Study||27
10986323|NCT00616018|12161565|FG000|COMPLETED|Overall Study||24
10986324|NCT00616018|12161565|FG000|NOT COMPLETED|Overall Study||3
10986325|NCT00616109|12161570|FG000|STARTED|Overall Study||16
10986326|NCT00616109|12161570|FG000|COMPLETED|Overall Study||16
10986327|NCT00616109|12161570|FG000|NOT COMPLETED|Overall Study||0
10986328|NCT00616122|12161575|FG000|STARTED|Overall Study||4
10986329|NCT00616122|12161576|FG001|STARTED|Overall Study||7
10986330|NCT00616122|12161577|FG002|STARTED|Overall Study||10
10986331|NCT00616122|12161578|FG003|STARTED|Overall Study||11
10986332|NCT00616122|12161575|FG000|COMPLETED|Overall Study||4
10986333|NCT00616122|12161576|FG001|COMPLETED|Overall Study||7
10986334|NCT00616122|12161577|FG002|COMPLETED|Overall Study||10
10986335|NCT00616122|12161578|FG003|COMPLETED|Overall Study||0
10986336|NCT00616122|12161575|FG000|NOT COMPLETED|Overall Study||0
10986337|NCT00616122|12161576|FG001|NOT COMPLETED|Overall Study||0
10986338|NCT00616122|12161577|FG002|NOT COMPLETED|Overall Study||0
10986339|NCT00616122|12161578|FG003|NOT COMPLETED|Overall Study||11
10986340|NCT00616200|12161585|FG000|STARTED|Two Week Standard Diet||17
10986341|NCT00616200|12161585|FG000|COMPLETED|Two Week Standard Diet||16
10986342|NCT00616200|12161585|FG000|NOT COMPLETED|Two Week Standard Diet||1
10986343|NCT00616200|12161585|FG000|STARTED|Four Week Very Low Carbohydrate Diet||16
10986344|NCT00616200|12161585|FG000|COMPLETED|Four Week Very Low Carbohydrate Diet||13
10986345|NCT00616200|12161585|FG000|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
10986346|NCT00616239|12161589|FG000|STARTED|Overall Study||20
10986347|NCT00616239|12161589|FG000|COMPLETED|Overall Study||18
10986348|NCT00616239|12161589|FG000|NOT COMPLETED|Overall Study||2
10986349|NCT00616421|12161596|FG000|STARTED|Overall Study||359
10986350|NCT00616421|12161597|FG001|STARTED|Overall Study||1278
10986351|NCT00616421|12161598|FG002|STARTED|Overall Study||1270
10986352|NCT00616421|12161596|FG000|COMPLETED|Overall Study||333
10986353|NCT00616421|12161597|FG001|COMPLETED|Overall Study||1240
10986354|NCT00616421|12161598|FG002|COMPLETED|Overall Study||1229
10986355|NCT00616421|12161596|FG000|NOT COMPLETED|Overall Study||26
10986356|NCT00616421|12161597|FG001|NOT COMPLETED|Overall Study||38
10986357|NCT00616421|12161598|FG002|NOT COMPLETED|Overall Study||41
10986358|NCT00616434|12161622|FG000|STARTED|Overall Study||62
10986359|NCT00616434|12161623|FG001|STARTED|Overall Study||61
10986360|NCT00616434|12161622|FG000|COMPLETED|Overall Study||56
10986361|NCT00616434|12161623|FG001|COMPLETED|Overall Study||53
10986362|NCT00616434|12161622|FG000|NOT COMPLETED|Overall Study||6
10986363|NCT00616434|12161623|FG001|NOT COMPLETED|Overall Study||8
10986364|NCT00616629|12161634|FG000|STARTED|Overall Study|Two patients never received study drug|13
10986365|NCT00616629|12161635|FG001|STARTED|Overall Study|Two patients never received study drug|14
10986366|NCT00616629|12161636|FG002|STARTED|Overall Study|One patient never received study drug|14
10986367|NCT00616629|12161637|FG003|STARTED|Overall Study||2
10986368|NCT00616629|12161638|FG004|STARTED|Overall Study||12
10986369|NCT00616629|12161634|FG000|COMPLETED|Overall Study||11
10986370|NCT00616629|12161635|FG001|COMPLETED|Overall Study||12
10986371|NCT00616629|12161636|FG002|COMPLETED|Overall Study||13
10986372|NCT00616629|12161637|FG003|COMPLETED|Overall Study||2
10986373|NCT00616629|12161638|FG004|COMPLETED|Overall Study||12
10986374|NCT00616629|12161634|FG000|NOT COMPLETED|Overall Study||2
10986375|NCT00616629|12161635|FG001|NOT COMPLETED|Overall Study||2
10986376|NCT00616629|12161636|FG002|NOT COMPLETED|Overall Study||1
10986377|NCT00616629|12161637|FG003|NOT COMPLETED|Overall Study||0
10986378|NCT00616629|12161638|FG004|NOT COMPLETED|Overall Study||0
10986379|NCT00616655|12161653|FG000|STARTED|Overall Study||152
10986380|NCT00616655|12161654|FG001|STARTED|Overall Study||153
10986381|NCT00616655|12161655|FG002|STARTED|Overall Study||151
10986382|NCT00616655|12161653|FG000|COMPLETED|Overall Study||117
10986383|NCT00616655|12161654|FG001|COMPLETED|Overall Study||112
10986384|NCT00616655|12161655|FG002|COMPLETED|Overall Study||103
10986385|NCT00616655|12161653|FG000|NOT COMPLETED|Overall Study||35
10986386|NCT00616655|12161654|FG001|NOT COMPLETED|Overall Study||41
10986387|NCT00616655|12161655|FG002|NOT COMPLETED|Overall Study||48
10986388|NCT00616772|12161665|FG000|STARTED|Overall Study||340
10986389|NCT00616772|12161666|FG001|STARTED|Overall Study||342
10986390|NCT00616772|12161665|FG000|Treated|Overall Study||337
10986391|NCT00616772|12161666|FG001|Treated|Overall Study||339
10986392|NCT00616772|12161665|FG000|COMPLETED|Overall Study||225
10986393|NCT00616772|12161666|FG001|COMPLETED|Overall Study||240
10986394|NCT00616772|12161665|FG000|NOT COMPLETED|Overall Study||115
10986395|NCT00616772|12161666|FG001|NOT COMPLETED|Overall Study||102
10986396|NCT00616902|12161674|FG000|STARTED|Overall Study||6
10986397|NCT00616902|12161675|FG001|STARTED|Overall Study||6
10986398|NCT00616902|12161674|FG000|COMPLETED|Overall Study||0
10986399|NCT00616902|12161675|FG001|COMPLETED|Overall Study||0
10986400|NCT00616902|12161674|FG000|NOT COMPLETED|Overall Study||6
10986401|NCT00616902|12161675|FG001|NOT COMPLETED|Overall Study||6
10986402|NCT00616928|12161685|FG000|STARTED|Overall Study||2304
10986403|NCT00616928|12161686|FG001|STARTED|Overall Study||768
10986404|NCT00616928|12161687|FG002|STARTED|Overall Study||1118
10986405|NCT00616928|12161688|FG003|STARTED|Overall Study||371
10986406|NCT00616928|12161685|FG000|COMPLETED|Overall Study||2242
10986407|NCT00616928|12161686|FG001|COMPLETED|Overall Study||750
10986408|NCT00616928|12161687|FG002|COMPLETED|Overall Study||1101
10986409|NCT00616928|12161688|FG003|COMPLETED|Overall Study||364
10986410|NCT00616928|12161685|FG000|NOT COMPLETED|Overall Study||62
10986411|NCT00616928|12161686|FG001|NOT COMPLETED|Overall Study||18
10986412|NCT00616928|12161687|FG002|NOT COMPLETED|Overall Study||17
10986413|NCT00616928|12161688|FG003|NOT COMPLETED|Overall Study||7
10986414|NCT00616941|12161713|FG000|STARTED|Overall Study||4
10986415|NCT00616941|12161714|FG001|STARTED|Overall Study||13
10986416|NCT00616941|12161715|FG002|STARTED|Overall Study||11
10986417|NCT00616941|12161713|FG000|COMPLETED|Overall Study||3
10986418|NCT00616941|12161714|FG001|COMPLETED|Overall Study||8
10986419|NCT00616941|12161715|FG002|COMPLETED|Overall Study||5
10986420|NCT00616941|12161713|FG000|NOT COMPLETED|Overall Study||1
10986421|NCT00616941|12161714|FG001|NOT COMPLETED|Overall Study||5
10986422|NCT00616941|12161715|FG002|NOT COMPLETED|Overall Study||6
10986423|NCT00617058|12161726|FG000|STARTED|Overall Study||1
10986424|NCT00617058|12161727|FG001|STARTED|Overall Study||0
10986425|NCT00617058|12161728|FG002|STARTED|Overall Study||0
10986426|NCT00617058|12161726|FG000|COMPLETED|Overall Study||1
10986427|NCT00617058|12161727|FG001|COMPLETED|Overall Study||0
10986428|NCT00617058|12161728|FG002|COMPLETED|Overall Study||0
10986429|NCT00617058|12161726|FG000|NOT COMPLETED|Overall Study||0
10986430|NCT00617058|12161727|FG001|NOT COMPLETED|Overall Study||0
10986431|NCT00617058|12161728|FG002|NOT COMPLETED|Overall Study||0
10986432|NCT00617084|12161738|FG000|STARTED|Overall Study||1140
10986433|NCT00617084|12161739|FG001|STARTED|Overall Study||1152
10986434|NCT00617084|12161738|FG000|COMPLETED|Overall Study||1119
10986435|NCT00617084|12161739|FG001|COMPLETED|Overall Study||1126
10986436|NCT00617084|12161738|FG000|NOT COMPLETED|Overall Study||21
10986437|NCT00617084|12161739|FG001|NOT COMPLETED|Overall Study||26
10986438|NCT00617097|12161747|FG000|STARTED|Overall Study||25
10986439|NCT00617097|12161748|FG001|STARTED|Overall Study||25
10986440|NCT00617097|12161747|FG000|COMPLETED|Overall Study||25
10986441|NCT00617097|12161748|FG001|COMPLETED|Overall Study||25
10986442|NCT00617097|12161747|FG000|NOT COMPLETED|Overall Study||0
10986443|NCT00617097|12161748|FG001|NOT COMPLETED|Overall Study||0
10986444|NCT00617123|12161758|FG000|STARTED|Referral Screening Period||137
10986445|NCT00617123|12161759|FG001|STARTED|Referral Screening Period||121
10986446|NCT00617123|12161758|FG000|COMPLETED|Referral Screening Period||98
10986447|NCT00617123|12161759|FG001|COMPLETED|Referral Screening Period||95
10986448|NCT00617123|12161758|FG000|NOT COMPLETED|Referral Screening Period||39
10986449|NCT00617123|12161759|FG001|NOT COMPLETED|Referral Screening Period||26
10986450|NCT00617123|12161758|FG000|STARTED|Study Treatment Period||98
10986451|NCT00617123|12161759|FG001|STARTED|Study Treatment Period||95
10986452|NCT00617123|12161758|FG000|Treated|Study Treatment Period|1 participant was not treated|97
10986453|NCT00617123|12161759|FG001|Treated|Study Treatment Period||95
10986454|NCT00617123|12161758|FG000|COMPLETED|Study Treatment Period||81
10986455|NCT00617123|12161759|FG001|COMPLETED|Study Treatment Period||79
10986456|NCT00617123|12161758|FG000|NOT COMPLETED|Study Treatment Period||17
10986457|NCT00617123|12161759|FG001|NOT COMPLETED|Study Treatment Period||16
10986458|NCT00617175|12161767|FG000|STARTED|Overall Study||954
10986459|NCT00617175|12161768|FG001|STARTED|Overall Study||948
10986460|NCT00617175|12161767|FG000|COMPLETED|Overall Study||954
10986461|NCT00617175|12161768|FG001|COMPLETED|Overall Study||948
10986462|NCT00617175|12161767|FG000|NOT COMPLETED|Overall Study||0
10986463|NCT00617175|12161768|FG001|NOT COMPLETED|Overall Study||0
10986464|NCT00617188|12161774|FG000|STARTED|Overall Study||26
10986465|NCT00617188|12161774|FG000|COMPLETED|Overall Study||26
10986466|NCT00617188|12161774|FG000|NOT COMPLETED|Overall Study||0
10986467|NCT00617201|12161780|FG000|STARTED|Overall Study||25
10986468|NCT00617201|12161781|FG001|STARTED|Overall Study||25
10986469|NCT00617201|12161780|FG000|COMPLETED|Overall Study||16
10986470|NCT00617201|12161781|FG001|COMPLETED|Overall Study||12
10986471|NCT00617201|12161780|FG000|NOT COMPLETED|Overall Study||9
10986472|NCT00617201|12161781|FG001|NOT COMPLETED|Overall Study||13
10986473|NCT00617240|12161791|FG000|STARTED|Overall Study||5
10986474|NCT00617240|12161792|FG001|STARTED|Overall Study||4
10986475|NCT00617240|12161791|FG000|COMPLETED|Overall Study||4
10986476|NCT00617240|12161792|FG001|COMPLETED|Overall Study||4
10986477|NCT00617240|12161791|FG000|NOT COMPLETED|Overall Study||1
10986478|NCT00617240|12161792|FG001|NOT COMPLETED|Overall Study||0
10986479|NCT00617279|12161800|FG000|STARTED|Overall Study||14
10986480|NCT00617279|12161801|FG001|STARTED|Overall Study||17
10986481|NCT00617279|12161800|FG000|COMPLETED|Overall Study||0
10986482|NCT00617279|12161801|FG001|COMPLETED|Overall Study||0
10986483|NCT00617279|12161800|FG000|NOT COMPLETED|Overall Study||14
10986484|NCT00617279|12161801|FG001|NOT COMPLETED|Overall Study||17
10986485|NCT00617305|12161810|FG000|STARTED|Overall Study||33
10986486|NCT00617305|12161811|FG001|STARTED|Overall Study||4
10986487|NCT00617305|12161812|FG002|STARTED|Overall Study||1
10986488|NCT00617305|12161810|FG000|Completed 24-week Primary Analysis|Overall Study||31
10986489|NCT00617305|12161811|FG001|Completed 24-week Primary Analysis|Overall Study||4
10986490|NCT00617305|12161812|FG002|Completed 24-week Primary Analysis|Overall Study||0
10986491|NCT00617305|12161810|FG000|COMPLETED|Overall Study||25
10986492|NCT00617305|12161811|FG001|COMPLETED|Overall Study||4
10986493|NCT00617305|12161812|FG002|COMPLETED|Overall Study||0
10986494|NCT00617305|12161810|FG000|NOT COMPLETED|Overall Study||8
10986495|NCT00617305|12161811|FG001|NOT COMPLETED|Overall Study||0
10986496|NCT00617305|12161812|FG002|NOT COMPLETED|Overall Study||1
10986497|NCT00617344|12161826|FG000|STARTED|Overall Study||104
10986498|NCT00617344|12161827|FG001|STARTED|Overall Study||103
10986499|NCT00617344|12161828|FG002|STARTED|Overall Study||53
10986500|NCT00617344|12161826|FG000|Received Vaccination 1|Overall Study||104
10986501|NCT00617344|12161827|FG001|Received Vaccination 1|Overall Study||103
10986502|NCT00617344|12161828|FG002|Received Vaccination 1|Overall Study||53
10986503|NCT00617344|12161826|FG000|Received Vaccination 2|Overall Study||86
10986504|NCT00617344|12161827|FG001|Received Vaccination 2|Overall Study||85
10986505|NCT00617344|12161828|FG002|Received Vaccination 2|Overall Study||46
10986506|NCT00617344|12161826|FG000|Received Vaccination 3|Overall Study||79
10986507|NCT00617344|12161827|FG001|Received Vaccination 3|Overall Study||81
10986508|NCT00617344|12161828|FG002|Received Vaccination 3|Overall Study||45
10986509|NCT00617344|12161826|FG000|COMPLETED|Overall Study||79
10986510|NCT00617344|12161827|FG001|COMPLETED|Overall Study||81
10986511|NCT00617344|12161828|FG002|COMPLETED|Overall Study||45
10986512|NCT00617344|12161826|FG000|NOT COMPLETED|Overall Study||25
10986513|NCT00617344|12161827|FG001|NOT COMPLETED|Overall Study||22
10986514|NCT00617344|12161828|FG002|NOT COMPLETED|Overall Study||8
10986515|NCT00617357|12161836|FG000|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
10986516|NCT00617357|12161836|FG000|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
10986517|NCT00617357|12161836|FG000|NOT COMPLETED|Overall Study||16
10986518|NCT00617396|12161841|FG000|STARTED|Overall Study||25
10986519|NCT00617396|12161841|FG000|COMPLETED|Overall Study||25
10986520|NCT00617396|12161841|FG000|NOT COMPLETED|Overall Study||0
10986521|NCT00617409|12161848|FG000|STARTED|Overall Study||18
10986522|NCT00617409|12161849|FG001|STARTED|Overall Study||20
10986523|NCT00617409|12161850|FG002|STARTED|Overall Study||31
10986524|NCT00617409|12161848|FG000|COMPLETED|Overall Study||2
10986525|NCT00617409|12161849|FG001|COMPLETED|Overall Study||2
10986526|NCT00617409|12161850|FG002|COMPLETED|Overall Study||4
10986527|NCT00617409|12161848|FG000|NOT COMPLETED|Overall Study||16
10986528|NCT00617409|12161849|FG001|NOT COMPLETED|Overall Study||18
10986529|NCT00617409|12161850|FG002|NOT COMPLETED|Overall Study||27
10986530|NCT00617461|12161859|FG000|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
10986531|NCT00617461|12161860|FG001|STARTED|First Treatment Intervention Period||44
10986532|NCT00617461|12161859|FG000|COMPLETED|First Treatment Intervention Period||42
10986533|NCT00617461|12161860|FG001|COMPLETED|First Treatment Intervention Period||41
10986534|NCT00617461|12161859|FG000|NOT COMPLETED|First Treatment Intervention Period||10
10986535|NCT00617461|12161860|FG001|NOT COMPLETED|First Treatment Intervention Period||3
10986536|NCT00617461|12161859|FG000|STARTED|4-Day Crossover Period||42
10986537|NCT00617461|12161860|FG001|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
10986538|NCT00617461|12161859|FG000|COMPLETED|4-Day Crossover Period||41
10986539|NCT00617461|12161860|FG001|COMPLETED|4-Day Crossover Period||40
10986540|NCT00617461|12161859|FG000|NOT COMPLETED|4-Day Crossover Period||1
10986541|NCT00617461|12161860|FG001|NOT COMPLETED|4-Day Crossover Period||0
10986542|NCT00617461|12161859|FG000|STARTED|Second Treatment Intervention Period||41
10986543|NCT00617461|12161860|FG001|STARTED|Second Treatment Intervention Period||41
10986544|NCT00617461|12161859|FG000|COMPLETED|Second Treatment Intervention Period||41
10986545|NCT00617461|12161860|FG001|COMPLETED|Second Treatment Intervention Period||37
10986546|NCT00617461|12161859|FG000|NOT COMPLETED|Second Treatment Intervention Period||0
10986547|NCT00617461|12161860|FG001|NOT COMPLETED|Second Treatment Intervention Period||4
10986548|NCT00617461|12161859|FG000|STARTED|6-Day Down-Titration Period||41
10986549|NCT00617461|12161860|FG001|STARTED|6-Day Down-Titration Period||37
10986550|NCT00617461|12161859|FG000|COMPLETED|6-Day Down-Titration Period||39
10986551|NCT00617461|12161860|FG001|COMPLETED|6-Day Down-Titration Period||35
10986552|NCT00617461|12161859|FG000|NOT COMPLETED|6-Day Down-Titration Period||2
10986553|NCT00617461|12161860|FG001|NOT COMPLETED|6-Day Down-Titration Period||2
10986554|NCT00617539|12161882|FG000|STARTED|Overall Study||30
10986555|NCT00617539|12161882|FG000|COMPLETED|Overall Study||30
10986556|NCT00617539|12161882|FG000|NOT COMPLETED|Overall Study||0
10986557|NCT00617591|12161887|FG000|STARTED|Overall Study||57
10986558|NCT00617591|12161887|FG000|COMPLETED|Overall Study||47
10986559|NCT00617591|12161887|FG000|NOT COMPLETED|Overall Study||10
10986560|NCT00617604|12161894|FG000|STARTED|Overall Study||110
10986561|NCT00617604|12161895|FG001|STARTED|Overall Study||108
10986562|NCT00617604|12161894|FG000|Received Treatment|Overall Study||107
10986563|NCT00617604|12161895|FG001|Received Treatment|Overall Study||105
10986564|NCT00617604|12161894|FG000|Completed 12 Weeks of Treatment|Overall Study||89
10986565|NCT00617604|12161895|FG001|Completed 12 Weeks of Treatment|Overall Study||83
10986566|NCT00617604|12161894|FG000|COMPLETED|Overall Study|Completed Month 6 assessment|92
10986567|NCT00617604|12161895|FG001|COMPLETED|Overall Study|Completed Month 6 assessment|88
10986568|NCT00617604|12161894|FG000|NOT COMPLETED|Overall Study||18
10986569|NCT00617604|12161895|FG001|NOT COMPLETED|Overall Study||20
10986570|NCT00617669|12161903|FG000|STARTED|Overall Study||524
10986571|NCT00617669|12161904|FG001|STARTED|Overall Study||528
10986572|NCT00617669|12161903|FG000|Patients Who Received IP|Overall Study||522
10986573|NCT00617669|12161904|FG001|Patients Who Received IP|Overall Study||525
10986574|NCT00617669|12161903|FG000|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
10986575|NCT00617669|12161904|FG001|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
10986576|NCT00617669|12161903|FG000|NOT COMPLETED|Overall Study||430
10986577|NCT00617669|12161904|FG001|NOT COMPLETED|Overall Study||451
10986578|NCT00617734|12161912|FG000|STARTED|Overall Study||49
10986579|NCT00617734|12161913|FG001|STARTED|Overall Study||48
10986580|NCT00617734|12161912|FG000|Received at Least 1 Dose of Study Drug|Overall Study||47
10986581|NCT00617734|12161913|FG001|Received at Least 1 Dose of Study Drug|Overall Study||44
10986582|NCT00617734|12161912|FG000|COMPLETED|Overall Study||41
10986583|NCT00617734|12161913|FG001|COMPLETED|Overall Study||42
10986584|NCT00617734|12161912|FG000|NOT COMPLETED|Overall Study||8
10986585|NCT00617734|12161913|FG001|NOT COMPLETED|Overall Study||6
10986586|NCT00617773|12161919|FG000|STARTED|Overall Study||31
10986587|NCT00617773|12161919|FG000|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
10986588|NCT00617773|12161919|FG000|NOT COMPLETED|Overall Study||24
10986589|NCT00617851|12161927|FG000|STARTED|Overall Study||430
10986590|NCT00617851|12161928|FG001|STARTED|Overall Study||431
10986591|NCT00617851|12161929|FG002|STARTED|Overall Study||429
10986592|NCT00617851|12161930|FG003|STARTED|Overall Study||217
10986593|NCT00617851|12161927|FG000|COMPLETED|Overall Study||383
10986594|NCT00617851|12161928|FG001|COMPLETED|Overall Study||391
10986595|NCT00617851|12161929|FG002|COMPLETED|Overall Study||384
10986596|NCT00617851|12161930|FG003|COMPLETED|Overall Study||192
10986597|NCT00617851|12161927|FG000|NOT COMPLETED|Overall Study||47
10986598|NCT00617851|12161928|FG001|NOT COMPLETED|Overall Study||40
10986599|NCT00617851|12161929|FG002|NOT COMPLETED|Overall Study||45
10986600|NCT00617851|12161930|FG003|NOT COMPLETED|Overall Study||25
10986601|NCT00617890|12161954|FG000|STARTED|Overall Study||35
10986602|NCT00617890|12161955|FG001|STARTED|Overall Study||33
10986603|NCT00617890|12161956|FG002|STARTED|Overall Study||35
10986604|NCT00617890|12161957|FG003|STARTED|Overall Study||116
10986605|NCT00617890|12161954|FG000|Received Treatment|Overall Study||34
10986606|NCT00617890|12161955|FG001|Received Treatment|Overall Study||33
10986607|NCT00617890|12161956|FG002|Received Treatment|Overall Study||34
10986608|NCT00617890|12161957|FG003|Received Treatment|Overall Study||115
10986609|NCT00617890|12161954|FG000|COMPLETED|Overall Study||4
10986610|NCT00617890|12161955|FG001|COMPLETED|Overall Study||5
10986611|NCT00617890|12161956|FG002|COMPLETED|Overall Study||0
10986612|NCT00617890|12161957|FG003|COMPLETED|Overall Study||1
10986613|NCT00617890|12161954|FG000|NOT COMPLETED|Overall Study||31
10986614|NCT00617890|12161955|FG001|NOT COMPLETED|Overall Study||28
10986615|NCT00617890|12161956|FG002|NOT COMPLETED|Overall Study||35
10986616|NCT00617890|12161957|FG003|NOT COMPLETED|Overall Study||115
10986617|NCT00617903|12161972|FG000|STARTED|Overall Study||41
10986618|NCT00617903|12161973|FG001|STARTED|Overall Study||42
10986619|NCT00617903|12161972|FG000|COMPLETED|Overall Study||38
10986620|NCT00617903|12161973|FG001|COMPLETED|Overall Study||35
10986621|NCT00617903|12161972|FG000|NOT COMPLETED|Overall Study||3
10986622|NCT00617903|12161973|FG001|NOT COMPLETED|Overall Study||7
10986623|NCT00617929|12161979|FG000|STARTED|Overall Study||12
10986624|NCT00617929|12161979|FG000|COMPLETED|Overall Study||11
10986625|NCT00617929|12161979|FG000|NOT COMPLETED|Overall Study||1
10986626|NCT00617942|12161985|FG000|STARTED|Overall Study||37
10986627|NCT00617942|12161986|FG001|STARTED|Overall Study||23
10986628|NCT00617942|12161985|FG000|COMPLETED|Overall Study||29
10986629|NCT00617942|12161986|FG001|COMPLETED|Overall Study||19
10986630|NCT00617942|12161985|FG000|NOT COMPLETED|Overall Study||8
10986631|NCT00617942|12161986|FG001|NOT COMPLETED|Overall Study||4
10986632|NCT00617981|12162000|FG000|STARTED|Overall Study||354
10986633|NCT00617981|12162001|FG001|STARTED|Overall Study||347
10986634|NCT00617981|12162000|FG000|COMPLETED|Overall Study||244
10986635|NCT00617981|12162001|FG001|COMPLETED|Overall Study||245
10986636|NCT00617981|12162000|FG000|NOT COMPLETED|Overall Study||110
10986637|NCT00617981|12162001|FG001|NOT COMPLETED|Overall Study||102
10986638|NCT00618072|12162010|FG000|STARTED|Overall Study||16
10986639|NCT00618072|12162011|FG001|STARTED|Overall Study||15
10986640|NCT00618072|12162012|FG002|STARTED|Overall Study||15
10986641|NCT00618072|12162010|FG000|COMPLETED|Overall Study||14
10986642|NCT00618072|12162011|FG001|COMPLETED|Overall Study||14
10986643|NCT00618072|12162012|FG002|COMPLETED|Overall Study||11
10986644|NCT00618072|12162010|FG000|NOT COMPLETED|Overall Study||2
10986645|NCT00618072|12162011|FG001|NOT COMPLETED|Overall Study||1
10986646|NCT00618072|12162012|FG002|NOT COMPLETED|Overall Study||4
10986647|NCT00618332|12162022|FG000|STARTED|Overall Study||20
10986648|NCT00618332|12162023|FG001|STARTED|Overall Study||20
10986649|NCT00618332|12162022|FG000|COMPLETED|Overall Study||20
10986650|NCT00618332|12162023|FG001|COMPLETED|Overall Study||20
10986651|NCT00618332|12162022|FG000|NOT COMPLETED|Overall Study||0
10986652|NCT00618332|12162023|FG001|NOT COMPLETED|Overall Study||0
10986653|NCT00618371|12162029|FG000|STARTED|Overall Study||12
10986654|NCT00618371|12162029|FG000|COMPLETED|Overall Study||10
10986655|NCT00618371|12162029|FG000|NOT COMPLETED|Overall Study||2
10986656|NCT00618410|12162034|FG000|STARTED|First Intervention||7
10986657|NCT00618410|12162035|FG001|STARTED|First Intervention||6
10986658|NCT00618410|12162034|FG000|COMPLETED|First Intervention||7
10986659|NCT00618410|12162035|FG001|COMPLETED|First Intervention||6
10986660|NCT00618410|12162034|FG000|NOT COMPLETED|First Intervention||0
10986661|NCT00618410|12162035|FG001|NOT COMPLETED|First Intervention||0
10986662|NCT00618410|12162034|FG000|STARTED|Washout Period (2 Weeks)||7
10986663|NCT00618410|12162035|FG001|STARTED|Washout Period (2 Weeks)||6
10986664|NCT00618410|12162034|FG000|COMPLETED|Washout Period (2 Weeks)||7
10986665|NCT00618410|12162035|FG001|COMPLETED|Washout Period (2 Weeks)||5
10986666|NCT00618410|12162034|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
10986667|NCT00618410|12162035|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1
10986668|NCT00618410|12162034|FG000|STARTED|Second Intervention||7
10986669|NCT00618410|12162035|FG001|STARTED|Second Intervention||5
10986670|NCT00618410|12162034|FG000|COMPLETED|Second Intervention||7
10986671|NCT00618410|12162035|FG001|COMPLETED|Second Intervention||5
10986672|NCT00618410|12162034|FG000|NOT COMPLETED|Second Intervention||0
10986673|NCT00618410|12162035|FG001|NOT COMPLETED|Second Intervention||0
10986674|NCT00618436|12162043|FG000|STARTED|Overall Study||34
10986675|NCT00618436|12162044|FG001|STARTED|Overall Study||18
10986676|NCT00618436|12162043|FG000|COMPLETED|Overall Study||34
10986677|NCT00618436|12162044|FG001|COMPLETED|Overall Study||18
10986678|NCT00618436|12162043|FG000|NOT COMPLETED|Overall Study||0
10986679|NCT00618436|12162044|FG001|NOT COMPLETED|Overall Study||0
10986680|NCT00618449|12162052|FG000|STARTED|Overall Study||679
10986681|NCT00618449|12162053|FG001|STARTED|Overall Study||668
10986682|NCT00618449|12162052|FG000|1-month, Post-treatment|Overall Study||666
10986683|NCT00618449|12162053|FG001|1-month, Post-treatment|Overall Study||656
10986684|NCT00618449|12162052|FG000|1-year, Post-treatment|Overall Study||581
10986685|NCT00618449|12162053|FG001|1-year, Post-treatment|Overall Study||558
10986686|NCT00618449|12162052|FG000|COMPLETED|Overall Study||581
10986687|NCT00618449|12162053|FG001|COMPLETED|Overall Study||558
10986688|NCT00618449|12162052|FG000|NOT COMPLETED|Overall Study||98
10986689|NCT00618449|12162053|FG001|NOT COMPLETED|Overall Study||110
10986690|NCT00618514|12162061|FG000|STARTED|Overall Study||36
10986691|NCT00618514|12162062|FG001|STARTED|Overall Study||38
10986692|NCT00618514|12162063|FG002|STARTED|Overall Study||16
10986693|NCT00618514|12162061|FG000|COMPLETED|Overall Study||25
10986694|NCT00618514|12162062|FG001|COMPLETED|Overall Study||26
10986695|NCT00618514|12162063|FG002|COMPLETED|Overall Study||12
10986696|NCT00618514|12162061|FG000|NOT COMPLETED|Overall Study||11
10986697|NCT00618514|12162062|FG001|NOT COMPLETED|Overall Study||12
10986698|NCT00618514|12162063|FG002|NOT COMPLETED|Overall Study||4
10986699|NCT00618540|12162069|FG000|STARTED|Overall Study||1
10986700|NCT00618540|12162069|FG000|COMPLETED|Overall Study||1
10986701|NCT00618540|12162069|FG000|NOT COMPLETED|Overall Study||0
10986702|NCT00618618|12162078|FG000|STARTED|Overall Study||24
10986703|NCT00618618|12162079|FG001|STARTED|Overall Study||14
10986704|NCT00618618|12162080|FG002|STARTED|Overall Study||21
10986705|NCT00618618|12162081|FG003|STARTED|Overall Study||14
10986706|NCT00618618|12162078|FG000|Received Treatment|Overall Study||24
10986707|NCT00618618|12162079|FG001|Received Treatment|Overall Study||13
10986708|NCT00618618|12162080|FG002|Received Treatment|Overall Study||20
10986709|NCT00618618|12162081|FG003|Received Treatment|Overall Study||14
10986710|NCT00618618|12162078|FG000|COMPLETED|Overall Study||20
10986711|NCT00618618|12162079|FG001|COMPLETED|Overall Study||11
10986712|NCT00618618|12162080|FG002|COMPLETED|Overall Study||18
10986713|NCT00618618|12162081|FG003|COMPLETED|Overall Study||13
10986714|NCT00618618|12162078|FG000|NOT COMPLETED|Overall Study||4
10986715|NCT00618618|12162079|FG001|NOT COMPLETED|Overall Study||3
10986716|NCT00618618|12162080|FG002|NOT COMPLETED|Overall Study||3
10986717|NCT00618618|12162081|FG003|NOT COMPLETED|Overall Study||1
10986718|NCT00618722|12162096|FG000|STARTED|Overall Study||21
10986719|NCT00618722|12162097|FG001|STARTED|Overall Study||20
10986720|NCT00618722|12162098|FG002|STARTED|Overall Study||22
10986721|NCT00618722|12162099|FG003|STARTED|Overall Study||22
10986722|NCT00618722|12162096|FG000|Received Treatment|Overall Study||20
10986723|NCT00618722|12162097|FG001|Received Treatment|Overall Study||20
10986724|NCT00618722|12162098|FG002|Received Treatment|Overall Study||22
10986725|NCT00618722|12162099|FG003|Received Treatment|Overall Study||22
10986726|NCT00618722|12162096|FG000|COMPLETED|Overall Study||18
10986727|NCT00618722|12162097|FG001|COMPLETED|Overall Study||18
10986728|NCT00618722|12162098|FG002|COMPLETED|Overall Study||19
10986729|NCT00618722|12162099|FG003|COMPLETED|Overall Study||18
10986730|NCT00618722|12162096|FG000|NOT COMPLETED|Overall Study||3
10986731|NCT00618722|12162097|FG001|NOT COMPLETED|Overall Study||2
10986732|NCT00618722|12162098|FG002|NOT COMPLETED|Overall Study||3
10986733|NCT00618722|12162099|FG003|NOT COMPLETED|Overall Study||4
10986734|NCT00618748|12162112|FG000|STARTED|Overall Study||56
10986735|NCT00618748|12162113|FG001|STARTED|Overall Study||25
10986736|NCT00618748|12162114|FG002|STARTED|Overall Study||20
10986737|NCT00618748|12162112|FG000|COMPLETED|Overall Study||45
10986738|NCT00618748|12162113|FG001|COMPLETED|Overall Study||20
10986739|NCT00618748|12162114|FG002|COMPLETED|Overall Study||6
10986740|NCT00618748|12162112|FG000|NOT COMPLETED|Overall Study||11
10986741|NCT00618748|12162113|FG001|NOT COMPLETED|Overall Study||5
10986742|NCT00618748|12162114|FG002|NOT COMPLETED|Overall Study||14
10986743|NCT00618774|12162124|FG000|STARTED|Overall Study||211
10986744|NCT00618774|12162125|FG001|STARTED|Overall Study||48
10986745|NCT00618774|12162124|FG000|COMPLETED|Overall Study||205
10986746|NCT00618774|12162125|FG001|COMPLETED|Overall Study||45
10986747|NCT00618774|12162124|FG000|NOT COMPLETED|Overall Study||6
10986748|NCT00618774|12162125|FG001|NOT COMPLETED|Overall Study||3
10986749|NCT00618787|12162133|FG000|STARTED|Overall Study||22
10986750|NCT00618787|12162134|FG001|STARTED|Overall Study||23
10986751|NCT00618787|12162133|FG000|COMPLETED|Overall Study||19
10986752|NCT00618787|12162134|FG001|COMPLETED|Overall Study||21
10986753|NCT00618787|12162133|FG000|NOT COMPLETED|Overall Study||3
10986754|NCT00618787|12162134|FG001|NOT COMPLETED|Overall Study||2
10986755|NCT00618813|12162140|FG000|STARTED|Overall Study||35
10986756|NCT00618813|12162140|FG000|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
10986757|NCT00618813|12162140|FG000|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
10986758|NCT00618813|12162140|FG000|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
10986759|NCT00618813|12162140|FG000|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
10986760|NCT00618813|12162140|FG000|COMPLETED|Overall Study||31
10986761|NCT00618813|12162140|FG000|NOT COMPLETED|Overall Study||4
10986762|NCT00618826|12162144|FG000|STARTED|Overall Study||14
10986763|NCT00618826|12162144|FG000|COMPLETED|Overall Study||13
10986764|NCT00618826|12162144|FG000|NOT COMPLETED|Overall Study||1
10986765|NCT00618839|12162149|FG000|STARTED|Overall Study||15
10986766|NCT00618839|12162149|FG000|COMPLETED|Overall Study||15
10986767|NCT00618839|12162149|FG000|NOT COMPLETED|Overall Study||0
10986768|NCT00618917|12162159|FG000|STARTED|Overall Study||4
10986769|NCT00618917|12162160|FG001|STARTED|Overall Study||3
10986770|NCT00618917|12162161|FG002|STARTED|Overall Study||11
10986771|NCT00618917|12162159|FG000|COMPLETED|Overall Study||3
10986772|NCT00618917|12162160|FG001|COMPLETED|Overall Study||3
10986773|NCT00618917|12162161|FG002|COMPLETED|Overall Study||11
10986774|NCT00618917|12162159|FG000|NOT COMPLETED|Overall Study||1
10986775|NCT00618917|12162160|FG001|NOT COMPLETED|Overall Study||0
10986776|NCT00618917|12162161|FG002|NOT COMPLETED|Overall Study||0
10986777|NCT00618956|12162171|FG000|STARTED|Overall Study||111
10986778|NCT00618956|12162172|FG001|STARTED|Overall Study||210
10986779|NCT00618956|12162171|FG000|COMPLETED|Overall Study||86
10986780|NCT00618956|12162172|FG001|COMPLETED|Overall Study||160
10986781|NCT00618956|12162171|FG000|NOT COMPLETED|Overall Study||25
10986782|NCT00618956|12162172|FG001|NOT COMPLETED|Overall Study||50
10986783|NCT00618982|12162184|FG000|STARTED|Overall Study||83
10986784|NCT00618982|12162184|FG000|COMPLETED|Overall Study||33
10986785|NCT00618982|12162184|FG000|NOT COMPLETED|Overall Study||50
10986786|NCT00618995|12162191|FG000|STARTED|Period 1||6
10986787|NCT00618995|12162192|FG001|STARTED|Period 1||7
10986788|NCT00618995|12162193|FG002|STARTED|Period 1||7
10986789|NCT00618995|12162194|FG003|STARTED|Period 1||6
10986790|NCT00618995|12162191|FG000|COMPLETED|Period 1||6
10986791|NCT00618995|12162192|FG001|COMPLETED|Period 1||6
10986792|NCT00618995|12162193|FG002|COMPLETED|Period 1||5
10986793|NCT00618995|12162194|FG003|COMPLETED|Period 1||6
10986794|NCT00618995|12162191|FG000|NOT COMPLETED|Period 1||0
10986795|NCT00618995|12162192|FG001|NOT COMPLETED|Period 1||1
10986796|NCT00618995|12162193|FG002|NOT COMPLETED|Period 1||2
10986797|NCT00618995|12162194|FG003|NOT COMPLETED|Period 1||0
10986798|NCT00618995|12162191|FG000|STARTED|Period 2||6
10986799|NCT00618995|12162192|FG001|STARTED|Period 2||6
10986800|NCT00618995|12162193|FG002|STARTED|Period 2||5
10986801|NCT00618995|12162194|FG003|STARTED|Period 2||6
10986802|NCT00618995|12162191|FG000|COMPLETED|Period 2||6
10986803|NCT00618995|12162192|FG001|COMPLETED|Period 2||6
10986804|NCT00618995|12162193|FG002|COMPLETED|Period 2||4
10986805|NCT00618995|12162194|FG003|COMPLETED|Period 2||6
10986806|NCT00618995|12162191|FG000|NOT COMPLETED|Period 2||0
10986807|NCT00618995|12162192|FG001|NOT COMPLETED|Period 2||0
10986808|NCT00618995|12162193|FG002|NOT COMPLETED|Period 2||1
10986809|NCT00618995|12162194|FG003|NOT COMPLETED|Period 2||0
10986810|NCT00618995|12162191|FG000|STARTED|Period 3||6
10986811|NCT00618995|12162192|FG001|STARTED|Period 3||6
10986812|NCT00618995|12162193|FG002|STARTED|Period 3||4
10986813|NCT00618995|12162194|FG003|STARTED|Period 3||6
10986814|NCT00618995|12162191|FG000|COMPLETED|Period 3||6
10986815|NCT00618995|12162192|FG001|COMPLETED|Period 3||6
10986816|NCT00618995|12162193|FG002|COMPLETED|Period 3||4
10986817|NCT00618995|12162194|FG003|COMPLETED|Period 3||6
10986818|NCT00618995|12162191|FG000|NOT COMPLETED|Period 3||0
10986819|NCT00618995|12162192|FG001|NOT COMPLETED|Period 3||0
10986820|NCT00618995|12162193|FG002|NOT COMPLETED|Period 3||0
10986821|NCT00618995|12162194|FG003|NOT COMPLETED|Period 3||0
10986822|NCT00618995|12162191|FG000|STARTED|Period 4||6
10986823|NCT00618995|12162192|FG001|STARTED|Period 4||6
10986824|NCT00618995|12162193|FG002|STARTED|Period 4||4
10986825|NCT00618995|12162194|FG003|STARTED|Period 4||6
10986826|NCT00618995|12162191|FG000|COMPLETED|Period 4||5
10986827|NCT00618995|12162192|FG001|COMPLETED|Period 4||6
10986828|NCT00618995|12162193|FG002|COMPLETED|Period 4||4
10986829|NCT00618995|12162194|FG003|COMPLETED|Period 4||6
10986830|NCT00618995|12162191|FG000|NOT COMPLETED|Period 4||1
10986831|NCT00618995|12162192|FG001|NOT COMPLETED|Period 4||0
10986832|NCT00618995|12162193|FG002|NOT COMPLETED|Period 4||0
10986833|NCT00618995|12162194|FG003|NOT COMPLETED|Period 4||0
10986834|NCT00619060|12162204|FG000|STARTED|Overall Study||10
10986835|NCT00619060|12162205|FG001|STARTED|Overall Study||12
10986836|NCT00619060|12162204|FG000|COMPLETED|Overall Study||10
10986837|NCT00619060|12162205|FG001|COMPLETED|Overall Study||12
10986838|NCT00619060|12162204|FG000|NOT COMPLETED|Overall Study||0
10986839|NCT00619060|12162205|FG001|NOT COMPLETED|Overall Study||0
10986840|NCT00619073|12162213|FG000|STARTED|First Intervention - 60 Days||8
10986841|NCT00619073|12162214|FG001|STARTED|First Intervention - 60 Days||8
10986842|NCT00619073|12162213|FG000|COMPLETED|First Intervention - 60 Days||8
10986843|NCT00619073|12162214|FG001|COMPLETED|First Intervention - 60 Days||8
10986844|NCT00619073|12162213|FG000|NOT COMPLETED|First Intervention - 60 Days||0
10986845|NCT00619073|12162214|FG001|NOT COMPLETED|First Intervention - 60 Days||0
10986846|NCT00619073|12162213|FG000|STARTED|Washout Period (30 Days)||8
10986847|NCT00619073|12162214|FG001|STARTED|Washout Period (30 Days)||8
10986848|NCT00619073|12162213|FG000|COMPLETED|Washout Period (30 Days)||8
10986849|NCT00619073|12162214|FG001|COMPLETED|Washout Period (30 Days)||8
10986850|NCT00619073|12162213|FG000|NOT COMPLETED|Washout Period (30 Days)||0
10986851|NCT00619073|12162214|FG001|NOT COMPLETED|Washout Period (30 Days)||0
10986852|NCT00619073|12162213|FG000|STARTED|Second Intervention - 60 Days||8
10986853|NCT00619073|12162214|FG001|STARTED|Second Intervention - 60 Days||8
10986854|NCT00619073|12162213|FG000|COMPLETED|Second Intervention - 60 Days||8
10986855|NCT00619073|12162214|FG001|COMPLETED|Second Intervention - 60 Days||8
10986856|NCT00619073|12162213|FG000|NOT COMPLETED|Second Intervention - 60 Days||0
10986857|NCT00619073|12162214|FG001|NOT COMPLETED|Second Intervention - 60 Days||0
10986858|NCT00619099|12162222|FG000|STARTED|Overall Study|All randomized subjects|44
10986859|NCT00619099|12162223|FG001|STARTED|Overall Study|All randomized subjects|23
10986860|NCT00619099|12162222|FG000|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
10986861|NCT00619099|12162223|FG001|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
10986862|NCT00619099|12162222|FG000|COMPLETED|Overall Study||11
10986863|NCT00619099|12162223|FG001|COMPLETED|Overall Study||4
10986864|NCT00619099|12162222|FG000|NOT COMPLETED|Overall Study||33
10986865|NCT00619099|12162223|FG001|NOT COMPLETED|Overall Study||19
10986866|NCT00619112|12162231|FG000|STARTED|Overall Study||40
10986867|NCT00619112|12162232|FG001|STARTED|Overall Study||20
10986868|NCT00619112|12162231|FG000|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
10986869|NCT00619112|12162232|FG001|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
10986870|NCT00619112|12162231|FG000|NOT COMPLETED|Overall Study||1
10986871|NCT00619112|12162232|FG001|NOT COMPLETED|Overall Study||2
10986872|NCT00619177|12162241|FG000|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
10986873|NCT00619177|12162241|FG000|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
10986874|NCT00619177|12162241|FG000|NOT COMPLETED|Overall Study||508
10986875|NCT00619190|12162247|FG000|STARTED|Overall Study||21
10986876|NCT00619190|12162248|FG001|STARTED|Overall Study||9
10986877|NCT00619190|12162247|FG000|COMPLETED|Overall Study||20
10986878|NCT00619190|12162248|FG001|COMPLETED|Overall Study||9
10986879|NCT00619190|12162247|FG000|NOT COMPLETED|Overall Study||1
10986880|NCT00619190|12162248|FG001|NOT COMPLETED|Overall Study||0
10986881|NCT00619229|12162256|FG000|STARTED|Overall Study||18
10986882|NCT00619229|12162257|FG001|STARTED|Overall Study||18
10986883|NCT00619229|12162256|FG000|Full Analysis Set (FAS)|Overall Study||16
10986884|NCT00619229|12162257|FG001|Full Analysis Set (FAS)|Overall Study||17
10986885|NCT00619229|12162256|FG000|COMPLETED|Overall Study||14
10986886|NCT00619229|12162257|FG001|COMPLETED|Overall Study||16
10986887|NCT00619229|12162256|FG000|NOT COMPLETED|Overall Study||4
10986888|NCT00619229|12162257|FG001|NOT COMPLETED|Overall Study||2
10986889|NCT00619255|12162265|FG000|STARTED|Overall Study||59
10986890|NCT00619255|12162266|FG001|STARTED|Overall Study||61
10986891|NCT00619255|12162265|FG000|COMPLETED|Overall Study||57
10986892|NCT00619255|12162266|FG001|COMPLETED|Overall Study||61
10986893|NCT00619255|12162265|FG000|NOT COMPLETED|Overall Study||2
10986894|NCT00619255|12162266|FG001|NOT COMPLETED|Overall Study||0
10986895|NCT00619307|12162274|FG000|STARTED|Overall Study||60
10986896|NCT00619307|12162275|FG001|STARTED|Overall Study||57
10986897|NCT00619307|12162274|FG000|COMPLETED|Overall Study||56
10986898|NCT00619307|12162275|FG001|COMPLETED|Overall Study||53
10986899|NCT00619307|12162274|FG000|NOT COMPLETED|Overall Study||4
10986900|NCT00619307|12162275|FG001|NOT COMPLETED|Overall Study||4
10986901|NCT00619359|12162283|FG000|STARTED|Overall Study||1147
10986902|NCT00619359|12162284|FG001|STARTED|Overall Study||1175
10986903|NCT00619359|12162283|FG000|COMPLETED|Overall Study||1080
10986904|NCT00619359|12162284|FG001|COMPLETED|Overall Study||1094
10986905|NCT00619359|12162283|FG000|NOT COMPLETED|Overall Study||67
10986906|NCT00619359|12162284|FG001|NOT COMPLETED|Overall Study||81
10986907|NCT00619385|12162293|FG000|STARTED|Overall Study||7
10986908|NCT00619385|12162294|FG001|STARTED|Overall Study||8
10986909|NCT00619385|12162295|FG002|STARTED|Overall Study||10
10986910|NCT00619385|12162293|FG000|COMPLETED|Overall Study||6
10986911|NCT00619385|12162294|FG001|COMPLETED|Overall Study||6
10986912|NCT00619385|12162295|FG002|COMPLETED|Overall Study||6
10986913|NCT00619385|12162293|FG000|NOT COMPLETED|Overall Study||1
10986914|NCT00619385|12162294|FG001|NOT COMPLETED|Overall Study||2
10986915|NCT00619385|12162295|FG002|NOT COMPLETED|Overall Study||4
10986916|NCT00619476|12162310|FG000|STARTED|Overall Study||95
10986917|NCT00619476|12162311|FG001|STARTED|Overall Study||107
10986918|NCT00619476|12162312|FG002|STARTED|Overall Study||84
10986919|NCT00619476|12162313|FG003|STARTED|Overall Study||90
10986920|NCT00619476|12162310|FG000|Intent-to-Treat Population|Overall Study||95
10986921|NCT00619476|12162311|FG001|Intent-to-Treat Population|Overall Study||107
10986922|NCT00619476|12162312|FG002|Intent-to-Treat Population|Overall Study||82
10986923|NCT00619476|12162313|FG003|Intent-to-Treat Population|Overall Study||87
10986924|NCT00619476|12162310|FG000|Safety Population|Overall Study||95
10986925|NCT00619476|12162311|FG001|Safety Population|Overall Study||107
10986926|NCT00619476|12162312|FG002|Safety Population|Overall Study||82
10986927|NCT00619476|12162313|FG003|Safety Population|Overall Study||87
10986928|NCT00619476|12162310|FG000|COMPLETED|Overall Study||64
10986929|NCT00619476|12162311|FG001|COMPLETED|Overall Study||85
10986930|NCT00619476|12162312|FG002|COMPLETED|Overall Study||60
10986931|NCT00619476|12162313|FG003|COMPLETED|Overall Study||56
10986932|NCT00619476|12162310|FG000|NOT COMPLETED|Overall Study||31
10986933|NCT00619476|12162311|FG001|NOT COMPLETED|Overall Study||22
10986934|NCT00619476|12162312|FG002|NOT COMPLETED|Overall Study||24
10986935|NCT00619476|12162313|FG003|NOT COMPLETED|Overall Study||34
10986936|NCT00619489|12162325|FG000|STARTED|Overall Study||37
10986937|NCT00619489|12162326|FG001|STARTED|Overall Study||35
10986938|NCT00619489|12162325|FG000|COMPLETED|Overall Study||14
10986939|NCT00619489|12162326|FG001|COMPLETED|Overall Study||1
10986940|NCT00619489|12162325|FG000|NOT COMPLETED|Overall Study||23
10986941|NCT00619489|12162326|FG001|NOT COMPLETED|Overall Study||34
10986942|NCT00619502|12162334|FG000|STARTED|Overall Study||130
10986943|NCT00619502|12162335|FG001|STARTED|Overall Study||124
10986944|NCT00619502|12162334|FG000|COMPLETED|Overall Study||122
10986945|NCT00619502|12162335|FG001|COMPLETED|Overall Study||114
10986946|NCT00619502|12162334|FG000|NOT COMPLETED|Overall Study||8
10986947|NCT00619502|12162335|FG001|NOT COMPLETED|Overall Study||10
10986948|NCT00619619|12162351|FG000|STARTED|Overall Study||6
10986949|NCT00619619|12162352|FG001|STARTED|Overall Study||7
10986950|NCT00619619|12162353|FG002|STARTED|Overall Study||9
10986951|NCT00619619|12162354|FG003|STARTED|Overall Study||7
10986952|NCT00619619|12162355|FG004|STARTED|Overall Study||7
10986953|NCT00619619|12162356|FG005|STARTED|Overall Study||7
10986954|NCT00619619|12162357|FG006|STARTED|Overall Study||8
10986955|NCT00619619|12162358|FG007|STARTED|Overall Study||8
10986956|NCT00619619|12162351|FG000|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
10986957|NCT00619619|12162352|FG001|Entered the Extension Study|Overall Study||5
10986958|NCT00619619|12162353|FG002|Entered the Extension Study|Overall Study||8
10986959|NCT00619619|12162354|FG003|Entered the Extension Study|Overall Study||3
10986960|NCT00619619|12162355|FG004|Entered the Extension Study|Overall Study||7
10986961|NCT00619619|12162356|FG005|Entered the Extension Study|Overall Study||6
10986962|NCT00619619|12162357|FG006|Entered the Extension Study|Overall Study||6
10986963|NCT00619619|12162358|FG007|Entered the Extension Study|Overall Study||7
10986964|NCT00619619|12162351|FG000|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
10986965|NCT00619619|12162352|FG001|COMPLETED|Overall Study||7
10986966|NCT00619619|12162353|FG002|COMPLETED|Overall Study||8
10986967|NCT00619619|12162354|FG003|COMPLETED|Overall Study||6
10986968|NCT00619619|12162355|FG004|COMPLETED|Overall Study||5
10986969|NCT00619619|12162356|FG005|COMPLETED|Overall Study||7
10986970|NCT00619619|12162357|FG006|COMPLETED|Overall Study||7
10986971|NCT00619619|12162358|FG007|COMPLETED|Overall Study||5
10986972|NCT00619619|12162351|FG000|NOT COMPLETED|Overall Study||0
10986973|NCT00619619|12162352|FG001|NOT COMPLETED|Overall Study||0
10986974|NCT00619619|12162353|FG002|NOT COMPLETED|Overall Study||1
10986975|NCT00619619|12162354|FG003|NOT COMPLETED|Overall Study||1
10986976|NCT00619619|12162355|FG004|NOT COMPLETED|Overall Study||2
10986977|NCT00619619|12162356|FG005|NOT COMPLETED|Overall Study||0
10986978|NCT00619619|12162357|FG006|NOT COMPLETED|Overall Study||1
10986979|NCT00619619|12162358|FG007|NOT COMPLETED|Overall Study||3
10986980|NCT00619645|12162379|FG000|STARTED|Overall Study||8
10986981|NCT00619645|12162379|FG000|COMPLETED|Overall Study||7
10986982|NCT00619645|12162379|FG000|NOT COMPLETED|Overall Study||1
10986983|NCT00619684|12162383|FG000|STARTED|Overall Study||18
10986984|NCT00619684|12162383|FG000|COMPLETED|Overall Study||18
10986985|NCT00619684|12162383|FG000|NOT COMPLETED|Overall Study||0
10986986|NCT00619723|12162389|FG000|STARTED|Overall Study||63
10986987|NCT00619723|12162390|FG001|STARTED|Overall Study||67
10986988|NCT00619723|12162389|FG000|COMPLETED|Overall Study||61
10986989|NCT00619723|12162390|FG001|COMPLETED|Overall Study||61
10986990|NCT00619723|12162389|FG000|NOT COMPLETED|Overall Study||2
10986991|NCT00619723|12162390|FG001|NOT COMPLETED|Overall Study||6
10986992|NCT00619762|12162396|FG000|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
10986993|NCT00619762|12162396|FG000|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
10986994|NCT00619762|12162396|FG000|NOT COMPLETED|Overall Study||3
10986995|NCT00619801|12162403|FG000|STARTED|Overall Study||59
10986996|NCT00619801|12162404|FG001|STARTED|Overall Study||114
10986997|NCT00619801|12162403|FG000|Safety Population|Overall Study||59
10986998|NCT00619801|12162404|FG001|Safety Population|Overall Study||114
10986999|NCT00619801|12162403|FG000|COMPLETED|Overall Study||58
10987000|NCT00619801|12162404|FG001|COMPLETED|Overall Study||111
10987001|NCT00619801|12162403|FG000|NOT COMPLETED|Overall Study||1
10987002|NCT00619801|12162404|FG001|NOT COMPLETED|Overall Study||3
10987003|NCT00619827|12162412|FG000|STARTED|Overall Study||45
10987004|NCT00619827|12162413|FG001|STARTED|Overall Study||44
10987005|NCT00619827|12162412|FG000|COMPLETED|Overall Study||42
10987006|NCT00619827|12162413|FG001|COMPLETED|Overall Study||40
10987007|NCT00619827|12162412|FG000|NOT COMPLETED|Overall Study||3
10987008|NCT00619827|12162413|FG001|NOT COMPLETED|Overall Study||4
10987009|NCT00619866|12162422|FG000|STARTED|Weeks 1 - 12||52
10987010|NCT00619866|12162423|FG001|STARTED|Weeks 1 - 12||51
10987011|NCT00619866|12162424|FG002|STARTED|Weeks 1 - 12||52
10987012|NCT00619866|12162425|FG003|STARTED|Weeks 1 - 12||0
10987013|NCT00619866|12162426|FG004|STARTED|Weeks 1 - 12||0
10987014|NCT00619866|12162422|FG000|COMPLETED|Weeks 1 - 12||38
10987015|NCT00619866|12162423|FG001|COMPLETED|Weeks 1 - 12||45
10987016|NCT00619866|12162424|FG002|COMPLETED|Weeks 1 - 12||42
10987017|NCT00619866|12162425|FG003|COMPLETED|Weeks 1 - 12||0
10987018|NCT00619866|12162426|FG004|COMPLETED|Weeks 1 - 12||0
10987019|NCT00619866|12162422|FG000|NOT COMPLETED|Weeks 1 - 12||14
10987020|NCT00619866|12162423|FG001|NOT COMPLETED|Weeks 1 - 12||6
10987021|NCT00619866|12162424|FG002|NOT COMPLETED|Weeks 1 - 12||10
10987022|NCT00619866|12162425|FG003|NOT COMPLETED|Weeks 1 - 12||0
10987023|NCT00619866|12162426|FG004|NOT COMPLETED|Weeks 1 - 12||0
10987024|NCT00619866|12162422|FG000|STARTED|Weeks 13 - 24||0
10987025|NCT00619866|12162423|FG001|STARTED|Weeks 13 - 24||45
10987026|NCT00619866|12162424|FG002|STARTED|Weeks 13 - 24||42
10987027|NCT00619866|12162425|FG003|STARTED|Weeks 13 - 24||18
10987028|NCT00619866|12162426|FG004|STARTED|Weeks 13 - 24||20
10987029|NCT00619866|12162422|FG000|COMPLETED|Weeks 13 - 24||0
10987030|NCT00619866|12162423|FG001|COMPLETED|Weeks 13 - 24||38
10987031|NCT00619866|12162424|FG002|COMPLETED|Weeks 13 - 24||37
10987032|NCT00619866|12162425|FG003|COMPLETED|Weeks 13 - 24||14
10987033|NCT00619866|12162426|FG004|COMPLETED|Weeks 13 - 24||18
10987034|NCT00619866|12162422|FG000|NOT COMPLETED|Weeks 13 - 24||0
10987035|NCT00619866|12162423|FG001|NOT COMPLETED|Weeks 13 - 24||7
10987036|NCT00619866|12162424|FG002|NOT COMPLETED|Weeks 13 - 24||5
10987037|NCT00619866|12162425|FG003|NOT COMPLETED|Weeks 13 - 24||4
10987038|NCT00619866|12162426|FG004|NOT COMPLETED|Weeks 13 - 24||2
10987039|NCT00619892|12162440|FG000|STARTED|Overall Study||13
10987040|NCT00619892|12162441|FG001|STARTED|Overall Study||13
10987041|NCT00619892|12162440|FG000|COMPLETED|Overall Study||10
10987042|NCT00619892|12162441|FG001|COMPLETED|Overall Study||11
10987043|NCT00619892|12162440|FG000|NOT COMPLETED|Overall Study||3
10987044|NCT00619892|12162441|FG001|NOT COMPLETED|Overall Study||2
10987045|NCT00619918|12162451|FG000|STARTED|Overall Study||230
10987046|NCT00619918|12162452|FG001|STARTED|Overall Study||217
10987047|NCT00619918|12162451|FG000|COMPLETED|Overall Study||210
10987048|NCT00619918|12162452|FG001|COMPLETED|Overall Study||195
10987049|NCT00619918|12162451|FG000|NOT COMPLETED|Overall Study||20
10987050|NCT00619918|12162452|FG001|NOT COMPLETED|Overall Study||22
10987051|NCT00619957|12162460|FG000|STARTED|Month 24 Double-Blind||93
10987052|NCT00619957|12162461|FG001|STARTED|Month 24 Double-Blind||192
10987053|NCT00619957|12162460|FG000|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
10987054|NCT00619957|12162461|FG001|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
10987055|NCT00619957|12162460|FG000|COMPLETED|Month 24 Double-Blind||75
10987056|NCT00619957|12162461|FG001|COMPLETED|Month 24 Double-Blind||175
10987057|NCT00619957|12162460|FG000|NOT COMPLETED|Month 24 Double-Blind||18
10987058|NCT00619957|12162461|FG001|NOT COMPLETED|Month 24 Double-Blind||17
10987059|NCT00619957|12162460|FG000|STARTED|Month 48 Open-Label||67
10987060|NCT00619957|12162461|FG001|STARTED|Month 48 Open-Label||151
10987061|NCT00619957|12162460|FG000|COMPLETED|Month 48 Open-Label||55
10987062|NCT00619957|12162461|FG001|COMPLETED|Month 48 Open-Label||134
10987063|NCT00619957|12162460|FG000|NOT COMPLETED|Month 48 Open-Label||12
10987064|NCT00619957|12162461|FG001|NOT COMPLETED|Month 48 Open-Label||17
10987065|NCT00619970|12162472|FG000|STARTED|Overall Study||40
10987066|NCT00619970|12162473|FG001|STARTED|Overall Study||49
10987067|NCT00619970|12162474|FG002|STARTED|Overall Study||26
10987068|NCT00619970|12162472|FG000|COMPLETED|Overall Study||40
10987069|NCT00619970|12162473|FG001|COMPLETED|Overall Study||46
10987070|NCT00619970|12162474|FG002|COMPLETED|Overall Study||24
10987071|NCT00619970|12162472|FG000|NOT COMPLETED|Overall Study||0
10987072|NCT00619970|12162473|FG001|NOT COMPLETED|Overall Study||3
10987073|NCT00619970|12162474|FG002|NOT COMPLETED|Overall Study||2
10987074|NCT00619983|12162488|FG000|STARTED|Test Drug Alone||5
10987075|NCT00619983|12162489|FG001|STARTED|Test Drug Alone||5
10987076|NCT00619983|12162490|FG002|STARTED|Test Drug Alone||6
10987077|NCT00619983|12162491|FG003|STARTED|Test Drug Alone||6
10987078|NCT00619983|12162488|FG000|COMPLETED|Test Drug Alone||3
10987079|NCT00619983|12162489|FG001|COMPLETED|Test Drug Alone||4
10987080|NCT00619983|12162490|FG002|COMPLETED|Test Drug Alone||4
10987081|NCT00619983|12162491|FG003|COMPLETED|Test Drug Alone||3
10987082|NCT00619983|12162488|FG000|NOT COMPLETED|Test Drug Alone||2
10987083|NCT00619983|12162489|FG001|NOT COMPLETED|Test Drug Alone||1
10987084|NCT00619983|12162490|FG002|NOT COMPLETED|Test Drug Alone||2
10987085|NCT00619983|12162491|FG003|NOT COMPLETED|Test Drug Alone||3
10987086|NCT00619983|12162488|FG000|STARTED|Test Drug Plus Gabapentin||3
10987087|NCT00619983|12162489|FG001|STARTED|Test Drug Plus Gabapentin||4
10987088|NCT00619983|12162490|FG002|STARTED|Test Drug Plus Gabapentin||4
10987089|NCT00619983|12162491|FG003|STARTED|Test Drug Plus Gabapentin||3
10987090|NCT00619983|12162488|FG000|COMPLETED|Test Drug Plus Gabapentin||3
10987091|NCT00619983|12162489|FG001|COMPLETED|Test Drug Plus Gabapentin||4
10987092|NCT00619983|12162490|FG002|COMPLETED|Test Drug Plus Gabapentin||4
10987093|NCT00619983|12162491|FG003|COMPLETED|Test Drug Plus Gabapentin||3
10987094|NCT00619983|12162488|FG000|NOT COMPLETED|Test Drug Plus Gabapentin||0
10987095|NCT00619983|12162489|FG001|NOT COMPLETED|Test Drug Plus Gabapentin||0
10987096|NCT00619983|12162490|FG002|NOT COMPLETED|Test Drug Plus Gabapentin||0
10987097|NCT00619983|12162491|FG003|NOT COMPLETED|Test Drug Plus Gabapentin||0
10987098|NCT00619983|12162488|FG000|STARTED|Gabapentin Alone||3
10987099|NCT00619983|12162489|FG001|STARTED|Gabapentin Alone||4
10987100|NCT00619983|12162490|FG002|STARTED|Gabapentin Alone||4
10987101|NCT00619983|12162491|FG003|STARTED|Gabapentin Alone||3
10987102|NCT00619983|12162488|FG000|COMPLETED|Gabapentin Alone||3
10987103|NCT00619983|12162489|FG001|COMPLETED|Gabapentin Alone||4
10987104|NCT00619983|12162490|FG002|COMPLETED|Gabapentin Alone||4
10987105|NCT00619983|12162491|FG003|COMPLETED|Gabapentin Alone||3
10987106|NCT00619983|12162488|FG000|NOT COMPLETED|Gabapentin Alone||0
10987107|NCT00619983|12162489|FG001|NOT COMPLETED|Gabapentin Alone||0
10987108|NCT00619983|12162490|FG002|NOT COMPLETED|Gabapentin Alone||0
10987109|NCT00619983|12162491|FG003|NOT COMPLETED|Gabapentin Alone||0
10987110|NCT00620022|12162501|FG000|STARTED|Treatment Period 1||46
10987111|NCT00620022|12162502|FG001|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
10987112|NCT00620022|12162501|FG000|COMPLETED|Treatment Period 1||41
10987113|NCT00620022|12162502|FG001|COMPLETED|Treatment Period 1||37
10987114|NCT00620022|12162501|FG000|NOT COMPLETED|Treatment Period 1||5
10987115|NCT00620022|12162502|FG001|NOT COMPLETED|Treatment Period 1||6
10987116|NCT00620022|12162501|FG000|STARTED|Treatment Period 2||41
10987117|NCT00620022|12162502|FG001|STARTED|Treatment Period 2||37
10987118|NCT00620022|12162501|FG000|COMPLETED|Treatment Period 2||39
10987119|NCT00620022|12162502|FG001|COMPLETED|Treatment Period 2||35
10987120|NCT00620022|12162501|FG000|NOT COMPLETED|Treatment Period 2||2
10987121|NCT00620022|12162502|FG001|NOT COMPLETED|Treatment Period 2||2
10987122|NCT00620061|12162508|FG000|STARTED|Overall Study||439
10987123|NCT00620061|12162508|FG000|COMPLETED|Overall Study||286
10987124|NCT00620061|12162508|FG000|NOT COMPLETED|Overall Study||153
10987125|NCT00620074|12162513|FG000|STARTED|Overall Study||6
10987126|NCT00620074|12162513|FG000|COMPLETED|Overall Study||5
10987127|NCT00620074|12162513|FG000|NOT COMPLETED|Overall Study||1
10987128|NCT00620113|12162521|FG000|STARTED|Overall Study||73
10987129|NCT00620113|12162522|FG001|STARTED|Overall Study||74
10987130|NCT00620113|12162523|FG002|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
10987131|NCT00620113|12162524|FG003|STARTED|Overall Study||69
10987132|NCT00620113|12162521|FG000|Efficacy/Safety Population|Overall Study||73
10987133|NCT00620113|12162522|FG001|Efficacy/Safety Population|Overall Study||74
10987134|NCT00620113|12162523|FG002|Efficacy/Safety Population|Overall Study||70
10987135|NCT00620113|12162524|FG003|Efficacy/Safety Population|Overall Study||69
10987136|NCT00620113|12162521|FG000|COMPLETED|Overall Study||60
10987137|NCT00620113|12162522|FG001|COMPLETED|Overall Study||67
10987138|NCT00620113|12162523|FG002|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
10987139|NCT00620113|12162524|FG003|COMPLETED|Overall Study||59
10987140|NCT00620113|12162521|FG000|NOT COMPLETED|Overall Study||13
10987141|NCT00620113|12162522|FG001|NOT COMPLETED|Overall Study||7
10987142|NCT00620113|12162523|FG002|NOT COMPLETED|Overall Study||5
10987143|NCT00620113|12162524|FG003|NOT COMPLETED|Overall Study||10
10987144|NCT00620126|12162536|FG000|STARTED|Overall Study||25
10987145|NCT00620126|12162537|FG001|STARTED|Overall Study||22
10987146|NCT00620126|12162536|FG000|COMPLETED|Overall Study||14
10987147|NCT00620126|12162537|FG001|COMPLETED|Overall Study||17
10987148|NCT00620126|12162536|FG000|NOT COMPLETED|Overall Study||11
10987149|NCT00620126|12162537|FG001|NOT COMPLETED|Overall Study||5
10987150|NCT00620191|12162545|FG000|STARTED|Overall Study||40
10987151|NCT00620191|12162546|FG001|STARTED|Overall Study||40
10987152|NCT00620191|12162545|FG000|3 Month Follow-up|Overall Study||39
10987153|NCT00620191|12162546|FG001|3 Month Follow-up|Overall Study||39
10987154|NCT00620191|12162545|FG000|6 Month Follow-up|Overall Study||38
10987155|NCT00620191|12162546|FG001|6 Month Follow-up|Overall Study||36
10987156|NCT00620191|12162545|FG000|9 Month Follow-up|Overall Study||37
10987157|NCT00620191|12162546|FG001|9 Month Follow-up|Overall Study||34
10987158|NCT00620191|12162545|FG000|COMPLETED|Overall Study|12 month follow-up|33
10987159|NCT00620191|12162546|FG001|COMPLETED|Overall Study|12 month follow-up|32
10987160|NCT00620191|12162545|FG000|NOT COMPLETED|Overall Study||7
10987161|NCT00620191|12162546|FG001|NOT COMPLETED|Overall Study||8
10987162|NCT00620282|12162560|FG000|STARTED|Overall Study||16
10987163|NCT00620282|12162561|FG001|STARTED|Overall Study||16
10987164|NCT00620282|12162562|FG002|STARTED|Overall Study||17
10987165|NCT00620282|12162560|FG000|COMPLETED|Overall Study||16
10987166|NCT00620282|12162561|FG001|COMPLETED|Overall Study||14
10987167|NCT00620282|12162562|FG002|COMPLETED|Overall Study||16
10987168|NCT00620282|12162560|FG000|NOT COMPLETED|Overall Study||0
10987169|NCT00620282|12162561|FG001|NOT COMPLETED|Overall Study||2
10987170|NCT00620282|12162562|FG002|NOT COMPLETED|Overall Study||1
10987171|NCT00620321|12162572|FG000|STARTED|Overall Study||8
10987172|NCT00620321|12162573|FG001|STARTED|Overall Study||16
10987173|NCT00620321|12162572|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
10987174|NCT00620321|12162573|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
10987175|NCT00620321|12162572|FG000|COMPLETED|Overall Study||0
10987176|NCT00620321|12162573|FG001|COMPLETED|Overall Study||0
10987177|NCT00620321|12162572|FG000|NOT COMPLETED|Overall Study||8
10987178|NCT00620321|12162573|FG001|NOT COMPLETED|Overall Study||16
10987179|NCT00620373|12162579|FG000|STARTED|Overall Study||969
10987180|NCT00620373|12162579|FG000|COMPLETED|Overall Study||936
10987181|NCT00620373|12162579|FG000|NOT COMPLETED|Overall Study||33
10987182|NCT00620425|12162586|FG000|STARTED|Overall Study||18
10987183|NCT00620425|12162586|FG000|COMPLETED|Overall Study||18
10987184|NCT00620425|12162586|FG000|NOT COMPLETED|Overall Study||0
10987185|NCT00620503|12162597|FG000|STARTED|Screening (up to 21 Days)||2
10987186|NCT00620503|12162598|FG001|STARTED|Screening (up to 21 Days)||2
10987187|NCT00620503|12162599|FG002|STARTED|Screening (up to 21 Days)||2
10987188|NCT00620503|12162600|FG003|STARTED|Screening (up to 21 Days)||2
10987189|NCT00620503|12162601|FG004|STARTED|Screening (up to 21 Days)||2
10987190|NCT00620503|12162602|FG005|STARTED|Screening (up to 21 Days)||2
10987191|NCT00620503|12162597|FG000|COMPLETED|Screening (up to 21 Days)||2
10987192|NCT00620503|12162598|FG001|COMPLETED|Screening (up to 21 Days)||2
10987193|NCT00620503|12162599|FG002|COMPLETED|Screening (up to 21 Days)||2
10987194|NCT00620503|12162600|FG003|COMPLETED|Screening (up to 21 Days)||2
10987195|NCT00620503|12162601|FG004|COMPLETED|Screening (up to 21 Days)||2
10987196|NCT00620503|12162602|FG005|COMPLETED|Screening (up to 21 Days)||2
10987197|NCT00620503|12162597|FG000|NOT COMPLETED|Screening (up to 21 Days)||0
10987198|NCT00620503|12162598|FG001|NOT COMPLETED|Screening (up to 21 Days)||0
10987199|NCT00620503|12162599|FG002|NOT COMPLETED|Screening (up to 21 Days)||0
10987200|NCT00620503|12162600|FG003|NOT COMPLETED|Screening (up to 21 Days)||0
10987201|NCT00620503|12162601|FG004|NOT COMPLETED|Screening (up to 21 Days)||0
10987202|NCT00620503|12162602|FG005|NOT COMPLETED|Screening (up to 21 Days)||0
10987203|NCT00620503|12162597|FG000|STARTED|Treatment Period 1 (TP1) (7days)||2
10987204|NCT00620503|12162598|FG001|STARTED|Treatment Period 1 (TP1) (7days)||2
10987205|NCT00620503|12162599|FG002|STARTED|Treatment Period 1 (TP1) (7days)||2
10987206|NCT00620503|12162600|FG003|STARTED|Treatment Period 1 (TP1) (7days)||2
10987207|NCT00620503|12162601|FG004|STARTED|Treatment Period 1 (TP1) (7days)||2
10987208|NCT00620503|12162602|FG005|STARTED|Treatment Period 1 (TP1) (7days)||2
10987209|NCT00620503|12162597|FG000|COMPLETED|Treatment Period 1 (TP1) (7days)||2
10987210|NCT00620503|12162598|FG001|COMPLETED|Treatment Period 1 (TP1) (7days)||2
10987211|NCT00620503|12162599|FG002|COMPLETED|Treatment Period 1 (TP1) (7days)||2
10987212|NCT00620503|12162600|FG003|COMPLETED|Treatment Period 1 (TP1) (7days)||2
10987213|NCT00620503|12162601|FG004|COMPLETED|Treatment Period 1 (TP1) (7days)||2
10987214|NCT00620503|12162602|FG005|COMPLETED|Treatment Period 1 (TP1) (7days)||2
10987215|NCT00620503|12162597|FG000|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
10987216|NCT00620503|12162598|FG001|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
10987217|NCT00620503|12162599|FG002|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
10987218|NCT00620503|12162600|FG003|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
10987219|NCT00620503|12162601|FG004|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
10987220|NCT00620503|12162602|FG005|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
10987221|NCT00620503|12162597|FG000|STARTED|Washout (at Least 1 Day)||2
10987222|NCT00620503|12162598|FG001|STARTED|Washout (at Least 1 Day)||2
10987223|NCT00620503|12162599|FG002|STARTED|Washout (at Least 1 Day)||2
10987224|NCT00620503|12162600|FG003|STARTED|Washout (at Least 1 Day)||2
10987225|NCT00620503|12162601|FG004|STARTED|Washout (at Least 1 Day)||2
10987226|NCT00620503|12162602|FG005|STARTED|Washout (at Least 1 Day)||2
10987227|NCT00620503|12162597|FG000|COMPLETED|Washout (at Least 1 Day)||2
10987228|NCT00620503|12162598|FG001|COMPLETED|Washout (at Least 1 Day)||2
10987229|NCT00620503|12162599|FG002|COMPLETED|Washout (at Least 1 Day)||2
10987230|NCT00620503|12162600|FG003|COMPLETED|Washout (at Least 1 Day)||2
10987231|NCT00620503|12162601|FG004|COMPLETED|Washout (at Least 1 Day)||2
10987232|NCT00620503|12162602|FG005|COMPLETED|Washout (at Least 1 Day)||2
10987233|NCT00620503|12162597|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0
10987234|NCT00620503|12162598|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0
10987235|NCT00620503|12162599|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0
10987236|NCT00620503|12162600|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0
10987237|NCT00620503|12162601|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0
10987238|NCT00620503|12162602|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0
10987239|NCT00620503|12162597|FG000|STARTED|Treatment Period 2 (TP2) (7days)||2
10987240|NCT00620503|12162598|FG001|STARTED|Treatment Period 2 (TP2) (7days)||2
10987241|NCT00620503|12162599|FG002|STARTED|Treatment Period 2 (TP2) (7days)||2
10987242|NCT00620503|12162600|FG003|STARTED|Treatment Period 2 (TP2) (7days)||2
10987243|NCT00620503|12162601|FG004|STARTED|Treatment Period 2 (TP2) (7days)||2
10987244|NCT00620503|12162602|FG005|STARTED|Treatment Period 2 (TP2) (7days)||2
10987245|NCT00620503|12162597|FG000|COMPLETED|Treatment Period 2 (TP2) (7days)||2
10987246|NCT00620503|12162598|FG001|COMPLETED|Treatment Period 2 (TP2) (7days)||2
10987247|NCT00620503|12162599|FG002|COMPLETED|Treatment Period 2 (TP2) (7days)||2
10987248|NCT00620503|12162600|FG003|COMPLETED|Treatment Period 2 (TP2) (7days)||2
10987249|NCT00620503|12162601|FG004|COMPLETED|Treatment Period 2 (TP2) (7days)||2
10987250|NCT00620503|12162602|FG005|COMPLETED|Treatment Period 2 (TP2) (7days)||2
10987251|NCT00620503|12162597|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
10987252|NCT00620503|12162598|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
10987253|NCT00620503|12162599|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
10987254|NCT00620503|12162600|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
10987255|NCT00620503|12162601|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
10987256|NCT00620503|12162602|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
10987257|NCT00620503|12162597|FG000|STARTED|Washout (at Least 1 Day)||2
10987258|NCT00620503|12162598|FG001|STARTED|Washout (at Least 1 Day)||2
10987259|NCT00620503|12162599|FG002|STARTED|Washout (at Least 1 Day)||2
10987260|NCT00620503|12162600|FG003|STARTED|Washout (at Least 1 Day)||2
10987261|NCT00620503|12162601|FG004|STARTED|Washout (at Least 1 Day)||2
10987262|NCT00620503|12162602|FG005|STARTED|Washout (at Least 1 Day)||2
10987263|NCT00620503|12162597|FG000|COMPLETED|Washout (at Least 1 Day)||2
10987264|NCT00620503|12162598|FG001|COMPLETED|Washout (at Least 1 Day)||2
10987265|NCT00620503|12162599|FG002|COMPLETED|Washout (at Least 1 Day)||2
10987266|NCT00620503|12162600|FG003|COMPLETED|Washout (at Least 1 Day)||2
10987267|NCT00620503|12162601|FG004|COMPLETED|Washout (at Least 1 Day)||2
10987268|NCT00620503|12162602|FG005|COMPLETED|Washout (at Least 1 Day)||2
10987269|NCT00620503|12162597|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0
10987270|NCT00620503|12162598|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0
10987271|NCT00620503|12162599|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0
10987272|NCT00620503|12162600|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0
10987273|NCT00620503|12162601|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0
10987274|NCT00620503|12162602|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0
10987275|NCT00620503|12162597|FG000|STARTED|Treatment Period 3 (TP3) (7 Days)||2
10987276|NCT00620503|12162598|FG001|STARTED|Treatment Period 3 (TP3) (7 Days)||2
10987277|NCT00620503|12162599|FG002|STARTED|Treatment Period 3 (TP3) (7 Days)||2
10987278|NCT00620503|12162600|FG003|STARTED|Treatment Period 3 (TP3) (7 Days)||2
10987279|NCT00620503|12162601|FG004|STARTED|Treatment Period 3 (TP3) (7 Days)||2
10987280|NCT00620503|12162602|FG005|STARTED|Treatment Period 3 (TP3) (7 Days)||2
10987281|NCT00620503|12162597|FG000|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
10987282|NCT00620503|12162598|FG001|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
10987283|NCT00620503|12162599|FG002|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
10987284|NCT00620503|12162600|FG003|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
10987285|NCT00620503|12162601|FG004|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
10987286|NCT00620503|12162602|FG005|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
10987287|NCT00620503|12162597|FG000|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
10987288|NCT00620503|12162598|FG001|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
10987289|NCT00620503|12162599|FG002|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
10987290|NCT00620503|12162600|FG003|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
10987291|NCT00620503|12162601|FG004|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
10987292|NCT00620503|12162602|FG005|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
10987293|NCT00620503|12162597|FG000|STARTED|Follow-up (up to 14 Days)||2
10987294|NCT00620503|12162598|FG001|STARTED|Follow-up (up to 14 Days)||2
10987295|NCT00620503|12162599|FG002|STARTED|Follow-up (up to 14 Days)||2
10987296|NCT00620503|12162600|FG003|STARTED|Follow-up (up to 14 Days)||2
10987297|NCT00620503|12162601|FG004|STARTED|Follow-up (up to 14 Days)||2
10987298|NCT00620503|12162602|FG005|STARTED|Follow-up (up to 14 Days)||2
10987299|NCT00620503|12162597|FG000|COMPLETED|Follow-up (up to 14 Days)||2
10987300|NCT00620503|12162598|FG001|COMPLETED|Follow-up (up to 14 Days)||2
10987301|NCT00620503|12162599|FG002|COMPLETED|Follow-up (up to 14 Days)||2
10987302|NCT00620503|12162600|FG003|COMPLETED|Follow-up (up to 14 Days)||2
10987303|NCT00620503|12162601|FG004|COMPLETED|Follow-up (up to 14 Days)||2
10987304|NCT00620503|12162602|FG005|COMPLETED|Follow-up (up to 14 Days)||2
10987305|NCT00620503|12162597|FG000|NOT COMPLETED|Follow-up (up to 14 Days)||0
10987306|NCT00620503|12162598|FG001|NOT COMPLETED|Follow-up (up to 14 Days)||0
10987307|NCT00620503|12162599|FG002|NOT COMPLETED|Follow-up (up to 14 Days)||0
10987308|NCT00620503|12162600|FG003|NOT COMPLETED|Follow-up (up to 14 Days)||0
10987309|NCT00620503|12162601|FG004|NOT COMPLETED|Follow-up (up to 14 Days)||0
10987310|NCT00620503|12162602|FG005|NOT COMPLETED|Follow-up (up to 14 Days)||0
10987311|NCT00620542|12162612|FG000|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
10987312|NCT00620542|12162613|FG001|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
10987313|NCT00620542|12162614|FG002|STARTED|Part A (Run-in - 2 Weeks)||0
10987314|NCT00620542|12162615|FG003|STARTED|Part A (Run-in - 2 Weeks)||0
10987315|NCT00620542|12162612|FG000|Received Treatment|Part A (Run-in - 2 Weeks)||783
10987316|NCT00620542|12162613|FG001|Received Treatment|Part A (Run-in - 2 Weeks)||795
10987317|NCT00620542|12162614|FG002|Received Treatment|Part A (Run-in - 2 Weeks)||0
10987318|NCT00620542|12162615|FG003|Received Treatment|Part A (Run-in - 2 Weeks)||0
10987319|NCT00620542|12162612|FG000|COMPLETED|Part A (Run-in - 2 Weeks)||695
10987320|NCT00620542|12162613|FG001|COMPLETED|Part A (Run-in - 2 Weeks)||690
10987321|NCT00620542|12162614|FG002|COMPLETED|Part A (Run-in - 2 Weeks)||0
10987322|NCT00620542|12162615|FG003|COMPLETED|Part A (Run-in - 2 Weeks)||0
10987323|NCT00620542|12162612|FG000|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
10987324|NCT00620542|12162613|FG001|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
10987325|NCT00620542|12162614|FG002|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
10987326|NCT00620542|12162615|FG003|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
10987327|NCT00620542|12162612|FG000|STARTED|Part B (2 Year Core Study)||0
10987328|NCT00620542|12162613|FG001|STARTED|Part B (2 Year Core Study)||0
10987329|NCT00620542|12162614|FG002|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
10987330|NCT00620542|12162615|FG003|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
10987331|NCT00620542|12162612|FG000|Received Treatment|Part B (2 Year Core Study)||0
10987332|NCT00620542|12162613|FG001|Received Treatment|Part B (2 Year Core Study)||0
10987333|NCT00620542|12162614|FG002|Received Treatment|Part B (2 Year Core Study)||691
10987334|NCT00620542|12162615|FG003|Received Treatment|Part B (2 Year Core Study)||689
10987335|NCT00620542|12162612|FG000|Intent-to-treat Population|Part B (2 Year Core Study)||0
10987336|NCT00620542|12162613|FG001|Intent-to-treat Population|Part B (2 Year Core Study)||0
10987337|NCT00620542|12162614|FG002|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
10987338|NCT00620542|12162615|FG003|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
10987339|NCT00620542|12162612|FG000|COMPLETED|Part B (2 Year Core Study)||0
10987340|NCT00620542|12162613|FG001|COMPLETED|Part B (2 Year Core Study)||0
10987341|NCT00620542|12162614|FG002|COMPLETED|Part B (2 Year Core Study)||546
10987342|NCT00620542|12162615|FG003|COMPLETED|Part B (2 Year Core Study)||547
10987343|NCT00620542|12162612|FG000|NOT COMPLETED|Part B (2 Year Core Study)||0
10987344|NCT00620542|12162613|FG001|NOT COMPLETED|Part B (2 Year Core Study)||0
10987345|NCT00620542|12162614|FG002|NOT COMPLETED|Part B (2 Year Core Study)||148
10987346|NCT00620542|12162615|FG003|NOT COMPLETED|Part B (2 Year Core Study)||144
10987347|NCT00620555|12162623|FG000|STARTED|Overall Study||65
10987348|NCT00620555|12162623|FG000|COMPLETED|Overall Study||44
10987349|NCT00620555|12162623|FG000|NOT COMPLETED|Overall Study||21
10987350|NCT00620659|12162627|FG000|STARTED|Treatment Period 1||21
10987351|NCT00620659|12162628|FG001|STARTED|Treatment Period 1||21
10987352|NCT00620659|12162629|FG002|STARTED|Treatment Period 1||21
10987353|NCT00620659|12162630|FG003|STARTED|Treatment Period 1||21
10987354|NCT00620659|12162631|FG004|STARTED|Treatment Period 1||21
10987355|NCT00620659|12162632|FG005|STARTED|Treatment Period 1||20
10987356|NCT00620659|12162627|FG000|COMPLETED|Treatment Period 1||18
10987357|NCT00620659|12162628|FG001|COMPLETED|Treatment Period 1||21
10987358|NCT00620659|12162629|FG002|COMPLETED|Treatment Period 1||20
10987359|NCT00620659|12162630|FG003|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
10987360|NCT00620659|12162631|FG004|COMPLETED|Treatment Period 1||20
10987361|NCT00620659|12162632|FG005|COMPLETED|Treatment Period 1||20
10987362|NCT00620659|12162627|FG000|NOT COMPLETED|Treatment Period 1||3
10987363|NCT00620659|12162628|FG001|NOT COMPLETED|Treatment Period 1||0
10987364|NCT00620659|12162629|FG002|NOT COMPLETED|Treatment Period 1||1
10987365|NCT00620659|12162630|FG003|NOT COMPLETED|Treatment Period 1||3
10987366|NCT00620659|12162631|FG004|NOT COMPLETED|Treatment Period 1||1
10987367|NCT00620659|12162632|FG005|NOT COMPLETED|Treatment Period 1||0
10987368|NCT00620659|12162627|FG000|STARTED|Placebo Washout Period 1||18
10987369|NCT00620659|12162628|FG001|STARTED|Placebo Washout Period 1||21
10987370|NCT00620659|12162629|FG002|STARTED|Placebo Washout Period 1||20
10987371|NCT00620659|12162630|FG003|STARTED|Placebo Washout Period 1||19
10987372|NCT00620659|12162631|FG004|STARTED|Placebo Washout Period 1||20
10987373|NCT00620659|12162632|FG005|STARTED|Placebo Washout Period 1||20
10987374|NCT00620659|12162627|FG000|COMPLETED|Placebo Washout Period 1||18
10987375|NCT00620659|12162628|FG001|COMPLETED|Placebo Washout Period 1||21
10987376|NCT00620659|12162629|FG002|COMPLETED|Placebo Washout Period 1||20
10987377|NCT00620659|12162630|FG003|COMPLETED|Placebo Washout Period 1||18
10987378|NCT00620659|12162631|FG004|COMPLETED|Placebo Washout Period 1||20
10987379|NCT00620659|12162632|FG005|COMPLETED|Placebo Washout Period 1||20
10987380|NCT00620659|12162627|FG000|NOT COMPLETED|Placebo Washout Period 1||0
10987381|NCT00620659|12162628|FG001|NOT COMPLETED|Placebo Washout Period 1||0
10987382|NCT00620659|12162629|FG002|NOT COMPLETED|Placebo Washout Period 1||0
10987383|NCT00620659|12162630|FG003|NOT COMPLETED|Placebo Washout Period 1||1
10987384|NCT00620659|12162631|FG004|NOT COMPLETED|Placebo Washout Period 1||0
10987385|NCT00620659|12162632|FG005|NOT COMPLETED|Placebo Washout Period 1||0
10987386|NCT00620659|12162627|FG000|STARTED|Treatment Period 2||18
10987387|NCT00620659|12162628|FG001|STARTED|Treatment Period 2||21
10987388|NCT00620659|12162629|FG002|STARTED|Treatment Period 2||20
10987389|NCT00620659|12162630|FG003|STARTED|Treatment Period 2||18
10987390|NCT00620659|12162631|FG004|STARTED|Treatment Period 2||20
10987391|NCT00620659|12162632|FG005|STARTED|Treatment Period 2||20
10987392|NCT00620659|12162627|FG000|COMPLETED|Treatment Period 2||18
10987393|NCT00620659|12162628|FG001|COMPLETED|Treatment Period 2||18
10987394|NCT00620659|12162629|FG002|COMPLETED|Treatment Period 2||19
10987395|NCT00620659|12162630|FG003|COMPLETED|Treatment Period 2||18
10987396|NCT00620659|12162631|FG004|COMPLETED|Treatment Period 2||15
10987397|NCT00620659|12162632|FG005|COMPLETED|Treatment Period 2||20
10987398|NCT00620659|12162627|FG000|NOT COMPLETED|Treatment Period 2||0
10987399|NCT00620659|12162628|FG001|NOT COMPLETED|Treatment Period 2||3
10987400|NCT00620659|12162629|FG002|NOT COMPLETED|Treatment Period 2||1
10987401|NCT00620659|12162630|FG003|NOT COMPLETED|Treatment Period 2||0
10987402|NCT00620659|12162631|FG004|NOT COMPLETED|Treatment Period 2||5
10987403|NCT00620659|12162632|FG005|NOT COMPLETED|Treatment Period 2||0
10987404|NCT00620659|12162627|FG000|STARTED|Placebo Washout Period 2||18
10987405|NCT00620659|12162628|FG001|STARTED|Placebo Washout Period 2||18
10987406|NCT00620659|12162629|FG002|STARTED|Placebo Washout Period 2||19
10987407|NCT00620659|12162630|FG003|STARTED|Placebo Washout Period 2||18
10987408|NCT00620659|12162631|FG004|STARTED|Placebo Washout Period 2||15
10987409|NCT00620659|12162632|FG005|STARTED|Placebo Washout Period 2||20
10987410|NCT00620659|12162627|FG000|COMPLETED|Placebo Washout Period 2||16
10987411|NCT00620659|12162628|FG001|COMPLETED|Placebo Washout Period 2||18
10987412|NCT00620659|12162629|FG002|COMPLETED|Placebo Washout Period 2||19
10987413|NCT00620659|12162630|FG003|COMPLETED|Placebo Washout Period 2||18
10987414|NCT00620659|12162631|FG004|COMPLETED|Placebo Washout Period 2||15
10987415|NCT00620659|12162632|FG005|COMPLETED|Placebo Washout Period 2||20
10987416|NCT00620659|12162627|FG000|NOT COMPLETED|Placebo Washout Period 2||2
10987417|NCT00620659|12162628|FG001|NOT COMPLETED|Placebo Washout Period 2||0
10987418|NCT00620659|12162629|FG002|NOT COMPLETED|Placebo Washout Period 2||0
10987419|NCT00620659|12162630|FG003|NOT COMPLETED|Placebo Washout Period 2||0
10987420|NCT00620659|12162631|FG004|NOT COMPLETED|Placebo Washout Period 2||0
10987421|NCT00620659|12162632|FG005|NOT COMPLETED|Placebo Washout Period 2||0
10987422|NCT00620659|12162627|FG000|STARTED|Treatment Period 3||16
10987423|NCT00620659|12162628|FG001|STARTED|Treatment Period 3||18
10987424|NCT00620659|12162629|FG002|STARTED|Treatment Period 3||19
10987425|NCT00620659|12162630|FG003|STARTED|Treatment Period 3||18
10987426|NCT00620659|12162631|FG004|STARTED|Treatment Period 3||15
10987427|NCT00620659|12162632|FG005|STARTED|Treatment Period 3||20
10987428|NCT00620659|12162627|FG000|COMPLETED|Treatment Period 3||16
10987429|NCT00620659|12162628|FG001|COMPLETED|Treatment Period 3||16
10987430|NCT00620659|12162629|FG002|COMPLETED|Treatment Period 3||19
10987431|NCT00620659|12162630|FG003|COMPLETED|Treatment Period 3||17
10987432|NCT00620659|12162631|FG004|COMPLETED|Treatment Period 3||15
10987433|NCT00620659|12162632|FG005|COMPLETED|Treatment Period 3||20
10987434|NCT00620659|12162627|FG000|NOT COMPLETED|Treatment Period 3||0
10987435|NCT00620659|12162628|FG001|NOT COMPLETED|Treatment Period 3||2
10987436|NCT00620659|12162629|FG002|NOT COMPLETED|Treatment Period 3||0
10987437|NCT00620659|12162630|FG003|NOT COMPLETED|Treatment Period 3||1
10987438|NCT00620659|12162631|FG004|NOT COMPLETED|Treatment Period 3||0
10987439|NCT00620659|12162632|FG005|NOT COMPLETED|Treatment Period 3||0
10987440|NCT00620698|12162645|FG000|STARTED|Overall Study||89
10987441|NCT00620698|12162645|FG000|COMPLETED|Overall Study||60
10987442|NCT00620698|12162645|FG000|NOT COMPLETED|Overall Study||29
10987443|NCT00620711|12162649|FG000|STARTED|Overall Study||4
10987444|NCT00620711|12162649|FG000|COMPLETED|Overall Study||4
10987445|NCT00620711|12162649|FG000|NOT COMPLETED|Overall Study||0
10987446|NCT00620750|12162653|FG000|STARTED|Overall Study||65
10987447|NCT00620750|12162653|FG000|COMPLETED|Overall Study||40
10987448|NCT00620750|12162653|FG000|NOT COMPLETED|Overall Study||25
10987449|NCT00620763|12162657|FG000|STARTED|Period: First Intervention||10
10987450|NCT00620763|12162658|FG001|STARTED|Period: First Intervention||12
10987451|NCT00620763|12162657|FG000|COMPLETED|Period: First Intervention||10
10987452|NCT00620763|12162658|FG001|COMPLETED|Period: First Intervention||7
10987453|NCT00620763|12162657|FG000|NOT COMPLETED|Period: First Intervention||0
10987454|NCT00620763|12162658|FG001|NOT COMPLETED|Period: First Intervention||5
10987455|NCT00620763|12162657|FG000|STARTED|Period: Washout Period of 1 Week||10
10987456|NCT00620763|12162658|FG001|STARTED|Period: Washout Period of 1 Week||7
10987457|NCT00620763|12162657|FG000|COMPLETED|Period: Washout Period of 1 Week||10
10987458|NCT00620763|12162658|FG001|COMPLETED|Period: Washout Period of 1 Week||7
10987459|NCT00620763|12162657|FG000|NOT COMPLETED|Period: Washout Period of 1 Week||0
10987460|NCT00620763|12162658|FG001|NOT COMPLETED|Period: Washout Period of 1 Week||0
10987461|NCT00620763|12162657|FG000|STARTED|Period: Second Intervention||10
10987462|NCT00620763|12162658|FG001|STARTED|Period: Second Intervention||7
10987463|NCT00620763|12162657|FG000|COMPLETED|Period: Second Intervention||9
10987464|NCT00620763|12162658|FG001|COMPLETED|Period: Second Intervention||7
10987465|NCT00620763|12162657|FG000|NOT COMPLETED|Period: Second Intervention||1
10987466|NCT00620763|12162658|FG001|NOT COMPLETED|Period: Second Intervention||0
10987467|NCT00620776|12162666|FG000|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
10987468|NCT00620776|12162667|FG001|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
10987469|NCT00620776|12162666|FG000|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
10987470|NCT00620776|12162667|FG001|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
10987471|NCT00620776|12162666|FG000|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
10987472|NCT00620776|12162667|FG001|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
10987473|NCT00620776|12162666|FG000|NOT COMPLETED|Overall Study||12
10987474|NCT00620776|12162667|FG001|NOT COMPLETED|Overall Study||16
10987475|NCT00620815|12162676|FG000|STARTED|Overall Study||199
10987476|NCT00620815|12162677|FG001|STARTED|Overall Study||203
10987477|NCT00620815|12162678|FG002|STARTED|Overall Study||199
10987478|NCT00620815|12162676|FG000|COMPLETED|Overall Study||195
10987479|NCT00620815|12162677|FG001|COMPLETED|Overall Study||192
10987480|NCT00620815|12162678|FG002|COMPLETED|Overall Study||192
10987481|NCT00620815|12162676|FG000|NOT COMPLETED|Overall Study||4
10987482|NCT00620815|12162677|FG001|NOT COMPLETED|Overall Study||11
10987483|NCT00620815|12162678|FG002|NOT COMPLETED|Overall Study||7
10987484|NCT00620828|12162704|FG000|STARTED|Overall Study||32
10987485|NCT00620828|12162705|FG001|STARTED|Overall Study||35
10987486|NCT00620828|12162704|FG000|Number of Subjects Enrolled = 67|Overall Study||32
10987487|NCT00620828|12162705|FG001|Number of Subjects Enrolled = 67|Overall Study||35
10987488|NCT00620828|12162704|FG000|COMPLETED|Overall Study||32
10987489|NCT00620828|12162705|FG001|COMPLETED|Overall Study||35
10987490|NCT00620828|12162704|FG000|NOT COMPLETED|Overall Study||0
10987491|NCT00620828|12162705|FG001|NOT COMPLETED|Overall Study||0
10987492|NCT00620854|12162717|FG000|STARTED|Period 1||4
10987493|NCT00620854|12162718|FG001|STARTED|Period 1||4
10987494|NCT00620854|12162719|FG002|STARTED|Period 1||4
10987495|NCT00620854|12162720|FG003|STARTED|Period 1||4
10987496|NCT00620854|12162721|FG004|STARTED|Period 1||4
10987497|NCT00620854|12162722|FG005|STARTED|Period 1||4
10987498|NCT00620854|12162717|FG000|COMPLETED|Period 1||4
10987499|NCT00620854|12162718|FG001|COMPLETED|Period 1||4
10987500|NCT00620854|12162719|FG002|COMPLETED|Period 1||4
10987501|NCT00620854|12162720|FG003|COMPLETED|Period 1||4
10987502|NCT00620854|12162721|FG004|COMPLETED|Period 1||4
10987503|NCT00620854|12162722|FG005|COMPLETED|Period 1||4
10987504|NCT00620854|12162717|FG000|NOT COMPLETED|Period 1||0
10987505|NCT00620854|12162718|FG001|NOT COMPLETED|Period 1||0
10987506|NCT00620854|12162719|FG002|NOT COMPLETED|Period 1||0
10987507|NCT00620854|12162720|FG003|NOT COMPLETED|Period 1||0
10987508|NCT00620854|12162721|FG004|NOT COMPLETED|Period 1||0
10987509|NCT00620854|12162722|FG005|NOT COMPLETED|Period 1||0
10987510|NCT00620854|12162717|FG000|STARTED|Washout 1||4
10987511|NCT00620854|12162718|FG001|STARTED|Washout 1||4
10987512|NCT00620854|12162719|FG002|STARTED|Washout 1||4
10987513|NCT00620854|12162720|FG003|STARTED|Washout 1||4
10987514|NCT00620854|12162721|FG004|STARTED|Washout 1||4
10987515|NCT00620854|12162722|FG005|STARTED|Washout 1||4
10987516|NCT00620854|12162717|FG000|COMPLETED|Washout 1||4
10987517|NCT00620854|12162718|FG001|COMPLETED|Washout 1||4
10987518|NCT00620854|12162719|FG002|COMPLETED|Washout 1||3
10987519|NCT00620854|12162720|FG003|COMPLETED|Washout 1||3
10987520|NCT00620854|12162721|FG004|COMPLETED|Washout 1||4
10987521|NCT00620854|12162722|FG005|COMPLETED|Washout 1||4
10987522|NCT00620854|12162717|FG000|NOT COMPLETED|Washout 1||0
10987523|NCT00620854|12162718|FG001|NOT COMPLETED|Washout 1||0
10987524|NCT00620854|12162719|FG002|NOT COMPLETED|Washout 1||1
10987525|NCT00620854|12162720|FG003|NOT COMPLETED|Washout 1||1
10987526|NCT00620854|12162721|FG004|NOT COMPLETED|Washout 1||0
10987527|NCT00620854|12162722|FG005|NOT COMPLETED|Washout 1||0
10987528|NCT00620854|12162717|FG000|STARTED|Period 2||4
10987529|NCT00620854|12162718|FG001|STARTED|Period 2||4
10987530|NCT00620854|12162719|FG002|STARTED|Period 2||3
10987531|NCT00620854|12162720|FG003|STARTED|Period 2||3
10987532|NCT00620854|12162721|FG004|STARTED|Period 2||4
10987533|NCT00620854|12162722|FG005|STARTED|Period 2||4
10987534|NCT00620854|12162717|FG000|COMPLETED|Period 2||4
10987535|NCT00620854|12162718|FG001|COMPLETED|Period 2||4
10987536|NCT00620854|12162719|FG002|COMPLETED|Period 2||3
10987537|NCT00620854|12162720|FG003|COMPLETED|Period 2||3
10987538|NCT00620854|12162721|FG004|COMPLETED|Period 2||4
10987539|NCT00620854|12162722|FG005|COMPLETED|Period 2||4
10987540|NCT00620854|12162717|FG000|NOT COMPLETED|Period 2||0
10987541|NCT00620854|12162718|FG001|NOT COMPLETED|Period 2||0
10987542|NCT00620854|12162719|FG002|NOT COMPLETED|Period 2||0
10987543|NCT00620854|12162720|FG003|NOT COMPLETED|Period 2||0
10987544|NCT00620854|12162721|FG004|NOT COMPLETED|Period 2||0
10987545|NCT00620854|12162722|FG005|NOT COMPLETED|Period 2||0
10987546|NCT00620854|12162717|FG000|STARTED|Washout 2||4
10987547|NCT00620854|12162718|FG001|STARTED|Washout 2||4
10987548|NCT00620854|12162719|FG002|STARTED|Washout 2||3
10987549|NCT00620854|12162720|FG003|STARTED|Washout 2||3
10987550|NCT00620854|12162721|FG004|STARTED|Washout 2||4
10987551|NCT00620854|12162722|FG005|STARTED|Washout 2||4
10987552|NCT00620854|12162717|FG000|COMPLETED|Washout 2||4
10987553|NCT00620854|12162718|FG001|COMPLETED|Washout 2||4
10987554|NCT00620854|12162719|FG002|COMPLETED|Washout 2||3
10987555|NCT00620854|12162720|FG003|COMPLETED|Washout 2||3
10987556|NCT00620854|12162721|FG004|COMPLETED|Washout 2||4
10987557|NCT00620854|12162722|FG005|COMPLETED|Washout 2||4
10987558|NCT00620854|12162717|FG000|NOT COMPLETED|Washout 2||0
10987559|NCT00620854|12162718|FG001|NOT COMPLETED|Washout 2||0
10987560|NCT00620854|12162719|FG002|NOT COMPLETED|Washout 2||0
10987561|NCT00620854|12162720|FG003|NOT COMPLETED|Washout 2||0
10987562|NCT00620854|12162721|FG004|NOT COMPLETED|Washout 2||0
10987563|NCT00620854|12162722|FG005|NOT COMPLETED|Washout 2||0
10987564|NCT00620854|12162717|FG000|STARTED|Period 3||4
10987565|NCT00620854|12162718|FG001|STARTED|Period 3||4
10987566|NCT00620854|12162719|FG002|STARTED|Period 3||3
10987567|NCT00620854|12162720|FG003|STARTED|Period 3||3
10987568|NCT00620854|12162721|FG004|STARTED|Period 3||4
10987569|NCT00620854|12162722|FG005|STARTED|Period 3||4
10987570|NCT00620854|12162717|FG000|COMPLETED|Period 3||4
10987571|NCT00620854|12162718|FG001|COMPLETED|Period 3||4
10987572|NCT00620854|12162719|FG002|COMPLETED|Period 3||3
10987573|NCT00620854|12162720|FG003|COMPLETED|Period 3||3
10987574|NCT00620854|12162721|FG004|COMPLETED|Period 3||4
10987575|NCT00620854|12162722|FG005|COMPLETED|Period 3||4
10987576|NCT00620854|12162717|FG000|NOT COMPLETED|Period 3||0
10987577|NCT00620854|12162718|FG001|NOT COMPLETED|Period 3||0
10987578|NCT00620854|12162719|FG002|NOT COMPLETED|Period 3||0
10987579|NCT00620854|12162720|FG003|NOT COMPLETED|Period 3||0
10987580|NCT00620854|12162721|FG004|NOT COMPLETED|Period 3||0
10987581|NCT00620854|12162722|FG005|NOT COMPLETED|Period 3||0
10987582|NCT00620945|12162733|FG000|STARTED|Overall Study|Total number in the study|87
10987583|NCT00620945|12162733|FG000|COMPLETED|Overall Study||87
10987584|NCT00620945|12162733|FG000|NOT COMPLETED|Overall Study||0
10987585|NCT00621023|12162737|FG000|STARTED|Overall Study||6
10987586|NCT00621023|12162737|FG000|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
10987587|NCT00621023|12162737|FG000|NOT COMPLETED|Overall Study||6
10987588|NCT00621049|12162743|FG000|STARTED|Adjuvant Treatment||55
10987589|NCT00621049|12162744|FG001|STARTED|Adjuvant Treatment||57
10987590|NCT00621049|12162743|FG000|COMPLETED|Adjuvant Treatment||52
10987591|NCT00621049|12162744|FG001|COMPLETED|Adjuvant Treatment||47
10987592|NCT00621049|12162743|FG000|NOT COMPLETED|Adjuvant Treatment||3
10987593|NCT00621049|12162744|FG001|NOT COMPLETED|Adjuvant Treatment||10
10987594|NCT00621049|12162743|FG000|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
10987595|NCT00621049|12162744|FG001|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
10987596|NCT00621049|12162743|FG000|COMPLETED|Maintenance Treatment||34
10987597|NCT00621049|12162744|FG001|COMPLETED|Maintenance Treatment||0
10987598|NCT00621049|12162743|FG000|NOT COMPLETED|Maintenance Treatment||15
10987599|NCT00621049|12162744|FG001|NOT COMPLETED|Maintenance Treatment||0
10987600|NCT00621140|12162752|FG000|STARTED|Overall Study|number who started treatment|167
10987601|NCT00621140|12162753|FG001|STARTED|Overall Study|number who started treatment|336
10987602|NCT00621140|12162752|FG000|COMPLETED|Overall Study|number who completed treatment|152
10987603|NCT00621140|12162753|FG001|COMPLETED|Overall Study|number who completed treatment|318
10987604|NCT00621140|12162752|FG000|NOT COMPLETED|Overall Study||15
10987605|NCT00621140|12162753|FG001|NOT COMPLETED|Overall Study||18
10987606|NCT00621153|12162761|FG000|STARTED|Overall Study|randomised|117
10987607|NCT00621153|12162762|FG001|STARTED|Overall Study|randomised|116
10987608|NCT00621153|12162761|FG000|Discontinued|Overall Study||20
10987609|NCT00621153|12162762|FG001|Discontinued|Overall Study||15
10987610|NCT00621153|12162761|FG000|COMPLETED|Overall Study|completed|97
10987611|NCT00621153|12162762|FG001|COMPLETED|Overall Study|completed|101
10987612|NCT00621153|12162761|FG000|NOT COMPLETED|Overall Study||20
10987613|NCT00621153|12162762|FG001|NOT COMPLETED|Overall Study||15
10987614|NCT00621179|12162772|FG000|STARTED|Overall Study||12
10987615|NCT00621179|12162773|FG001|STARTED|Overall Study||8
10987616|NCT00621179|12162774|FG002|STARTED|Overall Study||7
10987617|NCT00621179|12162775|FG003|STARTED|Overall Study||10
10987618|NCT00621179|12162772|FG000|COMPLETED|Overall Study||12
10987619|NCT00621179|12162773|FG001|COMPLETED|Overall Study||8
10987620|NCT00621179|12162774|FG002|COMPLETED|Overall Study||6
10987621|NCT00621179|12162775|FG003|COMPLETED|Overall Study||9
10987622|NCT00621179|12162772|FG000|NOT COMPLETED|Overall Study||0
10987623|NCT00621179|12162773|FG001|NOT COMPLETED|Overall Study||0
10987624|NCT00621179|12162774|FG002|NOT COMPLETED|Overall Study||1
10987625|NCT00621179|12162775|FG003|NOT COMPLETED|Overall Study||1
10987626|NCT00621192|12162789|FG000|STARTED|Overall Study||39
10987627|NCT00621192|12162790|FG001|STARTED|Overall Study||103
10987628|NCT00621192|12162791|FG002|STARTED|Overall Study||31
10987629|NCT00621192|12162792|FG003|STARTED|Overall Study||27
10987630|NCT00621192|12162789|FG000|Safety Population|Overall Study||39
10987631|NCT00621192|12162790|FG001|Safety Population|Overall Study||103
10987632|NCT00621192|12162791|FG002|Safety Population|Overall Study||31
10987633|NCT00621192|12162792|FG003|Safety Population|Overall Study||27
10987634|NCT00621192|12162789|FG000|Efficacy Population|Overall Study||39
10987635|NCT00621192|12162790|FG001|Efficacy Population|Overall Study||101
10987636|NCT00621192|12162791|FG002|Efficacy Population|Overall Study||28
10987637|NCT00621192|12162792|FG003|Efficacy Population|Overall Study||27
10987638|NCT00621192|12162789|FG000|COMPLETED|Overall Study||35
10987639|NCT00621192|12162790|FG001|COMPLETED|Overall Study||94
10987640|NCT00621192|12162791|FG002|COMPLETED|Overall Study||26
10987641|NCT00621192|12162792|FG003|COMPLETED|Overall Study||24
10987642|NCT00621192|12162789|FG000|NOT COMPLETED|Overall Study||4
10987643|NCT00621192|12162790|FG001|NOT COMPLETED|Overall Study||9
10987644|NCT00621192|12162791|FG002|NOT COMPLETED|Overall Study||5
10987645|NCT00621192|12162792|FG003|NOT COMPLETED|Overall Study||3
10987646|NCT00621244|12162806|FG000|STARTED|Overall Study||86
10987647|NCT00621244|12162807|FG001|STARTED|Overall Study||34
10987648|NCT00621244|12162808|FG002|STARTED|Overall Study||33
10987649|NCT00621244|12162809|FG003|STARTED|Overall Study||23
10987650|NCT00621244|12162806|FG000|COMPLETED|Overall Study||0
10987651|NCT00621244|12162807|FG001|COMPLETED|Overall Study||0
10987652|NCT00621244|12162808|FG002|COMPLETED|Overall Study||0
10987653|NCT00621244|12162809|FG003|COMPLETED|Overall Study||0
10987654|NCT00621244|12162806|FG000|NOT COMPLETED|Overall Study||86
10987655|NCT00621244|12162807|FG001|NOT COMPLETED|Overall Study||34
10987656|NCT00621244|12162808|FG002|NOT COMPLETED|Overall Study||33
10987657|NCT00621244|12162809|FG003|NOT COMPLETED|Overall Study||23
10987658|NCT00621257|12162888|FG000|STARTED|Overall Study||24
10987659|NCT00621257|12162889|FG001|STARTED|Overall Study||24
10987660|NCT00621257|12162890|FG002|STARTED|Overall Study||23
10987661|NCT00621257|12162891|FG003|STARTED|Overall Study||32
10987662|NCT00621257|12162892|FG004|STARTED|Overall Study||31
10987663|NCT00621257|12162888|FG000|COMPLETED|Overall Study||20
10987664|NCT00621257|12162889|FG001|COMPLETED|Overall Study||21
10987665|NCT00621257|12162890|FG002|COMPLETED|Overall Study||20
10987666|NCT00621257|12162891|FG003|COMPLETED|Overall Study||26
10987667|NCT00621257|12162892|FG004|COMPLETED|Overall Study||22
10987668|NCT00621257|12162888|FG000|NOT COMPLETED|Overall Study||4
10987669|NCT00621257|12162889|FG001|NOT COMPLETED|Overall Study||3
10987670|NCT00621257|12162890|FG002|NOT COMPLETED|Overall Study||3
10987671|NCT00621257|12162891|FG003|NOT COMPLETED|Overall Study||6
10987672|NCT00621257|12162892|FG004|NOT COMPLETED|Overall Study||9
10987673|NCT00621296|12162904|FG000|STARTED|Overall Study||15
10987674|NCT00621296|12162904|FG000|COMPLETED|Overall Study||1
10987675|NCT00621296|12162904|FG000|NOT COMPLETED|Overall Study||14
10987676|NCT00621309|12162908|FG000|STARTED|Overall Study||6
10987677|NCT00621309|12162909|FG001|STARTED|Overall Study||4
10987678|NCT00621309|12162910|FG002|STARTED|Overall Study||5
10987679|NCT00621309|12162911|FG003|STARTED|Overall Study||6
10987680|NCT00621309|12162912|FG004|STARTED|Overall Study||4
10987681|NCT00621309|12162913|FG005|STARTED|Overall Study||4
10987682|NCT00621309|12162908|FG000|COMPLETED|Overall Study||4
10987683|NCT00621309|12162909|FG001|COMPLETED|Overall Study||4
10987684|NCT00621309|12162910|FG002|COMPLETED|Overall Study||4
10987685|NCT00621309|12162911|FG003|COMPLETED|Overall Study||5
10987686|NCT00621309|12162912|FG004|COMPLETED|Overall Study||3
10987687|NCT00621309|12162913|FG005|COMPLETED|Overall Study||3
10987688|NCT00621309|12162908|FG000|NOT COMPLETED|Overall Study||2
10987689|NCT00621309|12162909|FG001|NOT COMPLETED|Overall Study||0
10987690|NCT00621309|12162910|FG002|NOT COMPLETED|Overall Study||1
10987691|NCT00621309|12162911|FG003|NOT COMPLETED|Overall Study||1
10987692|NCT00621309|12162912|FG004|NOT COMPLETED|Overall Study||1
10987693|NCT00621309|12162913|FG005|NOT COMPLETED|Overall Study||1
10987694|NCT00621322|12162925|FG000|STARTED|Overall Study||10
10987695|NCT00621322|12162926|FG001|STARTED|Overall Study||10
10987696|NCT00621322|12162927|FG002|STARTED|Overall Study||40
10987697|NCT00621322|12162928|FG003|STARTED|Overall Study||40
10987698|NCT00621322|12162929|FG004|STARTED|Overall Study||40
10987699|NCT00621322|12162930|FG005|STARTED|Overall Study||40
10987700|NCT00621322|12162925|FG000|COMPLETED|Overall Study||9
10987701|NCT00621322|12162926|FG001|COMPLETED|Overall Study||10
10987702|NCT00621322|12162927|FG002|COMPLETED|Overall Study||38
10987703|NCT00621322|12162928|FG003|COMPLETED|Overall Study||37
10987704|NCT00621322|12162929|FG004|COMPLETED|Overall Study||39
10987705|NCT00621322|12162930|FG005|COMPLETED|Overall Study||36
10987706|NCT00621322|12162925|FG000|NOT COMPLETED|Overall Study||1
10987707|NCT00621322|12162926|FG001|NOT COMPLETED|Overall Study||0
10987708|NCT00621322|12162927|FG002|NOT COMPLETED|Overall Study||2
10987709|NCT00621322|12162928|FG003|NOT COMPLETED|Overall Study||3
10987710|NCT00621322|12162929|FG004|NOT COMPLETED|Overall Study||1
10987711|NCT00621322|12162930|FG005|NOT COMPLETED|Overall Study||4
10987712|NCT00621348|12162947|FG000|STARTED|Overall Study||58
10987713|NCT00621348|12162948|FG001|STARTED|Overall Study||53
10987714|NCT00621348|12162949|FG002|STARTED|Overall Study||56
10987715|NCT00621348|12162947|FG000|COMPLETED|Overall Study||58
10987716|NCT00621348|12162948|FG001|COMPLETED|Overall Study||53
10987717|NCT00621348|12162949|FG002|COMPLETED|Overall Study||56
10987718|NCT00621348|12162947|FG000|NOT COMPLETED|Overall Study||0
10987719|NCT00621348|12162948|FG001|NOT COMPLETED|Overall Study||0
10987720|NCT00621348|12162949|FG002|NOT COMPLETED|Overall Study||0
10987721|NCT00621504|12162959|FG000|STARTED|Overall Study||299
10987722|NCT00621504|12162960|FG001|STARTED|Overall Study||307
10987723|NCT00621504|12162959|FG000|COMPLETED|Overall Study||273
10987724|NCT00621504|12162960|FG001|COMPLETED|Overall Study||282
10987725|NCT00621504|12162959|FG000|NOT COMPLETED|Overall Study||26
10987726|NCT00621504|12162960|FG001|NOT COMPLETED|Overall Study||25
10987727|NCT00621517|12162968|FG000|STARTED|Overall Study||29
10987728|NCT00621517|12162969|FG001|STARTED|Overall Study||31
10987729|NCT00621517|12162968|FG000|COMPLETED|Overall Study||22
10987730|NCT00621517|12162969|FG001|COMPLETED|Overall Study||24
10987731|NCT00621517|12162968|FG000|NOT COMPLETED|Overall Study||7
10987732|NCT00621517|12162969|FG001|NOT COMPLETED|Overall Study||7
10987733|NCT00621530|12162977|FG000|STARTED|Overall Study||30
10987734|NCT00621530|12162978|FG001|STARTED|Overall Study||32
10987735|NCT00621530|12162977|FG000|COMPLETED|Overall Study||28
10987736|NCT00621530|12162978|FG001|COMPLETED|Overall Study||29
10987737|NCT00621530|12162977|FG000|NOT COMPLETED|Overall Study||2
10987738|NCT00621530|12162978|FG001|NOT COMPLETED|Overall Study||3
10987739|NCT00621543|12162987|FG000|STARTED|Overall Study||120
10987740|NCT00621543|12162987|FG000|COMPLETED|Overall Study||97
10987741|NCT00621543|12162987|FG000|NOT COMPLETED|Overall Study||23
10987742|NCT00621582|12162991|FG000|STARTED|Overall Study||4918
10987743|NCT00621582|12162991|FG000|COMPLETED|Overall Study||4812
10987744|NCT00621582|12162991|FG000|NOT COMPLETED|Overall Study||106
10987745|NCT00621621|12162998|FG000|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
10987746|NCT00621621|12162999|FG001|STARTED|Overall Study||705
10987747|NCT00621621|12162998|FG000|COMPLETED|Overall Study|Treated with the experimental catheter|75
10987748|NCT00621621|12162999|FG001|COMPLETED|Overall Study||705
10987749|NCT00621621|12162998|FG000|NOT COMPLETED|Overall Study||30
10987750|NCT00621621|12162999|FG001|NOT COMPLETED|Overall Study||0
10987751|NCT00621686|12163009|FG000|STARTED|Overall Study||19
10987752|NCT00621686|12163010|FG001|STARTED|Overall Study||35
10987753|NCT00621686|12163009|FG000|COMPLETED|Overall Study||19
10987754|NCT00621686|12163010|FG001|COMPLETED|Overall Study||35
10987755|NCT00621686|12163009|FG000|NOT COMPLETED|Overall Study||0
10987756|NCT00621686|12163010|FG001|NOT COMPLETED|Overall Study||0
10987757|NCT00621764|12163021|FG000|STARTED|Overall Study||50
10987758|NCT00621764|12163022|FG001|STARTED|Overall Study||50
10987759|NCT00621764|12163023|FG002|STARTED|Overall Study||101
10987760|NCT00621764|12163024|FG003|STARTED|Overall Study||99
10987761|NCT00621764|12163021|FG000|COMPLETED|Overall Study||50
10987762|NCT00621764|12163022|FG001|COMPLETED|Overall Study||50
10987763|NCT00621764|12163023|FG002|COMPLETED|Overall Study||101
10987764|NCT00621764|12163024|FG003|COMPLETED|Overall Study||98
10987765|NCT00621764|12163021|FG000|NOT COMPLETED|Overall Study||0
10987766|NCT00621764|12163022|FG001|NOT COMPLETED|Overall Study||0
10987767|NCT00621764|12163023|FG002|NOT COMPLETED|Overall Study||0
10987768|NCT00621764|12163024|FG003|NOT COMPLETED|Overall Study||1
10987769|NCT00621777|12163037|FG000|STARTED|Open Phase||203
10987770|NCT00621777|12163038|FG001|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
10987771|NCT00621777|12163037|FG000|COMPLETED|Open Phase||87
10987772|NCT00621777|12163038|FG001|COMPLETED|Open Phase||0
10987773|NCT00621777|12163037|FG000|NOT COMPLETED|Open Phase||116
10987774|NCT00621777|12163038|FG001|NOT COMPLETED|Open Phase||0
10987775|NCT00621777|12163037|FG000|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
10987776|NCT00621777|12163038|FG001|STARTED|Randomized Phase||47
10987777|NCT00621777|12163037|FG000|COMPLETED|Randomized Phase||33
10987778|NCT00621777|12163038|FG001|COMPLETED|Randomized Phase||28
10987779|NCT00621777|12163037|FG000|NOT COMPLETED|Randomized Phase||7
10987780|NCT00621777|12163038|FG001|NOT COMPLETED|Randomized Phase||19
10987781|NCT00621842|12163046|FG000|STARTED|Overall Study||57
10987782|NCT00621842|12163046|FG000|COMPLETED|Overall Study||38
10987783|NCT00621842|12163046|FG000|NOT COMPLETED|Overall Study||19
10987784|NCT00621855|12163055|FG000|STARTED|Overall Study|Started means randomised to treatment|372
10987785|NCT00621855|12163056|FG001|STARTED|Overall Study|Started means randomised to treatment|371
10987786|NCT00621855|12163057|FG002|STARTED|Overall Study|Started means randomised to treatment|411
10987787|NCT00621855|12163058|FG003|STARTED|Overall Study|Started means randomised to treatment|351
10987788|NCT00621855|12163059|FG004|STARTED|Overall Study|Started means randomised to treatment|373
10987789|NCT00621855|12163055|FG000|COMPLETED|Overall Study|Completed means completed treatment|296
10987790|NCT00621855|12163056|FG001|COMPLETED|Overall Study|Completed means completed treatment|310
10987791|NCT00621855|12163057|FG002|COMPLETED|Overall Study|Completed means completed treatment|330
10987792|NCT00621855|12163058|FG003|COMPLETED|Overall Study|Completed means completed treatment|284
10987793|NCT00621855|12163059|FG004|COMPLETED|Overall Study|Completed means completed treatment|318
10987794|NCT00621855|12163055|FG000|NOT COMPLETED|Overall Study||76
10987795|NCT00621855|12163056|FG001|NOT COMPLETED|Overall Study||61
10987796|NCT00621855|12163057|FG002|NOT COMPLETED|Overall Study||81
10987797|NCT00621855|12163058|FG003|NOT COMPLETED|Overall Study||67
10987798|NCT00621855|12163059|FG004|NOT COMPLETED|Overall Study||55
10987799|NCT00621933|12163071|FG000|STARTED|Overall Study||399
10987800|NCT00621933|12163071|FG000|COMPLETED|Overall Study||399
10987801|NCT00621933|12163071|FG000|NOT COMPLETED|Overall Study||0
10987802|NCT00621946|12163077|FG000|STARTED|Overall Study||13
10987803|NCT00621946|12163078|FG001|STARTED|Overall Study||13
10987804|NCT00621946|12163077|FG000|COMPLETED|Overall Study||13
10987805|NCT00621946|12163078|FG001|COMPLETED|Overall Study||12
10987806|NCT00621946|12163077|FG000|NOT COMPLETED|Overall Study||0
10987807|NCT00621946|12163078|FG001|NOT COMPLETED|Overall Study||1
10987808|NCT00621959|12163087|FG000|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
10987809|NCT00621959|12163088|FG001|STARTED|Overall Study||301
10987810|NCT00621959|12163087|FG000|COMPLETED|Overall Study||288
10987811|NCT00621959|12163088|FG001|COMPLETED|Overall Study||292
10987812|NCT00621959|12163087|FG000|NOT COMPLETED|Overall Study||7
10987813|NCT00621959|12163088|FG001|NOT COMPLETED|Overall Study||9
10987814|NCT00621985|12163094|FG000|STARTED|Hydrocortisone Admission||5
10987815|NCT00621985|12163094|FG000|COMPLETED|Hydrocortisone Admission||5
10987816|NCT00621985|12163094|FG000|NOT COMPLETED|Hydrocortisone Admission||0
10987817|NCT00621985|12163094|FG000|STARTED|Dexamethasone Admission||5
10987818|NCT00621985|12163094|FG000|COMPLETED|Dexamethasone Admission||4
10987819|NCT00621985|12163094|FG000|NOT COMPLETED|Dexamethasone Admission||1
10987820|NCT00622180|12163100|FG000|STARTED|Overall Study||6
10987821|NCT00622180|12163101|FG001|STARTED|Overall Study||7
10987822|NCT00622180|12163100|FG000|COMPLETED|Overall Study||5
10987823|NCT00622180|12163101|FG001|COMPLETED|Overall Study||5
10987824|NCT00622180|12163100|FG000|NOT COMPLETED|Overall Study||1
10987825|NCT00622180|12163101|FG001|NOT COMPLETED|Overall Study||2
10987826|NCT00622284|12163109|FG000|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
10987827|NCT00622284|12163110|FG001|STARTED|Overall Study|Number who started treatment.|775
10987828|NCT00622284|12163109|FG000|COMPLETED|Overall Study|Number who completed treatment.|587
10987829|NCT00622284|12163110|FG001|COMPLETED|Overall Study|Number who completed treatment.|604
10987830|NCT00622284|12163109|FG000|NOT COMPLETED|Overall Study||189
10987831|NCT00622284|12163110|FG001|NOT COMPLETED|Overall Study||171
10987832|NCT00622336|12163116|FG000|STARTED|Treatment Phase||330
10987833|NCT00622336|12163116|FG000|Safety Population|Treatment Phase||330
10987834|NCT00622336|12163116|FG000|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
10987835|NCT00622336|12163116|FG000|NOT COMPLETED|Treatment Phase||309
10987836|NCT00622336|12163116|FG000|STARTED|Extension Phase||21
10987837|NCT00622336|12163116|FG000|COMPLETED|Extension Phase||0
10987838|NCT00622336|12163116|FG000|NOT COMPLETED|Extension Phase||21
10987839|NCT00622388|12163122|FG000|STARTED|Overall Study||81
10987840|NCT00622388|12163122|FG000|COMPLETED|Overall Study||9
10987841|NCT00622388|12163122|FG000|NOT COMPLETED|Overall Study||72
10987842|NCT00622401|12163130|FG000|STARTED|Overall Study||6
10987843|NCT00622401|12163131|FG001|STARTED|Overall Study||2
10987844|NCT00622401|12163132|FG002|STARTED|Overall Study|Never Opened|0
10987845|NCT00622401|12163130|FG000|COMPLETED|Overall Study||3
10987846|NCT00622401|12163131|FG001|COMPLETED|Overall Study||0
10987847|NCT00622401|12163132|FG002|COMPLETED|Overall Study||0
10987848|NCT00622401|12163130|FG000|NOT COMPLETED|Overall Study||3
10987849|NCT00622401|12163131|FG001|NOT COMPLETED|Overall Study||2
10987850|NCT00622401|12163132|FG002|NOT COMPLETED|Overall Study||0
10987851|NCT00622427|12163141|FG000|STARTED|Overall Study||16
10987852|NCT00622427|12163142|FG001|STARTED|Overall Study||16
10987853|NCT00622427|12163141|FG000|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
10987854|NCT00622427|12163142|FG001|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
10987855|NCT00622427|12163141|FG000|NOT COMPLETED|Overall Study||0
10987856|NCT00622427|12163142|FG001|NOT COMPLETED|Overall Study||0
10987857|NCT00622440|12163152|FG000|STARTED|Baseline - Week 12 (Treatment)||35
10987858|NCT00622440|12163153|FG001|STARTED|Baseline - Week 12 (Treatment)||35
10987859|NCT00622440|12163152|FG000|COMPLETED|Baseline - Week 12 (Treatment)||31
10987860|NCT00622440|12163153|FG001|COMPLETED|Baseline - Week 12 (Treatment)||34
10987861|NCT00622440|12163152|FG000|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
10987862|NCT00622440|12163153|FG001|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
10987863|NCT00622440|12163152|FG000|STARTED|Week 12 - Week 48 (Treatment)||31
10987864|NCT00622440|12163153|FG001|STARTED|Week 12 - Week 48 (Treatment)||34
10987865|NCT00622440|12163152|FG000|COMPLETED|Week 12 - Week 48 (Treatment)||28
10987866|NCT00622440|12163153|FG001|COMPLETED|Week 12 - Week 48 (Treatment)||28
10987867|NCT00622440|12163152|FG000|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
10987868|NCT00622440|12163153|FG001|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
10987869|NCT00622440|12163152|FG000|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
10987870|NCT00622440|12163153|FG001|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
10987871|NCT00622440|12163152|FG000|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
10987872|NCT00622440|12163153|FG001|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
10987873|NCT00622440|12163152|FG000|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
10987874|NCT00622440|12163153|FG001|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
10987875|NCT00622466|12163159|FG000|STARTED|Overall Study||20
10987876|NCT00622466|12163159|FG000|COMPLETED|Overall Study||16
10987877|NCT00622466|12163159|FG000|NOT COMPLETED|Overall Study||4
10987878|NCT00622505|12163165|FG000|STARTED|Overall Study||79
10987879|NCT00622505|12163166|FG001|STARTED|Overall Study||42
10987880|NCT00622505|12163165|FG000|COMPLETED|Overall Study||50
10987881|NCT00622505|12163166|FG001|COMPLETED|Overall Study||19
10987882|NCT00622505|12163165|FG000|NOT COMPLETED|Overall Study||29
10987883|NCT00622505|12163166|FG001|NOT COMPLETED|Overall Study||23
10987884|NCT00622518|12163174|FG000|STARTED|Overall Study||59
10987885|NCT00622518|12163175|FG001|STARTED|Overall Study||60
10987886|NCT00622518|12163174|FG000|COMPLETED|Overall Study||59
10987887|NCT00622518|12163175|FG001|COMPLETED|Overall Study||60
10987888|NCT00622518|12163174|FG000|NOT COMPLETED|Overall Study||0
10987889|NCT00622518|12163175|FG001|NOT COMPLETED|Overall Study||0
10987890|NCT00622544|12163181|FG000|STARTED|Overall Study||44
10987891|NCT00622544|12163181|FG000|COMPLETED|Overall Study|35|35
10987892|NCT00622544|12163181|FG000|NOT COMPLETED|Overall Study||9
10987893|NCT00622635|12163185|FG000|STARTED|Treatment Period 1||13
10987894|NCT00622635|12163186|FG001|STARTED|Treatment Period 1||11
10987895|NCT00622635|12163187|FG002|STARTED|Treatment Period 1||11
10987896|NCT00622635|12163188|FG003|STARTED|Treatment Period 1||13
10987897|NCT00622635|12163189|FG004|STARTED|Treatment Period 1||10
10987898|NCT00622635|12163190|FG005|STARTED|Treatment Period 1||10
10987899|NCT00622635|12163185|FG000|COMPLETED|Treatment Period 1||13
10987900|NCT00622635|12163186|FG001|COMPLETED|Treatment Period 1||10
10987901|NCT00622635|12163187|FG002|COMPLETED|Treatment Period 1||10
10987902|NCT00622635|12163188|FG003|COMPLETED|Treatment Period 1||13
10987903|NCT00622635|12163189|FG004|COMPLETED|Treatment Period 1||9
10987904|NCT00622635|12163190|FG005|COMPLETED|Treatment Period 1||10
10987905|NCT00622635|12163185|FG000|NOT COMPLETED|Treatment Period 1||0
10987906|NCT00622635|12163186|FG001|NOT COMPLETED|Treatment Period 1||1
10987907|NCT00622635|12163187|FG002|NOT COMPLETED|Treatment Period 1||1
10987908|NCT00622635|12163188|FG003|NOT COMPLETED|Treatment Period 1||0
10987909|NCT00622635|12163189|FG004|NOT COMPLETED|Treatment Period 1||1
10987910|NCT00622635|12163190|FG005|NOT COMPLETED|Treatment Period 1||0
10987911|NCT00622635|12163185|FG000|STARTED|Treatment Period 2||13
10987912|NCT00622635|12163186|FG001|STARTED|Treatment Period 2||10
10987913|NCT00622635|12163187|FG002|STARTED|Treatment Period 2||10
10987914|NCT00622635|12163188|FG003|STARTED|Treatment Period 2||13
10987915|NCT00622635|12163189|FG004|STARTED|Treatment Period 2||9
10987916|NCT00622635|12163190|FG005|STARTED|Treatment Period 2||10
10987917|NCT00622635|12163185|FG000|COMPLETED|Treatment Period 2||12
10987918|NCT00622635|12163186|FG001|COMPLETED|Treatment Period 2||10
10987919|NCT00622635|12163187|FG002|COMPLETED|Treatment Period 2||10
10987920|NCT00622635|12163188|FG003|COMPLETED|Treatment Period 2||13
10987921|NCT00622635|12163189|FG004|COMPLETED|Treatment Period 2||9
10987922|NCT00622635|12163190|FG005|COMPLETED|Treatment Period 2||10
10987923|NCT00622635|12163185|FG000|NOT COMPLETED|Treatment Period 2||1
10987924|NCT00622635|12163186|FG001|NOT COMPLETED|Treatment Period 2||0
10987925|NCT00622635|12163187|FG002|NOT COMPLETED|Treatment Period 2||0
10987926|NCT00622635|12163188|FG003|NOT COMPLETED|Treatment Period 2||0
10987927|NCT00622635|12163189|FG004|NOT COMPLETED|Treatment Period 2||0
10987928|NCT00622635|12163190|FG005|NOT COMPLETED|Treatment Period 2||0
10987929|NCT00622635|12163185|FG000|STARTED|Treatment Period 3||12
10987930|NCT00622635|12163186|FG001|STARTED|Treatment Period 3||10
10987931|NCT00622635|12163187|FG002|STARTED|Treatment Period 3||10
10987932|NCT00622635|12163188|FG003|STARTED|Treatment Period 3||13
10987933|NCT00622635|12163189|FG004|STARTED|Treatment Period 3||9
10987934|NCT00622635|12163190|FG005|STARTED|Treatment Period 3||10
10987935|NCT00622635|12163185|FG000|COMPLETED|Treatment Period 3||12
10987936|NCT00622635|12163186|FG001|COMPLETED|Treatment Period 3||10
10987937|NCT00622635|12163187|FG002|COMPLETED|Treatment Period 3||10
10987938|NCT00622635|12163188|FG003|COMPLETED|Treatment Period 3||10
10987939|NCT00622635|12163189|FG004|COMPLETED|Treatment Period 3||9
10987940|NCT00622635|12163190|FG005|COMPLETED|Treatment Period 3||10
10987941|NCT00622635|12163185|FG000|NOT COMPLETED|Treatment Period 3||0
10987942|NCT00622635|12163186|FG001|NOT COMPLETED|Treatment Period 3||0
10987943|NCT00622635|12163187|FG002|NOT COMPLETED|Treatment Period 3||0
10987944|NCT00622635|12163188|FG003|NOT COMPLETED|Treatment Period 3||3
10987945|NCT00622635|12163189|FG004|NOT COMPLETED|Treatment Period 3||0
10987946|NCT00622635|12163190|FG005|NOT COMPLETED|Treatment Period 3||0
10987947|NCT00622700|12163201|FG000|STARTED|Core Treatment Period||197
10987948|NCT00622700|12163202|FG001|STARTED|Core Treatment Period||205
10987949|NCT00622700|12163203|FG002|STARTED|Core Treatment Period||216
10987950|NCT00622700|12163204|FG003|STARTED|Core Treatment Period||0
10987951|NCT00622700|12163205|FG004|STARTED|Core Treatment Period||0
10987952|NCT00622700|12163206|FG005|STARTED|Core Treatment Period||0
10987953|NCT00622700|12163207|FG006|STARTED|Core Treatment Period||0
10987954|NCT00622700|12163201|FG000|Treated|Core Treatment Period||197
10987955|NCT00622700|12163202|FG001|Treated|Core Treatment Period||203
10987956|NCT00622700|12163203|FG002|Treated|Core Treatment Period||214
10987957|NCT00622700|12163204|FG003|Treated|Core Treatment Period||0
10987958|NCT00622700|12163205|FG004|Treated|Core Treatment Period||0
10987959|NCT00622700|12163206|FG005|Treated|Core Treatment Period||0
10987960|NCT00622700|12163207|FG006|Treated|Core Treatment Period||0
10987961|NCT00622700|12163201|FG000|COMPLETED|Core Treatment Period||141
10987962|NCT00622700|12163202|FG001|COMPLETED|Core Treatment Period||150
10987963|NCT00622700|12163203|FG002|COMPLETED|Core Treatment Period||163
10987964|NCT00622700|12163204|FG003|COMPLETED|Core Treatment Period||0
10987965|NCT00622700|12163205|FG004|COMPLETED|Core Treatment Period||0
10987966|NCT00622700|12163206|FG005|COMPLETED|Core Treatment Period||0
10987967|NCT00622700|12163207|FG006|COMPLETED|Core Treatment Period||0
10987968|NCT00622700|12163201|FG000|NOT COMPLETED|Core Treatment Period||56
10987969|NCT00622700|12163202|FG001|NOT COMPLETED|Core Treatment Period||55
10987970|NCT00622700|12163203|FG002|NOT COMPLETED|Core Treatment Period||53
10987971|NCT00622700|12163204|FG003|NOT COMPLETED|Core Treatment Period||0
10987972|NCT00622700|12163205|FG004|NOT COMPLETED|Core Treatment Period||0
10987973|NCT00622700|12163206|FG005|NOT COMPLETED|Core Treatment Period||0
10987974|NCT00622700|12163207|FG006|NOT COMPLETED|Core Treatment Period||0
10987975|NCT00622700|12163201|FG000|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
10987976|NCT00622700|12163202|FG001|STARTED|Extension Treatment Period||0
10987977|NCT00622700|12163203|FG002|STARTED|Extension Treatment Period||0
10987978|NCT00622700|12163204|FG003|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
10987979|NCT00622700|12163205|FG004|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
10987980|NCT00622700|12163206|FG005|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
10987981|NCT00622700|12163207|FG006|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
10987982|NCT00622700|12163201|FG000|COMPLETED|Extension Treatment Period||0
10987983|NCT00622700|12163202|FG001|COMPLETED|Extension Treatment Period||0
10987984|NCT00622700|12163203|FG002|COMPLETED|Extension Treatment Period||0
10987985|NCT00622700|12163204|FG003|COMPLETED|Extension Treatment Period||43
10987986|NCT00622700|12163205|FG004|COMPLETED|Extension Treatment Period||103
10987987|NCT00622700|12163206|FG005|COMPLETED|Extension Treatment Period||50
10987988|NCT00622700|12163207|FG006|COMPLETED|Extension Treatment Period||120
10987989|NCT00622700|12163201|FG000|NOT COMPLETED|Extension Treatment Period||0
10987990|NCT00622700|12163202|FG001|NOT COMPLETED|Extension Treatment Period||0
10987991|NCT00622700|12163203|FG002|NOT COMPLETED|Extension Treatment Period||0
10987992|NCT00622700|12163204|FG003|NOT COMPLETED|Extension Treatment Period||21
10987993|NCT00622700|12163205|FG004|NOT COMPLETED|Extension Treatment Period||39
10987994|NCT00622700|12163206|FG005|NOT COMPLETED|Extension Treatment Period||17
10987995|NCT00622700|12163207|FG006|NOT COMPLETED|Extension Treatment Period||30
10987996|NCT00622713|12163224|FG000|STARTED|Overall Study||228
10987997|NCT00622713|12163224|FG000|Exposed to Study Drug|Overall Study||226
10987998|NCT00622713|12163224|FG000|Intent to Treat (ITT) Population|Overall Study||218
10987999|NCT00622713|12163224|FG000|COMPLETED|Overall Study||169
10988000|NCT00622713|12163224|FG000|NOT COMPLETED|Overall Study||59
10988001|NCT00622726|12163230|FG000|STARTED|March, 2008 to August, 2010||75
10988002|NCT00622726|12163231|FG001|STARTED|March, 2008 to August, 2010||75
10988003|NCT00622726|12163230|FG000|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
10988004|NCT00622726|12163231|FG001|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
10988005|NCT00622726|12163230|FG000|NOT COMPLETED|March, 2008 to August, 2010||5
10988006|NCT00622726|12163231|FG001|NOT COMPLETED|March, 2008 to August, 2010||2
10988007|NCT00622726|12163230|FG000|STARTED|August, 2010 to April, 2013||70
10988008|NCT00622726|12163231|FG001|STARTED|August, 2010 to April, 2013||73
10988009|NCT00622726|12163230|FG000|COMPLETED|August, 2010 to April, 2013||69
10988010|NCT00622726|12163231|FG001|COMPLETED|August, 2010 to April, 2013||68
10988011|NCT00622726|12163230|FG000|NOT COMPLETED|August, 2010 to April, 2013||1
10988012|NCT00622726|12163231|FG001|NOT COMPLETED|August, 2010 to April, 2013||5
10988013|NCT00622739|12163243|FG000|STARTED|Overall Study||13
10988014|NCT00622739|12163244|FG001|STARTED|Overall Study||15
10988015|NCT00622739|12163243|FG000|COMPLETED|Overall Study||11
10988016|NCT00622739|12163244|FG001|COMPLETED|Overall Study||9
10988017|NCT00622739|12163243|FG000|NOT COMPLETED|Overall Study||2
10988018|NCT00622739|12163244|FG001|NOT COMPLETED|Overall Study||6
10988019|NCT00622869|12163255|FG000|STARTED|Overall Study||245
10988020|NCT00622869|12163256|FG001|STARTED|Overall Study||231
10988021|NCT00622869|12163257|FG002|STARTED|Overall Study||243
10988022|NCT00622869|12163255|FG000|COMPLETED|Overall Study||202
10988023|NCT00622869|12163256|FG001|COMPLETED|Overall Study||174
10988024|NCT00622869|12163257|FG002|COMPLETED|Overall Study||204
10988025|NCT00622869|12163255|FG000|NOT COMPLETED|Overall Study||43
10988026|NCT00622869|12163256|FG001|NOT COMPLETED|Overall Study||57
10988027|NCT00622869|12163257|FG002|NOT COMPLETED|Overall Study||39
10988028|NCT00622895|12163265|FG000|STARTED|Overall Study||3
10988029|NCT00622895|12163265|FG000|COMPLETED|Overall Study||3
10988030|NCT00622895|12163265|FG000|NOT COMPLETED|Overall Study||0
10988031|NCT00622908|12163274|FG000|STARTED|Overall Study|Intent to treat population|137
10988032|NCT00622908|12163275|FG001|STARTED|Overall Study|Intent to treat population|132
10988033|NCT00622908|12163274|FG000|COMPLETED|Overall Study||134
10988034|NCT00622908|12163275|FG001|COMPLETED|Overall Study||122
10988035|NCT00622908|12163274|FG000|NOT COMPLETED|Overall Study||3
10988036|NCT00622908|12163275|FG001|NOT COMPLETED|Overall Study||10
10988037|NCT00623012|12163281|FG000|STARTED|Overall Study||2
10988038|NCT00623012|12163281|FG000|COMPLETED|Overall Study||2
10988039|NCT00623012|12163281|FG000|NOT COMPLETED|Overall Study||0
10988040|NCT00623103|12163287|FG000|STARTED|Overall Study||295
10988041|NCT00623103|12163288|FG001|STARTED|Overall Study||288
10988042|NCT00623103|12163287|FG000|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
10988043|NCT00623103|12163288|FG001|Safety Set: Received Study Drug|Overall Study||288
10988044|NCT00623103|12163287|FG000|COMPLETED|Overall Study||184
10988045|NCT00623103|12163288|FG001|COMPLETED|Overall Study||175
10988046|NCT00623103|12163287|FG000|NOT COMPLETED|Overall Study||111
10988047|NCT00623103|12163288|FG001|NOT COMPLETED|Overall Study||113
10988048|NCT00623181|12163296|FG000|STARTED|Overall Study||56
10988049|NCT00623181|12163297|FG001|STARTED|Overall Study||54
10988050|NCT00623181|12163296|FG000|COMPLETED|Overall Study||56
10988051|NCT00623181|12163297|FG001|COMPLETED|Overall Study||54
10988052|NCT00623181|12163296|FG000|NOT COMPLETED|Overall Study||0
10988053|NCT00623181|12163297|FG001|NOT COMPLETED|Overall Study||0
10988054|NCT00623194|12163307|FG000|STARTED|Overall Study||146
10988055|NCT00623194|12163307|FG000|COMPLETED|Overall Study||141
10988056|NCT00623194|12163307|FG000|NOT COMPLETED|Overall Study||5
10988057|NCT00623233|12163311|FG000|STARTED|Overall Study||52
10988058|NCT00623233|12163311|FG000|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
10988059|NCT00623233|12163311|FG000|NOT COMPLETED|Overall Study||24
10988060|NCT00623363|12163317|FG000|STARTED|Overall Study||7
10988061|NCT00623363|12163318|FG001|STARTED|Overall Study||20
10988062|NCT00623363|12163317|FG000|COMPLETED|Overall Study||5
10988063|NCT00623363|12163318|FG001|COMPLETED|Overall Study||18
10988064|NCT00623363|12163317|FG000|NOT COMPLETED|Overall Study||2
10988065|NCT00623363|12163318|FG001|NOT COMPLETED|Overall Study||2
10988066|NCT00623428|12163327|FG000|STARTED|Treatment Period||95
10988067|NCT00623428|12163328|FG001|STARTED|Treatment Period||93
10988068|NCT00623428|12163327|FG000|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
10988069|NCT00623428|12163328|FG001|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
10988070|NCT00623428|12163327|FG000|NOT COMPLETED|Treatment Period||0
10988071|NCT00623428|12163328|FG001|NOT COMPLETED|Treatment Period||27
10988072|NCT00623428|12163327|FG000|STARTED|Follow-up Period||95
10988073|NCT00623428|12163328|FG001|STARTED|Follow-up Period||93
10988074|NCT00623428|12163327|FG000|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
10988075|NCT00623428|12163328|FG001|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
10988076|NCT00623428|12163327|FG000|NOT COMPLETED|Follow-up Period||29
10988077|NCT00623428|12163328|FG001|NOT COMPLETED|Follow-up Period||15
10988078|NCT00623441|12163334|FG000|STARTED|Overall Study||8314
10988079|NCT00623441|12163334|FG000|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
10988080|NCT00623441|12163334|FG000|NOT COMPLETED|Overall Study||0
10988081|NCT00623467|12163338|FG000|STARTED|Overall Study||343
10988082|NCT00623467|12163338|FG000|COMPLETED|Overall Study||336
10988083|NCT00623467|12163338|FG000|NOT COMPLETED|Overall Study||7
10988084|NCT00623480|12163346|FG000|STARTED|Overall Study||42
10988085|NCT00623480|12163347|FG001|STARTED|Overall Study||42
10988086|NCT00623480|12163346|FG000|COMPLETED|Overall Study||35
10988087|NCT00623480|12163347|FG001|COMPLETED|Overall Study||35
10988088|NCT00623480|12163346|FG000|NOT COMPLETED|Overall Study||7
10988089|NCT00623480|12163347|FG001|NOT COMPLETED|Overall Study||7
10988090|NCT00623506|12163355|FG000|STARTED|Overall Study||15
10988091|NCT00623506|12163356|FG001|STARTED|Overall Study||15
10988092|NCT00623506|12163355|FG000|Week 4|Overall Study||11
10988093|NCT00623506|12163356|FG001|Week 4|Overall Study||11
10988094|NCT00623506|12163355|FG000|COMPLETED|Overall Study||11
10988095|NCT00623506|12163356|FG001|COMPLETED|Overall Study||11
10988096|NCT00623506|12163355|FG000|NOT COMPLETED|Overall Study||4
10988097|NCT00623506|12163356|FG001|NOT COMPLETED|Overall Study||4
10988098|NCT00623545|12163362|FG000|STARTED|Overall Study||28
10988099|NCT00623545|12163362|FG000|COMPLETED|Overall Study||18
10988100|NCT00623545|12163362|FG000|NOT COMPLETED|Overall Study||10
10988101|NCT00623597|12163369|FG000|STARTED|Overall Study||5
10988102|NCT00623597|12163370|FG001|STARTED|Overall Study||13
10988103|NCT00623597|12163369|FG000|COMPLETED|Overall Study||4
10988104|NCT00623597|12163370|FG001|COMPLETED|Overall Study||13
10988105|NCT00623597|12163369|FG000|NOT COMPLETED|Overall Study||1
10988106|NCT00623597|12163370|FG001|NOT COMPLETED|Overall Study||0
10988107|NCT00623623|12163380|FG000|STARTED|Overall Study||950
10988108|NCT00623623|12163381|FG001|STARTED|Overall Study||949
10988109|NCT00623623|12163380|FG000|COMPLETED|Overall Study||949
10988110|NCT00623623|12163381|FG001|COMPLETED|Overall Study||948
10988111|NCT00623623|12163380|FG000|NOT COMPLETED|Overall Study||1
10988112|NCT00623623|12163381|FG001|NOT COMPLETED|Overall Study||1
10988113|NCT00623636|12163389|FG000|STARTED|Double Blind||452
10988114|NCT00623636|12163390|FG001|STARTED|Double Blind||450
10988115|NCT00623636|12163389|FG000|COMPLETED|Double Blind||419
10988116|NCT00623636|12163390|FG001|COMPLETED|Double Blind||422
10988117|NCT00623636|12163389|FG000|NOT COMPLETED|Double Blind||33
10988118|NCT00623636|12163390|FG001|NOT COMPLETED|Double Blind||28
10988119|NCT00623636|12163389|FG000|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
10988120|NCT00623636|12163390|FG001|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
10988121|NCT00623636|12163389|FG000|COMPLETED|Open Label||0
10988122|NCT00623636|12163390|FG001|COMPLETED|Open Label||263
10988123|NCT00623636|12163389|FG000|NOT COMPLETED|Open Label||0
10988124|NCT00623636|12163390|FG001|NOT COMPLETED|Open Label||412
10988125|NCT00623714|12163397|FG000|STARTED|Period 1||6
10988126|NCT00623714|12163398|FG001|STARTED|Period 1||7
10988127|NCT00623714|12163397|FG000|COMPLETED|Period 1||6
10988128|NCT00623714|12163398|FG001|COMPLETED|Period 1||7
10988129|NCT00623714|12163397|FG000|NOT COMPLETED|Period 1||0
10988130|NCT00623714|12163398|FG001|NOT COMPLETED|Period 1||0
10988131|NCT00623714|12163397|FG000|STARTED|Period 2||6
10988132|NCT00623714|12163398|FG001|STARTED|Period 2||7
10988133|NCT00623714|12163397|FG000|COMPLETED|Period 2||6
10988134|NCT00623714|12163398|FG001|COMPLETED|Period 2||7
10988135|NCT00623714|12163397|FG000|NOT COMPLETED|Period 2||0
10988136|NCT00623714|12163398|FG001|NOT COMPLETED|Period 2||0
10988137|NCT00623727|12163406|FG000|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
10988138|NCT00623727|12163407|FG001|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
10988139|NCT00623727|12163406|FG000|Participants Received Treatment|Double Blind (DB)||67
10988140|NCT00623727|12163407|FG001|Participants Received Treatment|Double Blind (DB)||72
10988141|NCT00623727|12163406|FG000|COMPLETED|Double Blind (DB)||34
10988142|NCT00623727|12163407|FG001|COMPLETED|Double Blind (DB)||41
10988143|NCT00623727|12163406|FG000|NOT COMPLETED|Double Blind (DB)||36
10988144|NCT00623727|12163407|FG001|NOT COMPLETED|Double Blind (DB)||32
10988145|NCT00623727|12163406|FG000|STARTED|Open Label Follow-up||0
10988146|NCT00623727|12163407|FG001|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
10988147|NCT00623727|12163406|FG000|COMPLETED|Open Label Follow-up||0
10988148|NCT00623727|12163407|FG001|COMPLETED|Open Label Follow-up||18
10988149|NCT00623727|12163406|FG000|NOT COMPLETED|Open Label Follow-up||0
10988150|NCT00623727|12163407|FG001|NOT COMPLETED|Open Label Follow-up||8
10988151|NCT00623727|12163406|FG000|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
10988152|NCT00623727|12163407|FG001|STARTED|Open Label Extension Period||0
10988153|NCT00623727|12163406|FG000|COMPLETED|Open Label Extension Period||20
10988154|NCT00623727|12163407|FG001|COMPLETED|Open Label Extension Period||0
10988155|NCT00623727|12163406|FG000|NOT COMPLETED|Open Label Extension Period||0
10988156|NCT00623727|12163407|FG001|NOT COMPLETED|Open Label Extension Period||0
10988157|NCT00623766|12163417|FG000|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
10988158|NCT00623766|12163418|FG001|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
10988159|NCT00623766|12163417|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
10988160|NCT00623766|12163418|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
10988161|NCT00623766|12163417|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
10988162|NCT00623766|12163418|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
10988163|NCT00623766|12163417|FG000|STARTED|Maintenance Phase (Week 24 to Year 2)||11
10988164|NCT00623766|12163418|FG001|STARTED|Maintenance Phase (Week 24 to Year 2)||2
10988165|NCT00623766|12163417|FG000|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
10988166|NCT00623766|12163418|FG001|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
10988167|NCT00623766|12163417|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
10988168|NCT00623766|12163418|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
10988169|NCT00623779|12163431|FG000|STARTED|Overall Study||41
10988170|NCT00623779|12163432|FG001|STARTED|Overall Study||42
10988171|NCT00623779|12163433|FG002|STARTED|Overall Study||45
10988172|NCT00623779|12163431|FG000|COMPLETED|Overall Study||38
10988173|NCT00623779|12163432|FG001|COMPLETED|Overall Study||39
10988174|NCT00623779|12163433|FG002|COMPLETED|Overall Study||44
10988175|NCT00623779|12163431|FG000|NOT COMPLETED|Overall Study||3
10988176|NCT00623779|12163432|FG001|NOT COMPLETED|Overall Study||3
10988177|NCT00623779|12163433|FG002|NOT COMPLETED|Overall Study||1
10988178|NCT00623805|12163443|FG000|STARTED|Overall Study||62
10988179|NCT00623805|12163444|FG001|STARTED|Overall Study||61
10988180|NCT00623805|12163443|FG000|COMPLETED|Overall Study||42
10988181|NCT00623805|12163444|FG001|COMPLETED|Overall Study||39
10988182|NCT00623805|12163443|FG000|NOT COMPLETED|Overall Study||20
10988183|NCT00623805|12163444|FG001|NOT COMPLETED|Overall Study||22
10988184|NCT00623831|12163452|FG000|STARTED|Overall Study||13
10988185|NCT00623831|12163453|FG001|STARTED|Overall Study||4
10988186|NCT00623831|12163452|FG000|COMPLETED|Overall Study||12
10988187|NCT00623831|12163453|FG001|COMPLETED|Overall Study||3
10988188|NCT00623831|12163452|FG000|NOT COMPLETED|Overall Study||1
10988189|NCT00623831|12163453|FG001|NOT COMPLETED|Overall Study||1
10988190|NCT00623935|12163462|FG000|STARTED|Overall Study||56
10988191|NCT00623935|12163462|FG000|COMPLETED|Overall Study||54
10988192|NCT00623935|12163462|FG000|NOT COMPLETED|Overall Study||2
10988193|NCT00624013|12163468|FG000|STARTED|Overall Study||44
10988194|NCT00624013|12163469|FG001|STARTED|Overall Study||45
10988195|NCT00624013|12163468|FG000|COMPLETED|Overall Study||36
10988196|NCT00624013|12163469|FG001|COMPLETED|Overall Study||39
10988197|NCT00624013|12163468|FG000|NOT COMPLETED|Overall Study||8
10988198|NCT00624013|12163469|FG001|NOT COMPLETED|Overall Study||6
10988199|NCT00624052|12163481|FG000|STARTED|Overall Study||219
10988200|NCT00624052|12163482|FG001|STARTED|Overall Study||436
10988201|NCT00624052|12163483|FG002|STARTED|Overall Study||91
10988202|NCT00624052|12163484|FG003|STARTED|Overall Study||92
10988203|NCT00624052|12163481|FG000|COMPLETED|Overall Study||204
10988204|NCT00624052|12163482|FG001|COMPLETED|Overall Study||422
10988205|NCT00624052|12163483|FG002|COMPLETED|Overall Study||88
10988206|NCT00624052|12163484|FG003|COMPLETED|Overall Study||88
10988207|NCT00624052|12163481|FG000|NOT COMPLETED|Overall Study||15
10988208|NCT00624052|12163482|FG001|NOT COMPLETED|Overall Study||14
10988209|NCT00624052|12163483|FG002|NOT COMPLETED|Overall Study||3
10988210|NCT00624052|12163484|FG003|NOT COMPLETED|Overall Study||4
10988211|NCT00624065|12163500|FG000|STARTED|Overall Study||216
10988212|NCT00624065|12163501|FG001|STARTED|Overall Study||216
10988213|NCT00624065|12163500|FG000|COMPLETED|Overall Study||197
10988214|NCT00624065|12163501|FG001|COMPLETED|Overall Study||192
10988215|NCT00624065|12163500|FG000|NOT COMPLETED|Overall Study||19
10988216|NCT00624065|12163501|FG001|NOT COMPLETED|Overall Study||24
10988217|NCT00624195|12163509|FG000|STARTED|Overall Study||29
10988218|NCT00624195|12163510|FG001|STARTED|Overall Study||30
10988219|NCT00624195|12163509|FG000|COMPLETED|Overall Study||26
10988220|NCT00624195|12163510|FG001|COMPLETED|Overall Study||23
10988221|NCT00624195|12163509|FG000|NOT COMPLETED|Overall Study||3
10988222|NCT00624195|12163510|FG001|NOT COMPLETED|Overall Study||7
10988223|NCT00624221|12163518|FG000|STARTED|Overall Study||20
10988224|NCT00624221|12163519|FG001|STARTED|Overall Study||20
10988225|NCT00624221|12163518|FG000|COMPLETED|Overall Study||20
10988226|NCT00624221|12163519|FG001|COMPLETED|Overall Study||20
10988227|NCT00624221|12163518|FG000|NOT COMPLETED|Overall Study||0
10988228|NCT00624221|12163519|FG001|NOT COMPLETED|Overall Study||0
10988229|NCT00624286|12163527|FG000|STARTED|Overall Study||211
10988230|NCT00624286|12163528|FG001|STARTED|Overall Study||205
10988231|NCT00624286|12163527|FG000|COMPLETED|Overall Study||186
10988232|NCT00624286|12163528|FG001|COMPLETED|Overall Study||178
10988233|NCT00624286|12163527|FG000|NOT COMPLETED|Overall Study||25
10988234|NCT00624286|12163528|FG001|NOT COMPLETED|Overall Study||27
10988235|NCT00624338|12163537|FG000|STARTED|Overall Study||159
10988236|NCT00624338|12163538|FG001|STARTED|Overall Study||145
10988237|NCT00624338|12163539|FG002|STARTED|Overall Study||157
10988238|NCT00624338|12163537|FG000|Treated|Overall Study||157
10988239|NCT00624338|12163538|FG001|Treated|Overall Study||144
10988240|NCT00624338|12163539|FG002|Treated|Overall Study||154
10988241|NCT00624338|12163537|FG000|COMPLETED|Overall Study||112
10988242|NCT00624338|12163538|FG001|COMPLETED|Overall Study||62
10988243|NCT00624338|12163539|FG002|COMPLETED|Overall Study||111
10988244|NCT00624338|12163537|FG000|NOT COMPLETED|Overall Study||47
10988245|NCT00624338|12163538|FG001|NOT COMPLETED|Overall Study||83
10988246|NCT00624338|12163539|FG002|NOT COMPLETED|Overall Study||46
10988247|NCT00624377|12163547|FG000|STARTED|Overall Study||2031
10988248|NCT00624377|12163547|FG000|COMPLETED|Overall Study||1387
10988249|NCT00624377|12163547|FG000|NOT COMPLETED|Overall Study||644
10988250|NCT00624416|12163551|FG000|STARTED|Overall Study||10
10988251|NCT00624416|12163551|FG000|COMPLETED|Overall Study||10
10988252|NCT00624416|12163551|FG000|NOT COMPLETED|Overall Study||0
10988253|NCT00624442|12163560|FG000|STARTED|Overall Study||8
10988254|NCT00624442|12163561|FG001|STARTED|Overall Study||9
10988255|NCT00624442|12163562|FG002|STARTED|Overall Study||10
10988256|NCT00624442|12163563|FG003|STARTED|Overall Study||8
10988257|NCT00624442|12163564|FG004|STARTED|Overall Study||10
10988258|NCT00624442|12163560|FG000|COMPLETED|Overall Study||8
10988259|NCT00624442|12163561|FG001|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
10988260|NCT00624442|12163562|FG002|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
10988261|NCT00624442|12163563|FG003|COMPLETED|Overall Study||8
10988262|NCT00624442|12163564|FG004|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
10988263|NCT00624442|12163560|FG000|NOT COMPLETED|Overall Study||0
10988264|NCT00624442|12163561|FG001|NOT COMPLETED|Overall Study||1
10988265|NCT00624442|12163562|FG002|NOT COMPLETED|Overall Study||2
10988266|NCT00624442|12163563|FG003|NOT COMPLETED|Overall Study||0
10988267|NCT00624442|12163564|FG004|NOT COMPLETED|Overall Study||2
10988268|NCT00624468|12163599|FG000|STARTED|Double-blind Period||17
10988269|NCT00624468|12163600|FG001|STARTED|Double-blind Period||17
10988270|NCT00624468|12163601|FG002|STARTED|Double-blind Period||0
10988271|NCT00624468|12163602|FG003|STARTED|Double-blind Period||0
10988272|NCT00624468|12163599|FG000|COMPLETED|Double-blind Period||3
10988273|NCT00624468|12163600|FG001|COMPLETED|Double-blind Period||4
10988274|NCT00624468|12163601|FG002|COMPLETED|Double-blind Period||0
10988275|NCT00624468|12163602|FG003|COMPLETED|Double-blind Period||0
10988276|NCT00624468|12163599|FG000|NOT COMPLETED|Double-blind Period||14
10988277|NCT00624468|12163600|FG001|NOT COMPLETED|Double-blind Period||13
10988278|NCT00624468|12163601|FG002|NOT COMPLETED|Double-blind Period||0
10988279|NCT00624468|12163602|FG003|NOT COMPLETED|Double-blind Period||0
10988280|NCT00624468|12163599|FG000|STARTED|Safety Follow-up (SFU) Period||0
10988281|NCT00624468|12163600|FG001|STARTED|Safety Follow-up (SFU) Period||0
10988282|NCT00624468|12163601|FG002|STARTED|Safety Follow-up (SFU) Period||13
10988283|NCT00624468|12163602|FG003|STARTED|Safety Follow-up (SFU) Period||14
10988284|NCT00624468|12163599|FG000|COMPLETED|Safety Follow-up (SFU) Period||0
10988285|NCT00624468|12163600|FG001|COMPLETED|Safety Follow-up (SFU) Period||0
10988286|NCT00624468|12163601|FG002|COMPLETED|Safety Follow-up (SFU) Period||11
10988287|NCT00624468|12163602|FG003|COMPLETED|Safety Follow-up (SFU) Period||11
10988288|NCT00624468|12163599|FG000|NOT COMPLETED|Safety Follow-up (SFU) Period||0
10988289|NCT00624468|12163600|FG001|NOT COMPLETED|Safety Follow-up (SFU) Period||0
10988290|NCT00624468|12163601|FG002|NOT COMPLETED|Safety Follow-up (SFU) Period||2
10988291|NCT00624468|12163602|FG003|NOT COMPLETED|Safety Follow-up (SFU) Period||3
10988292|NCT00624520|12163612|FG000|STARTED|Overall Study||56
10988293|NCT00624520|12163613|FG001|STARTED|Overall Study||47
10988294|NCT00624520|12163612|FG000|COMPLETED|Overall Study||44
10988295|NCT00624520|12163613|FG001|COMPLETED|Overall Study||39
10988296|NCT00624520|12163612|FG000|NOT COMPLETED|Overall Study||12
10988297|NCT00624520|12163613|FG001|NOT COMPLETED|Overall Study||8
10988298|NCT00624559|12163623|FG000|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
10988299|NCT00624559|12163624|FG001|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
10988300|NCT00624559|12163625|FG002|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
10988301|NCT00624559|12163626|FG003|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
10988302|NCT00624559|12163623|FG000|COMPLETED|Overall Study||3
10988303|NCT00624559|12163624|FG001|COMPLETED|Overall Study||3
10988304|NCT00624559|12163625|FG002|COMPLETED|Overall Study||3
10988305|NCT00624559|12163626|FG003|COMPLETED|Overall Study||3
10988306|NCT00624559|12163623|FG000|NOT COMPLETED|Overall Study||0
10988307|NCT00624559|12163624|FG001|NOT COMPLETED|Overall Study||0
10988308|NCT00624559|12163625|FG002|NOT COMPLETED|Overall Study||0
10988309|NCT00624559|12163626|FG003|NOT COMPLETED|Overall Study||0
10988310|NCT00624585|12163636|FG000|STARTED|Overall Study||18
10988311|NCT00624585|12163636|FG000|COMPLETED|Overall Study||6
10988312|NCT00624585|12163636|FG000|NOT COMPLETED|Overall Study||12
10988313|NCT00624780|12163646|FG000|STARTED|Treatment Optimization (Up to Week 12)||154
10988314|NCT00624780|12163647|FG001|STARTED|Treatment Optimization (Up to Week 12)||52
10988315|NCT00624780|12163648|FG002|STARTED|Treatment Optimization (Up to Week 12)||154
10988316|NCT00624780|12163649|FG003|STARTED|Treatment Optimization (Up to Week 12)||52
10988317|NCT00624780|12163650|FG004|STARTED|Treatment Optimization (Up to Week 12)||153
10988318|NCT00624780|12163651|FG005|STARTED|Treatment Optimization (Up to Week 12)||50
10988319|NCT00624780|12163646|FG000|COMPLETED|Treatment Optimization (Up to Week 12)||121
10988320|NCT00624780|12163647|FG001|COMPLETED|Treatment Optimization (Up to Week 12)||39
10988321|NCT00624780|12163648|FG002|COMPLETED|Treatment Optimization (Up to Week 12)||112
10988322|NCT00624780|12163649|FG003|COMPLETED|Treatment Optimization (Up to Week 12)||38
10988323|NCT00624780|12163650|FG004|COMPLETED|Treatment Optimization (Up to Week 12)||114
10988324|NCT00624780|12163651|FG005|COMPLETED|Treatment Optimization (Up to Week 12)||39
10988325|NCT00624780|12163646|FG000|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
10988326|NCT00624780|12163647|FG001|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
10988327|NCT00624780|12163648|FG002|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
10988328|NCT00624780|12163649|FG003|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
10988329|NCT00624780|12163650|FG004|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
10988330|NCT00624780|12163651|FG005|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
10988331|NCT00624780|12163646|FG000|STARTED|Fixed Dosing (Week 13 to Week 24)||121
10988332|NCT00624780|12163647|FG001|STARTED|Fixed Dosing (Week 13 to Week 24)||39
10988333|NCT00624780|12163648|FG002|STARTED|Fixed Dosing (Week 13 to Week 24)||112
10988334|NCT00624780|12163649|FG003|STARTED|Fixed Dosing (Week 13 to Week 24)||38
10988335|NCT00624780|12163650|FG004|STARTED|Fixed Dosing (Week 13 to Week 24)||114
10988336|NCT00624780|12163651|FG005|STARTED|Fixed Dosing (Week 13 to Week 24)||39
10988337|NCT00624780|12163646|FG000|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
10988338|NCT00624780|12163647|FG001|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
10988339|NCT00624780|12163648|FG002|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
10988340|NCT00624780|12163649|FG003|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
10988341|NCT00624780|12163650|FG004|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
10988342|NCT00624780|12163651|FG005|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
10988343|NCT00624780|12163646|FG000|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
10988344|NCT00624780|12163647|FG001|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
10988345|NCT00624780|12163648|FG002|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
10988346|NCT00624780|12163649|FG003|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
10988347|NCT00624780|12163650|FG004|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
10988348|NCT00624780|12163651|FG005|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
10988349|NCT00624780|12163646|FG000|STARTED|Treatment Discontinuation (Week 25)||106
10988350|NCT00624780|12163647|FG001|STARTED|Treatment Discontinuation (Week 25)||28
10988351|NCT00624780|12163648|FG002|STARTED|Treatment Discontinuation (Week 25)||94
10988352|NCT00624780|12163649|FG003|STARTED|Treatment Discontinuation (Week 25)||27
10988353|NCT00624780|12163650|FG004|STARTED|Treatment Discontinuation (Week 25)||95
10988354|NCT00624780|12163651|FG005|STARTED|Treatment Discontinuation (Week 25)||30
10988355|NCT00624780|12163646|FG000|COMPLETED|Treatment Discontinuation (Week 25)||104
10988356|NCT00624780|12163647|FG001|COMPLETED|Treatment Discontinuation (Week 25)||28
10988357|NCT00624780|12163648|FG002|COMPLETED|Treatment Discontinuation (Week 25)||91
10988358|NCT00624780|12163649|FG003|COMPLETED|Treatment Discontinuation (Week 25)||26
10988359|NCT00624780|12163650|FG004|COMPLETED|Treatment Discontinuation (Week 25)||95
10988360|NCT00624780|12163651|FG005|COMPLETED|Treatment Discontinuation (Week 25)||29
10988361|NCT00624780|12163646|FG000|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
10988362|NCT00624780|12163647|FG001|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
10988363|NCT00624780|12163648|FG002|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
10988364|NCT00624780|12163649|FG003|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
10988365|NCT00624780|12163650|FG004|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
10988366|NCT00624780|12163651|FG005|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
10988367|NCT00624780|12163646|FG000|STARTED|Follow-up (Week 26)||104
10988368|NCT00624780|12163647|FG001|STARTED|Follow-up (Week 26)||28
10988369|NCT00624780|12163648|FG002|STARTED|Follow-up (Week 26)||91
10988370|NCT00624780|12163649|FG003|STARTED|Follow-up (Week 26)||26
10988371|NCT00624780|12163650|FG004|STARTED|Follow-up (Week 26)||95
10988372|NCT00624780|12163651|FG005|STARTED|Follow-up (Week 26)||29
10988373|NCT00624780|12163646|FG000|COMPLETED|Follow-up (Week 26)||102
10988374|NCT00624780|12163647|FG001|COMPLETED|Follow-up (Week 26)||27
10988375|NCT00624780|12163648|FG002|COMPLETED|Follow-up (Week 26)||89
10988376|NCT00624780|12163649|FG003|COMPLETED|Follow-up (Week 26)||26
10988377|NCT00624780|12163650|FG004|COMPLETED|Follow-up (Week 26)||93
10988378|NCT00624780|12163651|FG005|COMPLETED|Follow-up (Week 26)||29
10988379|NCT00624780|12163646|FG000|NOT COMPLETED|Follow-up (Week 26)||2
10988380|NCT00624780|12163647|FG001|NOT COMPLETED|Follow-up (Week 26)||1
10988381|NCT00624780|12163648|FG002|NOT COMPLETED|Follow-up (Week 26)||2
10988382|NCT00624780|12163649|FG003|NOT COMPLETED|Follow-up (Week 26)||0
10988383|NCT00624780|12163650|FG004|NOT COMPLETED|Follow-up (Week 26)||2
10988384|NCT00624780|12163651|FG005|NOT COMPLETED|Follow-up (Week 26)||0
10988385|NCT00624806|12163670|FG000|STARTED|Overall Study||10
10988386|NCT00624806|12163671|FG001|STARTED|Overall Study||8
10988387|NCT00624806|12163670|FG000|COMPLETED|Overall Study||10
10988388|NCT00624806|12163671|FG001|COMPLETED|Overall Study||8
10988389|NCT00624806|12163670|FG000|NOT COMPLETED|Overall Study||0
10988390|NCT00624806|12163671|FG001|NOT COMPLETED|Overall Study||0
10988391|NCT00624819|12163681|FG000|STARTED|Follow-up Period: Year 1||391
10988392|NCT00624819|12163682|FG001|STARTED|Follow-up Period: Year 1||31
10988393|NCT00624819|12163683|FG002|STARTED|Follow-up Period: Year 1||102
10988394|NCT00624819|12163684|FG003|STARTED|Follow-up Period: Year 1||0
10988395|NCT00624819|12163681|FG000|COMPLETED|Follow-up Period: Year 1||391
10988396|NCT00624819|12163682|FG001|COMPLETED|Follow-up Period: Year 1||31
10988397|NCT00624819|12163683|FG002|COMPLETED|Follow-up Period: Year 1||102
10988398|NCT00624819|12163684|FG003|COMPLETED|Follow-up Period: Year 1||0
10988399|NCT00624819|12163681|FG000|NOT COMPLETED|Follow-up Period: Year 1||0
10988400|NCT00624819|12163682|FG001|NOT COMPLETED|Follow-up Period: Year 1||0
10988401|NCT00624819|12163683|FG002|NOT COMPLETED|Follow-up Period: Year 1||0
10988402|NCT00624819|12163684|FG003|NOT COMPLETED|Follow-up Period: Year 1||0
10988403|NCT00624819|12163681|FG000|STARTED|Follow-up Period: Year 2||370
10988404|NCT00624819|12163682|FG001|STARTED|Follow-up Period: Year 2||31
10988405|NCT00624819|12163683|FG002|STARTED|Follow-up Period: Year 2||96
10988406|NCT00624819|12163684|FG003|STARTED|Follow-up Period: Year 2||0
10988407|NCT00624819|12163681|FG000|COMPLETED|Follow-up Period: Year 2||370
10988408|NCT00624819|12163682|FG001|COMPLETED|Follow-up Period: Year 2||31
10988409|NCT00624819|12163683|FG002|COMPLETED|Follow-up Period: Year 2||96
10988410|NCT00624819|12163684|FG003|COMPLETED|Follow-up Period: Year 2||0
10988411|NCT00624819|12163681|FG000|NOT COMPLETED|Follow-up Period: Year 2||0
10988412|NCT00624819|12163682|FG001|NOT COMPLETED|Follow-up Period: Year 2||0
10988413|NCT00624819|12163683|FG002|NOT COMPLETED|Follow-up Period: Year 2||0
10988414|NCT00624819|12163684|FG003|NOT COMPLETED|Follow-up Period: Year 2||0
10988415|NCT00624819|12163681|FG000|STARTED|Follow-up Period: Year 4||264
10988416|NCT00624819|12163682|FG001|STARTED|Follow-up Period: Year 4||20
10988417|NCT00624819|12163683|FG002|STARTED|Follow-up Period: Year 4||65
10988418|NCT00624819|12163684|FG003|STARTED|Follow-up Period: Year 4||100
10988419|NCT00624819|12163681|FG000|COMPLETED|Follow-up Period: Year 4||263
10988420|NCT00624819|12163682|FG001|COMPLETED|Follow-up Period: Year 4||19
10988421|NCT00624819|12163683|FG002|COMPLETED|Follow-up Period: Year 4||64
10988422|NCT00624819|12163684|FG003|COMPLETED|Follow-up Period: Year 4||100
10988423|NCT00624819|12163681|FG000|NOT COMPLETED|Follow-up Period: Year 4||1
10988424|NCT00624819|12163682|FG001|NOT COMPLETED|Follow-up Period: Year 4||1
10988425|NCT00624819|12163683|FG002|NOT COMPLETED|Follow-up Period: Year 4||1
10988426|NCT00624819|12163684|FG003|NOT COMPLETED|Follow-up Period: Year 4||0
10988427|NCT00624832|12163698|FG000|STARTED|Overall Study||18
10988428|NCT00624832|12163699|FG001|STARTED|Overall Study||16
10988429|NCT00624832|12163700|FG002|STARTED|Overall Study||10
10988430|NCT00624832|12163701|FG003|STARTED|Overall Study||16
10988431|NCT00624832|12163698|FG000|COMPLETED|Overall Study||16
10988432|NCT00624832|12163699|FG001|COMPLETED|Overall Study||15
10988433|NCT00624832|12163700|FG002|COMPLETED|Overall Study||10
10988434|NCT00624832|12163701|FG003|COMPLETED|Overall Study||15
10988435|NCT00624832|12163698|FG000|NOT COMPLETED|Overall Study||2
10988436|NCT00624832|12163699|FG001|NOT COMPLETED|Overall Study||1
10988437|NCT00624832|12163700|FG002|NOT COMPLETED|Overall Study||0
10988438|NCT00624832|12163701|FG003|NOT COMPLETED|Overall Study||1
10988439|NCT00624910|12163713|FG000|STARTED|Overall Study||28
10988440|NCT00624910|12163714|FG001|STARTED|Overall Study||15
10988441|NCT00624910|12163715|FG002|STARTED|Overall Study||11
10988442|NCT00624910|12163713|FG000|COMPLETED|Overall Study||28
10988443|NCT00624910|12163714|FG001|COMPLETED|Overall Study||15
10988444|NCT00624910|12163715|FG002|COMPLETED|Overall Study||11
10988445|NCT00624910|12163713|FG000|NOT COMPLETED|Overall Study||0
10988446|NCT00624910|12163714|FG001|NOT COMPLETED|Overall Study||0
10988447|NCT00624910|12163715|FG002|NOT COMPLETED|Overall Study||0
10988448|NCT00624923|12163725|FG000|STARTED|Overall Study||127
10988449|NCT00624923|12163726|FG001|STARTED|Overall Study||124
10988450|NCT00624923|12163725|FG000|COMPLETED|Overall Study||89
10988451|NCT00624923|12163726|FG001|COMPLETED|Overall Study||101
10988452|NCT00624923|12163725|FG000|NOT COMPLETED|Overall Study||38
10988453|NCT00624923|12163726|FG001|NOT COMPLETED|Overall Study||23
10988454|NCT00625131|12163736|FG000|STARTED|Overall Study||38
10988455|NCT00625131|12163737|FG001|STARTED|Overall Study||44
10988456|NCT00625131|12163738|FG002|STARTED|Overall Study|These participants were not included in any analyses.|5
10988457|NCT00625131|12163736|FG000|COMPLETED|Overall Study||34
10988458|NCT00625131|12163737|FG001|COMPLETED|Overall Study||42
10988459|NCT00625131|12163738|FG002|COMPLETED|Overall Study||0
10988460|NCT00625131|12163736|FG000|NOT COMPLETED|Overall Study||4
10988461|NCT00625131|12163737|FG001|NOT COMPLETED|Overall Study||2
10988462|NCT00625131|12163738|FG002|NOT COMPLETED|Overall Study||5
10988463|NCT00625183|12163744|FG000|STARTED|Overall Study||5
10988464|NCT00625183|12163744|FG000|COMPLETED|Overall Study||4
10988465|NCT00625183|12163744|FG000|NOT COMPLETED|Overall Study||1
10988466|NCT00625365|12163750|FG000|STARTED|Overall Study||1060
10988467|NCT00625365|12163750|FG000|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
10988468|NCT00625365|12163750|FG000|NOT COMPLETED|Overall Study||7
10988469|NCT00625391|12163758|FG000|STARTED|Overall Study||44
10988470|NCT00625391|12163759|FG001|STARTED|Overall Study||47
10988471|NCT00625391|12163760|FG002|STARTED|Overall Study||42
10988472|NCT00625391|12163761|FG003|STARTED|Overall Study||38
10988473|NCT00625391|12163758|FG000|COMPLETED|Overall Study||37
10988474|NCT00625391|12163759|FG001|COMPLETED|Overall Study||39
10988475|NCT00625391|12163760|FG002|COMPLETED|Overall Study||37
10988476|NCT00625391|12163761|FG003|COMPLETED|Overall Study||37
10988477|NCT00625391|12163758|FG000|NOT COMPLETED|Overall Study||7
10988478|NCT00625391|12163759|FG001|NOT COMPLETED|Overall Study||8
10988479|NCT00625391|12163760|FG002|NOT COMPLETED|Overall Study||5
10988480|NCT00625391|12163761|FG003|NOT COMPLETED|Overall Study||1
10988481|NCT00625404|12163773|FG000|STARTED|Overall Study||1062
10988482|NCT00625404|12163774|FG001|STARTED|Overall Study||1058
10988483|NCT00625404|12163773|FG000|COMPLETED|Overall Study||855
10988484|NCT00625404|12163774|FG001|COMPLETED|Overall Study||885
10988485|NCT00625404|12163773|FG000|NOT COMPLETED|Overall Study||207
10988486|NCT00625404|12163774|FG001|NOT COMPLETED|Overall Study||173
10988487|NCT00625443|12163787|FG000|STARTED|Overall Study||12
10988488|NCT00625443|12163788|FG001|STARTED|Overall Study||26
10988489|NCT00625443|12163789|FG002|STARTED|Overall Study||15
10988490|NCT00625443|12163787|FG000|COMPLETED|Overall Study||10
10988491|NCT00625443|12163788|FG001|COMPLETED|Overall Study||15
10988492|NCT00625443|12163789|FG002|COMPLETED|Overall Study||10
10988493|NCT00625443|12163787|FG000|NOT COMPLETED|Overall Study||2
10988494|NCT00625443|12163788|FG001|NOT COMPLETED|Overall Study||11
10988495|NCT00625443|12163789|FG002|NOT COMPLETED|Overall Study||5
10988496|NCT00625729|12163800|FG000|STARTED|Overall Study||6
10988497|NCT00625729|12163800|FG000|COMPLETED|Overall Study||6
10988498|NCT00625729|12163800|FG000|NOT COMPLETED|Overall Study||0
10988499|NCT00625807|12163807|FG000|STARTED|Overall Study||22
10988500|NCT00625807|12163808|FG001|STARTED|Overall Study||28
10988501|NCT00625807|12163807|FG000|COMPLETED|Overall Study||20
10988502|NCT00625807|12163808|FG001|COMPLETED|Overall Study||20
10988503|NCT00625807|12163807|FG000|NOT COMPLETED|Overall Study||2
10988504|NCT00625807|12163808|FG001|NOT COMPLETED|Overall Study||8
10988505|NCT00625820|12163816|FG000|STARTED|Overall Study||17
10988506|NCT00625820|12163816|FG000|COMPLETED|Overall Study||16
10988507|NCT00625820|12163816|FG000|NOT COMPLETED|Overall Study||1
10988508|NCT00625846|12163825|FG000|STARTED|Overall Study||39
10988509|NCT00625846|12163826|FG001|STARTED|Overall Study||35
10988510|NCT00625846|12163827|FG002|STARTED|Overall Study||16
10988511|NCT00625846|12163828|FG003|STARTED|Overall Study||62
10988512|NCT00625846|12163825|FG000|COMPLETED|Overall Study||37
10988513|NCT00625846|12163826|FG001|COMPLETED|Overall Study||35
10988514|NCT00625846|12163827|FG002|COMPLETED|Overall Study||15
10988515|NCT00625846|12163828|FG003|COMPLETED|Overall Study||60
10988516|NCT00625846|12163825|FG000|NOT COMPLETED|Overall Study||2
10988517|NCT00625846|12163826|FG001|NOT COMPLETED|Overall Study||0
10988518|NCT00625846|12163827|FG002|NOT COMPLETED|Overall Study||1
10988519|NCT00625846|12163828|FG003|NOT COMPLETED|Overall Study||2
10988520|NCT00625872|12163844|FG000|STARTED|Overall Study||12
10988521|NCT00625872|12163845|FG001|STARTED|Overall Study||11
10988522|NCT00625872|12163844|FG000|Treated|Overall Study||12
10988523|NCT00625872|12163845|FG001|Treated|Overall Study||10
10988524|NCT00625872|12163844|FG000|COMPLETED|Overall Study||8
10988525|NCT00625872|12163845|FG001|COMPLETED|Overall Study||5
10988526|NCT00625872|12163844|FG000|NOT COMPLETED|Overall Study||4
10988527|NCT00625872|12163845|FG001|NOT COMPLETED|Overall Study||6
10988528|NCT00625989|12163851|FG000|STARTED|Overall Study||6
10988529|NCT00625989|12163852|FG001|STARTED|Overall Study||6
10988530|NCT00625989|12163851|FG000|COMPLETED|Overall Study||6
10988531|NCT00625989|12163852|FG001|COMPLETED|Overall Study||6
10988532|NCT00625989|12163851|FG000|NOT COMPLETED|Overall Study||0
10988533|NCT00625989|12163852|FG001|NOT COMPLETED|Overall Study||0
10988534|NCT00626028|12163859|FG000|STARTED|Overall Study||68
10988535|NCT00626028|12163860|FG001|STARTED|Overall Study||68
10988536|NCT00626028|12163859|FG000|COMPLETED|Overall Study||62
10988537|NCT00626028|12163860|FG001|COMPLETED|Overall Study||59
10988538|NCT00626028|12163859|FG000|NOT COMPLETED|Overall Study||6
10988539|NCT00626028|12163860|FG001|NOT COMPLETED|Overall Study||9
10988540|NCT00626093|12163866|FG000|STARTED|Overall Study||77
10988541|NCT00626093|12163866|FG000|COMPLETED|Overall Study||54
10988542|NCT00626093|12163866|FG000|NOT COMPLETED|Overall Study||23
10988543|NCT00626197|12163873|FG000|STARTED|Overall Study||127
10988544|NCT00626197|12163874|FG001|STARTED|Overall Study||128
10988545|NCT00626197|12163875|FG002|STARTED|Overall Study||126
10988546|NCT00626197|12163873|FG000|COMPLETED|Overall Study||83
10988547|NCT00626197|12163874|FG001|COMPLETED|Overall Study||74
10988548|NCT00626197|12163875|FG002|COMPLETED|Overall Study||49
10988549|NCT00626197|12163873|FG000|NOT COMPLETED|Overall Study||44
10988550|NCT00626197|12163874|FG001|NOT COMPLETED|Overall Study||54
10988551|NCT00626197|12163875|FG002|NOT COMPLETED|Overall Study||77
10988552|NCT00626210|12163889|FG000|STARTED|Overall Study||2
10988553|NCT00626210|12163889|FG000|COMPLETED|Overall Study||2
10988554|NCT00626210|12163889|FG000|NOT COMPLETED|Overall Study||0
10988555|NCT00626275|12163893|FG000|STARTED|Part A - Treatment Period 1||7
10988556|NCT00626275|12163894|FG001|STARTED|Part A - Treatment Period 1||7
10988557|NCT00626275|12163895|FG002|STARTED|Part A - Treatment Period 1||7
10988558|NCT00626275|12163896|FG003|STARTED|Part A - Treatment Period 1||8
10988559|NCT00626275|12163897|FG004|STARTED|Part A - Treatment Period 1||9
10988560|NCT00626275|12163898|FG005|STARTED|Part A - Treatment Period 1||8
10988561|NCT00626275|12163899|FG006|STARTED|Part A - Treatment Period 1||0
10988562|NCT00626275|12163900|FG007|STARTED|Part A - Treatment Period 1||0
10988563|NCT00626275|12163893|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
10988564|NCT00626275|12163894|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
10988565|NCT00626275|12163895|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
10988644|NCT00626275|12163894|FG001|STARTED|Part A - Washout Period 2||7
10988566|NCT00626275|12163896|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
10988567|NCT00626275|12163897|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
10988568|NCT00626275|12163898|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
10988569|NCT00626275|12163899|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
10988570|NCT00626275|12163900|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
10988571|NCT00626275|12163893|FG000|COMPLETED|Part A - Treatment Period 1||6
10988572|NCT00626275|12163894|FG001|COMPLETED|Part A - Treatment Period 1||7
10988573|NCT00626275|12163895|FG002|COMPLETED|Part A - Treatment Period 1||6
10988574|NCT00626275|12163896|FG003|COMPLETED|Part A - Treatment Period 1||8
10988575|NCT00626275|12163897|FG004|COMPLETED|Part A - Treatment Period 1||9
10988576|NCT00626275|12163898|FG005|COMPLETED|Part A - Treatment Period 1||8
10988577|NCT00626275|12163899|FG006|COMPLETED|Part A - Treatment Period 1||0
10988578|NCT00626275|12163900|FG007|COMPLETED|Part A - Treatment Period 1||0
10988579|NCT00626275|12163893|FG000|NOT COMPLETED|Part A - Treatment Period 1||1
10988580|NCT00626275|12163894|FG001|NOT COMPLETED|Part A - Treatment Period 1||0
10988581|NCT00626275|12163895|FG002|NOT COMPLETED|Part A - Treatment Period 1||1
10988582|NCT00626275|12163896|FG003|NOT COMPLETED|Part A - Treatment Period 1||0
10988583|NCT00626275|12163897|FG004|NOT COMPLETED|Part A - Treatment Period 1||0
10988584|NCT00626275|12163898|FG005|NOT COMPLETED|Part A - Treatment Period 1||0
10988585|NCT00626275|12163899|FG006|NOT COMPLETED|Part A - Treatment Period 1||0
10988586|NCT00626275|12163900|FG007|NOT COMPLETED|Part A - Treatment Period 1||0
10988587|NCT00626275|12163893|FG000|STARTED|Part A - Washout Period 1||6
10988588|NCT00626275|12163894|FG001|STARTED|Part A - Washout Period 1||7
10988589|NCT00626275|12163895|FG002|STARTED|Part A - Washout Period 1||6
10988590|NCT00626275|12163896|FG003|STARTED|Part A - Washout Period 1||8
10988591|NCT00626275|12163897|FG004|STARTED|Part A - Washout Period 1||9
10988592|NCT00626275|12163898|FG005|STARTED|Part A - Washout Period 1||8
10988593|NCT00626275|12163899|FG006|STARTED|Part A - Washout Period 1||0
10988594|NCT00626275|12163900|FG007|STARTED|Part A - Washout Period 1||0
10988595|NCT00626275|12163893|FG000|COMPLETED|Part A - Washout Period 1||6
10988596|NCT00626275|12163894|FG001|COMPLETED|Part A - Washout Period 1||7
10988597|NCT00626275|12163895|FG002|COMPLETED|Part A - Washout Period 1||6
10988598|NCT00626275|12163896|FG003|COMPLETED|Part A - Washout Period 1||8
10988599|NCT00626275|12163897|FG004|COMPLETED|Part A - Washout Period 1||9
10988600|NCT00626275|12163898|FG005|COMPLETED|Part A - Washout Period 1||8
10988601|NCT00626275|12163899|FG006|COMPLETED|Part A - Washout Period 1||0
10988602|NCT00626275|12163900|FG007|COMPLETED|Part A - Washout Period 1||0
10988603|NCT00626275|12163893|FG000|NOT COMPLETED|Part A - Washout Period 1||0
10988604|NCT00626275|12163894|FG001|NOT COMPLETED|Part A - Washout Period 1||0
10988605|NCT00626275|12163895|FG002|NOT COMPLETED|Part A - Washout Period 1||0
10988606|NCT00626275|12163896|FG003|NOT COMPLETED|Part A - Washout Period 1||0
10988607|NCT00626275|12163897|FG004|NOT COMPLETED|Part A - Washout Period 1||0
10988608|NCT00626275|12163898|FG005|NOT COMPLETED|Part A - Washout Period 1||0
10988609|NCT00626275|12163899|FG006|NOT COMPLETED|Part A - Washout Period 1||0
10988610|NCT00626275|12163900|FG007|NOT COMPLETED|Part A - Washout Period 1||0
10988611|NCT00626275|12163893|FG000|STARTED|Part A - Treatment Period 2||6
10988612|NCT00626275|12163894|FG001|STARTED|Part A - Treatment Period 2||7
10988613|NCT00626275|12163895|FG002|STARTED|Part A - Treatment Period 2||6
10988614|NCT00626275|12163896|FG003|STARTED|Part A - Treatment Period 2||8
10988615|NCT00626275|12163897|FG004|STARTED|Part A - Treatment Period 2||9
10988616|NCT00626275|12163898|FG005|STARTED|Part A - Treatment Period 2||8
10988617|NCT00626275|12163899|FG006|STARTED|Part A - Treatment Period 2||0
10988618|NCT00626275|12163900|FG007|STARTED|Part A - Treatment Period 2||0
10988619|NCT00626275|12163893|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
10988620|NCT00626275|12163894|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
10988621|NCT00626275|12163895|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
10988622|NCT00626275|12163896|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
10988623|NCT00626275|12163897|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
10988624|NCT00626275|12163898|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
10988625|NCT00626275|12163899|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
10988626|NCT00626275|12163900|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
10988627|NCT00626275|12163893|FG000|COMPLETED|Part A - Treatment Period 2||6
10988628|NCT00626275|12163894|FG001|COMPLETED|Part A - Treatment Period 2||7
10988629|NCT00626275|12163895|FG002|COMPLETED|Part A - Treatment Period 2||6
10988630|NCT00626275|12163896|FG003|COMPLETED|Part A - Treatment Period 2||8
10988631|NCT00626275|12163897|FG004|COMPLETED|Part A - Treatment Period 2||9
10988632|NCT00626275|12163898|FG005|COMPLETED|Part A - Treatment Period 2||8
10988633|NCT00626275|12163899|FG006|COMPLETED|Part A - Treatment Period 2||0
10988634|NCT00626275|12163900|FG007|COMPLETED|Part A - Treatment Period 2||0
10988635|NCT00626275|12163893|FG000|NOT COMPLETED|Part A - Treatment Period 2||0
10988636|NCT00626275|12163894|FG001|NOT COMPLETED|Part A - Treatment Period 2||0
10988637|NCT00626275|12163895|FG002|NOT COMPLETED|Part A - Treatment Period 2||0
10988638|NCT00626275|12163896|FG003|NOT COMPLETED|Part A - Treatment Period 2||0
10988639|NCT00626275|12163897|FG004|NOT COMPLETED|Part A - Treatment Period 2||0
10988640|NCT00626275|12163898|FG005|NOT COMPLETED|Part A - Treatment Period 2||0
10988641|NCT00626275|12163899|FG006|NOT COMPLETED|Part A - Treatment Period 2||0
10988642|NCT00626275|12163900|FG007|NOT COMPLETED|Part A - Treatment Period 2||0
10988643|NCT00626275|12163893|FG000|STARTED|Part A - Washout Period 2||6
10988645|NCT00626275|12163895|FG002|STARTED|Part A - Washout Period 2||6
10988646|NCT00626275|12163896|FG003|STARTED|Part A - Washout Period 2||8
10988647|NCT00626275|12163897|FG004|STARTED|Part A - Washout Period 2||9
10988648|NCT00626275|12163898|FG005|STARTED|Part A - Washout Period 2||8
10988649|NCT00626275|12163899|FG006|STARTED|Part A - Washout Period 2||0
10988650|NCT00626275|12163900|FG007|STARTED|Part A - Washout Period 2||0
10988651|NCT00626275|12163893|FG000|COMPLETED|Part A - Washout Period 2||6
10988652|NCT00626275|12163894|FG001|COMPLETED|Part A - Washout Period 2||7
10988653|NCT00626275|12163895|FG002|COMPLETED|Part A - Washout Period 2||6
10988654|NCT00626275|12163896|FG003|COMPLETED|Part A - Washout Period 2||8
10988655|NCT00626275|12163897|FG004|COMPLETED|Part A - Washout Period 2||9
10988656|NCT00626275|12163898|FG005|COMPLETED|Part A - Washout Period 2||8
10988657|NCT00626275|12163899|FG006|COMPLETED|Part A - Washout Period 2||0
10988658|NCT00626275|12163900|FG007|COMPLETED|Part A - Washout Period 2||0
10988659|NCT00626275|12163893|FG000|NOT COMPLETED|Part A - Washout Period 2||0
10988660|NCT00626275|12163894|FG001|NOT COMPLETED|Part A - Washout Period 2||0
10988661|NCT00626275|12163895|FG002|NOT COMPLETED|Part A - Washout Period 2||0
10988662|NCT00626275|12163896|FG003|NOT COMPLETED|Part A - Washout Period 2||0
10988663|NCT00626275|12163897|FG004|NOT COMPLETED|Part A - Washout Period 2||0
10988664|NCT00626275|12163898|FG005|NOT COMPLETED|Part A - Washout Period 2||0
10988665|NCT00626275|12163899|FG006|NOT COMPLETED|Part A - Washout Period 2||0
10988666|NCT00626275|12163900|FG007|NOT COMPLETED|Part A - Washout Period 2||0
10988667|NCT00626275|12163893|FG000|STARTED|Part A - Treatment Period 3||6
10988668|NCT00626275|12163894|FG001|STARTED|Part A - Treatment Period 3||7
10988669|NCT00626275|12163895|FG002|STARTED|Part A - Treatment Period 3||6
10988670|NCT00626275|12163896|FG003|STARTED|Part A - Treatment Period 3||8
10988671|NCT00626275|12163897|FG004|STARTED|Part A - Treatment Period 3||9
10988672|NCT00626275|12163898|FG005|STARTED|Part A - Treatment Period 3||8
10988673|NCT00626275|12163899|FG006|STARTED|Part A - Treatment Period 3||0
10988674|NCT00626275|12163900|FG007|STARTED|Part A - Treatment Period 3||0
10988675|NCT00626275|12163893|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
10988676|NCT00626275|12163894|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
10988677|NCT00626275|12163895|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
10988678|NCT00626275|12163896|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
10988679|NCT00626275|12163897|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
10988680|NCT00626275|12163898|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
10988681|NCT00626275|12163899|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
10988682|NCT00626275|12163900|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
10988683|NCT00626275|12163893|FG000|COMPLETED|Part A - Treatment Period 3||6
10988684|NCT00626275|12163894|FG001|COMPLETED|Part A - Treatment Period 3||7
10988685|NCT00626275|12163895|FG002|COMPLETED|Part A - Treatment Period 3||6
10988686|NCT00626275|12163896|FG003|COMPLETED|Part A - Treatment Period 3||8
10988687|NCT00626275|12163897|FG004|COMPLETED|Part A - Treatment Period 3||9
10988688|NCT00626275|12163898|FG005|COMPLETED|Part A - Treatment Period 3||8
10988689|NCT00626275|12163899|FG006|COMPLETED|Part A - Treatment Period 3||0
10988690|NCT00626275|12163900|FG007|COMPLETED|Part A - Treatment Period 3||0
10988691|NCT00626275|12163893|FG000|NOT COMPLETED|Part A - Treatment Period 3||0
10988692|NCT00626275|12163894|FG001|NOT COMPLETED|Part A - Treatment Period 3||0
10988693|NCT00626275|12163895|FG002|NOT COMPLETED|Part A - Treatment Period 3||0
10988694|NCT00626275|12163896|FG003|NOT COMPLETED|Part A - Treatment Period 3||0
10988695|NCT00626275|12163897|FG004|NOT COMPLETED|Part A - Treatment Period 3||0
10988696|NCT00626275|12163898|FG005|NOT COMPLETED|Part A - Treatment Period 3||0
10988697|NCT00626275|12163899|FG006|NOT COMPLETED|Part A - Treatment Period 3||0
10988698|NCT00626275|12163900|FG007|NOT COMPLETED|Part A - Treatment Period 3||0
10988699|NCT00626275|12163893|FG000|STARTED|Re-randomization Period for Part B||0
10988700|NCT00626275|12163894|FG001|STARTED|Re-randomization Period for Part B||0
10988701|NCT00626275|12163895|FG002|STARTED|Re-randomization Period for Part B||0
10988702|NCT00626275|12163896|FG003|STARTED|Re-randomization Period for Part B||0
10988703|NCT00626275|12163897|FG004|STARTED|Re-randomization Period for Part B||0
10988704|NCT00626275|12163898|FG005|STARTED|Re-randomization Period for Part B||0
10988705|NCT00626275|12163899|FG006|STARTED|Re-randomization Period for Part B||20
10988706|NCT00626275|12163900|FG007|STARTED|Re-randomization Period for Part B||24
10988707|NCT00626275|12163893|FG000|COMPLETED|Re-randomization Period for Part B||0
10988708|NCT00626275|12163894|FG001|COMPLETED|Re-randomization Period for Part B||0
10988709|NCT00626275|12163895|FG002|COMPLETED|Re-randomization Period for Part B||0
10988710|NCT00626275|12163896|FG003|COMPLETED|Re-randomization Period for Part B||0
10988711|NCT00626275|12163897|FG004|COMPLETED|Re-randomization Period for Part B||0
10988712|NCT00626275|12163898|FG005|COMPLETED|Re-randomization Period for Part B||0
10988713|NCT00626275|12163899|FG006|COMPLETED|Re-randomization Period for Part B||20
10988714|NCT00626275|12163900|FG007|COMPLETED|Re-randomization Period for Part B||24
10988715|NCT00626275|12163893|FG000|NOT COMPLETED|Re-randomization Period for Part B||0
10988716|NCT00626275|12163894|FG001|NOT COMPLETED|Re-randomization Period for Part B||0
10988717|NCT00626275|12163895|FG002|NOT COMPLETED|Re-randomization Period for Part B||0
10988718|NCT00626275|12163896|FG003|NOT COMPLETED|Re-randomization Period for Part B||0
10988719|NCT00626275|12163897|FG004|NOT COMPLETED|Re-randomization Period for Part B||0
10988720|NCT00626275|12163898|FG005|NOT COMPLETED|Re-randomization Period for Part B||0
10988721|NCT00626275|12163899|FG006|NOT COMPLETED|Re-randomization Period for Part B||0
10988722|NCT00626275|12163900|FG007|NOT COMPLETED|Re-randomization Period for Part B||0
10988723|NCT00626275|12163893|FG000|STARTED|Part B||0
10988724|NCT00626275|12163894|FG001|STARTED|Part B||0
10988725|NCT00626275|12163895|FG002|STARTED|Part B||0
10988726|NCT00626275|12163896|FG003|STARTED|Part B||0
10988727|NCT00626275|12163897|FG004|STARTED|Part B||0
10988728|NCT00626275|12163898|FG005|STARTED|Part B||0
10988729|NCT00626275|12163899|FG006|STARTED|Part B||20
10988730|NCT00626275|12163900|FG007|STARTED|Part B||24
10988731|NCT00626275|12163893|FG000|COMPLETED|Part B||0
10988732|NCT00626275|12163894|FG001|COMPLETED|Part B||0
10988733|NCT00626275|12163895|FG002|COMPLETED|Part B||0
10988734|NCT00626275|12163896|FG003|COMPLETED|Part B||0
10988735|NCT00626275|12163897|FG004|COMPLETED|Part B||0
10988736|NCT00626275|12163898|FG005|COMPLETED|Part B||0
10988737|NCT00626275|12163899|FG006|COMPLETED|Part B||19
10988738|NCT00626275|12163900|FG007|COMPLETED|Part B||23
10988739|NCT00626275|12163893|FG000|NOT COMPLETED|Part B||0
10988740|NCT00626275|12163894|FG001|NOT COMPLETED|Part B||0
10988741|NCT00626275|12163895|FG002|NOT COMPLETED|Part B||0
10988742|NCT00626275|12163896|FG003|NOT COMPLETED|Part B||0
10988743|NCT00626275|12163897|FG004|NOT COMPLETED|Part B||0
10988744|NCT00626275|12163898|FG005|NOT COMPLETED|Part B||0
10988745|NCT00626275|12163899|FG006|NOT COMPLETED|Part B||1
10988746|NCT00626275|12163900|FG007|NOT COMPLETED|Part B||1
10988747|NCT00626327|12163917|FG000|STARTED|Overall Study||504
10988748|NCT00626327|12163918|FG001|STARTED|Overall Study||616
10988749|NCT00626327|12163919|FG002|STARTED|Overall Study||510
10988750|NCT00626327|12163917|FG000|COMPLETED|Overall Study||426
10988751|NCT00626327|12163918|FG001|COMPLETED|Overall Study||557
10988752|NCT00626327|12163919|FG002|COMPLETED|Overall Study||422
10988753|NCT00626327|12163917|FG000|NOT COMPLETED|Overall Study||78
10988754|NCT00626327|12163918|FG001|NOT COMPLETED|Overall Study||59
10988755|NCT00626327|12163919|FG002|NOT COMPLETED|Overall Study||88
10988756|NCT00626340|12163935|FG000|STARTED|Overall Study||18
10988757|NCT00626340|12163935|FG000|COMPLETED|Overall Study||18
10988758|NCT00626340|12163935|FG000|NOT COMPLETED|Overall Study||0
10988759|NCT00626366|12163941|FG000|STARTED|Overall Study||9
10988760|NCT00626366|12163942|FG001|STARTED|Overall Study||9
10988761|NCT00626366|12163941|FG000|COMPLETED|Overall Study||9
10988762|NCT00626366|12163942|FG001|COMPLETED|Overall Study||9
10988763|NCT00626366|12163941|FG000|NOT COMPLETED|Overall Study||0
10988764|NCT00626366|12163942|FG001|NOT COMPLETED|Overall Study||0
10988765|NCT00626392|12163954|FG000|STARTED|Run-in Period||45
10988766|NCT00626392|12163955|FG001|STARTED|Run-in Period||44
10988767|NCT00626392|12163956|FG002|STARTED|Run-in Period||44
10988768|NCT00626392|12163957|FG003|STARTED|Run-in Period||44
10988769|NCT00626392|12163958|FG004|STARTED|Run-in Period||45
10988770|NCT00626392|12163959|FG005|STARTED|Run-in Period||45
10988771|NCT00626392|12163954|FG000|COMPLETED|Run-in Period||44
10988772|NCT00626392|12163955|FG001|COMPLETED|Run-in Period||43
10988773|NCT00626392|12163956|FG002|COMPLETED|Run-in Period||41
10988774|NCT00626392|12163957|FG003|COMPLETED|Run-in Period||43
10988775|NCT00626392|12163958|FG004|COMPLETED|Run-in Period||41
10988776|NCT00626392|12163959|FG005|COMPLETED|Run-in Period||44
10988777|NCT00626392|12163954|FG000|NOT COMPLETED|Run-in Period||1
10988778|NCT00626392|12163955|FG001|NOT COMPLETED|Run-in Period||1
10988779|NCT00626392|12163956|FG002|NOT COMPLETED|Run-in Period||3
10988780|NCT00626392|12163957|FG003|NOT COMPLETED|Run-in Period||1
10988781|NCT00626392|12163958|FG004|NOT COMPLETED|Run-in Period||4
10988782|NCT00626392|12163959|FG005|NOT COMPLETED|Run-in Period||1
10988783|NCT00626392|12163954|FG000|STARTED|Coadministration Period||44
10988784|NCT00626392|12163955|FG001|STARTED|Coadministration Period||43
10988785|NCT00626392|12163956|FG002|STARTED|Coadministration Period||41
10988786|NCT00626392|12163957|FG003|STARTED|Coadministration Period||43
10988787|NCT00626392|12163958|FG004|STARTED|Coadministration Period||41
10988788|NCT00626392|12163959|FG005|STARTED|Coadministration Period||44
10988789|NCT00626392|12163954|FG000|COMPLETED|Coadministration Period||40
10988790|NCT00626392|12163955|FG001|COMPLETED|Coadministration Period||38
10988791|NCT00626392|12163956|FG002|COMPLETED|Coadministration Period||31
10988792|NCT00626392|12163957|FG003|COMPLETED|Coadministration Period||36
10988793|NCT00626392|12163958|FG004|COMPLETED|Coadministration Period||36
10988794|NCT00626392|12163959|FG005|COMPLETED|Coadministration Period||38
10988795|NCT00626392|12163954|FG000|NOT COMPLETED|Coadministration Period||4
10988796|NCT00626392|12163955|FG001|NOT COMPLETED|Coadministration Period||5
10988797|NCT00626392|12163956|FG002|NOT COMPLETED|Coadministration Period||10
10988798|NCT00626392|12163957|FG003|NOT COMPLETED|Coadministration Period||7
10988799|NCT00626392|12163958|FG004|NOT COMPLETED|Coadministration Period||5
10988800|NCT00626392|12163959|FG005|NOT COMPLETED|Coadministration Period||6
10988801|NCT00626405|12163967|FG000|STARTED|Overall Study||43
10988802|NCT00626405|12163968|FG001|STARTED|Overall Study||52
10988803|NCT00626405|12163967|FG000|COMPLETED|Overall Study||42
10988804|NCT00626405|12163968|FG001|COMPLETED|Overall Study||51
10988805|NCT00626405|12163967|FG000|NOT COMPLETED|Overall Study||1
10988806|NCT00626405|12163968|FG001|NOT COMPLETED|Overall Study||1
10988807|NCT00626431|12163976|FG000|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
10988808|NCT00626431|12163977|FG001|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
10988809|NCT00626431|12163976|FG000|COMPLETED|Overall Study||134
10988810|NCT00626431|12163977|FG001|COMPLETED|Overall Study||114
10988811|NCT00626431|12163976|FG000|NOT COMPLETED|Overall Study||17
10988812|NCT00626431|12163977|FG001|NOT COMPLETED|Overall Study||45
10988813|NCT00626522|12163989|FG000|STARTED|Overall Study||121
10988814|NCT00626522|12163990|FG001|STARTED|Overall Study||120
10988815|NCT00626522|12163991|FG002|STARTED|Overall Study||125
10988816|NCT00626522|12163992|FG003|STARTED|Overall Study||76
10988817|NCT00626522|12163993|FG004|STARTED|Overall Study||65
10988818|NCT00626522|12163994|FG005|STARTED|Overall Study||59
10988819|NCT00626522|12163989|FG000|COMPLETED|Overall Study||115
10988820|NCT00626522|12163990|FG001|COMPLETED|Overall Study||113
10988821|NCT00626522|12163991|FG002|COMPLETED|Overall Study||117
10988822|NCT00626522|12163992|FG003|COMPLETED|Overall Study||74
10988823|NCT00626522|12163993|FG004|COMPLETED|Overall Study||58
10988824|NCT00626522|12163994|FG005|COMPLETED|Overall Study||57
10988825|NCT00626522|12163989|FG000|NOT COMPLETED|Overall Study||6
10988826|NCT00626522|12163990|FG001|NOT COMPLETED|Overall Study||7
10988827|NCT00626522|12163991|FG002|NOT COMPLETED|Overall Study||8
10988828|NCT00626522|12163992|FG003|NOT COMPLETED|Overall Study||2
10988829|NCT00626522|12163993|FG004|NOT COMPLETED|Overall Study||7
10988830|NCT00626522|12163994|FG005|NOT COMPLETED|Overall Study||2
10988831|NCT00626548|12164010|FG000|STARTED|Overall Study||705
10988832|NCT00626548|12164011|FG001|STARTED|Overall Study||716
10988833|NCT00626548|12164010|FG000|Patients Received Treatment|Overall Study||703
10988834|NCT00626548|12164011|FG001|Patients Received Treatment|Overall Study||712
10988835|NCT00626548|12164010|FG000|COMPLETED|Overall Study||0
10988836|NCT00626548|12164011|FG001|COMPLETED|Overall Study||0
10988837|NCT00626548|12164010|FG000|NOT COMPLETED|Overall Study||705
10988838|NCT00626548|12164011|FG001|NOT COMPLETED|Overall Study||716
10988839|NCT00626574|12164019|FG000|STARTED|Overall Study||2
10988840|NCT00626574|12164020|FG001|STARTED|Overall Study||1
10988841|NCT00626574|12164019|FG000|COMPLETED|Overall Study||2
10988842|NCT00626574|12164020|FG001|COMPLETED|Overall Study||1
10988843|NCT00626574|12164019|FG000|NOT COMPLETED|Overall Study||0
10988844|NCT00626574|12164020|FG001|NOT COMPLETED|Overall Study||0
10988845|NCT00626626|12164030|FG000|STARTED|Overall Study||5
10988846|NCT00626626|12164031|FG001|STARTED|Overall Study||3
10988847|NCT00626626|12164030|FG000|COMPLETED|Overall Study||5
10988848|NCT00626626|12164031|FG001|COMPLETED|Overall Study||3
10988849|NCT00626626|12164030|FG000|NOT COMPLETED|Overall Study||0
10988850|NCT00626626|12164031|FG001|NOT COMPLETED|Overall Study||0
10988851|NCT00626639|12164040|FG000|STARTED|Overall Study||2
10988852|NCT00626639|12164041|FG001|STARTED|Overall Study||3
10988853|NCT00626639|12164040|FG000|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
10988854|NCT00626639|12164041|FG001|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
10988855|NCT00626639|12164040|FG000|NOT COMPLETED|Overall Study||2
10988856|NCT00626639|12164041|FG001|NOT COMPLETED|Overall Study||2
10988857|NCT00626743|12164051|FG000|STARTED|Treatment Period 1||6
10988858|NCT00626743|12164052|FG001|STARTED|Treatment Period 1||7
10988859|NCT00626743|12164051|FG000|COMPLETED|Treatment Period 1||6
10988860|NCT00626743|12164052|FG001|COMPLETED|Treatment Period 1||6
10988861|NCT00626743|12164051|FG000|NOT COMPLETED|Treatment Period 1||0
10988862|NCT00626743|12164052|FG001|NOT COMPLETED|Treatment Period 1||1
10988863|NCT00626743|12164051|FG000|STARTED|Wash-out Period of 6 Days||6
10988864|NCT00626743|12164052|FG001|STARTED|Wash-out Period of 6 Days||6
10988865|NCT00626743|12164051|FG000|COMPLETED|Wash-out Period of 6 Days||6
10988866|NCT00626743|12164052|FG001|COMPLETED|Wash-out Period of 6 Days||6
10988867|NCT00626743|12164051|FG000|NOT COMPLETED|Wash-out Period of 6 Days||0
10988868|NCT00626743|12164052|FG001|NOT COMPLETED|Wash-out Period of 6 Days||0
10988869|NCT00626743|12164051|FG000|STARTED|Treatment Period 2||6
10988870|NCT00626743|12164052|FG001|STARTED|Treatment Period 2||6
10988871|NCT00626743|12164051|FG000|COMPLETED|Treatment Period 2||6
10988872|NCT00626743|12164052|FG001|COMPLETED|Treatment Period 2||6
10988873|NCT00626743|12164051|FG000|NOT COMPLETED|Treatment Period 2||0
10988874|NCT00626743|12164052|FG001|NOT COMPLETED|Treatment Period 2||0
10988875|NCT00626782|12164060|FG000|STARTED|Overall Study||12
10988876|NCT00626782|12164061|FG001|STARTED|Overall Study||12
10988877|NCT00626782|12164060|FG000|COMPLETED|Overall Study||12
10988878|NCT00626782|12164061|FG001|COMPLETED|Overall Study||12
10988879|NCT00626782|12164060|FG000|NOT COMPLETED|Overall Study||0
10988880|NCT00626782|12164061|FG001|NOT COMPLETED|Overall Study||0
10988881|NCT00626795|12164072|FG000|STARTED|Open-label TD1414 Cream TID Treatment||0
10988882|NCT00626795|12164073|FG001|STARTED|Open-label TD1414 Cream TID Treatment||65
10988883|NCT00626795|12164074|FG002|STARTED|Open-label TD1414 Cream TID Treatment||0
10988884|NCT00626795|12164072|FG000|COMPLETED|Open-label TD1414 Cream TID Treatment||0
10988885|NCT00626795|12164073|FG001|COMPLETED|Open-label TD1414 Cream TID Treatment||64
10988886|NCT00626795|12164074|FG002|COMPLETED|Open-label TD1414 Cream TID Treatment||0
10988887|NCT00626795|12164072|FG000|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
10988888|NCT00626795|12164073|FG001|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
10988889|NCT00626795|12164074|FG002|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
10988890|NCT00626795|12164072|FG000|STARTED|Blinded Treatment||204
10988891|NCT00626795|12164073|FG001|STARTED|Blinded Treatment||205
10988892|NCT00626795|12164074|FG002|STARTED|Blinded Treatment||205
10988893|NCT00626795|12164072|FG000|COMPLETED|Blinded Treatment||194
10988894|NCT00626795|12164073|FG001|COMPLETED|Blinded Treatment||200
10988895|NCT00626795|12164074|FG002|COMPLETED|Blinded Treatment||196
10988896|NCT00626795|12164072|FG000|NOT COMPLETED|Blinded Treatment||10
10988897|NCT00626795|12164073|FG001|NOT COMPLETED|Blinded Treatment||5
10988898|NCT00626795|12164074|FG002|NOT COMPLETED|Blinded Treatment||9
10988899|NCT00626808|12164090|FG000|STARTED|Overall Study||254464
10988900|NCT00626808|12164091|FG001|STARTED|Overall Study||34316
10988901|NCT00626808|12164092|FG002|STARTED|Overall Study||30011
10988902|NCT00626808|12164093|FG003|STARTED|Overall Study||2906
10988903|NCT00626808|12164090|FG000|COMPLETED|Overall Study||254464
10988904|NCT00626808|12164091|FG001|COMPLETED|Overall Study||34316
10988905|NCT00626808|12164092|FG002|COMPLETED|Overall Study||30011
10988906|NCT00626808|12164093|FG003|COMPLETED|Overall Study||2906
10988907|NCT00626808|12164090|FG000|NOT COMPLETED|Overall Study||0
10988908|NCT00626808|12164091|FG001|NOT COMPLETED|Overall Study||0
10988909|NCT00626808|12164092|FG002|NOT COMPLETED|Overall Study||0
10988910|NCT00626808|12164093|FG003|NOT COMPLETED|Overall Study||0
10988911|NCT00626821|12164103|FG000|STARTED|Overall Study||3017
10988912|NCT00626821|12164103|FG000|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
10988913|NCT00626821|12164103|FG000|COMPLETED|Overall Study||2796
10988914|NCT00626821|12164103|FG000|NOT COMPLETED|Overall Study||221
10988915|NCT00626886|12164109|FG000|STARTED|Overall Study||24
10988916|NCT00626886|12164110|FG001|STARTED|Overall Study||29
10988917|NCT00626886|12164109|FG000|COMPLETED|Overall Study||24
10988918|NCT00626886|12164110|FG001|COMPLETED|Overall Study||29
10988919|NCT00626886|12164109|FG000|NOT COMPLETED|Overall Study||0
10988920|NCT00626886|12164110|FG001|NOT COMPLETED|Overall Study||0
10988921|NCT00626912|12164118|FG000|STARTED|Overall Study||222
10988922|NCT00626912|12164119|FG001|STARTED|Overall Study||225
10988923|NCT00626912|12164118|FG000|COMPLETED|Overall Study||220
10988924|NCT00626912|12164119|FG001|COMPLETED|Overall Study||215
10988925|NCT00626912|12164118|FG000|NOT COMPLETED|Overall Study||2
10988926|NCT00626912|12164119|FG001|NOT COMPLETED|Overall Study||10
10988927|NCT00626925|12164127|FG000|STARTED|Overall Study||67
10988928|NCT00626925|12164128|FG001|STARTED|Overall Study||71
10988929|NCT00626925|12164127|FG000|COMPLETED|Overall Study||55
10988930|NCT00626925|12164128|FG001|COMPLETED|Overall Study||62
10988931|NCT00626925|12164127|FG000|NOT COMPLETED|Overall Study||12
10988932|NCT00626925|12164128|FG001|NOT COMPLETED|Overall Study||9
10988933|NCT00627016|12164150|FG000|STARTED|Overall Study||153
10988934|NCT00627016|12164151|FG001|STARTED|Overall Study||152
10988935|NCT00627016|12164150|FG000|COMPLETED|Overall Study||147
10988936|NCT00627016|12164151|FG001|COMPLETED|Overall Study||146
10988937|NCT00627016|12164150|FG000|NOT COMPLETED|Overall Study||6
10988938|NCT00627016|12164151|FG001|NOT COMPLETED|Overall Study||6
10988939|NCT00627042|12164157|FG000|STARTED|Overall Study||42
10988940|NCT00627042|12164157|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
10988941|NCT00627042|12164157|FG000|COMPLETED|Overall Study||40
10988942|NCT00627042|12164157|FG000|NOT COMPLETED|Overall Study||2
10988943|NCT00627094|12164163|FG000|STARTED|Overall Study||60
10988944|NCT00627094|12164164|FG001|STARTED|Overall Study||60
10988945|NCT00627094|12164163|FG000|COMPLETED|Overall Study||48
10988946|NCT00627094|12164164|FG001|COMPLETED|Overall Study||45
10988947|NCT00627094|12164163|FG000|NOT COMPLETED|Overall Study||12
10988948|NCT00627094|12164164|FG001|NOT COMPLETED|Overall Study||15
10988949|NCT00627367|12164174|FG000|STARTED|Overall Study||112
10988950|NCT00627367|12164175|FG001|STARTED|Overall Study||112
10988951|NCT00627367|12164174|FG000|COMPLETED|Overall Study||112
10988952|NCT00627367|12164175|FG001|COMPLETED|Overall Study||112
10988953|NCT00627367|12164174|FG000|NOT COMPLETED|Overall Study||0
10988954|NCT00627367|12164175|FG001|NOT COMPLETED|Overall Study||0
10988955|NCT00627393|12164184|FG000|STARTED|Intention-To-Treat Analysis||58
10988956|NCT00627393|12164185|FG001|STARTED|Intention-To-Treat Analysis||56
10988957|NCT00627393|12164184|FG000|COMPLETED|Intention-To-Treat Analysis||49
10988958|NCT00627393|12164185|FG001|COMPLETED|Intention-To-Treat Analysis||48
10988959|NCT00627393|12164184|FG000|NOT COMPLETED|Intention-To-Treat Analysis||9
10988960|NCT00627393|12164185|FG001|NOT COMPLETED|Intention-To-Treat Analysis||8
10988961|NCT00627393|12164184|FG000|STARTED|Per-Protocol Analysis||49
10988962|NCT00627393|12164185|FG001|STARTED|Per-Protocol Analysis||48
10988963|NCT00627393|12164184|FG000|COMPLETED|Per-Protocol Analysis||39
10988964|NCT00627393|12164185|FG001|COMPLETED|Per-Protocol Analysis||35
10988965|NCT00627393|12164184|FG000|NOT COMPLETED|Per-Protocol Analysis||10
10988966|NCT00627393|12164185|FG001|NOT COMPLETED|Per-Protocol Analysis||13
10988967|NCT00627406|12164197|FG000|STARTED|Overall Study||60
10988968|NCT00627406|12164198|FG001|STARTED|Overall Study||58
10988969|NCT00627406|12164199|FG002|STARTED|Overall Study||125
10988970|NCT00627406|12164200|FG003|STARTED|Overall Study||141
10988971|NCT00627406|12164197|FG000|COMPLETED|Overall Study||60
10988972|NCT00627406|12164198|FG001|COMPLETED|Overall Study||58
10988973|NCT00627406|12164199|FG002|COMPLETED|Overall Study||125
10988974|NCT00627406|12164200|FG003|COMPLETED|Overall Study||141
10988975|NCT00627406|12164197|FG000|NOT COMPLETED|Overall Study||0
10988976|NCT00627406|12164198|FG001|NOT COMPLETED|Overall Study||0
10988977|NCT00627406|12164199|FG002|NOT COMPLETED|Overall Study||0
10988978|NCT00627406|12164200|FG003|NOT COMPLETED|Overall Study||0
10988979|NCT00627445|12164212|FG000|STARTED|Overall Study||219
10988980|NCT00627445|12164213|FG001|STARTED|Overall Study||222
10988981|NCT00627445|12164212|FG000|Exposed to Study Drug|Overall Study||219
10988982|NCT00627445|12164213|FG001|Exposed to Study Drug|Overall Study||222
10988983|NCT00627445|12164212|FG000|COMPLETED|Overall Study||210
10988984|NCT00627445|12164213|FG001|COMPLETED|Overall Study||210
10988985|NCT00627445|12164212|FG000|NOT COMPLETED|Overall Study||9
10988986|NCT00627445|12164213|FG001|NOT COMPLETED|Overall Study||12
10988987|NCT00627458|12164224|FG000|STARTED|Overall Study||127
10988988|NCT00627458|12164225|FG001|STARTED|Overall Study||137
10988989|NCT00627458|12164226|FG002|STARTED|Overall Study||139
10988990|NCT00627458|12164224|FG000|COMPLETED|Overall Study||123
10988991|NCT00627458|12164225|FG001|COMPLETED|Overall Study||130
10988992|NCT00627458|12164226|FG002|COMPLETED|Overall Study||133
10988993|NCT00627458|12164224|FG000|NOT COMPLETED|Overall Study||4
10988994|NCT00627458|12164225|FG001|NOT COMPLETED|Overall Study||7
10988995|NCT00627458|12164226|FG002|NOT COMPLETED|Overall Study||6
10988996|NCT00627497|12164239|FG000|STARTED|Overall Study||14
10988997|NCT00627497|12164240|FG001|STARTED|Overall Study||12
10988998|NCT00627497|12164241|FG002|STARTED|Overall Study||4
10988999|NCT00627497|12164242|FG003|STARTED|Overall Study||2
10989000|NCT00627497|12164239|FG000|COMPLETED|Overall Study||13
10989001|NCT00627497|12164240|FG001|COMPLETED|Overall Study||11
10989002|NCT00627497|12164241|FG002|COMPLETED|Overall Study||4
10989003|NCT00627497|12164242|FG003|COMPLETED|Overall Study||2
10989004|NCT00627497|12164239|FG000|NOT COMPLETED|Overall Study||1
10989005|NCT00627497|12164240|FG001|NOT COMPLETED|Overall Study||1
10989006|NCT00627497|12164241|FG002|NOT COMPLETED|Overall Study||0
10989007|NCT00627497|12164242|FG003|NOT COMPLETED|Overall Study||0
10989008|NCT00627523|12164254|FG000|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
10989009|NCT00627523|12164255|FG001|STARTED|Overall Study||22
10989010|NCT00627523|12164254|FG000|COMPLETED|Overall Study||19
10989011|NCT00627523|12164255|FG001|COMPLETED|Overall Study||20
10989012|NCT00627523|12164254|FG000|NOT COMPLETED|Overall Study||2
10989013|NCT00627523|12164255|FG001|NOT COMPLETED|Overall Study||2
10989014|NCT00627679|12164261|FG000|STARTED|Overall Study||4
10989015|NCT00627679|12164262|FG001|STARTED|Overall Study||4
10989016|NCT00627679|12164263|FG002|STARTED|Overall Study||4
10989017|NCT00627679|12164264|FG003|STARTED|Overall Study||4
10989018|NCT00627679|12164261|FG000|COMPLETED|Overall Study||4
10989019|NCT00627679|12164262|FG001|COMPLETED|Overall Study||4
10989020|NCT00627679|12164263|FG002|COMPLETED|Overall Study||4
10989021|NCT00627679|12164264|FG003|COMPLETED|Overall Study||4
10989022|NCT00627679|12164261|FG000|NOT COMPLETED|Overall Study||0
10989023|NCT00627679|12164262|FG001|NOT COMPLETED|Overall Study||0
10989024|NCT00627679|12164263|FG002|NOT COMPLETED|Overall Study||0
10989025|NCT00627679|12164264|FG003|NOT COMPLETED|Overall Study||0
10989026|NCT00627705|12164276|FG000|STARTED|Overall Study||15
10989027|NCT00627705|12164277|FG001|STARTED|Overall Study||18
10989028|NCT00627705|12164276|FG000|COMPLETED|Overall Study||13
10989029|NCT00627705|12164277|FG001|COMPLETED|Overall Study||12
10989030|NCT00627705|12164276|FG000|NOT COMPLETED|Overall Study||2
10989031|NCT00627705|12164277|FG001|NOT COMPLETED|Overall Study||6
10989032|NCT00627861|12164283|FG000|STARTED|Overall Study||1
10989033|NCT00627861|12164283|FG000|COMPLETED|Overall Study||1
10989034|NCT00627861|12164283|FG000|NOT COMPLETED|Overall Study||0
10989035|NCT00627926|12164292|FG000|STARTED|Overall Study||361
10989036|NCT00627926|12164293|FG001|STARTED|Overall Study||364
10989037|NCT00627926|12164294|FG002|STARTED|Overall Study||363
10989038|NCT00627926|12164292|FG000|COMPLETED|Overall Study||202
10989039|NCT00627926|12164293|FG001|COMPLETED|Overall Study||260
10989040|NCT00627926|12164294|FG002|COMPLETED|Overall Study||268
10989041|NCT00627926|12164292|FG000|NOT COMPLETED|Overall Study||159
10989042|NCT00627926|12164293|FG001|NOT COMPLETED|Overall Study||104
10989043|NCT00627926|12164294|FG002|NOT COMPLETED|Overall Study||95
10989044|NCT00627978|12164304|FG000|STARTED|Overall Study||10
10989045|NCT00627978|12164305|FG001|STARTED|Overall Study||5
10989046|NCT00627978|12164304|FG000|COMPLETED|Overall Study||10
10989047|NCT00627978|12164305|FG001|COMPLETED|Overall Study||5
10989048|NCT00627978|12164304|FG000|NOT COMPLETED|Overall Study||0
10989049|NCT00627978|12164305|FG001|NOT COMPLETED|Overall Study||0
10989050|NCT00628030|12164313|FG000|STARTED|Baseline to Post-Assessment||92
10989051|NCT00628030|12164314|FG001|STARTED|Baseline to Post-Assessment||92
10989052|NCT00628030|12164313|FG000|COMPLETED|Baseline to Post-Assessment||59
10989053|NCT00628030|12164314|FG001|COMPLETED|Baseline to Post-Assessment||63
10989054|NCT00628030|12164313|FG000|NOT COMPLETED|Baseline to Post-Assessment||33
10989055|NCT00628030|12164314|FG001|NOT COMPLETED|Baseline to Post-Assessment||29
10989056|NCT00628030|12164313|FG000|STARTED|Post to 6 Month Follow-up||59
10989057|NCT00628030|12164314|FG001|STARTED|Post to 6 Month Follow-up||63
10989058|NCT00628030|12164313|FG000|COMPLETED|Post to 6 Month Follow-up||27
10989059|NCT00628030|12164314|FG001|COMPLETED|Post to 6 Month Follow-up||33
10989060|NCT00628030|12164313|FG000|NOT COMPLETED|Post to 6 Month Follow-up||32
10989061|NCT00628030|12164314|FG001|NOT COMPLETED|Post to 6 Month Follow-up||30
10989062|NCT00628108|12164322|FG000|STARTED|Overall Study||23
10989063|NCT00628108|12164323|FG001|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
10989064|NCT00628108|12164322|FG000|Safety Population|Overall Study||24
10989065|NCT00628108|12164323|FG001|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
10989066|NCT00628108|12164322|FG000|COMPLETED|Overall Study||22
10989067|NCT00628108|12164323|FG001|COMPLETED|Overall Study||43
10989068|NCT00628108|12164322|FG000|NOT COMPLETED|Overall Study||1
10989069|NCT00628108|12164323|FG001|NOT COMPLETED|Overall Study||3
10989070|NCT00628134|12164329|FG000|STARTED|Overall Study||4
10989071|NCT00628134|12164330|FG001|STARTED|Overall Study||4
10989072|NCT00628134|12164329|FG000|COMPLETED|Overall Study||4
10989073|NCT00628134|12164330|FG001|COMPLETED|Overall Study||4
10989074|NCT00628134|12164329|FG000|NOT COMPLETED|Overall Study||0
10989075|NCT00628134|12164330|FG001|NOT COMPLETED|Overall Study||0
10989076|NCT00628147|12164338|FG000|STARTED|Overall Study||142
10989077|NCT00628147|12164339|FG001|STARTED|Overall Study||142
10989078|NCT00628147|12164338|FG000|COMPLETED|Overall Study||135
10989079|NCT00628147|12164339|FG001|COMPLETED|Overall Study||141
10989080|NCT00628147|12164338|FG000|NOT COMPLETED|Overall Study||7
10989081|NCT00628147|12164339|FG001|NOT COMPLETED|Overall Study||1
10989082|NCT00628212|12164349|FG000|STARTED|Overall Study||80
10989083|NCT00628212|12164350|FG001|STARTED|Overall Study||84
10989084|NCT00628212|12164351|FG002|STARTED|Overall Study||79
10989085|NCT00628212|12164352|FG003|STARTED|Overall Study||81
10989086|NCT00628212|12164349|FG000|COMPLETED|Overall Study||77
10989087|NCT00628212|12164350|FG001|COMPLETED|Overall Study||83
10989088|NCT00628212|12164351|FG002|COMPLETED|Overall Study||76
10989089|NCT00628212|12164352|FG003|COMPLETED|Overall Study||76
10989090|NCT00628212|12164349|FG000|NOT COMPLETED|Overall Study||3
10989091|NCT00628212|12164350|FG001|NOT COMPLETED|Overall Study||1
10989092|NCT00628212|12164351|FG002|NOT COMPLETED|Overall Study||3
10989093|NCT00628212|12164352|FG003|NOT COMPLETED|Overall Study||5
10989094|NCT00628251|12164365|FG000|STARTED|Randomised Part|Patients randomised|32
10989095|NCT00628251|12164366|FG001|STARTED|Randomised Part|Patients randomised|32
10989096|NCT00628251|12164367|FG002|STARTED|Randomised Part|Patients randomised|33
10989097|NCT00628251|12164365|FG000|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
10989098|NCT00628251|12164366|FG001|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
10989099|NCT00628251|12164367|FG002|COMPLETED|Randomised Part|1 of 33 patients did not receive Liposomal Doxorubicin. Patient voluntarily discontinued|32
10989100|NCT00628251|12164365|FG000|NOT COMPLETED|Randomised Part||0
10989101|NCT00628251|12164366|FG001|NOT COMPLETED|Randomised Part||0
10989102|NCT00628251|12164367|FG002|NOT COMPLETED|Randomised Part||1
10989103|NCT00628251|12164365|FG000|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
10989104|NCT00628251|12164366|FG001|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
10989105|NCT00628251|12164367|FG002|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received Liposomal doxorubicin 50 mg/m2|32
10989106|NCT00628251|12164365|FG000|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22
10989107|NCT00628251|12164366|FG001|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20
10989108|NCT00628251|12164367|FG002|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25
10989109|NCT00628251|12164365|FG000|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
10989110|NCT00628251|12164366|FG001|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
10989111|NCT00628251|12164367|FG002|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO|Crossover dosage was 400 mg bd Olaparib|14
10989112|NCT00628251|12164365|FG000|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
10989113|NCT00628251|12164366|FG001|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
10989114|NCT00628251|12164367|FG002|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5
10989115|NCT00628251|12164365|FG000|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
10989116|NCT00628251|12164366|FG001|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
10989117|NCT00628251|12164367|FG002|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9
10989118|NCT00628251|12164365|FG000|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|10
10989119|NCT00628251|12164366|FG001|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|12
10989120|NCT00628251|12164367|FG002|COMPLETED|Ongoing Initial Study Treatment at DCO|Patients ongoing initial study treatment (Liposomal doxorubicin)|7
10989121|NCT00628251|12164365|FG000|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22
10989122|NCT00628251|12164366|FG001|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20
10989123|NCT00628251|12164367|FG002|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25
10989124|NCT00628355|12164379|FG000|STARTED|Overall Study||15
10989125|NCT00628355|12164380|FG001|STARTED|Overall Study||15
10989126|NCT00628355|12164379|FG000|COMPLETED|Overall Study||14
10989127|NCT00628355|12164380|FG001|COMPLETED|Overall Study||14
10989128|NCT00628355|12164379|FG000|NOT COMPLETED|Overall Study||1
10989129|NCT00628355|12164380|FG001|NOT COMPLETED|Overall Study||1
10989130|NCT00628394|12164391|FG000|STARTED|Overall Study||14
10989131|NCT00628394|12164392|FG001|STARTED|Overall Study||13
10989132|NCT00628394|12164393|FG002|STARTED|Overall Study||13
10989133|NCT00628394|12164394|FG003|STARTED|Overall Study||13
10989134|NCT00628394|12164391|FG000|COMPLETED|Overall Study||10
10989135|NCT00628394|12164392|FG001|COMPLETED|Overall Study||9
10989136|NCT00628394|12164393|FG002|COMPLETED|Overall Study||11
10989137|NCT00628394|12164394|FG003|COMPLETED|Overall Study||10
10989138|NCT00628394|12164391|FG000|NOT COMPLETED|Overall Study||4
10989139|NCT00628394|12164392|FG001|NOT COMPLETED|Overall Study||4
10989140|NCT00628394|12164393|FG002|NOT COMPLETED|Overall Study||2
10989141|NCT00628394|12164394|FG003|NOT COMPLETED|Overall Study||3
10989142|NCT00628407|12164404|FG000|STARTED|Overall Study||13
10989143|NCT00628407|12164404|FG000|COMPLETED|Overall Study||13
10989144|NCT00628407|12164404|FG000|NOT COMPLETED|Overall Study||0
10989145|NCT00628498|12164408|FG000|STARTED|Overall Study||1206
10989146|NCT00628498|12164408|FG000|COMPLETED|Overall Study||1154
10989147|NCT00628498|12164408|FG000|NOT COMPLETED|Overall Study||52
10989148|NCT00628589|12164415|FG000|STARTED|Overall Study||115
10989149|NCT00628589|12164416|FG001|STARTED|Overall Study||116
10989150|NCT00628589|12164417|FG002|STARTED|Overall Study||113
10989151|NCT00628589|12164415|FG000|COMPLETED|Overall Study||114
10989152|NCT00628589|12164416|FG001|COMPLETED|Overall Study||114
10989153|NCT00628589|12164417|FG002|COMPLETED|Overall Study||110
10989154|NCT00628589|12164415|FG000|NOT COMPLETED|Overall Study||1
10989155|NCT00628589|12164416|FG001|NOT COMPLETED|Overall Study||2
10989156|NCT00628589|12164417|FG002|NOT COMPLETED|Overall Study||3
10989157|NCT00628628|12164427|FG000|STARTED|Overall Study||40
10989158|NCT00628628|12164428|FG001|STARTED|Overall Study||40
10989159|NCT00628628|12164427|FG000|COMPLETED|Overall Study||40
10989160|NCT00628628|12164428|FG001|COMPLETED|Overall Study||40
10989161|NCT00628628|12164427|FG000|NOT COMPLETED|Overall Study||0
10989162|NCT00628628|12164428|FG001|NOT COMPLETED|Overall Study||0
10989163|NCT00628758|12164436|FG000|STARTED|Overall Study||209
10989164|NCT00628758|12164437|FG001|STARTED|Overall Study||221
10989165|NCT00628758|12164436|FG000|COMPLETED|Overall Study||165
10989166|NCT00628758|12164437|FG001|COMPLETED|Overall Study||179
10989167|NCT00628758|12164436|FG000|NOT COMPLETED|Overall Study||44
10989168|NCT00628758|12164437|FG001|NOT COMPLETED|Overall Study||42
10989169|NCT00628862|12164448|FG000|STARTED|Overall Study|randomised patients|206
10989170|NCT00628862|12164449|FG001|STARTED|Overall Study|randomised patients|199
10989171|NCT00628862|12164450|FG002|STARTED|Overall Study|randomised patients|208
10989172|NCT00628862|12164448|FG000|COMPLETED|Overall Study|randomised patients|195
10989173|NCT00628862|12164449|FG001|COMPLETED|Overall Study|randomised patients|182
10989174|NCT00628862|12164450|FG002|COMPLETED|Overall Study|randomised patients|186
10989175|NCT00628862|12164448|FG000|NOT COMPLETED|Overall Study||11
10989176|NCT00628862|12164449|FG001|NOT COMPLETED|Overall Study||17
10989177|NCT00628862|12164450|FG002|NOT COMPLETED|Overall Study||22
10989178|NCT00628901|12164460|FG000|STARTED|Overall Study||30
10989179|NCT00628901|12164461|FG001|STARTED|Overall Study||30
10989180|NCT00628901|12164460|FG000|COMPLETED|Overall Study||27
10989181|NCT00628901|12164461|FG001|COMPLETED|Overall Study||29
10989182|NCT00628901|12164460|FG000|NOT COMPLETED|Overall Study||3
10989183|NCT00628901|12164461|FG001|NOT COMPLETED|Overall Study||1
10989184|NCT00628927|12164469|FG000|STARTED|Overall Study||183
10989185|NCT00628927|12164470|FG001|STARTED|Overall Study||30
10989186|NCT00628927|12164469|FG000|COMPLETED|Overall Study||175
10989187|NCT00628927|12164470|FG001|COMPLETED|Overall Study||30
10989188|NCT00628927|12164469|FG000|NOT COMPLETED|Overall Study||8
10989189|NCT00628927|12164470|FG001|NOT COMPLETED|Overall Study||0
10989190|NCT00629018|12164483|FG000|STARTED|Overall Study||55
10989191|NCT00629018|12164484|FG001|STARTED|Overall Study||55
10989192|NCT00629018|12164483|FG000|COMPLETED|Overall Study||55
10989193|NCT00629018|12164484|FG001|COMPLETED|Overall Study||55
10989194|NCT00629018|12164483|FG000|NOT COMPLETED|Overall Study||0
10989195|NCT00629018|12164484|FG001|NOT COMPLETED|Overall Study||0
10989196|NCT00629083|12164492|FG000|STARTED|Overall Study||228
10989197|NCT00629083|12164493|FG001|STARTED|Overall Study||117
10989198|NCT00629083|12164492|FG000|COMPLETED|Overall Study||200
10989199|NCT00629083|12164493|FG001|COMPLETED|Overall Study||103
10989200|NCT00629083|12164492|FG000|NOT COMPLETED|Overall Study||28
10989201|NCT00629083|12164493|FG001|NOT COMPLETED|Overall Study||14
10989202|NCT00629122|12164503|FG000|STARTED|First Period: Day 1- 3 (Sublingual)||2
10989203|NCT00629122|12164504|FG001|STARTED|First Period: Day 1- 3 (Sublingual)||3
10989204|NCT00629122|12164503|FG000|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
10989205|NCT00629122|12164504|FG001|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
10989206|NCT00629122|12164503|FG000|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
10989207|NCT00629122|12164504|FG001|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
10989208|NCT00629122|12164503|FG000|STARTED|Second Period: Day 3-5 (Washout)||2
10989209|NCT00629122|12164504|FG001|STARTED|Second Period: Day 3-5 (Washout)||3
10989210|NCT00629122|12164503|FG000|COMPLETED|Second Period: Day 3-5 (Washout)||2
10989211|NCT00629122|12164504|FG001|COMPLETED|Second Period: Day 3-5 (Washout)||3
10989212|NCT00629122|12164503|FG000|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
10989213|NCT00629122|12164504|FG001|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
10989214|NCT00629122|12164503|FG000|STARTED|Third Period: Day 6-8 (Oral)||2
10989215|NCT00629122|12164504|FG001|STARTED|Third Period: Day 6-8 (Oral)||3
10989216|NCT00629122|12164503|FG000|COMPLETED|Third Period: Day 6-8 (Oral)||2
10989217|NCT00629122|12164504|FG001|COMPLETED|Third Period: Day 6-8 (Oral)||3
10989218|NCT00629122|12164503|FG000|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
10989219|NCT00629122|12164504|FG001|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
10989220|NCT00629239|12164512|FG000|STARTED|Overall Study||34
10989221|NCT00629239|12164513|FG001|STARTED|Overall Study||32
10989222|NCT00629239|12164512|FG000|COMPLETED|Overall Study||26
10989223|NCT00629239|12164513|FG001|COMPLETED|Overall Study||28
10989224|NCT00629239|12164512|FG000|NOT COMPLETED|Overall Study||8
10989225|NCT00629239|12164513|FG001|NOT COMPLETED|Overall Study||4
10989226|NCT00629265|12164521|FG000|STARTED|Overall Study||116
10989227|NCT00629265|12164522|FG001|STARTED|Overall Study||54
10989228|NCT00629265|12164521|FG000|COMPLETED|Overall Study||84
10989229|NCT00629265|12164522|FG001|COMPLETED|Overall Study||34
10989230|NCT00629265|12164521|FG000|NOT COMPLETED|Overall Study||32
10989231|NCT00629265|12164522|FG001|NOT COMPLETED|Overall Study||20
10989232|NCT00629499|12164528|FG000|STARTED|Overall Study||63
10989233|NCT00629499|12164528|FG000|COMPLETED|Overall Study||63
10989234|NCT00629499|12164528|FG000|NOT COMPLETED|Overall Study||0
10989235|NCT00629525|12164532|FG000|STARTED|Overall Study||35
10989236|NCT00629525|12164532|FG000|COMPLETED|Overall Study||32
10989237|NCT00629525|12164532|FG000|NOT COMPLETED|Overall Study||3
10989238|NCT00629707|12164538|FG000|STARTED|Overall Study||10
10989239|NCT00629707|12164539|FG001|STARTED|Overall Study||10
10989240|NCT00629707|12164538|FG000|COMPLETED|Overall Study||10
10989241|NCT00629707|12164539|FG001|COMPLETED|Overall Study||8
10989242|NCT00629707|12164538|FG000|NOT COMPLETED|Overall Study||0
10989243|NCT00629707|12164539|FG001|NOT COMPLETED|Overall Study||2
10989244|NCT00629772|12164547|FG000|STARTED|First Intervention - Day 0 - Week 14||12
10989245|NCT00629772|12164548|FG001|STARTED|First Intervention - Day 0 - Week 14||12
10989246|NCT00629772|12164547|FG000|COMPLETED|First Intervention - Day 0 - Week 14||12
10989247|NCT00629772|12164548|FG001|COMPLETED|First Intervention - Day 0 - Week 14||12
10989248|NCT00629772|12164547|FG000|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
10989249|NCT00629772|12164548|FG001|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
10989250|NCT00629772|12164547|FG000|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
10989251|NCT00629772|12164548|FG001|STARTED|Second Intervention Week 14 - Week 26||12
10989252|NCT00629772|12164547|FG000|COMPLETED|Second Intervention Week 14 - Week 26||11
10989253|NCT00629772|12164548|FG001|COMPLETED|Second Intervention Week 14 - Week 26||10
10989254|NCT00629772|12164547|FG000|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
10989255|NCT00629772|12164548|FG001|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
10989256|NCT00630032|12164557|FG000|STARTED|Overall Study||398
10989257|NCT00630032|12164558|FG001|STARTED|Overall Study||364
10989258|NCT00630032|12164557|FG000|COMPLETED|Overall Study||308
10989259|NCT00630032|12164558|FG001|COMPLETED|Overall Study||269
10989260|NCT00630032|12164557|FG000|NOT COMPLETED|Overall Study||90
10989261|NCT00630032|12164558|FG001|NOT COMPLETED|Overall Study||95
10989262|NCT00630058|12164566|FG000|STARTED|Overall Study||10
10989263|NCT00630058|12164567|FG001|STARTED|Overall Study||10
10989264|NCT00630058|12164566|FG000|COMPLETED|Overall Study||6
10989265|NCT00630058|12164567|FG001|COMPLETED|Overall Study||6
10989266|NCT00630058|12164566|FG000|NOT COMPLETED|Overall Study||4
10989267|NCT00630058|12164567|FG001|NOT COMPLETED|Overall Study||4
10989268|NCT00630253|12164576|FG000|STARTED|Overall Study||16
10989269|NCT00630253|12164577|FG001|STARTED|Overall Study||9
10989270|NCT00630253|12164578|FG002|STARTED|Overall Study||6
10989271|NCT00630253|12164576|FG000|COMPLETED|Overall Study||16
10989272|NCT00630253|12164577|FG001|COMPLETED|Overall Study||9
10989273|NCT00630253|12164578|FG002|COMPLETED|Overall Study||6
10989274|NCT00630253|12164576|FG000|NOT COMPLETED|Overall Study||0
10989275|NCT00630253|12164577|FG001|NOT COMPLETED|Overall Study||0
10989276|NCT00630253|12164578|FG002|NOT COMPLETED|Overall Study||0
10989277|NCT00630305|12164586|FG000|STARTED|Overall Study||37
10989278|NCT00630305|12164586|FG000|COMPLETED|Overall Study||35
10989279|NCT00630305|12164586|FG000|NOT COMPLETED|Overall Study||2
10989280|NCT00630331|12164602|FG000|STARTED|Overall Study||3828
10989281|NCT00630331|12164603|FG001|STARTED|Overall Study||3676
10989282|NCT00630331|12164604|FG002|STARTED|Overall Study||3900
10989283|NCT00630331|12164602|FG000|COMPLETED|Overall Study||3622
10989284|NCT00630331|12164603|FG001|COMPLETED|Overall Study||3510
10989285|NCT00630331|12164604|FG002|COMPLETED|Overall Study||3712
10989286|NCT00630331|12164602|FG000|NOT COMPLETED|Overall Study||206
10989287|NCT00630331|12164603|FG001|NOT COMPLETED|Overall Study||166
10989288|NCT00630331|12164604|FG002|NOT COMPLETED|Overall Study||188
10989289|NCT00630344|12164612|FG000|STARTED|Overall Study||36
10989290|NCT00630344|12164612|FG000|COMPLETED|Overall Study||0
10989291|NCT00630344|12164612|FG000|NOT COMPLETED|Overall Study||36
10989292|NCT00630396|12164617|FG000|STARTED|Overall Study||60
10989293|NCT00630396|12164617|FG000|COMPLETED|Overall Study||53
10989294|NCT00630396|12164617|FG000|NOT COMPLETED|Overall Study||7
10989295|NCT00630409|12164621|FG000|STARTED|Overall Study||5
10989296|NCT00630409|12164621|FG000|COMPLETED|Overall Study||4
10989297|NCT00630409|12164621|FG000|NOT COMPLETED|Overall Study||1
10989298|NCT00630539|12164630|FG000|STARTED|Overall Study||34
10989299|NCT00630539|12164631|FG001|STARTED|Overall Study||33
10989300|NCT00630539|12164632|FG002|STARTED|Overall Study||29
10989301|NCT00630539|12164633|FG003|STARTED|Overall Study||30
10989302|NCT00630539|12164630|FG000|COMPLETED|Overall Study||33
10989303|NCT00630539|12164631|FG001|COMPLETED|Overall Study||29
10989304|NCT00630539|12164632|FG002|COMPLETED|Overall Study||28
10989305|NCT00630539|12164633|FG003|COMPLETED|Overall Study||27
10989306|NCT00630539|12164630|FG000|NOT COMPLETED|Overall Study||1
10989307|NCT00630539|12164631|FG001|NOT COMPLETED|Overall Study||4
10989308|NCT00630539|12164632|FG002|NOT COMPLETED|Overall Study||1
10989309|NCT00630539|12164633|FG003|NOT COMPLETED|Overall Study||3
10989310|NCT00630734|12164653|FG000|STARTED|Overall Study||11
10989311|NCT00630734|12164654|FG001|STARTED|Overall Study||13
10989312|NCT00630734|12164655|FG002|STARTED|Overall Study||8
10989313|NCT00630734|12164653|FG000|COMPLETED|Overall Study||9
10989314|NCT00630734|12164654|FG001|COMPLETED|Overall Study||12
10989315|NCT00630734|12164655|FG002|COMPLETED|Overall Study||7
10989316|NCT00630734|12164653|FG000|NOT COMPLETED|Overall Study||2
10989317|NCT00630734|12164654|FG001|NOT COMPLETED|Overall Study||1
10989318|NCT00630734|12164655|FG002|NOT COMPLETED|Overall Study||1
10989319|NCT00630747|12164665|FG000|STARTED|Overall Study||94
10989320|NCT00630747|12164665|FG000|Participants Treated in Phase I of Study|Overall Study||94
10989321|NCT00630747|12164665|FG000|COMPLETED|Overall Study||85
10989322|NCT00630747|12164665|FG000|NOT COMPLETED|Overall Study||9
10989323|NCT00630786|12164672|FG000|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
10989324|NCT00630786|12164673|FG001|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
10989325|NCT00630786|12164674|FG002|STARTED|Overall Study|All patients were enrolled in Part 2.|9
10989326|NCT00630786|12164672|FG000|Received Study Medication|Overall Study||19
10989327|NCT00630786|12164673|FG001|Received Study Medication|Overall Study||25
10989328|NCT00630786|12164674|FG002|Received Study Medication|Overall Study||8
10989329|NCT00630786|12164672|FG000|COMPLETED|Overall Study|Completed study defined as participant death|18
10989330|NCT00630786|12164673|FG001|COMPLETED|Overall Study|Completed study defined as participant death|23
10989331|NCT00630786|12164674|FG002|COMPLETED|Overall Study|Completed study defined as participant death|7
10989332|NCT00630786|12164672|FG000|NOT COMPLETED|Overall Study||1
10989333|NCT00630786|12164673|FG001|NOT COMPLETED|Overall Study||2
10989334|NCT00630786|12164674|FG002|NOT COMPLETED|Overall Study||2
10989335|NCT00630812|12164682|FG000|STARTED|Randomisation to First Dose||192
10989336|NCT00630812|12164683|FG001|STARTED|Randomisation to First Dose||126
10989337|NCT00630812|12164682|FG000|COMPLETED|Randomisation to First Dose||184
10989338|NCT00630812|12164683|FG001|COMPLETED|Randomisation to First Dose||121
10989339|NCT00630812|12164682|FG000|NOT COMPLETED|Randomisation to First Dose||8
10989340|NCT00630812|12164683|FG001|NOT COMPLETED|Randomisation to First Dose||5
10989341|NCT00630812|12164682|FG000|STARTED|Double Blind Treatment Period||184
10989342|NCT00630812|12164683|FG001|STARTED|Double Blind Treatment Period||121
10989343|NCT00630812|12164682|FG000|COMPLETED|Double Blind Treatment Period||153
10989344|NCT00630812|12164683|FG001|COMPLETED|Double Blind Treatment Period||107
10989345|NCT00630812|12164682|FG000|NOT COMPLETED|Double Blind Treatment Period||31
10989346|NCT00630812|12164683|FG001|NOT COMPLETED|Double Blind Treatment Period||14
10989347|NCT00630825|12164693|FG000|STARTED|Overall Study||65
10989348|NCT00630825|12164694|FG001|STARTED|Overall Study||65
10989349|NCT00630825|12164695|FG002|STARTED|Overall Study||66
10989350|NCT00630825|12164696|FG003|STARTED|Overall Study||66
10989351|NCT00630825|12164693|FG000|Received at Least One Dose of Study Drug|Overall Study||65
10989352|NCT00630825|12164694|FG001|Received at Least One Dose of Study Drug|Overall Study||65
10989353|NCT00630825|12164695|FG002|Received at Least One Dose of Study Drug|Overall Study||66
10989354|NCT00630825|12164696|FG003|Received at Least One Dose of Study Drug|Overall Study||66
10989355|NCT00630825|12164693|FG000|COMPLETED|Overall Study||56
10989356|NCT00630825|12164694|FG001|COMPLETED|Overall Study||58
10989357|NCT00630825|12164695|FG002|COMPLETED|Overall Study||58
10989358|NCT00630825|12164696|FG003|COMPLETED|Overall Study||60
10989359|NCT00630825|12164693|FG000|NOT COMPLETED|Overall Study||9
10989360|NCT00630825|12164694|FG001|NOT COMPLETED|Overall Study||7
10989361|NCT00630825|12164695|FG002|NOT COMPLETED|Overall Study||8
10989362|NCT00630825|12164696|FG003|NOT COMPLETED|Overall Study||6
10989363|NCT00630838|12164708|FG000|STARTED|Overall Study||32
10989364|NCT00630838|12164709|FG001|STARTED|Overall Study||30
10989365|NCT00630838|12164708|FG000|COMPLETED|Overall Study||32
10989366|NCT00630838|12164709|FG001|COMPLETED|Overall Study||28
10989367|NCT00630838|12164708|FG000|NOT COMPLETED|Overall Study||0
10989368|NCT00630838|12164709|FG001|NOT COMPLETED|Overall Study||2
10989369|NCT00630864|12164717|FG000|STARTED|Part 1 (up to Week 6)||21
10989370|NCT00630864|12164717|FG000|COMPLETED|Part 1 (up to Week 6)||20
10989371|NCT00630864|12164717|FG000|NOT COMPLETED|Part 1 (up to Week 6)||1
10989372|NCT00630864|12164717|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||20
10989373|NCT00630864|12164717|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
10989374|NCT00630864|12164717|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
10989375|NCT00630877|12164724|FG000|STARTED|Overall Study|For all arms, started means treated.|91
10989376|NCT00630877|12164725|FG001|STARTED|Overall Study||90
10989377|NCT00630877|12164726|FG002|STARTED|Overall Study||90
10989378|NCT00630877|12164724|FG000|COMPLETED|Overall Study||72
10989379|NCT00630877|12164725|FG001|COMPLETED|Overall Study||75
10989380|NCT00630877|12164726|FG002|COMPLETED|Overall Study||80
10989381|NCT00630877|12164724|FG000|NOT COMPLETED|Overall Study||19
10989382|NCT00630877|12164725|FG001|NOT COMPLETED|Overall Study||15
10989383|NCT00630877|12164726|FG002|NOT COMPLETED|Overall Study||10
10989384|NCT00630916|12164738|FG000|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
10989385|NCT00630916|12164738|FG000|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
10989386|NCT00630916|12164738|FG000|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
10989387|NCT00630916|12164738|FG000|NOT COMPLETED|Overall Study||210
10989388|NCT00630955|12164745|FG000|STARTED|Overall Study||34
10989389|NCT00630955|12164746|FG001|STARTED|Overall Study||37
10989390|NCT00630955|12164747|FG002|STARTED|Overall Study||40
10989391|NCT00630955|12164745|FG000|COMPLETED|Overall Study||31
10989392|NCT00630955|12164746|FG001|COMPLETED|Overall Study||31
10989393|NCT00630955|12164747|FG002|COMPLETED|Overall Study||28
10989394|NCT00630955|12164745|FG000|NOT COMPLETED|Overall Study||3
10989395|NCT00630955|12164746|FG001|NOT COMPLETED|Overall Study||6
10989396|NCT00630955|12164747|FG002|NOT COMPLETED|Overall Study||12
10989397|NCT00630994|12164755|FG000|STARTED|Overall Study||4
10989398|NCT00630994|12164755|FG000|COMPLETED|Overall Study||0
10989399|NCT00630994|12164755|FG000|NOT COMPLETED|Overall Study||4
10989400|NCT00631007|12164765|FG000|STARTED|Overall Study||60
10989401|NCT00631007|12164766|FG001|STARTED|Overall Study||61
10989402|NCT00631007|12164767|FG002|STARTED|Overall Study||63
10989403|NCT00631007|12164768|FG003|STARTED|Overall Study||62
10989404|NCT00631007|12164769|FG004|STARTED|Overall Study||60
10989405|NCT00631007|12164770|FG005|STARTED|Overall Study||61
10989406|NCT00631007|12164765|FG000|COMPLETED|Overall Study||49
10989407|NCT00631007|12164766|FG001|COMPLETED|Overall Study||50
10989408|NCT00631007|12164767|FG002|COMPLETED|Overall Study||53
10989409|NCT00631007|12164768|FG003|COMPLETED|Overall Study||53
10989410|NCT00631007|12164769|FG004|COMPLETED|Overall Study||48
10989411|NCT00631007|12164770|FG005|COMPLETED|Overall Study||46
10989412|NCT00631007|12164765|FG000|NOT COMPLETED|Overall Study||11
10989413|NCT00631007|12164766|FG001|NOT COMPLETED|Overall Study||11
10989414|NCT00631007|12164767|FG002|NOT COMPLETED|Overall Study||10
10989415|NCT00631007|12164768|FG003|NOT COMPLETED|Overall Study||9
10989416|NCT00631007|12164769|FG004|NOT COMPLETED|Overall Study||12
10989417|NCT00631007|12164770|FG005|NOT COMPLETED|Overall Study||15
10989418|NCT00631020|12164784|FG000|STARTED|Overall Study||34
10989419|NCT00631020|12164784|FG000|COMPLETED|Overall Study||26
10989420|NCT00631020|12164784|FG000|NOT COMPLETED|Overall Study||8
10989421|NCT00631163|12164788|FG000|STARTED|Number of Participants in Year 1||102
10989422|NCT00631163|12164788|FG000|COMPLETED|Number of Participants in Year 1||68
10989423|NCT00631163|12164788|FG000|NOT COMPLETED|Number of Participants in Year 1||34
10989424|NCT00631163|12164788|FG000|STARTED|Number of Participants in Year 2||57
10989425|NCT00631163|12164788|FG000|COMPLETED|Number of Participants in Year 2||52
10989426|NCT00631163|12164788|FG000|NOT COMPLETED|Number of Participants in Year 2||5
10989427|NCT00631189|12164803|FG000|STARTED|Initial Phase||668
10989428|NCT00631189|12164804|FG001|STARTED|Initial Phase||0
10989429|NCT00631189|12164805|FG002|STARTED|Initial Phase||0
10989430|NCT00631189|12164806|FG003|STARTED|Initial Phase||0
10989431|NCT00631189|12164803|FG000|COMPLETED|Initial Phase||317
10989432|NCT00631189|12164804|FG001|COMPLETED|Initial Phase||0
10989433|NCT00631189|12164805|FG002|COMPLETED|Initial Phase||0
10989434|NCT00631189|12164806|FG003|COMPLETED|Initial Phase||0
10989435|NCT00631189|12164803|FG000|NOT COMPLETED|Initial Phase||351
10989436|NCT00631189|12164804|FG001|NOT COMPLETED|Initial Phase||0
10989437|NCT00631189|12164805|FG002|NOT COMPLETED|Initial Phase||0
10989438|NCT00631189|12164806|FG003|NOT COMPLETED|Initial Phase||0
10989439|NCT00631189|12164803|FG000|STARTED|Treatment Phase||0
10989440|NCT00631189|12164804|FG001|STARTED|Treatment Phase||104
10989441|NCT00631189|12164805|FG002|STARTED|Treatment Phase||103
10989442|NCT00631189|12164806|FG003|STARTED|Treatment Phase||110
10989443|NCT00631189|12164803|FG000|COMPLETED|Treatment Phase||0
10989444|NCT00631189|12164804|FG001|COMPLETED|Treatment Phase||97
10989445|NCT00631189|12164805|FG002|COMPLETED|Treatment Phase||92
10989446|NCT00631189|12164806|FG003|COMPLETED|Treatment Phase||103
10989447|NCT00631189|12164803|FG000|NOT COMPLETED|Treatment Phase||0
10989448|NCT00631189|12164804|FG001|NOT COMPLETED|Treatment Phase||7
10989449|NCT00631189|12164805|FG002|NOT COMPLETED|Treatment Phase||11
10989450|NCT00631189|12164806|FG003|NOT COMPLETED|Treatment Phase||7
10989451|NCT00631319|12164818|FG000|STARTED|Conversion and Titration Phase||343
10989452|NCT00631319|12164819|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
10989453|NCT00631319|12164818|FG000|COMPLETED|Conversion and Titration Phase||200
10989454|NCT00631319|12164819|FG001|COMPLETED|Conversion and Titration Phase||0
10989455|NCT00631319|12164818|FG000|NOT COMPLETED|Conversion and Titration Phase||143
10989456|NCT00631319|12164819|FG001|NOT COMPLETED|Conversion and Titration Phase||0
10989457|NCT00631319|12164818|FG000|STARTED|Double-blind Phase||100
10989458|NCT00631319|12164819|FG001|STARTED|Double-blind Phase||100
10989459|NCT00631319|12164818|FG000|COMPLETED|Double-blind Phase||60
10989460|NCT00631319|12164819|FG001|COMPLETED|Double-blind Phase||65
10989461|NCT00631319|12164818|FG000|NOT COMPLETED|Double-blind Phase||40
10989462|NCT00631319|12164819|FG001|NOT COMPLETED|Double-blind Phase||35
10989463|NCT00631358|12164828|FG000|STARTED|Overall Study||50
10989464|NCT00631358|12164829|FG001|STARTED|Overall Study||47
10989465|NCT00631358|12164828|FG000|COMPLETED|Overall Study||44
10989466|NCT00631358|12164829|FG001|COMPLETED|Overall Study||45
10989467|NCT00631358|12164828|FG000|NOT COMPLETED|Overall Study||6
10989468|NCT00631358|12164829|FG001|NOT COMPLETED|Overall Study||2
10989469|NCT00631371|12164837|FG000|STARTED|Overall Study||400
10989470|NCT00631371|12164838|FG001|STARTED|Overall Study||391
10989471|NCT00631371|12164837|FG000|Treated|Overall Study||393
10989472|NCT00631371|12164838|FG001|Treated|Overall Study||391
10989473|NCT00631371|12164837|FG000|COMPLETED|Overall Study||0
10989474|NCT00631371|12164838|FG001|COMPLETED|Overall Study||0
10989475|NCT00631371|12164837|FG000|NOT COMPLETED|Overall Study||400
10989476|NCT00631371|12164838|FG001|NOT COMPLETED|Overall Study||391
10989477|NCT00631410|12164846|FG000|STARTED|Overall Study||6
10989478|NCT00631410|12164847|FG001|STARTED|Overall Study||6
10989479|NCT00631410|12164846|FG000|COMPLETED|Overall Study||0
10989480|NCT00631410|12164847|FG001|COMPLETED|Overall Study||0
10989481|NCT00631410|12164846|FG000|NOT COMPLETED|Overall Study||6
10989482|NCT00631410|12164847|FG001|NOT COMPLETED|Overall Study||6
10989483|NCT00631449|12164858|FG000|STARTED|Overall Study||15
10989484|NCT00631449|12164859|FG001|STARTED|Overall Study||15
10989485|NCT00631449|12164858|FG000|COMPLETED|Overall Study||15
10989486|NCT00631449|12164859|FG001|COMPLETED|Overall Study||15
10989487|NCT00631449|12164858|FG000|NOT COMPLETED|Overall Study||0
10989488|NCT00631449|12164859|FG001|NOT COMPLETED|Overall Study||0
10989489|NCT00631475|12164867|FG000|STARTED|Overall Study||128
10989490|NCT00631475|12164867|FG000|COMPLETED|Overall Study||83
10989491|NCT00631475|12164867|FG000|NOT COMPLETED|Overall Study||45
10989492|NCT00631488|12164874|FG000|STARTED|Overall Study||48
10989493|NCT00631488|12164875|FG001|STARTED|Overall Study||49
10989494|NCT00631488|12164876|FG002|STARTED|Overall Study||49
10989495|NCT00631488|12164874|FG000|Completed Post-Treatment Period|Overall Study||44
10989496|NCT00631488|12164875|FG001|Completed Post-Treatment Period|Overall Study||47
10989497|NCT00631488|12164876|FG002|Completed Post-Treatment Period|Overall Study||47
10989498|NCT00631488|12164874|FG000|COMPLETED|Overall Study||44
10989499|NCT00631488|12164875|FG001|COMPLETED|Overall Study||47
10989500|NCT00631488|12164876|FG002|COMPLETED|Overall Study||47
10989501|NCT00631488|12164874|FG000|NOT COMPLETED|Overall Study||4
10989502|NCT00631488|12164875|FG001|NOT COMPLETED|Overall Study||2
10989503|NCT00631488|12164876|FG002|NOT COMPLETED|Overall Study||2
10989504|NCT00631540|12164884|FG000|STARTED|Overall Study||100
10989505|NCT00631540|12164884|FG000|COMPLETED|Overall Study||86
10989506|NCT00631540|12164884|FG000|NOT COMPLETED|Overall Study||14
10989507|NCT00631566|12164891|FG000|STARTED|Overall Study||21
10989508|NCT00631566|12164892|FG001|STARTED|Overall Study||28
10989509|NCT00631566|12164893|FG002|STARTED|Overall Study||501
10989510|NCT00631566|12164891|FG000|COMPLETED|Overall Study||19
10989511|NCT00631566|12164892|FG001|COMPLETED|Overall Study||24
10989512|NCT00631566|12164893|FG002|COMPLETED|Overall Study||501
10989513|NCT00631566|12164891|FG000|NOT COMPLETED|Overall Study||2
10989514|NCT00631566|12164892|FG001|NOT COMPLETED|Overall Study||4
10989515|NCT00631566|12164893|FG002|NOT COMPLETED|Overall Study||0
10989516|NCT00631657|12164903|FG000|STARTED|6-Month Treatment Period||344
10989517|NCT00631657|12164904|FG001|STARTED|6-Month Treatment Period||0
10989518|NCT00631657|12164905|FG002|STARTED|6-Month Treatment Period||116
10989519|NCT00631657|12164903|FG000|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
10989520|NCT00631657|12164904|FG001|Treated|6-Month Treatment Period||0
10989521|NCT00631657|12164905|FG002|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
10989522|NCT00631657|12164903|FG000|COMPLETED|6-Month Treatment Period||203
10989523|NCT00631657|12164904|FG001|COMPLETED|6-Month Treatment Period||0
10989524|NCT00631657|12164905|FG002|COMPLETED|6-Month Treatment Period||66
10989525|NCT00631657|12164903|FG000|NOT COMPLETED|6-Month Treatment Period||141
10989526|NCT00631657|12164904|FG001|NOT COMPLETED|6-Month Treatment Period||0
10989527|NCT00631657|12164905|FG002|NOT COMPLETED|6-Month Treatment Period||50
10989528|NCT00631657|12164903|FG000|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
10989529|NCT00631657|12164904|FG001|STARTED|7-Day Discontinuation Period||137
10989530|NCT00631657|12164905|FG002|STARTED|7-Day Discontinuation Period||66
10989531|NCT00631657|12164903|FG000|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
10989532|NCT00631657|12164904|FG001|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
10989533|NCT00631657|12164905|FG002|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
10989534|NCT00631657|12164903|FG000|COMPLETED|7-Day Discontinuation Period||65
10989535|NCT00631657|12164904|FG001|COMPLETED|7-Day Discontinuation Period||136
10989536|NCT00631657|12164905|FG002|COMPLETED|7-Day Discontinuation Period||65
10989537|NCT00631657|12164903|FG000|NOT COMPLETED|7-Day Discontinuation Period||2
10989538|NCT00631657|12164904|FG001|NOT COMPLETED|7-Day Discontinuation Period||1
10989539|NCT00631657|12164905|FG002|NOT COMPLETED|7-Day Discontinuation Period||1
10989540|NCT00631670|12164918|FG000|STARTED|Overall Study||21
10989541|NCT00631670|12164919|FG001|STARTED|Overall Study||0
10989542|NCT00631670|12164918|FG000|COMPLETED|Overall Study||21
10989543|NCT00631670|12164919|FG001|COMPLETED|Overall Study||0
10989544|NCT00631670|12164918|FG000|NOT COMPLETED|Overall Study||0
10989545|NCT00631670|12164919|FG001|NOT COMPLETED|Overall Study||0
10989546|NCT00631696|12164931|FG000|STARTED|Overall Study||112
10989547|NCT00631696|12164932|FG001|STARTED|Overall Study||110
10989548|NCT00631696|12164931|FG000|Received Study Treatment (Tx)|Overall Study||111
10989549|NCT00631696|12164932|FG001|Received Study Treatment (Tx)|Overall Study||109
10989550|NCT00631696|12164931|FG000|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
10989551|NCT00631696|12164932|FG001|Ongoing at Database Release 18Oct2011|Overall Study||0
10989552|NCT00631696|12164931|FG000|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
10989553|NCT00631696|12164932|FG001|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
10989554|NCT00631696|12164931|FG000|NOT COMPLETED|Overall Study||37
10989555|NCT00631696|12164932|FG001|NOT COMPLETED|Overall Study||40
10989556|NCT00631748|12164940|FG000|STARTED|Overall Study||29
10989557|NCT00631748|12164941|FG001|STARTED|Overall Study||31
10989558|NCT00631748|12164940|FG000|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
10989559|NCT00631748|12164941|FG001|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
10989560|NCT00631748|12164940|FG000|NOT COMPLETED|Overall Study||18
10989561|NCT00631748|12164941|FG001|NOT COMPLETED|Overall Study||22
10989562|NCT00631852|12164948|FG000|STARTED|Overall Study|Seventeen subjects were consented and 16 were considered enrolled and treated under the protocol. One was a screen fail.|16
10989563|NCT00631852|12164948|FG000|COMPLETED|Overall Study|2 patients were administratively withdrawn after treatment had been completed as they declined sharing of data after PI transfer.|16
10989564|NCT00631852|12164948|FG000|NOT COMPLETED|Overall Study||0
10989565|NCT00631917|12164954|FG000|STARTED|Overall Study||375
10989566|NCT00631917|12164955|FG001|STARTED|Overall Study||399
10989567|NCT00631917|12164954|FG000|COMPLETED|Overall Study||287
10989568|NCT00631917|12164955|FG001|COMPLETED|Overall Study||291
10989569|NCT00631917|12164954|FG000|NOT COMPLETED|Overall Study||88
10989570|NCT00631917|12164955|FG001|NOT COMPLETED|Overall Study||108
10989571|NCT00631969|12164963|FG000|STARTED|Overall Study||186
10989572|NCT00631969|12164964|FG001|STARTED|Overall Study||176
10989573|NCT00631969|12164963|FG000|Received Treatment|Overall Study|safety population|184
10989574|NCT00631969|12164964|FG001|Received Treatment|Overall Study|safety population|174
10989575|NCT00631969|12164963|FG000|COMPLETED|Overall Study||171
10989576|NCT00631969|12164964|FG001|COMPLETED|Overall Study||155
10989577|NCT00631969|12164963|FG000|NOT COMPLETED|Overall Study||15
10989578|NCT00631969|12164964|FG001|NOT COMPLETED|Overall Study||21
10989579|NCT00632021|12164974|FG000|STARTED|Overall Study||432
10989580|NCT00632021|12164975|FG001|STARTED|Overall Study||430
10989581|NCT00632021|12164974|FG000|COMPLETED|Overall Study||428
10989582|NCT00632021|12164975|FG001|COMPLETED|Overall Study||423
10989583|NCT00632021|12164974|FG000|NOT COMPLETED|Overall Study||4
10989584|NCT00632021|12164975|FG001|NOT COMPLETED|Overall Study||7
10989585|NCT00632099|12164984|FG000|STARTED|Overall Study||10
10989586|NCT00632099|12164985|FG001|STARTED|Overall Study||11
10989587|NCT00632099|12164984|FG000|COMPLETED|Overall Study||7
10989588|NCT00632099|12164985|FG001|COMPLETED|Overall Study||8
10989589|NCT00632099|12164984|FG000|NOT COMPLETED|Overall Study||3
10989590|NCT00632099|12164985|FG001|NOT COMPLETED|Overall Study||3
10989591|NCT00632125|12164991|FG000|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
10989592|NCT00632125|12164991|FG000|COMPLETED|Overall Study||1393
10989593|NCT00632125|12164991|FG000|NOT COMPLETED|Overall Study||302
10989594|NCT00632203|12164997|FG000|STARTED|Overall Study||26
10989595|NCT00632203|12164998|FG001|STARTED|Overall Study||27
10989596|NCT00632203|12164997|FG000|COMPLETED|Overall Study||25
10989597|NCT00632203|12164998|FG001|COMPLETED|Overall Study||27
10989598|NCT00632203|12164997|FG000|NOT COMPLETED|Overall Study||1
10989599|NCT00632203|12164998|FG001|NOT COMPLETED|Overall Study||0
10989600|NCT00632229|12165006|FG000|STARTED|Overall Study||17
10989601|NCT00632229|12165007|FG001|STARTED|Overall Study||17
10989602|NCT00632229|12165006|FG000|COMPLETED|Overall Study||11
10989603|NCT00632229|12165007|FG001|COMPLETED|Overall Study||11
10989604|NCT00632229|12165006|FG000|NOT COMPLETED|Overall Study||6
10989605|NCT00632229|12165007|FG001|NOT COMPLETED|Overall Study||6
10989606|NCT00632281|12165013|FG000|STARTED|Overall Study||38
10989607|NCT00632281|12165013|FG000|COMPLETED|Overall Study||38
10989608|NCT00632281|12165013|FG000|NOT COMPLETED|Overall Study||0
10989609|NCT00632359|12165017|FG000|STARTED|Overall Study||33
10989610|NCT00632359|12165017|FG000|COMPLETED|Overall Study||31
10989611|NCT00632359|12165017|FG000|NOT COMPLETED|Overall Study||2
10989612|NCT00632411|12165024|FG000|STARTED|Overall Study||649
10989613|NCT00632411|12165025|FG001|STARTED|Overall Study||649
10989614|NCT00632411|12165024|FG000|COMPLETED|Overall Study||489
10989615|NCT00632411|12165025|FG001|COMPLETED|Overall Study||473
10989616|NCT00632411|12165024|FG000|NOT COMPLETED|Overall Study||160
10989617|NCT00632411|12165025|FG001|NOT COMPLETED|Overall Study||176
10989618|NCT00632424|12165034|FG000|STARTED|Overall Study||18
10989619|NCT00632424|12165034|FG000|COMPLETED|Overall Study||0
10989620|NCT00632424|12165034|FG000|NOT COMPLETED|Overall Study||18
10989621|NCT00632463|12165051|FG000|STARTED|Overall Study||7
10989622|NCT00632463|12165052|FG001|STARTED|Overall Study||7
10989623|NCT00632463|12165053|FG002|STARTED|Overall Study||7
10989624|NCT00632463|12165051|FG000|COMPLETED|Overall Study||7
10989625|NCT00632463|12165052|FG001|COMPLETED|Overall Study||6
10989626|NCT00632463|12165053|FG002|COMPLETED|Overall Study||7
10989627|NCT00632463|12165051|FG000|NOT COMPLETED|Overall Study||0
10989628|NCT00632463|12165052|FG001|NOT COMPLETED|Overall Study||1
10989629|NCT00632463|12165053|FG002|NOT COMPLETED|Overall Study||0
10989630|NCT00632489|12165064|FG000|STARTED|Overall Study||15
10989631|NCT00632489|12165065|FG001|STARTED|Overall Study||5
10989632|NCT00632489|12165066|FG002|STARTED|Overall Study||0
10989633|NCT00632489|12165064|FG000|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
10989634|NCT00632489|12165065|FG001|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
10989635|NCT00632489|12165066|FG002|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
10989636|NCT00632489|12165064|FG000|NOT COMPLETED|Overall Study||15
10989637|NCT00632489|12165065|FG001|NOT COMPLETED|Overall Study||5
10989638|NCT00632489|12165066|FG002|NOT COMPLETED|Overall Study||0
10989639|NCT00632502|12165076|FG000|STARTED|Overall Study||25
10989640|NCT00632502|12165077|FG001|STARTED|Overall Study||12
10989641|NCT00632502|12165076|FG000|Treated|Overall Study||22
10989642|NCT00632502|12165077|FG001|Treated|Overall Study||12
10989643|NCT00632502|12165076|FG000|Completed Treatment|Overall Study||19
10989644|NCT00632502|12165077|FG001|Completed Treatment|Overall Study||9
10989645|NCT00632502|12165076|FG000|COMPLETED|Overall Study||22
10989646|NCT00632502|12165077|FG001|COMPLETED|Overall Study||11
10989647|NCT00632502|12165076|FG000|NOT COMPLETED|Overall Study||3
10989648|NCT00632502|12165077|FG001|NOT COMPLETED|Overall Study||1
10989649|NCT00632541|12165084|FG000|STARTED|Overall Study|18 subjects were accrued to the study|18
10989650|NCT00632541|12165084|FG000|COMPLETED|Overall Study||11
10989651|NCT00632541|12165084|FG000|NOT COMPLETED|Overall Study||7
10989652|NCT00632619|12165090|FG000|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
10989653|NCT00632619|12165091|FG001|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
10989654|NCT00632619|12165090|FG000|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
10989655|NCT00632619|12165091|FG001|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
10989656|NCT00632619|12165090|FG000|NOT COMPLETED|Overall Study||8
10989657|NCT00632619|12165091|FG001|NOT COMPLETED|Overall Study||4
10989658|NCT00632632|12165099|FG000|STARTED|Overall Study||13
10989659|NCT00632632|12165100|FG001|STARTED|Overall Study||12
10989660|NCT00632632|12165099|FG000|COMPLETED|Overall Study||13
10989661|NCT00632632|12165100|FG001|COMPLETED|Overall Study||9
10989662|NCT00632632|12165099|FG000|NOT COMPLETED|Overall Study||0
10989663|NCT00632632|12165100|FG001|NOT COMPLETED|Overall Study||3
10989664|NCT00632736|12165106|FG000|STARTED|Overall Study||419
10989665|NCT00632736|12165106|FG000|COMPLETED|Overall Study||151
10989666|NCT00632736|12165106|FG000|NOT COMPLETED|Overall Study||268
10989667|NCT00632749|12165124|FG000|STARTED|Overall Study||4
10989668|NCT00632749|12165125|FG001|STARTED|Overall Study||5
10989669|NCT00632749|12165126|FG002|STARTED|Overall Study||3
10989670|NCT00632749|12165127|FG003|STARTED|Overall Study||4
10989671|NCT00632749|12165128|FG004|STARTED|Overall Study||7
10989672|NCT00632749|12165129|FG005|STARTED|Overall Study||8
10989673|NCT00632749|12165130|FG006|STARTED|Overall Study||5
10989674|NCT00632749|12165131|FG007|STARTED|Overall Study||4
10989675|NCT00632749|12165132|FG008|STARTED|Overall Study||5
10989676|NCT00632749|12165133|FG009|STARTED|Overall Study||3
10989677|NCT00632749|12165134|FG010|STARTED|Overall Study||7
10989678|NCT00632749|12165135|FG011|STARTED|Overall Study||4
10989679|NCT00632749|12165136|FG012|STARTED|Overall Study||3
10989680|NCT00632749|12165137|FG013|STARTED|Overall Study||6
10989681|NCT00632749|12165124|FG000|Treated|Overall Study||4
10989682|NCT00632749|12165125|FG001|Treated|Overall Study||3
10989683|NCT00632749|12165126|FG002|Treated|Overall Study||3
10989684|NCT00632749|12165127|FG003|Treated|Overall Study||4
10989685|NCT00632749|12165128|FG004|Treated|Overall Study||7
10989686|NCT00632749|12165129|FG005|Treated|Overall Study||7
10989687|NCT00632749|12165130|FG006|Treated|Overall Study||4
10989688|NCT00632749|12165131|FG007|Treated|Overall Study||4
10989689|NCT00632749|12165132|FG008|Treated|Overall Study||5
10989690|NCT00632749|12165133|FG009|Treated|Overall Study||3
10989691|NCT00632749|12165134|FG010|Treated|Overall Study||7
10989692|NCT00632749|12165135|FG011|Treated|Overall Study||4
10989693|NCT00632749|12165136|FG012|Treated|Overall Study||3
10989694|NCT00632749|12165137|FG013|Treated|Overall Study||6
10989695|NCT00632749|12165124|FG000|Not Treated|Overall Study||0
10989696|NCT00632749|12165125|FG001|Not Treated|Overall Study||2
10989697|NCT00632749|12165126|FG002|Not Treated|Overall Study||0
10989698|NCT00632749|12165127|FG003|Not Treated|Overall Study||0
10989699|NCT00632749|12165128|FG004|Not Treated|Overall Study||0
10989700|NCT00632749|12165129|FG005|Not Treated|Overall Study||1
10989701|NCT00632749|12165130|FG006|Not Treated|Overall Study||1
10989702|NCT00632749|12165131|FG007|Not Treated|Overall Study||0
10989703|NCT00632749|12165132|FG008|Not Treated|Overall Study||0
10989704|NCT00632749|12165133|FG009|Not Treated|Overall Study||0
10989705|NCT00632749|12165134|FG010|Not Treated|Overall Study||0
10989706|NCT00632749|12165135|FG011|Not Treated|Overall Study||0
10989707|NCT00632749|12165136|FG012|Not Treated|Overall Study||0
10989708|NCT00632749|12165137|FG013|Not Treated|Overall Study||0
10989709|NCT00632749|12165124|FG000|COMPLETED|Overall Study||0
10989710|NCT00632749|12165125|FG001|COMPLETED|Overall Study||0
10989711|NCT00632749|12165126|FG002|COMPLETED|Overall Study||0
10989712|NCT00632749|12165127|FG003|COMPLETED|Overall Study||0
10989713|NCT00632749|12165128|FG004|COMPLETED|Overall Study||0
10989714|NCT00632749|12165129|FG005|COMPLETED|Overall Study||0
10989715|NCT00632749|12165130|FG006|COMPLETED|Overall Study||0
10989716|NCT00632749|12165131|FG007|COMPLETED|Overall Study||0
10989717|NCT00632749|12165132|FG008|COMPLETED|Overall Study||0
10989718|NCT00632749|12165133|FG009|COMPLETED|Overall Study||0
10989719|NCT00632749|12165134|FG010|COMPLETED|Overall Study||0
10989720|NCT00632749|12165135|FG011|COMPLETED|Overall Study||0
10989721|NCT00632749|12165136|FG012|COMPLETED|Overall Study||0
10989722|NCT00632749|12165137|FG013|COMPLETED|Overall Study||0
10989723|NCT00632749|12165124|FG000|NOT COMPLETED|Overall Study||4
10989724|NCT00632749|12165125|FG001|NOT COMPLETED|Overall Study||5
10989725|NCT00632749|12165126|FG002|NOT COMPLETED|Overall Study||3
10989726|NCT00632749|12165127|FG003|NOT COMPLETED|Overall Study||4
10989727|NCT00632749|12165128|FG004|NOT COMPLETED|Overall Study||7
10989728|NCT00632749|12165129|FG005|NOT COMPLETED|Overall Study||8
10989729|NCT00632749|12165130|FG006|NOT COMPLETED|Overall Study||5
10989730|NCT00632749|12165131|FG007|NOT COMPLETED|Overall Study||4
10989731|NCT00632749|12165132|FG008|NOT COMPLETED|Overall Study||5
10989732|NCT00632749|12165133|FG009|NOT COMPLETED|Overall Study||3
10989733|NCT00632749|12165134|FG010|NOT COMPLETED|Overall Study||7
10989734|NCT00632749|12165135|FG011|NOT COMPLETED|Overall Study||4
10989735|NCT00632749|12165136|FG012|NOT COMPLETED|Overall Study||3
10989736|NCT00632749|12165137|FG013|NOT COMPLETED|Overall Study||6
10989737|NCT00632814|12165176|FG000|STARTED|Overall Study||11
10989738|NCT00632814|12165177|FG001|STARTED|Overall Study||13
10989739|NCT00632814|12165178|FG002|STARTED|Overall Study||8
10989740|NCT00632814|12165176|FG000|COMPLETED|Overall Study||11
10989741|NCT00632814|12165177|FG001|COMPLETED|Overall Study||13
10989742|NCT00632814|12165178|FG002|COMPLETED|Overall Study||8
10989743|NCT00632814|12165176|FG000|NOT COMPLETED|Overall Study||0
10989744|NCT00632814|12165177|FG001|NOT COMPLETED|Overall Study||0
10989745|NCT00632814|12165178|FG002|NOT COMPLETED|Overall Study||0
10989746|NCT00632827|12165186|FG000|STARTED|Overall Study||21
10989747|NCT00632827|12165186|FG000|Received GVD|Overall Study||21
10989748|NCT00632827|12165186|FG000|Received M-CHOP|Overall Study||18
10989749|NCT00632827|12165186|FG000|Evaluated Post Stem Cell Transplant|Overall Study||16
10989750|NCT00632827|12165186|FG000|COMPLETED|Overall Study||11
10989751|NCT00632827|12165186|FG000|NOT COMPLETED|Overall Study||10
10989752|NCT00632931|12165191|FG000|STARTED|Part 1, Period 1||13
10989753|NCT00632931|12165192|FG001|STARTED|Part 1, Period 1||12
10989754|NCT00632931|12165193|FG002|STARTED|Part 1, Period 1||0
10989755|NCT00632931|12165191|FG000|COMPLETED|Part 1, Period 1||11
10989756|NCT00632931|12165192|FG001|COMPLETED|Part 1, Period 1||12
10989757|NCT00632931|12165193|FG002|COMPLETED|Part 1, Period 1||0
10989758|NCT00632931|12165191|FG000|NOT COMPLETED|Part 1, Period 1||2
10989759|NCT00632931|12165192|FG001|NOT COMPLETED|Part 1, Period 1||0
10989760|NCT00632931|12165193|FG002|NOT COMPLETED|Part 1, Period 1||0
10989761|NCT00632931|12165191|FG000|STARTED|Part 1, Washout||11
10989762|NCT00632931|12165192|FG001|STARTED|Part 1, Washout||12
10989763|NCT00632931|12165193|FG002|STARTED|Part 1, Washout||0
10989764|NCT00632931|12165191|FG000|COMPLETED|Part 1, Washout||11
10989765|NCT00632931|12165192|FG001|COMPLETED|Part 1, Washout||12
10989766|NCT00632931|12165193|FG002|COMPLETED|Part 1, Washout||0
10989767|NCT00632931|12165191|FG000|NOT COMPLETED|Part 1, Washout||0
10989768|NCT00632931|12165192|FG001|NOT COMPLETED|Part 1, Washout||0
10989769|NCT00632931|12165193|FG002|NOT COMPLETED|Part 1, Washout||0
10989770|NCT00632931|12165191|FG000|STARTED|Part 1, Period 2||11
10989771|NCT00632931|12165192|FG001|STARTED|Part 1, Period 2||12
10989772|NCT00632931|12165193|FG002|STARTED|Part 1, Period 2||0
10989773|NCT00632931|12165191|FG000|COMPLETED|Part 1, Period 2||11
10989774|NCT00632931|12165192|FG001|COMPLETED|Part 1, Period 2||12
10989775|NCT00632931|12165193|FG002|COMPLETED|Part 1, Period 2||0
10989776|NCT00632931|12165191|FG000|NOT COMPLETED|Part 1, Period 2||0
10989777|NCT00632931|12165192|FG001|NOT COMPLETED|Part 1, Period 2||0
10989778|NCT00632931|12165193|FG002|NOT COMPLETED|Part 1, Period 2||0
10989779|NCT00632931|12165191|FG000|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
10989780|NCT00632931|12165192|FG001|STARTED|Post-Part 1 Washout||12
10989781|NCT00632931|12165193|FG002|STARTED|Post-Part 1 Washout||0
10989782|NCT00632931|12165191|FG000|COMPLETED|Post-Part 1 Washout||12
10989783|NCT00632931|12165192|FG001|COMPLETED|Post-Part 1 Washout||12
10989784|NCT00632931|12165193|FG002|COMPLETED|Post-Part 1 Washout||0
10989785|NCT00632931|12165191|FG000|NOT COMPLETED|Post-Part 1 Washout||0
10989786|NCT00632931|12165192|FG001|NOT COMPLETED|Post-Part 1 Washout||0
10989787|NCT00632931|12165193|FG002|NOT COMPLETED|Post-Part 1 Washout||0
10989788|NCT00632931|12165191|FG000|STARTED|Part 2||0
10989789|NCT00632931|12165192|FG001|STARTED|Part 2||0
10989790|NCT00632931|12165193|FG002|STARTED|Part 2||24
10989791|NCT00632931|12165191|FG000|COMPLETED|Part 2||0
10989792|NCT00632931|12165192|FG001|COMPLETED|Part 2||0
10989793|NCT00632931|12165193|FG002|COMPLETED|Part 2||0
10989794|NCT00632931|12165191|FG000|NOT COMPLETED|Part 2||0
10989795|NCT00632931|12165192|FG001|NOT COMPLETED|Part 2||0
10989796|NCT00632931|12165193|FG002|NOT COMPLETED|Part 2||24
10989797|NCT00632970|12165200|FG000|STARTED|Overall Study||3
10989798|NCT00632970|12165201|FG001|STARTED|Overall Study||3
10989799|NCT00632970|12165200|FG000|COMPLETED|Overall Study||3
10989800|NCT00632970|12165201|FG001|COMPLETED|Overall Study||3
10989801|NCT00632970|12165200|FG000|NOT COMPLETED|Overall Study||0
10989802|NCT00632970|12165201|FG001|NOT COMPLETED|Overall Study||0
10989803|NCT00633009|12165210|FG000|STARTED|Overall Study||12
10989804|NCT00633009|12165211|FG001|STARTED|Overall Study||27
10989805|NCT00633009|12165212|FG002|STARTED|Overall Study||11
10989806|NCT00633009|12165210|FG000|COMPLETED|Overall Study||8
10989807|NCT00633009|12165211|FG001|COMPLETED|Overall Study||23
10989808|NCT00633009|12165212|FG002|COMPLETED|Overall Study||10
10989809|NCT00633009|12165210|FG000|NOT COMPLETED|Overall Study||4
10989810|NCT00633009|12165211|FG001|NOT COMPLETED|Overall Study||4
10989811|NCT00633009|12165212|FG002|NOT COMPLETED|Overall Study||1
10989812|NCT00633022|12165226|FG000|STARTED|Overall Study||34
10989813|NCT00633022|12165227|FG001|STARTED|Overall Study||33
10989814|NCT00633022|12165228|FG002|STARTED|Overall Study||32
10989815|NCT00633022|12165226|FG000|COMPLETED|Overall Study||33
10989816|NCT00633022|12165227|FG001|COMPLETED|Overall Study||32
10989817|NCT00633022|12165228|FG002|COMPLETED|Overall Study||27
10989818|NCT00633022|12165226|FG000|NOT COMPLETED|Overall Study||1
10989819|NCT00633022|12165227|FG001|NOT COMPLETED|Overall Study||1
10989820|NCT00633022|12165228|FG002|NOT COMPLETED|Overall Study||5
10989821|NCT00633074|12165238|FG000|STARTED|Overall Study||360
10989822|NCT00633074|12165239|FG001|STARTED|Overall Study||360
10989823|NCT00633074|12165238|FG000|COMPLETED|Overall Study||359
10989824|NCT00633074|12165239|FG001|COMPLETED|Overall Study||360
10989825|NCT00633074|12165238|FG000|NOT COMPLETED|Overall Study||1
10989826|NCT00633074|12165239|FG001|NOT COMPLETED|Overall Study||0
10989827|NCT00633126|12165245|FG000|STARTED|Overall Study||9
10989828|NCT00633126|12165245|FG000|COMPLETED|Overall Study||8
10989829|NCT00633126|12165245|FG000|NOT COMPLETED|Overall Study||1
10989830|NCT00633139|12165252|FG000|STARTED|Overall Study||4
10989831|NCT00633139|12165253|FG001|STARTED|Overall Study||5
10989832|NCT00633139|12165254|FG002|STARTED|Overall Study||4
10989833|NCT00633139|12165252|FG000|COMPLETED|Overall Study||4
10989834|NCT00633139|12165253|FG001|COMPLETED|Overall Study||4
10989835|NCT00633139|12165254|FG002|COMPLETED|Overall Study||3
10989836|NCT00633139|12165252|FG000|NOT COMPLETED|Overall Study||0
10989837|NCT00633139|12165253|FG001|NOT COMPLETED|Overall Study||1
10989838|NCT00633139|12165254|FG002|NOT COMPLETED|Overall Study||1
10989839|NCT00633152|12165264|FG000|STARTED|Overall Study||103
10989840|NCT00633152|12165265|FG001|STARTED|Overall Study||47
10989841|NCT00633152|12165264|FG000|MITT and Safety Population|Overall Study||98
10989842|NCT00633152|12165265|FG001|MITT and Safety Population|Overall Study||45
10989843|NCT00633152|12165264|FG000|Clinically Evaluable Population|Overall Study||86
10989844|NCT00633152|12165265|FG001|Clinically Evaluable Population|Overall Study||39
10989845|NCT00633152|12165264|FG000|COMPLETED|Overall Study||89
10989846|NCT00633152|12165265|FG001|COMPLETED|Overall Study||41
10989847|NCT00633152|12165264|FG000|NOT COMPLETED|Overall Study||14
10989848|NCT00633152|12165265|FG001|NOT COMPLETED|Overall Study||6
10989849|NCT00633217|12165275|FG000|STARTED|Overall Study||121
10989850|NCT00633217|12165276|FG001|STARTED|Overall Study||126
10989851|NCT00633217|12165275|FG000|COMPLETED|Overall Study||106
10989852|NCT00633217|12165276|FG001|COMPLETED|Overall Study||103
10989853|NCT00633217|12165275|FG000|NOT COMPLETED|Overall Study||15
10989854|NCT00633217|12165276|FG001|NOT COMPLETED|Overall Study||23
10989855|NCT00633243|12165284|FG000|STARTED|Overall Study||12
10989856|NCT00633243|12165285|FG001|STARTED|Overall Study||9
10989857|NCT00633243|12165284|FG000|COMPLETED|Overall Study||11
10989858|NCT00633243|12165285|FG001|COMPLETED|Overall Study||2
10989859|NCT00633243|12165284|FG000|NOT COMPLETED|Overall Study||1
10989860|NCT00633243|12165285|FG001|NOT COMPLETED|Overall Study||7
10989861|NCT00633256|12165293|FG000|STARTED|Overall Study||12
10989862|NCT00633256|12165294|FG001|STARTED|Overall Study||13
10989863|NCT00633256|12165293|FG000|COMPLETED|Overall Study||8
10989864|NCT00633256|12165294|FG001|COMPLETED|Overall Study||10
10989865|NCT00633256|12165293|FG000|NOT COMPLETED|Overall Study||4
10989866|NCT00633256|12165294|FG001|NOT COMPLETED|Overall Study||3
10989867|NCT00633360|12165302|FG000|STARTED|Overall Study||16
10989868|NCT00633360|12165303|FG001|STARTED|Overall Study||16
10989869|NCT00633360|12165302|FG000|COMPLETED|Overall Study||12
10989870|NCT00633360|12165303|FG001|COMPLETED|Overall Study||13
10989871|NCT00633360|12165302|FG000|NOT COMPLETED|Overall Study||4
10989872|NCT00633360|12165303|FG001|NOT COMPLETED|Overall Study||3
10989873|NCT00633399|12165313|FG000|STARTED|Overall Study||71
10989874|NCT00633399|12165314|FG001|STARTED|Overall Study||68
10989875|NCT00633399|12165313|FG000|COMPLETED|Overall Study||49
10989876|NCT00633399|12165314|FG001|COMPLETED|Overall Study||53
10989877|NCT00633399|12165313|FG000|NOT COMPLETED|Overall Study||22
10989878|NCT00633399|12165314|FG001|NOT COMPLETED|Overall Study||15
10989879|NCT00633464|12165322|FG000|STARTED|Overall Study||40
10989880|NCT00633464|12165323|FG001|STARTED|Overall Study||39
10989881|NCT00633464|12165322|FG000|Treated|Overall Study||40
10989882|NCT00633464|12165323|FG001|Treated|Overall Study||37
10989883|NCT00633464|12165322|FG000|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
10989884|NCT00633464|12165323|FG001|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
10989885|NCT00633464|12165322|FG000|NOT COMPLETED|Overall Study||0
10989886|NCT00633464|12165323|FG001|NOT COMPLETED|Overall Study||2
10989887|NCT00633477|12165331|FG000|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
10989888|NCT00633477|12165332|FG001|STARTED|Overall Study||11
10989889|NCT00633477|12165331|FG000|Randomized But Not Treated|Overall Study||1
10989890|NCT00633477|12165332|FG001|Randomized But Not Treated|Overall Study||0
10989891|NCT00633477|12165331|FG000|Prematurely Discontinued Study Drug|Overall Study||1
10989892|NCT00633477|12165332|FG001|Prematurely Discontinued Study Drug|Overall Study||0
10989893|NCT00633477|12165331|FG000|Completed Study Through Day 28|Overall Study||4
10989894|NCT00633477|12165332|FG001|Completed Study Through Day 28|Overall Study||8
10989895|NCT00633477|12165331|FG000|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
10989896|NCT00633477|12165332|FG001|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
10989897|NCT00633477|12165331|FG000|NOT COMPLETED|Overall Study||2
10989898|NCT00633477|12165332|FG001|NOT COMPLETED|Overall Study||0
10989899|NCT00633594|12165341|FG000|STARTED|Overall Study||5
10989900|NCT00633594|12165342|FG001|STARTED|Overall Study||8
10989901|NCT00633594|12165343|FG002|STARTED|Overall Study||26
10989902|NCT00633594|12165341|FG000|COMPLETED|Overall Study||5
10989903|NCT00633594|12165342|FG001|COMPLETED|Overall Study||3
10989904|NCT00633594|12165343|FG002|COMPLETED|Overall Study||16
10989905|NCT00633594|12165341|FG000|NOT COMPLETED|Overall Study||0
10989906|NCT00633594|12165342|FG001|NOT COMPLETED|Overall Study||5
10989907|NCT00633594|12165343|FG002|NOT COMPLETED|Overall Study||10
10989908|NCT00633750|12165354|FG000|STARTED|Overall Study||47
10989909|NCT00633750|12165354|FG000|COMPLETED|Overall Study||42
10989910|NCT00633750|12165354|FG000|NOT COMPLETED|Overall Study||5
10989911|NCT00633867|12165362|FG000|STARTED|Overall Study||60
10989912|NCT00633867|12165363|FG001|STARTED|Overall Study||60
10989913|NCT00633867|12165362|FG000|COMPLETED|Overall Study||60
10989914|NCT00633867|12165363|FG001|COMPLETED|Overall Study||60
10989915|NCT00633867|12165362|FG000|NOT COMPLETED|Overall Study||0
10989916|NCT00633867|12165363|FG001|NOT COMPLETED|Overall Study||0
10989917|NCT00633880|12165372|FG000|STARTED|Open Label Titration||181
10989918|NCT00633880|12165373|FG001|STARTED|Open Label Titration||0
10989919|NCT00633880|12165374|FG002|STARTED|Open Label Titration||0
10989920|NCT00633880|12165372|FG000|COMPLETED|Open Label Titration||101
10989921|NCT00633880|12165373|FG001|COMPLETED|Open Label Titration||0
10989922|NCT00633880|12165374|FG002|COMPLETED|Open Label Titration||0
10989923|NCT00633880|12165372|FG000|NOT COMPLETED|Open Label Titration||80
10989924|NCT00633880|12165373|FG001|NOT COMPLETED|Open Label Titration||0
10989925|NCT00633880|12165374|FG002|NOT COMPLETED|Open Label Titration||0
10989926|NCT00633880|12165372|FG000|STARTED|Randomized Double Blind||0
10989927|NCT00633880|12165373|FG001|STARTED|Randomized Double Blind||50
10989928|NCT00633880|12165374|FG002|STARTED|Randomized Double Blind||51
10989929|NCT00633880|12165372|FG000|COMPLETED|Randomized Double Blind||0
10989930|NCT00633880|12165373|FG001|COMPLETED|Randomized Double Blind||50
10989931|NCT00633880|12165374|FG002|COMPLETED|Randomized Double Blind||51
10989932|NCT00633880|12165372|FG000|NOT COMPLETED|Randomized Double Blind||0
10989933|NCT00633880|12165373|FG001|NOT COMPLETED|Randomized Double Blind||0
10989934|NCT00633880|12165374|FG002|NOT COMPLETED|Randomized Double Blind||0
10989935|NCT00633893|12165384|FG000|STARTED|Overall Study||840
10989936|NCT00633893|12165385|FG001|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
10989937|NCT00633893|12165386|FG002|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
10989938|NCT00633893|12165384|FG000|COMPLETED|Overall Study||726
10989939|NCT00633893|12165385|FG001|COMPLETED|Overall Study||684
10989940|NCT00633893|12165386|FG002|COMPLETED|Overall Study||641
10989941|NCT00633893|12165384|FG000|NOT COMPLETED|Overall Study||114
10989942|NCT00633893|12165385|FG001|NOT COMPLETED|Overall Study||129
10989943|NCT00633893|12165386|FG002|NOT COMPLETED|Overall Study||188
10989944|NCT00633919|12165396|FG000|STARTED|Overall Study||63
10989945|NCT00633919|12165397|FG001|STARTED|Overall Study||61
10989946|NCT00633919|12165396|FG000|COMPLETED|Overall Study||36
10989947|NCT00633919|12165397|FG001|COMPLETED|Overall Study||39
10989948|NCT00633919|12165396|FG000|NOT COMPLETED|Overall Study||27
10989949|NCT00633919|12165397|FG001|NOT COMPLETED|Overall Study||22
10989950|NCT00633932|12165406|FG000|STARTED|Overall Study|Randomised|191
10989951|NCT00633932|12165407|FG001|STARTED|Overall Study|Randomised|190
10989952|NCT00633932|12165408|FG002|STARTED|Overall Study|Randomised|191
10989953|NCT00633932|12165406|FG000|COMPLETED|Overall Study||179
10989954|NCT00633932|12165407|FG001|COMPLETED|Overall Study||176
10989955|NCT00633932|12165408|FG002|COMPLETED|Overall Study||180
10989956|NCT00633932|12165406|FG000|NOT COMPLETED|Overall Study||12
10989957|NCT00633932|12165407|FG001|NOT COMPLETED|Overall Study||14
10989958|NCT00633932|12165408|FG002|NOT COMPLETED|Overall Study||11
10989959|NCT00633945|12165416|FG000|STARTED|Overall Study||5
10989960|NCT00633945|12165416|FG000|COMPLETED|Overall Study||3
10989961|NCT00633945|12165416|FG000|NOT COMPLETED|Overall Study||2
10989962|NCT00633984|12165424|FG000|STARTED|Overall Study||87
10989963|NCT00633984|12165425|FG001|STARTED|Overall Study||82
10989964|NCT00633984|12165424|FG000|COMPLETED|Overall Study||78
10989965|NCT00633984|12165425|FG001|COMPLETED|Overall Study||69
10989966|NCT00633984|12165424|FG000|NOT COMPLETED|Overall Study||9
10989967|NCT00633984|12165425|FG001|NOT COMPLETED|Overall Study||13
10989968|NCT00634036|12165433|FG000|STARTED|Overall Study||12
10989969|NCT00634036|12165434|FG001|STARTED|Overall Study||11
10989970|NCT00634036|12165433|FG000|COMPLETED|Overall Study||10
10989971|NCT00634036|12165434|FG001|COMPLETED|Overall Study||9
10989972|NCT00634036|12165433|FG000|NOT COMPLETED|Overall Study||2
10989973|NCT00634036|12165434|FG001|NOT COMPLETED|Overall Study||2
10989974|NCT00634049|12165440|FG000|STARTED|Overall Study||149
10989975|NCT00634049|12165440|FG000|COMPLETED|Overall Study||146
10989976|NCT00634049|12165440|FG000|NOT COMPLETED|Overall Study||3
10989977|NCT00634088|12165477|FG000|STARTED|Time Period 1: Dose Level 1||6
10989978|NCT00634088|12165478|FG001|STARTED|Time Period 1: Dose Level 1||0
10989979|NCT00634088|12165479|FG002|STARTED|Time Period 1: Dose Level 1||0
10989980|NCT00634088|12165480|FG003|STARTED|Time Period 1: Dose Level 1||0
10989981|NCT00634088|12165477|FG000|COMPLETED|Time Period 1: Dose Level 1||0
10989982|NCT00634088|12165478|FG001|COMPLETED|Time Period 1: Dose Level 1||0
10989983|NCT00634088|12165479|FG002|COMPLETED|Time Period 1: Dose Level 1||0
10989984|NCT00634088|12165480|FG003|COMPLETED|Time Period 1: Dose Level 1||0
10989985|NCT00634088|12165477|FG000|NOT COMPLETED|Time Period 1: Dose Level 1||6
10989986|NCT00634088|12165478|FG001|NOT COMPLETED|Time Period 1: Dose Level 1||0
10989987|NCT00634088|12165479|FG002|NOT COMPLETED|Time Period 1: Dose Level 1||0
10989988|NCT00634088|12165480|FG003|NOT COMPLETED|Time Period 1: Dose Level 1||0
10989989|NCT00634088|12165477|FG000|STARTED|Time Period 2: Dose Level 2||0
10989990|NCT00634088|12165478|FG001|STARTED|Time Period 2: Dose Level 2||3
10989991|NCT00634088|12165479|FG002|STARTED|Time Period 2: Dose Level 2||0
10989992|NCT00634088|12165480|FG003|STARTED|Time Period 2: Dose Level 2||0
10989993|NCT00634088|12165477|FG000|COMPLETED|Time Period 2: Dose Level 2||0
10989994|NCT00634088|12165478|FG001|COMPLETED|Time Period 2: Dose Level 2||0
10989995|NCT00634088|12165479|FG002|COMPLETED|Time Period 2: Dose Level 2||0
10989996|NCT00634088|12165480|FG003|COMPLETED|Time Period 2: Dose Level 2||0
10989997|NCT00634088|12165477|FG000|NOT COMPLETED|Time Period 2: Dose Level 2||0
10989998|NCT00634088|12165478|FG001|NOT COMPLETED|Time Period 2: Dose Level 2||3
10989999|NCT00634088|12165479|FG002|NOT COMPLETED|Time Period 2: Dose Level 2||0
10990000|NCT00634088|12165480|FG003|NOT COMPLETED|Time Period 2: Dose Level 2||0
10990001|NCT00634088|12165477|FG000|STARTED|Time Period 3: Dose Level 3||0
10990002|NCT00634088|12165478|FG001|STARTED|Time Period 3: Dose Level 3||0
10990003|NCT00634088|12165479|FG002|STARTED|Time Period 3: Dose Level 3||1
10990004|NCT00634088|12165480|FG003|STARTED|Time Period 3: Dose Level 3||0
10990005|NCT00634088|12165477|FG000|COMPLETED|Time Period 3: Dose Level 3||0
10990006|NCT00634088|12165478|FG001|COMPLETED|Time Period 3: Dose Level 3||0
10990007|NCT00634088|12165479|FG002|COMPLETED|Time Period 3: Dose Level 3||0
10990008|NCT00634088|12165480|FG003|COMPLETED|Time Period 3: Dose Level 3||0
10990009|NCT00634088|12165477|FG000|NOT COMPLETED|Time Period 3: Dose Level 3||0
10990010|NCT00634088|12165478|FG001|NOT COMPLETED|Time Period 3: Dose Level 3||0
10990011|NCT00634088|12165479|FG002|NOT COMPLETED|Time Period 3: Dose Level 3||1
10990012|NCT00634088|12165480|FG003|NOT COMPLETED|Time Period 3: Dose Level 3||0
10990013|NCT00634088|12165477|FG000|STARTED|Time Period 4: Triplet Combination||0
10990014|NCT00634088|12165478|FG001|STARTED|Time Period 4: Triplet Combination||0
10990015|NCT00634088|12165479|FG002|STARTED|Time Period 4: Triplet Combination||0
10990016|NCT00634088|12165480|FG003|STARTED|Time Period 4: Triplet Combination||0
10990017|NCT00634088|12165477|FG000|COMPLETED|Time Period 4: Triplet Combination||0
10990018|NCT00634088|12165478|FG001|COMPLETED|Time Period 4: Triplet Combination||0
10990019|NCT00634088|12165479|FG002|COMPLETED|Time Period 4: Triplet Combination||0
10990020|NCT00634088|12165480|FG003|COMPLETED|Time Period 4: Triplet Combination||0
10990021|NCT00634088|12165477|FG000|NOT COMPLETED|Time Period 4: Triplet Combination||0
10990022|NCT00634088|12165478|FG001|NOT COMPLETED|Time Period 4: Triplet Combination||0
10990023|NCT00634088|12165479|FG002|NOT COMPLETED|Time Period 4: Triplet Combination||0
10990024|NCT00634088|12165480|FG003|NOT COMPLETED|Time Period 4: Triplet Combination||0
10990025|NCT00634101|12165492|FG000|STARTED|Overall Study||66
10990026|NCT00634101|12165493|FG001|STARTED|Overall Study||59
10990027|NCT00634101|12165492|FG000|COMPLETED|Overall Study||61
10990028|NCT00634101|12165493|FG001|COMPLETED|Overall Study||56
10990029|NCT00634101|12165492|FG000|NOT COMPLETED|Overall Study||5
10990030|NCT00634101|12165493|FG001|NOT COMPLETED|Overall Study||3
10990031|NCT00634114|12165502|FG000|STARTED|Overall Study|Randomised|188
10990032|NCT00634114|12165503|FG001|STARTED|Overall Study|Randomised|189
10990033|NCT00634114|12165504|FG002|STARTED|Overall Study|Randomised|187
10990034|NCT00634114|12165502|FG000|COMPLETED|Overall Study|Completed|160
10990035|NCT00634114|12165503|FG001|COMPLETED|Overall Study|Completed|154
10990036|NCT00634114|12165504|FG002|COMPLETED|Overall Study|Completed|148
10990037|NCT00634114|12165502|FG000|NOT COMPLETED|Overall Study||28
10990038|NCT00634114|12165503|FG001|NOT COMPLETED|Overall Study||35
10990039|NCT00634114|12165504|FG002|NOT COMPLETED|Overall Study||39
10990040|NCT00634179|12165512|FG000|STARTED|Phase I: Induction||19
10990041|NCT00634179|12165512|FG000|COMPLETED|Phase I: Induction||19
10990042|NCT00634179|12165512|FG000|NOT COMPLETED|Phase I: Induction||0
10990043|NCT00634179|12165512|FG000|STARTED|Phase II: Maintenance||30
10990044|NCT00634179|12165512|FG000|COMPLETED|Phase II: Maintenance||29
10990045|NCT00634179|12165512|FG000|NOT COMPLETED|Phase II: Maintenance||1
10990046|NCT00634244|12165522|FG000|STARTED|Overall Study||35
10990047|NCT00634244|12165523|FG001|STARTED|Overall Study||37
10990048|NCT00634244|12165524|FG002|STARTED|Overall Study||20
10990049|NCT00634244|12165522|FG000|Eligible and Treated|Overall Study||35
10990050|NCT00634244|12165523|FG001|Eligible and Treated|Overall Study||36
10990051|NCT00634244|12165524|FG002|Eligible and Treated|Overall Study||20
10990052|NCT00634244|12165522|FG000|COMPLETED|Overall Study||34
10990053|NCT00634244|12165523|FG001|COMPLETED|Overall Study||24
10990054|NCT00634244|12165524|FG002|COMPLETED|Overall Study||20
10990055|NCT00634244|12165522|FG000|NOT COMPLETED|Overall Study||1
10990056|NCT00634244|12165523|FG001|NOT COMPLETED|Overall Study||13
10990057|NCT00634244|12165524|FG002|NOT COMPLETED|Overall Study||0
10990058|NCT00634270|12165534|FG000|STARTED|Overall Study|February 12, 2008|49
10990059|NCT00634270|12165535|FG001|STARTED|Overall Study||13
10990060|NCT00634270|12165534|FG000|COMPLETED|Overall Study||46
10990061|NCT00634270|12165535|FG001|COMPLETED|Overall Study||12
10990062|NCT00634270|12165534|FG000|NOT COMPLETED|Overall Study||3
10990063|NCT00634270|12165535|FG001|NOT COMPLETED|Overall Study||1
10990064|NCT00634283|12165547|FG000|STARTED|Overall Study||6
10990065|NCT00634283|12165547|FG000|COMPLETED|Overall Study||6
10990066|NCT00634283|12165547|FG000|NOT COMPLETED|Overall Study||0
10990067|NCT00634543|12165555|FG000|STARTED|Overall Study||78
10990068|NCT00634543|12165556|FG001|STARTED|Overall Study||84
10990069|NCT00634543|12165555|FG000|Treated|Overall Study||76
10990070|NCT00634543|12165556|FG001|Treated|Overall Study||80
10990071|NCT00634543|12165555|FG000|COMPLETED|Overall Study||59
10990072|NCT00634543|12165556|FG001|COMPLETED|Overall Study||63
10990073|NCT00634543|12165555|FG000|NOT COMPLETED|Overall Study||19
10990074|NCT00634543|12165556|FG001|NOT COMPLETED|Overall Study||21
10990075|NCT00634569|12165564|FG000|STARTED|Overall Study||14
10990076|NCT00634569|12165565|FG001|STARTED|Overall Study||10
10990077|NCT00634569|12165564|FG000|COMPLETED|Overall Study||14
10990078|NCT00634569|12165565|FG001|COMPLETED|Overall Study||5
10990079|NCT00634569|12165564|FG000|NOT COMPLETED|Overall Study||0
10990080|NCT00634569|12165565|FG001|NOT COMPLETED|Overall Study||5
10990081|NCT00634621|12165571|FG000|STARTED|Overall Study||283
10990082|NCT00634621|12165571|FG000|COMPLETED|Overall Study||283
10990083|NCT00634621|12165571|FG000|NOT COMPLETED|Overall Study||0
10990084|NCT00634647|12165579|FG000|STARTED|Overall Study||24
10990085|NCT00634647|12165579|FG000|COMPLETED|Overall Study||17
10990086|NCT00634647|12165579|FG000|NOT COMPLETED|Overall Study||7
10990087|NCT00634751|12165587|FG000|STARTED|Phase I: 200mg Sorafenib+2DOC||9
10990088|NCT00634751|12165588|FG001|STARTED|Phase I: 200mg Sorafenib+2DOC||0
10990089|NCT00634751|12165589|FG002|STARTED|Phase I: 200mg Sorafenib+2DOC||0
10990090|NCT00634751|12165590|FG003|STARTED|Phase I: 200mg Sorafenib+2DOC||0
10990091|NCT00634751|12165587|FG000|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
10990092|NCT00634751|12165588|FG001|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
10990093|NCT00634751|12165589|FG002|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
10990094|NCT00634751|12165590|FG003|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
10990095|NCT00634751|12165587|FG000|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
10990096|NCT00634751|12165588|FG001|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
10990097|NCT00634751|12165589|FG002|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
10990098|NCT00634751|12165590|FG003|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
10990099|NCT00634751|12165587|FG000|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
10990100|NCT00634751|12165588|FG001|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
10990101|NCT00634751|12165589|FG002|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
10990102|NCT00634751|12165590|FG003|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
10990103|NCT00634751|12165587|FG000|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
10990104|NCT00634751|12165588|FG001|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
10990105|NCT00634751|12165589|FG002|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
10990106|NCT00634751|12165590|FG003|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
10990107|NCT00634751|12165587|FG000|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
10990108|NCT00634751|12165588|FG001|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
10990109|NCT00634751|12165589|FG002|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
10990110|NCT00634751|12165590|FG003|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
10990111|NCT00634751|12165587|FG000|STARTED|Pancreatic and Bilial Tract Cancer||0
10990112|NCT00634751|12165588|FG001|STARTED|Pancreatic and Bilial Tract Cancer||0
10990113|NCT00634751|12165589|FG002|STARTED|Pancreatic and Bilial Tract Cancer||24
10990114|NCT00634751|12165590|FG003|STARTED|Pancreatic and Bilial Tract Cancer||8
10990115|NCT00634751|12165587|FG000|COMPLETED|Pancreatic and Bilial Tract Cancer||0
10990116|NCT00634751|12165588|FG001|COMPLETED|Pancreatic and Bilial Tract Cancer||0
10990117|NCT00634751|12165589|FG002|COMPLETED|Pancreatic and Bilial Tract Cancer||23
10990118|NCT00634751|12165590|FG003|COMPLETED|Pancreatic and Bilial Tract Cancer||7
10990119|NCT00634751|12165587|FG000|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
10990120|NCT00634751|12165588|FG001|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
10990121|NCT00634751|12165589|FG002|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
10990122|NCT00634751|12165590|FG003|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
10990123|NCT00634803|12165603|FG000|STARTED|Overall Study||30
10990124|NCT00634803|12165604|FG001|STARTED|Overall Study||30
10990125|NCT00634803|12165605|FG002|STARTED|Overall Study||30
10990126|NCT00634803|12165603|FG000|Month 1|Overall Study||29
10990127|NCT00634803|12165604|FG001|Month 1|Overall Study||29
10990128|NCT00634803|12165605|FG002|Month 1|Overall Study||29
10990129|NCT00634803|12165603|FG000|Month 2|Overall Study||26
10990130|NCT00634803|12165604|FG001|Month 2|Overall Study||26
10990131|NCT00634803|12165605|FG002|Month 2|Overall Study||28
10990132|NCT00634803|12165603|FG000|Month 3|Overall Study||25
10990133|NCT00634803|12165604|FG001|Month 3|Overall Study||23
10990134|NCT00634803|12165605|FG002|Month 3|Overall Study||26
10990135|NCT00634803|12165603|FG000|COMPLETED|Overall Study||24
10990136|NCT00634803|12165604|FG001|COMPLETED|Overall Study||23
10990137|NCT00634803|12165605|FG002|COMPLETED|Overall Study||23
10990138|NCT00634803|12165603|FG000|NOT COMPLETED|Overall Study||6
10990139|NCT00634803|12165604|FG001|NOT COMPLETED|Overall Study||7
10990140|NCT00634803|12165605|FG002|NOT COMPLETED|Overall Study||7
10990141|NCT00634842|12165615|FG000|STARTED|Overall Study||122
10990142|NCT00634842|12165616|FG001|STARTED|Overall Study||122
10990143|NCT00634842|12165615|FG000|COMPLETED|Overall Study||107
10990144|NCT00634842|12165616|FG001|COMPLETED|Overall Study||104
10990145|NCT00634842|12165615|FG000|NOT COMPLETED|Overall Study||15
10990146|NCT00634842|12165616|FG001|NOT COMPLETED|Overall Study||18
10990147|NCT00634907|12165624|FG000|STARTED|Overall Study||131
10990148|NCT00634907|12165625|FG001|STARTED|Overall Study||132
10990149|NCT00634907|12165624|FG000|COMPLETED|Overall Study||114
10990150|NCT00634907|12165625|FG001|COMPLETED|Overall Study||115
10990151|NCT00634907|12165624|FG000|NOT COMPLETED|Overall Study||17
10990152|NCT00634907|12165625|FG001|NOT COMPLETED|Overall Study||17
10990153|NCT00634920|12165634|FG000|STARTED|Period 1 - Pre-Randomization||0
10990154|NCT00634920|12165635|FG001|STARTED|Period 1 - Pre-Randomization||0
10990155|NCT00634920|12165636|FG002|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
10990156|NCT00634920|12165634|FG000|COMPLETED|Period 1 - Pre-Randomization||0
10990157|NCT00634920|12165635|FG001|COMPLETED|Period 1 - Pre-Randomization||0
10990158|NCT00634920|12165636|FG002|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
10990159|NCT00634920|12165634|FG000|NOT COMPLETED|Period 1 - Pre-Randomization||0
10990160|NCT00634920|12165635|FG001|NOT COMPLETED|Period 1 - Pre-Randomization||0
10990161|NCT00634920|12165636|FG002|NOT COMPLETED|Period 1 - Pre-Randomization||137
10990162|NCT00634920|12165634|FG000|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
10990163|NCT00634920|12165635|FG001|STARTED|Period 2 - Post-Randomization||100
10990164|NCT00634920|12165636|FG002|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
10990165|NCT00634920|12165634|FG000|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
10990166|NCT00634920|12165635|FG001|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
10990167|NCT00634920|12165636|FG002|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
10990168|NCT00634920|12165634|FG000|COMPLETED|Period 2 - Post-Randomization||43
10990169|NCT00634920|12165635|FG001|COMPLETED|Period 2 - Post-Randomization||68
10990170|NCT00634920|12165636|FG002|COMPLETED|Period 2 - Post-Randomization||0
10990171|NCT00634920|12165634|FG000|NOT COMPLETED|Period 2 - Post-Randomization||61
10990172|NCT00634920|12165635|FG001|NOT COMPLETED|Period 2 - Post-Randomization||32
10990173|NCT00634920|12165636|FG002|NOT COMPLETED|Period 2 - Post-Randomization||0
10990174|NCT00634933|12165645|FG000|STARTED|Part A: Baseline to Week 24||74
10990175|NCT00634933|12165646|FG001|STARTED|Part A: Baseline to Week 24||75
10990176|NCT00634933|12165647|FG002|STARTED|Part A: Baseline to Week 24||73
10990177|NCT00634933|12165648|FG003|STARTED|Part A: Baseline to Week 24||0
10990178|NCT00634933|12165649|FG004|STARTED|Part A: Baseline to Week 24||0
10990179|NCT00634933|12165645|FG000|COMPLETED|Part A: Baseline to Week 24||63
10990180|NCT00634933|12165646|FG001|COMPLETED|Part A: Baseline to Week 24||57
10990181|NCT00634933|12165647|FG002|COMPLETED|Part A: Baseline to Week 24||55
10990182|NCT00634933|12165648|FG003|COMPLETED|Part A: Baseline to Week 24||0
10990183|NCT00634933|12165649|FG004|COMPLETED|Part A: Baseline to Week 24||0
10990184|NCT00634933|12165645|FG000|NOT COMPLETED|Part A: Baseline to Week 24||11
10990185|NCT00634933|12165646|FG001|NOT COMPLETED|Part A: Baseline to Week 24||18
10990186|NCT00634933|12165647|FG002|NOT COMPLETED|Part A: Baseline to Week 24||18
10990187|NCT00634933|12165648|FG003|NOT COMPLETED|Part A: Baseline to Week 24||0
10990188|NCT00634933|12165649|FG004|NOT COMPLETED|Part A: Baseline to Week 24||0
10990189|NCT00634933|12165645|FG000|STARTED|Between Part A and Part B||0
10990190|NCT00634933|12165646|FG001|STARTED|Between Part A and Part B||57
10990191|NCT00634933|12165647|FG002|STARTED|Between Part A and Part B||55
10990192|NCT00634933|12165648|FG003|STARTED|Between Part A and Part B||31
10990193|NCT00634933|12165649|FG004|STARTED|Between Part A and Part B||32
10990194|NCT00634933|12165645|FG000|COMPLETED|Between Part A and Part B||0
10990195|NCT00634933|12165646|FG001|COMPLETED|Between Part A and Part B||56
10990196|NCT00634933|12165647|FG002|COMPLETED|Between Part A and Part B||55
10990197|NCT00634933|12165648|FG003|COMPLETED|Between Part A and Part B||31
10990198|NCT00634933|12165649|FG004|COMPLETED|Between Part A and Part B||32
10990199|NCT00634933|12165645|FG000|NOT COMPLETED|Between Part A and Part B||0
10990200|NCT00634933|12165646|FG001|NOT COMPLETED|Between Part A and Part B||1
10990201|NCT00634933|12165647|FG002|NOT COMPLETED|Between Part A and Part B||0
10990202|NCT00634933|12165648|FG003|NOT COMPLETED|Between Part A and Part B||0
10990203|NCT00634933|12165649|FG004|NOT COMPLETED|Between Part A and Part B||0
10990204|NCT00634933|12165645|FG000|STARTED|Part B: Week 24 to Week 52||0
10990205|NCT00634933|12165646|FG001|STARTED|Part B: Week 24 to Week 52||56
10990206|NCT00634933|12165647|FG002|STARTED|Part B: Week 24 to Week 52||55
10990207|NCT00634933|12165648|FG003|STARTED|Part B: Week 24 to Week 52||31
10990208|NCT00634933|12165649|FG004|STARTED|Part B: Week 24 to Week 52||32
10990209|NCT00634933|12165645|FG000|COMPLETED|Part B: Week 24 to Week 52||0
10990210|NCT00634933|12165646|FG001|COMPLETED|Part B: Week 24 to Week 52||42
10990211|NCT00634933|12165647|FG002|COMPLETED|Part B: Week 24 to Week 52||33
10990212|NCT00634933|12165648|FG003|COMPLETED|Part B: Week 24 to Week 52||25
10990213|NCT00634933|12165649|FG004|COMPLETED|Part B: Week 24 to Week 52||22
10990214|NCT00634933|12165645|FG000|NOT COMPLETED|Part B: Week 24 to Week 52||0
10990215|NCT00634933|12165646|FG001|NOT COMPLETED|Part B: Week 24 to Week 52||14
10990216|NCT00634933|12165647|FG002|NOT COMPLETED|Part B: Week 24 to Week 52||22
10990217|NCT00634933|12165648|FG003|NOT COMPLETED|Part B: Week 24 to Week 52||6
10990218|NCT00634933|12165649|FG004|NOT COMPLETED|Part B: Week 24 to Week 52||10
10990219|NCT00635024|12165661|FG000|STARTED|Overall Study||1
10990220|NCT00635024|12165661|FG000|COMPLETED|Overall Study||0
10990221|NCT00635024|12165661|FG000|NOT COMPLETED|Overall Study||1
10990222|NCT00635050|12165665|FG000|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
10990223|NCT00635050|12165665|FG000|COMPLETED|Overall Study|Followup through 10 years planned.|31
10990224|NCT00635050|12165665|FG000|NOT COMPLETED|Overall Study||1
10990225|NCT00635089|12165672|FG000|STARTED|Overall Study||190
10990226|NCT00635089|12165672|FG000|Completed >/= 16 Weeks of Study|Overall Study||181
10990227|NCT00635089|12165672|FG000|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
10990228|NCT00635089|12165672|FG000|NOT COMPLETED|Overall Study||78
10990229|NCT00635102|12165691|FG000|STARTED|Overall Study||27
10990230|NCT00635102|12165692|FG001|STARTED|Overall Study||30
10990231|NCT00635102|12165691|FG000|COMPLETED|Overall Study||20
10990232|NCT00635102|12165692|FG001|COMPLETED|Overall Study||22
10990233|NCT00635102|12165691|FG000|NOT COMPLETED|Overall Study||7
10990234|NCT00635102|12165692|FG001|NOT COMPLETED|Overall Study||8
10990235|NCT00635128|12165700|FG000|STARTED|Overall Study||351
10990236|NCT00635128|12165701|FG001|STARTED|Overall Study||64
10990237|NCT00635128|12165700|FG000|COMPLETED|Overall Study||351
10990238|NCT00635128|12165701|FG001|COMPLETED|Overall Study||64
10990239|NCT00635128|12165700|FG000|NOT COMPLETED|Overall Study||0
10990240|NCT00635128|12165701|FG001|NOT COMPLETED|Overall Study||0
10990241|NCT00635154|12165709|FG000|STARTED|Overall Study||54
10990242|NCT00635154|12165709|FG000|COMPLETED|Overall Study||21
10990243|NCT00635154|12165709|FG000|NOT COMPLETED|Overall Study||33
10990244|NCT00635219|12165720|FG000|STARTED|Overall Study||148
10990245|NCT00635219|12165721|FG001|STARTED|Overall Study||155
10990246|NCT00635219|12165722|FG002|STARTED|Overall Study||157
10990247|NCT00635219|12165723|FG003|STARTED|Overall Study||151
10990248|NCT00635219|12165724|FG004|STARTED|Overall Study||155
10990249|NCT00635219|12165720|FG000|COMPLETED|Overall Study||123
10990250|NCT00635219|12165721|FG001|COMPLETED|Overall Study||130
10990251|NCT00635219|12165722|FG002|COMPLETED|Overall Study||122
10990252|NCT00635219|12165723|FG003|COMPLETED|Overall Study||117
10990253|NCT00635219|12165724|FG004|COMPLETED|Overall Study||113
10990254|NCT00635219|12165720|FG000|NOT COMPLETED|Overall Study||25
10990255|NCT00635219|12165721|FG001|NOT COMPLETED|Overall Study||25
10990256|NCT00635219|12165722|FG002|NOT COMPLETED|Overall Study||35
10990257|NCT00635219|12165723|FG003|NOT COMPLETED|Overall Study||34
10990258|NCT00635219|12165724|FG004|NOT COMPLETED|Overall Study||42
10990259|NCT00635232|12165741|FG000|STARTED|Overall Study||58
10990260|NCT00635232|12165742|FG001|STARTED|Overall Study||59
10990261|NCT00635232|12165743|FG002|STARTED|Overall Study||58
10990262|NCT00635232|12165744|FG003|STARTED|Overall Study||58
10990263|NCT00635232|12165745|FG004|STARTED|Overall Study||28
10990264|NCT00635232|12165741|FG000|COMPLETED|Overall Study||44
10990265|NCT00635232|12165742|FG001|COMPLETED|Overall Study||39
10990266|NCT00635232|12165743|FG002|COMPLETED|Overall Study||55
10990267|NCT00635232|12165744|FG003|COMPLETED|Overall Study||48
10990268|NCT00635232|12165745|FG004|COMPLETED|Overall Study||20
10990269|NCT00635232|12165741|FG000|NOT COMPLETED|Overall Study||14
10990270|NCT00635232|12165742|FG001|NOT COMPLETED|Overall Study||20
10990271|NCT00635232|12165743|FG002|NOT COMPLETED|Overall Study||3
10990272|NCT00635232|12165744|FG003|NOT COMPLETED|Overall Study||10
10990273|NCT00635232|12165745|FG004|NOT COMPLETED|Overall Study||8
10990274|NCT00635349|12165759|FG000|STARTED|Overall Study||73
10990275|NCT00635349|12165760|FG001|STARTED|Overall Study||67
10990276|NCT00635349|12165759|FG000|COMPLETED|Overall Study||29
10990277|NCT00635349|12165760|FG001|COMPLETED|Overall Study||19
10990278|NCT00635349|12165759|FG000|NOT COMPLETED|Overall Study||44
10990279|NCT00635349|12165760|FG001|NOT COMPLETED|Overall Study||48
10990280|NCT00635362|12165768|FG000|STARTED|Overall Study||22
10990281|NCT00635362|12165769|FG001|STARTED|Overall Study||20
10990282|NCT00635362|12165768|FG000|COMPLETED|Overall Study||9
10990283|NCT00635362|12165769|FG001|COMPLETED|Overall Study||12
10990284|NCT00635362|12165768|FG000|NOT COMPLETED|Overall Study||13
10990285|NCT00635362|12165769|FG001|NOT COMPLETED|Overall Study||8
10990286|NCT00635427|12165780|FG000|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
10990287|NCT00635427|12165781|FG001|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
10990288|NCT00635427|12165782|FG002|STARTED|Overall Study||16
10990289|NCT00635427|12165783|FG003|STARTED|Overall Study||16
10990290|NCT00635427|12165784|FG004|STARTED|Overall Study||38
10990291|NCT00635427|12165780|FG000|COMPLETED|Overall Study||1
10990292|NCT00635427|12165781|FG001|COMPLETED|Overall Study||6
10990293|NCT00635427|12165782|FG002|COMPLETED|Overall Study||5
10990294|NCT00635427|12165783|FG003|COMPLETED|Overall Study||7
10990295|NCT00635427|12165784|FG004|COMPLETED|Overall Study||30
10990296|NCT00635427|12165780|FG000|NOT COMPLETED|Overall Study||12
10990297|NCT00635427|12165781|FG001|NOT COMPLETED|Overall Study||6
10990298|NCT00635427|12165782|FG002|NOT COMPLETED|Overall Study||11
10990299|NCT00635427|12165783|FG003|NOT COMPLETED|Overall Study||9
10990300|NCT00635427|12165784|FG004|NOT COMPLETED|Overall Study||8
10990301|NCT00635453|12165796|FG000|STARTED|Overall Study||360
10990302|NCT00635453|12165797|FG001|STARTED|Overall Study||355
10990303|NCT00635453|12165796|FG000|6 Months Assessment|Overall Study||322
10990304|NCT00635453|12165797|FG001|6 Months Assessment|Overall Study||311
10990305|NCT00635453|12165796|FG000|12 Months Assessment|Overall Study||285
10990306|NCT00635453|12165797|FG001|12 Months Assessment|Overall Study||260
10990307|NCT00635453|12165796|FG000|3 Years Assessment|Overall Study||246
10990308|NCT00635453|12165797|FG001|3 Years Assessment|Overall Study||204
10990309|NCT00635453|12165796|FG000|COMPLETED|Overall Study||206
10990310|NCT00635453|12165797|FG001|COMPLETED|Overall Study||181
10990311|NCT00635453|12165796|FG000|NOT COMPLETED|Overall Study||154
10990312|NCT00635453|12165797|FG001|NOT COMPLETED|Overall Study||174
10990313|NCT00635479|12165805|FG000|STARTED|Overall Study||55
10990314|NCT00635479|12165806|FG001|STARTED|Overall Study||60
10990315|NCT00635479|12165805|FG000|COMPLETED|Overall Study||49
10990316|NCT00635479|12165806|FG001|COMPLETED|Overall Study||42
10990317|NCT00635479|12165805|FG000|NOT COMPLETED|Overall Study||6
10990318|NCT00635479|12165806|FG001|NOT COMPLETED|Overall Study||18
10990319|NCT00635492|12165814|FG000|STARTED|Overall Study|This population consists of the analysis population.|1114
10990320|NCT00635492|12165815|FG001|STARTED|Overall Study|This population consists of the analysis population.|1274
10990321|NCT00635492|12165814|FG000|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
10990322|NCT00635492|12165815|FG001|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
10990323|NCT00635492|12165814|FG000|NOT COMPLETED|Overall Study||279
10990324|NCT00635492|12165815|FG001|NOT COMPLETED|Overall Study||282
10990325|NCT00635570|12165827|FG000|STARTED|Overall Study||136
10990326|NCT00635570|12165828|FG001|STARTED|Overall Study||137
10990327|NCT00635570|12165827|FG000|COMPLETED|Overall Study||121
10990328|NCT00635570|12165828|FG001|COMPLETED|Overall Study||126
10990329|NCT00635570|12165827|FG000|NOT COMPLETED|Overall Study||15
10990330|NCT00635570|12165828|FG001|NOT COMPLETED|Overall Study||11
10990331|NCT00635609|12165836|FG000|STARTED|Overall Study||48
10990332|NCT00635609|12165837|FG001|STARTED|Overall Study||45
10990333|NCT00635609|12165836|FG000|COMPLETED|Overall Study||41
10990334|NCT00635609|12165837|FG001|COMPLETED|Overall Study||42
10990335|NCT00635609|12165836|FG000|NOT COMPLETED|Overall Study||7
10990336|NCT00635609|12165837|FG001|NOT COMPLETED|Overall Study||3
10990337|NCT00635648|12165843|FG000|STARTED|Overall Study||63
10990338|NCT00635648|12165843|FG000|COMPLETED|Overall Study||26
10990339|NCT00635648|12165843|FG000|NOT COMPLETED|Overall Study||37
10990340|NCT00635661|12165847|FG000|STARTED|Overall Study||34
10990341|NCT00635661|12165847|FG000|COMPLETED|Overall Study||30
10990342|NCT00635661|12165847|FG000|NOT COMPLETED|Overall Study||4
10990343|NCT00635739|12165853|FG000|STARTED|Overall Study||42
10990344|NCT00635739|12165854|FG001|STARTED|Overall Study||38
10990345|NCT00635739|12165853|FG000|COMPLETED|Overall Study||39
10990346|NCT00635739|12165854|FG001|COMPLETED|Overall Study||36
10990347|NCT00635739|12165853|FG000|NOT COMPLETED|Overall Study||3
10990348|NCT00635739|12165854|FG001|NOT COMPLETED|Overall Study||2
10990349|NCT00635778|12165867|FG000|STARTED|Overall Study||1
10990350|NCT00635778|12165868|FG001|STARTED|Overall Study||3
10990351|NCT00635778|12165869|FG002|STARTED|Overall Study||3
10990352|NCT00635778|12165870|FG003|STARTED|Overall Study||8
10990353|NCT00635778|12165871|FG004|STARTED|Overall Study||8
10990354|NCT00635778|12165872|FG005|STARTED|Overall Study||21
10990355|NCT00635778|12165873|FG006|STARTED|Overall Study||6
10990356|NCT00635778|12165867|FG000|COMPLETED|Overall Study||0
10990357|NCT00635778|12165868|FG001|COMPLETED|Overall Study||0
10990358|NCT00635778|12165869|FG002|COMPLETED|Overall Study||0
10990359|NCT00635778|12165870|FG003|COMPLETED|Overall Study||0
10990360|NCT00635778|12165871|FG004|COMPLETED|Overall Study||0
10990361|NCT00635778|12165872|FG005|COMPLETED|Overall Study||0
10990362|NCT00635778|12165873|FG006|COMPLETED|Overall Study||0
10990363|NCT00635778|12165867|FG000|NOT COMPLETED|Overall Study||1
10990364|NCT00635778|12165868|FG001|NOT COMPLETED|Overall Study||3
10990365|NCT00635778|12165869|FG002|NOT COMPLETED|Overall Study||3
10990366|NCT00635778|12165870|FG003|NOT COMPLETED|Overall Study||8
10990367|NCT00635778|12165871|FG004|NOT COMPLETED|Overall Study||8
10990368|NCT00635778|12165872|FG005|NOT COMPLETED|Overall Study||21
10990369|NCT00635778|12165873|FG006|NOT COMPLETED|Overall Study||6
10990370|NCT00635804|12165898|FG000|STARTED|Overall Study||7
10990371|NCT00635804|12165899|FG001|STARTED|Overall Study||6
10990372|NCT00635804|12165900|FG002|STARTED|Overall Study||6
10990373|NCT00635804|12165901|FG003|STARTED|Overall Study||6
10990374|NCT00635804|12165902|FG004|STARTED|Overall Study||6
10990375|NCT00635804|12165903|FG005|STARTED|Overall Study||12
10990376|NCT00635804|12165904|FG006|STARTED|Overall Study||3
10990377|NCT00635804|12165905|FG007|STARTED|Overall Study||14
10990378|NCT00635804|12165898|FG000|COMPLETED|Overall Study||6
10990379|NCT00635804|12165899|FG001|COMPLETED|Overall Study||6
10990380|NCT00635804|12165900|FG002|COMPLETED|Overall Study||6
10990381|NCT00635804|12165901|FG003|COMPLETED|Overall Study||6
10990382|NCT00635804|12165902|FG004|COMPLETED|Overall Study||6
10990383|NCT00635804|12165903|FG005|COMPLETED|Overall Study||11
10990384|NCT00635804|12165904|FG006|COMPLETED|Overall Study||3
10990385|NCT00635804|12165905|FG007|COMPLETED|Overall Study||14
10990386|NCT00635804|12165898|FG000|NOT COMPLETED|Overall Study||1
10990387|NCT00635804|12165899|FG001|NOT COMPLETED|Overall Study||0
10990388|NCT00635804|12165900|FG002|NOT COMPLETED|Overall Study||0
10990389|NCT00635804|12165901|FG003|NOT COMPLETED|Overall Study||0
10990390|NCT00635804|12165902|FG004|NOT COMPLETED|Overall Study||0
10990391|NCT00635804|12165903|FG005|NOT COMPLETED|Overall Study||1
10990392|NCT00635804|12165904|FG006|NOT COMPLETED|Overall Study||0
10990393|NCT00635804|12165905|FG007|NOT COMPLETED|Overall Study||0
10990394|NCT00635817|12165930|FG000|STARTED|Overall Study||21
10990395|NCT00635817|12165931|FG001|STARTED|Overall Study||21
10990396|NCT00635817|12165932|FG002|STARTED|Overall Study||21
10990397|NCT00635817|12165933|FG003|STARTED|Overall Study||21
10990398|NCT00635817|12165930|FG000|COMPLETED|Overall Study||15
10990399|NCT00635817|12165931|FG001|COMPLETED|Overall Study||19
10990400|NCT00635817|12165932|FG002|COMPLETED|Overall Study||19
10990401|NCT00635817|12165933|FG003|COMPLETED|Overall Study||21
10990402|NCT00635817|12165930|FG000|NOT COMPLETED|Overall Study||6
10990403|NCT00635817|12165931|FG001|NOT COMPLETED|Overall Study||2
10990404|NCT00635817|12165932|FG002|NOT COMPLETED|Overall Study||2
10990405|NCT00635817|12165933|FG003|NOT COMPLETED|Overall Study||0
10990406|NCT00635830|12165947|FG000|STARTED|Overall Study||20
10990407|NCT00635830|12165948|FG001|STARTED|Overall Study||20
10990408|NCT00635830|12165947|FG000|COMPLETED|Overall Study||20
10990409|NCT00635830|12165948|FG001|COMPLETED|Overall Study||20
10990410|NCT00635830|12165947|FG000|NOT COMPLETED|Overall Study||0
10990411|NCT00635830|12165948|FG001|NOT COMPLETED|Overall Study||0
10990412|NCT00635999|12165957|FG000|STARTED|Overall Study||27
10990413|NCT00635999|12165958|FG001|STARTED|Overall Study||25
10990414|NCT00635999|12165959|FG002|STARTED|Overall Study||24
10990415|NCT00635999|12165957|FG000|COMPLETED|Overall Study||23
10990416|NCT00635999|12165958|FG001|COMPLETED|Overall Study||23
10990417|NCT00635999|12165959|FG002|COMPLETED|Overall Study||23
10990418|NCT00635999|12165957|FG000|NOT COMPLETED|Overall Study||4
10990419|NCT00635999|12165958|FG001|NOT COMPLETED|Overall Study||2
10990420|NCT00635999|12165959|FG002|NOT COMPLETED|Overall Study||1
10990421|NCT00636077|12165967|FG000|STARTED|Week 1||3
10990422|NCT00636077|12165968|FG001|STARTED|Week 1||3
10990423|NCT00636077|12165969|FG002|STARTED|Week 1||3
10990424|NCT00636077|12165970|FG003|STARTED|Week 1||3
10990425|NCT00636077|12165967|FG000|COMPLETED|Week 1||3
10990426|NCT00636077|12165968|FG001|COMPLETED|Week 1||3
10990427|NCT00636077|12165969|FG002|COMPLETED|Week 1||3
10990428|NCT00636077|12165970|FG003|COMPLETED|Week 1||3
10990429|NCT00636077|12165967|FG000|NOT COMPLETED|Week 1||0
10990430|NCT00636077|12165968|FG001|NOT COMPLETED|Week 1||0
10990431|NCT00636077|12165969|FG002|NOT COMPLETED|Week 1||0
10990432|NCT00636077|12165970|FG003|NOT COMPLETED|Week 1||0
10990433|NCT00636077|12165967|FG000|STARTED|Week 2||3
10990434|NCT00636077|12165968|FG001|STARTED|Week 2||3
10990435|NCT00636077|12165969|FG002|STARTED|Week 2||3
10990436|NCT00636077|12165970|FG003|STARTED|Week 2||3
10990437|NCT00636077|12165967|FG000|COMPLETED|Week 2||3
10990438|NCT00636077|12165968|FG001|COMPLETED|Week 2||3
10990439|NCT00636077|12165969|FG002|COMPLETED|Week 2||3
10990440|NCT00636077|12165970|FG003|COMPLETED|Week 2||3
10990441|NCT00636077|12165967|FG000|NOT COMPLETED|Week 2||0
10990442|NCT00636077|12165968|FG001|NOT COMPLETED|Week 2||0
10990443|NCT00636077|12165969|FG002|NOT COMPLETED|Week 2||0
10990444|NCT00636077|12165970|FG003|NOT COMPLETED|Week 2||0
10990445|NCT00636077|12165967|FG000|STARTED|Week 3||3
10990446|NCT00636077|12165968|FG001|STARTED|Week 3||3
10990447|NCT00636077|12165969|FG002|STARTED|Week 3||3
10990448|NCT00636077|12165970|FG003|STARTED|Week 3||3
10990449|NCT00636077|12165967|FG000|COMPLETED|Week 3||3
10990450|NCT00636077|12165968|FG001|COMPLETED|Week 3||3
10990451|NCT00636077|12165969|FG002|COMPLETED|Week 3||3
10990452|NCT00636077|12165970|FG003|COMPLETED|Week 3||3
10990453|NCT00636077|12165967|FG000|NOT COMPLETED|Week 3||0
10990454|NCT00636077|12165968|FG001|NOT COMPLETED|Week 3||0
10990455|NCT00636077|12165969|FG002|NOT COMPLETED|Week 3||0
10990456|NCT00636077|12165970|FG003|NOT COMPLETED|Week 3||0
10990457|NCT00636077|12165967|FG000|STARTED|Week 4||3
10990458|NCT00636077|12165968|FG001|STARTED|Week 4||3
10990459|NCT00636077|12165969|FG002|STARTED|Week 4||3
10990460|NCT00636077|12165970|FG003|STARTED|Week 4||3
10990461|NCT00636077|12165967|FG000|COMPLETED|Week 4||3
10990462|NCT00636077|12165968|FG001|COMPLETED|Week 4||3
10990463|NCT00636077|12165969|FG002|COMPLETED|Week 4||3
10990464|NCT00636077|12165970|FG003|COMPLETED|Week 4||3
10990465|NCT00636077|12165967|FG000|NOT COMPLETED|Week 4||0
10990466|NCT00636077|12165968|FG001|NOT COMPLETED|Week 4||0
10990467|NCT00636077|12165969|FG002|NOT COMPLETED|Week 4||0
10990468|NCT00636077|12165970|FG003|NOT COMPLETED|Week 4||0
10990469|NCT00636155|12165980|FG000|STARTED|Overall Study||20
10990470|NCT00636155|12165980|FG000|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
10990471|NCT00636155|12165980|FG000|NOT COMPLETED|Overall Study||18
10990472|NCT00636168|12165986|FG000|STARTED|Randomized to Study Drug||475
10990473|NCT00636168|12165987|FG001|STARTED|Randomized to Study Drug||476
10990474|NCT00636168|12165986|FG000|COMPLETED|Randomized to Study Drug||471
10990475|NCT00636168|12165987|FG001|COMPLETED|Randomized to Study Drug||474
10990476|NCT00636168|12165986|FG000|NOT COMPLETED|Randomized to Study Drug||4
10990477|NCT00636168|12165987|FG001|NOT COMPLETED|Randomized to Study Drug||2
10990478|NCT00636168|12165986|FG000|STARTED|Treated With Study Drug||471
10990479|NCT00636168|12165987|FG001|STARTED|Treated With Study Drug||474
10990480|NCT00636168|12165986|FG000|COMPLETED|Treated With Study Drug||63
10990481|NCT00636168|12165987|FG001|COMPLETED|Treated With Study Drug||143
10990482|NCT00636168|12165986|FG000|NOT COMPLETED|Treated With Study Drug||408
10990483|NCT00636168|12165987|FG001|NOT COMPLETED|Treated With Study Drug||331
10990484|NCT00636168|12165986|FG000|STARTED|Long Term Follow-Up||141
10990485|NCT00636168|12165987|FG001|STARTED|Long Term Follow-Up||143
10990486|NCT00636168|12165986|FG000|COMPLETED|Long Term Follow-Up||130
10990487|NCT00636168|12165987|FG001|COMPLETED|Long Term Follow-Up||129
10990488|NCT00636168|12165986|FG000|NOT COMPLETED|Long Term Follow-Up||11
10990489|NCT00636168|12165987|FG001|NOT COMPLETED|Long Term Follow-Up||14
10990490|NCT00636181|12165996|FG000|STARTED|Overall Study||54
10990491|NCT00636181|12165997|FG001|STARTED|Overall Study||53
10990492|NCT00636181|12165998|FG002|STARTED|Overall Study||57
10990493|NCT00636181|12165996|FG000|COMPLETED|Overall Study||46
10990494|NCT00636181|12165997|FG001|COMPLETED|Overall Study||47
10990495|NCT00636181|12165998|FG002|COMPLETED|Overall Study||47
10990496|NCT00636181|12165996|FG000|NOT COMPLETED|Overall Study||8
10990497|NCT00636181|12165997|FG001|NOT COMPLETED|Overall Study||6
10990498|NCT00636181|12165998|FG002|NOT COMPLETED|Overall Study||10
10990499|NCT00636194|12166008|FG000|STARTED|Overall Study||175
10990500|NCT00636194|12166009|FG001|STARTED|Overall Study||175
10990501|NCT00636194|12166008|FG000|COMPLETED|Overall Study||172
10990502|NCT00636194|12166009|FG001|COMPLETED|Overall Study||175
10990503|NCT00636194|12166008|FG000|NOT COMPLETED|Overall Study||3
10990504|NCT00636194|12166009|FG001|NOT COMPLETED|Overall Study||0
10990505|NCT00636207|12166018|FG000|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
10990506|NCT00636207|12166019|FG001|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
10990507|NCT00636207|12166020|FG002|STARTED|Overall Study||18
10990508|NCT00636207|12166021|FG003|STARTED|Overall Study||6
10990509|NCT00636207|12166022|FG004|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
10990510|NCT00636207|12166023|FG005|STARTED|Overall Study||1
10990511|NCT00636207|12166024|FG006|STARTED|Overall Study||3
10990512|NCT00636207|12166018|FG000|COMPLETED|Overall Study||0
10990513|NCT00636207|12166019|FG001|COMPLETED|Overall Study||7
10990514|NCT00636207|12166020|FG002|COMPLETED|Overall Study||18
10990515|NCT00636207|12166021|FG003|COMPLETED|Overall Study||6
10990516|NCT00636207|12166022|FG004|COMPLETED|Overall Study||8
10990517|NCT00636207|12166023|FG005|COMPLETED|Overall Study||1
10990518|NCT00636207|12166024|FG006|COMPLETED|Overall Study||3
10990519|NCT00636207|12166018|FG000|NOT COMPLETED|Overall Study||1
10990520|NCT00636207|12166019|FG001|NOT COMPLETED|Overall Study||1
10990521|NCT00636207|12166020|FG002|NOT COMPLETED|Overall Study||0
10990522|NCT00636207|12166021|FG003|NOT COMPLETED|Overall Study||0
10990523|NCT00636207|12166022|FG004|NOT COMPLETED|Overall Study||1
10990524|NCT00636207|12166023|FG005|NOT COMPLETED|Overall Study||0
10990525|NCT00636207|12166024|FG006|NOT COMPLETED|Overall Study||0
10990526|NCT00636220|12166045|FG000|STARTED|Overall Study||101
10990527|NCT00636220|12166045|FG000|COMPLETED|Overall Study||101
10990528|NCT00636220|12166045|FG000|NOT COMPLETED|Overall Study||0
10990529|NCT00636363|12166052|FG000|STARTED|Overall Study||178
10990530|NCT00636363|12166053|FG001|STARTED|Overall Study||176
10990531|NCT00636363|12166054|FG002|STARTED|Overall Study||181
10990532|NCT00636363|12166052|FG000|COMPLETED|Overall Study||165
10990533|NCT00636363|12166053|FG001|COMPLETED|Overall Study||156
10990534|NCT00636363|12166054|FG002|COMPLETED|Overall Study||163
10990535|NCT00636363|12166052|FG000|NOT COMPLETED|Overall Study||13
10990536|NCT00636363|12166053|FG001|NOT COMPLETED|Overall Study||20
10990537|NCT00636363|12166054|FG002|NOT COMPLETED|Overall Study||18
10990538|NCT00636389|12166062|FG000|STARTED|Period 1 - 1 Week||7
10990539|NCT00636389|12166063|FG001|STARTED|Period 1 - 1 Week||5
10990540|NCT00636389|12166062|FG000|COMPLETED|Period 1 - 1 Week||7
10990541|NCT00636389|12166063|FG001|COMPLETED|Period 1 - 1 Week||5
10990542|NCT00636389|12166062|FG000|NOT COMPLETED|Period 1 - 1 Week||0
10990543|NCT00636389|12166063|FG001|NOT COMPLETED|Period 1 - 1 Week||0
10990544|NCT00636389|12166062|FG000|STARTED|Period 2 - 1 Week||7
10990545|NCT00636389|12166063|FG001|STARTED|Period 2 - 1 Week||5
10990546|NCT00636389|12166062|FG000|COMPLETED|Period 2 - 1 Week||7
10990547|NCT00636389|12166063|FG001|COMPLETED|Period 2 - 1 Week||5
10990548|NCT00636389|12166062|FG000|NOT COMPLETED|Period 2 - 1 Week||0
10990549|NCT00636389|12166063|FG001|NOT COMPLETED|Period 2 - 1 Week||0
10990550|NCT00636441|12166076|FG000|STARTED|Overall Study||6
10990551|NCT00636441|12166077|FG001|STARTED|Overall Study||7
10990552|NCT00636441|12166078|FG002|STARTED|Overall Study||6
10990553|NCT00636441|12166079|FG003|STARTED|Overall Study||6
10990554|NCT00636441|12166080|FG004|STARTED|Overall Study||6
10990555|NCT00636441|12166081|FG005|STARTED|Overall Study||7
10990556|NCT00636441|12166082|FG006|STARTED|Overall Study||18
10990557|NCT00636441|12166076|FG000|Assigned Treatment|Overall Study||6
10990558|NCT00636441|12166077|FG001|Assigned Treatment|Overall Study||7
10990559|NCT00636441|12166078|FG002|Assigned Treatment|Overall Study||6
10990560|NCT00636441|12166079|FG003|Assigned Treatment|Overall Study||6
10990561|NCT00636441|12166080|FG004|Assigned Treatment|Overall Study||6
10990562|NCT00636441|12166081|FG005|Assigned Treatment|Overall Study||7
10990563|NCT00636441|12166082|FG006|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
10990564|NCT00636441|12166076|FG000|COMPLETED|Overall Study||6
10990565|NCT00636441|12166077|FG001|COMPLETED|Overall Study||6
10990566|NCT00636441|12166078|FG002|COMPLETED|Overall Study||5
10990567|NCT00636441|12166079|FG003|COMPLETED|Overall Study||6
10990568|NCT00636441|12166080|FG004|COMPLETED|Overall Study||6
10990569|NCT00636441|12166081|FG005|COMPLETED|Overall Study||6
10990570|NCT00636441|12166082|FG006|COMPLETED|Overall Study||0
10990571|NCT00636441|12166076|FG000|NOT COMPLETED|Overall Study||0
10990572|NCT00636441|12166077|FG001|NOT COMPLETED|Overall Study||1
10990573|NCT00636441|12166078|FG002|NOT COMPLETED|Overall Study||1
10990574|NCT00636441|12166079|FG003|NOT COMPLETED|Overall Study||0
10990575|NCT00636441|12166080|FG004|NOT COMPLETED|Overall Study||0
10990576|NCT00636441|12166081|FG005|NOT COMPLETED|Overall Study||1
10990577|NCT00636441|12166082|FG006|NOT COMPLETED|Overall Study||18
10990578|NCT00636506|12166093|FG000|STARTED|Overall Study||76
10990579|NCT00636506|12166093|FG000|COMPLETED|Overall Study||60
10990580|NCT00636506|12166093|FG000|NOT COMPLETED|Overall Study||16
10990581|NCT00636610|12166117|FG000|STARTED|Overall Study||98
10990582|NCT00636610|12166118|FG001|STARTED|Overall Study||101
10990583|NCT00636610|12166117|FG000|COMPLETED|Overall Study||6
10990584|NCT00636610|12166118|FG001|COMPLETED|Overall Study||18
10990585|NCT00636610|12166117|FG000|NOT COMPLETED|Overall Study||92
10990586|NCT00636610|12166118|FG001|NOT COMPLETED|Overall Study||83
10990587|NCT00636636|12166128|FG000|STARTED|Overall Study||221
10990588|NCT00636636|12166129|FG001|STARTED|Overall Study||231
10990589|NCT00636636|12166128|FG000|Safety & Efficacy of Gabapentin ER|Overall Study||186
10990590|NCT00636636|12166129|FG001|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
10990591|NCT00636636|12166128|FG000|379|Overall Study||186
10990592|NCT00636636|12166129|FG001|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
10990593|NCT00636636|12166128|FG000|COMPLETED|Overall Study||185
10990594|NCT00636636|12166129|FG001|COMPLETED|Overall Study||192
10990595|NCT00636636|12166128|FG000|NOT COMPLETED|Overall Study||36
10990596|NCT00636636|12166129|FG001|NOT COMPLETED|Overall Study||39
10990597|NCT00636649|12166137|FG000|STARTED|Overall Study||20
10990598|NCT00636649|12166138|FG001|STARTED|Overall Study||20
10990599|NCT00636649|12166137|FG000|COMPLETED|Overall Study||20
10990600|NCT00636649|12166138|FG001|COMPLETED|Overall Study||20
10990601|NCT00636649|12166137|FG000|NOT COMPLETED|Overall Study||0
10990602|NCT00636649|12166138|FG001|NOT COMPLETED|Overall Study||0
10990603|NCT00636675|12166150|FG000|STARTED|Overall Study||951
10990604|NCT00636675|12166151|FG001|STARTED|Overall Study||775
10990605|NCT00636675|12166150|FG000|COMPLETED|Overall Study||811
10990606|NCT00636675|12166151|FG001|COMPLETED|Overall Study||734
10990607|NCT00636675|12166150|FG000|NOT COMPLETED|Overall Study||140
10990608|NCT00636675|12166151|FG001|NOT COMPLETED|Overall Study||41
10990609|NCT00636701|12166159|FG000|STARTED|Overall Study||2
10990610|NCT00636701|12166160|FG001|STARTED|Overall Study||2
10990611|NCT00636701|12166159|FG000|COMPLETED|Overall Study||2
10990612|NCT00636701|12166160|FG001|COMPLETED|Overall Study||2
10990613|NCT00636701|12166159|FG000|NOT COMPLETED|Overall Study||0
10990614|NCT00636701|12166160|FG001|NOT COMPLETED|Overall Study||0
10990615|NCT00636792|12166166|FG000|STARTED|Overall Study||73
10990616|NCT00636792|12166166|FG000|COMPLETED|Overall Study||40
10990617|NCT00636792|12166166|FG000|NOT COMPLETED|Overall Study||33
10990618|NCT00636805|12166170|FG000|STARTED|Overall Study||63
10990619|NCT00636805|12166170|FG000|COMPLETED|Overall Study||63
10990620|NCT00636805|12166170|FG000|NOT COMPLETED|Overall Study||0
10990621|NCT00636818|12166174|FG000|STARTED|Overall Study||45
10990622|NCT00636818|12166174|FG000|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
10990623|NCT00636818|12166174|FG000|COMPLETED|Overall Study||34
10990624|NCT00636818|12166174|FG000|NOT COMPLETED|Overall Study||11
10990625|NCT00636961|12166180|FG000|STARTED|Period 1||14
10990626|NCT00636961|12166181|FG001|STARTED|Period 1||13
10990627|NCT00636961|12166180|FG000|COMPLETED|Period 1||13
10990628|NCT00636961|12166181|FG001|COMPLETED|Period 1||12
10990629|NCT00636961|12166180|FG000|NOT COMPLETED|Period 1||1
10990630|NCT00636961|12166181|FG001|NOT COMPLETED|Period 1||1
10990631|NCT00636961|12166180|FG000|STARTED|Period 2||13
10990632|NCT00636961|12166181|FG001|STARTED|Period 2||12
10990633|NCT00636961|12166180|FG000|COMPLETED|Period 2||12
10990634|NCT00636961|12166181|FG001|COMPLETED|Period 2||12
10990635|NCT00636961|12166180|FG000|NOT COMPLETED|Period 2||1
10990636|NCT00636961|12166181|FG001|NOT COMPLETED|Period 2||0
10990637|NCT00636987|12166187|FG000|STARTED|Overall Study||297
10990638|NCT00636987|12166187|FG000|COMPLETED|Overall Study||108
10990639|NCT00636987|12166187|FG000|NOT COMPLETED|Overall Study||189
10990640|NCT00637000|12166197|FG000|STARTED|Overall Study|Randomized and treated|20
10990641|NCT00637000|12166198|FG001|STARTED|Overall Study|Randomized and treated|18
10990642|NCT00637000|12166197|FG000|Evaluable|Overall Study||18
10990643|NCT00637000|12166198|FG001|Evaluable|Overall Study||16
10990644|NCT00637000|12166197|FG000|COMPLETED|Overall Study||16
10990645|NCT00637000|12166198|FG001|COMPLETED|Overall Study||15
10990646|NCT00637000|12166197|FG000|NOT COMPLETED|Overall Study||4
10990647|NCT00637000|12166198|FG001|NOT COMPLETED|Overall Study||3
10990648|NCT00637156|12166206|FG000|STARTED|Overall Study||209
10990649|NCT00637156|12166207|FG001|STARTED|Overall Study||188
10990650|NCT00637156|12166206|FG000|COMPLETED|Overall Study||199
10990651|NCT00637156|12166207|FG001|COMPLETED|Overall Study||164
10990652|NCT00637156|12166206|FG000|NOT COMPLETED|Overall Study||10
10990653|NCT00637156|12166207|FG001|NOT COMPLETED|Overall Study||24
10990654|NCT00637195|12166215|FG000|STARTED|Overall Study||76
10990655|NCT00637195|12166216|FG001|STARTED|Overall Study||76
10990656|NCT00637195|12166215|FG000|COMPLETED|Overall Study||73
10990657|NCT00637195|12166216|FG001|COMPLETED|Overall Study||75
10990658|NCT00637195|12166215|FG000|NOT COMPLETED|Overall Study||3
10990659|NCT00637195|12166216|FG001|NOT COMPLETED|Overall Study||1
10990660|NCT00637247|12166224|FG000|STARTED|Overall Study||72
10990661|NCT00637247|12166225|FG001|STARTED|Overall Study||70
10990662|NCT00637247|12166224|FG000|COMPLETED|Overall Study||72
10990663|NCT00637247|12166225|FG001|COMPLETED|Overall Study||70
10990664|NCT00637247|12166224|FG000|NOT COMPLETED|Overall Study||0
10990665|NCT00637247|12166225|FG001|NOT COMPLETED|Overall Study||0
10990666|NCT00637273|12166236|FG000|STARTED|Overall Study||170
10990667|NCT00637273|12166237|FG001|STARTED|Overall Study||172
10990668|NCT00637273|12166238|FG002|STARTED|Overall Study||172
10990669|NCT00637273|12166236|FG000|Intent to Treat (ITT)|Overall Study||160
10990670|NCT00637273|12166237|FG001|Intent to Treat (ITT)|Overall Study||166
10990671|NCT00637273|12166238|FG002|Intent to Treat (ITT)|Overall Study||165
10990672|NCT00637273|12166236|FG000|COMPLETED|Overall Study||127
10990673|NCT00637273|12166237|FG001|COMPLETED|Overall Study||144
10990674|NCT00637273|12166238|FG002|COMPLETED|Overall Study||131
10990675|NCT00637273|12166236|FG000|NOT COMPLETED|Overall Study||43
10990676|NCT00637273|12166237|FG001|NOT COMPLETED|Overall Study||28
10990677|NCT00637273|12166238|FG002|NOT COMPLETED|Overall Study||41
10990678|NCT00637299|12166248|FG000|STARTED|Overall Study||10
10990679|NCT00637299|12166249|FG001|STARTED|Overall Study||10
10990680|NCT00637299|12166248|FG000|COMPLETED|Overall Study||10
10990681|NCT00637299|12166249|FG001|COMPLETED|Overall Study||10
10990682|NCT00637299|12166248|FG000|NOT COMPLETED|Overall Study||0
10990683|NCT00637299|12166249|FG001|NOT COMPLETED|Overall Study||0
10990684|NCT00637377|12166259|FG000|STARTED|Overall Study||303
10990685|NCT00637377|12166260|FG001|STARTED|Overall Study||313
10990686|NCT00637377|12166261|FG002|STARTED|Overall Study||311
10990687|NCT00637377|12166262|FG003|STARTED|Overall Study||313
10990688|NCT00637377|12166259|FG000|Participants Received Treatment|Overall Study|safety population|291
10990689|NCT00637377|12166260|FG001|Participants Received Treatment|Overall Study|safety population|309
10990690|NCT00637377|12166261|FG002|Participants Received Treatment|Overall Study|safety population|297
10990691|NCT00637377|12166262|FG003|Participants Received Treatment|Overall Study|safety population|307
10990692|NCT00637377|12166259|FG000|Participants Treated (FAS)|Overall Study||291
10990693|NCT00637377|12166260|FG001|Participants Treated (FAS)|Overall Study||309
10990694|NCT00637377|12166261|FG002|Participants Treated (FAS)|Overall Study||296
10990695|NCT00637377|12166262|FG003|Participants Treated (FAS)|Overall Study||306
10990696|NCT00637377|12166259|FG000|COMPLETED|Overall Study||276
10990697|NCT00637377|12166260|FG001|COMPLETED|Overall Study||281
10990698|NCT00637377|12166261|FG002|COMPLETED|Overall Study||274
10990699|NCT00637377|12166262|FG003|COMPLETED|Overall Study||284
10990700|NCT00637377|12166259|FG000|NOT COMPLETED|Overall Study||27
10990701|NCT00637377|12166260|FG001|NOT COMPLETED|Overall Study||32
10990702|NCT00637377|12166261|FG002|NOT COMPLETED|Overall Study||37
10990703|NCT00637377|12166262|FG003|NOT COMPLETED|Overall Study||29
10990704|NCT00637494|12166274|FG000|STARTED|Overall Study||141
10990705|NCT00637494|12166275|FG001|STARTED|Overall Study||151
10990706|NCT00637494|12166274|FG000|COMPLETED|Overall Study||109
10990707|NCT00637494|12166275|FG001|COMPLETED|Overall Study||108
10990708|NCT00637494|12166274|FG000|NOT COMPLETED|Overall Study||32
10990709|NCT00637494|12166275|FG001|NOT COMPLETED|Overall Study||43
10990710|NCT00637572|12166283|FG000|STARTED|Overall Study||32
10990711|NCT00637572|12166284|FG001|STARTED|Overall Study||31
10990712|NCT00637572|12166283|FG000|COMPLETED|Overall Study||29
10990713|NCT00637572|12166284|FG001|COMPLETED|Overall Study||24
10990714|NCT00637572|12166283|FG000|NOT COMPLETED|Overall Study||3
10990715|NCT00637572|12166284|FG001|NOT COMPLETED|Overall Study||7
10990716|NCT00637780|12166290|FG000|STARTED|Overall Study||2
10990717|NCT00637780|12166290|FG000|COMPLETED|Overall Study||2
10990718|NCT00637780|12166290|FG000|NOT COMPLETED|Overall Study||0
10990719|NCT00637923|12166296|FG000|STARTED|Overall Study||75
10990720|NCT00637923|12166297|FG001|STARTED|Overall Study||37
10990721|NCT00637923|12166296|FG000|COMPLETED|Overall Study||45
10990722|NCT00637923|12166297|FG001|COMPLETED|Overall Study||18
10990723|NCT00637923|12166296|FG000|NOT COMPLETED|Overall Study||30
10990724|NCT00637923|12166297|FG001|NOT COMPLETED|Overall Study||19
10990725|NCT00638014|12166305|FG000|STARTED|Overall Study||23
10990726|NCT00638014|12166306|FG001|STARTED|Overall Study||28
10990727|NCT00638014|12166305|FG000|COMPLETED|Overall Study||23
10990728|NCT00638014|12166306|FG001|COMPLETED|Overall Study||28
10990729|NCT00638014|12166305|FG000|NOT COMPLETED|Overall Study||0
10990730|NCT00638014|12166306|FG001|NOT COMPLETED|Overall Study||0
10990731|NCT00638027|12166314|FG000|STARTED|Overall Study||11
10990732|NCT00638027|12166315|FG001|STARTED|Overall Study||10
10990733|NCT00638027|12166314|FG000|COMPLETED|Overall Study||11
10990734|NCT00638027|12166315|FG001|COMPLETED|Overall Study|all 10 included in analyses|8
10990735|NCT00638027|12166314|FG000|NOT COMPLETED|Overall Study||0
10990736|NCT00638027|12166315|FG001|NOT COMPLETED|Overall Study||2
10990737|NCT00638157|12166323|FG000|STARTED|Overall Study||12
10990738|NCT00638157|12166324|FG001|STARTED|Overall Study||12
10990739|NCT00638157|12166323|FG000|Treated|Overall Study||10
10990740|NCT00638157|12166324|FG001|Treated|Overall Study||12
10990741|NCT00638157|12166323|FG000|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
10990742|NCT00638157|12166324|FG001|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
10990743|NCT00638157|12166323|FG000|NOT COMPLETED|Overall Study||7
10990744|NCT00638157|12166324|FG001|NOT COMPLETED|Overall Study||4
10990745|NCT00638183|12166331|FG000|STARTED|Overall Study||385
10990746|NCT00638183|12166331|FG000|COMPLETED|Overall Study||266
10990747|NCT00638183|12166331|FG000|NOT COMPLETED|Overall Study||119
10990748|NCT00638235|12166344|FG000|STARTED|Overall Study||141
10990749|NCT00638235|12166345|FG001|STARTED|Overall Study||26
10990750|NCT00638235|12166346|FG002|STARTED|Overall Study||81
10990751|NCT00638235|12166347|FG003|STARTED|Overall Study||56
10990752|NCT00638235|12166348|FG004|STARTED|Overall Study||55
10990753|NCT00638235|12166349|FG005|STARTED|Overall Study||139
10990754|NCT00638235|12166350|FG006|STARTED|Overall Study||23
10990755|NCT00638235|12166351|FG007|STARTED|Overall Study||35
10990756|NCT00638235|12166352|FG008|STARTED|Overall Study||142
10990757|NCT00638235|12166344|FG000|COMPLETED|Overall Study||110
10990758|NCT00638235|12166345|FG001|COMPLETED|Overall Study||23
10990759|NCT00638235|12166346|FG002|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
10990760|NCT00638235|12166347|FG003|COMPLETED|Overall Study||46
10990761|NCT00638235|12166348|FG004|COMPLETED|Overall Study||42
10990762|NCT00638235|12166349|FG005|COMPLETED|Overall Study||113
10990763|NCT00638235|12166350|FG006|COMPLETED|Overall Study||23
10990764|NCT00638235|12166351|FG007|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
10990765|NCT00638235|12166352|FG008|COMPLETED|Overall Study||124
10990766|NCT00638235|12166344|FG000|NOT COMPLETED|Overall Study||31
10990767|NCT00638235|12166345|FG001|NOT COMPLETED|Overall Study||3
10990768|NCT00638235|12166346|FG002|NOT COMPLETED|Overall Study||18
10990769|NCT00638235|12166347|FG003|NOT COMPLETED|Overall Study||10
10990770|NCT00638235|12166348|FG004|NOT COMPLETED|Overall Study||13
10990771|NCT00638235|12166349|FG005|NOT COMPLETED|Overall Study||26
10990772|NCT00638235|12166350|FG006|NOT COMPLETED|Overall Study||0
10990773|NCT00638235|12166351|FG007|NOT COMPLETED|Overall Study||1
10990774|NCT00638235|12166352|FG008|NOT COMPLETED|Overall Study||18
10990775|NCT00638274|12166381|FG000|STARTED|Overall Study||179
10990776|NCT00638274|12166382|FG001|STARTED|Overall Study||177
10990777|NCT00638274|12166381|FG000|COMPLETED|Overall Study||173
10990778|NCT00638274|12166382|FG001|COMPLETED|Overall Study||172
10990779|NCT00638274|12166381|FG000|NOT COMPLETED|Overall Study||6
10990780|NCT00638274|12166382|FG001|NOT COMPLETED|Overall Study||5
10990781|NCT00638365|12166391|FG000|STARTED|Overall Study||9
10990782|NCT00638365|12166392|FG001|STARTED|Overall Study||10
10990783|NCT00638365|12166393|FG002|STARTED|Overall Study||8
10990784|NCT00638365|12166391|FG000|COMPLETED|Overall Study||9
10990785|NCT00638365|12166392|FG001|COMPLETED|Overall Study||10
10990786|NCT00638365|12166393|FG002|COMPLETED|Overall Study||8
10990787|NCT00638365|12166391|FG000|NOT COMPLETED|Overall Study||0
10990788|NCT00638365|12166392|FG001|NOT COMPLETED|Overall Study||0
10990789|NCT00638365|12166393|FG002|NOT COMPLETED|Overall Study||0
10990790|NCT00638378|12166401|FG000|STARTED|Overall Study||22
10990791|NCT00638378|12166401|FG000|COMPLETED|Overall Study||0
10990792|NCT00638378|12166401|FG000|NOT COMPLETED|Overall Study||22
10990793|NCT00638404|12166407|FG000|STARTED|Overall Study||200
10990794|NCT00638404|12166408|FG001|STARTED|Overall Study||100
10990795|NCT00638404|12166407|FG000|COMPLETED|Overall Study||192
10990796|NCT00638404|12166408|FG001|COMPLETED|Overall Study||100
10990797|NCT00638404|12166407|FG000|NOT COMPLETED|Overall Study||8
10990798|NCT00638404|12166408|FG001|NOT COMPLETED|Overall Study||0
10990799|NCT00638443|12166418|FG000|STARTED|First Intervention||14
10990800|NCT00638443|12166419|FG001|STARTED|First Intervention||15
10990801|NCT00638443|12166418|FG000|COMPLETED|First Intervention||12
10990802|NCT00638443|12166419|FG001|COMPLETED|First Intervention||14
10990803|NCT00638443|12166418|FG000|NOT COMPLETED|First Intervention||2
10990804|NCT00638443|12166419|FG001|NOT COMPLETED|First Intervention||1
10990805|NCT00638443|12166418|FG000|STARTED|Washout||12
10990806|NCT00638443|12166419|FG001|STARTED|Washout||14
10990807|NCT00638443|12166418|FG000|COMPLETED|Washout||12
10990808|NCT00638443|12166419|FG001|COMPLETED|Washout||14
10990809|NCT00638443|12166418|FG000|NOT COMPLETED|Washout||0
10990810|NCT00638443|12166419|FG001|NOT COMPLETED|Washout||0
10990811|NCT00638443|12166418|FG000|STARTED|Second Intervention||12
10990812|NCT00638443|12166419|FG001|STARTED|Second Intervention||14
10990813|NCT00638443|12166418|FG000|COMPLETED|Second Intervention||12
10990814|NCT00638443|12166419|FG001|COMPLETED|Second Intervention||14
10990815|NCT00638443|12166418|FG000|NOT COMPLETED|Second Intervention||0
10990816|NCT00638443|12166419|FG001|NOT COMPLETED|Second Intervention||0
10990817|NCT00638456|12166429|FG000|STARTED|Overall Study||21
10990818|NCT00638456|12166430|FG001|STARTED|Overall Study||11
10990819|NCT00638456|12166429|FG000|COMPLETED|Overall Study||15
10990820|NCT00638456|12166430|FG001|COMPLETED|Overall Study||9
10990821|NCT00638456|12166429|FG000|NOT COMPLETED|Overall Study||6
10990822|NCT00638456|12166430|FG001|NOT COMPLETED|Overall Study||2
10990823|NCT00638508|12166438|FG000|STARTED|Overall Study||35
10990824|NCT00638508|12166439|FG001|STARTED|Overall Study||32
10990825|NCT00638508|12166438|FG000|COMPLETED|Overall Study||30
10990826|NCT00638508|12166439|FG001|COMPLETED|Overall Study||30
10990827|NCT00638508|12166438|FG000|NOT COMPLETED|Overall Study||5
10990828|NCT00638508|12166439|FG001|NOT COMPLETED|Overall Study||2
10990829|NCT00638651|12166449|FG000|STARTED|Overall Study||3
10990830|NCT00638651|12166449|FG000|COMPLETED|Overall Study||3
10990831|NCT00638651|12166449|FG000|NOT COMPLETED|Overall Study||0
10990832|NCT00638690|12166456|FG000|STARTED|Overall Study||797
10990833|NCT00638690|12166457|FG001|STARTED|Overall Study||398
10990834|NCT00638690|12166456|FG000|COMPLETED|Overall Study||116
10990835|NCT00638690|12166457|FG001|COMPLETED|Overall Study||56
10990836|NCT00638690|12166456|FG000|NOT COMPLETED|Overall Study||681
10990837|NCT00638690|12166457|FG001|NOT COMPLETED|Overall Study||342
10990838|NCT00638716|12166467|FG000|STARTED|Overall Study||50
10990839|NCT00638716|12166468|FG001|STARTED|Overall Study||52
10990840|NCT00638716|12166469|FG002|STARTED|Overall Study||58
10990841|NCT00638716|12166467|FG000|COMPLETED|Overall Study||43
10990842|NCT00638716|12166468|FG001|COMPLETED|Overall Study||37
10990843|NCT00638716|12166469|FG002|COMPLETED|Overall Study||46
10990844|NCT00638716|12166467|FG000|NOT COMPLETED|Overall Study||7
10990845|NCT00638716|12166468|FG001|NOT COMPLETED|Overall Study||15
10990846|NCT00638716|12166469|FG002|NOT COMPLETED|Overall Study||12
10990847|NCT00638820|12166477|FG000|STARTED|Overall Study||3
10990848|NCT00638820|12166477|FG000|COMPLETED|Overall Study||3
10990849|NCT00638820|12166477|FG000|NOT COMPLETED|Overall Study||0
10990850|NCT00638846|12166483|FG000|STARTED|Overall Study||137
10990851|NCT00638846|12166484|FG001|STARTED|Overall Study||139
10990852|NCT00638846|12166483|FG000|COMPLETED|Overall Study||133
10990853|NCT00638846|12166484|FG001|COMPLETED|Overall Study||133
10990854|NCT00638846|12166483|FG000|NOT COMPLETED|Overall Study||4
10990855|NCT00638846|12166484|FG001|NOT COMPLETED|Overall Study||6
10990856|NCT00638885|12166490|FG000|STARTED|Overall Study||142
10990857|NCT00638885|12166490|FG000|COMPLETED|Overall Study||142
10990858|NCT00638885|12166490|FG000|NOT COMPLETED|Overall Study||0
10990859|NCT00638924|12166494|FG000|STARTED|Overall Study||40
10990860|NCT00638924|12166494|FG000|2 Months|Overall Study||40
10990861|NCT00638924|12166494|FG000|COMPLETED|Overall Study||40
10990862|NCT00638924|12166494|FG000|NOT COMPLETED|Overall Study||0
10990863|NCT00638937|12166498|FG000|STARTED|Overall Study||37
10990864|NCT00638937|12166498|FG000|COMPLETED|Overall Study||37
10990865|NCT00638937|12166498|FG000|NOT COMPLETED|Overall Study||0
10990866|NCT00638963|12166506|FG000|STARTED|Overall Study|Received randomized treatment assignment|3
10990867|NCT00638963|12166507|FG001|STARTED|Overall Study|Received randomized treatment assignment|3
10990868|NCT00638963|12166506|FG000|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
10990869|NCT00638963|12166507|FG001|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
10990870|NCT00638963|12166506|FG000|NOT COMPLETED|Overall Study||1
10990871|NCT00638963|12166507|FG001|NOT COMPLETED|Overall Study||0
10990872|NCT00638989|12166516|FG000|STARTED|Overall Study||10
10990873|NCT00638989|12166517|FG001|STARTED|Overall Study||10
10990874|NCT00638989|12166518|FG002|STARTED|Overall Study||10
10990875|NCT00638989|12166516|FG000|COMPLETED|Overall Study||10
10990876|NCT00638989|12166517|FG001|COMPLETED|Overall Study||10
10990877|NCT00638989|12166518|FG002|COMPLETED|Overall Study||9
10990878|NCT00638989|12166516|FG000|NOT COMPLETED|Overall Study||0
10990879|NCT00638989|12166517|FG001|NOT COMPLETED|Overall Study||0
10990880|NCT00638989|12166518|FG002|NOT COMPLETED|Overall Study||1
10990881|NCT00639002|12166528|FG000|STARTED|Overall Study||13
10990882|NCT00639002|12166528|FG000|Received Ruxolitinib|Overall Study||13
10990883|NCT00639002|12166528|FG000|Received Ruxolitinib + Dexamethasone|Overall Study||7
10990884|NCT00639002|12166528|FG000|COMPLETED|Overall Study||0
10990885|NCT00639002|12166528|FG000|NOT COMPLETED|Overall Study||13
10990886|NCT00639093|12166535|FG000|STARTED|Overall Study|45|45
10990887|NCT00639093|12166536|FG001|STARTED|Overall Study|46|46
10990888|NCT00639093|12166535|FG000|COMPLETED|Overall Study|45|45
10990889|NCT00639093|12166536|FG001|COMPLETED|Overall Study|46|46
10990890|NCT00639093|12166535|FG000|NOT COMPLETED|Overall Study||0
10990891|NCT00639093|12166536|FG001|NOT COMPLETED|Overall Study||0
10990892|NCT00639158|12166544|FG000|STARTED|Overall Study|All randomized subjects were treated.|272
10990893|NCT00639158|12166545|FG001|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
10990894|NCT00639158|12166544|FG000|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
10990895|NCT00639158|12166545|FG001|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
10990896|NCT00639158|12166544|FG000|NOT COMPLETED|Overall Study||26
10990897|NCT00639158|12166545|FG001|NOT COMPLETED|Overall Study||30
10990898|NCT00639223|12166553|FG000|STARTED|Overall Study||22
10990899|NCT00639223|12166554|FG001|STARTED|Overall Study||21
10990900|NCT00639223|12166553|FG000|COMPLETED|Overall Study||22
10990901|NCT00639223|12166554|FG001|COMPLETED|Overall Study||19
10990902|NCT00639223|12166553|FG000|NOT COMPLETED|Overall Study||0
10990903|NCT00639223|12166554|FG001|NOT COMPLETED|Overall Study||2
10990904|NCT00639379|12166560|FG000|STARTED|Period 1 - 2 Weeks||44
10990905|NCT00639379|12166561|FG001|STARTED|Period 1 - 2 Weeks||45
10990906|NCT00639379|12166560|FG000|COMPLETED|Period 1 - 2 Weeks||39
10990907|NCT00639379|12166561|FG001|COMPLETED|Period 1 - 2 Weeks||45
10990908|NCT00639379|12166560|FG000|NOT COMPLETED|Period 1 - 2 Weeks||5
10990909|NCT00639379|12166561|FG001|NOT COMPLETED|Period 1 - 2 Weeks||0
10990910|NCT00639379|12166560|FG000|STARTED|Period 2 - 2 Weeks||39
10990911|NCT00639379|12166561|FG001|STARTED|Period 2 - 2 Weeks||45
10990912|NCT00639379|12166560|FG000|COMPLETED|Period 2 - 2 Weeks||39
10990913|NCT00639379|12166561|FG001|COMPLETED|Period 2 - 2 Weeks||45
10990914|NCT00639379|12166560|FG000|NOT COMPLETED|Period 2 - 2 Weeks||0
10990915|NCT00639379|12166561|FG001|NOT COMPLETED|Period 2 - 2 Weeks||0
10990916|NCT00639418|12166571|FG000|STARTED|Overall Study||28101
10990917|NCT00639418|12166572|FG001|STARTED|Overall Study||35967
10990918|NCT00639418|12166573|FG002|STARTED|Overall Study||36496
10990919|NCT00639418|12166574|FG003|STARTED|Overall Study||46930
10990920|NCT00639418|12166571|FG000|COMPLETED|Overall Study||28101
10990921|NCT00639418|12166572|FG001|COMPLETED|Overall Study||35967
10990922|NCT00639418|12166573|FG002|COMPLETED|Overall Study||36496
10990923|NCT00639418|12166574|FG003|COMPLETED|Overall Study||46930
10990924|NCT00639418|12166571|FG000|NOT COMPLETED|Overall Study||0
10990925|NCT00639418|12166572|FG001|NOT COMPLETED|Overall Study||0
10990926|NCT00639418|12166573|FG002|NOT COMPLETED|Overall Study||0
10990927|NCT00639418|12166574|FG003|NOT COMPLETED|Overall Study||0
10990928|NCT00639457|12166590|FG000|STARTED|Overall Study||22
10990929|NCT00639457|12166591|FG001|STARTED|Overall Study||22
10990930|NCT00639457|12166590|FG000|COMPLETED|Overall Study||20
10990931|NCT00639457|12166591|FG001|COMPLETED|Overall Study||19
10990932|NCT00639457|12166590|FG000|NOT COMPLETED|Overall Study||2
10990933|NCT00639457|12166591|FG001|NOT COMPLETED|Overall Study||3
10990934|NCT00639509|12166597|FG000|STARTED|Overall Study||24
10990935|NCT00639509|12166597|FG000|COMPLETED|Overall Study||23
10990936|NCT00639509|12166597|FG000|NOT COMPLETED|Overall Study||1
10990937|NCT00639678|12166605|FG000|STARTED|Overall Study||74
10990938|NCT00639678|12166606|FG001|STARTED|Overall Study||6
10990939|NCT00639678|12166607|FG002|STARTED|Overall Study||217
10990940|NCT00639678|12166608|FG003|STARTED|Overall Study||23
10990941|NCT00639678|12166605|FG000|COMPLETED|Overall Study||70
10990942|NCT00639678|12166606|FG001|COMPLETED|Overall Study||5
10990943|NCT00639678|12166607|FG002|COMPLETED|Overall Study||206
10990944|NCT00639678|12166608|FG003|COMPLETED|Overall Study||23
10990945|NCT00639678|12166605|FG000|NOT COMPLETED|Overall Study||4
10990946|NCT00639678|12166606|FG001|NOT COMPLETED|Overall Study||1
10990947|NCT00639678|12166607|FG002|NOT COMPLETED|Overall Study||11
10990948|NCT00639678|12166608|FG003|NOT COMPLETED|Overall Study||0
10990949|NCT00639717|12166620|FG000|STARTED|Overall Study||48
10990950|NCT00639717|12166620|FG000|COMPLETED|Overall Study||48
10990951|NCT00639717|12166620|FG000|NOT COMPLETED|Overall Study||0
10990952|NCT00639769|12166624|FG000|STARTED|Overall Study||40
10990953|NCT00639769|12166624|FG000|COMPLETED|Overall Study||0
10990954|NCT00639769|12166624|FG000|NOT COMPLETED|Overall Study||40
10990955|NCT00639860|12166628|FG000|STARTED|Overall Study||10
10990956|NCT00639860|12166628|FG000|COMPLETED|Overall Study||10
10990957|NCT00639860|12166628|FG000|NOT COMPLETED|Overall Study||0
10990958|NCT00640016|12166636|FG000|STARTED|Overall Study||3
10990959|NCT00640016|12166637|FG001|STARTED|Overall Study||3
10990960|NCT00640016|12166638|FG002|STARTED|Overall Study||4
10990961|NCT00640016|12166639|FG003|STARTED|Overall Study||4
10990962|NCT00640016|12166636|FG000|Treated|Overall Study||3
10990963|NCT00640016|12166637|FG001|Treated|Overall Study||2
10990964|NCT00640016|12166638|FG002|Treated|Overall Study||4
10990965|NCT00640016|12166639|FG003|Treated|Overall Study||4
10990966|NCT00640016|12166636|FG000|COMPLETED|Overall Study||1
10990967|NCT00640016|12166637|FG001|COMPLETED|Overall Study||1
10990968|NCT00640016|12166638|FG002|COMPLETED|Overall Study||1
10990969|NCT00640016|12166639|FG003|COMPLETED|Overall Study||1
10990970|NCT00640016|12166636|FG000|NOT COMPLETED|Overall Study||2
10990971|NCT00640016|12166637|FG001|NOT COMPLETED|Overall Study||2
10990972|NCT00640016|12166638|FG002|NOT COMPLETED|Overall Study||3
10990973|NCT00640016|12166639|FG003|NOT COMPLETED|Overall Study||3
10990974|NCT00640042|12166656|FG000|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
10990975|NCT00640042|12166656|FG000|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
10990976|NCT00640042|12166656|FG000|NOT COMPLETED|Enrollment||83
10990977|NCT00640042|12166656|FG000|STARTED|Treatment||1487
10990978|NCT00640042|12166656|FG000|COMPLETED|Treatment||561
10990979|NCT00640042|12166656|FG000|NOT COMPLETED|Treatment||926
10990980|NCT00640146|12166662|FG000|STARTED|Overall Study||19
10990981|NCT00640146|12166663|FG001|STARTED|Overall Study||18
10990982|NCT00640146|12166662|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
10990983|NCT00640146|12166663|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15
10990984|NCT00640146|12166662|FG000|COMPLETED|Overall Study||15
10990985|NCT00640146|12166663|FG001|COMPLETED|Overall Study||12
10990986|NCT00640146|12166662|FG000|NOT COMPLETED|Overall Study||4
10990987|NCT00640146|12166663|FG001|NOT COMPLETED|Overall Study||6
10990988|NCT00640224|12166673|FG000|STARTED|Overall Study||23
10990989|NCT00640224|12166674|FG001|STARTED|Overall Study||23
10990990|NCT00640224|12166675|FG002|STARTED|Overall Study||0
10990991|NCT00640224|12166676|FG003|STARTED|Overall Study||0
10990992|NCT00640224|12166673|FG000|COMPLETED|Overall Study||17
10990993|NCT00640224|12166674|FG001|COMPLETED|Overall Study||20
10990994|NCT00640224|12166675|FG002|COMPLETED|Overall Study||0
10990995|NCT00640224|12166676|FG003|COMPLETED|Overall Study||0
10990996|NCT00640224|12166673|FG000|NOT COMPLETED|Overall Study||6
10990997|NCT00640224|12166674|FG001|NOT COMPLETED|Overall Study||3
10990998|NCT00640224|12166675|FG002|NOT COMPLETED|Overall Study||0
10990999|NCT00640224|12166676|FG003|NOT COMPLETED|Overall Study||0
10991000|NCT00640250|12166686|FG000|STARTED|Overall Study||48
10991001|NCT00640250|12166686|FG000|COMPLETED|Overall Study||48
10991002|NCT00640250|12166686|FG000|NOT COMPLETED|Overall Study||0
10991003|NCT00640289|12166789|FG000|STARTED|Overall Study||72
10991004|NCT00640289|12166789|FG000|COMPLETED|Overall Study||59
10991005|NCT00640289|12166789|FG000|NOT COMPLETED|Overall Study||13
10991006|NCT00640315|12166795|FG000|STARTED|Overall Study||10
10991007|NCT00640315|12166796|FG001|STARTED|Overall Study||13
10991008|NCT00640315|12166795|FG000|Participants Received Treatment|Overall Study||10
10991009|NCT00640315|12166796|FG001|Participants Received Treatment|Overall Study||13
10991010|NCT00640315|12166795|FG000|COMPLETED|Overall Study||10
10991011|NCT00640315|12166796|FG001|COMPLETED|Overall Study||12
10991012|NCT00640315|12166795|FG000|NOT COMPLETED|Overall Study||0
10991013|NCT00640315|12166796|FG001|NOT COMPLETED|Overall Study||1
10991014|NCT00640328|12166808|FG000|STARTED|First Treatment Period (Weeks 0-24)||8
10991015|NCT00640328|12166809|FG001|STARTED|First Treatment Period (Weeks 0-24)||11
10991016|NCT00640328|12166810|FG002|STARTED|First Treatment Period (Weeks 0-24)||7
10991017|NCT00640328|12166811|FG003|STARTED|First Treatment Period (Weeks 0-24)||4
10991018|NCT00640328|12166812|FG004|STARTED|First Treatment Period (Weeks 0-24)||4
10991019|NCT00640328|12166813|FG005|STARTED|First Treatment Period (Weeks 0-24)||4
10991020|NCT00640328|12166808|FG000|COMPLETED|First Treatment Period (Weeks 0-24)||8
10991021|NCT00640328|12166809|FG001|COMPLETED|First Treatment Period (Weeks 0-24)||10
10991022|NCT00640328|12166810|FG002|COMPLETED|First Treatment Period (Weeks 0-24)||7
10991023|NCT00640328|12166811|FG003|COMPLETED|First Treatment Period (Weeks 0-24)||4
10991024|NCT00640328|12166812|FG004|COMPLETED|First Treatment Period (Weeks 0-24)||4
10991025|NCT00640328|12166813|FG005|COMPLETED|First Treatment Period (Weeks 0-24)||4
10991026|NCT00640328|12166808|FG000|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
10991027|NCT00640328|12166809|FG001|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
10991028|NCT00640328|12166810|FG002|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
10991029|NCT00640328|12166811|FG003|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
10991030|NCT00640328|12166812|FG004|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
10991031|NCT00640328|12166813|FG005|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
10991032|NCT00640328|12166808|FG000|STARTED|Second Treatment Period (Weeks 24-48)||8
10991033|NCT00640328|12166809|FG001|STARTED|Second Treatment Period (Weeks 24-48)||10
10991034|NCT00640328|12166810|FG002|STARTED|Second Treatment Period (Weeks 24-48)||7
10991035|NCT00640328|12166811|FG003|STARTED|Second Treatment Period (Weeks 24-48)||4
10991036|NCT00640328|12166812|FG004|STARTED|Second Treatment Period (Weeks 24-48)||4
10991037|NCT00640328|12166813|FG005|STARTED|Second Treatment Period (Weeks 24-48)||4
10991038|NCT00640328|12166808|FG000|COMPLETED|Second Treatment Period (Weeks 24-48)||8
10991039|NCT00640328|12166809|FG001|COMPLETED|Second Treatment Period (Weeks 24-48)||10
10991040|NCT00640328|12166810|FG002|COMPLETED|Second Treatment Period (Weeks 24-48)||7
10991041|NCT00640328|12166811|FG003|COMPLETED|Second Treatment Period (Weeks 24-48)||4
10991042|NCT00640328|12166812|FG004|COMPLETED|Second Treatment Period (Weeks 24-48)||3
10991043|NCT00640328|12166813|FG005|COMPLETED|Second Treatment Period (Weeks 24-48)||4
10991044|NCT00640328|12166808|FG000|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
10991045|NCT00640328|12166809|FG001|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
10991046|NCT00640328|12166810|FG002|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
10991047|NCT00640328|12166811|FG003|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
10991048|NCT00640328|12166812|FG004|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
10991049|NCT00640328|12166813|FG005|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
10991050|NCT00640328|12166808|FG000|STARTED|IFUP (Week 48 to Individual Termination)||8
10991051|NCT00640328|12166809|FG001|STARTED|IFUP (Week 48 to Individual Termination)||11
10991052|NCT00640328|12166810|FG002|STARTED|IFUP (Week 48 to Individual Termination)||7
10991053|NCT00640328|12166811|FG003|STARTED|IFUP (Week 48 to Individual Termination)||4
10991054|NCT00640328|12166812|FG004|STARTED|IFUP (Week 48 to Individual Termination)||4
10991055|NCT00640328|12166813|FG005|STARTED|IFUP (Week 48 to Individual Termination)||4
10991056|NCT00640328|12166808|FG000|COMPLETED|IFUP (Week 48 to Individual Termination)||8
10991057|NCT00640328|12166809|FG001|COMPLETED|IFUP (Week 48 to Individual Termination)||10
10991058|NCT00640328|12166810|FG002|COMPLETED|IFUP (Week 48 to Individual Termination)||6
10991059|NCT00640328|12166811|FG003|COMPLETED|IFUP (Week 48 to Individual Termination)||3
10991060|NCT00640328|12166812|FG004|COMPLETED|IFUP (Week 48 to Individual Termination)||4
10991061|NCT00640328|12166813|FG005|COMPLETED|IFUP (Week 48 to Individual Termination)||4
10991062|NCT00640328|12166808|FG000|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
10991063|NCT00640328|12166809|FG001|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
10991064|NCT00640328|12166810|FG002|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
10991065|NCT00640328|12166811|FG003|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
10991066|NCT00640328|12166812|FG004|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
10991067|NCT00640328|12166813|FG005|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
10991068|NCT00640341|12166837|FG000|STARTED|Overall Study|All Starting participants were dispensed lenses|170
10991069|NCT00640341|12166838|FG001|STARTED|Overall Study||170
10991070|NCT00640341|12166839|FG002|STARTED|Overall Study||170
10991071|NCT00640341|12166837|FG000|Eligible Participants at Baseline|Overall Study||165
10991072|NCT00640341|12166838|FG001|Eligible Participants at Baseline|Overall Study||167
10991073|NCT00640341|12166839|FG002|Eligible Participants at Baseline|Overall Study||168
10991074|NCT00640341|12166837|FG000|COMPLETED|Overall Study||149
10991075|NCT00640341|12166838|FG001|COMPLETED|Overall Study||165
10991076|NCT00640341|12166839|FG002|COMPLETED|Overall Study||163
10991077|NCT00640341|12166837|FG000|NOT COMPLETED|Overall Study||21
10991078|NCT00640341|12166838|FG001|NOT COMPLETED|Overall Study||5
10991079|NCT00640341|12166839|FG002|NOT COMPLETED|Overall Study||7
10991080|NCT00640393|12166847|FG000|STARTED|Part 1||99
10991081|NCT00640393|12166848|FG001|STARTED|Part 1||0
10991082|NCT00640393|12166849|FG002|STARTED|Part 1||0
10991083|NCT00640393|12166847|FG000|COMPLETED|Part 1||94
10991084|NCT00640393|12166848|FG001|COMPLETED|Part 1||0
10991085|NCT00640393|12166849|FG002|COMPLETED|Part 1||0
10991086|NCT00640393|12166847|FG000|NOT COMPLETED|Part 1||5
10991087|NCT00640393|12166848|FG001|NOT COMPLETED|Part 1||0
10991088|NCT00640393|12166849|FG002|NOT COMPLETED|Part 1||0
10991089|NCT00640393|12166847|FG000|STARTED|Randomization||94
10991090|NCT00640393|12166848|FG001|STARTED|Randomization||0
10991091|NCT00640393|12166849|FG002|STARTED|Randomization||0
10991092|NCT00640393|12166847|FG000|COMPLETED|Randomization||75
10991093|NCT00640393|12166848|FG001|COMPLETED|Randomization||0
10991094|NCT00640393|12166849|FG002|COMPLETED|Randomization||0
10991095|NCT00640393|12166847|FG000|NOT COMPLETED|Randomization||19
10991096|NCT00640393|12166848|FG001|NOT COMPLETED|Randomization||0
10991097|NCT00640393|12166849|FG002|NOT COMPLETED|Randomization||0
10991098|NCT00640393|12166847|FG000|STARTED|Part 2||0
10991099|NCT00640393|12166848|FG001|STARTED|Part 2||37
10991100|NCT00640393|12166849|FG002|STARTED|Part 2||38
10991101|NCT00640393|12166847|FG000|COMPLETED|Part 2||0
10991102|NCT00640393|12166848|FG001|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
10991103|NCT00640393|12166849|FG002|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
10991104|NCT00640393|12166847|FG000|NOT COMPLETED|Part 2||0
10991105|NCT00640393|12166848|FG001|NOT COMPLETED|Part 2||10
10991106|NCT00640393|12166849|FG002|NOT COMPLETED|Part 2||3
10991107|NCT00640510|12166859|FG000|STARTED|Overall Study||17
10991108|NCT00640510|12166860|FG001|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
10991109|NCT00640510|12166859|FG000|COMPLETED|Overall Study||16
10991110|NCT00640510|12166860|FG001|COMPLETED|Overall Study||15
10991111|NCT00640510|12166859|FG000|NOT COMPLETED|Overall Study||1
10991112|NCT00640510|12166860|FG001|NOT COMPLETED|Overall Study||2
10991113|NCT00640562|12166868|FG000|STARTED|Overall Study||109
10991114|NCT00640562|12166869|FG001|STARTED|Overall Study||107
10991115|NCT00640562|12166868|FG000|COMPLETED|Overall Study||91
10991116|NCT00640562|12166869|FG001|COMPLETED|Overall Study||81
10991117|NCT00640562|12166868|FG000|NOT COMPLETED|Overall Study||18
10991118|NCT00640562|12166869|FG001|NOT COMPLETED|Overall Study||26
10991119|NCT00640601|12166875|FG000|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
10991120|NCT00640601|12166875|FG000|COMPLETED|Overall Study||183
10991121|NCT00640601|12166875|FG000|NOT COMPLETED|Overall Study||112
10991122|NCT00640614|12166881|FG000|STARTED|Overall Study||125
10991123|NCT00640614|12166882|FG001|STARTED|Overall Study||110
10991124|NCT00640614|12166881|FG000|COMPLETED|Overall Study||124
10991125|NCT00640614|12166882|FG001|COMPLETED|Overall Study||110
10991126|NCT00640614|12166881|FG000|NOT COMPLETED|Overall Study||1
10991127|NCT00640614|12166882|FG001|NOT COMPLETED|Overall Study||0
10991128|NCT00640653|12166916|FG000|STARTED|Overall Study||131
10991129|NCT00640653|12166917|FG001|STARTED|Overall Study||134
10991130|NCT00640653|12166918|FG002|STARTED|Overall Study||129
10991131|NCT00640653|12166919|FG003|STARTED|Overall Study||134
10991132|NCT00640653|12166920|FG004|STARTED|Overall Study||134
10991133|NCT00640653|12166916|FG000|Followed-up at 3 mo|Overall Study||126
10991134|NCT00640653|12166917|FG001|Followed-up at 3 mo|Overall Study||127
10991135|NCT00640653|12166918|FG002|Followed-up at 3 mo|Overall Study||125
10991136|NCT00640653|12166919|FG003|Followed-up at 3 mo|Overall Study||129
10991137|NCT00640653|12166920|FG004|Followed-up at 3 mo|Overall Study||126
10991138|NCT00640653|12166916|FG000|Followed-up at 6 mo|Overall Study||127
10991139|NCT00640653|12166917|FG001|Followed-up at 6 mo|Overall Study||130
10991140|NCT00640653|12166918|FG002|Followed-up at 6 mo|Overall Study||124
10991141|NCT00640653|12166919|FG003|Followed-up at 6 mo|Overall Study||130
10991142|NCT00640653|12166920|FG004|Followed-up at 6 mo|Overall Study||125
10991143|NCT00640653|12166916|FG000|Followed-up at 12 mo|Overall Study||124
10991144|NCT00640653|12166917|FG001|Followed-up at 12 mo|Overall Study||121
10991145|NCT00640653|12166918|FG002|Followed-up at 12 mo|Overall Study||115
10991146|NCT00640653|12166919|FG003|Followed-up at 12 mo|Overall Study||122
10991147|NCT00640653|12166920|FG004|Followed-up at 12 mo|Overall Study||116
10991148|NCT00640653|12166916|FG000|Followed-up at 18 mo|Overall Study||118
10991149|NCT00640653|12166917|FG001|Followed-up at 18 mo|Overall Study||112
10991150|NCT00640653|12166918|FG002|Followed-up at 18 mo|Overall Study||113
10991151|NCT00640653|12166919|FG003|Followed-up at 18 mo|Overall Study||117
10991152|NCT00640653|12166920|FG004|Followed-up at 18 mo|Overall Study||117
10991153|NCT00640653|12166916|FG000|Followed-up at 24 mo|Overall Study||114
10991154|NCT00640653|12166917|FG001|Followed-up at 24 mo|Overall Study||116
10991155|NCT00640653|12166918|FG002|Followed-up at 24 mo|Overall Study||105
10991156|NCT00640653|12166919|FG003|Followed-up at 24 mo|Overall Study||112
10991157|NCT00640653|12166920|FG004|Followed-up at 24 mo|Overall Study||112
10991158|NCT00640653|12166916|FG000|COMPLETED|Overall Study||128
10991159|NCT00640653|12166917|FG001|COMPLETED|Overall Study||131
10991160|NCT00640653|12166918|FG002|COMPLETED|Overall Study||129
10991161|NCT00640653|12166919|FG003|COMPLETED|Overall Study||132
10991162|NCT00640653|12166920|FG004|COMPLETED|Overall Study||129
10991163|NCT00640653|12166916|FG000|NOT COMPLETED|Overall Study||3
10991164|NCT00640653|12166917|FG001|NOT COMPLETED|Overall Study||3
10991165|NCT00640653|12166918|FG002|NOT COMPLETED|Overall Study||0
10991166|NCT00640653|12166919|FG003|NOT COMPLETED|Overall Study||2
10991167|NCT00640653|12166920|FG004|NOT COMPLETED|Overall Study||5
10991168|NCT00640822|12166935|FG000|STARTED|Overall Study||322
10991169|NCT00640822|12166936|FG001|STARTED|Overall Study||317
10991170|NCT00640822|12166937|FG002|STARTED|Overall Study||102
10991171|NCT00640822|12166935|FG000|COMPLETED|Overall Study||279
10991172|NCT00640822|12166936|FG001|COMPLETED|Overall Study||258
10991173|NCT00640822|12166937|FG002|COMPLETED|Overall Study||77
10991174|NCT00640822|12166935|FG000|NOT COMPLETED|Overall Study||43
10991175|NCT00640822|12166936|FG001|NOT COMPLETED|Overall Study||59
10991176|NCT00640822|12166937|FG002|NOT COMPLETED|Overall Study||25
10991177|NCT00640835|12166947|FG000|STARTED|Overall Study||194
10991178|NCT00640835|12166948|FG001|STARTED|Overall Study||188
10991179|NCT00640835|12166947|FG000|COMPLETED|Overall Study||118
10991180|NCT00640835|12166948|FG001|COMPLETED|Overall Study||131
10991181|NCT00640835|12166947|FG000|NOT COMPLETED|Overall Study||76
10991182|NCT00640835|12166948|FG001|NOT COMPLETED|Overall Study||57
10991183|NCT00640926|12166957|FG000|STARTED|Overall Study||53
10991184|NCT00640926|12166958|FG001|STARTED|Overall Study||52
10991185|NCT00640926|12166959|FG002|STARTED|Overall Study||53
10991186|NCT00640926|12166957|FG000|COMPLETED|Overall Study||45
10991187|NCT00640926|12166958|FG001|COMPLETED|Overall Study||46
10991188|NCT00640926|12166959|FG002|COMPLETED|Overall Study||45
10991189|NCT00640926|12166957|FG000|NOT COMPLETED|Overall Study||8
10991190|NCT00640926|12166958|FG001|NOT COMPLETED|Overall Study||6
10991191|NCT00640926|12166959|FG002|NOT COMPLETED|Overall Study||8
10991192|NCT00640978|12166967|FG000|STARTED|Overall Study||15
10991193|NCT00640978|12166967|FG000|COMPLETED|Overall Study||15
10991194|NCT00640978|12166967|FG000|NOT COMPLETED|Overall Study||0
10991195|NCT00641043|12166973|FG000|STARTED|Overall Study|number who started treatment|130
10991196|NCT00641043|12166974|FG001|STARTED|Overall Study|number who started treatment|259
10991197|NCT00641043|12166973|FG000|COMPLETED|Overall Study|number who completed treatment|111
10991198|NCT00641043|12166974|FG001|COMPLETED|Overall Study|number who completed treatment|244
10991199|NCT00641043|12166973|FG000|NOT COMPLETED|Overall Study||19
10991200|NCT00641043|12166974|FG001|NOT COMPLETED|Overall Study||15
10991201|NCT00641056|12166982|FG000|STARTED|Overall Study||233
10991202|NCT00641056|12166983|FG001|STARTED|Overall Study||234
10991203|NCT00641056|12166982|FG000|Intent to Treat (ITT)|Overall Study||233
10991204|NCT00641056|12166983|FG001|Intent to Treat (ITT)|Overall Study||223
10991205|NCT00641056|12166982|FG000|COMPLETED|Overall Study||204
10991206|NCT00641056|12166983|FG001|COMPLETED|Overall Study||209
10991207|NCT00641056|12166982|FG000|NOT COMPLETED|Overall Study||29
10991208|NCT00641056|12166983|FG001|NOT COMPLETED|Overall Study||25
10991209|NCT00641147|12166995|FG000|STARTED|Completed 4 Months.||21
10991210|NCT00641147|12166996|FG001|STARTED|Completed 4 Months.||23
10991211|NCT00641147|12166995|FG000|COMPLETED|Completed 4 Months.||19
10991212|NCT00641147|12166996|FG001|COMPLETED|Completed 4 Months.||23
10991213|NCT00641147|12166995|FG000|NOT COMPLETED|Completed 4 Months.||2
10991214|NCT00641147|12166996|FG001|NOT COMPLETED|Completed 4 Months.||0
10991215|NCT00641147|12166995|FG000|STARTED|Completed 8 Months.||19
10991216|NCT00641147|12166996|FG001|STARTED|Completed 8 Months.||23
10991217|NCT00641147|12166995|FG000|COMPLETED|Completed 8 Months.||16
10991218|NCT00641147|12166996|FG001|COMPLETED|Completed 8 Months.||21
10991219|NCT00641147|12166995|FG000|NOT COMPLETED|Completed 8 Months.||3
10991220|NCT00641147|12166996|FG001|NOT COMPLETED|Completed 8 Months.||2
10991221|NCT00641147|12166995|FG000|STARTED|Completed 12 Months.||16
10991222|NCT00641147|12166996|FG001|STARTED|Completed 12 Months.||21
10991223|NCT00641147|12166995|FG000|COMPLETED|Completed 12 Months.||15
10991224|NCT00641147|12166996|FG001|COMPLETED|Completed 12 Months.||19
10991225|NCT00641147|12166995|FG000|NOT COMPLETED|Completed 12 Months.||1
10991226|NCT00641147|12166996|FG001|NOT COMPLETED|Completed 12 Months.||2
10991227|NCT00641147|12166995|FG000|STARTED|Completed 16 Months.||15
10991228|NCT00641147|12166996|FG001|STARTED|Completed 16 Months.||19
10991229|NCT00641147|12166995|FG000|COMPLETED|Completed 16 Months.||13
10991230|NCT00641147|12166996|FG001|COMPLETED|Completed 16 Months.||19
10991231|NCT00641147|12166995|FG000|NOT COMPLETED|Completed 16 Months.||2
10991232|NCT00641147|12166996|FG001|NOT COMPLETED|Completed 16 Months.||0
10991233|NCT00641563|12167006|FG000|STARTED|Infusion 1||5
10991234|NCT00641563|12167007|FG001|STARTED|Infusion 1||5
10991235|NCT00641563|12167006|FG000|COMPLETED|Infusion 1||5
10991236|NCT00641563|12167007|FG001|COMPLETED|Infusion 1||5
10991237|NCT00641563|12167006|FG000|NOT COMPLETED|Infusion 1||0
10991238|NCT00641563|12167007|FG001|NOT COMPLETED|Infusion 1||0
10991239|NCT00641563|12167006|FG000|STARTED|Infusion 2||5
10991240|NCT00641563|12167007|FG001|STARTED|Infusion 2||5
10991241|NCT00641563|12167006|FG000|COMPLETED|Infusion 2||5
10991242|NCT00641563|12167007|FG001|COMPLETED|Infusion 2||5
10991243|NCT00641563|12167006|FG000|NOT COMPLETED|Infusion 2||0
10991244|NCT00641563|12167007|FG001|NOT COMPLETED|Infusion 2||0
10991245|NCT00641641|12167013|FG000|STARTED|Overall Study||16
10991246|NCT00641641|12167013|FG000|COMPLETED|Overall Study||16
10991247|NCT00641641|12167013|FG000|NOT COMPLETED|Overall Study||0
10991248|NCT00641667|12167017|FG000|STARTED|Overall Study||66
10991249|NCT00641667|12167017|FG000|COMPLETED|Overall Study||60
10991250|NCT00641667|12167017|FG000|NOT COMPLETED|Overall Study||6
10991251|NCT00641706|12167023|FG000|STARTED|Overall Study||37
10991252|NCT00641706|12167024|FG001|STARTED|Overall Study||7
10991253|NCT00641706|12167023|FG000|COMPLETED|Overall Study||28
10991254|NCT00641706|12167024|FG001|COMPLETED|Overall Study||4
10991255|NCT00641706|12167023|FG000|NOT COMPLETED|Overall Study||9
10991256|NCT00641706|12167024|FG001|NOT COMPLETED|Overall Study||3
10991257|NCT00641719|12167032|FG000|STARTED|Overall Study||129
10991258|NCT00641719|12167033|FG001|STARTED|Overall Study||129
10991259|NCT00641719|12167032|FG000|COMPLETED|Overall Study||99
10991260|NCT00641719|12167033|FG001|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
10991261|NCT00641719|12167032|FG000|NOT COMPLETED|Overall Study||30
10991262|NCT00641719|12167033|FG001|NOT COMPLETED|Overall Study||37
10991263|NCT00641745|12167041|FG000|STARTED|Overall Study||427
10991264|NCT00641745|12167042|FG001|STARTED|Overall Study||202
10991265|NCT00641745|12167041|FG000|COMPLETED|Overall Study||147
10991266|NCT00641745|12167042|FG001|COMPLETED|Overall Study||89
10991267|NCT00641745|12167041|FG000|NOT COMPLETED|Overall Study||280
10991268|NCT00641745|12167042|FG001|NOT COMPLETED|Overall Study||113
10991269|NCT00641797|12167050|FG000|STARTED|Overall Study||11
10991270|NCT00641797|12167051|FG001|STARTED|Overall Study||15
10991271|NCT00641797|12167050|FG000|COMPLETED|Overall Study||11
10991272|NCT00641797|12167051|FG001|COMPLETED|Overall Study||15
10991273|NCT00641797|12167050|FG000|NOT COMPLETED|Overall Study||0
10991274|NCT00641797|12167051|FG001|NOT COMPLETED|Overall Study||0
10991275|NCT00641862|12167059|FG000|STARTED|Overall Study||183
10991276|NCT00641862|12167060|FG001|STARTED|Overall Study||183
10991277|NCT00641862|12167059|FG000|COMPLETED|Overall Study||139
10991278|NCT00641862|12167060|FG001|COMPLETED|Overall Study||145
10991279|NCT00641862|12167059|FG000|NOT COMPLETED|Overall Study||44
10991280|NCT00641862|12167060|FG001|NOT COMPLETED|Overall Study||38
10991281|NCT00642018|12167068|FG000|STARTED|Overall Study||52
10991282|NCT00642018|12167069|FG001|STARTED|Overall Study||102
10991283|NCT00642018|12167068|FG000|Received at Least One Dose of Study Drug|Overall Study||51
10991284|NCT00642018|12167069|FG001|Received at Least One Dose of Study Drug|Overall Study||98
10991285|NCT00642018|12167068|FG000|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24
10991286|NCT00642018|12167069|FG001|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23
10991287|NCT00642018|12167068|FG000|NOT COMPLETED|Overall Study||28
10991288|NCT00642018|12167069|FG001|NOT COMPLETED|Overall Study||79
10991289|NCT00642174|12167078|FG000|STARTED|Period 1 - Initial Drug||18
10991290|NCT00642174|12167079|FG001|STARTED|Period 1 - Initial Drug||17
10991291|NCT00642174|12167078|FG000|COMPLETED|Period 1 - Initial Drug||18
10991292|NCT00642174|12167079|FG001|COMPLETED|Period 1 - Initial Drug||16
10991293|NCT00642174|12167078|FG000|NOT COMPLETED|Period 1 - Initial Drug||0
10991294|NCT00642174|12167079|FG001|NOT COMPLETED|Period 1 - Initial Drug||1
10991295|NCT00642174|12167078|FG000|STARTED|Period 2 - Crossover Drug||18
10991296|NCT00642174|12167079|FG001|STARTED|Period 2 - Crossover Drug||16
10991297|NCT00642174|12167078|FG000|COMPLETED|Period 2 - Crossover Drug||18
10991298|NCT00642174|12167079|FG001|COMPLETED|Period 2 - Crossover Drug||16
10991299|NCT00642174|12167078|FG000|NOT COMPLETED|Period 2 - Crossover Drug||0
10991300|NCT00642174|12167079|FG001|NOT COMPLETED|Period 2 - Crossover Drug||0
10991301|NCT00642278|12167092|FG000|STARTED|Overall Study||65
10991302|NCT00642278|12167093|FG001|STARTED|Overall Study||64
10991303|NCT00642278|12167094|FG002|STARTED|Overall Study||64
10991304|NCT00642278|12167095|FG003|STARTED|Overall Study||65
10991305|NCT00642278|12167096|FG004|STARTED|Overall Study||64
10991306|NCT00642278|12167097|FG005|STARTED|Overall Study||64
10991307|NCT00642278|12167098|FG006|STARTED|Overall Study||65
10991308|NCT00642278|12167092|FG000|COMPLETED|Overall Study||55
10991309|NCT00642278|12167093|FG001|COMPLETED|Overall Study||59
10991310|NCT00642278|12167094|FG002|COMPLETED|Overall Study||59
10991311|NCT00642278|12167095|FG003|COMPLETED|Overall Study||56
10991312|NCT00642278|12167096|FG004|COMPLETED|Overall Study||56
10991313|NCT00642278|12167097|FG005|COMPLETED|Overall Study||57
10991314|NCT00642278|12167098|FG006|COMPLETED|Overall Study||60
10991315|NCT00642278|12167092|FG000|NOT COMPLETED|Overall Study||10
10991316|NCT00642278|12167093|FG001|NOT COMPLETED|Overall Study||5
10991317|NCT00642278|12167094|FG002|NOT COMPLETED|Overall Study||5
10991318|NCT00642278|12167095|FG003|NOT COMPLETED|Overall Study||9
10991319|NCT00642278|12167096|FG004|NOT COMPLETED|Overall Study||8
10991320|NCT00642278|12167097|FG005|NOT COMPLETED|Overall Study||7
10991321|NCT00642278|12167098|FG006|NOT COMPLETED|Overall Study||5
10991322|NCT00642304|12167114|FG000|STARTED|Overall Study||20
10991323|NCT00642304|12167114|FG000|COMPLETED|Overall Study||14
10991324|NCT00642304|12167114|FG000|NOT COMPLETED|Overall Study||6
10991325|NCT00642356|12167120|FG000|STARTED|Overall Study||7
10991326|NCT00642356|12167121|FG001|STARTED|Overall Study||7
10991327|NCT00642356|12167120|FG000|COMPLETED|Overall Study||5
10991328|NCT00642356|12167121|FG001|COMPLETED|Overall Study||4
10991329|NCT00642356|12167120|FG000|NOT COMPLETED|Overall Study||2
10991330|NCT00642356|12167121|FG001|NOT COMPLETED|Overall Study||3
10991331|NCT00642369|12167129|FG000|STARTED|Overall Study||30
10991332|NCT00642369|12167130|FG001|STARTED|Overall Study||30
10991333|NCT00642369|12167129|FG000|COMPLETED|Overall Study||25
10991334|NCT00642369|12167130|FG001|COMPLETED|Overall Study||24
10991335|NCT00642369|12167129|FG000|NOT COMPLETED|Overall Study||5
10991336|NCT00642369|12167130|FG001|NOT COMPLETED|Overall Study||6
10991337|NCT00642460|12167140|FG000|STARTED|Part I: 12 Week Double-Blind||37
10991338|NCT00642460|12167141|FG001|STARTED|Part I: 12 Week Double-Blind||38
10991339|NCT00642460|12167142|FG002|STARTED|Part I: 12 Week Double-Blind||37
10991340|NCT00642460|12167143|FG003|STARTED|Part I: 12 Week Double-Blind||0
10991341|NCT00642460|12167144|FG004|STARTED|Part I: 12 Week Double-Blind||0
10991342|NCT00642460|12167145|FG005|STARTED|Part I: 12 Week Double-Blind||0
10991343|NCT00642460|12167140|FG000|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
10991344|NCT00642460|12167141|FG001|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
10991345|NCT00642460|12167142|FG002|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
10991346|NCT00642460|12167143|FG003|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
10991347|NCT00642460|12167144|FG004|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
10991348|NCT00642460|12167145|FG005|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
10991349|NCT00642460|12167140|FG000|COMPLETED|Part I: 12 Week Double-Blind||36
10991350|NCT00642460|12167141|FG001|COMPLETED|Part I: 12 Week Double-Blind||37
10991351|NCT00642460|12167142|FG002|COMPLETED|Part I: 12 Week Double-Blind||36
10991352|NCT00642460|12167143|FG003|COMPLETED|Part I: 12 Week Double-Blind||0
10991353|NCT00642460|12167144|FG004|COMPLETED|Part I: 12 Week Double-Blind||0
10991354|NCT00642460|12167145|FG005|COMPLETED|Part I: 12 Week Double-Blind||0
10991355|NCT00642460|12167140|FG000|NOT COMPLETED|Part I: 12 Week Double-Blind||1
10991356|NCT00642460|12167141|FG001|NOT COMPLETED|Part I: 12 Week Double-Blind||1
10991357|NCT00642460|12167142|FG002|NOT COMPLETED|Part I: 12 Week Double-Blind||1
10991358|NCT00642460|12167143|FG003|NOT COMPLETED|Part I: 12 Week Double-Blind||0
10991359|NCT00642460|12167144|FG004|NOT COMPLETED|Part I: 12 Week Double-Blind||0
10991360|NCT00642460|12167145|FG005|NOT COMPLETED|Part I: 12 Week Double-Blind||0
10991361|NCT00642460|12167140|FG000|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
10991362|NCT00642460|12167141|FG001|STARTED|Part II: Open-Label Up to Week 92||40
10991363|NCT00642460|12167142|FG002|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
10991364|NCT00642460|12167143|FG003|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
10991365|NCT00642460|12167144|FG004|STARTED|Part II: Open-Label Up to Week 92||0
10991366|NCT00642460|12167145|FG005|STARTED|Part II: Open-Label Up to Week 92||0
10991367|NCT00642460|12167140|FG000|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
10991368|NCT00642460|12167141|FG001|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
10991369|NCT00642460|12167142|FG002|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
10991370|NCT00642460|12167143|FG003|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
10991371|NCT00642460|12167144|FG004|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
10991372|NCT00642460|12167145|FG005|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
10991373|NCT00642460|12167140|FG000|COMPLETED|Part II: Open-Label Up to Week 92||43
10991374|NCT00642460|12167141|FG001|COMPLETED|Part II: Open-Label Up to Week 92||32
10991375|NCT00642460|12167142|FG002|COMPLETED|Part II: Open-Label Up to Week 92||0
10991376|NCT00642460|12167143|FG003|COMPLETED|Part II: Open-Label Up to Week 92||17
10991377|NCT00642460|12167144|FG004|COMPLETED|Part II: Open-Label Up to Week 92||0
10991378|NCT00642460|12167145|FG005|COMPLETED|Part II: Open-Label Up to Week 92||0
10991379|NCT00642460|12167140|FG000|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
10991380|NCT00642460|12167141|FG001|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
10991381|NCT00642460|12167142|FG002|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
10991382|NCT00642460|12167143|FG003|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
10991383|NCT00642460|12167144|FG004|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
10991384|NCT00642460|12167145|FG005|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
10991385|NCT00642460|12167140|FG000|STARTED|Part III: Open-Label Up to Week 260||0
10991386|NCT00642460|12167141|FG001|STARTED|Part III: Open-Label Up to Week 260||0
10991387|NCT00642460|12167142|FG002|STARTED|Part III: Open-Label Up to Week 260||0
10991388|NCT00642460|12167143|FG003|STARTED|Part III: Open-Label Up to Week 260||0
10991389|NCT00642460|12167144|FG004|STARTED|Part III: Open-Label Up to Week 260||53
10991390|NCT00642460|12167145|FG005|STARTED|Part III: Open-Label Up to Week 260||59
10991391|NCT00642460|12167140|FG000|COMPLETED|Part III: Open-Label Up to Week 260||0
10991392|NCT00642460|12167141|FG001|COMPLETED|Part III: Open-Label Up to Week 260||0
10991393|NCT00642460|12167142|FG002|COMPLETED|Part III: Open-Label Up to Week 260||0
10991394|NCT00642460|12167143|FG003|COMPLETED|Part III: Open-Label Up to Week 260||0
10991395|NCT00642460|12167144|FG004|COMPLETED|Part III: Open-Label Up to Week 260||28
10991396|NCT00642460|12167145|FG005|COMPLETED|Part III: Open-Label Up to Week 260||38
10991397|NCT00642460|12167140|FG000|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
10991398|NCT00642460|12167141|FG001|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
10991399|NCT00642460|12167142|FG002|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
10991400|NCT00642460|12167143|FG003|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
10991401|NCT00642460|12167144|FG004|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
10991402|NCT00642460|12167145|FG005|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
10991403|NCT00642473|12167157|FG000|STARTED|Overall Study||18
10991404|NCT00642473|12167158|FG001|STARTED|Overall Study||16
10991405|NCT00642473|12167157|FG000|COMPLETED|Overall Study||14
10991406|NCT00642473|12167158|FG001|COMPLETED|Overall Study||5
10991407|NCT00642473|12167157|FG000|NOT COMPLETED|Overall Study||4
10991408|NCT00642473|12167158|FG001|NOT COMPLETED|Overall Study||11
10991409|NCT00642616|12167171|FG000|STARTED|Overall Study||9
10991410|NCT00642616|12167172|FG001|STARTED|Overall Study||8
10991411|NCT00642616|12167173|FG002|STARTED|Overall Study||9
10991412|NCT00642616|12167174|FG003|STARTED|Overall Study||8
10991413|NCT00642616|12167171|FG000|COMPLETED|Overall Study||0
10991414|NCT00642616|12167172|FG001|COMPLETED|Overall Study||1
10991415|NCT00642616|12167173|FG002|COMPLETED|Overall Study||0
10991416|NCT00642616|12167174|FG003|COMPLETED|Overall Study||1
10991417|NCT00642616|12167171|FG000|NOT COMPLETED|Overall Study||9
10991418|NCT00642616|12167172|FG001|NOT COMPLETED|Overall Study||7
10991419|NCT00642616|12167173|FG002|NOT COMPLETED|Overall Study||9
10991420|NCT00642616|12167174|FG003|NOT COMPLETED|Overall Study||7
10991421|NCT00642642|12167186|FG000|STARTED|Biopsy & Product Manufacture||122
10991422|NCT00642642|12167186|FG000|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
10991423|NCT00642642|12167186|FG000|NOT COMPLETED|Biopsy & Product Manufacture||13
10991424|NCT00642642|12167186|FG000|STARTED|Treatment & Follow Up||109
10991425|NCT00642642|12167186|FG000|COMPLETED|Treatment & Follow Up||92
10991426|NCT00642642|12167186|FG000|NOT COMPLETED|Treatment & Follow Up||17
10991427|NCT00642668|12167196|FG000|STARTED|Overall Study||35
10991428|NCT00642668|12167196|FG000|COMPLETED|Overall Study||21
10991429|NCT00642668|12167196|FG000|NOT COMPLETED|Overall Study||14
10991430|NCT00642694|12167202|FG000|STARTED|Overall Study||14
10991431|NCT00642694|12167203|FG001|STARTED|Overall Study||15
10991432|NCT00642694|12167202|FG000|COMPLETED|Overall Study||8
10991433|NCT00642694|12167203|FG001|COMPLETED|Overall Study||11
10991434|NCT00642694|12167202|FG000|NOT COMPLETED|Overall Study||6
10991435|NCT00642694|12167203|FG001|NOT COMPLETED|Overall Study||4
10991436|NCT00642707|12167213|FG000|STARTED|Overall Study||11
10991437|NCT00642707|12167214|FG001|STARTED|Overall Study||11
10991438|NCT00642707|12167215|FG002|STARTED|Overall Study||12
10991439|NCT00642707|12167216|FG003|STARTED|Overall Study||10
10991440|NCT00642707|12167213|FG000|COMPLETED|Overall Study||10
10991441|NCT00642707|12167214|FG001|COMPLETED|Overall Study||11
10991442|NCT00642707|12167215|FG002|COMPLETED|Overall Study||12
10991443|NCT00642707|12167216|FG003|COMPLETED|Overall Study||8
10991444|NCT00642707|12167213|FG000|NOT COMPLETED|Overall Study||1
10991445|NCT00642707|12167214|FG001|NOT COMPLETED|Overall Study||0
10991446|NCT00642707|12167215|FG002|NOT COMPLETED|Overall Study||0
10991447|NCT00642707|12167216|FG003|NOT COMPLETED|Overall Study||2
10991448|NCT00642746|12167228|FG000|STARTED|Overall Study||10
10991449|NCT00642746|12167229|FG001|STARTED|Overall Study||1
10991450|NCT00642746|12167228|FG000|COMPLETED|Overall Study||9
10991451|NCT00642746|12167229|FG001|COMPLETED|Overall Study||1
10991452|NCT00642746|12167228|FG000|NOT COMPLETED|Overall Study||1
10991453|NCT00642746|12167229|FG001|NOT COMPLETED|Overall Study||0
10991454|NCT00642759|12167235|FG000|STARTED|Overall Study||36
10991455|NCT00642759|12167235|FG000|COMPLETED|Overall Study||35
10991456|NCT00642759|12167235|FG000|NOT COMPLETED|Overall Study||1
10991457|NCT00642772|12167240|FG000|STARTED|Overall Study||24
10991458|NCT00642772|12167240|FG000|COMPLETED|Overall Study||14
10991459|NCT00642772|12167240|FG000|NOT COMPLETED|Overall Study||10
10991460|NCT00642811|12167250|FG000|STARTED|Overall Study||20
10991461|NCT00642811|12167251|FG001|STARTED|Overall Study||21
10991462|NCT00642811|12167252|FG002|STARTED|Overall Study||13
10991463|NCT00642811|12167253|FG003|STARTED|Overall Study||16
10991464|NCT00642811|12167254|FG004|STARTED|Overall Study||14
10991465|NCT00642811|12167255|FG005|STARTED|Overall Study||14
10991466|NCT00642811|12167250|FG000|COMPLETED|Overall Study||17
10991467|NCT00642811|12167251|FG001|COMPLETED|Overall Study||17
10991468|NCT00642811|12167252|FG002|COMPLETED|Overall Study||13
10991469|NCT00642811|12167253|FG003|COMPLETED|Overall Study||15
10991470|NCT00642811|12167254|FG004|COMPLETED|Overall Study||13
10991471|NCT00642811|12167255|FG005|COMPLETED|Overall Study||13
10991472|NCT00642811|12167250|FG000|NOT COMPLETED|Overall Study||3
10991473|NCT00642811|12167251|FG001|NOT COMPLETED|Overall Study||4
10991474|NCT00642811|12167252|FG002|NOT COMPLETED|Overall Study||0
10991475|NCT00642811|12167253|FG003|NOT COMPLETED|Overall Study||1
10991476|NCT00642811|12167254|FG004|NOT COMPLETED|Overall Study||1
10991477|NCT00642811|12167255|FG005|NOT COMPLETED|Overall Study||1
10991478|NCT00642850|12167269|FG000|STARTED|Overall Study||188
10991479|NCT00642850|12167269|FG000|COMPLETED|Overall Study||155
10991480|NCT00642850|12167269|FG000|NOT COMPLETED|Overall Study||33
10991481|NCT00642902|12167277|FG000|STARTED|Overall Study||63
10991482|NCT00642902|12167278|FG001|STARTED|Overall Study||63
10991483|NCT00642902|12167279|FG002|STARTED|Overall Study||64
10991484|NCT00642902|12167280|FG003|STARTED|Overall Study||65
10991485|NCT00642902|12167277|FG000|Treated|Overall Study||63
10991486|NCT00642902|12167278|FG001|Treated|Overall Study||63
10991487|NCT00642902|12167279|FG002|Treated|Overall Study||63
10991488|NCT00642902|12167280|FG003|Treated|Overall Study||65
10991489|NCT00642902|12167277|FG000|COMPLETED|Overall Study||23
10991490|NCT00642902|12167278|FG001|COMPLETED|Overall Study||21
10991491|NCT00642902|12167279|FG002|COMPLETED|Overall Study||21
10991492|NCT00642902|12167280|FG003|COMPLETED|Overall Study||25
10991493|NCT00642902|12167277|FG000|NOT COMPLETED|Overall Study||40
10991494|NCT00642902|12167278|FG001|NOT COMPLETED|Overall Study||42
10991495|NCT00642902|12167279|FG002|NOT COMPLETED|Overall Study||43
10991496|NCT00642902|12167280|FG003|NOT COMPLETED|Overall Study||40
10991497|NCT00642941|12167302|FG000|STARTED|Overall Study||70
10991498|NCT00642941|12167303|FG001|STARTED|Overall Study||54
10991499|NCT00642941|12167304|FG002|STARTED|Overall Study||7
10991500|NCT00642941|12167305|FG003|STARTED|Overall Study||40
10991501|NCT00642941|12167306|FG004|STARTED|Overall Study||25
10991502|NCT00642941|12167307|FG005|STARTED|Overall Study||41
10991503|NCT00642941|12167308|FG006|STARTED|Overall Study||23
10991504|NCT00642941|12167309|FG007|STARTED|Overall Study||14
10991505|NCT00642941|12167310|FG008|STARTED|Overall Study||11
10991506|NCT00642941|12167311|FG009|STARTED|Overall Study||9
10991507|NCT00642941|12167312|FG010|STARTED|Overall Study||12
10991508|NCT00642941|12167313|FG011|STARTED|Overall Study||11
10991509|NCT00642941|12167302|FG000|COMPLETED|Overall Study||0
10991510|NCT00642941|12167303|FG001|COMPLETED|Overall Study||0
10991511|NCT00642941|12167304|FG002|COMPLETED|Overall Study||0
10991512|NCT00642941|12167305|FG003|COMPLETED|Overall Study||0
10991513|NCT00642941|12167306|FG004|COMPLETED|Overall Study||0
10991514|NCT00642941|12167307|FG005|COMPLETED|Overall Study||0
10991515|NCT00642941|12167308|FG006|COMPLETED|Overall Study||0
10991516|NCT00642941|12167309|FG007|COMPLETED|Overall Study||0
10991517|NCT00642941|12167310|FG008|COMPLETED|Overall Study||0
10991518|NCT00642941|12167311|FG009|COMPLETED|Overall Study||0
10991519|NCT00642941|12167312|FG010|COMPLETED|Overall Study||0
10991520|NCT00642941|12167313|FG011|COMPLETED|Overall Study||0
10991521|NCT00642941|12167302|FG000|NOT COMPLETED|Overall Study||70
10991522|NCT00642941|12167303|FG001|NOT COMPLETED|Overall Study||54
10991523|NCT00642941|12167304|FG002|NOT COMPLETED|Overall Study||7
10991524|NCT00642941|12167305|FG003|NOT COMPLETED|Overall Study||40
10991525|NCT00642941|12167306|FG004|NOT COMPLETED|Overall Study||25
10991526|NCT00642941|12167307|FG005|NOT COMPLETED|Overall Study||41
10991527|NCT00642941|12167308|FG006|NOT COMPLETED|Overall Study||23
10991528|NCT00642941|12167309|FG007|NOT COMPLETED|Overall Study||14
10991529|NCT00642941|12167310|FG008|NOT COMPLETED|Overall Study||11
10991530|NCT00642941|12167311|FG009|NOT COMPLETED|Overall Study||9
10991531|NCT00642941|12167312|FG010|NOT COMPLETED|Overall Study||12
10991532|NCT00642941|12167313|FG011|NOT COMPLETED|Overall Study||11
10991533|NCT00642954|12167365|FG000|STARTED|Overall Study||4
10991534|NCT00642954|12167366|FG001|STARTED|Overall Study||4
10991535|NCT00642954|12167367|FG002|STARTED|Overall Study||3
10991536|NCT00642954|12167368|FG003|STARTED|Overall Study||3
10991537|NCT00642954|12167369|FG004|STARTED|Overall Study||17
10991538|NCT00642954|12167365|FG000|COMPLETED|Overall Study||0
10991539|NCT00642954|12167366|FG001|COMPLETED|Overall Study||0
10991540|NCT00642954|12167367|FG002|COMPLETED|Overall Study||0
10991541|NCT00642954|12167368|FG003|COMPLETED|Overall Study||0
10991542|NCT00642954|12167369|FG004|COMPLETED|Overall Study||1
10991543|NCT00642954|12167365|FG000|NOT COMPLETED|Overall Study||4
10991544|NCT00642954|12167366|FG001|NOT COMPLETED|Overall Study||4
10991545|NCT00642954|12167367|FG002|NOT COMPLETED|Overall Study||3
10991546|NCT00642954|12167368|FG003|NOT COMPLETED|Overall Study||3
10991547|NCT00642954|12167369|FG004|NOT COMPLETED|Overall Study||16
10991548|NCT00642993|12167383|FG000|STARTED|Overall Study||267
10991549|NCT00642993|12167384|FG001|STARTED|Overall Study||134
10991550|NCT00642993|12167383|FG000|COMPLETED|Overall Study||161
10991551|NCT00642993|12167384|FG001|COMPLETED|Overall Study||118
10991552|NCT00642993|12167383|FG000|NOT COMPLETED|Overall Study||106
10991553|NCT00642993|12167384|FG001|NOT COMPLETED|Overall Study||16
10991554|NCT00643006|12167392|FG000|STARTED|Overall Study||34
10991555|NCT00643006|12167393|FG001|STARTED|Overall Study||33
10991556|NCT00643006|12167392|FG000|COMPLETED|Overall Study||29
10991557|NCT00643006|12167393|FG001|COMPLETED|Overall Study||29
10991558|NCT00643006|12167392|FG000|NOT COMPLETED|Overall Study||5
10991559|NCT00643006|12167393|FG001|NOT COMPLETED|Overall Study||4
10991560|NCT00643097|12167404|FG000|STARTED|Overall Study||18
10991561|NCT00643097|12167405|FG001|STARTED|Overall Study||12
10991562|NCT00643097|12167406|FG002|STARTED|Overall Study||10
10991563|NCT00643097|12167404|FG000|COMPLETED|Overall Study||18
10991564|NCT00643097|12167405|FG001|COMPLETED|Overall Study||12
10991565|NCT00643097|12167406|FG002|COMPLETED|Overall Study||10
10991566|NCT00643097|12167404|FG000|NOT COMPLETED|Overall Study||0
10991567|NCT00643097|12167405|FG001|NOT COMPLETED|Overall Study||0
10991568|NCT00643097|12167406|FG002|NOT COMPLETED|Overall Study||0
10991569|NCT00643123|12167416|FG000|STARTED|Overall Study||15
10991570|NCT00643123|12167417|FG001|STARTED|Overall Study||12
10991571|NCT00643123|12167416|FG000|COMPLETED|Overall Study||10
10991572|NCT00643123|12167417|FG001|COMPLETED|Overall Study||11
10991573|NCT00643123|12167416|FG000|NOT COMPLETED|Overall Study||5
10991574|NCT00643123|12167417|FG001|NOT COMPLETED|Overall Study||1
10991575|NCT00643162|12167425|FG000|STARTED|Overall Study||7
10991576|NCT00643162|12167426|FG001|STARTED|Overall Study||5
10991577|NCT00643162|12167425|FG000|COMPLETED|Overall Study||6
10991578|NCT00643162|12167426|FG001|COMPLETED|Overall Study||4
10991579|NCT00643162|12167425|FG000|NOT COMPLETED|Overall Study||1
10991580|NCT00643162|12167426|FG001|NOT COMPLETED|Overall Study||1
10991581|NCT00643201|12167434|FG000|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
10991582|NCT00643201|12167435|FG001|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
10991583|NCT00643201|12167434|FG000|COMPLETED|Randomized, Completed 6 Months of Study||2314
10991584|NCT00643201|12167435|FG001|COMPLETED|Randomized, Completed 6 Months of Study||2291
10991585|NCT00643201|12167434|FG000|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
10991586|NCT00643201|12167435|FG001|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
10991587|NCT00643201|12167434|FG000|STARTED|Completed Study Follow Up||2617
10991588|NCT00643201|12167435|FG001|STARTED|Completed Study Follow Up||2639
10991589|NCT00643201|12167434|FG000|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
10991590|NCT00643201|12167435|FG001|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
10991591|NCT00643201|12167434|FG000|NOT COMPLETED|Completed Study Follow Up||70
10991592|NCT00643201|12167435|FG001|NOT COMPLETED|Completed Study Follow Up||79
10991593|NCT00643279|12167445|FG000|STARTED|Overall Study||134
10991594|NCT00643279|12167446|FG001|STARTED|Overall Study||140
10991595|NCT00643279|12167445|FG000|COMPLETED|Overall Study||118
10991596|NCT00643279|12167446|FG001|COMPLETED|Overall Study||127
10991597|NCT00643279|12167445|FG000|NOT COMPLETED|Overall Study||16
10991598|NCT00643279|12167446|FG001|NOT COMPLETED|Overall Study||13
10991599|NCT00643448|12167457|FG000|STARTED|Overall Study||21
10991600|NCT00643448|12167458|FG001|STARTED|Overall Study||22
10991601|NCT00643448|12167459|FG002|STARTED|Overall Study||22
10991602|NCT00643448|12167457|FG000|COMPLETED|Overall Study||17
10991603|NCT00643448|12167458|FG001|COMPLETED|Overall Study||17
10991604|NCT00643448|12167459|FG002|COMPLETED|Overall Study||16
10991605|NCT00643448|12167457|FG000|NOT COMPLETED|Overall Study||4
10991606|NCT00643448|12167458|FG001|NOT COMPLETED|Overall Study||5
10991607|NCT00643448|12167459|FG002|NOT COMPLETED|Overall Study||6
10991608|NCT00643487|12167469|FG000|STARTED|Overall Study||8
10991609|NCT00643487|12167469|FG000|COMPLETED|Overall Study||5
10991610|NCT00643487|12167469|FG000|NOT COMPLETED|Overall Study||3
10991611|NCT00643565|12167475|FG000|STARTED|Overall Study||80
10991612|NCT00643565|12167476|FG001|STARTED|Overall Study||74
10991613|NCT00643565|12167475|FG000|COMPLETED|Overall Study||7
10991614|NCT00643565|12167476|FG001|COMPLETED|Overall Study||7
10991615|NCT00643565|12167475|FG000|NOT COMPLETED|Overall Study||73
10991616|NCT00643565|12167476|FG001|NOT COMPLETED|Overall Study||67
10991617|NCT00643578|12167483|FG000|STARTED|Overall Study||6
10991618|NCT00643578|12167484|FG001|STARTED|Overall Study||6
10991619|NCT00643578|12167483|FG000|COMPLETED|Overall Study||4
10991620|NCT00643578|12167484|FG001|COMPLETED|Overall Study||6
10991621|NCT00643578|12167483|FG000|NOT COMPLETED|Overall Study||2
10991622|NCT00643578|12167484|FG001|NOT COMPLETED|Overall Study||0
10991623|NCT00643604|12167492|FG000|STARTED|Overall Study||7
10991624|NCT00643604|12167492|FG000|COMPLETED|Overall Study||6
10991625|NCT00643604|12167492|FG000|NOT COMPLETED|Overall Study||1
10991626|NCT00643682|12167498|FG000|STARTED|Overall Study||999
10991627|NCT00643682|12167499|FG001|STARTED|Overall Study||1001
10991628|NCT00643682|12167498|FG000|COMPLETED|Overall Study||477
10991629|NCT00643682|12167499|FG001|COMPLETED|Overall Study||492
10991630|NCT00643682|12167498|FG000|NOT COMPLETED|Overall Study||522
10991631|NCT00643682|12167499|FG001|NOT COMPLETED|Overall Study||509
10991632|NCT00643760|12167510|FG000|STARTED|Overall Study||120
10991633|NCT00643760|12167511|FG001|STARTED|Overall Study||62
10991634|NCT00643760|12167512|FG002|STARTED|Overall Study||56
10991635|NCT00643760|12167513|FG003|STARTED|Overall Study||117
10991636|NCT00643760|12167514|FG004|STARTED|Overall Study||66
10991637|NCT00643760|12167510|FG000|Safety Population/Treated With Drug|Overall Study||120
10991638|NCT00643760|12167511|FG001|Safety Population/Treated With Drug|Overall Study||62
10991639|NCT00643760|12167512|FG002|Safety Population/Treated With Drug|Overall Study||56
10991640|NCT00643760|12167513|FG003|Safety Population/Treated With Drug|Overall Study||116
10991641|NCT00643760|12167514|FG004|Safety Population/Treated With Drug|Overall Study||66
10991642|NCT00643760|12167510|FG000|ITT Population|Overall Study||120
10991643|NCT00643760|12167511|FG001|ITT Population|Overall Study||62
10991644|NCT00643760|12167512|FG002|ITT Population|Overall Study||56
10991645|NCT00643760|12167513|FG003|ITT Population|Overall Study||116
10991646|NCT00643760|12167514|FG004|ITT Population|Overall Study||66
10991647|NCT00643760|12167510|FG000|COMPLETED|Overall Study||90
10991648|NCT00643760|12167511|FG001|COMPLETED|Overall Study||47
10991649|NCT00643760|12167512|FG002|COMPLETED|Overall Study||37
10991650|NCT00643760|12167513|FG003|COMPLETED|Overall Study||79
10991651|NCT00643760|12167514|FG004|COMPLETED|Overall Study||47
10991652|NCT00643760|12167510|FG000|NOT COMPLETED|Overall Study||30
10991653|NCT00643760|12167511|FG001|NOT COMPLETED|Overall Study||15
10991654|NCT00643760|12167512|FG002|NOT COMPLETED|Overall Study||19
10991655|NCT00643760|12167513|FG003|NOT COMPLETED|Overall Study||38
10991656|NCT00643760|12167514|FG004|NOT COMPLETED|Overall Study||19
10991657|NCT00643851|12167529|FG000|STARTED|Overall Study||194
10991658|NCT00643851|12167530|FG001|STARTED|Overall Study||203
10991659|NCT00643851|12167531|FG002|STARTED|Overall Study||201
10991660|NCT00643851|12167529|FG000|COMPLETED|Overall Study||177
10991661|NCT00643851|12167530|FG001|COMPLETED|Overall Study||170
10991662|NCT00643851|12167531|FG002|COMPLETED|Overall Study||171
10991663|NCT00643851|12167529|FG000|NOT COMPLETED|Overall Study||17
10991664|NCT00643851|12167530|FG001|NOT COMPLETED|Overall Study||33
10991665|NCT00643851|12167531|FG002|NOT COMPLETED|Overall Study||30
10991666|NCT00643916|12167545|FG000|STARTED|Overall Study||55
10991667|NCT00643916|12167546|FG001|STARTED|Overall Study||67
10991668|NCT00643916|12167547|FG002|STARTED|Overall Study||68
10991669|NCT00643916|12167548|FG003|STARTED|Overall Study||62
10991670|NCT00643916|12167549|FG004|STARTED|Overall Study||59
10991671|NCT00643916|12167550|FG005|STARTED|Overall Study||67
10991672|NCT00643916|12167545|FG000|COMPLETED|Overall Study||51
10991673|NCT00643916|12167546|FG001|COMPLETED|Overall Study||61
10991674|NCT00643916|12167547|FG002|COMPLETED|Overall Study||62
10991675|NCT00643916|12167548|FG003|COMPLETED|Overall Study||60
10991676|NCT00643916|12167549|FG004|COMPLETED|Overall Study||57
10991677|NCT00643916|12167550|FG005|COMPLETED|Overall Study||66
10991678|NCT00643916|12167545|FG000|NOT COMPLETED|Overall Study||4
10991679|NCT00643916|12167546|FG001|NOT COMPLETED|Overall Study||6
10991680|NCT00643916|12167547|FG002|NOT COMPLETED|Overall Study||6
10991681|NCT00643916|12167548|FG003|NOT COMPLETED|Overall Study||2
10991682|NCT00643916|12167549|FG004|NOT COMPLETED|Overall Study||2
10991683|NCT00643916|12167550|FG005|NOT COMPLETED|Overall Study||1
10991684|NCT00644059|12167567|FG000|STARTED|Overall Study||2019
10991685|NCT00644059|12167568|FG001|STARTED|Overall Study||1849
10991686|NCT00644059|12167569|FG002|STARTED|Overall Study||1034
10991687|NCT00644059|12167567|FG000|COMPLETED|Overall Study||1895
10991688|NCT00644059|12167568|FG001|COMPLETED|Overall Study||1726
10991689|NCT00644059|12167569|FG002|COMPLETED|Overall Study||969
10991690|NCT00644059|12167567|FG000|NOT COMPLETED|Overall Study||124
10991691|NCT00644059|12167568|FG001|NOT COMPLETED|Overall Study||123
10991692|NCT00644059|12167569|FG002|NOT COMPLETED|Overall Study||65
10991693|NCT00644189|12167618|FG000|STARTED|Phase I||3
10991694|NCT00644189|12167619|FG001|STARTED|Phase I||3
10991695|NCT00644189|12167620|FG002|STARTED|Phase I||6
10991696|NCT00644189|12167621|FG003|STARTED|Phase I||18
10991697|NCT00644189|12167618|FG000|COMPLETED|Phase I||3
10991698|NCT00644189|12167619|FG001|COMPLETED|Phase I||3
10991699|NCT00644189|12167620|FG002|COMPLETED|Phase I||6
10991700|NCT00644189|12167621|FG003|COMPLETED|Phase I||18
10991701|NCT00644189|12167618|FG000|NOT COMPLETED|Phase I||0
10991702|NCT00644189|12167619|FG001|NOT COMPLETED|Phase I||0
10991703|NCT00644189|12167620|FG002|NOT COMPLETED|Phase I||0
10991704|NCT00644189|12167621|FG003|NOT COMPLETED|Phase I||0
10991705|NCT00644189|12167618|FG000|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
10991706|NCT00644189|12167619|FG001|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
10991707|NCT00644189|12167620|FG002|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
10991708|NCT00644189|12167621|FG003|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
10991709|NCT00644189|12167618|FG000|Completed All 6 Cycles of Treatment|Phase II||0
10991710|NCT00644189|12167619|FG001|Completed All 6 Cycles of Treatment|Phase II||0
10991711|NCT00644189|12167620|FG002|Completed All 6 Cycles of Treatment|Phase II||0
10991712|NCT00644189|12167621|FG003|Completed All 6 Cycles of Treatment|Phase II||19
10991713|NCT00644189|12167618|FG000|COMPLETED|Phase II||0
10991714|NCT00644189|12167619|FG001|COMPLETED|Phase II||0
10991715|NCT00644189|12167620|FG002|COMPLETED|Phase II||0
10991716|NCT00644189|12167621|FG003|COMPLETED|Phase II||50
10991717|NCT00644189|12167618|FG000|NOT COMPLETED|Phase II||0
10991718|NCT00644189|12167619|FG001|NOT COMPLETED|Phase II||0
10991719|NCT00644189|12167620|FG002|NOT COMPLETED|Phase II||0
10991720|NCT00644189|12167621|FG003|NOT COMPLETED|Phase II||0
10991721|NCT00644332|12167627|FG000|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
10991722|NCT00644332|12167627|FG000|COMPLETED|Overall Study||150
10991723|NCT00644332|12167627|FG000|NOT COMPLETED|Overall Study||21
10991724|NCT00644358|12167631|FG000|STARTED|Overall Study||616
10991725|NCT00644358|12167631|FG000|COMPLETED|Overall Study||254
10991726|NCT00644358|12167631|FG000|NOT COMPLETED|Overall Study||362
10991727|NCT00644423|12167637|FG000|STARTED|Overall Study||6
10991728|NCT00644423|12167638|FG001|STARTED|Overall Study||5
10991729|NCT00644423|12167637|FG000|COMPLETED|Overall Study||5
10991730|NCT00644423|12167638|FG001|COMPLETED|Overall Study||4
10991731|NCT00644423|12167637|FG000|NOT COMPLETED|Overall Study||1
10991732|NCT00644423|12167638|FG001|NOT COMPLETED|Overall Study||1
10991733|NCT00644592|12167646|FG000|STARTED|Overall Study||5
10991734|NCT00644592|12167647|FG001|STARTED|Overall Study||6
10991735|NCT00644592|12167646|FG000|COMPLETED|Overall Study||5
10991736|NCT00644592|12167647|FG001|COMPLETED|Overall Study||6
10991737|NCT00644592|12167646|FG000|NOT COMPLETED|Overall Study||0
10991738|NCT00644592|12167647|FG001|NOT COMPLETED|Overall Study||0
10991739|NCT00644657|12167653|FG000|STARTED|Overall Study||27
10991740|NCT00644657|12167653|FG000|COMPLETED|Overall Study||27
10991741|NCT00644657|12167653|FG000|NOT COMPLETED|Overall Study||0
10991742|NCT00644787|12167657|FG000|STARTED|Period 1: Titration Phase||156
10991743|NCT00644787|12167658|FG001|STARTED|Period 1: Titration Phase||0
10991744|NCT00644787|12167659|FG002|STARTED|Period 1: Titration Phase||0
10991745|NCT00644787|12167657|FG000|COMPLETED|Period 1: Titration Phase||129
10991746|NCT00644787|12167658|FG001|COMPLETED|Period 1: Titration Phase||0
10991747|NCT00644787|12167659|FG002|COMPLETED|Period 1: Titration Phase||0
10991748|NCT00644787|12167657|FG000|NOT COMPLETED|Period 1: Titration Phase||27
10991749|NCT00644787|12167658|FG001|NOT COMPLETED|Period 1: Titration Phase||0
10991750|NCT00644787|12167659|FG002|NOT COMPLETED|Period 1: Titration Phase||0
10991751|NCT00644787|12167657|FG000|STARTED|Period 2: Double Blind Phase||0
10991752|NCT00644787|12167658|FG001|STARTED|Period 2: Double Blind Phase||58
10991753|NCT00644787|12167659|FG002|STARTED|Period 2: Double Blind Phase||62
10991754|NCT00644787|12167657|FG000|COMPLETED|Period 2: Double Blind Phase||0
10991755|NCT00644787|12167658|FG001|COMPLETED|Period 2: Double Blind Phase||49
10991756|NCT00644787|12167659|FG002|COMPLETED|Period 2: Double Blind Phase||55
10991757|NCT00644787|12167657|FG000|NOT COMPLETED|Period 2: Double Blind Phase||0
10991758|NCT00644787|12167658|FG001|NOT COMPLETED|Period 2: Double Blind Phase||9
10991759|NCT00644787|12167659|FG002|NOT COMPLETED|Period 2: Double Blind Phase||7
10991760|NCT00644878|12167667|FG000|STARTED|Overall Study||18
10991761|NCT00644878|12167667|FG000|COMPLETED|Overall Study||0
10991762|NCT00644878|12167667|FG000|NOT COMPLETED|Overall Study||18
10991763|NCT00644917|12167671|FG000|STARTED|Overall Study||38
10991764|NCT00644917|12167671|FG000|COMPLETED|Overall Study||36
10991765|NCT00644917|12167671|FG000|NOT COMPLETED|Overall Study||2
10991766|NCT00644969|12167681|FG000|STARTED|Treatment Phase||85
10991767|NCT00644969|12167682|FG001|STARTED|Treatment Phase||43
10991768|NCT00644969|12167681|FG000|COMPLETED|Treatment Phase||71
10991769|NCT00644969|12167682|FG001|COMPLETED|Treatment Phase||40
10991770|NCT00644969|12167681|FG000|NOT COMPLETED|Treatment Phase||14
10991771|NCT00644969|12167682|FG001|NOT COMPLETED|Treatment Phase||3
10991772|NCT00644969|12167681|FG000|STARTED|Post Treatment Phase||71
10991773|NCT00644969|12167682|FG001|STARTED|Post Treatment Phase||40
10991774|NCT00644969|12167681|FG000|COMPLETED|Post Treatment Phase||61
10991775|NCT00644969|12167682|FG001|COMPLETED|Post Treatment Phase||37
10991776|NCT00644969|12167681|FG000|NOT COMPLETED|Post Treatment Phase||10
10991777|NCT00644969|12167682|FG001|NOT COMPLETED|Post Treatment Phase||3
10991778|NCT00644995|12167690|FG000|STARTED|Overall Study||25
10991779|NCT00644995|12167691|FG001|STARTED|Overall Study||27
10991780|NCT00644995|12167690|FG000|Completed 4 Month Assessment|Overall Study||23
10991781|NCT00644995|12167691|FG001|Completed 4 Month Assessment|Overall Study||24
10991782|NCT00644995|12167690|FG000|COMPLETED|Overall Study|Completed 6 month assessment|23
10991783|NCT00644995|12167691|FG001|COMPLETED|Overall Study||23
10991784|NCT00644995|12167690|FG000|NOT COMPLETED|Overall Study||2
10991785|NCT00644995|12167691|FG001|NOT COMPLETED|Overall Study||4
10991786|NCT00645047|12167701|FG000|STARTED|Overall Study||103
10991787|NCT00645047|12167702|FG001|STARTED|Overall Study||104
10991788|NCT00645047|12167701|FG000|Post|Overall Study||74
10991789|NCT00645047|12167702|FG001|Post|Overall Study||80
10991790|NCT00645047|12167701|FG000|COMPLETED|Overall Study|6 month follow up|60
10991791|NCT00645047|12167702|FG001|COMPLETED|Overall Study||65
10991792|NCT00645047|12167701|FG000|NOT COMPLETED|Overall Study||43
10991793|NCT00645047|12167702|FG001|NOT COMPLETED|Overall Study||39
10991794|NCT00645099|12167710|FG000|STARTED|Overall Study||239
10991795|NCT00645099|12167711|FG001|STARTED|Overall Study||220
10991796|NCT00645099|12167710|FG000|COMPLETED|Overall Study||168
10991797|NCT00645099|12167711|FG001|COMPLETED|Overall Study||178
10991798|NCT00645099|12167710|FG000|NOT COMPLETED|Overall Study||71
10991799|NCT00645099|12167711|FG001|NOT COMPLETED|Overall Study||42
10991800|NCT00645164|12167717|FG000|STARTED|Overall Study||59
10991801|NCT00645164|12167717|FG000|COMPLETED|Overall Study||52
10991802|NCT00645164|12167717|FG000|NOT COMPLETED|Overall Study||7
10991803|NCT00645333|12167721|FG000|STARTED|Overall Study||30
10991804|NCT00645333|12167721|FG000|COMPLETED|Overall Study||30
10991805|NCT00645333|12167721|FG000|NOT COMPLETED|Overall Study||0
10991806|NCT00645411|12167729|FG000|STARTED|Overall Study||656
10991807|NCT00645411|12167730|FG001|STARTED|Overall Study||318
10991808|NCT00645411|12167731|FG002|STARTED|Overall Study||1608
10991809|NCT00645411|12167732|FG003|STARTED|Overall Study||1022
10991810|NCT00645411|12167729|FG000|COMPLETED|Overall Study||643
10991811|NCT00645411|12167730|FG001|COMPLETED|Overall Study||312
10991812|NCT00645411|12167731|FG002|COMPLETED|Overall Study||1457
10991813|NCT00645411|12167732|FG003|COMPLETED|Overall Study||919
10991814|NCT00645411|12167729|FG000|NOT COMPLETED|Overall Study||13
10991815|NCT00645411|12167730|FG001|NOT COMPLETED|Overall Study||6
10991816|NCT00645411|12167731|FG002|NOT COMPLETED|Overall Study||151
10991817|NCT00645411|12167732|FG003|NOT COMPLETED|Overall Study||103
10991818|NCT00645450|12167751|FG000|STARTED|Overall Study||5
10991819|NCT00645450|12167752|FG001|STARTED|Overall Study||4
10991820|NCT00645450|12167751|FG000|COMPLETED|Overall Study||5
10991821|NCT00645450|12167752|FG001|COMPLETED|Overall Study||4
10991822|NCT00645450|12167751|FG000|NOT COMPLETED|Overall Study||0
10991823|NCT00645450|12167752|FG001|NOT COMPLETED|Overall Study||0
10991824|NCT00645528|12167758|FG000|STARTED|Overall Study||39
10991825|NCT00645528|12167758|FG000|COMPLETED|Overall Study||32
10991826|NCT00645528|12167758|FG000|NOT COMPLETED|Overall Study||7
10991827|NCT00645593|12167764|FG000|STARTED|Overall Study||29
10991828|NCT00645593|12167765|FG001|STARTED|Overall Study||60
10991829|NCT00645593|12167764|FG000|COMPLETED|Overall Study||28
10991830|NCT00645593|12167765|FG001|COMPLETED|Overall Study||60
10991831|NCT00645593|12167764|FG000|NOT COMPLETED|Overall Study||1
10991832|NCT00645593|12167765|FG001|NOT COMPLETED|Overall Study||0
10991833|NCT00645671|12167773|FG000|STARTED|Overall Study||201
10991834|NCT00645671|12167774|FG001|STARTED|Overall Study||199
10991835|NCT00645671|12167773|FG000|COMPLETED|Overall Study||200
10991836|NCT00645671|12167774|FG001|COMPLETED|Overall Study||193
10991837|NCT00645671|12167773|FG000|NOT COMPLETED|Overall Study||1
10991838|NCT00645671|12167774|FG001|NOT COMPLETED|Overall Study||6
10991839|NCT00645710|12167783|FG000|STARTED|Overall Study||3
10991840|NCT00645710|12167784|FG001|STARTED|Overall Study||3
10991841|NCT00645710|12167785|FG002|STARTED|Overall Study||10
10991842|NCT00645710|12167783|FG000|COMPLETED|Overall Study||3
10991843|NCT00645710|12167784|FG001|COMPLETED|Overall Study||3
10991844|NCT00645710|12167785|FG002|COMPLETED|Overall Study||10
10991845|NCT00645710|12167783|FG000|NOT COMPLETED|Overall Study||0
10991846|NCT00645710|12167784|FG001|NOT COMPLETED|Overall Study||0
10991847|NCT00645710|12167785|FG002|NOT COMPLETED|Overall Study||0
10991848|NCT00645762|12167794|FG000|STARTED|Overall Study||71
10991849|NCT00645762|12167794|FG000|COMPLETED|Overall Study||67
10991850|NCT00645762|12167794|FG000|NOT COMPLETED|Overall Study||4
10991851|NCT00645788|12167804|FG000|STARTED|Overall Study||94
10991852|NCT00645788|12167805|FG001|STARTED|Overall Study||94
10991853|NCT00645788|12167806|FG002|STARTED|Overall Study||65
10991854|NCT00645788|12167807|FG003|STARTED|Overall Study||35
10991855|NCT00645788|12167804|FG000|Participants Receive Treatment|Overall Study||93
10991856|NCT00645788|12167805|FG001|Participants Receive Treatment|Overall Study||93
10991857|NCT00645788|12167806|FG002|Participants Receive Treatment|Overall Study||65
10991858|NCT00645788|12167807|FG003|Participants Receive Treatment|Overall Study||35
10991859|NCT00645788|12167804|FG000|COMPLETED|Overall Study||74
10991860|NCT00645788|12167805|FG001|COMPLETED|Overall Study||67
10991861|NCT00645788|12167806|FG002|COMPLETED|Overall Study||47
10991862|NCT00645788|12167807|FG003|COMPLETED|Overall Study||21
10991863|NCT00645788|12167804|FG000|NOT COMPLETED|Overall Study||20
10991864|NCT00645788|12167805|FG001|NOT COMPLETED|Overall Study||27
10991865|NCT00645788|12167806|FG002|NOT COMPLETED|Overall Study||18
10991866|NCT00645788|12167807|FG003|NOT COMPLETED|Overall Study||14
10991867|NCT00645827|12167819|FG000|STARTED|Overall Study||14
10991868|NCT00645827|12167820|FG001|STARTED|Overall Study||17
10991869|NCT00645827|12167819|FG000|COMPLETED|Overall Study||14
10991870|NCT00645827|12167820|FG001|COMPLETED|Overall Study||17
10991871|NCT00645827|12167819|FG000|NOT COMPLETED|Overall Study||0
10991872|NCT00645827|12167820|FG001|NOT COMPLETED|Overall Study||0
10991873|NCT00645840|12167826|FG000|STARTED|Overall Study||15
10991874|NCT00645840|12167826|FG000|COMPLETED|Overall Study||12
10991875|NCT00645840|12167826|FG000|NOT COMPLETED|Overall Study||3
10991876|NCT00645853|12167832|FG000|STARTED|Overall Study||288
10991877|NCT00645853|12167833|FG001|STARTED|Overall Study||235
10991965|NCT00646906|12167934|FG000|COMPLETED|Crossover Period 1||8
10991966|NCT00646906|12167935|FG001|COMPLETED|Crossover Period 1||9
10991878|NCT00645853|12167832|FG000|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
10991879|NCT00645853|12167833|FG001|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
10991880|NCT00645853|12167832|FG000|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
10991881|NCT00645853|12167833|FG001|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
10991882|NCT00645853|12167832|FG000|AZ Study Closure in Hungary|Overall Study||60
10991883|NCT00645853|12167833|FG001|AZ Study Closure in Hungary|Overall Study||40
10991884|NCT00645853|12167832|FG000|COMPLETED|Overall Study||196
10991885|NCT00645853|12167833|FG001|COMPLETED|Overall Study||178
10991886|NCT00645853|12167832|FG000|NOT COMPLETED|Overall Study||92
10991887|NCT00645853|12167833|FG001|NOT COMPLETED|Overall Study||57
10991888|NCT00645944|12167841|FG000|STARTED|Randomized||20
10991889|NCT00645944|12167842|FG001|STARTED|Randomized||19
10991890|NCT00645944|12167841|FG000|COMPLETED|Randomized||19
10991891|NCT00645944|12167842|FG001|COMPLETED|Randomized||17
10991892|NCT00645944|12167841|FG000|NOT COMPLETED|Randomized||1
10991893|NCT00645944|12167842|FG001|NOT COMPLETED|Randomized||2
10991894|NCT00645944|12167841|FG000|STARTED|Received Medication||19
10991895|NCT00645944|12167842|FG001|STARTED|Received Medication||17
10991896|NCT00645944|12167841|FG000|COMPLETED|Received Medication||13
10991897|NCT00645944|12167842|FG001|COMPLETED|Received Medication||14
10991898|NCT00645944|12167841|FG000|NOT COMPLETED|Received Medication||6
10991899|NCT00645944|12167842|FG001|NOT COMPLETED|Received Medication||3
10991900|NCT00645970|12167850|FG000|STARTED|Overall Study||141
10991901|NCT00645970|12167851|FG001|STARTED|Overall Study||218
10991902|NCT00645970|12167850|FG000|6 Months|Overall Study||58
10991903|NCT00645970|12167851|FG001|6 Months|Overall Study||97
10991904|NCT00645970|12167850|FG000|1 Year|Overall Study||37
10991905|NCT00645970|12167851|FG001|1 Year|Overall Study||42
10991906|NCT00645970|12167850|FG000|COMPLETED|Overall Study||32
10991907|NCT00645970|12167851|FG001|COMPLETED|Overall Study||32
10991908|NCT00645970|12167850|FG000|NOT COMPLETED|Overall Study||109
10991909|NCT00645970|12167851|FG001|NOT COMPLETED|Overall Study||186
10991910|NCT00646048|12167857|FG000|STARTED|Overall Study||43
10991911|NCT00646048|12167857|FG000|COMPLETED|Overall Study||27
10991912|NCT00646048|12167857|FG000|NOT COMPLETED|Overall Study||16
10991913|NCT00646113|12167861|FG000|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69
10991914|NCT00646113|12167861|FG000|COMPLETED|Overall Study||61
10991915|NCT00646113|12167861|FG000|NOT COMPLETED|Overall Study||8
10991916|NCT00646399|12167867|FG000|STARTED|Overall Study||792
10991917|NCT00646399|12167868|FG001|STARTED|Overall Study||787
10991918|NCT00646399|12167867|FG000|COMPLETED|Overall Study||709
10991919|NCT00646399|12167868|FG001|COMPLETED|Overall Study||713
10991920|NCT00646399|12167867|FG000|NOT COMPLETED|Overall Study||83
10991921|NCT00646399|12167868|FG001|NOT COMPLETED|Overall Study||74
10991922|NCT00646451|12167874|FG000|STARTED|Overall Study||10
10991923|NCT00646451|12167875|FG001|STARTED|Overall Study||10
10991924|NCT00646451|12167874|FG000|COMPLETED|Overall Study||6
10991925|NCT00646451|12167875|FG001|COMPLETED|Overall Study||10
10991926|NCT00646451|12167874|FG000|NOT COMPLETED|Overall Study||4
10991927|NCT00646451|12167875|FG001|NOT COMPLETED|Overall Study||0
10991928|NCT00646581|12167885|FG000|STARTED|Overall Study||15
10991929|NCT00646581|12167886|FG001|STARTED|Overall Study||15
10991930|NCT00646581|12167885|FG000|COMPLETED|Overall Study||15
10991931|NCT00646581|12167886|FG001|COMPLETED|Overall Study||15
10991932|NCT00646581|12167885|FG000|NOT COMPLETED|Overall Study||0
10991933|NCT00646581|12167886|FG001|NOT COMPLETED|Overall Study||0
10991934|NCT00646646|12167896|FG000|STARTED|Overall Study||15
10991935|NCT00646646|12167897|FG001|STARTED|Overall Study||15
10991936|NCT00646646|12167898|FG002|STARTED|Overall Study||15
10991937|NCT00646646|12167899|FG003|STARTED|Overall Study||20
10991938|NCT00646646|12167896|FG000|COMPLETED|Overall Study||15
10991939|NCT00646646|12167897|FG001|COMPLETED|Overall Study||15
10991940|NCT00646646|12167898|FG002|COMPLETED|Overall Study||15
10991941|NCT00646646|12167899|FG003|COMPLETED|Overall Study||20
10991942|NCT00646646|12167896|FG000|NOT COMPLETED|Overall Study||0
10991943|NCT00646646|12167897|FG001|NOT COMPLETED|Overall Study||0
10991944|NCT00646646|12167898|FG002|NOT COMPLETED|Overall Study||0
10991945|NCT00646646|12167899|FG003|NOT COMPLETED|Overall Study||0
10991946|NCT00646763|12167911|FG000|STARTED|Overall Study||18
10991947|NCT00646763|12167912|FG001|STARTED|Overall Study||17
10991948|NCT00646763|12167911|FG000|COMPLETED|Overall Study||18
10991949|NCT00646763|12167912|FG001|COMPLETED|Overall Study||17
10991950|NCT00646763|12167911|FG000|NOT COMPLETED|Overall Study||0
10991951|NCT00646763|12167912|FG001|NOT COMPLETED|Overall Study||0
10991952|NCT00646776|12167920|FG000|STARTED|Overall Study|Treated on Day 1|15
10991953|NCT00646776|12167921|FG001|STARTED|Overall Study|Treated on Day 1|18
10991954|NCT00646776|12167920|FG000|COMPLETED|Overall Study||14
10991955|NCT00646776|12167921|FG001|COMPLETED|Overall Study||5
10991956|NCT00646776|12167920|FG000|NOT COMPLETED|Overall Study||1
10991957|NCT00646776|12167921|FG001|NOT COMPLETED|Overall Study||13
10991958|NCT00646906|12167934|FG000|STARTED|Crossover Period 1||9
10991959|NCT00646906|12167935|FG001|STARTED|Crossover Period 1||9
10991960|NCT00646906|12167936|FG002|STARTED|Crossover Period 1||10
10991961|NCT00646906|12167937|FG003|STARTED|Crossover Period 1||9
10991962|NCT00646906|12167938|FG004|STARTED|Crossover Period 1||8
10991963|NCT00646906|12167939|FG005|STARTED|Crossover Period 1||5
10991964|NCT00646906|12167940|FG006|STARTED|Crossover Period 1||5
10991967|NCT00646906|12167936|FG002|COMPLETED|Crossover Period 1||10
10991968|NCT00646906|12167937|FG003|COMPLETED|Crossover Period 1||9
10991969|NCT00646906|12167938|FG004|COMPLETED|Crossover Period 1|Phase 1b had only one treatment period and no crossover. Phase 1b ended here.|8
10991970|NCT00646906|12167939|FG005|COMPLETED|Crossover Period 1||4
10991971|NCT00646906|12167940|FG006|COMPLETED|Crossover Period 1||5
10991972|NCT00646906|12167934|FG000|NOT COMPLETED|Crossover Period 1||1
10991973|NCT00646906|12167935|FG001|NOT COMPLETED|Crossover Period 1||0
10991974|NCT00646906|12167936|FG002|NOT COMPLETED|Crossover Period 1||0
10991975|NCT00646906|12167937|FG003|NOT COMPLETED|Crossover Period 1||0
10991976|NCT00646906|12167938|FG004|NOT COMPLETED|Crossover Period 1||0
10991977|NCT00646906|12167939|FG005|NOT COMPLETED|Crossover Period 1||1
10991978|NCT00646906|12167940|FG006|NOT COMPLETED|Crossover Period 1||0
10991979|NCT00646906|12167934|FG000|STARTED|Washout (>/= 14 Days)||8
10991980|NCT00646906|12167935|FG001|STARTED|Washout (>/= 14 Days)||9
10991981|NCT00646906|12167936|FG002|STARTED|Washout (>/= 14 Days)||10
10991982|NCT00646906|12167937|FG003|STARTED|Washout (>/= 14 Days)||9
10991983|NCT00646906|12167938|FG004|STARTED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
10991984|NCT00646906|12167939|FG005|STARTED|Washout (>/= 14 Days)||4
10991985|NCT00646906|12167940|FG006|STARTED|Washout (>/= 14 Days)||5
10991986|NCT00646906|12167934|FG000|COMPLETED|Washout (>/= 14 Days)||8
10991987|NCT00646906|12167935|FG001|COMPLETED|Washout (>/= 14 Days)||9
10991988|NCT00646906|12167936|FG002|COMPLETED|Washout (>/= 14 Days)||10
10991989|NCT00646906|12167937|FG003|COMPLETED|Washout (>/= 14 Days)||9
10991990|NCT00646906|12167938|FG004|COMPLETED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
10991991|NCT00646906|12167939|FG005|COMPLETED|Washout (>/= 14 Days)||4
10991992|NCT00646906|12167940|FG006|COMPLETED|Washout (>/= 14 Days)||5
10991993|NCT00646906|12167934|FG000|NOT COMPLETED|Washout (>/= 14 Days)||0
10991994|NCT00646906|12167935|FG001|NOT COMPLETED|Washout (>/= 14 Days)||0
10991995|NCT00646906|12167936|FG002|NOT COMPLETED|Washout (>/= 14 Days)||0
10991996|NCT00646906|12167937|FG003|NOT COMPLETED|Washout (>/= 14 Days)||0
10991997|NCT00646906|12167938|FG004|NOT COMPLETED|Washout (>/= 14 Days)||0
10991998|NCT00646906|12167939|FG005|NOT COMPLETED|Washout (>/= 14 Days)||0
10991999|NCT00646906|12167940|FG006|NOT COMPLETED|Washout (>/= 14 Days)||0
10992000|NCT00646906|12167934|FG000|STARTED|Crossover Period 2||8
10992001|NCT00646906|12167935|FG001|STARTED|Crossover Period 2||9
10992002|NCT00646906|12167936|FG002|STARTED|Crossover Period 2||10
10992003|NCT00646906|12167937|FG003|STARTED|Crossover Period 2||9
10992004|NCT00646906|12167938|FG004|STARTED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
10992005|NCT00646906|12167939|FG005|STARTED|Crossover Period 2||4
10992006|NCT00646906|12167940|FG006|STARTED|Crossover Period 2||5
10992007|NCT00646906|12167934|FG000|COMPLETED|Crossover Period 2||8
10992008|NCT00646906|12167935|FG001|COMPLETED|Crossover Period 2||8
10992009|NCT00646906|12167936|FG002|COMPLETED|Crossover Period 2||8
10992010|NCT00646906|12167937|FG003|COMPLETED|Crossover Period 2||8
10992011|NCT00646906|12167938|FG004|COMPLETED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
10992012|NCT00646906|12167939|FG005|COMPLETED|Crossover Period 2||4
10992013|NCT00646906|12167940|FG006|COMPLETED|Crossover Period 2||4
10992014|NCT00646906|12167934|FG000|NOT COMPLETED|Crossover Period 2||0
10992015|NCT00646906|12167935|FG001|NOT COMPLETED|Crossover Period 2||1
10992016|NCT00646906|12167936|FG002|NOT COMPLETED|Crossover Period 2||2
10992017|NCT00646906|12167937|FG003|NOT COMPLETED|Crossover Period 2||1
10992018|NCT00646906|12167938|FG004|NOT COMPLETED|Crossover Period 2||0
10992019|NCT00646906|12167939|FG005|NOT COMPLETED|Crossover Period 2||0
10992020|NCT00646906|12167940|FG006|NOT COMPLETED|Crossover Period 2||1
10992021|NCT00646958|12167956|FG000|STARTED|Overall Study|Number (No.) Participants Randomized|51
10992022|NCT00646958|12167957|FG001|STARTED|Overall Study|No. Participants Randomized|50
10992023|NCT00646958|12167958|FG002|STARTED|Overall Study|No. Participants Randomized|49
10992024|NCT00646958|12167956|FG000|COMPLETED|Overall Study||40
10992025|NCT00646958|12167957|FG001|COMPLETED|Overall Study||41
10992026|NCT00646958|12167958|FG002|COMPLETED|Overall Study||40
10992027|NCT00646958|12167956|FG000|NOT COMPLETED|Overall Study||11
10992028|NCT00646958|12167957|FG001|NOT COMPLETED|Overall Study||9
10992029|NCT00646958|12167958|FG002|NOT COMPLETED|Overall Study||9
10992030|NCT00647270|12167969|FG000|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
10992031|NCT00647270|12167970|FG001|STARTED|Period 1, Placebo-control (12 Weeks)||159
10992032|NCT00647270|12167971|FG002|STARTED|Period 1, Placebo-control (12 Weeks)||205
10992033|NCT00647270|12167969|FG000|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
10992034|NCT00647270|12167970|FG001|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
10992035|NCT00647270|12167971|FG002|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
10992036|NCT00647270|12167969|FG000|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
10992037|NCT00647270|12167970|FG001|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
10992038|NCT00647270|12167971|FG002|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
10992039|NCT00647270|12167969|FG000|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
10992040|NCT00647270|12167970|FG001|STARTED|Period 2, Placebo Switched to Adalimumab||146
10992041|NCT00647270|12167971|FG002|STARTED|Period 2, Placebo Switched to Adalimumab||182
10992042|NCT00647270|12167969|FG000|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
10992043|NCT00647270|12167970|FG001|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
10992044|NCT00647270|12167971|FG002|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
10992045|NCT00647270|12167969|FG000|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
10992046|NCT00647270|12167970|FG001|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
10992047|NCT00647270|12167971|FG002|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
10992048|NCT00647296|12167986|FG000|STARTED|Part 1: 12-week Double-Blind Treatment||27
10992049|NCT00647296|12167987|FG001|STARTED|Part 1: 12-week Double-Blind Treatment||23
10992050|NCT00647296|12167988|FG002|STARTED|Part 1: 12-week Double-Blind Treatment||26
10992051|NCT00647296|12167989|FG003|STARTED|Part 1: 12-week Double-Blind Treatment||26
10992052|NCT00647296|12167986|FG000|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
10992053|NCT00647296|12167987|FG001|COMPLETED|Part 1: 12-week Double-Blind Treatment||22
10992054|NCT00647296|12167988|FG002|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
10992055|NCT00647296|12167989|FG003|COMPLETED|Part 1: 12-week Double-Blind Treatment||24
10992056|NCT00647296|12167986|FG000|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
10992057|NCT00647296|12167987|FG001|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
10992058|NCT00647296|12167988|FG002|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||0
10992059|NCT00647296|12167989|FG003|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||2
10992060|NCT00647296|12167986|FG000|STARTED|Part 2: 4-week Placebo Washout||97
10992061|NCT00647296|12167987|FG001|STARTED|Part 2: 4-week Placebo Washout||0
10992062|NCT00647296|12167988|FG002|STARTED|Part 2: 4-week Placebo Washout||0
10992063|NCT00647296|12167989|FG003|STARTED|Part 2: 4-week Placebo Washout||0
10992064|NCT00647296|12167986|FG000|COMPLETED|Part 2: 4-week Placebo Washout||92
10992065|NCT00647296|12167987|FG001|COMPLETED|Part 2: 4-week Placebo Washout||0
10992066|NCT00647296|12167988|FG002|COMPLETED|Part 2: 4-week Placebo Washout||0
10992067|NCT00647296|12167989|FG003|COMPLETED|Part 2: 4-week Placebo Washout||0
10992068|NCT00647296|12167986|FG000|NOT COMPLETED|Part 2: 4-week Placebo Washout||5
10992069|NCT00647296|12167987|FG001|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
10992070|NCT00647296|12167988|FG002|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
10992071|NCT00647296|12167989|FG003|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
10992072|NCT00647296|12167986|FG000|STARTED|Part 2: 76-week Double-Blind Treatment||0
10992073|NCT00647296|12167987|FG001|STARTED|Part 2: 76-week Double-Blind Treatment||48
10992074|NCT00647296|12167988|FG002|STARTED|Part 2: 76-week Double-Blind Treatment||0
10992075|NCT00647296|12167989|FG003|STARTED|Part 2: 76-week Double-Blind Treatment||44
10992076|NCT00647296|12167986|FG000|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
10992077|NCT00647296|12167987|FG001|COMPLETED|Part 2: 76-week Double-Blind Treatment||33
10992078|NCT00647296|12167988|FG002|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
10992079|NCT00647296|12167989|FG003|COMPLETED|Part 2: 76-week Double-Blind Treatment||30
10992080|NCT00647296|12167986|FG000|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
10992081|NCT00647296|12167987|FG001|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||15
10992082|NCT00647296|12167988|FG002|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
10992083|NCT00647296|12167989|FG003|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||14
10992084|NCT00647348|12168013|FG000|STARTED|Overall Study||70
10992085|NCT00647348|12168014|FG001|STARTED|Overall Study||70
10992086|NCT00647348|12168013|FG000|COMPLETED|Overall Study||67
10992087|NCT00647348|12168014|FG001|COMPLETED|Overall Study||64
10992088|NCT00647348|12168013|FG000|NOT COMPLETED|Overall Study||3
10992089|NCT00647348|12168014|FG001|NOT COMPLETED|Overall Study||6
10992090|NCT00647400|12168022|FG000|STARTED|Overall Study||89
10992091|NCT00647400|12168023|FG001|STARTED|Overall Study||58
10992092|NCT00647400|12168022|FG000|COMPLETED|Overall Study||67
10992093|NCT00647400|12168023|FG001|COMPLETED|Overall Study||45
10992094|NCT00647400|12168022|FG000|NOT COMPLETED|Overall Study||22
10992095|NCT00647400|12168023|FG001|NOT COMPLETED|Overall Study||13
10992096|NCT00647699|12168031|FG000|STARTED|Overall Study||73
10992097|NCT00647699|12168032|FG001|STARTED|Overall Study||74
10992098|NCT00647699|12168031|FG000|COMPLETED|Overall Study||65
10992099|NCT00647699|12168032|FG001|COMPLETED|Overall Study||62
10992100|NCT00647699|12168031|FG000|NOT COMPLETED|Overall Study||8
10992101|NCT00647699|12168032|FG001|NOT COMPLETED|Overall Study||12
10992102|NCT00647998|12168040|FG000|STARTED|Overall Study||9
10992103|NCT00647998|12168041|FG001|STARTED|Overall Study||9
10992104|NCT00647998|12168040|FG000|COMPLETED|Overall Study||9
10992105|NCT00647998|12168041|FG001|COMPLETED|Overall Study||9
10992106|NCT00647998|12168040|FG000|NOT COMPLETED|Overall Study||0
10992107|NCT00647998|12168041|FG001|NOT COMPLETED|Overall Study||0
10992108|NCT00648037|12168049|FG000|STARTED|Overall Study||26
10992109|NCT00648037|12168049|FG000|COMPLETED|Overall Study||10
10992110|NCT00648037|12168049|FG000|NOT COMPLETED|Overall Study||16
10992111|NCT00648115|12168056|FG000|STARTED|Overall Study||42
10992112|NCT00648115|12168057|FG001|STARTED|Overall Study||42
10992113|NCT00648115|12168058|FG002|STARTED|Overall Study||27
10992114|NCT00648115|12168056|FG000|COMPLETED|Overall Study||42
10992115|NCT00648115|12168057|FG001|COMPLETED|Overall Study||42
10992116|NCT00648115|12168058|FG002|COMPLETED|Overall Study||27
10992117|NCT00648115|12168056|FG000|NOT COMPLETED|Overall Study||0
10992118|NCT00648115|12168057|FG001|NOT COMPLETED|Overall Study||0
10992119|NCT00648115|12168058|FG002|NOT COMPLETED|Overall Study||0
10992120|NCT00648167|12168066|FG000|STARTED|Overall Study||55
10992121|NCT00648167|12168066|FG000|Start Dose 4.5 g/Day|Overall Study||34
10992122|NCT00648167|12168066|FG000|Start Dose 6 g/Day|Overall Study||21
10992123|NCT00648167|12168066|FG000|COMPLETED|Overall Study||48
10992124|NCT00648167|12168066|FG000|NOT COMPLETED|Overall Study||7
10992125|NCT00648375|12168072|FG000|STARTED|Overall Study||1
10992126|NCT00648375|12168073|FG001|STARTED|Overall Study||2
10992127|NCT00648375|12168072|FG000|COMPLETED|Overall Study||1
10992128|NCT00648375|12168073|FG001|COMPLETED|Overall Study||2
10992129|NCT00648375|12168072|FG000|NOT COMPLETED|Overall Study||0
10992130|NCT00648375|12168073|FG001|NOT COMPLETED|Overall Study||0
10992131|NCT00648648|12168107|FG000|STARTED|Overall Study||3
10992132|NCT00648648|12168108|FG001|STARTED|Overall Study||3
10992133|NCT00648648|12168109|FG002|STARTED|Overall Study||3
10992134|NCT00648648|12168110|FG003|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4
10992135|NCT00648648|12168111|FG004|STARTED|Overall Study||9
10992136|NCT00648648|12168112|FG005|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
10992137|NCT00648648|12168113|FG006|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10
10992138|NCT00648648|12168114|FG007|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
10992139|NCT00648648|12168115|FG008|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3
10992140|NCT00648648|12168116|FG009|STARTED|Overall Study||10
10992141|NCT00648648|12168117|FG010|STARTED|Overall Study||6
10992142|NCT00648648|12168118|FG011|STARTED|Overall Study||13
10992143|NCT00648648|12168119|FG012|STARTED|Overall Study||6
10992144|NCT00648648|12168120|FG013|STARTED|Overall Study||5
10992145|NCT00648648|12168121|FG014|STARTED|Overall Study||4
10992146|NCT00648648|12168122|FG015|STARTED|Overall Study||11
10992147|NCT00648648|12168123|FG016|STARTED|Overall Study||16
10992148|NCT00648648|12168124|FG017|STARTED|Overall Study||6
10992149|NCT00648648|12168125|FG018|STARTED|Overall Study||5
10992150|NCT00648648|12168126|FG019|STARTED|Overall Study||7
10992151|NCT00648648|12168127|FG020|STARTED|Overall Study||6
10992152|NCT00648648|12168128|FG021|STARTED|Overall Study||10
10992153|NCT00648648|12168129|FG022|STARTED|Overall Study||14
10992154|NCT00648648|12168130|FG023|STARTED|Overall Study||4
10992155|NCT00648648|12168131|FG024|STARTED|Overall Study||4
10992156|NCT00648648|12168132|FG025|STARTED|Overall Study||4
10992157|NCT00648648|12168133|FG026|STARTED|Overall Study||26
10992158|NCT00648648|12168134|FG027|STARTED|Overall Study||12
10992159|NCT00648648|12168107|FG000|Treated|Overall Study||3
10992160|NCT00648648|12168108|FG001|Treated|Overall Study||3
10992161|NCT00648648|12168109|FG002|Treated|Overall Study||3
10992162|NCT00648648|12168110|FG003|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4
10992163|NCT00648648|12168111|FG004|Treated|Overall Study||8
10992164|NCT00648648|12168112|FG005|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
10992165|NCT00648648|12168113|FG006|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
10992166|NCT00648648|12168114|FG007|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
10992167|NCT00648648|12168115|FG008|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3
10992168|NCT00648648|12168116|FG009|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
10992169|NCT00648648|12168117|FG010|Treated|Overall Study||6
10992170|NCT00648648|12168118|FG011|Treated|Overall Study||13
10992171|NCT00648648|12168119|FG012|Treated|Overall Study||6
10992172|NCT00648648|12168120|FG013|Treated|Overall Study||5
10992173|NCT00648648|12168121|FG014|Treated|Overall Study||4
10992174|NCT00648648|12168122|FG015|Treated|Overall Study||11
10992175|NCT00648648|12168123|FG016|Treated|Overall Study||16
10992176|NCT00648648|12168124|FG017|Treated|Overall Study||6
10992177|NCT00648648|12168125|FG018|Treated|Overall Study||4
10992178|NCT00648648|12168126|FG019|Treated|Overall Study||7
10992179|NCT00648648|12168127|FG020|Treated|Overall Study||6
10992180|NCT00648648|12168128|FG021|Treated|Overall Study||10
10992181|NCT00648648|12168129|FG022|Treated|Overall Study||14
10992182|NCT00648648|12168130|FG023|Treated|Overall Study||4
10992183|NCT00648648|12168131|FG024|Treated|Overall Study||4
10992184|NCT00648648|12168132|FG025|Treated|Overall Study||4
10992185|NCT00648648|12168133|FG026|Treated|Overall Study||26
10992186|NCT00648648|12168134|FG027|Treated|Overall Study||12
10992187|NCT00648648|12168107|FG000|COMPLETED|Overall Study||3
10992188|NCT00648648|12168108|FG001|COMPLETED|Overall Study||3
10992189|NCT00648648|12168109|FG002|COMPLETED|Overall Study||3
10992190|NCT00648648|12168110|FG003|COMPLETED|Overall Study||0
10992191|NCT00648648|12168111|FG004|COMPLETED|Overall Study||0
10992192|NCT00648648|12168112|FG005|COMPLETED|Overall Study||0
10992193|NCT00648648|12168113|FG006|COMPLETED|Overall Study||0
10992194|NCT00648648|12168114|FG007|COMPLETED|Overall Study||0
10992195|NCT00648648|12168115|FG008|COMPLETED|Overall Study||0
10992196|NCT00648648|12168116|FG009|COMPLETED|Overall Study||0
10992197|NCT00648648|12168117|FG010|COMPLETED|Overall Study||0
10992198|NCT00648648|12168118|FG011|COMPLETED|Overall Study||0
10992199|NCT00648648|12168119|FG012|COMPLETED|Overall Study||0
10992200|NCT00648648|12168120|FG013|COMPLETED|Overall Study||0
10992201|NCT00648648|12168121|FG014|COMPLETED|Overall Study||0
10992202|NCT00648648|12168122|FG015|COMPLETED|Overall Study||0
10992203|NCT00648648|12168123|FG016|COMPLETED|Overall Study||2
10992204|NCT00648648|12168124|FG017|COMPLETED|Overall Study||0
10992205|NCT00648648|12168125|FG018|COMPLETED|Overall Study||0
10992206|NCT00648648|12168126|FG019|COMPLETED|Overall Study||0
10992207|NCT00648648|12168127|FG020|COMPLETED|Overall Study||0
10992208|NCT00648648|12168128|FG021|COMPLETED|Overall Study||0
10992209|NCT00648648|12168129|FG022|COMPLETED|Overall Study||0
10992210|NCT00648648|12168130|FG023|COMPLETED|Overall Study||0
10992211|NCT00648648|12168131|FG024|COMPLETED|Overall Study||0
10992212|NCT00648648|12168132|FG025|COMPLETED|Overall Study||0
10992213|NCT00648648|12168133|FG026|COMPLETED|Overall Study||0
10992214|NCT00648648|12168134|FG027|COMPLETED|Overall Study||0
10992215|NCT00648648|12168107|FG000|NOT COMPLETED|Overall Study||0
10992216|NCT00648648|12168108|FG001|NOT COMPLETED|Overall Study||0
10992217|NCT00648648|12168109|FG002|NOT COMPLETED|Overall Study||0
10992218|NCT00648648|12168110|FG003|NOT COMPLETED|Overall Study||4
10992219|NCT00648648|12168111|FG004|NOT COMPLETED|Overall Study||9
10992220|NCT00648648|12168112|FG005|NOT COMPLETED|Overall Study||1
10992221|NCT00648648|12168113|FG006|NOT COMPLETED|Overall Study||10
10992222|NCT00648648|12168114|FG007|NOT COMPLETED|Overall Study||1
10992223|NCT00648648|12168115|FG008|NOT COMPLETED|Overall Study||3
10992224|NCT00648648|12168116|FG009|NOT COMPLETED|Overall Study||10
10992225|NCT00648648|12168117|FG010|NOT COMPLETED|Overall Study||6
10992226|NCT00648648|12168118|FG011|NOT COMPLETED|Overall Study||13
10992227|NCT00648648|12168119|FG012|NOT COMPLETED|Overall Study||6
10992228|NCT00648648|12168120|FG013|NOT COMPLETED|Overall Study||5
10992229|NCT00648648|12168121|FG014|NOT COMPLETED|Overall Study||4
10992230|NCT00648648|12168122|FG015|NOT COMPLETED|Overall Study||11
10992231|NCT00648648|12168123|FG016|NOT COMPLETED|Overall Study||14
10992232|NCT00648648|12168124|FG017|NOT COMPLETED|Overall Study||6
10992233|NCT00648648|12168125|FG018|NOT COMPLETED|Overall Study||5
10992234|NCT00648648|12168126|FG019|NOT COMPLETED|Overall Study||7
10992235|NCT00648648|12168127|FG020|NOT COMPLETED|Overall Study||6
10992236|NCT00648648|12168128|FG021|NOT COMPLETED|Overall Study||10
10992237|NCT00648648|12168129|FG022|NOT COMPLETED|Overall Study||14
10992238|NCT00648648|12168130|FG023|NOT COMPLETED|Overall Study||4
10992239|NCT00648648|12168131|FG024|NOT COMPLETED|Overall Study||4
10992240|NCT00648648|12168132|FG025|NOT COMPLETED|Overall Study||4
10992241|NCT00648648|12168133|FG026|NOT COMPLETED|Overall Study||26
10992242|NCT00648648|12168134|FG027|NOT COMPLETED|Overall Study||12
10992243|NCT00648739|12168192|FG000|STARTED|Overall Study||4
10992244|NCT00648739|12168193|FG001|STARTED|Overall Study||5
10992245|NCT00648739|12168194|FG002|STARTED|Overall Study||3
10992246|NCT00648739|12168195|FG003|STARTED|Overall Study||3
10992247|NCT00648739|12168196|FG004|STARTED|Overall Study||3
10992248|NCT00648739|12168197|FG005|STARTED|Overall Study||7
10992249|NCT00648739|12168198|FG006|STARTED|Overall Study||1
10992250|NCT00648739|12168192|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
10992251|NCT00648739|12168193|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
10992252|NCT00648739|12168194|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
10992253|NCT00648739|12168195|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
10992254|NCT00648739|12168196|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
10992255|NCT00648739|12168197|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7
10992256|NCT00648739|12168198|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1
10992257|NCT00648739|12168192|FG000|COMPLETED|Overall Study||2
10992258|NCT00648739|12168193|FG001|COMPLETED|Overall Study||3
10992259|NCT00648739|12168194|FG002|COMPLETED|Overall Study||0
10992260|NCT00648739|12168195|FG003|COMPLETED|Overall Study||1
10992261|NCT00648739|12168196|FG004|COMPLETED|Overall Study||1
10992262|NCT00648739|12168197|FG005|COMPLETED|Overall Study||2
10992263|NCT00648739|12168198|FG006|COMPLETED|Overall Study||0
10992264|NCT00648739|12168192|FG000|NOT COMPLETED|Overall Study||2
10992265|NCT00648739|12168193|FG001|NOT COMPLETED|Overall Study||2
10992266|NCT00648739|12168194|FG002|NOT COMPLETED|Overall Study||3
10992267|NCT00648739|12168195|FG003|NOT COMPLETED|Overall Study||2
10992268|NCT00648739|12168196|FG004|NOT COMPLETED|Overall Study||2
10992269|NCT00648739|12168197|FG005|NOT COMPLETED|Overall Study||5
10992270|NCT00648739|12168198|FG006|NOT COMPLETED|Overall Study||1
10992271|NCT00648908|12168219|FG000|STARTED|Overall Study||269
10992272|NCT00648908|12168219|FG000|COMPLETED|Overall Study||154
10992273|NCT00648908|12168219|FG000|NOT COMPLETED|Overall Study||115
10992274|NCT00649220|12168224|FG000|STARTED|Overall Study||19
10992275|NCT00649220|12168224|FG000|COMPLETED|Overall Study||16
10992276|NCT00649220|12168224|FG000|NOT COMPLETED|Overall Study||3
10992277|NCT00649389|12168232|FG000|STARTED|Overall Study||628
10992278|NCT00649389|12168233|FG001|STARTED|Overall Study||637
10992279|NCT00649389|12168234|FG002|STARTED|Overall Study||600
10992280|NCT00649389|12168235|FG003|STARTED|Overall Study||627
10992281|NCT00649389|12168232|FG000|COMPLETED|Overall Study||557
10992282|NCT00649389|12168233|FG001|COMPLETED|Overall Study||531
10992283|NCT00649389|12168234|FG002|COMPLETED|Overall Study||512
10992284|NCT00649389|12168235|FG003|COMPLETED|Overall Study||516
10992285|NCT00649389|12168232|FG000|NOT COMPLETED|Overall Study||71
10992286|NCT00649389|12168233|FG001|NOT COMPLETED|Overall Study||106
10992287|NCT00649389|12168234|FG002|NOT COMPLETED|Overall Study||88
10992288|NCT00649389|12168235|FG003|NOT COMPLETED|Overall Study||111
10992289|NCT00649428|12168247|FG000|STARTED|Overall Study||100
10992290|NCT00649428|12168248|FG001|STARTED|Overall Study||103
10992291|NCT00649428|12168247|FG000|COMPLETED|Overall Study||80
10992292|NCT00649428|12168248|FG001|COMPLETED|Overall Study||88
10992293|NCT00649428|12168247|FG000|NOT COMPLETED|Overall Study||20
10992294|NCT00649428|12168248|FG001|NOT COMPLETED|Overall Study||15
10992295|NCT00649792|12168255|FG000|STARTED|Overall Study||214
10992296|NCT00649792|12168255|FG000|COMPLETED|Overall Study||146
10992297|NCT00649792|12168255|FG000|NOT COMPLETED|Overall Study||68
10992298|NCT00649961|12168259|FG000|STARTED|Overall Study||18
10992299|NCT00649961|12168259|FG000|COMPLETED|Overall Study||18
10992300|NCT00649961|12168259|FG000|NOT COMPLETED|Overall Study||0
10992301|NCT00650078|12168265|FG000|STARTED|Overall Study||231
10992302|NCT00650078|12168266|FG001|STARTED|Overall Study||119
10992303|NCT00650078|12168265|FG000|COMPLETED|Overall Study||217
10992304|NCT00650078|12168266|FG001|COMPLETED|Overall Study||106
10992305|NCT00650078|12168265|FG000|NOT COMPLETED|Overall Study||14
10992306|NCT00650078|12168266|FG001|NOT COMPLETED|Overall Study||13
10992307|NCT00650091|12168274|FG000|STARTED|Initial Study Design - Interim Analysis||81
10992308|NCT00650091|12168275|FG001|STARTED|Initial Study Design - Interim Analysis||78
10992309|NCT00650091|12168276|FG002|STARTED|Initial Study Design - Interim Analysis||77
10992310|NCT00650091|12168274|FG000|COMPLETED|Initial Study Design - Interim Analysis||81
10992311|NCT00650091|12168275|FG001|COMPLETED|Initial Study Design - Interim Analysis||78
10992312|NCT00650091|12168276|FG002|COMPLETED|Initial Study Design - Interim Analysis||77
10992313|NCT00650091|12168274|FG000|NOT COMPLETED|Initial Study Design - Interim Analysis||0
10992314|NCT00650091|12168275|FG001|NOT COMPLETED|Initial Study Design - Interim Analysis||0
10992315|NCT00650091|12168276|FG002|NOT COMPLETED|Initial Study Design - Interim Analysis||0
10992316|NCT00650091|12168274|FG000|STARTED|Amended Study Design||133
10992317|NCT00650091|12168275|FG001|STARTED|Amended Study Design||131
10992318|NCT00650091|12168276|FG002|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
10992319|NCT00650091|12168274|FG000|COMPLETED|Amended Study Design||110
10992320|NCT00650091|12168275|FG001|COMPLETED|Amended Study Design||111
10992321|NCT00650091|12168276|FG002|COMPLETED|Amended Study Design||0
10992322|NCT00650091|12168274|FG000|NOT COMPLETED|Amended Study Design||23
10992323|NCT00650091|12168275|FG001|NOT COMPLETED|Amended Study Design||20
10992324|NCT00650091|12168276|FG002|NOT COMPLETED|Amended Study Design||0
10992325|NCT00650104|12168284|FG000|STARTED|Overall Study||83
10992326|NCT00650104|12168284|FG000|COMPLETED|Overall Study||42
10992327|NCT00650104|12168284|FG000|NOT COMPLETED|Overall Study||41
10992328|NCT00650260|12168290|FG000|STARTED|Overall Study||21
10992329|NCT00650260|12168291|FG001|STARTED|Overall Study||21
10992330|NCT00650260|12168290|FG000|COMPLETED|Overall Study||21
10992331|NCT00650260|12168291|FG001|COMPLETED|Overall Study||21
10992332|NCT00650260|12168290|FG000|NOT COMPLETED|Overall Study||0
10992333|NCT00650260|12168291|FG001|NOT COMPLETED|Overall Study||0
10992334|NCT00650546|12168297|FG000|STARTED|Overall Study||8
10992335|NCT00650546|12168297|FG000|COMPLETED|Overall Study||8
10992336|NCT00650546|12168297|FG000|NOT COMPLETED|Overall Study||0
10992337|NCT00650585|12168304|FG000|STARTED|Overall Study||4348
10992338|NCT00650585|12168305|FG001|STARTED|Overall Study||3990
10992339|NCT00650585|12168304|FG000|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
10992340|NCT00650585|12168305|FG001|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
10992341|NCT00650585|12168304|FG000|NOT COMPLETED|Overall Study||1797
10992342|NCT00650585|12168305|FG001|NOT COMPLETED|Overall Study||1477
10992343|NCT00650767|12168315|FG000|STARTED|Overall Study||51
10992344|NCT00650767|12168316|FG001|STARTED|Overall Study||50
10992345|NCT00650767|12168317|FG002|STARTED|Overall Study||50
10992346|NCT00650767|12168318|FG003|STARTED|Overall Study||50
10992347|NCT00650767|12168315|FG000|COMPLETED|Overall Study||46
10992348|NCT00650767|12168316|FG001|COMPLETED|Overall Study||41
10992349|NCT00650767|12168317|FG002|COMPLETED|Overall Study||36
10992350|NCT00650767|12168318|FG003|COMPLETED|Overall Study||39
10992351|NCT00650767|12168315|FG000|NOT COMPLETED|Overall Study||5
10992352|NCT00650767|12168316|FG001|NOT COMPLETED|Overall Study||9
10992353|NCT00650767|12168317|FG002|NOT COMPLETED|Overall Study||14
10992354|NCT00650767|12168318|FG003|NOT COMPLETED|Overall Study||11
10992355|NCT00650806|12168332|FG000|STARTED|Overall Study||89
10992356|NCT00650806|12168333|FG001|STARTED|Overall Study||98
10992357|NCT00650806|12168334|FG002|STARTED|Overall Study||93
10992358|NCT00650806|12168335|FG003|STARTED|Overall Study||96
10992359|NCT00650806|12168332|FG000|COMPLETED|Overall Study||71
10992360|NCT00650806|12168333|FG001|COMPLETED|Overall Study||77
10992361|NCT00650806|12168334|FG002|COMPLETED|Overall Study||64
10992362|NCT00650806|12168335|FG003|COMPLETED|Overall Study||70
10992363|NCT00650806|12168332|FG000|NOT COMPLETED|Overall Study||18
10992364|NCT00650806|12168333|FG001|NOT COMPLETED|Overall Study||21
10992365|NCT00650806|12168334|FG002|NOT COMPLETED|Overall Study||29
10992366|NCT00650806|12168335|FG003|NOT COMPLETED|Overall Study||26
10992367|NCT00650845|12168349|FG000|STARTED|Overall Study||75
10992368|NCT00650845|12168350|FG001|STARTED|Overall Study||57
10992369|NCT00650845|12168349|FG000|COMPLETED|Overall Study||70
10992370|NCT00650845|12168350|FG001|COMPLETED|Overall Study||44
10992371|NCT00650845|12168349|FG000|NOT COMPLETED|Overall Study||5
10992372|NCT00650845|12168350|FG001|NOT COMPLETED|Overall Study||13
10992373|NCT00650858|12168360|FG000|STARTED|Overall Study||8
10992374|NCT00650858|12168361|FG001|STARTED|Overall Study||8
10992375|NCT00650858|12168362|FG002|STARTED|Overall Study||36
10992376|NCT00650858|12168360|FG000|COMPLETED|Overall Study||8
10992377|NCT00650858|12168361|FG001|COMPLETED|Overall Study||8
10992378|NCT00650858|12168362|FG002|COMPLETED|Overall Study||36
10992379|NCT00650858|12168360|FG000|NOT COMPLETED|Overall Study||0
10992380|NCT00650858|12168361|FG001|NOT COMPLETED|Overall Study||0
10992381|NCT00650858|12168362|FG002|NOT COMPLETED|Overall Study||0
10992382|NCT00650936|12168370|FG000|STARTED|Overall Study||1000
10992383|NCT00650936|12168370|FG000|COMPLETED|Overall Study||930
10992384|NCT00650936|12168370|FG000|NOT COMPLETED|Overall Study||70
10992385|NCT00651040|12168376|FG000|STARTED|Overall Study||16
10992386|NCT00651040|12168377|FG001|STARTED|Overall Study||15
10992387|NCT00651040|12168376|FG000|COMPLETED|Overall Study||13
10992388|NCT00651040|12168377|FG001|COMPLETED|Overall Study||14
10992389|NCT00651040|12168376|FG000|NOT COMPLETED|Overall Study||3
10992390|NCT00651040|12168377|FG001|NOT COMPLETED|Overall Study||1
10992391|NCT00651118|12168387|FG000|STARTED|Overall Study||207
10992392|NCT00651118|12168388|FG001|STARTED|Overall Study||207
10992393|NCT00651118|12168389|FG002|STARTED|Overall Study||208
10992394|NCT00651118|12168390|FG003|STARTED|Overall Study||210
10992395|NCT00651118|12168387|FG000|COMPLETED|Overall Study||198
10992396|NCT00651118|12168388|FG001|COMPLETED|Overall Study||200
10992397|NCT00651118|12168389|FG002|COMPLETED|Overall Study||197
10992398|NCT00651118|12168390|FG003|COMPLETED|Overall Study||203
10992399|NCT00651118|12168387|FG000|NOT COMPLETED|Overall Study||9
10992400|NCT00651118|12168388|FG001|NOT COMPLETED|Overall Study||7
10992401|NCT00651118|12168389|FG002|NOT COMPLETED|Overall Study||11
10992402|NCT00651118|12168390|FG003|NOT COMPLETED|Overall Study||7
10992403|NCT00651157|12168403|FG000|STARTED|Overall Study||23
10992404|NCT00651157|12168403|FG000|COMPLETED|Overall Study||21
10992405|NCT00651157|12168403|FG000|NOT COMPLETED|Overall Study||2
10992406|NCT00651183|12168409|FG000|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
10992407|NCT00651183|12168410|FG001|STARTED|Overall Study||97
10992408|NCT00651183|12168409|FG000|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
10992409|NCT00651183|12168410|FG001|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
10992410|NCT00651183|12168409|FG000|NOT COMPLETED|Overall Study||20
10992411|NCT00651183|12168410|FG001|NOT COMPLETED|Overall Study||10
10992412|NCT00651261|12168418|FG000|STARTED|Overall Study||360
10992413|NCT00651261|12168419|FG001|STARTED|Overall Study||357
10992414|NCT00651261|12168418|FG000|COMPLETED|Overall Study||69
10992415|NCT00651261|12168419|FG001|COMPLETED|Overall Study||51
10992416|NCT00651261|12168418|FG000|NOT COMPLETED|Overall Study||291
10992417|NCT00651261|12168419|FG001|NOT COMPLETED|Overall Study||306
10992418|NCT00651313|12168427|FG000|STARTED|Overall Study||41
10992419|NCT00651313|12168428|FG001|STARTED|Overall Study||43
10992420|NCT00651313|12168427|FG000|COMPLETED|Overall Study||35
10992421|NCT00651313|12168428|FG001|COMPLETED|Overall Study||37
10992422|NCT00651313|12168427|FG000|NOT COMPLETED|Overall Study||6
10992423|NCT00651313|12168428|FG001|NOT COMPLETED|Overall Study||6
10992424|NCT00651482|12168434|FG000|STARTED|Overall Study||10
10992425|NCT00651482|12168434|FG000|COMPLETED|Overall Study||10
10992426|NCT00651482|12168434|FG000|NOT COMPLETED|Overall Study||0
10992427|NCT00651573|12168441|FG000|STARTED|Overall Study||365
10992428|NCT00651573|12168442|FG001|STARTED|Overall Study||357
10992429|NCT00651573|12168441|FG000|COMPLETED|Overall Study||363
10992430|NCT00651573|12168442|FG001|COMPLETED|Overall Study||354
10992431|NCT00651573|12168441|FG000|NOT COMPLETED|Overall Study||2
10992432|NCT00651573|12168442|FG001|NOT COMPLETED|Overall Study||3
10992433|NCT00651625|12168450|FG000|STARTED|Overall Study||219
10992434|NCT00651625|12168451|FG001|STARTED|Overall Study||218
10992435|NCT00651625|12168450|FG000|COMPLETED|Overall Study||219
10992436|NCT00651625|12168451|FG001|COMPLETED|Overall Study||218
10992437|NCT00651625|12168450|FG000|NOT COMPLETED|Overall Study||0
10992438|NCT00651625|12168451|FG001|NOT COMPLETED|Overall Study||0
10992439|NCT00651664|12168467|FG000|STARTED|Overall Study||3
10992440|NCT00651664|12168468|FG001|STARTED|Overall Study||3
10992441|NCT00651664|12168469|FG002|STARTED|Overall Study||3
10992442|NCT00651664|12168470|FG003|STARTED|Overall Study||14
10992443|NCT00651664|12168471|FG004|STARTED|Overall Study||6
10992444|NCT00651664|12168472|FG005|STARTED|Overall Study||3
10992445|NCT00651664|12168473|FG006|STARTED|Overall Study||6
10992446|NCT00651664|12168474|FG007|STARTED|Overall Study||7
10992447|NCT00651664|12168475|FG008|STARTED|Overall Study||7
10992448|NCT00651664|12168476|FG009|STARTED|Overall Study||7
10992449|NCT00651664|12168467|FG000|COMPLETED|Overall Study||0
10992450|NCT00651664|12168468|FG001|COMPLETED|Overall Study||0
10992451|NCT00651664|12168469|FG002|COMPLETED|Overall Study||0
10992452|NCT00651664|12168470|FG003|COMPLETED|Overall Study||0
10992453|NCT00651664|12168471|FG004|COMPLETED|Overall Study||0
10992454|NCT00651664|12168472|FG005|COMPLETED|Overall Study||0
10992455|NCT00651664|12168473|FG006|COMPLETED|Overall Study||0
10992456|NCT00651664|12168474|FG007|COMPLETED|Overall Study||0
10992457|NCT00651664|12168475|FG008|COMPLETED|Overall Study||0
10992458|NCT00651664|12168476|FG009|COMPLETED|Overall Study||0
10992459|NCT00651664|12168467|FG000|NOT COMPLETED|Overall Study||3
10992460|NCT00651664|12168468|FG001|NOT COMPLETED|Overall Study||3
10992461|NCT00651664|12168469|FG002|NOT COMPLETED|Overall Study||3
10992462|NCT00651664|12168470|FG003|NOT COMPLETED|Overall Study||14
10992463|NCT00651664|12168471|FG004|NOT COMPLETED|Overall Study||6
10992464|NCT00651664|12168472|FG005|NOT COMPLETED|Overall Study||3
10992465|NCT00651664|12168473|FG006|NOT COMPLETED|Overall Study||6
10992466|NCT00651664|12168474|FG007|NOT COMPLETED|Overall Study||7
10992467|NCT00651664|12168475|FG008|NOT COMPLETED|Overall Study||7
10992468|NCT00651664|12168476|FG009|NOT COMPLETED|Overall Study||7
10992469|NCT00651755|12168502|FG000|STARTED|Cycle 1 (First 21 Days)||11
10992470|NCT00651755|12168503|FG001|STARTED|Cycle 1 (First 21 Days)||9
10992471|NCT00651755|12168502|FG000|COMPLETED|Cycle 1 (First 21 Days)||10
10992472|NCT00651755|12168503|FG001|COMPLETED|Cycle 1 (First 21 Days)||9
10992473|NCT00651755|12168502|FG000|NOT COMPLETED|Cycle 1 (First 21 Days)||1
10992474|NCT00651755|12168503|FG001|NOT COMPLETED|Cycle 1 (First 21 Days)||0
10992475|NCT00651755|12168502|FG000|STARTED|Cycle 2 (Second 21 Days)||10
10992476|NCT00651755|12168503|FG001|STARTED|Cycle 2 (Second 21 Days)||9
10992477|NCT00651755|12168502|FG000|COMPLETED|Cycle 2 (Second 21 Days)||10
10992478|NCT00651755|12168503|FG001|COMPLETED|Cycle 2 (Second 21 Days)||8
10992479|NCT00651755|12168502|FG000|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
10992480|NCT00651755|12168503|FG001|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
10992481|NCT00651794|12168513|FG000|STARTED|Overall Study||36
10992482|NCT00651794|12168514|FG001|STARTED|Overall Study||31
10992483|NCT00651794|12168515|FG002|STARTED|Overall Study||31
10992484|NCT00651794|12168513|FG000|COMPLETED|Overall Study||15
10992485|NCT00651794|12168514|FG001|COMPLETED|Overall Study||9
10992486|NCT00651794|12168515|FG002|COMPLETED|Overall Study||10
10992487|NCT00651794|12168513|FG000|NOT COMPLETED|Overall Study||21
10992488|NCT00651794|12168514|FG001|NOT COMPLETED|Overall Study||22
10992489|NCT00651794|12168515|FG002|NOT COMPLETED|Overall Study||21
10992490|NCT00651820|12168523|FG000|STARTED|Overall Study||28
10992491|NCT00651820|12168523|FG000|COMPLETED|Overall Study||26
10992492|NCT00651820|12168523|FG000|NOT COMPLETED|Overall Study||2
10992493|NCT00651924|12168531|FG000|STARTED|Overall Study||18
10992494|NCT00651924|12168532|FG001|STARTED|Overall Study||9
10992495|NCT00651924|12168531|FG000|COMPLETED|Overall Study||18
10992496|NCT00651924|12168532|FG001|COMPLETED|Overall Study||2
10992497|NCT00651924|12168531|FG000|NOT COMPLETED|Overall Study||0
10992498|NCT00651924|12168532|FG001|NOT COMPLETED|Overall Study||7
10992499|NCT00651937|12168540|FG000|STARTED|Overall Study||39
10992500|NCT00651937|12168541|FG001|STARTED|Overall Study||41
10992501|NCT00651937|12168540|FG000|COMPLETED|Overall Study||35
10992502|NCT00651937|12168541|FG001|COMPLETED|Overall Study||40
10992503|NCT00651937|12168540|FG000|NOT COMPLETED|Overall Study||4
10992504|NCT00651937|12168541|FG001|NOT COMPLETED|Overall Study||1
10992505|NCT00652028|12168551|FG000|STARTED|Overall Study||16
10992506|NCT00652028|12168552|FG001|STARTED|Overall Study||14
10992507|NCT00652028|12168553|FG002|STARTED|Overall Study||15
10992508|NCT00652028|12168554|FG003|STARTED|Overall Study||14
10992509|NCT00652028|12168551|FG000|COMPLETED|Overall Study||15
10992510|NCT00652028|12168552|FG001|COMPLETED|Overall Study||13
10992511|NCT00652028|12168553|FG002|COMPLETED|Overall Study||14
10992512|NCT00652028|12168554|FG003|COMPLETED|Overall Study||14
10992513|NCT00652028|12168551|FG000|NOT COMPLETED|Overall Study||1
10992514|NCT00652028|12168552|FG001|NOT COMPLETED|Overall Study||1
10992515|NCT00652028|12168553|FG002|NOT COMPLETED|Overall Study||1
10992516|NCT00652028|12168554|FG003|NOT COMPLETED|Overall Study||0
10992517|NCT00652080|12168564|FG000|STARTED|Overall Study||35
10992518|NCT00652080|12168564|FG000|COMPLETED|Overall Study||31
10992519|NCT00652080|12168564|FG000|NOT COMPLETED|Overall Study||4
10992520|NCT00652093|12168576|FG000|STARTED|Overall Study||4
10992521|NCT00652093|12168577|FG001|STARTED|Overall Study||4
10992522|NCT00652093|12168578|FG002|STARTED|Overall Study||4
10992523|NCT00652093|12168579|FG003|STARTED|Overall Study||4
10992524|NCT00652093|12168580|FG004|STARTED|Overall Study||4
10992525|NCT00652093|12168581|FG005|STARTED|Overall Study||4
10992526|NCT00652093|12168576|FG000|COMPLETED|Overall Study||4
10992527|NCT00652093|12168577|FG001|COMPLETED|Overall Study||4
10992528|NCT00652093|12168578|FG002|COMPLETED|Overall Study||3
10992529|NCT00652093|12168579|FG003|COMPLETED|Overall Study||4
10992530|NCT00652093|12168580|FG004|COMPLETED|Overall Study||2
10992531|NCT00652093|12168581|FG005|COMPLETED|Overall Study||4
10992532|NCT00652093|12168576|FG000|NOT COMPLETED|Overall Study||0
10992533|NCT00652093|12168577|FG001|NOT COMPLETED|Overall Study||0
10992534|NCT00652093|12168578|FG002|NOT COMPLETED|Overall Study||1
10992535|NCT00652093|12168579|FG003|NOT COMPLETED|Overall Study||0
10992536|NCT00652093|12168580|FG004|NOT COMPLETED|Overall Study||2
10992537|NCT00652093|12168581|FG005|NOT COMPLETED|Overall Study||0
10992538|NCT00652145|12168597|FG000|STARTED|Overall Study||26
10992539|NCT00652145|12168598|FG001|STARTED|Overall Study||26
10992540|NCT00652145|12168597|FG000|COMPLETED|Overall Study||26
10992541|NCT00652145|12168598|FG001|COMPLETED|Overall Study||26
10992542|NCT00652145|12168597|FG000|NOT COMPLETED|Overall Study||0
10992543|NCT00652145|12168598|FG001|NOT COMPLETED|Overall Study||0
10992544|NCT00652314|12168608|FG000|STARTED|Overall Study||62
10992545|NCT00652314|12168609|FG001|STARTED|Overall Study||35
10992546|NCT00652314|12168608|FG000|COMPLETED|Overall Study||53
10992547|NCT00652314|12168609|FG001|COMPLETED|Overall Study||26
10992548|NCT00652314|12168608|FG000|NOT COMPLETED|Overall Study||9
10992549|NCT00652314|12168609|FG001|NOT COMPLETED|Overall Study||9
10992550|NCT00652340|12168617|FG000|STARTED|Overall Study||78
10992551|NCT00652340|12168618|FG001|STARTED|Overall Study||42
10992552|NCT00652340|12168617|FG000|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
10992553|NCT00652340|12168618|FG001|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
10992554|NCT00652340|12168617|FG000|NOT COMPLETED|Overall Study||4
10992555|NCT00652340|12168618|FG001|NOT COMPLETED|Overall Study||3
10992556|NCT00652366|12168629|FG000|STARTED|Overall Study||106
10992557|NCT00652366|12168630|FG001|STARTED|Overall Study||75
10992558|NCT00652366|12168631|FG002|STARTED|Overall Study||71
10992559|NCT00652366|12168632|FG003|STARTED|Overall Study||179
10992560|NCT00652366|12168633|FG004|STARTED|Overall Study||36
10992561|NCT00652366|12168629|FG000|COMPLETED|Overall Study||0
10992562|NCT00652366|12168630|FG001|COMPLETED|Overall Study||0
10992563|NCT00652366|12168631|FG002|COMPLETED|Overall Study||0
10992564|NCT00652366|12168632|FG003|COMPLETED|Overall Study||0
10992565|NCT00652366|12168633|FG004|COMPLETED|Overall Study||0
10992566|NCT00652366|12168629|FG000|NOT COMPLETED|Overall Study||106
10992567|NCT00652366|12168630|FG001|NOT COMPLETED|Overall Study||75
10992568|NCT00652366|12168631|FG002|NOT COMPLETED|Overall Study||71
10992569|NCT00652366|12168632|FG003|NOT COMPLETED|Overall Study||179
10992570|NCT00652366|12168633|FG004|NOT COMPLETED|Overall Study||36
10992571|NCT00652626|12168654|FG000|STARTED|Initial Treatment Phase||5
10992572|NCT00652626|12168655|FG001|STARTED|Initial Treatment Phase||5
10992573|NCT00652626|12168656|FG002|STARTED|Initial Treatment Phase||7
10992574|NCT00652626|12168657|FG003|STARTED|Initial Treatment Phase||6
10992575|NCT00652626|12168658|FG004|STARTED|Initial Treatment Phase||8
10992576|NCT00652626|12168659|FG005|STARTED|Initial Treatment Phase||0
10992577|NCT00652626|12168660|FG006|STARTED|Initial Treatment Phase||0
10992578|NCT00652626|12168654|FG000|Received Study Drug|Initial Treatment Phase||5
10992579|NCT00652626|12168655|FG001|Received Study Drug|Initial Treatment Phase||5
10992580|NCT00652626|12168656|FG002|Received Study Drug|Initial Treatment Phase||6
10992581|NCT00652626|12168657|FG003|Received Study Drug|Initial Treatment Phase||5
10992582|NCT00652626|12168658|FG004|Received Study Drug|Initial Treatment Phase||6
10992583|NCT00652626|12168659|FG005|Received Study Drug|Initial Treatment Phase||0
10992584|NCT00652626|12168660|FG006|Received Study Drug|Initial Treatment Phase||0
10992585|NCT00652626|12168654|FG000|COMPLETED|Initial Treatment Phase||5
10992586|NCT00652626|12168655|FG001|COMPLETED|Initial Treatment Phase||5
10992587|NCT00652626|12168656|FG002|COMPLETED|Initial Treatment Phase||6
10992588|NCT00652626|12168657|FG003|COMPLETED|Initial Treatment Phase||5
10992589|NCT00652626|12168658|FG004|COMPLETED|Initial Treatment Phase||5
10992590|NCT00652626|12168659|FG005|COMPLETED|Initial Treatment Phase||0
10992591|NCT00652626|12168660|FG006|COMPLETED|Initial Treatment Phase||0
10992592|NCT00652626|12168654|FG000|NOT COMPLETED|Initial Treatment Phase||0
10992593|NCT00652626|12168655|FG001|NOT COMPLETED|Initial Treatment Phase||0
10992594|NCT00652626|12168656|FG002|NOT COMPLETED|Initial Treatment Phase||1
10992595|NCT00652626|12168657|FG003|NOT COMPLETED|Initial Treatment Phase||1
10992596|NCT00652626|12168658|FG004|NOT COMPLETED|Initial Treatment Phase||3
10992597|NCT00652626|12168659|FG005|NOT COMPLETED|Initial Treatment Phase||0
10992598|NCT00652626|12168660|FG006|NOT COMPLETED|Initial Treatment Phase||0
10992599|NCT00652626|12168654|FG000|STARTED|Extension Phase||0
10992600|NCT00652626|12168655|FG001|STARTED|Extension Phase||0
10992601|NCT00652626|12168656|FG002|STARTED|Extension Phase||0
10992602|NCT00652626|12168657|FG003|STARTED|Extension Phase||0
10992603|NCT00652626|12168658|FG004|STARTED|Extension Phase||0
10992604|NCT00652626|12168659|FG005|STARTED|Extension Phase||14
10992605|NCT00652626|12168660|FG006|STARTED|Extension Phase||4
10992606|NCT00652626|12168654|FG000|COMPLETED|Extension Phase||0
10992607|NCT00652626|12168655|FG001|COMPLETED|Extension Phase||0
10992608|NCT00652626|12168656|FG002|COMPLETED|Extension Phase||0
10992609|NCT00652626|12168657|FG003|COMPLETED|Extension Phase||0
10992610|NCT00652626|12168658|FG004|COMPLETED|Extension Phase||0
10992611|NCT00652626|12168659|FG005|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
10992612|NCT00652626|12168660|FG006|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
10992613|NCT00652626|12168654|FG000|NOT COMPLETED|Extension Phase||0
10992614|NCT00652626|12168655|FG001|NOT COMPLETED|Extension Phase||0
10992615|NCT00652626|12168656|FG002|NOT COMPLETED|Extension Phase||0
10992616|NCT00652626|12168657|FG003|NOT COMPLETED|Extension Phase||0
10992617|NCT00652626|12168658|FG004|NOT COMPLETED|Extension Phase||0
10992618|NCT00652626|12168659|FG005|NOT COMPLETED|Extension Phase||12
10992619|NCT00652626|12168660|FG006|NOT COMPLETED|Extension Phase||3
10992620|NCT00652743|12168681|FG000|STARTED|Months 12-18||219
10992621|NCT00652743|12168682|FG001|STARTED|Months 12-18||188
10992622|NCT00652743|12168683|FG002|STARTED|Months 12-18||437
10992623|NCT00652743|12168681|FG000|COMPLETED|Months 12-18||218
10992624|NCT00652743|12168682|FG001|COMPLETED|Months 12-18||186
10992625|NCT00652743|12168683|FG002|COMPLETED|Months 12-18||430
10992626|NCT00652743|12168681|FG000|NOT COMPLETED|Months 12-18||1
10992627|NCT00652743|12168682|FG001|NOT COMPLETED|Months 12-18||2
10992628|NCT00652743|12168683|FG002|NOT COMPLETED|Months 12-18||7
10992629|NCT00652743|12168681|FG000|STARTED|Months 24-30||212
10992630|NCT00652743|12168682|FG001|STARTED|Months 24-30||186
10992631|NCT00652743|12168683|FG002|STARTED|Months 24-30||433
10992632|NCT00652743|12168681|FG000|COMPLETED|Months 24-30||207
10992633|NCT00652743|12168682|FG001|COMPLETED|Months 24-30||185
10992634|NCT00652743|12168683|FG002|COMPLETED|Months 24-30||422
10992635|NCT00652743|12168681|FG000|NOT COMPLETED|Months 24-30||5
10992636|NCT00652743|12168682|FG001|NOT COMPLETED|Months 24-30||1
10992637|NCT00652743|12168683|FG002|NOT COMPLETED|Months 24-30||11
10992638|NCT00652743|12168681|FG000|STARTED|Months 36-42||216
10992639|NCT00652743|12168682|FG001|STARTED|Months 36-42||185
10992640|NCT00652743|12168683|FG002|STARTED|Months 36-42||390
10992641|NCT00652743|12168681|FG000|COMPLETED|Months 36-42||210
10992642|NCT00652743|12168682|FG001|COMPLETED|Months 36-42||180
10992643|NCT00652743|12168683|FG002|COMPLETED|Months 36-42||381
10992644|NCT00652743|12168681|FG000|NOT COMPLETED|Months 36-42||6
10992645|NCT00652743|12168682|FG001|NOT COMPLETED|Months 36-42||5
10992646|NCT00652743|12168683|FG002|NOT COMPLETED|Months 36-42||9
10992647|NCT00652743|12168681|FG000|STARTED|Months 42-48||196
10992648|NCT00652743|12168682|FG001|STARTED|Months 42-48||170
10992649|NCT00652743|12168683|FG002|STARTED|Months 42-48||367
10992650|NCT00652743|12168681|FG000|COMPLETED|Months 42-48||196
10992651|NCT00652743|12168682|FG001|COMPLETED|Months 42-48||170
10992652|NCT00652743|12168683|FG002|COMPLETED|Months 42-48||367
10992653|NCT00652743|12168681|FG000|NOT COMPLETED|Months 42-48||0
10992654|NCT00652743|12168682|FG001|NOT COMPLETED|Months 42-48||0
10992655|NCT00652743|12168683|FG002|NOT COMPLETED|Months 42-48||0
10992656|NCT00652834|12168694|FG000|STARTED|Overall Study||23
10992657|NCT00652834|12168694|FG000|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
10992658|NCT00652834|12168694|FG000|NOT COMPLETED|Overall Study||5
10992659|NCT00652899|12168698|FG000|STARTED|Overall Study||14
10992660|NCT00652899|12168698|FG000|COMPLETED|Overall Study||12
10992661|NCT00652899|12168698|FG000|NOT COMPLETED|Overall Study||2
10992662|NCT00652938|12168709|FG000|STARTED|Overall Study||247
10992663|NCT00652938|12168710|FG001|STARTED|Overall Study||247
10992664|NCT00652938|12168711|FG002|STARTED|Overall Study||247
10992665|NCT00652938|12168709|FG000|COMPLETED|Overall Study||246
10992666|NCT00652938|12168710|FG001|COMPLETED|Overall Study||240
10992667|NCT00652938|12168711|FG002|COMPLETED|Overall Study||242
10992668|NCT00652938|12168709|FG000|NOT COMPLETED|Overall Study||1
10992669|NCT00652938|12168710|FG001|NOT COMPLETED|Overall Study||7
10992670|NCT00652938|12168711|FG002|NOT COMPLETED|Overall Study||5
10992671|NCT00652951|12168722|FG000|STARTED|Primary Phase||260
10992672|NCT00652951|12168723|FG001|STARTED|Primary Phase||260
10992673|NCT00652951|12168724|FG002|STARTED|Primary Phase||260
10992674|NCT00652951|12168722|FG000|COMPLETED|Primary Phase||260
10992675|NCT00652951|12168723|FG001|COMPLETED|Primary Phase||260
10992676|NCT00652951|12168724|FG002|COMPLETED|Primary Phase||260
10992677|NCT00652951|12168722|FG000|NOT COMPLETED|Primary Phase||0
10992678|NCT00652951|12168723|FG001|NOT COMPLETED|Primary Phase||0
10992679|NCT00652951|12168724|FG002|NOT COMPLETED|Primary Phase||0
10992680|NCT00652951|12168722|FG000|STARTED|Booster Phase||257
10992681|NCT00652951|12168723|FG001|STARTED|Booster Phase||259
10992682|NCT00652951|12168724|FG002|STARTED|Booster Phase||258
10992683|NCT00652951|12168722|FG000|COMPLETED|Booster Phase||256
10992684|NCT00652951|12168723|FG001|COMPLETED|Booster Phase||258
10992685|NCT00652951|12168724|FG002|COMPLETED|Booster Phase||258
10992686|NCT00652951|12168722|FG000|NOT COMPLETED|Booster Phase||1
10992687|NCT00652951|12168723|FG001|NOT COMPLETED|Booster Phase||1
10992688|NCT00652951|12168724|FG002|NOT COMPLETED|Booster Phase||0
10992689|NCT00653133|12168734|FG000|STARTED|Overall Study||1324
10992690|NCT00653133|12168735|FG001|STARTED|Overall Study||497
10992691|NCT00653133|12168734|FG000|COMPLETED|Overall Study||1324
10992692|NCT00653133|12168735|FG001|COMPLETED|Overall Study||497
10992693|NCT00653133|12168734|FG000|NOT COMPLETED|Overall Study||0
10992694|NCT00653133|12168735|FG001|NOT COMPLETED|Overall Study||0
10992695|NCT00653159|12168743|FG000|STARTED|Overall Study||11
10992696|NCT00653159|12168744|FG001|STARTED|Overall Study||12
10992697|NCT00653159|12168743|FG000|COMPLETED|Overall Study||6
10992698|NCT00653159|12168744|FG001|COMPLETED|Overall Study||9
10992699|NCT00653159|12168743|FG000|NOT COMPLETED|Overall Study||5
10992700|NCT00653159|12168744|FG001|NOT COMPLETED|Overall Study||3
10992701|NCT00653224|12168752|FG000|STARTED|Overall Study||293
10992702|NCT00653224|12168753|FG001|STARTED|Overall Study||287
10992703|NCT00653224|12168752|FG000|COMPLETED|Overall Study||286
10992704|NCT00653224|12168753|FG001|COMPLETED|Overall Study||280
10992705|NCT00653224|12168752|FG000|NOT COMPLETED|Overall Study||7
10992706|NCT00653224|12168753|FG001|NOT COMPLETED|Overall Study||7
10992707|NCT00653263|12168759|FG000|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
10992708|NCT00653263|12168759|FG000|COMPLETED|Overall Study||6
10992709|NCT00653263|12168759|FG000|NOT COMPLETED|Overall Study||2
10992710|NCT00653328|12168763|FG000|STARTED|Overall Study||15
10992711|NCT00653328|12168763|FG000|COMPLETED|Overall Study||0
10992712|NCT00653328|12168763|FG000|NOT COMPLETED|Overall Study||15
10992713|NCT00653432|12168769|FG000|STARTED|Overall Study||184
10992714|NCT00653432|12168770|FG001|STARTED|Overall Study||185
10992715|NCT00653432|12168769|FG000|Intend-to-treat ITT|Overall Study|3 of 184 excluded from ITT group for not having at least 1 post-injection visit. ITT=181 subjects|181
10992716|NCT00653432|12168770|FG001|Intend-to-treat ITT|Overall Study|1 of 185 excluded from ITT group for not having at least 1 post-injection visit. ITT=184 subjects|184
10992717|NCT00653432|12168769|FG000|COMPLETED|Overall Study||162
10992718|NCT00653432|12168770|FG001|COMPLETED|Overall Study||169
10992719|NCT00653432|12168769|FG000|NOT COMPLETED|Overall Study||22
10992720|NCT00653432|12168770|FG001|NOT COMPLETED|Overall Study||16
10992721|NCT00653861|12168776|FG000|STARTED|Overall Study||72
10992722|NCT00653861|12168776|FG000|COMPLETED|Overall Study||72
10992723|NCT00653861|12168776|FG000|NOT COMPLETED|Overall Study||0
10992724|NCT00653939|12168787|FG000|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
10992725|NCT00653939|12168788|FG001|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
10992726|NCT00653939|12168787|FG000|COMPLETED|Overall Study||19
10992727|NCT00653939|12168788|FG001|COMPLETED|Overall Study||17
10992728|NCT00653939|12168787|FG000|NOT COMPLETED|Overall Study||12
10992729|NCT00653939|12168788|FG001|NOT COMPLETED|Overall Study||15
10992730|NCT00653991|12168798|FG000|STARTED|3 Month Follow-up||444
10992731|NCT00653991|12168799|FG001|STARTED|3 Month Follow-up||491
10992732|NCT00653991|12168798|FG000|COMPLETED|3 Month Follow-up||294
10992733|NCT00653991|12168799|FG001|COMPLETED|3 Month Follow-up||334
10992734|NCT00653991|12168798|FG000|NOT COMPLETED|3 Month Follow-up||150
10992735|NCT00653991|12168799|FG001|NOT COMPLETED|3 Month Follow-up||157
10992736|NCT00653991|12168798|FG000|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444
10992737|NCT00653991|12168799|FG001|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491
10992738|NCT00653991|12168798|FG000|COMPLETED|6 Month Follow-up||311
10992739|NCT00653991|12168799|FG001|COMPLETED|6 Month Follow-up||350
10992740|NCT00653991|12168798|FG000|NOT COMPLETED|6 Month Follow-up||133
10992741|NCT00653991|12168799|FG001|NOT COMPLETED|6 Month Follow-up||141
10992742|NCT00654004|12168809|FG000|STARTED|Overall Study||14
10992743|NCT00654004|12168810|FG001|STARTED|Overall Study||12
10992744|NCT00654004|12168809|FG000|COMPLETED|Overall Study||13
10992745|NCT00654004|12168810|FG001|COMPLETED|Overall Study||12
10992746|NCT00654004|12168809|FG000|NOT COMPLETED|Overall Study||1
10992747|NCT00654004|12168810|FG001|NOT COMPLETED|Overall Study||0
10992748|NCT00654030|12168816|FG000|STARTED|Overall Study||12
10992749|NCT00654030|12168816|FG000|COMPLETED|Overall Study||11
10992750|NCT00654030|12168816|FG000|NOT COMPLETED|Overall Study||1
10992751|NCT00654069|12168823|FG000|STARTED|Overall Study||136
10992752|NCT00654069|12168824|FG001|STARTED|Overall Study||135
10992753|NCT00654069|12168825|FG002|STARTED|Overall Study||134
10992754|NCT00654069|12168823|FG000|COMPLETED|Overall Study||119
10992755|NCT00654069|12168824|FG001|COMPLETED|Overall Study||124
10992756|NCT00654069|12168825|FG002|COMPLETED|Overall Study||116
10992757|NCT00654069|12168823|FG000|NOT COMPLETED|Overall Study||17
10992758|NCT00654069|12168824|FG001|NOT COMPLETED|Overall Study||11
10992759|NCT00654069|12168825|FG002|NOT COMPLETED|Overall Study||18
10992760|NCT00654147|12168835|FG000|STARTED|Overall Study||21
10992761|NCT00654147|12168836|FG001|STARTED|Overall Study||23
10992762|NCT00654147|12168835|FG000|COMPLETED|Overall Study||19
10992763|NCT00654147|12168836|FG001|COMPLETED|Overall Study||19
10992764|NCT00654147|12168835|FG000|NOT COMPLETED|Overall Study||2
10992765|NCT00654147|12168836|FG001|NOT COMPLETED|Overall Study||4
10992766|NCT00654186|12168842|FG000|STARTED|Overall Study||32
10992767|NCT00654186|12168842|FG000|COMPLETED|Overall Study||27
10992768|NCT00654186|12168842|FG000|NOT COMPLETED|Overall Study||5
10992769|NCT00654238|12168846|FG000|STARTED|Overall Study||59
10992770|NCT00654238|12168846|FG000|COMPLETED|Overall Study||55
10992771|NCT00654238|12168846|FG000|NOT COMPLETED|Overall Study||4
10992772|NCT00654329|12168855|FG000|STARTED|Overall Study||23
10992773|NCT00654329|12168856|FG001|STARTED|Overall Study||28
10992774|NCT00654329|12168857|FG002|STARTED|Overall Study||23
10992775|NCT00654329|12168858|FG003|STARTED|Overall Study||27
10992776|NCT00654329|12168855|FG000|COMPLETED|Overall Study||23
10992777|NCT00654329|12168856|FG001|COMPLETED|Overall Study||28
10992778|NCT00654329|12168857|FG002|COMPLETED|Overall Study||23
10992779|NCT00654329|12168858|FG003|COMPLETED|Overall Study||27
10992780|NCT00654329|12168855|FG000|NOT COMPLETED|Overall Study||0
10992781|NCT00654329|12168856|FG001|NOT COMPLETED|Overall Study||0
10992782|NCT00654329|12168857|FG002|NOT COMPLETED|Overall Study||0
10992783|NCT00654329|12168858|FG003|NOT COMPLETED|Overall Study||0
10992784|NCT00654355|12168870|FG000|STARTED|Overall Study||15
10992785|NCT00654355|12168871|FG001|STARTED|Overall Study||15
10992786|NCT00654355|12168870|FG000|COMPLETED|Overall Study||13
10992787|NCT00654355|12168871|FG001|COMPLETED|Overall Study||13
10992788|NCT00654355|12168870|FG000|NOT COMPLETED|Overall Study||2
10992789|NCT00654355|12168871|FG001|NOT COMPLETED|Overall Study||2
10992790|NCT00654368|12168880|FG000|STARTED|Overall Study||53
10992791|NCT00654368|12168881|FG001|STARTED|Overall Study||98
10992792|NCT00654368|12168882|FG002|STARTED|Overall Study||107
10992793|NCT00654368|12168880|FG000|COMPLETED|Overall Study||0
10992794|NCT00654368|12168881|FG001|COMPLETED|Overall Study||50
10992795|NCT00654368|12168882|FG002|COMPLETED|Overall Study||75
10992796|NCT00654368|12168880|FG000|NOT COMPLETED|Overall Study||53
10992797|NCT00654368|12168881|FG001|NOT COMPLETED|Overall Study||48
10992798|NCT00654368|12168882|FG002|NOT COMPLETED|Overall Study||32
10992799|NCT00654381|12168893|FG000|STARTED|1st Stage||39
10992800|NCT00654381|12168894|FG001|STARTED|1st Stage||41
10992801|NCT00654381|12168895|FG002|STARTED|1st Stage||159
10992802|NCT00654381|12168896|FG003|STARTED|1st Stage||160
10992803|NCT00654381|12168897|FG004|STARTED|1st Stage||81
10992804|NCT00654381|12168898|FG005|STARTED|1st Stage||81
10992805|NCT00654381|12168893|FG000|COMPLETED|1st Stage||36
10992806|NCT00654381|12168894|FG001|COMPLETED|1st Stage||38
10992807|NCT00654381|12168895|FG002|COMPLETED|1st Stage||156
10992808|NCT00654381|12168896|FG003|COMPLETED|1st Stage||155
10992809|NCT00654381|12168897|FG004|COMPLETED|1st Stage||79
10992810|NCT00654381|12168898|FG005|COMPLETED|1st Stage||79
10992811|NCT00654381|12168893|FG000|NOT COMPLETED|1st Stage||3
10992812|NCT00654381|12168894|FG001|NOT COMPLETED|1st Stage||3
10992813|NCT00654381|12168895|FG002|NOT COMPLETED|1st Stage||3
10992814|NCT00654381|12168896|FG003|NOT COMPLETED|1st Stage||5
10992815|NCT00654381|12168897|FG004|NOT COMPLETED|1st Stage||2
10992816|NCT00654381|12168898|FG005|NOT COMPLETED|1st Stage||2
10992817|NCT00654381|12168893|FG000|STARTED|2nd Stage||36
10992818|NCT00654381|12168894|FG001|STARTED|2nd Stage||38
10992819|NCT00654381|12168895|FG002|STARTED|2nd Stage||156
10992820|NCT00654381|12168896|FG003|STARTED|2nd Stage||155
10992821|NCT00654381|12168897|FG004|STARTED|2nd Stage||79
10992822|NCT00654381|12168898|FG005|STARTED|2nd Stage||79
10992823|NCT00654381|12168893|FG000|COMPLETED|2nd Stage||34
10992824|NCT00654381|12168894|FG001|COMPLETED|2nd Stage||38
10992825|NCT00654381|12168895|FG002|COMPLETED|2nd Stage||153
10992826|NCT00654381|12168896|FG003|COMPLETED|2nd Stage||151
10992827|NCT00654381|12168897|FG004|COMPLETED|2nd Stage||71
10992828|NCT00654381|12168898|FG005|COMPLETED|2nd Stage||76
10992829|NCT00654381|12168893|FG000|NOT COMPLETED|2nd Stage||2
10992830|NCT00654381|12168894|FG001|NOT COMPLETED|2nd Stage||0
10992831|NCT00654381|12168895|FG002|NOT COMPLETED|2nd Stage||3
10992832|NCT00654381|12168896|FG003|NOT COMPLETED|2nd Stage||4
10992833|NCT00654381|12168897|FG004|NOT COMPLETED|2nd Stage||8
10992834|NCT00654381|12168898|FG005|NOT COMPLETED|2nd Stage||3
10992835|NCT00654381|12168893|FG000|STARTED|Extension Stage||34
10992836|NCT00654381|12168894|FG001|STARTED|Extension Stage||38
10992837|NCT00654381|12168895|FG002|STARTED|Extension Stage||153
10992838|NCT00654381|12168896|FG003|STARTED|Extension Stage||151
10992839|NCT00654381|12168897|FG004|STARTED|Extension Stage||71
10992840|NCT00654381|12168898|FG005|STARTED|Extension Stage||76
10992841|NCT00654381|12168893|FG000|COMPLETED|Extension Stage||33
10992842|NCT00654381|12168894|FG001|COMPLETED|Extension Stage||36
10992843|NCT00654381|12168895|FG002|COMPLETED|Extension Stage||142
10992844|NCT00654381|12168896|FG003|COMPLETED|Extension Stage||142
10992845|NCT00654381|12168897|FG004|COMPLETED|Extension Stage||68
10992846|NCT00654381|12168898|FG005|COMPLETED|Extension Stage||73
10992847|NCT00654381|12168893|FG000|NOT COMPLETED|Extension Stage||1
10992848|NCT00654381|12168894|FG001|NOT COMPLETED|Extension Stage||2
10992849|NCT00654381|12168895|FG002|NOT COMPLETED|Extension Stage||11
10992850|NCT00654381|12168896|FG003|NOT COMPLETED|Extension Stage||9
10992851|NCT00654381|12168897|FG004|NOT COMPLETED|Extension Stage||3
10992852|NCT00654381|12168898|FG005|NOT COMPLETED|Extension Stage||3
10992853|NCT00654420|12168919|FG000|STARTED|Phase I (Dose Escalation)||4
10992854|NCT00654420|12168920|FG001|STARTED|Phase I (Dose Escalation)||16
10992855|NCT00654420|12168921|FG002|STARTED|Phase I (Dose Escalation)||0
10992856|NCT00654420|12168922|FG003|STARTED|Phase I (Dose Escalation)||0
10992857|NCT00654420|12168919|FG000|COMPLETED|Phase I (Dose Escalation)||0
10992858|NCT00654420|12168920|FG001|COMPLETED|Phase I (Dose Escalation)||0
10992859|NCT00654420|12168921|FG002|COMPLETED|Phase I (Dose Escalation)||0
10992860|NCT00654420|12168922|FG003|COMPLETED|Phase I (Dose Escalation)||0
10992861|NCT00654420|12168919|FG000|NOT COMPLETED|Phase I (Dose Escalation)||4
10992862|NCT00654420|12168920|FG001|NOT COMPLETED|Phase I (Dose Escalation)||16
10992863|NCT00654420|12168921|FG002|NOT COMPLETED|Phase I (Dose Escalation)||0
10992864|NCT00654420|12168922|FG003|NOT COMPLETED|Phase I (Dose Escalation)||0
10992865|NCT00654420|12168919|FG000|STARTED|Phase II||0
10992866|NCT00654420|12168920|FG001|STARTED|Phase II||0
10992867|NCT00654420|12168921|FG002|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
10992868|NCT00654420|12168922|FG003|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
10992869|NCT00654420|12168919|FG000|COMPLETED|Phase II||0
10992870|NCT00654420|12168920|FG001|COMPLETED|Phase II||0
10992871|NCT00654420|12168921|FG002|COMPLETED|Phase II||0
10992872|NCT00654420|12168922|FG003|COMPLETED|Phase II||0
10992873|NCT00654420|12168919|FG000|NOT COMPLETED|Phase II||0
10992874|NCT00654420|12168920|FG001|NOT COMPLETED|Phase II||0
10992875|NCT00654420|12168921|FG002|NOT COMPLETED|Phase II||37
10992876|NCT00654420|12168922|FG003|NOT COMPLETED|Phase II||38
10992877|NCT00654498|12168934|FG000|STARTED|Overall Study||203
10992878|NCT00654498|12168935|FG001|STARTED|Overall Study||103
10992879|NCT00654498|12168934|FG000|COMPLETED|Overall Study||189
10992880|NCT00654498|12168935|FG001|COMPLETED|Overall Study||91
10992881|NCT00654498|12168934|FG000|NOT COMPLETED|Overall Study||14
10992882|NCT00654498|12168935|FG001|NOT COMPLETED|Overall Study||12
10992883|NCT00654511|12168945|FG000|STARTED|Overall Study||26
10992884|NCT00654511|12168946|FG001|STARTED|Overall Study||25
10992885|NCT00654511|12168947|FG002|STARTED|Overall Study||25
10992886|NCT00654511|12168948|FG003|STARTED|Overall Study||25
10992887|NCT00654511|12168945|FG000|COMPLETED|Overall Study||26
10992888|NCT00654511|12168946|FG001|COMPLETED|Overall Study||25
10992889|NCT00654511|12168947|FG002|COMPLETED|Overall Study||25
10992890|NCT00654511|12168948|FG003|COMPLETED|Overall Study||25
10992891|NCT00654511|12168945|FG000|NOT COMPLETED|Overall Study||0
10992892|NCT00654511|12168946|FG001|NOT COMPLETED|Overall Study||0
10992893|NCT00654511|12168947|FG002|NOT COMPLETED|Overall Study||0
10992894|NCT00654511|12168948|FG003|NOT COMPLETED|Overall Study||0
10992895|NCT00654615|12168964|FG000|STARTED|Overall Study||30
10992896|NCT00654615|12168965|FG001|STARTED|Overall Study||30
10992897|NCT00654615|12168964|FG000|COMPLETED|Overall Study||22
10992898|NCT00654615|12168965|FG001|COMPLETED|Overall Study||23
10992899|NCT00654615|12168964|FG000|NOT COMPLETED|Overall Study||8
10992900|NCT00654615|12168965|FG001|NOT COMPLETED|Overall Study||7
10992901|NCT00654641|12168973|FG000|STARTED|Overall Study||28
10992902|NCT00654641|12168974|FG001|STARTED|Overall Study||26
10992903|NCT00654641|12168973|FG000|COMPLETED|Overall Study||26
10992904|NCT00654641|12168974|FG001|COMPLETED|Overall Study||23
10992905|NCT00654641|12168973|FG000|NOT COMPLETED|Overall Study||2
10992906|NCT00654641|12168974|FG001|NOT COMPLETED|Overall Study||3
10992907|NCT00654654|12168980|FG000|STARTED|Overall Study||50
10992908|NCT00654654|12168980|FG000|COMPLETED|Overall Study||43
10992909|NCT00654654|12168980|FG000|NOT COMPLETED|Overall Study||7
10992910|NCT00654732|12168986|FG000|STARTED|Overall Study||26
10992911|NCT00654732|12168987|FG001|STARTED|Overall Study||32
10992912|NCT00654732|12168986|FG000|COMPLETED|Overall Study||22
10992913|NCT00654732|12168987|FG001|COMPLETED|Overall Study||26
10992914|NCT00654732|12168986|FG000|NOT COMPLETED|Overall Study||4
10992915|NCT00654732|12168987|FG001|NOT COMPLETED|Overall Study||6
10992916|NCT00654745|12168993|FG000|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
10992917|NCT00654745|12168993|FG000|COMPLETED|Overall Study||164
10992918|NCT00654745|12168993|FG000|NOT COMPLETED|Overall Study||43
10992919|NCT00654784|12169005|FG000|STARTED|Overall Study||13
10992920|NCT00654784|12169006|FG001|STARTED|Overall Study||8
10992921|NCT00654784|12169005|FG000|COMPLETED|Overall Study||13
10992922|NCT00654784|12169006|FG001|COMPLETED|Overall Study||8
10992923|NCT00654784|12169005|FG000|NOT COMPLETED|Overall Study||0
10992924|NCT00654784|12169006|FG001|NOT COMPLETED|Overall Study||0
10992925|NCT00654836|12169012|FG000|STARTED|Overall Study||32
10992926|NCT00654836|12169012|FG000|COMPLETED|Overall Study||32
10992927|NCT00654836|12169012|FG000|NOT COMPLETED|Overall Study||0
10992928|NCT00654875|12169018|FG000|STARTED|Overall Study||164
10992929|NCT00654875|12169019|FG001|STARTED|Overall Study||164
10992930|NCT00654875|12169018|FG000|COMPLETED|Overall Study||147
10992931|NCT00654875|12169019|FG001|COMPLETED|Overall Study||147
10992932|NCT00654875|12169018|FG000|NOT COMPLETED|Overall Study||17
10992933|NCT00654875|12169019|FG001|NOT COMPLETED|Overall Study||17
10992934|NCT00654901|12169029|FG000|STARTED|Overall Study||254
10992935|NCT00654901|12169030|FG001|STARTED|Overall Study||262
10992936|NCT00654901|12169031|FG002|STARTED|Overall Study||252
10992937|NCT00654901|12169032|FG003|STARTED|Overall Study||113
10992938|NCT00654901|12169029|FG000|COMPLETED|Overall Study||250
10992939|NCT00654901|12169030|FG001|COMPLETED|Overall Study||262
10992940|NCT00654901|12169031|FG002|COMPLETED|Overall Study||250
10992941|NCT00654901|12169032|FG003|COMPLETED|Overall Study||113
10992942|NCT00654901|12169029|FG000|NOT COMPLETED|Overall Study||4
10992943|NCT00654901|12169030|FG001|NOT COMPLETED|Overall Study||0
10992944|NCT00654901|12169031|FG002|NOT COMPLETED|Overall Study||2
10992945|NCT00654901|12169032|FG003|NOT COMPLETED|Overall Study||0
10992946|NCT00654927|12169042|FG000|STARTED|Overall Study||177
10992947|NCT00654927|12169042|FG000|COMPLETED|Overall Study||70
10992948|NCT00654927|12169042|FG000|NOT COMPLETED|Overall Study||107
10992949|NCT00654940|12169048|FG000|STARTED|Period 1|Assigned to study treatment.|13
10992950|NCT00654940|12169049|FG001|STARTED|Period 1|Assigned to study treatment.|12
10992951|NCT00654940|12169048|FG000|Received Study Treatment|Period 1||12
10992952|NCT00654940|12169049|FG001|Received Study Treatment|Period 1||12
10992953|NCT00654940|12169048|FG000|COMPLETED|Period 1||12
10992954|NCT00654940|12169049|FG001|COMPLETED|Period 1||11
10992955|NCT00654940|12169048|FG000|NOT COMPLETED|Period 1||1
10992956|NCT00654940|12169049|FG001|NOT COMPLETED|Period 1||1
10992957|NCT00654940|12169048|FG000|STARTED|Washout Period of 2 Weeks||12
10992958|NCT00654940|12169049|FG001|STARTED|Washout Period of 2 Weeks||11
10992959|NCT00654940|12169048|FG000|COMPLETED|Washout Period of 2 Weeks||12
10992960|NCT00654940|12169049|FG001|COMPLETED|Washout Period of 2 Weeks||11
10992961|NCT00654940|12169048|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10992962|NCT00654940|12169049|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10992963|NCT00654940|12169048|FG000|STARTED|Period 2||12
10992964|NCT00654940|12169049|FG001|STARTED|Period 2||11
10992965|NCT00654940|12169048|FG000|COMPLETED|Period 2||12
10992966|NCT00654940|12169049|FG001|COMPLETED|Period 2||11
10992967|NCT00654940|12169048|FG000|NOT COMPLETED|Period 2||0
10992968|NCT00654940|12169049|FG001|NOT COMPLETED|Period 2||0
10992969|NCT00654953|12169064|FG000|STARTED|Overall Study||36
10992970|NCT00654953|12169065|FG001|STARTED|Overall Study||36
10992971|NCT00654953|12169066|FG002|STARTED|Overall Study||30
10992972|NCT00654953|12169064|FG000|COMPLETED|Overall Study||6
10992973|NCT00654953|12169065|FG001|COMPLETED|Overall Study||8
10992974|NCT00654953|12169066|FG002|COMPLETED|Overall Study||8
10992975|NCT00654953|12169064|FG000|NOT COMPLETED|Overall Study||30
10992976|NCT00654953|12169065|FG001|NOT COMPLETED|Overall Study||28
10992977|NCT00654953|12169066|FG002|NOT COMPLETED|Overall Study||22
10992978|NCT00655083|12169076|FG000|STARTED|Overall Study||12
10992979|NCT00655083|12169077|FG001|STARTED|Overall Study||8
10992980|NCT00655083|12169076|FG000|COMPLETED|Overall Study||12
10992981|NCT00655083|12169077|FG001|COMPLETED|Overall Study||8
10992982|NCT00655083|12169076|FG000|NOT COMPLETED|Overall Study||0
10992983|NCT00655083|12169077|FG001|NOT COMPLETED|Overall Study||0
10992984|NCT00655356|12169085|FG000|STARTED|Overall Study||110
10992985|NCT00655356|12169086|FG001|STARTED|Overall Study||108
10992986|NCT00655356|12169085|FG000|COMPLETED|Overall Study||93
10992987|NCT00655356|12169086|FG001|COMPLETED|Overall Study||98
10992988|NCT00655356|12169085|FG000|NOT COMPLETED|Overall Study||17
10992989|NCT00655356|12169086|FG001|NOT COMPLETED|Overall Study||10
10992990|NCT00655473|12169094|FG000|STARTED|Overall Study||64
10992991|NCT00655473|12169095|FG001|STARTED|Overall Study||66
10992992|NCT00655473|12169094|FG000|COMPLETED|Overall Study||53
10992993|NCT00655473|12169095|FG001|COMPLETED|Overall Study||51
10992994|NCT00655473|12169094|FG000|NOT COMPLETED|Overall Study||11
10992995|NCT00655473|12169095|FG001|NOT COMPLETED|Overall Study||15
10992996|NCT00655486|12169101|FG000|STARTED|Overall Study||97
10992997|NCT00655486|12169101|FG000|COMPLETED|Overall Study||69
10992998|NCT00655486|12169101|FG000|NOT COMPLETED|Overall Study||28
10992999|NCT00655499|12169105|FG000|STARTED|Overall Study||69
10993000|NCT00655499|12169105|FG000|COMPLETED|Overall Study||65
10993001|NCT00655499|12169105|FG000|NOT COMPLETED|Overall Study||4
10993002|NCT00655538|12169112|FG000|STARTED|Overall Study||238
10993003|NCT00655538|12169113|FG001|STARTED|Overall Study||238
10993004|NCT00655538|12169112|FG000|COMPLETED|Overall Study||214
10993005|NCT00655538|12169113|FG001|COMPLETED|Overall Study||211
10993006|NCT00655538|12169112|FG000|NOT COMPLETED|Overall Study||24
10993007|NCT00655538|12169113|FG001|NOT COMPLETED|Overall Study||27
10993008|NCT00655551|12169122|FG000|STARTED|All Periods Combined||25
10993009|NCT00655551|12169123|FG001|STARTED|All Periods Combined||50
10993010|NCT00655551|12169124|FG002|STARTED|All Periods Combined||25
10993011|NCT00655551|12169122|FG000|COMPLETED|All Periods Combined||25
10993012|NCT00655551|12169123|FG001|COMPLETED|All Periods Combined||47
10993013|NCT00655551|12169124|FG002|COMPLETED|All Periods Combined||21
10993014|NCT00655551|12169122|FG000|NOT COMPLETED|All Periods Combined||0
10993015|NCT00655551|12169123|FG001|NOT COMPLETED|All Periods Combined||3
10993016|NCT00655551|12169124|FG002|NOT COMPLETED|All Periods Combined||4
10993017|NCT00655551|12169122|FG000|STARTED|Period 1 (up to 7 Days)||25
10993018|NCT00655551|12169123|FG001|STARTED|Period 1 (up to 7 Days)||0
10993019|NCT00655551|12169124|FG002|STARTED|Period 1 (up to 7 Days)||0
10993020|NCT00655551|12169122|FG000|COMPLETED|Period 1 (up to 7 Days)||25
10993021|NCT00655551|12169123|FG001|COMPLETED|Period 1 (up to 7 Days)||0
10993022|NCT00655551|12169124|FG002|COMPLETED|Period 1 (up to 7 Days)||0
10993023|NCT00655551|12169122|FG000|NOT COMPLETED|Period 1 (up to 7 Days)||0
10993024|NCT00655551|12169123|FG001|NOT COMPLETED|Period 1 (up to 7 Days)||0
10993025|NCT00655551|12169124|FG002|NOT COMPLETED|Period 1 (up to 7 Days)||0
10993026|NCT00655551|12169122|FG000|STARTED|Period 2 (up to 7 Days)||0
10993027|NCT00655551|12169123|FG001|STARTED|Period 2 (up to 7 Days)||25
10993028|NCT00655551|12169124|FG002|STARTED|Period 2 (up to 7 Days)||0
10993029|NCT00655551|12169122|FG000|COMPLETED|Period 2 (up to 7 Days)||0
10993030|NCT00655551|12169123|FG001|COMPLETED|Period 2 (up to 7 Days)||24
10993031|NCT00655551|12169124|FG002|COMPLETED|Period 2 (up to 7 Days)||0
10993032|NCT00655551|12169122|FG000|NOT COMPLETED|Period 2 (up to 7 Days)||0
10993033|NCT00655551|12169123|FG001|NOT COMPLETED|Period 2 (up to 7 Days)||1
10993034|NCT00655551|12169124|FG002|NOT COMPLETED|Period 2 (up to 7 Days)||0
10993035|NCT00655551|12169122|FG000|STARTED|Period 3 (up to 7 Days)||0
10993036|NCT00655551|12169123|FG001|STARTED|Period 3 (up to 7 Days)||0
10993037|NCT00655551|12169124|FG002|STARTED|Period 3 (up to 7 Days)||25
10993038|NCT00655551|12169122|FG000|COMPLETED|Period 3 (up to 7 Days)||0
10993039|NCT00655551|12169123|FG001|COMPLETED|Period 3 (up to 7 Days)||0
10993040|NCT00655551|12169124|FG002|COMPLETED|Period 3 (up to 7 Days)||21
10993041|NCT00655551|12169122|FG000|NOT COMPLETED|Period 3 (up to 7 Days)||0
10993042|NCT00655551|12169123|FG001|NOT COMPLETED|Period 3 (up to 7 Days)||0
10993043|NCT00655551|12169124|FG002|NOT COMPLETED|Period 3 (up to 7 Days)||4
10993044|NCT00655551|12169122|FG000|STARTED|Period 4 (up to 7 Days)||0
10993045|NCT00655551|12169123|FG001|STARTED|Period 4 (up to 7 Days)||25
10993046|NCT00655551|12169124|FG002|STARTED|Period 4 (up to 7 Days)||0
10993047|NCT00655551|12169122|FG000|COMPLETED|Period 4 (up to 7 Days)||0
10993048|NCT00655551|12169123|FG001|COMPLETED|Period 4 (up to 7 Days)||23
10993049|NCT00655551|12169124|FG002|COMPLETED|Period 4 (up to 7 Days)||0
10993050|NCT00655551|12169122|FG000|NOT COMPLETED|Period 4 (up to 7 Days)||0
10993051|NCT00655551|12169123|FG001|NOT COMPLETED|Period 4 (up to 7 Days)||2
10993052|NCT00655551|12169124|FG002|NOT COMPLETED|Period 4 (up to 7 Days)||0
10993053|NCT00655564|12169132|FG000|STARTED|Overall Study||15
10993054|NCT00655564|12169132|FG000|COMPLETED|Overall Study||12
10993055|NCT00655564|12169132|FG000|NOT COMPLETED|Overall Study||3
10993056|NCT00655629|12169139|FG000|STARTED|Overall Study||172
10993057|NCT00655629|12169140|FG001|STARTED|Overall Study||167
10993058|NCT00655629|12169139|FG000|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
10993059|NCT00655629|12169140|FG001|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
10993060|NCT00655629|12169139|FG000|COMPLETED|Overall Study||151
10993061|NCT00655629|12169140|FG001|COMPLETED|Overall Study||144
10993062|NCT00655629|12169139|FG000|NOT COMPLETED|Overall Study||21
10993063|NCT00655629|12169140|FG001|NOT COMPLETED|Overall Study||23
10993064|NCT00655642|12169150|FG000|STARTED|Overall Study||42
10993065|NCT00655642|12169151|FG001|STARTED|Overall Study||43
10993066|NCT00655642|12169152|FG002|STARTED|Overall Study||45
10993067|NCT00655642|12169153|FG003|STARTED|Overall Study||41
10993068|NCT00655642|12169150|FG000|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
10993069|NCT00655642|12169151|FG001|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
10993070|NCT00655642|12169152|FG002|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
10993071|NCT00655642|12169153|FG003|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
10993072|NCT00655642|12169150|FG000|NOT COMPLETED|Overall Study||1
10993073|NCT00655642|12169151|FG001|NOT COMPLETED|Overall Study||3
10993074|NCT00655642|12169152|FG002|NOT COMPLETED|Overall Study||2
10993075|NCT00655642|12169153|FG003|NOT COMPLETED|Overall Study||2
10993076|NCT00655668|12169163|FG000|STARTED|Overall Study|Planned enrollment: 80 participants|54
10993077|NCT00655668|12169163|FG000|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
10993078|NCT00655668|12169163|FG000|NOT COMPLETED|Overall Study||54
10993079|NCT00655707|12169167|FG000|STARTED|Overall Study||5
10993080|NCT00655707|12169167|FG000|COMPLETED|Overall Study||5
10993081|NCT00655707|12169167|FG000|NOT COMPLETED|Overall Study||0
10993082|NCT00655733|12169174|FG000|STARTED|Overall Study||51
10993083|NCT00655733|12169175|FG001|STARTED|Overall Study||50
10993084|NCT00655733|12169174|FG000|COMPLETED|Overall Study||44
10993085|NCT00655733|12169175|FG001|COMPLETED|Overall Study||42
10993086|NCT00655733|12169174|FG000|NOT COMPLETED|Overall Study||7
10993087|NCT00655733|12169175|FG001|NOT COMPLETED|Overall Study||8
10993088|NCT00655746|12169183|FG000|STARTED|Overall Study||14
10993089|NCT00655746|12169183|FG000|COMPLETED|Overall Study||13
10993090|NCT00655746|12169183|FG000|NOT COMPLETED|Overall Study||1
10993091|NCT00655811|12169191|FG000|STARTED|Overall Study||40
10993092|NCT00655811|12169191|FG000|COMPLETED|Overall Study||40
10993093|NCT00655811|12169191|FG000|NOT COMPLETED|Overall Study||0
10993094|NCT00655850|12169201|FG000|STARTED|Overall Study||39
10993095|NCT00655850|12169201|FG000|COMPLETED|Overall Study||36
10993096|NCT00655850|12169201|FG000|NOT COMPLETED|Overall Study||3
10993097|NCT00655863|12169210|FG000|STARTED|Overall Study||24
10993098|NCT00655863|12169211|FG001|STARTED|Overall Study||25
10993099|NCT00655863|12169212|FG002|STARTED|Overall Study||22
10993100|NCT00655863|12169210|FG000|COMPLETED|Overall Study||24
10993101|NCT00655863|12169211|FG001|COMPLETED|Overall Study||25
10993102|NCT00655863|12169212|FG002|COMPLETED|Overall Study||21
10993103|NCT00655863|12169210|FG000|NOT COMPLETED|Overall Study||0
10993104|NCT00655863|12169211|FG001|NOT COMPLETED|Overall Study||0
10993105|NCT00655863|12169212|FG002|NOT COMPLETED|Overall Study||1
10993106|NCT00655889|12169220|FG000|STARTED|Overall Study||13
10993107|NCT00655889|12169220|FG000|COMPLETED|Overall Study||11
10993108|NCT00655889|12169220|FG000|NOT COMPLETED|Overall Study||2
10993109|NCT00655928|12169226|FG000|STARTED|Overall Study||26
10993110|NCT00655928|12169227|FG001|STARTED|Overall Study||26
10993111|NCT00655928|12169226|FG000|COMPLETED|Overall Study||23
10993112|NCT00655928|12169227|FG001|COMPLETED|Overall Study||24
10993113|NCT00655928|12169226|FG000|NOT COMPLETED|Overall Study||3
10993114|NCT00655928|12169227|FG001|NOT COMPLETED|Overall Study||2
10993115|NCT00655980|12169236|FG000|STARTED|Overall Study||276
10993116|NCT00655980|12169237|FG001|STARTED|Overall Study||281
10993117|NCT00655980|12169238|FG002|STARTED|Overall Study||130
10993118|NCT00655980|12169236|FG000|COMPLETED|Overall Study||250
10993119|NCT00655980|12169237|FG001|COMPLETED|Overall Study||250
10993120|NCT00655980|12169238|FG002|COMPLETED|Overall Study||125
10993121|NCT00655980|12169236|FG000|NOT COMPLETED|Overall Study||26
10993122|NCT00655980|12169237|FG001|NOT COMPLETED|Overall Study||31
10993123|NCT00655980|12169238|FG002|NOT COMPLETED|Overall Study||5
10993124|NCT00656019|12169253|FG000|STARTED|Overall Study||29
10993125|NCT00656019|12169254|FG001|STARTED|Overall Study||19
10993126|NCT00656019|12169255|FG002|STARTED|Overall Study||11
10993127|NCT00656019|12169256|FG003|STARTED|Overall Study||4
10993128|NCT00656019|12169253|FG000|COMPLETED|Overall Study||15
10993129|NCT00656019|12169254|FG001|COMPLETED|Overall Study||18
10993130|NCT00656019|12169255|FG002|COMPLETED|Overall Study||11
10993131|NCT00656019|12169256|FG003|COMPLETED|Overall Study||4
10993132|NCT00656019|12169253|FG000|NOT COMPLETED|Overall Study||14
10993133|NCT00656019|12169254|FG001|NOT COMPLETED|Overall Study||1
10993134|NCT00656019|12169255|FG002|NOT COMPLETED|Overall Study||0
10993135|NCT00656019|12169256|FG003|NOT COMPLETED|Overall Study||0
10993136|NCT00656058|12169266|FG000|STARTED|Overall Study||25
10993137|NCT00656058|12169266|FG000|COMPLETED|Overall Study||19
10993138|NCT00656058|12169266|FG000|NOT COMPLETED|Overall Study||6
10993139|NCT00656084|12169270|FG000|STARTED|Overall Study||16
10993140|NCT00656084|12169270|FG000|COMPLETED|Overall Study||9
10993141|NCT00656084|12169270|FG000|NOT COMPLETED|Overall Study||7
10993142|NCT00656136|12169276|FG000|STARTED|Overall Study|Randomised patients.|195
10993143|NCT00656136|12169277|FG001|STARTED|Overall Study|Randomised patients.|390
10993144|NCT00656136|12169276|FG000|COMPLETED|Overall Study||0
10993145|NCT00656136|12169277|FG001|COMPLETED|Overall Study||0
10993146|NCT00656136|12169276|FG000|NOT COMPLETED|Overall Study||195
10993147|NCT00656136|12169277|FG001|NOT COMPLETED|Overall Study||390
10993148|NCT00656175|12169285|FG000|STARTED|Overall Study||18
10993149|NCT00656175|12169286|FG001|STARTED|Overall Study||21
10993150|NCT00656175|12169285|FG000|COMPLETED|Overall Study||17
10993151|NCT00656175|12169286|FG001|COMPLETED|Overall Study||20
10993152|NCT00656175|12169285|FG000|NOT COMPLETED|Overall Study||1
10993153|NCT00656175|12169286|FG001|NOT COMPLETED|Overall Study||1
10993154|NCT00656201|12169294|FG000|STARTED|Overall Study||235
10993155|NCT00656201|12169295|FG001|STARTED|Overall Study||233
10993156|NCT00656201|12169294|FG000|COMPLETED|Overall Study||206
10993157|NCT00656201|12169295|FG001|COMPLETED|Overall Study||201
10993158|NCT00656201|12169294|FG000|NOT COMPLETED|Overall Study||29
10993159|NCT00656201|12169295|FG001|NOT COMPLETED|Overall Study||32
10993160|NCT00656292|12169303|FG000|STARTED|Overall Study||32
10993161|NCT00656292|12169304|FG001|STARTED|Overall Study||29
10993162|NCT00656292|12169303|FG000|COMPLETED|Overall Study||29
10993163|NCT00656292|12169304|FG001|COMPLETED|Overall Study||24
10993164|NCT00656292|12169303|FG000|NOT COMPLETED|Overall Study||3
10993165|NCT00656292|12169304|FG001|NOT COMPLETED|Overall Study||5
10993166|NCT00656305|12169312|FG000|STARTED|Overall Study||87
10993167|NCT00656305|12169313|FG001|STARTED|Overall Study||28
10993168|NCT00656305|12169312|FG000|COMPLETED|Overall Study||65
10993169|NCT00656305|12169313|FG001|COMPLETED|Overall Study||21
10993170|NCT00656305|12169312|FG000|NOT COMPLETED|Overall Study||22
10993171|NCT00656305|12169313|FG001|NOT COMPLETED|Overall Study||7
10993172|NCT00656370|12169319|FG000|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
10993173|NCT00656370|12169319|FG000|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
10993174|NCT00656370|12169319|FG000|NOT COMPLETED|Overall Study||10
10993175|NCT00656448|12169327|FG000|STARTED|Overall Study||25
10993176|NCT00656448|12169328|FG001|STARTED|Overall Study||25
10993177|NCT00656448|12169327|FG000|COMPLETED|Overall Study||25
10993178|NCT00656448|12169328|FG001|COMPLETED|Overall Study||25
10993179|NCT00656448|12169327|FG000|NOT COMPLETED|Overall Study||0
10993180|NCT00656448|12169328|FG001|NOT COMPLETED|Overall Study||0
10993181|NCT00656474|12169335|FG000|STARTED|Overall Study||12
10993182|NCT00656474|12169335|FG000|COMPLETED|Overall Study||11
10993183|NCT00656474|12169335|FG000|NOT COMPLETED|Overall Study||1
10993184|NCT00656487|12169343|FG000|STARTED|Overall Study||23
10993185|NCT00656487|12169344|FG001|STARTED|Overall Study||23
10993186|NCT00656487|12169345|FG002|STARTED|Overall Study||20
10993187|NCT00656487|12169343|FG000|COMPLETED|Overall Study||21
10993188|NCT00656487|12169344|FG001|COMPLETED|Overall Study||19
10993189|NCT00656487|12169345|FG002|COMPLETED|Overall Study||20
10993190|NCT00656487|12169343|FG000|NOT COMPLETED|Overall Study||2
10993191|NCT00656487|12169344|FG001|NOT COMPLETED|Overall Study||4
10993192|NCT00656487|12169345|FG002|NOT COMPLETED|Overall Study||0
10993193|NCT00656513|12169356|FG000|STARTED|Overall Study||48
10993194|NCT00656513|12169357|FG001|STARTED|Overall Study||73
10993195|NCT00656513|12169358|FG002|STARTED|Overall Study||75
10993196|NCT00656513|12169356|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
10993197|NCT00656513|12169357|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
10993287|NCT00657280|12169460|FG000|NOT COMPLETED|Overall Study||0
10993198|NCT00656513|12169358|FG002|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
10993199|NCT00656513|12169356|FG000|NOT COMPLETED|Overall Study||4
10993200|NCT00656513|12169357|FG001|NOT COMPLETED|Overall Study||30
10993201|NCT00656513|12169358|FG002|NOT COMPLETED|Overall Study||22
10993202|NCT00656617|12169366|FG000|STARTED|Overall Study||106
10993203|NCT00656617|12169366|FG000|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
10993204|NCT00656617|12169366|FG000|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
10993205|NCT00656617|12169366|FG000|COMPLETED|Overall Study||99
10993206|NCT00656617|12169366|FG000|NOT COMPLETED|Overall Study||7
10993207|NCT00656630|12169374|FG000|STARTED|Overall Study||22
10993208|NCT00656630|12169375|FG001|STARTED|Overall Study||27
10993209|NCT00656630|12169376|FG002|STARTED|Overall Study||19
10993210|NCT00656630|12169374|FG000|COMPLETED|Overall Study||20
10993211|NCT00656630|12169375|FG001|COMPLETED|Overall Study||25
10993212|NCT00656630|12169376|FG002|COMPLETED|Overall Study||17
10993213|NCT00656630|12169374|FG000|NOT COMPLETED|Overall Study||2
10993214|NCT00656630|12169375|FG001|NOT COMPLETED|Overall Study||2
10993215|NCT00656630|12169376|FG002|NOT COMPLETED|Overall Study||2
10993216|NCT00656656|12169384|FG000|STARTED|Overall Study||23
10993217|NCT00656656|12169384|FG000|COMPLETED|Overall Study||23
10993218|NCT00656656|12169384|FG000|NOT COMPLETED|Overall Study||0
10993219|NCT00656669|12169388|FG000|STARTED|Single Agent Sunitinib (Cycle 1)||23
10993220|NCT00656669|12169388|FG000|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
10993221|NCT00656669|12169388|FG000|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
10993222|NCT00656669|12169388|FG000|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
10993223|NCT00656669|12169388|FG000|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
10993224|NCT00656669|12169388|FG000|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
10993225|NCT00656669|12169388|FG000|STARTED|AC (Cycles 6-9)||17
10993226|NCT00656669|12169388|FG000|COMPLETED|AC (Cycles 6-9)||15
10993227|NCT00656669|12169388|FG000|NOT COMPLETED|AC (Cycles 6-9)||2
10993228|NCT00656799|12169397|FG000|STARTED|Overall Study||6
10993229|NCT00656799|12169397|FG000|COMPLETED|Overall Study||4
10993230|NCT00656799|12169397|FG000|NOT COMPLETED|Overall Study||2
10993231|NCT00656851|12169403|FG000|STARTED|Overall Study||12
10993232|NCT00656851|12169404|FG001|STARTED|Overall Study||12
10993233|NCT00656851|12169403|FG000|COMPLETED|Overall Study||12
10993234|NCT00656851|12169404|FG001|COMPLETED|Overall Study||8
10993235|NCT00656851|12169403|FG000|NOT COMPLETED|Overall Study||0
10993236|NCT00656851|12169404|FG001|NOT COMPLETED|Overall Study||4
10993237|NCT00656968|12169412|FG000|STARTED|Overall Study||115
10993238|NCT00656968|12169413|FG001|STARTED|Overall Study||117
10993239|NCT00656968|12169412|FG000|COMPLETED|Overall Study||115
10993240|NCT00656968|12169413|FG001|COMPLETED|Overall Study||117
10993241|NCT00656968|12169412|FG000|NOT COMPLETED|Overall Study||0
10993242|NCT00656968|12169413|FG001|NOT COMPLETED|Overall Study||0
10993243|NCT00657020|12169419|FG000|STARTED|PERIOD 1||11
10993244|NCT00657020|12169420|FG001|STARTED|PERIOD 1||12
10993245|NCT00657020|12169419|FG000|COMPLETED|PERIOD 1||11
10993246|NCT00657020|12169420|FG001|COMPLETED|PERIOD 1||11
10993247|NCT00657020|12169419|FG000|NOT COMPLETED|PERIOD 1||0
10993248|NCT00657020|12169420|FG001|NOT COMPLETED|PERIOD 1||1
10993249|NCT00657020|12169419|FG000|STARTED|PERIOD 2||11
10993250|NCT00657020|12169420|FG001|STARTED|PERIOD 2||11
10993251|NCT00657020|12169419|FG000|COMPLETED|PERIOD 2||11
10993252|NCT00657020|12169420|FG001|COMPLETED|PERIOD 2||11
10993253|NCT00657020|12169419|FG000|NOT COMPLETED|PERIOD 2||0
10993254|NCT00657020|12169420|FG001|NOT COMPLETED|PERIOD 2||0
10993255|NCT00657046|12169435|FG000|STARTED|Overall Study||30
10993256|NCT00657046|12169436|FG001|STARTED|Overall Study||32
10993257|NCT00657046|12169437|FG002|STARTED|Overall Study||23
10993258|NCT00657046|12169435|FG000|Had at Least 1 Post Baseline Visit|Overall Study||30
10993259|NCT00657046|12169436|FG001|Had at Least 1 Post Baseline Visit|Overall Study||31
10993260|NCT00657046|12169437|FG002|Had at Least 1 Post Baseline Visit|Overall Study||23
10993261|NCT00657046|12169435|FG000|Had Visits up to Visit 18|Overall Study||28
10993262|NCT00657046|12169436|FG001|Had Visits up to Visit 18|Overall Study||30
10993263|NCT00657046|12169437|FG002|Had Visits up to Visit 18|Overall Study||23
10993264|NCT00657046|12169435|FG000|COMPLETED|Overall Study||26
10993265|NCT00657046|12169436|FG001|COMPLETED|Overall Study||29
10993266|NCT00657046|12169437|FG002|COMPLETED|Overall Study||21
10993267|NCT00657046|12169435|FG000|NOT COMPLETED|Overall Study||4
10993268|NCT00657046|12169436|FG001|NOT COMPLETED|Overall Study||3
10993269|NCT00657046|12169437|FG002|NOT COMPLETED|Overall Study||2
10993270|NCT00657150|12169447|FG000|STARTED|Overall Study||1010
10993271|NCT00657150|12169448|FG001|STARTED|Overall Study||1003
10993272|NCT00657150|12169447|FG000|COMPLETED|Overall Study||895
10993273|NCT00657150|12169448|FG001|COMPLETED|Overall Study||910
10993274|NCT00657150|12169447|FG000|NOT COMPLETED|Overall Study||115
10993275|NCT00657150|12169448|FG001|NOT COMPLETED|Overall Study||93
10993276|NCT00657150|12169447|FG000|STARTED|Treatment||1010
10993277|NCT00657150|12169448|FG001|STARTED|Treatment||1003
10993278|NCT00657150|12169447|FG000|COMPLETED|Treatment||903
10993279|NCT00657150|12169448|FG001|COMPLETED|Treatment||906
10993280|NCT00657150|12169447|FG000|NOT COMPLETED|Treatment||107
10993281|NCT00657150|12169448|FG001|NOT COMPLETED|Treatment||97
10993282|NCT00657267|12169454|FG000|STARTED|Overall Study||58
10993283|NCT00657267|12169454|FG000|COMPLETED|Overall Study||4
10993284|NCT00657267|12169454|FG000|NOT COMPLETED|Overall Study||54
10993285|NCT00657280|12169460|FG000|STARTED|Overall Study||16
10993286|NCT00657280|12169460|FG000|COMPLETED|Overall Study||16
10993288|NCT00657358|12169464|FG000|STARTED|Overall Study||22
10993289|NCT00657358|12169464|FG000|COMPLETED|Overall Study||16
10993290|NCT00657358|12169464|FG000|NOT COMPLETED|Overall Study||6
10993291|NCT00657371|12169469|FG000|STARTED|Overall Study||288
10993292|NCT00657371|12169469|FG000|COMPLETED|Overall Study||249
10993293|NCT00657371|12169469|FG000|NOT COMPLETED|Overall Study||39
10993294|NCT00657540|12169475|FG000|STARTED|Overall Study||29
10993295|NCT00657540|12169476|FG001|STARTED|Overall Study||31
10993296|NCT00657540|12169475|FG000|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
10993297|NCT00657540|12169476|FG001|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
10993298|NCT00657540|12169475|FG000|NOT COMPLETED|Overall Study||1
10993299|NCT00657540|12169476|FG001|NOT COMPLETED|Overall Study||4
10993300|NCT00657605|12169482|FG000|STARTED|Overall Study||3
10993301|NCT00657605|12169482|FG000|COMPLETED|Overall Study||3
10993302|NCT00657605|12169482|FG000|NOT COMPLETED|Overall Study||0
10993303|NCT00657618|12169486|FG000|STARTED|Overall Study||77
10993304|NCT00657618|12169486|FG000|COMPLETED|Overall Study||34
10993305|NCT00657618|12169486|FG000|NOT COMPLETED|Overall Study||43
10993306|NCT00657657|12169490|FG000|STARTED|Overall Study||29
10993307|NCT00657657|12169490|FG000|COMPLETED|Overall Study||29
10993308|NCT00657657|12169490|FG000|NOT COMPLETED|Overall Study||0
10993309|NCT00657709|12169499|FG000|STARTED|Overall Study||833
10993310|NCT00657709|12169500|FG001|STARTED|Overall Study||828
10993311|NCT00657709|12169501|FG002|STARTED|Overall Study||820
10993312|NCT00657709|12169502|FG003|STARTED|Overall Study||659
10993313|NCT00657709|12169503|FG004|STARTED|Overall Study||490
10993314|NCT00657709|12169499|FG000|COMPLETED|Overall Study||810
10993315|NCT00657709|12169500|FG001|COMPLETED|Overall Study||795
10993316|NCT00657709|12169501|FG002|COMPLETED|Overall Study||792
10993317|NCT00657709|12169502|FG003|COMPLETED|Overall Study||645
10993318|NCT00657709|12169503|FG004|COMPLETED|Overall Study||457
10993319|NCT00657709|12169499|FG000|NOT COMPLETED|Overall Study||23
10993320|NCT00657709|12169500|FG001|NOT COMPLETED|Overall Study||33
10993321|NCT00657709|12169501|FG002|NOT COMPLETED|Overall Study||28
10993322|NCT00657709|12169502|FG003|NOT COMPLETED|Overall Study||14
10993323|NCT00657709|12169503|FG004|NOT COMPLETED|Overall Study||33
10993324|NCT00657917|12169525|FG000|STARTED|Overall Study||1
10993325|NCT00657917|12169525|FG000|COMPLETED|Overall Study||1
10993326|NCT00657917|12169525|FG000|NOT COMPLETED|Overall Study||0
10993327|NCT00658021|12169532|FG000|STARTED|28-Week Treatment Period||42
10993328|NCT00658021|12169533|FG001|STARTED|28-Week Treatment Period||38
10993329|NCT00658021|12169534|FG002|STARTED|28-Week Treatment Period||42
10993330|NCT00658021|12169532|FG000|Received Treatment|28-Week Treatment Period||40
10993331|NCT00658021|12169533|FG001|Received Treatment|28-Week Treatment Period||38
10993332|NCT00658021|12169534|FG002|Received Treatment|28-Week Treatment Period||42
10993333|NCT00658021|12169532|FG000|COMPLETED|28-Week Treatment Period||31
10993334|NCT00658021|12169533|FG001|COMPLETED|28-Week Treatment Period||25
10993335|NCT00658021|12169534|FG002|COMPLETED|28-Week Treatment Period||25
10993336|NCT00658021|12169532|FG000|NOT COMPLETED|28-Week Treatment Period||11
10993337|NCT00658021|12169533|FG001|NOT COMPLETED|28-Week Treatment Period||13
10993338|NCT00658021|12169534|FG002|NOT COMPLETED|28-Week Treatment Period||17
10993339|NCT00658021|12169532|FG000|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
10993340|NCT00658021|12169533|FG001|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|5
10993341|NCT00658021|12169534|FG002|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
10993342|NCT00658021|12169532|FG000|COMPLETED|Long-term Safety Follow-up Period||7
10993343|NCT00658021|12169533|FG001|COMPLETED|Long-term Safety Follow-up Period||2
10993344|NCT00658021|12169534|FG002|COMPLETED|Long-term Safety Follow-up Period||7
10993345|NCT00658021|12169532|FG000|NOT COMPLETED|Long-term Safety Follow-up Period||0
10993346|NCT00658021|12169533|FG001|NOT COMPLETED|Long-term Safety Follow-up Period||3
10993347|NCT00658021|12169534|FG002|NOT COMPLETED|Long-term Safety Follow-up Period||0
10993348|NCT00658112|12169544|FG000|STARTED|Overall Study||20
10993349|NCT00658112|12169544|FG000|COMPLETED|Overall Study||11
10993350|NCT00658112|12169544|FG000|NOT COMPLETED|Overall Study||9
10993351|NCT00658138|12169548|FG000|STARTED|Overall Study||61
10993352|NCT00658138|12169548|FG000|COMPLETED|Overall Study||40
10993353|NCT00658138|12169548|FG000|NOT COMPLETED|Overall Study||21
10993354|NCT00658320|12169555|FG000|STARTED|Core Study: 12 Months||61
10993355|NCT00658320|12169556|FG001|STARTED|Core Study: 12 Months||61
10993356|NCT00658320|12169555|FG000|COMPLETED|Core Study: 12 Months||56
10993357|NCT00658320|12169556|FG001|COMPLETED|Core Study: 12 Months||58
10993358|NCT00658320|12169555|FG000|NOT COMPLETED|Core Study: 12 Months||5
10993359|NCT00658320|12169556|FG001|NOT COMPLETED|Core Study: 12 Months||3
10993360|NCT00658320|12169555|FG000|STARTED|Extension Study: Month 12 to Month 24||53
10993361|NCT00658320|12169556|FG001|STARTED|Extension Study: Month 12 to Month 24||57
10993362|NCT00658320|12169555|FG000|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
10993363|NCT00658320|12169556|FG001|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
10993364|NCT00658320|12169555|FG000|COMPLETED|Extension Study: Month 12 to Month 24||47
10993365|NCT00658320|12169556|FG001|COMPLETED|Extension Study: Month 12 to Month 24||50
10993366|NCT00658320|12169555|FG000|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
10993367|NCT00658320|12169556|FG001|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
10993368|NCT00658320|12169555|FG000|STARTED|Extension Study: After Month 24||44
10993369|NCT00658320|12169556|FG001|STARTED|Extension Study: After Month 24||0
10993370|NCT00658320|12169555|FG000|COMPLETED|Extension Study: After Month 24||42
10993371|NCT00658320|12169556|FG001|COMPLETED|Extension Study: After Month 24||0
10993372|NCT00658320|12169555|FG000|NOT COMPLETED|Extension Study: After Month 24||2
10993373|NCT00658320|12169556|FG001|NOT COMPLETED|Extension Study: After Month 24||0
10993374|NCT00658333|12169566|FG000|STARTED|Overall Study||15
10993375|NCT00658333|12169567|FG001|STARTED|Overall Study||15
10993376|NCT00658333|12169566|FG000|COMPLETED|Overall Study||13
10993377|NCT00658333|12169567|FG001|COMPLETED|Overall Study||14
10993378|NCT00658333|12169566|FG000|NOT COMPLETED|Overall Study||2
10993379|NCT00658333|12169567|FG001|NOT COMPLETED|Overall Study||1
10993380|NCT00658359|12169576|FG000|STARTED|Overall Study||64
10993381|NCT00658359|12169577|FG001|STARTED|Overall Study||60
10993382|NCT00658359|12169578|FG002|STARTED|Overall Study||54
10993383|NCT00658359|12169576|FG000|COMPLETED|Overall Study||36
10993384|NCT00658359|12169577|FG001|COMPLETED|Overall Study||15
10993385|NCT00658359|12169578|FG002|COMPLETED|Overall Study||8
10993386|NCT00658359|12169576|FG000|NOT COMPLETED|Overall Study||28
10993387|NCT00658359|12169577|FG001|NOT COMPLETED|Overall Study||45
10993388|NCT00658359|12169578|FG002|NOT COMPLETED|Overall Study||46
10993389|NCT00658385|12169588|FG000|STARTED|Overall Study||5
10993390|NCT00658385|12169588|FG000|COMPLETED|Overall Study||5
10993391|NCT00658385|12169588|FG000|NOT COMPLETED|Overall Study||0
10993392|NCT00658411|12169592|FG000|STARTED|Overall Study||5
10993393|NCT00658411|12169592|FG000|COMPLETED|Overall Study||5
10993394|NCT00658411|12169592|FG000|NOT COMPLETED|Overall Study||0
10993395|NCT00658515|12169602|FG000|STARTED|Overall Study||7938
10993396|NCT00658515|12169603|FG001|STARTED|Overall Study||7933
10993397|NCT00658515|12169602|FG000|COMPLETED|Overall Study||7626
10993398|NCT00658515|12169603|FG001|COMPLETED|Overall Study||7668
10993399|NCT00658515|12169602|FG000|NOT COMPLETED|Overall Study||312
10993400|NCT00658515|12169603|FG001|NOT COMPLETED|Overall Study||265
10993401|NCT00658528|12169611|FG000|STARTED|Overall Study|Treated|531
10993402|NCT00658528|12169612|FG001|STARTED|Overall Study|Treated|524
10993403|NCT00658528|12169611|FG000|COMPLETED|Overall Study||491
10993404|NCT00658528|12169612|FG001|COMPLETED|Overall Study||479
10993405|NCT00658528|12169611|FG000|NOT COMPLETED|Overall Study||40
10993406|NCT00658528|12169612|FG001|NOT COMPLETED|Overall Study||45
10993407|NCT00658541|12169618|FG000|STARTED|First Intervention||19
10993408|NCT00658541|12169619|FG001|STARTED|First Intervention||19
10993409|NCT00658541|12169618|FG000|COMPLETED|First Intervention||19
10993410|NCT00658541|12169619|FG001|COMPLETED|First Intervention||19
10993411|NCT00658541|12169618|FG000|NOT COMPLETED|First Intervention||0
10993412|NCT00658541|12169619|FG001|NOT COMPLETED|First Intervention||0
10993413|NCT00658541|12169618|FG000|STARTED|Washout Period of 7 Days||19
10993414|NCT00658541|12169619|FG001|STARTED|Washout Period of 7 Days||19
10993415|NCT00658541|12169618|FG000|COMPLETED|Washout Period of 7 Days||18
10993416|NCT00658541|12169619|FG001|COMPLETED|Washout Period of 7 Days||17
10993417|NCT00658541|12169618|FG000|NOT COMPLETED|Washout Period of 7 Days||1
10993418|NCT00658541|12169619|FG001|NOT COMPLETED|Washout Period of 7 Days||2
10993419|NCT00658541|12169618|FG000|STARTED|Second Intervention||18
10993420|NCT00658541|12169619|FG001|STARTED|Second Intervention||17
10993421|NCT00658541|12169618|FG000|COMPLETED|Second Intervention||18
10993422|NCT00658541|12169619|FG001|COMPLETED|Second Intervention||17
10993423|NCT00658541|12169618|FG000|NOT COMPLETED|Second Intervention||0
10993424|NCT00658541|12169619|FG001|NOT COMPLETED|Second Intervention||0
10993425|NCT00658567|12169628|FG000|STARTED|Overall Study||40
10993426|NCT00658567|12169629|FG001|STARTED|Overall Study||42
10993427|NCT00658567|12169630|FG002|STARTED|Overall Study||41
10993428|NCT00658567|12169628|FG000|COMPLETED|Overall Study||32
10993429|NCT00658567|12169629|FG001|COMPLETED|Overall Study||38
10993430|NCT00658567|12169630|FG002|COMPLETED|Overall Study||35
10993431|NCT00658567|12169628|FG000|NOT COMPLETED|Overall Study||8
10993432|NCT00658567|12169629|FG001|NOT COMPLETED|Overall Study||4
10993433|NCT00658567|12169630|FG002|NOT COMPLETED|Overall Study||6
10993434|NCT00658606|12169640|FG000|STARTED|Overall Study||49
10993435|NCT00658606|12169641|FG001|STARTED|Overall Study||49
10993436|NCT00658606|12169640|FG000|Completed Treatment|Overall Study||42
10993437|NCT00658606|12169641|FG001|Completed Treatment|Overall Study||44
10993438|NCT00658606|12169640|FG000|COMPLETED|Overall Study|Represents patients who completed follow-up|33
10993439|NCT00658606|12169641|FG001|COMPLETED|Overall Study|Represents patients who completed follow-up|26
10993440|NCT00658606|12169640|FG000|NOT COMPLETED|Overall Study||16
10993441|NCT00658606|12169641|FG001|NOT COMPLETED|Overall Study||23
10993442|NCT00658619|12169652|FG000|STARTED|Overall Study||3
10993443|NCT00658619|12169653|FG001|STARTED|Overall Study||3
10993444|NCT00658619|12169654|FG002|STARTED|Overall Study||41
10993445|NCT00658619|12169655|FG003|STARTED|Overall Study||49
10993446|NCT00658619|12169656|FG004|STARTED|Overall Study||23
10993447|NCT00658619|12169652|FG000|COMPLETED|Overall Study||3
10993448|NCT00658619|12169653|FG001|COMPLETED|Overall Study||2
10993449|NCT00658619|12169654|FG002|COMPLETED|Overall Study||31
10993450|NCT00658619|12169655|FG003|COMPLETED|Overall Study||37
10993451|NCT00658619|12169656|FG004|COMPLETED|Overall Study||21
10993452|NCT00658619|12169652|FG000|NOT COMPLETED|Overall Study||0
10993453|NCT00658619|12169653|FG001|NOT COMPLETED|Overall Study||1
10993454|NCT00658619|12169654|FG002|NOT COMPLETED|Overall Study||10
10993455|NCT00658619|12169655|FG003|NOT COMPLETED|Overall Study||12
10993456|NCT00658619|12169656|FG004|NOT COMPLETED|Overall Study||2
10993457|NCT00658632|12169667|FG000|STARTED|Overall Study|Treated|682
10993458|NCT00658632|12169668|FG001|STARTED|Overall Study|Treated|698
10993459|NCT00658632|12169667|FG000|COMPLETED|Overall Study||618
10993460|NCT00658632|12169668|FG001|COMPLETED|Overall Study||633
10993461|NCT00658632|12169667|FG000|NOT COMPLETED|Overall Study||64
10993462|NCT00658632|12169668|FG001|NOT COMPLETED|Overall Study||65
10993463|NCT00658658|12169679|FG000|STARTED|Overall Study||6
10993464|NCT00658658|12169680|FG001|STARTED|Overall Study||7
10993465|NCT00658658|12169681|FG002|STARTED|Overall Study||4
10993466|NCT00658658|12169682|FG003|STARTED|Overall Study||6
10993467|NCT00658658|12169683|FG004|STARTED|Overall Study||8
10993468|NCT00658658|12169679|FG000|COMPLETED|Overall Study||1
10993469|NCT00658658|12169680|FG001|COMPLETED|Overall Study||5
10993470|NCT00658658|12169681|FG002|COMPLETED|Overall Study||4
10993471|NCT00658658|12169682|FG003|COMPLETED|Overall Study||4
10993472|NCT00658658|12169683|FG004|COMPLETED|Overall Study||3
10993473|NCT00658658|12169679|FG000|NOT COMPLETED|Overall Study||5
10993474|NCT00658658|12169680|FG001|NOT COMPLETED|Overall Study||2
10993475|NCT00658658|12169681|FG002|NOT COMPLETED|Overall Study||0
10993476|NCT00658658|12169682|FG003|NOT COMPLETED|Overall Study||2
10993477|NCT00658658|12169683|FG004|NOT COMPLETED|Overall Study||5
10993478|NCT00658684|12169698|FG000|STARTED|Overall Study||152
10993479|NCT00658684|12169699|FG001|STARTED|Overall Study||99
10993480|NCT00658684|12169700|FG002|STARTED|Overall Study||25
10993481|NCT00658684|12169701|FG003|STARTED|Overall Study||28
10993482|NCT00658684|12169698|FG000|COMPLETED|Overall Study||133
10993483|NCT00658684|12169699|FG001|COMPLETED|Overall Study||84
10993484|NCT00658684|12169700|FG002|COMPLETED|Overall Study||22
10993485|NCT00658684|12169701|FG003|COMPLETED|Overall Study||27
10993486|NCT00658684|12169698|FG000|NOT COMPLETED|Overall Study||19
10993487|NCT00658684|12169699|FG001|NOT COMPLETED|Overall Study||15
10993488|NCT00658684|12169700|FG002|NOT COMPLETED|Overall Study||3
10993489|NCT00658684|12169701|FG003|NOT COMPLETED|Overall Study||1
10993490|NCT00658697|12169711|FG000|STARTED|Overall Study||41
10993491|NCT00658697|12169711|FG000|COMPLETED|Overall Study||41
10993492|NCT00658697|12169711|FG000|NOT COMPLETED|Overall Study||0
10993493|NCT00658723|12169719|FG000|STARTED|Overall Study||60
10993494|NCT00658723|12169720|FG001|STARTED|Overall Study||30
10993495|NCT00658723|12169721|FG002|STARTED|Overall Study||51
10993496|NCT00658723|12169719|FG000|COMPLETED|Overall Study||56
10993497|NCT00658723|12169720|FG001|COMPLETED|Overall Study||26
10993498|NCT00658723|12169721|FG002|COMPLETED|Overall Study||44
10993499|NCT00658723|12169719|FG000|NOT COMPLETED|Overall Study||4
10993500|NCT00658723|12169720|FG001|NOT COMPLETED|Overall Study||4
10993501|NCT00658723|12169721|FG002|NOT COMPLETED|Overall Study||7
10993502|NCT00658736|12169734|FG000|STARTED|Overall Study||19
10993503|NCT00658736|12169735|FG001|STARTED|Overall Study||21
10993504|NCT00658736|12169734|FG000|COMPLETED|Overall Study||13
10993505|NCT00658736|12169735|FG001|COMPLETED|Overall Study||19
10993506|NCT00658736|12169734|FG000|NOT COMPLETED|Overall Study||6
10993507|NCT00658736|12169735|FG001|NOT COMPLETED|Overall Study||2
10993508|NCT00658775|12169743|FG000|STARTED|Overall Study|Treated|537
10993509|NCT00658775|12169744|FG001|STARTED|Overall Study|Treated|528
10993510|NCT00658775|12169743|FG000|COMPLETED|Overall Study||495
10993511|NCT00658775|12169744|FG001|COMPLETED|Overall Study||485
10993512|NCT00658775|12169743|FG000|NOT COMPLETED|Overall Study||42
10993513|NCT00658775|12169744|FG001|NOT COMPLETED|Overall Study||43
10993514|NCT00658879|12169750|FG000|STARTED|Overall Study||251
10993515|NCT00658879|12169750|FG000|COMPLETED|Overall Study||250
10993516|NCT00658879|12169750|FG000|NOT COMPLETED|Overall Study||1
10993517|NCT00658996|12169754|FG000|STARTED|First Intervention||109
10993518|NCT00658996|12169755|FG001|STARTED|First Intervention||107
10993519|NCT00658996|12169754|FG000|COMPLETED|First Intervention||108
10993520|NCT00658996|12169755|FG001|COMPLETED|First Intervention||106
10993521|NCT00658996|12169754|FG000|NOT COMPLETED|First Intervention||1
10993522|NCT00658996|12169755|FG001|NOT COMPLETED|First Intervention||1
10993523|NCT00658996|12169754|FG000|STARTED|Crossover Period||108
10993524|NCT00658996|12169755|FG001|STARTED|Crossover Period||106
10993525|NCT00658996|12169754|FG000|COMPLETED|Crossover Period||106
10993526|NCT00658996|12169755|FG001|COMPLETED|Crossover Period||105
10993527|NCT00658996|12169754|FG000|NOT COMPLETED|Crossover Period||2
10993528|NCT00658996|12169755|FG001|NOT COMPLETED|Crossover Period||1
10993529|NCT00658996|12169754|FG000|STARTED|Second Intervention||106
10993530|NCT00658996|12169755|FG001|STARTED|Second Intervention||105
10993531|NCT00658996|12169754|FG000|COMPLETED|Second Intervention||105
10993532|NCT00658996|12169755|FG001|COMPLETED|Second Intervention||104
10993533|NCT00658996|12169754|FG000|NOT COMPLETED|Second Intervention||1
10993534|NCT00658996|12169755|FG001|NOT COMPLETED|Second Intervention||1
10993535|NCT00659165|12169763|FG000|STARTED|Overall Study||5
10993536|NCT00659165|12169764|FG001|STARTED|Overall Study||5
10993537|NCT00659165|12169763|FG000|COMPLETED|Overall Study||5
10993538|NCT00659165|12169764|FG001|COMPLETED|Overall Study||5
10993539|NCT00659165|12169763|FG000|NOT COMPLETED|Overall Study||0
10993540|NCT00659165|12169764|FG001|NOT COMPLETED|Overall Study||0
10993541|NCT00659230|12169772|FG000|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
10993542|NCT00659230|12169773|FG001|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
10993543|NCT00659230|12169772|FG000|COMPLETED|Overall Study||42
10993544|NCT00659230|12169773|FG001|COMPLETED|Overall Study||37
10993545|NCT00659230|12169772|FG000|NOT COMPLETED|Overall Study||9
10993546|NCT00659230|12169773|FG001|NOT COMPLETED|Overall Study||12
10993547|NCT00659269|12169781|FG000|STARTED|Overall Study||157
10993548|NCT00659269|12169782|FG001|STARTED|Overall Study||162
10993549|NCT00659269|12169781|FG000|Group 1 (Heavy Metals)|Overall Study||52
10993550|NCT00659269|12169782|FG001|Group 1 (Heavy Metals)|Overall Study||52
10993551|NCT00659269|12169781|FG000|Group 2 (Vinca Alkaloids)|Overall Study||12
10993552|NCT00659269|12169782|FG001|Group 2 (Vinca Alkaloids)|Overall Study||12
10993553|NCT00659269|12169781|FG000|Group 3 (Taxanes)|Overall Study||92
10993554|NCT00659269|12169782|FG001|Group 3 (Taxanes)|Overall Study||97
10993555|NCT00659269|12169781|FG000|COMPLETED|Overall Study||156
10993556|NCT00659269|12169782|FG001|COMPLETED|Overall Study||161
10993557|NCT00659269|12169781|FG000|NOT COMPLETED|Overall Study||1
10993558|NCT00659269|12169782|FG001|NOT COMPLETED|Overall Study||1
10993559|NCT00659295|12169799|FG000|STARTED|Overall Study||13529
10993560|NCT00659295|12169800|FG001|STARTED|Overall Study||37641
10993561|NCT00659295|12169799|FG000|COMPLETED|Overall Study||10821
10993562|NCT00659295|12169800|FG001|COMPLETED|Overall Study||32038
10993563|NCT00659295|12169799|FG000|NOT COMPLETED|Overall Study||2708
10993564|NCT00659295|12169800|FG001|NOT COMPLETED|Overall Study||5603
10993565|NCT00659334|12169813|FG000|STARTED|Overall Study||46
10993566|NCT00659334|12169814|FG001|STARTED|Overall Study||41
10993567|NCT00659334|12169815|FG002|STARTED|Overall Study||5
10993568|NCT00659334|12169816|FG003|STARTED|Overall Study||2
10993569|NCT00659334|12169817|FG004|STARTED|Overall Study||1
10993570|NCT00659334|12169818|FG005|STARTED|Overall Study||0
10993571|NCT00659334|12169819|FG006|STARTED|Overall Study||21
10993572|NCT00659334|12169813|FG000|COMPLETED|Overall Study|8 Screen failures|38
10993573|NCT00659334|12169814|FG001|COMPLETED|Overall Study|5 Screen failures|36
10993574|NCT00659334|12169815|FG002|COMPLETED|Overall Study||5
10993575|NCT00659334|12169816|FG003|COMPLETED|Overall Study||2
10993576|NCT00659334|12169817|FG004|COMPLETED|Overall Study||1
10993577|NCT00659334|12169818|FG005|COMPLETED|Overall Study||0
10993578|NCT00659334|12169819|FG006|COMPLETED|Overall Study|1 screen failure|20
10993579|NCT00659334|12169813|FG000|NOT COMPLETED|Overall Study||8
10993580|NCT00659334|12169814|FG001|NOT COMPLETED|Overall Study||5
10993581|NCT00659334|12169815|FG002|NOT COMPLETED|Overall Study||0
10993582|NCT00659334|12169816|FG003|NOT COMPLETED|Overall Study||0
10993583|NCT00659334|12169817|FG004|NOT COMPLETED|Overall Study||0
10993584|NCT00659334|12169818|FG005|NOT COMPLETED|Overall Study||0
10993585|NCT00659334|12169819|FG006|NOT COMPLETED|Overall Study||1
10993586|NCT00659360|12169835|FG000|STARTED|Overall Study||17
10993587|NCT00659360|12169835|FG000|COMPLETED|Overall Study||17
10993588|NCT00659360|12169835|FG000|NOT COMPLETED|Overall Study||0
10993589|NCT00659373|12169843|FG000|STARTED|Overall Study||25
10993590|NCT00659373|12169844|FG001|STARTED|Overall Study||61
10993591|NCT00659373|12169843|FG000|COMPLETED|Overall Study||20
10993592|NCT00659373|12169844|FG001|COMPLETED|Overall Study||54
10993593|NCT00659373|12169843|FG000|NOT COMPLETED|Overall Study||5
10993594|NCT00659373|12169844|FG001|NOT COMPLETED|Overall Study||7
10993595|NCT00659425|12169860|FG000|STARTED|Overall Study||1
10993596|NCT00659425|12169861|FG001|STARTED|Overall Study||1
10993597|NCT00659425|12169862|FG002|STARTED|Overall Study||1
10993598|NCT00659425|12169863|FG003|STARTED|Overall Study||4
10993599|NCT00659425|12169864|FG004|STARTED|Overall Study||4
10993600|NCT00659425|12169865|FG005|STARTED|Overall Study||5
10993601|NCT00659425|12169866|FG006|STARTED|Overall Study||8
10993602|NCT00659425|12169867|FG007|STARTED|Overall Study||11
10993603|NCT00659425|12169868|FG008|STARTED|Overall Study||6
10993604|NCT00659425|12169869|FG009|STARTED|Overall Study||14
10993605|NCT00659425|12169860|FG000|COMPLETED|Overall Study||0
10993606|NCT00659425|12169861|FG001|COMPLETED|Overall Study||0
10993607|NCT00659425|12169862|FG002|COMPLETED|Overall Study||0
10993608|NCT00659425|12169863|FG003|COMPLETED|Overall Study||0
10993609|NCT00659425|12169864|FG004|COMPLETED|Overall Study||0
10993610|NCT00659425|12169865|FG005|COMPLETED|Overall Study||1
10993611|NCT00659425|12169866|FG006|COMPLETED|Overall Study||0
10993612|NCT00659425|12169867|FG007|COMPLETED|Overall Study||0
10993613|NCT00659425|12169868|FG008|COMPLETED|Overall Study||0
10993614|NCT00659425|12169869|FG009|COMPLETED|Overall Study||1
10993615|NCT00659425|12169860|FG000|NOT COMPLETED|Overall Study||1
10993616|NCT00659425|12169861|FG001|NOT COMPLETED|Overall Study||1
10993617|NCT00659425|12169862|FG002|NOT COMPLETED|Overall Study||1
10993618|NCT00659425|12169863|FG003|NOT COMPLETED|Overall Study||4
10993619|NCT00659425|12169864|FG004|NOT COMPLETED|Overall Study||4
10993620|NCT00659425|12169865|FG005|NOT COMPLETED|Overall Study||4
10993621|NCT00659425|12169866|FG006|NOT COMPLETED|Overall Study||8
10993622|NCT00659425|12169867|FG007|NOT COMPLETED|Overall Study||11
10993623|NCT00659425|12169868|FG008|NOT COMPLETED|Overall Study||6
10993624|NCT00659425|12169869|FG009|NOT COMPLETED|Overall Study||13
10993625|NCT00659438|12169906|FG000|STARTED|Overall Study||47
10993626|NCT00659438|12169907|FG001|STARTED|Overall Study||48
10993627|NCT00659438|12169906|FG000|Assessable Set : Primary Analysis|Overall Study||44
10993628|NCT00659438|12169907|FG001|Assessable Set : Primary Analysis|Overall Study||45
10993629|NCT00659438|12169906|FG000|Secondary Analysis Set|Overall Study||47
10993630|NCT00659438|12169907|FG001|Secondary Analysis Set|Overall Study||48
10993631|NCT00659438|12169906|FG000|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
10993632|NCT00659438|12169907|FG001|Safety Analysis Set|Overall Study||47
10993633|NCT00659438|12169906|FG000|COMPLETED|Overall Study||33
10993634|NCT00659438|12169907|FG001|COMPLETED|Overall Study||40
10993635|NCT00659438|12169906|FG000|NOT COMPLETED|Overall Study||14
10993636|NCT00659438|12169907|FG001|NOT COMPLETED|Overall Study||8
10993637|NCT00659490|12169916|FG000|STARTED|Overall Study||61
10993638|NCT00659490|12169917|FG001|STARTED|Overall Study||59
10993639|NCT00659490|12169918|FG002|STARTED|Overall Study||31
10993640|NCT00659490|12169916|FG000|COMPLETED|Overall Study||59
10993641|NCT00659490|12169917|FG001|COMPLETED|Overall Study||59
10993642|NCT00659490|12169918|FG002|COMPLETED|Overall Study||30
10993643|NCT00659490|12169916|FG000|NOT COMPLETED|Overall Study||2
10993644|NCT00659490|12169917|FG001|NOT COMPLETED|Overall Study||0
10993645|NCT00659490|12169918|FG002|NOT COMPLETED|Overall Study||1
10993646|NCT00659529|12169926|FG000|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
10993647|NCT00659529|12169926|FG000|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
10993648|NCT00659529|12169926|FG000|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
10993649|NCT00659529|12169926|FG000|NOT COMPLETED|Overall Study||16
10993650|NCT00659581|12169930|FG000|STARTED|Overall Study||20994
10993651|NCT00659581|12169930|FG000|COMPLETED|Overall Study||12412
10993652|NCT00659581|12169930|FG000|NOT COMPLETED|Overall Study||8582
10993653|NCT00659607|12169934|FG000|STARTED|Overall Study||3932
10993654|NCT00659607|12169934|FG000|COMPLETED|Overall Study||3616
10993655|NCT00659607|12169934|FG000|NOT COMPLETED|Overall Study||316
10993656|NCT00659633|12169940|FG000|STARTED|Overall Study||10
10993657|NCT00659633|12169940|FG000|COMPLETED|Overall Study||10
10993658|NCT00659633|12169940|FG000|NOT COMPLETED|Overall Study||0
10993659|NCT00659724|12169944|FG000|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
10993660|NCT00659724|12169944|FG000|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
10993661|NCT00659724|12169944|FG000|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
10993662|NCT00659724|12169944|FG000|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
10993663|NCT00659724|12169944|FG000|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
10993664|NCT00659724|12169944|FG000|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
10993665|NCT00659737|12169952|FG000|STARTED|Overall Study||57
10993666|NCT00659737|12169953|FG001|STARTED|Overall Study||58
10993667|NCT00659737|12169952|FG000|COMPLETED|Overall Study||57
10993668|NCT00659737|12169953|FG001|COMPLETED|Overall Study||58
10993669|NCT00659737|12169952|FG000|NOT COMPLETED|Overall Study||0
10993670|NCT00659737|12169953|FG001|NOT COMPLETED|Overall Study||0
10993671|NCT00659789|12169961|FG000|STARTED|Overall Study||93
10993672|NCT00659789|12169962|FG001|STARTED|Overall Study||43
10993673|NCT00659789|12169961|FG000|COMPLETED|Overall Study||86
10993674|NCT00659789|12169962|FG001|COMPLETED|Overall Study||36
10993675|NCT00659789|12169961|FG000|NOT COMPLETED|Overall Study||7
10993676|NCT00659789|12169962|FG001|NOT COMPLETED|Overall Study||7
10993677|NCT00659802|12169971|FG000|STARTED|Overall Study||74
10993678|NCT00659802|12169972|FG001|STARTED|Overall Study|One patient was incorrectly randomized and was excluded from the efficacy analyses.|75
10993679|NCT00659802|12169973|FG002|STARTED|Overall Study||75
10993680|NCT00659802|12169971|FG000|COMPLETED|Overall Study||59
10993681|NCT00659802|12169972|FG001|COMPLETED|Overall Study||57
10993682|NCT00659802|12169973|FG002|COMPLETED|Overall Study||64
10993683|NCT00659802|12169971|FG000|NOT COMPLETED|Overall Study||15
10993684|NCT00659802|12169972|FG001|NOT COMPLETED|Overall Study||18
10993685|NCT00659802|12169973|FG002|NOT COMPLETED|Overall Study||11
10993686|NCT00659815|12169983|FG000|STARTED|Overall Study||157
10993687|NCT00659815|12169984|FG001|STARTED|Overall Study||151
10993688|NCT00659815|12169983|FG000|COMPLETED|Overall Study||153
10993689|NCT00659815|12169984|FG001|COMPLETED|Overall Study||147
10993690|NCT00659815|12169983|FG000|NOT COMPLETED|Overall Study||4
10993691|NCT00659815|12169984|FG001|NOT COMPLETED|Overall Study||4
10993692|NCT00659828|12169990|FG000|STARTED|Overall Study||1
10993693|NCT00659828|12169990|FG000|COMPLETED|Overall Study||1
10993694|NCT00659828|12169990|FG000|NOT COMPLETED|Overall Study||0
10993695|NCT00659880|12169994|FG000|STARTED|Overall Study||9
10993696|NCT00659880|12169994|FG000|6 Weeks|Overall Study||9
10993697|NCT00659880|12169994|FG000|6 Months|Overall Study||9
10993698|NCT00659880|12169994|FG000|12 Months|Overall Study||7
10993699|NCT00659880|12169994|FG000|24 Months|Overall Study||6
10993700|NCT00659880|12169994|FG000|COMPLETED|Overall Study|60 months|4
10993701|NCT00659880|12169994|FG000|NOT COMPLETED|Overall Study||5
10993702|NCT00659945|12170001|FG000|STARTED|Overall Study||75
10993703|NCT00659945|12170002|FG001|STARTED|Overall Study||75
10993704|NCT00659945|12170001|FG000|COMPLETED|Overall Study||75
10993705|NCT00659945|12170002|FG001|COMPLETED|Overall Study||75
10993706|NCT00659945|12170001|FG000|NOT COMPLETED|Overall Study||0
10993707|NCT00659945|12170002|FG001|NOT COMPLETED|Overall Study||0
10993708|NCT00659984|12170008|FG000|STARTED|Overall Study||15
10993709|NCT00659984|12170008|FG000|COMPLETED|Overall Study||14
10993710|NCT00659984|12170008|FG000|NOT COMPLETED|Overall Study||1
10993711|NCT00660010|12170018|FG000|STARTED|Overall Study||55
10993712|NCT00660010|12170018|FG000|COMPLETED|Overall Study||46
10993713|NCT00660010|12170018|FG000|NOT COMPLETED|Overall Study||9
10993714|NCT00660023|12170022|FG000|STARTED|Overall Study||124
10993715|NCT00660023|12170022|FG000|Treated|Overall Study||114
10993716|NCT00660023|12170022|FG000|COMPLETED|Overall Study||95
10993717|NCT00660023|12170022|FG000|NOT COMPLETED|Overall Study||29
10993718|NCT00660049|12170026|FG000|STARTED|Overall Study||12
10993719|NCT00660049|12170026|FG000|COMPLETED|Overall Study||6
10993720|NCT00660049|12170026|FG000|NOT COMPLETED|Overall Study||6
10993721|NCT00660075|12170032|FG000|STARTED|First Intervention (Week 1 to Week 6)||18
10993722|NCT00660075|12170033|FG001|STARTED|First Intervention (Week 1 to Week 6)||18
10993723|NCT00660075|12170032|FG000|COMPLETED|First Intervention (Week 1 to Week 6)||18
10993724|NCT00660075|12170033|FG001|COMPLETED|First Intervention (Week 1 to Week 6)||18
10993725|NCT00660075|12170032|FG000|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
10993726|NCT00660075|12170033|FG001|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
10993727|NCT00660075|12170032|FG000|STARTED|Washout Period (Week 7 to Week 10)||18
10993728|NCT00660075|12170033|FG001|STARTED|Washout Period (Week 7 to Week 10)||18
10993729|NCT00660075|12170032|FG000|COMPLETED|Washout Period (Week 7 to Week 10)||18
10993730|NCT00660075|12170033|FG001|COMPLETED|Washout Period (Week 7 to Week 10)||18
10993731|NCT00660075|12170032|FG000|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
10993732|NCT00660075|12170033|FG001|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
10993733|NCT00660075|12170032|FG000|STARTED|Second Intervention (Week 11 to Week 16||18
10993734|NCT00660075|12170033|FG001|STARTED|Second Intervention (Week 11 to Week 16||18
10993735|NCT00660075|12170032|FG000|COMPLETED|Second Intervention (Week 11 to Week 16||18
10993736|NCT00660075|12170033|FG001|COMPLETED|Second Intervention (Week 11 to Week 16||18
10993737|NCT00660075|12170032|FG000|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
10993738|NCT00660075|12170033|FG001|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
10993739|NCT00660179|12170042|FG000|STARTED|Overall Study||250
10993740|NCT00660179|12170043|FG001|STARTED|Overall Study||250
10993741|NCT00660179|12170044|FG002|STARTED|Overall Study||242
10993742|NCT00660179|12170042|FG000|COMPLETED|Overall Study||194
10993743|NCT00660179|12170043|FG001|COMPLETED|Overall Study||192
10993744|NCT00660179|12170044|FG002|COMPLETED|Overall Study||201
10993745|NCT00660179|12170042|FG000|NOT COMPLETED|Overall Study||56
10993746|NCT00660179|12170043|FG001|NOT COMPLETED|Overall Study||58
10993747|NCT00660179|12170044|FG002|NOT COMPLETED|Overall Study||41
10993748|NCT00660192|12170054|FG000|STARTED|Overall Study||12
10993749|NCT00660192|12170055|FG001|STARTED|Overall Study||13
10993750|NCT00660192|12170054|FG000|COMPLETED|Overall Study||10
10993751|NCT00660192|12170055|FG001|COMPLETED|Overall Study||10
10993752|NCT00660192|12170054|FG000|NOT COMPLETED|Overall Study||2
10993753|NCT00660192|12170055|FG001|NOT COMPLETED|Overall Study||3
10993754|NCT00660309|12170063|FG000|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
10993755|NCT00660309|12170064|FG001|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
10993756|NCT00660309|12170063|FG000|Treated With Aliskiren or Irbesartan|Overall Study||22
10993757|NCT00660309|12170064|FG001|Treated With Aliskiren or Irbesartan|Overall Study||21
10993758|NCT00660309|12170063|FG000|Pharmacodynamic Analysis Set|Overall Study||22
10993759|NCT00660309|12170064|FG001|Pharmacodynamic Analysis Set|Overall Study||20
10993760|NCT00660309|12170063|FG000|COMPLETED|Overall Study||21
10993761|NCT00660309|12170064|FG001|COMPLETED|Overall Study||19
10993762|NCT00660309|12170063|FG000|NOT COMPLETED|Overall Study||2
10993763|NCT00660309|12170064|FG001|NOT COMPLETED|Overall Study||3
10993764|NCT00660387|12170073|FG000|STARTED|Overall Study||37
10993765|NCT00660387|12170074|FG001|STARTED|Overall Study||34
10993766|NCT00660387|12170073|FG000|COMPLETED|Overall Study||35
10993767|NCT00660387|12170074|FG001|COMPLETED|Overall Study||31
10993768|NCT00660387|12170073|FG000|NOT COMPLETED|Overall Study||2
10993769|NCT00660387|12170074|FG001|NOT COMPLETED|Overall Study||3
10993770|NCT00660400|12170080|FG000|STARTED|Overall Study||25
10993771|NCT00660400|12170080|FG000|COMPLETED|Overall Study||21
10993772|NCT00660400|12170080|FG000|NOT COMPLETED|Overall Study||4
10993773|NCT00660504|12170086|FG000|STARTED|Overall Study||149
10993774|NCT00660504|12170087|FG001|STARTED|Overall Study||151
10993775|NCT00660504|12170086|FG000|COMPLETED|Overall Study||149
10993776|NCT00660504|12170087|FG001|COMPLETED|Overall Study||150
10993777|NCT00660504|12170086|FG000|NOT COMPLETED|Overall Study||0
10993778|NCT00660504|12170087|FG001|NOT COMPLETED|Overall Study||1
10993779|NCT00660517|12170097|FG000|STARTED|Overall Study||153
10993780|NCT00660517|12170098|FG001|STARTED|Overall Study||152
10993781|NCT00660517|12170099|FG002|STARTED|Overall Study||151
10993782|NCT00660517|12170100|FG003|STARTED|Overall Study||151
10993783|NCT00660517|12170097|FG000|COMPLETED|Overall Study||145
10993784|NCT00660517|12170098|FG001|COMPLETED|Overall Study||144
10993785|NCT00660517|12170099|FG002|COMPLETED|Overall Study||144
10993786|NCT00660517|12170100|FG003|COMPLETED|Overall Study||144
10993787|NCT00660517|12170097|FG000|NOT COMPLETED|Overall Study||8
10993788|NCT00660517|12170098|FG001|NOT COMPLETED|Overall Study||8
10993789|NCT00660517|12170099|FG002|NOT COMPLETED|Overall Study||7
10993790|NCT00660517|12170100|FG003|NOT COMPLETED|Overall Study||7
10993791|NCT00660530|12170111|FG000|STARTED|Overall Study||11
10993792|NCT00660530|12170111|FG000|COMPLETED|Overall Study||11
10993793|NCT00660530|12170111|FG000|NOT COMPLETED|Overall Study||0
10993794|NCT00660543|12170117|FG000|STARTED|Overall Study||14
10993795|NCT00660543|12170117|FG000|COMPLETED|Overall Study||14
10993796|NCT00660543|12170117|FG000|NOT COMPLETED|Overall Study||0
10993797|NCT00660660|12170128|FG000|STARTED|Overall Study|Randomized|143
10993798|NCT00660660|12170129|FG001|STARTED|Overall Study|Randomized|133
10993799|NCT00660660|12170128|FG000|Met Criteria for MITT Population|Overall Study||137
10993800|NCT00660660|12170129|FG001|Met Criteria for MITT Population|Overall Study||125
10993801|NCT00660660|12170128|FG000|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
10993802|NCT00660660|12170129|FG001|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
10993803|NCT00660660|12170128|FG000|NOT COMPLETED|Overall Study||5
10993804|NCT00660660|12170129|FG001|NOT COMPLETED|Overall Study||9
10993805|NCT00660699|12170135|FG000|STARTED|Overall Study||50
10993806|NCT00660699|12170135|FG000|COMPLETED|Overall Study||48
10993807|NCT00660699|12170135|FG000|NOT COMPLETED|Overall Study||2
10993808|NCT00660790|12170139|FG000|STARTED|Baseline to 3 Months||97
10993809|NCT00660790|12170139|FG000|COMPLETED|Baseline to 3 Months||94
10993810|NCT00660790|12170139|FG000|NOT COMPLETED|Baseline to 3 Months||3
10993811|NCT00660790|12170139|FG000|STARTED|3 Months to 2 Years||94
10993812|NCT00660790|12170139|FG000|COMPLETED|3 Months to 2 Years||77
10993813|NCT00660790|12170139|FG000|NOT COMPLETED|3 Months to 2 Years||17
10993814|NCT00660816|12170145|FG000|STARTED|Overall Study||24
10993815|NCT00660816|12170146|FG001|STARTED|Overall Study||22
10993816|NCT00660816|12170145|FG000|COMPLETED|Overall Study||4
10993817|NCT00660816|12170146|FG001|COMPLETED|Overall Study||3
10993818|NCT00660816|12170145|FG000|NOT COMPLETED|Overall Study||20
10993819|NCT00660816|12170146|FG001|NOT COMPLETED|Overall Study||19
10993820|NCT00660829|12170154|FG000|STARTED|Overall Study|2 subjects were randomized in error|268
10993821|NCT00660829|12170155|FG001|STARTED|Overall Study|2 subjects were randomized in error|268
10993822|NCT00660829|12170154|FG000|COMPLETED|Overall Study||250
10993823|NCT00660829|12170155|FG001|COMPLETED|Overall Study||249
10993824|NCT00660829|12170154|FG000|NOT COMPLETED|Overall Study||18
10993825|NCT00660829|12170155|FG001|NOT COMPLETED|Overall Study||19
10993826|NCT00660907|12170163|FG000|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
10993827|NCT00660907|12170164|FG001|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
10993828|NCT00660907|12170163|FG000|COMPLETED|Overall Study||322
10993829|NCT00660907|12170164|FG001|COMPLETED|Overall Study||314
10993830|NCT00660907|12170163|FG000|NOT COMPLETED|Overall Study||84
10993831|NCT00660907|12170164|FG001|NOT COMPLETED|Overall Study||94
10993832|NCT00660985|12170172|FG000|STARTED|Overall Study||26
10993833|NCT00660985|12170173|FG001|STARTED|Overall Study||25
10993834|NCT00660985|12170172|FG000|COMPLETED|Overall Study||25
10993835|NCT00660985|12170173|FG001|COMPLETED|Overall Study||25
10993836|NCT00660985|12170172|FG000|NOT COMPLETED|Overall Study||1
10993837|NCT00660985|12170173|FG001|NOT COMPLETED|Overall Study||0
10993838|NCT00661037|12170181|FG000|STARTED|Overall Study||836
10993839|NCT00661037|12170182|FG001|STARTED|Overall Study||1284
10993840|NCT00661037|12170181|FG000|Witdrawn|Overall Study||47
10993841|NCT00661037|12170182|FG001|Witdrawn|Overall Study||68
10993842|NCT00661037|12170181|FG000|Deaths|Overall Study||108
10993843|NCT00661037|12170182|FG001|Deaths|Overall Study||188
10993844|NCT00661037|12170181|FG000|COMPLETED|Overall Study||682
10993845|NCT00661037|12170182|FG001|COMPLETED|Overall Study||1027
10993846|NCT00661037|12170181|FG000|NOT COMPLETED|Overall Study||154
10993847|NCT00661037|12170182|FG001|NOT COMPLETED|Overall Study||257
10993848|NCT00661089|12170192|FG000|STARTED|Overall Study||10
10993849|NCT00661089|12170193|FG001|STARTED|Overall Study||11
10993850|NCT00661089|12170192|FG000|COMPLETED|Overall Study||10
10993851|NCT00661089|12170193|FG001|COMPLETED|Overall Study||9
10993852|NCT00661089|12170192|FG000|NOT COMPLETED|Overall Study||0
10993853|NCT00661089|12170193|FG001|NOT COMPLETED|Overall Study||2
10993854|NCT00661141|12170203|FG000|STARTED|Overall Study||8
10993855|NCT00661141|12170204|FG001|STARTED|Overall Study||8
10993856|NCT00661141|12170205|FG002|STARTED|Overall Study||4
10993857|NCT00661141|12170206|FG003|STARTED|Overall Study||4
10993858|NCT00661141|12170207|FG004|STARTED|Overall Study||4
10993859|NCT00661141|12170208|FG005|STARTED|Overall Study||4
10993860|NCT00661141|12170203|FG000|Administered 30 Minutes Prior to Ethanol|Overall Study||6
10993861|NCT00661141|12170204|FG001|Administered 30 Minutes Prior to Ethanol|Overall Study||6
10993862|NCT00661141|12170205|FG002|Administered 30 Minutes Prior to Ethanol|Overall Study||2
10993863|NCT00661141|12170206|FG003|Administered 30 Minutes Prior to Ethanol|Overall Study||2
10993864|NCT00661141|12170207|FG004|Administered 30 Minutes Prior to Ethanol|Overall Study||4
10993865|NCT00661141|12170208|FG005|Administered 30 Minutes Prior to Ethanol|Overall Study||4
10993866|NCT00661141|12170203|FG000|Administered 30 Minutes After Ethanol|Overall Study||2
10993867|NCT00661141|12170204|FG001|Administered 30 Minutes After Ethanol|Overall Study||2
10993868|NCT00661141|12170205|FG002|Administered 30 Minutes After Ethanol|Overall Study||2
10993869|NCT00661141|12170206|FG003|Administered 30 Minutes After Ethanol|Overall Study||2
10993870|NCT00661141|12170207|FG004|Administered 30 Minutes After Ethanol|Overall Study||0
10993871|NCT00661141|12170208|FG005|Administered 30 Minutes After Ethanol|Overall Study||0
10993872|NCT00661141|12170203|FG000|COMPLETED|Overall Study||8
10993873|NCT00661141|12170204|FG001|COMPLETED|Overall Study||8
10993874|NCT00661141|12170205|FG002|COMPLETED|Overall Study||4
10993875|NCT00661141|12170206|FG003|COMPLETED|Overall Study||4
10993876|NCT00661141|12170207|FG004|COMPLETED|Overall Study||4
10993877|NCT00661141|12170208|FG005|COMPLETED|Overall Study||4
10993878|NCT00661141|12170203|FG000|NOT COMPLETED|Overall Study||0
10993879|NCT00661141|12170204|FG001|NOT COMPLETED|Overall Study||0
10993880|NCT00661141|12170205|FG002|NOT COMPLETED|Overall Study||0
10993881|NCT00661141|12170206|FG003|NOT COMPLETED|Overall Study||0
10993882|NCT00661141|12170207|FG004|NOT COMPLETED|Overall Study||0
10993883|NCT00661141|12170208|FG005|NOT COMPLETED|Overall Study||0
10993884|NCT00661193|12170229|FG000|STARTED|Overall Study||33
10993885|NCT00661193|12170230|FG001|STARTED|Overall Study||26
10993886|NCT00661193|12170229|FG000|COMPLETED|Overall Study||0
10993887|NCT00661193|12170230|FG001|COMPLETED|Overall Study||0
10993888|NCT00661193|12170229|FG000|NOT COMPLETED|Overall Study||33
10993889|NCT00661193|12170230|FG001|NOT COMPLETED|Overall Study||26
10993890|NCT00661258|12170238|FG000|STARTED|Overall Study||34
10993891|NCT00661258|12170239|FG001|STARTED|Overall Study||34
10993892|NCT00661258|12170238|FG000|COMPLETED|Overall Study||31
10993893|NCT00661258|12170239|FG001|COMPLETED|Overall Study||33
10993894|NCT00661258|12170238|FG000|NOT COMPLETED|Overall Study||3
10993895|NCT00661258|12170239|FG001|NOT COMPLETED|Overall Study||1
10993896|NCT00661271|12170247|FG000|STARTED|Overall Study||48
10993897|NCT00661271|12170248|FG001|STARTED|Overall Study||45
10993898|NCT00661271|12170247|FG000|COMPLETED|Overall Study||20
10993899|NCT00661271|12170248|FG001|COMPLETED|Overall Study||20
10993900|NCT00661271|12170247|FG000|NOT COMPLETED|Overall Study||28
10993901|NCT00661271|12170248|FG001|NOT COMPLETED|Overall Study||25
10993902|NCT00661362|12170256|FG000|STARTED|Overall Study|Randomized and treated|283
10993903|NCT00661362|12170257|FG001|STARTED|Overall Study|Randomized and treated|287
10993904|NCT00661362|12170256|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
10993905|NCT00661362|12170257|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
10993906|NCT00661362|12170256|FG000|NOT COMPLETED|Overall Study||29
10993907|NCT00661362|12170257|FG001|NOT COMPLETED|Overall Study||40
10993908|NCT00661388|12170263|FG000|STARTED|Overall Study||75
10993909|NCT00661388|12170263|FG000|COMPLETED|Overall Study||51
10993910|NCT00661388|12170263|FG000|NOT COMPLETED|Overall Study||24
10993911|NCT00661427|12170269|FG000|STARTED|Overall Study||35
10993912|NCT00661427|12170270|FG001|STARTED|Overall Study||26
10993913|NCT00661427|12170269|FG000|COMPLETED|Overall Study||30
10993914|NCT00661427|12170270|FG001|COMPLETED|Overall Study||19
10993915|NCT00661427|12170269|FG000|NOT COMPLETED|Overall Study||5
10993916|NCT00661427|12170270|FG001|NOT COMPLETED|Overall Study||7
10993917|NCT00661453|12170276|FG000|STARTED|Overall Study||38
10993918|NCT00661453|12170276|FG000|COMPLETED|Overall Study||25
10993919|NCT00661453|12170276|FG000|NOT COMPLETED|Overall Study||13
10993920|NCT00661479|12170284|FG000|STARTED|Overall Study||12
10993921|NCT00661479|12170285|FG001|STARTED|Overall Study||3
10993922|NCT00661479|12170286|FG002|STARTED|Overall Study||3
10993923|NCT00661479|12170287|FG003|STARTED|Overall Study||3
10993924|NCT00661479|12170284|FG000|COMPLETED|Overall Study||12
10993925|NCT00661479|12170285|FG001|COMPLETED|Overall Study||3
10993926|NCT00661479|12170286|FG002|COMPLETED|Overall Study||3
10993927|NCT00661479|12170287|FG003|COMPLETED|Overall Study||3
10993928|NCT00661479|12170284|FG000|NOT COMPLETED|Overall Study||0
10993929|NCT00661479|12170285|FG001|NOT COMPLETED|Overall Study||0
10993930|NCT00661479|12170286|FG002|NOT COMPLETED|Overall Study||0
10993931|NCT00661479|12170287|FG003|NOT COMPLETED|Overall Study||0
10993932|NCT00661492|12170298|FG000|STARTED|Overall Study||75
10993933|NCT00661492|12170299|FG001|STARTED|Overall Study||40
10993934|NCT00661492|12170298|FG000|COMPLETED|Overall Study||7
10993935|NCT00661492|12170299|FG001|COMPLETED|Overall Study||11
10993936|NCT00661492|12170298|FG000|NOT COMPLETED|Overall Study||68
10993937|NCT00661492|12170299|FG001|NOT COMPLETED|Overall Study||29
10993938|NCT00661505|12170305|FG000|STARTED|Overall Study||132
10993939|NCT00661505|12170305|FG000|COMPLETED|Overall Study||102
10993940|NCT00661505|12170305|FG000|NOT COMPLETED|Overall Study||30
10993941|NCT00661531|12170310|FG000|STARTED|Overall Study||11
10993942|NCT00661531|12170310|FG000|COMPLETED|Overall Study||8
10993943|NCT00661531|12170310|FG000|NOT COMPLETED|Overall Study||3
10993944|NCT00661544|12170314|FG000|STARTED|Overall Study||48
10993945|NCT00661544|12170314|FG000|COMPLETED|Overall Study||48
10993946|NCT00661544|12170314|FG000|NOT COMPLETED|Overall Study||0
10993947|NCT00661557|12170320|FG000|STARTED|Overall Study||192
10993948|NCT00661557|12170321|FG001|STARTED|Overall Study||79
10993949|NCT00661557|12170320|FG000|COMPLETED|Overall Study||183
10993950|NCT00661557|12170321|FG001|COMPLETED|Overall Study||79
10993951|NCT00661557|12170320|FG000|NOT COMPLETED|Overall Study||9
10993952|NCT00661557|12170321|FG001|NOT COMPLETED|Overall Study||0
10993953|NCT00661570|12170327|FG000|STARTED|Overall Study||26
10993954|NCT00661570|12170327|FG000|COMPLETED|Overall Study||26
10993955|NCT00661570|12170327|FG000|NOT COMPLETED|Overall Study||0
10993956|NCT00661583|12170334|FG000|STARTED|Overall Study||10
10993957|NCT00661583|12170335|FG001|STARTED|Overall Study||10
10993958|NCT00661583|12170336|FG002|STARTED|Overall Study||10
10993959|NCT00661583|12170334|FG000|COMPLETED|Overall Study||10
10993960|NCT00661583|12170335|FG001|COMPLETED|Overall Study||10
10993961|NCT00661583|12170336|FG002|COMPLETED|Overall Study||10
10993962|NCT00661583|12170334|FG000|NOT COMPLETED|Overall Study||0
10993963|NCT00661583|12170335|FG001|NOT COMPLETED|Overall Study||0
10993964|NCT00661583|12170336|FG002|NOT COMPLETED|Overall Study||0
10993965|NCT00661609|12170344|FG000|STARTED|Overall Study|All dosed patients|41
10993966|NCT00661609|12170344|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
10993967|NCT00661609|12170344|FG000|NOT COMPLETED|Overall Study||41
10993968|NCT00661622|12170350|FG000|STARTED|Overall Study||26
10993969|NCT00661622|12170351|FG001|STARTED|Overall Study||27
10993970|NCT00661622|12170350|FG000|COMPLETED|Overall Study||25
10993971|NCT00661622|12170351|FG001|COMPLETED|Overall Study||27
10993972|NCT00661622|12170350|FG000|NOT COMPLETED|Overall Study||1
10993973|NCT00661622|12170351|FG001|NOT COMPLETED|Overall Study||0
10993974|NCT00661661|12170360|FG000|STARTED|Overall Study||382
10993975|NCT00661661|12170361|FG001|STARTED|Overall Study||105
10993976|NCT00661661|12170360|FG000|COMPLETED|Overall Study||242
10993977|NCT00661661|12170361|FG001|COMPLETED|Overall Study||66
10993978|NCT00661661|12170360|FG000|NOT COMPLETED|Overall Study||140
10993979|NCT00661661|12170361|FG001|NOT COMPLETED|Overall Study||39
10993980|NCT00661674|12170369|FG000|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
10993981|NCT00661674|12170370|FG001|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
10993982|NCT00661674|12170371|FG002|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
10993983|NCT00661674|12170372|FG003|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
10993984|NCT00661674|12170373|FG004|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
10993985|NCT00661674|12170374|FG005|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
10993986|NCT00661674|12170369|FG000|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
10994076|NCT00662155|12170498|FG003|STARTED|Overall Study||18
10993987|NCT00661674|12170370|FG001|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
10993988|NCT00661674|12170371|FG002|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
10993989|NCT00661674|12170372|FG003|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
10993990|NCT00661674|12170373|FG004|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
10993991|NCT00661674|12170374|FG005|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
10993992|NCT00661674|12170369|FG000|NOT COMPLETED|Overall Study||0
10993993|NCT00661674|12170370|FG001|NOT COMPLETED|Overall Study||0
10993994|NCT00661674|12170371|FG002|NOT COMPLETED|Overall Study||0
10993995|NCT00661674|12170372|FG003|NOT COMPLETED|Overall Study||0
10993996|NCT00661674|12170373|FG004|NOT COMPLETED|Overall Study||0
10993997|NCT00661674|12170374|FG005|NOT COMPLETED|Overall Study||0
10993998|NCT00661687|12170382|FG000|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
10993999|NCT00661687|12170382|FG000|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
10994000|NCT00661687|12170382|FG000|NOT COMPLETED|Overall Study||15
10994001|NCT00661713|12170396|FG000|STARTED|Overall Study||128
10994002|NCT00661713|12170397|FG001|STARTED|Overall Study||247
10994003|NCT00661713|12170398|FG002|STARTED|Overall Study||128
10994004|NCT00661713|12170399|FG003|STARTED|Overall Study||247
10994005|NCT00661713|12170400|FG004|STARTED|Overall Study||127
10994006|NCT00661713|12170401|FG005|STARTED|Overall Study||253
10994007|NCT00661713|12170402|FG006|STARTED|Overall Study||373
10994008|NCT00661713|12170403|FG007|STARTED|Overall Study||128
10994009|NCT00661713|12170396|FG000|COMPLETED|Overall Study||112
10994010|NCT00661713|12170397|FG001|COMPLETED|Overall Study||208
10994011|NCT00661713|12170398|FG002|COMPLETED|Overall Study||111
10994012|NCT00661713|12170399|FG003|COMPLETED|Overall Study||219
10994013|NCT00661713|12170400|FG004|COMPLETED|Overall Study||107
10994014|NCT00661713|12170401|FG005|COMPLETED|Overall Study||216
10994015|NCT00661713|12170402|FG006|COMPLETED|Overall Study||309
10994016|NCT00661713|12170403|FG007|COMPLETED|Overall Study||117
10994017|NCT00661713|12170396|FG000|NOT COMPLETED|Overall Study||16
10994018|NCT00661713|12170397|FG001|NOT COMPLETED|Overall Study||39
10994019|NCT00661713|12170398|FG002|NOT COMPLETED|Overall Study||17
10994020|NCT00661713|12170399|FG003|NOT COMPLETED|Overall Study||28
10994021|NCT00661713|12170400|FG004|NOT COMPLETED|Overall Study||20
10994022|NCT00661713|12170401|FG005|NOT COMPLETED|Overall Study||37
10994023|NCT00661713|12170402|FG006|NOT COMPLETED|Overall Study||64
10994024|NCT00661713|12170403|FG007|NOT COMPLETED|Overall Study||11
10994025|NCT00661726|12170423|FG000|STARTED|Overall Study||6
10994026|NCT00661726|12170423|FG000|COMPLETED|Overall Study||5
10994027|NCT00661726|12170423|FG000|NOT COMPLETED|Overall Study||1
10994028|NCT00661778|12170427|FG000|STARTED|Overall Study||50
10994029|NCT00661778|12170427|FG000|COMPLETED|Overall Study||0
10994030|NCT00661778|12170427|FG000|NOT COMPLETED|Overall Study||50
10994031|NCT00661830|12170433|FG000|STARTED|Overall Study||49
10994032|NCT00661830|12170434|FG001|STARTED|Overall Study||48
10994033|NCT00661830|12170433|FG000|COMPLETED|Overall Study||9
10994034|NCT00661830|12170434|FG001|COMPLETED|Overall Study||6
10994035|NCT00661830|12170433|FG000|NOT COMPLETED|Overall Study||40
10994036|NCT00661830|12170434|FG001|NOT COMPLETED|Overall Study||42
10994037|NCT00661895|12170442|FG000|STARTED|Overall Study||49
10994038|NCT00661895|12170443|FG001|STARTED|Overall Study||50
10994039|NCT00661895|12170442|FG000|COMPLETED|Overall Study||49
10994040|NCT00661895|12170443|FG001|COMPLETED|Overall Study||50
10994041|NCT00661895|12170442|FG000|NOT COMPLETED|Overall Study||0
10994042|NCT00661895|12170443|FG001|NOT COMPLETED|Overall Study||0
10994043|NCT00661960|12170452|FG000|STARTED|Overall Study||5
10994044|NCT00661960|12170453|FG001|STARTED|Overall Study||10
10994045|NCT00661960|12170454|FG002|STARTED|Overall Study||10
10994046|NCT00661960|12170452|FG000|COMPLETED|Overall Study||5
10994047|NCT00661960|12170453|FG001|COMPLETED|Overall Study||7
10994048|NCT00661960|12170454|FG002|COMPLETED|Overall Study||9
10994049|NCT00661960|12170452|FG000|NOT COMPLETED|Overall Study||0
10994050|NCT00661960|12170453|FG001|NOT COMPLETED|Overall Study||3
10994051|NCT00661960|12170454|FG002|NOT COMPLETED|Overall Study||1
10994052|NCT00661999|12170465|FG000|STARTED|Overall Study||164
10994053|NCT00661999|12170466|FG001|STARTED|Overall Study||163
10994054|NCT00661999|12170467|FG002|STARTED|Overall Study||163
10994055|NCT00661999|12170465|FG000|COMPLETED|Overall Study||105
10994056|NCT00661999|12170466|FG001|COMPLETED|Overall Study||113
10994057|NCT00661999|12170467|FG002|COMPLETED|Overall Study||106
10994058|NCT00661999|12170465|FG000|NOT COMPLETED|Overall Study||59
10994059|NCT00661999|12170466|FG001|NOT COMPLETED|Overall Study||50
10994060|NCT00661999|12170467|FG002|NOT COMPLETED|Overall Study||57
10994061|NCT00662012|12170475|FG000|STARTED|Overall Study||414
10994062|NCT00662012|12170475|FG000|COMPLETED|Overall Study||327
10994063|NCT00662012|12170475|FG000|NOT COMPLETED|Overall Study||87
10994064|NCT00662025|12170479|FG000|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
10994065|NCT00662025|12170479|FG000|COMPLETED|Overall Study||0
10994066|NCT00662025|12170479|FG000|NOT COMPLETED|Overall Study||63
10994067|NCT00662038|12170483|FG000|STARTED|Overall Study||1058
10994068|NCT00662038|12170483|FG000|COMPLETED|Overall Study||427
10994069|NCT00662038|12170483|FG000|NOT COMPLETED|Overall Study||631
10994070|NCT00662129|12170487|FG000|STARTED|Overall Study||50
10994071|NCT00662129|12170487|FG000|COMPLETED|Overall Study||47
10994072|NCT00662129|12170487|FG000|NOT COMPLETED|Overall Study||3
10994073|NCT00662155|12170495|FG000|STARTED|Overall Study||16
10994074|NCT00662155|12170496|FG001|STARTED|Overall Study||20
10994075|NCT00662155|12170497|FG002|STARTED|Overall Study||20
10994077|NCT00662155|12170495|FG000|COMPLETED|Overall Study||13
10994078|NCT00662155|12170496|FG001|COMPLETED|Overall Study||15
10994079|NCT00662155|12170497|FG002|COMPLETED|Overall Study||13
10994080|NCT00662155|12170498|FG003|COMPLETED|Overall Study||14
10994081|NCT00662155|12170495|FG000|NOT COMPLETED|Overall Study||3
10994082|NCT00662155|12170496|FG001|NOT COMPLETED|Overall Study||5
10994083|NCT00662155|12170497|FG002|NOT COMPLETED|Overall Study||7
10994084|NCT00662155|12170498|FG003|NOT COMPLETED|Overall Study||4
10994085|NCT00662207|12170508|FG000|STARTED|Overall Study||3
10994086|NCT00662207|12170508|FG000|COMPLETED|Overall Study||3
10994087|NCT00662207|12170508|FG000|NOT COMPLETED|Overall Study||0
10994088|NCT00662259|12170514|FG000|STARTED|Overall Study||21
10994089|NCT00662259|12170515|FG001|STARTED|Overall Study||11
10994090|NCT00662259|12170514|FG000|COMPLETED|Overall Study||19
10994091|NCT00662259|12170515|FG001|COMPLETED|Overall Study||11
10994092|NCT00662259|12170514|FG000|NOT COMPLETED|Overall Study||2
10994093|NCT00662259|12170515|FG001|NOT COMPLETED|Overall Study||0
10994094|NCT00662298|12170521|FG000|STARTED|Overall Study||5
10994095|NCT00662298|12170521|FG000|COMPLETED|Overall Study||5
10994096|NCT00662298|12170521|FG000|NOT COMPLETED|Overall Study||0
10994097|NCT00662311|12170528|FG000|STARTED|Overall Study||5
10994098|NCT00662311|12170529|FG001|STARTED|Overall Study||0
10994099|NCT00662311|12170530|FG002|STARTED|Overall Study||0
10994100|NCT00662311|12170528|FG000|COMPLETED|Overall Study||4
10994101|NCT00662311|12170529|FG001|COMPLETED|Overall Study||0
10994102|NCT00662311|12170530|FG002|COMPLETED|Overall Study||0
10994103|NCT00662311|12170528|FG000|NOT COMPLETED|Overall Study||1
10994104|NCT00662311|12170529|FG001|NOT COMPLETED|Overall Study||0
10994105|NCT00662311|12170530|FG002|NOT COMPLETED|Overall Study||0
10994106|NCT00662363|12170540|FG000|STARTED|Overall Study||32
10994107|NCT00662363|12170541|FG001|STARTED|Overall Study||32
10994108|NCT00662363|12170540|FG000|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
10994109|NCT00662363|12170541|FG001|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
10994110|NCT00662363|12170540|FG000|NOT COMPLETED|Overall Study||11
10994111|NCT00662363|12170541|FG001|NOT COMPLETED|Overall Study||10
10994112|NCT00662532|12170551|FG000|STARTED|Overall Study||22
10994113|NCT00662532|12170552|FG001|STARTED|Overall Study||22
10994114|NCT00662532|12170551|FG000|COMPLETED|Overall Study||22
10994115|NCT00662532|12170552|FG001|COMPLETED|Overall Study||20
10994116|NCT00662532|12170551|FG000|NOT COMPLETED|Overall Study||0
10994117|NCT00662532|12170552|FG001|NOT COMPLETED|Overall Study||2
10994118|NCT00662545|12170560|FG000|STARTED|Overall Study||5
10994119|NCT00662545|12170561|FG001|STARTED|Overall Study||5
10994120|NCT00662545|12170560|FG000|COMPLETED|Overall Study||5
10994121|NCT00662545|12170561|FG001|COMPLETED|Overall Study||5
10994122|NCT00662545|12170560|FG000|NOT COMPLETED|Overall Study||0
10994123|NCT00662545|12170561|FG001|NOT COMPLETED|Overall Study||0
10994124|NCT00662558|12170569|FG000|STARTED|Overall Study||398
10994125|NCT00662558|12170570|FG001|STARTED|Overall Study||404
10994126|NCT00662558|12170569|FG000|Received Treatment|Overall Study||396
10994127|NCT00662558|12170570|FG001|Received Treatment|Overall Study||396
10994128|NCT00662558|12170569|FG000|COMPLETED|Overall Study||342
10994129|NCT00662558|12170570|FG001|COMPLETED|Overall Study||294
10994130|NCT00662558|12170569|FG000|NOT COMPLETED|Overall Study||56
10994131|NCT00662558|12170570|FG001|NOT COMPLETED|Overall Study||110
10994132|NCT00662649|12170580|FG000|STARTED|Core Study (24 Months)||429
10994133|NCT00662649|12170581|FG001|STARTED|Core Study (24 Months)||425
10994134|NCT00662649|12170582|FG002|STARTED|Core Study (24 Months)||418
10994135|NCT00662649|12170583|FG003|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
10994136|NCT00662649|12170584|FG004|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
10994137|NCT00662649|12170580|FG000|Intent to Treat (ITT)|Core Study (24 Months)||429
10994138|NCT00662649|12170581|FG001|Intent to Treat (ITT)|Core Study (24 Months)||425
10994139|NCT00662649|12170582|FG002|Intent to Treat (ITT)|Core Study (24 Months)||418
10994140|NCT00662649|12170583|FG003|Intent to Treat (ITT)|Core Study (24 Months)||0
10994141|NCT00662649|12170584|FG004|Intent to Treat (ITT)|Core Study (24 Months)||0
10994142|NCT00662649|12170580|FG000|COMPLETED|Core Study (24 Months)||332
10994143|NCT00662649|12170581|FG001|COMPLETED|Core Study (24 Months)||369
10994144|NCT00662649|12170582|FG002|COMPLETED|Core Study (24 Months)||332
10994145|NCT00662649|12170583|FG003|COMPLETED|Core Study (24 Months)||0
10994146|NCT00662649|12170584|FG004|COMPLETED|Core Study (24 Months)||0
10994147|NCT00662649|12170580|FG000|NOT COMPLETED|Core Study (24 Months)||97
10994148|NCT00662649|12170581|FG001|NOT COMPLETED|Core Study (24 Months)||56
10994149|NCT00662649|12170582|FG002|NOT COMPLETED|Core Study (24 Months)||86
10994150|NCT00662649|12170583|FG003|NOT COMPLETED|Core Study (24 Months)||0
10994151|NCT00662649|12170584|FG004|NOT COMPLETED|Core Study (24 Months)||0
10994152|NCT00662649|12170580|FG000|STARTED|Extension Study (Month 24 to 60)||289
10994153|NCT00662649|12170581|FG001|STARTED|Extension Study (Month 24 to 60)||331
10994154|NCT00662649|12170582|FG002|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
10994155|NCT00662649|12170583|FG003|STARTED|Extension Study (Month 24 to 60)||145
10994156|NCT00662649|12170584|FG004|STARTED|Extension Study (Month 24 to 60)||155
10994157|NCT00662649|12170580|FG000|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
10994158|NCT00662649|12170581|FG001|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
10994159|NCT00662649|12170582|FG002|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
10994160|NCT00662649|12170583|FG003|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
10994161|NCT00662649|12170584|FG004|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
10994162|NCT00662649|12170580|FG000|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
10994163|NCT00662649|12170581|FG001|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
10994164|NCT00662649|12170582|FG002|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
10994165|NCT00662649|12170583|FG003|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
10994166|NCT00662649|12170584|FG004|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
10994167|NCT00662649|12170580|FG000|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
10994168|NCT00662649|12170581|FG001|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
10994169|NCT00662649|12170582|FG002|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
10994170|NCT00662649|12170583|FG003|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
10994171|NCT00662649|12170584|FG004|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
10994172|NCT00662649|12170580|FG000|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
10994173|NCT00662649|12170581|FG001|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
10994174|NCT00662649|12170582|FG002|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
10994175|NCT00662649|12170583|FG003|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
10994176|NCT00662649|12170584|FG004|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
10994177|NCT00662649|12170580|FG000|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
10994178|NCT00662649|12170581|FG001|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
10994179|NCT00662649|12170582|FG002|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
10994180|NCT00662649|12170583|FG003|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
10994181|NCT00662649|12170584|FG004|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
10994182|NCT00662649|12170580|FG000|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
10994183|NCT00662649|12170581|FG001|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
10994184|NCT00662649|12170582|FG002|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
10994185|NCT00662649|12170583|FG003|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
10994186|NCT00662649|12170584|FG004|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
10994187|NCT00662649|12170580|FG000|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
10994188|NCT00662649|12170581|FG001|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
10994189|NCT00662649|12170582|FG002|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
10994190|NCT00662649|12170583|FG003|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
10994191|NCT00662649|12170584|FG004|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
10994192|NCT00662649|12170580|FG000|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
10994193|NCT00662649|12170581|FG001|COMPLETED|Extension Study (Month 24 to 60)||290
10994194|NCT00662649|12170582|FG002|COMPLETED|Extension Study (Month 24 to 60)||0
10994195|NCT00662649|12170583|FG003|COMPLETED|Extension Study (Month 24 to 60)||112
10994196|NCT00662649|12170584|FG004|COMPLETED|Extension Study (Month 24 to 60)||126
10994197|NCT00662649|12170580|FG000|NOT COMPLETED|Extension Study (Month 24 to 60)||44
10994198|NCT00662649|12170581|FG001|NOT COMPLETED|Extension Study (Month 24 to 60)||41
10994199|NCT00662649|12170582|FG002|NOT COMPLETED|Extension Study (Month 24 to 60)||0
10994200|NCT00662649|12170583|FG003|NOT COMPLETED|Extension Study (Month 24 to 60)||33
10994201|NCT00662649|12170584|FG004|NOT COMPLETED|Extension Study (Month 24 to 60)||29
10994202|NCT00662675|12170600|FG000|STARTED|Overall Study||20
10994203|NCT00662675|12170601|FG001|STARTED|Overall Study||20
10994204|NCT00662675|12170600|FG000|COMPLETED|Overall Study||20
10994205|NCT00662675|12170601|FG001|COMPLETED|Overall Study||20
10994206|NCT00662675|12170600|FG000|NOT COMPLETED|Overall Study||0
10994207|NCT00662675|12170601|FG001|NOT COMPLETED|Overall Study||0
10994208|NCT00662818|12170609|FG000|STARTED|Period 1 (6 Weeks)||84
10994209|NCT00662818|12170610|FG001|STARTED|Period 1 (6 Weeks)||81
10994210|NCT00662818|12170609|FG000|Treated|Period 1 (6 Weeks)||56
10994211|NCT00662818|12170610|FG001|Treated|Period 1 (6 Weeks)||58
10994212|NCT00662818|12170609|FG000|COMPLETED|Period 1 (6 Weeks)||56
10994213|NCT00662818|12170610|FG001|COMPLETED|Period 1 (6 Weeks)||58
10994214|NCT00662818|12170609|FG000|NOT COMPLETED|Period 1 (6 Weeks)||28
10994215|NCT00662818|12170610|FG001|NOT COMPLETED|Period 1 (6 Weeks)||23
10994216|NCT00662818|12170609|FG000|STARTED|Wash-Out (14 Days)||56
10994217|NCT00662818|12170610|FG001|STARTED|Wash-Out (14 Days)||58
10994218|NCT00662818|12170609|FG000|COMPLETED|Wash-Out (14 Days)||51
10994219|NCT00662818|12170610|FG001|COMPLETED|Wash-Out (14 Days)||53
10994220|NCT00662818|12170609|FG000|NOT COMPLETED|Wash-Out (14 Days)||5
10994221|NCT00662818|12170610|FG001|NOT COMPLETED|Wash-Out (14 Days)||5
10994222|NCT00662818|12170609|FG000|STARTED|Period 2 (6 Weeks)||51
10994223|NCT00662818|12170610|FG001|STARTED|Period 2 (6 Weeks)||53
10994224|NCT00662818|12170609|FG000|COMPLETED|Period 2 (6 Weeks)||38
10994225|NCT00662818|12170610|FG001|COMPLETED|Period 2 (6 Weeks)||41
10994226|NCT00662818|12170609|FG000|NOT COMPLETED|Period 2 (6 Weeks)||13
10994227|NCT00662818|12170610|FG001|NOT COMPLETED|Period 2 (6 Weeks)||12
10994228|NCT00662831|12170620|FG000|STARTED|Overall Study||184
10994229|NCT00662831|12170621|FG001|STARTED|Overall Study||92
10994230|NCT00662831|12170620|FG000|COMPLETED|Overall Study||78
10994231|NCT00662831|12170621|FG001|COMPLETED|Overall Study||33
10994232|NCT00662831|12170620|FG000|NOT COMPLETED|Overall Study||106
10994233|NCT00662831|12170621|FG001|NOT COMPLETED|Overall Study||59
10994234|NCT00662857|12170627|FG000|STARTED|TI Dosing Period 1 (1 Day)||13
10994235|NCT00662857|12170628|FG001|STARTED|TI Dosing Period 1 (1 Day)||16
10994236|NCT00662857|12170627|FG000|COMPLETED|TI Dosing Period 1 (1 Day)||13
10994237|NCT00662857|12170628|FG001|COMPLETED|TI Dosing Period 1 (1 Day)||16
10994238|NCT00662857|12170627|FG000|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
10994239|NCT00662857|12170628|FG001|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
10994240|NCT00662857|12170627|FG000|STARTED|Washout 1 (3 - 14 Days)||13
10994241|NCT00662857|12170628|FG001|STARTED|Washout 1 (3 - 14 Days)||16
10994242|NCT00662857|12170627|FG000|COMPLETED|Washout 1 (3 - 14 Days)||13
10994243|NCT00662857|12170628|FG001|COMPLETED|Washout 1 (3 - 14 Days)||14
10994244|NCT00662857|12170627|FG000|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
10994245|NCT00662857|12170628|FG001|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
10994246|NCT00662857|12170627|FG000|STARTED|TI Dosing Period 2 (1 Day)||13
10994247|NCT00662857|12170628|FG001|STARTED|TI Dosing Period 2 (1 Day)||14
10994248|NCT00662857|12170627|FG000|COMPLETED|TI Dosing Period 2 (1 Day)||13
10994249|NCT00662857|12170628|FG001|COMPLETED|TI Dosing Period 2 (1 Day)||14
10994250|NCT00662857|12170627|FG000|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
10994251|NCT00662857|12170628|FG001|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
10994252|NCT00662857|12170627|FG000|STARTED|Washout 2 (3 - 14 Days)||13
10994253|NCT00662857|12170628|FG001|STARTED|Washout 2 (3 - 14 Days)||14
10994254|NCT00662857|12170627|FG000|COMPLETED|Washout 2 (3 - 14 Days)||12
10994255|NCT00662857|12170628|FG001|COMPLETED|Washout 2 (3 - 14 Days)||14
10994256|NCT00662857|12170627|FG000|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
10994257|NCT00662857|12170628|FG001|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
10994258|NCT00662857|12170627|FG000|STARTED|Lispro Dosing Period (1 Day)||12
10994259|NCT00662857|12170628|FG001|STARTED|Lispro Dosing Period (1 Day)||14
10994260|NCT00662857|12170627|FG000|COMPLETED|Lispro Dosing Period (1 Day)||12
10994261|NCT00662857|12170628|FG001|COMPLETED|Lispro Dosing Period (1 Day)||14
10994262|NCT00662857|12170627|FG000|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
10994263|NCT00662857|12170628|FG001|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
10994264|NCT00662909|12170640|FG000|STARTED|Overall Study||454
10994265|NCT00662909|12170641|FG001|STARTED|Overall Study||442
10994266|NCT00662909|12170642|FG002|STARTED|Overall Study||433
10994267|NCT00662909|12170640|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
10994268|NCT00662909|12170641|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
10994269|NCT00662909|12170642|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
10994270|NCT00662909|12170640|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
10994271|NCT00662909|12170641|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
10994272|NCT00662909|12170642|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
10994273|NCT00662909|12170640|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
10994274|NCT00662909|12170641|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
10994275|NCT00662909|12170642|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
10994276|NCT00662909|12170640|FG000|COMPLETED|Overall Study||385
10994277|NCT00662909|12170641|FG001|COMPLETED|Overall Study||383
10994278|NCT00662909|12170642|FG002|COMPLETED|Overall Study||380
10994279|NCT00662909|12170640|FG000|NOT COMPLETED|Overall Study||69
10994280|NCT00662909|12170641|FG001|NOT COMPLETED|Overall Study||59
10994281|NCT00662909|12170642|FG002|NOT COMPLETED|Overall Study||53
10994282|NCT00663026|12170653|FG000|STARTED|Overall Study||19
10994283|NCT00663026|12170654|FG001|STARTED|Overall Study||29
10994284|NCT00663026|12170655|FG002|STARTED|Overall Study||31
10994285|NCT00663026|12170653|FG000|COMPLETED|Overall Study||17
10994286|NCT00663026|12170654|FG001|COMPLETED|Overall Study||23
10994287|NCT00663026|12170655|FG002|COMPLETED|Overall Study||27
10994288|NCT00663026|12170653|FG000|NOT COMPLETED|Overall Study||2
10994289|NCT00663026|12170654|FG001|NOT COMPLETED|Overall Study||6
10994290|NCT00663026|12170655|FG002|NOT COMPLETED|Overall Study||4
10994291|NCT00663039|12170665|FG000|STARTED|Overall Study||14
10994292|NCT00663039|12170666|FG001|STARTED|Overall Study||13
10994293|NCT00663039|12170665|FG000|COMPLETED|Overall Study||10
10994294|NCT00663039|12170666|FG001|COMPLETED|Overall Study||9
10994295|NCT00663039|12170665|FG000|NOT COMPLETED|Overall Study||4
10994296|NCT00663039|12170666|FG001|NOT COMPLETED|Overall Study||4
10994297|NCT00663117|12170674|FG000|STARTED|Overall Study||20
10994298|NCT00663117|12170675|FG001|STARTED|Overall Study||20
10994299|NCT00663117|12170674|FG000|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
10994300|NCT00663117|12170675|FG001|COMPLETED|Overall Study||20
10994301|NCT00663117|12170674|FG000|NOT COMPLETED|Overall Study||1
10994302|NCT00663117|12170675|FG001|NOT COMPLETED|Overall Study||0
10994303|NCT00663169|12170689|FG000|STARTED|Overall Study||3
10994304|NCT00663169|12170690|FG001|STARTED|Overall Study||3
10994305|NCT00663169|12170689|FG000|COMPLETED|Overall Study||3
10994306|NCT00663169|12170690|FG001|COMPLETED|Overall Study||3
10994307|NCT00663169|12170689|FG000|NOT COMPLETED|Overall Study||0
10994308|NCT00663169|12170690|FG001|NOT COMPLETED|Overall Study||0
10994309|NCT00663208|12170703|FG000|STARTED|Treatment Period||4
10994310|NCT00663208|12170704|FG001|STARTED|Treatment Period||4
10994311|NCT00663208|12170705|FG002|STARTED|Treatment Period||4
10994312|NCT00663208|12170706|FG003|STARTED|Treatment Period||4
10994313|NCT00663208|12170707|FG004|STARTED|Treatment Period||4
10994314|NCT00663208|12170708|FG005|STARTED|Treatment Period||4
10994315|NCT00663208|12170709|FG006|STARTED|Treatment Period||6
10994316|NCT00663208|12170703|FG000|COMPLETED|Treatment Period||4
10994317|NCT00663208|12170704|FG001|COMPLETED|Treatment Period||3
10994318|NCT00663208|12170705|FG002|COMPLETED|Treatment Period||4
10994319|NCT00663208|12170706|FG003|COMPLETED|Treatment Period||4
10994320|NCT00663208|12170707|FG004|COMPLETED|Treatment Period||4
10994321|NCT00663208|12170708|FG005|COMPLETED|Treatment Period||4
10994322|NCT00663208|12170709|FG006|COMPLETED|Treatment Period||6
10994323|NCT00663208|12170703|FG000|NOT COMPLETED|Treatment Period||0
10994324|NCT00663208|12170704|FG001|NOT COMPLETED|Treatment Period||1
10994325|NCT00663208|12170705|FG002|NOT COMPLETED|Treatment Period||0
10994326|NCT00663208|12170706|FG003|NOT COMPLETED|Treatment Period||0
10994327|NCT00663208|12170707|FG004|NOT COMPLETED|Treatment Period||0
10994328|NCT00663208|12170708|FG005|NOT COMPLETED|Treatment Period||0
10994329|NCT00663208|12170709|FG006|NOT COMPLETED|Treatment Period||0
10994330|NCT00663208|12170703|FG000|STARTED|Follow-up Period||4
10994331|NCT00663208|12170704|FG001|STARTED|Follow-up Period||3
10994332|NCT00663208|12170705|FG002|STARTED|Follow-up Period||4
10994333|NCT00663208|12170706|FG003|STARTED|Follow-up Period||4
10994334|NCT00663208|12170707|FG004|STARTED|Follow-up Period||4
10994335|NCT00663208|12170708|FG005|STARTED|Follow-up Period||4
10994336|NCT00663208|12170709|FG006|STARTED|Follow-up Period||6
10994337|NCT00663208|12170703|FG000|COMPLETED|Follow-up Period||1
10994338|NCT00663208|12170704|FG001|COMPLETED|Follow-up Period||3
10994339|NCT00663208|12170705|FG002|COMPLETED|Follow-up Period||1
10994340|NCT00663208|12170706|FG003|COMPLETED|Follow-up Period||2
10994341|NCT00663208|12170707|FG004|COMPLETED|Follow-up Period||4
10994342|NCT00663208|12170708|FG005|COMPLETED|Follow-up Period||4
10994343|NCT00663208|12170709|FG006|COMPLETED|Follow-up Period||5
10994344|NCT00663208|12170703|FG000|NOT COMPLETED|Follow-up Period||3
10994345|NCT00663208|12170704|FG001|NOT COMPLETED|Follow-up Period||0
10994346|NCT00663208|12170705|FG002|NOT COMPLETED|Follow-up Period||3
10994347|NCT00663208|12170706|FG003|NOT COMPLETED|Follow-up Period||2
10994348|NCT00663208|12170707|FG004|NOT COMPLETED|Follow-up Period||0
10994349|NCT00663208|12170708|FG005|NOT COMPLETED|Follow-up Period||0
10994350|NCT00663208|12170709|FG006|NOT COMPLETED|Follow-up Period||1
10994351|NCT00663234|12170727|FG000|STARTED|Overall Study||28
10994352|NCT00663234|12170727|FG000|Dose Increased to 20 mg at Week 8|Overall Study||10
10994353|NCT00663234|12170727|FG000|COMPLETED|Overall Study||27
10994354|NCT00663234|12170727|FG000|NOT COMPLETED|Overall Study||1
10994355|NCT00663260|12170738|FG000|STARTED|Overall Study||84
10994356|NCT00663260|12170739|FG001|STARTED|Overall Study||83
10994357|NCT00663260|12170740|FG002|STARTED|Overall Study||85
10994358|NCT00663260|12170738|FG000|COMPLETED|Overall Study||63
10994359|NCT00663260|12170739|FG001|COMPLETED|Overall Study||72
10994360|NCT00663260|12170740|FG002|COMPLETED|Overall Study||69
10994361|NCT00663260|12170738|FG000|NOT COMPLETED|Overall Study||21
10994362|NCT00663260|12170739|FG001|NOT COMPLETED|Overall Study||11
10994363|NCT00663260|12170740|FG002|NOT COMPLETED|Overall Study||16
10994364|NCT00663403|12170748|FG000|STARTED|Overall Study||8
10994365|NCT00663403|12170748|FG000|COMPLETED|Overall Study||8
10994366|NCT00663403|12170748|FG000|NOT COMPLETED|Overall Study||0
10994367|NCT00663702|12170754|FG000|STARTED|Overall Study||52
10994368|NCT00663702|12170755|FG001|STARTED|Overall Study||71
10994369|NCT00663702|12170754|FG000|COMPLETED|Overall Study||34
10994370|NCT00663702|12170755|FG001|COMPLETED|Overall Study||61
10994371|NCT00663702|12170754|FG000|NOT COMPLETED|Overall Study||18
10994372|NCT00663702|12170755|FG001|NOT COMPLETED|Overall Study||10
10994373|NCT00663793|12170763|FG000|STARTED|Overall Study||8
10994374|NCT00663793|12170764|FG001|STARTED|Overall Study||8
10994375|NCT00663793|12170763|FG000|COMPLETED|Overall Study||8
10994376|NCT00663793|12170764|FG001|COMPLETED|Overall Study||8
10994377|NCT00663793|12170763|FG000|NOT COMPLETED|Overall Study||0
10994378|NCT00663793|12170764|FG001|NOT COMPLETED|Overall Study||0
10994379|NCT00663819|12170772|FG000|STARTED|Overall Study||123
10994380|NCT00663819|12170773|FG001|STARTED|Overall Study||135
10994381|NCT00663819|12170772|FG000|COMPLETED|Overall Study||123
10994382|NCT00663819|12170773|FG001|COMPLETED|Overall Study||135
10994383|NCT00663819|12170772|FG000|NOT COMPLETED|Overall Study||0
10994384|NCT00663819|12170773|FG001|NOT COMPLETED|Overall Study||0
10994385|NCT00663858|12170784|FG000|STARTED|Overall Study||212
10994386|NCT00663858|12170785|FG001|STARTED|Overall Study||106
10994387|NCT00663858|12170786|FG002|STARTED|Overall Study||102
10994388|NCT00663858|12170784|FG000|COMPLETED|Overall Study||178
10994389|NCT00663858|12170785|FG001|COMPLETED|Overall Study||96
10994390|NCT00663858|12170786|FG002|COMPLETED|Overall Study||82
10994391|NCT00663858|12170784|FG000|NOT COMPLETED|Overall Study||34
10994392|NCT00663858|12170785|FG001|NOT COMPLETED|Overall Study||10
10994393|NCT00663858|12170786|FG002|NOT COMPLETED|Overall Study||20
10994394|NCT00663871|12170796|FG000|STARTED|Overall Study||134
10994395|NCT00663871|12170797|FG001|STARTED|Overall Study||138
10994396|NCT00663871|12170796|FG000|COMPLETED|Overall Study||124
10994397|NCT00663871|12170797|FG001|COMPLETED|Overall Study||131
10994398|NCT00663871|12170796|FG000|NOT COMPLETED|Overall Study||10
10994399|NCT00663871|12170797|FG001|NOT COMPLETED|Overall Study||7
10994400|NCT00663923|12170805|FG000|STARTED|Overall Study||50
10994401|NCT00663923|12170805|FG000|COMPLETED|Overall Study||48
10994402|NCT00663923|12170805|FG000|NOT COMPLETED|Overall Study||2
10994403|NCT00663962|12170813|FG000|STARTED|Overall Study||7
10994404|NCT00663962|12170814|FG001|STARTED|Overall Study||8
10994405|NCT00663962|12170813|FG000|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
10994406|NCT00663962|12170814|FG001|COMPLETED|Overall Study||8
10994407|NCT00663962|12170813|FG000|NOT COMPLETED|Overall Study||1
10994408|NCT00663962|12170814|FG001|NOT COMPLETED|Overall Study||0
10994409|NCT00664105|12170820|FG000|STARTED|Overall Study||63
10994410|NCT00664105|12170820|FG000|COMPLETED|Overall Study||39
10994411|NCT00664105|12170820|FG000|NOT COMPLETED|Overall Study||24
10994412|NCT00664209|12170825|FG000|STARTED|Motor Fluctuations Screen||13
10994413|NCT00664209|12170825|FG000|COMPLETED|Motor Fluctuations Screen||6
10994414|NCT00664209|12170825|FG000|NOT COMPLETED|Motor Fluctuations Screen||7
10994415|NCT00664209|12170825|FG000|STARTED|Study Treatment Period||6
10994416|NCT00664209|12170825|FG000|COMPLETED|Study Treatment Period||0
10994417|NCT00664209|12170825|FG000|NOT COMPLETED|Study Treatment Period||6
10994418|NCT00664326|12170830|FG000|STARTED|Overall Study||49
10994419|NCT00664326|12170830|FG000|COMPLETED|Overall Study|transitioned to rollover study|1
10994420|NCT00664326|12170830|FG000|NOT COMPLETED|Overall Study||48
10994421|NCT00664430|12170834|FG000|STARTED|Overall Study||13
10994422|NCT00664430|12170834|FG000|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
10994423|NCT00664430|12170834|FG000|NOT COMPLETED|Overall Study||13
10994424|NCT00664521|12170840|FG000|STARTED|Overall Study||18
10994425|NCT00664521|12170841|FG001|STARTED|Overall Study||9
10994426|NCT00664521|12170840|FG000|COMPLETED|Overall Study||12
10994427|NCT00664521|12170841|FG001|COMPLETED|Overall Study||8
10994428|NCT00664521|12170840|FG000|NOT COMPLETED|Overall Study||6
10994429|NCT00664521|12170841|FG001|NOT COMPLETED|Overall Study||1
10994430|NCT00664534|12170849|FG000|STARTED|Overall Study||173
10994431|NCT00664534|12170850|FG001|STARTED|Overall Study||171
10994432|NCT00664534|12170849|FG000|COMPLETED|Overall Study||132
10994433|NCT00664534|12170850|FG001|COMPLETED|Overall Study||138
10994434|NCT00664534|12170849|FG000|NOT COMPLETED|Overall Study||41
10994435|NCT00664534|12170850|FG001|NOT COMPLETED|Overall Study||33
10994436|NCT00664560|12170859|FG000|STARTED|Overall Study|Safety Population|247
10994437|NCT00664560|12170860|FG001|STARTED|Overall Study|Safety Population|243
10994438|NCT00664560|12170861|FG002|STARTED|Overall Study|Safety Population|124
10994439|NCT00664560|12170859|FG000|COMPLETED|Overall Study||208
10994440|NCT00664560|12170860|FG001|COMPLETED|Overall Study||208
10994441|NCT00664560|12170861|FG002|COMPLETED|Overall Study||105
10994442|NCT00664560|12170859|FG000|NOT COMPLETED|Overall Study||39
10994443|NCT00664560|12170860|FG001|NOT COMPLETED|Overall Study||35
10994444|NCT00664560|12170861|FG002|NOT COMPLETED|Overall Study||19
10994445|NCT00664742|12170869|FG000|STARTED|Overall Study||607
10994446|NCT00664742|12170869|FG000|COMPLETED|Overall Study||481
10994447|NCT00664742|12170869|FG000|NOT COMPLETED|Overall Study||126
10994448|NCT00664755|12170875|FG000|STARTED|Overall Study||67
10994449|NCT00664755|12170876|FG001|STARTED|Overall Study||73
10994450|NCT00664755|12170875|FG000|COMPLETED|Overall Study||67
10994451|NCT00664755|12170876|FG001|COMPLETED|Overall Study||73
10994452|NCT00664755|12170875|FG000|NOT COMPLETED|Overall Study||0
10994453|NCT00664755|12170876|FG001|NOT COMPLETED|Overall Study||0
10994454|NCT00664859|12170885|FG000|STARTED|Overall Study||51
10994455|NCT00664859|12170886|FG001|STARTED|Overall Study||45
10994456|NCT00664859|12170887|FG002|STARTED|Overall Study||44
10994457|NCT00664859|12170885|FG000|COMPLETED|Overall Study||34
10994458|NCT00664859|12170886|FG001|COMPLETED|Overall Study||35
10994459|NCT00664859|12170887|FG002|COMPLETED|Overall Study||23
10994460|NCT00664859|12170885|FG000|NOT COMPLETED|Overall Study||17
10994461|NCT00664859|12170886|FG001|NOT COMPLETED|Overall Study||10
10994462|NCT00664859|12170887|FG002|NOT COMPLETED|Overall Study||21
10994463|NCT00665002|12170895|FG000|STARTED|Overall Study||16
10994464|NCT00665002|12170895|FG000|COMPLETED|Overall Study||4
10994465|NCT00665002|12170895|FG000|NOT COMPLETED|Overall Study||12
10994466|NCT00665132|12170899|FG000|STARTED|Overall Study||10
10994467|NCT00665132|12170899|FG000|COMPLETED|Overall Study||10
10994468|NCT00665132|12170899|FG000|NOT COMPLETED|Overall Study||0
10994469|NCT00665353|12170903|FG000|STARTED|Study Step 1||19
10994470|NCT00665353|12170903|FG000|COMPLETED|Study Step 1||16
10994471|NCT00665353|12170903|FG000|NOT COMPLETED|Study Step 1||3
10994472|NCT00665353|12170903|FG000|STARTED|Study Step 2||16
10994473|NCT00665353|12170903|FG000|COMPLETED|Study Step 2||2
10994474|NCT00665353|12170903|FG000|NOT COMPLETED|Study Step 2||14
10994475|NCT00665366|12170909|FG000|STARTED|Overall Study|Participants randomized|189
10994476|NCT00665366|12170910|FG001|STARTED|Overall Study|Participants randomized|181
10994477|NCT00665366|12170909|FG000|COMPLETED|Overall Study||131
10994478|NCT00665366|12170910|FG001|COMPLETED|Overall Study||122
10994479|NCT00665366|12170909|FG000|NOT COMPLETED|Overall Study||58
10994480|NCT00665366|12170910|FG001|NOT COMPLETED|Overall Study||59
10994481|NCT00665392|12170916|FG000|STARTED|Overall Study||42
10994482|NCT00665392|12170916|FG000|COMPLETED|Overall Study||41
10994483|NCT00665392|12170916|FG000|NOT COMPLETED|Overall Study||1
10994484|NCT00665431|12170924|FG000|STARTED|Overall Study|Safety population|243
10994485|NCT00665431|12170925|FG001|STARTED|Overall Study|Safety population|245
10994486|NCT00665431|12170926|FG002|STARTED|Overall Study|Safety population|122
10994487|NCT00665431|12170924|FG000|COMPLETED|Overall Study||203
10994488|NCT00665431|12170925|FG001|COMPLETED|Overall Study||188
10994489|NCT00665431|12170926|FG002|COMPLETED|Overall Study||98
10994490|NCT00665431|12170924|FG000|NOT COMPLETED|Overall Study||40
10994491|NCT00665431|12170925|FG001|NOT COMPLETED|Overall Study||57
10994492|NCT00665431|12170926|FG002|NOT COMPLETED|Overall Study||24
10994493|NCT00665457|12170934|FG000|STARTED|Overall Study||3
10994494|NCT00665457|12170934|FG000|COMPLETED|Overall Study||3
10994495|NCT00665457|12170934|FG000|NOT COMPLETED|Overall Study||0
10994496|NCT00665470|12170940|FG000|STARTED|Overall Study||10
10994497|NCT00665470|12170941|FG001|STARTED|Overall Study||0
10994498|NCT00665470|12170940|FG000|COMPLETED|Overall Study||10
10994499|NCT00665470|12170941|FG001|COMPLETED|Overall Study||0
10994500|NCT00665470|12170940|FG000|NOT COMPLETED|Overall Study||0
10994501|NCT00665470|12170941|FG001|NOT COMPLETED|Overall Study||0
10994502|NCT00665561|12170949|FG000|STARTED|Overall Study||1316
10994503|NCT00665561|12170950|FG001|STARTED|Overall Study||1130
10994504|NCT00665561|12170949|FG000|COMPLETED|Overall Study||814
10994505|NCT00665561|12170950|FG001|COMPLETED|Overall Study||596
10994506|NCT00665561|12170949|FG000|NOT COMPLETED|Overall Study||502
10994507|NCT00665561|12170950|FG001|NOT COMPLETED|Overall Study||534
10994508|NCT00665626|12170958|FG000|STARTED|Overall Study|Participants randomized|73
10994509|NCT00665626|12170959|FG001|STARTED|Overall Study|Participants randomized|146
10994510|NCT00665626|12170958|FG000|COMPLETED|Overall Study|Participants completed the study|63
10994511|NCT00665626|12170959|FG001|COMPLETED|Overall Study|Participants completed the study|124
10994512|NCT00665626|12170958|FG000|NOT COMPLETED|Overall Study||10
10994513|NCT00665626|12170959|FG001|NOT COMPLETED|Overall Study||22
10994514|NCT00665652|12170965|FG000|STARTED|Overall Study||8
10994515|NCT00665652|12170965|FG000|COMPLETED|Overall Study||2
10994516|NCT00665652|12170965|FG000|NOT COMPLETED|Overall Study||6
10994517|NCT00665704|12170969|FG000|STARTED|Overall Study||9
10994518|NCT00665704|12170969|FG000|COMPLETED|Overall Study||9
10994519|NCT00665704|12170969|FG000|NOT COMPLETED|Overall Study||0
10994520|NCT00665847|12170973|FG000|STARTED|Overall Study||101
10994521|NCT00665847|12170973|FG000|COMPLETED|Overall Study||76
10994522|NCT00665847|12170973|FG000|NOT COMPLETED|Overall Study||25
10994523|NCT00665925|12170981|FG000|STARTED|Overall Study|Participants randomized|77
10994524|NCT00665925|12170982|FG001|STARTED|Overall Study|Participants randomized|76
10994525|NCT00665925|12170983|FG002|STARTED|Overall Study|Participants randomized|152
10994526|NCT00665925|12170984|FG003|STARTED|Overall Study|Participants randomized|152
10994527|NCT00665925|12170981|FG000|COMPLETED|Overall Study|Participants completed the study|62
10994528|NCT00665925|12170982|FG001|COMPLETED|Overall Study|Participants completed the study|59
10994529|NCT00665925|12170983|FG002|COMPLETED|Overall Study|Participants completed the study|126
10994530|NCT00665925|12170984|FG003|COMPLETED|Overall Study|Participants completed the study|131
10994531|NCT00665925|12170981|FG000|NOT COMPLETED|Overall Study||15
10994532|NCT00665925|12170982|FG001|NOT COMPLETED|Overall Study||17
10994533|NCT00665925|12170983|FG002|NOT COMPLETED|Overall Study||26
10994534|NCT00665925|12170984|FG003|NOT COMPLETED|Overall Study||21
10994535|NCT00666029|12170997|FG000|STARTED|Overall Study||20
10994536|NCT00666029|12170998|FG001|STARTED|Overall Study||20
10994537|NCT00666029|12170997|FG000|COMPLETED|Overall Study||19
10994538|NCT00666029|12170998|FG001|COMPLETED|Overall Study||20
10994539|NCT00666029|12170997|FG000|NOT COMPLETED|Overall Study||1
10994540|NCT00666029|12170998|FG001|NOT COMPLETED|Overall Study||0
10994541|NCT00666198|12171005|FG000|STARTED|Overall Study||3337
10994542|NCT00666198|12171005|FG000|COMPLETED|Overall Study||3304
10994543|NCT00666198|12171005|FG000|NOT COMPLETED|Overall Study||33
10994544|NCT00666211|12171011|FG000|STARTED|Overall Study||42
10994545|NCT00666211|12171012|FG001|STARTED|Overall Study||56
10994546|NCT00666211|12171011|FG000|COMPLETED|Overall Study||22
10994547|NCT00666211|12171012|FG001|COMPLETED|Overall Study||18
10994548|NCT00666211|12171011|FG000|NOT COMPLETED|Overall Study||20
10994549|NCT00666211|12171012|FG001|NOT COMPLETED|Overall Study||38
10994550|NCT00666224|12171020|FG000|STARTED|Double-Blind||243
10994551|NCT00666224|12171021|FG001|STARTED|Double-Blind||238
10994552|NCT00666224|12171020|FG000|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
10994553|NCT00666224|12171021|FG001|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
10994554|NCT00666224|12171020|FG000|NOT COMPLETED|Double-Blind||45
10994555|NCT00666224|12171021|FG001|NOT COMPLETED|Double-Blind||27
10994556|NCT00666224|12171020|FG000|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
10994557|NCT00666224|12171021|FG001|STARTED|Open-Label||211
10994558|NCT00666224|12171020|FG000|COMPLETED|Open-Label||163
10994559|NCT00666224|12171021|FG001|COMPLETED|Open-Label||126
10994560|NCT00666224|12171020|FG000|NOT COMPLETED|Open-Label||35
10994561|NCT00666224|12171021|FG001|NOT COMPLETED|Open-Label||85
10994562|NCT00666263|12171028|FG000|STARTED|Study Part 1 (Stabilization Phase 1)||22
10994563|NCT00666263|12171029|FG001|STARTED|Study Part 1 (Stabilization Phase 1)||22
10994564|NCT00666263|12171028|FG000|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
10994565|NCT00666263|12171029|FG001|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
10994566|NCT00666263|12171028|FG000|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
10994567|NCT00666263|12171029|FG001|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
10994568|NCT00666263|12171028|FG000|STARTED|Study Part 2 (Cross-over Period 1)||22
10994569|NCT00666263|12171029|FG001|STARTED|Study Part 2 (Cross-over Period 1)||21
10994570|NCT00666263|12171028|FG000|COMPLETED|Study Part 2 (Cross-over Period 1)||22
10994571|NCT00666263|12171029|FG001|COMPLETED|Study Part 2 (Cross-over Period 1)||21
10994572|NCT00666263|12171028|FG000|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
10994573|NCT00666263|12171029|FG001|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
10994574|NCT00666263|12171028|FG000|STARTED|Study Part 3 (Stabilization Phase 2)||22
10994575|NCT00666263|12171029|FG001|STARTED|Study Part 3 (Stabilization Phase 2)||21
10994576|NCT00666263|12171028|FG000|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
10994577|NCT00666263|12171029|FG001|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
10994578|NCT00666263|12171028|FG000|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
10994579|NCT00666263|12171029|FG001|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
10994580|NCT00666263|12171028|FG000|STARTED|Study Part 4 (Cross-over Period 2)||22
10994581|NCT00666263|12171029|FG001|STARTED|Study Part 4 (Cross-over Period 2)||21
10994582|NCT00666263|12171028|FG000|COMPLETED|Study Part 4 (Cross-over Period 2)||21
10994583|NCT00666263|12171029|FG001|COMPLETED|Study Part 4 (Cross-over Period 2)||21
10994584|NCT00666263|12171028|FG000|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
10994585|NCT00666263|12171029|FG001|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
10994586|NCT00666263|12171028|FG000|STARTED|Study Part 5 (Stabilization Phase 3)||21
10994587|NCT00666263|12171029|FG001|STARTED|Study Part 5 (Stabilization Phase 3)||21
10994588|NCT00666263|12171028|FG000|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
10994589|NCT00666263|12171029|FG001|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
10994590|NCT00666263|12171028|FG000|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
10994591|NCT00666263|12171029|FG001|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
10994592|NCT00666263|12171028|FG000|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
10994593|NCT00666263|12171029|FG001|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
10994594|NCT00666263|12171028|FG000|COMPLETED|End of Study Visit||22
10994595|NCT00666263|12171029|FG001|COMPLETED|End of Study Visit||22
10994596|NCT00666263|12171028|FG000|NOT COMPLETED|End of Study Visit||0
10994597|NCT00666263|12171029|FG001|NOT COMPLETED|End of Study Visit||0
10994598|NCT00666276|12171074|FG000|STARTED|Overall Study||1004
10994599|NCT00666276|12171074|FG000|COMPLETED|Overall Study||970
10994600|NCT00666276|12171074|FG000|NOT COMPLETED|Overall Study||34
10994601|NCT00666328|12171097|FG000|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
10994602|NCT00666328|12171097|FG000|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
10994603|NCT00666328|12171097|FG000|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
10994604|NCT00666328|12171097|FG000|NOT COMPLETED|Overall Study||5
10994605|NCT00666406|12171103|FG000|STARTED|First PK Infusion||6
10994606|NCT00666406|12171104|FG001|STARTED|First PK Infusion||3
10994607|NCT00666406|12171103|FG000|COMPLETED|First PK Infusion||6
10994608|NCT00666406|12171104|FG001|COMPLETED|First PK Infusion||3
10994609|NCT00666406|12171103|FG000|NOT COMPLETED|First PK Infusion||0
10994610|NCT00666406|12171104|FG001|NOT COMPLETED|First PK Infusion||0
10994611|NCT00666406|12171103|FG000|STARTED|Second PK Infusion||6
10994612|NCT00666406|12171104|FG001|STARTED|Second PK Infusion||3
10994613|NCT00666406|12171103|FG000|COMPLETED|Second PK Infusion||6
10994614|NCT00666406|12171104|FG001|COMPLETED|Second PK Infusion||3
10994615|NCT00666406|12171103|FG000|NOT COMPLETED|Second PK Infusion||0
10994616|NCT00666406|12171104|FG001|NOT COMPLETED|Second PK Infusion||0
10994617|NCT00666458|12171111|FG000|STARTED|Overall Study|Randomized and treated|403
10994618|NCT00666458|12171112|FG001|STARTED|Overall Study|Randomized and treated|398
10994619|NCT00666458|12171111|FG000|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
10994620|NCT00666458|12171112|FG001|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
10994621|NCT00666458|12171111|FG000|NOT COMPLETED|Overall Study||38
10994622|NCT00666458|12171112|FG001|NOT COMPLETED|Overall Study||24
10994623|NCT00666536|12171120|FG000|STARTED|Overall Study||369
10994624|NCT00666536|12171121|FG001|STARTED|Overall Study||359
10994625|NCT00666536|12171120|FG000|COMPLETED|Overall Study||336
10994626|NCT00666536|12171121|FG001|COMPLETED|Overall Study||322
10994627|NCT00666536|12171120|FG000|NOT COMPLETED|Overall Study||33
10994628|NCT00666536|12171121|FG001|NOT COMPLETED|Overall Study||37
10994629|NCT00666562|12171130|FG000|STARTED|Overall Study||11
10994630|NCT00666562|12171131|FG001|STARTED|Overall Study||10
10994631|NCT00666562|12171132|FG002|STARTED|Overall Study||10
10994632|NCT00666562|12171130|FG000|COMPLETED|Overall Study||11
10994633|NCT00666562|12171131|FG001|COMPLETED|Overall Study||8
10994634|NCT00666562|12171132|FG002|COMPLETED|Overall Study||10
10994635|NCT00666562|12171130|FG000|NOT COMPLETED|Overall Study||0
10994636|NCT00666562|12171131|FG001|NOT COMPLETED|Overall Study||2
10994637|NCT00666562|12171132|FG002|NOT COMPLETED|Overall Study||0
10994638|NCT00666588|12171151|FG000|STARTED|Overall Study||18
10994639|NCT00666588|12171152|FG001|STARTED|Overall Study||6
10994640|NCT00666588|12171153|FG002|STARTED|Overall Study||6
10994641|NCT00666588|12171154|FG003|STARTED|Overall Study||22
10994642|NCT00666588|12171151|FG000|COMPLETED|Overall Study||14
10994643|NCT00666588|12171152|FG001|COMPLETED|Overall Study||6
10994644|NCT00666588|12171153|FG002|COMPLETED|Overall Study||6
10994645|NCT00666588|12171154|FG003|COMPLETED|Overall Study||20
10994646|NCT00666588|12171151|FG000|NOT COMPLETED|Overall Study||4
10994647|NCT00666588|12171152|FG001|NOT COMPLETED|Overall Study||0
10994648|NCT00666588|12171153|FG002|NOT COMPLETED|Overall Study||0
10994649|NCT00666588|12171154|FG003|NOT COMPLETED|Overall Study||2
10994650|NCT00666666|12171164|FG000|STARTED|Overall Study||55
10994651|NCT00666666|12171164|FG000|COMPLETED|Overall Study||55
10994652|NCT00666666|12171164|FG000|NOT COMPLETED|Overall Study||0
10994653|NCT00666679|12171170|FG000|STARTED|First Intervention||66
10994654|NCT00666679|12171171|FG001|STARTED|First Intervention||68
10994655|NCT00666679|12171170|FG000|COMPLETED|First Intervention||62
10994656|NCT00666679|12171171|FG001|COMPLETED|First Intervention||67
10994657|NCT00666679|12171170|FG000|NOT COMPLETED|First Intervention||4
10994658|NCT00666679|12171171|FG001|NOT COMPLETED|First Intervention||1
10994659|NCT00666679|12171170|FG000|STARTED|Washout Period of 1 Week||62
10994660|NCT00666679|12171171|FG001|STARTED|Washout Period of 1 Week||67
10994661|NCT00666679|12171170|FG000|COMPLETED|Washout Period of 1 Week||62
10994662|NCT00666679|12171171|FG001|COMPLETED|Washout Period of 1 Week||65
10994663|NCT00666679|12171170|FG000|NOT COMPLETED|Washout Period of 1 Week||0
10994664|NCT00666679|12171171|FG001|NOT COMPLETED|Washout Period of 1 Week||2
10994665|NCT00666679|12171170|FG000|STARTED|Second Intervention||62
10994666|NCT00666679|12171171|FG001|STARTED|Second Intervention||65
10994667|NCT00666679|12171170|FG000|COMPLETED|Second Intervention||61
10994668|NCT00666679|12171171|FG001|COMPLETED|Second Intervention||64
10994669|NCT00666679|12171170|FG000|NOT COMPLETED|Second Intervention||1
10994670|NCT00666679|12171171|FG001|NOT COMPLETED|Second Intervention||1
10994671|NCT00666705|12171177|FG000|STARTED|Overall Study||18
10994672|NCT00666705|12171177|FG000|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
10994673|NCT00666705|12171177|FG000|Washout (Days 4 - 5)|Overall Study||18
10994674|NCT00666705|12171177|FG000|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
10994675|NCT00666705|12171177|FG000|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
10994676|NCT00666705|12171177|FG000|COMPLETED|Overall Study||17
10994677|NCT00666705|12171177|FG000|NOT COMPLETED|Overall Study||1
10994678|NCT00666718|12171188|FG000|STARTED|Overall Study||187
10994679|NCT00666718|12171189|FG001|STARTED|Overall Study||187
10994680|NCT00666718|12171188|FG000|COMPLETED|Overall Study||175
10994681|NCT00666718|12171189|FG001|COMPLETED|Overall Study||169
10994682|NCT00666718|12171188|FG000|NOT COMPLETED|Overall Study||12
10994683|NCT00666718|12171189|FG001|NOT COMPLETED|Overall Study||18
10994684|NCT00666757|12171197|FG000|STARTED|Overall Study||372
10994685|NCT00666757|12171198|FG001|STARTED|Overall Study||378
10994686|NCT00666757|12171197|FG000|COMPLETED|Overall Study||272
10994687|NCT00666757|12171198|FG001|COMPLETED|Overall Study||281
10994688|NCT00666757|12171197|FG000|NOT COMPLETED|Overall Study||100
10994689|NCT00666757|12171198|FG001|NOT COMPLETED|Overall Study||97
10994690|NCT00666835|12171209|FG000|STARTED|Overall Study||314
10994691|NCT00666835|12171210|FG001|STARTED|Overall Study||164
10994692|NCT00666835|12171209|FG000|COMPLETED|Overall Study||261
10994693|NCT00666835|12171210|FG001|COMPLETED|Overall Study||142
10994694|NCT00666835|12171209|FG000|NOT COMPLETED|Overall Study||53
10994695|NCT00666835|12171210|FG001|NOT COMPLETED|Overall Study||22
10994696|NCT00666848|12171220|FG000|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
10994697|NCT00666848|12171221|FG001|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
10994698|NCT00666848|12171222|FG002|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
10994699|NCT00666848|12171220|FG000|COMPLETED|Overall Study|finished Aim 2|8
10994700|NCT00666848|12171221|FG001|COMPLETED|Overall Study|finished Aim 1|9
10994701|NCT00666848|12171222|FG002|COMPLETED|Overall Study|finished Aim 3|7
10994702|NCT00666848|12171220|FG000|NOT COMPLETED|Overall Study||0
10994703|NCT00666848|12171221|FG001|NOT COMPLETED|Overall Study||0
10994704|NCT00666848|12171222|FG002|NOT COMPLETED|Overall Study||0
10994705|NCT00666926|12171230|FG000|STARTED|Overall Study||2
10994706|NCT00666926|12171231|FG001|STARTED|Overall Study||4
10994707|NCT00666926|12171232|FG002|STARTED|Overall Study||3
10994708|NCT00666926|12171233|FG003|STARTED|Overall Study||4
10994709|NCT00666926|12171234|FG004|STARTED|Overall Study||3
10994710|NCT00666926|12171235|FG005|STARTED|Overall Study||4
10994711|NCT00666926|12171236|FG006|STARTED|Overall Study||4
10994712|NCT00666926|12171237|FG007|STARTED|Overall Study||1
10994713|NCT00666926|12171238|FG008|STARTED|Overall Study||3
10994714|NCT00666926|12171239|FG009|STARTED|Overall Study||10
10994715|NCT00666926|12171240|FG010|STARTED|Overall Study||6
10994716|NCT00666926|12171241|FG011|STARTED|Overall Study||33
10994717|NCT00666926|12171242|FG012|STARTED|Overall Study||3
10994718|NCT00666926|12171243|FG013|STARTED|Overall Study||4
10994719|NCT00666926|12171244|FG014|STARTED|Overall Study||7
10994720|NCT00666926|12171245|FG015|STARTED|Overall Study||8
10994721|NCT00666926|12171230|FG000|COMPLETED|Overall Study||0
10994722|NCT00666926|12171231|FG001|COMPLETED|Overall Study||0
10994723|NCT00666926|12171232|FG002|COMPLETED|Overall Study||0
10994724|NCT00666926|12171233|FG003|COMPLETED|Overall Study||0
10994725|NCT00666926|12171234|FG004|COMPLETED|Overall Study||0
10994726|NCT00666926|12171235|FG005|COMPLETED|Overall Study||0
10994727|NCT00666926|12171236|FG006|COMPLETED|Overall Study||0
10994728|NCT00666926|12171237|FG007|COMPLETED|Overall Study||0
10994729|NCT00666926|12171238|FG008|COMPLETED|Overall Study||0
10994730|NCT00666926|12171239|FG009|COMPLETED|Overall Study||0
10994731|NCT00666926|12171240|FG010|COMPLETED|Overall Study||0
10994732|NCT00666926|12171241|FG011|COMPLETED|Overall Study||0
10994733|NCT00666926|12171242|FG012|COMPLETED|Overall Study||0
10994734|NCT00666926|12171243|FG013|COMPLETED|Overall Study||0
10994735|NCT00666926|12171244|FG014|COMPLETED|Overall Study||0
10994736|NCT00666926|12171245|FG015|COMPLETED|Overall Study||0
10994737|NCT00666926|12171230|FG000|NOT COMPLETED|Overall Study||2
10994738|NCT00666926|12171231|FG001|NOT COMPLETED|Overall Study||4
10994739|NCT00666926|12171232|FG002|NOT COMPLETED|Overall Study||3
10994740|NCT00666926|12171233|FG003|NOT COMPLETED|Overall Study||4
10994741|NCT00666926|12171234|FG004|NOT COMPLETED|Overall Study||3
10994742|NCT00666926|12171235|FG005|NOT COMPLETED|Overall Study||4
10994743|NCT00666926|12171236|FG006|NOT COMPLETED|Overall Study||4
10994744|NCT00666926|12171237|FG007|NOT COMPLETED|Overall Study||1
10994745|NCT00666926|12171238|FG008|NOT COMPLETED|Overall Study||3
10994746|NCT00666926|12171239|FG009|NOT COMPLETED|Overall Study||10
10994747|NCT00666926|12171240|FG010|NOT COMPLETED|Overall Study||6
10994748|NCT00666926|12171241|FG011|NOT COMPLETED|Overall Study||33
10994749|NCT00666926|12171242|FG012|NOT COMPLETED|Overall Study||3
10994750|NCT00666926|12171243|FG013|NOT COMPLETED|Overall Study||4
10994751|NCT00666926|12171244|FG014|NOT COMPLETED|Overall Study||7
10994752|NCT00666926|12171245|FG015|NOT COMPLETED|Overall Study||8
10994753|NCT00666965|12171300|FG000|STARTED|Overall Study||58
10994754|NCT00666965|12171301|FG001|STARTED|Overall Study||57
10994755|NCT00666965|12171302|FG002|STARTED|Overall Study||58
10994756|NCT00666965|12171303|FG003|STARTED|Overall Study||57
10994757|NCT00666965|12171300|FG000|COMPLETED|Overall Study||55
10994758|NCT00666965|12171301|FG001|COMPLETED|Overall Study||53
10994759|NCT00666965|12171302|FG002|COMPLETED|Overall Study||56
10994760|NCT00666965|12171303|FG003|COMPLETED|Overall Study||42
10994761|NCT00666965|12171300|FG000|NOT COMPLETED|Overall Study||3
10994762|NCT00666965|12171301|FG001|NOT COMPLETED|Overall Study||4
10994763|NCT00666965|12171302|FG002|NOT COMPLETED|Overall Study||2
10994764|NCT00666965|12171303|FG003|NOT COMPLETED|Overall Study||15
10994765|NCT00666978|12171315|FG000|STARTED|Overall Study||270
10994766|NCT00666978|12171316|FG001|STARTED|Overall Study||270
10994767|NCT00666978|12171315|FG000|COMPLETED|Overall Study||192
10994768|NCT00666978|12171316|FG001|COMPLETED|Overall Study||187
10994769|NCT00666978|12171315|FG000|NOT COMPLETED|Overall Study||78
10994770|NCT00666978|12171316|FG001|NOT COMPLETED|Overall Study||83
10994771|NCT00667004|12171326|FG000|STARTED|Overall Study||95
10994772|NCT00667004|12171327|FG001|STARTED|Overall Study||88
10994773|NCT00667004|12171326|FG000|COMPLETED|Overall Study||93
10994774|NCT00667004|12171327|FG001|COMPLETED|Overall Study||85
10994775|NCT00667004|12171326|FG000|NOT COMPLETED|Overall Study||2
10994776|NCT00667004|12171327|FG001|NOT COMPLETED|Overall Study||3
10994777|NCT00667095|12171335|FG000|STARTED|Overall Study||11
10994778|NCT00667095|12171336|FG001|STARTED|Overall Study||10
10994779|NCT00667095|12171335|FG000|COMPLETED|Overall Study||11
10994780|NCT00667095|12171336|FG001|COMPLETED|Overall Study||9
10994781|NCT00667095|12171335|FG000|NOT COMPLETED|Overall Study||0
10994782|NCT00667095|12171336|FG001|NOT COMPLETED|Overall Study||1
10994783|NCT00667186|12171344|FG000|STARTED|Overall Study||4692
10994784|NCT00667186|12171345|FG001|STARTED|Overall Study||4880
10994785|NCT00667186|12171344|FG000|COMPLETED|Overall Study||4692
10994786|NCT00667186|12171345|FG001|COMPLETED|Overall Study||4880
10994787|NCT00667186|12171344|FG000|NOT COMPLETED|Overall Study||0
10994788|NCT00667186|12171345|FG001|NOT COMPLETED|Overall Study||0
10994789|NCT00667225|12171353|FG000|STARTED|Overall Study||16
10994790|NCT00667225|12171354|FG001|STARTED|Overall Study||13
10994791|NCT00667225|12171353|FG000|COMPLETED|Overall Study||15
10994792|NCT00667225|12171354|FG001|COMPLETED|Overall Study||12
10994793|NCT00667225|12171353|FG000|NOT COMPLETED|Overall Study||1
10994794|NCT00667225|12171354|FG001|NOT COMPLETED|Overall Study||1
10994795|NCT00667277|12171360|FG000|STARTED|Overall Study||13
10994796|NCT00667277|12171360|FG000|COMPLETED|Overall Study||11
10994797|NCT00667277|12171360|FG000|NOT COMPLETED|Overall Study||2
10994798|NCT00667342|12171367|FG000|STARTED|Overall Study||31
10994799|NCT00667342|12171368|FG001|STARTED|Overall Study||0
10994800|NCT00667342|12171369|FG002|STARTED|Overall Study||12
10994801|NCT00667342|12171367|FG000|COMPLETED|Overall Study||17
10994802|NCT00667342|12171368|FG001|COMPLETED|Overall Study||0
10994803|NCT00667342|12171369|FG002|COMPLETED|Overall Study||3
10994804|NCT00667342|12171367|FG000|NOT COMPLETED|Overall Study||14
10994805|NCT00667342|12171368|FG001|NOT COMPLETED|Overall Study||0
10994806|NCT00667342|12171369|FG002|NOT COMPLETED|Overall Study||9
10994807|NCT00667355|12171383|FG000|STARTED|Overall Study||41
10994808|NCT00667355|12171383|FG000|COMPLETED|Overall Study||30
10994809|NCT00667355|12171383|FG000|NOT COMPLETED|Overall Study||11
10994810|NCT00667368|12171389|FG000|STARTED|Overall Study||682
10994811|NCT00667368|12171390|FG001|STARTED|Overall Study||683
10994812|NCT00667368|12171389|FG000|COMPLETED|Overall Study||482
10994813|NCT00667368|12171390|FG001|COMPLETED|Overall Study||511
10994814|NCT00667368|12171389|FG000|NOT COMPLETED|Overall Study||200
10994815|NCT00667368|12171390|FG001|NOT COMPLETED|Overall Study||172
10994816|NCT00667381|12171398|FG000|STARTED|Overall Study||501
10994817|NCT00667381|12171399|FG001|STARTED|Overall Study||503
10994818|NCT00667381|12171398|FG000|COMPLETED|Overall Study||501
10994819|NCT00667381|12171399|FG001|COMPLETED|Overall Study||503
10994820|NCT00667381|12171398|FG000|NOT COMPLETED|Overall Study||0
10994821|NCT00667381|12171399|FG001|NOT COMPLETED|Overall Study||0
10994822|NCT00667394|12171407|FG000|STARTED|Overall Study||41
10994823|NCT00667394|12171408|FG001|STARTED|Overall Study||1
10994824|NCT00667394|12171407|FG000|COMPLETED|Overall Study||37
10994825|NCT00667394|12171408|FG001|COMPLETED|Overall Study||1
10994826|NCT00667394|12171407|FG000|NOT COMPLETED|Overall Study||4
10994827|NCT00667394|12171408|FG001|NOT COMPLETED|Overall Study||0
10994828|NCT00667420|12171414|FG000|STARTED|Overall Study||17
10994829|NCT00667420|12171414|FG000|Completion of Pre-operative EOX-P|Overall Study||15
10994830|NCT00667420|12171414|FG000|Completion of Surgery/Re-staging|Overall Study||11
10994831|NCT00667420|12171414|FG000|COMPLETED|Overall Study||7
10994832|NCT00667420|12171414|FG000|NOT COMPLETED|Overall Study||10
10994833|NCT00667446|12171421|FG000|STARTED|Treatment Period (36 Months)||34
10994834|NCT00667446|12171422|FG001|STARTED|Treatment Period (36 Months)||38
10994835|NCT00667446|12171421|FG000|COMPLETED|Treatment Period (36 Months)||11
10994836|NCT00667446|12171422|FG001|COMPLETED|Treatment Period (36 Months)||13
10994837|NCT00667446|12171421|FG000|NOT COMPLETED|Treatment Period (36 Months)||23
10994838|NCT00667446|12171422|FG001|NOT COMPLETED|Treatment Period (36 Months)||25
10994839|NCT00667446|12171421|FG000|STARTED|Safety Follow-up Period (12 Weeks)||28
10994840|NCT00667446|12171422|FG001|STARTED|Safety Follow-up Period (12 Weeks)||26
10994841|NCT00667446|12171421|FG000|COMPLETED|Safety Follow-up Period (12 Weeks)||28
10994842|NCT00667446|12171422|FG001|COMPLETED|Safety Follow-up Period (12 Weeks)||25
10994843|NCT00667446|12171421|FG000|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
10994844|NCT00667446|12171422|FG001|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
10994845|NCT00667459|12171430|FG000|STARTED|Overall Study||280
10994846|NCT00667459|12171431|FG001|STARTED|Overall Study||265
10994847|NCT00667459|12171430|FG000|COMPLETED|Overall Study||272
10994848|NCT00667459|12171431|FG001|COMPLETED|Overall Study||220
10994849|NCT00667459|12171430|FG000|NOT COMPLETED|Overall Study||8
10994850|NCT00667459|12171431|FG001|NOT COMPLETED|Overall Study||45
10994851|NCT00667511|12171437|FG000|STARTED|Intervention 1: Home DHD||58
10994852|NCT00667511|12171437|FG000|COMPLETED|Intervention 1: Home DHD||51
10994853|NCT00667511|12171437|FG000|NOT COMPLETED|Intervention 1: Home DHD||7
10994854|NCT00667511|12171437|FG000|STARTED|Training/Transition Period||51
10994855|NCT00667511|12171437|FG000|COMPLETED|Training/Transition Period||43
10994856|NCT00667511|12171437|FG000|NOT COMPLETED|Training/Transition Period||8
10994857|NCT00667511|12171437|FG000|STARTED|Intervention 2: Home NHD||43
10994858|NCT00667511|12171437|FG000|COMPLETED|Intervention 2: Home NHD||39
10994859|NCT00667511|12171437|FG000|NOT COMPLETED|Intervention 2: Home NHD||4
10994860|NCT00667563|12171443|FG000|STARTED|Overall Study||150
10994861|NCT00667563|12171443|FG000|COMPLETED|Overall Study||126
10994862|NCT00667563|12171443|FG000|NOT COMPLETED|Overall Study||24
10994863|NCT00667576|12171452|FG000|STARTED|Overall Study||30
10994864|NCT00667576|12171453|FG001|STARTED|Overall Study||31
10994865|NCT00667576|12171454|FG002|STARTED|Overall Study||31
10994866|NCT00667576|12171455|FG003|STARTED|Overall Study||31
10994867|NCT00667576|12171456|FG004|STARTED|Overall Study||30
10994868|NCT00667576|12171452|FG000|COMPLETED|Overall Study||28
10994869|NCT00667576|12171453|FG001|COMPLETED|Overall Study||30
10994870|NCT00667576|12171454|FG002|COMPLETED|Overall Study||29
10994871|NCT00667576|12171455|FG003|COMPLETED|Overall Study||27
10994872|NCT00667576|12171456|FG004|COMPLETED|Overall Study||29
10994873|NCT00667576|12171452|FG000|NOT COMPLETED|Overall Study||2
10994874|NCT00667576|12171453|FG001|NOT COMPLETED|Overall Study||1
10994875|NCT00667576|12171454|FG002|NOT COMPLETED|Overall Study||2
10994876|NCT00667576|12171455|FG003|NOT COMPLETED|Overall Study||4
10994877|NCT00667576|12171456|FG004|NOT COMPLETED|Overall Study||1
10994878|NCT00667589|12171472|FG000|STARTED|Overall Study||1
10994879|NCT00667589|12171473|FG001|STARTED|Overall Study||0
10994880|NCT00667589|12171474|FG002|STARTED|Overall Study||3
10994881|NCT00667589|12171475|FG003|STARTED|Overall Study||2
10994882|NCT00667589|12171472|FG000|COMPLETED|Overall Study||0
10994883|NCT00667589|12171473|FG001|COMPLETED|Overall Study||0
10994884|NCT00667589|12171474|FG002|COMPLETED|Overall Study||0
10994885|NCT00667589|12171475|FG003|COMPLETED|Overall Study||1
10994886|NCT00667589|12171472|FG000|NOT COMPLETED|Overall Study||1
10994887|NCT00667589|12171473|FG001|NOT COMPLETED|Overall Study||0
10994888|NCT00667589|12171474|FG002|NOT COMPLETED|Overall Study||3
10994889|NCT00667589|12171475|FG003|NOT COMPLETED|Overall Study||1
10994890|NCT00667602|12171488|FG000|STARTED|Overall Study||219
10994891|NCT00667602|12171489|FG001|STARTED|Overall Study||228
10994892|NCT00667602|12171490|FG002|STARTED|Overall Study||215
10994893|NCT00667602|12171488|FG000|COMPLETED|Overall Study||211
10994894|NCT00667602|12171489|FG001|COMPLETED|Overall Study||213
10994895|NCT00667602|12171490|FG002|COMPLETED|Overall Study||197
10994896|NCT00667602|12171488|FG000|NOT COMPLETED|Overall Study||8
10994897|NCT00667602|12171489|FG001|NOT COMPLETED|Overall Study||15
10994898|NCT00667602|12171490|FG002|NOT COMPLETED|Overall Study||18
10994899|NCT00667615|12171503|FG000|STARTED|Overall Study||30
10994900|NCT00667615|12171503|FG000|COMPLETED|Overall Study||30
10994901|NCT00667615|12171503|FG000|NOT COMPLETED|Overall Study||0
10994902|NCT00667693|12171509|FG000|STARTED|Overall Study||49
10994903|NCT00667693|12171510|FG001|STARTED|Overall Study||52
10994904|NCT00667693|12171509|FG000|COMPLETED|Overall Study||49
10994905|NCT00667693|12171510|FG001|COMPLETED|Overall Study||50
10994906|NCT00667693|12171509|FG000|NOT COMPLETED|Overall Study||0
10994907|NCT00667693|12171510|FG001|NOT COMPLETED|Overall Study||2
10994908|NCT00667719|12171516|FG000|STARTED|Overall Study||564
10994909|NCT00667719|12171516|FG000|COMPLETED|Overall Study||493
10994910|NCT00667719|12171516|FG000|NOT COMPLETED|Overall Study||71
10994911|NCT00667732|12171527|FG000|STARTED|Run -In (8 Weeks)||41
10994912|NCT00667732|12171528|FG001|STARTED|Run -In (8 Weeks)||0
10994913|NCT00667732|12171529|FG002|STARTED|Run -In (8 Weeks)||0
10994914|NCT00667732|12171527|FG000|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
10994915|NCT00667732|12171528|FG001|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
10994916|NCT00667732|12171529|FG002|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
10994917|NCT00667732|12171527|FG000|COMPLETED|Run -In (8 Weeks)||34
10994918|NCT00667732|12171528|FG001|COMPLETED|Run -In (8 Weeks)||0
10994919|NCT00667732|12171529|FG002|COMPLETED|Run -In (8 Weeks)||0
10994920|NCT00667732|12171527|FG000|NOT COMPLETED|Run -In (8 Weeks)||7
10994921|NCT00667732|12171528|FG001|NOT COMPLETED|Run -In (8 Weeks)||0
10994922|NCT00667732|12171529|FG002|NOT COMPLETED|Run -In (8 Weeks)||0
10994923|NCT00667732|12171527|FG000|STARTED|Randomization (24 Weeks)||0
10994924|NCT00667732|12171528|FG001|STARTED|Randomization (24 Weeks)||17
10994925|NCT00667732|12171529|FG002|STARTED|Randomization (24 Weeks)||17
10994926|NCT00667732|12171527|FG000|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
10994927|NCT00667732|12171528|FG001|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
10994928|NCT00667732|12171529|FG002|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
10994929|NCT00667732|12171527|FG000|COMPLETED|Randomization (24 Weeks)||0
10994930|NCT00667732|12171528|FG001|COMPLETED|Randomization (24 Weeks)||16
10994931|NCT00667732|12171529|FG002|COMPLETED|Randomization (24 Weeks)||17
10994932|NCT00667732|12171527|FG000|NOT COMPLETED|Randomization (24 Weeks)||0
10994933|NCT00667732|12171528|FG001|NOT COMPLETED|Randomization (24 Weeks)||1
10994934|NCT00667732|12171529|FG002|NOT COMPLETED|Randomization (24 Weeks)||0
10994935|NCT00667732|12171527|FG000|STARTED|Extension (26 Weeks)||0
10994936|NCT00667732|12171528|FG001|STARTED|Extension (26 Weeks)||14
10994937|NCT00667732|12171529|FG002|STARTED|Extension (26 Weeks)||17
10994938|NCT00667732|12171527|FG000|COMPLETED|Extension (26 Weeks)||0
10994939|NCT00667732|12171528|FG001|COMPLETED|Extension (26 Weeks)||14
10994940|NCT00667732|12171529|FG002|COMPLETED|Extension (26 Weeks)||17
10994941|NCT00667732|12171527|FG000|NOT COMPLETED|Extension (26 Weeks)||0
10994942|NCT00667732|12171528|FG001|NOT COMPLETED|Extension (26 Weeks)||0
10994943|NCT00667732|12171529|FG002|NOT COMPLETED|Extension (26 Weeks)||0
10994944|NCT00667745|12171541|FG000|STARTED|Overall Study||141
10994945|NCT00667745|12171542|FG001|STARTED|Overall Study||142
10994946|NCT00667745|12171541|FG000|COMPLETED|Overall Study||116
10994947|NCT00667745|12171542|FG001|COMPLETED|Overall Study||121
10994948|NCT00667745|12171541|FG000|NOT COMPLETED|Overall Study||25
10994949|NCT00667745|12171542|FG001|NOT COMPLETED|Overall Study||21
10994950|NCT00667810|12171553|FG000|STARTED|Overall Study||269
10994951|NCT00667810|12171554|FG001|STARTED|Overall Study||264
10994952|NCT00667810|12171555|FG002|STARTED|Overall Study||346
10994953|NCT00667810|12171556|FG003|STARTED|Overall Study||11
10994954|NCT00667810|12171553|FG000|Treated|Overall Study||267
10994955|NCT00667810|12171554|FG001|Treated|Overall Study||263
10994956|NCT00667810|12171555|FG002|Treated|Overall Study||344
10994957|NCT00667810|12171556|FG003|Treated|Overall Study||11
10994958|NCT00667810|12171553|FG000|COMPLETED|Overall Study||102
10994959|NCT00667810|12171554|FG001|COMPLETED|Overall Study||94
10994960|NCT00667810|12171555|FG002|COMPLETED|Overall Study||124
10994961|NCT00667810|12171556|FG003|COMPLETED|Overall Study||9
10994962|NCT00667810|12171553|FG000|NOT COMPLETED|Overall Study||167
10994963|NCT00667810|12171554|FG001|NOT COMPLETED|Overall Study||170
10994964|NCT00667810|12171555|FG002|NOT COMPLETED|Overall Study||222
10994965|NCT00667810|12171556|FG003|NOT COMPLETED|Overall Study||2
10994966|NCT00667849|12171573|FG000|STARTED|Overall Study||250
10994967|NCT00667849|12171574|FG001|STARTED|Overall Study||251
10994968|NCT00667849|12171573|FG000|COMPLETED|Overall Study||142
10994969|NCT00667849|12171574|FG001|COMPLETED|Overall Study||130
10994970|NCT00667849|12171573|FG000|NOT COMPLETED|Overall Study||108
10994971|NCT00667849|12171574|FG001|NOT COMPLETED|Overall Study||121
10994972|NCT00667862|12171583|FG000|STARTED|Overall Study||35
10994973|NCT00667862|12171583|FG000|COMPLETED|Overall Study||0
10994974|NCT00667862|12171583|FG000|NOT COMPLETED|Overall Study||35
10994975|NCT00667875|12171590|FG000|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
10994976|NCT00667875|12171591|FG001|STARTED|Overall Study||21
10994977|NCT00667875|12171592|FG002|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
10994978|NCT00667875|12171590|FG000|Subjects Included in Analysisd|Overall Study||20
10994979|NCT00667875|12171591|FG001|Subjects Included in Analysisd|Overall Study||21
10994980|NCT00667875|12171592|FG002|Subjects Included in Analysisd|Overall Study||19
10994981|NCT00667875|12171590|FG000|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
10994982|NCT00667875|12171591|FG001|COMPLETED|Overall Study||10
10994983|NCT00667875|12171592|FG002|COMPLETED|Overall Study||8
10994984|NCT00667875|12171590|FG000|NOT COMPLETED|Overall Study||10
10994985|NCT00667875|12171591|FG001|NOT COMPLETED|Overall Study||11
10994986|NCT00667875|12171592|FG002|NOT COMPLETED|Overall Study||13
10994987|NCT00667888|12171608|FG000|STARTED|Overall Study||111
10994988|NCT00667888|12171609|FG001|STARTED|Overall Study||111
10994989|NCT00667888|12171608|FG000|COMPLETED|Overall Study||101
10994990|NCT00667888|12171609|FG001|COMPLETED|Overall Study||102
10994991|NCT00667888|12171608|FG000|NOT COMPLETED|Overall Study||10
10994992|NCT00667888|12171609|FG001|NOT COMPLETED|Overall Study||9
10994993|NCT00667992|12171617|FG000|STARTED|First Intervention 100 Mcg Twice Daily||49
10994994|NCT00667992|12171618|FG001|STARTED|First Intervention 100 Mcg Twice Daily||50
10994995|NCT00667992|12171617|FG000|COMPLETED|First Intervention 100 Mcg Twice Daily||44
10994996|NCT00667992|12171618|FG001|COMPLETED|First Intervention 100 Mcg Twice Daily||45
10994997|NCT00667992|12171617|FG000|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
10994998|NCT00667992|12171618|FG001|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
10994999|NCT00667992|12171617|FG000|STARTED|Second Intervention 400 Mcg Twice Daily||44
10995000|NCT00667992|12171618|FG001|STARTED|Second Intervention 400 Mcg Twice Daily||45
10995001|NCT00667992|12171617|FG000|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
10995002|NCT00667992|12171618|FG001|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
10995003|NCT00667992|12171617|FG000|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
10995004|NCT00667992|12171618|FG001|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
10995005|NCT00667992|12171617|FG000|STARTED|Wash-out||41
10995006|NCT00667992|12171618|FG001|STARTED|Wash-out||41
10995007|NCT00667992|12171617|FG000|COMPLETED|Wash-out||34
10995008|NCT00667992|12171618|FG001|COMPLETED|Wash-out||36
10995009|NCT00667992|12171617|FG000|NOT COMPLETED|Wash-out||7
10995010|NCT00667992|12171618|FG001|NOT COMPLETED|Wash-out||5
10995011|NCT00667992|12171617|FG000|STARTED|Third Intervention 100 Mcg Twice Daily||34
10995012|NCT00667992|12171618|FG001|STARTED|Third Intervention 100 Mcg Twice Daily||36
10995013|NCT00667992|12171617|FG000|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
10995014|NCT00667992|12171618|FG001|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
10995015|NCT00667992|12171617|FG000|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
10995016|NCT00667992|12171618|FG001|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
10995017|NCT00667992|12171617|FG000|STARTED|Forth Intervention 400 Mcg Twice Daily||33
10995018|NCT00667992|12171618|FG001|STARTED|Forth Intervention 400 Mcg Twice Daily||35
10995019|NCT00667992|12171617|FG000|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
10995020|NCT00667992|12171618|FG001|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
10995021|NCT00667992|12171617|FG000|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
10995022|NCT00667992|12171618|FG001|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
10995023|NCT00668148|12171634|FG000|STARTED|Overall Study||113
10995024|NCT00668148|12171634|FG000|Received at Least 1 Dose of Study Drug|Overall Study||111
10995025|NCT00668148|12171634|FG000|COMPLETED|Overall Study||103
10995026|NCT00668148|12171634|FG000|NOT COMPLETED|Overall Study||10
10995027|NCT00668200|12171649|FG000|STARTED|Overall Study||80
10995028|NCT00668200|12171649|FG000|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
10995029|NCT00668200|12171649|FG000|Intent to Treat (ITT)|Overall Study||80
10995030|NCT00668200|12171649|FG000|COMPLETED|Overall Study||77
10995031|NCT00668200|12171649|FG000|NOT COMPLETED|Overall Study||3
10995032|NCT00668317|12171653|FG000|STARTED|Overall Study||5
10995033|NCT00668317|12171653|FG000|COMPLETED|Overall Study||3
10995034|NCT00668317|12171653|FG000|NOT COMPLETED|Overall Study||2
10995035|NCT00668382|12171657|FG000|STARTED|Overall Study|beginning of trial|11
10995036|NCT00668382|12171657|FG000|COMPLETED|Overall Study||11
10995037|NCT00668382|12171657|FG000|NOT COMPLETED|Overall Study||0
10995038|NCT00668395|12171664|FG000|STARTED|Overall Study||45
10995039|NCT00668395|12171665|FG001|STARTED|Overall Study||22
10995040|NCT00668395|12171666|FG002|STARTED|Overall Study||6
10995041|NCT00668395|12171664|FG000|COMPLETED|Overall Study||39
10995042|NCT00668395|12171665|FG001|COMPLETED|Overall Study||16
10995043|NCT00668395|12171666|FG002|COMPLETED|Overall Study||5
10995044|NCT00668395|12171664|FG000|NOT COMPLETED|Overall Study||6
10995045|NCT00668395|12171665|FG001|NOT COMPLETED|Overall Study||6
10995046|NCT00668395|12171666|FG002|NOT COMPLETED|Overall Study||1
10995047|NCT00668434|12171676|FG000|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
10995048|NCT00668434|12171677|FG001|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
10995049|NCT00668434|12171676|FG000|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
10995050|NCT00668434|12171677|FG001|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
10995051|NCT00668434|12171676|FG000|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
10995052|NCT00668434|12171677|FG001|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
10995053|NCT00668434|12171676|FG000|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
10995054|NCT00668434|12171677|FG001|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
10995055|NCT00668434|12171676|FG000|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
10995056|NCT00668434|12171677|FG001|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
10995057|NCT00668434|12171676|FG000|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
10995058|NCT00668434|12171677|FG001|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
10995059|NCT00668525|12171686|FG000|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
10995060|NCT00668525|12171687|FG001|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
10995061|NCT00668525|12171688|FG002|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
10995062|NCT00668525|12171686|FG000|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
10995063|NCT00668525|12171687|FG001|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
10995064|NCT00668525|12171688|FG002|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
10995065|NCT00668525|12171686|FG000|NOT COMPLETED|Overall Study||77
10995066|NCT00668525|12171687|FG001|NOT COMPLETED|Overall Study||93
10995067|NCT00668525|12171688|FG002|NOT COMPLETED|Overall Study||53
10995068|NCT00668564|12171696|FG000|STARTED|Overall Study||18
10995069|NCT00668564|12171696|FG000|COMPLETED|Overall Study||18
10995070|NCT00668564|12171696|FG000|NOT COMPLETED|Overall Study||0
10995071|NCT00668707|12171702|FG000|STARTED|Overall Study||356
10995072|NCT00668707|12171703|FG001|STARTED|Overall Study||353
10995073|NCT00668707|12171702|FG000|COMPLETED|Overall Study||157
10995074|NCT00668707|12171703|FG001|COMPLETED|Overall Study||173
10995075|NCT00668707|12171702|FG000|NOT COMPLETED|Overall Study||199
10995076|NCT00668707|12171703|FG001|NOT COMPLETED|Overall Study||180
10995077|NCT00668733|12171716|FG000|STARTED|Overall Study||89
10995078|NCT00668733|12171717|FG001|STARTED|Overall Study||90
10995079|NCT00668733|12171716|FG000|COMPLETED|Overall Study||87
10995080|NCT00668733|12171717|FG001|COMPLETED|Overall Study||83
10995081|NCT00668733|12171716|FG000|NOT COMPLETED|Overall Study||2
10995082|NCT00668733|12171717|FG001|NOT COMPLETED|Overall Study||7
10995083|NCT00668746|12171725|FG000|STARTED|Overall Study||23
10995084|NCT00668746|12171726|FG001|STARTED|Overall Study||12
10995085|NCT00668746|12171725|FG000|COMPLETED|Overall Study||21
10995086|NCT00668746|12171726|FG001|COMPLETED|Overall Study||11
10995087|NCT00668746|12171725|FG000|NOT COMPLETED|Overall Study||2
10995088|NCT00668746|12171726|FG001|NOT COMPLETED|Overall Study||1
10995089|NCT00668811|12171742|FG000|STARTED|Overall Study||23
10995090|NCT00668811|12171742|FG000|COMPLETED|Overall Study||23
10995091|NCT00668811|12171742|FG000|NOT COMPLETED|Overall Study||0
10995092|NCT00668863|12171746|FG000|STARTED|Overall Study||71
10995093|NCT00668863|12171746|FG000|COMPLETED|Overall Study||0
10995094|NCT00668863|12171746|FG000|NOT COMPLETED|Overall Study||71
10995095|NCT00668902|12171753|FG000|STARTED|Overall Study||10
10995096|NCT00668902|12171754|FG001|STARTED|Overall Study||10
10995097|NCT00668902|12171755|FG002|STARTED|Overall Study||5
10995098|NCT00668902|12171753|FG000|COMPLETED|Overall Study||10
10995099|NCT00668902|12171754|FG001|COMPLETED|Overall Study||10
10995100|NCT00668902|12171755|FG002|COMPLETED|Overall Study||5
10995101|NCT00668902|12171753|FG000|NOT COMPLETED|Overall Study||0
10995102|NCT00668902|12171754|FG001|NOT COMPLETED|Overall Study||0
10995103|NCT00668902|12171755|FG002|NOT COMPLETED|Overall Study||0
10995104|NCT00669019|12171763|FG000|STARTED|Overall Study||23
10995105|NCT00669019|12171763|FG000|COMPLETED|Overall Study||23
10995106|NCT00669019|12171763|FG000|NOT COMPLETED|Overall Study||0
10995107|NCT00669032|12171769|FG000|STARTED|Overall Study||153
10995108|NCT00669032|12171770|FG001|STARTED|Overall Study||153
10995109|NCT00669032|12171769|FG000|COMPLETED|Overall Study||109
10995110|NCT00669032|12171770|FG001|COMPLETED|Overall Study||94
10995111|NCT00669032|12171769|FG000|NOT COMPLETED|Overall Study||44
10995112|NCT00669032|12171770|FG001|NOT COMPLETED|Overall Study||59
10995113|NCT00669110|12171778|FG000|STARTED|Overall Study||20
10995114|NCT00669110|12171779|FG001|STARTED|Overall Study||20
10995115|NCT00669110|12171778|FG000|COMPLETED|Overall Study||12
10995116|NCT00669110|12171779|FG001|COMPLETED|Overall Study||7
10995117|NCT00669110|12171778|FG000|NOT COMPLETED|Overall Study||8
10995118|NCT00669110|12171779|FG001|NOT COMPLETED|Overall Study||13
10995119|NCT00669162|12171785|FG000|STARTED|Overall Study||27
10995120|NCT00669162|12171785|FG000|COMPLETED|Overall Study||26
10995121|NCT00669162|12171785|FG000|NOT COMPLETED|Overall Study||1
10995122|NCT00669214|12171791|FG000|STARTED|Double-Blind Treatment Period (Week 12)||27
10995123|NCT00669214|12171792|FG001|STARTED|Double-Blind Treatment Period (Week 12)||62
10995124|NCT00669214|12171791|FG000|COMPLETED|Double-Blind Treatment Period (Week 12)||22
10995125|NCT00669214|12171792|FG001|COMPLETED|Double-Blind Treatment Period (Week 12)||55
10995126|NCT00669214|12171791|FG000|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
10995127|NCT00669214|12171792|FG001|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
10995128|NCT00669214|12171791|FG000|STARTED|Open-Label Treatment Period (Week 24)||22
10995129|NCT00669214|12171792|FG001|STARTED|Open-Label Treatment Period (Week 24)||55
10995130|NCT00669214|12171791|FG000|COMPLETED|Open-Label Treatment Period (Week 24)||18
10995131|NCT00669214|12171792|FG001|COMPLETED|Open-Label Treatment Period (Week 24)||46
10995132|NCT00669214|12171791|FG000|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
10995133|NCT00669214|12171792|FG001|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
10995134|NCT00669240|12171802|FG000|STARTED|Overall Study||567
10995135|NCT00669240|12171802|FG000|Assigned to Treatment|Overall Study||566
10995136|NCT00669240|12171802|FG000|Received Treatment|Overall Study||551
10995137|NCT00669240|12171802|FG000|COMPLETED|Overall Study||402
10995138|NCT00669240|12171802|FG000|NOT COMPLETED|Overall Study||165
10995139|NCT00669279|12171808|FG000|STARTED|Overall Study||22
10995140|NCT00669279|12171809|FG001|STARTED|Overall Study||19
10995141|NCT00669279|12171808|FG000|COMPLETED|Overall Study||22
10995142|NCT00669279|12171809|FG001|COMPLETED|Overall Study||19
10995143|NCT00669279|12171808|FG000|NOT COMPLETED|Overall Study||0
10995144|NCT00669279|12171809|FG001|NOT COMPLETED|Overall Study||0
10995145|NCT00669318|12171815|FG000|STARTED|Overall Study||41
10995146|NCT00669318|12171815|FG000|COMPLETED|Overall Study||39
10995147|NCT00669318|12171815|FG000|NOT COMPLETED|Overall Study||2
10995148|NCT00669331|12171821|FG000|STARTED|Randomisation to First Dose||244
10995149|NCT00669331|12171822|FG001|STARTED|Randomisation to First Dose||241
10995150|NCT00669331|12171821|FG000|COMPLETED|Randomisation to First Dose||233
10995151|NCT00669331|12171822|FG001|COMPLETED|Randomisation to First Dose||228
10995152|NCT00669331|12171821|FG000|NOT COMPLETED|Randomisation to First Dose||11
10995153|NCT00669331|12171822|FG001|NOT COMPLETED|Randomisation to First Dose||13
10995154|NCT00669331|12171821|FG000|STARTED|Blinded Treatment Period||233
10995155|NCT00669331|12171822|FG001|STARTED|Blinded Treatment Period||228
10995156|NCT00669331|12171821|FG000|COMPLETED|Blinded Treatment Period||191
10995157|NCT00669331|12171822|FG001|COMPLETED|Blinded Treatment Period||189
10995158|NCT00669331|12171821|FG000|NOT COMPLETED|Blinded Treatment Period||42
10995159|NCT00669331|12171822|FG001|NOT COMPLETED|Blinded Treatment Period||39
10995160|NCT00669383|12171832|FG000|STARTED|Overall Study||44
10995161|NCT00669383|12171833|FG001|STARTED|Overall Study||41
10995162|NCT00669383|12171832|FG000|COMPLETED|Overall Study||44
10995163|NCT00669383|12171833|FG001|COMPLETED|Overall Study||41
10995164|NCT00669383|12171832|FG000|NOT COMPLETED|Overall Study||0
10995165|NCT00669383|12171833|FG001|NOT COMPLETED|Overall Study||0
10995166|NCT00669396|12171841|FG000|STARTED|Overall Study||23
10995167|NCT00669396|12171842|FG001|STARTED|Overall Study||34
10995168|NCT00669396|12171841|FG000|COMPLETED|Overall Study||13
10995169|NCT00669396|12171842|FG001|COMPLETED|Overall Study||22
10995170|NCT00669396|12171841|FG000|NOT COMPLETED|Overall Study||10
10995171|NCT00669396|12171842|FG001|NOT COMPLETED|Overall Study||12
10995172|NCT00669409|12171854|FG000|STARTED|Part 1||6
10995173|NCT00669409|12171855|FG001|STARTED|Part 1||6
10995174|NCT00669409|12171856|FG002|STARTED|Part 1||6
10995175|NCT00669409|12171857|FG003|STARTED|Part 1||6
10995176|NCT00669409|12171858|FG004|STARTED|Part 1||6
10995177|NCT00669409|12171859|FG005|STARTED|Part 1||12
10995178|NCT00669409|12171860|FG006|STARTED|Part 1||0
10995179|NCT00669409|12171861|FG007|STARTED|Part 1||0
10995180|NCT00669409|12171862|FG008|STARTED|Part 1||0
10995181|NCT00669409|12171863|FG009|STARTED|Part 1||0
10995182|NCT00669409|12171864|FG010|STARTED|Part 1||0
10995183|NCT00669409|12171854|FG000|COMPLETED|Part 1||6
10995184|NCT00669409|12171855|FG001|COMPLETED|Part 1||6
10995185|NCT00669409|12171856|FG002|COMPLETED|Part 1||6
10995186|NCT00669409|12171857|FG003|COMPLETED|Part 1||6
10995187|NCT00669409|12171858|FG004|COMPLETED|Part 1||6
10995188|NCT00669409|12171859|FG005|COMPLETED|Part 1||12
10995189|NCT00669409|12171860|FG006|COMPLETED|Part 1||0
10995190|NCT00669409|12171861|FG007|COMPLETED|Part 1||0
10995191|NCT00669409|12171862|FG008|COMPLETED|Part 1||0
10995192|NCT00669409|12171863|FG009|COMPLETED|Part 1||0
10995193|NCT00669409|12171864|FG010|COMPLETED|Part 1||0
10995194|NCT00669409|12171854|FG000|NOT COMPLETED|Part 1||0
10995195|NCT00669409|12171855|FG001|NOT COMPLETED|Part 1||0
10995196|NCT00669409|12171856|FG002|NOT COMPLETED|Part 1||0
10995197|NCT00669409|12171857|FG003|NOT COMPLETED|Part 1||0
10995198|NCT00669409|12171858|FG004|NOT COMPLETED|Part 1||0
10995199|NCT00669409|12171859|FG005|NOT COMPLETED|Part 1||0
10995200|NCT00669409|12171860|FG006|NOT COMPLETED|Part 1||0
10995201|NCT00669409|12171861|FG007|NOT COMPLETED|Part 1||0
10995202|NCT00669409|12171862|FG008|NOT COMPLETED|Part 1||0
10995203|NCT00669409|12171863|FG009|NOT COMPLETED|Part 1||0
10995204|NCT00669409|12171864|FG010|NOT COMPLETED|Part 1||0
10995205|NCT00669409|12171854|FG000|STARTED|Part 2||0
10995206|NCT00669409|12171855|FG001|STARTED|Part 2||0
10995207|NCT00669409|12171856|FG002|STARTED|Part 2||0
10995208|NCT00669409|12171857|FG003|STARTED|Part 2||0
10995209|NCT00669409|12171858|FG004|STARTED|Part 2||0
10995210|NCT00669409|12171859|FG005|STARTED|Part 2||0
10995211|NCT00669409|12171860|FG006|STARTED|Part 2||9
10995212|NCT00669409|12171861|FG007|STARTED|Part 2||9
10995213|NCT00669409|12171862|FG008|STARTED|Part 2||9
10995214|NCT00669409|12171863|FG009|STARTED|Part 2||10
10995215|NCT00669409|12171864|FG010|STARTED|Part 2||4
10995216|NCT00669409|12171854|FG000|COMPLETED|Part 2||0
10995217|NCT00669409|12171855|FG001|COMPLETED|Part 2||0
10995218|NCT00669409|12171856|FG002|COMPLETED|Part 2||0
10995219|NCT00669409|12171857|FG003|COMPLETED|Part 2||0
10995220|NCT00669409|12171858|FG004|COMPLETED|Part 2||0
10995221|NCT00669409|12171859|FG005|COMPLETED|Part 2||0
10995222|NCT00669409|12171860|FG006|COMPLETED|Part 2||9
10995223|NCT00669409|12171861|FG007|COMPLETED|Part 2||9
10995224|NCT00669409|12171862|FG008|COMPLETED|Part 2||9
10995225|NCT00669409|12171863|FG009|COMPLETED|Part 2||9
10995226|NCT00669409|12171864|FG010|COMPLETED|Part 2||4
10995227|NCT00669409|12171854|FG000|NOT COMPLETED|Part 2||0
10995228|NCT00669409|12171855|FG001|NOT COMPLETED|Part 2||0
10995229|NCT00669409|12171856|FG002|NOT COMPLETED|Part 2||0
10995230|NCT00669409|12171857|FG003|NOT COMPLETED|Part 2||0
10995231|NCT00669409|12171858|FG004|NOT COMPLETED|Part 2||0
10995232|NCT00669409|12171859|FG005|NOT COMPLETED|Part 2||0
10995233|NCT00669409|12171860|FG006|NOT COMPLETED|Part 2||0
10995234|NCT00669409|12171861|FG007|NOT COMPLETED|Part 2||0
10995235|NCT00669409|12171862|FG008|NOT COMPLETED|Part 2||0
10995236|NCT00669409|12171863|FG009|NOT COMPLETED|Part 2||1
10995237|NCT00669409|12171864|FG010|NOT COMPLETED|Part 2||0
10995238|NCT00669539|12171893|FG000|STARTED|Overall Study||94
10995239|NCT00669539|12171894|FG001|STARTED|Overall Study||52
10995240|NCT00669539|12171893|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
10995241|NCT00669539|12171894|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
10995242|NCT00669539|12171893|FG000|NOT COMPLETED|Overall Study||8
10995243|NCT00669539|12171894|FG001|NOT COMPLETED|Overall Study||9
10995244|NCT00669552|12171900|FG000|STARTED|Overall Study||11
10995245|NCT00669552|12171900|FG000|COMPLETED|Overall Study||11
10995246|NCT00669552|12171900|FG000|NOT COMPLETED|Overall Study||0
10995247|NCT00669578|12171906|FG000|STARTED|Overall Study||12
10995248|NCT00669578|12171907|FG001|STARTED|Overall Study||65
10995249|NCT00669578|12171906|FG000|COMPLETED|Overall Study||12
10995250|NCT00669578|12171907|FG001|COMPLETED|Overall Study||65
10995251|NCT00669578|12171906|FG000|NOT COMPLETED|Overall Study||0
10995252|NCT00669578|12171907|FG001|NOT COMPLETED|Overall Study||0
10995253|NCT00669617|12171914|FG000|STARTED|Period 1||18
10995254|NCT00669617|12171915|FG001|STARTED|Period 1||17
10995255|NCT00669617|12171916|FG002|STARTED|Period 1||18
10995256|NCT00669617|12171917|FG003|STARTED|Period 1||18
10995257|NCT00669617|12171918|FG004|STARTED|Period 1||18
10995258|NCT00669617|12171914|FG000|COMPLETED|Period 1||18
10995259|NCT00669617|12171915|FG001|COMPLETED|Period 1||17
10995260|NCT00669617|12171916|FG002|COMPLETED|Period 1||17
10995261|NCT00669617|12171917|FG003|COMPLETED|Period 1||18
10995262|NCT00669617|12171918|FG004|COMPLETED|Period 1||17
10995263|NCT00669617|12171914|FG000|NOT COMPLETED|Period 1||0
10995264|NCT00669617|12171915|FG001|NOT COMPLETED|Period 1||0
10995265|NCT00669617|12171916|FG002|NOT COMPLETED|Period 1||1
10995266|NCT00669617|12171917|FG003|NOT COMPLETED|Period 1||0
10995267|NCT00669617|12171918|FG004|NOT COMPLETED|Period 1||1
10995268|NCT00669617|12171914|FG000|STARTED|Period 2||18
10995269|NCT00669617|12171915|FG001|STARTED|Period 2||17
10995270|NCT00669617|12171916|FG002|STARTED|Period 2||17
10995271|NCT00669617|12171917|FG003|STARTED|Period 2||18
10995272|NCT00669617|12171918|FG004|STARTED|Period 2||17
10995273|NCT00669617|12171914|FG000|COMPLETED|Period 2||18
10995274|NCT00669617|12171915|FG001|COMPLETED|Period 2||17
10995275|NCT00669617|12171916|FG002|COMPLETED|Period 2||17
10995276|NCT00669617|12171917|FG003|COMPLETED|Period 2||18
10995277|NCT00669617|12171918|FG004|COMPLETED|Period 2||17
10995278|NCT00669617|12171914|FG000|NOT COMPLETED|Period 2||0
10995279|NCT00669617|12171915|FG001|NOT COMPLETED|Period 2||0
10995280|NCT00669617|12171916|FG002|NOT COMPLETED|Period 2||0
10995281|NCT00669617|12171917|FG003|NOT COMPLETED|Period 2||0
10995282|NCT00669617|12171918|FG004|NOT COMPLETED|Period 2||0
10995283|NCT00669617|12171914|FG000|STARTED|Period 3||18
10995284|NCT00669617|12171915|FG001|STARTED|Period 3||17
10995285|NCT00669617|12171916|FG002|STARTED|Period 3||17
10995286|NCT00669617|12171917|FG003|STARTED|Period 3||18
10995287|NCT00669617|12171918|FG004|STARTED|Period 3||17
10995288|NCT00669617|12171914|FG000|COMPLETED|Period 3||17
10995289|NCT00669617|12171915|FG001|COMPLETED|Period 3||17
10995290|NCT00669617|12171916|FG002|COMPLETED|Period 3||17
10995291|NCT00669617|12171917|FG003|COMPLETED|Period 3||18
10995292|NCT00669617|12171918|FG004|COMPLETED|Period 3||17
10995293|NCT00669617|12171914|FG000|NOT COMPLETED|Period 3||1
10995294|NCT00669617|12171915|FG001|NOT COMPLETED|Period 3||0
10995295|NCT00669617|12171916|FG002|NOT COMPLETED|Period 3||0
10995296|NCT00669617|12171917|FG003|NOT COMPLETED|Period 3||0
10995297|NCT00669617|12171918|FG004|NOT COMPLETED|Period 3||0
10995298|NCT00669617|12171914|FG000|STARTED|Period 4||17
10995299|NCT00669617|12171915|FG001|STARTED|Period 4||17
10995300|NCT00669617|12171916|FG002|STARTED|Period 4||17
10995301|NCT00669617|12171917|FG003|STARTED|Period 4||18
10995302|NCT00669617|12171918|FG004|STARTED|Period 4||17
10995303|NCT00669617|12171914|FG000|COMPLETED|Period 4||17
10995304|NCT00669617|12171915|FG001|COMPLETED|Period 4||17
10995305|NCT00669617|12171916|FG002|COMPLETED|Period 4||17
10995306|NCT00669617|12171917|FG003|COMPLETED|Period 4||18
10995307|NCT00669617|12171918|FG004|COMPLETED|Period 4||17
10995308|NCT00669617|12171914|FG000|NOT COMPLETED|Period 4||0
10995309|NCT00669617|12171915|FG001|NOT COMPLETED|Period 4||0
10995310|NCT00669617|12171916|FG002|NOT COMPLETED|Period 4||0
10995311|NCT00669617|12171917|FG003|NOT COMPLETED|Period 4||0
10995312|NCT00669617|12171918|FG004|NOT COMPLETED|Period 4||0
10995313|NCT00669617|12171914|FG000|STARTED|Period 5||17
10995314|NCT00669617|12171915|FG001|STARTED|Period 5||17
10995315|NCT00669617|12171916|FG002|STARTED|Period 5||17
10995316|NCT00669617|12171917|FG003|STARTED|Period 5||18
10995317|NCT00669617|12171918|FG004|STARTED|Period 5||17
10995318|NCT00669617|12171914|FG000|COMPLETED|Period 5||17
10995319|NCT00669617|12171915|FG001|COMPLETED|Period 5||17
10995320|NCT00669617|12171916|FG002|COMPLETED|Period 5||17
10995321|NCT00669617|12171917|FG003|COMPLETED|Period 5||18
10995322|NCT00669617|12171918|FG004|COMPLETED|Period 5||17
10995323|NCT00669617|12171914|FG000|NOT COMPLETED|Period 5||0
10995324|NCT00669617|12171915|FG001|NOT COMPLETED|Period 5||0
10995325|NCT00669617|12171916|FG002|NOT COMPLETED|Period 5||0
10995326|NCT00669617|12171917|FG003|NOT COMPLETED|Period 5||0
10995327|NCT00669617|12171918|FG004|NOT COMPLETED|Period 5||0
10995328|NCT00669682|12171930|FG000|STARTED|Overall Study||9
10995329|NCT00669682|12171930|FG000|COMPLETED|Overall Study||9
10995330|NCT00669682|12171930|FG000|NOT COMPLETED|Overall Study||0
10995331|NCT00669864|12171935|FG000|STARTED|Overall Study||293
10995332|NCT00669864|12171935|FG000|COMPLETED|Overall Study||284
10995333|NCT00669864|12171935|FG000|NOT COMPLETED|Overall Study||9
10995334|NCT00669877|12171939|FG000|STARTED|Overall Study||56
10995335|NCT00669877|12171939|FG000|COMPLETED|Overall Study||52
10995336|NCT00669877|12171939|FG000|NOT COMPLETED|Overall Study||4
10995337|NCT00669903|12171947|FG000|STARTED|Overall Study||23
10995338|NCT00669903|12171948|FG001|STARTED|Overall Study||37
10995339|NCT00669903|12171949|FG002|STARTED|Overall Study||18
10995340|NCT00669903|12171950|FG003|STARTED|Overall Study||22
10995341|NCT00669903|12171947|FG000|Completed Treatment Period|Overall Study||23
10995342|NCT00669903|12171948|FG001|Completed Treatment Period|Overall Study||33
10995343|NCT00669903|12171949|FG002|Completed Treatment Period|Overall Study||13
10995344|NCT00669903|12171950|FG003|Completed Treatment Period|Overall Study||19
10995345|NCT00669903|12171947|FG000|COMPLETED|Overall Study||22
10995346|NCT00669903|12171948|FG001|COMPLETED|Overall Study||32
10995347|NCT00669903|12171949|FG002|COMPLETED|Overall Study||13
10995348|NCT00669903|12171950|FG003|COMPLETED|Overall Study||18
10995349|NCT00669903|12171947|FG000|NOT COMPLETED|Overall Study||1
10995350|NCT00669903|12171948|FG001|NOT COMPLETED|Overall Study||5
10995351|NCT00669903|12171949|FG002|NOT COMPLETED|Overall Study||5
10995352|NCT00669903|12171950|FG003|NOT COMPLETED|Overall Study||4
10995353|NCT00669916|12171962|FG000|STARTED|Overall Study||18
10995354|NCT00669916|12171963|FG001|STARTED|Overall Study||18
10995355|NCT00669916|12171962|FG000|COMPLETED|Overall Study||18
10995356|NCT00669916|12171963|FG001|COMPLETED|Overall Study||18
10995357|NCT00669916|12171962|FG000|NOT COMPLETED|Overall Study||0
10995358|NCT00669916|12171963|FG001|NOT COMPLETED|Overall Study||0
10995359|NCT00669942|12171981|FG000|STARTED|Part 1||6
10995360|NCT00669942|12171982|FG001|STARTED|Part 1||6
10995361|NCT00669942|12171983|FG002|STARTED|Part 1||6
10995362|NCT00669942|12171984|FG003|STARTED|Part 1||6
10995363|NCT00669942|12171985|FG004|STARTED|Part 1||8
10995364|NCT00669942|12171986|FG005|STARTED|Part 1||0
10995365|NCT00669942|12171987|FG006|STARTED|Part 1||0
10995366|NCT00669942|12171988|FG007|STARTED|Part 1||0
10995367|NCT00669942|12171989|FG008|STARTED|Part 1||0
10995368|NCT00669942|12171990|FG009|STARTED|Part 1||0
10995369|NCT00669942|12171991|FG010|STARTED|Part 1||0
10995370|NCT00669942|12171992|FG011|STARTED|Part 1||0
10995371|NCT00669942|12171981|FG000|COMPLETED|Part 1||6
10995372|NCT00669942|12171982|FG001|COMPLETED|Part 1||6
10995373|NCT00669942|12171983|FG002|COMPLETED|Part 1||6
10995374|NCT00669942|12171984|FG003|COMPLETED|Part 1||6
10995375|NCT00669942|12171985|FG004|COMPLETED|Part 1||8
10995376|NCT00669942|12171986|FG005|COMPLETED|Part 1||0
10995377|NCT00669942|12171987|FG006|COMPLETED|Part 1||0
10995378|NCT00669942|12171988|FG007|COMPLETED|Part 1||0
10995379|NCT00669942|12171989|FG008|COMPLETED|Part 1||0
10995380|NCT00669942|12171990|FG009|COMPLETED|Part 1||0
10995381|NCT00669942|12171991|FG010|COMPLETED|Part 1||0
10995382|NCT00669942|12171992|FG011|COMPLETED|Part 1||0
10995383|NCT00669942|12171981|FG000|NOT COMPLETED|Part 1||0
10995384|NCT00669942|12171982|FG001|NOT COMPLETED|Part 1||0
10995385|NCT00669942|12171983|FG002|NOT COMPLETED|Part 1||0
10995386|NCT00669942|12171984|FG003|NOT COMPLETED|Part 1||0
10995387|NCT00669942|12171985|FG004|NOT COMPLETED|Part 1||0
10995388|NCT00669942|12171986|FG005|NOT COMPLETED|Part 1||0
10995389|NCT00669942|12171987|FG006|NOT COMPLETED|Part 1||0
10995390|NCT00669942|12171988|FG007|NOT COMPLETED|Part 1||0
10995391|NCT00669942|12171989|FG008|NOT COMPLETED|Part 1||0
10995392|NCT00669942|12171990|FG009|NOT COMPLETED|Part 1||0
10995393|NCT00669942|12171991|FG010|NOT COMPLETED|Part 1||0
10995394|NCT00669942|12171992|FG011|NOT COMPLETED|Part 1||0
10995395|NCT00669942|12171981|FG000|STARTED|Parts 2 and 3||0
10995396|NCT00669942|12171982|FG001|STARTED|Parts 2 and 3||0
10995397|NCT00669942|12171983|FG002|STARTED|Parts 2 and 3||0
10995398|NCT00669942|12171984|FG003|STARTED|Parts 2 and 3||0
10995399|NCT00669942|12171985|FG004|STARTED|Parts 2 and 3||0
10995400|NCT00669942|12171986|FG005|STARTED|Parts 2 and 3||6
10995401|NCT00669942|12171987|FG006|STARTED|Parts 2 and 3||6
10995402|NCT00669942|12171988|FG007|STARTED|Parts 2 and 3||26
10995403|NCT00669942|12171989|FG008|STARTED|Parts 2 and 3||26
10995404|NCT00669942|12171990|FG009|STARTED|Parts 2 and 3||0
10995405|NCT00669942|12171991|FG010|STARTED|Parts 2 and 3||0
10995406|NCT00669942|12171992|FG011|STARTED|Parts 2 and 3||0
10995407|NCT00669942|12171981|FG000|COMPLETED|Parts 2 and 3||0
10995408|NCT00669942|12171982|FG001|COMPLETED|Parts 2 and 3||0
10995409|NCT00669942|12171983|FG002|COMPLETED|Parts 2 and 3||0
10995410|NCT00669942|12171984|FG003|COMPLETED|Parts 2 and 3||0
10995411|NCT00669942|12171985|FG004|COMPLETED|Parts 2 and 3||0
10995412|NCT00669942|12171986|FG005|COMPLETED|Parts 2 and 3||4
10995413|NCT00669942|12171987|FG006|COMPLETED|Parts 2 and 3||6
10995414|NCT00669942|12171988|FG007|COMPLETED|Parts 2 and 3||24
10995415|NCT00669942|12171989|FG008|COMPLETED|Parts 2 and 3||23
10995416|NCT00669942|12171990|FG009|COMPLETED|Parts 2 and 3||0
10995417|NCT00669942|12171991|FG010|COMPLETED|Parts 2 and 3||0
10995418|NCT00669942|12171992|FG011|COMPLETED|Parts 2 and 3||0
10995419|NCT00669942|12171981|FG000|NOT COMPLETED|Parts 2 and 3||0
10995420|NCT00669942|12171982|FG001|NOT COMPLETED|Parts 2 and 3||0
10995421|NCT00669942|12171983|FG002|NOT COMPLETED|Parts 2 and 3||0
10995422|NCT00669942|12171984|FG003|NOT COMPLETED|Parts 2 and 3||0
10995423|NCT00669942|12171985|FG004|NOT COMPLETED|Parts 2 and 3||0
10995424|NCT00669942|12171986|FG005|NOT COMPLETED|Parts 2 and 3||2
10995425|NCT00669942|12171987|FG006|NOT COMPLETED|Parts 2 and 3||0
10995426|NCT00669942|12171988|FG007|NOT COMPLETED|Parts 2 and 3||2
10995427|NCT00669942|12171989|FG008|NOT COMPLETED|Parts 2 and 3||3
10995428|NCT00669942|12171990|FG009|NOT COMPLETED|Parts 2 and 3||0
10995429|NCT00669942|12171991|FG010|NOT COMPLETED|Parts 2 and 3||0
10995430|NCT00669942|12171992|FG011|NOT COMPLETED|Parts 2 and 3||0
10995431|NCT00669942|12171981|FG000|STARTED|Healthy Volunteers||0
10995432|NCT00669942|12171982|FG001|STARTED|Healthy Volunteers||0
10995433|NCT00669942|12171983|FG002|STARTED|Healthy Volunteers||0
10995434|NCT00669942|12171984|FG003|STARTED|Healthy Volunteers||0
10995435|NCT00669942|12171985|FG004|STARTED|Healthy Volunteers||0
10995436|NCT00669942|12171986|FG005|STARTED|Healthy Volunteers||0
10995437|NCT00669942|12171987|FG006|STARTED|Healthy Volunteers||0
10995438|NCT00669942|12171988|FG007|STARTED|Healthy Volunteers||0
10995439|NCT00669942|12171989|FG008|STARTED|Healthy Volunteers||0
10995440|NCT00669942|12171990|FG009|STARTED|Healthy Volunteers||3
10995441|NCT00669942|12171991|FG010|STARTED|Healthy Volunteers||3
10995442|NCT00669942|12171992|FG011|STARTED|Healthy Volunteers||2
10995443|NCT00669942|12171981|FG000|COMPLETED|Healthy Volunteers||0
10995444|NCT00669942|12171982|FG001|COMPLETED|Healthy Volunteers||0
10995445|NCT00669942|12171983|FG002|COMPLETED|Healthy Volunteers||0
10995446|NCT00669942|12171984|FG003|COMPLETED|Healthy Volunteers||0
10995447|NCT00669942|12171985|FG004|COMPLETED|Healthy Volunteers||0
10995448|NCT00669942|12171986|FG005|COMPLETED|Healthy Volunteers||0
10995449|NCT00669942|12171987|FG006|COMPLETED|Healthy Volunteers||0
10995450|NCT00669942|12171988|FG007|COMPLETED|Healthy Volunteers||0
10995451|NCT00669942|12171989|FG008|COMPLETED|Healthy Volunteers||0
10995452|NCT00669942|12171990|FG009|COMPLETED|Healthy Volunteers||3
10995453|NCT00669942|12171991|FG010|COMPLETED|Healthy Volunteers||2
10995454|NCT00669942|12171992|FG011|COMPLETED|Healthy Volunteers||2
10995455|NCT00669942|12171981|FG000|NOT COMPLETED|Healthy Volunteers||0
10995456|NCT00669942|12171982|FG001|NOT COMPLETED|Healthy Volunteers||0
10995457|NCT00669942|12171983|FG002|NOT COMPLETED|Healthy Volunteers||0
10995458|NCT00669942|12171984|FG003|NOT COMPLETED|Healthy Volunteers||0
10995459|NCT00669942|12171985|FG004|NOT COMPLETED|Healthy Volunteers||0
10995460|NCT00669942|12171986|FG005|NOT COMPLETED|Healthy Volunteers||0
10995461|NCT00669942|12171987|FG006|NOT COMPLETED|Healthy Volunteers||0
10995462|NCT00669942|12171988|FG007|NOT COMPLETED|Healthy Volunteers||0
10995463|NCT00669942|12171989|FG008|NOT COMPLETED|Healthy Volunteers||0
10995464|NCT00669942|12171990|FG009|NOT COMPLETED|Healthy Volunteers||0
10995465|NCT00669942|12171991|FG010|NOT COMPLETED|Healthy Volunteers||1
10995466|NCT00669942|12171992|FG011|NOT COMPLETED|Healthy Volunteers||0
10995549|NCT00670267|12172082|FG000|COMPLETED|Overall Study||9
10995467|NCT00669955|12172017|FG000|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
10995468|NCT00669955|12172018|FG001|STARTED|Overall Study||222
10995469|NCT00669955|12172017|FG000|COMPLETED|Overall Study||204
10995470|NCT00669955|12172018|FG001|COMPLETED|Overall Study||195
10995471|NCT00669955|12172017|FG000|NOT COMPLETED|Overall Study||14
10995472|NCT00669955|12172018|FG001|NOT COMPLETED|Overall Study||27
10995473|NCT00670007|12172024|FG000|STARTED|Overall Study||140
10995474|NCT00670007|12172024|FG000|COMPLETED|Overall Study||131
10995475|NCT00670007|12172024|FG000|NOT COMPLETED|Overall Study||9
10995476|NCT00670046|12172031|FG000|STARTED|Overall Study||7
10995477|NCT00670046|12172032|FG001|STARTED|Overall Study||8
10995478|NCT00670046|12172031|FG000|COMPLETED|Overall Study||6
10995479|NCT00670046|12172032|FG001|COMPLETED|Overall Study||6
10995480|NCT00670046|12172031|FG000|NOT COMPLETED|Overall Study||1
10995481|NCT00670046|12172032|FG001|NOT COMPLETED|Overall Study||2
10995482|NCT00670111|12172041|FG000|STARTED|Enrollment to One Month||5
10995483|NCT00670111|12172042|FG001|STARTED|Enrollment to One Month||8
10995484|NCT00670111|12172043|FG002|STARTED|Enrollment to One Month||19
10995485|NCT00670111|12172041|FG000|COMPLETED|Enrollment to One Month||4
10995486|NCT00670111|12172042|FG001|COMPLETED|Enrollment to One Month||8
10995487|NCT00670111|12172043|FG002|COMPLETED|Enrollment to One Month||0
10995488|NCT00670111|12172041|FG000|NOT COMPLETED|Enrollment to One Month||1
10995489|NCT00670111|12172042|FG001|NOT COMPLETED|Enrollment to One Month||0
10995490|NCT00670111|12172043|FG002|NOT COMPLETED|Enrollment to One Month||19
10995491|NCT00670111|12172041|FG000|STARTED|One Month Period A||4
10995492|NCT00670111|12172042|FG001|STARTED|One Month Period A||8
10995493|NCT00670111|12172043|FG002|STARTED|One Month Period A||0
10995494|NCT00670111|12172041|FG000|COMPLETED|One Month Period A||4
10995495|NCT00670111|12172042|FG001|COMPLETED|One Month Period A||8
10995496|NCT00670111|12172043|FG002|COMPLETED|One Month Period A||0
10995497|NCT00670111|12172041|FG000|NOT COMPLETED|One Month Period A||0
10995498|NCT00670111|12172042|FG001|NOT COMPLETED|One Month Period A||0
10995499|NCT00670111|12172043|FG002|NOT COMPLETED|One Month Period A||0
10995500|NCT00670111|12172041|FG000|STARTED|One Month Period B||4
10995501|NCT00670111|12172042|FG001|STARTED|One Month Period B||8
10995502|NCT00670111|12172043|FG002|STARTED|One Month Period B||0
10995503|NCT00670111|12172041|FG000|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
10995504|NCT00670111|12172042|FG001|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
10995505|NCT00670111|12172043|FG002|COMPLETED|One Month Period B||0
10995506|NCT00670111|12172041|FG000|NOT COMPLETED|One Month Period B||0
10995507|NCT00670111|12172042|FG001|NOT COMPLETED|One Month Period B||0
10995508|NCT00670111|12172043|FG002|NOT COMPLETED|One Month Period B||0
10995509|NCT00670111|12172041|FG000|STARTED|One Month to Six Months||4
10995510|NCT00670111|12172042|FG001|STARTED|One Month to Six Months||8
10995511|NCT00670111|12172043|FG002|STARTED|One Month to Six Months||0
10995512|NCT00670111|12172041|FG000|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
10995513|NCT00670111|12172042|FG001|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
10995514|NCT00670111|12172043|FG002|COMPLETED|One Month to Six Months||0
10995515|NCT00670111|12172041|FG000|NOT COMPLETED|One Month to Six Months||0
10995516|NCT00670111|12172042|FG001|NOT COMPLETED|One Month to Six Months||0
10995517|NCT00670111|12172043|FG002|NOT COMPLETED|One Month to Six Months||0
10995518|NCT00670111|12172041|FG000|STARTED|Six Months to Twelve Months||4
10995519|NCT00670111|12172042|FG001|STARTED|Six Months to Twelve Months||8
10995520|NCT00670111|12172043|FG002|STARTED|Six Months to Twelve Months||0
10995521|NCT00670111|12172041|FG000|COMPLETED|Six Months to Twelve Months||4
10995522|NCT00670111|12172042|FG001|COMPLETED|Six Months to Twelve Months||8
10995523|NCT00670111|12172043|FG002|COMPLETED|Six Months to Twelve Months||0
10995524|NCT00670111|12172041|FG000|NOT COMPLETED|Six Months to Twelve Months||0
10995525|NCT00670111|12172042|FG001|NOT COMPLETED|Six Months to Twelve Months||0
10995526|NCT00670111|12172043|FG002|NOT COMPLETED|Six Months to Twelve Months||0
10995527|NCT00670202|12172053|FG000|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
10995528|NCT00670202|12172054|FG001|STARTED|Overall Study||0
10995529|NCT00670202|12172053|FG000|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
10995530|NCT00670202|12172054|FG001|COMPLETED|Overall Study||0
10995531|NCT00670202|12172053|FG000|NOT COMPLETED|Overall Study||0
10995532|NCT00670202|12172054|FG001|NOT COMPLETED|Overall Study||0
10995533|NCT00670228|12172062|FG000|STARTED|Overall Study||18
10995534|NCT00670228|12172063|FG001|STARTED|Overall Study||15
10995535|NCT00670228|12172062|FG000|COMPLETED|Overall Study||13
10995536|NCT00670228|12172063|FG001|COMPLETED|Overall Study||12
10995537|NCT00670228|12172062|FG000|NOT COMPLETED|Overall Study||5
10995538|NCT00670228|12172063|FG001|NOT COMPLETED|Overall Study||3
10995539|NCT00670241|12172072|FG000|STARTED|Overall Study||183
10995540|NCT00670241|12172073|FG001|STARTED|Overall Study||184
10995541|NCT00670241|12172074|FG002|STARTED|Overall Study||91
10995542|NCT00670241|12172072|FG000|COMPLETED|Overall Study||171
10995543|NCT00670241|12172073|FG001|COMPLETED|Overall Study||163
10995544|NCT00670241|12172074|FG002|COMPLETED|Overall Study||64
10995545|NCT00670241|12172072|FG000|NOT COMPLETED|Overall Study||12
10995546|NCT00670241|12172073|FG001|NOT COMPLETED|Overall Study||21
10995547|NCT00670241|12172074|FG002|NOT COMPLETED|Overall Study||27
10995548|NCT00670267|12172082|FG000|STARTED|Overall Study||10
10995550|NCT00670267|12172082|FG000|NOT COMPLETED|Overall Study||1
10995551|NCT00670306|12172088|FG000|STARTED|Overall Study||528
10995552|NCT00670306|12172088|FG000|COMPLETED|Overall Study||473
10995553|NCT00670306|12172088|FG000|NOT COMPLETED|Overall Study||55
10995554|NCT00670449|12172096|FG000|STARTED|Overall Study||47
10995555|NCT00670449|12172097|FG001|STARTED|Overall Study||46
10995556|NCT00670449|12172098|FG002|STARTED|Overall Study||27
10995557|NCT00670449|12172099|FG003|STARTED|Overall Study||23
10995558|NCT00670449|12172096|FG000|Switched to 0.5mg (Open Label)|Overall Study||45
10995559|NCT00670449|12172097|FG001|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
10995560|NCT00670449|12172098|FG002|Switched to 0.5mg (Open Label)|Overall Study||23
10995561|NCT00670449|12172099|FG003|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
10995562|NCT00670449|12172096|FG000|COMPLETED|Overall Study||38
10995563|NCT00670449|12172097|FG001|COMPLETED|Overall Study||36
10995564|NCT00670449|12172098|FG002|COMPLETED|Overall Study||18
10995565|NCT00670449|12172099|FG003|COMPLETED|Overall Study||15
10995566|NCT00670449|12172096|FG000|NOT COMPLETED|Overall Study||9
10995567|NCT00670449|12172097|FG001|NOT COMPLETED|Overall Study||10
10995568|NCT00670449|12172098|FG002|NOT COMPLETED|Overall Study||9
10995569|NCT00670449|12172099|FG003|NOT COMPLETED|Overall Study||8
10995570|NCT00670462|12172110|FG000|STARTED|Overall Study||106
10995571|NCT00670462|12172111|FG001|STARTED|Overall Study||107
10995572|NCT00670462|12172110|FG000|COMPLETED|Overall Study||76
10995573|NCT00670462|12172111|FG001|COMPLETED|Overall Study||76
10995574|NCT00670462|12172110|FG000|NOT COMPLETED|Overall Study||30
10995575|NCT00670462|12172111|FG001|NOT COMPLETED|Overall Study||31
10995576|NCT00670488|12172129|FG000|STARTED|Overall Study||3
10995577|NCT00670488|12172130|FG001|STARTED|Overall Study||58
10995578|NCT00670488|12172131|FG002|STARTED|Overall Study||3
10995579|NCT00670488|12172132|FG003|STARTED|Overall Study||7
10995580|NCT00670488|12172133|FG004|STARTED|Overall Study||3
10995581|NCT00670488|12172134|FG005|STARTED|Overall Study||5
10995582|NCT00670488|12172135|FG006|STARTED|Overall Study||17
10995583|NCT00670488|12172136|FG007|STARTED|Overall Study||3
10995584|NCT00670488|12172137|FG008|STARTED|Overall Study||3
10995585|NCT00670488|12172138|FG009|STARTED|Overall Study||2
10995586|NCT00670488|12172129|FG000|COMPLETED|Overall Study||0
10995587|NCT00670488|12172130|FG001|COMPLETED|Overall Study||0
10995588|NCT00670488|12172131|FG002|COMPLETED|Overall Study||0
10995589|NCT00670488|12172132|FG003|COMPLETED|Overall Study||0
10995590|NCT00670488|12172133|FG004|COMPLETED|Overall Study||0
10995591|NCT00670488|12172134|FG005|COMPLETED|Overall Study||0
10995592|NCT00670488|12172135|FG006|COMPLETED|Overall Study||0
10995593|NCT00670488|12172136|FG007|COMPLETED|Overall Study||0
10995594|NCT00670488|12172137|FG008|COMPLETED|Overall Study||0
10995595|NCT00670488|12172138|FG009|COMPLETED|Overall Study||0
10995596|NCT00670488|12172129|FG000|NOT COMPLETED|Overall Study||3
10995597|NCT00670488|12172130|FG001|NOT COMPLETED|Overall Study||58
10995598|NCT00670488|12172131|FG002|NOT COMPLETED|Overall Study||3
10995599|NCT00670488|12172132|FG003|NOT COMPLETED|Overall Study||7
10995600|NCT00670488|12172133|FG004|NOT COMPLETED|Overall Study||3
10995601|NCT00670488|12172134|FG005|NOT COMPLETED|Overall Study||5
10995602|NCT00670488|12172135|FG006|NOT COMPLETED|Overall Study||17
10995603|NCT00670488|12172136|FG007|NOT COMPLETED|Overall Study||3
10995604|NCT00670488|12172137|FG008|NOT COMPLETED|Overall Study||3
10995605|NCT00670488|12172138|FG009|NOT COMPLETED|Overall Study||2
10995606|NCT00670540|12172160|FG000|STARTED|Overall Study||8256
10995607|NCT00670540|12172160|FG000|COMPLETED|Overall Study|total recruited for the follow up|4931
10995608|NCT00670540|12172160|FG000|NOT COMPLETED|Overall Study||3325
10995609|NCT00670709|12172166|FG000|STARTED|Overall Study||27
10995610|NCT00670709|12172167|FG001|STARTED|Overall Study||15
10995611|NCT00670709|12172166|FG000|COMPLETED|Overall Study||27
10995612|NCT00670709|12172167|FG001|COMPLETED|Overall Study||15
10995613|NCT00670709|12172166|FG000|NOT COMPLETED|Overall Study||0
10995614|NCT00670709|12172167|FG001|NOT COMPLETED|Overall Study||0
10995615|NCT00670748|12172177|FG000|STARTED|Overall Study||17
10995616|NCT00670748|12172178|FG001|STARTED|Overall Study||16
10995617|NCT00670748|12172179|FG002|STARTED|Overall Study||7
10995618|NCT00670748|12172180|FG003|STARTED|Overall Study||5
10995619|NCT00670748|12172177|FG000|COMPLETED|Overall Study||14
10995620|NCT00670748|12172178|FG001|COMPLETED|Overall Study||14
10995621|NCT00670748|12172179|FG002|COMPLETED|Overall Study||5
10995622|NCT00670748|12172180|FG003|COMPLETED|Overall Study||4
10995623|NCT00670748|12172177|FG000|NOT COMPLETED|Overall Study||3
10995624|NCT00670748|12172178|FG001|NOT COMPLETED|Overall Study||2
10995625|NCT00670748|12172179|FG002|NOT COMPLETED|Overall Study||2
10995626|NCT00670748|12172180|FG003|NOT COMPLETED|Overall Study||1
10995627|NCT00670774|12172190|FG000|STARTED|Overall Study||26
10995628|NCT00670774|12172190|FG000|COMPLETED|Overall Study||26
10995629|NCT00670774|12172190|FG000|NOT COMPLETED|Overall Study||0
10995630|NCT00670800|12172196|FG000|STARTED|Overall Study||7
10995631|NCT00670800|12172197|FG001|STARTED|Overall Study||7
10995632|NCT00670800|12172196|FG000|COMPLETED|Overall Study||7
10995633|NCT00670800|12172197|FG001|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
10995634|NCT00670800|12172196|FG000|NOT COMPLETED|Overall Study||0
10995635|NCT00670800|12172197|FG001|NOT COMPLETED|Overall Study||2
10995636|NCT00670930|12172207|FG000|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
10995637|NCT00670930|12172208|FG001|STARTED|Overall Study||13
10995638|NCT00670930|12172207|FG000|Intent to Treat (ITT) Population|Overall Study||23
10995639|NCT00670930|12172208|FG001|Intent to Treat (ITT) Population|Overall Study||12
10995640|NCT00670930|12172207|FG000|COMPLETED|Overall Study||22
10995641|NCT00670930|12172208|FG001|COMPLETED|Overall Study||12
10995642|NCT00670930|12172207|FG000|NOT COMPLETED|Overall Study||1
10995643|NCT00670930|12172208|FG001|NOT COMPLETED|Overall Study||1
10995644|NCT00670956|12172214|FG000|STARTED|Overall Study||1
10995645|NCT00670956|12172214|FG000|COMPLETED|Overall Study||1
10995646|NCT00670956|12172214|FG000|NOT COMPLETED|Overall Study||0
10995647|NCT00670982|12172220|FG000|STARTED|Overall Study||22
10995648|NCT00670982|12172221|FG001|STARTED|Overall Study||7
10995649|NCT00670982|12172220|FG000|COMPLETED|Overall Study||22
10995650|NCT00670982|12172221|FG001|COMPLETED|Overall Study||7
10995651|NCT00670982|12172220|FG000|NOT COMPLETED|Overall Study||0
10995652|NCT00670982|12172221|FG001|NOT COMPLETED|Overall Study||0
10995653|NCT00671034|12172229|FG000|STARTED|Overall Study||69
10995654|NCT00671034|12172230|FG001|STARTED|Overall Study||42
10995655|NCT00671034|12172231|FG002|STARTED|Overall Study||55
10995656|NCT00671034|12172229|FG000|COMPLETED|Overall Study||30
10995657|NCT00671034|12172230|FG001|COMPLETED|Overall Study||22
10995658|NCT00671034|12172231|FG002|COMPLETED|Overall Study||31
10995659|NCT00671034|12172229|FG000|NOT COMPLETED|Overall Study||39
10995660|NCT00671034|12172230|FG001|NOT COMPLETED|Overall Study||20
10995661|NCT00671034|12172231|FG002|NOT COMPLETED|Overall Study||24
10995662|NCT00671060|12172242|FG000|STARTED|Overall Study||77
10995663|NCT00671060|12172243|FG001|STARTED|Overall Study||76
10995664|NCT00671060|12172242|FG000|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
10995665|NCT00671060|12172243|FG001|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
10995666|NCT00671060|12172242|FG000|NOT COMPLETED|Overall Study||1
10995667|NCT00671060|12172243|FG001|NOT COMPLETED|Overall Study||1
10995668|NCT00671177|12172251|FG000|STARTED|Overall Study||114
10995669|NCT00671177|12172252|FG001|STARTED|Overall Study||115
10995670|NCT00671177|12172251|FG000|COMPLETED|Overall Study||112
10995671|NCT00671177|12172252|FG001|COMPLETED|Overall Study||114
10995672|NCT00671177|12172251|FG000|NOT COMPLETED|Overall Study||2
10995673|NCT00671177|12172252|FG001|NOT COMPLETED|Overall Study||1
10995674|NCT00671437|12172258|FG000|STARTED|Overall Study||42
10995675|NCT00671437|12172258|FG000|COMPLETED|Overall Study||27
10995676|NCT00671437|12172258|FG000|NOT COMPLETED|Overall Study||15
10995677|NCT00671502|12172273|FG000|STARTED|Overall Study||281
10995678|NCT00671502|12172274|FG001|STARTED|Overall Study||280
10995679|NCT00671502|12172275|FG002|STARTED|Overall Study||279
10995680|NCT00671502|12172273|FG000|COMPLETED|Overall Study||242
10995681|NCT00671502|12172274|FG001|COMPLETED|Overall Study||241
10995682|NCT00671502|12172275|FG002|COMPLETED|Overall Study||252
10995683|NCT00671502|12172273|FG000|NOT COMPLETED|Overall Study||39
10995684|NCT00671502|12172274|FG001|NOT COMPLETED|Overall Study||39
10995685|NCT00671502|12172275|FG002|NOT COMPLETED|Overall Study||27
10995686|NCT00671515|12172283|FG000|STARTED|Phase 1||23
10995687|NCT00671515|12172283|FG000|COMPLETED|Phase 1||20
10995688|NCT00671515|12172283|FG000|NOT COMPLETED|Phase 1||3
10995689|NCT00671515|12172283|FG000|STARTED|Phase 2||13
10995690|NCT00671515|12172283|FG000|COMPLETED|Phase 2||9
10995691|NCT00671515|12172283|FG000|NOT COMPLETED|Phase 2||4
10995692|NCT00671554|12172287|FG000|STARTED|Overall Study||3
10995693|NCT00671554|12172287|FG000|COMPLETED|Overall Study||0
10995694|NCT00671554|12172287|FG000|NOT COMPLETED|Overall Study||3
10995695|NCT00671658|12172292|FG000|STARTED|Overall Study||220
10995696|NCT00671658|12172292|FG000|COMPLETED|Overall Study||215
10995697|NCT00671658|12172292|FG000|NOT COMPLETED|Overall Study||5
10995698|NCT00671671|12172298|FG000|STARTED|Overall Study||10
10995699|NCT00671671|12172299|FG001|STARTED|Overall Study||10
10995700|NCT00671671|12172298|FG000|COMPLETED|Overall Study||10
10995701|NCT00671671|12172299|FG001|COMPLETED|Overall Study||10
10995702|NCT00671671|12172298|FG000|NOT COMPLETED|Overall Study||0
10995703|NCT00671671|12172299|FG001|NOT COMPLETED|Overall Study||0
10995704|NCT00671723|12172309|FG000|STARTED|Overall Study||11
10995705|NCT00671723|12172310|FG001|STARTED|Overall Study||11
10995706|NCT00671723|12172311|FG002|STARTED|Overall Study||11
10995707|NCT00671723|12172309|FG000|COMPLETED|Overall Study||11
10995708|NCT00671723|12172310|FG001|COMPLETED|Overall Study||11
10995709|NCT00671723|12172311|FG002|COMPLETED|Overall Study||11
10995710|NCT00671723|12172309|FG000|NOT COMPLETED|Overall Study||0
10995711|NCT00671723|12172310|FG001|NOT COMPLETED|Overall Study||0
10995712|NCT00671723|12172311|FG002|NOT COMPLETED|Overall Study||0
10995713|NCT00671788|12172319|FG000|STARTED|Overall Study||35
10995714|NCT00671788|12172319|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
10995715|NCT00671788|12172319|FG000|NOT COMPLETED|Overall Study||14
10995716|NCT00671853|12172325|FG000|STARTED|Overall Study||46
10995717|NCT00671853|12172326|FG001|STARTED|Overall Study||45
10995718|NCT00671853|12172325|FG000|COMPLETED|Overall Study||26
10995719|NCT00671853|12172326|FG001|COMPLETED|Overall Study||18
10995720|NCT00671853|12172325|FG000|NOT COMPLETED|Overall Study||20
10995721|NCT00671853|12172326|FG001|NOT COMPLETED|Overall Study||27
10995722|NCT00671879|12172337|FG000|STARTED|Overall Study||281
10995723|NCT00671879|12172338|FG001|STARTED|Overall Study||279
10995724|NCT00671879|12172339|FG002|STARTED|Overall Study||280
10995725|NCT00671879|12172337|FG000|COMPLETED|Overall Study||281
10995726|NCT00671879|12172338|FG001|COMPLETED|Overall Study||275
10995727|NCT00671879|12172339|FG002|COMPLETED|Overall Study||274
10995728|NCT00671879|12172337|FG000|NOT COMPLETED|Overall Study||0
10995729|NCT00671879|12172338|FG001|NOT COMPLETED|Overall Study||4
10995730|NCT00671879|12172339|FG002|NOT COMPLETED|Overall Study||6
10995731|NCT00671918|12172348|FG000|STARTED|Overall Study||186
10995732|NCT00671918|12172348|FG000|COMPLETED|Overall Study||169
10995733|NCT00671918|12172348|FG000|NOT COMPLETED|Overall Study||17
10995734|NCT00671931|12172358|FG000|STARTED|Overall Study||9
10995735|NCT00671931|12172359|FG001|STARTED|Overall Study||8
10995736|NCT00671931|12172360|FG002|STARTED|Overall Study||9
10995737|NCT00671931|12172361|FG003|STARTED|Overall Study||10
10995738|NCT00671931|12172362|FG004|STARTED|Overall Study||8
10995739|NCT00671931|12172358|FG000|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
10995740|NCT00671931|12172359|FG001|COMPLETED|Overall Study|All completed|8
10995741|NCT00671931|12172360|FG002|COMPLETED|Overall Study|all completed|9
10995742|NCT00671931|12172361|FG003|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
10995743|NCT00671931|12172362|FG004|COMPLETED|Overall Study|Low heart rate requiring treatment|7
10995744|NCT00671931|12172358|FG000|NOT COMPLETED|Overall Study||1
10995745|NCT00671931|12172359|FG001|NOT COMPLETED|Overall Study||0
10995746|NCT00671931|12172360|FG002|NOT COMPLETED|Overall Study||0
10995747|NCT00671931|12172361|FG003|NOT COMPLETED|Overall Study||2
10995748|NCT00671931|12172362|FG004|NOT COMPLETED|Overall Study||1
10995749|NCT00671970|12172376|FG000|STARTED|Overall Study||32
10995750|NCT00671970|12172377|FG001|STARTED|Overall Study||25
10995751|NCT00671970|12172376|FG000|COMPLETED|Overall Study||32
10995752|NCT00671970|12172377|FG001|COMPLETED|Overall Study||25
10995753|NCT00671970|12172376|FG000|NOT COMPLETED|Overall Study||0
10995754|NCT00671970|12172377|FG001|NOT COMPLETED|Overall Study||0
10995755|NCT00672100|12172398|FG000|STARTED|Overall Study||12
10995756|NCT00672100|12172399|FG001|STARTED|Overall Study||12
10995757|NCT00672100|12172400|FG002|STARTED|Overall Study||12
10995758|NCT00672100|12172398|FG000|PACU (Within 8 Hours)|Overall Study||12
10995759|NCT00672100|12172399|FG001|PACU (Within 8 Hours)|Overall Study||12
10995760|NCT00672100|12172400|FG002|PACU (Within 8 Hours)|Overall Study||12
10995761|NCT00672100|12172398|FG000|COMPLETED|Overall Study||12
10995762|NCT00672100|12172399|FG001|COMPLETED|Overall Study||12
10995763|NCT00672100|12172400|FG002|COMPLETED|Overall Study||12
10995764|NCT00672100|12172398|FG000|NOT COMPLETED|Overall Study||0
10995765|NCT00672100|12172399|FG001|NOT COMPLETED|Overall Study||0
10995766|NCT00672100|12172400|FG002|NOT COMPLETED|Overall Study||0
10995767|NCT00672139|12172414|FG000|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
10995768|NCT00672139|12172415|FG001|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
10995769|NCT00672139|12172414|FG000|COMPLETED|Overall Study||27
10995770|NCT00672139|12172415|FG001|COMPLETED|Overall Study||47
10995771|NCT00672139|12172414|FG000|NOT COMPLETED|Overall Study||30
10995772|NCT00672139|12172415|FG001|NOT COMPLETED|Overall Study||45
10995773|NCT00672204|12172421|FG000|STARTED|Overall Study||23
10995774|NCT00672204|12172421|FG000|COMPLETED|Overall Study||3
10995775|NCT00672204|12172421|FG000|NOT COMPLETED|Overall Study||20
10995776|NCT00672243|12172425|FG000|STARTED|Overall Study||32
10995777|NCT00672243|12172425|FG000|COMPLETED|Overall Study||32
10995778|NCT00672243|12172425|FG000|NOT COMPLETED|Overall Study||0
10995779|NCT00672256|12172430|FG000|STARTED|Overall Study|January 2007|62
10995780|NCT00672256|12172430|FG000|COMPLETED|Overall Study||18
10995781|NCT00672256|12172430|FG000|NOT COMPLETED|Overall Study||44
10995782|NCT00672438|12172436|FG000|STARTED|Infusion 1||119
10995783|NCT00672438|12172437|FG001|STARTED|Infusion 1||118
10995784|NCT00672438|12172436|FG000|COMPLETED|Infusion 1||119
10995785|NCT00672438|12172437|FG001|COMPLETED|Infusion 1||118
10995786|NCT00672438|12172436|FG000|NOT COMPLETED|Infusion 1||0
10995787|NCT00672438|12172437|FG001|NOT COMPLETED|Infusion 1||0
10995788|NCT00672438|12172436|FG000|STARTED|Washout||119
10995789|NCT00672438|12172437|FG001|STARTED|Washout||118
10995790|NCT00672438|12172436|FG000|COMPLETED|Washout||119
10995791|NCT00672438|12172437|FG001|COMPLETED|Washout||118
10995792|NCT00672438|12172436|FG000|NOT COMPLETED|Washout||0
10995793|NCT00672438|12172437|FG001|NOT COMPLETED|Washout||0
10995794|NCT00672438|12172436|FG000|STARTED|Infusion 2||119
10995795|NCT00672438|12172437|FG001|STARTED|Infusion 2||118
10995796|NCT00672438|12172436|FG000|COMPLETED|Infusion 2||119
10995797|NCT00672438|12172437|FG001|COMPLETED|Infusion 2||118
10995798|NCT00672438|12172436|FG000|NOT COMPLETED|Infusion 2||0
10995799|NCT00672438|12172437|FG001|NOT COMPLETED|Infusion 2||0
10995800|NCT00672451|12172445|FG000|STARTED|Overall Study||1
10995801|NCT00672451|12172446|FG001|STARTED|Overall Study||2
10995802|NCT00672451|12172445|FG000|COMPLETED|Overall Study||1
10995803|NCT00672451|12172446|FG001|COMPLETED|Overall Study||2
10995804|NCT00672451|12172445|FG000|NOT COMPLETED|Overall Study||0
10995805|NCT00672451|12172446|FG001|NOT COMPLETED|Overall Study||0
10995806|NCT00672477|12172454|FG000|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
10995807|NCT00672477|12172455|FG001|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
10995808|NCT00672477|12172454|FG000|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
10995809|NCT00672477|12172455|FG001|COMPLETED|Overall Study||88
10995810|NCT00672477|12172454|FG000|NOT COMPLETED|Overall Study||27
10995811|NCT00672477|12172455|FG001|NOT COMPLETED|Overall Study||26
10995812|NCT00672490|12172463|FG000|STARTED|Overall Study||187
10995813|NCT00672490|12172464|FG001|STARTED|Overall Study||189
10995814|NCT00672490|12172463|FG000|COMPLETED|Overall Study||163
10995815|NCT00672490|12172464|FG001|COMPLETED|Overall Study||157
10995816|NCT00672490|12172463|FG000|NOT COMPLETED|Overall Study||24
10995817|NCT00672490|12172464|FG001|NOT COMPLETED|Overall Study||32
10995818|NCT00672555|12172470|FG000|STARTED|Overall Study||70
10995819|NCT00672555|12172470|FG000|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
10995820|NCT00672555|12172470|FG000|NOT COMPLETED|Overall Study||6
10995821|NCT00672594|12172474|FG000|STARTED|Overall Study||30
10995822|NCT00672594|12172474|FG000|COMPLETED|Overall Study||27
10995823|NCT00672594|12172474|FG000|NOT COMPLETED|Overall Study||3
10995824|NCT00672620|12172482|FG000|STARTED|Overall Study||153
10995825|NCT00672620|12172483|FG001|STARTED|Overall Study||153
10995826|NCT00672620|12172484|FG002|STARTED|Overall Study||153
10995827|NCT00672620|12172485|FG003|STARTED|Overall Study||152
10995828|NCT00672620|12172482|FG000|Treated|Overall Study||151
10995829|NCT00672620|12172483|FG001|Treated|Overall Study||149
10995830|NCT00672620|12172484|FG002|Treated|Overall Study||153
10995831|NCT00672620|12172485|FG003|Treated|Overall Study||150
10995832|NCT00672620|12172482|FG000|COMPLETED|Overall Study||120
10995833|NCT00672620|12172483|FG001|COMPLETED|Overall Study||99
10995834|NCT00672620|12172484|FG002|COMPLETED|Overall Study||122
10995835|NCT00672620|12172485|FG003|COMPLETED|Overall Study||110
10995836|NCT00672620|12172482|FG000|NOT COMPLETED|Overall Study||33
10995837|NCT00672620|12172483|FG001|NOT COMPLETED|Overall Study||54
10995838|NCT00672620|12172484|FG002|NOT COMPLETED|Overall Study||31
10995839|NCT00672620|12172485|FG003|NOT COMPLETED|Overall Study||42
10995840|NCT00672633|12172497|FG000|STARTED|Overall Study||12
10995841|NCT00672633|12172498|FG001|STARTED|Overall Study||13
10995842|NCT00672633|12172497|FG000|COMPLETED|Overall Study||12
10995843|NCT00672633|12172498|FG001|COMPLETED|Overall Study||12
10995844|NCT00672633|12172497|FG000|NOT COMPLETED|Overall Study||0
10995845|NCT00672633|12172498|FG001|NOT COMPLETED|Overall Study||1
10995846|NCT00672646|12172507|FG000|STARTED|Overall Study||40
10995847|NCT00672646|12172508|FG001|STARTED|Overall Study||23
10995848|NCT00672646|12172509|FG002|STARTED|Overall Study||40
10995849|NCT00672646|12172507|FG000|COMPLETED|Overall Study||40
10995850|NCT00672646|12172508|FG001|COMPLETED|Overall Study||22
10995851|NCT00672646|12172509|FG002|COMPLETED|Overall Study||37
10995852|NCT00672646|12172507|FG000|NOT COMPLETED|Overall Study||0
10995853|NCT00672646|12172508|FG001|NOT COMPLETED|Overall Study||1
10995854|NCT00672646|12172509|FG002|NOT COMPLETED|Overall Study||3
10995855|NCT00672737|12172517|FG000|STARTED|Overall Study||56
10995856|NCT00672737|12172517|FG000|COMPLETED|Overall Study||48
10995857|NCT00672737|12172517|FG000|NOT COMPLETED|Overall Study||8
10995858|NCT00672841|12172524|FG000|STARTED|Overall Study||17
10995859|NCT00672841|12172525|FG001|STARTED|Overall Study||47
10995860|NCT00672841|12172524|FG000|COMPLETED|Overall Study||16
10995861|NCT00672841|12172525|FG001|COMPLETED|Overall Study||32
10995862|NCT00672841|12172524|FG000|NOT COMPLETED|Overall Study||1
10995863|NCT00672841|12172525|FG001|NOT COMPLETED|Overall Study||15
10995864|NCT00672854|12172536|FG000|STARTED|Overall Study||49
10995865|NCT00672854|12172537|FG001|STARTED|Overall Study||51
10995866|NCT00672854|12172536|FG000|COMPLETED|Overall Study||49
10995867|NCT00672854|12172537|FG001|COMPLETED|Overall Study||51
10995868|NCT00672854|12172536|FG000|NOT COMPLETED|Overall Study||0
10995869|NCT00672854|12172537|FG001|NOT COMPLETED|Overall Study||0
10995870|NCT00672932|12172547|FG000|STARTED|Overall Study||9
10995871|NCT00672932|12172548|FG001|STARTED|Overall Study||9
10995872|NCT00672932|12172547|FG000|Completed Initial 12-week Assignment|Overall Study||9
10995873|NCT00672932|12172548|FG001|Completed Initial 12-week Assignment|Overall Study||9
10995874|NCT00672932|12172547|FG000|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
10995875|NCT00672932|12172548|FG001|Provided Analyzable Blood and CSF Sample|Overall Study||9
10995876|NCT00672932|12172547|FG000|Rolled Over to Raltegravir|Overall Study||0
10995877|NCT00672932|12172548|FG001|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
10995878|NCT00672932|12172547|FG000|COMPLETED|Overall Study||9
10995879|NCT00672932|12172548|FG001|COMPLETED|Overall Study||9
10995880|NCT00672932|12172547|FG000|NOT COMPLETED|Overall Study||0
10995881|NCT00672932|12172548|FG001|NOT COMPLETED|Overall Study||0
10995882|NCT00672958|12172556|FG000|STARTED|Overall Study||300
10995883|NCT00672958|12172557|FG001|STARTED|Overall Study||300
10995884|NCT00672958|12172556|FG000|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
10995885|NCT00672958|12172557|FG001|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
10995886|NCT00672958|12172556|FG000|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
10995887|NCT00672958|12172557|FG001|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
10995888|NCT00672958|12172556|FG000|COMPLETED|Overall Study||236
10995889|NCT00672958|12172557|FG001|COMPLETED|Overall Study||244
10995890|NCT00672958|12172556|FG000|NOT COMPLETED|Overall Study||64
10995891|NCT00672958|12172557|FG001|NOT COMPLETED|Overall Study||56
10995892|NCT00672984|12172566|FG000|STARTED|First Intervention||31
10995893|NCT00672984|12172567|FG001|STARTED|First Intervention||25
10995894|NCT00672984|12172568|FG002|STARTED|First Intervention||27
10995895|NCT00672984|12172566|FG000|COMPLETED|First Intervention||22
10995896|NCT00672984|12172567|FG001|COMPLETED|First Intervention||23
10995897|NCT00672984|12172568|FG002|COMPLETED|First Intervention||25
10995898|NCT00672984|12172566|FG000|NOT COMPLETED|First Intervention||9
10995899|NCT00672984|12172567|FG001|NOT COMPLETED|First Intervention||2
10995900|NCT00672984|12172568|FG002|NOT COMPLETED|First Intervention||2
10995901|NCT00672984|12172566|FG000|STARTED|Second Intervention||22
10995902|NCT00672984|12172567|FG001|STARTED|Second Intervention||23
10995903|NCT00672984|12172568|FG002|STARTED|Second Intervention||25
10995904|NCT00672984|12172566|FG000|COMPLETED|Second Intervention||22
10995905|NCT00672984|12172567|FG001|COMPLETED|Second Intervention||17
10995906|NCT00672984|12172568|FG002|COMPLETED|Second Intervention||24
10995907|NCT00672984|12172566|FG000|NOT COMPLETED|Second Intervention||0
10995908|NCT00672984|12172567|FG001|NOT COMPLETED|Second Intervention||6
10995909|NCT00672984|12172568|FG002|NOT COMPLETED|Second Intervention||1
10995910|NCT00672984|12172566|FG000|STARTED|Third Intervention||22
10995911|NCT00672984|12172567|FG001|STARTED|Third Intervention||17
10995912|NCT00672984|12172568|FG002|STARTED|Third Intervention||24
10995913|NCT00672984|12172566|FG000|COMPLETED|Third Intervention||21
10995914|NCT00672984|12172567|FG001|COMPLETED|Third Intervention||17
10995915|NCT00672984|12172568|FG002|COMPLETED|Third Intervention||23
10995916|NCT00672984|12172566|FG000|NOT COMPLETED|Third Intervention||1
10995917|NCT00672984|12172567|FG001|NOT COMPLETED|Third Intervention||0
10995918|NCT00672984|12172568|FG002|NOT COMPLETED|Third Intervention||1
10995919|NCT00673049|12172580|FG000|STARTED|Before Progression on Erlotinib||292
10995920|NCT00673049|12172581|FG001|STARTED|Before Progression on Erlotinib||290
10995921|NCT00673049|12172582|FG002|STARTED|Before Progression on Erlotinib||1
10995922|NCT00673049|12172583|FG003|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
10995923|NCT00673049|12172580|FG000|Treated|Before Progression on Erlotinib||289
10995924|NCT00673049|12172581|FG001|Treated|Before Progression on Erlotinib||289
10995925|NCT00673049|12172582|FG002|Treated|Before Progression on Erlotinib||1
10995926|NCT00673049|12172583|FG003|Treated|Before Progression on Erlotinib||0
10995927|NCT00673049|12172580|FG000|COMPLETED|Before Progression on Erlotinib||0
10995928|NCT00673049|12172581|FG001|COMPLETED|Before Progression on Erlotinib||0
10995929|NCT00673049|12172582|FG002|COMPLETED|Before Progression on Erlotinib||0
10995930|NCT00673049|12172583|FG003|COMPLETED|Before Progression on Erlotinib||0
10995931|NCT00673049|12172580|FG000|NOT COMPLETED|Before Progression on Erlotinib||292
10995932|NCT00673049|12172581|FG001|NOT COMPLETED|Before Progression on Erlotinib||290
10995933|NCT00673049|12172582|FG002|NOT COMPLETED|Before Progression on Erlotinib||1
10995934|NCT00673049|12172583|FG003|NOT COMPLETED|Before Progression on Erlotinib||0
10995935|NCT00673049|12172580|FG000|STARTED|After Progression on Erlotinib||0
10995936|NCT00673049|12172581|FG001|STARTED|After Progression on Erlotinib||0
10995937|NCT00673049|12172582|FG002|STARTED|After Progression on Erlotinib||0
10995938|NCT00673049|12172583|FG003|STARTED|After Progression on Erlotinib||83
10995939|NCT00673049|12172580|FG000|COMPLETED|After Progression on Erlotinib||0
10995940|NCT00673049|12172581|FG001|COMPLETED|After Progression on Erlotinib||0
10995941|NCT00673049|12172582|FG002|COMPLETED|After Progression on Erlotinib||0
10995942|NCT00673049|12172583|FG003|COMPLETED|After Progression on Erlotinib||0
10995943|NCT00673049|12172580|FG000|NOT COMPLETED|After Progression on Erlotinib||0
10995944|NCT00673049|12172581|FG001|NOT COMPLETED|After Progression on Erlotinib||0
10995945|NCT00673049|12172582|FG002|NOT COMPLETED|After Progression on Erlotinib||0
10995946|NCT00673049|12172583|FG003|NOT COMPLETED|After Progression on Erlotinib||83
10995947|NCT00673075|12172593|FG000|STARTED|Overall Study||21
10995948|NCT00673075|12172594|FG001|STARTED|Overall Study||18
10995949|NCT00673075|12172593|FG000|COMPLETED|Overall Study||12
10995950|NCT00673075|12172594|FG001|COMPLETED|Overall Study||11
10995951|NCT00673075|12172593|FG000|NOT COMPLETED|Overall Study||9
10995952|NCT00673075|12172594|FG001|NOT COMPLETED|Overall Study||7
10995953|NCT00673114|12172602|FG000|STARTED|Overall Study||3
10995954|NCT00673114|12172602|FG000|COMPLETED|Overall Study||3
10995955|NCT00673114|12172602|FG000|NOT COMPLETED|Overall Study||0
10995956|NCT00673127|12172606|FG000|STARTED|Overall Study||57
10995957|NCT00673127|12172606|FG000|COMPLETED|Overall Study||57
10995958|NCT00673127|12172606|FG000|NOT COMPLETED|Overall Study||0
10995959|NCT00673153|12172611|FG000|STARTED|Overall Study||31
10995960|NCT00673153|12172611|FG000|COMPLETED|Overall Study||30
10995961|NCT00673153|12172611|FG000|NOT COMPLETED|Overall Study||1
10995962|NCT00673231|12172619|FG000|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
10995963|NCT00673231|12172620|FG001|STARTED|Overall Study|All 202 were included in the full analysis set|202
10995964|NCT00673231|12172621|FG002|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
10995965|NCT00673231|12172622|FG003|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
10995966|NCT00673231|12172619|FG000|COMPLETED|Overall Study||168
10995967|NCT00673231|12172620|FG001|COMPLETED|Overall Study||180
10995968|NCT00673231|12172621|FG002|COMPLETED|Overall Study||186
10995969|NCT00673231|12172622|FG003|COMPLETED|Overall Study||178
10995970|NCT00673231|12172619|FG000|NOT COMPLETED|Overall Study||29
10995971|NCT00673231|12172620|FG001|NOT COMPLETED|Overall Study||22
10995972|NCT00673231|12172621|FG002|NOT COMPLETED|Overall Study||26
10995973|NCT00673231|12172622|FG003|NOT COMPLETED|Overall Study||18
10995974|NCT00673244|12172634|FG000|STARTED|Overall Study||52
10995975|NCT00673244|12172635|FG001|STARTED|Overall Study||25
10995976|NCT00673244|12172634|FG000|COMPLETED|Overall Study||52
10995977|NCT00673244|12172635|FG001|COMPLETED|Overall Study||25
10995978|NCT00673244|12172634|FG000|NOT COMPLETED|Overall Study||0
10995979|NCT00673244|12172635|FG001|NOT COMPLETED|Overall Study||0
10995980|NCT00673257|12172641|FG000|STARTED|Overall Study||107
10995981|NCT00673257|12172641|FG000|COMPLETED|Overall Study||102
10995982|NCT00673257|12172641|FG000|NOT COMPLETED|Overall Study||5
10995983|NCT00673387|12172653|FG000|STARTED|Overall Study||75
10995984|NCT00673387|12172654|FG001|STARTED|Overall Study||77
10995985|NCT00673387|12172655|FG002|STARTED|Overall Study||72
10995986|NCT00673387|12172656|FG003|STARTED|Overall Study||75
10995987|NCT00673387|12172657|FG004|STARTED|Overall Study||78
10995988|NCT00673387|12172658|FG005|STARTED|Overall Study||78
10995989|NCT00673387|12172659|FG006|STARTED|Overall Study||78
10995990|NCT00673387|12172660|FG007|STARTED|Overall Study||75
10995991|NCT00673387|12172653|FG000|COMPLETED|Overall Study||46
10995992|NCT00673387|12172654|FG001|COMPLETED|Overall Study||54
10995993|NCT00673387|12172655|FG002|COMPLETED|Overall Study||41
10995994|NCT00673387|12172656|FG003|COMPLETED|Overall Study||49
10995995|NCT00673387|12172657|FG004|COMPLETED|Overall Study||48
10995996|NCT00673387|12172658|FG005|COMPLETED|Overall Study||44
10995997|NCT00673387|12172659|FG006|COMPLETED|Overall Study||48
10995998|NCT00673387|12172660|FG007|COMPLETED|Overall Study||40
10995999|NCT00673387|12172653|FG000|NOT COMPLETED|Overall Study||29
10996000|NCT00673387|12172654|FG001|NOT COMPLETED|Overall Study||23
10996001|NCT00673387|12172655|FG002|NOT COMPLETED|Overall Study||31
10996002|NCT00673387|12172656|FG003|NOT COMPLETED|Overall Study||26
10996003|NCT00673387|12172657|FG004|NOT COMPLETED|Overall Study||30
10996004|NCT00673387|12172658|FG005|NOT COMPLETED|Overall Study||34
10996005|NCT00673387|12172659|FG006|NOT COMPLETED|Overall Study||30
10996006|NCT00673387|12172660|FG007|NOT COMPLETED|Overall Study||35
10996007|NCT00673400|12172688|FG000|STARTED|Overall Study||52
10996008|NCT00673400|12172688|FG000|COMPLETED|Overall Study||52
10996009|NCT00673400|12172688|FG000|NOT COMPLETED|Overall Study||0
10996010|NCT00673439|12172698|FG000|STARTED|Overall Study||3
10996011|NCT00673439|12172698|FG000|COMPLETED|Overall Study||3
10996012|NCT00673439|12172698|FG000|NOT COMPLETED|Overall Study||0
10996013|NCT00673452|12172705|FG000|STARTED|Acute Double-Blind Phase||263
10996014|NCT00673452|12172706|FG001|STARTED|Acute Double-Blind Phase||267
10996015|NCT00673452|12172705|FG000|COMPLETED|Acute Double-Blind Phase||176
10996016|NCT00673452|12172706|FG001|COMPLETED|Acute Double-Blind Phase||187
10996017|NCT00673452|12172705|FG000|NOT COMPLETED|Acute Double-Blind Phase||87
10996018|NCT00673452|12172706|FG001|NOT COMPLETED|Acute Double-Blind Phase||80
10996019|NCT00673452|12172705|FG000|STARTED|Continuation Double-Blind Phase||176
10996020|NCT00673452|12172706|FG001|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
10996021|NCT00673452|12172705|FG000|COMPLETED|Continuation Double-Blind Phase||151
10996022|NCT00673452|12172706|FG001|COMPLETED|Continuation Double-Blind Phase||153
10996023|NCT00673452|12172705|FG000|NOT COMPLETED|Continuation Double-Blind Phase||25
10996024|NCT00673452|12172706|FG001|NOT COMPLETED|Continuation Double-Blind Phase||34
10996025|NCT00673465|12172712|FG000|STARTED|Part 1/Period 1 (United States)||3
10996026|NCT00673465|12172713|FG001|STARTED|Part 1/Period 1 (United States)||3
10996027|NCT00673465|12172714|FG002|STARTED|Part 1/Period 1 (United States)||3
10996028|NCT00673465|12172715|FG003|STARTED|Part 1/Period 1 (United States)||3
10996029|NCT00673465|12172716|FG004|STARTED|Part 1/Period 1 (United States)||3
10996030|NCT00673465|12172717|FG005|STARTED|Part 1/Period 1 (United States)||2
10996031|NCT00673465|12172718|FG006|STARTED|Part 1/Period 1 (United States)||0
10996032|NCT00673465|12172719|FG007|STARTED|Part 1/Period 1 (United States)||0
10996033|NCT00673465|12172720|FG008|STARTED|Part 1/Period 1 (United States)||0
10996034|NCT00673465|12172721|FG009|STARTED|Part 1/Period 1 (United States)||0
10996035|NCT00673465|12172722|FG010|STARTED|Part 1/Period 1 (United States)||0
10996036|NCT00673465|12172723|FG011|STARTED|Part 1/Period 1 (United States)||0
10996037|NCT00673465|12172712|FG000|COMPLETED|Part 1/Period 1 (United States)||3
10996038|NCT00673465|12172713|FG001|COMPLETED|Part 1/Period 1 (United States)||3
10996039|NCT00673465|12172714|FG002|COMPLETED|Part 1/Period 1 (United States)||3
10996040|NCT00673465|12172715|FG003|COMPLETED|Part 1/Period 1 (United States)||3
10996041|NCT00673465|12172716|FG004|COMPLETED|Part 1/Period 1 (United States)||2
10996042|NCT00673465|12172717|FG005|COMPLETED|Part 1/Period 1 (United States)||1
10996043|NCT00673465|12172718|FG006|COMPLETED|Part 1/Period 1 (United States)||0
10996044|NCT00673465|12172719|FG007|COMPLETED|Part 1/Period 1 (United States)||0
10996045|NCT00673465|12172720|FG008|COMPLETED|Part 1/Period 1 (United States)||0
10996046|NCT00673465|12172721|FG009|COMPLETED|Part 1/Period 1 (United States)||0
10996047|NCT00673465|12172722|FG010|COMPLETED|Part 1/Period 1 (United States)||0
10996048|NCT00673465|12172723|FG011|COMPLETED|Part 1/Period 1 (United States)||0
10996049|NCT00673465|12172712|FG000|NOT COMPLETED|Part 1/Period 1 (United States)||0
10996050|NCT00673465|12172713|FG001|NOT COMPLETED|Part 1/Period 1 (United States)||0
10996051|NCT00673465|12172714|FG002|NOT COMPLETED|Part 1/Period 1 (United States)||0
10996052|NCT00673465|12172715|FG003|NOT COMPLETED|Part 1/Period 1 (United States)||0
10996053|NCT00673465|12172716|FG004|NOT COMPLETED|Part 1/Period 1 (United States)||1
10996054|NCT00673465|12172717|FG005|NOT COMPLETED|Part 1/Period 1 (United States)||1
10996055|NCT00673465|12172718|FG006|NOT COMPLETED|Part 1/Period 1 (United States)||0
10996056|NCT00673465|12172719|FG007|NOT COMPLETED|Part 1/Period 1 (United States)||0
10996057|NCT00673465|12172720|FG008|NOT COMPLETED|Part 1/Period 1 (United States)||0
10996058|NCT00673465|12172721|FG009|NOT COMPLETED|Part 1/Period 1 (United States)||0
10996059|NCT00673465|12172722|FG010|NOT COMPLETED|Part 1/Period 1 (United States)||0
10996060|NCT00673465|12172723|FG011|NOT COMPLETED|Part 1/Period 1 (United States)||0
10996061|NCT00673465|12172712|FG000|STARTED|Part 1/Period 2 (United States)||3
10996062|NCT00673465|12172713|FG001|STARTED|Part 1/Period 2 (United States)||3
10996063|NCT00673465|12172714|FG002|STARTED|Part 1/Period 2 (United States)||3
10996064|NCT00673465|12172715|FG003|STARTED|Part 1/Period 2 (United States)||3
10996065|NCT00673465|12172716|FG004|STARTED|Part 1/Period 2 (United States)||2
10996066|NCT00673465|12172717|FG005|STARTED|Part 1/Period 2 (United States)||1
10996067|NCT00673465|12172718|FG006|STARTED|Part 1/Period 2 (United States)||0
10996068|NCT00673465|12172719|FG007|STARTED|Part 1/Period 2 (United States)||0
10996069|NCT00673465|12172720|FG008|STARTED|Part 1/Period 2 (United States)||0
10996070|NCT00673465|12172721|FG009|STARTED|Part 1/Period 2 (United States)||0
10996071|NCT00673465|12172722|FG010|STARTED|Part 1/Period 2 (United States)||0
10996072|NCT00673465|12172723|FG011|STARTED|Part 1/Period 2 (United States)||0
10996073|NCT00673465|12172712|FG000|COMPLETED|Part 1/Period 2 (United States)||3
10996074|NCT00673465|12172713|FG001|COMPLETED|Part 1/Period 2 (United States)||3
10996075|NCT00673465|12172714|FG002|COMPLETED|Part 1/Period 2 (United States)||3
10996076|NCT00673465|12172715|FG003|COMPLETED|Part 1/Period 2 (United States)||3
10996077|NCT00673465|12172716|FG004|COMPLETED|Part 1/Period 2 (United States)||1
10996078|NCT00673465|12172717|FG005|COMPLETED|Part 1/Period 2 (United States)||1
10996079|NCT00673465|12172718|FG006|COMPLETED|Part 1/Period 2 (United States)||0
10996080|NCT00673465|12172719|FG007|COMPLETED|Part 1/Period 2 (United States)||0
10996081|NCT00673465|12172720|FG008|COMPLETED|Part 1/Period 2 (United States)||0
10996082|NCT00673465|12172721|FG009|COMPLETED|Part 1/Period 2 (United States)||0
10996083|NCT00673465|12172722|FG010|COMPLETED|Part 1/Period 2 (United States)||0
10996084|NCT00673465|12172723|FG011|COMPLETED|Part 1/Period 2 (United States)||0
10996085|NCT00673465|12172712|FG000|NOT COMPLETED|Part 1/Period 2 (United States)||0
10996086|NCT00673465|12172713|FG001|NOT COMPLETED|Part 1/Period 2 (United States)||0
10996087|NCT00673465|12172714|FG002|NOT COMPLETED|Part 1/Period 2 (United States)||0
10996088|NCT00673465|12172715|FG003|NOT COMPLETED|Part 1/Period 2 (United States)||0
10996089|NCT00673465|12172716|FG004|NOT COMPLETED|Part 1/Period 2 (United States)||1
10996090|NCT00673465|12172717|FG005|NOT COMPLETED|Part 1/Period 2 (United States)||0
10996091|NCT00673465|12172718|FG006|NOT COMPLETED|Part 1/Period 2 (United States)||0
10996092|NCT00673465|12172719|FG007|NOT COMPLETED|Part 1/Period 2 (United States)||0
10996093|NCT00673465|12172720|FG008|NOT COMPLETED|Part 1/Period 2 (United States)||0
10996094|NCT00673465|12172721|FG009|NOT COMPLETED|Part 1/Period 2 (United States)||0
10996095|NCT00673465|12172722|FG010|NOT COMPLETED|Part 1/Period 2 (United States)||0
10996096|NCT00673465|12172723|FG011|NOT COMPLETED|Part 1/Period 2 (United States)||0
10996097|NCT00673465|12172712|FG000|STARTED|Part 1/Period 3 (United States)||3
10996098|NCT00673465|12172713|FG001|STARTED|Part 1/Period 3 (United States)||3
10996099|NCT00673465|12172714|FG002|STARTED|Part 1/Period 3 (United States)||3
10996100|NCT00673465|12172715|FG003|STARTED|Part 1/Period 3 (United States)||3
10996101|NCT00673465|12172716|FG004|STARTED|Part 1/Period 3 (United States)||1
10996102|NCT00673465|12172717|FG005|STARTED|Part 1/Period 3 (United States)||1
10996103|NCT00673465|12172718|FG006|STARTED|Part 1/Period 3 (United States)||0
10996104|NCT00673465|12172719|FG007|STARTED|Part 1/Period 3 (United States)||0
10996105|NCT00673465|12172720|FG008|STARTED|Part 1/Period 3 (United States)||0
10996106|NCT00673465|12172721|FG009|STARTED|Part 1/Period 3 (United States)||0
10996107|NCT00673465|12172722|FG010|STARTED|Part 1/Period 3 (United States)||0
10996108|NCT00673465|12172723|FG011|STARTED|Part 1/Period 3 (United States)||0
10996109|NCT00673465|12172712|FG000|COMPLETED|Part 1/Period 3 (United States)||3
10996110|NCT00673465|12172713|FG001|COMPLETED|Part 1/Period 3 (United States)||3
10996111|NCT00673465|12172714|FG002|COMPLETED|Part 1/Period 3 (United States)||3
10996112|NCT00673465|12172715|FG003|COMPLETED|Part 1/Period 3 (United States)||3
10996113|NCT00673465|12172716|FG004|COMPLETED|Part 1/Period 3 (United States)||1
10996114|NCT00673465|12172717|FG005|COMPLETED|Part 1/Period 3 (United States)||1
10996115|NCT00673465|12172718|FG006|COMPLETED|Part 1/Period 3 (United States)||0
10996116|NCT00673465|12172719|FG007|COMPLETED|Part 1/Period 3 (United States)||0
10996117|NCT00673465|12172720|FG008|COMPLETED|Part 1/Period 3 (United States)||0
10996118|NCT00673465|12172721|FG009|COMPLETED|Part 1/Period 3 (United States)||0
10996119|NCT00673465|12172722|FG010|COMPLETED|Part 1/Period 3 (United States)||0
10996120|NCT00673465|12172723|FG011|COMPLETED|Part 1/Period 3 (United States)||0
10996121|NCT00673465|12172712|FG000|NOT COMPLETED|Part 1/Period 3 (United States)||0
10996122|NCT00673465|12172713|FG001|NOT COMPLETED|Part 1/Period 3 (United States)||0
10996123|NCT00673465|12172714|FG002|NOT COMPLETED|Part 1/Period 3 (United States)||0
10996124|NCT00673465|12172715|FG003|NOT COMPLETED|Part 1/Period 3 (United States)||0
10996125|NCT00673465|12172716|FG004|NOT COMPLETED|Part 1/Period 3 (United States)||0
10996126|NCT00673465|12172717|FG005|NOT COMPLETED|Part 1/Period 3 (United States)||0
10996127|NCT00673465|12172718|FG006|NOT COMPLETED|Part 1/Period 3 (United States)||0
10996128|NCT00673465|12172719|FG007|NOT COMPLETED|Part 1/Period 3 (United States)||0
10996129|NCT00673465|12172720|FG008|NOT COMPLETED|Part 1/Period 3 (United States)||0
10996130|NCT00673465|12172721|FG009|NOT COMPLETED|Part 1/Period 3 (United States)||0
10996131|NCT00673465|12172722|FG010|NOT COMPLETED|Part 1/Period 3 (United States)||0
10996132|NCT00673465|12172723|FG011|NOT COMPLETED|Part 1/Period 3 (United States)||0
10996133|NCT00673465|12172712|FG000|STARTED|Part 2 (India)||0
10996134|NCT00673465|12172713|FG001|STARTED|Part 2 (India)||0
10996135|NCT00673465|12172714|FG002|STARTED|Part 2 (India)||0
10996136|NCT00673465|12172715|FG003|STARTED|Part 2 (India)||0
10996137|NCT00673465|12172716|FG004|STARTED|Part 2 (India)||0
10996138|NCT00673465|12172717|FG005|STARTED|Part 2 (India)||0
10996139|NCT00673465|12172718|FG006|STARTED|Part 2 (India)||0
10996140|NCT00673465|12172719|FG007|STARTED|Part 2 (India)||0
10996141|NCT00673465|12172720|FG008|STARTED|Part 2 (India)||0
10996142|NCT00673465|12172721|FG009|STARTED|Part 2 (India)||0
10996143|NCT00673465|12172722|FG010|STARTED|Part 2 (India)||0
10996144|NCT00673465|12172723|FG011|STARTED|Part 2 (India)||0
10996145|NCT00673465|12172712|FG000|COMPLETED|Part 2 (India)||0
10996146|NCT00673465|12172713|FG001|COMPLETED|Part 2 (India)||0
10996147|NCT00673465|12172714|FG002|COMPLETED|Part 2 (India)||0
10996148|NCT00673465|12172715|FG003|COMPLETED|Part 2 (India)||0
10996149|NCT00673465|12172716|FG004|COMPLETED|Part 2 (India)||0
10996150|NCT00673465|12172717|FG005|COMPLETED|Part 2 (India)||0
10996151|NCT00673465|12172718|FG006|COMPLETED|Part 2 (India)||0
10996152|NCT00673465|12172719|FG007|COMPLETED|Part 2 (India)||0
10996153|NCT00673465|12172720|FG008|COMPLETED|Part 2 (India)||0
10996154|NCT00673465|12172721|FG009|COMPLETED|Part 2 (India)||0
10996155|NCT00673465|12172722|FG010|COMPLETED|Part 2 (India)||0
10996156|NCT00673465|12172723|FG011|COMPLETED|Part 2 (India)||0
10996157|NCT00673465|12172712|FG000|NOT COMPLETED|Part 2 (India)||0
10996158|NCT00673465|12172713|FG001|NOT COMPLETED|Part 2 (India)||0
10996159|NCT00673465|12172714|FG002|NOT COMPLETED|Part 2 (India)||0
10996160|NCT00673465|12172715|FG003|NOT COMPLETED|Part 2 (India)||0
10996161|NCT00673465|12172716|FG004|NOT COMPLETED|Part 2 (India)||0
10996162|NCT00673465|12172717|FG005|NOT COMPLETED|Part 2 (India)||0
10996163|NCT00673465|12172718|FG006|NOT COMPLETED|Part 2 (India)||0
10996164|NCT00673465|12172719|FG007|NOT COMPLETED|Part 2 (India)||0
10996165|NCT00673465|12172720|FG008|NOT COMPLETED|Part 2 (India)||0
10996166|NCT00673465|12172721|FG009|NOT COMPLETED|Part 2 (India)||0
10996167|NCT00673465|12172722|FG010|NOT COMPLETED|Part 2 (India)||0
10996168|NCT00673465|12172723|FG011|NOT COMPLETED|Part 2 (India)||0
10996169|NCT00673660|12172731|FG000|STARTED|Overall Study||375
10996170|NCT00673660|12172731|FG000|COMPLETED|Overall Study||268
10996171|NCT00673660|12172731|FG000|NOT COMPLETED|Overall Study||107
10996172|NCT00673673|12172740|FG000|STARTED|Overall Study||39
10996173|NCT00673673|12172740|FG000|COMPLETED|Overall Study||3
10996174|NCT00673673|12172740|FG000|NOT COMPLETED|Overall Study||36
10996175|NCT00673712|12172746|FG000|STARTED|Overall Study||321
10996176|NCT00673712|12172747|FG001|STARTED|Overall Study||326
10996177|NCT00673712|12172746|FG000|COMPLETED|Overall Study||321
10996178|NCT00673712|12172747|FG001|COMPLETED|Overall Study||326
10996179|NCT00673712|12172746|FG000|NOT COMPLETED|Overall Study||0
10996180|NCT00673712|12172747|FG001|NOT COMPLETED|Overall Study||0
10996181|NCT00673738|12172753|FG000|STARTED|Overall Study||27
10996182|NCT00673738|12172753|FG000|COMPLETED|Overall Study||27
10996183|NCT00673738|12172753|FG000|NOT COMPLETED|Overall Study||0
10996184|NCT00673764|12172757|FG000|STARTED|Overall Study||24
10996185|NCT00673764|12172758|FG001|STARTED|Overall Study||24
10996186|NCT00673764|12172757|FG000|COMPLETED|Overall Study||24
10996187|NCT00673764|12172758|FG001|COMPLETED|Overall Study||24
10996188|NCT00673764|12172757|FG000|NOT COMPLETED|Overall Study||0
10996189|NCT00673764|12172758|FG001|NOT COMPLETED|Overall Study||0
10996190|NCT00673790|12172767|FG000|STARTED|Overall Study||223
10996191|NCT00673790|12172768|FG001|STARTED|Overall Study||212
10996192|NCT00673790|12172769|FG002|STARTED|Overall Study||102
10996193|NCT00673790|12172767|FG000|COMPLETED|Overall Study||178
10996194|NCT00673790|12172768|FG001|COMPLETED|Overall Study||174
10996195|NCT00673790|12172769|FG002|COMPLETED|Overall Study||90
10996196|NCT00673790|12172767|FG000|NOT COMPLETED|Overall Study||45
10996197|NCT00673790|12172768|FG001|NOT COMPLETED|Overall Study||38
10996198|NCT00673790|12172769|FG002|NOT COMPLETED|Overall Study||12
10996199|NCT00673816|12172778|FG000|STARTED|Overall Study||2
10996200|NCT00673816|12172778|FG000|COMPLETED|Overall Study||0
10996201|NCT00673816|12172778|FG000|NOT COMPLETED|Overall Study||2
10996202|NCT00673855|12172783|FG000|STARTED|First Intervention||10
10996203|NCT00673855|12172784|FG001|STARTED|First Intervention||10
10996204|NCT00673855|12172783|FG000|COMPLETED|First Intervention||10
10996205|NCT00673855|12172784|FG001|COMPLETED|First Intervention||10
10996206|NCT00673855|12172783|FG000|NOT COMPLETED|First Intervention||0
10996207|NCT00673855|12172784|FG001|NOT COMPLETED|First Intervention||0
10996208|NCT00673855|12172783|FG000|STARTED|Second Intervention||10
10996209|NCT00673855|12172784|FG001|STARTED|Second Intervention||10
10996210|NCT00673855|12172783|FG000|COMPLETED|Second Intervention||10
10996211|NCT00673855|12172784|FG001|COMPLETED|Second Intervention||10
10996212|NCT00673855|12172783|FG000|NOT COMPLETED|Second Intervention||0
10996213|NCT00673855|12172784|FG001|NOT COMPLETED|Second Intervention||0
10996214|NCT00673881|12172790|FG000|STARTED|Overall Study||25
10996215|NCT00673881|12172790|FG000|COMPLETED|Overall Study||24
10996216|NCT00673881|12172790|FG000|NOT COMPLETED|Overall Study||1
10996217|NCT00673894|12172796|FG000|STARTED|First Intervention 4 Weeks||8
10996218|NCT00673894|12172797|FG001|STARTED|First Intervention 4 Weeks||7
10996219|NCT00673894|12172796|FG000|COMPLETED|First Intervention 4 Weeks||6
10996220|NCT00673894|12172797|FG001|COMPLETED|First Intervention 4 Weeks||7
10996221|NCT00673894|12172796|FG000|NOT COMPLETED|First Intervention 4 Weeks||2
10996222|NCT00673894|12172797|FG001|NOT COMPLETED|First Intervention 4 Weeks||0
10996223|NCT00673894|12172796|FG000|STARTED|Washout 4-6 Weeks||6
10996224|NCT00673894|12172797|FG001|STARTED|Washout 4-6 Weeks||7
10996225|NCT00673894|12172796|FG000|COMPLETED|Washout 4-6 Weeks||6
10996226|NCT00673894|12172797|FG001|COMPLETED|Washout 4-6 Weeks||7
10996227|NCT00673894|12172796|FG000|NOT COMPLETED|Washout 4-6 Weeks||0
10996228|NCT00673894|12172797|FG001|NOT COMPLETED|Washout 4-6 Weeks||0
10996229|NCT00673894|12172796|FG000|STARTED|Second Intervention 4 Weeks||6
10996230|NCT00673894|12172797|FG001|STARTED|Second Intervention 4 Weeks||7
10996231|NCT00673894|12172796|FG000|COMPLETED|Second Intervention 4 Weeks||6
10996232|NCT00673894|12172797|FG001|COMPLETED|Second Intervention 4 Weeks||7
10996233|NCT00673894|12172796|FG000|NOT COMPLETED|Second Intervention 4 Weeks||0
10996234|NCT00673894|12172797|FG001|NOT COMPLETED|Second Intervention 4 Weeks||0
10996235|NCT00673920|12172811|FG000|STARTED|Baseline up to Week 48||64
10996236|NCT00673920|12172812|FG001|STARTED|Baseline up to Week 48||117
10996237|NCT00673920|12172813|FG002|STARTED|Baseline up to Week 48||133
10996238|NCT00673920|12172814|FG003|STARTED|Baseline up to Week 48||0
10996239|NCT00673920|12172815|FG004|STARTED|Baseline up to Week 48||0
10996240|NCT00673920|12172816|FG005|STARTED|Baseline up to Week 48||0
10996241|NCT00673920|12172817|FG006|STARTED|Baseline up to Week 48||0
10996242|NCT00673920|12172818|FG007|STARTED|Baseline up to Week 48||0
10996243|NCT00673920|12172811|FG000|COMPLETED|Baseline up to Week 48||60
10996244|NCT00673920|12172812|FG001|COMPLETED|Baseline up to Week 48||114
10996245|NCT00673920|12172813|FG002|COMPLETED|Baseline up to Week 48||126
10996246|NCT00673920|12172814|FG003|COMPLETED|Baseline up to Week 48||0
10996247|NCT00673920|12172815|FG004|COMPLETED|Baseline up to Week 48||0
10996248|NCT00673920|12172816|FG005|COMPLETED|Baseline up to Week 48||0
10996249|NCT00673920|12172817|FG006|COMPLETED|Baseline up to Week 48||0
10996250|NCT00673920|12172818|FG007|COMPLETED|Baseline up to Week 48||0
10996251|NCT00673920|12172811|FG000|NOT COMPLETED|Baseline up to Week 48||4
10996252|NCT00673920|12172812|FG001|NOT COMPLETED|Baseline up to Week 48||3
10996253|NCT00673920|12172813|FG002|NOT COMPLETED|Baseline up to Week 48||7
10996254|NCT00673920|12172814|FG003|NOT COMPLETED|Baseline up to Week 48||0
10996255|NCT00673920|12172815|FG004|NOT COMPLETED|Baseline up to Week 48||0
10996256|NCT00673920|12172816|FG005|NOT COMPLETED|Baseline up to Week 48||0
10996257|NCT00673920|12172817|FG006|NOT COMPLETED|Baseline up to Week 48||0
10996258|NCT00673920|12172818|FG007|NOT COMPLETED|Baseline up to Week 48||0
10996259|NCT00673920|12172811|FG000|STARTED|Week 24 to Week 48||0
10996260|NCT00673920|12172812|FG001|STARTED|Week 24 to Week 48||0
10996261|NCT00673920|12172813|FG002|STARTED|Week 24 to Week 48||0
10996262|NCT00673920|12172814|FG003|STARTED|Week 24 to Week 48||61
10996263|NCT00673920|12172815|FG004|STARTED|Week 24 to Week 48||61
10996264|NCT00673920|12172816|FG005|STARTED|Week 24 to Week 48||109
10996265|NCT00673920|12172817|FG006|STARTED|Week 24 to Week 48||29
10996266|NCT00673920|12172818|FG007|STARTED|Week 24 to Week 48||28
10996267|NCT00673920|12172811|FG000|COMPLETED|Week 24 to Week 48||0
10996268|NCT00673920|12172812|FG001|COMPLETED|Week 24 to Week 48||0
10996269|NCT00673920|12172813|FG002|COMPLETED|Week 24 to Week 48||0
10996270|NCT00673920|12172814|FG003|COMPLETED|Week 24 to Week 48||60
10996271|NCT00673920|12172815|FG004|COMPLETED|Week 24 to Week 48||61
10996272|NCT00673920|12172816|FG005|COMPLETED|Week 24 to Week 48||106
10996273|NCT00673920|12172817|FG006|COMPLETED|Week 24 to Week 48||28
10996274|NCT00673920|12172818|FG007|COMPLETED|Week 24 to Week 48||28
10996275|NCT00673920|12172811|FG000|NOT COMPLETED|Week 24 to Week 48||0
10996276|NCT00673920|12172812|FG001|NOT COMPLETED|Week 24 to Week 48||0
10996277|NCT00673920|12172813|FG002|NOT COMPLETED|Week 24 to Week 48||0
10996278|NCT00673920|12172814|FG003|NOT COMPLETED|Week 24 to Week 48||1
10996279|NCT00673920|12172815|FG004|NOT COMPLETED|Week 24 to Week 48||0
10996280|NCT00673920|12172816|FG005|NOT COMPLETED|Week 24 to Week 48||3
10996281|NCT00673920|12172817|FG006|NOT COMPLETED|Week 24 to Week 48||1
10996282|NCT00673920|12172818|FG007|NOT COMPLETED|Week 24 to Week 48||0
10996283|NCT00673933|12172840|FG000|STARTED|Overall Study||20
10996284|NCT00673933|12172840|FG000|COMPLETED|Overall Study||17
10996285|NCT00673933|12172840|FG000|NOT COMPLETED|Overall Study||3
10996286|NCT00673959|12172846|FG000|STARTED|Overall Study||10
10996287|NCT00673959|12172847|FG001|STARTED|Overall Study||10
10996288|NCT00673959|12172846|FG000|COMPLETED|Overall Study||10
10996289|NCT00673959|12172847|FG001|COMPLETED|Overall Study||10
10996290|NCT00673959|12172846|FG000|NOT COMPLETED|Overall Study||0
10996291|NCT00673959|12172847|FG001|NOT COMPLETED|Overall Study||0
10996292|NCT00674115|12172853|FG000|STARTED|First Intervention||14
10996293|NCT00674115|12172854|FG001|STARTED|First Intervention||16
10996294|NCT00674115|12172855|FG002|STARTED|First Intervention||14
10996295|NCT00674115|12172856|FG003|STARTED|First Intervention||16
10996296|NCT00674115|12172853|FG000|COMPLETED|First Intervention||14
10996297|NCT00674115|12172854|FG001|COMPLETED|First Intervention||16
10996298|NCT00674115|12172855|FG002|COMPLETED|First Intervention||14
10996299|NCT00674115|12172856|FG003|COMPLETED|First Intervention||16
10996300|NCT00674115|12172853|FG000|NOT COMPLETED|First Intervention||0
10996301|NCT00674115|12172854|FG001|NOT COMPLETED|First Intervention||0
10996302|NCT00674115|12172855|FG002|NOT COMPLETED|First Intervention||0
10996303|NCT00674115|12172856|FG003|NOT COMPLETED|First Intervention||0
10996304|NCT00674115|12172853|FG000|STARTED|Washout Period of 2 Weeks||14
10996305|NCT00674115|12172854|FG001|STARTED|Washout Period of 2 Weeks||16
10996306|NCT00674115|12172855|FG002|STARTED|Washout Period of 2 Weeks||14
10996307|NCT00674115|12172856|FG003|STARTED|Washout Period of 2 Weeks||16
10996308|NCT00674115|12172853|FG000|COMPLETED|Washout Period of 2 Weeks||14
10996309|NCT00674115|12172854|FG001|COMPLETED|Washout Period of 2 Weeks||16
10996310|NCT00674115|12172855|FG002|COMPLETED|Washout Period of 2 Weeks||14
10996311|NCT00674115|12172856|FG003|COMPLETED|Washout Period of 2 Weeks||16
10996312|NCT00674115|12172853|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10996313|NCT00674115|12172854|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10996314|NCT00674115|12172855|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
10996315|NCT00674115|12172856|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
10996316|NCT00674115|12172853|FG000|STARTED|Second Intervention||14
10996317|NCT00674115|12172854|FG001|STARTED|Second Intervention||16
10996318|NCT00674115|12172855|FG002|STARTED|Second Intervention||14
10996319|NCT00674115|12172856|FG003|STARTED|Second Intervention||16
10996320|NCT00674115|12172853|FG000|COMPLETED|Second Intervention||14
10996321|NCT00674115|12172854|FG001|COMPLETED|Second Intervention||16
10996322|NCT00674115|12172855|FG002|COMPLETED|Second Intervention||14
10996323|NCT00674115|12172856|FG003|COMPLETED|Second Intervention||16
10996324|NCT00674115|12172853|FG000|NOT COMPLETED|Second Intervention||0
10996325|NCT00674115|12172854|FG001|NOT COMPLETED|Second Intervention||0
10996326|NCT00674115|12172855|FG002|NOT COMPLETED|Second Intervention||0
10996327|NCT00674115|12172856|FG003|NOT COMPLETED|Second Intervention||0
10996328|NCT00674115|12172853|FG000|STARTED|Washout Period of 2 Weeks||14
10996329|NCT00674115|12172854|FG001|STARTED|Washout Period of 2 Weeks||16
10996330|NCT00674115|12172855|FG002|STARTED|Washout Period of 2 Weeks||0
10996331|NCT00674115|12172856|FG003|STARTED|Washout Period of 2 Weeks||0
10996332|NCT00674115|12172853|FG000|COMPLETED|Washout Period of 2 Weeks||14
10996333|NCT00674115|12172854|FG001|COMPLETED|Washout Period of 2 Weeks||16
10996334|NCT00674115|12172855|FG002|COMPLETED|Washout Period of 2 Weeks||0
10996335|NCT00674115|12172856|FG003|COMPLETED|Washout Period of 2 Weeks||0
10996336|NCT00674115|12172853|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
10996337|NCT00674115|12172854|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
10996338|NCT00674115|12172855|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
10996339|NCT00674115|12172856|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
10996340|NCT00674115|12172853|FG000|STARTED|Third Intervention||14
10996341|NCT00674115|12172854|FG001|STARTED|Third Intervention||16
10996342|NCT00674115|12172855|FG002|STARTED|Third Intervention||0
10996343|NCT00674115|12172856|FG003|STARTED|Third Intervention||0
10996344|NCT00674115|12172853|FG000|COMPLETED|Third Intervention||14
10996345|NCT00674115|12172854|FG001|COMPLETED|Third Intervention||16
10996346|NCT00674115|12172855|FG002|COMPLETED|Third Intervention||0
10996347|NCT00674115|12172856|FG003|COMPLETED|Third Intervention||0
10996348|NCT00674115|12172853|FG000|NOT COMPLETED|Third Intervention||0
10996349|NCT00674115|12172854|FG001|NOT COMPLETED|Third Intervention||0
10996350|NCT00674115|12172855|FG002|NOT COMPLETED|Third Intervention||0
10996351|NCT00674115|12172856|FG003|NOT COMPLETED|Third Intervention||0
10996352|NCT00674128|12172867|FG000|STARTED|Overall Study||50
10996353|NCT00674128|12172868|FG001|STARTED|Overall Study||44
10996354|NCT00674128|12172867|FG000|COMPLETED|Overall Study||25
10996355|NCT00674128|12172868|FG001|COMPLETED|Overall Study||21
10996356|NCT00674128|12172867|FG000|NOT COMPLETED|Overall Study||25
10996357|NCT00674128|12172868|FG001|NOT COMPLETED|Overall Study||23
10996358|NCT00674154|12172876|FG000|STARTED|Overall Study||23
10996359|NCT00674154|12172877|FG001|STARTED|Overall Study||23
10996360|NCT00674154|12172876|FG000|COMPLETED|Overall Study||20
10996361|NCT00674154|12172877|FG001|COMPLETED|Overall Study||20
10996362|NCT00674154|12172876|FG000|NOT COMPLETED|Overall Study||3
10996363|NCT00674154|12172877|FG001|NOT COMPLETED|Overall Study||3
10996364|NCT00674206|12172883|FG000|STARTED|Overall Study||6
10996365|NCT00674206|12172883|FG000|COMPLETED|Overall Study||6
10996366|NCT00674206|12172883|FG000|NOT COMPLETED|Overall Study||0
10996367|NCT00674219|12172889|FG000|STARTED|Overall Study||10
10996368|NCT00674219|12172890|FG001|STARTED|Overall Study||7
10996369|NCT00674219|12172889|FG000|COMPLETED|Overall Study||10
10996370|NCT00674219|12172890|FG001|COMPLETED|Overall Study||7
10996371|NCT00674219|12172889|FG000|NOT COMPLETED|Overall Study||0
10996372|NCT00674219|12172890|FG001|NOT COMPLETED|Overall Study||0
10996373|NCT00674297|12172896|FG000|STARTED|Overall Study||18
10996374|NCT00674297|12172897|FG001|STARTED|Overall Study||7
10996375|NCT00674297|12172898|FG002|STARTED|Overall Study||9
10996376|NCT00674297|12172899|FG003|STARTED|Overall Study||7
10996377|NCT00674297|12172896|FG000|COMPLETED|Overall Study||8
10996378|NCT00674297|12172897|FG001|COMPLETED|Overall Study||7
10996379|NCT00674297|12172898|FG002|COMPLETED|Overall Study||5
10996380|NCT00674297|12172899|FG003|COMPLETED|Overall Study||4
10996381|NCT00674297|12172896|FG000|NOT COMPLETED|Overall Study||10
10996382|NCT00674297|12172897|FG001|NOT COMPLETED|Overall Study||0
10996383|NCT00674297|12172898|FG002|NOT COMPLETED|Overall Study||4
10996384|NCT00674297|12172899|FG003|NOT COMPLETED|Overall Study||3
10996385|NCT00674323|12172909|FG000|STARTED|Overall Study||19
10996386|NCT00674323|12172910|FG001|STARTED|Overall Study||21
10996387|NCT00674323|12172911|FG002|STARTED|Overall Study||21
10996388|NCT00674323|12172909|FG000|COMPLETED|Overall Study||18
10996389|NCT00674323|12172910|FG001|COMPLETED|Overall Study||20
10996390|NCT00674323|12172911|FG002|COMPLETED|Overall Study||21
10996391|NCT00674323|12172909|FG000|NOT COMPLETED|Overall Study||1
10996392|NCT00674323|12172910|FG001|NOT COMPLETED|Overall Study||1
10996393|NCT00674323|12172911|FG002|NOT COMPLETED|Overall Study||0
10996394|NCT00674362|12172921|FG000|STARTED|Double Blind||96
10996395|NCT00674362|12172922|FG001|STARTED|Double Blind||98
10996396|NCT00674362|12172921|FG000|COMPLETED|Double Blind||84
10996397|NCT00674362|12172922|FG001|COMPLETED|Double Blind||80
10996398|NCT00674362|12172921|FG000|NOT COMPLETED|Double Blind||12
10996399|NCT00674362|12172922|FG001|NOT COMPLETED|Double Blind||18
10996400|NCT00674362|12172921|FG000|STARTED|Open Label||20
10996401|NCT00674362|12172922|FG001|STARTED|Open Label||7
10996402|NCT00674362|12172921|FG000|COMPLETED|Open Label||18
10996403|NCT00674362|12172922|FG001|COMPLETED|Open Label||7
10996404|NCT00674362|12172921|FG000|NOT COMPLETED|Open Label||2
10996405|NCT00674362|12172922|FG001|NOT COMPLETED|Open Label||0
10996406|NCT00674466|12172932|FG000|STARTED|Overall Study||30
10996407|NCT00674466|12172933|FG001|STARTED|Overall Study||30
10996408|NCT00674466|12172934|FG002|STARTED|Overall Study||30
10996409|NCT00674466|12172932|FG000|COMPLETED|Overall Study||23
10996410|NCT00674466|12172933|FG001|COMPLETED|Overall Study||22
10996411|NCT00674466|12172934|FG002|COMPLETED|Overall Study||21
10996412|NCT00674466|12172932|FG000|NOT COMPLETED|Overall Study||7
10996413|NCT00674466|12172933|FG001|NOT COMPLETED|Overall Study||8
10996414|NCT00674466|12172934|FG002|NOT COMPLETED|Overall Study||9
10996415|NCT00674479|12172942|FG000|STARTED|Overall Study||51
10996416|NCT00674479|12172942|FG000|COMPLETED|Overall Study||51
10996417|NCT00674479|12172942|FG000|NOT COMPLETED|Overall Study||0
10996418|NCT00674492|12172946|FG000|STARTED|Overall Study||21
10996419|NCT00674492|12172946|FG000|COMPLETED|Overall Study||21
10996420|NCT00674492|12172946|FG000|NOT COMPLETED|Overall Study||0
10996421|NCT00674570|12172953|FG000|STARTED|Overall Study||37
10996422|NCT00674570|12172954|FG001|STARTED|Overall Study||34
10996423|NCT00674570|12172955|FG002|STARTED|Overall Study||35
10996424|NCT00674570|12172953|FG000|COMPLETED|Overall Study||37
10996425|NCT00674570|12172954|FG001|COMPLETED|Overall Study||32
10996426|NCT00674570|12172955|FG002|COMPLETED|Overall Study||35
10996427|NCT00674570|12172953|FG000|NOT COMPLETED|Overall Study||0
10996428|NCT00674570|12172954|FG001|NOT COMPLETED|Overall Study||2
10996429|NCT00674570|12172955|FG002|NOT COMPLETED|Overall Study||0
10996430|NCT00674583|12172965|FG000|STARTED|Overall Study||311
10996431|NCT00674583|12172966|FG001|STARTED|Overall Study||103
10996432|NCT00674583|12172965|FG000|COMPLETED|Overall Study||311
10996433|NCT00674583|12172966|FG001|COMPLETED|Overall Study||103
10996434|NCT00674583|12172965|FG000|NOT COMPLETED|Overall Study||0
10996435|NCT00674583|12172966|FG001|NOT COMPLETED|Overall Study||0
10996436|NCT00674609|12172979|FG000|STARTED|Overall Study||60
10996437|NCT00674609|12172980|FG001|STARTED|Overall Study||58
10996438|NCT00674609|12172981|FG002|STARTED|Overall Study||59
10996439|NCT00674609|12172979|FG000|COMPLETED|Overall Study||48
10996440|NCT00674609|12172980|FG001|COMPLETED|Overall Study||45
10996441|NCT00674609|12172981|FG002|COMPLETED|Overall Study||51
10996442|NCT00674609|12172979|FG000|NOT COMPLETED|Overall Study||12
10996443|NCT00674609|12172980|FG001|NOT COMPLETED|Overall Study||13
10996444|NCT00674609|12172981|FG002|NOT COMPLETED|Overall Study||8
10996445|NCT00674622|12172992|FG000|STARTED|Overall Study||22
10996446|NCT00674622|12172993|FG001|STARTED|Overall Study||22
10996447|NCT00674622|12172994|FG002|STARTED|Overall Study||22
10996448|NCT00674622|12172992|FG000|COMPLETED|Overall Study||21
10996449|NCT00674622|12172993|FG001|COMPLETED|Overall Study||18
10996450|NCT00674622|12172994|FG002|COMPLETED|Overall Study||22
10996451|NCT00674622|12172992|FG000|NOT COMPLETED|Overall Study||1
10996452|NCT00674622|12172993|FG001|NOT COMPLETED|Overall Study||4
10996453|NCT00674622|12172994|FG002|NOT COMPLETED|Overall Study||0
10996454|NCT00674661|12173004|FG000|STARTED|Overall Study||67
10996455|NCT00674661|12173005|FG001|STARTED|Overall Study||63
10996456|NCT00674661|12173004|FG000|COMPLETED|Overall Study||56
10996457|NCT00674661|12173005|FG001|COMPLETED|Overall Study||48
10996458|NCT00674661|12173004|FG000|NOT COMPLETED|Overall Study||11
10996459|NCT00674661|12173005|FG001|NOT COMPLETED|Overall Study||15
10996460|NCT00674700|12173014|FG000|STARTED|Year 1||170
10996461|NCT00674700|12173015|FG001|STARTED|Year 1||169
10996462|NCT00674700|12173016|FG002|STARTED|Year 1||170
10996463|NCT00674700|12173014|FG000|COMPLETED|Year 1||139
10996464|NCT00674700|12173015|FG001|COMPLETED|Year 1||135
10996465|NCT00674700|12173016|FG002|COMPLETED|Year 1||153
10996466|NCT00674700|12173014|FG000|NOT COMPLETED|Year 1||31
10996467|NCT00674700|12173015|FG001|NOT COMPLETED|Year 1||34
10996468|NCT00674700|12173016|FG002|NOT COMPLETED|Year 1||17
10996469|NCT00674700|12173014|FG000|STARTED|Year 2 Follow-up Without Treatment||139
10996470|NCT00674700|12173015|FG001|STARTED|Year 2 Follow-up Without Treatment||135
10996471|NCT00674700|12173016|FG002|STARTED|Year 2 Follow-up Without Treatment||153
10996472|NCT00674700|12173014|FG000|COMPLETED|Year 2 Follow-up Without Treatment||133
10996473|NCT00674700|12173015|FG001|COMPLETED|Year 2 Follow-up Without Treatment||123
10996474|NCT00674700|12173016|FG002|COMPLETED|Year 2 Follow-up Without Treatment||141
10996475|NCT00674700|12173014|FG000|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
10996476|NCT00674700|12173015|FG001|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
10996477|NCT00674700|12173016|FG002|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
10996478|NCT00674739|12173027|FG000|STARTED|Overall Study||178
10996479|NCT00674739|12173028|FG001|STARTED|Overall Study||195
10996480|NCT00674739|12173029|FG002|STARTED|Overall Study||97
10996481|NCT00674739|12173027|FG000|COMPLETED|Overall Study||121
10996482|NCT00674739|12173028|FG001|COMPLETED|Overall Study||136
10996483|NCT00674739|12173029|FG002|COMPLETED|Overall Study||65
10996484|NCT00674739|12173027|FG000|NOT COMPLETED|Overall Study||57
10996485|NCT00674739|12173028|FG001|NOT COMPLETED|Overall Study||59
10996486|NCT00674739|12173029|FG002|NOT COMPLETED|Overall Study||32
10996487|NCT00674765|12173039|FG000|STARTED|Overall Study||81
10996488|NCT00674765|12173040|FG001|STARTED|Overall Study||75
10996489|NCT00674765|12173039|FG000|COMPLETED|Overall Study||45
10996490|NCT00674765|12173040|FG001|COMPLETED|Overall Study||46
10996491|NCT00674765|12173039|FG000|NOT COMPLETED|Overall Study||36
10996492|NCT00674765|12173040|FG001|NOT COMPLETED|Overall Study||29
10996493|NCT00674817|12173046|FG000|STARTED|Period 1||44
10996494|NCT00674817|12173046|FG000|COMPLETED|Period 1||41
10996495|NCT00674817|12173046|FG000|NOT COMPLETED|Period 1||3
10996496|NCT00674817|12173046|FG000|STARTED|Period 2||41
10996497|NCT00674817|12173046|FG000|COMPLETED|Period 2||41
10996498|NCT00674817|12173046|FG000|NOT COMPLETED|Period 2||0
10996499|NCT00674817|12173046|FG000|STARTED|Period 3||41
10996500|NCT00674817|12173046|FG000|COMPLETED|Period 3||39
10996501|NCT00674817|12173046|FG000|NOT COMPLETED|Period 3||2
10996502|NCT00674817|12173046|FG000|STARTED|Period 4||39
10996503|NCT00674817|12173046|FG000|COMPLETED|Period 4||38
10996504|NCT00674817|12173046|FG000|NOT COMPLETED|Period 4||1
10996505|NCT00674817|12173046|FG000|STARTED|Period 5||38
10996506|NCT00674817|12173046|FG000|COMPLETED|Period 5||38
10996507|NCT00674817|12173046|FG000|NOT COMPLETED|Period 5||0
10996508|NCT00674817|12173046|FG000|STARTED|Period 6||38
10996509|NCT00674817|12173046|FG000|COMPLETED|Period 6||38
10996510|NCT00674817|12173046|FG000|NOT COMPLETED|Period 6||0
10996511|NCT00674973|12173062|FG000|STARTED|Overall Study||103
10996512|NCT00674973|12173063|FG001|STARTED|Overall Study||104
10996513|NCT00674973|12173062|FG000|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
10996514|NCT00674973|12173063|FG001|Switch to Open-Label Erlotinib|Overall Study||0
10996515|NCT00674973|12173062|FG000|COMPLETED|Overall Study|Completed double-blind treatment.|3
10996516|NCT00674973|12173063|FG001|COMPLETED|Overall Study|Completed double-blind treatment.|2
10996517|NCT00674973|12173062|FG000|NOT COMPLETED|Overall Study||100
10996518|NCT00674973|12173063|FG001|NOT COMPLETED|Overall Study||102
10996519|NCT00674986|12173071|FG000|STARTED|Overall Study||230
10996520|NCT00674986|12173072|FG001|STARTED|Overall Study||269
10996521|NCT00674986|12173071|FG000|Intent to Treat Population|Overall Study||227
10996522|NCT00674986|12173072|FG001|Intent to Treat Population|Overall Study||256
10996523|NCT00674986|12173071|FG000|COMPLETED|Overall Study||187
10996524|NCT00674986|12173072|FG001|COMPLETED|Overall Study||188
10996525|NCT00674986|12173071|FG000|NOT COMPLETED|Overall Study||43
10996526|NCT00674986|12173072|FG001|NOT COMPLETED|Overall Study||81
10996527|NCT00675025|12173081|FG000|STARTED|Overall Study||54
10996528|NCT00675025|12173082|FG001|STARTED|Overall Study||63
10996529|NCT00675025|12173081|FG000|COMPLETED|Overall Study||0
10996530|NCT00675025|12173082|FG001|COMPLETED|Overall Study||0
10996531|NCT00675025|12173081|FG000|NOT COMPLETED|Overall Study||54
10996532|NCT00675025|12173082|FG001|NOT COMPLETED|Overall Study||63
10996533|NCT00675103|12173088|FG000|STARTED|Overall Study||7
10996534|NCT00675103|12173088|FG000|COMPLETED|Overall Study||4
10996535|NCT00675103|12173088|FG000|NOT COMPLETED|Overall Study||3
10996536|NCT00675259|12173092|FG000|STARTED|Overall Study||33
10996537|NCT00675259|12173092|FG000|COMPLETED|Overall Study||19
10996538|NCT00675259|12173092|FG000|NOT COMPLETED|Overall Study||14
10996539|NCT00675415|12173102|FG000|STARTED|Overall Study||132
10996540|NCT00675415|12173103|FG001|STARTED|Overall Study||131
10996541|NCT00675415|12173102|FG000|COMPLETED|Overall Study||124
10996542|NCT00675415|12173103|FG001|COMPLETED|Overall Study||123
10996543|NCT00675415|12173102|FG000|NOT COMPLETED|Overall Study||8
10996544|NCT00675415|12173103|FG001|NOT COMPLETED|Overall Study||8
10996545|NCT00675428|12173111|FG000|STARTED|Overall Study||3
10996546|NCT00675428|12173112|FG001|STARTED|Overall Study||3
10996547|NCT00675428|12173111|FG000|COMPLETED|Overall Study||0
10996548|NCT00675428|12173112|FG001|COMPLETED|Overall Study||0
10996549|NCT00675428|12173111|FG000|NOT COMPLETED|Overall Study||3
10996550|NCT00675428|12173112|FG001|NOT COMPLETED|Overall Study||3
10996551|NCT00675441|12173118|FG000|STARTED|Overall Study||5
10996552|NCT00675441|12173118|FG000|COMPLETED|Overall Study||2
10996553|NCT00675441|12173118|FG000|NOT COMPLETED|Overall Study||3
10996554|NCT00675506|12173124|FG000|STARTED|Overall Study||31
10996555|NCT00675506|12173125|FG001|STARTED|Overall Study||29
10996556|NCT00675506|12173124|FG000|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
10996557|NCT00675506|12173125|FG001|Received Intervention|Overall Study||29
10996558|NCT00675506|12173124|FG000|COMPLETED|Overall Study||19
10996559|NCT00675506|12173125|FG001|COMPLETED|Overall Study||17
10996560|NCT00675506|12173124|FG000|NOT COMPLETED|Overall Study||12
10996561|NCT00675506|12173125|FG001|NOT COMPLETED|Overall Study||12
10996562|NCT00675558|12173135|FG000|STARTED|Surgery||10
10996563|NCT00675558|12173136|FG001|STARTED|Surgery||10
10996564|NCT00675558|12173137|FG002|STARTED|Surgery||30
10996565|NCT00675558|12173135|FG000|COMPLETED|Surgery||10
10996566|NCT00675558|12173136|FG001|COMPLETED|Surgery||10
10996567|NCT00675558|12173137|FG002|COMPLETED|Surgery||30
10996568|NCT00675558|12173135|FG000|NOT COMPLETED|Surgery||0
10996569|NCT00675558|12173136|FG001|NOT COMPLETED|Surgery||0
10996570|NCT00675558|12173137|FG002|NOT COMPLETED|Surgery||0
10996571|NCT00675558|12173135|FG000|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
10996572|NCT00675558|12173136|FG001|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
10996573|NCT00675558|12173137|FG002|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
10996574|NCT00675558|12173135|FG000|COMPLETED|Second Operation||0
10996575|NCT00675558|12173136|FG001|COMPLETED|Second Operation||0
10996576|NCT00675558|12173137|FG002|COMPLETED|Second Operation||10
10996577|NCT00675558|12173135|FG000|NOT COMPLETED|Second Operation||0
10996578|NCT00675558|12173136|FG001|NOT COMPLETED|Second Operation||0
10996579|NCT00675558|12173137|FG002|NOT COMPLETED|Second Operation||0
10996580|NCT00675584|12173147|FG000|STARTED|Overall Study||139
10996581|NCT00675584|12173148|FG001|STARTED|Overall Study||139
10996582|NCT00675584|12173147|FG000|COMPLETED|Overall Study||100
10996583|NCT00675584|12173148|FG001|COMPLETED|Overall Study||113
10996584|NCT00675584|12173147|FG000|NOT COMPLETED|Overall Study||39
10996585|NCT00675584|12173148|FG001|NOT COMPLETED|Overall Study||26
10996586|NCT00675597|12173154|FG000|STARTED|Overall Study||26
10996587|NCT00675597|12173154|FG000|COMPLETED|Overall Study||23
10996588|NCT00675597|12173154|FG000|NOT COMPLETED|Overall Study||3
10996589|NCT00675766|12173162|FG000|STARTED|Overall Study||106
10996590|NCT00675766|12173163|FG001|STARTED|Overall Study||30
10996591|NCT00675766|12173164|FG002|STARTED|Overall Study||50
10996592|NCT00675766|12173165|FG003|STARTED|Overall Study||37
10996593|NCT00675766|12173162|FG000|Year 2|Overall Study||105
10996594|NCT00675766|12173163|FG001|Year 2|Overall Study||28
10996595|NCT00675766|12173164|FG002|Year 2|Overall Study||34
10996596|NCT00675766|12173165|FG003|Year 2|Overall Study||20
10996597|NCT00675766|12173162|FG000|Year 3|Overall Study||100
10996598|NCT00675766|12173163|FG001|Year 3|Overall Study||25
10996599|NCT00675766|12173164|FG002|Year 3|Overall Study||29
10996600|NCT00675766|12173165|FG003|Year 3|Overall Study||11
10996601|NCT00675766|12173162|FG000|COMPLETED|Overall Study||100
10996602|NCT00675766|12173163|FG001|COMPLETED|Overall Study||25
10996603|NCT00675766|12173164|FG002|COMPLETED|Overall Study||29
10996604|NCT00675766|12173165|FG003|COMPLETED|Overall Study||11
10996605|NCT00675766|12173162|FG000|NOT COMPLETED|Overall Study||6
10996606|NCT00675766|12173163|FG001|NOT COMPLETED|Overall Study||5
10996607|NCT00675766|12173164|FG002|NOT COMPLETED|Overall Study||21
10996608|NCT00675766|12173165|FG003|NOT COMPLETED|Overall Study||26
10996609|NCT00675792|12173177|FG000|STARTED|Overall Study||51
10996610|NCT00675792|12173178|FG001|STARTED|Overall Study||49
10996611|NCT00675792|12173177|FG000|COMPLETED|Overall Study||51
10996612|NCT00675792|12173178|FG001|COMPLETED|Overall Study||49
10996613|NCT00675792|12173177|FG000|NOT COMPLETED|Overall Study||0
10996614|NCT00675792|12173178|FG001|NOT COMPLETED|Overall Study||0
10996615|NCT00675909|12173187|FG000|STARTED|Overall Study||60
10996616|NCT00675909|12173188|FG001|STARTED|Overall Study||60
10996617|NCT00675909|12173189|FG002|STARTED|Overall Study||60
10996618|NCT00675909|12173187|FG000|COMPLETED|Overall Study||60
10996619|NCT00675909|12173188|FG001|COMPLETED|Overall Study||60
10996620|NCT00675909|12173189|FG002|COMPLETED|Overall Study||60
10996621|NCT00675909|12173187|FG000|NOT COMPLETED|Overall Study||0
10996622|NCT00675909|12173188|FG001|NOT COMPLETED|Overall Study||0
10996623|NCT00675909|12173189|FG002|NOT COMPLETED|Overall Study||0
10996624|NCT00675922|12173197|FG000|STARTED|Overall Study||98
10996625|NCT00675922|12173197|FG000|COMPLETED|Overall Study||98
10996626|NCT00675922|12173197|FG000|NOT COMPLETED|Overall Study||0
10996627|NCT00675948|12173204|FG000|STARTED|Overall Study||39
10996628|NCT00675948|12173205|FG001|STARTED|Overall Study||4
10996629|NCT00675948|12173204|FG000|COMPLETED|Overall Study||0
10996630|NCT00675948|12173205|FG001|COMPLETED|Overall Study||1
10996631|NCT00675948|12173204|FG000|NOT COMPLETED|Overall Study||39
10996632|NCT00675948|12173205|FG001|NOT COMPLETED|Overall Study||3
10996633|NCT00675987|12173214|FG000|STARTED|Overall Study||26
10996634|NCT00675987|12173215|FG001|STARTED|Overall Study||27
10996635|NCT00675987|12173214|FG000|COMPLETED|Overall Study||26
10996636|NCT00675987|12173215|FG001|COMPLETED|Overall Study||27
10996637|NCT00675987|12173214|FG000|NOT COMPLETED|Overall Study||0
10996638|NCT00675987|12173215|FG001|NOT COMPLETED|Overall Study||0
10996639|NCT00676013|12173223|FG000|STARTED|Overall Study||158
10996640|NCT00676013|12173223|FG000|COMPLETED|Overall Study||157
10996641|NCT00676013|12173223|FG000|NOT COMPLETED|Overall Study||1
10996642|NCT00676052|12173236|FG000|STARTED|Overall Study||96
10996643|NCT00676052|12173237|FG001|STARTED|Overall Study||95
10996644|NCT00676052|12173238|FG002|STARTED|Overall Study||96
10996645|NCT00676052|12173239|FG003|STARTED|Overall Study||97
10996646|NCT00676052|12173240|FG004|STARTED|Overall Study||95
10996647|NCT00676052|12173241|FG005|STARTED|Overall Study||97
10996648|NCT00676052|12173236|FG000|COMPLETED|Overall Study||87
10996649|NCT00676052|12173237|FG001|COMPLETED|Overall Study||88
10996650|NCT00676052|12173238|FG002|COMPLETED|Overall Study||90
10996651|NCT00676052|12173239|FG003|COMPLETED|Overall Study||92
10996652|NCT00676052|12173240|FG004|COMPLETED|Overall Study||89
10996653|NCT00676052|12173241|FG005|COMPLETED|Overall Study||91
10996654|NCT00676052|12173236|FG000|NOT COMPLETED|Overall Study||9
10996655|NCT00676052|12173237|FG001|NOT COMPLETED|Overall Study||7
10996656|NCT00676052|12173238|FG002|NOT COMPLETED|Overall Study||6
10996657|NCT00676052|12173239|FG003|NOT COMPLETED|Overall Study||5
10996658|NCT00676052|12173240|FG004|NOT COMPLETED|Overall Study||6
10996659|NCT00676052|12173241|FG005|NOT COMPLETED|Overall Study||6
10996660|NCT00676065|12173258|FG000|STARTED|Overall Study||16534
10996661|NCT00676065|12173259|FG001|STARTED|Overall Study||15428
10996662|NCT00676065|12173260|FG002|STARTED|Overall Study||26341
10996663|NCT00676065|12173258|FG000|COMPLETED|Overall Study||16534
10996664|NCT00676065|12173259|FG001|COMPLETED|Overall Study||15428
10996665|NCT00676065|12173260|FG002|COMPLETED|Overall Study||26341
10996666|NCT00676065|12173258|FG000|NOT COMPLETED|Overall Study||0
10996667|NCT00676065|12173259|FG001|NOT COMPLETED|Overall Study||0
10996668|NCT00676065|12173260|FG002|NOT COMPLETED|Overall Study||0
10996669|NCT00676091|12173270|FG000|STARTED|Infant Series||177
10996670|NCT00676091|12173271|FG001|STARTED|Infant Series||177
10996671|NCT00676091|12173270|FG000|Vaccinated Dose 1|Infant Series||163
10996672|NCT00676091|12173271|FG001|Vaccinated Dose 1|Infant Series||162
10996673|NCT00676091|12173270|FG000|Vaccinated Dose 2|Infant Series||159
10996674|NCT00676091|12173271|FG001|Vaccinated Dose 2|Infant Series||162
10996675|NCT00676091|12173270|FG000|Vaccinated Dose 3|Infant Series||158
10996676|NCT00676091|12173271|FG001|Vaccinated Dose 3|Infant Series||161
10996677|NCT00676091|12173270|FG000|COMPLETED|Infant Series||157
10996678|NCT00676091|12173271|FG001|COMPLETED|Infant Series||159
10996679|NCT00676091|12173270|FG000|NOT COMPLETED|Infant Series||20
10996680|NCT00676091|12173271|FG001|NOT COMPLETED|Infant Series||18
10996681|NCT00676091|12173270|FG000|STARTED|After Infant Series||157
10996682|NCT00676091|12173271|FG001|STARTED|After Infant Series||159
10996683|NCT00676091|12173270|FG000|COMPLETED|After Infant Series||156
10996684|NCT00676091|12173271|FG001|COMPLETED|After Infant Series||156
10996685|NCT00676091|12173270|FG000|NOT COMPLETED|After Infant Series||1
10996686|NCT00676091|12173271|FG001|NOT COMPLETED|After Infant Series||3
10996687|NCT00676091|12173270|FG000|STARTED|Toddler Dose||156
10996688|NCT00676091|12173271|FG001|STARTED|Toddler Dose||156
10996689|NCT00676091|12173270|FG000|COMPLETED|Toddler Dose||153
10996690|NCT00676091|12173271|FG001|COMPLETED|Toddler Dose||156
10996691|NCT00676091|12173270|FG000|NOT COMPLETED|Toddler Dose||3
10996692|NCT00676091|12173271|FG001|NOT COMPLETED|Toddler Dose||0
10996693|NCT00676130|12173283|FG000|STARTED|Overall Study||76
10996694|NCT00676130|12173284|FG001|STARTED|Overall Study||77
10996695|NCT00676130|12173283|FG000|COMPLETED|Overall Study||73
10996696|NCT00676130|12173284|FG001|COMPLETED|Overall Study||73
10996697|NCT00676130|12173283|FG000|NOT COMPLETED|Overall Study||3
10996698|NCT00676130|12173284|FG001|NOT COMPLETED|Overall Study||4
10996699|NCT00676143|12173292|FG000|STARTED|Overall Study||441
10996700|NCT00676143|12173293|FG001|STARTED|Overall Study||658
10996701|NCT00676143|12173292|FG000|Treated|Overall Study||439
10996702|NCT00676143|12173293|FG001|Treated|Overall Study||654
10996703|NCT00676143|12173292|FG000|COMPLETED|Overall Study||285
10996704|NCT00676143|12173293|FG001|COMPLETED|Overall Study||398
10996705|NCT00676143|12173292|FG000|NOT COMPLETED|Overall Study||156
10996706|NCT00676143|12173293|FG001|NOT COMPLETED|Overall Study||260
10996707|NCT00676182|12173302|FG000|STARTED|Overall Study||75
10996708|NCT00676182|12173302|FG000|COMPLETED|Overall Study||75
10996709|NCT00676182|12173302|FG000|NOT COMPLETED|Overall Study||0
10996710|NCT00676195|12173312|FG000|STARTED|Overall Study||24
10996711|NCT00676195|12173312|FG000|COMPLETED|Overall Study||21
10996712|NCT00676195|12173312|FG000|NOT COMPLETED|Overall Study||3
10996713|NCT00676208|12173319|FG000|STARTED|Overall Study||14
10996714|NCT00676208|12173320|FG001|STARTED|Overall Study||19
10996715|NCT00676208|12173319|FG000|COMPLETED|Overall Study||12
10996716|NCT00676208|12173320|FG001|COMPLETED|Overall Study||13
10996717|NCT00676208|12173319|FG000|NOT COMPLETED|Overall Study||2
10996718|NCT00676208|12173320|FG001|NOT COMPLETED|Overall Study||6
10996719|NCT00676338|12173332|FG000|STARTED|Overall Study||248
10996720|NCT00676338|12173333|FG001|STARTED|Overall Study||246
10996721|NCT00676338|12173334|FG002|STARTED|Overall Study||163
10996722|NCT00676338|12173335|FG003|STARTED|Overall Study||163
10996723|NCT00676338|12173332|FG000|COMPLETED|Overall Study||210
10996724|NCT00676338|12173333|FG001|COMPLETED|Overall Study||213
10996725|NCT00676338|12173334|FG002|COMPLETED|Overall Study||133
10996726|NCT00676338|12173335|FG003|COMPLETED|Overall Study||140
10996727|NCT00676338|12173332|FG000|NOT COMPLETED|Overall Study||38
10996728|NCT00676338|12173333|FG001|NOT COMPLETED|Overall Study||33
10996729|NCT00676338|12173334|FG002|NOT COMPLETED|Overall Study||30
10996730|NCT00676338|12173335|FG003|NOT COMPLETED|Overall Study||23
10996731|NCT00676364|12173347|FG000|STARTED|Overall Study||57
10996732|NCT00676364|12173348|FG001|STARTED|Overall Study||57
10996733|NCT00676364|12173347|FG000|COMPLETED|Overall Study||57
10996734|NCT00676364|12173348|FG001|COMPLETED|Overall Study||57
10996735|NCT00676364|12173347|FG000|NOT COMPLETED|Overall Study||0
10996736|NCT00676364|12173348|FG001|NOT COMPLETED|Overall Study||0
10996737|NCT00676403|12173362|FG000|STARTED|Overall Study||23
10996738|NCT00676403|12173363|FG001|STARTED|Overall Study||22
10996739|NCT00676403|12173364|FG002|STARTED|Overall Study||23
10996740|NCT00676403|12173365|FG003|STARTED|Overall Study||22
10996741|NCT00676403|12173366|FG004|STARTED|Overall Study||24
10996742|NCT00676403|12173367|FG005|STARTED|Overall Study||23
10996743|NCT00676403|12173362|FG000|COMPLETED|Overall Study||21
10996744|NCT00676403|12173363|FG001|COMPLETED|Overall Study||20
10996745|NCT00676403|12173364|FG002|COMPLETED|Overall Study||22
10996746|NCT00676403|12173365|FG003|COMPLETED|Overall Study||17
10996747|NCT00676403|12173366|FG004|COMPLETED|Overall Study||23
10996748|NCT00676403|12173367|FG005|COMPLETED|Overall Study||18
10996749|NCT00676403|12173362|FG000|NOT COMPLETED|Overall Study||2
10996750|NCT00676403|12173363|FG001|NOT COMPLETED|Overall Study||2
10996751|NCT00676403|12173364|FG002|NOT COMPLETED|Overall Study||1
10996752|NCT00676403|12173365|FG003|NOT COMPLETED|Overall Study||5
10996753|NCT00676403|12173366|FG004|NOT COMPLETED|Overall Study||1
10996754|NCT00676403|12173367|FG005|NOT COMPLETED|Overall Study||5
10996755|NCT00676520|12173387|FG000|STARTED|Overall Study||8040
10996756|NCT00676520|12173387|FG000|COMPLETED|Overall Study||7309
10996757|NCT00676520|12173387|FG000|NOT COMPLETED|Overall Study||731
10996758|NCT00676572|12173398|FG000|STARTED|Overall Study||6
10996759|NCT00676572|12173399|FG001|STARTED|Overall Study||6
10996760|NCT00676572|12173398|FG000|COMPLETED|Overall Study||6
10996761|NCT00676572|12173399|FG001|COMPLETED|Overall Study||6
10996762|NCT00676572|12173398|FG000|NOT COMPLETED|Overall Study||0
10996763|NCT00676572|12173399|FG001|NOT COMPLETED|Overall Study||0
10996764|NCT00676585|12173407|FG000|STARTED|Overall Study||25
10996765|NCT00676585|12173408|FG001|STARTED|Overall Study||25
10996766|NCT00676585|12173407|FG000|COMPLETED|Overall Study||25
10996767|NCT00676585|12173408|FG001|COMPLETED|Overall Study||25
10996768|NCT00676585|12173407|FG000|NOT COMPLETED|Overall Study||0
10996769|NCT00676585|12173408|FG001|NOT COMPLETED|Overall Study||0
10996770|NCT00676650|12173416|FG000|STARTED|Overall Study||584
10996771|NCT00676650|12173417|FG001|STARTED|Overall Study||289
10996772|NCT00676650|12173416|FG000|Treated|Overall Study||581
10996773|NCT00676650|12173417|FG001|Treated|Overall Study||285
10996774|NCT00676650|12173416|FG000|COMPLETED|Overall Study||0
10996775|NCT00676650|12173417|FG001|COMPLETED|Overall Study||0
10996776|NCT00676650|12173416|FG000|NOT COMPLETED|Overall Study||584
10996777|NCT00676650|12173417|FG001|NOT COMPLETED|Overall Study||289
10996778|NCT00676676|12173423|FG000|STARTED|Overall Study||9
10996779|NCT00676676|12173423|FG000|COMPLETED|Overall Study||9
10996780|NCT00676676|12173423|FG000|NOT COMPLETED|Overall Study||0
10996781|NCT00676689|12173427|FG000|STARTED|Overall Study||81
10996782|NCT00676689|12173427|FG000|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
10996783|NCT00676689|12173427|FG000|30 Day Follow-up|Overall Study||78
10996784|NCT00676689|12173427|FG000|1 Year Follow-up|Overall Study||64
10996785|NCT00676689|12173427|FG000|COMPLETED|Overall Study||20
10996786|NCT00676689|12173427|FG000|NOT COMPLETED|Overall Study||61
10996787|NCT00676780|12173431|FG000|STARTED|Overall Study||33
10996788|NCT00676780|12173431|FG000|COMPLETED|Overall Study||26
10996789|NCT00676780|12173431|FG000|NOT COMPLETED|Overall Study||7
10996790|NCT00676793|12173437|FG000|STARTED|Overall Study||32
10996791|NCT00676793|12173437|FG000|COMPLETED|Overall Study||19
10996792|NCT00676793|12173437|FG000|NOT COMPLETED|Overall Study||13
10996793|NCT00676806|12173444|FG000|STARTED|Overall Study||3
10996794|NCT00676806|12173445|FG001|STARTED|Overall Study||3
10996795|NCT00676806|12173444|FG000|COMPLETED|Overall Study||3
10996796|NCT00676806|12173445|FG001|COMPLETED|Overall Study||3
10996797|NCT00676806|12173444|FG000|NOT COMPLETED|Overall Study||0
10996798|NCT00676806|12173445|FG001|NOT COMPLETED|Overall Study||0
10996799|NCT00676897|12173457|FG000|STARTED|Overall Study||8
10996800|NCT00676897|12173458|FG001|STARTED|Overall Study||10
10996801|NCT00676897|12173457|FG000|COMPLETED|Overall Study||8
10996802|NCT00676897|12173458|FG001|COMPLETED|Overall Study||10
10996803|NCT00676897|12173457|FG000|NOT COMPLETED|Overall Study||0
10996804|NCT00676897|12173458|FG001|NOT COMPLETED|Overall Study||0
10996805|NCT00677014|12173467|FG000|STARTED|Overall Study||325
10996806|NCT00677014|12173468|FG001|STARTED|Overall Study||323
10996807|NCT00677014|12173469|FG002|STARTED|Overall Study||332
10996808|NCT00677014|12173467|FG000|COMPLETED|Overall Study||281
10996809|NCT00677014|12173468|FG001|COMPLETED|Overall Study||282
10996810|NCT00677014|12173469|FG002|COMPLETED|Overall Study||283
10996811|NCT00677014|12173467|FG000|NOT COMPLETED|Overall Study||44
10996812|NCT00677014|12173468|FG001|NOT COMPLETED|Overall Study||41
10996813|NCT00677014|12173469|FG002|NOT COMPLETED|Overall Study||49
10996814|NCT00677040|12173477|FG000|STARTED|Overall Study||20
10996815|NCT00677040|12173477|FG000|COMPLETED|Overall Study||20
10996816|NCT00677040|12173477|FG000|NOT COMPLETED|Overall Study||0
10996817|NCT00677092|12173482|FG000|STARTED|Overall Study||12
10996818|NCT00677092|12173482|FG000|Received Study Treatment|Overall Study||11
10996819|NCT00677092|12173482|FG000|COMPLETED|Overall Study||6
10996820|NCT00677092|12173482|FG000|NOT COMPLETED|Overall Study||6
10996821|NCT00677235|12173489|FG000|STARTED|Overall Study||138
10996822|NCT00677235|12173490|FG001|STARTED|Overall Study||132
10996823|NCT00677235|12173489|FG000|COMPLETED|Overall Study||97
10996824|NCT00677235|12173490|FG001|COMPLETED|Overall Study||94
10996825|NCT00677235|12173489|FG000|NOT COMPLETED|Overall Study||41
10996826|NCT00677235|12173490|FG001|NOT COMPLETED|Overall Study||38
10996827|NCT00677352|12173498|FG000|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
10996828|NCT00677352|12173499|FG001|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
10996829|NCT00677352|12173498|FG000|COMPLETED|Treatment Phase||132
10996830|NCT00677352|12173499|FG001|COMPLETED|Treatment Phase||122
10996831|NCT00677352|12173498|FG000|NOT COMPLETED|Treatment Phase||25
10996832|NCT00677352|12173499|FG001|NOT COMPLETED|Treatment Phase||42
10996833|NCT00677352|12173498|FG000|STARTED|Tapering Phase||132
10996834|NCT00677352|12173499|FG001|STARTED|Tapering Phase||122
10996835|NCT00677352|12173498|FG000|COMPLETED|Tapering Phase||126
10996836|NCT00677352|12173499|FG001|COMPLETED|Tapering Phase||112
10996837|NCT00677352|12173498|FG000|NOT COMPLETED|Tapering Phase||6
10996838|NCT00677352|12173499|FG001|NOT COMPLETED|Tapering Phase||10
10996839|NCT00677365|12173509|FG000|STARTED|Overall Study||37
10996840|NCT00677365|12173510|FG001|STARTED|Overall Study||38
10996841|NCT00677365|12173511|FG002|STARTED|Overall Study||37
10996842|NCT00677365|12173512|FG003|STARTED|Overall Study||39
10996843|NCT00677365|12173509|FG000|COMPLETED|Overall Study||35
10996844|NCT00677365|12173510|FG001|COMPLETED|Overall Study||37
10996845|NCT00677365|12173511|FG002|COMPLETED|Overall Study||35
10996846|NCT00677365|12173512|FG003|COMPLETED|Overall Study||36
10996847|NCT00677365|12173509|FG000|NOT COMPLETED|Overall Study||2
10996848|NCT00677365|12173510|FG001|NOT COMPLETED|Overall Study||1
10996849|NCT00677365|12173511|FG002|NOT COMPLETED|Overall Study||2
10996850|NCT00677365|12173512|FG003|NOT COMPLETED|Overall Study||3
10996851|NCT00677534|12173522|FG000|STARTED|Washout (Weeks 1-4)||10
10996852|NCT00677534|12173522|FG000|COMPLETED|Washout (Weeks 1-4)||7
10996853|NCT00677534|12173522|FG000|NOT COMPLETED|Washout (Weeks 1-4)||3
10996854|NCT00677534|12173522|FG000|STARTED|Cholecalciferol (Weeks 5-12)||7
10996855|NCT00677534|12173522|FG000|COMPLETED|Cholecalciferol (Weeks 5-12)||7
10996856|NCT00677534|12173522|FG000|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
10996857|NCT00677534|12173522|FG000|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
10996858|NCT00677534|12173522|FG000|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
10996859|NCT00677534|12173522|FG000|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
10996860|NCT00677690|12173528|FG000|STARTED|Overall Study||42
10996861|NCT00677690|12173529|FG001|STARTED|Overall Study||41
10996862|NCT00677690|12173528|FG000|COMPLETED|Overall Study||42
10996863|NCT00677690|12173529|FG001|COMPLETED|Overall Study||41
10996864|NCT00677690|12173528|FG000|NOT COMPLETED|Overall Study||0
10996865|NCT00677690|12173529|FG001|NOT COMPLETED|Overall Study||0
10996866|NCT00677807|12173538|FG000|STARTED|Overall Study||144
10996867|NCT00677807|12173539|FG001|STARTED|Overall Study||146
10996868|NCT00677807|12173540|FG002|STARTED|Overall Study||125
10996869|NCT00677807|12173538|FG000|Safety/ITT: Received Study Drug|Overall Study||144
10996870|NCT00677807|12173539|FG001|Safety/ITT: Received Study Drug|Overall Study||146
10996871|NCT00677807|12173540|FG002|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
10996872|NCT00677807|12173538|FG000|COMPLETED|Overall Study||126
10996873|NCT00677807|12173539|FG001|COMPLETED|Overall Study||135
10996874|NCT00677807|12173540|FG002|COMPLETED|Overall Study||105
10996875|NCT00677807|12173538|FG000|NOT COMPLETED|Overall Study||18
10996876|NCT00677807|12173539|FG001|NOT COMPLETED|Overall Study||11
10996877|NCT00677807|12173540|FG002|NOT COMPLETED|Overall Study||20
10996878|NCT00677820|12173550|FG000|STARTED|Overall Study||240
10996879|NCT00677820|12173551|FG001|STARTED|Overall Study||60
10996880|NCT00677820|12173550|FG000|COMPLETED|Overall Study||239
10996881|NCT00677820|12173551|FG001|COMPLETED|Overall Study||60
10996882|NCT00677820|12173550|FG000|NOT COMPLETED|Overall Study||1
10996883|NCT00677820|12173551|FG001|NOT COMPLETED|Overall Study||0
10996884|NCT00677833|12173561|FG000|STARTED|Overall Study||55
10996885|NCT00677833|12173562|FG001|STARTED|Overall Study||51
10996886|NCT00677833|12173563|FG002|STARTED|Overall Study||124
10996887|NCT00677833|12173564|FG003|STARTED|Overall Study||131
10996888|NCT00677833|12173561|FG000|COMPLETED|Overall Study||51
10996889|NCT00677833|12173562|FG001|COMPLETED|Overall Study||51
10996890|NCT00677833|12173563|FG002|COMPLETED|Overall Study||122
10996891|NCT00677833|12173564|FG003|COMPLETED|Overall Study||128
10996892|NCT00677833|12173561|FG000|NOT COMPLETED|Overall Study||4
10996893|NCT00677833|12173562|FG001|NOT COMPLETED|Overall Study||0
10996894|NCT00677833|12173563|FG002|NOT COMPLETED|Overall Study||2
10996895|NCT00677833|12173564|FG003|NOT COMPLETED|Overall Study||3
10996896|NCT00677898|12173574|FG000|STARTED|Overall Study||119
10996897|NCT00677898|12173575|FG001|STARTED|Overall Study||120
10996898|NCT00677898|12173574|FG000|COMPLETED|Overall Study||99
10996899|NCT00677898|12173575|FG001|COMPLETED|Overall Study||102
10996900|NCT00677898|12173574|FG000|NOT COMPLETED|Overall Study||20
10996901|NCT00677898|12173575|FG001|NOT COMPLETED|Overall Study||18
10996902|NCT00677924|12173583|FG000|STARTED|Overall Study||3
10996903|NCT00677924|12173584|FG001|STARTED|Overall Study||6
10996904|NCT00677924|12173583|FG000|COMPLETED|Overall Study||3
10996905|NCT00677924|12173584|FG001|COMPLETED|Overall Study||6
10996906|NCT00677924|12173583|FG000|NOT COMPLETED|Overall Study||0
10996907|NCT00677924|12173584|FG001|NOT COMPLETED|Overall Study||0
10996908|NCT00678015|12173590|FG000|STARTED|Overall Study||12
10996909|NCT00678015|12173590|FG000|COMPLETED|Overall Study||12
10996910|NCT00678015|12173590|FG000|NOT COMPLETED|Overall Study||0
10996911|NCT00678080|12173596|FG000|STARTED|Overall Study||11
10996912|NCT00678080|12173597|FG001|STARTED|Overall Study||14
10996913|NCT00678080|12173596|FG000|COMPLETED|Overall Study||8
10996914|NCT00678080|12173597|FG001|COMPLETED|Overall Study||13
10996915|NCT00678080|12173596|FG000|NOT COMPLETED|Overall Study||3
10996916|NCT00678080|12173597|FG001|NOT COMPLETED|Overall Study||1
10996917|NCT00678210|12173607|FG000|STARTED|Overall Study||49
10996918|NCT00678210|12173608|FG001|STARTED|Overall Study||49
10996919|NCT00678210|12173609|FG002|STARTED|Overall Study||49
10996920|NCT00678210|12173610|FG003|STARTED|Overall Study||50
10996921|NCT00678210|12173607|FG000|COMPLETED|Overall Study||38
10996922|NCT00678210|12173608|FG001|COMPLETED|Overall Study||38
10996923|NCT00678210|12173609|FG002|COMPLETED|Overall Study||43
10996924|NCT00678210|12173610|FG003|COMPLETED|Overall Study||30
10996925|NCT00678210|12173607|FG000|NOT COMPLETED|Overall Study||11
10996926|NCT00678210|12173608|FG001|NOT COMPLETED|Overall Study||11
10996927|NCT00678210|12173609|FG002|NOT COMPLETED|Overall Study||6
10996928|NCT00678210|12173610|FG003|NOT COMPLETED|Overall Study||20
10996929|NCT00678249|12173623|FG000|STARTED|Overall Study||97
10996930|NCT00678249|12173624|FG001|STARTED|Overall Study||93
10996931|NCT00678249|12173625|FG002|STARTED|Overall Study||37
10996932|NCT00678249|12173623|FG000|COMPLETED|Overall Study||97
10996933|NCT00678249|12173624|FG001|COMPLETED|Overall Study||93
10996934|NCT00678249|12173625|FG002|COMPLETED|Overall Study||37
10996935|NCT00678249|12173623|FG000|NOT COMPLETED|Overall Study||0
10996936|NCT00678249|12173624|FG001|NOT COMPLETED|Overall Study||0
10996937|NCT00678249|12173625|FG002|NOT COMPLETED|Overall Study||0
10996938|NCT00678301|12173635|FG000|STARTED|Overall Study||239
10996939|NCT00678301|12173636|FG001|STARTED|Overall Study||118
10996940|NCT00678301|12173635|FG000|COMPLETED|Overall Study||231
10996941|NCT00678301|12173636|FG001|COMPLETED|Overall Study||116
10996942|NCT00678301|12173635|FG000|NOT COMPLETED|Overall Study||8
10996943|NCT00678301|12173636|FG001|NOT COMPLETED|Overall Study||2
10996944|NCT00678379|12173645|FG000|STARTED|Overall Study||40
10996945|NCT00678379|12173646|FG001|STARTED|Overall Study||40
10996946|NCT00678379|12173647|FG002|STARTED|Overall Study||40
10996947|NCT00678379|12173645|FG000|COMPLETED|Overall Study||34
10996948|NCT00678379|12173646|FG001|COMPLETED|Overall Study||37
10996949|NCT00678379|12173647|FG002|COMPLETED|Overall Study||36
10996950|NCT00678379|12173645|FG000|NOT COMPLETED|Overall Study||6
10996951|NCT00678379|12173646|FG001|NOT COMPLETED|Overall Study||3
10996952|NCT00678379|12173647|FG002|NOT COMPLETED|Overall Study||4
10996953|NCT00678392|12173657|FG000|STARTED|Overall Study||361
10996954|NCT00678392|12173658|FG001|STARTED|Overall Study||362
10996955|NCT00678392|12173657|FG000|Treated|Overall Study||359
10996956|NCT00678392|12173658|FG001|Treated|Overall Study||355
10996957|NCT00678392|12173657|FG000|COMPLETED|Overall Study||0
10996958|NCT00678392|12173658|FG001|COMPLETED|Overall Study||0
10996959|NCT00678392|12173657|FG000|NOT COMPLETED|Overall Study||361
10996960|NCT00678392|12173658|FG001|NOT COMPLETED|Overall Study||362
10996961|NCT00678418|12173666|FG000|STARTED|Part A (Double Blind)||126
10996962|NCT00678418|12173667|FG001|STARTED|Part A (Double Blind)||124
10996963|NCT00678418|12173666|FG000|COMPLETED|Part A (Double Blind)||67
10996964|NCT00678418|12173667|FG001|COMPLETED|Part A (Double Blind)||47
10996965|NCT00678418|12173666|FG000|NOT COMPLETED|Part A (Double Blind)||59
10996966|NCT00678418|12173667|FG001|NOT COMPLETED|Part A (Double Blind)||77
10996967|NCT00678418|12173666|FG000|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
10996968|NCT00678418|12173667|FG001|STARTED|Part B (Open Label)||0
10996969|NCT00678418|12173666|FG000|COMPLETED|Part B (Open Label)||71
10996970|NCT00678418|12173667|FG001|COMPLETED|Part B (Open Label)||0
10996971|NCT00678418|12173666|FG000|NOT COMPLETED|Part B (Open Label)||43
10996972|NCT00678418|12173667|FG001|NOT COMPLETED|Part B (Open Label)||0
10996973|NCT00678444|12173675|FG000|STARTED|Overall Study||100
10996974|NCT00678444|12173676|FG001|STARTED|Overall Study||99
10996975|NCT00678444|12173675|FG000|COMPLETED|Overall Study||100
10996976|NCT00678444|12173676|FG001|COMPLETED|Overall Study||99
10996977|NCT00678444|12173675|FG000|NOT COMPLETED|Overall Study||0
10996978|NCT00678444|12173676|FG001|NOT COMPLETED|Overall Study||0
10996979|NCT00678470|12173682|FG000|STARTED|Overall Study||18
10996980|NCT00678470|12173682|FG000|COMPLETED|Overall Study||14
10996981|NCT00678470|12173682|FG000|NOT COMPLETED|Overall Study||4
10996982|NCT00678496|12173688|FG000|STARTED|Overall Study||12
10996983|NCT00678496|12173689|FG001|STARTED|Overall Study||12
10996984|NCT00678496|12173688|FG000|Completed 8 Weeks Follow-up|Overall Study||9
10996985|NCT00678496|12173689|FG001|Completed 8 Weeks Follow-up|Overall Study||12
10996986|NCT00678496|12173688|FG000|COMPLETED|Overall Study||10
10996987|NCT00678496|12173689|FG001|COMPLETED|Overall Study||8
10996988|NCT00678496|12173688|FG000|NOT COMPLETED|Overall Study||2
10996989|NCT00678496|12173689|FG001|NOT COMPLETED|Overall Study||4
10996990|NCT00678535|12173699|FG000|STARTED|Overall Study|ITT population|455
10996991|NCT00678535|12173700|FG001|STARTED|Overall Study|ITT population|449
10996992|NCT00678535|12173699|FG000|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
10996993|NCT00678535|12173700|FG001|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
10996994|NCT00678535|12173699|FG000|NOT COMPLETED|Overall Study||93
10996995|NCT00678535|12173700|FG001|NOT COMPLETED|Overall Study||98
10996996|NCT00678561|12173714|FG000|STARTED|Overall Study||6
10996997|NCT00678561|12173715|FG001|STARTED|Overall Study||6
10996998|NCT00678561|12173716|FG002|STARTED|Overall Study||8
10996999|NCT00678561|12173717|FG003|STARTED|Overall Study||4
10997000|NCT00678561|12173718|FG004|STARTED|Overall Study||17
10997001|NCT00678561|12173719|FG005|STARTED|Overall Study||17
10997002|NCT00678561|12173720|FG006|STARTED|Overall Study||15
10997003|NCT00678561|12173721|FG007|STARTED|Overall Study||8
10997004|NCT00678561|12173714|FG000|COMPLETED|Overall Study||6
10997005|NCT00678561|12173715|FG001|COMPLETED|Overall Study||5
10997006|NCT00678561|12173716|FG002|COMPLETED|Overall Study||7
10997007|NCT00678561|12173717|FG003|COMPLETED|Overall Study||4
10997008|NCT00678561|12173718|FG004|COMPLETED|Overall Study||15
10997009|NCT00678561|12173719|FG005|COMPLETED|Overall Study||16
10997010|NCT00678561|12173720|FG006|COMPLETED|Overall Study||15
10997011|NCT00678561|12173721|FG007|COMPLETED|Overall Study||7
10997012|NCT00678561|12173714|FG000|NOT COMPLETED|Overall Study||0
10997013|NCT00678561|12173715|FG001|NOT COMPLETED|Overall Study||1
10997014|NCT00678561|12173716|FG002|NOT COMPLETED|Overall Study||1
10997015|NCT00678561|12173717|FG003|NOT COMPLETED|Overall Study||0
10997016|NCT00678561|12173718|FG004|NOT COMPLETED|Overall Study||2
10997017|NCT00678561|12173719|FG005|NOT COMPLETED|Overall Study||1
10997018|NCT00678561|12173720|FG006|NOT COMPLETED|Overall Study||0
10997019|NCT00678561|12173721|FG007|NOT COMPLETED|Overall Study||1
10997020|NCT00678587|12173748|FG000|STARTED|Overall Study||147
10997021|NCT00678587|12173749|FG001|STARTED|Overall Study||145
10997022|NCT00678587|12173748|FG000|COMPLETED|Overall Study||127
10997023|NCT00678587|12173749|FG001|COMPLETED|Overall Study||127
10997024|NCT00678587|12173748|FG000|NOT COMPLETED|Overall Study||20
10997025|NCT00678587|12173749|FG001|NOT COMPLETED|Overall Study||18
10997026|NCT00678639|12173758|FG000|STARTED|Overall Study||53
10997027|NCT00678639|12173759|FG001|STARTED|Overall Study||57
10997028|NCT00678639|12173758|FG000|Hospital Discharge|Overall Study||53
10997029|NCT00678639|12173759|FG001|Hospital Discharge|Overall Study||57
10997030|NCT00678639|12173758|FG000|COMPLETED|Overall Study||51
10997031|NCT00678639|12173759|FG001|COMPLETED|Overall Study||57
10997032|NCT00678639|12173758|FG000|NOT COMPLETED|Overall Study||2
10997033|NCT00678639|12173759|FG001|NOT COMPLETED|Overall Study||0
10997034|NCT00678652|12173770|FG000|STARTED|Overall Study||9
10997035|NCT00678652|12173771|FG001|STARTED|Overall Study||9
10997036|NCT00678652|12173772|FG002|STARTED|Overall Study||9
10997037|NCT00678652|12173773|FG003|STARTED|Overall Study||9
10997038|NCT00678652|12173770|FG000|COMPLETED|Overall Study||6
10997039|NCT00678652|12173771|FG001|COMPLETED|Overall Study||9
10997040|NCT00678652|12173772|FG002|COMPLETED|Overall Study||8
10997041|NCT00678652|12173773|FG003|COMPLETED|Overall Study||9
10997042|NCT00678652|12173770|FG000|NOT COMPLETED|Overall Study||3
10997043|NCT00678652|12173771|FG001|NOT COMPLETED|Overall Study||0
10997044|NCT00678652|12173772|FG002|NOT COMPLETED|Overall Study||1
10997045|NCT00678652|12173773|FG003|NOT COMPLETED|Overall Study||0
10997046|NCT00678691|12173785|FG000|STARTED|Overall Study||27
10997047|NCT00678691|12173786|FG001|STARTED|Overall Study||28
10997048|NCT00678691|12173785|FG000|COMPLETED|Overall Study||21
10997049|NCT00678691|12173786|FG001|COMPLETED|Overall Study||24
10997050|NCT00678691|12173785|FG000|NOT COMPLETED|Overall Study||6
10997051|NCT00678691|12173786|FG001|NOT COMPLETED|Overall Study||4
10997052|NCT00678795|12173794|FG000|STARTED|Overall Study||67
10997053|NCT00678795|12173795|FG001|STARTED|Overall Study||68
10997054|NCT00678795|12173794|FG000|COMPLETED|Overall Study||56
10997055|NCT00678795|12173795|FG001|COMPLETED|Overall Study||62
10997056|NCT00678795|12173794|FG000|NOT COMPLETED|Overall Study||11
10997057|NCT00678795|12173795|FG001|NOT COMPLETED|Overall Study||6
10997058|NCT00678834|12173804|FG000|STARTED|Overall Study||40
10997059|NCT00678834|12173805|FG001|STARTED|Overall Study||15
10997060|NCT00678834|12173806|FG002|STARTED|Overall Study||25
10997061|NCT00678834|12173804|FG000|COMPLETED|Overall Study||24
10997062|NCT00678834|12173805|FG001|COMPLETED|Overall Study||15
10997063|NCT00678834|12173806|FG002|COMPLETED|Overall Study||16
10997064|NCT00678834|12173804|FG000|NOT COMPLETED|Overall Study||16
10997065|NCT00678834|12173805|FG001|NOT COMPLETED|Overall Study||0
10997066|NCT00678834|12173806|FG002|NOT COMPLETED|Overall Study||9
10997067|NCT00678886|12173826|FG000|STARTED|Overall Study||10
10997068|NCT00678886|12173827|FG001|STARTED|Overall Study||19
10997069|NCT00678886|12173828|FG002|STARTED|Overall Study||81
10997070|NCT00678886|12173829|FG003|STARTED|Overall Study||162
10997071|NCT00678886|12173826|FG000|COMPLETED|Overall Study||10
10997072|NCT00678886|12173827|FG001|COMPLETED|Overall Study||19
10997073|NCT00678886|12173828|FG002|COMPLETED|Overall Study||72
10997074|NCT00678886|12173829|FG003|COMPLETED|Overall Study||153
10997075|NCT00678886|12173826|FG000|NOT COMPLETED|Overall Study||0
10997076|NCT00678886|12173827|FG001|NOT COMPLETED|Overall Study||0
10997077|NCT00678886|12173828|FG002|NOT COMPLETED|Overall Study||9
10997078|NCT00678886|12173829|FG003|NOT COMPLETED|Overall Study||9
10997079|NCT00678899|12173838|FG000|STARTED|Overall Study||50
10997080|NCT00678899|12173838|FG000|COMPLETED|Overall Study||49
10997081|NCT00678899|12173838|FG000|NOT COMPLETED|Overall Study||1
10997082|NCT00679029|12173843|FG000|STARTED|Overall Study||15
10997083|NCT00679029|12173843|FG000|COMPLETED|Overall Study||10
10997084|NCT00679029|12173843|FG000|NOT COMPLETED|Overall Study||5
10997085|NCT00679055|12173849|FG000|STARTED|Overall Study||8
10997086|NCT00679055|12173850|FG001|STARTED|Overall Study||6
10997087|NCT00679055|12173849|FG000|COMPLETED|Overall Study||6
10997088|NCT00679055|12173850|FG001|COMPLETED|Overall Study||1
10997089|NCT00679055|12173849|FG000|NOT COMPLETED|Overall Study||2
10997090|NCT00679055|12173850|FG001|NOT COMPLETED|Overall Study||5
10997091|NCT00679081|12173856|FG000|STARTED|Overall Study|Study design was within-subject control.|15
10997092|NCT00679081|12173856|FG000|COMPLETED|Overall Study||14
10997093|NCT00679081|12173856|FG000|NOT COMPLETED|Overall Study||1
10997094|NCT00679172|12173869|FG000|STARTED|Overall Study||37
10997095|NCT00679172|12173870|FG001|STARTED|Overall Study||38
10997096|NCT00679172|12173871|FG002|STARTED|Overall Study||36
10997097|NCT00679172|12173872|FG003|STARTED|Overall Study||39
10997098|NCT00679172|12173873|FG004|STARTED|Overall Study||37
10997099|NCT00679172|12173869|FG000|COMPLETED|Overall Study||36
10997100|NCT00679172|12173870|FG001|COMPLETED|Overall Study||37
10997101|NCT00679172|12173871|FG002|COMPLETED|Overall Study||35
10997102|NCT00679172|12173872|FG003|COMPLETED|Overall Study||38
10997103|NCT00679172|12173873|FG004|COMPLETED|Overall Study||37
10997104|NCT00679172|12173869|FG000|NOT COMPLETED|Overall Study||1
10997105|NCT00679172|12173870|FG001|NOT COMPLETED|Overall Study||1
10997106|NCT00679172|12173871|FG002|NOT COMPLETED|Overall Study||1
10997107|NCT00679172|12173872|FG003|NOT COMPLETED|Overall Study||1
10997108|NCT00679172|12173873|FG004|NOT COMPLETED|Overall Study||0
10997109|NCT00679211|12173888|FG000|STARTED|Overall Study||110
10997110|NCT00679211|12173888|FG000|COMPLETED|Overall Study||0
10997111|NCT00679211|12173888|FG000|NOT COMPLETED|Overall Study||110
10997112|NCT00679263|12173897|FG000|STARTED|Visit 3/Dose 2||10
10997113|NCT00679263|12173898|FG001|STARTED|Visit 3/Dose 2||11
10997114|NCT00679263|12173899|FG002|STARTED|Visit 3/Dose 2||11
10997115|NCT00679263|12173897|FG000|COMPLETED|Visit 3/Dose 2||9
10997116|NCT00679263|12173898|FG001|COMPLETED|Visit 3/Dose 2||6
10997117|NCT00679263|12173899|FG002|COMPLETED|Visit 3/Dose 2||11
10997118|NCT00679263|12173897|FG000|NOT COMPLETED|Visit 3/Dose 2||1
10997119|NCT00679263|12173898|FG001|NOT COMPLETED|Visit 3/Dose 2||5
10997120|NCT00679263|12173899|FG002|NOT COMPLETED|Visit 3/Dose 2||0
10997121|NCT00679263|12173897|FG000|STARTED|Visit 2/Dose 1||11
10997122|NCT00679263|12173898|FG001|STARTED|Visit 2/Dose 1||6
10997123|NCT00679263|12173899|FG002|STARTED|Visit 2/Dose 1||11
10997124|NCT00679263|12173897|FG000|COMPLETED|Visit 2/Dose 1||9
10997125|NCT00679263|12173898|FG001|COMPLETED|Visit 2/Dose 1||5
10997126|NCT00679263|12173899|FG002|COMPLETED|Visit 2/Dose 1||11
10997127|NCT00679263|12173897|FG000|NOT COMPLETED|Visit 2/Dose 1||2
10997128|NCT00679263|12173898|FG001|NOT COMPLETED|Visit 2/Dose 1||1
10997129|NCT00679263|12173899|FG002|NOT COMPLETED|Visit 2/Dose 1||0
10997130|NCT00679289|12173910|FG000|STARTED|Overall Study||6
10997131|NCT00679289|12173911|FG001|STARTED|Overall Study||6
10997132|NCT00679289|12173912|FG002|STARTED|Overall Study||24
10997133|NCT00679289|12173910|FG000|COMPLETED|Overall Study||1
10997134|NCT00679289|12173911|FG001|COMPLETED|Overall Study||0
10997135|NCT00679289|12173912|FG002|COMPLETED|Overall Study||1
10997136|NCT00679289|12173910|FG000|NOT COMPLETED|Overall Study||5
10997137|NCT00679289|12173911|FG001|NOT COMPLETED|Overall Study||6
10997138|NCT00679289|12173912|FG002|NOT COMPLETED|Overall Study||23
10997139|NCT00679302|12173924|FG000|STARTED|Overall Study||84
10997140|NCT00679302|12173925|FG001|STARTED|Overall Study||77
10997141|NCT00679302|12173924|FG000|COMPLETED|Overall Study||76
10997142|NCT00679302|12173925|FG001|COMPLETED|Overall Study||73
10997143|NCT00679302|12173924|FG000|NOT COMPLETED|Overall Study||8
10997144|NCT00679302|12173925|FG001|NOT COMPLETED|Overall Study||4
10997145|NCT00679341|12173933|FG000|STARTED|Overall Study||67
10997146|NCT00679341|12173934|FG001|STARTED|Overall Study||70
10997147|NCT00679341|12173933|FG000|COMPLETED|Overall Study||14
10997148|NCT00679341|12173934|FG001|COMPLETED|Overall Study||19
10997149|NCT00679341|12173933|FG000|NOT COMPLETED|Overall Study||53
10997150|NCT00679341|12173934|FG001|NOT COMPLETED|Overall Study||51
10997151|NCT00679354|12173941|FG000|STARTED|Overall Study||30
10997152|NCT00679354|12173941|FG000|COMPLETED|Overall Study||0
10997153|NCT00679354|12173941|FG000|NOT COMPLETED|Overall Study||30
10997154|NCT00679367|12173946|FG000|STARTED|Overall Study||16
10997155|NCT00679367|12173946|FG000|COMPLETED|Overall Study||4
10997156|NCT00679367|12173946|FG000|NOT COMPLETED|Overall Study||12
10997157|NCT00679380|12173955|FG000|STARTED|Overall Study||109
10997158|NCT00679380|12173956|FG001|STARTED|Overall Study||109
10997159|NCT00679380|12173957|FG002|STARTED|Overall Study||103
10997160|NCT00679380|12173958|FG003|STARTED|Overall Study||89
10997161|NCT00679380|12173955|FG000|COMPLETED|Overall Study||67
10997162|NCT00679380|12173956|FG001|COMPLETED|Overall Study||76
10997163|NCT00679380|12173957|FG002|COMPLETED|Overall Study||68
10997164|NCT00679380|12173958|FG003|COMPLETED|Overall Study||61
10997165|NCT00679380|12173955|FG000|NOT COMPLETED|Overall Study||42
10997166|NCT00679380|12173956|FG001|NOT COMPLETED|Overall Study||33
10997167|NCT00679380|12173957|FG002|NOT COMPLETED|Overall Study||35
10997168|NCT00679380|12173958|FG003|NOT COMPLETED|Overall Study||28
10997169|NCT00679432|12173972|FG000|STARTED|Overall Study||126
10997170|NCT00679432|12173973|FG001|STARTED|Overall Study||127
10997171|NCT00679432|12173974|FG002|STARTED|Overall Study||129
10997172|NCT00679432|12173975|FG003|STARTED|Overall Study||127
10997173|NCT00679432|12173972|FG000|COMPLETED|Overall Study||89
10997174|NCT00679432|12173973|FG001|COMPLETED|Overall Study||89
10997175|NCT00679432|12173974|FG002|COMPLETED|Overall Study||76
10997176|NCT00679432|12173975|FG003|COMPLETED|Overall Study||95
10997177|NCT00679432|12173972|FG000|NOT COMPLETED|Overall Study||37
10997178|NCT00679432|12173973|FG001|NOT COMPLETED|Overall Study||38
10997179|NCT00679432|12173974|FG002|NOT COMPLETED|Overall Study||53
10997180|NCT00679432|12173975|FG003|NOT COMPLETED|Overall Study||32
10997181|NCT00679549|12173987|FG000|STARTED|Overall Study||75
10997182|NCT00679549|12173988|FG001|STARTED|Overall Study||75
10997183|NCT00679549|12173987|FG000|COMPLETED|Overall Study||69
10997184|NCT00679549|12173988|FG001|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66
10997185|NCT00679549|12173987|FG000|NOT COMPLETED|Overall Study||6
10997186|NCT00679549|12173988|FG001|NOT COMPLETED|Overall Study||9
10997187|NCT00679627|12173996|FG000|STARTED|Overall Study||1021
10997188|NCT00679627|12173997|FG001|STARTED|Overall Study||1024
10997189|NCT00679627|12173996|FG000|COMPLETED|Overall Study||322
10997190|NCT00679627|12173997|FG001|COMPLETED|Overall Study||339
10997191|NCT00679627|12173996|FG000|NOT COMPLETED|Overall Study||699
10997192|NCT00679627|12173997|FG001|NOT COMPLETED|Overall Study||685
10997193|NCT00679913|12174005|FG000|STARTED|Overall Study||101
10997194|NCT00679913|12174006|FG001|STARTED|Overall Study||99
10997195|NCT00679913|12174005|FG000|COMPLETED|Overall Study||83
10997196|NCT00679913|12174006|FG001|COMPLETED|Overall Study||86
10997197|NCT00679913|12174005|FG000|NOT COMPLETED|Overall Study||18
10997198|NCT00679913|12174006|FG001|NOT COMPLETED|Overall Study||13
10997199|NCT00679939|12174015|FG000|STARTED|52-Week Double-Blind (DB) Period||114
10997200|NCT00679939|12174016|FG001|STARTED|52-Week Double-Blind (DB) Period||112
10997201|NCT00679939|12174015|FG000|COMPLETED|52-Week Double-Blind (DB) Period||77
10997202|NCT00679939|12174016|FG001|COMPLETED|52-Week Double-Blind (DB) Period||85
10997203|NCT00679939|12174015|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
10997204|NCT00679939|12174016|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
10997205|NCT00679939|12174015|FG000|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
10997206|NCT00679939|12174016|FG001|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
10997207|NCT00679939|12174015|FG000|COMPLETED|24-Week Open-Label (OL) Period||69
10997208|NCT00679939|12174016|FG001|COMPLETED|24-Week Open-Label (OL) Period||80
10997209|NCT00679939|12174015|FG000|NOT COMPLETED|24-Week Open-Label (OL) Period||7
10997210|NCT00679939|12174016|FG001|NOT COMPLETED|24-Week Open-Label (OL) Period||4
10997211|NCT00679952|12174028|FG000|STARTED|Overall Study||86
10997212|NCT00679952|12174029|FG001|STARTED|Overall Study||82
10997213|NCT00679952|12174028|FG000|COMPLETED|Overall Study||86
10997214|NCT00679952|12174029|FG001|COMPLETED|Overall Study||82
10997215|NCT00679952|12174028|FG000|NOT COMPLETED|Overall Study||0
10997216|NCT00679952|12174029|FG001|NOT COMPLETED|Overall Study||0
10997217|NCT00680017|12174037|FG000|STARTED|Overall Study||140
10997218|NCT00680017|12174038|FG001|STARTED|Overall Study||140
10997219|NCT00680017|12174037|FG000|COMPLETED|Overall Study||123
10997220|NCT00680017|12174038|FG001|COMPLETED|Overall Study||128
10997221|NCT00680017|12174037|FG000|NOT COMPLETED|Overall Study||17
10997222|NCT00680017|12174038|FG001|NOT COMPLETED|Overall Study||12
10997223|NCT00680043|12174047|FG000|STARTED|Overall Study||39
10997224|NCT00680043|12174048|FG001|STARTED|Overall Study||37
10997225|NCT00680043|12174049|FG002|STARTED|Overall Study||38
10997226|NCT00680043|12174047|FG000|COMPLETED|Overall Study||37
10997227|NCT00680043|12174048|FG001|COMPLETED|Overall Study||36
10997228|NCT00680043|12174049|FG002|COMPLETED|Overall Study||34
10997229|NCT00680043|12174047|FG000|NOT COMPLETED|Overall Study||2
10997230|NCT00680043|12174048|FG001|NOT COMPLETED|Overall Study||1
10997231|NCT00680043|12174049|FG002|NOT COMPLETED|Overall Study||4
10997232|NCT00680056|12174059|FG000|STARTED|First Intervention||16
10997233|NCT00680056|12174060|FG001|STARTED|First Intervention||17
10997234|NCT00680056|12174059|FG000|COMPLETED|First Intervention||15
10997235|NCT00680056|12174060|FG001|COMPLETED|First Intervention||15
10997236|NCT00680056|12174059|FG000|NOT COMPLETED|First Intervention||1
10997237|NCT00680056|12174060|FG001|NOT COMPLETED|First Intervention||2
10997238|NCT00680056|12174059|FG000|STARTED|Washout Period of One Week||15
10997239|NCT00680056|12174060|FG001|STARTED|Washout Period of One Week||15
10997240|NCT00680056|12174059|FG000|COMPLETED|Washout Period of One Week||15
10997241|NCT00680056|12174060|FG001|COMPLETED|Washout Period of One Week||15
10997242|NCT00680056|12174059|FG000|NOT COMPLETED|Washout Period of One Week||0
10997243|NCT00680056|12174060|FG001|NOT COMPLETED|Washout Period of One Week||0
10997244|NCT00680056|12174059|FG000|STARTED|Second Intervention||15
10997245|NCT00680056|12174060|FG001|STARTED|Second Intervention||15
10997246|NCT00680056|12174059|FG000|COMPLETED|Second Intervention||12
10997247|NCT00680056|12174060|FG001|COMPLETED|Second Intervention||14
10997248|NCT00680056|12174059|FG000|NOT COMPLETED|Second Intervention||3
10997249|NCT00680056|12174060|FG001|NOT COMPLETED|Second Intervention||1
10997250|NCT00680121|12174069|FG000|STARTED|Overall Study||60
10997251|NCT00680121|12174070|FG001|STARTED|Overall Study||60
10997252|NCT00680121|12174069|FG000|COMPLETED|Overall Study||33
10997253|NCT00680121|12174070|FG001|COMPLETED|Overall Study||37
10997254|NCT00680121|12174069|FG000|NOT COMPLETED|Overall Study||27
10997255|NCT00680121|12174070|FG001|NOT COMPLETED|Overall Study||23
10997256|NCT00680186|12174078|FG000|STARTED|Overall Study|Started treatment.|1280
10997257|NCT00680186|12174079|FG001|STARTED|Overall Study|Started treatment.|1288
10997258|NCT00680186|12174078|FG000|COMPLETED|Overall Study|Completed planned observation time.|1155
10997259|NCT00680186|12174079|FG001|COMPLETED|Overall Study|Completed planned observation time.|1172
10997260|NCT00680186|12174078|FG000|NOT COMPLETED|Overall Study||125
10997261|NCT00680186|12174079|FG001|NOT COMPLETED|Overall Study||116
10997262|NCT00680225|12174085|FG000|STARTED|Overall Study||10
10997263|NCT00680225|12174085|FG000|COMPLETED|Overall Study||8
10997264|NCT00680225|12174085|FG000|NOT COMPLETED|Overall Study||2
10997265|NCT00680368|12174089|FG000|STARTED|Overall Study||112
10997266|NCT00680368|12174089|FG000|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
10997267|NCT00680368|12174089|FG000|NOT COMPLETED|Overall Study||15
10997268|NCT00680407|12174098|FG000|STARTED|Overall Study||26
10997269|NCT00680407|12174099|FG001|STARTED|Overall Study||27
10997270|NCT00680407|12174100|FG002|STARTED|Overall Study||25
10997271|NCT00680407|12174098|FG000|COMPLETED|Overall Study||18
10997272|NCT00680407|12174099|FG001|COMPLETED|Overall Study||22
10997273|NCT00680407|12174100|FG002|COMPLETED|Overall Study||22
10997274|NCT00680407|12174098|FG000|NOT COMPLETED|Overall Study||8
10997275|NCT00680407|12174099|FG001|NOT COMPLETED|Overall Study||5
10997276|NCT00680407|12174100|FG002|NOT COMPLETED|Overall Study||3
10997277|NCT00680459|12174110|FG000|STARTED|Overall Study||7
10997278|NCT00680459|12174111|FG001|STARTED|Overall Study||6
10997279|NCT00680459|12174110|FG000|COMPLETED|Overall Study||7
10997280|NCT00680459|12174111|FG001|COMPLETED|Overall Study||6
10997281|NCT00680459|12174110|FG000|NOT COMPLETED|Overall Study||0
10997282|NCT00680459|12174111|FG001|NOT COMPLETED|Overall Study||0
10997283|NCT00680524|12174117|FG000|STARTED|Overall Study||20
10997284|NCT00680524|12174117|FG000|COMPLETED|Overall Study||17
10997285|NCT00680524|12174117|FG000|NOT COMPLETED|Overall Study||3
10997286|NCT00680628|12174123|FG000|STARTED|Overall Study||43
10997287|NCT00680628|12174124|FG001|STARTED|Overall Study||40
10997288|NCT00680628|12174123|FG000|COMPLETED|Overall Study||43
10997289|NCT00680628|12174124|FG001|COMPLETED|Overall Study||40
10997290|NCT00680628|12174123|FG000|NOT COMPLETED|Overall Study||0
10997291|NCT00680628|12174124|FG001|NOT COMPLETED|Overall Study||0
10997292|NCT00680706|12174132|FG000|STARTED|Overall Study||70
10997293|NCT00680706|12174133|FG001|STARTED|Overall Study||60
10997294|NCT00680706|12174132|FG000|COMPLETED|Overall Study||63
10997295|NCT00680706|12174133|FG001|COMPLETED|Overall Study||55
10997296|NCT00680706|12174132|FG000|NOT COMPLETED|Overall Study||7
10997297|NCT00680706|12174133|FG001|NOT COMPLETED|Overall Study||5
10997298|NCT00680745|12174143|FG000|STARTED|Overall Study|Safety Analysis Set|154
10997299|NCT00680745|12174144|FG001|STARTED|Overall Study|Safety Analysis Set|145
10997300|NCT00680745|12174145|FG002|STARTED|Overall Study|Safety Analysis Set|151
10997301|NCT00680745|12174146|FG003|STARTED|Overall Study|Safety Analysis Set|146
10997302|NCT00680745|12174143|FG000|COMPLETED|Overall Study||140
10997303|NCT00680745|12174144|FG001|COMPLETED|Overall Study||132
10997304|NCT00680745|12174145|FG002|COMPLETED|Overall Study||141
10997305|NCT00680745|12174146|FG003|COMPLETED|Overall Study||133
10997306|NCT00680745|12174143|FG000|NOT COMPLETED|Overall Study||14
10997307|NCT00680745|12174144|FG001|NOT COMPLETED|Overall Study||13
10997308|NCT00680745|12174145|FG002|NOT COMPLETED|Overall Study||10
10997309|NCT00680745|12174146|FG003|NOT COMPLETED|Overall Study||13
10997310|NCT00680771|12174159|FG000|STARTED|Overall Study||15
10997311|NCT00680771|12174160|FG001|STARTED|Overall Study||13
10997312|NCT00680771|12174159|FG000|COMPLETED|Overall Study||9
10997313|NCT00680771|12174160|FG001|COMPLETED|Overall Study||11
10997314|NCT00680771|12174159|FG000|NOT COMPLETED|Overall Study||6
10997315|NCT00680771|12174160|FG001|NOT COMPLETED|Overall Study||2
10997316|NCT00680797|12174170|FG000|STARTED|Overall Study||9
10997317|NCT00680797|12174171|FG001|STARTED|Overall Study||8
10997318|NCT00680797|12174172|FG002|STARTED|Overall Study||8
10997319|NCT00680797|12174173|FG003|STARTED|Overall Study||8
10997320|NCT00680797|12174170|FG000|COMPLETED|Overall Study||9
10997321|NCT00680797|12174171|FG001|COMPLETED|Overall Study||8
10997322|NCT00680797|12174172|FG002|COMPLETED|Overall Study||8
10997323|NCT00680797|12174173|FG003|COMPLETED|Overall Study||8
10997324|NCT00680797|12174170|FG000|NOT COMPLETED|Overall Study||0
10997325|NCT00680797|12174171|FG001|NOT COMPLETED|Overall Study||0
10997326|NCT00680797|12174172|FG002|NOT COMPLETED|Overall Study||0
10997327|NCT00680797|12174173|FG003|NOT COMPLETED|Overall Study||0
10997328|NCT00680823|12174186|FG000|STARTED|Overall Study||50
10997329|NCT00680823|12174187|FG001|STARTED|Overall Study||50
10997330|NCT00680823|12174188|FG002|STARTED|Overall Study||50
10997331|NCT00680823|12174186|FG000|COMPLETED|Overall Study||50
10997332|NCT00680823|12174187|FG001|COMPLETED|Overall Study||50
10997333|NCT00680823|12174188|FG002|COMPLETED|Overall Study||50
10997334|NCT00680823|12174186|FG000|NOT COMPLETED|Overall Study||0
10997335|NCT00680823|12174187|FG001|NOT COMPLETED|Overall Study||0
10997336|NCT00680823|12174188|FG002|NOT COMPLETED|Overall Study||0
10997337|NCT00680836|12174198|FG000|STARTED|Overall Study||27
10997338|NCT00680836|12174199|FG001|STARTED|Overall Study||27
10997339|NCT00680836|12174198|FG000|COMPLETED|Overall Study||19
10997340|NCT00680836|12174199|FG001|COMPLETED|Overall Study||25
10997341|NCT00680836|12174198|FG000|NOT COMPLETED|Overall Study||8
10997342|NCT00680836|12174199|FG001|NOT COMPLETED|Overall Study||2
10997343|NCT00680862|12174206|FG000|STARTED|Overall Study||25
10997344|NCT00680862|12174206|FG000|COMPLETED|Overall Study||25
10997345|NCT00680862|12174206|FG000|NOT COMPLETED|Overall Study||0
10997346|NCT00680914|12174212|FG000|STARTED|Overall Study||374
10997347|NCT00680914|12174213|FG001|STARTED|Overall Study||129
10997348|NCT00680914|12174212|FG000|COMPLETED|Overall Study||364
10997349|NCT00680914|12174213|FG001|COMPLETED|Overall Study||125
10997350|NCT00680914|12174212|FG000|NOT COMPLETED|Overall Study||10
10997351|NCT00680914|12174213|FG001|NOT COMPLETED|Overall Study||4
10997352|NCT00680953|12174222|FG000|STARTED|Overall Study||500
10997353|NCT00680953|12174223|FG001|STARTED|Overall Study||511
10997354|NCT00680953|12174224|FG002|STARTED|Overall Study||251
10997355|NCT00680953|12174222|FG000|COMPLETED|Overall Study||414
10997356|NCT00680953|12174223|FG001|COMPLETED|Overall Study||416
10997357|NCT00680953|12174224|FG002|COMPLETED|Overall Study||204
10997358|NCT00680953|12174222|FG000|NOT COMPLETED|Overall Study||86
10997359|NCT00680953|12174223|FG001|NOT COMPLETED|Overall Study||95
10997360|NCT00680953|12174224|FG002|NOT COMPLETED|Overall Study||47
10997361|NCT00681031|12174232|FG000|STARTED|Overall Study||96
10997362|NCT00681031|12174232|FG000|COMPLETED|Overall Study||96
10997363|NCT00681031|12174232|FG000|NOT COMPLETED|Overall Study||0
10997364|NCT00681083|12174236|FG000|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
10997365|NCT00681083|12174237|FG001|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
10997366|NCT00681083|12174236|FG000|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
10997367|NCT00681083|12174237|FG001|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
10997368|NCT00681083|12174236|FG000|NOT COMPLETED|Night 1||3
10997369|NCT00681083|12174237|FG001|NOT COMPLETED|Night 1||3
10997370|NCT00681083|12174236|FG000|STARTED|Night 2 (Crossover of Night 1)||10
10997371|NCT00681083|12174237|FG001|STARTED|Night 2 (Crossover of Night 1)||10
10997372|NCT00681083|12174236|FG000|COMPLETED|Night 2 (Crossover of Night 1)||10
10997373|NCT00681083|12174237|FG001|COMPLETED|Night 2 (Crossover of Night 1)||10
10997374|NCT00681083|12174236|FG000|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
10997375|NCT00681083|12174237|FG001|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
10997376|NCT00681109|12174246|FG000|STARTED|Overall Study||30
10997377|NCT00681109|12174247|FG001|STARTED|Overall Study||30
10997378|NCT00681109|12174248|FG002|STARTED|Overall Study||15
10997379|NCT00681109|12174246|FG000|COMPLETED|Overall Study||28
10997380|NCT00681109|12174247|FG001|COMPLETED|Overall Study||24
10997381|NCT00681109|12174248|FG002|COMPLETED|Overall Study||15
10997382|NCT00681109|12174246|FG000|NOT COMPLETED|Overall Study||2
10997383|NCT00681109|12174247|FG001|NOT COMPLETED|Overall Study||6
10997384|NCT00681109|12174248|FG002|NOT COMPLETED|Overall Study||0
10997385|NCT00681187|12174261|FG000|STARTED|Overall Study||11
10997386|NCT00681187|12174262|FG001|STARTED|Overall Study||15
10997387|NCT00681187|12174261|FG000|COMPLETED|Overall Study||10
10997388|NCT00681187|12174262|FG001|COMPLETED|Overall Study||13
10997389|NCT00681187|12174261|FG000|NOT COMPLETED|Overall Study||1
10997390|NCT00681187|12174262|FG001|NOT COMPLETED|Overall Study||2
10997391|NCT00681265|12174281|FG000|STARTED|Overall Study||16
10997392|NCT00681265|12174281|FG000|COMPLETED|Overall Study||16
10997393|NCT00681265|12174281|FG000|NOT COMPLETED|Overall Study||0
10997394|NCT00681291|12174289|FG000|STARTED|Overall Study||88
10997395|NCT00681291|12174290|FG001|STARTED|Overall Study||84
10997396|NCT00681291|12174289|FG000|COMPLETED|Overall Study||75
10997397|NCT00681291|12174290|FG001|COMPLETED|Overall Study||57
10997398|NCT00681291|12174289|FG000|NOT COMPLETED|Overall Study||13
10997399|NCT00681291|12174290|FG001|NOT COMPLETED|Overall Study||27
10997400|NCT00681473|12174296|FG000|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
10997401|NCT00681473|12174296|FG000|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
10997402|NCT00681473|12174296|FG000|NOT COMPLETED|Overall Study||0
10997403|NCT00681538|12174302|FG000|STARTED|Phase A- 4 Weeks Single Blind||572
10997404|NCT00681538|12174303|FG001|STARTED|Phase A- 4 Weeks Single Blind||0
10997405|NCT00681538|12174302|FG000|COMPLETED|Phase A- 4 Weeks Single Blind||538
10997406|NCT00681538|12174303|FG001|COMPLETED|Phase A- 4 Weeks Single Blind||0
10997407|NCT00681538|12174302|FG000|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
10997408|NCT00681538|12174303|FG001|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
10997409|NCT00681538|12174302|FG000|STARTED|Phase B- Responders;12 Week Double-blind||124
10997410|NCT00681538|12174303|FG001|STARTED|Phase B- Responders;12 Week Double-blind||117
10997411|NCT00681538|12174302|FG000|COMPLETED|Phase B- Responders;12 Week Double-blind||109
10997412|NCT00681538|12174303|FG001|COMPLETED|Phase B- Responders;12 Week Double-blind||115
10997413|NCT00681538|12174302|FG000|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
10997414|NCT00681538|12174303|FG001|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
10997415|NCT00681564|12174311|FG000|STARTED|Overall Study||47
10997416|NCT00681564|12174312|FG001|STARTED|Overall Study||55
10997417|NCT00681564|12174311|FG000|COMPLETED|Overall Study||41
10997418|NCT00681564|12174312|FG001|COMPLETED|Overall Study||47
10997419|NCT00681564|12174311|FG000|NOT COMPLETED|Overall Study||6
10997420|NCT00681564|12174312|FG001|NOT COMPLETED|Overall Study||8
10997421|NCT00681590|12174320|FG000|STARTED|Overall Study||34
10997422|NCT00681590|12174321|FG001|STARTED|Overall Study||71
10997423|NCT00681590|12174320|FG000|COMPLETED|Overall Study||32
10997424|NCT00681590|12174321|FG001|COMPLETED|Overall Study||59
10997425|NCT00681590|12174320|FG000|NOT COMPLETED|Overall Study||2
10997426|NCT00681590|12174321|FG001|NOT COMPLETED|Overall Study||12
10997427|NCT00681668|12174327|FG000|STARTED|Overall Study||5
10997428|NCT00681668|12174327|FG000|COMPLETED|Overall Study||3
10997429|NCT00681668|12174327|FG000|NOT COMPLETED|Overall Study||2
10997430|NCT00681811|12174333|FG000|STARTED|Overall Study||6
10997431|NCT00681811|12174334|FG001|STARTED|Overall Study||5
10997432|NCT00681811|12174333|FG000|COMPLETED|Overall Study||3
10997433|NCT00681811|12174334|FG001|COMPLETED|Overall Study||1
10997434|NCT00681811|12174333|FG000|NOT COMPLETED|Overall Study||3
10997435|NCT00681811|12174334|FG001|NOT COMPLETED|Overall Study||4
10997436|NCT00681824|12174354|FG000|STARTED|Overall Study||28
10997437|NCT00681824|12174355|FG001|STARTED|Overall Study||13
10997438|NCT00681824|12174356|FG002|STARTED|Overall Study||34
10997439|NCT00681824|12174354|FG000|COMPLETED|Overall Study||27
10997440|NCT00681824|12174355|FG001|COMPLETED|Overall Study||12
10997441|NCT00681824|12174356|FG002|COMPLETED|Overall Study||33
10997442|NCT00681824|12174354|FG000|NOT COMPLETED|Overall Study||1
10997443|NCT00681824|12174355|FG001|NOT COMPLETED|Overall Study||1
10997444|NCT00681824|12174356|FG002|NOT COMPLETED|Overall Study||1
10997445|NCT00681863|12174364|FG000|STARTED|Overall Study||45
10997446|NCT00681863|12174364|FG000|COMPLETED|Overall Study||22
10997447|NCT00681863|12174364|FG000|NOT COMPLETED|Overall Study||23
10997448|NCT00681889|12174368|FG000|STARTED|Overall Study||9
10997449|NCT00681889|12174368|FG000|COMPLETED|Overall Study||9
10997450|NCT00681889|12174368|FG000|NOT COMPLETED|Overall Study||0
10997451|NCT00682357|12174375|FG000|STARTED|Overall Study||10
10997452|NCT00682357|12174376|FG001|STARTED|Overall Study||10
10997453|NCT00682357|12174377|FG002|STARTED|Overall Study||5
10997454|NCT00682357|12174375|FG000|COMPLETED|Overall Study||10
10997455|NCT00682357|12174376|FG001|COMPLETED|Overall Study||10
10997456|NCT00682357|12174377|FG002|COMPLETED|Overall Study||5
10997457|NCT00682357|12174375|FG000|NOT COMPLETED|Overall Study||0
10997458|NCT00682357|12174376|FG001|NOT COMPLETED|Overall Study||0
10997459|NCT00682357|12174377|FG002|NOT COMPLETED|Overall Study||0
10997460|NCT00682435|12174385|FG000|STARTED|Overall Study||230
10997461|NCT00682435|12174385|FG000|Ensured Enrolled Only Once|Overall Study||228
10997462|NCT00682435|12174385|FG000|Sufficient Data to Carry Out Analysis|Overall Study||223
10997463|NCT00682435|12174385|FG000|COMPLETED|Overall Study||223
10997464|NCT00682435|12174385|FG000|NOT COMPLETED|Overall Study||7
10997465|NCT00682448|12174391|FG000|STARTED|Overall Study||12
10997466|NCT00682448|12174392|FG001|STARTED|Overall Study||13
10997467|NCT00682448|12174391|FG000|COMPLETED|Overall Study||7
10997468|NCT00682448|12174392|FG001|COMPLETED|Overall Study||7
10997469|NCT00682448|12174391|FG000|NOT COMPLETED|Overall Study||5
10997470|NCT00682448|12174392|FG001|NOT COMPLETED|Overall Study||6
10997471|NCT00682539|12174401|FG000|STARTED|Bevacizumab vs Triamcinolone||18
10997472|NCT00682539|12174402|FG001|STARTED|Bevacizumab vs Triamcinolone||16
10997473|NCT00682539|12174403|FG002|STARTED|Bevacizumab vs Triamcinolone||0
10997474|NCT00682539|12174401|FG000|COMPLETED|Bevacizumab vs Triamcinolone||15
10997475|NCT00682539|12174402|FG001|COMPLETED|Bevacizumab vs Triamcinolone||15
10997476|NCT00682539|12174403|FG002|COMPLETED|Bevacizumab vs Triamcinolone||0
10997477|NCT00682539|12174401|FG000|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
10997478|NCT00682539|12174402|FG001|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
10997479|NCT00682539|12174403|FG002|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
10997480|NCT00682539|12174401|FG000|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
10997481|NCT00682539|12174402|FG001|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
10997482|NCT00682539|12174403|FG002|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
10997483|NCT00682539|12174401|FG000|COMPLETED|Ranibizumab vs Triamcinolone||0
10997484|NCT00682539|12174402|FG001|COMPLETED|Ranibizumab vs Triamcinolone||15
10997485|NCT00682539|12174403|FG002|COMPLETED|Ranibizumab vs Triamcinolone||10
10997486|NCT00682539|12174401|FG000|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
10997487|NCT00682539|12174402|FG001|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
10997488|NCT00682539|12174403|FG002|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
10997489|NCT00682565|12174414|FG000|STARTED|Overall Study||31
10997490|NCT00682565|12174415|FG001|STARTED|Overall Study||35
10997491|NCT00682565|12174416|FG002|STARTED|Overall Study||29
10997492|NCT00682565|12174414|FG000|COMPLETED|Overall Study||30
10997493|NCT00682565|12174415|FG001|COMPLETED|Overall Study||32
10997494|NCT00682565|12174416|FG002|COMPLETED|Overall Study||29
10997495|NCT00682565|12174414|FG000|NOT COMPLETED|Overall Study||1
10997496|NCT00682565|12174415|FG001|NOT COMPLETED|Overall Study||3
10997497|NCT00682565|12174416|FG002|NOT COMPLETED|Overall Study||0
10997498|NCT00682461|12174427|FG000|STARTED|Overall Study||100
10997499|NCT00682461|12174428|FG001|STARTED|Overall Study||100
10997500|NCT00682461|12174427|FG000|COMPLETED|Overall Study||75
10997501|NCT00682461|12174428|FG001|COMPLETED|Overall Study||69
10997502|NCT00682461|12174427|FG000|NOT COMPLETED|Overall Study||25
10997503|NCT00682461|12174428|FG001|NOT COMPLETED|Overall Study||31
10997504|NCT00682617|12174437|FG000|STARTED|Overall Study||13
10997505|NCT00682617|12174438|FG001|STARTED|Overall Study||28
10997506|NCT00682617|12174437|FG000|COMPLETED|Overall Study||10
10997507|NCT00682617|12174438|FG001|COMPLETED|Overall Study||21
10997508|NCT00682617|12174437|FG000|NOT COMPLETED|Overall Study||3
10997509|NCT00682617|12174438|FG001|NOT COMPLETED|Overall Study||7
10997510|NCT00682643|12174446|FG000|STARTED|Overall Study||182
10997511|NCT00682643|12174447|FG001|STARTED|Overall Study||368
10997512|NCT00682643|12174446|FG000|COMPLETED|Overall Study||104
10997513|NCT00682643|12174447|FG001|COMPLETED|Overall Study||199
10997514|NCT00682643|12174446|FG000|NOT COMPLETED|Overall Study||78
10997515|NCT00682643|12174447|FG001|NOT COMPLETED|Overall Study||169
10997516|NCT00682734|12174457|FG000|STARTED|Emergency Department Portion||113
10997517|NCT00682734|12174458|FG001|STARTED|Emergency Department Portion||118
10997518|NCT00682734|12174459|FG002|STARTED|Emergency Department Portion||118
10997519|NCT00682734|12174457|FG000|COMPLETED|Emergency Department Portion||113
10997520|NCT00682734|12174458|FG001|COMPLETED|Emergency Department Portion||117
10997521|NCT00682734|12174459|FG002|COMPLETED|Emergency Department Portion||117
10997522|NCT00682734|12174457|FG000|NOT COMPLETED|Emergency Department Portion||0
10997523|NCT00682734|12174458|FG001|NOT COMPLETED|Emergency Department Portion||1
10997524|NCT00682734|12174459|FG002|NOT COMPLETED|Emergency Department Portion||1
10997525|NCT00682734|12174457|FG000|STARTED|48 Hour Follow-up||113
10997526|NCT00682734|12174458|FG001|STARTED|48 Hour Follow-up||117
10997527|NCT00682734|12174459|FG002|STARTED|48 Hour Follow-up||117
10997528|NCT00682734|12174457|FG000|COMPLETED|48 Hour Follow-up||107
10997529|NCT00682734|12174458|FG001|COMPLETED|48 Hour Follow-up||111
10997530|NCT00682734|12174459|FG002|COMPLETED|48 Hour Follow-up||106
10997531|NCT00682734|12174457|FG000|NOT COMPLETED|48 Hour Follow-up||6
10997532|NCT00682734|12174458|FG001|NOT COMPLETED|48 Hour Follow-up||6
10997533|NCT00682734|12174459|FG002|NOT COMPLETED|48 Hour Follow-up||11
10997534|NCT00682786|12174469|FG000|STARTED|Overall Study||98
10997535|NCT00682786|12174470|FG001|STARTED|Overall Study||37
10997536|NCT00682786|12174469|FG000|COMPLETED|Overall Study||96
10997537|NCT00682786|12174470|FG001|COMPLETED|Overall Study||34
10997538|NCT00682786|12174469|FG000|NOT COMPLETED|Overall Study||2
10997539|NCT00682786|12174470|FG001|NOT COMPLETED|Overall Study||3
10997540|NCT00682838|12174486|FG000|STARTED|Overall Study||65
10997541|NCT00682838|12174487|FG001|STARTED|Overall Study||67
10997542|NCT00682838|12174488|FG002|STARTED|Overall Study||75
10997543|NCT00682838|12174489|FG003|STARTED|Overall Study||73
10997544|NCT00682838|12174486|FG000|COMPLETED|Overall Study||65
10997545|NCT00682838|12174487|FG001|COMPLETED|Overall Study||67
10997546|NCT00682838|12174488|FG002|COMPLETED|Overall Study||75
10997547|NCT00682838|12174489|FG003|COMPLETED|Overall Study||73
10997548|NCT00682838|12174486|FG000|NOT COMPLETED|Overall Study||0
10997549|NCT00682838|12174487|FG001|NOT COMPLETED|Overall Study||0
10997550|NCT00682838|12174488|FG002|NOT COMPLETED|Overall Study||0
10997551|NCT00682838|12174489|FG003|NOT COMPLETED|Overall Study||0
10997552|NCT00682851|12174501|FG000|STARTED|Overall Study||251
10997553|NCT00682851|12174502|FG001|STARTED|Overall Study||268
10997554|NCT00682851|12174501|FG000|COMPLETED|Overall Study||251
10997555|NCT00682851|12174502|FG001|COMPLETED|Overall Study||268
10997556|NCT00682851|12174501|FG000|NOT COMPLETED|Overall Study||0
10997557|NCT00682851|12174502|FG001|NOT COMPLETED|Overall Study||0
10997558|NCT00682890|12174510|FG000|STARTED|Overall Study||12
10997559|NCT00682890|12174511|FG001|STARTED|Overall Study||11
10997560|NCT00682890|12174510|FG000|COMPLETED|Overall Study||10
10997561|NCT00682890|12174511|FG001|COMPLETED|Overall Study||9
10997562|NCT00682890|12174510|FG000|NOT COMPLETED|Overall Study||2
10997563|NCT00682890|12174511|FG001|NOT COMPLETED|Overall Study||2
10997564|NCT00682929|12174520|FG000|STARTED|Overall Study||13
10997565|NCT00682929|12174521|FG001|STARTED|Overall Study||14
10997566|NCT00682929|12174522|FG002|STARTED|Overall Study||14
10997567|NCT00682929|12174520|FG000|COMPLETED|Overall Study||7
10997568|NCT00682929|12174521|FG001|COMPLETED|Overall Study||9
10997569|NCT00682929|12174522|FG002|COMPLETED|Overall Study||12
10997570|NCT00682929|12174520|FG000|NOT COMPLETED|Overall Study||6
10997571|NCT00682929|12174521|FG001|NOT COMPLETED|Overall Study||5
10997572|NCT00682929|12174522|FG002|NOT COMPLETED|Overall Study||2
10997573|NCT00683020|12174532|FG000|STARTED|Overall Study||182
10997574|NCT00683020|12174533|FG001|STARTED|Overall Study||180
10997575|NCT00683020|12174532|FG000|COMPLETED|Overall Study||127
10997576|NCT00683020|12174533|FG001|COMPLETED|Overall Study||125
10997577|NCT00683020|12174532|FG000|NOT COMPLETED|Overall Study||55
10997578|NCT00683020|12174533|FG001|NOT COMPLETED|Overall Study||55
10997579|NCT00683046|12174539|FG000|STARTED|Overall Study||204
10997580|NCT00683046|12174539|FG000|COMPLETED|Overall Study||204
10997581|NCT00683046|12174539|FG000|NOT COMPLETED|Overall Study||0
10997582|NCT00683085|12174543|FG000|STARTED|Overall Study||2
10997583|NCT00683085|12174543|FG000|COMPLETED|Overall Study||2
10997584|NCT00683085|12174543|FG000|NOT COMPLETED|Overall Study||0
10997585|NCT00683163|12174549|FG000|STARTED|Overall Study||22
10997586|NCT00683163|12174550|FG001|STARTED|Overall Study||22
10997587|NCT00683163|12174549|FG000|COMPLETED|Overall Study||22
10997588|NCT00683163|12174550|FG001|COMPLETED|Overall Study||22
10997589|NCT00683163|12174549|FG000|NOT COMPLETED|Overall Study||0
10997590|NCT00683163|12174550|FG001|NOT COMPLETED|Overall Study||0
10997591|NCT00683293|12174558|FG000|STARTED|Overall Study||50
10997592|NCT00683293|12174559|FG001|STARTED|Overall Study||50
10997593|NCT00683293|12174558|FG000|COMPLETED|Overall Study||48
10997594|NCT00683293|12174559|FG001|COMPLETED|Overall Study||47
10997595|NCT00683293|12174558|FG000|NOT COMPLETED|Overall Study||2
10997596|NCT00683293|12174559|FG001|NOT COMPLETED|Overall Study||3
10997597|NCT00683332|12174565|FG000|STARTED|Overall Study||621
10997598|NCT00683332|12174565|FG000|COMPLETED|Overall Study||621
10997599|NCT00683332|12174565|FG000|NOT COMPLETED|Overall Study||0
10997600|NCT00683384|12174569|FG000|STARTED|Overall Study||93
10997601|NCT00683384|12174569|FG000|COMPLETED|Overall Study||91
10997602|NCT00683384|12174569|FG000|NOT COMPLETED|Overall Study||2
10997603|NCT00683410|12174573|FG000|STARTED|Overall Study||3366
10997604|NCT00683410|12174573|FG000|Vaccinated Dose 1|Overall Study||3240
10997605|NCT00683410|12174573|FG000|Vaccinated Dose 2|Overall Study||1623
10997606|NCT00683410|12174573|FG000|Vaccinated Dose 3|Overall Study||817
10997607|NCT00683410|12174573|FG000|Vaccinated Dose 4|Overall Study||175
10997608|NCT00683410|12174573|FG000|COMPLETED|Overall Study||3366
10997609|NCT00683410|12174573|FG000|NOT COMPLETED|Overall Study||0
10997610|NCT00683449|12174582|FG000|STARTED|Overall Study||5
10997611|NCT00683449|12174583|FG001|STARTED|Overall Study||13
10997612|NCT00683449|12174584|FG002|STARTED|Overall Study||3
10997613|NCT00683449|12174585|FG003|STARTED|Overall Study||6
10997614|NCT00683449|12174586|FG004|STARTED|Overall Study||2
10997615|NCT00683449|12174582|FG000|COMPLETED|Overall Study||5
10997616|NCT00683449|12174583|FG001|COMPLETED|Overall Study||12
10997617|NCT00683449|12174584|FG002|COMPLETED|Overall Study||3
10997618|NCT00683449|12174585|FG003|COMPLETED|Overall Study||6
10997619|NCT00683449|12174586|FG004|COMPLETED|Overall Study||2
10997620|NCT00683449|12174582|FG000|NOT COMPLETED|Overall Study||0
10997621|NCT00683449|12174583|FG001|NOT COMPLETED|Overall Study||1
10997622|NCT00683449|12174584|FG002|NOT COMPLETED|Overall Study||0
10997623|NCT00683449|12174585|FG003|NOT COMPLETED|Overall Study||0
10997624|NCT00683449|12174586|FG004|NOT COMPLETED|Overall Study||0
10997625|NCT00683475|12174605|FG000|STARTED|Overall Study||69
10997626|NCT00683475|12174606|FG001|STARTED|Overall Study||69
10997627|NCT00683475|12174605|FG000|Received Any Quantity of Study Drug|Overall Study||66
10997628|NCT00683475|12174606|FG001|Received Any Quantity of Study Drug|Overall Study||66
10997629|NCT00683475|12174605|FG000|COMPLETED|Overall Study||65
10997630|NCT00683475|12174606|FG001|COMPLETED|Overall Study||66
10997631|NCT00683475|12174605|FG000|NOT COMPLETED|Overall Study||4
10997632|NCT00683475|12174606|FG001|NOT COMPLETED|Overall Study||3
10997633|NCT00683592|12174615|FG000|STARTED|Overall Study||240
10997634|NCT00683592|12174616|FG001|STARTED|Overall Study||241
10997635|NCT00683592|12174615|FG000|Intent to Treat Population|Overall Study||231
10997636|NCT00683592|12174616|FG001|Intent to Treat Population|Overall Study||232
10997637|NCT00683592|12174615|FG000|Safety Population|Overall Study||235
10997638|NCT00683592|12174616|FG001|Safety Population|Overall Study||233
10997639|NCT00683592|12174615|FG000|COMPLETED|Overall Study||193
10997640|NCT00683592|12174616|FG001|COMPLETED|Overall Study||195
10997641|NCT00683592|12174615|FG000|NOT COMPLETED|Overall Study||47
10997642|NCT00683592|12174616|FG001|NOT COMPLETED|Overall Study||46
10997643|NCT00683618|12174625|FG000|STARTED|Randomised Treatment Period||145
10997644|NCT00683618|12174626|FG001|STARTED|Randomised Treatment Period||145
10997645|NCT00683618|12174627|FG002|STARTED|Randomised Treatment Period||146
10997646|NCT00683618|12174625|FG000|COMPLETED|Randomised Treatment Period||139
10997647|NCT00683618|12174626|FG001|COMPLETED|Randomised Treatment Period||143
10997648|NCT00683618|12174627|FG002|COMPLETED|Randomised Treatment Period||140
10997649|NCT00683618|12174625|FG000|NOT COMPLETED|Randomised Treatment Period||6
10997650|NCT00683618|12174626|FG001|NOT COMPLETED|Randomised Treatment Period||2
10997651|NCT00683618|12174627|FG002|NOT COMPLETED|Randomised Treatment Period||6
10997652|NCT00683618|12174625|FG000|STARTED|Extension Treatment Period||36
10997653|NCT00683618|12174626|FG001|STARTED|Extension Treatment Period||23
10997654|NCT00683618|12174627|FG002|STARTED|Extension Treatment Period||0
10997655|NCT00683618|12174625|FG000|COMPLETED|Extension Treatment Period||33
10997656|NCT00683618|12174626|FG001|COMPLETED|Extension Treatment Period||23
10997657|NCT00683618|12174627|FG002|COMPLETED|Extension Treatment Period||0
10997658|NCT00683618|12174625|FG000|NOT COMPLETED|Extension Treatment Period||3
10997659|NCT00683618|12174626|FG001|NOT COMPLETED|Extension Treatment Period||0
10997660|NCT00683618|12174627|FG002|NOT COMPLETED|Extension Treatment Period||0
10997661|NCT00683644|12174639|FG000|STARTED|Overall Study||58
10997662|NCT00683644|12174640|FG001|STARTED|Overall Study||58
10997663|NCT00683644|12174639|FG000|COMPLETED|Overall Study||45
10997664|NCT00683644|12174640|FG001|COMPLETED|Overall Study||44
10997665|NCT00683644|12174639|FG000|NOT COMPLETED|Overall Study||13
10997666|NCT00683644|12174640|FG001|NOT COMPLETED|Overall Study||14
10997667|NCT00683657|12174652|FG000|STARTED|Overall Study||46
10997668|NCT00683657|12174653|FG001|STARTED|Overall Study||47
10997669|NCT00683657|12174652|FG000|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
10997670|NCT00683657|12174653|FG001|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
10997671|NCT00683657|12174652|FG000|COMPLETED|Overall Study||45
10997672|NCT00683657|12174653|FG001|COMPLETED|Overall Study||46
10997673|NCT00683657|12174652|FG000|NOT COMPLETED|Overall Study||1
10997674|NCT00683657|12174653|FG001|NOT COMPLETED|Overall Study||1
10997675|NCT00683696|12174661|FG000|STARTED|Overall Study||404
10997676|NCT00683696|12174662|FG001|STARTED|Overall Study||405
10997677|NCT00683696|12174661|FG000|COMPLETED|Overall Study||0
10997678|NCT00683696|12174662|FG001|COMPLETED|Overall Study||0
10997679|NCT00683696|12174661|FG000|NOT COMPLETED|Overall Study||404
10997680|NCT00683696|12174662|FG001|NOT COMPLETED|Overall Study||405
10997681|NCT00683774|12174671|FG000|STARTED|Overall Study||11
10997682|NCT00683774|12174672|FG001|STARTED|Overall Study||10
10997683|NCT00683774|12174671|FG000|COMPLETED|Overall Study||8
10997684|NCT00683774|12174672|FG001|COMPLETED|Overall Study||9
10997685|NCT00683774|12174671|FG000|NOT COMPLETED|Overall Study||3
10997686|NCT00683774|12174672|FG001|NOT COMPLETED|Overall Study||1
10997687|NCT00683800|12174680|FG000|STARTED|Overall Study||1101
10997688|NCT00683800|12174681|FG001|STARTED|Overall Study||1085
10997689|NCT00683800|12174680|FG000|Treated|Overall Study||1066
10997690|NCT00683800|12174681|FG001|Treated|Overall Study||1052
10997691|NCT00683800|12174680|FG000|COMPLETED|Overall Study||669
10997692|NCT00683800|12174681|FG001|COMPLETED|Overall Study||719
10997693|NCT00683800|12174680|FG000|NOT COMPLETED|Overall Study||432
10997694|NCT00683800|12174681|FG001|NOT COMPLETED|Overall Study||366
10997695|NCT00683826|12174690|FG000|STARTED|Overall Study||8
10997696|NCT00683826|12174690|FG000|0g Leucine|Overall Study||8
10997697|NCT00683826|12174690|FG000|8g Leucine|Overall Study||8
10997698|NCT00683826|12174690|FG000|4g Leucine|Overall Study||7
10997699|NCT00683826|12174690|FG000|COMPLETED|Overall Study||7
10997700|NCT00683826|12174690|FG000|NOT COMPLETED|Overall Study||1
10997701|NCT00683852|12174700|FG000|STARTED|30-Day Phase 1 Period||56
10997702|NCT00683852|12174701|FG001|STARTED|30-Day Phase 1 Period||84
10997703|NCT00683852|12174702|FG002|STARTED|30-Day Phase 1 Period||85
10997704|NCT00683852|12174700|FG000|COMPLETED|30-Day Phase 1 Period||54
10997705|NCT00683852|12174701|FG001|COMPLETED|30-Day Phase 1 Period||83
10997706|NCT00683852|12174702|FG002|COMPLETED|30-Day Phase 1 Period||84
10997707|NCT00683852|12174700|FG000|NOT COMPLETED|30-Day Phase 1 Period||2
10997708|NCT00683852|12174701|FG001|NOT COMPLETED|30-Day Phase 1 Period||1
10997709|NCT00683852|12174702|FG002|NOT COMPLETED|30-Day Phase 1 Period||1
10997710|NCT00683852|12174700|FG000|STARTED|30-Day Phase 2 Period||54
10997711|NCT00683852|12174701|FG001|STARTED|30-Day Phase 2 Period||83
10997712|NCT00683852|12174702|FG002|STARTED|30-Day Phase 2 Period||84
10997713|NCT00683852|12174700|FG000|COMPLETED|30-Day Phase 2 Period||48
10997714|NCT00683852|12174701|FG001|COMPLETED|30-Day Phase 2 Period||78
10997715|NCT00683852|12174702|FG002|COMPLETED|30-Day Phase 2 Period||75
10997716|NCT00683852|12174700|FG000|NOT COMPLETED|30-Day Phase 2 Period||6
10997717|NCT00683852|12174701|FG001|NOT COMPLETED|30-Day Phase 2 Period||5
10997718|NCT00683852|12174702|FG002|NOT COMPLETED|30-Day Phase 2 Period||9
10997719|NCT00683878|12174720|FG000|STARTED|Overall Study||139
10997720|NCT00683878|12174721|FG001|STARTED|Overall Study||141
10997721|NCT00683878|12174722|FG002|STARTED|Overall Study||140
10997722|NCT00683878|12174720|FG000|COMPLETED|Overall Study||116
10997723|NCT00683878|12174721|FG001|COMPLETED|Overall Study||125
10997724|NCT00683878|12174722|FG002|COMPLETED|Overall Study||126
10997725|NCT00683878|12174720|FG000|NOT COMPLETED|Overall Study||23
10997726|NCT00683878|12174721|FG001|NOT COMPLETED|Overall Study||16
10997727|NCT00683878|12174722|FG002|NOT COMPLETED|Overall Study||14
10997728|NCT00683904|12174732|FG000|STARTED|Dose Level 1||6
10997729|NCT00683904|12174733|FG001|STARTED|Dose Level 1||0
10997730|NCT00683904|12174732|FG000|COMPLETED|Dose Level 1||3
10997731|NCT00683904|12174733|FG001|COMPLETED|Dose Level 1||0
10997732|NCT00683904|12174732|FG000|NOT COMPLETED|Dose Level 1||3
10997733|NCT00683904|12174733|FG001|NOT COMPLETED|Dose Level 1||0
10997734|NCT00683904|12174732|FG000|STARTED|Dose Level 2||0
10997735|NCT00683904|12174733|FG001|STARTED|Dose Level 2||6
10997736|NCT00683904|12174732|FG000|COMPLETED|Dose Level 2||0
10997737|NCT00683904|12174733|FG001|COMPLETED|Dose Level 2||4
10997738|NCT00683904|12174732|FG000|NOT COMPLETED|Dose Level 2||0
10997739|NCT00683904|12174733|FG001|NOT COMPLETED|Dose Level 2||2
10997740|NCT00683930|12174748|FG000|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
10997741|NCT00683930|12174749|FG001|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
10997742|NCT00683930|12174750|FG002|STARTED|Overall Study||37
10997743|NCT00683930|12174748|FG000|COMPLETED|Overall Study||29
10997744|NCT00683930|12174749|FG001|COMPLETED|Overall Study||18
10997745|NCT00683930|12174750|FG002|COMPLETED|Overall Study||28
10997746|NCT00683930|12174748|FG000|NOT COMPLETED|Overall Study||7
10997747|NCT00683930|12174749|FG001|NOT COMPLETED|Overall Study||3
10997748|NCT00683930|12174750|FG002|NOT COMPLETED|Overall Study||9
10997749|NCT00684021|12174763|FG000|STARTED|Overall Study||43
10997750|NCT00684021|12174764|FG001|STARTED|Overall Study||24
10997751|NCT00684021|12174765|FG002|STARTED|Overall Study||36
10997752|NCT00684021|12174766|FG003|STARTED|Overall Study||17
10997753|NCT00684021|12174763|FG000|COMPLETED|Overall Study||41
10997754|NCT00684021|12174764|FG001|COMPLETED|Overall Study||22
10997755|NCT00684021|12174765|FG002|COMPLETED|Overall Study||34
10997756|NCT00684021|12174766|FG003|COMPLETED|Overall Study||15
10997757|NCT00684021|12174763|FG000|NOT COMPLETED|Overall Study||2
10997758|NCT00684021|12174764|FG001|NOT COMPLETED|Overall Study||2
10997759|NCT00684021|12174765|FG002|NOT COMPLETED|Overall Study||2
10997760|NCT00684021|12174766|FG003|NOT COMPLETED|Overall Study||2
10997761|NCT00684047|12174779|FG000|STARTED|Overall Study||72
10997762|NCT00684047|12174780|FG001|STARTED|Overall Study||110
10997763|NCT00684047|12174781|FG002|STARTED|Overall Study||57
10997764|NCT00684047|12174779|FG000|COMPLETED|Overall Study||59
10997765|NCT00684047|12174780|FG001|COMPLETED|Overall Study||94
10997766|NCT00684047|12174781|FG002|COMPLETED|Overall Study||52
10997767|NCT00684047|12174779|FG000|NOT COMPLETED|Overall Study||13
10997768|NCT00684047|12174780|FG001|NOT COMPLETED|Overall Study||16
10997769|NCT00684047|12174781|FG002|NOT COMPLETED|Overall Study||5
10997770|NCT00684060|12174791|FG000|STARTED|Overall Study||58
10997771|NCT00684060|12174792|FG001|STARTED|Overall Study||29
10997772|NCT00684060|12174791|FG000|COMPLETED|Overall Study||55
10997773|NCT00684060|12174792|FG001|COMPLETED|Overall Study||26
10997774|NCT00684060|12174791|FG000|NOT COMPLETED|Overall Study||3
10997775|NCT00684060|12174792|FG001|NOT COMPLETED|Overall Study||3
10997776|NCT00684073|12174798|FG000|STARTED|Selection||60
10997777|NCT00684073|12174798|FG000|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
10997778|NCT00684073|12174798|FG000|NOT COMPLETED|Selection||7
10997779|NCT00684073|12174798|FG000|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
10997780|NCT00684073|12174798|FG000|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
10997781|NCT00684073|12174798|FG000|NOT COMPLETED|Treatment (Days 1 Through 5)||1
10997782|NCT00684138|12174808|FG000|STARTED|Overall Study||141
10997783|NCT00684138|12174809|FG001|STARTED|Overall Study||139
10997784|NCT00684138|12174808|FG000|COMPLETED|Overall Study||138
10997785|NCT00684138|12174809|FG001|COMPLETED|Overall Study||131
10997786|NCT00684138|12174808|FG000|NOT COMPLETED|Overall Study||3
10997787|NCT00684138|12174809|FG001|NOT COMPLETED|Overall Study||8
10997788|NCT00684177|12174819|FG000|STARTED|Overall Study||343
10997789|NCT00684177|12174820|FG001|STARTED|Overall Study||164
10997790|NCT00684177|12174819|FG000|COMPLETED|Overall Study||322
10997791|NCT00684177|12174820|FG001|COMPLETED|Overall Study||141
10997792|NCT00684177|12174819|FG000|NOT COMPLETED|Overall Study||21
10997793|NCT00684177|12174820|FG001|NOT COMPLETED|Overall Study||23
10997794|NCT00684203|12174832|FG000|STARTED|Overall Study||40
10997795|NCT00684203|12174833|FG001|STARTED|Overall Study||31
10997796|NCT00684203|12174834|FG002|STARTED|Overall Study||21
10997797|NCT00684203|12174835|FG003|STARTED|Overall Study||6
10997798|NCT00684203|12174836|FG004|STARTED|Overall Study||17
10997799|NCT00684203|12174837|FG005|STARTED|Overall Study||2
10997800|NCT00684203|12174832|FG000|COMPLETED|Overall Study||31
10997801|NCT00684203|12174833|FG001|COMPLETED|Overall Study||23
10997802|NCT00684203|12174834|FG002|COMPLETED|Overall Study||12
10997803|NCT00684203|12174835|FG003|COMPLETED|Overall Study||6
10997804|NCT00684203|12174836|FG004|COMPLETED|Overall Study||17
10997805|NCT00684203|12174837|FG005|COMPLETED|Overall Study||2
10997806|NCT00684203|12174832|FG000|NOT COMPLETED|Overall Study||9
10997807|NCT00684203|12174833|FG001|NOT COMPLETED|Overall Study||8
10997808|NCT00684203|12174834|FG002|NOT COMPLETED|Overall Study||9
10997809|NCT00684203|12174835|FG003|NOT COMPLETED|Overall Study||0
10997810|NCT00684203|12174836|FG004|NOT COMPLETED|Overall Study||0
10997811|NCT00684203|12174837|FG005|NOT COMPLETED|Overall Study||0
10997812|NCT00684242|12174858|FG000|STARTED|Overall Study||3
10997813|NCT00684242|12174858|FG000|COMPLETED|Overall Study||3
10997814|NCT00684242|12174858|FG000|NOT COMPLETED|Overall Study||0
10997815|NCT00684307|12174867|FG000|STARTED|Overall Study|Patients who received treatment|164
10997816|NCT00684307|12174868|FG001|STARTED|Overall Study||151
10997817|NCT00684307|12174869|FG002|STARTED|Overall Study||156
10997818|NCT00684307|12174870|FG003|STARTED|Overall Study||160
10997819|NCT00684307|12174871|FG004|STARTED|Overall Study||318
10997820|NCT00684307|12174867|FG000|On Treatment Period Started|Overall Study||164
10997821|NCT00684307|12174868|FG001|On Treatment Period Started|Overall Study||151
10997822|NCT00684307|12174869|FG002|On Treatment Period Started|Overall Study||156
10997823|NCT00684307|12174870|FG003|On Treatment Period Started|Overall Study||160
10997824|NCT00684307|12174871|FG004|On Treatment Period Started|Overall Study||318
10997825|NCT00684307|12174867|FG000|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
10997826|NCT00684307|12174868|FG001|On Treatment Period Completed|Overall Study||129
10997827|NCT00684307|12174869|FG002|On Treatment Period Completed|Overall Study||128
10997828|NCT00684307|12174870|FG003|On Treatment Period Completed|Overall Study||128
10997829|NCT00684307|12174871|FG004|On Treatment Period Completed|Overall Study||293
10997830|NCT00684307|12174867|FG000|COMPLETED|Overall Study||140
10997831|NCT00684307|12174868|FG001|COMPLETED|Overall Study||129
10997832|NCT00684307|12174869|FG002|COMPLETED|Overall Study||128
10997833|NCT00684307|12174870|FG003|COMPLETED|Overall Study||128
10997834|NCT00684307|12174871|FG004|COMPLETED|Overall Study||293
10997835|NCT00684307|12174867|FG000|NOT COMPLETED|Overall Study||24
10997836|NCT00684307|12174868|FG001|NOT COMPLETED|Overall Study||22
10997837|NCT00684307|12174869|FG002|NOT COMPLETED|Overall Study||28
10997838|NCT00684307|12174870|FG003|NOT COMPLETED|Overall Study||32
10997839|NCT00684307|12174871|FG004|NOT COMPLETED|Overall Study||25
10997840|NCT00684320|12174885|FG000|STARTED|Overall Study||26
10997841|NCT00684320|12174886|FG001|STARTED|Overall Study||22
10997842|NCT00684320|12174885|FG000|COMPLETED|Overall Study||22
10997843|NCT00684320|12174886|FG001|COMPLETED|Overall Study||22
10997844|NCT00684320|12174885|FG000|NOT COMPLETED|Overall Study||4
10997845|NCT00684320|12174886|FG001|NOT COMPLETED|Overall Study||0
10997846|NCT00684411|12174892|FG000|STARTED|Overall Study||12
10997847|NCT00684411|12174892|FG000|Disease Evaluable|Overall Study||11
10997848|NCT00684411|12174892|FG000|COMPLETED|Overall Study||0
10997849|NCT00684411|12174892|FG000|NOT COMPLETED|Overall Study||12
10997850|NCT00684424|12174896|FG000|STARTED|Overall Study||199
10997851|NCT00684424|12174896|FG000|COMPLETED|Overall Study||194
10997852|NCT00684424|12174896|FG000|NOT COMPLETED|Overall Study||5
10997853|NCT00684515|12174904|FG000|STARTED|Overall Study||33
10997854|NCT00684515|12174905|FG001|STARTED|Overall Study||29
10997855|NCT00684515|12174906|FG002|STARTED|Overall Study||28
10997856|NCT00684515|12174904|FG000|COMPLETED|Overall Study||29
10997857|NCT00684515|12174905|FG001|COMPLETED|Overall Study||26
10997858|NCT00684515|12174906|FG002|COMPLETED|Overall Study||27
10997859|NCT00684515|12174904|FG000|NOT COMPLETED|Overall Study||4
10997860|NCT00684515|12174905|FG001|NOT COMPLETED|Overall Study||3
10997861|NCT00684515|12174906|FG002|NOT COMPLETED|Overall Study||1
10997862|NCT00684541|12174916|FG000|STARTED|Overall Study||23
10997863|NCT00684541|12174917|FG001|STARTED|Overall Study||26
10997864|NCT00684541|12174916|FG000|COMPLETED|Overall Study||20
10997865|NCT00684541|12174917|FG001|COMPLETED|Overall Study||23
10997866|NCT00684541|12174916|FG000|NOT COMPLETED|Overall Study||3
10997867|NCT00684541|12174917|FG001|NOT COMPLETED|Overall Study||3
10997868|NCT00684554|12174926|FG000|STARTED|Overall Study||10
10997869|NCT00684554|12174927|FG001|STARTED|Overall Study||10
10997870|NCT00684554|12174926|FG000|COMPLETED|Overall Study||10
10997871|NCT00684554|12174927|FG001|COMPLETED|Overall Study||10
10997872|NCT00684554|12174926|FG000|NOT COMPLETED|Overall Study||0
10997873|NCT00684554|12174927|FG001|NOT COMPLETED|Overall Study||0
10997874|NCT00684567|12174933|FG000|STARTED|Concomitant Radiotherapy Period||30
10997875|NCT00684567|12174933|FG000|COMPLETED|Concomitant Radiotherapy Period||28
10997876|NCT00684567|12174933|FG000|NOT COMPLETED|Concomitant Radiotherapy Period||2
10997877|NCT00684567|12174933|FG000|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
10997878|NCT00684567|12174933|FG000|COMPLETED|Monotherapy Period||9
10997879|NCT00684567|12174933|FG000|NOT COMPLETED|Monotherapy Period||14
10997880|NCT00684593|12174939|FG000|STARTED|Overall Study||21
10997881|NCT00684593|12174940|FG001|STARTED|Overall Study||10
10997882|NCT00684593|12174939|FG000|COMPLETED|Overall Study||21
10997883|NCT00684593|12174940|FG001|COMPLETED|Overall Study||8
10997884|NCT00684593|12174939|FG000|NOT COMPLETED|Overall Study||0
10997885|NCT00684593|12174940|FG001|NOT COMPLETED|Overall Study||2
10997886|NCT00684645|12174946|FG000|STARTED|Overall Study||186
10997887|NCT00684645|12174946|FG000|COMPLETED|Overall Study||72
10997888|NCT00684645|12174946|FG000|NOT COMPLETED|Overall Study||114
10997889|NCT00684671|12174953|FG000|STARTED|Overall Study||172
10997890|NCT00684671|12174954|FG001|STARTED|Overall Study||170
10997891|NCT00684671|12174955|FG002|STARTED|Overall Study||164
10997892|NCT00684671|12174953|FG000|COMPLETED|Overall Study||169
10997893|NCT00684671|12174954|FG001|COMPLETED|Overall Study||170
10997894|NCT00684671|12174955|FG002|COMPLETED|Overall Study||164
10997895|NCT00684671|12174953|FG000|NOT COMPLETED|Overall Study||3
10997896|NCT00684671|12174954|FG001|NOT COMPLETED|Overall Study||0
10997897|NCT00684671|12174955|FG002|NOT COMPLETED|Overall Study||0
10997898|NCT00684723|12174963|FG000|STARTED|First Intervention||27
10997899|NCT00684723|12174964|FG001|STARTED|First Intervention||27
10997900|NCT00684723|12174963|FG000|COMPLETED|First Intervention||27
10997901|NCT00684723|12174964|FG001|COMPLETED|First Intervention||27
10997902|NCT00684723|12174963|FG000|NOT COMPLETED|First Intervention||0
10997903|NCT00684723|12174964|FG001|NOT COMPLETED|First Intervention||0
10997904|NCT00684723|12174963|FG000|STARTED|Washout Period of 7 Days||27
10997905|NCT00684723|12174964|FG001|STARTED|Washout Period of 7 Days||27
10997906|NCT00684723|12174963|FG000|COMPLETED|Washout Period of 7 Days||27
10997907|NCT00684723|12174964|FG001|COMPLETED|Washout Period of 7 Days||27
10997908|NCT00684723|12174963|FG000|NOT COMPLETED|Washout Period of 7 Days||0
10997909|NCT00684723|12174964|FG001|NOT COMPLETED|Washout Period of 7 Days||0
10997910|NCT00684723|12174963|FG000|STARTED|Second Intervention||27
10997911|NCT00684723|12174964|FG001|STARTED|Second Intervention||27
10997912|NCT00684723|12174963|FG000|COMPLETED|Second Intervention||27
10997913|NCT00684723|12174964|FG001|COMPLETED|Second Intervention||27
10997914|NCT00684723|12174963|FG000|NOT COMPLETED|Second Intervention||0
10997915|NCT00684723|12174964|FG001|NOT COMPLETED|Second Intervention||0
10997916|NCT00684749|12174970|FG000|STARTED|Overall Study||142
10997917|NCT00684749|12174970|FG000|COMPLETED|Overall Study||142
10997918|NCT00684749|12174970|FG000|NOT COMPLETED|Overall Study||0
10997919|NCT00684762|12174974|FG000|STARTED|First Intervention||16
10997920|NCT00684762|12174975|FG001|STARTED|First Intervention||16
10997921|NCT00684762|12174974|FG000|COMPLETED|First Intervention||16
10997922|NCT00684762|12174975|FG001|COMPLETED|First Intervention||16
10997923|NCT00684762|12174974|FG000|NOT COMPLETED|First Intervention||0
10997924|NCT00684762|12174975|FG001|NOT COMPLETED|First Intervention||0
10997925|NCT00684762|12174974|FG000|STARTED|Washout Period of 7 Days||16
10997926|NCT00684762|12174975|FG001|STARTED|Washout Period of 7 Days||16
10997927|NCT00684762|12174974|FG000|COMPLETED|Washout Period of 7 Days||14
10997928|NCT00684762|12174975|FG001|COMPLETED|Washout Period of 7 Days||14
10997929|NCT00684762|12174974|FG000|NOT COMPLETED|Washout Period of 7 Days||2
10997930|NCT00684762|12174975|FG001|NOT COMPLETED|Washout Period of 7 Days||2
10997931|NCT00684762|12174974|FG000|STARTED|Second Intervention||14
10997932|NCT00684762|12174975|FG001|STARTED|Second Intervention||14
10997933|NCT00684762|12174974|FG000|COMPLETED|Second Intervention||14
10997934|NCT00684762|12174975|FG001|COMPLETED|Second Intervention||14
10997935|NCT00684762|12174974|FG000|NOT COMPLETED|Second Intervention||0
10997936|NCT00684762|12174975|FG001|NOT COMPLETED|Second Intervention||0
10997937|NCT00684775|12174983|FG000|STARTED|Overall Study||19
10997938|NCT00684775|12174984|FG001|STARTED|Overall Study||19
10997939|NCT00684775|12174983|FG000|COMPLETED|Overall Study||19
10997940|NCT00684775|12174984|FG001|COMPLETED|Overall Study||19
10997941|NCT00684775|12174983|FG000|NOT COMPLETED|Overall Study||0
10997942|NCT00684775|12174984|FG001|NOT COMPLETED|Overall Study||0
10997943|NCT00684788|12175000|FG000|STARTED|Overall Study||17
10997944|NCT00684788|12175001|FG001|STARTED|Overall Study||18
10997945|NCT00684788|12175000|FG000|COMPLETED|Overall Study||17
10997946|NCT00684788|12175001|FG001|COMPLETED|Overall Study||18
10997947|NCT00684788|12175000|FG000|NOT COMPLETED|Overall Study||0
10997948|NCT00684788|12175001|FG001|NOT COMPLETED|Overall Study||0
10997949|NCT00684814|12175013|FG000|STARTED|First Intervention||19
10997950|NCT00684814|12175014|FG001|STARTED|First Intervention||19
10997951|NCT00684814|12175013|FG000|COMPLETED|First Intervention||19
10997952|NCT00684814|12175014|FG001|COMPLETED|First Intervention||19
10997953|NCT00684814|12175013|FG000|NOT COMPLETED|First Intervention||0
10997954|NCT00684814|12175014|FG001|NOT COMPLETED|First Intervention||0
10997955|NCT00684814|12175013|FG000|STARTED|Washout Period of 7 Days||19
10997956|NCT00684814|12175014|FG001|STARTED|Washout Period of 7 Days||19
10997957|NCT00684814|12175013|FG000|COMPLETED|Washout Period of 7 Days||17
10997958|NCT00684814|12175014|FG001|COMPLETED|Washout Period of 7 Days||15
10997959|NCT00684814|12175013|FG000|NOT COMPLETED|Washout Period of 7 Days||2
10997960|NCT00684814|12175014|FG001|NOT COMPLETED|Washout Period of 7 Days||4
10997961|NCT00684814|12175013|FG000|STARTED|Second Intervention||17
10997962|NCT00684814|12175014|FG001|STARTED|Second Intervention||15
10997963|NCT00684814|12175013|FG000|COMPLETED|Second Intervention||16
10997964|NCT00684814|12175014|FG001|COMPLETED|Second Intervention||15
10997965|NCT00684814|12175013|FG000|NOT COMPLETED|Second Intervention||1
10997966|NCT00684814|12175014|FG001|NOT COMPLETED|Second Intervention||0
10997967|NCT00684983|12175022|FG000|STARTED|Overall Study||19
10997968|NCT00684983|12175023|FG001|STARTED|Overall Study||45
10997969|NCT00684983|12175022|FG000|COMPLETED|Overall Study||19
10997970|NCT00684983|12175023|FG001|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
10997971|NCT00684983|12175022|FG000|NOT COMPLETED|Overall Study||0
10997972|NCT00684983|12175023|FG001|NOT COMPLETED|Overall Study||0
10997973|NCT00684996|12175031|FG000|STARTED|Overall Study||5
10997974|NCT00684996|12175031|FG000|Eligible|Overall Study||5
10997975|NCT00684996|12175031|FG000|COMPLETED|Overall Study||0
10997976|NCT00684996|12175031|FG000|NOT COMPLETED|Overall Study||5
10997977|NCT00685035|12175038|FG000|STARTED|Period 1: First Intervention: 30 Minutes||9
10997978|NCT00685035|12175039|FG001|STARTED|Period 1: First Intervention: 30 Minutes||8
10997979|NCT00685035|12175038|FG000|COMPLETED|Period 1: First Intervention: 30 Minutes||8
10997980|NCT00685035|12175039|FG001|COMPLETED|Period 1: First Intervention: 30 Minutes||8
10997981|NCT00685035|12175038|FG000|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
10997982|NCT00685035|12175039|FG001|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
10997983|NCT00685035|12175038|FG000|STARTED|Period 2: 2-day Washout||8
10997984|NCT00685035|12175039|FG001|STARTED|Period 2: 2-day Washout||8
10997985|NCT00685035|12175038|FG000|COMPLETED|Period 2: 2-day Washout||8
10997986|NCT00685035|12175039|FG001|COMPLETED|Period 2: 2-day Washout||8
10997987|NCT00685035|12175038|FG000|NOT COMPLETED|Period 2: 2-day Washout||0
10997988|NCT00685035|12175039|FG001|NOT COMPLETED|Period 2: 2-day Washout||0
10997989|NCT00685035|12175038|FG000|STARTED|Period 3: 2nd Intervention||8
10997990|NCT00685035|12175039|FG001|STARTED|Period 3: 2nd Intervention||8
10997991|NCT00685035|12175038|FG000|COMPLETED|Period 3: 2nd Intervention||8
10997992|NCT00685035|12175039|FG001|COMPLETED|Period 3: 2nd Intervention||8
10997993|NCT00685035|12175038|FG000|NOT COMPLETED|Period 3: 2nd Intervention||0
10997994|NCT00685035|12175039|FG001|NOT COMPLETED|Period 3: 2nd Intervention||0
10997995|NCT00685139|12175063|FG000|STARTED|First Intervention||17
10997996|NCT00685139|12175064|FG001|STARTED|First Intervention||17
10997997|NCT00685139|12175063|FG000|COMPLETED|First Intervention||17
10997998|NCT00685139|12175064|FG001|COMPLETED|First Intervention||17
10997999|NCT00685139|12175063|FG000|NOT COMPLETED|First Intervention||0
10998000|NCT00685139|12175064|FG001|NOT COMPLETED|First Intervention||0
10998001|NCT00685139|12175063|FG000|STARTED|Washout Period of 28 Days||17
10998002|NCT00685139|12175064|FG001|STARTED|Washout Period of 28 Days||17
10998003|NCT00685139|12175063|FG000|COMPLETED|Washout Period of 28 Days||17
10998004|NCT00685139|12175064|FG001|COMPLETED|Washout Period of 28 Days||17
10998005|NCT00685139|12175063|FG000|NOT COMPLETED|Washout Period of 28 Days||0
10998006|NCT00685139|12175064|FG001|NOT COMPLETED|Washout Period of 28 Days||0
10998007|NCT00685139|12175063|FG000|STARTED|Second Intervention||17
10998008|NCT00685139|12175064|FG001|STARTED|Second Intervention||17
10998009|NCT00685139|12175063|FG000|COMPLETED|Second Intervention||17
10998010|NCT00685139|12175064|FG001|COMPLETED|Second Intervention||17
10998011|NCT00685139|12175063|FG000|NOT COMPLETED|Second Intervention||0
10998012|NCT00685139|12175064|FG001|NOT COMPLETED|Second Intervention||0
10998013|NCT00685165|12175070|FG000|STARTED|First Intervention||11
10998014|NCT00685165|12175071|FG001|STARTED|First Intervention||11
10998015|NCT00685165|12175070|FG000|COMPLETED|First Intervention||11
10998016|NCT00685165|12175071|FG001|COMPLETED|First Intervention||11
10998017|NCT00685165|12175070|FG000|NOT COMPLETED|First Intervention||0
10998018|NCT00685165|12175071|FG001|NOT COMPLETED|First Intervention||0
10998019|NCT00685165|12175070|FG000|STARTED|Washout Period of 14 Days||11
10998020|NCT00685165|12175071|FG001|STARTED|Washout Period of 14 Days||11
10998021|NCT00685165|12175070|FG000|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
10998022|NCT00685165|12175071|FG001|COMPLETED|Washout Period of 14 Days||11
10998023|NCT00685165|12175070|FG000|NOT COMPLETED|Washout Period of 14 Days||1
10998024|NCT00685165|12175071|FG001|NOT COMPLETED|Washout Period of 14 Days||0
10998025|NCT00685165|12175070|FG000|STARTED|Second Intervention||10
10998026|NCT00685165|12175071|FG001|STARTED|Second Intervention||11
10998027|NCT00685165|12175070|FG000|COMPLETED|Second Intervention||10
10998028|NCT00685165|12175071|FG001|COMPLETED|Second Intervention||11
10998029|NCT00685165|12175070|FG000|NOT COMPLETED|Second Intervention||0
10998030|NCT00685165|12175071|FG001|NOT COMPLETED|Second Intervention||0
10998031|NCT00685178|12175081|FG000|STARTED|Overall Study||40
10998032|NCT00685178|12175082|FG001|STARTED|Overall Study||45
10998033|NCT00685178|12175083|FG002|STARTED|Overall Study||39
10998034|NCT00685178|12175084|FG003|STARTED|Overall Study||47
10998035|NCT00685178|12175081|FG000|COMPLETED|Overall Study||27
10998036|NCT00685178|12175082|FG001|COMPLETED|Overall Study||26
10998037|NCT00685178|12175083|FG002|COMPLETED|Overall Study||27
10998038|NCT00685178|12175084|FG003|COMPLETED|Overall Study||33
10998039|NCT00685178|12175081|FG000|NOT COMPLETED|Overall Study||13
10998040|NCT00685178|12175082|FG001|NOT COMPLETED|Overall Study||19
10998041|NCT00685178|12175083|FG002|NOT COMPLETED|Overall Study||12
10998042|NCT00685178|12175084|FG003|NOT COMPLETED|Overall Study||14
10998043|NCT00685295|12175096|FG000|STARTED|Overall Study||30
10998044|NCT00685295|12175097|FG001|STARTED|Overall Study||30
10998045|NCT00685295|12175096|FG000|COMPLETED|Overall Study||30
10998046|NCT00685295|12175097|FG001|COMPLETED|Overall Study||30
10998047|NCT00685295|12175096|FG000|NOT COMPLETED|Overall Study||0
10998048|NCT00685295|12175097|FG001|NOT COMPLETED|Overall Study||0
10998049|NCT00685334|12175107|FG000|STARTED|Overall Study||12
10998050|NCT00685334|12175108|FG001|STARTED|Overall Study||10
10998051|NCT00685334|12175107|FG000|COMPLETED|Overall Study||2
10998052|NCT00685334|12175108|FG001|COMPLETED|Overall Study||3
10998053|NCT00685334|12175107|FG000|NOT COMPLETED|Overall Study||10
10998054|NCT00685334|12175108|FG001|NOT COMPLETED|Overall Study||7
10998055|NCT00685373|12175114|FG000|STARTED|Overall Study||166
10998056|NCT00685373|12175114|FG000|COMPLETED|Overall Study||151
10998057|NCT00685373|12175114|FG000|NOT COMPLETED|Overall Study||15
10998058|NCT00685399|12175125|FG000|STARTED|Treatment Period 1||16
10998059|NCT00685399|12175126|FG001|STARTED|Treatment Period 1||0
10998060|NCT00685399|12175127|FG002|STARTED|Treatment Period 1||0
10998061|NCT00685399|12175128|FG003|STARTED|Treatment Period 1||0
10998062|NCT00685399|12175129|FG004|STARTED|Treatment Period 1||0
10998063|NCT00685399|12175130|FG005|STARTED|Treatment Period 1||0
10998064|NCT00685399|12175131|FG006|STARTED|Treatment Period 1||0
10998065|NCT00685399|12175132|FG007|STARTED|Treatment Period 1||0
10998066|NCT00685399|12175125|FG000|COMPLETED|Treatment Period 1||10
10998067|NCT00685399|12175126|FG001|COMPLETED|Treatment Period 1||0
10998068|NCT00685399|12175127|FG002|COMPLETED|Treatment Period 1||0
10998069|NCT00685399|12175128|FG003|COMPLETED|Treatment Period 1||0
10998070|NCT00685399|12175129|FG004|COMPLETED|Treatment Period 1||0
10998071|NCT00685399|12175130|FG005|COMPLETED|Treatment Period 1||0
10998072|NCT00685399|12175131|FG006|COMPLETED|Treatment Period 1||0
10998073|NCT00685399|12175132|FG007|COMPLETED|Treatment Period 1||0
10998074|NCT00685399|12175125|FG000|NOT COMPLETED|Treatment Period 1||6
10998075|NCT00685399|12175126|FG001|NOT COMPLETED|Treatment Period 1||0
10998076|NCT00685399|12175127|FG002|NOT COMPLETED|Treatment Period 1||0
10998077|NCT00685399|12175128|FG003|NOT COMPLETED|Treatment Period 1||0
10998078|NCT00685399|12175129|FG004|NOT COMPLETED|Treatment Period 1||0
10998079|NCT00685399|12175130|FG005|NOT COMPLETED|Treatment Period 1||0
10998080|NCT00685399|12175131|FG006|NOT COMPLETED|Treatment Period 1||0
10998081|NCT00685399|12175132|FG007|NOT COMPLETED|Treatment Period 1||0
10998082|NCT00685399|12175125|FG000|STARTED|Treatment Period 2||0
10998083|NCT00685399|12175126|FG001|STARTED|Treatment Period 2||14
10998084|NCT00685399|12175127|FG002|STARTED|Treatment Period 2||5
10998085|NCT00685399|12175128|FG003|STARTED|Treatment Period 2|in extension period only|0
10998086|NCT00685399|12175129|FG004|STARTED|Treatment Period 2||4
10998087|NCT00685399|12175130|FG005|STARTED|Treatment Period 2||12
10998088|NCT00685399|12175131|FG006|STARTED|Treatment Period 2||13
10998089|NCT00685399|12175132|FG007|STARTED|Treatment Period 2||12
10998090|NCT00685399|12175125|FG000|COMPLETED|Treatment Period 2||0
10998091|NCT00685399|12175126|FG001|COMPLETED|Treatment Period 2||2
10998092|NCT00685399|12175127|FG002|COMPLETED|Treatment Period 2||2
10998093|NCT00685399|12175128|FG003|COMPLETED|Treatment Period 2|in extension period only|0
10998094|NCT00685399|12175129|FG004|COMPLETED|Treatment Period 2||4
10998095|NCT00685399|12175130|FG005|COMPLETED|Treatment Period 2||10
10998096|NCT00685399|12175131|FG006|COMPLETED|Treatment Period 2||13
10998097|NCT00685399|12175132|FG007|COMPLETED|Treatment Period 2||10
10998098|NCT00685399|12175125|FG000|NOT COMPLETED|Treatment Period 2||0
10998099|NCT00685399|12175126|FG001|NOT COMPLETED|Treatment Period 2||12
10998100|NCT00685399|12175127|FG002|NOT COMPLETED|Treatment Period 2||3
10998101|NCT00685399|12175128|FG003|NOT COMPLETED|Treatment Period 2||0
10998102|NCT00685399|12175129|FG004|NOT COMPLETED|Treatment Period 2||0
10998103|NCT00685399|12175130|FG005|NOT COMPLETED|Treatment Period 2||2
10998104|NCT00685399|12175131|FG006|NOT COMPLETED|Treatment Period 2||0
10998105|NCT00685399|12175132|FG007|NOT COMPLETED|Treatment Period 2||2
10998106|NCT00685399|12175125|FG000|STARTED|Extension||0
10998107|NCT00685399|12175126|FG001|STARTED|Extension||0
10998108|NCT00685399|12175127|FG002|STARTED|Extension||0
10998109|NCT00685399|12175128|FG003|STARTED|Extension||28
10998110|NCT00685399|12175129|FG004|STARTED|Extension||0
10998111|NCT00685399|12175130|FG005|STARTED|Extension||0
10998112|NCT00685399|12175131|FG006|STARTED|Extension||0
10998113|NCT00685399|12175132|FG007|STARTED|Extension||0
10998114|NCT00685399|12175125|FG000|COMPLETED|Extension||0
10998115|NCT00685399|12175126|FG001|COMPLETED|Extension||0
10998116|NCT00685399|12175127|FG002|COMPLETED|Extension||0
10998117|NCT00685399|12175128|FG003|COMPLETED|Extension||21
10998118|NCT00685399|12175129|FG004|COMPLETED|Extension||0
10998119|NCT00685399|12175130|FG005|COMPLETED|Extension||0
10998120|NCT00685399|12175131|FG006|COMPLETED|Extension||0
10998121|NCT00685399|12175132|FG007|COMPLETED|Extension||0
10998122|NCT00685399|12175125|FG000|NOT COMPLETED|Extension||0
10998123|NCT00685399|12175126|FG001|NOT COMPLETED|Extension||0
10998124|NCT00685399|12175127|FG002|NOT COMPLETED|Extension||0
10998125|NCT00685399|12175128|FG003|NOT COMPLETED|Extension||7
10998126|NCT00685399|12175129|FG004|NOT COMPLETED|Extension||0
10998127|NCT00685399|12175130|FG005|NOT COMPLETED|Extension||0
10998128|NCT00685399|12175131|FG006|NOT COMPLETED|Extension||0
10998129|NCT00685399|12175132|FG007|NOT COMPLETED|Extension||0
10998130|NCT00685477|12175159|FG000|STARTED|Overall Study||10
10998131|NCT00685477|12175160|FG001|STARTED|Overall Study||10
10998132|NCT00685477|12175161|FG002|STARTED|Overall Study||10
10998133|NCT00685477|12175162|FG003|STARTED|Overall Study||10
10998134|NCT00685477|12175163|FG004|STARTED|Overall Study||10
10998135|NCT00685477|12175164|FG005|STARTED|Overall Study||10
10998136|NCT00685477|12175159|FG000|COMPLETED|Overall Study||10
10998137|NCT00685477|12175160|FG001|COMPLETED|Overall Study||10
10998138|NCT00685477|12175161|FG002|COMPLETED|Overall Study||10
10998139|NCT00685477|12175162|FG003|COMPLETED|Overall Study||10
10998140|NCT00685477|12175163|FG004|COMPLETED|Overall Study||10
10998141|NCT00685477|12175164|FG005|COMPLETED|Overall Study||10
10998142|NCT00685477|12175159|FG000|NOT COMPLETED|Overall Study||0
10998143|NCT00685477|12175160|FG001|NOT COMPLETED|Overall Study||0
10998144|NCT00685477|12175161|FG002|NOT COMPLETED|Overall Study||0
10998145|NCT00685477|12175162|FG003|NOT COMPLETED|Overall Study||0
10998146|NCT00685477|12175163|FG004|NOT COMPLETED|Overall Study||0
10998147|NCT00685477|12175164|FG005|NOT COMPLETED|Overall Study||0
10998148|NCT00685516|12175176|FG000|STARTED|Overall Study||42
10998149|NCT00685516|12175177|FG001|STARTED|Overall Study||38
10998150|NCT00685516|12175178|FG002|STARTED|Overall Study||33
10998151|NCT00685516|12175176|FG000|COMPLETED|Overall Study||34
10998152|NCT00685516|12175177|FG001|COMPLETED|Overall Study||33
10998153|NCT00685516|12175178|FG002|COMPLETED|Overall Study||26
10998154|NCT00685516|12175176|FG000|NOT COMPLETED|Overall Study||8
10998155|NCT00685516|12175177|FG001|NOT COMPLETED|Overall Study||5
10998156|NCT00685516|12175178|FG002|NOT COMPLETED|Overall Study||7
10998157|NCT00685659|12175192|FG000|STARTED|Overall Study||108
10998158|NCT00685659|12175193|FG001|STARTED|Overall Study||106
10998159|NCT00685659|12175194|FG002|STARTED|Overall Study||107
10998160|NCT00685659|12175192|FG000|COMPLETED|Overall Study||77
10998161|NCT00685659|12175193|FG001|COMPLETED|Overall Study||81
10998162|NCT00685659|12175194|FG002|COMPLETED|Overall Study||92
10998163|NCT00685659|12175192|FG000|NOT COMPLETED|Overall Study||31
10998164|NCT00685659|12175193|FG001|NOT COMPLETED|Overall Study||25
10998165|NCT00685659|12175194|FG002|NOT COMPLETED|Overall Study||15
10998166|NCT00685685|12175202|FG000|STARTED|First Intervention||27
10998167|NCT00685685|12175203|FG001|STARTED|First Intervention||27
10998168|NCT00685685|12175202|FG000|COMPLETED|First Intervention||27
10998169|NCT00685685|12175203|FG001|COMPLETED|First Intervention||27
10998170|NCT00685685|12175202|FG000|NOT COMPLETED|First Intervention||0
10998171|NCT00685685|12175203|FG001|NOT COMPLETED|First Intervention||0
10998172|NCT00685685|12175202|FG000|STARTED|Washout Period of 7 Days||27
10998173|NCT00685685|12175203|FG001|STARTED|Washout Period of 7 Days||27
10998174|NCT00685685|12175202|FG000|COMPLETED|Washout Period of 7 Days||25
10998175|NCT00685685|12175203|FG001|COMPLETED|Washout Period of 7 Days||26
10998176|NCT00685685|12175202|FG000|NOT COMPLETED|Washout Period of 7 Days||2
10998177|NCT00685685|12175203|FG001|NOT COMPLETED|Washout Period of 7 Days||1
10998178|NCT00685685|12175202|FG000|STARTED|Second Intervention||25
10998179|NCT00685685|12175203|FG001|STARTED|Second Intervention||26
10998180|NCT00685685|12175202|FG000|COMPLETED|Second Intervention||25
10998181|NCT00685685|12175203|FG001|COMPLETED|Second Intervention||26
10998182|NCT00685685|12175202|FG000|NOT COMPLETED|Second Intervention||0
10998183|NCT00685685|12175203|FG001|NOT COMPLETED|Second Intervention||0
10998184|NCT00685698|12175209|FG000|STARTED|Overall Study||38
10998185|NCT00685698|12175209|FG000|COMPLETED|Overall Study||25
10998186|NCT00685698|12175209|FG000|NOT COMPLETED|Overall Study||13
10998187|NCT00685750|12175232|FG000|STARTED|Overall Study||17
10998188|NCT00685750|12175233|FG001|STARTED|Overall Study||3
10998189|NCT00685750|12175234|FG002|STARTED|Overall Study||21
10998190|NCT00685750|12175235|FG003|STARTED|Overall Study||2
10998191|NCT00685750|12175236|FG004|STARTED|Overall Study||15
10998192|NCT00685750|12175237|FG005|STARTED|Overall Study||20
10998193|NCT00685750|12175238|FG006|STARTED|Overall Study||10
10998194|NCT00685750|12175232|FG000|COMPLETED|Overall Study||17
10998195|NCT00685750|12175233|FG001|COMPLETED|Overall Study||3
10998196|NCT00685750|12175234|FG002|COMPLETED|Overall Study||19
10998197|NCT00685750|12175235|FG003|COMPLETED|Overall Study||2
10998198|NCT00685750|12175236|FG004|COMPLETED|Overall Study||15
10998199|NCT00685750|12175237|FG005|COMPLETED|Overall Study||20
10998200|NCT00685750|12175238|FG006|COMPLETED|Overall Study||9
10998201|NCT00685750|12175232|FG000|NOT COMPLETED|Overall Study||0
10998202|NCT00685750|12175233|FG001|NOT COMPLETED|Overall Study||0
10998203|NCT00685750|12175234|FG002|NOT COMPLETED|Overall Study||2
10998204|NCT00685750|12175235|FG003|NOT COMPLETED|Overall Study||0
10998205|NCT00685750|12175236|FG004|NOT COMPLETED|Overall Study||0
10998206|NCT00685750|12175237|FG005|NOT COMPLETED|Overall Study||0
10998207|NCT00685750|12175238|FG006|NOT COMPLETED|Overall Study||1
10998208|NCT00685763|12175258|FG000|STARTED|Overall Study||13
10998209|NCT00685763|12175258|FG000|COMPLETED|Overall Study||11
10998210|NCT00685763|12175258|FG000|NOT COMPLETED|Overall Study||2
10998211|NCT00685802|12175262|FG000|STARTED|First Intervention||16
10998212|NCT00685802|12175263|FG001|STARTED|First Intervention||16
10998213|NCT00685802|12175262|FG000|COMPLETED|First Intervention||16
10998214|NCT00685802|12175263|FG001|COMPLETED|First Intervention||16
10998215|NCT00685802|12175262|FG000|NOT COMPLETED|First Intervention||0
10998216|NCT00685802|12175263|FG001|NOT COMPLETED|First Intervention||0
10998217|NCT00685802|12175262|FG000|STARTED|Washout Period of 7 Days||16
10998218|NCT00685802|12175263|FG001|STARTED|Washout Period of 7 Days||16
10998219|NCT00685802|12175262|FG000|COMPLETED|Washout Period of 7 Days||14
10998220|NCT00685802|12175263|FG001|COMPLETED|Washout Period of 7 Days||15
10998221|NCT00685802|12175262|FG000|NOT COMPLETED|Washout Period of 7 Days||2
10998222|NCT00685802|12175263|FG001|NOT COMPLETED|Washout Period of 7 Days||1
10998223|NCT00685802|12175262|FG000|STARTED|Second Intervention||14
10998224|NCT00685802|12175263|FG001|STARTED|Second Intervention||15
10998225|NCT00685802|12175262|FG000|COMPLETED|Second Intervention||14
10998226|NCT00685802|12175263|FG001|COMPLETED|Second Intervention||15
10998227|NCT00685802|12175262|FG000|NOT COMPLETED|Second Intervention||0
10998228|NCT00685802|12175263|FG001|NOT COMPLETED|Second Intervention||0
10998229|NCT00685932|12175271|FG000|STARTED|Overall Study||76
10998230|NCT00685932|12175272|FG001|STARTED|Overall Study||78
10998231|NCT00685932|12175271|FG000|COMPLETED|Overall Study||55
10998232|NCT00685932|12175272|FG001|COMPLETED|Overall Study||58
10998233|NCT00685932|12175271|FG000|NOT COMPLETED|Overall Study||21
10998234|NCT00685932|12175272|FG001|NOT COMPLETED|Overall Study||20
10998235|NCT00685945|12175278|FG000|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
10998236|NCT00685945|12175278|FG000|COMPLETED|Control (Bradykinin Infusion)||24
10998237|NCT00685945|12175278|FG000|NOT COMPLETED|Control (Bradykinin Infusion)||0
10998238|NCT00685945|12175278|FG000|STARTED|L-NMMA + Bradykinin||24
10998239|NCT00685945|12175278|FG000|COMPLETED|L-NMMA + Bradykinin||23
10998240|NCT00685945|12175278|FG000|NOT COMPLETED|L-NMMA + Bradykinin||1
10998241|NCT00685945|12175278|FG000|STARTED|Isosorbide + L-NMMA + Bradykinin||11
10998242|NCT00685945|12175278|FG000|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
10998243|NCT00685945|12175278|FG000|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
10998244|NCT00685945|12175278|FG000|STARTED|Sildenafil + L-NMMA + Bradykinin||12
10998245|NCT00685945|12175278|FG000|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
10998246|NCT00685945|12175278|FG000|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
10998247|NCT00686075|12175298|FG000|STARTED|Overall Study||79
10998248|NCT00686075|12175299|FG001|STARTED|Overall Study||81
10998249|NCT00686075|12175300|FG002|STARTED|Overall Study||80
10998250|NCT00686075|12175301|FG003|STARTED|Overall Study||80
10998251|NCT00686075|12175302|FG004|STARTED|Overall Study||40
10998252|NCT00686075|12175303|FG005|STARTED|Overall Study||40
10998253|NCT00686075|12175304|FG006|STARTED|Overall Study||82
10998254|NCT00686075|12175305|FG007|STARTED|Overall Study||78
10998255|NCT00686075|12175306|FG008|STARTED|Overall Study||81
10998256|NCT00686075|12175307|FG009|STARTED|Overall Study||79
10998257|NCT00686075|12175298|FG000|Treated|Overall Study||78
10998258|NCT00686075|12175299|FG001|Treated|Overall Study||79
10998259|NCT00686075|12175300|FG002|Treated|Overall Study||80
10998260|NCT00686075|12175301|FG003|Treated|Overall Study||80
10998261|NCT00686075|12175302|FG004|Treated|Overall Study||40
10998262|NCT00686075|12175303|FG005|Treated|Overall Study||40
10998263|NCT00686075|12175304|FG006|Treated|Overall Study||82
10998264|NCT00686075|12175305|FG007|Treated|Overall Study||77
10998265|NCT00686075|12175306|FG008|Treated|Overall Study||80
10998266|NCT00686075|12175307|FG009|Treated|Overall Study||78
10998267|NCT00686075|12175298|FG000|COMPLETED|Overall Study||71
10998268|NCT00686075|12175299|FG001|COMPLETED|Overall Study||71
10998269|NCT00686075|12175300|FG002|COMPLETED|Overall Study||74
10998270|NCT00686075|12175301|FG003|COMPLETED|Overall Study||71
10998271|NCT00686075|12175302|FG004|COMPLETED|Overall Study||36
10998272|NCT00686075|12175303|FG005|COMPLETED|Overall Study||37
10998273|NCT00686075|12175304|FG006|COMPLETED|Overall Study||82
10998274|NCT00686075|12175305|FG007|COMPLETED|Overall Study||76
10998275|NCT00686075|12175306|FG008|COMPLETED|Overall Study||75
10998276|NCT00686075|12175307|FG009|COMPLETED|Overall Study||69
10998277|NCT00686075|12175298|FG000|NOT COMPLETED|Overall Study||8
10998278|NCT00686075|12175299|FG001|NOT COMPLETED|Overall Study||10
10998279|NCT00686075|12175300|FG002|NOT COMPLETED|Overall Study||6
10998280|NCT00686075|12175301|FG003|NOT COMPLETED|Overall Study||9
10998281|NCT00686075|12175302|FG004|NOT COMPLETED|Overall Study||4
10998282|NCT00686075|12175303|FG005|NOT COMPLETED|Overall Study||3
10998283|NCT00686075|12175304|FG006|NOT COMPLETED|Overall Study||0
10998284|NCT00686075|12175305|FG007|NOT COMPLETED|Overall Study||2
10998285|NCT00686075|12175306|FG008|NOT COMPLETED|Overall Study||6
10998286|NCT00686075|12175307|FG009|NOT COMPLETED|Overall Study||10
10998287|NCT00686127|12175331|FG000|STARTED|Overall Study||14
10998288|NCT00686127|12175332|FG001|STARTED|Overall Study||7
10998289|NCT00686127|12175331|FG000|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
10998290|NCT00686127|12175332|FG001|COMPLETED|Overall Study||1
10998291|NCT00686127|12175331|FG000|NOT COMPLETED|Overall Study||14
10998292|NCT00686127|12175332|FG001|NOT COMPLETED|Overall Study||6
10998293|NCT00686166|12175338|FG000|STARTED|Overall Study||83
10998294|NCT00686166|12175338|FG000|Eligible|Overall Study||78
10998295|NCT00686166|12175338|FG000|Eligible and Began Protocol Therapy|Overall Study||74
10998296|NCT00686166|12175338|FG000|COMPLETED|Overall Study||63
10998297|NCT00686166|12175338|FG000|NOT COMPLETED|Overall Study||20
10998298|NCT00686205|12175349|FG000|STARTED|Overall Study||21606
10998299|NCT00686205|12175350|FG001|STARTED|Overall Study||2505
10998300|NCT00686205|12175349|FG000|COMPLETED|Overall Study||15599
10998301|NCT00686205|12175350|FG001|COMPLETED|Overall Study||1524
10998302|NCT00686205|12175349|FG000|NOT COMPLETED|Overall Study||6007
10998303|NCT00686205|12175350|FG001|NOT COMPLETED|Overall Study||981
10998304|NCT00686231|12175356|FG000|STARTED|Dose Test - Visit 1||12
10998305|NCT00686231|12175357|FG001|STARTED|Dose Test - Visit 1||7
10998306|NCT00686231|12175358|FG002|STARTED|Dose Test - Visit 1||0
10998307|NCT00686231|12175359|FG003|STARTED|Dose Test - Visit 1||0
10998308|NCT00686231|12175356|FG000|COMPLETED|Dose Test - Visit 1||12
10998309|NCT00686231|12175357|FG001|COMPLETED|Dose Test - Visit 1||7
10998310|NCT00686231|12175358|FG002|COMPLETED|Dose Test - Visit 1||0
10998311|NCT00686231|12175359|FG003|COMPLETED|Dose Test - Visit 1||0
10998312|NCT00686231|12175356|FG000|NOT COMPLETED|Dose Test - Visit 1||0
10998313|NCT00686231|12175357|FG001|NOT COMPLETED|Dose Test - Visit 1||0
10998314|NCT00686231|12175358|FG002|NOT COMPLETED|Dose Test - Visit 1||0
10998315|NCT00686231|12175359|FG003|NOT COMPLETED|Dose Test - Visit 1||0
10998316|NCT00686231|12175356|FG000|STARTED|Combination Test - Visit 2||0
10998317|NCT00686231|12175357|FG001|STARTED|Combination Test - Visit 2||0
10998318|NCT00686231|12175358|FG002|STARTED|Combination Test - Visit 2||10
10998319|NCT00686231|12175359|FG003|STARTED|Combination Test - Visit 2||9
10998320|NCT00686231|12175356|FG000|COMPLETED|Combination Test - Visit 2||0
10998321|NCT00686231|12175357|FG001|COMPLETED|Combination Test - Visit 2||0
10998322|NCT00686231|12175358|FG002|COMPLETED|Combination Test - Visit 2||10
10998323|NCT00686231|12175359|FG003|COMPLETED|Combination Test - Visit 2||9
10998324|NCT00686231|12175356|FG000|NOT COMPLETED|Combination Test - Visit 2||0
10998325|NCT00686231|12175357|FG001|NOT COMPLETED|Combination Test - Visit 2||0
10998326|NCT00686231|12175358|FG002|NOT COMPLETED|Combination Test - Visit 2||0
10998327|NCT00686231|12175359|FG003|NOT COMPLETED|Combination Test - Visit 2||0
10998328|NCT00686257|12175371|FG000|STARTED|Overall Study||29
10998329|NCT00686257|12175372|FG001|STARTED|Overall Study||31
10998330|NCT00686257|12175371|FG000|COMPLETED|Overall Study||29
10998331|NCT00686257|12175372|FG001|COMPLETED|Overall Study||31
10998332|NCT00686257|12175371|FG000|NOT COMPLETED|Overall Study||0
10998333|NCT00686257|12175372|FG001|NOT COMPLETED|Overall Study||0
10998334|NCT00686335|12175380|FG000|STARTED|Run-in Period||12
10998335|NCT00686335|12175380|FG000|COMPLETED|Run-in Period||7
10998336|NCT00686335|12175380|FG000|NOT COMPLETED|Run-in Period||5
10998337|NCT00686335|12175380|FG000|STARTED|Treatment Period||7
10998338|NCT00686335|12175380|FG000|COMPLETED|Treatment Period||7
10998339|NCT00686335|12175380|FG000|NOT COMPLETED|Treatment Period||0
10998340|NCT00686517|12175389|FG000|STARTED|Treatment||44
10998341|NCT00686517|12175390|FG001|STARTED|Treatment||43
10998342|NCT00686517|12175391|FG002|STARTED|Treatment||43
10998343|NCT00686517|12175389|FG000|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
10998344|NCT00686517|12175390|FG001|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
10998345|NCT00686517|12175391|FG002|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
10998346|NCT00686517|12175389|FG000|COMPLETED|Treatment||38
10998347|NCT00686517|12175390|FG001|COMPLETED|Treatment||40
10998348|NCT00686517|12175391|FG002|COMPLETED|Treatment||42
10998349|NCT00686517|12175389|FG000|NOT COMPLETED|Treatment||6
10998350|NCT00686517|12175390|FG001|NOT COMPLETED|Treatment||3
10998351|NCT00686517|12175391|FG002|NOT COMPLETED|Treatment||1
10998352|NCT00686517|12175389|FG000|STARTED|Follow-up||37
10998353|NCT00686517|12175390|FG001|STARTED|Follow-up||38
10998354|NCT00686517|12175391|FG002|STARTED|Follow-up||39
10998355|NCT00686517|12175389|FG000|COMPLETED|Follow-up||29
10998356|NCT00686517|12175390|FG001|COMPLETED|Follow-up||28
10998357|NCT00686517|12175391|FG002|COMPLETED|Follow-up||29
10998358|NCT00686517|12175389|FG000|NOT COMPLETED|Follow-up||8
10998359|NCT00686517|12175390|FG001|NOT COMPLETED|Follow-up||10
10998360|NCT00686517|12175391|FG002|NOT COMPLETED|Follow-up||10
10998361|NCT00686543|12175403|FG000|STARTED|Overall Study||14
10998362|NCT00686543|12175404|FG001|STARTED|Overall Study||21
10998363|NCT00686543|12175405|FG002|STARTED|Overall Study||20
10998364|NCT00686543|12175406|FG003|STARTED|Overall Study||20
10998365|NCT00686543|12175403|FG000|COMPLETED|Overall Study||0
10998366|NCT00686543|12175404|FG001|COMPLETED|Overall Study||20
10998367|NCT00686543|12175405|FG002|COMPLETED|Overall Study||15
10998368|NCT00686543|12175406|FG003|COMPLETED|Overall Study||17
10998369|NCT00686543|12175403|FG000|NOT COMPLETED|Overall Study||14
10998370|NCT00686543|12175404|FG001|NOT COMPLETED|Overall Study||1
10998371|NCT00686543|12175405|FG002|NOT COMPLETED|Overall Study||5
10998372|NCT00686543|12175406|FG003|NOT COMPLETED|Overall Study||3
10998373|NCT00686582|12175419|FG000|STARTED|Overall Study||92
10998374|NCT00686582|12175420|FG001|STARTED|Overall Study||91
10998375|NCT00686582|12175421|FG002|STARTED|Overall Study||121
10998376|NCT00686582|12175419|FG000|Booster Vaccination|Overall Study||75
10998377|NCT00686582|12175420|FG001|Booster Vaccination|Overall Study||77
10998378|NCT00686582|12175421|FG002|Booster Vaccination|Overall Study||0
10998379|NCT00686582|12175419|FG000|COMPLETED|Overall Study||74
10998380|NCT00686582|12175420|FG001|COMPLETED|Overall Study||77
10998381|NCT00686582|12175421|FG002|COMPLETED|Overall Study||121
10998382|NCT00686582|12175419|FG000|NOT COMPLETED|Overall Study||18
10998383|NCT00686582|12175420|FG001|NOT COMPLETED|Overall Study||14
10998384|NCT00686582|12175421|FG002|NOT COMPLETED|Overall Study||0
10998385|NCT00686595|12175427|FG000|STARTED|Overall Study||38
10998386|NCT00686595|12175427|FG000|COMPLETED|Overall Study||31
10998387|NCT00686595|12175427|FG000|NOT COMPLETED|Overall Study||7
10998388|NCT00686634|12175431|FG000|STARTED|Overall Study||108
10998389|NCT00686634|12175431|FG000|COMPLETED|Overall Study||102
10998390|NCT00686634|12175431|FG000|NOT COMPLETED|Overall Study||6
10998391|NCT00686647|12175436|FG000|STARTED|Overall Study||93
10998392|NCT00686647|12175436|FG000|COMPLETED|Overall Study||91
10998393|NCT00686647|12175436|FG000|NOT COMPLETED|Overall Study||2
10998394|NCT00686686|12175441|FG000|STARTED|Overall Study||23
10998395|NCT00686686|12175441|FG000|COMPLETED|Overall Study||17
10998396|NCT00686686|12175441|FG000|NOT COMPLETED|Overall Study||6
10998397|NCT00686699|12175447|FG000|STARTED|Treatment Period 1||4
10998398|NCT00686699|12175448|FG001|STARTED|Treatment Period 1||7
10998399|NCT00686699|12175447|FG000|COMPLETED|Treatment Period 1||4
10998400|NCT00686699|12175448|FG001|COMPLETED|Treatment Period 1||5
10998401|NCT00686699|12175447|FG000|NOT COMPLETED|Treatment Period 1||0
10998402|NCT00686699|12175448|FG001|NOT COMPLETED|Treatment Period 1||2
10998403|NCT00686699|12175447|FG000|STARTED|Treatment Period 2||4
10998404|NCT00686699|12175448|FG001|STARTED|Treatment Period 2||5
10998405|NCT00686699|12175447|FG000|COMPLETED|Treatment Period 2||4
10998406|NCT00686699|12175448|FG001|COMPLETED|Treatment Period 2||5
10998407|NCT00686699|12175447|FG000|NOT COMPLETED|Treatment Period 2||0
10998408|NCT00686699|12175448|FG001|NOT COMPLETED|Treatment Period 2||0
10998409|NCT00686712|12175457|FG000|STARTED|Overall Study||30
10998410|NCT00686712|12175458|FG001|STARTED|Overall Study||25
10998411|NCT00686712|12175459|FG002|STARTED|Overall Study||30
10998412|NCT00686712|12175457|FG000|COMPLETED|Overall Study||20
10998413|NCT00686712|12175458|FG001|COMPLETED|Overall Study||14
10998414|NCT00686712|12175459|FG002|COMPLETED|Overall Study||17
10998415|NCT00686712|12175457|FG000|NOT COMPLETED|Overall Study||10
10998416|NCT00686712|12175458|FG001|NOT COMPLETED|Overall Study||11
10998417|NCT00686712|12175459|FG002|NOT COMPLETED|Overall Study||13
10998418|NCT00686725|12175472|FG000|STARTED|Overall Study||47
10998419|NCT00686725|12175473|FG001|STARTED|Overall Study||52
10998420|NCT00686725|12175472|FG000|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
10998421|NCT00686725|12175473|FG001|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
10998422|NCT00686725|12175472|FG000|NOT COMPLETED|Overall Study||46
10998423|NCT00686725|12175473|FG001|NOT COMPLETED|Overall Study||42
10998424|NCT00686777|12175479|FG000|STARTED|Overall Study||75
10998425|NCT00686777|12175479|FG000|Completed 24 Weeks of Treatment|Overall Study||69
10998426|NCT00686777|12175479|FG000|Completed 48 Weeks of Treatment|Overall Study||65
10998427|NCT00686777|12175479|FG000|Included in Follow-up (All Treated)|Overall Study||75
10998428|NCT00686777|12175479|FG000|Completed 24 Weeks of Follow-up|Overall Study||70
10998429|NCT00686777|12175479|FG000|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
10998430|NCT00686777|12175479|FG000|NOT COMPLETED|Overall Study||10
10998431|NCT00686790|12175483|FG000|STARTED|Overall Study||48
10998432|NCT00686790|12175483|FG000|COMPLETED|Overall Study||32
10998433|NCT00686790|12175483|FG000|NOT COMPLETED|Overall Study||16
10998434|NCT00686803|12175490|FG000|STARTED|Overall Study||6
10998435|NCT00686803|12175491|FG001|STARTED|Overall Study||12
10998436|NCT00686803|12175492|FG002|STARTED|Overall Study||3
10998437|NCT00686803|12175490|FG000|COMPLETED|Overall Study||6
10998438|NCT00686803|12175491|FG001|COMPLETED|Overall Study||12
10998439|NCT00686803|12175492|FG002|COMPLETED|Overall Study||3
10998440|NCT00686803|12175490|FG000|NOT COMPLETED|Overall Study||0
10998441|NCT00686803|12175491|FG001|NOT COMPLETED|Overall Study||0
10998442|NCT00686803|12175492|FG002|NOT COMPLETED|Overall Study||0
10998443|NCT00686829|12175500|FG000|STARTED|Overall Study||79
10998444|NCT00686829|12175500|FG000|COMPLETED|Overall Study||0
10998445|NCT00686829|12175500|FG000|NOT COMPLETED|Overall Study||79
10998446|NCT00686842|12175504|FG000|STARTED|Overall Study||17
10998447|NCT00686842|12175504|FG000|COMPLETED|Overall Study||17
10998448|NCT00686842|12175504|FG000|NOT COMPLETED|Overall Study||0
10998449|NCT00686855|12175510|FG000|STARTED|Overall Study||28
10998450|NCT00686855|12175511|FG001|STARTED|Overall Study||18
10998451|NCT00686855|12175510|FG000|COMPLETED|Overall Study||27
10998452|NCT00686855|12175511|FG001|COMPLETED|Overall Study||17
10998453|NCT00686855|12175510|FG000|NOT COMPLETED|Overall Study||1
10998454|NCT00686855|12175511|FG001|NOT COMPLETED|Overall Study||1
10998455|NCT00686881|12175519|FG000|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
10998456|NCT00686881|12175520|FG001|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
10998457|NCT00686881|12175519|FG000|COMPLETED|Overall Study||45
10998458|NCT00686881|12175520|FG001|COMPLETED|Overall Study||53
10998459|NCT00686881|12175519|FG000|NOT COMPLETED|Overall Study||82
10998460|NCT00686881|12175520|FG001|NOT COMPLETED|Overall Study||81
10998461|NCT00686894|12175528|FG000|STARTED|Overall Study||7
10998462|NCT00686894|12175528|FG000|COMPLETED|Overall Study||1
10998463|NCT00686894|12175528|FG000|NOT COMPLETED|Overall Study||6
10998464|NCT00686920|12175534|FG000|STARTED|Overall Study||252
10998465|NCT00686920|12175535|FG001|STARTED|Overall Study||70
10998466|NCT00686920|12175534|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||252
10998467|NCT00686920|12175535|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||70
10998468|NCT00686920|12175534|FG000|COMPLETED|Overall Study||120
10998469|NCT00686920|12175535|FG001|COMPLETED|Overall Study||34
10998470|NCT00686920|12175534|FG000|NOT COMPLETED|Overall Study||132
10998471|NCT00686920|12175535|FG001|NOT COMPLETED|Overall Study||36
10998472|NCT00686959|12175543|FG000|STARTED|Overall Study||301
10998473|NCT00686959|12175544|FG001|STARTED|Overall Study||297
10998474|NCT00686959|12175543|FG000|Received at Least One Dose of Study Drug|Overall Study||283
10998475|NCT00686959|12175544|FG001|Received at Least One Dose of Study Drug|Overall Study||272
10998476|NCT00686959|12175543|FG000|Entered Consolidation Phase|Overall Study||229
10998477|NCT00686959|12175544|FG001|Entered Consolidation Phase|Overall Study||202
10998478|NCT00686959|12175543|FG000|COMPLETED|Overall Study|Study completion includes death due to any cause|177
10998479|NCT00686959|12175544|FG001|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
10998480|NCT00686959|12175543|FG000|NOT COMPLETED|Overall Study||124
10998481|NCT00686959|12175544|FG001|NOT COMPLETED|Overall Study||117
10998482|NCT00686998|12175553|FG000|STARTED|Overall Study|Randomized & received study medication|43
10998483|NCT00686998|12175554|FG001|STARTED|Overall Study|Randomized & received study medication|41
10998484|NCT00686998|12175555|FG002|STARTED|Overall Study|Randomized & received study medication|22
10998485|NCT00686998|12175553|FG000|Randomized|Overall Study||43
10998486|NCT00686998|12175554|FG001|Randomized|Overall Study||41
10998487|NCT00686998|12175555|FG002|Randomized|Overall Study||22
10998488|NCT00686998|12175553|FG000|Received Treatment|Overall Study||43
10998489|NCT00686998|12175554|FG001|Received Treatment|Overall Study||41
10998490|NCT00686998|12175555|FG002|Received Treatment|Overall Study||22
10998491|NCT00686998|12175553|FG000|Eligible for Efficacy Analysis|Overall Study||42
10998492|NCT00686998|12175554|FG001|Eligible for Efficacy Analysis|Overall Study||39
10998493|NCT00686998|12175555|FG002|Eligible for Efficacy Analysis|Overall Study||21
10998494|NCT00686998|12175553|FG000|Completed Scheduled Treatment|Overall Study||30
10998495|NCT00686998|12175554|FG001|Completed Scheduled Treatment|Overall Study||33
10998496|NCT00686998|12175555|FG002|Completed Scheduled Treatment|Overall Study||18
10998497|NCT00686998|12175553|FG000|COMPLETED|Overall Study||30
10998498|NCT00686998|12175554|FG001|COMPLETED|Overall Study||33
10998499|NCT00686998|12175555|FG002|COMPLETED|Overall Study||18
10998500|NCT00686998|12175553|FG000|NOT COMPLETED|Overall Study||13
10998501|NCT00686998|12175554|FG001|NOT COMPLETED|Overall Study||8
10998502|NCT00686998|12175555|FG002|NOT COMPLETED|Overall Study||4
10998503|NCT00687076|12175565|FG000|STARTED|Overall Study||51
10998504|NCT00687076|12175566|FG001|STARTED|Overall Study||51
10998505|NCT00687076|12175565|FG000|COMPLETED|Overall Study||19
10998506|NCT00687076|12175566|FG001|COMPLETED|Overall Study||21
10998507|NCT00687076|12175565|FG000|NOT COMPLETED|Overall Study||32
10998508|NCT00687076|12175566|FG001|NOT COMPLETED|Overall Study||30
10998509|NCT00687102|12175574|FG000|STARTED|Overall Study||733
10998510|NCT00687102|12175575|FG001|STARTED|Overall Study||765
10998511|NCT00687102|12175574|FG000|COMPLETED|Overall Study||733
10998512|NCT00687102|12175575|FG001|COMPLETED|Overall Study||765
10998513|NCT00687102|12175574|FG000|NOT COMPLETED|Overall Study||0
10998514|NCT00687102|12175575|FG001|NOT COMPLETED|Overall Study||0
10998515|NCT00687167|12175581|FG000|STARTED|First Intervention||17
10998516|NCT00687167|12175582|FG001|STARTED|First Intervention||17
10998517|NCT00687167|12175581|FG000|COMPLETED|First Intervention||17
10998518|NCT00687167|12175582|FG001|COMPLETED|First Intervention||17
10998519|NCT00687167|12175581|FG000|NOT COMPLETED|First Intervention||0
10998520|NCT00687167|12175582|FG001|NOT COMPLETED|First Intervention||0
10998521|NCT00687167|12175581|FG000|STARTED|Washout Period of 28 Days||17
10998522|NCT00687167|12175582|FG001|STARTED|Washout Period of 28 Days||17
10998523|NCT00687167|12175581|FG000|COMPLETED|Washout Period of 28 Days||17
10998524|NCT00687167|12175582|FG001|COMPLETED|Washout Period of 28 Days||17
10998525|NCT00687167|12175581|FG000|NOT COMPLETED|Washout Period of 28 Days||0
10998526|NCT00687167|12175582|FG001|NOT COMPLETED|Washout Period of 28 Days||0
10998527|NCT00687167|12175581|FG000|STARTED|Second Intervention||17
10998528|NCT00687167|12175582|FG001|STARTED|Second Intervention||17
10998529|NCT00687167|12175581|FG000|COMPLETED|Second Intervention||17
10998530|NCT00687167|12175582|FG001|COMPLETED|Second Intervention||17
10998531|NCT00687167|12175581|FG000|NOT COMPLETED|Second Intervention||0
10998532|NCT00687167|12175582|FG001|NOT COMPLETED|Second Intervention||0
10998533|NCT00687193|12175594|FG000|STARTED|Overall Study||53
10998534|NCT00687193|12175595|FG001|STARTED|Overall Study||53
10998535|NCT00687193|12175596|FG002|STARTED|Overall Study||52
10998536|NCT00687193|12175597|FG003|STARTED|Overall Study||53
10998537|NCT00687193|12175598|FG004|STARTED|Overall Study||54
10998538|NCT00687193|12175599|FG005|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
10998539|NCT00687193|12175594|FG000|COMPLETED|Overall Study||51
10998540|NCT00687193|12175595|FG001|COMPLETED|Overall Study||49
10998541|NCT00687193|12175596|FG002|COMPLETED|Overall Study||50
10998542|NCT00687193|12175597|FG003|COMPLETED|Overall Study||49
10998543|NCT00687193|12175598|FG004|COMPLETED|Overall Study||52
10998544|NCT00687193|12175599|FG005|COMPLETED|Overall Study||48
10998545|NCT00687193|12175594|FG000|NOT COMPLETED|Overall Study||2
10998546|NCT00687193|12175595|FG001|NOT COMPLETED|Overall Study||4
10998547|NCT00687193|12175596|FG002|NOT COMPLETED|Overall Study||2
10998548|NCT00687193|12175597|FG003|NOT COMPLETED|Overall Study||4
10998549|NCT00687193|12175598|FG004|NOT COMPLETED|Overall Study||2
10998550|NCT00687193|12175599|FG005|NOT COMPLETED|Overall Study||4
10998551|NCT00687219|12175616|FG000|STARTED|Overall Study||102
10998552|NCT00687219|12175616|FG000|COMPLETED|Overall Study||51
10998553|NCT00687219|12175616|FG000|NOT COMPLETED|Overall Study||51
10998554|NCT00687271|12175624|FG000|STARTED|Overall Study||94
10998555|NCT00687271|12175625|FG001|STARTED|Overall Study||96
10998556|NCT00687271|12175626|FG002|STARTED|Overall Study||96
10998557|NCT00687271|12175627|FG003|STARTED|Overall Study||48
10998558|NCT00687271|12175624|FG000|Treated|Overall Study||94
10998559|NCT00687271|12175625|FG001|Treated|Overall Study||95
10998560|NCT00687271|12175626|FG002|Treated|Overall Study||96
10998561|NCT00687271|12175627|FG003|Treated|Overall Study||48
10998562|NCT00687271|12175624|FG000|COMPLETED|Overall Study||91
10998563|NCT00687271|12175625|FG001|COMPLETED|Overall Study||90
10998564|NCT00687271|12175626|FG002|COMPLETED|Overall Study||91
10998565|NCT00687271|12175627|FG003|COMPLETED|Overall Study||48
10998566|NCT00687271|12175624|FG000|NOT COMPLETED|Overall Study||3
10998567|NCT00687271|12175625|FG001|NOT COMPLETED|Overall Study||6
10998568|NCT00687271|12175626|FG002|NOT COMPLETED|Overall Study||5
10998569|NCT00687271|12175627|FG003|NOT COMPLETED|Overall Study||0
10998570|NCT00687297|12175639|FG000|STARTED|Randomization||80
10998571|NCT00687297|12175640|FG001|STARTED|Randomization||82
10998572|NCT00687297|12175639|FG000|COMPLETED|Randomization||77
10998573|NCT00687297|12175640|FG001|COMPLETED|Randomization||81
10998574|NCT00687297|12175639|FG000|NOT COMPLETED|Randomization||3
10998575|NCT00687297|12175640|FG001|NOT COMPLETED|Randomization||1
10998576|NCT00687297|12175639|FG000|STARTED|Induction||77
10998577|NCT00687297|12175640|FG001|STARTED|Induction||81
10998578|NCT00687297|12175639|FG000|COMPLETED|Induction||32
10998579|NCT00687297|12175640|FG001|COMPLETED|Induction||26
10998580|NCT00687297|12175639|FG000|NOT COMPLETED|Induction||45
10998581|NCT00687297|12175640|FG001|NOT COMPLETED|Induction||55
10998582|NCT00687297|12175639|FG000|STARTED|Maintenance||32
10998583|NCT00687297|12175640|FG001|STARTED|Maintenance||26
10998584|NCT00687297|12175639|FG000|COMPLETED|Maintenance||29
10998585|NCT00687297|12175640|FG001|COMPLETED|Maintenance||25
10998586|NCT00687297|12175639|FG000|NOT COMPLETED|Maintenance||3
10998587|NCT00687297|12175640|FG001|NOT COMPLETED|Maintenance||1
10998588|NCT00687323|12175648|FG000|STARTED|Overall Study|Number of screened participants|195
10998589|NCT00687323|12175648|FG000|Received Treatment|Overall Study||47
10998590|NCT00687323|12175648|FG000|COMPLETED|Overall Study|Number of participants alive at one year|15
10998591|NCT00687323|12175648|FG000|NOT COMPLETED|Overall Study||180
10998592|NCT00687362|12175652|FG000|STARTED|Overall Study||22
10998593|NCT00687362|12175652|FG000|COMPLETED|Overall Study|Completed protocol at Week 24|19
10998594|NCT00687362|12175652|FG000|NOT COMPLETED|Overall Study||3
10998595|NCT00687401|12175656|FG000|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
10998596|NCT00687401|12175656|FG000|COMPLETED|Overall Study||129
10998597|NCT00687401|12175656|FG000|NOT COMPLETED|Overall Study||30
10998598|NCT00687440|12175661|FG000|STARTED|Overall Study|Number of screened participants|27
10998599|NCT00687440|12175661|FG000|COMPLETED|Overall Study||15
10998600|NCT00687440|12175661|FG000|NOT COMPLETED|Overall Study||12
10998601|NCT00687453|12175667|FG000|STARTED|Overall Study||11
10998602|NCT00687453|12175668|FG001|STARTED|Overall Study||13
10998603|NCT00687453|12175667|FG000|COMPLETED|Overall Study||8
10998604|NCT00687453|12175668|FG001|COMPLETED|Overall Study||7
10998605|NCT00687453|12175667|FG000|NOT COMPLETED|Overall Study||3
10998606|NCT00687453|12175668|FG001|NOT COMPLETED|Overall Study||6
10998607|NCT00687544|12175674|FG000|STARTED|Overall Study||11
10998608|NCT00687544|12175674|FG000|COMPLETED|Overall Study||0
10998609|NCT00687544|12175674|FG000|NOT COMPLETED|Overall Study||11
10998610|NCT00687609|12175678|FG000|STARTED|Overall Study||7
10998611|NCT00687609|12175678|FG000|COMPLETED|Overall Study||4
10998612|NCT00687609|12175678|FG000|NOT COMPLETED|Overall Study||3
10998613|NCT00687674|12175682|FG000|STARTED|Overall Study||13
10998614|NCT00687674|12175682|FG000|COMPLETED|Overall Study||11
10998615|NCT00687674|12175682|FG000|NOT COMPLETED|Overall Study||2
10998616|NCT00687713|12175688|FG000|STARTED|Overall Study||100
10998617|NCT00687713|12175689|FG001|STARTED|Overall Study||104
10998618|NCT00687713|12175688|FG000|COMPLETED|Overall Study||68
10998619|NCT00687713|12175689|FG001|COMPLETED|Overall Study||64
10998620|NCT00687713|12175688|FG000|NOT COMPLETED|Overall Study||32
10998621|NCT00687713|12175689|FG001|NOT COMPLETED|Overall Study||40
10998622|NCT00687739|12175701|FG000|STARTED|Overall Study||25
10998623|NCT00687739|12175702|FG001|STARTED|Overall Study||15
10998624|NCT00687739|12175703|FG002|STARTED|Overall Study||25
10998625|NCT00687739|12175704|FG003|STARTED|Overall Study||14
10998626|NCT00687739|12175701|FG000|COMPLETED|Overall Study||23
10998627|NCT00687739|12175702|FG001|COMPLETED|Overall Study||12
10998628|NCT00687739|12175703|FG002|COMPLETED|Overall Study||23
10998629|NCT00687739|12175704|FG003|COMPLETED|Overall Study||12
10998630|NCT00687739|12175701|FG000|NOT COMPLETED|Overall Study||2
10998631|NCT00687739|12175702|FG001|NOT COMPLETED|Overall Study||3
10998632|NCT00687739|12175703|FG002|NOT COMPLETED|Overall Study||2
10998633|NCT00687739|12175704|FG003|NOT COMPLETED|Overall Study||2
10998634|NCT00687804|12175719|FG000|STARTED|Core Study||116
10998635|NCT00687804|12175720|FG001|STARTED|Core Study||118
10998636|NCT00687804|12175721|FG002|STARTED|Core Study||111
10998637|NCT00687804|12175719|FG000|COMPLETED|Core Study||102
10998638|NCT00687804|12175720|FG001|COMPLETED|Core Study||103
10998639|NCT00687804|12175721|FG002|COMPLETED|Core Study||98
10998640|NCT00687804|12175719|FG000|NOT COMPLETED|Core Study||14
10998641|NCT00687804|12175720|FG001|NOT COMPLETED|Core Study||15
10998642|NCT00687804|12175721|FG002|NOT COMPLETED|Core Study||13
10998643|NCT00687804|12175719|FG000|STARTED|Open-Label Extension Study||83
10998644|NCT00687804|12175720|FG001|STARTED|Open-Label Extension Study||83
10998645|NCT00687804|12175721|FG002|STARTED|Open-Label Extension Study||74
10998646|NCT00687804|12175719|FG000|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
10998647|NCT00687804|12175720|FG001|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
10998648|NCT00687804|12175721|FG002|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
10998649|NCT00687804|12175719|FG000|COMPLETED|Open-Label Extension Study||73
10998650|NCT00687804|12175720|FG001|COMPLETED|Open-Label Extension Study||72
10998651|NCT00687804|12175721|FG002|COMPLETED|Open-Label Extension Study||63
10998652|NCT00687804|12175719|FG000|NOT COMPLETED|Open-Label Extension Study||10
10998653|NCT00687804|12175720|FG001|NOT COMPLETED|Open-Label Extension Study||11
10998654|NCT00687804|12175721|FG002|NOT COMPLETED|Open-Label Extension Study||11
10998655|NCT00687830|12175737|FG000|STARTED|Overall Study||68
10998656|NCT00687830|12175738|FG001|STARTED|Overall Study||68
10998657|NCT00687830|12175737|FG000|COMPLETED|Overall Study||68
10998658|NCT00687830|12175738|FG001|COMPLETED|Overall Study||68
10998659|NCT00687830|12175737|FG000|NOT COMPLETED|Overall Study||0
10998660|NCT00687830|12175738|FG001|NOT COMPLETED|Overall Study||0
10998661|NCT00687856|12175744|FG000|STARTED|Overall Study||211
10998662|NCT00687856|12175744|FG000|COMPLETED|Overall Study||211
10998663|NCT00687856|12175744|FG000|NOT COMPLETED|Overall Study||0
10998664|NCT00687908|12175750|FG000|STARTED|Overall Study||123
10998665|NCT00687908|12175751|FG001|STARTED|Overall Study||120
10998666|NCT00687908|12175750|FG000|COMPLETED|Overall Study||105
10998667|NCT00687908|12175751|FG001|COMPLETED|Overall Study||78
10998668|NCT00687908|12175750|FG000|NOT COMPLETED|Overall Study||18
10998669|NCT00687908|12175751|FG001|NOT COMPLETED|Overall Study||42
10998670|NCT00687973|12175759|FG000|STARTED|Overall Study||193
10998671|NCT00687973|12175760|FG001|STARTED|Overall Study||200
10998672|NCT00687973|12175759|FG000|COMPLETED|Overall Study||169
10998673|NCT00687973|12175760|FG001|COMPLETED|Overall Study||162
10998674|NCT00687973|12175759|FG000|NOT COMPLETED|Overall Study||24
10998675|NCT00687973|12175760|FG001|NOT COMPLETED|Overall Study||38
10998676|NCT00688064|12175769|FG000|STARTED|Overall Study||232
10998677|NCT00688064|12175770|FG001|STARTED|Overall Study||227
10998678|NCT00688064|12175769|FG000|COMPLETED|Overall Study||211
10998679|NCT00688064|12175770|FG001|COMPLETED|Overall Study||201
10998680|NCT00688064|12175769|FG000|NOT COMPLETED|Overall Study||21
10998681|NCT00688064|12175770|FG001|NOT COMPLETED|Overall Study||26
10998682|NCT00688103|12175778|FG000|STARTED|Overall Study||74
10998683|NCT00688103|12175779|FG001|STARTED|Overall Study||77
10998684|NCT00688103|12175778|FG000|Actually Treated|Overall Study||71
10998685|NCT00688103|12175779|FG001|Actually Treated|Overall Study||76
10998686|NCT00688103|12175778|FG000|COMPLETED|Overall Study||44
10998687|NCT00688103|12175779|FG001|COMPLETED|Overall Study||64
10998688|NCT00688103|12175778|FG000|NOT COMPLETED|Overall Study||30
10998689|NCT00688103|12175779|FG001|NOT COMPLETED|Overall Study||13
10998690|NCT00688155|12175791|FG000|STARTED|Overall Study||18
10998691|NCT00688155|12175792|FG001|STARTED|Overall Study||18
10998692|NCT00688155|12175793|FG002|STARTED|Overall Study||19
10998693|NCT00688155|12175794|FG003|STARTED|Overall Study||18
10998694|NCT00688155|12175791|FG000|COMPLETED|Overall Study||16
10998695|NCT00688155|12175792|FG001|COMPLETED|Overall Study||16
10998696|NCT00688155|12175793|FG002|COMPLETED|Overall Study||18
10998697|NCT00688155|12175794|FG003|COMPLETED|Overall Study||17
10998698|NCT00688155|12175791|FG000|NOT COMPLETED|Overall Study||2
10998699|NCT00688155|12175792|FG001|NOT COMPLETED|Overall Study||2
10998700|NCT00688155|12175793|FG002|NOT COMPLETED|Overall Study||1
10998701|NCT00688155|12175794|FG003|NOT COMPLETED|Overall Study||1
10998702|NCT00688181|12175804|FG000|STARTED|Overall Study||36
10998703|NCT00688181|12175804|FG000|COMPLETED|Overall Study||13
10998704|NCT00688181|12175804|FG000|NOT COMPLETED|Overall Study||23
10998705|NCT00688259|12175812|FG000|STARTED|Overall Study||44
10998706|NCT00688259|12175813|FG001|STARTED|Overall Study||44
10998707|NCT00688259|12175812|FG000|End to Active Treatment,|Overall Study||37
10998708|NCT00688259|12175813|FG001|End to Active Treatment,|Overall Study||37
10998709|NCT00688259|12175812|FG000|COMPLETED|Overall Study||37
10998710|NCT00688259|12175813|FG001|COMPLETED|Overall Study||36
10998711|NCT00688259|12175812|FG000|NOT COMPLETED|Overall Study||7
10998712|NCT00688259|12175813|FG001|NOT COMPLETED|Overall Study||8
10998713|NCT00688324|12175819|FG000|STARTED|Overall Study||36
10998714|NCT00688324|12175819|FG000|COMPLETED|Overall Study||28
10998715|NCT00688324|12175819|FG000|NOT COMPLETED|Overall Study||8
10998716|NCT00688467|12175826|FG000|STARTED|Treatment Period 1||9
10998717|NCT00688467|12175827|FG001|STARTED|Treatment Period 1||10
10998718|NCT00688467|12175826|FG000|COMPLETED|Treatment Period 1||7
10998719|NCT00688467|12175827|FG001|COMPLETED|Treatment Period 1||8
10998720|NCT00688467|12175826|FG000|NOT COMPLETED|Treatment Period 1||2
10998721|NCT00688467|12175827|FG001|NOT COMPLETED|Treatment Period 1||2
10998722|NCT00688467|12175826|FG000|STARTED|Treatment Period 2||7
10998723|NCT00688467|12175827|FG001|STARTED|Treatment Period 2||8
10998724|NCT00688467|12175826|FG000|COMPLETED|Treatment Period 2||7
10998725|NCT00688467|12175827|FG001|COMPLETED|Treatment Period 2||6
10998726|NCT00688467|12175826|FG000|NOT COMPLETED|Treatment Period 2||0
10998727|NCT00688467|12175827|FG001|NOT COMPLETED|Treatment Period 2||2
10998728|NCT00688519|12175835|FG000|STARTED|Overall Study||223
10998729|NCT00688519|12175836|FG001|STARTED|Overall Study||113
10998730|NCT00688519|12175835|FG000|COMPLETED|Overall Study||204
10998731|NCT00688519|12175836|FG001|COMPLETED|Overall Study||98
10998732|NCT00688519|12175835|FG000|NOT COMPLETED|Overall Study||19
10998733|NCT00688519|12175836|FG001|NOT COMPLETED|Overall Study||15
10998734|NCT00688545|12175844|FG000|STARTED|Overall Study||55
10998735|NCT00688545|12175845|FG001|STARTED|Overall Study||219
10998736|NCT00688545|12175844|FG000|Switched Treatment at Least Once|Overall Study||6
10998737|NCT00688545|12175845|FG001|Switched Treatment at Least Once|Overall Study||13
10998738|NCT00688545|12175844|FG000|COMPLETED|Overall Study||50
10998739|NCT00688545|12175845|FG001|COMPLETED|Overall Study||204
10998740|NCT00688545|12175844|FG000|NOT COMPLETED|Overall Study||5
10998741|NCT00688545|12175845|FG001|NOT COMPLETED|Overall Study||15
10998742|NCT00688597|12175856|FG000|STARTED|Overall Study||3
10998743|NCT00688597|12175857|FG001|STARTED|Overall Study||0
10998744|NCT00688597|12175858|FG002|STARTED|Overall Study||0
10998745|NCT00688597|12175856|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
10998746|NCT00688597|12175857|FG001|Received at Least 1 Dose of Study Drug|Overall Study||0
10998747|NCT00688597|12175858|FG002|Received at Least 1 Dose of Study Drug|Overall Study||0
10998748|NCT00688597|12175856|FG000|COMPLETED|Overall Study||0
10998749|NCT00688597|12175857|FG001|COMPLETED|Overall Study||0
10998750|NCT00688597|12175858|FG002|COMPLETED|Overall Study||0
10998751|NCT00688597|12175856|FG000|NOT COMPLETED|Overall Study||3
10998752|NCT00688597|12175857|FG001|NOT COMPLETED|Overall Study||0
10998753|NCT00688597|12175858|FG002|NOT COMPLETED|Overall Study||0
10998754|NCT00688623|12175866|FG000|STARTED|Overall Study|Intent to treat (ITT)|73
10998755|NCT00688623|12175866|FG000|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73
10998756|NCT00688623|12175866|FG000|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60
10998757|NCT00688623|12175866|FG000|COMPLETED|Overall Study||18
10998758|NCT00688623|12175866|FG000|NOT COMPLETED|Overall Study||55
10998759|NCT00688636|12175872|FG000|STARTED|Overall Study||11
10998760|NCT00688636|12175873|FG001|STARTED|Overall Study||13
10998761|NCT00688636|12175872|FG000|COMPLETED|Overall Study||9
10998762|NCT00688636|12175873|FG001|COMPLETED|Overall Study||12
10998763|NCT00688636|12175872|FG000|NOT COMPLETED|Overall Study||2
10998764|NCT00688636|12175873|FG001|NOT COMPLETED|Overall Study||1
10998765|NCT00688662|12175881|FG000|STARTED|Overall Study||141
10998766|NCT00688662|12175882|FG001|STARTED|Overall Study||73
10998767|NCT00688662|12175881|FG000|COMPLETED|Overall Study||118
10998768|NCT00688662|12175882|FG001|COMPLETED|Overall Study||55
10998769|NCT00688662|12175881|FG000|NOT COMPLETED|Overall Study||23
10998770|NCT00688662|12175882|FG001|NOT COMPLETED|Overall Study||18
10998771|NCT00688688|12175892|FG000|STARTED|Overall Study||815
10998772|NCT00688688|12175893|FG001|STARTED|Overall Study||824
10998773|NCT00688688|12175894|FG002|STARTED|Overall Study||813
10998774|NCT00688688|12175892|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
10998775|NCT00688688|12175893|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
10998776|NCT00688688|12175894|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
10998777|NCT00688688|12175892|FG000|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
10998778|NCT00688688|12175893|FG001|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
10998779|NCT00688688|12175894|FG002|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
10998780|NCT00688688|12175892|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
10998781|NCT00688688|12175893|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
10998782|NCT00688688|12175894|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
10998783|NCT00688688|12175892|FG000|COMPLETED|Overall Study||629
10998784|NCT00688688|12175893|FG001|COMPLETED|Overall Study||645
10998785|NCT00688688|12175894|FG002|COMPLETED|Overall Study||621
10998786|NCT00688688|12175892|FG000|NOT COMPLETED|Overall Study||186
10998787|NCT00688688|12175893|FG001|NOT COMPLETED|Overall Study||179
10998788|NCT00688688|12175894|FG002|NOT COMPLETED|Overall Study||192
10998789|NCT00688701|12175905|FG000|STARTED|Overall Study|Randomized|61
10998790|NCT00688701|12175906|FG001|STARTED|Overall Study||61
10998791|NCT00688701|12175907|FG002|STARTED|Overall Study||120
10998792|NCT00688701|12175908|FG003|STARTED|Overall Study||119
10998793|NCT00688701|12175905|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
10998794|NCT00688701|12175906|FG001|Treated/Safety Population|Overall Study||61
10998795|NCT00688701|12175907|FG002|Treated/Safety Population|Overall Study||120
10998796|NCT00688701|12175908|FG003|Treated/Safety Population|Overall Study||119
10998797|NCT00688701|12175905|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
10998798|NCT00688701|12175906|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||60
10998799|NCT00688701|12175907|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||120
10998800|NCT00688701|12175908|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||118
10998801|NCT00688701|12175905|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
10998802|NCT00688701|12175906|FG001|Subgroup for Standardized Meal Test|Overall Study||35
10998803|NCT00688701|12175907|FG002|Subgroup for Standardized Meal Test|Overall Study||60
10998804|NCT00688701|12175908|FG003|Subgroup for Standardized Meal Test|Overall Study||65
10998805|NCT00688701|12175905|FG000|COMPLETED|Overall Study||57
10998806|NCT00688701|12175906|FG001|COMPLETED|Overall Study||56
10998807|NCT00688701|12175907|FG002|COMPLETED|Overall Study||110
10998808|NCT00688701|12175908|FG003|COMPLETED|Overall Study||108
10998809|NCT00688701|12175905|FG000|NOT COMPLETED|Overall Study||4
10998810|NCT00688701|12175906|FG001|NOT COMPLETED|Overall Study||5
10998811|NCT00688701|12175907|FG002|NOT COMPLETED|Overall Study||10
10998812|NCT00688701|12175908|FG003|NOT COMPLETED|Overall Study||11
10998813|NCT00688740|12175921|FG000|STARTED|Overall Study||745
10998814|NCT00688740|12175922|FG001|STARTED|Overall Study||746
10998815|NCT00688740|12175921|FG000|COMPLETED|Overall Study||679
10998816|NCT00688740|12175922|FG001|COMPLETED|Overall Study||711
10998817|NCT00688740|12175921|FG000|NOT COMPLETED|Overall Study||66
10998818|NCT00688740|12175922|FG001|NOT COMPLETED|Overall Study||35
10998819|NCT00688753|12175928|FG000|STARTED|Overall Study||92
10998820|NCT00688753|12175928|FG000|COMPLETED|Overall Study||0
10998821|NCT00688753|12175928|FG000|NOT COMPLETED|Overall Study||92
10998822|NCT00688844|12175932|FG000|STARTED|Overall Study||58
10998823|NCT00688844|12175932|FG000|COMPLETED|Overall Study||48
10998824|NCT00688844|12175932|FG000|NOT COMPLETED|Overall Study||10
10998825|NCT00688870|12175938|FG000|STARTED|Infant Series||84
10998826|NCT00688870|12175939|FG001|STARTED|Infant Series||84
10998827|NCT00688870|12175938|FG000|Vaccinated Dose 1|Infant Series||83
10998828|NCT00688870|12175939|FG001|Vaccinated Dose 1|Infant Series||84
10998829|NCT00688870|12175938|FG000|Vaccinated Dose 2|Infant Series||80
10998830|NCT00688870|12175939|FG001|Vaccinated Dose 2|Infant Series||84
10998831|NCT00688870|12175938|FG000|Vaccinated Dose 3|Infant Series||80
10998832|NCT00688870|12175939|FG001|Vaccinated Dose 3|Infant Series||84
10998833|NCT00688870|12175938|FG000|COMPLETED|Infant Series||80
10998834|NCT00688870|12175939|FG001|COMPLETED|Infant Series||84
10998835|NCT00688870|12175938|FG000|NOT COMPLETED|Infant Series||4
10998836|NCT00688870|12175939|FG001|NOT COMPLETED|Infant Series||0
10998837|NCT00688870|12175938|FG000|STARTED|After Infant Series||80
10998838|NCT00688870|12175939|FG001|STARTED|After Infant Series||84
10998839|NCT00688870|12175938|FG000|COMPLETED|After Infant Series||80
10998840|NCT00688870|12175939|FG001|COMPLETED|After Infant Series||84
10998841|NCT00688870|12175938|FG000|NOT COMPLETED|After Infant Series||0
10998842|NCT00688870|12175939|FG001|NOT COMPLETED|After Infant Series||0
10998843|NCT00688870|12175938|FG000|STARTED|Toddler Dose||80
10998844|NCT00688870|12175939|FG001|STARTED|Toddler Dose||84
10998845|NCT00688870|12175938|FG000|COMPLETED|Toddler Dose||80
10998846|NCT00688870|12175939|FG001|COMPLETED|Toddler Dose||84
10998847|NCT00688870|12175938|FG000|NOT COMPLETED|Toddler Dose||0
10998848|NCT00688870|12175939|FG001|NOT COMPLETED|Toddler Dose||0
10998849|NCT00688909|12175949|FG000|STARTED|Overall Study||261
10998850|NCT00688909|12175949|FG000|COMPLETED|Overall Study||228
10998851|NCT00688909|12175949|FG000|NOT COMPLETED|Overall Study||33
10998852|NCT00689026|12175956|FG000|STARTED|Overall Study||30
10998853|NCT00689026|12175957|FG001|STARTED|Overall Study||30
10998854|NCT00689026|12175956|FG000|COMPLETED|Overall Study||17
10998855|NCT00689026|12175957|FG001|COMPLETED|Overall Study||24
10998856|NCT00689026|12175956|FG000|NOT COMPLETED|Overall Study||13
10998857|NCT00689026|12175957|FG001|NOT COMPLETED|Overall Study||6
10998858|NCT00689078|12175967|FG000|STARTED|Overall Study||9
10998859|NCT00689078|12175968|FG001|STARTED|Overall Study||9
10998860|NCT00689078|12175969|FG002|STARTED|Overall Study||9
10998861|NCT00689078|12175970|FG003|STARTED|Overall Study||9
10998862|NCT00689078|12175967|FG000|Intent to Treat|Overall Study||9
10998863|NCT00689078|12175968|FG001|Intent to Treat|Overall Study||7
10998864|NCT00689078|12175969|FG002|Intent to Treat|Overall Study||8
10998865|NCT00689078|12175970|FG003|Intent to Treat|Overall Study||8
10998866|NCT00689078|12175967|FG000|COMPLETED|Overall Study||9
10998867|NCT00689078|12175968|FG001|COMPLETED|Overall Study||7
10998868|NCT00689078|12175969|FG002|COMPLETED|Overall Study||8
10998869|NCT00689078|12175970|FG003|COMPLETED|Overall Study||8
10998870|NCT00689078|12175967|FG000|NOT COMPLETED|Overall Study||0
10998871|NCT00689078|12175968|FG001|NOT COMPLETED|Overall Study||2
10998872|NCT00689078|12175969|FG002|NOT COMPLETED|Overall Study||1
10998873|NCT00689078|12175970|FG003|NOT COMPLETED|Overall Study||1
10998874|NCT00689091|12175982|FG000|STARTED|Overall Study||10831
10998875|NCT00689091|12175983|FG001|STARTED|Overall Study||10770
10998876|NCT00689091|12175982|FG000|COMPLETED|Overall Study||9460
10998877|NCT00689091|12175983|FG001|COMPLETED|Overall Study||9376
10998878|NCT00689091|12175982|FG000|NOT COMPLETED|Overall Study||1371
10998879|NCT00689091|12175983|FG001|NOT COMPLETED|Overall Study||1394
10998880|NCT00689104|12175997|FG000|STARTED|Overall Study||497
10998881|NCT00689104|12175998|FG001|STARTED|Overall Study||497
10998882|NCT00689104|12175999|FG002|STARTED|Overall Study||498
10998883|NCT00689104|12176000|FG003|STARTED|Overall Study||495
10998884|NCT00689104|12175997|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
10998885|NCT00689104|12175998|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
10998886|NCT00689104|12175999|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
10998887|NCT00689104|12176000|FG003|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
10998888|NCT00689104|12175997|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
10998889|NCT00689104|12175998|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
10998890|NCT00689104|12175999|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
10998891|NCT00689104|12176000|FG003|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
10998892|NCT00689104|12175997|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
10998893|NCT00689104|12175998|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
10998894|NCT00689104|12175999|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
10998895|NCT00689104|12176000|FG003|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
10998896|NCT00689104|12175997|FG000|COMPLETED|Overall Study||453
10998897|NCT00689104|12175998|FG001|COMPLETED|Overall Study||440
10998898|NCT00689104|12175999|FG002|COMPLETED|Overall Study||453
10998899|NCT00689104|12176000|FG003|COMPLETED|Overall Study||445
10998900|NCT00689104|12175997|FG000|NOT COMPLETED|Overall Study||44
10998901|NCT00689104|12175998|FG001|NOT COMPLETED|Overall Study||57
10998902|NCT00689104|12175999|FG002|NOT COMPLETED|Overall Study||45
10998903|NCT00689104|12176000|FG003|NOT COMPLETED|Overall Study||50
10998904|NCT00689117|12176014|FG000|STARTED|Overall Study||476
10998905|NCT00689117|12176015|FG001|STARTED|Overall Study||467
10998906|NCT00689117|12176016|FG002|STARTED|Overall Study||464
10998907|NCT00689117|12176017|FG003|STARTED|Overall Study||242
10998908|NCT00689117|12176014|FG000|COMPLETED|Overall Study||414
10998909|NCT00689117|12176015|FG001|COMPLETED|Overall Study||416
10998910|NCT00689117|12176016|FG002|COMPLETED|Overall Study||405
10998911|NCT00689117|12176017|FG003|COMPLETED|Overall Study||211
10998912|NCT00689117|12176014|FG000|NOT COMPLETED|Overall Study||62
10998913|NCT00689117|12176015|FG001|NOT COMPLETED|Overall Study||51
10998914|NCT00689117|12176016|FG002|NOT COMPLETED|Overall Study||59
10998915|NCT00689117|12176017|FG003|NOT COMPLETED|Overall Study||31
10998916|NCT00689221|12176029|FG000|STARTED|Overall Study||272
10998917|NCT00689221|12176030|FG001|STARTED|Overall Study||273
10998918|NCT00689221|12176029|FG000|COMPLETED|Overall Study||233
10998919|NCT00689221|12176030|FG001|COMPLETED|Overall Study||237
10998920|NCT00689221|12176029|FG000|NOT COMPLETED|Overall Study||39
10998921|NCT00689221|12176030|FG001|NOT COMPLETED|Overall Study||36
10998922|NCT00689260|12176038|FG000|STARTED|Overall Study||21
10998923|NCT00689260|12176039|FG001|STARTED|Overall Study||21
10998924|NCT00689260|12176038|FG000|COMPLETED|Overall Study||19
10998925|NCT00689260|12176039|FG001|COMPLETED|Overall Study||21
10998926|NCT00689260|12176038|FG000|NOT COMPLETED|Overall Study||2
10998927|NCT00689260|12176039|FG001|NOT COMPLETED|Overall Study||0
10998928|NCT00689273|12176050|FG000|STARTED|Overall Study||79
10998929|NCT00689273|12176051|FG001|STARTED|Overall Study||78
10998930|NCT00689273|12176050|FG000|Treated|Overall Study||78
10998931|NCT00689273|12176051|FG001|Treated|Overall Study||78
10998932|NCT00689273|12176050|FG000|COMPLETED|Overall Study||66
10998933|NCT00689273|12176051|FG001|COMPLETED|Overall Study||73
10998934|NCT00689273|12176050|FG000|NOT COMPLETED|Overall Study||13
10998935|NCT00689273|12176051|FG001|NOT COMPLETED|Overall Study||5
10998936|NCT00689299|12176060|FG000|STARTED|Overall Study||58
10998937|NCT00689299|12176061|FG001|STARTED|Overall Study||57
10998938|NCT00689299|12176062|FG002|STARTED|Overall Study||54
10998939|NCT00689299|12176060|FG000|COMPLETED|Overall Study||51
10998940|NCT00689299|12176061|FG001|COMPLETED|Overall Study||54
10998941|NCT00689299|12176062|FG002|COMPLETED|Overall Study||49
10998942|NCT00689299|12176060|FG000|NOT COMPLETED|Overall Study||7
10998943|NCT00689299|12176061|FG001|NOT COMPLETED|Overall Study||3
10998944|NCT00689299|12176062|FG002|NOT COMPLETED|Overall Study||5
10998945|NCT00689338|12176070|FG000|STARTED|Overall Study||216
10998946|NCT00689338|12176070|FG000|COMPLETED|Overall Study||73
10998947|NCT00689338|12176070|FG000|NOT COMPLETED|Overall Study||143
10998948|NCT00689351|12176076|FG000|STARTED|Infant Series of Dosing||91
10998949|NCT00689351|12176077|FG001|STARTED|Infant Series of Dosing||89
10998950|NCT00689351|12176076|FG000|Vaccinated Dose 1|Infant Series of Dosing||88
10998951|NCT00689351|12176077|FG001|Vaccinated Dose 1|Infant Series of Dosing||89
10998952|NCT00689351|12176076|FG000|Vaccinated Dose 2|Infant Series of Dosing||86
10998953|NCT00689351|12176077|FG001|Vaccinated Dose 2|Infant Series of Dosing||88
10998954|NCT00689351|12176076|FG000|Vaccinated Dose 3|Infant Series of Dosing||85
10998955|NCT00689351|12176077|FG001|Vaccinated Dose 3|Infant Series of Dosing||88
10998956|NCT00689351|12176076|FG000|COMPLETED|Infant Series of Dosing||85
10998957|NCT00689351|12176077|FG001|COMPLETED|Infant Series of Dosing||88
10998958|NCT00689351|12176076|FG000|NOT COMPLETED|Infant Series of Dosing||6
10998959|NCT00689351|12176077|FG001|NOT COMPLETED|Infant Series of Dosing||1
10998960|NCT00689351|12176076|FG000|STARTED|After Infant Series||85
10998961|NCT00689351|12176077|FG001|STARTED|After Infant Series||88
10998962|NCT00689351|12176076|FG000|COMPLETED|After Infant Series||84
10998963|NCT00689351|12176077|FG001|COMPLETED|After Infant Series||88
10998964|NCT00689351|12176076|FG000|NOT COMPLETED|After Infant Series||1
10998965|NCT00689351|12176077|FG001|NOT COMPLETED|After Infant Series||0
10998966|NCT00689351|12176076|FG000|STARTED|Toddler Dose||84
10998967|NCT00689351|12176077|FG001|STARTED|Toddler Dose||88
10998968|NCT00689351|12176076|FG000|COMPLETED|Toddler Dose||84
10998969|NCT00689351|12176077|FG001|COMPLETED|Toddler Dose||88
10998970|NCT00689351|12176076|FG000|NOT COMPLETED|Toddler Dose||0
10998971|NCT00689351|12176077|FG001|NOT COMPLETED|Toddler Dose||0
10998972|NCT00689390|12176089|FG000|STARTED|Overall Study||1907
10998973|NCT00689390|12176090|FG001|STARTED|Overall Study||47
10998974|NCT00689390|12176089|FG000|COMPLETED|Overall Study||1481
10998975|NCT00689390|12176090|FG001|COMPLETED|Overall Study||37
10998976|NCT00689390|12176089|FG000|NOT COMPLETED|Overall Study||426
10998977|NCT00689390|12176090|FG001|NOT COMPLETED|Overall Study||10
10998978|NCT00689481|12176103|FG000|STARTED|Overall Study||214
10998979|NCT00689481|12176104|FG001|STARTED|Overall Study||109
10998980|NCT00689481|12176103|FG000|COMPLETED|Overall Study||190
10998981|NCT00689481|12176104|FG001|COMPLETED|Overall Study||95
10998982|NCT00689481|12176103|FG000|NOT COMPLETED|Overall Study||24
10998983|NCT00689481|12176104|FG001|NOT COMPLETED|Overall Study||14
10998984|NCT00689572|12176112|FG000|STARTED|Overall Study||53
10998985|NCT00689572|12176113|FG001|STARTED|Overall Study||55
10998986|NCT00689572|12176112|FG000|COMPLETED|Overall Study||39
10998987|NCT00689572|12176113|FG001|COMPLETED|Overall Study||34
10998988|NCT00689572|12176112|FG000|NOT COMPLETED|Overall Study||14
10998989|NCT00689572|12176113|FG001|NOT COMPLETED|Overall Study||21
10998990|NCT00689611|12176121|FG000|STARTED|Overall Study||200
10998991|NCT00689611|12176122|FG001|STARTED|Overall Study||192
10998992|NCT00689611|12176121|FG000|COMPLETED|Overall Study||159
10998993|NCT00689611|12176122|FG001|COMPLETED|Overall Study||146
10998994|NCT00689611|12176121|FG000|NOT COMPLETED|Overall Study||41
10998995|NCT00689611|12176122|FG001|NOT COMPLETED|Overall Study||46
10998996|NCT00689728|12176131|FG000|STARTED|Double-Blind Treatment||35
10998997|NCT00689728|12176132|FG001|STARTED|Double-Blind Treatment||30
10998998|NCT00689728|12176133|FG002|STARTED|Double-Blind Treatment||35
10998999|NCT00689728|12176131|FG000|COMPLETED|Double-Blind Treatment||31
10999000|NCT00689728|12176132|FG001|COMPLETED|Double-Blind Treatment||26
10999001|NCT00689728|12176133|FG002|COMPLETED|Double-Blind Treatment||30
10999002|NCT00689728|12176131|FG000|NOT COMPLETED|Double-Blind Treatment||4
10999003|NCT00689728|12176132|FG001|NOT COMPLETED|Double-Blind Treatment||4
10999004|NCT00689728|12176133|FG002|NOT COMPLETED|Double-Blind Treatment||5
10999005|NCT00689728|12176131|FG000|STARTED|Rescue||31
10999006|NCT00689728|12176132|FG001|STARTED|Rescue||26
10999007|NCT00689728|12176133|FG002|STARTED|Rescue||30
10999008|NCT00689728|12176131|FG000|COMPLETED|Rescue||30
10999009|NCT00689728|12176132|FG001|COMPLETED|Rescue||24
10999010|NCT00689728|12176133|FG002|COMPLETED|Rescue||29
10999011|NCT00689728|12176131|FG000|NOT COMPLETED|Rescue||1
10999012|NCT00689728|12176132|FG001|NOT COMPLETED|Rescue||2
10999013|NCT00689728|12176133|FG002|NOT COMPLETED|Rescue||1
10999014|NCT00689728|12176131|FG000|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
10999015|NCT00689728|12176132|FG001|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
10999016|NCT00689728|12176133|FG002|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
10999017|NCT00689728|12176131|FG000|COMPLETED|Optional Follow-Up||6
10999018|NCT00689728|12176132|FG001|COMPLETED|Optional Follow-Up||5
10999019|NCT00689728|12176133|FG002|COMPLETED|Optional Follow-Up||4
10999020|NCT00689728|12176131|FG000|NOT COMPLETED|Optional Follow-Up||3
10999021|NCT00689728|12176132|FG001|NOT COMPLETED|Optional Follow-Up||6
10999022|NCT00689728|12176133|FG002|NOT COMPLETED|Optional Follow-Up||6
10999023|NCT00689793|12176164|FG000|STARTED|Overall Study||78
10999024|NCT00689793|12176165|FG001|STARTED|Overall Study||76
10999025|NCT00689793|12176164|FG000|COMPLETED|Overall Study||74
10999026|NCT00689793|12176165|FG001|COMPLETED|Overall Study||71
10999027|NCT00689793|12176164|FG000|NOT COMPLETED|Overall Study||4
10999028|NCT00689793|12176165|FG001|NOT COMPLETED|Overall Study||5
10999029|NCT00689819|12176175|FG000|STARTED|Overall Study||65
10999030|NCT00689819|12176176|FG001|STARTED|Overall Study||58
10999031|NCT00689819|12176175|FG000|COMPLETED|Overall Study||45
10999032|NCT00689819|12176176|FG001|COMPLETED|Overall Study||43
10999033|NCT00689819|12176175|FG000|NOT COMPLETED|Overall Study||20
10999034|NCT00689819|12176176|FG001|NOT COMPLETED|Overall Study||15
10999035|NCT00689871|12176186|FG000|STARTED|Overall Study|908 Implants|455
10999036|NCT00689871|12176187|FG001|STARTED|Overall Study|127 Implants|98
10999037|NCT00689871|12176188|FG002|STARTED|Overall Study|288 Implants|147
10999038|NCT00689871|12176189|FG003|STARTED|Overall Study|25 Implants|15
10999039|NCT00689871|12176186|FG000|COMPLETED|Overall Study|35 Patients discontinued|280
10999040|NCT00689871|12176187|FG001|COMPLETED|Overall Study|35 Patients discontinued|46
10999041|NCT00689871|12176188|FG002|COMPLETED|Overall Study|28 Patients discontinued|74
10999042|NCT00689871|12176189|FG003|COMPLETED|Overall Study|4 Patients discontinued|8
10999043|NCT00689871|12176186|FG000|NOT COMPLETED|Overall Study||175
10999044|NCT00689871|12176187|FG001|NOT COMPLETED|Overall Study||52
10999045|NCT00689871|12176188|FG002|NOT COMPLETED|Overall Study||73
10999046|NCT00689871|12176189|FG003|NOT COMPLETED|Overall Study||7
10999047|NCT00689936|12176202|FG000|STARTED|Active Treatment Phase||535
10999048|NCT00689936|12176203|FG001|STARTED|Active Treatment Phase||541
10999049|NCT00689936|12176204|FG002|STARTED|Active Treatment Phase||547
10999050|NCT00689936|12176202|FG000|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
10999051|NCT00689936|12176203|FG001|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
10999052|NCT00689936|12176204|FG002|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
10999053|NCT00689936|12176202|FG000|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
10999054|NCT00689936|12176203|FG001|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
10999055|NCT00689936|12176204|FG002|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
10999056|NCT00689936|12176202|FG000|COMPLETED|Active Treatment Phase||0
10999057|NCT00689936|12176203|FG001|COMPLETED|Active Treatment Phase||0
10999058|NCT00689936|12176204|FG002|COMPLETED|Active Treatment Phase||0
10999059|NCT00689936|12176202|FG000|NOT COMPLETED|Active Treatment Phase||535
10999060|NCT00689936|12176203|FG001|NOT COMPLETED|Active Treatment Phase||541
10999061|NCT00689936|12176204|FG002|NOT COMPLETED|Active Treatment Phase||547
10999062|NCT00689936|12176202|FG000|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
10999063|NCT00689936|12176203|FG001|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
10999064|NCT00689936|12176204|FG002|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
10999065|NCT00689936|12176202|FG000|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
10999066|NCT00689936|12176203|FG001|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
10999067|NCT00689936|12176204|FG002|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
10999068|NCT00689936|12176202|FG000|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
10999069|NCT00689936|12176203|FG001|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
10999070|NCT00689936|12176204|FG002|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
10999155|NCT00690495|12176299|FG001|NOT COMPLETED|Overall Study||0
10999071|NCT00689936|12176202|FG000|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
10999072|NCT00689936|12176203|FG001|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
10999073|NCT00689936|12176204|FG002|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
10999074|NCT00689936|12176202|FG000|COMPLETED|Long-Term Follow Up Phase||255
10999075|NCT00689936|12176203|FG001|COMPLETED|Long-Term Follow Up Phase||275
10999076|NCT00689936|12176204|FG002|COMPLETED|Long-Term Follow Up Phase||315
10999077|NCT00689936|12176202|FG000|NOT COMPLETED|Long-Term Follow Up Phase||127
10999078|NCT00689936|12176203|FG001|NOT COMPLETED|Long-Term Follow Up Phase||188
10999079|NCT00689936|12176204|FG002|NOT COMPLETED|Long-Term Follow Up Phase||144
10999080|NCT00690040|12176214|FG000|STARTED|Overall Study||145
10999081|NCT00690040|12176215|FG001|STARTED|Overall Study||148
10999082|NCT00690040|12176214|FG000|COMPLETED|Overall Study||145
10999083|NCT00690040|12176215|FG001|COMPLETED|Overall Study||148
10999084|NCT00690040|12176214|FG000|NOT COMPLETED|Overall Study||0
10999085|NCT00690040|12176215|FG001|NOT COMPLETED|Overall Study||0
10999086|NCT00690235|12176223|FG000|STARTED|Overall Study||17
10999087|NCT00690235|12176224|FG001|STARTED|Overall Study||16
10999088|NCT00690235|12176223|FG000|COMPLETED|Overall Study||12
10999089|NCT00690235|12176224|FG001|COMPLETED|Overall Study||12
10999090|NCT00690235|12176223|FG000|NOT COMPLETED|Overall Study||5
10999091|NCT00690235|12176224|FG001|NOT COMPLETED|Overall Study||4
10999092|NCT00690274|12176232|FG000|STARTED|Overall Study||29
10999093|NCT00690274|12176233|FG001|STARTED|Overall Study||23
10999094|NCT00690274|12176232|FG000|COMPLETED|Overall Study||23
10999095|NCT00690274|12176233|FG001|COMPLETED|Overall Study||15
10999096|NCT00690274|12176232|FG000|NOT COMPLETED|Overall Study||6
10999097|NCT00690274|12176233|FG001|NOT COMPLETED|Overall Study||8
10999098|NCT00690339|12176243|FG000|STARTED|Overall Study||492
10999099|NCT00690339|12176244|FG001|STARTED|Overall Study||225
10999100|NCT00690339|12176245|FG002|STARTED|Overall Study||156
10999101|NCT00690339|12176246|FG003|STARTED|Overall Study||68
10999102|NCT00690339|12176243|FG000|COMPLETED|Overall Study||375
10999103|NCT00690339|12176244|FG001|COMPLETED|Overall Study||144
10999104|NCT00690339|12176245|FG002|COMPLETED|Overall Study||99
10999105|NCT00690339|12176246|FG003|COMPLETED|Overall Study||43
10999106|NCT00690339|12176243|FG000|NOT COMPLETED|Overall Study||117
10999107|NCT00690339|12176244|FG001|NOT COMPLETED|Overall Study||81
10999108|NCT00690339|12176245|FG002|NOT COMPLETED|Overall Study||57
10999109|NCT00690339|12176246|FG003|NOT COMPLETED|Overall Study||25
10999110|NCT00690378|12176258|FG000|STARTED|Overall Study|Randomized|69
10999111|NCT00690378|12176259|FG001|STARTED|Overall Study|Randomized|68
10999112|NCT00690378|12176258|FG000|Treated|Overall Study||68
10999113|NCT00690378|12176259|FG001|Treated|Overall Study||67
10999114|NCT00690378|12176258|FG000|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
10999115|NCT00690378|12176259|FG001|COMPLETED|Overall Study|Up to LFU visit|54
10999116|NCT00690378|12176258|FG000|NOT COMPLETED|Overall Study||20
10999117|NCT00690378|12176259|FG001|NOT COMPLETED|Overall Study||14
10999118|NCT00690430|12176267|FG000|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
10999119|NCT00690430|12176268|FG001|STARTED|Core Phase||57
10999120|NCT00690430|12176269|FG002|STARTED|Core Phase|This arm belongs to Extension Phase.|0
10999121|NCT00690430|12176267|FG000|COMPLETED|Core Phase||35
10999122|NCT00690430|12176268|FG001|COMPLETED|Core Phase||34
10999123|NCT00690430|12176269|FG002|COMPLETED|Core Phase||0
10999124|NCT00690430|12176267|FG000|NOT COMPLETED|Core Phase||18
10999125|NCT00690430|12176268|FG001|NOT COMPLETED|Core Phase||23
10999126|NCT00690430|12176269|FG002|NOT COMPLETED|Core Phase||0
10999127|NCT00690430|12176267|FG000|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
10999128|NCT00690430|12176268|FG001|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
10999129|NCT00690430|12176269|FG002|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
10999130|NCT00690430|12176267|FG000|COMPLETED|Extension Phase||2
10999131|NCT00690430|12176268|FG001|COMPLETED|Extension Phase||1
10999132|NCT00690430|12176269|FG002|COMPLETED|Extension Phase||2
10999133|NCT00690430|12176267|FG000|NOT COMPLETED|Extension Phase||18
10999134|NCT00690430|12176268|FG001|NOT COMPLETED|Extension Phase||5
10999135|NCT00690430|12176269|FG002|NOT COMPLETED|Extension Phase||13
10999136|NCT00690443|12176280|FG000|STARTED|Overall Study||23
10999137|NCT00690443|12176281|FG001|STARTED|Overall Study||21
10999138|NCT00690443|12176280|FG000|COMPLETED|Overall Study||22
10999139|NCT00690443|12176281|FG001|COMPLETED|Overall Study||19
10999140|NCT00690443|12176280|FG000|NOT COMPLETED|Overall Study||1
10999141|NCT00690443|12176281|FG001|NOT COMPLETED|Overall Study||2
10999142|NCT00690482|12176289|FG000|STARTED|Overall Study||61
10999143|NCT00690482|12176290|FG001|STARTED|Overall Study||57
10999144|NCT00690482|12176289|FG000|COMPLETED|Overall Study||57
10999145|NCT00690482|12176290|FG001|COMPLETED|Overall Study||54
10999146|NCT00690482|12176289|FG000|NOT COMPLETED|Overall Study||4
10999147|NCT00690482|12176290|FG001|NOT COMPLETED|Overall Study||3
10999148|NCT00690495|12176298|FG000|STARTED|Overall Study||50
10999149|NCT00690495|12176299|FG001|STARTED|Overall Study||50
10999150|NCT00690495|12176298|FG000|Primary Endpoint|Overall Study||50
10999151|NCT00690495|12176299|FG001|Primary Endpoint|Overall Study||50
10999152|NCT00690495|12176298|FG000|COMPLETED|Overall Study||50
10999153|NCT00690495|12176299|FG001|COMPLETED|Overall Study||50
10999154|NCT00690495|12176298|FG000|NOT COMPLETED|Overall Study||0
10999156|NCT00690573|12176305|FG000|STARTED|Overall Study||25
10999157|NCT00690573|12176305|FG000|COMPLETED|Overall Study||16
10999158|NCT00690573|12176305|FG000|NOT COMPLETED|Overall Study||9
10999159|NCT00690612|12176309|FG000|STARTED|Overall Study||35
10999160|NCT00690612|12176309|FG000|COMPLETED|Overall Study||32
10999161|NCT00690612|12176309|FG000|NOT COMPLETED|Overall Study||3
10999162|NCT00690755|12176320|FG000|STARTED|Overall Study||30
10999163|NCT00690755|12176321|FG001|STARTED|Overall Study||0
10999164|NCT00690755|12176322|FG002|STARTED|Overall Study||97
10999165|NCT00690755|12176323|FG003|STARTED|Overall Study||20
10999166|NCT00690755|12176324|FG004|STARTED|Overall Study||0
10999167|NCT00690755|12176325|FG005|STARTED|Overall Study||10
10999168|NCT00690755|12176326|FG006|STARTED|Overall Study||0
10999169|NCT00690755|12176320|FG000|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
10999170|NCT00690755|12176321|FG001|COMPLETED|Overall Study||0
10999171|NCT00690755|12176322|FG002|COMPLETED|Overall Study||51
10999172|NCT00690755|12176323|FG003|COMPLETED|Overall Study||15
10999173|NCT00690755|12176324|FG004|COMPLETED|Overall Study||0
10999174|NCT00690755|12176325|FG005|COMPLETED|Overall Study||6
10999175|NCT00690755|12176326|FG006|COMPLETED|Overall Study||0
10999176|NCT00690755|12176320|FG000|NOT COMPLETED|Overall Study||2
10999177|NCT00690755|12176321|FG001|NOT COMPLETED|Overall Study||0
10999178|NCT00690755|12176322|FG002|NOT COMPLETED|Overall Study||46
10999179|NCT00690755|12176323|FG003|NOT COMPLETED|Overall Study||5
10999180|NCT00690755|12176324|FG004|NOT COMPLETED|Overall Study||0
10999181|NCT00690755|12176325|FG005|NOT COMPLETED|Overall Study||4
10999182|NCT00690755|12176326|FG006|NOT COMPLETED|Overall Study||0
10999183|NCT00690794|12176344|FG000|STARTED|Overall Study||363
10999184|NCT00690794|12176345|FG001|STARTED|Overall Study||363
10999185|NCT00690794|12176344|FG000|COMPLETED|Overall Study||342
10999186|NCT00690794|12176345|FG001|COMPLETED|Overall Study||328
10999187|NCT00690794|12176344|FG000|NOT COMPLETED|Overall Study||21
10999188|NCT00690794|12176345|FG001|NOT COMPLETED|Overall Study||35
10999189|NCT00690820|12176353|FG000|STARTED|Period 1||8
10999190|NCT00690820|12176354|FG001|STARTED|Period 1||9
10999191|NCT00690820|12176353|FG000|COMPLETED|Period 1||8
10999192|NCT00690820|12176354|FG001|COMPLETED|Period 1||8
10999193|NCT00690820|12176353|FG000|NOT COMPLETED|Period 1||0
10999194|NCT00690820|12176354|FG001|NOT COMPLETED|Period 1||1
10999195|NCT00690820|12176353|FG000|STARTED|Period 2||8
10999196|NCT00690820|12176354|FG001|STARTED|Period 2||8
10999197|NCT00690820|12176353|FG000|COMPLETED|Period 2||8
10999198|NCT00690820|12176354|FG001|COMPLETED|Period 2||8
10999199|NCT00690820|12176353|FG000|NOT COMPLETED|Period 2||0
10999200|NCT00690820|12176354|FG001|NOT COMPLETED|Period 2||0
10999201|NCT00690833|12176360|FG000|STARTED|Overall Study||41
10999202|NCT00690833|12176360|FG000|COMPLETED|Overall Study||39
10999203|NCT00690833|12176360|FG000|NOT COMPLETED|Overall Study||2
10999204|NCT00690898|12176364|FG000|STARTED|SCREENING|Total of patients screened for the study.|108
10999205|NCT00690898|12176364|FG000|COMPLETED|SCREENING|Number of patients included in the study.|90
10999206|NCT00690898|12176364|FG000|NOT COMPLETED|SCREENING||18
10999207|NCT00690898|12176364|FG000|STARTED|TREATMENT|Total number of patients treated.|90
10999208|NCT00690898|12176364|FG000|COMPLETED|TREATMENT||64
10999209|NCT00690898|12176364|FG000|NOT COMPLETED|TREATMENT||26
10999210|NCT00690924|12176368|FG000|STARTED|Overall Study||16
10999211|NCT00690924|12176368|FG000|COMPLETED|Overall Study||16
10999212|NCT00690924|12176368|FG000|NOT COMPLETED|Overall Study||0
10999213|NCT00691002|12176376|FG000|STARTED|8-week, Double-blind, 4-arm||353
10999214|NCT00691002|12176377|FG001|STARTED|8-week, Double-blind, 4-arm||342
10999215|NCT00691002|12176378|FG002|STARTED|8-week, Double-blind, 4-arm||363
10999216|NCT00691002|12176379|FG003|STARTED|8-week, Double-blind, 4-arm||181
10999217|NCT00691002|12176380|FG004|STARTED|8-week, Double-blind, 4-arm||0
10999218|NCT00691002|12176376|FG000|COMPLETED|8-week, Double-blind, 4-arm||325
10999219|NCT00691002|12176377|FG001|COMPLETED|8-week, Double-blind, 4-arm||308
10999220|NCT00691002|12176378|FG002|COMPLETED|8-week, Double-blind, 4-arm||340
10999221|NCT00691002|12176379|FG003|COMPLETED|8-week, Double-blind, 4-arm||169
10999222|NCT00691002|12176380|FG004|COMPLETED|8-week, Double-blind, 4-arm||0
10999223|NCT00691002|12176376|FG000|NOT COMPLETED|8-week, Double-blind, 4-arm||28
10999224|NCT00691002|12176377|FG001|NOT COMPLETED|8-week, Double-blind, 4-arm||34
10999225|NCT00691002|12176378|FG002|NOT COMPLETED|8-week, Double-blind, 4-arm||23
10999226|NCT00691002|12176379|FG003|NOT COMPLETED|8-week, Double-blind, 4-arm||12
10999227|NCT00691002|12176380|FG004|NOT COMPLETED|8-week, Double-blind, 4-arm||0
10999228|NCT00691002|12176376|FG000|STARTED|52-week, Open-label, Single Arm||454
10999229|NCT00691002|12176377|FG001|STARTED|52-week, Open-label, Single Arm||0
10999230|NCT00691002|12176378|FG002|STARTED|52-week, Open-label, Single Arm||0
10999231|NCT00691002|12176379|FG003|STARTED|52-week, Open-label, Single Arm||0
10999232|NCT00691002|12176380|FG004|STARTED|52-week, Open-label, Single Arm||0
10999233|NCT00691002|12176376|FG000|COMPLETED|52-week, Open-label, Single Arm||403
10999234|NCT00691002|12176377|FG001|COMPLETED|52-week, Open-label, Single Arm||0
10999235|NCT00691002|12176378|FG002|COMPLETED|52-week, Open-label, Single Arm||0
10999236|NCT00691002|12176379|FG003|COMPLETED|52-week, Open-label, Single Arm||0
10999237|NCT00691002|12176380|FG004|COMPLETED|52-week, Open-label, Single Arm||0
10999238|NCT00691002|12176376|FG000|NOT COMPLETED|52-week, Open-label, Single Arm||51
10999239|NCT00691002|12176377|FG001|NOT COMPLETED|52-week, Open-label, Single Arm||0
10999240|NCT00691002|12176378|FG002|NOT COMPLETED|52-week, Open-label, Single Arm||0
10999241|NCT00691002|12176379|FG003|NOT COMPLETED|52-week, Open-label, Single Arm||0
10999242|NCT00691002|12176380|FG004|NOT COMPLETED|52-week, Open-label, Single Arm||0
10999243|NCT00691015|12176391|FG000|STARTED|Overall Study||48
10999244|NCT00691015|12176391|FG000|COMPLETED|Overall Study||47
10999245|NCT00691015|12176391|FG000|NOT COMPLETED|Overall Study||1
10999246|NCT00691028|12176398|FG000|STARTED|Open-label Period||0
10999247|NCT00691028|12176399|FG001|STARTED|Open-label Period||0
10999248|NCT00691028|12176400|FG002|STARTED|Open-label Period||0
10999249|NCT00691028|12176401|FG003|STARTED|Open-label Period||327
10999250|NCT00691028|12176398|FG000|COMPLETED|Open-label Period||0
10999251|NCT00691028|12176399|FG001|COMPLETED|Open-label Period||0
10999252|NCT00691028|12176400|FG002|COMPLETED|Open-label Period||0
10999253|NCT00691028|12176401|FG003|COMPLETED|Open-label Period||307
10999254|NCT00691028|12176398|FG000|NOT COMPLETED|Open-label Period||0
10999255|NCT00691028|12176399|FG001|NOT COMPLETED|Open-label Period||0
10999256|NCT00691028|12176400|FG002|NOT COMPLETED|Open-label Period||0
10999257|NCT00691028|12176401|FG003|NOT COMPLETED|Open-label Period||20
10999258|NCT00691028|12176398|FG000|STARTED|Double-blind Period||99
10999259|NCT00691028|12176399|FG001|STARTED|Double-blind Period||104
10999260|NCT00691028|12176400|FG002|STARTED|Double-blind Period||104
10999261|NCT00691028|12176401|FG003|STARTED|Double-blind Period||0
10999262|NCT00691028|12176398|FG000|COMPLETED|Double-blind Period||86
10999263|NCT00691028|12176399|FG001|COMPLETED|Double-blind Period||91
10999264|NCT00691028|12176400|FG002|COMPLETED|Double-blind Period||95
10999265|NCT00691028|12176401|FG003|COMPLETED|Double-blind Period||0
10999266|NCT00691028|12176398|FG000|NOT COMPLETED|Double-blind Period||13
10999267|NCT00691028|12176399|FG001|NOT COMPLETED|Double-blind Period||13
10999268|NCT00691028|12176400|FG002|NOT COMPLETED|Double-blind Period||9
10999269|NCT00691028|12176401|FG003|NOT COMPLETED|Double-blind Period||0
10999270|NCT00691054|12176413|FG000|STARTED|Overall Study||20
10999271|NCT00691054|12176413|FG000|COMPLETED|Overall Study||19
10999272|NCT00691054|12176413|FG000|NOT COMPLETED|Overall Study||1
10999273|NCT00691093|12176419|FG000|STARTED|Overall Study||823
10999274|NCT00691093|12176419|FG000|COMPLETED|Overall Study||816
10999275|NCT00691093|12176419|FG000|NOT COMPLETED|Overall Study||7
10999276|NCT00691132|12176430|FG000|STARTED|Overall Study||53
10999277|NCT00691132|12176431|FG001|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
10999278|NCT00691132|12176430|FG000|COMPLETED|Overall Study||41
10999279|NCT00691132|12176431|FG001|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
10999280|NCT00691132|12176430|FG000|NOT COMPLETED|Overall Study||12
10999281|NCT00691132|12176431|FG001|NOT COMPLETED|Overall Study||13
10999282|NCT00691197|12176449|FG000|STARTED|Overall Study||166
10999283|NCT00691197|12176450|FG001|STARTED|Overall Study||80
10999284|NCT00691197|12176449|FG000|COMPLETED|Overall Study||155
10999285|NCT00691197|12176450|FG001|COMPLETED|Overall Study||75
10999286|NCT00691197|12176449|FG000|NOT COMPLETED|Overall Study||11
10999287|NCT00691197|12176450|FG001|NOT COMPLETED|Overall Study||5
10999288|NCT00691210|12176464|FG000|STARTED|Overall Study||3
10999289|NCT00691210|12176465|FG001|STARTED|Overall Study||5
10999290|NCT00691210|12176466|FG002|STARTED|Overall Study||3
10999291|NCT00691210|12176467|FG003|STARTED|Overall Study||9
10999292|NCT00691210|12176468|FG004|STARTED|Overall Study||5
10999293|NCT00691210|12176469|FG005|STARTED|Overall Study||7
10999294|NCT00691210|12176470|FG006|STARTED|Overall Study||6
10999295|NCT00691210|12176471|FG007|STARTED|Overall Study||0
10999296|NCT00691210|12176464|FG000|COMPLETED|Overall Study||3
10999297|NCT00691210|12176465|FG001|COMPLETED|Overall Study||5
10999298|NCT00691210|12176466|FG002|COMPLETED|Overall Study||3
10999299|NCT00691210|12176467|FG003|COMPLETED|Overall Study||6
10999300|NCT00691210|12176468|FG004|COMPLETED|Overall Study||5
10999301|NCT00691210|12176469|FG005|COMPLETED|Overall Study||6
10999302|NCT00691210|12176470|FG006|COMPLETED|Overall Study||6
10999303|NCT00691210|12176471|FG007|COMPLETED|Overall Study||0
10999304|NCT00691210|12176464|FG000|NOT COMPLETED|Overall Study||0
10999305|NCT00691210|12176465|FG001|NOT COMPLETED|Overall Study||0
10999306|NCT00691210|12176466|FG002|NOT COMPLETED|Overall Study||0
10999307|NCT00691210|12176467|FG003|NOT COMPLETED|Overall Study||3
10999308|NCT00691210|12176468|FG004|NOT COMPLETED|Overall Study||0
10999309|NCT00691210|12176469|FG005|NOT COMPLETED|Overall Study||1
10999310|NCT00691210|12176470|FG006|NOT COMPLETED|Overall Study||0
10999311|NCT00691210|12176471|FG007|NOT COMPLETED|Overall Study||0
10999312|NCT00691301|12176489|FG000|STARTED|Overall Study||55
10999313|NCT00691301|12176489|FG000|COMPLETED|Overall Study||1
10999314|NCT00691301|12176489|FG000|NOT COMPLETED|Overall Study||54
10999315|NCT00691327|12176501|FG000|STARTED|Overall Study||45055
10999316|NCT00691327|12176502|FG001|STARTED|Overall Study||39274
10999317|NCT00691327|12176501|FG000|COMPLETED|Overall Study||42214
10999318|NCT00691327|12176502|FG001|COMPLETED|Overall Study||36766
10999319|NCT00691327|12176501|FG000|NOT COMPLETED|Overall Study||2841
10999320|NCT00691327|12176502|FG001|NOT COMPLETED|Overall Study||2508
10999321|NCT00691483|12176510|FG000|STARTED|Overall Study||493
10999322|NCT00691483|12176511|FG001|STARTED|Overall Study||166
10999323|NCT00691483|12176510|FG000|Received Treatment|Overall Study||486
10999324|NCT00691483|12176511|FG001|Received Treatment|Overall Study||165
10999325|NCT00691483|12176510|FG000|COMPLETED|Overall Study|Completed refers to completion of the study.|425
10999326|NCT00691483|12176511|FG001|COMPLETED|Overall Study||141
10999327|NCT00691483|12176510|FG000|NOT COMPLETED|Overall Study||68
10999328|NCT00691483|12176511|FG001|NOT COMPLETED|Overall Study||25
10999329|NCT00691600|12176519|FG000|STARTED|Overall Study||12
10999330|NCT00691600|12176520|FG001|STARTED|Overall Study||11
10999331|NCT00691600|12176519|FG000|COMPLETED|Overall Study||12
10999332|NCT00691600|12176520|FG001|COMPLETED|Overall Study||11
10999333|NCT00691600|12176519|FG000|NOT COMPLETED|Overall Study||0
10999334|NCT00691600|12176520|FG001|NOT COMPLETED|Overall Study||0
10999335|NCT00691665|12176528|FG000|STARTED|Overall Study||65
10999336|NCT00691665|12176529|FG001|STARTED|Overall Study||65
10999337|NCT00691665|12176528|FG000|COMPLETED|Overall Study||65
10999338|NCT00691665|12176529|FG001|COMPLETED|Overall Study||65
10999339|NCT00691665|12176528|FG000|NOT COMPLETED|Overall Study||0
10999340|NCT00691665|12176529|FG001|NOT COMPLETED|Overall Study||0
10999341|NCT00691704|12176535|FG000|STARTED|Induction Therapy||18
10999342|NCT00691704|12176535|FG000|COMPLETED|Induction Therapy||16
10999343|NCT00691704|12176535|FG000|NOT COMPLETED|Induction Therapy||2
10999344|NCT00691704|12176535|FG000|STARTED|Two Years of Maintenance Therapy||16
10999345|NCT00691704|12176535|FG000|COMPLETED|Two Years of Maintenance Therapy||3
10999346|NCT00691704|12176535|FG000|NOT COMPLETED|Two Years of Maintenance Therapy||13
10999347|NCT00691808|12176542|FG000|STARTED|Overall Study||35
10999348|NCT00691808|12176543|FG001|STARTED|Overall Study||36
10999349|NCT00691808|12176544|FG002|STARTED|Overall Study||32
10999350|NCT00691808|12176542|FG000|COMPLETED|Overall Study||35
10999351|NCT00691808|12176543|FG001|COMPLETED|Overall Study||35
10999352|NCT00691808|12176544|FG002|COMPLETED|Overall Study||32
10999353|NCT00691808|12176542|FG000|NOT COMPLETED|Overall Study||0
10999354|NCT00691808|12176543|FG001|NOT COMPLETED|Overall Study||1
10999355|NCT00691808|12176544|FG002|NOT COMPLETED|Overall Study||0
10999356|NCT00691938|12176559|FG000|STARTED|Overall Study||5
10999357|NCT00691938|12176560|FG001|STARTED|Overall Study||3
10999358|NCT00691938|12176561|FG002|STARTED|Overall Study||6
10999359|NCT00691938|12176562|FG003|STARTED|Overall Study||8
10999360|NCT00691938|12176563|FG004|STARTED|Overall Study||10
10999361|NCT00691938|12176564|FG005|STARTED|Overall Study||6
10999362|NCT00691938|12176565|FG006|STARTED|Overall Study||14
10999363|NCT00691938|12176559|FG000|COMPLETED|Overall Study||4
10999364|NCT00691938|12176560|FG001|COMPLETED|Overall Study||3
10999365|NCT00691938|12176561|FG002|COMPLETED|Overall Study||6
10999366|NCT00691938|12176562|FG003|COMPLETED|Overall Study||8
10999367|NCT00691938|12176563|FG004|COMPLETED|Overall Study||10
10999368|NCT00691938|12176564|FG005|COMPLETED|Overall Study||6
10999369|NCT00691938|12176565|FG006|COMPLETED|Overall Study||14
10999370|NCT00691938|12176559|FG000|NOT COMPLETED|Overall Study||1
10999371|NCT00691938|12176560|FG001|NOT COMPLETED|Overall Study||0
10999372|NCT00691938|12176561|FG002|NOT COMPLETED|Overall Study||0
10999373|NCT00691938|12176562|FG003|NOT COMPLETED|Overall Study||0
10999374|NCT00691938|12176563|FG004|NOT COMPLETED|Overall Study||0
10999375|NCT00691938|12176564|FG005|NOT COMPLETED|Overall Study||0
10999376|NCT00691938|12176565|FG006|NOT COMPLETED|Overall Study||0
10999377|NCT00692185|12176578|FG000|STARTED|Overall Study||11
10999378|NCT00692185|12176579|FG001|STARTED|Overall Study||12
10999379|NCT00692185|12176578|FG000|COMPLETED|Overall Study||8
10999380|NCT00692185|12176579|FG001|COMPLETED|Overall Study||9
10999381|NCT00692185|12176578|FG000|NOT COMPLETED|Overall Study||3
10999382|NCT00692185|12176579|FG001|NOT COMPLETED|Overall Study||3
10999383|NCT00692198|12176589|FG000|STARTED|Overall Study||368
10999384|NCT00692198|12176590|FG001|STARTED|Overall Study||370
10999385|NCT00692198|12176589|FG000|COMPLETED|Overall Study||368
10999386|NCT00692198|12176590|FG001|COMPLETED|Overall Study||370
10999387|NCT00692198|12176589|FG000|NOT COMPLETED|Overall Study||0
10999388|NCT00692198|12176590|FG001|NOT COMPLETED|Overall Study||0
10999389|NCT00692211|12176599|FG000|STARTED|Overall Study||202
10999390|NCT00692211|12176600|FG001|STARTED|Overall Study||202
10999391|NCT00692211|12176599|FG000|COMPLETED|Overall Study||202
10999392|NCT00692211|12176600|FG001|COMPLETED|Overall Study||202
10999393|NCT00692211|12176599|FG000|NOT COMPLETED|Overall Study||0
10999394|NCT00692211|12176600|FG001|NOT COMPLETED|Overall Study||0
10999395|NCT00692237|12176608|FG000|STARTED|Overall Study||30
10999396|NCT00692237|12176609|FG001|STARTED|Overall Study||29
10999397|NCT00692237|12176608|FG000|COMPLETED|Overall Study||29
10999398|NCT00692237|12176609|FG001|COMPLETED|Overall Study||25
10999399|NCT00692237|12176608|FG000|NOT COMPLETED|Overall Study||1
10999400|NCT00692237|12176609|FG001|NOT COMPLETED|Overall Study||4
10999401|NCT00692276|12176617|FG000|STARTED|Randomized Population||190
10999402|NCT00692276|12176618|FG001|STARTED|Randomized Population||201
10999403|NCT00692276|12176617|FG000|COMPLETED|Randomized Population||190
10999404|NCT00692276|12176618|FG001|COMPLETED|Randomized Population||201
10999405|NCT00692276|12176617|FG000|NOT COMPLETED|Randomized Population||0
10999406|NCT00692276|12176618|FG001|NOT COMPLETED|Randomized Population||0
10999407|NCT00692276|12176617|FG000|STARTED|Completed 24 Months||190
10999408|NCT00692276|12176618|FG001|STARTED|Completed 24 Months||201
10999409|NCT00692276|12176617|FG000|COMPLETED|Completed 24 Months||183
10999410|NCT00692276|12176618|FG001|COMPLETED|Completed 24 Months||187
10999411|NCT00692276|12176617|FG000|NOT COMPLETED|Completed 24 Months||7
10999412|NCT00692276|12176618|FG001|NOT COMPLETED|Completed 24 Months||14
10999413|NCT00692341|12176627|FG000|STARTED|Overall Study||8
10999414|NCT00692341|12176628|FG001|STARTED|Overall Study||8
10999415|NCT00692341|12176629|FG002|STARTED|Overall Study||8
10999416|NCT00692341|12176627|FG000|COMPLETED|Overall Study||8
10999417|NCT00692341|12176628|FG001|COMPLETED|Overall Study||8
10999418|NCT00692341|12176629|FG002|COMPLETED|Overall Study||8
10999419|NCT00692341|12176627|FG000|NOT COMPLETED|Overall Study||0
10999420|NCT00692341|12176628|FG001|NOT COMPLETED|Overall Study||0
10999421|NCT00692341|12176629|FG002|NOT COMPLETED|Overall Study||0
10999422|NCT00692406|12176637|FG000|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
10999423|NCT00692406|12176637|FG000|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
10999424|NCT00692406|12176637|FG000|NOT COMPLETED|Overall Study||57
10999425|NCT00692419|12176643|FG000|STARTED|Overall Study||100
10999426|NCT00692419|12176644|FG001|STARTED|Overall Study||120
10999427|NCT00692419|12176643|FG000|COMPLETED|Overall Study||84
10999428|NCT00692419|12176644|FG001|COMPLETED|Overall Study||102
10999429|NCT00692419|12176643|FG000|NOT COMPLETED|Overall Study||16
10999430|NCT00692419|12176644|FG001|NOT COMPLETED|Overall Study||18
10999431|NCT00692692|12176654|FG000|STARTED|Overall Study||20
10999432|NCT00692692|12176655|FG001|STARTED|Overall Study||16
10999433|NCT00692692|12176654|FG000|COMPLETED|Overall Study||20
10999434|NCT00692692|12176655|FG001|COMPLETED|Overall Study||16
10999435|NCT00692692|12176654|FG000|NOT COMPLETED|Overall Study||0
10999436|NCT00692692|12176655|FG001|NOT COMPLETED|Overall Study||0
10999437|NCT00692770|12176663|FG000|STARTED|Overall Study||556
10999438|NCT00692770|12176664|FG001|STARTED|Overall Study||558
10999439|NCT00692770|12176663|FG000|Participants Received Treatment|Overall Study||553
10999440|NCT00692770|12176664|FG001|Participants Received Treatment|Overall Study||554
10999441|NCT00692770|12176663|FG000|COMPLETED|Overall Study||0
10999442|NCT00692770|12176664|FG001|COMPLETED|Overall Study||0
10999443|NCT00692770|12176663|FG000|NOT COMPLETED|Overall Study||556
10999444|NCT00692770|12176664|FG001|NOT COMPLETED|Overall Study||558
10999445|NCT00692978|12176678|FG000|STARTED|FP From Active 250 ug MDI Inhaler||15
10999446|NCT00692978|12176679|FG001|STARTED|FP From Active 250 ug MDI Inhaler||15
10999447|NCT00692978|12176678|FG000|COMPLETED|FP From Active 250 ug MDI Inhaler||15
10999448|NCT00692978|12176679|FG001|COMPLETED|FP From Active 250 ug MDI Inhaler||15
10999449|NCT00692978|12176678|FG000|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
10999450|NCT00692978|12176679|FG001|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
10999451|NCT00692978|12176678|FG000|STARTED|FP1.5 Microns Size With MDI Inhaler||15
10999452|NCT00692978|12176679|FG001|STARTED|FP1.5 Microns Size With MDI Inhaler||15
10999453|NCT00692978|12176678|FG000|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
10999454|NCT00692978|12176679|FG001|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
10999455|NCT00692978|12176678|FG000|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
10999456|NCT00692978|12176679|FG001|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
10999457|NCT00692978|12176678|FG000|STARTED|FP 3 Microns Size With MDI Inhaler||15
10999458|NCT00692978|12176679|FG001|STARTED|FP 3 Microns Size With MDI Inhaler||15
10999459|NCT00692978|12176678|FG000|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
10999460|NCT00692978|12176679|FG001|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
10999461|NCT00692978|12176678|FG000|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
10999462|NCT00692978|12176679|FG001|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
10999463|NCT00692978|12176678|FG000|STARTED|FP 6 Microns Size With MDI Inhaler||15
10999464|NCT00692978|12176679|FG001|STARTED|FP 6 Microns Size With MDI Inhaler||15
10999465|NCT00692978|12176678|FG000|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
10999466|NCT00692978|12176679|FG001|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
10999467|NCT00692978|12176678|FG000|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
10999468|NCT00692978|12176679|FG001|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
10999469|NCT00693160|12176699|FG000|STARTED|Overall Study||14
10999470|NCT00693160|12176700|FG001|STARTED|Overall Study||16
10999471|NCT00693160|12176699|FG000|COMPLETED|Overall Study||14
10999472|NCT00693160|12176700|FG001|COMPLETED|Overall Study||16
10999473|NCT00693160|12176699|FG000|NOT COMPLETED|Overall Study||0
10999474|NCT00693160|12176700|FG001|NOT COMPLETED|Overall Study||0
10999475|NCT00693225|12176708|FG000|STARTED|Overall Study||43
10999476|NCT00693225|12176709|FG001|STARTED|Overall Study||48
10999477|NCT00693225|12176708|FG000|COMPLETED|Overall Study||41
10999478|NCT00693225|12176709|FG001|COMPLETED|Overall Study||43
10999479|NCT00693225|12176708|FG000|NOT COMPLETED|Overall Study||2
10999480|NCT00693225|12176709|FG001|NOT COMPLETED|Overall Study||5
10999481|NCT00693303|12176715|FG000|STARTED|Overall Study||21
10999482|NCT00693303|12176715|FG000|COMPLETED|Overall Study||21
10999483|NCT00693303|12176715|FG000|NOT COMPLETED|Overall Study||0
10999484|NCT00693420|12176721|FG000|STARTED|Overall Study||137
10999485|NCT00693420|12176722|FG001|STARTED|Overall Study||141
10999486|NCT00693420|12176721|FG000|COMPLETED|Overall Study||131
10999487|NCT00693420|12176722|FG001|COMPLETED|Overall Study||126
10999488|NCT00693420|12176721|FG000|NOT COMPLETED|Overall Study||6
10999489|NCT00693420|12176722|FG001|NOT COMPLETED|Overall Study||15
10999490|NCT00693472|12176732|FG000|STARTED|Part 1||19
10999491|NCT00693472|12176733|FG001|STARTED|Part 1||13
10999492|NCT00693472|12176734|FG002|STARTED|Part 1||0
10999493|NCT00693472|12176735|FG003|STARTED|Part 1||0
10999494|NCT00693472|12176732|FG000|COMPLETED|Part 1||13
10999495|NCT00693472|12176733|FG001|COMPLETED|Part 1||9
10999496|NCT00693472|12176734|FG002|COMPLETED|Part 1||0
10999497|NCT00693472|12176735|FG003|COMPLETED|Part 1||0
10999498|NCT00693472|12176732|FG000|NOT COMPLETED|Part 1||6
10999499|NCT00693472|12176733|FG001|NOT COMPLETED|Part 1||4
10999500|NCT00693472|12176734|FG002|NOT COMPLETED|Part 1||0
10999501|NCT00693472|12176735|FG003|NOT COMPLETED|Part 1||0
10999502|NCT00693472|12176732|FG000|STARTED|Part 2||0
10999503|NCT00693472|12176733|FG001|STARTED|Part 2||0
10999504|NCT00693472|12176734|FG002|STARTED|Part 2||8
10999505|NCT00693472|12176735|FG003|STARTED|Part 2||6
10999506|NCT00693472|12176732|FG000|COMPLETED|Part 2||0
10999507|NCT00693472|12176733|FG001|COMPLETED|Part 2||0
10999508|NCT00693472|12176734|FG002|COMPLETED|Part 2||6
10999509|NCT00693472|12176735|FG003|COMPLETED|Part 2||4
10999510|NCT00693472|12176732|FG000|NOT COMPLETED|Part 2||0
10999511|NCT00693472|12176733|FG001|NOT COMPLETED|Part 2||0
10999512|NCT00693472|12176734|FG002|NOT COMPLETED|Part 2||2
10999513|NCT00693472|12176735|FG003|NOT COMPLETED|Part 2||2
10999514|NCT00693485|12176748|FG000|STARTED|Overall Study||25
10999515|NCT00693485|12176749|FG001|STARTED|Overall Study||21
10999516|NCT00693485|12176750|FG002|STARTED|Overall Study||24
10999517|NCT00693485|12176748|FG000|COMPLETED|Overall Study||25
10999518|NCT00693485|12176749|FG001|COMPLETED|Overall Study||19
10999519|NCT00693485|12176750|FG002|COMPLETED|Overall Study||24
10999520|NCT00693485|12176748|FG000|NOT COMPLETED|Overall Study||0
10999521|NCT00693485|12176749|FG001|NOT COMPLETED|Overall Study||2
10999522|NCT00693485|12176750|FG002|NOT COMPLETED|Overall Study||0
10999523|NCT00693498|12176760|FG000|STARTED|Overall Study||81
10999524|NCT00693498|12176761|FG001|STARTED|Overall Study||81
10999525|NCT00693498|12176760|FG000|COMPLETED|Overall Study||81
10999526|NCT00693498|12176761|FG001|COMPLETED|Overall Study||81
10999527|NCT00693498|12176760|FG000|NOT COMPLETED|Overall Study||0
10999528|NCT00693498|12176761|FG001|NOT COMPLETED|Overall Study||0
10999529|NCT00693654|12176769|FG000|STARTED|Overall Study||14
10999530|NCT00693654|12176770|FG001|STARTED|Overall Study||14
10999531|NCT00693654|12176769|FG000|COMPLETED|Overall Study||14
10999532|NCT00693654|12176770|FG001|COMPLETED|Overall Study||14
10999533|NCT00693654|12176769|FG000|NOT COMPLETED|Overall Study||0
10999534|NCT00693654|12176770|FG001|NOT COMPLETED|Overall Study||0
10999535|NCT00693693|12176780|FG000|STARTED|Overall Study||7
10999536|NCT00693693|12176781|FG001|STARTED|Overall Study||9
10999537|NCT00693693|12176782|FG002|STARTED|Overall Study||9
10999538|NCT00693693|12176780|FG000|COMPLETED|Overall Study||6
10999539|NCT00693693|12176781|FG001|COMPLETED|Overall Study||8
10999540|NCT00693693|12176782|FG002|COMPLETED|Overall Study||7
10999541|NCT00693693|12176780|FG000|NOT COMPLETED|Overall Study||1
10999542|NCT00693693|12176781|FG001|NOT COMPLETED|Overall Study||1
10999543|NCT00693693|12176782|FG002|NOT COMPLETED|Overall Study||2
10999544|NCT00693706|12176792|FG000|STARTED|Overall Study||101
10999545|NCT00693706|12176793|FG001|STARTED|Overall Study||99
10999546|NCT00693706|12176792|FG000|COMPLETED|Overall Study||101
10999547|NCT00693706|12176793|FG001|COMPLETED|Overall Study||98
10999548|NCT00693706|12176792|FG000|NOT COMPLETED|Overall Study||0
10999549|NCT00693706|12176793|FG001|NOT COMPLETED|Overall Study||1
10999550|NCT00693719|12176799|FG000|STARTED|Overall Study||31
10999551|NCT00693719|12176799|FG000|COMPLETED|Overall Study||31
10999552|NCT00693719|12176799|FG000|NOT COMPLETED|Overall Study||0
10999553|NCT00693784|12176803|FG000|STARTED|Overall Study||15
10999554|NCT00693784|12176803|FG000|26-Week Primary Endpoint|Overall Study||15
10999555|NCT00693784|12176803|FG000|52-week Extended Follow-up|Overall Study||13
10999556|NCT00693784|12176803|FG000|104-week Extended Follow-up|Overall Study||11
10999557|NCT00693784|12176803|FG000|COMPLETED|Overall Study||11
10999558|NCT00693784|12176803|FG000|NOT COMPLETED|Overall Study||4
10999559|NCT00693992|12176809|FG000|STARTED|Overall Study||106
10999560|NCT00693992|12176810|FG001|STARTED|Overall Study||104
10999561|NCT00693992|12176809|FG000|COMPLETED|Overall Study||106
10999562|NCT00693992|12176810|FG001|COMPLETED|Overall Study||104
10999563|NCT00693992|12176809|FG000|NOT COMPLETED|Overall Study||0
10999564|NCT00693992|12176810|FG001|NOT COMPLETED|Overall Study||0
10999565|NCT00694018|12176818|FG000|STARTED|Overall Study||118
10999566|NCT00694018|12176819|FG001|STARTED|Overall Study||111
10999567|NCT00694018|12176818|FG000|6 Months|Overall Study||106
10999568|NCT00694018|12176819|FG001|6 Months|Overall Study||101
10999569|NCT00694018|12176818|FG000|COMPLETED|Overall Study||105
10999570|NCT00694018|12176819|FG001|COMPLETED|Overall Study||102
10999571|NCT00694018|12176818|FG000|NOT COMPLETED|Overall Study||13
10999572|NCT00694018|12176819|FG001|NOT COMPLETED|Overall Study||9
10999573|NCT00694070|12176825|FG000|STARTED|Overall Study||51
10999574|NCT00694070|12176825|FG000|COMPLETED|Overall Study||51
10999575|NCT00694070|12176825|FG000|NOT COMPLETED|Overall Study||0
10999576|NCT00694096|12176829|FG000|STARTED|Overall Study||25
10999577|NCT00694096|12176829|FG000|COMPLETED|Overall Study||20
10999578|NCT00694096|12176829|FG000|NOT COMPLETED|Overall Study||5
10999579|NCT00694109|12176833|FG000|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
10999580|NCT00694109|12176833|FG000|Treated|Overall Study||141
10999581|NCT00694109|12176833|FG000|Consented 2 Years Additional Treatment|Overall Study||42
10999582|NCT00694109|12176833|FG000|Completed Consented Length of Treatment|Overall Study||60
10999583|NCT00694109|12176833|FG000|COMPLETED|Overall Study||25
10999584|NCT00694109|12176833|FG000|NOT COMPLETED|Overall Study||117
10999585|NCT00694122|12176838|FG000|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
10999586|NCT00694122|12176839|FG001|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
10999587|NCT00694122|12176838|FG000|COMPLETED|First Intervention (3-4 Weeks)||10
10999588|NCT00694122|12176839|FG001|COMPLETED|First Intervention (3-4 Weeks)||5
10999589|NCT00694122|12176838|FG000|NOT COMPLETED|First Intervention (3-4 Weeks)||10
10999590|NCT00694122|12176839|FG001|NOT COMPLETED|First Intervention (3-4 Weeks)||2
10999591|NCT00694122|12176838|FG000|STARTED|Washout (1 Day)||10
10999592|NCT00694122|12176839|FG001|STARTED|Washout (1 Day)||5
10999593|NCT00694122|12176838|FG000|COMPLETED|Washout (1 Day)||10
10999594|NCT00694122|12176839|FG001|COMPLETED|Washout (1 Day)||5
10999595|NCT00694122|12176838|FG000|NOT COMPLETED|Washout (1 Day)||0
10999596|NCT00694122|12176839|FG001|NOT COMPLETED|Washout (1 Day)||0
10999597|NCT00694122|12176838|FG000|STARTED|Second Intervention (3-4 Weeks)||10
10999598|NCT00694122|12176839|FG001|STARTED|Second Intervention (3-4 Weeks)||5
10999599|NCT00694122|12176838|FG000|COMPLETED|Second Intervention (3-4 Weeks)||10
10999600|NCT00694122|12176839|FG001|COMPLETED|Second Intervention (3-4 Weeks)||5
10999601|NCT00694122|12176838|FG000|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
10999602|NCT00694122|12176839|FG001|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
10999603|NCT00694161|12176850|FG000|STARTED|Part 1 (up to Week 6)||35
10999604|NCT00694161|12176850|FG000|COMPLETED|Part 1 (up to Week 6)||35
10999605|NCT00694161|12176850|FG000|NOT COMPLETED|Part 1 (up to Week 6)||0
10999606|NCT00694161|12176850|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||35
10999607|NCT00694161|12176850|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
10999608|NCT00694161|12176850|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
10999609|NCT00694304|12176854|FG000|STARTED|Overall Study||535
10999610|NCT00694304|12176854|FG000|COMPLETED|Overall Study||328
10999611|NCT00694304|12176854|FG000|NOT COMPLETED|Overall Study||207
10999612|NCT00694356|12176861|FG000|STARTED|Overall Study||3
10999613|NCT00694356|12176862|FG001|STARTED|Overall Study||6
10999614|NCT00694356|12176863|FG002|STARTED|Overall Study||6
10999615|NCT00694356|12176861|FG000|COMPLETED|Overall Study||0
10999616|NCT00694356|12176862|FG001|COMPLETED|Overall Study||0
10999617|NCT00694356|12176863|FG002|COMPLETED|Overall Study||0
10999618|NCT00694356|12176861|FG000|NOT COMPLETED|Overall Study||3
10999619|NCT00694356|12176862|FG001|NOT COMPLETED|Overall Study||6
10999620|NCT00694356|12176863|FG002|NOT COMPLETED|Overall Study||6
10999621|NCT00694473|12176871|FG000|STARTED|Overall Study|Aug 2008|76
10999622|NCT00694473|12176871|FG000|COMPLETED|Overall Study|Dec 2010|69
10999623|NCT00694473|12176871|FG000|NOT COMPLETED|Overall Study||7
10999624|NCT00694551|12176878|FG000|STARTED|Overall Study||10
10999625|NCT00694551|12176879|FG001|STARTED|Overall Study||10
10999626|NCT00694551|12176880|FG002|STARTED|Overall Study||9
10999627|NCT00694551|12176878|FG000|COMPLETED|Overall Study||9
10999628|NCT00694551|12176879|FG001|COMPLETED|Overall Study||10
10999629|NCT00694551|12176880|FG002|COMPLETED|Overall Study||8
10999630|NCT00694551|12176878|FG000|NOT COMPLETED|Overall Study||1
10999631|NCT00694551|12176879|FG001|NOT COMPLETED|Overall Study||0
10999632|NCT00694551|12176880|FG002|NOT COMPLETED|Overall Study||1
10999633|NCT00694564|12176889|FG000|STARTED|Overall Study||8
10999634|NCT00694564|12176889|FG000|COMPLETED|Overall Study||6
10999635|NCT00694564|12176889|FG000|NOT COMPLETED|Overall Study||2
10999636|NCT00694603|12176893|FG000|STARTED|Overall Study||18
10999637|NCT00694603|12176893|FG000|COMPLETED|Overall Study||18
10999638|NCT00694603|12176893|FG000|NOT COMPLETED|Overall Study||0
10999639|NCT00694707|12176902|FG000|STARTED|Overall Study||151
10999640|NCT00694707|12176903|FG001|STARTED|Overall Study||145
10999641|NCT00694707|12176904|FG002|STARTED|Overall Study||147
10999642|NCT00694707|12176905|FG003|STARTED|Overall Study||148
10999643|NCT00694707|12176906|FG004|STARTED|Overall Study||141
10999644|NCT00694707|12176902|FG000|COMPLETED|Overall Study||79
10999645|NCT00694707|12176903|FG001|COMPLETED|Overall Study||90
10999646|NCT00694707|12176904|FG002|COMPLETED|Overall Study||96
10999647|NCT00694707|12176905|FG003|COMPLETED|Overall Study||98
10999648|NCT00694707|12176906|FG004|COMPLETED|Overall Study||101
10999649|NCT00694707|12176902|FG000|NOT COMPLETED|Overall Study||72
10999650|NCT00694707|12176903|FG001|NOT COMPLETED|Overall Study||55
10999651|NCT00694707|12176904|FG002|NOT COMPLETED|Overall Study||51
10999652|NCT00694707|12176905|FG003|NOT COMPLETED|Overall Study||50
10999653|NCT00694707|12176906|FG004|NOT COMPLETED|Overall Study||40
10999654|NCT00695019|12176921|FG000|STARTED|Overall Study||59
10999655|NCT00695019|12176922|FG001|STARTED|Overall Study||53
10999656|NCT00695019|12176923|FG002|STARTED|Overall Study||57
10999657|NCT00695019|12176921|FG000|COMPLETED|Overall Study||46
10999658|NCT00695019|12176922|FG001|COMPLETED|Overall Study||39
10999659|NCT00695019|12176923|FG002|COMPLETED|Overall Study||47
10999660|NCT00695019|12176921|FG000|NOT COMPLETED|Overall Study||13
10999661|NCT00695019|12176922|FG001|NOT COMPLETED|Overall Study||14
10999662|NCT00695019|12176923|FG002|NOT COMPLETED|Overall Study||10
10999663|NCT00695097|12176933|FG000|STARTED|Overall Study||10
10999664|NCT00695097|12176934|FG001|STARTED|Overall Study||5
10999665|NCT00695097|12176933|FG000|COMPLETED|Overall Study||9
10999666|NCT00695097|12176934|FG001|COMPLETED|Overall Study||5
10999667|NCT00695097|12176933|FG000|NOT COMPLETED|Overall Study||1
10999668|NCT00695097|12176934|FG001|NOT COMPLETED|Overall Study||0
10999669|NCT00695110|12176940|FG000|STARTED|Treatment Period 1||29
10999670|NCT00695110|12176940|FG000|COMPLETED|Treatment Period 1||26
10999671|NCT00695110|12176940|FG000|NOT COMPLETED|Treatment Period 1||3
10999672|NCT00695110|12176940|FG000|STARTED|Treatment Period 2||26
10999673|NCT00695110|12176940|FG000|COMPLETED|Treatment Period 2||26
10999674|NCT00695110|12176940|FG000|NOT COMPLETED|Treatment Period 2||0
10999675|NCT00695110|12176940|FG000|STARTED|Treatment Period 3||26
10999676|NCT00695110|12176940|FG000|COMPLETED|Treatment Period 3||25
10999677|NCT00695110|12176940|FG000|NOT COMPLETED|Treatment Period 3||1
10999678|NCT00695110|12176940|FG000|STARTED|Treatment Period 4||25
10999679|NCT00695110|12176940|FG000|COMPLETED|Treatment Period 4||24
10999680|NCT00695110|12176940|FG000|NOT COMPLETED|Treatment Period 4||1
10999681|NCT00695136|12176947|FG000|STARTED|Overall Study|7|7
10999682|NCT00695136|12176947|FG000|COMPLETED|Overall Study||5
10999683|NCT00695136|12176947|FG000|NOT COMPLETED|Overall Study||2
10999684|NCT00695188|12176953|FG000|STARTED|Overall Study||10
10999685|NCT00695188|12176954|FG001|STARTED|Overall Study||9
10999686|NCT00695188|12176953|FG000|COMPLETED|Overall Study||10
10999687|NCT00695188|12176954|FG001|COMPLETED|Overall Study||9
10999688|NCT00695188|12176953|FG000|NOT COMPLETED|Overall Study||0
10999689|NCT00695188|12176954|FG001|NOT COMPLETED|Overall Study||0
10999690|NCT00695253|12176960|FG000|STARTED|Overall Study|75 patients were screened and a total of 49 were enrolled in the study.|49
10999691|NCT00695253|12176960|FG000|COMPLETED|Overall Study|Eighteen (18) completed the study up to the 5 year followup.|18
10999692|NCT00695253|12176960|FG000|NOT COMPLETED|Overall Study||31
10999693|NCT00695292|12176965|FG000|STARTED|Overall Study||37
10999694|NCT00695292|12176965|FG000|COMPLETED|Overall Study||37
10999695|NCT00695292|12176965|FG000|NOT COMPLETED|Overall Study||0
10999696|NCT00695318|12176971|FG000|STARTED|Overall Study||10
10999697|NCT00695318|12176972|FG001|STARTED|Overall Study||7
10999698|NCT00695318|12176971|FG000|COMPLETED|Overall Study||5
10999699|NCT00695318|12176972|FG001|COMPLETED|Overall Study||6
10999700|NCT00695318|12176971|FG000|NOT COMPLETED|Overall Study||5
10999701|NCT00695318|12176972|FG001|NOT COMPLETED|Overall Study||1
10999702|NCT00695396|12176986|FG000|STARTED|Overall Study||8
10999703|NCT00695396|12176987|FG001|STARTED|Overall Study||8
10999704|NCT00695396|12176988|FG002|STARTED|Overall Study||9
10999705|NCT00695396|12176986|FG000|COMPLETED|Overall Study||1
10999706|NCT00695396|12176987|FG001|COMPLETED|Overall Study||0
10999707|NCT00695396|12176988|FG002|COMPLETED|Overall Study||1
10999708|NCT00695396|12176986|FG000|NOT COMPLETED|Overall Study||7
10999709|NCT00695396|12176987|FG001|NOT COMPLETED|Overall Study||8
10999710|NCT00695396|12176988|FG002|NOT COMPLETED|Overall Study||8
10999711|NCT00695409|12176996|FG000|STARTED|Overall Study||122
10999712|NCT00695409|12176996|FG000|COMPLETED|Overall Study||122
10999713|NCT00695409|12176996|FG000|NOT COMPLETED|Overall Study||0
10999714|NCT00695435|12177001|FG000|STARTED|Overall Study||7
10999715|NCT00695435|12177002|FG001|STARTED|Overall Study||7
10999716|NCT00695435|12177003|FG002|STARTED|Overall Study||7
10999717|NCT00695435|12177001|FG000|COMPLETED|Overall Study||7
10999718|NCT00695435|12177002|FG001|COMPLETED|Overall Study||7
10999719|NCT00695435|12177003|FG002|COMPLETED|Overall Study||7
10999720|NCT00695435|12177001|FG000|NOT COMPLETED|Overall Study||0
10999721|NCT00695435|12177002|FG001|NOT COMPLETED|Overall Study||0
10999722|NCT00695435|12177003|FG002|NOT COMPLETED|Overall Study||0
10999723|NCT00695500|12177013|FG000|STARTED|Overall Study||24
10999724|NCT00695500|12177014|FG001|STARTED|Overall Study||22
10999725|NCT00695500|12177013|FG000|COMPLETED|Overall Study||21
10999726|NCT00695500|12177014|FG001|COMPLETED|Overall Study||17
10999727|NCT00695500|12177013|FG000|NOT COMPLETED|Overall Study||3
10999728|NCT00695500|12177014|FG001|NOT COMPLETED|Overall Study||5
10999729|NCT00695565|12177022|FG000|STARTED|Overall Study||90
10999730|NCT00695565|12177023|FG001|STARTED|Overall Study||90
10999731|NCT00695565|12177022|FG000|COMPLETED|Overall Study||77
10999732|NCT00695565|12177023|FG001|COMPLETED|Overall Study||81
10999733|NCT00695565|12177022|FG000|NOT COMPLETED|Overall Study||13
10999734|NCT00695565|12177023|FG001|NOT COMPLETED|Overall Study||9
10999735|NCT00695578|12177031|FG000|STARTED|Overall Study||10
10999736|NCT00695578|12177032|FG001|STARTED|Overall Study||10
10999737|NCT00695578|12177031|FG000|COMPLETED|Overall Study||10
10999738|NCT00695578|12177032|FG001|COMPLETED|Overall Study||10
10999739|NCT00695578|12177031|FG000|NOT COMPLETED|Overall Study||0
10999740|NCT00695578|12177032|FG001|NOT COMPLETED|Overall Study||0
10999741|NCT00695669|12177042|FG000|STARTED|Overall Study||78
10999742|NCT00695669|12177043|FG001|STARTED|Overall Study||78
10999743|NCT00695669|12177044|FG002|STARTED|Overall Study||78
10999744|NCT00695669|12177045|FG003|STARTED|Overall Study||78
10999745|NCT00695669|12177042|FG000|COMPLETED|Overall Study||74
10999746|NCT00695669|12177043|FG001|COMPLETED|Overall Study||74
10999747|NCT00695669|12177044|FG002|COMPLETED|Overall Study||75
10999748|NCT00695669|12177045|FG003|COMPLETED|Overall Study||74
10999749|NCT00695669|12177042|FG000|NOT COMPLETED|Overall Study||4
10999750|NCT00695669|12177043|FG001|NOT COMPLETED|Overall Study||4
10999751|NCT00695669|12177044|FG002|NOT COMPLETED|Overall Study||3
10999752|NCT00695669|12177045|FG003|NOT COMPLETED|Overall Study||4
10999753|NCT00695786|12177062|FG000|STARTED|Overall Study||2
10999754|NCT00695786|12177063|FG001|STARTED|Overall Study||79
10999755|NCT00695786|12177064|FG002|STARTED|Overall Study||31
10999756|NCT00695786|12177065|FG003|STARTED|Overall Study||44
10999757|NCT00695786|12177062|FG000|COMPLETED|Overall Study||1
10999758|NCT00695786|12177063|FG001|COMPLETED|Overall Study||67
10999759|NCT00695786|12177064|FG002|COMPLETED|Overall Study||23
10999760|NCT00695786|12177065|FG003|COMPLETED|Overall Study||36
10999761|NCT00695786|12177062|FG000|NOT COMPLETED|Overall Study||1
10999762|NCT00695786|12177063|FG001|NOT COMPLETED|Overall Study||12
10999763|NCT00695786|12177064|FG002|NOT COMPLETED|Overall Study||8
10999764|NCT00695786|12177065|FG003|NOT COMPLETED|Overall Study||8
10999765|NCT00695864|12177075|FG000|STARTED|Placebo||14
10999766|NCT00695864|12177075|FG000|COMPLETED|Placebo||9
10999767|NCT00695864|12177075|FG000|NOT COMPLETED|Placebo||5
10999768|NCT00695864|12177075|FG000|STARTED|Ondansetron||14
10999769|NCT00695864|12177075|FG000|COMPLETED|Ondansetron||9
10999770|NCT00695864|12177075|FG000|NOT COMPLETED|Ondansetron||5
10999771|NCT00695903|12177083|FG000|STARTED|Had End of Therapy (EOT) Assessment||19
10999772|NCT00695903|12177084|FG001|STARTED|Had End of Therapy (EOT) Assessment||19
10999773|NCT00695903|12177083|FG000|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
10999774|NCT00695903|12177084|FG001|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
10999775|NCT00695903|12177083|FG000|COMPLETED|Had End of Therapy (EOT) Assessment||7
10999776|NCT00695903|12177084|FG001|COMPLETED|Had End of Therapy (EOT) Assessment||4
10999777|NCT00695903|12177083|FG000|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
10999778|NCT00695903|12177084|FG001|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
10999779|NCT00695903|12177083|FG000|STARTED|Had Test of Cure (TOC) Assessment||7
10999780|NCT00695903|12177084|FG001|STARTED|Had Test of Cure (TOC) Assessment||4
10999781|NCT00695903|12177083|FG000|COMPLETED|Had Test of Cure (TOC) Assessment||5
10999782|NCT00695903|12177084|FG001|COMPLETED|Had Test of Cure (TOC) Assessment||3
10999783|NCT00695903|12177083|FG000|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
10999874|NCT00696436|12177198|FG004|NOT COMPLETED|Overall Study||13
10999784|NCT00695903|12177084|FG001|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
10999785|NCT00695955|12177090|FG000|STARTED|Cohort 1||362
10999786|NCT00695955|12177090|FG000|COMPLETED|Cohort 1||260
10999787|NCT00695955|12177090|FG000|NOT COMPLETED|Cohort 1||102
10999788|NCT00695955|12177090|FG000|STARTED|Cohort 2||307
10999789|NCT00695955|12177090|FG000|COMPLETED|Cohort 2||203
10999790|NCT00695955|12177090|FG000|NOT COMPLETED|Cohort 2||104
10999791|NCT00696020|12177100|FG000|STARTED|Overall Study||90
10999792|NCT00696020|12177101|FG001|STARTED|Overall Study||89
10999793|NCT00696020|12177102|FG002|STARTED|Overall Study||93
10999794|NCT00696020|12177103|FG003|STARTED|Overall Study||88
10999795|NCT00696020|12177100|FG000|COMPLETED|Overall Study||86
10999796|NCT00696020|12177101|FG001|COMPLETED|Overall Study||87
10999797|NCT00696020|12177102|FG002|COMPLETED|Overall Study||90
10999798|NCT00696020|12177103|FG003|COMPLETED|Overall Study||84
10999799|NCT00696020|12177100|FG000|NOT COMPLETED|Overall Study||4
10999800|NCT00696020|12177101|FG001|NOT COMPLETED|Overall Study||2
10999801|NCT00696020|12177102|FG002|NOT COMPLETED|Overall Study||3
10999802|NCT00696020|12177103|FG003|NOT COMPLETED|Overall Study||4
10999803|NCT00696072|12177117|FG000|STARTED|Overall Study||57
10999804|NCT00696072|12177118|FG001|STARTED|Overall Study||63
10999805|NCT00696072|12177117|FG000|COMPLETED|Overall Study||0
10999806|NCT00696072|12177118|FG001|COMPLETED|Overall Study||0
10999807|NCT00696072|12177117|FG000|NOT COMPLETED|Overall Study||57
10999808|NCT00696072|12177118|FG001|NOT COMPLETED|Overall Study||63
10999809|NCT00696137|12177125|FG000|STARTED|Overall Study||5
10999810|NCT00696137|12177125|FG000|COMPLETED|Overall Study||3
10999811|NCT00696137|12177125|FG000|NOT COMPLETED|Overall Study||2
10999812|NCT00696241|12177134|FG000|STARTED|Overall Study||283
10999813|NCT00696241|12177135|FG001|STARTED|Overall Study||283
10999814|NCT00696241|12177136|FG002|STARTED|Overall Study||285
10999815|NCT00696241|12177137|FG003|STARTED|Overall Study||282
10999816|NCT00696241|12177138|FG004|STARTED|Overall Study||142
10999817|NCT00696241|12177134|FG000|COMPLETED|Overall Study||259
10999818|NCT00696241|12177135|FG001|COMPLETED|Overall Study||261
10999819|NCT00696241|12177136|FG002|COMPLETED|Overall Study||261
10999820|NCT00696241|12177137|FG003|COMPLETED|Overall Study||268
10999821|NCT00696241|12177138|FG004|COMPLETED|Overall Study||130
10999822|NCT00696241|12177134|FG000|NOT COMPLETED|Overall Study||24
10999823|NCT00696241|12177135|FG001|NOT COMPLETED|Overall Study||22
10999824|NCT00696241|12177136|FG002|NOT COMPLETED|Overall Study||24
10999825|NCT00696241|12177137|FG003|NOT COMPLETED|Overall Study||14
10999826|NCT00696241|12177138|FG004|NOT COMPLETED|Overall Study||12
10999827|NCT00696293|12177150|FG000|STARTED|Overall Study||30
10999828|NCT00696293|12177150|FG000|COMPLETED|Overall Study||28
10999829|NCT00696293|12177150|FG000|NOT COMPLETED|Overall Study||2
10999830|NCT00696384|12177155|FG000|STARTED|Open Label Phase||418
10999831|NCT00696384|12177156|FG001|STARTED|Open Label Phase||0
10999832|NCT00696384|12177157|FG002|STARTED|Open Label Phase||0
10999833|NCT00696384|12177155|FG000|COMPLETED|Open Label Phase||299
10999834|NCT00696384|12177156|FG001|COMPLETED|Open Label Phase||0
10999835|NCT00696384|12177157|FG002|COMPLETED|Open Label Phase||0
10999836|NCT00696384|12177155|FG000|NOT COMPLETED|Open Label Phase||119
10999837|NCT00696384|12177156|FG001|NOT COMPLETED|Open Label Phase||0
10999838|NCT00696384|12177157|FG002|NOT COMPLETED|Open Label Phase||0
10999839|NCT00696384|12177155|FG000|STARTED|Double Blind Phase||0
10999840|NCT00696384|12177156|FG001|STARTED|Double Blind Phase||148
10999841|NCT00696384|12177157|FG002|STARTED|Double Blind Phase||151
10999842|NCT00696384|12177155|FG000|COMPLETED|Double Blind Phase||0
10999843|NCT00696384|12177156|FG001|COMPLETED|Double Blind Phase||137
10999844|NCT00696384|12177157|FG002|COMPLETED|Double Blind Phase||145
10999845|NCT00696384|12177155|FG000|NOT COMPLETED|Double Blind Phase||0
10999846|NCT00696384|12177156|FG001|NOT COMPLETED|Double Blind Phase||11
10999847|NCT00696384|12177157|FG002|NOT COMPLETED|Double Blind Phase||6
10999848|NCT00696410|12177168|FG000|STARTED|Overall Study||38
10999849|NCT00696410|12177169|FG001|STARTED|Overall Study||10
10999850|NCT00696410|12177168|FG000|COMPLETED|Overall Study||25
10999851|NCT00696410|12177169|FG001|COMPLETED|Overall Study||10
10999852|NCT00696410|12177168|FG000|NOT COMPLETED|Overall Study||13
10999853|NCT00696410|12177169|FG001|NOT COMPLETED|Overall Study||0
10999854|NCT00696423|12177182|FG000|STARTED|Overall Study||244
10999855|NCT00696423|12177183|FG001|STARTED|Overall Study||223
10999856|NCT00696423|12177182|FG000|COMPLETED|Overall Study||244
10999857|NCT00696423|12177183|FG001|COMPLETED|Overall Study||218
10999858|NCT00696423|12177182|FG000|NOT COMPLETED|Overall Study||0
10999859|NCT00696423|12177183|FG001|NOT COMPLETED|Overall Study||5
10999860|NCT00696436|12177194|FG000|STARTED|Overall Study|Randomized participants only.|280
10999861|NCT00696436|12177195|FG001|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
10999862|NCT00696436|12177196|FG002|STARTED|Overall Study|Randomized participants only.|282
10999863|NCT00696436|12177197|FG003|STARTED|Overall Study|Randomized participants only.|290
10999864|NCT00696436|12177198|FG004|STARTED|Overall Study|Randomized participants only.|154
10999865|NCT00696436|12177194|FG000|COMPLETED|Overall Study||257
10999866|NCT00696436|12177195|FG001|COMPLETED|Overall Study||255
10999867|NCT00696436|12177196|FG002|COMPLETED|Overall Study||254
10999868|NCT00696436|12177197|FG003|COMPLETED|Overall Study||268
10999869|NCT00696436|12177198|FG004|COMPLETED|Overall Study||141
10999870|NCT00696436|12177194|FG000|NOT COMPLETED|Overall Study||23
10999871|NCT00696436|12177195|FG001|NOT COMPLETED|Overall Study||30
10999872|NCT00696436|12177196|FG002|NOT COMPLETED|Overall Study||28
10999873|NCT00696436|12177197|FG003|NOT COMPLETED|Overall Study||22
10999875|NCT00696449|12177214|FG000|STARTED|Overall Study||15
10999876|NCT00696449|12177215|FG001|STARTED|Overall Study||15
10999877|NCT00696449|12177216|FG002|STARTED|Overall Study||15
10999878|NCT00696449|12177217|FG003|STARTED|Overall Study||16
10999879|NCT00696449|12177214|FG000|COMPLETED|Overall Study||12
10999880|NCT00696449|12177215|FG001|COMPLETED|Overall Study||9
10999881|NCT00696449|12177216|FG002|COMPLETED|Overall Study||14
10999882|NCT00696449|12177217|FG003|COMPLETED|Overall Study||13
10999883|NCT00696449|12177214|FG000|NOT COMPLETED|Overall Study||3
10999884|NCT00696449|12177215|FG001|NOT COMPLETED|Overall Study||6
10999885|NCT00696449|12177216|FG002|NOT COMPLETED|Overall Study||1
10999886|NCT00696449|12177217|FG003|NOT COMPLETED|Overall Study||3
10999887|NCT00696488|12177227|FG000|STARTED|Overall Study||20
10999888|NCT00696488|12177227|FG000|COMPLETED|Overall Study||20
10999889|NCT00696488|12177227|FG000|NOT COMPLETED|Overall Study||0
10999890|NCT00696618|12177234|FG000|STARTED|Overall Study||3
10999891|NCT00696618|12177235|FG001|STARTED|Overall Study||3
10999892|NCT00696618|12177236|FG002|STARTED|Overall Study||3
10999893|NCT00696618|12177234|FG000|COMPLETED|Overall Study||3
10999894|NCT00696618|12177235|FG001|COMPLETED|Overall Study||3
10999895|NCT00696618|12177236|FG002|COMPLETED|Overall Study||3
10999896|NCT00696618|12177234|FG000|NOT COMPLETED|Overall Study||0
10999897|NCT00696618|12177235|FG001|NOT COMPLETED|Overall Study||0
10999898|NCT00696618|12177236|FG002|NOT COMPLETED|Overall Study||0
10999899|NCT00696657|12177253|FG000|STARTED|Overall Study||46
10999900|NCT00696657|12177254|FG001|STARTED|Overall Study||47
10999901|NCT00696657|12177255|FG002|STARTED|Overall Study||44
10999902|NCT00696657|12177256|FG003|STARTED|Overall Study||49
10999903|NCT00696657|12177257|FG004|STARTED|Overall Study||44
10999904|NCT00696657|12177258|FG005|STARTED|Overall Study||45
10999905|NCT00696657|12177259|FG006|STARTED|Overall Study||45
10999906|NCT00696657|12177260|FG007|STARTED|Overall Study||45
10999907|NCT00696657|12177261|FG008|STARTED|Overall Study||50
10999908|NCT00696657|12177253|FG000|EXPOSED|Overall Study||46
10999909|NCT00696657|12177254|FG001|EXPOSED|Overall Study||47
10999910|NCT00696657|12177255|FG002|EXPOSED|Overall Study||43
10999911|NCT00696657|12177256|FG003|EXPOSED|Overall Study||48
10999912|NCT00696657|12177257|FG004|EXPOSED|Overall Study||44
10999913|NCT00696657|12177258|FG005|EXPOSED|Overall Study||43
10999914|NCT00696657|12177259|FG006|EXPOSED|Overall Study||45
10999915|NCT00696657|12177260|FG007|EXPOSED|Overall Study||45
10999916|NCT00696657|12177261|FG008|EXPOSED|Overall Study||50
10999917|NCT00696657|12177253|FG000|COMPLETED|Overall Study||45
10999918|NCT00696657|12177254|FG001|COMPLETED|Overall Study||42
10999919|NCT00696657|12177255|FG002|COMPLETED|Overall Study||36
10999920|NCT00696657|12177256|FG003|COMPLETED|Overall Study||38
10999921|NCT00696657|12177257|FG004|COMPLETED|Overall Study||34
10999922|NCT00696657|12177258|FG005|COMPLETED|Overall Study||33
10999923|NCT00696657|12177259|FG006|COMPLETED|Overall Study||30
10999924|NCT00696657|12177260|FG007|COMPLETED|Overall Study||42
10999925|NCT00696657|12177261|FG008|COMPLETED|Overall Study||41
10999926|NCT00696657|12177253|FG000|NOT COMPLETED|Overall Study||1
10999927|NCT00696657|12177254|FG001|NOT COMPLETED|Overall Study||5
10999928|NCT00696657|12177255|FG002|NOT COMPLETED|Overall Study||8
10999929|NCT00696657|12177256|FG003|NOT COMPLETED|Overall Study||11
10999930|NCT00696657|12177257|FG004|NOT COMPLETED|Overall Study||10
10999931|NCT00696657|12177258|FG005|NOT COMPLETED|Overall Study||12
10999932|NCT00696657|12177259|FG006|NOT COMPLETED|Overall Study||15
10999933|NCT00696657|12177260|FG007|NOT COMPLETED|Overall Study||3
10999934|NCT00696657|12177261|FG008|NOT COMPLETED|Overall Study||9
10999935|NCT00696696|12177281|FG000|STARTED|Overall Study||44
10999936|NCT00696696|12177281|FG000|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
10999937|NCT00696696|12177281|FG000|NOT COMPLETED|Overall Study||18
10999938|NCT00696709|12177290|FG000|STARTED|Overall Study||65
10999939|NCT00696709|12177291|FG001|STARTED|Overall Study||63
10999940|NCT00696709|12177292|FG002|STARTED|Overall Study||33
10999941|NCT00696709|12177293|FG003|STARTED|Overall Study||64
10999942|NCT00696709|12177294|FG004|STARTED|Overall Study||65
10999943|NCT00696709|12177290|FG000|Vaccination 1 (Day 1)|Overall Study||65
10999944|NCT00696709|12177291|FG001|Vaccination 1 (Day 1)|Overall Study||63
10999945|NCT00696709|12177292|FG002|Vaccination 1 (Day 1)|Overall Study||32
10999946|NCT00696709|12177293|FG003|Vaccination 1 (Day 1)|Overall Study||64
10999947|NCT00696709|12177294|FG004|Vaccination 1 (Day 1)|Overall Study||65
10999948|NCT00696709|12177290|FG000|Vaccination 2 (~Day 30)|Overall Study||64
10999949|NCT00696709|12177291|FG001|Vaccination 2 (~Day 30)|Overall Study||60
10999950|NCT00696709|12177292|FG002|Vaccination 2 (~Day 30)|Overall Study||32
10999951|NCT00696709|12177293|FG003|Vaccination 2 (~Day 30)|Overall Study||61
10999952|NCT00696709|12177294|FG004|Vaccination 2 (~Day 30)|Overall Study||64
10999953|NCT00696709|12177290|FG000|Vaccination 3 (~Day 60)|Overall Study||64
10999954|NCT00696709|12177291|FG001|Vaccination 3 (~Day 60)|Overall Study||60
10999955|NCT00696709|12177292|FG002|Vaccination 3 (~Day 60)|Overall Study||32
10999956|NCT00696709|12177293|FG003|Vaccination 3 (~Day 60)|Overall Study||59
10999957|NCT00696709|12177294|FG004|Vaccination 3 (~Day 60)|Overall Study||63
10999958|NCT00696709|12177290|FG000|Vaccination 4 (~Day 90)|Overall Study||62
10999959|NCT00696709|12177291|FG001|Vaccination 4 (~Day 90)|Overall Study||60
10999960|NCT00696709|12177292|FG002|Vaccination 4 (~Day 90)|Overall Study||32
10999961|NCT00696709|12177293|FG003|Vaccination 4 (~Day 90)|Overall Study||59
10999962|NCT00696709|12177294|FG004|Vaccination 4 (~Day 90)|Overall Study||63
10999963|NCT00696709|12177290|FG000|COMPLETED|Overall Study||62
10999964|NCT00696709|12177291|FG001|COMPLETED|Overall Study||60
10999965|NCT00696709|12177292|FG002|COMPLETED|Overall Study||32
10999966|NCT00696709|12177293|FG003|COMPLETED|Overall Study||59
10999967|NCT00696709|12177294|FG004|COMPLETED|Overall Study||62
10999968|NCT00696709|12177290|FG000|NOT COMPLETED|Overall Study||3
10999969|NCT00696709|12177291|FG001|NOT COMPLETED|Overall Study||3
10999970|NCT00696709|12177292|FG002|NOT COMPLETED|Overall Study||1
10999971|NCT00696709|12177293|FG003|NOT COMPLETED|Overall Study||5
10999972|NCT00696709|12177294|FG004|NOT COMPLETED|Overall Study||3
10999973|NCT00696761|12177314|FG000|STARTED|Overall Study||61
10999974|NCT00696761|12177315|FG001|STARTED|Overall Study||76
10999975|NCT00696761|12177316|FG002|STARTED|Overall Study||41
10999976|NCT00696761|12177317|FG003|STARTED|Overall Study||54
10999977|NCT00696761|12177314|FG000|COMPLETED|Overall Study||41
10999978|NCT00696761|12177315|FG001|COMPLETED|Overall Study||50
10999979|NCT00696761|12177316|FG002|COMPLETED|Overall Study||30
10999980|NCT00696761|12177317|FG003|COMPLETED|Overall Study||44
10999981|NCT00696761|12177314|FG000|NOT COMPLETED|Overall Study||20
10999982|NCT00696761|12177315|FG001|NOT COMPLETED|Overall Study||26
10999983|NCT00696761|12177316|FG002|NOT COMPLETED|Overall Study||11
10999984|NCT00696761|12177317|FG003|NOT COMPLETED|Overall Study||10
10999985|NCT00696774|12177338|FG000|STARTED|Period II||115
10999986|NCT00696774|12177339|FG001|STARTED|Period II||91
10999987|NCT00696774|12177340|FG002|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
10999988|NCT00696774|12177338|FG000|COMPLETED|Period II||115
10999989|NCT00696774|12177339|FG001|COMPLETED|Period II||91
10999990|NCT00696774|12177340|FG002|COMPLETED|Period II||0
10999991|NCT00696774|12177338|FG000|NOT COMPLETED|Period II||0
10999992|NCT00696774|12177339|FG001|NOT COMPLETED|Period II||0
10999993|NCT00696774|12177340|FG002|NOT COMPLETED|Period II||36
10999994|NCT00696774|12177338|FG000|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
10999995|NCT00696774|12177339|FG001|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
10999996|NCT00696774|12177340|FG002|STARTED|Period III||0
10999997|NCT00696774|12177338|FG000|COMPLETED|Period III||106
10999998|NCT00696774|12177339|FG001|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
10999999|NCT00696774|12177340|FG002|COMPLETED|Period III||0
11000000|NCT00696774|12177338|FG000|NOT COMPLETED|Period III||7
11000001|NCT00696774|12177339|FG001|NOT COMPLETED|Period III||7
11000002|NCT00696774|12177340|FG002|NOT COMPLETED|Period III||0
11000003|NCT00696787|12177351|FG000|STARTED|Overall Study||40
11000004|NCT00696787|12177352|FG001|STARTED|Overall Study||42
11000005|NCT00696787|12177353|FG002|STARTED|Overall Study||43
11000006|NCT00696787|12177351|FG000|COMPLETED|Overall Study||25
11000007|NCT00696787|12177352|FG001|COMPLETED|Overall Study||22
11000008|NCT00696787|12177353|FG002|COMPLETED|Overall Study||17
11000009|NCT00696787|12177351|FG000|NOT COMPLETED|Overall Study||15
11000010|NCT00696787|12177352|FG001|NOT COMPLETED|Overall Study||20
11000011|NCT00696787|12177353|FG002|NOT COMPLETED|Overall Study||26
11000012|NCT00697073|12177361|FG000|STARTED|Overall Study||68
11000013|NCT00697073|12177361|FG000|COMPLETED|Overall Study||59
11000014|NCT00697073|12177361|FG000|NOT COMPLETED|Overall Study||9
11000015|NCT00697112|12177365|FG000|STARTED|Overall Study||53
11000016|NCT00697112|12177365|FG000|Met the Inclusion Criteria|Overall Study||52
11000017|NCT00697112|12177365|FG000|COMPLETED|Overall Study||43
11000018|NCT00697112|12177365|FG000|NOT COMPLETED|Overall Study||10
11000019|NCT00697190|12177369|FG000|STARTED|First Intervention||19
11000020|NCT00697190|12177370|FG001|STARTED|First Intervention||20
11000021|NCT00697190|12177369|FG000|COMPLETED|First Intervention||19
11000022|NCT00697190|12177370|FG001|COMPLETED|First Intervention||20
11000023|NCT00697190|12177369|FG000|NOT COMPLETED|First Intervention||0
11000024|NCT00697190|12177370|FG001|NOT COMPLETED|First Intervention||0
11000025|NCT00697190|12177369|FG000|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
11000026|NCT00697190|12177370|FG001|STARTED|Second Intervention||20
11000027|NCT00697190|12177369|FG000|COMPLETED|Second Intervention||18
11000028|NCT00697190|12177370|FG001|COMPLETED|Second Intervention||20
11000029|NCT00697190|12177369|FG000|NOT COMPLETED|Second Intervention||0
11000030|NCT00697190|12177370|FG001|NOT COMPLETED|Second Intervention||0
11000031|NCT00697203|12177384|FG000|STARTED|Overall Study||76
11000032|NCT00697203|12177385|FG001|STARTED|Overall Study||68
11000033|NCT00697203|12177386|FG002|STARTED|Overall Study||74
11000034|NCT00697203|12177387|FG003|STARTED|Overall Study||74
11000035|NCT00697203|12177384|FG000|COMPLETED|Overall Study||67
11000036|NCT00697203|12177385|FG001|COMPLETED|Overall Study||62
11000037|NCT00697203|12177386|FG002|COMPLETED|Overall Study||66
11000038|NCT00697203|12177387|FG003|COMPLETED|Overall Study||67
11000039|NCT00697203|12177384|FG000|NOT COMPLETED|Overall Study||9
11000040|NCT00697203|12177385|FG001|NOT COMPLETED|Overall Study||6
11000041|NCT00697203|12177386|FG002|NOT COMPLETED|Overall Study||8
11000042|NCT00697203|12177387|FG003|NOT COMPLETED|Overall Study||7
11000043|NCT00697346|12177400|FG000|STARTED|Overall Study||28
11000044|NCT00697346|12177401|FG001|STARTED|Overall Study||28
11000045|NCT00697346|12177402|FG002|STARTED|Overall Study||2
11000046|NCT00697346|12177400|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
11000047|NCT00697346|12177401|FG001|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2
11000048|NCT00697346|12177402|FG002|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1
11000049|NCT00697346|12177400|FG000|NOT COMPLETED|Overall Study||28
11000050|NCT00697346|12177401|FG001|NOT COMPLETED|Overall Study||26
11000051|NCT00697346|12177402|FG002|NOT COMPLETED|Overall Study||1
11000052|NCT00697463|12177429|FG000|STARTED|Overall Study||22
11000053|NCT00697463|12177429|FG000|COMPLETED|Overall Study||21
11000054|NCT00697463|12177429|FG000|NOT COMPLETED|Overall Study||1
11000055|NCT00697515|12177433|FG000|STARTED|Dose Optimization Period||142
11000056|NCT00697515|12177434|FG001|STARTED|Dose Optimization Period||0
11000057|NCT00697515|12177433|FG000|COMPLETED|Dose Optimization Period||127
11000058|NCT00697515|12177434|FG001|COMPLETED|Dose Optimization Period||0
11000059|NCT00697515|12177433|FG000|NOT COMPLETED|Dose Optimization Period||15
11000060|NCT00697515|12177434|FG001|NOT COMPLETED|Dose Optimization Period||0
11000061|NCT00697515|12177433|FG000|STARTED|First Intervention (Crossover Period)||63
11000062|NCT00697515|12177434|FG001|STARTED|First Intervention (Crossover Period)||64
11000063|NCT00697515|12177433|FG000|COMPLETED|First Intervention (Crossover Period)||53
11000064|NCT00697515|12177434|FG001|COMPLETED|First Intervention (Crossover Period)||52
11000065|NCT00697515|12177433|FG000|NOT COMPLETED|First Intervention (Crossover Period)||10
11000066|NCT00697515|12177434|FG001|NOT COMPLETED|First Intervention (Crossover Period)||12
11000067|NCT00697515|12177433|FG000|STARTED|Second Intervention (Crossover Period)||53
11000068|NCT00697515|12177434|FG001|STARTED|Second Intervention (Crossover Period)||52
11000069|NCT00697515|12177433|FG000|COMPLETED|Second Intervention (Crossover Period)||52
11000070|NCT00697515|12177434|FG001|COMPLETED|Second Intervention (Crossover Period)||51
11000071|NCT00697515|12177433|FG000|NOT COMPLETED|Second Intervention (Crossover Period)||1
11000072|NCT00697515|12177434|FG001|NOT COMPLETED|Second Intervention (Crossover Period)||1
11000073|NCT00697541|12177442|FG000|STARTED|Overall Study||10
11000074|NCT00697541|12177443|FG001|STARTED|Overall Study||10
11000075|NCT00697541|12177442|FG000|COMPLETED|Overall Study||8
11000076|NCT00697541|12177443|FG001|COMPLETED|Overall Study||9
11000077|NCT00697541|12177442|FG000|NOT COMPLETED|Overall Study||2
11000078|NCT00697541|12177443|FG001|NOT COMPLETED|Overall Study||1
11000079|NCT00697593|12177450|FG000|STARTED|Overall Study||70
11000080|NCT00697593|12177450|FG000|COMPLETED|Overall Study||51
11000081|NCT00697593|12177450|FG000|NOT COMPLETED|Overall Study||19
11000082|NCT00697619|12177456|FG000|STARTED|Overall Study||30
11000083|NCT00697619|12177457|FG001|STARTED|Overall Study||30
11000084|NCT00697619|12177456|FG000|COMPLETED|Overall Study||24
11000085|NCT00697619|12177457|FG001|COMPLETED|Overall Study||22
11000086|NCT00697619|12177456|FG000|NOT COMPLETED|Overall Study||6
11000087|NCT00697619|12177457|FG001|NOT COMPLETED|Overall Study||8
11000088|NCT00697697|12177465|FG000|STARTED|Overall Study||94
11000089|NCT00697697|12177466|FG001|STARTED|Overall Study||98
11000090|NCT00697697|12177465|FG000|COMPLETED|Overall Study||45
11000091|NCT00697697|12177466|FG001|COMPLETED|Overall Study||44
11000092|NCT00697697|12177465|FG000|NOT COMPLETED|Overall Study||49
11000093|NCT00697697|12177466|FG001|NOT COMPLETED|Overall Study||54
11000094|NCT00697788|12177472|FG000|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
11000095|NCT00697788|12177473|FG001|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
11000096|NCT00697788|12177474|FG002|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
11000097|NCT00697788|12177475|FG003|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
11000098|NCT00697788|12177476|FG004|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
11000099|NCT00697788|12177477|FG005|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
11000100|NCT00697788|12177478|FG006|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
11000101|NCT00697788|12177479|FG007|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
11000102|NCT00697788|12177472|FG000|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
11000103|NCT00697788|12177473|FG001|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000104|NCT00697788|12177474|FG002|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000105|NCT00697788|12177475|FG003|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000106|NCT00697788|12177476|FG004|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000107|NCT00697788|12177477|FG005|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000108|NCT00697788|12177478|FG006|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000109|NCT00697788|12177479|FG007|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000110|NCT00697788|12177472|FG000|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000111|NCT00697788|12177473|FG001|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000112|NCT00697788|12177474|FG002|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000113|NCT00697788|12177475|FG003|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000114|NCT00697788|12177476|FG004|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000115|NCT00697788|12177477|FG005|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000116|NCT00697788|12177478|FG006|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000117|NCT00697788|12177479|FG007|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
11000118|NCT00697788|12177472|FG000|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000119|NCT00697788|12177473|FG001|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
11000120|NCT00697788|12177474|FG002|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000121|NCT00697788|12177475|FG003|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000122|NCT00697788|12177476|FG004|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000123|NCT00697788|12177477|FG005|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000124|NCT00697788|12177478|FG006|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000125|NCT00697788|12177479|FG007|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000126|NCT00697788|12177472|FG000|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000127|NCT00697788|12177473|FG001|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
11000128|NCT00697788|12177474|FG002|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000129|NCT00697788|12177475|FG003|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000130|NCT00697788|12177476|FG004|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000131|NCT00697788|12177477|FG005|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000132|NCT00697788|12177478|FG006|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000133|NCT00697788|12177479|FG007|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000134|NCT00697788|12177472|FG000|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000135|NCT00697788|12177473|FG001|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
11000136|NCT00697788|12177474|FG002|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000137|NCT00697788|12177475|FG003|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000138|NCT00697788|12177476|FG004|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000139|NCT00697788|12177477|FG005|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000140|NCT00697788|12177478|FG006|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000141|NCT00697788|12177479|FG007|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
11000142|NCT00697788|12177472|FG000|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000143|NCT00697788|12177473|FG001|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000144|NCT00697788|12177474|FG002|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
11000145|NCT00697788|12177475|FG003|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000146|NCT00697788|12177476|FG004|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000147|NCT00697788|12177477|FG005|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000148|NCT00697788|12177478|FG006|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000149|NCT00697788|12177479|FG007|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000150|NCT00697788|12177472|FG000|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000151|NCT00697788|12177473|FG001|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000152|NCT00697788|12177474|FG002|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
11000153|NCT00697788|12177475|FG003|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000154|NCT00697788|12177476|FG004|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000155|NCT00697788|12177477|FG005|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000156|NCT00697788|12177478|FG006|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000157|NCT00697788|12177479|FG007|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000158|NCT00697788|12177472|FG000|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000159|NCT00697788|12177473|FG001|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000160|NCT00697788|12177474|FG002|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000161|NCT00697788|12177475|FG003|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000162|NCT00697788|12177476|FG004|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000163|NCT00697788|12177477|FG005|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000164|NCT00697788|12177478|FG006|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000165|NCT00697788|12177479|FG007|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
11000166|NCT00697788|12177472|FG000|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000167|NCT00697788|12177473|FG001|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000168|NCT00697788|12177474|FG002|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000169|NCT00697788|12177475|FG003|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
11000170|NCT00697788|12177476|FG004|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000171|NCT00697788|12177477|FG005|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000172|NCT00697788|12177478|FG006|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000173|NCT00697788|12177479|FG007|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000174|NCT00697788|12177472|FG000|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000175|NCT00697788|12177473|FG001|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000176|NCT00697788|12177474|FG002|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000177|NCT00697788|12177475|FG003|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
11000178|NCT00697788|12177476|FG004|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000179|NCT00697788|12177477|FG005|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000180|NCT00697788|12177478|FG006|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000181|NCT00697788|12177479|FG007|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000182|NCT00697788|12177472|FG000|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000183|NCT00697788|12177473|FG001|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000184|NCT00697788|12177474|FG002|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000185|NCT00697788|12177475|FG003|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000186|NCT00697788|12177476|FG004|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000187|NCT00697788|12177477|FG005|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000188|NCT00697788|12177478|FG006|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000189|NCT00697788|12177479|FG007|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
11000190|NCT00697788|12177472|FG000|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000191|NCT00697788|12177473|FG001|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000192|NCT00697788|12177474|FG002|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000193|NCT00697788|12177475|FG003|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000194|NCT00697788|12177476|FG004|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
11000195|NCT00697788|12177477|FG005|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000196|NCT00697788|12177478|FG006|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000197|NCT00697788|12177479|FG007|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000198|NCT00697788|12177472|FG000|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000199|NCT00697788|12177473|FG001|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000200|NCT00697788|12177474|FG002|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000201|NCT00697788|12177475|FG003|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000202|NCT00697788|12177476|FG004|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
11000203|NCT00697788|12177477|FG005|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000204|NCT00697788|12177478|FG006|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000205|NCT00697788|12177479|FG007|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000206|NCT00697788|12177472|FG000|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000207|NCT00697788|12177473|FG001|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000208|NCT00697788|12177474|FG002|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000209|NCT00697788|12177475|FG003|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000210|NCT00697788|12177476|FG004|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
11000211|NCT00697788|12177477|FG005|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000212|NCT00697788|12177478|FG006|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000213|NCT00697788|12177479|FG007|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
11000214|NCT00697788|12177472|FG000|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000215|NCT00697788|12177473|FG001|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000216|NCT00697788|12177474|FG002|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000217|NCT00697788|12177475|FG003|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000218|NCT00697788|12177476|FG004|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000219|NCT00697788|12177477|FG005|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
11000220|NCT00697788|12177478|FG006|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000221|NCT00697788|12177479|FG007|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000222|NCT00697788|12177472|FG000|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000223|NCT00697788|12177473|FG001|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000224|NCT00697788|12177474|FG002|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000225|NCT00697788|12177475|FG003|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000226|NCT00697788|12177476|FG004|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000227|NCT00697788|12177477|FG005|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
11000228|NCT00697788|12177478|FG006|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000229|NCT00697788|12177479|FG007|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000230|NCT00697788|12177472|FG000|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000231|NCT00697788|12177473|FG001|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000232|NCT00697788|12177474|FG002|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000233|NCT00697788|12177475|FG003|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000234|NCT00697788|12177476|FG004|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000235|NCT00697788|12177477|FG005|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000236|NCT00697788|12177478|FG006|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000237|NCT00697788|12177479|FG007|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
11000238|NCT00697788|12177472|FG000|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000239|NCT00697788|12177473|FG001|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000240|NCT00697788|12177474|FG002|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000241|NCT00697788|12177475|FG003|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000242|NCT00697788|12177476|FG004|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000243|NCT00697788|12177477|FG005|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000244|NCT00697788|12177478|FG006|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
11000245|NCT00697788|12177479|FG007|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000246|NCT00697788|12177472|FG000|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000247|NCT00697788|12177473|FG001|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000248|NCT00697788|12177474|FG002|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000249|NCT00697788|12177475|FG003|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000250|NCT00697788|12177476|FG004|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000251|NCT00697788|12177477|FG005|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000252|NCT00697788|12177478|FG006|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
11000253|NCT00697788|12177479|FG007|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000254|NCT00697788|12177472|FG000|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000255|NCT00697788|12177473|FG001|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000256|NCT00697788|12177474|FG002|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000257|NCT00697788|12177475|FG003|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000258|NCT00697788|12177476|FG004|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000259|NCT00697788|12177477|FG005|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000260|NCT00697788|12177478|FG006|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000261|NCT00697788|12177479|FG007|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
11000262|NCT00697788|12177472|FG000|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000263|NCT00697788|12177473|FG001|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000264|NCT00697788|12177474|FG002|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000265|NCT00697788|12177475|FG003|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000266|NCT00697788|12177476|FG004|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000267|NCT00697788|12177477|FG005|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000268|NCT00697788|12177478|FG006|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000269|NCT00697788|12177479|FG007|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
11000270|NCT00697788|12177472|FG000|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000271|NCT00697788|12177473|FG001|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000272|NCT00697788|12177474|FG002|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000273|NCT00697788|12177475|FG003|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000274|NCT00697788|12177476|FG004|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000275|NCT00697788|12177477|FG005|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000276|NCT00697788|12177478|FG006|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000277|NCT00697788|12177479|FG007|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
11000278|NCT00697788|12177472|FG000|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000279|NCT00697788|12177473|FG001|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000280|NCT00697788|12177474|FG002|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000281|NCT00697788|12177475|FG003|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000282|NCT00697788|12177476|FG004|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000283|NCT00697788|12177477|FG005|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000284|NCT00697788|12177478|FG006|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000285|NCT00697788|12177479|FG007|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
11000286|NCT00697801|12177509|FG000|STARTED|Overall Study||69
11000287|NCT00697801|12177510|FG001|STARTED|Overall Study||70
11000288|NCT00697801|12177511|FG002|STARTED|Overall Study||69
11000289|NCT00697801|12177509|FG000|COMPLETED|Overall Study||57
11000290|NCT00697801|12177510|FG001|COMPLETED|Overall Study||58
11000291|NCT00697801|12177511|FG002|COMPLETED|Overall Study||45
11000292|NCT00697801|12177509|FG000|NOT COMPLETED|Overall Study||12
11000293|NCT00697801|12177510|FG001|NOT COMPLETED|Overall Study||12
11000294|NCT00697801|12177511|FG002|NOT COMPLETED|Overall Study||24
11000295|NCT00697827|12177521|FG000|STARTED|Overall Study||28
11000296|NCT00697827|12177522|FG001|STARTED|Overall Study||16
11000297|NCT00697827|12177521|FG000|COMPLETED|Overall Study||26
11000298|NCT00697827|12177522|FG001|COMPLETED|Overall Study||15
11000299|NCT00697827|12177521|FG000|NOT COMPLETED|Overall Study||2
11000300|NCT00697827|12177522|FG001|NOT COMPLETED|Overall Study||1
11000301|NCT00698035|12177530|FG000|STARTED|Overall Study||39
11000302|NCT00698035|12177531|FG001|STARTED|Overall Study||36
11000303|NCT00698035|12177530|FG000|COMPLETED|Overall Study||35
11000304|NCT00698035|12177531|FG001|COMPLETED|Overall Study||34
11000305|NCT00698035|12177530|FG000|NOT COMPLETED|Overall Study||4
11000306|NCT00698035|12177531|FG001|NOT COMPLETED|Overall Study||2
11000307|NCT00698139|12177543|FG000|STARTED|Overall Study||1
11000308|NCT00698139|12177544|FG001|STARTED|Overall Study||1
11000309|NCT00698139|12177545|FG002|STARTED|Overall Study||1
11000310|NCT00698139|12177543|FG000|2nd Visit|Overall Study||1
11000311|NCT00698139|12177544|FG001|2nd Visit|Overall Study||1
11000312|NCT00698139|12177545|FG002|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
11000313|NCT00698139|12177543|FG000|COMPLETED|Overall Study||1
11000314|NCT00698139|12177544|FG001|COMPLETED|Overall Study||1
11000315|NCT00698139|12177545|FG002|COMPLETED|Overall Study||1
11000316|NCT00698139|12177543|FG000|NOT COMPLETED|Overall Study||0
11000317|NCT00698139|12177544|FG001|NOT COMPLETED|Overall Study||0
11000318|NCT00698139|12177545|FG002|NOT COMPLETED|Overall Study||0
11000319|NCT00698204|12177555|FG000|STARTED|Overall Study||20
11000320|NCT00698204|12177556|FG001|STARTED|Overall Study||20
11000321|NCT00698204|12177555|FG000|COMPLETED|Overall Study||19
11000322|NCT00698204|12177556|FG001|COMPLETED|Overall Study||20
11000323|NCT00698204|12177555|FG000|NOT COMPLETED|Overall Study||1
11000324|NCT00698204|12177556|FG001|NOT COMPLETED|Overall Study||0
11000325|NCT00698451|12177564|FG000|STARTED|Overall Study||54
11000326|NCT00698451|12177564|FG000|COMPLETED|Overall Study||15
11000327|NCT00698451|12177564|FG000|NOT COMPLETED|Overall Study||39
11000328|NCT00698516|12177568|FG000|STARTED|Overall Study||50
11000329|NCT00698516|12177568|FG000|COMPLETED|Overall Study||45
11000330|NCT00698516|12177568|FG000|NOT COMPLETED|Overall Study||5
11000331|NCT00698581|12177578|FG000|STARTED|Overall Study||68
11000332|NCT00698581|12177579|FG001|STARTED|Overall Study||20
11000333|NCT00698581|12177578|FG000|COMPLETED|Overall Study||23
11000334|NCT00698581|12177579|FG001|COMPLETED|Overall Study||8
11000335|NCT00698581|12177578|FG000|NOT COMPLETED|Overall Study||45
11000336|NCT00698581|12177579|FG001|NOT COMPLETED|Overall Study||12
11000337|NCT00698646|12177589|FG000|STARTED|Overall Study||128
11000338|NCT00698646|12177590|FG001|STARTED|Overall Study||128
11000339|NCT00698646|12177591|FG002|STARTED|Overall Study||128
11000340|NCT00698646|12177589|FG000|COMPLETED|Overall Study||92
11000341|NCT00698646|12177590|FG001|COMPLETED|Overall Study||97
11000342|NCT00698646|12177591|FG002|COMPLETED|Overall Study||99
11000343|NCT00698646|12177589|FG000|NOT COMPLETED|Overall Study||36
11000344|NCT00698646|12177590|FG001|NOT COMPLETED|Overall Study||31
11000345|NCT00698646|12177591|FG002|NOT COMPLETED|Overall Study||29
11000346|NCT00698685|12177599|FG000|STARTED|Overall Study||14
11000347|NCT00698685|12177599|FG000|COMPLETED|Overall Study||12
11000348|NCT00698685|12177599|FG000|NOT COMPLETED|Overall Study||2
11000349|NCT00698841|12177603|FG000|STARTED|Overall Study||51
11000350|NCT00698841|12177603|FG000|COMPLETED|Overall Study||33
11000351|NCT00698841|12177603|FG000|NOT COMPLETED|Overall Study||18
11000352|NCT00698867|12177607|FG000|STARTED|Overall Study||118
11000353|NCT00698867|12177607|FG000|Subjects With 1 Year Data|Overall Study||68
11000354|NCT00698867|12177607|FG000|Subjects With 2 Year Data|Overall Study||55
11000355|NCT00698867|12177607|FG000|Subjects With 3 Year Data|Overall Study||35
11000356|NCT00698867|12177607|FG000|Subjects With 4 Year Data|Overall Study||34
11000357|NCT00698867|12177607|FG000|COMPLETED|Overall Study||27
11000358|NCT00698867|12177607|FG000|NOT COMPLETED|Overall Study||91
11000359|NCT00698932|12177613|FG000|STARTED|Overall Study|Randomized and treated|284
11000360|NCT00698932|12177614|FG001|STARTED|Overall Study|Randomized and treated|284
11000361|NCT00698932|12177613|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
11000362|NCT00698932|12177614|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
11000363|NCT00698932|12177613|FG000|NOT COMPLETED|Overall Study||22
11000364|NCT00698932|12177614|FG001|NOT COMPLETED|Overall Study||36
11000365|NCT00698997|12177622|FG000|STARTED|Overall Study|1 enrollment|55
11000366|NCT00698997|12177623|FG001|STARTED|Overall Study|1 enrollment|63
11000367|NCT00698997|12177622|FG000|COMPLETED|Overall Study|45 - final participant assessment completed|45
11000368|NCT00698997|12177623|FG001|COMPLETED|Overall Study|36 - final assessment completed|36
11000369|NCT00698997|12177622|FG000|NOT COMPLETED|Overall Study||10
11000370|NCT00698997|12177623|FG001|NOT COMPLETED|Overall Study||27
11000371|NCT00699010|12177632|FG000|STARTED|Overall Study||15
11000372|NCT00699010|12177633|FG001|STARTED|Overall Study||15
11000373|NCT00699010|12177632|FG000|COMPLETED|Overall Study||15
11000374|NCT00699010|12177633|FG001|COMPLETED|Overall Study||15
11000375|NCT00699010|12177632|FG000|NOT COMPLETED|Overall Study||0
11000376|NCT00699010|12177633|FG001|NOT COMPLETED|Overall Study||0
11000377|NCT00699140|12177639|FG000|STARTED|Overall Study||18
11000378|NCT00699140|12177639|FG000|COMPLETED|Overall Study||18
11000379|NCT00699140|12177639|FG000|NOT COMPLETED|Overall Study||0
11000380|NCT00699153|12177649|FG000|STARTED|Overall Study|Intent to treat population|203
11000381|NCT00699153|12177650|FG001|STARTED|Overall Study|Intent to treat population|202
11000382|NCT00699153|12177649|FG000|COMPLETED|Overall Study||200
11000383|NCT00699153|12177650|FG001|COMPLETED|Overall Study||200
11000384|NCT00699153|12177649|FG000|NOT COMPLETED|Overall Study||3
11000385|NCT00699153|12177650|FG001|NOT COMPLETED|Overall Study||2
11000386|NCT00699192|12177659|FG000|STARTED|Overall Study||275
11000387|NCT00699192|12177660|FG001|STARTED|Overall Study||272
11000388|NCT00699192|12177661|FG002|STARTED|Overall Study||272
11000389|NCT00699192|12177659|FG000|COMPLETED|Overall Study||259
11000390|NCT00699192|12177660|FG001|COMPLETED|Overall Study||260
11000391|NCT00699192|12177661|FG002|COMPLETED|Overall Study||261
11000392|NCT00699192|12177659|FG000|NOT COMPLETED|Overall Study||16
11000393|NCT00699192|12177660|FG001|NOT COMPLETED|Overall Study||12
11000394|NCT00699192|12177661|FG002|NOT COMPLETED|Overall Study||11
11000395|NCT00699218|12177669|FG000|STARTED|Overall Study||15
11000396|NCT00699218|12177669|FG000|COMPLETED|Overall Study||15
11000397|NCT00699218|12177669|FG000|NOT COMPLETED|Overall Study||0
11000398|NCT00699283|12177675|FG000|STARTED|Overall Study||47
11000399|NCT00699283|12177676|FG001|STARTED|Overall Study||15
11000400|NCT00699283|12177675|FG000|COMPLETED|Overall Study||14
11000401|NCT00699283|12177676|FG001|COMPLETED|Overall Study||7
11000402|NCT00699283|12177675|FG000|NOT COMPLETED|Overall Study||33
11000403|NCT00699283|12177676|FG001|NOT COMPLETED|Overall Study||8
11000404|NCT00699335|12177681|FG000|STARTED|Overall Study||5308
11000405|NCT00699335|12177681|FG000|COMPLETED|Overall Study||5080
11000406|NCT00699335|12177681|FG000|NOT COMPLETED|Overall Study||228
11000407|NCT00699348|12177688|FG000|STARTED|Overall Study||351
11000408|NCT00699348|12177688|FG000|COMPLETED|Overall Study||261
11000409|NCT00699348|12177688|FG000|NOT COMPLETED|Overall Study||90
11000410|NCT00699374|12177694|FG000|STARTED|Overall Study||530
11000411|NCT00699374|12177695|FG001|STARTED|Overall Study||544
11000412|NCT00699374|12177694|FG000|Treated|Overall Study||526
11000413|NCT00699374|12177695|FG001|Treated|Overall Study||542
11000414|NCT00699374|12177694|FG000|COMPLETED|Overall Study||0
11000415|NCT00699374|12177695|FG001|COMPLETED|Overall Study||0
11000416|NCT00699374|12177694|FG000|NOT COMPLETED|Overall Study||530
11000417|NCT00699374|12177695|FG001|NOT COMPLETED|Overall Study||544
11000418|NCT00699400|12177704|FG000|STARTED|Overall Study||42
11000419|NCT00699400|12177705|FG001|STARTED|Overall Study||3
11000420|NCT00699400|12177706|FG002|STARTED|Overall Study||138
11000421|NCT00699400|12177707|FG003|STARTED|Overall Study||6
11000422|NCT00699400|12177708|FG004|STARTED|Overall Study||4
11000423|NCT00699400|12177709|FG005|STARTED|Overall Study||11
11000424|NCT00699400|12177704|FG000|COMPLETED|Overall Study||42
11000425|NCT00699400|12177705|FG001|COMPLETED|Overall Study||3
11000426|NCT00699400|12177706|FG002|COMPLETED|Overall Study||138
11000427|NCT00699400|12177707|FG003|COMPLETED|Overall Study||6
11000428|NCT00699400|12177708|FG004|COMPLETED|Overall Study||4
11000429|NCT00699400|12177709|FG005|COMPLETED|Overall Study||0
11000430|NCT00699400|12177704|FG000|NOT COMPLETED|Overall Study||0
11000431|NCT00699400|12177705|FG001|NOT COMPLETED|Overall Study||0
11000432|NCT00699400|12177706|FG002|NOT COMPLETED|Overall Study||0
11000433|NCT00699400|12177707|FG003|NOT COMPLETED|Overall Study||0
11000434|NCT00699400|12177708|FG004|NOT COMPLETED|Overall Study||0
11000435|NCT00699400|12177709|FG005|NOT COMPLETED|Overall Study||11
11000436|NCT00699491|12177723|FG000|STARTED|Overall Study||3
11000437|NCT00699491|12177724|FG001|STARTED|Overall Study||2
11000438|NCT00699491|12177725|FG002|STARTED|Overall Study||7
11000439|NCT00699491|12177726|FG003|STARTED|Overall Study||6
11000440|NCT00699491|12177727|FG004|STARTED|Overall Study||8
11000441|NCT00699491|12177728|FG005|STARTED|Overall Study||22
11000442|NCT00699491|12177723|FG000|COMPLETED|Overall Study||3
11000443|NCT00699491|12177724|FG001|COMPLETED|Overall Study||2
11000444|NCT00699491|12177725|FG002|COMPLETED|Overall Study||7
11000445|NCT00699491|12177726|FG003|COMPLETED|Overall Study||6
11000446|NCT00699491|12177727|FG004|COMPLETED|Overall Study||8
11000447|NCT00699491|12177728|FG005|COMPLETED|Overall Study||22
11000448|NCT00699491|12177723|FG000|NOT COMPLETED|Overall Study||0
11000449|NCT00699491|12177724|FG001|NOT COMPLETED|Overall Study||0
11000450|NCT00699491|12177725|FG002|NOT COMPLETED|Overall Study||0
11000451|NCT00699491|12177726|FG003|NOT COMPLETED|Overall Study||0
11000452|NCT00699491|12177727|FG004|NOT COMPLETED|Overall Study||0
11000453|NCT00699491|12177728|FG005|NOT COMPLETED|Overall Study||0
11000454|NCT00699556|12177742|FG000|STARTED|First Intervention (1 Day)||11
11000455|NCT00699556|12177743|FG001|STARTED|First Intervention (1 Day)||11
11000456|NCT00699556|12177742|FG000|COMPLETED|First Intervention (1 Day)||11
11000457|NCT00699556|12177743|FG001|COMPLETED|First Intervention (1 Day)||11
11000458|NCT00699556|12177742|FG000|NOT COMPLETED|First Intervention (1 Day)||0
11000459|NCT00699556|12177743|FG001|NOT COMPLETED|First Intervention (1 Day)||0
11000460|NCT00699556|12177742|FG000|STARTED|Second Intervention (1 Day)||11
11000461|NCT00699556|12177743|FG001|STARTED|Second Intervention (1 Day)||11
11000462|NCT00699556|12177742|FG000|COMPLETED|Second Intervention (1 Day)||11
11000463|NCT00699556|12177743|FG001|COMPLETED|Second Intervention (1 Day)||11
11000464|NCT00699556|12177742|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
11000465|NCT00699556|12177743|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
11000466|NCT00699582|12177753|FG000|STARTED|Overall Study||138
11000467|NCT00699582|12177754|FG001|STARTED|Overall Study||130
11000468|NCT00699582|12177755|FG002|STARTED|Overall Study||121
11000469|NCT00699582|12177753|FG000|COMPLETED|Overall Study||120
11000470|NCT00699582|12177754|FG001|COMPLETED|Overall Study||108
11000471|NCT00699582|12177755|FG002|COMPLETED|Overall Study||93
11000472|NCT00699582|12177753|FG000|NOT COMPLETED|Overall Study||18
11000473|NCT00699582|12177754|FG001|NOT COMPLETED|Overall Study||22
11000474|NCT00699582|12177755|FG002|NOT COMPLETED|Overall Study||28
11000475|NCT00699608|12177763|FG000|STARTED|First Intervention||16
11000476|NCT00699608|12177764|FG001|STARTED|First Intervention||15
11000477|NCT00699608|12177765|FG002|STARTED|First Intervention||15
11000478|NCT00699608|12177766|FG003|STARTED|First Intervention||15
11000479|NCT00699608|12177767|FG004|STARTED|First Intervention||15
11000480|NCT00699608|12177768|FG005|STARTED|First Intervention||15
11000481|NCT00699608|12177763|FG000|COMPLETED|First Intervention||16
11000482|NCT00699608|12177764|FG001|COMPLETED|First Intervention||15
11000483|NCT00699608|12177765|FG002|COMPLETED|First Intervention||14
11000484|NCT00699608|12177766|FG003|COMPLETED|First Intervention||15
11000485|NCT00699608|12177767|FG004|COMPLETED|First Intervention||14
11000486|NCT00699608|12177768|FG005|COMPLETED|First Intervention||15
11000487|NCT00699608|12177763|FG000|NOT COMPLETED|First Intervention||0
11000488|NCT00699608|12177764|FG001|NOT COMPLETED|First Intervention||0
11000489|NCT00699608|12177765|FG002|NOT COMPLETED|First Intervention||1
11000490|NCT00699608|12177766|FG003|NOT COMPLETED|First Intervention||0
11000491|NCT00699608|12177767|FG004|NOT COMPLETED|First Intervention||1
11000492|NCT00699608|12177768|FG005|NOT COMPLETED|First Intervention||0
11000493|NCT00699608|12177763|FG000|STARTED|First 4-14 Day Washout Period||16
11000494|NCT00699608|12177764|FG001|STARTED|First 4-14 Day Washout Period||15
11000495|NCT00699608|12177765|FG002|STARTED|First 4-14 Day Washout Period||14
11000496|NCT00699608|12177766|FG003|STARTED|First 4-14 Day Washout Period||15
11000497|NCT00699608|12177767|FG004|STARTED|First 4-14 Day Washout Period||14
11000498|NCT00699608|12177768|FG005|STARTED|First 4-14 Day Washout Period||15
11000499|NCT00699608|12177763|FG000|COMPLETED|First 4-14 Day Washout Period||16
11000500|NCT00699608|12177764|FG001|COMPLETED|First 4-14 Day Washout Period||15
11000501|NCT00699608|12177765|FG002|COMPLETED|First 4-14 Day Washout Period||14
11000502|NCT00699608|12177766|FG003|COMPLETED|First 4-14 Day Washout Period||15
11000503|NCT00699608|12177767|FG004|COMPLETED|First 4-14 Day Washout Period||14
11000504|NCT00699608|12177768|FG005|COMPLETED|First 4-14 Day Washout Period||15
11000505|NCT00699608|12177763|FG000|NOT COMPLETED|First 4-14 Day Washout Period||0
11000506|NCT00699608|12177764|FG001|NOT COMPLETED|First 4-14 Day Washout Period||0
11000507|NCT00699608|12177765|FG002|NOT COMPLETED|First 4-14 Day Washout Period||0
11000508|NCT00699608|12177766|FG003|NOT COMPLETED|First 4-14 Day Washout Period||0
11000509|NCT00699608|12177767|FG004|NOT COMPLETED|First 4-14 Day Washout Period||0
11000510|NCT00699608|12177768|FG005|NOT COMPLETED|First 4-14 Day Washout Period||0
11000511|NCT00699608|12177763|FG000|STARTED|Second Intervention||16
11000512|NCT00699608|12177764|FG001|STARTED|Second Intervention||15
11000513|NCT00699608|12177765|FG002|STARTED|Second Intervention||14
11000514|NCT00699608|12177766|FG003|STARTED|Second Intervention||15
11000515|NCT00699608|12177767|FG004|STARTED|Second Intervention||14
11000516|NCT00699608|12177768|FG005|STARTED|Second Intervention||15
11000517|NCT00699608|12177763|FG000|COMPLETED|Second Intervention||16
11000518|NCT00699608|12177764|FG001|COMPLETED|Second Intervention||15
11000519|NCT00699608|12177765|FG002|COMPLETED|Second Intervention||13
11000520|NCT00699608|12177766|FG003|COMPLETED|Second Intervention||14
11000521|NCT00699608|12177767|FG004|COMPLETED|Second Intervention||14
11000522|NCT00699608|12177768|FG005|COMPLETED|Second Intervention||15
11000523|NCT00699608|12177763|FG000|NOT COMPLETED|Second Intervention||0
11000524|NCT00699608|12177764|FG001|NOT COMPLETED|Second Intervention||0
11000525|NCT00699608|12177765|FG002|NOT COMPLETED|Second Intervention||1
11000526|NCT00699608|12177766|FG003|NOT COMPLETED|Second Intervention||1
11000527|NCT00699608|12177767|FG004|NOT COMPLETED|Second Intervention||0
11000528|NCT00699608|12177768|FG005|NOT COMPLETED|Second Intervention||0
11000529|NCT00699608|12177763|FG000|STARTED|Second 4-14 Day Washout Period||16
11000530|NCT00699608|12177764|FG001|STARTED|Second 4-14 Day Washout Period||15
11000531|NCT00699608|12177765|FG002|STARTED|Second 4-14 Day Washout Period||13
11000532|NCT00699608|12177766|FG003|STARTED|Second 4-14 Day Washout Period||14
11000533|NCT00699608|12177767|FG004|STARTED|Second 4-14 Day Washout Period||14
11000534|NCT00699608|12177768|FG005|STARTED|Second 4-14 Day Washout Period||15
11000535|NCT00699608|12177763|FG000|COMPLETED|Second 4-14 Day Washout Period||16
11000536|NCT00699608|12177764|FG001|COMPLETED|Second 4-14 Day Washout Period||15
11000537|NCT00699608|12177765|FG002|COMPLETED|Second 4-14 Day Washout Period||13
11000538|NCT00699608|12177766|FG003|COMPLETED|Second 4-14 Day Washout Period||14
11000539|NCT00699608|12177767|FG004|COMPLETED|Second 4-14 Day Washout Period||14
11000540|NCT00699608|12177768|FG005|COMPLETED|Second 4-14 Day Washout Period||15
11000541|NCT00699608|12177763|FG000|NOT COMPLETED|Second 4-14 Day Washout Period||0
11000542|NCT00699608|12177764|FG001|NOT COMPLETED|Second 4-14 Day Washout Period||0
11000543|NCT00699608|12177765|FG002|NOT COMPLETED|Second 4-14 Day Washout Period||0
11000544|NCT00699608|12177766|FG003|NOT COMPLETED|Second 4-14 Day Washout Period||0
11000545|NCT00699608|12177767|FG004|NOT COMPLETED|Second 4-14 Day Washout Period||0
11000546|NCT00699608|12177768|FG005|NOT COMPLETED|Second 4-14 Day Washout Period||0
11000547|NCT00699608|12177763|FG000|STARTED|Third Intervention||16
11000548|NCT00699608|12177764|FG001|STARTED|Third Intervention||15
11000549|NCT00699608|12177765|FG002|STARTED|Third Intervention||13
11000550|NCT00699608|12177766|FG003|STARTED|Third Intervention||14
11000551|NCT00699608|12177767|FG004|STARTED|Third Intervention||14
11000552|NCT00699608|12177768|FG005|STARTED|Third Intervention||15
11000553|NCT00699608|12177763|FG000|COMPLETED|Third Intervention||16
11000554|NCT00699608|12177764|FG001|COMPLETED|Third Intervention||15
11000555|NCT00699608|12177765|FG002|COMPLETED|Third Intervention||13
11000556|NCT00699608|12177766|FG003|COMPLETED|Third Intervention||14
11000557|NCT00699608|12177767|FG004|COMPLETED|Third Intervention||14
11000558|NCT00699608|12177768|FG005|COMPLETED|Third Intervention||15
11000559|NCT00699608|12177763|FG000|NOT COMPLETED|Third Intervention||0
11000560|NCT00699608|12177764|FG001|NOT COMPLETED|Third Intervention||0
11000561|NCT00699608|12177765|FG002|NOT COMPLETED|Third Intervention||0
11000562|NCT00699608|12177766|FG003|NOT COMPLETED|Third Intervention||0
11000563|NCT00699608|12177767|FG004|NOT COMPLETED|Third Intervention||0
11000564|NCT00699608|12177768|FG005|NOT COMPLETED|Third Intervention||0
11000565|NCT00699660|12177778|FG000|STARTED|Overall Study||190
11000566|NCT00699660|12177779|FG001|STARTED|Overall Study||216
11000567|NCT00699660|12177778|FG000|COMPLETED|Overall Study||176
11000568|NCT00699660|12177779|FG001|COMPLETED|Overall Study||208
11000569|NCT00699660|12177778|FG000|NOT COMPLETED|Overall Study||14
11000570|NCT00699660|12177779|FG001|NOT COMPLETED|Overall Study||8
11000571|NCT00699699|12177785|FG000|STARTED|Overall Study||1280
11000572|NCT00699699|12177785|FG000|COMPLETED|Overall Study||1223
11000573|NCT00699699|12177785|FG000|NOT COMPLETED|Overall Study||57
11000574|NCT00699751|12177791|FG000|STARTED|Period 1: Without/Before Drug Switch||614
11000575|NCT00699751|12177792|FG001|STARTED|Period 1: Without/Before Drug Switch||307
11000576|NCT00699751|12177791|FG000|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
11000577|NCT00699751|12177792|FG001|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
11000578|NCT00699751|12177791|FG000|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
11000579|NCT00699751|12177792|FG001|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
11000580|NCT00699751|12177791|FG000|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
11000581|NCT00699751|12177792|FG001|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
11000582|NCT00699751|12177791|FG000|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
11000583|NCT00699751|12177792|FG001|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
11000584|NCT00699751|12177791|FG000|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
11000585|NCT00699751|12177792|FG001|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
11000586|NCT00699751|12177791|FG000|STARTED|Period 2:Switched From Placebo to Xofigo||0
11000587|NCT00699751|12177792|FG001|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
11000588|NCT00699751|12177791|FG000|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
11000589|NCT00699751|12177792|FG001|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
11000590|NCT00699751|12177791|FG000|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
11000591|NCT00699751|12177792|FG001|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
11000592|NCT00699751|12177791|FG000|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
11000593|NCT00699751|12177792|FG001|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
11000594|NCT00699751|12177791|FG000|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
11000595|NCT00699751|12177792|FG001|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
11000596|NCT00699751|12177791|FG000|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
11000597|NCT00699751|12177792|FG001|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
11000598|NCT00699803|12177801|FG000|STARTED|Overall Study||32
11000599|NCT00699803|12177802|FG001|STARTED|Overall Study||32
11000600|NCT00699803|12177801|FG000|COMPLETED|Overall Study||30
11000601|NCT00699803|12177802|FG001|COMPLETED|Overall Study||26
11000602|NCT00699803|12177801|FG000|NOT COMPLETED|Overall Study||2
11000603|NCT00699803|12177802|FG001|NOT COMPLETED|Overall Study||6
11000604|NCT00699816|12177810|FG000|STARTED|Overall Study||115
11000605|NCT00699816|12177811|FG001|STARTED|Overall Study||115
11000606|NCT00699816|12177810|FG000|COMPLETED|Overall Study||114
11000607|NCT00699816|12177811|FG001|COMPLETED|Overall Study||112
11000608|NCT00699816|12177810|FG000|NOT COMPLETED|Overall Study||1
11000609|NCT00699816|12177811|FG001|NOT COMPLETED|Overall Study||3
11000610|NCT00699907|12177820|FG000|STARTED|Overall Study||14
11000611|NCT00699907|12177821|FG001|STARTED|Overall Study||57
11000612|NCT00699907|12177822|FG002|STARTED|Overall Study||56
11000613|NCT00699907|12177820|FG000|COMPLETED|Overall Study||12
11000614|NCT00699907|12177821|FG001|COMPLETED|Overall Study||47
11000615|NCT00699907|12177822|FG002|COMPLETED|Overall Study||48
11000616|NCT00699907|12177820|FG000|NOT COMPLETED|Overall Study||2
11000617|NCT00699907|12177821|FG001|NOT COMPLETED|Overall Study||10
11000618|NCT00699907|12177822|FG002|NOT COMPLETED|Overall Study||8
11000619|NCT00699972|12177833|FG000|STARTED|Overall Study||122
11000620|NCT00699972|12177834|FG001|STARTED|Overall Study||133
11000621|NCT00699972|12177835|FG002|STARTED|Overall Study||135
11000622|NCT00699972|12177833|FG000|COMPLETED|Overall Study||106
11000623|NCT00699972|12177834|FG001|COMPLETED|Overall Study||114
11000624|NCT00699972|12177835|FG002|COMPLETED|Overall Study||100
11000625|NCT00699972|12177833|FG000|NOT COMPLETED|Overall Study||16
11000626|NCT00699972|12177834|FG001|NOT COMPLETED|Overall Study||19
11000627|NCT00699972|12177835|FG002|NOT COMPLETED|Overall Study||35
11000628|NCT00699998|12177847|FG000|STARTED|Overall Study||3620
11000629|NCT00699998|12177848|FG001|STARTED|Overall Study||1043
11000630|NCT00699998|12177849|FG002|STARTED|Overall Study||3623
11000631|NCT00699998|12177850|FG003|STARTED|Overall Study||1040
11000632|NCT00699998|12177847|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3590
11000633|NCT00699998|12177848|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1033
11000634|NCT00699998|12177849|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3590
11000635|NCT00699998|12177850|FG003|Received at Least 1 Dose of Study Drug|Overall Study||1027
11000636|NCT00699998|12177847|FG000|COMPLETED|Overall Study||3421
11000637|NCT00699998|12177848|FG001|COMPLETED|Overall Study||957
11000638|NCT00699998|12177849|FG002|COMPLETED|Overall Study||3417
11000639|NCT00699998|12177850|FG003|COMPLETED|Overall Study||958
11000640|NCT00699998|12177847|FG000|NOT COMPLETED|Overall Study||199
11000641|NCT00699998|12177848|FG001|NOT COMPLETED|Overall Study||86
11000642|NCT00699998|12177849|FG002|NOT COMPLETED|Overall Study||206
11000643|NCT00699998|12177850|FG003|NOT COMPLETED|Overall Study||82
11000644|NCT00700011|12177867|FG000|STARTED|Overall Study||8
11000645|NCT00700011|12177868|FG001|STARTED|Overall Study||2
11000646|NCT00700011|12177867|FG000|COMPLETED|Overall Study||8
11000647|NCT00700011|12177868|FG001|COMPLETED|Overall Study||1
11000648|NCT00700011|12177867|FG000|NOT COMPLETED|Overall Study||0
11000649|NCT00700011|12177868|FG001|NOT COMPLETED|Overall Study||1
11000650|NCT00700063|12177882|FG000|STARTED|Overall Study||33
11000651|NCT00700063|12177883|FG001|STARTED|Overall Study||34
11000652|NCT00700063|12177884|FG002|STARTED|Overall Study||33
11000653|NCT00700063|12177885|FG003|STARTED|Overall Study||33
11000654|NCT00700063|12177886|FG004|STARTED|Overall Study||33
11000655|NCT00700063|12177887|FG005|STARTED|Overall Study||34
11000656|NCT00700063|12177888|FG006|STARTED|Overall Study||32
11000657|NCT00700063|12177889|FG007|STARTED|Overall Study||33
11000658|NCT00700063|12177882|FG000|COMPLETED|Overall Study||32
11000659|NCT00700063|12177883|FG001|COMPLETED|Overall Study||34
11000660|NCT00700063|12177884|FG002|COMPLETED|Overall Study||33
11000661|NCT00700063|12177885|FG003|COMPLETED|Overall Study||31
11000662|NCT00700063|12177886|FG004|COMPLETED|Overall Study||31
11000663|NCT00700063|12177887|FG005|COMPLETED|Overall Study||34
11000664|NCT00700063|12177888|FG006|COMPLETED|Overall Study||32
11000665|NCT00700063|12177889|FG007|COMPLETED|Overall Study||33
11000666|NCT00700063|12177882|FG000|NOT COMPLETED|Overall Study||1
11000667|NCT00700063|12177883|FG001|NOT COMPLETED|Overall Study||0
11000668|NCT00700063|12177884|FG002|NOT COMPLETED|Overall Study||0
11000669|NCT00700063|12177885|FG003|NOT COMPLETED|Overall Study||2
11000670|NCT00700063|12177886|FG004|NOT COMPLETED|Overall Study||2
11000671|NCT00700063|12177887|FG005|NOT COMPLETED|Overall Study||0
11000672|NCT00700063|12177888|FG006|NOT COMPLETED|Overall Study||0
11000673|NCT00700063|12177889|FG007|NOT COMPLETED|Overall Study||0
11000674|NCT00700102|12177909|FG000|STARTED|Overall Study||411
11000675|NCT00700102|12177910|FG001|STARTED|Overall Study||409
11000676|NCT00700102|12177909|FG000|Intention to Treat|Overall Study||410
11000677|NCT00700102|12177910|FG001|Intention to Treat|Overall Study||409
11000678|NCT00700102|12177909|FG000|Received at Least One Dose|Overall Study||407
11000679|NCT00700102|12177910|FG001|Received at Least One Dose|Overall Study||403
11000680|NCT00700102|12177909|FG000|COMPLETED|Overall Study||9
11000681|NCT00700102|12177910|FG001|COMPLETED|Overall Study||14
11000682|NCT00700102|12177909|FG000|NOT COMPLETED|Overall Study||402
11000683|NCT00700102|12177910|FG001|NOT COMPLETED|Overall Study||395
11000684|NCT00700115|12177918|FG000|STARTED|Overall Study||40
11000685|NCT00700115|12177919|FG001|STARTED|Overall Study||20
11000686|NCT00700115|12177918|FG000|COMPLETED|Overall Study||39
11000687|NCT00700115|12177919|FG001|COMPLETED|Overall Study||19
11000688|NCT00700115|12177918|FG000|NOT COMPLETED|Overall Study||1
11000689|NCT00700115|12177919|FG001|NOT COMPLETED|Overall Study||1
11000690|NCT00700141|12177925|FG000|STARTED|Overall Study||482
11000691|NCT00700141|12177925|FG000|COMPLETED|Overall Study||482
11000692|NCT00700141|12177925|FG000|NOT COMPLETED|Overall Study||0
11000693|NCT00700180|12177931|FG000|STARTED|Overall Study||154
11000694|NCT00700180|12177932|FG001|STARTED|Overall Study||149
11000695|NCT00700180|12177931|FG000|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
11000696|NCT00700180|12177932|FG001|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
11000697|NCT00700180|12177931|FG000|NOT COMPLETED|Overall Study||154
11000698|NCT00700180|12177932|FG001|NOT COMPLETED|Overall Study||149
11000699|NCT00700271|12177940|FG000|STARTED|Overall Study||278
11000700|NCT00700271|12177941|FG001|STARTED|Overall Study||268
11000701|NCT00700271|12177940|FG000|COMPLETED|Overall Study||264
11000702|NCT00700271|12177941|FG001|COMPLETED|Overall Study||256
11000703|NCT00700271|12177940|FG000|NOT COMPLETED|Overall Study||14
11000704|NCT00700271|12177941|FG001|NOT COMPLETED|Overall Study||12
11000705|NCT00700310|12177951|FG000|STARTED|Overall Study||187
11000706|NCT00700310|12177952|FG001|STARTED|Overall Study||180
11000707|NCT00700310|12177953|FG002|STARTED|Overall Study||174
11000708|NCT00700310|12177954|FG003|STARTED|Overall Study||171
11000709|NCT00700310|12177951|FG000|COMPLETED|Overall Study||166
11000710|NCT00700310|12177952|FG001|COMPLETED|Overall Study||154
11000711|NCT00700310|12177953|FG002|COMPLETED|Overall Study||158
11000712|NCT00700310|12177954|FG003|COMPLETED|Overall Study||145
11000713|NCT00700310|12177951|FG000|NOT COMPLETED|Overall Study||21
11000714|NCT00700310|12177952|FG001|NOT COMPLETED|Overall Study||26
11000715|NCT00700310|12177953|FG002|NOT COMPLETED|Overall Study||16
11000716|NCT00700310|12177954|FG003|NOT COMPLETED|Overall Study||26
11000717|NCT00700336|12177967|FG000|STARTED|Overall Study||40
11000718|NCT00700336|12177968|FG001|STARTED|Overall Study||23
11000719|NCT00700336|12177969|FG002|STARTED|Overall Study||6
11000720|NCT00700336|12177967|FG000|COMPLETED|Overall Study||40
11000721|NCT00700336|12177968|FG001|COMPLETED|Overall Study||23
11000722|NCT00700336|12177969|FG002|COMPLETED|Overall Study||6
11000723|NCT00700336|12177967|FG000|NOT COMPLETED|Overall Study||0
11000724|NCT00700336|12177968|FG001|NOT COMPLETED|Overall Study||0
11000725|NCT00700336|12177969|FG002|NOT COMPLETED|Overall Study||0
11000726|NCT00700375|12177978|FG000|STARTED|Overall Study||30
11000727|NCT00700375|12177979|FG001|STARTED|Overall Study||29
11000728|NCT00700375|12177978|FG000|2 Days After Creatinine Mesurement|Overall Study||30
11000729|NCT00700375|12177979|FG001|2 Days After Creatinine Mesurement|Overall Study||29
11000730|NCT00700375|12177978|FG000|COMPLETED|Overall Study||30
11000731|NCT00700375|12177979|FG001|COMPLETED|Overall Study||29
11000732|NCT00700375|12177978|FG000|NOT COMPLETED|Overall Study||0
11000733|NCT00700375|12177979|FG001|NOT COMPLETED|Overall Study||0
11000734|NCT00700401|12177985|FG000|STARTED|Overall Study||262
11000735|NCT00700401|12177985|FG000|COMPLETED|Overall Study||168
11000736|NCT00700401|12177985|FG000|NOT COMPLETED|Overall Study||94
11000737|NCT00700427|12177989|FG000|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
11000738|NCT00700427|12177990|FG001|STARTED|Study Period 2 (Open-Label Acute Trx)||0
11000739|NCT00700427|12177991|FG002|STARTED|Study Period 2 (Open-Label Acute Trx)||0
11000740|NCT00700427|12177992|FG003|STARTED|Study Period 2 (Open-Label Acute Trx)||0
11000741|NCT00700427|12177993|FG004|STARTED|Study Period 2 (Open-Label Acute Trx)||0
11000742|NCT00700427|12177989|FG000|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
11000743|NCT00700427|12177990|FG001|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
11000744|NCT00700427|12177991|FG002|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
11000745|NCT00700427|12177992|FG003|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
11000746|NCT00700427|12177993|FG004|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
11000747|NCT00700427|12177989|FG000|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
11000748|NCT00700427|12177990|FG001|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
11000749|NCT00700427|12177991|FG002|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
11000750|NCT00700427|12177992|FG003|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
11000751|NCT00700427|12177993|FG004|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
11000752|NCT00700427|12177989|FG000|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
11000753|NCT00700427|12177990|FG001|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
11000754|NCT00700427|12177991|FG002|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
11000755|NCT00700427|12177992|FG003|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
11000756|NCT00700427|12177993|FG004|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
11000757|NCT00700427|12177989|FG000|STARTED|Study Period 3A (Blinded Maintenance)||0
11000758|NCT00700427|12177990|FG001|STARTED|Study Period 3A (Blinded Maintenance)||1005
11000759|NCT00700427|12177991|FG002|STARTED|Study Period 3A (Blinded Maintenance)||0
11000760|NCT00700427|12177992|FG003|STARTED|Study Period 3A (Blinded Maintenance)||0
11000761|NCT00700427|12177993|FG004|STARTED|Study Period 3A (Blinded Maintenance)||0
11000762|NCT00700427|12177989|FG000|COMPLETED|Study Period 3A (Blinded Maintenance)||0
11000763|NCT00700427|12177990|FG001|COMPLETED|Study Period 3A (Blinded Maintenance)||524
11000764|NCT00700427|12177991|FG002|COMPLETED|Study Period 3A (Blinded Maintenance)||0
11000765|NCT00700427|12177992|FG003|COMPLETED|Study Period 3A (Blinded Maintenance)||0
11000766|NCT00700427|12177993|FG004|COMPLETED|Study Period 3A (Blinded Maintenance)||0
11000767|NCT00700427|12177989|FG000|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
11000768|NCT00700427|12177990|FG001|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
11000769|NCT00700427|12177991|FG002|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
11000770|NCT00700427|12177992|FG003|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
11000771|NCT00700427|12177993|FG004|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
11000772|NCT00700427|12177989|FG000|STARTED|Study Period 3B (Randomized Withdrawal)||0
11000773|NCT00700427|12177990|FG001|STARTED|Study Period 3B (Randomized Withdrawal)||0
11000774|NCT00700427|12177991|FG002|STARTED|Study Period 3B (Randomized Withdrawal)||266
11000775|NCT00700427|12177992|FG003|STARTED|Study Period 3B (Randomized Withdrawal)||258
11000776|NCT00700427|12177993|FG004|STARTED|Study Period 3B (Randomized Withdrawal)||0
11000777|NCT00700427|12177989|FG000|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
11000778|NCT00700427|12177990|FG001|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
11000779|NCT00700427|12177991|FG002|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
11000780|NCT00700427|12177992|FG003|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
11000781|NCT00700427|12177993|FG004|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
11000782|NCT00700427|12177989|FG000|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
11000783|NCT00700427|12177990|FG001|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
11000784|NCT00700427|12177991|FG002|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
11000785|NCT00700427|12177992|FG003|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
11000786|NCT00700427|12177993|FG004|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
11000787|NCT00700427|12177989|FG000|STARTED|Study Period 4 (Open-Label Extension)||0
11000788|NCT00700427|12177990|FG001|STARTED|Study Period 4 (Open-Label Extension)||0
11000789|NCT00700427|12177991|FG002|STARTED|Study Period 4 (Open-Label Extension)||0
11000790|NCT00700427|12177992|FG003|STARTED|Study Period 4 (Open-Label Extension)||0
11000791|NCT00700427|12177993|FG004|STARTED|Study Period 4 (Open-Label Extension)||180
11000792|NCT00700427|12177989|FG000|COMPLETED|Study Period 4 (Open-Label Extension)||0
11000793|NCT00700427|12177990|FG001|COMPLETED|Study Period 4 (Open-Label Extension)||0
11000794|NCT00700427|12177991|FG002|COMPLETED|Study Period 4 (Open-Label Extension)||0
11000795|NCT00700427|12177992|FG003|COMPLETED|Study Period 4 (Open-Label Extension)||0
11000796|NCT00700427|12177993|FG004|COMPLETED|Study Period 4 (Open-Label Extension)||96
11000797|NCT00700427|12177989|FG000|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
11000798|NCT00700427|12177990|FG001|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
11000799|NCT00700427|12177991|FG002|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
11000800|NCT00700427|12177992|FG003|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
11000801|NCT00700427|12177993|FG004|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
11000802|NCT00700440|12178001|FG000|STARTED|Overall Study||100
11000803|NCT00700440|12178001|FG000|COMPLETED|Overall Study||100
11000804|NCT00700440|12178001|FG000|NOT COMPLETED|Overall Study||0
11000805|NCT00700570|12178007|FG000|STARTED|Overall Study||19
11000806|NCT00700570|12178008|FG001|STARTED|Overall Study||26
11000807|NCT00700570|12178007|FG000|COMPLETED|Overall Study||8
11000808|NCT00700570|12178008|FG001|COMPLETED|Overall Study||0
11000809|NCT00700570|12178007|FG000|NOT COMPLETED|Overall Study||11
11000810|NCT00700570|12178008|FG001|NOT COMPLETED|Overall Study||26
11000811|NCT00700622|12178016|FG000|STARTED|Overall Study||65
11000812|NCT00700622|12178017|FG001|STARTED|Overall Study||65
11000813|NCT00700622|12178016|FG000|COMPLETED|Overall Study||52
11000814|NCT00700622|12178017|FG001|COMPLETED|Overall Study||60
11000815|NCT00700622|12178016|FG000|NOT COMPLETED|Overall Study||13
11000816|NCT00700622|12178017|FG001|NOT COMPLETED|Overall Study||5
11000817|NCT00700635|12178026|FG000|STARTED|Overall Study||111
11000818|NCT00700635|12178027|FG001|STARTED|Overall Study||111
11000819|NCT00700635|12178028|FG002|STARTED|Overall Study||111
11000820|NCT00700635|12178026|FG000|COMPLETED|Overall Study||100
11000821|NCT00700635|12178027|FG001|COMPLETED|Overall Study||103
11000822|NCT00700635|12178028|FG002|COMPLETED|Overall Study||110
11000823|NCT00700635|12178026|FG000|NOT COMPLETED|Overall Study||11
11000824|NCT00700635|12178027|FG001|NOT COMPLETED|Overall Study||8
11000825|NCT00700635|12178028|FG002|NOT COMPLETED|Overall Study||1
11000826|NCT00700713|12178039|FG000|STARTED|Overall Study||48
11000827|NCT00700713|12178040|FG001|STARTED|Overall Study||66
11000828|NCT00700713|12178041|FG002|STARTED|Overall Study||67
11000829|NCT00700713|12178039|FG000|COMPLETED|Overall Study||47
11000830|NCT00700713|12178040|FG001|COMPLETED|Overall Study||66
11000831|NCT00700713|12178041|FG002|COMPLETED|Overall Study||65
11000832|NCT00700713|12178039|FG000|NOT COMPLETED|Overall Study||1
11000833|NCT00700713|12178040|FG001|NOT COMPLETED|Overall Study||0
11000834|NCT00700713|12178041|FG002|NOT COMPLETED|Overall Study||2
11000835|NCT00700739|12178051|FG000|STARTED|Overall Study||22
11000836|NCT00700739|12178052|FG001|STARTED|Overall Study||16
11000837|NCT00700739|12178051|FG000|COMPLETED|Overall Study||18
11000838|NCT00700739|12178052|FG001|COMPLETED|Overall Study||12
11000839|NCT00700739|12178051|FG000|NOT COMPLETED|Overall Study||4
11000840|NCT00700739|12178052|FG001|NOT COMPLETED|Overall Study||4
11000841|NCT00700752|12178059|FG000|STARTED|First Intervention||20
11000842|NCT00700752|12178060|FG001|STARTED|First Intervention||20
11000843|NCT00700752|12178059|FG000|COMPLETED|First Intervention||20
11000844|NCT00700752|12178060|FG001|COMPLETED|First Intervention||18
11000845|NCT00700752|12178059|FG000|NOT COMPLETED|First Intervention||0
11000846|NCT00700752|12178060|FG001|NOT COMPLETED|First Intervention||2
11000847|NCT00700752|12178059|FG000|STARTED|Second Intervention||20
11000848|NCT00700752|12178060|FG001|STARTED|Second Intervention||18
11000849|NCT00700752|12178059|FG000|COMPLETED|Second Intervention||20
11000850|NCT00700752|12178060|FG001|COMPLETED|Second Intervention||18
11000851|NCT00700752|12178059|FG000|NOT COMPLETED|Second Intervention||0
11000852|NCT00700752|12178060|FG001|NOT COMPLETED|Second Intervention||0
11000853|NCT00700804|12178068|FG000|STARTED|Overall Study||17
11000854|NCT00700804|12178069|FG001|STARTED|Overall Study||17
11000855|NCT00700804|12178068|FG000|COMPLETED|Overall Study||14
11000856|NCT00700804|12178069|FG001|COMPLETED|Overall Study||13
11000857|NCT00700804|12178068|FG000|NOT COMPLETED|Overall Study||3
11000858|NCT00700804|12178069|FG001|NOT COMPLETED|Overall Study||4
11000859|NCT00700817|12178080|FG000|STARTED|Week 0-26 (Main Period)|Randomised|225
11000860|NCT00700817|12178081|FG001|STARTED|Week 0-26 (Main Period)|Randomised|221
11000861|NCT00700817|12178082|FG002|STARTED|Week 0-26 (Main Period)|Randomised|219
11000862|NCT00700817|12178083|FG003|STARTED|Week 0-26 (Main Period)||0
11000863|NCT00700817|12178084|FG004|STARTED|Week 0-26 (Main Period)||0
11000864|NCT00700817|12178080|FG000|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
11000865|NCT00700817|12178081|FG001|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
11000866|NCT00700817|12178082|FG002|Exposed|Week 0-26 (Main Period)||219
11000867|NCT00700817|12178083|FG003|Exposed|Week 0-26 (Main Period)||0
11000868|NCT00700817|12178084|FG004|Exposed|Week 0-26 (Main Period)||0
11000869|NCT00700817|12178080|FG000|COMPLETED|Week 0-26 (Main Period)||169
11000870|NCT00700817|12178081|FG001|COMPLETED|Week 0-26 (Main Period)||191
11000871|NCT00700817|12178082|FG002|COMPLETED|Week 0-26 (Main Period)||194
11000872|NCT00700817|12178083|FG003|COMPLETED|Week 0-26 (Main Period)||0
11000873|NCT00700817|12178084|FG004|COMPLETED|Week 0-26 (Main Period)||0
11000874|NCT00700817|12178080|FG000|NOT COMPLETED|Week 0-26 (Main Period)||56
11000875|NCT00700817|12178081|FG001|NOT COMPLETED|Week 0-26 (Main Period)||30
11000876|NCT00700817|12178082|FG002|NOT COMPLETED|Week 0-26 (Main Period)||25
11000877|NCT00700817|12178083|FG003|NOT COMPLETED|Week 0-26 (Main Period)||0
11000878|NCT00700817|12178084|FG004|NOT COMPLETED|Week 0-26 (Main Period)||0
11000879|NCT00700817|12178080|FG000|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
11000880|NCT00700817|12178081|FG001|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
11000881|NCT00700817|12178082|FG002|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
11000882|NCT00700817|12178083|FG003|STARTED|Week 26-52 (Extension Period 1)||0
11000883|NCT00700817|12178084|FG004|STARTED|Week 26-52 (Extension Period 1)||0
11000884|NCT00700817|12178080|FG000|COMPLETED|Week 26-52 (Extension Period 1)||135
11000885|NCT00700817|12178081|FG001|COMPLETED|Week 26-52 (Extension Period 1)||150
11000886|NCT00700817|12178082|FG002|COMPLETED|Week 26-52 (Extension Period 1)||151
11000887|NCT00700817|12178083|FG003|COMPLETED|Week 26-52 (Extension Period 1)||0
11000888|NCT00700817|12178084|FG004|COMPLETED|Week 26-52 (Extension Period 1)||0
11000889|NCT00700817|12178080|FG000|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
11000890|NCT00700817|12178081|FG001|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
11000891|NCT00700817|12178082|FG002|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
11000892|NCT00700817|12178083|FG003|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
11000893|NCT00700817|12178084|FG004|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
11000894|NCT00700817|12178080|FG000|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
11000895|NCT00700817|12178081|FG001|STARTED|Week 52-78 (Extension Period 2)||150
11000896|NCT00700817|12178082|FG002|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
11000897|NCT00700817|12178083|FG003|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
11000898|NCT00700817|12178084|FG004|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
11000899|NCT00700817|12178080|FG000|COMPLETED|Week 52-78 (Extension Period 2)||124
11000900|NCT00700817|12178081|FG001|COMPLETED|Week 52-78 (Extension Period 2)||135
11000901|NCT00700817|12178082|FG002|COMPLETED|Week 52-78 (Extension Period 2)||0
11000902|NCT00700817|12178083|FG003|COMPLETED|Week 52-78 (Extension Period 2)||59
11000903|NCT00700817|12178084|FG004|COMPLETED|Week 52-78 (Extension Period 2)||63
11000904|NCT00700817|12178080|FG000|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
11000905|NCT00700817|12178081|FG001|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
11000906|NCT00700817|12178082|FG002|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
11000907|NCT00700817|12178083|FG003|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
11000908|NCT00700817|12178084|FG004|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
11000909|NCT00700973|12178096|FG000|STARTED|Overall Study||71
11000910|NCT00700973|12178097|FG001|STARTED|Overall Study||70
11000911|NCT00700973|12178096|FG000|COMPLETED|Overall Study||63
11000912|NCT00700973|12178097|FG001|COMPLETED|Overall Study||63
11000913|NCT00700973|12178096|FG000|NOT COMPLETED|Overall Study||8
11000914|NCT00700973|12178097|FG001|NOT COMPLETED|Overall Study||7
11000915|NCT00700999|12178105|FG000|STARTED|Overall Study||36
11000916|NCT00700999|12178106|FG001|STARTED|Overall Study||29
11000917|NCT00700999|12178105|FG000|First MRI Scan|Overall Study||29
11000918|NCT00700999|12178106|FG001|First MRI Scan|Overall Study||22
11000919|NCT00700999|12178105|FG000|Second MRI Scan|Overall Study||19
11000920|NCT00700999|12178106|FG001|Second MRI Scan|Overall Study||18
11000921|NCT00700999|12178105|FG000|COMPLETED|Overall Study||21
11000922|NCT00700999|12178106|FG001|COMPLETED|Overall Study||20
11000923|NCT00700999|12178105|FG000|NOT COMPLETED|Overall Study||15
11000924|NCT00700999|12178106|FG001|NOT COMPLETED|Overall Study||9
11000925|NCT00701038|12178114|FG000|STARTED|Overall Study||27
11000926|NCT00701038|12178115|FG001|STARTED|Overall Study||27
11000927|NCT00701038|12178114|FG000|COMPLETED|Overall Study||23
11000928|NCT00701038|12178115|FG001|COMPLETED|Overall Study||23
11000929|NCT00701038|12178114|FG000|NOT COMPLETED|Overall Study||4
11000930|NCT00701038|12178115|FG001|NOT COMPLETED|Overall Study||4
11000931|NCT00701051|12178123|FG000|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
11000932|NCT00701051|12178124|FG001|STARTED|Screening||0
11000933|NCT00701051|12178125|FG002|STARTED|Screening||0
11000934|NCT00701051|12178123|FG000|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
11000935|NCT00701051|12178124|FG001|COMPLETED|Screening||0
11000936|NCT00701051|12178125|FG002|COMPLETED|Screening||0
11000937|NCT00701051|12178123|FG000|NOT COMPLETED|Screening||59
11000938|NCT00701051|12178124|FG001|NOT COMPLETED|Screening||0
11000939|NCT00701051|12178125|FG002|NOT COMPLETED|Screening||0
11000940|NCT00701051|12178123|FG000|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
11000941|NCT00701051|12178124|FG001|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
11000942|NCT00701051|12178125|FG002|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
11000943|NCT00701051|12178123|FG000|COMPLETED|Exercise Intervention||0
11000944|NCT00701051|12178124|FG001|COMPLETED|Exercise Intervention||14
11000945|NCT00701051|12178125|FG002|COMPLETED|Exercise Intervention||9
11000946|NCT00701051|12178123|FG000|NOT COMPLETED|Exercise Intervention||0
11000947|NCT00701051|12178124|FG001|NOT COMPLETED|Exercise Intervention||5
11000948|NCT00701051|12178125|FG002|NOT COMPLETED|Exercise Intervention||3
11000949|NCT00701051|12178123|FG000|STARTED|Detraining Intervention (Optional)||0
11000950|NCT00701051|12178124|FG001|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
11000951|NCT00701051|12178125|FG002|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
11000952|NCT00701051|12178123|FG000|COMPLETED|Detraining Intervention (Optional)||0
11000953|NCT00701051|12178124|FG001|COMPLETED|Detraining Intervention (Optional)||6
11000954|NCT00701051|12178125|FG002|COMPLETED|Detraining Intervention (Optional)||6
11000955|NCT00701051|12178123|FG000|NOT COMPLETED|Detraining Intervention (Optional)||0
11000956|NCT00701051|12178124|FG001|NOT COMPLETED|Detraining Intervention (Optional)||0
11000957|NCT00701051|12178125|FG002|NOT COMPLETED|Detraining Intervention (Optional)||0
11000958|NCT00701064|12178133|FG000|STARTED|Overall Study||35
11000959|NCT00701064|12178134|FG001|STARTED|Overall Study||36
11000960|NCT00701064|12178133|FG000|COMPLETED|Overall Study||31
11000961|NCT00701064|12178134|FG001|COMPLETED|Overall Study||32
11000962|NCT00701064|12178133|FG000|NOT COMPLETED|Overall Study||4
11000963|NCT00701064|12178134|FG001|NOT COMPLETED|Overall Study||4
11000964|NCT00701090|12178142|FG000|STARTED|Overall Study||516
11000965|NCT00701090|12178143|FG001|STARTED|Overall Study||519
11000966|NCT00701090|12178142|FG000|COMPLETED|Overall Study||468
11000967|NCT00701090|12178143|FG001|COMPLETED|Overall Study||468
11000968|NCT00701090|12178142|FG000|NOT COMPLETED|Overall Study||48
11000969|NCT00701090|12178143|FG001|NOT COMPLETED|Overall Study||51
11000970|NCT00701103|12178160|FG000|STARTED|Overall Study||5
11000971|NCT00701103|12178161|FG001|STARTED|Overall Study||3
11000972|NCT00701103|12178162|FG002|STARTED|Overall Study||8
11000973|NCT00701103|12178163|FG003|STARTED|Overall Study||6
11000974|NCT00701103|12178164|FG004|STARTED|Overall Study||6
11000975|NCT00701103|12178165|FG005|STARTED|Overall Study||6
11000976|NCT00701103|12178166|FG006|STARTED|Overall Study||8
11000977|NCT00701103|12178167|FG007|STARTED|Overall Study||7
11000978|NCT00701103|12178168|FG008|STARTED|Overall Study||9
11000979|NCT00701103|12178169|FG009|STARTED|Overall Study||11
11000980|NCT00701103|12178170|FG010|STARTED|Overall Study||11
11000981|NCT00701103|12178160|FG000|COMPLETED|Overall Study||0
11000982|NCT00701103|12178161|FG001|COMPLETED|Overall Study||0
11000983|NCT00701103|12178162|FG002|COMPLETED|Overall Study||0
11000984|NCT00701103|12178163|FG003|COMPLETED|Overall Study||0
11000985|NCT00701103|12178164|FG004|COMPLETED|Overall Study||0
11000986|NCT00701103|12178165|FG005|COMPLETED|Overall Study||0
11000987|NCT00701103|12178166|FG006|COMPLETED|Overall Study||0
11000988|NCT00701103|12178167|FG007|COMPLETED|Overall Study||0
11000989|NCT00701103|12178168|FG008|COMPLETED|Overall Study||0
11000990|NCT00701103|12178169|FG009|COMPLETED|Overall Study||0
11000991|NCT00701103|12178170|FG010|COMPLETED|Overall Study||0
11000992|NCT00701103|12178160|FG000|NOT COMPLETED|Overall Study||5
11000993|NCT00701103|12178161|FG001|NOT COMPLETED|Overall Study||3
11000994|NCT00701103|12178162|FG002|NOT COMPLETED|Overall Study||8
11000995|NCT00701103|12178163|FG003|NOT COMPLETED|Overall Study||6
11000996|NCT00701103|12178164|FG004|NOT COMPLETED|Overall Study||6
11000997|NCT00701103|12178165|FG005|NOT COMPLETED|Overall Study||6
11000998|NCT00701103|12178166|FG006|NOT COMPLETED|Overall Study||8
11000999|NCT00701103|12178167|FG007|NOT COMPLETED|Overall Study||7
11001000|NCT00701103|12178168|FG008|NOT COMPLETED|Overall Study||9
11001001|NCT00701103|12178169|FG009|NOT COMPLETED|Overall Study||11
11001002|NCT00701103|12178170|FG010|NOT COMPLETED|Overall Study||11
11001003|NCT00701129|12178198|FG000|STARTED|Overall Study||4
11001004|NCT00701129|12178198|FG000|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
11001005|NCT00701129|12178198|FG000|COMPLETED|Overall Study||2
11001006|NCT00701129|12178198|FG000|NOT COMPLETED|Overall Study||2
11001007|NCT00701311|12178202|FG000|STARTED|Overall Study||17
11001008|NCT00701311|12178202|FG000|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
11001009|NCT00701311|12178202|FG000|NOT COMPLETED|Overall Study||8
11001010|NCT00701363|12178210|FG000|STARTED|Screening (Pre-assignment) Phase||128
11001011|NCT00701363|12178211|FG001|STARTED|Screening (Pre-assignment) Phase||0
11001012|NCT00701363|12178212|FG002|STARTED|Screening (Pre-assignment) Phase||0
11001013|NCT00701363|12178213|FG003|STARTED|Screening (Pre-assignment) Phase||0
11001014|NCT00701363|12178210|FG000|COMPLETED|Screening (Pre-assignment) Phase||124
11001015|NCT00701363|12178211|FG001|COMPLETED|Screening (Pre-assignment) Phase||0
11001016|NCT00701363|12178212|FG002|COMPLETED|Screening (Pre-assignment) Phase||0
11001017|NCT00701363|12178213|FG003|COMPLETED|Screening (Pre-assignment) Phase||0
11001018|NCT00701363|12178210|FG000|NOT COMPLETED|Screening (Pre-assignment) Phase||4
11001019|NCT00701363|12178211|FG001|NOT COMPLETED|Screening (Pre-assignment) Phase||0
11001020|NCT00701363|12178212|FG002|NOT COMPLETED|Screening (Pre-assignment) Phase||0
11001021|NCT00701363|12178213|FG003|NOT COMPLETED|Screening (Pre-assignment) Phase||0
11001022|NCT00701363|12178210|FG000|STARTED|Treatment Phase 1||124
11001023|NCT00701363|12178211|FG001|STARTED|Treatment Phase 1||0
11001024|NCT00701363|12178212|FG002|STARTED|Treatment Phase 1||0
11001025|NCT00701363|12178213|FG003|STARTED|Treatment Phase 1||0
11001026|NCT00701363|12178210|FG000|COMPLETED|Treatment Phase 1||109
11001027|NCT00701363|12178211|FG001|COMPLETED|Treatment Phase 1||0
11001028|NCT00701363|12178212|FG002|COMPLETED|Treatment Phase 1||0
11001029|NCT00701363|12178213|FG003|COMPLETED|Treatment Phase 1||0
11001030|NCT00701363|12178210|FG000|NOT COMPLETED|Treatment Phase 1||15
11001031|NCT00701363|12178211|FG001|NOT COMPLETED|Treatment Phase 1||0
11001032|NCT00701363|12178212|FG002|NOT COMPLETED|Treatment Phase 1||0
11001033|NCT00701363|12178213|FG003|NOT COMPLETED|Treatment Phase 1||0
11001034|NCT00701363|12178210|FG000|STARTED|Treatment Phase 2||0
11001035|NCT00701363|12178211|FG001|STARTED|Treatment Phase 2||13
11001036|NCT00701363|12178212|FG002|STARTED|Treatment Phase 2||70
11001037|NCT00701363|12178213|FG003|STARTED|Treatment Phase 2||26
11001038|NCT00701363|12178210|FG000|COMPLETED|Treatment Phase 2||0
11001039|NCT00701363|12178211|FG001|COMPLETED|Treatment Phase 2||13
11001040|NCT00701363|12178212|FG002|COMPLETED|Treatment Phase 2||68
11001041|NCT00701363|12178213|FG003|COMPLETED|Treatment Phase 2||26
11001042|NCT00701363|12178210|FG000|NOT COMPLETED|Treatment Phase 2||0
11001043|NCT00701363|12178211|FG001|NOT COMPLETED|Treatment Phase 2||0
11001044|NCT00701363|12178212|FG002|NOT COMPLETED|Treatment Phase 2||2
11001045|NCT00701363|12178213|FG003|NOT COMPLETED|Treatment Phase 2||0
11001046|NCT00701376|12178233|FG000|STARTED|Overall Study||106
11001047|NCT00701376|12178233|FG000|COMPLETED|Overall Study||105
11001048|NCT00701376|12178233|FG000|NOT COMPLETED|Overall Study||1
11001049|NCT00701389|12178238|FG000|STARTED|Period 1||6
11001050|NCT00701389|12178239|FG001|STARTED|Period 1||6
11001051|NCT00701389|12178240|FG002|STARTED|Period 1||6
11001052|NCT00701389|12178241|FG003|STARTED|Period 1||6
11001053|NCT00701389|12178238|FG000|COMPLETED|Period 1||6
11001054|NCT00701389|12178239|FG001|COMPLETED|Period 1||6
11001055|NCT00701389|12178240|FG002|COMPLETED|Period 1||6
11001056|NCT00701389|12178241|FG003|COMPLETED|Period 1||6
11001057|NCT00701389|12178238|FG000|NOT COMPLETED|Period 1||0
11001058|NCT00701389|12178239|FG001|NOT COMPLETED|Period 1||0
11001059|NCT00701389|12178240|FG002|NOT COMPLETED|Period 1||0
11001060|NCT00701389|12178241|FG003|NOT COMPLETED|Period 1||0
11001061|NCT00701389|12178238|FG000|STARTED|Period 2||6
11001062|NCT00701389|12178239|FG001|STARTED|Period 2||6
11001063|NCT00701389|12178240|FG002|STARTED|Period 2||6
11001064|NCT00701389|12178241|FG003|STARTED|Period 2||6
11001065|NCT00701389|12178238|FG000|COMPLETED|Period 2||6
11001066|NCT00701389|12178239|FG001|COMPLETED|Period 2||6
11001067|NCT00701389|12178240|FG002|COMPLETED|Period 2||6
11001068|NCT00701389|12178241|FG003|COMPLETED|Period 2||6
11001069|NCT00701389|12178238|FG000|NOT COMPLETED|Period 2||0
11001070|NCT00701389|12178239|FG001|NOT COMPLETED|Period 2||0
11001071|NCT00701389|12178240|FG002|NOT COMPLETED|Period 2||0
11001072|NCT00701389|12178241|FG003|NOT COMPLETED|Period 2||0
11001073|NCT00701389|12178238|FG000|STARTED|Period 3||6
11001074|NCT00701389|12178239|FG001|STARTED|Period 3||6
11001075|NCT00701389|12178240|FG002|STARTED|Period 3||6
11001076|NCT00701389|12178241|FG003|STARTED|Period 3||6
11001077|NCT00701389|12178238|FG000|COMPLETED|Period 3||6
11001078|NCT00701389|12178239|FG001|COMPLETED|Period 3||6
11001079|NCT00701389|12178240|FG002|COMPLETED|Period 3||6
11001080|NCT00701389|12178241|FG003|COMPLETED|Period 3||6
11001081|NCT00701389|12178238|FG000|NOT COMPLETED|Period 3||0
11001082|NCT00701389|12178239|FG001|NOT COMPLETED|Period 3||0
11001083|NCT00701389|12178240|FG002|NOT COMPLETED|Period 3||0
11001084|NCT00701389|12178241|FG003|NOT COMPLETED|Period 3||0
11001085|NCT00701389|12178238|FG000|STARTED|Period 4||6
11001086|NCT00701389|12178239|FG001|STARTED|Period 4||6
11001087|NCT00701389|12178240|FG002|STARTED|Period 4||6
11001088|NCT00701389|12178241|FG003|STARTED|Period 4||6
11001089|NCT00701389|12178238|FG000|COMPLETED|Period 4||6
11001090|NCT00701389|12178239|FG001|COMPLETED|Period 4||6
11001091|NCT00701389|12178240|FG002|COMPLETED|Period 4||6
11001092|NCT00701389|12178241|FG003|COMPLETED|Period 4||6
11001093|NCT00701389|12178238|FG000|NOT COMPLETED|Period 4||0
11001094|NCT00701389|12178239|FG001|NOT COMPLETED|Period 4||0
11001095|NCT00701389|12178240|FG002|NOT COMPLETED|Period 4||0
11001096|NCT00701389|12178241|FG003|NOT COMPLETED|Period 4||0
11001097|NCT00701415|12178257|FG000|STARTED|Overall Study||16
11001098|NCT00701415|12178258|FG001|STARTED|Overall Study||15
11001099|NCT00701415|12178257|FG000|COMPLETED|Overall Study||15
11001100|NCT00701415|12178258|FG001|COMPLETED|Overall Study||14
11001101|NCT00701415|12178257|FG000|NOT COMPLETED|Overall Study||1
11001102|NCT00701415|12178258|FG001|NOT COMPLETED|Overall Study||1
11001103|NCT00701441|12178266|FG000|STARTED|Overall Study||9
11001104|NCT00701441|12178267|FG001|STARTED|Overall Study||16
11001105|NCT00701441|12178266|FG000|COMPLETED|Overall Study||9
11001106|NCT00701441|12178267|FG001|COMPLETED|Overall Study||12
11001107|NCT00701441|12178266|FG000|NOT COMPLETED|Overall Study||0
11001108|NCT00701441|12178267|FG001|NOT COMPLETED|Overall Study||4
11001109|NCT00701558|12178277|FG000|STARTED|Overall Study||19
11001110|NCT00701558|12178277|FG000|COMPLETED|Overall Study||4
11001111|NCT00701558|12178277|FG000|NOT COMPLETED|Overall Study||15
11001112|NCT00701636|12178283|FG000|STARTED|Overall Study||15
11001113|NCT00701636|12178284|FG001|STARTED|Overall Study||15
11001114|NCT00701636|12178283|FG000|COMPLETED|Overall Study||15
11001115|NCT00701636|12178284|FG001|COMPLETED|Overall Study||15
11001116|NCT00701636|12178283|FG000|NOT COMPLETED|Overall Study||0
11001117|NCT00701636|12178284|FG001|NOT COMPLETED|Overall Study||0
11001118|NCT00701662|12178289|FG000|STARTED|Overall Study||8
11001119|NCT00701662|12178289|FG000|COMPLETED|Overall Study||7
11001120|NCT00701662|12178289|FG000|NOT COMPLETED|Overall Study||1
11001121|NCT00701675|12178296|FG000|STARTED|Overall Study||14
11001122|NCT00701675|12178297|FG001|STARTED|Overall Study||14
11001123|NCT00701675|12178298|FG002|STARTED|Overall Study||14
11001124|NCT00701675|12178296|FG000|COMPLETED|Overall Study||10
11001125|NCT00701675|12178297|FG001|COMPLETED|Overall Study||6
11001126|NCT00701675|12178298|FG002|COMPLETED|Overall Study||7
11001127|NCT00701675|12178296|FG000|NOT COMPLETED|Overall Study||4
11001128|NCT00701675|12178297|FG001|NOT COMPLETED|Overall Study||8
11001129|NCT00701675|12178298|FG002|NOT COMPLETED|Overall Study||7
11001130|NCT00701701|12178308|FG000|STARTED|Overall Study||1
11001131|NCT00701701|12178309|FG001|STARTED|Overall Study||3
11001132|NCT00701701|12178308|FG000|COMPLETED|Overall Study||1
11001133|NCT00701701|12178309|FG001|COMPLETED|Overall Study||1
11001134|NCT00701701|12178308|FG000|NOT COMPLETED|Overall Study||0
11001135|NCT00701701|12178309|FG001|NOT COMPLETED|Overall Study||2
11001136|NCT00701714|12178318|FG000|STARTED|Treatment Period (up to 1 Year)||174
11001137|NCT00701714|12178319|FG001|STARTED|Treatment Period (up to 1 Year)||163
11001138|NCT00701714|12178318|FG000|COMPLETED|Treatment Period (up to 1 Year)||37
11001139|NCT00701714|12178319|FG001|COMPLETED|Treatment Period (up to 1 Year)||29
11001140|NCT00701714|12178318|FG000|NOT COMPLETED|Treatment Period (up to 1 Year)||137
11001141|NCT00701714|12178319|FG001|NOT COMPLETED|Treatment Period (up to 1 Year)||134
11001142|NCT00701714|12178318|FG000|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
11001143|NCT00701714|12178319|FG001|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
11001144|NCT00701714|12178318|FG000|COMPLETED|Safety Follow-up Period (6 Months)||144
11001145|NCT00701714|12178319|FG001|COMPLETED|Safety Follow-up Period (6 Months)||112
11001146|NCT00701714|12178318|FG000|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
11001147|NCT00701714|12178319|FG001|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
11001148|NCT00701727|12178329|FG000|STARTED|First Treatment Period||16
11001149|NCT00701727|12178330|FG001|STARTED|First Treatment Period||15
11001150|NCT00701727|12178329|FG000|COMPLETED|First Treatment Period||15
11001151|NCT00701727|12178330|FG001|COMPLETED|First Treatment Period||13
11001152|NCT00701727|12178329|FG000|NOT COMPLETED|First Treatment Period||1
11001153|NCT00701727|12178330|FG001|NOT COMPLETED|First Treatment Period||2
11001154|NCT00701727|12178329|FG000|STARTED|Second Treatment Period||15
11001155|NCT00701727|12178330|FG001|STARTED|Second Treatment Period||13
11001156|NCT00701727|12178329|FG000|COMPLETED|Second Treatment Period||13
11001157|NCT00701727|12178330|FG001|COMPLETED|Second Treatment Period||13
11001158|NCT00701727|12178329|FG000|NOT COMPLETED|Second Treatment Period||2
11001159|NCT00701727|12178330|FG001|NOT COMPLETED|Second Treatment Period||0
11001160|NCT00701779|12178336|FG000|STARTED|Overall Study||63
11001161|NCT00701779|12178336|FG000|3 Month|Overall Study||60
11001162|NCT00701779|12178336|FG000|6 Month|Overall Study||58
11001163|NCT00701779|12178336|FG000|9 Month|Overall Study||56
11001164|NCT00701779|12178336|FG000|12 Month|Overall Study||54
11001165|NCT00701779|12178336|FG000|COMPLETED|Overall Study||54
11001166|NCT00701779|12178336|FG000|NOT COMPLETED|Overall Study||9
11001167|NCT00701805|12178344|FG000|STARTED|Overall Study||26
11001168|NCT00701805|12178345|FG001|STARTED|Overall Study||29
11001169|NCT00701805|12178346|FG002|STARTED|Overall Study||23
11001170|NCT00701805|12178347|FG003|STARTED|Overall Study||26
11001171|NCT00701805|12178344|FG000|COMPLETED|Overall Study||23
11001172|NCT00701805|12178345|FG001|COMPLETED|Overall Study||25
11001173|NCT00701805|12178346|FG002|COMPLETED|Overall Study||16
11001174|NCT00701805|12178347|FG003|COMPLETED|Overall Study||22
11001175|NCT00701805|12178344|FG000|NOT COMPLETED|Overall Study||3
11001176|NCT00701805|12178345|FG001|NOT COMPLETED|Overall Study||4
11001177|NCT00701805|12178346|FG002|NOT COMPLETED|Overall Study||7
11001178|NCT00701805|12178347|FG003|NOT COMPLETED|Overall Study||4
11001179|NCT00701896|12178359|FG000|STARTED|Overall Study|Includes those eligible but declined to participate|143
11001180|NCT00701896|12178360|FG001|STARTED|Overall Study|Includes those eligible but declined to participate|151
11001181|NCT00701896|12178359|FG000|COMPLETED|Overall Study||110
11001182|NCT00701896|12178360|FG001|COMPLETED|Overall Study||118
11001183|NCT00701896|12178359|FG000|NOT COMPLETED|Overall Study||33
11001184|NCT00701896|12178360|FG001|NOT COMPLETED|Overall Study||33
11001185|NCT00701935|12178368|FG000|STARTED|Overall Study||43
11001186|NCT00701935|12178369|FG001|STARTED|Overall Study||37
11001187|NCT00701935|12178368|FG000|COMPLETED|Overall Study||27
11001188|NCT00701935|12178369|FG001|COMPLETED|Overall Study||26
11001189|NCT00701935|12178368|FG000|NOT COMPLETED|Overall Study||16
11001190|NCT00701935|12178369|FG001|NOT COMPLETED|Overall Study||11
11001191|NCT00702052|12178375|FG000|STARTED|Overall Study||58
11001192|NCT00702052|12178375|FG000|COMPLETED|Overall Study||0
11001193|NCT00702052|12178375|FG000|NOT COMPLETED|Overall Study||58
11001194|NCT00702143|12178382|FG000|STARTED|Overall Study||45
11001195|NCT00702143|12178383|FG001|STARTED|Overall Study||60
11001196|NCT00702143|12178384|FG002|STARTED|Overall Study||79
11001197|NCT00702143|12178382|FG000|COMPLETED|Overall Study||45
11001198|NCT00702143|12178383|FG001|COMPLETED|Overall Study||60
11001199|NCT00702143|12178384|FG002|COMPLETED|Overall Study||78
11001200|NCT00702143|12178382|FG000|NOT COMPLETED|Overall Study||0
11001201|NCT00702143|12178383|FG001|NOT COMPLETED|Overall Study||0
11001202|NCT00702143|12178384|FG002|NOT COMPLETED|Overall Study||1
11001203|NCT00702208|12178390|FG000|STARTED|Overall Study||198
11001204|NCT00702208|12178390|FG000|COMPLETED|Overall Study||167
11001205|NCT00702208|12178390|FG000|NOT COMPLETED|Overall Study||31
11001206|NCT00702221|12178397|FG000|STARTED|Overall Study||10
11001207|NCT00702221|12178398|FG001|STARTED|Overall Study||10
11001208|NCT00702221|12178397|FG000|COMPLETED|Overall Study||6
11001209|NCT00702221|12178398|FG001|COMPLETED|Overall Study||7
11001210|NCT00702221|12178397|FG000|NOT COMPLETED|Overall Study||4
11001211|NCT00702221|12178398|FG001|NOT COMPLETED|Overall Study||3
11001212|NCT00702299|12178404|FG000|STARTED|Overall Study||15
11001213|NCT00702299|12178404|FG000|COMPLETED|Overall Study||15
11001214|NCT00702299|12178404|FG000|NOT COMPLETED|Overall Study||0
11001215|NCT00702325|12178413|FG000|STARTED|Overall Study|Randomized|156
11001216|NCT00702325|12178414|FG001|STARTED|Overall Study|Randomized|155
11001217|NCT00702325|12178413|FG000|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
11001218|NCT00702325|12178414|FG001|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
11001219|NCT00702325|12178413|FG000|NOT COMPLETED|Overall Study||38
11001220|NCT00702325|12178414|FG001|NOT COMPLETED|Overall Study||53
11001221|NCT00702364|12178422|FG000|STARTED|Overall Study||26
11001222|NCT00702364|12178423|FG001|STARTED|Overall Study||29
11001223|NCT00702364|12178422|FG000|COMPLETED|Overall Study||24
11001224|NCT00702364|12178423|FG001|COMPLETED|Overall Study||25
11001225|NCT00702364|12178422|FG000|NOT COMPLETED|Overall Study||2
11001226|NCT00702364|12178423|FG001|NOT COMPLETED|Overall Study||4
11001227|NCT00702377|12178431|FG000|STARTED|Overall Study||53
11001228|NCT00702377|12178432|FG001|STARTED|Overall Study||56
11001229|NCT00702377|12178431|FG000|COMPLETED|Overall Study||52
11001230|NCT00702377|12178432|FG001|COMPLETED|Overall Study||53
11001231|NCT00702377|12178431|FG000|NOT COMPLETED|Overall Study||1
11001232|NCT00702377|12178432|FG001|NOT COMPLETED|Overall Study||3
11001233|NCT00702403|12178438|FG000|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
11001234|NCT00702403|12178438|FG000|Ineligible for Study Drug|From Consent to Engraftment||17
11001235|NCT00702403|12178438|FG000|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
11001236|NCT00702403|12178438|FG000|NOT COMPLETED|From Consent to Engraftment||17
11001237|NCT00702403|12178438|FG000|STARTED|From Engraftment to Study Completion||40
11001238|NCT00702403|12178438|FG000|Patient Drop-outs|From Engraftment to Study Completion||27
11001239|NCT00702403|12178438|FG000|COMPLETED|From Engraftment to Study Completion||13
11001240|NCT00702403|12178438|FG000|NOT COMPLETED|From Engraftment to Study Completion||27
11001241|NCT00702468|12178447|FG000|STARTED|Overall Study||18
11001242|NCT00702468|12178448|FG001|STARTED|Overall Study||18
11001243|NCT00702468|12178447|FG000|COMPLETED|Overall Study||15
11001244|NCT00702468|12178448|FG001|COMPLETED|Overall Study||2
11001245|NCT00702468|12178447|FG000|NOT COMPLETED|Overall Study||3
11001246|NCT00702468|12178448|FG001|NOT COMPLETED|Overall Study||16
11001247|NCT00702507|12178454|FG000|STARTED|Initial Treatment Phase||200
11001248|NCT00702507|12178454|FG000|COMPLETED|Initial Treatment Phase||159
11001249|NCT00702507|12178454|FG000|NOT COMPLETED|Initial Treatment Phase||41
11001250|NCT00702507|12178454|FG000|STARTED|Follow-up Phase||159
11001251|NCT00702507|12178454|FG000|COMPLETED|Follow-up Phase||132
11001252|NCT00702507|12178454|FG000|NOT COMPLETED|Follow-up Phase||27
11001253|NCT00702650|12178459|FG000|STARTED|Overall Study||155
11001254|NCT00702650|12178459|FG000|COMPLETED|Overall Study||135
11001255|NCT00702650|12178459|FG000|NOT COMPLETED|Overall Study||20
11001256|NCT00702689|12178463|FG000|STARTED|Overall Study||20
11001257|NCT00702689|12178463|FG000|COMPLETED|Overall Study||14
11001258|NCT00702689|12178463|FG000|NOT COMPLETED|Overall Study||6
11001259|NCT00702715|12178469|FG000|STARTED|Overall Study||35
11001260|NCT00702715|12178470|FG001|STARTED|Overall Study|One subject was enrolled but did not start study|33
11001261|NCT00702715|12178469|FG000|COMPLETED|Overall Study||34
11001262|NCT00702715|12178470|FG001|COMPLETED|Overall Study||33
11001263|NCT00702715|12178469|FG000|NOT COMPLETED|Overall Study||1
11001264|NCT00702715|12178470|FG001|NOT COMPLETED|Overall Study||0
11001265|NCT00702754|12178476|FG000|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
11001266|NCT00702754|12178476|FG000|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
11001267|NCT00702754|12178476|FG000|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
11001268|NCT00702754|12178476|FG000|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
11001269|NCT00702754|12178476|FG000|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
11001270|NCT00702754|12178476|FG000|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
11001271|NCT00702754|12178476|FG000|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
11001272|NCT00702754|12178476|FG000|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
11001273|NCT00702754|12178476|FG000|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
11001274|NCT00702754|12178476|FG000|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
11001275|NCT00702754|12178476|FG000|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
11001276|NCT00702754|12178476|FG000|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
11001277|NCT00702754|12178476|FG000|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
11001278|NCT00702754|12178476|FG000|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
11001279|NCT00702754|12178476|FG000|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
11001280|NCT00702754|12178476|FG000|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
11001281|NCT00702754|12178476|FG000|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
11001282|NCT00702754|12178476|FG000|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
11001283|NCT00702754|12178476|FG000|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
11001284|NCT00702754|12178476|FG000|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
11001285|NCT00702754|12178476|FG000|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
11001286|NCT00702754|12178476|FG000|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
11001287|NCT00702754|12178476|FG000|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
11001288|NCT00702754|12178476|FG000|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
11001289|NCT00702780|12178482|FG000|STARTED|Overall Study||37
11001290|NCT00702780|12178483|FG001|STARTED|Overall Study||37
11001291|NCT00702780|12178482|FG000|COMPLETED|Overall Study||28
11001292|NCT00702780|12178483|FG001|COMPLETED|Overall Study||29
11001293|NCT00702780|12178482|FG000|NOT COMPLETED|Overall Study||9
11001294|NCT00702780|12178483|FG001|NOT COMPLETED|Overall Study||8
11001295|NCT00702884|12178489|FG000|STARTED|Overall Study||25
11001296|NCT00702884|12178489|FG000|COMPLETED|Overall Study||25
11001297|NCT00702884|12178489|FG000|NOT COMPLETED|Overall Study||0
11001298|NCT00702923|12178496|FG000|STARTED|Overall Study||12
11001299|NCT00702923|12178496|FG000|COMPLETED|Overall Study||11
11001300|NCT00702923|12178496|FG000|NOT COMPLETED|Overall Study||1
11001301|NCT00702949|12178504|FG000|STARTED|Overall Study||63
11001302|NCT00702949|12178505|FG001|STARTED|Overall Study||66
11001303|NCT00702949|12178506|FG002|STARTED|Overall Study||62
11001304|NCT00702949|12178504|FG000|Evaluable for Primary Endpoint|Overall Study||56
11001305|NCT00702949|12178505|FG001|Evaluable for Primary Endpoint|Overall Study||56
11001306|NCT00702949|12178506|FG002|Evaluable for Primary Endpoint|Overall Study||51
11001307|NCT00702949|12178504|FG000|COMPLETED|Overall Study||58
11001308|NCT00702949|12178505|FG001|COMPLETED|Overall Study||57
11001309|NCT00702949|12178506|FG002|COMPLETED|Overall Study||54
11001310|NCT00702949|12178504|FG000|NOT COMPLETED|Overall Study||5
11001311|NCT00702949|12178505|FG001|NOT COMPLETED|Overall Study||9
11001312|NCT00702949|12178506|FG002|NOT COMPLETED|Overall Study||8
11001313|NCT00703053|12178525|FG000|STARTED|Overall Study||27
11001314|NCT00703053|12178526|FG001|STARTED|Overall Study||26
11001315|NCT00703053|12178527|FG002|STARTED|Overall Study||51
11001316|NCT00703053|12178528|FG003|STARTED|Overall Study||49
11001317|NCT00703053|12178529|FG004|STARTED|Overall Study||51
11001318|NCT00703053|12178530|FG005|STARTED|Overall Study||49
11001319|NCT00703053|12178531|FG006|STARTED|Overall Study||52
11001320|NCT00703053|12178532|FG007|STARTED|Overall Study||97
11001321|NCT00703053|12178533|FG008|STARTED|Overall Study||103
11001322|NCT00703053|12178525|FG000|COMPLETED|Overall Study||26
11001323|NCT00703053|12178526|FG001|COMPLETED|Overall Study||24
11001324|NCT00703053|12178527|FG002|COMPLETED|Overall Study||48
11001325|NCT00703053|12178528|FG003|COMPLETED|Overall Study||46
11001326|NCT00703053|12178529|FG004|COMPLETED|Overall Study||50
11001327|NCT00703053|12178530|FG005|COMPLETED|Overall Study||43
11001328|NCT00703053|12178531|FG006|COMPLETED|Overall Study||45
11001329|NCT00703053|12178532|FG007|COMPLETED|Overall Study||91
11001330|NCT00703053|12178533|FG008|COMPLETED|Overall Study||102
11001331|NCT00703053|12178525|FG000|NOT COMPLETED|Overall Study||1
11001332|NCT00703053|12178526|FG001|NOT COMPLETED|Overall Study||2
11001333|NCT00703053|12178527|FG002|NOT COMPLETED|Overall Study||3
11001334|NCT00703053|12178528|FG003|NOT COMPLETED|Overall Study||3
11001335|NCT00703053|12178529|FG004|NOT COMPLETED|Overall Study||1
11001336|NCT00703053|12178530|FG005|NOT COMPLETED|Overall Study||6
11001337|NCT00703053|12178531|FG006|NOT COMPLETED|Overall Study||7
11001338|NCT00703053|12178532|FG007|NOT COMPLETED|Overall Study||6
11001339|NCT00703053|12178533|FG008|NOT COMPLETED|Overall Study||1
11001340|NCT00703118|12178558|FG000|STARTED|Overall Study||266
11001341|NCT00703118|12178559|FG001|STARTED|Overall Study||264
11001342|NCT00703118|12178560|FG002|STARTED|Overall Study||132
11001343|NCT00703118|12178558|FG000|COMPLETED|Overall Study||245
11001344|NCT00703118|12178559|FG001|COMPLETED|Overall Study||248
11001345|NCT00703118|12178560|FG002|COMPLETED|Overall Study||110
11001346|NCT00703118|12178558|FG000|NOT COMPLETED|Overall Study||21
11001347|NCT00703118|12178559|FG001|NOT COMPLETED|Overall Study||16
11001348|NCT00703118|12178560|FG002|NOT COMPLETED|Overall Study||22
11001349|NCT00703157|12178573|FG000|STARTED|Overall Study||26
11001350|NCT00703157|12178574|FG001|STARTED|Overall Study||26
11001351|NCT00703157|12178573|FG000|6 Months FU|Overall Study||25
11001352|NCT00703157|12178574|FG001|6 Months FU|Overall Study||25
11001353|NCT00703157|12178573|FG000|24 Months FU|Overall Study||22
11001354|NCT00703157|12178574|FG001|24 Months FU|Overall Study||24
11001355|NCT00703157|12178573|FG000|COMPLETED|Overall Study||22
11001356|NCT00703157|12178574|FG001|COMPLETED|Overall Study||24
11001357|NCT00703157|12178573|FG000|NOT COMPLETED|Overall Study||4
11001358|NCT00703157|12178574|FG001|NOT COMPLETED|Overall Study||2
11001359|NCT00703261|12178584|FG000|STARTED|Overall Study||42
11001360|NCT00703261|12178585|FG001|STARTED|Overall Study||41
11001361|NCT00703261|12178584|FG000|COMPLETED|Overall Study||36
11001362|NCT00703261|12178585|FG001|COMPLETED|Overall Study||35
11001363|NCT00703261|12178584|FG000|NOT COMPLETED|Overall Study||6
11001364|NCT00703261|12178585|FG001|NOT COMPLETED|Overall Study||6
11001365|NCT00703391|12178594|FG000|STARTED|Overall Study||12
11001366|NCT00703391|12178595|FG001|STARTED|Overall Study||6
11001367|NCT00703391|12178594|FG000|COMPLETED|Overall Study||12
11001368|NCT00703391|12178595|FG001|COMPLETED|Overall Study||6
11001369|NCT00703391|12178594|FG000|NOT COMPLETED|Overall Study||0
11001370|NCT00703391|12178595|FG001|NOT COMPLETED|Overall Study||0
11001371|NCT00703508|12178601|FG000|STARTED|Overall Study||26
11001372|NCT00703508|12178601|FG000|COMPLETED|Overall Study||26
11001373|NCT00703508|12178601|FG000|NOT COMPLETED|Overall Study||0
11001374|NCT00703664|12178610|FG000|STARTED|Overall Study||22
11001375|NCT00703664|12178611|FG001|STARTED|Overall Study||4
11001376|NCT00703664|12178612|FG002|STARTED|Overall Study||39
11001377|NCT00703664|12178610|FG000|COMPLETED|Overall Study||22
11001378|NCT00703664|12178611|FG001|COMPLETED|Overall Study||4
11001379|NCT00703664|12178612|FG002|COMPLETED|Overall Study||39
11001380|NCT00703664|12178610|FG000|NOT COMPLETED|Overall Study||0
11001381|NCT00703664|12178611|FG001|NOT COMPLETED|Overall Study||0
11001382|NCT00703664|12178612|FG002|NOT COMPLETED|Overall Study||0
11001383|NCT00703677|12178620|FG000|STARTED|Overall Study||17
11001384|NCT00703677|12178620|FG000|COMPLETED|Overall Study||14
11001385|NCT00703677|12178620|FG000|NOT COMPLETED|Overall Study||3
11001386|NCT00703729|12178626|FG000|STARTED|Overall Study||25
11001387|NCT00703729|12178627|FG001|STARTED|Overall Study||24
11001388|NCT00703729|12178626|FG000|COMPLETED|Overall Study||25
11001389|NCT00703729|12178627|FG001|COMPLETED|Overall Study||21
11001390|NCT00703729|12178626|FG000|NOT COMPLETED|Overall Study||0
11001391|NCT00703729|12178627|FG001|NOT COMPLETED|Overall Study||3
11001392|NCT00703781|12178635|FG000|STARTED|Overall Study||63
11001393|NCT00703781|12178636|FG001|STARTED|Overall Study||63
11001394|NCT00703781|12178635|FG000|COMPLETED|Overall Study||61
11001395|NCT00703781|12178636|FG001|COMPLETED|Overall Study||61
11001396|NCT00703781|12178635|FG000|NOT COMPLETED|Overall Study||2
11001397|NCT00703781|12178636|FG001|NOT COMPLETED|Overall Study||2
11001398|NCT00703820|12178644|FG000|STARTED|Overall Study||133
11001399|NCT00703820|12178645|FG001|STARTED|Overall Study||129
11001400|NCT00703820|12178644|FG000|COMPLETED|Overall Study||98
11001401|NCT00703820|12178645|FG001|COMPLETED|Overall Study||95
11001402|NCT00703820|12178644|FG000|NOT COMPLETED|Overall Study||35
11001403|NCT00703820|12178645|FG001|NOT COMPLETED|Overall Study||34
11001404|NCT00703846|12178653|FG000|STARTED|Overall Study||500
11001405|NCT00703846|12178653|FG000|COMPLETED|Overall Study||363
11001406|NCT00703846|12178653|FG000|NOT COMPLETED|Overall Study||137
11001407|NCT00703911|12178657|FG000|STARTED|Overall Study||102
11001408|NCT00703911|12178657|FG000|COMPLETED|Overall Study||92
11001409|NCT00703911|12178657|FG000|NOT COMPLETED|Overall Study||10
11001410|NCT00703924|12178663|FG000|STARTED|Overall Study||50
11001411|NCT00703924|12178664|FG001|STARTED|Overall Study||42
11001412|NCT00703924|12178663|FG000|COMPLETED|Overall Study||49
11001413|NCT00703924|12178664|FG001|COMPLETED|Overall Study||41
11001414|NCT00703924|12178663|FG000|NOT COMPLETED|Overall Study||1
11001415|NCT00703924|12178664|FG001|NOT COMPLETED|Overall Study||1
11001416|NCT00703937|12178676|FG000|STARTED|Overall Study||343
11001417|NCT00703937|12178677|FG001|STARTED|Overall Study||360
11001418|NCT00703937|12178676|FG000|COMPLETED|Overall Study||278
11001419|NCT00703937|12178677|FG001|COMPLETED|Overall Study||267
11001420|NCT00703937|12178676|FG000|NOT COMPLETED|Overall Study||65
11001421|NCT00703937|12178677|FG001|NOT COMPLETED|Overall Study||93
11001422|NCT00703963|12178685|FG000|STARTED|Overall Study||100
11001423|NCT00703963|12178686|FG001|STARTED|Overall Study||100
11001424|NCT00703963|12178685|FG000|COMPLETED|Overall Study||93
11001425|NCT00703963|12178686|FG001|COMPLETED|Overall Study||86
11001426|NCT00703963|12178685|FG000|NOT COMPLETED|Overall Study||7
11001427|NCT00703963|12178686|FG001|NOT COMPLETED|Overall Study||14
11001428|NCT00703976|12178694|FG000|STARTED|Overall Study||37
11001429|NCT00703976|12178695|FG001|STARTED|Overall Study||41
11001430|NCT00703976|12178694|FG000|COMPLETED|Overall Study||37
11001431|NCT00703976|12178695|FG001|COMPLETED|Overall Study||41
11001432|NCT00703976|12178694|FG000|NOT COMPLETED|Overall Study||0
11001433|NCT00703976|12178695|FG001|NOT COMPLETED|Overall Study||0
11001434|NCT00704028|12178705|FG000|STARTED|Overall Study||82
11001435|NCT00704028|12178706|FG001|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
11001436|NCT00704028|12178705|FG000|COMPLETED|Overall Study||70
11001437|NCT00704028|12178706|FG001|COMPLETED|Overall Study||57
11001438|NCT00704028|12178705|FG000|NOT COMPLETED|Overall Study||12
11001439|NCT00704028|12178706|FG001|NOT COMPLETED|Overall Study||21
11001440|NCT00704132|12178714|FG000|STARTED|Overall Study||26
11001441|NCT00704132|12178715|FG001|STARTED|Overall Study||24
11001442|NCT00704132|12178714|FG000|COMPLETED|Overall Study||25
11001443|NCT00704132|12178715|FG001|COMPLETED|Overall Study||22
11001444|NCT00704132|12178714|FG000|NOT COMPLETED|Overall Study||1
11001445|NCT00704132|12178715|FG001|NOT COMPLETED|Overall Study||2
11001446|NCT00704171|12178723|FG000|STARTED|Overall Study||62
11001447|NCT00704171|12178724|FG001|STARTED|Overall Study||59
11001448|NCT00704171|12178723|FG000|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
11001449|NCT00704171|12178724|FG001|COMPLETED|Overall Study|All control subjects completed the study.|59
11001450|NCT00704171|12178723|FG000|NOT COMPLETED|Overall Study||1
11001451|NCT00704171|12178724|FG001|NOT COMPLETED|Overall Study||0
11001452|NCT00704184|12178735|FG000|STARTED|Double-Blind Treatment||20
11001453|NCT00704184|12178736|FG001|STARTED|Double-Blind Treatment||18
11001454|NCT00704184|12178737|FG002|STARTED|Double-Blind Treatment||20
11001455|NCT00704184|12178738|FG003|STARTED|Double-Blind Treatment||18
11001456|NCT00704184|12178739|FG004|STARTED|Double-Blind Treatment||19
11001457|NCT00704184|12178735|FG000|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
11001458|NCT00704184|12178736|FG001|Treated|Double-Blind Treatment||18
11001459|NCT00704184|12178737|FG002|Treated|Double-Blind Treatment||20
11001460|NCT00704184|12178738|FG003|Treated|Double-Blind Treatment||18
11001461|NCT00704184|12178739|FG004|Treated|Double-Blind Treatment||19
11001462|NCT00704184|12178735|FG000|COMPLETED|Double-Blind Treatment||19
11001463|NCT00704184|12178736|FG001|COMPLETED|Double-Blind Treatment||18
11001464|NCT00704184|12178737|FG002|COMPLETED|Double-Blind Treatment||20
11001465|NCT00704184|12178738|FG003|COMPLETED|Double-Blind Treatment||18
11001466|NCT00704184|12178739|FG004|COMPLETED|Double-Blind Treatment||19
11001467|NCT00704184|12178735|FG000|NOT COMPLETED|Double-Blind Treatment||1
11001468|NCT00704184|12178736|FG001|NOT COMPLETED|Double-Blind Treatment||0
11001469|NCT00704184|12178737|FG002|NOT COMPLETED|Double-Blind Treatment||0
11001470|NCT00704184|12178738|FG003|NOT COMPLETED|Double-Blind Treatment||0
11001471|NCT00704184|12178739|FG004|NOT COMPLETED|Double-Blind Treatment||0
11001472|NCT00704184|12178735|FG000|STARTED|Open-Label Treatment||19
11001473|NCT00704184|12178736|FG001|STARTED|Open-Label Treatment||18
11001474|NCT00704184|12178737|FG002|STARTED|Open-Label Treatment||20
11001475|NCT00704184|12178738|FG003|STARTED|Open-Label Treatment||18
11001476|NCT00704184|12178739|FG004|STARTED|Open-Label Treatment||19
11001477|NCT00704184|12178735|FG000|COMPLETED|Open-Label Treatment||18
11001478|NCT00704184|12178736|FG001|COMPLETED|Open-Label Treatment||16
11001479|NCT00704184|12178737|FG002|COMPLETED|Open-Label Treatment||16
11001480|NCT00704184|12178738|FG003|COMPLETED|Open-Label Treatment||13
11001481|NCT00704184|12178739|FG004|COMPLETED|Open-Label Treatment||16
11001482|NCT00704184|12178735|FG000|NOT COMPLETED|Open-Label Treatment||1
11001483|NCT00704184|12178736|FG001|NOT COMPLETED|Open-Label Treatment||2
11001484|NCT00704184|12178737|FG002|NOT COMPLETED|Open-Label Treatment||4
11001485|NCT00704184|12178738|FG003|NOT COMPLETED|Open-Label Treatment||5
11001486|NCT00704184|12178739|FG004|NOT COMPLETED|Open-Label Treatment||3
11001487|NCT00704262|12178751|FG000|STARTED|Overall Study||33
11001488|NCT00704262|12178751|FG000|COMPLETED|Overall Study||31
11001489|NCT00704262|12178751|FG000|NOT COMPLETED|Overall Study||2
11001490|NCT00704340|12178757|FG000|STARTED|Overall Study||120
11001491|NCT00704340|12178758|FG001|STARTED|Overall Study||117
11001492|NCT00704340|12178757|FG000|COMPLETED|Overall Study||118
11001493|NCT00704340|12178758|FG001|COMPLETED|Overall Study||115
11001494|NCT00704340|12178757|FG000|NOT COMPLETED|Overall Study||2
11001495|NCT00704340|12178758|FG001|NOT COMPLETED|Overall Study||2
11001496|NCT00704353|12178766|FG000|STARTED|Overall Study||366
11001497|NCT00704353|12178767|FG001|STARTED|Overall Study||369
11001498|NCT00704353|12178766|FG000|COMPLETED|Overall Study||268
11001499|NCT00704353|12178767|FG001|COMPLETED|Overall Study||255
11001500|NCT00704353|12178766|FG000|NOT COMPLETED|Overall Study||98
11001501|NCT00704353|12178767|FG001|NOT COMPLETED|Overall Study||114
11001502|NCT00704379|12178775|FG000|STARTED|Overall Study||46
11001503|NCT00704379|12178776|FG001|STARTED|Overall Study||48
11001504|NCT00704379|12178775|FG000|COMPLETED|Overall Study||39
11001505|NCT00704379|12178776|FG001|COMPLETED|Overall Study||41
11001506|NCT00704379|12178775|FG000|NOT COMPLETED|Overall Study||7
11001507|NCT00704379|12178776|FG001|NOT COMPLETED|Overall Study||7
11001508|NCT00704405|12178789|FG000|STARTED|Overall Study (NC Population)||42
11001509|NCT00704405|12178790|FG001|STARTED|Overall Study (NC Population)||44
11001510|NCT00704405|12178791|FG002|STARTED|Overall Study (NC Population)||41
11001511|NCT00704405|12178792|FG003|STARTED|Overall Study (NC Population)||42
11001512|NCT00704405|12178793|FG004|STARTED|Overall Study (NC Population)||42
11001513|NCT00704405|12178789|FG000|COMPLETED|Overall Study (NC Population)||37
11001514|NCT00704405|12178790|FG001|COMPLETED|Overall Study (NC Population)||40
11001515|NCT00704405|12178791|FG002|COMPLETED|Overall Study (NC Population)||38
11001516|NCT00704405|12178792|FG003|COMPLETED|Overall Study (NC Population)||38
11001517|NCT00704405|12178793|FG004|COMPLETED|Overall Study (NC Population)||37
11001518|NCT00704405|12178789|FG000|NOT COMPLETED|Overall Study (NC Population)||5
11001519|NCT00704405|12178790|FG001|NOT COMPLETED|Overall Study (NC Population)||4
11001520|NCT00704405|12178791|FG002|NOT COMPLETED|Overall Study (NC Population)||3
11001521|NCT00704405|12178792|FG003|NOT COMPLETED|Overall Study (NC Population)||4
11001522|NCT00704405|12178793|FG004|NOT COMPLETED|Overall Study (NC Population)||5
11001523|NCT00704405|12178789|FG000|STARTED|Overall Study (C Population)||16
11001524|NCT00704405|12178790|FG001|STARTED|Overall Study (C Population)||14
11001525|NCT00704405|12178791|FG002|STARTED|Overall Study (C Population)||15
11001526|NCT00704405|12178792|FG003|STARTED|Overall Study (C Population)||15
11001527|NCT00704405|12178793|FG004|STARTED|Overall Study (C Population)||14
11001528|NCT00704405|12178789|FG000|COMPLETED|Overall Study (C Population)||15
11001529|NCT00704405|12178790|FG001|COMPLETED|Overall Study (C Population)||11
11001530|NCT00704405|12178791|FG002|COMPLETED|Overall Study (C Population)||14
11001531|NCT00704405|12178792|FG003|COMPLETED|Overall Study (C Population)||14
11001532|NCT00704405|12178793|FG004|COMPLETED|Overall Study (C Population)||14
11001533|NCT00704405|12178789|FG000|NOT COMPLETED|Overall Study (C Population)||1
11001534|NCT00704405|12178790|FG001|NOT COMPLETED|Overall Study (C Population)||3
11001535|NCT00704405|12178791|FG002|NOT COMPLETED|Overall Study (C Population)||1
11001536|NCT00704405|12178792|FG003|NOT COMPLETED|Overall Study (C Population)||1
11001537|NCT00704405|12178793|FG004|NOT COMPLETED|Overall Study (C Population)||0
11001538|NCT00704418|12178813|FG000|STARTED|Overall Study||78
11001539|NCT00704418|12178814|FG001|STARTED|Overall Study||78
11001540|NCT00704418|12178813|FG000|COMPLETED|Overall Study||73
11001541|NCT00704418|12178814|FG001|COMPLETED|Overall Study||72
11001542|NCT00704418|12178813|FG000|NOT COMPLETED|Overall Study||5
11001543|NCT00704418|12178814|FG001|NOT COMPLETED|Overall Study||6
11001544|NCT00704522|12178822|FG000|STARTED|Overall Study||481
11001545|NCT00704522|12178823|FG001|STARTED|Overall Study||120
11001546|NCT00704522|12178822|FG000|COMPLETED|Overall Study||298
11001547|NCT00704522|12178823|FG001|COMPLETED|Overall Study||75
11001548|NCT00704522|12178822|FG000|NOT COMPLETED|Overall Study||183
11001549|NCT00704522|12178823|FG001|NOT COMPLETED|Overall Study||45
11001550|NCT00704717|12178828|FG000|STARTED|Overall Study||185
11001551|NCT00704717|12178828|FG000|COMPLETED|Overall Study||185
11001552|NCT00704717|12178828|FG000|NOT COMPLETED|Overall Study||0
11001553|NCT00704730|12178834|FG000|STARTED|Overall Study|Randomized|219
11001554|NCT00704730|12178835|FG001|STARTED|Overall Study|Randomized|111
11001555|NCT00704730|12178834|FG000|COMPLETED|Overall Study|Continuing treatment at data cutoff for primary analysis, but subsequently discontinued study|98
11001556|NCT00704730|12178835|FG001|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
11001557|NCT00704730|12178834|FG000|NOT COMPLETED|Overall Study||121
11001558|NCT00704730|12178835|FG001|NOT COMPLETED|Overall Study||96
11001559|NCT00704808|12178842|FG000|STARTED|Overall Study||180
11001560|NCT00704808|12178842|FG000|COMPLETED|Overall Study||49
11001561|NCT00704808|12178842|FG000|NOT COMPLETED|Overall Study||131
11001562|NCT00704847|12178848|FG000|STARTED|Overall Study||521
11001563|NCT00704847|12178849|FG001|STARTED|Overall Study||509
11001564|NCT00704847|12178848|FG000|COMPLETED|Overall Study||300
11001565|NCT00704847|12178849|FG001|COMPLETED|Overall Study||339
11001566|NCT00704847|12178848|FG000|NOT COMPLETED|Overall Study||221
11001567|NCT00704847|12178849|FG001|NOT COMPLETED|Overall Study||170
11001568|NCT00704912|12178858|FG000|STARTED|Overall Study||50
11001569|NCT00704912|12178859|FG001|STARTED|Overall Study||49
11001570|NCT00704912|12178860|FG002|STARTED|Overall Study||50
11001571|NCT00704912|12178858|FG000|COMPLETED|Overall Study||44
11001572|NCT00704912|12178859|FG001|COMPLETED|Overall Study||45
11001573|NCT00704912|12178860|FG002|COMPLETED|Overall Study||43
11001574|NCT00704912|12178858|FG000|NOT COMPLETED|Overall Study||6
11001575|NCT00704912|12178859|FG001|NOT COMPLETED|Overall Study||4
11001576|NCT00704912|12178860|FG002|NOT COMPLETED|Overall Study||7
11001577|NCT00704938|12178870|FG000|STARTED|Overall Study||2
11001578|NCT00704938|12178871|FG001|STARTED|Overall Study||1
11001579|NCT00704938|12178870|FG000|COMPLETED|Overall Study||2
11001580|NCT00704938|12178871|FG001|COMPLETED|Overall Study||1
11001581|NCT00704938|12178870|FG000|NOT COMPLETED|Overall Study||0
11001582|NCT00704938|12178871|FG001|NOT COMPLETED|Overall Study||0
11001583|NCT00704964|12178877|FG000|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
11001584|NCT00704964|12178877|FG000|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
11001585|NCT00704964|12178877|FG000|NOT COMPLETED|Overall Study||328
11001586|NCT00705003|12178884|FG000|STARTED|Enrolled||71
11001587|NCT00705003|12178885|FG001|STARTED|Enrolled||37
11001588|NCT00705003|12178886|FG002|STARTED|Enrolled||34
11001589|NCT00705003|12178884|FG000|COMPLETED|Enrolled||67
11001590|NCT00705003|12178885|FG001|COMPLETED|Enrolled||34
11001591|NCT00705003|12178886|FG002|COMPLETED|Enrolled||33
11001592|NCT00705003|12178884|FG000|NOT COMPLETED|Enrolled||4
11001593|NCT00705003|12178885|FG001|NOT COMPLETED|Enrolled||3
11001594|NCT00705003|12178886|FG002|NOT COMPLETED|Enrolled||1
11001595|NCT00705003|12178884|FG000|STARTED|Treated||67
11001596|NCT00705003|12178885|FG001|STARTED|Treated||34
11001597|NCT00705003|12178886|FG002|STARTED|Treated||33
11001598|NCT00705003|12178884|FG000|COMPLETED|Treated||54
11001599|NCT00705003|12178885|FG001|COMPLETED|Treated||28
11001600|NCT00705003|12178886|FG002|COMPLETED|Treated||30
11001601|NCT00705003|12178884|FG000|NOT COMPLETED|Treated||13
11001602|NCT00705003|12178885|FG001|NOT COMPLETED|Treated||6
11001603|NCT00705003|12178886|FG002|NOT COMPLETED|Treated||3
11001604|NCT00705016|12178898|FG000|STARTED|Overall Study||62
11001605|NCT00705016|12178899|FG001|STARTED|Overall Study||60
11001606|NCT00705016|12178900|FG002|STARTED|Overall Study||62
11001607|NCT00705016|12178898|FG000|COMPLETED|Overall Study||2
11001608|NCT00705016|12178899|FG001|COMPLETED|Overall Study||2
11001609|NCT00705016|12178900|FG002|COMPLETED|Overall Study||4
11001610|NCT00705016|12178898|FG000|NOT COMPLETED|Overall Study||60
11001611|NCT00705016|12178899|FG001|NOT COMPLETED|Overall Study||58
11001612|NCT00705016|12178900|FG002|NOT COMPLETED|Overall Study||58
11001613|NCT00705107|12178908|FG000|STARTED|Overall Study||267
11001614|NCT00705107|12178908|FG000|COMPLETED|Overall Study||218
11001615|NCT00705107|12178908|FG000|NOT COMPLETED|Overall Study||49
11001616|NCT00705133|12178912|FG000|STARTED|Overall Study||15
11001617|NCT00705133|12178912|FG000|COMPLETED|Overall Study||15
11001618|NCT00705133|12178912|FG000|NOT COMPLETED|Overall Study||0
11001619|NCT00705146|12178918|FG000|STARTED|Overall Study||32
11001620|NCT00705146|12178919|FG001|STARTED|Overall Study||24
11001621|NCT00705146|12178918|FG000|COMPLETED|Overall Study||31
11001622|NCT00705146|12178919|FG001|COMPLETED|Overall Study||23
11001623|NCT00705146|12178918|FG000|NOT COMPLETED|Overall Study||1
11001624|NCT00705146|12178919|FG001|NOT COMPLETED|Overall Study||1
11001625|NCT00705159|12178929|FG000|STARTED|Overall Study||34
11001626|NCT00705159|12178930|FG001|STARTED|Overall Study||35
11001627|NCT00705159|12178931|FG002|STARTED|Overall Study||34
11001628|NCT00705159|12178932|FG003|STARTED|Overall Study||34
11001629|NCT00705159|12178929|FG000|COMPLETED|Overall Study||34
11001630|NCT00705159|12178930|FG001|COMPLETED|Overall Study||33
11001631|NCT00705159|12178931|FG002|COMPLETED|Overall Study||29
11001632|NCT00705159|12178932|FG003|COMPLETED|Overall Study||30
11001633|NCT00705159|12178929|FG000|NOT COMPLETED|Overall Study||0
11001634|NCT00705159|12178930|FG001|NOT COMPLETED|Overall Study||2
11001635|NCT00705159|12178931|FG002|NOT COMPLETED|Overall Study||5
11001636|NCT00705159|12178932|FG003|NOT COMPLETED|Overall Study||4
11001637|NCT00705224|12178942|FG000|STARTED|Overall Study||250
11001638|NCT00705224|12178942|FG000|COMPLETED|Overall Study||239
11001639|NCT00705224|12178942|FG000|NOT COMPLETED|Overall Study||11
11001640|NCT00705250|12178949|FG000|STARTED|Overall Study||36
11001641|NCT00705250|12178949|FG000|COMPLETED|Overall Study||34
11001642|NCT00705250|12178949|FG000|NOT COMPLETED|Overall Study||2
11001643|NCT00705263|12178953|FG000|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
11001644|NCT00705263|12178953|FG000|COMPLETED|Overall Study||108
11001645|NCT00705263|12178953|FG000|NOT COMPLETED|Overall Study||2
11001646|NCT00705289|12178957|FG000|STARTED|Overall Study||728
11001647|NCT00705289|12178957|FG000|COMPLETED|Overall Study||597
11001648|NCT00705289|12178957|FG000|NOT COMPLETED|Overall Study||131
11001649|NCT00705341|12178980|FG000|STARTED|Phase 1:Control Challenge||126
11001650|NCT00705341|12178981|FG001|STARTED|Phase 1:Control Challenge||93
11001651|NCT00705341|12178982|FG002|STARTED|Phase 1:Control Challenge||0
11001652|NCT00705341|12178983|FG003|STARTED|Phase 1:Control Challenge||0
11001653|NCT00705341|12178980|FG000|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
11001654|NCT00705341|12178981|FG001|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
11001655|NCT00705341|12178982|FG002|COMPLETED|Phase 1:Control Challenge||0
11001656|NCT00705341|12178983|FG003|COMPLETED|Phase 1:Control Challenge||0
11001657|NCT00705341|12178980|FG000|NOT COMPLETED|Phase 1:Control Challenge||0
11001658|NCT00705341|12178981|FG001|NOT COMPLETED|Phase 1:Control Challenge||0
11001659|NCT00705341|12178982|FG002|NOT COMPLETED|Phase 1:Control Challenge||0
11001660|NCT00705341|12178983|FG003|NOT COMPLETED|Phase 1:Control Challenge||0
11001661|NCT00705341|12178980|FG000|STARTED|Phase 2: Trial||0
11001662|NCT00705341|12178981|FG001|STARTED|Phase 2: Trial||0
11001663|NCT00705341|12178982|FG002|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
11001664|NCT00705341|12178983|FG003|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
11001665|NCT00705341|12178980|FG000|COMPLETED|Phase 2: Trial||0
11001666|NCT00705341|12178981|FG001|COMPLETED|Phase 2: Trial||0
11001667|NCT00705341|12178982|FG002|COMPLETED|Phase 2: Trial||23
11001668|NCT00705341|12178983|FG003|COMPLETED|Phase 2: Trial||28
11001669|NCT00705341|12178980|FG000|NOT COMPLETED|Phase 2: Trial||0
11001670|NCT00705341|12178981|FG001|NOT COMPLETED|Phase 2: Trial||0
11001671|NCT00705341|12178982|FG002|NOT COMPLETED|Phase 2: Trial||7
11001672|NCT00705341|12178983|FG003|NOT COMPLETED|Phase 2: Trial||4
11001673|NCT00705367|12178993|FG000|STARTED|Short-term Period||6
11001674|NCT00705367|12178994|FG001|STARTED|Short-term Period||3
11001675|NCT00705367|12178993|FG000|COMPLETED|Short-term Period||6
11001676|NCT00705367|12178994|FG001|COMPLETED|Short-term Period||3
11001677|NCT00705367|12178993|FG000|NOT COMPLETED|Short-term Period||0
11001678|NCT00705367|12178994|FG001|NOT COMPLETED|Short-term Period||0
11001679|NCT00705367|12178993|FG000|STARTED|Long-term Extension Period||9
11001680|NCT00705367|12178994|FG001|STARTED|Long-term Extension Period||0
11001681|NCT00705367|12178993|FG000|COMPLETED|Long-term Extension Period||0
11001682|NCT00705367|12178994|FG001|COMPLETED|Long-term Extension Period||0
11001683|NCT00705367|12178993|FG000|NOT COMPLETED|Long-term Extension Period||9
11001684|NCT00705367|12178994|FG001|NOT COMPLETED|Long-term Extension Period||0
11001685|NCT00705406|12179004|FG000|STARTED|Overall Study||203
11001686|NCT00705406|12179005|FG001|STARTED|Overall Study||202
11001687|NCT00705406|12179004|FG000|COMPLETED|Overall Study||199
11001688|NCT00705406|12179005|FG001|COMPLETED|Overall Study||197
11001689|NCT00705406|12179004|FG000|NOT COMPLETED|Overall Study||4
11001690|NCT00705406|12179005|FG001|NOT COMPLETED|Overall Study||5
